id|nct_id|name|downcase_name
4634611|NCT03653117|BPO|bpo
4635247|NCT03649360|KOOS|koos
4636156|NCT03643939|NIV|niv
4636267|NCT03643055|PET|pet
4636405|NCT03642067|MSS|mss
4637493|NCT03635021|FOLFOX|folfox
4637615|NCT03634358|bipolar|bipolar
4637869|NCT03632694|mHealth|mhealth
4639537|NCT03621930|RSV|rsv
4639626|NCT03621410|AMS|ams
4639894|NCT03619902|GPP|gpp
4640257|NCT03617497|EEG|eeg
4640518|NCT03615781|surgery|surgery
4641023|NCT03612739|NKR-2|nkr-2
4642903|NCT03601273|obesity|obesity
4644532|NCT03590483|ART|art
4644984|NCT03587649|AD|ad
4646087|NCT03580213|ADL|adl
4646671|NCT03576729|MPS I|mps i
4647043|NCT03574701|CRS|crs
4647694|NCT03570372|ASD|asd
4647916|NCT03569254|devices|devices
4648842|NCT03563170|HCC|hcc
4649149|NCT03561064|CBT|cbt
4649829|NCT03557099|SAA|saa
4650335|NCT03553693|HIV|hiv
4651680|NCT03545425|LRRK2|lrrk2
4652223|NCT03541707|TMS|tms
4652568|NCT03539445|AIS|ais
4655713|NCT03520075|MAPK|mapk
4656197|NCT03517085|AAV|aav
4656776|NCT03513601|PR|pr
4658589|NCT03501888|ACT|act
4658765|NCT03500731|BMT|bmt
4659129|NCT03498287|CTS|cts
4661591|NCT03482258|Stress|stress
4661961|NCT03479658|fitness|fitness
4662275|NCT03477500|RCT|rct
4662461|NCT03476382|Knee|knee
4664712|NCT03462615|malaria|malaria
4664846|NCT03461510|MRI|mri
4665852|NCT03454711|Obesity|obesity
4668482|NCT03439046|ctDNA|ctdna
4670011|NCT03429712|CT Scan|ct scan
4670614|NCT03426189|PD1|pd1
4670860|NCT03424564|E2007|e2007
4671409|NCT03421340|DSC|dsc
4672196|NCT03416504|OCD|ocd
4672246|NCT03416192|MCO|mco
4672603|NCT03413800|DLI|dli
4672860|NCT03412227|CBT|cbt
4673066|NCT03410992|PSO|pso
4673515|NCT03408171|FNA|fna
4673607|NCT03407612|HOS-ADL|hos-adl
4673733|NCT03406910|egg|egg
4673999|NCT03405233|ESRD|esrd
4675409|NCT03395860|ATG|atg
4675629|NCT03394534|eFI|efi
4676336|NCT03390296|RR|rr
4676635|NCT03388411|Gut|gut
4676982|NCT03386110|MSM|msm
4677581|NCT03382457|TR|tr
4677965|NCT03380026|MF|mf
4682311|NCT03352024|CSF|csf
4683064|NCT03347162|PRO|pro
4683809|NCT03342404|NTDT|ntdt
4684305|NCT03339037|PPCS|ppcs
4684554|NCT03337594|Bone|bone
4684805|NCT03336177|aged|aged
4686555|NCT03325647|XXY|xxy
4686826|NCT03323879|LDR|ldr
4687555|NCT03319147|muscle|muscle
4688417|NCT03313986|Nesbit|nesbit
4688922|NCT03310515|MSM|msm
4689805|NCT03304691|Malaria|malaria
4690306|NCT03301467|C3GN|c3gn
4690613|NCT03299400|IOP|iop
4690845|NCT03297775|RA|ra
4691807|NCT03291613|Pain|pain
4692180|NCT03289091|aging|aging
4692311|NCT03288298|PCR|pcr
4692558|NCT03286933|JIA|jia
4693436|NCT03281135|HDSS|hdss
4694083|NCT03276871|TEP|tep
4694396|NCT03274674|PRF|prf
4694563|NCT03273465|IBD|ibd
4695129|NCT03269773|AD|ad
4697814|NCT03253146|sepsis|sepsis
4698312|NCT03249805|LMIC|lmic
4699056|NCT03244696|Walking|walking
4701078|NCT03231943|PK|pk
4701183|NCT03231072|EIT|eit
4701444|NCT03229499|PAH|pah
4702046|NCT03225703|MRI|mri
4703459|NCT03216733|DES|des
4703930|NCT03213951|Ex-vivo|ex-vivo
4705172|NCT03205761|BRCA|brca
4705462|NCT03203837|Y90|y90
4706177|NCT03199469|XLMTM|xlmtm
4707123|NCT03193671|HE4|he4
4707566|NCT03191045|MRI|mri
4707683|NCT03190265|cy|cy
4707811|NCT03189394|HIV|hiv
4708816|NCT03183037|17-298|17-298
4709059|NCT03181880|ASTUTE|astute
4710323|NCT03173391|GKA|gka
4710816|NCT03169855|Glare|glare
4712370|NCT03159364|CTL|ctl
4713069|NCT03155594|CGM|cgm
4713701|NCT03151785|CPR|cpr
4713822|NCT03150992|Ovarian|ovarian
4714198|NCT03148548|VTE|vte
4714885|NCT03143842|VNS|vns
4715069|NCT03142412|SLE|sle
4715569|NCT03138889|Bladder|bladder
4715813|NCT03137147|sleep|sleep
4716095|NCT03135366|TB|tb
4716257|NCT03134183|D&E|d&e
4716714|NCT03131362|COPD|copd
4717090|NCT03128502|GCF|gcf
4718353|NCT03119974|ITP|itp
4718835|NCT03117114|polyp|polyp
4719251|NCT03114228|AML|aml
4719341|NCT03113747|repair|repair
4721093|NCT03103269|Obesity|obesity
4722101|NCT03097315|Choroid|choroid
4725385|NCT03077841|XRT|xrt
4727767|NCT03064126|PTA|pta
4729746|NCT03050736|GBM|gbm
4730402|NCT03046641|Men|men
4731507|NCT03039907|Knee|knee
4731636|NCT03038776|vaccine|vaccine
4733140|NCT03029507|Obesity|obesity
4733569|NCT03027193|MAP|map
4733888|NCT03025256|LMD|lmd
4734633|NCT03020433|CVA|cva
4735899|NCT03012724|TMS|tms
4738429|NCT02997046|MRI|mri
4739611|NCT02988843|GCT|gct
4740288|NCT02984787|3D|3d
4741521|NCT02977637|hht|hht
4741894|NCT02975765|pain|pain
4742398|NCT02972658|Memory|memory
4742656|NCT02971072|motor|motor
4744911|NCT02956993|PAD|pad
4745315|NCT02954653|AML|aml
4745530|NCT02953522|Folate|folate
4746047|NCT02950051|CLL|cll
4746221|NCT02949011|Flu|flu
4746429|NCT02947685|HR+|hr+
4749307|NCT02929017|IPF|ipf
4749590|NCT02927587|TCI|tci
4750439|NCT02922673|LPS|lps
4751335|NCT02917707|CRC|crc
4751440|NCT02916992|BHD|bhd
4752861|NCT02907788|PMN|pmn
4754201|NCT02898987|HIV|hiv
4754450|NCT02897141|HIV|hiv
4755065|NCT02893176|BOS|bos
4756575|NCT02883439|MP29-02|mp29-02
4757952|NCT02874885|CTC|ctc
4758995|NCT02867891|AML|aml
4759090|NCT02867085|MDS|mds
4759958|NCT02862067|SGLT2|sglt2
4760963|NCT02855515|AHI|ahi
4761347|NCT02853396|CBT|cbt
4761598|NCT02851706|Glioma|glioma
4761966|NCT02849249|allergy|allergy
4762605|NCT02845765|ED|ed
4762729|NCT02845011|CPR|cpr
4763630|NCT02839330|Flu|flu
4764313|NCT02834637|HPV|hpv
4764456|NCT02833805|ATG|atg
4764489|NCT02833519|anxiety|anxiety
4764751|NCT02831959|TTF|ttf
4764871|NCT02831296|SMA|sma
4766759|NCT02819570|EOS|eos
4767883|NCT02813031|obesity|obesity
4770519|NCT02797821|HPP|hpp
4772211|NCT02787811|IUI|iui
4773432|NCT02781220|MCI|mci
4773811|NCT02779478|NTM|ntm
4774055|NCT02777775|NF1|nf1
4774816|NCT02773303|EEG|eeg
4775952|NCT02766049|HIV|hiv
4776188|NCT02764671|safety|safety
4777569|NCT02756897|ABT-199|abt-199
4777697|NCT02756013|BSA|bsa
4778963|NCT02747888|Thyroid|thyroid
4779586|NCT02744053|MBI|mbi
4779935|NCT02742090|CLL|cll
4781213|NCT02733692|women|women
4781456|NCT02732184|AML|aml
4781845|NCT02729987|CBT|cbt
4782779|NCT02724449|IAD|iad
4783387|NCT02720796|PDX|pdx
4784912|NCT02711917|BIS|bis
4786087|NCT02704325|DMD|dmd
4786106|NCT02704130|TAE|tae
4786366|NCT02702505|Pulp|pulp
4787369|NCT02696733|ONB|onb
4788540|NCT02690103|HCV|hcv
4789501|NCT02684201|Implant|implant
4790632|NCT02676778|E7777|e7777
4791655|NCT02669888|TCM|tcm
4792383|NCT02665104|TCD|tcd
4794415|NCT02654171|RSV|rsv
4795658|NCT02646865|shame|shame
4797589|NCT02635321|MRI|mri
4797787|NCT02634450|HIV|hiv
4798288|NCT02631876|ADC|adc
4798852|NCT02628912|HPV|hpv
4799792|NCT02623959|MPE|mpe
4800011|NCT02622607|ZOL|zol
4800339|NCT02620631|TKA|tka
4800551|NCT02619383|DCE|dce
4800678|NCT02618707|CPB|cpb
4802905|NCT02604017|HCV|hcv
4802960|NCT02603835|PCI|pci
4803322|NCT02601820|HCV|hcv
4804081|NCT02597374|Child|child
4805332|NCT02589847|CDI|cdi
4805839|NCT02586935|ASD|asd
4805953|NCT02586194|ASP015K|asp015k
4807084|NCT02579096|CKD|ckd
4808096|NCT02573831|labor|labor
4808228|NCT02573155|AZD8871|azd8871
4810209|NCT02561715|DBS|dbs
4810475|NCT02560233|EEG|eeg
4812093|NCT02550171|DNA|dna
4812345|NCT02548793|CPR|cpr
4813103|NCT02544022|QOL|qol
4813221|NCT02543320|EEG|eeg
4813471|NCT02541773|miRNA|mirna
4815516|NCT02529306|men|men
4816098|NCT02525354|atopy|atopy
4817087|NCT02519283|ER|er
4817363|NCT02517593|PRS|prs
4818215|NCT02512328|APP|app
4820005|NCT02502240|ALK|alk
4820998|NCT02496637|Obesity|obesity
4821637|NCT02493283|dapsone|dapsone
4821886|NCT02491814|Soy|soy
4822149|NCT02489812|anxiety|anxiety
4823266|NCT02483611|Onset|onset
4823997|NCT02479243|MRI|mri
4824611|NCT02475707|ALL|all
4824773|NCT02474667|DGF|dgf
4825154|NCT02472691|MDS|mds
4827059|NCT02462239|FDG|fdg
4828767|NCT02451683|SCI|sci
4828864|NCT02451085|hip|hip
4829327|NCT02448381|MF|mf
4829435|NCT02447536|BCG|bcg
4830703|NCT02440685|DLBCL|dlbcl
4830826|NCT02439944|Tobacco|tobacco
4834133|NCT02421653|MNP|mnp
4834236|NCT02421133|elderly|elderly
4839403|NCT02392754|ECG|ecg
4840051|NCT02389101|MRI|mri
4840140|NCT02388490|EBV|ebv
4840392|NCT02387229|Stroke|stroke
4840532|NCT02386423|RLS|rls
4841949|NCT02378701|MDS|mds
4843561|NCT02369263|DVT|dvt
4844449|NCT02364063|child|child
4845352|NCT02358980|HFR|hfr
4845588|NCT02357784|SNM|snm
4846093|NCT02354586|HRD|hrd
4846196|NCT02354131|PARP|parp
4846941|NCT02349711|allergy|allergy
4847232|NCT02347904|S-1|s-1
4847860|NCT02344589|ACB|acb
4849093|NCT02337322|HIV|hiv
4849836|NCT02332668|PD1|pd1
4849963|NCT02331966|FGF-23|fgf-23
4850707|NCT02327546|HIF|hif
4852088|NCT02320604|Obesity|obesity
4852536|NCT02318030|EBV|ebv
4853209|NCT02314481|ALK|alk
4854333|NCT02307799|tobacco|tobacco
4855588|NCT02301104|LFT|lft
4856846|NCT02293746|OSA|osa
4858073|NCT02287116|BPD|bpd
4858197|NCT02286414|Safety|safety
4858439|NCT02285023|CU-Q2oL|cu-q2ol
4859595|NCT02278536|XXX|xxx
4859957|NCT02276547|Mitral|mitral
4860318|NCT02274207|foot|foot
4860870|NCT02271074|HIV|hiv
4861486|NCT02267629|OCD|ocd
4861843|NCT02265614|PGS|pgs
4862871|NCT02258945|NHS|nhs
4863926|NCT02253108|DES|des
4864811|NCT02248571|HR+|hr+
4865054|NCT02247440|HCV|hcv
4865781|NCT02244164|RMN|rmn
4866803|NCT02239211|PSC|psc
4866973|NCT02238509|MBC|mbc
4867045|NCT02238002|SS-OCT|ss-oct
4867251|NCT02237066|OCT|oct
4868599|NCT02231008|SMS|sms
4870024|NCT02225028|SCI|sci
4870241|NCT02224235|PCI|pci
4870349|NCT02223767|TMS|tms
4873702|NCT02208466|TMS|tms
4875386|NCT02200848|CLL|cll
4875548|NCT02200159|ICU|icu
4875860|NCT02198664|OIT|oit
4876619|NCT02195063|UDT|udt
4877380|NCT02191826|TTR|ttr
4877985|NCT02189447|Ectasia|ectasia
4878483|NCT02187510|Milking|milking
4879171|NCT02184624|MDI|mdi
4880627|NCT02175862|ISS|iss
4881409|NCT02171104|IMD|imd
4881965|NCT02168413|EEG|eeg
4881988|NCT02168244|ice|ice
4882356|NCT02166502|HIV|hiv
4882987|NCT02163525|GFA|gfa
4883136|NCT02162849|NRT|nrt
4883985|NCT02159001|ECT|ect
4886000|NCT02149589|ARDS|ards
4887109|NCT02144532|pain|pain
4888564|NCT02137915|AMD|amd
4889116|NCT02135094|Sam|sam
4889497|NCT02133586|Ozone|ozone
4889999|NCT02131142|CAD|cad
4890364|NCT02129699|NSCLC|nsclc
4891526|NCT02124486|IIH|iih
4891720|NCT02123498|LPR|lpr
4891968|NCT02122445|TFL|tfl
4892608|NCT02119754|Wound|wound
4893479|NCT02115919|HIV|hiv
4894595|NCT02111681|13-174|13-174
4896492|NCT02103478|MDS|mds
4898137|NCT02096055|AML|aml
4898378|NCT02095015|MPS I|mps i
4899509|NCT02089802|RCC|rcc
4900983|NCT02082678|BPD|bpd
4901990|NCT02077985|autism|autism
4902418|NCT02076282|MRI|mri
4903480|NCT02071394|HIE|hie
4903808|NCT02069847|EMR|emr
4905542|NCT02061917|Tobacco|tobacco
4906190|NCT02059031|HIV|hiv
4906377|NCT02058212|ROS|ros
4907657|NCT02052453|ICD|icd
4907920|NCT02051283|RFA|rfa
4908351|NCT02049437|HIV|hiv
4908658|NCT02048085|ACS|acs
4909447|NCT02044822|CLL|cll
4911414|NCT02036177|IUB|iub
4911683|NCT02034838|PK|pk
4912426|NCT02031198|tau|tau
4913274|NCT02027506|ECG|ecg
4913787|NCT02025218|TKI|tki
4914773|NCT02020382|IBD|ibd
4915047|NCT02019147|HIE|hie
4915932|NCT02015208|CLL|cll
4916208|NCT02014246|DNA|dna
4917763|NCT02007317|BCC|bcc
4918958|NCT02001649|SNP|snp
4919278|NCT02000284|ASD|asd
4921021|NCT01992289|HED|hed
4922277|NCT01986348|GBM|gbm
4922692|NCT01984294|HCV|hcv
4922987|NCT01983293|QLV|qlv
4923415|NCT01981486|safety|safety
4923754|NCT01979692|CLM|clm
4924369|NCT01977092|HIV|hiv
4924549|NCT01976429|flying|flying
4927804|NCT01962272|cancer|cancer
4928917|NCT01956513|ADC|adc
4929409|NCT01954277|TNF|tnf
4929660|NCT01953068|POCD|pocd
4931811|NCT01943006|MPS|mps
4932069|NCT01941849|RET|ret
4932282|NCT01940848|safety|safety
4932543|NCT01939665|IRE|ire
4933914|NCT01933256|HIP2B|hip2b
4934773|NCT01928966|women|women
4934932|NCT01928238|NIV|niv
4935191|NCT01927159|TB|tb
4935541|NCT01925469|HSG|hsg
4936035|NCT01923402|Tobacco|tobacco
4936677|NCT01920360|VAS|vas
4936862|NCT01919723|PCI|pci
4937789|NCT01915563|Weaning|weaning
4938959|NCT01909869|TVR|tvr
4939794|NCT01905475|AMI|ami
4940276|NCT01903447|MRI|mri
4941404|NCT01898065|MRI|mri
4941587|NCT01896973|BPH|bph
4941775|NCT01895920|HIV|hiv
4942267|NCT01893996|tnf|tnf
4943291|NCT01889862|PKU|pku
4944032|NCT01886378|TFP|tfp
4944154|NCT01885767|NF|nf
4944277|NCT01885299|Lung|lung
4945917|NCT01878474|MT-8995|mt-8995
4949156|NCT01863615|Mexico|mexico
4951826|NCT01852487|Men|men
4953125|NCT01846793|BPH|bph
4953720|NCT01843920|eye|eye
4955097|NCT01837446|pain|pain
4955334|NCT01836393|Plai|plai
4956353|NCT01831726|Trk|trk
4956487|NCT01831115|BNP|bnp
4956593|NCT01830673|IL2|il2
4957538|NCT01826474|DMD|dmd
4957856|NCT01824888|JUC|juc
4958364|NCT01822626|obesity|obesity
4958999|NCT01819597|Stroke|stroke
4959488|NCT01817114|PCI|pci
4959616|NCT01816542|allergy|allergy
4959874|NCT01815463|FIT|fit
4960115|NCT01814514|AGV|agv
4960759|NCT01811459|ICU|icu
4960984|NCT01810354|obese|obese
4962897|NCT01802177|UVB|uvb
4963257|NCT01800344|LMA|lma
4966630|NCT01785186|TB|tb
4966876|NCT01784055|MR|mr
4967009|NCT01783314|Eovist|eovist
4967752|NCT01779765|IBS|ibs
4968668|NCT01775930|RCC|rcc
4969020|NCT01774318|aEEG|aeeg
4969571|NCT01772017|OSA|osa
4971630|NCT01762826|GDM|gdm
4971998|NCT01761045|Satiety|satiety
4972292|NCT01759615|SGA|sga
4973126|NCT01755624|TTF|ttf
4973652|NCT01753011|TOT|tot
4974415|NCT01749280|MRI|mri
4975546|NCT01744093|HIV|hiv
4975897|NCT01742676|kidney|kidney
4976025|NCT01742156|CAD|cad
4976276|NCT01741012|Lupus|lupus
4976536|NCT01740115|HIV|hiv
4978299|NCT01732341|BMS|bms
4978495|NCT01731405|FDA|fda
4978568|NCT01731132|IUD|iud
4978907|NCT01729416|air|air
4980299|NCT01723215|combat|combat
4980433|NCT01722552|HIV|hiv
4980585|NCT01721733|EPI743|epi743
4982070|NCT01715389|Asthma|asthma
4982251|NCT01714635|IOL|iol
4984466|NCT01704781|CD4|cd4
4984967|NCT01702922|Stress|stress
4985129|NCT01702194|OIC|oic
4985643|NCT01700153|ICF|icf
4986484|NCT01696084|AML|aml
4988503|NCT01687179|LAM|lam
4990374|NCT01679054|Cost|cost
4990630|NCT01678105|ACC|acc
4993589|NCT01664910|ATG|atg
4993799|NCT01663805|DGF|dgf
4994659|NCT01659697|BMI|bmi
4995191|NCT01656993|ASA|asa
4995325|NCT01656564|HIV|hiv
4996300|NCT01651975|DSS|dss
4996749|NCT01649960|CAD|cad
4996930|NCT01649115|growth|growth
4999428|NCT01637259|HIV|hiv
4999522|NCT01636726|AMI|ami
5000088|NCT01634126|FIT|fit
5000390|NCT01632605|m-TOR|m-tor
5001512|NCT01627548|OIF|oif
5001762|NCT01626287|pain|pain
5003188|NCT01619956|RCT|rct
5003646|NCT01618435|ODI|odi
5004532|NCT01614522|HER-1|her-1
5004678|NCT01613976|MDS|mds
5004910|NCT01612689|EMU|emu
5005201|NCT01611285|FDA|fda
5005562|NCT01609933|HCV|hcv
5005758|NCT01609465|CAD|cad
5007725|NCT01600872|TAS|tas
5008896|NCT01596218|Acute|acute
5010836|NCT01587703|NMC|nmc
5012795|NCT01579617|STI|sti
5013295|NCT01577472|IVF|ivf
5015766|NCT01567202|Vaccine|vaccine
5019393|NCT01551706|SOD|sod
5019589|NCT01550809|CGM|cgm
5019941|NCT01549444|renin|renin
5020885|NCT01545648|DTC|dtc
5021133|NCT01544712|hip|hip
5022812|NCT01537471|PPI|ppi
5023412|NCT01534819|AAA|aaa
5023917|NCT01532388|Alcohol|alcohol
5024065|NCT01531842|CNV|cnv
5025319|NCT01526486|urology|urology
5025999|NCT01523496|HIV|hiv
5026335|NCT01521975|LdT|ldt
5027391|NCT01517724|MM|mm
5027684|NCT01516515|AK|ak
5027807|NCT01515956|LSD|lsd
5029563|NCT01508273|HRQOL|hrqol
5030705|NCT01503879|SPB|spb
5031594|NCT01500161|AML|aml
5031957|NCT01498458|GBG|gbg
5033688|NCT01491217|MTD|mtd
5035314|NCT01484678|Muscle|muscle
5035991|NCT01481675|PYY|pyy
5037071|NCT01477476|DKA|dka
5037460|NCT01475591|neck|neck
5038081|NCT01473173|Safety|safety
5038231|NCT01472627|MM|mm
5040009|NCT01465360|AD|ad
5042074|NCT01456780|MGD|mgd
5043857|NCT01449188|Zofran|zofran
5043984|NCT01448707|HIV|hiv
5045764|NCT01441609|IL9|il9
5046994|NCT01436851|ECP|ecp
5049542|NCT01426880|GBG|gbg
5049623|NCT01426581|Asthma|asthma
5050516|NCT01423006|RFA|rfa
5051563|NCT01419119|D3|d3
5052123|NCT01416558|GBG|gbg
5052759|NCT01413841|PCI|pci
5053516|NCT01410942|MMT|mmt
5056489|NCT01398969|CDI|cdi
5056525|NCT01398813|HED|hed
5058050|NCT01392014|DHP|dhp
5058173|NCT01391507|COR-1|cor-1
5058919|NCT01388244|Women|women
5059287|NCT01386762|obesity|obesity
5060683|NCT01380665|hip|hip
5060785|NCT01380301|Therapy|therapy
5061190|NCT01378637|Leg|leg
5061797|NCT01376336|water|water
5063062|NCT01370954|NAC|nac
5064331|NCT01365676|PMS|pms
5065339|NCT01361724|PD|pd
5065700|NCT01360320|EGCG|egcg
5066612|NCT01356160|HCV|hcv
5066687|NCT01355861|aging|aging
5067578|NCT01352091|AI|ai
5067833|NCT01350960|LDL|ldl
5068208|NCT01349465|TMC435|tmc435
5068835|NCT01347112|smoking|smoking
5069492|NCT01344447|MRA|mra
5070082|NCT01341730|PET CT|pet ct
5070209|NCT01341132|HCC|hcc
5070582|NCT01339676|MRI|mri
5070925|NCT01338129|rds|rds
5072713|NCT01330758|Phase I|phase i
5072836|NCT01330238|RCT|rct
5073221|NCT01328561|Placebo|placebo
5074866|NCT01321710|infant|infant
5075357|NCT01319799|Aorta|aorta
5076685|NCT01314664|CIS|cis
5077932|NCT01309334|MRI|mri
5078335|NCT01307488|HIV|hiv
5079657|NCT01302418|RSV|rsv
5079789|NCT01302028|ASP1941|asp1941
5080779|NCT01297569|DME|dme
5081640|NCT01294215|14024|14024
5081800|NCT01293565|HED|hed
5082270|NCT01291628|Socks|socks
5082665|NCT01290029|CKD|ckd
5085169|NCT01278771|CHD|chd
5086452|NCT01273662|HCC|hcc
5086676|NCT01273064|HCV|hcv
5086979|NCT01271790|HCV|hcv
5088610|NCT01264679|CKD|ckd
5089392|NCT01261312|AML|aml
5089760|NCT01259713|ALL|all
5090501|NCT01256203|PDT|pdt
5091844|NCT01250171|Dry eye|dry eye
5092582|NCT01246817|FLT-PET|flt-pet
5093010|NCT01244763|CKD|ckd
5093197|NCT01243788|COPD|copd
5093824|NCT01241214|SAR|sar
5093940|NCT01240694|SLE|sle
5094084|NCT01240161|FLT|flt
5096339|NCT01230567|BCC|bcc
5096570|NCT01229579|OPV|opv
5098440|NCT01220817|psa|psa
5099042|NCT01218152|NF1|nf1
5099314|NCT01217060|XRT|xrt
5099532|NCT01216176|PK|pk
5099657|NCT01215630|Veins|veins
5100810|NCT01210846|QTc|qtc
5101186|NCT01209039|PET|pet
5101276|NCT01208701|L-NMMA|l-nmma
5102150|NCT01204801|Surgery|surgery
5103270|NCT01200537|IVF|ivf
5103459|NCT01199939|HIV|hiv
5104531|NCT01195246|HBV|hbv
5105772|NCT01190423|AN|an
5105875|NCT01189955|RLN|rln
5105993|NCT01189396|asthma|asthma
5107121|NCT01184703|HbA1c|hba1c
5108170|NCT01180582|RSA|rsa
5108714|NCT01178190|NBI|nbi
5108863|NCT01177410|IBS|ibs
5109768|NCT01173913|MTD|mtd
5113065|NCT01160354|AML|aml
5113899|NCT01156584|GBM|gbm
5114629|NCT01153737|TENS|tens
5115098|NCT01151657|IBS|ibs
5116088|NCT01147718|digoxin|digoxin
5116584|NCT01145573|bone|bone
5117075|NCT01143493|HV|hv
5117456|NCT01141933|QOL|qol
5118311|NCT01138358|dyspnea|dyspnea
5118416|NCT01138046|ErbB2|erbb2
5119201|NCT01135914|DME|dme
5119319|NCT01135368|GERD|gerd
5121352|NCT01126814|aml|aml
5122233|NCT01123161|tPA|tpa
5122488|NCT01121952|ROM|rom
5123233|NCT01118767|web|web
5126745|NCT01105117|PAH|pah
5128794|NCT01096784|ROP|rop
5132445|NCT01082536|NIRS|nirs
5134420|NCT01074749|AF|af
5135122|NCT01071811|Stress|stress
5135786|NCT01068873|HIV|hiv
5136494|NCT01066065|HIV|hiv
5136606|NCT01065467|LBH589|lbh589
5138347|NCT01058239|PTLD|ptld
5139002|NCT01055483|AML|aml
5139242|NCT01054456|LEC|lec
5141333|NCT01047553|COPD|copd
5142193|NCT01044186|ICL670A|icl670a
5142948|NCT01041235|Breast|breast
5143439|NCT01039402|France|france
5143936|NCT01037452|PPI|ppi
5144129|NCT01036087|IBC|ibc
5144437|NCT01034709|CMV|cmv
5145515|NCT01030536|NHL|nhl
5145909|NCT01029002|CKD|ckd
5146286|NCT01027182|HIV|hiv
5146763|NCT01025206|safety|safety
5147239|NCT01023295|PCV|pcv
5147756|NCT01021189|AD|ad
5147879|NCT01020695|EEG|eeg
5148856|NCT01016093|HSCT|hsct
5148987|NCT01015924|TEN|ten
5151452|NCT01006005|HIV|hiv
5153051|NCT00999544|opioid|opioid
5154143|NCT00995709|uveitis|uveitis
5154636|NCT00993733|cost|cost
5155081|NCT00992459|UCD|ucd
5156199|NCT00987974|statins|statins
5156814|NCT00985647|HIV|hiv
5157203|NCT00984152|HIV|hiv
5157334|NCT00983983|ALS|als
5157570|NCT00983060|HCV|hcv
5157653|NCT00982774|PKDL|pkdl
5157815|NCT00982007|IDA|ida
5159407|NCT00975845|ACL|acl
5159629|NCT00974961|HRV|hrv
5159790|NCT00974402|OEF|oef
5159894|NCT00974064|Smoker|smoker
5161223|NCT00968747|Fasting|fasting
5161602|NCT00967421|DUI|dui
5161727|NCT00967044|NHL|nhl
5162212|NCT00964873|Synta|synta
5162912|NCT00962715|CLL|cll
5163533|NCT00960167|HCC|hcc
5164211|NCT00957671|TBI|tbi
5165067|NCT00954733|Co2|co2
5165158|NCT00954148|cancer|cancer
5166351|NCT00950092|AF|af
5170657|NCT00934505|FDG|fdg
5171354|NCT00931242|eczema|eczema
5171726|NCT00929682|Opiates|opiates
5172103|NCT00928213|IUGR|iugr
5172726|NCT00925587|CKD|ckd
5174567|NCT00918983|BPH|bph
5174802|NCT00917956|IBM|ibm
5175086|NCT00916838|MRI|mri
5175203|NCT00916409|GBM|gbm
5175427|NCT00915512|Invega|invega
5175646|NCT00914628|GvL|gvl
5176856|NCT00909584|SCN|scn
5177596|NCT00906399|MS|ms
5177672|NCT00906061|ECOG 2|ecog 2
5178195|NCT00904332|HV|hv
5178894|NCT00901550|MTX|mtx
5179481|NCT00900159|MWT|mwt
5179852|NCT00900029|VLU|vlu
5181722|NCT00896883|implant|implant
5182352|NCT00894569|CUP|cup
5182618|NCT00893412|HSG|hsg
5183574|NCT00890097|GA|ga
5183907|NCT00888966|outcome|outcome
5184287|NCT00887211|stent|stent
5184761|NCT00885508|MDS|mds
5186002|NCT00880269|AML|aml
5186444|NCT00878579|DDD|ddd
5187020|NCT00876499|Fatigue|fatigue
5187628|NCT00873860|CAT-354|cat-354
5189614|NCT00866281|AML|aml
5192274|NCT00854984|CBT|cbt
5193206|NCT00851292|biopsy|biopsy
5193439|NCT00850707|AVF|avf
5194217|NCT00847379|DMD|dmd
5194571|NCT00846014|MRI|mri
5196105|NCT00839436|ICL|icl
5196916|NCT00836394|JIA|jia
5198530|NCT00829439|L-dopa|l-dopa
5198985|NCT00827736|botox|botox
5200302|NCT00823147|Pain|pain
5201304|NCT00819221|phase I|phase i
5201537|NCT00818636|alcohol|alcohol
5201691|NCT00818038|MS|ms
5201770|NCT00817791|NSE|nse
5202136|NCT00816504|FSGS|fsgs
5203807|NCT00810576|NHL|nhl
5204400|NCT00808418|cancer|cancer
5204646|NCT00807378|PCR|pcr
5204837|NCT00806754|PAR|par
5206207|NCT00800943|CLL|cll
5207427|NCT00796211|CRx-197|crx-197
5208295|NCT00792233|TNF|tnf
5209157|NCT00788957|AMG 102|amg 102
5210098|NCT00786019|2|2
5213840|NCT00770237|Smoking|smoking
5214283|NCT00768846|PCI|pci
5215378|NCT00763737|feto|feto
5215995|NCT00761098|SBP|sbp
5216285|NCT00759876|DMD|dmd
5217575|NCT00754247|HSE|hse
5217910|NCT00752999|SLE|sle
5217948|NCT00752856|Adult|adult
5219191|NCT00748943|saliva|saliva
5219829|NCT00746369|HIV|hiv
5220067|NCT00745394|CPB|cpb
5220568|NCT00743535|TOT|tot
5220693|NCT00743067|XL880|xl880
5221695|NCT00739531|eNO|eno
5222315|NCT00737438|STOMACH|stomach
5223195|NCT00734526|XRT|xrt
5223538|NCT00733239|opioid|opioid
5224537|NCT00729053|renal|renal
5224841|NCT00728039|CVS|cvs
5226106|NCT00723320|ABI|abi
5226715|NCT00720850|MDS|mds
5227078|NCT00719745|MR4|mr4
5228512|NCT00714870|BMI|bmi
5229459|NCT00711399|Wheeze|wheeze
5230481|NCT00707434|ICU|icu
5230959|NCT00705094|VO2peak|vo2peak
5232863|NCT00696761|BPH|bph
5233092|NCT00695708|MEG|meg
5235164|NCT00688168|IVR|ivr
5235379|NCT00687245|reflux|reflux
5235510|NCT00686556|ALL|all
5239624|NCT00670917|pain|pain
5239745|NCT00670384|SAR|sar
5241284|NCT00664443|CPR|cpr
5241420|NCT00663806|UTI|uti
5242244|NCT00660764|CVA|cva
5242863|NCT00658281|CBCT|cbct
5243364|NCT00656175|fat|fat
5243460|NCT00655785|CTL|ctl
5243961|NCT00654147|HIV|hiv
5244095|NCT00653601|GPI|gpi
5244702|NCT00651352|NRT|nrt
5246863|NCT00640003|AT|at
5248337|NCT00633958|FLT|flt
5248713|NCT00632515|CRC|crc
5248822|NCT00632086|PK|pk
5251065|NCT00623506|TBI|tbi
5251372|NCT00622440|TCM|tcm
5251741|NCT00621023|MDS|mds
5254531|NCT00610181|MRI|mri
5254734|NCT00609401|RCC|rcc
5255566|NCT00605982|MRI|mri
5255679|NCT00605319|BPH|bph
5255902|NCT00604201|MDS|mds
5256631|NCT00601237|HIV|hiv
5256772|NCT00600639|NIV|niv
5256928|NCT00599937|APL|apl
5258069|NCT00594893|Hip|hip
5258265|NCT00593944|CLL|cll
5258813|NCT00591526|APL|apl
5260448|NCT00584818|SPECT|spect
5261197|NCT00581425|BCC|bcc
5261329|NCT00580814|PET|pet
5262442|NCT00576147|TBI|tbi
5262553|NCT00575614|QOL|qol
5263376|NCT00571961|HIV|hiv
5263615|NCT00570999|Placebo|placebo
5264433|NCT00567463|Asthma|asthma
5264562|NCT00566917|Vagina|vagina
5264809|NCT00566085|MBI|mbi
5265178|NCT00564174|aspirin|aspirin
5265644|NCT00562276|IUD|iud
5266371|NCT00559091|AML|aml
5266864|NCT00557050|Muscles|muscles
5267159|NCT00555698|DBS|dbs
5268100|NCT00551928|CD34|cd34
5268228|NCT00551356|Insulin|insulin
5268714|NCT00549081|IVF|ivf
5269298|NCT00545987|HIV|hiv
5269944|NCT00544102|SLE|sle
5270771|NCT00539994|Altabax|altabax
5271030|NCT00538915|PID|pid
5271643|NCT00538278|AML|aml
5271990|NCT00536796|NIS|nis
5272345|NCT00535262|Bipolar|bipolar
5272581|NCT00534352|HIV|hiv
5273219|NCT00531557|HIV|hiv
5273924|NCT00528619|Phase 1|phase 1
5274927|NCT00525057|Leg|leg
5275518|NCT00522964|Obesity|obesity
5275638|NCT00522535|EVAR|evar
5276200|NCT00520702|TRP|trp
5276483|NCT00519311|RCT|rct
5276732|NCT00518219|TW|tw
5279574|NCT00508222|HIV|hiv
5280430|NCT00505245|IVR|ivr
5281415|NCT00501982|RDS|rds
5281778|NCT00500812|rho|rho
5281992|NCT00500123|AAT|aat
5282256|NCT00499707|HbA1c|hba1c
5282526|NCT00499278|hip|hip
5283372|NCT00496132|CLL|cll
5284440|NCT00492141|L9-NC|l9-nc
5284697|NCT00491075|RCC|rcc
5284820|NCT00490503|DCE-MRI|dce-mri
5285205|NCT00489034|HIV|hiv
5285331|NCT00488592|MDS|mds
5286073|NCT00485836|CRVO|crvo
5286487|NCT00484029|TMD|tmd
5286617|NCT00483769|FEV1%|fev1%
5286676|NCT00483509|SCLC|sclc
5288656|NCT00476216|VTE|vte
5290001|NCT00471302|Malaria|malaria
5290393|NCT00470028|TMS|tms
5290595|NCT00469352|AMD|amd
5291149|NCT00467090|PD|pd
5292332|NCT00462761|RTK|rtk
5292556|NCT00462085|emg|emg
5293816|NCT00457262|LDL|ldl
5294161|NCT00455923|mild|mild
5294645|NCT00453973|CKD|ckd
5295055|NCT00453180|PDD NOS|pdd nos
5295314|NCT00452127|NHL|nhl
5296488|NCT00448084|HV|hv
5296735|NCT00447005|PK|pk
5296846|NCT00446602|MDS|mds
5297010|NCT00445978|SCD|scd
5298030|NCT00443950|Chinese|chinese
5298375|NCT00442975|CMV|cmv
5298634|NCT00442806|AMI|ami
5301371|NCT00433108|ALT|alt
5302442|NCT00429169|MDD|mdd
5303478|NCT00425607|FTI|fti
5303816|NCT00424216|HV|hv
5304023|NCT00423813|FMS|fms
5304106|NCT00423605|FMS|fms
5304226|NCT00423189|LUV|luv
5304585|NCT00421668|HIV|hiv
5308330|NCT00408512|gene|gene
5308962|NCT00405379|RSA|rsa
5309979|NCT00401648|POC|poc
5310065|NCT00401258|IBS|ibs
5310457|NCT00399763|SUD|sud
5311035|NCT00397280|HV|hv
5311918|NCT00393822|KGF|kgf
5312392|NCT00392132|HIV|hiv
5313022|NCT00389753|Scars|scars
5313710|NCT00387348|fatigue|fatigue
5313961|NCT00386542|safety|safety
5315356|NCT00380887|MPA|mpa
5315769|NCT00378976|MSM|msm
5316655|NCT00376870|PCI|pci
5317328|NCT00374582|Ascites|ascites
5317937|NCT00372489|Hb|hb
5319634|NCT00365612|HIV|hiv
5320088|NCT00364390|CAD|cad
5320488|NCT00362492|TKR|tkr
5321376|NCT00359385|PTH|pth
5321582|NCT00358696|hiv|hiv
5321945|NCT00357266|Uveitis|uveitis
5322283|NCT00356265|L-NMMA|l-nmma
5322782|NCT00354523|MTC|mtc
5325032|NCT00345839|CKD|ckd
5325110|NCT00345605|ASA|asa
5326238|NCT00341484|HIV|hiv
5327055|NCT00339196|AML|aml
5328142|NCT00334529|Flu|flu
5328239|NCT00334230|fMRI|fmri
5329808|NCT00327613|PEX|pex
5329882|NCT00327262|Ph+|ph+
5332538|NCT00317317|IVF|ivf
5333418|NCT00314028|Men|men
5333983|NCT00311779|Ova|ova
5334625|NCT00309465|Surgery|surgery
5334875|NCT00308087|NHL|nhl
5335002|NCT00307606|Seroma|seroma
5335375|NCT00306189|RANKL|rankl
5335960|NCT00304395|CAP|cap
5336539|NCT00302341|Dyspnea|dyspnea
5337085|NCT00300573|DFC|dfc
5337224|NCT00300040|PVD|pvd
5337328|NCT00299689|Ontak|ontak
5337705|NCT00298350|ART|art
5338105|NCT00296777|EEG|eeg
5338631|NCT00295646|BMD|bmd
5338875|NCT00294632|CC-5013|cc-5013
5340244|NCT00290498|AD|ad
5340879|NCT00287768|S-1|s-1
5341315|NCT00285883|HIV|hiv
5341604|NCT00284453|ICD|icd
5342074|NCT00282347|LN|ln
5342559|NCT00281619|MPA|mpa
5342694|NCT00280826|OCT|oct
5344670|NCT00272519|HIV|hiv
5346528|NCT00265486|EPO|epo
5346981|NCT00263237|T Cell|t cell
5348559|NCT00256490|PET/CT|pet/ct
5349332|NCT00254046|HIV|hiv
5350033|NCT00251459|CNV|cnv
5350342|NCT00250185|HV|hv
5350840|NCT00248469|HIV|hiv
5353327|NCT00237796|Older|older
5355052|NCT00230607|GL3|gl3
5355211|NCT00229814|MRI|mri
5355548|NCT00228215|mothers|mothers
5355722|NCT00227500|HIV|hiv
5355786|NCT00227136|5HIAA|5hiaa
5356347|NCT00224367|hip|hip
5357280|NCT00220467|MCI|mci
5358422|NCT00213785|ANP|anp
5359675|NCT00208468|Hip|hip
5360059|NCT00206518|AC|ac
5360663|NCT00202813|CVC|cvc
5361041|NCT00201058|urban|urban
5361441|NCT00199329|PCA|pca
5361792|NCT00197678|HIV|hiv
5363314|NCT00187941|MMF|mmf
5363553|NCT00186784|TMS|tms
5364413|NCT00182078|burns|burns
5367909|NCT00164762|HIV|hiv
5368299|NCT00162864|asthma|asthma
5369211|NCT00158665|Flu|flu
5370166|NCT00154154|BPD|bpd
5370432|NCT00152737|Surgery|surgery
5371035|NCT00149357|VTE|vte
5372171|NCT00144352|Malaria|malaria
5372741|NCT00140998|GH|gh
5374655|NCT00132535|IPT|ipt
5375112|NCT00130910|HIV|hiv
5375774|NCT00128505|PMD|pmd
5376904|NCT00124111|CMF|cmf
5377043|NCT00123448|HV|hv
5378122|NCT00119496|Asthma|asthma
5378493|NCT00118027|Anaemia|anaemia
5378997|NCT00116376|GBM|gbm
5379622|NCT00114400|CVD|cvd
5380796|NCT00110188|cancer|cancer
5381306|NCT00024635|Anxiety|anxiety
5382294|NCT00105781|Nurses|nurses
5382666|NCT00104585|PD|pd
5382772|NCT00104299|MPA|mpa
5383245|NCT00102440|tophi|tophi
5383658|NCT00100919|HV|hv
5384663|NCT00097214|IV|iv
5385463|NCT00094380|SLE|sle
5385744|NCT00093379|XRT|xrt
5385908|NCT00092235|cGVHD|cgvhd
5386465|NCT00091533|fMRI|fmri
5389728|NCT00088218|AML|aml
5390269|NCT00087763|AMD|amd
5391475|NCT00085917|HIV|hiv
5391672|NCT00085696|NHL|nhl
5391977|NCT00084279|Liver|liver
5393245|NCT00083395|Heart|heart
5393864|NCT00083330|Healthy|healthy
5395228|NCT00003646|cancer|cancer
5395333|NCT00003239|HHT|hht
5399948|NCT00079768|IBM|ibm
5400436|NCT00079313|CML|cml
5401100|NCT00078546|EBV|ebv
5403525|NCT00075088|Cardiac|cardiac
5403645|NCT00074763|ALL|all
5406257|NCT00069082|EC|ec
5407429|NCT00066924|cancer|cancer
5407877|NCT00066053|Stroke|stroke
5409992|NCT00061607|SMA|sma
5410415|NCT00060983|Gait|gait
5410546|NCT00060775|HV|hv
5410948|NCT00060450|IRLI|irli
5411401|NCT00059748|Disease|disease
5411611|NCT00059579|MDD|mdd
5412617|NCT00056836|AMD|amd
5413642|NCT00053846|dyspnea|dyspnea
5416973|NCT00027963|pain|pain
5426386|NCT00001840|MRI|mri
5427087|NCT00001385|FDG|fdg
5427242|NCT00001296|TNF|tnf
5427545|NCT00050180|HV|hv
5430896|NCT00031551|TNF|tnf
5431197|NCT00029939|HV|hv
5431280|NCT00029640|MDD|mdd
5431476|NCT00029120|HV|hv
5436081|NCT00001137|HIV-1|hiv-1
5438998|NCT00000675|IgG|igg
5440344|NCT00013702|Chronic|chronic
5440604|NCT00011466|ADHD|adhd
5444202|NCT00001661|Use|use
5446003|NCT00001145|KLH|klh
4634095|NCT03655912|Amblyopia|amblyopia
4634096|NCT03655912|Binocular therapy|binocular therapy
4634097|NCT03655912|Videogames|videogames
4634098|NCT03655899|metabolomics|metabolomics
4634099|NCT03655899|systems biology|systems biology
4634100|NCT03655899|Sepsis|sepsis
4634101|NCT03655886|metastatic|metastatic
4634102|NCT03655886|prostate cancer|prostate cancer
4634103|NCT03655886|local|local
4634104|NCT03655886|cytoreductive|cytoreductive
4634105|NCT03655808|Bronchiectasis|bronchiectasis
4634106|NCT03655808|Bronchial basal cells|bronchial basal cells
4634107|NCT03655808|Autologous transplantation|autologous transplantation
4634108|NCT03655756|Unresectable|unresectable
4634109|NCT03655756|Melanoma|melanoma
4634110|NCT03655756|pDNA|pdna
4634111|NCT03655756|Plasmid DNA|plasmid dna
4634112|NCT03655756|Gene Therapy|gene therapy
4634113|NCT03655730|Depression|depression
4634114|NCT03655730|suicidal risk|suicidal risk
4634115|NCT03655730|self-harm behavior|self-harm behavior
4634116|NCT03655730|young people|young people
4634117|NCT03655717|fNIRS|fnirs
4634118|NCT03655717|THC|thc
4634119|NCT03655717|Intoxication|intoxication
4634120|NCT03655704|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
4634121|NCT03655704|Apabetalone|apabetalone
4634122|NCT03655704|Bromodomain-Containing Protein 4 (BRD4)|bromodomain-containing protein 4 (brd4)
4634123|NCT03655704|BRD4 inhibitor|brd4 inhibitor
4634124|NCT03655704|Feasibility pilot study|feasibility pilot study
4634125|NCT03655704|Phase 2 clinical trial|phase 2 clinical trial
4634126|NCT03655704|Open-label|open-label
4634127|NCT03655704|Two-centre|two-centre
4634128|NCT03655678|CRISPR-Cas9|crispr-cas9
4634129|NCT03655678|Beta-Thalassemia|beta-thalassemia
4634130|NCT03655678|Hemoglobinapathies|hemoglobinapathies
4634131|NCT03655652|positioning|positioning
4634132|NCT03655626|Machine Learning|machine learning
4634133|NCT03655626|Sepsis|sepsis
4634134|NCT03655626|Implementation Science|implementation science
4634135|NCT03655626|Health Information Technology|health information technology
4634136|NCT03655613|Immunotherapy|immunotherapy
4634137|NCT03655613|PD-1 inhibitor|pd-1 inhibitor
4634138|NCT03655613|c-Met inhibitor|c-met inhibitor
4634139|NCT03655574|Brief intervention|brief intervention
4634140|NCT03655574|Behavioral intervention|behavioral intervention
4634141|NCT03655574|Juvenile justice|juvenile justice
4634142|NCT03655574|Motivational enhancement|motivational enhancement
4634143|NCT03655561|Lassa fever|lassa fever
4634144|NCT03655561|Lassa virus|lassa virus
4634145|NCT03655561|Nigeria|nigeria
4634146|NCT03655561|Pregnancy|pregnancy
4634147|NCT03655561|Acute kidney injury|acute kidney injury
4634148|NCT03655535|BTI320|bti320
4634149|NCT03655535|Sugardown|sugardown
4634150|NCT03655535|Post-prandial glucose excursions|post-prandial glucose excursions
4634151|NCT03655496|patient centred|patient centred
4634152|NCT03655496|m-health|m-health
4634153|NCT03655496|e-health|e-health
4634154|NCT03655496|home-based|home-based
4634155|NCT03655496|self-care|self-care
4634156|NCT03655470|suicidal ideation, suicide attempts, nonsuicidal self-injury, adolescents, safety planning|suicidal ideation, suicide attempts, nonsuicidal self-injury, adolescents, safety planning
4634157|NCT03655457|Lung|lung
4634158|NCT03655457|RDS|rds
4634159|NCT03655457|Surfaktant|surfaktant
4634160|NCT03655431|multiple sclerosis|multiple sclerosis
4634161|NCT03655431|rehabilitation|rehabilitation
4634162|NCT03655431|telerehabilitation|telerehabilitation
4634163|NCT03655431|telehealth|telehealth
4634164|NCT03655431|veteran health|veteran health
4634165|NCT03655431|physical therapy|physical therapy
4634166|NCT03655405|Deprescribing|deprescribing
4634167|NCT03655405|Nursing Home|nursing home
4634168|NCT03655405|Potentially Inappropriate Medication|potentially inappropriate medication
4634169|NCT03655392|asthma|asthma
4634170|NCT03655392|inflammation|inflammation
4634171|NCT03655392|patients education|patients education
4634172|NCT03655392|spirometry|spirometry
4634173|NCT03655379|Preterm birth|preterm birth
4634174|NCT03655379|Fetal nasal Doppler|fetal nasal doppler
4634175|NCT03655379|Fetal breathing|fetal breathing
4634176|NCT03655366|epilepsy|epilepsy
4634177|NCT03655366|seizures|seizures
4634178|NCT03655366|seizure alert dogs|seizure alert dogs
4634179|NCT03655366|seizure response dogs|seizure response dogs
4634180|NCT03655366|assistance dogs|assistance dogs
4634181|NCT03655340|Blood Coagulation Disorder|blood coagulation disorder
4634182|NCT03655340|Hematologic Diseases|hematologic diseases
4634183|NCT03655340|Coagulation Protein Disorder|coagulation protein disorder
4634184|NCT03655340|Hemorrhagic Disorder|hemorrhagic disorder
4634185|NCT03655340|Genetic Diseases, Inborn|genetic diseases, inborn
4634186|NCT03655327|stroke rehabilitation|stroke rehabilitation
4634187|NCT03655314|formula|formula
4634188|NCT03655275|subluxation , platelet rich plasma (PRP), prolotherapy.|subluxation , platelet rich plasma (prp), prolotherapy.
4634189|NCT03655262|unconscious fear conditioning|unconscious fear conditioning
4634190|NCT03655262|anxiety disorders|anxiety disorders
4634191|NCT03655262|decoded neuro-reinforcement|decoded neuro-reinforcement
4634192|NCT03655249|Multiple breath washout|multiple breath washout
4634193|NCT03655249|Electrical impedance tomography|electrical impedance tomography
4634194|NCT03655249|Lung clearance index|lung clearance index
4634195|NCT03655249|Chest physiotherapy|chest physiotherapy
4634196|NCT03655249|Autogenic drainage|autogenic drainage
4634197|NCT03655249|Cystic fibrosis|cystic fibrosis
4634198|NCT03655223|Newborn Screening|newborn screening
4634199|NCT03655223|Rare Disorders|rare disorders
4634200|NCT03655223|Genetic Counseling|genetic counseling
4634201|NCT03655223|Families|families
4634202|NCT03655223|Development|development
4634203|NCT03655223|Risk|risk
4634204|NCT03655197|Microbiome|microbiome
4634205|NCT03655197|Lipidome|lipidome
4634206|NCT03655184|melatonin|melatonin
4634207|NCT03655184|medication Overuse Headache|medication overuse headache
4634208|NCT03655184|migraine|migraine
4634209|NCT03655184|Neuropsychology|neuropsychology
4634210|NCT03655171|Parkinson Disease|parkinson disease
4634211|NCT03655171|Exploratory study|exploratory study
4634212|NCT03655171|Quantitative method|quantitative method
4634213|NCT03655171|AI Video analysis|ai video analysis
4634214|NCT03655171|Motor dysfunction|motor dysfunction
4634215|NCT03655132|chronic pain|chronic pain
4634216|NCT03655132|veterans|veterans
4634217|NCT03655132|ACT|act
4634218|NCT03655132|online treatment|online treatment
4634219|NCT03655119|Child|child
4634220|NCT03655119|Adoelscent|adoelscent
4634221|NCT03655119|Crisis Intervention|crisis intervention
4634222|NCT03655106|Ultrasound guided intravenous access|ultrasound guided intravenous access
4634223|NCT03655106|vascular access|vascular access
4634224|NCT03655106|extended dwell catheter|extended dwell catheter
4634225|NCT03655106|IV survival|iv survival
4634226|NCT03655093|Multiple sclerosis|multiple sclerosis
4634227|NCT03655093|Self-questionnaire|self-questionnaire
4634228|NCT03655093|Measurement tools|measurement tools
4634229|NCT03655041|Physiological Phenomena|physiological phenomena
4634230|NCT03655028|COPD|copd
4634231|NCT03655028|Exercise|exercise
4634232|NCT03655028|Rehabilitation|rehabilitation
4634233|NCT03654989|Iontophoresis|iontophoresis
4634234|NCT03654989|Treprostinil|treprostinil
4634235|NCT03654989|Diabetic|diabetic
4634236|NCT03654989|Foot Ulcer|foot ulcer
4634237|NCT03654989|Wound Healing|wound healing
4634238|NCT03654976|Allergic asthma, allergic rhinitis, HDM, pediatric|allergic asthma, allergic rhinitis, hdm, pediatric
4634239|NCT03654963|medication reconciliation|medication reconciliation
4634240|NCT03654963|safe pharmacotherapy|safe pharmacotherapy
4634241|NCT03654937|Influenza vaccination|influenza vaccination
4634242|NCT03654937|elite athletes|elite athletes
4634243|NCT03654937|Immune response|immune response
4634244|NCT03654937|Side effects|side effects
4634245|NCT03654924|LMA|lma
4634246|NCT03654924|Leak|leak
4634247|NCT03654924|Sore Throat|sore throat
4634248|NCT03654898|pregnant women|pregnant women
4634249|NCT03654898|viral suppression|viral suppression
4634250|NCT03654898|retention|retention
4634251|NCT03654898|video intervention|video intervention
4634252|NCT03654898|pre-ART|pre-art
4634253|NCT03654898|counseling|counseling
4634254|NCT03654898|HIV|hiv
4634255|NCT03654898|adherence|adherence
4634256|NCT03654898|PMTCT|pmtct
4634257|NCT03654872|ribotypes|ribotypes
4634258|NCT03654872|Hong Kong|hong kong
4634259|NCT03654872|virulence mechanism|virulence mechanism
4634260|NCT03654859|OHCA|ohca
4634261|NCT03654859|cardiac arrest|cardiac arrest
4634262|NCT03654859|cardiopulmonary resuscitation|cardiopulmonary resuscitation
4634263|NCT03654833|Drug: multi-arm|drug: multi-arm
4634264|NCT03654833|Phase IIa|phase iia
4634265|NCT03654794|Tacrolimus|tacrolimus
4634266|NCT03654794|Pharmacokinetics|pharmacokinetics
4634267|NCT03654781|periodontal treatment|periodontal treatment
4634268|NCT03654781|Initial periodontal therapy|initial periodontal therapy
4634269|NCT03654781|H. pylori|h. pylori
4634270|NCT03654755|eczema|eczema
4634271|NCT03654742|tonsil surgery|tonsil surgery
4634272|NCT03654742|tonsillectomy|tonsillectomy
4634273|NCT03654742|intracapsular|intracapsular
4634274|NCT03654742|microdebrider|microdebrider
4634275|NCT03654742|coblation|coblation
4634276|NCT03654742|extracapsular|extracapsular
4634277|NCT03654742|electrocautery|electrocautery
4634278|NCT03654729|Metastatic|metastatic
4634279|NCT03654729|Colorectal|colorectal
4634280|NCT03654729|Cancer|cancer
4634281|NCT03654729|Metastatic Colorectal Cancer|metastatic colorectal cancer
4634282|NCT03654729|Oxaliplatin induced CIPN|oxaliplatin induced cipn
4634283|NCT03654729|CIPN|cipn
4634284|NCT03654729|Oxaliplatin|oxaliplatin
4634285|NCT03654716|Leukemia|leukemia
4634286|NCT03654716|Solid Tumor|solid tumor
4634287|NCT03654716|Brain Tumor|brain tumor
4634288|NCT03654716|Lymphoma|lymphoma
4634289|NCT03654716|TP53|tp53
4634290|NCT03654716|p53|p53
4634291|NCT03654716|MDM2|mdm2
4634292|NCT03654716|MDMX|mdmx
4634293|NCT03654703|HSCT, AML， R-AML|hsct, aml， r-aml
4634294|NCT03654677|Hepatitis A Vaccine|hepatitis a vaccine
4634295|NCT03654664|Hepatitis A vaccine|hepatitis a vaccine
4634296|NCT03654625|Worry|worry
4634297|NCT03654625|Anxiety|anxiety
4634298|NCT03654625|Generalized Anxiety Disorder|generalized anxiety disorder
4634299|NCT03654625|Written Exposure|written exposure
4634300|NCT03654599|Digital Storytelling|digital storytelling
4634301|NCT03654599|Narrative|narrative
4634302|NCT03654599|Cancer patients|cancer patients
4634303|NCT03654599|Psychosocial health|psychosocial health
4634304|NCT03654599|bone marrow transplant|bone marrow transplant
4634305|NCT03654534|gastric cancer|gastric cancer
4634306|NCT03654534|chemothrapy|chemothrapy
4634307|NCT03654534|oral nutritional supplements|oral nutritional supplements
4634308|NCT03654534|malnutrition|malnutrition
4634309|NCT03654508|long-acting beta2-agonist|long-acting beta2-agonist
4634310|NCT03654508|pharmacogenetics|pharmacogenetics
4634311|NCT03654482|Knotless seton|knotless seton
4634312|NCT03654482|Quality of life|quality of life
4634313|NCT03654482|Perianal Disease Activity Index|perianal disease activity index
4634314|NCT03654456|obstructive sleep apnea|obstructive sleep apnea
4634315|NCT03654456|sepsis|sepsis
4634316|NCT03654456|outcome|outcome
4634317|NCT03654456|prognosis|prognosis
4634318|NCT03654456|sleep-disordered breathing|sleep-disordered breathing
4634319|NCT03654430|Left ventricular Twist|left ventricular twist
4634320|NCT03654430|2D-speckle-tracking|2d-speckle-tracking
4634321|NCT03654430|Postnatal adaptation|postnatal adaptation
4634322|NCT03654417|vulvar biopsy|vulvar biopsy
4634323|NCT03654404|Hematopoietic Stem Cell Transplant|hematopoietic stem cell transplant
4634324|NCT03654404|Positive Psychology|positive psychology
4634325|NCT03654404|Hematologic malignancy|hematologic malignancy
4634326|NCT03654404|Positive Psychological Intervention|positive psychological intervention
4634327|NCT03654391|Astragalus and Notoginseng extrats|astragalus and notoginseng extrats
4634328|NCT03654391|Body weight|body weight
4634329|NCT03654391|BMI|bmi
4634330|NCT03654391|Triglyceride|triglyceride
4634331|NCT03654391|obese|obese
4634332|NCT03654378|Nifedipine|nifedipine
4634333|NCT03654378|Pregnancy|pregnancy
4634334|NCT03654378|Hypertension|hypertension
4634335|NCT03654365|preventative screening|preventative screening
4634336|NCT03654365|electronic health records|electronic health records
4634337|NCT03654365|personal health records|personal health records
4634338|NCT03654365|population health tools|population health tools
4634339|NCT03654352|lung, ceramide, sphingolipid, inflammation|lung, ceramide, sphingolipid, inflammation
4634340|NCT03654313|Atherosclerosis|atherosclerosis
4634341|NCT03654313|Cardiovascular Disease|cardiovascular disease
4634342|NCT03654313|CAD|cad
4634343|NCT03654313|Atherosclerotic Cardiovascular Disease|atherosclerotic cardiovascular disease
4634344|NCT03654287|sepsis|sepsis
4634345|NCT03654287|CRRT|crrt
4634346|NCT03654287|ECMO|ecmo
4634347|NCT03654287|CELS|cels
4634348|NCT03654274|Endometriosis, Pain, Dysmenorrhea|endometriosis, pain, dysmenorrhea
4634349|NCT03654261|Cognitive Therapy; Postpartum Depression; Workshop;|cognitive therapy; postpartum depression; workshop;
4634350|NCT03654248|Time management|time management
4634351|NCT03654248|Group intervention|group intervention
4634352|NCT03654248|Executive function|executive function
4634353|NCT03654209|Argon Plasma Coagulation|argon plasma coagulation
4634354|NCT03654209|Snare Tip Soft Coagulation|snare tip soft coagulation
4634355|NCT03654209|Recurrence rates|recurrence rates
4634356|NCT03654196|Acute Bronchitis|acute bronchitis
4634357|NCT03654118|Arthroscopy|arthroscopy
4634358|NCT03654118|Bankart|bankart
4634359|NCT03654118|Shoulder|shoulder
4634360|NCT03654118|ISIS|isis
4634361|NCT03654105|Inflammation|inflammation
4634362|NCT03654105|Primary Prevention|primary prevention
4634363|NCT03654105|Multiple Prevention|multiple prevention
4634364|NCT03654105|Lung Cancer Screening|lung cancer screening
4634365|NCT03654105|Smoking Cessation|smoking cessation
4634366|NCT03654105|Diet|diet
4634367|NCT03654105|Physical Activity|physical activity
4634368|NCT03654105|CRP|crp
4634369|NCT03654092|Exercise|exercise
4634370|NCT03654092|Minimal equipment|minimal equipment
4634371|NCT03654092|Home-based|home-based
4634372|NCT03654092|COPD|copd
4634373|NCT03654092|Exercise training intervention|exercise training intervention
4634374|NCT03654092|Randomized controlled trial|randomized controlled trial
4634375|NCT03654079|Simulation|simulation
4634376|NCT03654079|Pregnancy|pregnancy
4634377|NCT03654079|Labor and Delivery|labor and delivery
4634378|NCT03654079|Childbirth|childbirth
4634379|NCT03654053|cirrhosis, hepatic decompensation,|cirrhosis, hepatic decompensation,
4634380|NCT03654040|alloantigen-reactive Tregs ( arTreg)|alloantigen-reactive tregs ( artreg)
4634381|NCT03654040|immunosuppression|immunosuppression
4634382|NCT03654040|operational tolerance|operational tolerance
4634383|NCT03654014|Pulsed Electromagnetic Field therapy|pulsed electromagnetic field therapy
4634384|NCT03654014|Traumatic Brain Injury|traumatic brain injury
4634385|NCT03654014|Neurologic outcome|neurologic outcome
4634386|NCT03654014|Cerebrospinal fluid biomarkers|cerebrospinal fluid biomarkers
4634387|NCT03654014|serum biomarkers|serum biomarkers
4634388|NCT03654001|Septic Shock|septic shock
4634389|NCT03654001|Albumin|albumin
4634390|NCT03654001|Balanced crystalloids|balanced crystalloids
4634391|NCT03653988|Nerve block|nerve block
4634392|NCT03653988|Pectoralis nerve blocks|pectoralis nerve blocks
4634393|NCT03653988|PECS I|pecs i
4634394|NCT03653988|PECS II|pecs ii
4634395|NCT03653988|Mastectomy|mastectomy
4634396|NCT03653975|Nodding Syndrome|nodding syndrome
4634397|NCT03653975|Head Nodding|head nodding
4634398|NCT03653975|Epilepsy|epilepsy
4634399|NCT03653975|Onchocerciasis|onchocerciasis
4634400|NCT03653975|Cognitive impairment|cognitive impairment
4634401|NCT03653975|Mahenge|mahenge
4634402|NCT03653962|Multimedia|multimedia
4634403|NCT03653962|informed consent|informed consent
4634404|NCT03653962|metabolic surgery|metabolic surgery
4634405|NCT03653962|Roux-en-Y gastric bypass|roux-en-y gastric bypass
4634406|NCT03653949|Cystic fibrosis|cystic fibrosis
4634407|NCT03653949|Insulin Resistance|insulin resistance
4634408|NCT03653949|Aerobic Exercise|aerobic exercise
4634409|NCT03653949|Child|child
4634410|NCT03653949|Adolescents|adolescents
4634411|NCT03653910|double-lumen tube intubation|double-lumen tube intubation
4634412|NCT03653910|remifentanil|remifentanil
4634413|NCT03653910|target controlled infusion|target controlled infusion
4634414|NCT03653897|Ingestion event marker|ingestion event marker
4634415|NCT03653897|Ingestible sensor|ingestible sensor
4634416|NCT03653897|Medication adherence|medication adherence
4634417|NCT03653897|ID-Cap Medication Adherence Feedback System|id-cap medication adherence feedback system
4634418|NCT03653871|Alzheimer Disease|alzheimer disease
4634419|NCT03653871|Dementia|dementia
4634420|NCT03653871|Caregiver|caregiver
4634421|NCT03653871|Performing Arts|performing arts
4634422|NCT03653858|Deep Brain Stimulation|deep brain stimulation
4634423|NCT03653858|Treatment-resistant depression|treatment-resistant depression
4634424|NCT03653858|Medial forebrain bundle|medial forebrain bundle
4634425|NCT03653845|Hypertension|hypertension
4634426|NCT03653845|Primary Aldosteronism|primary aldosteronism
4634427|NCT03653845|Ablation|ablation
4634428|NCT03653845|Adrenal Gland|adrenal gland
4634429|NCT03653832|Sedation|sedation
4634430|NCT03653832|Ventilation|ventilation
4634431|NCT03653819|Compression Stockings|compression stockings
4634432|NCT03653819|Feasibility Study|feasibility study
4634433|NCT03653819|Physical Activity|physical activity
4634434|NCT03653819|High Intensity Interval Training|high intensity interval training
4634435|NCT03653819|Cross over trial|cross over trial
4634436|NCT03653806|PEEP|peep
4634437|NCT03653806|Electrical Impedance Tomography|electrical impedance tomography
4634438|NCT03653780|Wearable Exoskeleton|wearable exoskeleton
4634439|NCT03653780|Stroke|stroke
4634440|NCT03653780|Oxygen Consumption|oxygen consumption
4634441|NCT03653780|Cardiorespiratory Responses|cardiorespiratory responses
4634442|NCT03653767|classroom ergonomics|classroom ergonomics
4634443|NCT03653767|sedentary behavior|sedentary behavior
4634444|NCT03653767|school interventions|school interventions
4634445|NCT03653767|physical activity|physical activity
4634446|NCT03653754|growth|growth
4634447|NCT03653754|Body Composition|body composition
4634448|NCT03653728|non-invasive monitoring; near-infrared spectroscopy; traumatic brain injury; cerebral contusion|non-invasive monitoring; near-infrared spectroscopy; traumatic brain injury; cerebral contusion
4634449|NCT03653715|Refractive Errors|refractive errors
4634450|NCT03653715|Myopia|myopia
4634451|NCT03653715|Hyperopia|hyperopia
4634452|NCT03653715|Astigmatism|astigmatism
4634453|NCT03653689|IBS|ibs
4634454|NCT03653689|metabotype|metabotype
4634455|NCT03653689|FODMAP|fodmap
4634456|NCT03653689|gluten|gluten
4634457|NCT03653676|Sickle Cell Anemia|sickle cell anemia
4634458|NCT03653676|Sickle Cell Disease|sickle cell disease
4634459|NCT03653676|Exercise|exercise
4634460|NCT03653676|Fitness|fitness
4634461|NCT03653676|Asthma|asthma
4634462|NCT03653676|Inflammation|inflammation
4634463|NCT03653650|Platelet-Rich Plasma|platelet-rich plasma
4634464|NCT03653650|Persistent Epithelial Defect|persistent epithelial defect
4634465|NCT03653637|Suicide|suicide
4634466|NCT03653637|Safety Plan|safety plan
4634467|NCT03653637|Group Treatment|group treatment
4634468|NCT03653637|Veterans|veterans
4634469|NCT03653611|COPD|copd
4634470|NCT03653611|CAPTURE|capture
4634471|NCT03653611|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
4634472|NCT03653598|Atrial Fibrillation|atrial fibrillation
4634473|NCT03653585|Multiple Sclerosis|multiple sclerosis
4634474|NCT03653585|Magnetic Resonance Imaging|magnetic resonance imaging
4634475|NCT03653585|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
4634476|NCT03653585|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
4634477|NCT03653585|Functional Neuroimaging|functional neuroimaging
4634478|NCT03653585|Cortical Lesion|cortical lesion
4634479|NCT03653585|Sensorimotor cortex|sensorimotor cortex
4634480|NCT03653585|7T|7t
4634481|NCT03653585|7 Tesla|7 tesla
4634482|NCT03653572|Ultrasound|ultrasound
4634483|NCT03653572|Emergency care|emergency care
4634484|NCT03653546|Central Nervous System Metastases|central nervous system metastases
4634485|NCT03653546|Respiratory Tract Diseases|respiratory tract diseases
4634486|NCT03653546|EGFR|egfr
4634487|NCT03653546|Exon 19Del|exon 19del
4634488|NCT03653546|L858R|l858r
4634489|NCT03653546|Lung Neoplasm|lung neoplasm
4634490|NCT03653546|Carcinoma, Non-Small-Cell Lung|carcinoma, non-small-cell lung
4634491|NCT03653546|Neoplasms|neoplasms
4634492|NCT03653507|CLDN 18.2|cldn 18.2
4634591|NCT03653195|metabolomic|metabolomic
4634493|NCT03653507|gastroesophageal junction cancer|gastroesophageal junction cancer
4634494|NCT03653507|adenocarcinoma|adenocarcinoma
4634495|NCT03653507|IMAB362|imab362
4634496|NCT03653507|oxaliplatin|oxaliplatin
4634497|NCT03653507|HER2|her2
4634498|NCT03653507|claudiximab|claudiximab
4634499|NCT03653507|capecitabine|capecitabine
4634500|NCT03653507|gastric cancer|gastric cancer
4634501|NCT03653507|HER2 Negative|her2 negative
4634502|NCT03653507|zolbetuximab|zolbetuximab
4634503|NCT03653494|non-intubated general anaesthesia|non-intubated general anaesthesia
4634504|NCT03653494|video-assisted thoracoscopic surgery|video-assisted thoracoscopic surgery
4634505|NCT03653494|phrenic block|phrenic block
4634506|NCT03653481|diet|diet
4634507|NCT03653481|inulin|inulin
4634508|NCT03653481|prebiotic|prebiotic
4634509|NCT03653481|IBD|ibd
4634510|NCT03653481|Inflammatory Bowel Disease|inflammatory bowel disease
4634511|NCT03653455|Shoulder|shoulder
4634512|NCT03653455|Arthroscopy|arthroscopy
4634513|NCT03653455|sub-acromial decompression|sub-acromial decompression
4634514|NCT03653455|distal clavicle resection|distal clavicle resection
4634515|NCT03653455|biceps tenodesis|biceps tenodesis
4634516|NCT03653455|rotator cuff repair|rotator cuff repair
4634517|NCT03653455|Patient reported outcomes|patient reported outcomes
4634518|NCT03653442|Induced hypotension|induced hypotension
4634519|NCT03653442|Spinal Anaesthesia|spinal anaesthesia
4634520|NCT03653442|Elective Caesarean section|elective caesarean section
4634521|NCT03653442|non-invasive haemodynamic parameters|non-invasive haemodynamic parameters
4634522|NCT03653429|foot and ankle surgeries|foot and ankle surgeries
4634523|NCT03653429|tranexamic acid|tranexamic acid
4634524|NCT03653429|wound healing|wound healing
4634525|NCT03653429|blood loss|blood loss
4634526|NCT03653416|Total knee arthroplasty|total knee arthroplasty
4634527|NCT03653416|Peri articular infiltration|peri articular infiltration
4634528|NCT03653416|Pack block|pack block
4634529|NCT03653416|Adductor canal catheter|adductor canal catheter
4634530|NCT03653390|health promotion intervention|health promotion intervention
4634531|NCT03653390|community participation|community participation
4634532|NCT03653390|quality of life|quality of life
4634533|NCT03653390|middle age|middle age
4634534|NCT03653390|multiple sclerosis|multiple sclerosis
4634535|NCT03653390|spinal cord injury|spinal cord injury
4634536|NCT03653390|muscular dystrophy|muscular dystrophy
4634537|NCT03653390|post-polio syndrome|post-polio syndrome
4634538|NCT03653377|mucoviscidosis|mucoviscidosis
4634539|NCT03653377|Human Papilloma Virus|human papilloma virus
4634540|NCT03653377|Vaccination|vaccination
4634541|NCT03653377|Young girl|young girl
4634542|NCT03653338|Sickle Cell|sickle cell
4634543|NCT03653338|Diamond-Blackfan|diamond-blackfan
4634544|NCT03653338|Beta-thalassemia|beta-thalassemia
4634545|NCT03653338|Anemia|anemia
4634546|NCT03653338|Stem cell transplantation|stem cell transplantation
4634547|NCT03653338|Unrelated Donor|unrelated donor
4634548|NCT03653338|haploidentical|haploidentical
4634549|NCT03653338|hematopoietic stem cell transplant (HSCT)|hematopoietic stem cell transplant (hsct)
4634550|NCT03653338|bone marrow transplant (BMT)|bone marrow transplant (bmt)
4634551|NCT03653338|mismatched|mismatched
4634552|NCT03653338|t-cell depletion|t-cell depletion
4634553|NCT03653325|hyperoxia|hyperoxia
4634554|NCT03653325|post rosc|post rosc
4634555|NCT03653325|oxygen reserve index|oxygen reserve index
4634556|NCT03653325|Fi02 titration|fi02 titration
4634557|NCT03653325|post cardiac arrest care|post cardiac arrest care
4634558|NCT03653325|oxygen|oxygen
4634559|NCT03653312|Ischemic Stroke|ischemic stroke
4634560|NCT03653312|Neuromuscular electrical stimulation|neuromuscular electrical stimulation
4634561|NCT03653312|Activities of daily living|activities of daily living
4634562|NCT03653312|Patient reported outcome|patient reported outcome
4634563|NCT03653312|Neuroplasticity|neuroplasticity
4634564|NCT03653312|Transcranial magnetic stimulation|transcranial magnetic stimulation
4634565|NCT03653312|Fugl Meyer|fugl meyer
4634566|NCT03653299|stroke|stroke
4634567|NCT03653299|phototherapy|phototherapy
4634568|NCT03653299|gait|gait
4634569|NCT03653299|balance|balance
4634570|NCT03653299|functional mobility|functional mobility
4634571|NCT03653286|Neuromuscular Eletrical Stimulation|neuromuscular eletrical stimulation
4634572|NCT03653286|Torque|torque
4634573|NCT03653286|Runners|runners
4634574|NCT03653273|multiple sclerosis|multiple sclerosis
4634575|NCT03653273|secondary progressive|secondary progressive
4634576|NCT03653273|disease modifying treatment|disease modifying treatment
4634577|NCT03653273|medico economic impact|medico economic impact
4634578|NCT03653273|treatment withdrawal|treatment withdrawal
4634579|NCT03653247|Intervention: Genetic: BIVV003|intervention: genetic: bivv003
4634580|NCT03653247|Drug: Busulfan|drug: busulfan
4634581|NCT03653247|Biological: Plerixafor|biological: plerixafor
4634582|NCT03653247|Phase: Phase 1/2|phase: phase 1/2
4634583|NCT03653234|active and assisted living|active and assisted living
4634584|NCT03653234|assistive technology|assistive technology
4634585|NCT03653234|telecare|telecare
4634586|NCT03653234|remote consultations|remote consultations
4634587|NCT03653234|informal caregivers|informal caregivers
4634588|NCT03653234|quality of life|quality of life
4634589|NCT03653195|concussion|concussion
4634590|NCT03653195|biomarker|biomarker
4634592|NCT03653195|urine|urine
4634593|NCT03653195|NMR spectroscopy|nmr spectroscopy
4634594|NCT03653169|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
4634595|NCT03653143|Behavioral regulation|behavioral regulation
4634596|NCT03653143|Emotional regulation|emotional regulation
4634597|NCT03653143|Social communication|social communication
4634598|NCT03653143|Development|development
4634599|NCT03653130|homeless|homeless
4634600|NCT03653130|recreational therapy|recreational therapy
4634601|NCT03653130|community integration|community integration
4634602|NCT03653130|reintegration|reintegration
4634603|NCT03653130|Veteran|veteran
4634604|NCT03653130|housing insecurity|housing insecurity
4634605|NCT03653130|Domiciliary|domiciliary
4634606|NCT03653130|Human Occupation|human occupation
4634607|NCT03653130|Occupational therapy|occupational therapy
4634608|NCT03653130|Music|music
4634609|NCT03653117|Transperineal laser ablation|transperineal laser ablation
4634610|NCT03653117|LUTS|luts
4634612|NCT03653117|Laser ablation|laser ablation
4634613|NCT03653104|Melodica|melodica
4634614|NCT03653104|pursed lip breathing|pursed lip breathing
4634615|NCT03653104|breathing exercise|breathing exercise
4634616|NCT03653104|Music|music
4634617|NCT03653091|Type 2 diabetes|type 2 diabetes
4634618|NCT03653091|Diabetes Mellitus|diabetes mellitus
4634619|NCT03653091|Noninsulin-Dependent Diabetes Mellitus|noninsulin-dependent diabetes mellitus
4634620|NCT03653091|Glucose Metabolism Disorders|glucose metabolism disorders
4634621|NCT03653091|Metabolic Diseases|metabolic diseases
4634622|NCT03653091|Endocrine System Diseases|endocrine system diseases
4634623|NCT03653091|Revita System|revita system
4634624|NCT03653091|Anti-diabetic medications|anti-diabetic medications
4634625|NCT03653091|Duodenal Mucosal Resurfacing|duodenal mucosal resurfacing
4634626|NCT03653078|Surgical guide|surgical guide
4634627|NCT03653078|Surgical stent|surgical stent
4634628|NCT03653078|orthodontic mini screw|orthodontic mini screw
4634629|NCT03653078|temporary anchorage device|temporary anchorage device
4634630|NCT03653026|Upadacitinib|upadacitinib
4634631|NCT03653026|ABT-494|abt-494
4634632|NCT03653026|Ulcerative Colitis|ulcerative colitis
4634633|NCT03653000|Regional anesthesia|regional anesthesia
4634634|NCT03653000|Ultrasound guided brachial plexus blockade|ultrasound guided brachial plexus blockade
4634635|NCT03653000|Local anesthetics : Ropivacaine|local anesthetics : ropivacaine
4634636|NCT03652987|PCOS|pcos
4634637|NCT03652987|Hyperandrogenemia|hyperandrogenemia
4634638|NCT03652987|Rotterdam Criteria|rotterdam criteria
4634639|NCT03652987|Insulin sensitivity|insulin sensitivity
4634640|NCT03652987|BMI|bmi
4634641|NCT03652987|AFC|afc
4634642|NCT03652974|Schizophrenia， clozapine， valproate， ECT|schizophrenia， clozapine， valproate， ect
4634643|NCT03652948|mobile app|mobile app
4634644|NCT03652948|middle age adults|middle age adults
4634645|NCT03652948|older adults|older adults
4634646|NCT03652935|Breast cancer, mindfulness, immune, stress|breast cancer, mindfulness, immune, stress
4634647|NCT03652896|hepatocellular carcinoma|hepatocellular carcinoma
4634648|NCT03652896|anatomical liver resection|anatomical liver resection
4634649|NCT03652883|Implementation|implementation
4634650|NCT03652883|Tailored implementation strategies|tailored implementation strategies
4634651|NCT03652883|iCBT|icbt
4634652|NCT03652883|Common mental disorders|common mental disorders
4634653|NCT03652857|Apatinib plus Vinorelbine|apatinib plus vinorelbine
4634654|NCT03652857|NSCLC|nsclc
4634655|NCT03652831|Cervical radiculopathy,|cervical radiculopathy,
4634656|NCT03652831|Soft tissue mobilization,|soft tissue mobilization,
4634657|NCT03652831|Neural mobilization|neural mobilization
4634658|NCT03652766|Overweight|overweight
4634659|NCT03652766|Obesity|obesity
4634660|NCT03652766|e-Health|e-health
4634661|NCT03652766|Gestational Weight Gain|gestational weight gain
4634662|NCT03652740|over-the-counter|over-the-counter
4634663|NCT03652740|prescription medication|prescription medication
4634664|NCT03652740|subjective effects|subjective effects
4634665|NCT03652727|PICC|picc
4634666|NCT03652727|PIC Line|pic line
4634667|NCT03652727|ECG|ecg
4634668|NCT03652688|clubs|clubs
4634669|NCT03652675|Heavy Drinking|heavy drinking
4634670|NCT03652675|HIV|hiv
4634671|NCT03652675|Hepatitis C|hepatitis c
4634672|NCT03652649|type 2 diabetes|type 2 diabetes
4634673|NCT03652649|diabetes|diabetes
4634674|NCT03652649|ketogenic diet|ketogenic diet
4634675|NCT03652649|low carb diet|low carb diet
4634676|NCT03652649|weight loss|weight loss
4634677|NCT03652649|obesity|obesity
4634678|NCT03652649|diet treatment|diet treatment
4634679|NCT03652649|nutrition|nutrition
4634680|NCT03652649|BMI|bmi
4634681|NCT03652623|Transgender|transgender
4634682|NCT03652623|Pre-exposure Prophylaxis (PrEP)|pre-exposure prophylaxis (prep)
4634683|NCT03652623|HIV Prevention|hiv prevention
4634684|NCT03652623|Tenofovir Disoproxil Fumarate/Emtricitabine (TDF/FTC)|tenofovir disoproxil fumarate/emtricitabine (tdf/ftc)
4634685|NCT03652623|Cross-sex Hormone Therapy|cross-sex hormone therapy
4634686|NCT03652623|Adherence|adherence
4634687|NCT03652623|Behavior Change|behavior change
4634688|NCT03652623|Gender Affirmation|gender affirmation
4634689|NCT03652610|Meningitis|meningitis
4634690|NCT03652610|Liquid formulation|liquid formulation
4634691|NCT03652610|Meningococcal disease|meningococcal disease
4634692|NCT03652597|Target engagement|target engagement
4634693|NCT03652597|TMS|tms
4634694|NCT03652597|Heart-brain pathway|heart-brain pathway
4634695|NCT03652597|Depression|depression
4634696|NCT03652597|Neuromodulation|neuromodulation
4634697|NCT03652597|DLPFC|dlpfc
4634698|NCT03652597|Heart rate|heart rate
4634699|NCT03652584|postmenopause|postmenopause
4634700|NCT03652584|diet|diet
4634701|NCT03652584|Skeletal muscle mass|skeletal muscle mass
4634702|NCT03652519|Exercise|exercise
4634703|NCT03652519|Immune Signalling|immune signalling
4634704|NCT03652519|Cognition|cognition
4634705|NCT03652519|Health-related Quality of Life|health-related quality of life
4634706|NCT03652493|Anomaly of the Homologous Recombination (HR) pathway|anomaly of the homologous recombination (hr) pathway
4634707|NCT03652493|Carboplatin|carboplatin
4634708|NCT03652480|shoulder pain|shoulder pain
4634709|NCT03652480|type 2 diabetes|type 2 diabetes
4634710|NCT03652480|subacromial corticosteroid injection|subacromial corticosteroid injection
4634711|NCT03652480|glycemia|glycemia
4634712|NCT03652480|efficacy|efficacy
4634713|NCT03652480|safety|safety
4634714|NCT03652467|Deferoxamine|deferoxamine
4634715|NCT03652467|Transarterial chemoembolization|transarterial chemoembolization
4634716|NCT03652467|Unresectable hepatocellular carcinoma|unresectable hepatocellular carcinoma
4634717|NCT03652454|regional acceleratory phenomenon|regional acceleratory phenomenon
4634718|NCT03652454|micro-osteoperforation|micro-osteoperforation
4634719|NCT03652454|orthodontic alignment|orthodontic alignment
4634720|NCT03652428|LAPC|lapc
4634721|NCT03652428|Nab-paclitaxel +Gemcitabine|nab-paclitaxel +gemcitabine
4634722|NCT03652428|Proton Therapy|proton therapy
4634723|NCT03652402|Kidney|kidney
4634724|NCT03652402|Allogenic transplantation|allogenic transplantation
4634725|NCT03652402|Cohort study|cohort study
4634726|NCT03652402|Rejection|rejection
4634727|NCT03652402|Biomarkers|biomarkers
4634728|NCT03652402|Response to treatment|response to treatment
4634729|NCT03652402|Integrative medicine|integrative medicine
4634730|NCT03652324|coil treatment|coil treatment
4634731|NCT03652324|general anesthesia|general anesthesia
4634732|NCT03652324|deep sedation|deep sedation
4634733|NCT03652311|opiate use disorder|opiate use disorder
4634734|NCT03652311|neuromodulation|neuromodulation
4634735|NCT03652311|caloric vestibular stimulation|caloric vestibular stimulation
4634736|NCT03652311|adjunct therapy|adjunct therapy
4634737|NCT03652298|PTSD|ptsd
4634738|NCT03652298|Memory Structuring Intervention (MSI)|memory structuring intervention (msi)
4634739|NCT03652298|Cancer|cancer
4634740|NCT03652298|Vagal breathing|vagal breathing
4634741|NCT03652272|medication safety|medication safety
4634742|NCT03652272|adherence|adherence
4634743|NCT03652272|electronic health record|electronic health record
4634744|NCT03652259|limb girdle muscular dystrophy|limb girdle muscular dystrophy
4634745|NCT03652259|LGMD2E|lgmd2e
4634746|NCT03652259|beta-sarcoglycan|beta-sarcoglycan
4634747|NCT03652259|gene transfer|gene transfer
4634748|NCT03652259|adeno-associated virus|adeno-associated virus
4634749|NCT03652181|CCM (Cerebral Cavernous Malformations)|ccm (cerebral cavernous malformations)
4634750|NCT03652181|Dynamic Contrast Enhanced Quantitative Perfusion (DCEQP)|dynamic contrast enhanced quantitative perfusion (dceqp)
4634751|NCT03652181|Quantitative Susceptibility Mapping (QSM)|quantitative susceptibility mapping (qsm)
4634752|NCT03652181|Cerebral Cavernous Malformation|cerebral cavernous malformation
4634753|NCT03652181|Cavernoma|cavernoma
4634754|NCT03652181|Cavernous Angioma|cavernous angioma
4634755|NCT03652168|stress|stress
4634756|NCT03652168|health|health
4634757|NCT03652168|mindfulness|mindfulness
4634758|NCT03652168|employees|employees
4634759|NCT03652142|HNSCC|hnscc
4634760|NCT03652142|DDR|ddr
4634761|NCT03652142|DNA damage|dna damage
4634762|NCT03652142|DNA damage repair|dna damage repair
4634763|NCT03652142|PD-L1|pd-l1
4634764|NCT03652142|PD-1|pd-1
4634765|NCT03652142|NIVOLUMAB|nivolumab
4634766|NCT03652142|Head and Neck cancer|head and neck cancer
4634767|NCT03652103|Truncal Nerve Blocks, Ultrasound Guided Nerve Blocks|truncal nerve blocks, ultrasound guided nerve blocks
4634768|NCT03652090|biomarker|biomarker
4634769|NCT03652077|Advanced malignancies|advanced malignancies
4634770|NCT03652077|immunoglobulin (Ig)G1k monoclonal antibody|immunoglobulin (ig)g1k monoclonal antibody
4634771|NCT03652077|T-cell immunoglobulin and mucin domain 3 (TIM-3)|t-cell immunoglobulin and mucin domain 3 (tim-3)
4634772|NCT03652038|Single ascending dose|single ascending dose
4634773|NCT03652038|SAD|sad
4634774|NCT03652038|Multiple ascending dose|multiple ascending dose
4634775|NCT03652038|MAD|mad
4634776|NCT03652038|Phase 1|phase 1
4634777|NCT03652038|first-in-human|first-in-human
4634778|NCT03652038|TD-8236|td-8236
4634779|NCT03652038|asthma|asthma
4634780|NCT03652012|Mild Cognitive Impairment|mild cognitive impairment
4634781|NCT03651986|Circulating Tumor DNA (ctDNA)|circulating tumor dna (ctdna)
4634782|NCT03651986|DNA Methylation Analysis|dna methylation analysis
4634783|NCT03651986|Next-Generation Sequencing (NGS)|next-generation sequencing (ngs)
4634784|NCT03651986|Low-Dose Computed Tomography (LDCT)|low-dose computed tomography (ldct)
4634785|NCT03651973|Self massages and self stretching|self massages and self stretching
4634786|NCT03651973|Workshops for self massages and stretching learning|workshops for self massages and stretching learning
4634787|NCT03651921|Breast Cancer|breast cancer
4634788|NCT03651921|Self-Management|self-management
4634789|NCT03651921|Cancer Survivorship|cancer survivorship
4634790|NCT03651869|Ritualistic Behavior|ritualistic behavior
4634791|NCT03651869|Cognitive Control|cognitive control
4634792|NCT03651869|Concentration|concentration
4634793|NCT03651869|Negative Reinforcement|negative reinforcement
4634794|NCT03651843|high risk|high risk
4634795|NCT03651843|pregnant women|pregnant women
4634796|NCT03651843|occupational hazard|occupational hazard
4634797|NCT03651843|occupational risk|occupational risk
4634798|NCT03651830|Amputation|amputation
4634799|NCT03651830|Rehabilitation|rehabilitation
4634800|NCT03651830|Prescriptions|prescriptions
4634801|NCT03651830|Emulator|emulator
4634802|NCT03651830|Prosthetics|prosthetics
4634803|NCT03651778|GHB|ghb
4634804|NCT03651778|gamma-Hydroxybutyric acid|gamma-hydroxybutyric acid
4634805|NCT03651778|Substances of abuse|substances of abuse
4634806|NCT03651778|Poisoning induced by others|poisoning induced by others
4634807|NCT03651778|Recreational drugs|recreational drugs
4634808|NCT03651778|Poisoning|poisoning
4634809|NCT03651778|Intoxication|intoxication
4634810|NCT03651765|setmelanotide|setmelanotide
4634811|NCT03651765|RM-493|rm-493
4634812|NCT03651765|obesity|obesity
4634813|NCT03651765|leptin-melanocortin|leptin-melanocortin
4634814|NCT03651765|melanocortin 4 receptor|melanocortin 4 receptor
4634815|NCT03651739|Rehabilitation|rehabilitation
4634816|NCT03651713|exercise|exercise
4634817|NCT03651713|glucose|glucose
4634818|NCT03651713|vascular function|vascular function
4634819|NCT03651687|Head circumference|head circumference
4634820|NCT03651687|Neurodevelopment|neurodevelopment
4634821|NCT03651687|Newborn|newborn
4634822|NCT03651687|Infant|infant
4634823|NCT03651687|Surveillance|surveillance
4634824|NCT03651687|Prediction|prediction
4634825|NCT03651648|apnea; prematurity; kinesthetic stimulation|apnea; prematurity; kinesthetic stimulation
4634826|NCT03651635|ICU|icu
4634827|NCT03651635|Biomarkers|biomarkers
4634828|NCT03651622|Type 1 diabetes|type 1 diabetes
4634829|NCT03651622|T1D|t1d
4634830|NCT03651622|Type 1 diabetes mellitus (T1DM)|type 1 diabetes mellitus (t1dm)
4634831|NCT03651622|weight management|weight management
4634832|NCT03651622|overweight|overweight
4634833|NCT03651622|obese|obese
4634834|NCT03651609|Ulnar neuropathy at the elbow|ulnar neuropathy at the elbow
4634835|NCT03651609|Electromyography|electromyography
4634836|NCT03651609|Ultrasonography|ultrasonography
4634837|NCT03651609|Treatment|treatment
4634838|NCT03651609|Surgery|surgery
4634839|NCT03651609|Conservative treatment|conservative treatment
4634840|NCT03651596|Adherence|adherence
4634841|NCT03651596|Adolescence|adolescence
4634842|NCT03651596|mHealth|mhealth
4634843|NCT03651583|Migraine|migraine
4634844|NCT03651583|Kiko|kiko
4634845|NCT03651583|Qigong|qigong
4634846|NCT03651583|Relaxation|relaxation
4634847|NCT03651583|Exercise|exercise
4634848|NCT03651557|Neu2000KWL|neu2000kwl
4634849|NCT03651557|cerebral performance category|cerebral performance category
4634850|NCT03651557|out-of-hospital cardiac arrest|out-of-hospital cardiac arrest
4634851|NCT03651557|neuroprotection|neuroprotection
4634852|NCT03651557|glutamate|glutamate
4634853|NCT03651557|N-Methyl-D-aspartate (NMDA) receptor antagonist|n-methyl-d-aspartate (nmda) receptor antagonist
4634854|NCT03651557|Anti-oxidant|anti-oxidant
4634855|NCT03651557|free radical|free radical
4634856|NCT03651544|influenza|influenza
4634857|NCT03651544|vaccine|vaccine
4634858|NCT03651544|vector vaccine|vector vaccine
4634859|NCT03651531|metformin|metformin
4634860|NCT03651518|Personalized treatment|personalized treatment
4634861|NCT03651518|Inflammatory diseases|inflammatory diseases
4634862|NCT03651518|auto-inflammatory diseases|auto-inflammatory diseases
4634863|NCT03651518|auto-immune diseases|auto-immune diseases
4634864|NCT03651518|Targeted treatments|targeted treatments
4634865|NCT03651518|skin|skin
4634866|NCT03651505|X-linked Hypophosphatemia|x-linked hypophosphatemia
4634867|NCT03651505|Fibroblast growth factor 23 (FGF23)|fibroblast growth factor 23 (fgf23)
4634868|NCT03651505|KRN23|krn23
4634869|NCT03651505|XLH|xlh
4634870|NCT03651505|Hypophosphatemia|hypophosphatemia
4634871|NCT03651505|Familial Hypophosphatemic Rickets|familial hypophosphatemic rickets
4634872|NCT03651505|FGF23|fgf23
4634873|NCT03651505|Crysvita|crysvita
4634874|NCT03651492|nocturnal hypertension|nocturnal hypertension
4634875|NCT03651492|renal transplantation|renal transplantation
4634876|NCT03651492|sleep quality|sleep quality
4634877|NCT03651479|virtual reality|virtual reality
4634878|NCT03651479|boxing|boxing
4634879|NCT03651479|upper extremity function|upper extremity function
4634880|NCT03651479|cognitive function|cognitive function
4634881|NCT03651479|balance|balance
4634882|NCT03651440|Disc herniation|disc herniation
4634883|NCT03651440|Endurance|endurance
4634884|NCT03651440|Lumbar stabilization exercise|lumbar stabilization exercise
4634885|NCT03651440|PNF|pnf
4634886|NCT03651440|Strength|strength
4634887|NCT03651427|Estradiol;|estradiol;
4634888|NCT03651427|Brain|brain
4634889|NCT03651427|glutamate|glutamate
4634890|NCT03651427|spectroscopy|spectroscopy
4634891|NCT03651427|hypogonadism|hypogonadism
4634892|NCT03651414|Outliers|outliers
4634893|NCT03651375|Dose Hypofractionation|dose hypofractionation
4634894|NCT03651375|Neoadjuvant Therapy|neoadjuvant therapy
4634895|NCT03651375|Chemoradiotherapy|chemoradiotherapy
4634896|NCT03651375|Sarcoma|sarcoma
4634897|NCT03651375|Dose Fractionation|dose fractionation
4634898|NCT03651375|Dose-Response Relationship|dose-response relationship
4634899|NCT03651375|Antineoplastic Agents|antineoplastic agents
4634900|NCT03651375|Drug Therapy|drug therapy
4634901|NCT03651375|Antineoplastic Combined Chemotherapy Protocols|antineoplastic combined chemotherapy protocols
4634902|NCT03651362|optic neuritis|optic neuritis
4634903|NCT03651362|DIR|dir
4634904|NCT03651362|visual disability|visual disability
4634905|NCT03651362|CIS|cis
4634906|NCT03651362|multiple sclerosis|multiple sclerosis
4634907|NCT03651362|NMOSD|nmosd
4634908|NCT03651336|POAG|poag
4634909|NCT03651336|Primary Open Angle Glaucoma|primary open angle glaucoma
4634910|NCT03651336|Cataract|cataract
4634911|NCT03651336|Intraocular Pressure|intraocular pressure
4634912|NCT03651336|Intraocular Pressure Sensor System|intraocular pressure sensor system
4634913|NCT03651336|IOP|iop
4634914|NCT03651336|Self-monitoring of intraocular pressure|self-monitoring of intraocular pressure
4634915|NCT03651323|Atrial fibrillation|atrial fibrillation
4634916|NCT03651323|Left atrial appendage|left atrial appendage
4634917|NCT03651323|Stroke|stroke
4634918|NCT03651297|Harness Assist|harness assist
4634919|NCT03651297|Balance training|balance training
4634920|NCT03651297|Types of harness assist|types of harness assist
4634921|NCT03651297|Fall-arrest harness|fall-arrest harness
4634922|NCT03651297|Adjustable harness|adjustable harness
4634923|NCT03651284|obesity|obesity
4634924|NCT03651284|physical activity|physical activity
4634925|NCT03651284|nutrition|nutrition
4634926|NCT03651284|adolescents|adolescents
4634927|NCT03651284|gamification|gamification
4634928|NCT03651284|video game|video game
4634929|NCT03651284|sedentary activity|sedentary activity
4634930|NCT03651258|Feeding Behavior|feeding behavior
4634931|NCT03651245|Alpha-Mannosidosis disease|alpha-mannosidosis disease
4634932|NCT03651245|prevalence|prevalence
4634933|NCT03651219|SCLC|sclc
4634934|NCT03651219|apatinib|apatinib
4634935|NCT03651219|Irinotecan|irinotecan
4634936|NCT03651206|Malignant mixed Mullerian tumors|malignant mixed mullerian tumors
4634937|NCT03651206|Metastatic ovarian carcinosarcoma|metastatic ovarian carcinosarcoma
4634938|NCT03651206|Recurrent ovarian carcinosarcoma|recurrent ovarian carcinosarcoma
4634939|NCT03651206|Metastatic endometrial carcinosarcoma|metastatic endometrial carcinosarcoma
4634940|NCT03651206|Recurrent endometrial carcinosarcoma|recurrent endometrial carcinosarcoma
4634941|NCT03651206|Niraparib|niraparib
4634942|NCT03651206|TSR-042|tsr-042
4634943|NCT03651193|Adult Onset Still's Disease|adult onset still's disease
4634944|NCT03651193|Chinese population|chinese population
4634945|NCT03651180|Polymer free drug eluting stent|polymer free drug eluting stent
4634946|NCT03651167|skin care|skin care
4634947|NCT03651167|skin tone|skin tone
4634948|NCT03651167|tanning|tanning
4634949|NCT03651167|skin tone preference|skin tone preference
4634950|NCT03651141|Hamstring tightness|hamstring tightness
4634951|NCT03651141|myofascial decompression|myofascial decompression
4634952|NCT03651141|cupping|cupping
4634953|NCT03651141|neurodynamic sliding|neurodynamic sliding
4634954|NCT03651128|Multiple Myeloma|multiple myeloma
4634955|NCT03651128|bb2121|bb2121
4634956|NCT03651128|Relapsed and Refractory Multiple Myeloma|relapsed and refractory multiple myeloma
4634957|NCT03651128|High Risk Multiple Myeloma|high risk multiple myeloma
4634958|NCT03651102|Thalidomide|thalidomide
4634959|NCT03651089|acute myocardial infarction|acute myocardial infarction
4634960|NCT03651089|inflammation|inflammation
4634961|NCT03651063|rehabilitation; social robots|rehabilitation; social robots
4634962|NCT03651037|cancer, bone health, physical activity, technology platform|cancer, bone health, physical activity, technology platform
4634963|NCT03651011|Branch Retinal Vein Occlusion|branch retinal vein occlusion
4634964|NCT03651011|Navigated laser photocoagulation|navigated laser photocoagulation
4634965|NCT03651011|Macular Edema|macular edema
4634966|NCT03651011|Oximetry|oximetry
4634967|NCT03651011|Retinal vascular caliber measurements|retinal vascular caliber measurements
4634968|NCT03651011|Microperimetry|microperimetry
4634969|NCT03650998|nerve block|nerve block
4634970|NCT03650998|ultrasound|ultrasound
4634971|NCT03650998|opioids|opioids
4634972|NCT03650998|hysterectomy|hysterectomy
4634973|NCT03650946|Prostate cancer|prostate cancer
4634974|NCT03650946|Ga-68 PSMA PET|ga-68 psma pet
4634975|NCT03650933|GB241|gb241
4634976|NCT03650933|Rituximab|rituximab
4634977|NCT03650933|Diffuse Large B-cell Lymphoma|diffuse large b-cell lymphoma
4634978|NCT03650933|Non Hodgkin's Lymphoma|non hodgkin's lymphoma
4634979|NCT03650920|HCV|hcv
4634980|NCT03650894|Breast Cancer|breast cancer
4634981|NCT03650894|Her2 negative breast cancer|her2 negative breast cancer
4634982|NCT03650894|Immunotherapy|immunotherapy
4634983|NCT03650894|Opdivo|opdivo
4634984|NCT03650894|Nivolumab|nivolumab
4634985|NCT03650894|Yervoy|yervoy
4634986|NCT03650894|Ipilimumab|ipilimumab
4634987|NCT03650894|Bicalutamide|bicalutamide
4634988|NCT03650894|Casodex|casodex
4634989|NCT03650868|Thoracal Paravertebral Block|thoracal paravertebral block
4634990|NCT03650868|Breast Surgery|breast surgery
4634991|NCT03650868|Seroma Reduction|seroma reduction
4634992|NCT03650855|degenerative spine disease|degenerative spine disease
4634993|NCT03650855|screw loosening|screw loosening
4634994|NCT03650855|Quantitative CT scan|quantitative ct scan
4634995|NCT03650855|vertebral bone density|vertebral bone density
4634996|NCT03650829|ART|art
4634997|NCT03650829|Offspring|offspring
4634998|NCT03650829|Development|development
4634999|NCT03650829|Cohort|cohort
4635000|NCT03650816|Alzheimer Disease|alzheimer disease
4635001|NCT03650816|Subjective cognitive impairment|subjective cognitive impairment
4635002|NCT03650816|Cognitive Dysfunction|cognitive dysfunction
4635003|NCT03650816|Neurodegenerative Diseases|neurodegenerative diseases
4635004|NCT03650816|Cerebrovascular reactivity|cerebrovascular reactivity
4635005|NCT03650816|Doppler ultrasonography|doppler ultrasonography
4635006|NCT03650816|Biomarker|biomarker
4635007|NCT03650816|Endothelin-1|endothelin-1
4635008|NCT03650816|Big-Endothelin-1|big-endothelin-1
4635009|NCT03650816|ADMA|adma
4635010|NCT03650816|Renin|renin
4635011|NCT03650803|3D MR Fingerprinting|3d mr fingerprinting
4635012|NCT03650803|Quantitative MR Imaging|quantitative mr imaging
4635013|NCT03650790|CTRP|ctrp
4635014|NCT03650790|Adipocytokines|adipocytokines
4635015|NCT03650790|pre-eclampsia|pre-eclampsia
4635016|NCT03650751|stroke；nursing assessment；condition of a patient；deterioration；|stroke；nursing assessment；condition of a patient；deterioration；
4635017|NCT03650725|Colonoscopy|colonoscopy
4635018|NCT03650725|bowel preparation|bowel preparation
4635019|NCT03650712|cystic fibrosis|cystic fibrosis
4635020|NCT03650712|insulin|insulin
4635021|NCT03650712|glucose|glucose
4635022|NCT03650712|children|children
4635023|NCT03650712|abnormal glucose tolerance|abnormal glucose tolerance
4635024|NCT03650712|impaired glucose tolerance|impaired glucose tolerance
4635025|NCT03650712|indeterminate glycemia|indeterminate glycemia
4635026|NCT03650712|diabetes|diabetes
4635027|NCT03650699|Oral Cavity Squamous Cell Carcinoma|oral cavity squamous cell carcinoma
4635028|NCT03650699|Biofeedback|biofeedback
4635029|NCT03650699|Rehabilitation|rehabilitation
4635030|NCT03650699|Head and Neck Cancer|head and neck cancer
4635031|NCT03650699|electropalatography|electropalatography
4635032|NCT03650699|EPG|epg
4635033|NCT03650673|Hand osteoarthritis|hand osteoarthritis
4635034|NCT03650673|Prospective cohort|prospective cohort
4635035|NCT03650673|Cartilage|cartilage
4635036|NCT03650673|Mobility|mobility
4635037|NCT03650647|Dental caries|dental caries
4635038|NCT03650647|Dentin|dentin
4635039|NCT03650647|Pulp exposure prevention|pulp exposure prevention
4635040|NCT03650647|Deep caries lesion|deep caries lesion
4635041|NCT03650647|Conservative Treatment|conservative treatment
4635042|NCT03650634|supernumerary tooth|supernumerary tooth
4635043|NCT03650634|hyperdontia|hyperdontia
4635044|NCT03650634|mesiodens|mesiodens
4635045|NCT03650634|paramolar|paramolar
4635046|NCT03650595|MRI|mri
4635047|NCT03650595|Focal Laser Ablation|focal laser ablation
4635048|NCT03650595|MR-Guided Focal Laser Ablation|mr-guided focal laser ablation
4635049|NCT03650582|food intake|food intake
4635050|NCT03650582|energy expenditure|energy expenditure
4635051|NCT03650582|central nervous system|central nervous system
4635052|NCT03650582|appetite|appetite
4635053|NCT03650569|Angelman Syndrome|angelman syndrome
4635054|NCT03650569|Caregivers|caregivers
4635055|NCT03650569|Parents|parents
4635056|NCT03650569|Rare diseases|rare diseases
4635057|NCT03650569|Registries|registries
4635058|NCT03650530|Family-centred intervention|family-centred intervention
4635059|NCT03650530|Support program|support program
4635060|NCT03650530|The Family Talk Intervention|the family talk intervention
4635061|NCT03650517|Laparoscopic|laparoscopic
4635062|NCT03650517|Robotic|robotic
4635063|NCT03650517|Right colon tumor|right colon tumor
4635064|NCT03650517|Anastomosis|anastomosis
4635065|NCT03650517|Intracorporeal|intracorporeal
4635066|NCT03650517|Extracorporeal|extracorporeal
4635067|NCT03650478|Intensive Care|intensive care
4635068|NCT03650478|mechanical ventilation|mechanical ventilation
4635069|NCT03650478|noninvasive ventilation|noninvasive ventilation
4635070|NCT03650465|generalized anxiety|generalized anxiety
4635071|NCT03650465|GAD|gad
4635072|NCT03650465|worry|worry
4635073|NCT03650465|CBT|cbt
4635074|NCT03650465|REBT|rebt
4635075|NCT03650465|ACT|act
4635076|NCT03650452|Drug Therapy|drug therapy
4635077|NCT03650400|Fevipiprant,|fevipiprant,
4635078|NCT03650400|GINA 2018,|gina 2018,
4635079|NCT03650400|Pediatrics|pediatrics
4635080|NCT03650374|Meniscus root tear|meniscus root tear
4635081|NCT03650348|HER2-positive breast cancer|her2-positive breast cancer
4635082|NCT03650348|HER2-positive gastric cancer|her2-positive gastric cancer
4635083|NCT03650348|HER2-positive bladder cancer|her2-positive bladder cancer
4635084|NCT03650348|Pieris|pieris
4635085|NCT03650348|PRS-343|prs-343
4635086|NCT03650348|Anticalin|anticalin
4635087|NCT03650348|Bispecific|bispecific
4635088|NCT03650348|4-1BB|4-1bb
4635089|NCT03650348|CD137|cd137
4635090|NCT03650348|HER2|her2
4635091|NCT03650348|Atezolizumab|atezolizumab
4635092|NCT03650335|erector spine plan block|erector spine plan block
4635093|NCT03650335|postoperative opioid consumption|postoperative opioid consumption
4635094|NCT03650335|thoracotomy|thoracotomy
4635095|NCT03650335|analgesia|analgesia
4635096|NCT03650335|anesthesia|anesthesia
4635097|NCT03650309|Deep Brain Stimulation|deep brain stimulation
4635098|NCT03650309|Functional Neurosurgery|functional neurosurgery
4635099|NCT03650309|Neuromodulation|neuromodulation
4635100|NCT03650309|Bariatrics|bariatrics
4635101|NCT03650309|Weight Loss|weight loss
4635102|NCT03650309|Addiction|addiction
4635103|NCT03650257|supratentorial glioma|supratentorial glioma
4635104|NCT03650231|Epstein-barr virus|epstein-barr virus
4635105|NCT03650231|infectious mononucleosis|infectious mononucleosis
4635106|NCT03650179|urine stream interruption exercise|urine stream interruption exercise
4635107|NCT03650179|voiding function|voiding function
4635108|NCT03650179|pelvic floor muscles exercise|pelvic floor muscles exercise
4635109|NCT03650166|mhealth|mhealth
4635110|NCT03650166|short-messaging system|short-messaging system
4635111|NCT03650166|self-management|self-management
4635112|NCT03650166|home blood pressure monitoring|home blood pressure monitoring
4635113|NCT03650166|health literacy|health literacy
4635114|NCT03650140|Gout|gout
4635115|NCT03650140|Tart Cherry|tart cherry
4635116|NCT03650140|Pharmacokinetics|pharmacokinetics
4635117|NCT03650127|Genetic risk score|genetic risk score
4635118|NCT03650127|metabolic risk score|metabolic risk score
4635119|NCT03650127|health promotion|health promotion
4635120|NCT03650127|web-based|web-based
4635121|NCT03650127|intervention|intervention
4635122|NCT03650114|ofatumumab|ofatumumab
4635123|NCT03650114|relapsing multiple sclerosis|relapsing multiple sclerosis
4635124|NCT03650101|Hydrocephalus|hydrocephalus
4635125|NCT03650062|Patient Reported Outcome Measures|patient reported outcome measures
4635126|NCT03650062|Follow-Up Studies|follow-up studies
4635127|NCT03650062|Patient Outcome Assessment|patient outcome assessment
4635128|NCT03650062|Treatment Outcome|treatment outcome
4635129|NCT03650062|Pancreatitis, Acute Necrotizing|pancreatitis, acute necrotizing
4635130|NCT03650036|Primary teeth|primary teeth
4635131|NCT03650036|Dental Pulp Necrosis|dental pulp necrosis
4635132|NCT03650036|Root Canal Obturation|root canal obturation
4635133|NCT03650023|Chitosan Oligosaccharide|chitosan oligosaccharide
4635134|NCT03650023|diabetes mellitus|diabetes mellitus
4635135|NCT03650023|blood glucose|blood glucose
4635136|NCT03650023|fasting blood sugar|fasting blood sugar
4635137|NCT03650023|normal blood glucose|normal blood glucose
4635138|NCT03650023|impaired fasting glucose|impaired fasting glucose
4635139|NCT03650023|Impaired Glucose Tolerance|impaired glucose tolerance
4635140|NCT03649984|Symptom-management|symptom-management
4635141|NCT03649984|Outpatients|outpatients
4635142|NCT03649984|Nurse-led intervention|nurse-led intervention
4635143|NCT03649984|Implementation|implementation
4635144|NCT03649958|concussion|concussion
4635145|NCT03649958|mTBI|mtbi
4635146|NCT03649958|headache|headache
4635147|NCT03649958|insomnia|insomnia
4635148|NCT03649958|PTS|pts
4635149|NCT03649958|anxiety|anxiety
4635150|NCT03649958|pain|pain
4635151|NCT03649958|depression|depression
4635152|NCT03649958|sleep|sleep
4635153|NCT03649932|Bronchopulmonary dysplasia|bronchopulmonary dysplasia
4635154|NCT03649932|Pulmonary hypertension|pulmonary hypertension
4635155|NCT03649932|Citrulline|citrulline
4635156|NCT03649906|Micro-coil|micro-coil
4635157|NCT03649906|CT-guided locate|ct-guided locate
4635158|NCT03649893|sedentary behavior|sedentary behavior
4635159|NCT03649893|phyical activity|phyical activity
4635160|NCT03649893|workplace interventions|workplace interventions
4635161|NCT03649893|active breaks|active breaks
4635162|NCT03649893|workplace ergonomics|workplace ergonomics
4635163|NCT03649854|TAPSE|tapse
4635164|NCT03649854|Right heart function|right heart function
4635165|NCT03649841|Prostate Cancer|prostate cancer
4635166|NCT03649828|kefir|kefir
4635167|NCT03649828|Probiotics|probiotics
4635168|NCT03649828|Metabolic Syndrome|metabolic syndrome
4635169|NCT03649828|Cardiovascular Diseases|cardiovascular diseases
4635170|NCT03649828|Hypertension|hypertension
4635171|NCT03649815|schizophrenia|schizophrenia
4635172|NCT03649815|psychosis|psychosis
4635173|NCT03649815|mHealth|mhealth
4635174|NCT03649815|digital health|digital health
4635175|NCT03649789|healing|healing
4635176|NCT03649789|biomarkers|biomarkers
4635177|NCT03649789|sanative therapy|sanative therapy
4635178|NCT03649789|nutritional supplements|nutritional supplements
4635179|NCT03649789|medications|medications
4635180|NCT03649789|salivary flow|salivary flow
4635181|NCT03649776|Disparities|disparities
4635182|NCT03649711|P2Y12 inhibitors|p2y12 inhibitors
4635183|NCT03649711|Platelet aggregation|platelet aggregation
4635184|NCT03649711|ticagrelor|ticagrelor
4635185|NCT03649711|clopidogrel|clopidogrel
4635186|NCT03649711|chronic kidney disease|chronic kidney disease
4635187|NCT03649698|Sarcopenia|sarcopenia
4635188|NCT03649698|Nutrition|nutrition
4635189|NCT03649698|Protein|protein
4635190|NCT03649698|Vitamin D|vitamin d
4635191|NCT03649698|Exercise|exercise
4635192|NCT03649698|Older people|older people
4635193|NCT03649698|Frailty|frailty
4635194|NCT03649672|Tof Watch, rocuronium|tof watch, rocuronium
4635195|NCT03649646|Hypertension|hypertension
4635196|NCT03649646|Fimasartan|fimasartan
4635197|NCT03649633|Shock, Septic|shock, septic
4635198|NCT03649633|Cerebrovascular Circulation|cerebrovascular circulation
4635199|NCT03649633|Spectroscopy, Near-Infrared|spectroscopy, near-infrared
4635200|NCT03649633|Patient Reported Outcome Measure|patient reported outcome measure
4635201|NCT03649620|cholesterol|cholesterol
4635202|NCT03649620|Bokbunja|bokbunja
4635203|NCT03649620|Clinical Trial|clinical trial
4635204|NCT03649529|HLA-A2|hla-a2
4635205|NCT03649529|gp100|gp100
4635206|NCT03649516|mHealth|mhealth
4635207|NCT03649516|Mobile application|mobile application
4635208|NCT03649516|Chronic Kidney Diseases|chronic kidney diseases
4635209|NCT03649503|Brain Health|brain health
4635210|NCT03649503|Brain Research|brain research
4635211|NCT03649503|parkinsonism|parkinsonism
4635212|NCT03649503|prospective cohort study|prospective cohort study
4635213|NCT03649503|large sample size|large sample size
4635214|NCT03649477|PWS|pws
4635215|NCT03649477|Prader-Willi syndrome|prader-willi syndrome
4635216|NCT03649477|carbetocin|carbetocin
4635217|NCT03649464|recurrent high-grade glioma|recurrent high-grade glioma
4635218|NCT03649451|Reference dose levels|reference dose levels
4635219|NCT03649451|Surgery|surgery
4635220|NCT03649451|C-arm|c-arm
4635221|NCT03649451|Orthopedic|orthopedic
4635222|NCT03649451|Urology|urology
4635223|NCT03649451|Vascular|vascular
4635224|NCT03649451|Neurosurgery|neurosurgery
4635225|NCT03649451|Cardiology|cardiology
4635226|NCT03649451|Digestive|digestive
4635227|NCT03649451|Fluoroscopy|fluoroscopy
4635228|NCT03649451|Patient radiation protection|patient radiation protection
4635229|NCT03649451|X-ray|x-ray
4635230|NCT03649451|Interventional radiology|interventional radiology
4635231|NCT03649451|Optimization|optimization
4635232|NCT03649451|Kerma Area Product|kerma area product
4635233|NCT03649425|infection|infection
4635234|NCT03649425|pin site|pin site
4635235|NCT03649425|external fixator|external fixator
4635236|NCT03649425|hydroxyapatite coated|hydroxyapatite coated
4635237|NCT03649412|Tablet formulation|tablet formulation
4635238|NCT03649412|Sequence|sequence
4635239|NCT03649412|Immediate release|immediate release
4635240|NCT03649412|Pharmacokinetic|pharmacokinetic
4635241|NCT03649373|Shoulder|shoulder
4635242|NCT03649373|Dislocation|dislocation
4635243|NCT03649373|Noergaard|noergaard
4635244|NCT03649373|Reduction|reduction
4635245|NCT03649360|Knee pain|knee pain
4635246|NCT03649360|Intramedullary tibial nail|intramedullary tibial nail
4635248|NCT03649347|Exposure therapy|exposure therapy
4635249|NCT03649347|Technology|technology
4635250|NCT03649347|Telemedicine|telemedicine
4635251|NCT03649308|Negative pressure wound therapy|negative pressure wound therapy
4635252|NCT03649308|Skin graft|skin graft
4635253|NCT03649308|split-thickness skin graft|split-thickness skin graft
4635254|NCT03649282|NCPAP|ncpap
4635255|NCT03649282|HFNC|hfnc
4635256|NCT03649282|Preterm infants|preterm infants
4635257|NCT03649282|Cardiorespiratory behaviour|cardiorespiratory behaviour
4635258|NCT03649282|Non-invasive respiratory support|non-invasive respiratory support
4635259|NCT03649269|Eryngium heterophyllum|eryngium heterophyllum
4635260|NCT03649269|Amphipterygium adstringens|amphipterygium adstringens
4635261|NCT03649269|tea|tea
4635262|NCT03649256|conventional suture, barbed suture, niche, scar, cesarean section|conventional suture, barbed suture, niche, scar, cesarean section
4635263|NCT03649243|Diabetes|diabetes
4635264|NCT03649243|Foot wounds|foot wounds
4635265|NCT03649243|oxidative stress|oxidative stress
4635266|NCT03649243|inflammation|inflammation
4635267|NCT03649243|propolis|propolis
4635268|NCT03649204|PAD|pad
4635269|NCT03649191|Advance Care Planning|advance care planning
4635270|NCT03649191|Evidence-based practice|evidence-based practice
4635271|NCT03649191|Sustainability|sustainability
4635272|NCT03649191|Scalability|scalability
4635273|NCT03649165|MEK Inhibitor|mek inhibitor
4635274|NCT03649165|Selumetinib capsule|selumetinib capsule
4635275|NCT03649165|Selumetinib granule|selumetinib granule
4635276|NCT03649165|PK|pk
4635277|NCT03649165|Bioavailibilty|bioavailibilty
4635278|NCT03649165|Crossover study|crossover study
4635279|NCT03649165|Open-label|open-label
4635280|NCT03649165|Food effect|food effect
4635281|NCT03649126|standardized structured reporting|standardized structured reporting
4635282|NCT03649126|treatment decisions|treatment decisions
4635283|NCT03649126|multidisciplinary team|multidisciplinary team
4635284|NCT03649126|pathology|pathology
4635285|NCT03649126|implementation tools|implementation tools
4635286|NCT03649100|Dental implants|dental implants
4635287|NCT03649100|Implant stability|implant stability
4635288|NCT03649100|Osseointegration|osseointegration
4635289|NCT03649100|ISQ measurement|isq measurement
4635290|NCT03649074|ADHD|adhd
4635291|NCT03649061|COBRA-Slim|cobra-slim
4635292|NCT03649061|Accelerated access to anti-TNF|accelerated access to anti-tnf
4635293|NCT03649061|treat to target|treat to target
4635294|NCT03649061|remission induction|remission induction
4635295|NCT03649009|Thiamine|thiamine
4635296|NCT03649009|Lactate|lactate
4635297|NCT03649009|Septic shock|septic shock
4635298|NCT03648996|arterial stiffness|arterial stiffness
4635299|NCT03648996|endothelial dysfunction|endothelial dysfunction
4635300|NCT03648996|type 2 diabetes|type 2 diabetes
4635301|NCT03648996|hyperuricemia|hyperuricemia
4635302|NCT03648983|Enhanced Lymphedema|enhanced lymphedema
4635303|NCT03648970|Preeclampsia|preeclampsia
4635304|NCT03648970|Pravastatin|pravastatin
4635305|NCT03648970|Maternal morbidity|maternal morbidity
4635306|NCT03648970|Neonatal mortality|neonatal mortality
4635307|NCT03648970|Neonatal morbidity|neonatal morbidity
4635308|NCT03648944|Rehabilitation Outcome|rehabilitation outcome
4635309|NCT03648918|Family|family
4635310|NCT03648918|Healthy Controls|healthy controls
4635311|NCT03648905|Autonomic Failure|autonomic failure
4635312|NCT03648905|Dysautonomia|dysautonomia
4635313|NCT03648905|Parkinson's Disease|parkinson's disease
4635314|NCT03648905|Pure Autonomic Failure|pure autonomic failure
4635315|NCT03648905|Multiple System Atrophy|multiple system atrophy
4635316|NCT03648905|Lewy Body|lewy body
4635317|NCT03648905|Catecholamines|catecholamines
4635318|NCT03648905|Alpha-Synuclein|alpha-synuclein
4635319|NCT03648892|Dopamine Response|dopamine response
4635320|NCT03648892|Energy Expenditure|energy expenditure
4635321|NCT03648892|Neurocognitive Function|neurocognitive function
4635322|NCT03648892|Obesity|obesity
4635323|NCT03648879|Diagnostic|diagnostic
4635324|NCT03648879|Diagnosis|diagnosis
4635325|NCT03648879|EGD|egd
4635326|NCT03648879|Examination of Stomach|examination of stomach
4635327|NCT03648853|photoplethysmography|photoplethysmography
4635328|NCT03648853|stress response|stress response
4635329|NCT03648814|Neovascular glaucoma|neovascular glaucoma
4635330|NCT03648775|Osteosynthesis|osteosynthesis
4635331|NCT03648775|Prophylactic consolidation|prophylactic consolidation
4635332|NCT03648775|Proximal femur|proximal femur
4635333|NCT03648762|Heart failure|heart failure
4635334|NCT03648762|Exercise|exercise
4635335|NCT03648762|Cardiopulmonary|cardiopulmonary
4635336|NCT03648736|FGF23, TASH|fgf23, tash
4635337|NCT03648710|Sickle Cell Disease|sickle cell disease
4635338|NCT03648684|Nonmedical prescription stimulant use|nonmedical prescription stimulant use
4635339|NCT03648684|Expectancy challenge|expectancy challenge
4635340|NCT03648684|College students|college students
4635341|NCT03648671|Safinamide|safinamide
4635342|NCT03648671|Pain|pain
4635343|NCT03648671|Parkinson|parkinson
4635344|NCT03648645|Pregnancy|pregnancy
4635345|NCT03648645|Hypertension|hypertension
4635346|NCT03648645|telemonitoring|telemonitoring
4635347|NCT03648632|Stereotactic Radiotherapy|stereotactic radiotherapy
4635348|NCT03648606|infant|infant
4635349|NCT03648606|thermoregulation|thermoregulation
4635350|NCT03648606|wakefulness episode|wakefulness episode
4635351|NCT03648593|microenterpreneur|microenterpreneur
4635352|NCT03648593|work ability|work ability
4635353|NCT03648593|work recovery|work recovery
4635354|NCT03648593|native mobile app|native mobile app
4635355|NCT03648593|health behaviour|health behaviour
4635356|NCT03648593|work|work
4635357|NCT03648593|stress|stress
4635358|NCT03648593|work performance|work performance
4635359|NCT03648567|GLILD|glild
4635360|NCT03648567|Common variable immunodeficiency|common variable immunodeficiency
4635361|NCT03648567|children|children
4635362|NCT03648528|Vitamin D Deficiency|vitamin d deficiency
4635363|NCT03648528|hyperparathyroidism|hyperparathyroidism
4635364|NCT03648528|hemodialysis|hemodialysis
4635365|NCT03648515|Validity|validity
4635366|NCT03648515|Reliability|reliability
4635367|NCT03648515|Reproducibility|reproducibility
4635368|NCT03648515|Intra-oral images|intra-oral images
4635369|NCT03648515|Plaster models|plaster models
4635370|NCT03648515|Digital images|digital images
4635371|NCT03648515|Little's index of irregularity|little's index of irregularity
4635372|NCT03648515|Bolton's analysis|bolton's analysis
4635373|NCT03648515|Tooth-size-arch-length-discrepancy|tooth-size-arch-length-discrepancy
4635374|NCT03648502|dementia|dementia
4635375|NCT03648502|hearing loss|hearing loss
4635376|NCT03648502|auditory process|auditory process
4635377|NCT03648489|TAK228|tak228
4635378|NCT03648489|TAK-228|tak-228
4635379|NCT03648489|Paclitaxel|paclitaxel
4635380|NCT03648489|Ovarian cancer|ovarian cancer
4635381|NCT03648489|Platinum resistant|platinum resistant
4635382|NCT03648476|Anger|anger
4635383|NCT03648476|Aggression|aggression
4635384|NCT03648476|Hostility|hostility
4635385|NCT03648437|acetaminophen|acetaminophen
4635386|NCT03648437|ibuprofen|ibuprofen
4635387|NCT03648437|preterm infant|preterm infant
4635388|NCT03648437|near infra-red spectroscopy|near infra-red spectroscopy
4635389|NCT03648424|Linagliptin|linagliptin
4635390|NCT03648424|Cardiovascular Death|cardiovascular death
4635391|NCT03648424|Stroke|stroke
4635392|NCT03648424|Myocardial Infarction|myocardial infarction
4635393|NCT03648424|Hospitalization for Unstable Angina|hospitalization for unstable angina
4635394|NCT03648424|Type 2 diabetes mellitus|type 2 diabetes mellitus
4635395|NCT03648424|Glimepiride|glimepiride
4635396|NCT03648411|malaria|malaria
4635397|NCT03648411|falciparum|falciparum
4635398|NCT03648411|vivax|vivax
4635399|NCT03648411|Myanmar|myanmar
4635400|NCT03648411|migrant workers|migrant workers
4635401|NCT03648411|asymptomatic infection|asymptomatic infection
4636284|NCT03642938|Dose|dose
4635402|NCT03648411|drug resistance|drug resistance
4635403|NCT03648398|Therapeutic education program|therapeutic education program
4635404|NCT03648398|Online|online
4635405|NCT03648372|Drug therapy|drug therapy
4635406|NCT03648359|Prostate biopsy|prostate biopsy
4635407|NCT03648359|Prostate cancer|prostate cancer
4635408|NCT03648359|Magnetic resonance imaging|magnetic resonance imaging
4635409|NCT03648359|Neoplasm staging|neoplasm staging
4635410|NCT03648333|amlodipine|amlodipine
4635411|NCT03648333|valsartan|valsartan
4635412|NCT03648333|hypertension|hypertension
4635413|NCT03648320|IgE mediated peanut allergy|ige mediated peanut allergy
4635414|NCT03648320|Oral immunotherapy|oral immunotherapy
4635415|NCT03648320|Desensitisation|desensitisation
4635416|NCT03648320|GUPI|gupi
4635417|NCT03648307|Splenectomy|splenectomy
4635418|NCT03648307|metabolism|metabolism
4635419|NCT03648307|diabetes|diabetes
4635420|NCT03648307|stem cells|stem cells
4635421|NCT03648307|trauma surgery|trauma surgery
4635422|NCT03648294|blood pressure|blood pressure
4635423|NCT03648268|brain|brain
4635424|NCT03648268|networks|networks
4635425|NCT03648268|schizophrenia|schizophrenia
4635426|NCT03648242|pediatric obesity|pediatric obesity
4635427|NCT03648242|electronic health record|electronic health record
4635428|NCT03648242|clinical decision support|clinical decision support
4635429|NCT03648229|glaucoma|glaucoma
4635430|NCT03648229|laser|laser
4635431|NCT03648229|Africa|africa
4635432|NCT03648216|Sedentary Behaviour|sedentary behaviour
4635433|NCT03648216|Subjective Well-Being|subjective well-being
4635434|NCT03648216|University Students|university students
4635435|NCT03648203|asthma|asthma
4635436|NCT03648203|quality of life|quality of life
4635437|NCT03648203|self-care|self-care
4635438|NCT03648203|healthcare utilization|healthcare utilization
4635439|NCT03648190|GT|gt
4635440|NCT03648190|CD|cd
4635441|NCT03648177|Behavioral Intervention|behavioral intervention
4635442|NCT03648177|Medication Adherence|medication adherence
4635443|NCT03648177|Psychosocial Treatment|psychosocial treatment
4635444|NCT03648164|well-being|well-being
4635445|NCT03648164|health behavior|health behavior
4635446|NCT03648164|choice|choice
4635447|NCT03648164|rest|rest
4635448|NCT03648164|environment|environment
4635449|NCT03648164|activity|activity
4635450|NCT03648164|trust|trust
4635451|NCT03648164|interpersonal relationships|interpersonal relationships
4635452|NCT03648164|outlook|outlook
4635453|NCT03648164|nutrition|nutrition
4635454|NCT03648164|survey|survey
4635455|NCT03648164|student|student
4635456|NCT03648164|college|college
4635457|NCT03648164|university|university
4635458|NCT03648151|Radomic feature|radomic feature
4635459|NCT03648151|PET|pet
4635460|NCT03648151|CT|ct
4635461|NCT03648125|young elite rowers|young elite rowers
4635462|NCT03648112|dietary fibres|dietary fibres
4635463|NCT03648112|ß-glucan|ß-glucan
4635464|NCT03648112|low-density-lipoprotein-cholesterol|low-density-lipoprotein-cholesterol
4635465|NCT03648112|insulin|insulin
4635466|NCT03648112|fasting glucose|fasting glucose
4635467|NCT03648112|microbiota|microbiota
4635468|NCT03648099|Labor Pain|labor pain
4635469|NCT03648099|Labor dance|labor dance
4635470|NCT03648099|Music|music
4635471|NCT03648099|Fear of childbirth|fear of childbirth
4635472|NCT03648086|NAFLD|nafld
4635473|NCT03647995|Probiotics|probiotics
4635474|NCT03647995|Diarrhea|diarrhea
4635475|NCT03647995|Clostridium difficile|clostridium difficile
4635476|NCT03647995|Antibiotics|antibiotics
4635477|NCT03647995|Antibiotic-associated diarrhea|antibiotic-associated diarrhea
4635478|NCT03647995|Clostridium difficile-associated diarrhea|clostridium difficile-associated diarrhea
4635479|NCT03647995|Microbial flora|microbial flora
4635480|NCT03647956|Atezolizumab|atezolizumab
4635481|NCT03647956|Bevacizumab|bevacizumab
4635482|NCT03647956|Carboplatin|carboplatin
4635483|NCT03647956|Pemetrexed|pemetrexed
4635484|NCT03647956|EGFR-mutant metastatic NSCLC|egfr-mutant metastatic nsclc
4635485|NCT03647904|Employment|employment
4635486|NCT03647904|Self efficacy|self efficacy
4635487|NCT03647891|obstructive sleep apnea|obstructive sleep apnea
4635488|NCT03647891|CPAP|cpap
4635489|NCT03647891|hospital readmission|hospital readmission
4635490|NCT03647891|heart failure|heart failure
4635491|NCT03647891|myocardial infarction|myocardial infarction
4635492|NCT03647891|cardiac arrhythmia|cardiac arrhythmia
4635493|NCT03647865|Computer Guided,|computer guided,
4635494|NCT03647865|Osseous Genioplasty|osseous genioplasty
4635495|NCT03647865|Custom Made Titanium Plates|custom made titanium plates
4635496|NCT03647865|Orthognathic Surgery|orthognathic surgery
4635497|NCT03647865|Genioplasty|genioplasty
4635498|NCT03647865|patient Specific device|patient specific device
4635499|NCT03647852|severe gastrointestinal involvement|severe gastrointestinal involvement
4635500|NCT03647839|Microsatellite stable tumour|microsatellite stable tumour
4635501|NCT03647839|Refractory colorectal cancer|refractory colorectal cancer
4635502|NCT03647839|Tumour microenvironment|tumour microenvironment
4635503|NCT03647839|Vascular Disrupting Agent|vascular disrupting agent
4635504|NCT03647839|STAT3 inhibitors|stat3 inhibitors
4635505|NCT03647839|PD1 inhibitors|pd1 inhibitors
4636285|NCT03642938|Analgesia|analgesia
4635506|NCT03647839|Unresectable colorectal cancer|unresectable colorectal cancer
4635507|NCT03647839|nivolumab|nivolumab
4635508|NCT03647839|BNC105|bnc105
4635509|NCT03647839|BBI-608|bbi-608
4635510|NCT03647826|youth mental health|youth mental health
4635511|NCT03647826|mental health prevention|mental health prevention
4635512|NCT03647826|empowerment|empowerment
4635513|NCT03647800|APVO436|apvo436
4635514|NCT03647774|Extended release naltrexone|extended release naltrexone
4635515|NCT03647774|Opioid dependence|opioid dependence
4635516|NCT03647774|Recovery|recovery
4635517|NCT03647774|Health economics|health economics
4635518|NCT03647761|Tetra-grip|tetra-grip
4635519|NCT03647761|Assisting Hand Assessment|assisting hand assessment
4635520|NCT03647696|respiratory depression, opioid-induced sedation|respiratory depression, opioid-induced sedation
4635521|NCT03647670|PF-04965842|pf-04965842
4635522|NCT03647657|Calcitonin|calcitonin
4635523|NCT03647657|Medullary thyroid carcinoma|medullary thyroid carcinoma
4635524|NCT03647657|Peptide receptor radionuclide therapy|peptide receptor radionuclide therapy
4635525|NCT03647657|Gastrin|gastrin
4635526|NCT03647657|Cholecystokinin-2 receptor|cholecystokinin-2 receptor
4635527|NCT03647644|Cardiac Surgery|cardiac surgery
4635528|NCT03647644|Bleeding|bleeding
4635529|NCT03647644|Transfusion|transfusion
4635530|NCT03647644|Acute Normovolemic Hemodilution|acute normovolemic hemodilution
4635531|NCT03647605|vr|vr
4635532|NCT03647605|virtual reality|virtual reality
4635533|NCT03647605|social phobia|social phobia
4635534|NCT03647605|vret|vret
4635535|NCT03647605|virtual reality exposure therapy|virtual reality exposure therapy
4635536|NCT03647592|Non-small Cell Lung Cancer|non-small cell lung cancer
4635537|NCT03647592|Bevacizumab|bevacizumab
4635538|NCT03647592|erlotinib|erlotinib
4635539|NCT03647592|EGFR mutation positive|egfr mutation positive
4635540|NCT03647566|sodium fluoride|sodium fluoride
4635541|NCT03647566|positron emission tomography|positron emission tomography
4635542|NCT03647566|computed tomography|computed tomography
4635543|NCT03647566|acute aortic syndrome|acute aortic syndrome
4635544|NCT03647566|aortic dissection|aortic dissection
4635545|NCT03647566|intramural haematoma|intramural haematoma
4635546|NCT03647566|penetrating aortic ulcer|penetrating aortic ulcer
4635547|NCT03647540|fluorescence laparoscopy|fluorescence laparoscopy
4635548|NCT03647540|adenocarcinoma of the esophagogastric junction (AEG)|adenocarcinoma of the esophagogastric junction (aeg)
4635549|NCT03647527|nasopharyngeal carcinoma|nasopharyngeal carcinoma
4635550|NCT03647527|acute radiation oral mucositis|acute radiation oral mucositis
4635551|NCT03647527|intensity modulated radiotherapy|intensity modulated radiotherapy
4635552|NCT03647527|tomography radiotherapy|tomography radiotherapy
4635553|NCT03647514|neoadjuvant chemotherapy|neoadjuvant chemotherapy
4635554|NCT03647514|Abraxane|abraxane
4635555|NCT03647514|Xeloda|xeloda
4635556|NCT03647501|lumbar spinal arthrodesis|lumbar spinal arthrodesis
4635557|NCT03647501|interbody cage|interbody cage
4635558|NCT03647501|3D-printing|3d-printing
4635559|NCT03647488|Non-small-cell lung carcinoma|non-small-cell lung carcinoma
4635560|NCT03647488|Non-small-cell lung cancer|non-small-cell lung cancer
4635561|NCT03647488|NSCLC|nsclc
4635562|NCT03647488|epidermal growth factor receptor wild type|epidermal growth factor receptor wild type
4635563|NCT03647488|EGFRwt|egfrwt
4635564|NCT03647488|Anaplastic lymphoma kinase negative|anaplastic lymphoma kinase negative
4635565|NCT03647488|ALK-|alk-
4635566|NCT03647488|INC280|inc280
4635567|NCT03647488|capmatinib and spartalizumab|capmatinib and spartalizumab
4635568|NCT03647488|combination therapy|combination therapy
4635569|NCT03647488|docetaxel|docetaxel
4635570|NCT03647462|obstructive sleep apnea|obstructive sleep apnea
4635571|NCT03647462|chronic obstructive sleep apnea|chronic obstructive sleep apnea
4635572|NCT03647462|hospital readmission|hospital readmission
4635573|NCT03647449|Juice fasting; methylation; microbiome; caloric restriction|juice fasting; methylation; microbiome; caloric restriction
4635574|NCT03647397|asthma|asthma
4635575|NCT03647397|environmental intervention|environmental intervention
4635576|NCT03647397|respiratory distress|respiratory distress
4635577|NCT03647397|pediatric hospitalization|pediatric hospitalization
4635578|NCT03647397|pneumonia|pneumonia
4635579|NCT03647397|bronchiolitis|bronchiolitis
4635580|NCT03647384|Traditional Chinese medicine|traditional chinese medicine
4635581|NCT03647384|Randomized clinical trial|randomized clinical trial
4635582|NCT03647384|Mild-to-moderate cognitive impairment|mild-to-moderate cognitive impairment
4635583|NCT03647371|Difficult Intubation|difficult intubation
4635584|NCT03647371|Thyromental Height Test|thyromental height test
4635585|NCT03647371|Videolaryngoscopy|videolaryngoscopy
4635586|NCT03647358|Iodine-124|iodine-124
4635587|NCT03647358|PET Scan|pet scan
4635588|NCT03647358|18-253|18-253
4635589|NCT03647345|Noninvasive brain stimulation|noninvasive brain stimulation
4635590|NCT03647345|Repetitive Transcranial Magnetic Stimulation|repetitive transcranial magnetic stimulation
4635591|NCT03647345|Transcranial Direct Current Stimulation|transcranial direct current stimulation
4635592|NCT03647319|Noninvasive Brain Stimulation|noninvasive brain stimulation
4635593|NCT03647319|Repetitive Transcranial Magnetic Stimulation|repetitive transcranial magnetic stimulation
4635594|NCT03647319|Transcranial Direct Current Stimulation|transcranial direct current stimulation
4635595|NCT03647306|peripheral circadian clock|peripheral circadian clock
4635596|NCT03647306|central circadian clocks|central circadian clocks
4635597|NCT03647306|chronotype|chronotype
4635598|NCT03647306|diet|diet
4635599|NCT03647293|Central Catheter|central catheter
4635600|NCT03647293|Central Line|central line
4635601|NCT03647293|Internal Jugular Vein|internal jugular vein
4635602|NCT03647293|Neonate|neonate
4635603|NCT03647293|Peripherally Inserted Central Line|peripherally inserted central line
4635604|NCT03647293|Ultrasound Guided|ultrasound guided
4635605|NCT03647293|Pain Score|pain score
4635606|NCT03647280|Neoadjuvant Chemotherapy|neoadjuvant chemotherapy
4635607|NCT03647280|Abraxane|abraxane
4635608|NCT03647280|Epirubicin|epirubicin
4635609|NCT03647254|Anticoagulants|anticoagulants
4635610|NCT03647254|Warfarin|warfarin
4635611|NCT03647228|ION-827359|ion-827359
4635612|NCT03647228|ENaC|enac
4635613|NCT03647215|Chronic myeloid leukemia|chronic myeloid leukemia
4635614|NCT03647215|chronic phase|chronic phase
4635615|NCT03647215|accelerated phase|accelerated phase
4635616|NCT03647215|blast phase|blast phase
4635617|NCT03647215|Philadelphia chromosome-positive acute lymphoblastic leukemia|philadelphia chromosome-positive acute lymphoblastic leukemia
4635618|NCT03647215|tyrosine kinase inhibitor|tyrosine kinase inhibitor
4635619|NCT03647176|Cold snare polypectomy|cold snare polypectomy
4635620|NCT03647176|Colorectal polyps|colorectal polyps
4635621|NCT03647176|CARE Study|care study
4635622|NCT03647137|freezing of gait|freezing of gait
4635623|NCT03647137|amyloid|amyloid
4635624|NCT03647137|cholinergic|cholinergic
4635625|NCT03647137|mobility|mobility
4635626|NCT03647137|PET|pet
4635627|NCT03647137|imaging|imaging
4635628|NCT03647137|MRI|mri
4635629|NCT03647124|Mantle Cell Lymphoma|mantle cell lymphoma
4635630|NCT03647124|MCL|mcl
4635631|NCT03647124|Revlimid|revlimid
4635632|NCT03647124|Non-Interventional|non-interventional
4635633|NCT03647124|PASS|pass
4635634|NCT03647124|CC-5013|cc-5013
4635635|NCT03647124|Relapsed|relapsed
4635636|NCT03647124|Refractory|refractory
4635637|NCT03647124|TFR|tfr
4635638|NCT03647124|Tumor Flare Reaction|tumor flare reaction
4635639|NCT03647124|High Tumor Burden|high tumor burden
4635640|NCT03647111|Non-small Cell Lung Cancer|non-small cell lung cancer
4635641|NCT03647111|ALK rearranged|alk rearranged
4635642|NCT03647111|Crizotinib|crizotinib
4635643|NCT03647085|atrial fibrillation|atrial fibrillation
4635644|NCT03647085|atrial flutter|atrial flutter
4635645|NCT03647085|arrhythmia|arrhythmia
4635646|NCT03647046|Keratoconus, scleral lens|keratoconus, scleral lens
4635647|NCT03647033|istent|istent
4635648|NCT03647033|primary angle closure|primary angle closure
4635649|NCT03647020|oocyte|oocyte
4635650|NCT03647020|ovarian stimulation|ovarian stimulation
4635651|NCT03647020|dysmorphic cytoplasm|dysmorphic cytoplasm
4635652|NCT03647007|fat percentage|fat percentage
4635653|NCT03647007|physical fitness|physical fitness
4635654|NCT03647007|well-being|well-being
4635655|NCT03647007|small-sided games|small-sided games
4635656|NCT03646994|Non-small Cell Lung Cancer|non-small cell lung cancer
4635657|NCT03646994|Crizotinib|crizotinib
4635658|NCT03646994|ROS1 Rearranged|ros1 rearranged
4635659|NCT03646981|visceral leishmaniasis|visceral leishmaniasis
4635660|NCT03646981|diagnostics|diagnostics
4635661|NCT03646981|RDT|rdt
4635662|NCT03646981|Eastern Africa|eastern africa
4635663|NCT03646968|Anlotinib Combined With Docetaxel|anlotinib combined with docetaxel
4635664|NCT03646929|facilitation technique|facilitation technique
4635665|NCT03646929|multimodal evoked potentials (mmEP) in multiple sclerosis|multimodal evoked potentials (mmep) in multiple sclerosis
4635666|NCT03646929|motor evoked potential (MEP) in multiple sclerosis|motor evoked potential (mep) in multiple sclerosis
4635667|NCT03646890|Epidemiology|epidemiology
4635668|NCT03646890|Clinical features|clinical features
4635669|NCT03646890|Etiology|etiology
4635670|NCT03646890|Tertiary center|tertiary center
4635671|NCT03646838|International adoption|international adoption
4635672|NCT03646838|Family experiences|family experiences
4635673|NCT03646838|Adolescents|adolescents
4635674|NCT03646838|France|france
4635675|NCT03646747|head and neck|head and neck
4635676|NCT03646747|radiotherapy|radiotherapy
4635677|NCT03646747|magnetic resonance imaging|magnetic resonance imaging
4635678|NCT03646669|Older adults|older adults
4635679|NCT03646669|Asthma|asthma
4635680|NCT03646669|Symptom perception|symptom perception
4635681|NCT03646669|Self-management behaviors|self-management behaviors
4635682|NCT03646669|Medication adherence|medication adherence
4635683|NCT03646656|cardiovascular disease|cardiovascular disease
4635684|NCT03646656|social support|social support
4635685|NCT03646643|Atrial fibrillation|atrial fibrillation
4635686|NCT03646643|Coronary sinus-left atrium connection|coronary sinus-left atrium connection
4635687|NCT03646643|Ablation|ablation
4635688|NCT03646630|lower abdominal surgeries|lower abdominal surgeries
4635689|NCT03646630|quadratus lumborum block|quadratus lumborum block
4635690|NCT03646630|caudal block|caudal block
4635691|NCT03646604|Upadacitinib|upadacitinib
4635692|NCT03646604|ABT-494|abt-494
4635693|NCT03646604|Atopic Dermatitis|atopic dermatitis
4635694|NCT03646591|gastric cancer|gastric cancer
4635695|NCT03646591|neoadjuvant chemotherapy|neoadjuvant chemotherapy
4636483|NCT03641599|HFrEF|hfref
4635696|NCT03646591|FLOT regimen|flot regimen
4635697|NCT03646578|maternal anxiety|maternal anxiety
4635698|NCT03646539|Automated conversational agent|automated conversational agent
4635699|NCT03646526|Amitriptyline hydrochloride|amitriptyline hydrochloride
4635700|NCT03646513|THA|tha
4635701|NCT03646487|pregnancy|pregnancy
4635702|NCT03646487|iron status|iron status
4635703|NCT03646487|structural violence|structural violence
4635704|NCT03646461|oropharyngeal|oropharyngeal
4635705|NCT03646448|Internet Use Disorders|internet use disorders
4635706|NCT03646448|Brief Intervention|brief intervention
4635707|NCT03646448|Motivational Interviewing|motivational interviewing
4635708|NCT03646448|CBT|cbt
4635709|NCT03646448|Proactive|proactive
4635710|NCT03646435|inpatients|inpatients
4635711|NCT03646435|wearables|wearables
4635712|NCT03646435|continuous monitoring|continuous monitoring
4635713|NCT03646383|benign thyroid nodule|benign thyroid nodule
4635714|NCT03646383|radiofrequency|radiofrequency
4635715|NCT03646383|symptomatic thyroid nodule|symptomatic thyroid nodule
4635716|NCT03646357|Infarction|infarction
4635717|NCT03646357|Myocardial Infarction|myocardial infarction
4635718|NCT03646357|ST Elevation Myocardial Infarction|st elevation myocardial infarction
4635719|NCT03646357|Non-ST Elevated Myocardial Infarction|non-st elevated myocardial infarction
4635720|NCT03646357|Ischemia|ischemia
4635721|NCT03646357|Myocardial Ischemia|myocardial ischemia
4635722|NCT03646357|Heart Diseases|heart diseases
4635723|NCT03646357|Cardiovascular Diseases|cardiovascular diseases
4635724|NCT03646357|Metoprolol|metoprolol
4635725|NCT03646357|Bisoprolol|bisoprolol
4635726|NCT03646357|Betablocker|betablocker
4635727|NCT03646357|Anti-Arrhythmia Agents|anti-arrhythmia agents
4635728|NCT03646357|Physiological Effects of Drugs|physiological effects of drugs
4635729|NCT03646357|Beta-blocker|beta-blocker
4635730|NCT03646357|Beta blocker|beta blocker
4635731|NCT03646344|Deceased donor renal transplantation|deceased donor renal transplantation
4635732|NCT03646344|Heme Arginate|heme arginate
4635733|NCT03646344|Delayed graft function|delayed graft function
4635734|NCT03646253|Proximal humerus fracture|proximal humerus fracture
4635735|NCT03646227|Carbapenem-resistant enterobacteriaceae (CRE)|carbapenem-resistant enterobacteriaceae (cre)
4635736|NCT03646227|Carbapenem-resistant Pseudomonas aeruginosa (CRPA)|carbapenem-resistant pseudomonas aeruginosa (crpa)
4635737|NCT03646227|Vancomycin-resistant enterococcus (VRE)|vancomycin-resistant enterococcus (vre)
4635738|NCT03646227|Klebsiella pneumoniae|klebsiella pneumoniae
4635739|NCT03646227|Acinetobacter baumannii|acinetobacter baumannii
4635740|NCT03646227|Bloodstream infection (BSI)|bloodstream infection (bsi)
4635741|NCT03646227|Microbiological characterization|microbiological characterization
4635742|NCT03646201|childhood|childhood
4635743|NCT03646201|obesity|obesity
4635744|NCT03646201|nutrition|nutrition
4635745|NCT03646201|intervention|intervention
4635746|NCT03646201|portion size|portion size
4635747|NCT03646201|behavioral|behavioral
4635748|NCT03646201|environmental|environmental
4635749|NCT03646201|feeding practices|feeding practices
4635750|NCT03646175|Choline|choline
4635751|NCT03646175|Trimethylamine N-Oxide|trimethylamine n-oxide
4635752|NCT03646175|Vascular health|vascular health
4635753|NCT03646149|Social Skills|social skills
4635754|NCT03646149|Housing|housing
4635755|NCT03646123|Brentuximab vedotin|brentuximab vedotin
4635756|NCT03646123|Doxorubicin|doxorubicin
4635757|NCT03646123|Vinblastine|vinblastine
4635758|NCT03646123|Dacarbazine|dacarbazine
4635759|NCT03646110|esophageal cancer|esophageal cancer
4635760|NCT03646110|Minimally invasive esophagectomy (MIE)|minimally invasive esophagectomy (mie)
4635761|NCT03646110|single-incision Minimally invasive esophagectomy (SIMIE)|single-incision minimally invasive esophagectomy (simie)
4635762|NCT03646097|OCT|oct
4635763|NCT03646097|Co-Registration|co-registration
4635764|NCT03646097|Stent|stent
4635765|NCT03646097|PCI|pci
4635766|NCT03646097|Geographical mismatch|geographical mismatch
4635767|NCT03646097|Edge Dissection|edge dissection
4635768|NCT03646084|pain|pain
4635769|NCT03646084|sleep|sleep
4635770|NCT03646084|circadian rhythm|circadian rhythm
4635771|NCT03646071|Locally Advanced|locally advanced
4635772|NCT03646071|Metastatic|metastatic
4635773|NCT03646071|Solid Tumor|solid tumor
4635774|NCT03646058|Treatment|treatment
4635775|NCT03646058|Suicidal ideas|suicidal ideas
4635776|NCT03646058|Depression|depression
4635777|NCT03646058|Buprenorphine|buprenorphine
4635778|NCT03646058|Opioid agonist|opioid agonist
4635779|NCT03646058|Mental pain|mental pain
4635780|NCT03646019|Coronary artery disease|coronary artery disease
4635781|NCT03646019|paraoxanase 1|paraoxanase 1
4635782|NCT03646019|Thiobarbituric Acid Reactive Substances|thiobarbituric acid reactive substances
4635783|NCT03646019|Thiol groups|thiol groups
4635784|NCT03645993|Early-Onset Alzheimer's disease|early-onset alzheimer's disease
4635785|NCT03645980|DKN-01|dkn-01
4635786|NCT03645980|Hepatocellular Carcinoma|hepatocellular carcinoma
4635787|NCT03645980|WNT signaling|wnt signaling
4635788|NCT03645954|Femoral triangle block|femoral triangle block
4635789|NCT03645954|Adductor canal block|adductor canal block
4635790|NCT03645954|Femoral nerve block|femoral nerve block
4635791|NCT03645954|Primary total knee arthroplasty|primary total knee arthroplasty
4635792|NCT03645954|Pain management|pain management
4635793|NCT03645954|Functional recovery|functional recovery
4635794|NCT03645941|Social Media|social media
4635795|NCT03645941|Alaska Native|alaska native
4635796|NCT03645928|LN-144|ln-144
4635797|NCT03645928|LN-145|ln-145
4635798|NCT03645928|Cell Therapy|cell therapy
4635799|NCT03645928|Autologous Adoptive Cell Transfer|autologous adoptive cell transfer
4635800|NCT03645928|Autologous Adoptive Cell Therapy|autologous adoptive cell therapy
4635801|NCT03645928|Cellular Immuno-therapy|cellular immuno-therapy
4635802|NCT03645928|Tumor Infiltrating Lymphocytes|tumor infiltrating lymphocytes
4635803|NCT03645928|TIL|til
4635804|NCT03645928|IL-2|il-2
4635805|NCT03645928|Multiple Tumor Type|multiple tumor type
4635806|NCT03645928|Lifileucel|lifileucel
4635807|NCT03645928|Pembrolizumab|pembrolizumab
4635808|NCT03645915|glut1|glut1
4635809|NCT03645915|biomarkers|biomarkers
4635810|NCT03645915|diagnosis|diagnosis
4635811|NCT03645902|Acute stroke|acute stroke
4635812|NCT03645902|Susceptibility-weighted imaging|susceptibility-weighted imaging
4635813|NCT03645902|Arterial occlusion|arterial occlusion
4635814|NCT03645902|Time of flight|time of flight
4635815|NCT03645889|Traditional Chinese Medicine|traditional chinese medicine
4635816|NCT03645876|SHR-1210|shr-1210
4635817|NCT03645876|BP102|bp102
4635818|NCT03645876|Phase II|phase ii
4635819|NCT03645824|Hemato-Oncology|hemato-oncology
4635820|NCT03645824|Allogeneic Stem Cell Transplantation|allogeneic stem cell transplantation
4635821|NCT03645824|Pacritinib|pacritinib
4635822|NCT03645824|JAK2 inhibitor|jak2 inhibitor
4635823|NCT03645824|Myelofibrosis|myelofibrosis
4635824|NCT03645811|anxiety|anxiety
4635825|NCT03645811|OSCE|osce
4635826|NCT03645811|EFT|eft
4635827|NCT03645811|breath|breath
4635828|NCT03645811|music|music
4635829|NCT03645798|burnout|burnout
4635830|NCT03645798|turnover intention|turnover intention
4635831|NCT03645798|job performance|job performance
4635832|NCT03645798|job satisfaction|job satisfaction
4635833|NCT03645798|resilience|resilience
4635834|NCT03645798|self-efficacy|self-efficacy
4635835|NCT03645798|coping style|coping style
4635836|NCT03645798|cortisol|cortisol
4635837|NCT03645798|nurse|nurse
4635838|NCT03645759|behavioral treatment|behavioral treatment
4635839|NCT03645759|telehealth|telehealth
4635840|NCT03645759|stroke self-management|stroke self-management
4635841|NCT03645759|psychological distress|psychological distress
4635842|NCT03645759|social integration|social integration
4635843|NCT03645733|Haemodialysis|haemodialysis
4635844|NCT03645733|Kidney Disease|kidney disease
4635845|NCT03645733|Mental Health|mental health
4635846|NCT03645733|Cognitive Impairment|cognitive impairment
4635847|NCT03645707|Critical Care Nurse|critical care nurse
4635848|NCT03645707|Resilience|resilience
4635849|NCT03645707|Stress Mindset|stress mindset
4635850|NCT03645694|Caregiving|caregiving
4635851|NCT03645694|Technology|technology
4635852|NCT03645694|Social support|social support
4635853|NCT03645681|Vascular Access|vascular access
4635854|NCT03645681|Hemodialysis Access|hemodialysis access
4635855|NCT03645681|End Stage Renal Disease|end stage renal disease
4635856|NCT03645681|Kidney Failure|kidney failure
4635857|NCT03645681|Hemodialysis|hemodialysis
4635858|NCT03645681|Arteriovenous Graft|arteriovenous graft
4635859|NCT03645681|AVG|avg
4635860|NCT03645681|Cannulation|cannulation
4635861|NCT03645681|Quick Sealing dialysis graft|quick sealing dialysis graft
4635862|NCT03645668|sepsis，meropenem，2 steps administration|sepsis，meropenem，2 steps administration
4635863|NCT03645655|hepatoblastoma|hepatoblastoma
4635864|NCT03645655|Hepatic Hemangioendothelioma|hepatic hemangioendothelioma
4635865|NCT03645655|Protein induced by vitamin K absence or antagonist-II|protein induced by vitamin k absence or antagonist-ii
4635866|NCT03645655|Alpha-fetoprotein|alpha-fetoprotein
4635867|NCT03645655|infant|infant
4635868|NCT03645655|Differential diagnosis|differential diagnosis
4635869|NCT03645616|Musculoskeletal disease|musculoskeletal disease
4635870|NCT03645616|Stress test|stress test
4635871|NCT03645616|Reproducibility|reproducibility
4635872|NCT03645616|Gait Speed|gait speed
4635873|NCT03645603|pediatrics|pediatrics
4635874|NCT03645603|dexmedetomidine|dexmedetomidine
4635875|NCT03645603|analgesia|analgesia
4635876|NCT03645603|sedation|sedation
4635877|NCT03645603|pediatric intensive care unit|pediatric intensive care unit
4635878|NCT03645603|abstinence syndrome|abstinence syndrome
4635879|NCT03645603|assessment tool|assessment tool
4635880|NCT03645577|Pulmonary vein isolation|pulmonary vein isolation
4635881|NCT03645577|Phrenic nerve palsy|phrenic nerve palsy
4635882|NCT03645577|Paroxysmal atrial fibrillation|paroxysmal atrial fibrillation
4635883|NCT03645577|Persistent atrial fibrillation|persistent atrial fibrillation
4635884|NCT03645564|Stroke|stroke
4635885|NCT03645564|Anti-vitamin K|anti-vitamin k
4635886|NCT03645564|Direct anti-coagulant|direct anti-coagulant
4635887|NCT03645564|Nurse|nurse
4635888|NCT03645551|dentistry|dentistry
4635889|NCT03645551|laminate veneer|laminate veneer
4635890|NCT03645551|existing restoration|existing restoration
4635891|NCT03645551|survival|survival
4635892|NCT03645538|Parkinson's disease|parkinson's disease
4635893|NCT03645538|Healthy subjects|healthy subjects
4635894|NCT03645525|Bronchopulmonary Dysplasia|bronchopulmonary dysplasia
4635895|NCT03645525|Mesenchymal stem cell|mesenchymal stem cell
4635896|NCT03645512|Resilience|resilience
4635897|NCT03645512|High Performance|high performance
4635898|NCT03645512|Critical Care Nurse|critical care nurse
4635899|NCT03645486|Chronic granulomatous disease|chronic granulomatous disease
4635900|NCT03645486|Lentiviral vector|lentiviral vector
4635901|NCT03645460|Adenosine deaminase severe combined immunodeficiency lentiviral vector|adenosine deaminase severe combined immunodeficiency lentiviral vector
4635902|NCT03645447|Depression|depression
4635903|NCT03645447|Diagnostic aid|diagnostic aid
4635904|NCT03645447|Taste|taste
4635905|NCT03645434|Moderate to severe COPD|moderate to severe copd
4635906|NCT03645434|Muscarinic receptor antagonist|muscarinic receptor antagonist
4635907|NCT03645434|β2 adrenoceptor agonist (MABA)|β2 adrenoceptor agonist (maba)
4635908|NCT03645434|Long-acting muscarinic antagonist (LAMA)|long-acting muscarinic antagonist (lama)
4635909|NCT03645434|Long-acting β2-agonist (LABA)|long-acting β2-agonist (laba)
4635910|NCT03645434|Inhaled long-acting bronchodilator|inhaled long-acting bronchodilator
4635911|NCT03645434|Small airways disease (obstructive bronchiolitis)|small airways disease (obstructive bronchiolitis)
4635912|NCT03645434|Parenchymal destruction (emphysema),|parenchymal destruction (emphysema),
4635913|NCT03645421|Diabetes|diabetes
4635914|NCT03645421|MEDI0382|medi0382
4635915|NCT03645421|D5674C00001|d5674c00001
4635916|NCT03645421|T2DM|t2dm
4635917|NCT03645421|Type 2 Diabetes|type 2 diabetes
4635918|NCT03645408|exenatide|exenatide
4635919|NCT03645408|alcohol craving|alcohol craving
4635920|NCT03645408|alcohol consumption|alcohol consumption
4635921|NCT03645382|overweight|overweight
4635922|NCT03645382|body fat|body fat
4635923|NCT03645382|diabetic,|diabetic,
4635924|NCT03645382|obersity|obersity
4635925|NCT03645382|diabetes mellitus|diabetes mellitus
4635926|NCT03645382|DM|dm
4635927|NCT03645382|glycemic|glycemic
4635928|NCT03645369|subcutaneous heparin|subcutaneous heparin
4635929|NCT03645369|injection pain|injection pain
4635930|NCT03645369|ecchymosis|ecchymosis
4635931|NCT03645330|Atezolizumab|atezolizumab
4635932|NCT03645291|insect sting allergy|insect sting allergy
4635933|NCT03645291|Hymenoptera allergy|hymenoptera allergy
4635934|NCT03645291|local insect allergen extracts|local insect allergen extracts
4635935|NCT03645265|speech rhythm|speech rhythm
4635936|NCT03645265|speech therapy|speech therapy
4635937|NCT03645239|Postoperative pain|postoperative pain
4635938|NCT03645239|Cesarean delivery|cesarean delivery
4635939|NCT03645239|Postoperative nausea and vomiting|postoperative nausea and vomiting
4635940|NCT03645226|Idiopathic REM sleep|idiopathic rem sleep
4635941|NCT03645226|Parkinson's disease|parkinson's disease
4635942|NCT03645226|Gut microbiota|gut microbiota
4635943|NCT03645226|Syncleinpathy|syncleinpathy
4635944|NCT03645213|School-age children|school-age children
4635945|NCT03645213|pain|pain
4635946|NCT03645213|fear|fear
4635947|NCT03645213|venipuncture|venipuncture
4635948|NCT03645213|distraction|distraction
4635949|NCT03645200|TP53|tp53
4635950|NCT03645200|Solid tumor|solid tumor
4635951|NCT03645200|Fluzoparib|fluzoparib
4635952|NCT03645200|Apatinib|apatinib
4635953|NCT03645174|intubation|intubation
4635954|NCT03645174|Aintree|aintree
4635955|NCT03645174|Laryngeal mask airway|laryngeal mask airway
4635956|NCT03645174|fiberoptic|fiberoptic
4635957|NCT03645148|Neoantigen, Pancreatic Cancer, iNeo-Vac-P01,Peptide Vaccine|neoantigen, pancreatic cancer, ineo-vac-p01,peptide vaccine
4635958|NCT03645122|Spike timing-dependent plasticity|spike timing-dependent plasticity
4635959|NCT03645122|cerebrovasculor accident|cerebrovasculor accident
4635960|NCT03645122|paralysis|paralysis
4635961|NCT03645122|hemiparesis|hemiparesis
4635962|NCT03645122|stimulation|stimulation
4635963|NCT03645096|Depression|depression
4635964|NCT03645096|Pregnenolone|pregnenolone
4635965|NCT03645096|Women|women
4635966|NCT03645070|atrial-esophageal fistula|atrial-esophageal fistula
4635967|NCT03645070|radiofrequency ablation|radiofrequency ablation
4635968|NCT03645070|Atrial Fibrillation ablation|atrial fibrillation ablation
4635969|NCT03645044|HBV sAg loss/seroconversion|hbv sag loss/seroconversion
4635970|NCT03645044|"HBV e antigen (eAg) loss/seroconversion"|"hbv e antigen (eag) loss/seroconversion"
4635971|NCT03645044|antiretroviral therapy|antiretroviral therapy
4635972|NCT03645031|acute intermittent hypoxia (AIH)|acute intermittent hypoxia (aih)
4635973|NCT03645031|respiratory motor function|respiratory motor function
4635974|NCT03645031|hypoxia|hypoxia
4635975|NCT03645031|normoxia|normoxia
4635976|NCT03645031|EMG (electromyography)|emg (electromyography)
4635977|NCT03645018|lung|lung
4635978|NCT03645018|cancer|cancer
4635979|NCT03645018|early diagnosis|early diagnosis
4635980|NCT03645018|DTS|dts
4635981|NCT03645005|eHealth|ehealth
4635982|NCT03645005|Health Related Quality of Life|health related quality of life
4635983|NCT03645005|Symptom Burden|symptom burden
4635984|NCT03645005|Breast Cancer|breast cancer
4635985|NCT03645005|Hispanic|hispanic
4635986|NCT03644966|Probiotics|probiotics
4635987|NCT03644966|multi-drug resistant UTI|multi-drug resistant uti
4635988|NCT03644966|recurrent UTI|recurrent uti
4635989|NCT03644953|Hydroxyurea|hydroxyurea
4635990|NCT03644953|Transfusion|transfusion
4635991|NCT03644940|Dascena|dascena
4635992|NCT03644940|patient mortality|patient mortality
4635993|NCT03644940|machine learning|machine learning
4635994|NCT03644940|algorithm|algorithm
4635995|NCT03644940|diagnostic|diagnostic
4635996|NCT03644927|Veterans|veterans
4635997|NCT03644927|Cardiopulmonary exercise testing|cardiopulmonary exercise testing
4635998|NCT03644927|Exercise maintenance|exercise maintenance
4635999|NCT03644927|Neuropeptide Y (NPY)|neuropeptide y (npy)
4636000|NCT03644927|Exercise-related intrinsic motivation|exercise-related intrinsic motivation
4636001|NCT03644927|Exercise Self efficacy|exercise self efficacy
4636002|NCT03644927|Transtheoretical Model (TTM)|transtheoretical model (ttm)
4636003|NCT03644927|Self-Determination Theory (SDT)|self-determination theory (sdt)
4636004|NCT03644888|COPD|copd
4636005|NCT03644888|Vibration|vibration
4636006|NCT03644888|Rehabilitation|rehabilitation
4636007|NCT03644849|Leg Ulcer|leg ulcer
4636008|NCT03644849|Lower extremity ulcer|lower extremity ulcer
4636009|NCT03644849|carbon dioxide laser|carbon dioxide laser
4636010|NCT03644849|CO2 Laser|co2 laser
4636011|NCT03644849|Ablative fractional carbon dioxide lasers|ablative fractional carbon dioxide lasers
4636012|NCT03644823|radiotherapy|radiotherapy
4636013|NCT03644823|PD1-inhibitor|pd1-inhibitor
4636014|NCT03644758|Firefighter|firefighter
4636015|NCT03644758|Sleep|sleep
4636016|NCT03644758|Sleep disorders|sleep disorders
4636017|NCT03644758|Pittsburgh Sleep Quality Index (PSQI)|pittsburgh sleep quality index (psqi)
4636018|NCT03644758|Epworth Sleepiness Scale|epworth sleepiness scale
4636019|NCT03644758|Insomnia Severity Index (ISI)|insomnia severity index (isi)
4636020|NCT03644758|stop-BANG questionnaire|stop-bang questionnaire
4636021|NCT03644745|Aging|aging
4636022|NCT03644732|Cognition|cognition
4636023|NCT03644719|Substance Abuse|substance abuse
4636024|NCT03644719|Cognitive behavioral treatment|cognitive behavioral treatment
4636025|NCT03644719|Ketamine|ketamine
4636026|NCT03644719|Stage of Change|stage of change
4636027|NCT03644693|Angelman Syndrome|angelman syndrome
4636028|NCT03644693|Ketosis|ketosis
4636029|NCT03644693|Children|children
4636030|NCT03644667|heart transplant recipients|heart transplant recipients
4636031|NCT03644667|alloimmunity|alloimmunity
4636032|NCT03644667|anti-inflammatory|anti-inflammatory
4636033|NCT03644667|tocilizumab|tocilizumab
4636034|NCT03644667|efficacy clinical trial|efficacy clinical trial
4636035|NCT03644667|immunosuppression (IS)|immunosuppression (is)
4636036|NCT03644654|fluid responsiveness, stroke volume variation, neurosurgery|fluid responsiveness, stroke volume variation, neurosurgery
4636037|NCT03644654|ClearSight, noninvasive monitoring, haemodynamic|clearsight, noninvasive monitoring, haemodynamic
4636038|NCT03644641|Desflurane, propofol, spinal surgery, prone position|desflurane, propofol, spinal surgery, prone position
4636039|NCT03644641|Near-infrared spectroscopy, visual acuity, visual loss|near-infrared spectroscopy, visual acuity, visual loss
4636040|NCT03644615|Osteoarthritis|osteoarthritis
4636041|NCT03644615|Mindfulness|mindfulness
4636042|NCT03644615|MBSR|mbsr
4636043|NCT03644602|low FODMAPs diet|low fodmaps diet
4636044|NCT03644602|Adherence|adherence
4636045|NCT03644602|Inflammatory Bowel Diseases|inflammatory bowel diseases
4636046|NCT03644602|Irritable Bowel Syndrome|irritable bowel syndrome
4636047|NCT03644602|Coeliac Disease|coeliac disease
4636048|NCT03644589|Cisplatin|cisplatin
4636049|NCT03644589|Pembrolizumab|pembrolizumab
4636050|NCT03644589|Keytruda|keytruda
4636051|NCT03644589|Triple Negative Breast Cancer|triple negative breast cancer
4636052|NCT03644589|Immune-Checkpoint Inhibitor|immune-checkpoint inhibitor
4636053|NCT03644589|Metastatic Breast Cancer|metastatic breast cancer
4636054|NCT03644589|Breast Carcinoma|breast carcinoma
4636055|NCT03644589|Recurrent Breast Cancer|recurrent breast cancer
4636056|NCT03644576|Ozanimod|ozanimod
4636057|NCT03644576|Pseudoephedrine|pseudoephedrine
4636058|NCT03644576|Healthy Adult Subjects|healthy adult subjects
4636059|NCT03644563|Oral HPV|oral hpv
4636060|NCT03644563|Persistent oncogenic HPV infection|persistent oncogenic hpv infection
4636061|NCT03644563|Oropharyngeal cancer (OPC)|oropharyngeal cancer (opc)
4636062|NCT03644563|HPV serum E6 antibody|hpv serum e6 antibody
4636063|NCT03644550|Checkpoint Inhibitor|checkpoint inhibitor
4636064|NCT03644550|Immunotherapy|immunotherapy
4636065|NCT03644524|heat therapy|heat therapy
4636066|NCT03644524|blood pressure|blood pressure
4636067|NCT03644524|oral glucose tolerance test|oral glucose tolerance test
4636068|NCT03644524|adipose tissue|adipose tissue
4636069|NCT03644524|muscle sympathetic nerve activity|muscle sympathetic nerve activity
4636070|NCT03644511|HCC|hcc
4636071|NCT03644511|Liver cancer|liver cancer
4636072|NCT03644511|Live cell carcinoma|live cell carcinoma
4636073|NCT03644498|influenza|influenza
4636074|NCT03644498|myositis|myositis
4636075|NCT03644498|myocarditis|myocarditis
4636076|NCT03644498|rhabdomyolysis|rhabdomyolysis
4636077|NCT03644498|checkpoint inhibitors|checkpoint inhibitors
4636078|NCT03644485|kidney transplant|kidney transplant
4636079|NCT03644485|Tacrolimus|tacrolimus
4636080|NCT03644485|Prograf|prograf
4636081|NCT03644485|Advagraf|advagraf
4636082|NCT03644485|FK506|fk506
4636083|NCT03644472|dietary nitrate supplementation|dietary nitrate supplementation
4636084|NCT03644472|beetroot juice|beetroot juice
4636085|NCT03644459|Tolerability|tolerability
4636086|NCT03644459|Safety|safety
4636183|NCT03643744|Actinic Keratosis|actinic keratosis
4636087|NCT03644459|Humanized Anti-VEGF Monoclonal Antibody|humanized anti-vegf monoclonal antibody
4636088|NCT03644459|autocrine loops|autocrine loops
4636089|NCT03644459|LYN00101|lyn00101
4636090|NCT03644446|Bisoprolol|bisoprolol
4636091|NCT03644420|Osteoarthritis|osteoarthritis
4636092|NCT03644420|Knee|knee
4636093|NCT03644420|Bone|bone
4636094|NCT03644420|Bone Marrow|bone marrow
4636095|NCT03644420|Magnetic Resonance Imaging|magnetic resonance imaging
4636096|NCT03644407|registry|registry
4636097|NCT03644407|scoliosis|scoliosis
4636098|NCT03644407|disc disease|disc disease
4636099|NCT03644407|spinal fracture|spinal fracture
4636100|NCT03644407|spinal fusion|spinal fusion
4636101|NCT03644407|spine surgery|spine surgery
4636102|NCT03644368|cervical phlegmon|cervical phlegmon
4636103|NCT03644368|tonsillar abscesses|tonsillar abscesses
4636104|NCT03644368|retropharyngeal or parapharyngeal abscesses|retropharyngeal or parapharyngeal abscesses
4636105|NCT03644368|medical and chirurgical treatment|medical and chirurgical treatment
4636106|NCT03644368|Bacteria in deep neck infections|bacteria in deep neck infections
4636107|NCT03644342|cervical cancer|cervical cancer
4636108|NCT03644342|Niraparib|niraparib
4636109|NCT03644342|radiotherapy|radiotherapy
4636110|NCT03644342|carcinoma of the cervix|carcinoma of the cervix
4636111|NCT03644329|Breast Cancer Survivors|breast cancer survivors
4636112|NCT03644329|resistance Training|resistance training
4636113|NCT03644329|fatigability|fatigability
4636114|NCT03644329|Body Composition|body composition
4636115|NCT03644329|Functional capacity|functional capacity
4636116|NCT03644290|vascular ischemic lesion|vascular ischemic lesion
4636117|NCT03644264|Chronic Kidney Disease|chronic kidney disease
4636118|NCT03644264|Hyperphosphatemia|hyperphosphatemia
4636119|NCT03644264|Dialysis|dialysis
4636120|NCT03644212|Polycystic Ovary Syndrome|polycystic ovary syndrome
4636121|NCT03644212|Vitamin D|vitamin d
4636122|NCT03644212|Anti Mullerian Hormone|anti mullerian hormone
4636123|NCT03644212|Soluble receptor for Advanced Glycation End Products|soluble receptor for advanced glycation end products
4636124|NCT03644199|Gastric emptying|gastric emptying
4636125|NCT03644199|Cystic Fibrosis related diabetes|cystic fibrosis related diabetes
4636126|NCT03644199|Incretins|incretins
4636127|NCT03644186|hormone receptor positive early breast cancer|hormone receptor positive early breast cancer
4636128|NCT03644186|HER2 receptor positive early breast cancer|her2 receptor positive early breast cancer
4636129|NCT03644173|integrative medicine|integrative medicine
4636130|NCT03644173|cancer patients|cancer patients
4636131|NCT03644160|Physical activity|physical activity
4636132|NCT03644160|Behaviour Change|behaviour change
4636133|NCT03644160|Physiotherapy|physiotherapy
4636134|NCT03644134|Type 2 Diabetes, Physiological Stress, Sleep Pattern|type 2 diabetes, physiological stress, sleep pattern
4636135|NCT03644056|IMC-001|imc-001
4636136|NCT03644030|FFM index|ffm index
4636137|NCT03644030|tissue edema index [extracellular / total water - ECW / TBW]|tissue edema index [extracellular / total water - ecw / tbw]
4636138|NCT03644030|phase angle|phase angle
4636139|NCT03644017|Dialysis|dialysis
4636140|NCT03644017|Venous Stenosis|venous stenosis
4636141|NCT03644017|Venous Occlusion|venous occlusion
4636142|NCT03644017|Stent Graft|stent graft
4636143|NCT03643991|Agitation|agitation
4636144|NCT03643991|Dementia|dementia
4636145|NCT03643991|Inpatient|inpatient
4636146|NCT03643978|Decision aids|decision aids
4636147|NCT03643965|IgA Nephropathy|iga nephropathy
4636148|NCT03643952|methicillin-resistant S. aureus (MRSA) infections|methicillin-resistant s. aureus (mrsa) infections
4636149|NCT03643952|complicated skin and soft tissue infections (cSSTI)|complicated skin and soft tissue infections (cssti)
4636150|NCT03643939|respiratory insufficiency|respiratory insufficiency
4636151|NCT03643939|respiratory failure|respiratory failure
4636152|NCT03643939|non-invasive ventilation|non-invasive ventilation
4636153|NCT03643939|high flow nasal cannula|high flow nasal cannula
4636154|NCT03643939|nasal high flow|nasal high flow
4636155|NCT03643939|trans-nasal insufflation|trans-nasal insufflation
4636157|NCT03643939|HFNC|hfnc
4636158|NCT03643926|ankle|ankle
4636159|NCT03643926|instability|instability
4636160|NCT03643926|brostrom|brostrom
4636161|NCT03643926|open|open
4636162|NCT03643926|arthroscopic|arthroscopic
4636163|NCT03643874|Single-dose disposable dry powder inhaler|single-dose disposable dry powder inhaler
4636164|NCT03643861|SBRT|sbrt
4636165|NCT03643861|Breast cancer|breast cancer
4636166|NCT03643861|Early stage|early stage
4636167|NCT03643861|Radiation therapy|radiation therapy
4636168|NCT03643822|ACB adjuncts|acb adjuncts
4636169|NCT03643822|Dexamethasone|dexamethasone
4636170|NCT03643822|Dexmedetomidine|dexmedetomidine
4636171|NCT03643822|post operative analgesia|post operative analgesia
4636172|NCT03643809|Systemic autoinflammatory diseases (SAIDs)|systemic autoinflammatory diseases (saids)
4636173|NCT03643783|Bariatric Surgery|bariatric surgery
4636174|NCT03643783|Prorenin|prorenin
4636175|NCT03643783|Hypertension|hypertension
4636176|NCT03643783|Obesity|obesity
4636177|NCT03643770|hypoxia|hypoxia
4636178|NCT03643757|Blood gas analysis|blood gas analysis
4636179|NCT03643757|Epidural analgesia|epidural analgesia
4636180|NCT03643757|Lung cancer|lung cancer
4636181|NCT03643757|Respiratory function tests|respiratory function tests
4636182|NCT03643757|Thoracotomy|thoracotomy
4636184|NCT03643744|Photodynamic Therapy|photodynamic therapy
4636185|NCT03643705|Implementation Science|implementation science
4636186|NCT03643705|Cardiovascular Disease|cardiovascular disease
4636187|NCT03643705|Prevention|prevention
4636188|NCT03643653|Bronchiectasis|bronchiectasis
4636189|NCT03643653|multi-centered registry|multi-centered registry
4636190|NCT03643614|adipose derived stromal cells|adipose derived stromal cells
4636191|NCT03643614|stromal vascular fraction|stromal vascular fraction
4636192|NCT03643614|mesenchymal stem cells|mesenchymal stem cells
4636193|NCT03643614|rectovaginal fistula|rectovaginal fistula
4636194|NCT03643601|erythropoiesis stimulating agent|erythropoiesis stimulating agent
4636195|NCT03643601|chronic kidney disease associated anemia|chronic kidney disease associated anemia
4636196|NCT03643601|ASP1517|asp1517
4636197|NCT03643588|Hyaluronan|hyaluronan
4636198|NCT03643588|synovial fluid supplement|synovial fluid supplement
4636199|NCT03643562|Niemann-Pick|niemann-pick
4636200|NCT03643562|NPC1|npc1
4636201|NCT03643562|NPC|npc
4636202|NCT03643549|Temozolomide|temozolomide
4636203|NCT03643549|Bortezomib|bortezomib
4636204|NCT03643549|Recurrent disease|recurrent disease
4636205|NCT03643536|left ventricular ejection fraction; quality of life|left ventricular ejection fraction; quality of life
4636206|NCT03643523|anastomitic leak, infectious complications, colorectal surgery|anastomitic leak, infectious complications, colorectal surgery
4636207|NCT03643510|Hormone Receptor Positive|hormone receptor positive
4636208|NCT03643510|Fulvestrant|fulvestrant
4636209|NCT03643510|Abemaciclib|abemaciclib
4636210|NCT03643510|18-107|18-107
4636211|NCT03643484|Lung Diseases, Interstitial|lung diseases, interstitial
4636212|NCT03643484|Radiation Pneumonitis|radiation pneumonitis
4636213|NCT03643458|NIRS|nirs
4636214|NCT03643458|TANEC|tanec
4636215|NCT03643458|splanchnic oxygenation|splanchnic oxygenation
4636216|NCT03643458|enteral feeding|enteral feeding
4636217|NCT03643458|preterm infants|preterm infants
4636218|NCT03643445|motivational Interviewing; motivation|motivational interviewing; motivation
4636219|NCT03643445|psychoeducation; psychoeducational-oriented treatment|psychoeducation; psychoeducational-oriented treatment
4636220|NCT03643367|Sepsis|sepsis
4636221|NCT03643367|Septic Shock|septic shock
4636222|NCT03643367|Sevoflurane Conditioning|sevoflurane conditioning
4636223|NCT03643341|Family-based|family-based
4636224|NCT03643341|Community-based|community-based
4636225|NCT03643341|Healthy Weights|healthy weights
4636226|NCT03643328|Staphylococcus Aureus|staphylococcus aureus
4636227|NCT03643328|haemodialysis|haemodialysis
4636228|NCT03643328|vaccine|vaccine
4636229|NCT03643328|immune response|immune response
4636230|NCT03643315|Appetite regulation|appetite regulation
4636231|NCT03643315|Eating behaviour|eating behaviour
4636232|NCT03643315|Exercise|exercise
4636233|NCT03643315|HIIT|hiit
4636234|NCT03643276|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
4636235|NCT03643276|Childhood|childhood
4636236|NCT03643276|Pediatric|pediatric
4636237|NCT03643276|Immunotherapy|immunotherapy
4636238|NCT03643276|Blinatumomab|blinatumomab
4636239|NCT03643276|Proteasome Inhibitor|proteasome inhibitor
4636240|NCT03643276|Bispecific antibody|bispecific antibody
4636241|NCT03643276|Bortezomib|bortezomib
4636242|NCT03643276|Chemotherapy|chemotherapy
4636243|NCT03643276|Randomized trial|randomized trial
4636244|NCT03643237|video game|video game
4636245|NCT03643237|older adults|older adults
4636246|NCT03643237|active aging|active aging
4636247|NCT03643237|health promotion|health promotion
4636248|NCT03643237|study protocol|study protocol
4636249|NCT03643224|ablation|ablation
4636250|NCT03643224|electrophysiology|electrophysiology
4636251|NCT03643224|atrial fibrillation|atrial fibrillation
4636252|NCT03643224|catheter|catheter
4636253|NCT03643224|persistent|persistent
4636254|NCT03643211|Xljanz, Ulcerative colitis, UC, Long-term|xljanz, ulcerative colitis, uc, long-term
4636255|NCT03643185|cytokine|cytokine
4636256|NCT03643185|ABPA|abpa
4636257|NCT03643159|Digital Medicine System|digital medicine system
4636258|NCT03643133|Bone|bone
4636259|NCT03643133|Neoplasm, bone tissue|neoplasm, bone tissue
4636260|NCT03643133|Acetylmuramyl-Alanyl-Isoglutamine|acetylmuramyl-alanyl-isoglutamine
4636261|NCT03643107|Drug Response Prediction (DRP)|drug response prediction (drp)
4636262|NCT03643055|medullary thyroid cancer|medullary thyroid cancer
4636263|NCT03643055|imaging|imaging
4636264|NCT03643055|hybrid-imaging|hybrid-imaging
4636265|NCT03643055|18F-choline|18f-choline
4636266|NCT03643055|18F-fluorocholine|18f-fluorocholine
4636268|NCT03643055|PET/CT|pet/ct
4636269|NCT03643042|Myelodysplastic Syndromes|myelodysplastic syndromes
4636270|NCT03643042|Transfusion|transfusion
4636271|NCT03643042|Quality of life|quality of life
4636272|NCT03643042|Physical performance|physical performance
4636273|NCT03643003|music|music
4636274|NCT03643003|music therapy|music therapy
4636275|NCT03642990|paclitaxel|paclitaxel
4636276|NCT03642990|nicotinamide riboside|nicotinamide riboside
4636277|NCT03642990|NIAGEN|niagen
4636278|NCT03642977|Longitudinal study|longitudinal study
4636279|NCT03642977|Real time PCR|real time pcr
4636280|NCT03642951|magnetic|magnetic
4636281|NCT03642951|brain|brain
4636282|NCT03642951|stimulation|stimulation
4636283|NCT03642938|Exercise|exercise
4636286|NCT03642925|Meal replacement|meal replacement
4636287|NCT03642925|calorie restriction|calorie restriction
4636288|NCT03642925|body weight|body weight
4636289|NCT03642912|ECMO|ecmo
4636290|NCT03642912|haemostasis|haemostasis
4636291|NCT03642912|coagulation|coagulation
4636292|NCT03642912|haemostatic alterations|haemostatic alterations
4636293|NCT03642782|electroretinogram pattern|electroretinogram pattern
4636294|NCT03642769|Pancreatitis|pancreatitis
4636295|NCT03642769|Fluids|fluids
4636296|NCT03642769|SIRS|sirs
4636297|NCT03642769|Management|management
4636298|NCT03642769|Lactated Ringer|lactated ringer
4636299|NCT03642769|Normal Saline|normal saline
4636300|NCT03642743|hysterectomy|hysterectomy
4636301|NCT03642743|minimally invasive surgery|minimally invasive surgery
4636302|NCT03642743|gynecology|gynecology
4636303|NCT03642743|satisfaction|satisfaction
4636304|NCT03642730|echocardiography|echocardiography
4636305|NCT03642730|training|training
4636306|NCT03642730|follow-up|follow-up
4636307|NCT03642704|PMTCT|pmtct
4636308|NCT03642704|HIV early diagnosis|hiv early diagnosis
4636309|NCT03642704|HIV preventive therapy|hiv preventive therapy
4636310|NCT03642704|prevention of mother to child HIV transmission|prevention of mother to child hiv transmission
4636311|NCT03642678|Prediction Model|prediction model
4636312|NCT03642678|Malnutrition|malnutrition
4636313|NCT03642678|Hemodialysis|hemodialysis
4636314|NCT03642626|ALL|all
4636315|NCT03642613|COPD, RWE, Physical Activity|copd, rwe, physical activity
4636316|NCT03642574|Preimplantation Methylome Screening|preimplantation methylome screening
4636317|NCT03642574|Preimplantation Genetic Screening|preimplantation genetic screening
4636318|NCT03642574|single embryo transfer|single embryo transfer
4636319|NCT03642574|cumulative live birth rate|cumulative live birth rate
4636320|NCT03642548|NSCLC|nsclc
4636321|NCT03642548|Bifico|bifico
4636322|NCT03642548|gut-lung axis|gut-lung axis
4636323|NCT03642535|Photodynamic Therapy|photodynamic therapy
4636324|NCT03642535|Actinic Keratoses|actinic keratoses
4636325|NCT03642522|repetitive transcranial magnetic stimulation|repetitive transcranial magnetic stimulation
4636326|NCT03642522|rTMS|rtms
4636327|NCT03642522|neurostimulation|neurostimulation
4636328|NCT03642522|biomarker|biomarker
4636329|NCT03642522|treatment-resistant|treatment-resistant
4636330|NCT03642509|Left atrial appendage occlusion|left atrial appendage occlusion
4636331|NCT03642509|Novel oral anticoagulation|novel oral anticoagulation
4636332|NCT03642483|type 1 diabetes|type 1 diabetes
4636333|NCT03642483|metabolic control|metabolic control
4636334|NCT03642483|psychosocial risk factors|psychosocial risk factors
4636335|NCT03642483|FEPB|fepb
4636336|NCT03642483|children|children
4636337|NCT03642483|adolescents|adolescents
4636338|NCT03642470|type 1 diabetes|type 1 diabetes
4636339|NCT03642470|metabolic control|metabolic control
4636340|NCT03642470|psychosocial risk factors|psychosocial risk factors
4636341|NCT03642470|cortisol|cortisol
4636342|NCT03642470|children|children
4636343|NCT03642470|adolescents|adolescents
4636344|NCT03642457|Video assisted thoracoscopic surgery|video assisted thoracoscopic surgery
4636345|NCT03642457|Serratus plane block|serratus plane block
4636346|NCT03642457|local infiltration|local infiltration
4636347|NCT03642444|stroke|stroke
4636348|NCT03642444|hemiplegia|hemiplegia
4636349|NCT03642418|asthma, children, spirometry, lung function, asthma action plan, asthma exacerbation, self management|asthma, children, spirometry, lung function, asthma action plan, asthma exacerbation, self management
4636350|NCT03642392|Achilles tendon|achilles tendon
4636351|NCT03642392|Patellar tendon|patellar tendon
4636352|NCT03642392|Inflammation|inflammation
4636353|NCT03642366|Low Intensity Shockwave Therapy|low intensity shockwave therapy
4636354|NCT03642353|plaque control|plaque control
4636355|NCT03642353|bacteria|bacteria
4636356|NCT03642353|inflammation|inflammation
4636357|NCT03642353|familial aggregation|familial aggregation
4636358|NCT03642353|prevention|prevention
4636359|NCT03642327|Child Abuse Prevention|child abuse prevention
4636360|NCT03642327|Primary Care|primary care
4636361|NCT03642327|Professional Education in Primary Care|professional education in primary care
4636362|NCT03642314|pre exposure prophylaxis|pre exposure prophylaxis
4636363|NCT03642314|men who have sex with men|men who have sex with men
4636364|NCT03642301|o-toluidine-hemoglobin|o-toluidine-hemoglobin
4636365|NCT03642301|Urinary o-toluidine|urinary o-toluidine
4636366|NCT03642301|Intrathecal anesthesia|intrathecal anesthesia
4636367|NCT03642301|Hyperbaric prilocaine|hyperbaric prilocaine
4636368|NCT03642301|Ambulatory surgery|ambulatory surgery
4636369|NCT03642275|heart failure|heart failure
4636370|NCT03642275|mHealth|mhealth
4636371|NCT03642275|smartphone|smartphone
4636372|NCT03642275|wearable electronic devices|wearable electronic devices
4636373|NCT03642275|text messaging|text messaging
4636374|NCT03642275|self-management|self-management
4636375|NCT03642275|self-care|self-care
4636376|NCT03642249|delirium|delirium
4636377|NCT03642249|knowledge translation|knowledge translation
4636378|NCT03642249|Objective Structured Clinical Examination|objective structured clinical examination
4636379|NCT03642249|evidence-based practice|evidence-based practice
4636380|NCT03642197|Bariatric Surgery|bariatric surgery
4636381|NCT03642197|Obesity|obesity
4637091|NCT03637556|transfusion|transfusion
4636382|NCT03642197|Social Support|social support
4636383|NCT03642197|Health Behavior|health behavior
4636384|NCT03642184|empagliflozin|empagliflozin
4636385|NCT03642184|linagliptin|linagliptin
4636386|NCT03642184|diabetes|diabetes
4636387|NCT03642184|kidney transplantation|kidney transplantation
4636388|NCT03642171|Contraception|contraception
4636389|NCT03642171|Intrauterine Device|intrauterine device
4636390|NCT03642171|UT380|ut380
4636391|NCT03642132|untreated epithelial ovarian cancer|untreated epithelial ovarian cancer
4636392|NCT03642132|fallopian tube carncer|fallopian tube carncer
4636393|NCT03642132|primary peritoneal cancer|primary peritoneal cancer
4636394|NCT03642106|Adolescent|adolescent
4636395|NCT03642106|Latino|latino
4636396|NCT03642106|Immigrant|immigrant
4636397|NCT03642093|Frailty|frailty
4636398|NCT03642093|Prehabilitation|prehabilitation
4636399|NCT03642067|Relatlimab|relatlimab
4636400|NCT03642067|Nivolumab|nivolumab
4636401|NCT03642067|Immunotherapy|immunotherapy
4636402|NCT03642067|Anti-PD-1|anti-pd-1
4636403|NCT03642067|Anti-LAG-3|anti-lag-3
4636404|NCT03642067|Antibody|antibody
4636406|NCT03642067|PD-L1|pd-l1
4636407|NCT03642067|Microsatellite stability|microsatellite stability
4636408|NCT03642067|Colorectal cancer|colorectal cancer
4636409|NCT03642067|Colon cancer|colon cancer
4636410|NCT03642067|Rectal cancer|rectal cancer
4636411|NCT03642041|Smoking|smoking
4636412|NCT03642041|Lung cancer|lung cancer
4636413|NCT03642041|Survival|survival
4636414|NCT03642041|Quality of life|quality of life
4636415|NCT03642028|Sleep Initiation and Maintenance Disorders|sleep initiation and maintenance disorders
4636416|NCT03642028|Stress Disorders, Posttraumatic|stress disorders, posttraumatic
4636417|NCT03642028|Suvorexant|suvorexant
4636418|NCT03642028|Veterans|veterans
4636419|NCT03642015|music|music
4636420|NCT03642015|anxiety|anxiety
4636421|NCT03642015|digestive tract endoscopy|digestive tract endoscopy
4636422|NCT03642002|music therapy|music therapy
4636423|NCT03642002|song of kin|song of kin
4636424|NCT03642002|music medicine|music medicine
4636425|NCT03641989|Toothpaste|toothpaste
4636426|NCT03641989|Inflammation|inflammation
4636427|NCT03641989|Periodontal Disease|periodontal disease
4636428|NCT03641989|hsCRP|hscrp
4636429|NCT03641989|Oral health|oral health
4636430|NCT03641989|Oral hygiene|oral hygiene
4636431|NCT03641950|Essential Blepharospasm|essential blepharospasm
4636432|NCT03641924|Posttraumatic Stress Disorder|posttraumatic stress disorder
4636433|NCT03641924|Psychotherapy|psychotherapy
4636434|NCT03641924|Neuropsychology|neuropsychology
4636435|NCT03641911|incidence|incidence
4636436|NCT03641911|surgical ICU|surgical icu
4636437|NCT03641898|Fractional flow reserve|fractional flow reserve
4636438|NCT03641898|Intravascular ultrasound|intravascular ultrasound
4636439|NCT03641898|Major adverse cardiovascular events|major adverse cardiovascular events
4636440|NCT03641898|Non-ST-segment acute coronary syndrome|non-st-segment acute coronary syndrome
4636441|NCT03641898|Percutaneous coronary intervention|percutaneous coronary intervention
4636442|NCT03641872|acute-on-chronic liver disease|acute-on-chronic liver disease
4636443|NCT03641872|acute decompensation|acute decompensation
4636444|NCT03641872|multiple organ failures|multiple organ failures
4636445|NCT03641872|acute-on-chronic liver failure|acute-on-chronic liver failure
4636446|NCT03641859|pain|pain
4636447|NCT03641859|anxiety|anxiety
4636448|NCT03641833|cardiac|cardiac
4636449|NCT03641833|surgery|surgery
4636450|NCT03641833|postoperative cognitive dysfunction|postoperative cognitive dysfunction
4636451|NCT03641833|bypass|bypass
4636452|NCT03641833|brain biomarkers|brain biomarkers
4636453|NCT03641833|transcranial Doppler|transcranial doppler
4636454|NCT03641781|Isokinetic, Isometric, Agility|isokinetic, isometric, agility
4636455|NCT03641781|Athletic Single Leg Stability,|athletic single leg stability,
4636456|NCT03641781|Vertical Jump Biodex, Knee Pain|vertical jump biodex, knee pain
4636457|NCT03641768|Alzheimer Dementia|alzheimer dementia
4636458|NCT03641768|PTSD|ptsd
4636459|NCT03641768|MRI|mri
4636460|NCT03641755|Breast Cancer|breast cancer
4636461|NCT03641742|Interstitial Lung Disease|interstitial lung disease
4636462|NCT03641742|Pulmonary Fibrosis|pulmonary fibrosis
4636463|NCT03641729|hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
4636464|NCT03641729|exercise training|exercise training
4636465|NCT03641729|feasibility|feasibility
4636466|NCT03641729|safety|safety
4636467|NCT03641716|early childhood, family, occupational therapy|early childhood, family, occupational therapy
4636468|NCT03641690|pandemic influenza|pandemic influenza
4636469|NCT03641690|mortality|mortality
4636470|NCT03641690|ICU|icu
4636471|NCT03641638|Postpartum thyroiditis|postpartum thyroiditis
4636472|NCT03641638|PPT|ppt
4636473|NCT03641638|TPOAb|tpoab
4636474|NCT03641625|Postoperative Nausea and Vomiting|postoperative nausea and vomiting
4636475|NCT03641625|Laparoscopic Hysterectomy|laparoscopic hysterectomy
4636476|NCT03641625|Muscular Tissue Oxygen Saturation|muscular tissue oxygen saturation
4636477|NCT03641625|Hemodynamic Management|hemodynamic management
4636478|NCT03641612|rotary instruments|rotary instruments
4636479|NCT03641612|endotoxins|endotoxins
4636480|NCT03641599|RV systolic function|rv systolic function
4636481|NCT03641599|HFpEF|hfpef
4636482|NCT03641599|HFmrEF|hfmref
4636484|NCT03641586|Dose Escalation|dose escalation
4636485|NCT03641586|Dose Expansion|dose expansion
4636486|NCT03641586|BGB-283|bgb-283
4636487|NCT03641560|Progressive Metastatic Castration-Resistant Prostate Cancer (mCRPC)|progressive metastatic castration-resistant prostate cancer (mcrpc)
4636488|NCT03641560|Enzalutamide|enzalutamide
4636489|NCT03641560|Xtandi|xtandi
4636490|NCT03641560|MDV3100|mdv3100
4636491|NCT03641547|Oesophageal cancer|oesophageal cancer
4636492|NCT03641534|Perfusion|perfusion
4636493|NCT03641534|Lung congestion|lung congestion
4636494|NCT03641521|child vegetable intake|child vegetable intake
4636495|NCT03641521|behavioral strategy|behavioral strategy
4636496|NCT03641521|intervention|intervention
4636497|NCT03641508|trigger finger|trigger finger
4636498|NCT03641495|fibromyalgia|fibromyalgia
4636499|NCT03641495|therapeutic exercise|therapeutic exercise
4636500|NCT03641495|physiotherapy|physiotherapy
4636501|NCT03641482|third molar surgery|third molar surgery
4636502|NCT03641482|oral surgery|oral surgery
4636503|NCT03641482|propolis|propolis
4636504|NCT03641482|NBF gingival gel|nbf gingival gel
4636505|NCT03641482|post-surgical complications|post-surgical complications
4636506|NCT03641482|clinica trial|clinica trial
4636507|NCT03641469|Adolescent Idiopathic Scoliosis|adolescent idiopathic scoliosis
4636508|NCT03641469|thoracolumbosacral orthosis|thoracolumbosacral orthosis
4636509|NCT03641469|spinal orthotic|spinal orthotic
4636510|NCT03641469|health-related quality of life|health-related quality of life
4636511|NCT03641469|treatment adherence|treatment adherence
4636512|NCT03641417|Obesity|obesity
4636513|NCT03641417|Appetite|appetite
4636514|NCT03641417|Ghrelin|ghrelin
4636515|NCT03641417|Energy intake|energy intake
4636516|NCT03641404|ergothioneine|ergothioneine
4636517|NCT03641404|mild cognitive impairment|mild cognitive impairment
4636518|NCT03641404|dementia|dementia
4636519|NCT03641404|dietary antioxidant|dietary antioxidant
4636520|NCT03641391|Awake surgery|awake surgery
4636521|NCT03641391|Direct cortical stimulation|direct cortical stimulation
4636522|NCT03641391|Language mapping|language mapping
4636523|NCT03641391|Glioma|glioma
4636524|NCT03641378|Cancer Care|cancer care
4636525|NCT03641365|Intraoral scanner|intraoral scanner
4636526|NCT03641365|Guided surgery|guided surgery
4636527|NCT03641365|Implant accuracy|implant accuracy
4636528|NCT03641365|Dental implants|dental implants
4636529|NCT03641339|Vector-Borne Diseases|vector-borne diseases
4636530|NCT03641339|Sand Flies and Mosquito Transmission|sand flies and mosquito transmission
4636531|NCT03641339|Skin Immune Response|skin immune response
4636532|NCT03641339|Vector Bite Exposures|vector bite exposures
4636533|NCT03641339|Vaccine|vaccine
4636534|NCT03641326|Gliosarcoma|gliosarcoma
4636535|NCT03641326|Brain Tumor|brain tumor
4636536|NCT03641326|MDASI|mdasi
4636537|NCT03641300|Magnetic Seizure Therapy|magnetic seizure therapy
4636538|NCT03641300|Electroconvulsive Therapy|electroconvulsive therapy
4636539|NCT03641300|Bipolar Disorder|bipolar disorder
4636540|NCT03641300|Depression|depression
4636541|NCT03641300|Suicidal Ideation|suicidal ideation
4636542|NCT03641274|Vulnerable populations|vulnerable populations
4636543|NCT03641274|Emergency department|emergency department
4636544|NCT03641261|Hereditary ichthyosis|hereditary ichthyosis
4636545|NCT03641235|pulmonary microbiota|pulmonary microbiota
4636546|NCT03641235|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
4636547|NCT03641222|Acupuncture|acupuncture
4636548|NCT03641222|Group|group
4636549|NCT03641222|Community Based|community based
4636550|NCT03641222|Individual|individual
4636551|NCT03641222|Randomized|randomized
4636552|NCT03641209|acetaminophen|acetaminophen
4636553|NCT03641209|ductus arteriosus|ductus arteriosus
4636554|NCT03641209|NIRS|nirs
4636555|NCT03641209|intravenous|intravenous
4636556|NCT03641196|Orthodontic Appliances|orthodontic appliances
4636557|NCT03641196|Dentition, Mixed|dentition, mixed
4636558|NCT03641183|FOLFIRINOX Drugs|folfirinox drugs
4636559|NCT03641183|Gemcitabine-nab Paclitaxel (Abraxane)|gemcitabine-nab paclitaxel (abraxane)
4636560|NCT03641183|Stereotactic Body Radiotherapy (SBRT)|stereotactic body radiotherapy (sbrt)
4636561|NCT03641157|Difficult intubation|difficult intubation
4636562|NCT03641157|Pediatrics|pediatrics
4636563|NCT03641157|predictive tests|predictive tests
4636564|NCT03641144|Diabetic Macular Edema|diabetic macular edema
4636565|NCT03641144|navigation laser|navigation laser
4636566|NCT03641144|laser photocoagulation|laser photocoagulation
4636567|NCT03641131|Febrile Neutropenia|febrile neutropenia
4636568|NCT03641131|Fungal Infection|fungal infection
4636569|NCT03641118|cancer|cancer
4636570|NCT03641118|sarcopenia|sarcopenia
4636571|NCT03641118|surgery|surgery
4636572|NCT03641118|chemotherapy|chemotherapy
4636573|NCT03641092|School readiness|school readiness
4636574|NCT03641092|Child development|child development
4636575|NCT03641092|Child behavior|child behavior
4636576|NCT03641092|Parenting behavior|parenting behavior
4636577|NCT03641092|CenteringParenting|centeringparenting
4636578|NCT03641066|ankle|ankle
4636579|NCT03641066|biomechanics|biomechanics
4636580|NCT03641053|honey|honey
4636581|NCT03641053|povidone-iodine|povidone-iodine
4636582|NCT03641053|randomized control trial|randomized control trial
4637390|NCT03635736|sonography|sonography
4636583|NCT03641053|wound healing|wound healing
4636584|NCT03641040|Video-oculography|video-oculography
4636585|NCT03641040|Intermittent exotropia|intermittent exotropia
4636586|NCT03641040|ocular deviation|ocular deviation
4636587|NCT03641027|Obesity|obesity
4636588|NCT03641027|Physical Activity|physical activity
4636589|NCT03641001|Intervention|intervention
4636590|NCT03641001|Food voucher|food voucher
4636591|NCT03641001|Child feeding|child feeding
4636592|NCT03641001|Growth|growth
4636593|NCT03641001|WASH|wash
4636594|NCT03640975|eosinophilic esophagitis|eosinophilic esophagitis
4636595|NCT03640975|children|children
4636596|NCT03640975|innate immunity|innate immunity
4636597|NCT03640962|Postmenopause|postmenopause
4636598|NCT03640962|Low back pain|low back pain
4636599|NCT03640962|Woman|woman
4636600|NCT03640936|asthma|asthma
4636601|NCT03640936|allergy|allergy
4636602|NCT03640936|specific IgE|specific ige
4636603|NCT03640910|Dental implants|dental implants
4636604|NCT03640910|Overdenture|overdenture
4636605|NCT03640910|Randomized controlled trial|randomized controlled trial
4636606|NCT03640897|Infant diaper rash|infant diaper rash
4636607|NCT03640897|Baby wipes|baby wipes
4636608|NCT03640897|Oleocalcareous liniment|oleocalcareous liniment
4636609|NCT03640858|Hemodialysis|hemodialysis
4636610|NCT03640858|Larger middle molecules|larger middle molecules
4636611|NCT03640858|Theranova|theranova
4636612|NCT03640793|Snoring, Obstructive Sleep Apnea|snoring, obstructive sleep apnea
4636613|NCT03640780|surgical timing|surgical timing
4636614|NCT03640780|cataract extraction|cataract extraction
4636615|NCT03640780|IOL implantation|iol implantation
4636616|NCT03640780|childhood cataract|childhood cataract
4636617|NCT03640780|real-world data|real-world data
4636618|NCT03640767|Rehabilitation|rehabilitation
4636619|NCT03640767|Peripheral artery disease|peripheral artery disease
4636620|NCT03640767|Mobile phone text message|mobile phone text message
4636621|NCT03640754|Hot Flashes|hot flashes
4636622|NCT03640754|Vasomotor Symptoms|vasomotor symptoms
4636623|NCT03640754|Menopause|menopause
4636624|NCT03640741|intra-abdominal pressure|intra-abdominal pressure
4636625|NCT03640741|intra-cerebral pressure|intra-cerebral pressure
4636626|NCT03640741|laparoscopy|laparoscopy
4636627|NCT03640741|brain perfusion|brain perfusion
4636628|NCT03640741|brain oxygenation|brain oxygenation
4636629|NCT03640741|time-resolved near infrared spectroscopy|time-resolved near infrared spectroscopy
4636630|NCT03640728|Hepatitis B, Acute-on-chronic liver failure|hepatitis b, acute-on-chronic liver failure
4636631|NCT03640689|Venous ulcer|venous ulcer
4636632|NCT03640689|Great saphenous incompetence|great saphenous incompetence
4636633|NCT03640689|Iliac vein|iliac vein
4636634|NCT03640689|Endovenous therapy|endovenous therapy
4636635|NCT03640663|Midwifery-led continuity of care|midwifery-led continuity of care
4636636|NCT03640663|Birth complications|birth complications
4636637|NCT03640650|Sequential bilateral cataract surgery|sequential bilateral cataract surgery
4636638|NCT03640637|Positron emission tomography|positron emission tomography
4636639|NCT03640637|Magnetic resonance imaging|magnetic resonance imaging
4636640|NCT03640624|Physical Therapy Modalities|physical therapy modalities
4636641|NCT03640611|cerebral palsy, activity, participation, environmental factors, ICF-CY|cerebral palsy, activity, participation, environmental factors, icf-cy
4636642|NCT03640585|Cerebral palsy|cerebral palsy
4636643|NCT03640585|Music therapy|music therapy
4636644|NCT03640585|Gross motor function|gross motor function
4636645|NCT03640559|Adhesion|adhesion
4636646|NCT03640559|Safety|safety
4636647|NCT03640507|vaginal preparation|vaginal preparation
4636648|NCT03640507|antisepsis|antisepsis
4636649|NCT03640507|C-section|c-section
4636650|NCT03640494|Optical Coherence Tomography|optical coherence tomography
4636651|NCT03640494|Newborn|newborn
4636652|NCT03640494|Infant|infant
4636653|NCT03640416|night on call|night on call
4636654|NCT03640416|sleep deprivation|sleep deprivation
4636655|NCT03640416|fitbit|fitbit
4636656|NCT03640416|smartwatch|smartwatch
4636657|NCT03640416|stress|stress
4636658|NCT03640403|Malaria|malaria
4636659|NCT03640403|school children|school children
4636660|NCT03640403|randomized controlled trial|randomized controlled trial
4636661|NCT03640403|safety|safety
4636662|NCT03640403|effectiveness|effectiveness
4636663|NCT03640403|Sulfadoxine-pyrimethamine|sulfadoxine-pyrimethamine
4636664|NCT03640403|Amodiaquine|amodiaquine
4636665|NCT03640403|Piperaquine|piperaquine
4636666|NCT03640403|malaria serology|malaria serology
4636667|NCT03640403|drug resistance|drug resistance
4636668|NCT03640364|pelvic organ prolapse|pelvic organ prolapse
4636669|NCT03640364|incontinence|incontinence
4636670|NCT03640364|minimally invasive|minimally invasive
4636671|NCT03640364|vaginal surgery|vaginal surgery
4636672|NCT03640364|macroporous|macroporous
4636673|NCT03640364|lightweight|lightweight
4636674|NCT03640364|mesh|mesh
4636675|NCT03640364|polypropylene|polypropylene
4636676|NCT03640364|POP|pop
4636677|NCT03640364|urge|urge
4636678|NCT03640351|Dry eye|dry eye
4636679|NCT03640351|Cataract surgery|cataract surgery
4636680|NCT03640351|Diquas|diquas
4636681|NCT03640351|preservative free|preservative free
4636682|NCT03640299|Gynecologic Cancer|gynecologic cancer
4637391|NCT03635723|Technology|technology
4636683|NCT03640299|Enhanced Recovery After Surgery|enhanced recovery after surgery
4636684|NCT03640299|Laparoscopic surgery|laparoscopic surgery
4636685|NCT03640273|Loratadine|loratadine
4636686|NCT03640273|Prapchompoothaweep|prapchompoothaweep
4636687|NCT03640273|Allergic rhinitis|allergic rhinitis
4636688|NCT03640247|Thyroidectomy|thyroidectomy
4636689|NCT03640247|Parathryoidectomy|parathryoidectomy
4636690|NCT03640221|Hypertension|hypertension
4636691|NCT03640221|Diabetes|diabetes
4636692|NCT03640208|health disparities|health disparities
4636693|NCT03640208|African American|african american
4636694|NCT03640208|risk assessment|risk assessment
4636695|NCT03640208|secondary prevention|secondary prevention
4636696|NCT03640182|Health Management Model|health management model
4636697|NCT03640182|Chinese Medicine|chinese medicine
4636698|NCT03640182|Preventive Medicine|preventive medicine
4636699|NCT03640182|Body Constitution|body constitution
4636700|NCT03640182|Health Promotion|health promotion
4636701|NCT03640169|Health Management Model|health management model
4636702|NCT03640169|Chinese Medicine|chinese medicine
4636703|NCT03640169|Preventive Medicine|preventive medicine
4636704|NCT03640169|Body Constitution|body constitution
4636705|NCT03640169|Health Promotion|health promotion
4636706|NCT03640156|Oxytocin|oxytocin
4636707|NCT03640156|Eye Contact|eye contact
4636708|NCT03640156|Mirror System|mirror system
4636709|NCT03640156|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
4636710|NCT03640117|aging|aging
4636711|NCT03640117|geriatric assessment|geriatric assessment
4636712|NCT03640117|chemotherapy toxicity|chemotherapy toxicity
4636713|NCT03640117|overall survival|overall survival
4636714|NCT03640104|Food-based intervention|food-based intervention
4636715|NCT03640104|postpartum weight management|postpartum weight management
4636716|NCT03640104|hepatic retinol|hepatic retinol
4636717|NCT03640039|3d strut plate|3d strut plate
4636718|NCT03640039|mandibular angle fracture|mandibular angle fracture
4636719|NCT03639961|Integrated|integrated
4636720|NCT03639961|leading|leading
4636721|NCT03639961|managing|managing
4636722|NCT03639961|governing|governing
4636723|NCT03639961|practices|practices
4636724|NCT03639948|Pembrolizumab|pembrolizumab
4636725|NCT03639948|Carboplatin|carboplatin
4636726|NCT03639948|Docetaxel|docetaxel
4636727|NCT03639948|Pegfilgrastim|pegfilgrastim
4636728|NCT03639948|breast cancer|breast cancer
4636729|NCT03639935|Metastatic|metastatic
4636730|NCT03639935|Platinum|platinum
4636731|NCT03639935|Rucaparib|rucaparib
4636732|NCT03639935|Nivolumab|nivolumab
4636733|NCT03639935|PARP Inhibitor|parp inhibitor
4636734|NCT03639935|Anti-PD-1 Antibody|anti-pd-1 antibody
4636735|NCT03639922|acute ischaemic stroke|acute ischaemic stroke
4636736|NCT03639922|Imatinib|imatinib
4636737|NCT03639922|blood-brain-barrier|blood-brain-barrier
4636738|NCT03639922|trombectomy|trombectomy
4636739|NCT03639922|iv trombolysis|iv trombolysis
4636740|NCT03639909|sweat gland|sweat gland
4636741|NCT03639883|wound healing|wound healing
4636742|NCT03639870|refractory|refractory
4636743|NCT03639831|Mood|mood
4636744|NCT03639831|Anxiety|anxiety
4636745|NCT03639831|Stress|stress
4636746|NCT03639831|Dietary supplement|dietary supplement
4636747|NCT03639831|Botanical|botanical
4636748|NCT03639792|gastric cancer|gastric cancer
4636749|NCT03639792|postoperative complication|postoperative complication
4636750|NCT03639792|octogenarian|octogenarian
4636751|NCT03639779|Calcinosis cutis|calcinosis cutis
4636752|NCT03639779|sodium thiosulfate|sodium thiosulfate
4636753|NCT03639779|sodium chloride|sodium chloride
4636754|NCT03639766|Raynaud Phenomenon|raynaud phenomenon
4636755|NCT03639766|AbobotulinumtoxinA|abobotulinumtoxina
4636756|NCT03639753|teen driver safety|teen driver safety
4636757|NCT03639753|injury prevention|injury prevention
4636758|NCT03639727|cough|cough
4636759|NCT03639727|cough provocation test|cough provocation test
4636760|NCT03639727|mannitol|mannitol
4636761|NCT03639727|citric acid|citric acid
4636762|NCT03639714|neoantigen cancer vaccine|neoantigen cancer vaccine
4636763|NCT03639714|personalized neoantigen cancer vaccine|personalized neoantigen cancer vaccine
4636764|NCT03639714|GRT-C901|grt-c901
4636765|NCT03639714|GRT-R902|grt-r902
4636766|NCT03639714|immunotherapy|immunotherapy
4636767|NCT03639714|PD-1|pd-1
4636768|NCT03639714|CTLA-4|ctla-4
4636769|NCT03639701|Thymidine|thymidine
4636770|NCT03639701|Deoxycytidine|deoxycytidine
4636771|NCT03639636|periodontitis|periodontitis
4636772|NCT03639636|sclerostin|sclerostin
4636773|NCT03639636|periodontal surgery|periodontal surgery
4636774|NCT03639636|scaling and root planing|scaling and root planing
4636775|NCT03639623|Peroxisome proliferator-activated receptors|peroxisome proliferator-activated receptors
4636776|NCT03639623|NAFLD|nafld
4636777|NCT03639623|NASH|nash
4636778|NCT03639623|Post Transplant Metabolic Syndrome|post transplant metabolic syndrome
4636779|NCT03639597|ablation|ablation
4636780|NCT03639597|ultrasound|ultrasound
4636781|NCT03639597|automation|automation
4636782|NCT03639597|catheter|catheter
4636783|NCT03639584|Vitamin D Deficiency|vitamin d deficiency
4636784|NCT03639584|Critical Illness|critical illness
4636785|NCT03639506|repetition failure|repetition failure
4636786|NCT03639506|autologous mitochondria transplantation|autologous mitochondria transplantation
4636787|NCT03639506|embryo quality|embryo quality
4636788|NCT03639506|live birth rate|live birth rate
4636789|NCT03639467|anlotinib|anlotinib
4636790|NCT03639467|nasopharyngeal carcinoma|nasopharyngeal carcinoma
4636791|NCT03639467|gemcitabine|gemcitabine
4636792|NCT03639467|cisplatin|cisplatin
4636793|NCT03639454|dry needling|dry needling
4636794|NCT03639454|myofascial trigger point|myofascial trigger point
4636795|NCT03639454|muscle tone|muscle tone
4636796|NCT03639441|dry needling|dry needling
4636797|NCT03639441|myofascial trigger point|myofascial trigger point
4636798|NCT03639441|muscle tone|muscle tone
4636799|NCT03639428|pharmacokinetics|pharmacokinetics
4636800|NCT03639428|child|child
4636801|NCT03639428|cyclodextrin|cyclodextrin
4636802|NCT03639428|moderate sedation|moderate sedation
4636803|NCT03639415|Opioid|opioid
4636804|NCT03639415|Refractory Pain|refractory pain
4636805|NCT03639415|dose frequency|dose frequency
4636806|NCT03639415|nausea|nausea
4636807|NCT03639415|vomit|vomit
4636808|NCT03639415|dizziness|dizziness
4636809|NCT03639402|Diet|diet
4636810|NCT03639402|Physical activity|physical activity
4636811|NCT03639402|Attitude|attitude
4636812|NCT03639402|Knowledge|knowledge
4636813|NCT03639402|Practice|practice
4636814|NCT03639402|Cardiovascular disease|cardiovascular disease
4636815|NCT03639402|Mothers|mothers
4636816|NCT03639402|Peer education|peer education
4636817|NCT03639389|Robot assisted surgery|robot assisted surgery
4636818|NCT03639389|Prostatectomy|prostatectomy
4636819|NCT03639389|Spinal anesthesia|spinal anesthesia
4636820|NCT03639389|Postoperative pain|postoperative pain
4636821|NCT03639389|Home discharge|home discharge
4636822|NCT03639376|Children|children
4636823|NCT03639376|Cotinine|cotinine
4636824|NCT03639376|LL-37|ll-37
4636825|NCT03639376|Passive smoking|passive smoking
4636826|NCT03639376|Periodontal health|periodontal health
4636827|NCT03639376|Saliva|saliva
4636828|NCT03639363|4% chlorhexidine gluconate|4% chlorhexidine gluconate
4636829|NCT03639363|infection control|infection control
4636830|NCT03639350|intermittent energy restriction|intermittent energy restriction
4636831|NCT03639350|Randomized Controlled Trial|randomized controlled trial
4636832|NCT03639350|Adiposity|adiposity
4636833|NCT03639337|Probiotic|probiotic
4636834|NCT03639337|Food allergy|food allergy
4636835|NCT03639324|venetoclax|venetoclax
4636836|NCT03639324|idelalisib|idelalisib
4636837|NCT03639311|HIV|hiv
4636838|NCT03639311|ART|art
4636839|NCT03639311|maintenance|maintenance
4636840|NCT03639311|Long acting|long acting
4636841|NCT03639311|LATTE|latte
4636842|NCT03639298|premature children|premature children
4636843|NCT03639298|processing speed|processing speed
4636844|NCT03639298|executive functions|executive functions
4636845|NCT03639272|talar fractures|talar fractures
4636846|NCT03639272|talar neck fractures;|talar neck fractures;
4636847|NCT03639272|talar body fractures;|talar body fractures;
4636848|NCT03639272|talus;|talus;
4636849|NCT03639272|ORIF;|orif;
4636850|NCT03639272|screw fixation.|screw fixation.
4636851|NCT03639246|Ovarian cancer|ovarian cancer
4636852|NCT03639246|Platinum resistant|platinum resistant
4636853|NCT03639207|IFNL4|ifnl4
4636854|NCT03639207|Genetics|genetics
4636855|NCT03639207|Ledipasvir/Sofosbuvir Treatment|ledipasvir/sofosbuvir treatment
4636856|NCT03639194|Cancer|cancer
4636857|NCT03639194|Small Cell Lung Cancer|small cell lung cancer
4636858|NCT03639194|Small Cell Lung Carcinoma|small cell lung carcinoma
4636859|NCT03639181|B-NHL|b-nhl
4636860|NCT03639155|vadadustat|vadadustat
4636861|NCT03639155|AKB-6548|akb-6548
4636862|NCT03639155|hypoxia-inducible factor|hypoxia-inducible factor
4636863|NCT03639155|HIF|hif
4636864|NCT03639155|hypoxia-inducible factor prolyl-hydroxylase inhibitor|hypoxia-inducible factor prolyl-hydroxylase inhibitor
4636865|NCT03639155|HIF-PHI|hif-phi
4636866|NCT03639142|constipation, prunes, children|constipation, prunes, children
4636867|NCT03639116|Spike timing-dependent plasticity|spike timing-dependent plasticity
4636868|NCT03639116|cerebrovascular accident|cerebrovascular accident
4636869|NCT03639116|stroke|stroke
4636870|NCT03639116|paralysis|paralysis
4636871|NCT03639116|hemiparesis|hemiparesis
4636872|NCT03639090|chemotherapy, mass spectrometry|chemotherapy, mass spectrometry
4636873|NCT03639077|Bone graft|bone graft
4636874|NCT03639077|Lateral window approach|lateral window approach
4636875|NCT03639077|Sinus augmentation|sinus augmentation
4636876|NCT03639077|Volumetric change|volumetric change
4636877|NCT03638960|peripheral nerve block|peripheral nerve block
4636878|NCT03638960|interscalene|interscalene
4636879|NCT03638960|arthroscopic rotator cuff repair|arthroscopic rotator cuff repair
4636880|NCT03638960|liposomal bupivacaine|liposomal bupivacaine
4636881|NCT03638934|Advance care planning|advance care planning
4636882|NCT03638895|weight management|weight management
4636883|NCT03638895|obesity|obesity
4636884|NCT03638895|severe obesity|severe obesity
4636885|NCT03638895|structured dietary intervention|structured dietary intervention
4636886|NCT03638895|calorie restriction|calorie restriction
4636887|NCT03638895|indirect calorimetry|indirect calorimetry
4636888|NCT03638895|resting energy expenditure|resting energy expenditure
4636889|NCT03638895|resting metabolic rate|resting metabolic rate
4636890|NCT03638895|respiratory quotient|respiratory quotient
4636891|NCT03638895|substrate oxidation|substrate oxidation
4636892|NCT03638895|glycemic variability|glycemic variability
4636893|NCT03638895|insulin sensitivity|insulin sensitivity
4636894|NCT03638895|peripheral neuropathy|peripheral neuropathy
4636895|NCT03638856|Cervical priming|cervical priming
4636896|NCT03638856|Diagnosis hysteroscopy|diagnosis hysteroscopy
4636897|NCT03638856|Oral Misoprostal|oral misoprostal
4636898|NCT03638856|Premenopause|premenopause
4636899|NCT03638843|bariatric endoscopy|bariatric endoscopy
4636900|NCT03638843|obesity|obesity
4636901|NCT03638843|metabolic syndrome|metabolic syndrome
4636902|NCT03638843|gastric mucosal devitalization|gastric mucosal devitalization
4636903|NCT03638843|Endoscopic bariatric therapies|endoscopic bariatric therapies
4636904|NCT03638830|Pseudomonas Aeruginosa|pseudomonas aeruginosa
4636905|NCT03638830|antibiotic resistance|antibiotic resistance
4636906|NCT03638830|factors of pathogenicity of bacteria|factors of pathogenicity of bacteria
4636907|NCT03638830|the system of secretion of type III pathogenic bacteria|the system of secretion of type iii pathogenic bacteria
4636908|NCT03638830|Pseudomonas Infections|pseudomonas infections
4636909|NCT03638830|Urinary Tract Infections|urinary tract infections
4636910|NCT03638817|Inherited thrombocytopenias (IT)|inherited thrombocytopenias (it)
4636911|NCT03638817|Platelet concentrates (PC)|platelet concentrates (pc)
4636912|NCT03638817|Eltrombopag|eltrombopag
4636913|NCT03638817|Surgery|surgery
4636914|NCT03638817|Invasive acts|invasive acts
4636915|NCT03638817|Perioperative|perioperative
4636916|NCT03638817|Rare disease|rare disease
4636917|NCT03638817|Thrombopoietin mimetic|thrombopoietin mimetic
4636918|NCT03638804|89Zr|89zr
4636919|NCT03638804|PD-L1|pd-l1
4636920|NCT03638804|KN035|kn035
4636921|NCT03638804|PET|pet
4636922|NCT03638765|immunotherapy|immunotherapy
4636923|NCT03638765|dendritic cells|dendritic cells
4636924|NCT03638765|brain metastases|brain metastases
4636925|NCT03638726|intraoperative mydriasis|intraoperative mydriasis
4636926|NCT03638726|subconjunctival atropine|subconjunctival atropine
4636927|NCT03638726|intracameral epinephrine|intracameral epinephrine
4636928|NCT03638726|cataract surgery|cataract surgery
4636929|NCT03638713|water exchange|water exchange
4636930|NCT03638713|colonoscopy|colonoscopy
4636931|NCT03638713|cecal insertion time|cecal insertion time
4636932|NCT03638713|bidirectional endoscopy|bidirectional endoscopy
4636933|NCT03638700|stenosis|stenosis
4636934|NCT03638700|bile duct|bile duct
4636935|NCT03638700|guidewire|guidewire
4636936|NCT03638700|ercp|ercp
4636937|NCT03638687|Pregnancy|pregnancy
4636938|NCT03638687|Postpartum|postpartum
4636939|NCT03638648|breast cancer|breast cancer
4636940|NCT03638648|neoadjuvant|neoadjuvant
4636941|NCT03638648|multiple gene detection|multiple gene detection
4636942|NCT03638635|Bupivacaine|bupivacaine
4636943|NCT03638635|Exparel|exparel
4636944|NCT03638635|TAP Block|tap block
4636945|NCT03638635|Opioids|opioids
4636946|NCT03638635|Narcotics|narcotics
4636947|NCT03638635|ERAS|eras
4636948|NCT03638622|Oral cancer, Photodynamic Therapy, Photosensitizer, ALA|oral cancer, photodynamic therapy, photosensitizer, ala
4636949|NCT03638609|IABP|iabp
4636950|NCT03638609|Post-Cardiac Arrest Syndrome|post-cardiac arrest syndrome
4636951|NCT03638609|Beclin-1|beclin-1
4636952|NCT03638609|Caspase-3|caspase-3
4636953|NCT03638609|Mortality|mortality
4636954|NCT03638596|Alcohol Impaired Driving|alcohol impaired driving
4636955|NCT03638596|Driving While Intoxicated|driving while intoxicated
4636956|NCT03638596|Driving Under the Influence|driving under the influence
4636957|NCT03638596|Driving While Impaired|driving while impaired
4636958|NCT03638583|Alzheimer's|alzheimer's
4636959|NCT03638583|Prevention|prevention
4636960|NCT03638583|Web-Based|web-based
4636961|NCT03638570|Spike timing-dependent plasticity|spike timing-dependent plasticity
4636962|NCT03638570|cerebrovascular accident|cerebrovascular accident
4636963|NCT03638570|stroke|stroke
4636964|NCT03638570|paralysis|paralysis
4636965|NCT03638570|hemiparesis|hemiparesis
4636966|NCT03638531|tDCS|tdcs
4636967|NCT03638531|cortical excitability|cortical excitability
4636968|NCT03638531|motor cortex|motor cortex
4636969|NCT03638531|motor learning|motor learning
4636970|NCT03638531|handwriting|handwriting
4636971|NCT03638531|micrographia|micrographia
4636972|NCT03638518|rehabilitation|rehabilitation
4636973|NCT03638518|balance|balance
4636974|NCT03638518|functional capacity|functional capacity
4636975|NCT03638492|Melanoma/mortality/pathology/*surgery|melanoma/mortality/pathology/*surgery
4636976|NCT03638492|Randomized Controlled Trials as Topic|randomized controlled trials as topic
4636977|NCT03638492|Survival|survival
4636978|NCT03638492|Margin|margin
4636979|NCT03638453|Pedi Care|pedi care
4636980|NCT03638440|Opioid Induced Constipation|opioid induced constipation
4636981|NCT03638440|Naloxegol|naloxegol
4636982|NCT03638440|Peripherally Acting Mu-Opioids Receptor Antagonist (PAMORA)|peripherally acting mu-opioids receptor antagonist (pamora)
4636983|NCT03638427|menstrual blood, high risk HPV|menstrual blood, high risk hpv
4636984|NCT03638375|Metastatic melanoma|metastatic melanoma
4636985|NCT03638375|anti-PD1|anti-pd1
4636986|NCT03638375|TIL|til
4636987|NCT03638375|interferon-alpha|interferon-alpha
4636988|NCT03638375|adoptive cell therapy|adoptive cell therapy
4636989|NCT03638375|nivolumab|nivolumab
4636990|NCT03638362|obese|obese
4636991|NCT03638362|overweight|overweight
4636992|NCT03638362|tart cherry juice|tart cherry juice
4636993|NCT03638297|MSI-H|msi-h
4636994|NCT03638297|dMMR|dmmr
4636995|NCT03638297|PD-1 antibody|pd-1 antibody
4636996|NCT03638297|COX inhibitor|cox inhibitor
4636997|NCT03638297|tumor mutation burden|tumor mutation burden
4636998|NCT03638284|Dementia|dementia
4636999|NCT03638284|neuropsychiatric symptoms|neuropsychiatric symptoms
4637000|NCT03638284|tDCS|tdcs
4637001|NCT03638284|Transcranial direct current stimulation|transcranial direct current stimulation
4637002|NCT03638284|Alzheimer Disease|alzheimer disease
4637003|NCT03638284|Mixed Dementia|mixed dementia
4637004|NCT03638284|agitation in dementia|agitation in dementia
4637005|NCT03638284|non-invasive brain stimulation|non-invasive brain stimulation
4637006|NCT03638232|Drug consumption|drug consumption
4637007|NCT03638232|Response to treatment|response to treatment
4637008|NCT03638232|Non optimal drug use|non optimal drug use
4637009|NCT03638167|CNS, CAR T cell, EGFR-positive|cns, car t cell, egfr-positive
4637010|NCT03638167|pediatric, young adults, brain tumor|pediatric, young adults, brain tumor
4637011|NCT03638141|HCC|hcc
4637012|NCT03638141|Durvalumab|durvalumab
4637013|NCT03638141|Tremelimumab|tremelimumab
4637014|NCT03638141|Immunotherapy|immunotherapy
4637015|NCT03638141|PD-L1|pd-l1
4637016|NCT03638141|Antibodies|antibodies
4637017|NCT03638141|Hepatocellular Carcinoma|hepatocellular carcinoma
4637018|NCT03638141|CTLA-4|ctla-4
4637019|NCT03638141|DEB-TACE|deb-tace
4637020|NCT03638128|OI|oi
4637021|NCT03638128|Bone.|bone.
4637022|NCT03638102|sleep duration|sleep duration
4637023|NCT03638102|glucose metabolism|glucose metabolism
4637024|NCT03638063|Adenosine triphosphate|adenosine triphosphate
4637025|NCT03638063|Capsaicin|capsaicin
4637026|NCT03638063|cough provocation test|cough provocation test
4637027|NCT03638011|Cesarean Section|cesarean section
4637028|NCT03638011|Pregnancy|pregnancy
4637029|NCT03637998|Gene expression|gene expression
4637030|NCT03637998|Quantitative Sensory Testing|quantitative sensory testing
4637031|NCT03637998|Genotyping|genotyping
4637032|NCT03637985|resistive exercises|resistive exercises
4637033|NCT03637985|aerobic|aerobic
4637034|NCT03637985|Menopause|menopause
4637035|NCT03637985|hypertension|hypertension
4637036|NCT03637946|Resin composite|resin composite
4637037|NCT03637946|clinical trial|clinical trial
4637038|NCT03637946|biocompatibility|biocompatibility
4637039|NCT03637946|cytokines|cytokines
4637040|NCT03637920|Transmen|transmen
4637041|NCT03637920|Sexuality|sexuality
4637042|NCT03637920|Sexual behavior|sexual behavior
4637043|NCT03637920|Body Image|body image
4637044|NCT03637920|Trassexualism|trassexualism
4637045|NCT03637894|Newborns|newborns
4637046|NCT03637894|Fermented milk|fermented milk
4637047|NCT03637894|Innate immunity|innate immunity
4637048|NCT03637881|Milk|milk
4637049|NCT03637881|Consumer choice|consumer choice
4637050|NCT03637868|HER2-negative breast cancer|her2-negative breast cancer
4637051|NCT03637868|brain metastases|brain metastases
4637052|NCT03637842|cannabis|cannabis
4637053|NCT03637842|impulsivity|impulsivity
4637054|NCT03637829|Healthy adults|healthy adults
4637055|NCT03637829|Cognitive performance|cognitive performance
4637056|NCT03637829|Chocolate|chocolate
4637057|NCT03637829|Food intake|food intake
4637058|NCT03637829|Glycemic response|glycemic response
4637059|NCT03637803|MK-3475|mk-3475
4637060|NCT03637803|pembrolizumab|pembrolizumab
4637061|NCT03637803|MRx0518|mrx0518
4637062|NCT03637803|PD-1 Inhibitor|pd-1 inhibitor
4637063|NCT03637803|Oncology|oncology
4637064|NCT03637803|Live Biotherapeutic Product|live biotherapeutic product
4637065|NCT03637790|healthy volunteers|healthy volunteers
4637066|NCT03637738|Intrabeam®|intrabeam®
4637067|NCT03637738|intraoperative radiation therapy|intraoperative radiation therapy
4637068|NCT03637738|conventional external radiotherapy|conventional external radiotherapy
4637069|NCT03637738|conservative surgery|conservative surgery
4637070|NCT03637699|Positive Psychology|positive psychology
4637071|NCT03637699|Positive Affect|positive affect
4637072|NCT03637686|Colorectal cancer|colorectal cancer
4637073|NCT03637686|Circulating tumor DNA|circulating tumor dna
4637074|NCT03637660|Benzathine penicillin G|benzathine penicillin g
4637075|NCT03637660|Early Syphillis|early syphillis
4637076|NCT03637660|HIV|hiv
4637077|NCT03637660|Phase 4|phase 4
4637078|NCT03637647|cardiopulmonary exercise testing|cardiopulmonary exercise testing
4637079|NCT03637647|oesophagogastric|oesophagogastric
4637080|NCT03637647|surgery|surgery
4637081|NCT03637647|chemotherapy|chemotherapy
4637082|NCT03637634|children and adolescents|children and adolescents
4637083|NCT03637582|voiding efficiency|voiding efficiency
4637084|NCT03637582|detrusor underactivity|detrusor underactivity
4637085|NCT03637582|urodynamics|urodynamics
4637086|NCT03637556|thalassemia|thalassemia
4637087|NCT03637556|iron|iron
4637088|NCT03637556|chelation|chelation
4637089|NCT03637556|deferasirox|deferasirox
4637090|NCT03637556|DST-0509|dst-0509
4637092|NCT03637543|Prostate Cancer|prostate cancer
4637093|NCT03637504|Feasibility|feasibility
4637094|NCT03637504|Mobile Medication Plan Application|mobile medication plan application
4637095|NCT03637504|Patient Care|patient care
4637096|NCT03637504|Nebulized Medications|nebulized medications
4637097|NCT03637504|Oral Medications|oral medications
4637098|NCT03637504|MedActionPlan|medactionplan
4637099|NCT03637504|eTrack Nebulizer|etrack nebulizer
4637100|NCT03637504|AdhereTech Pill Bottles|adheretech pill bottles
4637101|NCT03637491|Lung Cancer|lung cancer
4637102|NCT03637491|NSCLC|nsclc
4637103|NCT03637491|KRAS|kras
4637104|NCT03637491|NRAS|nras
4637105|NCT03637491|PDAC|pdac
4637106|NCT03637491|Pancreatic Cancer|pancreatic cancer
4637107|NCT03637465|hydration|hydration
4637108|NCT03637465|water intake|water intake
4637109|NCT03637465|sugar sweetened beverages|sugar sweetened beverages
4637110|NCT03637465|youth|youth
4637111|NCT03637465|children|children
4637112|NCT03637452|e-cigarettes|e-cigarettes
4637113|NCT03637452|juul brand e-cigarette|juul brand e-cigarette
4637114|NCT03637452|njoy brand e-cigarette|njoy brand e-cigarette
4637115|NCT03637452|evolv brand mod e-cigarette|evolv brand mod e-cigarette
4637116|NCT03637426|nano-hydroxyapatite|nano-hydroxyapatite
4637117|NCT03637426|Laser|laser
4637118|NCT03637426|desensitizing|desensitizing
4637119|NCT03637413|preterm infants|preterm infants
4637120|NCT03637413|hindmilk|hindmilk
4637121|NCT03637387|TGN|tgn
4637122|NCT03637387|TN|tn
4637123|NCT03637374|aortic aneurysm|aortic aneurysm
4637124|NCT03637335|irradiation|irradiation
4637125|NCT03637335|placebo|placebo
4637126|NCT03637335|carboplatin|carboplatin
4637127|NCT03637257|Capnography|capnography
4637128|NCT03637257|Pediatric|pediatric
4637129|NCT03637257|nasal cannula|nasal cannula
4637130|NCT03637257|Guedel airway|guedel airway
4637131|NCT03637244|HIV PrEP Decision support African Caribbean Black Canadians|hiv prep decision support african caribbean black canadians
4637132|NCT03637218|High Altitude|high altitude
4637133|NCT03637218|non-invasive cardiac output|non-invasive cardiac output
4637134|NCT03637218|Finapres|finapres
4637135|NCT03637192|High Altitude|high altitude
4637136|NCT03637192|cognitive function|cognitive function
4637137|NCT03637179|High Altitude|high altitude
4637138|NCT03637179|Pulmonary artery pressure|pulmonary artery pressure
4637139|NCT03637179|Echocardiography|echocardiography
4637140|NCT03637179|Right heart function|right heart function
4637141|NCT03637179|exercise|exercise
4637142|NCT03637166|High Altitude|high altitude
4637143|NCT03637166|Pulmonary artery pressure|pulmonary artery pressure
4637144|NCT03637166|Echocardiography|echocardiography
4637145|NCT03637166|Right heart function|right heart function
4637146|NCT03637153|exercise capacity|exercise capacity
4637147|NCT03637153|High Altitude|high altitude
4637148|NCT03637153|contant loaded exercise test|contant loaded exercise test
4637149|NCT03637140|Simulated altitude|simulated altitude
4637150|NCT03637140|Pulmonary artery pressure|pulmonary artery pressure
4637151|NCT03637140|Echocardiography|echocardiography
4637152|NCT03637140|Right heart function|right heart function
4637153|NCT03637140|exercise|exercise
4637154|NCT03637127|Simulated altitude|simulated altitude
4637155|NCT03637127|cognitive function|cognitive function
4637156|NCT03637114|Simulated altitude|simulated altitude
4637157|NCT03637114|arterial blood gas analysis|arterial blood gas analysis
4637158|NCT03637114|near infrared spectroscopy|near infrared spectroscopy
4637159|NCT03637101|Ischemia modified albumin|ischemia modified albumin
4637160|NCT03637101|Traumatic brain injury|traumatic brain injury
4637161|NCT03637101|Troponin|troponin
4637162|NCT03637101|Conscious Level|conscious level
4637163|NCT03637101|Poor outcome|poor outcome
4637164|NCT03637088|Simulated altitude|simulated altitude
4637165|NCT03637088|Pulmonary artery pressure|pulmonary artery pressure
4637166|NCT03637088|Echocardiography|echocardiography
4637167|NCT03637088|Right heart function|right heart function
4637168|NCT03637075|Diabetes mellitus, Type 2|diabetes mellitus, type 2
4637169|NCT03637075|cerebral insulin resistance|cerebral insulin resistance
4637170|NCT03637075|insulin action in the human brain|insulin action in the human brain
4637171|NCT03637075|dopamine signalling|dopamine signalling
4637172|NCT03637049|PBI-4050|pbi-4050
4637173|NCT03637049|drug-drug interaction|drug-drug interaction
4637174|NCT03637049|CYP3A|cyp3a
4637175|NCT03637049|midazolam|midazolam
4637176|NCT03637049|healthy subjects|healthy subjects
4637177|NCT03637023|fMRI|fmri
4637178|NCT03637023|Virtual Reality Therapy|virtual reality therapy
4637179|NCT03637023|Exercise Therapy|exercise therapy
4637180|NCT03636906|Safety|safety
4637181|NCT03636906|Respiratory syncytial virus (RSV)|respiratory syncytial virus (rsv)
4637182|NCT03636906|Vaccine|vaccine
4637183|NCT03636906|Reactogenicity|reactogenicity
4637184|NCT03636906|Immunogenicity|immunogenicity
4637185|NCT03636906|Infants|infants
4637186|NCT03636893|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
4637187|NCT03636893|perioperative chemotherapy|perioperative chemotherapy
4637188|NCT03636893|Systemic chemotherapy|systemic chemotherapy
4637189|NCT03636893|FLOT|flot
4637190|NCT03636893|SOX|sox
4637191|NCT03636893|Gastric cancer|gastric cancer
4637192|NCT03636880|heart failure|heart failure
4637193|NCT03636880|insomnia|insomnia
4637194|NCT03636880|anxiety|anxiety
4637195|NCT03636880|depression|depression
4637196|NCT03636880|memory|memory
4637197|NCT03636880|attention|attention
4637198|NCT03636880|executive functioning|executive functioning
4637199|NCT03636880|decision making|decision making
4637200|NCT03636880|self-care|self-care
4637201|NCT03636880|quality of life|quality of life
4637202|NCT03636880|functional status|functional status
4637203|NCT03636880|walk test|walk test
4637204|NCT03636880|sleep monitoring|sleep monitoring
4637205|NCT03636854|Eccentric|eccentric
4637206|NCT03636854|Concentric|concentric
4637207|NCT03636854|Strength|strength
4637208|NCT03636854|Balance|balance
4637209|NCT03636854|Thickness|thickness
4637210|NCT03636815|Left ventricular assist device|left ventricular assist device
4637211|NCT03636815|Physical therapy|physical therapy
4637212|NCT03636776|Quality of Life|quality of life
4637213|NCT03636776|Psychological vulnerability|psychological vulnerability
4637214|NCT03636724|E-health intervention|e-health intervention
4637215|NCT03636724|multiple health behavior change|multiple health behavior change
4637216|NCT03636724|Health Action Process Approach Model|health action process approach model
4637217|NCT03636724|Cardiac patients|cardiac patients
4637218|NCT03636685|Anlotinib|anlotinib
4637219|NCT03636685|NSCLC|nsclc
4637220|NCT03636685|platinum-based chemotherapy|platinum-based chemotherapy
4637221|NCT03636672|falls|falls
4637222|NCT03636672|Balance control|balance control
4637223|NCT03636672|Aging|aging
4637224|NCT03636672|Balance reactions|balance reactions
4637225|NCT03636672|Perturbation|perturbation
4637226|NCT03636633|Robotic Heart Surgery|robotic heart surgery
4637227|NCT03636633|Inspiratory Muscle Training|inspiratory muscle training
4637228|NCT03636633|Pulmonary Function Test|pulmonary function test
4637229|NCT03636633|6-Minute Walk Test|6-minute walk test
4637230|NCT03636633|Respiratory Muscle Strength|respiratory muscle strength
4637231|NCT03636633|Functional Capacity|functional capacity
4637232|NCT03636594|Dance|dance
4637233|NCT03636594|COPD|copd
4637234|NCT03636594|Maintenance program|maintenance program
4637235|NCT03636594|Pulmonary rehabilitation|pulmonary rehabilitation
4637236|NCT03636568|hyponatremia|hyponatremia
4637237|NCT03636568|hyponatremic|hyponatremic
4637238|NCT03636568|pituitary tumor|pituitary tumor
4637239|NCT03636568|transsphenoidal resection|transsphenoidal resection
4637240|NCT03636568|pituitary surgery|pituitary surgery
4637241|NCT03636568|pituitary|pituitary
4637242|NCT03636555|Oxytocin|oxytocin
4637243|NCT03636555|Heavy drinking|heavy drinking
4637244|NCT03636555|Moderate drinking|moderate drinking
4637245|NCT03636529|obese|obese
4637246|NCT03636529|overweight|overweight
4637247|NCT03636529|tart cherry juice|tart cherry juice
4637248|NCT03636503|Lymphoma|lymphoma
4637249|NCT03636490|Non-Dipping Blood Pressure|non-dipping blood pressure
4637250|NCT03636464|Pharmacokinetics|pharmacokinetics
4637251|NCT03636464|antibiotics|antibiotics
4637252|NCT03636464|RRT|rrt
4637253|NCT03636451|Dilation & curettage|dilation & curettage
4637254|NCT03636451|Paracervical block|paracervical block
4637255|NCT03636438|gene therapy|gene therapy
4637256|NCT03636438|OTC Deficiency|otc deficiency
4637257|NCT03636438|Urea Cycle Disorder|urea cycle disorder
4637258|NCT03636425|Running|running
4637259|NCT03636425|Resistance Training|resistance training
4637260|NCT03636425|Mountain|mountain
4637261|NCT03636425|Physiotherapy|physiotherapy
4637262|NCT03636412|lung transplant|lung transplant
4637263|NCT03636412|frailty|frailty
4637264|NCT03636399|adults|adults
4637265|NCT03636399|rehabilitation|rehabilitation
4637266|NCT03636399|social communication disorder|social communication disorder
4637267|NCT03636399|cognitive communication disorder|cognitive communication disorder
4637268|NCT03636399|groups|groups
4637269|NCT03636399|evidence-based|evidence-based
4637270|NCT03636386|Electrotherapy|electrotherapy
4637271|NCT03636386|Electrolysis|electrolysis
4637272|NCT03636386|Myofascial Pain Syndromes|myofascial pain syndromes
4637273|NCT03636386|Pain Threshold|pain threshold
4637274|NCT03636386|Visual Analog Pain Scale|visual analog pain scale
4637275|NCT03636347|PiZZ or Null genotype|pizz or null genotype
4637276|NCT03636347|Neutrophil elastase inhibitor|neutrophil elastase inhibitor
4637277|NCT03636347|Alpha-1|alpha-1
4637278|NCT03636347|Alvelestat|alvelestat
4637279|NCT03636347|AZD9668|azd9668
4637280|NCT03636347|MPH966|mph966
4637281|NCT03636334|Hypertension|hypertension
4637282|NCT03636334|Decision support system|decision support system
4637283|NCT03636334|Staged cluster randomized controlled trial|staged cluster randomized controlled trial
4637284|NCT03636321|living donor liver transplantation|living donor liver transplantation
4637285|NCT03636321|intraductal stent|intraductal stent
4637286|NCT03636321|biliary complications after liver transplantation|biliary complications after liver transplantation
4637287|NCT03636308|advanced pancreatic cancer|advanced pancreatic cancer
4637288|NCT03636308|nanoparticle albumin-bound paclitaxel|nanoparticle albumin-bound paclitaxel
4637289|NCT03636308|S-1|s-1
4637290|NCT03636308|gemcitabine|gemcitabine
4637291|NCT03636295|Mechanical valve replacement|mechanical valve replacement
4637494|NCT03635021|FOLFIRI|folfiri
4637292|NCT03636295|Vitamin K antagonist|vitamin k antagonist
4637293|NCT03636295|INR targets|inr targets
4637294|NCT03636295|Bleeding|bleeding
4637295|NCT03636295|Thromboembolism|thromboembolism
4637296|NCT03636282|Chronic disease|chronic disease
4637297|NCT03636282|Men's health|men's health
4637298|NCT03636282|Health promotion|health promotion
4637299|NCT03636282|Exercise|exercise
4637300|NCT03636282|Healthy diet|healthy diet
4637301|NCT03636282|Health Technology|health technology
4637302|NCT03636282|Weight loss|weight loss
4637303|NCT03636282|Hockey|hockey
4637304|NCT03636269|Hemodialysis|hemodialysis
4637305|NCT03636256|non-muscle invasive bladder cancer|non-muscle invasive bladder cancer
4637306|NCT03636256|muscle invasive bladder cancer|muscle invasive bladder cancer
4637307|NCT03636256|high-risk bladder cancer|high-risk bladder cancer
4637308|NCT03636256|BCG-unresponsive bladder cancer|bcg-unresponsive bladder cancer
4637309|NCT03636256|BCG failure|bcg failure
4637310|NCT03636256|BCG-refractory bladder cancer|bcg-refractory bladder cancer
4637311|NCT03636256|BCG-resistant bladder cancer|bcg-resistant bladder cancer
4637312|NCT03636256|NMIBC|nmibc
4637313|NCT03636256|MIBC|mibc
4637314|NCT03636217|Appetite|appetite
4637315|NCT03636217|Postprandial glycemia|postprandial glycemia
4637316|NCT03636217|Probiotic|probiotic
4637317|NCT03636178|alar base|alar base
4637318|NCT03636178|le fort I osteotomy|le fort i osteotomy
4637319|NCT03636165|Postoperative Pain|postoperative pain
4637320|NCT03636165|Post-Craniotomy Headache|post-craniotomy headache
4637321|NCT03636165|Methylprednisolone|methylprednisolone
4637322|NCT03636165|Ropivacaine|ropivacaine
4637323|NCT03636165|Pre-emptive Scalp Infiltration|pre-emptive scalp infiltration
4637324|NCT03636165|Child|child
4637325|NCT03636152|chronic kidney disease|chronic kidney disease
4637326|NCT03636152|cardiovascular disease|cardiovascular disease
4637327|NCT03636152|Inflammation|inflammation
4637328|NCT03636152|Atherosclerosis|atherosclerosis
4637329|NCT03636152|Vascular stiffness|vascular stiffness
4637330|NCT03636100|Atrial fibrillation|atrial fibrillation
4637331|NCT03636100|Catheter ablation|catheter ablation
4637332|NCT03636100|Cryoballon ablation|cryoballon ablation
4637333|NCT03636100|Acetylcholine|acetylcholine
4637334|NCT03636100|Ganglionated plexus|ganglionated plexus
4637335|NCT03636100|Pulmonary veins|pulmonary veins
4637336|NCT03636100|Pulmonary vein isolation|pulmonary vein isolation
4637337|NCT03636035|dietary supplement|dietary supplement
4637338|NCT03636035|arthritis|arthritis
4637339|NCT03636035|joint|joint
4637340|NCT03636035|complementary medicine|complementary medicine
4637341|NCT03636009|cervical radiculopathy|cervical radiculopathy
4637342|NCT03636009|neck pain|neck pain
4637343|NCT03636009|neuromobilizations|neuromobilizations
4637344|NCT03635996|Paroxysmal supraventricular tachycardia|paroxysmal supraventricular tachycardia
4637345|NCT03635996|cardiac monitoring|cardiac monitoring
4637346|NCT03635996|atrioventricular nodal reentrant tachycardia|atrioventricular nodal reentrant tachycardia
4637347|NCT03635996|atrioventricular reciprocating tachycardia|atrioventricular reciprocating tachycardia
4637348|NCT03635996|calcium channel blocker|calcium channel blocker
4637349|NCT03635996|conversion rate|conversion rate
4637350|NCT03635983|NKTR-214|nktr-214
4637351|NCT03635983|Nivolumab|nivolumab
4637352|NCT03635983|Immunotherapy|immunotherapy
4637353|NCT03635957|gout|gout
4637354|NCT03635957|uncontrolled gout|uncontrolled gout
4637355|NCT03635944|growth|growth
4637356|NCT03635944|small for gestational age|small for gestational age
4637357|NCT03635944|prematurity|prematurity
4637358|NCT03635944|breastfeeding|breastfeeding
4637359|NCT03635944|fortification|fortification
4637360|NCT03635944|parenteral nutrition|parenteral nutrition
4637361|NCT03635944|nutrition|nutrition
4637362|NCT03635931|CGF|cgf
4637363|NCT03635931|lost interdental papilla|lost interdental papilla
4637364|NCT03635905|abortion|abortion
4637365|NCT03635905|gabapentin|gabapentin
4637366|NCT03635905|Neurontin|neurontin
4637367|NCT03635905|Dilation and evacuation|dilation and evacuation
4637368|NCT03635892|Nivolumab|nivolumab
4637369|NCT03635892|Cabozantinib|cabozantinib
4637370|NCT03635892|18-254|18-254
4637371|NCT03635840|IABP|iabp
4637372|NCT03635840|Cardiogenic Shock|cardiogenic shock
4637373|NCT03635840|Myocardial Infarction|myocardial infarction
4637374|NCT03635814|Clinicaltrial, DME, DR, AMD, imatinib mesylate|clinicaltrial, dme, dr, amd, imatinib mesylate
4637375|NCT03635775|non-invasive brain stimulation|non-invasive brain stimulation
4637376|NCT03635775|rehabilitation|rehabilitation
4637377|NCT03635775|pediatrics|pediatrics
4637378|NCT03635762|Nutrition|nutrition
4637379|NCT03635762|Behavioral Intervention|behavioral intervention
4637380|NCT03635749|Acute Stroke|acute stroke
4637381|NCT03635749|Transient Ischemic Attack|transient ischemic attack
4637382|NCT03635749|Antiplatelet Therapy|antiplatelet therapy
4637383|NCT03635749|Randomized Controlled Trial|randomized controlled trial
4637384|NCT03635749|Double Blind Study|double blind study
4637385|NCT03635749|Multicenter Study|multicenter study
4637386|NCT03635749|Symptomatic Extracranial or Intracranial Arterial Stenosis|symptomatic extracranial or intracranial arterial stenosis
4637387|NCT03635749|Statin Therapy|statin therapy
4637388|NCT03635749|Clinical Trial|clinical trial
4637389|NCT03635736|brain damage|brain damage
4637392|NCT03635723|Rehabilitation|rehabilitation
4637393|NCT03635723|Wearables|wearables
4637394|NCT03635723|Breast surgery|breast surgery
4637395|NCT03635723|Physical activity|physical activity
4637396|NCT03635723|Enhanced recovery after surgery|enhanced recovery after surgery
4637397|NCT03635697|Pregnancy|pregnancy
4637398|NCT03635697|Mindfulness|mindfulness
4637399|NCT03635697|Anxiety|anxiety
4637400|NCT03635697|Depression|depression
4637401|NCT03635697|NST|nst
4637402|NCT03635697|Non-stress test|non-stress test
4637403|NCT03635684|Acetaminophen|acetaminophen
4637404|NCT03635684|Palliative Care|palliative care
4637405|NCT03635684|Infusions, Subcutaneous|infusions, subcutaneous
4637406|NCT03635684|Treatment Outcome|treatment outcome
4637407|NCT03635671|Imaging|imaging
4637408|NCT03635671|Diabetes|diabetes
4637409|NCT03635671|OCTA|octa
4637410|NCT03635632|Gene Therapy|gene therapy
4637411|NCT03635632|CAR T-cells|car t-cells
4637412|NCT03635632|Neuroblastoma|neuroblastoma
4637413|NCT03635632|chimeric antigen receptor|chimeric antigen receptor
4637414|NCT03635632|Immunotherapy|immunotherapy
4637415|NCT03635619|Esophageal Cancer|esophageal cancer
4637416|NCT03635619|Magnetic Resonance Imaging|magnetic resonance imaging
4637417|NCT03635619|Prognosis|prognosis
4637418|NCT03635619|neoplasm staging|neoplasm staging
4637419|NCT03635567|Programmed Cell Death 1|programmed cell death 1
4637420|NCT03635567|PD1|pd1
4637421|NCT03635567|PD-1|pd-1
4637422|NCT03635567|Programmed Cell Death Ligand 1|programmed cell death ligand 1
4637423|NCT03635567|PDL1|pdl1
4637424|NCT03635567|PD-L1|pd-l1
4637425|NCT03635554|Aphasia|aphasia
4637426|NCT03635541|non alcoholic fatty liver disease|non alcoholic fatty liver disease
4637427|NCT03635541|non alcoholic steatohepatitis|non alcoholic steatohepatitis
4637428|NCT03635541|steatosis|steatosis
4637429|NCT03635541|fibrosis|fibrosis
4637430|NCT03635541|progression|progression
4637431|NCT03635541|risk factors|risk factors
4637432|NCT03635476|Stroke Rehabilitation|stroke rehabilitation
4637433|NCT03635476|Personalized Nutrition|personalized nutrition
4637434|NCT03635476|Mobile-Health|mobile-health
4637435|NCT03635476|Stroke|stroke
4637436|NCT03635450|hypoxic-ischemic encephalopathy|hypoxic-ischemic encephalopathy
4637437|NCT03635450|newborn infants|newborn infants
4637438|NCT03635450|therapeutic hypothermia|therapeutic hypothermia
4637439|NCT03635450|hCT-MSC, an Umbilical Cord Tissue-Derived Mesenchymal Stromal Cell Product|hct-msc, an umbilical cord tissue-derived mesenchymal stromal cell product
4637440|NCT03635437|Remygen|remygen
4637441|NCT03635437|GABA|gaba
4637442|NCT03635372|Dyspepsia|dyspepsia
4637443|NCT03635372|Emergency Department|emergency department
4637444|NCT03635372|Antacid|antacid
4637445|NCT03635372|Viscous Lidocaine|viscous lidocaine
4637446|NCT03635359|fetal|fetal
4637447|NCT03635359|screening test|screening test
4637448|NCT03635359|trisomy|trisomy
4637449|NCT03635359|aneuploidy|aneuploidy
4637450|NCT03635359|copy number variant|copy number variant
4637451|NCT03635307|Blood Volume expansion|blood volume expansion
4637452|NCT03635307|Fluid responsiveness|fluid responsiveness
4637453|NCT03635307|Stroke volume|stroke volume
4637454|NCT03635307|Perioperative optimization|perioperative optimization
4637455|NCT03635255|CAD|cad
4637456|NCT03635255|miRNA|mirna
4637457|NCT03635242|postural control|postural control
4637458|NCT03635242|Chronic Low Back Pain|chronic low back pain
4637459|NCT03635242|therapeutic excercise|therapeutic excercise
4637460|NCT03635242|healed patients|healed patients
4637461|NCT03635229|cardiac surgery|cardiac surgery
4637462|NCT03635229|perioperative care|perioperative care
4637463|NCT03635229|postoperative delirium|postoperative delirium
4637464|NCT03635229|postoperative cognitive dysfunction|postoperative cognitive dysfunction
4637465|NCT03635216|Cervical cancer|cervical cancer
4637466|NCT03635216|Biomarker|biomarker
4637467|NCT03635216|Recurrence|recurrence
4637468|NCT03635203|C-shaped root canal / C-shaped canals|c-shaped root canal / c-shaped canals
4637469|NCT03635190|Peripheral Arterial Diseases|peripheral arterial diseases
4637470|NCT03635190|Peripheral Artery Diseases|peripheral artery diseases
4637471|NCT03635190|Arterial Occlusive Diseases|arterial occlusive diseases
4637472|NCT03635190|Peripheral Vascular Diseases|peripheral vascular diseases
4637473|NCT03635164|HPV Negative|hpv negative
4637474|NCT03635164|Durvalumab|durvalumab
4637475|NCT03635164|Surgical Resection|surgical resection
4637476|NCT03635164|Neoadjuvant|neoadjuvant
4637477|NCT03635164|Radiation|radiation
4637478|NCT03635151|Clinical trial|clinical trial
4637479|NCT03635112|TD-1473|td-1473
4637480|NCT03635112|Janus kinase inhibitor|janus kinase inhibitor
4637481|NCT03635112|JAK inhibitor|jak inhibitor
4637482|NCT03635112|Inflammatory Bowel Disease|inflammatory bowel disease
4637483|NCT03635112|IBD|ibd
4637484|NCT03635112|Crohn's Disease|crohn's disease
4637485|NCT03635112|Intestinal restriction|intestinal restriction
4637486|NCT03635086|Chikungunya virus|chikungunya virus
4637487|NCT03635086|mosquito-borne pathogen|mosquito-borne pathogen
4637488|NCT03635086|chikungunya fever|chikungunya fever
4637489|NCT03635086|Phase II|phase ii
4637490|NCT03635034|urinary catheter|urinary catheter
4637491|NCT03635034|catheter ablation procedures|catheter ablation procedures
4637492|NCT03635021|colorectal cancer|colorectal cancer
4637495|NCT03635021|panitumumab|panitumumab
4637496|NCT03635021|bevacizumab|bevacizumab
4637497|NCT03635021|wild-type RAS|wild-type ras
4637498|NCT03635021|primary left-sided|primary left-sided
4637499|NCT03634982|SHP2|shp2
4637500|NCT03634982|PTPN11|ptpn11
4637501|NCT03634982|NSCLC|nsclc
4637502|NCT03634982|EGFR|egfr
4637503|NCT03634982|RTK|rtk
4637504|NCT03634982|KRAS G12|kras g12
4637505|NCT03634982|BRAF Class 3|braf class 3
4637506|NCT03634982|NF1 LOF|nf1 lof
4637507|NCT03634982|advanced solid tumor|advanced solid tumor
4637508|NCT03634982|advanced solid malignancies|advanced solid malignancies
4637509|NCT03634982|melanoma|melanoma
4637510|NCT03634982|skin cancer|skin cancer
4637511|NCT03634982|ovarian cancer|ovarian cancer
4637512|NCT03634982|pancreatic cancer|pancreatic cancer
4637513|NCT03634982|endometrium/uterus cancer|endometrium/uterus cancer
4637514|NCT03634982|bladder cancer|bladder cancer
4637515|NCT03634982|cervical cancer|cervical cancer
4637516|NCT03634982|Carcinoma, Non-Small-Cell Lung|carcinoma, non-small-cell lung
4637517|NCT03634982|Neoplasms, Squamous Cell|neoplasms, squamous cell
4637518|NCT03634982|Carcinoma, Squamous Cell|carcinoma, squamous cell
4637519|NCT03634982|Esophageal Neoplasms|esophageal neoplasms
4637520|NCT03634982|Carcinoma, Bronchogenic|carcinoma, bronchogenic
4637521|NCT03634982|Bronchial Neoplasms|bronchial neoplasms
4637522|NCT03634982|Lung Neoplasms|lung neoplasms
4637523|NCT03634982|Respiratory Tract Neoplasms|respiratory tract neoplasms
4637524|NCT03634982|Thoracic Neoplasms|thoracic neoplasms
4637525|NCT03634982|Neoplasms by Site|neoplasms by site
4637526|NCT03634982|Neoplasms|neoplasms
4637527|NCT03634982|Lung Diseases|lung diseases
4637528|NCT03634982|Respiratory Tract Diseases|respiratory tract diseases
4637529|NCT03634982|Neoplasms, Glandular and Epithelial|neoplasms, glandular and epithelial
4637530|NCT03634982|Gastrointestinal Neoplasms|gastrointestinal neoplasms
4637531|NCT03634982|Digestive System Neoplasms|digestive system neoplasms
4637532|NCT03634982|Head and Neck Neoplasms|head and neck neoplasms
4637533|NCT03634982|Digestive System Diseases|digestive system diseases
4637534|NCT03634982|Esophageal Diseases|esophageal diseases
4637535|NCT03634982|Gastrointestinal Diseases|gastrointestinal diseases
4637536|NCT03634956|multinoduler goitre|multinoduler goitre
4637537|NCT03634956|thyroid cancer|thyroid cancer
4637538|NCT03634956|sugammadex sodium|sugammadex sodium
4637539|NCT03634956|intraoperative nerve monitorization|intraoperative nerve monitorization
4637540|NCT03634943|Clinical Practice Guidelines|clinical practice guidelines
4637541|NCT03634930|Breast Feeding, Exclusive versus Formula Feeding, Exclusive|breast feeding, exclusive versus formula feeding, exclusive
4637542|NCT03634930|satiety cues|satiety cues
4637543|NCT03634930|childhood obesity|childhood obesity
4637544|NCT03634930|biomarker|biomarker
4637545|NCT03634930|nutritional status|nutritional status
4637546|NCT03634930|infant body composition|infant body composition
4637547|NCT03634930|infant weight gain velocity|infant weight gain velocity
4637548|NCT03634930|metabolic programming|metabolic programming
4637549|NCT03634930|inflammation|inflammation
4637550|NCT03634917|Acamprosate|acamprosate
4637551|NCT03634917|Calcium|calcium
4637552|NCT03634917|alcohol self-administration|alcohol self-administration
4637553|NCT03634904|antibiotic dosing|antibiotic dosing
4637554|NCT03634904|pharmacokinetics|pharmacokinetics
4637555|NCT03634904|pharmacodynamics|pharmacodynamics
4637556|NCT03634904|hemodialysis|hemodialysis
4637557|NCT03634865|Bone trauma-fracture|bone trauma-fracture
4637558|NCT03634865|Radius|radius
4637559|NCT03634865|CT-scan|ct-scan
4637560|NCT03634865|Internal fixation|internal fixation
4637561|NCT03634852|IC Moxifloxacin hydrochloride|ic moxifloxacin hydrochloride
4637562|NCT03634852|SC triamcinolone acetonide|sc triamcinolone acetonide
4637563|NCT03634826|circulating tumor DNA|circulating tumor dna
4637564|NCT03634826|ctDNA methylation|ctdna methylation
4637565|NCT03634826|lung cancer|lung cancer
4637566|NCT03634826|surveillance|surveillance
4637567|NCT03634787|Heat Shock Proteins, early diagnosis|heat shock proteins, early diagnosis
4637568|NCT03634774|meals|meals
4637569|NCT03634774|staff training|staff training
4637570|NCT03634761|Program Quality|program quality
4637571|NCT03634761|Intervention Setting|intervention setting
4637572|NCT03634761|Autism|autism
4637573|NCT03634735|Inflammatory Bowel Disease|inflammatory bowel disease
4637574|NCT03634735|Fatigue|fatigue
4637575|NCT03634735|Thiamine|thiamine
4637576|NCT03634735|Vitamin B1|vitamin b1
4637577|NCT03634722|transcutaneous electrical nerve stimulation;|transcutaneous electrical nerve stimulation;
4637578|NCT03634696|Late-stage|late-stage
4637579|NCT03634696|Palliative care|palliative care
4637580|NCT03634696|Novel technology|novel technology
4637581|NCT03634696|Communication|communication
4637582|NCT03634683|recurrent hepatocellular carcinoma|recurrent hepatocellular carcinoma
4637583|NCT03634683|hepatitis B virus-related|hepatitis b virus-related
4637584|NCT03634683|post liver transplantation|post liver transplantation
4637585|NCT03634683|HCC|hcc
4637586|NCT03634657|Scattered radiation|scattered radiation
4637587|NCT03634657|X-ray protection|x-ray protection
4637588|NCT03634657|Radiation in cath lab|radiation in cath lab
4637589|NCT03634644|male infertility|male infertility
4637590|NCT03634644|oligoasthenoteratospermia|oligoasthenoteratospermia
4637591|NCT03634618|carpal tunnel syndrome|carpal tunnel syndrome
4637592|NCT03634618|mirror therapy|mirror therapy
4637593|NCT03634618|postoperative rehabilitation|postoperative rehabilitation
4637594|NCT03634618|physical therapy modalities|physical therapy modalities
4637595|NCT03634618|median nerve|median nerve
4637596|NCT03634605|Tetracycline|tetracycline
4637597|NCT03634605|Pleurodesis|pleurodesis
4637598|NCT03634579|Cancer/Carcinogenesis|cancer/carcinogenesis
4637599|NCT03634579|Laser Treatment|laser treatment
4637600|NCT03634579|Magnetic Resonance Imaging (MRI)|magnetic resonance imaging (mri)
4637601|NCT03634579|Radiology|radiology
4637602|NCT03634488|sickle cell disease|sickle cell disease
4637603|NCT03634488|sub-Saharan Africa|sub-saharan africa
4637604|NCT03634488|malnutrition|malnutrition
4637605|NCT03634488|low-income settings|low-income settings
4637606|NCT03634462|lipedema|lipedema
4637607|NCT03634462|lymphedema|lymphedema
4637608|NCT03634462|therapy|therapy
4637609|NCT03634462|sodium|sodium
4637610|NCT03634462|swelling|swelling
4637611|NCT03634436|SHR-1209 Phase 1|shr-1209 phase 1
4637612|NCT03634423|Interest in exercising more|interest in exercising more
4637613|NCT03634384|Myocardial Infarction|myocardial infarction
4637614|NCT03634384|Chest Pain|chest pain
4637616|NCT03634358|scalpel|scalpel
4637617|NCT03634358|foreskin|foreskin
4637618|NCT03634358|prepuce|prepuce
4637619|NCT03634345|Atopic dermatitis|atopic dermatitis
4637620|NCT03634332|pancreatic|pancreatic
4637621|NCT03634332|pancreas|pancreas
4637622|NCT03634332|cancer|cancer
4637623|NCT03634332|adenocarcinoma|adenocarcinoma
4637624|NCT03634306|Visual clearing System Laparoscopic Hysterectomy Myomectomy|visual clearing system laparoscopic hysterectomy myomectomy
4637625|NCT03634293|sepsis|sepsis
4637626|NCT03634293|septic shock|septic shock
4637627|NCT03634293|PCSK9 INHIBITOR|pcsk9 inhibitor
4637628|NCT03634280|Ankle Sprains|ankle sprains
4637629|NCT03634280|Kinesio Tape|kinesio tape
4637630|NCT03634280|Splint|splint
4637631|NCT03634254|AAC|aac
4637632|NCT03634254|Satisfaction level of communication quality|satisfaction level of communication quality
4637633|NCT03634202|Intensity Modulated Radiotherapy|intensity modulated radiotherapy
4637634|NCT03634202|Simultaneous Integrated Boost|simultaneous integrated boost
4637635|NCT03634202|Low and middle Rectal carcinoma|low and middle rectal carcinoma
4637636|NCT03634189|Cannabidiol|cannabidiol
4637637|NCT03634189|Heart Failure|heart failure
4637638|NCT03634189|AHA/ACC stage A-C|aha/acc stage a-c
4637639|NCT03634163|disability|disability
4637640|NCT03634137|Afamelanotide|afamelanotide
4637641|NCT03634137|Nontherapeutic Human Experimentation in healthy volunteers|nontherapeutic human experimentation in healthy volunteers
4637642|NCT03634111|transversus abdominis plane block (TAP block)|transversus abdominis plane block (tap block)
4637643|NCT03634111|postoperative analgesia|postoperative analgesia
4637644|NCT03634111|cesarean section|cesarean section
4637645|NCT03634098|Patients|patients
4637646|NCT03634085|safety|safety
4637647|NCT03634085|tolerability|tolerability
4637648|NCT03634085|pharmacokinetics|pharmacokinetics
4637649|NCT03634046|Lumbar Disc Herniation|lumbar disc herniation
4637650|NCT03634046|Low Back Pain|low back pain
4637651|NCT03634046|Percutaneous Transforaminal Endoscopic Discectomy|percutaneous transforaminal endoscopic discectomy
4637652|NCT03634046|Radiofrequency Ablation|radiofrequency ablation
4637653|NCT03634033|Implementation Science|implementation science
4637654|NCT03634033|Adoption|adoption
4637655|NCT03634033|Sustainability|sustainability
4637656|NCT03633994|Randomized controlled trial|randomized controlled trial
4637657|NCT03633994|Heparin instillation|heparin instillation
4637658|NCT03633968|sinus augmentation,lifting|sinus augmentation,lifting
4637659|NCT03633916|adolescents|adolescents
4637660|NCT03633916|urban|urban
4637661|NCT03633916|school|school
4637662|NCT03633916|demand for mental health care|demand for mental health care
4637663|NCT03633903|Early life stress|early life stress
4637664|NCT03633903|Adolescent|adolescent
4637665|NCT03633903|Mindfulness|mindfulness
4637666|NCT03633903|Neurobiological|neurobiological
4637667|NCT03633903|Stress|stress
4637668|NCT03633903|Resilience|resilience
4637669|NCT03633864|IgA nephropathy|iga nephropathy
4637670|NCT03633864|fecal microbiota transplantation|fecal microbiota transplantation
4637671|NCT03633825|suicide|suicide
4637672|NCT03633825|mental health crisis|mental health crisis
4637673|NCT03633825|crisis referrals|crisis referrals
4637674|NCT03633825|help-seeking|help-seeking
4637675|NCT03633825|risk assessment|risk assessment
4637676|NCT03633825|treatment barrier|treatment barrier
4637677|NCT03633812|End Stage Liver Disease|end stage liver disease
4637678|NCT03633812|Acute Kidney Injury|acute kidney injury
4637679|NCT03633812|Beta blocker|beta blocker
4637680|NCT03633786|endometriosis|endometriosis
4637681|NCT03633786|robot-assisted surgery|robot-assisted surgery
4637682|NCT03633786|standard laparoscopic surgery|standard laparoscopic surgery
4637683|NCT03633773|ICC|icc
4637684|NCT03633773|Mucin-1|mucin-1
4637685|NCT03633773|CAR-T|car-t
4637686|NCT03633773|Immunotherapy|immunotherapy
4637687|NCT03633747|hepatic hemangioma|hepatic hemangioma
4637688|NCT03633747|propranolol|propranolol
4637689|NCT03633734|Pancreatic cancer|pancreatic cancer
4637690|NCT03633734|Pancreatic Adenocarcinoma|pancreatic adenocarcinoma
4637691|NCT03633734|Gemcitabine|gemcitabine
4637692|NCT03633734|Nab-paclitaxel|nab-paclitaxel
4637693|NCT03633734|Modified Folfirinox|modified folfirinox
4637694|NCT03633734|Sequential treatment|sequential treatment
4637695|NCT03633721|mobility|mobility
4637696|NCT03633721|cognition|cognition
4637697|NCT03633721|WIHS|wihs
4637698|NCT03633708|sHPT|shpt
4637699|NCT03633708|CKD|ckd
4637700|NCT03633708|pediatric|pediatric
4637701|NCT03633695|Cataract, IOL|cataract, iol
4637702|NCT03633643|Greenlight Laser Vaporisation of the Prostate|greenlight laser vaporisation of the prostate
4637703|NCT03633643|Transurethral resection of the prostate|transurethral resection of the prostate
4637704|NCT03633643|Cotrimoxazole Prophylaxis|cotrimoxazole prophylaxis
4637705|NCT03633630|Amla|amla
4637706|NCT03633630|Emblica officinalis|emblica officinalis
4637707|NCT03633630|Metabolic Syndrome|metabolic syndrome
4637708|NCT03633630|Insulin Secretion|insulin secretion
4637709|NCT03633630|Insulin Sensitivity|insulin sensitivity
4637710|NCT03633604|Hematologic Diseases|hematologic diseases
4637711|NCT03633604|Blood Substitutes|blood substitutes
4637712|NCT03633552|Glioblastoma Multiforme|glioblastoma multiforme
4637713|NCT03633552|Anaplastic Astrocytoma|anaplastic astrocytoma
4637714|NCT03633552|Adjuvant treatment|adjuvant treatment
4637715|NCT03633552|Extended chemotherapy|extended chemotherapy
4637716|NCT03633539|SILS|sils
4637717|NCT03633539|colorectal cancer|colorectal cancer
4637718|NCT03633513|Immune System|immune system
4637719|NCT03633513|Immunology|immunology
4637720|NCT03633513|Neuroinflammation|neuroinflammation
4637721|NCT03633513|Inflammation|inflammation
4637722|NCT03633513|Neuroprotection|neuroprotection
4637723|NCT03633500|Colostrum|colostrum
4637724|NCT03633500|Oral immune therapy|oral immune therapy
4637725|NCT03633500|Preterm|preterm
4637726|NCT03633500|Oral feeding|oral feeding
4637727|NCT03633500|Sepsis|sepsis
4637728|NCT03633474|Healthy volunteer|healthy volunteer
4637729|NCT03633474|Human Challenge study|human challenge study
4637730|NCT03633422|Rehabilitation|rehabilitation
4637731|NCT03633422|Screening|screening
4637732|NCT03633422|Enrollment|enrollment
4637733|NCT03633409|IBD|ibd
4637734|NCT03633409|EBI2|ebi2
4637735|NCT03633409|G protein coupled receptor|g protein coupled receptor
4637736|NCT03633409|FACS|facs
4637737|NCT03633409|UBAC2|ubac2
4637738|NCT03633409|lymphocyte migration|lymphocyte migration
4637739|NCT03633409|single nucleotide polymorphism|single nucleotide polymorphism
4637740|NCT03633396|PPP|ppp
4637741|NCT03633370|Cardiac Arrest|cardiac arrest
4637742|NCT03633370|Dispatcher|dispatcher
4637743|NCT03633370|Cardiopulmonary Resuscitation|cardiopulmonary resuscitation
4637744|NCT03633357|Bipolar Disorder|bipolar disorder
4637745|NCT03633357|Cognitive Impairment|cognitive impairment
4637746|NCT03633344|Diarrhoea|diarrhoea
4637747|NCT03633344|Carbowhite|carbowhite
4637748|NCT03633344|Colloidal silicon dioxide|colloidal silicon dioxide
4637749|NCT03633318|electrical impedance myography|electrical impedance myography
4637750|NCT03633318|EIM|eim
4637751|NCT03633305|Insomnia|insomnia
4637752|NCT03633305|Pragmatic Clinical Trial|pragmatic clinical trial
4637753|NCT03633305|Drug Therapy|drug therapy
4637754|NCT03633305|Cognitive Behavior Therapy|cognitive behavior therapy
4637755|NCT03633305|Primary Care|primary care
4637756|NCT03633227|Primary Biliary Cholangitis|primary biliary cholangitis
4637757|NCT03633227|Primary Biliary Cirrhosis|primary biliary cirrhosis
4637758|NCT03633227|PBC|pbc
4637759|NCT03633227|Hepatic Impairment|hepatic impairment
4637760|NCT03633227|Cirrhosis|cirrhosis
4637761|NCT03633227|Liver|liver
4637762|NCT03633214|Prostatic neoplasms|prostatic neoplasms
4637763|NCT03633214|Mass screening|mass screening
4637764|NCT03633214|General practitioners|general practitioners
4637765|NCT03633214|Primary health care|primary health care
4637766|NCT03633214|Clinical trial|clinical trial
4637767|NCT03633188|Bone and Joint Infections (BJI)|bone and joint infections (bji)
4637768|NCT03633188|gut dysbiosis|gut dysbiosis
4637769|NCT03633188|antimicrobial resistance|antimicrobial resistance
4637770|NCT03633188|antibiotic resistance gene|antibiotic resistance gene
4637771|NCT03633188|mobile genetic elements|mobile genetic elements
4637772|NCT03633162|Maternal Grandmother|maternal grandmother
4637773|NCT03633162|Genes|genes
4637774|NCT03633162|Immune|immune
4637775|NCT03633162|Cohort|cohort
4637776|NCT03633162|Child development|child development
4637777|NCT03633149|prenatal alcohol exposure|prenatal alcohol exposure
4637778|NCT03633149|marijuana|marijuana
4637779|NCT03633149|smoking cessation|smoking cessation
4637780|NCT03633149|computer-delivered intervention|computer-delivered intervention
4637781|NCT03633149|contraception|contraception
4637782|NCT03633149|behavioral intervention|behavioral intervention
4637783|NCT03633149|motivational interviewing|motivational interviewing
4637784|NCT03633136|video|video
4637785|NCT03633136|patient education|patient education
4637786|NCT03633123|Surgical site infection|surgical site infection
4637787|NCT03633123|Abdominal surgery|abdominal surgery
4637788|NCT03633123|Colon and small bowl surgery|colon and small bowl surgery
4637789|NCT03633110|Vaccine|vaccine
4637790|NCT03633110|Personalized|personalized
4637791|NCT03633110|Immunotherapy|immunotherapy
4637792|NCT03633110|Solid Tumor|solid tumor
4637793|NCT03633058|MECP2|mecp2
4637794|NCT03633058|RTT|rtt
4637795|NCT03633058|Retts|retts
4637796|NCT03633058|ketamine|ketamine
4637797|NCT03633045|CLL, chronic lymphocytic leukemia, ibrutinib|cll, chronic lymphocytic leukemia, ibrutinib
4637798|NCT03633032|bone imaging; MRI; UTE; radiation-free; ultrashort echo time ; anatomy|bone imaging; mri; ute; radiation-free; ultrashort echo time ; anatomy
4637799|NCT03633019|thrombocytopenia|thrombocytopenia
4637800|NCT03633019|rhTPO|rhtpo
4637801|NCT03633019|real-world study|real-world study
4637802|NCT03633019|safety|safety
4637803|NCT03633019|efficacy|efficacy
4637804|NCT03632993|Edematous Fibrosclerotic Panniculopathy|edematous fibrosclerotic panniculopathy
4637805|NCT03632993|Cellulite|cellulite
4637806|NCT03632980|HIFU|hifu
4637807|NCT03632980|Localized Prostate cancer|localized prostate cancer
4637808|NCT03632980|MRI|mri
4637809|NCT03632980|PSA nadir|psa nadir
4637810|NCT03632980|Biopsy|biopsy
4637811|NCT03632980|High Intensity Focused Ultrasound|high intensity focused ultrasound
4637812|NCT03632980|Prostate Specific Antigen (PSA)|prostate specific antigen (psa)
4637813|NCT03632954|Wounds|wounds
4637814|NCT03632954|ACell|acell
4637815|NCT03632954|ACell MicroMatrix®|acell micromatrix®
4637816|NCT03632954|ACell Cytal® Wound Matrix|acell cytal® wound matrix
4637817|NCT03632954|Extracellular Matrix|extracellular matrix
4637818|NCT03632954|Urinary Bladder Matrix|urinary bladder matrix
4637819|NCT03632941|Cancer|cancer
4637820|NCT03632941|Immunotherapy|immunotherapy
4637821|NCT03632941|PD-1 Antibody|pd-1 antibody
4637822|NCT03632941|HER2|her2
4637823|NCT03632941|T cell|t cell
4637824|NCT03632928|Ultrasound elastography|ultrasound elastography
4637825|NCT03632928|Pressure pain threshold|pressure pain threshold
4637826|NCT03632928|variation|variation
4637827|NCT03632915|Antiepileptics|antiepileptics
4637828|NCT03632915|Continuous Renal Replacement Therapy|continuous renal replacement therapy
4637829|NCT03632902|supraglottic devices|supraglottic devices
4637830|NCT03632876|Retinol|retinol
4637831|NCT03632876|Stable isotope dilution|stable isotope dilution
4637832|NCT03632876|DXA|dxa
4637833|NCT03632876|retinyl palmitate|retinyl palmitate
4637834|NCT03632863|Pregnancy|pregnancy
4637835|NCT03632863|Depression|depression
4637836|NCT03632863|Antidepressant Use|antidepressant use
4637837|NCT03632863|Decision Aid|decision aid
4637838|NCT03632850|pancreatic cancer|pancreatic cancer
4637839|NCT03632850|shared decision-making|shared decision-making
4637840|NCT03632850|decision aids|decision aids
4637841|NCT03632850|web-based decision tool|web-based decision tool
4637842|NCT03632850|mixed methods|mixed methods
4637843|NCT03632837|extracorporal circulation|extracorporal circulation
4637844|NCT03632837|hemoadsorption|hemoadsorption
4637845|NCT03632837|post resuscitation syndrome|post resuscitation syndrome
4637846|NCT03632824|Placental abruption|placental abruption
4637847|NCT03632824|Placenta previa|placenta previa
4637848|NCT03632824|Threatened|threatened
4637849|NCT03632824|Miscarriage|miscarriage
4637850|NCT03632811|cutaneous mastocytosis|cutaneous mastocytosis
4637851|NCT03632811|indolent systemic mastocytosis|indolent systemic mastocytosis
4637852|NCT03632811|quality of life questionnaire in mastocytosis patient|quality of life questionnaire in mastocytosis patient
4637853|NCT03632798|ChemoID|chemoid
4637854|NCT03632798|cancer stem cells|cancer stem cells
4637855|NCT03632798|drug response assay|drug response assay
4637856|NCT03632798|ovarian cancer|ovarian cancer
4637857|NCT03632785|Platelet|platelet
4637858|NCT03632785|Coronary stenosis|coronary stenosis
4637859|NCT03632785|Coronary angiography|coronary angiography
4637860|NCT03632772|Overactive bladder|overactive bladder
4637861|NCT03632772|Transurethral Resection of the Prostate|transurethral resection of the prostate
4637862|NCT03632772|Pharmacotherapy|pharmacotherapy
4637863|NCT03632772|Mirabegron|mirabegron
4637864|NCT03632772|Solifenacin|solifenacin
4637865|NCT03632694|cancer survivor|cancer survivor
4637866|NCT03632694|cancer survivorship|cancer survivorship
4637867|NCT03632694|light physical activity|light physical activity
4637868|NCT03632694|sedentary behavior|sedentary behavior
4637870|NCT03632694|Jawbone|jawbone
4637871|NCT03632681|Cognitive processes|cognitive processes
4637872|NCT03632681|Reward processes|reward processes
4637873|NCT03632681|fMRI|fmri
4637874|NCT03632681|Insulin|insulin
4637875|NCT03632629|cognitive training|cognitive training
4637876|NCT03632629|developmental delay|developmental delay
4637877|NCT03632629|children|children
4637878|NCT03632629|therapeutic effect|therapeutic effect
4637879|NCT03632616|chronic pancreatitis|chronic pancreatitis
4637880|NCT03632616|quality of life|quality of life
4637881|NCT03632590|Magnesium|magnesium
4637882|NCT03632590|Supplements|supplements
4637883|NCT03632577|High Flow Oxygen|high flow oxygen
4637884|NCT03632577|Non Invasive Ventilation|non invasive ventilation
4637885|NCT03632577|Automated Flow Oxygen Titration|automated flow oxygen titration
4637886|NCT03632577|respiratory risk|respiratory risk
4637887|NCT03632551|Mismatch negativity|mismatch negativity
4637888|NCT03632551|EEG|eeg
4637889|NCT03632551|Single sided deafness|single sided deafness
4637890|NCT03632551|Cochlear implant|cochlear implant
4637891|NCT03632551|Asymmetrical hearing loss|asymmetrical hearing loss
4637892|NCT03632551|Spatial hearing|spatial hearing
4637893|NCT03632551|Binaural hearing|binaural hearing
4637894|NCT03632551|Localization|localization
4637895|NCT03632538|Acute Kidney Injury|acute kidney injury
4637896|NCT03632538|Cardiac Surgery|cardiac surgery
4637897|NCT03632512|Hericium erinaceus|hericium erinaceus
4637898|NCT03632512|Hearing|hearing
4637899|NCT03632486|Ultrasound|ultrasound
4637900|NCT03632486|Dengue|dengue
4637901|NCT03632473|Multimodal Evoked potentials|multimodal evoked potentials
4637902|NCT03632473|Visual evoked potentials|visual evoked potentials
4637903|NCT03632473|Somato-sensory evoked potentials|somato-sensory evoked potentials
4637904|NCT03632473|Motor evoked potentials|motor evoked potentials
4637905|NCT03632473|Expanded Disability Status Scale (EDSS)|expanded disability status scale (edss)
4637906|NCT03632447|Digital Health|digital health
4637907|NCT03632447|Female|female
4637908|NCT03632395|gastric cancer|gastric cancer
4637909|NCT03632395|postoperative complication|postoperative complication
4637910|NCT03632395|anastomotic leak|anastomotic leak
4637911|NCT03632395|oral contrast agent|oral contrast agent
4637912|NCT03632395|computed tomography|computed tomography
4637913|NCT03632382|Sleep apnea diagnosis|sleep apnea diagnosis
4637914|NCT03632382|3D acquisition|3d acquisition
4637915|NCT03632369|MRI|mri
4637916|NCT03632369|Hyperpolarized|hyperpolarized
4637917|NCT03632369|xenon-129|xenon-129
4637918|NCT03632343|self-management|self-management
4637919|NCT03632343|pain|pain
4637920|NCT03632343|adolescents|adolescents
4637921|NCT03632343|mHealth|mhealth
4637922|NCT03632317|H3.1K27M|h3.1k27m
4637923|NCT03632317|H3.3K27M|h3.3k27m
4637924|NCT03632317|diffuse intrinsic pontine glioma|diffuse intrinsic pontine glioma
4637925|NCT03632317|DIPG|dipg
4637926|NCT03632317|high-grade glioma|high-grade glioma
4637927|NCT03632317|pediatric glioma|pediatric glioma
4637928|NCT03632317|H3K27M|h3k27m
4637929|NCT03632317|panobinostat|panobinostat
4637930|NCT03632304|hand surgery|hand surgery
4637931|NCT03632304|quality of recovery|quality of recovery
4637932|NCT03632304|local anesthesia|local anesthesia
4637933|NCT03632304|regional anesthesia|regional anesthesia
4637934|NCT03632304|QoR-15|qor-15
4637935|NCT03632291|UB-221|ub-221
4637936|NCT03632291|anti-IgE monoclonal antibody|anti-ige monoclonal antibody
4637937|NCT03632291|chronic spontaneous urticaria (CSU)|chronic spontaneous urticaria (csu)
4637938|NCT03632239|Resource|resource
4637939|NCT03632239|Exome Sequencing|exome sequencing
4637940|NCT03632239|Variant|variant
4637941|NCT03632239|Sequencing|sequencing
4637942|NCT03632239|Genome|genome
4637943|NCT03632239|Phenotype|phenotype
4637944|NCT03632239|Genome Sequencing|genome sequencing
4637945|NCT03632239|Genomic Ascertainment Phenotyping Strategy|genomic ascertainment phenotyping strategy
4637946|NCT03632226|PET Imaging|pet imaging
4637947|NCT03632226|Neurodegeneration|neurodegeneration
4637948|NCT03632213|Mucopolysaccharidoses|mucopolysaccharidoses
4637949|NCT03632213|Losartan|losartan
4637950|NCT03632213|Aortic root dilatation|aortic root dilatation
4637951|NCT03632213|Echocardiogram|echocardiogram
4637952|NCT03632174|Probiotic|probiotic
4637953|NCT03632174|Atopic Dermatitis|atopic dermatitis
4637954|NCT03632174|Lactobacillus reuteri|lactobacillus reuteri
4637955|NCT03632135|ChemoID|chemoid
4637956|NCT03632135|Cancer stem cells|cancer stem cells
4637957|NCT03632135|Drug response assay|drug response assay
4637958|NCT03632135|Glioblastoma|glioblastoma
4637959|NCT03632135|Brain Cancer|brain cancer
4637960|NCT03632122|comorbidity|comorbidity
4637961|NCT03632122|pain|pain
4637962|NCT03632122|function|function
4637963|NCT03632122|older adults|older adults
4637964|NCT03632122|Medicare|medicare
4637965|NCT03632109|gonorrhea|gonorrhea
4637966|NCT03632109|pharynx|pharynx
4637967|NCT03632109|treatment|treatment
4637968|NCT03632109|gentamicin|gentamicin
4637969|NCT03632031|partial and full-thickness wounds|partial and full-thickness wounds
4637970|NCT03632031|pressure ulcer|pressure ulcer
4637971|NCT03632031|venous ulcer|venous ulcer
4637972|NCT03632031|chronic vascular ulcer|chronic vascular ulcer
4637973|NCT03632031|diabetic ulcer|diabetic ulcer
4637974|NCT03632018|cardiac rehabilitation|cardiac rehabilitation
4637975|NCT03632018|physical activity|physical activity
4637976|NCT03632005|Surgical Site Infection|surgical site infection
4637977|NCT03631992|Children|children
4637978|NCT03631992|Sugar|sugar
4637979|NCT03631992|Taste|taste
4637980|NCT03631992|Snacking|snacking
4637981|NCT03631992|Biomarker|biomarker
4637982|NCT03631992|Mothers|mothers
4637983|NCT03631940|Umbilical Cord Milking|umbilical cord milking
4637984|NCT03631940|Immediate Cord Clamping|immediate cord clamping
4637985|NCT03631940|Resuscitation|resuscitation
4637986|NCT03631927|critical care unit|critical care unit
4637987|NCT03631901|Melatonin|melatonin
4637988|NCT03631901|Diazepam|diazepam
4637989|NCT03631901|recurrence|recurrence
4637990|NCT03631901|prophylaxis|prophylaxis
4637991|NCT03631901|Febrile convulsions|febrile convulsions
4637992|NCT03631862|peripheral T-cell lymphoma|peripheral t-cell lymphoma
4637993|NCT03631862|Apatinib|apatinib
4637994|NCT03631862|targeted therapy|targeted therapy
4637995|NCT03631862|RR|rr
4637996|NCT03631862|PFS|pfs
4637997|NCT03631810|Acute pulmonary embolism|acute pulmonary embolism
4637998|NCT03631810|International guidelines|international guidelines
4637999|NCT03631797|Thoracic Surgery|thoracic surgery
4638000|NCT03631797|Microcirculation|microcirculation
4638001|NCT03631797|Endothelium, vascular|endothelium, vascular
4638002|NCT03631797|Microvascular reactivity|microvascular reactivity
4638003|NCT03631797|Laser Speckle|laser speckle
4638004|NCT03631784|PD1|pd1
4638005|NCT03631784|PD-1|pd-1
4638006|NCT03631784|PDL1|pdl1
4638007|NCT03631784|PD-L1|pd-l1
4638008|NCT03631771|Hypothyroidism|hypothyroidism
4638009|NCT03631771|Child|child
4638010|NCT03631771|Iodine|iodine
4638011|NCT03631771|Iodinated contrast medium (ICM)|iodinated contrast medium (icm)
4638012|NCT03631771|Thyroid function test (TFT)|thyroid function test (tft)
4638013|NCT03631771|Iodixanol|iodixanol
4638014|NCT03631771|Iohexol|iohexol
4638015|NCT03631771|Iopromide|iopromide
4638016|NCT03631758|Screening|screening
4638017|NCT03631758|Mammography|mammography
4638018|NCT03631758|Patient Decision Aid|patient decision aid
4638019|NCT03631745|mental health literacy|mental health literacy
4638020|NCT03631745|stigma|stigma
4638021|NCT03631745|help-seeking|help-seeking
4638022|NCT03631745|Latino|latino
4638023|NCT03631745|faith-based|faith-based
4638024|NCT03631745|religious congregations|religious congregations
4638025|NCT03631745|contact-based interventions|contact-based interventions
4638026|NCT03631719|Wolbachia|wolbachia
4638027|NCT03631719|Impact assessment|impact assessment
4638028|NCT03631719|Medellin|medellin
4638029|NCT03631719|Dengue|dengue
4638030|NCT03631719|Zika|zika
4638031|NCT03631719|Chikungunya|chikungunya
4638032|NCT03631719|Arboviral diseases|arboviral diseases
4638033|NCT03631719|Vector borne diseases|vector borne diseases
4638034|NCT03631706|M7824|m7824
4638035|NCT03631706|Pembrolizumab|pembrolizumab
4638036|NCT03631706|PD-L1-tumor Expression|pd-l1-tumor expression
4638037|NCT03631693|postoperative healing|postoperative healing
4638038|NCT03631667|Benzo[a]pyrene|benzo[a]pyrene
4638039|NCT03631667|Accelerator Mass Spectrometry|accelerator mass spectrometry
4638040|NCT03631667|Polycyclic Aromatic Hydrocarbons|polycyclic aromatic hydrocarbons
4638041|NCT03631667|Phenanthrene|phenanthrene
4638042|NCT03631615|neoadjuvant chemoradiation|neoadjuvant chemoradiation
4638043|NCT03631615|PD-1 antibody(SHR-1210)|pd-1 antibody(shr-1210)
4638044|NCT03631615|locally advanced proximal stomach adenocarcinoma|locally advanced proximal stomach adenocarcinoma
4638045|NCT03631524|deconditioning, isolation precautions, telerehabilitation|deconditioning, isolation precautions, telerehabilitation
4638046|NCT03631511|direct pulp capping, RetroMTA, histological evaluation|direct pulp capping, retromta, histological evaluation
4638047|NCT03631498|smoking|smoking
4638048|NCT03631498|hypoxia|hypoxia
4638049|NCT03631498|apoptosis|apoptosis
4638050|NCT03631498|chronic periodontitis|chronic periodontitis
4638051|NCT03631459|Kanglaita Injection/Capsule|kanglaita injection/capsule
4638052|NCT03631459|Cancer cachexia|cancer cachexia
4638053|NCT03631459|Real-world evidences|real-world evidences
4638054|NCT03631459|Overall survival|overall survival
4638055|NCT03631407|programmed cell death 1 (PD-1, PD1 )|programmed cell death 1 (pd-1, pd1 )
4638056|NCT03631407|programmed cell death ligand 1 (PD-L1, PDL1)|programmed cell death ligand 1 (pd-l1, pdl1)
4638057|NCT03631407|microsatellite stable (MSS) colorectal cancer (CRC)|microsatellite stable (mss) colorectal cancer (crc)
4638058|NCT03631407|chemokine receptor type 5 (CCR5)|chemokine receptor type 5 (ccr5)
4638059|NCT03631342|Ventilator Hyperinflation|ventilator hyperinflation
4638060|NCT03631342|Physical Therapy|physical therapy
4638061|NCT03631342|Mechanical Ventilation|mechanical ventilation
4638062|NCT03631316|valganciclovir|valganciclovir
4638063|NCT03631316|kidney transplantation|kidney transplantation
4638064|NCT03631316|pharmacokinetics|pharmacokinetics
4638065|NCT03631303|Implantable cardioverter defibrillator|implantable cardioverter defibrillator
4638066|NCT03631303|Post-extrasystolic Potentiation|post-extrasystolic potentiation
4638067|NCT03631303|Sudden Cardiac Death|sudden cardiac death
4638068|NCT03631290|kidney failure, chronic|kidney failure, chronic
4638069|NCT03631290|renal dialysis|renal dialysis
4638070|NCT03631290|aged|aged
4638071|NCT03631290|inappropriate prescribing|inappropriate prescribing
4638072|NCT03631290|preliminary data|preliminary data
4638073|NCT03631277|Indirect pulp treatment|indirect pulp treatment
4638074|NCT03631277|Photo-activated oral disinfection|photo-activated oral disinfection
4638075|NCT03631277|Calcium Hydroxide|calcium hydroxide
4638076|NCT03631264|preterm infants|preterm infants
4638077|NCT03631264|kinesiotape|kinesiotape
4638078|NCT03631264|swallowing|swallowing
4638079|NCT03631238|Cholesterol|cholesterol
4638080|NCT03631238|Dementia|dementia
4638081|NCT03631238|Homocysteine|homocysteine
4638082|NCT03631238|Cognitive dysfunctions|cognitive dysfunctions
4638083|NCT03631225|Rheumatoid Arthritis|rheumatoid arthritis
4638084|NCT03631225|Vectra DA|vectra da
4638085|NCT03631225|Radiographic Projections|radiographic projections
4638086|NCT03631212|virtual humans|virtual humans
4638087|NCT03631212|smoking cessation|smoking cessation
4638088|NCT03631212|youth|youth
4638089|NCT03631212|digital intervention|digital intervention
4638090|NCT03631212|Acceptance and Commitment Therapy|acceptance and commitment therapy
4638091|NCT03631199|ACZ885|acz885
4638092|NCT03631199|canakinumab|canakinumab
4638093|NCT03631199|pembrolizumab|pembrolizumab
4638094|NCT03631199|carboplatin|carboplatin
4638095|NCT03631199|cisplatin|cisplatin
4638096|NCT03631199|paclitaxel|paclitaxel
4638097|NCT03631199|nab-paclitaxel|nab-paclitaxel
4638098|NCT03631199|pemetrexed|pemetrexed
4638099|NCT03631199|NSCLC|nsclc
4638100|NCT03631199|non-small cell lung cancer|non-small cell lung cancer
4638101|NCT03631199|non small cell lung cancer|non small cell lung cancer
4638102|NCT03631199|squamous|squamous
4638103|NCT03631199|non-squamous|non-squamous
4638104|NCT03631199|hsCRP|hscrp
4638105|NCT03631199|IL-1β|il-1β
4638106|NCT03631199|PD-L1|pd-l1
4638107|NCT03631199|CANOPY|canopy
4638108|NCT03631199|CANOPY-1|canopy-1
4638109|NCT03631199|platinum-based doublet chemotherapy|platinum-based doublet chemotherapy
4638110|NCT03631199|first line therapy|first line therapy
4638111|NCT03631199|locally advanced|locally advanced
4638112|NCT03631199|metastatic|metastatic
4638113|NCT03631173|Pancreaticoduodenectomy|pancreaticoduodenectomy
4638114|NCT03631173|Pancreatectomy|pancreatectomy
4638115|NCT03631173|Anastomosis, Surgical|anastomosis, surgical
4638116|NCT03631160|Laparoscopic Cholecystectomy|laparoscopic cholecystectomy
4638117|NCT03631160|Transcutaneous Acupoint Electrical Stimulation|transcutaneous acupoint electrical stimulation
4638118|NCT03631160|Postoperative spontaneous voiding|postoperative spontaneous voiding
4638119|NCT03631160|Postoperative Dysuria|postoperative dysuria
4638120|NCT03631108|Iris Vessel|iris vessel
4638121|NCT03631108|OCTA|octa
4638122|NCT03631082|effects|effects
4638123|NCT03631082|slump stretching|slump stretching
4638124|NCT03631082|lumbar mobilization|lumbar mobilization
4638125|NCT03631082|non radiculating|non radiculating
4638126|NCT03631082|Low back pain|low back pain
4638127|NCT03631082|exercises|exercises
4638128|NCT03631082|quality of life|quality of life
4638129|NCT03631082|modified oswestry low back pain disability|modified oswestry low back pain disability
4638130|NCT03631082|numeric pain rating scale|numeric pain rating scale
4638131|NCT03631082|fear avoidance beliefs|fear avoidance beliefs
4638132|NCT03631030|Cooled radiofrequency ablation|cooled radiofrequency ablation
4638133|NCT03631030|MRI|mri
4638134|NCT03631017|Radiation Dosimetry of [18F]PARPi|radiation dosimetry of [18f]parpi
4638135|NCT03631017|PET/CT scans|pet/ct scans
4638136|NCT03631004|nausea and vomiting|nausea and vomiting
4638137|NCT03630978|hepatocellular carcinoma|hepatocellular carcinoma
4638138|NCT03630978|colorectal liver metastases|colorectal liver metastases
4638139|NCT03630978|non-colorectal liver metastases|non-colorectal liver metastases
4638140|NCT03630978|focal nodular hyperplasia|focal nodular hyperplasia
4638141|NCT03630978|liver hemangioma|liver hemangioma
4638142|NCT03630978|liver cysts|liver cysts
4638143|NCT03630978|surgical morbidity|surgical morbidity
4638144|NCT03630978|surgical mortality|surgical mortality
4638145|NCT03630978|sarcopenia|sarcopenia
4638146|NCT03630926|NV-VPAC1 Prostate Cancer Urine Diagnostic test|nv-vpac1 prostate cancer urine diagnostic test
4638147|NCT03630913|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
4638148|NCT03630913|Sentinel lymph node|sentinel lymph node
4638149|NCT03630913|Axillary lymphadenectomy|axillary lymphadenectomy
4638150|NCT03630913|Tagged axillary metastatic node|tagged axillary metastatic node
4638151|NCT03630887|Prewarming|prewarming
4638152|NCT03630887|Tympanic temperature|tympanic temperature
4638153|NCT03630887|Transurethral Resection|transurethral resection
4638154|NCT03630861|MicroRNAs|micrornas
4638155|NCT03630861|Glioblastoma|glioblastoma
4638156|NCT03630861|nonglial tumors|nonglial tumors
4638157|NCT03630861|stroke|stroke
4638158|NCT03630861|diagnosis|diagnosis
4638159|NCT03630835|Complicated carotid atherosclerotic plaques|complicated carotid atherosclerotic plaques
4638160|NCT03630835|Endarterectomy|endarterectomy
4638161|NCT03630835|99mTc-ANNexin-V-128|99mtc-annexin-v-128
4638162|NCT03630809|nonmetastatic|nonmetastatic
4638163|NCT03630809|classic HER2|classic her2
4638164|NCT03630809|Nonmetastatic classic HER2|nonmetastatic classic her2
4638165|NCT03630757|Fibromyalgia syndrome|fibromyalgia syndrome
4638166|NCT03630757|Manual Therapies|manual therapies
4638167|NCT03630757|Pain|pain
4638168|NCT03630744|fluid theraphy|fluid theraphy
4638169|NCT03630744|surgical procedures|surgical procedures
4638170|NCT03630744|adult patients|adult patients
4638171|NCT03630744|glycocalyx|glycocalyx
4638172|NCT03630744|practice guideline|practice guideline
4638173|NCT03630718|Liver Cirrhosis, Biliary|liver cirrhosis, biliary
4638174|NCT03630718|Female|female
4638175|NCT03630718|Cholangitis|cholangitis
4638176|NCT03630718|Hypnosis|hypnosis
4638177|NCT03630718|Psychological treatment|psychological treatment
4638178|NCT03630692|kidney cancer,|kidney cancer,
4638179|NCT03630692|oral drug|oral drug
4638180|NCT03630692|safety|safety
4638181|NCT03630692|adherence|adherence
4638182|NCT03630666|Oligometastatic pelvic lymph nod, IADT, radiotherapy|oligometastatic pelvic lymph nod, iadt, radiotherapy
4638183|NCT03630653|Neoplasm Staging|neoplasm staging
4638184|NCT03630653|Neoplasm Recurrence|neoplasm recurrence
4638185|NCT03630653|Axillary lymph node dissection|axillary lymph node dissection
4638186|NCT03630653|Conservative surgery|conservative surgery
4638187|NCT03630640|nivolumab; neoadjuvant; electroporation,adjuvant|nivolumab; neoadjuvant; electroporation,adjuvant
4638188|NCT03630614|smokers|smokers
4638189|NCT03630614|electronic cigarette|electronic cigarette
4638190|NCT03630614|nicotine|nicotine
4638191|NCT03630614|varenicline|varenicline
4638192|NCT03630614|randomized|randomized
4638193|NCT03630614|double blind|double blind
4638194|NCT03630614|double dummy|double dummy
4638195|NCT03630588|probiotics|probiotics
4638196|NCT03630588|visceral fat|visceral fat
4638197|NCT03630588|abdominal obesity|abdominal obesity
4638198|NCT03630549|HIV|hiv
4638199|NCT03630549|Village Health Worker|village health worker
4638200|NCT03630549|Differentiated Care|differentiated care
4638201|NCT03630549|Lesotho|lesotho
4638202|NCT03630549|Africa|africa
4638203|NCT03630549|antiretroviral therapy|antiretroviral therapy
4638204|NCT03630523|PHTS|phts
4638205|NCT03630523|PTEN|pten
4638206|NCT03630523|Vaccination|vaccination
4638207|NCT03630510|Physical Therapy Modalities,|physical therapy modalities,
4638208|NCT03630510|Respiration Artificial,|respiration artificial,
4638209|NCT03630510|Respiratory Care Units,|respiratory care units,
4638210|NCT03630510|Respiratory Mechanics,|respiratory mechanics,
4638211|NCT03630510|Positive-Pressure Respiration|positive-pressure respiration
4638212|NCT03630497|Acute Optic Neuritis (AON)|acute optic neuritis (aon)
4638213|NCT03630497|Demyelination|demyelination
4638214|NCT03630497|Optic Neuritis|optic neuritis
4638215|NCT03630484|Ventilator Hyperinflation|ventilator hyperinflation
4638216|NCT03630484|Expiratory Rib Cage Compression|expiratory rib cage compression
4638217|NCT03630484|Physical Therapy|physical therapy
4638218|NCT03630484|Mechanical Ventilation|mechanical ventilation
4638219|NCT03630471|Adolescents|adolescents
4638220|NCT03630432|Severe|severe
4638221|NCT03630432|Difficult|difficult
4638222|NCT03630432|Overweight and obese|overweight and obese
4638223|NCT03630393|Prostatectomy|prostatectomy
4638224|NCT03630393|Robotic|robotic
4638225|NCT03630393|Urology|urology
4638226|NCT03630328|Cogni.Q|cogni.q
4638227|NCT03630328|immune enhancement|immune enhancement
4638228|NCT03630328|natural killer cells|natural killer cells
4638229|NCT03630328|NK cells|nk cells
4638230|NCT03630328|Korean Angelica gigas|korean angelica gigas
4638231|NCT03630328|AGN|agn
4638232|NCT03630289|tissue autograft|tissue autograft
4638233|NCT03630289|blood brain barrier|blood brain barrier
4638234|NCT03630263|Gastric emptying|gastric emptying
4638235|NCT03630263|Postprandial blood glucose|postprandial blood glucose
4638236|NCT03630250|meningitis|meningitis
4638237|NCT03630250|GMO|gmo
4638238|NCT03630224|Severe trauma|severe trauma
4638239|NCT03630224|Acute kidney injury|acute kidney injury
4638240|NCT03630224|Fluid resuscitation|fluid resuscitation
4638241|NCT03630224|Sodium chloride|sodium chloride
4638242|NCT03630224|Plasmalyte|plasmalyte
4638243|NCT03630211|Stem Cell Transplantation|stem cell transplantation
4638244|NCT03630211|Systemic Sclerosis|systemic sclerosis
4638245|NCT03630211|Scleroderma|scleroderma
4638246|NCT03630211|Interstitial Lung Disease|interstitial lung disease
4638247|NCT03630211|ILD (Interstitial Lung Disease)|ild (interstitial lung disease)
4638248|NCT03630211|Pulmonary Hypertension|pulmonary hypertension
4638249|NCT03630211|BMT ( bone marrow transplantation)|bmt ( bone marrow transplantation)
4638250|NCT03630211|Autologous|autologous
4638251|NCT03630198|corticosteroid|corticosteroid
4638252|NCT03630198|local anesthetic|local anesthetic
4638253|NCT03630172|low back pain|low back pain
4638254|NCT03630172|dry needling|dry needling
4638255|NCT03630172|flexibility|flexibility
4638256|NCT03630172|sympathetic nervous system|sympathetic nervous system
4638257|NCT03630159|Lymphoma tisagenlecleucel|lymphoma tisagenlecleucel
4638258|NCT03630159|Diffuse Large B-cell Lymphoma|diffuse large b-cell lymphoma
4638259|NCT03630159|CTL019|ctl019
4638260|NCT03630159|PORTIA|portia
4638261|NCT03630159|DLBCL|dlbcl
4638262|NCT03630159|tisagenlecleucel|tisagenlecleucel
4638263|NCT03630159|pembrolizumab|pembrolizumab
4638264|NCT03630159|r/r Diffuse large B-cell Lymphoma|r/r diffuse large b-cell lymphoma
4638265|NCT03630159|relapsed/refractory Diffuse large B-cell Lymphoma|relapsed/refractory diffuse large b-cell lymphoma
4638266|NCT03630120|Thyroid disease|thyroid disease
4638267|NCT03630120|Tyrosine kinase inhibitor|tyrosine kinase inhibitor
4638268|NCT03630120|TKI|tki
4638269|NCT03630120|Medullary thyroid cancer|medullary thyroid cancer
4638270|NCT03630120|DTC|dtc
4638271|NCT03630120|Advanced thyroid cancer|advanced thyroid cancer
4638272|NCT03630120|Progressive thyroid cancer|progressive thyroid cancer
4638273|NCT03630120|MTC|mtc
4638274|NCT03630107|itchy scalp|itchy scalp
4638275|NCT03630107|chronic pruritus|chronic pruritus
4638276|NCT03630068|Liver Neoplasms|liver neoplasms
4638277|NCT03630068|Hepatocellular Carcinoma|hepatocellular carcinoma
4638278|NCT03630068|Ablation Techniques|ablation techniques
4638279|NCT03630068|Stereotaxic Techniques|stereotaxic techniques
4638280|NCT03630068|Computer-Assisted Therapy|computer-assisted therapy
4638281|NCT03630068|Computer-Assisted Surgery|computer-assisted surgery
4638282|NCT03630068|Interventional Radiology|interventional radiology
4638283|NCT03630055|Direct oral anticoagulants|direct oral anticoagulants
4638284|NCT03630055|Transradial access|transradial access
4638285|NCT03630055|Percutaneous coronary intervention|percutaneous coronary intervention
4638286|NCT03630042|Waldenstrom Macroglobulinemia|waldenstrom macroglobulinemia
4638287|NCT03630042|Relapsed|relapsed
4638288|NCT03630042|Refractory|refractory
4638289|NCT03630042|Rituximab|rituximab
4638290|NCT03630042|Pembrolizumab|pembrolizumab
4638291|NCT03630003|ICU|icu
4638292|NCT03630003|critical care|critical care
4638293|NCT03630003|alternative communication|alternative communication
4638294|NCT03630003|augmentative communication|augmentative communication
4638295|NCT03629938|Feiss line|feiss line
4638296|NCT03629938|Medial longitudinal arch|medial longitudinal arch
4638297|NCT03629938|Navicular drop|navicular drop
4638298|NCT03629938|Pes planus|pes planus
4638299|NCT03629899|Retinitis Pigmentosa|retinitis pigmentosa
4638300|NCT03629899|Inherited Retinal Degeneration|inherited retinal degeneration
4638301|NCT03629899|Retina Implant|retina implant
4638302|NCT03629899|Retinal Prosthesis|retinal prosthesis
4638303|NCT03629899|Artificial Vision|artificial vision
4638304|NCT03629886|Adults|adults
4638305|NCT03629886|Human Papillomavirus (HPV)|human papillomavirus (hpv)
4638306|NCT03629886|Cervical cancer|cervical cancer
4638307|NCT03629886|Safety|safety
4638308|NCT03629860|Atrophic, augmetation, bone regeneration|atrophic, augmetation, bone regeneration
4638309|NCT03629847|NETs, MTD, Everolimus.|nets, mtd, everolimus.
4638310|NCT03629821|Postural Balance|postural balance
4638311|NCT03629821|Dance Therapy|dance therapy
4638312|NCT03629821|Exercise Therapy|exercise therapy
4638313|NCT03629808|metabolic surgery|metabolic surgery
4638314|NCT03629808|laparoscopic sleeve gastrectomy|laparoscopic sleeve gastrectomy
4638315|NCT03629769|Prostate inflammation|prostate inflammation
4638316|NCT03629769|CPS/CPPS|cps/cpps
4638317|NCT03629769|Prostatitis|prostatitis
4638318|NCT03629769|Proxelan|proxelan
4638319|NCT03629730|coordination|coordination
4638320|NCT03629717|Mammographic density|mammographic density
4638321|NCT03629717|Premenopausal|premenopausal
4638322|NCT03629717|Breast cancer|breast cancer
4638323|NCT03629717|Chemoprevention|chemoprevention
4638324|NCT03629717|Denosumab|denosumab
4638325|NCT03629691|Cavitation|cavitation
4638326|NCT03629691|PFS|pfs
4638327|NCT03629678|mhealth|mhealth
4638328|NCT03629665|chronic aphasia|chronic aphasia
4638329|NCT03629665|rehabilitation|rehabilitation
4638330|NCT03629665|randomized controlled trial (RCT)|randomized controlled trial (rct)
4638331|NCT03629652|head-down position|head-down position
4638332|NCT03629652|ischemic stroke|ischemic stroke
4638333|NCT03629652|rehabilitation|rehabilitation
4638334|NCT03629639|Psoriasis|psoriasis
4638335|NCT03629639|Metformin|metformin
4638336|NCT03629639|Gut microbiota|gut microbiota
4638337|NCT03629626|preoperative / intraoperative/ postoperative management|preoperative / intraoperative/ postoperative management
4638338|NCT03629561|"Paraproteinemias[Mesh]"|"paraproteinemias[mesh]"
4638339|NCT03629561|"Kidney Diseases[Mesh]"|"kidney diseases[mesh]"
4638340|NCT03629548|dinoprostone|dinoprostone
4638341|NCT03629548|early amniotomy|early amniotomy
4638342|NCT03629548|labor induction|labor induction
4638343|NCT03629548|foley bulb|foley bulb
4638344|NCT03629509|decision aid|decision aid
4638345|NCT03629509|breast cancer|breast cancer
4638346|NCT03629509|young females|young females
4638347|NCT03629509|implementation|implementation
4638348|NCT03629509|stepped wedge trial|stepped wedge trial
4638349|NCT03629483|Elderly|elderly
4638350|NCT03629483|Knee Arthroplasty|knee arthroplasty
4638351|NCT03629483|Nerve Block|nerve block
4638352|NCT03629483|Dexmedetomidine|dexmedetomidine
4638353|NCT03629483|Postoperative Delirium|postoperative delirium
4638354|NCT03629483|Long-term Outcome|long-term outcome
4638355|NCT03629431|ARISCAT|ariscat
4638356|NCT03629431|complications|complications
4638357|NCT03629431|postoperative|postoperative
4638358|NCT03629418|Coronary Artery Bypass, Off-Pump|coronary artery bypass, off-pump
4638359|NCT03629418|Intraoperative Hypotension|intraoperative hypotension
4638360|NCT03629418|Acute Kidney Injury|acute kidney injury
4638361|NCT03629418|Preventive Medicine|preventive medicine
4638362|NCT03629418|Intraoperative Care|intraoperative care
4638363|NCT03629405|pH of the skin|ph of the skin
4638364|NCT03629405|SDS|sds
4638365|NCT03629405|Lipbarvis|lipbarvis
4638366|NCT03629405|TEWL|tewl
4638367|NCT03629405|Skin hydration|skin hydration
4638368|NCT03629392|Methionine|methionine
4638369|NCT03629392|Cysteine|cysteine
4638370|NCT03629392|Energy metabolism|energy metabolism
4638371|NCT03629392|Sulfur amino acids|sulfur amino acids
4638372|NCT03629366|Refugees|refugees
4638373|NCT03629366|Supported Employment|supported employment
4638374|NCT03629366|Individual Placement and Support|individual placement and support
4638375|NCT03629366|Employment|employment
4638376|NCT03629366|Vocational Rehabilitation|vocational rehabilitation
4638377|NCT03629366|Mental Health|mental health
4638378|NCT03629353|airway management|airway management
4638379|NCT03629353|high flow nasal cannula|high flow nasal cannula
4638380|NCT03629353|laryngeal microsurgery|laryngeal microsurgery
4638381|NCT03629314|Opioid|opioid
4638382|NCT03629301|Obesity|obesity
4638383|NCT03629301|Overweight|overweight
4638384|NCT03629301|Lifestyle Intervention|lifestyle intervention
4638385|NCT03629301|Randomized controlled Trial|randomized controlled trial
4638386|NCT03629301|Internet delivered|internet delivered
4638387|NCT03629301|Online|online
4638388|NCT03629301|Weight loss|weight loss
4638389|NCT03629288|Azithromycin|azithromycin
4638390|NCT03629288|Periodontal debridement|periodontal debridement
4638391|NCT03629288|Antibiotics|antibiotics
4638392|NCT03629288|Periodontitis|periodontitis
4638393|NCT03629275|Efficacy|efficacy
4638394|NCT03629275|Neural Stem cells|neural stem cells
4638395|NCT03629275|Intracerebral|intracerebral
4638396|NCT03629275|Cerebral Infarction|cerebral infarction
4638397|NCT03629275|Cerebrovascular disorders|cerebrovascular disorders
4638398|NCT03629275|Brain diseases|brain diseases
4638399|NCT03629275|Stereotactic surgery|stereotactic surgery
4638400|NCT03629262|Elderly|elderly
4638401|NCT03629262|Orthopedic Surgery|orthopedic surgery
4638402|NCT03629262|Analgesia|analgesia
4638403|NCT03629262|Dexmedetomidine|dexmedetomidine
4638404|NCT03629262|Postoperative Delirium|postoperative delirium
4638405|NCT03629262|Long-term Outcome|long-term outcome
4638406|NCT03629223|Tepotinib|tepotinib
4638407|NCT03629223|Pharmacokinetics|pharmacokinetics
4638408|NCT03629223|Bioequivalence|bioequivalence
4638409|NCT03629197|primary care|primary care
4638410|NCT03629197|chronic pain|chronic pain
4638411|NCT03629197|patient-physician communication|patient-physician communication
4638412|NCT03629197|opioid analgesics|opioid analgesics
4638413|NCT03629197|standardized patients|standardized patients
4638414|NCT03629158|Behavioral Medicine|behavioral medicine
4638415|NCT03629158|Clinical Trial|clinical trial
4638416|NCT03629158|Cardiology|cardiology
4638417|NCT03629158|Health Behavior|health behavior
4638418|NCT03629158|Healthy Lifestyle|healthy lifestyle
4638419|NCT03629158|Self Efficacy|self efficacy
4638420|NCT03629106|Bipolar Disorder|bipolar disorder
4638421|NCT03629106|Cannabis Use Disorder|cannabis use disorder
4638422|NCT03629106|Cognitive Function|cognitive function
4638423|NCT03629093|General anesthesia|general anesthesia
4638424|NCT03629093|Infant|infant
4638425|NCT03629093|Neurodevelopment|neurodevelopment
4638426|NCT03629093|Postoperative|postoperative
4638427|NCT03629093|the Gesell Developmental Inventory|the gesell developmental inventory
4638428|NCT03629080|solid organ transplantation|solid organ transplantation
4638429|NCT03629080|vaccine|vaccine
4638430|NCT03629067|Hypertension|hypertension
4638431|NCT03629028|uterine closure; uterine scar defect; niche; cesarean;|uterine closure; uterine scar defect; niche; cesarean;
4638432|NCT03628976|tVNS, training, neuromotor adaptation|tvns, training, neuromotor adaptation
4638433|NCT03628963|Diabetes|diabetes
4638434|NCT03628963|hypertension|hypertension
4638435|NCT03628963|dyslipidemia|dyslipidemia
4638436|NCT03628950|Interscalene block|interscalene block
4638437|NCT03628950|Postoperative analgesia|postoperative analgesia
4638438|NCT03628950|Suprascapular nerve block|suprascapular nerve block
4638439|NCT03628950|Infraclavicular nerve block|infraclavicular nerve block
4638440|NCT03628950|Arthroscopic rotator cuff repair|arthroscopic rotator cuff repair
4638441|NCT03628950|Hemi-diaphragmatic paralysis|hemi-diaphragmatic paralysis
4638442|NCT03628937|Green tea polyphenols|green tea polyphenols
4638443|NCT03628937|Children obesity|children obesity
4638444|NCT03628937|Precocious puberty|precocious puberty
4638445|NCT03628937|Prevention|prevention
4638446|NCT03628872|Scaling and root planing|scaling and root planing
4638447|NCT03628872|Laser scaling|laser scaling
4638448|NCT03628859|Renal cancer metastatic|renal cancer metastatic
4638449|NCT03628859|Immunotherapy|immunotherapy
4638450|NCT03628859|Predictive biomarkers|predictive biomarkers
4638451|NCT03628859|Translational study|translational study
4638452|NCT03628820|Stress|stress
4638453|NCT03628820|Anxiety|anxiety
4638454|NCT03628820|Cortisol|cortisol
4638455|NCT03628820|Therapy|therapy
4638456|NCT03628820|Dog|dog
4638457|NCT03628820|Coloring|coloring
4638458|NCT03628820|Mandala|mandala
4638459|NCT03628807|transjugular intrahepatic portosystemic shunt (TIPS)|transjugular intrahepatic portosystemic shunt (tips)
4638460|NCT03628807|non-invasive assessments|non-invasive assessments
4638461|NCT03628807|Transthoracic echocardiography (TTE) with Speckle-tracking|transthoracic echocardiography (tte) with speckle-tracking
4638462|NCT03628807|Computer tomography scan (CT-scan)|computer tomography scan (ct-scan)
4638463|NCT03628807|Magnetic resonance imaging (MRI)|magnetic resonance imaging (mri)
4638464|NCT03628807|circulating biomarkers|circulating biomarkers
4638465|NCT03628807|Electroencephalography (EEG)|electroencephalography (eeg)
4638466|NCT03628781|Behavioral intervention|behavioral intervention
4638467|NCT03628755|Fluency shaping therapy|fluency shaping therapy
4638468|NCT03628755|Digital Manipulation|digital manipulation
4638469|NCT03628755|Stuttering|stuttering
4638470|NCT03628755|communication|communication
4638471|NCT03628742|periodontal probe|periodontal probe
4638472|NCT03628742|gingival thickness|gingival thickness
4638473|NCT03628742|gingival biotype|gingival biotype
4638474|NCT03628599|Dry eyes|dry eyes
4638475|NCT03628586|acute coronary syndrome; biomarkers, HS troponins|acute coronary syndrome; biomarkers, hs troponins
4638476|NCT03628573|rTMS|rtms
4638477|NCT03628573|Depression|depression
4638478|NCT03628573|Theta Burst Stimulation|theta burst stimulation
4638479|NCT03628573|Inpatients|inpatients
4638480|NCT03628573|Biomarkers|biomarkers
4638481|NCT03628560|Healthy volunteer|healthy volunteer
4638482|NCT03628560|Oximetry|oximetry
4638483|NCT03628560|Pulse oximeter|pulse oximeter
4638484|NCT03628560|Hypoxia|hypoxia
4638485|NCT03628547|musculoskeletal system pain|musculoskeletal system pain
4638486|NCT03628547|athlete|athlete
4638487|NCT03628547|psychosocial problems|psychosocial problems
4638488|NCT03628547|algometer|algometer
4638489|NCT03628534|Cardiac Arrhythmia|cardiac arrhythmia
4638490|NCT03628534|Ventricular Tachycardia|ventricular tachycardia
4638491|NCT03628534|Arrhythmia|arrhythmia
4638492|NCT03628534|Pathological processes|pathological processes
4638493|NCT03628521|lung cancer|lung cancer
4638494|NCT03628521|first-line|first-line
4638495|NCT03628521|combination|combination
4638496|NCT03628508|muscle tension|muscle tension
4638497|NCT03628508|alignment|alignment
4638498|NCT03628508|knee osteoarthritis|knee osteoarthritis
4638499|NCT03628508|loading|loading
4638500|NCT03628495|insert|insert
4638501|NCT03628495|pressure therapy|pressure therapy
4638502|NCT03628495|silicone gel|silicone gel
4638503|NCT03628443|CKD|ckd
4638504|NCT03628443|HFrEF|hfref
4638505|NCT03628443|HFpEF|hfpef
4638506|NCT03628443|FGF23|fgf23
4638507|NCT03628443|Dialysis|dialysis
4638508|NCT03628443|Atherosclerosis|atherosclerosis
4638509|NCT03628443|Coronary Artery Disease|coronary artery disease
4638510|NCT03628430|Anesthesia;|anesthesia;
4638511|NCT03628430|lidocaine;|lidocaine;
4638512|NCT03628430|patient experience|patient experience
4638513|NCT03628430|patient pain|patient pain
4638514|NCT03628430|sodium bicarbonate|sodium bicarbonate
4638515|NCT03628430|Vascular Access Devices|vascular access devices
4638516|NCT03628417|cutaneous metastases|cutaneous metastases
4638517|NCT03628417|calcium electroporation|calcium electroporation
4638518|NCT03628417|bleomycin electroporation|bleomycin electroporation
4638519|NCT03628404|Alzheimer disease|alzheimer disease
4638520|NCT03628404|Dementia|dementia
4638521|NCT03628404|Faroe Islands|faroe islands
4638522|NCT03628404|Isolated population|isolated population
4638523|NCT03628404|Environmental exposure|environmental exposure
4638524|NCT03628391|delirium|delirium
4638525|NCT03628391|intensive care unit|intensive care unit
4638526|NCT03628391|critical illness|critical illness
4638527|NCT03628391|cognitive impairment|cognitive impairment
4638528|NCT03628365|Body composition|body composition
4638529|NCT03628365|muscle mass|muscle mass
4638530|NCT03628365|protein metabolism|protein metabolism
4638531|NCT03628365|enteral nutrition|enteral nutrition
4638532|NCT03628365|ICU|icu
4638533|NCT03628339|Tepotinib|tepotinib
4638534|NCT03628339|Midazolam|midazolam
4638535|NCT03628339|Cytochrome P450|cytochrome p450
4638536|NCT03628339|Pharmacokinetics|pharmacokinetics
4638537|NCT03628326|Pulmonary artery|pulmonary artery
4638538|NCT03628326|3D reconstruction|3d reconstruction
4638539|NCT03628326|Video-assisted thoracic surgery lobectomy|video-assisted thoracic surgery lobectomy
4638540|NCT03628326|CT angiography|ct angiography
4638541|NCT03628326|Anatomic variation|anatomic variation
4638542|NCT03628313|Echoacrdiography|echoacrdiography
4638543|NCT03628313|EchoDoppler|echodoppler
4638544|NCT03628313|Aortic valve stenosis|aortic valve stenosis
4638545|NCT03628313|Prognosis|prognosis
4638546|NCT03628300|neurotoxicity|neurotoxicity
4638547|NCT03628287|viral load suppression|viral load suppression
4638548|NCT03628287|medical case management|medical case management
4638549|NCT03628235|online survey|online survey
4638550|NCT03628235|indirect costs|indirect costs
4638551|NCT03628235|out-of-pocket costs|out-of-pocket costs
4638552|NCT03628235|HD|hd
4638553|NCT03628235|Huntington's disease|huntington's disease
4638554|NCT03628235|companions|companions
4638555|NCT03628235|Enroll-HD|enroll-hd
4638556|NCT03628222|Lung lesion|lung lesion
4638557|NCT03628222|Electromagnetic navigation bronchoscopy (ENB)|electromagnetic navigation bronchoscopy (enb)
4638558|NCT03628222|Transbronchial lung biopsy(TBLB)|transbronchial lung biopsy(tblb)
4638559|NCT03628222|bronchoscopy|bronchoscopy
4638560|NCT03628209|resectable osteosarcoma|resectable osteosarcoma
4638561|NCT03628144|Immunonutrition|immunonutrition
4638562|NCT03628144|Radiotherapy|radiotherapy
4638563|NCT03628144|Unresectable|unresectable
4638564|NCT03628144|Stage IIIA-B|stage iiia-b
4638565|NCT03628144|Lung cancer|lung cancer
4638566|NCT03628144|Radiation oncology|radiation oncology
4638567|NCT03628144|Thoracic oncology|thoracic oncology
4638568|NCT03628144|Epidemiology|epidemiology
4638569|NCT03628144|Nutrition|nutrition
4638570|NCT03628105|Anxiety|anxiety
4638571|NCT03628105|Specific Phobia|specific phobia
4638572|NCT03628105|Claustrophobia|claustrophobia
4638573|NCT03628105|Exposure|exposure
4638574|NCT03628105|Cognitive therapy|cognitive therapy
4638575|NCT03628105|Cognitive restructuring|cognitive restructuring
4638576|NCT03628105|Consolidation|consolidation
4638577|NCT03628105|Inhibitory learning|inhibitory learning
4638578|NCT03628105|Expectancy violation|expectancy violation
4638579|NCT03628105|Expectancy|expectancy
4638580|NCT03628105|Exposure therapy|exposure therapy
4638581|NCT03628105|Anxiety disorder|anxiety disorder
4638582|NCT03628092|genitourinary symptoms of menopause|genitourinary symptoms of menopause
4638583|NCT03628092|CO2 fractional ablative laser|co2 fractional ablative laser
4638584|NCT03628092|Early breast cancer|early breast cancer
4638585|NCT03628092|Vulvovaginal atrophy|vulvovaginal atrophy
4638586|NCT03628092|Vaginal dryness|vaginal dryness
4638587|NCT03628092|Dyspareunia|dyspareunia
4638588|NCT03628092|Vaginal itch|vaginal itch
4638589|NCT03628092|Dysuria|dysuria
4638590|NCT03628066|Ovarian Suppression|ovarian suppression
4638591|NCT03628066|Neoadjuvant|neoadjuvant
4638592|NCT03628066|Premenopausal|premenopausal
4638593|NCT03628066|Estrogen-Receptor Positive|estrogen-receptor positive
4638594|NCT03628066|HER2-Negative|her2-negative
4638595|NCT03628066|Primary|primary
4638596|NCT03628066|Palbociclib|palbociclib
4638597|NCT03628066|Letrozole|letrozole
4638598|NCT03628066|Goserelin|goserelin
4638599|NCT03628066|Ki67|ki67
4638600|NCT03628066|Oncotype DX Breast Recurrence Score|oncotype dx breast recurrence score
4638601|NCT03628066|Open-Label|open-label
4638602|NCT03628053|Acute lymphoblastic leukemia|acute lymphoblastic leukemia
4638603|NCT03628053|tisagenlecleucel|tisagenlecleucel
4638604|NCT03628053|intouzumab|intouzumab
4638605|NCT03628053|blinatumomab|blinatumomab
4638606|NCT03628053|CAR-T|car-t
4638607|NCT03628053|CTL019|ctl019
4638608|NCT03628027|Major Depressive Disorder|major depressive disorder
4638609|NCT03628027|Antidepressant Medication|antidepressant medication
4638610|NCT03628027|Digital Health|digital health
4638611|NCT03628027|Computerised Decision Support Tool|computerised decision support tool
4638612|NCT03628014|older, hospital, program|older, hospital, program
4638736|NCT03627351|Pediatric Medicines|pediatric medicines
4638613|NCT03628001|Endoscopic retrograde cholangiopancreatography (ERCP)|endoscopic retrograde cholangiopancreatography (ercp)
4638614|NCT03628001|Distal malignant bile duct obstruction|distal malignant bile duct obstruction
4638615|NCT03628001|Sphincterotomy|sphincterotomy
4638616|NCT03627988|Breast Cancer Invasive|breast cancer invasive
4638617|NCT03627988|TomoTherapy|tomotherapy
4638618|NCT03627988|Immediate prosthetic breast reconstruction|immediate prosthetic breast reconstruction
4638619|NCT03627975|revascularization|revascularization
4638620|NCT03627975|hemorrhagic moyamoya disease|hemorrhagic moyamoya disease
4638621|NCT03627962|gaze-directed oculomotor training, reading in Chinese|gaze-directed oculomotor training, reading in chinese
4638622|NCT03627949|Web-based intervention|web-based intervention
4638623|NCT03627949|Health behavior change|health behavior change
4638624|NCT03627949|University students|university students
4638625|NCT03627949|Health Action Process Approach Model|health action process approach model
4638626|NCT03627936|Lorcaserin|lorcaserin
4638627|NCT03627936|Bioequivalence|bioequivalence
4638628|NCT03627936|Extended release|extended release
4638629|NCT03627936|Tablets|tablets
4638630|NCT03627936|Phase 1|phase 1
4638631|NCT03627936|Healthy|healthy
4638632|NCT03627923|Postprandial glucose response|postprandial glucose response
4638633|NCT03627923|Mediterranean diet|mediterranean diet
4638634|NCT03627923|Personalized nutrition|personalized nutrition
4638635|NCT03627910|gut microbiota|gut microbiota
4638636|NCT03627910|Iatrogenic malnutrition|iatrogenic malnutrition
4638637|NCT03627910|pressure ulcer|pressure ulcer
4638638|NCT03627884|Central Venous Catheters|central venous catheters
4638639|NCT03627884|End Stage Renal Disease|end stage renal disease
4638640|NCT03627884|Hemodialysis|hemodialysis
4638641|NCT03627884|Catheter-related infection|catheter-related infection
4638642|NCT03627884|Catheter loss due to clot formation|catheter loss due to clot formation
4638643|NCT03627884|Acute Renal Failure|acute renal failure
4638644|NCT03627871|exercise|exercise
4638645|NCT03627871|social norms|social norms
4638646|NCT03627871|interest in exercising more|interest in exercising more
4638647|NCT03627832|alcohol|alcohol
4638648|NCT03627832|drinking|drinking
4638649|NCT03627832|sleep|sleep
4638650|NCT03627832|insomnia|insomnia
4638651|NCT03627832|young adult|young adult
4638652|NCT03627819|Plant sterols|plant sterols
4638653|NCT03627819|Plant stanols|plant stanols
4638654|NCT03627819|Liver inflammation|liver inflammation
4638655|NCT03627806|Disparities|disparities
4638656|NCT03627806|Florida-Puerto Rico Stroke Registry|florida-puerto rico stroke registry
4638657|NCT03627793|frailty|frailty
4638658|NCT03627793|exercise|exercise
4638659|NCT03627793|resistance training|resistance training
4638660|NCT03627793|strength|strength
4638661|NCT03627793|older adults|older adults
4638662|NCT03627767|atopic dermatitis|atopic dermatitis
4638663|NCT03627767|atopic eczema|atopic eczema
4638664|NCT03627767|eczema|eczema
4638665|NCT03627767|JAK|jak
4638666|NCT03627767|janus kinase|janus kinase
4638667|NCT03627754|Glasdegib|glasdegib
4638668|NCT03627754|PF-04449913|pf-04449913
4638669|NCT03627754|Pharmacokinetics|pharmacokinetics
4638670|NCT03627754|Hepatic Impairment|hepatic impairment
4638671|NCT03627689|asthma|asthma
4638672|NCT03627689|environmental intervention|environmental intervention
4638673|NCT03627689|allergies|allergies
4638674|NCT03627689|air purifier|air purifier
4638675|NCT03627676|Nodules of endometriosis|nodules of endometriosis
4638676|NCT03627676|Cryoablation|cryoablation
4638677|NCT03627650|burn|burn
4638678|NCT03627650|scar|scar
4638679|NCT03627650|fat|fat
4638680|NCT03627650|grafting|grafting
4638681|NCT03627624|MCID|mcid
4638682|NCT03627624|30 STS test|30 sts test
4638683|NCT03627624|Pulmonary rehabilitation|pulmonary rehabilitation
4638684|NCT03627611|Thyroxine|thyroxine
4638685|NCT03627611|Triiodothyronine|triiodothyronine
4638686|NCT03627598|high flow oxygen|high flow oxygen
4638687|NCT03627598|non invasive ventilation|non invasive ventilation
4638688|NCT03627598|hypercapnic respiratory failure|hypercapnic respiratory failure
4638689|NCT03627585|pacemaker|pacemaker
4638690|NCT03627585|heart failure|heart failure
4638691|NCT03627585|left ventricular dysfunction|left ventricular dysfunction
4638692|NCT03627585|bradycardia|bradycardia
4638693|NCT03627585|remodelling|remodelling
4638694|NCT03627572|RESCEU (consortium)|resceu (consortium)
4638695|NCT03627572|Burden of Disease|burden of disease
4638696|NCT03627559|Pancreaticoduodenectomy|pancreaticoduodenectomy
4638697|NCT03627559|Pancreatectomy|pancreatectomy
4638698|NCT03627546|PWID|pwid
4638699|NCT03627507|Hepatitis B, Seroconversion, Seroprotection, Vaccine|hepatitis b, seroconversion, seroprotection, vaccine
4638700|NCT03627494|Dose proportionality|dose proportionality
4638701|NCT03627494|Food effect|food effect
4638702|NCT03627494|Pharmacokinetics|pharmacokinetics
4638703|NCT03627494|FTIH|ftih
4638704|NCT03627494|Pharmacodynamics|pharmacodynamics
4638705|NCT03627494|Dose Escalation|dose escalation
4638706|NCT03627481|endoscopic sinus surgery|endoscopic sinus surgery
4638707|NCT03627429|temporomandibular arthritis|temporomandibular arthritis
4638708|NCT03627429|temporomandibular joint|temporomandibular joint
4638709|NCT03627429|rheumatoid arthritis|rheumatoid arthritis
4638710|NCT03627429|viscosupplementation|viscosupplementation
4638711|NCT03627429|hyaluronic acid|hyaluronic acid
4638712|NCT03627416|Hereditary spastic paraplegia|hereditary spastic paraplegia
4638713|NCT03627416|repetitive transcranial magnetic stimulation|repetitive transcranial magnetic stimulation
4638714|NCT03627416|disturbed gait|disturbed gait
4638715|NCT03627416|Adrenomyeloneuropthy|adrenomyeloneuropthy
4638716|NCT03627390|Benzene polycarboxylic acids complex with cis-diammineplatinum(II)|benzene polycarboxylic acids complex with cis-diammineplatinum(ii)
4638717|NCT03627390|BP-C1|bp-c1
4638718|NCT03627390|Cis-coordinated complexes of platinum(II) with polymer of benzene polycarboxylic acids derived from lignin|cis-coordinated complexes of platinum(ii) with polymer of benzene polycarboxylic acids derived from lignin
4638719|NCT03627390|CDBPA|cdbpa
4638720|NCT03627390|Platinum analogue|platinum analogue
4638721|NCT03627390|Metronomic chemotherapy|metronomic chemotherapy
4638722|NCT03627390|Cisplatin|cisplatin
4638723|NCT03627390|Pancreatic cancer|pancreatic cancer
4638724|NCT03627390|BP-C2|bp-c2
4638725|NCT03627390|molybdenum salts of benzene-polycarboxylic acids|molybdenum salts of benzene-polycarboxylic acids
4638726|NCT03627377|Schizophrenia|schizophrenia
4638727|NCT03627377|Serious mental illness|serious mental illness
4638728|NCT03627377|Obesity|obesity
4638729|NCT03627377|Diabetes|diabetes
4638730|NCT03627377|Lifestyle Risk Reduction|lifestyle risk reduction
4638731|NCT03627351|Taste|taste
4638732|NCT03627351|Odor|odor
4638733|NCT03627351|Sensory Panel|sensory panel
4638734|NCT03627351|Flavor|flavor
4638735|NCT03627351|Genes|genes
4638737|NCT03627247|cognitive behavioral|cognitive behavioral
4638738|NCT03627247|stress management|stress management
4638739|NCT03627247|pregnancy|pregnancy
4638740|NCT03627247|cortisol|cortisol
4638741|NCT03627221|social network|social network
4638742|NCT03627221|nursing students|nursing students
4638743|NCT03627221|sleep|sleep
4638744|NCT03627221|music care|music care
4638745|NCT03627208|LYMPHOBLASTIC LYMPHOMA|lymphoblastic lymphoma
4638746|NCT03627208|Minimal Residual Disease|minimal residual disease
4638747|NCT03627208|Childhood All|childhood all
4638748|NCT03627208|B-Cell Malignancies|b-cell malignancies
4638749|NCT03627195|Schizophrenia|schizophrenia
4638750|NCT03627156|Guided counseling|guided counseling
4638751|NCT03627156|nutrition outcome|nutrition outcome
4638752|NCT03627156|Ethiopia|ethiopia
4638753|NCT03627156|Community trial|community trial
4638754|NCT03627130|Percutaneous Coronary Intervention|percutaneous coronary intervention
4638755|NCT03627130|Nitric Oxide|nitric oxide
4638756|NCT03627130|Nitrite|nitrite
4638757|NCT03627130|Acute Kidney Injury|acute kidney injury
4638758|NCT03627130|Acute Coronary Syndrome|acute coronary syndrome
4638759|NCT03627091|Crohn's disease|crohn's disease
4638760|NCT03627078|traumatic memories|traumatic memories
4638761|NCT03627078|post traumatic stress disorder|post traumatic stress disorder
4638762|NCT03627078|motor interference therapy|motor interference therapy
4638763|NCT03627078|non pharmacological therapy|non pharmacological therapy
4638764|NCT03627078|trauma related disorders|trauma related disorders
4638765|NCT03627065|Primary Sjögren's syndrome|primary sjögren's syndrome
4638766|NCT03627065|PI3Kδ inhibitor|pi3kδ inhibitor
4638767|NCT03627052|Inflammatory bowel disease|inflammatory bowel disease
4638768|NCT03627052|ulcerative colitis|ulcerative colitis
4638769|NCT03627052|Janus kinase inhibitor|janus kinase inhibitor
4638770|NCT03627052|JAK1|jak1
4638771|NCT03627026|Melanoma|melanoma
4638772|NCT03627026|Sphingolipids|sphingolipids
4638773|NCT03627026|Immune checkpoints|immune checkpoints
4638774|NCT03627026|Tumor-infiltrating lymphocytes|tumor-infiltrating lymphocytes
4638775|NCT03627026|Immunosuppressive cytokines|immunosuppressive cytokines
4638776|NCT03627026|Circulating leukocytes|circulating leukocytes
4638777|NCT03626961|NEWS|news
4638778|NCT03626935|ankle joint|ankle joint
4638779|NCT03626935|arthrodesis|arthrodesis
4638780|NCT03626935|3d printing|3d printing
4638781|NCT03626935|customized guide|customized guide
4638782|NCT03626922|NSABP|nsabp
4638783|NCT03626922|Merck & Co|merck & co
4638784|NCT03626922|Eli Lilly and Company|eli lilly and company
4638785|NCT03626922|Pembrolizumab|pembrolizumab
4638786|NCT03626922|Pemetrexed|pemetrexed
4638787|NCT03626922|Oxaliplatin|oxaliplatin
4638788|NCT03626922|MSS mCRC|mss mcrc
4638789|NCT03626896|BBB disruption|bbb disruption
4638790|NCT03626896|NaviFUS System|navifus system
4638791|NCT03626896|Focused Ultrasound|focused ultrasound
4638792|NCT03626896|GBM|gbm
4638793|NCT03626883|arthroscopy|arthroscopy
4638794|NCT03626857|Knee|knee
4638795|NCT03626857|ACL|acl
4638796|NCT03626857|Reconstruction|reconstruction
4638797|NCT03626857|Rehabilitation|rehabilitation
4638798|NCT03626857|Eccentric Exercise|eccentric exercise
4638799|NCT03626857|Electrical Stimulation|electrical stimulation
4638800|NCT03626844|Manual Lysis, Postpartum Hemorrhage, Third Stage of Delivery.|manual lysis, postpartum hemorrhage, third stage of delivery.
4638801|NCT03626831|CVD|cvd
4638802|NCT03626831|LDL|ldl
4638803|NCT03626831|heart failure|heart failure
4638804|NCT03626831|PCSK9|pcsk9
4638805|NCT03626818|WBRT|wbrt
4638806|NCT03626818|NCT|nct
4638807|NCT03626792|Pilates|pilates
4638808|NCT03626792|Blood Pressure|blood pressure
4638809|NCT03626792|Postmenopausal women|postmenopausal women
4638810|NCT03626753|Pain|pain
4638811|NCT03626753|multimodal|multimodal
4638812|NCT03626753|analgesia|analgesia
4638813|NCT03626753|postoperative|postoperative
4638814|NCT03626753|cesarean section|cesarean section
4638815|NCT03626753|obstetric|obstetric
4638816|NCT03626753|Agents|agents
4638817|NCT03626753|Physiological effects of drugs|physiological effects of drugs
4638818|NCT03626753|opioid|opioid
4638819|NCT03626753|Paracetamol|paracetamol
4638820|NCT03626753|NSAIDs|nsaids
4638821|NCT03626740|dental pulp|dental pulp
4638822|NCT03626740|deep carious lesions|deep carious lesions
4638823|NCT03626740|treatment effect|treatment effect
4638824|NCT03626727|Excessive Daytime Sleepiness|excessive daytime sleepiness
4638825|NCT03626727|Prolonged sleep|prolonged sleep
4638826|NCT03626727|Traumatic Brain Injury|traumatic brain injury
4638827|NCT03626714|Tacrolimus|tacrolimus
4638828|NCT03626714|Immunosuppressant|immunosuppressant
4638829|NCT03626714|Sustained-release|sustained-release
4638830|NCT03626714|Plexis|plexis
4638831|NCT03626701|Pediatric|pediatric
4638832|NCT03626701|Burns|burns
4638833|NCT03626701|Partial-thickness|partial-thickness
4638834|NCT03626688|Prostacyclin|prostacyclin
4638835|NCT03626688|Connective Tissue Disease-Associated|connective tissue disease-associated
4638836|NCT03626688|6 Minute Walk Test|6 minute walk test
4638837|NCT03626688|6 Minute Walk Distance|6 minute walk distance
4638838|NCT03626688|Pulmonary Vascular Resistance|pulmonary vascular resistance
4638839|NCT03626688|Right Ventricular Function|right ventricular function
4638840|NCT03626623|Diabetes|diabetes
4638841|NCT03626623|Foot Ulcer|foot ulcer
4638842|NCT03626610|Prehabilitation|prehabilitation
4638843|NCT03626610|Exercise|exercise
4638844|NCT03626610|Cancer|cancer
4638845|NCT03626610|Neo-adjuvant chemotherapy|neo-adjuvant chemotherapy
4638846|NCT03626545|ACZ885|acz885
4638847|NCT03626545|canakinumab|canakinumab
4638848|NCT03626545|docetaxel|docetaxel
4638849|NCT03626545|NSCLC|nsclc
4638850|NCT03626545|Non Small Cell Lung Cancer|non small cell lung cancer
4638851|NCT03626545|Carcinoma|carcinoma
4638852|NCT03626545|IL-1β|il-1β
4638853|NCT03626545|PD-(L)1|pd-(l)1
4638854|NCT03626545|CANOPY|canopy
4638855|NCT03626545|CANOPY-2|canopy-2
4638856|NCT03626545|second or third line therapy|second or third line therapy
4638857|NCT03626545|PD-(L)1 inhibitors|pd-(l)1 inhibitors
4638858|NCT03626545|platinum-based chemotherapy|platinum-based chemotherapy
4638859|NCT03626532|Mindfulness-based stress reduction|mindfulness-based stress reduction
4638860|NCT03626532|Cognitive function|cognitive function
4638861|NCT03626532|Emotion regulation|emotion regulation
4638862|NCT03626532|Lifestyle education|lifestyle education
4638863|NCT03626532|Attentional control|attentional control
4638864|NCT03626532|Mindfulness training|mindfulness training
4638865|NCT03626532|Aging|aging
4638866|NCT03626532|Older adults|older adults
4638867|NCT03626532|Mind-wandering|mind-wandering
4638868|NCT03626532|Functional connectivity|functional connectivity
4638869|NCT03626532|Randomized controlled trial|randomized controlled trial
4638870|NCT03626519|COPD|copd
4638871|NCT03626519|Menthol|menthol
4638872|NCT03626519|Exercise|exercise
4638873|NCT03626519|Dyspnea|dyspnea
4638874|NCT03626506|spironolactone|spironolactone
4638875|NCT03626506|Indapamide|indapamide
4638876|NCT03626506|Obesity|obesity
4638877|NCT03626506|Hypertension|hypertension
4638878|NCT03626506|Target organ damage|target organ damage
4638879|NCT03626480|Surgery|surgery
4638880|NCT03626480|Nutritional outcome|nutritional outcome
4638881|NCT03626480|Infants|infants
4638882|NCT03626454|Norepinephrine, hypotension, spinal, caesarean section|norepinephrine, hypotension, spinal, caesarean section
4638883|NCT03626441|Postoperative Nausea and Vomiting|postoperative nausea and vomiting
4638884|NCT03626441|Ginger|ginger
4638885|NCT03626428|EEG|eeg
4638886|NCT03626428|fMRI|fmri
4638887|NCT03626428|correlation clinical data|correlation clinical data
4638888|NCT03626428|effective connectivity|effective connectivity
4638889|NCT03626402|advanced cancer|advanced cancer
4638890|NCT03626402|African American|african american
4638891|NCT03626389|physiotherapy|physiotherapy
4638892|NCT03626389|primary health care setting|primary health care setting
4638893|NCT03626324|Spinal Cord Injury (SCI)|spinal cord injury (sci)
4638894|NCT03626324|Neurogenic Lower Urinary Tract Dysfunction (NLUTD)|neurogenic lower urinary tract dysfunction (nlutd)
4638895|NCT03626324|Catheter associated Urinary Tract Infection (CAUTI)|catheter associated urinary tract infection (cauti)
4638896|NCT03626324|Urinary Catheters|urinary catheters
4638897|NCT03626324|Dementia|dementia
4638898|NCT03626324|Stroke|stroke
4638899|NCT03626324|Diabetes|diabetes
4638900|NCT03626324|Parkinson's|parkinson's
4638901|NCT03626311|Lupus|lupus
4638902|NCT03626311|SLE|sle
4638903|NCT03626259|hypertension|hypertension
4638904|NCT03626259|losartan/amlodipine|losartan/amlodipine
4638905|NCT03626259|arterial stiffness|arterial stiffness
4638906|NCT03626246|Bone loss|bone loss
4638907|NCT03626246|Bone fracture|bone fracture
4638908|NCT03626246|Bone biopsy|bone biopsy
4638909|NCT03626246|Kidney|kidney
4638910|NCT03626220|acupuncture|acupuncture
4638911|NCT03626220|chemotherapy-induced peripheral neuropathy|chemotherapy-induced peripheral neuropathy
4638912|NCT03626207|Retinitis pigmentosa|retinitis pigmentosa
4638913|NCT03626207|Visual function evaluation|visual function evaluation
4638914|NCT03626155|Walking|walking
4638915|NCT03626155|type 2 diabetes|type 2 diabetes
4638916|NCT03626155|continuous glucose monitoring|continuous glucose monitoring
4638917|NCT03626129|Haemostasis|haemostasis
4638918|NCT03626129|Trans radial band|trans radial band
4638919|NCT03626129|Coronary angiography|coronary angiography
4638920|NCT03626129|Radial artery occlusion|radial artery occlusion
4638921|NCT03626129|Percutaneous coronary intervention|percutaneous coronary intervention
4638922|NCT03626103|depression|depression
4638923|NCT03626103|violence|violence
4638924|NCT03626103|emergency department|emergency department
4638925|NCT03626103|mhealth|mhealth
4638926|NCT03626103|text message|text message
4638927|NCT03626090|Liver|liver
4638928|NCT03626090|Cirrhosis|cirrhosis
4638929|NCT03626090|Child B|child b
4638930|NCT03626090|Child C|child c
4638931|NCT03626090|Advance|advance
4638932|NCT03626090|Advanced|advanced
4638933|NCT03626090|Singapore|singapore
4638934|NCT03626090|MSC|msc
4638935|NCT03626090|Mesenchymal|mesenchymal
4638936|NCT03626090|Stem Cell|stem cell
4638937|NCT03626090|Cell Therapy|cell therapy
4638938|NCT03626090|MSC Therapy|msc therapy
4638939|NCT03626090|Treatment|treatment
4638940|NCT03626077|Biofeedback|biofeedback
4638941|NCT03626077|Visual-Motor Integration|visual-motor integration
4638942|NCT03626077|Visual Perception|visual perception
4638943|NCT03626051|ankle taping|ankle taping
4638944|NCT03626038|Trauma|trauma
4638945|NCT03626038|Medical Device|medical device
4638946|NCT03626038|Performance|performance
4638947|NCT03626038|Safety|safety
4638948|NCT03626038|Proximal Humeral Fracture|proximal humeral fracture
4638949|NCT03625999|Auditory attention|auditory attention
4638950|NCT03625986|smoking|smoking
4638951|NCT03625986|electronic cigarettes|electronic cigarettes
4638952|NCT03625986|nicotine|nicotine
4638953|NCT03625986|ecig|ecig
4638954|NCT03625973|Dementia|dementia
4638955|NCT03625973|Memory, Episodic|memory, episodic
4638956|NCT03625973|Printing, Three-Dimensional|printing, three-dimensional
4638957|NCT03625960|warts|warts
4638958|NCT03625960|trichloroacetic acid|trichloroacetic acid
4638959|NCT03625947|Hemoptysis|hemoptysis
4638960|NCT03625947|Lung cancer|lung cancer
4638961|NCT03625921|Physical Therapy|physical therapy
4638962|NCT03625921|Powered Prosthesis|powered prosthesis
4638963|NCT03625921|Biomechanical outcomes|biomechanical outcomes
4638964|NCT03625908|Coronary artery disease|coronary artery disease
4638965|NCT03625908|Optical coherence tomography|optical coherence tomography
4638966|NCT03625908|antiplatelet therapy|antiplatelet therapy
4638967|NCT03625843|urodynamics|urodynamics
4638968|NCT03625804|Electrical Stimulation|electrical stimulation
4638969|NCT03625804|Cortical Excitability|cortical excitability
4638970|NCT03625804|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
4638971|NCT03625791|sarcoma|sarcoma
4638972|NCT03625791|genetic|genetic
4638973|NCT03625778|Obesity|obesity
4638974|NCT03625778|MEDI0382|medi0382
4638975|NCT03625778|Overweight|overweight
4638976|NCT03625765|Indocyanine green|indocyanine green
4638977|NCT03625765|SmartGoggles|smartgoggles
4638978|NCT03625726|cirrhosis|cirrhosis
4638979|NCT03625726|hypercoagulability|hypercoagulability
4638980|NCT03625726|thrombin generation assay|thrombin generation assay
4638981|NCT03625726|soluble Endothelial Protein C Receptor|soluble endothelial protein c receptor
4638982|NCT03625687|Lung disease|lung disease
4638983|NCT03625687|Lung Transplant|lung transplant
4638984|NCT03625687|HCV|hcv
4638985|NCT03625687|Hepatitis C|hepatitis c
4638986|NCT03625661|Treatment Related Cancer,iron deficiency|treatment related cancer,iron deficiency
4638987|NCT03625648|Diabetic Kidney disease|diabetic kidney disease
4638988|NCT03625648|pentoxifylline|pentoxifylline
4638989|NCT03625635|primary noninvasive breast cancer|primary noninvasive breast cancer
4638990|NCT03625635|sarcopenic obesity prevention|sarcopenic obesity prevention
4638991|NCT03625635|individualized nutrition intervention|individualized nutrition intervention
4638992|NCT03625635|food-based intervention|food-based intervention
4638993|NCT03625622|Alzheimer's disease|alzheimer's disease
4638994|NCT03625570|muscle weakness|muscle weakness
4638995|NCT03625570|muscle power|muscle power
4638996|NCT03625570|resistance training|resistance training
4638997|NCT03625570|treadmill training|treadmill training
4638998|NCT03625557|Guardant Health|guardant health
4638999|NCT03625557|GRECO|greco
4639000|NCT03625544|bone graft|bone graft
4639001|NCT03625544|ceramic|ceramic
4639002|NCT03625544|spinal fusion|spinal fusion
4639003|NCT03625544|RCT|rct
4639004|NCT03625531|Acupuncture|acupuncture
4639005|NCT03625531|Polycystic Ovary Syndrome|polycystic ovary syndrome
4639006|NCT03625531|Personalized protocol|personalized protocol
4639007|NCT03625531|Standardized protocol|standardized protocol
4639008|NCT03625531|Letrozole|letrozole
4639009|NCT03625505|Cancer|cancer
4639010|NCT03625505|Acute Myeloid Leukemia (AML)|acute myeloid leukemia (aml)
4639011|NCT03625505|Relapsed or Refractory AML|relapsed or refractory aml
4639012|NCT03625505|Pharmacokinetics|pharmacokinetics
4639013|NCT03625505|venetoclax|venetoclax
4639014|NCT03625505|gilteritinib|gilteritinib
4639015|NCT03625492|artificial sweeteners|artificial sweeteners
4639016|NCT03625492|caffeine|caffeine
4639017|NCT03625492|alcohol drinking|alcohol drinking
4639018|NCT03625492|urinary urgency|urinary urgency
4639019|NCT03625492|overactive bladder|overactive bladder
4639020|NCT03625492|urinary incontinence, urge|urinary incontinence, urge
4639021|NCT03625492|lower urinary tract symptoms|lower urinary tract symptoms
4639022|NCT03625453|Tourette Syndrome|tourette syndrome
4639023|NCT03625453|Chronic Motor Tic Disorder|chronic motor tic disorder
4639024|NCT03625440|cognitive tests|cognitive tests
4639025|NCT03625440|carboxyhemoglobin|carboxyhemoglobin
4639026|NCT03625440|nicotine|nicotine
4639027|NCT03625427|palmitoleic acid|palmitoleic acid
4639028|NCT03625427|monounsaturated fatty acid|monounsaturated fatty acid
4639029|NCT03625427|chronic inflammation|chronic inflammation
4639030|NCT03625401|mild to moderate|mild to moderate
4639031|NCT03625388|Leukemia, Myeloid, Philadelphia Positive|leukemia, myeloid, philadelphia positive
4639032|NCT03625388|Dasatinib|dasatinib
4639033|NCT03625388|Generic Dasatinib|generic dasatinib
4639034|NCT03625388|Dasatinib 50 mg once daily|dasatinib 50 mg once daily
4639035|NCT03625388|Early chronic phase chronic myeloid leukemia|early chronic phase chronic myeloid leukemia
4639036|NCT03625375|exercise|exercise
4639037|NCT03625336|prostate|prostate
4639038|NCT03625336|calcification|calcification
4639039|NCT03625336|MRI|mri
4639040|NCT03625284|fucoxanthin|fucoxanthin
4639041|NCT03625284|microalgae|microalgae
4639042|NCT03625284|non alcoholic fatty liver|non alcoholic fatty liver
4639043|NCT03625271|Electroencephalogram|electroencephalogram
4639044|NCT03625271|data base|data base
4639045|NCT03625271|machine learning|machine learning
4639046|NCT03625258|mutations|mutations
4639047|NCT03625258|infected patients|infected patients
4639048|NCT03625245|Satiety|satiety
4639049|NCT03625245|Vegetable protein|vegetable protein
4639050|NCT03625245|Yogurt|yogurt
4639051|NCT03625245|Fiber|fiber
4639052|NCT03625245|Visual Analogue Scale|visual analogue scale
4639053|NCT03625245|Cross-over|cross-over
4639054|NCT03625193|Sit-to-stand test|sit-to-stand test
4639055|NCT03625193|Psychometric properties|psychometric properties
4639056|NCT03625180|nanofractured autologous matrix-induced chondrogenesis|nanofractured autologous matrix-induced chondrogenesis
4639057|NCT03625167|skin ageing|skin ageing
4639058|NCT03625167|suction blister|suction blister
4639059|NCT03625167|dermo-epidermal junction|dermo-epidermal junction
4639060|NCT03625115|Early Intervention|early intervention
4639061|NCT03625115|Developmental outcomes|developmental outcomes
4639062|NCT03625115|Health disparities|health disparities
4639063|NCT03625115|Early Childhood|early childhood
4639064|NCT03625102|Antroquinonol|antroquinonol
4639065|NCT03625102|Hocena|hocena
4639066|NCT03625089|Carotid Atherosclerosis|carotid atherosclerosis
4639067|NCT03625089|Arterial Stiffness|arterial stiffness
4639068|NCT03625089|Cardiovascular Risk|cardiovascular risk
4639069|NCT03625063|exercise capacity|exercise capacity
4639070|NCT03625063|physical activity|physical activity
4639071|NCT03625063|respiratory muscle strength|respiratory muscle strength
4639072|NCT03625063|respiratory muscle endurance|respiratory muscle endurance
4639073|NCT03625011|Pain Relief|pain relief
4639074|NCT03625011|Non-Narcotic Pain relief|non-narcotic pain relief
4639075|NCT03624985|lidocaine|lidocaine
4639076|NCT03624985|lumbar spine surgery|lumbar spine surgery
4639077|NCT03624985|postoperative pain|postoperative pain
4639078|NCT03624985|opioid reduction|opioid reduction
4639079|NCT03624972|communication|communication
4639080|NCT03624972|sexual health|sexual health
4639081|NCT03624972|menopausal health|menopausal health
4639082|NCT03624959|Healthy Volunteer|healthy volunteer
4639083|NCT03624959|Cytochrome P450 (CYP)|cytochrome p450 (cyp)
4639084|NCT03624959|ozanimod|ozanimod
4639085|NCT03624946|Zika virus|zika virus
4639086|NCT03624946|Human immune globulin|human immune globulin
4639087|NCT03624946|Hyperimmune|hyperimmune
4639088|NCT03624946|Polyclonal antibodies|polyclonal antibodies
4639089|NCT03624933|Depression|depression
4639090|NCT03624933|Cognitive Functioning|cognitive functioning
4639091|NCT03624933|Cannabis Use Disorder|cannabis use disorder
4639092|NCT03624907|stereotactic body radiotherapy (SBRT)|stereotactic body radiotherapy (sbrt)
4639093|NCT03624894|oral impressions|oral impressions
4639094|NCT03624894|glassionomer cements|glassionomer cements
4639095|NCT03624894|dental restorations|dental restorations
4639096|NCT03624894|dental wear|dental wear
4639097|NCT03624868|Tai Chi|tai chi
4639098|NCT03624868|Older Veterans|older veterans
4639099|NCT03624868|Physical activity|physical activity
4639100|NCT03624868|PTSD|ptsd
4639101|NCT03624764|promontofixation|promontofixation
4639102|NCT03624764|prolapse surgery|prolapse surgery
4639103|NCT03624738|Femoro-femoral bypass|femoro-femoral bypass
4639104|NCT03624725|Gastric cancer|gastric cancer
4639105|NCT03624725|Quality of life|quality of life
4639106|NCT03624699|glaucoma|glaucoma
4639107|NCT03624699|Minimally Invasive Glaucoma Surgery|minimally invasive glaucoma surgery
4639108|NCT03624686|Acute Lymphoblastic Leukemia,Immunotherapy,chimeric antigen receptor,non-Hodgkin's lymphoma|acute lymphoblastic leukemia,immunotherapy,chimeric antigen receptor,non-hodgkin's lymphoma
4639109|NCT03624660|High-risk|high-risk
4639110|NCT03624660|Prostate cancer|prostate cancer
4639111|NCT03624660|Proton Radiation|proton radiation
4639112|NCT03624660|Dose-escalated|dose-escalated
4639113|NCT03624660|Hypofractionation|hypofractionation
4639114|NCT03624660|Simultaneous Integrated Boost (SIB)|simultaneous integrated boost (sib)
4639115|NCT03624660|Intraprostatic Tumor (IPT)|intraprostatic tumor (ipt)
4639116|NCT03624660|Proton Therapy (PT)|proton therapy (pt)
4639117|NCT03624660|Androgen Deprivation Therapy (ADT)|androgen deprivation therapy (adt)
4639118|NCT03624660|Magnetic Resonance Imaging (MRI)|magnetic resonance imaging (mri)
4639119|NCT03624621|Major Depressive Disorder|major depressive disorder
4639120|NCT03624621|Cognitive Remediation|cognitive remediation
4639121|NCT03624621|Functioning|functioning
4639122|NCT03624621|Full Recovery|full recovery
4639123|NCT03624621|Functional Remediation|functional remediation
4639124|NCT03624595|Cardiac Surgery|cardiac surgery
4639125|NCT03624595|Cardiopulmonary Bypass|cardiopulmonary bypass
4639126|NCT03624595|Dexmedetomidine|dexmedetomidine
4639127|NCT03624595|Delirium|delirium
4639128|NCT03624595|Survival|survival
4639129|NCT03624582|Cardiorespiratory fitness|cardiorespiratory fitness
4639130|NCT03624582|Sedentary behavior|sedentary behavior
4639131|NCT03624582|Physical activity|physical activity
4639132|NCT03624582|Decision-making|decision-making
4639133|NCT03624582|Cardiometabolic risk factors|cardiometabolic risk factors
4639134|NCT03624556|Down Syndrome (DS)|down syndrome (ds)
4639135|NCT03624556|Fragile X Syndrome (FXS)|fragile x syndrome (fxs)
4639136|NCT03624556|Intellectual Development Disorder (IDD)|intellectual development disorder (idd)
4639137|NCT03624556|FontUp|fontup
4639138|NCT03624556|EGCG|egcg
4639139|NCT03624556|Epigallocatechin gallate|epigallocatechin gallate
4639140|NCT03624556|Dual specificity tyrosine-phosphorylation-regulated kinase 1A (Dyrk1A)|dual specificity tyrosine-phosphorylation-regulated kinase 1a (dyrk1a)
4639141|NCT03624556|Homocysteine|homocysteine
4639142|NCT03624556|Dietary supplement|dietary supplement
4639143|NCT03624556|Green tea|green tea
4639144|NCT03624556|IMIM|imim
4639145|NCT03624556|PERSEUS|perseus
4639146|NCT03624504|Transcatheter Pacing System|transcatheter pacing system
4639147|NCT03624504|Micra Implantable Device|micra implantable device
4639148|NCT03624504|Transfermoral Catheter Delivery System|transfermoral catheter delivery system
4639149|NCT03624439|double-lumen tube|double-lumen tube
4639150|NCT03624439|ETView|etview
4639151|NCT03624439|medical simulation|medical simulation
4639152|NCT03624439|anesthesiologist|anesthesiologist
4639153|NCT03624439|difficult airway|difficult airway
4639154|NCT03624426|nerve monitoring|nerve monitoring
4639155|NCT03624426|automated somatosensory evoked potential|automated somatosensory evoked potential
4639156|NCT03624426|nerve injury|nerve injury
4639157|NCT03624413|adolescent|adolescent
4639158|NCT03624413|HIV|hiv
4639159|NCT03624413|transition care|transition care
4639160|NCT03624413|mobile health|mobile health
4639161|NCT03624413|Social media|social media
4639162|NCT03624413|South Africa|south africa
4639163|NCT03624400|Autism spectrum disorder|autism spectrum disorder
4639164|NCT03624400|Sleep|sleep
4639165|NCT03624400|Cognitive-behavioral treatment|cognitive-behavioral treatment
4639166|NCT03624400|Internet delivered treatment|internet delivered treatment
4639167|NCT03624387|older adults, cognitive impairment, art therapy, hospital|older adults, cognitive impairment, art therapy, hospital
4639168|NCT03624374|Natural History Study|natural history study
4639169|NCT03624374|Kennedy Krieger Institute|kennedy krieger institute
4639170|NCT03624374|Virtual assessment|virtual assessment
4639171|NCT03624374|DARS2|dars2
4639172|NCT03624374|Johns Hopkins Hospital|johns hopkins hospital
4639173|NCT03624361|Minimally Invasive Glaucoma Surgery|minimally invasive glaucoma surgery
4639174|NCT03624361|Glaucoma Implant|glaucoma implant
4639175|NCT03624361|Lower IOP|lower iop
4639176|NCT03624361|IOP|iop
4639177|NCT03624361|Intraocular Pressure|intraocular pressure
4639178|NCT03624348|stress|stress
4639179|NCT03624348|mindfulness|mindfulness
4639180|NCT03624348|work related stress|work related stress
4639181|NCT03624348|health|health
4639182|NCT03624348|meditation|meditation
4639183|NCT03624335|Umbilical cord clamping|umbilical cord clamping
4639184|NCT03624335|Anemia Neonatal|anemia neonatal
4639185|NCT03624335|Iron metabolism disorders|iron metabolism disorders
4639186|NCT03624322|Agitation|agitation
4639187|NCT03624322|Schizophrenia|schizophrenia
4639188|NCT03624322|Bipolar I disorder|bipolar i disorder
4639189|NCT03624322|OLZ|olz
4639190|NCT03624322|Olanzapine|olanzapine
4639191|NCT03624322|Zyprexa|zyprexa
4639192|NCT03624322|POD® device|pod® device
4639193|NCT03624270|Acute promyelocytic leukaemia|acute promyelocytic leukaemia
4639194|NCT03624270|Oral arsenic trioxide|oral arsenic trioxide
4639195|NCT03624257|Laser treatment|laser treatment
4639196|NCT03624257|surgical treatment|surgical treatment
4639197|NCT03624257|patient reported outcomes|patient reported outcomes
4639198|NCT03624257|microbiology|microbiology
4639199|NCT03624257|immunology|immunology
4639200|NCT03624257|radiological examination|radiological examination
4639201|NCT03624244|Low Grade Endometrial Stromal Sarcoma|low grade endometrial stromal sarcoma
4639202|NCT03624244|Aromatase inhibitors|aromatase inhibitors
4639203|NCT03624231|Squamous Cell Carcinoma of the Head and Neck|squamous cell carcinoma of the head and neck
4639204|NCT03624218|PTSD|ptsd
4639205|NCT03624218|SCI|sci
4639206|NCT03624218|PE|pe
4639207|NCT03624218|Prolonged Exposure|prolonged exposure
4639208|NCT03624192|Pediatric, Complex Skin Deformities|pediatric, complex skin deformities
4639209|NCT03624140|major pediatric surgery|major pediatric surgery
4639210|NCT03624140|hemoglobin measurement|hemoglobin measurement
4639211|NCT03624114|pituitary adenoma surgery|pituitary adenoma surgery
4639212|NCT03624114|endoscopic transsphenoidal surgery|endoscopic transsphenoidal surgery
4639213|NCT03624114|sphenoid septation|sphenoid septation
4639214|NCT03624088|Breast Cancer Prevention|breast cancer prevention
4639215|NCT03624088|Genetic Testing|genetic testing
4639216|NCT03624088|Orthodox Jewish|orthodox jewish
4639217|NCT03624088|Community-Based Participatory Research|community-based participatory research
4639218|NCT03624088|BRCA|brca
4639219|NCT03624088|Decision Support|decision support
4639220|NCT03624062|New onset|new onset
4639221|NCT03623984|Gallium-DOTATATE (68)|gallium-dotatate (68)
4639222|NCT03623984|Neuroendocrine Tumors|neuroendocrine tumors
4639223|NCT03623984|Pancreatic Neuroendocrine Tumors|pancreatic neuroendocrine tumors
4639224|NCT03623984|Molecular|molecular
4639225|NCT03623984|Surgery|surgery
4639226|NCT03623971|Cataract|cataract
4639227|NCT03623971|Artificial Intelligence|artificial intelligence
4639228|NCT03623971|Medical Referral Pattern|medical referral pattern
4639229|NCT03623958|image guided|image guided
4639230|NCT03623958|lung nodule|lung nodule
4639231|NCT03623958|lung cancer|lung cancer
4639232|NCT03623958|lung mass|lung mass
4639233|NCT03623893|Metachronous contralateral inguinal hernia|metachronous contralateral inguinal hernia
4639234|NCT03623893|Hernia repair|hernia repair
4639235|NCT03623893|Contralateral exploration|contralateral exploration
4639236|NCT03623893|Cost-effectiveness|cost-effectiveness
4639237|NCT03623893|Infants|infants
4639238|NCT03623841|Executive function|executive function
4639239|NCT03623841|Dual-task performance|dual-task performance
4639240|NCT03623841|Dual-task training|dual-task training
4639241|NCT03623828|unresponsive wakefulness syndrome|unresponsive wakefulness syndrome
4639242|NCT03623828|minimally conscious state|minimally conscious state
4639243|NCT03623828|apomorphine|apomorphine
4639244|NCT03623828|crs-r|crs-r
4639245|NCT03623802|Chronic low back pain|chronic low back pain
4639246|NCT03623802|Movement therapy|movement therapy
4639247|NCT03623802|Supervised training|supervised training
4639248|NCT03623789|Total hip arthroplasty|total hip arthroplasty
4639249|NCT03623789|Tranexamic acid|tranexamic acid
4639250|NCT03623789|Floseal|floseal
4639251|NCT03623789|postoperative blood loss|postoperative blood loss
4639252|NCT03623789|Thrombin|thrombin
4639253|NCT03623776|Non-Small Cell Lung Cancer|non-small cell lung cancer
4639254|NCT03623776|Neoadjuvant|neoadjuvant
4639255|NCT03623776|Programmed Death-1|programmed death-1
4639256|NCT03623763|vitamin D|vitamin d
4639257|NCT03623763|water sport|water sport
4639258|NCT03623763|IL-4|il-4
4639259|NCT03623763|IL-6|il-6
4639260|NCT03623763|TNF-a|tnf-a
4639261|NCT03623763|IFN-gamma|ifn-gamma
4639262|NCT03623763|athletes|athletes
4639263|NCT03623763|respiratory infection|respiratory infection
4639264|NCT03623724|Major Depression|major depression
4639265|NCT03623724|Blended Therapy|blended therapy
4639266|NCT03623724|Randomized Clinical Trials|randomized clinical trials
4639267|NCT03623724|e-Mental Health|e-mental health
4639268|NCT03623724|Routine Practice|routine practice
4639269|NCT03623711|major depressive disorder|major depressive disorder
4639270|NCT03623711|Magnetic Resonance Imaging|magnetic resonance imaging
4639271|NCT03623711|Antidepressant Treatment|antidepressant treatment
4639272|NCT03623698|Hypertonic saline|hypertonic saline
4639273|NCT03623698|nebulised|nebulised
4639274|NCT03623698|children|children
4639275|NCT03623698|young people|young people
4639276|NCT03623698|adolescents|adolescents
4639277|NCT03623698|respiratory|respiratory
4639278|NCT03623685|uterocervical angle|uterocervical angle
4639279|NCT03623685|preterm labor|preterm labor
4639280|NCT03623672|sleep|sleep
4639281|NCT03623672|REM|rem
4639282|NCT03623672|rapid eye movement|rapid eye movement
4639283|NCT03623672|parkinson|parkinson
4639284|NCT03623672|lewy body disease|lewy body disease
4639285|NCT03623672|dementia with lewy bodies|dementia with lewy bodies
4639286|NCT03623672|Multiple System Atrophy|multiple system atrophy
4639287|NCT03623672|parasomnia|parasomnia
4639288|NCT03623672|synuclein|synuclein
4639289|NCT03623672|synucleinopathy|synucleinopathy
4639290|NCT03623659|Assisted hatching|assisted hatching
4639291|NCT03623659|Zona pellucida|zona pellucida
4639292|NCT03623659|Implantation failure|implantation failure
4639293|NCT03623659|Blastocyst|blastocyst
4639294|NCT03623659|Cryopreservation|cryopreservation
4639295|NCT03623646|Oropharyngeal Squamous Cell Carcinoma|oropharyngeal squamous cell carcinoma
4639296|NCT03623646|Anti PD-L1|anti pd-l1
4639297|NCT03623646|Durvalumab|durvalumab
4639298|NCT03623646|Radiation therapy|radiation therapy
4639299|NCT03623646|Cisplatin|cisplatin
4639300|NCT03623646|Human Papilloma Virus|human papilloma virus
4639301|NCT03623620|Depression|depression
4639302|NCT03623620|Pregnancy|pregnancy
4639303|NCT03623620|Antidepressants|antidepressants
4639304|NCT03623620|Mindfulness|mindfulness
4639305|NCT03623620|Medication use during pregnancy|medication use during pregnancy
4639306|NCT03623620|Depression Relapse|depression relapse
4639307|NCT03623581|ASPS|asps
4639308|NCT03623568|CKD|ckd
4639309|NCT03623568|HCV|hcv
4639310|NCT03623568|Hepatitis C|hepatitis c
4639311|NCT03623568|Transplant|transplant
4639312|NCT03623555|Stress regulation|stress regulation
4639313|NCT03623555|Depression|depression
4639314|NCT03623555|Intimate partner violence|intimate partner violence
4639315|NCT03623555|Resilience|resilience
4639316|NCT03623555|Psychophysiology|psychophysiology
4639317|NCT03623555|Endocrine response|endocrine response
4639318|NCT03623555|Risk factor|risk factor
4639319|NCT03623542|Dementia|dementia
4639320|NCT03623542|alzheimer dementia|alzheimer dementia
4639321|NCT03623516|Thyroid neoplasms; Thyroid gland; ;|thyroid neoplasms; thyroid gland; ;
4639322|NCT03623516|Thyroid gland|thyroid gland
4639323|NCT03623516|Incidence|incidence
4639324|NCT03623516|Overdiagnosis|overdiagnosis
4639325|NCT03623503|newborn|newborn
4639326|NCT03623503|neonatal spesis|neonatal spesis
4639327|NCT03623503|clinical sriteria|clinical sriteria
4639328|NCT03623490|kidney cancer|kidney cancer
4639329|NCT03623490|breast cancer|breast cancer
4639330|NCT03623490|oral therapy|oral therapy
4639331|NCT03623490|managment|managment
4639332|NCT03623477|Cognitive Remediation|cognitive remediation
4639333|NCT03623477|Social Cognition Training|social cognition training
4639334|NCT03623477|Emotion Regulation|emotion regulation
4639335|NCT03623477|Urgency|urgency
4639336|NCT03623399|postoperative pain|postoperative pain
4639337|NCT03623399|Intraabdominal laparoscopic gas pressure|intraabdominal laparoscopic gas pressure
4639338|NCT03623360|Gadoxetate disodium|gadoxetate disodium
4639339|NCT03623347|bully glioblastoma|bully glioblastoma
4639340|NCT03623347|multifocal glioblastoma|multifocal glioblastoma
4639341|NCT03623347|bevacizumab|bevacizumab
4639342|NCT03623347|temozolomide|temozolomide
4639343|NCT03623282|Synatura|synatura
4639344|NCT03623282|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
4639345|NCT03623282|Ahn Gook Pharmaceuticals|ahn gook pharmaceuticals
4639346|NCT03623243|Multiple Sclerosis|multiple sclerosis
4639347|NCT03623243|Advancing Multiple Sclerosis|advancing multiple sclerosis
4639348|NCT03623243|Conversion|conversion
4639349|NCT03623243|Siponimod|siponimod
4639350|NCT03623243|Relapsing MS|relapsing ms
4639351|NCT03623230|Femoral nerve block|femoral nerve block
4639352|NCT03623230|peripheral nerve block|peripheral nerve block
4639353|NCT03623230|Concentration|concentration
4639354|NCT03623230|volume|volume
4639355|NCT03623230|bupivacaine|bupivacaine
4639356|NCT03623230|post operative analgesia|post operative analgesia
4639357|NCT03623230|total knee arthroplasty|total knee arthroplasty
4639358|NCT03623217|Behavioral|behavioral
4639359|NCT03623217|Questionnaire development|questionnaire development
4639360|NCT03623217|Questionnaire|questionnaire
4639361|NCT03623217|Interview with patients|interview with patients
4639362|NCT03623217|Observational|observational
4639363|NCT03623217|Tacrolimus|tacrolimus
4639364|NCT03623217|Patient reported outcome tool|patient reported outcome tool
4639365|NCT03623217|Validation|validation
4639366|NCT03623217|Kidney transplantation|kidney transplantation
4639367|NCT03623204|Obesity|obesity
4639368|NCT03623204|Dyspnea|dyspnea
4639369|NCT03623204|Bariatric Surgery|bariatric surgery
4639370|NCT03623191|Erosive pustular dermatosis of the leg|erosive pustular dermatosis of the leg
4639371|NCT03623191|Erosive pustular dermatosis of the scalp|erosive pustular dermatosis of the scalp
4639372|NCT03623191|Venous insufficiency|venous insufficiency
4639373|NCT03623178|Substance Use Disorders|substance use disorders
4639374|NCT03623178|Assertive Community Treatment|assertive community treatment
4639375|NCT03623178|Community Treatment|community treatment
4639376|NCT03623178|Treatment engagement|treatment engagement
4639377|NCT03623178|Service Use|service use
4639378|NCT03623165|Heart Failure|heart failure
4639379|NCT03623165|NYHA Class III|nyha class iii
4639380|NCT03623139|carbohydrates|carbohydrates
4639381|NCT03623139|basic carbohydrate counting|basic carbohydrate counting
4639382|NCT03623139|diet|diet
4639383|NCT03623139|type 2 diabetes|type 2 diabetes
4639384|NCT03623113|Carbohydrate counting|carbohydrate counting
4639385|NCT03623113|Basic carbohydrate counting|basic carbohydrate counting
4639386|NCT03623113|Advanced carbohydrate counting|advanced carbohydrate counting
4639387|NCT03623113|Carbohydrates|carbohydrates
4639388|NCT03623113|Diet|diet
4639389|NCT03623100|Children|children
4639390|NCT03623100|Phonology|phonology
4639391|NCT03623100|EEG|eeg
4639392|NCT03623100|ERP|erp
4639393|NCT03623074|Myopia|myopia
4639394|NCT03623035|Lumbar Plexus block|lumbar plexus block
4639395|NCT03623035|total hip arthroplasty|total hip arthroplasty
4639396|NCT03623035|Arthroplasty, direct anterior approach|arthroplasty, direct anterior approach
4639397|NCT03623035|Pain|pain
4639398|NCT03623022|healthy|healthy
4639399|NCT03622944|neck pain|neck pain
4639400|NCT03622944|physiotherapy|physiotherapy
4639401|NCT03622944|rehabilitation|rehabilitation
4639402|NCT03622931|ovarian|ovarian
4639403|NCT03622931|cancer|cancer
4639404|NCT03622931|romiplostim|romiplostim
4639405|NCT03622931|nplate|nplate
4639406|NCT03622905|Mild Probable Alzheimer's Disease|mild probable alzheimer's disease
4639407|NCT03622892|Non Invasive Prenatal Diagnosis|non invasive prenatal diagnosis
4639408|NCT03622879|Mirror therapy|mirror therapy
4639409|NCT03622879|Transcutaneous Electric Nerve Stimulation|transcutaneous electric nerve stimulation
4639410|NCT03622879|Rehabilitation|rehabilitation
4639411|NCT03622853|adhesive capsulitis|adhesive capsulitis
4639412|NCT03622840|Cognitive Remediation|cognitive remediation
4639413|NCT03622827|Adjuvant therapy|adjuvant therapy
4639414|NCT03622827|chemoradiotherapy|chemoradiotherapy
4639415|NCT03622827|Uterine Cervical Neoplasms|uterine cervical neoplasms
4639416|NCT03622827|high risk|high risk
4639417|NCT03622827|Endostar|endostar
4639418|NCT03622814|caregiving|caregiving
4639419|NCT03622814|mealtimes|mealtimes
4639420|NCT03622814|respite care|respite care
4639421|NCT03622814|train-the-trainer|train-the-trainer
4639422|NCT03622762|Green tea extract|green tea extract
4639423|NCT03622762|Kidney damage|kidney damage
4639424|NCT03622762|type 2 diabetes mellitus|type 2 diabetes mellitus
4639425|NCT03622736|Rhizarthrosis|rhizarthrosis
4639426|NCT03622736|basal thumb arthritis|basal thumb arthritis
4639427|NCT03622736|Osteoarthritis Thumb|osteoarthritis thumb
4639428|NCT03622736|viscosupplementation|viscosupplementation
4639429|NCT03622736|hyaluronic acid|hyaluronic acid
4639430|NCT03622736|rheumatoid arthritis|rheumatoid arthritis
4639431|NCT03622723|hallux rigidus|hallux rigidus
4639432|NCT03622723|viscosupplementation|viscosupplementation
4639433|NCT03622723|hyaluronic acid|hyaluronic acid
4639434|NCT03622723|metartarsophalangeal joint|metartarsophalangeal joint
4639435|NCT03622723|foot arthritis|foot arthritis
4639436|NCT03622723|osteoarthritis of the big toe|osteoarthritis of the big toe
4639437|NCT03622710|Rehabilitation|rehabilitation
4639438|NCT03622710|Surfaces|surfaces
4639439|NCT03622710|Walking|walking
4639440|NCT03622710|Spinal cord injury|spinal cord injury
4639441|NCT03622697|mindfulness|mindfulness
4639442|NCT03622697|meditation|meditation
4639443|NCT03622697|facial paralysis|facial paralysis
4639444|NCT03622697|quality of life|quality of life
4639445|NCT03622697|social functioning|social functioning
4639446|NCT03622684|TMJ- temporomandibular joint-disorder|tmj- temporomandibular joint-disorder
4639447|NCT03622684|Muscle relaxation|muscle relaxation
4639448|NCT03622684|Psychoemotional factor|psychoemotional factor
4639449|NCT03622684|Stress|stress
4639450|NCT03622671|Coronary Artery By-pass Grafting|coronary artery by-pass grafting
4639451|NCT03622671|CABG|cabg
4639452|NCT03622671|Fibrin|fibrin
4639453|NCT03622671|Clot Lysis Time|clot lysis time
4639454|NCT03622671|CLT|clt
4639455|NCT03622671|Bleeding|bleeding
4639456|NCT03622671|Drainage|drainage
4639457|NCT03622671|Rethoracotomy|rethoracotomy
4639458|NCT03622645|Range of motion|range of motion
4639459|NCT03622645|Wrist|wrist
4639460|NCT03622645|Hand|hand
4639461|NCT03622645|Finger|finger
4639462|NCT03622645|Measurement|measurement
4639463|NCT03622632|uric acid|uric acid
4639464|NCT03622632|organ failure|organ failure
4639465|NCT03622606|Right hemispheric Stroke|right hemispheric stroke
4639466|NCT03622606|Crossed aphasia|crossed aphasia
4639467|NCT03622606|Acute phase|acute phase
4639468|NCT03622502|dexmedetomidine|dexmedetomidine
4639469|NCT03622502|remifentanil|remifentanil
4639470|NCT03622502|extubation|extubation
4639471|NCT03622476|Hemophilia A，pharmacokinetics|hemophilia a，pharmacokinetics
4639472|NCT03622463|Antroquinonol|antroquinonol
4639473|NCT03622463|Hocena|hocena
4639474|NCT03622437|Aftercare|aftercare
4639475|NCT03622437|Follow-up|follow-up
4639476|NCT03622437|Patient Involvement|patient involvement
4639477|NCT03622437|Patient-reported Outcomes (PRO)|patient-reported outcomes (pro)
4639478|NCT03622398|total knee arthroplasty|total knee arthroplasty
4639479|NCT03622398|highly cross-linked polyethylene|highly cross-linked polyethylene
4639480|NCT03622385|DNA Methylation|dna methylation
4639481|NCT03622385|DNA Biomarkers|dna biomarkers
4639482|NCT03622385|Pelvic Mass|pelvic mass
4639483|NCT03622372|FLEXOR TENDON|flexor tendon
4639484|NCT03622372|ZONE 2|zone 2
4639485|NCT03622359|Radionuclide imaging|radionuclide imaging
4639486|NCT03622359|Perfusion imaging|perfusion imaging
4639487|NCT03622346|Echinococcosis, Hydatidosis, TKR, Fracture|echinococcosis, hydatidosis, tkr, fracture
4639488|NCT03622333|Neuroendocrine tumors|neuroendocrine tumors
4639489|NCT03622333|carcinoid tumors|carcinoid tumors
4639490|NCT03622333|midgut|midgut
4639491|NCT03622333|small intestine|small intestine
4639492|NCT03622333|genetic predisposition|genetic predisposition
4639493|NCT03622333|hereditary|hereditary
4639494|NCT03622320|insulin resistance|insulin resistance
4639495|NCT03622307|Subcutaneous ICD Therapy|subcutaneous icd therapy
4639496|NCT03622307|VT Ablation|vt ablation
4639497|NCT03622268|indirect calorimetry|indirect calorimetry
4639498|NCT03622268|energy expenditure assessment|energy expenditure assessment
4639499|NCT03622268|intensive care unit|intensive care unit
4639500|NCT03622255|Intrabony defects|intrabony defects
4639501|NCT03622255|Minimally invasive non-surgical technique|minimally invasive non-surgical technique
4639502|NCT03622255|Enamel Matrix Derivative|enamel matrix derivative
4639503|NCT03622229|pancreatic cancer, endoscopic ultrasound, fine needle biopsy|pancreatic cancer, endoscopic ultrasound, fine needle biopsy
4639504|NCT03622190|playing-related musculoskeletal disorder (PRMD)|playing-related musculoskeletal disorder (prmd)
4639505|NCT03622190|music students|music students
4639506|NCT03622190|pain|pain
4639507|NCT03622190|musculoskeletal (MSK) disorder|musculoskeletal (msk) disorder
4639508|NCT03622164|radiotherapy|radiotherapy
4639509|NCT03622151|mental health|mental health
4639510|NCT03622151|Housing First|housing first
4639511|NCT03622151|homeless|homeless
4639512|NCT03622138|Evidence-based Prevention Programs|evidence-based prevention programs
4639513|NCT03622138|Youth Prevention Programs|youth prevention programs
4639514|NCT03622138|Outcomes Data|outcomes data
4639515|NCT03622138|Continuous Quality Improvement|continuous quality improvement
4639516|NCT03622112|Inhaled non-steroidal glucocorticoid receptor modulator|inhaled non-steroidal glucocorticoid receptor modulator
4639517|NCT03622112|Asthma|asthma
4639518|NCT03622112|Inhaled corticosteroids.|inhaled corticosteroids.
4639519|NCT03622112|Glucocorticoid receptor (GA) agonists.|glucocorticoid receptor (ga) agonists.
4639520|NCT03622112|Chronic obstructive pulmonary disease.|chronic obstructive pulmonary disease.
4639521|NCT03622112|Short-acting B2 agonist.|short-acting b2 agonist.
4639522|NCT03622112|Fluticasone furoate.|fluticasone furoate.
4639523|NCT03622073|Post abortion care|post abortion care
4639524|NCT03622073|Misoprostol|misoprostol
4639525|NCT03622073|Second trimester|second trimester
4639526|NCT03622047|Labor, Analgesia, Dexmedetomidine, Sufentanil|labor, analgesia, dexmedetomidine, sufentanil
4639527|NCT03622034|knee features|knee features
4639528|NCT03622034|ethnic changes|ethnic changes
4639529|NCT03621982|Camidanlumab tesirine|camidanlumab tesirine
4639530|NCT03621969|Vagus Nerve Stimulation|vagus nerve stimulation
4639531|NCT03621956|Near-Infrared Spectroscopy|near-infrared spectroscopy
4639532|NCT03621943|Neurodevelopmental impairment|neurodevelopmental impairment
4639533|NCT03621943|Disability|disability
4639534|NCT03621943|Umbilical cord milking|umbilical cord milking
4639535|NCT03621943|Early Cord Clamping|early cord clamping
4639536|NCT03621930|RESCEU (consortium)|resceu (consortium)
4639538|NCT03621930|Respiratory Syncytial Virus|respiratory syncytial virus
4639539|NCT03621917|near infrared spectroscopy|near infrared spectroscopy
4639540|NCT03621917|acute ischemic stroke|acute ischemic stroke
4639541|NCT03621917|thrombolytic therapy|thrombolytic therapy
4639542|NCT03621904|Hormonal therapy|hormonal therapy
4639543|NCT03621904|Endocrine therapy|endocrine therapy
4639544|NCT03621904|Translational research|translational research
4639545|NCT03621904|Tumor factors|tumor factors
4639546|NCT03621891|hyper-occlusion|hyper-occlusion
4639547|NCT03621891|hypoxia|hypoxia
4639548|NCT03621891|occlusal trauma|occlusal trauma
4639549|NCT03621891|periodontitis|periodontitis
4639550|NCT03621891|subgingival microbiota|subgingival microbiota
4639551|NCT03621878|Lumbosacral radiculopathy|lumbosacral radiculopathy
4639552|NCT03621878|peripheral sensitization|peripheral sensitization
4639553|NCT03621878|Neural mobilization|neural mobilization
4639554|NCT03621878|radicular LBP|radicular lbp
4639555|NCT03621878|slider|slider
4639556|NCT03621878|tensioner|tensioner
4639557|NCT03621865|bioavailability|bioavailability
4639558|NCT03621865|pharmacokinetic study|pharmacokinetic study
4639559|NCT03621865|curcuminoids|curcuminoids
4639560|NCT03621865|curcumin|curcumin
4639561|NCT03621865|healthy volunteers|healthy volunteers
4639562|NCT03621852|Endosonography|endosonography
4639563|NCT03621852|fine needle biopsy|fine needle biopsy
4639564|NCT03621826|sickle cell anemia|sickle cell anemia
4639565|NCT03621826|TCD|tcd
4639566|NCT03621826|screening|screening
4639567|NCT03621826|dissemination|dissemination
4639568|NCT03621826|implementation|implementation
4639569|NCT03621813|Neuropathic Pain|neuropathic pain
4639570|NCT03621813|Exercise|exercise
4639571|NCT03621813|Lung Cancer|lung cancer
4639572|NCT03621800|Thirst|thirst
4639573|NCT03621800|Elderly|elderly
4640488|NCT03615924|Brilinta|brilinta
4639574|NCT03621800|Postoperative Period|postoperative period
4639575|NCT03621800|Surgical Patient|surgical patient
4639576|NCT03621800|Menthol|menthol
4639577|NCT03621800|Ice|ice
4639578|NCT03621800|Randomized Controlled Trial|randomized controlled trial
4639579|NCT03621774|Schizophrenia|schizophrenia
4639580|NCT03621774|CBT|cbt
4639581|NCT03621774|Mobile CBT|mobile cbt
4639582|NCT03621774|Negative Symptoms|negative symptoms
4639583|NCT03621761|cognitive behavioral therapy|cognitive behavioral therapy
4639584|NCT03621761|modafinil|modafinil
4639585|NCT03621761|Provigil|provigil
4639586|NCT03621761|fatigue|fatigue
4639587|NCT03621761|MS|ms
4639588|NCT03621748|craniotomy|craniotomy
4639589|NCT03621748|awake craniotomy|awake craniotomy
4639590|NCT03621735|Tinnitus|tinnitus
4639591|NCT03621735|Ringing in the ear|ringing in the ear
4639592|NCT03621709|TAVR|tavr
4639593|NCT03621709|TAVI|tavi
4639594|NCT03621709|Aortic valve stenosis|aortic valve stenosis
4639595|NCT03621670|Meningitis|meningitis
4639596|NCT03621670|Immune response|immune response
4639597|NCT03621670|Sufficiency|sufficiency
4639598|NCT03621670|Neisseria meningitides|neisseria meningitides
4639599|NCT03621670|Bexsero|bexsero
4639600|NCT03621631|knee osteoarthritis|knee osteoarthritis
4639601|NCT03621631|Tai Chi|tai chi
4639602|NCT03621631|Biofeedback|biofeedback
4639603|NCT03621631|External Knee Adduction Moment|external knee adduction moment
4639604|NCT03621618|vasoactive medication|vasoactive medication
4639605|NCT03621618|dynamic arterial elastance|dynamic arterial elastance
4639606|NCT03621579|RNFLT|rnflt
4639607|NCT03621540|transcranial direct current stimulation|transcranial direct current stimulation
4639608|NCT03621540|schizophrenia|schizophrenia
4639609|NCT03621540|cognitive deficits|cognitive deficits
4639610|NCT03621540|working memory training|working memory training
4639611|NCT03621514|Painless indwelling urethral catheter|painless indwelling urethral catheter
4639612|NCT03621514|uniportal video-assisted thoracoscopic surgery|uniportal video-assisted thoracoscopic surgery
4639613|NCT03621514|Lobectomy|lobectomy
4639614|NCT03621514|Lung cancer|lung cancer
4639615|NCT03621501|Percutaneous coronary intervention|percutaneous coronary intervention
4639616|NCT03621501|Multivessel disease|multivessel disease
4639617|NCT03621488|Behavioral Activation|behavioral activation
4639618|NCT03621488|Virtual reality|virtual reality
4639619|NCT03621488|Depression|depression
4639620|NCT03621449|passive leg raising|passive leg raising
4639621|NCT03621449|fluid responsiveness|fluid responsiveness
4639622|NCT03621449|pulse contour analysis|pulse contour analysis
4639623|NCT03621449|transthoracic ultrasound|transthoracic ultrasound
4639624|NCT03621449|velocity time integral|velocity time integral
4639625|NCT03621410|Acute Mountains Sickness|acute mountains sickness
4639627|NCT03621397|Spanish-speakers|spanish-speakers
4639628|NCT03621397|Subarachnoid hemorrhage|subarachnoid hemorrhage
4639629|NCT03621397|Cognitive Intervention|cognitive intervention
4639630|NCT03621384|BsmI|bsmi
4639631|NCT03621384|Diabetic kidney disease|diabetic kidney disease
4639632|NCT03621384|Polymorphisms|polymorphisms
4639633|NCT03621384|Vitamin D receptor gene|vitamin d receptor gene
4639634|NCT03621358|Satiety|satiety
4639635|NCT03621358|Encapsulated flavour|encapsulated flavour
4639636|NCT03621358|Gummies|gummies
4639637|NCT03621358|Visual Analogue Scale|visual analogue scale
4639638|NCT03621358|Cross-over|cross-over
4639639|NCT03621319|Hybrid argon plasma coagulation|hybrid argon plasma coagulation
4639640|NCT03621319|Submucosal injection|submucosal injection
4639641|NCT03621293|Long term outcome|long term outcome
4639642|NCT03621293|Brain|brain
4639643|NCT03621293|Lung|lung
4639644|NCT03621293|Oxygen strategies|oxygen strategies
4639645|NCT03621254|Functional Electrical Stimulation|functional electrical stimulation
4639646|NCT03621254|Exercise Training|exercise training
4639647|NCT03621254|Aerobic Fitness|aerobic fitness
4639648|NCT03621254|Muscle Strength|muscle strength
4639649|NCT03621228|Delirium|delirium
4639650|NCT03621228|Hyperactive|hyperactive
4639651|NCT03621228|Aggression|aggression
4639652|NCT03621228|Anxiety|anxiety
4639653|NCT03621228|Digital therapy|digital therapy
4639654|NCT03621215|tart cherries|tart cherries
4639655|NCT03621215|gout|gout
4639656|NCT03621215|cardiovascular disease risk|cardiovascular disease risk
4639657|NCT03621215|gout attack|gout attack
4639658|NCT03621215|gout flare|gout flare
4639659|NCT03621176|Exercise|exercise
4639660|NCT03621176|Health-related quality of life|health-related quality of life
4639661|NCT03621176|Physical function|physical function
4639662|NCT03621176|Hemodialysis|hemodialysis
4639663|NCT03621176|Peritoneal dialysis|peritoneal dialysis
4639664|NCT03621163|bleaching agent|bleaching agent
4639665|NCT03621150|mri|mri
4639666|NCT03621150|musculoskeletal ultrasound|musculoskeletal ultrasound
4639667|NCT03621150|tendinopathy|tendinopathy
4639668|NCT03621137|Atopic Eczema|atopic eczema
4639669|NCT03621137|Atopic Dermatitis|atopic dermatitis
4639670|NCT03621137|Registries|registries
4639671|NCT03621137|Systemic therapies|systemic therapies
4639672|NCT03621137|Off-label use|off-label use
4639673|NCT03621137|Phototherapy|phototherapy
4639674|NCT03621137|Child|child
4639675|NCT03621137|Adult|adult
4639676|NCT03621111|Myocardial Infarct|myocardial infarct
4639677|NCT03621111|Medication Adherence|medication adherence
4639678|NCT03621111|Community Pharmacist|community pharmacist
4639679|NCT03621111|Patient counseling|patient counseling
4639680|NCT03621111|Pill counts|pill counts
4639681|NCT03621111|Hospital re-admission|hospital re-admission
4639682|NCT03621111|Antiplatelet therapy|antiplatelet therapy
4639683|NCT03621111|Beta-blockers|beta-blockers
4639684|NCT03621111|Lipid-lowering therapy|lipid-lowering therapy
4639685|NCT03621111|Angiotensin-Converting Enzyme Inhibitors (ACEi)|angiotensin-converting enzyme inhibitors (acei)
4639686|NCT03621111|Renin Angiotensin System Inhibitors (RASi)|renin angiotensin system inhibitors (rasi)
4639687|NCT03621111|Mineralocorticoid/aldosterone receptor antagonists|mineralocorticoid/aldosterone receptor antagonists
4639688|NCT03621098|Exercise|exercise
4639689|NCT03621072|Fluconazole|fluconazole
4639690|NCT03621072|Bioequivalence|bioequivalence
4639691|NCT03621072|Phase I|phase i
4639692|NCT03621072|Chinese|chinese
4639693|NCT03621072|Healthy Subjects|healthy subjects
4639694|NCT03621059|Tourette syndrome|tourette syndrome
4639695|NCT03621059|behavior therapy|behavior therapy
4639696|NCT03621059|children and adolescents|children and adolescents
4639697|NCT03621046|motor;|motor;
4639698|NCT03621046|cognition|cognition
4639699|NCT03621033|transendoscopic enteral tubing|transendoscopic enteral tubing
4639700|NCT03621033|Microbiota Transplantation|microbiota transplantation
4639701|NCT03621033|transparent cap-assisted colonoscopy|transparent cap-assisted colonoscopy
4639702|NCT03621007|POMC|pomc
4639703|NCT03621007|LEPR|lepr
4639704|NCT03621007|PCSK1|pcsk1
4639705|NCT03621007|Bi-Allelic Loss|bi-allelic loss
4639706|NCT03621007|Obesity|obesity
4639707|NCT03620994|Irritable Bowel Syndrome|irritable bowel syndrome
4639708|NCT03620994|alarm symptoms|alarm symptoms
4639709|NCT03620994|Roman IV|roman iv
4639710|NCT03620968|Postoperative cognitive dysfunction|postoperative cognitive dysfunction
4639711|NCT03620968|Cognitive training|cognitive training
4639712|NCT03620968|Anaesthesia in Non-cardiac surgery|anaesthesia in non-cardiac surgery
4639713|NCT03620968|Elderly adult|elderly adult
4639714|NCT03620968|Perioperative management.|perioperative management.
4639715|NCT03620942|Maternal hypotension|maternal hypotension
4639716|NCT03620942|Spinal anaesthesia|spinal anaesthesia
4639717|NCT03620942|Caesarean section|caesarean section
4639718|NCT03620929|estradiol|estradiol
4639719|NCT03620916|liver resection|liver resection
4639720|NCT03620916|analgesia|analgesia
4639721|NCT03620916|pain|pain
4639722|NCT03620916|postoperative recovery|postoperative recovery
4639723|NCT03620903|Waldenstrom Macroglobulinemia, Ibrutinib, Bortezomib|waldenstrom macroglobulinemia, ibrutinib, bortezomib
4639724|NCT03620890|Pregnancy|pregnancy
4639725|NCT03620851|enhanced recovery program|enhanced recovery program
4639726|NCT03620851|colorectal surgery|colorectal surgery
4639727|NCT03620851|elderly|elderly
4639728|NCT03620812|rapeseed, protein, postprandial, glucose|rapeseed, protein, postprandial, glucose
4639729|NCT03620799|Roller intervention|roller intervention
4639730|NCT03620799|Knee pain|knee pain
4639731|NCT03620799|Algometry|algometry
4639732|NCT03620760|Unstable Angina|unstable angina
4639733|NCT03620760|Stent|stent
4639734|NCT03620760|Ticagrelor|ticagrelor
4639735|NCT03620760|Platelet aggregation|platelet aggregation
4639736|NCT03620760|Percutaneous Coronary Intervention|percutaneous coronary intervention
4639737|NCT03620760|Coronary Artery Disease|coronary artery disease
4639738|NCT03620760|Major Adverse Cardiovascular and Cerebrovascular Events|major adverse cardiovascular and cerebrovascular events
4639739|NCT03620760|Bleeding Events|bleeding events
4639740|NCT03620708|tobacco|tobacco
4639741|NCT03620708|smoking|smoking
4639742|NCT03620708|cigarette|cigarette
4639743|NCT03620669|Lung cancer|lung cancer
4639744|NCT03620669|Durvalumab|durvalumab
4639745|NCT03620669|PD-L1|pd-l1
4639746|NCT03620669|NSCLC|nsclc
4639747|NCT03620669|Phase II|phase ii
4639748|NCT03620669|PS 2|ps 2
4639749|NCT03620656|Atrial Fibrillation|atrial fibrillation
4639750|NCT03620656|FibriCheck|fibricheck
4639751|NCT03620656|Validation|validation
4639752|NCT03620656|Smartphone|smartphone
4639753|NCT03620656|Smartwatch|smartwatch
4639754|NCT03620643|Advanced E-cadherin negative gastric cancer|advanced e-cadherin negative gastric cancer
4639755|NCT03620643|Oestrogen receptor positive lobular breast cancer|oestrogen receptor positive lobular breast cancer
4639756|NCT03620643|Crizotinib|crizotinib
4639757|NCT03620643|Fulvestrant|fulvestrant
4639758|NCT03620617|Raspberry|raspberry
4639759|NCT03620617|Diet|diet
4639760|NCT03620604|single incision sling|single incision sling
4639761|NCT03620604|safety|safety
4639762|NCT03620604|efficacy|efficacy
4639763|NCT03620591|Lidocaine|lidocaine
4639764|NCT03620591|Postoperative Pain|postoperative pain
4639765|NCT03620591|Opioid consumption|opioid consumption
4639766|NCT03620591|Laparoscopic cholecystectomy|laparoscopic cholecystectomy
4639767|NCT03620578|DLBCL|dlbcl
4639768|NCT03620578|HGBL|hgbl
4639769|NCT03620578|BCL-2|bcl-2
4639770|NCT03620578|BCL-6|bcl-6
4639771|NCT03620578|double-hit|double-hit
4639772|NCT03620578|triple-hit|triple-hit
4639773|NCT03620578|R-CHOP|r-chop
4639774|NCT03620578|DA-EPOCH-R|da-epoch-r
4639775|NCT03620578|Nivolumab|nivolumab
4640489|NCT03615924|VOC|voc
4639776|NCT03620578|PD1/PDL1 expression|pd1/pdl1 expression
4639777|NCT03620565|Pelvic floor reconstructive surgery|pelvic floor reconstructive surgery
4639778|NCT03620565|Mesh|mesh
4639779|NCT03620565|Native tissue|native tissue
4639780|NCT03620565|Tape|tape
4639781|NCT03620565|Complication|complication
4639782|NCT03620565|the CTS coding|the cts coding
4639783|NCT03620552|18F-S16|18f-s16
4639784|NCT03620552|Neurodegenerative Dementia|neurodegenerative dementia
4639785|NCT03620552|PET/CT|pet/ct
4639786|NCT03620539|flow-mediated dilation|flow-mediated dilation
4639787|NCT03620539|sauna|sauna
4639788|NCT03620539|vascular|vascular
4639789|NCT03620539|heat|heat
4639790|NCT03620526|Iloprost|iloprost
4639791|NCT03620526|Heart failure with preserved ejection fraction|heart failure with preserved ejection fraction
4639792|NCT03620526|hemodynamic|hemodynamic
4639793|NCT03620526|Pulmonary wedge pressure|pulmonary wedge pressure
4639794|NCT03620487|NGS|ngs
4639795|NCT03620487|Sequencing|sequencing
4639796|NCT03620474|Hepatitis C virus|hepatitis c virus
4639797|NCT03620474|Hepatitis B virus|hepatitis b virus
4639798|NCT03620474|liver Cirrhosis|liver cirrhosis
4639799|NCT03620461|metastatic pancreatic cancer|metastatic pancreatic cancer
4639800|NCT03620461|real world data|real world data
4639801|NCT03620461|gemcitabine|gemcitabine
4639802|NCT03620461|nabpaclitaxel|nabpaclitaxel
4639803|NCT03620461|efficacy|efficacy
4639804|NCT03620461|safety|safety
4639805|NCT03620422|Mannitol|mannitol
4639806|NCT03620422|Bronchoconstriction|bronchoconstriction
4639807|NCT03620422|Airway nerve function|airway nerve function
4639808|NCT03620422|Cough|cough
4639809|NCT03620422|Diagnostic Test|diagnostic test
4639810|NCT03620422|Osmolarity|osmolarity
4639811|NCT03620422|Salbutamol|salbutamol
4639812|NCT03620383|Transradial access|transradial access
4639813|NCT03620383|Radial artery|radial artery
4639814|NCT03620383|Vasodilation|vasodilation
4639815|NCT03620383|Heat|heat
4639816|NCT03620370|Normobaric hyperoxia;|normobaric hyperoxia;
4639817|NCT03620370|Acute ischemic stroke;|acute ischemic stroke;
4639818|NCT03620370|vascular recanalization;|vascular recanalization;
4639819|NCT03620370|Endovascular treatment;|endovascular treatment;
4639820|NCT03620370|reperfusion therapy|reperfusion therapy
4639821|NCT03620318|Compassionate use|compassionate use
4639822|NCT03620279|motor training for cerebral palsy|motor training for cerebral palsy
4639823|NCT03620266|AMI, anthocyanin, bilberry, exercise capacity, cholesterol|ami, anthocyanin, bilberry, exercise capacity, cholesterol
4639824|NCT03620253|modafinil|modafinil
4639825|NCT03620253|remitted depression|remitted depression
4639826|NCT03620253|cognition|cognition
4639827|NCT03620227|Combined Exercise|combined exercise
4639828|NCT03620227|Beetroot juice|beetroot juice
4639829|NCT03620227|Women health|women health
4639830|NCT03620214|CHILD|child
4639831|NCT03620214|GROWTH|growth
4639832|NCT03620214|PHYSIOLOGICAL PARAMETERS|physiological parameters
4639833|NCT03620214|FACE|face
4639834|NCT03620214|MAXILLARY|maxillary
4639835|NCT03620188|Patient treatment goals|patient treatment goals
4639836|NCT03620175|Healthy Participants|healthy participants
4639837|NCT03620175|Skin|skin
4639838|NCT03620175|Dermal|dermal
4639839|NCT03620175|Biopsy|biopsy
4639840|NCT03620149|denosumab|denosumab
4639841|NCT03620149|Giant cell tumor of bone|giant cell tumor of bone
4639842|NCT03620136|Total knee prosthesis|total knee prosthesis
4639843|NCT03620136|Adductor canal block|adductor canal block
4639844|NCT03620136|Local peri-articular infiltrations|local peri-articular infiltrations
4639845|NCT03620136|Postoperative analgesia|postoperative analgesia
4639846|NCT03620136|Early rehabilitation|early rehabilitation
4639847|NCT03620136|Patient Controlled Analgesia|patient controlled analgesia
4639848|NCT03620123|SCCHN|scchn
4639849|NCT03620123|Nivolumab|nivolumab
4639850|NCT03620123|Ipilimumab|ipilimumab
4639851|NCT03620097|Autism Spectrum Disorders|autism spectrum disorders
4639852|NCT03620097|ASD|asd
4639853|NCT03620097|Children|children
4639854|NCT03620097|Autism|autism
4639855|NCT03620097|Docosahexaenoic acid|docosahexaenoic acid
4639856|NCT03620097|Inflammation|inflammation
4639857|NCT03620097|Oxidative stress|oxidative stress
4639858|NCT03620097|Intestinal microbiota|intestinal microbiota
4639859|NCT03620097|heavy metals|heavy metals
4639860|NCT03620071|complex chronic condition|complex chronic condition
4639861|NCT03620071|care coordination|care coordination
4639862|NCT03620071|shared decision making|shared decision making
4639863|NCT03620071|health literacy|health literacy
4639864|NCT03620019|Denosumab|denosumab
4639865|NCT03620019|Pembrolizumab|pembrolizumab
4639866|NCT03620019|Melanoma|melanoma
4639867|NCT03620019|Unresectable|unresectable
4639868|NCT03620019|Cutaneous|cutaneous
4639869|NCT03619993|R-CHOP|r-chop
4639870|NCT03619993|G-CSF|g-csf
4639871|NCT03619993|Early breast cancer|early breast cancer
4639872|NCT03619993|Anthracycline/cyclophosphamide|anthracycline/cyclophosphamide
4639873|NCT03619993|1st line|1st line
4639874|NCT03619993|immunochemotherapy|immunochemotherapy
4639875|NCT03619993|taxane|taxane
4639876|NCT03619980|Prostate Cancer|prostate cancer
4639877|NCT03619980|Non interventional|non interventional
4639878|NCT03619980|Registry|registry
4639879|NCT03619967|breast cancer|breast cancer
4639880|NCT03619967|sentynel lymph node|sentynel lymph node
4639881|NCT03619967|fluorescence imaging|fluorescence imaging
4639882|NCT03619954|NK cell infusion|nk cell infusion
4639883|NCT03619941|Montmorency Tart Cherry|montmorency tart cherry
4639884|NCT03619941|Anthocyanins|anthocyanins
4639885|NCT03619941|Polyphenols|polyphenols
4639886|NCT03619941|Metabolic Syndrome|metabolic syndrome
4639887|NCT03619941|Insulin Resistance|insulin resistance
4639888|NCT03619941|Hypertension|hypertension
4639889|NCT03619941|Lipid Profile|lipid profile
4639890|NCT03619941|Prediabetes|prediabetes
4639891|NCT03619928|Dry needling|dry needling
4639892|NCT03619928|Massotherapy|massotherapy
4639893|NCT03619928|Delayed onset muscle soreness|delayed onset muscle soreness
4639895|NCT03619889|Chronic Pain|chronic pain
4639896|NCT03619889|Physical Therapy modalities|physical therapy modalities
4639897|NCT03619876|CTLA4-Ig|ctla4-ig
4639898|NCT03619876|Abatacept|abatacept
4639899|NCT03619876|Myocarditis|myocarditis
4639900|NCT03619876|RA|ra
4639901|NCT03619863|Hemophilia|hemophilia
4639902|NCT03619863|Non-Factor Products|non-factor products
4639903|NCT03619863|Bypassing Agents|bypassing agents
4639904|NCT03619863|Clotting Factor Replacement Products|clotting factor replacement products
4639905|NCT03619850|Iron Deficiency Anemia, IDA, Chronic Kidney Disease, CKD, pediatrics, ferumoxytol, iron sucrose, Feraheme, Venofer|iron deficiency anemia, ida, chronic kidney disease, ckd, pediatrics, ferumoxytol, iron sucrose, feraheme, venofer
4639906|NCT03619811|esophageal disorders|esophageal disorders
4639907|NCT03619785|Nerve Block|nerve block
4639908|NCT03619785|Serratus Anterior Plane Block|serratus anterior plane block
4639909|NCT03619785|Ultrasound|ultrasound
4639910|NCT03619785|Emergency Department|emergency department
4639911|NCT03619772|hand|hand
4639912|NCT03619772|stroke|stroke
4639913|NCT03619772|therapy|therapy
4639914|NCT03619772|rehabilitation|rehabilitation
4639915|NCT03619759|Sugammadex|sugammadex
4639916|NCT03619759|Colorectal surgery|colorectal surgery
4639917|NCT03619759|postoperative complication|postoperative complication
4639918|NCT03619746|infection|infection
4639919|NCT03619733|HEART score, troponins|heart score, troponins
4639920|NCT03619720|Emotions, Respiratory Rate, Phonation|emotions, respiratory rate, phonation
4639921|NCT03619707|Luteal Phase Support|luteal phase support
4639922|NCT03619707|Cryo-warmed Embryo Transfer|cryo-warmed embryo transfer
4639923|NCT03619707|Assisted Reproductive Technology|assisted reproductive technology
4639924|NCT03619668|Effect of radiotherapy|effect of radiotherapy
4639925|NCT03619655|J1835|j1835
4639926|NCT03619655|SPECT CT|spect ct
4639927|NCT03619655|PSMA|psma
4639928|NCT03619655|18F-DCFPyL PET/CT|18f-dcfpyl pet/ct
4639929|NCT03619655|WB-MRI|wb-mri
4639930|NCT03619655|NaF|naf
4639931|NCT03619629|Kinesio-taping|kinesio-taping
4639932|NCT03619629|Mulligan|mulligan
4639933|NCT03619629|Mobilization|mobilization
4639934|NCT03619629|balance|balance
4639935|NCT03619629|ankle|ankle
4639936|NCT03619590|Teratogenicity|teratogenicity
4639937|NCT03619590|Pregnancy|pregnancy
4639938|NCT03619590|Hepatitis B|hepatitis b
4639939|NCT03619590|Twinrix|twinrix
4639940|NCT03619590|Prenatal exposure|prenatal exposure
4639941|NCT03619590|Hepatitis A|hepatitis a
4639942|NCT03619577|Mild Cognitive Impairment|mild cognitive impairment
4639943|NCT03619577|cognitive training|cognitive training
4639944|NCT03619577|exercise|exercise
4639945|NCT03619512|Richter Syndrome|richter syndrome
4639946|NCT03619512|Genomics|genomics
4639947|NCT03619512|Proteomics|proteomics
4639948|NCT03619512|Chemotherapy resistance|chemotherapy resistance
4639949|NCT03619486|Low Energy Shock Wave (LESW)|low energy shock wave (lesw)
4639950|NCT03619486|Extracorporeal Shockwave Therapy|extracorporeal shockwave therapy
4639951|NCT03619486|interstitial cystitis/bladder pain syndrome (IC/BPS)|interstitial cystitis/bladder pain syndrome (ic/bps)
4639952|NCT03619473|standard motorcycle child safety helmet|standard motorcycle child safety helmet
4639953|NCT03619473|chinstrap|chinstrap
4639954|NCT03619473|toy/game helmet|toy/game helmet
4639955|NCT03619460|wisdom teeth|wisdom teeth
4639956|NCT03619460|extraction|extraction
4639957|NCT03619460|piezoelectric technique|piezoelectric technique
4639958|NCT03619434|Femtolaser|femtolaser
4639959|NCT03619434|Corneal Transplant|corneal transplant
4639960|NCT03619434|Keratoplasty|keratoplasty
4639961|NCT03619434|Corneal Graft|corneal graft
4639962|NCT03619434|Laser|laser
4639963|NCT03619434|Trephine|trephine
4639964|NCT03619421|zinc|zinc
4639965|NCT03619421|nutrition|nutrition
4639966|NCT03619421|supplement|supplement
4639967|NCT03619421|food|food
4639968|NCT03619408|Esophageal Atresia|esophageal atresia
4639969|NCT03619408|Esophagitis|esophagitis
4639970|NCT03619408|GER|ger
4639971|NCT03619408|Gastroesopheal reflux|gastroesopheal reflux
4639972|NCT03619408|PPI|ppi
4639973|NCT03619395|Cardiovascular Secondary prevention|cardiovascular secondary prevention
4639974|NCT03619395|Cardiovascular risk factors control|cardiovascular risk factors control
4639975|NCT03619382|ankle|ankle
4639976|NCT03619356|hemoglobin|hemoglobin
4639977|NCT03619356|oxygenation concentration|oxygenation concentration
4639978|NCT03619317|Heartdisease|heartdisease
4639979|NCT03619317|Radiation|radiation
4639980|NCT03619317|Chemoradiotherapy|chemoradiotherapy
4639981|NCT03619317|cardiovascular disease|cardiovascular disease
4639982|NCT03619304|coffee, oral squamous cell carcinoma|coffee, oral squamous cell carcinoma
4639983|NCT03619278|HIV|hiv
4639984|NCT03619239|Phase 1b/2a|phase 1b/2a
4639985|NCT03619200|Primary prevention|primary prevention
4639986|NCT03619200|Adults|adults
4639987|NCT03619200|Pressure platform|pressure platform
4639988|NCT03619200|Inertial Sensors|inertial sensors
4639989|NCT03619200|Clinical Protocol|clinical protocol
4639990|NCT03619174|incontinence|incontinence
4639991|NCT03619174|urine|urine
4639992|NCT03619174|urinary|urinary
4639993|NCT03619174|pee|pee
4639994|NCT03619174|leak|leak
4639995|NCT03619174|SUI|sui
4639996|NCT03619161|atopic dermatitis|atopic dermatitis
4639997|NCT03619161|eczema|eczema
4639998|NCT03619161|bleach bath|bleach bath
4639999|NCT03619161|bacteria|bacteria
4640000|NCT03619161|bathroom|bathroom
4640001|NCT03619161|cleaning|cleaning
4640002|NCT03619135|Pain|pain
4640003|NCT03619135|Anxiety|anxiety
4640004|NCT03619135|intravenous access|intravenous access
4640005|NCT03619109|C-Reactive Protein|c-reactive protein
4640006|NCT03619109|CRP|crp
4640007|NCT03619109|Procalcitonin|procalcitonin
4640008|NCT03619109|Lactate|lactate
4640009|NCT03619109|In Vitro Diagnostic Product|in vitro diagnostic product
4640010|NCT03619109|IVD|ivd
4640011|NCT03619096|Gingival recession|gingival recession
4640012|NCT03619096|porcine collagen matrix|porcine collagen matrix
4640013|NCT03619096|multiple gingival recessions|multiple gingival recessions
4640014|NCT03619096|tunnel technique|tunnel technique
4640015|NCT03619083|Assessments|assessments
4640016|NCT03619083|Sensory Gating|sensory gating
4640017|NCT03619083|Attention|attention
4640018|NCT03619083|Executive Control|executive control
4640019|NCT03619083|18-240|18-240
4640020|NCT03619070|Fatigability|fatigability
4640021|NCT03619070|Postmenopausal Woman|postmenopausal woman
4640022|NCT03619070|Resistance training|resistance training
4640023|NCT03619070|Physical performance|physical performance
4640024|NCT03619070|Older adults|older adults
4640025|NCT03619044|Metastatic breast cancer|metastatic breast cancer
4640026|NCT03619044|FES-PET|fes-pet
4640027|NCT03619044|HER2-positive Breast Cancer|her2-positive breast cancer
4640028|NCT03619031|type 1 diabetes|type 1 diabetes
4640029|NCT03619031|postprandial glycemia|postprandial glycemia
4640030|NCT03619031|pizza leavening|pizza leavening
4640031|NCT03619005|Prasterone|prasterone
4640032|NCT03619005|DHEA|dhea
4640033|NCT03619005|Menopause|menopause
4640034|NCT03619005|Sexual Disorder|sexual disorder
4640035|NCT03619005|HSDD|hsdd
4640036|NCT03618992|Valley Fever|valley fever
4640037|NCT03618992|Coccidioidomycosis|coccidioidomycosis
4640038|NCT03618979|regenerative medicine|regenerative medicine
4640039|NCT03618979|low back pain|low back pain
4640040|NCT03618979|multifidus|multifidus
4640041|NCT03618979|platelet rich plasma|platelet rich plasma
4640042|NCT03618966|Amyotrophic lateral sclerosis|amyotrophic lateral sclerosis
4640043|NCT03618966|Muscle disease|muscle disease
4640044|NCT03618966|Neuromuscular magnetic stimulation|neuromuscular magnetic stimulation
4640045|NCT03618940|fire|fire
4640046|NCT03618940|burn injury|burn injury
4640047|NCT03618940|children|children
4640048|NCT03618940|scalds|scalds
4640049|NCT03618927|intervention|intervention
4640050|NCT03618927|health policy|health policy
4640051|NCT03618927|psychosocial health|psychosocial health
4640052|NCT03618927|education|education
4640053|NCT03618888|Out-of-Hospital Cardiac arrest|out-of-hospital cardiac arrest
4640054|NCT03618888|Cardiopulmonary Resuscitation|cardiopulmonary resuscitation
4640055|NCT03618888|Automated External Defibrillator|automated external defibrillator
4640056|NCT03618888|Self-learning|self-learning
4640057|NCT03618888|Basic Life Support|basic life support
4640058|NCT03618849|Disorders of Consciousness|disorders of consciousness
4640059|NCT03618849|Transcranial Direct Current Stimulation|transcranial direct current stimulation
4640060|NCT03618849|Pediatric|pediatric
4640061|NCT03618849|Safety|safety
4640062|NCT03618849|Feasibility|feasibility
4640063|NCT03618836|Bacterial vaginosis|bacterial vaginosis
4640064|NCT03618836|Vaginal microbiota|vaginal microbiota
4640065|NCT03618836|Molecular methods|molecular methods
4640066|NCT03618836|Next generation sequencing|next generation sequencing
4640067|NCT03618823|analgesia|analgesia
4640068|NCT03618823|pain control|pain control
4640069|NCT03618823|adenotonsillectomy|adenotonsillectomy
4640070|NCT03618823|tonsillectomy|tonsillectomy
4640071|NCT03618823|opioids|opioids
4640072|NCT03618823|post-operative pain|post-operative pain
4640073|NCT03618810|breast cancer|breast cancer
4640074|NCT03618810|chemotherapy|chemotherapy
4640075|NCT03618810|PEG-rh-CSF|peg-rh-csf
4640076|NCT03618810|prophylactic|prophylactic
4640077|NCT03618810|febrile neutropenia|febrile neutropenia
4640078|NCT03618784|FURESTEM-RA Inj.|furestem-ra inj.
4640079|NCT03618771|Total Knee Arthroplasty|total knee arthroplasty
4640080|NCT03618771|Osteoarthritis|osteoarthritis
4640081|NCT03618771|Stability|stability
4640082|NCT03618771|Knee|knee
4640083|NCT03618771|Functional Outcome|functional outcome
4640084|NCT03618771|Gait|gait
4640085|NCT03618771|Biomechanics|biomechanics
4640086|NCT03618758|Gastric cancer|gastric cancer
4640087|NCT03618758|Peritoneal carcinomatosis|peritoneal carcinomatosis
4640088|NCT03618758|Intraperitoneal chemotherapy|intraperitoneal chemotherapy
4640089|NCT03618758|Paclitaxel|paclitaxel
4640090|NCT03618758|FOLFOX|folfox
4640091|NCT03618732|stroke|stroke
4640092|NCT03618732|upper limb|upper limb
4640093|NCT03618732|motor control|motor control
4640094|NCT03618732|function|function
4640095|NCT03618732|bilateral movement|bilateral movement
4640096|NCT03618732|virtual reality|virtual reality
4640097|NCT03618719|obstructive sleep apnea|obstructive sleep apnea
4640098|NCT03618719|intermittent hypoxia|intermittent hypoxia
4640099|NCT03618719|granulocyte function|granulocyte function
4640100|NCT03618719|continuous positive airway pressure (CPAP) therapy|continuous positive airway pressure (cpap) therapy
4640101|NCT03618693|prostatectomy|prostatectomy
4640102|NCT03618693|pain|pain
4640103|NCT03618693|recovery|recovery
4640104|NCT03618680|Sleep|sleep
4640105|NCT03618641|Stage IIIB/C/D|stage iiib/c/d
4640106|NCT03618563|daily function|daily function
4640107|NCT03618563|executive functions|executive functions
4640108|NCT03618550|Pembrolizumab|pembrolizumab
4640109|NCT03618550|GVD|gvd
4640110|NCT03618550|18-160|18-160
4640111|NCT03618537|Ixazomib|ixazomib
4640112|NCT03618537|18-069|18-069
4640113|NCT03618524|heat stress|heat stress
4640114|NCT03618524|endothelial function|endothelial function
4640115|NCT03618524|hot water immersion|hot water immersion
4640116|NCT03618524|arterial stiffness|arterial stiffness
4640117|NCT03618498|macular hole|macular hole
4640118|NCT03618498|retinal detachment|retinal detachment
4640119|NCT03618498|PDR|pdr
4640120|NCT03618459|Breast surgery|breast surgery
4640121|NCT03618459|Paravertebral block|paravertebral block
4640122|NCT03618459|Pain Control|pain control
4640123|NCT03618446|Pelvic fractures|pelvic fractures
4640124|NCT03618446|mortality|mortality
4640125|NCT03618446|predictors|predictors
4640126|NCT03618446|trauma registry|trauma registry
4640127|NCT03618433|kinect|kinect
4640128|NCT03618433|breast cancer|breast cancer
4640129|NCT03618433|mastectomy|mastectomy
4640130|NCT03618433|upper extremity dysfunction|upper extremity dysfunction
4640131|NCT03618407|Influenza|influenza
4640132|NCT03618407|Antiviral Treatment|antiviral treatment
4640133|NCT03618407|Cough|cough
4640134|NCT03618407|Oseltamivir capsule|oseltamivir capsule
4640135|NCT03618407|Lotus Clear Capsule|lotus clear capsule
4640136|NCT03618394|preterms|preterms
4640137|NCT03618394|parenteral|parenteral
4640138|NCT03618394|lipid|lipid
4640139|NCT03618381|CAR T cell|car t cell
4640140|NCT03618381|Pediatric|pediatric
4640141|NCT03618381|Young Adults|young adults
4640142|NCT03618381|Non-CNS solid tumor|non-cns solid tumor
4640143|NCT03618329|COLON CANCER|colon cancer
4640144|NCT03618329|ERAS|eras
4640145|NCT03618329|NUTRITION|nutrition
4640146|NCT03618316|pharmacokinetics|pharmacokinetics
4640147|NCT03618316|Drug-drug interaction|drug-drug interaction
4640148|NCT03618290|Acute ischemic stroke|acute ischemic stroke
4640149|NCT03618290|plasma free fatty acid|plasma free fatty acid
4640150|NCT03618264|Postoperative Pain|postoperative pain
4640151|NCT03618264|Post-Craniotomy Headache|post-craniotomy headache
4640152|NCT03618264|Dexamethasone|dexamethasone
4640153|NCT03618264|Ropivacaine|ropivacaine
4640154|NCT03618264|Pre-emptive Scalp Infiltration|pre-emptive scalp infiltration
4640155|NCT03618238|anlotinib|anlotinib
4640156|NCT03618238|L-asparaginase resistant|l-asparaginase resistant
4640157|NCT03618199|Caloric testing|caloric testing
4640158|NCT03618199|vestibular nystagmography|vestibular nystagmography
4640159|NCT03618199|VNG|vng
4640160|NCT03618199|Videonystagmography|videonystagmography
4640161|NCT03618186|African Americans|african americans
4640162|NCT03618186|neurological exam|neurological exam
4640163|NCT03618186|Dementia|dementia
4640164|NCT03618186|Alzheimer's Disease|alzheimer's disease
4640165|NCT03618173|dexamethasone|dexamethasone
4640166|NCT03618173|analgesia|analgesia
4640167|NCT03618173|lower limb blockade|lower limb blockade
4640168|NCT03618173|children|children
4640169|NCT03618173|pediatric|pediatric
4640170|NCT03618121|Videogames|videogames
4640171|NCT03618121|Commercial biofeedback device|commercial biofeedback device
4640172|NCT03618082|prospective|prospective
4640173|NCT03618082|single blind|single blind
4640174|NCT03618082|multicenter|multicenter
4640175|NCT03618082|randomized|randomized
4640176|NCT03618082|controlled|controlled
4640177|NCT03618082|Analgesia Nociception Index (ANI)|analgesia nociception index (ani)
4640178|NCT03618082|Postoperative pain|postoperative pain
4640179|NCT03618017|Breast cancer|breast cancer
4640180|NCT03618017|Survivors|survivors
4640181|NCT03618017|Survivorship plan|survivorship plan
4640182|NCT03618017|Transitional cancer care|transitional cancer care
4640183|NCT03618004|Restriction of blood flow|restriction of blood flow
4640184|NCT03618004|Anaerobic capacity|anaerobic capacity
4640185|NCT03618004|Subjective perception of effort|subjective perception of effort
4640186|NCT03618004|Wingate|wingate
4640187|NCT03618004|Isometric strength|isometric strength
4640188|NCT03617991|rehabilitation|rehabilitation
4640189|NCT03617978|cardiopulmonary resuscitation|cardiopulmonary resuscitation
4640190|NCT03617978|hemodynamic|hemodynamic
4640191|NCT03617978|medical simulation|medical simulation
4640192|NCT03617978|leg elevation|leg elevation
4640193|NCT03617952|Cookstoves|cookstoves
4640194|NCT03617952|Household Air Pollution|household air pollution
4640195|NCT03617952|Behavior Change|behavior change
4640196|NCT03617952|Global Health|global health
4640197|NCT03617939|Tissue Repository|tissue repository
4640198|NCT03617939|Blood Samples|blood samples
4640199|NCT03617939|Biological Samples|biological samples
4640200|NCT03617939|Surveys|surveys
4640201|NCT03617939|Early Detection|early detection
4640202|NCT03617939|Risk Assessment|risk assessment
4640203|NCT03617900|ginger extract|ginger extract
4640204|NCT03617900|pain relief|pain relief
4640205|NCT03617900|postpartum women|postpartum women
4640206|NCT03617887|Core|core
4640207|NCT03617887|Isometric abdominal|isometric abdominal
4640208|NCT03617887|Gluteus medius|gluteus medius
4640209|NCT03617887|Adductor|adductor
4640210|NCT03617887|Lumbo-pelvic stability|lumbo-pelvic stability
4640211|NCT03617874|Pre-exposure prophylaxis|pre-exposure prophylaxis
4640212|NCT03617874|Human Immunodeficiency Virus|human immunodeficiency virus
4640213|NCT03617874|PrEP|prep
4640214|NCT03617874|Risk for HIV acquisition|risk for hiv acquisition
4640215|NCT03617874|PrEP candidacy|prep candidacy
4640216|NCT03617848|HFpEF|hfpef
4640217|NCT03617809|Prewarming|prewarming
4640218|NCT03617809|Perioperative hypothermia|perioperative hypothermia
4640219|NCT03617809|Esophageal thermometer|esophageal thermometer
4640220|NCT03617796|markers CD64|markers cd64
4640221|NCT03617770|type 1 diabetes|type 1 diabetes
4640222|NCT03617770|glycemic control|glycemic control
4640223|NCT03617770|sleep|sleep
4640224|NCT03617770|diabetes distress|diabetes distress
4640225|NCT03617757|Chinese|chinese
4640226|NCT03617757|Diabetes Mellitus|diabetes mellitus
4640227|NCT03617757|Impaired fasting glucose|impaired fasting glucose
4640228|NCT03617757|Incidence|incidence
4640229|NCT03617757|Progression|progression
4640230|NCT03617757|Risk factors|risk factors
4640231|NCT03617705|alcohol consumption|alcohol consumption
4640232|NCT03617692|Stage III|stage iii
4640233|NCT03617692|Stage IV|stage iv
4640234|NCT03617692|Cannabis|cannabis
4640235|NCT03617692|Lung Cancer|lung cancer
4640236|NCT03617692|Tumors|tumors
4640237|NCT03617692|Observational Study|observational study
4640238|NCT03617679|Rucaparib|rucaparib
4640239|NCT03617679|Placebo|placebo
4640240|NCT03617679|Randomized|randomized
4640241|NCT03617679|Double Blind|double blind
4640242|NCT03617679|Stage III/IV|stage iii/iv
4640243|NCT03617666|avelumab|avelumab
4640244|NCT03617640|enteric neuropathies|enteric neuropathies
4640245|NCT03617640|Immune cells|immune cells
4640246|NCT03617640|Nervous cells|nervous cells
4640247|NCT03617640|Microbiom|microbiom
4640248|NCT03617627|chronic pain|chronic pain
4640249|NCT03617627|women|women
4640250|NCT03617627|self-management|self-management
4640251|NCT03617549|neonatal intensive care|neonatal intensive care
4640252|NCT03617510|Tolerance; Pharmacokinetic characteristics|tolerance; pharmacokinetic characteristics
4640253|NCT03617497|Alzheimer Disease|alzheimer disease
4640254|NCT03617497|Alzheimer dementia|alzheimer dementia
4640255|NCT03617497|Epilepsy|epilepsy
4640256|NCT03617497|Sleep Wake Disorders|sleep wake disorders
4640258|NCT03617497|Polysomnography|polysomnography
4640259|NCT03617497|Foramen ovale electrodes|foramen ovale electrodes
4640260|NCT03617484|Relapsed|relapsed
4640261|NCT03617458|PAH|pah
4640262|NCT03617406|Low - flow|low - flow
4640263|NCT03617406|Low - gradient|low - gradient
4640264|NCT03617406|Low - dose dobutamine|low - dose dobutamine
4640265|NCT03617406|Volume challenge|volume challenge
4640266|NCT03617406|Echocardiography|echocardiography
4640267|NCT03617393|Early Warning Model|early warning model
4640268|NCT03617393|Clinical Pathway|clinical pathway
4640269|NCT03617393|Diabetes|diabetes
4640270|NCT03617393|Pulmonary Infection|pulmonary infection
4640271|NCT03617367|DAXI|daxi
4640272|NCT03617367|Cervical Dystonia|cervical dystonia
4640273|NCT03617367|TWSTRS|twstrs
4640274|NCT03617367|Toxin|toxin
4640275|NCT03617367|multiple treatment|multiple treatment
4640276|NCT03617341|Breast cancer|breast cancer
4640277|NCT03617341|brain metastases|brain metastases
4640278|NCT03617341|screening|screening
4640279|NCT03617341|brain MRI|brain mri
4640280|NCT03617328|peptide|peptide
4640281|NCT03617328|vaccine|vaccine
4640282|NCT03617328|adjuvant|adjuvant
4640283|NCT03617328|cyclophosphamide|cyclophosphamide
4640284|NCT03617328|6MHP|6mhp
4640285|NCT03617328|polyICLC|polyiclc
4640286|NCT03617328|varlilumab|varlilumab
4640287|NCT03617328|CDX-1127|cdx-1127
4640288|NCT03617328|Montanide ISA-51|montanide isa-51
4640289|NCT03617315|Crosslinked Hyaluronic Acid|crosslinked hyaluronic acid
4640290|NCT03617315|Meibomian Gland Disfunction|meibomian gland disfunction
4640291|NCT03617315|Lubricants|lubricants
4640292|NCT03617315|Contact Lens|contact lens
4640293|NCT03617315|Dry Eye|dry eye
4640294|NCT03617302|Carotid artery stiffness|carotid artery stiffness
4640592|NCT03615404|recurrent|recurrent
4640295|NCT03617302|Cerebrovascular function|cerebrovascular function
4640296|NCT03617302|Cerebral blood flow|cerebral blood flow
4640297|NCT03617302|Pulsatility|pulsatility
4640298|NCT03617302|Beetroot juice|beetroot juice
4640299|NCT03617302|Dietary Inorganic Nitrate Supplementation|dietary inorganic nitrate supplementation
4640300|NCT03617302|Cerebral Small Vessel Disease|cerebral small vessel disease
4640301|NCT03617302|Cerebrovascular Reserve|cerebrovascular reserve
4640302|NCT03617302|Neurovascular Coupling|neurovascular coupling
4640303|NCT03617263|NAFLD|nafld
4640304|NCT03617263|PCOS|pcos
4640305|NCT03617263|Saroglitazar Magnesium|saroglitazar magnesium
4640306|NCT03617224|Mycosis Fungoides (MF), Sezary Syndrome (SS), Pembrolizumab, Total Skin Electron Beam Therapy (TSEBT)|mycosis fungoides (mf), sezary syndrome (ss), pembrolizumab, total skin electron beam therapy (tsebt)
4640307|NCT03617211|pelvic reconstructive surgery|pelvic reconstructive surgery
4640308|NCT03617211|mesh|mesh
4640309|NCT03617211|native tissue|native tissue
4640310|NCT03617211|tape|tape
4640311|NCT03617211|complications|complications
4640312|NCT03617211|Category-time-site (CTS) coding|category-time-site (cts) coding
4640313|NCT03617185|Metabolic syndrome|metabolic syndrome
4640314|NCT03617185|Exercise|exercise
4640315|NCT03617159|magnetic resonance imaging|magnetic resonance imaging
4640316|NCT03617159|diffusion weighted imaging|diffusion weighted imaging
4640317|NCT03617146|Diabetes Distress|diabetes distress
4640318|NCT03617146|Diabetes Mellitus|diabetes mellitus
4640319|NCT03617146|Diabetes Control|diabetes control
4640320|NCT03617146|Health Coaching|health coaching
4640321|NCT03617146|Diabetes Self-management|diabetes self-management
4640322|NCT03617120|Scoliosis brace|scoliosis brace
4640323|NCT03617120|Conventional treatment for Adolescent Idiopathic Scoliosis|conventional treatment for adolescent idiopathic scoliosis
4640324|NCT03617120|In-brace correction|in-brace correction
4640325|NCT03617120|Trunk listing|trunk listing
4640326|NCT03617120|Vertebral rotation|vertebral rotation
4640327|NCT03617120|Interface pressure|interface pressure
4640328|NCT03617120|3D body scanning|3d body scanning
4640329|NCT03617120|Surface topography|surface topography
4640330|NCT03617120|Trunk asymmetry|trunk asymmetry
4640331|NCT03617120|Quality of Life|quality of life
4640332|NCT03617094|Vertebral fracture|vertebral fracture
4640333|NCT03617094|Early Percutaneous Vertebroplasty|early percutaneous vertebroplasty
4640334|NCT03617094|Standard Conservative Treatment|standard conservative treatment
4640335|NCT03617094|Kyphosis angle|kyphosis angle
4640336|NCT03617055|kidney injury, asphyxia,cystatin c|kidney injury, asphyxia,cystatin c
4640337|NCT03617042|Dalbavancin|dalbavancin
4640338|NCT03617042|DALVANCE®|dalvance®
4640339|NCT03617042|Suspected or Confirmed Bacterial Infection|suspected or confirmed bacterial infection
4640340|NCT03617029|Deep-seated|deep-seated
4640341|NCT03617029|Needle localization|needle localization
4640342|NCT03617029|CT-guided|ct-guided
4640343|NCT03617029|Thoracoscopy|thoracoscopy
4640344|NCT03617029|Fiducial marker|fiducial marker
4640345|NCT03617003|WST-11|wst-11
4640346|NCT03617003|Phototherapy|phototherapy
4640347|NCT03617003|18-140|18-140
4640348|NCT03616990|Recidivism|recidivism
4640349|NCT03616990|Substance use|substance use
4640350|NCT03616990|Jail|jail
4640351|NCT03616990|Mental health|mental health
4640352|NCT03616990|Continuity of care|continuity of care
4640353|NCT03616990|Chicago|chicago
4640354|NCT03616990|Needs Assessment|needs assessment
4640355|NCT03616964|SLE|sle
4640356|NCT03616938|cardiopulmonary resuscitation|cardiopulmonary resuscitation
4640357|NCT03616938|chest compression|chest compression
4640358|NCT03616938|medical simulation|medical simulation
4640359|NCT03616938|randomization|randomization
4640360|NCT03616938|quality|quality
4640361|NCT03616912|SLE|sle
4640362|NCT03616886|Breast cancer|breast cancer
4640363|NCT03616886|Triple negative|triple negative
4640364|NCT03616886|Metastatic|metastatic
4640365|NCT03616886|Previously untreated|previously untreated
4640366|NCT03616886|Locally Recurrent Inoperable|locally recurrent inoperable
4640367|NCT03616847|Randomised controlled trial|randomised controlled trial
4640368|NCT03616847|Hallux valgus correction|hallux valgus correction
4640369|NCT03616847|Hallux rigidus correction|hallux rigidus correction
4640370|NCT03616847|Tourniquet|tourniquet
4640371|NCT03616847|Foot volume|foot volume
4640372|NCT03616808|Traumatic brain injury|traumatic brain injury
4640373|NCT03616808|Craniotomy|craniotomy
4640374|NCT03616808|Goal-directed treatment|goal-directed treatment
4640375|NCT03616808|Thromboelastometry|thromboelastometry
4640376|NCT03616769|Uric Acid Serum; Prospective;|uric acid serum; prospective;
4640377|NCT03616756|Nurse leader|nurse leader
4640378|NCT03616756|Resilience|resilience
4640379|NCT03616756|Parenting|parenting
4640380|NCT03616756|Stress|stress
4640381|NCT03616756|Depression|depression
4640382|NCT03616730|Non-invasive cardiac output monitor|non-invasive cardiac output monitor
4640383|NCT03616730|Cardiac output|cardiac output
4640384|NCT03616704|ARDS|ards
4640385|NCT03616704|strain|strain
4640386|NCT03616704|stress|stress
4640387|NCT03616704|Mechanical Power|mechanical power
4640388|NCT03616665|persistent depressive disorder|persistent depressive disorder
4640389|NCT03616665|psychotherapy|psychotherapy
4640390|NCT03616665|cognitive behavioral therapy|cognitive behavioral therapy
4640391|NCT03616665|inpatient treatment|inpatient treatment
4640392|NCT03616665|childhood maltreatment|childhood maltreatment
4640393|NCT03616665|treatment-resistance|treatment-resistance
4640394|NCT03616665|randomized controlled trial|randomized controlled trial
4640395|NCT03616665|clinical effectiveness|clinical effectiveness
4640396|NCT03616665|personalized psychotherapy|personalized psychotherapy
4640397|NCT03616665|comorbidity|comorbidity
4640398|NCT03616665|cognitive behavioral analysis system of psychotherapy|cognitive behavioral analysis system of psychotherapy
4640399|NCT03616626|Breast Cancer|breast cancer
4640400|NCT03616626|Accelerated partial Breast Irradiation|accelerated partial breast irradiation
4640401|NCT03616626|Breast cosmesis|breast cosmesis
4640402|NCT03616626|radiation Toxicity|radiation toxicity
4640403|NCT03616600|Myopia|myopia
4640404|NCT03616600|Orthokeratology|orthokeratology
4640405|NCT03616587|Breast Cancer|breast cancer
4640406|NCT03616587|Phase 1|phase 1
4640407|NCT03616587|Safety|safety
4640408|NCT03616587|Tolerability|tolerability
4640409|NCT03616587|Pharmacokinetics|pharmacokinetics
4640410|NCT03616587|ER Positive|er positive
4640411|NCT03616587|HER2 Negative|her2 negative
4640412|NCT03616587|Advanced Breast Cancer|advanced breast cancer
4640413|NCT03616561|psoriasis nail|psoriasis nail
4640414|NCT03616561|apremilast|apremilast
4640415|NCT03616548|intestinal transplantation|intestinal transplantation
4640416|NCT03616548|graft rejection|graft rejection
4640417|NCT03616548|image enhanced endoscopy|image enhanced endoscopy
4640418|NCT03616548|narrow band imaging|narrow band imaging
4640419|NCT03616509|Growth Hormone|growth hormone
4640420|NCT03616509|Functional Magnetic Resonance|functional magnetic resonance
4640421|NCT03616509|Strength|strength
4640422|NCT03616509|Body composition|body composition
4640423|NCT03616496|PET imaging|pet imaging
4640424|NCT03616496|Cardiac Amyloidosis|cardiac amyloidosis
4640425|NCT03616496|Florbetaben|florbetaben
4640426|NCT03616496|Heart failure|heart failure
4640427|NCT03616496|Cardiology|cardiology
4640428|NCT03616483|Multiple myeloma|multiple myeloma
4640429|NCT03616483|Monoclonal gammopathy of undetermined significance|monoclonal gammopathy of undetermined significance
4640430|NCT03616483|Plasmacytoma|plasmacytoma
4640431|NCT03616483|Smoldering multiple myeloma|smoldering multiple myeloma
4640432|NCT03616470|acute myeloid leukemia|acute myeloid leukemia
4640433|NCT03616470|AML|aml
4640434|NCT03616470|Relapsed AML|relapsed aml
4640435|NCT03616470|Refractory AML|refractory aml
4640436|NCT03616457|Screening Diagnostic|screening diagnostic
4640437|NCT03616444|colorectal adenomatous polyps|colorectal adenomatous polyps
4640438|NCT03616444|Clinical curative effect|clinical curative effect
4640439|NCT03616431|Pancreatic malignancy|pancreatic malignancy
4640440|NCT03616431|Pancreatic enzyme insufficiency|pancreatic enzyme insufficiency
4640441|NCT03616431|Pancreatic enzyme replacement therapy|pancreatic enzyme replacement therapy
4640442|NCT03616431|Pancreo-kit breath test|pancreo-kit breath test
4640443|NCT03616405|Sequential Therapy|sequential therapy
4640444|NCT03616405|Rescue Treatment|rescue treatment
4640445|NCT03616392|Diabetes Mellitus, Type II|diabetes mellitus, type ii
4640446|NCT03616366|VTE|vte
4640447|NCT03616366|SNP|snp
4640448|NCT03616366|biomarkers|biomarkers
4640449|NCT03616301|Bioequivalence|bioequivalence
4640450|NCT03616223|Intratympanic Administration|intratympanic administration
4640451|NCT03616223|Hearing Restoration|hearing restoration
4640452|NCT03616210|mechanical ventilation|mechanical ventilation
4640453|NCT03616210|protective ventilation|protective ventilation
4640454|NCT03616210|vascular surgery|vascular surgery
4640455|NCT03616210|postoperative pulmonary complications|postoperative pulmonary complications
4640456|NCT03616197|gingival biotype of adjacent teeth|gingival biotype of adjacent teeth
4640457|NCT03616197|free gingival graft|free gingival graft
4640458|NCT03616197|shrinkage of graft|shrinkage of graft
4640459|NCT03616171|Sleep Behavior|sleep behavior
4640460|NCT03616171|Insulin resistance|insulin resistance
4640461|NCT03616158|Rheumatoid arthritis|rheumatoid arthritis
4640462|NCT03616158|Interstitial Lung Disease|interstitial lung disease
4640463|NCT03616158|RA|ra
4640464|NCT03616158|ILD|ild
4640465|NCT03616145|Osteopathic Manipulative Treatment|osteopathic manipulative treatment
4640466|NCT03616119|gastoesophageal reflux disease|gastoesophageal reflux disease
4640467|NCT03616119|prevalence|prevalence
4640468|NCT03616119|Azerbaijan|azerbaijan
4640469|NCT03616106|Information Visualization|information visualization
4640470|NCT03616080|cerebral palsy|cerebral palsy
4640471|NCT03616054|Airway management|airway management
4640472|NCT03616041|Severe hematochezia|severe hematochezia
4640473|NCT03616015|HSCT|hsct
4640474|NCT03616015|intestinal dysbiosis|intestinal dysbiosis
4640475|NCT03616015|immune reconstitution|immune reconstitution
4640476|NCT03615989|Bone Health|bone health
4640477|NCT03615989|Females|females
4640478|NCT03615989|Creatine|creatine
4640479|NCT03615989|Dairy|dairy
4640480|NCT03615989|Exercise|exercise
4640481|NCT03615976|arthroscopy|arthroscopy
4640482|NCT03615976|Patellofemoral Osteoarthritis|patellofemoral osteoarthritis
4640483|NCT03615924|Sickle Cell Disease|sickle cell disease
4640484|NCT03615924|Sickle Cell Anemia|sickle cell anemia
4640485|NCT03615924|SCD|scd
4640486|NCT03615924|Platelet aggregation|platelet aggregation
4640487|NCT03615924|Ticagrelor|ticagrelor
4640490|NCT03615924|Vaso-Occlusive Crises|vaso-occlusive crises
4640491|NCT03615924|ACS|acs
4640492|NCT03615924|painful crisis|painful crisis
4640493|NCT03615911|vaccine|vaccine
4640494|NCT03615911|clinical phase 1|clinical phase 1
4640495|NCT03615911|modified vaccinia Ankara vector|modified vaccinia ankara vector
4640623|NCT03615261|stress reduction|stress reduction
4640496|NCT03615898|medication incidents, incidents reporting systems, errors, morbidity, Spain|medication incidents, incidents reporting systems, errors, morbidity, spain
4640497|NCT03615885|Montmorency Tart Cherry|montmorency tart cherry
4640498|NCT03615885|Anthocyanins|anthocyanins
4640499|NCT03615885|Polyphenols|polyphenols
4640500|NCT03615885|Metabolic Syndrome|metabolic syndrome
4640501|NCT03615885|Insulin Resistance|insulin resistance
4640502|NCT03615885|Hypertension|hypertension
4640503|NCT03615885|Lipid Profile|lipid profile
4640504|NCT03615872|quality of life|quality of life
4640505|NCT03615872|efficiency|efficiency
4640506|NCT03615859|Glucocorticoids|glucocorticoids
4640507|NCT03615859|Hydrocortisone|hydrocortisone
4640508|NCT03615859|Prednisolone|prednisolone
4640509|NCT03615833|peripheral artery disease|peripheral artery disease
4640510|NCT03615833|Vitamin D|vitamin d
4640511|NCT03615820|Nanovesicles|nanovesicles
4640512|NCT03615820|Aphthous ulcer|aphthous ulcer
4640513|NCT03615807|diabetic foot infections|diabetic foot infections
4640514|NCT03615807|antibiotic reduction|antibiotic reduction
4640515|NCT03615807|osteomyelitis|osteomyelitis
4640516|NCT03615807|soft tissue infections|soft tissue infections
4640517|NCT03615781|septic arthritis|septic arthritis
4640519|NCT03615781|antibiotic duration|antibiotic duration
4640520|NCT03615781|remission|remission
4640521|NCT03615781|sequelae|sequelae
4640522|NCT03615755|Hyperbaric Oxygen Therapy|hyperbaric oxygen therapy
4640523|NCT03615755|Diabetic Foot Ulcer|diabetic foot ulcer
4640524|NCT03615755|HbA1c|hba1c
4640525|NCT03615755|Leukocyte|leukocyte
4640526|NCT03615755|Serum creatinine|serum creatinine
4640527|NCT03615742|Diesel Exhaust|diesel exhaust
4640528|NCT03615742|Air Pollution|air pollution
4640529|NCT03615742|Inhaled Corticosteroids|inhaled corticosteroids
4640530|NCT03615742|Gene Expression|gene expression
4640531|NCT03615742|Asthma|asthma
4640532|NCT03615742|Controlled Human Exposure Study|controlled human exposure study
4640533|NCT03615729|Rheumatoid arthritis|rheumatoid arthritis
4640534|NCT03615729|Genetic polymorphism|genetic polymorphism
4640535|NCT03615729|RORc2 protein|rorc2 protein
4640536|NCT03615729|T helper 17|t helper 17
4640537|NCT03615716|violence|violence
4640538|NCT03615716|adolescence|adolescence
4640539|NCT03615690|ulcerative colitis|ulcerative colitis
4640540|NCT03615690|IBD|ibd
4640541|NCT03615690|diet|diet
4640542|NCT03615690|fasting|fasting
4640543|NCT03615690|fasting mimicking diet|fasting mimicking diet
4640544|NCT03615690|crohns|crohns
4640545|NCT03615664|Lymphoma|lymphoma
4640546|NCT03615664|Immunochemotherapy|immunochemotherapy
4640547|NCT03615664|Salvage therapy|salvage therapy
4640548|NCT03615664|Bendamustine|bendamustine
4640549|NCT03615664|Gemcitabine|gemcitabine
4640550|NCT03615664|Dexamethasone|dexamethasone
4640551|NCT03615664|Hodgkin's Lymphoma|hodgkin's lymphoma
4640552|NCT03615664|ASCT|asct
4640553|NCT03615638|Fall prevention|fall prevention
4640554|NCT03615638|Total knee arthroplasty|total knee arthroplasty
4640555|NCT03615638|Commnuity-based|commnuity-based
4640556|NCT03615625|Exercise|exercise
4640557|NCT03615625|Aging|aging
4640558|NCT03615625|Ambulatory Blood Pressure Monitoring|ambulatory blood pressure monitoring
4640559|NCT03615625|Power Exercise|power exercise
4640560|NCT03615599|Seventh-day Adventists|seventh-day adventists
4640561|NCT03615599|vegetarian|vegetarian
4640562|NCT03615599|mortality|mortality
4640563|NCT03615599|cancer|cancer
4640564|NCT03615599|dietary pattern|dietary pattern
4640565|NCT03615599|soy consumption|soy consumption
4640566|NCT03615599|dairy consumption|dairy consumption
4640567|NCT03615599|plant-based|plant-based
4640568|NCT03615560|Medical staff; preeclampsia; cohort study; further effect|medical staff; preeclampsia; cohort study; further effect
4640569|NCT03615547|azoospermia|azoospermia
4640570|NCT03615547|clominophene|clominophene
4640571|NCT03615534|Extended Release Niacin|extended release niacin
4640572|NCT03615534|Fenofibrate|fenofibrate
4640573|NCT03615534|treatment|treatment
4640574|NCT03615534|Obesity|obesity
4640575|NCT03615534|Atherogenic Dyslipidemia|atherogenic dyslipidemia
4640576|NCT03615508|Alpha blockers|alpha blockers
4640577|NCT03615508|Tamsulosin|tamsulosin
4640578|NCT03615495|Esophageal|esophageal
4640579|NCT03615495|Atresia|atresia
4640580|NCT03615495|Congential|congential
4640581|NCT03615469|Neuromuscular Electrical Stimulation|neuromuscular electrical stimulation
4640582|NCT03615469|Transcutaneous Electrical Nerve Stimulation|transcutaneous electrical nerve stimulation
4640583|NCT03615469|6 minute walk test|6 minute walk test
4640584|NCT03615469|DXA|dxa
4640585|NCT03615469|Double Blinded randomized control trial|double blinded randomized control trial
4640586|NCT03615469|ActivPal|activpal
4640587|NCT03615469|EMPI Continuum Device|empi continuum device
4640588|NCT03615404|glioblastoma|glioblastoma
4640589|NCT03615404|medulloblastoma|medulloblastoma
4640590|NCT03615404|glioma|glioma
4640591|NCT03615404|pediatric|pediatric
4640593|NCT03615404|newly diagnosed|newly diagnosed
4640594|NCT03615404|Pro00092868|pro00092868
4640595|NCT03615404|Landi|landi
4640596|NCT03615365|Capnography|capnography
4640597|NCT03615365|Diagnosis|diagnosis
4640598|NCT03615365|Breathlessness|breathlessness
4640599|NCT03615365|Exacerbations|exacerbations
4640600|NCT03615365|Device|device
4640601|NCT03615352|Endometrioma|endometrioma
4640602|NCT03615352|laparoscopy|laparoscopy
4640603|NCT03615352|ovarian reserve|ovarian reserve
4640604|NCT03615352|pelvic pain|pelvic pain
4640605|NCT03615339|Food supplement, Fermented food, Whey|food supplement, fermented food, whey
4640606|NCT03615326|programmed cell death receptor 1 (PD-1)|programmed cell death receptor 1 (pd-1)
4640607|NCT03615326|programmed cell death ligand 1 (PD-L1)|programmed cell death ligand 1 (pd-l1)
4640608|NCT03615326|anti-PD-1|anti-pd-1
4640609|NCT03615326|anti PD-1|anti pd-1
4640610|NCT03615326|GEJ|gej
4640611|NCT03615326|Gastric Cancer|gastric cancer
4640612|NCT03615313|mesothelin, PD-1, CAR T cells, solid tumor|mesothelin, pd-1, car t cells, solid tumor
4640613|NCT03615274|childhood obesity|childhood obesity
4640614|NCT03615274|cognitive training|cognitive training
4640615|NCT03615274|executive function|executive function
4640616|NCT03615274|quality of life|quality of life
4640617|NCT03615274|neuroimaging|neuroimaging
4640618|NCT03615274|magnetic resonance|magnetic resonance
4640619|NCT03615274|connectivity|connectivity
4640620|NCT03615274|decision making|decision making
4640621|NCT03615261|prenatal maternal stress|prenatal maternal stress
4640622|NCT03615261|mindfulness|mindfulness
4640624|NCT03615261|health sensing|health sensing
4640625|NCT03615261|mhealth|mhealth
4640626|NCT03615235|Apolopoprotein L1 gene (APOL1)|apolopoprotein l1 gene (apol1)
4640627|NCT03615235|Kidney Transplantation|kidney transplantation
4640628|NCT03615235|Kidney Donor|kidney donor
4640629|NCT03615235|United Network for Organ Sharing (UNOS)|united network for organ sharing (unos)
4640630|NCT03615235|Association of Organ Procurement Organizations (AOPO)|association of organ procurement organizations (aopo)
4640631|NCT03615235|Kidney Transplantation Outcomes Network|kidney transplantation outcomes network
4640632|NCT03615222|functional impairment|functional impairment
4640633|NCT03615222|quality of life|quality of life
4640634|NCT03615222|Veterans|veterans
4640635|NCT03615222|mindfulness|mindfulness
4640636|NCT03615222|Acceptance and Commitment Therapy|acceptance and commitment therapy
4640637|NCT03615196|NorLeu3-A(1-7)|norleu3-a(1-7)
4640638|NCT03615196|USB005|usb005
4640639|NCT03615196|aclerastide|aclerastide
4640640|NCT03615196|corneal repair|corneal repair
4640641|NCT03615196|corneal injury|corneal injury
4640642|NCT03615157|Home-based exercise|home-based exercise
4640643|NCT03615157|Functional capacity|functional capacity
4640644|NCT03615157|Chronic Heart Failure|chronic heart failure
4640645|NCT03615144|T-cell|t-cell
4640646|NCT03615144|B-cell|b-cell
4640647|NCT03615144|CliniMACS System|clinimacs system
4640648|NCT03615144|Melphalan|melphalan
4640649|NCT03615144|Thiotepa|thiotepa
4640650|NCT03615144|Clofarabine|clofarabine
4640651|NCT03615144|Fludarabine|fludarabine
4640652|NCT03615144|17-596|17-596
4640653|NCT03615131|Prostate cancer|prostate cancer
4640654|NCT03615131|mpMRI-TRUS fusion biopsy|mpmri-trus fusion biopsy
4640655|NCT03615131|PIRADS|pirads
4640656|NCT03615131|Gleason score|gleason score
4640657|NCT03615105|Allogeneic Hematopoietic Cell Transplantation|allogeneic hematopoietic cell transplantation
4640658|NCT03615105|α/β+ T-lymphocyte|α/β+ t-lymphocyte
4640659|NCT03615105|18-224|18-224
4640660|NCT03615092|Acellular dermal matrix graft|acellular dermal matrix graft
4640661|NCT03615092|Clinical Trial|clinical trial
4640662|NCT03615092|Root coverage|root coverage
4640663|NCT03615092|Noncarious cervical lesion|noncarious cervical lesion
4640664|NCT03615053|pharmacokinetics|pharmacokinetics
4640665|NCT03615053|popPK|poppk
4640666|NCT03615053|PK|pk
4640667|NCT03615053|Hemophilia|hemophilia
4640668|NCT03615040|COPD|copd
4640669|NCT03615040|Exacerbations|exacerbations
4640670|NCT03615040|ST2 MAb|st2 mab
4640671|NCT03615040|RG6149|rg6149
4640672|NCT03615040|MSTT1041A|mstt1041a
4640673|NCT03615040|Anti-ST2|anti-st2
4640674|NCT03615040|Phase IIa|phase iia
4640675|NCT03615040|placebo controlled|placebo controlled
4640676|NCT03614988|Polypharmacy|polypharmacy
4640677|NCT03614988|Elderly|elderly
4640678|NCT03614975|inactivated|inactivated
4640679|NCT03614975|influenza|influenza
4640680|NCT03614975|vaccine|vaccine
4640681|NCT03614962|Transcutaneous electrical nerve stimulation|transcutaneous electrical nerve stimulation
4640682|NCT03614962|Cognitive|cognitive
4640683|NCT03614962|Memory|memory
4640684|NCT03614949|persistent cervical cancer|persistent cervical cancer
4640685|NCT03614923|ANB020|anb020
4640686|NCT03614923|Etikomab|etikomab
4640687|NCT03614923|CRSwNP|crswnp
4640688|NCT03614910|Locally advanced pancreatic cancer|locally advanced pancreatic cancer
4640689|NCT03614910|irreversible electroporation|irreversible electroporation
4640690|NCT03614910|Nanoknife|nanoknife
4640691|NCT03614884|gambling|gambling
4640692|NCT03614884|smoking|smoking
4640693|NCT03614884|online intervention|online intervention
4640694|NCT03614884|Cognitive Behavioural Therapy|cognitive behavioural therapy
4640695|NCT03614884|Motivational Interviewing|motivational interviewing
4640696|NCT03614884|Randomized Controlled Trial|randomized controlled trial
4640697|NCT03614871|Tobacco|tobacco
4640698|NCT03614871|Calculus|calculus
4640699|NCT03614871|Gingiva|gingiva
4640700|NCT03614871|Oral hygiene|oral hygiene
4640701|NCT03614871|Periodontitis|periodontitis
4640702|NCT03614871|Biofilm|biofilm
4640703|NCT03614858|CD19|cd19
4640704|NCT03614858|CD22|cd22
4640705|NCT03614845|postoperative atelectasis|postoperative atelectasis
4640706|NCT03614845|mechanical ventilation|mechanical ventilation
4640707|NCT03614845|laparoscopic surgery|laparoscopic surgery
4640708|NCT03614845|lung ultrasonography|lung ultrasonography
4640709|NCT03614845|volume controlled ventilation|volume controlled ventilation
4640710|NCT03614845|pressure controlled|pressure controlled
4640711|NCT03614832|ticagrelor|ticagrelor
4640712|NCT03614832|clopidogrel|clopidogrel
4640713|NCT03614832|platelet reactivity|platelet reactivity
4640714|NCT03614819|Lasers|lasers
4640715|NCT03614819|Dental enamel hypoplasia|dental enamel hypoplasia
4640716|NCT03614819|Preventive dentistry|preventive dentistry
4640717|NCT03614819|Dental caries|dental caries
4640718|NCT03614780|rurality|rurality
4640719|NCT03614728|Acute myeloid leukaemia|acute myeloid leukaemia
4640720|NCT03614728|Myelodysplastic syndrome|myelodysplastic syndrome
4640721|NCT03614728|GSK3326595|gsk3326595
4640722|NCT03614702|bOPV|bopv
4640723|NCT03614702|IPV|ipv
4640724|NCT03614702|sequential immunization|sequential immunization
4640725|NCT03614702|immunogenecity|immunogenecity
4640726|NCT03614702|safety|safety
4640727|NCT03614676|third trimester|third trimester
4640728|NCT03614676|Respiratory Syncytial Virus (RSV) infection|respiratory syncytial virus (rsv) infection
4640729|NCT03614676|Pregnancy|pregnancy
4640730|NCT03614676|Maternal Immunization|maternal immunization
4640731|NCT03614676|Pregnant Women|pregnant women
4640732|NCT03614676|Neonates|neonates
4640733|NCT03614676|Respiratory Tract Infection|respiratory tract infection
4640734|NCT03614650|immunotherapyT cellGI cancergene therapy|immunotherapyt cellgi cancergene therapy
4640735|NCT03614637|Cannabis Abstinence Sperm Cells|cannabis abstinence sperm cells
4640736|NCT03614624|Healthy subject|healthy subject
4640737|NCT03614624|Echocardiography|echocardiography
4640738|NCT03614624|2D and 3D Strain|2d and 3d strain
4640739|NCT03614624|General Electric|general electric
4640740|NCT03614624|Philips|philips
4640741|NCT03614611|pessaries|pessaries
4640742|NCT03614611|Urinary Incontinence/therapy|urinary incontinence/therapy
4640743|NCT03614611|Patient Satisfaction|patient satisfaction
4640744|NCT03614611|Female|female
4640745|NCT03614611|Surveys and Questionnaires|surveys and questionnaires
4640746|NCT03614611|Treatment Outcome|treatment outcome
4640747|NCT03614585|Stroke|stroke
4640748|NCT03614585|Rehabilitation|rehabilitation
4640749|NCT03614585|Neurosciences|neurosciences
4640750|NCT03614585|Exercise|exercise
4640751|NCT03614585|Neurorecovery|neurorecovery
4640752|NCT03614585|Cardiovascular health|cardiovascular health
4640753|NCT03614585|High-intensity interval training|high-intensity interval training
4640754|NCT03614585|Moderate-intensity continuous training|moderate-intensity continuous training
4640755|NCT03614572|Sleep deprivation|sleep deprivation
4640756|NCT03614572|Motivational Interviewing|motivational interviewing
4640757|NCT03614572|Text reminders|text reminders
4640758|NCT03614559|chronic total occlusion|chronic total occlusion
4640759|NCT03614546|primary hepatocellular carcinoma|primary hepatocellular carcinoma
4640760|NCT03614546|radiotherapy|radiotherapy
4640761|NCT03614546|transarterial chemoembolization|transarterial chemoembolization
4640762|NCT03614533|Typhoid in Burkina Faso|typhoid in burkina faso
4640763|NCT03614533|Typhoid Conjugate Vaccine|typhoid conjugate vaccine
4640764|NCT03614507|oxygen dependent|oxygen dependent
4640765|NCT03614507|Infant Between 1 Month and 12 Months Old|infant between 1 month and 12 months old
4640766|NCT03614494|Piroxicam|piroxicam
4640767|NCT03614494|Levonorgestrel|levonorgestrel
4640768|NCT03614494|Placebo|placebo
4640769|NCT03614494|Randomised controlled control|randomised controlled control
4640770|NCT03614494|Emergency contraception|emergency contraception
4640771|NCT03614429|Penile Prosthesis|penile prosthesis
4640772|NCT03614429|Urethral injury|urethral injury
4640773|NCT03614429|Urethral sterilization|urethral sterilization
4640774|NCT03614351|protein|protein
4640775|NCT03614351|nutritional guidance|nutritional guidance
4640776|NCT03614351|ACL surgery|acl surgery
4640777|NCT03614273|nebulization|nebulization
4640778|NCT03614273|adrenaline|adrenaline
4640779|NCT03614273|hypertonic saline|hypertonic saline
4640780|NCT03614273|bronchiolitis|bronchiolitis
4640781|NCT03614260|Denervation|denervation
4640782|NCT03614260|Resistant Hypertension|resistant hypertension
4640783|NCT03614260|Essential Hypertension|essential hypertension
4640784|NCT03614260|Uncontrolled Hypertension|uncontrolled hypertension
4640785|NCT03614247|Lower calyceal stone|lower calyceal stone
4640786|NCT03614247|cost-effectiveness|cost-effectiveness
4640787|NCT03614247|percutaneous nephrolithotomy|percutaneous nephrolithotomy
4640788|NCT03614247|retrograde intrarenal surgery|retrograde intrarenal surgery
4640789|NCT03614234|Glomerular filtration rate|glomerular filtration rate
4640790|NCT03614234|Proteinuria|proteinuria
4640791|NCT03614234|PRX-102|prx-102
4640792|NCT03614234|pegunigalsidase alfa|pegunigalsidase alfa
4640793|NCT03614234|Fabry disease|fabry disease
4640794|NCT03614221|Atopic Dermatitis|atopic dermatitis
4640795|NCT03614221|Indigo naturalis|indigo naturalis
4640796|NCT03614221|Tacrolimus|tacrolimus
4640797|NCT03614208|Systemic sclerosis|systemic sclerosis
4640798|NCT03614208|Home based rehabilitation|home based rehabilitation
4640799|NCT03614208|Quality of life|quality of life
4640800|NCT03614208|Hand mobility|hand mobility
4640801|NCT03614208|Exercise capacity|exercise capacity
4640802|NCT03614169|HIS-pacing|his-pacing
4640803|NCT03614169|Biventricular pacing|biventricular pacing
4640804|NCT03614156|Depression|depression
4640805|NCT03614104|Mobile health technology|mobile health technology
4640806|NCT03614091|Paravertebral block|paravertebral block
4640807|NCT03614091|Erector spinae plane block|erector spinae plane block
4640808|NCT03614091|Modified radical mastectomy|modified radical mastectomy
4640809|NCT03614091|respirometer|respirometer
4640810|NCT03614039|diosmectite|diosmectite
4640811|NCT03614039|nutraceuticals|nutraceuticals
4640812|NCT03614039|non-alcoholic fatty liver disease|non-alcoholic fatty liver disease
4640813|NCT03614039|probiotics|probiotics
4640814|NCT03614039|Lactobacillus|lactobacillus
4640815|NCT03614039|Bifidobacterium|bifidobacterium
4640816|NCT03614039|Propionibacterium|propionibacterium
4640817|NCT03613974|foot and ankle|foot and ankle
4640818|NCT03613974|day case surgery|day case surgery
4640819|NCT03613922|manual therapy|manual therapy
4640820|NCT03613922|radius fracture|radius fracture
4640821|NCT03613922|function|function
4640822|NCT03613922|disability|disability
4640823|NCT03613922|physiotherapy|physiotherapy
4640824|NCT03613883|aneurysm|aneurysm
4640825|NCT03613883|embolization|embolization
4640826|NCT03613883|stent graft|stent graft
4640827|NCT03613870|PermeaDerm, Mepilex Ag, partial thickness burn wounds|permeaderm, mepilex ag, partial thickness burn wounds
4640828|NCT03613844|Alzheimer's disease|alzheimer's disease
4640829|NCT03613844|Docosahexaenoic Acids|docosahexaenoic acids
4640830|NCT03613844|Apolipoprotein E4|apolipoprotein e4
4640831|NCT03613792|dynamic|dynamic
4640832|NCT03613792|flexible|flexible
4640833|NCT03613779|Lung ultrasound|lung ultrasound
4640834|NCT03613779|Heart failure|heart failure
4640835|NCT03613779|Management|management
4640836|NCT03613753|relapsed|relapsed
4640837|NCT03613740|Insulin Sensitivity|insulin sensitivity
4640838|NCT03613740|Metabolic Syndrome|metabolic syndrome
4640839|NCT03613740|Fucoxanthin|fucoxanthin
4640840|NCT03613740|Insulin Secretion|insulin secretion
4640841|NCT03613727|Vitamin C|vitamin c
4640842|NCT03613727|Hematopoietic cell transplant (HCT)|hematopoietic cell transplant (hct)
4640843|NCT03613727|Non-relapse mortality|non-relapse mortality
4640844|NCT03613727|Graft versus Host Disease (GVHD)|graft versus host disease (gvhd)
4640845|NCT03613701|Moyamoya disease|moyamoya disease
4640846|NCT03613701|Endothelial progenitor cells|endothelial progenitor cells
4640847|NCT03613701|revascularization|revascularization
4640848|NCT03613675|video games|video games
4640849|NCT03613662|lumbosacral radicular pain|lumbosacral radicular pain
4640850|NCT03613662|sciatica|sciatica
4640851|NCT03613662|leg pain|leg pain
4640852|NCT03613649|AZD0914|azd0914
4640853|NCT03613649|Cardiac|cardiac
4640854|NCT03613649|ETX0914|etx0914
4640855|NCT03613649|Healthy|healthy
4640856|NCT03613649|Moxifloxacin|moxifloxacin
4640857|NCT03613649|QT|qt
4640858|NCT03613649|Repolarization|repolarization
4640859|NCT03613649|Study|study
4640860|NCT03613649|Volunteers|volunteers
4640861|NCT03613649|Zoliflodacin|zoliflodacin
4640862|NCT03613610|Genicular nerve radio-frequency ablation|genicular nerve radio-frequency ablation
4640863|NCT03613558|Dexmedetomidine|dexmedetomidine
4640864|NCT03613532|Acute Myeloid Leukemia (AML)|acute myeloid leukemia (aml)
4640865|NCT03613532|Myelodysplastic Syndrome (MDS)|myelodysplastic syndrome (mds)
4640866|NCT03613532|Chronic Myelomonocytic Leukemia (CMML)|chronic myelomonocytic leukemia (cmml)
4640867|NCT03613532|MDS/myeloproliferative neoplasm-unclassifiable (MDS/MPN-unclassifiable)|mds/myeloproliferative neoplasm-unclassifiable (mds/mpn-unclassifiable)
4640868|NCT03613532|Hematopoietic Stem Cell Transplant|hematopoietic stem cell transplant
4640869|NCT03613519|Sleep hygiene|sleep hygiene
4640870|NCT03613519|Sleep Healthy Using the Internet (SHUTi)|sleep healthy using the internet (shuti)
4640871|NCT03613519|Cognitive-behavioral therapy (CBT)|cognitive-behavioral therapy (cbt)
4640872|NCT03613519|Black Women's Health Study|black women's health study
4640873|NCT03613493|HPV|hpv
4640874|NCT03613493|self-sampling|self-sampling
4640875|NCT03613493|culture|culture
4640876|NCT03613493|message design|message design
4640877|NCT03613493|health communication|health communication
4640878|NCT03613493|Jamaica|jamaica
4640879|NCT03613467|Vedio-assisted thoracoscopic lobectomy|vedio-assisted thoracoscopic lobectomy
4640880|NCT03613467|Thoracotomy lobectomy|thoracotomy lobectomy
4640881|NCT03613467|Real-world evidences;|real-world evidences;
4640882|NCT03613467|pN2 NSCLC|pn2 nsclc
4640883|NCT03613441|Mindfulness|mindfulness
4640884|NCT03613441|Residency training|residency training
4640885|NCT03613376|Varicose veins|varicose veins
4640886|NCT03613376|Compression stockings|compression stockings
4640887|NCT03613376|Sclerotherapy|sclerotherapy
4640888|NCT03613376|Radiofrequency ablation|radiofrequency ablation
4640889|NCT03613350|Cystocele|cystocele
4640890|NCT03613350|Urodynamic stress incontinence|urodynamic stress incontinence
4640891|NCT03613350|Detrusor overactivity|detrusor overactivity
4640892|NCT03613350|Pad test|pad test
4640893|NCT03613350|Urodynamic study|urodynamic study
4640894|NCT03613324|Cystocele|cystocele
4640895|NCT03613324|Bladder outlet obstruction|bladder outlet obstruction
4640896|NCT03613324|Detrusor underactivity|detrusor underactivity
4640897|NCT03613324|Urodynamic study|urodynamic study
4640898|NCT03613311|Cystocele|cystocele
4640899|NCT03613311|Urodynamic stress incontinence|urodynamic stress incontinence
4640900|NCT03613311|Pad test|pad test
4640901|NCT03613311|Urodynamic study|urodynamic study
4640902|NCT03613298|HIFU|hifu
4640903|NCT03613298|High Intensity Focused Ultrasound|high intensity focused ultrasound
4640904|NCT03613298|DIE|die
4640905|NCT03613298|rectal endometriosis|rectal endometriosis
4640906|NCT03613298|safety profile|safety profile
4640907|NCT03613298|Deep invasive endometriosis|deep invasive endometriosis
4640908|NCT03613298|Endometriosis, rectum|endometriosis, rectum
4640909|NCT03613272|thymoma|thymoma
4640910|NCT03613272|thymectomy|thymectomy
4640911|NCT03613272|Myasthenia Gravis|myasthenia gravis
4640912|NCT03613272|VATS|vats
4640913|NCT03613272|subxiphoid|subxiphoid
4640914|NCT03613272|elevation of the sternum|elevation of the sternum
4640915|NCT03613272|curative effect|curative effect
4640916|NCT03613246|TAVI|tavi
4640917|NCT03613246|Aortic valve stenosis|aortic valve stenosis
4640918|NCT03613246|ALLEGRA|allegra
4640919|NCT03613233|MIGS|migs
4640920|NCT03613233|canaloplasty|canaloplasty
4640921|NCT03613233|glaucoma|glaucoma
4640922|NCT03613233|glaucoma surgery|glaucoma surgery
4640923|NCT03613233|glaucoma implant|glaucoma implant
4640924|NCT03613233|deep sclerectomy|deep sclerectomy
4640925|NCT03613233|iridencleisis|iridencleisis
4640926|NCT03613233|QoL|qol
4640927|NCT03613233|quality of life|quality of life
4640928|NCT03613233|NEI VFQ 25|nei vfq 25
4640929|NCT03613220|advanced HR+ HER2 breast cancer|advanced hr+ her2 breast cancer
4640930|NCT03613220|breast cancer|breast cancer
4640931|NCT03613220|proteomic analysis|proteomic analysis
4640932|NCT03613220|protein expression|protein expression
4640933|NCT03613220|ctDNA Analysis|ctdna analysis
4640934|NCT03613220|adult|adult
4640935|NCT03613220|LEE011|lee011
4640936|NCT03613207|Dermal open flow microperfusion|dermal open flow microperfusion
4640937|NCT03613207|dOFM|dofm
4640938|NCT03613181|ANG1005|ang1005
4640939|NCT03613181|Leptomeningeal carcinomatosis|leptomeningeal carcinomatosis
4640940|NCT03613181|Leptomeningeal disease|leptomeningeal disease
4640941|NCT03613181|Leptomeningeal metastases|leptomeningeal metastases
4640942|NCT03613181|Brain metastases|brain metastases
4640943|NCT03613181|HER2-negative|her2-negative
4640944|NCT03613181|Breast cancer|breast cancer
4640945|NCT03613181|Targeted therapy|targeted therapy
4640946|NCT03613168|Cholangiocarcinoma|cholangiocarcinoma
4640947|NCT03613168|Biliary Tract Cancer|biliary tract cancer
4640948|NCT03613168|Trastuzumab|trastuzumab
4640949|NCT03613155|Emergency|emergency
4640950|NCT03613142|Double tract|double tract
4640951|NCT03613142|Esophagogastrostomy|esophagogastrostomy
4640952|NCT03613142|Gastric cancer|gastric cancer
4640953|NCT03613142|GastroEsophageal Cancer|gastroesophageal cancer
4640954|NCT03613129|myalgic encephalomyelitis|myalgic encephalomyelitis
4640955|NCT03613129|chronic fatigue syndrome|chronic fatigue syndrome
4640956|NCT03613129|corticotropin releasing-factor receptor subtype 2 (CRF2)|corticotropin releasing-factor receptor subtype 2 (crf2)
4640957|NCT03613129|corticotropin releasing-hormone receptor subtype 2 (CRH2)|corticotropin releasing-hormone receptor subtype 2 (crh2)
4640958|NCT03613116|vitamin D|vitamin d
4640959|NCT03613116|cognitive decline|cognitive decline
4640960|NCT03613103|video laryngoscopy|video laryngoscopy
4640961|NCT03613103|airway|airway
4640962|NCT03613103|injury|injury
4640963|NCT03613103|direct laryngoscopy|direct laryngoscopy
4640964|NCT03613103|intubation|intubation
4640965|NCT03613103|endotracheal|endotracheal
4640966|NCT03613077|Survival rate|survival rate
4640967|NCT03613077|Success rate|success rate
4640968|NCT03613077|Straumann® BLX Implant Roxolid® SLActive®,|straumann® blx implant roxolid® slactive®,
4640969|NCT03613038|Dysarthria|dysarthria
4640970|NCT03613038|Speech motor performance|speech motor performance
4640971|NCT03613038|Speech motor control|speech motor control
4640972|NCT03613038|Speech kinematics|speech kinematics
4640973|NCT03613012|Pain assessment|pain assessment
4640974|NCT03613012|electroencephalographic|electroencephalographic
4640975|NCT03613012|numerical rating scale|numerical rating scale
4640976|NCT03613012|pain index|pain index
4640977|NCT03612960|Tobacco|tobacco
4640978|NCT03612960|Nicotine|nicotine
4640979|NCT03612960|Smoking|smoking
4640980|NCT03612960|Functional magnetic resonance imaging|functional magnetic resonance imaging
4640981|NCT03612960|Addiction|addiction
4640982|NCT03612934|Breast Cancer|breast cancer
4640983|NCT03612934|palliative care|palliative care
4640984|NCT03612934|life quality|life quality
4640985|NCT03612934|performance status|performance status
4640986|NCT03612934|esas|esas
4640987|NCT03612921|oral amantadine|oral amantadine
4640988|NCT03612921|IV amantadine|iv amantadine
4640989|NCT03612921|tracheal intubation|tracheal intubation
4640990|NCT03612908|Hyperthyroidism|hyperthyroidism
4640991|NCT03612908|Polymorphism|polymorphism
4640992|NCT03612908|TSHβX1|tshβx1
4640993|NCT03612908|D2 THR92ALA|d2 thr92ala
4640994|NCT03612908|Hypothyroidism|hypothyroidism
4640995|NCT03612882|Sedentary Behaviour|sedentary behaviour
4640996|NCT03612882|Subjective Well-Being|subjective well-being
4640997|NCT03612882|University Students|university students
4640998|NCT03612869|MPS IIIA|mps iiia
4640999|NCT03612869|Sanfilippo syndrome Type A|sanfilippo syndrome type a
4641000|NCT03612869|Mucopolysaccharidosis Type IIIA|mucopolysaccharidosis type iiia
4641001|NCT03612869|Lysosomal Storage Disease|lysosomal storage disease
4641002|NCT03612856|Hemodialysis|hemodialysis
4641003|NCT03612843|dry needling|dry needling
4641004|NCT03612843|adverse event|adverse event
4641005|NCT03612843|physical therapy|physical therapy
4641006|NCT03612830|The Third Space|the third space
4641007|NCT03612817|tafluprost/timolol fixed combination, 24-hour IOP control|tafluprost/timolol fixed combination, 24-hour iop control
4641008|NCT03612804|smoking cessation|smoking cessation
4641009|NCT03612804|lung cancer screening|lung cancer screening
4641010|NCT03612804|telephone counseling|telephone counseling
4641011|NCT03612804|quitline|quitline
4641012|NCT03612778|nutrition|nutrition
4641013|NCT03612778|dyslipidemia|dyslipidemia
4641014|NCT03612778|insulin resistance|insulin resistance
4641015|NCT03612778|inflammation|inflammation
4641016|NCT03612765|heart failure|heart failure
4641017|NCT03612765|self-care|self-care
4641018|NCT03612765|behavio*|behavio*
4641019|NCT03612765|intervention|intervention
4641020|NCT03612765|randomized controlled trial|randomized controlled trial
4641021|NCT03612752|Chicken essence, cognitive function|chicken essence, cognitive function
4641022|NCT03612739|CAR-T Cells|car-t cells
4641024|NCT03612739|AML|aml
4641025|NCT03612739|Epigenetic drug therapy|epigenetic drug therapy
4641026|NCT03612700|Cyclopropane fatty acids|cyclopropane fatty acids
4641027|NCT03612700|GC-MS|gc-ms
4641028|NCT03612687|Hemodynamic Monitoring|hemodynamic monitoring
4641029|NCT03612687|Perioperative Fluid Management|perioperative fluid management
4641030|NCT03612687|Hepatobiliary and Pancreas Surgery|hepatobiliary and pancreas surgery
4641031|NCT03612674|Mass screening|mass screening
4641032|NCT03612674|Adenoma detection rate|adenoma detection rate
4641033|NCT03612674|ARC Endocuff Vision|arc endocuff vision
4641034|NCT03612674|Colonoscopy|colonoscopy
4641035|NCT03612661|disordered eating, body image, intuitive eating, undergraduates, college, unhealthy weight control behaviors, eating disorders, weight stigma, weight bias|disordered eating, body image, intuitive eating, undergraduates, college, unhealthy weight control behaviors, eating disorders, weight stigma, weight bias
4641036|NCT03612622|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
4641037|NCT03612622|Functional Magnetic Resonance Imaging|functional magnetic resonance imaging
4641038|NCT03612622|Alzheimer Disease|alzheimer disease
4641039|NCT03612609|Dengue virus|dengue virus
4641040|NCT03612609|Semen|semen
4641041|NCT03612596|wearable|wearable
4641042|NCT03612596|mobile app|mobile app
4641043|NCT03612596|physical activity|physical activity
4641044|NCT03612596|survivorship|survivorship
4641045|NCT03612596|narrative|narrative
4641046|NCT03612596|identity|identity
4641047|NCT03612583|Diaphragm Dysfunction|diaphragm dysfunction
4641048|NCT03612583|Acute Respiratory Failure|acute respiratory failure
4641049|NCT03612583|Sedation|sedation
4641050|NCT03612583|Mechanical Ventilation|mechanical ventilation
4641051|NCT03612583|Lung Stress|lung stress
4641052|NCT03612570|Nano-Pulse Stimulation|nano-pulse stimulation
4641053|NCT03612570|NPS|nps
4641054|NCT03612557|Benzathine benzylpenicillin, penicillin G benzathine|benzathine benzylpenicillin, penicillin g benzathine
4641055|NCT03612518|postpartum family planning|postpartum family planning
4641056|NCT03612518|RCT|rct
4641057|NCT03612518|mhealth|mhealth
4641058|NCT03612492|esmolol|esmolol
4641059|NCT03612492|lidocaine|lidocaine
4641060|NCT03612492|intubation|intubation
4641061|NCT03612492|hemodynamic response|hemodynamic response
4641062|NCT03612466|dosimetry|dosimetry
4641063|NCT03612466|radiopharmaceutical|radiopharmaceutical
4641064|NCT03612466|radiotherapy|radiotherapy
4641065|NCT03612466|Maximally tolerated dose|maximally tolerated dose
4641066|NCT03612466|MTD|mtd
4641067|NCT03612466|tumor|tumor
4641068|NCT03612466|myelosuppression|myelosuppression
4641069|NCT03612440|dexmedetomidine|dexmedetomidine
4641070|NCT03612440|oxygenation index|oxygenation index
4641071|NCT03612440|respiratory index|respiratory index
4641072|NCT03612440|inflammatory factors|inflammatory factors
4641073|NCT03612414|xerostomia|xerostomia
4641074|NCT03612414|pH|ph
4641075|NCT03612414|Carnosine|carnosine
4641076|NCT03612414|karkadé|karkadé
4641077|NCT03612414|Aqualief|aqualief
4641078|NCT03612414|Mucoadhesive|mucoadhesive
4641079|NCT03612401|Spinal cord injury|spinal cord injury
4641080|NCT03612401|SCI|sci
4641081|NCT03612401|Neurogenic bladder|neurogenic bladder
4641082|NCT03612401|Overactive bladder|overactive bladder
4641083|NCT03612401|anticholinergic|anticholinergic
4641084|NCT03612401|mirabegron|mirabegron
4641085|NCT03612401|cognitive|cognitive
4641086|NCT03612401|cognition|cognition
4641087|NCT03612401|NGB|ngb
4641088|NCT03612401|OAB|oab
4641089|NCT03612362|Acute Respiratory Infection, Household Air Pollution|acute respiratory infection, household air pollution
4641090|NCT03612349|cigarettes|cigarettes
4641091|NCT03612349|smoking|smoking
4641092|NCT03612297|Antimicrobial resistance|antimicrobial resistance
4641093|NCT03612297|Antimicrobial stewardship|antimicrobial stewardship
4641094|NCT03612297|Selective reporting antimicrobial susceptibility tests|selective reporting antimicrobial susceptibility tests
4641095|NCT03612297|Escherichia coli|escherichia coli
4641096|NCT03612284|Contact lens solution|contact lens solution
4641097|NCT03612271|Hypertension|hypertension
4641098|NCT03612271|mHealth|mhealth
4641099|NCT03612258|Fibromyalgia|fibromyalgia
4641100|NCT03612258|Pain|pain
4641101|NCT03612258|Neuroimaging|neuroimaging
4641102|NCT03612258|Sensory sensitivity|sensory sensitivity
4641103|NCT03612258|Fatigue|fatigue
4641104|NCT03612232|adrenal cancer|adrenal cancer
4641105|NCT03612232|adrenal cortex neoplasm|adrenal cortex neoplasm
4641106|NCT03612232|adrenal cortical carcinoma|adrenal cortical carcinoma
4641107|NCT03612232|cabozantinib|cabozantinib
4641108|NCT03612232|c-MET|c-met
4641109|NCT03612219|Nasopharyngeal Carcinoma|nasopharyngeal carcinoma
4641110|NCT03612219|Apatinib|apatinib
4641111|NCT03612219|Adjuvant treatment|adjuvant treatment
4641112|NCT03612219|Progression-free survival|progression-free survival
4641113|NCT03612141|Severe stroke|severe stroke
4641114|NCT03612141|Brain Death|brain death
4641115|NCT03612141|organ donation|organ donation
4641116|NCT03612128|cerebral palsy|cerebral palsy
4641117|NCT03612128|mirror therapy|mirror therapy
4641118|NCT03612128|cerebral re-organization|cerebral re-organization
4641119|NCT03612128|upper extremity|upper extremity
4641120|NCT03612128|daily life activities|daily life activities
4641121|NCT03612128|functional motor capacity|functional motor capacity
4641122|NCT03612128|motor functions|motor functions
4641123|NCT03612102|Selective Mutism|selective mutism
4641124|NCT03612102|Treatment|treatment
4641125|NCT03612102|Anxiety|anxiety
4641126|NCT03612102|Intensive Treatment|intensive treatment
4641127|NCT03612102|CBT|cbt
4641128|NCT03612102|Group Treatment|group treatment
4641129|NCT03612076|prosthetic joint infection|prosthetic joint infection
4641130|NCT03612050|Palliative care|palliative care
4641131|NCT03612050|Despair|despair
4641132|NCT03612050|Spiritual well-being|spiritual well-being
4641133|NCT03612037|pre-diabetes|pre-diabetes
4641134|NCT03612037|glucose|glucose
4641135|NCT03612037|insulin|insulin
4641136|NCT03612037|blood lipids|blood lipids
4641137|NCT03612037|alpha lipoic acid|alpha lipoic acid
4641138|NCT03612011|Hand Foot Syndrome Grade 2|hand foot syndrome grade 2
4641139|NCT03612011|Common Terminology Criteria for Adverse Events (CTCAE)|common terminology criteria for adverse events (ctcae)
4641140|NCT03612011|Oncology|oncology
4641141|NCT03612011|Repair Cream|repair cream
4641142|NCT03612011|Cutaneous events|cutaneous events
4641143|NCT03612011|Palmar-plantar erythrodysesthesia syndrome|palmar-plantar erythrodysesthesia syndrome
4641144|NCT03612011|Targeted Therapies or Conventional Chemotherapy|targeted therapies or conventional chemotherapy
4641145|NCT03611998|Sex trafficking|sex trafficking
4641146|NCT03611998|Occupational therapy|occupational therapy
4641147|NCT03611998|Occupation-based programming|occupation-based programming
4641148|NCT03611998|Activity-based programming|activity-based programming
4641149|NCT03611998|Brain trauma|brain trauma
4641150|NCT03611985|breast cancer|breast cancer
4641151|NCT03611985|Epidiferphane|epidiferphane
4641152|NCT03611985|taxane|taxane
4641153|NCT03611946|Zika virus|zika virus
4641154|NCT03611946|Vaccine|vaccine
4641155|NCT03611933|Back pain|back pain
4641156|NCT03611933|patient positioning|patient positioning
4641157|NCT03611933|vascular complications|vascular complications
4641158|NCT03611933|vital signs|vital signs
4641159|NCT03611894|RMI|rmi
4641160|NCT03611881|lung screening|lung screening
4641161|NCT03611855|Brain-Computer Interface|brain-computer interface
4641162|NCT03611855|Motor Rehabilitation|motor rehabilitation
4641163|NCT03611855|Electroencephalography|electroencephalography
4641164|NCT03611855|Magnetic Resonance Imaging|magnetic resonance imaging
4641165|NCT03611829|emotional eating|emotional eating
4641166|NCT03611803|Robotic-assisted gait training|robotic-assisted gait training
4641167|NCT03611803|SCI|sci
4641168|NCT03611803|Ambulatory activity|ambulatory activity
4641169|NCT03611738|Advanced NSCLC|advanced nsclc
4641170|NCT03611738|Advanced Non-small Cell Lung Cancer|advanced non-small cell lung cancer
4641171|NCT03611738|anaplastic lymphoma kinase (ALK)|anaplastic lymphoma kinase (alk)
4641172|NCT03611738|ALK-negative|alk-negative
4641173|NCT03611738|epidermal growth factor receptor (EGFR)|epidermal growth factor receptor (egfr)
4641174|NCT03611738|wild-type (WT)|wild-type (wt)
4641175|NCT03611725|Distal radial approach|distal radial approach
4641176|NCT03611725|ST Elevation Myocardial Infarction|st elevation myocardial infarction
4641177|NCT03611712|Cancer-related Fatigue|cancer-related fatigue
4641178|NCT03611712|Tumor response|tumor response
4641179|NCT03611712|Survival|survival
4641180|NCT03611712|Chemoradiation|chemoradiation
4641181|NCT03611712|esophageal cancer|esophageal cancer
4641182|NCT03611673|sense of smell|sense of smell
4641183|NCT03611673|smell test|smell test
4641184|NCT03611673|at-home smell test|at-home smell test
4641185|NCT03611673|essential oil|essential oil
4641186|NCT03611673|olfactory loss|olfactory loss
4641187|NCT03611660|pediatric obesity, stress|pediatric obesity, stress
4641188|NCT03611647|Microbiome|microbiome
4641189|NCT03611647|Probiotic|probiotic
4641190|NCT03611634|gut microbiote, bone and joint infection, antibiotics|gut microbiote, bone and joint infection, antibiotics
4641191|NCT03611595|13-cis-Retinoic Acid|13-cis-retinoic acid
4641192|NCT03611595|Children|children
4641193|NCT03611595|Relapsed Solid Tumors|relapsed solid tumors
4641194|NCT03611595|Refractory Solid Tumors|refractory solid tumors
4641195|NCT03611595|Solid Tumors|solid tumors
4641196|NCT03611595|cancer|cancer
4641197|NCT03611556|MEDI9447|medi9447
4641198|NCT03611556|oleclumab|oleclumab
4641199|NCT03611556|immunotherapy|immunotherapy
4641200|NCT03611556|pancreatic cancer|pancreatic cancer
4641201|NCT03611556|durvalumab|durvalumab
4641202|NCT03611543|Breast Cancer|breast cancer
4641203|NCT03611543|Tomosynthesis|tomosynthesis
4641204|NCT03611543|3D Mammogram|3d mammogram
4641205|NCT03611543|Diagnostic Mammogram|diagnostic mammogram
4641206|NCT03611517|Endometrial cancer|endometrial cancer
4641207|NCT03611517|Cervical cancer|cervical cancer
4641208|NCT03611517|Vaginal cancer|vaginal cancer
4641209|NCT03611517|sexuality|sexuality
4641210|NCT03611517|sexual problems|sexual problems
4641211|NCT03611517|dilator|dilator
4641212|NCT03611517|radiotherapy|radiotherapy
4641213|NCT03611517|gynaecological cancer|gynaecological cancer
4641214|NCT03611517|sexual rehabilitation programme|sexual rehabilitation programme
4641215|NCT03611504|Hemospray, Gastrointestinal bleeding, Gastrointestinal hemorrhage, Hemostatic powder|hemospray, gastrointestinal bleeding, gastrointestinal hemorrhage, hemostatic powder
4641216|NCT03611465|Sudden cardiac death|sudden cardiac death
4641217|NCT03611465|Electrophisiologic exploration|electrophisiologic exploration
4641218|NCT03611465|Myocardial infarction|myocardial infarction
4641219|NCT03611426|Serine protease|serine protease
4641220|NCT03611426|Tolerance|tolerance
4641221|NCT03611426|Immunogenicity|immunogenicity
4641222|NCT03611426|Safety|safety
4641223|NCT03611413|COLON PERFORATION SURGERY|colon perforation surgery
4641224|NCT03611400|Probiotic|probiotic
4641225|NCT03611400|Intestinal Permeability|intestinal permeability
4641226|NCT03611400|Leaky Gut|leaky gut
4641227|NCT03611387|Primary Angle-Closure Glaucoma|primary angle-closure glaucoma
4641228|NCT03611387|Artificial Intelligence|artificial intelligence
4641229|NCT03611361|peripheral arterial disease|peripheral arterial disease
4641230|NCT03611361|re-amputation|re-amputation
4641231|NCT03611361|optical imaging|optical imaging
4641232|NCT03611361|Computer Assisted Detection (CADe)|computer assisted detection (cade)
4641233|NCT03611348|acrofacal vitiligo, latanoprost, microneedling|acrofacal vitiligo, latanoprost, microneedling
4641234|NCT03611309|Pancreatic Cancer|pancreatic cancer
4641235|NCT03611309|Hepatocellular Cancer|hepatocellular cancer
4641236|NCT03611309|Esophageal Cancer|esophageal cancer
4641237|NCT03611309|Gastric Cancer|gastric cancer
4641238|NCT03611309|Cholangio carcinomas|cholangio carcinomas
4641239|NCT03611296|Cardiorespiratory fitness|cardiorespiratory fitness
4641240|NCT03611296|Inhibitory control|inhibitory control
4641241|NCT03611296|Motivation|motivation
4641242|NCT03611296|Food intake|food intake
4641243|NCT03611296|Body composition|body composition
4641244|NCT03611283|Xerostomia|xerostomia
4641245|NCT03611283|Sjögren's syndrome|sjögren's syndrome
4641246|NCT03611283|Topical dry mouth products|topical dry mouth products
4641247|NCT03611283|Olive Oil|olive oil
4641248|NCT03611283|Oral Health Impact Profile|oral health impact profile
4641249|NCT03611257|Bacteremia|bacteremia
4641250|NCT03611257|Optimal targeted antibiotics|optimal targeted antibiotics
4641251|NCT03611257|Antibiotic susceptibility test|antibiotic susceptibility test
4641252|NCT03611257|Antimicrobial stewardship|antimicrobial stewardship
4641253|NCT03611218|Hemodialysis|hemodialysis
4641254|NCT03611218|Hemodiafiltration|hemodiafiltration
4641255|NCT03611218|Renal replacement therapy|renal replacement therapy
4641256|NCT03611205|Oropharyngeal|oropharyngeal
4641257|NCT03611205|Squamous Cell Carcinoma|squamous cell carcinoma
4641258|NCT03611205|HPV|hpv
4641259|NCT03611192|Multicomponent Exercise|multicomponent exercise
4641260|NCT03611192|Executive Function|executive function
4641261|NCT03611192|Balance|balance
4641262|NCT03611192|Pre-frail|pre-frail
4641263|NCT03611179|advanced ovarian cancer|advanced ovarian cancer
4641264|NCT03611179|upfront treatment|upfront treatment
4641265|NCT03611179|bevacizumab|bevacizumab
4641266|NCT03611166|proteomics|proteomics
4641267|NCT03611166|plasma|plasma
4641268|NCT03611166|chronic disorder of consciousness|chronic disorder of consciousness
4641269|NCT03611153|Heart Failure|heart failure
4641270|NCT03611153|Ejection Fraction|ejection fraction
4641271|NCT03611153|Preserved|preserved
4641272|NCT03611153|Myeloperoxidase Inhibitor|myeloperoxidase inhibitor
4641273|NCT03611153|Exercise|exercise
4641274|NCT03611140|metabolic syndrome|metabolic syndrome
4641275|NCT03611140|gut microbiota|gut microbiota
4641276|NCT03611140|metabolic endotoxemia|metabolic endotoxemia
4641277|NCT03611140|functional foods|functional foods
4641278|NCT03611114|endothelial function|endothelial function
4641279|NCT03611114|flow mediated dilation|flow mediated dilation
4641280|NCT03611114|lipid profile|lipid profile
4641281|NCT03611114|blood pressure|blood pressure
4641282|NCT03611114|flavanones|flavanones
4641283|NCT03611114|Caucasian|caucasian
4641284|NCT03611088|Child Development|child development
4641285|NCT03611088|Kangaroo Mother Care Method|kangaroo mother care method
4641286|NCT03611088|Electromyography|electromyography
4641287|NCT03611088|Microcirculation|microcirculation
4641288|NCT03611088|Premature|premature
4641289|NCT03611062|children|children
4641290|NCT03611062|executive function|executive function
4641291|NCT03611062|virtual reality|virtual reality
4641292|NCT03611062|traumatic brain injury|traumatic brain injury
4641293|NCT03610971|CP-CML|cp-cml
4641294|NCT03610971|Chronic Myeloid Leukemia|chronic myeloid leukemia
4641295|NCT03610971|CML|cml
4641296|NCT03610971|combination therapy|combination therapy
4641297|NCT03610971|BCR-ABL oncogene|bcr-abl oncogene
4641298|NCT03610958|overweight|overweight
4641299|NCT03610958|obesity|obesity
4641300|NCT03610945|drug-drug interaction|drug-drug interaction
4641301|NCT03610919|multiple doses|multiple doses
4641302|NCT03610919|oxytocin|oxytocin
4641303|NCT03610919|genotype|genotype
4641304|NCT03610919|autism trait|autism trait
4641305|NCT03610906|Pilot Study|pilot study
4641306|NCT03610906|Biological Targets|biological targets
4641307|NCT03610906|CTNNB1|ctnnb1
4641308|NCT03610906|Tumor|tumor
4641309|NCT03610893|nerve block adjuvants|nerve block adjuvants
4641310|NCT03610893|dexamethasone|dexamethasone
4641311|NCT03610893|dexmedetomidine|dexmedetomidine
4641312|NCT03610893|nerve block duration|nerve block duration
4641313|NCT03610880|healthy Chinese volunteers|healthy chinese volunteers
4641314|NCT03610880|TG-2349|tg-2349
4641315|NCT03610880|DAG181|dag181
4641316|NCT03610880|pharmacokinetics|pharmacokinetics
4641317|NCT03610880|safety|safety
4641318|NCT03610880|multiple ascending oral doses|multiple ascending oral doses
4641319|NCT03610867|safety|safety
4641320|NCT03610867|tolerability|tolerability
4641321|NCT03610867|PK|pk
4641322|NCT03610867|single ascending oral dose|single ascending oral dose
4641323|NCT03610867|multiple ascending oral doses|multiple ascending oral doses
4641324|NCT03610828|Vegetarian Diet|vegetarian diet
4641325|NCT03610828|Vegan Diet|vegan diet
4641326|NCT03610828|Systematic Reviews and Meta-Analysis|systematic reviews and meta-analysis
4641327|NCT03610828|Clinical practice guidelines|clinical practice guidelines
4641328|NCT03610828|Prospective cohort studies|prospective cohort studies
4641329|NCT03610828|Cardiovascular disease|cardiovascular disease
4641330|NCT03610828|Coronary heart disease|coronary heart disease
4641331|NCT03610828|Stroke|stroke
4641332|NCT03610828|Cardiovascular mortality|cardiovascular mortality
4641333|NCT03610828|Coronary heart disease mortality|coronary heart disease mortality
4641334|NCT03610828|Stroke mortality|stroke mortality
4641335|NCT03610815|Alcohol|alcohol
4641336|NCT03610815|SBIRT|sbirt
4641337|NCT03610815|Mobile Technology|mobile technology
4641338|NCT03610815|Implementation Science|implementation science
4641339|NCT03610815|Dissemination Research|dissemination research
4641340|NCT03610815|Hybrid Effectiveness-Implementation Design|hybrid effectiveness-implementation design
4641341|NCT03610802|Immunophenotyping|immunophenotyping
4641342|NCT03610802|Functional Assays|functional assays
4641343|NCT03610802|Repository|repository
4641344|NCT03610802|HLA-Typing|hla-typing
4641345|NCT03610802|Next Generation Sequencing|next generation sequencing
4641346|NCT03610776|Portion control plate|portion control plate
4641347|NCT03610776|Visual attention|visual attention
4641348|NCT03610776|Eating rate|eating rate
4641349|NCT03610776|Cephalic satiety response|cephalic satiety response
4641350|NCT03610763|Rehabilitation Neuroscience|rehabilitation neuroscience
4641351|NCT03610763|Transcranial Direct Current Stimulation|transcranial direct current stimulation
4641352|NCT03610763|Rehabilitation Therapy|rehabilitation therapy
4641353|NCT03610763|Neuroplasticity|neuroplasticity
4641354|NCT03610763|Transplantation|transplantation
4641355|NCT03610763|Hand Therapy|hand therapy
4641356|NCT03610763|Constraint Induced Movement Therapy|constraint induced movement therapy
4641357|NCT03610763|Peripheral Nerve Injuries|peripheral nerve injuries
4641358|NCT03610763|tDCS|tdcs
4641359|NCT03610763|CIMT|cimt
4641360|NCT03610750|Community Mental Health Care|community mental health care
4641361|NCT03610750|Task-shifting|task-shifting
4641362|NCT03610724|Tisagenlecleucel|tisagenlecleucel
4641363|NCT03610724|relapsed/refractory B-cell non-Hodgkin lymphoma|relapsed/refractory b-cell non-hodgkin lymphoma
4641364|NCT03610724|pediatric patients|pediatric patients
4641365|NCT03610724|Burkitt's lymphoma (BL)|burkitt's lymphoma (bl)
4641366|NCT03610724|diffuse large B-cell lymphoma (DLBCL)|diffuse large b-cell lymphoma (dlbcl)
4641367|NCT03610724|primary mediastinal large B-cell lymphoma (PMBCL)|primary mediastinal large b-cell lymphoma (pmbcl)
4641368|NCT03610724|gray zone lymphoma (GZL)|gray zone lymphoma (gzl)
4641369|NCT03610724|follicular lymphoma (FL)|follicular lymphoma (fl)
4641370|NCT03610724|leukapheresis|leukapheresis
4641371|NCT03610724|lymphodepleting chemotherapy (LD)|lymphodepleting chemotherapy (ld)
4641372|NCT03610724|NHL|nhl
4641373|NCT03610698|caregiving|caregiving
4641374|NCT03610698|psychological well-being|psychological well-being
4641375|NCT03610698|alzheimer's|alzheimer's
4641376|NCT03610698|positive emotion|positive emotion
4641377|NCT03610685|Severe asthma|severe asthma
4641378|NCT03610685|Mepolizumab|mepolizumab
4641379|NCT03610685|IL5|il5
4641380|NCT03610685|Steroid resistance|steroid resistance
4641381|NCT03610685|Eosinophilic asthma|eosinophilic asthma
4641382|NCT03610685|Type 2 inflammation|type 2 inflammation
4641383|NCT03610659|COPD|copd
4641384|NCT03610659|Burden of disease|burden of disease
4641385|NCT03610646|Diabetic Macular Edema,|diabetic macular edema,
4641386|NCT03610646|BCVA,|bcva,
4641387|NCT03610646|ETDRS Letters.|etdrs letters.
4641388|NCT03610620|Basal cell carcinoma|basal cell carcinoma
4641389|NCT03610620|Mohs surgery|mohs surgery
4641390|NCT03610620|Vivascope 2500 ex-vivo fluorescent confocal microscope|vivascope 2500 ex-vivo fluorescent confocal microscope
4641391|NCT03610620|Frozen section Mohs histology|frozen section mohs histology
4641392|NCT03610568|Gender Norms|gender norms
4641393|NCT03610568|Gender-Based Violence|gender-based violence
4641394|NCT03610568|Mental Health|mental health
4641395|NCT03610568|Sexual & Reproductive Health|sexual & reproductive health
4641396|NCT03610568|Adolescent Health|adolescent health
4641397|NCT03610542|Test Anxiety|test anxiety
4641398|NCT03610542|Wellbeing|wellbeing
4641399|NCT03610529|ECG Monitoring|ecg monitoring
4641400|NCT03610529|Controlled|controlled
4641401|NCT03610529|Comparative|comparative
4641402|NCT03610529|Clinical trial|clinical trial
4641403|NCT03610516|anti-CD40|anti-cd40
4641404|NCT03610516|CFZ533|cfz533
4641405|NCT03610516|moderately active lupus nephritis|moderately active lupus nephritis
4641406|NCT03610477|Microbiome|microbiome
4641407|NCT03610451|Anorexia nervosa|anorexia nervosa
4641408|NCT03610451|Floatation therapy|floatation therapy
4641409|NCT03610438|Acute Lymphoid Leukemia|acute lymphoid leukemia
4641410|NCT03610438|Inotuzumab Ozogamicin|inotuzumab ozogamicin
4641411|NCT03610412|Diabetes Mellitus Type 2|diabetes mellitus type 2
4641412|NCT03610412|IGF1|igf1
4641413|NCT03610412|Cinnamomum cassia|cinnamomum cassia
4641414|NCT03610412|Metabolic control|metabolic control
4641415|NCT03610412|Metformin|metformin
4641416|NCT03610399|treatment response|treatment response
4641417|NCT03610399|efficacy|efficacy
4641418|NCT03610399|primaquine|primaquine
4641419|NCT03610399|chloroquine|chloroquine
4641420|NCT03610386|Atopic|atopic
4641421|NCT03610386|Dermatitis|dermatitis
4641422|NCT03610386|TRPM8|trpm8
4641423|NCT03610386|menthol|menthol
4641424|NCT03610373|anxiety|anxiety
4641425|NCT03610373|depression|depression
4641426|NCT03610373|childhood|childhood
4641427|NCT03610373|therapy|therapy
4641428|NCT03610373|treatment|treatment
4641429|NCT03610373|medical decision making|medical decision making
4641430|NCT03610360|DENIM|denim
4641431|NCT03610334|First-In-Human|first-in-human
4641432|NCT03610295|congenital cataract|congenital cataract
4641433|NCT03610295|prophylactic peripheral iridectomy|prophylactic peripheral iridectomy
4641434|NCT03610295|aphakic angle-closure glaucoma|aphakic angle-closure glaucoma
4641435|NCT03610295|aphakic open-angle glaucoma|aphakic open-angle glaucoma
4641436|NCT03610295|iris posterior synechia|iris posterior synechia
4641437|NCT03610295|visual axis opacity|visual axis opacity
4641438|NCT03610282|Propofol|propofol
4641439|NCT03610282|Methylphenidate|methylphenidate
4641440|NCT03610282|Ritalin|ritalin
4641441|NCT03610282|Anesthetics|anesthetics
4641442|NCT03610282|Anesthetics, Intravenous|anesthetics, intravenous
4641443|NCT03610282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
4641444|NCT03610282|Anesthetics, General|anesthetics, general
4641445|NCT03610282|Neurotransmitter Agents|neurotransmitter agents
4641446|NCT03610282|Physiological Effects of Drugs|physiological effects of drugs
4641447|NCT03610256|Obesity|obesity
4641448|NCT03610256|Bariatric surgery|bariatric surgery
4641449|NCT03610256|Single-anastomosis duodeno ileal bypass (SADI)|single-anastomosis duodeno ileal bypass (sadi)
4641450|NCT03610256|Roux-en-Y Gastric Bypass|roux-en-y gastric bypass
4641451|NCT03610204|Alternative therapy|alternative therapy
4641452|NCT03610204|Massage|massage
4641453|NCT03610204|Manual therapy|manual therapy
4641454|NCT03610204|Myofascial|myofascial
4641455|NCT03610191|biomarkers|biomarkers
4641456|NCT03610191|MD2|md2
4641457|NCT03610191|Cystatin C|cystatin c
4641458|NCT03610191|DNA methylation markers|dna methylation markers
4641459|NCT03610139|cognitive performance|cognitive performance
4641460|NCT03610139|vitamin D3 replacement|vitamin d3 replacement
4641461|NCT03610139|Lebanon|lebanon
4641462|NCT03610126|BASKA mask|baska mask
4641463|NCT03610126|controlled ventilation|controlled ventilation
4641464|NCT03610113|Conservative treatment|conservative treatment
4641465|NCT03610113|Reverse shoulder arthroplasty|reverse shoulder arthroplasty
4641466|NCT03610113|Proximal humeral fractures|proximal humeral fractures
4641467|NCT03610100|Pancreatic|pancreatic
4641468|NCT03610100|Neoplasms|neoplasms
4641469|NCT03610100|Metastatic|metastatic
4641470|NCT03610100|Gemcitabine|gemcitabine
4641471|NCT03610100|Gemzar|gemzar
4641472|NCT03610100|Phosphoramidate|phosphoramidate
4641473|NCT03610100|Cytidine Aminohydrolase|cytidine aminohydrolase
4641474|NCT03610100|Deoxycytidine Kinase|deoxycytidine kinase
4641475|NCT03610100|Nucleoside Transport Proteins|nucleoside transport proteins
4641476|NCT03610100|hENT1 protein, human|hent1 protein, human
4641477|NCT03610074|thirst|thirst
4641478|NCT03610074|mouth|mouth
4641479|NCT03610074|critical care|critical care
4641480|NCT03610074|water deprivation|water deprivation
4641481|NCT03610048|Alkermes|alkermes
4641482|NCT03610048|Major depressive disorder|major depressive disorder
4641483|NCT03610048|Depression|depression
4641484|NCT03610048|ALKS 5461|alks 5461
4641485|NCT03610022|Vismodegib|vismodegib
4641486|NCT03610022|Pharmacokinetic|pharmacokinetic
4641487|NCT03610022|LC-MS/MS-MRM|lc-ms/ms-mrm
4641488|NCT03610022|Human plasma concentrations|human plasma concentrations
4641489|NCT03610022|Adverse events|adverse events
4641490|NCT03609970|Vitamin D|vitamin d
4641491|NCT03609970|UVR|uvr
4641492|NCT03609970|Immune system|immune system
4641493|NCT03609944|ERCP|ercp
4641494|NCT03609944|Endoscopic retrograde cholangiopancreatography|endoscopic retrograde cholangiopancreatography
4641495|NCT03609931|Mitral Valve|mitral valve
4641496|NCT03609918|Chinese NSCLC|chinese nsclc
4641497|NCT03609918|next-generation sequencing|next-generation sequencing
4641498|NCT03609905|ulcerative colitis (UC)|ulcerative colitis (uc)
4641499|NCT03609905|mesenchymal stem cells(MSC)|mesenchymal stem cells(msc)
4641500|NCT03609879|cervical collar|cervical collar
4641501|NCT03609879|sonography|sonography
4641502|NCT03609879|adult patients|adult patients
4641503|NCT03609879|Optic nerve sheath diameter|optic nerve sheath diameter
4641504|NCT03609879|Ultrasonography|ultrasonography
4641505|NCT03609866|intracranial pressure increase|intracranial pressure increase
4641506|NCT03609866|chest physiotherapy|chest physiotherapy
4641507|NCT03609866|ventilated patients|ventilated patients
4641508|NCT03609840|Thiotepa|thiotepa
4641509|NCT03609840|TEPA|tepa
4641510|NCT03609840|Pediatric|pediatric
4641511|NCT03609840|Hematopoietic|hematopoietic
4641512|NCT03609840|Transplant|transplant
4641513|NCT03609827|Melphalan|melphalan
4641514|NCT03609827|Pharmacokinetics|pharmacokinetics
4641515|NCT03609827|Pediatric|pediatric
4641516|NCT03609827|Allogeneic|allogeneic
4641517|NCT03609814|fludarabine|fludarabine
4641518|NCT03609814|clofarabine|clofarabine
4641519|NCT03609814|pharmacokinetics|pharmacokinetics
4641520|NCT03609814|pediatric|pediatric
4641521|NCT03609814|allogeneic|allogeneic
4641522|NCT03609788|pain sensitivity|pain sensitivity
4641523|NCT03609762|Musculoskeletal Problems|musculoskeletal problems
4641524|NCT03609762|Health-Related Quality of Life|health-related quality of life
4641525|NCT03609762|Routine Measurement|routine measurement
4641526|NCT03609762|Randomized Controlled Trial|randomized controlled trial
4641527|NCT03609762|Clinical Outcomes|clinical outcomes
4641528|NCT03609710|Low rectal cancer|low rectal cancer
4641529|NCT03609710|Robotic surgery|robotic surgery
4641530|NCT03609710|Anastomotic leak|anastomotic leak
4641531|NCT03609697|Diabetes prevention|diabetes prevention
4641532|NCT03609697|Pre-diabetes|pre-diabetes
4641533|NCT03609697|Weight loss|weight loss
4641534|NCT03609697|Cardio-metabolic risks|cardio-metabolic risks
4641535|NCT03609697|Obesity|obesity
4641536|NCT03609697|Lifestyle intervention|lifestyle intervention
4641537|NCT03609697|Community-based|community-based
4641538|NCT03609684|core stabilization|core stabilization
4641539|NCT03609684|endurance|endurance
4641540|NCT03609684|gymnastics|gymnastics
4641541|NCT03609684|children|children
4641542|NCT03609671|Breast Cancer|breast cancer
4641543|NCT03609671|Emotions Immunology|emotions immunology
4641544|NCT03609658|Vulnerable Older Adults|vulnerable older adults
4641545|NCT03609658|Nurse Navigator|nurse navigator
4641546|NCT03609658|Usual Care|usual care
4641547|NCT03609658|Family|family
4641548|NCT03609658|Multimorbid patients|multimorbid patients
4641549|NCT03609645|Fascia Iliaca Block|fascia iliaca block
4641550|NCT03609645|Femoral and Obturator Articular Branch Block|femoral and obturator articular branch block
4641551|NCT03609632|Roux-en-Y gastric bypass (RYGB)|roux-en-y gastric bypass (rygb)
4641552|NCT03609632|Hypoglycaemia|hypoglycaemia
4641553|NCT03609632|Insulin|insulin
4641554|NCT03609632|Glucose|glucose
4641555|NCT03609632|Incretins|incretins
4641556|NCT03609632|Stable isotope|stable isotope
4641557|NCT03609606|Dyslipidemia|dyslipidemia
4641558|NCT03609606|Hypertension|hypertension
4641559|NCT03609606|CKD-386|ckd-386
4641560|NCT03609606|Drug-Drug Interaction|drug-drug interaction
4641561|NCT03609593|Chronic Lymphocytic Leukemia (CLL)|chronic lymphocytic leukemia (cll)
4641562|NCT03609593|Leukemia|leukemia
4641563|NCT03609593|Bendamustine|bendamustine
4641564|NCT03609593|Rituximab|rituximab
4641565|NCT03609593|Venetoclax|venetoclax
4641566|NCT03609580|post operative urinary retention|post operative urinary retention
4641567|NCT03609580|inability to urinate|inability to urinate
4641568|NCT03609580|urinary retentions|urinary retentions
4641569|NCT03609580|lung cancer|lung cancer
4641570|NCT03609580|VATs|vats
4641571|NCT03609580|Robotic Lung Surgery|robotic lung surgery
4641572|NCT03609580|lung resections|lung resections
4641573|NCT03609554|trunk flexor endurance|trunk flexor endurance
4641574|NCT03609554|trunk extensor endurance|trunk extensor endurance
4641575|NCT03609554|hamstring extensibility|hamstring extensibility
4641576|NCT03609502|sleep|sleep
4641577|NCT03609502|memory consolidation|memory consolidation
4641578|NCT03609502|speech perception|speech perception
4641579|NCT03609489|Biliary cancer|biliary cancer
4641580|NCT03609489|adjuvant therapy|adjuvant therapy
4641581|NCT03609489|apatinib|apatinib
4641582|NCT03609489|capecitabine|capecitabine
4641583|NCT03609463|diabetes|diabetes
4641584|NCT03609463|overweight|overweight
4641585|NCT03609463|obesity|obesity
4641586|NCT03609463|well-being|well-being
4641587|NCT03609463|behavioral|behavioral
4641588|NCT03609463|small change|small change
4641589|NCT03609463|weight loss|weight loss
4641590|NCT03609437|Embolic stroke|embolic stroke
4641591|NCT03609437|Arterial stiffness|arterial stiffness
4641592|NCT03609437|Endothelial function|endothelial function
4641593|NCT03609437|Endothelial glycocalyx|endothelial glycocalyx
4641594|NCT03609437|Left ventricular function|left ventricular function
4641595|NCT03609437|Oxidative stress|oxidative stress
4641596|NCT03609385|stroke|stroke
4641597|NCT03609385|troponin|troponin
4641598|NCT03609385|acute coronary syndrome|acute coronary syndrome
4641599|NCT03609385|culprit lesion|culprit lesion
4641600|NCT03609372|HPV|hpv
4641601|NCT03609372|Vaccination|vaccination
4641602|NCT03609372|Practice Based Research|practice based research
4641603|NCT03609359|lenvatinib, pembrolizumab, phase II, gastric cancer|lenvatinib, pembrolizumab, phase ii, gastric cancer
4641604|NCT03609346|STEMI|stemi
4641605|NCT03609320|HPV|hpv
4641606|NCT03609320|Vaccination|vaccination
4641607|NCT03609320|Practice Based Intervention|practice based intervention
4641608|NCT03609294|Fimasartan|fimasartan
4641609|NCT03609294|Linagliptin|linagliptin
4641610|NCT03609268|Recurrent Hepatocellular Carcinoma|recurrent hepatocellular carcinoma
4641611|NCT03609268|Microwave ablation|microwave ablation
4641612|NCT03609268|Stereotactic body radiotherapy|stereotactic body radiotherapy
4641613|NCT03609268|Small liver cancer|small liver cancer
4641614|NCT03609242|HPV|hpv
4641615|NCT03609242|Vaccination|vaccination
4641616|NCT03609242|Practice Based Intervention|practice based intervention
4641617|NCT03609177|Cancer Care|cancer care
4641618|NCT03609164|arthroscopic surgery|arthroscopic surgery
4641619|NCT03609164|massive rotator cuff repair|massive rotator cuff repair
4641620|NCT03609164|single-row repair|single-row repair
4641621|NCT03609164|suture-spanning augmentation|suture-spanning augmentation
4641622|NCT03609151|Hepatocellular carcinoma|hepatocellular carcinoma
4641623|NCT03609151|Early-stage liver cancer|early-stage liver cancer
4641624|NCT03609151|Hepatectomy|hepatectomy
4641625|NCT03609151|Stereotactic body radiotherapy|stereotactic body radiotherapy
4641626|NCT03609125|cord blood|cord blood
4641627|NCT03609125|neuroprotection|neuroprotection
4641628|NCT03609125|growth factors|growth factors
4641629|NCT03609073|endoscopy|endoscopy
4641630|NCT03609073|mini invasive|mini invasive
4641631|NCT03609060|Elderly patients|elderly patients
4641632|NCT03609047|Breast cancer|breast cancer
4641633|NCT03609047|elderly patients|elderly patients
4641634|NCT03609047|CDK4/6 inhibitor|cdk4/6 inhibitor
4641635|NCT03608995|preterm labor|preterm labor
4641636|NCT03608995|biomarkers|biomarkers
4641637|NCT03608995|Preterm delivery threat|preterm delivery threat
4641638|NCT03608982|First aid|first aid
4641639|NCT03608982|Simulated patient|simulated patient
4641640|NCT03608982|Laypeople|laypeople
4641641|NCT03608969|Cerebral palsy|cerebral palsy
4641642|NCT03608969|Orofacial dysfunction|orofacial dysfunction
4641643|NCT03608969|Oral Health|oral health
4641644|NCT03608969|Quality of Life|quality of life
4641645|NCT03608956|regional oximetry|regional oximetry
4641646|NCT03608956|cerebral oximetry|cerebral oximetry
4641647|NCT03608943|glucocorticoids|glucocorticoids
4641648|NCT03608943|prednisolone|prednisolone
4641649|NCT03608943|hydrocortisone|hydrocortisone
4641650|NCT03608917|Vitiligo|vitiligo
4641651|NCT03608917|Total Glucosides of Paeony(TGP)|total glucosides of paeony(tgp)
4641652|NCT03608917|narrow-band ultraviolet B (NB-UVB)|narrow-band ultraviolet b (nb-uvb)
4641653|NCT03608904|Stroke|stroke
4641654|NCT03608904|Music|music
4641655|NCT03608904|Ischemic Stroke|ischemic stroke
4641656|NCT03608904|fMRI|fmri
4641657|NCT03608904|functional MRI|functional mri
4641658|NCT03608839|Diabetic macular edema|diabetic macular edema
4641659|NCT03608839|Intravitreal dexamethasone solution|intravitreal dexamethasone solution
4641660|NCT03608839|Short term treament|short term treament
4641661|NCT03608813|Metabolomics|metabolomics
4641662|NCT03608787|Alcohol Intoxication|alcohol intoxication
4641663|NCT03608787|Alcohol Overservice|alcohol overservice
4641664|NCT03608787|Prevention|prevention
4641665|NCT03608787|Alcohol Serving Establishments|alcohol serving establishments
4641666|NCT03608774|Azithromycin|azithromycin
4641667|NCT03608774|Doxycycline|doxycycline
4641668|NCT03608774|MSM|msm
4641669|NCT03608774|Phase 4|phase 4
4641670|NCT03608774|Rectal Chlamydia|rectal chlamydia
4641671|NCT03608761|dry eye|dry eye
4641672|NCT03608761|Sjögren syndrome|sjögren syndrome
4641673|NCT03608761|Rebamipida 2%|rebamipida 2%
4641674|NCT03608761|autologous serum|autologous serum
4641675|NCT03608748|Nafld Score|nafld score
4641676|NCT03608748|Elastography|elastography
4641677|NCT03608709|Accidental falls|accidental falls
4641678|NCT03608709|Prediction model|prediction model
4641679|NCT03608696|buprenorphine|buprenorphine
4641680|NCT03608696|pharmacometrics|pharmacometrics
4641681|NCT03608657|Psoriatic Arthritis|psoriatic arthritis
4641682|NCT03608657|Canada|canada
4641683|NCT03608657|CC-10004|cc-10004
4641684|NCT03608657|Apremilast|apremilast
4641685|NCT03608657|APPRAISE|appraise
4641686|NCT03608657|Safety|safety
4641687|NCT03608657|Non-interventional|non-interventional
4641688|NCT03608657|Observation|observation
4641689|NCT03608657|DMARDs|dmards
4641690|NCT03608618|platinum resistant|platinum resistant
4641691|NCT03608618|high grade serous adenocarcinoma|high grade serous adenocarcinoma
4641692|NCT03608618|recurrence after chemotherapy|recurrence after chemotherapy
4641693|NCT03608618|intraperitoneal|intraperitoneal
4641694|NCT03608592|acuter respiratory distress syndrome|acuter respiratory distress syndrome
4641695|NCT03608592|mesenchymal stem cells|mesenchymal stem cells
4641696|NCT03608566|severe asthma|severe asthma
4641697|NCT03608553|MRgFUS|mrgfus
4641698|NCT03608553|BBB|bbb
4641699|NCT03608553|Blood Brain Barrier Disruption|blood brain barrier disruption
4641700|NCT03608527|Upper limb motor rehabilitation|upper limb motor rehabilitation
4641701|NCT03608527|Voluntary movements|voluntary movements
4641702|NCT03608527|functional magnetic resonance imaging|functional magnetic resonance imaging
4641703|NCT03608501|Drug therapy|drug therapy
4641704|NCT03608488|balance|balance
4641705|NCT03608488|vitamin D|vitamin d
4641706|NCT03608488|exercise|exercise
4641707|NCT03608488|fall risk|fall risk
4641708|NCT03608462|first episode schizophrenia|first episode schizophrenia
4641709|NCT03608462|rTMS|rtms
4641710|NCT03608462|hippocampal neurogenesis|hippocampal neurogenesis
4641711|NCT03608462|MRS|mrs
4641712|NCT03608462|cognitive function|cognitive function
4641713|NCT03608436|Quality of recovery|quality of recovery
4641714|NCT03608436|Laparoscopic surgery|laparoscopic surgery
4641715|NCT03608436|Deep neuromuscular block|deep neuromuscular block
4641716|NCT03608436|Low pressure pneumoperitoneum|low pressure pneumoperitoneum
4641717|NCT03608423|Intracerebral Hemorrhage|intracerebral hemorrhage
4641718|NCT03608423|Surgical Procedures, Minimally Invasive|surgical procedures, minimally invasive
4641719|NCT03608423|Surgical Procedures, Endoscopic|surgical procedures, endoscopic
4641720|NCT03608410|Patient reported outcomes|patient reported outcomes
4641721|NCT03608410|Internet|internet
4641722|NCT03608410|TelePRO|telepro
4641723|NCT03608397|DAXI|daxi
4641724|NCT03608397|Cervical Dystonia|cervical dystonia
4641725|NCT03608397|TWSTRS|twstrs
4641726|NCT03608397|Toxin|toxin
4641727|NCT03608358|DPP-4 inhibitor|dpp-4 inhibitor
4641728|NCT03608358|HbA1c|hba1c
4641729|NCT03608358|Incretin|incretin
4641730|NCT03608358|Dapagliflozin|dapagliflozin
4641731|NCT03608345|oral health|oral health
4641732|NCT03608345|dental plaque|dental plaque
4641733|NCT03608345|space maintenance|space maintenance
4641734|NCT03608306|Clinical Performance|clinical performance
4641735|NCT03608306|Bioactive Restorative Material|bioactive restorative material
4641736|NCT03608306|Glass Hybrid Restorative|glass hybrid restorative
4641737|NCT03608280|orbital reconstruction|orbital reconstruction
4641738|NCT03608280|3D-printed patient specific porous titanium implant|3d-printed patient specific porous titanium implant
4641739|NCT03608280|autologous bone graft|autologous bone graft
4641740|NCT03608280|medico-economic study|medico-economic study
4641741|NCT03608267|endoscopy|endoscopy
4641742|NCT03608267|mini invasive|mini invasive
4641743|NCT03608241|female|female
4641744|NCT03608241|post-menopausal|post-menopausal
4641745|NCT03608241|healthy|healthy
4641746|NCT03608241|oral contraceptive|oral contraceptive
4641747|NCT03608215|Dysmenorrhea|dysmenorrhea
4641748|NCT03608215|Neuromodulation|neuromodulation
4641749|NCT03608215|Transcranial direct current stimulation|transcranial direct current stimulation
4641750|NCT03608215|Neuroplasticity|neuroplasticity
4641751|NCT03608215|Neuroimaging|neuroimaging
4641752|NCT03608202|Intensive Care|intensive care
4641753|NCT03608202|Point-of-Care Ultrasound|point-of-care ultrasound
4641754|NCT03608202|Thoracic Ultrasound|thoracic ultrasound
4641755|NCT03608202|Diagnostic Techniques and procedures.|diagnostic techniques and procedures.
4641756|NCT03608189|Osteoarthritis|osteoarthritis
4641757|NCT03608189|ACL injury|acl injury
4641758|NCT03608189|Knee trauma|knee trauma
4641759|NCT03608189|Meniscus tear|meniscus tear
4641760|NCT03608176|Obesity|obesity
4641761|NCT03608176|Randomized Controlled Trial|randomized controlled trial
4641762|NCT03608176|Lifestyle Intervention|lifestyle intervention
4641763|NCT03608176|Plants|plants
4641764|NCT03608176|Water|water
4641765|NCT03608176|Weight loss|weight loss
4641766|NCT03608176|Diet|diet
4641767|NCT03608163|diabetes|diabetes
4641768|NCT03608163|hypoglycemia|hypoglycemia
4641769|NCT03608163|diazoxide|diazoxide
4641770|NCT03608163|naloxone|naloxone
4641771|NCT03608163|healthy subjects|healthy subjects
4641772|NCT03608163|low blood sugar|low blood sugar
4641773|NCT03608137|Schizophrenia ; Cannabis|schizophrenia ; cannabis
4641774|NCT03608098|Basketing|basketing
4641775|NCT03608098|Dusting|dusting
4641776|NCT03608098|Holmium Laser|holmium laser
4641777|NCT03608098|Laser Lithotripsy|laser lithotripsy
4641778|NCT03608098|Intracorporeal Lithotripsy|intracorporeal lithotripsy
4641779|NCT03608098|Urolithiasis|urolithiasis
4641780|NCT03608059|ATG|atg
4641781|NCT03608059|PTCy|ptcy
4641782|NCT03608059|haplo-PBSCT|haplo-pbsct
4641783|NCT03608059|GVHD|gvhd
4641784|NCT03608007|ROS1 NSCLC|ros1 nsclc
4641785|NCT03608007|X-396|x-396
4641786|NCT03607994|Neurotechnology|neurotechnology
4641787|NCT03607994|Autonomic Dysregulation|autonomic dysregulation
4641788|NCT03607994|Hyperarousal|hyperarousal
4641789|NCT03607994|Brain Electrical Activity|brain electrical activity
4641790|NCT03607994|Closed-loop|closed-loop
4641791|NCT03607994|Acoustic Stimulation|acoustic stimulation
4641792|NCT03607994|Allostasis|allostasis
4641793|NCT03607994|Insomnia|insomnia
4641794|NCT03607994|HIRREM-SOP|hirrem-sop
4641795|NCT03607994|Sleep Deprivation|sleep deprivation
4641796|NCT03607968|Pelvic organ prolapse|pelvic organ prolapse
4641797|NCT03607968|Transvaginal mesh|transvaginal mesh
4641798|NCT03607968|Urodynamic stress incontinence|urodynamic stress incontinence
4641799|NCT03607929|ARE|are
4641800|NCT03607929|deshydration|deshydration
4641801|NCT03607929|adverse events|adverse events
4641802|NCT03607929|cesarean|cesarean
4641803|NCT03607929|fever|fever
4641804|NCT03607916|Scheduled cesarean delivery,spinal anesthesia,local anesthesia|scheduled cesarean delivery,spinal anesthesia,local anesthesia
4641805|NCT03607903|intradermal|intradermal
4641806|NCT03607903|adalimumab|adalimumab
4641807|NCT03607903|microneedle|microneedle
4641808|NCT03607903|subcutaneous|subcutaneous
4641809|NCT03607903|healthy volunteers|healthy volunteers
4641810|NCT03607890|Relatlimab|relatlimab
4641811|NCT03607890|Nivolumab|nivolumab
4641812|NCT03607890|Immunotherapy|immunotherapy
4641813|NCT03607890|Anti - PD-1|anti - pd-1
4641814|NCT03607890|Anti - LAG-3|anti - lag-3
4641815|NCT03607890|Antibodies|antibodies
4641816|NCT03607890|MSI|msi
4641817|NCT03607890|MMR deficient|mmr deficient
4641818|NCT03607890|Microsatellite instability|microsatellite instability
4641819|NCT03607877|Positive education|positive education
4641820|NCT03607877|Walking exercise|walking exercise
4641821|NCT03607877|Well-being|well-being
4641822|NCT03607877|Pedometer|pedometer
4641823|NCT03607877|Cardiovascular fitness|cardiovascular fitness
4641824|NCT03607838|Lumbar disc herniation|lumbar disc herniation
4641825|NCT03607838|Radiculopathy|radiculopathy
4641826|NCT03607838|Sciatica|sciatica
4641827|NCT03607838|Intradiscal injection|intradiscal injection
4641828|NCT03607838|Chemonucleolysis|chemonucleolysis
4641829|NCT03607812|Hypertension|hypertension
4641830|NCT03607812|ABPM|abpm
4641831|NCT03607799|South Asian|south asian
4641832|NCT03607799|diet|diet
4641833|NCT03607773|Multiple Sclerosis|multiple sclerosis
4641834|NCT03607773|Mindfulness|mindfulness
4641835|NCT03607747|Arterial Stiffness|arterial stiffness
4641836|NCT03607747|Pulse Wave Velocity|pulse wave velocity
4641837|NCT03607747|Peritoneal Dialysis|peritoneal dialysis
4641838|NCT03607721|deep brain stimulation|deep brain stimulation
4641839|NCT03607721|kinematics|kinematics
4641840|NCT03607721|markerless|markerless
4641841|NCT03607721|body motion evaluation|body motion evaluation
4641842|NCT03607721|gait analysis|gait analysis
4641843|NCT03607695|gait|gait
4641844|NCT03607695|exercise|exercise
4641845|NCT03607695|cognition|cognition
4641846|NCT03607695|genetics|genetics
4641847|NCT03607630|Imagery rescripting|imagery rescripting
4641848|NCT03607630|case series|case series
4641849|NCT03607630|ImRs|imrs
4641850|NCT03607630|Psychosis|psychosis
4641851|NCT03607617|social determinants of health|social determinants of health
4641852|NCT03607617|community health clinic|community health clinic
4641853|NCT03607617|primary care|primary care
4641854|NCT03607617|electronic medical record|electronic medical record
4641855|NCT03607604|MODY|mody
4641856|NCT03607604|Diabetes Mellitus|diabetes mellitus
4641857|NCT03607604|UCPCR|ucpcr
4641858|NCT03607604|Monogenic Diabetes|monogenic diabetes
4641859|NCT03607591|rTMS|rtms
4641860|NCT03607591|Craving|craving
4641861|NCT03607591|Mood and cognitive behavior|mood and cognitive behavior
4641862|NCT03607591|Substance-Related Disorders|substance-related disorders
4641863|NCT03607578|Prevention|prevention
4641864|NCT03607552|Supplemental Screening|supplemental screening
4641865|NCT03607552|Dense Breasts|dense breasts
4641866|NCT03607552|Diffusion Weighted Imaging|diffusion weighted imaging
4641867|NCT03607526|Vegetable Intake|vegetable intake
4641868|NCT03607500|Caloric Intake Reduction|caloric intake reduction
4641869|NCT03607500|Dietician|dietician
4641870|NCT03607487|Hidradenitis suppurativa|hidradenitis suppurativa
4641871|NCT03607487|Janus kinase (JAK) inhibitor|janus kinase (jak) inhibitor
4641872|NCT03607487|skin disease|skin disease
4641873|NCT03607422|Atopic Dermatitis|atopic dermatitis
4641874|NCT03607422|Upadacitinib|upadacitinib
4641875|NCT03607422|ABT-494|abt-494
4641876|NCT03607383|statins|statins
4641877|NCT03607383|red rice yeast|red rice yeast
4641878|NCT03607383|adverse effects|adverse effects
4641879|NCT03607383|cholesterol, LDL|cholesterol, ldl
4641880|NCT03607383|treatment outcome|treatment outcome
4641881|NCT03607383|tolerability|tolerability
4641882|NCT03607370|Rectal cancer|rectal cancer
4641883|NCT03607370|Chemoradiotherapy|chemoradiotherapy
4641884|NCT03607370|Surgery|surgery
4641885|NCT03607357|High Flow Nasal Oxygen|high flow nasal oxygen
4641886|NCT03607357|Non-invasive Ventilation|non-invasive ventilation
4641887|NCT03607357|Acute Left Heart Failure|acute left heart failure
4641888|NCT03607344|Sacrocolpopexy|sacrocolpopexy
4641889|NCT03607344|Day case surgery|day case surgery
4641890|NCT03607344|Laparoscopic|laparoscopic
4641891|NCT03607331|depression|depression
4641892|NCT03607331|electro-acupuncture|electro-acupuncture
4641893|NCT03607331|auricular concha|auricular concha
4641894|NCT03607318|alcohol|alcohol
4641895|NCT03607318|suicide|suicide
4641896|NCT03607318|adolescents|adolescents
4641897|NCT03607292|Sciatic Nerve Blocks|sciatic nerve blocks
4641898|NCT03607292|Ankle surgery|ankle surgery
4641899|NCT03607279|NGAL|ngal
4641900|NCT03607279|Prostatectomy|prostatectomy
4641901|NCT03607279|Acute kidney injury|acute kidney injury
4641902|NCT03607266|ibuprofen ,|ibuprofen ,
4641903|NCT03607266|Preemptive analgesia|preemptive analgesia
4641904|NCT03607266|laparoscopic cholecystectomy|laparoscopic cholecystectomy
4641905|NCT03607266|preemptive|preemptive
4641906|NCT03607253|medial longitudinal arch|medial longitudinal arch
4641907|NCT03607253|foot|foot
4641908|NCT03607227|microsurgical free flaps|microsurgical free flaps
4641909|NCT03607227|popliteal nerve block|popliteal nerve block
4641910|NCT03607227|head and neck cancer|head and neck cancer
4641911|NCT03607227|postoperative pain|postoperative pain
4641912|NCT03607201|acute coronary syndrome|acute coronary syndrome
4641913|NCT03607201|diabetes|diabetes
4641914|NCT03607201|heart failure|heart failure
4641915|NCT03607201|acute pulmonary edema|acute pulmonary edema
4641916|NCT03607201|malignant arrhythmia|malignant arrhythmia
4641917|NCT03607162|Bacteriemia|bacteriemia
4641918|NCT03607162|meningitis|meningitis
4641919|NCT03607162|Urinary tract infection|urinary tract infection
4641920|NCT03607162|antibiotic treatment|antibiotic treatment
4641921|NCT03607149|Pemetrexed|pemetrexed
4641922|NCT03607149|Non-small cell lung cancer|non-small cell lung cancer
4641923|NCT03607149|Clearance of creatine|clearance of creatine
4641924|NCT03607136|early detection|early detection
4641925|NCT03607136|health promotion|health promotion
4641926|NCT03607136|community-dwelling|community-dwelling
4641927|NCT03607136|elderly|elderly
4641928|NCT03607097|secondary prevention|secondary prevention
4641929|NCT03607097|pharmaceutical care|pharmaceutical care
4641930|NCT03607097|drug related problems|drug related problems
4641931|NCT03607097|emergency department|emergency department
4641932|NCT03607084|school-aged children|school-aged children
4641933|NCT03607084|school-based health program|school-based health program
4641934|NCT03607084|Zambia|zambia
4641935|NCT03607084|child and adolescent health|child and adolescent health
4641936|NCT03607045|Boxer's Fracture|boxer's fracture
4641937|NCT03607019|Intensive care|intensive care
4641938|NCT03607019|Critical care|critical care
4641939|NCT03607019|Poverty|poverty
4641940|NCT03607019|inequalities|inequalities
4641941|NCT03607006|Anterior maxillary region|anterior maxillary region
4641942|NCT03607006|Patient specific|patient specific
4641943|NCT03607006|Autogenous bone shell|autogenous bone shell
4641944|NCT03607006|PEEK|peek
4641945|NCT03607006|Ridge augmentation|ridge augmentation
4641946|NCT03606993|Iron-deficiency|iron-deficiency
4641947|NCT03606993|Iron Deficiency Anemia|iron deficiency anemia
4641948|NCT03606941|electroacupuncture; delirium; the elderly; surgery, major|electroacupuncture; delirium; the elderly; surgery, major
4641949|NCT03606915|pain|pain
4641950|NCT03606902|Epidural, Fentanyl, Kidney, Continuous, nephrotoxic.|epidural, fentanyl, kidney, continuous, nephrotoxic.
4641951|NCT03606850|cortical excitability|cortical excitability
4641952|NCT03606850|marker of response|marker of response
4641953|NCT03606837|Prostate Cancer|prostate cancer
4641954|NCT03606837|68Ga-RM2|68ga-rm2
4641955|NCT03606837|68Ga-Prostate Specific Membrane Antigen|68ga-prostate specific membrane antigen
4641956|NCT03606837|PET/CT|pet/ct
4641957|NCT03606837|Prostate cancer imaging|prostate cancer imaging
4641958|NCT03606798|Frontotemporal Lobar Degeneration|frontotemporal lobar degeneration
4641959|NCT03606798|Behavioral disorders|behavioral disorders
4641960|NCT03606785|colorectal,blood, transfusion,haemorrhage,tranexamic acid.|colorectal,blood, transfusion,haemorrhage,tranexamic acid.
4641961|NCT03606759|Addiction|addiction
4641962|NCT03606759|High-risk relapse situation|high-risk relapse situation
4641963|NCT03606759|Craving|craving
4641964|NCT03606759|Individual cues|individual cues
4641965|NCT03606759|Individually tailored treatment|individually tailored treatment
4641966|NCT03606746|Kidney Transplant|kidney transplant
4641967|NCT03606746|Kidney Failure|kidney failure
4641968|NCT03606746|Anti-rejection therapy|anti-rejection therapy
4641969|NCT03606746|Living Donor|living donor
4641970|NCT03606746|HLA-matched|hla-matched
4641971|NCT03606746|Hematopoietic Stem Cells (HSC)|hematopoietic stem cells (hsc)
4641972|NCT03606746|CD34+|cd34+
4641973|NCT03606746|CD3+|cd3+
4641974|NCT03606746|T cells|t cells
4641975|NCT03606746|Cellular Therapy|cellular therapy
4641976|NCT03606746|Immunotherapy|immunotherapy
4641977|NCT03606746|Immunosuppression|immunosuppression
4641978|NCT03606720|Pelvic Girdle Pain|pelvic girdle pain
4641979|NCT03606720|low level laser therapy|low level laser therapy
4641980|NCT03606720|pelvic stabilisation exercises|pelvic stabilisation exercises
4641981|NCT03606720|pain|pain
4641982|NCT03606694|dihydromyricetin|dihydromyricetin
4641983|NCT03606694|metformin|metformin
4641984|NCT03606694|type 2 diabetes mellitus|type 2 diabetes mellitus
4641985|NCT03606681|Dental Pulp|dental pulp
4641986|NCT03606681|calcium hydroxide|calcium hydroxide
4641987|NCT03606681|Dental Pulp Capping|dental pulp capping
4641988|NCT03606655|kava|kava
4641989|NCT03606655|tobacco|tobacco
4641990|NCT03606655|cessation|cessation
4641991|NCT03606655|cancer|cancer
4641992|NCT03606642|Cardiovascular disease|cardiovascular disease
4641993|NCT03606642|peripheral vascular disease (PVD)|peripheral vascular disease (pvd)
4641994|NCT03606642|Ischemia|ischemia
4641995|NCT03606616|ACOSOG Z0011|acosog z0011
4641996|NCT03606616|Chinese breast cancer|chinese breast cancer
4641997|NCT03606616|sentinel lymph node|sentinel lymph node
4641998|NCT03606616|overall survival|overall survival
4641999|NCT03606616|disease-free survival|disease-free survival
4642000|NCT03606603|nutritional status|nutritional status
4642001|NCT03606603|malnutrition|malnutrition
4642002|NCT03606603|energy intake|energy intake
4642003|NCT03606603|protein intake|protein intake
4642004|NCT03606603|ICU|icu
4642005|NCT03606603|surgical ward|surgical ward
4642006|NCT03606603|hospital|hospital
4642007|NCT03606603|enteral nutrition|enteral nutrition
4642008|NCT03606603|parenteral nutrition|parenteral nutrition
4642009|NCT03606603|nutrition|nutrition
4642010|NCT03606590|Hepatocellular Carcinoma|hepatocellular carcinoma
4642011|NCT03606590|Treatment|treatment
4642012|NCT03606590|Minimal toxicity|minimal toxicity
4642013|NCT03606590|TTFields|ttfields
4642014|NCT03606590|Tumor Treating Fields|tumor treating fields
4642015|NCT03606590|Novocure|novocure
4642016|NCT03606590|Sorafenib|sorafenib
4642017|NCT03606590|Nexavar|nexavar
4642018|NCT03606577|Multiple Myeloma|multiple myeloma
4642019|NCT03606577|Newly Diagnosed|newly diagnosed
4642020|NCT03606577|High Risk|high risk
4642021|NCT03606577|Revlimid|revlimid
4642022|NCT03606577|Carfilzomib|carfilzomib
4642023|NCT03606577|Daratumumab|daratumumab
4642024|NCT03606577|Dexaméthasone|dexaméthasone
4642025|NCT03606564|compliance|compliance
4642026|NCT03606564|fasting guidelines|fasting guidelines
4642027|NCT03606551|Self-ligating|self-ligating
4642028|NCT03606551|Orthodontic|orthodontic
4642029|NCT03606551|Esthetic|esthetic
4642030|NCT03606538|MDMA|mdma
4642031|NCT03606538|metabolism|metabolism
4642032|NCT03606538|methylenedioxymethamphetamine|methylenedioxymethamphetamine
4642033|NCT03606473|prenatal exposure|prenatal exposure
4642034|NCT03606408|Cushing's syndrome|cushing's syndrome
4642035|NCT03606408|osilodrostat|osilodrostat
4642036|NCT03606408|LCI699|lci699
4642037|NCT03606408|endogenous Cushing's syndrome|endogenous cushing's syndrome
4642038|NCT03606369|Breast Neoplasm|breast neoplasm
4642039|NCT03606369|Antiemetics|antiemetics
4642040|NCT03606369|Quality of Life|quality of life
4642041|NCT03606369|Palonosetron|palonosetron
4642042|NCT03606369|Ondansetron|ondansetron
4642043|NCT03606330|coronary artery disease|coronary artery disease
4642044|NCT03606330|myocardial infarction|myocardial infarction
4642045|NCT03606330|cardiac imaging techniques|cardiac imaging techniques
4642046|NCT03606330|major adverse cardiovascular events|major adverse cardiovascular events
4642047|NCT03606330|vulnerable coronary plaques|vulnerable coronary plaques
4642048|NCT03606330|serum biomarkers|serum biomarkers
4642049|NCT03606330|coronary shear stress|coronary shear stress
4642050|NCT03606317|Lung and Pancreatic Cancer|lung and pancreatic cancer
4642051|NCT03606304|self-care|self-care
4642052|NCT03606304|quality of life|quality of life
4642053|NCT03606291|isotoxic|isotoxic
4642054|NCT03606291|hypofractionation|hypofractionation
4642055|NCT03606291|Non-Small-Cell Lung|non-small-cell lung
4642056|NCT03606278|Debriefing|debriefing
4642057|NCT03606252|Pneumocystis jirovecii|pneumocystis jirovecii
4642058|NCT03606252|Pneumonia|pneumonia
4642059|NCT03606252|Specialized Proresolving Mediators|specialized proresolving mediators
4642060|NCT03606252|Inflammation|inflammation
4642061|NCT03606252|prognosis|prognosis
4642062|NCT03606239|isotoxic|isotoxic
4642063|NCT03606239|hypofractionated radiotherapy|hypofractionated radiotherapy
4642064|NCT03606239|Non-Small-Cell Lung|non-small-cell lung
4642065|NCT03606213|HIV Vaccine|hiv vaccine
4642066|NCT03606213|Electroporation|electroporation
4642067|NCT03606187|Back Pain, Spinal Cord Stimulation|back pain, spinal cord stimulation
4642068|NCT03606174|MGCD516|mgcd516
4642069|NCT03606174|Antineoplastic Agents|antineoplastic agents
4642070|NCT03606174|Immunologic Factors|immunologic factors
4642071|NCT03606174|Nivolumab|nivolumab
4642072|NCT03606174|Tyrosine Kinase Inhibitor|tyrosine kinase inhibitor
4642073|NCT03606174|VEGFR|vegfr
4642074|NCT03606174|TAM RTKs|tam rtks
4642075|NCT03606174|PD-1|pd-1
4642076|NCT03606174|PD-L1|pd-l1
4642077|NCT03606135|Pneumonia|pneumonia
4642078|NCT03606135|Streptococcus pneumoniae|streptococcus pneumoniae
4642079|NCT03606135|Incidence|incidence
4642080|NCT03606135|Ethiology|ethiology
4642081|NCT03606135|Serotype|serotype
4642082|NCT03606122|Actinic keratosis on the upper extremities|actinic keratosis on the upper extremities
4642083|NCT03606109|Tranexamic acid (TXA)|tranexamic acid (txa)
4642084|NCT03606096|immune response|immune response
4642289|NCT03604861|Analgesics|analgesics
4642085|NCT03606096|impact of acellular pertussis vaccination|impact of acellular pertussis vaccination
4642086|NCT03606083|aorto-iliac|aorto-iliac
4642087|NCT03606083|iliac|iliac
4642088|NCT03606083|aneurysm|aneurysm
4642089|NCT03606018|Pharmacokinetics|pharmacokinetics
4642090|NCT03606018|Pharmacodynamics|pharmacodynamics
4642091|NCT03606018|Insulin Lispro|insulin lispro
4642092|NCT03606005|stem cell transplantation|stem cell transplantation
4642093|NCT03606005|Pulmonary Functions|pulmonary functions
4642094|NCT03606005|exercise capacity|exercise capacity
4642095|NCT03606005|dyspnea|dyspnea
4642096|NCT03606005|Quality of Life|quality of life
4642097|NCT03606005|physical activity|physical activity
4642098|NCT03605992|Rehabilitation|rehabilitation
4642099|NCT03605992|Coronary artery disease|coronary artery disease
4642100|NCT03605992|Telerehabilitation|telerehabilitation
4642101|NCT03605992|Randomized Controlled Trial|randomized controlled trial
4642102|NCT03605992|Protocol|protocol
4642103|NCT03605979|type 1 diabetes|type 1 diabetes
4642104|NCT03605979|hypoglycemia unawareness|hypoglycemia unawareness
4642105|NCT03605979|Insulin pump|insulin pump
4642106|NCT03605979|Continuous glucose monitoring systems|continuous glucose monitoring systems
4642107|NCT03605979|Low glucose suspend|low glucose suspend
4642108|NCT03605966|analgesia|analgesia
4642109|NCT03605966|pain|pain
4642110|NCT03605966|nociception|nociception
4642111|NCT03605966|pupillometry|pupillometry
4642112|NCT03605966|analgesic|analgesic
4642113|NCT03605966|opioid|opioid
4642114|NCT03605953|Cell therapy|cell therapy
4642115|NCT03605953|immuno-modulation|immuno-modulation
4642116|NCT03605953|immunotherapy|immunotherapy
4642117|NCT03605953|Hematology|hematology
4642118|NCT03605940|Acute-graft-versus-host Disease|acute-graft-versus-host disease
4642119|NCT03605940|Extracorporal Photopheresis|extracorporal photopheresis
4642120|NCT03605927|HCT|hct
4642121|NCT03605927|hematopoietic cell transplantation|hematopoietic cell transplantation
4642122|NCT03605927|antibody therapy|antibody therapy
4642123|NCT03605901|Post-operative pain|post-operative pain
4642124|NCT03605901|Spine surgery|spine surgery
4642125|NCT03605901|Methadone|methadone
4642126|NCT03605901|Opiod|opiod
4642127|NCT03605888|Nutrition|nutrition
4642128|NCT03605862|Enterovirus|enterovirus
4642129|NCT03605862|Rhinovirus|rhinovirus
4642130|NCT03605849|Centanafadine|centanafadine
4642131|NCT03605849|ADD|add
4642132|NCT03605849|ADHD|adhd
4642133|NCT03605836|Centanafadine|centanafadine
4642134|NCT03605836|ADD|add
4642135|NCT03605836|ADHD|adhd
4642136|NCT03605823|Express Mini shunt; Pars plana; Vitrectomized eye|express mini shunt; pars plana; vitrectomized eye
4642137|NCT03605810|Renal function, eGRF, Atrial fibrillation, Coronary artery disease, Type 2 diabetes mellitus, Machine learning, Prognostic modeling|renal function, egrf, atrial fibrillation, coronary artery disease, type 2 diabetes mellitus, machine learning, prognostic modeling
4642138|NCT03605758|Ivermectin|ivermectin
4642139|NCT03605758|S. stercoralis|s. stercoralis
4642140|NCT03605758|parasite|parasite
4642141|NCT03605758|helminth|helminth
4642142|NCT03605758|Filariform|filariform
4642143|NCT03605758|larvae|larvae
4642144|NCT03605758|Baermann technique|baermann technique
4642145|NCT03605745|BPH|bph
4642146|NCT03605745|Minimally Invasive|minimally invasive
4642147|NCT03605745|Water Vapor Therapy|water vapor therapy
4642148|NCT03605745|Rezum|rezum
4642149|NCT03605680|Centanafadine|centanafadine
4642150|NCT03605680|ADHD|adhd
4642151|NCT03605680|ADD|add
4642152|NCT03605641|E-Cigarettes|e-cigarettes
4642153|NCT03605641|Conventional Cigarettes|conventional cigarettes
4642154|NCT03605641|JUUL|juul
4642155|NCT03605641|VUSE|vuse
4642156|NCT03605615|vaginal delivery|vaginal delivery
4642157|NCT03605615|perineal tear|perineal tear
4642158|NCT03605615|randomized controled trial|randomized controled trial
4642159|NCT03605589|Blinatumomab|blinatumomab
4642160|NCT03605589|Pembrolizumab|pembrolizumab
4642161|NCT03605589|CD19 positive|cd19 positive
4642162|NCT03605589|Relapsed|relapsed
4642163|NCT03605589|Refractory|refractory
4642164|NCT03605576|Fu's subcutaneous needle|fu's subcutaneous needle
4642165|NCT03605576|Transcutaneous electrical nerve stimulation|transcutaneous electrical nerve stimulation
4642166|NCT03605563|Fu's subcutaneous needling (FSN)|fu's subcutaneous needling (fsn)
4642167|NCT03605563|Myofascial trigger point|myofascial trigger point
4642168|NCT03605550|DIPG|dipg
4642169|NCT03605550|High Grade Glioma|high grade glioma
4642170|NCT03605524|Sensory training|sensory training
4642171|NCT03605524|Depression|depression
4642172|NCT03605524|Olfaction|olfaction
4642173|NCT03605524|Emotion|emotion
4642174|NCT03605524|Perception|perception
4642175|NCT03605472|primary hyperparathyroidism|primary hyperparathyroidism
4642176|NCT03605472|cervical ultrasound|cervical ultrasound
4642177|NCT03605472|echoscintigraphy|echoscintigraphy
4642178|NCT03605394|Maxillary sinus|maxillary sinus
4642179|NCT03605394|sinus septa|sinus septa
4642180|NCT03605394|sinus septum|sinus septum
4642181|NCT03605394|CBCT|cbct
4642182|NCT03605381|Stroke|stroke
4642183|NCT03605381|PROMs|proms
4642184|NCT03605381|Cohort|cohort
4642185|NCT03605368|Intervention|intervention
4642186|NCT03605368|Technology|technology
4642187|NCT03605355|minor stroke|minor stroke
4642188|NCT03605355|cost-effectiveness|cost-effectiveness
4642189|NCT03605355|feasibility|feasibility
4642190|NCT03605355|day clinic|day clinic
4642191|NCT03605342|PTSD|ptsd
4642192|NCT03605342|Opiate Use Disorder|opiate use disorder
4642193|NCT03605329|Sleep Apnea, Obstructive|sleep apnea, obstructive
4642194|NCT03605329|diabetes|diabetes
4642195|NCT03605316|Deep brain stimulation|deep brain stimulation
4642196|NCT03605316|obsessive-compulsive disorder|obsessive-compulsive disorder
4642197|NCT03605316|neuromodulation|neuromodulation
4642198|NCT03605316|psychiatry|psychiatry
4642199|NCT03605316|quality of life|quality of life
4642200|NCT03605290|total knee replacement|total knee replacement
4642201|NCT03605290|gait analysis|gait analysis
4642202|NCT03605290|PROMS|proms
4642203|NCT03605290|mechanical aligment|mechanical aligment
4642204|NCT03605290|kinematic alignment|kinematic alignment
4642205|NCT03605277|ABL001|abl001
4642206|NCT03605277|asciminib|asciminib
4642207|NCT03605277|impaired renal function|impaired renal function
4642208|NCT03605277|pharmacokinetics|pharmacokinetics
4642209|NCT03605238|Neuromyelitis Optica Spectrum Disorder|neuromyelitis optica spectrum disorder
4642210|NCT03605238|aquaporin4-IgG|aquaporin4-igg
4642211|NCT03605238|CAR-T therapy|car-t therapy
4642212|NCT03605225|Android application|android application
4642213|NCT03605225|Anesthesia|anesthesia
4642214|NCT03605225|intraoperative|intraoperative
4642215|NCT03605212|TLS|tls
4642216|NCT03605212|FLO-02|flo-02
4642217|NCT03605212|Hematological Malignancies|hematological malignancies
4642218|NCT03605199|denosumab|denosumab
4642219|NCT03605199|giant cell rich tumor of bone|giant cell rich tumor of bone
4642220|NCT03605186|chamomile cryotherapy|chamomile cryotherapy
4642221|NCT03605186|cryotherapy|cryotherapy
4642222|NCT03605186|cancer|cancer
4642223|NCT03605186|children|children
4642224|NCT03605186|pediatric|pediatric
4642225|NCT03605186|chemotherapy|chemotherapy
4642226|NCT03605160|cataract surgery|cataract surgery
4642227|NCT03605160|lens fibzrs|lens fibzrs
4642228|NCT03605147|HMB|hmb
4642229|NCT03605147|sarcopenia|sarcopenia
4642230|NCT03605147|liver cirrhosis|liver cirrhosis
4642231|NCT03605147|chronic liver disease|chronic liver disease
4642232|NCT03605147|malnutrition|malnutrition
4642233|NCT03605147|muscle wasting|muscle wasting
4642234|NCT03605134|troponin|troponin
4642235|NCT03605134|diastolic function|diastolic function
4642236|NCT03605121|waist circumference|waist circumference
4642237|NCT03605121|body mass index|body mass index
4642238|NCT03605121|cardiac surgery|cardiac surgery
4642239|NCT03605121|mortality|mortality
4642240|NCT03605095|spreading vasodilation|spreading vasodilation
4642241|NCT03605095|gingival microcirculation|gingival microcirculation
4642242|NCT03605082|UCB0107|ucb0107
4642243|NCT03605082|Phase 1|phase 1
4642244|NCT03605069|Recessive Dystrophic Epidermolysis Bullosa|recessive dystrophic epidermolysis bullosa
4642245|NCT03605069|EB|eb
4642246|NCT03605069|COL7A1|col7a1
4642247|NCT03605069|RNA Therapies|rna therapies
4642248|NCT03605069|Antisense oligonucleotide|antisense oligonucleotide
4642249|NCT03605069|Exon skipping|exon skipping
4642250|NCT03605069|WINGS|wings
4642251|NCT03605069|Topical treatment|topical treatment
4642252|NCT03605069|RDEB|rdeb
4642253|NCT03605069|Exon 73|exon 73
4642254|NCT03605069|Mutations in exon 73|mutations in exon 73
4642255|NCT03605043|Integrated|integrated
4642256|NCT03605043|Care cascade|care cascade
4642257|NCT03605043|Uganda|uganda
4642258|NCT03605030|Cardiac Catheterization|cardiac catheterization
4642259|NCT03605030|Percutaneous Coronary Intervention|percutaneous coronary intervention
4642260|NCT03605030|Radiation|radiation
4642261|NCT03605030|Lead Shielding|lead shielding
4642262|NCT03605017|cognitive rehabilitation|cognitive rehabilitation
4642263|NCT03605017|attention|attention
4642264|NCT03605017|executive function|executive function
4642265|NCT03605004|Genetic Testing|genetic testing
4642266|NCT03605004|Variant of Uncertain Significance|variant of uncertain significance
4642267|NCT03605004|Uncertainty|uncertainty
4642268|NCT03605004|Qualitative|qualitative
4642269|NCT03604952|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
4642270|NCT03604952|Ramadan observance|ramadan observance
4642271|NCT03604952|pulmonary variables|pulmonary variables
4642272|NCT03604952|postural balance|postural balance
4642273|NCT03604952|exercise performance|exercise performance
4642274|NCT03604939|cardio-vascular disease|cardio-vascular disease
4642275|NCT03604939|stroke cancer|stroke cancer
4642276|NCT03604939|breast cancer|breast cancer
4642277|NCT03604939|oral cancer|oral cancer
4642278|NCT03604939|cervical cancer|cervical cancer
4642279|NCT03604913|Valve sparing aortic root replacement|valve sparing aortic root replacement
4642280|NCT03604861|Opioid recovery|opioid recovery
4642281|NCT03604861|Recovery|recovery
4642282|NCT03604861|Opioid-related disorders|opioid-related disorders
4642283|NCT03604861|Substance-related disorders|substance-related disorders
4642284|NCT03604861|Heroin dependence|heroin dependence
4642285|NCT03604861|Opioid dependence|opioid dependence
4642286|NCT03604861|Addiction|addiction
4642287|NCT03604861|Buprenorphine|buprenorphine
4642288|NCT03604861|Opiate substitution treatment|opiate substitution treatment
4642290|NCT03604861|Opioid|opioid
4642291|NCT03604861|Narcotics|narcotics
4642292|NCT03604861|Patient outcome assessment|patient outcome assessment
4642293|NCT03604861|Patient-centered care|patient-centered care
4642294|NCT03604861|Cost of illness|cost of illness
4642295|NCT03604861|Employment|employment
4642296|NCT03604861|Health-related quality-of-life|health-related quality-of-life
4642297|NCT03604861|Family relations|family relations
4642298|NCT03604861|Lifestyle|lifestyle
4642299|NCT03604861|Citizenship|citizenship
4642300|NCT03604848|Multidrug Resistant Tuberculosis|multidrug resistant tuberculosis
4642301|NCT03604848|next generation sequencing|next generation sequencing
4642302|NCT03604848|drug susceptibility test|drug susceptibility test
4642303|NCT03604848|precision treatment|precision treatment
4642304|NCT03604835|UX003|ux003
4642305|NCT03604835|Mepsevii|mepsevii
4642306|NCT03604835|vestronidase alfa-vjbk|vestronidase alfa-vjbk
4642307|NCT03604835|vestronidase alfa|vestronidase alfa
4642308|NCT03604835|recombinant human beta-glucuronidase|recombinant human beta-glucuronidase
4642309|NCT03604822|Music Therapy|music therapy
4642310|NCT03604822|Neurologic Music Therapy|neurologic music therapy
4642311|NCT03604822|Rehabilitation|rehabilitation
4642312|NCT03604822|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
4642313|NCT03604822|ALS|als
4642314|NCT03604796|acetaminophen|acetaminophen
4642315|NCT03604783|Tolero, Phase 1, First in Human, Advanced Malignancy, Cancer|tolero, phase 1, first in human, advanced malignancy, cancer
4642316|NCT03604770|Caloric Intake|caloric intake
4642317|NCT03604770|Anti-mullerian hormone (AMH)|anti-mullerian hormone (amh)
4642318|NCT03604770|Antral follicles (AFC)|antral follicles (afc)
4642319|NCT03604770|Infertility|infertility
4642320|NCT03604770|Fertility|fertility
4642321|NCT03604770|Diet|diet
4642322|NCT03604770|Ovarian Reserve|ovarian reserve
4642323|NCT03604770|Obesity|obesity
4642324|NCT03604770|Nutrition|nutrition
4642325|NCT03604757|Prostate Cancer|prostate cancer
4642326|NCT03604757|68Ga-RM2|68ga-rm2
4642327|NCT03604757|bombesin|bombesin
4642328|NCT03604757|GRP-R|grp-r
4642329|NCT03604757|68Ga-Prostate Specific Membrane Antigen|68ga-prostate specific membrane antigen
4642330|NCT03604757|PSMA|psma
4642331|NCT03604757|PET/CT|pet/ct
4642332|NCT03604731|Immunology, Suppression, Inflammation, Cardiac, Surgery|immunology, suppression, inflammation, cardiac, surgery
4642333|NCT03604692|cGVHD|cgvhd
4642334|NCT03604666|Breast Cancer|breast cancer
4642335|NCT03604666|Skin cancer|skin cancer
4642336|NCT03604666|Surgery|surgery
4642337|NCT03604666|Ambulatory|ambulatory
4642338|NCT03604653|HIPEC|hipec
4642339|NCT03604653|Stomach cancer|stomach cancer
4642340|NCT03604653|colorectal cancer|colorectal cancer
4642341|NCT03604653|appendiceal cancer|appendiceal cancer
4642342|NCT03604653|ovarian cancer|ovarian cancer
4642343|NCT03604653|uterine cancer|uterine cancer
4642344|NCT03604653|cervical cancer|cervical cancer
4642345|NCT03604653|fallopian tube cancer|fallopian tube cancer
4642346|NCT03604653|primary peritoneal carcinoma|primary peritoneal carcinoma
4642347|NCT03604653|intraperitoneal chemotherapy|intraperitoneal chemotherapy
4642348|NCT03604640|Functional impairment|functional impairment
4642349|NCT03604640|Hospital associated disability|hospital associated disability
4642350|NCT03604614|peritoneal metastatis|peritoneal metastatis
4642351|NCT03604614|Hyperthermic Intraperitoneal Chemotherapy|hyperthermic intraperitoneal chemotherapy
4642352|NCT03604614|Advanced gastric adenocarcinoma|advanced gastric adenocarcinoma
4642353|NCT03604601|salvage surgery|salvage surgery
4642354|NCT03604601|recurrent laryngeal carcinoma|recurrent laryngeal carcinoma
4642355|NCT03604601|experience|experience
4642356|NCT03604575|Pharmacokinetics|pharmacokinetics
4642357|NCT03604575|Pharmacodynamics|pharmacodynamics
4642358|NCT03604575|Insulin Lispro|insulin lispro
4642359|NCT03604536|Adherence|adherence
4642360|NCT03604536|eHealth|ehealth
4642361|NCT03604536|Aminosalicylate|aminosalicylate
4642362|NCT03604458|Universal Health Coverage, Surgery in resource limited settings|universal health coverage, surgery in resource limited settings
4642363|NCT03604406|Shingles|shingles
4642364|NCT03604406|abatacept|abatacept
4642365|NCT03604406|Varicella Zoster Vaccine|varicella zoster vaccine
4642366|NCT03604393|Immunization|immunization
4642367|NCT03604367|fMRI|fmri
4642368|NCT03604367|BOLD Signal|bold signal
4642369|NCT03604367|Rehabilitation|rehabilitation
4642370|NCT03604354|osteoarthritis knee,pre-emptive analgesia,TKA,Opioids,gabapentinoids|osteoarthritis knee,pre-emptive analgesia,tka,opioids,gabapentinoids
4642371|NCT03604341|Medical Abortion|medical abortion
4642372|NCT03604341|Pain|pain
4642373|NCT03604341|Cannabis|cannabis
4642374|NCT03604302|Functional Magnetic Resonance Imaging (fMRI)|functional magnetic resonance imaging (fmri)
4642375|NCT03604302|18-331|18-331
4642376|NCT03604289|angiotensin-1-7|angiotensin-1-7
4642377|NCT03604276|Headache; subarachnoid hemorrhage; neuroinflammation|headache; subarachnoid hemorrhage; neuroinflammation
4642378|NCT03604237|forceps biopsy|forceps biopsy
4642379|NCT03604237|colorectal tumors|colorectal tumors
4642380|NCT03604198|Cushing Syndrome|cushing syndrome
4642381|NCT03604198|Cushing Disease|cushing disease
4642382|NCT03604198|Cushing|cushing
4642383|NCT03604198|Hypercortisolemia|hypercortisolemia
4642384|NCT03604198|Cushingoid|cushingoid
4642385|NCT03604198|Type 2 Diabetes|type 2 diabetes
4642386|NCT03604198|Impaired Glucose Intolerance|impaired glucose intolerance
4642387|NCT03604198|Hypertension|hypertension
4642388|NCT03604198|Adrenal Corticotrophic Hormone (ACTH)|adrenal corticotrophic hormone (acth)
4642389|NCT03604198|Adrenocortical Carcinoma|adrenocortical carcinoma
4642390|NCT03604198|Primary Pigmented Nodular Adrenal Disease (PPNAD)|primary pigmented nodular adrenal disease (ppnad)
4642391|NCT03604198|Moon Facies|moon facies
4642392|NCT03604198|Dorsocervical Fat Pad|dorsocervical fat pad
4642393|NCT03604198|Adrenal Adenoma|adrenal adenoma
4642394|NCT03604198|Adrenal Carcinoma|adrenal carcinoma
4642395|NCT03604198|Adrenal Autonomy|adrenal autonomy
4642396|NCT03604198|Cortisol|cortisol
4642397|NCT03604185|Hearing Loss|hearing loss
4642398|NCT03604185|Auditory Processing|auditory processing
4642399|NCT03604185|Aging|aging
4642400|NCT03604185|Speech Perception in Noise (SIN)|speech perception in noise (sin)
4642401|NCT03604185|Pitch Discrimination|pitch discrimination
4642402|NCT03604185|Frequency Following Response (FFR)|frequency following response (ffr)
4642403|NCT03604185|Choir Singing|choir singing
4642404|NCT03604185|Musical Training|musical training
4642405|NCT03604172|binge eating disorder|binge eating disorder
4642406|NCT03604172|obesity|obesity
4642407|NCT03604172|cognitive behavioral therapy|cognitive behavioral therapy
4642408|NCT03604146|COPD|copd
4642409|NCT03604146|Quality Control|quality control
4642410|NCT03604120|Preoxygenation|preoxygenation
4642411|NCT03604120|High flow nasal cannula|high flow nasal cannula
4642412|NCT03604094|central venous catheter, pediatrics, ultrasound imaging|central venous catheter, pediatrics, ultrasound imaging
4642413|NCT03604081|Constraint Induced Movement Therapy|constraint induced movement therapy
4642414|NCT03604068|Caesarean section|caesarean section
4642415|NCT03604055|Hamartoma, Cryotherapy|hamartoma, cryotherapy
4642416|NCT03604029|ACS|acs
4642417|NCT03604003|CKD, bedtime dosing, isolated nocturnal hypertension|ckd, bedtime dosing, isolated nocturnal hypertension
4642418|NCT03603990|Edema|edema
4642419|NCT03603990|Macular Edema|macular edema
4642420|NCT03603990|Diabetic Retinopathy|diabetic retinopathy
4642421|NCT03603990|Macular Degeneration|macular degeneration
4642422|NCT03603990|Diabetic Angiopathies|diabetic angiopathies
4642423|NCT03603990|Retinal Disease|retinal disease
4642424|NCT03603990|Signs and Symptoms|signs and symptoms
4642425|NCT03603990|Vitrectomy|vitrectomy
4642426|NCT03603977|Simplified Therapy Regimen|simplified therapy regimen
4642427|NCT03603977|Real World Study|real world study
4642428|NCT03603977|HIV-1-infected patients|hiv-1-infected patients
4642429|NCT03603964|Guadecitabine|guadecitabine
4642430|NCT03603951|SHR2554|shr2554
4642431|NCT03603951|EZH2 inhibitor|ezh2 inhibitor
4642432|NCT03603951|phase 1|phase 1
4642433|NCT03603951|mature lymphoid neoplasm|mature lymphoid neoplasm
4642434|NCT03603938|potassium losartan, CKD, nondipping BP pattern|potassium losartan, ckd, nondipping bp pattern
4642435|NCT03603925|Computed tomography|computed tomography
4642436|NCT03603925|standardized update values|standardized update values
4642437|NCT03603873|Anxiety|anxiety
4642438|NCT03603873|Premedication|premedication
4642439|NCT03603873|general anaesthetic|general anaesthetic
4642440|NCT03603860|vital signs|vital signs
4642441|NCT03603860|blood pressure|blood pressure
4642442|NCT03603860|cardiac surgery|cardiac surgery
4642443|NCT03603860|non-invasive monitoring|non-invasive monitoring
4642444|NCT03603834|Neoadjuvant|neoadjuvant
4642445|NCT03603834|Potentially resectable|potentially resectable
4642446|NCT03603834|Chemotherapy|chemotherapy
4642447|NCT03603834|Bile duct cancer|bile duct cancer
4642448|NCT03603821|LUTS|luts
4642449|NCT03603821|QUESTIONNAIRE|questionnaire
4642450|NCT03603821|IPSS|ipss
4642451|NCT03603743|exercise training|exercise training
4642452|NCT03603743|chronic heart failure|chronic heart failure
4642453|NCT03603743|parasympathetic|parasympathetic
4642454|NCT03603743|autonomic nervous system|autonomic nervous system
4642455|NCT03603743|cardiorespiratory fitness|cardiorespiratory fitness
4642456|NCT03603743|cardiac rehabilitation|cardiac rehabilitation
4642457|NCT03603730|Functional Dyspepsia|functional dyspepsia
4642458|NCT03603730|Gastroparesis|gastroparesis
4642459|NCT03603717|insomnia|insomnia
4642460|NCT03603717|suicidal ideation|suicidal ideation
4642461|NCT03603717|depression|depression
4642462|NCT03603717|posttraumatic stress disorder|posttraumatic stress disorder
4642463|NCT03603717|cognitive behavioral therapy for insomnia|cognitive behavioral therapy for insomnia
4642464|NCT03603717|sleep|sleep
4642465|NCT03603717|suicide|suicide
4642466|NCT03603678|Obstructive sleep apnea|obstructive sleep apnea
4642467|NCT03603678|Potassium channel blocker|potassium channel blocker
4642468|NCT03603678|Polysomnography|polysomnography
4642469|NCT03603678|PSG|psg
4642470|NCT03603665|Botulism|botulism
4642471|NCT03603665|Dose Escalation|dose escalation
4642472|NCT03603665|Double-Blind|double-blind
4642473|NCT03603665|NTM-1633|ntm-1633
4642474|NCT03603665|Pharmacokinetics|pharmacokinetics
4642475|NCT03603665|Phase I|phase i
4642476|NCT03603665|Safety|safety
4642477|NCT03603652|Lung Lesions; Soft Tissue- Lung|lung lesions; soft tissue- lung
4642478|NCT03603639|E2730|e2730
4642479|NCT03603639|Epilepsy|epilepsy
4642480|NCT03603639|Photosensitive|photosensitive
4642481|NCT03603639|Seizures|seizures
4642482|NCT03603639|PPR|ppr
4642483|NCT03603639|Anti-epileptic|anti-epileptic
4642484|NCT03603626|Endoscopic ear surgery|endoscopic ear surgery
4642485|NCT03603626|Myringoplasty|myringoplasty
4642486|NCT03603626|Pregabalin|pregabalin
4642487|NCT03603626|Preemptive analgesia|preemptive analgesia
4642488|NCT03603587|biologic markers|biologic markers
4642489|NCT03603587|skin cancer|skin cancer
4642490|NCT03603587|solar aging of skin|solar aging of skin
4642491|NCT03603587|alopecic scalp|alopecic scalp
4642492|NCT03603574|Abdomen/surgery|abdomen/surgery
4642493|NCT03603574|Thoracic Surgery|thoracic surgery
4642494|NCT03603561|bipolar depression|bipolar depression
4642495|NCT03603561|TMS|tms
4642496|NCT03603561|transcranial magnetic stimulation|transcranial magnetic stimulation
4642497|NCT03603561|add-on treatment|add-on treatment
4642498|NCT03603535|Stress urinary incontinence|stress urinary incontinence
4642499|NCT03603535|objective outcome|objective outcome
4642500|NCT03603522|Cough|cough
4642501|NCT03603522|Capsaicin|capsaicin
4642502|NCT03603522|Probiotics|probiotics
4642503|NCT03603522|TRPV1|trpv1
4642504|NCT03603509|Fluad, MF59, Fluzone, HDFlu, Influenza, Vaccine|fluad, mf59, fluzone, hdflu, influenza, vaccine
4642505|NCT03603496|Tobacco|tobacco
4642506|NCT03603496|Cessation|cessation
4642507|NCT03603496|Hospitalization|hospitalization
4642508|NCT03603496|eReferral|ereferral
4642509|NCT03603496|Interactive Voice Response|interactive voice response
4642510|NCT03603496|Tobacco Quitline|tobacco quitline
4642511|NCT03603483|patients- prosthesis mismatching|patients- prosthesis mismatching
4642512|NCT03603457|Epidemiology|epidemiology
4642513|NCT03603457|Prognostic factors|prognostic factors
4642514|NCT03603457|Stratified medicine|stratified medicine
4642515|NCT03603457|Quality of life|quality of life
4642516|NCT03603457|Economic assessment|economic assessment
4642517|NCT03603431|Healthy Volunteers|healthy volunteers
4642518|NCT03603431|MicroRNAs|micrornas
4642519|NCT03603431|Angiogenesis Inducing Agents|angiogenesis inducing agents
4642520|NCT03603405|GBM, AA, Glioblastoma, Astrocytoma|gbm, aa, glioblastoma, astrocytoma
4642521|NCT03603379|anti- EGFR- immunoliposomes|anti- egfr- immunoliposomes
4642522|NCT03603288|respiratory function in DMD|respiratory function in dmd
4642523|NCT03603249|platelet inhibition|platelet inhibition
4642524|NCT03603249|platelet reactivity|platelet reactivity
4642525|NCT03603249|clopidogrel|clopidogrel
4642526|NCT03603249|trimetazidine|trimetazidine
4642527|NCT03603210|Ischaemic heart disease|ischaemic heart disease
4642528|NCT03603210|coronary angioplasty|coronary angioplasty
4642529|NCT03603210|drug coated balloons (DCB)|drug coated balloons (dcb)
4642530|NCT03603197|BP-C1|bp-c1
4642531|NCT03603197|CDBPA|cdbpa
4642532|NCT03603197|is-coordinated complexes of platinum(II) with polymer of benzene polycarboxylic acids derived from lignin|is-coordinated complexes of platinum(ii) with polymer of benzene polycarboxylic acids derived from lignin
4642533|NCT03603197|Benzene polycarboxylic acids complex with cis-diammineplatinum(II)|benzene polycarboxylic acids complex with cis-diammineplatinum(ii)
4642534|NCT03603197|Metastatic Breast Cancer|metastatic breast cancer
4642535|NCT03603197|Platinum analogue|platinum analogue
4642536|NCT03603197|Metronomic chemotherapy|metronomic chemotherapy
4642537|NCT03603197|Breast cancer|breast cancer
4642538|NCT03603197|Cisplatin|cisplatin
4642539|NCT03603184|endometrial cancer|endometrial cancer
4642540|NCT03603184|neoplasm|neoplasm
4642541|NCT03603184|immunotherapy|immunotherapy
4642542|NCT03603171|myotonic dystrophy type 2|myotonic dystrophy type 2
4642543|NCT03603171|outcome scale|outcome scale
4642544|NCT03603171|muscle strength|muscle strength
4642545|NCT03603171|outcome measures|outcome measures
4642546|NCT03603171|disease specific severity scale|disease specific severity scale
4642547|NCT03603158|HERG|herg
4642548|NCT03603158|KCNH2|kcnh2
4642549|NCT03603158|METHADONE|methadone
4642550|NCT03603158|OPIOID|opioid
4642551|NCT03603119|Postoperative Nausea and Vomiting|postoperative nausea and vomiting
4642552|NCT03603119|Dexamethasone|dexamethasone
4642553|NCT03603119|Ondansetron|ondansetron
4642554|NCT03603119|Midazolam|midazolam
4642555|NCT03603119|Laparoscopy|laparoscopy
4642556|NCT03603119|High risk|high risk
4642557|NCT03603093|Esophagogastroduodenoscopy|esophagogastroduodenoscopy
4642558|NCT03603093|Paediatric|paediatric
4642559|NCT03603067|monophthalmos|monophthalmos
4642560|NCT03603067|social psychology|social psychology
4642561|NCT03603067|ocular surgery|ocular surgery
4642562|NCT03603054|Neck pain|neck pain
4642563|NCT03603054|Neural mobilization|neural mobilization
4642564|NCT03603054|Myofascial trigger point|myofascial trigger point
4642565|NCT03603054|Sciatic nerve|sciatic nerve
4642566|NCT03603028|Walking|walking
4642567|NCT03603028|Exercise|exercise
4642568|NCT03603028|Exergaming|exergaming
4642569|NCT03603015|bladder|bladder
4642570|NCT03603015|urinary tract|urinary tract
4642571|NCT03603015|symptoms|symptoms
4642572|NCT03603015|contractility|contractility
4642573|NCT03603015|urodynamics|urodynamics
4642574|NCT03603015|penile cuff test|penile cuff test
4642575|NCT03602976|hepatic sarcoidosis|hepatic sarcoidosis
4642576|NCT03602976|elevated alp|elevated alp
4642577|NCT03602963|Diabetes Mellitus|diabetes mellitus
4642578|NCT03602963|Child|child
4642579|NCT03602963|Glucose sensor|glucose sensor
4642580|NCT03602963|Accuracy|accuracy
4642581|NCT03602963|Usability|usability
4642582|NCT03602937|Acceptability|acceptability
4642583|NCT03602937|Renal|renal
4642584|NCT03602937|CKD|ckd
4642585|NCT03602937|Kidney|kidney
4642586|NCT03602937|Vitaflo|vitaflo
4642587|NCT03602937|High energy, low volume|high energy, low volume
4642588|NCT03602937|Low potassium|low potassium
4642589|NCT03602937|Low phosphorus|low phosphorus
4642590|NCT03602937|Low vitamin A|low vitamin a
4642591|NCT03602924|levodopa infusion|levodopa infusion
4642592|NCT03602885|Gastrointestinal Cancer|gastrointestinal cancer
4642593|NCT03602885|cancer|cancer
4642594|NCT03602885|palliative|palliative
4642595|NCT03602885|chemotherapy|chemotherapy
4642596|NCT03602885|metastatic|metastatic
4642597|NCT03602885|colorectal|colorectal
4642598|NCT03602885|pancreatic|pancreatic
4642599|NCT03602885|communication|communication
4642600|NCT03602885|informed consent|informed consent
4642601|NCT03602885|video|video
4642602|NCT03602885|education|education
4642603|NCT03602885|oncology|oncology
4642604|NCT03602885|patient-centered|patient-centered
4642605|NCT03602885|outcomes research|outcomes research
4642606|NCT03602872|Knee osteoarthritis, safety, MSCs|knee osteoarthritis, safety, mscs
4642607|NCT03602859|FIRST|first
4642608|NCT03602859|FIRST trial|first trial
4642609|NCT03602859|Niraparib|niraparib
4642610|NCT03602859|TSR-042|tsr-042
4642611|NCT03602846|diabetes mellitus in pregnancy|diabetes mellitus in pregnancy
4642612|NCT03602846|gestational diabetes|gestational diabetes
4642613|NCT03602846|pregnancy outcomes|pregnancy outcomes
4642614|NCT03602820|Leber congenital amaurosis, retinitis pigmentosa|leber congenital amaurosis, retinitis pigmentosa
4642615|NCT03602781|PAH|pah
4642616|NCT03602781|Inhaled Nitric Oxide|inhaled nitric oxide
4642617|NCT03602781|iNO|ino
4642618|NCT03602781|Long Term Oxygen Therapy|long term oxygen therapy
4642619|NCT03602781|Oxygen therapy|oxygen therapy
4642620|NCT03602768|Healthy aging|healthy aging
4642621|NCT03602768|executive functions|executive functions
4642622|NCT03602768|memory|memory
4642623|NCT03602768|cognitive training|cognitive training
4642624|NCT03602768|cognitive intervention|cognitive intervention
4642625|NCT03602768|subjective cognitive impairment|subjective cognitive impairment
4642626|NCT03602755|Transplant|transplant
4642627|NCT03602755|Multiple Myeloma|multiple myeloma
4642628|NCT03602755|Spain|spain
4642629|NCT03602742|Atrial Fibrillation|atrial fibrillation
4642630|NCT03602742|Arrhythmias, Cardiac|arrhythmias, cardiac
4642631|NCT03602742|EZYPRO ECG Recorder|ezypro ecg recorder
4642632|NCT03602742|ECG monitor|ecg monitor
4642633|NCT03602742|Long term ECG monitor|long term ecg monitor
4642634|NCT03602742|14-day ECG monitor|14-day ecg monitor
4642635|NCT03602729|Breastfeeding|breastfeeding
4642636|NCT03602729|Teaching|teaching
4642637|NCT03602729|Intervention|intervention
4642638|NCT03602729|NICU|nicu
4642639|NCT03602716|schizophrenia|schizophrenia
4642640|NCT03602716|HD-tDCS|hd-tdcs
4642641|NCT03602716|negative symptoms|negative symptoms
4642642|NCT03602703|Direct acting antiviral drugs immune responses|direct acting antiviral drugs immune responses
4642643|NCT03602690|Third-line regimen|third-line regimen
4642644|NCT03602690|Dolutegravir|dolutegravir
4642645|NCT03602690|Darunavir|darunavir
4642646|NCT03602690|Cambodia|cambodia
4642647|NCT03602677|Colorectal surgery|colorectal surgery
4642648|NCT03602677|Anastomosis|anastomosis
4642649|NCT03602677|Anastomosis leak|anastomosis leak
4642650|NCT03602677|Fluorescence imaging|fluorescence imaging
4642651|NCT03602625|Premature birth; Risk factors|premature birth; risk factors
4642652|NCT03602612|B-cell Maturation Antigen|b-cell maturation antigen
4642653|NCT03602612|Immunotherapy|immunotherapy
4642654|NCT03602612|Chimeric Antigen Receptor|chimeric antigen receptor
4642655|NCT03602612|Adoptive T Cell Therapy|adoptive t cell therapy
4642656|NCT03602599|Mouth|mouth
4642657|NCT03602599|Alloimmunity|alloimmunity
4642658|NCT03602599|Autoimmunity|autoimmunity
4642659|NCT03602599|Salivary Gland|salivary gland
4642660|NCT03602599|Ulcer|ulcer
4642661|NCT03602573|Nonalcoholic steatohepatitis|nonalcoholic steatohepatitis
4642662|NCT03602573|Liver fibrosis|liver fibrosis
4642663|NCT03602573|Menopause|menopause
4642664|NCT03602573|Hormone|hormone
4642665|NCT03602560|PBC|pbc
4642666|NCT03602560|Primary Biliary Cholangitis (PBC)|primary biliary cholangitis (pbc)
4642667|NCT03602534|acne vulgaris|acne vulgaris
4642668|NCT03602534|thyroid dysfunction|thyroid dysfunction
4642669|NCT03602521|Psychiatry|psychiatry
4642670|NCT03602521|Suicidal Behavior|suicidal behavior
4642671|NCT03602521|Borderline Personality Disorder|borderline personality disorder
4642672|NCT03602521|Interpersonal Relations|interpersonal relations
4642673|NCT03602521|Social Stress|social stress
4642674|NCT03602521|Oxytocin|oxytocin
4642675|NCT03602521|Neuropeptide|neuropeptide
4642676|NCT03602508|darifenacin|darifenacin
4642677|NCT03602508|fesoterodine|fesoterodine
4642678|NCT03602508|trospium|trospium
4642679|NCT03602508|solifenacin|solifenacin
4642680|NCT03602508|oxybutynin|oxybutynin
4642681|NCT03602508|tolterodine|tolterodine
4642682|NCT03602508|Betmiga|betmiga
4642683|NCT03602508|YM178|ym178
4642684|NCT03602508|mirabegron|mirabegron
4642685|NCT03602508|Overactive bladder|overactive bladder
4642686|NCT03602508|propiverine|propiverine
4642687|NCT03602508|antimuscarinics|antimuscarinics
4642688|NCT03602508|OAB|oab
4642689|NCT03602508|imidafenacin|imidafenacin
4642690|NCT03602482|postural tachycardia syndrome|postural tachycardia syndrome
4642691|NCT03602482|cognition|cognition
4642692|NCT03602443|Upper Extremity Hemiparesis|upper extremity hemiparesis
4642693|NCT03602417|colorectal cancer|colorectal cancer
4642694|NCT03602417|stent|stent
4642695|NCT03602404|Iodine|iodine
4642696|NCT03602378|Parents|parents
4642697|NCT03602378|Quality of life|quality of life
4642698|NCT03602378|Stress|stress
4642699|NCT03602378|Children with developmental disability|children with developmental disability
4642700|NCT03602378|Children with chronic disease|children with chronic disease
4642701|NCT03602378|Cortisol|cortisol
4642702|NCT03602378|Heart rate variability|heart rate variability
4642703|NCT03602378|Advanced glycation end products|advanced glycation end products
4642704|NCT03602378|Sleep quality|sleep quality
4642705|NCT03602378|Family cohesion|family cohesion
4642706|NCT03602378|Stigma|stigma
4642707|NCT03602378|Resilience|resilience
4642708|NCT03602378|Anxiety|anxiety
4642709|NCT03602378|Depression|depression
4642710|NCT03602378|Self Esteem|self esteem
4642711|NCT03602365|Oxygen Consumption|oxygen consumption
4642712|NCT03602365|Physical Activity|physical activity
4642713|NCT03602365|Passive Motion|passive motion
4642714|NCT03602352|Cohort|cohort
4642715|NCT03602352|Surgery|surgery
4642716|NCT03602352|Adhesive Small Bowel Obstruction|adhesive small bowel obstruction
4642717|NCT03602352|Cost|cost
4642718|NCT03602339|Gadolinium|gadolinium
4642719|NCT03602339|Contrast enhancement|contrast enhancement
4642720|NCT03602339|Central nervous system lesion|central nervous system lesion
4642721|NCT03602326|Stroke|stroke
4642722|NCT03602326|Early term|early term
4642723|NCT03602326|Bobath|bobath
4642724|NCT03602326|Neurodevelopmental treatment|neurodevelopmental treatment
4642725|NCT03602326|Rehabilitation|rehabilitation
4642726|NCT03602313|Body Weight Support|body weight support
4642727|NCT03602287|anterior nasal pack|anterior nasal pack
4642728|NCT03602287|nasal pack removal|nasal pack removal
4642729|NCT03602287|2% lignocaine|2% lignocaine
4642730|NCT03602274|Paracetamol|paracetamol
4642731|NCT03602274|APAP|apap
4642732|NCT03602274|malnutrition|malnutrition
4642733|NCT03602274|biomarker|biomarker
4642734|NCT03602274|liver toxicity|liver toxicity
4642735|NCT03602274|NAPQI|napqi
4642736|NCT03602222|LGBT mental health|lgbt mental health
4642737|NCT03602222|provider training in LGBT-affirmative clinical practice|provider training in lgbt-affirmative clinical practice
4642738|NCT03602209|implant-related infections|implant-related infections
4642739|NCT03602209|orthopaedics|orthopaedics
4642740|NCT03602209|implant removal|implant removal
4642741|NCT03602209|antibiotic duration|antibiotic duration
4642742|NCT03602209|outcome|outcome
4642743|NCT03602183|difficult airway|difficult airway
4642744|NCT03602183|endotracheal intubation|endotracheal intubation
4642745|NCT03602183|chest compression|chest compression
4642746|NCT03602183|physician|physician
4642747|NCT03602170|High-Intensity Interval Training|high-intensity interval training
4642748|NCT03602170|Exercise|exercise
4642749|NCT03602170|Cardiovascular Health|cardiovascular health
4642750|NCT03602170|Blood Pressure|blood pressure
4642751|NCT03602157|CAR T cells|car t cells
4642752|NCT03602157|CD30|cd30
4642753|NCT03602157|CCR4|ccr4
4642754|NCT03602157|Lymphoma|lymphoma
4642755|NCT03602157|T lymphocytes|t lymphocytes
4642756|NCT03602131|Chidamide|chidamide
4642757|NCT03602131|autologous stem cell transplantation|autologous stem cell transplantation
4642758|NCT03602118|clinical seizures,|clinical seizures,
4642759|NCT03602105|exercise|exercise
4642760|NCT03602105|prehabilitation|prehabilitation
4642761|NCT03602105|arthritis|arthritis
4642762|NCT03602105|quality of life|quality of life
4642763|NCT03602105|osteoarthritis|osteoarthritis
4642764|NCT03602105|rehabilitation|rehabilitation
4642765|NCT03602053|diarrhea|diarrhea
4642766|NCT03602053|Rotavirus|rotavirus
4642767|NCT03602053|ROTAVAC|rotavac
4642768|NCT03602053|Rotavirus vaccine|rotavirus vaccine
4642769|NCT03602014|Hypotension|hypotension
4642770|NCT03602014|Spinal Cord Injury|spinal cord injury
4642771|NCT03602014|Droxidopa|droxidopa
4642772|NCT03602014|Northera|northera
4642773|NCT03602014|Neurogenic Orthostatic Hypotension|neurogenic orthostatic hypotension
4642774|NCT03602001|attentive eating|attentive eating
4642775|NCT03602001|e-health|e-health
4642776|NCT03602001|weight loss|weight loss
4642777|NCT03602001|food intake|food intake
4642778|NCT03601988|gastric cancer|gastric cancer
4642779|NCT03601988|radiotherapy|radiotherapy
4642780|NCT03601988|postoperative|postoperative
4642781|NCT03601962|Xerostomia|xerostomia
4642782|NCT03601962|pH|ph
4642783|NCT03601962|Saliva|saliva
4642784|NCT03601962|Aqualief|aqualief
4642785|NCT03601962|Carnosine|carnosine
4642786|NCT03601962|hibiscus|hibiscus
4642787|NCT03601962|oral health|oral health
4642788|NCT03601949|Back Pain|back pain
4642789|NCT03601949|Low Back Pain|low back pain
4643085|NCT03599908|laboratory|laboratory
4642790|NCT03601949|Sacroiliac Back Pain|sacroiliac back pain
4642791|NCT03601923|Pancreatic Cancer|pancreatic cancer
4642792|NCT03601884|Well-being|well-being
4642793|NCT03601884|Self-efficacy|self-efficacy
4642794|NCT03601884|Self-management|self-management
4642795|NCT03601884|Psychosocial|psychosocial
4642796|NCT03601884|Malaysia|malaysia
4642797|NCT03601871|Thalidomide|thalidomide
4642798|NCT03601871|Chemotherapy-induced Nausea and Vomiting|chemotherapy-induced nausea and vomiting
4642799|NCT03601871|cisplatin|cisplatin
4642800|NCT03601858|Attention deficit|attention deficit
4642801|NCT03601858|hyperactivity disorder|hyperactivity disorder
4642802|NCT03601858|Adult|adult
4642803|NCT03601858|Epidemiology|epidemiology
4642804|NCT03601858|Evolution|evolution
4642805|NCT03601858|treatment|treatment
4642806|NCT03601845|Magnetic resonance elastography|magnetic resonance elastography
4642807|NCT03601845|Intrinsic activation|intrinsic activation
4642808|NCT03601845|Liver disease|liver disease
4642809|NCT03601845|Cerebral function|cerebral function
4642810|NCT03601832|scar-related|scar-related
4642811|NCT03601832|ventricular tachycardia|ventricular tachycardia
4642812|NCT03601832|substrate ablation|substrate ablation
4642813|NCT03601832|stereotactic radiosurgery|stereotactic radiosurgery
4642814|NCT03601832|functional radiosurgery|functional radiosurgery
4642815|NCT03601832|4D navigation|4d navigation
4642816|NCT03601819|Relapsed|relapsed
4642817|NCT03601819|Refractory|refractory
4642818|NCT03601819|MyD88|myd88
4642819|NCT03601819|JAK2|jak2
4642820|NCT03601819|JAK3|jak3
4642821|NCT03601819|TYK2|tyk2
4642822|NCT03601819|IRAK1|irak1
4642823|NCT03601819|CLL|cll
4642824|NCT03601819|SMZL|smzl
4642825|NCT03601819|LPL|lpl
4642826|NCT03601819|WM|wm
4642827|NCT03601819|MCL|mcl
4642828|NCT03601819|CTCL|ctcl
4642829|NCT03601819|PTCL|ptcl
4642830|NCT03601767|sepsis|sepsis
4642831|NCT03601767|score|score
4642832|NCT03601728|elective|elective
4642833|NCT03601715|Diathermy|diathermy
4642834|NCT03601715|Short-Wave Therapy|short-wave therapy
4642835|NCT03601715|Body temperature|body temperature
4642836|NCT03601715|Skin Temperature|skin temperature
4642837|NCT03601702|acute ischemic stroke|acute ischemic stroke
4642838|NCT03601702|endovascular treatment|endovascular treatment
4642839|NCT03601702|stent retriever device|stent retriever device
4642840|NCT03601702|mechanical thrombectomy|mechanical thrombectomy
4642841|NCT03601689|Low rectal cancer|low rectal cancer
4642842|NCT03601689|Neoadjuvant treatment|neoadjuvant treatment
4642843|NCT03601689|Complete pathological response|complete pathological response
4642844|NCT03601689|ypT0N0|ypt0n0
4642845|NCT03601689|disease free survival|disease free survival
4642846|NCT03601689|Predictive factors|predictive factors
4642847|NCT03601663|physical activity|physical activity
4642848|NCT03601663|obesity|obesity
4642849|NCT03601663|pilot study|pilot study
4642850|NCT03601663|randomized controlled trial|randomized controlled trial
4642851|NCT03601663|women|women
4642852|NCT03601663|eHealth|ehealth
4642853|NCT03601624|Multiple Myeloma|multiple myeloma
4642854|NCT03601624|Relapse|relapse
4642855|NCT03601624|Progression|progression
4642856|NCT03601624|Pomalidomide|pomalidomide
4642857|NCT03601559|gut-brain axis, cognitve demand battery, probiotics|gut-brain axis, cognitve demand battery, probiotics
4642858|NCT03601494|Diabetic Neuropathies|diabetic neuropathies
4642859|NCT03601494|Chronic pain|chronic pain
4642860|NCT03601481|telemedicine|telemedicine
4642861|NCT03601481|cardiac images|cardiac images
4642862|NCT03601442|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
4642863|NCT03601442|ALL|all
4642864|NCT03601442|Pediatric|pediatric
4642865|NCT03601442|Diffuse Large b-cell Lymphoma|diffuse large b-cell lymphoma
4642866|NCT03601442|DLBCL|dlbcl
4642867|NCT03601442|Adult|adult
4642868|NCT03601442|Relapse|relapse
4642869|NCT03601442|Refractory|refractory
4642870|NCT03601442|CTL019|ctl019
4642871|NCT03601442|tisagenlecleucel|tisagenlecleucel
4642872|NCT03601442|Kymriah|kymriah
4642873|NCT03601442|CART19|cart19
4642874|NCT03601442|CART|cart
4642875|NCT03601442|CAR T cells|car t cells
4642876|NCT03601442|Chimeric antigen receptor|chimeric antigen receptor
4642877|NCT03601442|Manufacturing|manufacturing
4642878|NCT03601442|Expanded Access|expanded access
4642879|NCT03601442|Out of Specification|out of specification
4642880|NCT03601416|human umbilical cord -derived mesenchymal stem cells|human umbilical cord -derived mesenchymal stem cells
4642881|NCT03601416|refractory pulmonary diseases|refractory pulmonary diseases
4642882|NCT03601403|Education|education
4642883|NCT03601403|Dry Powder Inhalers|dry powder inhalers
4642884|NCT03601403|Metered Dose Inhalers|metered dose inhalers
4642885|NCT03601403|Pulmonary Disease|pulmonary disease
4642886|NCT03601403|Chronic Obstructive|chronic obstructive
4642887|NCT03601390|PET/CT|pet/ct
4642888|NCT03601390|EBV DNA|ebv dna
4642889|NCT03601390|predicting predicting|predicting predicting
4642890|NCT03601377|attention bias|attention bias
4642891|NCT03601377|treatment predictors|treatment predictors
4642892|NCT03601364|peep, tidal volume, cardiopulmonary bypass, oxidative stress|peep, tidal volume, cardiopulmonary bypass, oxidative stress
4643383|NCT03597906|LASIK|lasik
4642893|NCT03601351|CANCER, COLON, OPIOIDS, MOR-1|cancer, colon, opioids, mor-1
4642894|NCT03601338|Unexplained stillbirth|unexplained stillbirth
4642895|NCT03601338|Low molecular Weight Heparin|low molecular weight heparin
4642896|NCT03601338|Umbilical artery|umbilical artery
4642897|NCT03601338|Doppler Ultrasound|doppler ultrasound
4642898|NCT03601338|Antenatal care|antenatal care
4642899|NCT03601325|pancreatitis|pancreatitis
4642900|NCT03601273|left gastric artery embolization|left gastric artery embolization
4642901|NCT03601273|bariatric embolization|bariatric embolization
4642902|NCT03601273|interventional radiology|interventional radiology
4642904|NCT03601273|morbid obesity|morbid obesity
4642905|NCT03601273|weight loss|weight loss
4642906|NCT03601234|Gastric stromal tumors|gastric stromal tumors
4642907|NCT03601195|Sonoelastography|sonoelastography
4642908|NCT03601169|cognition|cognition
4642909|NCT03601169|mood|mood
4642910|NCT03601169|sleep|sleep
4642911|NCT03601156|rectal cancer|rectal cancer
4642912|NCT03601156|intraarterial chemoembolization|intraarterial chemoembolization
4642913|NCT03601156|radiotherpy|radiotherpy
4642914|NCT03601156|Oxaliplatin|oxaliplatin
4642915|NCT03601156|Tegafur Gimeracil and Oteracil Porassium Capsule|tegafur gimeracil and oteracil porassium capsule
4642916|NCT03601130|osteotomy|osteotomy
4642917|NCT03601130|osteoarthritis|osteoarthritis
4642918|NCT03601130|bone graft substitute|bone graft substitute
4642919|NCT03601104|Eccentric Training|eccentric training
4642920|NCT03601104|Resistance Training|resistance training
4642921|NCT03601091|dexmedetomidine|dexmedetomidine
4642922|NCT03601091|coronary artery bypass graft|coronary artery bypass graft
4642923|NCT03601091|heart rate variability|heart rate variability
4642924|NCT03601078|Multiple Myeloma|multiple myeloma
4642925|NCT03601078|bb2121|bb2121
4642926|NCT03601078|Relapsed and Refractory Multiple Myeloma|relapsed and refractory multiple myeloma
4642927|NCT03601078|High Risk Multiple Myeloma|high risk multiple myeloma
4642928|NCT03601052|Keloid|keloid
4642929|NCT03601052|MicroRNAs|micrornas
4642930|NCT03601052|Wound healing|wound healing
4642931|NCT03601039|Absnow Absorbable Occluder|absnow absorbable occluder
4642932|NCT03601039|ASD Occluder|asd occluder
4642933|NCT03601026|Severe mental illness|severe mental illness
4642934|NCT03601026|Developmental psychopathology|developmental psychopathology
4642935|NCT03601026|Trial-within-cohort|trial-within-cohort
4642936|NCT03601026|Genetic counselling|genetic counselling
4642937|NCT03601026|Cannabis use|cannabis use
4642938|NCT03601026|Prevention|prevention
4642939|NCT03601000|amnestic|amnestic
4642940|NCT03600987|left middle cerebral artery|left middle cerebral artery
4642941|NCT03600987|cerebrovascular accident (CVA)|cerebrovascular accident (cva)
4642942|NCT03600987|stroke|stroke
4642943|NCT03600935|Transcatheter Aortic Valve Replacement|transcatheter aortic valve replacement
4642944|NCT03600922|Osteoarthritis|osteoarthritis
4642945|NCT03600922|Patellar resurfacing|patellar resurfacing
4642946|NCT03600922|Anterior knee pain|anterior knee pain
4642947|NCT03600909|Blood Stem Cell Transplant|blood stem cell transplant
4642948|NCT03600909|busulfan|busulfan
4642949|NCT03600909|cyclophosphamide|cyclophosphamide
4642950|NCT03600909|fludarabine|fludarabine
4642951|NCT03600909|17-498|17-498
4642952|NCT03600896|Umbilical Cord Blood Transplant|umbilical cord blood transplant
4642953|NCT03600896|Recombinant human interleukin-7|recombinant human interleukin-7
4642954|NCT03600896|CYT107|cyt107
4642955|NCT03600896|T-Cell Recovery after Cord Blood Transplantation|t-cell recovery after cord blood transplantation
4642956|NCT03600896|CBT|cbt
4642957|NCT03600857|medical abortion|medical abortion
4642958|NCT03600857|mifepristone|mifepristone
4642959|NCT03600857|misoprostol|misoprostol
4642960|NCT03600857|home use|home use
4642961|NCT03600831|esophageal neoplasma|esophageal neoplasma
4642962|NCT03600831|adjuvant therapy|adjuvant therapy
4642963|NCT03600831|chemotherapy|chemotherapy
4642964|NCT03600831|radiotherapy|radiotherapy
4642965|NCT03600792|Agenesis of the corpus callosum|agenesis of the corpus callosum
4642966|NCT03600792|whole exome sequencing|whole exome sequencing
4642967|NCT03600792|prenatal diagnosis|prenatal diagnosis
4642968|NCT03600740|Parkinson Disease|parkinson disease
4642969|NCT03600740|Deep Brain Stimulation|deep brain stimulation
4642970|NCT03600740|Diffusion Tensor Imaging|diffusion tensor imaging
4642971|NCT03600714|Hepatitis D|hepatitis d
4642972|NCT03600714|Hepatitis D Virus|hepatitis d virus
4642973|NCT03600714|Cirrhosis|cirrhosis
4642974|NCT03600675|Body composition|body composition
4642975|NCT03600675|Abdominal fat|abdominal fat
4642976|NCT03600675|Inflammatory cytokines|inflammatory cytokines
4642977|NCT03600675|Bone markers|bone markers
4642978|NCT03600675|Bone mineral density|bone mineral density
4642979|NCT03600662|aortic stenosis|aortic stenosis
4642980|NCT03600662|aortic regurgitation|aortic regurgitation
4642981|NCT03600662|Trileaflet reconstruction of the aortic valve|trileaflet reconstruction of the aortic valve
4642982|NCT03600662|Biological aortic valve prosthesis|biological aortic valve prosthesis
4642983|NCT03600662|Effective orifice area|effective orifice area
4642984|NCT03600623|advanced pancreatic cancer|advanced pancreatic cancer
4642985|NCT03600623|inoperable pancreatic cancer|inoperable pancreatic cancer
4642986|NCT03600623|Folfirinox|folfirinox
4642987|NCT03600623|Gemcitabine-Abraxane|gemcitabine-abraxane
4642988|NCT03600623|Gemcitabine-nab-Paclitaxel|gemcitabine-nab-paclitaxel
4642989|NCT03600623|Stereotactic Body Radiotherapy|stereotactic body radiotherapy
4642990|NCT03600571|Viscosupplementation|viscosupplementation
4642991|NCT03600571|Hyaluronate|hyaluronate
4642992|NCT03600571|Distribution|distribution
4642993|NCT03600571|Knee osteoarthritis|knee osteoarthritis
4642994|NCT03600571|Injection approach|injection approach
4642995|NCT03600558|FLAG|flag
4642996|NCT03600532|experimental pain|experimental pain
4642997|NCT03600467|Androgen Receptor Positive|androgen receptor positive
4642998|NCT03600467|Seviteronel|seviteronel
4642999|NCT03600467|Advanced Cancers|advanced cancers
4643000|NCT03600441|cancer|cancer
4643001|NCT03600428|asthma|asthma
4643002|NCT03600428|influenza vaccine|influenza vaccine
4643003|NCT03600428|inactivated influenza vaccine|inactivated influenza vaccine
4643004|NCT03600428|live attenuated influenza vaccine|live attenuated influenza vaccine
4643005|NCT03600415|High Altitude|high altitude
4643006|NCT03600415|arterial blood gas analysis|arterial blood gas analysis
4643007|NCT03600415|near infrared spectroscopy|near infrared spectroscopy
4643008|NCT03600402|ROM|rom
4643009|NCT03600402|Manual Therapy|manual therapy
4643010|NCT03600402|Mobilization|mobilization
4643011|NCT03600402|Ankle|ankle
4643012|NCT03600389|Patient Health Priorities|patient health priorities
4643013|NCT03600389|Health Outcome Goals|health outcome goals
4643014|NCT03600389|Healthcare Preferences|healthcare preferences
4643015|NCT03600324|mild traumatic brain injury|mild traumatic brain injury
4643016|NCT03600324|vestibular impairment|vestibular impairment
4643017|NCT03600324|vestibular rehabilitation|vestibular rehabilitation
4643018|NCT03600272|Combined spinal-epidural analgesia|combined spinal-epidural analgesia
4643019|NCT03600272|Epidural analgesia|epidural analgesia
4643020|NCT03600272|Labor duration|labor duration
4643021|NCT03600259|Myocardial Infarction|myocardial infarction
4643022|NCT03600259|Coronary Disease|coronary disease
4643023|NCT03600259|Coronary Artery Disease|coronary artery disease
4643024|NCT03600259|Myocardial Ischemia|myocardial ischemia
4643025|NCT03600233|Oncology|oncology
4643026|NCT03600233|Neuroendocrine Tumors|neuroendocrine tumors
4643027|NCT03600233|NET|net
4643028|NCT03600233|Vasculogenic mimicry|vasculogenic mimicry
4643029|NCT03600220|acupuncture, hypertension, elderly, home health care|acupuncture, hypertension, elderly, home health care
4643030|NCT03600207|Low Back Pain|low back pain
4643031|NCT03600207|Diaphragm|diaphragm
4643032|NCT03600181|Preoxygenation|preoxygenation
4643033|NCT03600181|Hypoxemia|hypoxemia
4643034|NCT03600181|ICU|icu
4643035|NCT03600181|ORI|ori
4643036|NCT03600181|Orotracheal intubation|orotracheal intubation
4643037|NCT03600142|Stigma|stigma
4643038|NCT03600142|HIV|hiv
4643039|NCT03600142|Counseling|counseling
4643040|NCT03600142|Tanzania|tanzania
4643041|NCT03600142|Pregnancy|pregnancy
4643042|NCT03600142|Cognitive-behavioral therapy|cognitive-behavioral therapy
4643043|NCT03600142|Retention in care|retention in care
4643044|NCT03600142|Prevention of mother to child transmission|prevention of mother to child transmission
4643045|NCT03600129|regional anesthesia|regional anesthesia
4643046|NCT03600129|quadratus lumborum block|quadratus lumborum block
4643047|NCT03600129|patient controlled anesthesia|patient controlled anesthesia
4643048|NCT03600129|laparoscopic prostatectomy|laparoscopic prostatectomy
4643049|NCT03600103|adolescent|adolescent
4643050|NCT03600103|community health nursing|community health nursing
4643051|NCT03600103|text messaging|text messaging
4643052|NCT03600103|mobile health|mobile health
4643053|NCT03600090|Breast Cancer|breast cancer
4643054|NCT03600038|Smoking cessation|smoking cessation
4643055|NCT03600038|App for quitting smoking|app for quitting smoking
4643056|NCT03600038|Cancer|cancer
4643057|NCT03600038|Oncology|oncology
4643058|NCT03600012|Diplegic Cerebral Palsy|diplegic cerebral palsy
4643059|NCT03600012|Cycling With Functional Electrical Stimulation|cycling with functional electrical stimulation
4643060|NCT03600012|Gait Analysis|gait analysis
4643061|NCT03600012|Functional Strenght Training|functional strenght training
4643062|NCT03600012|Quality of Life|quality of life
4643063|NCT03600012|Qxygen Consumption|qxygen consumption
4643064|NCT03599986|RA|ra
4643065|NCT03599973|Rehydration Solutions|rehydration solutions
4643066|NCT03599947|colorectal cancer|colorectal cancer
4643067|NCT03599947|early diagnosis|early diagnosis
4643068|NCT03599947|5-hydroxymethylcytosine|5-hydroxymethylcytosine
4643069|NCT03599934|Elderly|elderly
4643070|NCT03599934|Exercise|exercise
4643071|NCT03599934|Fall|fall
4643072|NCT03599934|Home safety|home safety
4643073|NCT03599921|Family-based Treatment|family-based treatment
4643074|NCT03599921|Enhanced Cognitive Behavioral Therapy|enhanced cognitive behavioral therapy
4643075|NCT03599921|Anorexia Nervosa|anorexia nervosa
4643076|NCT03599921|Other Specified Feeding or Eating Disorder|other specified feeding or eating disorder
4643077|NCT03599921|Bulimia Nervosa|bulimia nervosa
4643078|NCT03599921|Unspecified Feeding or Eating Disorder|unspecified feeding or eating disorder
4643079|NCT03599908|IgE|ige
4643080|NCT03599908|skin prick tests|skin prick tests
4643081|NCT03599908|diagnosis|diagnosis
4643082|NCT03599908|rhinitis|rhinitis
4643083|NCT03599908|asthma|asthma
4643084|NCT03599908|allergy|allergy
4643086|NCT03599895|3D printing technology|3d printing technology
4643087|NCT03599882|human immunodeficiency virus|human immunodeficiency virus
4643088|NCT03599882|liver steatosis|liver steatosis
4643089|NCT03599882|liver fibrosis|liver fibrosis
4643090|NCT03599882|controlled attenuation parameter|controlled attenuation parameter
4643091|NCT03599882|transient elastography|transient elastography
4643092|NCT03599856|Checklist|checklist
4643093|NCT03599856|Intensive Care Unit|intensive care unit
4643094|NCT03599856|Clinical decision support systems|clinical decision support systems
4643095|NCT03599856|Medical errors|medical errors
4643096|NCT03599856|Patient safety|patient safety
4643097|NCT03599830|Immunotherapy|immunotherapy
4643098|NCT03599830|Cognition|cognition
4643099|NCT03599830|Cancer|cancer
4643100|NCT03599804|Vestibular|vestibular
4643101|NCT03599804|Cochlear|cochlear
4643102|NCT03599804|Implant|implant
4643103|NCT03599804|Hearing|hearing
4643104|NCT03599804|Child|child
4643105|NCT03599791|Allergic Rhinitis|allergic rhinitis
4643106|NCT03599791|hayfever|hayfever
4643107|NCT03599791|rhinoconjunctivitis|rhinoconjunctivitis
4643108|NCT03599791|azelastine|azelastine
4643109|NCT03599791|fluticasone|fluticasone
4643110|NCT03599791|nasal spray|nasal spray
4643111|NCT03599791|seasonal|seasonal
4643112|NCT03599791|perennial|perennial
4643113|NCT03599791|TNSS|tnss
4643114|NCT03599791|TOSS|toss
4643115|NCT03599778|apatinib|apatinib
4643116|NCT03599778|Gastric Carcinoma|gastric carcinoma
4643117|NCT03599778|post-operative chemotherapy|post-operative chemotherapy
4643118|NCT03599739|Influenza|influenza
4643119|NCT03599739|Vaccine|vaccine
4643120|NCT03599739|Vaccination|vaccination
4643121|NCT03599739|Nursing Home|nursing home
4643122|NCT03599739|Respiratory-Related Hospitalizations|respiratory-related hospitalizations
4643123|NCT03599713|Metastatic merkel cell carcinoma|metastatic merkel cell carcinoma
4643124|NCT03599713|anti-PD-1 antibody|anti-pd-1 antibody
4643125|NCT03599713|immunoglobulin G4 (IgG4) monoclonal antibody|immunoglobulin g4 (igg4) monoclonal antibody
4643126|NCT03599713|INCMGA00012|incmga00012
4643127|NCT03599700|thrombosis|thrombosis
4643128|NCT03599700|myeloproliferative neoplasms|myeloproliferative neoplasms
4643129|NCT03599661|Cancer|cancer
4643130|NCT03599661|Fertility|fertility
4643131|NCT03599661|Preservation|preservation
4643132|NCT03599648|intervention|intervention
4643133|NCT03599648|behavioral parent training|behavioral parent training
4643134|NCT03599648|mindfulness-based stress reduction|mindfulness-based stress reduction
4643135|NCT03599583|HPV|hpv
4643136|NCT03599583|Vaccination|vaccination
4643137|NCT03599583|Practice based intervention|practice based intervention
4643138|NCT03599570|HPV|hpv
4643139|NCT03599570|Vaccination|vaccination
4643140|NCT03599570|Practice based intervention|practice based intervention
4643141|NCT03599557|HPV|hpv
4643142|NCT03599557|Vaccination|vaccination
4643143|NCT03599557|Practice based intervention|practice based intervention
4643144|NCT03599544|Upper limb function|upper limb function
4643145|NCT03599544|Arm and hand weakness|arm and hand weakness
4643146|NCT03599505|intraoperative ultrasonographic localization|intraoperative ultrasonographic localization
4643147|NCT03599505|pulmonary nodules|pulmonary nodules
4643148|NCT03599505|video-assisted thoracoscopic surgery|video-assisted thoracoscopic surgery
4643149|NCT03599492|Gut Microflora|gut microflora
4643150|NCT03599492|Transjugular Intraheptic Portosystemic Shunting|transjugular intraheptic portosystemic shunting
4643151|NCT03599479|Virtual reality|virtual reality
4643152|NCT03599479|Acute pain|acute pain
4643153|NCT03599479|Anxiety|anxiety
4643154|NCT03599440|cardiac output|cardiac output
4643155|NCT03599440|pulse contour analysis|pulse contour analysis
4643156|NCT03599440|stroke volume|stroke volume
4643157|NCT03599440|hemodynamic monitoring|hemodynamic monitoring
4643158|NCT03599427|postoperative analgesia|postoperative analgesia
4643159|NCT03599427|knee surgery|knee surgery
4643160|NCT03599427|intravenous lidocaine|intravenous lidocaine
4643161|NCT03599414|sarcoidosis|sarcoidosis
4643162|NCT03599414|cardiac|cardiac
4643163|NCT03599414|MRI|mri
4643164|NCT03599414|Echocardiography|echocardiography
4643165|NCT03599414|pulmonary|pulmonary
4643166|NCT03599414|cytokine|cytokine
4643167|NCT03599375|Chimeric Antigen Receptor-Modified T Cells|chimeric antigen receptor-modified t cells
4643168|NCT03599375|CART|cart
4643169|NCT03599375|Recurrent B Cell Acute Lymphoblastic Leukemia|recurrent b cell acute lymphoblastic leukemia
4643170|NCT03599375|refractory B Cell Acute Lymphoblastic Leukemia|refractory b cell acute lymphoblastic leukemia
4643171|NCT03599375|ALL|all
4643172|NCT03599310|Advance care planning|advance care planning
4643173|NCT03599310|Communication|communication
4643174|NCT03599310|Nurse|nurse
4643175|NCT03599310|End-of-life|end-of-life
4643176|NCT03599232|formative assessment|formative assessment
4643177|NCT03599232|objective structured clinical examination (OSCE)|objective structured clinical examination (osce)
4643178|NCT03599232|Iraq|iraq
4643179|NCT03599232|impact|impact
4643180|NCT03599232|feedback|feedback
4643181|NCT03599219|platelets|platelets
4643182|NCT03599219|bleeding|bleeding
4643183|NCT03599206|genetic: CXCR3 polymorphism rs2280964|genetic: cxcr3 polymorphism rs2280964
4643184|NCT03599180|Knee Osteoarthritis|knee osteoarthritis
4643185|NCT03599180|Sensitized Acupoints|sensitized acupoints
4643186|NCT03599180|Microdialysis|microdialysis
4643187|NCT03599180|High performance liquid chromatography（HPLC）|high performance liquid chromatography（hplc）
4643188|NCT03599167|red blood cell transfusion|red blood cell transfusion
4643189|NCT03599167|preterm infant|preterm infant
4643190|NCT03599167|HAS guideline|has guideline
4643191|NCT03599167|transfusion guidelines|transfusion guidelines
4643192|NCT03599167|kappa agreement test application|kappa agreement test application
4643193|NCT03599154|Gemcitabine|gemcitabine
4643194|NCT03599141|adolescent|adolescent
4643195|NCT03599141|parent|parent
4643196|NCT03599115|inhibitory control training|inhibitory control training
4643197|NCT03599115|food|food
4643198|NCT03599115|event-related potentials|event-related potentials
4643199|NCT03599115|weight reduction|weight reduction
4643200|NCT03599037|ICOUGH Recovery App|icough recovery app
4643201|NCT03599037|Length of stay|length of stay
4643202|NCT03599037|Care coach|care coach
4643203|NCT03599037|Incentive spirometry|incentive spirometry
4643204|NCT03599037|Coughing|coughing
4643205|NCT03599037|Post operative ambulation|post operative ambulation
4643206|NCT03599037|Deep breathing|deep breathing
4643207|NCT03599037|Smartphone|smartphone
4643208|NCT03599024|patient-controlled analgesia|patient-controlled analgesia
4643209|NCT03599024|epidural analgesia|epidural analgesia
4643210|NCT03599024|analgesics|analgesics
4643211|NCT03599024|drug consumption|drug consumption
4643212|NCT03599024|total hip replacement|total hip replacement
4643213|NCT03599024|pain relief|pain relief
4643214|NCT03598985|Balance|balance
4643215|NCT03598985|Smartphone|smartphone
4643216|NCT03598985|Validity|validity
4643217|NCT03598985|Reliability|reliability
4643218|NCT03598985|chronic ankle instability|chronic ankle instability
4643219|NCT03598933|Upper Esophageal Sphincter|upper esophageal sphincter
4643220|NCT03598933|botulinum toxin|botulinum toxin
4643221|NCT03598933|Cricopharyngeal dysfunction|cricopharyngeal dysfunction
4643222|NCT03598933|Cricopharyngeal botulinum toxin injection|cricopharyngeal botulinum toxin injection
4643223|NCT03598920|obesity|obesity
4643224|NCT03598920|bariatric medicine|bariatric medicine
4643225|NCT03598920|endoscopy treatment|endoscopy treatment
4643226|NCT03598920|body composition|body composition
4643227|NCT03598920|Adipokines|adipokines
4643228|NCT03598920|Ghrelin|ghrelin
4643229|NCT03598920|Quality of Life|quality of life
4643230|NCT03598920|nutrition status|nutrition status
4643231|NCT03598920|vitamins|vitamins
4643232|NCT03598907|point of care|point of care
4643233|NCT03598907|coagulopathy|coagulopathy
4643234|NCT03598907|lung transplantation|lung transplantation
4643235|NCT03598907|primary graft dysfunction|primary graft dysfunction
4643236|NCT03598868|Bipolar Disorder|bipolar disorder
4643237|NCT03598868|Depression, Bipolar|depression, bipolar
4643238|NCT03598868|vortioxetine|vortioxetine
4643239|NCT03598842|blood signature of Tb risk|blood signature of tb risk
4643240|NCT03598842|anti Mtb immunity|anti mtb immunity
4643241|NCT03598842|RNA biomarkers|rna biomarkers
4643242|NCT03598842|RePORT Study|report study
4643243|NCT03598842|India|india
4643244|NCT03598790|Bimekizumab|bimekizumab
4643245|NCT03598790|PSO|pso
4643246|NCT03598790|Psoriasis|psoriasis
4643247|NCT03598738|Esomeprazole|esomeprazole
4643248|NCT03598738|Gastrin|gastrin
4643249|NCT03598738|HbA1c|hba1c
4643250|NCT03598738|Glycaemic Regulation|glycaemic regulation
4643251|NCT03598686|HIV|hiv
4643252|NCT03598686|HIV/AIDS|hiv/aids
4643253|NCT03598686|self-testing|self-testing
4643254|NCT03598686|HIVST|hivst
4643255|NCT03598686|home-based|home-based
4643256|NCT03598686|community-based|community-based
4643257|NCT03598686|lesotho|lesotho
4643258|NCT03598686|oraquick|oraquick
4643259|NCT03598686|testing coverage|testing coverage
4643260|NCT03598686|htc campaign|htc campaign
4643261|NCT03598660|Breast cancer, SORCIN, Annexin A3|breast cancer, sorcin, annexin a3
4643262|NCT03598647|exercise|exercise
4643263|NCT03598647|physical activity|physical activity
4643264|NCT03598647|obesity|obesity
4643265|NCT03598647|weight loss|weight loss
4643266|NCT03598634|cross-linking|cross-linking
4643267|NCT03598608|programmed cell death 1 (PD-1, PD1)|programmed cell death 1 (pd-1, pd1)
4643268|NCT03598608|programmed cell death ligand 1 (PD-L1, PDL1)|programmed cell death ligand 1 (pd-l1, pdl1)
4643269|NCT03598608|programmed cell death ligand 2 (PD-L2, PDL2)|programmed cell death ligand 2 (pd-l2, pdl2)
4643270|NCT03598582|myelodysplastic syndromes|myelodysplastic syndromes
4643271|NCT03598582|erythropoiesis stimulating agents|erythropoiesis stimulating agents
4643272|NCT03598582|factors of response|factors of response
4643273|NCT03598556|China|china
4643274|NCT03598556|Anti-retroviral Therapy|anti-retroviral therapy
4643275|NCT03598556|Vitamin D|vitamin d
4643276|NCT03598556|Tenofovir|tenofovir
4643277|NCT03598556|Efavirenz|efavirenz
4643278|NCT03598556|Lamivudine|lamivudine
4643279|NCT03598530|Fracture fixation|fracture fixation
4643280|NCT03598530|Surgical treatment|surgical treatment
4643281|NCT03598530|Fracture reduction|fracture reduction
4643282|NCT03598504|SCI|sci
4643283|NCT03598504|Spasms|spasms
4643284|NCT03598504|Vibration|vibration
4643384|NCT03597893|intranasal oxytocin|intranasal oxytocin
4643285|NCT03598465|Post-hepatectomy liver failure|post-hepatectomy liver failure
4643286|NCT03598465|Sphingolipids metabolism|sphingolipids metabolism
4643287|NCT03598452|Cytomegalovirus retinopathy|cytomegalovirus retinopathy
4643288|NCT03598452|High-dose|high-dose
4643289|NCT03598452|Ganciclovir|ganciclovir
4643290|NCT03598452|Intravitreal injection|intravitreal injection
4643291|NCT03598439|influenza vaccine|influenza vaccine
4643292|NCT03598439|adults|adults
4643293|NCT03598439|Immune response|immune response
4643294|NCT03598413|enhanced recovery|enhanced recovery
4643295|NCT03598413|perioperative nutrition|perioperative nutrition
4643296|NCT03598413|macrophages|macrophages
4643297|NCT03598413|omega 3 fatty acids|omega 3 fatty acids
4643298|NCT03598387|acute kidney injury|acute kidney injury
4643299|NCT03598387|automated peritoneal dialysis|automated peritoneal dialysis
4643300|NCT03598387|intermittent hemodialysis|intermittent hemodialysis
4643301|NCT03598387|renal recovery|renal recovery
4643302|NCT03598374|Inositol|inositol
4643303|NCT03598374|Polycystic ovarian syndrome|polycystic ovarian syndrome
4643304|NCT03598374|Fertility|fertility
4643305|NCT03598374|Clinical pregnancy rate|clinical pregnancy rate
4643306|NCT03598374|Miscarriage rate|miscarriage rate
4643307|NCT03598374|Live birth rate|live birth rate
4643308|NCT03598361|pregnancy outcomes, minerals|pregnancy outcomes, minerals
4643309|NCT03598348|advanced gastric cancer, apatinib, capecitabine, maintenance|advanced gastric cancer, apatinib, capecitabine, maintenance
4643310|NCT03598309|Lung RADS 3|lung rads 3
4643311|NCT03598309|Lung nodule|lung nodule
4643312|NCT03598309|Lung cancer risk|lung cancer risk
4643313|NCT03598309|Chemoprevention|chemoprevention
4643314|NCT03598296|ERAS(Enhanced Recovery After Surgery)|eras(enhanced recovery after surgery)
4643315|NCT03598296|lobectomy|lobectomy
4643316|NCT03598296|Non-Small Cell Lung Cancer (NSCLC)|non-small cell lung cancer (nsclc)
4643317|NCT03598296|Thoracoscopes|thoracoscopes
4643318|NCT03598270|Ovarian|ovarian
4643319|NCT03598270|Atezolizumab|atezolizumab
4643320|NCT03598270|Niraparib|niraparib
4643321|NCT03598218|Hypofractionated Radiation|hypofractionated radiation
4643322|NCT03598218|initial distant metastases|initial distant metastases
4643323|NCT03598218|nasopharyngeal carcinoma|nasopharyngeal carcinoma
4643324|NCT03598205|Therapy for diabetic macular edema|therapy for diabetic macular edema
4643325|NCT03598205|Curcumin formulation (DIABEC)|curcumin formulation (diabec)
4643326|NCT03598192|Hepatectomy|hepatectomy
4643327|NCT03598192|Transversus abdominis plane block (TAP block)|transversus abdominis plane block (tap block)
4643328|NCT03598192|Paravertebral block|paravertebral block
4643329|NCT03598192|Postoperative analgesia|postoperative analgesia
4643330|NCT03598192|Liver resection|liver resection
4643331|NCT03598166|colorectal cancer screening|colorectal cancer screening
4643332|NCT03598166|septin 9|septin 9
4643333|NCT03598153|Waist and knee pain|waist and knee pain
4643334|NCT03598153|sciatica|sciatica
4643335|NCT03598140|Sildenafil|sildenafil
4643336|NCT03598140|Concussion|concussion
4643337|NCT03598140|CBF|cbf
4643338|NCT03598140|CVR|cvr
4643339|NCT03598127|Vitamin A|vitamin a
4643340|NCT03598127|status|status
4643341|NCT03598127|sepsis|sepsis
4643342|NCT03598127|illness severity|illness severity
4643343|NCT03598049|Implants|implants
4643344|NCT03598049|Stability|stability
4643345|NCT03598049|Bone loss|bone loss
4643346|NCT03598049|Success|success
4643347|NCT03598036|calcineurin inhibitors|calcineurin inhibitors
4643348|NCT03598036|Focal Segmental Glomerulosclerosis|focal segmental glomerulosclerosis
4643349|NCT03598023|ACell|acell
4643350|NCT03598023|Hand|hand
4643351|NCT03598023|Burn|burn
4643352|NCT03598023|ACell Cytal Burn Matrix®|acell cytal burn matrix®
4643353|NCT03598023|Extracellular Matrix|extracellular matrix
4643354|NCT03598023|Urinary Bladder Matrix|urinary bladder matrix
4643355|NCT03598023|Wound|wound
4643356|NCT03598023|Partial-Thickness|partial-thickness
4643357|NCT03598023|Burn Management|burn management
4643358|NCT03597997|Postoperative pain|postoperative pain
4643359|NCT03597997|Total intravenous anaesthesia|total intravenous anaesthesia
4643360|NCT03597997|TIVA|tiva
4643361|NCT03597997|Propofol|propofol
4643362|NCT03597997|Hepatectomy|hepatectomy
4643363|NCT03597958|Familial Hypercholesterolemia|familial hypercholesterolemia
4643364|NCT03597958|Hypercholesterolemia|hypercholesterolemia
4643365|NCT03597958|Cascade Screening|cascade screening
4643366|NCT03597958|Novel FH Genes|novel fh genes
4643367|NCT03597958|Novel FH Mutations|novel fh mutations
4643368|NCT03597958|Next generation sequencing|next generation sequencing
4643369|NCT03597945|Magnesium sulfate|magnesium sulfate
4643370|NCT03597945|lidocaine|lidocaine
4643371|NCT03597945|femoral nerve block|femoral nerve block
4643372|NCT03597945|prehospital|prehospital
4643373|NCT03597945|pain|pain
4643374|NCT03597932|major surgery|major surgery
4643375|NCT03597932|ansethesia care|ansethesia care
4643376|NCT03597932|postoperative complication|postoperative complication
4643377|NCT03597932|handover checklist|handover checklist
4643378|NCT03597932|anesthesiologist burnout|anesthesiologist burnout
4643379|NCT03597919|Inactivated Poliovirus Vaccine|inactivated poliovirus vaccine
4643380|NCT03597919|Sabin strain|sabin strain
4643381|NCT03597906|Topography guided ablation|topography guided ablation
4643382|NCT03597906|Astigmatism|astigmatism
4643385|NCT03597893|stress|stress
4643386|NCT03597893|belief updating|belief updating
4643387|NCT03597880|difficult airway, obese patient,|difficult airway, obese patient,
4643388|NCT03597867|vitreoretinal surgery|vitreoretinal surgery
4643389|NCT03597867|epiretinal membrane|epiretinal membrane
4643390|NCT03597867|macular hole|macular hole
4643391|NCT03597867|non steroidal antinflammatory drugs|non steroidal antinflammatory drugs
4643392|NCT03597867|prostaglandin E2|prostaglandin e2
4643393|NCT03597854|Acute kidney disease|acute kidney disease
4643394|NCT03597854|critically ill|critically ill
4643395|NCT03597841|Monotherapy|monotherapy
4643396|NCT03597841|Combination therapy|combination therapy
4643397|NCT03597841|Colistin-resistant|colistin-resistant
4643398|NCT03597841|Klebsiella Pneumonia|klebsiella pneumonia
4643399|NCT03597841|Bacteremia|bacteremia
4643400|NCT03597841|Blood stream infection|blood stream infection
4643401|NCT03597828|Monitored Anesthesia Care|monitored anesthesia care
4643402|NCT03597828|Pleuroscopy|pleuroscopy
4643403|NCT03597828|dexmedetomidine|dexmedetomidine
4643404|NCT03597828|fentanyl|fentanyl
4643405|NCT03597828|midazolam|midazolam
4643406|NCT03597828|sedation|sedation
4643407|NCT03597802|Ergonomics|ergonomics
4643408|NCT03597802|Workplace|workplace
4643409|NCT03597802|Exercise|exercise
4643410|NCT03597789|Tantrums|tantrums
4643411|NCT03597789|Inattentive|inattentive
4643412|NCT03597789|Noncompliance|noncompliance
4643413|NCT03597776|intravenous lidocaine|intravenous lidocaine
4643414|NCT03597776|pain|pain
4643415|NCT03597776|total knee replacement|total knee replacement
4643416|NCT03597776|spinal anaesthesia|spinal anaesthesia
4643417|NCT03597763|persistent fatigue|persistent fatigue
4643418|NCT03597763|traumatic brain injury|traumatic brain injury
4643419|NCT03597750|Static air support devices|static air support devices
4643420|NCT03597750|Alternating-pressure devices|alternating-pressure devices
4643421|NCT03597750|High risk population|high risk population
4643422|NCT03597750|Elderly|elderly
4643423|NCT03597750|Prevention|prevention
4643424|NCT03597711|Peripheral Intravenous cannulation|peripheral intravenous cannulation
4643425|NCT03597698|job loss|job loss
4643426|NCT03597698|unfit for a job|unfit for a job
4643427|NCT03597672|Gastric carcinoma|gastric carcinoma
4643428|NCT03597672|Early diagnosis|early diagnosis
4643429|NCT03597672|screening stragety|screening stragety
4643430|NCT03597672|health population cohort|health population cohort
4643431|NCT03597646|Kinesio Taping|kinesio taping
4643432|NCT03597646|inspiratory muscle training|inspiratory muscle training
4643433|NCT03597646|respiratory|respiratory
4643434|NCT03597607|Smoking cessation|smoking cessation
4643435|NCT03597607|pharmacist|pharmacist
4643436|NCT03597607|self-efficacy|self-efficacy
4643437|NCT03597594|Severe Combined Immunodeficiency|severe combined immunodeficiency
4643438|NCT03597594|SCID|scid
4643439|NCT03597594|TCRα/β/CD19-depleted graft|tcrα/β/cd19-depleted graft
4643440|NCT03597594|CD45RA-depleted DLI|cd45ra-depleted dli
4643441|NCT03597594|Graft-Versus-Host-Disease|graft-versus-host-disease
4643442|NCT03597594|Transplant|transplant
4643443|NCT03597581|SLC6a8|slc6a8
4643444|NCT03597581|Creatine transporter|creatine transporter
4643445|NCT03597581|FOLFIRI|folfiri
4643446|NCT03597568|Resveratrol|resveratrol
4643447|NCT03597568|Kidney Diseases|kidney diseases
4643448|NCT03597568|Renal Insufficiency|renal insufficiency
4643449|NCT03597568|Diabetes|diabetes
4643450|NCT03597568|Oxidative stress|oxidative stress
4643451|NCT03597568|Endothelial dysfunction|endothelial dysfunction
4643452|NCT03597555|Idiopathic Hypersomnia|idiopathic hypersomnia
4643453|NCT03597542|Children|children
4643454|NCT03597542|Inflammation|inflammation
4643455|NCT03597542|Obesity|obesity
4643456|NCT03597516|Lactose Intolerance|lactose intolerance
4643457|NCT03597490|Partial Thickness Rotator Cuff Tear|partial thickness rotator cuff tear
4643458|NCT03597490|Physical Therapy|physical therapy
4643459|NCT03597477|Autism Spectrum Disorder|autism spectrum disorder
4643460|NCT03597477|Dexmedetomidine|dexmedetomidine
4643461|NCT03597464|lupus nephritis|lupus nephritis
4643462|NCT03597464|calcineurin inhibitors|calcineurin inhibitors
4643463|NCT03597464|voclosporin|voclosporin
4643464|NCT03597451|strength|strength
4643465|NCT03597451|walking|walking
4643466|NCT03597451|sit-to-stand|sit-to-stand
4643467|NCT03597425|Cardiac arrest|cardiac arrest
4643468|NCT03597425|Cardiopulmonary resuscitation|cardiopulmonary resuscitation
4643469|NCT03597425|Survival|survival
4643470|NCT03597425|Prediction|prediction
4643471|NCT03597399|Leber Congenital Amaurosis (LCA)|leber congenital amaurosis (lca)
4643472|NCT03597399|Inherited Retinal Dystrophy|inherited retinal dystrophy
4643473|NCT03597399|RPE65|rpe65
4643474|NCT03597399|Retinitis Pigmentosa (RP)|retinitis pigmentosa (rp)
4643475|NCT03597373|Prediction|prediction
4643476|NCT03597373|Myasthenia gravis|myasthenia gravis
4643477|NCT03597373|Reintubation|reintubation
4643478|NCT03597347|Non-tuberculosis mycobacterial (NTM) infection|non-tuberculosis mycobacterial (ntm) infection
4643479|NCT03597347|Cystic Fibrosis (CF)|cystic fibrosis (cf)
4643480|NCT03597347|M. avium complex (MAC)|m. avium complex (mac)
4643481|NCT03597347|M. abscessus complex (MABSC)|m. abscessus complex (mabsc)
4643482|NCT03597347|Mycobacterium Infections, Nontuberculous|mycobacterium infections, nontuberculous
4643483|NCT03597334|administration,inhalation|administration,inhalation
4643484|NCT03597334|metered dose inhalers|metered dose inhalers
4643485|NCT03597334|nebulizers and vaporizers|nebulizers and vaporizers
4643486|NCT03597334|bronchodilator agents|bronchodilator agents
4643487|NCT03597334|anti-bacterial agents|anti-bacterial agents
4643488|NCT03597321|Allogeneic hematopoietic stem cell transplantation|allogeneic hematopoietic stem cell transplantation
4643489|NCT03597321|donor lymphocyte infusion|donor lymphocyte infusion
4643490|NCT03597295|Squamous carcinoma of the anal canal|squamous carcinoma of the anal canal
4643491|NCT03597295|anti-PD-1 antibody|anti-pd-1 antibody
4643492|NCT03597295|IgG4 monoclonal antibody|igg4 monoclonal antibody
4643493|NCT03597295|INCMGA00012|incmga00012
4643494|NCT03597282|Checkpoint Inhibitor|checkpoint inhibitor
4643495|NCT03597282|Immunotherapy|immunotherapy
4643496|NCT03597282|Personalized Vaccine|personalized vaccine
4643497|NCT03597282|Neoantigen|neoantigen
4643498|NCT03597282|POLY-ICLC|poly-iclc
4643499|NCT03597282|Peptide|peptide
4643500|NCT03597256|Hyaluronic acid|hyaluronic acid
4643501|NCT03597256|Chin Retrusion|chin retrusion
4643502|NCT03597243|Cash transfer|cash transfer
4643503|NCT03597243|HIV|hiv
4643504|NCT03597243|adolescent girls|adolescent girls
4643505|NCT03597243|Tanzania|tanzania
4643506|NCT03597217|PF-05221304, PK, Japanese, NASH, ACC inhibitor|pf-05221304, pk, japanese, nash, acc inhibitor
4643507|NCT03597191|Y-balance test|y-balance test
4643508|NCT03597191|Functional Movement Screen|functional movement screen
4643509|NCT03597191|Spinal stabilization exercises|spinal stabilization exercises
4643510|NCT03597191|Dynamic balance|dynamic balance
4643511|NCT03597191|Postural control|postural control
4643512|NCT03597191|Physical performance|physical performance
4643513|NCT03597165|Incidental Findings|incidental findings
4643514|NCT03597165|Genomic Sequencing|genomic sequencing
4643515|NCT03597165|Randomized Controlled Trial|randomized controlled trial
4643516|NCT03597165|Clinical Utility|clinical utility
4643517|NCT03597165|Personal Utility|personal utility
4643518|NCT03597152|uncomplicated recurrent urinary tract infection|uncomplicated recurrent urinary tract infection
4643519|NCT03597139|Dry Eye|dry eye
4643520|NCT03597139|Calcineurin Inhibitors|calcineurin inhibitors
4643521|NCT03597126|Robotic|robotic
4643522|NCT03597126|Intersphincteric Resection|intersphincteric resection
4643523|NCT03597126|rectal cancer|rectal cancer
4643524|NCT03597126|pelvic autonomic nerve anal function|pelvic autonomic nerve anal function
4643525|NCT03597087|Anesthesia, Bladder cancer, Recurrence rate, Transurethral resection of bladder mass|anesthesia, bladder cancer, recurrence rate, transurethral resection of bladder mass
4643526|NCT03597074|ICU|icu
4643527|NCT03597074|Renal Resistive Index|renal resistive index
4643528|NCT03597074|Acute Kidney Injury|acute kidney injury
4643529|NCT03597074|Sepsis|sepsis
4643530|NCT03597061|obesity prevention|obesity prevention
4643531|NCT03597061|infant|infant
4643532|NCT03597061|complementary feeding|complementary feeding
4643533|NCT03597061|diet variety|diet variety
4643534|NCT03597061|weight-for-length|weight-for-length
4643535|NCT03597061|food responsiveness|food responsiveness
4643536|NCT03597061|satiety responsiveness|satiety responsiveness
4643537|NCT03597048|stigma intervention|stigma intervention
4643538|NCT03597022|Subcutaneous|subcutaneous
4643539|NCT03597022|Prophylaxis|prophylaxis
4643540|NCT03597022|Non-Inhibitors|non-inhibitors
4643541|NCT03597022|Inhibitors|inhibitors
4643542|NCT03597009|talimogene laherparepvec|talimogene laherparepvec
4643543|NCT03597009|Nivolumab|nivolumab
4643544|NCT03597009|PleurX|pleurx
4643545|NCT03596983|Short Sleeping|short sleeping
4643546|NCT03596970|Open-label|open-label
4643547|NCT03596970|randomized|randomized
4643548|NCT03596970|calcineurin-inhibitor|calcineurin-inhibitor
4643549|NCT03596970|CNI|cni
4643550|NCT03596970|tacrolimus|tacrolimus
4643551|NCT03596970|MMF|mmf
4643552|NCT03596970|maintenance liver transplant|maintenance liver transplant
4643553|NCT03596970|RAD001H|rad001h
4643554|NCT03596970|CRAD001H|crad001h
4643555|NCT03596970|liver transplant|liver transplant
4643556|NCT03596970|transplantation|transplantation
4643557|NCT03596944|acute coronary syndrome|acute coronary syndrome
4643558|NCT03596944|statin|statin
4643559|NCT03596944|mortality|mortality
4643560|NCT03596944|GRACE score|grace score
4643561|NCT03596944|TIMI score|timi score
4643562|NCT03596931|acute coronary syndrome|acute coronary syndrome
4643563|NCT03596931|statin|statin
4643564|NCT03596931|acute pulmonary edema|acute pulmonary edema
4643565|NCT03596931|malignant arrhythmia|malignant arrhythmia
4643566|NCT03596931|heart failure|heart failure
4643567|NCT03596879|insomnia|insomnia
4643568|NCT03596879|post partum depression (PPD)|post partum depression (ppd)
4643569|NCT03596879|digital CBTI (dCBTI)|digital cbti (dcbti)
4643570|NCT03596879|online CBTI|online cbti
4643571|NCT03596879|rumination|rumination
4643572|NCT03596866|Drug Therapy|drug therapy
4643573|NCT03596840|Hypertension|hypertension
4643574|NCT03596840|Microalbuminuria|microalbuminuria
4643575|NCT03596840|Effectiveness|effectiveness
4643576|NCT03596840|Antihypertensive medications|antihypertensive medications
4643577|NCT03596827|Diarrhea|diarrhea
4643578|NCT03596827|Gastroenteritis|gastroenteritis
4643579|NCT03596827|Bacterial Infections|bacterial infections
4643580|NCT03596827|Escherichia Coli Infections|escherichia coli infections
4643581|NCT03596827|E.coli|e.coli
4643582|NCT03596814|Hemophilia A|hemophilia a
4643583|NCT03596814|Hemophilia B|hemophilia b
4643584|NCT03596814|Research database|research database
4643585|NCT03596814|Clotting Factors|clotting factors
4643586|NCT03596814|Regimen of Treatment|regimen of treatment
4643587|NCT03596814|Impact Budget Analysis|impact budget analysis
4643588|NCT03596736|Distal Humerus Fracture|distal humerus fracture
4643589|NCT03596736|Arthroplasty, Replacement, Elbow|arthroplasty, replacement, elbow
4643590|NCT03596697|CRV431|crv431
4643591|NCT03596697|Hepatitis B Virus|hepatitis b virus
4643592|NCT03596697|Hepatitis Virus|hepatitis virus
4643593|NCT03596684|Carbohydrate Metabolism|carbohydrate metabolism
4643594|NCT03596684|Citrulline|citrulline
4643595|NCT03596684|Statine|statine
4643596|NCT03596619|plum-blossom needling|plum-blossom needling
4643597|NCT03596619|Photodynamic Therapy|photodynamic therapy
4643598|NCT03596619|Actinic Keratoses|actinic keratoses
4643599|NCT03596606|Chronic Facial Pain|chronic facial pain
4643600|NCT03596606|Osteopathic Manual treatment|osteopathic manual treatment
4643601|NCT03596606|Therapeutic Exercise|therapeutic exercise
4643602|NCT03596593|Solid tumor|solid tumor
4643603|NCT03596593|China|china
4643604|NCT03596593|MSI|msi
4643605|NCT03596593|ctDNA|ctdna
4643606|NCT03596580|Screening tool|screening tool
4643607|NCT03596567|Glasdegib|glasdegib
4643608|NCT03596567|PF-04449913|pf-04449913
4643609|NCT03596567|Pharmacokinetics|pharmacokinetics
4643610|NCT03596567|Renal Impairment|renal impairment
4643611|NCT03596541|Telemedicina|telemedicina
4643612|NCT03596541|Respiratory sounds|respiratory sounds
4643613|NCT03596541|Tele-stethoscopy|tele-stethoscopy
4643614|NCT03596541|Wireless|wireless
4643615|NCT03596541|Real-time|real-time
4643616|NCT03596541|e-health|e-health
4643617|NCT03596541|Heart sounds|heart sounds
4643618|NCT03596528|Interstitial lung disease, cryobiopsy, surgical biopsy|interstitial lung disease, cryobiopsy, surgical biopsy
4643619|NCT03596502|Direct oral anticoagulants|direct oral anticoagulants
4643620|NCT03596502|Safety|safety
4643621|NCT03596502|Atrial fibrillation|atrial fibrillation
4643622|NCT03596502|Ischemic stroke|ischemic stroke
4643623|NCT03596502|Systemic embolization|systemic embolization
4643624|NCT03596476|Gastro-esophageal reflux|gastro-esophageal reflux
4643625|NCT03596476|High resolution Impedance Manometry|high resolution impedance manometry
4643626|NCT03596476|Resistance to proton pump inhibitors (PPI)|resistance to proton pump inhibitors (ppi)
4643627|NCT03596437|Fibromuscular dysplasia|fibromuscular dysplasia
4643628|NCT03596437|Vascular Ehler-Danlos Syndrome|vascular ehler-danlos syndrome
4643629|NCT03596437|Ultrasound|ultrasound
4643630|NCT03596398|Fabry disease|fabry disease
4643631|NCT03596398|Young stroke|young stroke
4643632|NCT03596372|First-in-human,|first-in-human,
4643633|NCT03596372|Immuno-oncology,|immuno-oncology,
4643634|NCT03596372|CEACAM6,|ceacam6,
4643635|NCT03596372|Checkpoint inhibition|checkpoint inhibition
4643636|NCT03596359|Self Care|self care
4643637|NCT03596359|Heart Failure|heart failure
4643638|NCT03596359|Quality of Life|quality of life
4643639|NCT03596359|Teach-Back|teach-back
4643640|NCT03596346|Rapeseed|rapeseed
4643641|NCT03596346|Ingredient|ingredient
4643642|NCT03596346|Safety|safety
4643643|NCT03596346|Tolerability|tolerability
4643644|NCT03596307|Ashwagandha|ashwagandha
4643645|NCT03596307|Endurance|endurance
4643646|NCT03596307|VO2 max|vo2 max
4643647|NCT03596307|Glycowithanolides|glycowithanolides
4643648|NCT03596307|Shoden|shoden
4643649|NCT03596242|high blood pressure|high blood pressure
4643650|NCT03596242|SMS|sms
4643651|NCT03596242|text messaging|text messaging
4643652|NCT03596242|monitoring|monitoring
4643653|NCT03596229|carotid endarterectomy|carotid endarterectomy
4643654|NCT03596229|adverse cardiac events|adverse cardiac events
4643655|NCT03596177|Diabetes Mellitus, Type II|diabetes mellitus, type ii
4643656|NCT03596177|Obesity|obesity
4643657|NCT03596177|MEDI0382|medi0382
4643658|NCT03596151|Chlamydia trachomatis|chlamydia trachomatis
4643659|NCT03596151|device|device
4643660|NCT03596151|diagnostic|diagnostic
4643661|NCT03596151|molecular|molecular
4643662|NCT03596151|Neisseria gonorrhoeae|neisseria gonorrhoeae
4643663|NCT03596151|Trichomonas vaginalis|trichomonas vaginalis
4643664|NCT03596138|angle measurement|angle measurement
4643665|NCT03596138|automated|automated
4643666|NCT03596138|strabismus|strabismus
4643667|NCT03596125|Glutathione|glutathione
4643668|NCT03596125|Antioxidant|antioxidant
4643669|NCT03596125|Oxidative stress|oxidative stress
4643670|NCT03596125|Preterm|preterm
4643671|NCT03596099|Prehypertension|prehypertension
4643672|NCT03596099|Rice vinegar|rice vinegar
4643673|NCT03596099|vinegar|vinegar
4643674|NCT03596099|acetic acid|acetic acid
4643675|NCT03596086|GBM|gbm
4643676|NCT03596086|glioblastoma|glioblastoma
4643677|NCT03596086|Astrocytoma|astrocytoma
4643678|NCT03596073|Breast Cancer|breast cancer
4643679|NCT03596060|hip fracture, general anesthesia, regional anesthesia, clopidogrel, cognitive impairment, mortality|hip fracture, general anesthesia, regional anesthesia, clopidogrel, cognitive impairment, mortality
4643680|NCT03596047|radial wave therapy|radial wave therapy
4643681|NCT03596034|Electronic Nicotine Delivery System (ENDS)|electronic nicotine delivery system (ends)
4643682|NCT03596034|ENDS|ends
4643683|NCT03596034|Puff Topography|puff topography
4643684|NCT03596021|exercise|exercise
4643685|NCT03596021|toe walking|toe walking
4643686|NCT03596021|scale|scale
4643687|NCT03596021|reliability|reliability
4643688|NCT03596021|validity|validity
4643689|NCT03596008|strawberry|strawberry
4643690|NCT03596008|monocytes|monocytes
4643691|NCT03596008|endothelial function|endothelial function
4643692|NCT03595982|chronic hypertension|chronic hypertension
4643693|NCT03595982|postpartum hypertension|postpartum hypertension
4643694|NCT03595982|preeclampsia|preeclampsia
4643695|NCT03595982|treatment|treatment
4643696|NCT03595982|Procardia XL|procardia xl
4643697|NCT03595969|mitochondrial DNA|mitochondrial dna
4643698|NCT03595956|Transgender|transgender
4643699|NCT03595956|HIV/AIDS|hiv/aids
4643700|NCT03595956|Gender affirmation|gender affirmation
4643701|NCT03595956|PrEP|prep
4643702|NCT03595930|ARNUITY|arnuity
4643703|NCT03595930|Effectiveness|effectiveness
4643704|NCT03595930|Asthma|asthma
4643705|NCT03595930|Post-marketing surveillance|post-marketing surveillance
4643706|NCT03595930|Safety|safety
4643707|NCT03595917|B-cell Acute Lymphoblastic Leukemia|b-cell acute lymphoblastic leukemia
4643708|NCT03595917|Chronic Myeloid Leukemia (CML) in lymphoid blast crisis|chronic myeloid leukemia (cml) in lymphoid blast crisis
4643709|NCT03595917|Philadelphia chromosome positive Acute Lymphoblastic Leukemia (Ph+ ALL).|philadelphia chromosome positive acute lymphoblastic leukemia (ph+ all).
4643710|NCT03595904|colorectal neoplasms|colorectal neoplasms
4643711|NCT03595904|colonoscopy|colonoscopy
4643712|NCT03595904|African Americans|african americans
4643713|NCT03595904|Telemedicine|telemedicine
4643714|NCT03595878|Whole Brain Radiation|whole brain radiation
4643715|NCT03595826|ADHD/ADD DCD Exercises Neurostimulant Drugs|adhd/add dcd exercises neurostimulant drugs
4643716|NCT03595813|Immune check point blockade|immune check point blockade
4643717|NCT03595813|biomarkers|biomarkers
4643718|NCT03595813|immunomonitoring|immunomonitoring
4643719|NCT03595787|prehabilitation|prehabilitation
4643720|NCT03595787|coaching|coaching
4643721|NCT03595787|nutritional support|nutritional support
4643722|NCT03595787|physical activity|physical activity
4643723|NCT03595787|allogeneic stem cells transplantation|allogeneic stem cells transplantation
4643724|NCT03595774|nitric oxide|nitric oxide
4643725|NCT03595761|cerebral vasculitis|cerebral vasculitis
4643726|NCT03595748|Hospitalizations|hospitalizations
4643727|NCT03595748|Dialysis patients|dialysis patients
4643728|NCT03595748|Peer mentorship|peer mentorship
4643729|NCT03595722|Pelvic cancer|pelvic cancer
4643730|NCT03595722|rectal cancer|rectal cancer
4643731|NCT03595722|HIFU|hifu
4643732|NCT03595722|QoL|qol
4643733|NCT03595722|complications|complications
4643734|NCT03595709|EFV|efv
4643735|NCT03595709|HIV Infections|hiv infections
4643736|NCT03595631|neurodynamics|neurodynamics
4643737|NCT03595631|pain|pain
4643738|NCT03595592|Unilateral, HER2 positive|unilateral, her2 positive
4643739|NCT03595579|AXS-05|axs-05
4643740|NCT03595579|Major Depressive Disorder|major depressive disorder
4643741|NCT03595579|MDD|mdd
4643742|NCT03595579|Axsome|axsome
4643743|NCT03595579|NMDA Receptor|nmda receptor
4643744|NCT03595579|Depression|depression
4643745|NCT03595579|Dextromethorphan|dextromethorphan
4643746|NCT03595579|Bupropion|bupropion
4643747|NCT03595540|fasting-mimicking diet|fasting-mimicking diet
4643748|NCT03595540|cancer|cancer
4643749|NCT03595540|nutritional status|nutritional status
4643750|NCT03595540|body composition|body composition
4643751|NCT03595540|fasting|fasting
4643752|NCT03595527|Screening|screening
4643753|NCT03595527|Linkage to care|linkage to care
4643754|NCT03595475|Prodromal markers|prodromal markers
4643755|NCT03595475|Psychiatric disorders|psychiatric disorders
4643756|NCT03595475|α-synucleinopathy|α-synucleinopathy
4643757|NCT03595475|Family study|family study
4643758|NCT03595423|long-term survival|long-term survival
4643759|NCT03595423|bioprosthesis|bioprosthesis
4643760|NCT03595410|risk of recurrence|risk of recurrence
4643761|NCT03595410|Nomograms|nomograms
4643762|NCT03595410|Laryngeal cancer|laryngeal cancer
4643763|NCT03595384|Behavioral intervention|behavioral intervention
4643764|NCT03595371|Schnitzler|schnitzler
4643765|NCT03595345|delisting|delisting
4643766|NCT03595345|tumor-specific death|tumor-specific death
4643767|NCT03595345|Milan Criteria|milan criteria
4643768|NCT03595319|Hypotension|hypotension
4643769|NCT03595319|Sevoflurane|sevoflurane
4643770|NCT03595319|Elderly|elderly
4643771|NCT03595293|Prescription Opioid Use Disorder|prescription opioid use disorder
4643772|NCT03595293|Alcohol Use Disorder|alcohol use disorder
4643773|NCT03595293|Functional Near-infrared Spectroscopy|functional near-infrared spectroscopy
4643774|NCT03595293|Treatment Outcome|treatment outcome
4643775|NCT03595293|Resisting Craving|resisting craving
4643776|NCT03595267|Indigenous Canadians|indigenous canadians
4643777|NCT03595267|Screening Study|screening study
4643778|NCT03595215|TENS|tens
4643779|NCT03595163|Sevoflurane|sevoflurane
4643780|NCT03595163|Propofol|propofol
4643781|NCT03595163|Folic Acid Concentrations|folic acid concentrations
4643782|NCT03595163|Homocysteine Concentrations|homocysteine concentrations
4643783|NCT03595163|Cochlear Implant Surgery|cochlear implant surgery
4643784|NCT03595150|Endoscopic Retrograde Cholangiopancreatography|endoscopic retrograde cholangiopancreatography
4643785|NCT03595150|Pancreatitis|pancreatitis
4643786|NCT03595150|Diclofenac|diclofenac
4643787|NCT03595111|Cardiac Protection|cardiac protection
4643788|NCT03595111|Pediatric|pediatric
4643789|NCT03595111|Myocardial biopsy|myocardial biopsy
4643790|NCT03595111|Cardiopulmonary Bypass|cardiopulmonary bypass
4643791|NCT03595098|OCD|ocd
4643792|NCT03595059|Cancer|cancer
4643793|NCT03595059|Advanced Solid Tumors|advanced solid tumors
4643794|NCT03595059|Relapsed and/or Refractory Solid Tumors|relapsed and/or refractory solid tumors
4643795|NCT03595059|ABBV-155|abbv-155
4643796|NCT03595059|Taxane|taxane
4643797|NCT03595059|Paclitaxel|paclitaxel
4643798|NCT03595059|Docetaxel|docetaxel
4643799|NCT03595059|breast cancer|breast cancer
4643800|NCT03595059|non-small cell lung cancer (NSCLC)|non-small cell lung cancer (nsclc)
4643801|NCT03595059|small cell lung cancer (SCLC)|small cell lung cancer (sclc)
4643802|NCT03595046|thoracic paravertebral block|thoracic paravertebral block
4643803|NCT03595046|erector spinae plane block|erector spinae plane block
4643804|NCT03595046|thoracic postherpetic neuralgia|thoracic postherpetic neuralgia
4643805|NCT03595020|major depression disorder|major depression disorder
4643806|NCT03595020|functional near-infrared spectroscopy|functional near-infrared spectroscopy
4643807|NCT03595020|facial emotion recognition|facial emotion recognition
4643808|NCT03594916|Dysmenorrhea|dysmenorrhea
4643809|NCT03594916|Neuromodulation|neuromodulation
4643810|NCT03594916|Transcranial direct current stimulation|transcranial direct current stimulation
4643811|NCT03594916|Neuroimaging|neuroimaging
4643812|NCT03594916|Neuroplasticity|neuroplasticity
4643813|NCT03594903|therapy expectation|therapy expectation
4643814|NCT03594903|therapy motivation|therapy motivation
4643815|NCT03594903|critical attitudes towards psychotherapy|critical attitudes towards psychotherapy
4643816|NCT03594903|expectation violation|expectation violation
4643817|NCT03594903|Violex model|violex model
4643818|NCT03594903|psychological online-experiment|psychological online-experiment
4643819|NCT03594890|influenza|influenza
4643820|NCT03594890|vaccine|vaccine
4643821|NCT03594890|nucleoprotein|nucleoprotein
4643822|NCT03594877|mare milk|mare milk
4643823|NCT03594877|gut microbiome|gut microbiome
4643824|NCT03594877|psoriasis|psoriasis
4643825|NCT03594877|immune markers|immune markers
4643826|NCT03594864|Liver|liver
4643827|NCT03594864|Transplantation|transplantation
4643828|NCT03594864|Hyper-reduction|hyper-reduction
4643829|NCT03594864|Graft survival|graft survival
4643830|NCT03594864|Overall survival|overall survival
4643831|NCT03594851|quality of sleep|quality of sleep
4643832|NCT03594851|elderly|elderly
4643833|NCT03594851|health education|health education
4643834|NCT03594851|quantity of sleep|quantity of sleep
4643835|NCT03594851|caregiver's burden|caregiver's burden
4643836|NCT03594838|HCV viremia testing|hcv viremia testing
4643837|NCT03594825|Nocturnal Hypertension; Hemodialysis; Valsartan|nocturnal hypertension; hemodialysis; valsartan
4643838|NCT03594799|Simulated Microgravity|simulated microgravity
4643839|NCT03594799|Weightlessness|weightlessness
4643840|NCT03594799|Countermeasure|countermeasure
4643841|NCT03594799|Bedrest|bedrest
4643842|NCT03594734|Traumatic Brain Injury|traumatic brain injury
4643843|NCT03594734|Group Lifestyle Balance|group lifestyle balance
4643844|NCT03594734|Weight-Loss|weight-loss
4643845|NCT03594695|cesarean section, anesthesia, hs-CRP, NLR|cesarean section, anesthesia, hs-crp, nlr
4643846|NCT03594682|Apatinib,NSCLC,Dose titration|apatinib,nsclc,dose titration
4643847|NCT03594656|Parkinson's disease|parkinson's disease
4643848|NCT03594656|Lingzhi|lingzhi
4643849|NCT03594656|Traditional Chinese Medicine|traditional chinese medicine
4643850|NCT03594643|electronic cigarette|electronic cigarette
4643851|NCT03594643|surgery|surgery
4643852|NCT03594643|outcome|outcome
4643853|NCT03594643|anesthesia|anesthesia
4643854|NCT03594604|norethindrone|norethindrone
4643855|NCT03594552|Autism Spectrum Disorder|autism spectrum disorder
4643856|NCT03594552|Arbaclofen|arbaclofen
4643857|NCT03594552|E-I balance|e-i balance
4643858|NCT03594552|pharmacological imaging|pharmacological imaging
4643859|NCT03594552|GABA|gaba
4643860|NCT03594539|ESRD|esrd
4643861|NCT03594539|Microvascular|microvascular
4643862|NCT03594539|Hyperphosphatemia|hyperphosphatemia
4643863|NCT03594539|LDF|ldf
4643864|NCT03594526|Nursing Care|nursing care
4643865|NCT03594526|Mothers|mothers
4643866|NCT03594526|Research|research
4643867|NCT03594526|Support|support
4643868|NCT03594513|Gingival Recession|gingival recession
4643869|NCT03594513|Tooth Abrasion|tooth abrasion
4643870|NCT03594513|Mucoderm|mucoderm
4643871|NCT03594500|Emergency service|emergency service
4643872|NCT03594500|Hearing loss|hearing loss
4643873|NCT03594500|Patient readmission|patient readmission
4643874|NCT03594500|Communication|communication
4643875|NCT03594487|Multiple Sclerosis|multiple sclerosis
4643876|NCT03594487|Relapsing Remitting Multiple Sclerosis|relapsing remitting multiple sclerosis
4643877|NCT03594487|Fecal Microbiota Transplantation|fecal microbiota transplantation
4643878|NCT03594474|intravenous fat emulsions|intravenous fat emulsions
4643879|NCT03594474|preterm infants|preterm infants
4643880|NCT03594435|ibudilast, treatment, medication development|ibudilast, treatment, medication development
4643881|NCT03594383|Lung|lung
4643882|NCT03594383|POCUS|pocus
4643883|NCT03594383|Pneumonia|pneumonia
4643884|NCT03594383|ARI|ari
4643885|NCT03594383|CHWs|chws
4643886|NCT03594357|Multiple sclerosis|multiple sclerosis
4643887|NCT03594357|Balance|balance
4643888|NCT03594357|Cognition|cognition
4643889|NCT03594357|Functional exercise capacity|functional exercise capacity
4643890|NCT03594357|Fatigue|fatigue
4643891|NCT03594357|Sleep quality|sleep quality
4643892|NCT03594344|Diabetic foot|diabetic foot
4643893|NCT03594344|Diabetes|diabetes
4643894|NCT03594344|Lower extremity amputation|lower extremity amputation
4643895|NCT03594344|Hyperbaric oxygen therapy|hyperbaric oxygen therapy
4643896|NCT03594344|HBOT|hbot
4643897|NCT03594292|hallux valgus and Bunion|hallux valgus and bunion
4643898|NCT03594253|oppositional defiant disorder|oppositional defiant disorder
4643899|NCT03594253|regulation focused psychotherapy for children|regulation focused psychotherapy for children
4643900|NCT03594253|emotion regulation|emotion regulation
4643901|NCT03594253|psychodynamic psychotherapy|psychodynamic psychotherapy
4643902|NCT03594214|breast cancer|breast cancer
4643903|NCT03594214|vitamin d|vitamin d
4643904|NCT03594214|prognosis|prognosis
4643905|NCT03594201|ICSI, progressive sperm count, embryo|icsi, progressive sperm count, embryo
4643906|NCT03594175|CVAD|cvad
4643907|NCT03594175|CUSA-081|cusa-081
4643908|NCT03594175|reteplase|reteplase
4643909|NCT03594175|alteplase|alteplase
4643910|NCT03594175|occluded catheters|occluded catheters
4643911|NCT03594175|catheter|catheter
4643912|NCT03594175|occlusion|occlusion
4643913|NCT03594175|thrombosis|thrombosis
4643914|NCT03594175|thrombotic occlusion|thrombotic occlusion
4643915|NCT03594162|CAR T cells|car t cells
4643916|NCT03594162|CD19|cd19
4643917|NCT03594162|Leukemia|leukemia
4643918|NCT03594162|T Lymphocytes|t lymphocytes
4643919|NCT03594162|AP1903|ap1903
4643920|NCT03594149|levofloxacin, antibacterial prophylaxis, febrile episode|levofloxacin, antibacterial prophylaxis, febrile episode
4643921|NCT03594136|Intracranial pressure|intracranial pressure
4643922|NCT03594136|ICP|icp
4643923|NCT03594136|Normal value|normal value
4643924|NCT03594136|Reference value|reference value
4643925|NCT03594136|Hydrocephalus|hydrocephalus
4643926|NCT03594123|Agitation|agitation
4643927|NCT03594084|Malaria|malaria
4643928|NCT03594084|Malaria imported cases|malaria imported cases
4643929|NCT03594084|Recurrent malaria|recurrent malaria
4643930|NCT03594084|Endemic malaria areas|endemic malaria areas
4643931|NCT03594084|Biological diagnosis|biological diagnosis
4643932|NCT03594084|Hospital vs private laboratory diagnosis|hospital vs private laboratory diagnosis
4643933|NCT03594058|overactive bladder|overactive bladder
4643934|NCT03594058|urinary conditions|urinary conditions
4643935|NCT03594058|urgency urinary incontinence|urgency urinary incontinence
4643936|NCT03594058|urgency|urgency
4643937|NCT03594058|micturitions|micturitions
4643938|NCT03594045|Heparin-induced Thrombocytopenia|heparin-induced thrombocytopenia
4643939|NCT03594032|bronchiectasis|bronchiectasis
4643940|NCT03594032|NTM infections|ntm infections
4643941|NCT03594032|Middle-aged and old women|middle-aged and old women
4643942|NCT03594019|immediate implant placement|immediate implant placement
4643943|NCT03594019|connective tissue graft|connective tissue graft
4643944|NCT03594019|samll dehiscence|samll dehiscence
4643945|NCT03594006|Active Therapy|active therapy
4643946|NCT03593980|Gastric Ultrasound|gastric ultrasound
4643947|NCT03593967|wellbeing|wellbeing
4643948|NCT03593967|intergenerational arts|intergenerational arts
4643949|NCT03593967|aspiration|aspiration
4643950|NCT03593967|resilience|resilience
4643951|NCT03593967|storytelling|storytelling
4643952|NCT03593967|art making|art making
4643953|NCT03593967|seniors|seniors
4643954|NCT03593967|youth|youth
4643955|NCT03593941|Ageing|ageing
4643956|NCT03593941|Gut Microbiota|gut microbiota
4643957|NCT03593941|Challenging behaviour|challenging behaviour
4643958|NCT03593941|Dementia|dementia
4643959|NCT03593928|biomarker|biomarker
4643960|NCT03593928|plaque morphology|plaque morphology
4643961|NCT03593915|Patients with previously untreated MDS|patients with previously untreated mds
4643962|NCT03593915|Patients with MDS who have received <6 cycles of treatment with hypomethylating agents (HMAs)|patients with mds who have received <6 cycles of treatment with hypomethylating agents (hmas)
4643963|NCT03593915|Patients with de novo or secondary MDS (treatment-related) who are not eligible for intensive induction chemotherapy or stem cell transplant|patients with de novo or secondary mds (treatment-related) who are not eligible for intensive induction chemotherapy or stem cell transplant
4643964|NCT03593915|FAB subtypes: refractory anemia [RA], RA w/ ringed sideroblasts, RA w/ excess blasts, RA w/ excess blasts in transformation or chronic myelomonocytic leukemia|fab subtypes: refractory anemia [ra], ra w/ ringed sideroblasts, ra w/ excess blasts, ra w/ excess blasts in transformation or chronic myelomonocytic leukemia
4643965|NCT03593915|Intermediate and above per the Revised International Prognostic Scoring System (IPSS-R) groups|intermediate and above per the revised international prognostic scoring system (ipss-r) groups
4643966|NCT03593915|Tolero|tolero
4643967|NCT03593915|Cancer|cancer
4643968|NCT03593915|Phase 1b/2|phase 1b/2
4644275|NCT03592147|Meditation|meditation
4643969|NCT03593902|Autologous Stem Cell Transplantation|autologous stem cell transplantation
4643970|NCT03593902|Hematopoietic Stem Cell Transplant|hematopoietic stem cell transplant
4643971|NCT03593889|Collaborative stepped care|collaborative stepped care
4643972|NCT03593889|Peer support|peer support
4643973|NCT03593889|Early identification|early identification
4643974|NCT03593889|Selective prevention|selective prevention
4643975|NCT03593889|Indicated prevention|indicated prevention
4643976|NCT03593876|Stroke|stroke
4643977|NCT03593876|Aphasia|aphasia
4643978|NCT03593876|Rehabilitation|rehabilitation
4643979|NCT03593876|Cognition|cognition
4643980|NCT03593876|Disability|disability
4643981|NCT03593863|Brain structure and function|brain structure and function
4643982|NCT03593863|Adolescents|adolescents
4643983|NCT03593863|Physical activity|physical activity
4643984|NCT03593863|Cognitive function|cognitive function
4643985|NCT03593863|Mental health|mental health
4643986|NCT03593863|Fitness|fitness
4643987|NCT03593850|Pain management|pain management
4643988|NCT03593850|Pain|pain
4643989|NCT03593850|Primary dysmenorrhea|primary dysmenorrhea
4643990|NCT03593850|Music|music
4643991|NCT03593850|Music Therapy|music therapy
4643992|NCT03593824|Phenotypic plasticity|phenotypic plasticity
4643993|NCT03593824|Adversity|adversity
4643994|NCT03593824|Prosperity|prosperity
4643995|NCT03593785|Cholesterol|cholesterol
4643996|NCT03593785|Biomarkers|biomarkers
4643997|NCT03593772|chronic pain|chronic pain
4643998|NCT03593772|PTSD|ptsd
4643999|NCT03593759|Cardiac Sarcoidosis|cardiac sarcoidosis
4644000|NCT03593759|Prednisone|prednisone
4644001|NCT03593759|Methotrexate|methotrexate
4644002|NCT03593746|Cardiopulmonary Exercise Test|cardiopulmonary exercise test
4644003|NCT03593746|Rehabilitation|rehabilitation
4644004|NCT03593746|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
4644005|NCT03593746|Functional Capacity|functional capacity
4644006|NCT03593746|Photobiomodulation Therapy|photobiomodulation therapy
4644007|NCT03593720|hypaspadius|hypaspadius
4644008|NCT03593707|PF-06865571|pf-06865571
4644009|NCT03593707|Metformin|metformin
4644010|NCT03593707|Drug-drug interaction|drug-drug interaction
4644011|NCT03593707|Pharmacokinetics|pharmacokinetics
4644012|NCT03593681|salpingo-oophorectomy|salpingo-oophorectomy
4644013|NCT03593681|salpingectomy|salpingectomy
4644014|NCT03593681|ovarian cancer|ovarian cancer
4644015|NCT03593681|fallopian tube cancer|fallopian tube cancer
4644016|NCT03593681|high grade serous carcinoma|high grade serous carcinoma
4644017|NCT03593681|hysteroscopic biopsy|hysteroscopic biopsy
4644018|NCT03593681|fallopian tube cell collection|fallopian tube cell collection
4644019|NCT03593681|peritoneal cancer|peritoneal cancer
4644020|NCT03593668|Metformin|metformin
4644021|NCT03593668|Benaglutide|benaglutide
4644022|NCT03593629|HIV|hiv
4644023|NCT03593629|AIDS|aids
4644024|NCT03593629|PrEP|prep
4644025|NCT03593629|Truvada|truvada
4644026|NCT03593629|Public Health|public health
4644027|NCT03593629|Global Health|global health
4644028|NCT03593629|Infectious Disease|infectious disease
4644029|NCT03593629|Self-Testing|self-testing
4644030|NCT03593629|Kenya|kenya
4644031|NCT03593629|Africa|africa
4644032|NCT03593629|Low and/or Middle Income Countries (LMIC)|low and/or middle income countries (lmic)
4644033|NCT03593629|Cost-Effectiveness|cost-effectiveness
4644034|NCT03593577|Schwannoma|schwannoma
4644035|NCT03593577|saccular dilatation|saccular dilatation
4644036|NCT03593577|endolymphatic hydrops|endolymphatic hydrops
4644037|NCT03593577|magnetic resonnance imaging|magnetic resonnance imaging
4644038|NCT03593577|vertigo|vertigo
4644039|NCT03593564|Randomized Controlled Trial|randomized controlled trial
4644040|NCT03593564|Cognitive Behavioral Therapy|cognitive behavioral therapy
4644041|NCT03593564|Intervention Study|intervention study
4644042|NCT03593551|stress|stress
4644043|NCT03593551|anxiety|anxiety
4644044|NCT03593551|breastfeeding|breastfeeding
4644045|NCT03593551|relaxation|relaxation
4644046|NCT03593551|meditation|meditation
4644047|NCT03593551|music|music
4644048|NCT03593525|Pediatric Oncology|pediatric oncology
4644049|NCT03593525|Randomized Control Trial|randomized control trial
4644050|NCT03593525|Symptom Screening|symptom screening
4644051|NCT03593525|Quality of Life|quality of life
4644052|NCT03593512|multiple system atrophy|multiple system atrophy
4644053|NCT03593512|autonomic|autonomic
4644054|NCT03593499|melanoma|melanoma
4644055|NCT03593499|omaveloxolone|omaveloxolone
4644056|NCT03593499|expanded access|expanded access
4644057|NCT03593473|Oxytocin|oxytocin
4644058|NCT03593473|Hypothalamic-pituitary-adrenal axis (HPA)|hypothalamic-pituitary-adrenal axis (hpa)
4644059|NCT03593447|Chronic hepatics C virus (HCV) genotype 1|chronic hepatics c virus (hcv) genotype 1
4644060|NCT03593447|treatment naïve|treatment naïve
4644061|NCT03593447|non-cirrhotic|non-cirrhotic
4644062|NCT03593447|cirrhotic|cirrhotic
4644063|NCT03593447|efficacy|efficacy
4644064|NCT03593447|safety|safety
4644065|NCT03593447|TG-2349|tg-2349
4644066|NCT03593447|DAG181|dag181
4644067|NCT03593447|Ribavirin|ribavirin
4644068|NCT03593395|Transition|transition
4644069|NCT03593395|Emerging Adults|emerging adults
4644070|NCT03593395|Peer Mentoring|peer mentoring
4644276|NCT03592147|Music|music
4644071|NCT03593382|Female endurance athletes|female endurance athletes
4644072|NCT03593382|Energy Availability|energy availability
4644073|NCT03593382|Nutrient Availability|nutrient availability
4644074|NCT03593382|Bone Mineral Density|bone mineral density
4644075|NCT03593382|Menstrual dysfunction|menstrual dysfunction
4644076|NCT03593382|Female athlete triad|female athlete triad
4644077|NCT03593382|Energy metabolism|energy metabolism
4644078|NCT03593382|Recovery after exercise|recovery after exercise
4644079|NCT03593382|Endothelial function|endothelial function
4644080|NCT03593382|Eating disorders|eating disorders
4644081|NCT03593382|Performance|performance
4644082|NCT03593356|Poverty|poverty
4644083|NCT03593356|Income|income
4644084|NCT03593356|Child Development|child development
4644085|NCT03593356|Brain Development|brain development
4644086|NCT03593330|Transitional Care|transitional care
4644087|NCT03593330|Discharge Planning|discharge planning
4644088|NCT03593330|Readmission|readmission
4644089|NCT03593330|Elective Neurosurgery|elective neurosurgery
4644090|NCT03593330|Elective Spinal Surgery|elective spinal surgery
4644091|NCT03593330|Elective Brain Surgery|elective brain surgery
4644092|NCT03593330|Transitional Care Program|transitional care program
4644093|NCT03593330|TCP|tcp
4644094|NCT03593317|Heart Failure|heart failure
4644095|NCT03593317|Right ventricle|right ventricle
4644096|NCT03593291|Stroke, VTE prophylaxis, Anti Xa|stroke, vte prophylaxis, anti xa
4644097|NCT03593239|Electronic Nicotine Delivery System|electronic nicotine delivery system
4644098|NCT03593239|Combustible Cigarettes|combustible cigarettes
4644099|NCT03593239|Nicotine|nicotine
4644100|NCT03593187|HIV-1|hiv-1
4644101|NCT03593187|Lymphoma|lymphoma
4644102|NCT03593187|Gene therapy|gene therapy
4644103|NCT03593174|Amputation|amputation
4644104|NCT03593161|stem cell transplantation|stem cell transplantation
4644105|NCT03593161|allogeneic|allogeneic
4644106|NCT03593161|humor therapy|humor therapy
4644107|NCT03593161|distress|distress
4644108|NCT03593161|supportive care|supportive care
4644109|NCT03593135|vinegar|vinegar
4644110|NCT03593135|diabetes|diabetes
4644111|NCT03593135|hyperglycemia|hyperglycemia
4644112|NCT03593135|hypercholesterolemia|hypercholesterolemia
4644113|NCT03593135|nutraceutical|nutraceutical
4644114|NCT03593122|Vulvovaginal Dryness|vulvovaginal dryness
4644115|NCT03593109|Chimeric Antigen Receptor T cells|chimeric antigen receptor t cells
4644116|NCT03593109|CD19 and CD22|cd19 and cd22
4644117|NCT03593096|High Altitude|high altitude
4644118|NCT03593096|Exercise|exercise
4644119|NCT03593096|Ventilation|ventilation
4644120|NCT03593096|Heart rate|heart rate
4644121|NCT03593083|High Altitude|high altitude
4644122|NCT03593083|Exercise|exercise
4644123|NCT03593083|Electrocardiography|electrocardiography
4644124|NCT03593083|Non-invasive Blood Pressure|non-invasive blood pressure
4644125|NCT03593083|Finapres|finapres
4644126|NCT03593070|online group intervention|online group intervention
4644127|NCT03593057|dysmenorrhoea|dysmenorrhoea
4644128|NCT03593057|manual therapy|manual therapy
4644129|NCT03593044|atropine|atropine
4644130|NCT03593044|photophobia|photophobia
4644131|NCT03593044|pupil|pupil
4644132|NCT03593044|reading speed|reading speed
4644133|NCT03593044|myopia|myopia
4644134|NCT03593044|Surveys and Questionnaires|surveys and questionnaires
4644135|NCT03593018|oral azacitidine|oral azacitidine
4644136|NCT03593005|High Altitude|high altitude
4644137|NCT03593005|Altitude related symptoms|altitude related symptoms
4644138|NCT03592979|Simulated altitude|simulated altitude
4644139|NCT03592979|exercise|exercise
4644140|NCT03592979|ventilation|ventilation
4644141|NCT03592979|heart rate|heart rate
4644142|NCT03592966|(Poly)phenols|(poly)phenols
4644143|NCT03592966|Blueberries|blueberries
4644144|NCT03592966|Anthocyanins|anthocyanins
4644145|NCT03592966|Cognitive function|cognitive function
4644146|NCT03592966|Vascular function|vascular function
4644147|NCT03592953|Serious game|serious game
4644148|NCT03592953|Post partum hemorrhage|post partum hemorrhage
4644149|NCT03592953|Non technical skills|non technical skills
4644150|NCT03592927|exercise capacity|exercise capacity
4644151|NCT03592927|simulated altitude|simulated altitude
4644152|NCT03592888|Pancreatic Adenocarcinoma|pancreatic adenocarcinoma
4644153|NCT03592888|Cancer vaccine|cancer vaccine
4644154|NCT03592888|Dendritic cell vaccine|dendritic cell vaccine
4644155|NCT03592888|Mutant KRAS|mutant kras
4644156|NCT03592849|thin endometrium|thin endometrium
4644157|NCT03592849|infertility|infertility
4644158|NCT03592797|Low-level laser therapy|low-level laser therapy
4644159|NCT03592797|Laser acupuncture|laser acupuncture
4644160|NCT03592797|Sequelae of Bell's palsy|sequelae of bell's palsy
4644161|NCT03592797|Randomized controlled trial|randomized controlled trial
4644162|NCT03592745|Transcutaneous vagus nerve stimulation (tVNS)|transcutaneous vagus nerve stimulation (tvns)
4644163|NCT03592745|VNS|vns
4644164|NCT03592745|robotic therapy|robotic therapy
4644165|NCT03592745|occupational therapy|occupational therapy
4644166|NCT03592745|motor rehabilitation|motor rehabilitation
4644167|NCT03592719|HIV Prevention|hiv prevention
4644168|NCT03592719|PrEP|prep
4644169|NCT03592719|Black|black
4644170|NCT03592719|African American|african american
4644171|NCT03592719|Women|women
4644172|NCT03592719|Motivational Interviewing|motivational interviewing
4644173|NCT03592706|HepatoCellular Carcinoma|hepatocellular carcinoma
4644174|NCT03592706|Liver Cancer|liver cancer
4644175|NCT03592706|Immune Killer Cells|immune killer cells
4644176|NCT03592706|IKC|ikc
4644177|NCT03592706|Immune Therapy|immune therapy
4644178|NCT03592706|Immunotherapy|immunotherapy
4644179|NCT03592706|Cell Therapy|cell therapy
4644180|NCT03592706|IVY|ivy
4644181|NCT03592706|IVY02|ivy02
4644182|NCT03592693|Shock, Septic|shock, septic
4644183|NCT03592693|Vitamin C|vitamin c
4644184|NCT03592693|Hydrocortisone|hydrocortisone
4644185|NCT03592680|Post-operative atrial fibrillation|post-operative atrial fibrillation
4644186|NCT03592680|Ascorbic Acid|ascorbic acid
4644187|NCT03592680|Vitamin C|vitamin c
4644188|NCT03592680|antioxidant|antioxidant
4644189|NCT03592680|Cardiac surgery|cardiac surgery
4644190|NCT03592667|Stage I Hypertension|stage i hypertension
4644191|NCT03592667|Without type 2 diabetes mellitus|without type 2 diabetes mellitus
4644192|NCT03592667|Variability of blood pressure|variability of blood pressure
4644193|NCT03592667|Ambulatory arterial stiffness index|ambulatory arterial stiffness index
4644194|NCT03592667|Dapagliflozin|dapagliflozin
4644195|NCT03592667|ABPM|abpm
4644196|NCT03592615|prevalence|prevalence
4644197|NCT03592615|binocular vision disorders|binocular vision disorders
4644198|NCT03592615|accommodative disorders|accommodative disorders
4644199|NCT03592615|cataract surgery|cataract surgery
4644200|NCT03592615|corneal refractive surgery|corneal refractive surgery
4644201|NCT03592576|Expanded Access|expanded access
4644202|NCT03592576|Pre-approval Access|pre-approval access
4644203|NCT03592576|Compassionate Use|compassionate use
4644204|NCT03592576|Special Access Program|special access program
4644205|NCT03592576|Named Patient Basis|named patient basis
4644206|NCT03592576|Special Access Scheme|special access scheme
4644207|NCT03592563|stroke|stroke
4644208|NCT03592563|dementia|dementia
4644209|NCT03592563|Alzheimer disease|alzheimer disease
4644210|NCT03592537|Fentanyl versus midazolam|fentanyl versus midazolam
4644211|NCT03592511|Intervention study|intervention study
4644212|NCT03592511|Functional food|functional food
4644213|NCT03592511|Grape pomace|grape pomace
4644214|NCT03592498|Burns|burns
4644215|NCT03592498|Wounds and Injuries|wounds and injuries
4644216|NCT03592498|Biocompatible Materials|biocompatible materials
4644217|NCT03592498|Nile Tilapia|nile tilapia
4644218|NCT03592498|Oreochromis niloticus.|oreochromis niloticus.
4644219|NCT03592485|Erector Spinae Plane blockade|erector spinae plane blockade
4644220|NCT03592485|Pectoral Fascia block|pectoral fascia block
4644221|NCT03592485|patient control anlagesia|patient control anlagesia
4644222|NCT03592485|mitral valve replacement|mitral valve replacement
4644223|NCT03592472|Renal Cell Carcinoma|renal cell carcinoma
4644224|NCT03592472|Progression-free survival|progression-free survival
4644225|NCT03592472|Abexinostat|abexinostat
4644226|NCT03592472|Pazopanib|pazopanib
4644227|NCT03592472|RECIST|recist
4644228|NCT03592472|Cancer therapy|cancer therapy
4644229|NCT03592433|Decision Making|decision making
4644230|NCT03592433|Decision Support|decision support
4644231|NCT03592433|Health Literacy|health literacy
4644232|NCT03592420|Accidental falls|accidental falls
4644233|NCT03592420|Clinical trial|clinical trial
4644234|NCT03592420|Aged|aged
4644235|NCT03592420|Parkinson's Disease|parkinson's disease
4644236|NCT03592420|Stroke|stroke
4644237|NCT03592420|Exercise|exercise
4644238|NCT03592420|Education|education
4644239|NCT03592355|virtual care|virtual care
4644240|NCT03592355|virtual visit|virtual visit
4644241|NCT03592355|telemedicine|telemedicine
4644242|NCT03592342|Patch|patch
4644243|NCT03592342|Rivelin-Clo Patch|rivelin-clo patch
4644244|NCT03592342|Oral Lichen Planus|oral lichen planus
4644245|NCT03592342|Ulcerative|ulcerative
4644246|NCT03592342|Erythematous|erythematous
4644247|NCT03592342|OLP|olp
4644248|NCT03592342|OLPClinROM|olpclinrom
4644249|NCT03592342|OLPSSM|olpssm
4644250|NCT03592303|Post-partum haemorrhage|post-partum haemorrhage
4644251|NCT03592303|Thromboelastography|thromboelastography
4644252|NCT03592303|Coagulopathy|coagulopathy
4644253|NCT03592303|Fibrinogenemia|fibrinogenemia
4644254|NCT03592277|Sepsis|sepsis
4644255|NCT03592277|Septic Shock|septic shock
4644256|NCT03592277|Vitamin C|vitamin c
4644257|NCT03592277|Thiamine|thiamine
4644258|NCT03592225|General Practitioners|general practitioners
4644259|NCT03592225|France|france
4644260|NCT03592225|RCT|rct
4644261|NCT03592225|HPV vaccination|hpv vaccination
4644262|NCT03592212|Asthma|asthma
4644263|NCT03592212|Salbutamol response|salbutamol response
4644264|NCT03592212|Phosphodiesterase 4 variant|phosphodiesterase 4 variant
4644265|NCT03592212|lung function|lung function
4644266|NCT03592212|airflow limitation|airflow limitation
4644267|NCT03592199|biomarker|biomarker
4644268|NCT03592199|metastatic|metastatic
4644269|NCT03592199|sunitinib|sunitinib
4644270|NCT03592199|axitinib|axitinib
4644271|NCT03592199|next generation sequencing|next generation sequencing
4644272|NCT03592199|clear cell renal cell carcinoma|clear cell renal cell carcinoma
4644273|NCT03592186|adolescent|adolescent
4644274|NCT03592186|substance use|substance use
4644277|NCT03592147|Relaxation|relaxation
4644278|NCT03592147|Light Therapy|light therapy
4644279|NCT03592147|Stress|stress
4644280|NCT03592121|Nipple Neuropathy, Cancer Survivor|nipple neuropathy, cancer survivor
4644281|NCT03592108|Obstructive sleep apnea (OAS)|obstructive sleep apnea (oas)
4644282|NCT03592108|Cheyne-Stokes respiration (CSR)|cheyne-stokes respiration (csr)
4644283|NCT03592108|Continuous positive airway pressure (CPAP)|continuous positive airway pressure (cpap)
4644284|NCT03592108|Telemedicine|telemedicine
4644285|NCT03592108|Heart failure|heart failure
4644286|NCT03592095|Dry needling|dry needling
4644287|NCT03592095|Placebo|placebo
4644288|NCT03592095|Myofascial pain sindrome|myofascial pain sindrome
4644289|NCT03592095|Masking|masking
4644290|NCT03592056|hemidiaphragmatic paralysis|hemidiaphragmatic paralysis
4644291|NCT03592056|continuous plexus block|continuous plexus block
4644292|NCT03592056|interscalene plexus block|interscalene plexus block
4644293|NCT03592056|diluted local anesthetic infusion|diluted local anesthetic infusion
4644294|NCT03592056|ambulatory regional analgesia|ambulatory regional analgesia
4644295|NCT03592056|ambulatory continuous nerve block|ambulatory continuous nerve block
4644296|NCT03592056|continuous local anesthetic infusion|continuous local anesthetic infusion
4644297|NCT03592043|MitraClip|mitraclip
4644298|NCT03592043|Degenerative Mitral Regurgitation|degenerative mitral regurgitation
4644299|NCT03592030|Idiopathic nephrotic syndrome|idiopathic nephrotic syndrome
4644300|NCT03592030|Minimal change diseases|minimal change diseases
4644301|NCT03592030|Primitive FSGS|primitive fsgs
4644302|NCT03591991|Empagliflozin|empagliflozin
4644303|NCT03591991|Percutaneous coronary intervention|percutaneous coronary intervention
4644304|NCT03591991|Reperfusion Injury|reperfusion injury
4644305|NCT03591991|Microvascular protection|microvascular protection
4644306|NCT03591991|CI-AKI|ci-aki
4644307|NCT03591991|No-Reflow Phenomenon|no-reflow phenomenon
4644308|NCT03591978|Disease progression|disease progression
4644309|NCT03591978|Circulating Pulmonary Cells|circulating pulmonary cells
4644310|NCT03591965|HCC|hcc
4644311|NCT03591952|Thoracentesis|thoracentesis
4644312|NCT03591926|SM04646|sm04646
4644313|NCT03591926|IPF|ipf
4644314|NCT03591926|nebulized|nebulized
4644315|NCT03591926|inhalation|inhalation
4644316|NCT03591900|early diabetes|early diabetes
4644317|NCT03591900|prediabetes|prediabetes
4644318|NCT03591900|continuous glucose monitoring system|continuous glucose monitoring system
4644319|NCT03591900|detection|detection
4644320|NCT03591848|Breast cancer|breast cancer
4644321|NCT03591848|Preservation of fertility|preservation of fertility
4644322|NCT03591848|Online support decision tool|online support decision tool
4644323|NCT03591835|Nasal septum-tragus length; newborn|nasal septum-tragus length; newborn
4644324|NCT03591822|Dementia|dementia
4644325|NCT03591822|Pain|pain
4644326|NCT03591822|Nursing care|nursing care
4644327|NCT03591822|Psychosocial intervention|psychosocial intervention
4644328|NCT03591822|Robot-assisted therapy|robot-assisted therapy
4644329|NCT03591822|paro robot|paro robot
4644330|NCT03591809|cognitive function|cognitive function
4644331|NCT03591809|fatigue|fatigue
4644332|NCT03591809|quality of life|quality of life
4644333|NCT03591809|Functional exercise capacity|functional exercise capacity
4644334|NCT03591770|Shingrix vaccine|shingrix vaccine
4644335|NCT03591770|tofacitinib monotherapy|tofacitinib monotherapy
4644336|NCT03591770|anti-TNF monotherapy|anti-tnf monotherapy
4644337|NCT03591770|anti-TNF agent|anti-tnf agent
4644338|NCT03591770|thiopurine|thiopurine
4644339|NCT03591770|aminosalicylates|aminosalicylates
4644340|NCT03591757|Tolcapone|tolcapone
4644341|NCT03591757|Transthyretin (TTR)|transthyretin (ttr)
4644342|NCT03591757|Mutant TTR|mutant ttr
4644343|NCT03591757|Plasma TTR|plasma ttr
4644344|NCT03591757|CSF TTR|csf ttr
4644345|NCT03591757|Tetramer stability|tetramer stability
4644346|NCT03591757|Leptomeningeal|leptomeningeal
4644347|NCT03591757|Amyloidosis|amyloidosis
4644348|NCT03591731|IFCT|ifct
4644349|NCT03591731|NIPINEC|nipinec
4644350|NCT03591731|Neuroendocrine|neuroendocrine
4644351|NCT03591731|FFCD|ffcd
4644352|NCT03591731|GERCOR|gercor
4644353|NCT03591666|head and neck adenocarcinoma|head and neck adenocarcinoma
4644354|NCT03591666|Anlotinib|anlotinib
4644355|NCT03591627|Atrial fibrillation|atrial fibrillation
4644356|NCT03591627|Atrial Flutter|atrial flutter
4644357|NCT03591627|Transesophageal echocardiography|transesophageal echocardiography
4644358|NCT03591627|Ablation|ablation
4644359|NCT03591627|Cardioversion|cardioversion
4644360|NCT03591627|Thrombus; Embolism|thrombus; embolism
4644361|NCT03591614|Vaccine|vaccine
4644362|NCT03591614|DKK1|dkk1
4644363|NCT03591601|Tension-type headache|tension-type headache
4644364|NCT03591601|Pain|pain
4644365|NCT03591575|thalassemia|thalassemia
4644366|NCT03591575|iron overload|iron overload
4644367|NCT03591575|chelation|chelation
4644368|NCT03591575|deferiprone|deferiprone
4644369|NCT03591575|Ferriprox|ferriprox
4644370|NCT03591562|MRI|mri
4644371|NCT03591562|COPD|copd
4644372|NCT03591562|Disease Progression|disease progression
4644373|NCT03591523|cerebrovascular circulation|cerebrovascular circulation
4644374|NCT03591523|arterial blood flow|arterial blood flow
4644375|NCT03591523|magnetic resonance|magnetic resonance
4645272|NCT03585413|NAFLD|nafld
4644376|NCT03591523|duplex sonography|duplex sonography
4644377|NCT03591510|PKC412|pkc412
4644378|NCT03591510|Acute Myeloid Leukemia|acute myeloid leukemia
4644379|NCT03591510|AML|aml
4644380|NCT03591510|FLT3-mutated|flt3-mutated
4644381|NCT03591510|pediatric population|pediatric population
4644382|NCT03591510|midostaurin|midostaurin
4644383|NCT03591510|midostaurin combined with standard chemotherapy|midostaurin combined with standard chemotherapy
4644384|NCT03591510|single agent post-consolidation therapy|single agent post-consolidation therapy
4644385|NCT03591510|untreated FLT3-mutated AML|untreated flt3-mutated aml
4644386|NCT03591497|Myelopathy|myelopathy
4644387|NCT03591497|Virtual Reality|virtual reality
4644388|NCT03591497|Rehabilitation|rehabilitation
4644389|NCT03591497|Balance|balance
4644390|NCT03591484|Halitosis|halitosis
4644391|NCT03591484|photodynamic therapy|photodynamic therapy
4644392|NCT03591484|bronchiectasis|bronchiectasis
4644393|NCT03591471|Children，|children，
4644394|NCT03591471|Henoch-Schönlein Purpura Nephritis|henoch-schönlein purpura nephritis
4644395|NCT03591471|Integrated and Stepped Treatment in TCM|integrated and stepped treatment in tcm
4644396|NCT03591380|Donor Specific Antibody|donor specific antibody
4644397|NCT03591380|Donors, Living|donors, living
4644398|NCT03591380|Allograft Tolerance|allograft tolerance
4644399|NCT03591354|Artificial Pancreas (AP)|artificial pancreas (ap)
4644400|NCT03591354|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
4644401|NCT03591354|Insulin Pump|insulin pump
4644402|NCT03591354|Continuous Glucose Monitor (CGM)|continuous glucose monitor (cgm)
4644403|NCT03591354|Closed Loop Control (CLC)|closed loop control (clc)
4644404|NCT03591354|Sensor-Augmented Pump (SAP)|sensor-augmented pump (sap)
4644405|NCT03591341|melatonin|melatonin
4644406|NCT03591341|breast milk|breast milk
4644407|NCT03591328|Acute myocardial infarction|acute myocardial infarction
4644408|NCT03591328|Unstable angina|unstable angina
4644409|NCT03591328|Acute coronary syndrome|acute coronary syndrome
4644410|NCT03591328|Computational fluid dynamics|computational fluid dynamics
4644411|NCT03591328|Coronary computed tomography angiography|coronary computed tomography angiography
4644412|NCT03591328|Fractional flow reserve|fractional flow reserve
4644413|NCT03591315|visual pathway|visual pathway
4644414|NCT03591315|functional magnetic resonance imaging|functional magnetic resonance imaging
4644415|NCT03591315|pituitary adenoma|pituitary adenoma
4644416|NCT03591302|Kidney Transplantation|kidney transplantation
4644417|NCT03591302|Blood Stem Cell Transplantation|blood stem cell transplantation
4644418|NCT03591289|Robotic Surgery|robotic surgery
4644419|NCT03591276|metastatic breast cancer|metastatic breast cancer
4644420|NCT03591276|immune check point inhibitors|immune check point inhibitors
4644421|NCT03591276|chemotherapy|chemotherapy
4644422|NCT03591276|liposomal doxorubicin|liposomal doxorubicin
4644423|NCT03591276|pharmacokinetics|pharmacokinetics
4644424|NCT03591276|Anti-PD1 antibodies|anti-pd1 antibodies
4644425|NCT03591250|Healthcare renunciation|healthcare renunciation
4644426|NCT03591250|Continuous positive airway pressure|continuous positive airway pressure
4644427|NCT03591250|Non-invasive ventilation|non-invasive ventilation
4644428|NCT03591250|Oxygen therapy|oxygen therapy
4644429|NCT03591237|cancer|cancer
4644430|NCT03591237|late effects|late effects
4644431|NCT03591237|pain|pain
4644432|NCT03591224|pharmacogenetics|pharmacogenetics
4644433|NCT03591224|pharmacogenomics|pharmacogenomics
4644434|NCT03591224|antidepressants|antidepressants
4644435|NCT03591224|pharmacy|pharmacy
4644436|NCT03591224|pharmacist|pharmacist
4644437|NCT03591224|community|community
4644438|NCT03591185|Accidental Falls|accidental falls
4644439|NCT03591185|Primary prevention|primary prevention
4644440|NCT03591185|Pressure platform|pressure platform
4644441|NCT03591185|Inertial Sensor|inertial sensor
4644442|NCT03591146|Postsurgical Pain Management|postsurgical pain management
4644443|NCT03591081|Diabetic foot|diabetic foot
4644444|NCT03591055|Frail elderly|frail elderly
4644445|NCT03591055|Clinical Trial|clinical trial
4644446|NCT03590977|Streptococcus Mutans|streptococcus mutans
4644447|NCT03590977|licorice|licorice
4644448|NCT03590977|chlorohexidine|chlorohexidine
4644449|NCT03590977|caries index|caries index
4644450|NCT03590964|Implant, Bone ring, Sinus lift.|implant, bone ring, sinus lift.
4644451|NCT03590847|Intermittent fasting|intermittent fasting
4644452|NCT03590847|Inflammation|inflammation
4644453|NCT03590847|Diet|diet
4644454|NCT03590847|Lifestyle|lifestyle
4644455|NCT03590847|Eating habits|eating habits
4644456|NCT03590847|Time Restricted Feeding|time restricted feeding
4644457|NCT03590808|Influenza|influenza
4644458|NCT03590808|vaccine|vaccine
4644459|NCT03590808|solid carcinoma|solid carcinoma
4644460|NCT03590808|immune checkpoint|immune checkpoint
4644461|NCT03590808|efficacy|efficacy
4644462|NCT03590808|safety|safety
4644463|NCT03590769|Peripheral Arterial Disease|peripheral arterial disease
4644464|NCT03590769|PAD|pad
4644465|NCT03590769|Claudication, Intermittent|claudication, intermittent
4644466|NCT03590769|Claudication|claudication
4644467|NCT03590769|SFA Occlusion|sfa occlusion
4644468|NCT03590769|Arterial Occlusion|arterial occlusion
4644469|NCT03590769|Iliac Artery Occlusion|iliac artery occlusion
4644470|NCT03590769|Vascular Calcification|vascular calcification
4644471|NCT03590756|Skin Health|skin health
4644472|NCT03590756|Skin Wrinkle|skin wrinkle
4644473|NCT03590756|Skin Redness|skin redness
4644474|NCT03590756|Carotenoid|carotenoid
4644475|NCT03590756|Mango|mango
4644476|NCT03590717|dietary diversity|dietary diversity
4644477|NCT03590717|minimum acceptable diet|minimum acceptable diet
4644478|NCT03590717|fruits|fruits
4644479|NCT03590717|vegetables|vegetables
4644480|NCT03590717|animal sourced foods|animal sourced foods
4644481|NCT03590704|Taping|taping
4644482|NCT03590704|Seroma|seroma
4644483|NCT03590704|Safety|safety
4644484|NCT03590704|Breast Cancer|breast cancer
4644485|NCT03590704|Physiotherapy|physiotherapy
4644486|NCT03590691|storytelling|storytelling
4644487|NCT03590665|exercise, blood flow, strength, blood pressure, heart rate,|exercise, blood flow, strength, blood pressure, heart rate,
4644488|NCT03590652|multiple myeloma|multiple myeloma
4644489|NCT03590652|relapsed/refractory multiple myeloma|relapsed/refractory multiple myeloma
4644490|NCT03590652|Daratumumab|daratumumab
4644491|NCT03590652|Pomalidomide|pomalidomide
4644492|NCT03590652|Ixazomib|ixazomib
4644493|NCT03590652|Dexamethasone|dexamethasone
4644494|NCT03590652|cancer|cancer
4644495|NCT03590652|Phase 2|phase 2
4644496|NCT03590652|Darzalex|darzalex
4644497|NCT03590652|Pomalyst|pomalyst
4644498|NCT03590652|Ninlaro|ninlaro
4644499|NCT03590652|Decadron|decadron
4644500|NCT03590639|Inflammatory Bowel Diseases|inflammatory bowel diseases
4644501|NCT03590639|disability|disability
4644502|NCT03590639|quality of life|quality of life
4644503|NCT03590639|IBD Disk|ibd disk
4644504|NCT03590639|IBD-Disability Index|ibd-disability index
4644505|NCT03590639|Patient-Reported Outcomes|patient-reported outcomes
4644506|NCT03590626|Non Alcoholic Fatty Liver Disease|non alcoholic fatty liver disease
4644507|NCT03590626|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
4644508|NCT03590626|GLP-1 receptor agonist|glp-1 receptor agonist
4644509|NCT03590626|Dulaglutide|dulaglutide
4644510|NCT03590626|MRI-Proton density fat fraction|mri-proton density fat fraction
4644511|NCT03590626|Fat Mapping|fat mapping
4644512|NCT03590626|Non Alcoholic Steatohepatitis|non alcoholic steatohepatitis
4644513|NCT03590613|Sentinel-dosing|sentinel-dosing
4644514|NCT03590613|GSK2982772|gsk2982772
4644515|NCT03590613|Japnese|japnese
4644516|NCT03590613|Dose-ascending|dose-ascending
4644517|NCT03590613|Crossover|crossover
4644518|NCT03590613|Healthy|healthy
4644519|NCT03590600|Phase 1|phase 1
4644520|NCT03590600|Anti-Bacterial Agents|anti-bacterial agents
4644521|NCT03590600|Respiratory Tract Infections|respiratory tract infections
4644522|NCT03590574|T cell lymphoma|t cell lymphoma
4644523|NCT03590574|Relapsed T cell Non-Hodgkin Lymphoma|relapsed t cell non-hodgkin lymphoma
4644524|NCT03590574|Refractory T cell Non-Hodgkin Lymphoma|refractory t cell non-hodgkin lymphoma
4644525|NCT03590574|AUTO4|auto4
4644526|NCT03590522|pathogenesis of heart failure|pathogenesis of heart failure
4644527|NCT03590522|cardiac ryanodine Receptor 2|cardiac ryanodine receptor 2
4644528|NCT03590522|Amino acids|amino acids
4644529|NCT03590509|Telemedicine|telemedicine
4644530|NCT03590496|propionate|propionate
4644531|NCT03590483|Twins|twins
4644533|NCT03590483|Induction of Ovulation|induction of ovulation
4644534|NCT03590483|Perinatal mortality|perinatal mortality
4644535|NCT03590470|avoidable hospitalisations|avoidable hospitalisations
4644536|NCT03590470|quality of care|quality of care
4644537|NCT03590470|nursing homes|nursing homes
4644538|NCT03590470|implementation science|implementation science
4644539|NCT03590470|quality improvement|quality improvement
4644540|NCT03590431|iodine|iodine
4644541|NCT03590431|bioavailability|bioavailability
4644542|NCT03590431|milk|milk
4644543|NCT03590418|Intestinal failure|intestinal failure
4644544|NCT03590418|Microbiota|microbiota
4644545|NCT03590405|uterus|uterus
4644546|NCT03590405|infertility|infertility
4644547|NCT03590405|transplantation|transplantation
4644548|NCT03590392|Vaccine|vaccine
4644549|NCT03590392|Chikungunya Virus|chikungunya virus
4644550|NCT03590392|Chikungunya Fever|chikungunya fever
4644551|NCT03590366|Type 1 erythematotelangiectatic rosacea|type 1 erythematotelangiectatic rosacea
4644552|NCT03590340|Plasmodium falciparum|plasmodium falciparum
4644553|NCT03590340|PfSPZ Vaccine|pfspz vaccine
4644554|NCT03590340|PfSPZ Challenge (NF54)|pfspz challenge (nf54)
4644555|NCT03590340|CHMI|chmi
4644556|NCT03590314|Stroke|stroke
4644557|NCT03590314|Upper limb|upper limb
4644558|NCT03590314|Recovery|recovery
4644559|NCT03590288|Liver cirrhosis|liver cirrhosis
4644560|NCT03590288|Transjugular intrahepatic portosystemic shunt|transjugular intrahepatic portosystemic shunt
4644561|NCT03590288|Pressure gradient|pressure gradient
4644562|NCT03590288|Outcome prediction|outcome prediction
4644563|NCT03590275|pancreatic cancer|pancreatic cancer
4644564|NCT03590275|chemotherapy|chemotherapy
4644565|NCT03590275|FOLFIRINOX|folfirinox
4644566|NCT03590275|prognostic|prognostic
4644567|NCT03590249|osteopathic manipulative treatment|osteopathic manipulative treatment
4644568|NCT03590236|women|women
4644569|NCT03590236|chronic pelvic pain|chronic pelvic pain
4644570|NCT03590236|fear avoidance|fear avoidance
4644571|NCT03590197|Melatonin|melatonin
4644572|NCT03590197|Neuron-specific Enolase|neuron-specific enolase
4644573|NCT03590197|Responder rate|responder rate
4644574|NCT03590184|Abdominal wall repair|abdominal wall repair
4644575|NCT03590184|Infection|infection
4644576|NCT03590184|Biologic mesh|biologic mesh
4644577|NCT03590184|Biosynthetic mesh|biosynthetic mesh
4644578|NCT03590184|Cost-effectiveness|cost-effectiveness
4644579|NCT03590171|ALL|all
4644580|NCT03590145|Groin pain|groin pain
4644581|NCT03590145|Adductor-related|adductor-related
4644582|NCT03590145|Inguinal-related|inguinal-related
4644583|NCT03590145|Pubic-related|pubic-related
4644584|NCT03590145|Iliopsoas-related|iliopsoas-related
4644585|NCT03590145|Hip-related|hip-related
4644586|NCT03590132|adolescent|adolescent
4644587|NCT03590132|alcohol|alcohol
4644588|NCT03590132|family-centered prevention|family-centered prevention
4644589|NCT03590132|African American|african american
4644590|NCT03590119|LUTIA|lutia
4644591|NCT03590119|neuroendocrine tumor|neuroendocrine tumor
4644592|NCT03590119|lutetium-177-dotatate|lutetium-177-dotatate
4644593|NCT03590119|intra-arterial|intra-arterial
4644594|NCT03590119|liver metastases|liver metastases
4644595|NCT03590080|Graves' Disease|graves' disease
4644596|NCT03590080|Graves' Ophthalmopathy|graves' ophthalmopathy
4644597|NCT03590080|Hypertension|hypertension
4644598|NCT03590080|Blood Pressure|blood pressure
4644599|NCT03590080|Methylprednisolone|methylprednisolone
4644600|NCT03590080|Glucocorticoids|glucocorticoids
4644601|NCT03590067|End stage renal disease|end stage renal disease
4644602|NCT03590067|Haemodialysis|haemodialysis
4644603|NCT03590067|Renal transplantation|renal transplantation
4644604|NCT03590067|pediatric|pediatric
4644605|NCT03590067|chronic kidney disease|chronic kidney disease
4644606|NCT03590067|oral finding|oral finding
4644607|NCT03590067|oral manifestation|oral manifestation
4644608|NCT03590041|Diabetes Mellitus Type 2, Comparative Effectiveness Trial|diabetes mellitus type 2, comparative effectiveness trial
4644609|NCT03590015|Recruitment|recruitment
4644610|NCT03590015|Invitation Letter|invitation letter
4644611|NCT03590015|patients|patients
4644612|NCT03590015|Schizophrenia|schizophrenia
4644613|NCT03590002|Patient Transfer|patient transfer
4644614|NCT03590002|Patient Discharge Summaries|patient discharge summaries
4644615|NCT03590002|Continuity of Patient Care|continuity of patient care
4644616|NCT03590002|Intensive Care Unit|intensive care unit
4644617|NCT03590002|Critical Care|critical care
4644618|NCT03590002|Health Information Exchange|health information exchange
4644619|NCT03590002|Medical Order Entry Systems|medical order entry systems
4644620|NCT03590002|Point-of-Care Systems|point-of-care systems
4644621|NCT03590002|Medical Informatics|medical informatics
4644622|NCT03589950|anlotinib|anlotinib
4644623|NCT03589950|docetaxel|docetaxel
4644624|NCT03589950|pemetrexed|pemetrexed
4644625|NCT03589937|refractive error|refractive error
4644626|NCT03589937|ocular structural parameters|ocular structural parameters
4644627|NCT03589924|Immediate implant reconstruction|immediate implant reconstruction
4644628|NCT03589924|TiLoop® Bra|tiloop® bra
4644629|NCT03589898|magnetic resonance imaging|magnetic resonance imaging
4644630|NCT03589898|spectroscopy|spectroscopy
4644631|NCT03589898|GABA|gaba
4644632|NCT03589898|glutamate|glutamate
4644633|NCT03589898|social cognition|social cognition
4644634|NCT03589885|Plaque psoriasis, auto-injector, 2 mL injection, secukinumab|plaque psoriasis, auto-injector, 2 ml injection, secukinumab
4644635|NCT03589872|hand function, dual task, Parkinson disease, motor demand, cognitive demand|hand function, dual task, parkinson disease, motor demand, cognitive demand
4644636|NCT03589859|neurologic rehabilitation|neurologic rehabilitation
4644637|NCT03589859|computer games|computer games
4644638|NCT03589833|Rheumatoid Arthritis|rheumatoid arthritis
4644639|NCT03589833|Methotrexate|methotrexate
4644640|NCT03589833|Tripterygium|tripterygium
4644641|NCT03589833|TNF inhibitor|tnf inhibitor
4644642|NCT03589820|Wilson Disease|wilson disease
4644643|NCT03589820|Liver Failure|liver failure
4644644|NCT03589820|plasma exchange|plasma exchange
4644645|NCT03589820|continuous hemodiafiltration|continuous hemodiafiltration
4644646|NCT03589807|A/H7N9|a/h7n9
4644647|NCT03589807|Adults|adults
4644648|NCT03589807|ASO3|aso3
4644649|NCT03589807|Immunogenicity|immunogenicity
4644650|NCT03589807|Influenza|influenza
4644651|NCT03589807|Prime-Boost|prime-boost
4644652|NCT03589807|Reactogenicity|reactogenicity
4644653|NCT03589807|Safety|safety
4644654|NCT03589807|Vaccine|vaccine
4644655|NCT03589794|AP 10-602 [GLA-LSQ]|ap 10-602 [gla-lsq]
4644656|NCT03589794|Challenge|challenge
4644657|NCT03589794|Malaria|malaria
4644658|NCT03589794|P. falciparum|p. falciparum
4644659|NCT03589794|rCSP|rcsp
4644660|NCT03589794|Vaccine|vaccine
4644661|NCT03589768|Effect|effect
4644662|NCT03589768|Immunogenicity|immunogenicity
4644663|NCT03589768|Infant|infant
4644664|NCT03589768|Phase II|phase ii
4644665|NCT03589768|Pregnant Women|pregnant women
4644666|NCT03589768|Safety|safety
4644667|NCT03589768|Tdap|tdap
4644668|NCT03589755|mindfulness|mindfulness
4644669|NCT03589755|meditation|meditation
4644670|NCT03589755|anxiety|anxiety
4644671|NCT03589755|depression|depression
4644672|NCT03589742|Atrial Fibrillation|atrial fibrillation
4644673|NCT03589742|Atrial Flutter|atrial flutter
4644674|NCT03589742|Radiofrequency Ablation|radiofrequency ablation
4644675|NCT03589742|Pulmonary Vein Isolation|pulmonary vein isolation
4644676|NCT03589742|Catheter|catheter
4644677|NCT03589742|AblaView Ablation Catheter|ablaview ablation catheter
4644678|NCT03589742|Atrioventricular node|atrioventricular node
4644679|NCT03589716|Vital Signs|vital signs
4644680|NCT03589703|Chronic Low Back Pain|chronic low back pain
4644681|NCT03589703|cLBP|clbp
4644682|NCT03589703|pain|pain
4644683|NCT03589703|acupressure|acupressure
4644684|NCT03589690|Metabolic Syndrome|metabolic syndrome
4644685|NCT03589690|Thioctic Acid|thioctic acid
4644686|NCT03589690|Inflammation|inflammation
4644687|NCT03589690|Insulin Resistance|insulin resistance
4644688|NCT03589677|DM1|dm1
4644689|NCT03589677|Brain|brain
4644690|NCT03589677|MRI|mri
4644691|NCT03589651|Solid tumors|solid tumors
4644692|NCT03589651|locally advanced unresectable tumor|locally advanced unresectable tumor
4644693|NCT03589651|metastatic solid tumors|metastatic solid tumors
4644694|NCT03589638|tracheal intubation|tracheal intubation
4644695|NCT03589638|videolaryngoscopy|videolaryngoscopy
4644696|NCT03589638|hemodynamics|hemodynamics
4644697|NCT03589638|intraocular pressure|intraocular pressure
4644698|NCT03589625|electricity and health|electricity and health
4644699|NCT03589625|maternal health|maternal health
4644700|NCT03589625|quality of care|quality of care
4644701|NCT03589625|solar power|solar power
4644702|NCT03589612|Duchenne Muscular Dystrophy|duchenne muscular dystrophy
4644703|NCT03589612|performance|performance
4644704|NCT03589612|hamstring flexibility|hamstring flexibility
4644705|NCT03589612|regression|regression
4644706|NCT03589573|Duchenne Muscular Dystrophy|duchenne muscular dystrophy
4644707|NCT03589573|muscle strength|muscle strength
4644708|NCT03589573|hamstring flexibility|hamstring flexibility
4644709|NCT03589573|back muscle|back muscle
4644710|NCT03589573|lower extremity|lower extremity
4644711|NCT03589560|revascularization|revascularization
4644712|NCT03589560|necrotic|necrotic
4644713|NCT03589560|immature|immature
4644714|NCT03589560|coronal plug|coronal plug
4644715|NCT03589547|Lung cancer|lung cancer
4644716|NCT03589547|NSCLC|nsclc
4644717|NCT03589547|Stage III|stage iii
4644718|NCT03589547|Post chemoradiation|post chemoradiation
4644719|NCT03589521|Veterans|veterans
4644720|NCT03589521|Cognitive Therapy|cognitive therapy
4644721|NCT03589521|Couple Therapy|couple therapy
4644722|NCT03589508|National Guard|national guard
4644723|NCT03589508|Telehealth|telehealth
4644724|NCT03589508|Prevention|prevention
4644725|NCT03589469|Loncastuximab tesirine|loncastuximab tesirine
4644726|NCT03589456|lung cancer|lung cancer
4644727|NCT03589456|lung carcinoma|lung carcinoma
4644728|NCT03589456|lung metastases|lung metastases
4644729|NCT03589456|metastases|metastases
4644730|NCT03589391|Epidural injection|epidural injection
4644731|NCT03589391|loss of resistance detection|loss of resistance detection
4644732|NCT03589391|mechatronic device|mechatronic device
4644733|NCT03589352|gynaecological aftercare|gynaecological aftercare
4644734|NCT03589352|contraception|contraception
4644735|NCT03589352|breast cancer|breast cancer
4644736|NCT03589352|cervix cancer|cervix cancer
4644737|NCT03589352|cervical screening|cervical screening
4644738|NCT03589352|breast self examination|breast self examination
4644739|NCT03589352|mammography|mammography
4644740|NCT03589352|midwife|midwife
4644741|NCT03589352|body knowledge|body knowledge
4644742|NCT03589352|prevention|prevention
4644743|NCT03589352|self care|self care
4644744|NCT03589326|Ponatinib|ponatinib
4644745|NCT03589326|Imatinib mesylate|imatinib mesylate
4644746|NCT03589326|Bcr-Abl Tyrosine Kinase|bcr-abl tyrosine kinase
4644747|NCT03589326|Bcr-abl fusion proteins|bcr-abl fusion proteins
4644748|NCT03589326|Iclusig|iclusig
4644749|NCT03589326|Gleevec|gleevec
4644750|NCT03589287|Intra-articular (IA), Allogeneic, MSC, OA|intra-articular (ia), allogeneic, msc, oa
4644751|NCT03589274|alcohol use disorder|alcohol use disorder
4644752|NCT03589274|women|women
4644753|NCT03589274|female specific therapy|female specific therapy
4644754|NCT03589274|cognitive behavior therapy|cognitive behavior therapy
4644755|NCT03589274|group therapy|group therapy
4644756|NCT03589235|autografts|autografts
4644757|NCT03589235|gingival recession|gingival recession
4644758|NCT03589235|free gingival graft|free gingival graft
4644759|NCT03589235|Attached gingival width|attached gingival width
4644760|NCT03589235|Platelet-Rich Fibrin dressing|platelet-rich fibrin dressing
4644761|NCT03589209|Round window visibility|round window visibility
4644762|NCT03589209|Cochlear implantation|cochlear implantation
4644763|NCT03589183|Gastrointestinal Microbiome|gastrointestinal microbiome
4644764|NCT03589170|Atrial fibrillation|atrial fibrillation
4644765|NCT03589170|Opportunistic screening|opportunistic screening
4644766|NCT03589170|ischaemic stroke|ischaemic stroke
4644767|NCT03589118|Substance Addiction|substance addiction
4644768|NCT03589118|Craving|craving
4644769|NCT03589118|Chinese Medecine|chinese medecine
4644770|NCT03589118|Qi Gong|qi gong
4644771|NCT03589118|Psychology|psychology
4644772|NCT03589092|GDM|gdm
4644773|NCT03589092|MODY|mody
4644774|NCT03589092|Genetic testing|genetic testing
4644775|NCT03589092|Next Generation Sequencing|next generation sequencing
4644776|NCT03589092|NGS|ngs
4644777|NCT03589079|Monogenic Disorder|monogenic disorder
4644778|NCT03589079|Mendelian Disease|mendelian disease
4644779|NCT03589079|Single Gene Disorder|single gene disorder
4644780|NCT03589079|Next Generation Sequencing|next generation sequencing
4644781|NCT03589079|Genetic testing|genetic testing
4644782|NCT03589066|rotigotine|rotigotine
4644783|NCT03589066|parkinson|parkinson
4644784|NCT03589066|parkinsons|parkinsons
4644785|NCT03589066|intramuscular injection|intramuscular injection
4644786|NCT03589066|UPDRS|updrs
4644787|NCT03589053|Limb remote ischemic conditioning|limb remote ischemic conditioning
4644788|NCT03589053|Cerebrovascular reserve|cerebrovascular reserve
4644789|NCT03589014|Cerebral Cavernous Malformation|cerebral cavernous malformation
4644790|NCT03589014|Propranolol|propranolol
4644791|NCT03589014|Magnetic Resonance Imaging|magnetic resonance imaging
4644792|NCT03588962|allergy to metals, restenosis, in-stent restenosis|allergy to metals, restenosis, in-stent restenosis
4644793|NCT03588962|coronary artery disease|coronary artery disease
4644794|NCT03588923|HCV|hcv
4644795|NCT03588923|NS5B|ns5b
4644796|NCT03588923|SH229|sh229
4644797|NCT03588910|ambulatory|ambulatory
4644798|NCT03588910|narcotics|narcotics
4644799|NCT03588910|opioids|opioids
4644800|NCT03588910|postoperative|postoperative
4644801|NCT03588910|gynecology|gynecology
4644802|NCT03588910|laparoscopy|laparoscopy
4644803|NCT03588910|pain|pain
4644804|NCT03588910|surgery|surgery
4644805|NCT03588897|nutritional status|nutritional status
4644806|NCT03588897|Nutridrink|nutridrink
4644807|NCT03588897|elderly nutrition|elderly nutrition
4644808|NCT03588871|Tooth bleaching|tooth bleaching
4644809|NCT03588871|Quality of life|quality of life
4644810|NCT03588832|Stroke|stroke
4644811|NCT03588832|Spasticity|spasticity
4644812|NCT03588832|Upper Extremity|upper extremity
4644813|NCT03588832|Quality of Life|quality of life
4644814|NCT03588806|Abuse-deterrent opioid drugs|abuse-deterrent opioid drugs
4644815|NCT03588806|Xtampza ER|xtampza er
4644816|NCT03588780|acute stroke|acute stroke
4644817|NCT03588780|thrombectomy|thrombectomy
4644818|NCT03588780|tandem lesions|tandem lesions
4644819|NCT03588767|polytrauma|polytrauma
4644820|NCT03588767|endocrine response|endocrine response
4644821|NCT03588767|metabolic response|metabolic response
4644822|NCT03588767|bone metabolism|bone metabolism
4644823|NCT03588767|anabolic substance|anabolic substance
4644824|NCT03588767|vitamin D|vitamin d
4644825|NCT03588728|Transcranial Direct Current Stimulation|transcranial direct current stimulation
4644826|NCT03588728|Smoking|smoking
4644827|NCT03588728|Schizophrenia|schizophrenia
4644828|NCT03588715|HIV|hiv
4644829|NCT03588715|HIV/AIDS|hiv/aids
4644830|NCT03588715|HIV Cure|hiv cure
4644831|NCT03588715|HIV-1|hiv-1
4644832|NCT03588715|HIV-1 Infection|hiv-1 infection
4644833|NCT03588715|BEAT-HIV|beat-hiv
4644834|NCT03588715|bNAbs|bnabs
4644835|NCT03588715|Broadly neutralizing antibodies|broadly neutralizing antibodies
4644836|NCT03588702|radiofrequency|radiofrequency
4644837|NCT03588702|pulsed electro-magnetic fields|pulsed electro-magnetic fields
4644838|NCT03588702|liposuction|liposuction
4644839|NCT03588689|hip fracture|hip fracture
4644840|NCT03588689|fascia iliaca block|fascia iliaca block
4644841|NCT03588689|continuous fascia iliaca block|continuous fascia iliaca block
4644842|NCT03588689|neuromuscular blockade|neuromuscular blockade
4644843|NCT03588676|Hypoxia|hypoxia
4644844|NCT03588676|High Altitude|high altitude
4644845|NCT03588676|Melatonin|melatonin
4644846|NCT03588676|Neurocognitive|neurocognitive
4644847|NCT03588663|Robotics|robotics
4644848|NCT03588663|Walking|walking
4644849|NCT03588663|Balance|balance
4644850|NCT03588611|bivalirudin|bivalirudin
4644851|NCT03588611|bolus injection|bolus injection
4644852|NCT03588611|activated clotting time|activated clotting time
4644853|NCT03588611|Renal insufficiency|renal insufficiency
4644854|NCT03588598|CLL|cll
4644855|NCT03588598|SLL|sll
4644856|NCT03588598|NHL|nhl
4644857|NCT03588598|SHC014748M|shc014748m
4644858|NCT03588598|Phosphatidylinositol 3-kinase (PI3K)|phosphatidylinositol 3-kinase (pi3k)
4644859|NCT03588572|Behavioural evaluation|behavioural evaluation
4644860|NCT03588572|Functional magnetic resonance imaging|functional magnetic resonance imaging
4644861|NCT03588572|Venlafaxine|venlafaxine
4644862|NCT03588559|Monitors, Blood Pressure|monitors, blood pressure
4644863|NCT03588546|Fasenra Benralizumab Bronchial asthma|fasenra benralizumab bronchial asthma
4644864|NCT03588533|HER-2 Positive|her-2 positive
4644865|NCT03588533|Gastric or gastroesophageal adenocarcinoma|gastric or gastroesophageal adenocarcinoma
4644866|NCT03588533|Herzuma|herzuma
4644867|NCT03588520|Hypertension|hypertension
4644868|NCT03588520|Chronic Kidney Disease|chronic kidney disease
4644869|NCT03588520|Home Blood Pressure Monitoring|home blood pressure monitoring
4644870|NCT03588520|Blood Pressure Management|blood pressure management
4644871|NCT03588520|Masked Hypertension|masked hypertension
4644872|NCT03588520|White Coat Hypertension|white coat hypertension
4644873|NCT03588520|Renal Insufficiency|renal insufficiency
4644874|NCT03588520|Cardiovascular Risk|cardiovascular risk
4644875|NCT03588507|papilla preservation|papilla preservation
4644876|NCT03588507|modified papilla preservation|modified papilla preservation
4644877|NCT03588507|simplified papilla preservation|simplified papilla preservation
4644878|NCT03588507|nanocrystalline hydroxyapetite|nanocrystalline hydroxyapetite
4644879|NCT03588507|nanobone graft|nanobone graft
4644880|NCT03588494|Recombinant human endostatin|recombinant human endostatin
4644881|NCT03588494|NSCLC|nsclc
4644882|NCT03588494|chemoradiotherapy|chemoradiotherapy
4644883|NCT03588481|PCI|pci
4644884|NCT03588481|DES|des
4644885|NCT03588481|real world|real world
4644886|NCT03588429|Sevoflurane|sevoflurane
4644887|NCT03588429|Isoflurane|isoflurane
4644888|NCT03588416|pT1|pt1
4644889|NCT03588416|Polypectomy|polypectomy
4644890|NCT03588416|Lymphnode metastasis|lymphnode metastasis
4644891|NCT03588364|osteopathic manipulation|osteopathic manipulation
4644892|NCT03588338|PONV|ponv
4644893|NCT03588338|Paracetamol|paracetamol
4644894|NCT03588325|MDW|mdw
4644895|NCT03588325|Sepsis|sepsis
4644896|NCT03588312|Aortic arch hypoplasia|aortic arch hypoplasia
4644897|NCT03588312|Glutaraldehyde treated autologous pericardium|glutaraldehyde treated autologous pericardium
4644898|NCT03588312|Single stage repair|single stage repair
4644899|NCT03588312|Congenital heart defects|congenital heart defects
4644900|NCT03588312|Newborns|newborns
4644901|NCT03588299|Severe hemophilia A (<1% FVIII activity)|severe hemophilia a (<1% fviii activity)
4644902|NCT03588299|Factor VIII gene therapy|factor viii gene therapy
4644903|NCT03588273|Bariatric surgery|bariatric surgery
4644904|NCT03588273|Pharmacokinetics|pharmacokinetics
4644905|NCT03588273|Amoxicillin|amoxicillin
4644906|NCT03588273|Obesity|obesity
4644907|NCT03588260|idiopathic pulmonary fibrosis|idiopathic pulmonary fibrosis
4644908|NCT03588260|respiratory muscle strength|respiratory muscle strength
4644909|NCT03588260|physical activity|physical activity
4644910|NCT03588260|quality of life|quality of life
4644911|NCT03588260|dyspnea|dyspnea
4644912|NCT03588260|fatigue severity|fatigue severity
4644913|NCT03588260|exercise capacity|exercise capacity
4644914|NCT03588208|Fibromyalgia|fibromyalgia
4644915|NCT03588208|Pain|pain
4644916|NCT03588208|Function|function
4644917|NCT03588208|Quality of life|quality of life
4644918|NCT03588195|Education|education
4644919|NCT03588195|Pain|pain
4644920|NCT03588195|Function|function
4644921|NCT03588195|Quality of life|quality of life
4644922|NCT03588156|Healthy Subject|healthy subject
4644923|NCT03588156|PK Study|pk study
4644924|NCT03588156|Tolerability|tolerability
4644925|NCT03588156|Safety Evaluation|safety evaluation
4644926|NCT03588143|Subacromial pain|subacromial pain
4644927|NCT03588143|Joint range of motion|joint range of motion
4644928|NCT03588143|Electrotherapy|electrotherapy
4644929|NCT03588143|Physiotherapy|physiotherapy
4644930|NCT03588143|Impingement|impingement
4644931|NCT03588130|Debridement|debridement
4644932|NCT03588117|Metabolic Syndrome|metabolic syndrome
4644933|NCT03588104|Electronic Health (eHealth)|electronic health (ehealth)
4644934|NCT03588078|Azacitidine|azacitidine
4644935|NCT03588065|public health|public health
4644936|NCT03588065|Soccer|soccer
4644937|NCT03588052|Vestibular incision subperiosteal tunnel access, Subepithelial connective tissue graft, Platelets rich fibrin, Multiple gingival recessions|vestibular incision subperiosteal tunnel access, subepithelial connective tissue graft, platelets rich fibrin, multiple gingival recessions
4644938|NCT03587935|Colon Adenoma|colon adenoma
4644939|NCT03587935|Colon Polyp|colon polyp
4644940|NCT03587935|Adenoma detection rate|adenoma detection rate
4644941|NCT03587935|Magnetic Endoscopy Imaging|magnetic endoscopy imaging
4644942|NCT03587909|FLACS|flacs
4644943|NCT03587909|Phaco|phaco
4644944|NCT03587909|Shallow Anterior Chamber|shallow anterior chamber
4644945|NCT03587896|distress|distress
4644946|NCT03587896|post-traumatic stress disorder|post-traumatic stress disorder
4644947|NCT03587896|prevention|prevention
4644948|NCT03587896|refugees|refugees
4644949|NCT03587896|Self Help Plus|self help plus
4644950|NCT03587896|Turkey|turkey
4644951|NCT03587883|flavanol|flavanol
4644952|NCT03587883|cocoa flavanols|cocoa flavanols
4644953|NCT03587883|arterial stiffness|arterial stiffness
4644954|NCT03587883|blood pressure|blood pressure
4644955|NCT03587883|step test|step test
4644956|NCT03587870|intensive care unit|intensive care unit
4644957|NCT03587870|intermittent enteral nutrition|intermittent enteral nutrition
4644958|NCT03587870|continuous enteral nutrition|continuous enteral nutrition
4644959|NCT03587870|muscle wasting|muscle wasting
4644960|NCT03587857|Health Disparity|health disparity
4644961|NCT03587844|Brentuximab Vedotin|brentuximab vedotin
4644962|NCT03587844|18-147|18-147
4644963|NCT03587818|Patient-Centered Care|patient-centered care
4644964|NCT03587818|Health Communication|health communication
4644965|NCT03587818|Clinical trial|clinical trial
4644966|NCT03587818|Colorectal neoplasms|colorectal neoplasms
4644967|NCT03587818|Colorectal surgery|colorectal surgery
4644968|NCT03587818|Continuity of patient care|continuity of patient care
4644969|NCT03587818|Medical-surgical nursing|medical-surgical nursing
4644970|NCT03587818|Qualitative Research|qualitative research
4644971|NCT03587779|patient state index|patient state index
4644972|NCT03587779|sevoflurane|sevoflurane
4644973|NCT03587779|desflurane|desflurane
4644974|NCT03587779|minimum alveolar concentration|minimum alveolar concentration
4644975|NCT03587766|Trypanosoma cruzi Infection|trypanosoma cruzi infection
4644976|NCT03587766|Chagas' Disease|chagas' disease
4644977|NCT03587766|Trypanosomiasis, South American|trypanosomiasis, south american
4644978|NCT03587766|American Trypanosomiasis|american trypanosomiasis
4644979|NCT03587766|Kissing bug|kissing bug
4644980|NCT03587740|Breast Cancer|breast cancer
4644981|NCT03587727|bariatric surgery|bariatric surgery
4644982|NCT03587727|hepatic mitochondria|hepatic mitochondria
4644983|NCT03587727|insulin secretion|insulin secretion
4644985|NCT03587649|PD|pd
4644986|NCT03587649|HV|hv
4644987|NCT03587610|vaccination coverage|vaccination coverage
4644988|NCT03587558|carvedilol|carvedilol
4644989|NCT03587558|SOICR|soicr
4644990|NCT03587558|triggered activity|triggered activity
4644991|NCT03587558|outflow tract PVC/VT|outflow tract pvc/vt
4644992|NCT03587532|esophagectomy|esophagectomy
4644993|NCT03587532|indocyanine green|indocyanine green
4644994|NCT03587532|near infrared fluorescence|near infrared fluorescence
4644995|NCT03587506|Generalized epilepsy, idiopathic, periodic limb movement|generalized epilepsy, idiopathic, periodic limb movement
4644996|NCT03587480|Low rectal cancer with regional lymph node metastasis|low rectal cancer with regional lymph node metastasis
4644997|NCT03587480|Total Mesorectal Excision with lateral lymph node dissection|total mesorectal excision with lateral lymph node dissection
4644998|NCT03587480|Total Mesorectal Excision after neoadjuvant Chemo-radiotherapy|total mesorectal excision after neoadjuvant chemo-radiotherapy
4644999|NCT03587454|teleglaucoma|teleglaucoma
4645000|NCT03587454|teleophthalmology|teleophthalmology
4645001|NCT03587441|postural headache|postural headache
4645002|NCT03587441|intrathecal neostigmine for prevention of PDPH|intrathecal neostigmine for prevention of pdph
4645003|NCT03587415|amylin; obesity; polycystic ovarian syndrome; preptin|amylin; obesity; polycystic ovarian syndrome; preptin
4645004|NCT03587389|Rotavirus|rotavirus
4645005|NCT03587389|Vaccine|vaccine
4645006|NCT03587389|Diarrhea|diarrhea
4645007|NCT03587389|Host genetics|host genetics
4645008|NCT03587337|Per-Oral Endoscopy Myotomy|per-oral endoscopy myotomy
4645009|NCT03587337|Microbial Translocation|microbial translocation
4645010|NCT03587298|ShearWave Elastography|shearwave elastography
4645011|NCT03587285|prostate cancer|prostate cancer
4645012|NCT03587285|central memory T cell|central memory t cell
4645013|NCT03587259|breast cancer screening|breast cancer screening
4645014|NCT03587259|tomosynthesis|tomosynthesis
4645015|NCT03587259|digital mammography|digital mammography
4645016|NCT03587233|Weight status|weight status
4645017|NCT03587233|Body mass index|body mass index
4645018|NCT03587233|Physical activity level|physical activity level
4645019|NCT03587233|Lifestyle behaviour|lifestyle behaviour
4645020|NCT03587207|Meningitis|meningitis
4645021|NCT03587207|Concomitantly|concomitantly
4645022|NCT03587207|Adolescent|adolescent
4645023|NCT03587207|Neisseria meningitidis|neisseria meningitidis
4645024|NCT03587207|Healthy subjects|healthy subjects
4645025|NCT03587207|Adult|adult
4645026|NCT03587181|Cryoballoon, Cryoablation, biobanking, Loop recorder, biopsy|cryoballoon, cryoablation, biobanking, loop recorder, biopsy
4645027|NCT03587168|Parkinson's Disease|parkinson's disease
4645028|NCT03587168|The Timed 360° Turn Test|the timed 360° turn test
4645029|NCT03587168|Validity|validity
4645030|NCT03587168|Reliability|reliability
4645031|NCT03587155|ASNS, single cell RNA seq, Neurodevelopmental Dysplasia,|asns, single cell rna seq, neurodevelopmental dysplasia,
4645032|NCT03587142|gastroparesis|gastroparesis
4645033|NCT03587142|early satiety|early satiety
4645034|NCT03587142|stomach|stomach
4645035|NCT03587142|buspirone|buspirone
4645036|NCT03587142|5-HT 1a receptor agonist|5-ht 1a receptor agonist
4645037|NCT03587129|epithelial ovarian cancer|epithelial ovarian cancer
4645038|NCT03587129|ovarian cancer|ovarian cancer
4645039|NCT03587129|platinum-resistant|platinum-resistant
4645040|NCT03587129|platinum-refractory|platinum-refractory
4645041|NCT03587064|CRT-D|crt-d
4645042|NCT03587064|CRT-DX|crt-dx
4645043|NCT03587064|Atrial pacing|atrial pacing
4645044|NCT03587025|amitryptyline|amitryptyline
4645045|NCT03587025|Analgesia|analgesia
4645046|NCT03587025|Hysterectomy|hysterectomy
4645047|NCT03587025|Pain, Postoperative|pain, postoperative
4645048|NCT03586999|Nivolumab|nivolumab
4645049|NCT03586999|First Line Treatment|first line treatment
4645050|NCT03586999|EPOCH|epoch
4645051|NCT03586999|Standard of Care|standard of care
4645052|NCT03586986|First degree relative|first degree relative
4645053|NCT03586856|Continuous positive airway pressure|continuous positive airway pressure
4645054|NCT03586856|Air Leakage|air leakage
4645055|NCT03586856|Work of breathing|work of breathing
4645056|NCT03586804|menstrual|menstrual
4645057|NCT03586804|postural sway|postural sway
4645058|NCT03586804|dual task|dual task
4645059|NCT03586778|Back Pain|back pain
4645060|NCT03586778|Dry Needling|dry needling
4645061|NCT03586765|incontinence|incontinence
4645062|NCT03586765|female|female
4645063|NCT03586765|observational study|observational study
4645064|NCT03586765|self filled survey|self filled survey
4645065|NCT03586765|epidemiology|epidemiology
4645066|NCT03586752|HQCPR between standard and on-line program|hqcpr between standard and on-line program
4645067|NCT03586752|Education|education
4645068|NCT03586739|Mesenteric Ischemia Chronic|mesenteric ischemia chronic
4645069|NCT03586739|Atherosclerosis|atherosclerosis
4645070|NCT03586739|Restenosis|restenosis
4645071|NCT03586739|Primary endovascular treatment|primary endovascular treatment
4645072|NCT03586739|Covered stents|covered stents
4645073|NCT03586739|Bare metal stents|bare metal stents
4645074|NCT03586700|Knee Osteoarthritis|knee osteoarthritis
4645075|NCT03586700|Synovium effusion|synovium effusion
4645076|NCT03586700|RCT|rct
4645077|NCT03586700|placebo|placebo
4645078|NCT03586687|Ultrasound guided injection|ultrasound guided injection
4645079|NCT03586674|pediatric cholestasis, Fibrate|pediatric cholestasis, fibrate
4645080|NCT03586622|Home monitoring|home monitoring
4645081|NCT03586622|Irritable Bowel Syndrome|irritable bowel syndrome
4645082|NCT03586596|Smokers|smokers
4645083|NCT03586596|Mobile intervention|mobile intervention
4645084|NCT03586596|Latino|latino
4645085|NCT03586596|Promotores de Salud|promotores de salud
4645086|NCT03586596|Pharmacotherapy|pharmacotherapy
4645087|NCT03586596|Cultural accomodation|cultural accomodation
4645088|NCT03586596|Tobacco use|tobacco use
4645089|NCT03586596|Health Disparities|health disparities
4645090|NCT03586596|Cancer Disparities|cancer disparities
4645091|NCT03586557|Optic Neuritis|optic neuritis
4645092|NCT03586557|aquaporin4-IgG|aquaporin4-igg
4645093|NCT03586557|Treatment|treatment
4645094|NCT03586544|pediatric|pediatric
4645095|NCT03586544|bronchoconstriction|bronchoconstriction
4645096|NCT03586531|renal biopsy|renal biopsy
4645097|NCT03586518|Cardiac MRI|cardiac mri
4645098|NCT03586518|Hemodialysis|hemodialysis
4645099|NCT03586518|Myocardial Fibrosis|myocardial fibrosis
4645100|NCT03586518|Myocardial Inflammation|myocardial inflammation
4645101|NCT03586505|Keratitis|keratitis
4645102|NCT03586505|Eye Infection|eye infection
4645103|NCT03586505|Photophobia|photophobia
4645104|NCT03586505|Red light|red light
4645105|NCT03586505|Infrared light|infrared light
4645106|NCT03586492|CFR|cfr
4645107|NCT03586492|SPECT|spect
4645108|NCT03586492|CZT|czt
4645109|NCT03586492|Coronary|coronary
4645110|NCT03586492|Calcium score|calcium score
4645111|NCT03586492|Scintigraphy|scintigraphy
4645112|NCT03586492|Myocardial perfusion|myocardial perfusion
4645113|NCT03586479|Vocabulary|vocabulary
4645114|NCT03586466|opioid abuse|opioid abuse
4645115|NCT03586466|opioid dependence|opioid dependence
4645116|NCT03586466|medication assisted treatment|medication assisted treatment
4645117|NCT03586466|opioids|opioids
4645118|NCT03586466|buprenorphine|buprenorphine
4645119|NCT03586466|buprenorphine/naloxone|buprenorphine/naloxone
4645120|NCT03586466|MedicaSafe|medicasafe
4645121|NCT03586453|Non-Small Cell Lung Cancer (NSCLC) with an EGFR mutation|non-small cell lung cancer (nsclc) with an egfr mutation
4645122|NCT03586440|RS-FHRSP-grip strength|rs-fhrsp-grip strength
4645123|NCT03586414|MitoQ|mitoq
4645124|NCT03586401|Children who have been treated for cancer|children who have been treated for cancer
4645125|NCT03586401|Qualification of health|qualification of health
4645126|NCT03586401|Physical insolvency|physical insolvency
4645127|NCT03586401|Late toxic effects|late toxic effects
4645128|NCT03586401|Physical therapy|physical therapy
4645129|NCT03586401|Physical activity|physical activity
4645130|NCT03586401|Systems for decision making support|systems for decision making support
4645131|NCT03586388|Hypersensitivity, Milk|hypersensitivity, milk
4645132|NCT03586388|Cow's Milk|cow's milk
4645133|NCT03586388|Immunotherapy|immunotherapy
4645134|NCT03586388|Infant|infant
4645135|NCT03586362|Vancomycin|vancomycin
4645136|NCT03586362|MRSA nasal swab|mrsa nasal swab
4645137|NCT03586362|Pneumonia|pneumonia
4645138|NCT03586297|BCRF|bcrf
4645139|NCT03586297|Microbiome|microbiome
4645140|NCT03586284|Cytomegalovirus uveitis|cytomegalovirus uveitis
4645141|NCT03586284|Cytomegalovirus endotheliitis|cytomegalovirus endotheliitis
4645142|NCT03586284|Cytomegalovirus keratouveitis|cytomegalovirus keratouveitis
4645143|NCT03586284|Cytomegalovirus iridocyclitis|cytomegalovirus iridocyclitis
4645144|NCT03586258|Neuropsychological study|neuropsychological study
4645145|NCT03586258|Brain imaging|brain imaging
4645146|NCT03586245|Iron Bioavailability|iron bioavailability
4645147|NCT03586245|Iron Fortification|iron fortification
4645148|NCT03586245|ferrous sulfate|ferrous sulfate
4645149|NCT03586245|ferric pyrophosphate|ferric pyrophosphate
4645150|NCT03586245|aspergillus oryzae|aspergillus oryzae
4645151|NCT03586245|stable isotope|stable isotope
4645152|NCT03586232|Rhinoplasty|rhinoplasty
4645153|NCT03586232|Arnica Montana|arnica montana
4645154|NCT03586232|Bromelain|bromelain
4645155|NCT03586232|Body healing post op|body healing post op
4645156|NCT03586232|Rhinoplasty Outcome Evaluation|rhinoplasty outcome evaluation
4645157|NCT03586219|Surgery|surgery
4645158|NCT03586219|Patient Education|patient education
4645159|NCT03586219|Opioid|opioid
4645160|NCT03586219|Medication Storage|medication storage
4645161|NCT03586219|Medication Disposal|medication disposal
4645162|NCT03586206|Clostridium difficile|clostridium difficile
4645163|NCT03586206|toxins|toxins
4645164|NCT03586206|serum|serum
4645165|NCT03586206|infection|infection
4645166|NCT03586154|Ketamine; pain; platelet rich plasma; mastectomy; shoulder|ketamine; pain; platelet rich plasma; mastectomy; shoulder
4645167|NCT03586102|Protein supplementation|protein supplementation
4645168|NCT03586102|Human milk fortification|human milk fortification
4645169|NCT03586089|Phenobarbital|phenobarbital
4645170|NCT03586089|Alcohol|alcohol
4645171|NCT03586089|Withdrawal|withdrawal
4645273|NCT03585413|Micronutrient supplementation|micronutrient supplementation
4645172|NCT03586050|Hepatocellular Carcinoma; liver cancer; cancer; liver|hepatocellular carcinoma; liver cancer; cancer; liver
4645173|NCT03586011|Physical activity on prescription|physical activity on prescription
4645174|NCT03586011|Correlate of physical activity|correlate of physical activity
4645175|NCT03586011|Predicting factor|predicting factor
4645176|NCT03585933|Myocardial fibrosis|myocardial fibrosis
4645177|NCT03585933|Severe aortic stenosis|severe aortic stenosis
4645178|NCT03585933|Cardiovascular magnetic resonance|cardiovascular magnetic resonance
4645179|NCT03585933|Scintigraphy|scintigraphy
4645180|NCT03585933|SAVR/TAVI|savr/tavi
4645181|NCT03585920|Fat|fat
4645182|NCT03585920|Oral sensitivity|oral sensitivity
4645183|NCT03585920|Appetite|appetite
4645184|NCT03585920|Metabolism|metabolism
4645185|NCT03585868|flavonoids|flavonoids
4645186|NCT03585842|Scale Translation|scale translation
4645187|NCT03585842|Substance Use Disorder|substance use disorder
4645188|NCT03585842|Comorbidities psychiatric|comorbidities psychiatric
4645189|NCT03585829|treatment|treatment
4645190|NCT03585829|quality of life|quality of life
4645191|NCT03585829|hypoglycemia|hypoglycemia
4645192|NCT03585816|Pneumoperitoneum|pneumoperitoneum
4645193|NCT03585816|Exhaust gas|exhaust gas
4645194|NCT03585816|chromatographic study|chromatographic study
4645195|NCT03585816|Nitrous oxide|nitrous oxide
4645196|NCT03585816|Nitrogen dioxide|nitrogen dioxide
4645197|NCT03585790|Eye Fatigue|eye fatigue
4645198|NCT03585751|non vital|non vital
4645199|NCT03585751|deciduous|deciduous
4645200|NCT03585751|3mixstatin|3mixstatin
4645201|NCT03585751|simvastatin|simvastatin
4645202|NCT03585751|triple antibiotic mix|triple antibiotic mix
4645203|NCT03585751|3 mix|3 mix
4645204|NCT03585738|Inositol|inositol
4645205|NCT03585738|Polycystic ovarian syndrome|polycystic ovarian syndrome
4645206|NCT03585738|Pregnancy|pregnancy
4645207|NCT03585738|Obstetrics outcomes|obstetrics outcomes
4645208|NCT03585738|Gestational diabetes|gestational diabetes
4645209|NCT03585738|Preeclampsia|preeclampsia
4645210|NCT03585725|Ribavirin|ribavirin
4645211|NCT03585725|Follicular Lymphoma|follicular lymphoma
4645212|NCT03585725|Mantle Cell Lymphoma|mantle cell lymphoma
4645213|NCT03585725|Lymphoma|lymphoma
4645214|NCT03585725|Non-Hodgkin lymphoma|non-hodgkin lymphoma
4645215|NCT03585725|Indolent Lymphoma|indolent lymphoma
4645216|NCT03585712|Birth Control|birth control
4645217|NCT03585712|Progestin Only Pill|progestin only pill
4645218|NCT03585712|Estrogen Free Pill|estrogen free pill
4645219|NCT03585712|Norgestrel|norgestrel
4645220|NCT03585712|Oral Contraception|oral contraception
4645221|NCT03585712|Female Contraception|female contraception
4645222|NCT03585712|Cervical Mucus|cervical mucus
4645223|NCT03585712|Ovarian Activity|ovarian activity
4645224|NCT03585699|spinal biopsy|spinal biopsy
4645225|NCT03585699|prospective randomizd trial|prospective randomizd trial
4645226|NCT03585686|LCH|lch
4645227|NCT03585686|Langerhans|langerhans
4645228|NCT03585686|histiocytosis|histiocytosis
4645229|NCT03585686|vemurafenib|vemurafenib
4645230|NCT03585686|BRAF|braf
4645231|NCT03585673|esophageal cancer|esophageal cancer
4645232|NCT03585673|metastatic|metastatic
4645233|NCT03585673|inoperable|inoperable
4645234|NCT03585673|relapsed|relapsed
4645235|NCT03585647|General anesthesia|general anesthesia
4645236|NCT03585647|Regional anesthesia|regional anesthesia
4645237|NCT03585647|Integrated anesthesia|integrated anesthesia
4645238|NCT03585647|Hip arthroplasty|hip arthroplasty
4645239|NCT03585647|Toxicological gene expression|toxicological gene expression
4645240|NCT03585634|Fathers|fathers
4645241|NCT03585634|Masculinity|masculinity
4645242|NCT03585634|Gender role|gender role
4645243|NCT03585634|Health Behaviour|health behaviour
4645244|NCT03585634|Family health|family health
4645245|NCT03585595|Antihypertensive treatment|antihypertensive treatment
4645246|NCT03585582|Respiratory Health|respiratory health
4645247|NCT03585556|Wet Age-related Macular Degeneration|wet age-related macular degeneration
4645248|NCT03585556|Gene therapy|gene therapy
4645249|NCT03585556|Wet AMD|wet amd
4645250|NCT03585530|Esophageal neoplasma|esophageal neoplasma
4645251|NCT03585530|adjuvant therapy|adjuvant therapy
4645252|NCT03585530|raltitrexed|raltitrexed
4645253|NCT03585530|radiotherapy|radiotherapy
4645254|NCT03585504|Implanon|implanon
4645255|NCT03585504|Bleeding Acceptability|bleeding acceptability
4645256|NCT03585504|Contraceptive Implant|contraceptive implant
4645257|NCT03585504|Adolescent Pregnancy Prevention|adolescent pregnancy prevention
4645258|NCT03585504|Post Partum Insertion of Implanon|post partum insertion of implanon
4645259|NCT03585478|Celiac|celiac
4645260|NCT03585452|dexmedetomidine|dexmedetomidine
4645261|NCT03585452|cardiac surgery|cardiac surgery
4645262|NCT03585452|brain injury biomarkers|brain injury biomarkers
4645263|NCT03585452|cognitive examination|cognitive examination
4645264|NCT03585439|Isthmic spondylolisthesis|isthmic spondylolisthesis
4645265|NCT03585439|vertebral fusion|vertebral fusion
4645266|NCT03585439|combined approach|combined approach
4645267|NCT03585439|circumferential fusion|circumferential fusion
4645268|NCT03585439|ALIF|alif
4645269|NCT03585439|posterior fusion|posterior fusion
4645270|NCT03585413|Bariatric surgery|bariatric surgery
4645271|NCT03585413|Obesity|obesity
4645274|NCT03585413|Probiotic supplementation|probiotic supplementation
4645275|NCT03585400|Neuromuscular Blockade Agents|neuromuscular blockade agents
4645276|NCT03585400|Neuromuscular Blockade Reversal|neuromuscular blockade reversal
4645277|NCT03585400|Perioperative Care|perioperative care
4645278|NCT03585400|Quality Improvement|quality improvement
4645279|NCT03585374|pain|pain
4645280|NCT03585374|methoxyflurane|methoxyflurane
4645281|NCT03585374|Penthrox|penthrox
4645282|NCT03585361|Contraceptive Usage|contraceptive usage
4645283|NCT03585361|Pregnancy|pregnancy
4645284|NCT03585361|Postpartum Family Planning|postpartum family planning
4645285|NCT03585361|Contraception|contraception
4645286|NCT03585361|Prenatal Care|prenatal care
4645287|NCT03585361|Postnatal Care|postnatal care
4645288|NCT03585361|Postpartum Care|postpartum care
4645289|NCT03585361|Family Planning|family planning
4645290|NCT03585361|Ethiopia|ethiopia
4645291|NCT03585361|Community Health Workers|community health workers
4645292|NCT03585361|Community Based Care|community based care
4645293|NCT03585361|Health Extension Workers|health extension workers
4645294|NCT03585348|Neuromuscular Blockade Agents|neuromuscular blockade agents
4645295|NCT03585348|Provider Variability|provider variability
4645296|NCT03585348|Quality Improvement|quality improvement
4645297|NCT03585348|Perioperative Care|perioperative care
4645298|NCT03585348|Neuromuscular Blockade Reversal|neuromuscular blockade reversal
4645299|NCT03585335|Cardiorespiratory Risk Score|cardiorespiratory risk score
4645300|NCT03585335|BMI|bmi
4645301|NCT03585283|Myofascial Release|myofascial release
4645302|NCT03585283|Manual Therapies|manual therapies
4645303|NCT03585257|covert hepatic encephalopathy|covert hepatic encephalopathy
4645304|NCT03585257|inflammation|inflammation
4645305|NCT03585257|cognition|cognition
4645306|NCT03585257|quality of life|quality of life
4645307|NCT03585231|Smoking|smoking
4645308|NCT03585231|Chatbot|chatbot
4645309|NCT03585231|Conversational agent|conversational agent
4645310|NCT03585231|Chatbot for quitting smoking|chatbot for quitting smoking
4645311|NCT03585218|Quality of Life|quality of life
4645312|NCT03585218|Breast Cancer|breast cancer
4645313|NCT03585218|Essentials Oils|essentials oils
4645314|NCT03585218|Adjuvant Chemotherapy|adjuvant chemotherapy
4645315|NCT03585218|Salivary cortisol|salivary cortisol
4645316|NCT03585218|Neuropsychophysiology|neuropsychophysiology
4645317|NCT03585205|Stress response|stress response
4645318|NCT03585205|Cognitive Load|cognitive load
4645319|NCT03585179|Melasma|melasma
4645320|NCT03585179|Chloasma|chloasma
4645321|NCT03585179|Melanosis|melanosis
4645322|NCT03585179|Tranexamic acid|tranexamic acid
4645323|NCT03585179|Hydroquinone|hydroquinone
4645324|NCT03585179|Therapeutics|therapeutics
4645325|NCT03585166|Liver Cancer|liver cancer
4645326|NCT03585166|laparoscopic hepatectomy|laparoscopic hepatectomy
4645327|NCT03585166|open hepatectomy|open hepatectomy
4645328|NCT03585140|Acne Vulgaris|acne vulgaris
4645329|NCT03585140|Low Glycemic Diet|low glycemic diet
4645330|NCT03585140|Doxycycline|doxycycline
4645331|NCT03585140|Adapalene|adapalene
4645332|NCT03585127|Auditory verbal hallucinations|auditory verbal hallucinations
4645333|NCT03585127|Schizophrenia|schizophrenia
4645334|NCT03585127|Treatment-resistant|treatment-resistant
4645335|NCT03585127|Psychotherapy|psychotherapy
4645336|NCT03585127|Cognitive Behavioral Therapy|cognitive behavioral therapy
4645337|NCT03585127|Avatar Therapy|avatar therapy
4645338|NCT03585127|Virtual reality|virtual reality
4645339|NCT03585101|Hepatitis C virus|hepatitis c virus
4645340|NCT03585101|Endothelial function|endothelial function
4645341|NCT03585101|Cardiovascular disease risk|cardiovascular disease risk
4645342|NCT03585101|Metabolic disease|metabolic disease
4645343|NCT03585101|Inflammation|inflammation
4645344|NCT03585101|Insulin resistance|insulin resistance
4645345|NCT03585062|S-1|s-1
4645346|NCT03585062|Paclitaxel-albumin|paclitaxel-albumin
4645347|NCT03585062|Unresectable Pancreatic Cancer|unresectable pancreatic cancer
4645348|NCT03585062|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
4645349|NCT03585010|anxiety disorders|anxiety disorders
4645350|NCT03584971|estradiol|estradiol
4645351|NCT03584971|cooperation|cooperation
4645352|NCT03584971|competitiveness|competitiveness
4645353|NCT03584971|risk preferences|risk preferences
4645354|NCT03584958|glaucoma surgery|glaucoma surgery
4645355|NCT03584958|MIGS, minimally invasive glaucoma surgery|migs, minimally invasive glaucoma surgery
4645356|NCT03584958|refractive outcomes|refractive outcomes
4645357|NCT03584958|visual outcomes|visual outcomes
4645358|NCT03584932|Youth,|youth,
4645359|NCT03584932|Criminal justice|criminal justice
4645360|NCT03584932|Sexual/gender minorities|sexual/gender minorities
4645361|NCT03584932|Navigation|navigation
4645362|NCT03584893|Juvenile Cataract|juvenile cataract
4645363|NCT03584893|CTX|ctx
4645364|NCT03584893|Diarrhea|diarrhea
4645365|NCT03584893|Neonatal Jaundice|neonatal jaundice
4645366|NCT03584893|Xanthoma|xanthoma
4645367|NCT03584880|postoperative pain|postoperative pain
4645368|NCT03584880|Diode laser|diode laser
4645369|NCT03584880|retreatment|retreatment
4645370|NCT03584867|Basic life support|basic life support
4645371|NCT03584867|CPR skills|cpr skills
4645372|NCT03584867|Training|training
4645471|NCT03584308|Glizigen|glizigen
4645373|NCT03584867|High quality CPR|high quality cpr
4645374|NCT03584828|Cardiac Rehabilitation|cardiac rehabilitation
4645375|NCT03584828|exercise|exercise
4645376|NCT03584802|severe acute exacerbation of idiopathic pulmonary fibrosis|severe acute exacerbation of idiopathic pulmonary fibrosis
4645377|NCT03584789|Decision Support Systems, Clinical|decision support systems, clinical
4645378|NCT03584789|Pain Management|pain management
4645379|NCT03584789|Analgesics|analgesics
4645380|NCT03584776|Virtual reality|virtual reality
4645381|NCT03584750|Somatic and psychological factors|somatic and psychological factors
4645382|NCT03584737|acute sinusitis|acute sinusitis
4645383|NCT03584737|bacterial sinusitis|bacterial sinusitis
4645384|NCT03584737|point-of-care|point-of-care
4645385|NCT03584737|in vitro diagnostic device (IVD)|in vitro diagnostic device (ivd)
4645386|NCT03584724|HLA-B27|hla-b27
4645387|NCT03584724|relapses|relapses
4645388|NCT03584724|curcumin|curcumin
4645389|NCT03584711|Stop and Go strategy|stop and go strategy
4645390|NCT03584711|RAS Wild-type|ras wild-type
4645391|NCT03584672|Multiple Sclerosis|multiple sclerosis
4645392|NCT03584672|Static Balance Test|static balance test
4645393|NCT03584672|Balance|balance
4645394|NCT03584672|Reliability|reliability
4645395|NCT03584672|Validity|validity
4645396|NCT03584659|Patient-reported outcomes|patient-reported outcomes
4645397|NCT03584659|Electronic reporting of symptoms|electronic reporting of symptoms
4645398|NCT03584659|Immunotherapy|immunotherapy
4645399|NCT03584659|Chemotherapy|chemotherapy
4645400|NCT03584646|liver transplantation|liver transplantation
4645401|NCT03584646|malnutrition|malnutrition
4645402|NCT03584646|exercise|exercise
4645403|NCT03584646|prehabilitation|prehabilitation
4645404|NCT03584646|nutrition|nutrition
4645405|NCT03584646|sarcopenia|sarcopenia
4645406|NCT03584633|Indocyanine Green|indocyanine green
4645407|NCT03584633|Indocyanine Green Lymphography|indocyanine green lymphography
4645408|NCT03584633|Exercise|exercise
4645409|NCT03584620|lung transplantation|lung transplantation
4645410|NCT03584620|inspiratory muscle training|inspiratory muscle training
4645411|NCT03584620|pulmonary rehabilitation|pulmonary rehabilitation
4645412|NCT03584620|quality of life|quality of life
4645413|NCT03584620|physical activity|physical activity
4645414|NCT03584594|presepsin|presepsin
4645415|NCT03584594|biomarkers|biomarkers
4645416|NCT03584594|sepsis|sepsis
4645417|NCT03584594|diagnosis|diagnosis
4645418|NCT03584568|Caregiving|caregiving
4645419|NCT03584568|Intergeneration|intergeneration
4645420|NCT03584568|Reappraisal through perspective taking|reappraisal through perspective taking
4645421|NCT03584555|Small incision lenticule extraction|small incision lenticule extraction
4645422|NCT03584555|Cap thickness|cap thickness
4645423|NCT03584542|Zolpidem|zolpidem
4645424|NCT03584542|hypnotics and sedatives|hypnotics and sedatives
4645425|NCT03584542|Drug and narcotic control|drug and narcotic control
4645426|NCT03584542|Drug prescription|drug prescription
4645427|NCT03584542|Substance-related Disorders|substance-related disorders
4645428|NCT03584542|Health Impact Assessment|health impact assessment
4645429|NCT03584516|Graft-versus-host-disease|graft-versus-host-disease
4645430|NCT03584516|itacitinib|itacitinib
4645431|NCT03584516|Janus kinase inhibitor|janus kinase inhibitor
4645432|NCT03584516|corticosteroids|corticosteroids
4645433|NCT03584503|general anesthesia|general anesthesia
4645434|NCT03584503|laryngospasm|laryngospasm
4645435|NCT03584503|postoperative complications|postoperative complications
4645436|NCT03584503|rhinoplasty|rhinoplasty
4645437|NCT03584503|Suction Above Cuff Endotracheal Tube|suction above cuff endotracheal tube
4645438|NCT03584477|Stroke|stroke
4645439|NCT03584477|Robot,|robot,
4645440|NCT03584477|Rehabilitation|rehabilitation
4645441|NCT03584477|Hemiparesis|hemiparesis
4645442|NCT03584477|Upper limb|upper limb
4645443|NCT03584477|Function|function
4645444|NCT03584477|Motor control|motor control
4645445|NCT03584438|TMS|tms
4645446|NCT03584438|Motor Cortex|motor cortex
4645447|NCT03584438|Excitability|excitability
4645448|NCT03584438|LTP|ltp
4645449|NCT03584438|LTD|ltd
4645450|NCT03584425|BOLD Signal|bold signal
4645451|NCT03584425|Functional Magnetic Resonance Imaging|functional magnetic resonance imaging
4645452|NCT03584425|MR Spectroscopy|mr spectroscopy
4645453|NCT03584425|Anatomical Imaging|anatomical imaging
4645454|NCT03584425|Kinematics|kinematics
4645455|NCT03584386|Suicidality|suicidality
4645456|NCT03584386|Collaborative Assessment and Management of Suicidality|collaborative assessment and management of suicidality
4645457|NCT03584386|CAMS|cams
4645458|NCT03584386|Technology|technology
4645459|NCT03584386|Emergency Department|emergency department
4645460|NCT03584386|Suicide Intervention|suicide intervention
4645461|NCT03584386|Suicide Assessment|suicide assessment
4645462|NCT03584386|Suicide Prevention|suicide prevention
4645463|NCT03584373|Pain Outcomes|pain outcomes
4645464|NCT03584373|Ureteroscopy|ureteroscopy
4645465|NCT03584373|Percutaneous Nephrolithotomy|percutaneous nephrolithotomy
4645466|NCT03584373|Opioids|opioids
4645467|NCT03584321|Non-Obstructive Coronary Artery Disease|non-obstructive coronary artery disease
4645468|NCT03584321|Coronary Angiography|coronary angiography
4645469|NCT03584308|Papillomavirus|papillomavirus
4645470|NCT03584308|Viusid|viusid
4645472|NCT03584308|Papilloma virus Esophageal|papilloma virus esophageal
4645473|NCT03584308|Antioxidant|antioxidant
4645474|NCT03584282|Pre-Exposure Prophylaxis (PrEP)|pre-exposure prophylaxis (prep)
4645475|NCT03584282|Methamphetamine|methamphetamine
4645476|NCT03584269|COPD|copd
4645477|NCT03584269|Oxygenation Long term|oxygenation long term
4645478|NCT03584269|Non invasive Ventilation|non invasive ventilation
4645479|NCT03584269|Nocturnal Hypoventilation|nocturnal hypoventilation
4645480|NCT03584243|collagen crosslinking|collagen crosslinking
4645481|NCT03584243|transepithelial crosslinking|transepithelial crosslinking
4645482|NCT03584178|ACTH-axis|acth-axis
4645483|NCT03584178|Budesonide|budesonide
4645484|NCT03584178|MAD|mad
4645485|NCT03584178|INSI|insi
4645486|NCT03584178|Intraocular pressure|intraocular pressure
4645487|NCT03584178|Bone density|bone density
4645488|NCT03584165|NightstaRx|nightstarx
4645489|NCT03584165|NSR-REP1|nsr-rep1
4645490|NCT03584165|Choroideremia|choroideremia
4645491|NCT03584165|CHM|chm
4645492|NCT03584165|Gene Therapy|gene therapy
4645493|NCT03584165|AAV|aav
4645494|NCT03584165|REP1|rep1
4645495|NCT03584152|Postoperative pain|postoperative pain
4645496|NCT03584152|Rhinoplasty|rhinoplasty
4645497|NCT03584087|Terlipressin, Variceal Haemorrhage, EVL|terlipressin, variceal haemorrhage, evl
4645498|NCT03584074|Pregabalin|pregabalin
4645499|NCT03584074|Selective COX-2 inhibitor|selective cox-2 inhibitor
4645500|NCT03584061|Chronic Pain|chronic pain
4645501|NCT03584061|Herpes Zoster|herpes zoster
4645502|NCT03584061|Pain|pain
4645503|NCT03584035|sensory motor integration exercise|sensory motor integration exercise
4645504|NCT03583983|Physical Activity|physical activity
4645505|NCT03583983|Dietary Habits|dietary habits
4645506|NCT03583983|Genetic Scores|genetic scores
4645507|NCT03583983|Cardiovascular Health|cardiovascular health
4645508|NCT03583970|Left Ventricular Assist Device|left ventricular assist device
4645509|NCT03583970|Extracorporeal Membrane Oxygenation|extracorporeal membrane oxygenation
4645510|NCT03583970|Refractory Cardiogenic Shock|refractory cardiogenic shock
4645511|NCT03583970|Heart Failure|heart failure
4645512|NCT03583970|Cardiovascular diseases|cardiovascular diseases
4645513|NCT03583970|Myocardial Infarction|myocardial infarction
4645514|NCT03583970|Myocardial Ischemia|myocardial ischemia
4645515|NCT03583970|Shock|shock
4645516|NCT03583944|E7389|e7389
4645517|NCT03583944|Tumors, Breast|tumors, breast
4645518|NCT03583944|Breast Cancer|breast cancer
4645519|NCT03583944|Breast Carcinoma|breast carcinoma
4645520|NCT03583944|Neoplasms, Breast|neoplasms, breast
4645521|NCT03583931|VATS Decortication|vats decortication
4645522|NCT03583931|Surgical Pleural Decortication|surgical pleural decortication
4645523|NCT03583931|Fibrinolytic Therapy|fibrinolytic therapy
4645524|NCT03583931|Pneumonia|pneumonia
4645525|NCT03583931|Thoracostomy|thoracostomy
4645526|NCT03583918|facial wrinkles|facial wrinkles
4645527|NCT03583918|skin laxity|skin laxity
4645528|NCT03583918|sagging skin|sagging skin
4645529|NCT03583892|Gabapentin, laparoscopic cholecystectomy, postoperative pain|gabapentin, laparoscopic cholecystectomy, postoperative pain
4645530|NCT03583879|Exoskeleton|exoskeleton
4645531|NCT03583879|Functional exercise|functional exercise
4645532|NCT03583866|blood pressure|blood pressure
4645533|NCT03583866|microdialysis|microdialysis
4645534|NCT03583840|men's health|men's health
4645535|NCT03583840|internet|internet
4645536|NCT03583840|telemedicine|telemedicine
4645537|NCT03583840|mass screening|mass screening
4645538|NCT03583840|health behavior|health behavior
4645539|NCT03583827|Cerebrovascular disorders|cerebrovascular disorders
4645540|NCT03583827|Upper extremity|upper extremity
4645541|NCT03583827|Paresis|paresis
4645542|NCT03583827|Electroencephalography|electroencephalography
4645543|NCT03583827|Psychomotor Performance|psychomotor performance
4645544|NCT03583801|Perioperative Anxiety|perioperative anxiety
4645545|NCT03583801|Aromatherapy|aromatherapy
4645546|NCT03583801|Surgery|surgery
4645547|NCT03583801|Loco-regional Anesthesia|loco-regional anesthesia
4645548|NCT03583801|Ambulatory|ambulatory
4645549|NCT03583762|Microarray Assay Technique|microarray assay technique
4645550|NCT03583762|Mass Spectrometry Technique|mass spectrometry technique
4645551|NCT03583762|Time to appropriate antibiotic|time to appropriate antibiotic
4645552|NCT03583749|Antimicrobial agents|antimicrobial agents
4645553|NCT03583749|subcutaneous administration|subcutaneous administration
4645554|NCT03583749|safety|safety
4645555|NCT03583749|pharmacokinetics|pharmacokinetics
4645556|NCT03583749|elderly|elderly
4645557|NCT03583723|Adaptive radiotherapy|adaptive radiotherapy
4645558|NCT03583697|Dwarfism|dwarfism
4645559|NCT03583697|Bone Diseases|bone diseases
4645560|NCT03583697|Bone Diseases, Developmental|bone diseases, developmental
4645561|NCT03583697|ACH|ach
4645562|NCT03583697|Natriuretic Peptide, C-Type|natriuretic peptide, c-type
4645563|NCT03583697|Musculoskeletal Diseases|musculoskeletal diseases
4645564|NCT03583697|Natriuretic Agents|natriuretic agents
4645565|NCT03583697|Physiological Effect of Drugs|physiological effect of drugs
4645566|NCT03583697|Skeletal Dysplasias|skeletal dysplasias
4645567|NCT03583697|Genetic Diseases, Inborn|genetic diseases, inborn
4645568|NCT03583697|Osteochondrodysplasias|osteochondrodysplasias
4645569|NCT03583684|Pivotal Response Treatment|pivotal response treatment
4645570|NCT03583684|Imaging|imaging
4645571|NCT03583671|Molar Incisor Hypomineralization , enamel defects.|molar incisor hypomineralization , enamel defects.
4645572|NCT03583645|Adolescence|adolescence
4645573|NCT03583645|Prevention|prevention
4645574|NCT03583645|Aggressive behavior|aggressive behavior
4645575|NCT03583645|Dating Violence|dating violence
4645576|NCT03583606|Adenovirus vector|adenovirus vector
4645577|NCT03583606|Ebola Virus|ebola virus
4645578|NCT03583606|Immunogenicity|immunogenicity
4645579|NCT03583606|Non-Human Primates Vaccination/Challenge Studies|non-human primates vaccination/challenge studies
4645580|NCT03583606|Phase 1|phase 1
4645581|NCT03583606|Reactogenicity|reactogenicity
4645582|NCT03583606|Safety|safety
4645583|NCT03583606|Zaire ebolavirus vaccine|zaire ebolavirus vaccine
4645584|NCT03583593|Diabetes|diabetes
4645585|NCT03583593|Insulin|insulin
4645586|NCT03583593|Diabetic Foot|diabetic foot
4645587|NCT03583593|Nutritional supplement|nutritional supplement
4645588|NCT03583593|Diamel|diamel
4645589|NCT03583580|Breast conserving surgery|breast conserving surgery
4645590|NCT03583580|Accelerate partial breast irradiation|accelerate partial breast irradiation
4645591|NCT03583580|intensity-modulated radiation therapy|intensity-modulated radiation therapy
4645592|NCT03583580|phase II|phase ii
4645593|NCT03583567|protamine|protamine
4645594|NCT03583567|antihistamine|antihistamine
4645595|NCT03583541|Vulnerable women|vulnerable women
4645596|NCT03583541|Female sex workers|female sex workers
4645597|NCT03583541|Combination interventions|combination interventions
4645598|NCT03583541|Economic empowerment|economic empowerment
4645599|NCT03583541|HIV/AIDS|hiv/aids
4645600|NCT03583541|Sexually transmitted infections|sexually transmitted infections
4645601|NCT03583541|Sub-Saharan Africa|sub-saharan africa
4645602|NCT03583541|Uganda|uganda
4645603|NCT03583502|LCPUFA|lcpufa
4645604|NCT03583502|DHA|dha
4645605|NCT03583502|krill oil|krill oil
4645606|NCT03583502|supplementation|supplementation
4645607|NCT03583502|breast milk|breast milk
4645608|NCT03583476|Helicobacter pylori|helicobacter pylori
4645609|NCT03583476|Resistance|resistance
4645610|NCT03583476|Minimal inhibitory concentration|minimal inhibitory concentration
4645611|NCT03583476|Treatment efficacy|treatment efficacy
4645612|NCT03583411|thrombocytopenia|thrombocytopenia
4645613|NCT03583411|thrombocytosis|thrombocytosis
4645614|NCT03583398|TAVI|tavi
4645615|NCT03583398|quality of life|quality of life
4645616|NCT03583398|SAVR|savr
4645617|NCT03583372|Beta-3 adrenergic receptor (β3-AR) agonists|beta-3 adrenergic receptor (β3-ar) agonists
4645618|NCT03583372|incontinence|incontinence
4645619|NCT03583372|OAB|oab
4645620|NCT03583372|vibegron|vibegron
4645621|NCT03583372|urge urinary incontinence|urge urinary incontinence
4645622|NCT03583372|Urinary bladder, overactive|urinary bladder, overactive
4645623|NCT03583372|Urologic Diseases|urologic diseases
4645624|NCT03583372|Lower Urinary Tract Symptoms|lower urinary tract symptoms
4645625|NCT03583372|Urological Agents|urological agents
4645626|NCT03583346|M6495|m6495
4645627|NCT03583346|Anti-ADAMTS-5 Nanobody|anti-adamts-5 nanobody
4645628|NCT03583346|Osteoarthritis|osteoarthritis
4645629|NCT03583307|Sirolimus|sirolimus
4645630|NCT03583307|Vascular anomalies|vascular anomalies
4645631|NCT03583268|Type 1 diabetes|type 1 diabetes
4645632|NCT03583268|Physical activity|physical activity
4645633|NCT03583268|Hypoglycemia|hypoglycemia
4645634|NCT03583268|Glucose variability|glucose variability
4645635|NCT03583229|Heart Transplantation|heart transplantation
4645636|NCT03583229|Cardiac Allograft Vasculopathy|cardiac allograft vasculopathy
4645637|NCT03583216|Diabetic pregnancies, Factor XII|diabetic pregnancies, factor xii
4645638|NCT03583203|schizophrenia|schizophrenia
4645639|NCT03583203|bipolar disorder|bipolar disorder
4645640|NCT03583203|tobacco|tobacco
4645641|NCT03583203|COPD|copd
4645642|NCT03583190|Neck pain|neck pain
4645643|NCT03583190|Headache|headache
4645644|NCT03583190|Dry needling|dry needling
4645645|NCT03583190|manual therapy|manual therapy
4645646|NCT03583177|Proteolysis|proteolysis
4645647|NCT03583177|Muscle|muscle
4645648|NCT03583177|Cachexia|cachexia
4645649|NCT03583164|Anti fungal|anti fungal
4645650|NCT03583164|Invasive aspergillosis|invasive aspergillosis
4645651|NCT03583164|Rare moulds|rare moulds
4645652|NCT03583151|Corticosteroid|corticosteroid
4645653|NCT03583138|HIV|hiv
4645654|NCT03583138|AIDS|aids
4645655|NCT03583138|Opiate Addiction|opiate addiction
4645656|NCT03583138|Drug Dependence|drug dependence
4645657|NCT03583138|Buprenorphine|buprenorphine
4645658|NCT03583125|bladder cancer|bladder cancer
4645659|NCT03583125|cholangiocarcinoma|cholangiocarcinoma
4645660|NCT03583125|gastric cancer|gastric cancer
4645661|NCT03583125|breast cancer|breast cancer
4645662|NCT03583073|psychosis|psychosis
4645663|NCT03583073|clinical high risk|clinical high risk
4645664|NCT03583047|MACE|mace
4645665|NCT03583047|EPCs|epcs
4645666|NCT03583047|Cardiovascular risk|cardiovascular risk
4645667|NCT03583047|Endothelial dysfunction|endothelial dysfunction
4645668|NCT03583047|Prognosis|prognosis
4645669|NCT03583034|HoLEP|holep
4645670|NCT03583034|Prostate|prostate
4645671|NCT03582982|resistance exercise|resistance exercise
4645672|NCT03582982|muscle fatigue|muscle fatigue
4645673|NCT03582982|physical function|physical function
4645674|NCT03582969|IBD|ibd
4645675|NCT03582969|UC|uc
4645676|NCT03582969|fecal-transplantation|fecal-transplantation
4645677|NCT03582969|capsules|capsules
4645678|NCT03582969|microbiota|microbiota
4645679|NCT03582969|microbiome|microbiome
4645680|NCT03582969|colitis|colitis
4645681|NCT03582969|pediatric|pediatric
4645682|NCT03582943|remote ischemic conditioning, motor learning|remote ischemic conditioning, motor learning
4645683|NCT03582930|Infasurf|infasurf
4645684|NCT03582930|Surfactant|surfactant
4645685|NCT03582930|RDS|rds
4645686|NCT03582930|Respiratory Distress Syndrome|respiratory distress syndrome
4645687|NCT03582930|Aerosolized|aerosolized
4645688|NCT03582930|Nebulized|nebulized
4645689|NCT03582930|Inhaled|inhaled
4645690|NCT03582930|Pre-term|pre-term
4645691|NCT03582930|Premature|premature
4645692|NCT03582904|motor learning|motor learning
4645693|NCT03582904|tDCS|tdcs
4645694|NCT03582904|locomotion|locomotion
4645695|NCT03582865|Breast cancer|breast cancer
4645696|NCT03582865|Genotyping|genotyping
4645697|NCT03582865|Tamoxifen|tamoxifen
4645698|NCT03582826|systemic malodor|systemic malodor
4645699|NCT03582826|body odor|body odor
4645700|NCT03582826|bad breath|bad breath
4645701|NCT03582826|PATM|patm
4645702|NCT03582826|microbiome|microbiome
4645703|NCT03582826|TMAU|tmau
4645704|NCT03582826|Malabsorption|malabsorption
4645705|NCT03582826|Dysbiosis|dysbiosis
4645706|NCT03582813|self-directed care|self-directed care
4645707|NCT03582813|mental health services|mental health services
4645708|NCT03582813|mental health recovery|mental health recovery
4645709|NCT03582813|behavioral health service financing|behavioral health service financing
4645710|NCT03582800|Sodium thiosulfate|sodium thiosulfate
4645711|NCT03582800|Ectopic calcification|ectopic calcification
4645712|NCT03582800|Ectopic Ossification|ectopic ossification
4645713|NCT03582735|Carpal Tunnel Syndrome|carpal tunnel syndrome
4645714|NCT03582735|Ultrasound Imaging|ultrasound imaging
4645715|NCT03582735|Preoperative Care|preoperative care
4645716|NCT03582735|Exercise Therapy|exercise therapy
4645717|NCT03582722|Polybrominated Biphenyl Exposure|polybrominated biphenyl exposure
4645718|NCT03582722|Gastrointestinal lipase inhibitor|gastrointestinal lipase inhibitor
4645719|NCT03582683|Self-Management Programs|self-management programs
4645720|NCT03582683|Behavioral Health|behavioral health
4645721|NCT03582670|Prospective Memory|prospective memory
4645722|NCT03582670|Occupational Therapy|occupational therapy
4645723|NCT03582657|nanostructured-implant|nanostructured-implant
4645724|NCT03582657|titanium implant|titanium implant
4645725|NCT03582657|nano-roughness surface|nano-roughness surface
4645726|NCT03582657|hydrophilic surface|hydrophilic surface
4645727|NCT03582657|KONTACT N|kontact n
4645728|NCT03582657|BIOTECH DENTAL|biotech dental
4645729|NCT03582644|Osteoarthritis, Knee|osteoarthritis, knee
4645730|NCT03582644|Cryotherapy|cryotherapy
4645731|NCT03582644|Physiotherapy|physiotherapy
4645732|NCT03582644|Physical Agent|physical agent
4645733|NCT03582618|Oncology|oncology
4645734|NCT03582618|Hepatocellular Carcinoma (HCC)|hepatocellular carcinoma (hcc)
4645735|NCT03582618|Sorafenib|sorafenib
4645736|NCT03582618|Hepatoma|hepatoma
4645737|NCT03582605|antibiotics|antibiotics
4645738|NCT03582605|prophylaxis|prophylaxis
4645739|NCT03582605|temporary anchorage devices|temporary anchorage devices
4645740|NCT03582605|mini-screw implants|mini-screw implants
4645741|NCT03582605|TADs|tads
4645742|NCT03582605|MSIs|msis
4645743|NCT03582605|failure rate|failure rate
4645744|NCT03582592|Fluid distribution timetable|fluid distribution timetable
4645745|NCT03582592|Fluid restriction adherence|fluid restriction adherence
4645746|NCT03582592|End-Stage Kidney Disease|end-stage kidney disease
4645747|NCT03582592|Hemodialysis|hemodialysis
4645748|NCT03582592|Thirst|thirst
4645749|NCT03582592|Interdialytic Weight Gain|interdialytic weight gain
4645750|NCT03582592|Nursing|nursing
4645751|NCT03582527|osteosarcoma|osteosarcoma
4645752|NCT03582527|refractory to chemotherapy|refractory to chemotherapy
4645753|NCT03582527|unresectable|unresectable
4645754|NCT03582527|PD-L1|pd-l1
4645755|NCT03582527|VENTANA PD-L1 (SP263)|ventana pd-l1 (sp263)
4645756|NCT03582514|Radiotherapy|radiotherapy
4645757|NCT03582514|Preoperative single fraction|preoperative single fraction
4645758|NCT03582514|3+3 design|3+3 design
4645759|NCT03582462|IONIS FXI-L|ionis fxi-l
4645760|NCT03582462|Factor XI|factor xi
4645761|NCT03582449|Hunter syndrome (Mucopolysaccharydosis II)|hunter syndrome (mucopolysaccharydosis ii)
4645762|NCT03582436|Kidney|kidney
4645763|NCT03582436|Allogeneic transplantation|allogeneic transplantation
4645764|NCT03582436|Cohort study|cohort study
4645765|NCT03582436|Rejection|rejection
4645766|NCT03582436|Biomarkers|biomarkers
4645767|NCT03582436|Integrative medicine|integrative medicine
4645768|NCT03582371|Parkinson's Disease|parkinson's disease
4645769|NCT03582371|Rehabilitation|rehabilitation
4645770|NCT03582371|Balance|balance
4645771|NCT03582371|Aquatic therapy|aquatic therapy
4645772|NCT03582371|Stand Up Paddle|stand up paddle
4645773|NCT03582306|colon cancer|colon cancer
4645774|NCT03582306|dietary intervention|dietary intervention
4645775|NCT03582306|vegetables|vegetables
4645776|NCT03582306|microbiota|microbiota
4645777|NCT03582293|Tranexamic Acid|tranexamic acid
4645778|NCT03582293|Antifibrinolytic Agents|antifibrinolytic agents
4645779|NCT03582241|Acute myeloid leukemia|acute myeloid leukemia
4645780|NCT03582241|Relapse|relapse
4645781|NCT03582241|Mutations|mutations
4645782|NCT03582228|Virtual Environments|virtual environments
4645783|NCT03582228|Social Communication|social communication
4645784|NCT03582215|Sunscreen|sunscreen
4645785|NCT03582215|Pharmacokinetics|pharmacokinetics
4645786|NCT03582202|dietitic service, organization of service|dietitic service, organization of service
4645787|NCT03582189|Liver Cancer|liver cancer
4645788|NCT03582189|Pancreatic Cancer|pancreatic cancer
4645789|NCT03582189|Radiation|radiation
4645790|NCT03582176|Acute elbow fractures and/or dislocations|acute elbow fractures and/or dislocations
4645791|NCT03582163|Deep Brain Stimulation|deep brain stimulation
4645792|NCT03582163|Longitudinal Outcomes|longitudinal outcomes
4645793|NCT03582163|Subthalamic Nucleus|subthalamic nucleus
4645794|NCT03582163|Globus Pallidus Interna|globus pallidus interna
4645795|NCT03582150|Ambulatory alcohol detoxification; alcohol withdrawal; remote monitoring with breathalyzer|ambulatory alcohol detoxification; alcohol withdrawal; remote monitoring with breathalyzer
4645796|NCT03582137|Parkinson's Disease|parkinson's disease
4645797|NCT03582137|Motor symptoms|motor symptoms
4645798|NCT03582137|Tremor|tremor
4645799|NCT03582137|tolerability|tolerability
4645800|NCT03582137|safety|safety
4645801|NCT03582137|cognition|cognition
4645802|NCT03582137|anxiety|anxiety
4645803|NCT03582137|psychosis|psychosis
4645804|NCT03582137|mood|mood
4645805|NCT03582137|dyskinesia|dyskinesia
4645806|NCT03582137|sleep|sleep
4645807|NCT03582137|cannabidiol|cannabidiol
4645808|NCT03582137|cannabis|cannabis
4645809|NCT03582137|efficacy|efficacy
4645810|NCT03582137|non-motor symptoms|non-motor symptoms
4645811|NCT03582137|quality of life|quality of life
4645812|NCT03582137|seborrhea|seborrhea
4645813|NCT03582111|Ultrasound|ultrasound
4645814|NCT03582111|Pregnancy|pregnancy
4645815|NCT03582111|Diagnosis|diagnosis
4645816|NCT03582098|Idelalisib|idelalisib
4645817|NCT03582098|Zydelig|zydelig
4645818|NCT03582085|Fibromyalgia|fibromyalgia
4645819|NCT03582033|RRMM|rrmm
4645820|NCT03582033|Antibodies, monoclonal|antibodies, monoclonal
4645821|NCT03582033|Antigens, BCMA|antigens, bcma
4645822|NCT03582033|Immunotherapy|immunotherapy
4645823|NCT03582033|Hematologic diseases|hematologic diseases
4645824|NCT03582033|Myeloma|myeloma
4645825|NCT03582020|vegetarians|vegetarians
4645826|NCT03582020|vegans|vegans
4645827|NCT03582020|flexitarians|flexitarians
4645828|NCT03582020|western diet|western diet
4645829|NCT03581981|postraumatic stress disorder|postraumatic stress disorder
4645830|NCT03581968|diabetes|diabetes
4645831|NCT03581968|type 1 diabetes|type 1 diabetes
4645832|NCT03581968|diabetes mellitus|diabetes mellitus
4645833|NCT03581968|pediatrics|pediatrics
4645834|NCT03581968|diabetes camp|diabetes camp
4645835|NCT03581955|biomarkers|biomarkers
4645836|NCT03581955|diet|diet
4645837|NCT03581955|banana|banana
4645838|NCT03581955|tomato|tomato
4645839|NCT03581955|urine|urine
4645840|NCT03581955|plasma|plasma
4645841|NCT03581955|intake|intake
4645842|NCT03581955|exposure|exposure
4645843|NCT03581955|metabolomics|metabolomics
4645844|NCT03581942|Copanlisib|copanlisib
4645845|NCT03581942|Ibrutinib|ibrutinib
4645846|NCT03581942|Recurrent/ Refractory|recurrent/ refractory
4645847|NCT03581942|PCNSL|pcnsl
4645848|NCT03581942|Brain lymphoma|brain lymphoma
4645849|NCT03581942|Primary Central Nervous System Lymphoma|primary central nervous system lymphoma
4645850|NCT03581942|BTK|btk
4645851|NCT03581942|PI3K|pi3k
4645852|NCT03581929|Mild Cognitive Impairment|mild cognitive impairment
4645853|NCT03581929|Dementia|dementia
4645854|NCT03581929|Memormax|memormax
4645855|NCT03581929|Food Supplement|food supplement
4645856|NCT03581929|Microbiota|microbiota
4645857|NCT03581890|Colorectal cancer|colorectal cancer
4645858|NCT03581890|Socioeconomic position|socioeconomic position
4645859|NCT03581877|Alteplase|alteplase
4645860|NCT03581877|submassive pulmonary embolism|submassive pulmonary embolism
4645861|NCT03581877|Thrombolysis|thrombolysis
4645862|NCT03581877|pulmonary catheter|pulmonary catheter
4645863|NCT03581864|aphakia|aphakia
4645864|NCT03581864|black diaphragmintraocular lens|black diaphragmintraocular lens
4645865|NCT03581864|eye rupture|eye rupture
4645866|NCT03581864|aniridia|aniridia
4645867|NCT03581851|simulated altitude|simulated altitude
4645868|NCT03581851|exercise|exercise
4645869|NCT03581851|electrocardiography|electrocardiography
4645870|NCT03581851|non- invasive blood pressure|non- invasive blood pressure
4645871|NCT03581838|EoE|eoe
4645872|NCT03581838|Dysphagia|dysphagia
4645873|NCT03581812|Gut Microbiota|gut microbiota
4645874|NCT03581812|Microbiome|microbiome
4645875|NCT03581812|Gut Health|gut health
4645876|NCT03581812|Snack|snack
4645877|NCT03581799|Child|child
4645878|NCT03581760|cycling exercise|cycling exercise
4645879|NCT03581760|mechanically ventilated patient|mechanically ventilated patient
4646378|NCT03578432|Rapamycin|rapamycin
4645880|NCT03581760|muscle strength assessment|muscle strength assessment
4645881|NCT03581760|muscle weakness|muscle weakness
4645882|NCT03581747|Atopic dermatis|atopic dermatis
4645883|NCT03581747|Epithelial barrier|epithelial barrier
4645884|NCT03581747|Electrical impedance spectroscopy|electrical impedance spectroscopy
4645885|NCT03581747|Allergy|allergy
4645886|NCT03581734|Oral Polio Vaccine|oral polio vaccine
4645887|NCT03581734|Oral Cholera Vaccine|oral cholera vaccine
4645888|NCT03581734|Co-administration|co-administration
4645889|NCT03581734|Immunogenecity|immunogenecity
4645890|NCT03581721|Postoperative hypothermia|postoperative hypothermia
4645891|NCT03581721|caesarean section|caesarean section
4645892|NCT03581721|IV fluids warming|iv fluids warming
4645893|NCT03581708|lung cancer|lung cancer
4645894|NCT03581708|Venous Thromboembolism|venous thromboembolism
4645895|NCT03581656|Degenerative Mitral Leaflet Prolapse|degenerative mitral leaflet prolapse
4645896|NCT03581656|Heart Disease|heart disease
4645897|NCT03581656|Minimally Invasive|minimally invasive
4645898|NCT03581643|Montreal Cognitive Assessment|montreal cognitive assessment
4645899|NCT03581643|Sensitivity|sensitivity
4645900|NCT03581643|Specificity|specificity
4645901|NCT03581643|Validation Study|validation study
4645902|NCT03581617|Infertility|infertility
4645903|NCT03581617|NK cells|nk cells
4645904|NCT03581617|HLA-G|hla-g
4645905|NCT03581604|Penicillin/b-lactams|penicillin/b-lactams
4645906|NCT03581578|Troponin|troponin
4645907|NCT03581565|cementation|cementation
4645908|NCT03581565|dental implant|dental implant
4645909|NCT03581565|crown|crown
4645910|NCT03581565|periimplantitis|periimplantitis
4645911|NCT03581552|Post Menopausal|post menopausal
4645912|NCT03581552|ER positive|er positive
4645913|NCT03581552|Aromatase Inhibitor Therapy|aromatase inhibitor therapy
4645914|NCT03581552|Breast Cancer|breast cancer
4645915|NCT03581539|Laparoscopic Nephrectomy,|laparoscopic nephrectomy,
4645916|NCT03581539|Simple Nephrectomy|simple nephrectomy
4645917|NCT03581539|Partial Nephrectomy|partial nephrectomy
4645918|NCT03581539|Pain,acute|pain,acute
4645919|NCT03581539|Pain,postoperative|pain,postoperative
4645920|NCT03581461|Trauma|trauma
4645921|NCT03581461|Yoga|yoga
4645922|NCT03581461|Mindfulness|mindfulness
4645923|NCT03581409|antiplatelet preparation|antiplatelet preparation
4645924|NCT03581409|cerebral aneurysm|cerebral aneurysm
4645925|NCT03581409|coil embolization|coil embolization
4645926|NCT03581396|Hydrops sacculaire|hydrops sacculaire
4645927|NCT03581396|schwannoma intralabyrinth|schwannoma intralabyrinth
4645928|NCT03581383|Hepatitis C|hepatitis c
4645929|NCT03581383|Hep C|hep c
4645930|NCT03581383|CARE-C|care-c
4645931|NCT03581383|Kentucky|kentucky
4645932|NCT03581370|Pneumonia|pneumonia
4645933|NCT03581370|Pseudomonas aeruginosa|pseudomonas aeruginosa
4645934|NCT03581370|pharmacokinetics|pharmacokinetics
4645935|NCT03581357|Previous diagnosis of cancer, completed primary treatment of cancer|previous diagnosis of cancer, completed primary treatment of cancer
4645936|NCT03581344|Conservative Treatment|conservative treatment
4645937|NCT03581344|Neoadjuvant Therapy|neoadjuvant therapy
4645938|NCT03581344|Radiotherapy|radiotherapy
4645939|NCT03581318|MRI Technology Improvement|mri technology improvement
4645940|NCT03581305|18F-Fluoro-L-dopa|18f-fluoro-l-dopa
4645941|NCT03581305|Positron Emission Tomograhy (PET)|positron emission tomograhy (pet)
4645942|NCT03581305|HIV|hiv
4645943|NCT03581305|Depression|depression
4645944|NCT03581266|Rye|rye
4645945|NCT03581266|Wheat|wheat
4645946|NCT03581266|Rye factor|rye factor
4645947|NCT03581266|Glucose kinetics|glucose kinetics
4645948|NCT03581227|CAPTURE, COPD|capture, copd
4645949|NCT03581201|intestinal microbiome|intestinal microbiome
4645950|NCT03581201|oral contraceptives|oral contraceptives
4645951|NCT03581201|estrogens|estrogens
4645952|NCT03581201|bacterial population|bacterial population
4645953|NCT03581201|hormone status|hormone status
4645954|NCT03581201|glucose profiles|glucose profiles
4645955|NCT03581201|lipid parameters|lipid parameters
4645956|NCT03581201|body composition|body composition
4645957|NCT03581123|acute/subacute low back pain|acute/subacute low back pain
4645958|NCT03581123|randomized clinical trial|randomized clinical trial
4645959|NCT03581123|self-management|self-management
4645960|NCT03581123|behavioral modification|behavioral modification
4645961|NCT03581123|spinal manipulation therapy|spinal manipulation therapy
4645962|NCT03581123|standard medical care|standard medical care
4645963|NCT03581123|secondary prevention|secondary prevention
4645964|NCT03581110|COPD|copd
4645965|NCT03581110|Computed tomography|computed tomography
4645966|NCT03581110|Expiration|expiration
4645967|NCT03581110|organ specific radiation dose|organ specific radiation dose
4645968|NCT03581097|Anxiety disorders|anxiety disorders
4645969|NCT03581097|hand surgery|hand surgery
4645970|NCT03581097|Educational Video|educational video
4645971|NCT03581071|Dialysis, CKD|dialysis, ckd
4645972|NCT03581058|MRI|mri
4645973|NCT03581058|Cannabis|cannabis
4645974|NCT03581058|Driving|driving
4645975|NCT03581045|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
4645976|NCT03581045|ALL|all
4645977|NCT03581045|Survivors|survivors
4645978|NCT03581045|Cognitive performance|cognitive performance
4645979|NCT03581045|Postural control|postural control
4645980|NCT03581019|infertility, uterus, transplantation, MRKH|infertility, uterus, transplantation, mrkh
4645981|NCT03580993|Critical Illness|critical illness
4645982|NCT03580993|Ultrasonography|ultrasonography
4645983|NCT03580967|Type 2 Diabetes|type 2 diabetes
4645984|NCT03580967|Major Depressive Disorder|major depressive disorder
4645985|NCT03580967|Vortioxetine|vortioxetine
4645986|NCT03580941|Pregnancy|pregnancy
4645987|NCT03580941|Hemolytic-Uremic Syndrome|hemolytic-uremic syndrome
4645988|NCT03580928|Chronic Lymphocytic Leukemia (CLL)|chronic lymphocytic leukemia (cll)
4645989|NCT03580915|functional literacy|functional literacy
4645990|NCT03580915|homelessness|homelessness
4645991|NCT03580915|daily life activities|daily life activities
4645992|NCT03580863|Pediatric|pediatric
4645993|NCT03580863|emergency surgical and medical service|emergency surgical and medical service
4645994|NCT03580863|Liberal doctor|liberal doctor
4645995|NCT03580863|complaint|complaint
4645996|NCT03580850|intra labyrinthine schwannoma|intra labyrinthine schwannoma
4645997|NCT03580850|schwannoma|schwannoma
4645998|NCT03580850|magnetic resonance imaging (MRI)|magnetic resonance imaging (mri)
4645999|NCT03580850|gadolinium|gadolinium
4646000|NCT03580850|T2 weighted gradient echo|t2 weighted gradient echo
4646001|NCT03580837|Breast Cancer|breast cancer
4646002|NCT03580837|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
4646003|NCT03580811|Alloderm|alloderm
4646004|NCT03580811|Dental Implants|dental implants
4646005|NCT03580811|Alveolar bone grafting|alveolar bone grafting
4646006|NCT03580772|Total knee replacement|total knee replacement
4646007|NCT03580772|Total knee arthroplasty|total knee arthroplasty
4646008|NCT03580772|Gait analysis|gait analysis
4646009|NCT03580733|ICU|icu
4646010|NCT03580733|yeast intra abdominal infection|yeast intra abdominal infection
4646011|NCT03580733|candidiasis|candidiasis
4646012|NCT03580733|ß-D-glucan|ß-d-glucan
4646013|NCT03580733|caspofungin|caspofungin
4646014|NCT03580720|Monitoring|monitoring
4646015|NCT03580720|Breathing effort|breathing effort
4646016|NCT03580720|Intensive Care|intensive care
4646017|NCT03580720|Diaphragm weakness|diaphragm weakness
4646018|NCT03580694|Non-Small Cell Lung Cancer|non-small cell lung cancer
4646019|NCT03580694|NSCLC|nsclc
4646020|NCT03580694|Anti-PD-1|anti-pd-1
4646021|NCT03580694|Anti-CTLA-4|anti-ctla-4
4646022|NCT03580694|Immunotherapy|immunotherapy
4646023|NCT03580681|Rheumatoid Arthritis|rheumatoid arthritis
4646024|NCT03580681|Diet|diet
4646025|NCT03580681|Fat-Restricted|fat-restricted
4646026|NCT03580681|Vegeterian|vegeterian
4646027|NCT03580668|Observational|observational
4646028|NCT03580629|Live Donor Liver Transplant|live donor liver transplant
4646029|NCT03580629|Education|education
4646030|NCT03580629|Advocacy|advocacy
4646031|NCT03580629|Live Donor Champion|live donor champion
4646032|NCT03580551|Veterans|veterans
4646033|NCT03580551|Sedentary|sedentary
4646034|NCT03580551|Chronic illness|chronic illness
4646035|NCT03580486|Parkinson's Disease|parkinson's disease
4646036|NCT03580486|Hand Function|hand function
4646037|NCT03580486|Squares Test|squares test
4646038|NCT03580421|Endometrial Cancer|endometrial cancer
4646039|NCT03580421|Health-economics analysis|health-economics analysis
4646040|NCT03580421|Ambulatory surgery|ambulatory surgery
4646041|NCT03580421|QALY|qaly
4646042|NCT03580421|discrete choice experiment|discrete choice experiment
4646043|NCT03580408|Nivolumab|nivolumab
4646044|NCT03580408|Lymphoma|lymphoma
4646045|NCT03580408|Anti-PD1|anti-pd1
4646046|NCT03580395|apatinib|apatinib
4646047|NCT03580395|neoadjuvant therapy|neoadjuvant therapy
4646048|NCT03580395|breast cancer|breast cancer
4646049|NCT03580369|Anti-IgE, CSU (chronic spontaneous urticarial), hives severity score, itch severity score, urticaria activity score|anti-ige, csu (chronic spontaneous urticarial), hives severity score, itch severity score, urticaria activity score
4646050|NCT03580356|Anti-IgE, CSU (Chronic Spontaneous Urticaria), hives severity score, itch severity score, urticaria activity score|anti-ige, csu (chronic spontaneous urticaria), hives severity score, itch severity score, urticaria activity score
4646051|NCT03580330|noncommunicable diseases|noncommunicable diseases
4646052|NCT03580330|hypertension|hypertension
4646053|NCT03580330|diabetes mellitus|diabetes mellitus
4646054|NCT03580330|telemedicine|telemedicine
4646055|NCT03580330|mobile health|mobile health
4646056|NCT03580330|rural health|rural health
4646057|NCT03580330|refugees|refugees
4646058|NCT03580317|Classical trigeminal neuralgia|classical trigeminal neuralgia
4646059|NCT03580317|Electroacupuncture|electroacupuncture
4646060|NCT03580317|Randomized controlled clinical trial|randomized controlled clinical trial
4646061|NCT03580304|Fatigue Mental|fatigue mental
4646062|NCT03580304|Fatigue Signs and Symptoms|fatigue signs and symptoms
4646063|NCT03580304|Behavioral Symptoms|behavioral symptoms
4646064|NCT03580304|Industrial work|industrial work
4646065|NCT03580304|physical effort|physical effort
4646066|NCT03580304|mental effort|mental effort
4646067|NCT03580304|questionnaires|questionnaires
4646068|NCT03580304|ergonomic evaluation|ergonomic evaluation
4646069|NCT03580291|Lupus Nephritis|lupus nephritis
4646070|NCT03580291|Mesenchymal stem cell|mesenchymal stem cell
4646071|NCT03580252|preterm|preterm
4646072|NCT03580252|Child Development Disorders|child development disorders
4646073|NCT03580252|Hammersmith|hammersmith
4646074|NCT03580252|neurological outcomes|neurological outcomes
4646075|NCT03580252|epidemiology|epidemiology
4646076|NCT03580239|CRPC|crpc
4646077|NCT03580239|Everolimus|everolimus
4646078|NCT03580239|mTOR|mtor
4646079|NCT03580226|Diabetes mellitus|diabetes mellitus
4646080|NCT03580226|Glycemic control|glycemic control
4646081|NCT03580226|Lipid profile|lipid profile
4646082|NCT03580226|Kidney profile|kidney profile
4646083|NCT03580226|Uric acid|uric acid
4646084|NCT03580213|Occupational Therapy|occupational therapy
4646085|NCT03580213|Physical Therapy|physical therapy
4646086|NCT03580213|Hand Therapy|hand therapy
4646088|NCT03580213|COPM|copm
4646089|NCT03580213|URAM|uram
4646090|NCT03580213|ROM|rom
4646091|NCT03580213|Hand exercise|hand exercise
4646092|NCT03580213|Scar|scar
4646093|NCT03580213|Oedema|oedema
4646094|NCT03580213|Splint|splint
4646095|NCT03580213|Orthosis|orthosis
4646096|NCT03580200|Latent Trigger Point|latent trigger point
4646097|NCT03580200|Myofascial Trigger Point|myofascial trigger point
4646098|NCT03580200|Trigger Point Dry Needling|trigger point dry needling
4646099|NCT03580200|Deep Dry Needling|deep dry needling
4646100|NCT03580200|Muscle Strength|muscle strength
4646101|NCT03580200|Glutues Medius|glutues medius
4646102|NCT03580174|Physical therapy|physical therapy
4646103|NCT03580174|ICF|icf
4646104|NCT03580174|Botulinum toxin|botulinum toxin
4646105|NCT03580174|Activity|activity
4646106|NCT03580174|Function|function
4646107|NCT03580161|Absorbed Radiation Dose|absorbed radiation dose
4646108|NCT03580161|Radiation Risks|radiation risks
4646109|NCT03580161|Radiation Protection|radiation protection
4646110|NCT03580161|Dosimetry|dosimetry
4646111|NCT03580148|osteoarthritis|osteoarthritis
4646112|NCT03580148|glenohumeral joint|glenohumeral joint
4646113|NCT03580148|arthritis|arthritis
4646114|NCT03580148|shoulder|shoulder
4646115|NCT03580135|pulpotomy|pulpotomy
4646116|NCT03580135|primary molars|primary molars
4646117|NCT03580135|propolis|propolis
4646118|NCT03580109|Lymphoedema|lymphoedema
4646119|NCT03580109|Post breast cancer|post breast cancer
4646120|NCT03580109|Spa therapy|spa therapy
4646121|NCT03580109|Education therapeutic|education therapeutic
4646122|NCT03580083|MPS I , gene therapy, Hurler, Hurler- Scheie|mps i , gene therapy, hurler, hurler- scheie
4646123|NCT03580070|Head cancers|head cancers
4646124|NCT03580070|Neck squamous cells carcinoma|neck squamous cells carcinoma
4646125|NCT03580070|HPV|hpv
4646126|NCT03580070|Immunotherapy|immunotherapy
4646127|NCT03580044|Serious bacterial infection|serious bacterial infection
4646128|NCT03580044|cIAI|ciai
4646129|NCT03580044|HAP/(VAP|hap/(vap
4646130|NCT03580044|cUTI|cuti
4646131|NCT03580044|BSI|bsi
4646132|NCT03580044|MBL|mbl
4646133|NCT03580031|LUF|luf
4646134|NCT03580031|HCG|hcg
4646135|NCT03580031|Booster dose|booster dose
4646136|NCT03580031|Ovulation rate|ovulation rate
4646137|NCT03580031|pregnancy rate|pregnancy rate
4646138|NCT03580018|Anterior cruciate ligament reconstruction, knee, hemarthrosis, tranexamic acid|anterior cruciate ligament reconstruction, knee, hemarthrosis, tranexamic acid
4646139|NCT03579979|Near-infrared fluorescence|near-infrared fluorescence
4646140|NCT03579979|Image guided surgery|image guided surgery
4646141|NCT03579979|Sentinel lymph node biopsy|sentinel lymph node biopsy
4646142|NCT03579979|Indocyanine green|indocyanine green
4646143|NCT03579979|Methylene blue|methylene blue
4646144|NCT03579953|Brain Stimulation|brain stimulation
4646145|NCT03579914|Anterior Myocardial Infarction|anterior myocardial infarction
4646146|NCT03579914|Intravenous Metoprolol|intravenous metoprolol
4646147|NCT03579914|RIPC|ripc
4646148|NCT03579914|Myocardial Protection|myocardial protection
4646149|NCT03579901|Breast Implants|breast implants
4646150|NCT03579901|Breast Surgery|breast surgery
4646151|NCT03579901|Breast Augmentation|breast augmentation
4646152|NCT03579901|Breast Reconstruction|breast reconstruction
4646153|NCT03579836|Pancreatic Cancer|pancreatic cancer
4646154|NCT03579810|Behavioral Modification|behavioral modification
4646155|NCT03579810|Health Community|health community
4646156|NCT03579810|Community Intervention|community intervention
4646157|NCT03579810|Prevention|prevention
4646158|NCT03579810|Education Intervention|education intervention
4646159|NCT03579810|Cardiovascular Health|cardiovascular health
4646160|NCT03579810|Colombia|colombia
4646161|NCT03579797|diabetic eye diseases|diabetic eye diseases
4646162|NCT03579797|diabetic retinopathy|diabetic retinopathy
4646163|NCT03579745|lingual orthodontics|lingual orthodontics
4646164|NCT03579745|Lever arm|lever arm
4646165|NCT03579745|En masse retraction|en masse retraction
4646166|NCT03579732|Low-dose aspirin,|low-dose aspirin,
4646167|NCT03579732|Cancer prevention|cancer prevention
4646168|NCT03579693|Mitochondria|mitochondria
4646169|NCT03579693|Antioxidants|antioxidants
4646170|NCT03579693|CoQ10|coq10
4646171|NCT03579693|Nicotinamide riboside|nicotinamide riboside
4646172|NCT03579693|Ergometry|ergometry
4646173|NCT03579693|Fatigue|fatigue
4646174|NCT03579693|Aerobic capacity|aerobic capacity
4646175|NCT03579680|Prostatic Neoplasms|prostatic neoplasms
4646176|NCT03579680|De-implementation|de-implementation
4646177|NCT03579680|androgen deprivation therapy|androgen deprivation therapy
4646379|NCT03578432|Neck Cancer|neck cancer
4646178|NCT03579680|Provider Preferences|provider preferences
4646179|NCT03579654|Prostate Specific Antigen|prostate specific antigen
4646180|NCT03579654|Immunotherapy|immunotherapy
4646181|NCT03579641|Heart Failure|heart failure
4646182|NCT03579641|Implantable Cardioverter Defibrillator|implantable cardioverter defibrillator
4646183|NCT03579641|Cardiac Resynchronization Therapy Defibrillator|cardiac resynchronization therapy defibrillator
4646184|NCT03579641|HF Sensor Data|hf sensor data
4646185|NCT03579641|30-day HF Readmission|30-day hf readmission
4646186|NCT03579641|VT/VF Therapy|vt/vf therapy
4646187|NCT03579641|non-HF Hospitalization|non-hf hospitalization
4646188|NCT03579641|HeartLogic Feature|heartlogic feature
4646189|NCT03579641|Latitude Remote Patient Monitor|latitude remote patient monitor
4646190|NCT03579641|Data Linkage|data linkage
4646191|NCT03579641|Sleep Incline Sensor|sleep incline sensor
4646192|NCT03579641|Respiratory Sensor|respiratory sensor
4646193|NCT03579641|Decongestive IV therapy|decongestive iv therapy
4646194|NCT03579641|Decompensation|decompensation
4646195|NCT03579602|Tumor Paint|tumor paint
4646196|NCT03579602|tozuleristide|tozuleristide
4646197|NCT03579602|Canvas imaging system|canvas imaging system
4646198|NCT03579602|BLZ-100|blz-100
4646199|NCT03579602|CNS tumor|cns tumor
4646200|NCT03579602|brain cancer|brain cancer
4646201|NCT03579602|pediatrics|pediatrics
4646202|NCT03579602|fluorescence guided surgery|fluorescence guided surgery
4646203|NCT03579589|Neuromuscular Blockade Reversal|neuromuscular blockade reversal
4646204|NCT03579589|Outpatient Surgery|outpatient surgery
4646205|NCT03579576|PWID|pwid
4646206|NCT03579576|MSM|msm
4646207|NCT03579576|HCV|hcv
4646208|NCT03579576|HIV|hiv
4646209|NCT03579563|Presbycusis|presbycusis
4646210|NCT03579563|Hearing aid|hearing aid
4646211|NCT03579550|dysmorphic uterus, metroplasty, hysteroscopy|dysmorphic uterus, metroplasty, hysteroscopy
4646212|NCT03579537|Hemodialysis|hemodialysis
4646213|NCT03579537|Klotho Protein|klotho protein
4646214|NCT03579537|Excercise|excercise
4646215|NCT03579537|Lifestyle condition|lifestyle condition
4646216|NCT03579524|Erector Spinae Plane Block|erector spinae plane block
4646217|NCT03579524|Serratus Anterior Plane Block|serratus anterior plane block
4646218|NCT03579498|Cardiac arrest|cardiac arrest
4646219|NCT03579498|Cognitive impairment|cognitive impairment
4646220|NCT03579498|Depression|depression
4646221|NCT03579498|Anxiety|anxiety
4646222|NCT03579498|PTSD|ptsd
4646223|NCT03579498|Health- related quality of life|health- related quality of life
4646224|NCT03579498|functional MRI|functional mri
4646225|NCT03579485|raltegravir|raltegravir
4646226|NCT03579485|naive|naive
4646227|NCT03579485|Aging|aging
4646228|NCT03579459|Clostridium Difficile|clostridium difficile
4646229|NCT03579459|vaccine|vaccine
4646230|NCT03579407|osteoarthritis|osteoarthritis
4646231|NCT03579407|cell therapy|cell therapy
4646232|NCT03579407|stem cells|stem cells
4646233|NCT03579407|needle|needle
4646234|NCT03579407|bone marrow aspiration|bone marrow aspiration
4646235|NCT03579394|ovarian cancer|ovarian cancer
4646236|NCT03579394|retarded surgery|retarded surgery
4646237|NCT03579394|neoadjuvant chemotherapy|neoadjuvant chemotherapy
4646238|NCT03579368|Cataract|cataract
4646239|NCT03579368|IOL|iol
4646240|NCT03579368|Presbyopia Correcting IOL|presbyopia correcting iol
4646241|NCT03579368|Patient Satisfaction|patient satisfaction
4646242|NCT03579368|Spectacle Independence|spectacle independence
4646243|NCT03579329|sarcopenia|sarcopenia
4646244|NCT03579329|Osteoarthritis|osteoarthritis
4646245|NCT03579329|Total Knee Arthroplasty|total knee arthroplasty
4646246|NCT03579303|Homoeopathy|homoeopathy
4646247|NCT03579303|Yoga|yoga
4646248|NCT03579277|Radial Forearm Free Flap|radial forearm free flap
4646249|NCT03579277|Ulnar Forearm Free Flap|ulnar forearm free flap
4646250|NCT03579277|Free Tissue Transfer|free tissue transfer
4646251|NCT03579212|Osteosynthesis|osteosynthesis
4646252|NCT03579212|Prophylactic consolidation|prophylactic consolidation
4646253|NCT03579212|Proximal femur|proximal femur
4646254|NCT03579199|hepatic tumor|hepatic tumor
4646255|NCT03579199|liver|liver
4646256|NCT03579199|ICG|icg
4646257|NCT03579199|ICG camera|icg camera
4646258|NCT03579199|laparoscopy|laparoscopy
4646259|NCT03579173|Nutritional Status|nutritional status
4646260|NCT03579173|Infant Pulmonary Function Testing|infant pulmonary function testing
4646261|NCT03579173|Lung Clearance Index|lung clearance index
4646262|NCT03579173|Multiple Breath Washout|multiple breath washout
4646263|NCT03579121|pharmacogenomics|pharmacogenomics
4646264|NCT03579121|preoperative evaluation|preoperative evaluation
4646265|NCT03579121|perioperative opioid use|perioperative opioid use
4646266|NCT03579108|Hypertension|hypertension
4646267|NCT03579082|Decitabine|decitabine
4646268|NCT03579082|ORR|orr
4646269|NCT03579082|TTP|ttp
4646270|NCT03579082|OS|os
4646271|NCT03579082|PFS|pfs
4646272|NCT03579069|Ductus venosus Doppler|ductus venosus doppler
4646273|NCT03579030|RTA 1701|rta 1701
4646274|NCT03579030|RTA 1701 capsules|rta 1701 capsules
4646275|NCT03579017|Amyotrophic lateral sclerosis|amyotrophic lateral sclerosis
4646276|NCT03579017|Cognitive|cognitive
4646277|NCT03579017|Screening|screening
4646278|NCT03579017|Validation|validation
4646380|NCT03578432|Saliva|saliva
4646279|NCT03579004|esophageal squamous cell carcinoma|esophageal squamous cell carcinoma
4646280|NCT03579004|preoperative chemoradiotherapy|preoperative chemoradiotherapy
4646281|NCT03579004|preoperative chemotherapy|preoperative chemotherapy
4646282|NCT03578991|Type 2 diabetes mellitus|type 2 diabetes mellitus
4646283|NCT03578991|Mild cognitive impairment|mild cognitive impairment
4646284|NCT03578991|Alzheimer disease|alzheimer disease
4646285|NCT03578991|Intervention|intervention
4646286|NCT03578991|Clinical trial|clinical trial
4646287|NCT03578991|mHealth|mhealth
4646288|NCT03578991|Smart electronic pillbox|smart electronic pillbox
4646289|NCT03578991|Interactive digital platform|interactive digital platform
4646290|NCT03578952|TAVR|tavr
4646291|NCT03578952|TAVI|tavi
4646292|NCT03578952|Pure AR|pure ar
4646293|NCT03578913|PFM implant supported restoration|pfm implant supported restoration
4646294|NCT03578913|Clinical assessment|clinical assessment
4646295|NCT03578913|radiographic assessment|radiographic assessment
4646296|NCT03578900|Xerostomia|xerostomia
4646297|NCT03578900|Hyposalivation|hyposalivation
4646298|NCT03578900|Quality of Life|quality of life
4646299|NCT03578900|Sjogren's Syndrome|sjogren's syndrome
4646300|NCT03578887|Obesity, Gliosis, Weight-Loss, Roux-en-Y Gastric Bypass, Type 2 Diabetes Mellitus|obesity, gliosis, weight-loss, roux-en-y gastric bypass, type 2 diabetes mellitus
4646301|NCT03578848|blood pressure monitoring|blood pressure monitoring
4646302|NCT03578848|sphygmomanometer|sphygmomanometer
4646303|NCT03578835|BSI|bsi
4646304|NCT03578835|SF-36|sf-36
4646305|NCT03578835|Clinical Outcome|clinical outcome
4646306|NCT03578835|Whole Genome Sequencing|whole genome sequencing
4646307|NCT03578835|Predictive Score|predictive score
4646308|NCT03578835|Bloodstream Infection|bloodstream infection
4646309|NCT03578835|Septic Shock|septic shock
4646310|NCT03578835|Multi-resistant Bacteria|multi-resistant bacteria
4646311|NCT03578796|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
4646312|NCT03578796|Cognitive|cognitive
4646313|NCT03578796|Predictor|predictor
4646314|NCT03578757|stress|stress
4646315|NCT03578757|prevention|prevention
4646316|NCT03578757|obesity|obesity
4646317|NCT03578757|spa|spa
4646318|NCT03578757|psychology|psychology
4646319|NCT03578757|biomarkers|biomarkers
4646320|NCT03578731|APP|app
4646321|NCT03578705|Orthopedic trauma|orthopedic trauma
4646322|NCT03578692|acute severe ulcerative colitis|acute severe ulcerative colitis
4646323|NCT03578692|predictive indicator|predictive indicator
4646324|NCT03578692|surgery|surgery
4646325|NCT03578666|recovery intervention|recovery intervention
4646326|NCT03578666|fatigue|fatigue
4646327|NCT03578666|running|running
4646328|NCT03578666|cryotherapy|cryotherapy
4646329|NCT03578666|running economy|running economy
4646330|NCT03578640|Hepatitis C Virus|hepatitis c virus
4646331|NCT03578640|Chronic Hepatitis C|chronic hepatitis c
4646332|NCT03578640|Genotype 4|genotype 4
4646333|NCT03578640|Treatment-naive|treatment-naive
4646334|NCT03578640|Non-cirrhotic|non-cirrhotic
4646335|NCT03578614|Vascular cognitive impairment|vascular cognitive impairment
4646336|NCT03578614|Physical Activity|physical activity
4646337|NCT03578614|Randomized Clinical Trial|randomized clinical trial
4646338|NCT03578614|Stroke|stroke
4646339|NCT03578614|TIA|tia
4646340|NCT03578614|Small Vessel Disease|small vessel disease
4646341|NCT03578601|Intubation|intubation
4646342|NCT03578601|Difficult|difficult
4646343|NCT03578601|thyroid|thyroid
4646344|NCT03578588|single dose|single dose
4646345|NCT03578588|multiple dose|multiple dose
4646346|NCT03578588|Pharmacokinetic|pharmacokinetic
4646347|NCT03578588|Tolerability|tolerability
4646348|NCT03578588|Healthy Subject|healthy subject
4646349|NCT03578588|Benapenem|benapenem
4646350|NCT03578575|Nasopharyngeal carcinoma|nasopharyngeal carcinoma
4646351|NCT03578575|Concurrent chemo-radiotherapy|concurrent chemo-radiotherapy
4646352|NCT03578562|Femoroacetabular Impingement|femoroacetabular impingement
4646353|NCT03578562|Anterior Pelvic Tilt|anterior pelvic tilt
4646354|NCT03578549|Dental Pulp Test|dental pulp test
4646355|NCT03578549|Vitality Testing|vitality testing
4646356|NCT03578549|Pulpal Blood Flow Measure|pulpal blood flow measure
4646357|NCT03578536|Stroke|stroke
4646358|NCT03578536|Therapy, Occupational|therapy, occupational
4646359|NCT03578536|Hemiplegia|hemiplegia
4646360|NCT03578510|Hemodialysis, sodium, endothelium, sympathetic activity, vasopressin|hemodialysis, sodium, endothelium, sympathetic activity, vasopressin
4646361|NCT03578497|Interleukin-1 receptor antagonism|interleukin-1 receptor antagonism
4646362|NCT03578497|Kineret/Anakinra|kineret/anakinra
4646363|NCT03578497|testosteron|testosteron
4646364|NCT03578484|Breast Aesthetics|breast aesthetics
4646365|NCT03578484|3D scanning|3d scanning
4646366|NCT03578484|Aesthetic rating|aesthetic rating
4646367|NCT03578484|Cultural Differences Aesthetics|cultural differences aesthetics
4646368|NCT03578484|Mammometrics|mammometrics
4646369|NCT03578445|EUS|eus
4646370|NCT03578445|EUS-FNA|eus-fna
4646371|NCT03578445|microbiopsy|microbiopsy
4646372|NCT03578432|Xerostomia|xerostomia
4646373|NCT03578432|Dry Mouth|dry mouth
4646374|NCT03578432|Salivary Gland Dysfunction|salivary gland dysfunction
4646375|NCT03578432|Head and Neck Cancer|head and neck cancer
4646376|NCT03578432|Mouth Cancer|mouth cancer
4646377|NCT03578432|Everolimus|everolimus
4646381|NCT03578419|Anemia|anemia
4646382|NCT03578419|Blood transfusion|blood transfusion
4646383|NCT03578419|Intensive Care Unit|intensive care unit
4646384|NCT03578419|Blood sampling|blood sampling
4646385|NCT03578419|Stepped wedge|stepped wedge
4646386|NCT03578419|Red blood cells|red blood cells
4646387|NCT03578393|Preanesthetic visit|preanesthetic visit
4646388|NCT03578380|Lymphovenous bypass|lymphovenous bypass
4646389|NCT03578380|Lymphovenous anastomosis|lymphovenous anastomosis
4646390|NCT03578380|Supermicrosurgery|supermicrosurgery
4646391|NCT03578380|Lymphangiography|lymphangiography
4646392|NCT03578380|MD Anderson Lymphedema Stage|md anderson lymphedema stage
4646393|NCT03578367|CML|cml
4646394|NCT03578367|Chronic Myelogenous Leukemia|chronic myelogenous leukemia
4646395|NCT03578367|leukemia, myeloid chronic|leukemia, myeloid chronic
4646396|NCT03578367|Hematologic Diseases|hematologic diseases
4646397|NCT03578367|Asciminib|asciminib
4646398|NCT03578367|ABL001|abl001
4646399|NCT03578367|Imatinib|imatinib
4646400|NCT03578367|Nilotinib|nilotinib
4646401|NCT03578367|deep molecular response|deep molecular response
4646402|NCT03578367|DMR|dmr
4646403|NCT03578367|Ph+ CML|ph+ cml
4646404|NCT03578367|chronic phase|chronic phase
4646405|NCT03578367|cancer of the white blood cells|cancer of the white blood cells
4646406|NCT03578367|tyrosine kinase inhibitor|tyrosine kinase inhibitor
4646407|NCT03578367|leukemia, myeloid|leukemia, myeloid
4646408|NCT03578367|leukemia|leukemia
4646409|NCT03578341|Immunoglobulins A, G and M|immunoglobulins a, g and m
4646410|NCT03578341|Neonatal Sepsis|neonatal sepsis
4646411|NCT03578341|Human Milk|human milk
4646412|NCT03578341|Orally Colostrum|orally colostrum
4646413|NCT03578315|Solar Lentigo|solar lentigo
4646414|NCT03578315|Nevus Zygomaticus|nevus zygomaticus
4646415|NCT03578315|Harmonic Generation Microscopy|harmonic generation microscopy
4646416|NCT03578315|In Vivo|in vivo
4646417|NCT03578289|Parents of children with disabilities|parents of children with disabilities
4646418|NCT03578289|emotional functioning|emotional functioning
4646419|NCT03578276|cataract surgery|cataract surgery
4646420|NCT03578276|Prophylaxis|prophylaxis
4646421|NCT03578263|cesarean section|cesarean section
4646422|NCT03578263|post-partum hemorrhage|post-partum hemorrhage
4646423|NCT03578263|multiple pregnancy|multiple pregnancy
4646424|NCT03578250|Stroke|stroke
4646425|NCT03578250|Error augmentation|error augmentation
4646426|NCT03578250|Rehabilitation|rehabilitation
4646427|NCT03578250|Cerebellum|cerebellum
4646428|NCT03578250|Motor learning|motor learning
4646429|NCT03578250|Adaptation|adaptation
4646430|NCT03578133|pneumonia|pneumonia
4646431|NCT03578133|melioidosis|melioidosis
4646432|NCT03578133|Myanmar|myanmar
4646433|NCT03578133|diagnosis|diagnosis
4646434|NCT03578107|acute ischemic stroke|acute ischemic stroke
4646435|NCT03578107|IV-tPA|iv-tpa
4646436|NCT03578107|endovascular treatment|endovascular treatment
4646437|NCT03578107|intervention|intervention
4646438|NCT03578094|cohort|cohort
4646439|NCT03578094|Noncommunicable diseases|noncommunicable diseases
4646440|NCT03578094|pregnancy|pregnancy
4646441|NCT03578094|infant|infant
4646442|NCT03578094|cognition|cognition
4646443|NCT03578094|United Arab Emirates|united arab emirates
4646444|NCT03578094|gestational diabetes|gestational diabetes
4646445|NCT03578068|Quality of Recovery|quality of recovery
4646446|NCT03578068|Postoperative|postoperative
4646447|NCT03578068|Surgery|surgery
4646448|NCT03578068|French|french
4646449|NCT03578068|Translation|translation
4646450|NCT03578068|Validation|validation
4646451|NCT03578029|Epidermolysis Bullosa|epidermolysis bullosa
4646452|NCT03578016|attachment|attachment
4646453|NCT03578016|parent|parent
4646454|NCT03578016|training|training
4646455|NCT03578016|sensitivity|sensitivity
4646456|NCT03578003|Sleep|sleep
4646457|NCT03578003|Bright Light|bright light
4646458|NCT03577990|hypertension, Black women, self-management, coaching|hypertension, black women, self-management, coaching
4646459|NCT03577977|Multiple sclerosis (MS), Betaseron, Betaferon|multiple sclerosis (ms), betaseron, betaferon
4646460|NCT03577964|Pneumonia|pneumonia
4646461|NCT03577964|Glucose|glucose
4646462|NCT03577964|Infections|infections
4646463|NCT03577964|Respiratory Tract Infection|respiratory tract infection
4646464|NCT03577964|Hyperglycemia|hyperglycemia
4646465|NCT03577964|Critical Care|critical care
4646466|NCT03577938|Liver Failure|liver failure
4646467|NCT03577938|traditional Chinese medicine|traditional chinese medicine
4646468|NCT03577938|Hepatitis B|hepatitis b
4646469|NCT03577912|ERAS|eras
4646470|NCT03577912|transversus_abdominis_plane_block|transversus_abdominis_plane_block
4646471|NCT03577912|postoperative_pain|postoperative_pain
4646472|NCT03577873|gallbladder stones|gallbladder stones
4646473|NCT03577873|common bile duct stones|common bile duct stones
4646474|NCT03577873|Endoscopic retrograde cholangiopancreatography|endoscopic retrograde cholangiopancreatography
4646475|NCT03577847|Stroke, Thrombolysis, Rural CT|stroke, thrombolysis, rural ct
4646476|NCT03577834|randomized clinical trial|randomized clinical trial
4646477|NCT03577834|vinegar|vinegar
4646478|NCT03577834|adiposity|adiposity
4646479|NCT03577834|insulin resistance|insulin resistance
4646480|NCT03577795|COPD, ACO, RWE|copd, aco, rwe
4646481|NCT03577782|HIV|hiv
4646482|NCT03577782|CD4+|cd4+
4646483|NCT03577782|T-cell|t-cell
4646484|NCT03577782|Reservoir|reservoir
4646485|NCT03577782|Cure|cure
4646486|NCT03577782|Antiretroviral therapy|antiretroviral therapy
4646487|NCT03577782|Vedolizumab|vedolizumab
4646488|NCT03577782|Gut|gut
4646489|NCT03577782|Alpha4Beta7|alpha4beta7
4646490|NCT03577782|gp120|gp120
4646491|NCT03577782|Interruption|interruption
4646492|NCT03577769|Health care associated urinary tract infection|health care associated urinary tract infection
4646493|NCT03577769|Bacteriuria|bacteriuria
4646494|NCT03577769|Elderly|elderly
4646495|NCT03577769|Geriatrics|geriatrics
4646496|NCT03577769|Antimicrobial resistance|antimicrobial resistance
4646497|NCT03577769|Multi-resistant bacteria|multi-resistant bacteria
4646498|NCT03577756|cystic fibrosis|cystic fibrosis
4646499|NCT03577756|neurodevelopment|neurodevelopment
4646500|NCT03577756|early rehabilitation|early rehabilitation
4646501|NCT03577743|antiangiogenesis|antiangiogenesis
4646502|NCT03577743|taxanes and carboplatin|taxanes and carboplatin
4646503|NCT03577743|metastatic TNBC|metastatic tnbc
4646504|NCT03577730|Opioid Use|opioid use
4646505|NCT03577730|Opioid Dependence|opioid dependence
4646506|NCT03577730|Opioid-Related Disorders|opioid-related disorders
4646507|NCT03577730|Opioid Abuse|opioid abuse
4646508|NCT03577730|Opioid-use Disorder|opioid-use disorder
4646509|NCT03577730|Pain|pain
4646510|NCT03577730|Pain, Postoperative|pain, postoperative
4646511|NCT03577730|Cognitive Impairment|cognitive impairment
4646512|NCT03577730|Delirium|delirium
4646513|NCT03577730|Delirium on Emergence|delirium on emergence
4646514|NCT03577730|Depression|depression
4646515|NCT03577730|Anxiety|anxiety
4646516|NCT03577730|Anxiety Disorders|anxiety disorders
4646517|NCT03577730|Affect|affect
4646518|NCT03577691|Blood Disorders|blood disorders
4646519|NCT03577691|Hydroxyurea (HU)|hydroxyurea (hu)
4646520|NCT03577691|Decision Aid|decision aid
4646521|NCT03577678|Comminuted lateral clavicle fracture , New prosthesis,|comminuted lateral clavicle fracture , new prosthesis,
4646522|NCT03577665|Liver Metastasis, Curative Proton Beam Therapy|liver metastasis, curative proton beam therapy
4646523|NCT03577652|Ticagrelor|ticagrelor
4646524|NCT03577652|Clopidogrel|clopidogrel
4646525|NCT03577652|Switching strategy|switching strategy
4646526|NCT03577613|radical hysterectomy|radical hysterectomy
4646527|NCT03577613|minimally invasive surgery|minimally invasive surgery
4646528|NCT03577587|galactagogue|galactagogue
4646529|NCT03577587|milk thistle|milk thistle
4646530|NCT03577587|silymarin|silymarin
4646531|NCT03577587|Silitidil|silitidil
4646532|NCT03577535|Oral Mucositis|oral mucositis
4646533|NCT03577535|Nutritional supplement|nutritional supplement
4646534|NCT03577535|Chemotherapy|chemotherapy
4646535|NCT03577535|Radiotherapy|radiotherapy
4646536|NCT03577535|Ocoxin / Oncoxin|ocoxin / oncoxin
4646537|NCT03577457|oxytocin|oxytocin
4646538|NCT03577457|serotonin|serotonin
4646539|NCT03577457|social reward|social reward
4646540|NCT03577457|decision making|decision making
4646541|NCT03577444|gene polymorphism|gene polymorphism
4646542|NCT03577444|stroke|stroke
4646543|NCT03577444|dysphagia|dysphagia
4646544|NCT03577444|poststroke recovery|poststroke recovery
4646545|NCT03577431|alloantigen-reactive Tregs ( arTreg)|alloantigen-reactive tregs ( artreg)
4646546|NCT03577431|immunosuppression|immunosuppression
4646547|NCT03577431|operational tolerance|operational tolerance
4646548|NCT03577405|Critical Illness|critical illness
4646549|NCT03577405|Acute Disease|acute disease
4646550|NCT03577405|Shock|shock
4646551|NCT03577405|Acute Kidney Injury|acute kidney injury
4646552|NCT03577405|Ultrasonography|ultrasonography
4646553|NCT03577379|Rotator cuff repair, whole blood fibrin clot|rotator cuff repair, whole blood fibrin clot
4646554|NCT03577366|Bacteremia|bacteremia
4646555|NCT03577366|Sepsis|sepsis
4646556|NCT03577366|Diagnostic Error|diagnostic error
4646557|NCT03577301|HIV|hiv
4646558|NCT03577301|Intervention|intervention
4646559|NCT03577301|MSM|msm
4646560|NCT03577301|PrEP|prep
4646561|NCT03577301|YMHP|ymhp
4646562|NCT03577301|YMSM|ymsm
4646563|NCT03577288|Feelings|feelings
4646564|NCT03577288|Emotions|emotions
4646565|NCT03577288|Virtual Reality|virtual reality
4646566|NCT03577288|Young Adult|young adult
4646567|NCT03577288|Child|child
4646568|NCT03577223|Egg|egg
4646569|NCT03577223|HDL|hdl
4646570|NCT03577223|Inflammation|inflammation
4646571|NCT03577210|chin deficiency|chin deficiency
4646572|NCT03577210|chin asymmetry|chin asymmetry
4646573|NCT03577197|Breast neoplasms|breast neoplasms
4646574|NCT03577197|Neoplasm Metastasis|neoplasm metastasis
4646575|NCT03577197|Registry|registry
4646576|NCT03577184|GRIP, DM|grip, dm
4646577|NCT03577171|CHB|chb
4646578|NCT03577171|HBV|hbv
4646579|NCT03577171|HBeAg-positive|hbeag-positive
4646580|NCT03577171|hepatitis B|hepatitis b
4646581|NCT03577158|Diabetes Mellitus, Type 1|diabetes mellitus, type 1
4646582|NCT03577158|Insulin|insulin
4646583|NCT03577158|Exercise|exercise
4646584|NCT03577158|Closed-loop|closed-loop
4646585|NCT03577158|Artificial Pancreas|artificial pancreas
4646586|NCT03577145|Bioavailability|bioavailability
4646587|NCT03577145|Polyphenols|polyphenols
4646588|NCT03577145|Dietary fibre|dietary fibre
4646589|NCT03577145|Phenolic acids|phenolic acids
4646590|NCT03577132|neoadjuvant chemotherapy|neoadjuvant chemotherapy
4646591|NCT03577132|atezolizumab|atezolizumab
4646592|NCT03577119|Prediabetes|prediabetes
4646593|NCT03577119|Glucose Tolerance|glucose tolerance
4646594|NCT03577119|Bioactive fatty acids|bioactive fatty acids
4646595|NCT03577119|Insulin sensitivity|insulin sensitivity
4646596|NCT03577119|Diet|diet
4646597|NCT03577119|Milk fat|milk fat
4646598|NCT03577119|Lipid metabolism|lipid metabolism
4646599|NCT03577119|Inflammation markers|inflammation markers
4646600|NCT03577119|Fecal microbiota composition|fecal microbiota composition
4646601|NCT03577119|Dairy|dairy
4646602|NCT03577106|transcranial magnetic stimulation|transcranial magnetic stimulation
4646603|NCT03577106|TMS|tms
4646604|NCT03577106|MRI|mri
4646605|NCT03577106|magnetic resonance imaging|magnetic resonance imaging
4646606|NCT03577106|fMRI|fmri
4646607|NCT03577106|functional magnetic resonance imaging|functional magnetic resonance imaging
4646608|NCT03577106|sleep|sleep
4646609|NCT03577093|stroke, miR-494, neuroprotection, CDK|stroke, mir-494, neuroprotection, cdk
4646610|NCT03577080|COPD, Exercise training|copd, exercise training
4646611|NCT03577054|Helping Babies Breathe|helping babies breathe
4646612|NCT03577054|newborn resuscitation|newborn resuscitation
4646613|NCT03577054|skills retention|skills retention
4646614|NCT03577054|mobile health|mobile health
4646615|NCT03577054|user-centred design|user-centred design
4646616|NCT03577041|Neovascular Age-Related Macular Degeneration|neovascular age-related macular degeneration
4646617|NCT03577041|Bevacizumab|bevacizumab
4646618|NCT03577041|Cost-Effective|cost-effective
4646619|NCT03577041|Quality of life|quality of life
4646620|NCT03577015|disseminated intravascular coagulation|disseminated intravascular coagulation
4646621|NCT03577015|sepsis|sepsis
4646622|NCT03577015|trauma|trauma
4646623|NCT03577015|pancreatitis|pancreatitis
4646624|NCT03577015|malignancy|malignancy
4646625|NCT03577015|obstetric complication|obstetric complication
4646626|NCT03577002|Advance care planning|advance care planning
4646627|NCT03577002|Patient-provider communications|patient-provider communications
4646628|NCT03577002|Interdisciplinary teams|interdisciplinary teams
4646629|NCT03577002|Practice-based research networks|practice-based research networks
4646630|NCT03577002|Cluster-randomized controlled trial|cluster-randomized controlled trial
4646631|NCT03577002|Primary care|primary care
4646632|NCT03576989|leg ulcer, fish oil, wounds|leg ulcer, fish oil, wounds
4646633|NCT03576976|Cognitive Remediation|cognitive remediation
4646634|NCT03576950|Uterine rupture|uterine rupture
4646635|NCT03576950|Cesarean section|cesarean section
4646636|NCT03576950|Labour|labour
4646637|NCT03576950|Myomectomy|myomectomy
4646638|NCT03576950|Delivery|delivery
4646639|NCT03576924|Physical activity adherence|physical activity adherence
4646640|NCT03576924|Exercise motivation|exercise motivation
4646641|NCT03576924|Exercise enjoyment|exercise enjoyment
4646642|NCT03576924|Prediabetes|prediabetes
4646643|NCT03576872|Gastro Intestinal Cancer|gastro intestinal cancer
4646644|NCT03576846|neck pain|neck pain
4646645|NCT03576846|spinal manipulative therapy|spinal manipulative therapy
4646646|NCT03576846|heart rate variability|heart rate variability
4646647|NCT03576846|pain sensitivity|pain sensitivity
4646648|NCT03576846|conditioned pain modulation|conditioned pain modulation
4646649|NCT03576820|pediatrics|pediatrics
4646650|NCT03576820|intranasal lidocaine|intranasal lidocaine
4646651|NCT03576820|migraine|migraine
4646652|NCT03576820|headache|headache
4646653|NCT03576820|emergency department|emergency department
4646654|NCT03576820|pain|pain
4646655|NCT03576807|B-cell leukemia|b-cell leukemia
4646656|NCT03576794|PMR RCT|pmr rct
4646657|NCT03576794|Leflunomide|leflunomide
4646658|NCT03576781|Brain Stimulation|brain stimulation
4646659|NCT03576781|Treatment|treatment
4646660|NCT03576768|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
4646661|NCT03576768|Brain Stimulation|brain stimulation
4646662|NCT03576768|Treatment|treatment
4646663|NCT03576768|Neuroimaging|neuroimaging
4646664|NCT03576742|pancytopenia|pancytopenia
4646665|NCT03576742|aplastic anemia|aplastic anemia
4646666|NCT03576742|myelodysplastic syndrome|myelodysplastic syndrome
4646667|NCT03576742|primary immunodeficiency|primary immunodeficiency
4646668|NCT03576742|immune dysregulation|immune dysregulation
4646669|NCT03576742|autoimmune cytopenia|autoimmune cytopenia
4646670|NCT03576729|Mucopolysaccharidosis type I|mucopolysaccharidosis type i
4646672|NCT03576729|MPS IH|mps ih
4646673|NCT03576729|MPS IHS|mps ihs
4646674|NCT03576729|MPS IS|mps is
4646675|NCT03576729|Mucopolysaccharidosis I|mucopolysaccharidosis i
4646676|NCT03576716|chronic kidney disease|chronic kidney disease
4646677|NCT03576716|vitamin d catabolism|vitamin d catabolism
4646678|NCT03576703|metabolic syndrome|metabolic syndrome
4646679|NCT03576703|inflammation|inflammation
4646680|NCT03576703|insulin sensitivity|insulin sensitivity
4646681|NCT03576703|metabolic flexibility|metabolic flexibility
4646682|NCT03576703|overweight/obese|overweight/obese
4646683|NCT03576690|Positive Ebola Virus (EBOV) diagnostic test|positive ebola virus (ebov) diagnostic test
4646684|NCT03576677|Advanced chronic heart failure|advanced chronic heart failure
4646685|NCT03576677|Exercise capacity|exercise capacity
4646686|NCT03576677|Exercise hemodynamics|exercise hemodynamics
4646687|NCT03576677|Levosimendan|levosimendan
4646688|NCT03576664|carvedilol|carvedilol
4646689|NCT03576664|adrenergic antagonists|adrenergic antagonists
4646690|NCT03576664|glymphatic system|glymphatic system
4646691|NCT03576664|volunteers|volunteers
4646692|NCT03576664|Molecular Mechanisms of Pharmacological|molecular mechanisms of pharmacological
4646693|NCT03576625|Buglossoides arvensis|buglossoides arvensis
4646694|NCT03576625|vegetable oil|vegetable oil
4646695|NCT03576625|omega-3 fatty acids|omega-3 fatty acids
4646696|NCT03576625|participants|participants
4646697|NCT03576612|glioblastoma, newly diagnosed, GMCI, Checkpoint inhibitor|glioblastoma, newly diagnosed, gmci, checkpoint inhibitor
4646698|NCT03576573|Osteoarthritis|osteoarthritis
4646699|NCT03576573|Avascular necrosis|avascular necrosis
4646700|NCT03576573|Ankylosis|ankylosis
4646701|NCT03576573|Protrusio acetabuli|protrusio acetabuli
4646702|NCT03576573|Painful hip dysplasia|painful hip dysplasia
4646703|NCT03576573|Rheumatoid arthritis|rheumatoid arthritis
4646704|NCT03576573|Correction of functional deformity|correction of functional deformity
4646705|NCT03576547|Leukemia|leukemia
4646706|NCT03576547|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
4646707|NCT03576547|ALL|all
4646708|NCT03576547|Chronic Myelogenous Leukemia|chronic myelogenous leukemia
4646709|NCT03576547|CML|cml
4646710|NCT03576547|Venetoclax|venetoclax
4646711|NCT03576547|ABT-199|abt-199
4646712|NCT03576547|GDC-0199|gdc-0199
4646713|NCT03576547|Ponatinib|ponatinib
4646714|NCT03576547|Iclusig|iclusig
4646715|NCT03576547|AP24534|ap24534
4646716|NCT03576547|Dexamethasone|dexamethasone
4646717|NCT03576547|Decadron|decadron
4646718|NCT03576547|Methotrexate|methotrexate
4646719|NCT03576547|Rituximab|rituximab
4646720|NCT03576547|Rituxan|rituxan
4646721|NCT03576547|Cytarabine|cytarabine
4646722|NCT03576547|Ara-C|ara-c
4646723|NCT03576547|Cytosar|cytosar
4646724|NCT03576547|DepoCyt|depocyt
4646725|NCT03576547|Cytosine arabinosine hydrochloride|cytosine arabinosine hydrochloride
4646726|NCT03576521|breast cancer|breast cancer
4646727|NCT03576521|chemotherapy toxicity|chemotherapy toxicity
4646728|NCT03576521|Oxidative Stress|oxidative stress
4646729|NCT03576521|Nutritional supplement|nutritional supplement
4646730|NCT03576521|Ocoxin Viusid|ocoxin viusid
4646731|NCT03576508|Osteoarthritis|osteoarthritis
4646732|NCT03576508|Knee|knee
4646733|NCT03576495|Medical education|medical education
4646734|NCT03576495|Patient-reported Satisfaction|patient-reported satisfaction
4646735|NCT03576495|Patient-reported outcomes|patient-reported outcomes
4646736|NCT03576495|Cultural dexterity|cultural dexterity
4646737|NCT03576495|Cross cultural care|cross cultural care
4646738|NCT03576495|Resident physician education|resident physician education
4646739|NCT03576482|Anxiety disorders|anxiety disorders
4646740|NCT03576482|Depression|depression
4646741|NCT03576482|Transport to operating room|transport to operating room
4646742|NCT03576469|Intravenous Immunoglobulin|intravenous immunoglobulin
4646743|NCT03576469|C1-esterase inhibitor|c1-esterase inhibitor
4646744|NCT03576469|Adverse drug reaction (ADR)|adverse drug reaction (adr)
4646745|NCT03576456|coronary angiography|coronary angiography
4646746|NCT03576456|premedication|premedication
4646747|NCT03576456|pain|pain
4646748|NCT03576456|anxiety|anxiety
4646749|NCT03576391|Sensorimotor control|sensorimotor control
4646750|NCT03576391|Feedforward|feedforward
4646751|NCT03576391|Physical Fatigue|physical fatigue
4646752|NCT03576391|Cognitive Fatigue|cognitive fatigue
4646753|NCT03576391|Event-related potentials|event-related potentials
4646754|NCT03576365|Perceived Control|perceived control
4646755|NCT03576365|Distress|distress
4646756|NCT03576339|Wound Healing|wound healing
4646757|NCT03576339|Electrical Stimulation|electrical stimulation
4646758|NCT03576339|Palatal|palatal
4646759|NCT03576326|Preventive Dentistry|preventive dentistry
4646760|NCT03576326|Health Disparities|health disparities
4646761|NCT03576326|Health Behavior|health behavior
4646762|NCT03576326|Behavioral Economics|behavioral economics
4646763|NCT03576313|transmission|transmission
4646764|NCT03576313|reduction|reduction
4646765|NCT03576300|ocular surface|ocular surface
4646766|NCT03576287|apremilast|apremilast
4646767|NCT03576274|cancer related fatigue|cancer related fatigue
4646768|NCT03576274|Exercise|exercise
4646769|NCT03576274|biomarkers|biomarkers
4646770|NCT03576261|hemodynamics|hemodynamics
4646771|NCT03576261|venous return|venous return
4646772|NCT03576261|heart failure|heart failure
4646773|NCT03576261|anesthesia|anesthesia
4646774|NCT03576248|State of consciousness|state of consciousness
4646775|NCT03576248|tACS|tacs
4646776|NCT03576248|tDCS|tdcs
4646777|NCT03576248|Global neuronal workspace|global neuronal workspace
4646778|NCT03576248|Brain injury|brain injury
4646779|NCT03576235|Uremic pruritus|uremic pruritus
4646780|NCT03576235|Hemodialysis|hemodialysis
4646781|NCT03576222|PICO; incisional hernia; surgical site occurrences|pico; incisional hernia; surgical site occurrences
4646782|NCT03576209|Physical activity|physical activity
4646783|NCT03576209|sedentary behaviour|sedentary behaviour
4646784|NCT03576209|sleep|sleep
4646785|NCT03576209|Quality of life|quality of life
4646786|NCT03576209|functional ability|functional ability
4646787|NCT03576209|well-being|well-being
4646788|NCT03576209|Social identity and leadership|social identity and leadership
4646789|NCT03576209|social support and motivation|social support and motivation
4646790|NCT03576209|Aged, older adults|aged, older adults
4646791|NCT03576196|physical therapy|physical therapy
4646792|NCT03576196|Pain|pain
4646793|NCT03576196|disability|disability
4646794|NCT03576196|kinesiophobia.|kinesiophobia.
4646795|NCT03576157|mobile health, Pregnant and postpartum women, Frontline health workers, India|mobile health, pregnant and postpartum women, frontline health workers, india
4646796|NCT03576118|biotrauma|biotrauma
4646797|NCT03576118|laparoscopic surgery|laparoscopic surgery
4646798|NCT03576118|neuromuscular block|neuromuscular block
4646799|NCT03576118|sugammadex|sugammadex
4646800|NCT03576105|third molar|third molar
4646801|NCT03576105|pericoronitis|pericoronitis
4646802|NCT03576105|photodynamic therapy|photodynamic therapy
4646803|NCT03576105|microbiological analysis|microbiological analysis
4646804|NCT03576105|laser|laser
4646805|NCT03576105|randomized controlled clinical study|randomized controlled clinical study
4646806|NCT03576079|laser therapy|laser therapy
4646807|NCT03576079|anterior re-positioning splint|anterior re-positioning splint
4646808|NCT03576066|CHB|chb
4646809|NCT03576066|HBV|hbv
4646810|NCT03576066|HBeAg-positive|hbeag-positive
4646811|NCT03576066|hepatitis B|hepatitis b
4646812|NCT03576040|Positron Emission Tomography Computed Tomography|positron emission tomography computed tomography
4646813|NCT03576040|whole body dynamic acquisition|whole body dynamic acquisition
4646814|NCT03576040|Gallium 68|gallium 68
4646815|NCT03576014|CMV|cmv
4646816|NCT03576014|BKV|bkv
4646817|NCT03576014|CMV Reactivation|cmv reactivation
4646818|NCT03576014|BKV Reactivation|bkv reactivation
4646819|NCT03576014|DNA Vaccine|dna vaccine
4646820|NCT03576014|Kidney transplant|kidney transplant
4646821|NCT03576014|Cytomegalovirus|cytomegalovirus
4646822|NCT03576014|BK virus|bk virus
4646823|NCT03575988|Type 2 diabetes|type 2 diabetes
4646824|NCT03575988|Pulmonary function|pulmonary function
4646825|NCT03575988|Vascular endothelial function|vascular endothelial function
4646826|NCT03575988|Ultrasound|ultrasound
4646827|NCT03575975|x-ray motion analysis|x-ray motion analysis
4646828|NCT03575975|joint kinematics|joint kinematics
4646829|NCT03575975|functional range of motion|functional range of motion
4646830|NCT03575962|2-period|2-period
4646831|NCT03575962|Pharmacokinetics|pharmacokinetics
4646832|NCT03575962|FTIH|ftih
4646833|NCT03575962|GSK3640254|gsk3640254
4646834|NCT03575962|healthy subject|healthy subject
4646835|NCT03575962|bioavailability|bioavailability
4646836|NCT03575949|Malignant neoplasms of ill-defined secondary and unspecified sites|malignant neoplasms of ill-defined secondary and unspecified sites
4646837|NCT03575949|Head and neck primary squamous cell carcinoma|head and neck primary squamous cell carcinoma
4646838|NCT03575949|FDG|fdg
4646839|NCT03575949|PET/CT Scan|pet/ct scan
4646840|NCT03575949|FDG PET/CT Scan|fdg pet/ct scan
4646841|NCT03575936|Pharmacists Intervention|pharmacists intervention
4646842|NCT03575923|Physical activity|physical activity
4646843|NCT03575923|Wellbeing|wellbeing
4646844|NCT03575923|Urban green space|urban green space
4646845|NCT03575923|Older adults|older adults
4646846|NCT03575923|Natural experiment|natural experiment
4646847|NCT03575923|Protocol|protocol
4646848|NCT03575923|GHIA|ghia
4646849|NCT03575910|Heart|heart
4646850|NCT03575910|Transplantation|transplantation
4646851|NCT03575910|Acute cardiac rejection|acute cardiac rejection
4646852|NCT03575910|Biomarkers|biomarkers
4646853|NCT03575910|Genomics|genomics
4646854|NCT03575897|Premature Infants|premature infants
4646855|NCT03575897|Body composition|body composition
4646856|NCT03575871|atopic dermatitis|atopic dermatitis
4646857|NCT03575871|atopic eczema|atopic eczema
4646858|NCT03575871|eczema|eczema
4646859|NCT03575871|JAK|jak
4646860|NCT03575871|janus kinase|janus kinase
4646861|NCT03575858|Single dental implants|single dental implants
4646862|NCT03575858|Barrel Shaped Interdental toothbrush|barrel shaped interdental toothbrush
4646863|NCT03575858|Tapered Interdental toothbrush|tapered interdental toothbrush
4646864|NCT03575858|peri-implant mucositis and gingivitis|peri-implant mucositis and gingivitis
4646865|NCT03575845|Yoga|yoga
4646866|NCT03575832|Diseases of male genital organs|diseases of male genital organs
4646867|NCT03575832|Prostate Cancer|prostate cancer
4646868|NCT03575832|Questionnaires|questionnaires
4646869|NCT03575832|Surveys|surveys
4646870|NCT03575832|Physical Fitness Test|physical fitness test
4646871|NCT03575832|Blinded Accelerometer|blinded accelerometer
4646872|NCT03575832|Home-Based Physical Activity Program|home-based physical activity program
4646873|NCT03575832|Telephone Coaching Calls|telephone coaching calls
4646874|NCT03575832|Nutrition Counseling|nutrition counseling
4646875|NCT03575832|Focus Group|focus group
4646876|NCT03575819|castration-resistant|castration-resistant
4646877|NCT03575819|androgen-signaling blockade progression|androgen-signaling blockade progression
4646878|NCT03575767|TCR Repertoire|tcr repertoire
4646879|NCT03575767|Next Generation Sequencing|next generation sequencing
4646880|NCT03575767|ALL|all
4646881|NCT03575767|AML|aml
4646882|NCT03575767|MDS|mds
4646883|NCT03575767|Myeloablative|myeloablative
4646884|NCT03575741|postural control|postural control
4646885|NCT03575741|rehabilitation|rehabilitation
4646886|NCT03575741|return-to-sport|return-to-sport
4646887|NCT03575741|mTBI|mtbi
4646888|NCT03575728|Mental Health|mental health
4646889|NCT03575728|Information Technology|information technology
4646890|NCT03575728|Chronic Disease Prevention and Management|chronic disease prevention and management
4646891|NCT03575728|Support Patient Self-Care|support patient self-care
4646892|NCT03575715|endobronchial ultrasound|endobronchial ultrasound
4646893|NCT03575715|peripheral pulmonary lesions|peripheral pulmonary lesions
4646894|NCT03575715|image features|image features
4646895|NCT03575702|overactive bladder|overactive bladder
4646896|NCT03575702|urinary incontinence|urinary incontinence
4646897|NCT03575702|frequent urination|frequent urination
4646898|NCT03575702|urge incontinence|urge incontinence
4646899|NCT03575702|urgency episodes|urgency episodes
4646900|NCT03575689|Nasal Splint|nasal splint
4646901|NCT03575689|Septum deviation|septum deviation
4646902|NCT03575689|Septoplasty|septoplasty
4646903|NCT03575676|Huntington|huntington
4646904|NCT03575676|Chorea|chorea
4646905|NCT03575676|SOM3355|som3355
4646906|NCT03575663|Breathomics|breathomics
4646907|NCT03575663|Metabolomics|metabolomics
4646908|NCT03575663|Exhaled breath test|exhaled breath test
4646909|NCT03575663|Biomarker|biomarker
4646910|NCT03575637|Olanzapine|olanzapine
4646911|NCT03575637|Gastric Cancer|gastric cancer
4646912|NCT03575637|Tolerance|tolerance
4646913|NCT03575611|Malignant neoplasms of urinary tract|malignant neoplasms of urinary tract
4646914|NCT03575611|Oligometastatic renal cell carcinoma|oligometastatic renal cell carcinoma
4646915|NCT03575611|RCC|rcc
4646916|NCT03575611|Stereotactic Body Radiation Therapy|stereotactic body radiation therapy
4646917|NCT03575611|SBRT|sbrt
4646918|NCT03575611|XRT|xrt
4646919|NCT03575611|Radiation therapy|radiation therapy
4646920|NCT03575585|HIV|hiv
4646921|NCT03575585|Counselor Skills Training|counselor skills training
4646922|NCT03575585|Behavioral Intervention|behavioral intervention
4646923|NCT03575585|Personalized Feedback Report|personalized feedback report
4646924|NCT03575572|Fontan|fontan
4646925|NCT03575572|Colchicine|colchicine
4646926|NCT03575572|heart surgery|heart surgery
4646927|NCT03575520|breast cancer|breast cancer
4646928|NCT03575520|dose-dense chemotherapy|dose-dense chemotherapy
4646929|NCT03575520|pegfilgrastim|pegfilgrastim
4646930|NCT03575468|e-cigarette|e-cigarette
4646931|NCT03575468|vaping|vaping
4646932|NCT03575468|electronic nicotine delivery system (ENDS)|electronic nicotine delivery system (ends)
4646933|NCT03575468|smoking cessation|smoking cessation
4646934|NCT03575455|concussion|concussion
4646935|NCT03575455|aerobic exercise|aerobic exercise
4646936|NCT03575455|sub-acute|sub-acute
4646937|NCT03575429|Pediatrics|pediatrics
4646938|NCT03575429|Social Communication|social communication
4646939|NCT03575429|Family Navigators|family navigators
4646940|NCT03575390|Pomegranate|pomegranate
4646941|NCT03575390|Hearing|hearing
4646942|NCT03575364|ClotTriever|clottriever
4646943|NCT03575364|Thrombectomy|thrombectomy
4646944|NCT03575351|Non-Hodgkin Lymphomas|non-hodgkin lymphomas
4646945|NCT03575351|DLBCL|dlbcl
4646946|NCT03575351|Efficacy|efficacy
4646947|NCT03575351|Safety|safety
4646948|NCT03575351|JCAR017|jcar017
4646949|NCT03575351|Liso-cel|liso-cel
4646950|NCT03575351|High-Risk|high-risk
4646951|NCT03575351|Relapsed|relapsed
4646952|NCT03575351|Refractory|refractory
4646953|NCT03575338|scarf|scarf
4646954|NCT03575338|minimally invasive surgery|minimally invasive surgery
4646955|NCT03575338|hallux valgus|hallux valgus
4646956|NCT03575325|T-cell acute lymphoblastic leukemia|t-cell acute lymphoblastic leukemia
4646957|NCT03575325|B-cell acute lymphoblastic leukemia|b-cell acute lymphoblastic leukemia
4646958|NCT03575299|MDR-TB|mdr-tb
4646959|NCT03575299|Allogeneic γδT cells|allogeneic γδt cells
4646960|NCT03575299|adoptive treatment|adoptive treatment
4646961|NCT03575286|Pregnancy|pregnancy
4646962|NCT03575286|Urine Testing|urine testing
4646963|NCT03575286|Medical Diagnostics|medical diagnostics
4646964|NCT03575273|methadone|methadone
4646965|NCT03575273|opioid dependence|opioid dependence
4646966|NCT03575273|obesity|obesity
4646967|NCT03575273|food reward|food reward
4646968|NCT03575273|olfactory|olfactory
4646969|NCT03575260|Fulvestrant|fulvestrant
4646970|NCT03575260|Exemestane|exemestane
4646971|NCT03575221|Osteogenesis Imperfecta|osteogenesis imperfecta
4646972|NCT03575221|Collagen|collagen
4646973|NCT03575221|Short Stature|short stature
4646974|NCT03575208|Hepatitis B|hepatitis b
4646975|NCT03575208|Immune Response|immune response
4646976|NCT03575208|HBsAg Loss|hbsag loss
4646977|NCT03575208|Hepatitis B Virus|hepatitis b virus
4646978|NCT03575208|Interferon|interferon
4646979|NCT03575169|Bispectral index|bispectral index
4646980|NCT03575169|Monitoring|monitoring
4646981|NCT03575169|Sedation|sedation
4646982|NCT03575169|Traumatic Brain Injury|traumatic brain injury
4646983|NCT03575156|Systemic Lupus Erythematosus|systemic lupus erythematosus
4646984|NCT03575156|Systemic Scleroderma|systemic scleroderma
4646985|NCT03575156|autoimmunity|autoimmunity
4646986|NCT03575156|microparticles|microparticles
4646987|NCT03575156|platelets|platelets
4646988|NCT03575143|HIV|hiv
4646989|NCT03575143|OSA|osa
4646990|NCT03575143|PLWH|plwh
4646991|NCT03575143|Sleep|sleep
4646992|NCT03575143|Obstructive Sleep Apnea|obstructive sleep apnea
4646993|NCT03575143|Human Immunodeficiency Virus|human immunodeficiency virus
4646994|NCT03575143|CPAP|cpap
4646995|NCT03575091|Infant|infant
4646996|NCT03575091|Respiration|respiration
4646997|NCT03575026|Early dementia|early dementia
4646998|NCT03575026|Caregiver|caregiver
4646999|NCT03575026|Anxiety|anxiety
4647000|NCT03575026|Well-being|well-being
4647001|NCT03574987|Physical Activity|physical activity
4647002|NCT03574987|Nutrition|nutrition
4647003|NCT03574987|Carbohydrates|carbohydrates
4647004|NCT03574987|Sugar|sugar
4647005|NCT03574987|Energy Balance|energy balance
4647006|NCT03574974|PTSD|ptsd
4647007|NCT03574974|Neurofeedback|neurofeedback
4647008|NCT03574961|depression|depression
4647009|NCT03574961|social isolation|social isolation
4647010|NCT03574935|"Qing-Hua-Bu"|"qing-hua-bu"
4647011|NCT03574935|Dynamic sequential treatment|dynamic sequential treatment
4647012|NCT03574935|Clinical evaluation|clinical evaluation
4647013|NCT03574935|Generalized application|generalized application
4647014|NCT03574883|Conscious access|conscious access
4647015|NCT03574883|transcranial electric stimulation|transcranial electric stimulation
4647016|NCT03574883|tACS|tacs
4647017|NCT03574883|Global neuronal workspace|global neuronal workspace
4647018|NCT03574883|Masking paradigm|masking paradigm
4647019|NCT03574883|tDCS|tdcs
4647020|NCT03574857|Loop diuretics|loop diuretics
4647021|NCT03574857|Heart failure|heart failure
4647022|NCT03574857|Diuretic resistance|diuretic resistance
4647023|NCT03574857|Thiazide diuretics|thiazide diuretics
4647024|NCT03574831|GERD|gerd
4647025|NCT03574831|Radiofrequency ablation|radiofrequency ablation
4647026|NCT03574831|efficiency|efficiency
4647027|NCT03574831|safety|safety
4647028|NCT03574818|Neoadjuvant Chemotherapy; NSCLC; nacitumumab|neoadjuvant chemotherapy; nsclc; nacitumumab
4647029|NCT03574805|Asthma|asthma
4647030|NCT03574805|Anticalin|anticalin
4647031|NCT03574805|PRS-060|prs-060
4647032|NCT03574805|Pieris|pieris
4647033|NCT03574805|IL-4 receptor alpha|il-4 receptor alpha
4647034|NCT03574805|IL-13|il-13
4647035|NCT03574805|IL-4|il-4
4647036|NCT03574779|PARP Inhibitor|parp inhibitor
4647037|NCT03574779|OPAL|opal
4647038|NCT03574779|OPAL Clinical Trial|opal clinical trial
4647039|NCT03574779|OPAL Study|opal study
4647040|NCT03574701|olfactory|olfactory
4647041|NCT03574701|Vitamin A|vitamin a
4647042|NCT03574701|Olfactory training|olfactory training
4647044|NCT03574688|Hydration|hydration
4647045|NCT03574688|Water|water
4647046|NCT03574688|Vasopressin|vasopressin
4647047|NCT03574688|Copeptin|copeptin
4647048|NCT03574688|Glucose|glucose
4647049|NCT03574675|simulated altitude|simulated altitude
4647050|NCT03574675|exercise|exercise
4647051|NCT03574675|non-invasive cardiac output|non-invasive cardiac output
4647052|NCT03574662|frailty|frailty
4647053|NCT03574662|advanced|advanced
4647054|NCT03574623|stroke|stroke
4647055|NCT03574623|rehabilitation|rehabilitation
4647056|NCT03574623|therapy|therapy
4647057|NCT03574623|electrical stimulation|electrical stimulation
4647058|NCT03574623|hand|hand
4647059|NCT03574610|Neurogenic bladder|neurogenic bladder
4647060|NCT03574610|Functional Neuroimaging|functional neuroimaging
4647061|NCT03574610|Transcranial Rotating Permanent Magnet Stimulator (TRPMS)|transcranial rotating permanent magnet stimulator (trpms)
4647062|NCT03574571|Radium-223|radium-223
4647063|NCT03574571|Docetaxel|docetaxel
4647064|NCT03574571|18-150|18-150
4647065|NCT03574558|Pump therapy|pump therapy
4647066|NCT03574558|Multiple Daily Injections (MDI)|multiple daily injections (mdi)
4647067|NCT03574558|Decision Support Sysyem (DSS)|decision support sysyem (dss)
4647068|NCT03574545|Rheumatoid Arthritis|rheumatoid arthritis
4647069|NCT03574545|VAY736|vay736
4647070|NCT03574545|Ianalumab|ianalumab
4647071|NCT03574506|Atypical Hemolytic Uremic Syndrome|atypical hemolytic uremic syndrome
4647072|NCT03574506|Pregnancy|pregnancy
4647073|NCT03574493|laparotomy|laparotomy
4647074|NCT03574493|laparoscopy|laparoscopy
4647075|NCT03574493|low anterior resection|low anterior resection
4647076|NCT03574493|rectal cancer|rectal cancer
4647077|NCT03574493|robot assisted surgery|robot assisted surgery
4647078|NCT03574493|total mesorectal excision|total mesorectal excision
4647079|NCT03574493|transanal surgery|transanal surgery
4647080|NCT03574480|mHealth|mhealth
4647081|NCT03574480|Lifestyles|lifestyles
4647082|NCT03574480|Elderly|elderly
4647083|NCT03574480|Body composition|body composition
4647084|NCT03574480|Cognitive performance|cognitive performance
4647085|NCT03574480|Quality of life|quality of life
4647086|NCT03574467|brain neoplasms|brain neoplasms
4647087|NCT03574467|stroke|stroke
4647088|NCT03574467|rehabilitation|rehabilitation
4647089|NCT03574454|Whole Body Diffusion Weighted|whole body diffusion weighted
4647090|NCT03574454|Magnetic Resonance Imaging|magnetic resonance imaging
4647091|NCT03574454|Machine Learning|machine learning
4647092|NCT03574454|Reading Time|reading time
4647093|NCT03574454|Convolutional Neural Network|convolutional neural network
4647094|NCT03574454|Algorithm|algorithm
4647095|NCT03574454|Diagnostic performance|diagnostic performance
4647096|NCT03574376|Rib trauma, intercostal nerve block, liposomal bupivacaine|rib trauma, intercostal nerve block, liposomal bupivacaine
4647097|NCT03574363|Chronic Kidney Disease|chronic kidney disease
4647098|NCT03574363|Hypertension|hypertension
4647099|NCT03574350|Kangaroo position|kangaroo position
4647100|NCT03574350|Kinesthetic Stimulation|kinesthetic stimulation
4647101|NCT03574350|Kangaroo Mother Care|kangaroo mother care
4647102|NCT03574350|Bonding|bonding
4647103|NCT03574337|Residual neuromuscular blockade|residual neuromuscular blockade
4647104|NCT03574337|Reversal|reversal
4647105|NCT03574337|Cardiac surgery|cardiac surgery
4647106|NCT03574311|CABG|cabg
4647107|NCT03574311|cardiac surgery|cardiac surgery
4647108|NCT03574311|blood transfusion|blood transfusion
4647109|NCT03574311|intravenous iron|intravenous iron
4647110|NCT03574311|postoperative infection|postoperative infection
4647111|NCT03574298|Radical prostatectomy|radical prostatectomy
4647112|NCT03574298|urinary incontinence|urinary incontinence
4647113|NCT03574298|pelvic floor muscle|pelvic floor muscle
4647114|NCT03574298|reaction time|reaction time
4647115|NCT03574272|mobile IoT technology|mobile iot technology
4647116|NCT03574272|Patient Transfer Monitoring System|patient transfer monitoring system
4647117|NCT03574220|pembrolizumab|pembrolizumab
4647118|NCT03574220|radiotherapy|radiotherapy
4647119|NCT03574220|immunotherapy|immunotherapy
4647120|NCT03574181|Wrist watch blood alcohol level|wrist watch blood alcohol level
4647121|NCT03574181|Blood alcohol|blood alcohol
4647122|NCT03574181|Objective alcohol measure|objective alcohol measure
4647123|NCT03574155|Gynecological cancer|gynecological cancer
4647124|NCT03574155|Anxiety|anxiety
4647125|NCT03574155|Pre-operative counseling|pre-operative counseling
4647126|NCT03574142|Pharmacokinetics|pharmacokinetics
4647127|NCT03574142|Safety|safety
4647128|NCT03574142|Tolerability|tolerability
4647129|NCT03574142|Epanova|epanova
4647130|NCT03574142|Omega-3 carboxylic acids|omega-3 carboxylic acids
4647131|NCT03574142|Chinese|chinese
4647132|NCT03574116|Sarcopenia|sarcopenia
4647133|NCT03574116|jejunostomy|jejunostomy
4647134|NCT03574116|oesogastric adenocarcinoma|oesogastric adenocarcinoma
4647135|NCT03574116|scanography|scanography
4647136|NCT03574103|Obesity|obesity
4647137|NCT03574103|Overweight|overweight
4647138|NCT03574103|Weight loss|weight loss
4647139|NCT03574103|Fasting|fasting
4647140|NCT03574090|topical antibiotic|topical antibiotic
4647141|NCT03574090|surgical wound infection|surgical wound infection
4647142|NCT03574090|prevention of surgical wound infection|prevention of surgical wound infection
4647143|NCT03574051|oral microbiota|oral microbiota
4647144|NCT03574051|16S rRNA gene|16s rrna gene
4647145|NCT03574051|thyroid cancer|thyroid cancer
4647146|NCT03574051|iodine 131 treatment|iodine 131 treatment
4647147|NCT03574051|fecal microbiota|fecal microbiota
4647148|NCT03574051|radiotherapy|radiotherapy
4647149|NCT03574025|Observational, Paediatric, Cardiac Arrest, PICU,|observational, paediatric, cardiac arrest, picu,
4647150|NCT03573999|mannitol|mannitol
4647151|NCT03573999|hypertonic saline|hypertonic saline
4647152|NCT03573999|brain metabolism|brain metabolism
4647153|NCT03573999|brain oxygenation|brain oxygenation
4647154|NCT03573973|Dietary inequalities|dietary inequalities
4647155|NCT03573973|Public Health|public health
4647156|NCT03573973|Choice architecture|choice architecture
4647157|NCT03573973|Supermarkets|supermarkets
4647158|NCT03573960|Lenvatinib, E7080, Refractory Differentiated Thyroid Cancer|lenvatinib, e7080, refractory differentiated thyroid cancer
4647159|NCT03573947|Stage IV Non-Small Cell Lung Cancer|stage iv non-small cell lung cancer
4647160|NCT03573947|nivolumab|nivolumab
4647161|NCT03573947|ipilimumab|ipilimumab
4647162|NCT03573947|paclitaxel|paclitaxel
4647163|NCT03573947|immunotherapy|immunotherapy
4647164|NCT03573921|Paediatrics|paediatrics
4647165|NCT03573921|Gastrografin|gastrografin
4647166|NCT03573882|Open Label Extension|open label extension
4647167|NCT03573843|Delirium|delirium
4647168|NCT03573843|Prevention|prevention
4647169|NCT03573843|Cognitive stimulation|cognitive stimulation
4647170|NCT03573830|Child Passenger Injury|child passenger injury
4647171|NCT03573830|Child Restraint Systems|child restraint systems
4647172|NCT03573830|Traffic Accidents|traffic accidents
4647173|NCT03573817|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
4647174|NCT03573817|Pulmonary Function|pulmonary function
4647175|NCT03573817|COPD|copd
4647176|NCT03573804|Breast Cancer Locator|breast cancer locator
4647177|NCT03573778|health|health
4647178|NCT03573778|quality of life|quality of life
4647179|NCT03573778|safety|safety
4647180|NCT03573778|health promotion|health promotion
4647181|NCT03573778|intimate partner violence|intimate partner violence
4647182|NCT03573778|domestic violence|domestic violence
4647183|NCT03573778|confidence|confidence
4647184|NCT03573778|control|control
4647185|NCT03573778|nursing intervention|nursing intervention
4647186|NCT03573765|epidemiology|epidemiology
4647187|NCT03573765|upper limb|upper limb
4647188|NCT03573765|hand surgery|hand surgery
4647189|NCT03573765|wrist surgery|wrist surgery
4647190|NCT03573765|shoulder surgery|shoulder surgery
4647191|NCT03573765|elbow surgery|elbow surgery
4647192|NCT03573765|outcomes|outcomes
4647193|NCT03573765|complications|complications
4647194|NCT03573765|revision surgery|revision surgery
4647195|NCT03573752|Laparoscopic Promontofixation|laparoscopic promontofixation
4647196|NCT03573752|Outpatient management|outpatient management
4647197|NCT03573713|Hygiene practices|hygiene practices
4647198|NCT03573713|Sanitation|sanitation
4647199|NCT03573713|Nutrition|nutrition
4647200|NCT03573713|Interpersonal Psychotherapy|interpersonal psychotherapy
4647201|NCT03573713|Maternal depression|maternal depression
4647202|NCT03573713|clustered randomized controlled trial|clustered randomized controlled trial
4647203|NCT03573700|Leukemia|leukemia
4647204|NCT03573700|Leukemia, lymphoid|leukemia, lymphoid
4647205|NCT03573700|Leukemia, B-cell|leukemia, b-cell
4647206|NCT03573700|Relapsed|relapsed
4647207|NCT03573700|Refractory|refractory
4647208|NCT03573700|Pediatric|pediatric
4647209|NCT03573700|Chimeric antigen receptor|chimeric antigen receptor
4647210|NCT03573700|CAR|car
4647211|NCT03573700|CAR T cell|car t cell
4647212|NCT03573700|Anti-CD19|anti-cd19
4647213|NCT03573700|CD19|cd19
4647214|NCT03573687|protein|protein
4647215|NCT03573687|lipolysis|lipolysis
4647216|NCT03573687|fat oxidation|fat oxidation
4647217|NCT03573687|resistance training|resistance training
4647218|NCT03573687|nutrient timing|nutrient timing
4647219|NCT03573674|Working conditions,|working conditions,
4647220|NCT03573674|cognitive load|cognitive load
4647221|NCT03573674|disruptions|disruptions
4647222|NCT03573674|interruptions|interruptions
4647223|NCT03573674|information overload|information overload
4647224|NCT03573674|Mental contrasting with implementation intentions MCII|mental contrasting with implementation intentions mcii
4647225|NCT03573674|Cognitive ergonomics|cognitive ergonomics
4647226|NCT03573661|Breast Conserving Surgery|breast conserving surgery
4647227|NCT03573661|Breast Imaging|breast imaging
4647228|NCT03573661|Breast Cancer Locator|breast cancer locator
4647229|NCT03573661|Supine MRI|supine mri
4647230|NCT03573596|CML|cml
4647231|NCT03573596|second stop|second stop
4647232|NCT03573596|dasatinib|dasatinib
4647233|NCT03573583|muscle mass|muscle mass
4647234|NCT03573583|muscle loss|muscle loss
4647235|NCT03573583|Deuterated creatine (D3Cr) dilution|deuterated creatine (d3cr) dilution
4647236|NCT03573583|older adults|older adults
4647237|NCT03573583|resistance training|resistance training
4647238|NCT03573583|physical function|physical function
4647239|NCT03573544|mAbs|mabs
4647240|NCT03573544|monoclonal antibodies|monoclonal antibodies
4647241|NCT03573531|donor human milk|donor human milk
4647242|NCT03573531|lipid peroxidation|lipid peroxidation
4647243|NCT03573531|neonate|neonate
4647244|NCT03573531|omega-3 fatty acids|omega-3 fatty acids
4647245|NCT03573531|omega-6 fatty acids|omega-6 fatty acids
4647246|NCT03573531|preterm infants|preterm infants
4647247|NCT03573531|malondialdehyde|malondialdehyde
4647248|NCT03573479|rehabilitation|rehabilitation
4647249|NCT03573479|critical care|critical care
4647250|NCT03573479|child health|child health
4647251|NCT03573479|quality improvement|quality improvement
4647252|NCT03573466|ALS|als
4647253|NCT03573466|Motor Neuron|motor neuron
4647254|NCT03573466|Neuromuscular Junction|neuromuscular junction
4647255|NCT03573453|Critical Care|critical care
4647256|NCT03573453|Enteral Nutrition|enteral nutrition
4647257|NCT03573453|Ventilator Associated Pneumonia|ventilator associated pneumonia
4647258|NCT03573453|Gastric Residual Volume|gastric residual volume
4647259|NCT03573401|ALA-PDT|ala-pdt
4647260|NCT03573388|Intermediate coronary lesions|intermediate coronary lesions
4647261|NCT03573388|Fractional flow reserve|fractional flow reserve
4647262|NCT03573388|Optical coherence tomography|optical coherence tomography
4647263|NCT03573375|Questionnaires|questionnaires
4647264|NCT03573375|Surveys|surveys
4647265|NCT03573362|sarcoidosis|sarcoidosis
4647266|NCT03573362|ebus|ebus
4647267|NCT03573362|endobronchial ultrasound|endobronchial ultrasound
4647268|NCT03573323|biologic|biologic
4647269|NCT03573323|biologic therapy|biologic therapy
4647270|NCT03573284|cough variant asthma|cough variant asthma
4647271|NCT03573284|chronic cough|chronic cough
4647272|NCT03573284|fractional exhaled nitric oxide|fractional exhaled nitric oxide
4647273|NCT03573284|impulse oscillometry|impulse oscillometry
4647274|NCT03573284|forced mid-expiratory flow|forced mid-expiratory flow
4647275|NCT03573271|facial wrinkles|facial wrinkles
4647276|NCT03573271|skin laxity|skin laxity
4647277|NCT03573271|sagging skin|sagging skin
4647278|NCT03573232|Parkinson Disease|parkinson disease
4647279|NCT03573232|Pisa Syndrome|pisa syndrome
4647280|NCT03573232|Camptocormia|camptocormia
4647281|NCT03573232|Antecollis|antecollis
4647282|NCT03573232|Striatal deformities|striatal deformities
4647283|NCT03573219|Short-Wave Diathermy|short-wave diathermy
4647284|NCT03573219|Transient muscle pain|transient muscle pain
4647285|NCT03573219|Non-invasive pain model|non-invasive pain model
4647286|NCT03573206|vessel closure|vessel closure
4647287|NCT03573206|venous access site|venous access site
4647288|NCT03573206|femoral venotomy|femoral venotomy
4647289|NCT03573206|medium bore|medium bore
4647679|NCT03570450|recovery|recovery
4647290|NCT03573206|multiple access sites|multiple access sites
4647291|NCT03573193|xenograft bone|xenograft bone
4647292|NCT03573193|synthetic bone substitutes|synthetic bone substitutes
4647293|NCT03573180|CAST index, prevalence of caries, primary dentition caries|cast index, prevalence of caries, primary dentition caries
4647294|NCT03573154|nicotine|nicotine
4647295|NCT03573154|e-cigarette|e-cigarette
4647296|NCT03573154|exhaled breath|exhaled breath
4647297|NCT03573154|pharmacokinetic model|pharmacokinetic model
4647298|NCT03573115|Optical Coherence Tomography|optical coherence tomography
4647299|NCT03573115|Reflectance Confocal Microscopy|reflectance confocal microscopy
4647300|NCT03573115|Gold microparticles|gold microparticles
4647301|NCT03573115|Adapalene|adapalene
4647302|NCT03573115|Benzoyl Peroxide|benzoyl peroxide
4647303|NCT03573102|proteinuria , SGLT2 inhibitors , diabetes|proteinuria , sglt2 inhibitors , diabetes
4647304|NCT03573089|Renal dialysis|renal dialysis
4647305|NCT03573089|Randomised controlled trial|randomised controlled trial
4647306|NCT03573089|Bone markers|bone markers
4647307|NCT03573089|Cardiovascular risk factors|cardiovascular risk factors
4647308|NCT03573089|Phosphate lowering agent|phosphate lowering agent
4647309|NCT03573089|End stage kidney disease|end stage kidney disease
4647310|NCT03573089|Hyperphosphatemia|hyperphosphatemia
4647311|NCT03573063|starvation|starvation
4647312|NCT03573063|androgens|androgens
4647313|NCT03573063|healthy women|healthy women
4647314|NCT03573063|PCOS|pcos
4647315|NCT03573024|Venetoclax|venetoclax
4647316|NCT03573024|Azacitidine|azacitidine
4647317|NCT03573024|Non-Elderly|non-elderly
4647318|NCT03573024|Previously Untreated|previously untreated
4647319|NCT03573011|prostate cancer|prostate cancer
4647320|NCT03573011|biochemical recurrence|biochemical recurrence
4647321|NCT03573011|18F-PET imaging|18f-pet imaging
4647322|NCT03572933|refractory seizures|refractory seizures
4647323|NCT03572933|genetic pediatric encephalopathies|genetic pediatric encephalopathies
4647324|NCT03572933|epilepsy in children|epilepsy in children
4647325|NCT03572933|seizure disorder|seizure disorder
4647326|NCT03572920|Sleep|sleep
4647327|NCT03572920|Actigraphy|actigraphy
4647328|NCT03572920|Pain|pain
4647329|NCT03572920|Patients|patients
4647330|NCT03572920|Hospitalization|hospitalization
4647331|NCT03572920|Hip Replacement|hip replacement
4647332|NCT03572920|Knee Replacement|knee replacement
4647333|NCT03572920|Arthroplasty|arthroplasty
4647334|NCT03572881|Brugada syndrome|brugada syndrome
4647335|NCT03572881|ventricular arrhythmia|ventricular arrhythmia
4647336|NCT03572881|sudden death|sudden death
4647337|NCT03572803|ntratissue Percutaneous Electrolysis|ntratissue percutaneous electrolysis
4647338|NCT03572803|Dry needling|dry needling
4647339|NCT03572803|Eccentric exercise|eccentric exercise
4647340|NCT03572803|Lateral epicondyle|lateral epicondyle
4647341|NCT03572790|5-HT4|5-ht4
4647342|NCT03572790|Prucalopride|prucalopride
4647343|NCT03572790|Resolor|resolor
4647344|NCT03572790|Functional Magnetic Resonance Imaging (fMRI)|functional magnetic resonance imaging (fmri)
4647345|NCT03572790|Emotional Processing|emotional processing
4647346|NCT03572790|Healthy Volunteers|healthy volunteers
4647347|NCT03572777|Helicobacter pylori, eradication, hybrid therapy, concomitant therapy|helicobacter pylori, eradication, hybrid therapy, concomitant therapy
4647348|NCT03572751|Sensor|sensor
4647349|NCT03572751|Wearable|wearable
4647350|NCT03572738|acne inversa|acne inversa
4647351|NCT03572738|HS|hs
4647352|NCT03572738|Verneuil's Disease|verneuil's disease
4647353|NCT03572712|Obesity Hypoventilation Syndrome|obesity hypoventilation syndrome
4647354|NCT03572712|Non Invasive Ventilation|non invasive ventilation
4647355|NCT03572712|Transcutaneous capnography|transcutaneous capnography
4647356|NCT03572686|supraclavicular nerve block|supraclavicular nerve block
4647357|NCT03572686|dexamethasone|dexamethasone
4647358|NCT03572686|Ropivacaine|ropivacaine
4647359|NCT03572660|stem cell|stem cell
4647360|NCT03572660|circulatory support|circulatory support
4647361|NCT03572647|Erythropoeitin|erythropoeitin
4647362|NCT03572647|Chronic Kidney Disease|chronic kidney disease
4647363|NCT03572647|Anaemia|anaemia
4647364|NCT03572634|Tolero|tolero
4647365|NCT03572634|Phase 1/2|phase 1/2
4647366|NCT03572634|First in human|first in human
4647367|NCT03572634|Previously treated Chronic Lymphocytic Leukemia (CLL)|previously treated chronic lymphocytic leukemia (cll)
4647368|NCT03572634|Previously treated Small Lymphocytic Lymphoma (SLL)|previously treated small lymphocytic lymphoma (sll)
4647369|NCT03572634|AXL inhibitor|axl inhibitor
4647370|NCT03572634|Cancer|cancer
4647371|NCT03572634|Advanced Cancer|advanced cancer
4647372|NCT03572621|Prostatectomy|prostatectomy
4647373|NCT03572608|acupuncture|acupuncture
4647374|NCT03572608|infertility|infertility
4647375|NCT03572608|pregnancy|pregnancy
4647376|NCT03572595|FDG-PET/CT|fdg-pet/ct
4647377|NCT03572595|Staging and restaging|staging and restaging
4647378|NCT03572569|Pediatrics|pediatrics
4647379|NCT03572569|Cardiomyopathy|cardiomyopathy
4647380|NCT03572569|Heart failure|heart failure
4647381|NCT03572569|Risk stratification|risk stratification
4647382|NCT03572569|Family screening|family screening
4647383|NCT03572569|Genetics|genetics
4647384|NCT03572517|Delirium|delirium
4647385|NCT03572517|Anesthesia|anesthesia
4647386|NCT03572517|Surgical Oncology|surgical oncology
4647387|NCT03572465|Chronic liver disease|chronic liver disease
4647388|NCT03572465|Fibrosis|fibrosis
4647389|NCT03572465|Elastography|elastography
4647390|NCT03572465|Ultrasound|ultrasound
4647391|NCT03572465|Magnetic resonance elastography|magnetic resonance elastography
4647392|NCT03572465|Diagnostic performance|diagnostic performance
4647393|NCT03572465|Sensitivity and specificity|sensitivity and specificity
4647394|NCT03572439|epidural|epidural
4647395|NCT03572439|sensory block level|sensory block level
4647396|NCT03572439|dermatome|dermatome
4647397|NCT03572413|Laparoscopic surgery|laparoscopic surgery
4647398|NCT03572413|Deep neuromuscular block|deep neuromuscular block
4647399|NCT03572413|Low pressure pneumoperitoneum|low pressure pneumoperitoneum
4647400|NCT03572413|Postoperative immune suppression|postoperative immune suppression
4647401|NCT03572400|pancreatic cancer|pancreatic cancer
4647402|NCT03572400|pancreas cancer|pancreas cancer
4647403|NCT03572387|Prostate Neoplasms|prostate neoplasms
4647404|NCT03572387|Prostatic Neoplasms|prostatic neoplasms
4647405|NCT03572387|5-Azacitidine|5-azacitidine
4647406|NCT03572387|all-trans retinoic acid|all-trans retinoic acid
4647407|NCT03572387|PSA|psa
4647408|NCT03572374|Workforce|workforce
4647409|NCT03572374|Employers|employers
4647410|NCT03572374|Talking to Employers and Medical Staff About Work (TEAMWork)|talking to employers and medical staff about work (teamwork)
4647411|NCT03572374|18-217|18-217
4647412|NCT03572348|urethral stricture|urethral stricture
4647413|NCT03572348|urethroplasty|urethroplasty
4647414|NCT03572348|bulbar urethra|bulbar urethra
4647415|NCT03572348|reconstructive surgery|reconstructive surgery
4647416|NCT03572348|lower urinary tract symptoms|lower urinary tract symptoms
4647417|NCT03572348|erectile function|erectile function
4647418|NCT03572335|HIV|hiv
4647419|NCT03572335|emphysema|emphysema
4647420|NCT03572335|diffusing capacity|diffusing capacity
4647421|NCT03572335|chronic obstructive pulmonary disease(COPD)|chronic obstructive pulmonary disease(copd)
4647422|NCT03572309|trauma induced coagulopathy|trauma induced coagulopathy
4647423|NCT03572309|multiple trauma|multiple trauma
4647424|NCT03572309|fibrinogen|fibrinogen
4647425|NCT03572296|Blackcurrant|blackcurrant
4647426|NCT03572296|Polyphenols|polyphenols
4647427|NCT03572296|Pulp|pulp
4647428|NCT03572296|Fibre|fibre
4647429|NCT03572296|Glucose|glucose
4647430|NCT03572296|Postprandial|postprandial
4647431|NCT03572296|Metabolism|metabolism
4647432|NCT03572296|Cognition|cognition
4647433|NCT03572283|Pancreas|pancreas
4647434|NCT03572283|pancreatic adenocarcinoma|pancreatic adenocarcinoma
4647435|NCT03572283|adenocarcinoma|adenocarcinoma
4647436|NCT03572283|bethanechol|bethanechol
4647437|NCT03572283|parasympathetic|parasympathetic
4647438|NCT03572270|HIV|hiv
4647439|NCT03572270|Ovarian reserve|ovarian reserve
4647440|NCT03572270|Fertility preservation|fertility preservation
4647441|NCT03572270|Anti HIV agents|anti hiv agents
4647442|NCT03572244|Laser-Lok|laser-lok
4647443|NCT03572244|Crevicular fluid|crevicular fluid
4647444|NCT03572244|Machined|machined
4647445|NCT03572244|Abutment|abutment
4647446|NCT03572231|Betmiga|betmiga
4647447|NCT03572231|OAB|oab
4647448|NCT03572231|YM178|ym178
4647449|NCT03572231|Overactive Bladder|overactive bladder
4647450|NCT03572231|mirabegron|mirabegron
4647451|NCT03572205|Nutrigenetics|nutrigenetics
4647452|NCT03572179|3d printed positioning tray|3d printed positioning tray
4647453|NCT03572166|Copeptin|copeptin
4647454|NCT03572153|Hot Flashes|hot flashes
4647455|NCT03572153|Postmenopausal Symptoms|postmenopausal symptoms
4647456|NCT03572153|Hypnotic Relaxation Therapy|hypnotic relaxation therapy
4647457|NCT03572153|Mind Body|mind body
4647458|NCT03572153|Hypnosis|hypnosis
4647459|NCT03572140|HCV|hcv
4647460|NCT03572140|Sofosbuvir|sofosbuvir
4647461|NCT03572140|Safety|safety
4647462|NCT03572140|RAVs|ravs
4647463|NCT03572140|Daclatasvir|daclatasvir
4647464|NCT03572127|Protein|protein
4647465|NCT03572127|Resistance Exercise|resistance exercise
4647466|NCT03572127|Skeletal Muscle|skeletal muscle
4647467|NCT03572127|Mycoprotein|mycoprotein
4647468|NCT03572127|Sustainability|sustainability
4647469|NCT03572101|colorectal cancer|colorectal cancer
4647470|NCT03572101|palliative care|palliative care
4647471|NCT03572101|patients|patients
4647472|NCT03572101|caregivers|caregivers
4647473|NCT03572101|quality of life|quality of life
4647474|NCT03572062|Respiratory tract infection, RSV, Adjuvant, vaccine|respiratory tract infection, rsv, adjuvant, vaccine
4647475|NCT03572036|Outcomes Assessment|outcomes assessment
4647476|NCT03572036|Sickle Cell Disease|sickle cell disease
4647477|NCT03572023|acute coronary syndrome|acute coronary syndrome
4647478|NCT03572023|non-obstructive coronary artery atherosclerosis|non-obstructive coronary artery atherosclerosis
4647479|NCT03571984|Breast cancer|breast cancer
4647480|NCT03571984|depression|depression
4647481|NCT03571984|Moving on ABC Plus|moving on abc plus
4647482|NCT03571984|Pakistan|pakistan
4647483|NCT03571919|Lidocaine infusion|lidocaine infusion
4647484|NCT03571906|Rehabilitation|rehabilitation
4647485|NCT03571867|Adenotonsillectomy|adenotonsillectomy
4647486|NCT03571867|Severity of Agitation|severity of agitation
4647487|NCT03571867|Sugammadex|sugammadex
4647488|NCT03571841|Breast Cancer Survivors|breast cancer survivors
4647489|NCT03571841|Sexual Function Disturbances|sexual function disturbances
4647490|NCT03571841|Ovarian Suppression Treatment|ovarian suppression treatment
4647491|NCT03571815|Fluoride varnish|fluoride varnish
4647492|NCT03571815|clinical trial|clinical trial
4647493|NCT03571815|dental caries|dental caries
4647494|NCT03571802|pharmacokinetics|pharmacokinetics
4647495|NCT03571802|simvastatin|simvastatin
4647496|NCT03571802|bariatric surgery|bariatric surgery
4647497|NCT03571802|laparoscopic sleeve gastrectomy|laparoscopic sleeve gastrectomy
4647498|NCT03571789|AF|af
4647499|NCT03571763|Cerebral Hemorrhage|cerebral hemorrhage
4647500|NCT03571763|anti-thrombosis|anti-thrombosis
4647501|NCT03571750|Suicide|suicide
4647502|NCT03571750|Prevention|prevention
4647503|NCT03571750|Risk Factor|risk factor
4647504|NCT03571750|Intervention|intervention
4647505|NCT03571750|Military|military
4647506|NCT03571737|acute pain|acute pain
4647507|NCT03571737|muscle strain|muscle strain
4647508|NCT03571737|muscle sprain|muscle sprain
4647509|NCT03571737|injury|injury
4647510|NCT03571737|emergency department|emergency department
4647511|NCT03571724|Very Low Nicotine|very low nicotine
4647512|NCT03571724|Cigarette|cigarette
4647513|NCT03571724|VLN|vln
4647514|NCT03571698|Knee Osteoarthritis|knee osteoarthritis
4647515|NCT03571698|Neuromuscular Electrical Stimulation|neuromuscular electrical stimulation
4647516|NCT03571698|Exercise|exercise
4647517|NCT03571698|Pain|pain
4647518|NCT03571698|Function|function
4647519|NCT03571672|Left Ventricular Ejection Fraction|left ventricular ejection fraction
4647520|NCT03571672|DEFINITY|definity
4647521|NCT03571672|Enhanced Echocardiogram|enhanced echocardiogram
4647522|NCT03571672|Cardiac Magnetic Resonance|cardiac magnetic resonance
4647523|NCT03571633|Pegfilgrastim|pegfilgrastim
4647524|NCT03571633|Trastuzumab/Paclitaxel|trastuzumab/paclitaxel
4647525|NCT03571633|Antibody-dependent cell-mediated cytotoxicity|antibody-dependent cell-mediated cytotoxicity
4647526|NCT03571581|Medication adherence|medication adherence
4647527|NCT03571581|Heart failure|heart failure
4647528|NCT03571581|Mindfulness interventions|mindfulness interventions
4647529|NCT03571555|HIV|hiv
4647530|NCT03571555|perinatal|perinatal
4647531|NCT03571555|adolescent|adolescent
4647532|NCT03571555|camp|camp
4647533|NCT03571555|psychosocial|psychosocial
4647534|NCT03571542|Children|children
4647535|NCT03571542|transplanted|transplanted
4647536|NCT03571542|kidney transplantation|kidney transplantation
4647537|NCT03571542|respiratory function|respiratory function
4647538|NCT03571542|pulmonary function tests|pulmonary function tests
4647539|NCT03571542|respiratory disease|respiratory disease
4647540|NCT03571542|immunosuppression|immunosuppression
4647541|NCT03571529|EMG driven exoskeleton|emg driven exoskeleton
4647542|NCT03571529|hand rehabilitation|hand rehabilitation
4647543|NCT03571529|hand function|hand function
4647544|NCT03571529|upper extremity outcome|upper extremity outcome
4647545|NCT03571516|Short bowel syndrome|short bowel syndrome
4647546|NCT03571516|Teduglutide|teduglutide
4647547|NCT03571503|Complementary Therapies|complementary therapies
4647548|NCT03571503|Exercise|exercise
4647549|NCT03571503|Acupuncture|acupuncture
4647550|NCT03571477|Sleep apnea diagnosis|sleep apnea diagnosis
4647551|NCT03571477|Sleep apnea monitoring|sleep apnea monitoring
4647552|NCT03571464|obsessive compulsive disorder|obsessive compulsive disorder
4647553|NCT03571464|cognitive therapy|cognitive therapy
4647554|NCT03571464|maladaptive beliefs|maladaptive beliefs
4647555|NCT03571464|mobile app|mobile app
4647556|NCT03571451|peritoneal dialysis|peritoneal dialysis
4647557|NCT03571451|survival rate|survival rate
4647558|NCT03571451|technique survival rate|technique survival rate
4647559|NCT03571451|risk factors|risk factors
4647560|NCT03571451|end stage renal disease|end stage renal disease
4647561|NCT03571412|Depression|depression
4647562|NCT03571412|Major Depressive Disorder|major depressive disorder
4647563|NCT03571386|Mindfulness|mindfulness
4647564|NCT03571386|Depression|depression
4647565|NCT03571386|Anxiety|anxiety
4647566|NCT03571386|stress|stress
4647567|NCT03571360|Immunotherapy|immunotherapy
4647568|NCT03571347|distress|distress
4647569|NCT03571347|post-traumatic stress disorder|post-traumatic stress disorder
4647570|NCT03571347|prevention|prevention
4647571|NCT03571347|asylum seekers|asylum seekers
4647572|NCT03571347|refugees|refugees
4647573|NCT03571347|Self Help Plus|self help plus
4647574|NCT03571347|Europe|europe
4647575|NCT03571308|Diffused Large B-Cell Lymphoma|diffused large b-cell lymphoma
4647576|NCT03571308|Acalabrunitib|acalabrunitib
4647577|NCT03571308|Bruton Tyrosine Kinase|bruton tyrosine kinase
4647578|NCT03571308|R-CHOP|r-chop
4647579|NCT03571308|Molecular Profiling|molecular profiling
4647580|NCT03571308|Chemoimmunotherapy|chemoimmunotherapy
4647581|NCT03571295|pediatric airway management|pediatric airway management
4647582|NCT03571295|learning curve|learning curve
4647583|NCT03571282|conbercept|conbercept
4647584|NCT03571282|circumscribed choroidal haemangioma|circumscribed choroidal haemangioma
4647585|NCT03571282|safety|safety
4647586|NCT03571282|effectiveness|effectiveness
4647587|NCT03571230|Helicobacter Pylori Infection|helicobacter pylori infection
4647588|NCT03571230|Antimicrobial Susceptibility testing(AST)|antimicrobial susceptibility testing(ast)
4647589|NCT03571217|Type 2 diabetes mellitus|type 2 diabetes mellitus
4647590|NCT03571217|diabetic retinopathy|diabetic retinopathy
4647591|NCT03571217|visual impairment|visual impairment
4647592|NCT03571217|diabetic choroidopathy|diabetic choroidopathy
4647593|NCT03571204|Treatment Interruption|treatment interruption
4647594|NCT03571204|Neutralizing Monoclonal Antibody|neutralizing monoclonal antibody
4647595|NCT03571191|Bone Diseases|bone diseases
4647596|NCT03571191|Fibrous Dysplasia (FD)|fibrous dysplasia (fd)
4647597|NCT03571191|Bone Turnover|bone turnover
4647598|NCT03571165|carers|carers
4647599|NCT03571165|quality of life|quality of life
4647600|NCT03571165|dementia|dementia
4647601|NCT03571165|web-based intervention|web-based intervention
4647602|NCT03571152|Caregivers|caregivers
4647603|NCT03571152|Educational videos|educational videos
4647604|NCT03571152|Subacute phase|subacute phase
4647605|NCT03571139|OCT angiography|oct angiography
4647606|NCT03571139|Diabetic retinopathy|diabetic retinopathy
4647607|NCT03571139|Cataract surgery|cataract surgery
4647608|NCT03571113|cardiac arrest, OHCA survival score, predicting survival, German Resuscitation Registry|cardiac arrest, ohca survival score, predicting survival, german resuscitation registry
4647609|NCT03571061|water-aided colonoscopy; difficult colonoscopy|water-aided colonoscopy; difficult colonoscopy
4647610|NCT03571035|Mandibular deviation|mandibular deviation
4647611|NCT03571035|mandibular movement recording|mandibular movement recording
4647612|NCT03570996|esophageal cancer|esophageal cancer
4647613|NCT03570996|transversus abdominis plane catheter|transversus abdominis plane catheter
4647614|NCT03570996|epidural|epidural
4647615|NCT03570996|pain, postoperative|pain, postoperative
4647616|NCT03570944|Postoperative Complications|postoperative complications
4647617|NCT03570931|INAD|inad
4647618|NCT03570931|Infantile Neuroaxonal Dystrophy|infantile neuroaxonal dystrophy
4647619|NCT03570918|HIV, Latent HIV-1 infection, HIV therapy, antibody-based therapy|hiv, latent hiv-1 infection, hiv therapy, antibody-based therapy
4647620|NCT03570905|acute, displaced distal radius fracture|acute, displaced distal radius fracture
4647621|NCT03570892|Non-Hodgkin's Lympoma|non-hodgkin's lympoma
4647622|NCT03570892|B-Cell Lymphoma|b-cell lymphoma
4647623|NCT03570892|Diffuse Large B-cell Lymphoma|diffuse large b-cell lymphoma
4647624|NCT03570892|High Grade B-cell Lymphoma|high grade b-cell lymphoma
4647625|NCT03570892|Follicular Lymphoma grade 3B|follicular lymphoma grade 3b
4647626|NCT03570892|CAR-T|car-t
4647627|NCT03570892|Tisagenlecleucel|tisagenlecleucel
4647628|NCT03570892|Kymriah|kymriah
4647629|NCT03570892|Immunotherapy|immunotherapy
4647630|NCT03570892|Cellular therapy|cellular therapy
4647631|NCT03570892|CTL019|ctl019
4647632|NCT03570879|Laparoscopy|laparoscopy
4647633|NCT03570879|Power morcellation|power morcellation
4647634|NCT03570879|Transvaginal extraction|transvaginal extraction
4647635|NCT03570866|Endometrial cancer|endometrial cancer
4647636|NCT03570866|Positron emission tomography|positron emission tomography
4647637|NCT03570853|Resiliency|resiliency
4647638|NCT03570840|pediatric metabolic syndrome|pediatric metabolic syndrome
4647639|NCT03570801|Lumbar Spondylolisthesis|lumbar spondylolisthesis
4647640|NCT03570801|Grade 1 Spondylolisthesis|grade 1 spondylolisthesis
4647641|NCT03570801|Lumbar Spinal Stenosis|lumbar spinal stenosis
4647642|NCT03570801|Degenerative Spondylolisthesis|degenerative spondylolisthesis
4647643|NCT03570775|hyperbilirubinemia|hyperbilirubinemia
4647644|NCT03570775|treatment|treatment
4647645|NCT03570775|devices|devices
4647646|NCT03570775|newborn|newborn
4647647|NCT03570775|phototherapy|phototherapy
4647648|NCT03570762|bioresorbable vascular scaffold|bioresorbable vascular scaffold
4647649|NCT03570710|cesarean section|cesarean section
4647650|NCT03570710|placenta accreta spectrum|placenta accreta spectrum
4647651|NCT03570710|tranexamic acid|tranexamic acid
4647652|NCT03570697|Optical coherence tomography (OCT)|optical coherence tomography (oct)
4647653|NCT03570697|Intravascular ultrasound (IVUS)|intravascular ultrasound (ivus)
4647654|NCT03570697|Coronary angiography|coronary angiography
4647655|NCT03570697|Coronary artery disease|coronary artery disease
4647656|NCT03570697|Cardiovascular events|cardiovascular events
4647657|NCT03570697|Coronary atherosclerotic plaques|coronary atherosclerotic plaques
4647658|NCT03570697|Lipid-lowering therapy|lipid-lowering therapy
4647659|NCT03570697|Statin|statin
4647788|NCT03569891|Viral vector|viral vector
4647660|NCT03570697|Maximally tolerated statin therapy|maximally tolerated statin therapy
4647661|NCT03570671|MDCTA|mdcta
4647662|NCT03570671|Coronary artery spasm|coronary artery spasm
4647663|NCT03570619|Metastatic Cancer|metastatic cancer
4647664|NCT03570619|Metastatic Castration Resistant Prostate Cancer|metastatic castration resistant prostate cancer
4647665|NCT03570619|mCRPC|mcrpc
4647666|NCT03570619|Immunotherapy|immunotherapy
4647667|NCT03570619|CDK12|cdk12
4647668|NCT03570580|Sleep Apnea, Obstructive, Mass Screening|sleep apnea, obstructive, mass screening
4647669|NCT03570541|Colon cancer|colon cancer
4647670|NCT03570541|nerve block|nerve block
4647671|NCT03570541|ultra-sound|ultra-sound
4647672|NCT03570541|opioids|opioids
4647673|NCT03570541|surgical stress|surgical stress
4647674|NCT03570489|Cardiovascular fitness, refractory epilepsy,|cardiovascular fitness, refractory epilepsy,
4647675|NCT03570450|Cell therapy|cell therapy
4647676|NCT03570450|stem cell|stem cell
4647677|NCT03570450|transplantation|transplantation
4647678|NCT03570450|graft|graft
4647680|NCT03570450|repair|repair
4647681|NCT03570450|stroke|stroke
4647682|NCT03570450|msesenchymal stem cell|msesenchymal stem cell
4647683|NCT03570450|regenerative|regenerative
4647684|NCT03570437|Endometrial|endometrial
4647685|NCT03570437|Cancer|cancer
4647686|NCT03570437|Paclitaxel|paclitaxel
4647687|NCT03570437|Cediranib|cediranib
4647688|NCT03570437|Olaparib|olaparib
4647689|NCT03570424|Organelle Biogenesis|organelle biogenesis
4647690|NCT03570424|Adaptation, Physiological|adaptation, physiological
4647691|NCT03570424|Whey Proteins|whey proteins
4647692|NCT03570424|Protein Hydrolysates|protein hydrolysates
4647693|NCT03570372|Life quality|life quality
4647695|NCT03570372|Internet based treatment|internet based treatment
4647696|NCT03570372|Autism|autism
4647697|NCT03570372|ICBT|icbt
4647698|NCT03570359|COPD|copd
4647699|NCT03570333|gingival recession|gingival recession
4647700|NCT03570333|gingival graft|gingival graft
4647701|NCT03570333|Palate|palate
4647702|NCT03570333|Gingival mesenchymal stem cells|gingival mesenchymal stem cells
4647703|NCT03570333|molar|molar
4647704|NCT03570333|premolar|premolar
4647705|NCT03570320|opioid|opioid
4647706|NCT03570320|narcotic|narcotic
4647707|NCT03570320|postoperative|postoperative
4647708|NCT03570320|prescription|prescription
4647709|NCT03570320|refill|refill
4647710|NCT03570320|upper extremity surgery|upper extremity surgery
4647711|NCT03570307|MISCARRAGE, CURATTAGE MISOPROSTOL|miscarrage, curattage misoprostol
4647712|NCT03570281|cancer-related stroke|cancer-related stroke
4647713|NCT03570281|coagulopathy|coagulopathy
4647714|NCT03570281|D-dimer|d-dimer
4647715|NCT03570281|Edoxaban|edoxaban
4647716|NCT03570281|enoxaparine|enoxaparine
4647717|NCT03570268|Falls prevention|falls prevention
4647718|NCT03570268|Education|education
4647719|NCT03570268|Neurological disease|neurological disease
4647720|NCT03570242|gynecologic cancer|gynecologic cancer
4647721|NCT03570242|WB-EMS|wb-ems
4647722|NCT03570242|whole-body electromyostimulation|whole-body electromyostimulation
4647723|NCT03570242|nutrition|nutrition
4647724|NCT03570242|protein|protein
4647725|NCT03570242|exercise|exercise
4647726|NCT03570242|cancer cachexia|cancer cachexia
4647727|NCT03570229|Quality of life (QOL)|quality of life (qol)
4647728|NCT03570229|Hyperbaric oxygen treatment (HBOT)|hyperbaric oxygen treatment (hbot)
4647729|NCT03570229|Late radiation tissue injury (LRTI)|late radiation tissue injury (lrti)
4647730|NCT03570229|Longitudinal|longitudinal
4647731|NCT03570229|Mixed methods|mixed methods
4647732|NCT03570229|Patient experiences|patient experiences
4647733|NCT03570216|acute exercise|acute exercise
4647734|NCT03570216|High-intensity interval exercise|high-intensity interval exercise
4647735|NCT03570216|feasibility|feasibility
4647736|NCT03570216|arterial stiffness|arterial stiffness
4647737|NCT03570203|Hyponatremia|hyponatremia
4647738|NCT03570203|Dysnatremia|dysnatremia
4647739|NCT03570203|Neurosurgery|neurosurgery
4647740|NCT03570203|Neurointensive Care|neurointensive care
4647741|NCT03570177|osteoporotic fractures|osteoporotic fractures
4647742|NCT03570177|QCT|qct
4647743|NCT03570177|BND|bnd
4647744|NCT03570177|automatic measurement|automatic measurement
4647745|NCT03570138|Freestyle libre|freestyle libre
4647746|NCT03570138|Type 2 diabetes|type 2 diabetes
4647747|NCT03570138|Hypoglycemia-induced cardiac arrhythmias|hypoglycemia-induced cardiac arrhythmias
4647748|NCT03570138|Flash Continuous Glucose Monitoring|flash continuous glucose monitoring
4647749|NCT03570099|opioid overdose|opioid overdose
4647750|NCT03570099|mortality|mortality
4647751|NCT03570099|naloxone|naloxone
4647752|NCT03570099|substance use disorder|substance use disorder
4647753|NCT03570099|prevention|prevention
4647754|NCT03570047|Non-valvular atrial fibrillation, NVAF|non-valvular atrial fibrillation, nvaf
4647755|NCT03570008|prevention|prevention
4647756|NCT03570008|bone|bone
4647757|NCT03570008|physical activity|physical activity
4647758|NCT03570008|spa bath|spa bath
4647759|NCT03570008|women|women
4647760|NCT03569982|Integrative medicine|integrative medicine
4647761|NCT03569982|Peri-operative anxiety|peri-operative anxiety
4647762|NCT03569982|Pain|pain
4647763|NCT03569982|MOHS surgery|mohs surgery
4647764|NCT03569969|amniotic membrane|amniotic membrane
4647765|NCT03569969|Tympanic Membrane Perforation|tympanic membrane perforation
4647766|NCT03569956|Razor bumps|razor bumps
4647767|NCT03569956|Skin Irritation|skin irritation
4647768|NCT03569956|Shaving|shaving
4647769|NCT03569943|Robot based procedure|robot based procedure
4647770|NCT03569943|RobOtol|robotol
4647771|NCT03569943|Tympanic drain|tympanic drain
4647772|NCT03569930|Flavonoid-based supplements|flavonoid-based supplements
4647773|NCT03569930|Centella asiatica|centella asiatica
4647774|NCT03569930|Hemorrhoids|hemorrhoids
4647775|NCT03569930|defecation|defecation
4647776|NCT03569930|bleeding|bleeding
4647777|NCT03569930|pain|pain
4647778|NCT03569904|Cystic fibrosis|cystic fibrosis
4647779|NCT03569904|Pulmonary Dysbiosis|pulmonary dysbiosis
4647780|NCT03569904|pulmonary exacerbation|pulmonary exacerbation
4647781|NCT03569904|Fungal bacterial pulmonary dysbiosis|fungal bacterial pulmonary dysbiosis
4647782|NCT03569904|Viral bacterial pulmonary dysbiosis|viral bacterial pulmonary dysbiosis
4647783|NCT03569904|Microbiota|microbiota
4647784|NCT03569891|Gene therapy|gene therapy
4647785|NCT03569891|FIX|fix
4647786|NCT03569891|Factor IX|factor ix
4647787|NCT03569891|Bleeding|bleeding
4647789|NCT03569891|Padua|padua
4647790|NCT03569891|Hemophilia|hemophilia
4647791|NCT03569891|AAV (adeno-associated virus)|aav (adeno-associated virus)
4647792|NCT03569891|serotype 5 AAV (adeno-associated virus)|serotype 5 aav (adeno-associated virus)
4647793|NCT03569891|serotype 5|serotype 5
4647794|NCT03569878|PTSD|ptsd
4647795|NCT03569878|Physical Injury|physical injury
4647796|NCT03569878|Patient Concerns|patient concerns
4647797|NCT03569878|Emergency Department Utilization|emergency department utilization
4647798|NCT03569813|Pre-exposure prophylaxis (PrEP)|pre-exposure prophylaxis (prep)
4647799|NCT03569813|Home-based monitoring|home-based monitoring
4647800|NCT03569800|Levothyrox®|levothyrox®
4647801|NCT03569800|thyroid hormones|thyroid hormones
4647802|NCT03569800|bioequivalent|bioequivalent
4647803|NCT03569761|colorectal cancer screening|colorectal cancer screening
4647804|NCT03569761|decision aids|decision aids
4647805|NCT03569761|American Indians|american indians
4647806|NCT03569748|smoking|smoking
4647807|NCT03569748|harm reduction|harm reduction
4647808|NCT03569748|electronic cigarette|electronic cigarette
4647809|NCT03569748|heated tobacco product|heated tobacco product
4647810|NCT03569735|Prospective Cohort Study|prospective cohort study
4647811|NCT03569735|Nutrition|nutrition
4647812|NCT03569735|Chronic diseases|chronic diseases
4647813|NCT03569735|Nanshan|nanshan
4647814|NCT03569735|Chinese|chinese
4647815|NCT03569722|Cognitive screen|cognitive screen
4647816|NCT03569670|cost|cost
4647817|NCT03569670|total knee replacement|total knee replacement
4647818|NCT03569670|arthroplasty|arthroplasty
4647819|NCT03569670|posterior stabilized|posterior stabilized
4647820|NCT03569670|cruciate retaining|cruciate retaining
4647821|NCT03569670|all-polyethylene|all-polyethylene
4647822|NCT03569657|Caregivers|caregivers
4647823|NCT03569631|Phosphodiesterase Type 4D|phosphodiesterase type 4d
4647824|NCT03569631|PDE4D|pde4d
4647825|NCT03569631|Cognitive Dysfunction|cognitive dysfunction
4647826|NCT03569631|Neurocognitive Disorders|neurocognitive disorders
4647827|NCT03569631|Fragile X Syndrome|fragile x syndrome
4647828|NCT03569631|Fragile X|fragile x
4647829|NCT03569631|FXS|fxs
4647830|NCT03569631|Brain Diseases|brain diseases
4647831|NCT03569631|Central Nervous System Diseases|central nervous system diseases
4647832|NCT03569631|Nervous System Diseases|nervous system diseases
4647833|NCT03569631|Mental Disorders|mental disorders
4647834|NCT03569631|Cognition Disorders|cognition disorders
4647835|NCT03569631|Enzyme Inhibitors|enzyme inhibitors
4647836|NCT03569631|Nootropic Agents|nootropic agents
4647837|NCT03569631|Developmental Disorder|developmental disorder
4647838|NCT03569631|Autism|autism
4647839|NCT03569631|Autistic Spectrum Disorder|autistic spectrum disorder
4647840|NCT03569631|Genetic Disease|genetic disease
4647841|NCT03569631|Behavioral Disorder|behavioral disorder
4647842|NCT03569631|Learning Disorder|learning disorder
4647843|NCT03569605|young adult|young adult
4647844|NCT03569605|cancer survivor|cancer survivor
4647845|NCT03569592|HIV/AIDS|hiv/aids
4647846|NCT03569592|naloxone|naloxone
4647847|NCT03569592|incarceration|incarceration
4647848|NCT03569566|Age|age
4647849|NCT03569566|Genes|genes
4647850|NCT03569566|Training volume|training volume
4647851|NCT03569566|Training intensity|training intensity
4647852|NCT03569566|Tick-bourne disease|tick-bourne disease
4647853|NCT03569566|Endurance performance|endurance performance
4647854|NCT03569566|Elite endurance athletes|elite endurance athletes
4647855|NCT03569553|Anthrax|anthrax
4647856|NCT03569553|Bacillus anthracis|bacillus anthracis
4647857|NCT03569553|Inhalational anthrax|inhalational anthrax
4647858|NCT03569553|Bacterial infection|bacterial infection
4647859|NCT03569553|AIGIV|aigiv
4647860|NCT03569553|Anthrasil|anthrasil
4647861|NCT03569553|Anthrax immune globulin|anthrax immune globulin
4647862|NCT03569553|Anti toxin|anti toxin
4647863|NCT03569553|Poluclonal antibodies|poluclonal antibodies
4647864|NCT03569540|Subarachnoid hemorrhage|subarachnoid hemorrhage
4647865|NCT03569540|Glibenclamide|glibenclamide
4647866|NCT03569527|Kiwifruit|kiwifruit
4647867|NCT03569514|Anthrax|anthrax
4647868|NCT03569514|Bacillus anthracis|bacillus anthracis
4647869|NCT03569514|Bacterial infection|bacterial infection
4647870|NCT03569514|AIGIV|aigiv
4647871|NCT03569514|Anthrax immune globulin|anthrax immune globulin
4647872|NCT03569514|Anti toxin|anti toxin
4647873|NCT03569514|Polyclonal antibodies|polyclonal antibodies
4647874|NCT03569501|gestational diabetes mellitus|gestational diabetes mellitus
4647875|NCT03569501|oat|oat
4647876|NCT03569501|docosahexaenoic acid|docosahexaenoic acid
4647877|NCT03569501|glycemic control|glycemic control
4647878|NCT03569501|intestinal flora|intestinal flora
4647879|NCT03569501|newborn|newborn
4647880|NCT03569501|leptin|leptin
4647881|NCT03569462|HIV self-testing|hiv self-testing
4647882|NCT03569462|Mobile Health|mobile health
4647883|NCT03569462|Men who have sex with men|men who have sex with men
4647884|NCT03569462|China|china
4647885|NCT03569449|Family navigation|family navigation
4647886|NCT03569449|Family partners|family partners
4647887|NCT03569449|Multiphase optimization strategy (MOST)|multiphase optimization strategy (most)
4647888|NCT03569449|Pediatric Symptom Checklist-17|pediatric symptom checklist-17
4647889|NCT03569449|Survey of Wellbeing of Young children (SWYC)|survey of wellbeing of young children (swyc)
4647890|NCT03569449|Family Resource Scale|family resource scale
4647891|NCT03569449|Federally qualified community health center|federally qualified community health center
4647892|NCT03569410|peritoneal dialysis|peritoneal dialysis
4647893|NCT03569410|albumin|albumin
4647894|NCT03569410|end stage renal disease|end stage renal disease
4647895|NCT03569371|Hidradenitis suppurativa (HS)|hidradenitis suppurativa (hs)
4647896|NCT03569371|Janus kinase (JAK)|janus kinase (jak)
4647897|NCT03569371|Janus kinase 1 (JAK1) inhibitor|janus kinase 1 (jak1) inhibitor
4647898|NCT03569358|Randomised Controlled Study|randomised controlled study
4647899|NCT03569358|Unblinded|unblinded
4647900|NCT03569358|Electroencephalogram|electroencephalogram
4647901|NCT03569358|Feasibility|feasibility
4647902|NCT03569332|Incentive Spirometer|incentive spirometer
4647903|NCT03569319|Mediterranean Diet|mediterranean diet
4647904|NCT03569319|Lifestyle|lifestyle
4647905|NCT03569306|Electromagnetic navigation bronchoscopy(ENB)|electromagnetic navigation bronchoscopy(enb)
4647906|NCT03569306|peripheral pulmonary nodules|peripheral pulmonary nodules
4647907|NCT03569306|diagnostic yield|diagnostic yield
4647908|NCT03569293|Atopic Dermatitis|atopic dermatitis
4647909|NCT03569293|Upadacitinib|upadacitinib
4647910|NCT03569280|KPG-121|kpg-121
4647911|NCT03569280|enzalutamide|enzalutamide
4647912|NCT03569280|prostate|prostate
4647913|NCT03569280|cancer|cancer
4647914|NCT03569280|metastatic|metastatic
4647915|NCT03569254|infant, newborn|infant, newborn
4647917|NCT03569254|treatment|treatment
4647918|NCT03569254|hyperbilirubinemia|hyperbilirubinemia
4647919|NCT03569241|Radiotherapy|radiotherapy
4647920|NCT03569241|metastasis-directed therapy|metastasis-directed therapy
4647921|NCT03569228|hearing loss|hearing loss
4647922|NCT03569228|hearing aids|hearing aids
4647923|NCT03569202|Lubricant Eye Drops|lubricant eye drops
4647924|NCT03569202|Moderate or Severe Dry Eye|moderate or severe dry eye
4647925|NCT03569202|Hyaluronic Acid|hyaluronic acid
4647926|NCT03569202|Trehalose|trehalose
4647927|NCT03569202|Disaccharides|disaccharides
4647928|NCT03569202|Polysaccharides|polysaccharides
4647929|NCT03569202|Fatty Acids, Omega-3|fatty acids, omega-3
4647930|NCT03569202|Tears|tears
4647931|NCT03569202|Osmolar Concentration|osmolar concentration
4647932|NCT03569202|Anterior Eye Segment|anterior eye segment
4647933|NCT03569202|Severity of Illness Index|severity of illness index
4647934|NCT03569176|mobile health, autism, ASD, mobile therapy, digital, wearable computing, technology|mobile health, autism, asd, mobile therapy, digital, wearable computing, technology
4647935|NCT03569150|palliative care|palliative care
4647936|NCT03569150|end-of-life care|end-of-life care
4647937|NCT03569150|advance care planning|advance care planning
4647938|NCT03569150|communication|communication
4647939|NCT03569150|health literacy|health literacy
4647940|NCT03569150|serious life-limiting illness|serious life-limiting illness
4647941|NCT03569137|Gut Microbiome|gut microbiome
4647942|NCT03569137|hematologic malignancies B|hematologic malignancies b
4647943|NCT03569137|biomarkers|biomarkers
4647944|NCT03569137|targeted therapy|targeted therapy
4647945|NCT03569137|Gut microbiota|gut microbiota
4647946|NCT03569111|Lung Nodule|lung nodule
4647947|NCT03569111|Bronchoscopy|bronchoscopy
4647948|NCT03569111|Ablation, Microwave|ablation, microwave
4647949|NCT03569059|Stroke|stroke
4647950|NCT03569059|Virtual Environment|virtual environment
4647951|NCT03569059|Robotics|robotics
4647952|NCT03569059|Upper Extremity|upper extremity
4647953|NCT03569059|Hand|hand
4647954|NCT03569059|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
4647955|NCT03569020|Diet|diet
4647956|NCT03569020|Nutrition|nutrition
4647957|NCT03569020|DASH|dash
4647958|NCT03569020|Gout|gout
4647959|NCT03569020|Hyperuricemia|hyperuricemia
4647960|NCT03569020|Potassium|potassium
4647961|NCT03569020|Uric acid|uric acid
4647962|NCT03569020|Trial|trial
4647963|NCT03569020|Blood pressure|blood pressure
4647964|NCT03569020|Glucose|glucose
4647965|NCT03569020|Lipid|lipid
4647966|NCT03569020|Cholesterol|cholesterol
4647967|NCT03569020|Weight|weight
4647968|NCT03569020|Arthritis|arthritis
4647969|NCT03569020|BMI|bmi
4647970|NCT03569020|Body mass index|body mass index
4647971|NCT03569020|Fruit|fruit
4647972|NCT03569020|Vegetable|vegetable
4647973|NCT03569020|Low fat dairy|low fat dairy
4647974|NCT03569020|Lean meat|lean meat
4647975|NCT03569020|Fiber|fiber
4647976|NCT03568968|Parkinson's Disease|parkinson's disease
4647977|NCT03568968|NAD metabolism|nad metabolism
4647978|NCT03568968|Mitochondria|mitochondria
4647979|NCT03568968|Nicotinamide Riboside|nicotinamide riboside
4647980|NCT03568955|assessment|assessment
4647981|NCT03568955|validation|validation
4647982|NCT03568955|prolonged grief disorder|prolonged grief disorder
4647983|NCT03568955|cross cultural|cross cultural
4647984|NCT03568955|questionnaire|questionnaire
4647985|NCT03568942|gepotidacin|gepotidacin
4647986|NCT03568942|GSK2140944|gsk2140944
4647987|NCT03568942|acute cystitis|acute cystitis
4647988|NCT03568942|pharmacokinetics|pharmacokinetics
4647989|NCT03568942|urinary tract infections|urinary tract infections
4647990|NCT03568916|Direct oral anticoagulants|direct oral anticoagulants
4647991|NCT03568916|Safety|safety
4647992|NCT03568916|Atrial fibrillation|atrial fibrillation
4647993|NCT03568916|Ischemic stroke|ischemic stroke
4647994|NCT03568916|Systemic embolization|systemic embolization
4647995|NCT03568903|Parkinson Disease|parkinson disease
4647996|NCT03568903|Gait|gait
4647997|NCT03568903|Physical therapy|physical therapy
4647998|NCT03568903|functional performance|functional performance
4647999|NCT03568903|group therapy|group therapy
4648000|NCT03568890|Left Atrial Appendage Closure|left atrial appendage closure
4648001|NCT03568890|Anticoagulation therapy|anticoagulation therapy
4648002|NCT03568890|Antiplatelet therapy|antiplatelet therapy
4648003|NCT03568825|Two-dimensional randomized response surface pathway design|two-dimensional randomized response surface pathway design
4648004|NCT03568825|Osteopathic Manual Therapy|osteopathic manual therapy
4648005|NCT03568825|OMT in treatment of GERD|omt in treatment of gerd
4648006|NCT03568825|Dose-response|dose-response
4648007|NCT03568812|HIV|hiv
4648008|NCT03568812|immunological non responder|immunological non responder
4648009|NCT03568812|gut inflammation|gut inflammation
4648010|NCT03568786|end-inspiratory pause|end-inspiratory pause
4648011|NCT03568786|lung protection|lung protection
4648012|NCT03568786|intraoperative ventilation|intraoperative ventilation
4648013|NCT03568786|lung compliance|lung compliance
4648014|NCT03568760|Anomia|anomia
4648015|NCT03568734|microbiome|microbiome
4648016|NCT03568734|transplant|transplant
4648017|NCT03568734|infant|infant
4648018|NCT03568734|newborn|newborn
4648019|NCT03568721|pain|pain
4648020|NCT03568721|orthodontics|orthodontics
4648021|NCT03568708|Primary Ovarian Insufficiency|primary ovarian insufficiency
4648022|NCT03568708|Hormone Replacement Therapy|hormone replacement therapy
4648023|NCT03568708|Estrogen Deficiency|estrogen deficiency
4648024|NCT03568695|pooled analysis|pooled analysis
4648025|NCT03568695|sensitivity|sensitivity
4648026|NCT03568695|men who have sex with men|men who have sex with men
4648027|NCT03568682|food insecurity|food insecurity
4648028|NCT03568682|nutrition|nutrition
4648029|NCT03568682|treatment adherence|treatment adherence
4648030|NCT03568669|NIH Toolbox|nih toolbox
4648031|NCT03568669|Toolbox|toolbox
4648032|NCT03568669|Congenital Central Hypoventilation Syndrome|congenital central hypoventilation syndrome
4648033|NCT03568669|CCHS|cchs
4648034|NCT03568669|Autonomic Nervous System Dysregulation|autonomic nervous system dysregulation
4648035|NCT03568669|PHOX2B|phox2b
4648036|NCT03568617|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
4648037|NCT03568617|Migraine Disorders|migraine disorders
4648038|NCT03568617|Prophylaxis|prophylaxis
4648039|NCT03568617|Treatment Outcome|treatment outcome
4648040|NCT03568617|Brain|brain
4648041|NCT03568604|vulvovaginal atrophy|vulvovaginal atrophy
4648042|NCT03568604|dyspareunia|dyspareunia
4648043|NCT03568604|prasterone|prasterone
4648044|NCT03568604|vulvoscopy|vulvoscopy
4648045|NCT03568591|Psychosensory Therapy|psychosensory therapy
4648046|NCT03568591|Trauma, Psychological|trauma, psychological
4648047|NCT03568591|DS14|ds14
4648048|NCT03568591|CD-RISC|cd-risc
4648049|NCT03568591|Resilience|resilience
4648050|NCT03568591|Psychosomatic Medicine|psychosomatic medicine
4648051|NCT03568591|Type D Personality|type d personality
4648052|NCT03568591|Salivary Cortisol|salivary cortisol
4648053|NCT03568591|Blood Pressure|blood pressure
4648054|NCT03568591|Havening Techniques|havening techniques
4648055|NCT03568578|Fibrosis|fibrosis
4648056|NCT03568578|Liver Cirrhosis|liver cirrhosis
4648057|NCT03568578|non-invasive biopsy|non-invasive biopsy
4648058|NCT03568578|hepatitis B virus|hepatitis b virus
4648059|NCT03568552|Opioid Use Disorder (OUD)|opioid use disorder (oud)
4648060|NCT03568552|Medication Assisted Therapy (MAT)|medication assisted therapy (mat)
4648061|NCT03568552|Patient Decision Aid|patient decision aid
4648062|NCT03568539|Advanced/metastatic solid malignancies, TMB high|advanced/metastatic solid malignancies, tmb high
4648063|NCT03568513|Curcumin|curcumin
4648064|NCT03568513|IBS and microbiota|ibs and microbiota
4648065|NCT03568500|Digital Medicine System|digital medicine system
4648066|NCT03568487|scapular dyskinesis|scapular dyskinesis
4648067|NCT03568487|EMG biofeedback|emg biofeedback
4648068|NCT03568487|scapulometer|scapulometer
4648069|NCT03568461|Refractory or relapsed Follicular Lymphoma|refractory or relapsed follicular lymphoma
4648070|NCT03568461|Refractory|refractory
4648071|NCT03568461|Relapsed|relapsed
4648072|NCT03568461|Follicular lymphoma|follicular lymphoma
4648073|NCT03568461|CTL019|ctl019
4648074|NCT03568461|Tisagenlecleucel|tisagenlecleucel
4648075|NCT03568461|Chimeric antigen receptor|chimeric antigen receptor
4648076|NCT03568448|HER2 negative breast cancer|her2 negative breast cancer
4648077|NCT03568396|Nociceptive stimulation|nociceptive stimulation
4648078|NCT03568383|Tuberculosis|tuberculosis
4648079|NCT03568383|Multidrug Resistance|multidrug resistance
4648080|NCT03568383|Prevention|prevention
4648081|NCT03568383|Household Contact|household contact
4648082|NCT03568357|tetralogy of Fallot|tetralogy of fallot
4648083|NCT03568344|Severe malaria|severe malaria
4648084|NCT03568344|Mortality|mortality
4648085|NCT03568344|Referral|referral
4648086|NCT03568344|Rectal artesunate|rectal artesunate
4648087|NCT03568344|iCCM|iccm
4648088|NCT03568344|Community based treatment|community based treatment
4648089|NCT03568331|Chronic Pruritus|chronic pruritus
4648090|NCT03568331|Eczema|eczema
4648091|NCT03568318|Atopic Dermatitis|atopic dermatitis
4648092|NCT03568318|Upadacitinib|upadacitinib
4648093|NCT03568305|asthma|asthma
4648094|NCT03568305|occupational asthma|occupational asthma
4648095|NCT03568253|Bulk composite|bulk composite
4648096|NCT03568253|High viscisity glassionomer|high viscisity glassionomer
4648097|NCT03568253|Cambra application (Caries management by risk assessment)|cambra application (caries management by risk assessment)
4648098|NCT03568253|E-dentistry|e-dentistry
4648099|NCT03568227|Hypnosis|hypnosis
4648100|NCT03568227|Neurophysiology|neurophysiology
4648101|NCT03568227|fMRI|fmri
4648102|NCT03568227|Resting-State|resting-state
4648103|NCT03568227|Hypnotic Sub-States|hypnotic sub-states
4648104|NCT03568214|Primary Prevention|primary prevention
4648105|NCT03568201|Diagnosis|diagnosis
4648106|NCT03568201|Peripheral artery disease|peripheral artery disease
4648107|NCT03568201|Sports|sports
4648108|NCT03568188|prostate cancer|prostate cancer
4648109|NCT03568188|HIFU focal|hifu focal
4648110|NCT03568188|adverse effect|adverse effect
4648111|NCT03568188|intermediate risk|intermediate risk
4648112|NCT03568162|GRB 830 for the treatment of moderate to severe atopic dermatitis|grb 830 for the treatment of moderate to severe atopic dermatitis
4648113|NCT03568136|neurodermatitis|neurodermatitis
4648114|NCT03568136|moderate to severe inflammatory reaction of the skin|moderate to severe inflammatory reaction of the skin
4648115|NCT03568136|Skin and Connective Tissue Diseases|skin and connective tissue diseases
4648116|NCT03568084|elderly|elderly
4648117|NCT03568084|physical activity|physical activity
4648118|NCT03568084|exercise|exercise
4648119|NCT03568084|frailty|frailty
4648120|NCT03568058|immunotherapy|immunotherapy
4648121|NCT03568058|personalized cancer vaccine|personalized cancer vaccine
4648122|NCT03568058|personalized immunotherapy|personalized immunotherapy
4648123|NCT03568058|pembrolizumab|pembrolizumab
4648124|NCT03568058|Keytruda|keytruda
4648125|NCT03568058|cancer|cancer
4648126|NCT03568045|circadian misalignment|circadian misalignment
4648127|NCT03568045|entrainment|entrainment
4648128|NCT03568045|zeitgeber|zeitgeber
4648129|NCT03568045|bright light|bright light
4648130|NCT03568045|critical illness|critical illness
4648131|NCT03568032|intima media thickness|intima media thickness
4648132|NCT03568006|subacromial impingement|subacromial impingement
4648133|NCT03568006|pain|pain
4648134|NCT03568006|shoulder|shoulder
4648135|NCT03568006|passive mobilization|passive mobilization
4648136|NCT03567993|mhealth|mhealth
4648137|NCT03567993|Tobacco cessation|tobacco cessation
4648138|NCT03567993|Vietnam|vietnam
4648139|NCT03567993|Smoking cessation|smoking cessation
4648140|NCT03567967|nutrition|nutrition
4648141|NCT03567967|fruits and vegetables|fruits and vegetables
4648142|NCT03567967|sugar-sweetened beverages|sugar-sweetened beverages
4648143|NCT03567954|Diagnostic ultrasound|diagnostic ultrasound
4648144|NCT03567902|C-MAC|c-mac
4648145|NCT03567876|Mantle cell lymphoma|mantle cell lymphoma
4648146|NCT03567876|Elderly patients|elderly patients
4648147|NCT03567876|First line|first line
4648148|NCT03567785|Therapy adherence|therapy adherence
4648149|NCT03567772|Video-game assisted rehabilitation|video-game assisted rehabilitation
4648150|NCT03567772|COPD|copd
4648151|NCT03567772|Exercise tolerance|exercise tolerance
4648152|NCT03567746|Colonic Polyp|colonic polyp
4648153|NCT03567746|Endoscopic mucosal resection|endoscopic mucosal resection
4648154|NCT03567733|Dual antiplatelet treatment|dual antiplatelet treatment
4648155|NCT03567733|Elderly patients|elderly patients
4648156|NCT03567720|Metastatic|metastatic
4648157|NCT03567720|Inoperable Locally Advanced|inoperable locally advanced
4648158|NCT03567720|TNBC|tnbc
4648159|NCT03567720|pIL-12|pil-12
4648160|NCT03567720|tavokinogene telseplasmid|tavokinogene telseplasmid
4648161|NCT03567720|pembrolizumab|pembrolizumab
4648162|NCT03567707|Vaginal seeding|vaginal seeding
4648163|NCT03567707|Immune responses|immune responses
4648164|NCT03567707|Allergen sensitization|allergen sensitization
4648165|NCT03567694|asthma, allergic rhinitis, HA115, CRTH2 antagonists|asthma, allergic rhinitis, ha115, crth2 antagonists
4648166|NCT03567694|CT133|ct133
4648167|NCT03567655|medroxyprogestrone acetate|medroxyprogestrone acetate
4648168|NCT03567642|Osimertinib|osimertinib
4648169|NCT03567642|Platinum|platinum
4648170|NCT03567642|Etoposide|etoposide
4648171|NCT03567642|EGFR Mutant|egfr mutant
4648172|NCT03567642|18-211|18-211
4648173|NCT03567629|Irinotecan|irinotecan
4648174|NCT03567629|Oxaliplatin|oxaliplatin
4648175|NCT03567629|refractory|refractory
4648176|NCT03567629|mCRC|mcrc
4648177|NCT03567616|Cancer|cancer
4648178|NCT03567616|Multiple Myeloma (MM)|multiple myeloma (mm)
4648179|NCT03567616|Relapsed or Refractory (R/R)|relapsed or refractory (r/r)
4648180|NCT03567616|venetoclax|venetoclax
4648181|NCT03567616|pomalidomide|pomalidomide
4648182|NCT03567616|dexamethasone|dexamethasone
4648183|NCT03567590|Cluster Headache, pulsed radiofrequency|cluster headache, pulsed radiofrequency
4648387|NCT03565939|MAYO|mayo
4648184|NCT03567564|abdominal muscles|abdominal muscles
4648185|NCT03567564|spontaneous breathing trial|spontaneous breathing trial
4648186|NCT03567564|critically ill patients|critically ill patients
4648187|NCT03567551|Preeclampsia|preeclampsia
4648188|NCT03567551|Pregnancy|pregnancy
4648189|NCT03567551|Complications|complications
4648190|NCT03567551|Eclampsia|eclampsia
4648191|NCT03567551|Aquaporin|aquaporin
4648192|NCT03567551|Aquaporin 4|aquaporin 4
4648193|NCT03567538|Thoracic surgery|thoracic surgery
4648194|NCT03567538|Lung surgery|lung surgery
4648195|NCT03567538|Epidemiologic Methods|epidemiologic methods
4648196|NCT03567499|Pro-arrhythmic|pro-arrhythmic
4648197|NCT03567499|Holter ECG|holter ecg
4648198|NCT03567499|SAP|sap
4648199|NCT03567499|Cardiac telemetry|cardiac telemetry
4648200|NCT03567499|Benign arrhythmic|benign arrhythmic
4648201|NCT03567447|Parkinsons Disease|parkinsons disease
4648202|NCT03567447|PD|pd
4648203|NCT03567447|Patient Falls|patient falls
4648204|NCT03567447|Neurogenic Orthostatic Hypotension|neurogenic orthostatic hypotension
4648205|NCT03567421|stone disease|stone disease
4648206|NCT03567421|ureteral stent|ureteral stent
4648207|NCT03567421|stenting|stenting
4648208|NCT03567421|ureteroscopy treatment|ureteroscopy treatment
4648209|NCT03567421|stent placement|stent placement
4648210|NCT03567421|postoperative ureteral stenting|postoperative ureteral stenting
4648211|NCT03567421|Société Internationale d'Urologie|société internationale d'urologie
4648212|NCT03567421|uCARE|ucare
4648213|NCT03567369|Third molar|third molar
4648214|NCT03567369|Surgery|surgery
4648215|NCT03567369|Swelling|swelling
4648216|NCT03567343|sleep|sleep
4648217|NCT03567317|CPAP|cpap
4648218|NCT03567317|Weight Gain|weight gain
4648219|NCT03567317|obstructive sleep apnea|obstructive sleep apnea
4648220|NCT03567304|HIV|hiv
4648221|NCT03567304|Neurocognitive disorder|neurocognitive disorder
4648222|NCT03567304|Efavirenz|efavirenz
4648223|NCT03567304|Rilpivirine|rilpivirine
4648224|NCT03567291|adolescents|adolescents
4648225|NCT03567291|children|children
4648226|NCT03567278|Severe Symptomatic Aortic Valve Stenosis|severe symptomatic aortic valve stenosis
4648227|NCT03567252|Appalachia|appalachia
4648228|NCT03567252|Exercise|exercise
4648229|NCT03567239|Rehabilitation Engineering|rehabilitation engineering
4648230|NCT03567239|Adaptive Devices|adaptive devices
4648231|NCT03567239|Assistive Technology|assistive technology
4648232|NCT03567213|Tetraplegia|tetraplegia
4648233|NCT03567213|ALS|als
4648234|NCT03567213|Locked-in Syndrome|locked-in syndrome
4648235|NCT03567213|Brainstem stroke|brainstem stroke
4648236|NCT03567213|Brain Computer Interface|brain computer interface
4648237|NCT03567213|Rehabilitation|rehabilitation
4648238|NCT03567213|Stroke|stroke
4648239|NCT03567213|Hopkins|hopkins
4648240|NCT03567187|Cryoneurolysis|cryoneurolysis
4648241|NCT03567187|iovera|iovera
4648242|NCT03567187|Superficial nerve treatment|superficial nerve treatment
4648243|NCT03567174|hepatitis C|hepatitis c
4648244|NCT03567148|Graft|graft
4648245|NCT03567148|Pain|pain
4648246|NCT03567148|Palate|palate
4648247|NCT03567148|Wound healing|wound healing
4648248|NCT03567135|Temozolomide|temozolomide
4648249|NCT03567135|Apatinib|apatinib
4648250|NCT03567135|Radiotherapy|radiotherapy
4648251|NCT03567122|Cranio-cervical|cranio-cervical
4648252|NCT03567122|Motor Control|motor control
4648253|NCT03567122|Deep Flexor muscles|deep flexor muscles
4648254|NCT03567096|Cardiac resynchronization therapy|cardiac resynchronization therapy
4648255|NCT03567096|MultiPoint Pacing|multipoint pacing
4648256|NCT03567083|Refugees|refugees
4648257|NCT03567083|Mental Health Problems|mental health problems
4648258|NCT03567031|Pediatric Anesthesia|pediatric anesthesia
4648259|NCT03567031|Near-Infrared Spectroscopy|near-infrared spectroscopy
4648260|NCT03567031|End-Tidal CO2|end-tidal co2
4648261|NCT03567031|Cerebral Blood Flow|cerebral blood flow
4648262|NCT03566966|hepatitis C virus infection|hepatitis c virus infection
4648263|NCT03566966|non-organ-specific antibodies|non-organ-specific antibodies
4648264|NCT03566966|prognostic value|prognostic value
4648265|NCT03566966|sustained virological response|sustained virological response
4648266|NCT03566953|Dental Decay|dental decay
4648267|NCT03566927|Arteriovenous Fistula|arteriovenous fistula
4648268|NCT03566927|Vascular Fistula|vascular fistula
4648269|NCT03566927|Scoring|scoring
4648270|NCT03566927|Fistula|fistula
4648271|NCT03566927|Cardiovascular Disease|cardiovascular disease
4648272|NCT03566901|Balance, Gait, Rehabilitation, Stroke, Robotics, Postural|balance, gait, rehabilitation, stroke, robotics, postural
4648273|NCT03566875|TKA robot assisted with the Stryker's MAKO™ system|tka robot assisted with the stryker's mako™ system
4648274|NCT03566875|surgery precision|surgery precision
4648275|NCT03566849|Volleyball|volleyball
4648276|NCT03566849|Shoulder impingement|shoulder impingement
4648277|NCT03566849|Scapular dyskinesis|scapular dyskinesis
4648278|NCT03566849|Kinetic chain|kinetic chain
4648279|NCT03566836|Smart Watch|smart watch
4648280|NCT03566836|Garmin|garmin
4648281|NCT03566836|Wearable|wearable
4648282|NCT03566836|Cardioversion|cardioversion
4648283|NCT03566810|Diabetes Mellitus|diabetes mellitus
4648284|NCT03566810|Glucophage Extended Release (GXR)|glucophage extended release (gxr)
4648285|NCT03566810|Bioequivalence Study|bioequivalence study
4648286|NCT03566784|inguinal hernia repair|inguinal hernia repair
4648287|NCT03566784|electrocoagulation|electrocoagulation
4648288|NCT03566784|postoperative pain|postoperative pain
4648289|NCT03566784|thermal injury|thermal injury
4648290|NCT03566784|neuralgia|neuralgia
4648291|NCT03566771|Mobile Health|mobile health
4648292|NCT03566771|Self-Monitoring|self-monitoring
4648293|NCT03566771|Behavioural Treatment|behavioural treatment
4648294|NCT03566732|questionnaire survey|questionnaire survey
4648295|NCT03566732|care for dying patients|care for dying patients
4648296|NCT03566719|Prevention|prevention
4648297|NCT03566719|Active Ageing|active ageing
4648298|NCT03566719|Fall|fall
4648299|NCT03566719|Fall Risk|fall risk
4648300|NCT03566719|Exercise Programs|exercise programs
4648301|NCT03566667|Beta-blockers|beta-blockers
4648302|NCT03566654|remote ischemic conditioning|remote ischemic conditioning
4648303|NCT03566628|Cerebral Angiography|cerebral angiography
4648304|NCT03566628|Shivering|shivering
4648305|NCT03566628|Anaesthesia|anaesthesia
4648306|NCT03566628|Warmed solutions|warmed solutions
4648307|NCT03566615|colonoscopy|colonoscopy
4648308|NCT03566615|adenoma detection rate|adenoma detection rate
4648309|NCT03566615|caps|caps
4648310|NCT03566563|Community Screening|community screening
4648311|NCT03566563|Halfway house|halfway house
4648312|NCT03566563|People who inject drugs|people who inject drugs
4648313|NCT03566563|Substance users|substance users
4648314|NCT03566563|Released prisoners|released prisoners
4648315|NCT03566511|diabetes|diabetes
4648316|NCT03566511|type 2 diabetes|type 2 diabetes
4648317|NCT03566511|insulin resistance|insulin resistance
4648318|NCT03566511|diazoxide|diazoxide
4648319|NCT03566511|MRI|mri
4648320|NCT03566459|Opioid Use Disorder (OUD)|opioid use disorder (oud)
4648321|NCT03566459|Medication Assisted Treatment (MAT)|medication assisted treatment (mat)
4648322|NCT03566459|Telemedicine|telemedicine
4648323|NCT03566459|Veteran|veteran
4648324|NCT03566446|CALR mutation|calr mutation
4648325|NCT03566381|Wearable sensor, sweat sensor|wearable sensor, sweat sensor
4648326|NCT03566368|Cardiac Dysfunction|cardiac dysfunction
4648327|NCT03566368|Traumatic Brain Injury|traumatic brain injury
4648328|NCT03566355|Lung Metastasis, Curative Proton Beam Therapy|lung metastasis, curative proton beam therapy
4648329|NCT03566329|craniotomy- Emergence- hypertension|craniotomy- emergence- hypertension
4648330|NCT03566303|Valve Heart Disease|valve heart disease
4648331|NCT03566303|Rivaroxaban|rivaroxaban
4648332|NCT03566303|Warfarin|warfarin
4648333|NCT03566251|Multiple Sclerosis|multiple sclerosis
4648334|NCT03566251|Balance|balance
4648335|NCT03566251|Core Stability|core stability
4648336|NCT03566251|Proprioception|proprioception
4648337|NCT03566251|Functional Mobility|functional mobility
4648338|NCT03566238|Pediatric|pediatric
4648339|NCT03566238|Cholestasis|cholestasis
4648340|NCT03566212|Anxiety|anxiety
4648341|NCT03566212|Camouflaged syringe|camouflaged syringe
4648342|NCT03566212|Conventional syringe|conventional syringe
4648343|NCT03566186|Photobiomodulation|photobiomodulation
4648344|NCT03566186|Autonomic nervous system|autonomic nervous system
4648345|NCT03566186|Heart rate variability|heart rate variability
4648346|NCT03566186|Recovery of function|recovery of function
4648347|NCT03566186|Super-pulsed laser|super-pulsed laser
4648348|NCT03566186|Led light|led light
4648349|NCT03566095|Rural|rural
4648350|NCT03566095|Food Policy Councils|food policy councils
4648351|NCT03566095|Food Pantry|food pantry
4648352|NCT03566095|Community Coaching|community coaching
4648353|NCT03566069|Oxytocin|oxytocin
4648354|NCT03566069|Psychotherapy|psychotherapy
4648355|NCT03566069|Depression|depression
4648356|NCT03566069|Anxiety|anxiety
4648357|NCT03566069|Therapeutic working Alliance|therapeutic working alliance
4648358|NCT03566043|MPS II|mps ii
4648359|NCT03566043|gene therapy|gene therapy
4648360|NCT03566043|Hunter|hunter
4648361|NCT03566030|Hepatitis B|hepatitis b
4648362|NCT03566030|Tenofovir Disoproxil Fumarate|tenofovir disoproxil fumarate
4648363|NCT03566030|Tenofovir Alafenamide|tenofovir alafenamide
4648364|NCT03566030|Switch|switch
4648365|NCT03566017|Glomerular filtration rate|glomerular filtration rate
4648366|NCT03566017|Proteinuria|proteinuria
4648367|NCT03566017|PRX-102|prx-102
4648368|NCT03566017|pegunigalsidase alfa|pegunigalsidase alfa
4648369|NCT03566017|Fabry disease|fabry disease
4648370|NCT03565991|BRCA, ATM|brca, atm
4648371|NCT03565965|Randomized clinical trial|randomized clinical trial
4648372|NCT03565965|Parkinson's disease|parkinson's disease
4648373|NCT03565965|Gait disorders|gait disorders
4648374|NCT03565965|Locomotor imagery training|locomotor imagery training
4648375|NCT03565952|Menopausal women|menopausal women
4648376|NCT03565952|Insomnia|insomnia
4648377|NCT03565939|Ulcerative Colitis|ulcerative colitis
4648378|NCT03565939|Trichuris suis|trichuris suis
4648379|NCT03565939|Trichuris suis ova|trichuris suis ova
4648380|NCT03565939|Probiotic|probiotic
4648381|NCT03565939|IBD|ibd
4648382|NCT03565939|Inflammatory bowel diseases|inflammatory bowel diseases
4648383|NCT03565939|Anti inflammatory|anti inflammatory
4648384|NCT03565939|Hygiene Hypothesis|hygiene hypothesis
4648385|NCT03565939|Helminths|helminths
4648386|NCT03565939|Microbiome|microbiome
4648388|NCT03565926|low back pain|low back pain
4648389|NCT03565926|manual therapy|manual therapy
4648390|NCT03565926|hypopressive therapeutic exercises|hypopressive therapeutic exercises
4648391|NCT03565848|Laparoscopy|laparoscopy
4648392|NCT03565848|Colorectal resection|colorectal resection
4648393|NCT03565848|Deep infiltrating endometriosis|deep infiltrating endometriosis
4648394|NCT03565848|Constipation|constipation
4648395|NCT03565835|abiraterone|abiraterone
4648396|NCT03565835|prostate cancer|prostate cancer
4648397|NCT03565835|androgen deprivation therapy|androgen deprivation therapy
4648398|NCT03565822|Oesophageal Atresia|oesophageal atresia
4648399|NCT03565822|Congenital Diaphragmatic Hernia|congenital diaphragmatic hernia
4648400|NCT03565822|Short Bowel Syndrome|short bowel syndrome
4648401|NCT03565809|Diabetes mellitus|diabetes mellitus
4648402|NCT03565809|Alzheimer Disease or related disorders|alzheimer disease or related disorders
4648403|NCT03565796|Smoking cessation|smoking cessation
4648404|NCT03565796|Quit to Win|quit to win
4648405|NCT03565796|Brief intervention|brief intervention
4648406|NCT03565796|Financial incentive|financial incentive
4648407|NCT03565796|Active referral|active referral
4648408|NCT03565796|AWARD model|award model
4648409|NCT03565770|child|child
4648410|NCT03565770|coaching|coaching
4648411|NCT03565770|telemedicine|telemedicine
4648412|NCT03565770|nurses|nurses
4648413|NCT03565770|individual follow-up|individual follow-up
4648414|NCT03565757|Stress Management|stress management
4648415|NCT03565757|Resilience|resilience
4648416|NCT03565744|obesity|obesity
4648417|NCT03565744|adolescents|adolescents
4648418|NCT03565744|school-based|school-based
4648419|NCT03565744|weight management|weight management
4648420|NCT03565744|wellness|wellness
4648421|NCT03565692|Microbiome|microbiome
4648422|NCT03565692|Microbiota|microbiota
4648423|NCT03565692|Mycobiota|mycobiota
4648424|NCT03565692|Mycobiome|mycobiome
4648425|NCT03565692|Deep-Sequencing|deep-sequencing
4648426|NCT03565692|Cystic Fibrosis|cystic fibrosis
4648427|NCT03565666|bionic pancreas|bionic pancreas
4648428|NCT03565666|closed loop|closed loop
4648429|NCT03565666|insulin|insulin
4648430|NCT03565666|continuous glucose monitor|continuous glucose monitor
4648431|NCT03565640|Buttock pain|buttock pain
4648432|NCT03565640|Thigh pain|thigh pain
4648433|NCT03565640|Sacrospinous ligament fixation|sacrospinous ligament fixation
4648434|NCT03565627|mHealth|mhealth
4648435|NCT03565627|digital health|digital health
4648436|NCT03565627|behavior change|behavior change
4648437|NCT03565627|physical activity|physical activity
4648438|NCT03565627|mobile apps|mobile apps
4648439|NCT03565614|reablement|reablement
4648440|NCT03565614|older people|older people
4648441|NCT03565614|personal care services|personal care services
4648442|NCT03565614|rehabilitation|rehabilitation
4648443|NCT03565614|multimorbidity|multimorbidity
4648444|NCT03565614|disability|disability
4648445|NCT03565588|Voluntary medical male circumcision|voluntary medical male circumcision
4648446|NCT03565588|HIV prevention|hiv prevention
4648447|NCT03565588|Risk perception|risk perception
4648448|NCT03565575|Pre-Exposure Prophylaxis (PrEP) for HIV|pre-exposure prophylaxis (prep) for hiv
4648449|NCT03565575|Risk perception|risk perception
4648450|NCT03565575|HIV|hiv
4648451|NCT03565562|Health promotion|health promotion
4648452|NCT03565562|Local authorities involvement|local authorities involvement
4648453|NCT03565562|Suicide and attempted suicide|suicide and attempted suicide
4648454|NCT03565562|Primary prevention|primary prevention
4648455|NCT03565562|Psychological Distress|psychological distress
4648456|NCT03565549|Brain|brain
4648457|NCT03565549|Trauma|trauma
4648458|NCT03565549|Medical education|medical education
4648459|NCT03565549|Emergency department|emergency department
4648460|NCT03565536|Nexavar|nexavar
4648461|NCT03565536|Anaplastic Thyroid Cancer|anaplastic thyroid cancer
4648462|NCT03565536|Neoadjuvant Treatment|neoadjuvant treatment
4648463|NCT03565510|High-protein diet|high-protein diet
4648464|NCT03565510|Energy metabolism|energy metabolism
4648465|NCT03565484|Antimicrobial Susceptibility Testing|antimicrobial susceptibility testing
4648466|NCT03565484|Rescue Therapy|rescue therapy
4648467|NCT03565471|Atrial Septal Defect|atrial septal defect
4648468|NCT03565471|Exercise Capacity|exercise capacity
4648469|NCT03565471|Pulmonary Hypertension|pulmonary hypertension
4648470|NCT03565471|Heart Rate Variability|heart rate variability
4648471|NCT03565471|Congenital Heart Disease|congenital heart disease
4648472|NCT03565445|NSCLC|nsclc
4648473|NCT03565445|Tumors|tumors
4648474|NCT03565445|squamous cell carcinoma of the head and neck (SCCHN)|squamous cell carcinoma of the head and neck (scchn)
4648475|NCT03565445|Oncology|oncology
4648476|NCT03565445|breast cancer|breast cancer
4648477|NCT03565445|ASP1948|asp1948
4648478|NCT03565445|mCRPC|mcrpc
4648479|NCT03565445|melanoma|melanoma
4648480|NCT03565445|ovarian cancer|ovarian cancer
4648481|NCT03565445|Locally advanced or metastatic solid tumor malignancies|locally advanced or metastatic solid tumor malignancies
4648482|NCT03565445|Advanced solid tumors|advanced solid tumors
4648483|NCT03565432|work disability|work disability
4648484|NCT03565432|quality of life|quality of life
4648485|NCT03565432|psychosocial distress|psychosocial distress
4648486|NCT03565393|Tolerability|tolerability
4648487|NCT03565393|Acceptability|acceptability
4648488|NCT03565393|Fibersol-2|fibersol-2
4648489|NCT03565393|Children|children
4648490|NCT03565380|Tai Chi|tai chi
4648491|NCT03565380|Fall|fall
4648492|NCT03565380|Balance|balance
4648493|NCT03565380|Post operative|post operative
4648494|NCT03565380|Elderly|elderly
4648495|NCT03565354|Patient blood management|patient blood management
4648496|NCT03565328|Mitochondrial bioenergetic dysfunction|mitochondrial bioenergetic dysfunction
4648497|NCT03565328|Mitochondrial oxidative phosphorylation in sceletal muscles|mitochondrial oxidative phosphorylation in sceletal muscles
4648498|NCT03565328|Hyperacetylation of mitochondrial bioenergetic enzymes|hyperacetylation of mitochondrial bioenergetic enzymes
4648499|NCT03565328|NAD+ dependent sirtuin enzymes|nad+ dependent sirtuin enzymes
4648500|NCT03565328|NAD+/NADH ratio|nad+/nadh ratio
4648501|NCT03565315|HIV Prevention|hiv prevention
4648502|NCT03565315|Broadly Neutralizing Monoclonal Antibodies|broadly neutralizing monoclonal antibodies
4648503|NCT03565315|First in Human Study|first in human study
4648504|NCT03565315|Anti-Drug Antibody Response to 10E8VLS or VRC07-523LS|anti-drug antibody response to 10e8vls or vrc07-523ls
4648505|NCT03565302|Proteome|proteome
4648506|NCT03565302|VO2max|vo2max
4648507|NCT03565302|Muscle function|muscle function
4648508|NCT03565302|Exercise performance|exercise performance
4648509|NCT03565302|Skeletal muscle|skeletal muscle
4648510|NCT03565302|Doping|doping
4648511|NCT03565302|Anti-Doping|anti-doping
4648512|NCT03565302|Enantiomeric analysis|enantiomeric analysis
4648513|NCT03565276|Post partum hemorrhage|post partum hemorrhage
4648514|NCT03565276|Tranexamic acid|tranexamic acid
4648515|NCT03565276|TXA|txa
4648516|NCT03565276|Dose-finding|dose-finding
4648517|NCT03565276|Prevention|prevention
4648518|NCT03565250|Attention Deficit Disorder with Hyperactivity|attention deficit disorder with hyperactivity
4648519|NCT03565250|Self concept|self concept
4648520|NCT03565250|Child|child
4648521|NCT03565250|Neuropsychology|neuropsychology
4648522|NCT03565224|Cervical vertebrae|cervical vertebrae
4648523|NCT03565224|Postoperative complications|postoperative complications
4648524|NCT03565224|Radiography|radiography
4648525|NCT03565224|Spinal fusion|spinal fusion
4648526|NCT03565224|Coating|coating
4648527|NCT03565211|Progesterone vaginal ring (PVR)|progesterone vaginal ring (pvr)
4648528|NCT03565211|Vaginal progesterone ring|vaginal progesterone ring
4648529|NCT03565211|Assisted reproductive technology (ART)|assisted reproductive technology (art)
4648530|NCT03565211|Infertility|infertility
4648531|NCT03565172|cerebral palsy|cerebral palsy
4648532|NCT03565172|stretching|stretching
4648533|NCT03565172|isokinetic dynamometer|isokinetic dynamometer
4648534|NCT03565172|ultrasound|ultrasound
4648535|NCT03565172|ankle|ankle
4648536|NCT03565172|children|children
4648537|NCT03565107|Epigenetic|epigenetic
4648538|NCT03565107|Female age|female age
4648539|NCT03565107|Gene regulation|gene regulation
4648540|NCT03565107|Methylation pattern|methylation pattern
4648541|NCT03565081|Prader-Willi Syndrome|prader-willi syndrome
4648542|NCT03565081|Resistance Training|resistance training
4648543|NCT03565081|Body Composition|body composition
4648544|NCT03565042|Arthritis, Psoriatic|arthritis, psoriatic
4648545|NCT03565042|Mechanism of Action|mechanism of action
4648546|NCT03565042|Ustekinumab|ustekinumab
4648547|NCT03565042|anti-p40|anti-p40
4648548|NCT03565042|anti-IL23/Il12 p40|anti-il23/il12 p40
4648549|NCT03565029|rectal cancer|rectal cancer
4648550|NCT03565029|neoadjuvant|neoadjuvant
4648551|NCT03565029|non operative management|non operative management
4648552|NCT03565016|Alcohol use disorders|alcohol use disorders
4648553|NCT03565016|agitation|agitation
4648554|NCT03565016|intensive care unit|intensive care unit
4648555|NCT03565016|restlessness|restlessness
4648556|NCT03565016|alcohol withdrawal syndrome|alcohol withdrawal syndrome
4648557|NCT03565016|alcohol-dependence|alcohol-dependence
4648558|NCT03565016|heavy drinking|heavy drinking
4648559|NCT03564977|CAR-T|car-t
4648560|NCT03564977|minimal residual disease|minimal residual disease
4648561|NCT03564977|B cell maliganacy|b cell maliganacy
4648562|NCT03564964|SUVN-502|suvn-502
4648563|NCT03564964|Expanded Access|expanded access
4648564|NCT03564938|metastatic colorectal cancer|metastatic colorectal cancer
4648565|NCT03564938|mCRC|mcrc
4648566|NCT03564925|Atrial Fibrillation|atrial fibrillation
4648567|NCT03564925|CryoAblation|cryoablation
4648568|NCT03564925|pulmonary vein isolation|pulmonary vein isolation
4648569|NCT03564925|wide area circumferential ablation|wide area circumferential ablation
4648570|NCT03564925|contact force|contact force
4648571|NCT03564899|Breast cancer|breast cancer
4648572|NCT03564899|Survivorship|survivorship
4648573|NCT03564899|Physical activity intervention|physical activity intervention
4648574|NCT03564899|Activity trackers|activity trackers
4648575|NCT03564899|Sedentary time|sedentary time
4648576|NCT03564873|Omacetaxine|omacetaxine
4648577|NCT03564873|Azacitidine|azacitidine
4648578|NCT03564873|Previously Untreated|previously untreated
4648579|NCT03564873|Phase I/II|phase i/ii
4648580|NCT03564873|Dose Escalation|dose escalation
4648581|NCT03564873|Maximum Tolerated Dose|maximum tolerated dose
4648582|NCT03564847|Learning Through Play Plus|learning through play plus
4648583|NCT03564847|Cognitive Behavior Therapy|cognitive behavior therapy
4648584|NCT03564847|Parenting Intervention|parenting intervention
4648585|NCT03564847|Low and middle-income country|low and middle-income country
4648586|NCT03564834|Elderly patients|elderly patients
4648587|NCT03564834|Open gastrectomy|open gastrectomy
4648588|NCT03564834|Laparoscopic gastrectomy|laparoscopic gastrectomy
4648589|NCT03564821|myeloid neoplasms|myeloid neoplasms
4648590|NCT03564808|Contour defects, Pigmentation, Enriched fat grafting|contour defects, pigmentation, enriched fat grafting
4648591|NCT03564795|Wound Dressing|wound dressing
4648592|NCT03564795|Keratin|keratin
4648593|NCT03564795|Hydrogel|hydrogel
4648594|NCT03564795|Burn Dressing|burn dressing
4648595|NCT03564782|PVSRIPO|pvsripo
4648596|NCT03564782|Triple Negative Breast Cancer|triple negative breast cancer
4648597|NCT03564769|screening|screening
4648598|NCT03564756|Anemia|anemia
4648599|NCT03564756|Pregnancy|pregnancy
4648600|NCT03564756|Iron|iron
4648601|NCT03564756|Vitamin C|vitamin c
4648602|NCT03564743|Spondyloarthritis|spondyloarthritis
4648603|NCT03564743|ASAS criteria|asas criteria
4648604|NCT03564743|Diagnosis criteria|diagnosis criteria
4648605|NCT03564743|Classification criteria|classification criteria
4648606|NCT03564730|Bilateral, staged, simultaneous|bilateral, staged, simultaneous
4648607|NCT03564691|PD1|pd1
4648608|NCT03564691|PD-1|pd-1
4648609|NCT03564691|PDL1|pdl1
4648610|NCT03564691|PD-L1|pd-l1
4648611|NCT03564678|Acute lymphoblastic leukemia|acute lymphoblastic leukemia
4648612|NCT03564678|ALL|all
4648613|NCT03564678|Levocarnitine|levocarnitine
4648614|NCT03564678|Vitamin B complex|vitamin b complex
4648615|NCT03564678|Hyperbilirubinemia|hyperbilirubinemia
4648616|NCT03564613|HIV|hiv
4648617|NCT03564613|Dolutegravir|dolutegravir
4648618|NCT03564613|Europe|europe
4648619|NCT03564613|NEAT ID|neat id
4648620|NCT03564613|pregnancy|pregnancy
4648621|NCT03564613|Safety|safety
4648622|NCT03564613|Antiretroviral|antiretroviral
4648623|NCT03564600|low back pain|low back pain
4648624|NCT03564587|Cancer Survivors|cancer survivors
4648625|NCT03564587|Adolescent|adolescent
4648626|NCT03564587|Achieving Wellness After Kancer in Early Life|achieving wellness after kancer in early life
4648627|NCT03564587|AWAKE|awake
4648628|NCT03564587|Health-Promoting Behaviors|health-promoting behaviors
4648629|NCT03564561|glycogen storage disease type II, adult|glycogen storage disease type ii, adult
4648630|NCT03564561|Pompe disease|pompe disease
4648631|NCT03564561|clinical evolution|clinical evolution
4648632|NCT03564561|molecular evolution|molecular evolution
4648633|NCT03564561|follow-up|follow-up
4648634|NCT03564561|c.-32-13T>G mutation|c.-32-13t>g mutation
4648635|NCT03564561|antisense oligonucleotide treatment|antisense oligonucleotide treatment
4648636|NCT03564561|in vitro|in vitro
4648637|NCT03564535|Adult|adult
4648638|NCT03564535|Inguinal hernia|inguinal hernia
4648639|NCT03564535|Inflammatory|inflammatory
4648640|NCT03564535|Surgical Mesh|surgical mesh
4648641|NCT03564535|Laparoscopy/Methods|laparoscopy/methods
4648642|NCT03564535|Postoperative pain|postoperative pain
4648643|NCT03564535|Recurrence|recurrence
4648644|NCT03564535|Randomized Controlled Trials|randomized controlled trials
4648645|NCT03564535|Double-Blind Method|double-blind method
4648646|NCT03564535|Pain|pain
4648647|NCT03564535|Chronic pain|chronic pain
4648648|NCT03564535|Seroma|seroma
4648649|NCT03564535|Total extraperitoneal repair|total extraperitoneal repair
4648650|NCT03564535|Tacker|tacker
4648651|NCT03564535|Mesh fixation|mesh fixation
4648652|NCT03564535|Self gripping|self gripping
4648653|NCT03564509|Human Chorionic Gonadotropin (hCG)|human chorionic gonadotropin (hcg)
4648654|NCT03564509|Recombinant Human Chorionic Gonadotropin (rhCG)|recombinant human chorionic gonadotropin (rhcg)
4648655|NCT03564509|Controlled Ovarian Stimulation (COS)|controlled ovarian stimulation (cos)
4648656|NCT03564509|Assisted Reproductive Technologies (ART)|assisted reproductive technologies (art)
4648657|NCT03564496|Anodal transcranial stimulation (tDCS)|anodal transcranial stimulation (tdcs)
4648658|NCT03564470|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
4648659|NCT03564470|Ph-like|ph-like
4648660|NCT03564470|Tyrosine Kinase Inhibitor|tyrosine kinase inhibitor
4648661|NCT03564470|Histone Deacetylase Inhibitor|histone deacetylase inhibitor
4648662|NCT03564444|Bivalent.|bivalent.
4648663|NCT03564444|Influenza.|influenza.
4648664|NCT03564444|FluMist Quadrivalent.|flumist quadrivalent.
4648665|NCT03564444|Vaccine Prevention in Healthy Adults.|vaccine prevention in healthy adults.
4648666|NCT03564353|transcranial Direct Current Stimulation (tDCS)|transcranial direct current stimulation (tdcs)
4648667|NCT03564353|memory|memory
4648668|NCT03564314|Acute kidney injury|acute kidney injury
4648669|NCT03564314|Major surgery|major surgery
4648670|NCT03564314|Clinical decision support|clinical decision support
4648671|NCT03564301|Peri-implantitis|peri-implantitis
4648672|NCT03564301|antibiotics|antibiotics
4648673|NCT03564301|Metronidazole|metronidazole
4648674|NCT03564301|non- surgical treatment|non- surgical treatment
4648675|NCT03564275|Radiation Therapy|radiation therapy
4648676|NCT03564275|Proton Therapy|proton therapy
4648677|NCT03564223|Adolescent|adolescent
4648678|NCT03564223|Parental concerns|parental concerns
4648679|NCT03564223|Child Health|child health
4648680|NCT03564223|Paediatrician Concerns|paediatrician concerns
4648681|NCT03564210|screen time|screen time
4648682|NCT03564197|EGFR WT|egfr wt
4648683|NCT03564197|negative EML4-ALK fusion|negative eml4-alk fusion
4648684|NCT03564197|eligible for nivolumab treatment|eligible for nivolumab treatment
4648685|NCT03564184|Parent-infant bonding|parent-infant bonding
4648686|NCT03564184|Music therapy|music therapy
4648687|NCT03564132|Yigansan|yigansan
4648688|NCT03564132|YGTSS|ygtss
4648689|NCT03564119|papulopustular rosacea|papulopustular rosacea
4648690|NCT03564106|chronic sacroilitis,radiofrequancy,intraarticular steroids injection|chronic sacroilitis,radiofrequancy,intraarticular steroids injection
4648691|NCT03564093|pediatrics|pediatrics
4648692|NCT03564093|sedation|sedation
4648693|NCT03564093|emergency room sedation|emergency room sedation
4648694|NCT03564093|intranasal sedation|intranasal sedation
4648695|NCT03564093|dexmedetomidine|dexmedetomidine
4648696|NCT03564093|intranasal dexmedetomidine|intranasal dexmedetomidine
4648697|NCT03564093|children|children
4648698|NCT03564093|pediatric|pediatric
4648699|NCT03564093|pediatric sedation|pediatric sedation
4648700|NCT03564080|exercise rehabilitation|exercise rehabilitation
4648701|NCT03564080|supervised exercise programmes|supervised exercise programmes
4648702|NCT03564067|TRD|trd
4648703|NCT03564067|tDCS|tdcs
4648704|NCT03564067|cCBT|ccbt
4648705|NCT03564067|Home-based tDCS-cCBT|home-based tdcs-ccbt
4648706|NCT03564054|non small cell lung cancer|non small cell lung cancer
4648707|NCT03564054|photodynamic therapy|photodynamic therapy
4648708|NCT03564054|argon plasma coagulation|argon plasma coagulation
4648709|NCT03564054|endobronchial obstruction|endobronchial obstruction
4648710|NCT03564041|depression|depression
4648711|NCT03564041|late-life|late-life
4648712|NCT03564041|executive functioning|executive functioning
4648713|NCT03564041|sahaj samadhi|sahaj samadhi
4648714|NCT03564041|meditation|meditation
4648715|NCT03564041|treatment-resistant|treatment-resistant
4648716|NCT03564028|COPD|copd
4648717|NCT03564028|daily activity|daily activity
4648718|NCT03564028|stair climbing|stair climbing
4648719|NCT03564028|rehabilitation|rehabilitation
4648720|NCT03563989|Chronic total occlusion|chronic total occlusion
4648721|NCT03563989|Self-expandable stent|self-expandable stent
4648722|NCT03563989|Percutaneous coronary intervention|percutaneous coronary intervention
4648723|NCT03563989|Coronary artery disease|coronary artery disease
4648724|NCT03563976|Early Stage Lung Cancer|early stage lung cancer
4648725|NCT03563872|hypertension|hypertension
4648726|NCT03563872|team-based|team-based
4648727|NCT03563872|guidelines|guidelines
4648728|NCT03563872|implementation|implementation
4648729|NCT03563833|Minimal Flow Anesthesia|minimal flow anesthesia
4648730|NCT03563833|Thiol/disulfide balance|thiol/disulfide balance
4648731|NCT03563833|Tissue oxygen saturation|tissue oxygen saturation
4648732|NCT03563833|hypotensive anesthesia|hypotensive anesthesia
4648733|NCT03563820|Positive Psychology|positive psychology
4648734|NCT03563820|Resilience|resilience
4648735|NCT03563820|Well-Being|well-being
4648736|NCT03563781|ovarian cancer|ovarian cancer
4648737|NCT03563781|laparoscopy|laparoscopy
4648738|NCT03563781|sentinel node|sentinel node
4648739|NCT03563781|lymphadenectomy|lymphadenectomy
4648740|NCT03563768|coronary artery disease|coronary artery disease
4648741|NCT03563768|aortic atherosclerotic disease|aortic atherosclerotic disease
4648742|NCT03563768|one-stop|one-stop
4648743|NCT03563768|endovascular aortic repair|endovascular aortic repair
4648744|NCT03563768|percutaneous coronary intervention|percutaneous coronary intervention
4648745|NCT03563742|Treatment-naive|treatment-naive
4648746|NCT03563742|rilpivirine|rilpivirine
4648747|NCT03563742|India|india
4648748|NCT03563729|Immune therapy|immune therapy
4648749|NCT03563729|checkpoint inhibitor|checkpoint inhibitor
4648750|NCT03563729|pembrolizumab|pembrolizumab
4648751|NCT03563729|ipilimumab|ipilimumab
4648752|NCT03563729|nivolumab|nivolumab
4648753|NCT03563729|steroid|steroid
4648754|NCT03563729|brain metastasis|brain metastasis
4648755|NCT03563703|Catheterization, Peripheral|catheterization, peripheral
4648756|NCT03563703|Ultrasound|ultrasound
4648757|NCT03563703|Near Infrared Light|near infrared light
4648758|NCT03563690|KOA|koa
4648759|NCT03563690|Acupuncture treatment|acupuncture treatment
4648760|NCT03563690|Multi-center RCT|multi-center rct
4648761|NCT03563677|psychosomatic|psychosomatic
4648762|NCT03563677|unclear diagnosis|unclear diagnosis
4648763|NCT03563625|Local anesthetic|local anesthetic
4648764|NCT03563625|Hernioraphy|hernioraphy
4648765|NCT03563625|Wound healing|wound healing
4648766|NCT03563612|one lung ventilation|one lung ventilation
4648767|NCT03563612|continuous positive airway pressure|continuous positive airway pressure
4648768|NCT03563612|differential lung ventilation|differential lung ventilation
4648769|NCT03563586|oral antibiotic|oral antibiotic
4648770|NCT03563586|mechanical bowel preparation|mechanical bowel preparation
4648771|NCT03563586|colorectal cancer|colorectal cancer
4648772|NCT03563586|surgical site infection|surgical site infection
4648773|NCT03563573|Conditions in which lidocaine is ineffective|conditions in which lidocaine is ineffective
4648774|NCT03563560|Newly diagnosed AML|newly diagnosed aml
4648775|NCT03563560|Relapsed/refractory AML|relapsed/refractory aml
4648776|NCT03563560|Alvocidib|alvocidib
4648777|NCT03563547|LDL-Cholesterol|ldl-cholesterol
4648778|NCT03563547|Heterozygous Familial Hypercholesterolemia|heterozygous familial hypercholesterolemia
4648779|NCT03563547|Paediatrics|paediatrics
4648780|NCT03563547|Dietary Treatment|dietary treatment
4648781|NCT03563534|Silver diamine fluoride, dental caries children|silver diamine fluoride, dental caries children
4648782|NCT03563521|severe asthma|severe asthma
4648783|NCT03563521|inflammatory phenotypes|inflammatory phenotypes
4648784|NCT03563521|serum cytokines|serum cytokines
4648785|NCT03563521|eosinophilia|eosinophilia
4648786|NCT03563521|atopy|atopy
4648787|NCT03563521|chronic rhinosinusitis with nasal polyposis|chronic rhinosinusitis with nasal polyposis
4648788|NCT03563508|cone beam computed tomography|cone beam computed tomography
4648789|NCT03563508|maxillary premolars|maxillary premolars
4648790|NCT03563508|root canal anatomy|root canal anatomy
4648791|NCT03563508|root canal morphology|root canal morphology
4648792|NCT03563508|Egyptian population|egyptian population
4648793|NCT03563495|tissue engineering.|tissue engineering.
4648794|NCT03563495|stem cells.|stem cells.
4648795|NCT03563495|autogenous grafts.|autogenous grafts.
4648796|NCT03563456|structured exercise|structured exercise
4648797|NCT03563456|glycemic control|glycemic control
4648798|NCT03563456|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
4648799|NCT03563456|interval training|interval training
4648800|NCT03563456|resistance training|resistance training
4648801|NCT03563456|oxydative stress|oxydative stress
4648802|NCT03563456|physical fitness|physical fitness
4648803|NCT03563443|Bladder Cancer|bladder cancer
4648804|NCT03563443|Genomic imprinting|genomic imprinting
4648805|NCT03563443|Urine biomarker|urine biomarker
4648806|NCT03563443|Diagnosis|diagnosis
4648807|NCT03563443|Surveillance|surveillance
4648808|NCT03563430|foam roller|foam roller
4648809|NCT03563430|electrical stimulation|electrical stimulation
4648810|NCT03563430|low intensity aerobic training|low intensity aerobic training
4648811|NCT03563430|lactate removal|lactate removal
4648812|NCT03563326|Epithelial Cell Adhesion Molecule|epithelial cell adhesion molecule
4648813|NCT03563326|Chimeric Antigen Receptor-modified T cell|chimeric antigen receptor-modified t cell
4648814|NCT03563326|Gastric carcinoma|gastric carcinoma
4648815|NCT03563326|Peritoneal metastasis|peritoneal metastasis
4648816|NCT03563313|Artificial Pancreas (AP)|artificial pancreas (ap)
4648817|NCT03563313|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
4648818|NCT03563313|Insulin Pump|insulin pump
4648819|NCT03563313|Continuous Glucose Monitor (CGM)|continuous glucose monitor (cgm)
4648820|NCT03563313|Closed Loop Control (CLC)|closed loop control (clc)
4648821|NCT03563313|Sensor-Augmented Pump (SAP)|sensor-augmented pump (sap)
4648822|NCT03563274|Hepatocellular Carcinoma,Holmium-166,SIRT,QuiremSpheres|hepatocellular carcinoma,holmium-166,sirt,quiremspheres
4648823|NCT03563261|Older Adults|older adults
4648824|NCT03563261|Collagen supplementation|collagen supplementation
4648825|NCT03563261|Locomotor behaviour|locomotor behaviour
4648826|NCT03563248|Pancreatic Cancer|pancreatic cancer
4648827|NCT03563235|Osteoporosis|osteoporosis
4648828|NCT03563235|kidney deficiency and blood stasis syndrome|kidney deficiency and blood stasis syndrome
4648829|NCT03563235|Xuling Jiangu Granules|xuling jiangu granules
4648830|NCT03563222|Parenteral nutrition|parenteral nutrition
4648831|NCT03563222|Pediatrics|pediatrics
4648832|NCT03563222|Malnutrition|malnutrition
4648833|NCT03563222|Nutritional needs|nutritional needs
4648834|NCT03563209|Elbow spasticity|elbow spasticity
4648835|NCT03563209|Stroke|stroke
4648836|NCT03563183|immunogenicity|immunogenicity
4648837|NCT03563183|Herpes Zoster|herpes zoster
4648838|NCT03563183|efficacy|efficacy
4648839|NCT03563183|safety|safety
4648840|NCT03563183|frailty|frailty
4648841|NCT03563183|Shingles vaccine|shingles vaccine
4648843|NCT03563157|Colorectal Cancer|colorectal cancer
4648844|NCT03563131|Osteoarthritis|osteoarthritis
4648845|NCT03563131|Knee|knee
4648846|NCT03563131|Arthroplasties|arthroplasties
4648847|NCT03563118|Prolidase Activity|prolidase activity
4648848|NCT03563118|Obstructive Sleep-Apnea Syndrome|obstructive sleep-apnea syndrome
4648849|NCT03563105|tissue oxygen saturation|tissue oxygen saturation
4648850|NCT03563092|Complete Inguinal Hernia|complete inguinal hernia
4648851|NCT03563092|Inguinoscrotal Hernia|inguinoscrotal hernia
4648852|NCT03563092|Laparoscopic hernia repair|laparoscopic hernia repair
4648853|NCT03563079|Handling, Musculoskeletal|handling, musculoskeletal
4648854|NCT03563079|Tissue, Subcutaneous|tissue, subcutaneous
4648855|NCT03563079|Myofascial Release|myofascial release
4648856|NCT03563079|Instrument-Mobilized Soft Tissue Mobilization|instrument-mobilized soft tissue mobilization
4648857|NCT03563066|Skin Lesions|skin lesions
4648858|NCT03563066|Benralizumab|benralizumab
4648859|NCT03563066|Eosinophils|eosinophils
4648860|NCT03563066|Intra-dermal challenge|intra-dermal challenge
4648861|NCT03563066|Anti-inflammatory agents|anti-inflammatory agents
4648862|NCT03563066|Physiological Effects of Drugs|physiological effects of drugs
4648863|NCT03563027|Physical activity|physical activity
4648864|NCT03563027|Incentive|incentive
4648865|NCT03563027|Wearable device|wearable device
4648866|NCT03563027|Gamification|gamification
4648867|NCT03563014|Radium-223|radium-223
4648868|NCT03563014|Metastatic castration-resistant prostate cancer|metastatic castration-resistant prostate cancer
4648869|NCT03563014|CRPC|crpc
4648870|NCT03563014|Phase IV|phase iv
4648871|NCT03563001|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
4648872|NCT03563001|asthma-chronic obstructive pulmonary disease overlap|asthma-chronic obstructive pulmonary disease overlap
4648873|NCT03563001|small airway|small airway
4648874|NCT03563001|quality of life|quality of life
4648875|NCT03562962|Functional Analytic Psychotherapy|functional analytic psychotherapy
4648876|NCT03562962|Process-Outcome Psychotherapies|process-outcome psychotherapies
4648877|NCT03562962|Mechanism of change|mechanism of change
4648878|NCT03562962|Interpersonal Functioning|interpersonal functioning
4648879|NCT03562962|Psychological Distress|psychological distress
4648880|NCT03562962|Contingencies of reinforcement|contingencies of reinforcement
4648881|NCT03562936|LSS,DS|lss,ds
4648882|NCT03562897|Dietary supplements|dietary supplements
4648883|NCT03562897|Ocoxin-Viusid|ocoxin-viusid
4648884|NCT03562897|Nutritional supplement|nutritional supplement
4648885|NCT03562897|Ovarian Cancer|ovarian cancer
4648886|NCT03562897|Metastasis|metastasis
4648887|NCT03562871|PD-1|pd-1
4648888|NCT03562871|PD-L1|pd-l1
4648889|NCT03562871|Programmed Cell Death 1|programmed cell death 1
4648890|NCT03562871|Chemotherapy|chemotherapy
4648891|NCT03562871|Pemetrexed|pemetrexed
4648892|NCT03562871|Carboplatin|carboplatin
4648893|NCT03562871|Pembrolizumab|pembrolizumab
4648894|NCT03562871|Immunotherapy|immunotherapy
4648895|NCT03562871|IO102|io102
4648896|NCT03562871|Keytruda|keytruda
4648897|NCT03562832|PARP inhibitor|parp inhibitor
4648898|NCT03562832|Drug Response Prediction (DRP)|drug response prediction (drp)
4648899|NCT03562832|Tankyrase 1/2 inhibitor|tankyrase 1/2 inhibitor
4648900|NCT03562832|mRNA biomarker|mrna biomarker
4648901|NCT03562819|Epidermal Growth Factor Receptor|epidermal growth factor receptor
4648902|NCT03562793|pain|pain
4648903|NCT03562793|healthcare disparities|healthcare disparities
4648904|NCT03562793|communication|communication
4648905|NCT03562767|Culturally-Tailored Cognitive Behavior intervention (CT-CB)|culturally-tailored cognitive behavior intervention (ct-cb)
4648906|NCT03562767|Family Practice|family practice
4648907|NCT03562767|Diabetes|diabetes
4648908|NCT03562728|Transplant|transplant
4648909|NCT03562728|ECMO|ecmo
4648910|NCT03562728|Sarcopenia|sarcopenia
4648911|NCT03562728|Deconditioning|deconditioning
4648912|NCT03562728|Physical therapy|physical therapy
4648913|NCT03562715|microRNAs|micrornas
4648914|NCT03562715|exosomes|exosomes
4648915|NCT03562715|preeclampsia|preeclampsia
4648916|NCT03562715|mesenchymal stem cells|mesenchymal stem cells
4648917|NCT03562702|vomiting|vomiting
4648918|NCT03562702|diarrhea|diarrhea
4648919|NCT03562689|Sepsis|sepsis
4648920|NCT03562689|Encephalopathy|encephalopathy
4648921|NCT03562689|Delirium|delirium
4648922|NCT03562689|ICU|icu
4648923|NCT03562689|EEG|eeg
4648924|NCT03562689|MRI|mri
4648925|NCT03562689|Cognitive tests|cognitive tests
4648926|NCT03562663|robotics|robotics
4648927|NCT03562663|transcranial direct current stimulation|transcranial direct current stimulation
4648928|NCT03562663|neurorehabilitation|neurorehabilitation
4648929|NCT03562663|transcranial magnetic stimulation|transcranial magnetic stimulation
4648930|NCT03562637|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
4648931|NCT03562637|Adjuvant chemotherapy|adjuvant chemotherapy
4648932|NCT03562637|TNBC|tnbc
4648933|NCT03562611|postoperative pain|postoperative pain
4648934|NCT03562611|general anesthesia|general anesthesia
4648935|NCT03562611|postoperative discomfort|postoperative discomfort
4648936|NCT03562585|Chronic hepatitis B|chronic hepatitis b
4648937|NCT03562585|Alanine Aminotransferase|alanine aminotransferase
4648938|NCT03562585|Aspartate Aminotransferase|aspartate aminotransferase
4648939|NCT03562559|Total Knee Arthroplasty|total knee arthroplasty
4648940|NCT03562559|Adductor Canal Block|adductor canal block
4648941|NCT03562546|CVI|cvi
4648942|NCT03562546|Calf Muscle Pump Function|calf muscle pump function
4648943|NCT03562546|Structured Exercise|structured exercise
4648944|NCT03562546|Varicose Veins|varicose veins
4648945|NCT03562520|Aerobic fitness|aerobic fitness
4648946|NCT03562520|Aerobic exercise|aerobic exercise
4648947|NCT03562520|Behavior change counseling|behavior change counseling
4648948|NCT03562507|ESK981|esk981
4648949|NCT03562494|PD, Parkinson's disease|pd, parkinson's disease
4648950|NCT03562494|Aromatic L-Amino Acid Decarboxylase|aromatic l-amino acid decarboxylase
4648951|NCT03562494|AADC|aadc
4648952|NCT03562494|AAV2-AADC|aav2-aadc
4648953|NCT03562494|AAV2|aav2
4648954|NCT03562494|VY-AADC|vy-aadc
4648955|NCT03562494|AAV2-hAADC|aav2-haadc
4648956|NCT03562481|Healthy pediatric volunteers|healthy pediatric volunteers
4648957|NCT03562468|Nicotinamide riboside|nicotinamide riboside
4648958|NCT03562468|NAD|nad
4648959|NCT03562468|TRU NIAGEN|tru niagen
4648960|NCT03562455|Virtual Reality|virtual reality
4648961|NCT03562455|Wheelchairs|wheelchairs
4648962|NCT03562403|deep brain stimulation|deep brain stimulation
4648963|NCT03562364|anti-gravity|anti-gravity
4648964|NCT03562338|chronic nonspecific neck pain|chronic nonspecific neck pain
4648965|NCT03562338|disability|disability
4648966|NCT03562338|predictive model|predictive model
4648967|NCT03562338|rehabilitation|rehabilitation
4648968|NCT03562338|pain intensity|pain intensity
4648969|NCT03562312|MPA|mpa
4648970|NCT03562312|Music Performance Anxiety|music performance anxiety
4648971|NCT03562312|HIIT|hiit
4648972|NCT03562312|Exercise|exercise
4648973|NCT03562312|Cortisol|cortisol
4648974|NCT03562312|HRV|hrv
4648975|NCT03562312|Heart Rate|heart rate
4648976|NCT03562286|Open spina bifida|open spina bifida
4648977|NCT03562286|spinal dysraphism|spinal dysraphism
4648978|NCT03562273|Breast Nomogram|breast nomogram
4648979|NCT03562273|Breast Cancer Quality of Life|breast cancer quality of life
4648980|NCT03562273|GammaPod Registry|gammapod registry
4648981|NCT03562221|coeliac disease|coeliac disease
4648982|NCT03562221|celiac disease autoimmunity|celiac disease autoimmunity
4648983|NCT03562208|Diabetes Mellitus|diabetes mellitus
4648984|NCT03562208|Bone Marrow|bone marrow
4648985|NCT03562208|Transplant|transplant
4648986|NCT03562195|Eosinophilic inflammation|eosinophilic inflammation
4648987|NCT03562195|Mepolizumab|mepolizumab
4648988|NCT03562195|Asthma|asthma
4648989|NCT03562143|Iron|iron
4648990|NCT03562143|Deficiency|deficiency
4648991|NCT03562143|Anemia|anemia
4648992|NCT03562143|Supplementation|supplementation
4648993|NCT03562143|Pregnancy|pregnancy
4648994|NCT03562130|Teduglutide|teduglutide
4648995|NCT03562130|Short Bowel Syndrome|short bowel syndrome
4648996|NCT03562130|Parenteral nutrition|parenteral nutrition
4648997|NCT03562130|Intestinal failure|intestinal failure
4648998|NCT03562117|Child-Pugh classification|child-pugh classification
4648999|NCT03562117|Open label|open label
4649000|NCT03562117|Hepatic Impairment|hepatic impairment
4649001|NCT03562117|Gepotidacin|gepotidacin
4649002|NCT03562078|Tai Chi Quan|tai chi quan
4649003|NCT03562078|HbA1c|hba1c
4649004|NCT03562078|quality of life|quality of life
4649005|NCT03562052|Cancer|cancer
4649006|NCT03562052|Lung|lung
4649007|NCT03562052|Occupational carcinogens|occupational carcinogens
4649008|NCT03562052|Tobacco smoking|tobacco smoking
4649009|NCT03562052|Screening|screening
4649010|NCT03562052|Chest CT Scan|chest ct scan
4649011|NCT03562052|Asbestos|asbestos
4649012|NCT03562000|ICU|icu
4649013|NCT03562000|Cough|cough
4649014|NCT03562000|Randomised study|randomised study
4649015|NCT03562000|Cough assistance|cough assistance
4649016|NCT03562000|Medical device|medical device
4649017|NCT03562000|Physiotherapy|physiotherapy
4649018|NCT03561987|ADIPOSE TISSUE, CARDIOVASCULAR, OBESE PATIENTS|adipose tissue, cardiovascular, obese patients
4649019|NCT03561948|intraperitoneal chemotherapy|intraperitoneal chemotherapy
4649020|NCT03561948|Peritoneal Carcinomatosis|peritoneal carcinomatosis
4649021|NCT03561948|Colonic Diseases|colonic diseases
4649022|NCT03561922|Retinal Degeneration|retinal degeneration
4649023|NCT03561922|Artificial Vision|artificial vision
4649024|NCT03561922|Retinal Prosthesis|retinal prosthesis
4649025|NCT03561922|Subretinal Implant|subretinal implant
4649026|NCT03561922|Inherited Retinal Dystrophy|inherited retinal dystrophy
4649027|NCT03561922|Vision Restoration|vision restoration
4649028|NCT03561922|Bionic Eye|bionic eye
4649029|NCT03561922|Bionic Vision|bionic vision
4649030|NCT03561922|Retinitis Pigmentosa|retinitis pigmentosa
4649031|NCT03561922|Artificial Retina|artificial retina
4649032|NCT03561922|Retina Implant|retina implant
4649033|NCT03561922|Cone-Rod Dystrophy|cone-rod dystrophy
4649034|NCT03561922|Choroideremia|choroideremia
4649035|NCT03561922|Retinopathia Pigmentosa|retinopathia pigmentosa
4649036|NCT03561896|Radation therapy|radation therapy
4649037|NCT03561896|sterotactic radiosurgery|sterotactic radiosurgery
4649038|NCT03561896|quality of life|quality of life
4649039|NCT03561896|solid cancer|solid cancer
4649040|NCT03561896|palliation|palliation
4649041|NCT03561896|neurologic functionning|neurologic functionning
4649042|NCT03561883|Gastroesophageal Reflux Disease|gastroesophageal reflux disease
4649043|NCT03561883|GERD|gerd
4649044|NCT03561883|Proton Pump Inhibitor|proton pump inhibitor
4649045|NCT03561883|IW-3718|iw-3718
4649046|NCT03561870|IDH-mutant|idh-mutant
4649047|NCT03561870|recurrent|recurrent
4649048|NCT03561870|glioma|glioma
4649049|NCT03561805|TAVI|tavi
4649050|NCT03561805|ECG monitoring|ecg monitoring
4649051|NCT03561779|Osteoarthritis|osteoarthritis
4649052|NCT03561753|Tuberculosis|tuberculosis
4649053|NCT03561740|breast cancer|breast cancer
4649054|NCT03561740|HER2-positive|her2-positive
4649055|NCT03561740|metronomic chemotherapy|metronomic chemotherapy
4649056|NCT03561740|capecitabine|capecitabine
4649057|NCT03561740|high-risk|high-risk
4649058|NCT03561727|incisional hernia|incisional hernia
4649059|NCT03561727|malignancy|malignancy
4649060|NCT03561727|transverse incision|transverse incision
4649061|NCT03561727|abdominal closure|abdominal closure
4649062|NCT03561727|surgical technique|surgical technique
4649063|NCT03561727|insicion|insicion
4649064|NCT03561727|surgery|surgery
4649065|NCT03561688|Biomechanics|biomechanics
4649066|NCT03561688|Pain|pain
4649067|NCT03561688|Gait|gait
4649068|NCT03561688|Foot orthotics|foot orthotics
4649069|NCT03561688|Rheumatoid Arthritis|rheumatoid arthritis
4649070|NCT03561675|healthy participants older than 40 years|healthy participants older than 40 years
4649071|NCT03561675|altitude|altitude
4649072|NCT03561675|prevention|prevention
4649073|NCT03561675|acetazolamide|acetazolamide
4649074|NCT03561662|soya|soya
4649075|NCT03561662|menopause|menopause
4649076|NCT03561662|cognitive function|cognitive function
4649077|NCT03561662|isoflavones|isoflavones
4649078|NCT03561649|TNF inhibitor|tnf inhibitor
4649079|NCT03561649|Adalimumab|adalimumab
4649080|NCT03561649|Spondyloarthritis|spondyloarthritis
4649081|NCT03561649|Biomarkers analysis|biomarkers analysis
4649082|NCT03561649|Personalized medicine|personalized medicine
4649083|NCT03561636|Health literacy|health literacy
4649084|NCT03561610|cancer cachexia|cancer cachexia
4649085|NCT03561610|malnutrition|malnutrition
4649086|NCT03561610|nutritional supplement|nutritional supplement
4649087|NCT03561610|sip feed|sip feed
4649088|NCT03561610|nutritional risk|nutritional risk
4649089|NCT03561597|stepped care|stepped care
4649090|NCT03561597|mobile application|mobile application
4649091|NCT03561584|Sclerosing|sclerosing
4649092|NCT03561584|Cholangitis|cholangitis
4649093|NCT03561571|chylomicrons|chylomicrons
4649094|NCT03561571|Very Low Density Lipoprotein|very low density lipoprotein
4649095|NCT03561571|saturated fat|saturated fat
4649096|NCT03561571|platelet function|platelet function
4649097|NCT03561571|type 2 diabetes|type 2 diabetes
4649098|NCT03561571|post prandial phase|post prandial phase
4649099|NCT03561558|Bioequivalence|bioequivalence
4649100|NCT03561441|Endoscopic retrograde pancreatocholangiography|endoscopic retrograde pancreatocholangiography
4649101|NCT03561441|Pancreatitis|pancreatitis
4649102|NCT03561441|Lactate ringer's solution|lactate ringer's solution
4649103|NCT03561441|Tailored therapy|tailored therapy
4649104|NCT03561428|lichen sclerosus|lichen sclerosus
4649105|NCT03561415|Lung transplant, prophylaxis, pre-emptive|lung transplant, prophylaxis, pre-emptive
4649106|NCT03561402|biomarker|biomarker
4649107|NCT03561402|teriflunomide|teriflunomide
4649108|NCT03561402|activity|activity
4649109|NCT03561376|Scar|scar
4649110|NCT03561363|insulin sensitivity|insulin sensitivity
4649111|NCT03561363|high-fat diet|high-fat diet
4649112|NCT03561350|Microsatellite Instability|microsatellite instability
4649113|NCT03561350|Circulating Tumor DNA|circulating tumor dna
4649114|NCT03561350|Colorectal Neoplasms|colorectal neoplasms
4649115|NCT03561298|Pharmacokinetics|pharmacokinetics
4649116|NCT03561298|Healthy subjects|healthy subjects
4649117|NCT03561259|Iobenguane Avid High-risk Neuroblastoma|iobenguane avid high-risk neuroblastoma
4649118|NCT03561259|3-Iodobenzylguanidine|3-iodobenzylguanidine
4649119|NCT03561259|Radiopharmaceutical|radiopharmaceutical
4649120|NCT03561246|Stroke|stroke
4649121|NCT03561246|Rehabilitation|rehabilitation
4649122|NCT03561246|Walking|walking
4649123|NCT03561246|Biomechanics|biomechanics
4649124|NCT03561220|Prostate Cancer|prostate cancer
4649125|NCT03561220|Proton Radiation|proton radiation
4649126|NCT03561220|Photon Radiation|photon radiation
4649127|NCT03561220|Cancer of the Prostate|cancer of the prostate
4649128|NCT03561168|Pediatric|pediatric
4649129|NCT03561168|MRI Indications|mri indications
4649130|NCT03561168|Anesthesia|anesthesia
4649131|NCT03561168|Anesthetic Neurotoxicity|anesthetic neurotoxicity
4649132|NCT03561168|MRI Diagnostic Yield|mri diagnostic yield
4649133|NCT03561155|Upper Extremity|upper extremity
4649134|NCT03561155|Recovery|recovery
4649135|NCT03561116|Metabolic Syndrome|metabolic syndrome
4649136|NCT03561116|Xanthohumol|xanthohumol
4649137|NCT03561116|Glucose metabolism|glucose metabolism
4649138|NCT03561116|DNA damage|dna damage
4649139|NCT03561090|Gastroesophageal Reflux Disease|gastroesophageal reflux disease
4649140|NCT03561090|GERD|gerd
4649141|NCT03561090|Proton Pump Inhibitors|proton pump inhibitors
4649142|NCT03561090|IW-3718|iw-3718
4649143|NCT03561077|Pain|pain
4649144|NCT03561077|Pediatrics|pediatrics
4649145|NCT03561077|Mindfulness|mindfulness
4649146|NCT03561077|Adolescents|adolescents
4649147|NCT03561064|cancer|cancer
4649148|NCT03561064|insomnia|insomnia
4649150|NCT03561064|CBT-I|cbt-i
4649151|NCT03561064|cognitive behavioral therapy|cognitive behavioral therapy
4649152|NCT03561051|T-MACS|t-macs
4649153|NCT03561051|Pre-hospital environment|pre-hospital environment
4649154|NCT03561025|Diagnostic Imaging|diagnostic imaging
4649155|NCT03561025|Positron Emission Tomography Computed Tomography|positron emission tomography computed tomography
4649156|NCT03561025|Magnetic Resonance Imaging|magnetic resonance imaging
4649157|NCT03561012|health|health
4649158|NCT03561012|nutrition|nutrition
4649159|NCT03561012|pregnancy|pregnancy
4649160|NCT03561012|infant|infant
4649161|NCT03561012|child|child
4649162|NCT03560986|Neridronic Acid|neridronic acid
4649163|NCT03560986|Neridronate|neridronate
4649164|NCT03560986|CRPS|crps
4649165|NCT03560986|RSD (reflex sympathetic dystrophy)|rsd (reflex sympathetic dystrophy)
4649166|NCT03560960|Early AD diagnosis|early ad diagnosis
4649167|NCT03560960|Pramlintide challenge test|pramlintide challenge test
4649168|NCT03560960|Amyloid|amyloid
4649169|NCT03560960|Amyloid PET imaging|amyloid pet imaging
4649170|NCT03560960|CSF Aβ|csf aβ
4649171|NCT03560960|CSF pTau|csf ptau
4649172|NCT03560960|Cognitive evaluation|cognitive evaluation
4649173|NCT03560947|chronic nonspecific neck pain|chronic nonspecific neck pain
4649174|NCT03560947|exercise|exercise
4649175|NCT03560947|manual therapy|manual therapy
4649176|NCT03560921|biomarkers|biomarkers
4649177|NCT03560908|leukemia,myeloid, acute|leukemia,myeloid, acute
4649178|NCT03560908|relapse|relapse
4649179|NCT03560908|mutation|mutation
4649180|NCT03560908|KIT|kit
4649181|NCT03560908|dasatinib|dasatinib
4649182|NCT03560882|atorvastatin|atorvastatin
4649183|NCT03560882|p53|p53
4649184|NCT03560882|tumor resection|tumor resection
4649185|NCT03560869|Dehydration|dehydration
4649186|NCT03560843|MBSR, TBI, insomnia|mbsr, tbi, insomnia
4649187|NCT03560817|QALY|qaly
4649188|NCT03560817|Cost-utility analysis|cost-utility analysis
4649189|NCT03560817|Time-trade-off method|time-trade-off method
4649190|NCT03560817|Discrete choice experiment method|discrete choice experiment method
4649191|NCT03560804|olmesartan|olmesartan
4649192|NCT03560804|chlorthalidone|chlorthalidone
4649193|NCT03560804|hemodynamics|hemodynamics
4649194|NCT03560778|Urinary Bladder, Overactive|urinary bladder, overactive
4649195|NCT03560778|Urinary Incontinence, Urge|urinary incontinence, urge
4649196|NCT03560778|Urodynamics|urodynamics
4649197|NCT03560765|Rehabilitation|rehabilitation
4649198|NCT03560765|Assistive technology|assistive technology
4649199|NCT03560739|Relapsing Multiple Sclerosis|relapsing multiple sclerosis
4649200|NCT03560739|Relapsing-remitting Multiple Sclerosis|relapsing-remitting multiple sclerosis
4649201|NCT03560739|Secondary progressive Multiple Sclerosis|secondary progressive multiple sclerosis
4649202|NCT03560739|Bioequivalence|bioequivalence
4649203|NCT03560739|Pharmacokinetics|pharmacokinetics
4649204|NCT03560739|Neurofilament light chain|neurofilament light chain
4649205|NCT03560739|Pre-filled Syringe|pre-filled syringe
4649206|NCT03560739|Auto-injector|auto-injector
4649207|NCT03560687|Anemia|anemia
4649208|NCT03560687|Heart Surgery|heart surgery
4649209|NCT03560687|Iron Supplementation|iron supplementation
4649210|NCT03560674|Dental trauma|dental trauma
4649211|NCT03560674|emergency management|emergency management
4649212|NCT03560674|traumatic injures.|traumatic injures.
4649213|NCT03560661|Acoustic and perceptual markers|acoustic and perceptual markers
4649214|NCT03560661|Dysarthria|dysarthria
4649215|NCT03560661|Amyotrophic lateral sclerosis|amyotrophic lateral sclerosis
4649216|NCT03560661|Primitive lateral sclerosis|primitive lateral sclerosis
4649217|NCT03560661|Kennedy's disease|kennedy's disease
4649218|NCT03560648|muscle aging|muscle aging
4649219|NCT03560648|sarcopenia|sarcopenia
4649220|NCT03560648|neuromuscular dysfunction|neuromuscular dysfunction
4649221|NCT03560635|weight loss maintenance|weight loss maintenance
4649222|NCT03560635|reverse diet|reverse diet
4649223|NCT03560635|body composition|body composition
4649224|NCT03560635|metabolic rate|metabolic rate
4649225|NCT03560635|dietary adherence|dietary adherence
4649226|NCT03560635|resting energy expenditure|resting energy expenditure
4649227|NCT03560635|weight loss|weight loss
4649228|NCT03560635|weight regain|weight regain
4649229|NCT03560622|focused ultrasound|focused ultrasound
4649230|NCT03560622|fMRI|fmri
4649231|NCT03560596|Latino|latino
4649232|NCT03560570|stroke-like|stroke-like
4649233|NCT03560570|thrombosis|thrombosis
4649234|NCT03560570|haemorrhages|haemorrhages
4649235|NCT03560557|Pharmacokinetics|pharmacokinetics
4649236|NCT03560557|Meropenem|meropenem
4649237|NCT03560557|Critical illness|critical illness
4649238|NCT03560557|Capillary leak|capillary leak
4649239|NCT03560557|Augmented renal clearance|augmented renal clearance
4649240|NCT03560531|Estrogen receptor|estrogen receptor
4649241|NCT03560531|Hormone receptor|hormone receptor
4649242|NCT03560531|Selective estrogen receptor degrader|selective estrogen receptor degrader
4649243|NCT03560531|Hormone sensitive|hormone sensitive
4649244|NCT03560531|Phase 1|phase 1
4649245|NCT03560518|Depression|depression
4649246|NCT03560505|Ultrasound reference material|ultrasound reference material
4649247|NCT03560505|Sensitivity|sensitivity
4649248|NCT03560505|Specificity|specificity
4649249|NCT03560505|Common fibular compression neuropathy|common fibular compression neuropathy
4649250|NCT03560505|Type 2 diabetes polyneuropathy|type 2 diabetes polyneuropathy
4649251|NCT03560505|Intra-rater reliability|intra-rater reliability
4649252|NCT03560505|Inter-rater reliability|inter-rater reliability
4649253|NCT03560492|posture|posture
4649254|NCT03560492|cervical pain|cervical pain
4649255|NCT03560492|exercise|exercise
4649256|NCT03560479|First-in human|first-in human
4649257|NCT03560479|Phase 1|phase 1
4649258|NCT03560479|Phase 2|phase 2
4649259|NCT03560479|Safety|safety
4649260|NCT03560479|Tolerability|tolerability
4649261|NCT03560479|Cancer|cancer
4649262|NCT03560479|Bladder cancer|bladder cancer
4649263|NCT03560479|Clinical trial|clinical trial
4649264|NCT03560479|Anti-cancer|anti-cancer
4649265|NCT03560479|Antineoplastic|antineoplastic
4649266|NCT03560479|alpha1H|alpha1h
4649267|NCT03560479|HAMLET|hamlet
4649268|NCT03560479|Urothelial|urothelial
4649269|NCT03560479|Malignant|malignant
4649270|NCT03560479|Papillary|papillary
4649271|NCT03560479|Transurethral|transurethral
4649272|NCT03560479|Non-muscle invasive|non-muscle invasive
4649273|NCT03560479|Instillation|instillation
4649274|NCT03560479|Intravesical|intravesical
4649275|NCT03560453|Autism|autism
4649276|NCT03560453|ASD|asd
4649277|NCT03560453|Competitive Integrated Employment|competitive integrated employment
4649278|NCT03560453|Project SEARCH|project search
4649279|NCT03560453|Outcomes|outcomes
4649280|NCT03560453|Support Intensity|support intensity
4649281|NCT03560440|Vancomycin|vancomycin
4649282|NCT03560440|Pharmacokinetics|pharmacokinetics
4649283|NCT03560440|Trough level|trough level
4649284|NCT03560440|Pediatric|pediatric
4649285|NCT03560401|Bracing; transforaminal lumbar interbody fusion (TLIF); outcome; fusion rate|bracing; transforaminal lumbar interbody fusion (tlif); outcome; fusion rate
4649286|NCT03560388|Integrative medicine|integrative medicine
4649287|NCT03560388|Acupuncture|acupuncture
4649288|NCT03560388|Gynecological oncology|gynecological oncology
4649289|NCT03560388|Surgery|surgery
4649290|NCT03560388|Analgesia|analgesia
4649291|NCT03560388|Pain|pain
4649292|NCT03560388|Anxiety|anxiety
4649293|NCT03560375|Weight loss; Diabetes; Frailty; Sarcopenia|weight loss; diabetes; frailty; sarcopenia
4649294|NCT03560362|bupivacaine|bupivacaine
4649295|NCT03560362|lipossomal extended release bupivacaine|lipossomal extended release bupivacaine
4649296|NCT03560362|Intercostal nerve block|intercostal nerve block
4649297|NCT03560362|thoracic surgery|thoracic surgery
4649298|NCT03560362|minimally invasive surgery|minimally invasive surgery
4649299|NCT03560323|Ketone Body Metabolism|ketone body metabolism
4649300|NCT03560323|Myocardial Glucose Uptake|myocardial glucose uptake
4649301|NCT03560323|Positron Emission Tomography|positron emission tomography
4649302|NCT03560323|Myocardial Function|myocardial function
4649303|NCT03560310|Coronary Bypass Grafting|coronary bypass grafting
4649304|NCT03560310|Antiplatelet treatment|antiplatelet treatment
4649305|NCT03560284|Marathon|marathon
4649306|NCT03560284|Half Marathon|half marathon
4649307|NCT03560284|Runners|runners
4649308|NCT03560284|Ederly|ederly
4649309|NCT03560284|Aging process|aging process
4649310|NCT03560284|Sport Addiction|sport addiction
4649311|NCT03560232|Open Fracture|open fracture
4649312|NCT03560232|Wound Infection|wound infection
4649313|NCT03560232|Antimicrobial Prophylaxis|antimicrobial prophylaxis
4649314|NCT03560232|Cefazolin|cefazolin
4649315|NCT03560232|Gentamicin|gentamicin
4649316|NCT03560232|Ceftriaxone|ceftriaxone
4649317|NCT03560232|Ampicillin/Sulbactam|ampicillin/sulbactam
4649318|NCT03560232|Clindamycin|clindamycin
4649319|NCT03560232|Piperacillin/tazobactam|piperacillin/tazobactam
4649320|NCT03560219|Atrial Fibrillation|atrial fibrillation
4649321|NCT03560219|Atrial Fibrosis|atrial fibrosis
4649322|NCT03560219|Genome Wide Association Studies|genome wide association studies
4649323|NCT03560219|Biomarkers|biomarkers
4649324|NCT03560219|Echocardiography|echocardiography
4649325|NCT03560219|Magnetic Resonance Imaging|magnetic resonance imaging
4649326|NCT03560219|Flow Mediated Dilatation|flow mediated dilatation
4649327|NCT03560219|Thrombogenic Substrate|thrombogenic substrate
4649328|NCT03560206|Diet, low-sodium|diet, low-sodium
4649329|NCT03560206|caregivers|caregivers
4649330|NCT03560193|Skin antisepsis|skin antisepsis
4649331|NCT03560193|Chlorhexidine|chlorhexidine
4649332|NCT03560193|Povidone Iodine|povidone iodine
4649333|NCT03560193|Surgical site infection|surgical site infection
4649334|NCT03560180|Anastomotic Leak|anastomotic leak
4649335|NCT03560180|Colorectal Surgery|colorectal surgery
4649336|NCT03560154|Pulmonary Function Test|pulmonary function test
4649337|NCT03560154|Peripheral Muscle strength|peripheral muscle strength
4649338|NCT03560154|Postural balance|postural balance
4649339|NCT03560154|Dyspnea|dyspnea
4649340|NCT03560154|Pulmonary Muscle Strength|pulmonary muscle strength
4649341|NCT03560154|Functional Capacity|functional capacity
4649342|NCT03560154|Fatigue|fatigue
4649343|NCT03560154|Quality of Life|quality of life
4649344|NCT03560128|Colonoscopy|colonoscopy
4649345|NCT03560115|Children|children
4649346|NCT03560115|Heel|heel
4649347|NCT03560115|Reliability|reliability
4649348|NCT03560089|Parkinson's disease|parkinson's disease
4649349|NCT03560089|Gait|gait
4649350|NCT03560089|Rehabilitation|rehabilitation
4649351|NCT03560089|Serious game|serious game
4649352|NCT03560076|Acute Care|acute care
4649353|NCT03560076|SBIRT|sbirt
4649354|NCT03560076|Substance Use|substance use
4649355|NCT03560076|Alcohol|alcohol
4649356|NCT03560076|Opioid|opioid
4649357|NCT03560076|Tobacco|tobacco
4649358|NCT03560076|Nurse|nurse
4649359|NCT03560076|Toolkit|toolkit
4649360|NCT03560076|Implementation|implementation
4649361|NCT03560063|arthroplasty|arthroplasty
4649362|NCT03560063|dislocation|dislocation
4649363|NCT03560063|templating|templating
4649364|NCT03560050|early childhood education|early childhood education
4649365|NCT03560050|family child care home|family child care home
4649366|NCT03560050|food environment|food environment
4649367|NCT03559998|Simulation training|simulation training
4649368|NCT03559998|role-play|role-play
4649369|NCT03559998|psychiatry|psychiatry
4649370|NCT03559998|students|students
4649371|NCT03559998|medical|medical
4649372|NCT03559998|psychology|psychology
4649373|NCT03559998|educational|educational
4649374|NCT03559998|learning|learning
4649375|NCT03559985|Paracetamol|paracetamol
4649376|NCT03559985|Neuropathic pain|neuropathic pain
4649377|NCT03559985|Analgesic effect|analgesic effect
4649378|NCT03559985|Pharmacogenetics|pharmacogenetics
4649379|NCT03559985|Biological parameters|biological parameters
4649380|NCT03559985|Cognitivo-emotional parameters|cognitivo-emotional parameters
4649381|NCT03559946|Overactive Bladder Syndrome|overactive bladder syndrome
4649382|NCT03559946|Percutaneous Tibial Nerve Stimulation|percutaneous tibial nerve stimulation
4649383|NCT03559907|prevention|prevention
4649384|NCT03559907|nutrition|nutrition
4649385|NCT03559907|early childhood|early childhood
4649386|NCT03559907|parent training|parent training
4649387|NCT03559907|underserved|underserved
4649388|NCT03559881|Skeletal muscle mass, muscle strength, dairy products, high protein diet, cancer treatment, lung cancer|skeletal muscle mass, muscle strength, dairy products, high protein diet, cancer treatment, lung cancer
4649389|NCT03559816|Episiotomy|episiotomy
4649390|NCT03559816|Vaginal delivery|vaginal delivery
4649391|NCT03559816|Perineal trauma|perineal trauma
4649392|NCT03559816|Laceration|laceration
4649393|NCT03559816|Classification of second-degree laceration|classification of second-degree laceration
4649394|NCT03559803|Cervical Cancer|cervical cancer
4649395|NCT03559803|PD-L1|pd-l1
4649396|NCT03559803|Concurrent Chemoradiotherapy|concurrent chemoradiotherapy
4649397|NCT03559790|chronic hepatitis B|chronic hepatitis b
4649398|NCT03559790|tenofovir alafenamide|tenofovir alafenamide
4649399|NCT03559790|tenofovir disoproxil fumarate|tenofovir disoproxil fumarate
4649400|NCT03559790|Safety|safety
4649401|NCT03559790|Efficacy|efficacy
4649402|NCT03559777|closed sinus lifiting|closed sinus lifiting
4649403|NCT03559777|implant stability|implant stability
4649404|NCT03559777|osteotome|osteotome
4649405|NCT03559777|densah bur|densah bur
4649406|NCT03559751|Abuse liability|abuse liability
4649407|NCT03559725|Abuse liability|abuse liability
4649408|NCT03559712|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
4649409|NCT03559712|Collaborative Care|collaborative care
4649410|NCT03559712|Telemedecine|telemedecine
4649411|NCT03559712|Telemental Health|telemental health
4649412|NCT03559608|arterial hypertension|arterial hypertension
4649413|NCT03559608|male health|male health
4649414|NCT03559608|Warmia-Masuria region|warmia-masuria region
4649415|NCT03559569|Shock|shock
4649416|NCT03559569|Cardiovascular Diseases|cardiovascular diseases
4649417|NCT03559569|Infection|infection
4649418|NCT03559543|Nutritional supplement|nutritional supplement
4649547|NCT03558828|workplace|workplace
4649419|NCT03559543|Metastatic colorectal Cancer|metastatic colorectal cancer
4649420|NCT03559543|Oxidative Stress|oxidative stress
4649421|NCT03559543|Ocoxin Viusid|ocoxin viusid
4649422|NCT03559543|Antioxidant|antioxidant
4649423|NCT03559530|osteomyelitis|osteomyelitis
4649424|NCT03559530|Acinetobacter baumannii|acinetobacter baumannii
4649425|NCT03559530|Anti-Infective Agents|anti-infective agents
4649426|NCT03559504|electroencephalography|electroencephalography
4649427|NCT03559504|general anesthesia|general anesthesia
4649428|NCT03559504|sevoflurane|sevoflurane
4649429|NCT03559491|steroid|steroid
4649430|NCT03559491|retinal vein occlusion|retinal vein occlusion
4649431|NCT03559491|macular edema|macular edema
4649432|NCT03559465|systemic sclerosis|systemic sclerosis
4649433|NCT03559465|B lymphocyte|b lymphocyte
4649434|NCT03559452|Muscle damage|muscle damage
4649435|NCT03559452|Inflammation|inflammation
4649436|NCT03559452|Immobilisation|immobilisation
4649437|NCT03559426|antipsychotics|antipsychotics
4649438|NCT03559426|schizophrenia|schizophrenia
4649439|NCT03559426|reduction|reduction
4649440|NCT03559413|Individualized peptide vaccination|individualized peptide vaccination
4649441|NCT03559413|Immunotherapy|immunotherapy
4649442|NCT03559413|Tumor-specific mutations|tumor-specific mutations
4649443|NCT03559413|Neoantigens|neoantigens
4649444|NCT03559374|Vanadis NIPT system|vanadis nipt system
4649445|NCT03559348|in Elderly Patients|in elderly patients
4649446|NCT03559335|Colorectal cancer|colorectal cancer
4649447|NCT03559335|Biomarkers|biomarkers
4649448|NCT03559335|Neutrophil CD64|neutrophil cd64
4649449|NCT03559335|Monocyte Human Leukocyte Antigen - DR|monocyte human leukocyte antigen - dr
4649450|NCT03559335|Postoperative Infectious Complications|postoperative infectious complications
4649451|NCT03559335|C-reactive protein (CRP)|c-reactive protein (crp)
4649452|NCT03559335|Procalcitonin (PCT)|procalcitonin (pct)
4649453|NCT03559296|imaging|imaging
4649454|NCT03559296|assessment|assessment
4649455|NCT03559296|edema|edema
4649456|NCT03559296|dermis|dermis
4649457|NCT03559296|postmastectomy Lymphedema|postmastectomy lymphedema
4649458|NCT03559296|reliability|reliability
4649459|NCT03559296|ultrasound|ultrasound
4649460|NCT03559296|grade|grade
4649461|NCT03559283|stroke, dual-task, gait parameters, fNIRS|stroke, dual-task, gait parameters, fnirs
4649462|NCT03559270|eczema|eczema
4649463|NCT03559270|atopic eczema|atopic eczema
4649464|NCT03559257|prevention|prevention
4649465|NCT03559257|prophylaxis|prophylaxis
4649466|NCT03559257|headache|headache
4649467|NCT03559257|treatment-resistant|treatment-resistant
4649468|NCT03559257|treatment resistant|treatment resistant
4649469|NCT03559244|exercise|exercise
4649470|NCT03559244|pectus carinatum|pectus carinatum
4649471|NCT03559244|orthosis|orthosis
4649472|NCT03559244|dynamic compression brace|dynamic compression brace
4649473|NCT03559231|duodenal adenoma|duodenal adenoma
4649474|NCT03559231|FTRD|ftrd
4649475|NCT03559231|dFTRD|dftrd
4649476|NCT03559231|EMR|emr
4649477|NCT03559231|endoscopic mucosal resection|endoscopic mucosal resection
4649478|NCT03559205|Musculoskeletal|musculoskeletal
4649479|NCT03559205|MSK|msk
4649480|NCT03559179|CDS|cds
4649481|NCT03559179|Medication Assisted Therapy|medication assisted therapy
4649482|NCT03559153|Office workers|office workers
4649483|NCT03559153|Worker health|worker health
4649484|NCT03559153|Work ability|work ability
4649485|NCT03559153|Musculoskeletal disease|musculoskeletal disease
4649486|NCT03559140|post-endodontic pain|post-endodontic pain
4649487|NCT03559140|pain|pain
4649488|NCT03559140|root canal treatment|root canal treatment
4649489|NCT03559140|cryotherapy|cryotherapy
4649490|NCT03559127|post-endodontic pain|post-endodontic pain
4649491|NCT03559127|pain|pain
4649492|NCT03559127|criotherapy|criotherapy
4649493|NCT03559127|cold irrigation|cold irrigation
4649494|NCT03559114|Sequential Compression Device|sequential compression device
4649495|NCT03559114|Anticoagulant Thromboprophylaxis|anticoagulant thromboprophylaxis
4649496|NCT03559114|Deep Vein Thrombosis|deep vein thrombosis
4649497|NCT03559114|Sub Cutaneous|sub cutaneous
4649498|NCT03559114|VTE|vte
4649499|NCT03559101|Hydration|hydration
4649500|NCT03559101|Plasma Volume|plasma volume
4649501|NCT03559101|Amino acids|amino acids
4649502|NCT03559101|Glucose|glucose
4649503|NCT03559101|Electrolytes|electrolytes
4649504|NCT03559101|Fluid Retention|fluid retention
4649505|NCT03559101|Aging|aging
4649506|NCT03559101|Beverage Hydration Index|beverage hydration index
4649507|NCT03559101|Dehydration|dehydration
4649508|NCT03559101|Oral Rehydration|oral rehydration
4649509|NCT03559075|atopic dermatitis|atopic dermatitis
4649510|NCT03559075|eczema|eczema
4649511|NCT03559075|children|children
4649512|NCT03559036|Locomotor Training|locomotor training
4649513|NCT03559036|Urodynamics|urodynamics
4649514|NCT03559023|Thoracic epidural|thoracic epidural
4649515|NCT03559010|Daily birth control|daily birth control
4649516|NCT03558984|Surgical Site Infection (SSI), Cardiac Surgery, Open Heart Surgery, Infection|surgical site infection (ssi), cardiac surgery, open heart surgery, infection
4649517|NCT03558971|Cortisol|cortisol
4649518|NCT03558945|pancreatic tumor|pancreatic tumor
4649519|NCT03558945|neoantigen|neoantigen
4649520|NCT03558945|vaccine|vaccine
4649521|NCT03558906|Periodontal disease|periodontal disease
4649522|NCT03558906|Hypoxia|hypoxia
4649523|NCT03558906|Cytokines|cytokines
4649524|NCT03558906|Gingival crevicular fluid|gingival crevicular fluid
4649525|NCT03558906|Saliva|saliva
4649526|NCT03558893|circadian rhythm|circadian rhythm
4649527|NCT03558867|Pre Diabetes|pre diabetes
4649528|NCT03558867|Insulin resistance|insulin resistance
4649529|NCT03558867|Metformin|metformin
4649530|NCT03558867|Gut microbiota|gut microbiota
4649531|NCT03558867|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
4649532|NCT03558854|Systemic sclerosis|systemic sclerosis
4649533|NCT03558854|Acetylsalicylic acid|acetylsalicylic acid
4649534|NCT03558854|Vascular dysfunction|vascular dysfunction
4649535|NCT03558841|gait|gait
4649536|NCT03558841|mobility|mobility
4649537|NCT03558841|geriatric|geriatric
4649538|NCT03558841|rehabilitation|rehabilitation
4649539|NCT03558841|inpatient|inpatient
4649540|NCT03558828|physical activity|physical activity
4649541|NCT03558828|women|women
4649542|NCT03558828|sedentary|sedentary
4649543|NCT03558828|accelerometer|accelerometer
4649544|NCT03558828|text message|text message
4649545|NCT03558828|group meeting|group meeting
4649546|NCT03558828|personal call|personal call
4649548|NCT03558828|cost-effectiveness|cost-effectiveness
4649549|NCT03558828|Sequential Multiple Assignment Randomized Trial|sequential multiple assignment randomized trial
4649550|NCT03558828|adaptive intervention|adaptive intervention
4649551|NCT03558828|Actigraph|actigraph
4649552|NCT03558828|Fitbit|fitbit
4649553|NCT03558828|iCardia|icardia
4649554|NCT03558815|intellectual disability|intellectual disability
4649555|NCT03558815|psychotropic medication|psychotropic medication
4649556|NCT03558815|mental health services evaluation|mental health services evaluation
4649557|NCT03558776|alpha linolenic acid, linseed oil, eicosapentaenoic acid, docosahexaenoic acid|alpha linolenic acid, linseed oil, eicosapentaenoic acid, docosahexaenoic acid
4649558|NCT03558763|Monitoring|monitoring
4649559|NCT03558737|non-invasive high frequency ventilation (nHFJV)|non-invasive high frequency ventilation (nhfjv)
4649560|NCT03558737|nasal intermittent positive pressure ventilation (NIPPV)|nasal intermittent positive pressure ventilation (nippv)
4649561|NCT03558724|Fluorescence|fluorescence
4649562|NCT03558724|Endoscopy|endoscopy
4649563|NCT03558724|Bevacizumab-800CW|bevacizumab-800cw
4649564|NCT03558724|Locally advanced esophageal cancer|locally advanced esophageal cancer
4649565|NCT03558711|prostate cancer|prostate cancer
4649566|NCT03558711|biochemical recurrence|biochemical recurrence
4649567|NCT03558711|18F-PET imaging|18f-pet imaging
4649568|NCT03558698|cognition|cognition
4649569|NCT03558698|sleep|sleep
4649570|NCT03558698|carbon dioxide|carbon dioxide
4649571|NCT03558698|bio effluents|bio effluents
4649572|NCT03558672|Flexitouch|flexitouch
4649573|NCT03558659|Stroke|stroke
4649574|NCT03558659|Obstructive sleep apnea|obstructive sleep apnea
4649575|NCT03558659|Positional therapy|positional therapy
4649576|NCT03558646|Smoke inhalation injury|smoke inhalation injury
4649577|NCT03558646|Acute kidney injury|acute kidney injury
4649578|NCT03558646|Intensive care unit|intensive care unit
4649579|NCT03558646|Burns|burns
4649580|NCT03558646|Prognosis|prognosis
4649581|NCT03558646|Hydroxocobalamin|hydroxocobalamin
4649582|NCT03558633|Cricoid pressure|cricoid pressure
4649583|NCT03558633|Paralaryngeal pressure|paralaryngeal pressure
4649584|NCT03558633|Intubation|intubation
4649585|NCT03558620|manual ventilation|manual ventilation
4649586|NCT03558581|Nursing Process|nursing process
4649587|NCT03558581|Nephrology Nursing|nephrology nursing
4649588|NCT03558581|Education Health|education health
4649589|NCT03558568|Parkinson's Disease|parkinson's disease
4649590|NCT03558568|Deep Brain Stimulation|deep brain stimulation
4649591|NCT03558568|Subthalamic Nucleus|subthalamic nucleus
4649592|NCT03558568|DBS|dbs
4649593|NCT03558568|STN|stn
4649594|NCT03558568|Face|face
4649595|NCT03558568|Facial expressions|facial expressions
4649596|NCT03558568|Parkinson|parkinson
4649597|NCT03558555|Acetaminophen|acetaminophen
4649598|NCT03558555|Tylenol|tylenol
4649599|NCT03558555|Intravenous versus oral|intravenous versus oral
4649600|NCT03558529|relapse|relapse
4649601|NCT03558529|early signs|early signs
4649602|NCT03558529|basic symptoms|basic symptoms
4649603|NCT03558529|smartphone app|smartphone app
4649604|NCT03558529|mhealth|mhealth
4649605|NCT03558516|Meningioma|meningioma
4649606|NCT03558516|Magnesium sulphate|magnesium sulphate
4649607|NCT03558516|Montreal cognitive assessment|montreal cognitive assessment
4649608|NCT03558516|Intraoperative blood loss|intraoperative blood loss
4649609|NCT03558503|UGN-102|ugn-102
4649610|NCT03558503|UG-1 gel|ug-1 gel
4649611|NCT03558503|Bladder cancer|bladder cancer
4649612|NCT03558503|Gel|gel
4649613|NCT03558503|Slow Release|slow release
4649614|NCT03558503|Non Muscle Invasive Bladder Cancer (NMIBC)|non muscle invasive bladder cancer (nmibc)
4649615|NCT03558503|Low grade (LG)|low grade (lg)
4649616|NCT03558503|Prolonged Release|prolonged release
4649617|NCT03558503|Mitomycin C|mitomycin c
4649618|NCT03558503|Local|local
4649619|NCT03558503|Intravesical|intravesical
4649620|NCT03558503|Ta|ta
4649621|NCT03558503|T1|t1
4649622|NCT03558503|MMC|mmc
4649623|NCT03558451|Primary health care|primary health care
4649624|NCT03558425|CKD-381|ckd-381
4649625|NCT03558425|D026|d026
4649626|NCT03558412|Decitabine|decitabine
4649627|NCT03558412|RR|rr
4649628|NCT03558412|TTP|ttp
4649629|NCT03558412|OS|os
4649630|NCT03558412|MST|mst
4649631|NCT03558399|Endometrial receptivity analysis|endometrial receptivity analysis
4649632|NCT03558399|Window of implantation|window of implantation
4649633|NCT03558399|Euploid|euploid
4649634|NCT03558399|Infertility, Female|infertility, female
4649635|NCT03558399|Implantation failure|implantation failure
4649636|NCT03558399|Frozen embryo transfer FET|frozen embryo transfer fet
4649637|NCT03558399|ERA|era
4649638|NCT03558399|WOI|woi
4649639|NCT03558399|FET|fet
4649640|NCT03558399|Synchrony|synchrony
4649641|NCT03558373|adherence|adherence
4649642|NCT03558373|tacrolimus|tacrolimus
4649643|NCT03558373|once-daily|once-daily
4649644|NCT03558360|lean body mass|lean body mass
4649645|NCT03558360|bariatric surgery|bariatric surgery
4649646|NCT03558334|Bronchopulmonary Dysplasia|bronchopulmonary dysplasia
4649647|NCT03558334|human umbilical cord -derived mesenchymal stem cells|human umbilical cord -derived mesenchymal stem cells
4649648|NCT03558295|Percutaneous coronary intervention (PCI), oral anticoagulants, atrial fibrillation, DOAC.|percutaneous coronary intervention (pci), oral anticoagulants, atrial fibrillation, doac.
4649649|NCT03558269|Autologous Umbilical cord blood infusion|autologous umbilical cord blood infusion
4649650|NCT03558269|Congenital Heart Disease|congenital heart disease
4649651|NCT03558269|Brain Injuries|brain injuries
4649652|NCT03558269|Low Cardiac Output Syndrome|low cardiac output syndrome
4649653|NCT03558269|Neonatal Disorder|neonatal disorder
4649654|NCT03558256|Mindfulness-Based Cognitive Therapy|mindfulness-based cognitive therapy
4649655|NCT03558243|radial artery occlusion|radial artery occlusion
4649656|NCT03558243|prevention|prevention
4649657|NCT03558243|patent hemostasis|patent hemostasis
4649658|NCT03558243|transradial intervention|transradial intervention
4649659|NCT03558243|ulnar compression|ulnar compression
4649660|NCT03558230|pediatric|pediatric
4649661|NCT03558230|hemiplegic|hemiplegic
4649662|NCT03558230|hand function|hand function
4649663|NCT03558217|total hip arthroplasty|total hip arthroplasty
4649664|NCT03558217|collarless femoral implant|collarless femoral implant
4649665|NCT03558217|collared femoral implant|collared femoral implant
4649666|NCT03558217|direct anterior approach|direct anterior approach
4649667|NCT03558217|direct lateral approach|direct lateral approach
4649668|NCT03558191|Recurrent/Metastatic Nasopharyngeal Carcinoma|recurrent/metastatic nasopharyngeal carcinoma
4649669|NCT03558191|PD-1|pd-1
4649670|NCT03558126|silicone tube|silicone tube
4649671|NCT03558126|miniature drainage device|miniature drainage device
4649672|NCT03558126|POAG|poag
4649673|NCT03558126|IOP|iop
4649674|NCT03558100|obesity|obesity
4649675|NCT03558100|gait|gait
4649676|NCT03558100|bariatric surgery|bariatric surgery
4649677|NCT03558100|walking|walking
4649678|NCT03558100|obstacles|obstacles
4649679|NCT03558087|muscle-invasive|muscle-invasive
4649680|NCT03558074|Refractory wAMD|refractory wamd
4649681|NCT03558048|Prostate Specific Antigen|prostate specific antigen
4649682|NCT03558048|IBD|ibd
4649683|NCT03558048|PSA|psa
4649684|NCT03558035|Hypopharyngeal carcinoma|hypopharyngeal carcinoma
4649685|NCT03558035|Locally advanced|locally advanced
4649686|NCT03558035|Multi-disciplinary treatment|multi-disciplinary treatment
4649687|NCT03558035|Functional MR|functional mr
4649688|NCT03558035|Prognosis|prognosis
4649689|NCT03558009|Hereditary Angioedema|hereditary angioedema
4649690|NCT03558009|DBS-based biochemical and genetic assay for HAE type I/II|dbs-based biochemical and genetic assay for hae type i/ii
4649691|NCT03557931|aripiprazole|aripiprazole
4649692|NCT03557931|ziprasidone|ziprasidone
4649693|NCT03557931|lurasidone|lurasidone
4649694|NCT03557931|schizophrenia|schizophrenia
4649695|NCT03557931|ASP4345|asp4345
4649696|NCT03557931|quetiapine|quetiapine
4649697|NCT03557931|olanzapine|olanzapine
4649698|NCT03557931|brexpiprazole|brexpiprazole
4649699|NCT03557931|risperidone|risperidone
4649700|NCT03557931|paliperidone|paliperidone
4649701|NCT03557879|Hearing impairment|hearing impairment
4649702|NCT03557879|familial|familial
4649703|NCT03557866|foot posture|foot posture
4649704|NCT03557866|running|running
4649705|NCT03557866|foot index|foot index
4649706|NCT03557840|temocillin|temocillin
4649707|NCT03557840|free concentration|free concentration
4649708|NCT03557840|total concentration|total concentration
4649709|NCT03557840|pharmacokinetics|pharmacokinetics
4649710|NCT03557840|pharmacodynamic|pharmacodynamic
4649711|NCT03557840|probability of target attainment|probability of target attainment
4649712|NCT03557840|non-ICU|non-icu
4649713|NCT03557827|periodontitis|periodontitis
4649714|NCT03557827|photodynamic therapy|photodynamic therapy
4649715|NCT03557814|chronic periodontitis|chronic periodontitis
4649716|NCT03557814|light-emitting diodes|light-emitting diodes
4649717|NCT03557788|Rifaximin|rifaximin
4649718|NCT03557762|Cancer survivors|cancer survivors
4649719|NCT03557762|Smartphone app|smartphone app
4649720|NCT03557762|Mindfulness|mindfulness
4649721|NCT03557723|Community-dwellers,older adults, museum, art|community-dwellers,older adults, museum, art
4649722|NCT03557710|eating|eating
4649723|NCT03557710|overweight|overweight
4649724|NCT03557710|obesity|obesity
4649725|NCT03557710|cancer risk|cancer risk
4649726|NCT03557710|translational neuroscience|translational neuroscience
4649727|NCT03557710|cognitive reappraisal|cognitive reappraisal
4649728|NCT03557710|functional magnetic resonance imaging (fMRI)|functional magnetic resonance imaging (fmri)
4649729|NCT03557710|vmPFC|vmpfc
4649730|NCT03557710|inhibitory control|inhibitory control
4649731|NCT03557710|valuation|valuation
4649732|NCT03557697|Chinese Americans|chinese americans
4649733|NCT03557697|SMS intervention|sms intervention
4649734|NCT03557645|mechanical ventilation|mechanical ventilation
4649735|NCT03557645|physiotherapy|physiotherapy
4649736|NCT03557645|ventilator hyperinflation|ventilator hyperinflation
4649737|NCT03557645|airway clearance technique|airway clearance technique
4649738|NCT03557632|Opioid Dependence|opioid dependence
4649739|NCT03557632|Injection Drug Use|injection drug use
4649740|NCT03557632|Hispanics|hispanics
4649741|NCT03557632|Mexican Americans|mexican americans
4649742|NCT03557632|Virtual Reality Cue Exposure|virtual reality cue exposure
4649743|NCT03557619|Cancer|cancer
4649744|NCT03557619|Hematologic Malignancies, venetoclax|hematologic malignancies, venetoclax
4649745|NCT03557619|ethinyl estradiol|ethinyl estradiol
4649746|NCT03557619|relapsed or refractory non-Hodgkin's lymphoma|relapsed or refractory non-hodgkin's lymphoma
4649747|NCT03557619|non-Hodgkin's lymphoma|non-hodgkin's lymphoma
4649748|NCT03557606|CCJ|ccj
4649749|NCT03557606|Bone Marrow Concentrate|bone marrow concentrate
4649750|NCT03557606|Stem Cell Therapy|stem cell therapy
4649751|NCT03557606|Alar Ligament|alar ligament
4649752|NCT03557606|Transverse Ligament|transverse ligament
4649753|NCT03557593|Antipsychotic|antipsychotic
4649754|NCT03557593|Nursing home|nursing home
4649755|NCT03557593|Long-term care|long-term care
4649756|NCT03557554|Massage|massage
4649757|NCT03557554|Breast Cancer|breast cancer
4649758|NCT03557554|Neuropathy|neuropathy
4649759|NCT03557541|diabetes|diabetes
4649760|NCT03557541|T2D|t2d
4649761|NCT03557541|diet|diet
4649762|NCT03557541|nutrition|nutrition
4649763|NCT03557541|prediabetes|prediabetes
4649764|NCT03557541|sardine|sardine
4649765|NCT03557541|elderly|elderly
4649766|NCT03557515|Depression|depression
4649767|NCT03557515|Cognitive Behavioral Therapy|cognitive behavioral therapy
4649768|NCT03557515|Coping|coping
4649769|NCT03557515|Meditation|meditation
4649770|NCT03557515|Anxiety|anxiety
4649771|NCT03557502|Stage 1 hypertension|stage 1 hypertension
4649772|NCT03557502|Arterial Stiffness|arterial stiffness
4649773|NCT03557476|Octacosanol|octacosanol
4649774|NCT03557476|Taekwondo|taekwondo
4649775|NCT03557476|Lipid Profiles|lipid profiles
4649776|NCT03557476|Oxidative Stress|oxidative stress
4649777|NCT03557437|Helicobacter pylori Therapy|helicobacter pylori therapy
4649778|NCT03557424|Polyglucosamine|polyglucosamine
4649779|NCT03557424|Glucomannan|glucomannan
4649780|NCT03557424|Weight reduction|weight reduction
4649781|NCT03557424|Weight loss|weight loss
4649782|NCT03557424|without change in lifestyle|without change in lifestyle
4649783|NCT03557411|SHR-1210,radiotherapy,Oligometastases,NSCLC|shr-1210,radiotherapy,oligometastases,nsclc
4649784|NCT03557398|Hyaluronic acid|hyaluronic acid
4649785|NCT03557398|Post-menopause|post-menopause
4649786|NCT03557385|Fractional Flow Reserve|fractional flow reserve
4649787|NCT03557372|Recurrent glioblastoma|recurrent glioblastoma
4649788|NCT03557372|Radiation Therapy|radiation therapy
4649789|NCT03557359|Recurrent|recurrent
4649790|NCT03557359|Progressive|progressive
4649791|NCT03557359|High Grade Glioma|high grade glioma
4649792|NCT03557359|IDH Mutant|idh mutant
4649793|NCT03557320|environment|environment
4649794|NCT03557320|pressure|pressure
4649795|NCT03557320|temperature|temperature
4649796|NCT03557320|case-crossover|case-crossover
4649797|NCT03557307|Asthma|asthma
4649798|NCT03557307|Severe Asthma|severe asthma
4649799|NCT03557307|Oral Corticosteroids|oral corticosteroids
4649800|NCT03557281|Early bactericidal activity|early bactericidal activity
4649801|NCT03557281|Mycobacterium Tuberculosis|mycobacterium tuberculosis
4649802|NCT03557281|GSK3036656|gsk3036656
4649803|NCT03557281|Pulmonary tuberculosis|pulmonary tuberculosis
4649804|NCT03557281|Colony forming units|colony forming units
4649805|NCT03557229|Oxidative Stress|oxidative stress
4649806|NCT03557229|Sepsis|sepsis
4649807|NCT03557229|Treatment|treatment
4649808|NCT03557229|Antioxidant therapy|antioxidant therapy
4649809|NCT03557216|Diverticulitis|diverticulitis
4649810|NCT03557216|Advanced colonic neoplasm|advanced colonic neoplasm
4649811|NCT03557216|Colonoscopy|colonoscopy
4649812|NCT03557203|Vernal Keratoconjunctivitis|vernal keratoconjunctivitis
4649813|NCT03557203|Atopic Keratoconjunctivitis|atopic keratoconjunctivitis
4649814|NCT03557203|tacrolimus|tacrolimus
4649815|NCT03557190|VEGF inhibitors|vegf inhibitors
4649816|NCT03557190|hypertension|hypertension
4649817|NCT03557190|endothelial function|endothelial function
4649818|NCT03557190|thrombosis|thrombosis
4649819|NCT03557190|venous occlusion plethysmography|venous occlusion plethysmography
4649820|NCT03557177|cisplatin|cisplatin
4649821|NCT03557177|flow mediated dilatation|flow mediated dilatation
4649822|NCT03557138|SGLT2 inhibitor|sglt2 inhibitor
4649823|NCT03557138|18F-FDG|18f-fdg
4649824|NCT03557138|alpha-Methyl-4-18F-FDG|alpha-methyl-4-18f-fdg
4649825|NCT03557112|Locally Advanced Nasopharyngeal Carcinoma|locally advanced nasopharyngeal carcinoma
4649826|NCT03557112|nimotuzumab|nimotuzumab
4649827|NCT03557112|chemoradiotherapy|chemoradiotherapy
4649828|NCT03557112|cisplatin|cisplatin
4649830|NCT03557073|Hand injuries, Hand trauma, Patient reported outcomes|hand injuries, hand trauma, patient reported outcomes
4649831|NCT03557060|Nucala|nucala
4649832|NCT03557060|Drug use investigation|drug use investigation
4649833|NCT03557060|EGPA|egpa
4649834|NCT03557060|Long-term|long-term
4649835|NCT03557034|pulmonary vein isolation|pulmonary vein isolation
4649836|NCT03557034|atrial fibrillation|atrial fibrillation
4649837|NCT03557034|remote monitoring|remote monitoring
4649838|NCT03557034|heart rhythm monitor|heart rhythm monitor
4649839|NCT03557008|Rabies Vaccine|rabies vaccine
4649840|NCT03557008|Antibiotics|antibiotics
4649841|NCT03557008|Biopsy|biopsy
4649842|NCT03556982|Acute Myeloid Leukemia|acute myeloid leukemia
4649843|NCT03556982|Relapsed|relapsed
4649844|NCT03556982|Refractory|refractory
4649845|NCT03556930|Non-sedated radiotherapy treatment|non-sedated radiotherapy treatment
4649846|NCT03556878|Circadian rhythm disorders|circadian rhythm disorders
4649847|NCT03556878|Sleep disorders|sleep disorders
4649848|NCT03556878|Acceptability|acceptability
4649849|NCT03556878|Adaptation|adaptation
4649850|NCT03556878|Feasibility|feasibility
4649851|NCT03556839|Cervix|cervix
4649852|NCT03556839|Carcinoma|carcinoma
4649853|NCT03556839|Atezolizumab|atezolizumab
4649854|NCT03556813|Patient information|patient information
4649855|NCT03556813|Natural Language Processing|natural language processing
4649856|NCT03556813|Conversational agent|conversational agent
4649857|NCT03556813|Chatbot|chatbot
4649858|NCT03556800|Hypoestrogenism|hypoestrogenism
4649859|NCT03556800|Menopausal hormone therapy|menopausal hormone therapy
4649860|NCT03556761|Furosemide|furosemide
4649861|NCT03556761|Postpartum|postpartum
4649862|NCT03556761|Hypertension|hypertension
4649863|NCT03556748|hematological malignancies|hematological malignancies
4649864|NCT03556748|leukemia|leukemia
4649865|NCT03556748|myeloma|myeloma
4649866|NCT03556748|lymphoma|lymphoma
4649867|NCT03556748|exercise|exercise
4649868|NCT03556748|nutrition|nutrition
4649869|NCT03556748|protein|protein
4649870|NCT03556748|WB-EMS|wb-ems
4649871|NCT03556748|whole-body electromyostimulation|whole-body electromyostimulation
4649872|NCT03556735|Depression, unipolar|depression, unipolar
4649873|NCT03556735|Treatment resistant|treatment resistant
4649874|NCT03556735|PEMF|pemf
4649875|NCT03556722|Repetitive Transcranial Magnetic Stimulation|repetitive transcranial magnetic stimulation
4649876|NCT03556722|Transcranial Doppler|transcranial doppler
4649877|NCT03556722|Neuromodulation|neuromodulation
4649878|NCT03556722|Randomized Controlled Trials|randomized controlled trials
4649879|NCT03556722|Pain|pain
4649880|NCT03556722|Migraine prophylaxis|migraine prophylaxis
4649881|NCT03556722|Dorsolateral Prefrontal Cortex|dorsolateral prefrontal cortex
4649882|NCT03556722|Protocol|protocol
4649982|NCT03556137|PET/MRI|pet/mri
4649883|NCT03556696|general anesthesia|general anesthesia
4649884|NCT03556696|analgesia/nociception balance monitoring|analgesia/nociception balance monitoring
4649885|NCT03556696|expert system|expert system
4649886|NCT03556683|asthma, hypertonic saline|asthma, hypertonic saline
4649887|NCT03556657|Music Therapy|music therapy
4649888|NCT03556657|Sickle Cell Disease|sickle cell disease
4649889|NCT03556657|Quality of Life|quality of life
4649890|NCT03556657|Chronic Pain|chronic pain
4649891|NCT03556644|Near Infrared Spectroscopy|near infrared spectroscopy
4649892|NCT03556644|Computed Tomography Coronary Angiography|computed tomography coronary angiography
4649893|NCT03556644|Atherosclerosis|atherosclerosis
4649894|NCT03556644|Endothelial Shear Stress|endothelial shear stress
4649895|NCT03556566|ovary|ovary
4649896|NCT03556566|ovarian|ovarian
4649897|NCT03556566|immunotherapy|immunotherapy
4649898|NCT03556566|cancer|cancer
4649899|NCT03556553|composite resin|composite resin
4649900|NCT03556553|occlusal caries|occlusal caries
4649901|NCT03556540|Chronic Kidney Disease|chronic kidney disease
4649902|NCT03556540|Hemodialysis|hemodialysis
4649903|NCT03556540|Exercise|exercise
4649904|NCT03556527|osteotomy|osteotomy
4649905|NCT03556527|reverse oblique sigmoid notch|reverse oblique sigmoid notch
4649906|NCT03556527|ulnar impaction syndrome|ulnar impaction syndrome
4649907|NCT03556527|ulnar shortening|ulnar shortening
4649908|NCT03556514|Locking Plate Fixaion|locking plate fixaion
4649909|NCT03556488|Chest ultrasound|chest ultrasound
4649910|NCT03556488|Pediatric community acquired pneumonia|pediatric community acquired pneumonia
4649911|NCT03556488|Air bronchogram|air bronchogram
4649912|NCT03556449|scapula/innervation*|scapula/innervation*
4649913|NCT03556449|Thoracic Nerves/injuries*|thoracic nerves/injuries*
4649914|NCT03556449|Peripheral Nerve Injuries|peripheral nerve injuries
4649915|NCT03556449|Shoulder|shoulder
4649916|NCT03556449|Musculoskeletal Diseases/diagnosis*|musculoskeletal diseases/diagnosis*
4649917|NCT03556436|YH25448|yh25448
4649918|NCT03556436|Non-Small Cell Lung Cancer|non-small cell lung cancer
4649919|NCT03556423|Arthritis|arthritis
4649920|NCT03556423|Chronic pain|chronic pain
4649921|NCT03556423|Transcranial magnetic stimulation (TMS)|transcranial magnetic stimulation (tms)
4649922|NCT03556423|Magnetic resonance imaging (MRI)|magnetic resonance imaging (mri)
4649923|NCT03556423|Conditioned pain modulation (CPM)|conditioned pain modulation (cpm)
4649924|NCT03556423|Clinical measures|clinical measures
4649925|NCT03556423|Knee osteoarthritis|knee osteoarthritis
4649926|NCT03556410|Sleep|sleep
4649927|NCT03556410|Obesity|obesity
4649928|NCT03556410|Metabolic Syndrome|metabolic syndrome
4649929|NCT03556410|Physical Activity|physical activity
4649930|NCT03556397|breast cancer|breast cancer
4649931|NCT03556397|neoadjuvant therapy|neoadjuvant therapy
4649932|NCT03556397|sentinel lymph node biopsy|sentinel lymph node biopsy
4649933|NCT03556397|axillary dissection|axillary dissection
4649934|NCT03556384|cancer|cancer
4649935|NCT03556384|Temozolomide|temozolomide
4649936|NCT03556384|GIST|gist
4649937|NCT03556384|SDH-Mutant/Deficient|sdh-mutant/deficient
4649938|NCT03556384|SDH|sdh
4649939|NCT03556384|Succinate Dehydrogenase|succinate dehydrogenase
4649940|NCT03556371|Cocaine|cocaine
4649941|NCT03556371|Coca Paste|coca paste
4649942|NCT03556371|N-Acetylcysteine|n-acetylcysteine
4649943|NCT03556371|Craving|craving
4649944|NCT03556371|Abstinence|abstinence
4649945|NCT03556358|trastuzumab|trastuzumab
4649946|NCT03556358|Herceptin|herceptin
4649947|NCT03556345|RC48-ADC|rc48-adc
4649948|NCT03556345|HER2 overexpression|her2 overexpression
4649949|NCT03556345|Gastric cancer|gastric cancer
4649950|NCT03556332|Carfilzomib|carfilzomib
4649951|NCT03556332|Lenalidomide|lenalidomide
4649952|NCT03556332|Dexamethasone|dexamethasone
4649953|NCT03556332|Daratumumab|daratumumab
4649954|NCT03556332|salvage autologous hematopoietic cell transplantation|salvage autologous hematopoietic cell transplantation
4649955|NCT03556332|17-493|17-493
4649956|NCT03556319|Multiple Dosage|multiple dosage
4649957|NCT03556280|Dementia|dementia
4649958|NCT03556280|Alzheimer's Disease|alzheimer's disease
4649959|NCT03556280|Cognitive Impairment|cognitive impairment
4649960|NCT03556254|Helicobacter pylori infection|helicobacter pylori infection
4649961|NCT03556254|Genotypic resistance|genotypic resistance
4649962|NCT03556254|Antimicrobial susceptibility|antimicrobial susceptibility
4649963|NCT03556228|TrkA|trka
4649964|NCT03556228|NTRK1|ntrk1
4649965|NCT03556228|Thymic|thymic
4649966|NCT03556228|Pancreatic|pancreatic
4649967|NCT03556228|TNBC|tnbc
4649968|NCT03556215|otitis media with effusion|otitis media with effusion
4649969|NCT03556215|balloon tuboplasty|balloon tuboplasty
4649970|NCT03556215|Eustachian tube|eustachian tube
4649971|NCT03556215|Eustachian tube dysfunction|eustachian tube dysfunction
4649972|NCT03556202|IL-23|il-23
4649973|NCT03556202|Interleukin-23|interleukin-23
4649974|NCT03556202|Psoriasis|psoriasis
4649975|NCT03556176|Anxiety|anxiety
4649976|NCT03556176|Mood|mood
4649977|NCT03556176|Physical activity|physical activity
4649978|NCT03556176|Polymorphisms|polymorphisms
4649979|NCT03556163|Chronic periodontitis|chronic periodontitis
4649980|NCT03556163|Modified Widman flap surgery|modified widman flap surgery
4649981|NCT03556163|Suturing technique|suturing technique
4649983|NCT03556137|Chronic Pain|chronic pain
4649984|NCT03556137|Pediatric|pediatric
4649985|NCT03556124|Transcranial direct current stimulation|transcranial direct current stimulation
4649986|NCT03556124|major depression|major depression
4649987|NCT03556124|MRI|mri
4649988|NCT03556111|implant , sticky bone|implant , sticky bone
4649989|NCT03556098|Diabetes Mellitus, Type 1|diabetes mellitus, type 1
4649990|NCT03556098|Hypoglycemia|hypoglycemia
4649991|NCT03556098|Gastric Inhibitory Polypeptide|gastric inhibitory polypeptide
4649992|NCT03556098|Glucagon|glucagon
4649993|NCT03556098|Incretin|incretin
4649994|NCT03556085|idiopathic intracranial hypertension|idiopathic intracranial hypertension
4649995|NCT03556085|venous sinus stenting|venous sinus stenting
4649996|NCT03556072|ERCP|ercp
4649997|NCT03556072|periampullary diverticula|periampullary diverticula
4649998|NCT03556072|difficulty cannulation|difficulty cannulation
4649999|NCT03556072|complication|complication
4650000|NCT03556072|biliary disorder|biliary disorder
4650001|NCT03556059|EOSS|eoss
4650002|NCT03556059|Obesity and metabolic surgery|obesity and metabolic surgery
4650003|NCT03556059|postoperative outcome|postoperative outcome
4650004|NCT03556059|procedure selection|procedure selection
4650005|NCT03556046|Clear Cell Renal Carcinoma|clear cell renal carcinoma
4650006|NCT03556007|T regulatory cells|t regulatory cells
4650007|NCT03555994|0382, T2DM|0382, t2dm
4650008|NCT03555968|THC|thc
4650009|NCT03555968|Alcohol|alcohol
4650010|NCT03555968|Driving|driving
4650011|NCT03555968|Dronabinol|dronabinol
4650012|NCT03555929|Axillary block|axillary block
4650013|NCT03555929|Dexamethasone|dexamethasone
4650014|NCT03555929|anesthesia|anesthesia
4650015|NCT03555916|BOTOX®-Allergan|botox®-allergan
4650016|NCT03555916|PPTTN|ppttn
4650017|NCT03555916|Pain measurements|pain measurements
4650018|NCT03555890|Oral disintegrating tablet|oral disintegrating tablet
4650019|NCT03555890|Levocetirizine|levocetirizine
4650020|NCT03555890|Immediate release tablet|immediate release tablet
4650021|NCT03555890|Bioequivalence|bioequivalence
4650022|NCT03555890|Japanese subjects|japanese subjects
4650023|NCT03555877|Ribociclib|ribociclib
4650024|NCT03555877|Anti-hormonal maintainance treatment|anti-hormonal maintainance treatment
4650025|NCT03555877|HR-positive|hr-positive
4650026|NCT03555877|HER2-negative|her2-negative
4650027|NCT03555812|Hip, Arthroplasty, pelvic inclination, ultrasound|hip, arthroplasty, pelvic inclination, ultrasound
4650028|NCT03555773|perianal Crohn's disease|perianal crohn's disease
4650029|NCT03555773|mesenchymal stromal cells|mesenchymal stromal cells
4650030|NCT03555773|complex anal fistulas|complex anal fistulas
4650031|NCT03555773|micro-fragmented adipose tissue|micro-fragmented adipose tissue
4650032|NCT03555773|regenerative medicine|regenerative medicine
4650033|NCT03555747|Canine distalization|canine distalization
4650034|NCT03555747|Gingival crevicular fluid|gingival crevicular fluid
4650035|NCT03555747|Cytokines|cytokines
4650036|NCT03555747|Orthodontic force|orthodontic force
4650037|NCT03555747|Periodontium|periodontium
4650038|NCT03555747|Gingivitis|gingivitis
4650039|NCT03555734|Pulses (beans, chickpeas, lentils, dry peas)|pulses (beans, chickpeas, lentils, dry peas)
4650040|NCT03555734|Legumes|legumes
4650041|NCT03555734|Cardiovascular disease|cardiovascular disease
4650042|NCT03555734|Coronary heart disease|coronary heart disease
4650043|NCT03555734|Stroke|stroke
4650044|NCT03555734|Diabetes|diabetes
4650045|NCT03555734|Hypertension|hypertension
4650046|NCT03555734|Obesity|obesity
4650047|NCT03555734|Prospective cohort studies|prospective cohort studies
4650048|NCT03555734|Umbrella review|umbrella review
4650049|NCT03555734|Systematic review and meta-analysis|systematic review and meta-analysis
4650050|NCT03555708|Gait Training|gait training
4650051|NCT03555708|Power Training|power training
4650052|NCT03555708|Action-Perception Training|action-perception training
4650053|NCT03555708|Brain Imaging|brain imaging
4650054|NCT03555708|Mobility|mobility
4650055|NCT03555695|karate|karate
4650056|NCT03555695|exercise|exercise
4650057|NCT03555682|Multiple Dosage|multiple dosage
4650058|NCT03555669|Implementation Science|implementation science
4650059|NCT03555669|Malawi|malawi
4650060|NCT03555643|TIA|tia
4650061|NCT03555643|Stroke|stroke
4650062|NCT03555643|Ischemia|ischemia
4650063|NCT03555643|MRI|mri
4650064|NCT03555643|FLAIR|flair
4650065|NCT03555643|hyperintense acute reperfusion marker|hyperintense acute reperfusion marker
4650066|NCT03555617|healthy volunteers|healthy volunteers
4650067|NCT03555617|drug-drug interaction|drug-drug interaction
4650068|NCT03555617|itraconazole|itraconazole
4650069|NCT03555617|CYP3A|cyp3a
4650070|NCT03555617|P-gp|p-gp
4650071|NCT03555617|Inflammatory Bowel Disease|inflammatory bowel disease
4650072|NCT03555617|IBD|ibd
4650073|NCT03555617|Irritable Bowel Syndrome|irritable bowel syndrome
4650074|NCT03555617|IBS|ibs
4650075|NCT03555539|Hepatic Impairment|hepatic impairment
4650076|NCT03555539|ACH-0144471|ach-0144471
4650077|NCT03555500|Fasting|fasting
4650078|NCT03555500|Non fasting|non fasting
4650079|NCT03555500|Cardiac catheterization|cardiac catheterization
4650080|NCT03555487|Hyperparathyroidism|hyperparathyroidism
4650081|NCT03555487|18F choline|18f choline
4650082|NCT03555487|PET|pet
4650584|NCT03552081|tobacco|tobacco
4650083|NCT03555487|Tc-99m sestaMIBI|tc-99m sestamibi
4650084|NCT03555487|SPECT|spect
4650085|NCT03555448|Immunosuppression|immunosuppression
4650086|NCT03555435|Problem-solving|problem-solving
4650087|NCT03555435|World Wide Web|world wide web
4650088|NCT03555435|Peer support|peer support
4650089|NCT03555435|Online mental health program|online mental health program
4650090|NCT03555383|bloodless transplantation|bloodless transplantation
4650091|NCT03555383|hemostasis reserve capacity|hemostasis reserve capacity
4650092|NCT03555383|surgery|surgery
4650093|NCT03555370|adolescent|adolescent
4650094|NCT03555370|concussion|concussion
4650095|NCT03555357|Abdomen|abdomen
4650096|NCT03555357|Abdominoplasty|abdominoplasty
4650097|NCT03555357|Scar Therapy|scar therapy
4650098|NCT03555357|Scar|scar
4650099|NCT03555331|responsive parenting|responsive parenting
4650100|NCT03555318|Heart failure|heart failure
4650101|NCT03555318|Frailty|frailty
4650102|NCT03555318|Outcome|outcome
4650103|NCT03555318|Hospitalization|hospitalization
4650104|NCT03555318|Mortality|mortality
4650105|NCT03555292|11C-PIB|11c-pib
4650106|NCT03555292|Parkinson's disease|parkinson's disease
4650107|NCT03555292|dementia|dementia
4650108|NCT03555292|mild cognitive impairment|mild cognitive impairment
4650109|NCT03555279|HIV Prevention|hiv prevention
4650110|NCT03555279|Juvenile Justice|juvenile justice
4650111|NCT03555279|Sexual Health|sexual health
4650112|NCT03555279|Evidence Based Intervention|evidence based intervention
4650113|NCT03555266|Pain Therapy|pain therapy
4650114|NCT03555266|Auricular Therapy|auricular therapy
4650115|NCT03555253|Resilience|resilience
4650116|NCT03555253|Telehealth|telehealth
4650117|NCT03555253|Well-being|well-being
4650118|NCT03555253|Support|support
4650119|NCT03555253|Caregiving|caregiving
4650120|NCT03555240|Rheumatoid Arthritis|rheumatoid arthritis
4650121|NCT03555227|breast cancer analgesia|breast cancer analgesia
4650122|NCT03555227|pecs2 blocks|pecs2 blocks
4650123|NCT03555227|ultrasound|ultrasound
4650124|NCT03555214|migraine|migraine
4650125|NCT03555214|manual therapy|manual therapy
4650126|NCT03555188|Diarrhoea|diarrhoea
4650127|NCT03555162|Tool|tool
4650128|NCT03555162|fMRI|fmri
4650129|NCT03555162|neuroimaging|neuroimaging
4650130|NCT03555162|Evolution|evolution
4650131|NCT03555110|EMDR Therapy|emdr therapy
4650132|NCT03555110|Bariatric Surgery|bariatric surgery
4650133|NCT03555110|Obesity|obesity
4650134|NCT03555097|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
4650135|NCT03555097|Non-invasive Positive Pressure Ventilation|non-invasive positive pressure ventilation
4650136|NCT03555097|Respiratory Mechanics|respiratory mechanics
4650137|NCT03555097|Neural Respiratory Drive|neural respiratory drive
4650138|NCT03555071|live attenuated varicella vaccine|live attenuated varicella vaccine
4650139|NCT03555071|consistency|consistency
4650140|NCT03555071|immunogenicity|immunogenicity
4650141|NCT03555071|safety|safety
4650142|NCT03555071|children|children
4650143|NCT03555019|Brain maturation|brain maturation
4650144|NCT03555019|Postnatal growth|postnatal growth
4650145|NCT03554993|Healthy Volunteer|healthy volunteer
4650146|NCT03554993|Safety|safety
4650147|NCT03554993|CC-99677|cc-99677
4650148|NCT03554967|Oral Squamous Cell Carcinoma|oral squamous cell carcinoma
4650149|NCT03554967|Toluidine Blue|toluidine blue
4650150|NCT03554967|Frozen Section|frozen section
4650151|NCT03554967|Tumor margin assessment|tumor margin assessment
4650152|NCT03554954|Nutrients|nutrients
4650153|NCT03554954|Diet|diet
4650154|NCT03554954|Sleep Quality|sleep quality
4650155|NCT03554954|Middle-aged adults|middle-aged adults
4650156|NCT03554954|Older adults|older adults
4650157|NCT03554915|Agitation, Ketamine, Midazolam, Emergency Medical Services|agitation, ketamine, midazolam, emergency medical services
4650158|NCT03554902|Endoscopic gastric tubulization|endoscopic gastric tubulization
4650159|NCT03554902|Weight loss|weight loss
4650160|NCT03554902|Quality of life|quality of life
4650161|NCT03554876|Biofilm|biofilm
4650162|NCT03554876|peri-implantitis|peri-implantitis
4650163|NCT03554876|metagenomic analysis|metagenomic analysis
4650164|NCT03554876|abutment|abutment
4650165|NCT03554863|Anesthesia genral, Oxygen|anesthesia genral, oxygen
4650166|NCT03554837|safety|safety
4650167|NCT03554837|effectiveness|effectiveness
4650168|NCT03554837|low dose|low dose
4650169|NCT03554759|Chronic Liver Disease|chronic liver disease
4650170|NCT03554759|Low Platelet Count|low platelet count
4650171|NCT03554733|self efficacy|self efficacy
4650172|NCT03554733|participation|participation
4650173|NCT03554733|satisfaction with life|satisfaction with life
4650174|NCT03554707|Childhood CNS tumor|childhood cns tumor
4650175|NCT03554707|Recurrent CNS malignancies|recurrent cns malignancies
4650176|NCT03554707|Progressive CNS malignancies|progressive cns malignancies
4650177|NCT03554707|Refractory CNS malignancies|refractory cns malignancies
4650178|NCT03554681|Bayes Model|bayes model
4650179|NCT03554655|Shared decision making|shared decision making
4650180|NCT03554655|Patient activation|patient activation
4650181|NCT03554655|Schizophrenia|schizophrenia
4650182|NCT03554655|First-episode psychosis|first-episode psychosis
4650183|NCT03554655|mHealth|mhealth
4650184|NCT03554655|Randomized clinical trial|randomized clinical trial
4650185|NCT03554603|Long term care|long term care
4650186|NCT03554603|Urine culture|urine culture
4650187|NCT03554590|carbohydrate counting|carbohydrate counting
4650188|NCT03554590|insulin therapy|insulin therapy
4650189|NCT03554564|peripheral artery disease|peripheral artery disease
4650190|NCT03554564|claudication|claudication
4650191|NCT03554564|supervised exercise therapy|supervised exercise therapy
4650192|NCT03554564|walking|walking
4650193|NCT03554564|quality of life|quality of life
4650194|NCT03554551|Parasympathetic|parasympathetic
4650195|NCT03554538|Shoulder impingement syndrome|shoulder impingement syndrome
4650196|NCT03554538|Exercise web app|exercise web app
4650197|NCT03554538|Efficacy|efficacy
4650198|NCT03554525|Obesity|obesity
4650199|NCT03554525|Overweight|overweight
4650200|NCT03554525|Weight Loss|weight loss
4650201|NCT03554525|Body weight maintenance|body weight maintenance
4650202|NCT03554525|Weight Change, Body|weight change, body
4650203|NCT03554525|Saccharomyces Cerevisiae|saccharomyces cerevisiae
4650204|NCT03554525|Beta-glucans|beta-glucans
4650205|NCT03554512|Neonatal Intensive Care|neonatal intensive care
4650206|NCT03554512|Telehealth|telehealth
4650207|NCT03554512|Anxiety|anxiety
4650208|NCT03554512|Self Efficacy|self efficacy
4650209|NCT03554512|Parenting/psychology|parenting/psychology
4650210|NCT03554499|Facial aging|facial aging
4650211|NCT03554499|Buccal fat pad|buccal fat pad
4650212|NCT03554473|Chemosensitivity|chemosensitivity
4650213|NCT03554473|DNA Damage and Replication|dna damage and replication
4650214|NCT03554473|PD-1/PD-L1|pd-1/pd-l1
4650215|NCT03554473|Solid Tumors|solid tumors
4650216|NCT03554473|Checkpoint Inhibitors|checkpoint inhibitors
4650217|NCT03554447|Pentoxifylline|pentoxifylline
4650218|NCT03554447|Anti-inflammatory|anti-inflammatory
4650219|NCT03554447|MDD|mdd
4650220|NCT03554447|phosphodiastrase inhibitors|phosphodiastrase inhibitors
4650221|NCT03554421|Key Words: Anal Fissure, tibial nerve stimulation|key words: anal fissure, tibial nerve stimulation
4650222|NCT03554408|10-1074-LS|10-1074-ls
4650223|NCT03554408|3BNC117-LS|3bnc117-ls
4650224|NCT03554408|First in Human|first in human
4650225|NCT03554408|Dose Escalation|dose escalation
4650226|NCT03554395|PD-1 activated CIK|pd-1 activated cik
4650227|NCT03554395|MUC1|muc1
4650228|NCT03554395|bispecific antibody|bispecific antibody
4650229|NCT03554395|gastric cancer|gastric cancer
4650230|NCT03554382|person-centred care (PCC)|person-centred care (pcc)
4650231|NCT03554382|self-efficacy|self-efficacy
4650232|NCT03554369|Prostate|prostate
4650233|NCT03554369|Dose-Limiting Toxicity|dose-limiting toxicity
4650234|NCT03554369|Maximum Tolerated Dose|maximum tolerated dose
4650235|NCT03554369|Stereotactic Body Radiation Therapy (SBRT)|stereotactic body radiation therapy (sbrt)
4650236|NCT03554343|newborn screening|newborn screening
4650237|NCT03554330|pulmonary arterial hypertension|pulmonary arterial hypertension
4650238|NCT03554330|balloon atrial septostomy|balloon atrial septostomy
4650239|NCT03554330|radiofrequency catheter ablation|radiofrequency catheter ablation
4650240|NCT03554330|spontaneous closure|spontaneous closure
4650241|NCT03554317|Bipolar Androgen Therapy|bipolar androgen therapy
4650242|NCT03554317|Testosterone|testosterone
4650243|NCT03554317|Nivolumab|nivolumab
4650244|NCT03554291|famotidine|famotidine
4650245|NCT03554291|H2 blocker|h2 blocker
4650246|NCT03554291|H2 antagonist|h2 antagonist
4650247|NCT03554278|NEC|nec
4650248|NCT03554278|transfusion|transfusion
4650249|NCT03554278|microbiome|microbiome
4650250|NCT03554278|premature|premature
4650251|NCT03554265|growth hormone|growth hormone
4650252|NCT03554265|Traumatic Brain injury|traumatic brain injury
4650253|NCT03554265|concussion|concussion
4650254|NCT03554265|mTBI|mtbi
4650255|NCT03554265|fatigue|fatigue
4650256|NCT03554265|cognitive impairment|cognitive impairment
4650257|NCT03554265|BIAFAC|biafac
4650258|NCT03554239|Genotyping techniques|genotyping techniques
4650259|NCT03554239|Fungal infection|fungal infection
4650260|NCT03554226|agitation|agitation
4650261|NCT03554226|aggressivity|aggressivity
4650262|NCT03554200|Empagliflozin|empagliflozin
4650263|NCT03554200|acute heart failure|acute heart failure
4650264|NCT03554200|cardiac output|cardiac output
4650265|NCT03554200|left ventricular systolic and diastolic function|left ventricular systolic and diastolic function
4650266|NCT03554200|exercise capacity|exercise capacity
4650267|NCT03554174|psilocybin|psilocybin
4650268|NCT03554161|Tocilizumab|tocilizumab
4650269|NCT03554161|Refractory uveitis|refractory uveitis
4650270|NCT03554109|TNBC|tnbc
4650271|NCT03554096|Multiple Dosage|multiple dosage
4650272|NCT03554070|Prostate|prostate
4650273|NCT03554070|BPH|bph
4650274|NCT03554070|Laser|laser
4650275|NCT03554070|Endoscopic Enucleation of the Prostate|endoscopic enucleation of the prostate
4650276|NCT03554070|Thulium|thulium
4650277|NCT03554070|Thulium Fiber Laser|thulium fiber laser
4650278|NCT03554057|Angiogram, Coronary Computed Tomographic Angiography|angiogram, coronary computed tomographic angiography
4650279|NCT03553992|Tobacco|tobacco
4650280|NCT03553992|Gender Identity Minority|gender identity minority
4650281|NCT03553992|Sexual Identity Minority|sexual identity minority
4650282|NCT03553992|Cessation|cessation
4650283|NCT03553992|Intervention|intervention
4650284|NCT03553992|Young Adults|young adults
4650285|NCT03553992|Social Media|social media
4650286|NCT03553992|Internet|internet
4650287|NCT03553992|Cigarette|cigarette
4650288|NCT03553979|stress management|stress management
4650289|NCT03553979|stress intervention|stress intervention
4650290|NCT03553979|smoking intervention|smoking intervention
4650291|NCT03553979|lower SES|lower ses
4650292|NCT03553979|lower income|lower income
4650293|NCT03553966|Dental caries|dental caries
4650294|NCT03553966|Toothpaste|toothpaste
4650295|NCT03553966|Fluoride|fluoride
4650296|NCT03553966|Hydroxyapatite|hydroxyapatite
4650297|NCT03553953|Anesthesia|anesthesia
4650298|NCT03553953|Bispectral index (BIS™)|bispectral index (bis™)
4650299|NCT03553940|H3N2 M2SR Prime|h3n2 m2sr prime
4650300|NCT03553940|Immunogenicity|immunogenicity
4650301|NCT03553940|Influenza|influenza
4650302|NCT03553940|Pediatric|pediatric
4650303|NCT03553940|QIV|qiv
4650304|NCT03553940|Safety|safety
4650305|NCT03553940|Vaccine|vaccine
4650306|NCT03553888|Hidradenitis Suppurativa|hidradenitis suppurativa
4650307|NCT03553888|Periodontal diseases|periodontal diseases
4650308|NCT03553888|Multicenter cross-sectional study|multicenter cross-sectional study
4650309|NCT03553888|Vibrational spectroscopies|vibrational spectroscopies
4650310|NCT03553888|Salivary biomarkers|salivary biomarkers
4650311|NCT03553875|Autism|autism
4650312|NCT03553875|Massachusetts General Hospital|massachusetts general hospital
4650313|NCT03553849|Very low calorie diet|very low calorie diet
4650314|NCT03553849|General surgery|general surgery
4650315|NCT03553836|Programmed Cell Death Receptor 1 (PD1)|programmed cell death receptor 1 (pd1)
4650316|NCT03553836|Programmed Cell Death Receptor 1 (PD-1)|programmed cell death receptor 1 (pd-1)
4650317|NCT03553836|Programmed Cell Death Receptor Ligand 1 (PDL1)|programmed cell death receptor ligand 1 (pdl1)
4650318|NCT03553836|Programmed Cell Death Receptor Ligand 1 (PD-L1)|programmed cell death receptor ligand 1 (pd-l1)
4650319|NCT03553823|Psoriasis|psoriasis
4650320|NCT03553784|Cancer|cancer
4650321|NCT03553784|Therapy|therapy
4650322|NCT03553771|aneurysm|aneurysm
4650323|NCT03553771|endovascular|endovascular
4650324|NCT03553732|active surveillance|active surveillance
4650325|NCT03553732|health information technology|health information technology
4650326|NCT03553732|patient safety|patient safety
4650327|NCT03553732|adherence|adherence
4650328|NCT03553732|ambulatory|ambulatory
4650329|NCT03553732|outpatient|outpatient
4650330|NCT03553732|human factors|human factors
4650331|NCT03553732|systems engineering|systems engineering
4650332|NCT03553732|vulnerable populations|vulnerable populations
4650333|NCT03553732|chronic disease|chronic disease
4650334|NCT03553706|growth restriction, nutritive status, comorbide disorders, Down Syndrome|growth restriction, nutritive status, comorbide disorders, down syndrome
4650336|NCT03553693|Viral Load|viral load
4650337|NCT03553693|Counseling|counseling
4650338|NCT03553693|Costs and Costs Analysis|costs and costs analysis
4650339|NCT03553693|Point-Of-Care Systems|point-of-care systems
4650340|NCT03553667|Hemodynamic Monitoring|hemodynamic monitoring
4650341|NCT03553667|Perioperative Care|perioperative care
4650342|NCT03553667|Outcome Assessment|outcome assessment
4650343|NCT03553641|capacity|capacity
4650344|NCT03553641|clinical ethics|clinical ethics
4650345|NCT03553641|autonomy|autonomy
4650346|NCT03553641|competence|competence
4650347|NCT03553628|dental caries|dental caries
4650348|NCT03553628|propolis|propolis
4650349|NCT03553628|chlorhexidine|chlorhexidine
4650350|NCT03553628|clove oil|clove oil
4650351|NCT03553628|bee wax|bee wax
4650352|NCT03553602|Prostate Cancer|prostate cancer
4650353|NCT03553602|HDR brachytherapy|hdr brachytherapy
4650354|NCT03553602|Recurrent Prostate Cancer|recurrent prostate cancer
4650355|NCT03553602|Oligometastasis|oligometastasis
4650356|NCT03553602|Salvage Brachytherapy|salvage brachytherapy
4650357|NCT03553602|Salvage Radiotherapy|salvage radiotherapy
4650358|NCT03553589|metabolomics|metabolomics
4650359|NCT03553589|proteomics|proteomics
4650360|NCT03553589|early diagnosis|early diagnosis
4650361|NCT03553589|prognosis|prognosis
4650362|NCT03553576|Labor pain|labor pain
4650363|NCT03553576|Epidural|epidural
4650364|NCT03553576|Obstetric|obstetric
4650365|NCT03553576|Labor Analgesia|labor analgesia
4650366|NCT03553563|D961H|d961h
4650367|NCT03553563|paediatric|paediatric
4650368|NCT03553563|reflux esophagitis|reflux esophagitis
4650369|NCT03553563|gastric ulcer|gastric ulcer
4650370|NCT03553537|Peripheral T-cell Lymphoma, decitabine|peripheral t-cell lymphoma, decitabine
4650371|NCT03553524|Type 2 Diabetes|type 2 diabetes
4650372|NCT03553524|Insulin independent|insulin independent
4650373|NCT03553524|HIIT|hiit
4650374|NCT03553524|CGM-based blood glucose|cgm-based blood glucose
4650375|NCT03553511|Laparoscopy|laparoscopy
4650376|NCT03553511|Hysterectomy|hysterectomy
4650377|NCT03553511|Uterosacral ligaments suspension|uterosacral ligaments suspension
4650378|NCT03553511|McCall culdoplasty|mccall culdoplasty
4650379|NCT03553511|Post-hysterectomy vault prolapse|post-hysterectomy vault prolapse
4650380|NCT03553498|pain|pain
4650381|NCT03553498|opioid analgesics|opioid analgesics
4650382|NCT03553498|Emergency Department|emergency department
4650383|NCT03553498|adult|adult
4650384|NCT03553498|randomized controlled trial|randomized controlled trial
4651484|NCT03546764|chest tube|chest tube
4650385|NCT03553459|fluid responsiveness|fluid responsiveness
4650386|NCT03553459|trendelenburg|trendelenburg
4650387|NCT03553459|extracorporeal membrane oxygenation|extracorporeal membrane oxygenation
4650388|NCT03553446|Sevoflurane|sevoflurane
4650389|NCT03553446|Motion|motion
4650390|NCT03553446|Botulinum toxins|botulinum toxins
4650391|NCT03553446|Cerebral palsy|cerebral palsy
4650392|NCT03553433|apremilast|apremilast
4650393|NCT03553433|quality of life|quality of life
4650394|NCT03553433|pruritus|pruritus
4650395|NCT03553433|oral drug|oral drug
4650396|NCT03553433|placebo|placebo
4650397|NCT03553420|lipodystrophy|lipodystrophy
4650398|NCT03553407|Low level laser|low level laser
4650399|NCT03553407|Pulpitis|pulpitis
4650400|NCT03553407|Mandibular molars|mandibular molars
4650401|NCT03553368|lung nodules|lung nodules
4650402|NCT03553355|infrared laser moxibustion|infrared laser moxibustion
4650403|NCT03553355|cancer-related fatigue|cancer-related fatigue
4650404|NCT03553355|breast cancer|breast cancer
4650405|NCT03553290|Dentistry|dentistry
4650406|NCT03553290|Dentinal Hypersensitivity|dentinal hypersensitivity
4650407|NCT03553290|lower-level laser therapy|lower-level laser therapy
4650408|NCT03553277|Dengue|dengue
4650409|NCT03553277|Zika|zika
4650410|NCT03553277|Chikungunya|chikungunya
4650411|NCT03553277|Spatial repellent|spatial repellent
4650412|NCT03553277|transfluthrin|transfluthrin
4650413|NCT03553251|Hypersensitivity|hypersensitivity
4650414|NCT03553251|Beta Lactam Adverse Reaction|beta lactam adverse reaction
4650415|NCT03553238|Early T-cell Precursor|early t-cell precursor
4650416|NCT03553238|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
4650417|NCT03553238|Histone Deacetylase Inhibitor|histone deacetylase inhibitor
4650418|NCT03553238|Chidamide|chidamide
4650419|NCT03553225|vascular function|vascular function
4650420|NCT03553225|endothelial function|endothelial function
4650421|NCT03553225|polyphenols|polyphenols
4650422|NCT03553225|Concord Grape|concord grape
4650423|NCT03553212|Prostate cancer|prostate cancer
4650424|NCT03553212|organ-confined|organ-confined
4650425|NCT03553212|external beam Radiotherapy|external beam radiotherapy
4650426|NCT03553212|Image-guided tomotherapy|image-guided tomotherapy
4650427|NCT03553199|Tissue Retraction System|tissue retraction system
4650428|NCT03553199|Colorectal polyps|colorectal polyps
4650429|NCT03553173|Smoking Cessation|smoking cessation
4650430|NCT03553173|App|app
4650431|NCT03553173|Decision Support System|decision support system
4650432|NCT03553147|denutrition screening tool|denutrition screening tool
4650433|NCT03553147|SARC-F score|sarc-f score
4650434|NCT03553147|denutrition in geriatric population|denutrition in geriatric population
4650435|NCT03553147|sarc-f score associated with denutrition|sarc-f score associated with denutrition
4650436|NCT03553121|gynecologic cancer|gynecologic cancer
4650437|NCT03553121|postoperative bowel function|postoperative bowel function
4650438|NCT03553121|walking|walking
4650439|NCT03553121|debulking|debulking
4650440|NCT03553108|Solid Tumor|solid tumor
4650441|NCT03553056|alcohol|alcohol
4650442|NCT03553056|hazardous drinking|hazardous drinking
4650443|NCT03553056|mobile phone app|mobile phone app
4650444|NCT03553056|clinical trial|clinical trial
4650445|NCT03553043|consumer behaviour|consumer behaviour
4650446|NCT03553043|alcohol labelling|alcohol labelling
4650447|NCT03553043|energy labelling|energy labelling
4650448|NCT03553017|Optical Coherence Tomography|optical coherence tomography
4650449|NCT03553017|Automated|automated
4650450|NCT03553017|Binocular|binocular
4650451|NCT03553004|Metastatic pancreatic cancer|metastatic pancreatic cancer
4650452|NCT03553004|germline mutation|germline mutation
4650453|NCT03553004|somatic mutation|somatic mutation
4650454|NCT03553004|Niraparib|niraparib
4650455|NCT03553004|pancreas|pancreas
4650456|NCT03552991|Dietary Fiber|dietary fiber
4650457|NCT03552991|Microbiota|microbiota
4650458|NCT03552991|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
4650459|NCT03552991|Metformin|metformin
4650460|NCT03552991|Sulfonylurea Compounds|sulfonylurea compounds
4650461|NCT03552965|xerostomia|xerostomia
4650462|NCT03552965|Robust photon radiotherapy|robust photon radiotherapy
4650463|NCT03552965|Margin based radiotherapy|margin based radiotherapy
4650464|NCT03552939|microbiota|microbiota
4650465|NCT03552939|breast milk|breast milk
4650466|NCT03552939|diet|diet
4650467|NCT03552926|Small subcortical infarct|small subcortical infarct
4650468|NCT03552926|Cerebrovascular disorders|cerebrovascular disorders
4650469|NCT03552926|Neurocognitive and cardiovascular disorders|neurocognitive and cardiovascular disorders
4650470|NCT03552926|Disability|disability
4650471|NCT03552926|Dementia|dementia
4650472|NCT03552926|Stroke|stroke
4650473|NCT03552913|Enhanced Recovery After Surgery|enhanced recovery after surgery
4650474|NCT03552913|Fast track|fast track
4650475|NCT03552913|Surgery|surgery
4650476|NCT03552913|Hysterectomy|hysterectomy
4650477|NCT03552913|Left colectomy|left colectomy
4650478|NCT03552913|Total knee arthroplasty|total knee arthroplasty
4650479|NCT03552887|Adverse Event|adverse event
4650480|NCT03552887|Physiotherapy|physiotherapy
4650481|NCT03552887|Cardiac Surgery|cardiac surgery
4650482|NCT03552861|Parkinson's disease|parkinson's disease
4650483|NCT03552861|rTMS|rtms
4651485|NCT03546764|trauma|trauma
4650484|NCT03552861|Dorsal prefrontal cortex|dorsal prefrontal cortex
4650485|NCT03552861|Depression|depression
4650486|NCT03552861|Cognitive impairment|cognitive impairment
4650487|NCT03552835|partial caries removal|partial caries removal
4650488|NCT03552835|no caries removal|no caries removal
4650489|NCT03552783|fathers|fathers
4650490|NCT03552783|parenting|parenting
4650491|NCT03552783|African American|african american
4650492|NCT03552770|neovascular age-related macular degeneration|neovascular age-related macular degeneration
4650493|NCT03552770|bevacizumab|bevacizumab
4650494|NCT03552770|pro-re-nata regimens|pro-re-nata regimens
4650495|NCT03552770|clinical governance|clinical governance
4650496|NCT03552718|solid tumors|solid tumors
4650497|NCT03552692|BCL-2 positive|bcl-2 positive
4650498|NCT03552692|PTCL-NOS|ptcl-nos
4650499|NCT03552692|angioimmunoblastic T-cell lymphoma (AITL)|angioimmunoblastic t-cell lymphoma (aitl)
4650500|NCT03552692|T-follicular helper origin (TFH)|t-follicular helper origin (tfh)
4650501|NCT03552692|Venetoclax|venetoclax
4650502|NCT03552692|single agent|single agent
4650503|NCT03552679|Right Heart Failure|right heart failure
4650504|NCT03552679|Ventricular Assist Device|ventricular assist device
4650505|NCT03552679|Mortality|mortality
4650506|NCT03552679|ICU Stay|icu stay
4650507|NCT03552679|Acute Kidney Injury|acute kidney injury
4650508|NCT03552666|Vitamin D|vitamin d
4650509|NCT03552640|Orthodontics|orthodontics
4650510|NCT03552640|Digitized Models|digitized models
4650511|NCT03552640|Root Position|root position
4650512|NCT03552627|hyperoxia|hyperoxia
4650513|NCT03552627|oxygen|oxygen
4650514|NCT03552627|surgery|surgery
4650515|NCT03552627|perioperative|perioperative
4650516|NCT03552614|robot-assisted rehabilitation|robot-assisted rehabilitation
4650517|NCT03552614|Armeo®Spring|armeo®spring
4650518|NCT03552614|quantitative assessment|quantitative assessment
4650519|NCT03552575|sacubritil|sacubritil
4650520|NCT03552575|valsartan|valsartan
4650521|NCT03552575|left ventricular remodelling|left ventricular remodelling
4650522|NCT03552575|asymptomatic left ventricular systolic dysfunction|asymptomatic left ventricular systolic dysfunction
4650523|NCT03552575|myocardial infarction|myocardial infarction
4650524|NCT03552523|bionic pancreas|bionic pancreas
4650525|NCT03552523|CGM|cgm
4650526|NCT03552497|Radiomics|radiomics
4650527|NCT03552497|Bosniak classification|bosniak classification
4650528|NCT03552497|Renal cell carcinoma|renal cell carcinoma
4650529|NCT03552497|Medical imaging|medical imaging
4650530|NCT03552458|oral mucositis|oral mucositis
4650531|NCT03552458|probiotics|probiotics
4650532|NCT03552458|anti-neoplastic chemotherapy|anti-neoplastic chemotherapy
4650533|NCT03552432|alirocumab|alirocumab
4650534|NCT03552432|Thin-cap fIbroatheroma (TCFA)|thin-cap fibroatheroma (tcfa)
4650535|NCT03552432|vulnerable plaque|vulnerable plaque
4650536|NCT03552432|Optical Coherence Tomography (OCT)|optical coherence tomography (oct)
4650537|NCT03552419|Operating room leveling|operating room leveling
4650538|NCT03552419|Obstetric anesthesia|obstetric anesthesia
4650539|NCT03552419|Time to incision|time to incision
4650540|NCT03552406|Solid tumor|solid tumor
4650541|NCT03552406|Breast cancer|breast cancer
4650542|NCT03552406|Head & Neck cancer|head & neck cancer
4650543|NCT03552367|Obesity|obesity
4650544|NCT03552367|Children|children
4650545|NCT03552367|Non-alcoholic fatty acid liver disease|non-alcoholic fatty acid liver disease
4650546|NCT03552367|Exercise|exercise
4650547|NCT03552367|Metabolic syndrome|metabolic syndrome
4650548|NCT03552367|Cardiovascular risk|cardiovascular risk
4650549|NCT03552341|Iodine|iodine
4650550|NCT03552341|Cognitive function|cognitive function
4650551|NCT03552341|Birth outcomes|birth outcomes
4650552|NCT03552341|Pregnancy|pregnancy
4650553|NCT03552302|Yoga|yoga
4650554|NCT03552302|Tinnitus|tinnitus
4650555|NCT03552302|Sleep|sleep
4650556|NCT03552289|Dialysis|dialysis
4650557|NCT03552289|Renal|renal
4650558|NCT03552289|Hemodialysis|hemodialysis
4650559|NCT03552289|Stenosis(es)|stenosis(es)
4650560|NCT03552289|Transluminal|transluminal
4650561|NCT03552289|Percutaneous Transluminal Angioplasty|percutaneous transluminal angioplasty
4650562|NCT03552263|Acute mountain sickness|acute mountain sickness
4650563|NCT03552250|Parenting Program|parenting program
4650564|NCT03552224|Evoked auditory nerve activity|evoked auditory nerve activity
4650565|NCT03552224|Hearing Loss|hearing loss
4650566|NCT03552224|Tinnitus|tinnitus
4650567|NCT03552211|Multiple Sclerosis|multiple sclerosis
4650568|NCT03552211|Progressive Multiple Sclerosis|progressive multiple sclerosis
4650569|NCT03552211|Biotin|biotin
4650570|NCT03552211|Relapse|relapse
4650571|NCT03552198|Air quality alerts|air quality alerts
4650572|NCT03552198|Health behaviour change|health behaviour change
4650573|NCT03552198|Adherence|adherence
4650574|NCT03552185|Neurogenic Dysphagia|neurogenic dysphagia
4650575|NCT03552185|Multiple Sclerosis|multiple sclerosis
4650576|NCT03552146|sedation|sedation
4650577|NCT03552133|variable deadspace|variable deadspace
4650578|NCT03552133|rebreathe|rebreathe
4650579|NCT03552133|hypercapnic side-effects|hypercapnic side-effects
4650580|NCT03552107|Lorcaserin|lorcaserin
4650581|NCT03552107|Belviq|belviq
4650582|NCT03552094|Arbovirus|arbovirus
4650583|NCT03552081|spermatogenesis|spermatogenesis
4650585|NCT03552081|DNA Fragmentation Index|dna fragmentation index
4650586|NCT03552068|Parkinson's disease|parkinson's disease
4650587|NCT03552068|Impulse control disorder|impulse control disorder
4650588|NCT03552068|Clonidine|clonidine
4650589|NCT03552068|Noradrenergic system|noradrenergic system
4650590|NCT03552055|placental proteins|placental proteins
4650591|NCT03552029|Relapsed/Refractory|relapsed/refractory
4650592|NCT03552029|Newly Diagnosed|newly diagnosed
4650593|NCT03552029|Unfit for Chemotherapy|unfit for chemotherapy
4650594|NCT03552029|Positive for FLT3 Biomarker|positive for flt3 biomarker
4650595|NCT03552016|Myopia|myopia
4650596|NCT03552016|Axial Myopia|axial myopia
4650597|NCT03552016|Children|children
4650598|NCT03552016|Refractive Error|refractive error
4650599|NCT03552016|Riboflavin|riboflavin
4650600|NCT03552016|Vitamin B2|vitamin b2
4650601|NCT03552003|Hodgkin|hodgkin
4650602|NCT03552003|Elderly patients|elderly patients
4650603|NCT03552003|CGA|cga
4650604|NCT03551990|Whole-body electromyostimulation|whole-body electromyostimulation
4650605|NCT03551990|WB-EMS|wb-ems
4650606|NCT03551990|Cancer|cancer
4650607|NCT03551990|Muscle atrophy|muscle atrophy
4650608|NCT03551990|Muscle protein|muscle protein
4650609|NCT03551990|Exercise|exercise
4650610|NCT03551990|Muscle fiber|muscle fiber
4650611|NCT03551964|Acute myocardial infarction|acute myocardial infarction
4650612|NCT03551964|Cardiogenic shock|cardiogenic shock
4650613|NCT03551964|Primary percutaneous coronary intervention|primary percutaneous coronary intervention
4650614|NCT03551964|Dual antiplatelet therapy|dual antiplatelet therapy
4650615|NCT03551964|Cangrelor|cangrelor
4650616|NCT03551964|Ticagrelor|ticagrelor
4650617|NCT03551938|HIV, telehealth, HIV testing, YMSM, couples|hiv, telehealth, hiv testing, ymsm, couples
4650618|NCT03551873|Breast milk|breast milk
4650619|NCT03551873|Lactating|lactating
4650620|NCT03551860|Total hip replacement|total hip replacement
4650621|NCT03551860|Motor block post-operatively|motor block post-operatively
4650622|NCT03551860|Morphine consumption post-operatively|morphine consumption post-operatively
4650623|NCT03551860|Transmuscular Quadratus Nerve Block|transmuscular quadratus nerve block
4650624|NCT03551860|Fascia Iliaca Nerve Block|fascia iliaca nerve block
4650625|NCT03551704|Smoking|smoking
4650626|NCT03551704|Substance addiction|substance addiction
4650627|NCT03551704|Cocaine|cocaine
4650628|NCT03551704|Alcohol|alcohol
4650629|NCT03551704|Behavioral treatment|behavioral treatment
4650630|NCT03551691|fat absorption|fat absorption
4650631|NCT03551691|pancreatic enzyme|pancreatic enzyme
4650632|NCT03551665|Multiple Sclerosis|multiple sclerosis
4650633|NCT03551665|Falls|falls
4650634|NCT03551665|Posture|posture
4650635|NCT03551665|Rehabilitation|rehabilitation
4650636|NCT03551665|Cognition|cognition
4650637|NCT03551665|Neuroimaging|neuroimaging
4650638|NCT03551626|dabrafenib|dabrafenib
4650639|NCT03551626|trametinib|trametinib
4650640|NCT03551626|adjuvant|adjuvant
4650641|NCT03551626|melanoma|melanoma
4650642|NCT03551626|combination treatment|combination treatment
4650643|NCT03551626|pyrexia|pyrexia
4650644|NCT03551600|Near-infrared spectroscopy (NIRS)|near-infrared spectroscopy (nirs)
4650645|NCT03551600|renal oxygen saturations|renal oxygen saturations
4650646|NCT03551600|splanchnic oxygen saturations|splanchnic oxygen saturations
4650647|NCT03551561|Chlorhexidine|chlorhexidine
4650648|NCT03551561|Infection|infection
4650649|NCT03551561|Orthopedics|orthopedics
4650650|NCT03551561|Surgical rooms|surgical rooms
4650651|NCT03551561|Antisepsis|antisepsis
4650652|NCT03551561|Surgical Procedures.|surgical procedures.
4650653|NCT03551535|Wearable technology|wearable technology
4650654|NCT03551535|Pregnancy|pregnancy
4650655|NCT03551535|Exercise|exercise
4650656|NCT03551535|Mobile Health|mobile health
4650657|NCT03551509|Rotator Cuff Tear|rotator cuff tear
4650658|NCT03551509|Large Rotator Cuff Tear|large rotator cuff tear
4650659|NCT03551509|Massive Rotator Cuff Tear|massive rotator cuff tear
4650660|NCT03551509|ECM|ecm
4650661|NCT03551509|Extracellular Matrix|extracellular matrix
4650662|NCT03551509|ArthroFLEX|arthroflex
4650663|NCT03551483|Arts-based Intervention|arts-based intervention
4650664|NCT03551483|Mobile Health|mobile health
4650665|NCT03551483|Online Recreation|online recreation
4650666|NCT03551470|robotic|robotic
4650667|NCT03551470|laparoscopy|laparoscopy
4650668|NCT03551470|liver surgery|liver surgery
4650669|NCT03551470|colorectal and synchronous liver metastases|colorectal and synchronous liver metastases
4650670|NCT03551470|simultaneous surgery|simultaneous surgery
4650671|NCT03551457|Patient Derived Xenograft|patient derived xenograft
4650672|NCT03551457|Treatment Response Phenotype|treatment response phenotype
4650673|NCT03551457|Personalised|personalised
4650674|NCT03551392|Cognitive Aging|cognitive aging
4650675|NCT03551392|Photobiomodulation|photobiomodulation
4650676|NCT03551392|Low Level Light Therapy|low level light therapy
4650677|NCT03551392|Near Infrared (NIR) Light|near infrared (nir) light
4650678|NCT03551392|Neuromodulation|neuromodulation
4650679|NCT03551379|Endoscopic Submucosal Dissection|endoscopic submucosal dissection
4650680|NCT03551366|Physical Activity|physical activity
4650681|NCT03551366|Physical Education|physical education
4650682|NCT03551366|Children|children
4650683|NCT03551366|Pedagogy|pedagogy
4650684|NCT03551366|Motor Competence|motor competence
4650685|NCT03551366|Perceived Motor Competence|perceived motor competence
4650686|NCT03551366|Self-perception|self-perception
4650687|NCT03551366|Cognition|cognition
4650688|NCT03551366|Fundamental Movement Skills|fundamental movement skills
4650689|NCT03551353|video feedback|video feedback
4650690|NCT03551353|checkout prosedures|checkout prosedures
4650691|NCT03551340|Gastroenteritis, panel by PCR, antibiotic use|gastroenteritis, panel by pcr, antibiotic use
4650692|NCT03551327|Post-stroke fatigue|post-stroke fatigue
4650693|NCT03551314|Non-invasive ventilation|non-invasive ventilation
4650694|NCT03551314|Preterm infant|preterm infant
4650695|NCT03551314|Breathing pattern|breathing pattern
4650696|NCT03551301|Substance Use Disorders|substance use disorders
4650697|NCT03551301|Case Management|case management
4650698|NCT03551301|Community Treatment|community treatment
4650699|NCT03551301|Hospital discharge|hospital discharge
4650700|NCT03551288|SUVN-911|suvn-911
4650701|NCT03551288|Depression|depression
4650702|NCT03551288|alpha4 beta2 receptor|alpha4 beta2 receptor
4650703|NCT03551275|BCD-132|bcd-132
4650704|NCT03551275|Multiple Sclerosis|multiple sclerosis
4650705|NCT03551275|anti-CD20|anti-cd20
4650706|NCT03551210|nemonoxacin|nemonoxacin
4650707|NCT03551210|community-acquired pneumonia|community-acquired pneumonia
4650708|NCT03551210|quinolones|quinolones
4650709|NCT03551197|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
4650710|NCT03551197|exercise|exercise
4650711|NCT03551197|lung function|lung function
4650712|NCT03551197|quality of life|quality of life
4650713|NCT03551184|Sickness behavior|sickness behavior
4650714|NCT03551184|Endotoxin|endotoxin
4650715|NCT03551184|Lipopolysaccharide|lipopolysaccharide
4650716|NCT03551184|Psychoneuroimmunology|psychoneuroimmunology
4650717|NCT03551171|PARP inhibitor|parp inhibitor
4650718|NCT03551171|BRCA mutation|brca mutation
4650719|NCT03551132|elderly|elderly
4650720|NCT03551132|resistance training|resistance training
4650721|NCT03551132|health|health
4650722|NCT03551106|e-learning|e-learning
4650723|NCT03551106|web based learning module|web based learning module
4650724|NCT03551093|Ischemic Stroke|ischemic stroke
4650725|NCT03551093|Mild Acute Ischemic Stroke|mild acute ischemic stroke
4650726|NCT03551093|Safety|safety
4650727|NCT03551093|Signal of Efficacy|signal of efficacy
4650728|NCT03551080|Sickness behavior|sickness behavior
4650729|NCT03551080|Cytokines|cytokines
4650730|NCT03551080|Psychoneuroimmunology|psychoneuroimmunology
4650731|NCT03551067|Dexmedetomidine|dexmedetomidine
4650732|NCT03551067|Adenotonsillectomy|adenotonsillectomy
4650733|NCT03551067|Parental Separation|parental separation
4650734|NCT03551067|Face Mask Acceptance|face mask acceptance
4650735|NCT03551041|depression, self-referential, neural representation|depression, self-referential, neural representation
4650736|NCT03551015|Coronary Artery Bypass Grafting|coronary artery bypass grafting
4650737|NCT03551015|Median sternotomy|median sternotomy
4650738|NCT03551015|Post-operative outpatient review|post-operative outpatient review
4650739|NCT03551015|Cardiac rehabilitation|cardiac rehabilitation
4650740|NCT03551015|Quality of life|quality of life
4650741|NCT03551002|HIV|hiv
4650742|NCT03551002|Hepatitis C|hepatitis c
4650743|NCT03551002|Direct acting antivirals|direct acting antivirals
4650744|NCT03551002|Hepatitis C modeling|hepatitis c modeling
4650745|NCT03550989|Environmental Aerosol Exposure|environmental aerosol exposure
4650746|NCT03550989|Environmental Tobacco Smoke|environmental tobacco smoke
4650747|NCT03550989|Indoor Air Quality|indoor air quality
4650748|NCT03550898|Dynamic Ultrasonography|dynamic ultrasonography
4650749|NCT03550898|Spinal Dysraphism|spinal dysraphism
4650750|NCT03550885|microbiome, human|microbiome, human
4650751|NCT03550885|bile acids and salts|bile acids and salts
4650752|NCT03550885|diet, western|diet, western
4650753|NCT03550872|heart failure, atrial fibrillation and exercise training|heart failure, atrial fibrillation and exercise training
4650754|NCT03550846|Spinal Fusion|spinal fusion
4650755|NCT03550833|Rheumatoid arthritis|rheumatoid arthritis
4650756|NCT03550833|Stress|stress
4650757|NCT03550820|pulmonary MAC|pulmonary mac
4650758|NCT03550820|energy metabolism|energy metabolism
4650759|NCT03550781|Takayasu Arteritis|takayasu arteritis
4650760|NCT03550781|Anti-Inflammatory Agents|anti-inflammatory agents
4650761|NCT03550781|Positron Emission Tomography Computed Tomography|positron emission tomography computed tomography
4650762|NCT03550768|ERCP|ercp
4650763|NCT03550768|anatomy of major duodenal papilla|anatomy of major duodenal papilla
4650764|NCT03550755|cervix|cervix
4650765|NCT03550755|uterus|uterus
4650766|NCT03550742|Human Milk Oligosaccharides|human milk oligosaccharides
4650767|NCT03550742|IBS-C|ibs-c
4650768|NCT03550742|IBS-D|ibs-d
4650769|NCT03550742|IBS-M|ibs-m
4650770|NCT03550729|Exercise training|exercise training
4650771|NCT03550729|Biomarkers|biomarkers
4650772|NCT03550716|azoospermia|azoospermia
4650773|NCT03550716|microdissection testicular sperm extraction|microdissection testicular sperm extraction
4650774|NCT03550716|testicular sperm aspiration|testicular sperm aspiration
4650775|NCT03550716|male infertility|male infertility
4650776|NCT03550716|surgical sperm retrieval|surgical sperm retrieval
4650777|NCT03550677|Ankle nerve block|ankle nerve block
4650778|NCT03550677|post operative analgesia|post operative analgesia
4650779|NCT03550677|patient satisfaction|patient satisfaction
4650780|NCT03550677|foot surgery|foot surgery
4650781|NCT03550651|Plaque|plaque
4650782|NCT03550651|Plaque regrowth|plaque regrowth
4650783|NCT03550651|Licorice extract|licorice extract
4650784|NCT03550651|Mouthrinse|mouthrinse
4650785|NCT03550651|Chlorhexidine mouthrinse|chlorhexidine mouthrinse
4650786|NCT03550651|Hypertonic salt solution|hypertonic salt solution
4650787|NCT03550651|Essential oils|essential oils
4650788|NCT03550573|Hypertrophic cardiomyopathy|hypertrophic cardiomyopathy
4650789|NCT03550573|sudden death|sudden death
4650790|NCT03550573|3D mapping|3d mapping
4650791|NCT03550560|Endoscopic Ultrasound-Guided|endoscopic ultrasound-guided
4650792|NCT03550560|EUS-Guided|eus-guided
4650793|NCT03550560|Transgastric plastic prostheses|transgastric plastic prostheses
4650794|NCT03550547|Physical Activity|physical activity
4650795|NCT03550547|Education|education
4650796|NCT03550547|Dietary|dietary
4650797|NCT03550547|Self-management|self-management
4650798|NCT03550534|Calcium carbonate|calcium carbonate
4650799|NCT03550534|Chronic kidney disease|chronic kidney disease
4650800|NCT03550534|Normophosphatemia|normophosphatemia
4650801|NCT03550534|FGF23|fgf23
4650802|NCT03550534|Phosphate binder|phosphate binder
4650803|NCT03550508|JMT103 in Patients with Bone Metastases from Tumors|jmt103 in patients with bone metastases from tumors
4650804|NCT03550495|ICU delirium|icu delirium
4650805|NCT03550495|prevention|prevention
4650806|NCT03550495|psychiatry|psychiatry
4650807|NCT03550482|Oncoxin|oncoxin
4650808|NCT03550482|Nutritional supplement|nutritional supplement
4650809|NCT03550482|Chemotherapy|chemotherapy
4650810|NCT03550482|Oxidative stress|oxidative stress
4650811|NCT03550482|Antioxidant|antioxidant
4650812|NCT03550469|hyperoxia|hyperoxia
4650813|NCT03550469|hypoxia|hypoxia
4650814|NCT03550456|Exercise Induced Asthma (EIA)|exercise induced asthma (eia)
4650815|NCT03550456|Exercise Induced Laryngeal Obstruction (EILO)|exercise induced laryngeal obstruction (eilo)
4650816|NCT03550456|Quality of life|quality of life
4650817|NCT03550456|Exercise challenge in cold chamber (ECC)|exercise challenge in cold chamber (ecc)
4650818|NCT03550456|Continous laryngoscopy while exercising (CLE)|continous laryngoscopy while exercising (cle)
4650819|NCT03550443|Bardoxolone Methyl|bardoxolone methyl
4650820|NCT03550443|Diabetic Kidney Disease|diabetic kidney disease
4650821|NCT03550443|Diabetes Mellitus|diabetes mellitus
4650822|NCT03550443|Kidney Diseases|kidney diseases
4650823|NCT03550430|tinnitus distress|tinnitus distress
4650824|NCT03550430|tinnitus intrusiveness|tinnitus intrusiveness
4650825|NCT03550430|synchronization by loss of inhibition model (SLIM)|synchronization by loss of inhibition model (slim)
4650826|NCT03550430|neurofeedback|neurofeedback
4650827|NCT03550430|alpha/delta neurofeedback|alpha/delta neurofeedback
4650828|NCT03550430|beta/theta neurofeedback|beta/theta neurofeedback
4650829|NCT03550430|electroencephalography (EEG)|electroencephalography (eeg)
4650830|NCT03550430|tinnitus intensity|tinnitus intensity
4650831|NCT03550430|tinnitus loudness|tinnitus loudness
4650832|NCT03550417|disease management|disease management
4650833|NCT03550417|best practice guidelines|best practice guidelines
4650834|NCT03550378|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
4650835|NCT03550378|MEDI0382|medi0382
4650836|NCT03550378|Renal Impairment|renal impairment
4650837|NCT03550352|HIV|hiv
4650838|NCT03550352|Cannabinoids|cannabinoids
4650839|NCT03550352|HIV reservoir|hiv reservoir
4650840|NCT03550352|Microbiome|microbiome
4650841|NCT03550352|CBD|cbd
4650842|NCT03550352|THC|thc
4650843|NCT03550352|Inflammation|inflammation
4650844|NCT03550352|Immune activation|immune activation
4650845|NCT03550339|obesity|obesity
4650846|NCT03550339|appetite|appetite
4650847|NCT03550339|food reward|food reward
4650848|NCT03550339|hormonal responses|hormonal responses
4650849|NCT03550339|psychophysiological responses|psychophysiological responses
4650850|NCT03550339|implicit measures|implicit measures
4650851|NCT03550339|explicit measures|explicit measures
4650852|NCT03550326|anesthesia|anesthesia
4650853|NCT03550326|difficult airway|difficult airway
4650854|NCT03550326|supraglottic airway device|supraglottic airway device
4650855|NCT03550326|difficult intubation|difficult intubation
4650856|NCT03550326|airway complications|airway complications
4650857|NCT03550274|Acute lateral ankle sprain|acute lateral ankle sprain
4650858|NCT03550274|Acute ankle injury|acute ankle injury
4650859|NCT03550274|Ankle sprain|ankle sprain
4650860|NCT03550274|Exercise therapy|exercise therapy
4650861|NCT03550274|App-based rehabilitation|app-based rehabilitation
4650862|NCT03550274|Mixed-method|mixed-method
4650863|NCT03550274|Pilot Study|pilot study
4650864|NCT03550261|CAH|cah
4650865|NCT03550261|Salt-wasting|salt-wasting
4650866|NCT03550261|LC-MSMS|lc-msms
4650867|NCT03550261|plasma and urine steroid profile|plasma and urine steroid profile
4650868|NCT03550261|Fludrocortisone|fludrocortisone
4650869|NCT03550248|Healthy Weights|healthy weights
4650870|NCT03550248|Health Promotion|health promotion
4650871|NCT03550248|Scale-up|scale-up
4650872|NCT03550248|Family Health|family health
4650873|NCT03550248|Prevention|prevention
4650874|NCT03550248|Childhood Obesity|childhood obesity
4650875|NCT03550248|Physical Activity|physical activity
4651486|NCT03546764|hemothorax|hemothorax
4650876|NCT03550248|Cooking Activity|cooking activity
4650877|NCT03550248|Family education model|family education model
4650878|NCT03550235|Heart failure|heart failure
4650879|NCT03550235|dyspnea|dyspnea
4650880|NCT03550235|stress test|stress test
4650881|NCT03550222|Diaphragmatic dysfunction|diaphragmatic dysfunction
4650882|NCT03550222|Mechanical Ventilation|mechanical ventilation
4650883|NCT03550222|ICU acquired weakness|icu acquired weakness
4650884|NCT03550222|Weaning|weaning
4650885|NCT03550222|Skeletal muscles|skeletal muscles
4650886|NCT03550222|Respiratory muscles|respiratory muscles
4650887|NCT03550170|Fatigue|fatigue
4650888|NCT03550170|Wellness|wellness
4650889|NCT03550170|Multiple Sclerosis|multiple sclerosis
4650890|NCT03550170|Quality of life|quality of life
4650891|NCT03550157|Cellulite|cellulite
4650892|NCT03550157|Cutaneous ultrasound|cutaneous ultrasound
4650893|NCT03550157|PnKCelulitis® program|pnkcelulitis® program
4650894|NCT03550144|Awe|awe
4650895|NCT03550144|Compassion|compassion
4650896|NCT03550144|Anxiety|anxiety
4650897|NCT03550144|Positive emotions|positive emotions
4650898|NCT03550144|Aging|aging
4650899|NCT03550131|LGBT|lgbt
4650900|NCT03550118|Prosthetic Socket|prosthetic socket
4650901|NCT03550118|Amputee|amputee
4650902|NCT03550118|Adjustable Socket|adjustable socket
4650903|NCT03550105|Glucose|glucose
4650904|NCT03550105|Diabetes|diabetes
4650905|NCT03550105|Physical Activity|physical activity
4650906|NCT03550105|Passive Exercise|passive exercise
4650907|NCT03550105|Blood Pressure|blood pressure
4650908|NCT03550105|Muscle Strength|muscle strength
4650909|NCT03550105|Muscle Endurance|muscle endurance
4650910|NCT03550105|Hypertension|hypertension
4650911|NCT03550105|Physical Inactivity|physical inactivity
4650912|NCT03550092|aphasia|aphasia
4650913|NCT03550092|treatment|treatment
4650914|NCT03550092|therapy|therapy
4650915|NCT03550092|anomia|anomia
4650916|NCT03550092|fMRI|fmri
4650917|NCT03550092|neuroimaging|neuroimaging
4650918|NCT03550092|semantics|semantics
4650919|NCT03550066|Diabetes, gestational|diabetes, gestational
4650920|NCT03550066|Diabetes Mellitus|diabetes mellitus
4650921|NCT03550040|radical prostatectomy|radical prostatectomy
4650922|NCT03550040|laparoscopic prostatectomy|laparoscopic prostatectomy
4650923|NCT03550040|robot assisted prostatectomy|robot assisted prostatectomy
4650924|NCT03550014|Low Back Pain|low back pain
4650925|NCT03550014|Hip|hip
4650926|NCT03550014|Physical Therapy|physical therapy
4650927|NCT03550001|locally advanced rectal cancer|locally advanced rectal cancer
4650928|NCT03550001|lymph node yeild|lymph node yeild
4650929|NCT03550001|lymph node tracer|lymph node tracer
4650930|NCT03550001|stage shift|stage shift
4650931|NCT03550001|prognosis|prognosis
4650932|NCT03549988|Ulcerative colitis|ulcerative colitis
4650933|NCT03549988|Fecal calprotectin|fecal calprotectin
4650934|NCT03549975|stroke|stroke
4650935|NCT03549975|hand|hand
4650936|NCT03549975|botulinum toxin|botulinum toxin
4650937|NCT03549975|functional electrical stimulation|functional electrical stimulation
4650938|NCT03549962|Preoperative|preoperative
4650939|NCT03549962|Nutritional Status|nutritional status
4650940|NCT03549962|Arthroplasty|arthroplasty
4650941|NCT03549962|Replacement|replacement
4650942|NCT03549962|Osteoarthritis|osteoarthritis
4650943|NCT03549962|Knee|knee
4650944|NCT03549949|pulmonary arteriovenous malformations|pulmonary arteriovenous malformations
4650945|NCT03549936|NAS, low lactose formula|nas, low lactose formula
4650946|NCT03549923|extracorporeal membrane oxygenation|extracorporeal membrane oxygenation
4650947|NCT03549923|renal replacement therapy|renal replacement therapy
4650948|NCT03549923|beta-blocker|beta-blocker
4650949|NCT03549884|Early cord Clamping|early cord clamping
4650950|NCT03549884|Delayed cord clamping|delayed cord clamping
4650951|NCT03549884|Full term infant|full term infant
4650952|NCT03549884|Elective cesarean section|elective cesarean section
4650953|NCT03549884|Hematocrit|hematocrit
4650954|NCT03549884|Postnatal adaptation|postnatal adaptation
4650955|NCT03549871|RNAi therapeutic|rnai therapeutic
4650956|NCT03549871|Hemophilia A|hemophilia a
4650957|NCT03549871|Hemophilia B|hemophilia b
4650958|NCT03549871|Hemophilia A, Severe|hemophilia a, severe
4650959|NCT03549871|Hemophilia B, Severe|hemophilia b, severe
4650960|NCT03549871|Blood Coagulation Disorders, Inherited|blood coagulation disorders, inherited
4650961|NCT03549871|Blood Coagulation Disorders|blood coagulation disorders
4650962|NCT03549871|Hematologic Diseases|hematologic diseases
4650963|NCT03549871|Coagulation Protein Disorders|coagulation protein disorders
4650964|NCT03549871|Hemorrhagic Disorders|hemorrhagic disorders
4650965|NCT03549871|Genetic Diseases, Inborn|genetic diseases, inborn
4650966|NCT03549871|Genetic Diseases, X-Linked|genetic diseases, x-linked
4650967|NCT03549871|Factor VIII|factor viii
4650968|NCT03549871|Factor IX|factor ix
4650969|NCT03549871|Inhibitor|inhibitor
4650970|NCT03549871|Coagulants|coagulants
4650971|NCT03549871|Fitusiran|fitusiran
4650972|NCT03549871|Prophylactic Treatment|prophylactic treatment
4650973|NCT03549845|Healthcare Utilization|healthcare utilization
4650974|NCT03549845|Emergency Department|emergency department
4650975|NCT03549845|Hospitalization|hospitalization
4650976|NCT03549845|Low Income|low income
4650977|NCT03549845|Social Housing|social housing
4650978|NCT03549845|Older Adults|older adults
4650979|NCT03549845|Quality of Life|quality of life
4650980|NCT03549832|HCV|hcv
4650981|NCT03549832|DAAs|daas
4650982|NCT03549832|Non-responder|non-responder
4650983|NCT03549819|Anxiety Disorders|anxiety disorders
4650984|NCT03549819|Cannabidiol|cannabidiol
4650985|NCT03549819|Cannabis|cannabis
4650986|NCT03549806|Atrium, tachyarrhythmias|atrium, tachyarrhythmias
4650987|NCT03549780|Brooke Ileostomy|brooke ileostomy
4650988|NCT03549780|stoma|stoma
4650989|NCT03549780|ileostomy|ileostomy
4650990|NCT03549754|Registry|registry
4650991|NCT03549754|Type 2 Diabetes|type 2 diabetes
4650992|NCT03549754|T2DM|t2dm
4650993|NCT03549754|Adult population|adult population
4650994|NCT03549728|endometriosis|endometriosis
4650995|NCT03549728|granulocyte colony-stimulating factor|granulocyte colony-stimulating factor
4650996|NCT03549728|recurrent implantation failure|recurrent implantation failure
4650997|NCT03549676|FMT|fmt
4650998|NCT03549676|GVHD|gvhd
4650999|NCT03549676|HSCT|hsct
4651000|NCT03549650|Non-Muscle-Invasive Bladder Cancer|non-muscle-invasive bladder cancer
4651001|NCT03549650|LUTS|luts
4651002|NCT03549637|Psychiatry, hypobetalipoproteinemia, LDL-Cholesterol|psychiatry, hypobetalipoproteinemia, ldl-cholesterol
4651003|NCT03549611|ureteroscopy|ureteroscopy
4651004|NCT03549611|opioids|opioids
4651005|NCT03549611|narcotics|narcotics
4651006|NCT03549611|text messaging|text messaging
4651007|NCT03549611|real time data acquisition|real time data acquisition
4651008|NCT03549611|ecologic momentary assessments|ecologic momentary assessments
4651009|NCT03549611|pre-emptive analgesia|pre-emptive analgesia
4651010|NCT03549611|gabapentin|gabapentin
4651011|NCT03549611|meloxicam|meloxicam
4651012|NCT03549611|tamsulosin|tamsulosin
4651013|NCT03549611|kidney stones|kidney stones
4651014|NCT03549611|lithotripsy|lithotripsy
4651015|NCT03549611|nephrolithiasis|nephrolithiasis
4651016|NCT03549585|End of life|end of life
4651017|NCT03549585|Spotting|spotting
4651018|NCT03549585|Emergency|emergency
4651019|NCT03549585|criSTAL|cristal
4651020|NCT03549546|Lymphopenia|lymphopenia
4651021|NCT03549546|Lung cancer surgery|lung cancer surgery
4651022|NCT03549546|TIM-3|tim-3
4651023|NCT03549546|PD-1|pd-1
4651024|NCT03549546|CTLA-4|ctla-4
4651025|NCT03549546|lymphocytes|lymphocytes
4651026|NCT03549546|CD4|cd4
4651027|NCT03549546|CD8|cd8
4651028|NCT03549533|Aluminum|aluminum
4651029|NCT03549533|Sperm|sperm
4651030|NCT03549533|DNA methylation|dna methylation
4651031|NCT03549533|DNA fragmentation|dna fragmentation
4651032|NCT03549533|Seminal plasma|seminal plasma
4651033|NCT03549520|Ultrasound|ultrasound
4651034|NCT03549507|Ultrasound|ultrasound
4651035|NCT03549481|risk score|risk score
4651036|NCT03549481|acute coronary syndrome|acute coronary syndrome
4651037|NCT03549481|left ventricular remodelng|left ventricular remodelng
4651038|NCT03549468|ischemic cardiomyopathy; neuromodulation; repolarization alternans|ischemic cardiomyopathy; neuromodulation; repolarization alternans
4651039|NCT03549455|anxious|anxious
4651040|NCT03549455|anxiety|anxiety
4651041|NCT03549442|Multiple Myeloma|multiple myeloma
4651042|NCT03549442|BCMA CART|bcma cart
4651043|NCT03549442|huCART19|hucart19
4651044|NCT03549416|Atopic dermatitis|atopic dermatitis
4651045|NCT03549416|Dupilumab|dupilumab
4651046|NCT03549416|Dupixent|dupixent
4651047|NCT03549416|BioDay|bioday
4651048|NCT03549416|Daily practice|daily practice
4651049|NCT03549416|Real world|real world
4651050|NCT03549416|Atopic Diseases Registry|atopic diseases registry
4651051|NCT03549416|Registry|registry
4651052|NCT03549416|Multi center|multi center
4651053|NCT03549403|Telephone education|telephone education
4651054|NCT03549403|Effectiveness|effectiveness
4651055|NCT03549403|Health|health
4651056|NCT03549403|Cost|cost
4651057|NCT03549403|Day surgery|day surgery
4651058|NCT03549403|Adult patient|adult patient
4651059|NCT03549390|Type 2 diabetes|type 2 diabetes
4651060|NCT03549390|ethnicity|ethnicity
4651061|NCT03549390|physical activity|physical activity
4651062|NCT03549390|yoga|yoga
4651063|NCT03549377|Sleep|sleep
4651064|NCT03549377|Academic functioning|academic functioning
4651065|NCT03549377|Problem behaviors|problem behaviors
4651066|NCT03549377|College age youth|college age youth
4651067|NCT03549377|Self-regulation|self-regulation
4651068|NCT03549351|Leukemia, Myeloid, Acute|leukemia, myeloid, acute
4651069|NCT03549351|measurable residual disease|measurable residual disease
4651070|NCT03549351|surrogate endpoint|surrogate endpoint
4651071|NCT03549351|multiparameter flow cytometry|multiparameter flow cytometry
4651072|NCT03549338|Metastatic Colorectal Cancer|metastatic colorectal cancer
4651073|NCT03549338|Colorectal Cancer|colorectal cancer
4651074|NCT03549338|Carcinoma|carcinoma
4651075|NCT03549325|Neisseria lactamica|neisseria lactamica
4651076|NCT03549325|healthy volunteers|healthy volunteers
4651077|NCT03549325|nasal inoculation|nasal inoculation
4651078|NCT03549325|colonisation|colonisation
4651079|NCT03549312|HIV|hiv
4651080|NCT03549312|HCV|hcv
4651081|NCT03549312|Hepatitis C|hepatitis c
4651082|NCT03549312|Methadone|methadone
4651781|NCT03544658|Tooth color|tooth color
4651083|NCT03549312|HIV/HCV Co-Infection|hiv/hcv co-infection
4651084|NCT03549312|Opioid Substitution Therapy|opioid substitution therapy
4651085|NCT03549312|Drug Abuse|drug abuse
4651086|NCT03549299|limbal stem cell deficiency|limbal stem cell deficiency
4651087|NCT03549299|ABCB5|abcb5
4651088|NCT03549299|Limbal stem cells|limbal stem cells
4651089|NCT03549299|LSCs|lscs
4651090|NCT03549299|LSC|lsc
4651091|NCT03549299|allogeneic|allogeneic
4651092|NCT03549299|tissue engineered product|tissue engineered product
4651093|NCT03549299|phase I/IIa|phase i/iia
4651094|NCT03549286|Pregnancy|pregnancy
4651095|NCT03549286|Down's syndrome|down's syndrome
4651096|NCT03549286|non invasive prenatal testing|non invasive prenatal testing
4651097|NCT03549273|carcinoma|carcinoma
4651098|NCT03549273|intraepithelial cervix lesions|intraepithelial cervix lesions
4651099|NCT03549273|Oxidative Stress|oxidative stress
4651100|NCT03549273|Ocoxin Viusid|ocoxin viusid
4651101|NCT03549273|Glizigen Spray|glizigen spray
4651102|NCT03549260|low density lipoprotein cholesterol|low density lipoprotein cholesterol
4651103|NCT03549260|PCSK9|pcsk9
4651104|NCT03549247|OHIP-14|ohip-14
4651105|NCT03549247|Periodontitis|periodontitis
4651106|NCT03549234|Regional anesthesia|regional anesthesia
4651107|NCT03549234|Paravertebral|paravertebral
4651108|NCT03549234|Erector spinae|erector spinae
4651109|NCT03549234|Nerve block|nerve block
4651110|NCT03549221|total knee arthroplasty|total knee arthroplasty
4651111|NCT03549221|multimodal anesthetic cocktail|multimodal anesthetic cocktail
4651112|NCT03549221|adrenaline|adrenaline
4651113|NCT03549221|morphine consumption|morphine consumption
4651114|NCT03549221|blood loss|blood loss
4651115|NCT03549221|Levobupivacaine|levobupivacaine
4651116|NCT03549182|acute tryptophan depletion|acute tryptophan depletion
4651117|NCT03549182|tryptophan hydroxylase 2 gene|tryptophan hydroxylase 2 gene
4651118|NCT03549182|emotion|emotion
4651119|NCT03549169|Intervention|intervention
4651120|NCT03549169|Heart Failure|heart failure
4651121|NCT03549169|Symptoms management|symptoms management
4651122|NCT03549169|Selft-care|selft-care
4651123|NCT03549156|Moderate Acute Malnutrition, Malnutrition|moderate acute malnutrition, malnutrition
4651124|NCT03549143|IBS; Irritable Bowel Syndrome; spasmolytics; mebeverine; Duspatalin|ibs; irritable bowel syndrome; spasmolytics; mebeverine; duspatalin
4651125|NCT03549104|fear of hypoglycemia|fear of hypoglycemia
4651126|NCT03549104|glycemic control|glycemic control
4651127|NCT03549104|glycemic variability|glycemic variability
4651128|NCT03549104|self-management behavior|self-management behavior
4651129|NCT03549065|Brain stimulation|brain stimulation
4651130|NCT03549039|quality of life|quality of life
4651131|NCT03549039|cleft lip|cleft lip
4651132|NCT03549039|cleft palate|cleft palate
4651133|NCT03549013|Tumor-related Trigeminal Neuralgia|tumor-related trigeminal neuralgia
4651134|NCT03549013|Percutaneous Radiofrequency Thermocoagulation|percutaneous radiofrequency thermocoagulation
4651135|NCT03549013|Three‐dimensional Computed Tomography|three‐dimensional computed tomography
4651136|NCT03549000|NZV930|nzv930
4651137|NCT03549000|PDR001|pdr001
4651138|NCT03549000|NIR178|nir178
4651139|NCT03549000|Immune checkpoint inhibitor|immune checkpoint inhibitor
4651140|NCT03549000|immunotherapy|immunotherapy
4651141|NCT03549000|CD73|cd73
4651142|NCT03549000|PD-1|pd-1
4651143|NCT03549000|PD-L1|pd-l1
4651144|NCT03549000|A2aR|a2ar
4651145|NCT03549000|Adenosine|adenosine
4651146|NCT03548974|Multiple Sclerosis|multiple sclerosis
4651147|NCT03548974|Spasticity|spasticity
4651148|NCT03548974|MOTOmed training|motomed training
4651149|NCT03548974|internet|internet
4651150|NCT03548922|Risser|risser
4651151|NCT03548922|Tanner|tanner
4651152|NCT03548922|pressure of correction|pressure of correction
4651153|NCT03548909|NT-proBNP|nt-probnp
4651154|NCT03548896|implant|implant
4651155|NCT03548857|Muscle dysfunction|muscle dysfunction
4651156|NCT03548857|Cardiovascular regulation|cardiovascular regulation
4651157|NCT03548857|Lung transplantation (LTx)|lung transplantation (ltx)
4651158|NCT03548831|Minilaparotomy|minilaparotomy
4651159|NCT03548831|Hysterectomy|hysterectomy
4651160|NCT03548831|Laparoscopic assisted vaginal hysterectomy|laparoscopic assisted vaginal hysterectomy
4651161|NCT03548831|Benign|benign
4651162|NCT03548831|Gynaecology|gynaecology
4651163|NCT03548792|Arthroplasty Knee|arthroplasty knee
4651164|NCT03548753|Angina|angina
4651165|NCT03548753|Chest pain|chest pain
4651166|NCT03548753|Diagnostic tests|diagnostic tests
4651167|NCT03548714|Alcohol|alcohol
4651168|NCT03548714|Alcoholic|alcoholic
4651169|NCT03548714|Alcoholism|alcoholism
4651170|NCT03548714|Alcohol abuse|alcohol abuse
4651171|NCT03548714|Alcohol interaction|alcohol interaction
4651172|NCT03548714|Alcohol Use Disorder|alcohol use disorder
4651173|NCT03548714|Alcohol use|alcohol use
4651174|NCT03548714|Alcohol dependence|alcohol dependence
4651175|NCT03548714|Alcohol dependent|alcohol dependent
4651176|NCT03548714|Ethanol abuse|ethanol abuse
4651177|NCT03548714|Ethanol use|ethanol use
4651178|NCT03548701|Thromboelastometry|thromboelastometry
4651179|NCT03548701|Vaginal Bleeding|vaginal bleeding
4651180|NCT03548701|Early Pregnancy|early pregnancy
4651181|NCT03548688|Bladder Cancer|bladder cancer
4651182|NCT03548688|Haematuria|haematuria
4652073|NCT03542890|Baska|baska
4651183|NCT03548688|Collaborative study|collaborative study
4651184|NCT03548675|Pharmacogenetics|pharmacogenetics
4651185|NCT03548675|Antidepressive Agents|antidepressive agents
4651186|NCT03548662|Rotator Cuff Tear|rotator cuff tear
4651187|NCT03548662|Platelet Rich Plasma|platelet rich plasma
4651188|NCT03548662|Ultrasound|ultrasound
4651189|NCT03548662|Exercise|exercise
4651190|NCT03548662|Hyaluronic Acid|hyaluronic acid
4651191|NCT03548649|spinal cord injury|spinal cord injury
4651192|NCT03548649|complete spinal cord injury|complete spinal cord injury
4651193|NCT03548649|incomplete spinal cord injury|incomplete spinal cord injury
4651194|NCT03548649|exoskeleton robot|exoskeleton robot
4651195|NCT03548649|gait training|gait training
4651196|NCT03548649|security testing|security testing
4651197|NCT03548649|functional testing|functional testing
4651198|NCT03548623|Hypertension|hypertension
4651199|NCT03548623|renal denervation|renal denervation
4651200|NCT03548623|preference|preference
4651201|NCT03548623|shared decision making|shared decision making
4651202|NCT03548610|nanofat|nanofat
4651203|NCT03548610|tumor defect|tumor defect
4651204|NCT03548584|Agitation|agitation
4651205|NCT03548558|Early Childhood Development|early childhood development
4651206|NCT03548558|Parenting Behaviors|parenting behaviors
4651207|NCT03548558|Group-based curriculum|group-based curriculum
4651208|NCT03548558|Kenya|kenya
4651209|NCT03548558|Child Outcomes|child outcomes
4651210|NCT03548558|Community Health Volunteers|community health volunteers
4651211|NCT03548545|MDD|mdd
4651212|NCT03548545|CBT|cbt
4651213|NCT03548545|tDCS|tdcs
4651214|NCT03548532|temperature|temperature
4651215|NCT03548506|STN|stn
4651216|NCT03548506|DBS|dbs
4651217|NCT03548506|steering|steering
4651218|NCT03548506|segmented electrode leads|segmented electrode leads
4651219|NCT03548493|Magnesium sulphate|magnesium sulphate
4651220|NCT03548493|Fentanyl|fentanyl
4651221|NCT03548493|Conscious sedation|conscious sedation
4651222|NCT03548493|chronic subdural haematoma|chronic subdural haematoma
4651223|NCT03548493|Propofol|propofol
4651224|NCT03548493|Burr hole|burr hole
4651225|NCT03548467|melanoma|melanoma
4651226|NCT03548467|NSCLC|nsclc
4651227|NCT03548467|clear renal cell carcinoma|clear renal cell carcinoma
4651228|NCT03548467|urothelial cancer or SCCHN|urothelial cancer or scchn
4651229|NCT03548428|Atezolizumab|atezolizumab
4651230|NCT03548428|Oligometastatic Sarcomas|oligometastatic sarcomas
4651231|NCT03548428|stereotactic body radiation therapy|stereotactic body radiation therapy
4651232|NCT03548415|Acromegaly, IONIS-GHR-LRx|acromegaly, ionis-ghr-lrx
4651233|NCT03548376|rehabilitation|rehabilitation
4651234|NCT03548376|cerebral palsy|cerebral palsy
4651235|NCT03548376|postural control|postural control
4651236|NCT03548376|balance|balance
4651237|NCT03548376|gross-motor function|gross-motor function
4651238|NCT03548376|quality of life|quality of life
4651239|NCT03548376|hippotherapy|hippotherapy
4651240|NCT03548324|Feeding Tolerance|feeding tolerance
4651241|NCT03548324|RDS|rds
4651242|NCT03548324|HFNC|hfnc
4651243|NCT03548324|NCPAP|ncpap
4651244|NCT03548324|Preterm|preterm
4651245|NCT03548324|NEC|nec
4651246|NCT03548324|Enteral Nutrition|enteral nutrition
4651247|NCT03548324|Non Invasive Respiratory Support|non invasive respiratory support
4651248|NCT03548324|Very Low Birth Weight Infant|very low birth weight infant
4651249|NCT03548311|ALS|als
4651250|NCT03548311|motor neuron disease|motor neuron disease
4651251|NCT03548311|Lou Gehrig's disease|lou gehrig's disease
4651252|NCT03548298|GERD, Hybrid-APC, efficacy, safety|gerd, hybrid-apc, efficacy, safety
4651253|NCT03548298|ARAT|arat
4651254|NCT03548272|dedicated bifurcation stent|dedicated bifurcation stent
4651255|NCT03548272|non-LM bifurcation|non-lm bifurcation
4651256|NCT03548272|sirolimus-eluting stent|sirolimus-eluting stent
4651257|NCT03548259|Carpal Tunnel Syndrome|carpal tunnel syndrome
4651258|NCT03548259|Platelet-rich plasma|platelet-rich plasma
4651259|NCT03548259|Surgery|surgery
4651260|NCT03548181|Tele-rehabilitation|tele-rehabilitation
4651261|NCT03548155|schizophrenia；berberine；symptoms；inflammation|schizophrenia；berberine；symptoms；inflammation
4651262|NCT03548142|Palliative Care|palliative care
4651263|NCT03548142|advanced dementia|advanced dementia
4651264|NCT03548142|life-prolonging treatment|life-prolonging treatment
4651265|NCT03548142|patient will|patient will
4651266|NCT03548142|advanced care planning|advanced care planning
4651267|NCT03548116|Healthy Volunteer|healthy volunteer
4651268|NCT03548116|Ultrasound|ultrasound
4651269|NCT03548116|Insonification|insonification
4651270|NCT03548116|Spleen|spleen
4651271|NCT03548090|stroke rehabilitation|stroke rehabilitation
4651272|NCT03548090|walking limitations|walking limitations
4651273|NCT03548090|gait rehabilitation|gait rehabilitation
4651274|NCT03548064|dmLT|dmlt
4651275|NCT03548064|E. coli|e. coli
4651276|NCT03548064|Enterotoxigenic Escherichia coli (ETEC)|enterotoxigenic escherichia coli (etec)
4651277|NCT03548064|LTR192G/L211A|ltr192g/l211a
4651278|NCT03548051|Clostridium difficle Associated Disease (CDAD)|clostridium difficle associated disease (cdad)
4651279|NCT03548051|Efficacy|efficacy
4651280|NCT03548051|Fecal Microbiota Transplantation (FMT)|fecal microbiota transplantation (fmt)
4651281|NCT03548051|Microbial Restoration|microbial restoration
4652074|NCT03542890|I-gel|i-gel
4651282|NCT03548051|Partially-Blinded|partially-blinded
4651283|NCT03548051|Phase 1/2|phase 1/2
4651284|NCT03548051|Placebo Controlled|placebo controlled
4651285|NCT03548051|Safety|safety
4651286|NCT03548038|taste perception|taste perception
4651287|NCT03548038|bariatric surgery|bariatric surgery
4651288|NCT03548038|taste preference|taste preference
4651289|NCT03548038|weight loss surgery|weight loss surgery
4651290|NCT03548012|Caregivers|caregivers
4651291|NCT03548012|Support Needs|support needs
4651292|NCT03548012|Intervention|intervention
4651293|NCT03548012|Randomised controlled trial|randomised controlled trial
4651294|NCT03547999|CV301 Vaccination|cv301 vaccination
4651295|NCT03547999|mFOLFOX6|mfolfox6
4651296|NCT03547999|Fowlpox (FP)-CV301|fowlpox (fp)-cv301
4651297|NCT03547999|nivolumab|nivolumab
4651298|NCT03547999|MVA-BN-CV301|mva-bn-cv301
4651299|NCT03547986|flow-limiting dissection|flow-limiting dissection
4651300|NCT03547986|residual stenosis|residual stenosis
4651301|NCT03547934|Abdominal fat|abdominal fat
4651302|NCT03547882|Opioid|opioid
4651303|NCT03547882|Buprenorphine|buprenorphine
4651304|NCT03547882|Naltrexone|naltrexone
4651305|NCT03547882|methadone|methadone
4651430|NCT03547180|Mediators|mediators
4651306|NCT03547869|Transcranial Direct Current Stimulation|transcranial direct current stimulation
4651307|NCT03547869|Gulf War Illness|gulf war illness
4651308|NCT03547869|Pain modulation|pain modulation
4651309|NCT03547843|Behavior therapy|behavior therapy
4651310|NCT03547843|Peer groups|peer groups
4651311|NCT03547843|Patient satisfaction|patient satisfaction
4651312|NCT03547843|Feasibility studies|feasibility studies
4651313|NCT03547830|chronic granulomatous disease|chronic granulomatous disease
4651314|NCT03547830|graft failure|graft failure
4651315|NCT03547830|stem cell transplantation|stem cell transplantation
4651316|NCT03547830|plerixafor|plerixafor
4651317|NCT03547830|conditioning regimen|conditioning regimen
4651318|NCT03547791|Antenatal corticosteroid|antenatal corticosteroid
4651319|NCT03547791|Twin pregnancies|twin pregnancies
4651320|NCT03547791|Respiratory morbidity|respiratory morbidity
4651321|NCT03547791|Randomized controlled trial|randomized controlled trial
4651322|NCT03547765|Obesity|obesity
4651323|NCT03547765|Sexual Dysfunction|sexual dysfunction
4651324|NCT03547752|motor imaginery|motor imaginery
4651325|NCT03547752|mental training|mental training
4651326|NCT03547687|Electrical stimulation|electrical stimulation
4651327|NCT03547687|Intubation|intubation
4651328|NCT03547687|ICU discharge|icu discharge
4651329|NCT03547661|Premenstrual Syndrome|premenstrual syndrome
4651330|NCT03547661|Open-Label Placebo Effect|open-label placebo effect
4651331|NCT03547661|randomized controlled trial|randomized controlled trial
4651332|NCT03547609|Kabuki Syndrome|kabuki syndrome
4651333|NCT03547609|Intellectual Profile|intellectual profile
4651334|NCT03547609|Memory|memory
4651335|NCT03547596|Lower urinary tract symptoms|lower urinary tract symptoms
4651336|NCT03547596|Erectile dysfunction|erectile dysfunction
4651337|NCT03547596|Obstructive Sleep Apneas Syndrom|obstructive sleep apneas syndrom
4651338|NCT03547570|Joint instability|joint instability
4651339|NCT03547570|Hypermobility|hypermobility
4651340|NCT03547570|Shoulder|shoulder
4651341|NCT03547570|Strength training|strength training
4651342|NCT03547557|Bone Tumors|bone tumors
4651343|NCT03547544|helicobacter pylori|helicobacter pylori
4651344|NCT03547544|urease test|urease test
4651345|NCT03547544|helicotec|helicotec
4651346|NCT03547518|Urinary Urgency|urinary urgency
4651347|NCT03547518|Urinary Frequency|urinary frequency
4651348|NCT03547518|Urge Incontinence|urge incontinence
4651349|NCT03547505|Glide path|glide path
4651350|NCT03547505|postoperative pain|postoperative pain
4651351|NCT03547505|R-Pilot|r-pilot
4651352|NCT03547505|ProGlider|proglider
4651353|NCT03547492|language|language
4651354|NCT03547492|LENA|lena
4651355|NCT03547492|adolescent|adolescent
4651356|NCT03547453|Menstrual cycles|menstrual cycles
4651357|NCT03547453|Ultrasound|ultrasound
4651358|NCT03547453|Ovary|ovary
4651359|NCT03547453|Polycystic Ovary Syndrome (PCOS)|polycystic ovary syndrome (pcos)
4651360|NCT03547440|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
4651361|NCT03547440|immigrant|immigrant
4651362|NCT03547440|microbiota|microbiota
4651363|NCT03547440|bioindicator|bioindicator
4651364|NCT03547440|Methanobrevibacter smithii|methanobrevibacter smithii
4651365|NCT03547427|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
4651366|NCT03547427|Pramlintide|pramlintide
4651367|NCT03547427|Lispro Insulin|lispro insulin
4651368|NCT03547427|Continuous Glucose Monitor (CGM)|continuous glucose monitor (cgm)
4651369|NCT03547427|Acetaminophen|acetaminophen
4651370|NCT03547427|Hypoglycemia|hypoglycemia
4651371|NCT03547427|Exercise|exercise
4651372|NCT03547388|head and neck squamous cell carcinoma|head and neck squamous cell carcinoma
4651373|NCT03547388|hyperthermia|hyperthermia
4651374|NCT03547388|hypoxia|hypoxia
4651375|NCT03547388|18f-fluoromisonidazole|18f-fluoromisonidazole
4651376|NCT03547388|positron emission tomography|positron emission tomography
4651377|NCT03547388|FMISO|fmiso
4651378|NCT03547388|PET|pet
4651379|NCT03547388|whole body hyperthermia|whole body hyperthermia
4651380|NCT03547388|local recurrence|local recurrence
4651381|NCT03547388|lymph node recurrence|lymph node recurrence
4651382|NCT03547388|radiochemotherapy|radiochemotherapy
4651383|NCT03547362|Amino acids|amino acids
4651384|NCT03547362|Dairy proteins|dairy proteins
4651385|NCT03547362|Postprandial|postprandial
4651386|NCT03547362|Older adults|older adults
4651387|NCT03547349|respiratory therapy|respiratory therapy
4651388|NCT03547349|videogaming therapy|videogaming therapy
4651389|NCT03547349|incentive spirometry|incentive spirometry
4651390|NCT03547349|atelectases|atelectases
4651391|NCT03547310|EMG|emg
4651392|NCT03547310|Prosthesis control|prosthesis control
4651393|NCT03547310|Neuromuscular rehabilitation|neuromuscular rehabilitation
4651394|NCT03547310|Games for health|games for health
4651395|NCT03547297|Acute Hepatic Porphyria|acute hepatic porphyria
4651396|NCT03547297|Hepatic Porphyrias|hepatic porphyrias
4651397|NCT03547297|Acute Intermittent Porphyria (AIP)|acute intermittent porphyria (aip)
4651398|NCT03547297|Hereditary Coproporphyria (HCP)|hereditary coproporphyria (hcp)
4651399|NCT03547297|Variegate Porphyria (VP)|variegate porphyria (vp)
4651400|NCT03547297|ALA Dehydratase Deficient Porphyria (ADP)|ala dehydratase deficient porphyria (adp)
4651401|NCT03547297|Porphyria Acute|porphyria acute
4651402|NCT03547271|Meningococcal meningitis|meningococcal meningitis
4651403|NCT03547271|MenACYW conjugate vaccine|menacyw conjugate vaccine
4651404|NCT03547271|Quadrivalent meningococcal vaccine|quadrivalent meningococcal vaccine
4651405|NCT03547258|AML|aml
4651406|NCT03547258|Italian observational study|italian observational study
4651407|NCT03547258|FLT3-ITD Mutation|flt3-itd mutation
4651408|NCT03547258|FLT3-TKD Mutation|flt3-tkd mutation
4651409|NCT03547232|Acute pancreatitis|acute pancreatitis
4651410|NCT03547232|Indomethacin|indomethacin
4651411|NCT03547232|Prognosis|prognosis
4651412|NCT03547232|Organ dysfunction|organ dysfunction
4651413|NCT03547219|Deprssion|deprssion
4651414|NCT03547219|Adolescent|adolescent
4651415|NCT03547219|Biomarker|biomarker
4651416|NCT03547219|Inflammation|inflammation
4651417|NCT03547219|BDNF|bdnf
4651418|NCT03547219|Functional MRI|functional mri
4651419|NCT03547219|Antidepressant|antidepressant
4651420|NCT03547219|Machine learning|machine learning
4651421|NCT03547206|NAION|naion
4651422|NCT03547206|ischemic optic neuropathy|ischemic optic neuropathy
4651423|NCT03547193|difficult laringoscopy|difficult laringoscopy
4651424|NCT03547193|difficult airway|difficult airway
4651425|NCT03547193|airway management|airway management
4651426|NCT03547180|Respiration panic|respiration panic
4651427|NCT03547180|Cognitions|cognitions
4651428|NCT03547180|Panic|panic
4651429|NCT03547180|Treatment|treatment
4651431|NCT03547180|Moderators|moderators
4651432|NCT03547128|fluoride|fluoride
4651433|NCT03547128|genetics|genetics
4651434|NCT03547128|physical activity|physical activity
4651435|NCT03547128|diet|diet
4651436|NCT03547115|B-Cell Malignancies, Voruciclib, Cyclin Dependent Kinase Inhibitor|b-cell malignancies, voruciclib, cyclin dependent kinase inhibitor
4651437|NCT03547076|Pocket sized imaging device|pocket sized imaging device
4651438|NCT03547076|Handheld ultrasound device|handheld ultrasound device
4651439|NCT03547076|General practitioner|general practitioner
4651440|NCT03547076|Nurse|nurse
4651441|NCT03547076|Focused cardiac ultrasound|focused cardiac ultrasound
4651442|NCT03547076|FoCUS|focus
4651443|NCT03547076|Telemedicine|telemedicine
4651444|NCT03547076|Support|support
4651445|NCT03547063|Obesity, appetite, taste, fMRI|obesity, appetite, taste, fmri
4651446|NCT03547050|Epilepsy|epilepsy
4651447|NCT03547050|Rolandic|rolandic
4651448|NCT03547050|Genetics|genetics
4651449|NCT03547050|Genomewide Association Study|genomewide association study
4651450|NCT03547050|RE|re
4651451|NCT03547050|Neurology|neurology
4651452|NCT03547050|Pediatrics|pediatrics
4651453|NCT03546998|epidermoid carcinoma|epidermoid carcinoma
4651454|NCT03546998|esophageal achalasia|esophageal achalasia
4651455|NCT03546998|risk factors|risk factors
4651456|NCT03546972|Obesity and other hyperalimentation|obesity and other hyperalimentation
4651457|NCT03546972|Questionnaires|questionnaires
4651458|NCT03546972|Surveys|surveys
4651459|NCT03546972|Hunger Training|hunger training
4651460|NCT03546972|HT|ht
4651461|NCT03546972|Diabetes Prevention Program|diabetes prevention program
4651462|NCT03546972|DPP|dpp
4651463|NCT03546972|Continuous glucose monitoring|continuous glucose monitoring
4651464|NCT03546972|CGM|cgm
4651465|NCT03546959|stroke|stroke
4651466|NCT03546959|spasticity|spasticity
4651467|NCT03546959|lycra|lycra
4651468|NCT03546959|orthosis|orthosis
4651469|NCT03546959|splint|splint
4651470|NCT03546959|treatment|treatment
4651471|NCT03546959|upper extremity|upper extremity
4651472|NCT03546946|Attention|attention
4651473|NCT03546946|Anxiety|anxiety
4651474|NCT03546946|Adolescence|adolescence
4651475|NCT03546894|Drug therapy|drug therapy
4651476|NCT03546881|PAOD|paod
4651477|NCT03546881|endovascular|endovascular
4651478|NCT03546881|fusion|fusion
4651479|NCT03546881|radiation|radiation
4651480|NCT03546881|exposure|exposure
4651481|NCT03546790|Cannabis|cannabis
4651482|NCT03546777|Shoulder pain, coracoacromial ligament thickness|shoulder pain, coracoacromial ligament thickness
4651483|NCT03546764|Percutatneous catheter|percutatneous catheter
4651487|NCT03546751|Endothelial Dysfunction|endothelial dysfunction
4651488|NCT03546751|Micro RNA|micro rna
4651489|NCT03546738|Lumbar Vertebrae|lumbar vertebrae
4651490|NCT03546738|Surgery|surgery
4651491|NCT03546738|Postoperational Complications|postoperational complications
4651492|NCT03546738|Spinal Cord Stimulation|spinal cord stimulation
4651493|NCT03546712|Acuity|acuity
4651494|NCT03546712|children|children
4651495|NCT03546712|forearm|forearm
4651496|NCT03546712|perception|perception
4651497|NCT03546712|touch location|touch location
4651498|NCT03546686|Hormone Receptor Negative|hormone receptor negative
4651499|NCT03546686|Her2- Negative|her2- negative
4651500|NCT03546686|Resectable Breast Cancer|resectable breast cancer
4651501|NCT03546686|breast cancer|breast cancer
4651502|NCT03546686|immunotherapy|immunotherapy
4651503|NCT03546673|Chinese breast cancer survivors expressive writing|chinese breast cancer survivors expressive writing
4651504|NCT03546634|Inactivated Poliovirus Vaccine|inactivated poliovirus vaccine
4651505|NCT03546634|Sabin strain|sabin strain
4651506|NCT03546621|Hepatitis D|hepatitis d
4651507|NCT03546608|Hepatic Impairment|hepatic impairment
4651508|NCT03546608|Tepotinib|tepotinib
4651509|NCT03546608|Pharmacokinetics|pharmacokinetics
4651510|NCT03546595|Polycystic Ovary Syndrome|polycystic ovary syndrome
4651511|NCT03546595|Insulin Resistance|insulin resistance
4651512|NCT03546582|HNSCC|hnscc
4651513|NCT03546582|Head and Neck Squamous Cell Carcinoma|head and neck squamous cell carcinoma
4651514|NCT03546582|KEYSTROKE|keystroke
4651515|NCT03546517|myofascial trigger point|myofascial trigger point
4651516|NCT03546517|dry needling|dry needling
4651517|NCT03546517|spasticity|spasticity
4651518|NCT03546517|stroke|stroke
4651519|NCT03546504|child|child
4651520|NCT03546504|dental|dental
4651521|NCT03546504|oral health|oral health
4651522|NCT03546504|sensory desensitization|sensory desensitization
4651523|NCT03546504|sensory processing|sensory processing
4651524|NCT03546504|occupational therapy|occupational therapy
4651525|NCT03546478|SPECT/CT|spect/ct
4651526|NCT03546478|HER2 imaging|her2 imaging
4651527|NCT03546452|NSCLC|nsclc
4651528|NCT03546452|malignant hydrothorax|malignant hydrothorax
4651529|NCT03546452|prospective study|prospective study
4651530|NCT03546439|atrial fibrillation|atrial fibrillation
4651531|NCT03546439|vascular closure|vascular closure
4651532|NCT03546426|Mesothelioma, Malignant|mesothelioma, malignant
4651533|NCT03546426|PDL-1 negative|pdl-1 negative
4651534|NCT03546426|advanced disease|advanced disease
4651535|NCT03546426|progressive disease|progressive disease
4651536|NCT03546413|food|food
4651537|NCT03546413|peanut|peanut
4651538|NCT03546413|allergy|allergy
4651539|NCT03546413|prevention|prevention
4651540|NCT03546387|18-126|18-126
4651541|NCT03546387|Memorial Sloan Kettering Cancer Center|memorial sloan kettering cancer center
4651542|NCT03546322|head and neck cancer|head and neck cancer
4651543|NCT03546322|health information technology|health information technology
4651544|NCT03546322|patient safety|patient safety
4651545|NCT03546322|adherence|adherence
4651546|NCT03546322|ambulatory|ambulatory
4651547|NCT03546322|outpatient|outpatient
4651548|NCT03546322|human factors|human factors
4651549|NCT03546322|vulnerable populations|vulnerable populations
4651550|NCT03546322|chronic disease|chronic disease
4651551|NCT03546309|pediatric moyamoya disease|pediatric moyamoya disease
4651552|NCT03546309|remote ischemic conditioning|remote ischemic conditioning
4651553|NCT03546309|revascularization therapy|revascularization therapy
4651554|NCT03546296|Dietary Exposure|dietary exposure
4651555|NCT03546296|gallbladder carcinoma|gallbladder carcinoma
4651556|NCT03546270|Swimming|swimming
4651557|NCT03546270|Arterial Stiffness|arterial stiffness
4651558|NCT03546270|Blood Pressure|blood pressure
4651559|NCT03546270|Muscular Strength|muscular strength
4651560|NCT03546270|Cardiorespiratory Endurance|cardiorespiratory endurance
4651561|NCT03546257|Early gastric cancer|early gastric cancer
4651562|NCT03546257|Invasion depth|invasion depth
4651563|NCT03546257|Narrow band imaging|narrow band imaging
4651564|NCT03546257|Endoscopic ultrasonography|endoscopic ultrasonography
4651565|NCT03546231|Tricuspid regurgitation|tricuspid regurgitation
4651566|NCT03546231|tricuspid valve|tricuspid valve
4651567|NCT03546231|surgery|surgery
4651568|NCT03546231|outcome|outcome
4651569|NCT03546231|prognosis|prognosis
4651570|NCT03546231|mortality|mortality
4651571|NCT03546231|right ventricle|right ventricle
4651572|NCT03546231|asymptomatic|asymptomatic
4651573|NCT03546192|Influenza|influenza
4651574|NCT03546192|Influenza virus vaccine|influenza virus vaccine
4651575|NCT03546192|Fluzone® Quadrivalent Influenza Vaccine (No Preservative)|fluzone® quadrivalent influenza vaccine (no preservative)
4651576|NCT03546179|PVI, Tidal volume challenge|pvi, tidal volume challenge
4651577|NCT03546166|basal cell carcinoma|basal cell carcinoma
4651578|NCT03546127|Next Generation Sequencing|next generation sequencing
4651579|NCT03546127|Exome|exome
4651580|NCT03546127|RNA sequencing|rna sequencing
4651581|NCT03546127|Soft-tissue sarcoma|soft-tissue sarcoma
4651582|NCT03546127|Colorectal carcinoma|colorectal carcinoma
4651583|NCT03546114|Stereotypes|stereotypes
4651584|NCT03546088|awake intubation|awake intubation
4651585|NCT03546088|nasal fiberscope|nasal fiberscope
4651586|NCT03546088|topical anesthesia|topical anesthesia
4651587|NCT03546075|Cognition|cognition
4651588|NCT03546075|Resveratrol|resveratrol
4651589|NCT03546075|Whole body metabolism|whole body metabolism
4651590|NCT03546049|ultrasound-guided percutaneous transhepatic biliary drainage|ultrasound-guided percutaneous transhepatic biliary drainage
4651591|NCT03546049|endoscopic ultrasound-guided antegrade biliary drainage|endoscopic ultrasound-guided antegrade biliary drainage
4651592|NCT03546049|endoscopic ultrasound-guided transhepatic biliary drainage|endoscopic ultrasound-guided transhepatic biliary drainage
4651593|NCT03546049|endoscopic ultrasound-guided choledochal biliary drainage|endoscopic ultrasound-guided choledochal biliary drainage
4651594|NCT03546049|self-expandable metal stent|self-expandable metal stent
4651595|NCT03546049|malignant bile duct obstruction|malignant bile duct obstruction
4651596|NCT03546023|Chronic cancer pain|chronic cancer pain
4651597|NCT03546023|pain clinic|pain clinic
4651598|NCT03546023|Brief Pain Inventory|brief pain inventory
4651599|NCT03545997|Montelukast|montelukast
4651600|NCT03545997|leukotriene pathway|leukotriene pathway
4651601|NCT03545997|endothelial function|endothelial function
4651602|NCT03545997|flux-mediated dilation|flux-mediated dilation
4651603|NCT03545958|Older adults|older adults
4651604|NCT03545958|Community-based|community-based
4651605|NCT03545958|High-intensity interval training (HIT)|high-intensity interval training (hit)
4651606|NCT03545958|Mind-motor training|mind-motor training
4651607|NCT03545932|Hydrogymnastics|hydrogymnastics
4651608|NCT03545932|Physical Condition|physical condition
4651609|NCT03545932|Physical Activity and Health|physical activity and health
4651610|NCT03545932|Gerontomotricity|gerontomotricity
4651611|NCT03545919|respiratory viral infections|respiratory viral infections
4651612|NCT03545919|chronic lung allograft dysfunction|chronic lung allograft dysfunction
4651613|NCT03545919|lung microbiome|lung microbiome
4651614|NCT03545867|postprandial|postprandial
4651615|NCT03545867|glycemia|glycemia
4651616|NCT03545867|lipemia|lipemia
4651617|NCT03545867|macronutrient metabolism|macronutrient metabolism
4651618|NCT03545867|physical activity|physical activity
4651619|NCT03545815|mesothelin, CRISPR-Cas9, PD-1, TCR|mesothelin, crispr-cas9, pd-1, tcr
4651620|NCT03545789|HV|hv
4651621|NCT03545789|AD|ad
4651622|NCT03545789|PSP|psp
4651623|NCT03545763|Hypertension|hypertension
4651624|NCT03545763|Social Determinants of Health|social determinants of health
4651625|NCT03545763|Health Insurance|health insurance
4651626|NCT03545763|Medicaid|medicaid
4651627|NCT03545763|Affordable Care Act|affordable care act
4651628|NCT03545750|Acute kidney injury|acute kidney injury
4651629|NCT03545750|Continuous renal replacement therapy|continuous renal replacement therapy
4651630|NCT03545750|Citrate|citrate
4651631|NCT03545750|Heparin|heparin
4651632|NCT03545672|Primary Biliary Cholangitis|primary biliary cholangitis
4651633|NCT03545672|Cardiac impairment|cardiac impairment
4651634|NCT03545672|Cardiovascular Magnetic Resonance|cardiovascular magnetic resonance
4651635|NCT03545646|Abdominal tissues|abdominal tissues
4651636|NCT03545633|Abdominal tissues|abdominal tissues
4651637|NCT03545620|difficult airway|difficult airway
4651638|NCT03545620|difficult intubation|difficult intubation
4651639|NCT03545620|videolaryngoscope|videolaryngoscope
4651640|NCT03545620|exchange catheter|exchange catheter
4651641|NCT03545620|fiberoptic bronchoscope|fiberoptic bronchoscope
4651642|NCT03545620|Laryngeal subglottic airway device|laryngeal subglottic airway device
4651643|NCT03545620|tracheostomy|tracheostomy
4651644|NCT03545607|ischemic stroke|ischemic stroke
4651645|NCT03545607|adult stem cells|adult stem cells
4651646|NCT03545594|Randomized trial,|randomized trial,
4651647|NCT03545594|Health care needs|health care needs
4651648|NCT03545594|Traumatic brain injury|traumatic brain injury
4651649|NCT03545594|Community|community
4651650|NCT03545594|Goal attainment|goal attainment
4651651|NCT03545581|Fructose|fructose
4651652|NCT03545581|Uric acid|uric acid
4651653|NCT03545581|Glucose homeostasis|glucose homeostasis
4651654|NCT03545568|Sialic acid|sialic acid
4651655|NCT03545568|Monosaccharide|monosaccharide
4651656|NCT03545555|kale|kale
4651657|NCT03545555|antioxidant capacity|antioxidant capacity
4651658|NCT03545555|cholesterol|cholesterol
4651659|NCT03545555|lipid status|lipid status
4651660|NCT03545542|Microbiome|microbiome
4651661|NCT03545542|Volatilome|volatilome
4651662|NCT03545542|Neuroblastoma|neuroblastoma
4651663|NCT03545516|Wound infiltration|wound infiltration
4651664|NCT03545516|Post Cesarean|post cesarean
4651665|NCT03545516|Pain management|pain management
4651666|NCT03545516|bupivacaine|bupivacaine
4651667|NCT03545516|dexmedetomidine|dexmedetomidine
4651668|NCT03545516|postoperative pain|postoperative pain
4651669|NCT03545503|Rapid Sequence Intubation|rapid sequence intubation
4651670|NCT03545503|Hemodynamics|hemodynamics
4651671|NCT03545503|Etomidate|etomidate
4651672|NCT03545503|Ketamine|ketamine
4651673|NCT03545477|gait rehabilitation|gait rehabilitation
4651674|NCT03545477|curved walking training|curved walking training
4651675|NCT03545477|lower limb|lower limb
4651676|NCT03545464|Acute urticaria|acute urticaria
4651677|NCT03545451|EEG, neurofeedback, fMRI, ALS, surgery, upper limbs|eeg, neurofeedback, fmri, als, surgery, upper limbs
4651678|NCT03545425|Parkinson's Disease|parkinson's disease
4651679|NCT03545425|Biomarker|biomarker
4651681|NCT03545373|antimicrobial resistance|antimicrobial resistance
4651682|NCT03545373|TB|tb
4651683|NCT03545373|Cough|cough
4651684|NCT03545373|antibiotics|antibiotics
4651685|NCT03545373|anti-infective agents|anti-infective agents
4651686|NCT03545347|Rehabilitation|rehabilitation
4651687|NCT03545347|Physiotherapy|physiotherapy
4651688|NCT03545347|Strength training|strength training
4651689|NCT03545347|Anabolic steroids|anabolic steroids
4651690|NCT03545347|Nutritional supplement|nutritional supplement
4651691|NCT03545334|Transcutaneous, SLN, melanoma, Merkel cell carcinoma|transcutaneous, sln, melanoma, merkel cell carcinoma
4651692|NCT03545321|Naloxone|naloxone
4651693|NCT03545321|Community pharmacies|community pharmacies
4651694|NCT03545321|MOON (Maximizing OpiOid safety with Naloxone)|moon (maximizing opioid safety with naloxone)
4651695|NCT03545321|MOON+|moon+
4651696|NCT03545321|RESPOND (Resources Encouraging Safe Prescription Opioid and Naloxone Dispensing)|respond (resources encouraging safe prescription opioid and naloxone dispensing)
4651697|NCT03545308|Neuromuscular|neuromuscular
4651698|NCT03545308|Deep Anesthesia|deep anesthesia
4651699|NCT03545308|Rocuronium|rocuronium
4651700|NCT03545282|Mental Health|mental health
4651701|NCT03545282|Minority Health|minority health
4651702|NCT03545282|Latina|latina
4651703|NCT03545269|Degenerative Arthritis|degenerative arthritis
4651704|NCT03545269|Autologous Chondrocyte Implantation|autologous chondrocyte implantation
4651705|NCT03545269|Cartilage defects|cartilage defects
4651706|NCT03545269|Cartilage lesion|cartilage lesion
4651707|NCT03545269|Arthritis|arthritis
4651708|NCT03545256|Outpatient|outpatient
4651709|NCT03545256|head neck cancer|head neck cancer
4651710|NCT03545256|Lymph node metastasis|lymph node metastasis
4651711|NCT03545256|surgery|surgery
4651712|NCT03545256|Quality of life|quality of life
4651713|NCT03545256|economical study|economical study
4651714|NCT03545243|duodenum|duodenum
4651715|NCT03545243|microbiome|microbiome
4651716|NCT03545243|proton pump inhibitor|proton pump inhibitor
4651717|NCT03545204|Neonatal Mortality & Neurodevelopment of an Infant.|neonatal mortality & neurodevelopment of an infant.
4651718|NCT03545178|white coat adherence|white coat adherence
4651719|NCT03545178|continuous glucose monitoring|continuous glucose monitoring
4651720|NCT03545178|flash glucose monitoring|flash glucose monitoring
4651721|NCT03545178|hypoglycemia prediction|hypoglycemia prediction
4651722|NCT03545178|deep learning algorithm|deep learning algorithm
4651723|NCT03545139|pulp revascularization|pulp revascularization
4651724|NCT03545139|endodontic regeneration|endodontic regeneration
4651725|NCT03545139|NeoMTA|neomta
4651726|NCT03545126|Tauopathies|tauopathies
4651727|NCT03545113|graft|graft
4651728|NCT03545113|fistula|fistula
4651729|NCT03545113|hemodialysis|hemodialysis
4651730|NCT03545113|Vascular access|vascular access
4651731|NCT03545100|oral cancer|oral cancer
4651732|NCT03545100|shoulder dysfunction|shoulder dysfunction
4651733|NCT03545100|quality of life|quality of life
4651734|NCT03545100|motor control|motor control
4651735|NCT03545100|strengthening exercise|strengthening exercise
4651736|NCT03545074|mindfulness|mindfulness
4651737|NCT03545074|depression|depression
4651738|NCT03545074|Spanish|spanish
4651739|NCT03545048|web-based exercises|web-based exercises
4651740|NCT03545048|Digital health|digital health
4651741|NCT03545048|knee exercises|knee exercises
4651742|NCT03545035|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
4651743|NCT03545035|Idelalisib|idelalisib
4651744|NCT03545035|Rituximab|rituximab
4651745|NCT03545022|third molar|third molar
4651746|NCT03545022|acupuncture|acupuncture
4651747|NCT03545022|pain|pain
4651748|NCT03545022|edema|edema
4651749|NCT03545022|trismus|trismus
4651750|NCT03545022|anxiety|anxiety
4651751|NCT03544996|Insulin, needle-less, transdermal|insulin, needle-less, transdermal
4651752|NCT03544983|Breast Cancer|breast cancer
4651753|NCT03544983|Ovarian Cancer|ovarian cancer
4651754|NCT03544983|Prostate Cancer|prostate cancer
4651755|NCT03544983|BRCA1|brca1
4651756|NCT03544983|BRCA2|brca2
4651757|NCT03544970|fetal MRI|fetal mri
4651758|NCT03544970|Posterior fossa|posterior fossa
4651759|NCT03544957|Screening instrument|screening instrument
4651760|NCT03544944|bowel preparation|bowel preparation
4651761|NCT03544892|Low carbohydrate diet|low carbohydrate diet
4651762|NCT03544853|Prosthetic socket|prosthetic socket
4651763|NCT03544853|Biomechanics|biomechanics
4651764|NCT03544827|Atropine|atropine
4651765|NCT03544788|mobile compression device|mobile compression device
4651766|NCT03544762|breast cancer|breast cancer
4651767|NCT03544762|PET|pet
4651768|NCT03544762|[18F]FES|[18f]fes
4651769|NCT03544762|estrogen receptor|estrogen receptor
4651770|NCT03544762|hormone treatment|hormone treatment
4651771|NCT03544762|personalized cancer care|personalized cancer care
4651772|NCT03544736|Nivolumab|nivolumab
4651773|NCT03544736|Immunotherapy|immunotherapy
4651774|NCT03544710|surgical site infection|surgical site infection
4651775|NCT03544671|Vitamin D|vitamin d
4651776|NCT03544671|Nutritional deficiencies|nutritional deficiencies
4651777|NCT03544671|Miconutrients|miconutrients
4651778|NCT03544671|Children|children
4651779|NCT03544671|Mexico|mexico
4651780|NCT03544658|Tooth extrinsic stain|tooth extrinsic stain
4651782|NCT03544658|Dental prophylaxis|dental prophylaxis
4651783|NCT03544658|Visual shade guide|visual shade guide
4651784|NCT03544658|Dental spectrophotometer|dental spectrophotometer
4651785|NCT03544645|Diabetic Education|diabetic education
4651786|NCT03544645|audiovisual material|audiovisual material
4651787|NCT03544645|Manual material|manual material
4651788|NCT03544632|adipose-derived extracellular matrix (ECM)|adipose-derived extracellular matrix (ecm)
4651789|NCT03544632|acellular adipose tissue (AAT)|acellular adipose tissue (aat)
4651790|NCT03544580|dentin|dentin
4651791|NCT03544580|immediate implant|immediate implant
4651792|NCT03544580|buccal bone resorption|buccal bone resorption
4651793|NCT03544580|crestal bone loss|crestal bone loss
4651794|NCT03544554|Overactive bladder|overactive bladder
4651795|NCT03544554|healthy lifestyle behaviors|healthy lifestyle behaviors
4651796|NCT03544554|quality of life|quality of life
4651797|NCT03544515|peri-implantitis|peri-implantitis
4651798|NCT03544515|laser treatment|laser treatment
4651799|NCT03544515|Biolase|biolase
4651800|NCT03544515|Er,Cr:YSGG|er,cr:ysgg
4651801|NCT03544502|music, anesthesia, surgery|music, anesthesia, surgery
4651802|NCT03544476|mobile Health|mobile health
4651803|NCT03544437|lymph node dissection|lymph node dissection
4651804|NCT03544437|upper tract urothelial carcinoma|upper tract urothelial carcinoma
4651805|NCT03544437|nephroureterectomy|nephroureterectomy
4651806|NCT03544411|Olive oil|olive oil
4651807|NCT03544411|Bran oil|bran oil
4651808|NCT03544411|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
4651809|NCT03544411|Antioxidant|antioxidant
4651810|NCT03544411|glycemic control|glycemic control
4651811|NCT03544411|lipid profile|lipid profile
4651812|NCT03544372|concussion, rugby, self-report, concussion history, reliability|concussion, rugby, self-report, concussion history, reliability
4651813|NCT03544359|transcranial direct current stimulation (tDCS)|transcranial direct current stimulation (tdcs)
4651814|NCT03544359|functional magnetic resonance imaging (MRI)|functional magnetic resonance imaging (mri)
4651815|NCT03544346|brain health, professional athlete, retired, neuropsychological assessment|brain health, professional athlete, retired, neuropsychological assessment
4651816|NCT03544333|transcranial magnetic stimulation (TMS)|transcranial magnetic stimulation (tms)
4651817|NCT03544333|brain stimulation|brain stimulation
4651818|NCT03544333|medication-free|medication-free
4651819|NCT03544320|Pre-diabetes|pre-diabetes
4651820|NCT03544320|diabetes|diabetes
4651821|NCT03544320|wearable devices|wearable devices
4651822|NCT03544320|mobile health|mobile health
4651823|NCT03544307|Taekwondo|taekwondo
4651824|NCT03544307|Menopause|menopause
4651825|NCT03544307|Hypertension|hypertension
4651826|NCT03544307|Arterial Stiffness|arterial stiffness
4651827|NCT03544307|Blood Catecholamines|blood catecholamines
4651828|NCT03544281|Relapsed / Refractory Multiple Myeloma|relapsed / refractory multiple myeloma
4651829|NCT03544281|Dose escalation|dose escalation
4651830|NCT03544281|Antibody-Drug Conjugate|antibody-drug conjugate
4651831|NCT03544281|Dose expansion|dose expansion
4651832|NCT03544268|ultrasound|ultrasound
4651833|NCT03544268|breast|breast
4651834|NCT03544268|angiography|angiography
4651835|NCT03544255|pancreatic cancer|pancreatic cancer
4651836|NCT03544255|EUS-FNA|eus-fna
4651837|NCT03544255|organoid|organoid
4651838|NCT03544242|Diabetes|diabetes
4651839|NCT03544242|Insulin Resistance|insulin resistance
4651840|NCT03544242|Nitrite|nitrite
4651841|NCT03544242|Pancreatic islet cells|pancreatic islet cells
4651842|NCT03544242|Autotransplantation|autotransplantation
4651843|NCT03544242|Ischemia reperfusion injury|ischemia reperfusion injury
4651844|NCT03544242|Mitigation|mitigation
4651845|NCT03544242|Cure|cure
4651846|NCT03544242|Nitric oxide|nitric oxide
4651847|NCT03544242|Sodium nitrite|sodium nitrite
4651848|NCT03544242|Islet cell|islet cell
4651849|NCT03544242|Survival|survival
4651850|NCT03544242|Pancreas|pancreas
4651851|NCT03544242|Liver|liver
4651852|NCT03544229|Drug Therapy|drug therapy
4651853|NCT03544216|Contact Lens|contact lens
4651854|NCT03544216|Multifocal|multifocal
4651855|NCT03544216|Accommodation|accommodation
4651856|NCT03544216|Presbyopia|presbyopia
4651857|NCT03544203|intraabdominal infections|intraabdominal infections
4651858|NCT03544203|peritonitis|peritonitis
4651859|NCT03544203|critically ill|critically ill
4651860|NCT03544177|mobility|mobility
4651861|NCT03544177|exercise therapy|exercise therapy
4651862|NCT03544177|blood flow restricted exercise|blood flow restricted exercise
4651863|NCT03544177|rehabilitation|rehabilitation
4651864|NCT03544099|nasopharyngeal carcinoma|nasopharyngeal carcinoma
4651865|NCT03544073|in-vitro fertilization|in-vitro fertilization
4651866|NCT03544060|Familial Chylomicronemia|familial chylomicronemia
4651867|NCT03544060|Familial Lipoprotein Lipase Deficiency|familial lipoprotein lipase deficiency
4651868|NCT03544060|Hyperlipoproteinemias|hyperlipoproteinemias
4651869|NCT03544060|Familial Hyperlipoproteinemia Type 1|familial hyperlipoproteinemia type 1
4651870|NCT03544060|Hyperlipoproteinemia Type 1|hyperlipoproteinemia type 1
4651871|NCT03544060|Hyperchylomicronemia, Familial|hyperchylomicronemia, familial
4651872|NCT03544060|Lipoprotein Lipase Deficiency, Familial|lipoprotein lipase deficiency, familial
4651873|NCT03544060|Hyperlipidemias|hyperlipidemias
4651874|NCT03544060|Dyslipidemias|dyslipidemias
4651875|NCT03544060|Lipid Metabolism Disorders|lipid metabolism disorders
4651876|NCT03544060|Lipid Metabolism, Inborn Errors|lipid metabolism, inborn errors
4651877|NCT03544060|Metabolic Diseases|metabolic diseases
4651878|NCT03544060|Metabolism, Inborn Errors|metabolism, inborn errors
4651879|NCT03544060|Genetic Diseases, Inborn|genetic diseases, inborn
4651880|NCT03544021|Acute Lymphocytic Leukemia|acute lymphocytic leukemia
4651881|NCT03544021|Relapsed|relapsed
4651882|NCT03544021|Refractory|refractory
4651883|NCT03543995|lower urinary tract symptoms|lower urinary tract symptoms
4651884|NCT03543995|nocturnal enuresis|nocturnal enuresis
4651885|NCT03543995|spina bifida occulta|spina bifida occulta
4651886|NCT03543995|treatment response|treatment response
4651887|NCT03543956|Silica|silica
4651888|NCT03543956|Organic Solvents|organic solvents
4651889|NCT03543956|Toxic substances exposure|toxic substances exposure
4651890|NCT03543904|Abdomen|abdomen
4651891|NCT03543904|Children|children
4651892|NCT03543904|Chest physical therapy|chest physical therapy
4651893|NCT03543904|Surgery|surgery
4651894|NCT03543891|Gut microbiota|gut microbiota
4651895|NCT03543891|16S rRNA gene|16s rrna gene
4651896|NCT03543891|Thyroid cancer|thyroid cancer
4651897|NCT03543891|Metabonomics|metabonomics
4651898|NCT03543865|American Indian|american indian
4651899|NCT03543865|Resilience|resilience
4651900|NCT03543865|Native American|native american
4651901|NCT03543852|Cancer survivor|cancer survivor
4651902|NCT03543852|Health promotion|health promotion
4651903|NCT03543852|Health education|health education
4651904|NCT03543839|lupus|lupus
4651905|NCT03543839|early lupus|early lupus
4651906|NCT03543839|belimumab|belimumab
4651907|NCT03543839|autoreactivity|autoreactivity
4651908|NCT03543826|neostigmine|neostigmine
4651909|NCT03543826|sugammadex|sugammadex
4651910|NCT03543826|rocuronium|rocuronium
4651911|NCT03543826|neuromuscular blocking agents|neuromuscular blocking agents
4651912|NCT03543813|cancer|cancer
4651913|NCT03543813|solid tumor|solid tumor
4651914|NCT03543813|DLBCL|dlbcl
4651915|NCT03543813|CX-2029|cx-2029
4651916|NCT03543813|PROBODY™ Therapeutic|probody™ therapeutic
4651917|NCT03543813|Drug Conjugate|drug conjugate
4651918|NCT03543813|Antibody drug conjugate|antibody drug conjugate
4651919|NCT03543813|CD71|cd71
4651920|NCT03543813|Transferrin receptor 1|transferrin receptor 1
4651921|NCT03543787|Referral networks|referral networks
4651922|NCT03543787|low and middle income countries|low and middle income countries
4651923|NCT03543787|PRECEDE-PROCEED|precede-proceed
4651924|NCT03543787|implementation research|implementation research
4651925|NCT03543787|hypertension|hypertension
4651926|NCT03543787|cardiovascular disease|cardiovascular disease
4651927|NCT03543787|process evaluation|process evaluation
4651928|NCT03543774|Chronic kidney disease|chronic kidney disease
4651929|NCT03543774|Lipid lowering therapy|lipid lowering therapy
4651930|NCT03543774|Hypercholesterolemia|hypercholesterolemia
4651931|NCT03543748|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
4651932|NCT03543748|cognitive impairment|cognitive impairment
4651933|NCT03543722|Veterans|veterans
4651934|NCT03543722|Disability|disability
4651935|NCT03543722|Employment|employment
4651936|NCT03543722|Vocational Rehabilitation|vocational rehabilitation
4651937|NCT03543722|Supported Employment|supported employment
4651938|NCT03543709|Behcet's disease|behcet's disease
4651939|NCT03543709|Fibromyalgia|fibromyalgia
4651940|NCT03543709|Disease activity|disease activity
4651941|NCT03543683|Non-Small Cell Lung Cancer|non-small cell lung cancer
4651942|NCT03543683|Aspirin|aspirin
4651943|NCT03543683|Osimertinib|osimertinib
4651944|NCT03543683|EGFR-TKI|egfr-tki
4651945|NCT03543683|T790M|t790m
4651946|NCT03543644|Microbiome|microbiome
4651947|NCT03543644|Sugar Sweetened Beverages|sugar sweetened beverages
4651948|NCT03543644|Diet Beverages|diet beverages
4651949|NCT03543644|Non-Nutritive Sweetened Beverages|non-nutritive sweetened beverages
4651950|NCT03543644|Glucose response|glucose response
4651951|NCT03543618|dental implant|dental implant
4651952|NCT03543618|edentulous ridge|edentulous ridge
4651953|NCT03543592|postmenopausal bleeding|postmenopausal bleeding
4651954|NCT03543592|ultrasound|ultrasound
4651955|NCT03543592|power doppler|power doppler
4651956|NCT03543592|endometrium|endometrium
4651957|NCT03543579|multiple myeloma|multiple myeloma
4651958|NCT03543579|Carfilzomib|carfilzomib
4651959|NCT03543579|Proteasome inhibition|proteasome inhibition
4651960|NCT03543566|antimuscarinic medication|antimuscarinic medication
4651961|NCT03543566|medical management|medical management
4651962|NCT03543566|dual incontinence|dual incontinence
4651963|NCT03543566|darifenacin|darifenacin
4651964|NCT03543566|quality of life|quality of life
4651965|NCT03543566|bowel diary|bowel diary
4651966|NCT03543514|colon cancer, rectal cancer, prehabilitation|colon cancer, rectal cancer, prehabilitation
4651967|NCT03543462|Ovarian Cancer|ovarian cancer
4651968|NCT03543462|Diaphragm|diaphragm
4651969|NCT03543462|Chest Drain|chest drain
4651970|NCT03543462|Diaphragmatic Resection|diaphragmatic resection
4651971|NCT03543462|Pleural Effusion|pleural effusion
4651972|NCT03543436|Non-inferiority study|non-inferiority study
4651973|NCT03543436|Temocillin|temocillin
4651974|NCT03543436|Carbapenem|carbapenem
4651975|NCT03543436|ESBL infection|esbl infection
4652172|NCT03541980|sickle cell|sickle cell
4651976|NCT03543436|Urinary tract infection|urinary tract infection
4651977|NCT03543423|Gut hormone secretion|gut hormone secretion
4651978|NCT03543423|Glucose absorption|glucose absorption
4651979|NCT03543423|early meal phase|early meal phase
4651980|NCT03543423|Insulin and glucagon secretion|insulin and glucagon secretion
4651981|NCT03543410|Depression, Depressive episode, Bipolar, Bipolar 1, Bipolar 1 depression|depression, depressive episode, bipolar, bipolar 1, bipolar 1 depression
4651982|NCT03543397|ductal carcinomas|ductal carcinomas
4651983|NCT03543397|ductal carcinoma in situ (DCIS)|ductal carcinoma in situ (dcis)
4651984|NCT03543397|MRI|mri
4651985|NCT03543384|facial neuritis|facial neuritis
4651986|NCT03543384|T2 weighted gradient-echo|t2 weighted gradient-echo
4651987|NCT03543384|fast imaging employing steady state acquisition (FIESTA-C)|fast imaging employing steady state acquisition (fiesta-c)
4651988|NCT03543384|magnetic resonance imaging (MRI)|magnetic resonance imaging (mri)
4651989|NCT03543371|Neuropsychology|neuropsychology
4651990|NCT03543358|rovalpituzumab tesirine|rovalpituzumab tesirine
4651991|NCT03543358|rollover study|rollover study
4651992|NCT03543358|cancer|cancer
4651993|NCT03543345|RCA|rca
4651994|NCT03543345|PCI|pci
4651995|NCT03543345|right ventricular function|right ventricular function
4651996|NCT03543332|Physical training|physical training
4651997|NCT03543332|Kinesiophobia|kinesiophobia
4651998|NCT03543293|perilymphatic fistulas|perilymphatic fistulas
4651999|NCT03543293|magnetic resonance imaging (MRI)|magnetic resonance imaging (mri)
4652000|NCT03543293|surgery|surgery
4652001|NCT03543293|round window|round window
4652002|NCT03543293|vertigo|vertigo
4652003|NCT03543293|tinnitus|tinnitus
4652004|NCT03543293|cophosis|cophosis
4652005|NCT03543280|fatigability post stroke|fatigability post stroke
4652006|NCT03543280|post stroke|post stroke
4652007|NCT03543280|high-speed CT|high-speed ct
4652008|NCT03543280|MRI|mri
4652009|NCT03543254|Botulinum Toxins, Type A|botulinum toxins, type a
4652010|NCT03543254|Injections|injections
4652011|NCT03543254|Cranial Sutures|cranial sutures
4652012|NCT03543254|Head|head
4652013|NCT03543241|Strain|strain
4652014|NCT03543228|Strain|strain
4652015|NCT03543215|MRI|mri
4652016|NCT03543215|Radiomics|radiomics
4652017|NCT03543215|Texture features|texture features
4652018|NCT03543215|Prognistication|prognistication
4652019|NCT03543215|Endometrial cancer|endometrial cancer
4652020|NCT03543202|Unilateral transversus abdominal plane block|unilateral transversus abdominal plane block
4652021|NCT03543202|Local infiltration anesthesia|local infiltration anesthesia
4652022|NCT03543202|Cholecystectomy|cholecystectomy
4652023|NCT03543202|Postoperative analgesia|postoperative analgesia
4652024|NCT03543189|Gleason Group 5|gleason group 5
4652025|NCT03543189|PCa|pca
4652026|NCT03543189|Advanced Stage Prostate Cancer|advanced stage prostate cancer
4652027|NCT03543189|Immunotherapy|immunotherapy
4652028|NCT03543189|Oligometastaic Disease|oligometastaic disease
4652029|NCT03543189|Brachytherapy|brachytherapy
4652030|NCT03543189|Androgen Deprivation Therapy|androgen deprivation therapy
4652031|NCT03543176|Cohort|cohort
4652032|NCT03543176|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
4652033|NCT03543176|Observational|observational
4652034|NCT03543176|GOLD|gold
4652035|NCT03543176|Claims|claims
4652036|NCT03543176|Health plan recruitment|health plan recruitment
4652037|NCT03543163|buccal fat pad graft|buccal fat pad graft
4652038|NCT03543163|sub-epithelial connective tissue graft|sub-epithelial connective tissue graft
4652039|NCT03543150|Spasmodic Dysphonia|spasmodic dysphonia
4652040|NCT03543150|VHI-10 scores|vhi-10 scores
4652041|NCT03543150|BOTOX|botox
4652042|NCT03543150|Drug use investigation|drug use investigation
4652043|NCT03543124|colonoscopy|colonoscopy
4652044|NCT03543124|pain|pain
4652045|NCT03543124|water exchange|water exchange
4652046|NCT03543124|cap|cap
4652047|NCT03543098|Knee Injury|knee injury
4652048|NCT03543098|Knee Injuries|knee injuries
4652049|NCT03543098|Knee Surgery|knee surgery
4652050|NCT03543098|Rehabilitation|rehabilitation
4652051|NCT03543098|Knee Dislocation|knee dislocation
4652052|NCT03543098|Multiple Ligament Knee Injury|multiple ligament knee injury
4652053|NCT03543033|lumbar radiculopathy|lumbar radiculopathy
4652054|NCT03543033|corticosteroid epidural injection|corticosteroid epidural injection
4652055|NCT03543020|radiation induced alopecia|radiation induced alopecia
4652056|NCT03543020|whole brain radiation|whole brain radiation
4652057|NCT03543020|partial brain radiation|partial brain radiation
4652058|NCT03543020|radiotherapy|radiotherapy
4652059|NCT03542981|pain|pain
4652060|NCT03542981|surgery|surgery
4652061|NCT03542981|interferential current|interferential current
4652062|NCT03542981|total knee arthroplasty|total knee arthroplasty
4652063|NCT03542968|Congenital heart disease|congenital heart disease
4652064|NCT03542968|Tetralogy of Fallot|tetralogy of fallot
4652065|NCT03542968|Imaging by 4D Flow,|imaging by 4d flow,
4652066|NCT03542968|Magnetic resonance imaging|magnetic resonance imaging
4652067|NCT03542968|Prevention of ventricular dysfunction|prevention of ventricular dysfunction
4652068|NCT03542942|locally advanced|locally advanced
4652069|NCT03542942|radiotherapy|radiotherapy
4652070|NCT03542942|DW-MRI|dw-mri
4652071|NCT03542942|target volume|target volume
4652072|NCT03542890|Anesthesia, General|anesthesia, general
4652075|NCT03542877|Cabozantinib|cabozantinib
4652076|NCT03542877|Progression Free Survival|progression free survival
4652077|NCT03542877|Metastatic Colorectal Cancer|metastatic colorectal cancer
4652078|NCT03542877|Tumor|tumor
4652079|NCT03542864|obesity|obesity
4652080|NCT03542864|overweight|overweight
4652081|NCT03542864|fat percentage|fat percentage
4652082|NCT03542864|body fat|body fat
4652083|NCT03542864|enteral feeding|enteral feeding
4652084|NCT03542864|fat loss|fat loss
4652085|NCT03542825|Iron|iron
4652086|NCT03542825|Deficiency|deficiency
4652087|NCT03542812|L-citrulline|l-citrulline
4652088|NCT03542812|Nitric oxide|nitric oxide
4652089|NCT03542786|HIV-1|hiv-1
4652090|NCT03542760|Methylene Blue|methylene blue
4652091|NCT03542747|Airway|airway
4652092|NCT03542747|extraglottic|extraglottic
4652093|NCT03542747|simulation|simulation
4652094|NCT03542747|laryngeal mask|laryngeal mask
4652095|NCT03542721|chronic fatigue symptom|chronic fatigue symptom
4652096|NCT03542721|blood circulation|blood circulation
4652097|NCT03542656|Stroke|stroke
4652098|NCT03542656|intracerebral hemorrhage|intracerebral hemorrhage
4652099|NCT03542656|amyoid PET|amyoid pet
4652100|NCT03542656|cerebral amyloid angiopathy|cerebral amyloid angiopathy
4652101|NCT03542643|ADHD|adhd
4652102|NCT03542643|n-3 polyunsaturated fatty acids|n-3 polyunsaturated fatty acids
4652103|NCT03542643|children|children
4652104|NCT03542643|adolescents|adolescents
4652105|NCT03542513|Human Papillomavirus|human papillomavirus
4652106|NCT03542513|Biomarker|biomarker
4652107|NCT03542513|Self-sampling|self-sampling
4652108|NCT03542513|First-void urine|first-void urine
4652109|NCT03542513|Cervical Intraepithelial Neoplasia|cervical intraepithelial neoplasia
4652110|NCT03542513|LLETZ|lletz
4652111|NCT03542487|Self Monitoring of Blood Glucose|self monitoring of blood glucose
4652112|NCT03542487|Electronic Medical Records|electronic medical records
4652113|NCT03542487|Nudge|nudge
4652114|NCT03542487|Secure Messaging|secure messaging
4652115|NCT03542487|Behavioral Economics|behavioral economics
4652116|NCT03542461|Squamous NSCLC|squamous nsclc
4652117|NCT03542461|Nivolumab|nivolumab
4652118|NCT03542396|CBT|cbt
4652119|NCT03542396|Endurance exercise|endurance exercise
4652120|NCT03542383|Gulf War Illness|gulf war illness
4652121|NCT03542383|Memory|memory
4652122|NCT03542383|Word Finding|word finding
4652123|NCT03542383|High Definition Transcranial Direct Current Stimulation|high definition transcranial direct current stimulation
4652124|NCT03542383|Transcranial Direct Current Stimulation|transcranial direct current stimulation
4652125|NCT03542370|dietary approaches to stop hypertension|dietary approaches to stop hypertension
4652126|NCT03542370|DASH|dash
4652127|NCT03542370|cardiometabolic health|cardiometabolic health
4652128|NCT03542370|Umbrella Review|umbrella review
4652129|NCT03542370|GRADE|grade
4652130|NCT03542370|Systematic review and meta-analysis|systematic review and meta-analysis
4652131|NCT03542318|Pulmonary Rehabilitation|pulmonary rehabilitation
4652132|NCT03542318|Functional outcomes|functional outcomes
4652133|NCT03542318|Health Status|health status
4652134|NCT03542318|Exercise|exercise
4652135|NCT03542279|Autoimmune encephalitis, Plasma exchange, Immunotherapy, Outcome|autoimmune encephalitis, plasma exchange, immunotherapy, outcome
4652136|NCT03542266|Peripheral T-cell Lymphoma|peripheral t-cell lymphoma
4652137|NCT03542266|Azacitidine|azacitidine
4652138|NCT03542266|Lymphoma|lymphoma
4652139|NCT03542253|Early lung cancer,ground-glass nodule,CT,exosome|early lung cancer,ground-glass nodule,ct,exosome
4652140|NCT03542240|curcumin|curcumin
4652141|NCT03542240|microbiome|microbiome
4652142|NCT03542240|dietary supplements|dietary supplements
4652143|NCT03542240|gut bacteria|gut bacteria
4652144|NCT03542227|Antibodies|antibodies
4652145|NCT03542227|Vaccination|vaccination
4652146|NCT03542227|Self-sampling|self-sampling
4652147|NCT03542227|First-void urine|first-void urine
4652148|NCT03542188|Large Vessel Occlusion|large vessel occlusion
4652149|NCT03542188|Stroke|stroke
4652150|NCT03542188|EVT|evt
4652151|NCT03542175|Rucaparib|rucaparib
4652152|NCT03542175|Radiotherapy|radiotherapy
4652153|NCT03542175|Triple Negative Breast Cancer|triple negative breast cancer
4652154|NCT03542175|18-002|18-002
4652155|NCT03542162|Healaflow|healaflow
4652156|NCT03542162|Rhegmatogenous retinal detachment|rhegmatogenous retinal detachment
4652157|NCT03542162|27-gauge Pars plana vitrectomy|27-gauge pars plana vitrectomy
4652158|NCT03542162|Minimally invasive surgery|minimally invasive surgery
4652159|NCT03542162|Complications|complications
4652160|NCT03542136|Polyneuropathy|polyneuropathy
4652161|NCT03542136|Oxaliplatin|oxaliplatin
4652162|NCT03542136|Colorectal cancer|colorectal cancer
4652163|NCT03542123|Electrical Stimulation Therapy; Electrodes; Parasympathetic Nervous System; Sympathetic Fibers, Post Ganglionic; Congestive Heart Failure; Heart Failure|electrical stimulation therapy; electrodes; parasympathetic nervous system; sympathetic fibers, post ganglionic; congestive heart failure; heart failure
4652164|NCT03542097|Ewing Sarcoma|ewing sarcoma
4652165|NCT03542032|i-gel|i-gel
4652166|NCT03542032|jaw-thrust|jaw-thrust
4652167|NCT03541993|Resveratrol|resveratrol
4652168|NCT03541993|Cerebral blood flow|cerebral blood flow
4652169|NCT03541993|Cognition|cognition
4652170|NCT03541993|Hypoxia|hypoxia
4652171|NCT03541993|Polyphenols|polyphenols
4652173|NCT03541980|acetaminophen in pain crises|acetaminophen in pain crises
4652174|NCT03541980|opioid-sparing|opioid-sparing
4652175|NCT03541967|bone conduction|bone conduction
4652176|NCT03541954|sensitization|sensitization
4652177|NCT03541954|pain thresholds|pain thresholds
4652178|NCT03541941|Liposomal Bupivacaine|liposomal bupivacaine
4652179|NCT03541941|Exparel|exparel
4652180|NCT03541941|Transversus Abdominis Plane block|transversus abdominis plane block
4652181|NCT03541941|Hernia|hernia
4652182|NCT03541928|gene therapy|gene therapy
4652183|NCT03541928|untreated prostate cancer|untreated prostate cancer
4652184|NCT03541902|Malignant Neoplasms of Urinary Tract|malignant neoplasms of urinary tract
4652185|NCT03541902|Renal cell carcinoma|renal cell carcinoma
4652186|NCT03541902|Cabozantinib|cabozantinib
4652187|NCT03541902|XL-184|xl-184
4652188|NCT03541902|XL184|xl184
4652189|NCT03541902|Sunitinib|sunitinib
4652190|NCT03541902|Sunitinib Malate|sunitinib malate
4652191|NCT03541902|SU011248|su011248
4652192|NCT03541902|Sutent|sutent
4652193|NCT03541876|children|children
4652194|NCT03541876|treatment|treatment
4652195|NCT03541876|observatory|observatory
4652196|NCT03541863|Fulvestrant|fulvestrant
4652197|NCT03541863|Progression|progression
4652198|NCT03541863|Endocrine sensitivity|endocrine sensitivity
4652199|NCT03541837|Bilateral ESP Catheter|bilateral esp catheter
4652200|NCT03541837|Open heart surgery|open heart surgery
4652201|NCT03541837|opioid free post op analgesia|opioid free post op analgesia
4652202|NCT03541811|gait|gait
4652203|NCT03541811|motion capture|motion capture
4652204|NCT03541811|hemophilia joint health score|hemophilia joint health score
4652205|NCT03541811|physical activity|physical activity
4652206|NCT03541811|body composition|body composition
4652207|NCT03541811|gait deviation index|gait deviation index
4652208|NCT03541811|hemophilia|hemophilia
4652209|NCT03541798|traditional sitting position|traditional sitting position
4652210|NCT03541798|combine spinal-epidural anesthesia|combine spinal-epidural anesthesia
4652211|NCT03541798|orthopedic surgery|orthopedic surgery
4652212|NCT03541785|NGAL|ngal
4652213|NCT03541785|Renal Angina Index|renal angina index
4652214|NCT03541772|Head Carcinoma|head carcinoma
4652215|NCT03541772|Neck Carcinoma|neck carcinoma
4652216|NCT03541772|Chemotherapy|chemotherapy
4652217|NCT03541772|Radiotherapy|radiotherapy
4652218|NCT03541772|Oncoxin Viusid|oncoxin viusid
4652219|NCT03541772|Nutritional supplement|nutritional supplement
4652220|NCT03541759|Elective shoulder surgery, hydromorphone, piritramide|elective shoulder surgery, hydromorphone, piritramide
4652221|NCT03541733|magnetic resonance enterography|magnetic resonance enterography
4652222|NCT03541733|bowel preparation|bowel preparation
4652224|NCT03541707|EEG|eeg
4652225|NCT03541707|Depression|depression
4652226|NCT03541707|adolescents|adolescents
4652227|NCT03541694|Yellow fever|yellow fever
4652228|NCT03541694|Stamaril®|stamaril®
4652229|NCT03541681|Epidural Steroid Injections|epidural steroid injections
4652230|NCT03541681|Cervical Epidural Injections|cervical epidural injections
4652231|NCT03541681|Transforaminal Epidural Injections|transforaminal epidural injections
4652232|NCT03541681|Steroids|steroids
4652233|NCT03541681|Local Anesthetic|local anesthetic
4652234|NCT03541655|total knee replacement|total knee replacement
4652235|NCT03541655|pain|pain
4652236|NCT03541655|celecoxib|celecoxib
4652237|NCT03541655|intra-articular|intra-articular
4652238|NCT03541603|PH-HFpEF|ph-hfpef
4652239|NCT03541590|percutaneous biliary drainage|percutaneous biliary drainage
4652240|NCT03541538|joint manipulation|joint manipulation
4652241|NCT03541538|cervical|cervical
4652242|NCT03541538|pressure pain|pressure pain
4652243|NCT03541538|manual therapy|manual therapy
4652244|NCT03541512|Mindfulness therapy|mindfulness therapy
4652245|NCT03541512|Vulvodynia|vulvodynia
4652246|NCT03541512|Vulvar pain|vulvar pain
4652247|NCT03541499|B. pertussis Vaccine|b. pertussis vaccine
4652248|NCT03541499|BPZE1|bpze1
4652249|NCT03541499|Immunogenicity|immunogenicity
4652250|NCT03541499|Safety|safety
4652251|NCT03541486|ascorbic acid|ascorbic acid
4652252|NCT03541486|ascorbate|ascorbate
4652253|NCT03541486|sodium ascorbate|sodium ascorbate
4652254|NCT03541486|radiotherapy|radiotherapy
4652255|NCT03541486|radiotherapy, image-guided|radiotherapy, image-guided
4652256|NCT03541486|gemcitabine|gemcitabine
4652257|NCT03541460|centenarians|centenarians
4652258|NCT03541460|epigenome|epigenome
4652259|NCT03541460|longevity|longevity
4652260|NCT03541460|healthy aging|healthy aging
4652261|NCT03541460|epigenetic|epigenetic
4652262|NCT03541447|ADPKD, Tolvaptan, Octrotide LAR|adpkd, tolvaptan, octrotide lar
4652263|NCT03541434|obstructive sleep apnea|obstructive sleep apnea
4652264|NCT03541434|tonsillitis|tonsillitis
4652265|NCT03541434|middle ear effusion|middle ear effusion
4652266|NCT03541434|pathophysiology|pathophysiology
4652267|NCT03541434|score|score
4652268|NCT03541382|HIV|hiv
4652269|NCT03541382|HIV Self-Testing|hiv self-testing
4652270|NCT03541382|Malawi|malawi
4652271|NCT03541356|Parkinsons|parkinsons
4652272|NCT03541356|L-dopa|l-dopa
4652273|NCT03541356|levodopa|levodopa
4652274|NCT03541356|ON|on
4652275|NCT03541356|OFF|off
4652276|NCT03541356|PD|pd
4652277|NCT03541356|POD device|pod device
4652278|NCT03541356|I231|i231
4652279|NCT03541356|benserazide|benserazide
4652280|NCT03541356|Precision olfactory delivery|precision olfactory delivery
4652281|NCT03541356|MDS-UPDRS|mds-updrs
4652282|NCT03541330|Siblings|siblings
4652283|NCT03541330|information|information
4652284|NCT03541330|malignant haemopathy|malignant haemopathy
4652285|NCT03541317|Adaptive implementation|adaptive implementation
4652286|NCT03541317|Coaching|coaching
4652287|NCT03541317|Facilitation|facilitation
4652288|NCT03541317|School mental health|school mental health
4652289|NCT03541317|Implementation intervention|implementation intervention
4652290|NCT03541304|high dose radiotherapy|high dose radiotherapy
4652291|NCT03541304|rectal cancer|rectal cancer
4652292|NCT03541278|Breast Cancer|breast cancer
4652293|NCT03541278|Internal Mammary Lymph Node|internal mammary lymph node
4652294|NCT03541278|Internal Mammary Sentinel Lymph Node Biopsy|internal mammary sentinel lymph node biopsy
4652295|NCT03541278|Detection Rate|detection rate
4652296|NCT03541265|liposomal bupivacaine|liposomal bupivacaine
4652297|NCT03541265|total knee arthroplasty|total knee arthroplasty
4652298|NCT03541213|ferric carboxymaltose|ferric carboxymaltose
4652299|NCT03541213|mitochondrial metabolism|mitochondrial metabolism
4652300|NCT03541213|cardiomyocyte|cardiomyocyte
4652301|NCT03541187|cockroach|cockroach
4652302|NCT03541187|immunotherapy|immunotherapy
4652303|NCT03541187|inner city asthma|inner city asthma
4652304|NCT03541187|subcutaneous immunotherapy (SCIT)|subcutaneous immunotherapy (scit)
4652305|NCT03541187|Nasal Allergen Challenge (NAC)|nasal allergen challenge (nac)
4652306|NCT03541161|Early rehabilitation|early rehabilitation
4652307|NCT03541161|Conventional protocol|conventional protocol
4652308|NCT03541161|Tissue expander insertion|tissue expander insertion
4652309|NCT03541148|Cutaneous malignant melanoma|cutaneous malignant melanoma
4652310|NCT03541148|Nutritional supplement|nutritional supplement
4652311|NCT03541148|survival|survival
4652312|NCT03541148|Green tea|green tea
4652313|NCT03541135|Cardiovascular health|cardiovascular health
4652314|NCT03541135|Diet|diet
4652315|NCT03541135|Functional limitations|functional limitations
4652316|NCT03541135|Frailty|frailty
4652317|NCT03541135|Older Adults|older adults
4652318|NCT03541109|Cardiovascular disease|cardiovascular disease
4652319|NCT03541109|fixed dose combination therapy|fixed dose combination therapy
4652320|NCT03541109|cost effectiveness|cost effectiveness
4652321|NCT03541070|kinesiology taping|kinesiology taping
4652322|NCT03541070|balance|balance
4652323|NCT03541070|Duchenne Muscular Dystrophy|duchenne muscular dystrophy
4652324|NCT03541018|TRV Reposition Chair|trv reposition chair
4652325|NCT03541018|Epley Maneuvre|epley maneuvre
4652326|NCT03541005|Overweight|overweight
4652327|NCT03541005|Obesity|obesity
4652328|NCT03541005|Nutritional supplement|nutritional supplement
4652329|NCT03541005|Weight loss|weight loss
4652330|NCT03541005|waist|waist
4652331|NCT03540953|Endoscopic injection of Mitomycin C|endoscopic injection of mitomycin c
4652332|NCT03540927|Well-being|well-being
4652333|NCT03540927|Entrepreneurs|entrepreneurs
4652334|NCT03540927|Conflict affected settings|conflict affected settings
4652335|NCT03540927|Psychosocial intervention|psychosocial intervention
4652336|NCT03540927|Psychological Capital|psychological capital
4652337|NCT03540914|healthy participants older than 40 years|healthy participants older than 40 years
4652338|NCT03540914|right heart function|right heart function
4652339|NCT03540914|prevention|prevention
4652340|NCT03540914|acetazolamide|acetazolamide
4652341|NCT03540901|prevention|prevention
4652342|NCT03540901|acetazolamide|acetazolamide
4652343|NCT03540901|obstructive airway disease|obstructive airway disease
4652344|NCT03540901|lung water|lung water
4652345|NCT03540888|Dynamic Stretching|dynamic stretching
4652346|NCT03540888|Static Stretching|static stretching
4652347|NCT03540888|Manual Therapy|manual therapy
4652348|NCT03540875|Anesthesia, general|anesthesia, general
4652349|NCT03540875|Total intravenous anesthesia|total intravenous anesthesia
4652350|NCT03540875|Closed loop anesthesia|closed loop anesthesia
4652351|NCT03540875|Conox|conox
4652352|NCT03540875|EEG monitoring|eeg monitoring
4652353|NCT03540875|qCon|qcon
4652354|NCT03540875|qNox|qnox
4652355|NCT03540862|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
4652356|NCT03540862|Maintenance Negative Pressure Ventilation- assisted pulmonary rehabilitation|maintenance negative pressure ventilation- assisted pulmonary rehabilitation
4652357|NCT03540862|Six minute walk test|six minute walk test
4652358|NCT03540862|Overall survival|overall survival
4652359|NCT03540810|antiphospholipid syndrome|antiphospholipid syndrome
4652360|NCT03540810|thrombosis|thrombosis
4652361|NCT03540810|hydroxychloroquine|hydroxychloroquine
4652362|NCT03540784|muscle weakness|muscle weakness
4652363|NCT03540784|muscle mass|muscle mass
4652364|NCT03540784|whole-body electromyostimulation|whole-body electromyostimulation
4652365|NCT03540784|WB-EMS|wb-ems
4652366|NCT03540784|nutrition|nutrition
4652367|NCT03540784|protein|protein
4652368|NCT03540784|crohn's disease|crohn's disease
4652369|NCT03540784|ulcerative colitis|ulcerative colitis
4652370|NCT03540771|palliative care|palliative care
4652371|NCT03540771|hepatology|hepatology
4652372|NCT03540758|type 2 diabetes|type 2 diabetes
4652373|NCT03540758|diabetes|diabetes
4652374|NCT03540758|insulin resistance|insulin resistance
4652375|NCT03540758|diazoxide|diazoxide
4652376|NCT03540719|classification|classification
4652377|NCT03540719|questionnaires|questionnaires
4652378|NCT03540719|open reduction|open reduction
4652379|NCT03540719|internal fixation|internal fixation
4652380|NCT03540706|Respiratory Infections|respiratory infections
4652381|NCT03540706|C-reactive protein|c-reactive protein
4652382|NCT03540706|antibiotic prescription|antibiotic prescription
4652383|NCT03540693|Bariatric surgery|bariatric surgery
4652384|NCT03540693|gastric bypass surgery|gastric bypass surgery
4652385|NCT03540693|sleeve gastrectomy|sleeve gastrectomy
4652386|NCT03540693|laparoscopic gastric banding|laparoscopic gastric banding
4652387|NCT03540693|food preferences|food preferences
4652388|NCT03540693|flavor perception|flavor perception
4652389|NCT03540667|Total hip arthroplasty|total hip arthroplasty
4652390|NCT03540667|Total knee arthroplasty|total knee arthroplasty
4652391|NCT03540667|Total joint arthroplasty|total joint arthroplasty
4652392|NCT03540667|Low middle income country|low middle income country
4652393|NCT03540667|Enhanced recovery pathway|enhanced recovery pathway
4652394|NCT03540641|Binge Eating Disorder|binge eating disorder
4652395|NCT03540641|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
4652396|NCT03540641|Food Craving|food craving
4652397|NCT03540602|Polyphenol rich supplementation|polyphenol rich supplementation
4652398|NCT03540602|Tart cherry|tart cherry
4652399|NCT03540602|Lifting|lifting
4652400|NCT03540602|Recovery|recovery
4652401|NCT03540563|ctDNA|ctdna
4652402|NCT03540511|cardiac surgery|cardiac surgery
4652403|NCT03540511|troponin|troponin
4652404|NCT03540511|mortality|mortality
4652405|NCT03540498|Oral health|oral health
4652406|NCT03540498|Probiotics|probiotics
4652407|NCT03540498|L. plantarum|l. plantarum
4652408|NCT03540498|L. brevis|l. brevis
4652409|NCT03540498|Periodontics|periodontics
4652410|NCT03540472|tacrolimus|tacrolimus
4652411|NCT03540472|refractory pure red cell aplasia|refractory pure red cell aplasia
4652412|NCT03540472|prospective study|prospective study
4652413|NCT03540420|Atezolizumab|atezolizumab
4652414|NCT03540420|Chemoradiotherapy|chemoradiotherapy
4652415|NCT03540420|Immunotherapy|immunotherapy
4652416|NCT03540407|Cervical carcinoma|cervical carcinoma
4652417|NCT03540407|Endometrial adenocarcinoma|endometrial adenocarcinoma
4652418|NCT03540407|Oncoxin-Viusid|oncoxin-viusid
4652419|NCT03540407|Nutritional supplement|nutritional supplement
4652420|NCT03540407|Antioxidant|antioxidant
4652421|NCT03540381|Neoatherosclerosis|neoatherosclerosis
4652422|NCT03540381|Cholesterol Uptake Capacity|cholesterol uptake capacity
4652423|NCT03540368|Gastrointestinal bleeding|gastrointestinal bleeding
4652424|NCT03540368|Tranexamic acid|tranexamic acid
4652425|NCT03540368|Clinical trial|clinical trial
4652426|NCT03540342|coronary artery disease|coronary artery disease
4652427|NCT03540342|aortic atherosclerotic disease|aortic atherosclerotic disease
4652428|NCT03540342|one-stop|one-stop
4652429|NCT03540342|percutaneous coronary intervention|percutaneous coronary intervention
4652430|NCT03540342|endovascular aortic repair|endovascular aortic repair
4652431|NCT03540329|osteogenesis|osteogenesis
4652432|NCT03540329|distraction|distraction
4652433|NCT03540329|Lower face asymmetry|lower face asymmetry
4652434|NCT03540303|relapsed/refractory, B cell, lymphoma, CAR|relapsed/refractory, b cell, lymphoma, car
4652435|NCT03540277|prevention program|prevention program
4652436|NCT03540277|body-image|body-image
4652437|NCT03540277|self-esteem|self-esteem
4652438|NCT03540277|parents|parents
4652439|NCT03540277|adolescents|adolescents
4652440|NCT03540238|sedation|sedation
4652441|NCT03540238|endoscopy|endoscopy
4652442|NCT03540238|anesthesia|anesthesia
4652443|NCT03540238|gastroenterologist|gastroenterologist
4652444|NCT03540225|Progesterone|progesterone
4652445|NCT03540199|activated CIK|activated cik
4652446|NCT03540199|MUC1|muc1
4652447|NCT03540199|bispecific antibody|bispecific antibody
4652448|NCT03540199|kidney cancer|kidney cancer
4652449|NCT03540147|blood flow restriction|blood flow restriction
4652450|NCT03540147|blood pressure|blood pressure
4652451|NCT03540147|yoga|yoga
4652452|NCT03540134|DBS|dbs
4652453|NCT03540121|video|video
4652454|NCT03540121|contract|contract
4652455|NCT03540121|patient education|patient education
4652456|NCT03540108|hypercholesterolemia|hypercholesterolemia
4652457|NCT03540108|bile acid synthesis|bile acid synthesis
4652458|NCT03540108|cholesterol|cholesterol
4652459|NCT03540108|bile salt hydrolysis|bile salt hydrolysis
4652460|NCT03540108|vitamin D|vitamin d
4652461|NCT03540082|Aging|aging
4652462|NCT03540082|Older Adults|older adults
4652463|NCT03540082|Fall prevention|fall prevention
4652464|NCT03540082|Fall safety|fall safety
4652465|NCT03540082|Safe landing|safe landing
4652466|NCT03540056|varicocele|varicocele
4652467|NCT03540056|testicular growth|testicular growth
4652468|NCT03540043|Mild moderate atopic dermatitis|mild moderate atopic dermatitis
4652469|NCT03540030|Primary Total Shoulder Arthroplasty|primary total shoulder arthroplasty
4652470|NCT03540030|Reverse Total Shoulder Arthroplasty|reverse total shoulder arthroplasty
4652471|NCT03540017|Ovarian Cancer|ovarian cancer
4652472|NCT03540017|Fallopian Tube Cancer|fallopian tube cancer
4652473|NCT03540017|Primary Peritoneal Cancer|primary peritoneal cancer
4652474|NCT03539991|Tobacco counseling|tobacco counseling
4652475|NCT03539991|e-Learning|e-learning
4652476|NCT03539991|Smartphone App|smartphone app
4652477|NCT03539991|Virtual meetings|virtual meetings
4652478|NCT03539965|Neoadjuvant Chemotherapy|neoadjuvant chemotherapy
4652479|NCT03539965|Predictive Biomarkers|predictive biomarkers
4652480|NCT03539965|Prognostic Biomarkers|prognostic biomarkers
4652481|NCT03539965|Complete Pathological Response|complete pathological response
4652482|NCT03539965|Tumor Infiltrating Lymphocytes|tumor infiltrating lymphocytes
4652483|NCT03539965|PD-L1|pd-l1
4652484|NCT03539965|PD-L2|pd-l2
4652485|NCT03539939|Gingival crevicular fluid|gingival crevicular fluid
4652486|NCT03539939|Gingival recession|gingival recession
4652487|NCT03539939|Saliva|saliva
4652488|NCT03539939|Smoking|smoking
4652489|NCT03539939|Wound healing|wound healing
4652490|NCT03539926|Cystinuria|cystinuria
4652491|NCT03539926|pH Control|ph control
4652492|NCT03539887|Ketamine|ketamine
4652493|NCT03539887|Depression|depression
4652494|NCT03539887|Suicidal Ideation|suicidal ideation
4652495|NCT03539887|Alcohol Abuse|alcohol abuse
4652496|NCT03539861|End Stage Renal Disease|end stage renal disease
4652497|NCT03539861|Hemodialysis|hemodialysis
4652498|NCT03539861|Chronic Kidney Disease Stage 5|chronic kidney disease stage 5
4652499|NCT03539848|TBI|tbi
4652500|NCT03539848|Community Setting|community setting
4652501|NCT03539848|Mild TBI|mild tbi
4652502|NCT03539835|Breast Cancer Survivors|breast cancer survivors
4652503|NCT03539835|Resistance Training|resistance training
4652504|NCT03539835|Fatigue|fatigue
4652505|NCT03539835|Physical Function|physical function
4652506|NCT03539835|Behavioral Function|behavioral function
4652507|NCT03539835|Kynurenine metabolism|kynurenine metabolism
4652508|NCT03539822|Cabozantinib|cabozantinib
4652509|NCT03539822|Durvalumab|durvalumab
4652510|NCT03539822|MEDI4736|medi4736
4652511|NCT03539809|Branched Chain Amino Acids|branched chain amino acids
4652512|NCT03539809|Direct Amino Acid Oxidation|direct amino acid oxidation
4652513|NCT03539809|Stable isotopes|stable isotopes
4652514|NCT03539796|dural puncture epidurals|dural puncture epidurals
4652515|NCT03539796|DPE|dpe
4652516|NCT03539796|combined-spinal epidural|combined-spinal epidural
4652517|NCT03539796|CSE|cse
4652518|NCT03539796|cesarean section|cesarean section
4652519|NCT03539796|patient satisfaction|patient satisfaction
4652520|NCT03539783|Endotype|endotype
4652521|NCT03539783|Pediatric Acute Respiratory Distress Syndrome|pediatric acute respiratory distress syndrome
4652522|NCT03539783|Gene Expression|gene expression
4652523|NCT03539783|Transcriptomics|transcriptomics
4652524|NCT03539770|Lung Development|lung development
4652525|NCT03539770|Lung Regeneration|lung regeneration
4652526|NCT03539770|Hyperpolarized Helium|hyperpolarized helium
4652527|NCT03539757|Liver fibrosis|liver fibrosis
4652528|NCT03539757|Fontan surgery|fontan surgery
4652529|NCT03539757|MRI|mri
4652530|NCT03539757|Novel Methods|novel methods
4652531|NCT03539744|Cancer|cancer
4652532|NCT03539744|Multiple Myeloma (MM)|multiple myeloma (mm)
4652533|NCT03539744|Relapsed or Refractory Multiple Myeloma (R/R MM)|relapsed or refractory multiple myeloma (r/r mm)
4652534|NCT03539744|pharmacokinetics|pharmacokinetics
4652535|NCT03539679|Exercise, sickness absences, health, military fitness|exercise, sickness absences, health, military fitness
4652536|NCT03539640|PEEP|peep
4652537|NCT03539640|Diaphragm|diaphragm
4652538|NCT03539627|diabetes mellitus|diabetes mellitus
4652539|NCT03539627|Edarbi|edarbi
4652540|NCT03539627|hypertension|hypertension
4652541|NCT03539614|Prazosin|prazosin
4652542|NCT03539614|Nightmares|nightmares
4652543|NCT03539614|N-of-1|n-of-1
4652544|NCT03539601|Atopic Dermatitis, Crisaborole ointment 2%, TCS, TCI|atopic dermatitis, crisaborole ointment 2%, tcs, tci
4652545|NCT03539588|dry needling|dry needling
4652546|NCT03539588|electrical stimulation|electrical stimulation
4652547|NCT03539588|E-Stim|e-stim
4652548|NCT03539588|LBP|lbp
4652549|NCT03539588|low back pain|low back pain
4652550|NCT03539588|trigger point|trigger point
4652551|NCT03539588|chronic|chronic
4652552|NCT03539588|subacute|subacute
4652553|NCT03539575|K2|k2
4652554|NCT03539575|Spice|spice
4652555|NCT03539575|Synthetic Marijuana|synthetic marijuana
4652556|NCT03539536|Non Small Cell Lung Cancer (NSCLC)|non small cell lung cancer (nsclc)
4652557|NCT03539536|Cancer|cancer
4652558|NCT03539536|Telisotuzumab vedotin|telisotuzumab vedotin
4652559|NCT03539536|ABBV-399|abbv-399
4652560|NCT03539536|c-Met, c-Met overexpression|c-met, c-met overexpression
4652561|NCT03539536|metastatic|metastatic
4652562|NCT03539523|L test|l test
4652563|NCT03539523|cerebral palsy|cerebral palsy
4652564|NCT03539523|children|children
4652565|NCT03539523|validity|validity
4652566|NCT03539523|reliability|reliability
4652567|NCT03539497|biomarker|biomarker
4652569|NCT03539445|butylphthalide|butylphthalide
4652570|NCT03539445|mechanical thrombectomy|mechanical thrombectomy
4652571|NCT03539445|iv-rtPA|iv-rtpa
4652572|NCT03539445|recovery of dysfunction|recovery of dysfunction
4652573|NCT03539419|Psoriasis|psoriasis
4652574|NCT03539419|Plaque Psoriasis|plaque psoriasis
4652575|NCT03539419|Apremilast|apremilast
4652576|NCT03539419|CC-10004|cc-10004
4652577|NCT03539367|healthy participants older than 40 years|healthy participants older than 40 years
4652578|NCT03539367|lung water|lung water
4652579|NCT03539367|prevention|prevention
4652580|NCT03539367|acetazolamide|acetazolamide
4652581|NCT03539354|Atrial fibrillation|atrial fibrillation
4652582|NCT03539354|Spinal cord stimulatoin|spinal cord stimulatoin
4652583|NCT03539354|Coronary artery bypass grafting|coronary artery bypass grafting
4652584|NCT03539302|Inhaled Flecainide|inhaled flecainide
4652585|NCT03539289|IPF|ipf
4652586|NCT03539289|Mitigating Adverse Events|mitigating adverse events
4652587|NCT03539276|quality improvement|quality improvement
4652588|NCT03539276|long term care|long term care
4652589|NCT03539276|polypharmacy|polypharmacy
4652590|NCT03539250|Radiation-induced temporal lobe injury;NPC|radiation-induced temporal lobe injury;npc
4652591|NCT03539250|Nasopharyngeal carcinoma|nasopharyngeal carcinoma
4652592|NCT03539250|Intensity-modulated radiotherapy|intensity-modulated radiotherapy
4652593|NCT03539237|Video demonstration|video demonstration
4652594|NCT03539237|Intensity levels|intensity levels
4652595|NCT03539237|Physical activity|physical activity
4652596|NCT03539237|Self-report|self-report
4652597|NCT03539237|Accelerometer|accelerometer
4652598|NCT03539185|Airtraq|airtraq
4652599|NCT03539185|Fiberoptic|fiberoptic
4652600|NCT03539185|Awake|awake
4652601|NCT03539185|Tracheal intubation|tracheal intubation
4652602|NCT03539185|laryngeal nerve blocks|laryngeal nerve blocks
4652603|NCT03539185|sedation|sedation
4652604|NCT03539185|remifentanil|remifentanil
4652605|NCT03539159|Allogeneic serum eye drops|allogeneic serum eye drops
4652606|NCT03539159|Micro eye drops|micro eye drops
4652607|NCT03539159|Cross-over multicenter trial|cross-over multicenter trial
4652608|NCT03539159|Ocular Surface Disease Index (OSDI)|ocular surface disease index (osdi)
4652609|NCT03539146|byproducts|byproducts
4652610|NCT03539146|functional yogurt|functional yogurt
4652611|NCT03539146|satiety|satiety
4652612|NCT03539146|sensory analysis|sensory analysis
4652613|NCT03539146|sustainable health|sustainable health
4652614|NCT03539146|novel food ingredient|novel food ingredient
4652615|NCT03539133|STEMI|stemi
4652616|NCT03539133|infarction|infarction
4652617|NCT03539133|coronary artery disease|coronary artery disease
4652618|NCT03539133|comorbidities|comorbidities
4652619|NCT03539133|diabetes|diabetes
4652620|NCT03539133|anemia|anemia
4652621|NCT03539094|Multiple Sclerosis|multiple sclerosis
4652622|NCT03539094|Intermittent fasting|intermittent fasting
4652623|NCT03539094|western diet|western diet
4652624|NCT03539094|microbiome|microbiome
4652625|NCT03539081|Epidural Spinal Cord Stimulation|epidural spinal cord stimulation
4652626|NCT03539081|Muscle Sympathetic Nerve Activity|muscle sympathetic nerve activity
4652627|NCT03539081|Blood Flow|blood flow
4652628|NCT03539068|Veteran|veteran
4652629|NCT03539068|Mental Health|mental health
4652630|NCT03539068|War|war
4652631|NCT03539068|Shared decision-making|shared decision-making
4652632|NCT03539068|Access to care|access to care
4652633|NCT03539055|DRT|drt
4652634|NCT03539055|Device related thrombus|device related thrombus
4652635|NCT03539055|Dabigatran etexilate|dabigatran etexilate
4652636|NCT03539055|Aspirin|aspirin
4652637|NCT03539055|Watchman|watchman
4652638|NCT03539042|DNA methylation|dna methylation
4652639|NCT03539042|Physical activity|physical activity
4652640|NCT03539042|Exercise capacity|exercise capacity
4652641|NCT03539016|Chronic hepatitis B, Mother-to-child transmission|chronic hepatitis b, mother-to-child transmission
4652642|NCT03538990|Nutrition|nutrition
4652643|NCT03538990|Dietary Approaches to Stop Hypertension|dietary approaches to stop hypertension
4652644|NCT03538990|Cardiometabolic Outcomes|cardiometabolic outcomes
4652645|NCT03538990|Pulmonary Artery Pressure|pulmonary artery pressure
4652646|NCT03538990|CardioMEMS|cardiomems
4652647|NCT03538977|Bronchopulmonary Dysplasia|bronchopulmonary dysplasia
4652648|NCT03538977|Hydrotherapy|hydrotherapy
4652649|NCT03538977|Electromyography|electromyography
4652650|NCT03538977|Pain|pain
4652651|NCT03538977|Prematurity|prematurity
4652652|NCT03538964|Cataract|cataract
4652653|NCT03538964|Low Astigmatism|low astigmatism
4652654|NCT03538951|actinic keratosis|actinic keratosis
4652655|NCT03538951|efficacy|efficacy
4652656|NCT03538951|safety|safety
4652657|NCT03538951|VDA-1102|vda-1102
4652658|NCT03538938|Smoking|smoking
4652659|NCT03538938|Smoking cessation|smoking cessation
4652660|NCT03538938|Quitline|quitline
4652661|NCT03538938|Nicotine Replacement Therapy|nicotine replacement therapy
4652662|NCT03538938|SmokefreeTXT text messages|smokefreetxt text messages
4652663|NCT03538938|Financial incentives|financial incentives
4652664|NCT03538912|empirical antifungal therapy|empirical antifungal therapy
4652665|NCT03538912|invasive candidiasis|invasive candidiasis
4652666|NCT03538912|biomarkers|biomarkers
4652667|NCT03538912|de-escalation|de-escalation
4652668|NCT03538912|ICU|icu
4652669|NCT03538899|Artemis-deficient Severe Combined Immunodeficiency|artemis-deficient severe combined immunodeficiency
4652670|NCT03538899|gene therapy|gene therapy
4652671|NCT03538899|autologous stem cell transplant|autologous stem cell transplant
4652672|NCT03538886|Coronary revascularization|coronary revascularization
4652771|NCT03538366|Pouchitis|pouchitis
4652673|NCT03538873|Subsyndromic symptoms of depression|subsyndromic symptoms of depression
4652674|NCT03538873|Subsyndromic symptoms of anxiety|subsyndromic symptoms of anxiety
4652675|NCT03538873|Elderly|elderly
4652676|NCT03538873|Physical activity|physical activity
4652677|NCT03538873|Population-based study|population-based study
4652678|NCT03538860|Telepsychiatry|telepsychiatry
4652679|NCT03538860|AsynchronousTelepsychiatry|asynchronoustelepsychiatry
4652680|NCT03538860|Automated Translation|automated translation
4652681|NCT03538847|postoperative pain|postoperative pain
4652682|NCT03538847|eye surgery|eye surgery
4652683|NCT03538847|vitrectomy|vitrectomy
4652684|NCT03538847|pain control protocol|pain control protocol
4652685|NCT03538795|stroke|stroke
4652686|NCT03538795|hemiplegia|hemiplegia
4652687|NCT03538795|hemiparesis|hemiparesis
4652688|NCT03538795|arm|arm
4652689|NCT03538795|upper-extremity|upper-extremity
4652690|NCT03538795|motor impairment|motor impairment
4652691|NCT03538795|TMS|tms
4652692|NCT03538795|brain stimulation|brain stimulation
4652693|NCT03538795|neuroplasticity|neuroplasticity
4652694|NCT03538782|percutaneous biliary drainage|percutaneous biliary drainage
4652695|NCT03538782|radiation exposure|radiation exposure
4652696|NCT03538756|Balance|balance
4652697|NCT03538756|Peripheral Neuropathy|peripheral neuropathy
4652698|NCT03538756|Neuropathy|neuropathy
4652699|NCT03538743|Type 2 diabetes mellitus|type 2 diabetes mellitus
4652700|NCT03538717|Axitinib,|axitinib,
4652701|NCT03538717|Renal Carcinoma,|renal carcinoma,
4652702|NCT03538717|Long responders|long responders
4652703|NCT03538704|Endometrial cancer|endometrial cancer
4652704|NCT03538704|Atypical hyperplasia|atypical hyperplasia
4652705|NCT03538704|Fertility-preserving|fertility-preserving
4652706|NCT03538704|Remission time|remission time
4652707|NCT03538704|Recurrence|recurrence
4652708|NCT03538704|Pregnancy|pregnancy
4652709|NCT03538704|Progesterone receptor|progesterone receptor
4652710|NCT03538691|Brexpiprazole|brexpiprazole
4652711|NCT03538691|MDD|mdd
4652712|NCT03538665|Endometrial Cancer|endometrial cancer
4652713|NCT03538665|Somatic Mutations|somatic mutations
4652714|NCT03538665|Early Detection|early detection
4652715|NCT03538665|Tampon Sampling|tampon sampling
4652716|NCT03538665|Tissue Discovery|tissue discovery
4652717|NCT03538652|CBT|cbt
4652718|NCT03538652|Mindfulness|mindfulness
4652719|NCT03538652|Opiates|opiates
4652720|NCT03538652|Ecological Monetary Assessment (EMA)|ecological monetary assessment (ema)
4652721|NCT03538652|Microrandomized Trial|microrandomized trial
4652722|NCT03538639|Etiology of Rare and Orphan Diseases with Vascular Phenotype|etiology of rare and orphan diseases with vascular phenotype
4652723|NCT03538639|Natural History of Rare and Orphan Diseases with Vascular Phenotype|natural history of rare and orphan diseases with vascular phenotype
4652724|NCT03538639|Pathophysiology of Uncommon Vascular Diseases|pathophysiology of uncommon vascular diseases
4652725|NCT03538639|Undiagnosed Diseases|undiagnosed diseases
4652726|NCT03538639|Rare Human Diseases with Vascular Features|rare human diseases with vascular features
4652727|NCT03538626|Immune Cells|immune cells
4652728|NCT03538626|bNAb|bnab
4652729|NCT03538626|Plasma Cell|plasma cell
4652730|NCT03538626|HIV|hiv
4652731|NCT03538626|Immunotherapy|immunotherapy
4652732|NCT03538613|Adoptive Cell Therapy|adoptive cell therapy
4652733|NCT03538613|Immunotherapy|immunotherapy
4652734|NCT03538613|Gene Therapy|gene therapy
4652735|NCT03538600|Blood|blood
4652736|NCT03538600|Microbiome Analysis|microbiome analysis
4652737|NCT03538600|Stool|stool
4652738|NCT03538600|Saliva|saliva
4652739|NCT03538600|Skin|skin
4652740|NCT03538587|high-grade astrocytoma|high-grade astrocytoma
4652741|NCT03538587|Diffuse Intrinsic Pontine Glioma|diffuse intrinsic pontine glioma
4652742|NCT03538587|Glioblastoma Multiforme|glioblastoma multiforme
4652743|NCT03538587|Meditation|meditation
4652744|NCT03538587|Quality of Life|quality of life
4652745|NCT03538548|Cocaine Abuse|cocaine abuse
4652746|NCT03538548|Cocaine Use Disorder|cocaine use disorder
4652747|NCT03538548|Substance-Related Disorders|substance-related disorders
4652748|NCT03538535|reinforcement learning|reinforcement learning
4652749|NCT03538535|computational models|computational models
4652750|NCT03538535|neuroimaging|neuroimaging
4652751|NCT03538457|Bariatric surgery|bariatric surgery
4652752|NCT03538457|Gastrointestinal tract|gastrointestinal tract
4652753|NCT03538457|Biological availability|biological availability
4652754|NCT03538457|Pharmacokinetics|pharmacokinetics
4652755|NCT03538457|Acetaminophen|acetaminophen
4652756|NCT03538431|Autism Spectrum Disorder|autism spectrum disorder
4652757|NCT03538431|ASD|asd
4652758|NCT03538431|Anxiety|anxiety
4652759|NCT03538418|Frailty|frailty
4652760|NCT03538418|Wearable technology|wearable technology
4652761|NCT03538418|Physical activity|physical activity
4652762|NCT03538418|Behaviour change|behaviour change
4652763|NCT03538405|harmonic techniques|harmonic techniques
4652764|NCT03538405|supporting cushions|supporting cushions
4652765|NCT03538405|intervention|intervention
4652766|NCT03538379|Tourniquets|tourniquets
4652767|NCT03538379|Bleeding Control Basic (B-Con) Course|bleeding control basic (b-con) course
4652768|NCT03538379|Layperson training|layperson training
4652769|NCT03538366|Ulcerative Colitis|ulcerative colitis
4652770|NCT03538366|Inflammatory bowel disease|inflammatory bowel disease
4652772|NCT03538366|Fecal microbiota transplant|fecal microbiota transplant
4652773|NCT03538366|Fecal microbiota treatment|fecal microbiota treatment
4652774|NCT03538340|Thoracotomy|thoracotomy
4652775|NCT03538340|Cryoanalgesia|cryoanalgesia
4652776|NCT03538340|Pain|pain
4652777|NCT03538327|essential hypertension|essential hypertension
4652778|NCT03538327|insulin resistance|insulin resistance
4652779|NCT03538327|silybin|silybin
4652780|NCT03538262|SURE-PD3|sure-pd3
4652781|NCT03538262|STEADY-PD III|steady-pd iii
4652782|NCT03538262|Parkinson disease|parkinson disease
4652783|NCT03538262|PD|pd
4652784|NCT03538262|Parkinson Study Group (PSG)|parkinson study group (psg)
4652785|NCT03538262|Telemedicine|telemedicine
4652786|NCT03538262|Smartphone|smartphone
4652787|NCT03538262|Disease progression|disease progression
4652788|NCT03538262|Televisits|televisits
4652789|NCT03538262|Patient-reported outcomes|patient-reported outcomes
4652790|NCT03538249|Heart Failure|heart failure
4652791|NCT03538249|Aerobic Exercise|aerobic exercise
4652792|NCT03538249|Respiratory Muscle Training|respiratory muscle training
4652793|NCT03538249|Strength Training|strength training
4652794|NCT03538223|Music listening|music listening
4652795|NCT03538223|Radiotherapy|radiotherapy
4652796|NCT03538223|Breast cancer|breast cancer
4652797|NCT03538223|Psychological rehabilitation|psychological rehabilitation
4652798|NCT03538210|obesity, bariatric surgery, gastrointestinal functions, adipose tissu, steatohepatitis|obesity, bariatric surgery, gastrointestinal functions, adipose tissu, steatohepatitis
4652799|NCT03538197|suicide attempt|suicide attempt
4652800|NCT03538197|suicide re attempt|suicide re attempt
4652801|NCT03538158|Older adults|older adults
4652802|NCT03538158|Physical well-being|physical well-being
4652803|NCT03538158|Quality of life|quality of life
4652804|NCT03538119|Cardiac Rehabilitation|cardiac rehabilitation
4652805|NCT03538119|High Intensity Interval Training|high intensity interval training
4652806|NCT03538119|Exercise-based Rehabilitation|exercise-based rehabilitation
4652807|NCT03538119|Secondary prevention|secondary prevention
4652808|NCT03538119|Sedentary Behavior|sedentary behavior
4652809|NCT03538106|Cesrean delivery|cesrean delivery
4652810|NCT03538106|Risks factors|risks factors
4652811|NCT03538106|Diabetes Type 1|diabetes type 1
4652812|NCT03538093|arthrodesis|arthrodesis
4652813|NCT03538093|core stabilization|core stabilization
4652814|NCT03538093|physical therapy|physical therapy
4652815|NCT03538080|venous disease|venous disease
4652816|NCT03538080|peripheral vascular disease|peripheral vascular disease
4652817|NCT03538080|vascular surgery|vascular surgery
4652818|NCT03538080|ultrasound imaging|ultrasound imaging
4652819|NCT03538067|percutaneous coronary intervention|percutaneous coronary intervention
4652820|NCT03538067|stent apposition|stent apposition
4652821|NCT03538067|stent deployment|stent deployment
4652822|NCT03538067|stent expansion|stent expansion
4652823|NCT03538067|intravascular ultrasound|intravascular ultrasound
4652824|NCT03538054|Fibromyalgia|fibromyalgia
4652825|NCT03538041|autoimmune hemolytic anemia|autoimmune hemolytic anemia
4652826|NCT03538041|phosphatidylinositol 3-kinase (PI3K) inhibitor|phosphatidylinositol 3-kinase (pi3k) inhibitor
4652827|NCT03538028|lymphocyte activation gene (LAG)|lymphocyte activation gene (lag)
4652828|NCT03538028|LAG-3|lag-3
4652829|NCT03538028|advanced solid tumor|advanced solid tumor
4652830|NCT03538028|metastatic solid tumor|metastatic solid tumor
4652831|NCT03538028|relapsed/refractory DLCBL|relapsed/refractory dlcbl
4652832|NCT03538015|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
4652833|NCT03538015|β-blocker|β-blocker
4652834|NCT03538002|blue light filtering spectacle lens|blue light filtering spectacle lens
4652835|NCT03537989|fluid therapy|fluid therapy
4652836|NCT03537989|Restricted fluid therapy|restricted fluid therapy
4652837|NCT03537989|saline|saline
4652838|NCT03537963|HCT survivors|hct survivors
4652839|NCT03537963|hematopoietic stem cell transplant (HCT)|hematopoietic stem cell transplant (hct)
4652840|NCT03537963|survivors of hematopoietic stem cell transplant|survivors of hematopoietic stem cell transplant
4652841|NCT03537950|Cannabidiol|cannabidiol
4652842|NCT03537950|Cannabidivarin|cannabidivarin
4652843|NCT03537950|E-I balance|e-i balance
4652844|NCT03537950|pharmacological imaging|pharmacological imaging
4652845|NCT03537924|healthy participants older than 40 years|healthy participants older than 40 years
4652846|NCT03537924|right heart function during exercise|right heart function during exercise
4652847|NCT03537924|prevention|prevention
4652848|NCT03537924|acetazolamide|acetazolamide
4652849|NCT03537898|balanced crystalloid|balanced crystalloid
4652850|NCT03537898|crystalloid|crystalloid
4652851|NCT03537898|isotonic|isotonic
4652852|NCT03537898|acetate|acetate
4652853|NCT03537898|non-acetate|non-acetate
4652854|NCT03537898|lactated Ringer's|lactated ringer's
4652855|NCT03537898|Normosol|normosol
4652856|NCT03537859|hospitalized child|hospitalized child
4652857|NCT03537859|salivary cortisol|salivary cortisol
4652858|NCT03537859|augmented reality|augmented reality
4652859|NCT03537807|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
4652860|NCT03537807|ALS|als
4652861|NCT03537807|Lou Gehrig Disease|lou gehrig disease
4652862|NCT03537807|Lou Gehrig's Disease|lou gehrig's disease
4652863|NCT03537807|Lou-Gehrigs Disease|lou-gehrigs disease
4652864|NCT03537807|Motor Neuron Disease, Amyotrophic Lateral Sclerosis|motor neuron disease, amyotrophic lateral sclerosis
4652865|NCT03537807|Riluzole|riluzole
4652866|NCT03537807|Rilutek®|rilutek®
4652867|NCT03537807|Sublingual|sublingual
4652868|NCT03537807|Oral formulation|oral formulation
4652869|NCT03537807|Neuroprotective Agents|neuroprotective agents
4652870|NCT03537807|Administration, Sublingual|administration, sublingual
4652871|NCT03537807|Administration, Oral|administration, oral
4652872|NCT03537807|Biological Availability|biological availability
4652873|NCT03537781|food choice, food labels|food choice, food labels
4652874|NCT03537742|Heart Transplant|heart transplant
4652875|NCT03537729|Alzheimer's disease|alzheimer's disease
4652876|NCT03537729|Age related memory disorders|age related memory disorders
4652877|NCT03537729|Environment design|environment design
4652878|NCT03537729|Long term care|long term care
4652879|NCT03537729|Dementia|dementia
4652880|NCT03537716|Abdominal Fat|abdominal fat
4652881|NCT03537703|Transcranial Direct Current Stimulation|transcranial direct current stimulation
4652882|NCT03537703|tDCS|tdcs
4652883|NCT03537703|Auditory Processing|auditory processing
4652884|NCT03537703|tone matching|tone matching
4652885|NCT03537664|Periapical Periodontitis|periapical periodontitis
4652886|NCT03537664|Bacterial Infections|bacterial infections
4652887|NCT03537664|Root Canal Preparation|root canal preparation
4652888|NCT03537664|Calcium Hydroxide|calcium hydroxide
4652889|NCT03537664|Real-Time Polymerase Chain Reaction|real-time polymerase chain reaction
4652890|NCT03537664|RNA-Directed DNA Polymerase|rna-directed dna polymerase
4652891|NCT03537638|Lupus|lupus
4652892|NCT03537638|Quality of life|quality of life
4652893|NCT03537638|Multicomponent intervention|multicomponent intervention
4652894|NCT03537638|Clinical Practice Guideline|clinical practice guideline
4652895|NCT03537638|Computerized clinical decision support system|computerized clinical decision support system
4652896|NCT03537638|Activity|activity
4652897|NCT03537612|Post-operative pain|post-operative pain
4652898|NCT03537573|Pragmatic clinical trial|pragmatic clinical trial
4652899|NCT03537573|Primary care|primary care
4652900|NCT03537573|Provider-targeted|provider-targeted
4652901|NCT03537573|Behavioral intervention|behavioral intervention
4652902|NCT03537573|Electronic health record|electronic health record
4652903|NCT03537547|treatment naive|treatment naive
4652904|NCT03537547|major depression|major depression
4652905|NCT03537547|pharmacotherapy|pharmacotherapy
4652906|NCT03537547|pharmacogenomic|pharmacogenomic
4652907|NCT03537547|genomics|genomics
4652908|NCT03537521|severe bleeding|severe bleeding
4652909|NCT03537521|dabigatran|dabigatran
4652910|NCT03537521|rivaroxaban|rivaroxaban
4652911|NCT03537521|apixaban|apixaban
4652912|NCT03537521|edoxaban|edoxaban
4652913|NCT03537521|PCC|pcc
4652914|NCT03537521|aPCC|apcc
4652915|NCT03537521|rVIIa|rviia
4652916|NCT03537521|hemodialysis|hemodialysis
4652917|NCT03537521|antidots|antidots
4652918|NCT03537521|idarucizumab|idarucizumab
4652919|NCT03537521|urgent surgery|urgent surgery
4652920|NCT03537521|andexanet alpha|andexanet alpha
4652921|NCT03537508|Meningococcal meningitis|meningococcal meningitis
4652922|NCT03537508|MenACYW conjugate vaccine|menacyw conjugate vaccine
4653049|NCT03536624|prevention|prevention
4652923|NCT03537508|Quadrivalent meningococcal vaccine|quadrivalent meningococcal vaccine
4652924|NCT03537495|tuberculous meningitis|tuberculous meningitis
4652925|NCT03537495|linezolid|linezolid
4652926|NCT03537495|pharmacokinetic study|pharmacokinetic study
4652927|NCT03537456|Dermal Filler|dermal filler
4652928|NCT03537456|Hyaluronic Acid|hyaluronic acid
4652929|NCT03537443|Childhood|childhood
4652930|NCT03537443|Vitamin D|vitamin d
4652931|NCT03537443|Bone mineral density|bone mineral density
4652932|NCT03537443|Bone mineral content|bone mineral content
4652933|NCT03537430|Postoperative pain|postoperative pain
4652934|NCT03537430|Tubeless Uniportal Video-assisted Thoracoscopic Surgery|tubeless uniportal video-assisted thoracoscopic surgery
4652935|NCT03537430|Hospital costs|hospital costs
4652936|NCT03537404|hepatitis C|hepatitis c
4652937|NCT03537404|chronic|chronic
4652938|NCT03537404|pharmacokinetics|pharmacokinetics
4652939|NCT03537404|HIV|hiv
4652940|NCT03537404|coinfection|coinfection
4652941|NCT03537404|concomitant therapy|concomitant therapy
4652942|NCT03537391|prostate cancer|prostate cancer
4652943|NCT03537391|imaging of prostate cancer|imaging of prostate cancer
4652944|NCT03537391|staging of prostate cancer|staging of prostate cancer
4652945|NCT03537391|prostate specific membrane antigen (PSMA)|prostate specific membrane antigen (psma)
4652946|NCT03537391|positron emission tomography|positron emission tomography
4652947|NCT03537391|bone scintigraphy|bone scintigraphy
4652948|NCT03537391|whole body magnetic resonance imaging|whole body magnetic resonance imaging
4652949|NCT03537391|whole body computer tomography|whole body computer tomography
4652950|NCT03537391|single photon emission tomography (SPECT)|single photon emission tomography (spect)
4652951|NCT03537378|Hybrid APC,Early Central Lung Cancer,|hybrid apc,early central lung cancer,
4652952|NCT03537365|Human Milk Fortification|human milk fortification
4652953|NCT03537365|Bovine Colostrum|bovine colostrum
4652954|NCT03537365|Very Preterm Infants|very preterm infants
4652955|NCT03537365|Enteral feeding|enteral feeding
4652956|NCT03537365|Human Milk|human milk
4652957|NCT03537365|Neonatology|neonatology
4652958|NCT03537365|Colostrum|colostrum
4652959|NCT03537326|doping|doping
4652960|NCT03537261|Parent Training|parent training
4652961|NCT03537261|Aggressive Behavior|aggressive behavior
4652962|NCT03537235|Libramed|libramed
4652963|NCT03537235|Policaptil Gel retard|policaptil gel retard
4652964|NCT03537235|Overweigth|overweigth
4652965|NCT03537235|Obesity|obesity
4652966|NCT03537235|Medical Device|medical device
4652967|NCT03537235|glycemic profile|glycemic profile
4652968|NCT03537235|incretin|incretin
4652969|NCT03537222|quality of life|quality of life
4652970|NCT03537222|psychometrics|psychometrics
4652971|NCT03537196|People who inject drugs|people who inject drugs
4652972|NCT03537196|Hepatitis C|hepatitis c
4652973|NCT03537196|Direct Acting Antiviral|direct acting antiviral
4652974|NCT03537196|HCV Elimination|hcv elimination
4652975|NCT03537196|Vietnam|vietnam
4652976|NCT03537183|hypertrophic cardiomyopathy|hypertrophic cardiomyopathy
4652977|NCT03537183|exercise training|exercise training
4652978|NCT03537183|PCWP|pcwp
4652979|NCT03537157|Crohn Disease recurrence|crohn disease recurrence
4652980|NCT03537144|Patent ductus arteriosus|patent ductus arteriosus
4652981|NCT03537144|acetaminophen|acetaminophen
4652982|NCT03537144|indomethacin|indomethacin
4652983|NCT03537131|diabetes|diabetes
4652984|NCT03537131|dapagliflozin|dapagliflozin
4652985|NCT03537131|exercise|exercise
4652986|NCT03537131|hypoglycemia|hypoglycemia
4652987|NCT03537105|cytokine|cytokine
4652988|NCT03537105|skin inflammation|skin inflammation
4652989|NCT03537079|hypoxia|hypoxia
4652990|NCT03537079|exercise training|exercise training
4652991|NCT03537079|heart failure|heart failure
4652992|NCT03537079|cardiac remodeling|cardiac remodeling
4652993|NCT03537053|Sedentary Lifestyle|sedentary lifestyle
4652994|NCT03537027|vitamin D3|vitamin d3
4652995|NCT03537027|cholecalciferol|cholecalciferol
4652996|NCT03537027|calcidiol|calcidiol
4652997|NCT03537027|25-hydroxyvitamin D|25-hydroxyvitamin d
4652998|NCT03537027|gene expression|gene expression
4652999|NCT03537027|vitamin D receptor|vitamin d receptor
4653000|NCT03537027|adults|adults
4653001|NCT03537027|clinical trial|clinical trial
4653002|NCT03537001|Methoxyflurane|methoxyflurane
4653003|NCT03537001|Penthrox|penthrox
4653004|NCT03537001|anesthetic|anesthetic
4653005|NCT03537001|analgesia|analgesia
4653006|NCT03537001|acute|acute
4653007|NCT03537001|traumatic|traumatic
4653008|NCT03537001|pain|pain
4653009|NCT03537001|prehospital setting|prehospital setting
4653010|NCT03537001|visual numeric scale|visual numeric scale
4653011|NCT03536988|Ulcerative Colitiis|ulcerative colitiis
4653012|NCT03536988|Ileal pouch anal anastomosis|ileal pouch anal anastomosis
4653013|NCT03536988|Transanal Minimally Invasive Surgery|transanal minimally invasive surgery
4653014|NCT03536988|Postoperative Outcome|postoperative outcome
4653015|NCT03536975|Dementia|dementia
4653016|NCT03536975|Mild Dementia|mild dementia
4653017|NCT03536975|Cognitive Impairment|cognitive impairment
4653018|NCT03536923|Female|female
4653019|NCT03536910|copeptin levels|copeptin levels
4653020|NCT03536910|Cesarean section|cesarean section
4653021|NCT03536910|general anesthesia|general anesthesia
4653022|NCT03536910|spinal anesthesia|spinal anesthesia
4653023|NCT03536897|breast cancer|breast cancer
4653024|NCT03536897|invasive ductal carcinoma|invasive ductal carcinoma
4653025|NCT03536897|intraoperative radiation therapy|intraoperative radiation therapy
4653026|NCT03536897|iort|iort
4653027|NCT03536884|Bimekizumab|bimekizumab
4653028|NCT03536884|PSO|pso
4653029|NCT03536884|Psoriasis|psoriasis
4653030|NCT03536858|End Stage Renal Disease|end stage renal disease
4653031|NCT03536858|Hemodialysis|hemodialysis
4653032|NCT03536858|Social Network|social network
4653033|NCT03536832|Cesarean Section; Complications|cesarean section; complications
4653034|NCT03536832|suture material|suture material
4653035|NCT03536806|Pharmacological cardioversion|pharmacological cardioversion
4653036|NCT03536806|Canrenone|canrenone
4653037|NCT03536793|Early detection of pancreatic cancer|early detection of pancreatic cancer
4653038|NCT03536793|Endo180|endo180
4653039|NCT03536793|Urinary tissue factor|urinary tissue factor
4653040|NCT03536728|DFMO|dfmo
4653041|NCT03536728|AMXT 1501|amxt 1501
4653042|NCT03536689|Amniotic fluid index|amniotic fluid index
4653043|NCT03536676|Breakfast|breakfast
4653044|NCT03536676|Obesity|obesity
4653045|NCT03536676|Mood|mood
4653046|NCT03536676|Eating Behavior|eating behavior
4653047|NCT03536676|Cognitive Function|cognitive function
4653048|NCT03536650|Metabolic diseases|metabolic diseases
4653050|NCT03536624|biomarkers|biomarkers
4653051|NCT03536624|stress|stress
4653052|NCT03536624|burn out|burn out
4653053|NCT03536624|occupation|occupation
4653054|NCT03536624|work|work
4653055|NCT03536624|spa bath|spa bath
4653056|NCT03536611|dabigatran|dabigatran
4653057|NCT03536611|warfarin|warfarin
4653058|NCT03536611|non-valve atrial fibrillation|non-valve atrial fibrillation
4653059|NCT03536611|percutaneous coronary intervention|percutaneous coronary intervention
4653060|NCT03536572|Sleep Apnea Syndromes|sleep apnea syndromes
4653061|NCT03536572|Chronic Disease|chronic disease
4653062|NCT03536572|Adherence|adherence
4653063|NCT03536572|Self-Care|self-care
4653064|NCT03536572|Patient Outcomes|patient outcomes
4653065|NCT03536559|gold|gold
4653066|NCT03536559|nanocrystal|nanocrystal
4653067|NCT03536559|multifocal visual evoked potential|multifocal visual evoked potential
4653068|NCT03536559|full field visual evoked potential|full field visual evoked potential
4653069|NCT03536559|low contrast vision|low contrast vision
4653070|NCT03536559|low contrast letter acuity|low contrast letter acuity
4653071|NCT03536559|remyelination|remyelination
4653072|NCT03536559|demyelination|demyelination
4653073|NCT03536546|Veterans Health|veterans health
4653074|NCT03536546|Intervention, Brief|intervention, brief
4653075|NCT03536546|Peer|peer
4653076|NCT03536520|healthy participants older than 40 years|healthy participants older than 40 years
4653077|NCT03536520|cognition|cognition
4653078|NCT03536520|visuo-motor learning performance|visuo-motor learning performance
4653079|NCT03536520|prevention|prevention
4653080|NCT03536520|acetazolamide|acetazolamide
4653081|NCT03536507|healthy participants older than 40 years|healthy participants older than 40 years
4653082|NCT03536507|sleep disordered breathing|sleep disordered breathing
4653083|NCT03536507|periodic breathing|periodic breathing
4653084|NCT03536507|prevention|prevention
4653085|NCT03536507|acetazolamide|acetazolamide
4653086|NCT03536494|Overactive bladder|overactive bladder
4653087|NCT03536494|Mirabegron|mirabegron
4653088|NCT03536494|Persistence|persistence
4653089|NCT03536494|Patient-Centered Care|patient-centered care
4653090|NCT03536494|Inappropriate prescribing|inappropriate prescribing
4653091|NCT03536494|Discontinuation|discontinuation
4653092|NCT03536468|Tooth loss, edentulousness, psychology, oral health-related|tooth loss, edentulousness, psychology, oral health-related
4653093|NCT03536455|healthy participants older than 40 years|healthy participants older than 40 years
4653094|NCT03536455|exercise performance|exercise performance
4653095|NCT03536455|prevention|prevention
4653096|NCT03536455|acetazolamide|acetazolamide
4653097|NCT03536442|antenatal|antenatal
4653098|NCT03536442|postpartum|postpartum
4653099|NCT03536442|mental health|mental health
4653100|NCT03536429|healthy participants older than 40 years|healthy participants older than 40 years
4653101|NCT03536429|postural control|postural control
4653102|NCT03536429|prevention|prevention
4653103|NCT03536429|acetazolamide|acetazolamide
4653104|NCT03536416|Self-management|self-management
4653105|NCT03536416|Children and young people|children and young people
4653106|NCT03536416|Schools|schools
4653107|NCT03536377|Diabetes Mellitus Remission|diabetes mellitus remission
4653108|NCT03536377|Prediabetic State|prediabetic state
4653109|NCT03536377|caloric restriction|caloric restriction
4653110|NCT03536377|weight loss|weight loss
4653111|NCT03536377|diet|diet
4653112|NCT03536377|Barbados|barbados
4653113|NCT03536351|social skills|social skills
4653114|NCT03536351|child|child
4653115|NCT03536351|theory of mind|theory of mind
4653116|NCT03536351|drama|drama
4653117|NCT03536351|occupational therapy|occupational therapy
4653118|NCT03536351|speech-language pathology|speech-language pathology
4653119|NCT03536351|neural activation|neural activation
4653120|NCT03536338|Sit-to-stand; Spinal Stimulation; transcutaneous|sit-to-stand; spinal stimulation; transcutaneous
4653121|NCT03536299|Physical therapy|physical therapy
4653122|NCT03536299|Gait training|gait training
4653123|NCT03536299|Cognitive-motor interference|cognitive-motor interference
4653124|NCT03536299|Rehabilitation|rehabilitation
4653125|NCT03536273|sedentary|sedentary
4653126|NCT03536273|pilates exercises|pilates exercises
4653127|NCT03536273|functional movement screen|functional movement screen
4653128|NCT03536273|posture|posture
4653129|NCT03536273|quality of life|quality of life
4653130|NCT03536247|bile duct stones|bile duct stones
4653131|NCT03536247|choledocholithiasis|choledocholithiasis
4653132|NCT03536247|ERCP|ercp
4653133|NCT03536247|endoscopic retrograde cholangiopancreatograhy|endoscopic retrograde cholangiopancreatograhy
4653134|NCT03536195|renal replacement therapy|renal replacement therapy
4653135|NCT03536195|acute renal failure|acute renal failure
4653136|NCT03536195|coagulation|coagulation
4653137|NCT03536195|bleeding|bleeding
4653138|NCT03536156|Dental implant|dental implant
4653139|NCT03536156|Implant Emergence Profile|implant emergence profile
4653140|NCT03536130|chest tube, lung resection, air leakage|chest tube, lung resection, air leakage
4653141|NCT03536078|home phototherapy|home phototherapy
4653142|NCT03536078|parental bonding|parental bonding
4653143|NCT03536039|CNS lymphoma|cns lymphoma
4653144|NCT03536039|BBB permeabilization|bbb permeabilization
4653145|NCT03536039|R-CHOP|r-chop
4653146|NCT03536039|TNF|tnf
4653147|NCT03536000|Cardiac function|cardiac function
4653148|NCT03536000|Fetal|fetal
4653149|NCT03536000|Strain|strain
4653150|NCT03535935|Chinese medicine|chinese medicine
4653151|NCT03535935|Astragalus|astragalus
4653152|NCT03535935|Pragmatic trial|pragmatic trial
4653153|NCT03535922|Hemodialysis|hemodialysis
4653154|NCT03535922|Chronic Kidney Disease|chronic kidney disease
4653155|NCT03535909|CHF|chf
4653156|NCT03535909|central venous pressure|central venous pressure
4653157|NCT03535909|noninvasive|noninvasive
4653158|NCT03535909|ADHF|adhf
4653159|NCT03535909|stroke volume|stroke volume
4653160|NCT03535857|overactive bladder|overactive bladder
4653161|NCT03535857|OAB|oab
4654156|NCT03529383|Obesity|obesity
4653162|NCT03535857|urge urinary incontinence|urge urinary incontinence
4653163|NCT03535857|PTNS|ptns
4653164|NCT03535844|Wolfberry (Goji berry)|wolfberry (goji berry)
4653165|NCT03535844|Healthy diet|healthy diet
4653166|NCT03535844|Cardiovascular diseases|cardiovascular diseases
4653167|NCT03535844|Endothelial function|endothelial function
4653168|NCT03535844|Lipidomics|lipidomics
4653169|NCT03535844|Middle-aged and older adults|middle-aged and older adults
4653170|NCT03535844|Oxidative stress|oxidative stress
4653171|NCT03535844|Inflammation|inflammation
4653172|NCT03535805|Cognitive and Behavioral Therapies|cognitive and behavioral therapies
4653173|NCT03535805|Children and Adolescents|children and adolescents
4653174|NCT03535805|Community Health Care|community health care
4653175|NCT03535805|Early Intervention|early intervention
4653176|NCT03535740|Drug Therapy|drug therapy
4653177|NCT03535714|Treatment|treatment
4653178|NCT03535714|Psychotherapy|psychotherapy
4653179|NCT03535714|Young Adult|young adult
4653180|NCT03535714|Adolescence|adolescence
4653181|NCT03535688|Chronic Pain|chronic pain
4653182|NCT03535688|Low Back Pain|low back pain
4653183|NCT03535688|D-cycloserine|d-cycloserine
4653184|NCT03535649|Drug therapy|drug therapy
4653185|NCT03535636|Polysomnography|polysomnography
4653186|NCT03535636|Refugees|refugees
4653187|NCT03535623|remote ischemic preconditioning|remote ischemic preconditioning
4653188|NCT03535623|free flap reconstruction|free flap reconstruction
4653189|NCT03535623|preoperative radiotherapy|preoperative radiotherapy
4653190|NCT03535610|Embolization|embolization
4653191|NCT03535610|Uterine Leiomyoma|uterine leiomyoma
4653192|NCT03535610|Embospheres|embospheres
4653193|NCT03535610|Microspheres|microspheres
4653194|NCT03535597|Transradial Access|transradial access
4653195|NCT03535597|Hemostasis|hemostasis
4653196|NCT03535571|Energy increase|energy increase
4653197|NCT03535571|Energy|energy
4653198|NCT03535571|Healthy|healthy
4653199|NCT03535571|anti-inflammatory|anti-inflammatory
4653200|NCT03535571|Open-label|open-label
4653201|NCT03535571|Salmon protein|salmon protein
4653202|NCT03535571|Natural health product|natural health product
4653203|NCT03535571|Dietary supplement|dietary supplement
4653204|NCT03535545|PET Imaging|pet imaging
4653205|NCT03535545|Molecular Imaging|molecular imaging
4653206|NCT03535532|resistant hypertension|resistant hypertension
4653207|NCT03535532|Adrenal Disease|adrenal disease
4653208|NCT03535532|medical treatment|medical treatment
4653209|NCT03535532|laparoscopic adrenalectomy|laparoscopic adrenalectomy
4653210|NCT03535506|Breast Cancer|breast cancer
4653211|NCT03535506|DCIS|dcis
4653212|NCT03535506|Ductal Carcinoma In Situ|ductal carcinoma in situ
4653213|NCT03535506|Palbociclib|palbociclib
4653214|NCT03535480|ovarian reserve|ovarian reserve
4653215|NCT03535467|Caregivers|caregivers
4653216|NCT03535467|Exoskeleton Device|exoskeleton device
4653217|NCT03535467|Stroke Rehabilitation|stroke rehabilitation
4653218|NCT03535454|Fibromyalgia|fibromyalgia
4653219|NCT03535454|Musculoskeletal Diseases|musculoskeletal diseases
4653220|NCT03535454|Work|work
4653221|NCT03535441|hemorrhagic shock|hemorrhagic shock
4653222|NCT03535441|HMGB1|hmgb1
4653223|NCT03535376|Bariatric surgery|bariatric surgery
4653224|NCT03535376|Gastrointestinal tract|gastrointestinal tract
4653225|NCT03535376|Biological availability|biological availability
4653226|NCT03535376|Pharmacokinetics|pharmacokinetics
4653227|NCT03535376|Valsartan|valsartan
4653228|NCT03535363|Osimertinib|osimertinib
4653229|NCT03535350|ibrutinib|ibrutinib
4653230|NCT03535350|temozolomide|temozolomide
4653231|NCT03535350|brain cancer|brain cancer
4653232|NCT03535337|Interventions|interventions
4653233|NCT03535337|youth living with HIV|youth living with hiv
4653234|NCT03535337|mHealth|mhealth
4653235|NCT03535337|ART adherence|art adherence
4653236|NCT03535337|adaptive intervention|adaptive intervention
4653237|NCT03535337|cell phone|cell phone
4653238|NCT03535337|text messaging|text messaging
4653239|NCT03535285|periodontal ligament|periodontal ligament
4653240|NCT03535285|dentoalveolar|dentoalveolar
4653241|NCT03535285|distraction|distraction
4653242|NCT03535285|orthodontic|orthodontic
4653243|NCT03535259|hepatocellular carcinoma|hepatocellular carcinoma
4653244|NCT03535259|intensity-modulated radiotherapy|intensity-modulated radiotherapy
4653245|NCT03535259|sorafenib|sorafenib
4653246|NCT03535259|portal vein thrombosis|portal vein thrombosis
4653247|NCT03535259|lymph node metastasis|lymph node metastasis
4653248|NCT03535246|immunotherapy|immunotherapy
4653249|NCT03535246|T cell|t cell
4653250|NCT03535246|Cancer|cancer
4653251|NCT03535246|Gene therapy|gene therapy
4653252|NCT03535233|Alopecia areata, intralesional corticosteroid, minoxidil, clobetasol propionate, IL-23, TGFβ-1|alopecia areata, intralesional corticosteroid, minoxidil, clobetasol propionate, il-23, tgfβ-1
4653253|NCT03535220|Multiple Myeloma|multiple myeloma
4653254|NCT03535220|Sickle Cell Disease|sickle cell disease
4653255|NCT03535194|Interleukin-23 (IL-23)|interleukin-23 (il-23)
4653256|NCT03535168|Healthy volunteers|healthy volunteers
4653257|NCT03535155|Ultrasound image, Neuraxial anesthesia, Landmark|ultrasound image, neuraxial anesthesia, landmark
4653258|NCT03535129|Functional Magnetic Resonance Imaging (fMRI)|functional magnetic resonance imaging (fmri)
4653259|NCT03535129|Neurofeedback|neurofeedback
4653260|NCT03535129|Drug Relapse|drug relapse
4653261|NCT03535090|Graves' Disease|graves' disease
4653262|NCT03535090|Graves Ophthalmopathy|graves ophthalmopathy
4653263|NCT03535090|Blood Coagulation|blood coagulation
4653264|NCT03535090|Venous Thromboembolism|venous thromboembolism
4653265|NCT03535090|Methylprednisolone|methylprednisolone
4653266|NCT03535077|Melanoma|melanoma
4653267|NCT03535077|Nevus|nevus
4653268|NCT03535077|Mole|mole
4653269|NCT03535077|Atypical Nevi|atypical nevi
4653270|NCT03535064|HAND HYGIENE, HAND WASHING, INFLUENZA, SCHOOL ABSENCE, SCHOOL CHILDREN, UPPER RESPIRATORY INFECTIONS|hand hygiene, hand washing, influenza, school absence, school children, upper respiratory infections
4653271|NCT03535051|vitiligo|vitiligo
4653272|NCT03535051|fractional carbon dioxide laser|fractional carbon dioxide laser
4653273|NCT03535051|tacrolimus|tacrolimus
4653274|NCT03535051|drug delivery|drug delivery
4653275|NCT03535038|Intravascular volume|intravascular volume
4653276|NCT03535038|Inferior vena cava diameter|inferior vena cava diameter
4653277|NCT03535038|Ultrasonography|ultrasonography
4653278|NCT03535038|Vascular Pedicle Width|vascular pedicle width
4653279|NCT03535038|Chest x-ray|chest x-ray
4653280|NCT03534999|TENS,|tens,
4653281|NCT03534999|VAS,|vas,
4653282|NCT03534999|Oxford-Hip-score,|oxford-hip-score,
4653283|NCT03534999|Hip-arthroplasthy,|hip-arthroplasthy,
4653284|NCT03534999|Pain-intensity|pain-intensity
4653285|NCT03534973|Cataract|cataract
4653286|NCT03534973|Caffeine|caffeine
4653287|NCT03534947|Neoadjuvant|neoadjuvant
4653288|NCT03534947|Sonidegib|sonidegib
4653289|NCT03534934|COPD|copd
4653290|NCT03534934|Osteoporosis|osteoporosis
4653291|NCT03534921|Diabetes mellitus|diabetes mellitus
4653292|NCT03534921|Schizophrenia|schizophrenia
4653293|NCT03534921|Schizoaffective disorder|schizoaffective disorder
4653294|NCT03534921|Bipolar disorder|bipolar disorder
4653295|NCT03534921|Severe mental illness|severe mental illness
4653296|NCT03534895|midazolam|midazolam
4653297|NCT03534895|ambulatory surgery|ambulatory surgery
4653298|NCT03534882|anti-glaucoma medications|anti-glaucoma medications
4653299|NCT03534882|glaucoma|glaucoma
4653300|NCT03534882|prostaglandin analogues|prostaglandin analogues
4653301|NCT03534882|medication washout|medication washout
4653302|NCT03534869|auricular acupuncture|auricular acupuncture
4653303|NCT03534869|episiotomy|episiotomy
4653304|NCT03534869|acupuncture|acupuncture
4653305|NCT03534869|pain relief|pain relief
4653306|NCT03534869|analgesic therapy|analgesic therapy
4653307|NCT03534843|Spontaneous rupture|spontaneous rupture
4653308|NCT03534843|survival|survival
4653309|NCT03534843|hepatocellular carcinoma|hepatocellular carcinoma
4653310|NCT03534843|Child-Pugh|child-pugh
4653311|NCT03534843|Albumin-bilirubin|albumin-bilirubin
4653312|NCT03534817|Cardiac Rehabilitation|cardiac rehabilitation
4653313|NCT03534817|Early Access Cardiac Rehabilitation|early access cardiac rehabilitation
4653314|NCT03534817|Cardiac Rehabilitation Adherence|cardiac rehabilitation adherence
4653315|NCT03534817|Myocardial Infarction|myocardial infarction
4653316|NCT03534817|Ventricular Remodeling|ventricular remodeling
4653317|NCT03534765|Laparotomy|laparotomy
4653318|NCT03534765|Frailty|frailty
4653319|NCT03534765|Sacropenia|sacropenia
4653320|NCT03534752|Inborn errors of Metabolism|inborn errors of metabolism
4653321|NCT03534752|Adulthood|adulthood
4653322|NCT03534752|Clinical characteristics|clinical characteristics
4653323|NCT03534739|conditioned pain modulation (CPM)|conditioned pain modulation (cpm)
4653324|NCT03534739|diffuse noxious inhibitory control (DNIC)|diffuse noxious inhibitory control (dnic)
4653325|NCT03534739|massage|massage
4653326|NCT03534739|hypoalgesia|hypoalgesia
4653327|NCT03534713|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
4653328|NCT03534713|Cervical Cancer|cervical cancer
4653329|NCT03534713|Paraaortic Lymph Node Involvement|paraaortic lymph node involvement
4653330|NCT03534713|Carboplatin|carboplatin
4653331|NCT03534713|Paclitaxel|paclitaxel
4653332|NCT03534700|sacrococcygeal pilonidal disease|sacrococcygeal pilonidal disease
4653333|NCT03534687|RAGE|rage
4653334|NCT03534687|ADAM10|adam10
4653335|NCT03534687|Exercise|exercise
4653336|NCT03534687|sRAGE|srage
4653337|NCT03534635|metastatic melanoma|metastatic melanoma
4653338|NCT03534635|tumor microenvironment|tumor microenvironment
4653339|NCT03534635|pembrolizumab|pembrolizumab
4653340|NCT03534635|PD1|pd1
4653341|NCT03534596|cohort|cohort
4653342|NCT03534596|surgery|surgery
4653343|NCT03534596|adhesive small bowel obstruction|adhesive small bowel obstruction
4653344|NCT03534557|spirometry|spirometry
4653345|NCT03534544|artificial pancreas|artificial pancreas
4653346|NCT03534544|pediatric|pediatric
4653347|NCT03534544|parents|parents
4653348|NCT03534544|adherence|adherence
4653349|NCT03534505|Inguinal Herniorrhaphy|inguinal herniorrhaphy
4653350|NCT03534505|Analgesic Effects of Local Wound|analgesic effects of local wound
4653351|NCT03534492|urothelial|urothelial
4653352|NCT03534492|bladder cancer|bladder cancer
4653353|NCT03534492|olaparib|olaparib
4653354|NCT03534492|durvalumab|durvalumab
4653355|NCT03534466|treadmill|treadmill
4653356|NCT03534466|infants|infants
4653357|NCT03534466|neonatal encephalopathy|neonatal encephalopathy
4653358|NCT03534466|neonatal brain injury|neonatal brain injury
4653359|NCT03534453|ovarian cancer|ovarian cancer
4653360|NCT03534453|PARP Inhibitor|parp inhibitor
4653361|NCT03534453|Platinum sensitive|platinum sensitive
4653362|NCT03534440|Diastolic Dysfunction|diastolic dysfunction
4653363|NCT03534440|Anesthesia|anesthesia
4653364|NCT03534440|Preoperative assessment|preoperative assessment
4653365|NCT03534440|Postoperative care|postoperative care
4653366|NCT03534440|TEVAR|tevar
4653367|NCT03534427|arterial stiffness|arterial stiffness
4653368|NCT03534427|endothelin-1|endothelin-1
4653369|NCT03534427|c-reactive protein|c-reactive protein
4653370|NCT03534427|adiposity|adiposity
4653371|NCT03534427|exercise|exercise
4653372|NCT03534427|jump rope|jump rope
4653373|NCT03534414|dietary portfolio|dietary portfolio
4653374|NCT03534414|plant sterols|plant sterols
4653375|NCT03534414|plant protein|plant protein
4653376|NCT03534414|viscous fibre|viscous fibre
4653377|NCT03534414|nuts|nuts
4653378|NCT03534401|Reproductive Coercion|reproductive coercion
4653379|NCT03534401|Gender-based violence|gender-based violence
4653380|NCT03534401|Contraception|contraception
4653381|NCT03534401|Clinic-based screening for IPV|clinic-based screening for ipv
4653382|NCT03534401|Clinic-based counseling|clinic-based counseling
4653383|NCT03534362|Propel Stent|propel stent
4653384|NCT03534362|Nasopore|nasopore
4653385|NCT03534349|Duchenne Muscular Dystrophy|duchenne muscular dystrophy
4653386|NCT03534349|lower limb flexibility|lower limb flexibility
4653387|NCT03534349|performance|performance
4653388|NCT03534336|Weight Reduction|weight reduction
4653389|NCT03534336|Health Literacy|health literacy
4653390|NCT03534336|Financial Incentives|financial incentives
4653391|NCT03534336|Lifestyle Change|lifestyle change
4653392|NCT03534323|chronic lymphocytic leukemia (CLL)|chronic lymphocytic leukemia (cll)
4653393|NCT03534310|obesity|obesity
4653394|NCT03534310|sleeve-gastrectomy|sleeve-gastrectomy
4653395|NCT03534310|liraglutide|liraglutide
4653396|NCT03534310|Weight-loss|weight-loss
4653397|NCT03534297|heart failure|heart failure
4653398|NCT03534297|systolic heart failure|systolic heart failure
4653399|NCT03534284|Hemodialysis|hemodialysis
4653400|NCT03534284|Kidney disease|kidney disease
4653401|NCT03534284|Trazodone|trazodone
4653402|NCT03534284|Cognitive behavioral therapy|cognitive behavioral therapy
4653403|NCT03534245|Mosquito Salivary Protein|mosquito salivary protein
4653404|NCT03534245|Dengue Fever|dengue fever
4653405|NCT03534245|Zika|zika
4653406|NCT03534245|Chikungunya|chikungunya
4653407|NCT03534245|Kampong Speu|kampong speu
4653408|NCT03534219|Earpopper|earpopper
4653409|NCT03534219|Prophylaxis|prophylaxis
4653410|NCT03534219|Randomized controlled trial|randomized controlled trial
4653411|NCT03534167|depression|depression
4653412|NCT03534167|anxiety|anxiety
4653413|NCT03534167|gay|gay
4653414|NCT03534167|youth|youth
4653415|NCT03534167|Cognitive Behavior Therapy|cognitive behavior therapy
4653416|NCT03534141|Hypothermia|hypothermia
4653417|NCT03534141|NGAL - Neutrophil Gelatinase-associated Lipocalin|ngal - neutrophil gelatinase-associated lipocalin
4653418|NCT03534128|Traumatic Brain Injury|traumatic brain injury
4653419|NCT03534128|Spatial navigation|spatial navigation
4653420|NCT03534128|Virtual Reality|virtual reality
4653421|NCT03534128|Cues|cues
4653422|NCT03534115|bleaching, toxicity, NAC|bleaching, toxicity, nac
4653423|NCT03534102|Total Hip Arthroplasty|total hip arthroplasty
4653424|NCT03534102|Total Knee Arthroplasty|total knee arthroplasty
4653425|NCT03534102|Opioid Dependence|opioid dependence
4653426|NCT03534102|Opioid Tapering|opioid tapering
4653427|NCT03534063|Arthroplasty Surgery|arthroplasty surgery
4653428|NCT03534063|Genotype-Guided Pain Management|genotype-guided pain management
4653429|NCT03534050|Glioma|glioma
4653430|NCT03534050|Low-Grade Glioma (LGG)|low-grade glioma (lgg)
4653431|NCT03534050|Neurobehavioral Assessments|neurobehavioral assessments
4653432|NCT03534050|Neurocognitive Functions (NCF)|neurocognitive functions (ncf)
4653433|NCT03534050|Radiation Therapy (RT)|radiation therapy (rt)
4653434|NCT03534050|Hippocampus|hippocampus
4653435|NCT03534050|Progression-Free Survival (PFS)|progression-free survival (pfs)
4653436|NCT03534037|Serum uric acid|serum uric acid
4653437|NCT03534037|Metabolic syndrome|metabolic syndrome
4653438|NCT03534037|Left ventricular diastolic dysfunction|left ventricular diastolic dysfunction
4653439|NCT03534037|Febuxostat|febuxostat
4653440|NCT03534037|Benzbromarone|benzbromarone
4653441|NCT03534011|Balloon occlusion|balloon occlusion
4653442|NCT03534011|Air ambulances|air ambulances
4653443|NCT03534011|Aorta|aorta
4653444|NCT03534011|Resuscitation|resuscitation
4653445|NCT03533985|Neonatal Abstinence Syndrome|neonatal abstinence syndrome
4653446|NCT03533985|Music therapy|music therapy
4653447|NCT03533985|Attachment|attachment
4653448|NCT03533985|Music medicine|music medicine
4653449|NCT03533985|Multi-modal stimulation|multi-modal stimulation
4653450|NCT03533959|in-stent neoatherosclerosis|in-stent neoatherosclerosis
4653451|NCT03533959|alirocumab|alirocumab
4653452|NCT03533933|collagen matrix|collagen matrix
4653453|NCT03533933|connective tissue graft|connective tissue graft
4653454|NCT03533933|histometry|histometry
4653455|NCT03533933|xenograft|xenograft
4653456|NCT03533933|periodontal regeneration|periodontal regeneration
4653457|NCT03533933|biometry|biometry
4653458|NCT03533881|collagen|collagen
4653459|NCT03533881|volatile oils|volatile oils
4653460|NCT03533881|metabolic syndrome|metabolic syndrome
4653461|NCT03533881|insulin resistance|insulin resistance
4653462|NCT03533868|Point-of-care|point-of-care
4653463|NCT03533868|Viral load monitoring|viral load monitoring
4653464|NCT03533868|Nigeria|nigeria
4653465|NCT03533842|Triage|triage
4653466|NCT03533842|Algorithms|algorithms
4653467|NCT03533842|Emergencies|emergencies
4653468|NCT03533842|Eyes emergencies|eyes emergencies
4653469|NCT03533842|Ophtalmology|ophtalmology
4653470|NCT03533829|vaccination|vaccination
4653471|NCT03533829|pre-syncope|pre-syncope
4653472|NCT03533829|syncope prevention|syncope prevention
4653473|NCT03533816|Gamma delta T-cells|gamma delta t-cells
4653474|NCT03533816|Hematopoietic Stem Cell Transplantation (HCT)|hematopoietic stem cell transplantation (hct)
4653475|NCT03533816|Post-transplant Cyclophosphamide (PTCy)|post-transplant cyclophosphamide (ptcy)
4653476|NCT03533816|Expanded/Activated gamma delta (EAGD)|expanded/activated gamma delta (eagd)
4653477|NCT03533816|Graft versus host disease (GVHD)|graft versus host disease (gvhd)
4653478|NCT03533816|haploidentical|haploidentical
4653479|NCT03533764|Asthma Self-Management for Adolescents (ASMA)|asthma self-management for adolescents (asma)
4653480|NCT03533764|Community Health Workers (CHW)|community health workers (chw)
4653481|NCT03533725|Initiation, Exclusivity, Duration|initiation, exclusivity, duration
4653482|NCT03533647|high myopia|high myopia
4653483|NCT03533647|ocular biometric parameters|ocular biometric parameters
4653484|NCT03533647|adolescent|adolescent
4653485|NCT03533647|children|children
4653486|NCT03533634|midshaft clavicle fracture|midshaft clavicle fracture
4653487|NCT03533634|functional outcome|functional outcome
4653488|NCT03533634|anteroinferior plate|anteroinferior plate
4653489|NCT03533634|superior plate|superior plate
4653490|NCT03533634|reconstruction plate|reconstruction plate
4653491|NCT03533608|PTSD|ptsd
4653492|NCT03533608|Prolonged Exposure|prolonged exposure
4653493|NCT03533608|Group Therapy|group therapy
4653494|NCT03533569|pain|pain
4653495|NCT03533569|inflammation|inflammation
4653496|NCT03533543|Myocardial infarction|myocardial infarction
4653497|NCT03533543|New-onset atrial fibrillation|new-onset atrial fibrillation
4653498|NCT03533543|Retrospective|retrospective
4653499|NCT03533543|Prognosis|prognosis
4653500|NCT03533530|Electrical source imaging|electrical source imaging
4653501|NCT03533504|pharmacokinetics|pharmacokinetics
4653502|NCT03533504|hemophilia|hemophilia
4653503|NCT03533504|factor VII|factor vii
4653504|NCT03533504|factor IX|factor ix
4653505|NCT03533504|population pharmacokinetics|population pharmacokinetics
4653506|NCT03533478|Nutritional supplement|nutritional supplement
4653507|NCT03533478|Diabetic Macular Edema|diabetic macular edema
4653508|NCT03533478|Diabetes|diabetes
4653509|NCT03533478|Alzer|alzer
4653510|NCT03533478|Oxidative Stress|oxidative stress
4653511|NCT03533478|Diamel|diamel
4653512|NCT03533400|respiratory therapy|respiratory therapy
4653513|NCT03533400|videogaming therapy|videogaming therapy
4653514|NCT03533400|incentive spirometry|incentive spirometry
4653515|NCT03533374|Accuracy|accuracy
4653516|NCT03533374|Inter-ictal EEG Discharges|inter-ictal eeg discharges
4653517|NCT03533374|Inter-rater agreement|inter-rater agreement
4653518|NCT03533374|Long Term Monitoring|long term monitoring
4653519|NCT03533374|Sensitivity|sensitivity
4653520|NCT03533374|Sharp transients|sharp transients
4653521|NCT03533374|Specificity|specificity
4653522|NCT03533374|Source Space|source space
4653523|NCT03533374|Voltage maps|voltage maps
4653524|NCT03533361|expanded access program|expanded access program
4653525|NCT03533361|radioiodine refractory|radioiodine refractory
4653526|NCT03533361|differentiated|differentiated
4653527|NCT03533361|lenvatinib|lenvatinib
4653528|NCT03533335|Oral Hygiene|oral hygiene
4653529|NCT03533335|Oral Sprays|oral sprays
4653530|NCT03533335|Oral Health|oral health
4653531|NCT03533335|Frail Elderly|frail elderly
4653532|NCT03533335|Nursing Homes|nursing homes
4653533|NCT03533335|Chlorhexidine|chlorhexidine
4653534|NCT03533335|Chlorine Dioxide|chlorine dioxide
4653535|NCT03533309|horizontal defect, Anterior maxillary|horizontal defect, anterior maxillary
4653536|NCT03533244|Hyperemia|hyperemia
4653537|NCT03533231|Pulp regeneration, intracanal medication|pulp regeneration, intracanal medication
4653538|NCT03533218|endotracheal tube, point of care ultrasound|endotracheal tube, point of care ultrasound
4653539|NCT03533179|Glucagon|glucagon
4653540|NCT03533179|Beta-adrenergic antagonist|beta-adrenergic antagonist
4653541|NCT03533179|poisoning|poisoning
4653542|NCT03533166|Peri-implant mucositis|peri-implant mucositis
4653543|NCT03533166|Chlorhexidine|chlorhexidine
4653544|NCT03533166|CPC|cpc
4653545|NCT03533166|Treatment|treatment
4653546|NCT03533153|MSC|msc
4653547|NCT03533101|Tocilizumab|tocilizumab
4653548|NCT03533101|Haploidentical|haploidentical
4653549|NCT03533101|Peripheral blood|peripheral blood
4653550|NCT03533088|shoulder|shoulder
4653551|NCT03533088|rotator cuff|rotator cuff
4653552|NCT03533088|scapula|scapula
4653553|NCT03533062|OAB , Botox , anticholinergics , quality of life|oab , botox , anticholinergics , quality of life
4653554|NCT03533036|Virtual Reality|virtual reality
4653555|NCT03533036|Anxiety|anxiety
4653556|NCT03533023|Firefighters|firefighters
4653557|NCT03533023|San Diego Fire and Rescue|san diego fire and rescue
4653558|NCT03533023|Cardiometabolic Health|cardiometabolic health
4653559|NCT03533023|First Responder|first responder
4653560|NCT03533023|Shift Workers|shift workers
4653561|NCT03533010|Adolescent Idiopathic Scoliosis|adolescent idiopathic scoliosis
4653562|NCT03533010|Bone Health|bone health
4653563|NCT03533010|Treatment|treatment
4653564|NCT03533010|Vitamin D|vitamin d
4653565|NCT03533010|Calcium|calcium
4653566|NCT03532971|BK virus|bk virus
4653567|NCT03532971|BK polyomavirus|bk polyomavirus
4653568|NCT03532971|hematopoietic-cell transplantation|hematopoietic-cell transplantation
4653569|NCT03532932|Drug therapy|drug therapy
4653570|NCT03532893|COPD incidence|copd incidence
4653571|NCT03532893|Decline in FEV1|decline in fev1
4653572|NCT03532893|Inflammatory biomarkers|inflammatory biomarkers
4653573|NCT03532893|EBC|ebc
4653574|NCT03532893|microRNA-23a|microrna-23a
4653575|NCT03532880|Olaparib|olaparib
4653576|NCT03532880|Radiation therapy|radiation therapy
4653577|NCT03532880|18-195|18-195
4653578|NCT03532880|Memorial Sloan Kettering Cancer Center|memorial sloan kettering cancer center
4653579|NCT03532867|Exercise Test|exercise test
4653580|NCT03532867|Blood Pressure|blood pressure
4653581|NCT03532867|Choroid|choroid
4653582|NCT03532815|Cardiovascular Diseases, Framingham risk score, Life style modification, Randomized Controlled Trial|cardiovascular diseases, framingham risk score, life style modification, randomized controlled trial
4653583|NCT03532802|metoprolol|metoprolol
4653584|NCT03532802|heart diseases|heart diseases
4653585|NCT03532802|cardiovascular diseases|cardiovascular diseases
4653586|NCT03532802|ventricular outflow obstruction|ventricular outflow obstruction
4653587|NCT03532802|hemodynamics|hemodynamics
4653588|NCT03532763|Inflammation|inflammation
4653589|NCT03532763|Tocotrienols|tocotrienols
4653590|NCT03532763|Cardiovascular disease|cardiovascular disease
4653591|NCT03532737|head and neck cancer|head and neck cancer
4653592|NCT03532737|check point inhibitor|check point inhibitor
4653593|NCT03532737|Pembrolizumab|pembrolizumab
4653594|NCT03532737|Chemoradiation|chemoradiation
4653595|NCT03532724|Patient Self-management, Acenocoumarol, Warfarin|patient self-management, acenocoumarol, warfarin
4653596|NCT03532698|lung cancer|lung cancer
4653597|NCT03532698|Aspirin|aspirin
4653598|NCT03532698|Osimertinib|osimertinib
4653599|NCT03532698|EGFR-TKI|egfr-tki
4653600|NCT03532698|resistance|resistance
4653601|NCT03532685|Asthma|asthma
4653602|NCT03532685|severity|severity
4653603|NCT03532685|follow up|follow up
4653604|NCT03532685|obesity|obesity
4653605|NCT03532685|bariatric surgery|bariatric surgery
4653606|NCT03532672|Acute fasting|acute fasting
4653607|NCT03532672|Inflammatory response|inflammatory response
4653608|NCT03532672|Energy Expenditure|energy expenditure
4653609|NCT03532659|adolescents|adolescents
4653610|NCT03532659|obesity|obesity
4653611|NCT03532659|lung function|lung function
4653612|NCT03532659|microcirculation|microcirculation
4653613|NCT03532659|intima media thickness|intima media thickness
4653614|NCT03532633|infant|infant
4653615|NCT03532633|cord|cord
4653616|NCT03532633|micronutrients|micronutrients
4653617|NCT03532633|purine|purine
4653618|NCT03532633|pyrimidine|pyrimidine
4653619|NCT03532620|Pitavastatin|pitavastatin
4653620|NCT03532620|Prediabetic State|prediabetic state
4653621|NCT03532620|Hypertension|hypertension
4653622|NCT03532620|Dyslipidemias|dyslipidemias
4653623|NCT03532620|Cardiovascular Disease|cardiovascular disease
4653624|NCT03532607|Chronic|chronic
4653625|NCT03532594|Protamine|protamine
4653626|NCT03532594|Heparin Antagonists|heparin antagonists
4653627|NCT03532594|Cardiopulmonary Bypass|cardiopulmonary bypass
4653628|NCT03532555|zinc|zinc
4653629|NCT03532542|Duchenne muscular dystrophy|duchenne muscular dystrophy
4653630|NCT03532542|Exon Skipping|exon skipping
4653631|NCT03532542|DMD|dmd
4653632|NCT03532542|Exon 53|exon 53
4653633|NCT03532542|Exon 45|exon 45
4653634|NCT03532503|pregnancy termination|pregnancy termination
4653635|NCT03532503|second trimester|second trimester
4653636|NCT03532503|foley catheter|foley catheter
4653637|NCT03532477|Bariatric surgery|bariatric surgery
4653638|NCT03532477|Gastrointestinal tract|gastrointestinal tract
4653639|NCT03532477|Biological availability|biological availability
4653640|NCT03532477|Pharmacokinetics|pharmacokinetics
4653641|NCT03532477|Venlafaxine Hydrochloride|venlafaxine hydrochloride
4653642|NCT03532464|Chlamydia Trachomatis|chlamydia trachomatis
4653643|NCT03532464|Infection|infection
4653644|NCT03532464|Vaginal|vaginal
4653645|NCT03532464|Anal|anal
4653646|NCT03532451|Muscle-Invasive|muscle-invasive
4653647|NCT03532451|Cisplatin-Ineligible|cisplatin-ineligible
4653648|NCT03532451|Nivolumab|nivolumab
4653649|NCT03532451|Lirilumab|lirilumab
4653650|NCT03532412|Polysomnography, Sleep apnea, Central sleep apnea|polysomnography, sleep apnea, central sleep apnea
4653651|NCT03532399|Bivalirudin|bivalirudin
4653652|NCT03532386|Infertility|infertility
4653653|NCT03532386|male factor infertility|male factor infertility
4653654|NCT03532386|oligoasthenospermia|oligoasthenospermia
4653655|NCT03532386|vaginal hydrocele|vaginal hydrocele
4653656|NCT03532334|19F MRI gas Ventilation|19f mri gas ventilation
4653657|NCT03532334|133 XE ventilation Scintigraphy|133 xe ventilation scintigraphy
4653658|NCT03532321|Stress|stress
4653659|NCT03532321|occupational risks|occupational risks
4653660|NCT03532321|hospital organization|hospital organization
4653661|NCT03532321|longitudinal|longitudinal
4653662|NCT03532308|Fermented Soy|fermented soy
4653663|NCT03532269|sleep|sleep
4653664|NCT03532269|nightmare|nightmare
4653665|NCT03532269|app|app
4653666|NCT03532256|Quality Improvement|quality improvement
4653667|NCT03532256|Prescription Use|prescription use
4653668|NCT03532256|Patient Experience|patient experience
4653669|NCT03532256|SMS Messaging|sms messaging
4653670|NCT03532256|Crowd Sourcing|crowd sourcing
4653671|NCT03532243|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
4653672|NCT03532243|inspiratory muscle training|inspiratory muscle training
4653673|NCT03532243|Central Drive|central drive
4653674|NCT03532230|Chronic Low Back Pain|chronic low back pain
4653675|NCT03532230|Osteopathic Manipulative Medicine|osteopathic manipulative medicine
4653676|NCT03532204|Oligometastatis|oligometastatis
4653677|NCT03532204|SBRT|sbrt
4653678|NCT03532191|Quality Improvement|quality improvement
4653679|NCT03532191|Healthcare Providers|healthcare providers
4653680|NCT03532191|Health Disparity|health disparity
4653681|NCT03532178|Electroconvulsive Therapy, Neuromuscular Blockade|electroconvulsive therapy, neuromuscular blockade
4653682|NCT03532152|VR|vr
4653683|NCT03532152|moderate stress|moderate stress
4653684|NCT03532139|Ovarian Cancer|ovarian cancer
4653685|NCT03532113|Cognitive intervention|cognitive intervention
4653686|NCT03532113|Cognitive training|cognitive training
4653687|NCT03532113|Aging|aging
4653688|NCT03532113|Working memory|working memory
4653689|NCT03532113|Cognitive reserve|cognitive reserve
4653690|NCT03532113|Brain imaging|brain imaging
4653691|NCT03532113|Brain plasticity|brain plasticity
4653692|NCT03532113|Polymorphisms|polymorphisms
4653693|NCT03532113|Transfer|transfer
4653694|NCT03532113|Inhibition|inhibition
4653695|NCT03532113|Updating|updating
4653696|NCT03532100|lower limb prosthesis|lower limb prosthesis
4653697|NCT03532100|transtibial amputation|transtibial amputation
4653698|NCT03532100|below knee amputation|below knee amputation
4653699|NCT03532100|biomechanics|biomechanics
4653700|NCT03532100|gait|gait
4653701|NCT03532087|Breast cancer|breast cancer
4653702|NCT03532087|Denosumab|denosumab
4653703|NCT03532087|Chemotherapy|chemotherapy
4653704|NCT03532087|Immunity|immunity
4653705|NCT03532087|Immune system|immune system
4653706|NCT03532087|PERIDENO|perideno
4653707|NCT03532061|Familial Caregiver|familial caregiver
4653708|NCT03532061|Cancer|cancer
4653709|NCT03532061|Symptom Management|symptom management
4653710|NCT03532061|COPE Principles|cope principles
4653711|NCT03532061|Problem-solving Skills Training Program|problem-solving skills training program
4653712|NCT03532048|Hispanic|hispanic
4653713|NCT03532048|Fathers|fathers
4653714|NCT03532048|Child|child
4653715|NCT03532048|Obesity Prevention|obesity prevention
4653716|NCT03532048|Cultural adaptation|cultural adaptation
4653717|NCT03532048|Weight Loss|weight loss
4653718|NCT03532009|Heart Failure|heart failure
4653719|NCT03532009|Chronic Heart Failure|chronic heart failure
4653720|NCT03532009|Hyperkalaemia|hyperkalaemia
4653721|NCT03531996|Pulmonary Surfactant|pulmonary surfactant
4653722|NCT03531996|Rare Lung Disease|rare lung disease
4653723|NCT03531996|Registry|registry
4653724|NCT03531983|gamma nail|gamma nail
4653725|NCT03531970|inferior alveolar nerve block|inferior alveolar nerve block
4653726|NCT03531970|irreversible pulpitis|irreversible pulpitis
4653727|NCT03531970|local anesthesia|local anesthesia
4653728|NCT03531970|dexamethasone|dexamethasone
4653729|NCT03531957|eczema|eczema
4653730|NCT03531905|diabetes|diabetes
4653731|NCT03531905|cholesterolemia|cholesterolemia
4653732|NCT03531905|type 2 diabetes|type 2 diabetes
4653733|NCT03531905|LDL-C|ldl-c
4653734|NCT03531905|T2D|t2d
4653735|NCT03531905|diabetes mellitus|diabetes mellitus
4653736|NCT03531892|Ulcerative Colitis|ulcerative colitis
4653737|NCT03531892|Inflammatory Bowel Disease, Ulcerative Colitis Type|inflammatory bowel disease, ulcerative colitis type
4653738|NCT03531892|Colitis|colitis
4653739|NCT03531892|AJM300|ajm300
4653740|NCT03531840|DNA Mismatch Repair|dna mismatch repair
4653741|NCT03531840|BAP1|bap1
4653742|NCT03531840|BRCA|brca
4653743|NCT03531827|Androgen Receptor Antagonist|androgen receptor antagonist
4653744|NCT03531827|PSA|psa
4653745|NCT03531827|Hormonal Therapy|hormonal therapy
4653746|NCT03531827|Nanoparticle Drug|nanoparticle drug
4653747|NCT03531827|Antitumor|antitumor
4653748|NCT03531814|Plexiform Neurofibromas|plexiform neurofibromas
4653749|NCT03531814|Medication Event Monitoring Systems|medication event monitoring systems
4653750|NCT03531814|Oral Medication|oral medication
4653751|NCT03531801|Referred pain|referred pain
4653752|NCT03531801|pressure algometry|pressure algometry
4653753|NCT03531801|pain mapping|pain mapping
4653754|NCT03531788|dynamic arm support|dynamic arm support
4653755|NCT03531788|mobile arm support|mobile arm support
4653756|NCT03531788|rehabilitation|rehabilitation
4653757|NCT03531788|occupational therapy|occupational therapy
4653758|NCT03531775|upright MRI|upright mri
4653759|NCT03531775|COPD with hyperinflation|copd with hyperinflation
4653760|NCT03531775|Diaphragmatic weakness|diaphragmatic weakness
4653761|NCT03531762|Proton Pump Inhibitor|proton pump inhibitor
4653762|NCT03531762|Omeprazole|omeprazole
4653763|NCT03531762|Tepotinib|tepotinib
4653764|NCT03531762|Non-small cell lung cancer (NSCLC)|non-small cell lung cancer (nsclc)
4653765|NCT03531762|Pharmacokinetics|pharmacokinetics
4653766|NCT03531736|Allogeneic Hematopoietic Stem Cell Transplantation|allogeneic hematopoietic stem cell transplantation
4653767|NCT03531736|intensity conditioning regimen|intensity conditioning regimen
4653768|NCT03531736|17-639|17-639
4653769|NCT03531723|external ventricular derivation|external ventricular derivation
4653770|NCT03531697|Loteprednol Etabonate|loteprednol etabonate
4653771|NCT03531645|Malignant neoplasms of female genital organs|malignant neoplasms of female genital organs
4653772|NCT03531645|Advanced low grade serous ovarian, primary peritoneal, or fallopian tube carcinomas|advanced low grade serous ovarian, primary peritoneal, or fallopian tube carcinomas
4653773|NCT03531645|Fulvestrant|fulvestrant
4653774|NCT03531645|Faslodex|faslodex
4653775|NCT03531645|Palbociclib|palbociclib
4653776|NCT03531645|PD-0332991|pd-0332991
4653777|NCT03531645|Ibrance|ibrance
4653778|NCT03531619|posturography|posturography
4653779|NCT03531619|quality of life|quality of life
4653780|NCT03531619|pressure algometry|pressure algometry
4653781|NCT03531619|cervicogenic dizziness|cervicogenic dizziness
4653782|NCT03531593|MTX|mtx
4653783|NCT03531593|IBD|ibd
4653784|NCT03531593|US Elastography|us elastography
4653785|NCT03531593|Liver Fibrosis|liver fibrosis
4653786|NCT03531567|Upper Extremity Hemiparesis|upper extremity hemiparesis
4653787|NCT03531567|Virtual Reality (VR)|virtual reality (vr)
4653788|NCT03531554|Fatty acid Oxidation Disorders|fatty acid oxidation disorders
4653789|NCT03531554|ketone ester|ketone ester
4653790|NCT03531554|VLCAD deficiency|vlcad deficiency
4653791|NCT03531541|TENS|tens
4653792|NCT03531541|cervical manipulation|cervical manipulation
4653793|NCT03531541|pressure pain|pressure pain
4653794|NCT03531502|tachycardia|tachycardia
4653795|NCT03531502|defibrillator|defibrillator
4653796|NCT03531502|arrythmia|arrythmia
4653797|NCT03531476|Mindfulness|mindfulness
4653798|NCT03531476|Chronic Pain|chronic pain
4653799|NCT03531476|Disability|disability
4653800|NCT03531476|Quality of Life|quality of life
4653801|NCT03531476|Online|online
4653802|NCT03531463|Displaced|displaced
4653803|NCT03531463|Non-Operative treatment|non-operative treatment
4653804|NCT03531463|Reversed Total Shoulder Prosthesis|reversed total shoulder prosthesis
4653805|NCT03531450|Gastroparesis|gastroparesis
4653806|NCT03531424|Coronary Stenosis|coronary stenosis
4653807|NCT03531424|Percutaneous Coronary Intervention|percutaneous coronary intervention
4653808|NCT03531424|Stents|stents
4653809|NCT03531424|Computed Tomography Angiography|computed tomography angiography
4653810|NCT03531424|Augmented Reality|augmented reality
4653811|NCT03531385|Behcet's disease|behcet's disease
4653812|NCT03531385|Central sensitisation|central sensitisation
4653813|NCT03531385|Neuropathic pain|neuropathic pain
4653814|NCT03531385|Sleep disturbance|sleep disturbance
4653815|NCT03531346|Tear film|tear film
4653816|NCT03531346|Tear osmolarity|tear osmolarity
4653817|NCT03531346|Contact lenses|contact lenses
4653818|NCT03531333|Glioma, intraoperative ultrasound, gross total resection, quality of life|glioma, intraoperative ultrasound, gross total resection, quality of life
4653819|NCT03531307|Lactate|lactate
4653820|NCT03531307|Ki-67|ki-67
4653821|NCT03531307|Mitotic index|mitotic index
4653822|NCT03531307|Brain tumor|brain tumor
4653823|NCT03531268|Pharmacogenomic Analysis|pharmacogenomic analysis
4653824|NCT03531268|Clinical Utility|clinical utility
4653825|NCT03531268|Outcomes|outcomes
4653826|NCT03531203|soursop|soursop
4653827|NCT03531203|supplementation|supplementation
4653828|NCT03531203|prehypertension|prehypertension
4653829|NCT03531203|uric acid|uric acid
4653830|NCT03531203|randomized controlled trial|randomized controlled trial
4653831|NCT03531190|Head and neck cancer|head and neck cancer
4653832|NCT03531190|wound healing|wound healing
4653833|NCT03531190|pre and post-surgical nutrition|pre and post-surgical nutrition
4653834|NCT03531190|zinc, arginine, vitamin C, protein, oral supplements|zinc, arginine, vitamin c, protein, oral supplements
4653835|NCT03531177|type 2 diabetes|type 2 diabetes
4653836|NCT03531177|Ethnicity|ethnicity
4653837|NCT03531177|African-caribbean|african-caribbean
4653838|NCT03531177|Education|education
4653839|NCT03531177|Self-management|self-management
4653840|NCT03531164|spinal cord injuries|spinal cord injuries
4653841|NCT03531164|kayak|kayak
4653842|NCT03531164|trunk control|trunk control
4653843|NCT03531138|performance test|performance test
4653844|NCT03531138|exercise capacity|exercise capacity
4653845|NCT03531138|rehabilitation outcome|rehabilitation outcome
4653846|NCT03531138|pulmonary rehabilitation|pulmonary rehabilitation
4653847|NCT03531099|Prostate cancer|prostate cancer
4653848|NCT03531099|HIFU focal|hifu focal
4653849|NCT03531099|adverse effect|adverse effect
4653850|NCT03531099|low risk|low risk
4653851|NCT03531086|dopamine transporter binding|dopamine transporter binding
4653852|NCT03531073|treat to target|treat to target
4653853|NCT03531047|progressive|progressive
4653854|NCT03531047|cross-linking|cross-linking
4653855|NCT03531047|customised|customised
4653856|NCT03531047|refractive|refractive
4653857|NCT03531034|Blood Pressure Variability|blood pressure variability
4653858|NCT03531034|Ambulatorial Blood Pressure Monitoring|ambulatorial blood pressure monitoring
4653859|NCT03531034|Combined Exercise|combined exercise
4653860|NCT03531021|type 1 diabetes|type 1 diabetes
4653861|NCT03531021|cardiovascular risk factor|cardiovascular risk factor
4653862|NCT03531021|teenager|teenager
4653863|NCT03531008|focal;|focal;
4653864|NCT03530956|AMPfoot|ampfoot
4653865|NCT03530956|dual-task|dual-task
4653866|NCT03530956|cognitive performance|cognitive performance
4653867|NCT03530956|physical performance|physical performance
4653868|NCT03530956|lower-limb prosthesis|lower-limb prosthesis
4653869|NCT03530891|anterior mandible fracture|anterior mandible fracture
4653870|NCT03530891|surgery computer assisted|surgery computer assisted
4653871|NCT03530865|mandibular molars|mandibular molars
4653872|NCT03530865|extra root|extra root
4653873|NCT03530865|extra root canal|extra root canal
4653874|NCT03530865|root morphology|root morphology
4653875|NCT03530865|cbct endodontics|cbct endodontics
4653876|NCT03530839|lesser toe deformity|lesser toe deformity
4653877|NCT03530839|claw toe|claw toe
4653878|NCT03530839|PIP joint|pip joint
4653879|NCT03530839|arthrodesis|arthrodesis
4653880|NCT03530839|resection arthroplasty|resection arthroplasty
4653881|NCT03530813|School|school
4653882|NCT03530813|Management|management
4653883|NCT03530813|Technology|technology
4653884|NCT03530813|Asthma Education|asthma education
4653885|NCT03530787|Ginger|ginger
4653886|NCT03530787|Curcumin|curcumin
4653887|NCT03530787|Zingerone|zingerone
4653888|NCT03530774|physical performance battery|physical performance battery
4653889|NCT03530774|24-hour dietary recalls|24-hour dietary recalls
4653890|NCT03530774|dual-energy X-ray absorptimetry|dual-energy x-ray absorptimetry
4653891|NCT03530774|dietary supplement|dietary supplement
4653892|NCT03530774|protein|protein
4653893|NCT03530735|Fingerprick Autologous Blood|fingerprick autologous blood
4653894|NCT03530696|Breast Cancer|breast cancer
4653895|NCT03530696|HER2-positive|her2-positive
4653896|NCT03530696|T-DM1|t-dm1
4653897|NCT03530696|HER2-positive Breast Cancer|her2-positive breast cancer
4653898|NCT03530696|Recurrent Breast Cancer|recurrent breast cancer
4653899|NCT03530696|Metastatic Breast Cancer|metastatic breast cancer
4653900|NCT03530683|Neoplasms|neoplasms
4653901|NCT03530683|Lymphoma|lymphoma
4653902|NCT03530683|Myeloma|myeloma
4653903|NCT03530644|Non-invasive glucose monitoring|non-invasive glucose monitoring
4653904|NCT03530605|PCNSL, primary central nervous system lymphoma|pcnsl, primary central nervous system lymphoma
4653905|NCT03530579|Diabetes Prevention|diabetes prevention
4653906|NCT03530566|PnK Method|pnk method
4653907|NCT03530566|obesity|obesity
4653908|NCT03530566|very low calorie ketogenic diet|very low calorie ketogenic diet
4653909|NCT03530566|Comorbidity|comorbidity
4653910|NCT03530566|Bariatric Surgery|bariatric surgery
4653911|NCT03530566|weight loss|weight loss
4653912|NCT03530527|ERCP|ercp
4653913|NCT03530527|Endoscopic ultrasound (EUS) guided biliary drainage|endoscopic ultrasound (eus) guided biliary drainage
4653914|NCT03530501|microbiota|microbiota
4653915|NCT03530501|obesity|obesity
4653916|NCT03530462|episodic memory|episodic memory
4653917|NCT03530462|executive control|executive control
4653918|NCT03530462|fMRI|fmri
4653919|NCT03530436|Bioavailability|bioavailability
4653920|NCT03530436|Pharmacokinetics|pharmacokinetics
4653921|NCT03530436|Curcumin|curcumin
4653922|NCT03530436|Demethoxycurcumin|demethoxycurcumin
4653923|NCT03530436|Bisdemethoxycurcumin|bisdemethoxycurcumin
4653924|NCT03530397|Advanced solid tumors|advanced solid tumors
4653925|NCT03530397|MEDI5752|medi5752
4653926|NCT03530397|durvalumab|durvalumab
4653927|NCT03530397|immuno-oncology|immuno-oncology
4653928|NCT03530397|Cancer|cancer
4653929|NCT03530397|PD-1/CTLA-4 Bispecific|pd-1/ctla-4 bispecific
4653930|NCT03530397|PD-1|pd-1
4653931|NCT03530397|CTLA-4|ctla-4
4653932|NCT03530397|Bispecific|bispecific
4653933|NCT03530397|Chemotherapy|chemotherapy
4653934|NCT03530397|Pemetrexed|pemetrexed
4653935|NCT03530397|Carboplatin|carboplatin
4653936|NCT03530397|Pembrolizumab|pembrolizumab
4653937|NCT03530358|Muscle Synergies|muscle synergies
4653938|NCT03530358|MRI|mri
4653939|NCT03530358|Virtual Reality|virtual reality
4653940|NCT03530358|Robotics|robotics
4653941|NCT03530345|Neridronic Acid|neridronic acid
4653942|NCT03530345|Neridronate|neridronate
4653943|NCT03530345|CRPS|crps
4653944|NCT03530345|RSD (reflex sympathetic dystrophy)|rsd (reflex sympathetic dystrophy)
4653945|NCT03530332|Preterm Birth|preterm birth
4653946|NCT03530332|Prematurity Prevention Clinic|prematurity prevention clinic
4653947|NCT03530332|Maternal-Fetal Medicine|maternal-fetal medicine
4653948|NCT03530319|Mycoplasma pneumoniae|mycoplasma pneumoniae
4653949|NCT03530319|Macrolide-resistance|macrolide-resistance
4653950|NCT03530319|Children|children
4653951|NCT03530280|pregabalin|pregabalin
4653952|NCT03530280|adductor canal block|adductor canal block
4653953|NCT03530280|postoperative pain|postoperative pain
4653954|NCT03530267|colorectal cancer|colorectal cancer
4653955|NCT03530267|5-FU|5-fu
4653956|NCT03530267|Aflibercept|aflibercept
4653957|NCT03530267|Oxaliplatin|oxaliplatin
4653958|NCT03530254|Endometrial receptivity|endometrial receptivity
4654155|NCT03529383|Therapeutic education|therapeutic education
4653959|NCT03530254|Preimplantation Genetic Diagnosis (PGD)|preimplantation genetic diagnosis (pgd)
4653960|NCT03530254|Preimplantation Genetic Testing for Aneuploidy (PGT-A)|preimplantation genetic testing for aneuploidy (pgt-a)
4653961|NCT03530254|Embryo Transfer (ET)|embryo transfer (et)
4653962|NCT03530254|Endometrial Receptivity Analysis (ERA)|endometrial receptivity analysis (era)
4653963|NCT03530254|Endometrial Diagnosis|endometrial diagnosis
4653964|NCT03530254|Live Newborn Rate (LBR)|live newborn rate (lbr)
4653965|NCT03530241|fluorescence|fluorescence
4653966|NCT03530241|cholangiography|cholangiography
4653967|NCT03530241|cholecystectomy, laparoscopic|cholecystectomy, laparoscopic
4653968|NCT03530215|Cardiotoxicity|cardiotoxicity
4653969|NCT03530215|Antineoplastic and immunomodulating agents|antineoplastic and immunomodulating agents
4653970|NCT03530202|muscle thickness|muscle thickness
4653971|NCT03530202|strength|strength
4653972|NCT03530202|power|power
4653973|NCT03530202|functionality|functionality
4653974|NCT03530189|Hyperglycemia;|hyperglycemia;
4653975|NCT03530189|Hypoglycemia;|hypoglycemia;
4653976|NCT03530189|Neurodevelopment;|neurodevelopment;
4653977|NCT03530189|Prematurity|prematurity
4653978|NCT03530163|Exercise|exercise
4653979|NCT03530163|Aerobic|aerobic
4653980|NCT03530163|Cognitive Function|cognitive function
4653981|NCT03530150|Burns|burns
4653982|NCT03530150|Partial-thickness burn wounds|partial-thickness burn wounds
4653983|NCT03530150|Re-epithelization|re-epithelization
4653984|NCT03530150|Second-Degree Wound|second-degree wound
4653985|NCT03530150|Pirfenidone|pirfenidone
4653986|NCT03530150|Wound Healing|wound healing
4653987|NCT03530137|homelessness|homelessness
4653988|NCT03530137|homeless children|homeless children
4653989|NCT03530137|homeless families|homeless families
4653990|NCT03530124|apnea following vaccination|apnea following vaccination
4653991|NCT03530111|Adipose tissue|adipose tissue
4653992|NCT03530111|Adipose turnover|adipose turnover
4653993|NCT03530111|Adipose kinetics|adipose kinetics
4653994|NCT03530111|Exercise|exercise
4653995|NCT03530111|Deuterium|deuterium
4653996|NCT03530098|Age Determination by Skeleton|age determination by skeleton
4653997|NCT03530098|Machine Learning|machine learning
4653998|NCT03530098|Deep Learning|deep learning
4653999|NCT03530098|Artificial Intelligence|artificial intelligence
4654000|NCT03530098|Prospective|prospective
4654001|NCT03530098|Clinical Validation|clinical validation
4654002|NCT03530059|Home-based training program|home-based training program
4654003|NCT03530020|monolithic zirconia|monolithic zirconia
4654004|NCT03530020|tooth wear|tooth wear
4654005|NCT03530020|all ceramic crown|all ceramic crown
4654006|NCT03529981|mindfulness, awareness|mindfulness, awareness
4654007|NCT03529968|esophageal adenocarcinoma|esophageal adenocarcinoma
4654008|NCT03529968|staging|staging
4654009|NCT03529968|CT|ct
4654010|NCT03529968|PET-CT|pet-ct
4654011|NCT03529968|EUS|eus
4654012|NCT03529955|dermatomyositis|dermatomyositis
4654013|NCT03529955|apremilast|apremilast
4654014|NCT03529955|recalcitrant cutaneous disease|recalcitrant cutaneous disease
4654015|NCT03529942|Osteoarthritis|osteoarthritis
4654016|NCT03529942|Knee|knee
4654017|NCT03529942|Pain|pain
4654018|NCT03529942|Intra-articular|intra-articular
4654019|NCT03529942|Injection|injection
4654020|NCT03529942|Corticosteroid|corticosteroid
4654021|NCT03529929|glucocorticoids|glucocorticoids
4654022|NCT03529929|aging|aging
4654023|NCT03529929|NFKB|nfkb
4654024|NCT03529929|Medrol|medrol
4654025|NCT03529929|methylprednisolone|methylprednisolone
4654026|NCT03529903|behavior change|behavior change
4654027|NCT03529903|health coaching|health coaching
4654028|NCT03529903|wearable activity tracker|wearable activity tracker
4654029|NCT03529903|text messaging|text messaging
4654030|NCT03529903|lifestyle-related chronic diseases|lifestyle-related chronic diseases
4654031|NCT03529890|locally advanced urothelial carcinoma|locally advanced urothelial carcinoma
4654032|NCT03529890|immunotherapy|immunotherapy
4654033|NCT03529890|cystectomy|cystectomy
4654034|NCT03529890|radiation|radiation
4654035|NCT03529890|nivolumab|nivolumab
4654036|NCT03529877|Epidermolysis Bullosa|epidermolysis bullosa
4654037|NCT03529877|Epidermolysis Bullosa Dystrophica|epidermolysis bullosa dystrophica
4654038|NCT03529877|Skin Abnormalities|skin abnormalities
4654039|NCT03529877|Congenital Abnormalities|congenital abnormalities
4654040|NCT03529877|Skin Diseases, Genetic|skin diseases, genetic
4654041|NCT03529877|Somatic Cell Therapy|somatic cell therapy
4654042|NCT03529877|Mesenchymal Stem Cells|mesenchymal stem cells
4654043|NCT03529877|ABCB5|abcb5
4654044|NCT03529877|Allogeneic|allogeneic
4654045|NCT03529851|Patient reported outcomes|patient reported outcomes
4654046|NCT03529851|Symptom monitoring|symptom monitoring
4654047|NCT03529851|Follow-up|follow-up
4654048|NCT03529838|Combined Exercise|combined exercise
4654049|NCT03529838|Ambulatorial Blood Pressure Monitoring|ambulatorial blood pressure monitoring
4654050|NCT03529838|Blood analysis|blood analysis
4654051|NCT03529838|Salivary analysis|salivary analysis
4654052|NCT03529838|Heart rate variability|heart rate variability
4654053|NCT03529825|Rifaximin|rifaximin
4654054|NCT03529825|Microbiome|microbiome
4654055|NCT03529825|Allogeneic hematopoietic stem cell transplantation|allogeneic hematopoietic stem cell transplantation
4654056|NCT03529825|Blood stream infections|blood stream infections
4654057|NCT03529825|Acute graft versus host disease|acute graft versus host disease
4654058|NCT03529812|Behavioral intervention|behavioral intervention
4654059|NCT03529812|Social intervention|social intervention
4654060|NCT03529799|mTBI|mtbi
4654061|NCT03529799|TBI|tbi
4654062|NCT03529799|brain injury|brain injury
4654063|NCT03529799|concussion|concussion
4654064|NCT03529786|Hunter Syndrome|hunter syndrome
4654065|NCT03529786|Natural History|natural history
4654066|NCT03529786|Iduronate-2-sulfatase|iduronate-2-sulfatase
4654067|NCT03529786|glycosaminoglycans|glycosaminoglycans
4654068|NCT03529773|Respiratory tract infections, RSV, vaccine|respiratory tract infections, rsv, vaccine
4654069|NCT03529760|Leukemia, occult hepatitis B virus infection|leukemia, occult hepatitis b virus infection
4654070|NCT03529734|Anticipatory postural adjustments|anticipatory postural adjustments
4654071|NCT03529734|Trunk muscles reflex responses|trunk muscles reflex responses
4654072|NCT03529734|Sitting balance|sitting balance
4654073|NCT03529734|Kinesthesia|kinesthesia
4654074|NCT03529695|obesity|obesity
4654075|NCT03529695|childhood obesity|childhood obesity
4654076|NCT03529695|maternal and child health|maternal and child health
4654077|NCT03529695|health disparities|health disparities
4654078|NCT03529695|prevention|prevention
4654079|NCT03529695|low-income|low-income
4654080|NCT03529695|social network|social network
4654081|NCT03529695|home environment|home environment
4654082|NCT03529682|Circuit Exercise|circuit exercise
4654083|NCT03529682|Trunk Control|trunk control
4654084|NCT03529682|Functional Strength Training|functional strength training
4654085|NCT03529669|Cancer|cancer
4654086|NCT03529669|Oesophageal Cancer|oesophageal cancer
4654087|NCT03529669|Gastrointestinal|gastrointestinal
4654088|NCT03529656|Liver transplantation|liver transplantation
4654089|NCT03529656|rehabilitation|rehabilitation
4654090|NCT03529656|ICU acquired weakness|icu acquired weakness
4654091|NCT03529604|Oral Cancer|oral cancer
4654092|NCT03529604|Potentially Malignant Oral Disorders|potentially malignant oral disorders
4654093|NCT03529604|Saliva|saliva
4654094|NCT03529604|Squamous cell carcinoma antigen 1|squamous cell carcinoma antigen 1
4654095|NCT03529604|Squamous cell carcinoma antigen 2|squamous cell carcinoma antigen 2
4654096|NCT03529604|Trophoblast cell surface antigen|trophoblast cell surface antigen
4654097|NCT03529604|Diadenosine tetraphosphate|diadenosine tetraphosphate
4654098|NCT03529578|Pressure Ulcer, Decubitus Ulcer|pressure ulcer, decubitus ulcer
4654099|NCT03529539|neuroendocrine disease of the pancreas.|neuroendocrine disease of the pancreas.
4654100|NCT03529500|dental caries|dental caries
4654101|NCT03529500|saliva|saliva
4654102|NCT03529500|child|child
4654103|NCT03529461|severe obesity|severe obesity
4654104|NCT03529461|non-invasive positive pressure ventilation|non-invasive positive pressure ventilation
4654105|NCT03529461|endoscopy|endoscopy
4654106|NCT03529461|hypoxia|hypoxia
4654107|NCT03529461|bariatric surgery|bariatric surgery
4654108|NCT03529461|sedation|sedation
4654109|NCT03529461|adverse events|adverse events
4654110|NCT03529461|BMI|bmi
4654111|NCT03529461|anesthesia|anesthesia
4654112|NCT03529461|complications|complications
4654113|NCT03529448|Glioblastoma|glioblastoma
4654114|NCT03529435|Posttraumatic Stress Disorder|posttraumatic stress disorder
4654115|NCT03529435|PTSD|ptsd
4654116|NCT03529435|Post-Traumatic Stress|post-traumatic stress
4654117|NCT03529435|Trauma and Stressor Related Disorders|trauma and stressor related disorders
4654118|NCT03529435|Trauma|trauma
4654119|NCT03529435|Combat|combat
4654120|NCT03529435|Military|military
4654121|NCT03529435|Veterans|veterans
4654122|NCT03529435|Prolonged Exposure|prolonged exposure
4654123|NCT03529435|Exposure Therapy|exposure therapy
4654124|NCT03529435|Behavior Therapy|behavior therapy
4654125|NCT03529435|Psychological Treatment|psychological treatment
4654126|NCT03529435|Psychotherapy|psychotherapy
4654127|NCT03529422|Head and Neck|head and neck
4654128|NCT03529422|Larynx|larynx
4654129|NCT03529422|Lip|lip
4654130|NCT03529422|Oral Cancer|oral cancer
4654131|NCT03529409|Immunologic Deficiency Syndromes|immunologic deficiency syndromes
4654132|NCT03529409|Substance Use|substance use
4654133|NCT03529409|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
4654134|NCT03529409|Immune System Diseases|immune system diseases
4654135|NCT03529409|Behavioral Symptoms|behavioral symptoms
4654136|NCT03529409|RNA Virus Infections|rna virus infections
4654137|NCT03529409|HIV Infections|hiv infections
4654138|NCT03529409|Alcohol Use|alcohol use
4654139|NCT03529409|Drug Use|drug use
4654140|NCT03529396|G6PD deficiency|g6pd deficiency
4654141|NCT03529396|Acute hemolytic anemia|acute hemolytic anemia
4654142|NCT03529396|Vivax malaria|vivax malaria
4654143|NCT03529396|Primaquine|primaquine
4654144|NCT03529396|Weekly primaquine|weekly primaquine
4654145|NCT03529396|Chloroquine|chloroquine
4654146|NCT03529396|Weekly chloroquine|weekly chloroquine
4654147|NCT03529396|Brazilian Amazon|brazilian amazon
4654148|NCT03529396|Oxidative stress|oxidative stress
4654149|NCT03529383|Localized breast cancer|localized breast cancer
4654150|NCT03529383|Exercise|exercise
4654151|NCT03529383|Adapted physical activity|adapted physical activity
4654152|NCT03529383|Sedentary|sedentary
4654153|NCT03529383|Connected device|connected device
4654154|NCT03529383|Activity trackers|activity trackers
4654157|NCT03529357|Biological Age|biological age
4654158|NCT03529357|Motivation|motivation
4654159|NCT03529331|Pain Medications, Analgesia, Emergency Medicine|pain medications, analgesia, emergency medicine
4654160|NCT03529305|Stroke|stroke
4654161|NCT03529305|rTMS|rtms
4654162|NCT03529305|MRI|mri
4654163|NCT03529253|Alirocumab|alirocumab
4654164|NCT03529253|NIRS-IVUS|nirs-ivus
4654165|NCT03529253|LCBI|lcbi
4654166|NCT03529240|kinesiology taping|kinesiology taping
4654167|NCT03529240|performance|performance
4654168|NCT03529240|energy consumption|energy consumption
4654169|NCT03529240|gait|gait
4654170|NCT03529240|Duchenne Muscular Dystrophy|duchenne muscular dystrophy
4654171|NCT03529227|chlorambucil|chlorambucil
4654172|NCT03529227|obinutuzumab|obinutuzumab
4654173|NCT03529214|Quality Improvement|quality improvement
4654174|NCT03529214|Program Evaluation|program evaluation
4654175|NCT03529214|Quality Assurance|quality assurance
4654176|NCT03529214|Feasibility|feasibility
4654177|NCT03529214|Acceptability|acceptability
4654178|NCT03529188|Diabetes type 1|diabetes type 1
4654179|NCT03529188|Child ans teenager|child ans teenager
4654180|NCT03529188|Fear of Hypoglycaemia|fear of hypoglycaemia
4654181|NCT03529162|Biceps Tendinitis|biceps tendinitis
4654182|NCT03529162|Subpectoral biceps tenodesis|subpectoral biceps tenodesis
4654183|NCT03529162|Biceps tendon disorder|biceps tendon disorder
4654184|NCT03529136|Mesenchymal Stem Cell|mesenchymal stem cell
4654185|NCT03529136|MSC|msc
4654186|NCT03529110|Breast Cancer|breast cancer
4654187|NCT03529110|Metastatic breast cancer|metastatic breast cancer
4654188|NCT03529110|DS-8201a|ds-8201a
4654189|NCT03529084|Non small cell lung cancer|non small cell lung cancer
4654190|NCT03529084|NSCLC|nsclc
4654191|NCT03529084|EGFR mutation|egfr mutation
4654192|NCT03529084|EGF816|egf816
4654193|NCT03529084|nazartinib|nazartinib
4654194|NCT03529084|erlotinib|erlotinib
4654195|NCT03529084|gefitinib|gefitinib
4654196|NCT03529071|communication|communication
4654197|NCT03529071|patient activation|patient activation
4654198|NCT03529045|VNS|vns
4654199|NCT03529045|VNS Therapy|vns therapy
4654200|NCT03529045|Vagus Nerve Stimulation|vagus nerve stimulation
4654201|NCT03529032|methadone|methadone
4654202|NCT03529032|postoperative pain|postoperative pain
4654203|NCT03529032|acute pain therapy|acute pain therapy
4654204|NCT03529032|postoperative pain therapy|postoperative pain therapy
4654205|NCT03529019|Enhanced Recovery After Surgery Protocol|enhanced recovery after surgery protocol
4654206|NCT03529006|bioresorbable vascular scaffold|bioresorbable vascular scaffold
4654207|NCT03529006|drug eluting balloon|drug eluting balloon
4654208|NCT03528993|stroke, hippotherapy, balance, postural control, gait|stroke, hippotherapy, balance, postural control, gait
4654209|NCT03528980|fertility|fertility
4654210|NCT03528980|bariatric surgery|bariatric surgery
4654211|NCT03528954|Emergence agitation|emergence agitation
4654212|NCT03528954|Propofol|propofol
4654213|NCT03528954|General anesthesia|general anesthesia
4654214|NCT03528941|Chronic Lymphoid Leukemia|chronic lymphoid leukemia
4654215|NCT03528941|Hepatitis B|hepatitis b
4654216|NCT03528941|Ibrutinib|ibrutinib
4654217|NCT03528928|pelvic floor|pelvic floor
4654218|NCT03528928|electrical stimulation|electrical stimulation
4654219|NCT03528928|bladder|bladder
4654220|NCT03528928|ultrasound|ultrasound
4654221|NCT03528915|neonate, infant; eyewash; delivery room; prophylaxis; risk factor's|neonate, infant; eyewash; delivery room; prophylaxis; risk factor's
4654222|NCT03528876|gastric cancer|gastric cancer
4654223|NCT03528876|esophageal cancer|esophageal cancer
4654224|NCT03528876|adnocarcinoma|adnocarcinoma
4654225|NCT03528876|FOLFIRI|folfiri
4654226|NCT03528876|FOLFOX|folfox
4654227|NCT03528876|Metastatic cancer|metastatic cancer
4654228|NCT03528811|Diabetes|diabetes
4654229|NCT03528811|Peripheral Vascular Disease|peripheral vascular disease
4654230|NCT03528811|Microcirculation|microcirculation
4654231|NCT03528785|Pancreatic Adenocarcinoma|pancreatic adenocarcinoma
4654232|NCT03528785|Liposomial IrinoTecan|liposomial irinotecan
4654233|NCT03528785|nal-IRI|nal-iri
4654234|NCT03528785|Resectable pancreatic cancer|resectable pancreatic cancer
4654235|NCT03528772|anal fissure, minoxidil, glycreyl trinitrate|anal fissure, minoxidil, glycreyl trinitrate
4654236|NCT03528746|Patellar tendinopathy|patellar tendinopathy
4654237|NCT03528720|Tomography, Optical Coherence|tomography, optical coherence
4654238|NCT03528720|Fluorescein Angiography|fluorescein angiography
4654239|NCT03528720|Fundus photographs|fundus photographs
4654240|NCT03528694|Durvalumab|durvalumab
4654241|NCT03528694|BCG|bcg
4654242|NCT03528694|MEDI4736|medi4736
4654243|NCT03528694|NMIBC|nmibc
4654244|NCT03528694|PD-L1|pd-l1
4654245|NCT03528694|DFS|dfs
4654246|NCT03528694|OS|os
4654247|NCT03528655|separation care|separation care
4654248|NCT03528655|rooming-in care|rooming-in care
4654249|NCT03528655|patient decision aid|patient decision aid
4654250|NCT03528629|zolbetuximab|zolbetuximab
4654251|NCT03528629|IMAB362|imab362
4654252|NCT03528629|pharmacokinetics|pharmacokinetics
4654253|NCT03528629|tolerability|tolerability
4654254|NCT03528629|safety|safety
4654255|NCT03528629|ASP8951|asp8951
4654256|NCT03528629|immunogenicity|immunogenicity
4654364|NCT03528044|Follow-up|follow-up
4654365|NCT03528044|Psychiatric|psychiatric
4654257|NCT03528603|platelet, aggregation, phenolic, olive oil, oleocanthal|platelet, aggregation, phenolic, olive oil, oleocanthal
4654258|NCT03528590|laryngeal mask airway|laryngeal mask airway
4654259|NCT03528590|breast surgery|breast surgery
4654260|NCT03528564|Preoperative Anemia|preoperative anemia
4654261|NCT03528564|Intravenous Iron|intravenous iron
4654262|NCT03528564|Erythropoietin|erythropoietin
4654263|NCT03528538|Fenugreek|fenugreek
4654264|NCT03528538|Aging Male Symptoms|aging male symptoms
4654265|NCT03528538|Testosterone|testosterone
4654266|NCT03528538|Supplementation|supplementation
4654267|NCT03528538|Double Blind|double blind
4654268|NCT03528538|Body Composition|body composition
4654269|NCT03528525|Diseases|diseases
4654270|NCT03528525|Children|children
4654271|NCT03528525|Respiratory|respiratory
4654272|NCT03528525|Monogenic diseases|monogenic diseases
4654273|NCT03528525|China|china
4654274|NCT03528512|Pediatric|pediatric
4654275|NCT03528512|analgesia|analgesia
4654276|NCT03528512|pain control|pain control
4654277|NCT03528512|sedation|sedation
4654278|NCT03528512|intranasal ketamine|intranasal ketamine
4654279|NCT03528512|intranasal midazolam|intranasal midazolam
4654280|NCT03528512|intranasal fentanyl|intranasal fentanyl
4654281|NCT03528499|Scapula|scapula
4654282|NCT03528499|Physical Therapy|physical therapy
4654283|NCT03528499|Movement|movement
4654284|NCT03528499|Rehabilitation|rehabilitation
4654285|NCT03528460|Parkinson Disease|parkinson disease
4654286|NCT03528460|Deep Brain Stimulation|deep brain stimulation
4654287|NCT03528460|Subthalamic Nucleus|subthalamic nucleus
4654288|NCT03528460|Predictive factors|predictive factors
4654289|NCT03528447|lung transplantation|lung transplantation
4654290|NCT03528447|cognition|cognition
4654291|NCT03528447|MOCA|moca
4654292|NCT03528447|exercise|exercise
4654293|NCT03528447|pulmonary rehabilitation|pulmonary rehabilitation
4654294|NCT03528434|Zinc|zinc
4654295|NCT03528421|CAR-T|car-t
4654296|NCT03528395|Balance|balance
4654297|NCT03528395|Baropodometry|baropodometry
4654298|NCT03528395|Video games|video games
4654299|NCT03528395|Virtual reality|virtual reality
4654300|NCT03528343|appendicitis|appendicitis
4654301|NCT03528343|postoperative pain|postoperative pain
4654302|NCT03528343|patient satisfaction|patient satisfaction
4654303|NCT03528343|children|children
4654304|NCT03528343|pediatric|pediatric
4654305|NCT03528343|narcotic|narcotic
4654306|NCT03528343|pain control|pain control
4654307|NCT03528304|Obesity|obesity
4654308|NCT03528304|Overweight|overweight
4654309|NCT03528304|Current smoker|current smoker
4654310|NCT03528304|American Indian/Alaska Native|american indian/alaska native
4654311|NCT03528291|Human,|human,
4654312|NCT03528291|adult,|adult,
4654313|NCT03528291|intensive care unit,|intensive care unit,
4654314|NCT03528291|cardiogenic shock,|cardiogenic shock,
4654315|NCT03528291|Transient circulatory support,|transient circulatory support,
4654316|NCT03528291|extra corporeal life support|extra corporeal life support
4654317|NCT03528291|Impella|impella
4654318|NCT03528265|lateral flow immunoassay|lateral flow immunoassay
4654319|NCT03528265|validation|validation
4654320|NCT03528252|cholesterol|cholesterol
4654321|NCT03528252|LDL cholesterol|ldl cholesterol
4654322|NCT03528252|Triglycerides|triglycerides
4654323|NCT03528252|Diet|diet
4654324|NCT03528252|Food|food
4654325|NCT03528252|Lipoproteins|lipoproteins
4654326|NCT03528226|Type 1 diabetes|type 1 diabetes
4654327|NCT03528226|endothelial function|endothelial function
4654328|NCT03528226|exercise training|exercise training
4654329|NCT03528226|physical activity|physical activity
4654330|NCT03528213|sepsis|sepsis
4654331|NCT03528213|fluid balance|fluid balance
4654332|NCT03528213|metabolism|metabolism
4654333|NCT03528213|ischemia-reperfusion|ischemia-reperfusion
4654334|NCT03528213|treatment|treatment
4654335|NCT03528161|hypersensitive troponin|hypersensitive troponin
4654336|NCT03528161|risk of serious adverse events|risk of serious adverse events
4654337|NCT03528161|emergency|emergency
4654338|NCT03528148|Post stroke|post stroke
4654339|NCT03528148|Gait|gait
4654340|NCT03528148|Elliptical cross bike.|elliptical cross bike.
4654341|NCT03528148|Postural control|postural control
4654342|NCT03528148|Balance|balance
4654343|NCT03528122|amniotic membrane|amniotic membrane
4654344|NCT03528122|retinal detachment|retinal detachment
4654345|NCT03528122|Myopic|myopic
4654346|NCT03528122|macular hole|macular hole
4654347|NCT03528122|internal limiting membrane|internal limiting membrane
4654348|NCT03528083|Bronchiolitis|bronchiolitis
4654349|NCT03528083|Children|children
4654350|NCT03528083|Hospital|hospital
4654351|NCT03528070|Sarcoidosis|sarcoidosis
4654352|NCT03528070|Tranilast|tranilast
4654353|NCT03528070|skin|skin
4654354|NCT03528070|lung|lung
4654355|NCT03528057|Kidney|kidney
4654356|NCT03528044|Bariatric surgery|bariatric surgery
4654357|NCT03528044|Reward|reward
4654358|NCT03528044|Cognition|cognition
4654359|NCT03528044|Working memory|working memory
4654360|NCT03528044|Grey matter|grey matter
4654361|NCT03528044|GLP-1|glp-1
4654362|NCT03528044|Inflammation|inflammation
4654363|NCT03528044|Stress|stress
4654366|NCT03528018|Virtual Reality|virtual reality
4654367|NCT03528018|Rehabilitation|rehabilitation
4654368|NCT03528018|Physical therapy|physical therapy
4654369|NCT03528005|Integrated Health Care Systems|integrated health care systems
4654370|NCT03528005|Multimorbid|multimorbid
4654371|NCT03528005|Multi-domain intervention|multi-domain intervention
4654372|NCT03528005|Clinical Trials, Randomized|clinical trials, randomized
4654373|NCT03527992|Randomized Therapeutic trial|randomized therapeutic trial
4654374|NCT03527992|Hypoxemic pneumonia|hypoxemic pneumonia
4654375|NCT03527992|Automated oxygen therapy|automated oxygen therapy
4654376|NCT03527992|Length of stay|length of stay
4654377|NCT03527992|medico-economic cost|medico-economic cost
4654378|NCT03527953|bulk-fill restorative resins, dental caries|bulk-fill restorative resins, dental caries
4654379|NCT03527927|COPD|copd
4654380|NCT03527914|Depression|depression
4654381|NCT03527914|Psychosis|psychosis
4654382|NCT03527914|Personality Disorder|personality disorder
4654383|NCT03527914|Substance Abuse|substance abuse
4654384|NCT03527901|aggressive periodontitis|aggressive periodontitis
4654385|NCT03527901|healthy peri-implant|healthy peri-implant
4654386|NCT03527901|chairside test|chairside test
4654387|NCT03527901|chronic periodontitis|chronic periodontitis
4654388|NCT03527849|Osteoarthritis|osteoarthritis
4654389|NCT03527849|Knee Osteoarthritis|knee osteoarthritis
4654390|NCT03527849|Knee Pain|knee pain
4654391|NCT03527823|Fertilization in Vitro|fertilization in vitro
4654392|NCT03527823|Granulosa Cells|granulosa cells
4654393|NCT03527823|Apoptosis|apoptosis
4654394|NCT03527810|sleeve gastrectomy|sleeve gastrectomy
4654395|NCT03527810|hiatal interrogation|hiatal interrogation
4654396|NCT03527810|GERD|gerd
4654397|NCT03527797|Critical illness associated diaphragm weakness|critical illness associated diaphragm weakness
4654398|NCT03527797|Mechanical ventilation|mechanical ventilation
4654399|NCT03527797|Critical illness|critical illness
4654400|NCT03527797|Respiratory muscle dysfunction|respiratory muscle dysfunction
4654401|NCT03527784|rectal adenocarcinoma|rectal adenocarcinoma
4654402|NCT03527784|abdominoperineal resection|abdominoperineal resection
4654403|NCT03527784|hernia prophylaxis|hernia prophylaxis
4654404|NCT03527758|Biomarkers|biomarkers
4654405|NCT03527758|Hypotension|hypotension
4654406|NCT03527758|Organ Protection|organ protection
4654407|NCT03527758|Intraoperative|intraoperative
4654408|NCT03527719|Hypertension|hypertension
4654409|NCT03527719|Stroke|stroke
4654410|NCT03527719|China|china
4654411|NCT03527719|Protocol-based treatment|protocol-based treatment
4654412|NCT03527693|Knee Chondropathy, Osteoarthritis, Micro-fragmented fat.|knee chondropathy, osteoarthritis, micro-fragmented fat.
4654413|NCT03527628|Stage II B Classical Hodgkin Lymphoma|stage ii b classical hodgkin lymphoma
4654414|NCT03527628|Stage III Classical Hodgkin Lymphoma|stage iii classical hodgkin lymphoma
4654415|NCT03527628|Stage IV Classical Hodgkin Lymphoma|stage iv classical hodgkin lymphoma
4654416|NCT03527602|Apical patency|apical patency
4654417|NCT03527602|Endodontics|endodontics
4654418|NCT03527589|Prostatic Artery Embolization|prostatic artery embolization
4654419|NCT03527589|Benign Prostatic Hyperplasia|benign prostatic hyperplasia
4654420|NCT03527589|Lower Urinary Tract Symptoms|lower urinary tract symptoms
4654421|NCT03527589|PAE|pae
4654422|NCT03527589|BPH|bph
4654423|NCT03527589|LUTS|luts
4654424|NCT03527589|Embolization|embolization
4654425|NCT03527589|Embolic|embolic
4654426|NCT03527589|Embosphere Microsphere|embosphere microsphere
4654427|NCT03527563|Hypertension|hypertension
4654428|NCT03527550|impulsivity|impulsivity
4654429|NCT03527550|Inhibition (Psychology)|inhibition (psychology)
4654430|NCT03527550|Working memory|working memory
4654431|NCT03527550|Cognitive Remediation|cognitive remediation
4654432|NCT03527524|exercise|exercise
4654433|NCT03527472|cognitive dysfunction|cognitive dysfunction
4654434|NCT03527472|memantine|memantine
4654435|NCT03527472|lupus|lupus
4654436|NCT03527446|Metabolic flexibility|metabolic flexibility
4654437|NCT03527446|Insulin sensitivity|insulin sensitivity
4654438|NCT03527446|Sprint interval training|sprint interval training
4654439|NCT03527446|Obesity|obesity
4654440|NCT03527446|Exercise intensity|exercise intensity
4654441|NCT03527433|Incisional hernia|incisional hernia
4654442|NCT03527433|Wound infection|wound infection
4654443|NCT03527433|Midline laparotomy|midline laparotomy
4654444|NCT03527420|Obesity|obesity
4654445|NCT03527420|DNA methylation|dna methylation
4654446|NCT03527420|Exercise|exercise
4654447|NCT03527420|Weight loss|weight loss
4654448|NCT03527420|Bariatric|bariatric
4654449|NCT03527420|Macrovascular|macrovascular
4654450|NCT03527420|Microvascular|microvascular
4654451|NCT03527420|Epigenetics|epigenetics
4654452|NCT03527420|Adipose tissue|adipose tissue
4654453|NCT03527420|Adipocytokines|adipocytokines
4654454|NCT03527420|Inflammation|inflammation
4654455|NCT03527420|Cardiovascular|cardiovascular
4654456|NCT03527394|Obesity|obesity
4654457|NCT03527394|Pediatric|pediatric
4654458|NCT03527394|Parent|parent
4654459|NCT03527394|Family|family
4654460|NCT03527394|Motivational Interviewing|motivational interviewing
4654461|NCT03527394|Lifestyle|lifestyle
4654462|NCT03527394|Health Behavior|health behavior
4654463|NCT03527381|Cardiopulmonary Bypass|cardiopulmonary bypass
4654464|NCT03527381|Nitric Oxide|nitric oxide
4654465|NCT03527381|Kidney Function Tests|kidney function tests
4654466|NCT03527381|Renal Insufficiency|renal insufficiency
4654467|NCT03527381|Protective Agents|protective agents
4654468|NCT03527381|Coronary Artery Bypass|coronary artery bypass
4654469|NCT03527381|Cardiac Surgery|cardiac surgery
4654470|NCT03527355|Typhoid|typhoid
4654471|NCT03527355|Vi-DT|vi-dt
4654472|NCT03527355|Conjugate vaccine|conjugate vaccine
4654473|NCT03527355|First in human|first in human
4654474|NCT03527355|New vaccine|new vaccine
4654475|NCT03527329|Prewarming|prewarming
4654476|NCT03527329|Tympanic temperature|tympanic temperature
4654477|NCT03527303|stress|stress
4654478|NCT03527303|health|health
4654479|NCT03527303|meditation|meditation
4654480|NCT03527303|mindfulness|mindfulness
4654481|NCT03527303|employees|employees
4654482|NCT03527303|job strain|job strain
4654483|NCT03527303|burnout|burnout
4654484|NCT03527303|work|work
4654485|NCT03527303|mood|mood
4654486|NCT03527303|affect|affect
4654487|NCT03527303|work related stress|work related stress
4654488|NCT03527277|orange juice|orange juice
4654489|NCT03527277|sugar-sweetened beverage|sugar-sweetened beverage
4654490|NCT03527277|triglyceride|triglyceride
4654491|NCT03527277|low density lipoprotein cholesterol|low density lipoprotein cholesterol
4654492|NCT03527277|apolipoprotein B|apolipoprotein b
4654493|NCT03527277|uric acid|uric acid
4654494|NCT03527277|de novo lipogenesis|de novo lipogenesis
4654495|NCT03527277|hepatic triglyceride|hepatic triglyceride
4654496|NCT03527277|hepatic glucose production|hepatic glucose production
4654497|NCT03527277|whole body insulin sensitivity|whole body insulin sensitivity
4654498|NCT03527264|cervical cancer|cervical cancer
4654499|NCT03527264|Stage IB|stage ib
4654500|NCT03527264|Stage IIA|stage iia
4654501|NCT03527264|Stage IIB|stage iib
4654502|NCT03527264|Stage IIIA|stage iiia
4654503|NCT03527264|Stage IIIB|stage iiib
4654504|NCT03527264|Stage IVA|stage iva
4654505|NCT03527251|clinical trial, phase I|clinical trial, phase i
4654506|NCT03527251|CTLA-4 antibody|ctla-4 antibody
4654507|NCT03527251|PD-1 antibody|pd-1 antibody
4654508|NCT03527251|non-small cell lung cancer|non-small cell lung cancer
4654509|NCT03527238|Phenotypic Precision Medicine (PPM)|phenotypic precision medicine (ppm)
4654510|NCT03527238|Tacrolimus|tacrolimus
4654511|NCT03527238|Calcineurin Inhibitors|calcineurin inhibitors
4654512|NCT03527225|Music Therapy|music therapy
4654513|NCT03527225|First Radiotherapy|first radiotherapy
4654514|NCT03527225|Anxiety Reduction|anxiety reduction
4654515|NCT03527225|Psychosocial Functioning|psychosocial functioning
4654516|NCT03527225|State - Trait Anxiety Inventory (STAI)|state - trait anxiety inventory (stai)
4654517|NCT03527225|Symptom Distress Thermometer (SDT)|symptom distress thermometer (sdt)
4654518|NCT03527212|Dry Eye Disease|dry eye disease
4654519|NCT03527212|Corneal Epithelial Disorders|corneal epithelial disorders
4654520|NCT03527212|Re-Epithelialization|re-epithelialization
4654521|NCT03527173|Challenge|challenge
4654522|NCT03527173|Efficacy|efficacy
4654523|NCT03527173|Shigellosis|shigellosis
4654524|NCT03527173|Vaccination|vaccination
4654525|NCT03527160|AKI|aki
4654526|NCT03527160|NGAL|ngal
4654527|NCT03527147|Acalabrutinib|acalabrutinib
4654528|NCT03527147|CALQUENCE®|calquence®
4654529|NCT03527147|ACP-196|acp-196
4654530|NCT03527147|Platform study|platform study
4654531|NCT03527147|Master protocol|master protocol
4654532|NCT03527147|PRISM|prism
4654533|NCT03527121|Ankle|ankle
4654534|NCT03527121|Exercise|exercise
4654535|NCT03527121|Activities of daily living|activities of daily living
4654536|NCT03527121|Treatment outcome|treatment outcome
4654537|NCT03527108|Non-small cell lung cancer|non-small cell lung cancer
4654538|NCT03527108|Immunotherapy|immunotherapy
4654539|NCT03527095|Cystic Fibrosis|cystic fibrosis
4654540|NCT03527082|mesh|mesh
4654541|NCT03527082|erosion|erosion
4654542|NCT03527082|transvaginal|transvaginal
4654543|NCT03527082|prolapse|prolapse
4654544|NCT03527082|laparoscopic|laparoscopic
4654545|NCT03527082|tension free tape|tension free tape
4654546|NCT03527056|CRE|cre
4654547|NCT03527030|Tobacco Use|tobacco use
4654548|NCT03527030|IQOS|iqos
4654549|NCT03527017|Tobacco Use|tobacco use
4654550|NCT03527017|IQOS|iqos
4654551|NCT03527004|Tobacco Use|tobacco use
4654552|NCT03527004|IQOS|iqos
4654553|NCT03526991|Freezing of Gait|freezing of gait
4654554|NCT03526991|Locomotion|locomotion
4654555|NCT03526991|Spinal cord stimulation|spinal cord stimulation
4654556|NCT03526978|Sabin strain|sabin strain
4654557|NCT03526978|Inactivated poliovirus vaccine|inactivated poliovirus vaccine
4654558|NCT03526978|poliomyelitis|poliomyelitis
4654559|NCT03526978|safety|safety
4654560|NCT03526978|immunogenicity|immunogenicity
4654561|NCT03526978|infant|infant
4654562|NCT03526939|Persons who inject drugs|persons who inject drugs
4654563|NCT03526939|HIV|hiv
4654564|NCT03526939|Hepatitis C|hepatitis c
4654565|NCT03526939|Vietnam|vietnam
4654566|NCT03526939|Behavioral Intervention|behavioral intervention
4654567|NCT03526926|newly-diagnosed t-AML or AML-MRC|newly-diagnosed t-aml or aml-mrc
4654568|NCT03526913|chronic leg ulcers, PRP|chronic leg ulcers, prp
4654775|NCT03525730|HIV|hiv
4654569|NCT03526913|split-thickness skin graft|split-thickness skin graft
4654570|NCT03526913|platelet-rich plasma|platelet-rich plasma
4654571|NCT03526874|Pain|pain
4654572|NCT03526874|Chronic Migraine|chronic migraine
4654573|NCT03526874|Episodic Migraine|episodic migraine
4654574|NCT03526874|Headache|headache
4654575|NCT03526874|Nerve Block|nerve block
4654576|NCT03526848|3BNC117|3bnc117
4654577|NCT03526848|10-1074|10-1074
4654578|NCT03526848|Broadly Neutralizing Antibody|broadly neutralizing antibody
4654579|NCT03526835|Bispecific antibody|bispecific antibody
4654580|NCT03526835|First-in-human|first-in-human
4654581|NCT03526835|MCLA-158|mcla-158
4654582|NCT03526835|Antibodies|antibodies
4654583|NCT03526835|Bispecific|bispecific
4654584|NCT03526835|immunologic factors|immunologic factors
4654585|NCT03526835|Cytokines|cytokines
4654586|NCT03526835|EGFR|egfr
4654587|NCT03526835|LGR5|lgr5
4654588|NCT03526809|Magnetic resonance imaging|magnetic resonance imaging
4654589|NCT03526796|Pouchitis|pouchitis
4654590|NCT03526796|Hyperbaric oxygen therapy|hyperbaric oxygen therapy
4654591|NCT03526783|Obesity Surgery|obesity surgery
4654592|NCT03526783|Failed Sleeve Gastrectomy|failed sleeve gastrectomy
4654593|NCT03526783|Roux-en-Y gastric bypass|roux-en-y gastric bypass
4654594|NCT03526783|Mini/One anastomosis gastric bypass|mini/one anastomosis gastric bypass
4654595|NCT03526770|pH of saliva|ph of saliva
4654596|NCT03526770|carbonated drink|carbonated drink
4654597|NCT03526770|buffering agent|buffering agent
4654598|NCT03526770|oral hygiene|oral hygiene
4654599|NCT03526757|Postural balance|postural balance
4654600|NCT03526757|Pilates method|pilates method
4654601|NCT03526757|Elderly|elderly
4654602|NCT03526744|Dietary Supplements|dietary supplements
4654603|NCT03526744|Fish Proteins|fish proteins
4654604|NCT03526744|Protein Hydrolysates|protein hydrolysates
4654605|NCT03526744|Aged|aged
4654606|NCT03526718|Transmission|transmission
4654607|NCT03526718|Genotyping|genotyping
4654608|NCT03526718|Risk factors|risk factors
4654609|NCT03526692|Mild cognitive impairment|mild cognitive impairment
4654610|NCT03526692|Neurofeedback|neurofeedback
4654611|NCT03526692|electroencephalography|electroencephalography
4654612|NCT03526692|attention|attention
4654613|NCT03526692|memory|memory
4654614|NCT03526679|soft tissue sarcoma|soft tissue sarcoma
4654615|NCT03526679|phase Ib/II|phase ib/ii
4654616|NCT03526679|advanced cancer|advanced cancer
4654617|NCT03526666|Vitamin C|vitamin c
4654618|NCT03526666|Ascorbic Acid|ascorbic acid
4654619|NCT03526666|Epigenetics|epigenetics
4654620|NCT03526666|5-hydroxymethylcytosine|5-hydroxymethylcytosine
4654621|NCT03526666|5-methylcytosine|5-methylcytosine
4654622|NCT03526627|advanced care management, advanced heart failure|advanced care management, advanced heart failure
4654623|NCT03526601|heart failure|heart failure
4654624|NCT03526601|prevalence|prevalence
4654625|NCT03526588|CDH|cdh
4654626|NCT03526523|Mindfulness based stress reduction|mindfulness based stress reduction
4654627|NCT03526523|Perimenopausal depression|perimenopausal depression
4654628|NCT03526523|Menopause transition|menopause transition
4654629|NCT03526510|High Risk Prostate Cancer|high risk prostate cancer
4654630|NCT03526510|Radiotherapy|radiotherapy
4654631|NCT03526497|Catheterization, Peripheral/methods|catheterization, peripheral/methods
4654632|NCT03526497|Humans|humans
4654633|NCT03526497|Acute Disease|acute disease
4654634|NCT03526497|Aged|aged
4654635|NCT03526497|Female|female
4654636|NCT03526497|Male|male
4654637|NCT03526497|Follow-Up Studies|follow-up studies
4654638|NCT03526497|Heart Failure/physiopathology|heart failure/physiopathology
4654639|NCT03526497|Prospective Studies|prospective studies
4654640|NCT03526497|Stroke Volume/physiology|stroke volume/physiology
4654641|NCT03526497|Venous Pressure/physiology|venous pressure/physiology
4654642|NCT03526484|UTI|uti
4654643|NCT03526484|Urinalysis|urinalysis
4654644|NCT03526484|Urine Culture|urine culture
4654645|NCT03526484|Cystoscopy|cystoscopy
4654646|NCT03526484|BCG treatment|bcg treatment
4654647|NCT03526484|Prostate Biopsy|prostate biopsy
4654648|NCT03526471|Left Atrial Appendage|left atrial appendage
4654649|NCT03526471|Non-valvular atrial fibrillation|non-valvular atrial fibrillation
4654650|NCT03526458|Holmium Laser|holmium laser
4654651|NCT03526458|Laser setting|laser setting
4654652|NCT03526458|Stone fragmentation|stone fragmentation
4654653|NCT03526445|Glucagon|glucagon
4654654|NCT03526445|Stable isotope|stable isotope
4654655|NCT03526445|Energy expenditure|energy expenditure
4654656|NCT03526445|Lipid metabolism|lipid metabolism
4654657|NCT03526445|Glucose metabolism|glucose metabolism
4654658|NCT03526445|Appetite|appetite
4654659|NCT03526419|Liposomal bupivacaine|liposomal bupivacaine
4654660|NCT03526419|TAP block|tap block
4654661|NCT03526419|cesarean section|cesarean section
4654662|NCT03526406|Cognition|cognition
4654663|NCT03526406|Mood|mood
4654664|NCT03526406|Flavonoid|flavonoid
4654665|NCT03526406|Grape Seed|grape seed
4654666|NCT03526406|Catechin|catechin
4654667|NCT03526406|Epicatechin|epicatechin
4654668|NCT03526406|Proanthocyanidin|proanthocyanidin
4654669|NCT03526380|Drug overdose|drug overdose
4654670|NCT03526380|Substance-Related Disorders|substance-related disorders
4654671|NCT03526380|Chemically-Induced Disorders|chemically-induced disorders
4654672|NCT03526380|Risk Reduction Behavior|risk reduction behavior
4654673|NCT03526380|Harm Reduction|harm reduction
4654674|NCT03526354|Schizophrenia|schizophrenia
4654675|NCT03526354|Schizoaffective Disorder|schizoaffective disorder
4654676|NCT03526354|Substance Use Disorders|substance use disorders
4654677|NCT03526354|Alcohol Use Disorder|alcohol use disorder
4654678|NCT03526354|Cannabis Use Disorder|cannabis use disorder
4654679|NCT03526354|Cocaine Use Disorder|cocaine use disorder
4654680|NCT03526354|Heroin Use Disorder|heroin use disorder
4654681|NCT03526328|DCLK1|dclk1
4654682|NCT03526328|Serum Biomarker|serum biomarker
4654683|NCT03526328|Barrett's Esophagus|barrett's esophagus
4654684|NCT03526328|Esophageal Adenocarcinoma|esophageal adenocarcinoma
4654685|NCT03526328|Tumor Stem Cell Marker|tumor stem cell marker
4654686|NCT03526315|CPP-ACP paste|cpp-acp paste
4654687|NCT03526315|Fluoride toothpaste|fluoride toothpaste
4654688|NCT03526315|Combined use of fluoride and CPP-ACP paste|combined use of fluoride and cpp-acp paste
4654689|NCT03526315|MS reduction|ms reduction
4654690|NCT03526315|Antibacterial|antibacterial
4654691|NCT03526315|Children|children
4654692|NCT03526276|Quantitative Laser Fluorescence (QLF)|quantitative laser fluorescence (qlf)
4654693|NCT03526276|CPP-ACP paste|cpp-acp paste
4654694|NCT03526276|Fluoride toothpaste|fluoride toothpaste
4654695|NCT03526276|Combined use of fluoride and CPP-ACP paste|combined use of fluoride and cpp-acp paste
4654696|NCT03526276|Primary teeth|primary teeth
4654697|NCT03526263|Gastric Mucosal Devitalization|gastric mucosal devitalization
4654698|NCT03526263|Obesity|obesity
4654699|NCT03526263|Endoscopic Bariatric Therapies|endoscopic bariatric therapies
4654700|NCT03526263|Bariatric surgery|bariatric surgery
4654701|NCT03526237|diabetes|diabetes
4654702|NCT03526237|prevention|prevention
4654703|NCT03526237|risk|risk
4654704|NCT03526237|obesity|obesity
4654705|NCT03526237|weight loss|weight loss
4654706|NCT03526237|community based|community based
4654707|NCT03526211|Intensive care unit acquired muscle weakness|intensive care unit acquired muscle weakness
4654708|NCT03526211|Cycloergometer|cycloergometer
4654709|NCT03526211|Neuromuscular electrical stimulation|neuromuscular electrical stimulation
4654710|NCT03526211|FES Cycling|fes cycling
4654711|NCT03526198|Force plate|force plate
4654712|NCT03526198|Center of mass|center of mass
4654713|NCT03526159|Herlitz|herlitz
4654714|NCT03526159|Laminin 332|laminin 332
4654715|NCT03526159|Laminin beta 3|laminin beta 3
4654716|NCT03526159|JEB|jeb
4654717|NCT03526133|sleep apnea|sleep apnea
4654718|NCT03526133|polygraph|polygraph
4654719|NCT03526133|home sleep apnea test (HSAT)|home sleep apnea test (hsat)
4654720|NCT03526133|apnea hypopnea index (AHI)|apnea hypopnea index (ahi)
4654721|NCT03526133|oxygen desaturation index (ODI)|oxygen desaturation index (odi)
4654722|NCT03526133|portable monitor|portable monitor
4654723|NCT03526120|Human subjects|human subjects
4654724|NCT03526120|Pistachio snack|pistachio snack
4654725|NCT03526120|Body mass index|body mass index
4654726|NCT03526120|Energy intake|energy intake
4654727|NCT03526120|Fat mass|fat mass
4654728|NCT03526107|flavanol|flavanol
4654729|NCT03526107|ADME|adme
4654730|NCT03526107|polyphenols|polyphenols
4654731|NCT03526107|cocoa|cocoa
4654732|NCT03526107|epicatechin|epicatechin
4654733|NCT03526107|methylxanthine|methylxanthine
4654734|NCT03526107|caffeine|caffeine
4654735|NCT03526094|flavanol|flavanol
4654736|NCT03526094|ADME|adme
4654737|NCT03526094|polyphenols|polyphenols
4654738|NCT03526094|Cocoa|cocoa
4654739|NCT03526094|Banana|banana
4654740|NCT03526094|epicatechin|epicatechin
4654741|NCT03526081|flavone|flavone
4654742|NCT03526081|ADME|adme
4654743|NCT03526081|apigenin|apigenin
4654744|NCT03526081|parsley|parsley
4654745|NCT03526081|chamomile|chamomile
4654746|NCT03526081|polyphenols|polyphenols
4654747|NCT03526016|Sleep Apnea|sleep apnea
4654748|NCT03526016|Acromegaly|acromegaly
4654749|NCT03526016|Transsphenoidal surgery|transsphenoidal surgery
4654750|NCT03526016|Respiratory polygraphy|respiratory polygraphy
4654751|NCT03525964|Individualized treatment|individualized treatment
4654752|NCT03525964|Functional outcome|functional outcome
4654753|NCT03525847|Contrast endosonograpy|contrast endosonograpy
4654754|NCT03525834|TSC|tsc
4654755|NCT03525834|tuberous sclerosis complex|tuberous sclerosis complex
4654756|NCT03525834|AML|aml
4654757|NCT03525834|afinitor|afinitor
4654758|NCT03525834|everolimus|everolimus
4654759|NCT03525834|RAD001|rad001
4654760|NCT03525834|mTOR|mtor
4654761|NCT03525834|kidney|kidney
4654762|NCT03525834|lymphangioleiomyomatosis|lymphangioleiomyomatosis
4654763|NCT03525834|renal angiomyolipoma|renal angiomyolipoma
4654764|NCT03525808|Pancreatic necrosis|pancreatic necrosis
4654765|NCT03525795|Phase 1/2|phase 1/2
4654766|NCT03525795|Oncology|oncology
4654767|NCT03525795|EZH2 Inhibitor|ezh2 inhibitor
4654768|NCT03525782|CAR-T cell therapy|car-t cell therapy
4654769|NCT03525782|MUC+|muc+
4654770|NCT03525782|PD-1 Knockout|pd-1 knockout
4654771|NCT03525782|Non-small cell lung cancer|non-small cell lung cancer
4654772|NCT03525756|cystogram|cystogram
4654773|NCT03525756|Foley catheter|foley catheter
4654774|NCT03525743|Intubation|intubation
4654776|NCT03525730|Latency reversing agents|latency reversing agents
4654777|NCT03525730|HDAC inhibitor|hdac inhibitor
4654778|NCT03525730|BAF inhibitor|baf inhibitor
4654779|NCT03525730|HIV reservoir|hiv reservoir
4654780|NCT03525730|HIV cure|hiv cure
4654781|NCT03525717|healthy volunteers|healthy volunteers
4654782|NCT03525717|metabolism|metabolism
4654783|NCT03525717|fat oxidation|fat oxidation
4654784|NCT03525717|obesity|obesity
4654785|NCT03525717|sleep|sleep
4654786|NCT03525678|Relapsed / refractory multiple myeloma|relapsed / refractory multiple myeloma
4654787|NCT03525678|Antibody-drug conjugate|antibody-drug conjugate
4654788|NCT03525678|Patient-Reported Outcome Version of the Common Term Criteria for Adverse Events|patient-reported outcome version of the common term criteria for adverse events
4654789|NCT03525678|Quality of Life Questionnaire 20-item Multiple Myeloma module|quality of life questionnaire 20-item multiple myeloma module
4654790|NCT03525678|Multiple Myeloma|multiple myeloma
4654791|NCT03525678|Quality of Life Questionnaire 30-item Core module|quality of life questionnaire 30-item core module
4654792|NCT03525665|Follicular lymphoma|follicular lymphoma
4654793|NCT03525665|FDG-PET|fdg-pet
4654794|NCT03525665|Relapse/progression|relapse/progression
4654795|NCT03525652|Prostate Cancer|prostate cancer
4654796|NCT03525652|Therapeutic vaccine|therapeutic vaccine
4654797|NCT03525652|PD-1 knockout|pd-1 knockout
4654798|NCT03525639|Cardiac Magnetic Resonance|cardiac magnetic resonance
4654799|NCT03525639|Acute Myocarditis|acute myocarditis
4654800|NCT03525639|Myocardial Inflammation|myocardial inflammation
4654801|NCT03525626|Tic Disorders|tic disorders
4654802|NCT03525626|Mindfulness|mindfulness
4654803|NCT03525626|Meditation|meditation
4654804|NCT03525626|Online|online
4654805|NCT03525626|Internet-based|internet-based
4654806|NCT03525626|Treatment|treatment
4654807|NCT03525587|Quality Improvement|quality improvement
4654808|NCT03525587|Quality of Life|quality of life
4654809|NCT03525587|Smartphone APP|smartphone app
4654810|NCT03525522|Lichen sclerosus|lichen sclerosus
4654811|NCT03525522|laser|laser
4654812|NCT03525522|Nd:YAG|nd:yag
4654813|NCT03525522|randomized controlled trial|randomized controlled trial
4654814|NCT03525509|Methadone|methadone
4654815|NCT03525509|Morphine|morphine
4654816|NCT03525509|Quantitative sensory testing|quantitative sensory testing
4654817|NCT03525509|Epidural|epidural
4654818|NCT03525496|Iodinated contrast agents|iodinated contrast agents
4654819|NCT03525496|Immediate hypersensitivity reactions|immediate hypersensitivity reactions
4654820|NCT03525496|Reintroduction tests|reintroduction tests
4654821|NCT03525483|ECMO|ecmo
4654822|NCT03525483|Acute renal failure|acute renal failure
4654823|NCT03525470|Hydration|hydration
4654824|NCT03525470|Brain functioning|brain functioning
4654825|NCT03525470|Heart-rate variability|heart-rate variability
4654826|NCT03525457|Glomerular filtration rate|glomerular filtration rate
4654827|NCT03525457|Periodontitis|periodontitis
4654828|NCT03525457|Chronic kidney disease|chronic kidney disease
4654829|NCT03525431|Exome|exome
4654830|NCT03525431|Sequencing|sequencing
4654831|NCT03525431|Clinical Utility|clinical utility
4654832|NCT03525431|Pediatric|pediatric
4654833|NCT03525431|Underrepresented|underrepresented
4654834|NCT03525431|Underserved|underserved
4654835|NCT03525418|Pediatrics|pediatrics
4654836|NCT03525379|Skeletal Muscle Blood Flow|skeletal muscle blood flow
4654837|NCT03525379|(calf muscle) targeted exercise|(calf muscle) targeted exercise
4654838|NCT03525340|Engagement to care, peer navigation, transgender|engagement to care, peer navigation, transgender
4654839|NCT03525327|Dance|dance
4654840|NCT03525301|Short Course Radiotherapy|short course radiotherapy
4654841|NCT03525301|Symptomatic brain metastases|symptomatic brain metastases
4654842|NCT03525262|Erectile dysfunction, Neurovascular, Prostate, Rectal spacer, Radiotherapy|erectile dysfunction, neurovascular, prostate, rectal spacer, radiotherapy
4654843|NCT03525223|23Na MRI|23na mri
4654844|NCT03525197|Muscle Physiology|muscle physiology
4654845|NCT03525197|Nutrition|nutrition
4654846|NCT03525145|Platelet Reactivity|platelet reactivity
4654847|NCT03525145|Thrombotic Events|thrombotic events
4654848|NCT03525119|Vaccine|vaccine
4654849|NCT03525054|Psychotic Disorders|psychotic disorders
4654850|NCT03525054|Diagnosis, Psychiatric|diagnosis, psychiatric
4654851|NCT03525054|Schizophrenia Prodromal|schizophrenia prodromal
4654852|NCT03525054|Ultra High Risk|ultra high risk
4654853|NCT03525054|Prediction Of Psychosis|prediction of psychosis
4654854|NCT03525054|Machine Learning|machine learning
4654855|NCT03525054|Automated Language Analysis|automated language analysis
4654856|NCT03525054|Semantic Coherence|semantic coherence
4654857|NCT03525054|Syntaxic Complexity|syntaxic complexity
4654858|NCT03524989|hbot|hbot
4654859|NCT03524989|hyperbaric oxygen|hyperbaric oxygen
4654860|NCT03524989|sport|sport
4654861|NCT03524989|mitochondria|mitochondria
4654862|NCT03524989|athletes|athletes
4654863|NCT03524989|aerobic|aerobic
4654864|NCT03524976|endovascular treatment|endovascular treatment
4654865|NCT03524976|liquid embolization|liquid embolization
4654866|NCT03524950|stress|stress
4654867|NCT03524950|dexmedetomidine|dexmedetomidine
4654868|NCT03524937|Delirium|delirium
4654869|NCT03524937|Mechanical ventilation|mechanical ventilation
4654870|NCT03524937|Intensive care unit|intensive care unit
4654871|NCT03524937|Prevention|prevention
4654872|NCT03524937|Pharmacokinetics|pharmacokinetics
4654873|NCT03524937|Melatonin|melatonin
4654874|NCT03524924|atrial fibrillation|atrial fibrillation
4654875|NCT03524924|elderly|elderly
4654876|NCT03524924|edoxaban|edoxaban
4654877|NCT03524924|frailty|frailty
4654878|NCT03524924|SHARE-FI|share-fi
4654879|NCT03524924|Stroke|stroke
4654880|NCT03524924|Major bleeding|major bleeding
4654881|NCT03524911|Nutrition education|nutrition education
4654882|NCT03524911|Evaluation|evaluation
4654883|NCT03524911|Child diet|child diet
4654884|NCT03524911|EFNEP|efnep
4654885|NCT03524898|Nab-Paclitaxel|nab-paclitaxel
4654886|NCT03524898|Gemcitabine|gemcitabine
4654887|NCT03524898|Advanced soft tissue sarcoma|advanced soft tissue sarcoma
4654888|NCT03524898|Cancer|cancer
4654889|NCT03524898|Sarcoma|sarcoma
4654890|NCT03524898|Abraxane®|abraxane®
4654891|NCT03524859|Cystic Fibrosis|cystic fibrosis
4654892|NCT03524859|Sit-to-stand|sit-to-stand
4654893|NCT03524859|Lung Function|lung function
4654894|NCT03524859|Handgrip|handgrip
4654895|NCT03524859|Walking Speed|walking speed
4654896|NCT03524859|Power|power
4654897|NCT03524859|Velocity|velocity
4654898|NCT03524859|Gait Speed|gait speed
4654899|NCT03524859|Chair rise|chair rise
4654900|NCT03524846|Ascorbic acid|ascorbic acid
4654901|NCT03524846|hemodialysis vascular access|hemodialysis vascular access
4654902|NCT03524846|restenosis|restenosis
4654903|NCT03524833|Lansoprazole, Amoxicillin, Metronidazole|lansoprazole, amoxicillin, metronidazole
4654904|NCT03524820|cetuximab, colon cancer, RAS|cetuximab, colon cancer, ras
4654905|NCT03524807|pelvic floor muscle electrophysiologic therapy|pelvic floor muscle electrophysiologic therapy
4654906|NCT03524807|enhanced recovery|enhanced recovery
4654907|NCT03524807|muscle soreness|muscle soreness
4654908|NCT03524807|postoperative retention of urine|postoperative retention of urine
4654909|NCT03524807|Intrauterine Adhesions|intrauterine adhesions
4654910|NCT03524807|enhanced recovery after gynecologic surgery|enhanced recovery after gynecologic surgery
4654911|NCT03524781|Anti-reflux surgery|anti-reflux surgery
4654912|NCT03524781|Proton-pump inhibitors|proton-pump inhibitors
4654913|NCT03524781|Upper endoscopy|upper endoscopy
4654914|NCT03524768|endothelial function, microvascular|endothelial function, microvascular
4654915|NCT03524768|laser speckle contrast imaging|laser speckle contrast imaging
4654916|NCT03524768|capillaroscopy, skin|capillaroscopy, skin
4654917|NCT03524742|Diet|diet
4654918|NCT03524742|Cholesterol|cholesterol
4654919|NCT03524729|Rocker bottom shoe|rocker bottom shoe
4654920|NCT03524729|Ankle-foot orthosis|ankle-foot orthosis
4654921|NCT03524729|Ankle osteoarthritis|ankle osteoarthritis
4654922|NCT03524716|physical activity|physical activity
4654923|NCT03524716|digital health|digital health
4654924|NCT03524716|text messages|text messages
4654925|NCT03524716|intervention|intervention
4654926|NCT03524716|exercise|exercise
4654927|NCT03524716|randomized|randomized
4654928|NCT03524716|Fitbit|fitbit
4654929|NCT03524703|dysphagia|dysphagia
4654930|NCT03524703|anterior cervical fusion|anterior cervical fusion
4654931|NCT03524703|chewing gum|chewing gum
4654932|NCT03524677|pancreatic cancer|pancreatic cancer
4654933|NCT03524677|liquid biopsy|liquid biopsy
4654934|NCT03524677|vascular invasion|vascular invasion
4654935|NCT03524677|early recurrence|early recurrence
4654936|NCT03524651|Iron Deficiency Anemia|iron deficiency anemia
4654937|NCT03524651|Fe-ASP|fe-asp
4654938|NCT03524651|Casein|casein
4654939|NCT03524651|Iron protein acetyl aspartate|iron protein acetyl aspartate
4654940|NCT03524651|Restoration of decreased hemoglobin|restoration of decreased hemoglobin
4654941|NCT03524651|Ferrous sulfate|ferrous sulfate
4654942|NCT03524612|Thrombocytopenic|thrombocytopenic
4654943|NCT03524612|Immune|immune
4654944|NCT03524612|Platelets|platelets
4654945|NCT03524612|Bleeding|bleeding
4654946|NCT03524612|ITP|itp
4654947|NCT03524612|eltrombopag|eltrombopag
4654948|NCT03524612|ETB115|etb115
4654949|NCT03524612|induce sustained remission|induce sustained remission
4654950|NCT03524612|refractory or relapsed|refractory or relapsed
4654951|NCT03524612|first-line steroids|first-line steroids
4654952|NCT03524599|Heavy drinking|heavy drinking
4654953|NCT03524599|Primary health care|primary health care
4654954|NCT03524599|Training|training
4654955|NCT03524599|Community|community
4654956|NCT03524560|comprehensive geriatric assesment, polypharmacy,geriatric depression scale,neutrophil/lymphocyte ratio|comprehensive geriatric assesment, polypharmacy,geriatric depression scale,neutrophil/lymphocyte ratio
4654957|NCT03524482|culturally specific|culturally specific
4654958|NCT03524456|home blood pressure monitoring|home blood pressure monitoring
4654959|NCT03524456|sms|sms
4654960|NCT03524456|primary care|primary care
4654961|NCT03524443|Affective symptom|affective symptom
4654962|NCT03524443|Art Therapy|art therapy
4654963|NCT03524443|alexithymia|alexithymia
4654964|NCT03524443|emotional disturbance|emotional disturbance
4654965|NCT03524443|hyperphagia|hyperphagia
4654966|NCT03524443|psychotherapy|psychotherapy
4654967|NCT03524443|rehabilitation|rehabilitation
4654968|NCT03524443|factor of resistance|factor of resistance
4654969|NCT03524430|Early breast cancer|early breast cancer
4654970|NCT03524417|Rabies immunoglobulin|rabies immunoglobulin
4654971|NCT03524378|repetitive strain|repetitive strain
4654972|NCT03524378|ergonomics|ergonomics
4654973|NCT03524378|participatory ergonomics|participatory ergonomics
4654974|NCT03524378|chronic low back pain|chronic low back pain
4654975|NCT03524378|seafood workers|seafood workers
4654976|NCT03524352|recurrent pouchitis|recurrent pouchitis
4654977|NCT03524352|fecal microbiota transplant|fecal microbiota transplant
4654978|NCT03524326|cetuximab|cetuximab
4654979|NCT03524326|Lenvatinib|lenvatinib
4654980|NCT03524326|Memorial Sloan Kettering Cancer Center|memorial sloan kettering cancer center
4654981|NCT03524326|17-635|17-635
4654982|NCT03524313|cardiac output|cardiac output
4654983|NCT03524313|end tidal carbon monoxide|end tidal carbon monoxide
4654984|NCT03524313|echocardiography|echocardiography
4654985|NCT03524313|intensive care|intensive care
4654986|NCT03524300|Stomach Neoplasm|stomach neoplasm
4654987|NCT03524300|Robotic Surgery|robotic surgery
4654988|NCT03524300|Total Gastrectomy|total gastrectomy
4654989|NCT03524287|Stomach Neoplasms|stomach neoplasms
4654990|NCT03524287|Robotic Surgery|robotic surgery
4654991|NCT03524287|Spleen-Preserving|spleen-preserving
4654992|NCT03524287|No.10 Lymph Node Dissection|no.10 lymph node dissection
4654993|NCT03524274|PD-1 activated CIK|pd-1 activated cik
4654994|NCT03524274|MUC1|muc1
4654995|NCT03524274|bispecific antibody|bispecific antibody
4654996|NCT03524274|Colorectal Cancer|colorectal cancer
4654997|NCT03524261|activated CIK|activated cik
4654998|NCT03524261|MUC1|muc1
4654999|NCT03524261|bispecific antibody|bispecific antibody
4655000|NCT03524261|breast cancer|breast cancer
4655001|NCT03524235|Relapsed/Refractory Lymphoma|relapsed/refractory lymphoma
4655002|NCT03524235|Multiple Myeloma|multiple myeloma
4655003|NCT03524235|CLL|cll
4655004|NCT03524235|Bendamustine|bendamustine
4655005|NCT03524235|Haploidentical Stem Cell Transplantation|haploidentical stem cell transplantation
4655006|NCT03524235|GVHD|gvhd
4655007|NCT03524235|Allogeneic Stem Cell Transplantation|allogeneic stem cell transplantation
4655008|NCT03524235|Natural Killer Cell|natural killer cell
4655009|NCT03524235|CliniMACS|clinimacs
4655010|NCT03524235|Post-transplantation cyclophosphamide|post-transplantation cyclophosphamide
4655011|NCT03524235|Donor Lymphocyte Infusion|donor lymphocyte infusion
4655012|NCT03524235|Minimal Residual Disease|minimal residual disease
4655013|NCT03524209|Spondylodiscitis|spondylodiscitis
4655014|NCT03524209|spinal infection|spinal infection
4655015|NCT03524209|back pain|back pain
4655016|NCT03524209|quality of life|quality of life
4655017|NCT03524209|fusion|fusion
4655018|NCT03524209|minimal invasive surgery|minimal invasive surgery
4655019|NCT03524209|brace treatment|brace treatment
4655020|NCT03524170|Malignant neoplasm of breast|malignant neoplasm of breast
4655021|NCT03524170|Metastatic HR+/HER2- breast cancer|metastatic hr+/her2- breast cancer
4655022|NCT03524170|M7824|m7824
4655023|NCT03524170|MSB0011359C|msb0011359c
4655024|NCT03524170|Radiation therapy|radiation therapy
4655025|NCT03524170|XRT|xrt
4655026|NCT03524170|External beam radiation therapy|external beam radiation therapy
4655027|NCT03524157|Humylub PF|humylub pf
4655028|NCT03524157|artificial tears|artificial tears
4655029|NCT03524157|Ophthalmic lubricant|ophthalmic lubricant
4655030|NCT03524157|Chondroitin sulfate|chondroitin sulfate
4655031|NCT03524157|Sodium hyaluronate|sodium hyaluronate
4655032|NCT03524105|Socio Economic Adversity|socio economic adversity
4655033|NCT03524105|Child Development|child development
4655034|NCT03524105|Poverty|poverty
4655035|NCT03524105|racial disparity|racial disparity
4655036|NCT03524105|ethnic disparity|ethnic disparity
4655037|NCT03524092|Interleukin-23 (IL-23)|interleukin-23 (il-23)
4655038|NCT03524092|IL-23p19|il-23p19
4655039|NCT03524092|Inflammatory Bowel Disease|inflammatory bowel disease
4655040|NCT03524040|Selective Photothermolysis|selective photothermolysis
4655041|NCT03524040|Reflectance Confocal Microscopy|reflectance confocal microscopy
4655042|NCT03524040|Optical Coherence Tomography|optical coherence tomography
4655043|NCT03524040|Pilosebaceous Unit|pilosebaceous unit
4655044|NCT03524040|Gold Microparticles|gold microparticles
4655045|NCT03524027|Vertebral Column Resection|vertebral column resection
4655046|NCT03524027|Congenital Spinal Deformity|congenital spinal deformity
4655047|NCT03524027|Congenital Thoracolumbar Kyphoscoliosis|congenital thoracolumbar kyphoscoliosis
4655048|NCT03523988|Pre-emptive analgesics|pre-emptive analgesics
4655049|NCT03523988|Acetaminophen|acetaminophen
4655050|NCT03523988|Ibuprofen|ibuprofen
4655051|NCT03523962|Surgical Site Infection|surgical site infection
4655052|NCT03523962|Open Fracture|open fracture
4655053|NCT03523962|Lower Extremity Fracture|lower extremity fracture
4655054|NCT03523962|Pelvis; Fracture|pelvis; fracture
4655055|NCT03523962|DuraPrep|duraprep
4655056|NCT03523962|ChloraPrep|chloraprep
4655057|NCT03523962|Peri-operative Preparation Solutions|peri-operative preparation solutions
4655058|NCT03523949|Pain Neuroscience Education|pain neuroscience education
4655059|NCT03523949|Elderly|elderly
4655060|NCT03523949|Pain Education|pain education
4655061|NCT03523936|antibiotics, prebiotics, dysbiosis|antibiotics, prebiotics, dysbiosis
4655062|NCT03523923|Collaborative Care|collaborative care
4655063|NCT03523923|Effectiveness Study|effectiveness study
4655187|NCT03522948|sexual risk behavior|sexual risk behavior
4655162|NCT03523130|Arterial inflammation|arterial inflammation
4655163|NCT03523130|Neuroinflammation|neuroinflammation
4655064|NCT03523845|"early apical peri-implantitis; implant periapical lesion; retrograde peri-implantitis; implant failure"|"early apical peri-implantitis; implant periapical lesion; retrograde peri-implantitis; implant failure"
4655065|NCT03523819|Solid Tumors|solid tumors
4655066|NCT03523793|Outpatient Physical Therapy|outpatient physical therapy
4655067|NCT03523754|Induction of labor|induction of labor
4655068|NCT03523754|isosorbide mononitrate|isosorbide mononitrate
4655069|NCT03523754|misoprostol|misoprostol
4655070|NCT03523741|genetic polymorphism|genetic polymorphism
4655071|NCT03523741|pharmacodynamic variability|pharmacodynamic variability
4655072|NCT03523741|personalized pharmacotherapy|personalized pharmacotherapy
4655073|NCT03523741|adverse drug reaction|adverse drug reaction
4655074|NCT03523741|quality of life|quality of life
4655075|NCT03523689|Malignant neoplasms of respiratory and intrathoracic organs|malignant neoplasms of respiratory and intrathoracic organs
4655076|NCT03523689|Endobronchial ultrasound-guided transbronchial needle aspiration|endobronchial ultrasound-guided transbronchial needle aspiration
4655077|NCT03523689|EBUS-TBNA|ebus-tbna
4655078|NCT03523624|factor XIII|factor xiii
4655079|NCT03523624|intramyocardial haemorrhage|intramyocardial haemorrhage
4655080|NCT03523624|microvascular injury|microvascular injury
4655081|NCT03523624|STEMI|stemi
4655082|NCT03523624|cardiac magnetic resonance|cardiac magnetic resonance
4655083|NCT03523611|lung cancer|lung cancer
4655084|NCT03523611|Ventricular Failure|ventricular failure
4655085|NCT03523585|Breast Cancer|breast cancer
4655086|NCT03523585|Metastatic breast cancer|metastatic breast cancer
4655087|NCT03523585|DS 8201a|ds 8201a
4655088|NCT03523572|Human epidermal growth factor receptor-2|human epidermal growth factor receptor-2
4655089|NCT03523572|HER2|her2
4655090|NCT03523572|Refractory|refractory
4655091|NCT03523572|Metastatic|metastatic
4655092|NCT03523572|Urothelial cancer|urothelial cancer
4655093|NCT03523572|Breast Cancer|breast cancer
4655094|NCT03523520|constipation|constipation
4655095|NCT03523520|opioid|opioid
4655096|NCT03523507|Repetitive Transcranial Magnetic Stimulation|repetitive transcranial magnetic stimulation
4655097|NCT03523507|Military|military
4655098|NCT03523468|VATS|vats
4655099|NCT03523468|Lung Cancer|lung cancer
4655100|NCT03523455|Iron|iron
4655101|NCT03523455|Exercise Performance|exercise performance
4655102|NCT03523455|Fatigue|fatigue
4655103|NCT03523403|Obesity|obesity
4655104|NCT03523403|Diet|diet
4655105|NCT03523403|Apples|apples
4655106|NCT03523403|Polyphenols|polyphenols
4655107|NCT03523403|Soluble fibre|soluble fibre
4655108|NCT03523403|Blood lipids|blood lipids
4655109|NCT03523403|Lipid digestion|lipid digestion
4655110|NCT03523403|Inflammation|inflammation
4655111|NCT03523403|Cytokines|cytokines
4655112|NCT03523403|Microbiota|microbiota
4655113|NCT03523403|Dysbiosis|dysbiosis
4655114|NCT03523403|Type 2 diabetes risk|type 2 diabetes risk
4655115|NCT03523403|Cardiovascular disease risk|cardiovascular disease risk
4655116|NCT03523390|Metastatic Solid Tumors|metastatic solid tumors
4655117|NCT03523390|Avelumab|avelumab
4655118|NCT03523390|MSB0010718C|msb0010718c
4655119|NCT03523377|Fasting|fasting
4655120|NCT03523377|18-199|18-199
4655121|NCT03523351|Palliative Radiation|palliative radiation
4655122|NCT03523351|18-196|18-196
4655123|NCT03523325|Tendinopathy|tendinopathy
4655124|NCT03523325|Tendon|tendon
4655125|NCT03523325|Rehabilitation|rehabilitation
4655126|NCT03523325|Exercise treatment|exercise treatment
4655127|NCT03523312|Ablative Irradiation|ablative irradiation
4655128|NCT03523312|18-090|18-090
4655129|NCT03523299|invasive ductal carcinoma|invasive ductal carcinoma
4655130|NCT03523299|breast cancer|breast cancer
4655131|NCT03523299|cryoablation|cryoablation
4655132|NCT03523286|Catheter ablation|catheter ablation
4655133|NCT03523286|ECG imaging|ecg imaging
4655134|NCT03523247|Cholesterol|cholesterol
4655135|NCT03523247|LDL|ldl
4655136|NCT03523247|HDL|hdl
4655137|NCT03523247|triglycerides|triglycerides
4655138|NCT03523247|c-reactive protein|c-reactive protein
4655139|NCT03523247|whole food diet|whole food diet
4655140|NCT03523247|plant based diet|plant based diet
4655141|NCT03523247|community based enrollment|community based enrollment
4655142|NCT03523234|neoadjuvant therapy|neoadjuvant therapy
4655143|NCT03523234|surgery|surgery
4655144|NCT03523182|Micronutrient supplementation|micronutrient supplementation
4655145|NCT03523182|Home fortification|home fortification
4655146|NCT03523182|Spirulina|spirulina
4655147|NCT03523182|Zambia|zambia
4655148|NCT03523169|Septic associated encephalopathy|septic associated encephalopathy
4655149|NCT03523169|Cerebral oxygenation|cerebral oxygenation
4655150|NCT03523169|Prognosis|prognosis
4655151|NCT03523169|Passive leg raising|passive leg raising
4655152|NCT03523156|Antibiotics|antibiotics
4655153|NCT03523156|Infectious diseases|infectious diseases
4655154|NCT03523156|Tropical medicine|tropical medicine
4655155|NCT03523156|Public health|public health
4655156|NCT03523143|early screening|early screening
4655157|NCT03523143|early intervention|early intervention
4655158|NCT03523143|gestational diabetes mellitus|gestational diabetes mellitus
4655159|NCT03523143|pregnancy outcomes|pregnancy outcomes
4655160|NCT03523143|randomized controlled trial|randomized controlled trial
4655161|NCT03523130|Macrophage-specific inflammation|macrophage-specific inflammation
4655164|NCT03523130|SPECT/CT|spect/ct
4655165|NCT03523130|Tilmanocept|tilmanocept
4655166|NCT03523091|OnabotulinumtoxinA|onabotulinumtoxina
4655167|NCT03523091|Bladder Injections|bladder injections
4655168|NCT03523039|Cardiac Arrest|cardiac arrest
4655169|NCT03523039|Cytokine Hemoadsorption|cytokine hemoadsorption
4655170|NCT03523026|Metabolic Syndrome|metabolic syndrome
4655171|NCT03523026|Coronary Artery Patients|coronary artery patients
4655172|NCT03523026|Neuromuscular Electrical Stimulation,|neuromuscular electrical stimulation,
4655173|NCT03523026|Respiratory Muscle Training|respiratory muscle training
4655174|NCT03523026|Peripheral Muscle Training|peripheral muscle training
4655175|NCT03523000|intractable chronic low back pain|intractable chronic low back pain
4655176|NCT03523000|lumbar post-laminectomy syndrome|lumbar post-laminectomy syndrome
4655177|NCT03523000|vertebral compression fracture|vertebral compression fracture
4655178|NCT03523000|intrathecal drug delivery system|intrathecal drug delivery system
4655179|NCT03522987|Neurologic Disorders|neurologic disorders
4655180|NCT03522987|Chronic Care|chronic care
4655181|NCT03522987|Management|management
4655182|NCT03522987|Treatment|treatment
4655183|NCT03522987|SSRI Medication|ssri medication
4655184|NCT03522987|SNRI Medication|snri medication
4655185|NCT03522987|Learning Healthcare System|learning healthcare system
4655186|NCT03522948|heavy drinking|heavy drinking
4655188|NCT03522922|Acne scars|acne scars
4655189|NCT03522922|dermaroller|dermaroller
4655190|NCT03522922|vitamin C|vitamin c
4655191|NCT03522909|obstetric anesthesia|obstetric anesthesia
4655192|NCT03522909|telemedicine|telemedicine
4655193|NCT03522883|Martial Arts|martial arts
4655194|NCT03522870|Flash glucose monitoring system|flash glucose monitoring system
4655195|NCT03522870|FGMS|fgms
4655196|NCT03522844|mindfulness|mindfulness
4655197|NCT03522844|escitalopram|escitalopram
4655198|NCT03522844|anxiety|anxiety
4655199|NCT03522831|dyspnea|dyspnea
4655200|NCT03522831|exercise endurance|exercise endurance
4655201|NCT03522831|lung disease|lung disease
4655202|NCT03522805|copd|copd
4655203|NCT03522805|lung|lung
4655204|NCT03522805|non-invasive ventilation|non-invasive ventilation
4655205|NCT03522805|hypercapnia|hypercapnia
4655206|NCT03522805|hypoventilation|hypoventilation
4655207|NCT03522792|food intake|food intake
4655208|NCT03522792|appetite|appetite
4655209|NCT03522792|obesity treatment|obesity treatment
4655210|NCT03522792|neurotensin|neurotensin
4655211|NCT03522792|gastrointestinal|gastrointestinal
4655212|NCT03522792|peptide|peptide
4655213|NCT03522740|Chronic Kidney Disease|chronic kidney disease
4655214|NCT03522740|Chronic Kidney Failure|chronic kidney failure
4655215|NCT03522740|Palliative Care|palliative care
4655216|NCT03522740|Dialysis|dialysis
4655217|NCT03522740|End-of-life care|end-of-life care
4655218|NCT03522740|Decision making|decision making
4655219|NCT03522714|support surface, pressure ulcer, flap closure|support surface, pressure ulcer, flap closure
4655220|NCT03522701|Adolescents|adolescents
4655221|NCT03522701|Youth|youth
4655222|NCT03522701|Insomnia|insomnia
4655223|NCT03522688|dexmedetomidine|dexmedetomidine
4655224|NCT03522688|acute kidney injury|acute kidney injury
4655225|NCT03522688|liver transplantation|liver transplantation
4655226|NCT03522649|CRC|crc
4655227|NCT03522636|Prehospital transfusion|prehospital transfusion
4655228|NCT03522636|Trauma|trauma
4655229|NCT03522636|Trauma induced coagulopathy|trauma induced coagulopathy
4655230|NCT03522623|colitis, costs, Crohn, pediatrics|colitis, costs, crohn, pediatrics
4655231|NCT03522610|Prevention|prevention
4655232|NCT03522610|Military Families|military families
4655233|NCT03522610|Parenting|parenting
4655234|NCT03522597|Obesity|obesity
4655235|NCT03522597|Gestational Diabetes|gestational diabetes
4655236|NCT03522597|Breast Milk|breast milk
4655237|NCT03522597|Microbiome|microbiome
4655238|NCT03522597|Infant Growth|infant growth
4655239|NCT03522545|treatment-resistant bipolar depression|treatment-resistant bipolar depression
4655240|NCT03522545|bipolar disorder|bipolar disorder
4655241|NCT03522545|manic depression|manic depression
4655242|NCT03522532|dental restorations|dental restorations
4655243|NCT03522532|gingival crevicular fluid|gingival crevicular fluid
4655244|NCT03522532|glutathione|glutathione
4655245|NCT03522532|lipid peroxidation|lipid peroxidation
4655246|NCT03522532|superoxide dismutase|superoxide dismutase
4655247|NCT03522519|Physical Activity|physical activity
4655248|NCT03522519|Upper Extremity|upper extremity
4655249|NCT03522519|Movement Sensors|movement sensors
4655250|NCT03522519|Prognosis|prognosis
4655251|NCT03522519|Observational Cohort Study|observational cohort study
4655252|NCT03522506|Drug Therapy|drug therapy
4655253|NCT03522480|cystic fibrosis|cystic fibrosis
4655254|NCT03522480|autogenic drainage|autogenic drainage
4655255|NCT03522480|respiratory therapy|respiratory therapy
4655256|NCT03522480|videogaming therapy|videogaming therapy
4655257|NCT03522467|Cannabis oil|cannabis oil
4655258|NCT03522467|Cannabis|cannabis
4655259|NCT03522467|Pain|pain
4655260|NCT03522467|Cancer|cancer
4655261|NCT03522454|Frailty|frailty
4655262|NCT03522454|TAVR|tavr
4655263|NCT03522428|vitamin b12|vitamin b12
4655264|NCT03522428|pregnancy|pregnancy
4655265|NCT03522428|anemia|anemia
4655670|NCT03520348|PRO-167|pro-167
4655266|NCT03522402|head position|head position
4655267|NCT03522402|obstructive airway|obstructive airway
4655268|NCT03522402|minimum alveolar concentration(MACendotracheal intubation)|minimum alveolar concentration(macendotracheal intubation)
4655269|NCT03522402|sevoflurane concentration|sevoflurane concentration
4655270|NCT03522389|Action Observation Training|action observation training
4655271|NCT03522389|Gait|gait
4655272|NCT03522363|oral health|oral health
4655273|NCT03522363|Streptococcus dentisani|streptococcus dentisani
4655274|NCT03522350|Infertility|infertility
4655275|NCT03522350|Embryo develpoment|embryo develpoment
4655276|NCT03522350|IVF|ivf
4655277|NCT03522350|ICSI|icsi
4655278|NCT03522350|EmbryoScope|embryoscope
4655279|NCT03522337|preschool children|preschool children
4655280|NCT03522337|special needs|special needs
4655281|NCT03522337|tooth brushing|tooth brushing
4655282|NCT03522337|social story|social story
4655283|NCT03522337|visual pedagogy|visual pedagogy
4655284|NCT03522324|Cannabis|cannabis
4655285|NCT03522324|Pain|pain
4655286|NCT03522324|Cytokines|cytokines
4655287|NCT03522324|Inflammation|inflammation
4655288|NCT03522324|Cognition|cognition
4655289|NCT03522298|newly diagnosed|newly diagnosed
4655290|NCT03522298|unmethylated O6 methylguanine-methyltransferase (MGMT) promoter status|unmethylated o6 methylguanine-methyltransferase (mgmt) promoter status
4655291|NCT03522285|hip arthroplasty|hip arthroplasty
4655292|NCT03522285|chronic renal diseases|chronic renal diseases
4655293|NCT03522272|denture|denture
4655294|NCT03522272|removable partial denture|removable partial denture
4655295|NCT03522272|denture cleansers|denture cleansers
4655296|NCT03522272|ultrasonics|ultrasonics
4655297|NCT03522272|cetylpyridinium chloride|cetylpyridinium chloride
4655298|NCT03522272|Staphylococcus aureus|staphylococcus aureus
4655299|NCT03522272|Gram negative bacilli|gram negative bacilli
4655300|NCT03522272|Candida|candida
4655301|NCT03522272|yeast|yeast
4655302|NCT03522259|Rivaroxaban|rivaroxaban
4655303|NCT03522259|Thromboembolic prophylaxis|thromboembolic prophylaxis
4655304|NCT03522259|Venous thromboembolism|venous thromboembolism
4655305|NCT03522246|PARP inhibitor|parp inhibitor
4655306|NCT03522246|PARPi|parpi
4655307|NCT03522246|HRD|hrd
4655308|NCT03522246|ATHENA|athena
4655309|NCT03522246|homologous recombination|homologous recombination
4655310|NCT03522246|DNA repair|dna repair
4655311|NCT03522246|LOH|loh
4655312|NCT03522246|DNA defect|dna defect
4655313|NCT03522246|DNA anomaly|dna anomaly
4655314|NCT03522246|Rucaparib|rucaparib
4655315|NCT03522246|Nivolumab|nivolumab
4655316|NCT03522246|PD-1|pd-1
4655317|NCT03522246|Immuno-|immuno-
4655318|NCT03522246|oncology|oncology
4655319|NCT03522246|Tumor|tumor
4655320|NCT03522246|mutational|mutational
4655321|NCT03522246|burden|burden
4655322|NCT03522246|BRCA|brca
4655323|NCT03522155|Conjoint Analysis|conjoint analysis
4655324|NCT03522155|Life Expectancy|life expectancy
4655325|NCT03522155|Patient-centered|patient-centered
4655326|NCT03522142|Advanced solid tumors|advanced solid tumors
4655327|NCT03522142|AXL|axl
4655328|NCT03522142|MER|mer
4655329|NCT03522142|AXL/MER|axl/mer
4655330|NCT03522129|Alzheimer's Disease|alzheimer's disease
4655331|NCT03522103|Cannabis|cannabis
4655332|NCT03522103|Marijuana|marijuana
4655333|NCT03522103|Cognition|cognition
4655334|NCT03522077|Angiogram|angiogram
4655335|NCT03522077|Hemostatic|hemostatic
4655336|NCT03522077|Activated clotting time|activated clotting time
4655337|NCT03522077|Quality of Life|quality of life
4655338|NCT03522064|Castrate-resistant prostate cancer|castrate-resistant prostate cancer
4655339|NCT03522064|bipolar androgen therapy|bipolar androgen therapy
4655340|NCT03522064|homologous recombination deficiency|homologous recombination deficiency
4655341|NCT03522064|BRCA|brca
4655342|NCT03522051|teeth|teeth
4655343|NCT03522051|pulpitis|pulpitis
4655344|NCT03522051|deep caries|deep caries
4655345|NCT03522051|pulpotomy|pulpotomy
4655346|NCT03522051|Mineral Trioxide Aggregate (MTA)|mineral trioxide aggregate (mta)
4655347|NCT03522038|coronary chronic total occlusion|coronary chronic total occlusion
4655348|NCT03522038|functional evaluation|functional evaluation
4655349|NCT03522012|Pharmacokinetics|pharmacokinetics
4655350|NCT03522012|Tocilizumab|tocilizumab
4655351|NCT03521999|PTSD|ptsd
4655352|NCT03521999|peer resource|peer resource
4655353|NCT03521999|Veterans|veterans
4655354|NCT03521999|web-based intervention|web-based intervention
4655355|NCT03521999|digital story telling|digital story telling
4655356|NCT03521986|Mediastinal Neoplasms|mediastinal neoplasms
4655357|NCT03521986|Pain|pain
4655358|NCT03521986|Quality of life|quality of life
4655359|NCT03521973|Plasmodium falciparum|plasmodium falciparum
4655360|NCT03521973|PfSPZ Vaccine|pfspz vaccine
4655361|NCT03521960|Buspirone|buspirone
4655362|NCT03521947|MCP|mcp
4655363|NCT03521856|spinal cord injuries|spinal cord injuries
4655364|NCT03521856|SCI|sci
4655365|NCT03521843|femoropopliteal occlusive disease|femoropopliteal occlusive disease
4655366|NCT03521843|local drug delivery|local drug delivery
4655367|NCT03521843|endovascular treatment|endovascular treatment
4655368|NCT03521804|Chronic Total Occlusion|chronic total occlusion
4655369|NCT03521804|coronary|coronary
4655370|NCT03521804|SoundBite™ Crossing System|soundbite™ crossing system
4655371|NCT03521804|CTO|cto
4655372|NCT03521804|distal cap|distal cap
4655373|NCT03521804|true lumen|true lumen
4655374|NCT03521804|Active wire|active wire
4655375|NCT03521804|Device|device
4655376|NCT03521804|Procedure|procedure
4655377|NCT03521804|Stenosis|stenosis
4655378|NCT03521804|CAD|cad
4655379|NCT03521804|Coronary Artery Disease|coronary artery disease
4655380|NCT03521791|zebesten|zebesten
4655381|NCT03521791|ocular anti-inflammatory|ocular anti-inflammatory
4655382|NCT03521791|ocular analgesic|ocular analgesic
4655383|NCT03521791|pterygium|pterygium
4655384|NCT03521791|anti-inflammatory non-steroidal ophthalmic|anti-inflammatory non-steroidal ophthalmic
4655385|NCT03521765|quality of life|quality of life
4655386|NCT03521765|occupational therapy|occupational therapy
4655387|NCT03521752|BALANCE|balance
4655388|NCT03521752|INSTITUTIONALIZED ELDERLY PEOPLE|institutionalized elderly people
4655389|NCT03521752|THERAPEUTIC EXERCISE|therapeutic exercise
4655390|NCT03521752|FUNCTIONAL CAPACITY|functional capacity
4655391|NCT03521739|blood pressure|blood pressure
4655392|NCT03521739|pulse wave velocity|pulse wave velocity
4655393|NCT03521739|ankle brachial index|ankle brachial index
4655394|NCT03521739|cardiovascular events|cardiovascular events
4655395|NCT03521726|Rabeprazole|rabeprazole
4655396|NCT03521726|Amoxicillin|amoxicillin
4655397|NCT03521726|Helicobacter Pylori|helicobacter pylori
4655398|NCT03521700|Renal Artery Obstruction|renal artery obstruction
4655399|NCT03521700|Stents|stents
4655400|NCT03521700|Glomerular filtration rate|glomerular filtration rate
4655401|NCT03521687|Central centrifugal cicatricial alopecia|central centrifugal cicatricial alopecia
4655402|NCT03521687|open-label pilot study|open-label pilot study
4655403|NCT03521674|second trimester pregnancy termination|second trimester pregnancy termination
4655404|NCT03521674|double-balloon catheter|double-balloon catheter
4655405|NCT03521674|foley catheter|foley catheter
4655406|NCT03521661|Vertebral fracture|vertebral fracture
4655407|NCT03521661|Kyphotic deformity|kyphotic deformity
4655408|NCT03521661|Kyphoplasty|kyphoplasty
4655409|NCT03521661|Vertebroplasty|vertebroplasty
4655410|NCT03521648|Prostatic Artery Embolization|prostatic artery embolization
4655411|NCT03521648|Transurethral Prostate Resection|transurethral prostate resection
4655412|NCT03521648|Transurethral Electroresection of Prostate|transurethral electroresection of prostate
4655413|NCT03521648|Contact Laser Ablation of Prostate|contact laser ablation of prostate
4655414|NCT03521648|Laser Enucleation of Prostate|laser enucleation of prostate
4655415|NCT03521648|Open prostatectomy|open prostatectomy
4655416|NCT03521622|counseling|counseling
4655417|NCT03521622|behavioral therapy|behavioral therapy
4655418|NCT03521622|tobacco|tobacco
4655419|NCT03521622|alcohol drinking|alcohol drinking
4655420|NCT03521596|IgM monoclonal gammopathy|igm monoclonal gammopathy
4655421|NCT03521596|Waldenström's Macroglobulinemia|waldenström's macroglobulinemia
4655422|NCT03521596|Minimal residual disease|minimal residual disease
4655423|NCT03521596|Clonal evolution|clonal evolution
4655424|NCT03521583|von Willebrand disease|von willebrand disease
4655425|NCT03521583|von Willebrand factor|von willebrand factor
4655426|NCT03521583|Nationwide study|nationwide study
4655427|NCT03521583|Prospective study|prospective study
4655428|NCT03521531|Quality of Life|quality of life
4655429|NCT03521531|Sarcoma|sarcoma
4655430|NCT03521531|Patient Reported Outcomes|patient reported outcomes
4655431|NCT03521505|Sedation|sedation
4655432|NCT03521505|dexmedetomidine|dexmedetomidine
4655433|NCT03521505|brain perfusion|brain perfusion
4655434|NCT03521505|bronchoscopy|bronchoscopy
4655435|NCT03521492|Early childhood caries, Vitamin D deficiency, Parathyroid hormone, Calcium|early childhood caries, vitamin d deficiency, parathyroid hormone, calcium
4655436|NCT03521479|Squaric Acid|squaric acid
4655437|NCT03521479|SADBE|sadbe
4655438|NCT03521479|Squaric acid dibutyl ester|squaric acid dibutyl ester
4655439|NCT03521466|Smoking cessation counselling|smoking cessation counselling
4655440|NCT03521466|Medical Students|medical students
4655441|NCT03521466|India|india
4655442|NCT03521440|Therapeutic relaxation|therapeutic relaxation
4655443|NCT03521440|Elderly|elderly
4655444|NCT03521440|Community dwelling|community dwelling
4655445|NCT03521427|Intensive Therapy|intensive therapy
4655446|NCT03521427|Cerebral Palsy|cerebral palsy
4655447|NCT03521414|Bispectral index|bispectral index
4655448|NCT03521414|Glasgow Coma Scale|glasgow coma scale
4655449|NCT03521414|intracranial pathology|intracranial pathology
4655450|NCT03521401|Adverse Childhood Experiences|adverse childhood experiences
4655451|NCT03521401|Exercise Intervention|exercise intervention
4655452|NCT03521401|Inflammation|inflammation
4655453|NCT03521401|Resilience|resilience
4655454|NCT03521401|Health|health
4655455|NCT03521388|depression|depression
4655456|NCT03521388|adolescence|adolescence
4655457|NCT03521388|prevention|prevention
4655458|NCT03521388|early intervention|early intervention
4655459|NCT03521388|internet-based|internet-based
4655460|NCT03521375|lung|lung
4655461|NCT03521375|cancer|cancer
4655462|NCT03521375|lobectomy|lobectomy
4655463|NCT03521362|mHealth|mhealth
4655464|NCT03521362|Adolescent|adolescent
4655465|NCT03521349|Electroencephalography|electroencephalography
4655671|NCT03520335|stroke|stroke
4655466|NCT03521349|Executive Function|executive function
4655467|NCT03521349|Egg|egg
4655468|NCT03521349|Diet|diet
4655469|NCT03521336|Spinal cord injury|spinal cord injury
4655470|NCT03521336|Umbilical Cord Mesenchymal Stem Cells|umbilical cord mesenchymal stem cells
4655471|NCT03521323|umbilical cord mesenchymal stem cells|umbilical cord mesenchymal stem cells
4655472|NCT03521323|spinal cord injury|spinal cord injury
4655473|NCT03521310|IPISTOSS|ipistoss
4655474|NCT03521310|Skin to skin|skin to skin
4655475|NCT03521310|SSC|ssc
4655476|NCT03521310|Neonatal|neonatal
4655477|NCT03521284|perinatal period|perinatal period
4655478|NCT03521271|Duchenne Muscular Dystrophy|duchenne muscular dystrophy
4655479|NCT03521271|Upper limb|upper limb
4655480|NCT03521271|Hand functions|hand functions
4655481|NCT03521271|Performance|performance
4655482|NCT03521271|Grip Strength|grip strength
4655483|NCT03521245|breast cancer|breast cancer
4655484|NCT03521245|epidermal growth factor receptor|epidermal growth factor receptor
4655485|NCT03521245|HER2|her2
4655486|NCT03521245|EGFR|egfr
4655487|NCT03521245|biomarkers|biomarkers
4655488|NCT03521245|targeted therapy|targeted therapy
4655489|NCT03521245|NGS|ngs
4655490|NCT03521245|RNAseq|rnaseq
4655491|NCT03521245|mRNA|mrna
4655492|NCT03521245|transcriptome analysis|transcriptome analysis
4655493|NCT03521245|signaling pathway|signaling pathway
4655494|NCT03521245|intracellular molecular pathway|intracellular molecular pathway
4655495|NCT03521245|Oncobox|oncobox
4655496|NCT03521245|trastuzumab|trastuzumab
4655497|NCT03521206|Advance directives|advance directives
4655498|NCT03521206|Effectiveness|effectiveness
4655499|NCT03521206|Process evaluation|process evaluation
4655500|NCT03521206|Care staff|care staff
4655501|NCT03521193|Migraine;|migraine;
4655502|NCT03521193|PFO|pfo
4655503|NCT03521193|platelet reactivity|platelet reactivity
4655504|NCT03521193|aura|aura
4655505|NCT03521180|Celiac Disease|celiac disease
4655506|NCT03521180|Gluten|gluten
4655507|NCT03521180|Immune Response|immune response
4655508|NCT03521180|Challenge|challenge
4655509|NCT03521154|Phase III|phase iii
4655510|NCT03521154|Osimertinib|osimertinib
4655511|NCT03521154|Non Small Cell Lung Cancer (Stage III)|non small cell lung cancer (stage iii)
4655512|NCT03521154|Unresectable NSCLC|unresectable nsclc
4655513|NCT03521154|EGFR|egfr
4655514|NCT03521154|chemoradiation therapy|chemoradiation therapy
4655515|NCT03521141|Tobacco Use Cessation|tobacco use cessation
4655516|NCT03521141|Precision Medicine|precision medicine
4655517|NCT03521089|Mild Cognitive Impairment (MCI)|mild cognitive impairment (mci)
4655518|NCT03521089|Transcranial Direct Current Stimulation (tDCS)|transcranial direct current stimulation (tdcs)
4655519|NCT03521076|Botulinum Toxin Injections|botulinum toxin injections
4655520|NCT03521076|Virtual Reality|virtual reality
4655521|NCT03521063|bronchopulmonary dysplasia|bronchopulmonary dysplasia
4655522|NCT03521063|respiratory distress syndrome|respiratory distress syndrome
4655523|NCT03521063|budesonide|budesonide
4655524|NCT03521063|poractant alfa|poractant alfa
4655525|NCT03521037|rucaparib|rucaparib
4655526|NCT03521037|CO-338|co-338
4655527|NCT03521037|Clovis|clovis
4655528|NCT03521037|Clovis Oncology|clovis oncology
4655529|NCT03521037|PARP inhibitor|parp inhibitor
4655530|NCT03521037|hepatic impairment|hepatic impairment
4655531|NCT03521024|Zirconia implants|zirconia implants
4655532|NCT03521024|PEKK crowns|pekk crowns
4655533|NCT03521024|high performance polymer crowns|high performance polymer crowns
4655534|NCT03520985|refractory Multiple Myeloma|refractory multiple myeloma
4655535|NCT03520985|Phase II|phase ii
4655536|NCT03520985|Pomalidomide|pomalidomide
4655537|NCT03520985|OptiPOM|optipom
4655538|NCT03520959|Synovate Study|synovate study
4655539|NCT03520959|NY-ESO-1|ny-eso-1
4655540|NCT03520959|cancer vaccine|cancer vaccine
4655541|NCT03520959|Sarcoma|sarcoma
4655542|NCT03520959|soft tissue sarcoma|soft tissue sarcoma
4655543|NCT03520959|immunotherapy|immunotherapy
4655544|NCT03520946|colorectal cancer|colorectal cancer
4655545|NCT03520946|ramucirumab|ramucirumab
4655546|NCT03520946|tas102|tas102
4655547|NCT03520933|Embryo|embryo
4655548|NCT03520933|Blastocyst|blastocyst
4655549|NCT03520933|Non-invasive|non-invasive
4655550|NCT03520933|PGT-A|pgt-a
4655551|NCT03520933|Chromosome|chromosome
4655552|NCT03520933|Aneuploidy|aneuploidy
4655553|NCT03520933|Spent culture medium|spent culture medium
4655554|NCT03520933|Trophectoderm biopsy|trophectoderm biopsy
4655555|NCT03520907|transversalis fascia|transversalis fascia
4655556|NCT03520907|ilioinguinal/iliohypogastric nerve|ilioinguinal/iliohypogastric nerve
4655557|NCT03520907|inguinal hernia repair|inguinal hernia repair
4655558|NCT03520907|children|children
4655559|NCT03520881|asthma|asthma
4655560|NCT03520855|Type 1 Diabetes|type 1 diabetes
4655561|NCT03520855|Paediatrics patients|paediatrics patients
4655562|NCT03520816|Fibronectin|fibronectin
4655563|NCT03520816|Prealbumin|prealbumin
4655564|NCT03520816|Physiotherapy|physiotherapy
4655565|NCT03520816|Major Burns|major burns
4655566|NCT03520816|biochemical parameters|biochemical parameters
4655567|NCT03520803|obesity|obesity
4655568|NCT03520803|bariatric surgery|bariatric surgery
4655569|NCT03520803|enhanced recovery after surgery|enhanced recovery after surgery
4655570|NCT03520803|sleeve gastrectomy|sleeve gastrectomy
4655571|NCT03520803|gastric bypass|gastric bypass
4655572|NCT03520790|Pancreatic Cancer|pancreatic cancer
4655573|NCT03520751|CMT1A|cmt1a
4655574|NCT03520751|scAAV1.tMCK.NTF3|scaav1.tmck.ntf3
4655575|NCT03520751|NTF3|ntf3
4655576|NCT03520725|antioxidant capacity|antioxidant capacity
4655577|NCT03520712|Hemophilia A|hemophilia a
4655578|NCT03520712|Blood Coagulation Disorders, Inherited|blood coagulation disorders, inherited
4655579|NCT03520712|Blood Coagulation Disorders|blood coagulation disorders
4655580|NCT03520712|Hematologic Diseases|hematologic diseases
4655581|NCT03520712|Coagulation Protein Disorders|coagulation protein disorders
4655582|NCT03520712|Hemorrhagic Disorders|hemorrhagic disorders
4655583|NCT03520712|Genetic Diseases, Inborn|genetic diseases, inborn
4655584|NCT03520712|Factor VIII|factor viii
4655585|NCT03520712|Coagulants|coagulants
4655586|NCT03520712|AAV5 antibodies|aav5 antibodies
4655587|NCT03520699|metabolic surgery|metabolic surgery
4655588|NCT03520699|metabolic disease|metabolic disease
4655589|NCT03520686|Pembrolizumab|pembrolizumab
4655590|NCT03520686|ALT-803|alt-803
4655591|NCT03520686|Non-Small Cell Lung Cancer|non-small cell lung cancer
4655592|NCT03520686|Immunotherapy|immunotherapy
4655593|NCT03520673|Lower Urinary Tract Symptoms|lower urinary tract symptoms
4655594|NCT03520673|Primary Care|primary care
4655595|NCT03520673|Urology|urology
4655596|NCT03520660|Natural History|natural history
4655597|NCT03520660|Hepatitis C Virus|hepatitis c virus
4655598|NCT03520660|Hepatocellular Carcinoma|hepatocellular carcinoma
4655599|NCT03520660|Fibrosis|fibrosis
4655600|NCT03520660|Immune Response|immune response
4655601|NCT03520647|Haploidentical CD34+cells|haploidentical cd34+cells
4655602|NCT03520647|Non-Myeloablative|non-myeloablative
4655603|NCT03520634|Melanoma|melanoma
4655604|NCT03520634|PD-L1|pd-l1
4655605|NCT03520634|Brain metastases|brain metastases
4655606|NCT03520634|PET imaging|pet imaging
4655607|NCT03520621|sulfur amino acid|sulfur amino acid
4655608|NCT03520556|EPA|epa
4655609|NCT03520556|DHA|dha
4655610|NCT03520556|low-grade inflammation|low-grade inflammation
4655611|NCT03520556|CRP|crp
4655612|NCT03520556|IL-6|il-6
4655613|NCT03520556|TNF-alpha|tnf-alpha
4655614|NCT03520556|adiponectin|adiponectin
4655615|NCT03520556|randomized controlled trials|randomized controlled trials
4655616|NCT03520556|systematic review and meta-analysis|systematic review and meta-analysis
4655617|NCT03520543|PET imaging|pet imaging
4655618|NCT03520543|Noradrenaline|noradrenaline
4655619|NCT03520543|Radiotracer|radiotracer
4655620|NCT03520530|second stage|second stage
4655621|NCT03520530|spontaneous vaginal delivery|spontaneous vaginal delivery
4655622|NCT03520517|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
4655623|NCT03520517|ALS|als
4655624|NCT03520517|Biohaven|biohaven
4655625|NCT03520517|Motor Neuron Disease, Amyotrophic Lateral Sclerosis|motor neuron disease, amyotrophic lateral sclerosis
4655626|NCT03520517|Lou Gehrig's Disease|lou gehrig's disease
4655627|NCT03520517|Lou-Gehrigs Disease|lou-gehrigs disease
4655628|NCT03520517|Lou Gehrig Disease|lou gehrig disease
4655629|NCT03520517|Riluzole|riluzole
4655630|NCT03520517|Rilutek®|rilutek®
4655631|NCT03520517|Neuroprotective Agents|neuroprotective agents
4655632|NCT03520517|Administration, Sublingual|administration, sublingual
4655633|NCT03520517|Administration, Oral|administration, oral
4655634|NCT03520517|Biological Availability|biological availability
4655635|NCT03520504|Proton Radiation|proton radiation
4655636|NCT03520504|craniospinal irradiation (CSI)|craniospinal irradiation (csi)
4655637|NCT03520504|18-205|18-205
4655638|NCT03520491|Immunotherapy|immunotherapy
4655639|NCT03520491|Nivolumab|nivolumab
4655640|NCT03520491|Ipilimumab|ipilimumab
4655641|NCT03520491|18-042|18-042
4655642|NCT03520478|Hormone sensitive prostate cancer|hormone sensitive prostate cancer
4655643|NCT03520478|SHR3680|shr3680
4655644|NCT03520478|Anti-androgen receptor|anti-androgen receptor
4655645|NCT03520439|Adenomyosis|adenomyosis
4655646|NCT03520439|mifepristone|mifepristone
4655647|NCT03520439|the selective progesterone receptor modulators|the selective progesterone receptor modulators
4655648|NCT03520439|treatment|treatment
4655649|NCT03520413|Complex Care|complex care
4655650|NCT03520413|Outcomes|outcomes
4655651|NCT03520413|Telemedicine|telemedicine
4655652|NCT03520413|Rural Health|rural health
4655653|NCT03520413|Diabetes|diabetes
4655654|NCT03520400|Cardiovascular Disease|cardiovascular disease
4655655|NCT03520400|Percutaneous Intervention|percutaneous intervention
4655656|NCT03520400|coronary artery disease|coronary artery disease
4655657|NCT03520400|exercise therapy|exercise therapy
4655658|NCT03520387|Randomized controlled trial|randomized controlled trial
4655659|NCT03520387|Chronic pain|chronic pain
4655660|NCT03520374|ultrasound|ultrasound
4655661|NCT03520374|gastric contents|gastric contents
4655662|NCT03520361|Colonoscopy|colonoscopy
4655663|NCT03520361|Bowel preparation|bowel preparation
4655664|NCT03520361|Oral sulfate solution|oral sulfate solution
4655665|NCT03520361|Polyethylene glycol|polyethylene glycol
4655666|NCT03520361|Ascorbic acid|ascorbic acid
4655667|NCT03520348|dry eye|dry eye
4655668|NCT03520348|eye lubricants|eye lubricants
4655669|NCT03520348|eye lubricant gel|eye lubricant gel
4655672|NCT03520335|conjugated eye deviation|conjugated eye deviation
4655673|NCT03520335|prehospital|prehospital
4655674|NCT03520335|stroke scale|stroke scale
4655675|NCT03520335|large vessel occlusion|large vessel occlusion
4655676|NCT03520309|Diagnosis|diagnosis
4655677|NCT03520309|Visual inspection|visual inspection
4655678|NCT03520309|Quality of Life|quality of life
4655679|NCT03520309|Restorations|restorations
4655680|NCT03520244|Microbiome|microbiome
4655681|NCT03520244|High intensity interval training|high intensity interval training
4655682|NCT03520244|Exercise|exercise
4655683|NCT03520244|Holistic education|holistic education
4655684|NCT03520244|Quality of life|quality of life
4655685|NCT03520244|Fatigue|fatigue
4655686|NCT03520205|stress response|stress response
4655687|NCT03520205|kidney donor|kidney donor
4655688|NCT03520205|Cellular Imunological Function|cellular imunological function
4655689|NCT03520205|quadratus lumborum block|quadratus lumborum block
4655690|NCT03520192|Paediatric|paediatric
4655691|NCT03520192|Critical care|critical care
4655692|NCT03520192|Transport|transport
4655693|NCT03520166|urgency|urgency
4655694|NCT03520166|frequency|frequency
4655695|NCT03520166|overactive bladder|overactive bladder
4655696|NCT03520166|LUTS|luts
4655697|NCT03520166|pelvic pain|pelvic pain
4655698|NCT03520166|electrostimulation|electrostimulation
4655699|NCT03520140|Familial hypercholesterolemia|familial hypercholesterolemia
4655700|NCT03520140|Coronary artery disease|coronary artery disease
4655701|NCT03520114|Retropubic sling|retropubic sling
4655702|NCT03520114|Single-incision sling|single-incision sling
4655703|NCT03520114|Vaginal repair|vaginal repair
4655704|NCT03520114|Management|management
4655705|NCT03520088|Rectal cancer|rectal cancer
4655706|NCT03520088|Sexual dysfunction|sexual dysfunction
4655707|NCT03520088|Urinary dysfunction|urinary dysfunction
4655708|NCT03520088|Rectal nerves damage|rectal nerves damage
4655709|NCT03520088|Total Mesorectal Excision|total mesorectal excision
4655710|NCT03520075|Neoplasms|neoplasms
4655711|NCT03520075|Solid Tumors|solid tumors
4655712|NCT03520075|Antineoplastic Agents|antineoplastic agents
4655714|NCT03520075|ERK|erk
4655715|NCT03520062|Amylase|amylase
4655716|NCT03520062|Lipase|lipase
4655717|NCT03520062|GLP-1|glp-1
4655718|NCT03520049|Thrombocytopenia|thrombocytopenia
4655719|NCT03520049|ITP|itp
4655720|NCT03520049|Platelets|platelets
4655721|NCT03520049|Bleeding|bleeding
4655722|NCT03520049|Immune|immune
4655723|NCT03520049|Oseltamivir|oseltamivir
4655724|NCT03520049|Glycoprotein|glycoprotein
4655725|NCT03520049|Sialylation|sialylation
4655726|NCT03520049|Antibody|antibody
4655727|NCT03520049|Autoantibody|autoantibody
4655728|NCT03519971|Locally Advanced, Unresectable Non-small Cell Lung Cancer, NSCLC, Carcinoma, Non-Small-Cell Lung Cancer|locally advanced, unresectable non-small cell lung cancer, nsclc, carcinoma, non-small-cell lung cancer
4655729|NCT03519945|Inflammatory Bowel Disease|inflammatory bowel disease
4655730|NCT03519906|Bariatric surgery|bariatric surgery
4655731|NCT03519906|Gastrointestinal tract|gastrointestinal tract
4655732|NCT03519906|Biological availability|biological availability
4655733|NCT03519906|Pharmacokinetics|pharmacokinetics
4655734|NCT03519906|Metoprolol|metoprolol
4655735|NCT03519893|Bariatric surgery|bariatric surgery
4655736|NCT03519893|Gastrointestinal tract|gastrointestinal tract
4655737|NCT03519893|Biological availability|biological availability
4655738|NCT03519893|Pharmacokinetics|pharmacokinetics
4655739|NCT03519893|Losartan|losartan
4655740|NCT03519880|amyotrophic lateral sclerosis, non-invasive ventilation, mask, custom, 3D-printing|amyotrophic lateral sclerosis, non-invasive ventilation, mask, custom, 3d-printing
4655741|NCT03519841|Non-invasive glucose monitoring|non-invasive glucose monitoring
4655742|NCT03519815|dry eye|dry eye
4655743|NCT03519815|eye spray|eye spray
4655744|NCT03519802|Cognitive functions|cognitive functions
4655745|NCT03519802|MoCA test|moca test
4655746|NCT03519789|Change blindness|change blindness
4655747|NCT03519789|Eye tracking|eye tracking
4655748|NCT03519789|Implicit response|implicit response
4655749|NCT03519750|Melatonin|melatonin
4655750|NCT03519750|Safety|safety
4655751|NCT03519750|Pharmacokinetics|pharmacokinetics
4655752|NCT03519737|Stroke|stroke
4655753|NCT03519737|Acute Stroke|acute stroke
4655754|NCT03519685|Contraception|contraception
4655755|NCT03519685|Hormonal contraception|hormonal contraception
4655756|NCT03519685|Long-acting reversible contraception|long-acting reversible contraception
4655757|NCT03519685|Condoms|condoms
4655758|NCT03519685|Emergency contraception|emergency contraception
4655759|NCT03519685|Family planning services|family planning services
4655760|NCT03519646|Enzyme Replacement Therapy|enzyme replacement therapy
4655761|NCT03519646|Eliglustat (Cerdelga®)|eliglustat (cerdelga®)
4655762|NCT03519607|Infertility|infertility
4655763|NCT03519607|Distress|distress
4655764|NCT03519607|Coping|coping
4655765|NCT03519607|Men|men
4655766|NCT03519594|angioembolization|angioembolization
4655767|NCT03519594|computed tomography|computed tomography
4655768|NCT03519581|DME|dme
4655769|NCT03519581|micropulse laser|micropulse laser
4655770|NCT03519529|sex hormone-binding globulin|sex hormone-binding globulin
4655771|NCT03519516|ocular antibiotic|ocular antibiotic
4655772|NCT03519516|quinolone|quinolone
4655773|NCT03519516|levofloxacin|levofloxacin
4655774|NCT03519516|ophthalmic antibiotic|ophthalmic antibiotic
4655775|NCT03519516|antibiotic in drops|antibiotic in drops
4655776|NCT03519503|HIV|hiv
4655777|NCT03519503|Neuropsychological tests|neuropsychological tests
4655778|NCT03519503|PMTCT|pmtct
4655779|NCT03519503|PreP|prep
4655780|NCT03519490|Myopia|myopia
4655781|NCT03519490|Myopia Control|myopia control
4655782|NCT03519490|Bifocal Contact Lenses|bifocal contact lenses
4655783|NCT03519490|Multifocal Contact Lenses|multifocal contact lenses
4655784|NCT03519490|Hybrid Contact Lenses|hybrid contact lenses
4655785|NCT03519490|Randomized Controlled Clinical Trial|randomized controlled clinical trial
4655786|NCT03519490|Distance Center Multifocal Contact Lens|distance center multifocal contact lens
4655787|NCT03519490|Near Center Multifocal Contact Lens|near center multifocal contact lens
4655788|NCT03519477|clinical decision support|clinical decision support
4655789|NCT03519477|drug levels in blood|drug levels in blood
4655790|NCT03519477|therapeutic drug monitoring|therapeutic drug monitoring
4655791|NCT03519477|medication adherence|medication adherence
4655792|NCT03519477|medication therapy management|medication therapy management
4655793|NCT03519464|Gardasil 9|gardasil 9
4655794|NCT03519464|Seroconversion|seroconversion
4655795|NCT03519464|Humoral immune response|humoral immune response
4655796|NCT03519464|Cellular Immune Response|cellular immune response
4655797|NCT03519464|Mucosal Lesions|mucosal lesions
4655798|NCT03519451|Smartphone mobile app|smartphone mobile app
4655799|NCT03519451|Questionnaires|questionnaires
4655800|NCT03519451|Surveys|surveys
4655801|NCT03519451|Phone calls|phone calls
4655802|NCT03519451|Interview|interview
4655803|NCT03519451|Tobacco cessation|tobacco cessation
4655804|NCT03519425|Tuberculosis|tuberculosis
4655805|NCT03519425|HIV|hiv
4655806|NCT03519425|Randomised controlled trial|randomised controlled trial
4655807|NCT03519425|Africa|africa
4655808|NCT03519425|Public Health|public health
4655809|NCT03519425|Screening|screening
4655810|NCT03519412|DNA Mismatch Repair|dna mismatch repair
4655811|NCT03519412|Pembrolizumab|pembrolizumab
4655812|NCT03519399|Bile Acids, Fetal ECG, Stillbirth,|bile acids, fetal ecg, stillbirth,
4655813|NCT03519360|arrythmia|arrythmia
4655814|NCT03519360|hemodialysis|hemodialysis
4655815|NCT03519334|Employment|employment
4655816|NCT03519334|Return to work|return to work
4655817|NCT03519334|Career Mobility|career mobility
4655818|NCT03519334|Employment supported|employment supported
4655819|NCT03519334|Workplace|workplace
4655820|NCT03519334|Chronic disease|chronic disease
4655821|NCT03519321|Early Onset Scoliosis (EOS)|early onset scoliosis (eos)
4655822|NCT03519295|Epidermoid Cancers of the Anal Canal|epidermoid cancers of the anal canal
4655823|NCT03519269|total knee replacement|total knee replacement
4655824|NCT03519269|robotic surgery|robotic surgery
4655825|NCT03519191|teen dating violence|teen dating violence
4655826|NCT03519191|sexual assault|sexual assault
4655827|NCT03519191|reproductive coercion|reproductive coercion
4655828|NCT03519178|Hormone Receptor (HR) Positive Breast Cancer|hormone receptor (hr) positive breast cancer
4655829|NCT03519178|Estrogen receptor (ER) positive|estrogen receptor (er) positive
4655830|NCT03519178|Progesterone receptor (PR) positive|progesterone receptor (pr) positive
4655831|NCT03519178|Cyclin-dependent kinase (CDK)|cyclin-dependent kinase (cdk)
4655832|NCT03519178|Human epidermal growth factor receptor 2 (HER2) negative|human epidermal growth factor receptor 2 (her2) negative
4655833|NCT03519178|Advanced breast cancer|advanced breast cancer
4655834|NCT03519178|Metastatic breast cancer (MBC)|metastatic breast cancer (mbc)
4655835|NCT03519178|Triple negative breast cancer (TNBC)|triple negative breast cancer (tnbc)
4655836|NCT03519178|Epithelial ovarian cancer (EOC)|epithelial ovarian cancer (eoc)
4655837|NCT03519178|Fallopian tube cancer|fallopian tube cancer
4655838|NCT03519178|Primary peritoneal cancer (PPC)|primary peritoneal cancer (ppc)
4655839|NCT03519178|CDK4/6 inhibitor|cdk4/6 inhibitor
4655840|NCT03519178|Endocrine Therapy (ET)|endocrine therapy (et)
4655841|NCT03519178|Measurable disease|measurable disease
4655842|NCT03519178|Luteinizing Hormone Releasing Hormone (LHRH) Agonist|luteinizing hormone releasing hormone (lhrh) agonist
4655843|NCT03519178|Goserelin|goserelin
4655844|NCT03519178|Leuprolide acetate|leuprolide acetate
4655845|NCT03519165|Ovarian cancer|ovarian cancer
4655846|NCT03519165|goal-directed fluid therapy|goal-directed fluid therapy
4655847|NCT03519165|SVV|svv
4655848|NCT03519139|Geriatric patients, nutritional counselling, homevisit|geriatric patients, nutritional counselling, homevisit
4655849|NCT03519126|Urinary Bladder, Overactive; Electric Stimulation|urinary bladder, overactive; electric stimulation
4655850|NCT03519113|HBV-related liver transplantation|hbv-related liver transplantation
4655851|NCT03519113|Hepatitis B immunoglobulin|hepatitis b immunoglobulin
4655852|NCT03519035|borderline|borderline
4655853|NCT03519035|hallucinations|hallucinations
4655854|NCT03519035|dissociation|dissociation
4655855|NCT03519035|post-traumatic stress disorder|post-traumatic stress disorder
4655856|NCT03519009|Employment|employment
4655857|NCT03518970|uncertainty|uncertainty
4655858|NCT03518970|caregivers|caregivers
4655859|NCT03518970|palliative care|palliative care
4655860|NCT03518970|nursing|nursing
4655861|NCT03518970|Hospice and Palliative Care Nursing|hospice and palliative care nursing
4655862|NCT03518918|Premature ovarian insufficiency|premature ovarian insufficiency
4656068|NCT03517826|Dyspnea|dyspnea
4655863|NCT03518918|Diagnosis standard|diagnosis standard
4655864|NCT03518918|Risk factors|risk factors
4655865|NCT03518892|Resting Metabolic Rate|resting metabolic rate
4655866|NCT03518879|informatics|informatics
4655867|NCT03518879|asthma|asthma
4655868|NCT03518827|asymmetry|asymmetry
4655869|NCT03518827|pain|pain
4655870|NCT03518827|sport|sport
4655871|NCT03518827|injury|injury
4655872|NCT03518827|risk factor|risk factor
4655873|NCT03518814|Melanoma stage IV|melanoma stage iv
4655874|NCT03518814|Remission|remission
4655875|NCT03518814|Quality of life|quality of life
4655876|NCT03518801|cannabidiol|cannabidiol
4655877|NCT03518801|CBD|cbd
4655878|NCT03518801|PTSD|ptsd
4655879|NCT03518801|Veterans|veterans
4655880|NCT03518749|Depression|depression
4655881|NCT03518749|transcranial direct current stimulation (tDCS)|transcranial direct current stimulation (tdcs)
4655882|NCT03518723|Muscle dysfunction|muscle dysfunction
4655883|NCT03518710|child|child
4655884|NCT03518710|reading|reading
4655885|NCT03518710|vision|vision
4655886|NCT03518710|attention|attention
4655887|NCT03518710|therapeutical perspectives|therapeutical perspectives
4655888|NCT03518697|Exercise|exercise
4655889|NCT03518697|Physical fitness|physical fitness
4655890|NCT03518697|Physical activity|physical activity
4655891|NCT03518697|Accelerometer|accelerometer
4655892|NCT03518697|Sleep|sleep
4655893|NCT03518671|head and neck cancer|head and neck cancer
4655894|NCT03518671|body image disturbance|body image disturbance
4655895|NCT03518671|cognitive behavioral therapy|cognitive behavioral therapy
4655896|NCT03518671|survivorship|survivorship
4655897|NCT03518658|remote monitoring|remote monitoring
4655898|NCT03518658|transmission compliance|transmission compliance
4655899|NCT03518658|patient engagement|patient engagement
4655900|NCT03518645|Coronary Artery Disease|coronary artery disease
4655901|NCT03518645|OPN NC|opn nc
4655902|NCT03518645|Angina|angina
4655903|NCT03518645|Stable|stable
4655904|NCT03518645|Unstable|unstable
4655905|NCT03518632|Exercise|exercise
4655906|NCT03518632|Adapted physical activity|adapted physical activity
4655907|NCT03518632|preoperative|preoperative
4655908|NCT03518632|liver resection|liver resection
4655909|NCT03518632|hepatectomy|hepatectomy
4655910|NCT03518606|Advanced solid tumours|advanced solid tumours
4655911|NCT03518606|Durvalumab|durvalumab
4655912|NCT03518606|Tremelimumab|tremelimumab
4655913|NCT03518606|Metronomic vinorelbine|metronomic vinorelbine
4655914|NCT03518606|High mutational load malignancies|high mutational load malignancies
4655915|NCT03518606|Immunotherapy|immunotherapy
4655916|NCT03518606|Early phase|early phase
4655917|NCT03518606|Combination study|combination study
4655918|NCT03518580|mobile technology|mobile technology
4655919|NCT03518580|real-time assessment|real-time assessment
4655920|NCT03518580|active life engagement|active life engagement
4655921|NCT03518515|nutrition intervention|nutrition intervention
4655922|NCT03518515|potato consumption|potato consumption
4655923|NCT03518515|energy balance|energy balance
4655924|NCT03518437|coronary artery disease|coronary artery disease
4655925|NCT03518437|CT|ct
4655926|NCT03518437|MACE|mace
4655927|NCT03518424|Association football|association football
4655928|NCT03518424|Soccer|soccer
4655929|NCT03518424|Injury|injury
4655930|NCT03518424|Epidemiology|epidemiology
4655931|NCT03518398|Intense pulsed light|intense pulsed light
4655932|NCT03518398|Meibomian gland dysfunction|meibomian gland dysfunction
4655933|NCT03518398|Dry eye|dry eye
4655934|NCT03518398|cytokines|cytokines
4655935|NCT03518372|Hypoxia|hypoxia
4655936|NCT03518372|Myocardial Injury|myocardial injury
4655937|NCT03518372|Surgery--Complications|surgery--complications
4655938|NCT03518372|Tissue Oximetry|tissue oximetry
4655939|NCT03518372|Near-infrared Spectroscopy (NIRS)|near-infrared spectroscopy (nirs)
4655940|NCT03518359|Residents|residents
4655941|NCT03518359|Stress|stress
4655942|NCT03518359|Well-being|well-being
4655943|NCT03518320|Bladder Cancer|bladder cancer
4655944|NCT03518320|Urothelial Carcinoma|urothelial carcinoma
4655945|NCT03518320|Cystectomy|cystectomy
4655946|NCT03518320|Radical Cystectomy|radical cystectomy
4655947|NCT03518307|Merkel carcinoma|merkel carcinoma
4655948|NCT03518294|NAFLD|nafld
4655949|NCT03518294|NASH|nash
4655950|NCT03518268|probiotics|probiotics
4655951|NCT03518268|aromatase inhibitors|aromatase inhibitors
4655952|NCT03518268|bone mass|bone mass
4655953|NCT03518268|postmenopausal|postmenopausal
4655954|NCT03518255|Nursing Care|nursing care
4655955|NCT03518255|Complementary therapies|complementary therapies
4655956|NCT03518255|Oncological Nursing|oncological nursing
4655957|NCT03518255|Photography|photography
4655958|NCT03518229|cancer prevention|cancer prevention
4655959|NCT03518229|sunburn|sunburn
4655960|NCT03518216|cognitive behavioral therapy|cognitive behavioral therapy
4655961|NCT03518216|mindfulness meditation|mindfulness meditation
4655962|NCT03518216|fMRI|fmri
4655963|NCT03518216|neuroimaging|neuroimaging
4655964|NCT03518203|Hematopoietic Stem Cell Transplant|hematopoietic stem cell transplant
4655965|NCT03518164|ACDF|acdf
4655966|NCT03518164|allograft|allograft
4655967|NCT03518164|autograft|autograft
4655968|NCT03518164|cervical fusion|cervical fusion
4655969|NCT03518164|NDI|ndi
4655970|NCT03518164|EQ-5D|eq-5d
4655971|NCT03518164|PROMIS-PF|promis-pf
4655972|NCT03518164|DSQ|dsq
4655973|NCT03518151|public health|public health
4655974|NCT03518151|dietary inequalities|dietary inequalities
4655975|NCT03518151|environment design|environment design
4655976|NCT03518125|Anthrax|anthrax
4655977|NCT03518125|Bacillaceae Infections|bacillaceae infections
4655978|NCT03518125|Gram-Positive Bacterial Infections|gram-positive bacterial infections
4655979|NCT03518125|Bacterial Infections|bacterial infections
4655980|NCT03518125|Anthrax Vaccine Adsorbed|anthrax vaccine adsorbed
4655981|NCT03518125|BioThrax|biothrax
4655982|NCT03518125|AV7909|av7909
4655983|NCT03518125|CPG 7909|cpg 7909
4655984|NCT03518125|Adjuvant|adjuvant
4655985|NCT03518125|Vaccines|vaccines
4655986|NCT03518125|Post-exposure Prophylaxis|post-exposure prophylaxis
4655987|NCT03518112|Leukemia|leukemia
4655988|NCT03518112|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
4655989|NCT03518112|ALL|all
4655990|NCT03518112|Relapsed/Refractory|relapsed/refractory
4655991|NCT03518112|Philadelphia Chromosome Negative|philadelphia chromosome negative
4655992|NCT03518112|Cyclophosphamide|cyclophosphamide
4655993|NCT03518112|Cytoxan|cytoxan
4655994|NCT03518112|Neosar|neosar
4655995|NCT03518112|Mesna|mesna
4655996|NCT03518112|Mesnex|mesnex
4655997|NCT03518112|Vincristine|vincristine
4655998|NCT03518112|Dexamethasone|dexamethasone
4655999|NCT03518112|Decadron|decadron
4656000|NCT03518112|G-CSF|g-csf
4656001|NCT03518112|Filgrastim|filgrastim
4656002|NCT03518112|Neupogen|neupogen
4656003|NCT03518112|Methotrexate|methotrexate
4656004|NCT03518112|Cytarabine|cytarabine
4656005|NCT03518112|Ara-C|ara-c
4656006|NCT03518112|Cytosar|cytosar
4656007|NCT03518112|DepoCyt|depocyt
4656008|NCT03518112|Cytosine arabinosine hydrochloride|cytosine arabinosine hydrochloride
4656009|NCT03518112|Rituximab|rituximab
4656010|NCT03518112|Rituxan|rituxan
4656011|NCT03518112|Blinatumomab|blinatumomab
4656012|NCT03518086|Interleukin-23 (IL-23) antibody|interleukin-23 (il-23) antibody
4656013|NCT03518086|IL-23p19|il-23p19
4656014|NCT03518073|Memory problems|memory problems
4656015|NCT03518073|Cognitive impairment|cognitive impairment
4656016|NCT03518073|PERISCOPE-ALZ|periscope-alz
4656017|NCT03518073|Dementia|dementia
4656018|NCT03518073|Tauopathy|tauopathy
4656019|NCT03518073|Neurofibrillary tangles|neurofibrillary tangles
4656020|NCT03518060|2 drug regimen|2 drug regimen
4656021|NCT03518060|Juluca|juluca
4656022|NCT03518060|Rilpivirine|rilpivirine
4656023|NCT03518060|Dolutegravir|dolutegravir
4656024|NCT03518060|Antiretroviral|antiretroviral
4656025|NCT03518060|One pill regimen|one pill regimen
4656026|NCT03518047|Plaque Psoriasis|plaque psoriasis
4656027|NCT03518034|hypogonadism|hypogonadism
4656028|NCT03518034|cardiovascular (CV) disease|cardiovascular (cv) disease
4656029|NCT03518034|AndroGel|androgel
4656030|NCT03518034|testosterone replacement therapy (TRT)|testosterone replacement therapy (trt)
4656031|NCT03518021|Naloxone|naloxone
4656032|NCT03518021|Administration, Intranasal|administration, intranasal
4656033|NCT03518021|Injections, Intramuscular|injections, intramuscular
4656034|NCT03518021|Narcotic Antagonists|narcotic antagonists
4656035|NCT03517995|primary bladder tumor|primary bladder tumor
4656036|NCT03517995|non-muscle invasive bladder tumor|non-muscle invasive bladder tumor
4656037|NCT03517995|muscle invasive bladder tumor|muscle invasive bladder tumor
4656038|NCT03517995|sulforaphane|sulforaphane
4656039|NCT03517995|chemoprevention|chemoprevention
4656040|NCT03517982|MyOra|myora
4656041|NCT03517982|Mycophenolate Mofetil|mycophenolate mofetil
4656042|NCT03517982|End stage renal disease|end stage renal disease
4656043|NCT03517982|De novo Renal transplant|de novo renal transplant
4656044|NCT03517982|Post authorization safety study|post authorization safety study
4656045|NCT03517982|Immunosuppressant|immunosuppressant
4656046|NCT03517982|Cohort study|cohort study
4656047|NCT03517956|Phase I|phase i
4656048|NCT03517956|Locally advanced or metastatic solid tumor|locally advanced or metastatic solid tumor
4656049|NCT03517956|Urothelial cancer|urothelial cancer
4656050|NCT03517956|FGFR inhibitor|fgfr inhibitor
4656051|NCT03517943|Upper respiratory allergy symptoms including congestion|upper respiratory allergy symptoms including congestion
4656052|NCT03517930|Upper respiratory allergy symptoms including congestion|upper respiratory allergy symptoms including congestion
4656053|NCT03517904|Femoropopliteal artery disease, drug-coated balloon, angioplasty, antiplatelet therapy|femoropopliteal artery disease, drug-coated balloon, angioplasty, antiplatelet therapy
4656054|NCT03517891|Physical activity|physical activity
4656055|NCT03517891|Sleep pattern|sleep pattern
4656056|NCT03517891|Nutrition|nutrition
4656057|NCT03517891|Education|education
4656058|NCT03517878|Community Health Worker|community health worker
4656059|NCT03517878|Pregnancy|pregnancy
4656060|NCT03517878|Breast Feeding|breast feeding
4656061|NCT03517878|Child Development|child development
4656062|NCT03517878|Home Visits|home visits
4656063|NCT03517878|Infants|infants
4656064|NCT03517839|Dyspnea|dyspnea
4656065|NCT03517839|Inspiratory Muscle Training|inspiratory muscle training
4656066|NCT03517839|Kinesiophobia|kinesiophobia
4656067|NCT03517826|COPD|copd
4656069|NCT03517826|Kinesiophobia|kinesiophobia
4656070|NCT03517800|Embolization|embolization
4656071|NCT03517800|surgery|surgery
4656072|NCT03517800|hysterectomy|hysterectomy
4656073|NCT03517800|arterial ligation|arterial ligation
4656074|NCT03517761|CCJ|ccj
4656075|NCT03517761|Bone Marrow Concentrate|bone marrow concentrate
4656076|NCT03517761|Stem Cell Therapy|stem cell therapy
4656077|NCT03517761|Alar Ligament|alar ligament
4656078|NCT03517761|Transverse Ligament|transverse ligament
4656079|NCT03517670|Cerebral vasospasm|cerebral vasospasm
4656080|NCT03517670|Subarachnoid hemorrhage|subarachnoid hemorrhage
4656081|NCT03517670|Milrinone|milrinone
4656082|NCT03517670|Hemodynamic tolerance|hemodynamic tolerance
4656083|NCT03517657|upper limb|upper limb
4656084|NCT03517657|occupational therapy|occupational therapy
4656085|NCT03517657|bilateral priming|bilateral priming
4656086|NCT03517631|HIV|hiv
4656087|NCT03517631|AIDS|aids
4656088|NCT03517631|Lentivirus|lentivirus
4656089|NCT03517631|shRNA|shrna
4656090|NCT03517631|Multiplex|multiplex
4656091|NCT03517631|Gene therapy|gene therapy
4656092|NCT03517618|A phase II study|a phase ii study
4656093|NCT03517618|Heavily pre-treated metastatic colorectal cancer|heavily pre-treated metastatic colorectal cancer
4656094|NCT03517618|S-1|s-1
4656095|NCT03517618|oral leucovrin|oral leucovrin
4656096|NCT03517605|Cardiac Rehabilitation|cardiac rehabilitation
4656097|NCT03517605|Quality of Life|quality of life
4656098|NCT03517605|Rehabilitation Nursing|rehabilitation nursing
4656099|NCT03517566|atopic dermatitis, AD, eczema, atopic eczema, itch, pruritus, histamine 4 receptor|atopic dermatitis, ad, eczema, atopic eczema, itch, pruritus, histamine 4 receptor
4656100|NCT03517566|antagonist, H4R, ZPL389, ZPL389A2203, dermatitis|antagonist, h4r, zpl389, zpl389a2203, dermatitis
4656101|NCT03517553|electrical muscle stimulation|electrical muscle stimulation
4656102|NCT03517540|Steatohepatitis|steatohepatitis
4656103|NCT03517540|NASH|nash
4656104|NCT03517540|NAFLD|nafld
4656105|NCT03517540|Fatty Liver Disease|fatty liver disease
4656106|NCT03517540|Liver|liver
4656107|NCT03517527|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
4656108|NCT03517527|Metabolic Control|metabolic control
4656109|NCT03517527|Walking Exercise|walking exercise
4656110|NCT03517527|Transtheoretical Model|transtheoretical model
4656111|NCT03517527|Nurse|nurse
4656112|NCT03517514|Heart Failure|heart failure
4656113|NCT03517514|Physical Therapy|physical therapy
4656114|NCT03517514|Hospital Readmission|hospital readmission
4656115|NCT03517488|DUET-2|duet-2
4656116|NCT03517488|Melanoma|melanoma
4656117|NCT03517488|Triple Negative Breast Cancer|triple negative breast cancer
4656118|NCT03517488|Hepatocellular|hepatocellular
4656119|NCT03517488|Urothelial Cancer|urothelial cancer
4656120|NCT03517488|Bladder Cancer|bladder cancer
4656121|NCT03517488|Renal Cell Cancer|renal cell cancer
4656122|NCT03517488|Head and Neck Cancer|head and neck cancer
4656123|NCT03517488|MSI-high Colorectal Cancer|msi-high colorectal cancer
4656124|NCT03517488|MSI-high Endometrial Cancer|msi-high endometrial cancer
4656125|NCT03517488|Non-small Cell Lung Cancer|non-small cell lung cancer
4656126|NCT03517488|Gastric Cancer|gastric cancer
4656127|NCT03517488|Gastroesophageal Junction Cancer|gastroesophageal junction cancer
4656128|NCT03517462|mass drug administration|mass drug administration
4656129|NCT03517462|ophthalmology|ophthalmology
4656130|NCT03517449|programmed cell death 1 (PD-1, PD1)|programmed cell death 1 (pd-1, pd1)
4656131|NCT03517449|programmed cell death ligand 1 (PD-L1, PDL1)|programmed cell death ligand 1 (pd-l1, pdl1)
4656132|NCT03517449|programmed cell death ligand 2 (PD-L2, PDL2)|programmed cell death ligand 2 (pd-l2, pdl2)
4656133|NCT03517449|vascular endothelial growth factor (VEGF) receptors|vascular endothelial growth factor (vegf) receptors
4656134|NCT03517449|lenvatinib|lenvatinib
4656135|NCT03517449|pembrolizumab|pembrolizumab
4656136|NCT03517449|doxorubicin|doxorubicin
4656137|NCT03517449|paclitaxel|paclitaxel
4656138|NCT03517449|phase 3 endometrial cancer|phase 3 endometrial cancer
4656139|NCT03517436|THV|thv
4656140|NCT03517436|Transcatheter Heart Valve|transcatheter heart valve
4656141|NCT03517436|CENTERA|centera
4656142|NCT03517436|self-expanding|self-expanding
4656143|NCT03517423|brivaracetam|brivaracetam
4656144|NCT03517423|post-marketing observational study|post-marketing observational study
4656145|NCT03517410|Mechanical Low Back Pain|mechanical low back pain
4656146|NCT03517410|Smart phone|smart phone
4656147|NCT03517410|Low Back Pain|low back pain
4656148|NCT03517410|Chronic Mechanical Low Back Pain|chronic mechanical low back pain
4656149|NCT03517410|CLBP|clbp
4656150|NCT03517397|Smoking Cessation|smoking cessation
4656151|NCT03517397|Socioeconomic Disadvantage|socioeconomic disadvantage
4656152|NCT03517397|Contingency Management|contingency management
4656153|NCT03517397|Financial Incentives|financial incentives
4656154|NCT03517397|Mobile Health|mobile health
4656155|NCT03517397|Biochemical Verification|biochemical verification
4656156|NCT03517371|Parkinson disease|parkinson disease
4656157|NCT03517371|Walking|walking
4656158|NCT03517371|Exercise|exercise
4656159|NCT03517371|Mobile Health|mobile health
4656160|NCT03517371|Physical Therapy|physical therapy
4656161|NCT03517371|Cognitive Behavioral|cognitive behavioral
4656162|NCT03517345|Bariatric surgery|bariatric surgery
4656163|NCT03517345|Prebiotics|prebiotics
4656164|NCT03517345|gut microbiota|gut microbiota
4656165|NCT03517345|GLP-1|glp-1
4656166|NCT03517345|PYY|pyy
4656167|NCT03517306|lung cancer, FDG, PET/CT, radiomics|lung cancer, fdg, pet/ct, radiomics
4656168|NCT03517280|Malnutrition|malnutrition
4656169|NCT03517280|Childhood Cancer|childhood cancer
4656170|NCT03517280|Nutrition Aspect of Cancer|nutrition aspect of cancer
4656171|NCT03517280|Child Malnutrition|child malnutrition
4656172|NCT03517280|Brazil|brazil
4656173|NCT03517280|Sao Paolo|sao paolo
4656174|NCT03517254|Glutamine,|glutamine,
4656175|NCT03517228|Robotic Uterine Manipulator|robotic uterine manipulator
4656176|NCT03517228|18-173|18-173
4656177|NCT03517202|Urologic surgery|urologic surgery
4656178|NCT03517202|Urinary incontinence|urinary incontinence
4656179|NCT03517202|Tension Free Vaginal Tape|tension free vaginal tape
4656180|NCT03517202|Post-operative urinary retention|post-operative urinary retention
4656181|NCT03517202|Outpatient surgery|outpatient surgery
4656182|NCT03517163|Asperger's|asperger's
4656183|NCT03517163|autism|autism
4656184|NCT03517163|autism spectrum disorder|autism spectrum disorder
4656185|NCT03517163|ASD|asd
4656186|NCT03517137|advanced Hodgkin lymphoma|advanced hodgkin lymphoma
4656187|NCT03517137|brentuximab vedotin|brentuximab vedotin
4656188|NCT03517137|phase 2|phase 2
4656189|NCT03517124|Zirconium oxide|zirconium oxide
4656190|NCT03517124|surface treatment|surface treatment
4656191|NCT03517124|resin cement|resin cement
4656192|NCT03517098|Enhanced recovery after surgery|enhanced recovery after surgery
4656193|NCT03517098|Desflurane|desflurane
4656194|NCT03517098|Total hip arthroplasty|total hip arthroplasty
4656195|NCT03517098|Total knee arthroplasty|total knee arthroplasty
4656196|NCT03517085|glycogen storage disorder Ia|glycogen storage disorder ia
4656198|NCT03517085|gene therapy|gene therapy
4656199|NCT03517085|von Gierke disease|von gierke disease
4656200|NCT03517085|glucose metabolism disorder|glucose metabolism disorder
4656201|NCT03517059|Levodopa|levodopa
4656202|NCT03517059|axial symptoms|axial symptoms
4656203|NCT03517046|Arthritis|arthritis
4656204|NCT03517046|Articular Cartilage|articular cartilage
4656205|NCT03517046|Autologous Chondrocyte Implantation|autologous chondrocyte implantation
4656206|NCT03517046|Degenerative Arthritis|degenerative arthritis
4656207|NCT03517046|Cartilage Lesion|cartilage lesion
4656208|NCT03517046|Cartilage Defect|cartilage defect
4656209|NCT03517007|antibiotic de-escalation|antibiotic de-escalation
4656210|NCT03517007|sepsis|sepsis
4656211|NCT03517007|antimicrobial stewardship|antimicrobial stewardship
4656212|NCT03516994|Advance Care Planning|advance care planning
4656213|NCT03516994|Disparities|disparities
4656214|NCT03516994|Palliative Care|palliative care
4656215|NCT03516994|End of Life Care|end of life care
4656216|NCT03516994|African Americans|african americans
4656217|NCT03516981|programmed cell death 1 (PD-1)|programmed cell death 1 (pd-1)
4656218|NCT03516981|programmed death ligand 1 (PD-L1)|programmed death ligand 1 (pd-l1)
4656219|NCT03516981|anti-PD-1|anti-pd-1
4656220|NCT03516981|anti PD-1|anti pd-1
4656221|NCT03516968|Obesity|obesity
4656222|NCT03516968|Vitamin D deficiency,|vitamin d deficiency,
4656223|NCT03516968|supplementation,|supplementation,
4656224|NCT03516968|Child|child
4656225|NCT03516968|Adolescent|adolescent
4656226|NCT03516955|Superstat|superstat
4656227|NCT03516955|Rosuvastatin|rosuvastatin
4656228|NCT03516955|Statins|statins
4656229|NCT03516955|LDL-C|ldl-c
4656230|NCT03516955|Cholesterol|cholesterol
4656231|NCT03516955|Hypercholesterolemia|hypercholesterolemia
4656232|NCT03516955|Dyslipidemia|dyslipidemia
4656233|NCT03516955|Coronary Artery Disease|coronary artery disease
4656234|NCT03516955|Cardiovascular Disease|cardiovascular disease
4656235|NCT03516916|Rectal cancer, HRQoL, Stoma, Colostomy, Patient reported outcome measure (PROM)|rectal cancer, hrqol, stoma, colostomy, patient reported outcome measure (prom)
4656236|NCT03516903|Anterior myocardial infarction|anterior myocardial infarction
4656237|NCT03516903|Methotrexate|methotrexate
4656238|NCT03516903|Myocardial remodeling|myocardial remodeling
4656239|NCT03516890|Partial hepatectomy|partial hepatectomy
4656240|NCT03516890|Emergency|emergency
4656241|NCT03516890|Staged|staged
4656242|NCT03516890|Peritoneal dissemination|peritoneal dissemination
4656243|NCT03516890|Propensity score matching|propensity score matching
4656244|NCT03516877|Mindfulness-Bases Stress Reduction, Stress, Resilience, Well-being|mindfulness-bases stress reduction, stress, resilience, well-being
4656245|NCT03516864|tissue oxygenation|tissue oxygenation
4656246|NCT03516864|near-infrared|near-infrared
4656247|NCT03516864|diabetic foot ulcer (DFU)|diabetic foot ulcer (dfu)
4656248|NCT03516864|diabetes|diabetes
4656249|NCT03516864|vascularity|vascularity
4656250|NCT03516851|Moyamoya Disease|moyamoya disease
4656251|NCT03516851|multimodal neuronavigation|multimodal neuronavigation
4656252|NCT03516851|flow800|flow800
4656253|NCT03516851|direct revascularization|direct revascularization
4656254|NCT03516838|Dental caries|dental caries
4656255|NCT03516838|Class II|class ii
4656256|NCT03516838|Primary molar|primary molar
4656257|NCT03516838|Restorative material|restorative material
4656258|NCT03516838|Bioactive material|bioactive material
4656259|NCT03516838|Compomer|compomer
4656260|NCT03516838|Activa bioactive|activa bioactive
4656261|NCT03516838|Ryge criteria|ryge criteria
4656262|NCT03516825|Musical Neglect Training|musical neglect training
4656263|NCT03516825|Neurologic Music Therapy|neurologic music therapy
4656264|NCT03516825|unilateral visual neglect|unilateral visual neglect
4656265|NCT03516825|hemispatial neglect|hemispatial neglect
4656266|NCT03516825|stroke|stroke
4656267|NCT03516825|spatial perception and attention|spatial perception and attention
4656268|NCT03516825|music therapy|music therapy
4656269|NCT03516799|pain management of adolescent and young adults with cancer|pain management of adolescent and young adults with cancer
4656270|NCT03516773|Hypoparathyroidism, PTH(1-34), Parathyroid Hormone|hypoparathyroidism, pth(1-34), parathyroid hormone
4656271|NCT03516747|cytology|cytology
4656272|NCT03516747|parathyroidectomy|parathyroidectomy
4656273|NCT03516747|parathyroid hormone level|parathyroid hormone level
4656274|NCT03516734|Iron deficiency|iron deficiency
4656275|NCT03516734|Food-based dietary intervention|food-based dietary intervention
4656276|NCT03516695|Registry|registry
4656277|NCT03516695|Liver Cancers|liver cancers
4656278|NCT03516695|HCC|hcc
4656279|NCT03516695|Dosimetry|dosimetry
4656280|NCT03516695|Simplicit90Y™|simplicit90y™
4656281|NCT03516695|TheraSphere®|therasphere®
4656282|NCT03516682|Logistic Barriers to Vaccination|logistic barriers to vaccination
4656283|NCT03516669|Lansoprazole, Amoxicillin, clarithromycin|lansoprazole, amoxicillin, clarithromycin
4656284|NCT03516630|Trazodone|trazodone
4656285|NCT03516630|QTc interval|qtc interval
4656286|NCT03516630|Moxifloxacin|moxifloxacin
4656287|NCT03516578|non-ST-elevation myocardial infarction|non-st-elevation myocardial infarction
4656288|NCT03516578|cardiac magnetic resonance|cardiac magnetic resonance
4656289|NCT03516578|prognosis|prognosis
4656290|NCT03516565|gingivitis|gingivitis
4656291|NCT03516565|saliva|saliva
4656292|NCT03516565|gingival crevicular fluid|gingival crevicular fluid
4656293|NCT03516539|Videolaryngoscopy|videolaryngoscopy
4656294|NCT03516526|natalizumab|natalizumab
4656295|NCT03516487|PKU|pku
4656296|NCT03516474|nir|nir
4656297|NCT03516474|diabetes|diabetes
4656298|NCT03516474|diabetic foot ulcer (DFU).|diabetic foot ulcer (dfu).
4656299|NCT03516474|wound|wound
4656300|NCT03516461|Gut Microbiota|gut microbiota
4656301|NCT03516461|Selective Microbiota Transplantation|selective microbiota transplantation
4656302|NCT03516461|Radiation Enteritis|radiation enteritis
4656303|NCT03516435|Intravaginal electrical stimulation|intravaginal electrical stimulation
4656304|NCT03516435|Parasacral transcutaneous electrical stimulation|parasacral transcutaneous electrical stimulation
4656305|NCT03516422|ultrasound debridement|ultrasound debridement
4656306|NCT03516422|diabetic foot ulcer|diabetic foot ulcer
4656307|NCT03516422|chronic wound|chronic wound
4656308|NCT03516422|biofilm|biofilm
4656309|NCT03516409|probiotics|probiotics
4656310|NCT03516409|prebiotics|prebiotics
4656311|NCT03516409|diarrhoea|diarrhoea
4656312|NCT03516396|Nepal|nepal
4656313|NCT03516396|child growth|child growth
4656314|NCT03516396|nutrition education|nutrition education
4656315|NCT03516396|community development|community development
4656316|NCT03516370|chronic periodontitis|chronic periodontitis
4656317|NCT03516370|Sacchraomyces boulardii|sacchraomyces boulardii
4656318|NCT03516370|probiotics|probiotics
4656319|NCT03516344|Breathing Exercises|breathing exercises
4656320|NCT03516344|Manipulation, Osteopathic|manipulation, osteopathic
4656321|NCT03516344|Quantitative Ultrasonography|quantitative ultrasonography
4656322|NCT03516344|Therapy, Soft Tissue|therapy, soft tissue
4656323|NCT03516344|Portal Vein|portal vein
4656324|NCT03516344|Venous flow|venous flow
4656325|NCT03516331|Cystic Fibrosis|cystic fibrosis
4656326|NCT03516318|HIV|hiv
4656327|NCT03516318|Youth|youth
4656328|NCT03516318|Social support|social support
4656329|NCT03516318|Social media|social media
4656330|NCT03516318|Retention|retention
4656331|NCT03516292|overactive bladder|overactive bladder
4656332|NCT03516292|biomarker|biomarker
4656333|NCT03516292|nerve growth factor|nerve growth factor
4656334|NCT03516292|vaginal prolapse|vaginal prolapse
4656335|NCT03516292|urinary incontinence|urinary incontinence
4656336|NCT03516266|Pelvic floor muscle strength|pelvic floor muscle strength
4656337|NCT03516266|Premenopausal nullipara|premenopausal nullipara
4656338|NCT03516266|Childbirth|childbirth
4656339|NCT03516266|Postmenopausal|postmenopausal
4656340|NCT03516214|Acquired resistance|acquired resistance
4656341|NCT03516214|EGFR p.T790M-positive|egfr p.t790m-positive
4656342|NCT03516201|bariatric surgery|bariatric surgery
4656343|NCT03516201|Periodontitis|periodontitis
4656344|NCT03516201|Caries|caries
4656345|NCT03516201|erosive tooth wear|erosive tooth wear
4656346|NCT03516201|Gingivitis|gingivitis
4656347|NCT03516201|BMI|bmi
4656348|NCT03516201|oral health|oral health
4656349|NCT03516201|obesity|obesity
4656350|NCT03516188|Gastroesophageal Reflux Disease|gastroesophageal reflux disease
4656351|NCT03516188|Acid pocket|acid pocket
4656352|NCT03516188|Acid Reflux|acid reflux
4656353|NCT03516188|Alginate antacid|alginate antacid
4656354|NCT03516188|Obesity|obesity
4656355|NCT03516162|Behaviour|behaviour
4656356|NCT03516162|Brain Tumor|brain tumor
4656357|NCT03516162|Hydrocephalus|hydrocephalus
4656358|NCT03516162|Smartphone|smartphone
4656359|NCT03516162|Big Data|big data
4656360|NCT03516162|Neuropsychology|neuropsychology
4656361|NCT03516162|Neuroradiology|neuroradiology
4656362|NCT03516162|Neurosurgery|neurosurgery
4656363|NCT03516162|Outcome Assessment|outcome assessment
4656364|NCT03516162|Functional Impairment|functional impairment
4656365|NCT03516162|Cognitive Function|cognitive function
4656366|NCT03516162|Touchscreen|touchscreen
4656367|NCT03516149|elbow|elbow
4656368|NCT03516149|foam rolling|foam rolling
4656369|NCT03516149|proprioception|proprioception
4656370|NCT03516149|sensorimotor|sensorimotor
4656371|NCT03516149|acute|acute
4656372|NCT03516071|Hepatocellular Carcinoma|hepatocellular carcinoma
4656373|NCT03516071|HCC|hcc
4656374|NCT03516071|Brivanib|brivanib
4656375|NCT03516045|18F-AlF-NOTA-neurotensin|18f-alf-nota-neurotensin
4656376|NCT03516032|exercises therapy|exercises therapy
4656377|NCT03516032|rehabilitation|rehabilitation
4656378|NCT03516032|aged|aged
4656379|NCT03516032|inpatients|inpatients
4656380|NCT03516019|mHealth|mhealth
4656381|NCT03516019|digital BP monitoring|digital bp monitoring
4656382|NCT03516019|patient provider communication|patient provider communication
4656383|NCT03516019|smart watch|smart watch
4656384|NCT03516019|user engagement|user engagement
4656385|NCT03516019|population health data|population health data
4656386|NCT03515993|long-term survival|long-term survival
4656387|NCT03515993|gynecologic cancer|gynecologic cancer
4656388|NCT03515993|quality of life|quality of life
4656389|NCT03515967|concussion, mild traumatic brain injury|concussion, mild traumatic brain injury
4656390|NCT03515954|conjunctiva|conjunctiva
4656391|NCT03515954|squamous neoplasia|squamous neoplasia
4656392|NCT03515954|amniotic|amniotic
4656393|NCT03515941|chemotherapy|chemotherapy
4656394|NCT03515941|chemoradiation|chemoradiation
4656395|NCT03515928|Ultrasound, Hearing|ultrasound, hearing
4656396|NCT03515915|multiple myeloma|multiple myeloma
4656397|NCT03515915|HDAC inhibitor|hdac inhibitor
4656398|NCT03515915|Biomarker|biomarker
4656399|NCT03515902|Dentine Hypersensitivity|dentine hypersensitivity
4656400|NCT03515902|Toothpaste|toothpaste
4656401|NCT03515902|Tooth erosion|tooth erosion
4656402|NCT03515837|PD1|pd1
4656403|NCT03515837|PD-1|pd-1
4656404|NCT03515837|PDL1|pdl1
4656405|NCT03515837|PD-L1|pd-l1
4656406|NCT03515785|acute lymphoblastic leukemia|acute lymphoblastic leukemia
4656407|NCT03515785|ponatinib|ponatinib
4656408|NCT03515785|tyrosine kinase inhibitor|tyrosine kinase inhibitor
4656409|NCT03515772|dolutegravir|dolutegravir
4656410|NCT03515772|darunavir|darunavir
4656411|NCT03515772|amlodipine|amlodipine
4656412|NCT03515772|rosuvastatin|rosuvastatin
4656413|NCT03515772|atorvastatin|atorvastatin
4656414|NCT03515759|PREECLAMPSIA|preeclampsia
4656415|NCT03515759|DOPPLER|doppler
4656416|NCT03515759|IUGR|iugr
4656417|NCT03515759|UMBILICAL ARTERY|umbilical artery
4656418|NCT03515759|MIDDLE CEREBRAL ARTERY|middle cerebral artery
4656419|NCT03515746|exergaming|exergaming
4656420|NCT03515746|physiotherapy|physiotherapy
4656421|NCT03515746|upper extremities|upper extremities
4656422|NCT03515746|telerehabilitation|telerehabilitation
4656423|NCT03515694|Bridion|bridion
4656424|NCT03515694|Sugammadex|sugammadex
4656425|NCT03515694|TOF|tof
4656426|NCT03515681|Text messaging|text messaging
4656427|NCT03515642|Gut microbiota|gut microbiota
4656428|NCT03515642|Hepatic function|hepatic function
4656429|NCT03515642|Obesity|obesity
4656430|NCT03515642|Exercise|exercise
4656431|NCT03515629|Stage IIIB|stage iiib
4656432|NCT03515629|Stage IV|stage iv
4656433|NCT03515629|Non-squamous NSCLC|non-squamous nsclc
4656434|NCT03515629|Squamous NSCLC|squamous nsclc
4656435|NCT03515551|Melanoma|melanoma
4656436|NCT03515551|Lung Cancer|lung cancer
4656437|NCT03515551|Bladder Cancer|bladder cancer
4656438|NCT03515551|Sarcoma|sarcoma
4656439|NCT03515551|IMCnyeso|imcnyeso
4656440|NCT03515551|Immunotherapy|immunotherapy
4656441|NCT03515538|head and neck cancer|head and neck cancer
4656442|NCT03515538|squamous|squamous
4656443|NCT03515538|neck cancer|neck cancer
4656444|NCT03515538|oral cancer|oral cancer
4656445|NCT03515538|mucositis|mucositis
4656446|NCT03515538|sores|sores
4656447|NCT03515538|mouth|mouth
4656448|NCT03515525|Breast surgery|breast surgery
4656449|NCT03515525|Closed-suction drains|closed-suction drains
4656450|NCT03515512|Acute Myeloid Leukemia|acute myeloid leukemia
4656451|NCT03515512|Chronic Myelomonocytic Leukemia|chronic myelomonocytic leukemia
4656452|NCT03515499|Adherence|adherence
4656453|NCT03515499|Incentives|incentives
4656454|NCT03515486|Stroke|stroke
4656455|NCT03515486|Cerebellum|cerebellum
4656456|NCT03515486|Depression|depression
4656457|NCT03515486|Anxiety|anxiety
4656458|NCT03515486|Mood|mood
4656459|NCT03515486|Magnetic resonance imaging (MRI)|magnetic resonance imaging (mri)
4656460|NCT03515473|cochlear implant|cochlear implant
4656461|NCT03515473|CI532|ci532
4656462|NCT03515473|CI512|ci512
4656463|NCT03515473|CI522|ci522
4656464|NCT03515473|electrode array|electrode array
4656465|NCT03515473|perimodiolar|perimodiolar
4656466|NCT03515473|electrophysiology|electrophysiology
4656467|NCT03515460|vascular endothelial function|vascular endothelial function
4656567|NCT03514992|Outcom study|outcom study
4656468|NCT03515460|systemic microvascular reactivity|systemic microvascular reactivity
4656469|NCT03515460|dysglycemia|dysglycemia
4656470|NCT03515460|dyslipidemia|dyslipidemia
4656471|NCT03515447|transfusion saving strategy|transfusion saving strategy
4656472|NCT03515447|heart or lung transplantation|heart or lung transplantation
4656473|NCT03515447|assist device|assist device
4656474|NCT03515447|Extra Corporal Life Support (ECLS)|extra corporal life support (ecls)
4656475|NCT03515447|Left Ventricular Assist Device (LVAD )|left ventricular assist device (lvad )
4656476|NCT03515447|Total artificial Heart|total artificial heart
4656477|NCT03515408|fMRI|fmri
4656478|NCT03515408|rTMS|rtms
4656479|NCT03515408|functional connectivity|functional connectivity
4656480|NCT03515395|exergaming|exergaming
4656481|NCT03515395|hip fracture|hip fracture
4656482|NCT03515395|training|training
4656483|NCT03515395|acceptance|acceptance
4656484|NCT03515369|hepatocellular carcinoma|hepatocellular carcinoma
4656485|NCT03515369|tumor recurrence|tumor recurrence
4656486|NCT03515369|adjuvant therapy|adjuvant therapy
4656487|NCT03515369|traditional Chinese medicine|traditional chinese medicine
4656488|NCT03515343|Cancer prevention|cancer prevention
4656489|NCT03515343|Endoscopy|endoscopy
4656490|NCT03515343|Gastroenterology|gastroenterology
4656491|NCT03515330|mHealth|mhealth
4656492|NCT03515330|liver transplantation|liver transplantation
4656493|NCT03515330|medication adherence|medication adherence
4656494|NCT03515330|video directly observed therapy|video directly observed therapy
4656495|NCT03515317|Cognitive impairments|cognitive impairments
4656496|NCT03515317|Low Resolution tomography|low resolution tomography
4656497|NCT03515317|Neurofeedback|neurofeedback
4656498|NCT03515317|Traumatic brain injury|traumatic brain injury
4656499|NCT03515291|Heart|heart
4656500|NCT03515291|CABG|cabg
4656501|NCT03515291|Injection|injection
4656502|NCT03515291|Scar|scar
4656503|NCT03515291|Fibrosis|fibrosis
4656504|NCT03515291|Cell|cell
4656505|NCT03515291|Progenitor|progenitor
4656506|NCT03515291|Immunomodulatory|immunomodulatory
4656507|NCT03515291|MRI|mri
4656508|NCT03515291|Randomized|randomized
4656509|NCT03515278|Frozen shoulder|frozen shoulder
4656510|NCT03515278|adhesive capsulitis|adhesive capsulitis
4656511|NCT03515278|ultrasound-guided intervention|ultrasound-guided intervention
4656512|NCT03515278|suprascapular nerve block|suprascapular nerve block
4656513|NCT03515278|intra-articular injection|intra-articular injection
4656514|NCT03515265|Fiber reinforced composite|fiber reinforced composite
4656515|NCT03515265|Microhybrid composite|microhybrid composite
4656516|NCT03515226|workforce development|workforce development
4656517|NCT03515226|intelligent tutoring systems|intelligent tutoring systems
4656518|NCT03515187|Dug induced dry eye|dug induced dry eye
4656519|NCT03515187|meibomian gland dysfunction, MGD|meibomian gland dysfunction, mgd
4656520|NCT03515187|Sodium hyaluronate ophthalmic solution|sodium hyaluronate ophthalmic solution
4656521|NCT03515187|Sodium bromide hydrate eye drops|sodium bromide hydrate eye drops
4656522|NCT03515187|Meibomian gland massage|meibomian gland massage
4656523|NCT03515174|Adolescent and Young Adult Oncology|adolescent and young adult oncology
4656524|NCT03515174|Carcinoma|carcinoma
4656525|NCT03515174|Lymphoma|lymphoma
4656526|NCT03515174|Sarcoma|sarcoma
4656527|NCT03515174|Cancer|cancer
4656528|NCT03515161|closedloop|closedloop
4656529|NCT03515161|vasopressor|vasopressor
4656530|NCT03515148|Achilles Tendinopathy|achilles tendinopathy
4656531|NCT03515148|Rectus Abominis|rectus abominis
4656532|NCT03515148|Vibration|vibration
4656533|NCT03515148|Cryotherapy|cryotherapy
4656534|NCT03515148|Eccentric Exercise|eccentric exercise
4656535|NCT03515135|ADHD|adhd
4656536|NCT03515135|executive function|executive function
4656537|NCT03515135|preschool|preschool
4656538|NCT03515135|intervention|intervention
4656539|NCT03515122|Epidemiology|epidemiology
4656540|NCT03515122|Rehabilitation|rehabilitation
4656541|NCT03515122|Clinical protocols|clinical protocols
4656542|NCT03515122|Middle aged|middle aged
4656543|NCT03515109|stress incontinence|stress incontinence
4656544|NCT03515109|female|female
4656545|NCT03515109|altis|altis
4656546|NCT03515109|transobturator tape|transobturator tape
4656547|NCT03515109|minisling|minisling
4656548|NCT03515096|rhTPO|rhtpo
4656549|NCT03515096|HSCT|hsct
4656550|NCT03515096|Thrombopoietin|thrombopoietin
4656551|NCT03515083|apixaban|apixaban
4656552|NCT03515083|atrial fibrillation|atrial fibrillation
4656553|NCT03515070|Gastrointestinal Microbiome|gastrointestinal microbiome
4656554|NCT03515070|Genetics|genetics
4656555|NCT03515031|High Flow Nasal Cannula|high flow nasal cannula
4656556|NCT03515031|Venturi mask|venturi mask
4656557|NCT03515018|Leukemia, Myeloid, Chronic-Phase|leukemia, myeloid, chronic-phase
4656558|NCT03515018|hydroxyurea|hydroxyurea
4656559|NCT03515018|Imatinib Mesylate|imatinib mesylate
4656560|NCT03515018|Pulse Therapy, Drug|pulse therapy, drug
4656561|NCT03515005|Hypertension|hypertension
4656562|NCT03515005|Community Health Workers|community health workers
4656563|NCT03515005|Community-Based Participatory Research|community-based participatory research
4656564|NCT03515005|Health Equity|health equity
4656565|NCT03514992|Developmental Dysgraphia|developmental dysgraphia
4656566|NCT03514992|Ambidexterity|ambidexterity
4656568|NCT03514966|Position change|position change
4656569|NCT03514966|Gastric cleanliness|gastric cleanliness
4656570|NCT03514966|Magnetically controlled capsule endoscopy|magnetically controlled capsule endoscopy
4656571|NCT03514914|LARC, contraception, family planning, India, male engagement|larc, contraception, family planning, india, male engagement
4656572|NCT03514888|High-risk bladder cancer|high-risk bladder cancer
4656573|NCT03514888|Urothelial cancer|urothelial cancer
4656574|NCT03514888|HIPEC|hipec
4656575|NCT03514888|Mitomycin|mitomycin
4656576|NCT03514836|Castrate-resistant|castrate-resistant
4656577|NCT03514810|Major depressive disorder|major depressive disorder
4656578|NCT03514810|sertraline|sertraline
4656579|NCT03514810|ketoprofen|ketoprofen
4656580|NCT03514797|Tooth bleaching|tooth bleaching
4656581|NCT03514797|Hydrogen peroxide|hydrogen peroxide
4656582|NCT03514797|Carbamide peroxide|carbamide peroxide
4656583|NCT03514797|Tooth Bleaching Agents|tooth bleaching agents
4656584|NCT03514784|Autism Spectrum Disorder, Gastrointestinal Symptoms, Constipation, Diarrhea,|autism spectrum disorder, gastrointestinal symptoms, constipation, diarrhea,
4656585|NCT03514719|89Zr-avelumab PET|89zr-avelumab pet
4656586|NCT03514719|avelumab|avelumab
4656587|NCT03514706|Extravascular lung water|extravascular lung water
4656588|NCT03514706|one lung ventilation|one lung ventilation
4656589|NCT03514706|volume controlled ventilation|volume controlled ventilation
4656590|NCT03514706|pressure controlled ventilation|pressure controlled ventilation
4656591|NCT03514693|Persistent atrial fibrillation|persistent atrial fibrillation
4656592|NCT03514693|non-inferiority trial|non-inferiority trial
4656593|NCT03514680|Cancer Care|cancer care
4656594|NCT03514654|Breast Cancer|breast cancer
4656595|NCT03514654|Mastectomy|mastectomy
4656596|NCT03514654|Therapeutic Mammoplasty|therapeutic mammoplasty
4656597|NCT03514654|Multiple Ipsilateral Breast Cancers|multiple ipsilateral breast cancers
4656598|NCT03514628|Valsalva Manoeuvre|valsalva manoeuvre
4656599|NCT03514628|SVT|svt
4656600|NCT03514628|Valsalva Assist Device|valsalva assist device
4656601|NCT03514576|gastric bypass|gastric bypass
4656602|NCT03514576|hypoglycemia|hypoglycemia
4656603|NCT03514576|hyperinsulinemia|hyperinsulinemia
4656604|NCT03514563|Cleft Lip and Palate|cleft lip and palate
4656605|NCT03514563|Maxillofacial|maxillofacial
4656606|NCT03514563|Growth|growth
4656607|NCT03514563|3D|3d
4656608|NCT03514498|anesthesia|anesthesia
4656609|NCT03514485|asthma disparities|asthma disparities
4656610|NCT03514485|community health worker|community health worker
4656611|NCT03514485|childhood asthma|childhood asthma
4656612|NCT03514472|Hb, Anemia,|hb, anemia,
4656613|NCT03514433|Patient Navigation|patient navigation
4656614|NCT03514433|Disparity|disparity
4656615|NCT03514433|Social Determinants|social determinants
4656616|NCT03514420|Lipodystrophy|lipodystrophy
4656617|NCT03514420|Lipodystrophy, Familial Partial|lipodystrophy, familial partial
4656618|NCT03514420|Lipid Metabolism Disorders|lipid metabolism disorders
4656619|NCT03514420|Dyslipidemias|dyslipidemias
4656620|NCT03514420|Kobberling-Dunnigan syndrome (type 1 and 2)|kobberling-dunnigan syndrome (type 1 and 2)
4656621|NCT03514420|Lipoatrophic Diabetes|lipoatrophic diabetes
4656622|NCT03514407|Relapsed Ewing sarcoma|relapsed ewing sarcoma
4656623|NCT03514407|bromodomain-containing protein (BRD) inhibitor|bromodomain-containing protein (brd) inhibitor
4656624|NCT03514407|lysine demethylase 1 (LSD1) inhibitor|lysine demethylase 1 (lsd1) inhibitor
4656625|NCT03514381|Soft Tissue Sarcoma|soft tissue sarcoma
4656626|NCT03514381|Ifosfamide|ifosfamide
4656627|NCT03514381|Aprepitant|aprepitant
4656628|NCT03514381|Doxorubicin|doxorubicin
4656629|NCT03514368|Immune checkpoint modulation|immune checkpoint modulation
4656630|NCT03514368|Tumor antigens|tumor antigens
4656631|NCT03514368|Adaptive immune responses|adaptive immune responses
4656632|NCT03514368|Tumor molecular signature|tumor molecular signature
4656633|NCT03514342|Heart rate variability|heart rate variability
4656634|NCT03514342|Scotopic pupil size|scotopic pupil size
4656635|NCT03514329|Non Small Cell Lung Cancer|non small cell lung cancer
4656636|NCT03514329|Metastatic Lung Cancer|metastatic lung cancer
4656637|NCT03514329|Lung Cancer|lung cancer
4656638|NCT03514329|Vapor Ablation|vapor ablation
4656639|NCT03514329|BTVA|btva
4656640|NCT03514316|gingival overgrowth|gingival overgrowth
4656641|NCT03514316|diode laser gingivectomy|diode laser gingivectomy
4656642|NCT03514316|scalpel gingivectomy|scalpel gingivectomy
4656643|NCT03514316|orthodontic treatment|orthodontic treatment
4656644|NCT03514303|Skin test, Microarray test|skin test, microarray test
4656645|NCT03514290|Laser|laser
4656646|NCT03514290|Color|color
4656647|NCT03514264|Endodontics|endodontics
4656648|NCT03514264|Biomaterials|biomaterials
4656649|NCT03514264|Dental pulp cavity|dental pulp cavity
4656650|NCT03514264|Periapical abscess|periapical abscess
4656651|NCT03514264|Root canal therapy|root canal therapy
4656652|NCT03514264|Root canal obturation|root canal obturation
4656653|NCT03514251|Thyroid Cancer|thyroid cancer
4656654|NCT03514251|Hypoparathyroidism|hypoparathyroidism
4656655|NCT03514251|parathyroid marker|parathyroid marker
4656656|NCT03514238|Exercise|exercise
4656657|NCT03514238|Physical Activity|physical activity
4656658|NCT03514238|Cardio-metabolic Health|cardio-metabolic health
4656659|NCT03514238|Myokines|myokines
4656660|NCT03514238|Cardiorespiratory Fitness|cardiorespiratory fitness
4656661|NCT03514238|Obesity|obesity
4656662|NCT03514238|Type 2 Diabetes|type 2 diabetes
4656663|NCT03514225|Metacognitive Therapy|metacognitive therapy
4656664|NCT03514212|physical activity|physical activity
4656665|NCT03514212|intervention|intervention
4656666|NCT03514212|walking|walking
4656667|NCT03514186|Aphasia|aphasia
4656668|NCT03514186|Speech and Language Treatment|speech and language treatment
4656669|NCT03514186|ICAP|icap
4656670|NCT03514186|Intensive Comprehensive Aphasia Program|intensive comprehensive aphasia program
4656671|NCT03514147|Women|women
4656672|NCT03514147|Pelvic Floor Muscles|pelvic floor muscles
4656673|NCT03514108|Heart failure|heart failure
4656674|NCT03514108|Diabetes|diabetes
4656675|NCT03514108|Insulin resistance|insulin resistance
4656676|NCT03514108|Metformin|metformin
4656677|NCT03514108|Hydralazine|hydralazine
4656678|NCT03514108|Isosorbide Dinitrate|isosorbide dinitrate
4656679|NCT03514069|ruxolitinib|ruxolitinib
4656680|NCT03514069|radiation|radiation
4656681|NCT03514069|temozolomide|temozolomide
4656682|NCT03514056|Fibromyalgia|fibromyalgia
4656683|NCT03514056|Behcet Disease|behcet disease
4656684|NCT03514056|Trigger points|trigger points
4656685|NCT03514043|Ambulatory care|ambulatory care
4656686|NCT03514043|Emergency general surgery|emergency general surgery
4656687|NCT03514043|Patient satisfaction|patient satisfaction
4656688|NCT03514017|Lymphocytic|lymphocytic
4656689|NCT03514017|Leukemia|leukemia
4656690|NCT03514017|CLL|cll
4656691|NCT03514017|Blood disease|blood disease
4656692|NCT03514017|White blood cells|white blood cells
4656693|NCT03514017|Bone marrow disease|bone marrow disease
4656694|NCT03514017|Immunotherapy|immunotherapy
4656695|NCT03514004|Suicide prevention|suicide prevention
4656696|NCT03514004|Information and Communication Technologies|information and communication technologies
4656697|NCT03514004|Cluster Randomized Controlled Trial|cluster randomized controlled trial
4656698|NCT03514004|Latin America|latin america
4656699|NCT03513991|human milk|human milk
4656700|NCT03513991|infant formula with low protein|infant formula with low protein
4656701|NCT03513991|alpha lactoalbumin|alpha lactoalbumin
4656702|NCT03513991|growth velocity|growth velocity
4656703|NCT03513991|gastrointestinal events|gastrointestinal events
4656704|NCT03513978|Soccer|soccer
4656705|NCT03513978|Prevention injury|prevention injury
4656706|NCT03513965|food allergy|food allergy
4656707|NCT03513965|oral immunotherapy|oral immunotherapy
4656708|NCT03513965|mindsets|mindsets
4656709|NCT03513965|patient experience|patient experience
4656710|NCT03513939|Type 1 Diabetes Mellitus, Diabetes, hypoglycemia|type 1 diabetes mellitus, diabetes, hypoglycemia
4656711|NCT03513926|miRNA|mirna
4656712|NCT03513926|Cardiovascular Risk|cardiovascular risk
4656713|NCT03513926|CPAP|cpap
4656714|NCT03513926|Obstructive Sleep Apnea|obstructive sleep apnea
4656715|NCT03513926|Hypertension|hypertension
4656716|NCT03513926|Molecular profile|molecular profile
4656717|NCT03513913|in vitro fertilization|in vitro fertilization
4656718|NCT03513913|intracytoplasmic sperm injection|intracytoplasmic sperm injection
4656719|NCT03513913|fertilization|fertilization
4656720|NCT03513913|Assisted reproduction|assisted reproduction
4656721|NCT03513900|Cirrhosis|cirrhosis
4656722|NCT03513900|Non-invasive methods|non-invasive methods
4656723|NCT03513900|portal hypertensive gastropathy|portal hypertensive gastropathy
4656724|NCT03513887|cirrhosis,varices,variceal bleeding, noninvasive tests,TE|cirrhosis,varices,variceal bleeding, noninvasive tests,te
4656725|NCT03513861|Low and Middle Income Countries|low and middle income countries
4656726|NCT03513861|Limited resource settings|limited resource settings
4656727|NCT03513861|Early warning signs|early warning signs
4656728|NCT03513822|KETAMINE|ketamine
4656729|NCT03513822|CHRONIC PAIN|chronic pain
4656730|NCT03513822|NEUROPATHIC PAIN|neuropathic pain
4656731|NCT03513822|KYNURENINE|kynurenine
4656732|NCT03513822|KYNURENINE PATHWAY|kynurenine pathway
4656733|NCT03513822|BEDSORES|bedsores
4656734|NCT03513822|ANTI-INFLAMMATORY|anti-inflammatory
4656735|NCT03513822|ULCER PRESSURE|ulcer pressure
4656736|NCT03513809|Acute Hypoxemic Respiratory Failure|acute hypoxemic respiratory failure
4656737|NCT03513809|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
4656738|NCT03513809|Electrical impedance tomography|electrical impedance tomography
4656739|NCT03513809|Spontaneous breathing|spontaneous breathing
4656740|NCT03513809|Ventilation induced-lung injury|ventilation induced-lung injury
4656741|NCT03513809|Patient self-inflicted lung injury|patient self-inflicted lung injury
4656742|NCT03513783|Spinal Cord Injury|spinal cord injury
4656743|NCT03513783|tendon transfer|tendon transfer
4656744|NCT03513783|muscle synergy|muscle synergy
4656745|NCT03513783|muscle co-activation|muscle co-activation
4656746|NCT03513783|electromyography|electromyography
4656747|NCT03513770|venous distension reflex|venous distension reflex
4656748|NCT03513744|human milk oligosaccharides|human milk oligosaccharides
4656749|NCT03513744|infant formula|infant formula
4656750|NCT03513718|Acute kidney injury, AKI|acute kidney injury, aki
4656751|NCT03513705|implementation|implementation
4656752|NCT03513705|randomized trial|randomized trial
4656753|NCT03513705|pancreatic cancer|pancreatic cancer
4656754|NCT03513705|nationwide|nationwide
4656755|NCT03513705|survival|survival
4656756|NCT03513705|quality of life|quality of life
4656757|NCT03513653|acute heart failure|acute heart failure
4656758|NCT03513653|global longitudinal strain|global longitudinal strain
4656759|NCT03513653|ejection fraction|ejection fraction
4656760|NCT03513653|echocardiography|echocardiography
4656761|NCT03513653|mortality|mortality
4656762|NCT03513627|periimplant soft tissue|periimplant soft tissue
4656763|NCT03513627|gingiva|gingiva
4656764|NCT03513627|human|human
4656765|NCT03513627|microcirculation|microcirculation
4656766|NCT03513614|Tailored Axillary Surgery|tailored axillary surgery
4656767|NCT03513614|TAXIS|taxis
4656768|NCT03513614|Breast Cancer|breast cancer
4656769|NCT03513614|node-positive breast cancer|node-positive breast cancer
4656770|NCT03513614|phase III trial|phase iii trial
4656771|NCT03513614|IBCSG 57-18|ibcsg 57-18
4656772|NCT03513614|ABCSG|abcsg
4656773|NCT03513601|Curative effect evaluation|curative effect evaluation
4656774|NCT03513601|Adverse reactions|adverse reactions
4656775|NCT03513601|Clinical characteristics|clinical characteristics
4656777|NCT03513601|PFS|pfs
4656778|NCT03513601|OS|os
4656779|NCT03513575|pH of saliva|ph of saliva
4656780|NCT03513575|Flavored Milk|flavored milk
4656781|NCT03513575|buffering agent|buffering agent
4656782|NCT03513575|oral hygiene|oral hygiene
4656783|NCT03513549|Agitation|agitation
4656784|NCT03513549|Schizophrenia|schizophrenia
4656785|NCT03513549|Bipolar I disorder|bipolar i disorder
4656786|NCT03513536|Aromatherapy|aromatherapy
4656787|NCT03513536|Essential Oils|essential oils
4656788|NCT03513510|evidence-based programs|evidence-based programs
4656789|NCT03513510|community-based participatory research|community-based participatory research
4656790|NCT03513510|program adoption|program adoption
4656791|NCT03513497|Teeth|teeth
4656792|NCT03513497|Periodontal disease|periodontal disease
4656793|NCT03513497|acute inflammatory response|acute inflammatory response
4656794|NCT03513497|stent-induced biofilm overgrowth|stent-induced biofilm overgrowth
4656795|NCT03513497|periodontal pathogens|periodontal pathogens
4656796|NCT03513471|Late Phase Asthmatic Response|late phase asthmatic response
4656797|NCT03513471|Allergen Challenge|allergen challenge
4656798|NCT03513458|Late Phase Asthmatic Response|late phase asthmatic response
4656799|NCT03513458|Allergen Challenge|allergen challenge
4656800|NCT03513432|Gut microbiota|gut microbiota
4656801|NCT03513432|Beer|beer
4656802|NCT03513432|Alcohol|alcohol
4656803|NCT03513432|Cardiovascular disease|cardiovascular disease
4656804|NCT03513406|muscle function|muscle function
4656805|NCT03513393|velpatasvir|velpatasvir
4656806|NCT03513393|cola|cola
4656807|NCT03513393|omeprazole|omeprazole
4656808|NCT03513393|proton pump inhibitors|proton pump inhibitors
4656809|NCT03513380|Exercise therapy|exercise therapy
4656810|NCT03513380|Physical fitness|physical fitness
4656811|NCT03513380|Gaming|gaming
4656812|NCT03513380|Adult|adult
4656813|NCT03513380|Healthy lifestyle|healthy lifestyle
4656814|NCT03513380|Fitness testing|fitness testing
4656815|NCT03513367|Duchenne Muscular Dystrophy,|duchenne muscular dystrophy,
4656816|NCT03513367|Pediatric Quality of Life Inventory|pediatric quality of life inventory
4656817|NCT03513367|disability paradox|disability paradox
4656818|NCT03513354|Aging; Physical activity; Motor activity; Quality of life|aging; physical activity; motor activity; quality of life
4656819|NCT03513341|Physical activity|physical activity
4656820|NCT03513341|Sedentary behaviour|sedentary behaviour
4656821|NCT03513341|Undergraduate|undergraduate
4656822|NCT03513328|human leukocyte antigen (HLA)|human leukocyte antigen (hla)
4656823|NCT03513315|Heat-related illnesses|heat-related illnesses
4656824|NCT03513315|Heat Illnesses|heat illnesses
4656825|NCT03513315|Community based interventions|community based interventions
4656826|NCT03513315|heatwave|heatwave
4656827|NCT03513315|Pakistan|pakistan
4656828|NCT03513315|emergency preparedness|emergency preparedness
4656829|NCT03513315|emergency medicine|emergency medicine
4656830|NCT03513315|heat stroke|heat stroke
4656831|NCT03513315|heat exhaustion|heat exhaustion
4656832|NCT03513315|urban health|urban health
4656833|NCT03513302|nitric oxide|nitric oxide
4656834|NCT03513289|ICU delirium|icu delirium
4656835|NCT03513289|post-intensive care syndrome|post-intensive care syndrome
4656836|NCT03513289|critical illness myopathy|critical illness myopathy
4656837|NCT03513211|Biochemically recurrent prostate cancer|biochemically recurrent prostate cancer
4656838|NCT03513211|Hormone sensitive prostate cancer|hormone sensitive prostate cancer
4656839|NCT03513198|contrast-enhanced endoscopic ultrasound|contrast-enhanced endoscopic ultrasound
4656840|NCT03513198|endoscopic ultrasound elastography|endoscopic ultrasound elastography
4656841|NCT03513198|tumor vascularity|tumor vascularity
4656842|NCT03513198|prognostic|prognostic
4656843|NCT03513185|somatic symptom disorder|somatic symptom disorder
4656844|NCT03513185|the Somatic Symptom Scale-China|the somatic symptom scale-china
4656845|NCT03513185|mental disorders management|mental disorders management
4656846|NCT03513172|Intraocular Pressure|intraocular pressure
4656847|NCT03513172|Anti-VEGF Agents|anti-vegf agents
4656848|NCT03513172|alpha2-agonists|alpha2-agonists
4656849|NCT03513159|transitional care, geriatric, readmission|transitional care, geriatric, readmission
4656850|NCT03513133|working memory|working memory
4656851|NCT03513133|cognitive rehabilitation|cognitive rehabilitation
4656852|NCT03513133|functional neuroimaging|functional neuroimaging
4656949|NCT03512665|cardiovascular risk|cardiovascular risk
4656853|NCT03513120|Adolescent Idiopathic Scoliosis|adolescent idiopathic scoliosis
4656854|NCT03513120|Posterior Spinal Fusion|posterior spinal fusion
4656855|NCT03513120|Return to Sport|return to sport
4656856|NCT03513107|Osteoporosis|osteoporosis
4656857|NCT03513094|Kinetics|kinetics
4656858|NCT03513094|Transversus abdominis|transversus abdominis
4656859|NCT03513081|food neophobia|food neophobia
4656860|NCT03513081|preschool|preschool
4656861|NCT03513081|children|children
4656862|NCT03513068|COPD|copd
4656863|NCT03513068|POC|poc
4656864|NCT03513068|Oxygen|oxygen
4656865|NCT03513068|QoL|qol
4656866|NCT03513055|glucose excursions|glucose excursions
4656867|NCT03513055|insulin technique|insulin technique
4656868|NCT03513055|insulin antibodies|insulin antibodies
4656869|NCT03513055|premixed insulin|premixed insulin
4656870|NCT03513042|intensity-modulated proton therapy|intensity-modulated proton therapy
4656871|NCT03513042|therapy response evaluation|therapy response evaluation
4656872|NCT03513042|positron emission tomography (PET)|positron emission tomography (pet)
4656873|NCT03513042|hypoxia|hypoxia
4656874|NCT03513042|metabolism|metabolism
4656875|NCT03513042|18F-fluoroazomycin-arabinoside (FAZA)|18f-fluoroazomycin-arabinoside (faza)
4656876|NCT03513042|18F-2-fluoro-2-deoxy-D-glucose (FDG)|18f-2-fluoro-2-deoxy-d-glucose (fdg)
4656877|NCT03513042|head and neck neoplasms|head and neck neoplasms
4656878|NCT03513042|image-guided proton therapy|image-guided proton therapy
4656879|NCT03513042|treatment outcome|treatment outcome
4656880|NCT03513042|predictive biomarker|predictive biomarker
4656881|NCT03513029|PAF|paf
4656882|NCT03513029|atrial fibrillation|atrial fibrillation
4656883|NCT03513029|ablation|ablation
4656884|NCT03513029|low intensity collimated ultrasound|low intensity collimated ultrasound
4656885|NCT03513016|Osteoarthritis|osteoarthritis
4656886|NCT03513016|Painful Osteoarthritis|painful osteoarthritis
4656887|NCT03513016|Osteoarthritis, Knee|osteoarthritis, knee
4656888|NCT03513016|Senescence|senescence
4656889|NCT03512990|Brachial Plexus Block|brachial plexus block
4656890|NCT03512990|Superior Trunk|superior trunk
4656891|NCT03512990|Phrenic Nerve|phrenic nerve
4656892|NCT03512977|spinal anesthesia|spinal anesthesia
4656893|NCT03512977|sphenopalatine ganglion block|sphenopalatine ganglion block
4656894|NCT03512977|postspinal headache|postspinal headache
4656895|NCT03512951|Hearing aids|hearing aids
4656896|NCT03512951|Remote microphone systems|remote microphone systems
4656897|NCT03512951|Roger technology|roger technology
4656898|NCT03512951|Sound externalization|sound externalization
4656899|NCT03512951|Auditory distance estimation|auditory distance estimation
4656900|NCT03512938|Generalized aggressive periodontitis|generalized aggressive periodontitis
4656901|NCT03512938|Non-surgical periodontal therapy|non-surgical periodontal therapy
4656902|NCT03512938|Periodontopathogens|periodontopathogens
4656903|NCT03512938|Smoking|smoking
4656904|NCT03512938|Gingival crevicular fluid|gingival crevicular fluid
4656905|NCT03512925|Coercion|coercion
4656906|NCT03512925|Debriefing|debriefing
4656907|NCT03512925|Mental health|mental health
4656908|NCT03512925|Seclusion|seclusion
4656909|NCT03512925|Mechanical restraint|mechanical restraint
4656910|NCT03512899|implantable port|implantable port
4656911|NCT03512886|Multiple sclerosis|multiple sclerosis
4656912|NCT03512886|Multi-task training|multi-task training
4656913|NCT03512886|Balance|balance
4656914|NCT03512886|Mobility|mobility
4656915|NCT03512886|Cognition|cognition
4656916|NCT03512886|Upper extremity function|upper extremity function
4656917|NCT03512873|Scleredema Diabeticorum|scleredema diabeticorum
4656918|NCT03512873|Tranilast|tranilast
4656919|NCT03512860|Estetrol|estetrol
4656920|NCT03512860|Drospirenone|drospirenone
4656921|NCT03512860|Uridine diphosphate glucuronosyltransferase-2B7|uridine diphosphate glucuronosyltransferase-2b7
4656922|NCT03512860|Drug-drug interaction|drug-drug interaction
4656923|NCT03512860|Valproic acid|valproic acid
4656924|NCT03512847|liquid biopsy|liquid biopsy
4656925|NCT03512847|genomic profiling|genomic profiling
4656926|NCT03512847|ctDNA|ctdna
4656927|NCT03512834|angiosarcoma|angiosarcoma
4656928|NCT03512834|paclitaxel|paclitaxel
4656929|NCT03512834|avelumab|avelumab
4656930|NCT03512769|jaw support device, third molars, wisdom teeth, partially erupted or impacted|jaw support device, third molars, wisdom teeth, partially erupted or impacted
4656931|NCT03512756|Pancreatic cancer|pancreatic cancer
4656932|NCT03512756|Pancreas cancer|pancreas cancer
4656933|NCT03512756|Pancreatic|pancreatic
4656934|NCT03512756|Pancreas|pancreas
4656935|NCT03512756|cancer|cancer
4656936|NCT03512756|non- toxic|non- toxic
4656937|NCT03512756|no toxicity|no toxicity
4656938|NCT03512756|chemotherapy|chemotherapy
4656939|NCT03512756|metastatic|metastatic
4656940|NCT03512743|bone mineral density|bone mineral density
4656941|NCT03512743|bone turnover markers|bone turnover markers
4656942|NCT03512743|ferritin|ferritin
4656943|NCT03512730|regenera|regenera
4656944|NCT03512704|Heart failure|heart failure
4656945|NCT03512704|clinical prediction rules|clinical prediction rules
4656946|NCT03512704|health services research|health services research
4656947|NCT03512691|Risk perceptions and attitudes, time preference, information|risk perceptions and attitudes, time preference, information
4656948|NCT03512665|Pre-diabetes|pre-diabetes
4656950|NCT03512665|lipids|lipids
4656951|NCT03512665|insulin resistance|insulin resistance
4656952|NCT03512665|obesity|obesity
4656953|NCT03512665|overweight|overweight
4656954|NCT03512639|Mastectomy, Breast Reconstruction, Homeopathic Treatment|mastectomy, breast reconstruction, homeopathic treatment
4656955|NCT03512626|OptiVis|optivis
4656956|NCT03512626|hybrid multifocal intraocular lens|hybrid multifocal intraocular lens
4656957|NCT03512626|multifocal intraocular lens|multifocal intraocular lens
4656958|NCT03512626|presbyopia|presbyopia
4656959|NCT03512600|lithiasis|lithiasis
4656960|NCT03512600|uric acid|uric acid
4656961|NCT03512600|crystallization|crystallization
4656962|NCT03512587|Personalized quantum sonotherapy|personalized quantum sonotherapy
4656963|NCT03512587|Regional anesthesia|regional anesthesia
4656964|NCT03512587|Peripheral nerve block|peripheral nerve block
4656965|NCT03512574|pregabalin, dexmedetomidine, postoperative pain|pregabalin, dexmedetomidine, postoperative pain
4656966|NCT03512522|chronic pain|chronic pain
4656967|NCT03512522|pain self-management|pain self-management
4656968|NCT03512522|remote delivery|remote delivery
4656969|NCT03512522|workbook|workbook
4656970|NCT03512522|online|online
4656971|NCT03512496|Energy Drink|energy drink
4656972|NCT03512496|Pediatric|pediatric
4656973|NCT03512496|Metabolism|metabolism
4656974|NCT03512496|Glucose|glucose
4656975|NCT03512496|Caffeine|caffeine
4656976|NCT03512496|Obesity|obesity
4656977|NCT03512496|Nutrition|nutrition
4656978|NCT03512496|Metabolomics|metabolomics
4656979|NCT03512496|Health Behavior|health behavior
4656980|NCT03512496|Glucose Intolerance|glucose intolerance
4656981|NCT03512483|Atrial Fibrillation|atrial fibrillation
4656982|NCT03512483|Rural|rural
4656983|NCT03512483|Virtual|virtual
4656984|NCT03512483|Older Adults|older adults
4656985|NCT03512470|surgical wound|surgical wound
4656986|NCT03512470|Prevena System|prevena system
4656987|NCT03512457|Melanoma|melanoma
4656988|NCT03512457|Skin self-examination|skin self-examination
4656989|NCT03512457|mammogram|mammogram
4656990|NCT03512444|negative pressure therapy|negative pressure therapy
4656991|NCT03512444|negative pressure|negative pressure
4656992|NCT03512444|Wound therapy|wound therapy
4656993|NCT03512444|NPWT|npwt
4656994|NCT03512444|Vacuum therapy|vacuum therapy
4656995|NCT03512444|VAC|vac
4656996|NCT03512431|analytical method validation|analytical method validation
4656997|NCT03512431|renal transplantation|renal transplantation
4656998|NCT03512431|limited sampling strategy|limited sampling strategy
4656999|NCT03512418|HIV prevention|hiv prevention
4657000|NCT03512418|Pre-exposure prophylaxis|pre-exposure prophylaxis
4657001|NCT03512418|Digital Pill|digital pill
4657002|NCT03512418|Substance use disorder|substance use disorder
4657003|NCT03512418|Stimulant use|stimulant use
4657004|NCT03512392|fluid therapy|fluid therapy
4657005|NCT03512392|furosemide|furosemide
4657006|NCT03512392|diuretics|diuretics
4657007|NCT03512392|Injections, Intravenous|injections, intravenous
4657008|NCT03512392|Infusions, Intravenous|infusions, intravenous
4657009|NCT03512392|Spironolactone|spironolactone
4657010|NCT03512392|Indapamide|indapamide
4657011|NCT03512379|robot-assisted surgery|robot-assisted surgery
4657012|NCT03512379|pedicle screw|pedicle screw
4657013|NCT03512379|spine|spine
4657014|NCT03512366|inguinal hernia|inguinal hernia
4657015|NCT03512366|lichtenstein's technique|lichtenstein's technique
4657016|NCT03512366|desarda's technique|desarda's technique
4657017|NCT03512366|local anaesthesia|local anaesthesia
4657018|NCT03512340|CD47|cd47
4657019|NCT03512340|SiRP α|sirp α
4657020|NCT03512340|tumor microenvironment|tumor microenvironment
4657021|NCT03512340|macrophage|macrophage
4657022|NCT03512340|solid tumor|solid tumor
4657023|NCT03512340|Phase 1|phase 1
4657024|NCT03512340|safety|safety
4657025|NCT03512340|efficacy|efficacy
4657026|NCT03512340|hematologic malignancies|hematologic malignancies
4657027|NCT03512340|SRF231|srf231
4657028|NCT03512275|Hidradenitis Suppurativa|hidradenitis suppurativa
4657029|NCT03512262|BA058|ba058
4657030|NCT03512262|abaloparatide|abaloparatide
4657031|NCT03512262|abaloparatide-SC|abaloparatide-sc
4657032|NCT03512262|osteoporosis|osteoporosis
4657033|NCT03512262|male osteoporosis|male osteoporosis
4657034|NCT03512262|TYMLOS™|tymlos™
4657035|NCT03512262|fracture|fracture
4657036|NCT03512262|bone loss|bone loss
4657037|NCT03512197|Newly diagnosed FLT3-mutation negative|newly diagnosed flt3-mutation negative
4657038|NCT03512197|PKC412|pkc412
4657039|NCT03512197|midostaurin|midostaurin
4657040|NCT03512197|cytarabine|cytarabine
4657041|NCT03512197|daunorubicin|daunorubicin
4657042|NCT03512197|idarubicin|idarubicin
4657043|NCT03512197|acute myeloid leukemia|acute myeloid leukemia
4657044|NCT03512197|AML|aml
4657045|NCT03512197|FLT3-MN (SR<0.05)|flt3-mn (sr<0.05)
4657046|NCT03512197|combination treatment|combination treatment
4657047|NCT03512197|induction failure|induction failure
4657048|NCT03512197|event free survival|event free survival
4657049|NCT03512197|EFS|efs
4657050|NCT03512197|minimal residual disease|minimal residual disease
4657051|NCT03512119|Cystic fibrosis|cystic fibrosis
4657052|NCT03512119|Glucose tolerance abnormalities|glucose tolerance abnormalities
4657053|NCT03512119|CFTR corrector and potentiator|cftr corrector and potentiator
4657054|NCT03512106|Arterial Hypertension|arterial hypertension
4657055|NCT03512106|Acupuncture|acupuncture
4657056|NCT03512093|Preterm Infant|preterm infant
4657057|NCT03512080|Warfarin|warfarin
4657058|NCT03512080|Anticoagulation|anticoagulation
4657059|NCT03512080|Clinical Dosing Algorithm|clinical dosing algorithm
4657060|NCT03512080|Genetic Dosing Algorithm|genetic dosing algorithm
4657061|NCT03512080|International Normalised Ratio|international normalised ratio
4657062|NCT03512080|Uganda|uganda
4657063|NCT03512080|Cape Town|cape town
4657064|NCT03512080|Cardiovascular Disease|cardiovascular disease
4657065|NCT03512080|Genome-wide Association Study|genome-wide association study
4657066|NCT03512080|Stratified Medicine|stratified medicine
4657067|NCT03512080|Pharmacogenetics|pharmacogenetics
4657068|NCT03512067|Mechanical Ventilation|mechanical ventilation
4657069|NCT03512067|Respiratory Support|respiratory support
4657070|NCT03512054|Tracheostomy|tracheostomy
4657071|NCT03512054|Decannulation|decannulation
4657072|NCT03512054|Rehabilitation|rehabilitation
4657073|NCT03512054|Brain injury|brain injury
4657074|NCT03512054|Neurosurgery|neurosurgery
4657075|NCT03512041|ischemic conditioning, motor learning|ischemic conditioning, motor learning
4657076|NCT03512028|ischemic conditioning, motor learning, strength, cognition|ischemic conditioning, motor learning, strength, cognition
4657077|NCT03512015|Lung Cancer|lung cancer
4657078|NCT03512002|Neurotechnology|neurotechnology
4657079|NCT03512002|Autonomic Dysregulation|autonomic dysregulation
4657080|NCT03512002|Hyperarousal|hyperarousal
4657081|NCT03512002|Brain Electrical Activity|brain electrical activity
4657082|NCT03512002|HIRREM|hirrem
4657083|NCT03512002|Acoustic Stimulation|acoustic stimulation
4657084|NCT03512002|Perimenopausal|perimenopausal
4657085|NCT03512002|Postmenopausal|postmenopausal
4657086|NCT03512002|Hot Flashes|hot flashes
4657087|NCT03512002|Night Sweats|night sweats
4657088|NCT03512002|Vasomotor Symptoms|vasomotor symptoms
4657089|NCT03512002|Allostatis|allostatis
4657090|NCT03511937|Food and beverage purchases|food and beverage purchases
4657091|NCT03511937|Sugar-sweetened beverages|sugar-sweetened beverages
4657092|NCT03511937|Beverages|beverages
4657093|NCT03511924|resistance training|resistance training
4657094|NCT03511924|circulating microRNA´s|circulating microrna´s
4657095|NCT03511924|muscle strength|muscle strength
4657096|NCT03511911|Pelvic floor muscle strength|pelvic floor muscle strength
4657097|NCT03511911|modified Oxford Grading Scale|modified oxford grading scale
4657098|NCT03511911|Levator ani testing|levator ani testing
4657099|NCT03511911|vaginal contraction pressure|vaginal contraction pressure
4657100|NCT03511911|reliability|reliability
4657101|NCT03511885|Cardiovascular|cardiovascular
4657102|NCT03511885|Prevention|prevention
4657103|NCT03511885|EUROASPIRE|euroaspire
4657104|NCT03511872|Basic life support|basic life support
4657105|NCT03511872|cardiopulmonary resuscitation|cardiopulmonary resuscitation
4657106|NCT03511872|medical undergraduate students|medical undergraduate students
4657107|NCT03511872|crisis|crisis
4657108|NCT03511872|randomized controlled trial.|randomized controlled trial.
4657109|NCT03511859|Breast cancer. Circulating tumor cells. CTCs. Cell free DNA. cfDNA|breast cancer. circulating tumor cells. ctcs. cell free dna. cfdna
4657110|NCT03511846|Brain Freeze|brain freeze
4657111|NCT03511846|Capsaicin|capsaicin
4657112|NCT03511833|Intra nasal ketamine|intra nasal ketamine
4657113|NCT03511833|IV morphine|iv morphine
4657114|NCT03511833|acute traumatic pain|acute traumatic pain
4657115|NCT03511820|Amphotericin B|amphotericin b
4657116|NCT03511820|liposome|liposome
4657117|NCT03511820|post marketing surveillance|post marketing surveillance
4657118|NCT03511794|Hepatitis B Reactivation|hepatitis b reactivation
4657119|NCT03511794|Allogenic Stem Cell Transplant|allogenic stem cell transplant
4657120|NCT03511768|18F-AlF-NOTA-octreotide|18f-alf-nota-octreotide
4657121|NCT03511729|Tau/P-Tau|tau/p-tau
4657122|NCT03511729|biomarker|biomarker
4657123|NCT03511729|neurocognitive|neurocognitive
4657124|NCT03511729|outcomes|outcomes
4657125|NCT03511729|children|children
4657126|NCT03511716|Mitral Insufficiency|mitral insufficiency
4657127|NCT03511716|Mitral Valve Incompetence|mitral valve incompetence
4657128|NCT03511690|Latinas, African Americans|latinas, african americans
4657129|NCT03511677|Insole|insole
4657130|NCT03511677|Morton Neuroma|morton neuroma
4657131|NCT03511677|Pain|pain
4657132|NCT03511677|Function|function
4657133|NCT03511664|mCRPC|mcrpc
4657134|NCT03511664|177Lu-PSMA-617|177lu-psma-617
4657135|NCT03511664|PSMA-617|psma-617
4657136|NCT03511664|PSMA-11|psma-11
4657137|NCT03511664|radioligand therapy|radioligand therapy
4657138|NCT03511560|Envarsus XR|envarsus xr
4657139|NCT03511560|Tacrolimus|tacrolimus
4657140|NCT03511560|Kidney Transplantation|kidney transplantation
4657141|NCT03511534|treatment, psychotherapy, pharmacotherapy|treatment, psychotherapy, pharmacotherapy
4657142|NCT03511521|steroid|steroid
4657143|NCT03511521|prednisone|prednisone
4657144|NCT03511521|methylprednisolone|methylprednisolone
4657145|NCT03511521|hyperglycemia|hyperglycemia
4657146|NCT03511521|insulin|insulin
4657147|NCT03511521|hypoglycemia|hypoglycemia
4657148|NCT03511508|pregnancy|pregnancy
4657149|NCT03511508|maternity Care|maternity care
4657150|NCT03511508|complex intervention|complex intervention
4657151|NCT03511508|interdisiplinary team|interdisiplinary team
4657152|NCT03511508|chronic disease|chronic disease
4657153|NCT03511508|interdisciplinary|interdisciplinary
4657154|NCT03511508|midwifery|midwifery
4657155|NCT03511469|Kontralateral Education, Bankart, Rehabilitation, Shoulder,|kontralateral education, bankart, rehabilitation, shoulder,
4657156|NCT03511456|leg pain|leg pain
4657157|NCT03511456|waist pain|waist pain
4657158|NCT03511456|life quality|life quality
4657159|NCT03511443|hsRDT|hsrdt
4657160|NCT03511443|usRDT|usrdt
4657161|NCT03511443|Reactive Case Detection (RCD)|reactive case detection (rcd)
4657162|NCT03511443|High risk for malaria|high risk for malaria
4657163|NCT03511430|Acute Coronary Syndrome|acute coronary syndrome
4657164|NCT03511430|Heart Diseases|heart diseases
4657165|NCT03511430|Cardiovascular Diseases|cardiovascular diseases
4657166|NCT03511430|Vascular Diseases|vascular diseases
4657167|NCT03511404|Non specific chronic low back pain|non specific chronic low back pain
4657168|NCT03511404|surface electromyography (EMG)|surface electromyography (emg)
4657169|NCT03511404|neuromuscular function|neuromuscular function
4657170|NCT03511404|physiotherapy|physiotherapy
4657171|NCT03511404|Numeric Pain Rating Scale|numeric pain rating scale
4657172|NCT03511391|radiotherapy|radiotherapy
4657173|NCT03511391|checkpoint inhibitors|checkpoint inhibitors
4657174|NCT03511378|Breast Carcinoma|breast carcinoma
4657175|NCT03511378|Breast neoplasms|breast neoplasms
4657176|NCT03511378|Breast Tumors|breast tumors
4657177|NCT03511378|Cancer of Breast|cancer of breast
4657178|NCT03511378|Anti-Drug Antibodies (ADA)|anti-drug antibodies (ada)
4657179|NCT03511378|Immunogenicity|immunogenicity
4657180|NCT03511365|Probiotic|probiotic
4657181|NCT03511365|Microbiome|microbiome
4657182|NCT03511365|Inflammation|inflammation
4657183|NCT03511365|Non-Alcoholic Fatty Liver Disease|non-alcoholic fatty liver disease
4657184|NCT03511326|field-treatment|field-treatment
4657185|NCT03511313|Primary Hypertension|primary hypertension
4657186|NCT03511313|Renal Denervation|renal denervation
4657187|NCT03511300|Cognition|cognition
4657188|NCT03511300|Apathy|apathy
4657189|NCT03511287|inspiratory muscle training|inspiratory muscle training
4657190|NCT03511287|advanced lung disease|advanced lung disease
4657191|NCT03511287|maximal inspiratory pressure|maximal inspiratory pressure
4657192|NCT03511287|inspiratory endurance|inspiratory endurance
4657193|NCT03511274|Cytomegalovirus Congenital|cytomegalovirus congenital
4657194|NCT03511274|CMV|cmv
4657195|NCT03511274|Cytomegalovirus infections|cytomegalovirus infections
4657196|NCT03511261|Oral submucous fibrosis|oral submucous fibrosis
4657197|NCT03511261|curcumin|curcumin
4657198|NCT03511261|potentially malignant disease|potentially malignant disease
4657199|NCT03511248|Heart Failure|heart failure
4657200|NCT03511248|Heart Failure with Reduced Ejection Fraction|heart failure with reduced ejection fraction
4657201|NCT03511248|Nitric Oxide|nitric oxide
4657202|NCT03511248|Inorganic Nitrate|inorganic nitrate
4657203|NCT03511209|Sleep Initiation and Maintenance Disorders|sleep initiation and maintenance disorders
4657204|NCT03511209|Hypnotics and Sedatives|hypnotics and sedatives
4657205|NCT03511196|stage IV castration sensitive prostate cancer|stage iv castration sensitive prostate cancer
4657206|NCT03511196|advanced castration sensitive prostate cancer|advanced castration sensitive prostate cancer
4657207|NCT03511157|ischemic preconditioning|ischemic preconditioning
4657208|NCT03511131|HIV prevention|hiv prevention
4657209|NCT03511131|Adolescent risk-taking behaviors|adolescent risk-taking behaviors
4657210|NCT03511105|Lipopolysaccharide|lipopolysaccharide
4657211|NCT03511105|Pharmacodynamics|pharmacodynamics
4657212|NCT03511105|Healthy subjects|healthy subjects
4657213|NCT03511105|GSK2798745|gsk2798745
4657214|NCT03511105|Placebo|placebo
4657215|NCT03511105|Segmental challenge|segmental challenge
4657216|NCT03511092|Leucine metabolites|leucine metabolites
4657217|NCT03511092|Resistance training|resistance training
4657218|NCT03511092|Hypertrophy|hypertrophy
4657219|NCT03511092|Strength|strength
4657220|NCT03511092|Supplement|supplement
4657221|NCT03511079|Music|music
4657222|NCT03511066|efficacy|efficacy
4657223|NCT03511066|safety|safety
4657224|NCT03511027|Medication Adherence|medication adherence
4657225|NCT03511027|Medication Dispensing|medication dispensing
4657226|NCT03511027|Homecare|homecare
4657227|NCT03511027|Elderly|elderly
4657228|NCT03510975|behavioural therapy|behavioural therapy
4657229|NCT03510975|mono symptomatic nocturnal enuresis|mono symptomatic nocturnal enuresis
4657230|NCT03510975|compliance|compliance
4657231|NCT03510975|response|response
4657232|NCT03510962|pH of saliva|ph of saliva
4657233|NCT03510962|Fruit juice|fruit juice
4657234|NCT03510962|buffering agent|buffering agent
4657235|NCT03510962|oral hygiene|oral hygiene
4657236|NCT03510936|Probiotics|probiotics
4657237|NCT03510936|Gut Microbiome|gut microbiome
4657238|NCT03510936|Infants|infants
4657239|NCT03510936|Jaundice|jaundice
4657240|NCT03510923|Appendix|appendix
4657241|NCT03510923|Appendectomy|appendectomy
4657242|NCT03510923|Gallbladder|gallbladder
4657243|NCT03510923|Cholecystectomy|cholecystectomy
4657244|NCT03510923|Neoplasms|neoplasms
4657245|NCT03510923|Pathology|pathology
4657246|NCT03510923|Selective|selective
4657247|NCT03510923|Routine|routine
4657248|NCT03510897|MAKE|make
4657249|NCT03510897|AKI|aki
4657250|NCT03510871|neoadjuvant therapy|neoadjuvant therapy
4657251|NCT03510819|Dental trauma|dental trauma
4657252|NCT03510819|Emergency management|emergency management
4657253|NCT03510819|Tooth avulsion|tooth avulsion
4657254|NCT03510819|Knowledge|knowledge
4657255|NCT03510819|Practice|practice
4657256|NCT03510819|Traumatic injuries|traumatic injuries
4657257|NCT03510819|Attitude|attitude
4657258|NCT03510793|microcirculation; aortic aneurysm; anesthesia|microcirculation; aortic aneurysm; anesthesia
4657259|NCT03510780|Platlet rich fibrin|platlet rich fibrin
4657260|NCT03510780|Enamel Matrix Derivative|enamel matrix derivative
4657261|NCT03510780|Bone graft|bone graft
4657262|NCT03510780|Non-inferiority study|non-inferiority study
4657263|NCT03510754|Endoscopic ultrasound|endoscopic ultrasound
4657264|NCT03510754|Biliary drainage|biliary drainage
4657265|NCT03510754|Endoscopic ultrasound guided biliary drainage|endoscopic ultrasound guided biliary drainage
4657266|NCT03510741|Schizophrenia|schizophrenia
4657267|NCT03510741|Sodium Benzoate|sodium benzoate
4657268|NCT03510741|N-Acetylcysteine|n-acetylcysteine
4657269|NCT03510741|NMDA receptor|nmda receptor
4657270|NCT03510741|Psychopharmacology|psychopharmacology
4657271|NCT03510741|Anti-oxidant|anti-oxidant
4657272|NCT03510741|Inflammation|inflammation
4657273|NCT03510728|Protective Behavioral Strategies|protective behavioral strategies
4657274|NCT03510702|Epigenetic.|epigenetic.
4657275|NCT03510702|microRNA.|microrna.
4657276|NCT03510702|Periodontitis.|periodontitis.
4657277|NCT03510650|Hemophagocytic Lymphohistiocytosis (HLH)|hemophagocytic lymphohistiocytosis (hlh)
4657278|NCT03510650|Hemophagocytic syndrome (HPS)|hemophagocytic syndrome (hps)
4657279|NCT03510650|critically ill|critically ill
4657280|NCT03510650|Intensive care unit (ICU)|intensive care unit (icu)
4657281|NCT03510637|Hepatitis C, Genotype 4, DAAs, Real life evaluation|hepatitis c, genotype 4, daas, real life evaluation
4657282|NCT03510585|mucociliary clearance|mucociliary clearance
4657283|NCT03510585|air pollution|air pollution
4657284|NCT03510585|nasal lavage|nasal lavage
4657285|NCT03510585|exhaled breath condensate|exhaled breath condensate
4657286|NCT03510585|inflammation|inflammation
4657287|NCT03510572|[18F]PI-2620, tauopathy, positron emission computed tomography|[18f]pi-2620, tauopathy, positron emission computed tomography
4657288|NCT03510533|autoantibodies (autoAc) circulating|autoantibodies (autoac) circulating
4657289|NCT03510533|neuropeptides (Ghrelin, l'α-MSH)|neuropeptides (ghrelin, l'α-msh)
4657290|NCT03510533|potential digestive origin|potential digestive origin
4657291|NCT03510520|Hemodialysis|hemodialysis
4657292|NCT03510520|Haemodialysis|haemodialysis
4657293|NCT03510520|Hemodiafiltration|hemodiafiltration
4657294|NCT03510520|Haemodiafiltration|haemodiafiltration
4657295|NCT03510520|Dialysis membrane|dialysis membrane
4657296|NCT03510520|Endothelial Microvesicles|endothelial microvesicles
4657297|NCT03510520|Pulse Wave Velocity|pulse wave velocity
4657298|NCT03510507|Lyme arthritis|lyme arthritis
4657299|NCT03510507|Borrelia burgdorferi|borrelia burgdorferi
4657300|NCT03510507|vector tick|vector tick
4657301|NCT03510507|Arthritis|arthritis
4657302|NCT03510507|joints|joints
4657303|NCT03510481|Infection|infection
4657304|NCT03510481|Malaria|malaria
4657305|NCT03510481|Transmission|transmission
4657306|NCT03510481|Treatment|treatment
4657307|NCT03510481|Disease|disease
4657308|NCT03510468|Antiretrovial Therapy|antiretrovial therapy
4657309|NCT03510468|Human Immunodeficiency Virus|human immunodeficiency virus
4657310|NCT03510468|Latent Tuberculosis Infection (LTBI)|latent tuberculosis infection (ltbi)
4657311|NCT03510468|Drug-Drug Interaction|drug-drug interaction
4657312|NCT03510468|Rifamycin|rifamycin
4657313|NCT03510455|Renal Phosphate Wasting|renal phosphate wasting
4657314|NCT03510455|Phosphaturic Mesenchymal Tumors|phosphaturic mesenchymal tumors
4657315|NCT03510455|Fibroblast Growth Factor (FGF23)|fibroblast growth factor (fgf23)
4657316|NCT03510455|FGFR Inhibitors|fgfr inhibitors
4657317|NCT03510455|Hypophosphatemia|hypophosphatemia
4657318|NCT03510442|Inflammation|inflammation
4657319|NCT03510442|Fever|fever
4657320|NCT03510442|Arthritis|arthritis
4657321|NCT03510442|Sequencing|sequencing
4657322|NCT03510416|apatinib，TACE， hepatocellular carcinoma|apatinib，tace， hepatocellular carcinoma
4657323|NCT03510390|head and neck cancer|head and neck cancer
4657324|NCT03510390|tissue hypoxia|tissue hypoxia
4657325|NCT03510390|metformin|metformin
4657326|NCT03510364|Subjective social status|subjective social status
4657327|NCT03510364|Obesity|obesity
4657328|NCT03510364|High calorie intake|high calorie intake
4657329|NCT03510364|Energy balance|energy balance
4657330|NCT03510364|Eating behavior|eating behavior
4657331|NCT03510325|Schizophrenia; Antipsychotics；Cost-Effectiveness Analyses|schizophrenia; antipsychotics；cost-effectiveness analyses
4657332|NCT03510286|proteinuria|proteinuria
4657333|NCT03510286|preeclampsia|preeclampsia
4657334|NCT03510286|diagnostic|diagnostic
4657335|NCT03510286|dipstick|dipstick
4657336|NCT03510286|protein|protein
4657337|NCT03510286|urine|urine
4657338|NCT03510286|creatinine|creatinine
4657339|NCT03510273|Thermocoagulation|thermocoagulation
4657340|NCT03510273|Treatment|treatment
4657341|NCT03510273|Cervical precancer|cervical precancer
4657648|NCT03507933|Hip|hip
4657342|NCT03510260|Cesarean, Consent, Electronic, Satisfaction|cesarean, consent, electronic, satisfaction
4657343|NCT03510234|Pigmentary retinopathy|pigmentary retinopathy
4657344|NCT03510234|Argus II retinal prosthesis|argus ii retinal prosthesis
4657345|NCT03510234|Self-confidence|self-confidence
4657346|NCT03510221|Hypertension|hypertension
4657347|NCT03510221|Oxidative stress|oxidative stress
4657348|NCT03510221|Antioxidant|antioxidant
4657349|NCT03510221|Autonomic imbalance|autonomic imbalance
4657350|NCT03510221|Insulin resistance|insulin resistance
4657351|NCT03510221|Cytokines|cytokines
4657352|NCT03510143|thyroid cancer|thyroid cancer
4657353|NCT03510143|Neoveil|neoveil
4657354|NCT03510143|seroma|seroma
4657355|NCT03510143|chyle leakage|chyle leakage
4657356|NCT03510117|Mindfulness|mindfulness
4657357|NCT03510117|Patient reported outcomes measures|patient reported outcomes measures
4657358|NCT03510117|PROMIS|promis
4657359|NCT03510104|MerTK|mertk
4657360|NCT03510078|Diabetes Mellitus|diabetes mellitus
4657361|NCT03510078|hyperglycemic control|hyperglycemic control
4657362|NCT03510078|hospitalization|hospitalization
4657363|NCT03510078|internal medicine|internal medicine
4657364|NCT03510065|hip arthroplasty|hip arthroplasty
4657365|NCT03510065|revision arthroplasty|revision arthroplasty
4657366|NCT03510065|survival|survival
4657367|NCT03510052|diet|diet
4657368|NCT03510052|Fecal Incontinence|fecal incontinence
4657369|NCT03510052|FI|fi
4657370|NCT03510052|ABL|abl
4657371|NCT03510039|Involuntary commitment hospitalization|involuntary commitment hospitalization
4657372|NCT03510039|close relative|close relative
4657373|NCT03510026|internal thoracic artery harvesting|internal thoracic artery harvesting
4657374|NCT03510026|arterial graft patency|arterial graft patency
4657375|NCT03510026|electrosurgery|electrosurgery
4657376|NCT03510026|arterial graft preparation|arterial graft preparation
4657377|NCT03510013|low flow anesthesia|low flow anesthesia
4657378|NCT03510013|wash-in|wash-in
4657379|NCT03510013|sevoflurane|sevoflurane
4657380|NCT03510000|T1DM|t1dm
4657381|NCT03510000|artificial pancreas|artificial pancreas
4657382|NCT03510000|insulin pump|insulin pump
4657383|NCT03510000|empagliflozin|empagliflozin
4657384|NCT03510000|SGLT2 inhibitor|sglt2 inhibitor
4657385|NCT03510000|carbohydrate counting|carbohydrate counting
4657386|NCT03509935|ultrasound,|ultrasound,
4657387|NCT03509935|high-risk surgery|high-risk surgery
4657388|NCT03509935|intensive care|intensive care
4657389|NCT03509909|yoga|yoga
4657390|NCT03509909|exercise|exercise
4657391|NCT03509909|randomized controlled trial|randomized controlled trial
4657392|NCT03509870|diabetes|diabetes
4657393|NCT03509818|Klotho|klotho
4657394|NCT03509818|Exercise|exercise
4657395|NCT03509818|Physical Fitness|physical fitness
4657396|NCT03509805|sleep apnea syndrome|sleep apnea syndrome
4657397|NCT03509805|obesity|obesity
4657398|NCT03509805|pregnancy|pregnancy
4657399|NCT03509805|preeclampsia|preeclampsia
4657400|NCT03509766|allergic|allergic
4657401|NCT03509766|rhinitis|rhinitis
4657402|NCT03509766|allergy|allergy
4657403|NCT03509766|asthma|asthma
4657404|NCT03509766|food allergy|food allergy
4657405|NCT03509766|skin testing|skin testing
4657406|NCT03509766|skin prick test|skin prick test
4657407|NCT03509753|Prebiotic fiber|prebiotic fiber
4657408|NCT03509701|Reversible cerebral vasoconstriction syndrome|reversible cerebral vasoconstriction syndrome
4657409|NCT03509701|Herpes zoster|herpes zoster
4657410|NCT03509701|Varicella-zoster virus infection|varicella-zoster virus infection
4657411|NCT03509688|entecavir|entecavir
4657412|NCT03509688|resveratrol|resveratrol
4657413|NCT03509688|thymosin|thymosin
4657414|NCT03509688|hepatitis B|hepatitis b
4657415|NCT03509675|Oral Ulceration|oral ulceration
4657416|NCT03509662|Vitamin C|vitamin c
4657417|NCT03509662|Cardiac Arrest|cardiac arrest
4657418|NCT03509662|Post-cardiac arrest syndrome|post-cardiac arrest syndrome
4657419|NCT03509662|Oxidative stress|oxidative stress
4657420|NCT03509623|neovascular age-related macular degeneration|neovascular age-related macular degeneration
4657421|NCT03509623|aflibercept|aflibercept
4657422|NCT03509623|intravitreal anti-VEGF|intravitreal anti-vegf
4657423|NCT03509623|coagulation|coagulation
4657424|NCT03509623|platelet count|platelet count
4657425|NCT03509623|D-Dimer|d-dimer
4657426|NCT03509623|Fibrinogen|fibrinogen
4657427|NCT03509610|Physical Activity|physical activity
4657428|NCT03509610|Nutrition|nutrition
4657429|NCT03509610|Carbohydrates|carbohydrates
4657430|NCT03509597|Cognitive remediation|cognitive remediation
4657431|NCT03509597|Aerobic exercise|aerobic exercise
4657432|NCT03509597|Physical exercise|physical exercise
4657433|NCT03509597|Negative symptoms|negative symptoms
4657434|NCT03509597|Functional outcome|functional outcome
4657435|NCT03509597|Cognition|cognition
4657436|NCT03509558|Spinal electrical stimulation|spinal electrical stimulation
4657437|NCT03509545|natriuresis|natriuresis
4657438|NCT03509519|neuromuscular electrical stimulation|neuromuscular electrical stimulation
4657439|NCT03509519|physical activity|physical activity
4657440|NCT03509519|muscular strength|muscular strength
4657441|NCT03509493|Primary prevention|primary prevention
4657442|NCT03509493|Secondary prevention|secondary prevention
4657443|NCT03509493|Clinical practice|clinical practice
4657444|NCT03509467|skin cancer prevention|skin cancer prevention
4657445|NCT03509467|educational materials|educational materials
4657446|NCT03509467|skin cancer risk|skin cancer risk
4657447|NCT03509467|questionnaire|questionnaire
4657448|NCT03509467|MC1R genotype|mc1r genotype
4657449|NCT03509441|South Asian|south asian
4657450|NCT03509441|Insulin Resistance|insulin resistance
4657451|NCT03509441|Cardiac Fibrosis|cardiac fibrosis
4657452|NCT03509441|MRI|mri
4657453|NCT03509441|Diabetes|diabetes
4657454|NCT03509441|Cardiomyopathy|cardiomyopathy
4657455|NCT03509428|Exercise|exercise
4657456|NCT03509428|mortality|mortality
4657457|NCT03509428|morbidity|morbidity
4657458|NCT03509428|surgery|surgery
4657459|NCT03509428|colorectal|colorectal
4657460|NCT03509428|upper gastrointestinal|upper gastrointestinal
4657461|NCT03509428|hepatobiliary|hepatobiliary
4657462|NCT03509428|urology|urology
4657463|NCT03509428|lung|lung
4657464|NCT03509428|nutrition|nutrition
4657465|NCT03509428|psychology|psychology
4657466|NCT03509415|Confocal|confocal
4657467|NCT03509415|RCM|rcm
4657468|NCT03509415|Imaging|imaging
4657469|NCT03509415|Skin cancer|skin cancer
4657470|NCT03509402|short dental implants|short dental implants
4657471|NCT03509402|full-arch prosthesis|full-arch prosthesis
4657472|NCT03509350|Vitamin C|vitamin c
4657473|NCT03509350|Thiamine|thiamine
4657474|NCT03509350|Corticosteroid|corticosteroid
4657475|NCT03509337|Elastography, Nervous tissue, Muscle tonus|elastography, nervous tissue, muscle tonus
4657476|NCT03509311|Asthma|asthma
4657477|NCT03509311|Physical activity|physical activity
4657478|NCT03509311|Cardiorespiratory fitness|cardiorespiratory fitness
4657479|NCT03509311|Quality of life|quality of life
4657480|NCT03509298|activated CIK|activated cik
4657481|NCT03509298|MUC1|muc1
4657482|NCT03509298|bispecific antibody|bispecific antibody
4657483|NCT03509298|pancreatic cancer|pancreatic cancer
4657484|NCT03509233|periodontitis|periodontitis
4657485|NCT03509233|full mouth scaling|full mouth scaling
4657486|NCT03509233|air abrasion|air abrasion
4657487|NCT03509233|scaling|scaling
4657488|NCT03509220|Colonoscopy|colonoscopy
4657489|NCT03509220|PBK-1701TC|pbk-1701tc
4657490|NCT03509220|Bowel cleansing|bowel cleansing
4657491|NCT03509207|Uterine sarcoma|uterine sarcoma
4657492|NCT03509207|Histone deacetylases|histone deacetylases
4657493|NCT03509194|liver|liver
4657494|NCT03509194|children|children
4657495|NCT03509194|liver transplantation|liver transplantation
4657496|NCT03509194|liver cirrhosis|liver cirrhosis
4657497|NCT03509181|interpretation bias|interpretation bias
4657498|NCT03509181|smartphone|smartphone
4657499|NCT03509181|partial hospital|partial hospital
4657500|NCT03509155|Infant and Young Child Feeding|infant and young child feeding
4657501|NCT03509155|Program Evaluation|program evaluation
4657502|NCT03509155|Food Supplementation|food supplementation
4657503|NCT03509155|Biscuit|biscuit
4657504|NCT03509155|wasting children|wasting children
4657505|NCT03509116|patient experience|patient experience
4657506|NCT03509116|disease-related malnutrition|disease-related malnutrition
4657507|NCT03509116|nutritional care|nutritional care
4657508|NCT03509116|dietetic consultation|dietetic consultation
4657509|NCT03509116|older adults|older adults
4657510|NCT03509116|oral nutritional support|oral nutritional support
4657511|NCT03509103|Partograpgh|partograpgh
4657512|NCT03509090|regional anesthesia|regional anesthesia
4657513|NCT03509090|erector spinae plane block|erector spinae plane block
4657514|NCT03509090|postoperative pain|postoperative pain
4657515|NCT03509077|geriatric|geriatric
4657516|NCT03509077|addiction|addiction
4657517|NCT03509064|Primary sjogren syndrome|primary sjogren syndrome
4657518|NCT03509064|Small fiber neuropathy|small fiber neuropathy
4657519|NCT03509064|Quality of life|quality of life
4657520|NCT03509064|Medico-economic impact|medico-economic impact
4657521|NCT03509051|Allogeneic stem cell transplantation|allogeneic stem cell transplantation
4657522|NCT03509012|Durvalumab|durvalumab
4657523|NCT03509012|Chemotherapy|chemotherapy
4657524|NCT03509012|Radiotherapy|radiotherapy
4657525|NCT03509012|HNSCC|hnscc
4657526|NCT03509012|NSCLC|nsclc
4657527|NCT03509012|SCLC|sclc
4657528|NCT03509012|locally-advanced|locally-advanced
4657529|NCT03509012|limited stage|limited stage
4657530|NCT03509012|first line|first line
4657531|NCT03508934|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
4657532|NCT03508934|hypoglycemia|hypoglycemia
4657533|NCT03508934|Continuous Glucose Monitoring|continuous glucose monitoring
4657534|NCT03508934|hospital|hospital
4657535|NCT03508934|inpatient|inpatient
4657536|NCT03508921|Onabotulinumtoxin|onabotulinumtoxin
4657537|NCT03508908|HIV testing|hiv testing
4657538|NCT03508908|ART|art
4657539|NCT03508908|partner notification|partner notification
4657540|NCT03508908|PrEP|prep
4657541|NCT03508895|Hemp protein|hemp protein
4657542|NCT03508895|Protein hydrolysate|protein hydrolysate
4657543|NCT03508895|Bioactive peptides|bioactive peptides
4657544|NCT03508895|Cannabis sativa|cannabis sativa
4657545|NCT03508882|Eyelid|eyelid
4657546|NCT03508882|Dystonia|dystonia
4657547|NCT03508882|Botulinum injection|botulinum injection
4657548|NCT03508882|Oculoplastics|oculoplastics
4657549|NCT03508830|Liposomal Bupivacaine|liposomal bupivacaine
4657550|NCT03508830|Intercostal Nerve Block|intercostal nerve block
4657551|NCT03508830|Minimally Invasive Thoracic Surgery|minimally invasive thoracic surgery
4657552|NCT03508817|Atropine, myopia, children|atropine, myopia, children
4657553|NCT03508804|surgical abortion|surgical abortion
4657554|NCT03508804|cervical anesthesia|cervical anesthesia
4657555|NCT03508804|pain control|pain control
4657556|NCT03508765|ASCT|asct
4657557|NCT03508765|Memorial Sloan Kettering Cancer Center|memorial sloan kettering cancer center
4657558|NCT03508765|18-154|18-154
4657559|NCT03508726|Sarcoma|sarcoma
4657560|NCT03508726|Soft tissue|soft tissue
4657561|NCT03508713|Rheumatoid Arthritis|rheumatoid arthritis
4657562|NCT03508713|prognosis|prognosis
4657563|NCT03508700|TNX-102 SL|tnx-102 sl
4657564|NCT03508700|Bedtime|bedtime
4657565|NCT03508700|Sublingual|sublingual
4657566|NCT03508700|Safety|safety
4657567|NCT03508700|PTSD|ptsd
4657568|NCT03508661|Scleroderma|scleroderma
4657569|NCT03508661|Systemic Sclerosis|systemic sclerosis
4657570|NCT03508661|Support group|support group
4657571|NCT03508661|Training|training
4657572|NCT03508661|Feasibility|feasibility
4657573|NCT03508635|Glucocorticoid receptor; antagonist|glucocorticoid receptor; antagonist
4657574|NCT03508583|mpoc|mpoc
4657575|NCT03508583|Validity and Reliability|validity and reliability
4657576|NCT03508518|Accessibility of health services|accessibility of health services
4657577|NCT03508518|Access to psychiatric care|access to psychiatric care
4657578|NCT03508518|Consultation-liaison|consultation-liaison
4657579|NCT03508518|General practitioner and psychiatrist collaboration|general practitioner and psychiatrist collaboration
4657580|NCT03508518|Care pathway|care pathway
4657581|NCT03508505|Acute Heart Failure|acute heart failure
4657582|NCT03508505|Low Output Heart Failure|low output heart failure
4657583|NCT03508505|Cardiac Low Output|cardiac low output
4657584|NCT03508505|Extracorporeal Membrane Oxygenation|extracorporeal membrane oxygenation
4657585|NCT03508505|ECMO|ecmo
4657586|NCT03508505|Venoarterial Extracorporeal membrane oxygenation|venoarterial extracorporeal membrane oxygenation
4657587|NCT03508505|Cardiac Surgery|cardiac surgery
4657588|NCT03508466|hypersensitivity|hypersensitivity
4657589|NCT03508453|monoclonal antibody|monoclonal antibody
4657590|NCT03508427|Bipolar Disorder|bipolar disorder
4657591|NCT03508427|Smartphone|smartphone
4657592|NCT03508427|Self-monitoring|self-monitoring
4657593|NCT03508427|Objective data|objective data
4657594|NCT03508414|Relapse-remitting Multiple Sclerosis|relapse-remitting multiple sclerosis
4657595|NCT03508401|superior vena cava|superior vena cava
4657596|NCT03508388|Liver volume|liver volume
4657597|NCT03508388|Alcoholic cirrhosis|alcoholic cirrhosis
4657598|NCT03508388|Liver transplantation|liver transplantation
4657599|NCT03508336|disorders of consciousness|disorders of consciousness
4657600|NCT03508336|swallowing|swallowing
4657601|NCT03508336|prognosis prediction|prognosis prediction
4657602|NCT03508336|minimally conscious state|minimally conscious state
4657603|NCT03508336|vegetative state|vegetative state
4657604|NCT03508297|Confocal|confocal
4657605|NCT03508297|RCM|rcm
4657606|NCT03508297|Imaging|imaging
4657607|NCT03508297|Skin cancer|skin cancer
4657608|NCT03508284|Multiple sclerosis|multiple sclerosis
4657609|NCT03508284|Dual-task|dual-task
4657610|NCT03508284|Balance|balance
4657611|NCT03508284|Mobility|mobility
4657612|NCT03508284|Cognition|cognition
4657613|NCT03508245|Tourette Syndrome|tourette syndrome
4657614|NCT03508245|Tourette's|tourette's
4657615|NCT03508245|Tics|tics
4657616|NCT03508245|Circadian|circadian
4657617|NCT03508245|Sleep|sleep
4657618|NCT03508219|Coronary Artery Disease (CAD)|coronary artery disease (cad)
4657619|NCT03508219|Percutaneous Coronary Intervention (PCI)|percutaneous coronary intervention (pci)
4657620|NCT03508219|Left Main Bifurcation|left main bifurcation
4657621|NCT03508206|Students, cognitive functions, memory|students, cognitive functions, memory
4657622|NCT03508180|Supportive care|supportive care
4657623|NCT03508180|cancer|cancer
4657624|NCT03508180|foot reflexology|foot reflexology
4657625|NCT03508180|nausea|nausea
4657626|NCT03508180|vomiting|vomiting
4657627|NCT03508141|Fibrinogen Concentrate|fibrinogen concentrate
4657628|NCT03508141|Cryoprecipitate|cryoprecipitate
4657629|NCT03508102|remifentanil|remifentanil
4657630|NCT03508102|bispectral index|bispectral index
4657631|NCT03508102|Caesarean delivery|caesarean delivery
4657632|NCT03508102|general anesthesia|general anesthesia
4657633|NCT03508076|Vibrating Capsule|vibrating capsule
4657634|NCT03508076|Efficacy and Safety|efficacy and safety
4657635|NCT03508076|Chronic Constipation|chronic constipation
4657636|NCT03508076|different vibrating modes|different vibrating modes
4657637|NCT03508011|Breast Cancer|breast cancer
4657638|NCT03508011|Ovarian Cancer|ovarian cancer
4657639|NCT03508011|Prostate Cancer|prostate cancer
4657640|NCT03508011|Advanced solid tumours|advanced solid tumours
4657641|NCT03507985|morphine|morphine
4657642|NCT03507985|attention disorders|attention disorders
4657643|NCT03507972|ankle|ankle
4657644|NCT03507972|diagnostic|diagnostic
4657645|NCT03507972|ankle's ultrasound|ankle's ultrasound
4657646|NCT03507972|traumatic lesion|traumatic lesion
4657647|NCT03507933|villo-nodular synovitis|villo-nodular synovitis
4657649|NCT03507933|Surgery|surgery
4657650|NCT03507907|neck pain|neck pain
4657651|NCT03507907|older adults|older adults
4657652|NCT03507907|mobilization|mobilization
4657653|NCT03507894|rehabilitation|rehabilitation
4657654|NCT03507894|exercise|exercise
4657655|NCT03507894|stroke|stroke
4657656|NCT03507894|adherence|adherence
4657657|NCT03507881|isthmic spondylolisthesis|isthmic spondylolisthesis
4657658|NCT03507816|Tuberculosis|tuberculosis
4657659|NCT03507816|Multi-drug Resistant Tuberculosis|multi-drug resistant tuberculosis
4657660|NCT03507816|Observational retrospective study|observational retrospective study
4657661|NCT03507816|Clinical epidemiology|clinical epidemiology
4657662|NCT03507816|Treatment outcome|treatment outcome
4657663|NCT03507816|Migrant|migrant
4657664|NCT03507816|Precarity|precarity
4657665|NCT03507803|Gait training|gait training
4657666|NCT03507803|Walking|walking
4657667|NCT03507790|Alzheimer's Disease|alzheimer's disease
4657668|NCT03507764|Treadmills|treadmills
4657669|NCT03507764|Exercise|exercise
4657670|NCT03507764|Number of steps|number of steps
4657671|NCT03507764|Dispatchers|dispatchers
4657672|NCT03507725|mind-body intervention|mind-body intervention
4657673|NCT03507725|18-189|18-189
4657674|NCT03507712|Asymmetric, Inferior Oblique, Overaction, Surgery, Symmetric|asymmetric, inferior oblique, overaction, surgery, symmetric
4657675|NCT03507699|radiotherapy|radiotherapy
4657676|NCT03507699|radiosurgery|radiosurgery
4657677|NCT03507699|immunotherapy|immunotherapy
4657678|NCT03507699|PD-1|pd-1
4657679|NCT03507699|CTLA-4|ctla-4
4657680|NCT03507699|TLR9|tlr9
4657681|NCT03507686|NightstaRx|nightstarx
4657682|NCT03507686|NSR-REP1|nsr-rep1
4657683|NCT03507686|Choroideremia|choroideremia
4657684|NCT03507686|CHM|chm
4657685|NCT03507686|Gene Therapy|gene therapy
4657686|NCT03507686|AAV|aav
4657687|NCT03507686|REP1|rep1
4657688|NCT03507660|verbal instruction, pelvic diaphragm, muscle contraction|verbal instruction, pelvic diaphragm, muscle contraction
4657689|NCT03507647|randomized controlled trial|randomized controlled trial
4657690|NCT03507647|Mindfulness based cognitive therapy|mindfulness based cognitive therapy
4657691|NCT03507647|clinical effectiveness|clinical effectiveness
4657692|NCT03507647|cost-effectiveness|cost-effectiveness
4657693|NCT03507647|working mechanisms|working mechanisms
4657694|NCT03507634|Lidocaine|lidocaine
4657695|NCT03507634|Dexmedetomidine|dexmedetomidine
4657696|NCT03507634|Opioid Free|opioid free
4657697|NCT03507634|Bariatric surgery|bariatric surgery
4657698|NCT03507595|prostate specific membrane antigen(PMSA)|prostate specific membrane antigen(pmsa)
4657699|NCT03507595|prostate cancer|prostate cancer
4657700|NCT03507595|PET/CT|pet/ct
4657701|NCT03507556|immature teeth, necrotic teeth|immature teeth, necrotic teeth
4657702|NCT03507543|Breast Cancer|breast cancer
4657703|NCT03507543|Ovarian Cancer|ovarian cancer
4657704|NCT03507543|Prostate Cancer|prostate cancer
4657705|NCT03507543|Advanced solid tumours|advanced solid tumours
4657706|NCT03507543|primary peritoneal Cancer|primary peritoneal cancer
4657707|NCT03507530|physiotherapy and rehabilitation|physiotherapy and rehabilitation
4657708|NCT03507530|fear of falling|fear of falling
4657709|NCT03507530|quality of life|quality of life
4657710|NCT03507517|prevention|prevention
4657711|NCT03507504|psychiatric aspects|psychiatric aspects
4657712|NCT03507491|Pediatric|pediatric
4657713|NCT03507491|Sarcoma|sarcoma
4657714|NCT03507491|Neuroblastoma|neuroblastoma
4657715|NCT03507491|Ewing sarcoma|ewing sarcoma
4657716|NCT03507491|Osteosarcoma|osteosarcoma
4657717|NCT03507491|Rhabdomyosarcoma|rhabdomyosarcoma
4657718|NCT03507491|Wilms tumor|wilms tumor
4657719|NCT03507491|Hepatoblastoma|hepatoblastoma
4657720|NCT03507491|Adolescent and young adult|adolescent and young adult
4657721|NCT03507491|Germ cell tumor|germ cell tumor
4657722|NCT03507465|letrozole|letrozole
4657723|NCT03507465|metronomic|metronomic
4657724|NCT03507465|capecitabine|capecitabine
4657725|NCT03507465|neoadjuvant|neoadjuvant
4657726|NCT03507465|chemotherapy|chemotherapy
4657727|NCT03507465|ER+/HER2-|er+/her2-
4657728|NCT03507452|Malignant Mesothelioma|malignant mesothelioma
4657729|NCT03507452|Malignant Pleural Epithelioid Mesothelioma|malignant pleural epithelioid mesothelioma
4657730|NCT03507452|Malignant Peritoneal Epithelioid Mesothelioma|malignant peritoneal epithelioid mesothelioma
4657731|NCT03507452|Serous Ovarian Cancer|serous ovarian cancer
4657732|NCT03507439|Heart failure with preserved ejection fraction (HFpEF)|heart failure with preserved ejection fraction (hfpef)
4657733|NCT03507439|Heart failure with reduced ejection fraction (HFrEF)|heart failure with reduced ejection fraction (hfref)
4657734|NCT03507426|Retrobulbar block|retrobulbar block
4657735|NCT03507426|Ketamine|ketamine
4657736|NCT03507426|Ocular enucleation|ocular enucleation
4657737|NCT03507426|Analgesia|analgesia
4657738|NCT03507413|abdominal aortic aneurysm|abdominal aortic aneurysm
4657739|NCT03507413|metformin|metformin
4657740|NCT03507413|non-diabetic|non-diabetic
4657741|NCT03507413|placebo|placebo
4657742|NCT03507400|Introvision: mental and emotional self-regulation technique|introvision: mental and emotional self-regulation technique
4657743|NCT03507400|Mindfulness, perception technique|mindfulness, perception technique
4657744|NCT03507400|Migraine|migraine
4657745|NCT03507387|Intramuscular|intramuscular
4657746|NCT03507387|Phenylephrine|phenylephrine
4657747|NCT03507374|Stroke|stroke
4657748|NCT03507374|alirocumab|alirocumab
4657749|NCT03507374|Intracranial Atherosclerosis|intracranial atherosclerosis
4657750|NCT03507374|Intraplaque Hemorrhage|intraplaque hemorrhage
4657751|NCT03507374|atorvastatin|atorvastatin
4657752|NCT03507374|praluent|praluent
4657753|NCT03507348|Anti-HLA alloantibodies|anti-hla alloantibodies
4657754|NCT03507348|Desensitization therapy|desensitization therapy
4657755|NCT03507348|Tocilizumab|tocilizumab
4657756|NCT03507348|Rituximab|rituximab
4657757|NCT03507335|Arrhythmia Atrial|arrhythmia atrial
4657758|NCT03507335|heart rate monitoring|heart rate monitoring
4657759|NCT03507335|stroke|stroke
4657760|NCT03507335|atrial fibrillation|atrial fibrillation
4657761|NCT03507322|texturization|texturization
4657762|NCT03507322|pregnancy rate|pregnancy rate
4657763|NCT03507322|oocyte donation|oocyte donation
4657764|NCT03507322|2D ultrasound|2d ultrasound
4657765|NCT03507322|3D ultrasound|3d ultrasound
4657766|NCT03507322|assisted reproductive technology (ART)|assisted reproductive technology (art)
4657767|NCT03507283|Pterygium|pterygium
4657768|NCT03507283|double-headed|double-headed
4657769|NCT03507283|vertical|vertical
4657770|NCT03507270|FABP|fabp
4657771|NCT03507270|non ST Segment Elevation Myocardial Infarction|non st segment elevation myocardial infarction
4657772|NCT03507257|Cognitively Normal|cognitively normal
4657773|NCT03507257|Amyloid|amyloid
4657774|NCT03507257|Plaques|plaques
4657775|NCT03507257|Neuroimaging|neuroimaging
4657776|NCT03507257|Biomarkers|biomarkers
4657777|NCT03507257|Cognition Disorder|cognition disorder
4657778|NCT03507257|Dementia|dementia
4657779|NCT03507257|Tau|tau
4657780|NCT03507257|Early Onset Alzheimer's Disease|early onset alzheimer's disease
4657781|NCT03507257|Alzheimer's Disease|alzheimer's disease
4657782|NCT03507257|Mild Cognitive Impairment|mild cognitive impairment
4657783|NCT03507244|Leptomeningeal metastasis|leptomeningeal metastasis
4657784|NCT03507244|Malignant solid tumors|malignant solid tumors
4657785|NCT03507244|Pemetrexed|pemetrexed
4657786|NCT03507244|Intrathecal chemotherapy|intrathecal chemotherapy
4657787|NCT03507244|Radiotherapy|radiotherapy
4657788|NCT03507231|incentives|incentives
4657789|NCT03507231|field study|field study
4657790|NCT03507231|vaccination|vaccination
4657791|NCT03507218|Obsessive Compulsive Disorder|obsessive compulsive disorder
4657792|NCT03507218|Anxiety Disorder|anxiety disorder
4657793|NCT03507218|PANDAS (Pediatric Autoimmune Neuropsychiatric Disorders Associated d|pandas (pediatric autoimmune neuropsychiatric disorders associated d
4657794|NCT03507218|Eating Disorders|eating disorders
4657795|NCT03507205|Everolimus|everolimus
4657796|NCT03507205|Sirolimus|sirolimus
4657797|NCT03507205|Zotarolimus|zotarolimus
4657798|NCT03507205|Biolimus|biolimus
4657799|NCT03507205|Drug-eluting stent|drug-eluting stent
4657800|NCT03507192|MCI, Alzheimer's disease, muscle relaxation|mci, alzheimer's disease, muscle relaxation
4657801|NCT03507166|RC48-ADC|rc48-adc
4657802|NCT03507166|HER2|her2
4657803|NCT03507153|"Nylon denture base and PEEK partial denture"|"nylon denture base and peek partial denture"
4657804|NCT03507140|cirrhosis|cirrhosis
4657805|NCT03507140|hepatocellular carcinoma|hepatocellular carcinoma
4657806|NCT03507140|Liver transplantation|liver transplantation
4657807|NCT03507140|Microbiota|microbiota
4657808|NCT03507114|Rumination|rumination
4657809|NCT03507114|Cognitive behavioural therapy (CBT)|cognitive behavioural therapy (cbt)
4657810|NCT03507114|Depression|depression
4657811|NCT03507114|Anxiety|anxiety
4657812|NCT03507088|fulvestrant 500 mg|fulvestrant 500 mg
4657813|NCT03507088|fluorine-18 fluoroestradiol PET-CT|fluorine-18 fluoroestradiol pet-ct
4657814|NCT03507062|pH|ph
4657815|NCT03507062|crystalloids|crystalloids
4657816|NCT03507036|knee area|knee area
4657817|NCT03507036|suprapatellar skin|suprapatellar skin
4657818|NCT03507036|aging|aging
4657819|NCT03507036|laxity|laxity
4657820|NCT03507010|Radiotherapy|radiotherapy
4657821|NCT03507010|Pain|pain
4657822|NCT03506997|Immune checkpoint inhibitor|immune checkpoint inhibitor
4657823|NCT03506997|Pembrolizumab|pembrolizumab
4657824|NCT03506971|Young child's development|young child's development
4657825|NCT03506971|Home visits|home visits
4657826|NCT03506971|Early interactions|early interactions
4657827|NCT03506971|attachment|attachment
4657828|NCT03506971|parenthood|parenthood
4657829|NCT03506932|blood sugar|blood sugar
4657830|NCT03506932|insulin|insulin
4657831|NCT03506932|peas|peas
4657832|NCT03506932|bread|bread
4657833|NCT03506932|metabolites|metabolites
4657834|NCT03506906|Chronic hypoventilation syndrome|chronic hypoventilation syndrome
4657835|NCT03506906|Polysomnography|polysomnography
4657836|NCT03506906|Transcutaneous Capnometry|transcutaneous capnometry
4657837|NCT03506906|Noninvasive Ventilation|noninvasive ventilation
4657838|NCT03506906|home mechanical ventilation|home mechanical ventilation
4657839|NCT03506906|Ventilator´s set-up|ventilator´s set-up
4657840|NCT03506893|refractory ascite|refractory ascite
4657841|NCT03506893|pump system|pump system
4657842|NCT03506867|Health Equity|health equity
4657843|NCT03506867|Community Based Participatory Action Research|community based participatory action research
4657844|NCT03506867|Poverty Reduction|poverty reduction
4657845|NCT03506815|Upper Extremity Deep Vein Thrombosis|upper extremity deep vein thrombosis
4657846|NCT03506815|Thromboprophylaxis|thromboprophylaxis
4657847|NCT03506815|Cancer|cancer
4657848|NCT03506815|Randomized Trial|randomized trial
4657849|NCT03506763|office hysteroscopy, pain measure|office hysteroscopy, pain measure
4657850|NCT03506750|Conbercept|conbercept
4657851|NCT03506750|PLGF|plgf
4657852|NCT03506724|Hypertension, Pregnancy-induced|hypertension, pregnancy-induced
4657853|NCT03506724|Pregnancy Induced Hypertension|pregnancy induced hypertension
4657854|NCT03506724|Gestational Hypertension|gestational hypertension
4657855|NCT03506724|Transient Hypertension, Pregnancy|transient hypertension, pregnancy
4657856|NCT03506724|Pharmacogenetics|pharmacogenetics
4657857|NCT03506711|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
4657858|NCT03506711|MRI|mri
4657859|NCT03506711|Isometric handgrip exercise|isometric handgrip exercise
4657860|NCT03506711|Children|children
4657861|NCT03506711|Adolescents|adolescents
4657862|NCT03506698|Birth weight|birth weight
4657863|NCT03506685|dry needling|dry needling
4657864|NCT03506685|ACL reconstruction|acl reconstruction
4657865|NCT03506685|knee ROM|knee rom
4657866|NCT03506685|pain management|pain management
4657867|NCT03506685|opioid use|opioid use
4657868|NCT03506672|Behavioral and psychological symptoms of dementia|behavioral and psychological symptoms of dementia
4657869|NCT03506672|Psychosocial interventions|psychosocial interventions
4657870|NCT03506672|Well-being|well-being
4657871|NCT03506672|Long-term care facilities|long-term care facilities
4657872|NCT03506672|Family and formal caregivers|family and formal caregivers
4657873|NCT03506672|Partnership|partnership
4657874|NCT03506620|femoroacetabular impingement|femoroacetabular impingement
4657875|NCT03506620|hip arthroscopy|hip arthroscopy
4657876|NCT03506620|QL nerve block|ql nerve block
4657877|NCT03506607|exercise|exercise
4657878|NCT03506607|cardiovascular|cardiovascular
4657879|NCT03506607|normobaric hypoxia|normobaric hypoxia
4657880|NCT03506568|Adherence|adherence
4657881|NCT03506568|Medication|medication
4657882|NCT03506568|Glaucoma|glaucoma
4657883|NCT03506568|Device|device
4657884|NCT03506555|Laparoscopy|laparoscopy
4657885|NCT03506555|Hasson technique|hasson technique
4657886|NCT03506555|Veress needle technique|veress needle technique
4657887|NCT03506555|complications|complications
4657888|NCT03506529|TEP|tep
4657889|NCT03506529|hypermetabolism|hypermetabolism
4657890|NCT03506516|alcohol, hangover|alcohol, hangover
4657891|NCT03506503|nanofat|nanofat
4657892|NCT03506503|hair loss|hair loss
4657893|NCT03506503|prp|prp
4657894|NCT03506477|skin of color|skin of color
4657895|NCT03506477|psoriasis|psoriasis
4657896|NCT03506477|Enstilar|enstilar
4657897|NCT03506477|skin diseases|skin diseases
4657898|NCT03506464|Plantar Fasciitis|plantar fasciitis
4657899|NCT03506464|physical therapy|physical therapy
4657900|NCT03506464|sonoelastography|sonoelastography
4657901|NCT03506451|Financial toxicity|financial toxicity
4657902|NCT03506438|critical illness|critical illness
4657903|NCT03506438|palliative care|palliative care
4657904|NCT03506438|mobile app|mobile app
4657905|NCT03506438|psychological distress|psychological distress
4657906|NCT03506438|depression|depression
4657907|NCT03506438|anxiety|anxiety
4657908|NCT03506438|informal caregiver|informal caregiver
4657909|NCT03506412|Heart Failure|heart failure
4657910|NCT03506412|HFpEF|hfpef
4657911|NCT03506412|Entresto™|entresto™
4657912|NCT03506412|Neprilysin|neprilysin
4657913|NCT03506412|Diastolic Heart Failure|diastolic heart failure
4657914|NCT03506386|Real World Evidence , Multiple Myeloma Profile, Brazil|real world evidence , multiple myeloma profile, brazil
4657915|NCT03506321|colonoscopy|colonoscopy
4657916|NCT03506321|Residual adenoma|residual adenoma
4657917|NCT03506321|Recurrent adenoma|recurrent adenoma
4657918|NCT03506282|Running biomechanics|running biomechanics
4657919|NCT03506282|Vertical loading rate|vertical loading rate
4657920|NCT03506282|Music exercise|music exercise
4657921|NCT03506282|Gait analysis|gait analysis
4657922|NCT03506256|urinary tract infection|urinary tract infection
4657923|NCT03506256|Norfloxacin|norfloxacin
4657924|NCT03506256|Fluroquinolone|fluroquinolone
4657925|NCT03506256|Safety|safety
4657926|NCT03506256|Pakistan|pakistan
4657927|NCT03506243|IVF, rhFSH|ivf, rhfsh
4657928|NCT03506230|Rewards|rewards
4657929|NCT03506230|Medication Adherence|medication adherence
4657930|NCT03506230|Health Behavior|health behavior
4657931|NCT03506230|Diabetes Mellitus|diabetes mellitus
4657932|NCT03506230|Copayments|copayments
4657933|NCT03506217|mitral valve prolaps,|mitral valve prolaps,
4657934|NCT03506217|chorda tendinea,|chorda tendinea,
4657935|NCT03506217|cardiac output|cardiac output
4657936|NCT03506204|Pelvic floor muscle strength|pelvic floor muscle strength
4657937|NCT03506204|Pelvic floor dysfunction|pelvic floor dysfunction
4657938|NCT03506204|Postpartum|postpartum
4657939|NCT03506204|primipara|primipara
4657940|NCT03506191|Stenotrophomonas maltophilia|stenotrophomonas maltophilia
4657941|NCT03506191|Pneumonia|pneumonia
4657942|NCT03506191|Intensive Care Unit|intensive care unit
4657943|NCT03506178|Upper airway|upper airway
4657944|NCT03506178|Obstructive sleep apnea|obstructive sleep apnea
4657945|NCT03506178|Polysomnography|polysomnography
4657946|NCT03506139|Radiotherapy|radiotherapy
4657947|NCT03506139|Magnetic Resonance Imaging|magnetic resonance imaging
4657948|NCT03506126|amino acid requirement|amino acid requirement
4657949|NCT03506126|elderly|elderly
4657950|NCT03506126|leucine|leucine
4657951|NCT03506126|dietary requirement|dietary requirement
4657952|NCT03506113|Gram staining|gram staining
4657953|NCT03506113|Antimicrobial therapy|antimicrobial therapy
4657954|NCT03506113|Empirical therapy|empirical therapy
4657955|NCT03506113|Nosocomial infection|nosocomial infection
4657956|NCT03506113|Mechanical ventilation|mechanical ventilation
4657957|NCT03506113|Intensive care|intensive care
4657958|NCT03506113|Sepsis|sepsis
4657959|NCT03506100|Spirometry|spirometry
4657960|NCT03506100|swimming|swimming
4657961|NCT03506100|water walking|water walking
4657962|NCT03506087|Advance Care Planning|advance care planning
4657963|NCT03506087|Shared Decision Making|shared decision making
4657964|NCT03506074|Obesity|obesity
4657965|NCT03506074|Flavor|flavor
4657966|NCT03506035|Shared epitope|shared epitope
4657967|NCT03506035|HLA-DRB1|hla-drb1
4657968|NCT03506035|Citrullinated peptides|citrullinated peptides
4657969|NCT03506035|Autoantibodies|autoantibodies
4657970|NCT03506022|Sleep apnea syndrome, polysomnography and glucose monitoring continu glycemia (CGMS )|sleep apnea syndrome, polysomnography and glucose monitoring continu glycemia (cgms )
4657971|NCT03505983|Prosthetic Limb Design|prosthetic limb design
4657972|NCT03505983|Prosthesis Fitting|prosthesis fitting
4657973|NCT03505970|Physiological Phenomena|physiological phenomena
4657974|NCT03505957|IV Dislodgement|iv dislodgement
4657975|NCT03505931|Peripheral artery disease|peripheral artery disease
4657976|NCT03505931|femoropopliteal|femoropopliteal
4657977|NCT03505931|drug-eluting stent|drug-eluting stent
4657978|NCT03505931|restenosis|restenosis
4657979|NCT03505905|Pregnenolone|pregnenolone
4657980|NCT03505892|Ankylosing Spondylitis (AS)|ankylosing spondylitis (as)
4657981|NCT03505892|Adaliumumab|adaliumumab
4657982|NCT03505892|Humira|humira
4657983|NCT03505879|Next Generation Sequencing|next generation sequencing
4657984|NCT03505866|HIV|hiv
4657985|NCT03505866|Anti-retroviral therapy|anti-retroviral therapy
4657986|NCT03505866|Intervention|intervention
4657987|NCT03505866|Mental Health|mental health
4657988|NCT03505853|RNAi therapeutic|rnai therapeutic
4657989|NCT03505853|Porphyria|porphyria
4657990|NCT03505853|Acute Hepatic Porphyria (AHP)|acute hepatic porphyria (ahp)
4657991|NCT03505853|Acute Intermittent Porphyria (AIP)|acute intermittent porphyria (aip)
4657992|NCT03505827|TECNIS Symfony|tecnis symfony
4657993|NCT03505814|post extubation care|post extubation care
4657994|NCT03505814|neonatal surgical critical care|neonatal surgical critical care
4657995|NCT03505814|oxygen therapy|oxygen therapy
4657996|NCT03505814|high nasal flow cannula|high nasal flow cannula
4657997|NCT03505775|Hormone replacement|hormone replacement
4657998|NCT03505775|Mineralocorticoids|mineralocorticoids
4657999|NCT03505775|23Na-magnetic resonance imaging|23na-magnetic resonance imaging
4658000|NCT03505775|Tissue sodium content|tissue sodium content
4658001|NCT03505723|Noncardiac surgery|noncardiac surgery
4658002|NCT03505723|Myocardial injury|myocardial injury
4658003|NCT03505723|Perioperative myocardial infarction|perioperative myocardial infarction
4658004|NCT03505723|Tranexamic Acid|tranexamic acid
4658005|NCT03505723|Hypotension|hypotension
4658006|NCT03505723|Hypertension|hypertension
4658007|NCT03505710|HER2 over-expression|her2 over-expression
4658008|NCT03505710|HER2 mutation|her2 mutation
4658009|NCT03505710|Unresectable or metastatic|unresectable or metastatic
4658010|NCT03505710|Non-squamous|non-squamous
4658011|NCT03505710|NSCLC|nsclc
4658012|NCT03505697|rehabilitation|rehabilitation
4658013|NCT03505697|exercise|exercise
4658014|NCT03505697|maximal inspiratory pressure|maximal inspiratory pressure
4658015|NCT03505697|6-minute walk test|6-minute walk test
4658016|NCT03505619|home care service|home care service
4658017|NCT03505619|reablement service|reablement service
4658018|NCT03505619|rehabilitation|rehabilitation
4658019|NCT03505606|Amblyopia|amblyopia
4658020|NCT03505606|Visual Acuity|visual acuity
4658021|NCT03505606|Crowding|crowding
4658022|NCT03505554|ALK|alk
4658023|NCT03505554|relapsed|relapsed
4658024|NCT03505554|lorlatinib|lorlatinib
4658025|NCT03505528|Nanoparticle albumin-bound paclitaxel (Abraxane)|nanoparticle albumin-bound paclitaxel (abraxane)
4658026|NCT03505528|Phenelzine Sulfate|phenelzine sulfate
4658027|NCT03505528|Cancer stem cells|cancer stem cells
4658028|NCT03505528|epigenetics|epigenetics
4658029|NCT03505528|LSD1|lsd1
4658030|NCT03505502|Cesarean Myomectomy|cesarean myomectomy
4658031|NCT03505502|Tranexamic Acid|tranexamic acid
4658032|NCT03505489|Mannitol|mannitol
4658033|NCT03505489|Methacholine|methacholine
4658034|NCT03505489|Deep inhalation|deep inhalation
4658035|NCT03505489|Tidal breathing|tidal breathing
4658036|NCT03505476|Ileus|ileus
4658037|NCT03505476|Abdominal surgery|abdominal surgery
4658038|NCT03505476|Bowel obstruction|bowel obstruction
4658039|NCT03505476|Postoperative Ileus|postoperative ileus
4658040|NCT03505463|Spinal cord injury|spinal cord injury
4658041|NCT03505463|Biomarkers|biomarkers
4658042|NCT03505463|Inflammation|inflammation
4658043|NCT03505463|Trauma|trauma
4658044|NCT03505450|decision support tools,|decision support tools,
4658045|NCT03505437|anxiety disorders|anxiety disorders
4658046|NCT03505437|spider phobia|spider phobia
4658047|NCT03505437|stress|stress
4658048|NCT03505437|exposure therapy|exposure therapy
4658049|NCT03505437|generalization|generalization
4658050|NCT03505424|Premature Infant|premature infant
4658051|NCT03505424|Premature Birth|premature birth
4658052|NCT03505424|Smartphone App|smartphone app
4658053|NCT03505424|NICU|nicu
4658054|NCT03505411|Melatonin|melatonin
4658055|NCT03505411|Glutathione|glutathione
4658056|NCT03505411|Glutathione peroxidase|glutathione peroxidase
4658057|NCT03505411|Malondialdehyde|malondialdehyde
4658058|NCT03505411|Isoprostanes|isoprostanes
4658059|NCT03505411|anti-ox-LDL|anti-ox-ldl
4658060|NCT03505411|Superoxide dismutase|superoxide dismutase
4658061|NCT03505411|Glutathione reductase|glutathione reductase
4658062|NCT03505411|Interleukin-6|interleukin-6
4658063|NCT03505411|C-reactive protein|c-reactive protein
4658064|NCT03505411|Autonomic nervous system|autonomic nervous system
4658065|NCT03505385|Co-creation|co-creation
4658066|NCT03505385|Service-learning methodology|service-learning methodology
4658067|NCT03505372|Atypical ductal hyperplasia|atypical ductal hyperplasia
4658068|NCT03505372|ADH|adh
4658069|NCT03505346|Positron Emission Tomography|positron emission tomography
4658070|NCT03505346|nuclear medicine|nuclear medicine
4658071|NCT03505346|prognosis|prognosis
4658072|NCT03505320|zolbetuximab|zolbetuximab
4658073|NCT03505320|oxaliplatin|oxaliplatin
4658074|NCT03505320|fluorouracil|fluorouracil
4658075|NCT03505320|claudiximab|claudiximab
4658076|NCT03505320|IMAB362|imab362
4658077|NCT03505320|Gastro-Esophageal Junction cancer|gastro-esophageal junction cancer
4658078|NCT03505320|Gastric cancer|gastric cancer
4658079|NCT03505294|Multiple Sclerosis|multiple sclerosis
4658080|NCT03505294|task-oriented training|task-oriented training
4658081|NCT03505294|physical performance|physical performance
4658082|NCT03505294|cognition|cognition
4658083|NCT03505268|Glycosylated hemoglobin A1c (HbA1c), Telemedicine|glycosylated hemoglobin a1c (hba1c), telemedicine
4658084|NCT03505164|Doxorubicin|doxorubicin
4658085|NCT03505164|suPAR|supar
4658086|NCT03505164|Caridomyopathy|caridomyopathy
4658087|NCT03505164|Heart Failure|heart failure
4658088|NCT03505164|Breast Cancer|breast cancer
4658089|NCT03505138|COPD|copd
4658090|NCT03505138|hospitalization|hospitalization
4658091|NCT03505138|telemedicine platform|telemedicine platform
4658092|NCT03505112|Goal-directed therapy|goal-directed therapy
4658093|NCT03505112|stroke volume index|stroke volume index
4658094|NCT03505099|gene therapy|gene therapy
4658095|NCT03505047|second trimester medical abortion|second trimester medical abortion
4658096|NCT03505047|Immediate versus delayed insertion|immediate versus delayed insertion
4658097|NCT03505047|copper intrauterine device|copper intrauterine device
4658098|NCT03505034|Spinal cord injury，Umbilical Cord Mesenchymal Stem Cells|spinal cord injury，umbilical cord mesenchymal stem cells
4658099|NCT03505008|Methotrexate|methotrexate
4658100|NCT03505008|Adalimumab|adalimumab
4658101|NCT03505008|Autoimmune Disease|autoimmune disease
4658102|NCT03505008|Connective Tissue Diseases|connective tissue diseases
4658103|NCT03505008|Rheumatic Disease|rheumatic disease
4658104|NCT03505008|Rheumatoid Arthritis|rheumatoid arthritis
4658105|NCT03504995|Prostate|prostate
4658106|NCT03504995|Irreversible Electroporation|irreversible electroporation
4658107|NCT03504995|Prostate Cancer|prostate cancer
4658108|NCT03504982|Vericiguat|vericiguat
4658109|NCT03504982|Stable CAD|stable cad
4658110|NCT03504982|QT/QTc|qt/qtc
4658111|NCT03504969|umbilical cord|umbilical cord
4658112|NCT03504956|MRI technique|mri technique
4658113|NCT03504956|High Resolution MRI Technique|high resolution mri technique
4658114|NCT03504943|Exercise|exercise
4658115|NCT03504943|Hemodialysis|hemodialysis
4658116|NCT03504943|Intradialytic hypotension|intradialytic hypotension
4658117|NCT03504930|Surgical|surgical
4658118|NCT03504930|Ileal pouch-anal anastomosis|ileal pouch-anal anastomosis
4658119|NCT03504904|Chronic pain|chronic pain
4658120|NCT03504904|Self-criticism|self-criticism
4658121|NCT03504904|Internet-based treatment|internet-based treatment
4658122|NCT03504904|ACT|act
4658123|NCT03504904|CFT|cft
4658124|NCT03504904|Guided self-help|guided self-help
4658125|NCT03504904|Acceptance|acceptance
4658126|NCT03504904|Compassion|compassion
4658127|NCT03504865|Exparel|exparel
4658128|NCT03504865|Bupivacaine|bupivacaine
4658129|NCT03504852|psoriasis|psoriasis
4658130|NCT03504852|secukinumab|secukinumab
4658131|NCT03504852|immune-mediated systemic disease|immune-mediated systemic disease
4658132|NCT03504852|papules|papules
4658133|NCT03504852|plaques|plaques
4658134|NCT03504852|itching|itching
4658135|NCT03504839|defibrillator|defibrillator
4658136|NCT03504826|adaptive robotics|adaptive robotics
4658137|NCT03504826|locomotor training|locomotor training
4658138|NCT03504826|Spinal Cord diseases|spinal cord diseases
4658139|NCT03504826|walking rehabilitation|walking rehabilitation
4658140|NCT03504826|Spinal Cord Injury|spinal cord injury
4658141|NCT03504813|Elderly|elderly
4658142|NCT03504813|Quality of life|quality of life
4658143|NCT03504813|Wearables|wearables
4658144|NCT03504813|Urinary incontinence|urinary incontinence
4658145|NCT03504813|Insomnia|insomnia
4658146|NCT03504813|Risk of falls|risk of falls
4658147|NCT03504800|OCT|oct
4658148|NCT03504800|Keratoconus|keratoconus
4658149|NCT03504787|cerebral palsy|cerebral palsy
4658150|NCT03504787|upper extremity|upper extremity
4658151|NCT03504787|selective motor control|selective motor control
4658152|NCT03504748|deep repetitive transcranial magnetic stimulation|deep repetitive transcranial magnetic stimulation
4658153|NCT03504748|chronic pain|chronic pain
4658154|NCT03504748|parkinson|parkinson
4658155|NCT03504748|treatment|treatment
4658156|NCT03504748|non-motor symptom|non-motor symptom
4658157|NCT03504670|Labor induction|labor induction
4658158|NCT03504670|Cesarean delivery|cesarean delivery
4658159|NCT03504670|Preterm labor induction|preterm labor induction
4658160|NCT03504670|Duration of labor induction|duration of labor induction
4658161|NCT03504657|Vertebral Artery Stenosis|vertebral artery stenosis
4658162|NCT03504657|Drug-coated balloon angioplasty|drug-coated balloon angioplasty
4658163|NCT03504657|Stenting|stenting
4658164|NCT03504631|tamoxifen|tamoxifen
4658165|NCT03504631|breast cancer|breast cancer
4658166|NCT03504631|Z-endoxifen|z-endoxifen
4658167|NCT03504579|rt-fMRI|rt-fmri
4658168|NCT03504579|MRI|mri
4658169|NCT03504579|schizophrenia|schizophrenia
4658170|NCT03504579|auditory hallucinations|auditory hallucinations
4658171|NCT03504579|neurofeedback|neurofeedback
4658172|NCT03504540|Lupus Erythematosus, Systemic|lupus erythematosus, systemic
4658173|NCT03504540|Age Related Macular Degeneration|age related macular degeneration
4658174|NCT03504540|"Pseudo-drusen-like deposits"|"pseudo-drusen-like deposits"
4658175|NCT03504527|ICS|ics
4658176|NCT03504527|LABA|laba
4658177|NCT03504527|LAMA|lama
4658178|NCT03504527|therapy|therapy
4658179|NCT03504527|asthma|asthma
4658180|NCT03504527|COPD|copd
4658181|NCT03504527|ACO|aco
4658182|NCT03504514|non invasive ventilation|non invasive ventilation
4658183|NCT03504514|invasive ventilation|invasive ventilation
4658184|NCT03504514|neuromuscular disorder|neuromuscular disorder
4658185|NCT03504514|phonation|phonation
4658186|NCT03504514|speech|speech
4658187|NCT03504501|RASopathies, neurofibromatosis type 1, noonan syndrome, synaptic plasticity, transcranial magnetic stimulation|rasopathies, neurofibromatosis type 1, noonan syndrome, synaptic plasticity, transcranial magnetic stimulation
4658188|NCT03504462|Foot surgery|foot surgery
4658189|NCT03504462|Regional Anesthesia|regional anesthesia
4658190|NCT03504462|Regional Analgesia|regional analgesia
4658191|NCT03504462|Ultrasound|ultrasound
4658192|NCT03504462|Distal block|distal block
4658193|NCT03504462|Plantar nerve block|plantar nerve block
4658194|NCT03504397|HER2|her2
4658195|NCT03504397|IMAB362|imab362
4658196|NCT03504397|leucovorin|leucovorin
4658197|NCT03504397|fluorouracil|fluorouracil
4658198|NCT03504397|Gastric cancer|gastric cancer
4658199|NCT03504397|claudiximab|claudiximab
4658200|NCT03504397|zolbetuximab|zolbetuximab
4658201|NCT03504397|oxaliplatin|oxaliplatin
4658202|NCT03504397|adenocarcinoma|adenocarcinoma
4658203|NCT03504397|Gastro-Esophageal Junction cancer|gastro-esophageal junction cancer
4658204|NCT03504397|HER2 Negative mFOLFOX6|her2 negative mfolfox6
4658205|NCT03504371|oesophageal surgeries-epidural-erector block|oesophageal surgeries-epidural-erector block
4658206|NCT03504358|surgery|surgery
4658207|NCT03504358|scoring system|scoring system
4658208|NCT03504358|hepatocellular carcinoma|hepatocellular carcinoma
4658209|NCT03504358|homogeneity and discriminatory ability|homogeneity and discriminatory ability
4658210|NCT03504358|survival|survival
4658211|NCT03504332|immature teeth, revascularization|immature teeth, revascularization
4658212|NCT03504319|exercise|exercise
4658213|NCT03504319|inflammation|inflammation
4658214|NCT03504319|metabolic inflexibility|metabolic inflexibility
4658215|NCT03504319|insulin resistance|insulin resistance
4658216|NCT03504319|neonatal adiposity|neonatal adiposity
4658217|NCT03504293|Endosonography|endosonography
4658218|NCT03504293|Endoscopic retrograde choledochography|endoscopic retrograde choledochography
4658219|NCT03504280|hypovitaminosis D|hypovitaminosis d
4658220|NCT03504280|cholecalciferol|cholecalciferol
4658221|NCT03504280|mehadose|mehadose
4658222|NCT03504267|physical activity|physical activity
4658223|NCT03504267|exercise|exercise
4658224|NCT03504267|patient-provider communication|patient-provider communication
4658225|NCT03504254|cervical spondylotic myelopathy|cervical spondylotic myelopathy
4658226|NCT03504254|diffusion tensor imaging|diffusion tensor imaging
4658227|NCT03504254|functional magnetic resonance imaging|functional magnetic resonance imaging
4658228|NCT03504241|mesenchymal stromal cells (MSCs)|mesenchymal stromal cells (mscs)
4658229|NCT03504241|anti-rejection drugs|anti-rejection drugs
4658230|NCT03504241|operational tolerance|operational tolerance
4658231|NCT03504215|extremely preterm|extremely preterm
4658232|NCT03504215|young adults|young adults
4658233|NCT03504215|term|term
4658234|NCT03504215|exercise capacity|exercise capacity
4658235|NCT03504215|pulmonary function|pulmonary function
4658236|NCT03504215|muscle oxygenation|muscle oxygenation
4658237|NCT03504189|Fetal monitoring, Prenatal monitoring|fetal monitoring, prenatal monitoring
4658238|NCT03504163|Pembrolizumab (MK-3475)|pembrolizumab (mk-3475)
4658239|NCT03504163|17-602|17-602
4658240|NCT03504137|mHealth|mhealth
4658241|NCT03504137|kidney transplantation|kidney transplantation
4658242|NCT03504137|medication adherence|medication adherence
4658243|NCT03504137|video directly observed therapy|video directly observed therapy
4658244|NCT03504098|One-carbon metabolism|one-carbon metabolism
4658245|NCT03504098|Folate|folate
4658246|NCT03504098|Choline|choline
4658247|NCT03504098|metabolomic marker|metabolomic marker
4658248|NCT03504098|Cancer risk|cancer risk
4658249|NCT03504085|Chronic Low Back Pain|chronic low back pain
4658250|NCT03504085|CLBP|clbp
4658251|NCT03504085|Chronic Neck Pain|chronic neck pain
4658252|NCT03504085|CNP|cnp
4658253|NCT03504085|Chronic Pain|chronic pain
4658254|NCT03504085|Military|military
4658255|NCT03504085|Active Duty|active duty
4658256|NCT03504085|Yoga|yoga
4658257|NCT03504085|Mindbody|mindbody
4658258|NCT03504072|Etanercept|etanercept
4658259|NCT03504072|Infection|infection
4658260|NCT03504072|Tofacitinib|tofacitinib
4658261|NCT03504072|Tuberculosis|tuberculosis
4658262|NCT03504072|Spondyloarthritis|spondyloarthritis
4658263|NCT03504059|Obesity|obesity
4658264|NCT03504059|Cardiovascular Diseases|cardiovascular diseases
4658265|NCT03504059|Diabetes|diabetes
4658266|NCT03504059|Adolescents|adolescents
4658267|NCT03504059|Physical Activity|physical activity
4658268|NCT03504059|Diet|diet
4658269|NCT03504059|School-Based|school-based
4658270|NCT03504046|artificial pancreas|artificial pancreas
4658271|NCT03504046|hyperglycemia|hyperglycemia
4658272|NCT03504046|hypoglycemia|hypoglycemia
4658273|NCT03504033|Xenon|xenon
4658274|NCT03504033|Liver resection|liver resection
4658275|NCT03504033|post-operative liver failure|post-operative liver failure
4658276|NCT03504033|anesthetics, inhalation|anesthetics, inhalation
4658277|NCT03504033|Desflurane|desflurane
4658278|NCT03504033|Randomized controlled trail|randomized controlled trail
4658279|NCT03504033|RCT|rct
4658280|NCT03504007|Deep Vein Thrombosis|deep vein thrombosis
4658281|NCT03504007|Pulmonary Embolism|pulmonary embolism
4658282|NCT03504007|Apixaban|apixaban
4658283|NCT03504007|Rivaroxaban|rivaroxaban
4658284|NCT03504007|Dabigatran|dabigatran
4658285|NCT03504007|Edoxaban|edoxaban
4658286|NCT03503981|Process-outcome study|process-outcome study
4658287|NCT03503981|Mechanisms of change|mechanisms of change
4658288|NCT03503916|Accidental fall|accidental fall
4658289|NCT03503916|Postural Balance|postural balance
4658290|NCT03503903|Wet cupping therapy|wet cupping therapy
4658291|NCT03503903|antioxidant capacity|antioxidant capacity
4658292|NCT03503890|Expanded Access, Pre-approval Access, Compassionate Use, Special Access Program, Named Patient Basis, Special Access Scheme.|expanded access, pre-approval access, compassionate use, special access program, named patient basis, special access scheme.
4658293|NCT03503864|Neuroblastoma|neuroblastoma
4658294|NCT03503864|Arsenic Trioxide|arsenic trioxide
4658295|NCT03503864|Children|children
4658296|NCT03503851|Mitral Regurgitation|mitral regurgitation
4658297|NCT03503851|transcatheter mitral valve repair|transcatheter mitral valve repair
4658298|NCT03503851|MitraClip|mitraclip
4658299|NCT03503812|Randomized clinical trial|randomized clinical trial
4658300|NCT03503812|Public Health Intervention|public health intervention
4658301|NCT03503812|Behavioral Intervention|behavioral intervention
4658302|NCT03503812|Exposure-Reduction Approaches|exposure-reduction approaches
4658303|NCT03503812|Desert dust storm events|desert dust storm events
4658304|NCT03503812|Climate change|climate change
4658305|NCT03503812|Asthma in children|asthma in children
4658306|NCT03503812|Atrial Fibrillation|atrial fibrillation
4658307|NCT03503812|Air pollution|air pollution
4658308|NCT03503799|breast cancer|breast cancer
4658309|NCT03503799|EndoPredict®|endopredict®
4658310|NCT03503799|endocrine therapy|endocrine therapy
4658311|NCT03503786|PD-L1 Expression|pd-l1 expression
4658312|NCT03503786|advanced endometrial cancer|advanced endometrial cancer
4658313|NCT03503786|recurrent endometrial cancer|recurrent endometrial cancer
4658314|NCT03503786|Patient reported outcomes|patient reported outcomes
4658315|NCT03503773|Renal Denervation|renal denervation
4658316|NCT03503773|Neurolysis|neurolysis
4658317|NCT03503760|Extremely low magnetic field (ELF)|extremely low magnetic field (elf)
4658318|NCT03503760|Fibromyalgia impact questionnaire (FIQ)|fibromyalgia impact questionnaire (fiq)
4658319|NCT03503760|Pittsburgh Sleep Quality Index (PSQI)|pittsburgh sleep quality index (psqi)
4658320|NCT03503760|Short Form-12 of Physical and Mental Health Summary (SF-12)|short form-12 of physical and mental health summary (sf-12)
4658321|NCT03503760|"LIMFA Therapy® machine from Eywa Srl system"|"limfa therapy® machine from eywa srl system"
4658322|NCT03503747|type 1 diabetes|type 1 diabetes
4658323|NCT03503747|Infants|infants
4658324|NCT03503747|INGR1D|ingr1d
4658325|NCT03503721|BipolEP|bipolep
4658326|NCT03503721|TURP|turp
4658327|NCT03503695|auricular acupuncture|auricular acupuncture
4658328|NCT03503695|battlefield acupuncture|battlefield acupuncture
4658329|NCT03503695|insomnia|insomnia
4658330|NCT03503695|chronic pain|chronic pain
4658331|NCT03503695|randomized|randomized
4658332|NCT03503682|Short Course Radiotherapy|short course radiotherapy
4658333|NCT03503682|Complicated Bone Metastases|complicated bone metastases
4658334|NCT03503669|Memory impairment|memory impairment
4658335|NCT03503669|Meditation|meditation
4658336|NCT03503669|Yoga|yoga
4658337|NCT03503669|Memory Training|memory training
4658338|NCT03503669|Mild Cognitive Impairment|mild cognitive impairment
4658339|NCT03503669|MCI|mci
4658340|NCT03503669|Geriatric|geriatric
4658341|NCT03503669|fMRI|fmri
4658342|NCT03503669|Alzheimer's disease|alzheimer's disease
4658343|NCT03503669|Cardiovascular risk|cardiovascular risk
4658344|NCT03503643|prostate cancer|prostate cancer
4658345|NCT03503643|cryoablation|cryoablation
4658346|NCT03503630|Locally advanced rectal cancer|locally advanced rectal cancer
4658347|NCT03503630|Immunotherapy|immunotherapy
4658348|NCT03503630|Short course radiation|short course radiation
4658349|NCT03503630|Folfox|folfox
4658350|NCT03503630|Response rate|response rate
4658351|NCT03503604|mAb|mab
4658352|NCT03503604|VEGF|vegf
4658353|NCT03503604|antibody|antibody
4658354|NCT03503604|phase1|phase1
4658355|NCT03503591|tympanostomy|tympanostomy
4658356|NCT03503591|myringotomy|myringotomy
4658357|NCT03503591|otitis media|otitis media
4658358|NCT03503591|ear tubes|ear tubes
4658359|NCT03503591|ear infection|ear infection
4658360|NCT03503565|one-lung ventilation|one-lung ventilation
4658361|NCT03503565|thoracic surgery|thoracic surgery
4658362|NCT03503565|atelectasis|atelectasis
4658363|NCT03503565|postoperative pulmonary complication|postoperative pulmonary complication
4658364|NCT03503500|Breastfeeding|breastfeeding
4658365|NCT03503500|Laid-back position|laid-back position
4658366|NCT03503500|Breast problems|breast problems
4658367|NCT03503500|Exclusive breastfeeding|exclusive breastfeeding
4658368|NCT03503461|Calcineurin inhibitors|calcineurin inhibitors
4658369|NCT03503461|hypertension|hypertension
4658370|NCT03503461|kidney transplant|kidney transplant
4658371|NCT03503461|acidosis|acidosis
4658372|NCT03503461|Gordon syndrome|gordon syndrome
4658373|NCT03503448|surgically assisted rapid maxillary expansion|surgically assisted rapid maxillary expansion
4658374|NCT03503448|surgically assisted rapid palatal expansion|surgically assisted rapid palatal expansion
4658375|NCT03503448|Malocclusion|malocclusion
4658376|NCT03503435|Heart Rate Variability|heart rate variability
4658377|NCT03503435|Art Therapy|art therapy
4658378|NCT03503435|Total Laryngectomy|total laryngectomy
4658379|NCT03503396|drunk driving|drunk driving
4658380|NCT03503396|alcohol impaired driving|alcohol impaired driving
4658381|NCT03503396|drinking and driving|drinking and driving
4658382|NCT03503396|ambulatory assessment|ambulatory assessment
4658383|NCT03503383|Hypertension with pregnancy|hypertension with pregnancy
4658384|NCT03503383|anxiety|anxiety
4658385|NCT03503383|depression|depression
4658386|NCT03503383|preeclampsia|preeclampsia
4658387|NCT03503383|mental health|mental health
4658388|NCT03503370|topical chlorhexidine|topical chlorhexidine
4658389|NCT03503370|prevention|prevention
4658390|NCT03503370|clinical trial|clinical trial
4658391|NCT03503357|Consciousness|consciousness
4658392|NCT03503357|Electroencephalography|electroencephalography
4658393|NCT03503357|Anesthesia|anesthesia
4658394|NCT03503305|Adipose-derived stem cells|adipose-derived stem cells
4658395|NCT03503305|osteoarthritis|osteoarthritis
4658396|NCT03503292|Pharmacogenetics|pharmacogenetics
4658397|NCT03503292|CYP2D6|cyp2d6
4658398|NCT03503292|Ondansetron|ondansetron
4658399|NCT03503292|Granisetron|granisetron
4658400|NCT03503292|Bariatric surgery|bariatric surgery
4658401|NCT03503266|Mass Balance Study with MT-7117|mass balance study with mt-7117
4658402|NCT03503240|Quality of Life|quality of life
4658403|NCT03503240|survey|survey
4658404|NCT03503240|18-168|18-168
4658405|NCT03503214|Acid-base equilibrium|acid-base equilibrium
4658406|NCT03503214|Stewart's approach|stewart's approach
4658407|NCT03503214|In vitro study|in vitro study
4658408|NCT03503214|Respiratory acid-base derangements|respiratory acid-base derangements
4658409|NCT03503162|bowel prepartion|bowel prepartion
4658410|NCT03503136|Nasopharyngeal Carcinoma|nasopharyngeal carcinoma
4658411|NCT03503136|Induction chemotherapy|induction chemotherapy
4658412|NCT03503136|Concurrent chemoradiotherapy|concurrent chemoradiotherapy
4658413|NCT03503136|Nedaplatin|nedaplatin
4658414|NCT03503136|Capecitabine|capecitabine
4658415|NCT03503097|Prostate cancer|prostate cancer
4658416|NCT03503097|metastatic|metastatic
4658417|NCT03503097|genetic testing|genetic testing
4658418|NCT03503097|cancer risk|cancer risk
4658419|NCT03503097|BRCA1|brca1
4658420|NCT03503097|BRCA2|brca2
4658421|NCT03503084|Tai Chi Chuan|tai chi chuan
4658422|NCT03503084|insulin resistance|insulin resistance
4658423|NCT03503084|cholesterol|cholesterol
4658424|NCT03503084|endothelin-1|endothelin-1
4658425|NCT03503058|Plasmodium falciparum|plasmodium falciparum
4658426|NCT03503058|Sporozoites|sporozoites
4658427|NCT03503058|PfSPZ|pfspz
4658428|NCT03503045|Diabetes Mellitus|diabetes mellitus
4658429|NCT03503045|Polypharmacy|polypharmacy
4658430|NCT03503045|Overtreatment|overtreatment
4658431|NCT03503045|Undertreatment|undertreatment
4658432|NCT03503032|Extracardiac Fontan|extracardiac fontan
4658433|NCT03503032|Total cavo-pulmonary connection|total cavo-pulmonary connection
4658434|NCT03503032|Fenestrated|fenestrated
4658435|NCT03503032|Congenital heart defects|congenital heart defects
4658436|NCT03503032|Pediatrics|pediatrics
4658437|NCT03502993|children|children
4658438|NCT03502980|Peripherally Inserted Central Catheter Line Insertion|peripherally inserted central catheter line insertion
4658439|NCT03502980|Catheterization, Peripheral Venous|catheterization, peripheral venous
4658440|NCT03502967|Traumatic Brain Injury|traumatic brain injury
4658441|NCT03502967|TBI|tbi
4658442|NCT03502915|breech presentation|breech presentation
4658443|NCT03502915|nitrous oxide|nitrous oxide
4658444|NCT03502915|analgesia|analgesia
4658445|NCT03502915|pregnancy|pregnancy
4658446|NCT03502889|Total Knee Arthroplasty|total knee arthroplasty
4658447|NCT03502889|SPANK Block|spank block
4658448|NCT03502889|Adductor Canal Block|adductor canal block
4658449|NCT03502889|Regional Anesthesia|regional anesthesia
4658450|NCT03502837|ERP;DOC;auditory|erp;doc;auditory
4658451|NCT03502824|Chronic wounds|chronic wounds
4658452|NCT03502824|PHMB|phmb
4658453|NCT03502824|Pressure Ulcer|pressure ulcer
4658454|NCT03502824|Wound Management|wound management
4658455|NCT03502824|Collagen|collagen
4658456|NCT03502824|Stage II|stage ii
4658457|NCT03502824|Stage III|stage iii
4658458|NCT03502824|Stage IV|stage iv
4658459|NCT03502824|Pressure Injury|pressure injury
4658460|NCT03502811|MitraClip|mitraclip
4658461|NCT03502811|MitraClip NTR|mitraclip ntr
4658462|NCT03502811|MitraClip XTR|mitraclip xtr
4658463|NCT03502811|Mitral Regurgitation|mitral regurgitation
4658464|NCT03502759|SUDEP|sudep
4658465|NCT03502759|Epilepsy|epilepsy
4658466|NCT03502681|Cisplatin-Ineligible|cisplatin-ineligible
4658467|NCT03502681|Avelumab|avelumab
4658468|NCT03502681|PD-L1 Monoclonal Antibody|pd-l1 monoclonal antibody
4658469|NCT03502681|Eribulin Mesylate|eribulin mesylate
4658470|NCT03502668|low risk myelodysplastic syndromes, MDS, ASTX727|low risk myelodysplastic syndromes, mds, astx727
4658471|NCT03502655|Pain|pain
4658472|NCT03502655|Peripheral intravenous catheter|peripheral intravenous catheter
4658473|NCT03502655|Peripheral catheterization|peripheral catheterization
4658474|NCT03502655|Communication|communication
4658475|NCT03502655|Emergency Department|emergency department
4658476|NCT03502642|Ropivacaine|ropivacaine
4658477|NCT03502642|wound infusion|wound infusion
4658478|NCT03502642|analgesia|analgesia
4658479|NCT03502642|cesarean|cesarean
4658480|NCT03502642|intrathecal morphine|intrathecal morphine
4658481|NCT03502642|randomized controlled trial|randomized controlled trial
4658482|NCT03502564|Posttraumatic stress disorder|posttraumatic stress disorder
4658483|NCT03502564|Eating disorders|eating disorders
4658484|NCT03502564|Cognitive behavior therapy|cognitive behavior therapy
4658485|NCT03502564|Cognitive processing therapy|cognitive processing therapy
4658486|NCT03502564|Randomized controlled trial|randomized controlled trial
4658487|NCT03502551|ketamine|ketamine
4658488|NCT03502551|suicide|suicide
4658489|NCT03502512|Breast reconstruction|breast reconstruction
4658490|NCT03502512|REVOLVE Tissue Process|revolve tissue process
4658491|NCT03502512|PureGraft Tissue Process|puregraft tissue process
4658492|NCT03502512|Questionnaires|questionnaires
4658493|NCT03502512|Surveys|surveys
4658494|NCT03502473|fat flanks|fat flanks
4658495|NCT03502460|Lung ultrasonography|lung ultrasonography
4658496|NCT03502460|fluid administration|fluid administration
4658497|NCT03502460|limitation|limitation
4658498|NCT03502460|stroke volume variation|stroke volume variation
4658499|NCT03502460|esophageal Doppler|esophageal doppler
4658500|NCT03502421|Ketamine|ketamine
4658501|NCT03502343|Pancreatic cancer|pancreatic cancer
4658502|NCT03502343|Metastatic|metastatic
4658503|NCT03502343|Modified|modified
4658504|NCT03502343|Gemcitabine|gemcitabine
4658505|NCT03502343|nab-Paclitaxel|nab-paclitaxel
4658506|NCT03502317|Prehabilitation|prehabilitation
4658507|NCT03502317|Gastrointestinal Cancer|gastrointestinal cancer
4658508|NCT03502317|Physical Activity|physical activity
4658509|NCT03502317|Exercise|exercise
4658510|NCT03502317|Surgery|surgery
4658511|NCT03502304|Metabolic syndrome|metabolic syndrome
4658512|NCT03502304|Obesity|obesity
4658513|NCT03502291|Human challenge models|human challenge models
4658514|NCT03502291|Immunity|immunity
4658515|NCT03502291|Streptococcus pneumoniae|streptococcus pneumoniae
4658516|NCT03502291|Live Attenuated Influenza Vaccine|live attenuated influenza vaccine
4658517|NCT03502278|refugee|refugee
4658518|NCT03502252|early childhood development|early childhood development
4658519|NCT03502252|social and emotional development|social and emotional development
4658520|NCT03502252|secure parenting relationships|secure parenting relationships
4658521|NCT03502213|Prostate Cancer|prostate cancer
4658522|NCT03502213|Localized Prostate Cancer|localized prostate cancer
4658523|NCT03502213|Low Risk Prostate Cancer|low risk prostate cancer
4658524|NCT03502213|Active Surveillance|active surveillance
4658525|NCT03502213|Active Monitoring|active monitoring
4658526|NCT03502213|OncotypeDX GPS|oncotypedx gps
4658527|NCT03502213|Genomic Prostate Score|genomic prostate score
4658528|NCT03502213|Genomic Test|genomic test
4658529|NCT03502213|Molecular Test|molecular test
4658530|NCT03502122|stroke|stroke
4658531|NCT03502122|rehabilitation|rehabilitation
4658532|NCT03502109|Medication review|medication review
4658533|NCT03502109|Pharmacist|pharmacist
4658534|NCT03502109|Medication therapy management|medication therapy management
4658535|NCT03502109|Cardiovascular diseases|cardiovascular diseases
4658536|NCT03502109|Economics|economics
4658537|NCT03502109|Elderly|elderly
4658538|NCT03502109|Primary Care|primary care
4658539|NCT03502096|portion size|portion size
4658540|NCT03502096|food intake|food intake
4658541|NCT03502096|energy intake|energy intake
4658542|NCT03502096|food choice|food choice
4658543|NCT03502070|CF, Human Factors, TOBI® Podhaler™, user interface, IFU|cf, human factors, tobi® podhaler™, user interface, ifu
4658544|NCT03502044|Myalgic Encephalomyelitis|myalgic encephalomyelitis
4658545|NCT03502044|Chronic Fatigue Syndrome|chronic fatigue syndrome
4658546|NCT03502044|Kinetic Oscillatory Stimulation in nasal cavity|kinetic oscillatory stimulation in nasal cavity
4658547|NCT03502018|Exparel|exparel
4658548|NCT03502018|Bupivacaine|bupivacaine
4658549|NCT03502018|Intracapsular Fracture of the Femur|intracapsular fracture of the femur
4658550|NCT03502018|Femoral Neck Fracture|femoral neck fracture
4658551|NCT03502018|Hip Hemiarthroplasty|hip hemiarthroplasty
4658552|NCT03501992|Papillomavirus vaccines|papillomavirus vaccines
4658553|NCT03501992|Vaccination|vaccination
4658554|NCT03501992|Patient acceptance of health care|patient acceptance of health care
4658555|NCT03501992|Child|child
4658556|NCT03501992|Parents|parents
4658557|NCT03501992|Primary health care|primary health care
4658558|NCT03501992|Health personnel|health personnel
4658559|NCT03501992|Primary prevention|primary prevention
4658560|NCT03501992|Neoplasms|neoplasms
4658561|NCT03501979|HER2+|her2+
4658562|NCT03501979|metastatic breast cancer|metastatic breast cancer
4658563|NCT03501979|leptomeningeal disease|leptomeningeal disease
4658564|NCT03501979|tucatinib|tucatinib
4658565|NCT03501979|trastuzumab|trastuzumab
4658566|NCT03501979|capecitabine|capecitabine
4658567|NCT03501966|headache|headache
4658568|NCT03501966|idiopathic intracranial hypertension (IIH)|idiopathic intracranial hypertension (iih)
4658569|NCT03501966|shunt|shunt
4658570|NCT03501966|fenestration|fenestration
4658571|NCT03501966|acetazolamide|acetazolamide
4658572|NCT03501966|visual loss|visual loss
4658573|NCT03501966|diamox|diamox
4658574|NCT03501953|Cognitive Change|cognitive change
4658575|NCT03501953|Physical Activity|physical activity
4658576|NCT03501953|Environmental Exposure|environmental exposure
4658577|NCT03501953|Health Behavior|health behavior
4658578|NCT03501927|Ultrasound|ultrasound
4658579|NCT03501927|FOCUS|focus
4658580|NCT03501927|Surgery|surgery
4658581|NCT03501927|Anesthesia|anesthesia
4658582|NCT03501914|Care givers|care givers
4658583|NCT03501914|Adults|adults
4658584|NCT03501914|Intellectual Disability|intellectual disability
4658585|NCT03501914|Mindfulness|mindfulness
4658586|NCT03501901|ESBL-producing enterobacteria|esbl-producing enterobacteria
4658587|NCT03501901|hospital- and community-acquired urinary tract infections|hospital- and community-acquired urinary tract infections
4658588|NCT03501888|Acceptance and Commitment Therapy|acceptance and commitment therapy
4658590|NCT03501888|Cognitive Behavior Therapy|cognitive behavior therapy
4658591|NCT03501888|CBT|cbt
4658592|NCT03501888|Schizophrenia|schizophrenia
4658593|NCT03501888|Psychoses|psychoses
4658594|NCT03501862|Mindfulness|mindfulness
4658595|NCT03501862|Cognitive therapy|cognitive therapy
4658596|NCT03501849|Cancer prevention|cancer prevention
4658597|NCT03501849|Cancer detection|cancer detection
4658598|NCT03501849|Colonoscopy|colonoscopy
4658599|NCT03501849|Polypectomy|polypectomy
4658600|NCT03501849|Cold Snare|cold snare
4658601|NCT03501849|Optivista|optivista
4658602|NCT03501771|Acupuncture|acupuncture
4658603|NCT03501771|Back pain|back pain
4658604|NCT03501771|Low Back Pain|low back pain
4658605|NCT03501771|Lumbago|lumbago
4658606|NCT03501771|pulse diagnosis|pulse diagnosis
4658607|NCT03501771|radial pressure pulse|radial pressure pulse
4658608|NCT03501758|ulcerative colitis|ulcerative colitis
4658609|NCT03501758|ultrasound|ultrasound
4658610|NCT03501758|remission|remission
4658611|NCT03501758|relapse|relapse
4658612|NCT03501719|HIV|hiv
4658613|NCT03501719|inflammation|inflammation
4658614|NCT03501719|antiretroviral therapy|antiretroviral therapy
4658615|NCT03501719|cohort studies|cohort studies
4658616|NCT03501719|mortality|mortality
4658617|NCT03501719|non-AIDS events|non-aids events
4658618|NCT03501706|intertemporal tradeoffs|intertemporal tradeoffs
4658619|NCT03501706|delayed gratification|delayed gratification
4658620|NCT03501706|executive functioning|executive functioning
4658621|NCT03501706|delay discounting|delay discounting
4658622|NCT03501706|working memory|working memory
4658623|NCT03501680|hyperlipidaemic pancreatitis|hyperlipidaemic pancreatitis
4658624|NCT03501680|Plasmapheresis|plasmapheresis
4658625|NCT03501680|insulin|insulin
4658626|NCT03501654|Lenses, Intraocular|lenses, intraocular
4658627|NCT03501641|cognitive load|cognitive load
4658628|NCT03501641|competence|competence
4658629|NCT03501641|heart rate variation|heart rate variation
4658630|NCT03501641|learning|learning
4658631|NCT03501641|otolaryngology|otolaryngology
4658632|NCT03501641|video|video
4658633|NCT03501641|virtual reality|virtual reality
4658634|NCT03501615|Early Access|early access
4658635|NCT03501615|Leukemia|leukemia
4658636|NCT03501615|Hairy cell|hairy cell
4658637|NCT03501615|Moxetumomab Pasudotox|moxetumomab pasudotox
4658638|NCT03501615|PNA|pna
4658639|NCT03501615|Purine analog|purine analog
4658640|NCT03501615|BRAF Inhibitor|braf inhibitor
4658641|NCT03501615|Rituximab|rituximab
4658642|NCT03501615|Pseudomonas-immunotoxin naïve|pseudomonas-immunotoxin naïve
4658643|NCT03501602|aintree, LMA protector; I-gel LMA, Fiberoptic Bronchoscope|aintree, lma protector; i-gel lma, fiberoptic bronchoscope
4658644|NCT03501563|hypotensive anesthesia|hypotensive anesthesia
4658645|NCT03501563|thiol / disulfide|thiol / disulfide
4658646|NCT03501563|oxidative stress markers|oxidative stress markers
4658647|NCT03501563|septoplasty|septoplasty
4658648|NCT03501550|HCV|hcv
4658649|NCT03501550|GT1|gt1
4658650|NCT03501511|Diabetes MellitusType1;Fasting;Health Education;Hypoglycemia|diabetes mellitustype1;fasting;health education;hypoglycemia
4658651|NCT03501498|Intestinal Transit, Bile Salts, Gut Bacteria, Volatile Organic Compounds|intestinal transit, bile salts, gut bacteria, volatile organic compounds
4658652|NCT03501472|pictorial warning labels|pictorial warning labels
4658653|NCT03501472|risk knowledge|risk knowledge
4658654|NCT03501472|emotion|emotion
4658655|NCT03501472|memory|memory
4658656|NCT03501472|risk perceptions|risk perceptions
4658657|NCT03501472|quit intentions|quit intentions
4658658|NCT03501472|numeracy|numeracy
4658659|NCT03501446|PEEP optimization|peep optimization
4658660|NCT03501446|Lung volumes|lung volumes
4658661|NCT03501433|postpandial|postpandial
4658662|NCT03501433|lipemia|lipemia
4658663|NCT03501433|microvascular|microvascular
4658664|NCT03501420|Belimumab|belimumab
4658665|NCT03501420|Disease Specific Programme|disease specific programme
4658666|NCT03501420|rheumatologist|rheumatologist
4658667|NCT03501420|Benlysta|benlysta
4658668|NCT03501420|Primary Sjögren's Syndrome|primary sjögren's syndrome
4658669|NCT03501420|Adelphi pSS DSP|adelphi pss dsp
4658670|NCT03501394|Magnetic Resonance Imaging|magnetic resonance imaging
4658671|NCT03501394|Neoadjuvant Chemotherapy|neoadjuvant chemotherapy
4658672|NCT03501368|cutaneous|cutaneous
4658673|NCT03501368|refractory|refractory
4658674|NCT03501368|melanoma|melanoma
4658675|NCT03501368|ceritinib|ceritinib
4658676|NCT03501355|pacemaker|pacemaker
4658677|NCT03501355|inspiratory muscle training|inspiratory muscle training
4658678|NCT03501355|exercise capacity|exercise capacity
4658679|NCT03501355|Quality of Life|quality of life
4658680|NCT03501355|Respiratory Muscle Strength|respiratory muscle strength
4658681|NCT03501342|Multiple Sclerosis|multiple sclerosis
4658682|NCT03501342|virtual reality|virtual reality
4658683|NCT03501342|balance|balance
4658684|NCT03501342|mobility|mobility
4658685|NCT03501342|fatigue|fatigue
4658686|NCT03501316|Root Surface Debridement|root surface debridement
4658687|NCT03501316|Hand Instrumentation|hand instrumentation
4658688|NCT03501316|Ultrasonic Instrumentation|ultrasonic instrumentation
4658689|NCT03501316|Systemic|systemic
4658690|NCT03501316|Immune|immune
4658691|NCT03501316|CRP|crp
4658692|NCT03501290|Frailty|frailty
4658693|NCT03501290|Malnutrition|malnutrition
4658694|NCT03501290|Older adults|older adults
4658695|NCT03501290|Oral Nutritional Supplements|oral nutritional supplements
4658696|NCT03501290|Compliance|compliance
4658697|NCT03501277|Drug therapy|drug therapy
4658698|NCT03501199|immediate implant placement|immediate implant placement
4658699|NCT03501186|Backward walking, stroke, gait training|backward walking, stroke, gait training
4658700|NCT03501160|Regressive behaviors|regressive behaviors
4658701|NCT03501160|Childish behaviors|childish behaviors
4658702|NCT03501160|Affection expression socially inappropriate behaviors|affection expression socially inappropriate behaviors
4658703|NCT03501160|Social Inappropriate Behaviors|social inappropriate behaviors
4658704|NCT03501160|Social Impairment|social impairment
4658705|NCT03501134|Pro000888900|pro000888900
4658706|NCT03501134|Katherine Peters|katherine peters
4658707|NCT03501134|Optune|optune
4658708|NCT03501134|NovoTTF|novottf
4658709|NCT03501134|ACTION|action
4658710|NCT03501134|Quality of life|quality of life
4658711|NCT03501134|Tumor treating fields|tumor treating fields
4658712|NCT03501121|intra-operative radiation therapy|intra-operative radiation therapy
4658713|NCT03501108|Polypharmacy|polypharmacy
4658714|NCT03501108|Multi-morbidity|multi-morbidity
4658715|NCT03501108|Deprescribing|deprescribing
4658716|NCT03501108|Older people|older people
4658717|NCT03501108|Elderly|elderly
4658718|NCT03501082|Gut microbiome|gut microbiome
4658719|NCT03501069|Drug Therapy|drug therapy
4658720|NCT03501056|PD-1 activated CIK|pd-1 activated cik
4658721|NCT03501056|MUC1|muc1
4658722|NCT03501056|Bispecific antibody|bispecific antibody
4658723|NCT03501056|lung cancer|lung cancer
4658724|NCT03500991|CNS, CAR T cell, HER2-positive, brain tumor|cns, car t cell, her2-positive, brain tumor
4658725|NCT03500991|pediatric, young adults|pediatric, young adults
4658726|NCT03500965|pictorial warning labels|pictorial warning labels
4658727|NCT03500965|risk knowledge|risk knowledge
4658728|NCT03500965|emotion|emotion
4658729|NCT03500965|memory|memory
4658730|NCT03500965|risk perceptions|risk perceptions
4658731|NCT03500965|quit intentions|quit intentions
4658732|NCT03500913|Growth Hormone Deficiency|growth hormone deficiency
4658733|NCT03500913|Adipose Tissue|adipose tissue
4658734|NCT03500913|Inflammation|inflammation
4658735|NCT03500900|gastric accommodation|gastric accommodation
4658736|NCT03500900|food intake|food intake
4658737|NCT03500900|gastrointestinal hormones|gastrointestinal hormones
4658738|NCT03500861|headache characteristics, health-related quality of life.|headache characteristics, health-related quality of life.
4659936|NCT03492892|acupuncture|acupuncture
4658739|NCT03500848|Liver transplantation|liver transplantation
4658740|NCT03500848|Sirolimus|sirolimus
4658741|NCT03500848|Tacrolimus|tacrolimus
4658742|NCT03500848|HCC recurrence free survival|hcc recurrence free survival
4658743|NCT03500822|dynamic hyperinflation|dynamic hyperinflation
4658744|NCT03500822|diastolic dysfunction|diastolic dysfunction
4658745|NCT03500822|COPD|copd
4658746|NCT03500822|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
4658747|NCT03500822|Metronome-paced Tachypnea|metronome-paced tachypnea
4658748|NCT03500822|Expiratory-stenosis Breathing|expiratory-stenosis breathing
4658749|NCT03500783|Cardioprotection|cardioprotection
4658750|NCT03500783|Ischemia-reperfusion injury|ischemia-reperfusion injury
4658751|NCT03500783|Nitric oxide|nitric oxide
4658752|NCT03500783|Cardiopulmonary bypass|cardiopulmonary bypass
4658753|NCT03500783|Coronary artery bypass grafting|coronary artery bypass grafting
4658754|NCT03500770|Post Treatment Lyme Disease Syndrome|post treatment lyme disease syndrome
4658755|NCT03500757|HoloLens|hololens
4658756|NCT03500757|3D holographic guidance|3d holographic guidance
4658757|NCT03500731|Lung Transplantation|lung transplantation
4658758|NCT03500731|Stem Cell Transplantation|stem cell transplantation
4658759|NCT03500731|Idiopathic Pulmonary Fibrosis|idiopathic pulmonary fibrosis
4658760|NCT03500731|Emphysema or COPD|emphysema or copd
4658761|NCT03500731|Bone marrow transplantation|bone marrow transplantation
4658762|NCT03500731|Cadaveric donor|cadaveric donor
4658763|NCT03500731|Unrelated donor|unrelated donor
4658764|NCT03500731|HLA-Mismatch|hla-mismatch
4658766|NCT03500731|HSCT|hsct
4658767|NCT03500731|IPF|ipf
4658768|NCT03500731|Pulmonary fibrosis|pulmonary fibrosis
4658769|NCT03500718|cochlear implant|cochlear implant
4658770|NCT03500718|threshold of electrically evoked compound action potential|threshold of electrically evoked compound action potential
4658771|NCT03500718|neural response telemetry|neural response telemetry
4658772|NCT03500692|Mitral Valve Regurgitation|mitral valve regurgitation
4658773|NCT03500692|MitraClip|mitraclip
4658774|NCT03500692|MitraClip NT|mitraclip nt
4658775|NCT03500692|Japan MitraClip NT Postmarketing Surveillance|japan mitraclip nt postmarketing surveillance
4658776|NCT03500666|Thyroid carcinoma|thyroid carcinoma
4658777|NCT03500666|Robot surgery|robot surgery
4658778|NCT03500666|Endoscopic surgery|endoscopic surgery
4658779|NCT03500640|Intervention|intervention
4658780|NCT03500640|Prevention|prevention
4658781|NCT03500640|Weight Management|weight management
4658782|NCT03500640|Physical Activity|physical activity
4658783|NCT03500640|Physical Function|physical function
4658784|NCT03500627|Adrenoleukodystrophy (ALD)|adrenoleukodystrophy (ald)
4658785|NCT03500627|Childhood Cerebral Adrenoleukodystrophy (ccALD)|childhood cerebral adrenoleukodystrophy (ccald)
4658786|NCT03500627|OP-101|op-101
4658787|NCT03500627|Dendrimer|dendrimer
4658788|NCT03500627|N-Acetyl-Cysteine (NAC)|n-acetyl-cysteine (nac)
4658789|NCT03500614|particulate matter|particulate matter
4658790|NCT03500614|phthalates|phthalates
4658791|NCT03500614|cytokines|cytokines
4658792|NCT03500614|chemokines|chemokines
4658793|NCT03500614|epigenetics|epigenetics
4658794|NCT03500614|DNA methylation|dna methylation
4658795|NCT03500614|peripheral blood mononuclear cells|peripheral blood mononuclear cells
4658796|NCT03500614|immune function|immune function
4658797|NCT03500601|Cognition|cognition
4658798|NCT03500601|Metagenomics|metagenomics
4658799|NCT03500601|Metabolomics|metabolomics
4658800|NCT03500575|induction therapy, photopheresis|induction therapy, photopheresis
4658801|NCT03500497|reticulocyte hemoglobin content (RetHe)|reticulocyte hemoglobin content (rethe)
4658802|NCT03500497|perioperative|perioperative
4658803|NCT03500497|colorectal surgery|colorectal surgery
4658804|NCT03500497|anemia|anemia
4658805|NCT03500471|Laparoscopic|laparoscopic
4658806|NCT03500471|Robotic|robotic
4658807|NCT03500471|Total Gastrectomy|total gastrectomy
4658808|NCT03500471|AGC|agc
4658809|NCT03500432|transperineal prostate biopsy|transperineal prostate biopsy
4658810|NCT03500432|local anesthesia|local anesthesia
4658811|NCT03500432|prostate cancer diagnosis|prostate cancer diagnosis
4658812|NCT03500367|mammilian target of rapamycin inhibitor|mammilian target of rapamycin inhibitor
4658813|NCT03500367|Rapamycin (sirolimus)|rapamycin (sirolimus)
4658814|NCT03500367|Treatment|treatment
4658815|NCT03500367|Complications|complications
4658816|NCT03500354|malnutrition|malnutrition
4658817|NCT03500276|yoga|yoga
4658818|NCT03500276|health-related quality of life|health-related quality of life
4658819|NCT03500276|proinflammatory genes|proinflammatory genes
4658820|NCT03500276|inflammatory markers|inflammatory markers
4658821|NCT03500276|rheumatoid arthritis|rheumatoid arthritis
4658822|NCT03500250|Complex intervention|complex intervention
4658823|NCT03500250|Depression|depression
4658824|NCT03500250|Nursing|nursing
4658825|NCT03500250|Stroke|stroke
4658826|NCT03500250|Feasibility|feasibility
4658827|NCT03500237|anxiety|anxiety
4658828|NCT03500237|depression|depression
4658829|NCT03500237|internet-delivered cognitive behaviour therapy|internet-delivered cognitive behaviour therapy
4658830|NCT03500237|randomized controlled trial|randomized controlled trial
4658831|NCT03500237|patient-centered|patient-centered
4658832|NCT03500237|knowledge implementation|knowledge implementation
4658833|NCT03500237|mental health system|mental health system
4658834|NCT03500237|therapist-assistance|therapist-assistance
4658835|NCT03500224|Drug therapy|drug therapy
4658836|NCT03500211|Cesarean section|cesarean section
4658837|NCT03500211|Postoperative pain|postoperative pain
4658838|NCT03500185|Physiotherapy|physiotherapy
4658839|NCT03500185|Pelvic floor|pelvic floor
4658840|NCT03500185|Urinary Incontinence|urinary incontinence
4658841|NCT03500172|HIV|hiv
4658842|NCT03500172|Female Sex Workers|female sex workers
4658843|NCT03500172|Viral Suppression|viral suppression
4658844|NCT03500172|South Africa|south africa
4658845|NCT03500172|Decentralized care|decentralized care
4658846|NCT03500172|Antiretroviral therapy|antiretroviral therapy
4658847|NCT03500172|Differentiated care|differentiated care
4658848|NCT03500133|Pediatric Hodgkin Lymphoma, therapy, reduced radiotherapy|pediatric hodgkin lymphoma, therapy, reduced radiotherapy
4658849|NCT03500107|Blue Light Emitting Diode|blue light emitting diode
4658850|NCT03500107|Women|women
4658851|NCT03500094|Lysosomal storage disease|lysosomal storage disease
4658852|NCT03500094|migalastat|migalastat
4658853|NCT03500094|AT1001|at1001
4658854|NCT03500068|Pancreatic cancer|pancreatic cancer
4658855|NCT03500068|Organoids|organoids
4658856|NCT03500042|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
4658857|NCT03500042|inspiratory muscle training|inspiratory muscle training
4658858|NCT03500042|expiratory muscle training|expiratory muscle training
4658859|NCT03500042|Neural Respiratory Drive|neural respiratory drive
4658860|NCT03500029|Depression|depression
4658861|NCT03500029|Transcranial magnetic stimulation(TMS)|transcranial magnetic stimulation(tms)
4658862|NCT03500029|Resting-state functional MRI(fMRI)|resting-state functional mri(fmri)
4658863|NCT03500016|Insulin resistance|insulin resistance
4658864|NCT03500016|Obesity|obesity
4658865|NCT03500016|Type 2 diabetes|type 2 diabetes
4658866|NCT03500016|Exercise training|exercise training
4658867|NCT03500003|dairy products|dairy products
4658868|NCT03500003|milk|milk
4658869|NCT03500003|yogurt|yogurt
4658870|NCT03500003|metabolomics|metabolomics
4658871|NCT03500003|elderly|elderly
4658872|NCT03499990|Adrenal crisis|adrenal crisis
4658873|NCT03499990|Risk factors|risk factors
4658874|NCT03499977|Physical Activity|physical activity
4658875|NCT03499977|Executive function|executive function
4658876|NCT03499977|Anti-saccade|anti-saccade
4658877|NCT03499964|pivotal trial|pivotal trial
4658878|NCT03499964|randomized|randomized
4658879|NCT03499964|lower urinary tract symptoms (LUTS)|lower urinary tract symptoms (luts)
4658880|NCT03499964|urethral stricture|urethral stricture
4658881|NCT03499964|obstruction|obstruction
4658882|NCT03499951|Quality of life|quality of life
4658883|NCT03499951|Participation|participation
4658884|NCT03499951|Training|training
4658885|NCT03499938|Asthma|asthma
4658886|NCT03499938|Bronchiolitis|bronchiolitis
4658887|NCT03499938|Wheezing|wheezing
4658888|NCT03499938|Structured Light Plethysmography|structured light plethysmography
4658889|NCT03499925|mental health|mental health
4658890|NCT03499925|intervention|intervention
4658891|NCT03499925|pregnancy-related complications|pregnancy-related complications
4658892|NCT03499912|Acute myeloid leukemia|acute myeloid leukemia
4658893|NCT03499912|IDH1|idh1
4658894|NCT03499912|IDH2|idh2
4658895|NCT03499912|Genetic mutations|genetic mutations
4658896|NCT03499912|Prognosis|prognosis
4658897|NCT03499899|triple-negative breast cancer|triple-negative breast cancer
4658898|NCT03499899|checkpoint inhibition|checkpoint inhibition
4658899|NCT03499899|LAG525|lag525
4658900|NCT03499899|spartalizumab|spartalizumab
4658901|NCT03499899|PDR001|pdr001
4658902|NCT03499899|carboplatin|carboplatin
4658903|NCT03499834|Immune Cell Therapy|immune cell therapy
4658904|NCT03499834|IKC|ikc
4658905|NCT03499795|High-grade squamous intraepithelial lesions (HSIL)|high-grade squamous intraepithelial lesions (hsil)
4658906|NCT03499795|Human papillomavirus (HPV)|human papillomavirus (hpv)
4658907|NCT03499795|HPV-16|hpv-16
4658908|NCT03499795|HPV-18|hpv-18
4658909|NCT03499795|Anal intraepithelial neoplasia 2 (AIN2)|anal intraepithelial neoplasia 2 (ain2)
4658910|NCT03499795|Anal intraepithelial neoplasia 3 (AIN3)|anal intraepithelial neoplasia 3 (ain3)
4658911|NCT03499795|Peri-anal intraepithelial neoplasia 2 (PAIN2)|peri-anal intraepithelial neoplasia 2 (pain2)
4658912|NCT03499795|Peri-anal intraepithelial neoplasia 3 (PAIN3)|peri-anal intraepithelial neoplasia 3 (pain3)
4658913|NCT03499782|Prognosis|prognosis
4658914|NCT03499782|Surgery options|surgery options
4658915|NCT03499782|Bayesian networks|bayesian networks
4658916|NCT03499756|Postnatal depression, interpersonal psychotherapy|postnatal depression, interpersonal psychotherapy
4658917|NCT03499730|Midazolam|midazolam
4658918|NCT03499730|Inguinal hernia|inguinal hernia
4658919|NCT03499717|Fall Risk|fall risk
4658920|NCT03499717|Patient Falls|patient falls
4658921|NCT03499717|Fall Prevention|fall prevention
4658922|NCT03499717|Patient Safety|patient safety
4658923|NCT03499704|Drug therapy|drug therapy
4658924|NCT03499665|Bruxism|bruxism
4658925|NCT03499665|Pain|pain
4658926|NCT03499665|Exercises|exercises
4658927|NCT03499665|Myofascial|myofascial
4658928|NCT03499665|Releasing|releasing
4658929|NCT03499613|Movement analysis|movement analysis
4658930|NCT03499613|Spinal kinematics|spinal kinematics
4658931|NCT03499613|Muscle activity|muscle activity
4658932|NCT03499613|Pain-related fear|pain-related fear
4658933|NCT03499613|Rehabilitation|rehabilitation
4658934|NCT03499613|Spine|spine
4658935|NCT03499600|Cultural assessment|cultural assessment
4658936|NCT03499600|Engagement|engagement
4658937|NCT03499600|Diverse Populations|diverse populations
4658938|NCT03499548|Intensive|intensive
4658939|NCT03499548|Cognitive Behavioral Therapy|cognitive behavioral therapy
4658940|NCT03499548|Male prisoners|male prisoners
4658941|NCT03499535|Risk Perception|risk perception
4658942|NCT03499522|Hemophilic arthropathy|hemophilic arthropathy
4658943|NCT03499522|Pain|pain
4658944|NCT03499522|Functional Disease Present|functional disease present
4658945|NCT03499522|Quality of life|quality of life
4658946|NCT03499522|Anxiety|anxiety
4658947|NCT03499522|Stress|stress
4658948|NCT03499522|Coping strategies|coping strategies
4658949|NCT03499496|plaques detection by ultrasound|plaques detection by ultrasound
4658950|NCT03499483|Post Exposure Prophylaxis|post exposure prophylaxis
4658951|NCT03499470|copd|copd
4658952|NCT03499470|exacerbation|exacerbation
4658953|NCT03499470|structured discharge|structured discharge
4658954|NCT03499470|readmission|readmission
4658955|NCT03499470|chronic respiratory failure|chronic respiratory failure
4658956|NCT03499457|Penicillin Allergy|penicillin allergy
4658957|NCT03499457|chalenge test|chalenge test
4658958|NCT03499457|primary clinic|primary clinic
4658959|NCT03499418|newborn|newborn
4658960|NCT03499418|TTN|ttn
4658961|NCT03499418|PPHN|pphn
4658962|NCT03499405|development and health disparities and navigation|development and health disparities and navigation
4658963|NCT03499392|psychological factors|psychological factors
4658964|NCT03499379|Intrauterine device (IUD)|intrauterine device (iud)
4658965|NCT03499379|Depression|depression
4658966|NCT03499379|Stress hormones|stress hormones
4658967|NCT03499379|Mood changes|mood changes
4658968|NCT03499366|enterovirus D68|enterovirus d68
4658969|NCT03499366|AFP|afp
4658970|NCT03499366|AFM|afm
4658971|NCT03499366|EV-D68|ev-d68
4658972|NCT03499366|acute flaccid myelitis|acute flaccid myelitis
4658973|NCT03499366|acute flaccid paresis|acute flaccid paresis
4658974|NCT03499353|Neoadjuvant Therapy, Triple Negative Breast Cancer, BRACA Positive|neoadjuvant therapy, triple negative breast cancer, braca positive
4658975|NCT03499340|pictorial warning labels|pictorial warning labels
4658976|NCT03499340|risk knowledge|risk knowledge
4658977|NCT03499340|emotion|emotion
4658978|NCT03499340|memory|memory
4658979|NCT03499340|risk perceptions|risk perceptions
4658980|NCT03499340|quit intentions|quit intentions
4658981|NCT03499327|vitamin D|vitamin d
4658982|NCT03499327|ergosterol|ergosterol
4658983|NCT03499327|7-dehydro-cholesterol|7-dehydro-cholesterol
4658984|NCT03499327|wheat germ oil|wheat germ oil
4658985|NCT03499314|Anodal transcranial stimulation (tDCS)|anodal transcranial stimulation (tdcs)
4658986|NCT03499301|Chronic pain|chronic pain
4658987|NCT03499301|Emergency|emergency
4658988|NCT03499301|Satisfaction|satisfaction
4658989|NCT03499288|Cerebral Palsy|cerebral palsy
4658990|NCT03499275|Neuromuscular electrical stimulation|neuromuscular electrical stimulation
4658991|NCT03499262|Social ABCs|social abcs
4658992|NCT03499262|Early Intervention|early intervention
4658993|NCT03499262|Autism Spectrum Disorder (ASD)|autism spectrum disorder (asd)
4658994|NCT03499262|Toddler|toddler
4658995|NCT03499262|Pivotal Response Treatment (PRT)|pivotal response treatment (prt)
4658996|NCT03499262|Group Intervention|group intervention
4658997|NCT03499262|Parent-Mediated|parent-mediated
4658998|NCT03499262|Caregiver-Mediated|caregiver-mediated
4658999|NCT03499262|Social Communication|social communication
4659000|NCT03499262|Positive Affect|positive affect
4659001|NCT03499262|Social Smiling|social smiling
4659002|NCT03499262|Social Orienting|social orienting
4659003|NCT03499262|Naturalistic Developmental Behaviour Intervention|naturalistic developmental behaviour intervention
4659004|NCT03499262|NDBI|ndbi
4659005|NCT03499262|Autism|autism
4659006|NCT03499262|Early Identification|early identification
4659007|NCT03499249|Biliary Atresia|biliary atresia
4659008|NCT03499249|N-Acetylcysteine|n-acetylcysteine
4659009|NCT03499249|Glutathione|glutathione
4659010|NCT03499249|Kasai portoenterostomy|kasai portoenterostomy
4659011|NCT03499249|Bile flow|bile flow
4659012|NCT03499249|Serum bile acids|serum bile acids
4659013|NCT03499249|Serum bilirubin|serum bilirubin
4659014|NCT03499210|Stroke|stroke
4659015|NCT03499210|Exoskeleton|exoskeleton
4659016|NCT03499210|Hemiparesis|hemiparesis
4659017|NCT03499210|Hemiplegia|hemiplegia
4659018|NCT03499145|conjunctivitis|conjunctivitis
4659019|NCT03499145|keratitis|keratitis
4659020|NCT03499145|pterygium|pterygium
4659021|NCT03499145|cataracts|cataracts
4659022|NCT03499132|anesthesia, obstructive sleep apnea|anesthesia, obstructive sleep apnea
4659023|NCT03499093|esthetics|esthetics
4659024|NCT03499093|orofacial esthetic scale|orofacial esthetic scale
4659025|NCT03499080|Medication free treatment, mental illness, outcome|medication free treatment, mental illness, outcome
4659026|NCT03499054|Breathing exercises|breathing exercises
4659027|NCT03499054|fatigue|fatigue
4659028|NCT03499054|quality of life|quality of life
4659029|NCT03499002|Simulation|simulation
4659030|NCT03499002|Medical Students|medical students
4659031|NCT03499002|In Situ Simulation|in situ simulation
4659032|NCT03498976|painful shoulder|painful shoulder
4659033|NCT03498937|Borderline Personality Disorder|borderline personality disorder
4659034|NCT03498937|Impulsive behavior|impulsive behavior
4659035|NCT03498937|Suicidal behavior|suicidal behavior
4659036|NCT03498937|Cognitive control|cognitive control
4659037|NCT03498937|tDCS|tdcs
4659038|NCT03498937|Noninvasive brain stimulation|noninvasive brain stimulation
4659039|NCT03498924|tumor marker|tumor marker
4659040|NCT03498924|HE4|he4
4659041|NCT03498924|CA125|ca125
4659042|NCT03498924|staging|staging
4659043|NCT03498924|diagnosis|diagnosis
4659044|NCT03498924|Endometrial Cancer|endometrial cancer
4659045|NCT03498898|Beta adrenergic receptor blockers|beta adrenergic receptor blockers
4659046|NCT03498898|Analgesia nociceptive index|analgesia nociceptive index
4659047|NCT03498898|Total hip replacement|total hip replacement
4659048|NCT03498898|Total knee replacement|total knee replacement
4659049|NCT03498885|Rectal Cancer|rectal cancer
4659050|NCT03498885|inferior mesenteric artery|inferior mesenteric artery
4659051|NCT03498885|Laparoscopic|laparoscopic
4659052|NCT03498872|AMPfoot|ampfoot
4659053|NCT03498872|Prosthetics|prosthetics
4659054|NCT03498872|gait|gait
4659055|NCT03498872|electro-encephalography|electro-encephalography
4659056|NCT03498872|dual-task walking|dual-task walking
4659057|NCT03498859|Rehabilitation|rehabilitation
4659058|NCT03498833|domains|domains
4659059|NCT03498833|item development|item development
4659060|NCT03498833|osteoarthritis|osteoarthritis
4659061|NCT03498833|scale formulation|scale formulation
4659062|NCT03498833|test retest reliability|test retest reliability
4659063|NCT03498820|Analgesia-Nociception Index (ANI)|analgesia-nociception index (ani)
4659064|NCT03498820|General anesthesia|general anesthesia
4659065|NCT03498820|Opioids|opioids
4659066|NCT03498820|Remifentanil|remifentanil
4659067|NCT03498820|Pain|pain
4659068|NCT03498820|Monitoring|monitoring
4659069|NCT03498807|ARDS|ards
4659070|NCT03498807|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
4659071|NCT03498807|PEEP|peep
4659072|NCT03498807|pressure-volume loop|pressure-volume loop
4659073|NCT03498807|Positive End-Expiratory Pressure|positive end-expiratory pressure
4659074|NCT03498807|hysteresis|hysteresis
4659075|NCT03498781|Exercise|exercise
4659076|NCT03498755|fisheries|fisheries
4659077|NCT03498755|Ghana|ghana
4659078|NCT03498755|sub-Saharan Africa|sub-saharan africa
4659079|NCT03498755|value chain|value chain
4659080|NCT03498755|fish processing|fish processing
4659081|NCT03498755|fish smoking|fish smoking
4659082|NCT03498742|asthma|asthma
4659083|NCT03498742|SABA|saba
4659084|NCT03498729|Autoimmune Diseases|autoimmune diseases
4659085|NCT03498690|online trial|online trial
4659086|NCT03498690|decision analysis|decision analysis
4659087|NCT03498677|online trial|online trial
4659088|NCT03498677|decision analysis|decision analysis
4659089|NCT03498664|EMR-C; EMR-S; LST|emr-c; emr-s; lst
4659090|NCT03498651|Anxiety|anxiety
4659091|NCT03498651|Cognitive bias|cognitive bias
4659092|NCT03498651|Telemedicine|telemedicine
4659093|NCT03498599|neuroimaging|neuroimaging
4659094|NCT03498599|fear conditioning|fear conditioning
4659095|NCT03498547|caudal block|caudal block
4659096|NCT03498547|saddle block|saddle block
4659097|NCT03498534|Treatment|treatment
4659098|NCT03498534|Latent infection|latent infection
4659099|NCT03498534|Tuberculosis|tuberculosis
4659100|NCT03498534|Interferon gamma|interferon gamma
4659101|NCT03498508|Cardiopulmonary Resuscitation|cardiopulmonary resuscitation
4659102|NCT03498508|Knowledge|knowledge
4659103|NCT03498508|In-hospital cardiac arrest|in-hospital cardiac arrest
4659104|NCT03498508|Skills|skills
4659105|NCT03498469|reintegration, reunification, child development|reintegration, reunification, child development
4659106|NCT03498430|Indolent Non-Hodgkin's Lymphoma (iNHL) (excluding CLL)|indolent non-hodgkin's lymphoma (inhl) (excluding cll)
4659107|NCT03498378|Avelumab|avelumab
4659108|NCT03498378|Palbociclib|palbociclib
4659109|NCT03498378|Cetuximab|cetuximab
4659110|NCT03498378|Head and Neck Squamous Cell Carcinoma|head and neck squamous cell carcinoma
4659111|NCT03498378|cancer|cancer
4659112|NCT03498378|Recurrent Head and Neck Squamous Cell Carcinoma|recurrent head and neck squamous cell carcinoma
4659113|NCT03498378|Metastatic Head and Neck Squamous Cell Carcinoma|metastatic head and neck squamous cell carcinoma
4659114|NCT03498365|decision analysis|decision analysis
4659115|NCT03498365|decision support|decision support
4659116|NCT03498352|cardiopulmonary exercise testing, thoracic surgery|cardiopulmonary exercise testing, thoracic surgery
4659117|NCT03498326|pancreatic cancer|pancreatic cancer
4659118|NCT03498326|gemcitabine|gemcitabine
4659119|NCT03498326|celecoxib|celecoxib
4659120|NCT03498326|R0 resection|r0 resection
4659121|NCT03498313|steroid hormones|steroid hormones
4659122|NCT03498313|estradiol|estradiol
4659123|NCT03498313|estrogen|estrogen
4659124|NCT03498313|progesterone|progesterone
4659125|NCT03498313|depression|depression
4659126|NCT03498313|suicide|suicide
4659127|NCT03498287|carpal tunnel syndrome|carpal tunnel syndrome
4659128|NCT03498287|carpal tunnel|carpal tunnel
4659130|NCT03498287|musculoskeletal disorder|musculoskeletal disorder
4659131|NCT03498287|peripheral neuropathy|peripheral neuropathy
4659132|NCT03498287|repetitive stress injury|repetitive stress injury
4659133|NCT03498287|non-invasive device|non-invasive device
4659134|NCT03498287|non-significant risk|non-significant risk
4659135|NCT03498287|medical device|medical device
4659136|NCT03498274|Fitting|fitting
4659137|NCT03498235|sevoflurane|sevoflurane
4659138|NCT03498235|propofol|propofol
4659139|NCT03498235|intracranial pressure|intracranial pressure
4659140|NCT03498235|optic nerve sheath diameter|optic nerve sheath diameter
4659141|NCT03498196|muscle invasive bladder cancer|muscle invasive bladder cancer
4659142|NCT03498196|non-muscle invasive bladder cancer|non-muscle invasive bladder cancer
4659143|NCT03498196|radical cystectomy|radical cystectomy
4659144|NCT03498196|monoclonal antibodies|monoclonal antibodies
4659145|NCT03498196|Avelumab|avelumab
4659146|NCT03498196|Invasive Resectable disease|invasive resectable disease
4659147|NCT03498196|MIBC|mibc
4659148|NCT03498196|NMIBC|nmibc
4659149|NCT03498196|neoadjuvant chemotherapy|neoadjuvant chemotherapy
4659150|NCT03498170|Healthy Male Volunteers|healthy male volunteers
4659151|NCT03498157|Prehabilitation|prehabilitation
4659152|NCT03498157|Exercise|exercise
4659153|NCT03498157|Breast Cancer|breast cancer
4659154|NCT03498157|Physical Activity|physical activity
4659155|NCT03498157|Surgery|surgery
4659156|NCT03498144|acquired punctal stenosis|acquired punctal stenosis
4659157|NCT03498144|epiphora|epiphora
4659158|NCT03498144|lower punctum|lower punctum
4659159|NCT03498144|AS-OCT|as-oct
4659160|NCT03498131|Multiple Sclerosis|multiple sclerosis
4659161|NCT03498131|MS|ms
4659162|NCT03498131|Melatonin|melatonin
4659163|NCT03498131|Supplement|supplement
4659164|NCT03498118|Transversus Abdominis Plane Block|transversus abdominis plane block
4659165|NCT03498118|Cesarean Delivery|cesarean delivery
4659166|NCT03498105|Acute Chest Syndrome|acute chest syndrome
4659167|NCT03498066|Myocardial Infarction|myocardial infarction
4659168|NCT03498066|Beta-Blockers|beta-blockers
4659169|NCT03498066|Stable Coronary Artery Disease|stable coronary artery disease
4659170|NCT03497936|vaccine narratives|vaccine narratives
4659171|NCT03497936|HPV prevention|hpv prevention
4659172|NCT03497936|vaccine promotion|vaccine promotion
4659173|NCT03497923|rocuronium, magnesium sulphate, neostigmine, sugammadex|rocuronium, magnesium sulphate, neostigmine, sugammadex
4659174|NCT03497897|Acne, efficacy, safety|acne, efficacy, safety
4659175|NCT03497884|fMRI|fmri
4659176|NCT03497884|rTMS|rtms
4659177|NCT03497884|functional connectivity|functional connectivity
4659178|NCT03497871|Heart failure|heart failure
4659179|NCT03497871|Self-management|self-management
4659180|NCT03497871|Health-related quality of life|health-related quality of life
4659181|NCT03497871|mHealth|mhealth
4659182|NCT03497845|vaccine|vaccine
4659183|NCT03497845|adjuvant|adjuvant
4659184|NCT03497845|Influenza in Birds|influenza in birds
4659185|NCT03497845|MF59|mf59
4659186|NCT03497845|AS03|as03
4659187|NCT03497832|Proton Magnetic Resonance Spectroscopy|proton magnetic resonance spectroscopy
4659188|NCT03497819|CART|cart
4659189|NCT03497819|Pancreatic Cancer|pancreatic cancer
4659190|NCT03497819|artery infusion|artery infusion
4659191|NCT03497780|Healthy Volunteers|healthy volunteers
4659192|NCT03497780|ACL (Anterior Cruciate Ligament) tear|acl (anterior cruciate ligament) tear
4659193|NCT03497767|Non Small Cell Lung Cancer (NSCLC)|non small cell lung cancer (nsclc)
4659194|NCT03497767|EGFR mutation|egfr mutation
4659195|NCT03497767|Osimertinib|osimertinib
4659196|NCT03497767|Stereotactic Radiosurgery|stereotactic radiosurgery
4659197|NCT03497754|ultrasound|ultrasound
4659198|NCT03497754|cardiac output|cardiac output
4659199|NCT03497754|Probefix|probefix
4659200|NCT03497754|passive leg raising test|passive leg raising test
4659201|NCT03497741|Intensive Care Unit|intensive care unit
4659202|NCT03497689|pulmonary hypertension|pulmonary hypertension
4659203|NCT03497689|treprostinil|treprostinil
4659204|NCT03497689|pulmonary arterial hypertension|pulmonary arterial hypertension
4659205|NCT03497689|PAH|pah
4659206|NCT03497689|Remodulin|remodulin
4659207|NCT03497689|Orenitram|orenitram
4659208|NCT03497663|Familial high risk|familial high risk
4659209|NCT03497663|offspring|offspring
4659210|NCT03497663|schizophrenia|schizophrenia
4659211|NCT03497663|bipolar disorder|bipolar disorder
4659212|NCT03497663|recurrent depression|recurrent depression
4659213|NCT03497663|early intervention|early intervention
4659214|NCT03497663|parental training|parental training
4659215|NCT03497663|family based intervention|family based intervention
4659216|NCT03497611|Transcatheter aortic valve implantation|transcatheter aortic valve implantation
4659217|NCT03497611|Pacemaker|pacemaker
4659218|NCT03497611|Aortic valve calcification|aortic valve calcification
4659219|NCT03497611|PPI|ppi
4659220|NCT03497598|D-mannose|d-mannose
4659221|NCT03497585|Rehabilitation|rehabilitation
4659222|NCT03497585|Pain Management|pain management
4659223|NCT03497572|Leptospirosis|leptospirosis
4659224|NCT03497546|Morbid obesity|morbid obesity
4659225|NCT03497546|Exercise|exercise
4659226|NCT03497546|Weight loss|weight loss
4659227|NCT03497546|Cardiometabolic risk|cardiometabolic risk
4659228|NCT03497546|Bariatric surgery|bariatric surgery
4659229|NCT03497533|CD19|cd19
4659230|NCT03497533|CAR-T|car-t
4659231|NCT03497533|TriCAR-T-CD19|tricar-t-cd19
4659232|NCT03497533|non-Hodgkin lymphoma|non-hodgkin lymphoma
4659233|NCT03497533|NHL|nhl
4659234|NCT03497520|surface EMG|surface emg
4659235|NCT03497520|cobb angle|cobb angle
4659236|NCT03497520|exercise|exercise
4659237|NCT03497520|Spinal Curvatures|spinal curvatures
4659238|NCT03497507|Shivering|shivering
4659239|NCT03497507|Cesarean delivery|cesarean delivery
4659240|NCT03497507|acupressure|acupressure
4659241|NCT03497507|P6 acupoint|p6 acupoint
4659242|NCT03497481|eye's anterior chamber fluid|eye's anterior chamber fluid
4659243|NCT03497481|cerebrospinal fluid|cerebrospinal fluid
4659244|NCT03497481|inflammatory pathology|inflammatory pathology
4659245|NCT03497468|task-oriented training|task-oriented training
4659246|NCT03497468|exercise training|exercise training
4659247|NCT03497468|mobility|mobility
4659248|NCT03497468|balance|balance
4659249|NCT03497468|fatigue|fatigue
4659250|NCT03497468|quality of life|quality of life
4659251|NCT03497416|Preoperative Anemia|preoperative anemia
4659252|NCT03497416|elderly|elderly
4659253|NCT03497416|healthcare outcomes|healthcare outcomes
4659254|NCT03497390|Type 2 diabetes|type 2 diabetes
4659255|NCT03497390|Obesity|obesity
4659256|NCT03497364|Cesarean Section|cesarean section
4659257|NCT03497364|Hypotension|hypotension
4659258|NCT03497364|Combined spinal-epidural anesthesia|combined spinal-epidural anesthesia
4659259|NCT03497312|Rehabilitation|rehabilitation
4659260|NCT03497312|children with disabilities|children with disabilities
4659261|NCT03497312|general anesthesia|general anesthesia
4659262|NCT03497312|Children with special healthcare need|children with special healthcare need
4659263|NCT03497312|handicapped children|handicapped children
4659264|NCT03497312|full mouth rehabilitation|full mouth rehabilitation
4659265|NCT03497299|Schizophrenia|schizophrenia
4659266|NCT03497299|Smoking|smoking
4659267|NCT03497299|Lapse|lapse
4659268|NCT03497299|Varenicline|varenicline
4659269|NCT03497299|Sham Repetitive Transcranial Magnetic Stimulation (rTMS)|sham repetitive transcranial magnetic stimulation (rtms)
4659270|NCT03497286|maternal health|maternal health
4659271|NCT03497286|maternal stress|maternal stress
4659272|NCT03497286|infant health|infant health
4659273|NCT03497273|JAK1 inhibitor|jak1 inhibitor
4659274|NCT03497273|GVHD|gvhd
4659275|NCT03497273|acute GVHD|acute gvhd
4659276|NCT03497273|Japan|japan
4659277|NCT03497273|corticosteroids|corticosteroids
4659278|NCT03497260|Type 1 Diabetes, Fructose, Exercise, Hypoglycaemia, Degludec|type 1 diabetes, fructose, exercise, hypoglycaemia, degludec
4659279|NCT03497221|Nursing Education|nursing education
4659280|NCT03497208|Surgery|surgery
4659281|NCT03497208|melanocytes|melanocytes
4659282|NCT03497208|dermarolling system|dermarolling system
4659283|NCT03497169|Bariatric surgery|bariatric surgery
4659284|NCT03497169|Gastrointestinal tract|gastrointestinal tract
4659285|NCT03497169|Biological availability|biological availability
4659286|NCT03497169|Pharmacokinetics|pharmacokinetics
4659287|NCT03497169|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate
4659288|NCT03497156|Bariatric surgery|bariatric surgery
4659289|NCT03497156|Gastrointestinal tract|gastrointestinal tract
4659290|NCT03497156|Biological availability|biological availability
4659291|NCT03497156|Pharmacokinetics|pharmacokinetics
4659292|NCT03497156|Lercanidipine|lercanidipine
4659293|NCT03497143|Bariatric surgery|bariatric surgery
4659294|NCT03497143|Gastrointestinal tract|gastrointestinal tract
4659295|NCT03497143|Biological availability|biological availability
4659296|NCT03497143|Pharmacokinetics|pharmacokinetics
4659297|NCT03497143|Lamotrigine|lamotrigine
4659298|NCT03497130|skin regimen|skin regimen
4659299|NCT03497130|moisturizer|moisturizer
4659300|NCT03497130|dry skin|dry skin
4659301|NCT03497130|dry|dry
4659302|NCT03497130|itchy skin|itchy skin
4659303|NCT03497130|skin care|skin care
4659304|NCT03497117|imaging|imaging
4659305|NCT03497117|hyperpolarized|hyperpolarized
4659306|NCT03497117|perfluorinated|perfluorinated
4659307|NCT03497117|MRI|mri
4659308|NCT03497117|lung|lung
4659309|NCT03497117|multiple breath washout|multiple breath washout
4659310|NCT03497117|lung clearance index|lung clearance index
4659311|NCT03497078|collimator|collimator
4659312|NCT03497078|bone scintigraphy|bone scintigraphy
4659313|NCT03497078|image quality|image quality
4659314|NCT03497078|scintigraphy|scintigraphy
4659315|NCT03497065|Dental devices|dental devices
4659316|NCT03497065|Home care|home care
4659317|NCT03497065|Awareness|awareness
4659318|NCT03497065|Peri-implant mucositis|peri-implant mucositis
4659319|NCT03497065|Peri-implantitis|peri-implantitis
4659320|NCT03497052|IVF culture media|ivf culture media
4659321|NCT03497052|Blastocyst|blastocyst
4659322|NCT03497052|Time-lapse microscopy|time-lapse microscopy
4659323|NCT03497013|transcranial Direct Current Stimulation|transcranial direct current stimulation
4659324|NCT03497013|Randomized Controlled Trial|randomized controlled trial
4659325|NCT03497013|Schizophrenia|schizophrenia
4659326|NCT03497013|Tardive Dyskinesia|tardive dyskinesia
4659327|NCT03497013|Abnormal Involuntary Movements Scale|abnormal involuntary movements scale
4659328|NCT03497013|Tardive Dyskinesia Rating Scale|tardive dyskinesia rating scale
4659329|NCT03497013|Cognition|cognition
4659330|NCT03497000|optical coherence tomography angiography|optical coherence tomography angiography
4660732|NCT03488225|Neupogen|neupogen
4659331|NCT03497000|central serous chorioretinopathy|central serous chorioretinopathy
4659332|NCT03497000|photodynamic therapy|photodynamic therapy
4659333|NCT03496987|Pleural Effusion|pleural effusion
4659334|NCT03496987|Pleural Drainage|pleural drainage
4659335|NCT03496987|Thoracentesis|thoracentesis
4659336|NCT03496961|Yan Nian Jiu Zhuan Fa|yan nian jiu zhuan fa
4659337|NCT03496948|PAD|pad
4659338|NCT03496948|Peripheral Artery Disease|peripheral artery disease
4659339|NCT03496948|Peripheral Arterial Disease|peripheral arterial disease
4659340|NCT03496935|Renal replacement therapy|renal replacement therapy
4659341|NCT03496922|Unventilated Cigarettes|unventilated cigarettes
4659342|NCT03496922|Experimental Tobacco Marketplace|experimental tobacco marketplace
4659343|NCT03496922|Demand|demand
4659344|NCT03496922|Delay Discounting|delay discounting
4659345|NCT03496896|Randomized Controlled Trial|randomized controlled trial
4659346|NCT03496896|Patient readmission|patient readmission
4659347|NCT03496896|Patient transfer|patient transfer
4659348|NCT03496896|Health care utilization|health care utilization
4659349|NCT03496896|Prognosis|prognosis
4659350|NCT03496896|Multimorbidity|multimorbidity
4659351|NCT03496896|Internal medicine|internal medicine
4659352|NCT03496857|labor pain|labor pain
4659353|NCT03496831|Hospitalization|hospitalization
4659354|NCT03496831|Infection|infection
4659355|NCT03496805|Muscadine Grape Extract|muscadine grape extract
4659356|NCT03496805|Androgen Deprivation Therapy|androgen deprivation therapy
4659357|NCT03496792|venous distension reflex|venous distension reflex
4659358|NCT03496779|Brentuximab Vedotin|brentuximab vedotin
4659359|NCT03496779|T-cell lymphoma|t-cell lymphoma
4659360|NCT03496753|nipple fissure|nipple fissure
4659361|NCT03496740|Postoperative pain|postoperative pain
4659362|NCT03496740|Ultrasound|ultrasound
4659363|NCT03496740|Dorsal Penile Nerve Block|dorsal penile nerve block
4659364|NCT03496740|Pudendal Block|pudendal block
4659365|NCT03496740|Hypospadias|hypospadias
4659366|NCT03496727|pain, VATS|pain, vats
4659367|NCT03496714|Posttraumatic stress disorder|posttraumatic stress disorder
4659368|NCT03496714|Safety behaviors|safety behaviors
4659369|NCT03496714|Threat appraisal|threat appraisal
4659370|NCT03496714|Secondary prevention|secondary prevention
4659371|NCT03496714|Internet-based|internet-based
4659372|NCT03496714|PTSD|ptsd
4659373|NCT03496688|Sinus floor augmentation|sinus floor augmentation
4659374|NCT03496688|Bone regeneration|bone regeneration
4659375|NCT03496688|Histology|histology
4659376|NCT03496688|Biocompatible materials|biocompatible materials
4659377|NCT03496688|Bone transplantation|bone transplantation
4659378|NCT03496649|Primary Adductor tendinopathies|primary adductor tendinopathies
4659379|NCT03496649|Pubalgia|pubalgia
4659380|NCT03496649|Botulinum toxin type A|botulinum toxin type a
4659381|NCT03496636|Ovary|ovary
4659382|NCT03496636|Transplant|transplant
4659383|NCT03496623|Pulmonary Hypertension|pulmonary hypertension
4659384|NCT03496623|COPD|copd
4659385|NCT03496623|Inhaled Treprostinil|inhaled treprostinil
4659386|NCT03496623|6-Minute Walk Test|6-minute walk test
4659387|NCT03496623|Tyvaso|tyvaso
4659388|NCT03496610|Bupivacaine|bupivacaine
4659389|NCT03496610|Living donor nephrectomy|living donor nephrectomy
4659390|NCT03496571|Eosinophilic Gastritis|eosinophilic gastritis
4659391|NCT03496571|Eosinophilic Gastroenteritis|eosinophilic gastroenteritis
4659392|NCT03496571|Eosinophil|eosinophil
4659393|NCT03496571|EG|eg
4659394|NCT03496571|EGE|ege
4659395|NCT03496571|Eosinophilic gastrointestinal disorders|eosinophilic gastrointestinal disorders
4659396|NCT03496571|EGID|egid
4659397|NCT03496558|lactogenesis, pregnant, TG, lipidic profile, breastfeeding.|lactogenesis, pregnant, tg, lipidic profile, breastfeeding.
4659398|NCT03496545|fever|fever
4659399|NCT03496545|central fever|central fever
4659400|NCT03496545|neurogenic fever|neurogenic fever
4659401|NCT03496545|hyperthermia|hyperthermia
4659402|NCT03496545|bromocriptine|bromocriptine
4659403|NCT03496545|subarachnoid hemorrhage|subarachnoid hemorrhage
4659404|NCT03496545|SAH|sah
4659405|NCT03496545|subdural hematoma|subdural hematoma
4659406|NCT03496545|SDH|sdh
4659407|NCT03496545|intracerebral hemorrhage|intracerebral hemorrhage
4659408|NCT03496545|ICH|ich
4659409|NCT03496545|traumatic brain injury|traumatic brain injury
4659410|NCT03496545|TBI|tbi
4659411|NCT03496545|ischemic stroke|ischemic stroke
4659412|NCT03496519|Durvalumab|durvalumab
4659413|NCT03496519|Trabectedin|trabectedin
4659414|NCT03496519|Maximum Tolerated Dose|maximum tolerated dose
4659415|NCT03496519|Lung Cancer|lung cancer
4659416|NCT03496519|Sarcoma|sarcoma
4659417|NCT03496506|selexipag|selexipag
4659418|NCT03496506|clopidogrel|clopidogrel
4659419|NCT03496493|perioperative|perioperative
4659420|NCT03496493|monitoring|monitoring
4659421|NCT03496493|plethysmography|plethysmography
4659422|NCT03496493|pulse oximetery|pulse oximetery
4659423|NCT03496480|ptsd|ptsd
4659424|NCT03496480|stress|stress
4659425|NCT03496480|traumatization|traumatization
4659426|NCT03496467|Treatment of pain and inflammation after Cataract Surgery|treatment of pain and inflammation after cataract surgery
4659427|NCT03496454|malaria|malaria
4659428|NCT03496454|infection|infection
4659429|NCT03496454|controlled|controlled
4659430|NCT03496428|intra-oral scanner|intra-oral scanner
4659431|NCT03496428|customized impression coping|customized impression coping
4659432|NCT03496428|extra-oral scanner|extra-oral scanner
4659433|NCT03496428|accuracy|accuracy
4659434|NCT03496376|kinesio taping|kinesio taping
4659435|NCT03496376|COPD|copd
4659436|NCT03496376|functional capacity|functional capacity
4659437|NCT03496376|pulmonary functions|pulmonary functions
4659438|NCT03496376|pulmonary rehabilitation|pulmonary rehabilitation
4659439|NCT03496363|Children|children
4659440|NCT03496337|activities of daily living|activities of daily living
4659441|NCT03496337|assessment of motor and process skills|assessment of motor and process skills
4659442|NCT03496337|validation study|validation study
4659443|NCT03496337|responsiveness study|responsiveness study
4659444|NCT03496259|Postoperative pain, on-Q pump, epidural, children|postoperative pain, on-q pump, epidural, children
4659445|NCT03496207|PAH|pah
4659446|NCT03496181|fMRI|fmri
4659447|NCT03496181|MRI|mri
4659448|NCT03496181|18-121|18-121
4659449|NCT03496181|Memorial Sloan Kettering Cancer Center|memorial sloan kettering cancer center
4659450|NCT03496168|Symptomatic|symptomatic
4659451|NCT03496168|Obstructive|obstructive
4659452|NCT03496168|Left ventricular outflow tract gradient|left ventricular outflow tract gradient
4659453|NCT03496155|parent-teen communication|parent-teen communication
4659454|NCT03496155|teen strengths|teen strengths
4659455|NCT03496155|adolescence|adolescence
4659456|NCT03496142|Prostate biopsy approach|prostate biopsy approach
4659457|NCT03496142|Transrectal prostate biopsy|transrectal prostate biopsy
4659458|NCT03496142|Transperineal prostate biopsy|transperineal prostate biopsy
4659459|NCT03496142|Iatrogenic infection|iatrogenic infection
4659460|NCT03496142|Prevention|prevention
4659461|NCT03496090|Diverticulitis|diverticulitis
4659462|NCT03496090|Uncomplicated Diverticular Disease|uncomplicated diverticular disease
4659463|NCT03496090|Free diet|free diet
4659464|NCT03496090|Dietary restriction|dietary restriction
4659465|NCT03496090|Acute Diverticulitis|acute diverticulitis
4659466|NCT03496077|Dual Use|dual use
4659467|NCT03496077|Little Cigars and Cigarillos|little cigars and cigarillos
4659468|NCT03496077|Cigarettes|cigarettes
4659469|NCT03496077|Flavored Tobacco Use|flavored tobacco use
4659470|NCT03496077|Addiction Potential|addiction potential
4659471|NCT03496064|Thrombectomy|thrombectomy
4659472|NCT03496064|Eligibility|eligibility
4659473|NCT03496064|Large vessel occlusion|large vessel occlusion
4659474|NCT03496025|facial nerve palsy|facial nerve palsy
4659475|NCT03496025|facial paralysis|facial paralysis
4659476|NCT03496025|functional electrical stimulation|functional electrical stimulation
4659477|NCT03496025|facial pacing|facial pacing
4659478|NCT03496012|NightstaRx|nightstarx
4659479|NCT03496012|NSR-REP1|nsr-rep1
4659480|NCT03496012|Choroideremia|choroideremia
4659481|NCT03496012|CHM|chm
4659482|NCT03496012|Gene Therapy|gene therapy
4659483|NCT03496012|AAV|aav
4659484|NCT03496012|REP1|rep1
4659485|NCT03495999|Hyperuricemia|hyperuricemia
4659486|NCT03495999|Metabolic syndrome|metabolic syndrome
4659487|NCT03495999|Left ventricular diastolic dysfunction|left ventricular diastolic dysfunction
4659488|NCT03495999|Inflammation|inflammation
4659489|NCT03495986|Functional Electrical Stimulation|functional electrical stimulation
4659490|NCT03495986|Exercise|exercise
4659491|NCT03495986|Body Composition|body composition
4659492|NCT03495960|non-Hodgkin's lymphoma|non-hodgkin's lymphoma
4659493|NCT03495960|elderly|elderly
4659494|NCT03495960|PCNSL|pcnsl
4659495|NCT03495947|High Flow Nasal Cannula (HFNC).|high flow nasal cannula (hfnc).
4659496|NCT03495947|Mechanical ventilation|mechanical ventilation
4659497|NCT03495947|Extubation failure|extubation failure
4659498|NCT03495921|ESFT|esft
4659499|NCT03495921|Immunotherapy|immunotherapy
4659500|NCT03495921|Phase 3|phase 3
4659501|NCT03495908|VGo|vgo
4659502|NCT03495908|Insulin|insulin
4659503|NCT03495908|Type 2 Diabetes|type 2 diabetes
4659504|NCT03495895|Disadvantaged families|disadvantaged families
4659505|NCT03495895|Pregnancy|pregnancy
4659506|NCT03495895|Intervention|intervention
4659507|NCT03495895|Minding the Baby|minding the baby
4659508|NCT03495856|Mindfulness-based stress reduction|mindfulness-based stress reduction
4659509|NCT03495856|Mindfulness|mindfulness
4659510|NCT03495856|chronic pain|chronic pain
4659511|NCT03495856|Feasibility|feasibility
4659512|NCT03495856|Intervention|intervention
4659513|NCT03495804|CT enterography|ct enterography
4659514|NCT03495804|oral contrast agent|oral contrast agent
4659515|NCT03495791|RA|ra
4659516|NCT03495791|Rheumatoid Arthritis|rheumatoid arthritis
4659517|NCT03495791|Arthritis|arthritis
4659518|NCT03495765|Diabetic macular oedema|diabetic macular oedema
4659519|NCT03495765|Lucentis|lucentis
4659520|NCT03495752|muscle performance|muscle performance
4659521|NCT03495752|injury prevention|injury prevention
4659522|NCT03495752|step down|step down
4659523|NCT03495752|fatigue|fatigue
4659524|NCT03495726|Contemplative|contemplative
4659525|NCT03495726|Applications|applications
4659526|NCT03495726|Well-being|well-being
4659527|NCT03495687|Respiratory function|respiratory function
4659528|NCT03495687|Spinal mobility|spinal mobility
4659529|NCT03495687|Chest expansion|chest expansion
4659530|NCT03495674|Lynch Syndrome|lynch syndrome
4659531|NCT03495674|Cycling Exercise|cycling exercise
4659532|NCT03495674|Lower GI Endoscopy|lower gi endoscopy
4659533|NCT03495674|Cardiopulmonary Exercise Test|cardiopulmonary exercise test
4659534|NCT03495674|CPET|cpet
4659535|NCT03495674|EKG|ekg
4659536|NCT03495674|Questionnaires|questionnaires
4659537|NCT03495674|Surveys|surveys
4659538|NCT03495674|FITBIT|fitbit
4659539|NCT03495661|lumbar spine stenosis|lumbar spine stenosis
4659540|NCT03495661|decompression|decompression
4659541|NCT03495661|laminectomy|laminectomy
4659542|NCT03495661|physiotherapy|physiotherapy
4659543|NCT03495661|physical therapy|physical therapy
4659544|NCT03495661|electroneurography|electroneurography
4659545|NCT03495661|ENG|eng
4659546|NCT03495661|electromyography|electromyography
4659547|NCT03495661|EMG|emg
4659548|NCT03495661|Neurogenic Claudication|neurogenic claudication
4659549|NCT03495661|Pseudoclaudication|pseudoclaudication
4659550|NCT03495648|farmers market|farmers market
4659551|NCT03495648|Appalachia|appalachia
4659552|NCT03495648|physical activity|physical activity
4659553|NCT03495648|fruit and vegetable voucher program|fruit and vegetable voucher program
4659554|NCT03495635|mentoring|mentoring
4659555|NCT03495635|prevention|prevention
4659556|NCT03495622|Text messaging|text messaging
4659557|NCT03495622|Community health worker|community health worker
4659558|NCT03495622|Smoking cessation|smoking cessation
4659559|NCT03495622|India|india
4659560|NCT03495622|Cardiovascular mortality|cardiovascular mortality
4659561|NCT03495583|Food allergy|food allergy
4659562|NCT03495583|Child Health|child health
4659563|NCT03495583|Oral tolerance induction|oral tolerance induction
4659564|NCT03495583|Food allergic sensitisation|food allergic sensitisation
4659565|NCT03495583|Obesity|obesity
4659566|NCT03495570|immunological|immunological
4659567|NCT03495557|Hernia|hernia
4659568|NCT03495557|Cholecystectomy|cholecystectomy
4659569|NCT03495557|Mesh fixation|mesh fixation
4659570|NCT03495531|virtual reality|virtual reality
4659571|NCT03495531|obstetrics|obstetrics
4659572|NCT03495531|labor procedures|labor procedures
4659573|NCT03495531|regional anesthesia|regional anesthesia
4659574|NCT03495518|Cancer|cancer
4659575|NCT03495518|Randomized Control Trial|randomized control trial
4659576|NCT03495518|Children|children
4659577|NCT03495518|Hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
4659578|NCT03495518|Quality of Life|quality of life
4659579|NCT03495505|WiSE-CRT|wise-crt
4659580|NCT03495505|Endocardial Pacing Optimisation|endocardial pacing optimisation
4659581|NCT03495505|Cardiac Resynchronisation Therapy|cardiac resynchronisation therapy
4659582|NCT03495492|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
4659583|NCT03495492|CLL|cll
4659584|NCT03495492|Dermal Chelation|dermal chelation
4659585|NCT03495492|Nutritional Therapy|nutritional therapy
4659586|NCT03495479|Prostate Cancer|prostate cancer
4659587|NCT03495479|PC|pc
4659588|NCT03495479|Active Surveillance|active surveillance
4659589|NCT03495479|Chemonaiive|chemonaiive
4659590|NCT03495479|OMN54|omn54
4659591|NCT03495479|Aneustat (TM)|aneustat (tm)
4659592|NCT03495479|PSA|psa
4659593|NCT03495479|BPH|bph
4659594|NCT03495440|Emotional Security|emotional security
4659595|NCT03495440|Intellectual Disability|intellectual disability
4659596|NCT03495440|Developmental Disability|developmental disability
4659597|NCT03495427|radioactive diagnostic imaging|radioactive diagnostic imaging
4659598|NCT03495375|Impulsivity|impulsivity
4659599|NCT03495375|Compulsivity|compulsivity
4659600|NCT03495375|Aggression|aggression
4659601|NCT03495375|Microbiome|microbiome
4659602|NCT03495375|Probiotic|probiotic
4659603|NCT03495375|Nutrition|nutrition
4659604|NCT03495375|Psychiatric disorders|psychiatric disorders
4659605|NCT03495375|Synbiotic2000Forte|synbiotic2000forte
4659606|NCT03495362|Yeast Beta-glucan|yeast beta-glucan
4659607|NCT03495362|Immune Function|immune function
4659608|NCT03495362|Prediabetes|prediabetes
4659609|NCT03495362|Gut Microbiota|gut microbiota
4659610|NCT03495336|Boiled coffee|boiled coffee
4659611|NCT03495336|Cardiovascular disease|cardiovascular disease
4659612|NCT03495336|Cholesterol|cholesterol
4659613|NCT03495336|Homocysteine|homocysteine
4659614|NCT03495336|Turkish coffee|turkish coffee
4659615|NCT03495336|Diterpenes|diterpenes
4659616|NCT03495336|Unfiltered coffee|unfiltered coffee
4659617|NCT03495323|Cancer Care|cancer care
4659618|NCT03495297|subcutaneous implantable cardioverter defibrillator|subcutaneous implantable cardioverter defibrillator
4659619|NCT03495297|Defibrillation testing|defibrillation testing
4659620|NCT03495271|Hemodialysis|hemodialysis
4659621|NCT03495271|Taste|taste
4659622|NCT03495271|Blood|blood
4659623|NCT03495271|Saliva|saliva
4659624|NCT03495245|pain|pain
4659625|NCT03495245|opioid|opioid
4659626|NCT03495245|fibromyalgia|fibromyalgia
4659627|NCT03495232|Total Knee Arthroplasty|total knee arthroplasty
4659628|NCT03495232|Persona knee system|persona knee system
4659629|NCT03495232|osteoarthrosis|osteoarthrosis
4659630|NCT03495232|Knee|knee
4659631|NCT03495193|exercise|exercise
4659632|NCT03495128|muscle protein breakdown|muscle protein breakdown
4659633|NCT03495128|inactivity|inactivity
4659634|NCT03495128|bed rest|bed rest
4661130|NCT03485313|Female|female
4659635|NCT03495115|Breast Cancer|breast cancer
4659636|NCT03495089|Screening; Sudomotor reflex; DEC; Primary Care|screening; sudomotor reflex; dec; primary care
4659637|NCT03495076|Tactile acuity|tactile acuity
4659638|NCT03495076|Tactile dysfunction|tactile dysfunction
4659639|NCT03495076|Sensory dissociation|sensory dissociation
4659640|NCT03495076|Two-point discrimination|two-point discrimination
4659641|NCT03495076|Perception|perception
4659642|NCT03495050|Bicuspid|bicuspid
4659643|NCT03495050|TAVI|tavi
4659644|NCT03495050|TAVR|tavr
4659645|NCT03495050|self-expanding|self-expanding
4659646|NCT03495050|Evolut|evolut
4659647|NCT03495037|Age-related cognitive changes|age-related cognitive changes
4659648|NCT03495024|Schizophrenia|schizophrenia
4659649|NCT03495024|Schizoaffective disorder|schizoaffective disorder
4659650|NCT03495024|Antipsychotics|antipsychotics
4659651|NCT03495024|Tobacco smoking|tobacco smoking
4659652|NCT03495024|Tardive dyskinesia|tardive dyskinesia
4659653|NCT03495024|Parkinsonism|parkinsonism
4659654|NCT03495011|Ductal Carcinoma in Situ|ductal carcinoma in situ
4659655|NCT03495011|MRI|mri
4659656|NCT03495011|Oncotype Dx|oncotype dx
4659657|NCT03494959|Pentaglobin|pentaglobin
4659658|NCT03494959|Carbapenem-resistant Klebsiella pneumoniae|carbapenem-resistant klebsiella pneumoniae
4659659|NCT03494959|Pseudomonas aeruginosa|pseudomonas aeruginosa
4659660|NCT03494959|febrile neutropenia|febrile neutropenia
4659661|NCT03494959|infection-related mortality|infection-related mortality
4659662|NCT03494946|Liver metastasis|liver metastasis
4659663|NCT03494946|Colorectal cancer|colorectal cancer
4659664|NCT03494920|Stroke|stroke
4659665|NCT03494920|Ischemia|ischemia
4659666|NCT03494920|Cerebral Infarction|cerebral infarction
4659667|NCT03494920|Cerebrovascular Disorders|cerebrovascular disorders
4659668|NCT03494920|Brain Diseases|brain diseases
4659669|NCT03494920|Central Nervous System Diseases|central nervous system diseases
4659670|NCT03494920|Nervous System Diseases|nervous system diseases
4659671|NCT03494920|Vascular Diseases|vascular diseases
4659672|NCT03494920|Cardiovascular Diseases|cardiovascular diseases
4659673|NCT03494920|Pathologic Processes|pathologic processes
4659674|NCT03494920|Brain Infarction|brain infarction
4659675|NCT03494920|Brain Ischemia|brain ischemia
4659676|NCT03494920|Tissue Plasminogen Activator|tissue plasminogen activator
4659677|NCT03494920|Plasminogen|plasminogen
4659678|NCT03494920|Fibrinolytic Agents|fibrinolytic agents
4659679|NCT03494920|Fibrin Modulating Agents|fibrin modulating agents
4659680|NCT03494920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
4659681|NCT03494842|TENS|tens
4659682|NCT03494842|pain relief|pain relief
4659683|NCT03494842|STOP|stop
4659684|NCT03494842|surgical abortion|surgical abortion
4659685|NCT03494829|early onset scoliosis|early onset scoliosis
4659686|NCT03494829|motor competence|motor competence
4659687|NCT03494829|physical activity|physical activity
4659688|NCT03494829|pulmonary function|pulmonary function
4659689|NCT03494829|health related quality of life|health related quality of life
4659690|NCT03494816|Neoadjuvant|neoadjuvant
4659691|NCT03494816|Venous Tumour Thrombus|venous tumour thrombus
4659692|NCT03494816|Axitinib|axitinib
4659693|NCT03494816|Mayo Classification|mayo classification
4659694|NCT03494816|Nephrectomy|nephrectomy
4659695|NCT03494816|Thrombectomy|thrombectomy
4659696|NCT03494790|MMP|mmp
4659697|NCT03494790|Matrix metalloproteinase|matrix metalloproteinase
4659698|NCT03494790|Metabolomics|metabolomics
4659699|NCT03494790|FGF-21|fgf-21
4659700|NCT03494790|Quick SOFA|quick sofa
4659701|NCT03494790|Infection|infection
4659702|NCT03494790|Triage|triage
4659703|NCT03494777|ART adherence|art adherence
4659704|NCT03494764|Hyperbaric Oxygen Therapy|hyperbaric oxygen therapy
4659705|NCT03494751|Monitoring|monitoring
4659706|NCT03494751|Myocardial infarction|myocardial infarction
4659707|NCT03494751|Clinical trial|clinical trial
4659708|NCT03494738|Prenatal alcohol exposure|prenatal alcohol exposure
4659709|NCT03494725|Probiotic|probiotic
4659710|NCT03494725|Gut-brain axis|gut-brain axis
4659711|NCT03494725|Stress|stress
4659712|NCT03494725|Anxiety|anxiety
4659713|NCT03494712|healthy volunteer|healthy volunteer
4659714|NCT03494712|antimiR|antimir
4659715|NCT03494712|single ascending dose|single ascending dose
4659716|NCT03494686|conization|conization
4659717|NCT03494686|LLETZ|lletz
4659718|NCT03494686|randomized controlled trial|randomized controlled trial
4659719|NCT03494686|loop excision|loop excision
4659720|NCT03494686|general anaesthesia|general anaesthesia
4659721|NCT03494686|local anaesthesia|local anaesthesia
4659722|NCT03494673|White matter hyperintensity|white matter hyperintensity
4659723|NCT03494673|Cerebrovascular reactivity|cerebrovascular reactivity
4659724|NCT03494660|Subchondroplasty|subchondroplasty
4659725|NCT03494660|Bone Marrow Lesion|bone marrow lesion
4659726|NCT03494660|Arthroscopy|arthroscopy
4659727|NCT03494660|Bone Substitute Material|bone substitute material
4659728|NCT03494660|AccuFill|accufill
4659729|NCT03494660|Subchondral Bone Defect|subchondral bone defect
4659730|NCT03494608|cognitive function|cognitive function
4659731|NCT03494608|quality of life|quality of life
4659732|NCT03494608|anxiety|anxiety
4659733|NCT03494608|depression|depression
4659734|NCT03494608|neurological function|neurological function
4659735|NCT03494595|Pediatric Liver Transplantation, Thromboelastometry|pediatric liver transplantation, thromboelastometry
4659736|NCT03494543|Ampullary Adenoma|ampullary adenoma
4659737|NCT03494543|Endoscopic Papillectomy|endoscopic papillectomy
4659738|NCT03494543|Familial Adenomatous Polyposis|familial adenomatous polyposis
4659739|NCT03494478|Cohort study|cohort study
4659740|NCT03494478|Emotion dysregulation|emotion dysregulation
4659741|NCT03494478|Questionnaires|questionnaires
4659742|NCT03494478|Actimetry|actimetry
4659743|NCT03494478|Neuropsychology|neuropsychology
4659744|NCT03494452|electromyography, strength, strength endurance|electromyography, strength, strength endurance
4659745|NCT03494400|Breast cancer|breast cancer
4659746|NCT03494400|Physical exercise|physical exercise
4659747|NCT03494400|Body mass|body mass
4659748|NCT03494387|Antioxidant|antioxidant
4659749|NCT03494387|Hyperoxia|hyperoxia
4659750|NCT03494387|Troponin|troponin
4659751|NCT03494387|MINS|mins
4659752|NCT03494387|Ascorbic acid|ascorbic acid
4659753|NCT03494387|N-acetylcysteine|n-acetylcysteine
4659754|NCT03494374|pes planus|pes planus
4659755|NCT03494374|UCBL|ucbl
4659756|NCT03494374|exercise|exercise
4659757|NCT03494361|deglutition disorders|deglutition disorders
4659758|NCT03494361|electromyography|electromyography
4659759|NCT03494348|Radiostereometry (RSA)|radiostereometry (rsa)
4659760|NCT03494348|Total Knee Arthroplasty|total knee arthroplasty
4659761|NCT03494309|Mandibular Subcondylar Fractures|mandibular subcondylar fractures
4659762|NCT03494309|Mouth Opening|mouth opening
4659763|NCT03494309|Open Reduction and Internal Fixation|open reduction and internal fixation
4659764|NCT03494309|Closed Reduction with External Fixation|closed reduction with external fixation
4659765|NCT03494283|CrossFit injuries|crossfit injuries
4659766|NCT03494257|phacoemulsification|phacoemulsification
4659767|NCT03494257|intraocular pressure|intraocular pressure
4659768|NCT03494257|cataract|cataract
4659769|NCT03494257|brinzolamide|brinzolamide
4659770|NCT03494257|brimonidinde|brimonidinde
4659771|NCT03494257|fixed combination|fixed combination
4659772|NCT03494244|acellular dermal matrix|acellular dermal matrix
4659773|NCT03494244|breast reconstruction|breast reconstruction
4659774|NCT03494244|efficacy|efficacy
4659775|NCT03494231|Metastatic|metastatic
4659776|NCT03494231|Refractory|refractory
4659777|NCT03494231|Cancer|cancer
4659778|NCT03494231|Solid|solid
4659779|NCT03494231|Tumor|tumor
4659780|NCT03494218|disorders of consciousness|disorders of consciousness
4659781|NCT03494218|vegetative state|vegetative state
4659782|NCT03494218|minimally conscious state|minimally conscious state
4659783|NCT03494218|consciousness|consciousness
4659784|NCT03494218|pain assessment|pain assessment
4659785|NCT03494218|nociception test|nociception test
4659786|NCT03494205|Radiation Dermatitis|radiation dermatitis
4659787|NCT03494205|Urtica comp.|urtica comp.
4659788|NCT03494192|acromiohumeral distance|acromiohumeral distance
4659789|NCT03494192|pain|pain
4659790|NCT03494192|functional level|functional level
4659791|NCT03494192|Subacromial Impingement Syndrome|subacromial impingement syndrome
4659792|NCT03494127|wheelchair seating|wheelchair seating
4659793|NCT03494127|tissue health|tissue health
4659794|NCT03494088|Autism|autism
4659795|NCT03494088|Abdominal Pain|abdominal pain
4659796|NCT03494075|Patients|patients
4659797|NCT03494075|Caregivers|caregivers
4659798|NCT03494036|synbiotic|synbiotic
4659799|NCT03494036|probiotic|probiotic
4659800|NCT03494036|lupus|lupus
4659801|NCT03494036|connective tissue disease|connective tissue disease
4659802|NCT03494010|Kidney Transplantation|kidney transplantation
4659803|NCT03493971|carotid endarterectomy|carotid endarterectomy
4659804|NCT03493971|carotid stenting|carotid stenting
4659805|NCT03493971|autonomic function|autonomic function
4659806|NCT03493971|computational fluid dynamic|computational fluid dynamic
4659807|NCT03493971|cognitive function|cognitive function
4659808|NCT03493958|Alcohol Dependence|alcohol dependence
4659809|NCT03493958|Alcohol use Disorder|alcohol use disorder
4659810|NCT03493958|Insomnia|insomnia
4659811|NCT03493945|Immunotherapy|immunotherapy
4659812|NCT03493945|Combined Treatment|combined treatment
4659813|NCT03493945|PD-1/PD-L1|pd-1/pd-l1
4659814|NCT03493945|Tumor-Specific T Cells|tumor-specific t cells
4659815|NCT03493945|Novel Cancer Vaccine|novel cancer vaccine
4659816|NCT03493932|Glioblastoma|glioblastoma
4659817|NCT03493932|Glioma|glioma
4659818|NCT03493932|Brain Tumor|brain tumor
4659819|NCT03493932|Immune Therapy|immune therapy
4659820|NCT03493932|Checkpoint Inhibition|checkpoint inhibition
4659821|NCT03493919|Immunological assays|immunological assays
4659822|NCT03493919|Human blood donors|human blood donors
4659823|NCT03493919|Meningococcal vaccination|meningococcal vaccination
4659824|NCT03493919|Meningococcal disease|meningococcal disease
4659825|NCT03493867|Non-invasive blood pressure monitoring|non-invasive blood pressure monitoring
4659826|NCT03493867|Wearable device|wearable device
4659827|NCT03493867|Medical device verification study|medical device verification study
4659828|NCT03493802|ADPKD|adpkd
4659829|NCT03493802|Endothelial dysfunction|endothelial dysfunction
4659830|NCT03493802|Oxidative stress|oxidative stress
4659831|NCT03493802|NADPH oxidase 4 (NOX4)|nadph oxidase 4 (nox4)
4659832|NCT03493802|Mitochondria|mitochondria
4659833|NCT03493763|Recurrence Monitoring|recurrence monitoring
4659834|NCT03493763|5-Hydroxymethylcytosine|5-hydroxymethylcytosine
4659835|NCT03493763|Liquid biopsy|liquid biopsy
4659836|NCT03493763|Cell-free DNA|cell-free dna
4659837|NCT03493672|Phase I clinical trial|phase i clinical trial
4659838|NCT03493672|Phase II clinical trial|phase ii clinical trial
4659839|NCT03493672|Early trial discontinuation|early trial discontinuation
4659840|NCT03493672|Objective smartphone measurements|objective smartphone measurements
4659841|NCT03493672|Physical activity|physical activity
4659842|NCT03493672|Physical fitness|physical fitness
4659843|NCT03493659|Standing|standing
4659844|NCT03493659|Sitting|sitting
4659845|NCT03493659|Learning|learning
4659846|NCT03493659|Problem-Based Learning|problem-based learning
4659847|NCT03493659|Undergraduate|undergraduate
4659848|NCT03493646|Myelodysplastic Syndrome|myelodysplastic syndrome
4659849|NCT03493646|MDS|mds
4659850|NCT03493646|Acute Myeloid Leukemia|acute myeloid leukemia
4659851|NCT03493646|AML|aml
4659852|NCT03493646|Chronic Myelomonocytic Leukemia|chronic myelomonocytic leukemia
4659853|NCT03493646|CMML|cmml
4659854|NCT03493607|AMO-01|amo-01
4659855|NCT03493607|Shank3|shank3
4659856|NCT03493607|Clinical Trial|clinical trial
4659857|NCT03493594|Early nutrition|early nutrition
4659858|NCT03493594|Breastfeeding|breastfeeding
4659859|NCT03493594|Infant growth|infant growth
4659860|NCT03493529|Endometrial microbiome|endometrial microbiome
4659861|NCT03493529|Obesity|obesity
4659862|NCT03493529|Bacterial pathogens|bacterial pathogens
4659863|NCT03493529|Dysbiosis|dysbiosis
4659864|NCT03493529|Endometrial receptivity|endometrial receptivity
4659865|NCT03493516|Positron Emission Tomography|positron emission tomography
4659866|NCT03493516|Sympathetic Innervation|sympathetic innervation
4659867|NCT03493516|Sudden Death|sudden death
4659868|NCT03493516|Ventricular Fibrillation|ventricular fibrillation
4659869|NCT03493516|LMI-1195|lmi-1195
4659870|NCT03493516|Ischemic Cardiomyopathy|ischemic cardiomyopathy
4659871|NCT03493516|Risk Prediction|risk prediction
4659872|NCT03493490|Double-Blind Method|double-blind method
4659873|NCT03493490|placebo-controlled|placebo-controlled
4659874|NCT03493490|parallel-group|parallel-group
4659875|NCT03493490|single-centre|single-centre
4659876|NCT03493490|exploratory clinical study|exploratory clinical study
4659877|NCT03493451|T/NK-cell|t/nk-cell
4659878|NCT03493451|NK/T-cell|nk/t-cell
4659879|NCT03493451|extranodal|extranodal
4659880|NCT03493451|nasal|nasal
4659881|NCT03493451|NK-cell|nk-cell
4659882|NCT03493451|ENKTL|enktl
4659883|NCT03493451|peripheral T-cell|peripheral t-cell
4659884|NCT03493451|anaplastic large cell|anaplastic large cell
4659885|NCT03493451|ALCL|alcl
4659886|NCT03493451|angioimmunoblastic|angioimmunoblastic
4659887|NCT03493451|PTCL-NOS|ptcl-nos
4659888|NCT03493451|Relapsed|relapsed
4659889|NCT03493451|Refractory|refractory
4659890|NCT03493399|Gambling|gambling
4659891|NCT03493399|Craving|craving
4659892|NCT03493399|Urge|urge
4659893|NCT03493399|Desire|desire
4659894|NCT03493399|Interference|interference
4659895|NCT03493399|Elaborated Intrusion Theory|elaborated intrusion theory
4659896|NCT03493399|Treatment|treatment
4659897|NCT03493399|Intervention|intervention
4659898|NCT03493399|Clinical Sample|clinical sample
4659899|NCT03493399|Single case|single case
4659900|NCT03493386|Japan|japan
4659901|NCT03493386|Crossover|crossover
4659902|NCT03493386|Daprodustat|daprodustat
4659903|NCT03493386|Bioequivalence|bioequivalence
4659904|NCT03493386|Pharmacokinetics|pharmacokinetics
4659905|NCT03493269|Rheumatoid Arthritis;|rheumatoid arthritis;
4659906|NCT03493269|Psoriasis|psoriasis
4659907|NCT03493243|Adolescent|adolescent
4659908|NCT03493243|Post Traumatic Stress Disorder|post traumatic stress disorder
4659909|NCT03493243|Terrorist Attack|terrorist attack
4659910|NCT03493204|Hepatic Encephalopathy|hepatic encephalopathy
4659911|NCT03493204|Ascites|ascites
4659912|NCT03493204|Liver Diseases|liver diseases
4659913|NCT03493204|Cirrhosis|cirrhosis
4659914|NCT03493126|postpartum, local estrogen|postpartum, local estrogen
4659915|NCT03493113|EEG|eeg
4659916|NCT03493100|oral nutritional supplementation|oral nutritional supplementation
4659917|NCT03493100|geriatrics|geriatrics
4659918|NCT03493100|bone fracture|bone fracture
4659919|NCT03493087|Dialysis, Vitamin-K, Malnutrition|dialysis, vitamin-k, malnutrition
4659920|NCT03493035|Middle Cerebral Artery|middle cerebral artery
4659921|NCT03493035|Aneurysm|aneurysm
4659922|NCT03493035|computed tomography angiogram|computed tomography angiogram
4659923|NCT03493035|hemodynamical theory|hemodynamical theory
4659924|NCT03492983|Cocoa|cocoa
4659925|NCT03492983|Vascular function|vascular function
4659926|NCT03492983|Body composition|body composition
4659927|NCT03492983|Quality of life|quality of life
4659928|NCT03492983|Cognitive performance|cognitive performance
4659929|NCT03492983|Postmenopausal women|postmenopausal women
4659930|NCT03492957|physical activity|physical activity
4659931|NCT03492957|exercise|exercise
4659932|NCT03492957|non-ambulatory|non-ambulatory
4659933|NCT03492957|feasibility|feasibility
4659934|NCT03492957|mixed methods|mixed methods
4659935|NCT03492931|Hb SS disease, Hb S Beta 0 Thalassemia|hb ss disease, hb s beta 0 thalassemia
4659937|NCT03492892|hypertension|hypertension
4659938|NCT03492892|targeted metabolome|targeted metabolome
4659939|NCT03492892|pilot clinical trial|pilot clinical trial
4659940|NCT03492814|impacted third molar|impacted third molar
4659941|NCT03492814|suturing|suturing
4659942|NCT03492814|post-operative morbidity|post-operative morbidity
4659943|NCT03492788|cardiac resynchronization therapy|cardiac resynchronization therapy
4659944|NCT03492788|electrocardiographic imaging|electrocardiographic imaging
4659945|NCT03492775|indolent lymphoma|indolent lymphoma
4659946|NCT03492775|Obinutuzumab|obinutuzumab
4659947|NCT03492775|GA101|ga101
4659948|NCT03492775|Bendamustine|bendamustine
4659949|NCT03492775|medically non-fit patients|medically non-fit patients
4659950|NCT03492684|nerve injury after total hip arthroplasty|nerve injury after total hip arthroplasty
4659951|NCT03492671|Pancreatic Cancer|pancreatic cancer
4659952|NCT03492658|abatacept|abatacept
4659953|NCT03492658|ACPA expressing B cells|acpa expressing b cells
4659954|NCT03492632|psoriasis|psoriasis
4659955|NCT03492632|Anti mullerian hormone|anti mullerian hormone
4659956|NCT03492632|ovarian reserve|ovarian reserve
4659957|NCT03492632|antral follicle count|antral follicle count
4659958|NCT03492619|obesity|obesity
4659959|NCT03492619|food insecurity|food insecurity
4659960|NCT03492619|depressive symptoms|depressive symptoms
4659961|NCT03492619|empowerment|empowerment
4659962|NCT03492593|carotenoids|carotenoids
4659963|NCT03492593|vitamin E|vitamin e
4659964|NCT03492593|digestion|digestion
4659965|NCT03492593|stability|stability
4659966|NCT03492593|metabolism|metabolism
4659967|NCT03492567|Cystic fibrosis|cystic fibrosis
4659968|NCT03492567|CFTR|cftr
4659969|NCT03492567|CFTR modulators|cftr modulators
4659970|NCT03492567|Monocyte|monocyte
4659971|NCT03492567|Osteoclast|osteoclast
4659972|NCT03492567|Osteoporosis|osteoporosis
4659973|NCT03492541|mixed dry eye|mixed dry eye
4659974|NCT03492541|aqueous-deficient dry eye|aqueous-deficient dry eye
4659975|NCT03492541|lipid-deficient dry eye|lipid-deficient dry eye
4659976|NCT03492541|evaporative dry eye|evaporative dry eye
4659977|NCT03492541|tear film|tear film
4659978|NCT03492541|eye drops|eye drops
4659979|NCT03492541|artificial tears|artificial tears
4659980|NCT03492541|lipid layer|lipid layer
4659981|NCT03492541|eye symptoms|eye symptoms
4659982|NCT03492541|meibomian gland dysfunction|meibomian gland dysfunction
4659983|NCT03492541|MGD|mgd
4659984|NCT03492541|SYSTANE|systane
4659985|NCT03492541|SYSTANE Complete|systane complete
4659986|NCT03492541|nanoemulsion|nanoemulsion
4659987|NCT03492515|immune thrombocytopenia|immune thrombocytopenia
4659988|NCT03492502|Fecal microbiota transplantation|fecal microbiota transplantation
4659989|NCT03492502|allogeneic stem cell transplantation|allogeneic stem cell transplantation
4659990|NCT03492502|microbiome|microbiome
4659991|NCT03492476|Lymphedema of Upper Arm reduction|lymphedema of upper arm reduction
4659992|NCT03492476|Lymphedema Upper Arm device|lymphedema upper arm device
4659993|NCT03492463|Nicotine addiction|nicotine addiction
4659994|NCT03492463|Cigarette smoking|cigarette smoking
4659995|NCT03492463|Nicotine patches|nicotine patches
4659996|NCT03492463|E-cigarettes|e-cigarettes
4659997|NCT03492450|Treadmill training|treadmill training
4659998|NCT03492450|Instrumented assessment|instrumented assessment
4659999|NCT03492450|Disease progression|disease progression
4660000|NCT03492437|Non-small cell lung cancer (NSCLC)|non-small cell lung cancer (nsclc)
4660001|NCT03492437|P-glycoprotein|p-glycoprotein
4660002|NCT03492437|Tepotinib|tepotinib
4660003|NCT03492437|Dabigatran Etexilate|dabigatran etexilate
4660004|NCT03492424|prostate cancer|prostate cancer
4660005|NCT03492424|cryotherapy|cryotherapy
4660006|NCT03492424|focal therapy|focal therapy
4660007|NCT03492411|Breastfeeding|breastfeeding
4660008|NCT03492411|Co-parenting|co-parenting
4660009|NCT03492411|eHealth|ehealth
4660010|NCT03492411|patient education|patient education
4660011|NCT03492411|fathers|fathers
4660012|NCT03492398|atopic dermatitis|atopic dermatitis
4660013|NCT03492359|COPD, Structured Light Plethysmography, COPD severity|copd, structured light plethysmography, copd severity
4660014|NCT03492346|LGMD2E|lgmd2e
4660015|NCT03492346|Limb Girdle Muscular Dystrophy|limb girdle muscular dystrophy
4660016|NCT03492346|sarcoglycanopathy|sarcoglycanopathy
4660017|NCT03492346|β -sarcoglycan|β -sarcoglycan
4660018|NCT03492346|Natural History|natural history
4660019|NCT03492333|antigliadin, gluten free diet, transit|antigliadin, gluten free diet, transit
4660020|NCT03492320|HRQoL|hrqol
4660021|NCT03492320|Quality of Life|quality of life
4660022|NCT03492320|End Stage Osteoarthritis|end stage osteoarthritis
4660023|NCT03492320|Total Knee Arthroplasty|total knee arthroplasty
4660024|NCT03492320|WOMAC|womac
4660025|NCT03492320|SF 36|sf 36
4660026|NCT03492320|Total Knee Replacement|total knee replacement
4660027|NCT03492307|High Flow Nasal Cannula|high flow nasal cannula
4660028|NCT03492294|disorders of consciousness|disorders of consciousness
4660029|NCT03492294|music stimulation|music stimulation
4660030|NCT03492294|functional magnetic resonance imaging|functional magnetic resonance imaging
4660031|NCT03492281|Beta-3 adrenergic receptor (β3-AR) agonists|beta-3 adrenergic receptor (β3-ar) agonists
4660032|NCT03492281|Incontinence|incontinence
4660033|NCT03492281|OAB|oab
4660034|NCT03492281|Vibegron|vibegron
4660035|NCT03492281|Urge urinary incontinence|urge urinary incontinence
4660036|NCT03492281|Urinary bladder, overactive|urinary bladder, overactive
4660037|NCT03492281|Urologic Diseases|urologic diseases
4660038|NCT03492281|Lower Urinary Tract Symptoms|lower urinary tract symptoms
4660039|NCT03492281|Urological Agents|urological agents
4660040|NCT03492242|Anti-PD-1|anti-pd-1
4660041|NCT03492242|Anti-PD-L1|anti-pd-l1
4660042|NCT03492242|Anti-CTLA-4|anti-ctla-4
4660043|NCT03492242|Immune checkpoint inhibitors|immune checkpoint inhibitors
4660044|NCT03492242|Immune adverse drug reactions|immune adverse drug reactions
4660045|NCT03492229|Gait|gait
4660046|NCT03492229|Brain stimulation|brain stimulation
4660047|NCT03492229|tDCS|tdcs
4660048|NCT03492229|Walking|walking
4660049|NCT03492203|Cognitive Remediation|cognitive remediation
4660050|NCT03492203|Neurocognition|neurocognition
4660051|NCT03492203|Severe mental illness|severe mental illness
4660052|NCT03492203|Remote treatment|remote treatment
4660053|NCT03492190|protein availability|protein availability
4660054|NCT03492190|beans|beans
4660055|NCT03492190|children|children
4660056|NCT03492190|elderly|elderly
4660057|NCT03492177|Pediatric|pediatric
4660058|NCT03492151|Confocal laser endomicroscopy|confocal laser endomicroscopy
4660059|NCT03492138|Multiple Myeloma|multiple myeloma
4660060|NCT03492138|Relapsed and Refractory|relapsed and refractory
4660061|NCT03492086|Rosmarinus officinalis L|rosmarinus officinalis l
4660062|NCT03492086|alkylglycerols|alkylglycerols
4660063|NCT03492086|immuno-nutrition|immuno-nutrition
4660064|NCT03492086|colon cancer|colon cancer
4660065|NCT03492073|Mindfulness|mindfulness
4660066|NCT03492073|Oncology|oncology
4660067|NCT03492073|Cancer|cancer
4660068|NCT03492073|Emotional distress|emotional distress
4660069|NCT03492073|Quality of life|quality of life
4660070|NCT03492060|Gene Variant|gene variant
4660071|NCT03492047|paclitaxel|paclitaxel
4660072|NCT03492047|peripheral neuropathy|peripheral neuropathy
4660073|NCT03492047|N-acetyl cysteine|n-acetyl cysteine
4660074|NCT03492021|rehabilitative nutrition|rehabilitative nutrition
4660075|NCT03492021|protein|protein
4660076|NCT03492021|beef|beef
4660077|NCT03492021|ACL reconstruction|acl reconstruction
4660078|NCT03492021|protein synthesis|protein synthesis
4660079|NCT03492021|proteolysis|proteolysis
4660080|NCT03492021|muscle mass|muscle mass
4660081|NCT03492021|muscle strength|muscle strength
4660082|NCT03492008|nasogastric tube|nasogastric tube
4660083|NCT03492008|general anesthesia|general anesthesia
4660084|NCT03492008|head position|head position
4660085|NCT03491982|Cardiac Rehabilitation|cardiac rehabilitation
4660086|NCT03491930|Weight Loss|weight loss
4660087|NCT03491930|Obesity|obesity
4660088|NCT03491930|Pre-Diabetes|pre-diabetes
4660089|NCT03491930|Metabolic Syndrome|metabolic syndrome
4660090|NCT03491891|Very Late Stent Thrombosis|very late stent thrombosis
4660091|NCT03491891|New generation DES|new generation des
4660092|NCT03491774|memory impairment, montessori intervention, neurocognitive disorder|memory impairment, montessori intervention, neurocognitive disorder
4660093|NCT03491761|Platelet Rich Plasma (PRP)|platelet rich plasma (prp)
4660094|NCT03491761|Viscosupplementation|viscosupplementation
4660095|NCT03491761|Knee Osteoarthritis|knee osteoarthritis
4660096|NCT03491761|Hyaluronic Acid (HA)|hyaluronic acid (ha)
4660097|NCT03491761|Supartz|supartz
4660098|NCT03491761|WOMAC|womac
4660099|NCT03491761|KOOS|koos
4660100|NCT03491748|Pharmacokinetics|pharmacokinetics
4660101|NCT03491748|ETX0282|etx0282
4660102|NCT03491748|Single Ascending Dose|single ascending dose
4660103|NCT03491748|Multiple Ascending Doses|multiple ascending doses
4660104|NCT03491748|ETX1317|etx1317
4660105|NCT03491748|Cefpodoxime Proxetil|cefpodoxime proxetil
4660106|NCT03491748|Cefpodoxime|cefpodoxime
4660107|NCT03491748|Enterobacteriaceae Infections|enterobacteriaceae infections
4660108|NCT03491735|patterns|patterns
4660109|NCT03491735|glaucoma|glaucoma
4660110|NCT03491735|egypt|egypt
4660111|NCT03491735|india|india
4660112|NCT03491735|2018|2018
4660113|NCT03491696|Depressive disorder|depressive disorder
4660114|NCT03491696|Metyrapone|metyrapone
4660115|NCT03491696|Dexamethasone Suppression Test|dexamethasone suppression test
4660116|NCT03491696|Antidepressive association|antidepressive association
4660117|NCT03491696|Hypothalamic-pituitary-adrenal axis|hypothalamic-pituitary-adrenal axis
4660118|NCT03491696|Cortisol|cortisol
4660119|NCT03491696|Selective Serotonin Reuptake Inhibitor|selective serotonin reuptake inhibitor
4660120|NCT03491696|Serotonin and Norepinephrine Reuptake Inhibitor|serotonin and norepinephrine reuptake inhibitor
4660121|NCT03491683|Glioblastoma|glioblastoma
4660122|NCT03491683|immunotherapy|immunotherapy
4660123|NCT03491683|DNA therapy|dna therapy
4660124|NCT03491683|checkpoint inhibitor|checkpoint inhibitor
4660125|NCT03491657|virtual reality pain|virtual reality pain
4660126|NCT03491657|opioid|opioid
4660127|NCT03491657|pediatric burn|pediatric burn
4660128|NCT03491657|wound care|wound care
4660129|NCT03491644|Traumatic accident|traumatic accident
4660130|NCT03491644|Oxygen|oxygen
4660131|NCT03491644|Intensive Care|intensive care
4660132|NCT03491644|Emergency|emergency
4660133|NCT03491618|lumbar facet joint pain|lumbar facet joint pain
4660134|NCT03491618|Lumbar Medial Branch Neurotomy|lumbar medial branch neurotomy
4660135|NCT03491618|Chronic Low Back Pain|chronic low back pain
4660136|NCT03491605|chronic EBV infection, hemophagocytic lymphohistiocytosis|chronic ebv infection, hemophagocytic lymphohistiocytosis
4660137|NCT03491592|Physical Activity|physical activity
4660138|NCT03491592|Latinas|latinas
4660139|NCT03491592|Spanish-language|spanish-language
4660140|NCT03491592|Text-Message|text-message
4660141|NCT03491592|Exercise|exercise
4660142|NCT03491592|Web-based|web-based
4660143|NCT03491579|AML|aml
4660144|NCT03491579|Epacadostat|epacadostat
4660145|NCT03491579|Cladribine|cladribine
4660146|NCT03491579|Cytarabine|cytarabine
4660147|NCT03491540|Mechanical Bowel Preparation (MBP)|mechanical bowel preparation (mbp)
4660148|NCT03491540|Oral antibiotics|oral antibiotics
4660149|NCT03491540|Rectal cancer surgery|rectal cancer surgery
4660150|NCT03491540|Surgical site infection|surgical site infection
4660151|NCT03491501|Industrial work|industrial work
4660152|NCT03491501|physical effort|physical effort
4660153|NCT03491501|mental effort|mental effort
4660154|NCT03491501|questionnaires|questionnaires
4660155|NCT03491501|ergonomic evaluation|ergonomic evaluation
4660156|NCT03491488|executive function|executive function
4660157|NCT03491488|Early childhood education|early childhood education
4660158|NCT03491488|self regulation|self regulation
4660159|NCT03491475|Ajmaline test|ajmaline test
4660160|NCT03491462|arimoclomol|arimoclomol
4660161|NCT03491462|ALS|als
4660162|NCT03491449|Brain ischemia|brain ischemia
4660163|NCT03491449|Cerebral ischemia|cerebral ischemia
4660164|NCT03491410|Metastatic|metastatic
4660165|NCT03491410|Active Surveillance|active surveillance
4660166|NCT03491397|Microspheres|microspheres
4660167|NCT03491397|Artery Embolization|artery embolization
4660168|NCT03491397|Knee Osteoarthritis|knee osteoarthritis
4660169|NCT03491397|Chronic Pain|chronic pain
4660170|NCT03491397|Embozene|embozene
4660171|NCT03491384|anxiety|anxiety
4660172|NCT03491384|inflammation|inflammation
4660173|NCT03491384|cannabis|cannabis
4660174|NCT03491384|marijuana|marijuana
4660175|NCT03491384|stress|stress
4660176|NCT03491371|apatinib|apatinib
4660177|NCT03491371|tyrosine-kinase inhibitors|tyrosine-kinase inhibitors
4660178|NCT03491371|osteosarcoma|osteosarcoma
4660179|NCT03491371|Ewing sarcoma|ewing sarcoma
4660180|NCT03491371|chondrosarcoma|chondrosarcoma
4660181|NCT03491371|soft-tissue sarcoma|soft-tissue sarcoma
4660182|NCT03491358|vibrating mesh nebulizer|vibrating mesh nebulizer
4660183|NCT03491358|allergen challenge|allergen challenge
4660184|NCT03491319|Anesthetics, Local|anesthetics, local
4660185|NCT03491319|Head-Down Tilt|head-down tilt
4660186|NCT03491319|Anesthesia, Spinal|anesthesia, spinal
4660187|NCT03491319|hypotension|hypotension
4660188|NCT03491306|PEEK|peek
4660189|NCT03491306|Breflex|breflex
4660190|NCT03491293|internet|internet
4660191|NCT03491293|behavioral weight loss|behavioral weight loss
4660192|NCT03491293|obesity|obesity
4660193|NCT03491280|Rare Diseases|rare diseases
4660194|NCT03491280|Genetic Predisposition|genetic predisposition
4660195|NCT03491280|Omics Technology|omics technology
4660196|NCT03491280|Next Generation Sequencing (NGS)|next generation sequencing (ngs)
4660197|NCT03491267|alopecia|alopecia
4660198|NCT03491215|Graft versus host disease (GvHD)|graft versus host disease (gvhd)
4660199|NCT03491215|acute graft versus host disease (aGvHD)|acute graft versus host disease (agvhd)
4660322|NCT03490474|conditioned pain modulation (CPM)|conditioned pain modulation (cpm)
4660200|NCT03491215|Steroid refractory acute graft versus host disease (SR-aGvHD)|steroid refractory acute graft versus host disease (sr-agvhd)
4660201|NCT03491215|Ruxolitinib|ruxolitinib
4660202|NCT03491215|INC424|inc424
4660203|NCT03491215|allogeneic stem cell transplantation|allogeneic stem cell transplantation
4660204|NCT03491176|Head and Neck Cancer|head and neck cancer
4660205|NCT03491176|Magnetic resonance imaging|magnetic resonance imaging
4660206|NCT03491176|MRI|mri
4660207|NCT03491176|Biomarker testing|biomarker testing
4660208|NCT03491176|Blood draws|blood draws
4660209|NCT03491176|Questionnaires|questionnaires
4660210|NCT03491176|Surveys|surveys
4660211|NCT03491163|syndecan-1|syndecan-1
4660212|NCT03491163|endothelial glycocalyx|endothelial glycocalyx
4660213|NCT03491163|On-pump heart surgery|on-pump heart surgery
4660214|NCT03491150|Dementia|dementia
4660215|NCT03491150|Neurodegenerative Diseases|neurodegenerative diseases
4660216|NCT03491150|Brain Diseases|brain diseases
4660217|NCT03491150|Central Nervous System Diseases|central nervous system diseases
4660218|NCT03491150|Nervous System Diseases|nervous system diseases
4660219|NCT03491150|Tauopathies|tauopathies
4660220|NCT03491150|Neurocognitive Disorders|neurocognitive disorders
4660221|NCT03491150|Mental Disorders|mental disorders
4660222|NCT03491137|Wireless monitoring, postoperative complications|wireless monitoring, postoperative complications
4660223|NCT03491111|Cerebrovascular disease|cerebrovascular disease
4660224|NCT03491111|respiratory muscle training|respiratory muscle training
4660225|NCT03491111|spirometry|spirometry
4660226|NCT03491111|peak flow|peak flow
4660227|NCT03491111|maximal inspiratory pressure, maximal expiratory pressure|maximal inspiratory pressure, maximal expiratory pressure
4660228|NCT03491098|Otitis Media with Effusion|otitis media with effusion
4660229|NCT03491072|extracorporeal shock-wave Lithotripsy,|extracorporeal shock-wave lithotripsy,
4661131|NCT03485313|Pregnancy|pregnancy
4660230|NCT03491072|pain relief during extracorporeal shock-wave Lithotripsy|pain relief during extracorporeal shock-wave lithotripsy
4660231|NCT03491072|fentanyl|fentanyl
4660232|NCT03491072|Transcutaneous electrical nerve stimulation|transcutaneous electrical nerve stimulation
4660233|NCT03491033|advanced-stage ovarian cancer|advanced-stage ovarian cancer
4660234|NCT03491033|neoadjuvant chemotherapy|neoadjuvant chemotherapy
4660235|NCT03491033|residual disease|residual disease
4660236|NCT03491033|genomic profiling|genomic profiling
4660237|NCT03491033|immunohistochemistry|immunohistochemistry
4660238|NCT03491020|Emission Patterns|emission patterns
4660239|NCT03491020|Respiratory|respiratory
4660240|NCT03491020|Aerosolization|aerosolization
4660241|NCT03491020|Airborne|airborne
4660242|NCT03491007|PTSD|ptsd
4660243|NCT03491007|DHEA|dhea
4660244|NCT03490981|primary care|primary care
4660245|NCT03490981|chronic pain|chronic pain
4660246|NCT03490981|musculoskeletal pain|musculoskeletal pain
4660247|NCT03490981|cognitive behavioral therapy|cognitive behavioral therapy
4660248|NCT03490981|integrated primary care|integrated primary care
4660249|NCT03490942|glucagon|glucagon
4660250|NCT03490942|hypoglycemia counter-regulation|hypoglycemia counter-regulation
4660251|NCT03490916|Acetazolamide|acetazolamide
4660252|NCT03490916|High-altitude illness|high-altitude illness
4660253|NCT03490916|High-altitude pulmonary edema|high-altitude pulmonary edema
4660254|NCT03490916|Lung comets|lung comets
4660255|NCT03490916|Lung ultrasound|lung ultrasound
4660256|NCT03490916|Subclinical high-altitude pulmonary edema|subclinical high-altitude pulmonary edema
4660257|NCT03490903|virtual reality|virtual reality
4660258|NCT03490903|anxiety|anxiety
4660259|NCT03490903|vasospasm|vasospasm
4660260|NCT03490903|pain|pain
4660261|NCT03490903|coronary artery angiography|coronary artery angiography
4660262|NCT03490903|angiogram|angiogram
4660263|NCT03490903|VR|vr
4660264|NCT03490890|microwave ablation|microwave ablation
4660265|NCT03490890|lung cancer|lung cancer
4660266|NCT03490890|ground glass nodules|ground glass nodules
4660267|NCT03490877|Atopic Dermatitis|atopic dermatitis
4660268|NCT03490877|Pruritus|pruritus
4660269|NCT03490877|Sleep Disturbance|sleep disturbance
4660270|NCT03490786|GT-001|gt-001
4660271|NCT03490773|Cpeptide|cpeptide
4660272|NCT03490773|Immunology|immunology
4660273|NCT03490760|Metastatic Adenocarcinoma of the Pancreas|metastatic adenocarcinoma of the pancreas
4660274|NCT03490747|Physical Activity|physical activity
4660275|NCT03490747|Pragmatic Evaluation|pragmatic evaluation
4660276|NCT03490747|Exercise Referral|exercise referral
4660277|NCT03490747|Mixed-methods|mixed-methods
4660278|NCT03490747|Behaviour Change|behaviour change
4660279|NCT03490747|Intervention|intervention
4660280|NCT03490734|nutrition|nutrition
4660281|NCT03490734|obesity|obesity
4660282|NCT03490734|weight gain|weight gain
4660283|NCT03490734|sugar|sugar
4660284|NCT03490734|sugar sweetened beverage|sugar sweetened beverage
4660285|NCT03490734|dopamine|dopamine
4660286|NCT03490734|neurobehavioral adaptation|neurobehavioral adaptation
4660287|NCT03490708|Mucinoses|mucinoses
4660288|NCT03490708|Tranilast|tranilast
4660289|NCT03490643|Plantar Pressure Distribution|plantar pressure distribution
4660290|NCT03490643|Posture|posture
4660291|NCT03490643|Posturescreen Mobile|posturescreen mobile
4660292|NCT03490643|RDC/TMD|rdc/tmd
4660293|NCT03490643|TMD|tmd
4660294|NCT03490630|patient reported outcome|patient reported outcome
4660295|NCT03490630|postoperative pain|postoperative pain
4660296|NCT03490630|pain related impairment|pain related impairment
4660297|NCT03490630|quality of life|quality of life
4660298|NCT03490630|prospective association study|prospective association study
4660299|NCT03490617|Intrauterine device|intrauterine device
4660300|NCT03490617|Misoprostol|misoprostol
4660301|NCT03490617|Nulliparous women|nulliparous women
4660302|NCT03490617|Contraception|contraception
4660303|NCT03490591|Cerebral Palsy|cerebral palsy
4660304|NCT03490591|Robotic rehabilitation|robotic rehabilitation
4660305|NCT03490591|Hand function|hand function
4660306|NCT03490591|Activities of Daily Living|activities of daily living
4660307|NCT03490578|Parkinson Disease|parkinson disease
4660308|NCT03490578|Gait|gait
4660309|NCT03490578|Balance|balance
4660310|NCT03490578|Rehabilitation|rehabilitation
4660311|NCT03490578|Robot-assisted gait training|robot-assisted gait training
4660312|NCT03490565|exercise training|exercise training
4660313|NCT03490565|treatment tolerability|treatment tolerability
4660314|NCT03490565|treatment complications|treatment complications
4660315|NCT03490539|observational|observational
4660316|NCT03490539|comparative effectiveness|comparative effectiveness
4660317|NCT03490539|myasthenia gravis|myasthenia gravis
4660318|NCT03490500|protein S100B|protein s100b
4660319|NCT03490500|negative predictive value|negative predictive value
4660320|NCT03490500|headache|headache
4660321|NCT03490500|intracranial hemorrhage|intracranial hemorrhage
4660323|NCT03490474|diffuse noxious inhibitory control (DNIC)|diffuse noxious inhibitory control (dnic)
4660324|NCT03490474|massage|massage
4660325|NCT03490474|hypoalgesia|hypoalgesia
4660326|NCT03490448|vitamin D|vitamin d
4660327|NCT03490448|obesity|obesity
4660328|NCT03490448|body composition|body composition
4660329|NCT03490448|glucose metabolism|glucose metabolism
4660330|NCT03490448|lipid metabolism|lipid metabolism
4660331|NCT03490435|Per os invasions|per os invasions
4660332|NCT03490435|Giardiasis|giardiasis
4660333|NCT03490435|Toxoplasmosis|toxoplasmosis
4660334|NCT03490435|Taeniasis|taeniasis
4660335|NCT03490435|Cryptosporidiosis|cryptosporidiosis
4660336|NCT03490435|Trichinosis|trichinosis
4660337|NCT03490435|Ascariasis|ascariasis
4660338|NCT03490435|Echinococcosis|echinococcosis
4660339|NCT03490422|pulpotomy|pulpotomy
4660340|NCT03490422|permanent teeth|permanent teeth
4660341|NCT03490422|deep caries management|deep caries management
4660342|NCT03490422|risk factors|risk factors
4660343|NCT03490422|clinical indicators for pulpotomy|clinical indicators for pulpotomy
4660344|NCT03490409|Arthroplasty|arthroplasty
4660345|NCT03490409|Replacement|replacement
4660346|NCT03490409|Knee|knee
4660347|NCT03490409|Compression|compression
4660348|NCT03490409|Edema|edema
4660349|NCT03490409|Pain|pain
4660350|NCT03490396|Oral Mucositis|oral mucositis
4660351|NCT03490396|Stomatitis|stomatitis
4660352|NCT03490396|Myeloablative|myeloablative
4660353|NCT03490383|ERCP|ercp
4660354|NCT03490383|CBD stone|cbd stone
4660355|NCT03490383|Microbial Colonization|microbial colonization
4660356|NCT03490344|bony plasmacytoma|bony plasmacytoma
4660357|NCT03490344|extramedullary plasmacytoma|extramedullary plasmacytoma
4660358|NCT03490344|Daratumumab|daratumumab
4660359|NCT03490344|lenalidomide|lenalidomide
4660360|NCT03490344|Memorial Sloan Kettering Cancer Center|memorial sloan kettering cancer center
4660361|NCT03490344|18-048|18-048
4660362|NCT03490331|JEB|jeb
4660363|NCT03490331|Stem cells|stem cells
4660364|NCT03490331|Gene Therapy|gene therapy
4660365|NCT03490305|War injury|war injury
4660366|NCT03490305|Penetrating abdominal trauma|penetrating abdominal trauma
4660367|NCT03490305|Exploratory laparotomy|exploratory laparotomy
4660368|NCT03490305|Improvised explosive device|improvised explosive device
4660369|NCT03490305|Mosul|mosul
4660370|NCT03490266|Ventral Hernia|ventral hernia
4660371|NCT03490266|Hernia Repair|hernia repair
4660372|NCT03490227|neonates|neonates
4660373|NCT03490227|brown adipose tissue|brown adipose tissue
4660374|NCT03490227|body composition|body composition
4660375|NCT03490214|Optoacoustics|optoacoustics
4660376|NCT03490214|MSOT|msot
4660377|NCT03490214|Multispectral Optoacoustic Tomography|multispectral optoacoustic tomography
4660378|NCT03490175|genetic association study|genetic association study
4660379|NCT03490175|postoperative nausea and vomiting|postoperative nausea and vomiting
4660380|NCT03490175|patient reported outcome|patient reported outcome
4660381|NCT03490175|antiemetics|antiemetics
4660382|NCT03490162|Anti-Malarial|anti-malarial
4660383|NCT03490162|DM1157|dm1157
4660384|NCT03490162|Pharmacokinetics|pharmacokinetics
4660385|NCT03490162|Safety|safety
4660386|NCT03490149|ECT|ect
4660387|NCT03490149|Electroconvulsive Therapy|electroconvulsive therapy
4660388|NCT03490149|Depression|depression
4660389|NCT03490149|Memory|memory
4660390|NCT03490149|Memory Impairment|memory impairment
4660391|NCT03490123|Azithromycin|azithromycin
4660392|NCT03490123|Endemic treponematoses|endemic treponematoses
4660393|NCT03490123|Mass drug administration|mass drug administration
4660394|NCT03490123|Eradication|eradication
4660395|NCT03490123|Papua New Guinea|papua new guinea
4660396|NCT03490110|cognitive rehabilitation|cognitive rehabilitation
4660397|NCT03490110|EEG|eeg
4660398|NCT03490110|TBI|tbi
4660399|NCT03490110|brain networks|brain networks
4660400|NCT03490110|attention|attention
4660401|NCT03490110|memory|memory
4660402|NCT03490110|executive function|executive function
4660403|NCT03490084|multiple myeloma|multiple myeloma
4660404|NCT03490084|elderly patients|elderly patients
4660405|NCT03490084|health outcomes|health outcomes
4660406|NCT03490084|hospital-at-home|hospital-at-home
4660407|NCT03490084|day hospitalization|day hospitalization
4660408|NCT03490084|quality of life|quality of life
4660409|NCT03490084|medico-economic evaluation|medico-economic evaluation
4660410|NCT03490084|qualitative study|qualitative study
4660411|NCT03490071|Longstanding hip and groin pain|longstanding hip and groin pain
4660412|NCT03490071|Patient reported outcome|patient reported outcome
4660413|NCT03490058|pre-exposure prophylaxis|pre-exposure prophylaxis
4660414|NCT03490058|young women|young women
4660415|NCT03490058|delivery of health care|delivery of health care
4660416|NCT03490058|HIV infections/prevention|hiv infections/prevention
4660417|NCT03490045|Diaper Need|diaper need
4660418|NCT03490045|Well-Child Care|well-child care
4660419|NCT03490045|Infant Immunizations|infant immunizations
4660420|NCT03490045|Incentives|incentives
4660421|NCT03490045|Basic Needs|basic needs
4660422|NCT03490006|regional anesthesia|regional anesthesia
4660423|NCT03490006|postoperative pain|postoperative pain
4660424|NCT03490006|mastectomy|mastectomy
4660425|NCT03490006|erector spinae plane block|erector spinae plane block
4660426|NCT03490006|paravertebral block|paravertebral block
4660427|NCT03489993|FGF23|fgf23
4660428|NCT03489993|Angiotensin-(1-7)|angiotensin-(1-7)
4660429|NCT03489993|Hypophosphatemia|hypophosphatemia
4660430|NCT03489980|STAI Questionnaire|stai questionnaire
4660431|NCT03489980|ECTM2-Qa|ectm2-qa
4661132|NCT03485287|PTSD|ptsd
4660432|NCT03489967|Hypoglycemia, carbohydrates|hypoglycemia, carbohydrates
4660433|NCT03489954|Non-specific Chronic Neck Pain|non-specific chronic neck pain
4660434|NCT03489954|Balance Master|balance master
4660435|NCT03489954|Joint Position Error|joint position error
4660436|NCT03489954|Neck pain|neck pain
4660437|NCT03489928|Labour|labour
4660438|NCT03489928|Induction|induction
4660439|NCT03489928|Misoprostol|misoprostol
4660440|NCT03489928|Dinoprostone|dinoprostone
4660441|NCT03489928|Oxytocin|oxytocin
4660442|NCT03489889|Liver Cirrhosis, Biliary|liver cirrhosis, biliary
4660443|NCT03489889|Ursodeoxycholic Acid|ursodeoxycholic acid
4660444|NCT03489876|Metatarsophalangeal Joint|metatarsophalangeal joint
4660445|NCT03489876|Arthritis|arthritis
4660446|NCT03489876|Synthetic Cartilage Implant|synthetic cartilage implant
4660447|NCT03489876|Cartiva|cartiva
4660448|NCT03489876|Osteochondral Autograft Transfer|osteochondral autograft transfer
4660449|NCT03489863|clopidogrel|clopidogrel
4660450|NCT03489863|prasugrel|prasugrel
4660451|NCT03489863|ticagrelor|ticagrelor
4660452|NCT03489811|Essential Oils|essential oils
4660453|NCT03489811|Aromatherapy|aromatherapy
4660454|NCT03489811|Anxiety|anxiety
4660455|NCT03489811|Autism Spectrum Disorder|autism spectrum disorder
4660456|NCT03489798|Induction of labor|induction of labor
4660457|NCT03489798|Misoprostol|misoprostol
4660458|NCT03489798|Failed induction|failed induction
4660459|NCT03489785|Predicted factor|predicted factor
4660460|NCT03489785|Motor Evoked Potentials|motor evoked potentials
4660461|NCT03489759|Acute Kidney Injury|acute kidney injury
4660462|NCT03489759|Oxidative Stress|oxidative stress
4660463|NCT03489759|Renal Replacement Therapy|renal replacement therapy
4660464|NCT03489759|Vitamine E-coated Polysulfone Membrane|vitamine e-coated polysulfone membrane
4660465|NCT03489746|Inhaled corticosteroids|inhaled corticosteroids
4660466|NCT03489746|Quality improvement|quality improvement
4660467|NCT03489746|Cluster randomized Trial|cluster randomized trial
4660468|NCT03489707|anal cancer|anal cancer
4660469|NCT03489707|human papillomavirus|human papillomavirus
4660470|NCT03489694|skin test endpoint|skin test endpoint
4660471|NCT03489681|acupuncture, sciatica, default mode network|acupuncture, sciatica, default mode network
4660472|NCT03489668|PCOS|pcos
4660473|NCT03489668|Androgen|androgen
4660474|NCT03489668|3D ultrasound|3d ultrasound
4660475|NCT03489655|Healthy Homes|healthy homes
4660476|NCT03489655|Asthma|asthma
4660477|NCT03489655|Community Health Worker|community health worker
4660478|NCT03489629|Methicillin-resistant Staphylococcus aureus (MRSA)|methicillin-resistant staphylococcus aureus (mrsa)
4660479|NCT03489629|Early infection|early infection
4660480|NCT03489629|Treatment|treatment
4660481|NCT03489629|Forced Expiratory Volume in 1 Second (FEV1)|forced expiratory volume in 1 second (fev1)
4660482|NCT03489603|Troponin|troponin
4660483|NCT03489590|Lung|lung
4660484|NCT03489590|imaging|imaging
4660485|NCT03489590|hyperpolarized|hyperpolarized
4660486|NCT03489590|perfluorinated|perfluorinated
4660487|NCT03489590|MRI|mri
4660488|NCT03489577|Inflammation|inflammation
4660489|NCT03489577|Multiple Organ Failure|multiple organ failure
4660490|NCT03489577|Sepsis|sepsis
4660491|NCT03489577|Wounds and Injuries|wounds and injuries
4660492|NCT03489577|Pathologic Processes|pathologic processes
4660493|NCT03489577|Shock|shock
4660494|NCT03489577|Infection|infection
4660495|NCT03489577|Systemic Inflammatory Response Syndrome|systemic inflammatory response syndrome
4660496|NCT03489577|Neutrophils|neutrophils
4660497|NCT03489577|PMN|pmn
4660498|NCT03489577|Granulocytes|granulocytes
4660499|NCT03489577|Innate immunity|innate immunity
4660500|NCT03489577|ICU|icu
4660501|NCT03489577|Intensive Care|intensive care
4660502|NCT03489577|polytrauma|polytrauma
4660503|NCT03489577|host-pathogen|host-pathogen
4660504|NCT03489564|Pregnancy|pregnancy
4660505|NCT03489564|Mitochondrial metabolism|mitochondrial metabolism
4660506|NCT03489564|Placenta|placenta
4660507|NCT03489538|bariatric surgery|bariatric surgery
4660508|NCT03489538|gastric bypass|gastric bypass
4660509|NCT03489538|homocysteine|homocysteine
4660510|NCT03489538|folate|folate
4660511|NCT03489538|vitamin b12|vitamin b12
4660512|NCT03489525|multiple myeloma|multiple myeloma
4660513|NCT03489525|relapsed/refractory|relapsed/refractory
4660514|NCT03489525|open-label|open-label
4660515|NCT03489499|postoperative pain|postoperative pain
4660516|NCT03489499|analgesics|analgesics
4660517|NCT03489499|patient reported outcome|patient reported outcome
4660518|NCT03489499|pain related impairment|pain related impairment
4660519|NCT03489499|genetic association study|genetic association study
4660520|NCT03489486|Presepsin|presepsin
4660521|NCT03489486|sCD14-ST|scd14-st
4660522|NCT03489486|biomarker|biomarker
4660523|NCT03489486|perioperative risk|perioperative risk
4660524|NCT03489473|Hormonal therapy|hormonal therapy
4660525|NCT03489473|FES PET scan|fes pet scan
4660526|NCT03489473|Estrogen receptor|estrogen receptor
4660527|NCT03489460|sleep health|sleep health
4660528|NCT03489434|adolescents|adolescents
4660529|NCT03489434|primary care|primary care
4660530|NCT03489434|sexual assault|sexual assault
4660531|NCT03489434|substance use|substance use
4660532|NCT03489434|sexual risk behavior|sexual risk behavior
4660533|NCT03489408|Proximal humerus fracture fixation|proximal humerus fracture fixation
4660534|NCT03489408|trauma|trauma
4660535|NCT03489382|self-harm|self-harm
4660536|NCT03489382|problem-solving therapy|problem-solving therapy
4660537|NCT03489382|emergency department|emergency department
4660538|NCT03489382|e-therapy|e-therapy
4660539|NCT03489382|suicide prevention|suicide prevention
4660540|NCT03489369|Locally advanced/unresectable|locally advanced/unresectable
4660541|NCT03489369|Metastatic solid tumor|metastatic solid tumor
4660542|NCT03489369|Lymphoma|lymphoma
4660543|NCT03489369|Anti-LAG-3|anti-lag-3
4660544|NCT03489369|LAG-3|lag-3
4660545|NCT03489369|LAG3|lag3
4660546|NCT03489356|Addressing Behavior Change (ABC)|addressing behavior change (abc)
4660547|NCT03489356|Addressing Behavior Change (ABC) Intervention|addressing behavior change (abc) intervention
4660548|NCT03489356|Addressing Behavior Change (ABC) Intervention Method|addressing behavior change (abc) intervention method
4660549|NCT03489343|Locally advanced/unresectable|locally advanced/unresectable
4660550|NCT03489343|Metastatic solid tumor|metastatic solid tumor
4660551|NCT03489343|Lymphoma|lymphoma
4660552|NCT03489343|Anti-TIM-3|anti-tim-3
4660553|NCT03489343|TIM-3|tim-3
4660554|NCT03489343|TIM3|tim3
4660555|NCT03489330|Anti-Bacterial Agents/therapeutic use|anti-bacterial agents/therapeutic use
4660556|NCT03489330|Drug Utilization/statistics & numerical data|drug utilization/statistics & numerical data
4660557|NCT03489330|Hospitals/statistics & numerical data|hospitals/statistics & numerical data
4660558|NCT03489330|Data Analysis, Statistical|data analysis, statistical
4660559|NCT03489330|Interpretation, Statistical Data|interpretation, statistical data
4660560|NCT03489330|Antibiotic Stewardship|antibiotic stewardship
4660561|NCT03489330|Electronic Medical Record|electronic medical record
4660562|NCT03489317|gut microbiome|gut microbiome
4660563|NCT03489317|stool|stool
4660564|NCT03489304|Insomnia|insomnia
4660565|NCT03489304|Zaleplon|zaleplon
4660566|NCT03489291|Hemophilia,|hemophilia,
4660567|NCT03489291|Gene Therapy|gene therapy
4660568|NCT03489291|Bleeding|bleeding
4660569|NCT03489291|Factor IX|factor ix
4660570|NCT03489291|FIX|fix
4660571|NCT03489291|viral vector|viral vector
4660572|NCT03489291|Padua|padua
4660573|NCT03489226|capsaicin|capsaicin
4660574|NCT03489226|energy expenditure|energy expenditure
4660575|NCT03489226|satiety|satiety
4660576|NCT03489226|food intake|food intake
4660577|NCT03489174|Opioid Substitution Therapy|opioid substitution therapy
4660578|NCT03489174|Pregnancy Tests|pregnancy tests
4660579|NCT03489148|Stress|stress
4660580|NCT03489148|Relaxation|relaxation
4660581|NCT03489148|Health promotion|health promotion
4660582|NCT03489122|Depressive Disorder, Major|depressive disorder, major
4660583|NCT03489122|yoga|yoga
4660584|NCT03489122|breathing exercise|breathing exercise
4660585|NCT03489122|parasympathetic|parasympathetic
4660586|NCT03489122|anxiety|anxiety
4660587|NCT03489122|Post Traumatic Stress Disorder|post traumatic stress disorder
4660588|NCT03489122|polyvagal|polyvagal
4660589|NCT03489109|Fasting|fasting
4660590|NCT03489096|Cryoballoon Ablation|cryoballoon ablation
4660591|NCT03489096|Persistent atrial fibrillation|persistent atrial fibrillation
4660592|NCT03489096|Paroxysmal atrial fibrillation|paroxysmal atrial fibrillation
4660593|NCT03489083|Diabetes|diabetes
4660594|NCT03489083|Heat Shock Response|heat shock response
4660595|NCT03489083|Aging|aging
4660596|NCT03489083|Exercise|exercise
4660597|NCT03489070|Liver resection|liver resection
4660598|NCT03489070|Liver Hemorrhage|liver hemorrhage
4660599|NCT03489070|Traumastem|traumastem
4660600|NCT03489070|Surgicel|surgicel
4660601|NCT03489057|symptom|symptom
4660602|NCT03489057|family research|family research
4660603|NCT03489057|self-management|self-management
4660604|NCT03489057|caregiving|caregiving
4660605|NCT03489057|social support|social support
4660606|NCT03489057|mHealth|mhealth
4660607|NCT03489057|healthy behavior|healthy behavior
4660608|NCT03489057|self-efficacy|self-efficacy
4660609|NCT03489057|quality of life|quality of life
4660610|NCT03489057|care transition|care transition
4660611|NCT03489044|Alzheimer|alzheimer
4660612|NCT03489044|Seizure|seizure
4660613|NCT03489044|Epilepsy|epilepsy
4660614|NCT03489044|Anti-epileptic drug|anti-epileptic drug
4660615|NCT03489044|Levetiracetam|levetiracetam
4660616|NCT03489005|BIA 5-1058|bia 5-1058
4660617|NCT03489005|Pulmonary arterial hypertension|pulmonary arterial hypertension
4660618|NCT03489005|Heart failure|heart failure
4660619|NCT03489005|Cardiovascular Disease|cardiovascular disease
4660620|NCT03488992|dietary supplement, cardiovascular health, oxidative stress|dietary supplement, cardiovascular health, oxidative stress
4660621|NCT03488979|Heart Failure|heart failure
4660622|NCT03488979|Medication Adherence|medication adherence
4660623|NCT03488966|Mindfulness|mindfulness
4660624|NCT03488966|Bariatric Surgery|bariatric surgery
4660625|NCT03488966|Obesity|obesity
4660626|NCT03488966|Group psychotherapy|group psychotherapy
4660627|NCT03488953|Liver transplantation|liver transplantation
4660628|NCT03488953|Two-stage hepatectomy|two-stage hepatectomy
4660629|NCT03488953|Living donor liver transplantation|living donor liver transplantation
4660630|NCT03488940|Sepsis|sepsis
4660631|NCT03488940|intestinal dysfunction|intestinal dysfunction
4660632|NCT03488940|enteral feeding|enteral feeding
4660633|NCT03488927|Sexual Violence|sexual violence
4660634|NCT03488927|Interpersonal Violence|interpersonal violence
4660635|NCT03488927|Prevention|prevention
4660636|NCT03488927|Mixed-Methods|mixed-methods
4660637|NCT03488927|Randomized Controlled Trial|randomized controlled trial
4660638|NCT03488927|Outcome Evaluation|outcome evaluation
4660639|NCT03488927|College Students|college students
4660640|NCT03488927|Post-traumatic Stress Disorder|post-traumatic stress disorder
4660641|NCT03488927|Alcohol|alcohol
4660642|NCT03488927|Sexual Assault|sexual assault
4660643|NCT03488927|Disclosure|disclosure
4660644|NCT03488927|Social Reactions|social reactions
4660645|NCT03488927|Coping|coping
4660646|NCT03488927|Depression|depression
4660647|NCT03488927|Intervention|intervention
4660648|NCT03488823|Endothelial Function|endothelial function
4660649|NCT03488823|Flavonols|flavonols
4660650|NCT03488823|Intima Injury|intima injury
4660651|NCT03488810|Apalutamide Prostate Cancer Radiotherapy|apalutamide prostate cancer radiotherapy
4660652|NCT03488771|kidney transplantation|kidney transplantation
4660653|NCT03488771|rejection|rejection
4660654|NCT03488771|infection|infection
4660655|NCT03488771|immunosuppression|immunosuppression
4660656|NCT03488667|resectable adenocarcinoma of Gastroesophageal Junction|resectable adenocarcinoma of gastroesophageal junction
4660657|NCT03488667|resectable adenocarcinoma of Stomach|resectable adenocarcinoma of stomach
4660658|NCT03488641|Biomarker|biomarker
4660659|NCT03488641|Signal Transduction Pathway Deregulation|signal transduction pathway deregulation
4660660|NCT03488641|Outcome|outcome
4660661|NCT03488641|Drug sensitivity testing|drug sensitivity testing
4660662|NCT03488641|Targeted Therapy|targeted therapy
4660663|NCT03488641|Genomic landscape|genomic landscape
4660664|NCT03488628|respiratory failure|respiratory failure
4660665|NCT03488628|oxygen therapy|oxygen therapy
4660666|NCT03488628|Noninvasive ventilation|noninvasive ventilation
4660667|NCT03488563|Headache|headache
4660668|NCT03488498|Balneotherapy|balneotherapy
4660669|NCT03488498|Chronic low back pain|chronic low back pain
4660670|NCT03488498|Controlled|controlled
4660671|NCT03488498|Randomized trial|randomized trial
4660672|NCT03488498|weight bath traction|weight bath traction
4660673|NCT03488498|follow-up|follow-up
4660674|NCT03488485|Mukh Mantri Punjab Hepatitis C Relief Fund,MMPHCRF|mukh mantri punjab hepatitis c relief fund,mmphcrf
4660675|NCT03488485|Direct antivirals, DAAs|direct antivirals, daas
4660676|NCT03488485|Chronic hepatitis C|chronic hepatitis c
4660677|NCT03488459|anxiety|anxiety
4660678|NCT03488459|preoperative education|preoperative education
4660679|NCT03488459|psychologist|psychologist
4660680|NCT03488459|thoracotomy|thoracotomy
4660681|NCT03488459|Ravitch procedure|ravitch procedure
4660682|NCT03488459|postoperative pain|postoperative pain
4660683|NCT03488446|Gastric Cancer|gastric cancer
4660684|NCT03488446|Radiomics|radiomics
4660685|NCT03488446|Computed Tomograpy|computed tomograpy
4660686|NCT03488446|Lymph Node Metastasis|lymph node metastasis
4660687|NCT03488446|Prediction|prediction
4660688|NCT03488433|Postoperative shoulder immobilization|postoperative shoulder immobilization
4660689|NCT03488433|Reverse total shoulder arthroplasty|reverse total shoulder arthroplasty
4660690|NCT03488433|Neutral rotation shoulder brace|neutral rotation shoulder brace
4660691|NCT03488433|Antirotation sling|antirotation sling
4660692|NCT03488407|Primary angioplasty|primary angioplasty
4660693|NCT03488407|Radial access|radial access
4660694|NCT03488407|STEMI|stemi
4660695|NCT03488394|Mucopolysaccharidosis IH|mucopolysaccharidosis ih
4660696|NCT03488394|Gene Therapy|gene therapy
4660697|NCT03488394|Transplantation, Autologous|transplantation, autologous
4660698|NCT03488394|Lentiviral vector|lentiviral vector
4660699|NCT03488355|Catheter|catheter
4660700|NCT03488342|Rives technique|rives technique
4660701|NCT03488342|Lichtenstein repair|lichtenstein repair
4660702|NCT03488329|Hospital readmissions|hospital readmissions
4660703|NCT03488329|Seniors|seniors
4660704|NCT03488290|Parents|parents
4660705|NCT03488290|Young Children|young children
4660706|NCT03488290|Trauma Focused Cognitive Behavior Therapy|trauma focused cognitive behavior therapy
4660707|NCT03488290|Learning Through Play|learning through play
4660708|NCT03488225|Acute Lymphocytic Leukemia|acute lymphocytic leukemia
4660709|NCT03488225|ALL|all
4660710|NCT03488225|B-Cell Lineage|b-cell lineage
4660711|NCT03488225|Cyclophosphamide|cyclophosphamide
4660712|NCT03488225|Cytoxan|cytoxan
4660713|NCT03488225|Neosar|neosar
4660714|NCT03488225|Mesna|mesna
4660715|NCT03488225|Mesnex|mesnex
4660716|NCT03488225|Doxorubicin hydrochloride|doxorubicin hydrochloride
4660717|NCT03488225|Adriamycin PFS|adriamycin pfs
4660718|NCT03488225|Adriamycin RDF|adriamycin rdf
4660719|NCT03488225|Rubex|rubex
4660720|NCT03488225|Adriamycin|adriamycin
4660721|NCT03488225|Doxorubicin|doxorubicin
4660722|NCT03488225|Vincristine|vincristine
4660723|NCT03488225|Ofatumumab|ofatumumab
4660724|NCT03488225|Arzerra|arzerra
4660725|NCT03488225|Rituximab|rituximab
4660726|NCT03488225|Rituxan|rituxan
4660727|NCT03488225|Pegfilgrastim|pegfilgrastim
4660728|NCT03488225|Neulasta|neulasta
4660729|NCT03488225|PEG-G-CSF|peg-g-csf
4660730|NCT03488225|Filgrastim|filgrastim
4660731|NCT03488225|G-CSF|g-csf
4660733|NCT03488225|Methotrexate|methotrexate
4660734|NCT03488225|Cytarabine|cytarabine
4660735|NCT03488225|Ara-C|ara-c
4660736|NCT03488225|Cytosar|cytosar
4660737|NCT03488225|DepoCyt|depocyt
4660738|NCT03488225|Cytosine arabinosine hydrochloride|cytosine arabinosine hydrochloride
4660739|NCT03488225|Citrovorum|citrovorum
4660740|NCT03488225|Leucovorin|leucovorin
4660741|NCT03488225|Wellcovorin|wellcovorin
4660742|NCT03488225|Inotuzumab Ozogamicin|inotuzumab ozogamicin
4660743|NCT03488225|CMC-544|cmc-544
4660744|NCT03488225|6-MP 6|6-mp 6
4660745|NCT03488225|Mercaptopurine|mercaptopurine
4660746|NCT03488225|Purinethol|purinethol
4660747|NCT03488225|MTX|mtx
4660748|NCT03488225|Prednisone|prednisone
4660749|NCT03488160|lymphoma CAR-T|lymphoma car-t
4660750|NCT03488147|Esomeprazole Magnesium|esomeprazole magnesium
4660751|NCT03488147|Postoperative dysphagia|postoperative dysphagia
4660752|NCT03488147|Gastroesophageal reflux disease|gastroesophageal reflux disease
4660753|NCT03488147|Anterior cervical surgery|anterior cervical surgery
4660754|NCT03488147|Proton pump inhibitor|proton pump inhibitor
4660755|NCT03488134|Exosome|exosome
4660756|NCT03488134|Anaplastic thyroid cancer|anaplastic thyroid cancer
4660757|NCT03488134|Urine|urine
4660758|NCT03488134|Biological marker|biological marker
4660759|NCT03488134|Thyroglobuin|thyroglobuin
4660760|NCT03488134|Galectin-3|galectin-3
4660761|NCT03488095|Tobacco, smokeless, chewing, betel quid|tobacco, smokeless, chewing, betel quid
4660762|NCT03488082|saccadic adaptation|saccadic adaptation
4660763|NCT03488082|visual-spatial perception|visual-spatial perception
4660764|NCT03488082|fMRI|fmri
4660765|NCT03488069|critical care|critical care
4660766|NCT03488069|sedation|sedation
4660767|NCT03488069|practice|practice
4660768|NCT03488069|survey|survey
4660769|NCT03488056|Dental Caries, ICCMS, Risk Assessment|dental caries, iccms, risk assessment
4660770|NCT03488043|Lung lesions|lung lesions
4660771|NCT03488043|Pneumothorax|pneumothorax
4660772|NCT03488043|CT-guided transthoracic biopsy|ct-guided transthoracic biopsy
4660773|NCT03488043|Risk score|risk score
4660774|NCT03488030|Drug therapy|drug therapy
4660775|NCT03487991|autonomic balance|autonomic balance
4660776|NCT03487991|sleep|sleep
4660777|NCT03487991|endothelial function|endothelial function
4660778|NCT03487991|behavior|behavior
4660779|NCT03487991|stress|stress
4660780|NCT03487965|dicarbonyl compounds|dicarbonyl compounds
4660781|NCT03487965|skin elasticity|skin elasticity
4660782|NCT03487965|glycation|glycation
4660783|NCT03487952|Lung nodule|lung nodule
4660784|NCT03487952|Computed tomography|computed tomography
4660785|NCT03487952|Artificial intelligence|artificial intelligence
4660786|NCT03487887|continuous glucose monitoring|continuous glucose monitoring
4660787|NCT03487887|glycemic variability|glycemic variability
4660788|NCT03487887|hypoglycemia|hypoglycemia
4660789|NCT03487874|8th cervical nerve root block|8th cervical nerve root block
4660790|NCT03487861|transglutaminase type 2|transglutaminase type 2
4660791|NCT03487861|kidney transplantation|kidney transplantation
4660792|NCT03487861|chronic allograft nephropathy|chronic allograft nephropathy
4660793|NCT03487861|biomarker|biomarker
4660794|NCT03487835|Athletic tape. Accidental Falls. Aging.|athletic tape. accidental falls. aging.
4660795|NCT03487809|Asthma|asthma
4660796|NCT03487809|Inhaled corticosteroid|inhaled corticosteroid
4660797|NCT03487809|pharmacogenomics|pharmacogenomics
4660798|NCT03487809|Therapeutic effect|therapeutic effect
4660799|NCT03487783|Tourette|tourette
4660800|NCT03487783|Aripiprazole Oral Solution|aripiprazole oral solution
4660801|NCT03487770|Autistic|autistic
4660802|NCT03487770|Aripiprazole Oral Solution|aripiprazole oral solution
4660803|NCT03487744|Tube Feeding|tube feeding
4660804|NCT03487744|Diarrhea|diarrhea
4660805|NCT03487744|Enteral Nutrition|enteral nutrition
4660806|NCT03487744|Critically Ill|critically ill
4660807|NCT03487744|Surgical|surgical
4660808|NCT03487744|Cardiovascular|cardiovascular
4660809|NCT03487731|stem cells|stem cells
4660810|NCT03487731|back pain|back pain
4660811|NCT03487718|Platelet-Rich Fibrin|platelet-rich fibrin
4660812|NCT03487718|high-density polytetrafluoroethylene membrane|high-density polytetrafluoroethylene membrane
4660813|NCT03487692|diabetes|diabetes
4660814|NCT03487692|group visit|group visit
4660815|NCT03487692|shared medical appointment|shared medical appointment
4660816|NCT03487692|text messaging|text messaging
4660817|NCT03487679|Microbiome|microbiome
4660818|NCT03487679|High Density Lipoprotein|high density lipoprotein
4660819|NCT03487679|Inflammation|inflammation
4660820|NCT03487666|Triple Negative Breast Cancer|triple negative breast cancer
4660821|NCT03487666|Nivolumab|nivolumab
4660822|NCT03487666|Capecitabine|capecitabine
4660823|NCT03487640|constipation, surgery|constipation, surgery
4660824|NCT03487627|adolescent|adolescent
4660825|NCT03487627|parental support|parental support
4660826|NCT03487627|parental coping|parental coping
4660827|NCT03487614|pediatric obesity|pediatric obesity
4660828|NCT03487614|preschool children|preschool children
4660829|NCT03487614|non-responsive feeding|non-responsive feeding
4660830|NCT03487614|body mass index|body mass index
4660831|NCT03487614|parenting|parenting
4660832|NCT03487601|docetaxel|docetaxel
4660833|NCT03487601|Stage I - IV|stage i - iv
4660834|NCT03487601|chemotherapy|chemotherapy
4660835|NCT03487575|Adolescent|adolescent
4660836|NCT03487575|Parental Support|parental support
4660837|NCT03487575|Parental Coping|parental coping
4660838|NCT03487523|Behavioural Economics|behavioural economics
4660839|NCT03487510|treatment standards|treatment standards
4660840|NCT03487510|diagnostical approaches|diagnostical approaches
4660841|NCT03487510|descriptive|descriptive
4660842|NCT03487497|gait analysis|gait analysis
4660843|NCT03487497|electromyography|electromyography
4660844|NCT03487497|strength test|strength test
4660845|NCT03487497|walking|walking
4660846|NCT03487419|left atrial echocardiography|left atrial echocardiography
4660847|NCT03487419|new onset atrial fibrillation|new onset atrial fibrillation
4660848|NCT03487419|coronary artery bypass grafting|coronary artery bypass grafting
4660849|NCT03487419|speckle tracking echocardiography|speckle tracking echocardiography
4660850|NCT03487393|facial nerve|facial nerve
4660851|NCT03487393|magnetic stimulation|magnetic stimulation
4660852|NCT03487393|cerebral blood flow|cerebral blood flow
4660853|NCT03487367|spinocerebellar ataxia|spinocerebellar ataxia
4660854|NCT03487367|ataxia|ataxia
4660855|NCT03487367|ataxias|ataxias
4660856|NCT03487367|SCA1|sca1
4660857|NCT03487367|SCA3|sca3
4660858|NCT03487367|spinocerebellar ataxia type 1|spinocerebellar ataxia type 1
4660859|NCT03487367|spinocerebellar ataxia type 3|spinocerebellar ataxia type 3
4660860|NCT03487367|READISCA|readisca
4660861|NCT03487328|treatment|treatment
4660862|NCT03487276|hidradenitis suppurativa|hidradenitis suppurativa
4660863|NCT03487276|monoclonal antibody|monoclonal antibody
4660864|NCT03487276|complement factor C5a|complement factor c5a
4660865|NCT03487276|IFX-1|ifx-1
4660866|NCT03487276|hidradenitis Suppurativa Clinical Response|hidradenitis suppurativa clinical response
4660867|NCT03487276|Inflammation|inflammation
4660868|NCT03487276|skin diseases|skin diseases
4660869|NCT03487263|motor neurone disease|motor neurone disease
4660870|NCT03487263|amyotrophic lateral sclerosis|amyotrophic lateral sclerosis
4660871|NCT03487263|IC14 [anti-CD14 (cluster of differentiation 14) monoclonal antibody]|ic14 [anti-cd14 (cluster of differentiation 14) monoclonal antibody]
4660872|NCT03487263|monoclonal antibody|monoclonal antibody
4660873|NCT03487263|anti-CD14|anti-cd14
4660874|NCT03487237|Syncope|syncope
4660875|NCT03487237|Pulmonary embolism|pulmonary embolism
4660876|NCT03487237|emergency department|emergency department
4660877|NCT03487237|clinical decision rule|clinical decision rule
4660878|NCT03487224|Hoarding Disorder|hoarding disorder
4660879|NCT03487211|Fibromyalgia treatment|fibromyalgia treatment
4660880|NCT03487211|Duloxetine|duloxetine
4660881|NCT03487211|Escitalopram|escitalopram
4660882|NCT03487198|Major Depressive Disorder|major depressive disorder
4660883|NCT03487198|Brexpiprazole|brexpiprazole
4660884|NCT03487185|CPAP|cpap
4660885|NCT03487185|Apnea|apnea
4660886|NCT03487185|pregnancy|pregnancy
4660887|NCT03487107|Chronic Genotype 1 HCV Infection|chronic genotype 1 hcv infection
4660888|NCT03487029|diabetes|diabetes
4660889|NCT03487029|high intensity interval training|high intensity interval training
4660890|NCT03487029|cardiorespiratory fitness|cardiorespiratory fitness
4660891|NCT03487016|Pancreatic Cancer|pancreatic cancer
4660892|NCT03487016|First line|first line
4660893|NCT03487016|Metastatic|metastatic
4660894|NCT03487003|laryngeal mask airway|laryngeal mask airway
4660895|NCT03487003|children, preschool|children, preschool
4660896|NCT03487003|muscle relaxant|muscle relaxant
4660897|NCT03486990|safety|safety
4660898|NCT03486990|tolerability|tolerability
4660899|NCT03486990|pharmacokinetics|pharmacokinetics
4660900|NCT03486990|celiac|celiac
4660901|NCT03486990|gliadin|gliadin
4660902|NCT03486990|gluten|gluten
4660903|NCT03486951|outpatient surgery|outpatient surgery
4660904|NCT03486951|ambulatory surgery|ambulatory surgery
4660905|NCT03486951|length of hospital stay|length of hospital stay
4660906|NCT03486925|oxytocin, eye-tracking, attention inhibition|oxytocin, eye-tracking, attention inhibition
4660907|NCT03486873|PD1|pd1
4660908|NCT03486873|PD-1|pd-1
4660909|NCT03486873|PDL1|pdl1
4660910|NCT03486873|PD-L1|pd-l1
4660911|NCT03486821|Radiation Therapy|radiation therapy
4660912|NCT03486821|ultra-short Radiation|ultra-short radiation
4660913|NCT03486821|SBRT|sbrt
4660914|NCT03486821|prostate|prostate
4660915|NCT03486821|quality of life|quality of life
4660916|NCT03486821|financial toxicity|financial toxicity
4660917|NCT03486808|transcranial direct current stimulation|transcranial direct current stimulation
4660918|NCT03486808|motor function|motor function
4660919|NCT03486795|transcranial direct current stimulation|transcranial direct current stimulation
4660920|NCT03486795|motor function|motor function
4660921|NCT03486782|transcranial direct current stimulation|transcranial direct current stimulation
4660922|NCT03486782|dual stimulation|dual stimulation
4660923|NCT03486769|transcranial direct current stimulation|transcranial direct current stimulation
4660924|NCT03486769|dual stimulation|dual stimulation
4660925|NCT03486756|Asthma|asthma
4660926|NCT03486756|Anxiety|anxiety
4660927|NCT03486756|Stress|stress
4660928|NCT03486743|LARC contraception cultural acceptance|larc contraception cultural acceptance
4660929|NCT03486678|BTC|btc
4660930|NCT03486678|PD-1 antibody|pd-1 antibody
4660931|NCT03486639|Urodynamics|urodynamics
4660932|NCT03486639|Bladder sensation|bladder sensation
4660933|NCT03486639|confounding factors|confounding factors
4660934|NCT03486587|afatinib|afatinib
4660935|NCT03486587|diarrhea|diarrhea
4660936|NCT03486587|Bacillus Cereus|bacillus cereus
4660937|NCT03486587|NSCLC|nsclc
4660938|NCT03486561|Ranolazine|ranolazine
4660939|NCT03486561|Pakistan|pakistan
4660940|NCT03486561|Ischemic Heart Disease|ischemic heart disease
4660941|NCT03486548|popliteal sciatic nerve block|popliteal sciatic nerve block
4660942|NCT03486548|total knee artgroplasty|total knee artgroplasty
4660943|NCT03486548|adductor canal block|adductor canal block
4660944|NCT03486548|dexamethasone|dexamethasone
4660945|NCT03486535|Diabetes mellitus|diabetes mellitus
4660946|NCT03486535|Infraclavicular brachial plexus block|infraclavicular brachial plexus block
4660947|NCT03486535|Block duration|block duration
4660948|NCT03486535|Time-to-first pain|time-to-first pain
4660949|NCT03486535|Postoperative analgesia|postoperative analgesia
4660950|NCT03486522|termination of pregnancy|termination of pregnancy
4660951|NCT03486509|afatinib|afatinib
4660952|NCT03486496|Lung Adenocarcinoma|lung adenocarcinoma
4660953|NCT03486496|EGFR mutation|egfr mutation
4660954|NCT03486496|Gefitinib|gefitinib
4660955|NCT03486496|Berberine|berberine
4660956|NCT03486457|psoriatic arthritis|psoriatic arthritis
4660957|NCT03486457|tofacitinib|tofacitinib
4660958|NCT03486431|Stereotactic Ablative Body Radiotherapy (SABR)|stereotactic ablative body radiotherapy (sabr)
4660959|NCT03486366|epilepsy, TSC, biomarkers, mTOR pathway|epilepsy, tsc, biomarkers, mtor pathway
4660960|NCT03486353|myelodysplastic syndrome (MDS)|myelodysplastic syndrome (mds)
4660961|NCT03486314|Drug therapy|drug therapy
4660962|NCT03486301|TLR|tlr
4660963|NCT03486301|Immuno-oncology|immuno-oncology
4660964|NCT03486288|delirium|delirium
4660965|NCT03486288|postoperative cognitive dysfunction|postoperative cognitive dysfunction
4660966|NCT03486288|spine surgery|spine surgery
4660967|NCT03486288|elderly|elderly
4660968|NCT03486288|neuroinflammation|neuroinflammation
4660969|NCT03486288|magnetic resonance imaging|magnetic resonance imaging
4660970|NCT03486288|resting state fmri|resting state fmri
4660971|NCT03486288|cerebral vasculature|cerebral vasculature
4660972|NCT03486288|quality of life|quality of life
4660973|NCT03486275|GENERAL PRACTICE|general practice
4660974|NCT03486275|SERIOUS GAME|serious game
4660975|NCT03486275|EVIDENCE BASED MEDICINE|evidence based medicine
4660976|NCT03486275|RANDOMIZED CONTROLLED TRIAL|randomized controlled trial
4660977|NCT03486275|PEDAGOGY|pedagogy
4660978|NCT03486262|Lung cancer; Idiopathic pulmonary fibrosis|lung cancer; idiopathic pulmonary fibrosis
4660979|NCT03486249|diaphragm dysfunction|diaphragm dysfunction
4660980|NCT03486249|ventilator weaning|ventilator weaning
4660981|NCT03486249|pulmonary edema|pulmonary edema
4660982|NCT03486171|difficult intubation|difficult intubation
4660983|NCT03486171|prehospital emergency|prehospital emergency
4660984|NCT03486171|risk factors|risk factors
4660985|NCT03486158|Leukocyte L1 Antigen Complex|leukocyte l1 antigen complex
4660986|NCT03486158|Feces|feces
4660987|NCT03486158|Cell Phone|cell phone
4660988|NCT03486158|Biomarkers|biomarkers
4660989|NCT03486158|Recurrence|recurrence
4660990|NCT03486158|Prognosis|prognosis
4660991|NCT03486158|Clinical Chemistry Tests|clinical chemistry tests
4660992|NCT03486145|beetroot juice|beetroot juice
4660993|NCT03486145|nitrates and nitrites|nitrates and nitrites
4660994|NCT03486119|Non -small cell lung cancer|non -small cell lung cancer
4660995|NCT03486093|Venous central catheter|venous central catheter
4660996|NCT03486093|Central line-associated bloodstream infections|central line-associated bloodstream infections
4660997|NCT03486093|Port protector|port protector
4660998|NCT03486093|Respiratory semi-Intensive Care Unit|respiratory semi-intensive care unit
4660999|NCT03486067|Multiple Myeloma|multiple myeloma
4661000|NCT03486067|BCMA X CD3 T Cell|bcma x cd3 t cell
4661001|NCT03486067|Antibody|antibody
4661002|NCT03486067|CC-93269|cc-93269
4661003|NCT03486067|Relapsed and Refractory|relapsed and refractory
4661004|NCT03486054|Anemia|anemia
4661005|NCT03486054|Transfusion|transfusion
4661006|NCT03486054|Pathogen inactivation|pathogen inactivation
4661007|NCT03486054|low-resource|low-resource
4661008|NCT03486054|Sub-saharan Africa|sub-saharan africa
4661009|NCT03486054|Uganda|uganda
4661010|NCT03486054|Transfusion-transmitted infection|transfusion-transmitted infection
4661011|NCT03486054|dose escalation|dose escalation
4661012|NCT03486054|Whole blood|whole blood
4661013|NCT03486028|Patient-Centered Outcomes Research Institute (PCORI)|patient-centered outcomes research institute (pcori)
4661014|NCT03486028|American Society of Addiction Medicine (ASAM)|american society of addiction medicine (asam)
4661015|NCT03486028|substance use|substance use
4661016|NCT03486028|addiction|addiction
4661017|NCT03486028|treatment|treatment
4661018|NCT03486028|RTI International|rti international
4661019|NCT03486028|UCLA|ucla
4661020|NCT03485989|hazelnuts|hazelnuts
4661021|NCT03485989|vitamin E|vitamin e
4661022|NCT03485989|aging|aging
4661023|NCT03485976|Ixekizumab|ixekizumab
4661024|NCT03485976|IL-17|il-17
4661025|NCT03485976|Pityriasis Rubra Pilaris (PRP)|pityriasis rubra pilaris (prp)
4661026|NCT03485950|Other infectious diseases|other infectious diseases
4661027|NCT03485950|Febrile neutropenic adults with cancer|febrile neutropenic adults with cancer
4661028|NCT03485950|Ceftolozane-Tazobactam|ceftolozane-tazobactam
4661029|NCT03485950|Cefepime|cefepime
4661030|NCT03485950|Meropenem|meropenem
4661031|NCT03485950|Piperacillin/Tazobactam|piperacillin/tazobactam
4661032|NCT03485937|anxiety|anxiety
4661033|NCT03485937|patient satisfaction|patient satisfaction
4661034|NCT03485937|video education|video education
4661035|NCT03485937|skin cancer|skin cancer
4661036|NCT03485937|linear closure on the face|linear closure on the face
4661037|NCT03485911|BCX7353|bcx7353
4661038|NCT03485898|UCC|ucc
4661039|NCT03485898|mortality|mortality
4661040|NCT03485898|alzheimer's disease|alzheimer's disease
4661041|NCT03485898|longitudinal study|longitudinal study
4661042|NCT03485885|anthocyanins, maqui berries, bioavailability|anthocyanins, maqui berries, bioavailability
4661043|NCT03485846|hepatitis C|hepatitis c
4661044|NCT03485846|chronic|chronic
4661045|NCT03485846|1b genotype|1b genotype
4661046|NCT03485846|oral treatment|oral treatment
4661047|NCT03485833|end-expiratory occlusion test|end-expiratory occlusion test
4661048|NCT03485833|end-inspiratory occlusion test|end-inspiratory occlusion test
4661049|NCT03485833|transesophageal echocardiography|transesophageal echocardiography
4661050|NCT03485833|passive legs raising|passive legs raising
4661051|NCT03485833|fluid challenge|fluid challenge
4661052|NCT03485820|environmental modifications|environmental modifications
4661053|NCT03485820|activity performance|activity performance
4661054|NCT03485807|stress|stress
4661055|NCT03485807|mindfulness|mindfulness
4661056|NCT03485807|active coping|active coping
4661057|NCT03485781|EEG|eeg
4661058|NCT03485781|Intensive Care|intensive care
4661059|NCT03485781|Propofol|propofol
4661060|NCT03485768|cervical vertigo|cervical vertigo
4661061|NCT03485768|percutaneous disc decompression with coblation nucleoplasty|percutaneous disc decompression with coblation nucleoplasty
4661062|NCT03485768|manual therapy|manual therapy
4661063|NCT03485768|clinical efficacy|clinical efficacy
4661064|NCT03485768|randomized controlled trial|randomized controlled trial
4661065|NCT03485755|microflora|microflora
4661066|NCT03485755|microbiome|microbiome
4661067|NCT03485755|bacteria taxa|bacteria taxa
4661068|NCT03485716|metabolism|metabolism
4661069|NCT03485716|metabolome|metabolome
4661070|NCT03485716|physical activity|physical activity
4661071|NCT03485716|hypoxia|hypoxia
4661072|NCT03485690|COPD|copd
4661073|NCT03485690|Cohort study|cohort study
4661074|NCT03485690|Prospective|prospective
4661075|NCT03485651|adrexal mass|adrexal mass
4661076|NCT03485651|ovarian cancer|ovarian cancer
4661077|NCT03485651|fallopian tube cancer|fallopian tube cancer
4661078|NCT03485651|peritoneal cancer|peritoneal cancer
4661079|NCT03485612|Optic Nerve Sheath Diameter|optic nerve sheath diameter
4661080|NCT03485612|Urological Anaesthesia|urological anaesthesia
4661081|NCT03485612|point of care USG|point of care usg
4661082|NCT03485586|cataract, higher order aberration,vitrectomy,diabetic retinopathy|cataract, higher order aberration,vitrectomy,diabetic retinopathy
4661083|NCT03485560|chronic skin disease|chronic skin disease
4661084|NCT03485560|psoriasis|psoriasis
4661085|NCT03485560|Eczema|eczema
4661086|NCT03485560|atopic dermatitis|atopic dermatitis
4661087|NCT03485547|Blastic Plasmacytoid Dendritic Cell Neoplasm|blastic plasmacytoid dendritic cell neoplasm
4661088|NCT03485547|BPDCN|bpdcn
4661089|NCT03485521|High Fidelity Simulation Training|high fidelity simulation training
4661090|NCT03485521|physiotherapy|physiotherapy
4661091|NCT03485521|tracheobronchial aspiration.|tracheobronchial aspiration.
4661092|NCT03485482|Pharmacokinetic drug interaction|pharmacokinetic drug interaction
4661093|NCT03485482|ivabtadine|ivabtadine
4661094|NCT03485482|bisoprolol|bisoprolol
4661095|NCT03485469|Obesity|obesity
4661096|NCT03485469|bariatric surgery|bariatric surgery
4661097|NCT03485469|Hypnosis|hypnosis
4661098|NCT03485456|Dry powder inhalation|dry powder inhalation
4661099|NCT03485456|Tobramycin|tobramycin
4661100|NCT03485443|fluid infusion|fluid infusion
4661101|NCT03485443|vomiting|vomiting
4661102|NCT03485443|otorhinolaringology|otorhinolaringology
4661103|NCT03485417|stimulant|stimulant
4661104|NCT03485417|psychosis|psychosis
4661105|NCT03485417|schizophrenia|schizophrenia
4661106|NCT03485417|dependence|dependence
4661107|NCT03485417|pharmacotherapy|pharmacotherapy
4661108|NCT03485404|POCD|pocd
4661109|NCT03485404|vitamin B12|vitamin b12
4661110|NCT03485404|folic acid|folic acid
4661111|NCT03485378|Stereotactic|stereotactic
4661112|NCT03485378|Ablative|ablative
4661113|NCT03485378|Radiation|radiation
4661114|NCT03485365|Pain|pain
4661115|NCT03485365|Osteoarthritis of the knee|osteoarthritis of the knee
4661116|NCT03485365|Target engagement|target engagement
4661117|NCT03485365|GSK3858279|gsk3858279
4661118|NCT03485365|Pharmacokinetics|pharmacokinetics
4661119|NCT03485365|Sequential|sequential
4661120|NCT03485352|Bariatric Surgery|bariatric surgery
4661121|NCT03485352|Sleep|sleep
4661122|NCT03485352|Chronotype|chronotype
4661123|NCT03485326|Osimertinib|osimertinib
4661124|NCT03485326|Tagrisso|tagrisso
4661125|NCT03485326|NSCLC|nsclc
4661126|NCT03485326|Non-small cell lung cancer|non-small cell lung cancer
4661127|NCT03485326|Safety|safety
4661128|NCT03485313|Healthy|healthy
4661129|NCT03485313|Volunteer|volunteer
4661133|NCT03485287|MDMA|mdma
4661134|NCT03485287|Psychotherapy|psychotherapy
4661135|NCT03485274|Cannabis|cannabis
4661136|NCT03485274|depression|depression
4661137|NCT03485274|anxiety|anxiety
4661138|NCT03485274|medication|medication
4661139|NCT03485248|HIV/AIDS|hiv/aids
4661140|NCT03485248|Arterial stiffness|arterial stiffness
4661141|NCT03485248|Flow mediated-dilatation|flow mediated-dilatation
4661142|NCT03485248|Muscle oxygenation|muscle oxygenation
4661143|NCT03485248|Exercise performance|exercise performance
4661144|NCT03485248|Dietary Nitrate|dietary nitrate
4661145|NCT03485222|Cardiovascular diseases|cardiovascular diseases
4661146|NCT03485222|Heart Failure|heart failure
4661147|NCT03485222|LV remodeling|lv remodeling
4661148|NCT03485222|SGLT-2 Inhibitors|sglt-2 inhibitors
4661149|NCT03485222|Empagliflozin|empagliflozin
4661150|NCT03485222|Cardiac MRI|cardiac mri
4661151|NCT03485209|Colorectal cancer|colorectal cancer
4661152|NCT03485209|NSCLC|nsclc
4661153|NCT03485209|SCCHN|scchn
4661154|NCT03485209|CRC|crc
4661155|NCT03485209|Pancreatic cancer|pancreatic cancer
4661156|NCT03485209|Head and neck cancer|head and neck cancer
4661157|NCT03485196|Microsatellite Instability|microsatellite instability
4661158|NCT03485196|Fluorouracil|fluorouracil
4661159|NCT03485196|Adjuvant chemotherapy|adjuvant chemotherapy
4661160|NCT03485196|Efficacy|efficacy
4661161|NCT03485196|Operation|operation
4661162|NCT03485183|delirium|delirium
4661163|NCT03485183|white noise|white noise
4661164|NCT03485183|pink noise|pink noise
4661165|NCT03485170|Hemophilia|hemophilia
4661166|NCT03485170|Hemophilic arthropathy|hemophilic arthropathy
4661167|NCT03485170|PET|pet
4661168|NCT03485144|Dengue Vaccine|dengue vaccine
4661169|NCT03485118|Previously untreated DLBCL|previously untreated dlbcl
4661170|NCT03485105|Gastric cancer|gastric cancer
4661171|NCT03485105|biomarker|biomarker
4661172|NCT03485105|chemotherapy|chemotherapy
4661173|NCT03485105|precise medicine|precise medicine
4661174|NCT03485092|heart failure|heart failure
4661175|NCT03485092|diabetes mellitus|diabetes mellitus
4661176|NCT03485092|empagliflozin|empagliflozin
4661177|NCT03485092|Randomised, placebo controlled trial|randomised, placebo controlled trial
4661178|NCT03485040|Rehabilitation|rehabilitation
4661179|NCT03485040|Neurorehabilitation|neurorehabilitation
4661180|NCT03485040|Neurotechnology|neurotechnology
4661181|NCT03485040|Neurorecovery|neurorecovery
4661182|NCT03485040|Neurorestoration|neurorestoration
4661183|NCT03484988|Polyunsaturated fatty acids|polyunsaturated fatty acids
4661184|NCT03484988|Echium oil|echium oil
4661185|NCT03484988|Hyperlipidemias|hyperlipidemias
4661186|NCT03484988|Metabolites|metabolites
4661187|NCT03484988|Gut Microbiota|gut microbiota
4661188|NCT03484962|activated CIK|activated cik
4661189|NCT03484962|MUC1|muc1
4661190|NCT03484962|bispecific antibody|bispecific antibody
4661191|NCT03484962|liver cancer|liver cancer
4661192|NCT03484949|Gastric cancer|gastric cancer
4661193|NCT03484949|Screening|screening
4661194|NCT03484949|Risk assessment|risk assessment
4661195|NCT03484936|Intracranial Hemorrhages|intracranial hemorrhages
4661196|NCT03484936|remote ischemic conditioning|remote ischemic conditioning
4661197|NCT03484923|Unresectable|unresectable
4661198|NCT03484923|melanoma|melanoma
4661199|NCT03484923|metastatic melanoma|metastatic melanoma
4661200|NCT03484923|advanced melanoma|advanced melanoma
4661201|NCT03484923|spartalizumab|spartalizumab
4661202|NCT03484923|PDR001|pdr001
4661203|NCT03484923|LAG525|lag525
4661204|NCT03484923|capmatinib|capmatinib
4661205|NCT03484923|INC280|inc280
4661206|NCT03484923|canakinumab|canakinumab
4661207|NCT03484923|ACZ885|acz885
4661208|NCT03484923|immunotherapy|immunotherapy
4661209|NCT03484923|platform study|platform study
4661210|NCT03484884|nodal metastases|nodal metastases
4661211|NCT03484884|17-538|17-538
4661212|NCT03484884|Memorial Sloan Kettering Cancer Center|memorial sloan kettering cancer center
4661213|NCT03484793|AESOP Model|aesop model
4661214|NCT03484793|Big data|big data
4661215|NCT03484793|medication error|medication error
4661216|NCT03484793|data mining|data mining
4661217|NCT03484793|patient safety|patient safety
4661218|NCT03484793|CPOE|cpoe
4661219|NCT03484793|CDSS|cdss
4661220|NCT03484793|alarm fatigue|alarm fatigue
4661221|NCT03484793|association rule mining.|association rule mining.
4661222|NCT03484780|Implantable Heart Failure Device Therapy|implantable heart failure device therapy
4661223|NCT03484780|Asymptomatic Diaphragmatic Stimulation|asymptomatic diaphragmatic stimulation
4661224|NCT03484767|methylmalonic acidemia|methylmalonic acidemia
4661225|NCT03484767|MMA|mma
4661226|NCT03484767|organic acidemia|organic acidemia
4661227|NCT03484767|mut deficiency|mut deficiency
4661228|NCT03484767|inborn errors of metabolism|inborn errors of metabolism
4661229|NCT03484767|mut0|mut0
4661230|NCT03484767|mut-|mut-
4661231|NCT03484767|PA|pa
4661232|NCT03484767|PCCA|pcca
4661233|NCT03484767|PCCB|pccb
4661234|NCT03484767|propionic acidemia|propionic acidemia
4661235|NCT03484728|Conditional pain modulation|conditional pain modulation
4661236|NCT03484728|pain|pain
4661237|NCT03484728|placebo|placebo
4661238|NCT03484715|Physical Activity|physical activity
4661239|NCT03484715|Nursing Home|nursing home
4661240|NCT03484715|Feasibility|feasibility
4661241|NCT03484715|Older Adults|older adults
4661242|NCT03484702|Non-Hodgkin lymphoma|non-hodgkin lymphoma
4661243|NCT03484702|Aggressive B-cell non-Hodgkin lymphoma|aggressive b-cell non-hodgkin lymphoma
4661244|NCT03484702|Diffuse large B-cell lymphoma|diffuse large b-cell lymphoma
4661245|NCT03484702|Relapse / refractory lymphoma|relapse / refractory lymphoma
4661246|NCT03484702|Transplant not eligible|transplant not eligible
4661247|NCT03484702|Double-hit lymphoma|double-hit lymphoma
4661248|NCT03484702|Triple-hit lymphoma|triple-hit lymphoma
4661249|NCT03484702|Primary/secondary central nervous system lymphoma|primary/secondary central nervous system lymphoma
4661250|NCT03484702|Richter's transformation/syndrome|richter's transformation/syndrome
4661251|NCT03484702|Transformed follicular lymphoma|transformed follicular lymphoma
4661252|NCT03484702|Follicular lymphoma Grade 3B|follicular lymphoma grade 3b
4661253|NCT03484702|JCAR017|jcar017
4661254|NCT03484702|CAR T cell therapy|car t cell therapy
4661255|NCT03484702|CD19 targeted therapy.|cd19 targeted therapy.
4661256|NCT03484702|Efficacy and safety|efficacy and safety
4661257|NCT03484702|Europe / Japan|europe / japan
4661258|NCT03484702|TPTD|tptd
4661259|NCT03484689|Diabetes-related distress|diabetes-related distress
4661260|NCT03484689|Mindfulness|mindfulness
4661261|NCT03484637|motivation|motivation
4661262|NCT03484637|Treatment adherence|treatment adherence
4661263|NCT03484637|Waist circumference|waist circumference
4661264|NCT03484637|obesity|obesity
4661265|NCT03484637|overweight|overweight
4661266|NCT03484624|Muscle; Fatigue|muscle; fatigue
4661267|NCT03484624|Wearable hip assist robot|wearable hip assist robot
4661268|NCT03484624|Metabolic energy expenditure|metabolic energy expenditure
4661269|NCT03484585|Mass Balance, metabolism and excretion pattern|mass balance, metabolism and excretion pattern
4661270|NCT03484559|In-hospital Cardiac Arrest|in-hospital cardiac arrest
4661271|NCT03484546|ovarian reserve|ovarian reserve
4661272|NCT03484546|endometriosis|endometriosis
4661273|NCT03484546|endometrioma|endometrioma
4661274|NCT03484520|Cancer, Acute Myeloid Leukemia (AML), venetoclax, dinaciclib, Relapsed/refractory AML, Pharmacokinetics, Venetoclax, Dinaciclib|cancer, acute myeloid leukemia (aml), venetoclax, dinaciclib, relapsed/refractory aml, pharmacokinetics, venetoclax, dinaciclib
4661275|NCT03484494|Geriatric|geriatric
4661276|NCT03484494|Low Field Magnetic Stimulation|low field magnetic stimulation
4661277|NCT03484494|Antidepressant|antidepressant
4661278|NCT03484494|fMRI|fmri
4661279|NCT03484494|MRS|mrs
4661280|NCT03484468|lasik|lasik
4661281|NCT03484468|flap_thickness|flap_thickness
4661282|NCT03484468|femtosecond|femtosecond
4661283|NCT03484468|laser|laser
4661284|NCT03484468|moria|moria
4661285|NCT03484468|microkeratome|microkeratome
4661286|NCT03484429|Neurostimulation|neurostimulation
4661287|NCT03484429|Peripheral nerve stimulation|peripheral nerve stimulation
4661288|NCT03484390|mindfulness|mindfulness
4661289|NCT03484390|posttraumatic stress disorder|posttraumatic stress disorder
4661290|NCT03484351|Falls|falls
4661291|NCT03484325|Registry|registry
4661292|NCT03484325|Joint Registry|joint registry
4661293|NCT03484325|OA|oa
4661294|NCT03484325|Osteoarthritis|osteoarthritis
4661295|NCT03484325|Osteo arthritis|osteo arthritis
4661296|NCT03484325|knee|knee
4661297|NCT03484325|hip|hip
4661298|NCT03484325|tka|tka
4661299|NCT03484325|tha|tha
4661300|NCT03484273|Tilt Table|tilt table
4661301|NCT03484273|Compression|compression
4661302|NCT03484273|Dysautonomia|dysautonomia
4661303|NCT03484273|POTS|pots
4661304|NCT03484260|Risk factors predicting the initiation of testosterone use|risk factors predicting the initiation of testosterone use
4661305|NCT03484247|infraclavicular block|infraclavicular block
4661306|NCT03484247|axillary block|axillary block
4661307|NCT03484234|Drug eluting stent|drug eluting stent
4661308|NCT03484234|everolimus eluting stent|everolimus eluting stent
4661309|NCT03484234|sirolimus eluting stent|sirolimus eluting stent
4661310|NCT03484182|Upper extremity|upper extremity
4661311|NCT03484182|Stroke|stroke
4661312|NCT03484182|Web-based program|web-based program
4661313|NCT03484182|Home exercise training|home exercise training
4661314|NCT03484169|Muscle Stretching Exercises|muscle stretching exercises
4661315|NCT03484169|Pelvic Floor|pelvic floor
4661316|NCT03484169|motor control|motor control
4661317|NCT03484169|motor skill|motor skill
4661318|NCT03484169|motor activity|motor activity
4661319|NCT03484156|Elderly|elderly
4661320|NCT03484156|Frailty|frailty
4661321|NCT03484156|Tele-monitoring|tele-monitoring
4661322|NCT03484156|Disability|disability
4661323|NCT03484143|Moderate to Severe Alzheimer's Disease,|moderate to severe alzheimer's disease,
4661324|NCT03484130|primary aldosteronism|primary aldosteronism
4661325|NCT03484104|Cardiopulmonary bypass|cardiopulmonary bypass
4661326|NCT03484104|Hypothermic circulatory arrest|hypothermic circulatory arrest
4661327|NCT03484104|Aortic arch surgery|aortic arch surgery
4661328|NCT03484091|Hyruan-One|hyruan-one
4661329|NCT03484091|Hylan G-F 20|hylan g-f 20
4661330|NCT03484091|Hyaluronic acid|hyaluronic acid
4661331|NCT03484091|Knee osteoarthritis|knee osteoarthritis
4661332|NCT03484091|Pain level|pain level
4661333|NCT03484065|Congenital fibrinogen disorders|congenital fibrinogen disorders
4661334|NCT03484039|memory problems|memory problems
4661335|NCT03484039|stress|stress
4661336|NCT03484039|depression|depression
4661337|NCT03484039|adherence|adherence
4661338|NCT03484039|seizure documentation|seizure documentation
4661339|NCT03484026|Iron Deficiency|iron deficiency
4661340|NCT03484026|Anemia|anemia
4661341|NCT03484026|Medical Food|medical food
4661342|NCT03483987|Hepatitis c virus|hepatitis c virus
4661343|NCT03483987|Direct acting antiviral drugs|direct acting antiviral drugs
4661344|NCT03483987|Virological relapse|virological relapse
4661345|NCT03483974|Hyperspectrum, excreta, neoplasm,|hyperspectrum, excreta, neoplasm,
4661346|NCT03483909|gesture|gesture
4661347|NCT03483909|rTMS|rtms
4661348|NCT03483909|nonverbal communication|nonverbal communication
4661349|NCT03483909|schizophrenia|schizophrenia
4661350|NCT03483909|psychosis|psychosis
4661351|NCT03483870|Granisetron, serum serotonin, morphine|granisetron, serum serotonin, morphine
4661352|NCT03483857|Peer Navigation|peer navigation
4661353|NCT03483844|scoliosis|scoliosis
4661354|NCT03483844|low dose|low dose
4661355|NCT03483844|arthrodesis|arthrodesis
4661356|NCT03483844|dual-energy CT|dual-energy ct
4661357|NCT03483818|Community Pharmacy|community pharmacy
4661358|NCT03483818|Antiviral Therapy|antiviral therapy
4661359|NCT03483805|synbiotic|synbiotic
4661360|NCT03483805|nutrition|nutrition
4661361|NCT03483805|permeability|permeability
4661362|NCT03483805|gluten free diet|gluten free diet
4661363|NCT03483805|quality of life|quality of life
4661364|NCT03483805|digestive comfort|digestive comfort
4661365|NCT03483792|PCOS|pcos
4661366|NCT03483792|AMH|amh
4661367|NCT03483792|Pregnancy|pregnancy
4661368|NCT03483792|Heritability|heritability
4661369|NCT03483792|LH|lh
4661370|NCT03483753|Vasopressin|vasopressin
4661371|NCT03483753|Norepinephrine|norepinephrine
4661372|NCT03483753|Post-operative|post-operative
4661373|NCT03483753|Critical Care|critical care
4661374|NCT03483740|HIV-Associated Neurocognitive Disorder (HAND)|hiv-associated neurocognitive disorder (hand)
4661375|NCT03483740|Cognitive remediation group therapy|cognitive remediation group therapy
4661376|NCT03483740|Mutual aid group therapy|mutual aid group therapy
4661377|NCT03483714|Manipulation|manipulation
4661378|NCT03483714|Spinal|spinal
4661379|NCT03483714|electromyography|electromyography
4661380|NCT03483714|kinetics|kinetics
4661381|NCT03483714|kinematic|kinematic
4661382|NCT03483701|Cognitive Remediation Therapy|cognitive remediation therapy
4661383|NCT03483688|B-cell Non-Hodgkin Lymphoma|b-cell non-hodgkin lymphoma
4661384|NCT03483688|Refractory|refractory
4661385|NCT03483688|Relapsed|relapsed
4661386|NCT03483662|hypertension|hypertension
4661387|NCT03483662|blood pressure|blood pressure
4661388|NCT03483662|medication adherence|medication adherence
4661389|NCT03483662|lifestyle modification|lifestyle modification
4661390|NCT03483662|blood pressure control|blood pressure control
4661391|NCT03483662|implementation|implementation
4661392|NCT03483636|Drug-alcohol interaction|drug-alcohol interaction
4661393|NCT03483636|Lemborexant|lemborexant
4661394|NCT03483636|E2006|e2006
4661395|NCT03483636|Postural stability|postural stability
4661396|NCT03483636|Cognitive performance|cognitive performance
4661397|NCT03483623|NATO Litter|nato litter
4661398|NCT03483623|Dolphin Fluid Immersion System|dolphin fluid immersion system
4661399|NCT03483623|Raven 90C litter|raven 90c litter
4661400|NCT03483623|Laser doppler pressure monitor|laser doppler pressure monitor
4661401|NCT03483623|Transcutanous oxygenation|transcutanous oxygenation
4661402|NCT03483623|WELP mattress|welp mattress
4661403|NCT03483571|asymptomatic|asymptomatic
4661404|NCT03483571|submicroscopic|submicroscopic
4661405|NCT03483571|PCR|pcr
4661406|NCT03483558|vegetable metabolite signature|vegetable metabolite signature
4661407|NCT03483558|human serum/urinary metabolite|human serum/urinary metabolite
4661408|NCT03483558|liquid chromatography mass spectrometry|liquid chromatography mass spectrometry
4661409|NCT03483545|Ovarian Response|ovarian response
4661410|NCT03483545|In vitro fertilization|in vitro fertilization
4661411|NCT03483545|Controlled ovarian stimulation|controlled ovarian stimulation
4661412|NCT03483532|lithiasis|lithiasis
4661413|NCT03483532|uric acid|uric acid
4661414|NCT03483532|crystallization|crystallization
4661415|NCT03483493|Tic disorders|tic disorders
4661416|NCT03483493|Tourette Syndrome|tourette syndrome
4661417|NCT03483493|Online delivered therapy|online delivered therapy
4661418|NCT03483454|exercise, fitness, sleep, children, obesity|exercise, fitness, sleep, children, obesity
4661419|NCT03483402|Pseudoexfoliation Glaucoma|pseudoexfoliation glaucoma
4661420|NCT03483402|Primary Open-angle Glaucoma|primary open-angle glaucoma
4661421|NCT03483402|Micropulse Laser Trabeculoplasty|micropulse laser trabeculoplasty
4661422|NCT03483402|Intraocular Pressure|intraocular pressure
4661423|NCT03483376|black stain|black stain
4661424|NCT03483376|dental plaque|dental plaque
4661425|NCT03483376|antimicrobial photodynamic therapy|antimicrobial photodynamic therapy
4661426|NCT03483376|curcumin|curcumin
4661427|NCT03483376|tooth discoloration|tooth discoloration
4661428|NCT03483337|(DW)-MRI|(dw)-mri
4661429|NCT03483337|oncological biomarkers|oncological biomarkers
4661430|NCT03483337|18-053|18-053
4661431|NCT03483285|intubation|intubation
4661432|NCT03483285|airtraq|airtraq
4661433|NCT03483285|open heart surgery|open heart surgery
4661637|NCT03481959|Cannabis|cannabis
4661434|NCT03483285|hemodynamic parameters|hemodynamic parameters
4661435|NCT03483272|Terlipressin|terlipressin
4661436|NCT03483272|Pharmacological respons|pharmacological respons
4661437|NCT03483272|Magnetic Resonance Imaging|magnetic resonance imaging
4661438|NCT03483272|Hemodynamic assessments|hemodynamic assessments
4661439|NCT03483272|Echocardiography|echocardiography
4661440|NCT03483272|Hepatorenal syndrome - acute kidney injury|hepatorenal syndrome - acute kidney injury
4661441|NCT03483259|Pharmacokinetics|pharmacokinetics
4661442|NCT03483259|Relative bioavailability|relative bioavailability
4661443|NCT03483246|Ulcerative colitis|ulcerative colitis
4661444|NCT03483246|Inflammatory bowel disease|inflammatory bowel disease
4661445|NCT03483246|Fecal microbiota transplantation|fecal microbiota transplantation
4661446|NCT03483233|Gyrus Cinguli|gyrus cinguli
4661447|NCT03483233|Cognitive Control Process|cognitive control process
4661448|NCT03483233|Check process|check process
4661449|NCT03483233|Decision Making|decision making
4661450|NCT03483233|fMRI|fmri
4661451|NCT03483220|Addiction, MRI, Decision making|addiction, mri, decision making
4661452|NCT03483194|Therapeutic Virtual Reality|therapeutic virtual reality
4661453|NCT03483194|Pain related medical procedure management|pain related medical procedure management
4661454|NCT03483194|Anxiety management|anxiety management
4661455|NCT03483194|Osteo-medullary biopsy|osteo-medullary biopsy
4661456|NCT03483116|Dose ranging|dose ranging
4661457|NCT03483116|Neonatal vaccine|neonatal vaccine
4661458|NCT03483116|RV3-BB vaccine|rv3-bb vaccine
4661459|NCT03483103|JCAR017|jcar017
4661460|NCT03483103|lisocabtagene maraleucel|lisocabtagene maraleucel
4661461|NCT03483103|NHL|nhl
4661462|NCT03483103|chimeric antigen receptor|chimeric antigen receptor
4661463|NCT03483103|CAR|car
4661464|NCT03483103|CAR T cell|car t cell
4661465|NCT03483103|autologous T cell therapy|autologous t cell therapy
4661466|NCT03483103|immunotherapy|immunotherapy
4661467|NCT03483103|cell therapy|cell therapy
4661468|NCT03483103|liso-cel|liso-cel
4661469|NCT03483090|mild|mild
4661470|NCT03483090|moderate|moderate
4661471|NCT03483090|krill oil|krill oil
4661472|NCT03483090|pain|pain
4661473|NCT03483090|osteoarthritis|osteoarthritis
4661474|NCT03483090|supplement|supplement
4661475|NCT03483051|aortic stenosis, aortic valve replacement|aortic stenosis, aortic valve replacement
4661476|NCT03483038|pancreatic adenocarcinoma|pancreatic adenocarcinoma
4661477|NCT03483038|neoadjuvant|neoadjuvant
4661478|NCT03483038|ONIVYDE|onivyde
4661479|NCT03483038|chemotherapy|chemotherapy
4661480|NCT03483038|borderline resectable|borderline resectable
4661481|NCT03483012|Breast Cancer|breast cancer
4661482|NCT03482986|Diet|diet
4661483|NCT03482986|Dietary Habits|dietary habits
4661484|NCT03482986|Weight changes|weight changes
4661485|NCT03482973|Cardiopulmonary Bypass|cardiopulmonary bypass
4661486|NCT03482973|Cardiac Surgery|cardiac surgery
4661487|NCT03482973|Sternotomy|sternotomy
4661488|NCT03482960|imaging|imaging
4661489|NCT03482960|hyperpolarized|hyperpolarized
4661490|NCT03482960|perfluorinated|perfluorinated
4661491|NCT03482960|MRI|mri
4661492|NCT03482960|lung|lung
4661493|NCT03482947|Dexmedetomidine|dexmedetomidine
4661494|NCT03482947|pediatrics; postoperative;|pediatrics; postoperative;
4661495|NCT03482947|Analgesia; caudal|analgesia; caudal
4661496|NCT03482908|Responsive parenting|responsive parenting
4661497|NCT03482895|Gastric Bypass|gastric bypass
4661498|NCT03482895|Intestinal Absorption|intestinal absorption
4661499|NCT03482895|Gastrointestinal Hormones|gastrointestinal hormones
4661500|NCT03482895|Enteroendocrine Cells|enteroendocrine cells
4661501|NCT03482869|walking impairment|walking impairment
4661502|NCT03482869|disability|disability
4661503|NCT03482869|diabetes mellitus|diabetes mellitus
4661504|NCT03482830|Inflammation|inflammation
4661505|NCT03482830|Insulin-glucose homeostasis|insulin-glucose homeostasis
4661506|NCT03482830|Hypothalamic-pituitary-adrenal axis|hypothalamic-pituitary-adrenal axis
4661507|NCT03482830|Endothelial function and damage|endothelial function and damage
4661508|NCT03482830|Thyroid hormones|thyroid hormones
4661509|NCT03482778|PROMIS|promis
4661510|NCT03482778|AYA|aya
4661511|NCT03482778|ONCOLOGY|oncology
4661512|NCT03482778|HRQOL|hrqol
4661513|NCT03482778|Adolescent and Young Adult|adolescent and young adult
4661514|NCT03482778|Health Related Quality of Life Measurement|health related quality of life measurement
4661515|NCT03482778|Patient-Reported Outcomes Measurement Information System|patient-reported outcomes measurement information system
4661516|NCT03482739|HPV|hpv
4661517|NCT03482739|Vaccine|vaccine
4661518|NCT03482739|HIV|hiv
4661519|NCT03482739|Solid organ transplantation|solid organ transplantation
4661520|NCT03482726|bicycle|bicycle
4661521|NCT03482726|cadence|cadence
4661522|NCT03482726|cyclist|cyclist
4661523|NCT03482726|modulation|modulation
4661524|NCT03482700|COPD; GP Surgeries|copd; gp surgeries
4661525|NCT03482687|adolescent behavior|adolescent behavior
4661526|NCT03482687|interpersonal relationships|interpersonal relationships
4661527|NCT03482687|intimate partner violence|intimate partner violence
4661528|NCT03482687|violence/prevention & control|violence/prevention & control
4661529|NCT03482687|program evaluation|program evaluation
4661530|NCT03482687|teen dating violence|teen dating violence
4661531|NCT03482674|Health literacy|health literacy
4661532|NCT03482674|Innovation Fund|innovation fund
4661533|NCT03482674|lifestyle intervention|lifestyle intervention
4661534|NCT03482674|risk screening|risk screening
4661535|NCT03482674|type 2 diabetes mellitus|type 2 diabetes mellitus
4661536|NCT03482674|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
4661537|NCT03482661|Magnetic steering|magnetic steering
4661538|NCT03482661|MCE|mce
4661539|NCT03482661|CECR|cecr
4661540|NCT03482648|Pellino-1|pellino-1
4661541|NCT03482622|Raman spectroscopy|raman spectroscopy
4661542|NCT03482596|Sedentary Behaviour|sedentary behaviour
4661543|NCT03482596|Prevention|prevention
4661544|NCT03482583|Smoking, Cancer, Treatment|smoking, cancer, treatment
4661545|NCT03482570|Activity behaviors|activity behaviors
4661546|NCT03482570|Malignant pleural effusion|malignant pleural effusion
4661547|NCT03482557|Breast Cancer|breast cancer
4661548|NCT03482557|screening|screening
4661549|NCT03482557|breast MRI|breast mri
4661550|NCT03482557|contrast enhanced spectral mammography|contrast enhanced spectral mammography
4661551|NCT03482544|pregabalin|pregabalin
4661552|NCT03482544|ischemia reperfusion injury|ischemia reperfusion injury
4661553|NCT03482544|muscle|muscle
4661554|NCT03482531|limit nocturnal activity|limit nocturnal activity
4661555|NCT03482531|cervical ripening|cervical ripening
4661556|NCT03482492|Acetaminophen|acetaminophen
4661557|NCT03482492|Tramadol|tramadol
4661558|NCT03482492|Discogenic pain|discogenic pain
4661559|NCT03482492|Lumbar Discectomy|lumbar discectomy
4661560|NCT03482453|Drug Therapy|drug therapy
4661561|NCT03482440|preeclampsia|preeclampsia
4661562|NCT03482440|microvascular|microvascular
4661563|NCT03482440|inflammation|inflammation
4661564|NCT03482440|angiotensin II|angiotensin ii
4661565|NCT03482414|stroke|stroke
4661566|NCT03482414|upper limb rehabilitation|upper limb rehabilitation
4661567|NCT03482414|neuro-rehabilitation|neuro-rehabilitation
4661568|NCT03482401|Polyphenol|polyphenol
4661569|NCT03482401|Methylxanthine|methylxanthine
4661570|NCT03482401|Metabolism|metabolism
4661571|NCT03482401|Breast tissue|breast tissue
4661572|NCT03482401|Disposition|disposition
4661573|NCT03482401|UPLC-QTOF|uplc-qtof
4661574|NCT03482388|Hepatitis|hepatitis
4661575|NCT03482388|Hepatitis B|hepatitis b
4661576|NCT03482388|Hepatitis C|hepatitis c
4661577|NCT03482388|Men who have sex with men|men who have sex with men
4661578|NCT03482388|Crowdsourcing|crowdsourcing
4661579|NCT03482388|China|china
4661580|NCT03482388|Testing|testing
4661581|NCT03482375|Gall Stones|gall stones
4661582|NCT03482375|ERCP|ercp
4661583|NCT03482375|Cholangioscopy|cholangioscopy
4661584|NCT03482362|vinorelbine|vinorelbine
4661585|NCT03482336|labeling|labeling
4661586|NCT03482336|Front of pack|front of pack
4661587|NCT03482336|nutrition|nutrition
4661588|NCT03482336|nutrition facts panel|nutrition facts panel
4661589|NCT03482310|Brain computer interface|brain computer interface
4661590|NCT03482310|electric stimulation|electric stimulation
4661592|NCT03482258|Galactooligosaccharide|galactooligosaccharide
4661593|NCT03482258|Prebiotic|prebiotic
4661594|NCT03482258|Early life stress|early life stress
4661595|NCT03482258|Emotional eating|emotional eating
4661596|NCT03482258|Gut microbiota|gut microbiota
4661597|NCT03482258|Short-chain fatty acids|short-chain fatty acids
4661598|NCT03482258|Serotonin|serotonin
4661599|NCT03482258|Cortisol|cortisol
4661600|NCT03482245|pneumonia|pneumonia
4661601|NCT03482245|appendicitis|appendicitis
4661602|NCT03482245|diverticulitis|diverticulitis
4661603|NCT03482245|circadian rhythms|circadian rhythms
4661604|NCT03482245|blue light|blue light
4661605|NCT03482245|sepsis|sepsis
4661606|NCT03482232|patient safety|patient safety
4661607|NCT03482232|quality assurance|quality assurance
4661608|NCT03482232|overuse|overuse
4661609|NCT03482167|blood pressure|blood pressure
4661610|NCT03482167|arterial stiffness|arterial stiffness
4661611|NCT03482167|cerebrovascular function|cerebrovascular function
4661612|NCT03482167|cognitive function|cognitive function
4661613|NCT03482128|transfusion|transfusion
4661614|NCT03482128|coagulation|coagulation
4661615|NCT03482128|cardiac surgery|cardiac surgery
4661616|NCT03482115|coma|coma
4661617|NCT03482115|traumatic brain injury|traumatic brain injury
4661618|NCT03482115|anoxic encephalopathy|anoxic encephalopathy
4661619|NCT03482115|brain connectome|brain connectome
4661620|NCT03482115|neuroinflammation|neuroinflammation
4661621|NCT03482115|prognosis|prognosis
4661622|NCT03482102|Hepatocellular Carcinoma|hepatocellular carcinoma
4661623|NCT03482102|Biliary Tract Cancer|biliary tract cancer
4661624|NCT03482063|B vitamin|b vitamin
4661625|NCT03482063|herbal supplement|herbal supplement
4661626|NCT03482063|attention|attention
4661627|NCT03482011|Psoriasis|psoriasis
4661628|NCT03482011|IL-23|il-23
4661629|NCT03481998|CDK4/6 inhibitor|cdk4/6 inhibitor
4661630|NCT03481998|Breast cancer|breast cancer
4661631|NCT03481998|Postmenopausal women|postmenopausal women
4661632|NCT03481998|Hormone-receptor positive|hormone-receptor positive
4661633|NCT03481998|HER2 negative|her2 negative
4661634|NCT03481985|Fontan-associated liver disease|fontan-associated liver disease
4661635|NCT03481959|TDAH|tdah
4661636|NCT03481959|Methylphenidate|methylphenidate
4661638|NCT03481920|pancreatic cancer, inmunotherapy|pancreatic cancer, inmunotherapy
4661639|NCT03481907|collagen powder|collagen powder
4661640|NCT03481907|punch biopsy wound|punch biopsy wound
4661641|NCT03481894|Parenteral nutrition|parenteral nutrition
4661642|NCT03481894|Malnutrition|malnutrition
4661643|NCT03481894|Pediatrics|pediatrics
4661644|NCT03481894|nutritional needs|nutritional needs
4661645|NCT03481881|pharmacokinetics|pharmacokinetics
4661646|NCT03481868|chronic myeloid leukemia|chronic myeloid leukemia
4661647|NCT03481868|epigenetic|epigenetic
4661648|NCT03481868|leukemic stem cell|leukemic stem cell
4661649|NCT03481842|Endometriosis|endometriosis
4661650|NCT03481842|VEGF(R)|vegf(r)
4661651|NCT03481829|American Indians|american indians
4661652|NCT03481829|Obesity|obesity
4661653|NCT03481829|Pregnancy|pregnancy
4661654|NCT03481829|Diabetes|diabetes
4661655|NCT03481829|Children|children
4661656|NCT03481816|mCRPC|mcrpc
4661657|NCT03481816|Therapeutic Cancer Vaccines|therapeutic cancer vaccines
4661658|NCT03481816|ETBX-071|etbx-071
4661659|NCT03481816|ETBX-061|etbx-061
4661660|NCT03481816|ETBX-051|etbx-051
4661661|NCT03481803|Exocrine Pancreatic Insufficiency|exocrine pancreatic insufficiency
4661662|NCT03481790|iron deficiency anemia of pregnancy - lactoferrin|iron deficiency anemia of pregnancy - lactoferrin
4661663|NCT03481777|Remote Ischemic Conditioning|remote ischemic conditioning
4661664|NCT03481777|Neuroprotection|neuroprotection
4661665|NCT03481764|febrile seizure|febrile seizure
4661666|NCT03481764|HRC-test|hrc-test
4661667|NCT03481764|genetic variation|genetic variation
4661668|NCT03481764|epilepsy|epilepsy
4661669|NCT03481751|Crohn Disease|crohn disease
4661670|NCT03481751|Ultrasound|ultrasound
4661671|NCT03481751|Monitoring|monitoring
4661672|NCT03481751|Disease activity|disease activity
4661673|NCT03481738|Glycolytic enzymopathy|glycolytic enzymopathy
4661674|NCT03481738|Congenital Non-spherocytic hemolytic anemia (CNSA)|congenital non-spherocytic hemolytic anemia (cnsa)
4661675|NCT03481699|Adolescence|adolescence
4661676|NCT03481699|Prevention|prevention
4661677|NCT03481699|Emotional disorders|emotional disorders
4661678|NCT03481699|Aggressive behavior|aggressive behavior
4661679|NCT03481686|Erythropoiesis|erythropoiesis
4661680|NCT03481686|stimulating|stimulating
4661681|NCT03481686|agents|agents
4661682|NCT03481686|therapeutic|therapeutic
4661683|NCT03481686|education|education
4661684|NCT03481686|program|program
4661685|NCT03481673|Childhood Asthma|childhood asthma
4661686|NCT03481673|Childhood Anxiety|childhood anxiety
4661687|NCT03481673|Childhood Depression|childhood depression
4661688|NCT03481673|Childhood Quality of Life|childhood quality of life
4661689|NCT03481660|Diabetic Macular Edema|diabetic macular edema
4661690|NCT03481660|intravitreal injection|intravitreal injection
4661691|NCT03481660|brolucizumab|brolucizumab
4661692|NCT03481660|aflibercept|aflibercept
4661693|NCT03481660|double-masked|double-masked
4661694|NCT03481634|Diabetic Macular Edema|diabetic macular edema
4661695|NCT03481634|intravitreal injection|intravitreal injection
4661696|NCT03481634|brolucizumab|brolucizumab
4661697|NCT03481634|aflibercept|aflibercept
4661698|NCT03481634|double-masked|double-masked
4661699|NCT03481621|Vulvodynia|vulvodynia
4661700|NCT03481608|fatty acid|fatty acid
4661701|NCT03481608|nutrition|nutrition
4661702|NCT03481608|metabolism|metabolism
4661703|NCT03481608|lauric acid|lauric acid
4661704|NCT03481608|dilauroylphosphatidylcholine|dilauroylphosphatidylcholine
4661705|NCT03481608|lrh-1|lrh-1
4661706|NCT03481582|Nitroglycerin Trans-dermal Patch|nitroglycerin trans-dermal patch
4661707|NCT03481543|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
4661708|NCT03481543|Nebulization|nebulization
4661709|NCT03481543|Respiratory failure|respiratory failure
4661710|NCT03481543|Non-invasive ventilation(NIV)|non-invasive ventilation(niv)
4661711|NCT03481517|adult|adult
4661712|NCT03481517|appendectomy|appendectomy
4661713|NCT03481517|appendicitis|appendicitis
4661714|NCT03481517|local anesthesia|local anesthesia
4661715|NCT03481517|pain|pain
4661716|NCT03481491|Cerebellum|cerebellum
4661717|NCT03481491|Striatum|striatum
4661718|NCT03481491|Human|human
4661719|NCT03481491|fMRI|fmri
4661720|NCT03481491|Transcranial magnetic stimulation|transcranial magnetic stimulation
4661721|NCT03481491|Genetic dystonia|genetic dystonia
4661722|NCT03481478|occult|occult
4661723|NCT03481478|proximal humeral neck fractures|proximal humeral neck fractures
4661724|NCT03481478|greater tuberosity|greater tuberosity
4661725|NCT03481478|shoulder dislocation|shoulder dislocation
4661726|NCT03481465|Biomarkers|biomarkers
4661727|NCT03481465|Hepatic dysfunction|hepatic dysfunction
4661728|NCT03481465|Metabolic dysfunction|metabolic dysfunction
4661729|NCT03481465|Endothelial dysfunction|endothelial dysfunction
4661730|NCT03481465|Antipsychotics|antipsychotics
4661731|NCT03481465|Non-alcoholic fatty liver disease|non-alcoholic fatty liver disease
4661732|NCT03481452|anxiety|anxiety
4661733|NCT03481452|regulation of states|regulation of states
4661734|NCT03481452|NBO|nbo
4661735|NCT03481452|HAMA|hama
4661736|NCT03481439|Pharmacist|pharmacist
4661737|NCT03481439|Led medication review|led medication review
4661738|NCT03481439|Orthopaedic surgery|orthopaedic surgery
4661739|NCT03481439|Traumatology|traumatology
4661740|NCT03481426|musculoskelelal disorder|musculoskelelal disorder
4661741|NCT03481426|occupational health service|occupational health service
4661742|NCT03481400|Calcitonin gene-related peptide|calcitonin gene-related peptide
4661743|NCT03481361|Obstructive sleep apnoea (OSA)|obstructive sleep apnoea (osa)
4661744|NCT03481361|Type 1 diabetes (T1D)|type 1 diabetes (t1d)
4661745|NCT03481361|Type 2 diabetes (T2D)|type 2 diabetes (t2d)
4661746|NCT03481361|Insulin-Dependent Diabetes Mellitus (IDDM)|insulin-dependent diabetes mellitus (iddm)
4661747|NCT03481322|sodium chloride|sodium chloride
4661748|NCT03481322|diet|diet
4661749|NCT03481322|cooking|cooking
4661750|NCT03481309|transcranial magnetic stimulation (TMS)|transcranial magnetic stimulation (tms)
4661751|NCT03481309|transcranial direct current stimulation (tDCS)|transcranial direct current stimulation (tdcs)
4661752|NCT03481309|electroencephalography (EEG)|electroencephalography (eeg)
4661753|NCT03481296|Colorectal Cancer Screening|colorectal cancer screening
4661754|NCT03481296|Asian Americans|asian americans
4661755|NCT03481296|Patient Navigation|patient navigation
4661756|NCT03481296|Decision Counseling Program|decision counseling program
4661757|NCT03481283|Amylin|amylin
4661758|NCT03481218|Type 1 diabetes|type 1 diabetes
4661759|NCT03481218|Quality of life|quality of life
4661760|NCT03481218|Personality traits|personality traits
4661761|NCT03481218|Young adults|young adults
4661762|NCT03481205|remote limb ischemic conditioning|remote limb ischemic conditioning
4661763|NCT03481205|large vessel occlusion|large vessel occlusion
4661764|NCT03481205|helicopter transport|helicopter transport
4661765|NCT03481179|Repetitive transcranial magnetic stimulation, Physiotherapy, Stroke, Spasticity|repetitive transcranial magnetic stimulation, physiotherapy, stroke, spasticity
4661766|NCT03481166|pilot|pilot
4661767|NCT03481166|randomized controlled trial|randomized controlled trial
4661768|NCT03481166|prenatal education|prenatal education
4661769|NCT03481166|anticipatory guidance|anticipatory guidance
4661770|NCT03481114|radiation therapy|radiation therapy
4661771|NCT03481114|chemotherapy|chemotherapy
4661772|NCT03481114|PET Imaging|pet imaging
4661773|NCT03481101|early response evaluation|early response evaluation
4661774|NCT03481101|immunotherapy|immunotherapy
4661775|NCT03481101|chemotherapy|chemotherapy
4661776|NCT03481101|liquid biopsy|liquid biopsy
4661777|NCT03481101|FDG-PET/CT|fdg-pet/ct
4661778|NCT03481075|Aortic Aneurysm, Abdominal|aortic aneurysm, abdominal
4661779|NCT03481075|Imaging, Three-Dimensional|imaging, three-dimensional
4661780|NCT03481075|Tomography Scanners, X-Ray Computed|tomography scanners, x-ray computed
4661781|NCT03481075|Angiography, Digital Subtraction|angiography, digital subtraction
4661782|NCT03481075|Endovascular Procedures|endovascular procedures
4661783|NCT03481075|Radiography, Interventional|radiography, interventional
4661784|NCT03481036|Mukh Mantri Punjab Hepatitis C Relief Fund,MMPHCRF|mukh mantri punjab hepatitis c relief fund,mmphcrf
4661785|NCT03481036|Direct acting antiviral agents (DAA)|direct acting antiviral agents (daa)
4661786|NCT03481036|Chronic Hepatitis C|chronic hepatitis c
4661787|NCT03481036|Pediatric population|pediatric population
4661788|NCT03481036|Adolescent Chronic Hepatitis C|adolescent chronic hepatitis c
4661789|NCT03481023|Atrial Fibrillation|atrial fibrillation
4661790|NCT03481023|Esophageal Cooling Device|esophageal cooling device
4661791|NCT03481023|Radiofrequency Ablation|radiofrequency ablation
4661792|NCT03481023|Arrhythmia|arrhythmia
4661793|NCT03480971|cisplatin toxicity|cisplatin toxicity
4661794|NCT03480958|erector spinae plane block|erector spinae plane block
4661795|NCT03480958|thoracic paravertebral block|thoracic paravertebral block
4661796|NCT03480958|breast surgery|breast surgery
4661797|NCT03480958|postoperative pain|postoperative pain
4661798|NCT03480932|directly observed therapy|directly observed therapy
4661799|NCT03480932|sofosbuvir|sofosbuvir
4661800|NCT03480932|daclatasvir|daclatasvir
4661801|NCT03480932|pegylated interferon|pegylated interferon
4661802|NCT03480932|resource-limited setting|resource-limited setting
4661803|NCT03480893|laminectomy|laminectomy
4661804|NCT03480893|laminotomy|laminotomy
4661805|NCT03480893|lumbar canal stenosis|lumbar canal stenosis
4661806|NCT03480880|Bispectral Index|bispectral index
4661807|NCT03480815|Asthma|asthma
4661808|NCT03480815|Controlled Laminar Airflow Device|controlled laminar airflow device
4661809|NCT03480815|Omalizumab|omalizumab
4661810|NCT03480802|Conjugate pneumococcal vaccine, 15-valent, 22F, 33F|conjugate pneumococcal vaccine, 15-valent, 22f, 33f
4661811|NCT03480750|Copper chelator|copper chelator
4661812|NCT03480750|Epithelial ovarian cancer|epithelial ovarian cancer
4661813|NCT03480750|Tubal cancer|tubal cancer
4661814|NCT03480750|Peritoneal cancer|peritoneal cancer
4661815|NCT03480750|Trientine|trientine
4661816|NCT03480750|Pegylated liposomal doxorubicin|pegylated liposomal doxorubicin
4661817|NCT03480750|Carboplatin|carboplatin
4661818|NCT03480711|subscleral trabeculectomy|subscleral trabeculectomy
4661819|NCT03480711|extended subscleral tunnel|extended subscleral tunnel
4661820|NCT03480711|mitomycinC|mitomycinc
4661821|NCT03480698|acute ischemic stroke|acute ischemic stroke
4661822|NCT03480646|Phase 1/2|phase 1/2
4661823|NCT03480646|Oncology|oncology
4661824|NCT03480646|EZH2 Inhibitor|ezh2 inhibitor
4661825|NCT03480620|Telehealth|telehealth
4661826|NCT03480620|Telerehabilitation|telerehabilitation
4661827|NCT03480620|Chronic pain|chronic pain
4661828|NCT03480620|Post-discharge care|post-discharge care
4661829|NCT03480581|Neurological|neurological
4661830|NCT03480581|Gait|gait
4661831|NCT03480581|Cardiorespiratory fitness|cardiorespiratory fitness
4661832|NCT03480581|Rehabilitation|rehabilitation
4661833|NCT03480581|Walking|walking
4661834|NCT03480581|Locomotor training|locomotor training
4661835|NCT03480581|Robotics|robotics
4661836|NCT03480568|Alirocumab|alirocumab
4661837|NCT03480529|adverse event|adverse event
4661838|NCT03480529|arthritis|arthritis
4661839|NCT03480529|Systemic Lupus Erythematosus|systemic lupus erythematosus
4661840|NCT03480529|Capillary Leak Syndrome|capillary leak syndrome
4661841|NCT03480516|Silver Diamine Fluoride|silver diamine fluoride
4661842|NCT03480516|Sodium Fluoride Varnish|sodium fluoride varnish
4661843|NCT03480516|Arrest caries|arrest caries
4661844|NCT03480516|Caries prevention|caries prevention
4661845|NCT03480516|Cost Effectiveness|cost effectiveness
4661846|NCT03480516|Oral Health|oral health
4661847|NCT03480516|Quality of Life|quality of life
4661848|NCT03480503|Apelin12|apelin12
4661849|NCT03480477|Adverse Childhood Experiences|adverse childhood experiences
4661850|NCT03480412|Luteal Phase Stimulation|luteal phase stimulation
4661851|NCT03480412|Poor Ovarian Response|poor ovarian response
4661852|NCT03480412|In Vitro Fertilization|in vitro fertilization
4661853|NCT03480399|retroperitoneal sarcoma|retroperitoneal sarcoma
4661854|NCT03480399|quality of life|quality of life
4661855|NCT03480399|morbidity|morbidity
4661856|NCT03480399|surgery|surgery
4661857|NCT03480386|Pulmonary Rehabilitation|pulmonary rehabilitation
4661858|NCT03480373|Nicotine|nicotine
4661859|NCT03480373|Nicotine addiction|nicotine addiction
4661860|NCT03480373|Tobacco Use Disorder|tobacco use disorder
4661861|NCT03480373|Pregnancy|pregnancy
4661862|NCT03480373|Electronic cigarettes|electronic cigarettes
4661863|NCT03480373|Cigarettes|cigarettes
4661864|NCT03480373|Vaping|vaping
4661865|NCT03480373|Carcinoma|carcinoma
4661866|NCT03480373|Pregnant|pregnant
4661867|NCT03480373|Birth Outcomes|birth outcomes
4661868|NCT03480373|E-liquid|e-liquid
4661869|NCT03480360|haploidentical|haploidentical
4661870|NCT03480360|transplant|transplant
4661871|NCT03480360|peripheral blood|peripheral blood
4661872|NCT03480360|allogeneic|allogeneic
4661873|NCT03480321|Peripheral Artery Disease|peripheral artery disease
4661874|NCT03480321|Cilostazol|cilostazol
4661875|NCT03480321|PMR|pmr
4661876|NCT03480321|Extended-Release Tablet of Cilostazol|extended-release tablet of cilostazol
4661877|NCT03480282|Life expectancy|life expectancy
4661878|NCT03480282|Older adults|older adults
4661879|NCT03480282|Primary care|primary care
4661880|NCT03480282|Cancer screening|cancer screening
4661881|NCT03480256|SHR6390|shr6390
4661882|NCT03480256|Pyrotinib|pyrotinib
4661883|NCT03480256|gastric cancer|gastric cancer
4661884|NCT03480256|Her-2 positive|her-2 positive
4661885|NCT03480243|Padsevonil|padsevonil
4661886|NCT03480230|Non-small cell lung cancer|non-small cell lung cancer
4661887|NCT03480230|Platinum doublet chemotherapy|platinum doublet chemotherapy
4661888|NCT03480230|Neoadjuvant|neoadjuvant
4661889|NCT03480217|hypertension|hypertension
4661890|NCT03480217|screening|screening
4661891|NCT03480217|guidelines|guidelines
4661892|NCT03480217|implementation|implementation
4661893|NCT03480217|randomized|randomized
4661894|NCT03480165|Randomized controlled trial|randomized controlled trial
4661895|NCT03480165|Double blind|double blind
4661896|NCT03480165|Parallel group|parallel group
4661897|NCT03480152|Metastatic Cancer|metastatic cancer
4661898|NCT03480152|Immunotherapy|immunotherapy
4661899|NCT03480152|Tumor Regression|tumor regression
4661900|NCT03480152|Cancer Vaccine|cancer vaccine
4661901|NCT03480152|Gene Therapy|gene therapy
4661902|NCT03480139|Prematurity|prematurity
4661903|NCT03480139|Perinatal Mortality|perinatal mortality
4661904|NCT03480139|Pregnancy Complications|pregnancy complications
4661905|NCT03480139|Prediction of Adverse Pregnancy Outcome|prediction of adverse pregnancy outcome
4661906|NCT03480139|Premature Rupture of Membranes|premature rupture of membranes
4661907|NCT03480100|rhinosinusitis|rhinosinusitis
4661908|NCT03480100|nasal irrigation|nasal irrigation
4661909|NCT03480100|nasal douche|nasal douche
4661910|NCT03480100|Ectoin|ectoin
4661911|NCT03480087|strain-rate echocardiography|strain-rate echocardiography
4661912|NCT03480087|chemotherapy|chemotherapy
4661913|NCT03480087|radiotherapy, mediastinal|radiotherapy, mediastinal
4661914|NCT03480087|Lymphoma|lymphoma
4661915|NCT03480087|Hodgkin|hodgkin
4661916|NCT03480022|prediabetes|prediabetes
4661917|NCT03480022|PCOS|pcos
4661918|NCT03480022|GLP-1 agonist|glp-1 agonist
4661919|NCT03480022|weight loss|weight loss
4661920|NCT03480009|medication abortion|medication abortion
4661921|NCT03480009|dextromethorphan|dextromethorphan
4661922|NCT03480009|pain control|pain control
4661923|NCT03479983|Indian gooseberry|indian gooseberry
4661924|NCT03479983|Total cholesterol|total cholesterol
4661925|NCT03479983|Triglycerides|triglycerides
4661926|NCT03479866|Gut microbiome|gut microbiome
4661927|NCT03479866|Personalised Nutrition|personalised nutrition
4661928|NCT03479866|Metabolic health|metabolic health
4661929|NCT03479853|Ocular Rosacea|ocular rosacea
4661930|NCT03479853|Keratoconjunctivitis|keratoconjunctivitis
4661931|NCT03479853|Meibomian Gland|meibomian gland
4661932|NCT03479853|Interferometry|interferometry
4661933|NCT03479853|Child|child
4661934|NCT03479840|SYNTAX score, PCI, elderly|syntax score, pci, elderly
4661935|NCT03479814|rectal cancer|rectal cancer
4661936|NCT03479814|neoadjuvant chemoradiation|neoadjuvant chemoradiation
4661937|NCT03479814|IMRT-SIB|imrt-sib
4661938|NCT03479814|adaptive radiotherapy|adaptive radiotherapy
4661939|NCT03479788|sleep apnea, coronary artery, diabetes|sleep apnea, coronary artery, diabetes
4661940|NCT03479697|HIRREM|hirrem
4661941|NCT03479697|Neurotechnology|neurotechnology
4661942|NCT03479697|Closed-Loop|closed-loop
4661943|NCT03479697|Allostasis|allostasis
4661944|NCT03479697|Stress|stress
4661945|NCT03479697|Autonomic Dysregulation|autonomic dysregulation
4661946|NCT03479697|Hyperarousal|hyperarousal
4661947|NCT03479697|Brain Electrical Activity|brain electrical activity
4661948|NCT03479697|Acoustic Stimulation|acoustic stimulation
4661949|NCT03479697|Primary Hypertension|primary hypertension
4661950|NCT03479697|High Blood Pressure|high blood pressure
4661951|NCT03479684|warfarin|warfarin
4661952|NCT03479684|gene|gene
4661953|NCT03479658|HIIT|hiit
4661954|NCT03479658|nutritional education|nutritional education
4661955|NCT03479658|Dose-effect|dose-effect
4661956|NCT03479658|school|school
4661957|NCT03479658|children|children
4661958|NCT03479658|cardiovascular|cardiovascular
4661959|NCT03479658|adiposity|adiposity
4661960|NCT03479658|blood pressure|blood pressure
4661962|NCT03479645|Colon cancer|colon cancer
4661963|NCT03479645|Bowel cancer|bowel cancer
4661964|NCT03479645|Cancer screening|cancer screening
4661965|NCT03479645|text message|text message
4661966|NCT03479645|Fecal immunochemistry test (FIT)|fecal immunochemistry test (fit)
4661967|NCT03479645|opt-out|opt-out
4661968|NCT03479645|behavioral intervention|behavioral intervention
4661969|NCT03479619|lancing device|lancing device
4661970|NCT03479619|lancet|lancet
4661971|NCT03479606|Traumatic Brain Injury|traumatic brain injury
4661972|NCT03479606|TBI|tbi
4661973|NCT03479606|Executive Dysfunction|executive dysfunction
4661974|NCT03479606|Emotional Regulation|emotional regulation
4661975|NCT03479606|Emotional Dysfunction|emotional dysfunction
4661976|NCT03479606|Problem Solving|problem solving
4661977|NCT03479606|Self-regulation|self-regulation
4661978|NCT03479606|Cognitive Rehabilitation|cognitive rehabilitation
4661979|NCT03479606|Metacognitive Strategies|metacognitive strategies
4661980|NCT03479606|Cognitive-behavioral therapy|cognitive-behavioral therapy
4661981|NCT03479606|Online Therapy|online therapy
4661982|NCT03479606|GroupTherapy|grouptherapy
4661983|NCT03479606|Group videoconference|group videoconference
4661984|NCT03479606|Telehealth|telehealth
4661985|NCT03479606|Telerehabilitation|telerehabilitation
4661986|NCT03479593|NSTEMI|nstemi
4661987|NCT03479593|Culprit|culprit
4661988|NCT03479593|Cardiac magnetic resonance|cardiac magnetic resonance
4661989|NCT03479593|Optical Coherence Tomography|optical coherence tomography
4661990|NCT03479580|Cardiomyopathy|cardiomyopathy
4661991|NCT03479580|Multimodal imaging|multimodal imaging
4661992|NCT03479580|Coronary artery disease|coronary artery disease
4661993|NCT03479580|Coronary microvascular disease|coronary microvascular disease
4661994|NCT03479580|Prognosis|prognosis
4661995|NCT03479580|Atherosclerosis|atherosclerosis
4661996|NCT03479580|Myocardial ischemia|myocardial ischemia
4661997|NCT03479554|antihypertensive treatment|antihypertensive treatment
4661998|NCT03479541|mild traumatic brain injury|mild traumatic brain injury
4661999|NCT03479541|vestibular impairment|vestibular impairment
4662000|NCT03479541|balance and gait|balance and gait
4662001|NCT03479541|dual-tasking|dual-tasking
4662002|NCT03479541|veterans|veterans
4662003|NCT03479541|quality of life|quality of life
4662004|NCT03479541|rehabilitation|rehabilitation
4662005|NCT03479528|Dyspepsia,alarm symptoms，Roman IV|dyspepsia,alarm symptoms，roman iv
4662006|NCT03479476|Congenital Abnormalities|congenital abnormalities
4662007|NCT03479476|Metformin|metformin
4662008|NCT03479476|Nervous System Diseases|nervous system diseases
4662009|NCT03479476|Chromosome Disorders|chromosome disorders
4662010|NCT03479437|Obesity|obesity
4662011|NCT03479437|Melanocortin|melanocortin
4662012|NCT03479437|TEMPO|tempo
4662013|NCT03479437|MC4R|mc4r
4662014|NCT03479437|Genetic Obesity|genetic obesity
4662015|NCT03479437|hypothalamic|hypothalamic
4662016|NCT03479437|POMC|pomc
4662017|NCT03479437|LEPR|lepr
4662018|NCT03479437|PCSK1|pcsk1
4662019|NCT03479398|Fidelity|fidelity
4662020|NCT03479398|Cognitive Behavioral Therapy|cognitive behavioral therapy
4662021|NCT03479398|Mobile Application|mobile application
4662022|NCT03479398|Routine Practice|routine practice
4662023|NCT03479372|AMD|amd
4662024|NCT03479372|wet AMD|wet amd
4662025|NCT03479372|exudative AMD|exudative amd
4662026|NCT03479372|macular degeneration|macular degeneration
4662027|NCT03479359|Prostate cancer; Benign Prostatic Hyperplasia; Digital Rectal Examination; Accuracy|prostate cancer; benign prostatic hyperplasia; digital rectal examination; accuracy
4662028|NCT03479346|Obesity|obesity
4662029|NCT03479346|Metabolic syndrome|metabolic syndrome
4662030|NCT03479346|Traditional Korean Medicine|traditional korean medicine
4662031|NCT03479346|Galgeun-tang|galgeun-tang
4662032|NCT03479255|Smartphone|smartphone
4662033|NCT03479255|Exercise|exercise
4662034|NCT03479255|Functional capacity|functional capacity
4662035|NCT03479229|vaginal laxity|vaginal laxity
4662036|NCT03479229|sexual function|sexual function
4662037|NCT03479229|vaginal childbirth|vaginal childbirth
4662038|NCT03479229|sexual dysfunction|sexual dysfunction
4662039|NCT03479229|diminished sexual function|diminished sexual function
4662040|NCT03479229|satisfaction|satisfaction
4662041|NCT03479229|arousal|arousal
4662042|NCT03479229|desire|desire
4662043|NCT03479229|lubrication|lubrication
4662044|NCT03479229|orgasm|orgasm
4662045|NCT03479216|Analgesia|analgesia
4662046|NCT03479216|Anesthesia|anesthesia
4662047|NCT03479216|Arthroscopy|arthroscopy
4662048|NCT03479216|Bupivacaine|bupivacaine
4662049|NCT03479216|Dexmedetomidine|dexmedetomidine
4662050|NCT03479216|Injections, Intra-Articular|injections, intra-articular
4662051|NCT03479216|Magnesium|magnesium
4662052|NCT03479216|Pain, Postoperative|pain, postoperative
4662053|NCT03479203|Inflammation|inflammation
4662054|NCT03479151|Magnetic Resonance Imaging (MRI)|magnetic resonance imaging (mri)
4662055|NCT03479151|High Intensity Focused Ultrasound (HIFU)|high intensity focused ultrasound (hifu)
4662056|NCT03479138|severe asthma|severe asthma
4662057|NCT03479138|induced sputum|induced sputum
4662058|NCT03479138|asthma phenotypes|asthma phenotypes
4662059|NCT03479138|neutrophilic inflammation|neutrophilic inflammation
4662060|NCT03479138|microbiome|microbiome
4662061|NCT03479112|Tourniquets, Layperson, hemorrhage control, first responder|tourniquets, layperson, hemorrhage control, first responder
4662062|NCT03479099|Lung cancer|lung cancer
4662063|NCT03479099|Circulating Tumor Cell|circulating tumor cell
4662064|NCT03479099|Cell-Free Tumor DNA|cell-free tumor dna
4662065|NCT03479099|Liquid Biopsy|liquid biopsy
4662066|NCT03479060|Wet cupping therapy|wet cupping therapy
4662067|NCT03479060|Migraine|migraine
4662068|NCT03479060|MIDAS|midas
4662069|NCT03479047|diaphragm ultrasound|diaphragm ultrasound
4662070|NCT03479047|spontaneous breathing trial|spontaneous breathing trial
4662071|NCT03479047|mechanical ventilation weaning|mechanical ventilation weaning
4662072|NCT03479047|rapid shallow breathing index|rapid shallow breathing index
4662073|NCT03479034|digital|digital
4662074|NCT03479034|prescription|prescription
4662075|NCT03479034|Application|application
4662076|NCT03478995|Phase1b|phase1b
4662077|NCT03478917|Vasoocclusive Crisis|vasoocclusive crisis
4662078|NCT03478917|Sickle Cell Disease|sickle cell disease
4662079|NCT03478917|Acute Chest Syndrome|acute chest syndrome
4662080|NCT03478917|Pulmonary Syndrome|pulmonary syndrome
4662081|NCT03478917|Pneumonia|pneumonia
4662082|NCT03478904|Castration Resistant Prostate Cancer|castration resistant prostate cancer
4662083|NCT03478904|Androgen Receptor|androgen receptor
4662084|NCT03478891|Ebola Virus|ebola virus
4662085|NCT03478891|Immune Response|immune response
4662086|NCT03478891|Filovirus|filovirus
4662087|NCT03478891|Ebola Hemorrhagic Fever|ebola hemorrhagic fever
4662088|NCT03478891|First in Human|first in human
4662089|NCT03478878|Eye Examinations|eye examinations
4662090|NCT03478878|Age-Related Macular Degeneration (AMD)|age-related macular degeneration (amd)
4662091|NCT03478878|Retinal Pigment Epithelium|retinal pigment epithelium
4662092|NCT03478865|Eye Examinations|eye examinations
4662093|NCT03478865|Retinal Pigment Epithelium|retinal pigment epithelium
4662094|NCT03478852|Seizure Disorder|seizure disorder
4662095|NCT03478852|Seizures|seizures
4662096|NCT03478852|Antiepileptic Drug|antiepileptic drug
4662097|NCT03478852|Natural History Study|natural history study
4662098|NCT03478852|Screening Protocol|screening protocol
4662099|NCT03478839|Generalized Arterial Calcification of Infancy|generalized arterial calcification of infancy
4662100|NCT03478839|Autosomal Recessive Hypophosphatemic Rickets|autosomal recessive hypophosphatemic rickets
4662101|NCT03478839|Pseudoxanthoma Elasticum|pseudoxanthoma elasticum
4662102|NCT03478839|Idiopathic Infantile Arterial Calcification|idiopathic infantile arterial calcification
4662103|NCT03478826|ILD|ild
4662104|NCT03478813|Intervention|intervention
4662105|NCT03478813|Implementation|implementation
4662106|NCT03478813|Children|children
4662107|NCT03478813|Urotherapy|urotherapy
4662108|NCT03478787|Plaque Psoriasis|plaque psoriasis
4662109|NCT03478761|CYP24A1 mutation|cyp24a1 mutation
4662110|NCT03478761|CYP24A1|cyp24a1
4662111|NCT03478761|24-hydroxylase deficiency|24-hydroxylase deficiency
4662112|NCT03478748|Dental caries|dental caries
4662113|NCT03478748|Oral health literacy|oral health literacy
4662114|NCT03478709|vasoplegia|vasoplegia
4662115|NCT03478709|dynamic arterial elastance|dynamic arterial elastance
4662116|NCT03478709|microcirculation|microcirculation
4662117|NCT03478696|fluticasone furoate/umeclidinium/vilanterol|fluticasone furoate/umeclidinium/vilanterol
4662118|NCT03478696|HRQoL|hrqol
4662119|NCT03478696|COPD|copd
4662120|NCT03478696|long-acting muscarinic receptor antagonists|long-acting muscarinic receptor antagonists
4662121|NCT03478696|Tiotropium|tiotropium
4662122|NCT03478696|Budesonide/formoterol|budesonide/formoterol
4662123|NCT03478683|long-acting muscarinic receptor antagonists|long-acting muscarinic receptor antagonists
4662124|NCT03478683|tiotropium|tiotropium
4662125|NCT03478683|HRQoL|hrqol
4662126|NCT03478683|Budesonide/formoterol|budesonide/formoterol
4662330|NCT03477240|Cervical Cancer|cervical cancer
4662127|NCT03478683|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
4662128|NCT03478683|COPD|copd
4662129|NCT03478670|gene therapy|gene therapy
4662130|NCT03478670|retroviral vector|retroviral vector
4662131|NCT03478670|inherited immune disorder|inherited immune disorder
4662132|NCT03478670|ADA-SCID|ada-scid
4662133|NCT03478670|GSK2696273|gsk2696273
4662134|NCT03478670|Strimvelis|strimvelis
4662135|NCT03478657|Asthma|asthma
4662136|NCT03478657|Dry Powder Inhaler|dry powder inhaler
4662137|NCT03478657|Metered Dose Inhaler|metered dose inhaler
4662138|NCT03478657|Long Acting beta 2 Agonist|long acting beta 2 agonist
4662139|NCT03478657|ELLIPTA|ellipta
4662140|NCT03478631|nitrate|nitrate
4662141|NCT03478631|vegetables|vegetables
4662142|NCT03478605|olanzapine|olanzapine
4662143|NCT03478605|aprepitant|aprepitant
4662144|NCT03478605|CINV|cinv
4662145|NCT03478605|nausea|nausea
4662146|NCT03478605|vomiting|vomiting
4662147|NCT03478605|nausea and vomiting|nausea and vomiting
4662148|NCT03478605|antiemetics|antiemetics
4662149|NCT03478592|Slow-freezing|slow-freezing
4662150|NCT03478592|Vitrification|vitrification
4662151|NCT03478592|Automated system|automated system
4662152|NCT03478592|Embryos|embryos
4662153|NCT03478592|Implantation|implantation
4662154|NCT03478579|serious game|serious game
4662155|NCT03478579|simulation|simulation
4662156|NCT03478579|virtual emergency department|virtual emergency department
4662157|NCT03478579|nontechnical skills|nontechnical skills
4662158|NCT03478527|Probiotics|probiotics
4662159|NCT03478527|Psychiatric Symptoms|psychiatric symptoms
4662160|NCT03478527|Cognitive Function|cognitive function
4662161|NCT03478527|Hippocampus|hippocampus
4662162|NCT03478527|Oxytocin|oxytocin
4662163|NCT03478527|Immunological Parameters|immunological parameters
4662164|NCT03478514|mantle cell lymphoma|mantle cell lymphoma
4662165|NCT03478514|B-cell lymphoma|b-cell lymphoma
4662166|NCT03478501|firearm|firearm
4662167|NCT03478501|lethal means|lethal means
4662168|NCT03478501|decision aid|decision aid
4662169|NCT03478475|Vitamin D|vitamin d
4662170|NCT03478475|HOMA-IR|homa-ir
4662171|NCT03478475|Glucose|glucose
4662172|NCT03478475|HbA1C|hba1c
4662173|NCT03478475|insulin resistance|insulin resistance
4662174|NCT03478436|pharmacokinetics|pharmacokinetics
4662175|NCT03478436|microdialysis|microdialysis
4662176|NCT03478436|healthy volunteers|healthy volunteers
4662177|NCT03478410|Epicardial fat|epicardial fat
4662178|NCT03478397|cervical cancer prevention|cervical cancer prevention
4662179|NCT03478397|self-collection HPV test|self-collection hpv test
4662180|NCT03478397|mHealth|mhealth
4662181|NCT03478397|Argentina|argentina
4662182|NCT03478384|self-efficacy expectation|self-efficacy expectation
4662183|NCT03478371|tampon|tampon
4662184|NCT03478319|ACE-2494|ace-2494
4662185|NCT03478241|Endodontic retreatment|endodontic retreatment
4662186|NCT03478241|postoperative pain|postoperative pain
4662187|NCT03478241|OneShape|oneshape
4662188|NCT03478241|Revo-S|revo-s
4662189|NCT03478241|WaveOne|waveone
4662190|NCT03478228|fracture|fracture
4662191|NCT03478228|rehabilitation|rehabilitation
4662192|NCT03478228|wrist|wrist
4662193|NCT03478228|sensation|sensation
4662194|NCT03478228|exercise|exercise
4662195|NCT03478215|kidney transplantation|kidney transplantation
4662196|NCT03478215|graft rejection|graft rejection
4662197|NCT03478176|Intraabdominal hypertension|intraabdominal hypertension
4662198|NCT03478176|Kidney transplantation|kidney transplantation
4662199|NCT03478163|Bakri|bakri
4662200|NCT03478163|Intrauterine balloon tamponade|intrauterine balloon tamponade
4662201|NCT03478163|Antibiotics|antibiotics
4662202|NCT03478137|Cognition|cognition
4662203|NCT03478137|Intervention|intervention
4662204|NCT03478098|Gut hormones|gut hormones
4662205|NCT03478098|Glucose excursions|glucose excursions
4662206|NCT03478033|Tuberculosis|tuberculosis
4662207|NCT03478033|AIDS|aids
4662208|NCT03478033|Rifampicin|rifampicin
4662209|NCT03478033|Rifabutin|rifabutin
4662210|NCT03478007|Exercise Compliance|exercise compliance
4662211|NCT03478007|Health Coaching|health coaching
4662212|NCT03477994|dexmedetomidine, clonidine, postoperative, CABG|dexmedetomidine, clonidine, postoperative, cabg
4662213|NCT03477955|spinopelvic alignment|spinopelvic alignment
4662214|NCT03477955|short lumbosacral instrumentation|short lumbosacral instrumentation
4662215|NCT03477955|PEEK|peek
4662216|NCT03477955|silicon spacer|silicon spacer
4662217|NCT03477929|In vitro fertilization|in vitro fertilization
4662218|NCT03477929|gnrh antagonist|gnrh antagonist
4662219|NCT03477929|pituitary suppression|pituitary suppression
4662220|NCT03477903|Drug therapy|drug therapy
4662221|NCT03477877|Intimate Partner Violence|intimate partner violence
4662222|NCT03477877|Gender-Based violence|gender-based violence
4662223|NCT03477877|Spouse Abuse|spouse abuse
4662224|NCT03477877|Rwanda|rwanda
4662225|NCT03477877|Heterosexual Couples|heterosexual couples
4662226|NCT03477877|Activists|activists
4662227|NCT03477877|Opinion Leaders|opinion leaders
4662228|NCT03477877|Social Change|social change
4662229|NCT03477877|Social-Ecological Model|social-ecological model
4662230|NCT03477877|Diffusion of Innovation|diffusion of innovation
4662231|NCT03477877|Cluster Randomized Controlled Trial|cluster randomized controlled trial
4662232|NCT03477877|Community Randomized Controlled Trial|community randomized controlled trial
4662233|NCT03477851|sciatic nerve block|sciatic nerve block
4662234|NCT03477851|tramadol|tramadol
4662235|NCT03477851|foot fracture|foot fracture
4662236|NCT03477838|continuous glucose monitoring|continuous glucose monitoring
4662237|NCT03477799|gambling disorder|gambling disorder
4662238|NCT03477799|cognition|cognition
4662239|NCT03477773|high-intensity interval training|high-intensity interval training
4662240|NCT03477773|video games|video games
4662241|NCT03477773|heart rate|heart rate
4662242|NCT03477773|boxing|boxing
4662243|NCT03477773|metabolic syndrome|metabolic syndrome
4662244|NCT03477747|Microcurrent|microcurrent
4662245|NCT03477747|Exercise training|exercise training
4662246|NCT03477747|Hypertrophy|hypertrophy
4662247|NCT03477747|Muscle damage|muscle damage
4662248|NCT03477747|Recovery|recovery
4662249|NCT03477747|Performance|performance
4662250|NCT03477721|Agrin Fragment C-terminus (CAF)|agrin fragment c-terminus (caf)
4662251|NCT03477669|Colic|colic
4662252|NCT03477656|ABO incompatible kidney transplantation|abo incompatible kidney transplantation
4662253|NCT03477656|Desensitization|desensitization
4662254|NCT03477656|Double Filtration PlasmaPherisis (DFPP)|double filtration plasmapherisis (dfpp)
4662255|NCT03477656|Specific immunoadsorption|specific immunoadsorption
4662256|NCT03477656|Living donor kidney transplantation|living donor kidney transplantation
4662257|NCT03477630|gonarthrosis|gonarthrosis
4662258|NCT03477604|Below the knee|below the knee
4662259|NCT03477604|Stent|stent
4662260|NCT03477591|Screening|screening
4662261|NCT03477591|PSA testing|psa testing
4662262|NCT03477591|Patient Decision Aid|patient decision aid
4662263|NCT03477552|Sickle Cell Crisis|sickle cell crisis
4662264|NCT03477552|intravenous catheter|intravenous catheter
4662265|NCT03477552|transillumination|transillumination
4662266|NCT03477526|pulmonary fibrosis|pulmonary fibrosis
4662267|NCT03477526|COPD|copd
4662268|NCT03477526|pulmonary rehabilitation|pulmonary rehabilitation
4662269|NCT03477526|mental status (anxiety and depression)|mental status (anxiety and depression)
4662270|NCT03477526|quality of life|quality of life
4662271|NCT03477526|physical activity|physical activity
4662272|NCT03477500|multiple sclerosis,|multiple sclerosis,
4662273|NCT03477500|HSCT|hsct
4662274|NCT03477500|alemtuzumab|alemtuzumab
4662276|NCT03477487|inflammation|inflammation
4662277|NCT03477487|Cytokines|cytokines
4662278|NCT03477487|Interleukin-10|interleukin-10
4662279|NCT03477487|Gene therapy|gene therapy
4662280|NCT03477474|Guardant Health|guardant health
4662281|NCT03477435|smoking|smoking
4662282|NCT03477435|tobacco dependence|tobacco dependence
4662283|NCT03477435|quitline|quitline
4662284|NCT03477435|smoking cessation|smoking cessation
4662285|NCT03477422|CSE-1034 Double Blind Study|cse-1034 double blind study
4662286|NCT03477422|Elores|elores
4662287|NCT03477422|Meropenem|meropenem
4662288|NCT03477422|PLEA-CT|plea-ct
4662289|NCT03477422|Bacterial Infections|bacterial infections
4662290|NCT03477422|ESBL|esbl
4662291|NCT03477422|MBL|mbl
4662292|NCT03477422|beta-lactamase|beta-lactamase
4662293|NCT03477422|Anti-Infective Agents, Urinary|anti-infective agents, urinary
4662294|NCT03477422|Anti-Infective Agents|anti-infective agents
4662295|NCT03477422|Urinary Tract Infections|urinary tract infections
4662296|NCT03477422|Pyelonephritis|pyelonephritis
4662297|NCT03477422|Infection|infection
4662298|NCT03477422|Sulbactam|sulbactam
4662299|NCT03477422|EDTA|edta
4662300|NCT03477422|Disodium EDTA|disodium edta
4662301|NCT03477422|Antibiotic Adjuvant Entity|antibiotic adjuvant entity
4662302|NCT03477422|Antibiotic Resistance Breaker|antibiotic resistance breaker
4662303|NCT03477409|plasticizers|plasticizers
4662304|NCT03477409|medical devices|medical devices
4662305|NCT03477409|neonates|neonates
4662306|NCT03477409|exposition|exposition
4662307|NCT03477383|diagnosis|diagnosis
4662308|NCT03477383|economics|economics
4662309|NCT03477383|cell-free DNA|cell-free dna
4662310|NCT03477383|digital droplet PCR|digital droplet pcr
4662311|NCT03477383|heart failure|heart failure
4662312|NCT03477344|Cardiac Surgery|cardiac surgery
4662313|NCT03477344|Delirium|delirium
4662314|NCT03477344|Sleep deprivation|sleep deprivation
4662315|NCT03477331|Direct oral anticoagulant|direct oral anticoagulant
4662316|NCT03477331|P2Y12 inhibitors|p2y12 inhibitors
4662317|NCT03477331|Physiologically-based pharmacokinetic model (PBPK)|physiologically-based pharmacokinetic model (pbpk)
4662318|NCT03477331|Population-based pharmacokinetic model (POPPK)|population-based pharmacokinetic model (poppk)
4662319|NCT03477318|colonoscopy, polyp, endoscopist|colonoscopy, polyp, endoscopist
4662320|NCT03477305|older adults|older adults
4662321|NCT03477305|community gardening|community gardening
4662322|NCT03477305|cooperative extension|cooperative extension
4662323|NCT03477279|couple HIV testing and counseling|couple hiv testing and counseling
4662324|NCT03477279|disclosure|disclosure
4662325|NCT03477279|Malawi|malawi
4662326|NCT03477266|Postoperative ileus|postoperative ileus
4662327|NCT03477266|mosapride|mosapride
4662328|NCT03477266|mouth dissolving tablets|mouth dissolving tablets
4662329|NCT03477266|Intraoperative vomiting|intraoperative vomiting
4662331|NCT03477240|TELEPHONIC QUESTIONNAIRE|telephonic questionnaire
4662332|NCT03477240|Follow up|follow up
4662333|NCT03477227|compression stocking|compression stocking
4662334|NCT03477227|elastic stocking|elastic stocking
4662335|NCT03477227|endovenous radiofrequency ablation|endovenous radiofrequency ablation
4662336|NCT03477227|compression therapy|compression therapy
4662337|NCT03477188|Stroke|stroke
4662338|NCT03477188|Vestibular|vestibular
4662339|NCT03477188|Somatosensory|somatosensory
4662340|NCT03477188|Rehabilitation|rehabilitation
4662341|NCT03477188|Balance|balance
4662342|NCT03477175|lenvatinib|lenvatinib
4662343|NCT03477175|E7080|e7080
4662344|NCT03477149|liquid embolics|liquid embolics
4662345|NCT03477123|Incomplete spinal cord injury|incomplete spinal cord injury
4662346|NCT03477123|Walking|walking
4662347|NCT03477123|Rehabilitation|rehabilitation
4662348|NCT03477123|Robotic exoskeleton|robotic exoskeleton
4662349|NCT03477097|Frailty|frailty
4662350|NCT03477097|Social Determinants|social determinants
4662351|NCT03477097|Biological Risk Factors|biological risk factors
4662352|NCT03477097|Intervention|intervention
4662353|NCT03477097|Cost Effectiveness|cost effectiveness
4662354|NCT03477071|Transplant renal artery stenosis|transplant renal artery stenosis
4662355|NCT03477071|Endovascular repair|endovascular repair
4662356|NCT03477071|Post-operative outcome|post-operative outcome
4662357|NCT03477058|chronic pruritus|chronic pruritus
4662358|NCT03477058|acute pruritus|acute pruritus
4662359|NCT03477045|omega 3 polyunsaturated fatty acid|omega 3 polyunsaturated fatty acid
4662360|NCT03477045|camelina sativa|camelina sativa
4662361|NCT03477045|fatty acid composition|fatty acid composition
4662362|NCT03477045|immune modulation|immune modulation
4662363|NCT03477019|Ultrasonic Therapy|ultrasonic therapy
4662364|NCT03477019|Liver|liver
4662365|NCT03477019|Neoplasm Metastasis|neoplasm metastasis
4662366|NCT03476993|primary biliary cholangitis|primary biliary cholangitis
4662367|NCT03476993|IL-17 monoclonal antibody|il-17 monoclonal antibody
4662368|NCT03476980|Neurodevelopmental impairment, prematurity|neurodevelopmental impairment, prematurity
4662369|NCT03476980|Disability|disability
4662370|NCT03476980|Umbilical cord milking|umbilical cord milking
4662371|NCT03476980|Delayed cord clamping|delayed cord clamping
4662372|NCT03476967|optic disc topography|optic disc topography
4662373|NCT03476967|panretinal photocoagulation|panretinal photocoagulation
4662374|NCT03476967|confocal scanning laser ophthalmoscopy|confocal scanning laser ophthalmoscopy
4662375|NCT03476967|stereoscopic disc photographs|stereoscopic disc photographs
4662376|NCT03476967|diabetic retinopathy|diabetic retinopathy
4662377|NCT03476967|optic nerve head parameters|optic nerve head parameters
4662378|NCT03476902|OCD|ocd
4662379|NCT03476902|Mobile|mobile
4662380|NCT03476902|Technology|technology
4662381|NCT03476902|CBT|cbt
4662382|NCT03476902|Cognitive-Behavioral Therapy|cognitive-behavioral therapy
4662383|NCT03476876|acellular matrix|acellular matrix
4662384|NCT03476837|secondhand smoke, African Americans, policies, tobacco use|secondhand smoke, african americans, policies, tobacco use
4662385|NCT03476785|LVH|lvh
4662386|NCT03476785|Ventricular Stiffness|ventricular stiffness
4662387|NCT03476785|Fitness|fitness
4662388|NCT03476785|HFpEF|hfpef
4662389|NCT03476733|Drug related problem|drug related problem
4662390|NCT03476733|inpatient|inpatient
4662391|NCT03476733|Medication Error|medication error
4662392|NCT03476733|Clinical Pharmacist|clinical pharmacist
4662393|NCT03476681|NEO-201|neo-201
4662394|NCT03476681|Monoclonal Antibody|monoclonal antibody
4662395|NCT03476681|Colorectal Cancer|colorectal cancer
4662396|NCT03476681|Pancreatic Cancer|pancreatic cancer
4662397|NCT03476681|Adenocarcinoma of Lung|adenocarcinoma of lung
4662398|NCT03476681|Squamous Cell Lung Cancer|squamous cell lung cancer
4662399|NCT03476681|Breast Cancer|breast cancer
4662400|NCT03476681|Mucinous Carcinoma of Ovary|mucinous carcinoma of ovary
4662401|NCT03476681|Signet Ring Cell Carcinoma of Ovary|signet ring cell carcinoma of ovary
4662402|NCT03476629|Cardiopulmonary Exercise Test|cardiopulmonary exercise test
4662403|NCT03476629|Rehabilitation|rehabilitation
4662404|NCT03476629|Distance Traveled|distance traveled
4662405|NCT03476629|Functional Capacity|functional capacity
4662406|NCT03476629|Autonomic Nervous System|autonomic nervous system
4662407|NCT03476616|Hypertension|hypertension
4662408|NCT03476616|Obesity|obesity
4662409|NCT03476616|Ambulatory Blood Pressure|ambulatory blood pressure
4662410|NCT03476616|Eplerenone|eplerenone
4662411|NCT03476616|Valsartan|valsartan
4662412|NCT03476616|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists
4662413|NCT03476616|Angiotensin II Receptor Blockers|angiotensin ii receptor blockers
4662414|NCT03476603|Bariatric surgery|bariatric surgery
4662415|NCT03476603|Gastrointestinal tract|gastrointestinal tract
4662416|NCT03476603|Biological availability|biological availability
4662417|NCT03476603|Pharmacokinetics|pharmacokinetics
4662418|NCT03476603|Irbesartan|irbesartan
4662419|NCT03476590|heart failure|heart failure
4662420|NCT03476590|ambulatory care|ambulatory care
4662421|NCT03476590|telemedicine|telemedicine
4662422|NCT03476590|impedance cardiography|impedance cardiography
4662423|NCT03476577|Bariatric surgery|bariatric surgery
4662424|NCT03476577|Gastrointestinal tract|gastrointestinal tract
4662425|NCT03476577|Biological availability|biological availability
4662426|NCT03476577|Pharmacokinetics|pharmacokinetics
4662427|NCT03476577|Ibuprofen|ibuprofen
4662428|NCT03476564|assisted reproductive techniques|assisted reproductive techniques
4662429|NCT03476551|Bariatric surgery|bariatric surgery
4662430|NCT03476551|Gastrointestinal tract|gastrointestinal tract
4662431|NCT03476551|Biological availability|biological availability
4662432|NCT03476551|Pharmacokinetics|pharmacokinetics
4662433|NCT03476551|Hydrochlorothiazide|hydrochlorothiazide
4662434|NCT03476538|Bariatric surgery|bariatric surgery
4662435|NCT03476538|Gastrointestinal tract|gastrointestinal tract
4662436|NCT03476538|Biological availability|biological availability
4662437|NCT03476538|Pharmacokinetics|pharmacokinetics
4662438|NCT03476538|Gabapentin|gabapentin
4662439|NCT03476525|Bariatric surgery|bariatric surgery
4662440|NCT03476525|Gastrointestinal tract|gastrointestinal tract
4662441|NCT03476525|Biological availability|biological availability
4662442|NCT03476525|Pharmacokinetics|pharmacokinetics
4662443|NCT03476525|Fluoxetine|fluoxetine
4662444|NCT03476512|Treatment adherence|treatment adherence
4662445|NCT03476512|Ambulatory hypertensive patients|ambulatory hypertensive patients
4662446|NCT03476512|Blood pressure|blood pressure
4662447|NCT03476512|Non-pharmacological measures|non-pharmacological measures
4662448|NCT03476473|Asthma|asthma
4662449|NCT03476473|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
4662450|NCT03476473|Spirometry|spirometry
4662451|NCT03476473|Lung disease|lung disease
4662452|NCT03476473|Smoke|smoke
4662453|NCT03476460|Acute kidney failure|acute kidney failure
4662454|NCT03476460|CT scan|ct scan
4662455|NCT03476460|Iodine contrast|iodine contrast
4662456|NCT03476460|Sodium chloride|sodium chloride
4662457|NCT03476434|sessile serrated polyp|sessile serrated polyp
4662458|NCT03476434|chromoendoscopy|chromoendoscopy
4662459|NCT03476434|indigo carmine|indigo carmine
4662460|NCT03476382|Osteoarthritis|osteoarthritis
4662462|NCT03476382|Bone Growth Stimulators|bone growth stimulators
4662463|NCT03476382|Rheumatic Diseases|rheumatic diseases
4662464|NCT03476382|Musculoskeletal Diseases|musculoskeletal diseases
4662465|NCT03476382|Joint Diseases|joint diseases
4662466|NCT03476382|Arthritis|arthritis
4662467|NCT03476343|NICU|nicu
4662468|NCT03476343|MRI|mri
4662469|NCT03476343|Neonatal|neonatal
4662470|NCT03476343|Cincinnati|cincinnati
4662471|NCT03476330|Hematopoietic cell transplantation|hematopoietic cell transplantation
4662472|NCT03476291|macular diseases|macular diseases
4662473|NCT03476291|screening|screening
4662474|NCT03476291|OCT|oct
4662475|NCT03476291|Deep learning|deep learning
4662476|NCT03476291|AI|ai
4662477|NCT03476278|Outcome Assessment (Health Care)|outcome assessment (health care)
4662478|NCT03476278|Patient Satisfaction|patient satisfaction
4662479|NCT03476278|Perioperative Period|perioperative period
4662480|NCT03476278|Regional Anesthesia|regional anesthesia
4662481|NCT03476278|Surveys and Questionnaires|surveys and questionnaires
4662482|NCT03476239|Relapsed|relapsed
4662483|NCT03476239|Refractory|refractory
4662484|NCT03476239|B-precursor|b-precursor
4662485|NCT03476239|Acute Lymphoblastic|acute lymphoblastic
4662486|NCT03476239|Leukemia ALL|leukemia all
4662487|NCT03476239|Blinatumomab|blinatumomab
4662488|NCT03476239|Chinese Adult Subjects|chinese adult subjects
4662489|NCT03476226|Quality of Life|quality of life
4662490|NCT03476226|Cognitive Dysfunction|cognitive dysfunction
4662491|NCT03476226|Breast Cancer|breast cancer
4662492|NCT03476213|Anesthesia Awareness|anesthesia awareness
4662493|NCT03476213|Dreaming in anesthesia|dreaming in anesthesia
4662494|NCT03476213|Total intravenous anesthesia|total intravenous anesthesia
4662495|NCT03476213|Target-controll infusion|target-controll infusion
4662496|NCT03476200|Cognitive Behavioral Therapy|cognitive behavioral therapy
4662497|NCT03476200|Hair Cortisol|hair cortisol
4662498|NCT03476200|Hypothalamic Pituitary Adrenal Axis|hypothalamic pituitary adrenal axis
4662499|NCT03476200|Stress|stress
4662500|NCT03476200|Psychopathology|psychopathology
4662501|NCT03476135|Meningococcal Meningitis|meningococcal meningitis
4662502|NCT03476135|MenACYW conjugate vaccine|menacyw conjugate vaccine
4662503|NCT03476135|Quadrivalent meningococcal vaccine|quadrivalent meningococcal vaccine
4662504|NCT03476122|Colorectal cancer|colorectal cancer
4662505|NCT03476122|CRC|crc
4662506|NCT03476122|Circulating tumor cells|circulating tumor cells
4662507|NCT03476122|CTCs|ctcs
4662508|NCT03476122|Early detection|early detection
4662509|NCT03476122|Automated|automated
4662510|NCT03476096|pregnancy|pregnancy
4662511|NCT03476096|microcirculation|microcirculation
4662512|NCT03476083|Mother to Child Transmission|mother to child transmission
4662513|NCT03476083|Hepatitis B Infection|hepatitis b infection
4662514|NCT03476083|Congenital Defects or Malformation|congenital defects or malformation
4662515|NCT03476083|Hepatitis B Vaccine|hepatitis b vaccine
4662516|NCT03476083|Hepatitis B Immunoglobulin|hepatitis b immunoglobulin
4662517|NCT03476083|Pregnancy|pregnancy
4662518|NCT03476083|Antiviral Treatment|antiviral treatment
4662519|NCT03476070|Adolescents and Young Adults (AYA)|adolescents and young adults (aya)
4662520|NCT03476070|breast cancer|breast cancer
4662521|NCT03476070|lymphoma|lymphoma
4662522|NCT03476070|germ cell tumor|germ cell tumor
4662523|NCT03476070|cognitive impairment|cognitive impairment
4662524|NCT03476070|survivorship|survivorship
4662525|NCT03476070|Singapore|singapore
4662526|NCT03476057|NGS|ngs
4662527|NCT03476057|cfDNA|cfdna
4662528|NCT03476057|OS|os
4662529|NCT03476057|Tumor Burden|tumor burden
4662530|NCT03475966|Nutrition|nutrition
4662531|NCT03475966|Exercise|exercise
4662532|NCT03475966|Relaxation techniques|relaxation techniques
4662533|NCT03475966|Prehabilitation|prehabilitation
4662534|NCT03475953|Advanced solid tumor|advanced solid tumor
4662535|NCT03475953|Metastatic tumor|metastatic tumor
4662536|NCT03475953|Phase Ib/II trial|phase ib/ii trial
4662537|NCT03475953|Colorectal cancer not MSI-H or MMR-deficient|colorectal cancer not msi-h or mmr-deficient
4662538|NCT03475953|GIST|gist
4662539|NCT03475953|Oesophageal or Gastric Carcinoma|oesophageal or gastric carcinoma
4662540|NCT03475953|Biliary Tract cancer|biliary tract cancer
4662541|NCT03475953|Hepatocellular Carcinoma|hepatocellular carcinoma
4662542|NCT03475914|Psoriasis Guttate, Psoriasis vulgaris|psoriasis guttate, psoriasis vulgaris
4662543|NCT03475901|procedural anxiety|procedural anxiety
4662544|NCT03475901|virtual reality|virtual reality
4662545|NCT03475901|anxiolysis|anxiolysis
4662546|NCT03475901|laceration repair|laceration repair
4662547|NCT03475901|pediatric|pediatric
4662548|NCT03475888|Chronic Total Occlusion of Coronary Artery|chronic total occlusion of coronary artery
4662549|NCT03475888|Ventricular Arrythmia|ventricular arrythmia
4662550|NCT03475888|Sustained VT|sustained vt
4662551|NCT03475888|Ventricular Fibrillation|ventricular fibrillation
4662552|NCT03475888|Implantable loop recorder|implantable loop recorder
4662553|NCT03475849|Roux-en-Y Gastric Bypass Surgery|roux-en-y gastric bypass surgery
4662554|NCT03475849|Bile Acid Circulation|bile acid circulation
4662555|NCT03475849|Obesity|obesity
4662556|NCT03475849|Bariatric Surgery|bariatric surgery
4662557|NCT03475836|Mentha|mentha
4662558|NCT03475836|Mint|mint
4662559|NCT03475836|Essential oil|essential oil
4662560|NCT03475836|Cognition|cognition
4662561|NCT03475836|Mood|mood
4662562|NCT03475836|Humans|humans
4662563|NCT03475810|VIRTUAL REALITY|virtual reality
4662564|NCT03475810|ANXIETY|anxiety
4662565|NCT03475810|SPINAL ANESTHESIA|spinal anesthesia
4662566|NCT03475745|resting-state|resting-state
4662567|NCT03475745|DTI|dti
4662568|NCT03475745|aphasia|aphasia
4662569|NCT03475745|stroke|stroke
4662570|NCT03475732|XueBiJing injection|xuebijing injection
4662571|NCT03475732|Sepsis|sepsis
4662572|NCT03475732|Septic shock|septic shock
4662573|NCT03475732|Pharmacokinetics|pharmacokinetics
4662574|NCT03475706|overactive bladder|overactive bladder
4662575|NCT03475706|urinary conditions|urinary conditions
4662576|NCT03475706|urgency urinary incontinence|urgency urinary incontinence
4662577|NCT03475706|urgency|urgency
4662578|NCT03475706|micturitions|micturitions
4662579|NCT03475680|Mechanical Bowel Preparation (MBP)|mechanical bowel preparation (mbp)
4662580|NCT03475680|Oral antibiotics|oral antibiotics
4662581|NCT03475680|Colon cancer surgery|colon cancer surgery
4662582|NCT03475680|Surgical site infection|surgical site infection
4662583|NCT03475667|Septic Shock|septic shock
4662584|NCT03475667|hemodynamic monitoring|hemodynamic monitoring
4662585|NCT03475667|blood pressure determination|blood pressure determination
4662586|NCT03475654|exercise|exercise
4662587|NCT03475654|therapy|therapy
4662588|NCT03475654|rehabilitation|rehabilitation
4662589|NCT03475654|home|home
4662590|NCT03475641|pain|pain
4662591|NCT03475641|femoral nerve blockade|femoral nerve blockade
4662592|NCT03475641|varicose vein|varicose vein
4662593|NCT03475589|apatinib； Adverse drug reactions； gastric cancer; non-small cell lung cancer;breast cancer; ovarian cancer|apatinib； adverse drug reactions； gastric cancer; non-small cell lung cancer;breast cancer; ovarian cancer
4662594|NCT03475576|elderly|elderly
4662595|NCT03475576|caregiving|caregiving
4662596|NCT03475576|needs|needs
4662597|NCT03475576|support|support
4662598|NCT03475563|Drug-eluting stent|drug-eluting stent
4662599|NCT03475563|Dedicated bifurcation stent|dedicated bifurcation stent
4662600|NCT03475563|Cobalt-chromium|cobalt-chromium
4662601|NCT03475563|Sirolimus-eluting stent|sirolimus-eluting stent
4662602|NCT03475485|Ingestion event marker|ingestion event marker
4662603|NCT03475485|Ingestible sensor|ingestible sensor
4662604|NCT03475485|Medication adherence|medication adherence
4662605|NCT03475485|ID-Cap Medication Adherence Feedback System|id-cap medication adherence feedback system
4662606|NCT03475459|QTc prolongation effect|qtc prolongation effect
4662607|NCT03475446|Cognitive Training|cognitive training
4662608|NCT03475446|Memory Impairment|memory impairment
4662609|NCT03475446|Mild Cognitive Impairment|mild cognitive impairment
4662610|NCT03475446|Alzheimer's Disease|alzheimer's disease
4662611|NCT03475446|tES|tes
4662612|NCT03475446|tACS|tacs
4662613|NCT03475446|tDCS|tdcs
4662614|NCT03475433|Cancer|cancer
4662615|NCT03475433|Questionnaire|questionnaire
4662616|NCT03475433|Survey|survey
4662617|NCT03475433|Sleep Disturbance|sleep disturbance
4662618|NCT03475433|Sleep Quality|sleep quality
4662619|NCT03475433|E-health|e-health
4662620|NCT03475433|M-health|m-health
4662621|NCT03475433|Actigraphy|actigraphy
4662622|NCT03475433|Physical activity|physical activity
4662716|NCT03474913|prostate imaging|prostate imaging
4662623|NCT03475433|Dyssomnias Medical Subject Headings [MeSH]|dyssomnias medical subject headings [mesh]
4662624|NCT03475433|Sleep Wake Disorders [MeSH]|sleep wake disorders [mesh]
4662625|NCT03475433|Parasomnias [MeSH]|parasomnias [mesh]
4662626|NCT03475433|Nervous System Diseases [MeSH]|nervous system diseases [mesh]
4662627|NCT03475433|Mental Disorders [MeSH]|mental disorders [mesh]
4662628|NCT03475433|Neurologic Manifestations [MeSH]|neurologic manifestations [mesh]
4662629|NCT03475433|Signs and Symptoms [MeSH]|signs and symptoms [mesh]
4662630|NCT03475433|Telemedicine [MeSH]|telemedicine [mesh]
4662631|NCT03475433|Actigraphy [MeSH]|actigraphy [mesh]
4662632|NCT03475433|Quality of Life [MeSH]|quality of life [mesh]
4662633|NCT03475433|Motor Activity [MeSH]|motor activity [mesh]
4662634|NCT03475433|Breast Neoplasms [MeSH]|breast neoplasms [mesh]
4662635|NCT03475433|Prostatic Neoplasms [MeSH]|prostatic neoplasms [mesh]
4662636|NCT03475433|Sleep Hygiene [MeSH]|sleep hygiene [mesh]
4662637|NCT03475433|Neoplasms [MeSH]|neoplasms [mesh]
4662638|NCT03475407|Diabetic macular edema|diabetic macular edema
4662639|NCT03475407|cytokine|cytokine
4662640|NCT03475407|dexamethasone|dexamethasone
4662641|NCT03475394|Chlorhexidine gluconate|chlorhexidine gluconate
4662642|NCT03475394|Morus alba|morus alba
4662643|NCT03475394|Microbiology|microbiology
4662644|NCT03475394|Gel|gel
4662645|NCT03475394|Root planing|root planing
4662646|NCT03475381|Cystic Fibrosis|cystic fibrosis
4662647|NCT03475381|ivacaftor|ivacaftor
4662648|NCT03475381|lumacaftor|lumacaftor
4662649|NCT03475355|action observation|action observation
4662650|NCT03475355|parkinson's disease|parkinson's disease
4662651|NCT03475355|physical therapy|physical therapy
4662652|NCT03475355|home-based|home-based
4662653|NCT03475355|neural plasticity|neural plasticity
4662654|NCT03475355|telerehabilitation|telerehabilitation
4662655|NCT03475342|prevention, postpartum haemorrhage|prevention, postpartum haemorrhage
4662656|NCT03475342|moderate anaemia|moderate anaemia
4662657|NCT03475342|severe anaemia|severe anaemia
4662658|NCT03475342|antifibrinolytic|antifibrinolytic
4662659|NCT03475342|tranexamic acid|tranexamic acid
4662660|NCT03475342|pregnancy|pregnancy
4662661|NCT03475329|pediatric obstructive sleep disordered breathing-partial tonsillectomy -unilateral complete tonsillectomy -adenoidectomy|pediatric obstructive sleep disordered breathing-partial tonsillectomy -unilateral complete tonsillectomy -adenoidectomy
4662662|NCT03475290|e-mental health|e-mental health
4662663|NCT03475290|stress|stress
4662664|NCT03475290|burnout|burnout
4662665|NCT03475290|self-efficacy|self-efficacy
4662666|NCT03475290|social support|social support
4662667|NCT03475264|Lung MRI, Bronchopulmonary Dysplasia, hyperpolarized xenon,|lung mri, bronchopulmonary dysplasia, hyperpolarized xenon,
4662668|NCT03475238|critical care|critical care
4662669|NCT03475225|Epilepsy|epilepsy
4662670|NCT03475225|Drug-resistance|drug-resistance
4662671|NCT03475225|Vitamin D deficiency|vitamin d deficiency
4662672|NCT03475225|Metabolism|metabolism
4662673|NCT03475225|Controlled study antiepileptic drugs|controlled study antiepileptic drugs
4662674|NCT03475212|Hematopoietic Stem Cell Transplant|hematopoietic stem cell transplant
4662675|NCT03475212|Primary Immune Deficiency Disease|primary immune deficiency disease
4662676|NCT03475186|Memory|memory
4662677|NCT03475186|Brain Cancer|brain cancer
4662678|NCT03475186|Ramipril|ramipril
4662679|NCT03475173|Optic Neuropathy|optic neuropathy
4662680|NCT03475173|, Retinopathy|, retinopathy
4662681|NCT03475095|Low Back Pain|low back pain
4662682|NCT03475095|Tuina therapy|tuina therapy
4662683|NCT03475095|lumbar disc herniation|lumbar disc herniation
4662684|NCT03475095|central motion control|central motion control
4662685|NCT03475095|functional magnetic resonanceimaging|functional magnetic resonanceimaging
4662686|NCT03475095|effect mechanism|effect mechanism
4662687|NCT03475095|Chronic nonspecific low Back pain|chronic nonspecific low back pain
4662688|NCT03475069|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
4662689|NCT03475069|Exercise|exercise
4662690|NCT03475069|Physical Performance|physical performance
4662691|NCT03475069|Physiological Cost Index|physiological cost index
4662692|NCT03475056|Marburg virus|marburg virus
4662693|NCT03475056|Marburg vaccine|marburg vaccine
4662694|NCT03475056|cAd3-Marburg vaccine|cad3-marburg vaccine
4662695|NCT03475004|Pembrolizumab|pembrolizumab
4662696|NCT03475004|Binimetinib|binimetinib
4662697|NCT03475004|Bevacizumab|bevacizumab
4662698|NCT03475004|Combination Therapy|combination therapy
4662699|NCT03474965|SEG101|seg101
4662700|NCT03474965|Sickle cell disease|sickle cell disease
4662701|NCT03474965|crizanlizumab|crizanlizumab
4662702|NCT03474965|pediatric|pediatric
4662703|NCT03474965|pharmacokinetic|pharmacokinetic
4662704|NCT03474965|P-selectin|p-selectin
4662705|NCT03474952|remote ischemic preconditioning|remote ischemic preconditioning
4662706|NCT03474952|free flap reconstruction|free flap reconstruction
4662707|NCT03474952|tissue oxygen saturation|tissue oxygen saturation
4662708|NCT03474926|urothelial cancer|urothelial cancer
4662709|NCT03474926|nephroureterectomy|nephroureterectomy
4662710|NCT03474926|Upper urinary tract|upper urinary tract
4662711|NCT03474913|Prostate Cancer|prostate cancer
4662712|NCT03474913|Magnetic Resonance Imaging|magnetic resonance imaging
4662713|NCT03474913|case cross over|case cross over
4662714|NCT03474913|diagnostic|diagnostic
4662715|NCT03474913|clinical trial|clinical trial
4662717|NCT03474913|PSA|psa
4662718|NCT03474900|intramedullary nailing|intramedullary nailing
4662719|NCT03474900|randomised controlled trial|randomised controlled trial
4662720|NCT03474900|biodegradable|biodegradable
4662721|NCT03474900|children|children
4662722|NCT03474900|forearm shaft fractures|forearm shaft fractures
4662723|NCT03474887|Telemedicine|telemedicine
4662724|NCT03474887|Remote consultation|remote consultation
4662725|NCT03474887|Mobile health|mobile health
4662726|NCT03474887|Telehealth|telehealth
4662727|NCT03474887|mhealth|mhealth
4662728|NCT03474887|eVisits|evisits
4662729|NCT03474887|eConsultation|econsultation
4662730|NCT03474887|ehealth|ehealth
4662731|NCT03474848|cerebral palsy|cerebral palsy
4662732|NCT03474848|rehabilitation|rehabilitation
4662733|NCT03474848|hand function|hand function
4662734|NCT03474848|daily functioning|daily functioning
4662735|NCT03474848|hand-arm bimanual intensive training|hand-arm bimanual intensive training
4662736|NCT03474835|atherosclerosis|atherosclerosis
4662737|NCT03474835|angiogenesis|angiogenesis
4662738|NCT03474835|cardiooncology|cardiooncology
4662739|NCT03474822|Advanced breast cancer|advanced breast cancer
4662740|NCT03474822|advanced liver cancer|advanced liver cancer
4662741|NCT03474822|Plasmodium immunotherapy|plasmodium immunotherapy
4662742|NCT03474822|Plasmodiun vivax|plasmodiun vivax
4662743|NCT03474809|Sepsis, PSP, Abionic|sepsis, psp, abionic
4662744|NCT03474718|scalp|scalp
4662745|NCT03474718|hair loss|hair loss
4662746|NCT03474718|platelet-rich plasma therapy|platelet-rich plasma therapy
4662747|NCT03474705|Clinical Pain|clinical pain
4662748|NCT03474705|Hyperalgesia|hyperalgesia
4662749|NCT03474705|Intervention|intervention
4662750|NCT03474705|Musculoskeletal disorders|musculoskeletal disorders
4662751|NCT03474705|Computer Work|computer work
4662752|NCT03474705|Strength Training|strength training
4662753|NCT03474666|Liver Transplantation|liver transplantation
4662754|NCT03474666|Surgical Wound Infection|surgical wound infection
4662755|NCT03474666|Hiperglycemia|hiperglycemia
4662756|NCT03474653|Stress urinary incontinence|stress urinary incontinence
4662757|NCT03474653|Bulking|bulking
4662758|NCT03474653|Bulkamid|bulkamid
4662759|NCT03474640|immunotherapy|immunotherapy
4662760|NCT03474640|check point inhibitor|check point inhibitor
4662761|NCT03474640|PD-1 antibody|pd-1 antibody
4662762|NCT03474640|solid tumor|solid tumor
4662763|NCT03474640|esophageal carcinoma|esophageal carcinoma
4662764|NCT03474640|gastric carcinoma|gastric carcinoma
4662765|NCT03474640|nasopharyngeal carcinoma|nasopharyngeal carcinoma
4662766|NCT03474640|endometrial cancer|endometrial cancer
4662767|NCT03474640|soft tissue sarcoma|soft tissue sarcoma
4662768|NCT03474640|orphan tumors|orphan tumors
4662769|NCT03474640|phase 1 trial|phase 1 trial
4662770|NCT03474601|Pituitary Diseases|pituitary diseases
4662771|NCT03474601|Pituitary incidentaloma|pituitary incidentaloma
4662772|NCT03474601|Central Diabetes Insipidus|central diabetes insipidus
4662773|NCT03474601|Pituitary Neoplasms|pituitary neoplasms
4662774|NCT03474575|homecare, COPD, Exacerbation|homecare, copd, exacerbation
4662775|NCT03474549|Mechanical thrombectomy,|mechanical thrombectomy,
4662776|NCT03474549|Brain|brain
4662777|NCT03474549|Brain clot|brain clot
4662778|NCT03474549|Brain infarction|brain infarction
4662779|NCT03474549|Cerebral ischemia|cerebral ischemia
4662780|NCT03474549|Neurovascular intervention|neurovascular intervention
4662781|NCT03474549|Revascularization|revascularization
4662782|NCT03474549|Reperfusion|reperfusion
4662783|NCT03474549|Stent retriever|stent retriever
4662784|NCT03474549|Tigertriever|tigertriever
4662785|NCT03474549|Stroke|stroke
4662786|NCT03474549|Rapid Medical|rapid medical
4662787|NCT03474536|Lung transplantation|lung transplantation
4662788|NCT03474536|HLA antibodies|hla antibodies
4662789|NCT03474536|concentration|concentration
4662790|NCT03474536|affinity|affinity
4662791|NCT03474536|surface plasmon resonance|surface plasmon resonance
4662792|NCT03474523|radio frequency diathermy|radio frequency diathermy
4662793|NCT03474523|cavitation|cavitation
4662794|NCT03474523|ultrasound|ultrasound
4662795|NCT03474523|edemato-fibrosclerotic panniculopathy|edemato-fibrosclerotic panniculopathy
4662796|NCT03474523|cellulitis|cellulitis
4662797|NCT03474510|pain control|pain control
4662798|NCT03474510|EXPAREL|exparel
4662799|NCT03474510|shoulder surgery|shoulder surgery
4662800|NCT03474510|continuous interscalene nerve block|continuous interscalene nerve block
4662801|NCT03474484|Biomarkers|biomarkers
4662802|NCT03474484|Sensitivity and Specificity|sensitivity and specificity
4662803|NCT03474484|Clinical Deterioration|clinical deterioration
4662804|NCT03474380|Caregiver|caregiver
4662805|NCT03474380|Veterans|veterans
4662806|NCT03474380|Skills training|skills training
4662807|NCT03474380|Informal care|informal care
4662808|NCT03474380|Days at home|days at home
4662809|NCT03474367|Unplanned Peritoneal Dialysis|unplanned peritoneal dialysis
4662810|NCT03474367|Unplanned Hemodialysis|unplanned hemodialysis
4662811|NCT03474367|Cost-Benefit Analysis|cost-benefit analysis
4662812|NCT03474367|Dialysis|dialysis
4662813|NCT03474367|Peritoneal Dialysis|peritoneal dialysis
4662814|NCT03474367|Hemodialysis|hemodialysis
4662815|NCT03474354|chemoembolization|chemoembolization
4662915|NCT03473938|Intolerance|intolerance
4662816|NCT03474354|drug eluting beads|drug eluting beads
4662817|NCT03474341|Neoadjuvant chemoradiotherapy (nCRT)|neoadjuvant chemoradiotherapy (ncrt)
4662818|NCT03474341|Pathologic complete response (pCR)|pathologic complete response (pcr)
4662819|NCT03474341|Magnetic Resonance Imaging (MRI)|magnetic resonance imaging (mri)
4662820|NCT03474341|PET-CT|pet-ct
4662821|NCT03474341|Circulating tumor DNA (ctDNA)|circulating tumor dna (ctdna)
4662822|NCT03474341|endoscopy|endoscopy
4662823|NCT03474315|Cardiac implantable electronic device|cardiac implantable electronic device
4662824|NCT03474315|Cardiac resynchronization therapy|cardiac resynchronization therapy
4662825|NCT03474315|Implantable cardioverter-defibrillator|implantable cardioverter-defibrillator
4662826|NCT03474315|Machine learning|machine learning
4662827|NCT03474315|Mobile application|mobile application
4662828|NCT03474315|Patient's assistance|patient's assistance
4662829|NCT03474302|African American|african american
4662830|NCT03474302|Aging|aging
4662831|NCT03474302|Physical activity|physical activity
4662832|NCT03474302|Cognition|cognition
4662833|NCT03474276|Children|children
4662834|NCT03474276|Africa|africa
4662835|NCT03474276|Metagenomic|metagenomic
4662836|NCT03474276|Prebiotic|prebiotic
4662837|NCT03474276|Randomized Controlled Trial|randomized controlled trial
4662838|NCT03474276|Pragmatic trial|pragmatic trial
4662839|NCT03474276|Azithromycin|azithromycin
4662840|NCT03474276|Cognitive impairment|cognitive impairment
4662841|NCT03474263|Motor Neurone Disease (MND)|motor neurone disease (mnd)
4662842|NCT03474263|Amyotrophic Lateral Sclerosis (ALS)|amyotrophic lateral sclerosis (als)
4662843|NCT03474237|algorithms|algorithms
4662844|NCT03474237|adrenal adenoma|adrenal adenoma
4662845|NCT03474237|cushing syndrome|cushing syndrome
4662846|NCT03474237|pheochromocytoma|pheochromocytoma
4662847|NCT03474237|adrenal incidentaloma|adrenal incidentaloma
4662848|NCT03474237|adreocortical carcinoma|adreocortical carcinoma
4662849|NCT03474237|primary hyperaldosteronism|primary hyperaldosteronism
4662850|NCT03474224|stroke volume|stroke volume
4662851|NCT03474224|goal directed therapy|goal directed therapy
4662852|NCT03474224|major abdominal surgery|major abdominal surgery
4662853|NCT03474172|Pediatric Tuina|pediatric tuina
4662854|NCT03474172|Massage therapy|massage therapy
4662855|NCT03474172|Sham Tuina|sham tuina
4662856|NCT03474172|Sham massage|sham massage
4662857|NCT03474172|Sham device|sham device
4662858|NCT03474159|Bicuspid aortic valve|bicuspid aortic valve
4662859|NCT03474159|aortic aneurysm|aortic aneurysm
4662860|NCT03474159|stiffness|stiffness
4662861|NCT03474159|Pulse wave velocity|pulse wave velocity
4662862|NCT03474146|Mouthrinse|mouthrinse
4662863|NCT03474146|Ocimum sanctum|ocimum sanctum
4662864|NCT03474146|Periodontal Diseases|periodontal diseases
4662865|NCT03474146|Tulsi|tulsi
4662866|NCT03474133|Hodgkin's lymphoma|hodgkin's lymphoma
4662867|NCT03474133|Hodgkin lymphoma|hodgkin lymphoma
4662868|NCT03474133|relapsed|relapsed
4662869|NCT03474133|refractory|refractory
4662870|NCT03474133|brentuximab vedotin|brentuximab vedotin
4662871|NCT03474133|autologous stem cell transplantation|autologous stem cell transplantation
4662872|NCT03474120|Genetic causes|genetic causes
4662873|NCT03474120|etiology|etiology
4662874|NCT03474120|POI|poi
4662875|NCT03474120|DOR|dor
4662876|NCT03474107|antibody drug conjugate|antibody drug conjugate
4662877|NCT03474107|enfortumab vedotin (EV)|enfortumab vedotin (ev)
4662878|NCT03474107|ASG-22ME|asg-22me
4662879|NCT03474107|ASG-22CE|asg-22ce
4662880|NCT03474107|urothelial cancer|urothelial cancer
4662881|NCT03474094|Clinical Trial|clinical trial
4662882|NCT03474094|randomized|randomized
4662883|NCT03474094|phase II|phase ii
4662884|NCT03474094|atezolizumab|atezolizumab
4662885|NCT03474094|PD-L1|pd-l1
4662886|NCT03474081|Umeclidinium|umeclidinium
4662887|NCT03474081|Lung function|lung function
4662888|NCT03474081|RESPIMAT|respimat
4662889|NCT03474081|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
4662890|NCT03474081|Triple Therapy|triple therapy
4662891|NCT03474081|Vilanterol|vilanterol
4662892|NCT03474081|HANDIHALER|handihaler
4662893|NCT03474081|Tiotropium|tiotropium
4662894|NCT03474081|Fluticasone furoate|fluticasone furoate
4662895|NCT03474068|Emergency Medical Services, Stroke, Ambulances|emergency medical services, stroke, ambulances
4662896|NCT03474055|Liquid rotavirus vaccine|liquid rotavirus vaccine
4662897|NCT03474055|LBRV-PV|lbrv-pv
4662898|NCT03474055|Gastroenteritis|gastroenteritis
4662899|NCT03474055|Diarrhoea|diarrhoea
4662900|NCT03474029|latent tuberculosis|latent tuberculosis
4662901|NCT03474029|rifapentine|rifapentine
4662902|NCT03474003|Score prediction|score prediction
4662903|NCT03474003|Allograft survival|allograft survival
4662904|NCT03473990|Home-based|home-based
4662905|NCT03473990|Short-term|short-term
4662906|NCT03473990|Randomised Control Trial|randomised control trial
4662907|NCT03473951|Hyperuricemia|hyperuricemia
4662908|NCT03473951|Metabolic syndrome|metabolic syndrome
4662909|NCT03473951|Left ventricular hypertrophy|left ventricular hypertrophy
4662910|NCT03473938|Obesity|obesity
4662911|NCT03473938|Weight loss|weight loss
4662912|NCT03473938|Intragastric balloons|intragastric balloons
4662913|NCT03473938|Adjustable gastric balloon|adjustable gastric balloon
4662914|NCT03473938|Weight loss plateau|weight loss plateau
4662916|NCT03473860|prognosis|prognosis
4662917|NCT03473860|all-cause mortality|all-cause mortality
4662918|NCT03473860|myocardial infarction|myocardial infarction
4662919|NCT03473860|stroke|stroke
4662920|NCT03473847|VHF digital ultrasound|vhf digital ultrasound
4662921|NCT03473847|Optical coherence tomography|optical coherence tomography
4662922|NCT03473847|Corneal thickness|corneal thickness
4662923|NCT03473847|Epithelial thickness|epithelial thickness
4662924|NCT03473847|LASIK|lasik
4662925|NCT03473847|SMILE|smile
4662926|NCT03473834|Parkinson's disease|parkinson's disease
4662927|NCT03473834|Exercise|exercise
4662928|NCT03473834|Rigidity|rigidity
4662929|NCT03473834|Turning|turning
4662930|NCT03473821|ACL Injury|acl injury
4662931|NCT03473821|Return to Sport|return to sport
4662932|NCT03473821|Mental Training|mental training
4662933|NCT03473821|Motor Imagery|motor imagery
4662934|NCT03473808|Hand Function|hand function
4662935|NCT03473808|Occupational Therapy|occupational therapy
4662936|NCT03473808|Physical Stimulation|physical stimulation
4662937|NCT03473795|Patient Outcomes|patient outcomes
4662938|NCT03473795|18-114|18-114
4662939|NCT03473769|Hospital Admission|hospital admission
4662940|NCT03473756|Locally advanced or metastatic urothelial carcinoma|locally advanced or metastatic urothelial carcinoma
4662941|NCT03473756|Bladder cancer|bladder cancer
4662942|NCT03473756|Checkpoint inhibition|checkpoint inhibition
4662943|NCT03473756|FGFR inhibition|fgfr inhibition
4662944|NCT03473730|Malignant neoplasms of urinary tract|malignant neoplasms of urinary tract
4662945|NCT03473730|Metastatic renal cell carcinoma|metastatic renal cell carcinoma
4662946|NCT03473730|Muscle invasive bladder cancer|muscle invasive bladder cancer
4662947|NCT03473730|Daratumumab|daratumumab
4662948|NCT03473717|pain|pain
4662949|NCT03473717|Intrauterine device (IUD)|intrauterine device (iud)
4662950|NCT03473717|Intrauterine system (IUS)|intrauterine system (ius)
4662951|NCT03473717|Patient-Reported Outcome|patient-reported outcome
4662952|NCT03473704|Type 1 diabetes|type 1 diabetes
4662953|NCT03473704|Depression|depression
4662954|NCT03473704|Telematic Program|telematic program
4662955|NCT03473704|Treatment|treatment
4662956|NCT03473704|Web-based|web-based
4662957|NCT03473665|ankylsoing spondylitis|ankylsoing spondylitis
4662958|NCT03473665|spondyloarthritis|spondyloarthritis
4662959|NCT03473639|Residual invasive breast cancer|residual invasive breast cancer
4662960|NCT03473639|Metastatic breast cancer|metastatic breast cancer
4662961|NCT03473613|Calcium infusion|calcium infusion
4662962|NCT03473613|Cabergoline|cabergoline
4662963|NCT03473548|Childhood OSA|childhood osa
4662964|NCT03473535|self-harm|self-harm
4662965|NCT03473535|problem-solving therapy|problem-solving therapy
4662966|NCT03473535|emergency department|emergency department
4662967|NCT03473535|e-therapy|e-therapy
4662968|NCT03473535|suicide prevention|suicide prevention
4662969|NCT03473522|Transcranial Direct Current Stimulation|transcranial direct current stimulation
4662970|NCT03473522|therapeutic exercises|therapeutic exercises
4662971|NCT03473522|Parkinson|parkinson
4662972|NCT03473496|BCMA-CART|bcma-cart
4662973|NCT03473496|CD138-CART|cd138-cart
4662974|NCT03473496|CD56-CART|cd56-cart
4662975|NCT03473496|CD38-CART|cd38-cart
4662976|NCT03473483|nicotine|nicotine
4662977|NCT03473483|tobacco|tobacco
4662978|NCT03473483|research electronic cigarette|research electronic cigarette
4662979|NCT03473483|e-cigarette|e-cigarette
4662980|NCT03473483|SREC|srec
4662981|NCT03473470|Maternal and Neonatal Hypothermia, cesarean delivery|maternal and neonatal hypothermia, cesarean delivery
4662982|NCT03473457|CD38-CART|cd38-cart
4662983|NCT03473457|CD33-CART|cd33-cart
4662984|NCT03473457|CD56-CART|cd56-cart
4662985|NCT03473457|CD123-CART|cd123-cart
4662986|NCT03473457|CD117-CART|cd117-cart
4662987|NCT03473457|CD133-CART|cd133-cart
4662988|NCT03473457|CD34-CART|cd34-cart
4662989|NCT03473457|Mucl-CART|mucl-cart
4662990|NCT03473444|uric acid|uric acid
4662991|NCT03473444|prevalence|prevalence
4662992|NCT03473444|pakistan|pakistan
4662993|NCT03473405|Total knee replacement|total knee replacement
4662994|NCT03473405|Operating room airborne CFU|operating room airborne cfu
4662995|NCT03473392|pre-treatment|pre-treatment
4662996|NCT03473392|antibiotherapy|antibiotherapy
4662997|NCT03473392|prosthetic joint infection|prosthetic joint infection
4662998|NCT03473392|treatment failure|treatment failure
4662999|NCT03473379|economic difficulty, financial toxicity|economic difficulty, financial toxicity
4663000|NCT03473353|Medical Scribe|medical scribe
4663001|NCT03473353|Outpatient|outpatient
4663002|NCT03473353|EHR|ehr
4663003|NCT03473340|CLAD|clad
4663004|NCT03473340|Chronic Rejection|chronic rejection
4663005|NCT03473340|Lung Transplant|lung transplant
4663006|NCT03473327|colorectal neoplasms|colorectal neoplasms
4663007|NCT03473327|Immunologic Factors|immunologic factors
4663008|NCT03473327|Postoperative Period|postoperative period
4663009|NCT03473314|Inhaled nitric oxide|inhaled nitric oxide
4663010|NCT03473314|Non-tuberculous mycobacteria|non-tuberculous mycobacteria
4663011|NCT03473314|Drug resistant bacteria|drug resistant bacteria
4663012|NCT03473314|Antimicrobial drug resistance|antimicrobial drug resistance
4663013|NCT03473301|CP|cp
4663014|NCT03473301|Cerebral Palsy|cerebral palsy
4663015|NCT03473301|Stem Cell|stem cell
4663016|NCT03473301|Cord Blood|cord blood
4663017|NCT03473301|MSCs|mscs
4663018|NCT03473275|Sympathetic nervous system|sympathetic nervous system
4663019|NCT03473275|Blood oxygen level dependent|blood oxygen level dependent
4663020|NCT03473275|Brainstem|brainstem
4663021|NCT03473275|Contrast enhanced ultrasound|contrast enhanced ultrasound
4663022|NCT03473275|Kidney function|kidney function
4663023|NCT03473275|Hypertension|hypertension
4663024|NCT03473275|Renal denervation|renal denervation
4663025|NCT03473262|Type 2 diabetes|type 2 diabetes
4663026|NCT03473262|Sodium glucose cotransporter 2 inhibitor|sodium glucose cotransporter 2 inhibitor
4663027|NCT03473262|Empagliflozin|empagliflozin
4663028|NCT03473262|Insulin glargine|insulin glargine
4663029|NCT03473171|nasal non-invasive ventilation|nasal non-invasive ventilation
4663030|NCT03473171|RAM Cannula|ram cannula
4663031|NCT03473171|Pediatric Complex Care|pediatric complex care
4663032|NCT03473171|Tracheostomy Avoidance|tracheostomy avoidance
4663033|NCT03473158|fetal reduction|fetal reduction
4663034|NCT03473158|embryo reduction|embryo reduction
4663035|NCT03473158|feticide|feticide
4663036|NCT03473158|potassium chloride|potassium chloride
4663037|NCT03473158|multiple pregnancy|multiple pregnancy
4663038|NCT03473158|multifetal pregnancy|multifetal pregnancy
4663039|NCT03473119|Sphingosine-1-phosphate|sphingosine-1-phosphate
4663040|NCT03473106|Pneumatic Tourniquet|pneumatic tourniquet
4663041|NCT03473106|Postoperative Muscle Dysfunction|postoperative muscle dysfunction
4663042|NCT03473080|OCD|ocd
4663043|NCT03473080|ASD|asd
4663044|NCT03473080|Obsessive Compulsive Disorder|obsessive compulsive disorder
4663045|NCT03473080|Autism Spectrum Disorder|autism spectrum disorder
4663046|NCT03473080|ICBT|icbt
4663047|NCT03473080|eHealth|ehealth
4663048|NCT03473080|Internet|internet
4663049|NCT03473080|CBT|cbt
4663050|NCT03473080|Pediatric|pediatric
4663051|NCT03473080|Adolescents|adolescents
4663052|NCT03473080|Children|children
4663053|NCT03473080|Internet-delivered|internet-delivered
4663054|NCT03473054|Stroke|stroke
4663055|NCT03473054|Cerebrovascular Accident|cerebrovascular accident
4663056|NCT03473054|Stress|stress
4663057|NCT03473054|Anxiety|anxiety
4663058|NCT03473054|Depression|depression
4663059|NCT03473054|Mindfulness|mindfulness
4663060|NCT03473054|Family caregivers|family caregivers
4663061|NCT03473054|Web-based|web-based
4663062|NCT03473041|female stress incontinence|female stress incontinence
4663063|NCT03473041|Transobturator tension free vaginal tape TVTO|transobturator tension free vaginal tape tvto
4663064|NCT03473028|obesity|obesity
4663065|NCT03473028|embryo transfer|embryo transfer
4663066|NCT03473028|invitro fertilization|invitro fertilization
4663067|NCT03473002|Immunogenicity|immunogenicity
4663068|NCT03473002|Respiratory Syncytial Virus|respiratory syncytial virus
4663069|NCT03473002|Safety|safety
4663070|NCT03473002|Sendai Virus|sendai virus
4663071|NCT03473002|Vaccine|vaccine
4663072|NCT03472989|plantar fasciopathy|plantar fasciopathy
4663073|NCT03472989|foot orthosis|foot orthosis
4663074|NCT03472989|rESWT|reswt
4663075|NCT03472989|exercise|exercise
4663076|NCT03472976|A/H7N9 Vaccine|a/h7n9 vaccine
4663077|NCT03472976|Adults|adults
4663078|NCT03472976|Immunogenicity|immunogenicity
4663079|NCT03472976|Influenza|influenza
4663080|NCT03472976|Phase I|phase i
4663081|NCT03472976|Reactogenicity|reactogenicity
4663082|NCT03472976|Safety|safety
4663083|NCT03472963|Post-Exposure Prophylaxis|post-exposure prophylaxis
4663084|NCT03472963|Anti-Retroviral|anti-retroviral
4663085|NCT03472963|Pharmacokinetics|pharmacokinetics
4663086|NCT03472937|Mechanical cervical ripening|mechanical cervical ripening
4663087|NCT03472937|Transcervical catheter|transcervical catheter
4663088|NCT03472937|Foley catheter for labor induction|foley catheter for labor induction
4663089|NCT03472937|Cervical ripening|cervical ripening
4663090|NCT03472937|Induction of labor|induction of labor
4663091|NCT03472924|AMI|ami
4663092|NCT03472885|PNH|pnh
4663093|NCT03472885|Paroxysmal Nocturnal Hemoglobinuria|paroxysmal nocturnal hemoglobinuria
4663094|NCT03472885|ACH-0144471|ach-0144471
4663095|NCT03472885|eculizumab|eculizumab
4663096|NCT03472872|acetaminophen|acetaminophen
4663097|NCT03472872|ketorolac|ketorolac
4663098|NCT03472872|prochlorperazine|prochlorperazine
4663099|NCT03472872|diphenhydramine|diphenhydramine
4663100|NCT03472859|laser|laser
4663101|NCT03472859|lasers|lasers
4663102|NCT03472859|KTP|ktp
4663103|NCT03472859|semiconductor|semiconductor
4663104|NCT03472859|tgs|tgs
4663105|NCT03472859|rosacea|rosacea
4663106|NCT03472859|telangiectasia|telangiectasia
4663107|NCT03472833|V|v
4663108|NCT03472820|Diet|diet
4663109|NCT03472820|Lifestyle|lifestyle
4663110|NCT03472820|DNA methylation|dna methylation
4663111|NCT03472768|ECMO|ecmo
4663112|NCT03472755|hip arthroplasty, surgeries, physical fitness, perception, energetic cost, autonomy|hip arthroplasty, surgeries, physical fitness, perception, energetic cost, autonomy
4663113|NCT03472729|Social isolation|social isolation
4663114|NCT03472729|Older adults|older adults
4663115|NCT03472729|Technology|technology
4663116|NCT03472716|Pancreatic adenocarcinoma|pancreatic adenocarcinoma
4663117|NCT03472716|βig-h3|βig-h3
4663118|NCT03472716|Pronostic marker|pronostic marker
4663119|NCT03472703|fMRI|fmri
4663120|NCT03472703|Cognitive processes|cognitive processes
4663121|NCT03472703|Inhibition|inhibition
4663122|NCT03472703|Food reward|food reward
4663123|NCT03472703|Appetite|appetite
4663124|NCT03472690|Inflammatory Bowel Disease 1|inflammatory bowel disease 1
4663125|NCT03472677|Osteoarthritis|osteoarthritis
4663126|NCT03472677|Knee Pain|knee pain
4663127|NCT03472664|Memory|memory
4663128|NCT03472664|Diet|diet
4663129|NCT03472664|ketogenic|ketogenic
4663130|NCT03472612|OSA|osa
4663131|NCT03472612|CPAP|cpap
4663132|NCT03472612|upper airway collapse|upper airway collapse
4663133|NCT03472612|neural respiratory drive|neural respiratory drive
4663134|NCT03472599|Neurogenic bladder dysfunction|neurogenic bladder dysfunction
4663135|NCT03472599|Genital Nerve Stimulation|genital nerve stimulation
4663136|NCT03472599|Electrical Stimulation|electrical stimulation
4663137|NCT03472599|Urinary Incontinence|urinary incontinence
4663138|NCT03472599|Spinal cord injury|spinal cord injury
4663139|NCT03472560|Cancer|cancer
4663140|NCT03472560|non-small cell lung cancer|non-small cell lung cancer
4663141|NCT03472560|non small cell lung cancer|non small cell lung cancer
4663142|NCT03472560|NSCLC|nsclc
4663143|NCT03472560|lung cancer|lung cancer
4663144|NCT03472560|urothelial cancer|urothelial cancer
4663145|NCT03472560|bladder cancer|bladder cancer
4663146|NCT03472560|Avelumab|avelumab
4663147|NCT03472560|Bavencio|bavencio
4663148|NCT03472560|Axitinib|axitinib
4663149|NCT03472560|Inlyta|inlyta
4663150|NCT03472508|Folic acid|folic acid
4663151|NCT03472508|Homocysteine|homocysteine
4663152|NCT03472508|MTHFR C677T|mthfr c677t
4663153|NCT03472508|RCT|rct
4663154|NCT03472508|Precision treatment|precision treatment
4663155|NCT03472495|Diltiazem|diltiazem
4663156|NCT03472495|Atrial Fibrillation|atrial fibrillation
4663157|NCT03472495|Atrial Flutter|atrial flutter
4663158|NCT03472495|Emergency Medicine|emergency medicine
4663159|NCT03472482|Alzheimer's disease|alzheimer's disease
4663160|NCT03472482|Dementia|dementia
4663161|NCT03472482|Lewy body disease|lewy body disease
4663162|NCT03472482|Retina|retina
4663163|NCT03472482|Retinal imaging|retinal imaging
4663164|NCT03472482|Optical Coherence Tomography|optical coherence tomography
4663165|NCT03472482|Hyperspectral imaging|hyperspectral imaging
4663166|NCT03472482|Mild Cognitive Impairment|mild cognitive impairment
4663167|NCT03472430|Oocyte Retrieval|oocyte retrieval
4663168|NCT03472430|Transcutaneous Electric Nerve Stimulation|transcutaneous electric nerve stimulation
4663169|NCT03472430|Pain relief|pain relief
4663170|NCT03472430|Conscious sedation|conscious sedation
4663171|NCT03472365|PD-1|pd-1
4663172|NCT03472365|SHR-1210|shr-1210
4663173|NCT03472365|Capecitabine|capecitabine
4663174|NCT03472365|Oxaliplatin|oxaliplatin
4663175|NCT03472365|Apatinib|apatinib
4663176|NCT03472339|Acute limb injury, Diclofenac, pain management|acute limb injury, diclofenac, pain management
4663177|NCT03472313|HV|hv
4663178|NCT03472300|Knee Osteoarthritis|knee osteoarthritis
4663179|NCT03472300|pain|pain
4663180|NCT03472300|Complementary Therapies|complementary therapies
4663181|NCT03472300|Survey|survey
4663182|NCT03472300|questionnaire|questionnaire
4663183|NCT03472261|cerebral palsy|cerebral palsy
4663184|NCT03472261|botulinum toxin-A|botulinum toxin-a
4663185|NCT03472261|pronator deformity|pronator deformity
4663186|NCT03472248|Adolescents|adolescents
4663187|NCT03472248|Acceptance and Commitment Therapy|acceptance and commitment therapy
4663188|NCT03472248|Smartphone|smartphone
4663189|NCT03472209|Postoperative Nausea and Vomiting|postoperative nausea and vomiting
4663190|NCT03472209|Gynecological Laparoscopic Surgery|gynecological laparoscopic surgery
4663191|NCT03472209|End-tidal carbon dioxide|end-tidal carbon dioxide
4663192|NCT03472183|Enteric nervous system|enteric nervous system
4663193|NCT03472183|Alzheimer disease|alzheimer disease
4663194|NCT03472183|biomarker|biomarker
4663195|NCT03472183|colonic biopsies|colonic biopsies
4663196|NCT03472183|neurodegenerative disease|neurodegenerative disease
4663197|NCT03472170|bovine lactoferrin, late sepsis|bovine lactoferrin, late sepsis
4663198|NCT03472157|Gastric bypass|gastric bypass
4663199|NCT03472157|Sleeve gastrectomy|sleeve gastrectomy
4663200|NCT03472157|Lifestyle therapy|lifestyle therapy
4663201|NCT03472157|NASH|nash
4663202|NCT03472157|Advanced fibrosis|advanced fibrosis
4663203|NCT03472157|Cirrhosis|cirrhosis
4663204|NCT03472131|Spondylodiscitis|spondylodiscitis
4663205|NCT03472131|Titanium Cage|titanium cage
4663206|NCT03472131|Posterolateral Debridement|posterolateral debridement
4663207|NCT03472131|Immunosuppressed|immunosuppressed
4663208|NCT03472131|Less Invasive|less invasive
4663209|NCT03472131|Spine Infection|spine infection
4663210|NCT03472118|Anesthesia, general|anesthesia, general
4663211|NCT03472118|Adult|adult
4663212|NCT03472118|Humans|humans
4663213|NCT03472118|Apnea|apnea
4663214|NCT03472118|Oxygen|oxygen
4663215|NCT03472118|Carbon dioxide|carbon dioxide
4663216|NCT03472118|Acidosis, respiratory|acidosis, respiratory
4663217|NCT03472118|Administration, Intranals/methods|administration, intranals/methods
4663218|NCT03472118|Airway management/methods|airway management/methods
4663219|NCT03472118|Continuous positive airway pressure/methods|continuous positive airway pressure/methods
4663220|NCT03472118|Insufflation/methods|insufflation/methods
4663221|NCT03472118|Oxygen/administration&dosage|oxygen/administration&dosage
4663222|NCT03472118|Laryngoscopy|laryngoscopy
4663223|NCT03472118|Larynx/surgery|larynx/surgery
4663224|NCT03472092|headache|headache
4663225|NCT03472092|migraine|migraine
4663226|NCT03472092|cognitive behavioral therapy|cognitive behavioral therapy
4663227|NCT03472092|amitriptyline|amitriptyline
4663228|NCT03472092|functional magnetic resonance imaging|functional magnetic resonance imaging
4663229|NCT03472092|conditioned pain modulation|conditioned pain modulation
4663230|NCT03472092|brain connectivity|brain connectivity
4663231|NCT03472092|pediatrics|pediatrics
4663232|NCT03472079|Acute kidney injury, septic shock, TIMP2*IGFBP7|acute kidney injury, septic shock, timp2*igfbp7
4663233|NCT03472053|Lung cancer|lung cancer
4663234|NCT03472053|non small cell|non small cell
4663235|NCT03472053|metastasis|metastasis
4663236|NCT03472040|BCX7353|bcx7353
4663237|NCT03472040|Hereditary Angioedema|hereditary angioedema
4663238|NCT03472040|HAE|hae
4663239|NCT03471988|deep mycosis|deep mycosis
4663240|NCT03471988|aspergillosis|aspergillosis
4663241|NCT03471988|mucormycosis|mucormycosis
4663242|NCT03471988|cryptococcosis|cryptococcosis
4663243|NCT03471988|isavuconazonium sulfate|isavuconazonium sulfate
4663244|NCT03471988|isavuconazole|isavuconazole
4663245|NCT03471988|AK1820|ak1820
4663246|NCT03471988|Cresemba|cresemba
4663247|NCT03471975|Video laryngoscopy|video laryngoscopy
4663248|NCT03471962|respiratory quotient (RQ)|respiratory quotient (rq)
4663249|NCT03471962|anaerobic metabolism|anaerobic metabolism
4663250|NCT03471962|major surgery|major surgery
4663251|NCT03471936|Congenital Heart Disease|congenital heart disease
4663252|NCT03471936|pressure-volume loops|pressure-volume loops
4663253|NCT03471936|diastolic function|diastolic function
4663254|NCT03471910|Chronic venous insufficiency|chronic venous insufficiency
4663255|NCT03471910|Diosmin|diosmin
4663256|NCT03471910|Hesperidin|hesperidin
4663257|NCT03471897|glycosaminoglycans|glycosaminoglycans
4663258|NCT03471897|biomarkers|biomarkers
4663259|NCT03471897|diagnostics|diagnostics
4663260|NCT03471897|prognostic|prognostic
4663261|NCT03471897|liquid biopsy|liquid biopsy
4663262|NCT03471884|Thoracoscopic surgery,Airway Management,Anesthesia|thoracoscopic surgery,airway management,anesthesia
4663263|NCT03471871|Elderly Healthy Subjects|elderly healthy subjects
4663264|NCT03471871|Adult Healthy Subjects|adult healthy subjects
4663265|NCT03471871|Lemborexant|lemborexant
4663266|NCT03471871|Respiratory Safety|respiratory safety
4663267|NCT03471871|Peripheral Oxygen Saturation|peripheral oxygen saturation
4663268|NCT03471871|Total Sleep Time|total sleep time
4663269|NCT03471858|caesarean, uterus|caesarean, uterus
4663270|NCT03471845|Major Adverse Cardiac Events (MACE)|major adverse cardiac events (mace)
4663271|NCT03471845|Myocardial Infarction (MI)|myocardial infarction (mi)
4663272|NCT03471845|Late Lumen Loss (LLL)|late lumen loss (lll)
4663273|NCT03471845|Target Lesion Revascularization (TLR)|target lesion revascularization (tlr)
4663274|NCT03471845|Target Vessel Revascularization (TVR)|target vessel revascularization (tvr)
4663275|NCT03471845|Target Vessel Failure (TVF)|target vessel failure (tvf)
4663276|NCT03471845|Target Lesion Failure (TLF)|target lesion failure (tlf)
4663277|NCT03471845|Stent Thrombosis (ST)|stent thrombosis (st)
4663278|NCT03471845|PERCUTANEOUS CORONARY INTERVENTION (PCI)|percutaneous coronary intervention (pci)
4663279|NCT03471819|Atopic Dermatitis|atopic dermatitis
4663280|NCT03471819|serotonin|serotonin
4663281|NCT03471806|Bulimia Nervosa|bulimia nervosa
4663282|NCT03471806|Eating disorder|eating disorder
4663283|NCT03471806|Dopamine|dopamine
4663284|NCT03471806|Food|food
4663285|NCT03471806|Reward|reward
4663286|NCT03471806|Positron Emission Tomography|positron emission tomography
4663287|NCT03471806|Magnetic Resonance|magnetic resonance
4663288|NCT03471806|Metabolic hormones|metabolic hormones
4663289|NCT03471767|Smoking cessation|smoking cessation
4663290|NCT03471767|Nicotine dependence|nicotine dependence
4663291|NCT03471767|Bupropion|bupropion
4663292|NCT03471767|DXM|dxm
4663293|NCT03471767|Nicotine addiction|nicotine addiction
4663294|NCT03471767|Cigarette smoking|cigarette smoking
4663295|NCT03471767|Dextromethorphan|dextromethorphan
4663296|NCT03471754|Depression, transcranial electronic stimulation, pilot, open label, safety, efficacy|depression, transcranial electronic stimulation, pilot, open label, safety, efficacy
4663297|NCT03471741|breast cancer|breast cancer
4663298|NCT03471741|radiotherapy|radiotherapy
4663299|NCT03471741|cutaneous toxicity|cutaneous toxicity
4663300|NCT03471741|subcutaneous toxicity|subcutaneous toxicity
4663301|NCT03471741|local control|local control
4663302|NCT03471741|IMRT|imrt
4663303|NCT03471728|Linzess|linzess
4663304|NCT03471728|Irritable Bowel Syndrome|irritable bowel syndrome
4663305|NCT03471728|linaclotide|linaclotide
4663306|NCT03471715|frequency fenesration dehiscence cbct population|frequency fenesration dehiscence cbct population
4663307|NCT03471689|Multimodal|multimodal
4663308|NCT03471689|Pain perception|pain perception
4663309|NCT03471689|Regulation|regulation
4663310|NCT03471689|Mindfulness|mindfulness
4663311|NCT03471650|J17149|j17149
4663312|NCT03471650|PSMA|psma
4663313|NCT03471650|18F-DCFPyL PET/CT|18f-dcfpyl pet/ct
4663314|NCT03471637|Chronic Pain|chronic pain
4663315|NCT03471637|Compassion-Focused Therapy|compassion-focused therapy
4663316|NCT03471637|Self-Compassion|self-compassion
4663317|NCT03471637|Psychological Flexibility|psychological flexibility
4663318|NCT03471624|Tenofovir alafenamide (TAF)|tenofovir alafenamide (taf)
4663319|NCT03471585|THC|thc
4663320|NCT03471585|adult|adult
4663321|NCT03471572|BRCA, ovarian cancer, fallopian tube cancer|brca, ovarian cancer, fallopian tube cancer
4663322|NCT03471546|Palliative Care|palliative care
4663323|NCT03471546|Pro00091481|pro00091481
4663324|NCT03471546|Malignant Glioma|malignant glioma
4663325|NCT03471546|Katherine Peters|katherine peters
4663326|NCT03471546|David Casarett|david casarett
4663327|NCT03471494|Surgery|surgery
4663328|NCT03471494|Quality|quality
4663329|NCT03471494|Outcomes|outcomes
4663330|NCT03471468|Microparticles|microparticles
4663331|NCT03471468|Pancreatic cancer|pancreatic cancer
4663332|NCT03471468|Gastric cancer|gastric cancer
4663333|NCT03471468|Chemotherapy|chemotherapy
4663334|NCT03471468|Venous thromboembolism|venous thromboembolism
4663335|NCT03471429|Anxiety|anxiety
4663336|NCT03471429|Dog|dog
4663337|NCT03471429|Canine|canine
4663338|NCT03471429|Therapy|therapy
4663339|NCT03471429|Depression|depression
4663340|NCT03471429|Pain|pain
4663341|NCT03471416|Guatemala|guatemala
4663342|NCT03471416|Guatemala City|guatemala city
4663343|NCT03471416|Malnutrition|malnutrition
4663344|NCT03471416|Leukemia|leukemia
4663345|NCT03471416|Childhood Cancer|childhood cancer
4663346|NCT03471403|Cold snare polypectomy|cold snare polypectomy
4663347|NCT03471390|Nursing Home|nursing home
4663348|NCT03471377|Planned Surgical Case|planned surgical case
4663349|NCT03471377|Predictive Modeling|predictive modeling
4663350|NCT03471377|18-115|18-115
4663351|NCT03471351|Hodgkin lymphoma|hodgkin lymphoma
4663352|NCT03471351|RP6530|rp6530
4663353|NCT03471351|Pembrolizumab|pembrolizumab
4663354|NCT03471351|Tenalisib|tenalisib
4663355|NCT03471338|multiple sclerosis|multiple sclerosis
4663356|NCT03471338|cognition|cognition
4663357|NCT03471338|neuropsychology|neuropsychology
4663358|NCT03471338|cognitive rehabilitation|cognitive rehabilitation
4663359|NCT03471325|plaque removal|plaque removal
4663360|NCT03471299|Ultrafiltration rate|ultrafiltration rate
4663361|NCT03471260|Other diseases of blood and blood-forming organs|other diseases of blood and blood-forming organs
4663362|NCT03471260|Advanced hematologic malignancies|advanced hematologic malignancies
4663363|NCT03471260|Acute myeloid leukemia|acute myeloid leukemia
4663364|NCT03471260|AML|aml
4663365|NCT03471260|IDH1 mutation|idh1 mutation
4663366|NCT03471260|Relapsed/refractory|relapsed/refractory
4663367|NCT03471260|Ivosidenib|ivosidenib
4663368|NCT03471260|AG120|ag120
4663369|NCT03471260|Venetoclax|venetoclax
4663370|NCT03471260|AB-199|ab-199
4663371|NCT03471260|GDC-0199|gdc-0199
4663372|NCT03471234|coronary disease|coronary disease
4663373|NCT03471234|drug eluting stent|drug eluting stent
4663374|NCT03471234|Inspiron|inspiron
4663375|NCT03471182|Cocaine Dependence|cocaine dependence
4663376|NCT03471182|Cocaine Addiction|cocaine addiction
4663377|NCT03471169|antithrombotic therapy|antithrombotic therapy
4663378|NCT03471117|blood pressure|blood pressure
4663379|NCT03471117|pioglitazone|pioglitazone
4663380|NCT03471117|hypertension|hypertension
4663381|NCT03471104|Diabetes-related distress|diabetes-related distress
4663382|NCT03471104|Living with diabetes|living with diabetes
4663383|NCT03471104|Patient-Reported Outcome Measures (PROMs)|patient-reported outcome measures (proms)
4663384|NCT03471078|CIT|cit
4663385|NCT03471078|Thrombocytopenia|thrombocytopenia
4663386|NCT03471065|Transcatheter|transcatheter
4663387|NCT03471065|Transcatheter Valve Replacement|transcatheter valve replacement
4663388|NCT03471065|SAPIEN 3 Ultra|sapien 3 ultra
4663389|NCT03471013|schizophrenia|schizophrenia
4663390|NCT03471013|beliefs|beliefs
4663391|NCT03471013|caregiver|caregiver
4663392|NCT03471000|implant|implant
4663393|NCT03471000|dental implant|dental implant
4663394|NCT03470987|obesity|obesity
4663395|NCT03470987|periodontitis|periodontitis
4663396|NCT03470987|cytokines|cytokines
4663397|NCT03470961|Grafalon ATG SPK|grafalon atg spk
4663398|NCT03470948|surgical apgar score, postoperative complication|surgical apgar score, postoperative complication
4663399|NCT03470935|breast cancer|breast cancer
4663400|NCT03470935|young women|young women
4663401|NCT03470922|Cancer|cancer
4663402|NCT03470922|Advanced Cancer|advanced cancer
4663403|NCT03470909|Remaining breast tissue|remaining breast tissue
4663404|NCT03470909|Skin-Sparing Mastectomy|skin-sparing mastectomy
4663405|NCT03470909|Nipple-Sparing Mastectomy|nipple-sparing mastectomy
4663406|NCT03470909|Prophylactic|prophylactic
4663407|NCT03470896|preanesthesia teleconsultation|preanesthesia teleconsultation
4663408|NCT03470896|video-conference|video-conference
4663409|NCT03470896|ambulatory surgery|ambulatory surgery
4663410|NCT03470896|telemedicine|telemedicine
4663411|NCT03470883|endoscopic resection|endoscopic resection
4663412|NCT03470883|colorectal adenomas|colorectal adenomas
4663413|NCT03470883|Colorectal adenocarcinomas|colorectal adenocarcinomas
4663414|NCT03470870|Enhanced recovery after surgery|enhanced recovery after surgery
4663415|NCT03470870|gynecologic oncology surgery|gynecologic oncology surgery
4663416|NCT03470870|Nomogram control|nomogram control
4663417|NCT03470857|Positron Emission Tomography Computed Tomography|positron emission tomography computed tomography
4663418|NCT03470857|Fluorodeoxyglucose F18|fluorodeoxyglucose f18
4663419|NCT03470857|Cancer|cancer
4663420|NCT03470857|Superooxide Dismutase|superooxide dismutase
4663421|NCT03470857|Catalase|catalase
4663422|NCT03470857|Glutathione Peroxidase|glutathione peroxidase
4663423|NCT03470857|Malondialdehyde|malondialdehyde
4663424|NCT03470857|Conjugated Dienes|conjugated dienes
4663425|NCT03470857|Acid Phosphatase|acid phosphatase
4663426|NCT03470857|Cathepsin D|cathepsin d
4663427|NCT03470857|Alpha-1-Antitrypsin|alpha-1-antitrypsin
4663428|NCT03470857|Arylsulfatase|arylsulfatase
4663429|NCT03470857|8-iso-Prostaglandin F2alpha|8-iso-prostaglandin f2alpha
4663430|NCT03470857|4-Hydroxynonenal|4-hydroxynonenal
4663431|NCT03470857|Total Antioxidant Capacity|total antioxidant capacity
4663432|NCT03470857|Vitamin A|vitamin a
4663433|NCT03470857|Vitamin E|vitamin e
4663434|NCT03470844|Major burns|major burns
4663435|NCT03470844|Intensive Care Medicine|intensive care medicine
4663436|NCT03470844|Neurocognitive dysfunction|neurocognitive dysfunction
4663437|NCT03470844|Functional magnetic resonance imaging|functional magnetic resonance imaging
4663438|NCT03470844|Neuroinflammation|neuroinflammation
4663439|NCT03470844|Long term quality of life|long term quality of life
4663440|NCT03470818|Medical Education|medical education
4663441|NCT03470818|Flipped Classroom|flipped classroom
4663442|NCT03470818|Anxiety|anxiety
4663443|NCT03470818|Simulation|simulation
4663444|NCT03470818|Achievement Emotions|achievement emotions
4663445|NCT03470792|Microcirculation, extracorporeal membrane oxygenation|microcirculation, extracorporeal membrane oxygenation
4663446|NCT03470766|Neuromodulation|neuromodulation
4663447|NCT03470766|HF10|hf10
4663448|NCT03470766|HF-10|hf-10
4663449|NCT03470766|Nevro|nevro
4663450|NCT03470766|High-frequency|high-frequency
4663451|NCT03470766|10kHz|10khz
4663452|NCT03470766|Spinal Cord Stimulation|spinal cord stimulation
4663453|NCT03470766|CNLBP|cnlbp
4663454|NCT03470766|Chronic Neuropathic Low Back Pain|chronic neuropathic low back pain
4663582|NCT03469921|Young adults|young adults
4663455|NCT03470766|Double blind randomised sham-controlled|double blind randomised sham-controlled
4663456|NCT03470766|PANARC|panarc
4663457|NCT03470766|SCS|scs
4663458|NCT03470714|Force Irradiation|force irradiation
4663459|NCT03470714|Kinesiotaping|kinesiotaping
4663460|NCT03470714|EMG|emg
4663461|NCT03470662|Hip fractures|hip fractures
4663462|NCT03470662|Delirium|delirium
4663463|NCT03470662|Aged|aged
4663464|NCT03470662|Care bundle|care bundle
4663465|NCT03470623|hallux valgus|hallux valgus
4663466|NCT03470623|chevron osteotomy|chevron osteotomy
4663467|NCT03470623|bioabsorbable screw|bioabsorbable screw
4663468|NCT03470623|steel screw|steel screw
4663469|NCT03470610|Progesterone|progesterone
4663470|NCT03470610|HRT|hrt
4663471|NCT03470610|frozen embryo transfer|frozen embryo transfer
4663472|NCT03470584|Diet, vegetarian|diet, vegetarian
4663473|NCT03470584|Dementia|dementia
4663474|NCT03470584|Depression|depression
4663475|NCT03470584|Cardiovascular Diseases|cardiovascular diseases
4663476|NCT03470584|Stroke|stroke
4663477|NCT03470584|Gout|gout
4663478|NCT03470584|Cataract|cataract
4663479|NCT03470584|Gallstone|gallstone
4663480|NCT03470584|Urinary Tract Infections|urinary tract infections
4663481|NCT03470558|Diet|diet
4663482|NCT03470558|Dietary Habits|dietary habits
4663483|NCT03470558|Weight changes|weight changes
4663484|NCT03470545|Symptomatic, left ventricular outflow tract gradient|symptomatic, left ventricular outflow tract gradient
4663485|NCT03470428|Fontan|fontan
4663486|NCT03470428|Single Ventricle|single ventricle
4663487|NCT03470402|Breast Cancer Prevention|breast cancer prevention
4663488|NCT03470402|Genetic Testing|genetic testing
4663489|NCT03470402|Genetic Counseling|genetic counseling
4663490|NCT03470402|Personalized Prevention|personalized prevention
4663491|NCT03470402|Precision Prevention|precision prevention
4663492|NCT03470402|Precision Medicine|precision medicine
4663493|NCT03470402|Risk Assessment|risk assessment
4663494|NCT03470402|Decision Making|decision making
4663495|NCT03470402|Decision Aid|decision aid
4663496|NCT03470376|cholesterol|cholesterol
4663497|NCT03470376|nutraceutical|nutraceutical
4663498|NCT03470376|HIV|hiv
4663499|NCT03470376|PCSK9|pcsk9
4663500|NCT03470376|hsCRP|hscrp
4663501|NCT03470376|stiffness|stiffness
4663502|NCT03470363|total knee arthroplasty|total knee arthroplasty
4663503|NCT03470363|tourniquet|tourniquet
4663504|NCT03470363|sevoflurane|sevoflurane
4663505|NCT03470363|spinal anesthesia|spinal anesthesia
4663506|NCT03470363|myeloperoxidase|myeloperoxidase
4663507|NCT03470363|elastase|elastase
4663508|NCT03470363|neutrophil|neutrophil
4663509|NCT03470350|TGF-beta activatied|tgf-beta activatied
4663510|NCT03470337|Thrombophlebitis|thrombophlebitis
4663511|NCT03470324|Parkinson's disease|parkinson's disease
4663512|NCT03470324|Dysphagia|dysphagia
4663513|NCT03470324|Parkinsonian Disorders|parkinsonian disorders
4663514|NCT03470324|Neurodegenerative Diseases|neurodegenerative diseases
4663515|NCT03470324|Movement Disorders|movement disorders
4663516|NCT03470324|Nervous System Diseases|nervous system diseases
4663517|NCT03470324|Basal Ganglia Diseases|basal ganglia diseases
4663518|NCT03470324|Brain Diseases|brain diseases
4663519|NCT03470324|Central Nervous System Diseases|central nervous system diseases
4663520|NCT03470324|Deep brain stimulation|deep brain stimulation
4663521|NCT03470324|substantia nigra pars reticulata|substantia nigra pars reticulata
4663522|NCT03470324|subthalamic nucleus|subthalamic nucleus
4663523|NCT03470311|Eosinophils|eosinophils
4663524|NCT03470311|asthma|asthma
4663525|NCT03470311|inflammation|inflammation
4663526|NCT03470311|prednisone|prednisone
4663527|NCT03470298|Endometrial Scratching|endometrial scratching
4663528|NCT03470298|Unexplained infertility|unexplained infertility
4663529|NCT03470298|ICSI|icsi
4663530|NCT03470285|Mulitparametric MR Imaging|mulitparametric mr imaging
4663531|NCT03470285|Small solid renal tumors|small solid renal tumors
4663532|NCT03470246|Accelerometer|accelerometer
4663533|NCT03470246|Aortic valve replacement|aortic valve replacement
4663534|NCT03470246|Aortic valve stenosis|aortic valve stenosis
4663535|NCT03470246|Coronary artery bypass grafting|coronary artery bypass grafting
4663536|NCT03470246|Coronary artery disease|coronary artery disease
4663537|NCT03470246|eHealth|ehealth
4663538|NCT03470246|Interactive guidance|interactive guidance
4663539|NCT03470246|Mitral valve insufficiency|mitral valve insufficiency
4663540|NCT03470246|Mitral valve repair|mitral valve repair
4663541|NCT03470246|Rehabilitation|rehabilitation
4663542|NCT03470194|Quality Care|quality care
4663543|NCT03470194|Access to health care|access to health care
4663544|NCT03470194|Interpretation services|interpretation services
4663545|NCT03470181|Chronic nausea, intermittent vomiting, impaired accommodation|chronic nausea, intermittent vomiting, impaired accommodation
4663546|NCT03470155|annuloplasty mitral valve|annuloplasty mitral valve
4663547|NCT03470155|reduced LV function|reduced lv function
4663548|NCT03470142|laparoscopy-assisted surgery|laparoscopy-assisted surgery
4663549|NCT03470142|NOSES|noses
4663550|NCT03470116|MacGrath MAC|macgrath mac
4663551|NCT03470116|curarization|curarization
4663552|NCT03470116|intubation|intubation
4663553|NCT03470116|MacIntosh|macintosh
4663554|NCT03470116|laryngoscope|laryngoscope
4663555|NCT03470103|Wet age-related macular degeneration(wAMD)|wet age-related macular degeneration(wamd)
4663556|NCT03470103|Diabetic macular edema(DME)|diabetic macular edema(dme)
4663557|NCT03470090|Physical activity|physical activity
4663558|NCT03470090|Function|function
4663559|NCT03470090|Balance|balance
4663560|NCT03470090|Neuromuscular exercises|neuromuscular exercises
4663561|NCT03470090|Osteoarthritis|osteoarthritis
4663562|NCT03470038|NGF-induced pain|ngf-induced pain
4663563|NCT03470038|Ischemia-induced pain|ischemia-induced pain
4663564|NCT03470038|Muscle hypersensitivity|muscle hypersensitivity
4663565|NCT03470038|NGF pain model|ngf pain model
4663566|NCT03470025|Rehabilitation|rehabilitation
4663567|NCT03470025|Psychological Intervention|psychological intervention
4663568|NCT03470025|Quality of life|quality of life
4663569|NCT03469999|Botulinum toxin A|botulinum toxin a
4663570|NCT03469999|Walking efficiency|walking efficiency
4663571|NCT03469999|Spasticity|spasticity
4663572|NCT03469999|Dysport|dysport
4663573|NCT03469960|IFCT|ifct
4663574|NCT03469960|DICIPLE|diciple
4663575|NCT03469960|NSCLC|nsclc
4663576|NCT03469947|Tranexamic Acid|tranexamic acid
4663577|NCT03469947|TXA|txa
4663578|NCT03469921|Malignant haemopathies|malignant haemopathies
4663579|NCT03469921|Acute Leukemia|acute leukemia
4663580|NCT03469921|Non-hodgkin Lymphoma|non-hodgkin lymphoma
4663581|NCT03469921|Hodgkin Lymphoma|hodgkin lymphoma
4663583|NCT03469921|Adolescent|adolescent
4663584|NCT03469895|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
4663585|NCT03469895|Autoimmune Cytopenias|autoimmune cytopenias
4663586|NCT03469895|BCR inhibitors|bcr inhibitors
4663587|NCT03469882|Protein, exercise, critical illness, outcome,|protein, exercise, critical illness, outcome,
4663588|NCT03469869|Obesity|obesity
4663589|NCT03469843|Congenital Heart Disease|congenital heart disease
4663590|NCT03469843|Cardiac denervation|cardiac denervation
4663591|NCT03469843|123I-metaiodobenzylguanidine|123i-metaiodobenzylguanidine
4663592|NCT03469843|Arterial switch operation|arterial switch operation
4663593|NCT03469830|insert|insert
4663594|NCT03469830|pressure therapy|pressure therapy
4663595|NCT03469830|silicone gel|silicone gel
4663596|NCT03469817|Bone apposition|bone apposition
4663597|NCT03469817|Stryker|stryker
4663598|NCT03469817|MRI|mri
4663599|NCT03469817|Trident II|trident ii
4663600|NCT03469817|Total Hip Replacement|total hip replacement
4663601|NCT03469791|Degenerative Spondylolisthesis|degenerative spondylolisthesis
4663602|NCT03469791|Treatment|treatment
4663603|NCT03469791|Decompression alone|decompression alone
4663604|NCT03469791|Instrumented fusion|instrumented fusion
4663605|NCT03469791|Oswestry Disability Index|oswestry disability index
4663606|NCT03469778|stroke|stroke
4663607|NCT03469778|rehabilitation|rehabilitation
4663608|NCT03469778|upper limb|upper limb
4663609|NCT03469778|motor activity|motor activity
4663610|NCT03469778|robotic|robotic
4663611|NCT03469765|AKI|aki
4663612|NCT03469752|Hispanic Latino families|hispanic latino families
4663613|NCT03469739|Intimate Partner Violence|intimate partner violence
4663614|NCT03469726|Liver metastases|liver metastases
4663813|NCT03468400|assessment|assessment
4663615|NCT03469726|Diffusion weighted MRI|diffusion weighted mri
4663616|NCT03469674|Radiotherapy|radiotherapy
4663617|NCT03469674|Vaginal brachytherapy|vaginal brachytherapy
4663618|NCT03469674|Molecular risk factors|molecular risk factors
4663619|NCT03469622|Adenoma|adenoma
4663620|NCT03469622|Polyp|polyp
4663621|NCT03469622|EndoRings|endorings
4663622|NCT03469622|Colonoscopy|colonoscopy
4663623|NCT03469622|Endoscopic device|endoscopic device
4663624|NCT03469622|Colon cancer screening|colon cancer screening
4663625|NCT03469609|infants|infants
4663626|NCT03469609|necrotizing enterocolitis (NEC)|necrotizing enterocolitis (nec)
4663627|NCT03469609|focal intestinal perforation (FIP)|focal intestinal perforation (fip)
4663628|NCT03469609|enterostomy creation|enterostomy creation
4663629|NCT03469609|bowel reanastomosis|bowel reanastomosis
4663630|NCT03469609|enteral feeding|enteral feeding
4663631|NCT03469609|caloric intake|caloric intake
4663632|NCT03469609|parenteral nutrition|parenteral nutrition
4663633|NCT03469609|complication rate|complication rate
4663634|NCT03469609|reduction of hospital expenses|reduction of hospital expenses
4663635|NCT03469609|length of hospital stay|length of hospital stay
4663636|NCT03469570|Non-cardiac|non-cardiac
4663637|NCT03469570|Non-Thoracic|non-thoracic
4663638|NCT03469570|Fluid Management|fluid management
4663639|NCT03469570|Perioperative Goal Directed Therapy|perioperative goal directed therapy
4663640|NCT03469531|Cervical Cancer|cervical cancer
4663641|NCT03469531|Radiation Therapy|radiation therapy
4663642|NCT03469531|Chemotherapy|chemotherapy
4663643|NCT03469531|Nimotuzumab|nimotuzumab
4663644|NCT03469531|Cisplatin|cisplatin
4663645|NCT03469518|beta-cryptoxanthin|beta-cryptoxanthin
4663646|NCT03469518|cholesterol|cholesterol
4663647|NCT03469518|Galactooligosaccharides|galactooligosaccharides
4663648|NCT03469518|Plant Sterols|plant sterols
4663649|NCT03469518|Cardiovascular risk|cardiovascular risk
4663650|NCT03469518|Bone Turnover markers|bone turnover markers
4663651|NCT03469518|Intestinal Inflammatory markers|intestinal inflammatory markers
4663652|NCT03469518|Microbiota|microbiota
4663653|NCT03469479|Neoadjuvant hepatic arterial infusion chemotherapy|neoadjuvant hepatic arterial infusion chemotherapy
4663654|NCT03469479|BCLC A/B|bclc a/b
4663655|NCT03469479|FOLFOX|folfox
4663656|NCT03469479|Resection|resection
4663657|NCT03469453|GAD|gad
4663658|NCT03469453|Adolescents|adolescents
4663659|NCT03469453|Internet-delivered Cognitive behavioral therapy|internet-delivered cognitive behavioral therapy
4663660|NCT03469453|ICBT|icbt
4663661|NCT03469453|CBT|cbt
4663662|NCT03469440|lactate|lactate
4663663|NCT03469440|central venous saturation|central venous saturation
4663664|NCT03469440|Pediatric Cardiac Surgery|pediatric cardiac surgery
4663665|NCT03469388|EVAR, central pressure, arterial stiffness, AAA, elective surgery|evar, central pressure, arterial stiffness, aaa, elective surgery
4663666|NCT03469375|FOLFIRINOX|folfirinox
4663667|NCT03469375|Pancreatic cancer|pancreatic cancer
4663668|NCT03469375|Conversion surgery|conversion surgery
4663669|NCT03469375|Overall survival|overall survival
4663670|NCT03469349|Drug Therapy|drug therapy
4663671|NCT03469336|Psoriasis|psoriasis
4663672|NCT03469336|Topical|topical
4663673|NCT03469323|Nonintubated video-assisted thoracic surgery (VATS)|nonintubated video-assisted thoracic surgery (vats)
4663674|NCT03469310|endocrine surgery|endocrine surgery
4663675|NCT03469310|opioid addiction|opioid addiction
4663676|NCT03469310|pain management|pain management
4663677|NCT03469310|analgesia|analgesia
4663678|NCT03469284|Diseases of Oral Cavity Salivary Glands and Jaws|diseases of oral cavity salivary glands and jaws
4663679|NCT03469284|Methylene Blue|methylene blue
4663680|NCT03469284|MB|mb
4663681|NCT03469284|Oral Mucositis|oral mucositis
4663682|NCT03469271|Pneumonia|pneumonia
4663683|NCT03469258|Pancreatic Cancer|pancreatic cancer
4663684|NCT03469245|Endovascular|endovascular
4663685|NCT03469245|Fenestrated endovascular repair|fenestrated endovascular repair
4663686|NCT03469245|numerical simulation|numerical simulation
4663687|NCT03469219|granulysin|granulysin
4663688|NCT03469193|knee unicompartmental prosthesis|knee unicompartmental prosthesis
4663689|NCT03469193|KneeKG system|kneekg system
4663690|NCT03469193|robotic-assisted|robotic-assisted
4663691|NCT03469193|alignment|alignment
4663692|NCT03469193|implants positioning|implants positioning
4663693|NCT03469193|International Knee Society|international knee society
4663694|NCT03469193|Forgotten joint score|forgotten joint score
4663695|NCT03469180|Treadmill Training|treadmill training
4663696|NCT03469180|Whole Body Vibration Training|whole body vibration training
4663697|NCT03469167|Bleeding|bleeding
4663698|NCT03469154|Layperson|layperson
4663699|NCT03469154|Paediatric Basic life Support|paediatric basic life support
4663700|NCT03469154|education|education
4663701|NCT03469141|Wheelchair|wheelchair
4663702|NCT03469141|Pressure Relief|pressure relief
4663703|NCT03469141|Activity|activity
4663704|NCT03469141|Monitor|monitor
4663705|NCT03469128|PTSD|ptsd
4663706|NCT03469128|CPT|cpt
4663707|NCT03469128|SUD|sud
4663708|NCT03469102|Positron emission tomography|positron emission tomography
4663709|NCT03469102|Texture indices|texture indices
4663710|NCT03469102|Diagnostic performance|diagnostic performance
4663711|NCT03469089|schizophrenia|schizophrenia
4663712|NCT03469089|cognitive symptom|cognitive symptom
4663713|NCT03469089|healthy volunteer|healthy volunteer
4663714|NCT03469089|cognitive testing|cognitive testing
4663715|NCT03469076|Acne, Comedonal, Mild to Moderate Papulopustular Acne|acne, comedonal, mild to moderate papulopustular acne
4663716|NCT03469050|Recurrent acute diverticulitis|recurrent acute diverticulitis
4663717|NCT03469050|Prevention|prevention
4663718|NCT03469050|Diverticular complications|diverticular complications
4663719|NCT03469050|Rifaximin delayed release|rifaximin delayed release
4663720|NCT03469050|Diverticulitis|diverticulitis
4663721|NCT03469050|SIBO|sibo
4663722|NCT03469037|Dyspnea, High flow nasal cannula|dyspnea, high flow nasal cannula
4663723|NCT03469024|Low back pain|low back pain
4663724|NCT03469024|Electroanalgesia|electroanalgesia
4663725|NCT03469024|Exercise program|exercise program
4663726|NCT03469024|Randomized clinical trial|randomized clinical trial
4663727|NCT03468998|Bone allograft|bone allograft
4663728|NCT03468998|Particle size|particle size
4663729|NCT03468998|Ridge preservation|ridge preservation
4663730|NCT03468998|Ridge augmentation|ridge augmentation
4663731|NCT03468998|Socket grafting|socket grafting
4663732|NCT03468998|Histology|histology
4663733|NCT03468998|New bone|new bone
4663734|NCT03468972|IgA nephropathy|iga nephropathy
4663735|NCT03468972|immunosuppression|immunosuppression
4663736|NCT03468946|taste perception|taste perception
4663737|NCT03468946|caries risk|caries risk
4663738|NCT03468946|cariogram|cariogram
4663739|NCT03468946|children|children
4663740|NCT03468907|hepatitis B virus|hepatitis b virus
4663741|NCT03468907|exacerbation|exacerbation
4663742|NCT03468907|antiviral agents|antiviral agents
4663743|NCT03468907|pregnancy|pregnancy
4663744|NCT03468907|flare|flare
4663745|NCT03468894|prolonged sitting|prolonged sitting
4663746|NCT03468894|sedentary behaviour|sedentary behaviour
4663747|NCT03468894|physical activity|physical activity
4663748|NCT03468894|office workplace|office workplace
4663749|NCT03468868|Multiple sclerosis|multiple sclerosis
4663750|NCT03468868|Exercise|exercise
4663751|NCT03468868|Physical activity|physical activity
4663752|NCT03468868|Telerehabilitation|telerehabilitation
4663753|NCT03468868|Comparative effectiveness study|comparative effectiveness study
4663754|NCT03468868|Social cognitive theory|social cognitive theory
4663755|NCT03468868|Health behavior change|health behavior change
4663756|NCT03468842|Streptococcus dentisani|streptococcus dentisani
4663757|NCT03468842|caries|caries
4663758|NCT03468842|salivary pH|salivary ph
4663759|NCT03468842|S. mutans|s. mutans
4663760|NCT03468764|anesthesia|anesthesia
4663761|NCT03468764|hemodynamic management|hemodynamic management
4663762|NCT03468764|lung recruitment maneuver|lung recruitment maneuver
4663763|NCT03468764|hypovolemia|hypovolemia
4663764|NCT03468751|Metastatic; Refractory; Cancer; Solid; Tumor|metastatic; refractory; cancer; solid; tumor
4663765|NCT03468725|Transcranial magnetic stimulation|transcranial magnetic stimulation
4663766|NCT03468712|mortality|mortality
4663767|NCT03468712|morbidity|morbidity
4663768|NCT03468712|neoadjuvant chemotherapy|neoadjuvant chemotherapy
4663769|NCT03468712|laparoscopic gastrectomy|laparoscopic gastrectomy
4663770|NCT03468712|gastric cancer|gastric cancer
4663771|NCT03468699|Autologous bone marrow Transplantation|autologous bone marrow transplantation
4663772|NCT03468699|biliary atresia|biliary atresia
4663773|NCT03468699|Kasai's operation|kasai's operation
4663774|NCT03468699|liver cirrhosis|liver cirrhosis
4663775|NCT03468673|AIDS|aids
4663776|NCT03468673|HCV|hcv
4663777|NCT03468673|Questionnaire|questionnaire
4663778|NCT03468673|Qualitative analysis|qualitative analysis
4663779|NCT03468673|Sexual Quality of Life|sexual quality of life
4663780|NCT03468673|Psychometric validation|psychometric validation
4663781|NCT03468660|Accented speech perception|accented speech perception
4663782|NCT03468647|frailty|frailty
4663783|NCT03468647|tele-monitoring|tele-monitoring
4663784|NCT03468647|self-management|self-management
4663785|NCT03468634|endoscopy|endoscopy
4663786|NCT03468634|Raman spectroscopy|raman spectroscopy
4663787|NCT03468621|woundclosure|woundclosure
4663788|NCT03468621|technique|technique
4663789|NCT03468621|surgical|surgical
4663790|NCT03468621|site|site
4663791|NCT03468621|infection|infection
4663792|NCT03468621|intrademal|intrademal
4663793|NCT03468621|transdermal|transdermal
4663794|NCT03468621|suture|suture
4663795|NCT03468608|procedural sedation|procedural sedation
4663796|NCT03468608|paediatric|paediatric
4663797|NCT03468608|parental satisfaction|parental satisfaction
4663798|NCT03468595|Listerine, CHX|listerine, chx
4663799|NCT03468569|Athletic Performance|athletic performance
4663800|NCT03468569|Functional Movement Screen|functional movement screen
4663801|NCT03468569|Handball Athletes|handball athletes
4663802|NCT03468569|Injury Prevention|injury prevention
4663803|NCT03468569|Injury History|injury history
4663804|NCT03468517|General Anaesthesia|general anaesthesia
4663805|NCT03468517|Preoperative Anxiety|preoperative anxiety
4663806|NCT03468517|BATHE method|bathe method
4663807|NCT03468465|Hyperactive Bladder Syndrome|hyperactive bladder syndrome
4663808|NCT03468439|nerve block|nerve block
4663809|NCT03468413|CP1050|cp1050
4663810|NCT03468413|Phase 1|phase 1
4663811|NCT03468413|Healthy subjects|healthy subjects
4663812|NCT03468400|sleep disorders|sleep disorders
4663814|NCT03468400|diagnosis|diagnosis
4663815|NCT03468348|duloxetine|duloxetine
4663816|NCT03468348|mastectomy|mastectomy
4663817|NCT03468348|postoperative pain|postoperative pain
4663818|NCT03468335|Second-line therapy|second-line therapy
4663819|NCT03468335|Nal-IRI|nal-iri
4663820|NCT03468335|failure gemcitabine/nab-paclitaxel|failure gemcitabine/nab-paclitaxel
4663821|NCT03468335|predictive role of 1st-line therapy|predictive role of 1st-line therapy
4663822|NCT03468309|polypharmacy|polypharmacy
4663823|NCT03468309|drug interactions|drug interactions
4663824|NCT03468309|DNA testing|dna testing
4663825|NCT03468309|mental health diagnosis|mental health diagnosis
4663826|NCT03468309|drug side effects|drug side effects
4663827|NCT03468309|presciption treatment plans|presciption treatment plans
4663828|NCT03468309|mental health medication treatment plans|mental health medication treatment plans
4663829|NCT03468296|age-related macular degeneration|age-related macular degeneration
4663830|NCT03468283|Mobile healthcare|mobile healthcare
4663831|NCT03468283|Health Services Research|health services research
4663832|NCT03468283|Community Health Services|community health services
4663833|NCT03468283|Diabetes self-management education|diabetes self-management education
4663834|NCT03468231|Hepatocellular Carcinoma|hepatocellular carcinoma
4663835|NCT03468231|Hepatic arterial infusion chemotherapy|hepatic arterial infusion chemotherapy
4663836|NCT03468231|Sorafenib|sorafenib
4663837|NCT03468231|Oxaliplatin plus Fluorouracil/Leucovorin|oxaliplatin plus fluorouracil/leucovorin
4663838|NCT03468231|Oxaliplatin|oxaliplatin
4663839|NCT03468205|breathlessness|breathlessness
4663840|NCT03468205|dyspnea|dyspnea
4663841|NCT03468205|measurement|measurement
4663842|NCT03468179|Diet|diet
4663843|NCT03468179|N-acyl-phosphatidylethanolamine|n-acyl-phosphatidylethanolamine
4663844|NCT03468179|N-acyl-ethanolamine|n-acyl-ethanolamine
4663845|NCT03468179|NAPE|nape
4663846|NCT03468179|NAE|nae
4663847|NCT03468179|Oatmeal|oatmeal
4663848|NCT03468166|Motor function|motor function
4663849|NCT03468166|Gait pattern|gait pattern
4663850|NCT03468127|Soy protein|soy protein
4663851|NCT03468127|LDL-Cholesterol|ldl-cholesterol
4663852|NCT03468127|Total Cholesterol|total cholesterol
4663853|NCT03468127|Cardiovascular disease|cardiovascular disease
4663854|NCT03468101|COPD|copd
4663855|NCT03468101|Dairy farmers|dairy farmers
4663856|NCT03468101|Exposure Occupational|exposure occupational
4663857|NCT03468101|FEV1|fev1
4663858|NCT03468075|Sarcoma|sarcoma
4663859|NCT03468075|Soft tissue|soft tissue
4663860|NCT03468075|Ascorbate|ascorbate
4663861|NCT03468036|critical illness|critical illness
4663862|NCT03468036|ICU|icu
4663863|NCT03468036|extubation|extubation
4663864|NCT03468036|respiratory failure|respiratory failure
4663865|NCT03468023|Cast treatment|cast treatment
4663866|NCT03468023|above-elbow cast|above-elbow cast
4663867|NCT03468023|below-elbow cast|below-elbow cast
4663868|NCT03468023|long arm cast|long arm cast
4663869|NCT03468023|short arm cast|short arm cast
4663870|NCT03467971|Metformin|metformin
4663871|NCT03467971|Bioavailability|bioavailability
4663872|NCT03467971|Food effect|food effect
4663873|NCT03467971|Pharmacokinetics|pharmacokinetics
4663874|NCT03467958|Crohn's Disease|crohn's disease
4663875|NCT03467958|Crohn Disease|crohn disease
4663876|NCT03467958|Oral|oral
4663877|NCT03467958|Ozanimod|ozanimod
4663878|NCT03467958|Moderately active|moderately active
4663879|NCT03467958|Severely active|severely active
4663880|NCT03467958|RPC01|rpc01
4663881|NCT03467958|RPC01-3204|rpc01-3204
4663882|NCT03467945|Metformin|metformin
4663883|NCT03467945|Gliclazide|gliclazide
4663884|NCT03467945|Bioequivalence|bioequivalence
4663885|NCT03467945|Drug-drug Interaction|drug-drug interaction
4663886|NCT03467945|Pharmacokinetics|pharmacokinetics
4663887|NCT03467919|osteoarthritis|osteoarthritis
4663888|NCT03467919|stem cell|stem cell
4663889|NCT03467919|knee pain|knee pain
4663890|NCT03467919|adipose derived stem cell|adipose derived stem cell
4663891|NCT03467919|injection|injection
4663892|NCT03467906|Diet|diet
4663893|NCT03467906|Dietary Habits|dietary habits
4663894|NCT03467906|Weight changes|weight changes
4663895|NCT03467880|Impulse Oscillometry|impulse oscillometry
4663896|NCT03467880|Chinese|chinese
4663897|NCT03467880|Healthy Subjects|healthy subjects
4663898|NCT03467880|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
4663899|NCT03467880|Asthma|asthma
4663900|NCT03467880|Interstitial Lung Disease|interstitial lung disease
4663901|NCT03467880|Upper Airway Obstruction|upper airway obstruction
4663902|NCT03467880|Reference Values|reference values
4663903|NCT03467867|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
4663904|NCT03467867|Leukemia|leukemia
4663905|NCT03467867|Venetoclax|venetoclax
4663906|NCT03467867|Rituximab|rituximab
4663907|NCT03467867|Lymphoid|lymphoid
4663908|NCT03467867|Lymphoproliferative Disorders|lymphoproliferative disorders
4663909|NCT03467867|Antineoplastic Agents|antineoplastic agents
4663910|NCT03467867|Neoplasm|neoplasm
4663911|NCT03467854|ECMO|ecmo
4663912|NCT03467854|Antimicrobials|antimicrobials
4663913|NCT03467815|Wireless monitoring|wireless monitoring
4663914|NCT03467815|Continuous monitoring|continuous monitoring
4663915|NCT03467815|Vital parameters|vital parameters
4663916|NCT03467815|Clinical deterioration|clinical deterioration
4663917|NCT03467802|Gingival Recession|gingival recession
4663918|NCT03467802|Enamel Matrix Derivative|enamel matrix derivative
4663919|NCT03467802|Porcine Collagen Matrix|porcine collagen matrix
4663920|NCT03467789|Vitamin D|vitamin d
4663921|NCT03467789|Photodynamic Therapy|photodynamic therapy
4663922|NCT03467776|infants|infants
4663923|NCT03467776|asthma|asthma
4663924|NCT03467776|bronchial dilation test|bronchial dilation test
4663925|NCT03467776|plethysmography|plethysmography
4663926|NCT03467750|Adenotonsillectomy|adenotonsillectomy
4663927|NCT03467750|Opioids|opioids
4663928|NCT03467750|Post-surgical pain|post-surgical pain
4663929|NCT03467750|Anesthesiology|anesthesiology
4663930|NCT03467750|Pediatrics|pediatrics
4663931|NCT03467724|Fractional Radiofrequency|fractional radiofrequency
4663932|NCT03467698|Aging|aging
4663933|NCT03467698|Memory|memory
4663934|NCT03467698|Associative learning|associative learning
4663935|NCT03467698|transcranial direct current stimulation|transcranial direct current stimulation
4663936|NCT03467581|gastric sleeve|gastric sleeve
4663937|NCT03467568|Mood Salt|mood salt
4663938|NCT03467542|Fistula|fistula
4663939|NCT03467542|Intracranial|intracranial
4663940|NCT03467542|Dural|dural
4663941|NCT03467542|Arteriovenous|arteriovenous
4663942|NCT03467542|Liquid Embolic|liquid embolic
4663943|NCT03467529|Superficial esophageal cancer|superficial esophageal cancer
4663944|NCT03467529|Squamous cell cancer|squamous cell cancer
4663945|NCT03467529|Mini invasive imaging|mini invasive imaging
4663946|NCT03467529|Pre therapeutic assessment|pre therapeutic assessment
4663947|NCT03467529|Optical coherence tomography|optical coherence tomography
4663948|NCT03467516|Metastatic Uveal Melanoma|metastatic uveal melanoma
4663949|NCT03467516|Uveal Diseases|uveal diseases
4663950|NCT03467516|Melanoma|melanoma
4663951|NCT03467464|Autism, EMDR; Children|autism, emdr; children
4663952|NCT03467438|heartburn|heartburn
4663953|NCT03467438|pyrosis|pyrosis
4663954|NCT03467438|regurgitation|regurgitation
4663955|NCT03467425|FF/VI/UMEC|ff/vi/umec
4663956|NCT03467425|TRELEGY ELLIPTA|trelegy ellipta
4663957|NCT03467425|COPD|copd
4663958|NCT03467425|Effectiveness|effectiveness
4663959|NCT03467347|Healthy Women|healthy women
4663960|NCT03467347|Contraception|contraception
4663961|NCT03467347|Vaginal Ring|vaginal ring
4663962|NCT03467347|dapivirine|dapivirine
4663963|NCT03467347|Levonorgestrel|levonorgestrel
4663964|NCT03467334|Infant colic|infant colic
4663965|NCT03467334|Bifidobacterium breve|bifidobacterium breve
4663966|NCT03467334|Lactobacillus fermentum|lactobacillus fermentum
4663967|NCT03467308|colorectal cancer|colorectal cancer
4663968|NCT03467308|TIGAR|tigar
4663969|NCT03467308|TRIM59|trim59
4663970|NCT03467295|Cavernous Malformations, treatment.|cavernous malformations, treatment.
4663971|NCT03467243|schizophrenia|schizophrenia
4663972|NCT03467243|Veterans|veterans
4663973|NCT03467243|depression|depression
4663974|NCT03467243|peer specialist|peer specialist
4663975|NCT03467243|social skills training|social skills training
4663976|NCT03467217|Losartan|losartan
4663977|NCT03467217|Nonalcoholic Fatty Liver Disease|nonalcoholic fatty liver disease
4663978|NCT03467165|MRgFUS|mrgfus
4663979|NCT03467165|Pain|pain
4663980|NCT03467165|Hip|hip
4663981|NCT03467165|Trapeziometacarpal joint|trapeziometacarpal joint
4663982|NCT03467165|Osteoarthritis|osteoarthritis
4663983|NCT03467152|E2027|e2027
4663984|NCT03467152|Montreal Cognitive Assessment|montreal cognitive assessment
4663985|NCT03467152|Neuropsychiatric Inventory|neuropsychiatric inventory
4663986|NCT03467152|Mini-Mental State Examination|mini-mental state examination
4663987|NCT03467152|Cognitive Fluctuation Inventory|cognitive fluctuation inventory
4663988|NCT03467139|Adhesive Capsulitis|adhesive capsulitis
4663989|NCT03467139|Breathing exercises|breathing exercises
4663990|NCT03467139|Pain|pain
4663991|NCT03467139|Sleep quality|sleep quality
4663992|NCT03467139|Quality of life|quality of life
4663993|NCT03467126|Atrial Fibrillation|atrial fibrillation
4663994|NCT03467113|Dravet Syndrome|dravet syndrome
4663995|NCT03467113|LGS|lgs
4663996|NCT03467087|Stem cell transplantation|stem cell transplantation
4663997|NCT03467087|Chemotherapy|chemotherapy
4663998|NCT03467087|Rehabilitation|rehabilitation
4663999|NCT03467087|Electrical muscle stimulation|electrical muscle stimulation
4664000|NCT03467022|alcohol withdrawal|alcohol withdrawal
4664001|NCT03467022|scurvy|scurvy
4664002|NCT03467022|vitamin C|vitamin c
4664003|NCT03467022|tiredness|tiredness
4664004|NCT03467009|cyber-victimization|cyber-victimization
4664005|NCT03467009|text message|text message
4664006|NCT03467009|mhealth|mhealth
4664007|NCT03466996|Transition to adult care|transition to adult care
4664008|NCT03466996|Telemedicine|telemedicine
4664009|NCT03466996|Myelomeningocele|myelomeningocele
4664010|NCT03466957|image guided brachytherapy|image guided brachytherapy
4664011|NCT03466957|3D print|3d print
4664012|NCT03466957|gynecological cancer|gynecological cancer
4664013|NCT03466944|Magnetic Resonance Imaging (MRI)|magnetic resonance imaging (mri)
4664014|NCT03466944|Leukaemia|leukaemia
4664015|NCT03466944|Whole-Body DiffusionWeighted-Magnetic Resonance Imaging (WB DW-MRI)|whole-body diffusionweighted-magnetic resonance imaging (wb dw-mri)
4664016|NCT03466944|Paediatrics|paediatrics
4664017|NCT03466918|TAVI|tavi
4664018|NCT03466918|TAVR|tavr
4664019|NCT03466918|CHINA|china
4664020|NCT03466918|SAPIEN 3|sapien 3
4664021|NCT03466918|High Risk|high risk
4664022|NCT03466918|Transcatheter aortic valve implantation|transcatheter aortic valve implantation
4664023|NCT03466918|Transcatheter aortic valve replacement|transcatheter aortic valve replacement
4664024|NCT03466892|Repetitive Negative Thinking|repetitive negative thinking
4664025|NCT03466892|Rumination|rumination
4664026|NCT03466892|Fibromyalgia|fibromyalgia
4664027|NCT03466892|Chronic pain|chronic pain
4664028|NCT03466892|Attentional Bias|attentional bias
4664029|NCT03466840|Ridge Augmentation|ridge augmentation
4664030|NCT03466840|Titanium mesh|titanium mesh
4664031|NCT03466840|Flap advancement|flap advancement
4664032|NCT03466801|prednisone alone|prednisone alone
4664033|NCT03466801|methylprednisolone and cyclophosphamide|methylprednisolone and cyclophosphamide
4664034|NCT03466801|membranous nephropathy in stage I|membranous nephropathy in stage i
4664035|NCT03466775|Kidney transplantation|kidney transplantation
4664036|NCT03466775|Allograft rejection|allograft rejection
4664037|NCT03466775|Allograft survival|allograft survival
4664038|NCT03466775|Anti-angiotensin II type 1 receptor antibody|anti-angiotensin ii type 1 receptor antibody
4664039|NCT03466762|Quality of life|quality of life
4664040|NCT03466762|Resilience|resilience
4664041|NCT03466762|Cancer Survivors|cancer survivors
4664042|NCT03466762|Life Satisfaction|life satisfaction
4664043|NCT03466762|Post-Cancer Depression|post-cancer depression
4664044|NCT03466762|Coping|coping
4664045|NCT03466749|Coronary Disease|coronary disease
4664046|NCT03466749|Drug eluting balloon|drug eluting balloon
4664047|NCT03466749|De-novo lesions|de-novo lesions
4664048|NCT03466736|practice effects|practice effects
4664049|NCT03466736|amyloid imaging|amyloid imaging
4664050|NCT03466710|Colposcopy|colposcopy
4664051|NCT03466710|Uterine cervical neoplasm|uterine cervical neoplasm
4664052|NCT03466710|HPV|hpv
4664053|NCT03466710|Pap|pap
4664054|NCT03466684|Trauma|trauma
4664055|NCT03466684|Open abdomen|open abdomen
4664056|NCT03466684|Fluid resuscitation|fluid resuscitation
4664057|NCT03466684|Fascial closure|fascial closure
4664058|NCT03466684|Bioelectrical impedance analysis|bioelectrical impedance analysis
4664059|NCT03466645|SSI|ssi
4664060|NCT03466645|elective Craniotomy|elective craniotomy
4664061|NCT03466645|Vancomycin|vancomycin
4664062|NCT03466645|Cefazolin|cefazolin
4664063|NCT03466645|Antibiotic|antibiotic
4664064|NCT03466593|Prehabilitation|prehabilitation
4664065|NCT03466593|Recovery|recovery
4664066|NCT03466593|Complications|complications
4664067|NCT03466580|Caregivers|caregivers
4664068|NCT03466580|Support needs|support needs
4664069|NCT03466580|Intervention|intervention
4664070|NCT03466580|Randomised controlled trial|randomised controlled trial
4664071|NCT03466541|Alcohol consumption|alcohol consumption
4664072|NCT03466541|Sick leave|sick leave
4664073|NCT03466541|Workplace interventions|workplace interventions
4664074|NCT03466541|Presenteeism|presenteeism
4664075|NCT03466515|stem cells therapy|stem cells therapy
4664076|NCT03466502|vancomycin|vancomycin
4664077|NCT03466502|Clostridium difficile|clostridium difficile
4664078|NCT03466502|Clostridium difficile infection|clostridium difficile infection
4664079|NCT03466502|Recurrent Clostridium difficile infection|recurrent clostridium difficile infection
4664080|NCT03466489|total joint arthroplasty|total joint arthroplasty
4664081|NCT03466476|Wearable Technology|wearable technology
4664082|NCT03466476|Total Knee Arthroplasty|total knee arthroplasty
4664083|NCT03466463|Crigler-Najjar|crigler-najjar
4664084|NCT03466463|Adeno Associated Virus|adeno associated virus
4664085|NCT03466450|glioblastoma|glioblastoma
4664086|NCT03466450|glasdegib|glasdegib
4664087|NCT03466450|temozolomide|temozolomide
4664088|NCT03466450|combined therapy|combined therapy
4664089|NCT03466424|Short-course radiotherapy|short-course radiotherapy
4664090|NCT03466424|dose escalation|dose escalation
4664091|NCT03466424|neo-adjuvant chemotherapy|neo-adjuvant chemotherapy
4664092|NCT03466424|mFOLFOX6|mfolfox6
4664093|NCT03466424|rectal cancer|rectal cancer
4664094|NCT03466424|Phase I trial|phase i trial
4664095|NCT03466398|Remote Patient Monitoring|remote patient monitoring
4664096|NCT03466398|Adolescents|adolescents
4664097|NCT03466385|Non-invasive ventilation|non-invasive ventilation
4664098|NCT03466385|Nasal High Flow|nasal high flow
4664099|NCT03466372|gait biofeedback|gait biofeedback
4664100|NCT03466372|gait rehabilitation|gait rehabilitation
4664101|NCT03466372|paretic propulsion|paretic propulsion
4664102|NCT03466372|gait motor learning|gait motor learning
4664103|NCT03466359|appetite control|appetite control
4664104|NCT03466359|obesity|obesity
4664105|NCT03466359|Adolescents|adolescents
4664106|NCT03466359|Physical activity|physical activity
4664107|NCT03466333|preterm pre-eclampsia|preterm pre-eclampsia
4664108|NCT03466333|cardiovascular dysfunction|cardiovascular dysfunction
4664109|NCT03466307|Nocturnal pain|nocturnal pain
4664110|NCT03466307|shoulder pain|shoulder pain
4664111|NCT03466307|ultrasonography|ultrasonography
4664112|NCT03466307|resistive index|resistive index
4664113|NCT03466307|quality of life|quality of life
4664114|NCT03466307|anterior circumflex humeral artery|anterior circumflex humeral artery
4664115|NCT03466294|Azacitidine|azacitidine
4664116|NCT03466294|Venetoclax|venetoclax
4664117|NCT03466294|AML|aml
4664118|NCT03466268|Safety|safety
4664119|NCT03466268|Tolerability|tolerability
4664120|NCT03466268|Pharmacokinetics|pharmacokinetics
4664121|NCT03466268|Anti-tumor activity|anti-tumor activity
4664122|NCT03466242|intranasal dexmedetomidine|intranasal dexmedetomidine
4664123|NCT03466229|sperm DNA strand breaks|sperm dna strand breaks
4664124|NCT03466229|antioxidants|antioxidants
4664125|NCT03466216|somatostatin receptor|somatostatin receptor
4664126|NCT03466203|obesity|obesity
4664127|NCT03466203|hypertriglyceridemia|hypertriglyceridemia
4664128|NCT03466190|Mandibular body fractures, PEEK plates, titanium plates.|mandibular body fractures, peek plates, titanium plates.
4664129|NCT03466177|Alzheimer's disease|alzheimer's disease
4664130|NCT03466177|Dementia|dementia
4664131|NCT03466177|Mild cognitive impairment|mild cognitive impairment
4664132|NCT03466177|Optical coherence tomography|optical coherence tomography
4664133|NCT03466177|Hyperspectral imaging|hyperspectral imaging
4664134|NCT03466177|Multimodal retinal imaging|multimodal retinal imaging
4664135|NCT03466151|Major Adverse Cardiac Events (MACE)|major adverse cardiac events (mace)
4664136|NCT03466151|Myocardial Infarction (MI)|myocardial infarction (mi)
4664137|NCT03466151|Late Lumen Loss (LLL)|late lumen loss (lll)
4664138|NCT03466151|Target Lesion Revascularization (TLR)|target lesion revascularization (tlr)
4664139|NCT03466151|Target Vessel Revascularization (TVR)|target vessel revascularization (tvr)
4664140|NCT03466151|Target Vessel Failure (TVF)|target vessel failure (tvf)
4664141|NCT03466151|Target Lesion Failure (TLF)|target lesion failure (tlf)
4664142|NCT03466151|Stent Thrombosis (ST)|stent thrombosis (st)
4664143|NCT03466151|The Randomized Controlled Trial|the randomized controlled trial
4664144|NCT03466151|PERCUTANEOUS CORONARY INTERVENTION (PCI)|percutaneous coronary intervention (pci)
4664145|NCT03466112|exercise|exercise
4664146|NCT03466073|recombinant human plasma gelsolin (rhu-pGSN)|recombinant human plasma gelsolin (rhu-pgsn)
4664147|NCT03466073|severe community-acquired pneumonia (sCAP)|severe community-acquired pneumonia (scap)
4664148|NCT03466073|adjunctive therapy|adjunctive therapy
4664149|NCT03466034|TP53|tp53
4664150|NCT03466034|Hypoxia|hypoxia
4664151|NCT03466034|Endometriod and Mucinous Carcinomas|endometriod and mucinous carcinomas
4664152|NCT03466034|Serous and Clear Cell Carcinomas|serous and clear cell carcinomas
4664153|NCT03466034|Magnetic Resonance Imaging, MRI|magnetic resonance imaging, mri
4664154|NCT03466021|GLP-1 receptor agonist|glp-1 receptor agonist
4664155|NCT03466021|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
4664156|NCT03466021|FDG/PET-CT|fdg/pet-ct
4664157|NCT03466021|inflammation|inflammation
4664158|NCT03466021|weightloss|weightloss
4664159|NCT03466021|quality of life|quality of life
4664160|NCT03466008|whole body cryotherapy|whole body cryotherapy
4664161|NCT03466008|fibromyalgia|fibromyalgia
4664162|NCT03466008|chronic pain|chronic pain
4664163|NCT03466008|quality of life|quality of life
4664164|NCT03466008|perceived health|perceived health
4664165|NCT03465982|rectal cancer|rectal cancer
4664166|NCT03465982|robotic rectal cancer resection|robotic rectal cancer resection
4664167|NCT03465982|minimally invasive surgery|minimally invasive surgery
4664168|NCT03465982|Colorectal Cancer|colorectal cancer
4664169|NCT03465982|chemoradiation treatment rectal cancer|chemoradiation treatment rectal cancer
4664170|NCT03465969|Kidney transplantation|kidney transplantation
4664171|NCT03465969|A Bioanalytical Method Cross-validation|a bioanalytical method cross-validation
4664172|NCT03465969|Advagraf|advagraf
4664173|NCT03465969|Liver transplantation|liver transplantation
4664174|NCT03465930|Lymphedema|lymphedema
4664175|NCT03465930|Lymphatic collecting vessels|lymphatic collecting vessels
4664176|NCT03465930|Supermicrosurgery|supermicrosurgery
4664177|NCT03465930|Lymphatic-venous anastomoses|lymphatic-venous anastomoses
4664178|NCT03465930|Immunohistochemistry|immunohistochemistry
4664179|NCT03465891|Advanced Stage Follicular Lymphoma|advanced stage follicular lymphoma
4664180|NCT03465891|Relapsed|relapsed
4664181|NCT03465891|Refractory|refractory
4664182|NCT03465891|Atezolizumab|atezolizumab
4664183|NCT03465891|Dose Local Radiotherapy (2 x 2Gy)|dose local radiotherapy (2 x 2gy)
4664184|NCT03465891|17-360|17-360
4664185|NCT03465800|overweight|overweight
4664186|NCT03465800|obesity|obesity
4664187|NCT03465800|physical activity|physical activity
4664188|NCT03465800|exercise|exercise
4664189|NCT03465787|Schizophrenia|schizophrenia
4664190|NCT03465787|Acutely Psychotic Patients with Schizophrenia|acutely psychotic patients with schizophrenia
4664191|NCT03465787|Latuda|latuda
4664192|NCT03465787|Lurasidone|lurasidone
4664193|NCT03465774|Malignant neoplasms of respiratory and intrathoracic organs|malignant neoplasms of respiratory and intrathoracic organs
4664194|NCT03465774|Pleural effusions|pleural effusions
4664195|NCT03465774|Indwelling Pleural Catheter|indwelling pleural catheter
4664196|NCT03465774|IPC|ipc
4664197|NCT03465774|Fentanyl|fentanyl
4664198|NCT03465774|Sublimaze|sublimaze
4664199|NCT03465774|Doxycycline|doxycycline
4664200|NCT03465774|Vibramycin|vibramycin
4664201|NCT03465774|Periostat|periostat
4664202|NCT03465774|Doryx|doryx
4664203|NCT03465774|Questionnaires|questionnaires
4664204|NCT03465774|Surveys|surveys
4664205|NCT03465761|MRgFUS|mrgfus
4664206|NCT03465761|ExAblate|exablate
4664207|NCT03465761|Bilateral Essential Tremor|bilateral essential tremor
4664208|NCT03465735|Deep|deep
4664209|NCT03465735|Pulmonary|pulmonary
4664210|NCT03465735|Venous|venous
4664211|NCT03465735|Vascular|vascular
4664212|NCT03465735|Post|post
4664213|NCT03465735|Vein|vein
4664214|NCT03465735|Thrombosis|thrombosis
4664215|NCT03465735|Embolism|embolism
4664216|NCT03465735|Thromboembolism|thromboembolism
4664217|NCT03465735|Thrombotic|thrombotic
4664218|NCT03465735|Syndrome|syndrome
4664219|NCT03465722|Other Relapsed or Refractory Solid Tumors|other relapsed or refractory solid tumors
4664220|NCT03465722|BLU-285|blu-285
4664221|NCT03465722|BLU 285|blu 285
4664222|NCT03465722|BLUE-285|blue-285
4664223|NCT03465722|BLUE 285|blue 285
4664224|NCT03465722|Avapritinib|avapritinib
4664225|NCT03465722|GIST imatinib relapse|gist imatinib relapse
4664226|NCT03465722|GIST gleevec relapse|gist gleevec relapse
4664227|NCT03465722|GIST KIT|gist kit
4664228|NCT03465722|GIST relapse|gist relapse
4664229|NCT03465722|GIST refractory|gist refractory
4664230|NCT03465722|GIST imatinib intolerance|gist imatinib intolerance
4664231|NCT03465722|GIST TKI treatment|gist tki treatment
4664232|NCT03465722|GIST tyrosine kinase inhibitor treatment|gist tyrosine kinase inhibitor treatment
4664233|NCT03465722|GIST TKI|gist tki
4664234|NCT03465722|GIST tyrosine kinase inhibitor|gist tyrosine kinase inhibitor
4664235|NCT03465722|Advanced GIST|advanced gist
4664236|NCT03465722|GIST mutations|gist mutations
4664237|NCT03465722|GIST treatments|gist treatments
4664238|NCT03465722|Blueprint GIST|blueprint gist
4664239|NCT03465722|Relapsed GIST clinical trial|relapsed gist clinical trial
4664240|NCT03465722|Refractory GIST clinical trial|refractory gist clinical trial
4664241|NCT03465722|KIT-mutant GIST|kit-mutant gist
4664242|NCT03465722|cancer gist|cancer gist
4664243|NCT03465722|gastrointestinal stromal tumor|gastrointestinal stromal tumor
4664244|NCT03465722|gist cancer|gist cancer
4664245|NCT03465722|PDGFRA|pdgfra
4664246|NCT03465696|psoriasis|psoriasis
4664247|NCT03465696|biologics|biologics
4664248|NCT03465696|treatment decision-making|treatment decision-making
4664249|NCT03465670|chlorhexidine|chlorhexidine
4664250|NCT03465670|hyaluronic acid|hyaluronic acid
4664251|NCT03465670|tooth discoloration|tooth discoloration
4664252|NCT03465657|Child Health|child health
4664253|NCT03465657|Sodium intake|sodium intake
4664254|NCT03465657|Food Sources|food sources
4664255|NCT03465657|Blood Pressure|blood pressure
4664256|NCT03465657|BMI|bmi
4664257|NCT03465657|Urinary sodium excretion|urinary sodium excretion
4664258|NCT03465644|antithrombotic strategy|antithrombotic strategy
4664259|NCT03465644|dual antiplatelet therapy|dual antiplatelet therapy
4664260|NCT03465631|stroke rehabilitation|stroke rehabilitation
4664261|NCT03465618|89Zr-cRGDY Ultrasmall Silica Particle Tracers|89zr-crgdy ultrasmall silica particle tracers
4664262|NCT03465618|Pet Scan|pet scan
4664263|NCT03465618|17-599|17-599
4664264|NCT03465579|Diagnosis Prostate Cancer|diagnosis prostate cancer
4664265|NCT03465579|TNM staging|tnm staging
4664266|NCT03465579|68Ga-PSMA PET/CT guided prostate biopsy|68ga-psma pet/ct guided prostate biopsy
4664267|NCT03465579|mp-3TMRI guided prostate biopsy|mp-3tmri guided prostate biopsy
4664268|NCT03465579|pre-surgical staging|pre-surgical staging
4664269|NCT03465579|clinically-suspected prostate cancer|clinically-suspected prostate cancer
4664270|NCT03465566|Emotion|emotion
4664271|NCT03465566|Social cognition|social cognition
4664272|NCT03465566|Childhood epilepsy|childhood epilepsy
4664273|NCT03465553|palliative care|palliative care
4664274|NCT03465553|thoracic cancer|thoracic cancer
4664275|NCT03465553|radiotherapy|radiotherapy
4664276|NCT03465553|pain|pain
4664277|NCT03465553|quality of life|quality of life
4664278|NCT03465540|Multiple Myeloma|multiple myeloma
4664279|NCT03465540|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
4664280|NCT03465540|Acute Myeloid Leukemia|acute myeloid leukemia
4664281|NCT03465540|AML|aml
4664282|NCT03465540|NHL|nhl
4664283|NCT03465540|MM|mm
4664284|NCT03465540|DLBCL|dlbcl
4664285|NCT03465540|Myeloid Cell Leukemia 1 Inhibitor|myeloid cell leukemia 1 inhibitor
4664286|NCT03465540|MCL1 Inhibitor|mcl1 inhibitor
4664287|NCT03465540|MCL1|mcl1
4664288|NCT03465501|Anal Canal Cancer|anal canal cancer
4664289|NCT03465501|brachytherapy|brachytherapy
4664290|NCT03465488|parasitology|parasitology
4664291|NCT03465488|helminth infections|helminth infections
4664292|NCT03465488|diagnosis|diagnosis
4664293|NCT03465488|drug resistance|drug resistance
4664294|NCT03465488|albendazole|albendazole
4664295|NCT03465488|benzimidazole drugs|benzimidazole drugs
4664296|NCT03465488|Ascaris|ascaris
4664297|NCT03465488|Trichuris|trichuris
4664298|NCT03465488|hookworm|hookworm
4664299|NCT03465488|qPCR|qpcr
4664300|NCT03465488|microscopy|microscopy
4664301|NCT03465475|Low flow anesthesia|low flow anesthesia
4664302|NCT03465475|Desflurane|desflurane
4664303|NCT03465475|Cost analysis|cost analysis
4664304|NCT03465462|hypertension,|hypertension,
4664305|NCT03465462|zinc|zinc
4664306|NCT03465462|zinc supplementation|zinc supplementation
4664307|NCT03465462|antihypertensive monotherapy|antihypertensive monotherapy
4664308|NCT03465462|mineral status|mineral status
4664705|NCT03462641|MRI|mri
4664309|NCT03465384|Parent-Child relations|parent-child relations
4664310|NCT03465384|Parenting|parenting
4664311|NCT03465384|Non-inferiority trial|non-inferiority trial
4664312|NCT03465384|Externalizing behaviors|externalizing behaviors
4664313|NCT03465384|Randomized controlled trial|randomized controlled trial
4664314|NCT03465384|Cost-effectiveness|cost-effectiveness
4664315|NCT03465332|blood eosinophil count|blood eosinophil count
4664316|NCT03465332|COPD|copd
4664317|NCT03465332|diagnostic test|diagnostic test
4664318|NCT03465332|doctor's questionnaire|doctor's questionnaire
4664319|NCT03465332|Lung specialist|lung specialist
4664320|NCT03465319|oxygen concentration|oxygen concentration
4664321|NCT03465319|volatile anesthetics concentration|volatile anesthetics concentration
4664322|NCT03465319|prediction model|prediction model
4664323|NCT03465306|Obesity|obesity
4664324|NCT03465306|Cognitive Behavioral Therapy|cognitive behavioral therapy
4664325|NCT03465293|Symptomatic diverticulosis|symptomatic diverticulosis
4664326|NCT03465293|Microbiota|microbiota
4664327|NCT03465293|Bowel preparation|bowel preparation
4664328|NCT03465280|Recurrent respiratory papillomatosis|recurrent respiratory papillomatosis
4664329|NCT03465267|stroke|stroke
4664330|NCT03465267|upper extremity rehabilitation robot|upper extremity rehabilitation robot
4664331|NCT03465267|stroke rehabilitation|stroke rehabilitation
4664332|NCT03465241|Non-Small Cell Lung Cancer|non-small cell lung cancer
4664333|NCT03465241|stage II to IIIA|stage ii to iiia
4664334|NCT03465241|circulating tumor DNA|circulating tumor dna
4664335|NCT03465241|The next generation of high-throughput gene sequencing|the next generation of high-throughput gene sequencing
4664336|NCT03465228|Low Back Pain|low back pain
4664337|NCT03465228|Photobiomodulation|photobiomodulation
4664338|NCT03465228|Deep Water Running|deep water running
4664339|NCT03465228|Training|training
4664340|NCT03465228|Running|running
4664341|NCT03465202|Capecitabine|capecitabine
4664342|NCT03465202|Pharmacokinetics|pharmacokinetics
4664343|NCT03465202|Ageing|ageing
4664344|NCT03465202|Frailty|frailty
4664345|NCT03465202|Breast cancer|breast cancer
4664346|NCT03465202|Colorectal cancer|colorectal cancer
4664347|NCT03465176|aromatherapy|aromatherapy
4664348|NCT03465176|fatigue|fatigue
4664349|NCT03465176|hypothyroidism|hypothyroidism
4664350|NCT03465176|essential oils|essential oils
4664351|NCT03465150|Acne|acne
4664352|NCT03465150|Cohort|cohort
4664353|NCT03465150|prospective|prospective
4664354|NCT03465150|risk factors|risk factors
4664355|NCT03465137|Exposure therapy|exposure therapy
4664356|NCT03465137|Behavioral therapy|behavioral therapy
4664357|NCT03465137|fMRI|fmri
4664358|NCT03465137|Extinction learning|extinction learning
4664359|NCT03465137|Social anxiety|social anxiety
4664360|NCT03465111|Scleritis|scleritis
4664361|NCT03465111|anterior|anterior
4664362|NCT03465111|adrenocorticotropic hormone|adrenocorticotropic hormone
4664363|NCT03465111|ACTH|acth
4664364|NCT03465111|Non-infectious|non-infectious
4664365|NCT03465098|Infective endocarditis|infective endocarditis
4664366|NCT03465098|PET/CT 18F-FDG|pet/ct 18f-fdg
4664367|NCT03465098|Low carbohydrate diet as Atkins diet|low carbohydrate diet as atkins diet
4664368|NCT03465085|ARDS|ards
4664369|NCT03465085|Streptokinase|streptokinase
4664370|NCT03465085|Heparin|heparin
4664371|NCT03465085|Nebulization|nebulization
4664372|NCT03465085|Inhaled Thrombolytics|inhaled thrombolytics
4664373|NCT03465085|Inhaled Anticoagulation|inhaled anticoagulation
4664374|NCT03465059|BGB-3111|bgb-3111
4664375|NCT03465059|Zanubrutinib|zanubrutinib
4664376|NCT03465059|pharmacokinetics|pharmacokinetics
4664377|NCT03465059|healthy subjects|healthy subjects
4664378|NCT03465059|hepatic impairment|hepatic impairment
4664379|NCT03465046|infantile hemiplegia|infantile hemiplegia
4664380|NCT03465046|upper extremity|upper extremity
4664381|NCT03465046|physical therapy|physical therapy
4664382|NCT03465033|Orthognathic surgery|orthognathic surgery
4664383|NCT03465033|Jaw rehabilitation|jaw rehabilitation
4664384|NCT03465033|Jaw Physiotherapy|jaw physiotherapy
4664385|NCT03465033|Pain|pain
4664386|NCT03465033|Mandibular range of motion|mandibular range of motion
4664387|NCT03465033|Sensorial disturbance|sensorial disturbance
4664388|NCT03465020|Idiopathic|idiopathic
4664389|NCT03465020|Thrombocytopenic|thrombocytopenic
4664390|NCT03465020|Purpura|purpura
4664391|NCT03465007|hemodialysis|hemodialysis
4664392|NCT03465007|cortisol|cortisol
4664393|NCT03465007|Hydrocortisone|hydrocortisone
4664394|NCT03464994|Hereditary ichthyosis|hereditary ichthyosis
4664395|NCT03464994|keratoconus|keratoconus
4664396|NCT03464968|second line|second line
4664397|NCT03464968|FOLFOX|folfox
4664398|NCT03464968|FOLFIRI|folfiri
4664399|NCT03464916|CAR2 Anti-CD38 A2 CAR-T Cells|car2 anti-cd38 a2 car-t cells
4664400|NCT03464903|amyotrophic lateral sclerosis|amyotrophic lateral sclerosis
4664401|NCT03464903|progressive muscular atrophy|progressive muscular atrophy
4664402|NCT03464903|motor neuron disease|motor neuron disease
4664403|NCT03464903|ALS reversals|als reversals
4664404|NCT03464903|whole genome sequencing|whole genome sequencing
4664405|NCT03464851|carotid artery stenosis|carotid artery stenosis
4664406|NCT03464851|plaque|plaque
4664407|NCT03464851|carotid duplex|carotid duplex
4664408|NCT03464851|ultrasound|ultrasound
4664409|NCT03464851|fibromsucular dysplasia|fibromsucular dysplasia
4664410|NCT03464851|carotid atherosclerosis|carotid atherosclerosis
4664411|NCT03464812|Diabetes education|diabetes education
4664412|NCT03464812|Psychosocial management of diabetes|psychosocial management of diabetes
4664413|NCT03464747|Lactic Acid|lactic acid
4664414|NCT03464708|Critical illness|critical illness
4664415|NCT03464708|HMB|hmb
4664416|NCT03464708|Nutrition|nutrition
4664417|NCT03464708|Muscle wasting|muscle wasting
4664418|NCT03464708|Recovery|recovery
4664419|NCT03464695|closed-loop|closed-loop
4664420|NCT03464695|oxygen treatment|oxygen treatment
4664421|NCT03464656|semen|semen
4664422|NCT03464656|male infertility|male infertility
4664423|NCT03464656|semen quality|semen quality
4664424|NCT03464656|sperm DNA fragmentation|sperm dna fragmentation
4664425|NCT03464656|oxidation reduction potential|oxidation reduction potential
4664426|NCT03464565|Large Vessel Occlusion|large vessel occlusion
4664427|NCT03464565|Acute Ischemic Stroke|acute ischemic stroke
4664428|NCT03464565|Mechanical Thrombectomy|mechanical thrombectomy
4664429|NCT03464565|Penumbra System|penumbra system
4664430|NCT03464565|3D Revascularization|3d revascularization
4664431|NCT03464552|colposcopy - colposcopic directed biopsy - celecoxib|colposcopy - colposcopic directed biopsy - celecoxib
4664432|NCT03464448|Teriflunomide|teriflunomide
4664433|NCT03464448|B cell|b cell
4664434|NCT03464448|T cell|t cell
4664435|NCT03464448|cytokines|cytokines
4664436|NCT03464435|Refractory Vernal Keratoconjunctivitis|refractory vernal keratoconjunctivitis
4664437|NCT03464435|0.1% tacrolimus|0.1% tacrolimus
4664438|NCT03464435|loteprednol etabonate 0.5%/tobramycin 0.3%|loteprednol etabonate 0.5%/tobramycin 0.3%
4664439|NCT03464422|HIV|hiv
4664440|NCT03464422|MSM|msm
4664441|NCT03464409|Nerve Transfer Surgery|nerve transfer surgery
4664442|NCT03464409|Tendon Transfer Surgery|tendon transfer surgery
4664443|NCT03464409|Decision Support Intervention|decision support intervention
4664444|NCT03464396|Periodic breathing|periodic breathing
4664445|NCT03464396|Apnea of prematurity|apnea of prematurity
4664446|NCT03464396|Chronic Lung disease|chronic lung disease
4664447|NCT03464396|Prematurity|prematurity
4664448|NCT03464396|Respiratory disease|respiratory disease
4664449|NCT03464396|Hypoxia|hypoxia
4664450|NCT03464396|Pulmonary Hypertension|pulmonary hypertension
4664451|NCT03464383|Neurologic Disorders|neurologic disorders
4664452|NCT03464383|Chronic Care|chronic care
4664453|NCT03464383|Management|management
4664454|NCT03464383|Treatment|treatment
4664455|NCT03464383|SSRI Medication|ssri medication
4664456|NCT03464383|SNRI Medication|snri medication
4664457|NCT03464383|Learning Healthcare System|learning healthcare system
4664458|NCT03464370|amygdala enlargement|amygdala enlargement
4664459|NCT03464370|temporal lobe epilepsy|temporal lobe epilepsy
4664460|NCT03464370|stress|stress
4664461|NCT03464370|attentional bias|attentional bias
4664462|NCT03464370|anxiety|anxiety
4664463|NCT03464370|depression|depression
4664464|NCT03464370|PTSD|ptsd
4664465|NCT03464357|functional MRI|functional mri
4664466|NCT03464344|intracerebral hemorrhage|intracerebral hemorrhage
4664467|NCT03464344|cerebral amyloid angiopathy|cerebral amyloid angiopathy
4664468|NCT03464344|cortical superficial siderosis|cortical superficial siderosis
4664469|NCT03464344|Magnetic Resonance Imaging|magnetic resonance imaging
4664470|NCT03464318|idiopathic scoliosis|idiopathic scoliosis
4664471|NCT03464318|radiographs|radiographs
4664472|NCT03464318|low dose|low dose
4664473|NCT03464305|Colonic Neoplasms|colonic neoplasms
4664474|NCT03464305|Colorectal Neoplasms|colorectal neoplasms
4664475|NCT03464305|Intestinal Neoplasms|intestinal neoplasms
4664476|NCT03464305|Gastrointestinal Neoplasms|gastrointestinal neoplasms
4664477|NCT03464305|Digestive System Neoplasms|digestive system neoplasms
4664478|NCT03464305|Neoplasms by Site|neoplasms by site
4664479|NCT03464305|Neoplasms|neoplasms
4664480|NCT03464305|Colonic Diseases|colonic diseases
4664481|NCT03464305|Aspirin|aspirin
4664482|NCT03464305|Recurrence|recurrence
4664483|NCT03464305|Digestive System Diseases|digestive system diseases
4664484|NCT03464305|Intestinal Diseases|intestinal diseases
4664485|NCT03464305|Disease Attributes|disease attributes
4664486|NCT03464305|Pathologic Processes|pathologic processes
4664487|NCT03464227|Phase 1|phase 1
4664488|NCT03464227|UCB0107|ucb0107
4664489|NCT03464214|Vibration|vibration
4664490|NCT03464214|Cervical stabilization exercises|cervical stabilization exercises
4664491|NCT03464214|Physiotherapy and rehabilitation|physiotherapy and rehabilitation
4664492|NCT03464214|Sensory organization test|sensory organization test
4664493|NCT03464214|Balance|balance
4664494|NCT03464188|early palliative care|early palliative care
4664495|NCT03464188|family caregiver|family caregiver
4664496|NCT03464188|rural|rural
4664497|NCT03464188|African-American|african-american
4664498|NCT03464188|telehealth|telehealth
4664499|NCT03464162|Social Network Meetings|social network meetings
4664500|NCT03464162|First Episode Psychosis|first episode psychosis
4664501|NCT03464162|OnTrackNY|ontrackny
4664502|NCT03464097|Crohn's Disease|crohn's disease
4664503|NCT03464097|Crohn Disease|crohn disease
4664504|NCT03464097|Oral|oral
4664505|NCT03464097|Ozanimod|ozanimod
4664506|NCT03464097|Moderately active|moderately active
4664706|NCT03462641|Mobility|mobility
4664507|NCT03464097|Severely active|severely active
4664508|NCT03464097|RPC01|rpc01
4664509|NCT03464097|RPC01-3203|rpc01-3203
4664510|NCT03464071|sepsis|sepsis
4664511|NCT03464071|biomarkers|biomarkers
4664512|NCT03464071|lung injury|lung injury
4664513|NCT03464058|Pharmacokinetics|pharmacokinetics
4664514|NCT03464058|Food Effect|food effect
4664515|NCT03464058|Proton Pump Inhibitors|proton pump inhibitors
4664516|NCT03464058|Drug Interaction|drug interaction
4664517|NCT03464058|Oral Prototype Formulations|oral prototype formulations
4664518|NCT03464019|Paroxysmal supraventricular tachycardia|paroxysmal supraventricular tachycardia
4664519|NCT03464019|cardiac monitoring|cardiac monitoring
4664520|NCT03464019|atrioventricular nodal reentrant tachycardia|atrioventricular nodal reentrant tachycardia
4664521|NCT03464019|atrioventricular reciprocating tachycardia|atrioventricular reciprocating tachycardia
4664522|NCT03464019|calcium channel blocker|calcium channel blocker
4664523|NCT03464019|conversion rate|conversion rate
4664524|NCT03463980|Meditation|meditation
4664525|NCT03463980|African American|african american
4664526|NCT03463980|Randomized controlled trial|randomized controlled trial
4664527|NCT03463967|nonalcoholic steatohepatitis|nonalcoholic steatohepatitis
4664528|NCT03463967|obesity|obesity
4664529|NCT03463967|dyslipidemia|dyslipidemia
4664530|NCT03463967|diet|diet
4664531|NCT03463967|children|children
4664532|NCT03463967|adolescents|adolescents
4664533|NCT03463954|less than or equal to 15 mm|less than or equal to 15 mm
4664534|NCT03463941|African American|african american
4664535|NCT03463941|Faith institutions|faith institutions
4664536|NCT03463941|Dyads|dyads
4664537|NCT03463941|Health disparities|health disparities
4664538|NCT03463915|Interstitial cystitis|interstitial cystitis
4664539|NCT03463915|Bladder pain syndrome|bladder pain syndrome
4664540|NCT03463915|IC/BPS|ic/bps
4664541|NCT03463915|Women|women
4664542|NCT03463915|Pelvic pain|pelvic pain
4664543|NCT03463915|Urologic pain|urologic pain
4664544|NCT03463915|gabapentin|gabapentin
4664545|NCT03463915|Antiepileptic|antiepileptic
4664546|NCT03463902|Gesture|gesture
4664547|NCT03463902|tDCS|tdcs
4664548|NCT03463902|schizophrenia|schizophrenia
4664549|NCT03463902|nonverbal communication|nonverbal communication
4664550|NCT03463798|structured light plethysmography|structured light plethysmography
4664551|NCT03463798|sonar|sonar
4664552|NCT03463798|transdiaphragmatic pressure|transdiaphragmatic pressure
4664553|NCT03463785|obstructive sleep apnea|obstructive sleep apnea
4664554|NCT03463785|race|race
4664555|NCT03463785|upper airway|upper airway
4664556|NCT03463785|cone beam computed tomography|cone beam computed tomography
4664557|NCT03463772|in vitro maturation|in vitro maturation
4664558|NCT03463772|polycystic ovarian syndrome|polycystic ovarian syndrome
4664559|NCT03463772|oocyte|oocyte
4664560|NCT03463733|Glioma|glioma
4664561|NCT03463733|Recurrent glioma|recurrent glioma
4664562|NCT03463733|Glioblastoma multiforme|glioblastoma multiforme
4664563|NCT03463733|Recurrent Glioblastoma multiforme|recurrent glioblastoma multiforme
4664564|NCT03463733|Hydroxyurea|hydroxyurea
4664565|NCT03463733|Temozolomide|temozolomide
4664566|NCT03463668|duodenal stenosis|duodenal stenosis
4664567|NCT03463668|pyloric stenosis|pyloric stenosis
4664568|NCT03463668|digestive neoplasias|digestive neoplasias
4664569|NCT03463668|non-digestive neoplasias|non-digestive neoplasias
4664570|NCT03463668|duodenal prosthesis|duodenal prosthesis
4664571|NCT03463655|palliative|palliative
4664572|NCT03463655|solid tumor|solid tumor
4664573|NCT03463655|ascites|ascites
4664574|NCT03463629|Multidisciplinary Team|multidisciplinary team
4664575|NCT03463629|Hispanic adults|hispanic adults
4664576|NCT03463616|Rectal Cancer|rectal cancer
4664577|NCT03463616|Liver Metastases|liver metastases
4664578|NCT03463616|CT abdomen|ct abdomen
4664579|NCT03463616|MRI Liver|mri liver
4664580|NCT03463603|ischemic heart disease|ischemic heart disease
4664581|NCT03463603|acute coronary syndrome|acute coronary syndrome
4664582|NCT03463603|racial bias|racial bias
4664583|NCT03463590|Habenula|habenula
4664584|NCT03463590|Obsessive-Compulsive Disorder|obsessive-compulsive disorder
4664585|NCT03463590|Deep brain stimulation|deep brain stimulation
4664586|NCT03463564|type 1 diabetes|type 1 diabetes
4664587|NCT03463564|transition|transition
4664588|NCT03463564|CSII|csii
4664589|NCT03463564|MDI|mdi
4664590|NCT03463564|glycemic control|glycemic control
4664591|NCT03463564|glucose variability|glucose variability
4664592|NCT03463525|Carcinoma, Non-Small-Cell Lung|carcinoma, non-small-cell lung
4664593|NCT03463486|outpatient cardiac rehabilitation, exercise training,|outpatient cardiac rehabilitation, exercise training,
4664594|NCT03463447|Dynamometer|dynamometer
4664595|NCT03463447|Handgrip|handgrip
4664596|NCT03463447|children|children
4664597|NCT03463434|pressure ulcer treatment|pressure ulcer treatment
4664598|NCT03463434|wound healing|wound healing
4664599|NCT03463421|Adherence to oral anticoagulation|adherence to oral anticoagulation
4664600|NCT03463421|Persistence to oral anticoagulation|persistence to oral anticoagulation
4664601|NCT03463421|AF patients|af patients
4664602|NCT03463421|Previous ischemic stroke|previous ischemic stroke
4664603|NCT03463408|Sarcoma|sarcoma
4664604|NCT03463382|Pediatric Surgery|pediatric surgery
4664605|NCT03463382|Postoperative Pain|postoperative pain
4664606|NCT03463382|Erector spinae plane block|erector spinae plane block
4664607|NCT03463382|quadratus lumborum block|quadratus lumborum block
4664608|NCT03463317|Atrial Fibrillation|atrial fibrillation
4664609|NCT03463317|Anticoagulation|anticoagulation
4664610|NCT03463317|Left atrial appendage closure|left atrial appendage closure
4664611|NCT03463317|Stroke|stroke
4664612|NCT03463304|Gut Microbiota|gut microbiota
4664613|NCT03463304|endocannabinoide|endocannabinoide
4664614|NCT03463304|Metabolic health|metabolic health
4664615|NCT03463304|Gastrointestinal health|gastrointestinal health
4664616|NCT03463304|Mental wellbeing|mental wellbeing
4664617|NCT03463239|Autologous tissue engineered corpora|autologous tissue engineered corpora
4664618|NCT03463226|Testosterone Deficiency|testosterone deficiency
4664619|NCT03463226|Sympathetic overactivity|sympathetic overactivity
4664620|NCT03463226|Exercise Intolerance|exercise intolerance
4664621|NCT03463213|health behavior|health behavior
4664622|NCT03463213|chronic disease prevention|chronic disease prevention
4664623|NCT03463213|healthy lifestyle|healthy lifestyle
4664624|NCT03463200|bandage|bandage
4664625|NCT03463200|low back pain|low back pain
4664626|NCT03463200|muscle fatigue|muscle fatigue
4664627|NCT03463200|electromyography|electromyography
4664628|NCT03463174|overdenture|overdenture
4664629|NCT03463174|edentulism|edentulism
4664630|NCT03463174|dental implant|dental implant
4664631|NCT03463174|cost-effectiveness|cost-effectiveness
4664632|NCT03463174|economic analysis|economic analysis
4664633|NCT03463174|effectiveness|effectiveness
4664634|NCT03463122|stroke|stroke
4664635|NCT03463122|neglect|neglect
4664636|NCT03463122|virtual reality|virtual reality
4664637|NCT03463122|head mount display|head mount display
4664638|NCT03463122|rehabilitation|rehabilitation
4664639|NCT03463109|Chronic low back pain|chronic low back pain
4664640|NCT03463096|respiratory|respiratory
4664641|NCT03463096|physiology|physiology
4664642|NCT03463096|gravity|gravity
4664643|NCT03463070|misoprostol|misoprostol
4664644|NCT03463070|postpartum haemorrhage|postpartum haemorrhage
4664645|NCT03463031|GSP 301 nasal spray for the treatment of Seasonal Allergic Rhinitis|gsp 301 nasal spray for the treatment of seasonal allergic rhinitis
4664646|NCT03463018|Echinacea, Subthreshold Anxiety|echinacea, subthreshold anxiety
4664647|NCT03462979|Gluten-free diet|gluten-free diet
4664648|NCT03462979|Urine|urine
4664649|NCT03462979|Stool|stool
4664650|NCT03462979|home testing|home testing
4664651|NCT03462966|Rifaximin|rifaximin
4664652|NCT03462966|Xifaxan|xifaxan
4664653|NCT03462940|Tauroursodeoxycholic acid (TUDCA)|tauroursodeoxycholic acid (tudca)
4664654|NCT03462940|Endothelial function in humans|endothelial function in humans
4664655|NCT03462940|Endoplasmic Reticulum Stress|endoplasmic reticulum stress
4664656|NCT03462901|Fixation of midshaft clavicular fracture by intramedullary|fixation of midshaft clavicular fracture by intramedullary
4664657|NCT03462888|Rhabdomyosarcoma|rhabdomyosarcoma
4664658|NCT03462888|Adolescents and young adults|adolescents and young adults
4664659|NCT03462888|prognostic factors|prognostic factors
4664660|NCT03462888|molecular profiling|molecular profiling
4664661|NCT03462875|Crohn's Disease|crohn's disease
4664662|NCT03462875|Microbiota|microbiota
4664663|NCT03462875|Dietary Pattern|dietary pattern
4664664|NCT03462875|Environmental factors|environmental factors
4664665|NCT03462862|PEEK|peek
4664666|NCT03462862|Breflex|breflex
4664667|NCT03462849|ARDS|ards
4664668|NCT03462849|expiratory flow limitation|expiratory flow limitation
4664669|NCT03462849|trans-pulmonary pressure|trans-pulmonary pressure
4664670|NCT03462849|airway closure|airway closure
4664671|NCT03462823|ACL Reconstruction|acl reconstruction
4664672|NCT03462823|Osteoconductive Scaffold|osteoconductive scaffold
4664673|NCT03462823|Bone Tunnel Widening|bone tunnel widening
4664674|NCT03462810|cabotegravir, CAB|cabotegravir, cab
4664675|NCT03462810|GSK1265744|gsk1265744
4664676|NCT03462810|Individual Patient Compassionate Use|individual patient compassionate use
4664677|NCT03462810|HIV|hiv
4664678|NCT03462771|elderly|elderly
4664679|NCT03462771|sarcopenia|sarcopenia
4664680|NCT03462771|dietary supplementation|dietary supplementation
4664681|NCT03462771|omega-3 fatty acid|omega-3 fatty acid
4664682|NCT03462758|Mirena|mirena
4664683|NCT03462758|ParaGard|paragard
4664684|NCT03462758|Skyla|skyla
4664685|NCT03462758|Liletta|liletta
4664686|NCT03462758|Kyleena|kyleena
4664687|NCT03462758|Intrauterine Device|intrauterine device
4664688|NCT03462758|Intrauterine System|intrauterine system
4664689|NCT03462758|Postpartum|postpartum
4664690|NCT03462758|Expulsion|expulsion
4664691|NCT03462706|Polyp Resection|polyp resection
4664692|NCT03462706|Cold Snare|cold snare
4664693|NCT03462706|Hot Snare|hot snare
4664694|NCT03462706|Cold Endoscopic Mucosal Resection (EMR)|cold endoscopic mucosal resection (emr)
4664695|NCT03462706|Hot Endoscopic Mucosal Resection (EMR)|hot endoscopic mucosal resection (emr)
4664696|NCT03462706|Colonoscopy|colonoscopy
4664697|NCT03462654|Health promotion|health promotion
4664698|NCT03462654|Behaviour change|behaviour change
4664699|NCT03462654|Physical activity|physical activity
4664700|NCT03462654|Fall prevention|fall prevention
4664701|NCT03462641|Gait|gait
4664702|NCT03462641|Balance|balance
4664703|NCT03462641|Flumazenil|flumazenil
4664704|NCT03462641|PET Imaging|pet imaging
4664707|NCT03462641|Intravenous|intravenous
4664708|NCT03462628|substrate modification|substrate modification
4664709|NCT03462628|pulmonary vein isolation|pulmonary vein isolation
4664710|NCT03462628|ablation|ablation
4664711|NCT03462628|Paroxysmal Atrial Fibrillation|paroxysmal atrial fibrillation
4664713|NCT03462615|pregnancy|pregnancy
4664714|NCT03462615|diagnosis|diagnosis
4664715|NCT03462615|rapid diagnostic test|rapid diagnostic test
4664716|NCT03462537|Aerobic Exercise|aerobic exercise
4664717|NCT03462537|Lipolytic Laser|lipolytic laser
4664718|NCT03462537|Lipid Profile|lipid profile
4664719|NCT03462537|C-reactive protein|c-reactive protein
4664720|NCT03462537|Lipolysis|lipolysis
4664721|NCT03462511|Hydroxyurea|hydroxyurea
4664722|NCT03462511|Community health worker (CHW)|community health worker (chw)
4664723|NCT03462511|Text messages|text messages
4664724|NCT03462511|Medication adherence|medication adherence
4664725|NCT03462498|Acute Coronary Syndrome|acute coronary syndrome
4664726|NCT03462498|Acute Myocardial Infarction|acute myocardial infarction
4664727|NCT03462498|Coronary Artery Disease|coronary artery disease
4664728|NCT03462498|Percutaneous Coronary Intervention|percutaneous coronary intervention
4664729|NCT03462498|Platelet Aggregation Inhibitors|platelet aggregation inhibitors
4664730|NCT03462446|Atrial fibrillation|atrial fibrillation
4664731|NCT03462446|VKA|vka
4664732|NCT03462446|Stroke|stroke
4664733|NCT03462433|Ruptured Intracranial Aneurysms|ruptured intracranial aneurysms
4664734|NCT03462433|Unruptured Intracranial Aneurysms|unruptured intracranial aneurysms
4664735|NCT03462433|Prospective cohort study|prospective cohort study
4664736|NCT03462433|China|china
4664737|NCT03462420|Adhesive capsulitis|adhesive capsulitis
4664738|NCT03462420|Frozen shoulder|frozen shoulder
4664739|NCT03462420|Diabetes|diabetes
4664740|NCT03462420|Physiotherapy|physiotherapy
4664741|NCT03462329|Post-Lyme symptoms|post-lyme symptoms
4664742|NCT03462329|Pretreatment expectations|pretreatment expectations
4664743|NCT03462290|Botulinum Toxins, Type A|botulinum toxins, type a
4664744|NCT03462290|Injections|injections
4664745|NCT03462290|Sphenopalatine Ganglion Block|sphenopalatine ganglion block
4664746|NCT03462277|methylation|methylation
4664747|NCT03462277|hydroxymethylation|hydroxymethylation
4664748|NCT03462277|atherosclerosis|atherosclerosis
4664749|NCT03462277|coronary heart disease|coronary heart disease
4664750|NCT03462251|Breast Cancer|breast cancer
4664751|NCT03462251|HR positive|hr positive
4664752|NCT03462251|HER2 negative|her2 negative
4664753|NCT03462251|Mamma carcinoma|mamma carcinoma
4664754|NCT03462199|Kiwi|kiwi
4664755|NCT03462199|Constipation|constipation
4664756|NCT03462199|Bowel Movements|bowel movements
4664757|NCT03462199|Healthy|healthy
4664758|NCT03462199|Functional Constipation|functional constipation
4664759|NCT03462160|Urinary Tract Infection|urinary tract infection
4664760|NCT03462160|prophylaxis|prophylaxis
4664761|NCT03462160|probiotics|probiotics
4664762|NCT03462121|Alzheimer's Disease,|alzheimer's disease,
4664763|NCT03462121|Dementia|dementia
4664764|NCT03462082|Parkinson's disease|parkinson's disease
4664765|NCT03462082|axial motor dysfunction|axial motor dysfunction
4664766|NCT03462082|asymmetric neuromodulation|asymmetric neuromodulation
4664767|NCT03462082|subthalamic nucleus deep brain stimulation|subthalamic nucleus deep brain stimulation
4664768|NCT03462030|food allergy|food allergy
4664769|NCT03462030|oral immunotherapy|oral immunotherapy
4664770|NCT03462004|Healthy Volunteer|healthy volunteer
4664771|NCT03461965|3D printing|3d printing
4664772|NCT03461965|Patient education|patient education
4664773|NCT03461939|ePRIME|eprime
4664774|NCT03461939|PRO|pro
4664775|NCT03461939|PROM|prom
4664776|NCT03461939|Adverse event|adverse event
4664777|NCT03461939|QTool|qtool
4664778|NCT03461939|Early phase|early phase
4664779|NCT03461939|CTCAE|ctcae
4664780|NCT03461926|Sedentary Behaviour|sedentary behaviour
4664781|NCT03461926|Health Behaviour Change|health behaviour change
4664782|NCT03461926|Health Action Process Approach|health action process approach
4664783|NCT03461926|mHealth|mhealth
4664784|NCT03461926|Intervention|intervention
4664785|NCT03461926|Non-Sedentary Behaviours|non-sedentary behaviours
4664786|NCT03461926|Break Frequency|break frequency
4664787|NCT03461926|Break Duration|break duration
4664788|NCT03461926|Action Planning|action planning
4664789|NCT03461926|Coping Planning|coping planning
4664790|NCT03461926|Work Performance|work performance
4664791|NCT03461926|Health Outcomes|health outcomes
4664792|NCT03461900|Septic shock|septic shock
4664793|NCT03461900|Fluid optimisation|fluid optimisation
4664794|NCT03461900|Minifluid challenge|minifluid challenge
4664795|NCT03461900|Fluid overload|fluid overload
4664796|NCT03461887|exercise|exercise
4664797|NCT03461887|minimal equipment|minimal equipment
4664798|NCT03461887|home-based|home-based
4664799|NCT03461887|COPD|copd
4664800|NCT03461874|High-Frequency Migraine without aura|high-frequency migraine without aura
4664801|NCT03461874|ACT|act
4664802|NCT03461861|Healthy|healthy
4664803|NCT03461861|Adult|adult
4664804|NCT03461861|Normal Memory|normal memory
4664805|NCT03461861|APOE 4|apoe 4
4664806|NCT03461861|Brain|brain
4664807|NCT03461861|Magnetic Resonance Imaging|magnetic resonance imaging
4664808|NCT03461861|MRI|mri
4664809|NCT03461861|Alzheimer's disease|alzheimer's disease
4664810|NCT03461861|Hippocampus|hippocampus
4664811|NCT03461861|Genetic testing|genetic testing
4664812|NCT03461861|Dementia|dementia
4664813|NCT03461809|diplopia; ocular motor nerve palsy; acupuncture|diplopia; ocular motor nerve palsy; acupuncture
4664814|NCT03461770|atelectasis|atelectasis
4664815|NCT03461770|children|children
4664816|NCT03461770|ultrasound|ultrasound
4664817|NCT03461757|Acute Migraine|acute migraine
4664818|NCT03461757|phonophobia|phonophobia
4664819|NCT03461757|photophobia|photophobia
4664820|NCT03461757|nausea|nausea
4664821|NCT03461731|Low-Level Light Therapy|low-level light therapy
4664822|NCT03461705|Coronary Artery Stenosis|coronary artery stenosis
4664823|NCT03461705|Stenosis|stenosis
4664824|NCT03461705|Resting Flow Reserve (RFR)|resting flow reserve (rfr)
4664825|NCT03461705|Volcano Verrata Pressure Wire|volcano verrata pressure wire
4664826|NCT03461666|Primary insomnia|primary insomnia
4664827|NCT03461666|Behavioral treatment of primary insomnia|behavioral treatment of primary insomnia
4664828|NCT03461666|Focus of attention|focus of attention
4664829|NCT03461666|cognitive behavioral therapy for insomnia|cognitive behavioral therapy for insomnia
4664830|NCT03461627|randomized|randomized
4664831|NCT03461627|double-blind|double-blind
4664832|NCT03461627|double-dummy|double-dummy
4664833|NCT03461627|positive-controlled|positive-controlled
4664834|NCT03461627|parallel-group|parallel-group
4664835|NCT03461614|pulmonary function|pulmonary function
4664836|NCT03461614|respiratory muscle strength|respiratory muscle strength
4664837|NCT03461614|functional capacity|functional capacity
4664838|NCT03461614|core exercises|core exercises
4664839|NCT03461614|rehabilitation|rehabilitation
4664840|NCT03461562|Aerobic Exercise|aerobic exercise
4664841|NCT03461562|Whole Body Vibration Therapy|whole body vibration therapy
4664842|NCT03461549|pressure sensor|pressure sensor
4664843|NCT03461549|temperature sensor|temperature sensor
4664844|NCT03461549|wearables|wearables
4664845|NCT03461510|Cognition|cognition
4664847|NCT03461510|Functional MRI|functional mri
4664848|NCT03461510|Pediatric Obesity|pediatric obesity
4664849|NCT03461510|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
4664850|NCT03461510|Adolescents|adolescents
4664851|NCT03461510|Continuous Glucose Monitoring|continuous glucose monitoring
4664852|NCT03461510|Insulin Clamp|insulin clamp
4664853|NCT03461497|Patient-Reported Outcome|patient-reported outcome
4664854|NCT03461497|Patient Outcome Assessment|patient outcome assessment
4664855|NCT03461497|Questionnaire|questionnaire
4664856|NCT03461497|Self-Report|self-report
4664857|NCT03461497|Abdominal Surgery|abdominal surgery
4664858|NCT03461497|Postoperative Period|postoperative period
4664859|NCT03461497|Recovery of Function|recovery of function
4664860|NCT03461497|Psychometrics|psychometrics
4664861|NCT03461497|Qualitative Research|qualitative research
4664862|NCT03461497|Patient-Centered|patient-centered
4664863|NCT03461458|Degenerative Disc Disease|degenerative disc disease
4664864|NCT03461458|Musculoskeletal Diseases|musculoskeletal diseases
4664865|NCT03461458|Lumbar|lumbar
4664866|NCT03461445|Elderly|elderly
4664867|NCT03461445|Neurotoxicity|neurotoxicity
4664868|NCT03461445|Calcineurin inhibitors|calcineurin inhibitors
4664869|NCT03461445|Tacrolimus|tacrolimus
4664870|NCT03461432|Cognitive Remediation Therapy CRT|cognitive remediation therapy crt
4664871|NCT03461419|Multiple Sclerosis|multiple sclerosis
4664872|NCT03461419|Demyelinating Disease|demyelinating disease
4664873|NCT03461419|Nervous System Degenerative Disease|nervous system degenerative disease
4664874|NCT03461419|Autoimmune Disease|autoimmune disease
4664875|NCT03461393|AMD|amd
4664876|NCT03461393|Mobile Device|mobile device
4664877|NCT03461393|Training|training
4664878|NCT03461380|Cimicifuga, Rhodiola, Menopause Symptoms|cimicifuga, rhodiola, menopause symptoms
4664879|NCT03461328|magnesium sulphate, chronic obstructive pulmonary diseases|magnesium sulphate, chronic obstructive pulmonary diseases
4664880|NCT03461315|home care|home care
4664881|NCT03461315|primary care|primary care
4664882|NCT03461315|preventive home visits|preventive home visits
4664883|NCT03461250|HCV infection|hcv infection
4664884|NCT03461250|hemodialysis|hemodialysis
4664885|NCT03461250|HCV genotype|hcv genotype
4664886|NCT03461250|Liver Fibrosis stage|liver fibrosis stage
4664887|NCT03461237|Second Hip Fracture|second hip fracture
4664888|NCT03461237|Quantitative Computed Tomography|quantitative computed tomography
4664889|NCT03461237|Bone structure|bone structure
4664890|NCT03461237|Muscle|muscle
4664891|NCT03461224|breast cancer|breast cancer
4664892|NCT03461224|radiotherapy|radiotherapy
4664893|NCT03461224|cutaneous toxicity|cutaneous toxicity
4664894|NCT03461224|subcutaneous toxicity|subcutaneous toxicity
4664895|NCT03461224|IMRT|imrt
4664896|NCT03461172|surgery|surgery
4664897|NCT03461172|breast cancer|breast cancer
4664898|NCT03461159|operant conditioning|operant conditioning
4664899|NCT03461159|H-reflex|h-reflex
4664900|NCT03461159|motor evoked potential|motor evoked potential
4664901|NCT03461159|transcranial magnetic stimulation|transcranial magnetic stimulation
4664902|NCT03461159|motor control|motor control
4664903|NCT03461042|Chronic insomnia|chronic insomnia
4664904|NCT03461042|Ramelteon|ramelteon
4664905|NCT03461042|Rozerem|rozerem
4664906|NCT03461042|dose reduction|dose reduction
4664907|NCT03461029|Sedation|sedation
4664908|NCT03461016|Smartphones|smartphones
4664909|NCT03461016|Exposure Therapy|exposure therapy
4664910|NCT03461016|Dental Anxiety|dental anxiety
4664911|NCT03460977|efficacy|efficacy
4664912|NCT03460977|safety|safety
4664913|NCT03460977|pharmacokinetics|pharmacokinetics
4664914|NCT03460977|pharmacodynamics|pharmacodynamics
4664915|NCT03460977|dose escalation|dose escalation
4664916|NCT03460977|dose expansion|dose expansion
4664917|NCT03460977|open-label|open-label
4664918|NCT03460977|EZH2|ezh2
4664919|NCT03460977|enhancer of zeste homolog 2|enhancer of zeste homolog 2
4664920|NCT03460977|castrate resistant prostate cancer|castrate resistant prostate cancer
4664921|NCT03460977|CRPC|crpc
4664922|NCT03460977|small cell lung cancer|small cell lung cancer
4664923|NCT03460977|SCLC|sclc
4664924|NCT03460977|follicular lymphoma|follicular lymphoma
4664925|NCT03460977|FL|fl
4664926|NCT03460977|relapsed|relapsed
4664927|NCT03460977|refractory|refractory
4664928|NCT03460964|Sensor|sensor
4664929|NCT03460964|Glucose|glucose
4664930|NCT03460964|Sweat|sweat
4664931|NCT03460951|Feasibility and reproductibility|feasibility and reproductibility
4664932|NCT03460951|DTI parameters (Fractional Anisotropy, Apparent Diffusion Coefficient)|dti parameters (fractional anisotropy, apparent diffusion coefficient)
4664933|NCT03460951|MRI morphological parameters (T1, STIR)|mri morphological parameters (t1, stir)
4664934|NCT03460925|pancreatic cancer|pancreatic cancer
4664935|NCT03460925|stereotactic body radiotherapy|stereotactic body radiotherapy
4664936|NCT03460925|resectability|resectability
4664937|NCT03460912|IONM|ionm
4664938|NCT03460912|thyroidectomy|thyroidectomy
4664939|NCT03460912|bipolar probe|bipolar probe
4664940|NCT03460912|monopolar probe|monopolar probe
4664941|NCT03460899|Hypoglycaemia|hypoglycaemia
4664942|NCT03460899|Platelet activity|platelet activity
4664943|NCT03460899|Type 2 diabetes mellitus|type 2 diabetes mellitus
4664944|NCT03460886|transcranial direct current stimulation|transcranial direct current stimulation
4664945|NCT03460834|Asthma|asthma
4664946|NCT03460834|Obesity|obesity
4664947|NCT03460834|Observational Study|observational study
4664948|NCT03460808|steroid-resistant|steroid-resistant
4664949|NCT03460808|refractory|refractory
4664950|NCT03460808|Atorvastatin|atorvastatin
4664951|NCT03460808|Acetylcysteine|acetylcysteine
4664952|NCT03460808|Danazol|danazol
4664953|NCT03460782|Ipilimumab|ipilimumab
4664954|NCT03460782|Glioblastoma|glioblastoma
4664955|NCT03460782|Glioma|glioma
4664956|NCT03460769|Pancreatic Cancer|pancreatic cancer
4664957|NCT03460769|Chronic Pancreatitis|chronic pancreatitis
4664958|NCT03460769|Diabetes Mellitus Type 3c|diabetes mellitus type 3c
4664959|NCT03460769|Data management|data management
4664960|NCT03460756|Postpartum Care|postpartum care
4664961|NCT03460756|Postpartum Depression|postpartum depression
4664962|NCT03460743|hemagglutinin influenza vaccine|hemagglutinin influenza vaccine
4664963|NCT03460743|recombinant influenza vaccine|recombinant influenza vaccine
4664964|NCT03460730|Invasive Pneumococcal Disease|invasive pneumococcal disease
4664965|NCT03460691|bariatric surgery|bariatric surgery
4664966|NCT03460691|central sensitization|central sensitization
4664967|NCT03460691|knee pain|knee pain
4664968|NCT03460691|function|function
4664969|NCT03460691|quality of life|quality of life
4664970|NCT03460678|Generic Erlotinib|generic erlotinib
4664971|NCT03460678|Generic Pemetrexed|generic pemetrexed
4664972|NCT03460678|NSCLC|nsclc
4664973|NCT03460678|Non-squamous|non-squamous
4664974|NCT03460678|Randomized Study|randomized study
4664975|NCT03460678|Maintenance Therapy|maintenance therapy
4664976|NCT03460678|Tyrosine kinase inhibitor|tyrosine kinase inhibitor
4664977|NCT03460678|Antifolate antineoplastic agents|antifolate antineoplastic agents
4664978|NCT03460639|Masseter muscle|masseter muscle
4664979|NCT03460639|initial fatigue|initial fatigue
4664980|NCT03460639|low-level laser|low-level laser
4664981|NCT03460626|stress|stress
4664982|NCT03460626|pharmacy students|pharmacy students
4664983|NCT03460626|Saudi Arabia|saudi arabia
4664984|NCT03460561|TEA|tea
4664985|NCT03460561|Rectus sheath block|rectus sheath block
4664986|NCT03460561|Major abdominal cancer surgery|major abdominal cancer surgery
4664987|NCT03460535|Rythmia system|rythmia system
4664988|NCT03460496|preterm infants|preterm infants
4664989|NCT03460496|transition to home|transition to home
4664990|NCT03460496|advanced practice nurse|advanced practice nurse
4664991|NCT03460496|cost-analysis|cost-analysis
4664992|NCT03460444|NLR Family, Pyrin Domain-Containing 3 Protein|nlr family, pyrin domain-containing 3 protein
4664993|NCT03460444|Caspase 1|caspase 1
4664994|NCT03460444|3-Hydroxybutyric Acid|3-hydroxybutyric acid
4664995|NCT03460444|Histone Deacetylase Inhibitors|histone deacetylase inhibitors
4664996|NCT03460444|MCT Oil|mct oil
4664997|NCT03460392|Human microbiota|human microbiota
4664998|NCT03460379|Bariatric surgery|bariatric surgery
4664999|NCT03460379|Gastrointestinal tract|gastrointestinal tract
4665000|NCT03460379|Biological availability|biological availability
4665001|NCT03460379|Pharmacokinetics|pharmacokinetics
4665002|NCT03460379|Citalopram|citalopram
4665003|NCT03460366|Bariatric surgery|bariatric surgery
4665004|NCT03460366|Gastrointestinal tract|gastrointestinal tract
4665005|NCT03460366|Biological availability|biological availability
4665006|NCT03460366|Pharmacokinetics|pharmacokinetics
4665007|NCT03460366|Enalapril|enalapril
4665008|NCT03460353|Bariatric surgery|bariatric surgery
4665009|NCT03460353|Gastrointestinal tract|gastrointestinal tract
4665010|NCT03460353|Biological availability|biological availability
4665011|NCT03460353|Pharmacokinetics|pharmacokinetics
4665012|NCT03460353|Dextroamphetamine|dextroamphetamine
4665013|NCT03460340|dTMS|dtms
4665014|NCT03460340|Fibromyalgia|fibromyalgia
4665015|NCT03460327|Bariatric surgery|bariatric surgery
4665016|NCT03460327|Gastrointestinal tract|gastrointestinal tract
4665017|NCT03460327|Biological availability|biological availability
4665018|NCT03460327|Pharmacokinetics|pharmacokinetics
4665019|NCT03460327|Candesartan|candesartan
4665020|NCT03460314|Bariatric surgery|bariatric surgery
4665021|NCT03460314|Gastrointestinal tract|gastrointestinal tract
4665022|NCT03460314|Biological availability|biological availability
4665023|NCT03460314|Pharmacokinetics|pharmacokinetics
4665024|NCT03460314|Buprenorphine|buprenorphine
4665025|NCT03460288|Gambling, Problematic Gambling, Pathological Gambling|gambling, problematic gambling, pathological gambling
4665026|NCT03460275|Osimertinib|osimertinib
4665027|NCT03460236|PRP|prp
4665028|NCT03460236|osteoarthritis|osteoarthritis
4665029|NCT03460236|MRI|mri
4665030|NCT03460236|gait|gait
4665031|NCT03460236|patient reported outcome|patient reported outcome
4665032|NCT03460210|Bariatric surgery|bariatric surgery
4665033|NCT03460210|Gastrointestinal tract|gastrointestinal tract
4665034|NCT03460210|Biological availability|biological availability
4665035|NCT03460210|Pharmacokinetics|pharmacokinetics
4665036|NCT03460210|Atomoxetine hydrochloride|atomoxetine hydrochloride
4665037|NCT03460197|Capillary technique|capillary technique
4665038|NCT03460197|Wet technique|wet technique
4665039|NCT03460197|Endoscopic Ultrasound-Guided Fine-Needle Aspiration|endoscopic ultrasound-guided fine-needle aspiration
4665040|NCT03460171|Human Metapneumovirus|human metapneumovirus
4665041|NCT03460171|Paramyxoviridae infections|paramyxoviridae infections
4665042|NCT03460171|Lower-respiratory tract infections|lower-respiratory tract infections
4665043|NCT03460171|Pneumonia|pneumonia
4665044|NCT03460158|facial filler|facial filler
4665045|NCT03460158|Retylane|retylane
4665046|NCT03460158|aesthetic improvement|aesthetic improvement
4665047|NCT03460158|volumizing fillers|volumizing fillers
4665048|NCT03460145|Lavender Oil,|lavender oil,
4665049|NCT03460145|Propofol|propofol
4665050|NCT03460132|orthodontic miniscrews|orthodontic miniscrews
4665051|NCT03460132|biological effect|biological effect
4665052|NCT03460132|cytotoxicity|cytotoxicity
4665053|NCT03460132|metal release|metal release
4665054|NCT03460119|High Flow Nasal Cannula|high flow nasal cannula
4665055|NCT03460119|Emergency department|emergency department
4665056|NCT03460119|Respiratory care|respiratory care
4665057|NCT03460106|Asthma Medical Adherence|asthma medical adherence
4665058|NCT03460093|nerve blockade|nerve blockade
4665059|NCT03460093|hypogastric plexus|hypogastric plexus
4665060|NCT03460093|cesarean section|cesarean section
4665061|NCT03460080|Hepatocellular carcinoma|hepatocellular carcinoma
4665062|NCT03460080|AFP-L3|afp-l3
4665063|NCT03460080|PIVKA-II|pivka-ii
4665064|NCT03460067|omission of radiation|omission of radiation
4665065|NCT03460067|trastuzumab|trastuzumab
4665066|NCT03460067|pertuzumab|pertuzumab
4665067|NCT03460067|biospecimen collection|biospecimen collection
4665068|NCT03460067|lumpectomy|lumpectomy
4665069|NCT03460015|COPD exacerbation|copd exacerbation
4665070|NCT03460015|Sevoflurane|sevoflurane
4665071|NCT03460015|Airway Resistance|airway resistance
4665072|NCT03460002|Measles vaccine|measles vaccine
4665073|NCT03460002|Oral polio vaccine|oral polio vaccine
4665074|NCT03460002|Campaign|campaign
4665075|NCT03460002|Child mortality|child mortality
4665076|NCT03460002|Child morbidity|child morbidity
4665077|NCT03460002|Non-specific effects|non-specific effects
4665078|NCT03459989|hadlock|hadlock
4665079|NCT03459989|thigh soft tissue|thigh soft tissue
4665080|NCT03459963|catheter|catheter
4665081|NCT03459963|cesarean section|cesarean section
4665082|NCT03459963|urinary tract infection|urinary tract infection
4665083|NCT03459963|patient's satisfaction|patient's satisfaction
4665084|NCT03459937|obesity|obesity
4665085|NCT03459937|yoga|yoga
4665086|NCT03459937|mindfulness|mindfulness
4665087|NCT03459937|weight loss|weight loss
4665088|NCT03459937|physical activity|physical activity
4665089|NCT03459924|Right ventricular function|right ventricular function
4665090|NCT03459924|Liver transplantation|liver transplantation
4665091|NCT03459924|Transesophageal echocardiography|transesophageal echocardiography
4665092|NCT03459911|Bioequivalence|bioequivalence
4665093|NCT03459872|acupuncture|acupuncture
4665094|NCT03459872|quantitative data|quantitative data
4665095|NCT03459872|outcomes based rehabilitation|outcomes based rehabilitation
4665096|NCT03459872|fine motor control|fine motor control
4665097|NCT03459846|Urinary Bladder Neoplasms|urinary bladder neoplasms
4665098|NCT03459833|premature ejaculation|premature ejaculation
4665099|NCT03459833|IELT|ielt
4665100|NCT03459833|hyaluronic acid|hyaluronic acid
4665101|NCT03459833|glans penis augmentation|glans penis augmentation
4665102|NCT03459807|Blood pressure|blood pressure
4665103|NCT03459807|Hemodialysis|hemodialysis
4665104|NCT03459807|End-stage-renal-disease|end-stage-renal-disease
4665105|NCT03459807|Chronic kidney disease|chronic kidney disease
4665106|NCT03459742|Obesity|obesity
4665107|NCT03459742|Gamification|gamification
4665108|NCT03459742|Schools|schools
4665109|NCT03459742|Cluster Randomized Trial|cluster randomized trial
4665110|NCT03459729|Anti-tumor B|anti-tumor b
4665111|NCT03459729|ACAPHA|acapha
4665112|NCT03459729|Pharmacokinetics|pharmacokinetics
4665113|NCT03459716|Biomarkers|biomarkers
4665114|NCT03459716|Endothelial microparticles|endothelial microparticles
4665115|NCT03459690|Meditation, EEG|meditation, eeg
4665116|NCT03459677|School Refusal|school refusal
4665117|NCT03459677|Truancy|truancy
4665118|NCT03459677|School Absenteeism|school absenteeism
4665119|NCT03459677|Anxiety|anxiety
4665120|NCT03459677|Depression|depression
4665121|NCT03459677|Behavioral problems|behavioral problems
4665122|NCT03459677|CBT|cbt
4665123|NCT03459664|stepped care|stepped care
4665124|NCT03459664|common mental disorders|common mental disorders
4665125|NCT03459664|managed care|managed care
4665126|NCT03459664|integrated care|integrated care
4665127|NCT03459664|psychiatric disorders|psychiatric disorders
4665128|NCT03459664|psychotherapy|psychotherapy
4665129|NCT03459664|severe mental disorders|severe mental disorders
4665130|NCT03459651|numeracy|numeracy
4665131|NCT03459651|number sense|number sense
4665132|NCT03459638|Screening|screening
4665133|NCT03459599|Antibiotic|antibiotic
4665134|NCT03459599|Endometritis|endometritis
4665135|NCT03459599|Placental membranes|placental membranes
4665136|NCT03459599|Prophylaxis|prophylaxis
4665137|NCT03459599|Ragged membranes|ragged membranes
4665138|NCT03459586|Parkinson|parkinson
4665139|NCT03459560|antihypertensive agents|antihypertensive agents
4665140|NCT03459560|acetylsalicylic acid|acetylsalicylic acid
4665141|NCT03459560|atorvastatin|atorvastatin
4665142|NCT03459508|Antiphospholipid Syndrome - Bad obstetric history - Ocular|antiphospholipid syndrome - bad obstetric history - ocular
4665143|NCT03459495|migraine, therapeutic ultrasound, pain, disability|migraine, therapeutic ultrasound, pain, disability
4665144|NCT03459456|OCD|ocd
4665145|NCT03459456|Obsessive-Compulsive Disorder|obsessive-compulsive disorder
4665146|NCT03459443|factor D|factor d
4665147|NCT03459443|fD|fd
4665148|NCT03459443|alternative pathway|alternative pathway
4665149|NCT03459443|complement mediated disease|complement mediated disease
4665150|NCT03459443|C3GN|c3gn
4665151|NCT03459443|DDD|ddd
4665152|NCT03459443|idiopathic MPGN|idiopathic mpgn
4665153|NCT03459443|MPGN Type I|mpgn type i
4665154|NCT03459443|MPGN Type II|mpgn type ii
4665155|NCT03459443|MPGN Type III|mpgn type iii
4665156|NCT03459443|Primary MPGN|primary mpgn
4665157|NCT03459443|MCGN|mcgn
4665158|NCT03459443|Mesangiocapillary Glomerulonephritis|mesangiocapillary glomerulonephritis
4665159|NCT03459430|trunk stability|trunk stability
4665160|NCT03459430|accelerometer|accelerometer
4665161|NCT03459430|smartphone|smartphone
4665162|NCT03459430|core training|core training
4665163|NCT03459430|isometric exercises|isometric exercises
4665164|NCT03459391|Healthy volunteers|healthy volunteers
4665165|NCT03459391|Phase I|phase i
4665166|NCT03459391|PHARMENTERPRISES|pharmenterprises
4665167|NCT03459352|Cancer|cancer
4665168|NCT03459352|Patient Reported Outcomes|patient reported outcomes
4665169|NCT03459352|Symptom management|symptom management
4665170|NCT03459326|male sexuality|male sexuality
4665171|NCT03459326|medical assisted to procreation|medical assisted to procreation
4665172|NCT03459326|International Index of Erectile Function questionnaire|international index of erectile function questionnaire
4665173|NCT03459300|actimetry|actimetry
4665174|NCT03459287|INTERCEPT|intercept
4665175|NCT03459287|Red Blood Cells|red blood cells
4665176|NCT03459287|RBC|rbc
4665177|NCT03459287|Pathogen Inactivation|pathogen inactivation
4665178|NCT03459287|Cerus|cerus
4665179|NCT03459287|Pathogen Reduction|pathogen reduction
4665180|NCT03459287|Cardiovascular surgery|cardiovascular surgery
4665181|NCT03459261|osteomyelitis|osteomyelitis
4665182|NCT03459261|tibial fracture|tibial fracture
4665183|NCT03459261|cytokines|cytokines
4665184|NCT03459261|PCT|pct
4665185|NCT03459261|CRP|crp
4665186|NCT03459261|albumin|albumin
4665187|NCT03459235|rectal cancer|rectal cancer
4665188|NCT03459235|proctectomy|proctectomy
4665189|NCT03459235|digestive sequelae|digestive sequelae
4665190|NCT03459235|quality of life|quality of life
4665191|NCT03459235|Urinary and Sexual sequelae|urinary and sexual sequelae
4665192|NCT03459222|immunotherapy|immunotherapy
4665193|NCT03459222|Relatlimab|relatlimab
4665194|NCT03459196|Interventional|interventional
4665195|NCT03459196|Radiofrequency Ablation|radiofrequency ablation
4665196|NCT03459196|Paroxysmal Atrial Fibrillation|paroxysmal atrial fibrillation
4665197|NCT03459170|leukemia|leukemia
4665198|NCT03459170|myelodysplastic syndrome|myelodysplastic syndrome
4665199|NCT03459170|lymphoma|lymphoma
4665200|NCT03459170|minimal residual disease|minimal residual disease
4665201|NCT03459170|BPX-501|bpx-501
4665202|NCT03459170|AP1903|ap1903
4665203|NCT03459170|rimiducid|rimiducid
4665204|NCT03459157|HIV infection|hiv infection
4665205|NCT03459157|Men who have sex with men|men who have sex with men
4665206|NCT03459157|Pre-exposure prophylaxis|pre-exposure prophylaxis
4665506|NCT03457402|shaping|shaping
4665207|NCT03459144|polypoidal choroidal vasculopathy|polypoidal choroidal vasculopathy
4665208|NCT03459144|photodynamic therapy|photodynamic therapy
4665209|NCT03459144|ranibizumab|ranibizumab
4665210|NCT03459144|combination therapy|combination therapy
4665211|NCT03459144|cost-benefit|cost-benefit
4665212|NCT03459092|Botulinum toxin, strabismus surgery, binocular vision|botulinum toxin, strabismus surgery, binocular vision
4665213|NCT03459066|Spasticity|spasticity
4665214|NCT03459066|Stroke|stroke
4665215|NCT03459066|Predictors|predictors
4665216|NCT03459066|Functionality|functionality
4665217|NCT03459066|Quality of life|quality of life
4665218|NCT03459027|exercise hyperemia|exercise hyperemia
4665219|NCT03459027|vasodilation|vasodilation
4665220|NCT03459027|nitric oxide|nitric oxide
4665221|NCT03459027|dietary nitrate|dietary nitrate
4665222|NCT03459014|Robot-Assisted Gait Training|robot-assisted gait training
4665223|NCT03459014|Virtual Reality|virtual reality
4665224|NCT03459014|Optic Flow|optic flow
4665225|NCT03459014|Active Participation|active participation
4665226|NCT03458988|Blood pressure measuring|blood pressure measuring
4665227|NCT03458975|microbubbles|microbubbles
4665228|NCT03458975|sonoporation|sonoporation
4665229|NCT03458975|hepatic metastases of colorectal cancer|hepatic metastases of colorectal cancer
4665230|NCT03458962|Nicklaus Children's|nicklaus children's
4665231|NCT03458962|Pediatric|pediatric
4665232|NCT03458962|Genomic|genomic
4665233|NCT03458962|Precision Medicine|precision medicine
4665234|NCT03458962|Biorepository|biorepository
4665235|NCT03458962|Rady Children's|rady children's
4665236|NCT03458936|Depression|depression
4665237|NCT03458936|Adolescence|adolescence
4665238|NCT03458936|Resilience|resilience
4665239|NCT03458936|Risk Factor|risk factor
4665240|NCT03458936|Biomarker|biomarker
4665241|NCT03458923|Diclofenac|diclofenac
4665242|NCT03458923|Ranibizumab|ranibizumab
4665243|NCT03458923|Diabetic Macular Edema|diabetic macular edema
4665244|NCT03458910|heart rate variability, HRV|heart rate variability, hrv
4665245|NCT03458897|bone marrow cellularity|bone marrow cellularity
4665246|NCT03458897|bone marrow transplant|bone marrow transplant
4665247|NCT03458884|Stroke|stroke
4665248|NCT03458884|Fatigue|fatigue
4665249|NCT03458884|PROBE design|probe design
4665250|NCT03458884|Cardiorespiratory fitness|cardiorespiratory fitness
4665251|NCT03458884|Cardiorespiratory training|cardiorespiratory training
4665252|NCT03458871|electric stimulation|electric stimulation
4665253|NCT03458845|Cirrhosis|cirrhosis
4665254|NCT03458845|Sarcopenia|sarcopenia
4665255|NCT03458845|Malnutrition|malnutrition
4665256|NCT03458845|Inguinal hernia|inguinal hernia
4665257|NCT03458845|Umbilical hernia|umbilical hernia
4665258|NCT03458845|Undernutrition|undernutrition
4665259|NCT03458832|muscular dystrophy.|muscular dystrophy.
4665260|NCT03458832|FSHD|fshd
4665261|NCT03458806|Auscultation|auscultation
4665262|NCT03458806|Phonocardiogram|phonocardiogram
4665263|NCT03458806|Machine Learning|machine learning
4665264|NCT03458806|Heart Sounds|heart sounds
4665265|NCT03458793|randomised controlled study|randomised controlled study
4665266|NCT03458793|physical activity|physical activity
4665267|NCT03458793|loneliness|loneliness
4665268|NCT03458780|yellow fever vaccine|yellow fever vaccine
4665269|NCT03458780|immune response|immune response
4665270|NCT03458780|"droplet microfluidics single cell (inDrop) RNA-Seq"|"droplet microfluidics single cell (indrop) rna-seq"
4665271|NCT03458767|Cognitive function|cognitive function
4665272|NCT03458767|Physical activity|physical activity
4665273|NCT03458767|Self-management|self-management
4665274|NCT03458754|Peripheral Arterial Disease|peripheral arterial disease
4665275|NCT03458754|Exercise capacity|exercise capacity
4665276|NCT03458754|Physical activity|physical activity
4665277|NCT03458754|Respiratory muscle strength|respiratory muscle strength
4665278|NCT03458754|Peripheric muscle strength|peripheric muscle strength
4665279|NCT03458728|Phase I: relapsed or refractory solid tumors or lymphoma|phase i: relapsed or refractory solid tumors or lymphoma
4665280|NCT03458728|Phase II: relapsed or refractory solid tumors (neuroblastoma, osteosarcoma, rhabdomyosarcoma or Ewing sarcoma)|phase ii: relapsed or refractory solid tumors (neuroblastoma, osteosarcoma, rhabdomyosarcoma or ewing sarcoma)
4665281|NCT03458715|SGLT2 inhibitor|sglt2 inhibitor
4665282|NCT03458715|DPP4 inhibitor|dpp4 inhibitor
4665283|NCT03458702|autonomic function|autonomic function
4665284|NCT03458702|emotion|emotion
4665285|NCT03458702|heart rate variability|heart rate variability
4665286|NCT03458676|Advanced magnetic resonance imaging|advanced magnetic resonance imaging
4665287|NCT03458676|AMRI|amri
4665288|NCT03458624|FURESTEM-AD Inj.|furestem-ad inj.
4665289|NCT03458624|Stem cells|stem cells
4665290|NCT03458585|ionising radiation|ionising radiation
4665291|NCT03458585|patient awareness|patient awareness
4665292|NCT03458585|patient knowledge|patient knowledge
4665293|NCT03458572|Caesarean section|caesarean section
4665294|NCT03458559|Bone metastases|bone metastases
4665295|NCT03458559|Rhenium-188-HEDP|rhenium-188-hedp
4665296|NCT03458559|Radium 223-chloride|radium 223-chloride
4665297|NCT03458559|Survival|survival
4665298|NCT03458559|Prostate cancer|prostate cancer
4665299|NCT03458533|Pituitary|pituitary
4665300|NCT03458533|Obesity|obesity
4665301|NCT03458533|Overweight|overweight
4665302|NCT03458533|Metabolic syndrome|metabolic syndrome
4665303|NCT03458533|MRI|mri
4665304|NCT03458507|Neuromuscular diseases|neuromuscular diseases
4665305|NCT03458507|Non-invasive ventilation|non-invasive ventilation
4665306|NCT03458507|Nasal mask|nasal mask
4665307|NCT03458507|Oronasal mask|oronasal mask
4665308|NCT03458507|Alveolar hypoventilation|alveolar hypoventilation
4665309|NCT03458507|leaks|leaks
4665310|NCT03458507|Sleep disorder breathing|sleep disorder breathing
4665311|NCT03458507|Side effects|side effects
4665312|NCT03458494|type 2 diabetes|type 2 diabetes
4665313|NCT03458494|glucose|glucose
4665314|NCT03458494|insulin|insulin
4665315|NCT03458494|CRP|crp
4665316|NCT03458494|Metabolomics|metabolomics
4665317|NCT03458494|gene-diet interaction|gene-diet interaction
4665318|NCT03458494|TCF7L2|tcf7l2
4665319|NCT03458481|Chronic Genotype 1 HCV Infection|chronic genotype 1 hcv infection
4665320|NCT03458468|tranexamic acid|tranexamic acid
4665321|NCT03458468|anterior shoulder instability|anterior shoulder instability
4665322|NCT03458468|latarjet|latarjet
4665323|NCT03458468|hematoma|hematoma
4665324|NCT03458455|TREATMENT|treatment
4665325|NCT03458455|Vessel Architectural Imaging|vessel architectural imaging
4665326|NCT03458455|Brain Metastases|brain metastases
4665327|NCT03458442|education|education
4665328|NCT03458442|developing country|developing country
4665329|NCT03458442|developing countries|developing countries
4665330|NCT03458442|low-and middle-income country|low-and middle-income country
4665331|NCT03458442|low-and middle-income countries|low-and middle-income countries
4665332|NCT03458442|surgical training|surgical training
4665333|NCT03458442|blindness|blindness
4665334|NCT03458442|china|china
4665335|NCT03458442|simulation|simulation
4665336|NCT03458442|model|model
4665337|NCT03458429|Young Donor Plasma|young donor plasma
4665338|NCT03458429|Frailty|frailty
4665339|NCT03458429|Aging|aging
4665340|NCT03458429|Immune Function|immune function
4665341|NCT03458429|G-CSF|g-csf
4665342|NCT03458403|Digestive endoscopy|digestive endoscopy
4665343|NCT03458403|Tracking motion|tracking motion
4665344|NCT03458377|Colonoscopy|colonoscopy
4665345|NCT03458377|Quality|quality
4665346|NCT03458377|Telephone intervention|telephone intervention
4665347|NCT03458364|Weaning; Noninvasive ventilation; High flow nasal cannula|weaning; noninvasive ventilation; high flow nasal cannula
4665348|NCT03458351|platelet activation|platelet activation
4665349|NCT03458351|remote ischemic preconditioning|remote ischemic preconditioning
4665350|NCT03458338|chronic kidney disease|chronic kidney disease
4665351|NCT03458338|communicable disease|communicable disease
4665352|NCT03458338|sub-Saharan Africa|sub-saharan africa
4665353|NCT03458338|Tanzania|tanzania
4665354|NCT03458338|neglected disease|neglected disease
4665355|NCT03458338|prevalence|prevalence
4665356|NCT03458338|double burden|double burden
4665357|NCT03458299|American Indian|american indian
4665358|NCT03458286|Diabetic Foot Ulcers|diabetic foot ulcers
4665359|NCT03458286|Chronic|chronic
4665360|NCT03458286|Combined ultrasound and electric current stimulation|combined ultrasound and electric current stimulation
4665361|NCT03458286|Adjunctive therapy|adjunctive therapy
4665362|NCT03458273|Atrial Arrhythmia|atrial arrhythmia
4665363|NCT03458273|Ventricular Arrythmia|ventricular arrythmia
4665364|NCT03458273|ablation|ablation
4665365|NCT03458273|fluoroscopy|fluoroscopy
4665366|NCT03458260|Diffuse Large B-Cell Lymphoma (DLBCL)|diffuse large b-cell lymphoma (dlbcl)
4665367|NCT03458260|relapsed or refractory|relapsed or refractory
4665368|NCT03458247|Prostate Cancer|prostate cancer
4665369|NCT03458247|Castration resistance|castration resistance
4665370|NCT03458247|Drug monitoring|drug monitoring
4665371|NCT03458247|Abiraterone acetate|abiraterone acetate
4665372|NCT03458234|Focal therapy|focal therapy
4665373|NCT03458234|Prostate cancer|prostate cancer
4665374|NCT03458234|SBRT|sbrt
4665375|NCT03458234|Intra-urethral transponder|intra-urethral transponder
4665376|NCT03458221|ovarian carcinoma|ovarian carcinoma
4665377|NCT03458221|Signal Transduction Pathway|signal transduction pathway
4665378|NCT03458221|therapy|therapy
4665379|NCT03458208|AUC|auc
4665380|NCT03458208|Cmax|cmax
4665381|NCT03458208|Pharmacokinetics|pharmacokinetics
4665382|NCT03458208|metformin|metformin
4665383|NCT03458208|fed|fed
4665384|NCT03458208|fasting|fasting
4665385|NCT03458195|ileo-caecal resection; post-operative recurrence|ileo-caecal resection; post-operative recurrence
4665386|NCT03458143|ketamine|ketamine
4665387|NCT03458143|remifentanil|remifentanil
4665388|NCT03458078|Bupivacaine,|bupivacaine,
4665389|NCT03458078|Anesthetics|anesthetics
4665390|NCT03458078|Adjuvants|adjuvants
4665391|NCT03458078|Analgesics|analgesics
4665392|NCT03458078|Peripheral system|peripheral system
4665393|NCT03458078|Central Nervous|central nervous
4665394|NCT03458078|sensory system|sensory system
4665395|NCT03458078|Agents|agents
4665396|NCT03458078|Physiological effects of drugs|physiological effects of drugs
4665397|NCT03458078|opioid|opioid
4665398|NCT03458078|Pain|pain
4665399|NCT03458078|Postoperative|postoperative
4665400|NCT03458078|Signs and Symptoms|signs and symptoms
4665401|NCT03458052|Intensive and critical care|intensive and critical care
4665402|NCT03458052|Organ donation|organ donation
4665403|NCT03458052|Knowledge|knowledge
4665404|NCT03458039|mental health capacity building|mental health capacity building
4665405|NCT03458039|low and middle-income country|low and middle-income country
4665406|NCT03458039|train the trainer strategy|train the trainer strategy
4665407|NCT03458039|technology-based training|technology-based training
4665408|NCT03458026|activity|activity
4665409|NCT03458026|Connected object|connected object
4665410|NCT03458013|Mindfulness|mindfulness
4665411|NCT03458013|Complementary Medicine|complementary medicine
4665412|NCT03458013|Integrative Health|integrative health
4665413|NCT03458013|Hand Therapy|hand therapy
4665414|NCT03457987|protein load|protein load
4665415|NCT03457987|cardiac surgery|cardiac surgery
4665416|NCT03457974|saliva composition|saliva composition
4665417|NCT03457974|antioxidant activity|antioxidant activity
4665418|NCT03457974|caries risk factors|caries risk factors
4665419|NCT03457974|congenital cardiac disease|congenital cardiac disease
4665420|NCT03457961|Perampanel|perampanel
4665421|NCT03457961|focal onset seizure|focal onset seizure
4665422|NCT03457961|epilepsy|epilepsy
4665423|NCT03457909|string|string
4665424|NCT03457909|capsule endoscopy|capsule endoscopy
4665425|NCT03457896|NSABP|nsabp
4665426|NCT03457896|PUMA|puma
4665427|NCT03457896|Neratinib|neratinib
4665428|NCT03457896|Trastuzumab|trastuzumab
4665429|NCT03457896|Cetuximab|cetuximab
4665430|NCT03457896|RAS|ras
4665431|NCT03457896|NRAS|nras
4665432|NCT03457896|BRAF|braf
4665433|NCT03457896|PIK3CA wild-type|pik3ca wild-type
4665434|NCT03457896|Quadruple wild-type|quadruple wild-type
4665435|NCT03457896|HER2 status|her2 status
4665436|NCT03457883|Pelvic organ prolapse|pelvic organ prolapse
4665437|NCT03457883|Vaginal mesh|vaginal mesh
4665438|NCT03457883|biological graft|biological graft
4665439|NCT03457883|Recurrence|recurrence
4665440|NCT03457870|Intermittent fasting|intermittent fasting
4665441|NCT03457870|Adult hippocampal neurogenesis|adult hippocampal neurogenesis
4665442|NCT03457870|Mastication|mastication
4665443|NCT03457870|Pattern separation|pattern separation
4665444|NCT03457870|Recognition memory|recognition memory
4665445|NCT03457870|Klotho|klotho
4665446|NCT03457857|Microbiome|microbiome
4665447|NCT03457857|Microbiota|microbiota
4665448|NCT03457818|Prolia|prolia
4665449|NCT03457818|Denosumab|denosumab
4665450|NCT03457818|Diabetes|diabetes
4665451|NCT03457805|prostate cancer|prostate cancer
4665452|NCT03457805|prostate|prostate
4665453|NCT03457805|embolization|embolization
4665454|NCT03457805|minimally invasive|minimally invasive
4665455|NCT03457805|cytoreductive therapy|cytoreductive therapy
4665456|NCT03457753|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
4665457|NCT03457740|muscular strength|muscular strength
4665458|NCT03457740|testosterone|testosterone
4665459|NCT03457740|sexual function|sexual function
4665460|NCT03457740|quality of life|quality of life
4665461|NCT03457727|Danirixin|danirixin
4665462|NCT03457727|Healthy|healthy
4665463|NCT03457727|Food effect|food effect
4665464|NCT03457727|Relative Bioavailability|relative bioavailability
4665465|NCT03457727|Hydrobromide Salt|hydrobromide salt
4665466|NCT03457714|spinal cord injuries|spinal cord injuries
4665467|NCT03457714|anxiety|anxiety
4665468|NCT03457714|depression|depression
4665469|NCT03457714|internet-delivered cognitive behaviour therapy|internet-delivered cognitive behaviour therapy
4665470|NCT03457714|pilot study|pilot study
4665471|NCT03457701|recombinant human erythropoietin|recombinant human erythropoietin
4665472|NCT03457701|anemia|anemia
4665473|NCT03457701|daprodustat|daprodustat
4665474|NCT03457701|chronic kidney disease|chronic kidney disease
4665475|NCT03457675|Deep Brain Stimulation (DBS)|deep brain stimulation (dbs)
4665476|NCT03457675|Treatment Resistant OCD|treatment resistant ocd
4665477|NCT03457675|Intractable OCD|intractable ocd
4665478|NCT03457675|Obsessive Compulsive Disorder (OCD)|obsessive compulsive disorder (ocd)
4665479|NCT03457675|Cognitive Behavior Therapy (CBT)|cognitive behavior therapy (cbt)
4665480|NCT03457675|Exposure and Response Prevention (ERP)|exposure and response prevention (erp)
4665481|NCT03457610|chronic cough|chronic cough
4665482|NCT03457610|speech and language intervention|speech and language intervention
4665483|NCT03457610|difficult-to-treat cough|difficult-to-treat cough
4665484|NCT03457532|Safety, Tolerability, Pharmacokinetics, Anti-tumor Activity|safety, tolerability, pharmacokinetics, anti-tumor activity
4665485|NCT03457519|ChARM|charm
4665486|NCT03457519|community health worker|community health worker
4665487|NCT03457506|Cancer|cancer
4665488|NCT03457506|Digital pet|digital pet
4665489|NCT03457506|Conventional pet|conventional pet
4665490|NCT03457480|Cancer Prevention|cancer prevention
4665491|NCT03457480|Focus Group|focus group
4665492|NCT03457480|Text messaging|text messaging
4665493|NCT03457480|Questionnaires|questionnaires
4665494|NCT03457480|Surveys|surveys
4665495|NCT03457467|oligometacosis|oligometacosis
4665496|NCT03457467|anti-angiogenic|anti-angiogenic
4665497|NCT03457467|apatinib|apatinib
4665498|NCT03457428|obstructive sleep apnea|obstructive sleep apnea
4665499|NCT03457428|home sleep testing|home sleep testing
4665500|NCT03457415|LDCT|ldct
4665501|NCT03457415|Sputum|sputum
4665502|NCT03457415|High-risk Smoker|high-risk smoker
4665503|NCT03457415|Porphyrin|porphyrin
4665504|NCT03457415|Early detection|early detection
4665505|NCT03457402|delay discounting|delay discounting
4665507|NCT03457389|Prolactinoma|prolactinoma
4665508|NCT03457389|Cabergoline|cabergoline
4665509|NCT03457389|Recurrence|recurrence
4665510|NCT03457363|oxygen|oxygen
4665511|NCT03457363|nasal cannula|nasal cannula
4665512|NCT03457363|double trunk mask|double trunk mask
4665513|NCT03457363|hypoxia|hypoxia
4665514|NCT03457350|hysteroscopy|hysteroscopy
4665515|NCT03457350|cervical stenosis|cervical stenosis
4665516|NCT03457350|probing|probing
4665517|NCT03457324|JCM-16021|jcm-16021
4665518|NCT03457324|Trial|trial
4665519|NCT03457324|Irritable Bowel Syndrome|irritable bowel syndrome
4665520|NCT03457324|Chinese Medicine|chinese medicine
4665521|NCT03457311|GSP, oral galactose single point (OGSP)|gsp, oral galactose single point (ogsp)
4665522|NCT03457285|Ankylosing spondylitis; physiotherapy; Salaso|ankylosing spondylitis; physiotherapy; salaso
4665523|NCT03457272|Patient Safety|patient safety
4665524|NCT03457272|Risk Factors|risk factors
4665525|NCT03457272|Quality Indicators, Health Care|quality indicators, health care
4665526|NCT03457272|Risk Assessment|risk assessment
4665527|NCT03457259|Midline catheter, peripheral venous catheter, central venous catheter, complication rate|midline catheter, peripheral venous catheter, central venous catheter, complication rate
4665528|NCT03457246|solar lentigos|solar lentigos
4665529|NCT03457246|physical Hyperpigmentation therapies|physical hyperpigmentation therapies
4665530|NCT03457246|cosmetic topical depigmenting product|cosmetic topical depigmenting product
4665531|NCT03457246|topical Hyperpigmentation therapies|topical hyperpigmentation therapies
4665532|NCT03457194|Obesity|obesity
4665533|NCT03457194|Vaccination|vaccination
4665534|NCT03457194|Pregnancy|pregnancy
4665535|NCT03457194|Influenza|influenza
4665536|NCT03457194|Pertussis|pertussis
4665537|NCT03457194|Maternal antibodies|maternal antibodies
4665538|NCT03457168|Sleep-time hypertension|sleep-time hypertension
4665539|NCT03457168|Ambulatory blood pressure monitoring|ambulatory blood pressure monitoring
4665540|NCT03457168|Hypertension chronotherapy|hypertension chronotherapy
4665541|NCT03457168|Asleep blood pressure|asleep blood pressure
4665542|NCT03457168|Cardiovascular risk|cardiovascular risk
4665543|NCT03457168|Type 2 diabetes|type 2 diabetes
4665544|NCT03457168|Chronic kidney disease|chronic kidney disease
4665545|NCT03457129|Epilepsy|epilepsy
4665546|NCT03457129|Epilepsy, partial onset|epilepsy, partial onset
4665547|NCT03457129|Epilepsy, generalized onset|epilepsy, generalized onset
4665548|NCT03457129|Fycompa|fycompa
4665549|NCT03457129|perampanel|perampanel
4665550|NCT03457090|neurologic complication, transcranial Doppler ultrasound|neurologic complication, transcranial doppler ultrasound
4665551|NCT03457077|brief intervention|brief intervention
4665552|NCT03457077|fMRI|fmri
4665553|NCT03457038|Mannose-Binding Lectin, PAMPs,|mannose-binding lectin, pamps,
4665554|NCT03457025|Oxygen Therapy|oxygen therapy
4665555|NCT03457025|Bells Palsy|bells palsy
4665556|NCT03456999|BKV, renal transplant, renal and kidney transplant|bkv, renal transplant, renal and kidney transplant
4665557|NCT03456934|Protein requirements|protein requirements
4665558|NCT03456934|Adiposity|adiposity
4665559|NCT03456934|Body composition|body composition
4665560|NCT03456934|Cardiovascular health|cardiovascular health
4665561|NCT03456921|health games|health games
4665562|NCT03456921|community engagement|community engagement
4665563|NCT03456882|AMYOTROPHIC LATERAL SCLEROSIS|amyotrophic lateral sclerosis
4665564|NCT03456882|RNS60|rns60
4665565|NCT03456882|Biomarkers|biomarkers
4665566|NCT03456882|clinical trial|clinical trial
4665567|NCT03456882|therapy|therapy
4665568|NCT03456869|patient specific implant|patient specific implant
4665569|NCT03456869|computer-aided surgery|computer-aided surgery
4665570|NCT03456869|clinical accuracy|clinical accuracy
4665571|NCT03456856|Cardiac|cardiac
4665572|NCT03456856|Congestive|congestive
4665573|NCT03456856|Decompensation|decompensation
4665574|NCT03456856|Heart Failure|heart failure
4665575|NCT03456856|Left-Sided|left-sided
4665576|NCT03456856|Myocardial|myocardial
4665577|NCT03456856|Corlanor|corlanor
4665578|NCT03456856|Ivabradine|ivabradine
4665579|NCT03456856|African American|african american
4665580|NCT03456856|Black|black
4665581|NCT03456856|Michigan|michigan
4665582|NCT03456830|Kidney stones|kidney stones
4665583|NCT03456830|Hyperoxaluria|hyperoxaluria
4665584|NCT03456830|Enteric hyperoxaluria|enteric hyperoxaluria
4665585|NCT03456830|Oxalate|oxalate
4665586|NCT03456791|Epididymal secretory protein E4|epididymal secretory protein e4
4665587|NCT03456791|Major epididymis specific protein E4|major epididymis specific protein e4
4665588|NCT03456778|Sonographic imaging|sonographic imaging
4665589|NCT03456778|Platelet-rich plasma (PRP) injection|platelet-rich plasma (prp) injection
4665590|NCT03456778|Shear Wave Elastography|shear wave elastography
4665591|NCT03456752|Inflammatory Bowel Diseases|inflammatory bowel diseases
4665592|NCT03456752|Glucocorticosteroids|glucocorticosteroids
4665593|NCT03456752|Postoperative Outcome|postoperative outcome
4665594|NCT03456726|EZH2 gene mutation|ezh2 gene mutation
4665595|NCT03456726|Tazemetostat|tazemetostat
4665596|NCT03456726|Diffuse large B-cell lymphoma|diffuse large b-cell lymphoma
4665597|NCT03456726|Follicular lymphoma|follicular lymphoma
4665598|NCT03456687|Exenatide|exenatide
4665599|NCT03456661|Pectoral block|pectoral block
4665600|NCT03456661|Ultrasound|ultrasound
4665601|NCT03456661|Mastectomy|mastectomy
4665602|NCT03456661|Levobupivacaine|levobupivacaine
4665603|NCT03456661|Dexmedetomidine|dexmedetomidine
4665604|NCT03456635|antimicrobial|antimicrobial
4665605|NCT03456635|prophylaxys|prophylaxys
4665606|NCT03456635|CDSS|cdss
4665607|NCT03456622|G7|g7
4665608|NCT03456596|CBPR|cbpr
4665609|NCT03456596|RE-AIM|re-aim
4665610|NCT03456583|Breast Biopsy|breast biopsy
4665611|NCT03456583|Breast Biopsy Imaging|breast biopsy imaging
4665612|NCT03456583|Stereotactic Imaging|stereotactic imaging
4665613|NCT03456414|exercise|exercise
4665614|NCT03456414|physical function|physical function
4665615|NCT03456414|health related quality of life|health related quality of life
4665616|NCT03456375|progesterone|progesterone
4665617|NCT03456375|artificial endometrial preparation cycle|artificial endometrial preparation cycle
4665618|NCT03456375|endometrial receptivity|endometrial receptivity
4665619|NCT03456349|Alzheimer's disease|alzheimer's disease
4665620|NCT03456323|Critical Illness|critical illness
4665621|NCT03456323|Frailty|frailty
4665622|NCT03456323|Palliative Care|palliative care
4665623|NCT03456297|Web-based clinical pedagogy program|web-based clinical pedagogy program
4665624|NCT03456297|nurse preceptors|nurse preceptors
4665625|NCT03456297|teaching competency|teaching competency
4665626|NCT03456232|hemodialysis|hemodialysis
4665627|NCT03456232|hemodiafiltration|hemodiafiltration
4665628|NCT03456232|end-stage renal disease|end-stage renal disease
4665629|NCT03456219|Food intake|food intake
4665630|NCT03456219|Sleep|sleep
4665631|NCT03456219|Shift work|shift work
4665632|NCT03456219|Postprandial metabolic response|postprandial metabolic response
4665633|NCT03456206|Life Style|life style
4665634|NCT03456206|Diet|diet
4665635|NCT03456206|Food|food
4665636|NCT03456206|CID|cid
4665637|NCT03456206|Disease risk|disease risk
4665638|NCT03456180|septic shock|septic shock
4665639|NCT03456180|microcirculation|microcirculation
4665640|NCT03456180|acute renal failure|acute renal failure
4665641|NCT03456180|renal replacement therapy|renal replacement therapy
4665642|NCT03456180|haemoadsorption|haemoadsorption
4665643|NCT03456167|telemedicine|telemedicine
4665644|NCT03456167|mobile applications|mobile applications
4665645|NCT03456167|ERAS|eras
4665646|NCT03456167|postoperative care|postoperative care
4665647|NCT03456167|patient satisfaction|patient satisfaction
4665648|NCT03456167|breast reconstruction|breast reconstruction
4665649|NCT03456167|gynecologic oncology|gynecologic oncology
4665650|NCT03456167|mastectomy|mastectomy
4665651|NCT03456128|Older Adult|older adult
4665652|NCT03456128|Rehospitalization|rehospitalization
4665653|NCT03456128|Physical function|physical function
4665654|NCT03456115|nasal obstruction|nasal obstruction
4665655|NCT03456115|nasal valve collapse|nasal valve collapse
4665656|NCT03456089|urodynamics|urodynamics
4665657|NCT03456089|neurogenic|neurogenic
4665658|NCT03456089|bladder|bladder
4665659|NCT03456076|NSCLC, alectinib, ALK positive,adjuvant treatment, platinum based chemotherapy, complete resection, Stage IB-IIIA.|nsclc, alectinib, alk positive,adjuvant treatment, platinum based chemotherapy, complete resection, stage ib-iiia.
4665660|NCT03456037|HBsAg|hbsag
4665661|NCT03456037|Anti-HCV,|anti-hcv,
4665662|NCT03456037|seropositivity|seropositivity
4665663|NCT03455998|morbid obesity|morbid obesity
4665664|NCT03455998|gastric bypass|gastric bypass
4665665|NCT03455998|pain|pain
4665666|NCT03455998|symptoms|symptoms
4665667|NCT03455959|Asthma|asthma
4665668|NCT03455959|Allergic|allergic
4665669|NCT03455959|Inflammation|inflammation
4665670|NCT03455959|Airway|airway
4665671|NCT03455946|Digital Health|digital health
4665672|NCT03455946|Amazon Alexa|amazon alexa
4665673|NCT03455907|Bevacizumab|bevacizumab
4665674|NCT03455894|Fall detection|fall detection
4665675|NCT03455894|Smart carpet|smart carpet
4665676|NCT03455894|Elderly people|elderly people
4665677|NCT03455881|TEF|tef
4665678|NCT03455881|EA|ea
4665679|NCT03455881|Tracheal Esophageal birth Defect (TED)|tracheal esophageal birth defect (ted)
4665680|NCT03455855|Atherectomy|atherectomy
4665681|NCT03455855|occlusive atherosclerotic lesions|occlusive atherosclerotic lesions
4665682|NCT03455829|Lung Cancer|lung cancer
4665683|NCT03455829|Non-small Cell Lung Cancer|non-small cell lung cancer
4665684|NCT03455829|CDK 4/6 Inhibitor|cdk 4/6 inhibitor
4665685|NCT03455829|EGFR-Positive|egfr-positive
4665686|NCT03455829|EGFR Mutation- Positive|egfr mutation- positive
4665687|NCT03455829|T790M|t790m
4665688|NCT03455829|EGFR Mutant|egfr mutant
4665689|NCT03455816|mobile app|mobile app
4665690|NCT03455790|Wheelchair Basketball,|wheelchair basketball,
4665691|NCT03455790|Isokinetic|isokinetic
4665692|NCT03455790|Anaerobic Capacity|anaerobic capacity
4665693|NCT03455790|Shoulder Muscle Strength|shoulder muscle strength
4665694|NCT03455790|Aerobic Capacity,|aerobic capacity,
4665695|NCT03455790|Sportive Performance|sportive performance
4665696|NCT03455764|Melanoma|melanoma
4665697|NCT03455751|Pain Management|pain management
4665698|NCT03455751|Pharmacogenomics|pharmacogenomics
4665699|NCT03455738|Vasoplegia, norepinephrine, dynamic arterial elastance|vasoplegia, norepinephrine, dynamic arterial elastance
4665700|NCT03455725|Cardiovascular Stem Cell Therapy|cardiovascular stem cell therapy
4665701|NCT03455725|Bone Marrow Mononuclear Stem Cells|bone marrow mononuclear stem cells
4665702|NCT03455725|Intramyocardial Injection|intramyocardial injection
4665703|NCT03455712|Pregnancy|pregnancy
4665704|NCT03455712|Gestational weight gain|gestational weight gain
4665705|NCT03455712|Weight gain|weight gain
4665706|NCT03455712|Patient education|patient education
4665707|NCT03455712|Patient knowledge|patient knowledge
4665708|NCT03455712|Institute of Medicine|institute of medicine
4665709|NCT03455699|GSV|gsv
4665710|NCT03455686|magnetic resonance imaging|magnetic resonance imaging
4665711|NCT03455686|hyperpolarized xenon-129|hyperpolarized xenon-129
4665712|NCT03455686|lung function|lung function
4665713|NCT03455686|lung structure|lung structure
4665714|NCT03455660|Cesarean|cesarean
4665715|NCT03455660|C-Section|c-section
4665716|NCT03455647|stunting|stunting
4665717|NCT03455647|underweight|underweight
4665718|NCT03455647|wasting|wasting
4665719|NCT03455634|quality of life|quality of life
4665720|NCT03455621|dental caries|dental caries
4665721|NCT03455621|fluoride|fluoride
4665722|NCT03455621|toothpaste|toothpaste
4665723|NCT03455621|dentifrice|dentifrice
4665724|NCT03455608|dysphagia|dysphagia
4665725|NCT03455608|swallowing disorder|swallowing disorder
4665726|NCT03455608|speech pathology|speech pathology
4665727|NCT03455608|swallowing therapy|swallowing therapy
4665728|NCT03455608|head and neck cancer|head and neck cancer
4665729|NCT03455608|radiotherapy|radiotherapy
4665730|NCT03455608|toxicity|toxicity
4665731|NCT03455608|supportive care|supportive care
4665732|NCT03455582|cognitive impairment|cognitive impairment
4665733|NCT03455582|ecological assessment|ecological assessment
4665734|NCT03455582|brain MRI|brain mri
4665735|NCT03455569|Behavioral sleep management|behavioral sleep management
4665736|NCT03455569|Alzheimer's disease|alzheimer's disease
4665737|NCT03455569|Informal caregiver|informal caregiver
4665738|NCT03455517|Chronic myeloid leukemia|chronic myeloid leukemia
4665739|NCT03455517|Umutated IGVH|umutated igvh
4665740|NCT03455517|Disrupted TP53|disrupted tp53
4665741|NCT03455504|Acute myeloid leukemia|acute myeloid leukemia
4665742|NCT03455504|Venetoclax|venetoclax
4665743|NCT03455413|electrical impedance tomography|electrical impedance tomography
4665744|NCT03455387|sFLt1|sflt1
4665745|NCT03455387|PlGF|plgf
4665746|NCT03455361|implant stability, dental implants, primary stability|implant stability, dental implants, primary stability
4665747|NCT03455309|Als3|als3
4665748|NCT03455309|SSTI|ssti
4665749|NCT03455309|vaccine|vaccine
4665750|NCT03455309|NDV-3A|ndv-3a
4665751|NCT03455309|incident nasal colonization|incident nasal colonization
4665752|NCT03455270|Breast Cancer|breast cancer
4665753|NCT03455270|Oral SERD|oral serd
4665754|NCT03455270|SERD|serd
4665755|NCT03455270|HER2-Negative|her2-negative
4665756|NCT03455270|ER-Positive|er-positive
4665757|NCT03455270|ER+|er+
4665758|NCT03455270|HER2-|her2-
4665759|NCT03455270|HER2 -ve|her2 -ve
4665760|NCT03455270|ER +ve|er +ve
4665761|NCT03455231|palliative care|palliative care
4665762|NCT03455231|complicated bone metastases|complicated bone metastases
4665763|NCT03455231|radiotherapy|radiotherapy
4665764|NCT03455231|pain|pain
4665765|NCT03455231|quality of life|quality of life
4665766|NCT03455218|Cardiopulmonary Bypass|cardiopulmonary bypass
4665767|NCT03455218|Infant|infant
4665768|NCT03455218|Nitric Oxide|nitric oxide
4665769|NCT03455218|Thrombocytopenia|thrombocytopenia
4665770|NCT03455218|Blood Platelets|blood platelets
4665771|NCT03455192|gingivitis|gingivitis
4665772|NCT03455192|gingival crevicular fluid|gingival crevicular fluid
4665773|NCT03455192|probiotics|probiotics
4665774|NCT03455192|smoking|smoking
4665775|NCT03455192|periodontal medicine|periodontal medicine
4665776|NCT03455179|Older|older
4665777|NCT03455179|Physical function|physical function
4665778|NCT03455179|Power training|power training
4665779|NCT03455179|Oxidative stress|oxidative stress
4665780|NCT03455179|Elastic band|elastic band
4665781|NCT03455179|OMNI-RES perceived exertion scale|omni-res perceived exertion scale
4665782|NCT03455179|Strength training|strength training
4665783|NCT03455153|Pulmonary Rehabilitation|pulmonary rehabilitation
4665784|NCT03455153|Neutrophils|neutrophils
4665785|NCT03455140|Arginine|arginine
4665786|NCT03455140|Arginase|arginase
4665787|NCT03455140|Children|children
4665788|NCT03455140|Young Adult|young adult
4665789|NCT03455127|Child Development|child development
4665790|NCT03455127|Home Visiting|home visiting
4665791|NCT03455127|Parenting Program|parenting program
4665792|NCT03455127|Social Protection|social protection
4665793|NCT03455127|Public Works|public works
4665794|NCT03455101|Cardiovascular risk status|cardiovascular risk status
4665795|NCT03455101|Optimal metabolic control|optimal metabolic control
4665796|NCT03455075|Healthy Men|healthy men
4665797|NCT03455075|Male Contraception|male contraception
4665798|NCT03455075|Androgen|androgen
4665799|NCT03455075|Dimethandrolone|dimethandrolone
4665800|NCT03455075|Levonorgestrel|levonorgestrel
4665801|NCT03455062|Transplant, fertility|transplant, fertility
4665802|NCT03455036|whole body vibration, erythema, tryptase, unpleasantness|whole body vibration, erythema, tryptase, unpleasantness
4665803|NCT03455023|Cancer pain|cancer pain
4665804|NCT03455023|Pharmaceutical care|pharmaceutical care
4665805|NCT03455010|Ambulatory load|ambulatory load
4665806|NCT03455010|Biomarker|biomarker
4665807|NCT03455010|Articular cartilage|articular cartilage
4665808|NCT03454945|Mycosis fungoides|mycosis fungoides
4665809|NCT03454945|Doxycycline|doxycycline
4665810|NCT03454932|Rheumatoid Arthritis|rheumatoid arthritis
4665811|NCT03454932|Psoriatic Arthritis|psoriatic arthritis
4665812|NCT03454932|Spondylarthritis|spondylarthritis
4665813|NCT03454932|Rheumatic diseases|rheumatic diseases
4665814|NCT03454932|Inflammation|inflammation
4665815|NCT03454932|Autoimmune diseases|autoimmune diseases
4665816|NCT03454932|Osteoimmunology|osteoimmunology
4665817|NCT03454906|hemodialysis|hemodialysis
4665818|NCT03454906|hemoglobin variability|hemoglobin variability
4665819|NCT03454906|mortality|mortality
4665820|NCT03454906|nutrition|nutrition
4665821|NCT03454906|inflammation|inflammation
4665822|NCT03454880|Accelerometry|accelerometry
4665823|NCT03454880|Wearable electronic devices|wearable electronic devices
4665824|NCT03454854|risk evaluation|risk evaluation
4665825|NCT03454854|individualized treatment|individualized treatment
4665826|NCT03454854|coronary artery disease|coronary artery disease
4665827|NCT03454854|antithrombotic therapy|antithrombotic therapy
4665828|NCT03454854|Chinese people|chinese people
4665829|NCT03454854|Application|application
4665830|NCT03454841|prasugrel|prasugrel
4665831|NCT03454841|ticagrelor|ticagrelor
4665832|NCT03454841|VASP|vasp
4665833|NCT03454841|platelet reactivity|platelet reactivity
4665834|NCT03454841|STEMI|stemi
4665835|NCT03454841|NSTEMI|nstemi
4665836|NCT03454815|Apical Patency|apical patency
4665837|NCT03454815|Root Canal Treatment|root canal treatment
4665838|NCT03454789|brachial plexus block|brachial plexus block
4665839|NCT03454789|local anesthetic mixture solution|local anesthetic mixture solution
4665840|NCT03454789|axillary-supraclavicular approach|axillary-supraclavicular approach
4665841|NCT03454789|outcome quality|outcome quality
4665842|NCT03454789|lidocaine, bupivacaine|lidocaine, bupivacaine
4665843|NCT03454789|onset time|onset time
4665844|NCT03454789|duration action local anesthetic|duration action local anesthetic
4665845|NCT03454789|postoperative analgesia|postoperative analgesia
4665846|NCT03454763|sst2-positive tumors|sst2-positive tumors
4665847|NCT03454763|Neuroendocrine Tumors|neuroendocrine tumors
4665848|NCT03454763|radiolabelled somatostatin analogues (PRRT)|radiolabelled somatostatin analogues (prrt)
4665849|NCT03454750|Metastatic castration resistant prostate cancer|metastatic castration resistant prostate cancer
4665850|NCT03454750|68Ga-PSMA PET/CT positive|68ga-psma pet/ct positive
4665851|NCT03454724|BioResorbable Vascular Scaffold System|bioresorbable vascular scaffold system
4665853|NCT03454711|Food addictions|food addictions
4665854|NCT03454711|Functional magnetic resonance imaging (fMRI)|functional magnetic resonance imaging (fmri)
4665855|NCT03454711|Metabolomics|metabolomics
4665856|NCT03454633|Hyperthermic circulatory arrest; Surgery|hyperthermic circulatory arrest; surgery
4665857|NCT03454607|FREE|free
4665858|NCT03454607|Robotic|robotic
4665859|NCT03454594|hypertension|hypertension
4665860|NCT03454594|high blood viscosity|high blood viscosity
4665861|NCT03454581|Temporomandibular Diseases|temporomandibular diseases
4665862|NCT03454581|Photobiomodulation|photobiomodulation
4665863|NCT03454581|Low level laser|low level laser
4665864|NCT03454581|Treatment|treatment
4665865|NCT03454581|Manual Therapy|manual therapy
4665866|NCT03454568|Stem Cell Transplant|stem cell transplant
4665867|NCT03454555|Pragmatic Clinical Trial|pragmatic clinical trial
4665868|NCT03454555|Comparative Effectiveness Research|comparative effectiveness research
4665869|NCT03454555|Analgesics, Opioid|analgesics, opioid
4665870|NCT03454555|Decision Making, Shared|decision making, shared
4665871|NCT03454555|Motivational Interviewing|motivational interviewing
4665872|NCT03454555|Cognitive Therapy|cognitive therapy
4665873|NCT03454555|Patient Reported Outcome Measures|patient reported outcome measures
4665874|NCT03454516|Hypertension|hypertension
4665875|NCT03454516|Telemonitoring|telemonitoring
4665876|NCT03454516|Digital Health|digital health
4665877|NCT03454503|Imatinib|imatinib
4665878|NCT03454503|Generic Imatinib|generic imatinib
4665879|NCT03454503|Leukemia|leukemia
4665880|NCT03454503|Chronic myeloid leukemia|chronic myeloid leukemia
4665881|NCT03454503|Philadelphia chromosome-positive|philadelphia chromosome-positive
4665882|NCT03454503|Chronic phase|chronic phase
4665883|NCT03454503|Observational study|observational study
4665884|NCT03454503|Switched patients|switched patients
4665885|NCT03454503|Tyrosine kinase inhibitor|tyrosine kinase inhibitor
4665886|NCT03454490|Gingival graft|gingival graft
4665887|NCT03454490|Pseudoaneurysm|pseudoaneurysm
4665888|NCT03454490|Postoperative complication|postoperative complication
4665889|NCT03454490|Gingival recession treatment|gingival recession treatment
4665890|NCT03454490|Palatine mass|palatine mass
4665891|NCT03454490|Palatine bleeding|palatine bleeding
4665892|NCT03454477|Endoscopy|endoscopy
4665893|NCT03454477|Robotics|robotics
4665894|NCT03454477|Thyroidectomy|thyroidectomy
4665895|NCT03454477|Papillary Thyroid Carcinoma|papillary thyroid carcinoma
4665896|NCT03454451|NSCLC|nsclc
4665897|NCT03454451|RCC|rcc
4665898|NCT03454451|TNBC|tnbc
4665899|NCT03454451|mCRPC|mcrpc
4665900|NCT03454451|CRC|crc
4665901|NCT03454451|Lung Cancer|lung cancer
4665902|NCT03454451|Kidney Cancer|kidney cancer
4665903|NCT03454451|Rectal Cancer|rectal cancer
4665904|NCT03454451|Breast Cancer|breast cancer
4665905|NCT03454451|Sarcoma|sarcoma
4665906|NCT03454451|Endometrial|endometrial
4665907|NCT03454451|Pancreatic|pancreatic
4665908|NCT03454451|Ovarian|ovarian
4665909|NCT03454451|SCCHN|scchn
4665910|NCT03454438|Referral|referral
4665911|NCT03454438|Primary care|primary care
4665912|NCT03454438|Rheumatologist|rheumatologist
4665913|NCT03454425|Parkinson's Disease|parkinson's disease
4665914|NCT03454425|ExAblate|exablate
4665915|NCT03454425|MRgFUS|mrgfus
4665916|NCT03454425|Sub-Thalamotomy|sub-thalamotomy
4665917|NCT03454412|Cerebral Palsy|cerebral palsy
4665918|NCT03454412|Rehabilitation|rehabilitation
4665919|NCT03454412|Hand|hand
4665920|NCT03454386|Irritable Bowel Syndrome (IBS)|irritable bowel syndrome (ibs)
4665921|NCT03454386|Stress|stress
4665922|NCT03454386|Resilience|resilience
4665923|NCT03454386|Stress Management and Resilience Training Program (SMART)|stress management and resilience training program (smart)
4665924|NCT03454373|HIV|hiv
4665925|NCT03454373|Food Insecurities|food insecurities
4665926|NCT03454373|Antiretroviral Therapy|antiretroviral therapy
4665927|NCT03454360|TAVI|tavi
4665928|NCT03454360|Transcatheter Aortic Valve Replacement|transcatheter aortic valve replacement
4665929|NCT03454360|Transcatheter Aortic Valve|transcatheter aortic valve
4665930|NCT03454360|Transapical Access|transapical access
4665931|NCT03454321|Rotator cuff tendinopathy|rotator cuff tendinopathy
4665932|NCT03454321|ultrasound|ultrasound
4665933|NCT03454321|subacromial bursitis|subacromial bursitis
4665934|NCT03454321|steroid injection|steroid injection
4665935|NCT03454295|Cancer Caregivers|cancer caregivers
4665936|NCT03454295|Caregiver|caregiver
4665937|NCT03454295|Caregivers|caregivers
4665938|NCT03454295|Memorial Sloan Kettering Cancer Center|memorial sloan kettering cancer center
4665939|NCT03454295|18-075|18-075
4665940|NCT03454282|Breast|breast
4665941|NCT03454282|Cancer|cancer
4665942|NCT03454282|Malignant|malignant
4665943|NCT03454282|Melanoma|melanoma
4665944|NCT03454282|Fasting Mimicking Diet (FMD)|fasting mimicking diet (fmd)
4665945|NCT03454282|Tumor|tumor
4665946|NCT03454282|Immunity|immunity
4665947|NCT03454282|Metabolic Effects|metabolic effects
4665948|NCT03454282|Immunological Effects|immunological effects
4665949|NCT03454269|Parkinson disease|parkinson disease
4665950|NCT03454269|Visual Hallucinations|visual hallucinations
4665951|NCT03454269|Illusions|illusions
4665952|NCT03454269|Retina|retina
4665953|NCT03454256|Virtual Reality|virtual reality
4665954|NCT03454256|Total Knee Replacement|total knee replacement
4665955|NCT03454256|Proprioception|proprioception
4665956|NCT03454256|Balance|balance
4665957|NCT03454256|Gait|gait
4665958|NCT03454243|Solid Tumors|solid tumors
4665959|NCT03454243|TYRO3|tyro3
4665960|NCT03454243|AXL|axl
4665961|NCT03454243|MER|mer
4665962|NCT03454243|Receptor tyrosine kinases (RTKs)|receptor tyrosine kinases (rtks)
4665963|NCT03454243|Checkpoint inhibitors|checkpoint inhibitors
4665964|NCT03454243|Melanoma|melanoma
4665965|NCT03454243|Non-small cell lung cancer (NSCLC)|non-small cell lung cancer (nsclc)
4665966|NCT03454243|Squamous cell carcinoma|squamous cell carcinoma
4665967|NCT03454243|Hodgkin lymphoma|hodgkin lymphoma
4665968|NCT03454243|Urothelial carcinoma|urothelial carcinoma
4665969|NCT03454243|Microsatellite instability-high carcinomas|microsatellite instability-high carcinomas
4665970|NCT03454243|TAM Inhibitor|tam inhibitor
4665971|NCT03454230|Intensive care unit|intensive care unit
4665972|NCT03454230|ICU|icu
4665973|NCT03454230|adult critical care patients|adult critical care patients
4665974|NCT03454230|repositioning schedule|repositioning schedule
4665975|NCT03454230|patient handling|patient handling
4665976|NCT03454230|practical nursing|practical nursing
4665977|NCT03454230|nursing care|nursing care
4665978|NCT03454230|pressure ulcers|pressure ulcers
4665979|NCT03454230|decubitus ulcers|decubitus ulcers
4665980|NCT03454230|pressure injury|pressure injury
4665981|NCT03454178|AOBP|aobp
4665982|NCT03454178|ABPM|abpm
4665983|NCT03454139|percutaneous nephrolithotomy|percutaneous nephrolithotomy
4665984|NCT03454139|subcostal transversus abdominis plane block|subcostal transversus abdominis plane block
4665985|NCT03454139|pain|pain
4665986|NCT03454139|paracetamol|paracetamol
4665987|NCT03454139|tramadol|tramadol
4665988|NCT03454139|morphine|morphine
4665989|NCT03454139|nephrolithiasis|nephrolithiasis
4665990|NCT03454139|lidocaine|lidocaine
4665991|NCT03454139|bupivacaine|bupivacaine
4665992|NCT03454126|Chronic pain|chronic pain
4665993|NCT03454126|Neuropathic pain|neuropathic pain
4665994|NCT03454126|Neuralgia|neuralgia
4665995|NCT03454126|Healthy volunteers|healthy volunteers
4665996|NCT03454113|dialysis autogenous arterio-venous fistula|dialysis autogenous arterio-venous fistula
4665997|NCT03454087|enteral nutrition|enteral nutrition
4665998|NCT03454087|inflammation|inflammation
4665999|NCT03454087|incretin hormones|incretin hormones
4666000|NCT03454087|microbiome|microbiome
4666001|NCT03454074|healthy aging|healthy aging
4666002|NCT03454074|behavior change|behavior change
4666003|NCT03454074|older adults|older adults
4666004|NCT03454061|sport|sport
4666005|NCT03454061|physical activity|physical activity
4666006|NCT03454061|education|education
4666007|NCT03454061|fundamental motor skills|fundamental motor skills
4666008|NCT03454061|childhood|childhood
4666009|NCT03454061|exercise|exercise
4666010|NCT03454061|health|health
4666011|NCT03454061|training|training
4666012|NCT03454061|intervention|intervention
4666013|NCT03454061|gross motor development|gross motor development
4666014|NCT03454009|multi-modal intervention;|multi-modal intervention;
4666015|NCT03454009|office-based employees|office-based employees
4666016|NCT03454009|hand hygiene|hand hygiene
4666017|NCT03454009|hand sanitizer|hand sanitizer
4666018|NCT03454009|hand sanitizer surface wipes|hand sanitizer surface wipes
4666019|NCT03454009|self-reported infections|self-reported infections
4666020|NCT03454009|absenteeism|absenteeism
4666021|NCT03454009|presenteeism|presenteeism
4666022|NCT03453996|acute kidney injury|acute kidney injury
4666023|NCT03453996|heart disease|heart disease
4666024|NCT03453996|cardiac catheterization|cardiac catheterization
4666025|NCT03453983|Neurodevelopment|neurodevelopment
4666026|NCT03453983|Pediatrics|pediatrics
4666027|NCT03453983|Motor Learning|motor learning
4666028|NCT03453983|Brain Imaging|brain imaging
4666029|NCT03453983|Neuroscience|neuroscience
4666030|NCT03453970|patient education|patient education
4666031|NCT03453970|self-care|self-care
4666032|NCT03453970|Controlled Trial|controlled trial
4666033|NCT03453957|Practice based research|practice based research
4666034|NCT03453944|Expiratory muscles|expiratory muscles
4666035|NCT03453944|Mechanically ventilated patients|mechanically ventilated patients
4666036|NCT03453944|Neuromuscular electrical stimulation|neuromuscular electrical stimulation
4666037|NCT03453944|Respiratory function|respiratory function
4666038|NCT03453944|Ventilator-acquired muscle atrophy|ventilator-acquired muscle atrophy
4666039|NCT03453931|Corticosteroids|corticosteroids
4666040|NCT03453931|Arrhythmia|arrhythmia
4666041|NCT03453931|Heart Rate Variability|heart rate variability
4666042|NCT03453931|Albuminuria|albuminuria
4666043|NCT03453918|Iron absorption|iron absorption
4666044|NCT03453918|Polyphenols|polyphenols
4666045|NCT03453918|Dysmetabolic iron overload syndrome|dysmetabolic iron overload syndrome
4666046|NCT03453918|Metabolic syndrome X|metabolic syndrome x
4666047|NCT03453918|Genetic Hemochromatosis|genetic hemochromatosis
4666048|NCT03453918|Oxylipin|oxylipin
4666049|NCT03453918|Lipidomic analysis|lipidomic analysis
4666050|NCT03453905|CT-based Finite Element Analysis|ct-based finite element analysis
4666051|NCT03453905|Randomized Controlled Study|randomized controlled study
4666052|NCT03453905|Preventive bone fixation|preventive bone fixation
4666053|NCT03453905|Randomized Controlled Trial|randomized controlled trial
4666054|NCT03453892|Metastatic cancer|metastatic cancer
4666055|NCT03453892|Radiotherapy|radiotherapy
4666056|NCT03453892|Immunotherapy|immunotherapy
4666057|NCT03453892|radioimmuno therapy|radioimmuno therapy
4666058|NCT03453866|Hip Arthroscopy|hip arthroscopy
4666059|NCT03453866|Warmed Fluids|warmed fluids
4666060|NCT03453853|Percutaneous mitral valve repair|percutaneous mitral valve repair
4666061|NCT03453853|Coronary sinus annuloplasty|coronary sinus annuloplasty
4666062|NCT03453853|Mitral loop cerclage|mitral loop cerclage
4666063|NCT03453853|atrial fibrillation|atrial fibrillation
4666064|NCT03453853|Mitral Regurgitation|mitral regurgitation
4666065|NCT03453840|malaria|malaria
4666066|NCT03453840|HIV|hiv
4666067|NCT03453840|Children|children
4666068|NCT03453840|Efavirenz|efavirenz
4666069|NCT03453840|artemether|artemether
4666070|NCT03453840|lumefantrine|lumefantrine
4666071|NCT03453827|Pseudoexfoliation Syndrome|pseudoexfoliation syndrome
4666072|NCT03453827|Cataract|cataract
4666073|NCT03453827|Aberration|aberration
4666074|NCT03453827|IOL decentration|iol decentration
4666075|NCT03453827|IOL tilt|iol tilt
4666076|NCT03453814|PICU|picu
4666077|NCT03453814|critical care|critical care
4666078|NCT03453814|music|music
4666079|NCT03453814|music therapy|music therapy
4666080|NCT03453814|agitation|agitation
4666081|NCT03453801|Inactivated, influenza vaccine quadrivalent|inactivated, influenza vaccine quadrivalent
4666082|NCT03453801|Live, attenuated influenza vaccine quadrivalent|live, attenuated influenza vaccine quadrivalent
4666083|NCT03453801|Young children|young children
4666084|NCT03453801|Identical twins|identical twins
4666085|NCT03453788|follow up|follow up
4666086|NCT03453788|side effects|side effects
4666087|NCT03453788|smartphone app|smartphone app
4666088|NCT03453788|physical activity|physical activity
4666089|NCT03453788|empowerment|empowerment
4666090|NCT03453788|patient reported outcomes|patient reported outcomes
4666091|NCT03453749|Traumatic brain injury|traumatic brain injury
4666092|NCT03453749|Cerebral edema|cerebral edema
4666093|NCT03453749|Microdialysis|microdialysis
4666094|NCT03453749|Inflammatory cytokines|inflammatory cytokines
4666095|NCT03453736|Robotic surgery|robotic surgery
4666096|NCT03453736|theatre staff|theatre staff
4666097|NCT03453736|teamwork|teamwork
4666098|NCT03453736|patient safety|patient safety
4666099|NCT03453723|hypnoanalgesia|hypnoanalgesia
4666100|NCT03453723|lidocaine|lidocaine
4666101|NCT03453723|propofol|propofol
4666102|NCT03453723|children|children
4666103|NCT03453710|Bankart Repair|bankart repair
4666104|NCT03453710|Remplissage|remplissage
4666105|NCT03453710|Latarjet coracoid transfer|latarjet coracoid transfer
4666106|NCT03453697|Intermittent Hypoxemia|intermittent hypoxemia
4666107|NCT03453697|diffusion tensor imaging|diffusion tensor imaging
4666108|NCT03453697|oxidative stress|oxidative stress
4666109|NCT03453658|Endodontics|endodontics
4666110|NCT03453658|Primary Teeth|primary teeth
4666111|NCT03453658|Reciprocating instrumentation|reciprocating instrumentation
4666112|NCT03453658|Mechanized instrumentation|mechanized instrumentation
4666113|NCT03453645|ablation|ablation
4666114|NCT03453645|sudden death|sudden death
4666115|NCT03453645|signal averaged ECG|signal averaged ecg
4666116|NCT03453645|T wave alternans|t wave alternans
4666117|NCT03453645|heart rate variability|heart rate variability
4666118|NCT03453632|Dermatology|dermatology
4666119|NCT03453632|Rare skin diseases|rare skin diseases
4666120|NCT03453632|epidermolysis bullosa simplex|epidermolysis bullosa simplex
4666121|NCT03453632|botulinic toxin|botulinic toxin
4666122|NCT03453632|blisters|blisters
4666123|NCT03453606|Pulmonary rehabilitation|pulmonary rehabilitation
4666124|NCT03453606|home-based|home-based
4666125|NCT03453593|Trauma|trauma
4666126|NCT03453593|India|india
4666127|NCT03453593|Computed tomography|computed tomography
4666128|NCT03453567|TAVR|tavr
4666129|NCT03453567|SAVR|savr
4666130|NCT03453567|TAVI|tavi
4666131|NCT03453567|Conventional AVR|conventional avr
4666132|NCT03453567|Sutureless AVR|sutureless avr
4666133|NCT03453554|technology|technology
4666134|NCT03453554|activities of daily living|activities of daily living
4666135|NCT03453554|everyday functioning|everyday functioning
4666136|NCT03453554|quality of life|quality of life
4666137|NCT03453554|memory impairment|memory impairment
4666138|NCT03453528|mCRPC or advanced/metastatic solid tumors|mcrpc or advanced/metastatic solid tumors
4666139|NCT03453528|Prostate-specific membrane antigen|prostate-specific membrane antigen
4666140|NCT03453502|quality improvement|quality improvement
4666141|NCT03453502|breast milk|breast milk
4666142|NCT03453476|Photodynamic therapy|photodynamic therapy
4666143|NCT03453476|Interleukin 1-beta|interleukin 1-beta
4666144|NCT03453476|Tumour necrosis factor - alpha|tumour necrosis factor - alpha
4666145|NCT03453476|Interleukin-6|interleukin-6
4666146|NCT03453476|Interleukin-8|interleukin-8
4666147|NCT03453476|Matrix metalloproteinase-8|matrix metalloproteinase-8
4666148|NCT03453463|sarcopenia|sarcopenia
4666149|NCT03453463|osteopenia|osteopenia
4666150|NCT03453463|older men|older men
4666151|NCT03453463|community dwelling|community dwelling
4666152|NCT03453463|physical functioning|physical functioning
4666153|NCT03453450|Primary Care|primary care
4666154|NCT03453411|Equimolar Mixture of Oxygen and Nitrous Oxide (EMONO)|equimolar mixture of oxygen and nitrous oxide (emono)
4666155|NCT03453411|Substance-Related Disorders|substance-related disorders
4666156|NCT03453398|Chronotype|chronotype
4666157|NCT03453398|Shift work|shift work
4666158|NCT03453398|Health status|health status
4666159|NCT03453385|Smoking|smoking
4666160|NCT03453385|Nicotine|nicotine
4666161|NCT03453385|Tobacco|tobacco
4666162|NCT03453385|Electronic Cigarette|electronic cigarette
4666163|NCT03453372|Osteoarthritis|osteoarthritis
4666164|NCT03453372|Knee|knee
4666165|NCT03453372|MRgFUS|mrgfus
4666166|NCT03453372|ExAblate|exablate
4666167|NCT03453372|Pain|pain
4666168|NCT03453372|High-Intensity Focused Ultrasound Ablation|high-intensity focused ultrasound ablation
4666169|NCT03453359|deep sedation|deep sedation
4666170|NCT03453359|spontaneous ventilation|spontaneous ventilation
4666171|NCT03453346|Hepatitis C virus|hepatitis c virus
4666172|NCT03453346|Sofosbuvir|sofosbuvir
4666173|NCT03453346|RNA polymerase inhibitor|rna polymerase inhibitor
4666174|NCT03453346|Ribavirin|ribavirin
4666175|NCT03453346|Genotype 2|genotype 2
4666176|NCT03453346|Sustained virologic response|sustained virologic response
4666177|NCT03453346|Confirmatory study|confirmatory study
4666178|NCT03453307|Tumor Organoids|tumor organoids
4666179|NCT03453307|Drug Sensitivity|drug sensitivity
4666180|NCT03453307|NSCLC|nsclc
4666181|NCT03453294|THRIVE|thrive
4666182|NCT03453281|Aflibercept|aflibercept
4666183|NCT03453281|Diabetic Macular Edema|diabetic macular edema
4666184|NCT03453281|Electroretinogram|electroretinogram
4666185|NCT03453281|Central Macular Thickness|central macular thickness
4666186|NCT03453281|ETDRS|etdrs
4666187|NCT03453268|Blood pressure|blood pressure
4666188|NCT03453268|Aged|aged
4666189|NCT03453268|Frailty|frailty
4666190|NCT03453268|Polypharmacy|polypharmacy
4666191|NCT03453255|AML, chidamide, decitabine|aml, chidamide, decitabine
4666192|NCT03453242|Osteoporosis|osteoporosis
4666193|NCT03453203|Chronic migraine|chronic migraine
4666194|NCT03453203|Osteopathic manipulative treatment|osteopathic manipulative treatment
4666195|NCT03453203|Cervicalgia|cervicalgia
4666196|NCT03453164|Radiotherapy|radiotherapy
4666197|NCT03453164|anti-PD-1 antibody|anti-pd-1 antibody
4666198|NCT03453138|laryngel mask airway|laryngel mask airway
4666199|NCT03453138|laparoscopic surgery|laparoscopic surgery
4666200|NCT03453125|cognitive rehabilitation|cognitive rehabilitation
4666201|NCT03453125|memory|memory
4666202|NCT03453112|Peek Expiratory Flow (PEF) Lung function tests|peek expiratory flow (pef) lung function tests
4666203|NCT03453099|propofol|propofol
4666204|NCT03453099|anaesthetic dose|anaesthetic dose
4666205|NCT03453099|sleep|sleep
4666206|NCT03453099|caffeine|caffeine
4666207|NCT03453099|anxiety|anxiety
4666208|NCT03453099|induction|induction
4666209|NCT03453073|Coronary heart disease|coronary heart disease
4666210|NCT03453073|stroke|stroke
4666211|NCT03453073|chocolate consumption|chocolate consumption
4666212|NCT03453073|postmenopausal women|postmenopausal women
4666213|NCT03453073|nutrition|nutrition
4666214|NCT03453073|dietary intake|dietary intake
4666215|NCT03453073|epidemiology|epidemiology
4666216|NCT03453047|S100β|s100β
4666217|NCT03453047|Neuron specific enolase|neuron specific enolase
4666218|NCT03453047|Liver transplantation|liver transplantation
4666219|NCT03453034|TQ-B3233|tq-b3233
4666220|NCT03453034|tumor|tumor
4666221|NCT03453034|toleration|toleration
4666222|NCT03453034|pharmacokinetics|pharmacokinetics
4666223|NCT03453021|asthma|asthma
4666224|NCT03453021|mepolizumab|mepolizumab
4666225|NCT03453021|corticosteroids|corticosteroids
4666226|NCT03453008|Cerebrovascular Accident|cerebrovascular accident
4666227|NCT03453008|Botulinum toxin A|botulinum toxin a
4666228|NCT03453008|Stroke|stroke
4666229|NCT03452982|SENTINEL LYMPH NODE|sentinel lymph node
4666230|NCT03452969|visual outcomes|visual outcomes
4666231|NCT03452969|mulitfocal intraocular lens|mulitfocal intraocular lens
4666232|NCT03452969|patient satisfaction|patient satisfaction
4666233|NCT03452969|spectacle independence|spectacle independence
4666234|NCT03452969|contrast sensitivity|contrast sensitivity
4666235|NCT03452943|Tourette Syndrome|tourette syndrome
4666236|NCT03452943|adolescents|adolescents
4666237|NCT03452943|children|children
4666238|NCT03452930|Malignant neoplasms of eye brain and other parts of central nervous system|malignant neoplasms of eye brain and other parts of central nervous system
4666239|NCT03452930|Unmethylated Glioblastoma|unmethylated glioblastoma
4666240|NCT03452930|nGBM|ngbm
4666241|NCT03452930|Glioma|glioma
4666242|NCT03452930|Gliosarcoma|gliosarcoma
4666243|NCT03452930|EDO-S101|edo-s101
4666244|NCT03452930|Radiation Therapy|radiation therapy
4666245|NCT03452930|XRT|xrt
4666246|NCT03452904|In suit coronary lesions|in suit coronary lesions
4666247|NCT03452904|Drug-coated balloon|drug-coated balloon
4666248|NCT03452904|Drug-eluting stent|drug-eluting stent
4666249|NCT03452904|Restenosis|restenosis
4666250|NCT03452878|Amygdala, neurosurgery, aggressive behavior|amygdala, neurosurgery, aggressive behavior
4666251|NCT03452865|proton pump inhibitor|proton pump inhibitor
4666252|NCT03452865|esomeprazole|esomeprazole
4666253|NCT03452865|sepsis|sepsis
4666254|NCT03452865|septic shock|septic shock
4666255|NCT03452865|organ failure|organ failure
4666256|NCT03452865|SOFA|sofa
4666257|NCT03452865|mortality|mortality
4666258|NCT03452852|Split thickness skin graft|split thickness skin graft
4666259|NCT03452852|Lower leg|lower leg
4666260|NCT03452852|Compression therapy|compression therapy
4666261|NCT03452852|PICO|pico
4666262|NCT03452852|Coban 2 lite|coban 2 lite
4666263|NCT03452839|meropenem|meropenem
4666264|NCT03452839|antibiotic resistance|antibiotic resistance
4666265|NCT03452839|critical illness|critical illness
4666266|NCT03452839|β-lactams|β-lactams
4666267|NCT03452839|continuous antibacterial drug infusion|continuous antibacterial drug infusion
4666268|NCT03452839|mortality|mortality
4666269|NCT03452813|transitions of care|transitions of care
4666270|NCT03452813|stroke disparities|stroke disparities
4666271|NCT03452800|addiction|addiction
4666272|NCT03452800|mental health|mental health
4666273|NCT03452787|Body mass index|body mass index
4666274|NCT03452787|genetics|genetics
4666275|NCT03452787|diet|diet
4666276|NCT03452787|saturated fat|saturated fat
4666277|NCT03452774|artificial intelligence|artificial intelligence
4666278|NCT03452774|virtual tumor board|virtual tumor board
4666279|NCT03452774|clinical trial|clinical trial
4666280|NCT03452774|clinical trial matching|clinical trial matching
4666281|NCT03452774|electronic medical record|electronic medical record
4666282|NCT03452774|machine learning|machine learning
4666283|NCT03452774|cost of care|cost of care
4666284|NCT03452774|targeted therapy|targeted therapy
4666285|NCT03452774|immunotherapy|immunotherapy
4666286|NCT03452774|precision medicine|precision medicine
4666287|NCT03452774|precision oncology|precision oncology
4666288|NCT03452774|cancer|cancer
4666289|NCT03452774|value based care|value based care
4666290|NCT03452774|real world data|real world data
4666291|NCT03452774|data analytics|data analytics
4666292|NCT03452761|exogenous ketone salts|exogenous ketone salts
4666293|NCT03452761|ketosis|ketosis
4666294|NCT03452761|safety|safety
4666295|NCT03452761|comprehensive metabolic panel|comprehensive metabolic panel
4666296|NCT03452761|complete blood count|complete blood count
4666297|NCT03452761|lipid panel|lipid panel
4666298|NCT03452761|insulin|insulin
4666299|NCT03452735|Chronic inflammatory rheumatism|chronic inflammatory rheumatism
4666300|NCT03452735|Fertility|fertility
4666301|NCT03452735|Procreation|procreation
4666302|NCT03452722|secondary brain injury|secondary brain injury
4666303|NCT03452722|neuroinflammation|neuroinflammation
4666304|NCT03452709|Cardiovascular Disease;|cardiovascular disease;
4666305|NCT03452709|primary prevention;|primary prevention;
4666306|NCT03452709|physical activity;|physical activity;
4666307|NCT03452709|Blood Pressure Monitoring, Ambulatory|blood pressure monitoring, ambulatory
4666308|NCT03452670|Workplace|workplace
4666309|NCT03452670|Applications|applications
4666310|NCT03452670|Anxiety|anxiety
4666311|NCT03452670|Burnout|burnout
4666312|NCT03452670|Meditation|meditation
4666313|NCT03452670|Mindfulness|mindfulness
4666314|NCT03452644|US-CNB|us-cnb
4666315|NCT03452644|Soft Tissue Mass|soft tissue mass
4666316|NCT03452644|Soft Tissue Sarcoma|soft tissue sarcoma
4666317|NCT03452644|Soft Tissue Neoplasm|soft tissue neoplasm
4666318|NCT03452644|Soft Tissue Lesion|soft tissue lesion
4666319|NCT03452631|Psoas hematomas|psoas hematomas
4666320|NCT03452618|diagnostic criteria|diagnostic criteria
4666321|NCT03452579|Nivolumab|nivolumab
4666322|NCT03452579|Bevacizumab|bevacizumab
4666323|NCT03452566|actinic cheilitis|actinic cheilitis
4666324|NCT03452566|ingenol mebutate|ingenol mebutate
4666325|NCT03452566|treatment|treatment
4666326|NCT03452566|phase 1/2 clinical trial|phase 1/2 clinical trial
4666327|NCT03452553|Liver Cancer|liver cancer
4666328|NCT03452553|Hepatocellular Carcinoma (HCC)|hepatocellular carcinoma (hcc)
4666329|NCT03452553|Trans Arterial Chemo Embolization (TACE)|trans arterial chemo embolization (tace)
4666330|NCT03452553|Drug Eluting Beads (DEB)|drug eluting beads (deb)
4666331|NCT03452553|Doxorubicin (DOX)|doxorubicin (dox)
4666332|NCT03452501|Infliximab|infliximab
4666333|NCT03452501|Remsima|remsima
4666334|NCT03452501|Biosimilar|biosimilar
4666335|NCT03452501|Inflammatory Bowel Diseases|inflammatory bowel diseases
4666336|NCT03452501|Crohn's Disease|crohn's disease
4666337|NCT03452501|Ulcerative Colitis|ulcerative colitis
4666338|NCT03452501|Fistulizing Crohn's Disease|fistulizing crohn's disease
4666339|NCT03452501|Observational|observational
4666340|NCT03452501|Follow up|follow up
4666341|NCT03452501|Safety|safety
4666342|NCT03452501|Effectiveness|effectiveness
4666343|NCT03452501|Disease modifying anti-rheumatic drugs|disease modifying anti-rheumatic drugs
4666344|NCT03452501|Tumor necrosis factor-alpha inhibitors|tumor necrosis factor-alpha inhibitors
4666345|NCT03452488|Sarcopenia|sarcopenia
4666346|NCT03452488|Sarcopenic Obesity|sarcopenic obesity
4666347|NCT03452488|6-minute walking distance|6-minute walking distance
4666348|NCT03452488|400 meters walking test|400 meters walking test
4666349|NCT03452488|Patient Reported Outcomes|patient reported outcomes
4666350|NCT03452488|BIO101|bio101
4666351|NCT03452488|SPPB|sppb
4666352|NCT03452488|ALM; ALM/BMI|alm; alm/bmi
4666353|NCT03452449|activity monitor|activity monitor
4666354|NCT03452449|questionnaire|questionnaire
4666355|NCT03452449|Oswestry Disability Index|oswestry disability index
4666356|NCT03452436|Cancer-related Cognitive Impairment|cancer-related cognitive impairment
4666357|NCT03452436|Cognitive Dysfunction|cognitive dysfunction
4666358|NCT03452436|Cognition Disorders|cognition disorders
4666359|NCT03452436|Neurocognitive Disorder|neurocognitive disorder
4666360|NCT03452436|Testosterone|testosterone
4666361|NCT03452436|Endocrinology|endocrinology
4666362|NCT03452436|Testicular Cancer|testicular cancer
4666363|NCT03452436|Prostate Cancer|prostate cancer
4666364|NCT03452423|Osteoarthritis of knees|osteoarthritis of knees
4666365|NCT03452423|Arthroscopic cartilage regeneration facilitating procedure (ACRFP)|arthroscopic cartilage regeneration facilitating procedure (acrfp)
4666366|NCT03452423|Foot pressure|foot pressure
4666367|NCT03452423|Gait|gait
4666368|NCT03452410|Vestibular neuritis|vestibular neuritis
4666369|NCT03452410|Magnetic resonance imaging (MRI)|magnetic resonance imaging (mri)
4666370|NCT03452410|Vertigo|vertigo
4666371|NCT03452410|Fluid attenuated inversion recuperation (FLAIR)|fluid attenuated inversion recuperation (flair)
4666372|NCT03452384|Acupuncture|acupuncture
4666373|NCT03452384|Traditional chinese medicine|traditional chinese medicine
4666374|NCT03452384|Major depressive disorder|major depressive disorder
4666375|NCT03452371|Patient Navigation|patient navigation
4666376|NCT03452371|Hospitalized smokers|hospitalized smokers
4666377|NCT03452332|Malignant neoplasms of female genital organs|malignant neoplasms of female genital organs
4666378|NCT03452332|Cervical Cancer|cervical cancer
4666379|NCT03452332|Vaginal Cancer|vaginal cancer
4666380|NCT03452332|Vulvar Cancer|vulvar cancer
4666381|NCT03452332|Durvalumab|durvalumab
4666382|NCT03452332|MEDI4736|medi4736
4666383|NCT03452332|Tremelimumab|tremelimumab
4666384|NCT03452332|Ticilimumab|ticilimumab
4666385|NCT03452332|CP-675,206|cp-675,206
4666386|NCT03452332|Stereotactic Ablative Radiotherapy|stereotactic ablative radiotherapy
4666387|NCT03452332|SABR|sabr
4666388|NCT03452332|Radiation therapy|radiation therapy
4666389|NCT03452319|Thoracoabdominal surgery|thoracoabdominal surgery
4666390|NCT03452319|Physical Therapy|physical therapy
4666391|NCT03452319|Inspiratory Muscle Training|inspiratory muscle training
4666392|NCT03452319|Physical Activity|physical activity
4666393|NCT03452306|AUC|auc
4666394|NCT03452306|Cmax|cmax
4666395|NCT03452306|Pharmacokinetics|pharmacokinetics
4666396|NCT03452306|metformin|metformin
4666397|NCT03452306|fed|fed
4666398|NCT03452306|fasting|fasting
4666399|NCT03452254|Stroke|stroke
4666400|NCT03452254|Upper Extremity Paresis|upper extremity paresis
4666401|NCT03452254|Neuro Rehabilitation|neuro rehabilitation
4666402|NCT03452254|tDCS|tdcs
4666403|NCT03452254|mCIMT|mcimt
4666404|NCT03452254|Occupational Therapy|occupational therapy
4666405|NCT03452241|Screening, Brief Intervention, and Referral to Treatment|screening, brief intervention, and referral to treatment
4666406|NCT03452241|Substance Use|substance use
4666407|NCT03452215|Pregnancy|pregnancy
4666408|NCT03452215|Mobile Phone Application|mobile phone application
4666409|NCT03452202|Stroke|stroke
4666410|NCT03452111|Healthy Men|healthy men
4666411|NCT03452111|Couple|couple
4666412|NCT03452111|Gel|gel
4666413|NCT03452111|Male Contraception|male contraception
4666414|NCT03452111|Nestorone|nestorone
4666415|NCT03452111|Testosterone|testosterone
4666416|NCT03452085|xerostomia|xerostomia
4666417|NCT03452085|diabetes type II|diabetes type ii
4666418|NCT03452085|salivary flow|salivary flow
4666419|NCT03452085|antioxidant capacity of saliva|antioxidant capacity of saliva
4666420|NCT03452085|aldiamed|aldiamed
4666421|NCT03452059|Paralysis|paralysis
4666422|NCT03452059|Lower Extremities|lower extremities
4666423|NCT03452059|Ai-Robotics|ai-robotics
4666424|NCT03452046|Ultrasound,inferior vena cava, positive pressure|ultrasound,inferior vena cava, positive pressure
4666425|NCT03452033|glaucoma|glaucoma
4666426|NCT03452007|Epidural Stimulation|epidural stimulation
4666427|NCT03452007|Bladder dysfunction|bladder dysfunction
4666428|NCT03452007|Spinal cord injury|spinal cord injury
4666429|NCT03451981|surgical therapy|surgical therapy
4666430|NCT03451981|laser|laser
4666431|NCT03451981|air powder|air powder
4666432|NCT03451968|amino acid|amino acid
4666433|NCT03451968|stable isotope|stable isotope
4666434|NCT03451968|critical care|critical care
4666435|NCT03451955|gluten|gluten
4666436|NCT03451955|gluten free diet|gluten free diet
4666437|NCT03451955|blood brain barrier permeability|blood brain barrier permeability
4666438|NCT03451955|intestinal permeability|intestinal permeability
4666439|NCT03451955|neuroinflammation|neuroinflammation
4666440|NCT03451955|autoimmunity|autoimmunity
4666441|NCT03451929|primary healthcare|primary healthcare
4666442|NCT03451929|cohort|cohort
4666443|NCT03451903|stroke|stroke
4666444|NCT03451903|thrombectomy|thrombectomy
4666445|NCT03451903|procedure time|procedure time
4666446|NCT03451903|revascularisation|revascularisation
4666447|NCT03451903|thrombolytic therapy|thrombolytic therapy
4666448|NCT03451890|Healthy participants|healthy participants
4666449|NCT03451890|E2730|e2730
4666450|NCT03451890|Pharmacokinetics|pharmacokinetics
4666451|NCT03451877|High myopia|high myopia
4666452|NCT03451877|TGFB1Gene Polymorphisms|tgfb1gene polymorphisms
4666453|NCT03451877|LAMA1 Gene Polymorphisms|lama1 gene polymorphisms
4666454|NCT03451825|Avelumab|avelumab
4666455|NCT03451825|Anti PD-L1|anti pd-l1
4666456|NCT03451825|Solid tumors|solid tumors
4666457|NCT03451825|CNS tumors|cns tumors
4666458|NCT03451825|Lymphoma|lymphoma
4666459|NCT03451825|Pediatric subjects|pediatric subjects
4666460|NCT03451812|prostate cancer|prostate cancer
4666461|NCT03451812|metabolomics|metabolomics
4666462|NCT03451812|molecular imaging|molecular imaging
4666463|NCT03451812|PET|pet
4666464|NCT03451812|MRI|mri
4666465|NCT03451812|11C-choline tracer|11c-choline tracer
4666466|NCT03451799|Glioblastoma|glioblastoma
4666467|NCT03451799|Ketogenic diet|ketogenic diet
4666468|NCT03451799|Keto diet|keto diet
4666469|NCT03451799|GBM|gbm
4666470|NCT03451773|TGF Ligand Trap|tgf ligand trap
4666471|NCT03451773|Extracellular Domain of Human TGF Receptor II|extracellular domain of human tgf receptor ii
4666472|NCT03451773|Avelumab|avelumab
4666473|NCT03451773|Human IgG1 mAb Directed Against Human PD-L1|human igg1 mab directed against human pd-l1
4666474|NCT03451773|Health-Related Quality of Life|health-related quality of life
4666475|NCT03451747|hypertension|hypertension
4666476|NCT03451747|female|female
4666477|NCT03451643|colorectal cancer|colorectal cancer
4666478|NCT03451643|liver metastases|liver metastases
4666479|NCT03451643|stage IV|stage iv
4666480|NCT03451591|Cerebral Small Vessel Diseases|cerebral small vessel diseases
4666481|NCT03451591|Stroke, Lacunar|stroke, lacunar
4666482|NCT03451591|Dementia|dementia
4666483|NCT03451591|Alzheimer's disease|alzheimer's disease
4666484|NCT03451578|macular degeneration|macular degeneration
4666485|NCT03451578|blindness|blindness
4666486|NCT03451565|Hypotension|hypotension
4666487|NCT03451565|Systemic blood pressure|systemic blood pressure
4666488|NCT03451552|Community Resources, Patient Navigator|community resources, patient navigator
4666489|NCT03451539|Anaesthetist|anaesthetist
4666490|NCT03451539|ICU|icu
4666491|NCT03451539|Intensif care unit|intensif care unit
4666492|NCT03451526|Chinese|chinese
4666493|NCT03451526|real-world evidences|real-world evidences
4666494|NCT03451526|NSCLC|nsclc
4666495|NCT03451526|surgeries|surgeries
4666496|NCT03451513|Prevention|prevention
4666497|NCT03451513|Sexual minority men|sexual minority men
4666498|NCT03451513|Internalization of the appearance ideal|internalization of the appearance ideal
4666499|NCT03451513|Body dissatisfaction|body dissatisfaction
4666500|NCT03451500|GPR 143|gpr 143
4666501|NCT03451500|PEDF|pedf
4666502|NCT03451500|VEGF|vegf
4666503|NCT03451500|LDOPA|ldopa
4666504|NCT03451487|acetaminophen|acetaminophen
4666505|NCT03451487|acute liver failure|acute liver failure
4666506|NCT03451461|Asynchronies|asynchronies
4666507|NCT03451448|PET/MRI|pet/mri
4666508|NCT03451448|ultra-small-superparamagnetic particles|ultra-small-superparamagnetic particles
4666509|NCT03451422|AMG 592|amg 592
4666510|NCT03451422|Systemic lupus erythematosus|systemic lupus erythematosus
4666511|NCT03451422|Phase 1b/2a|phase 1b/2a
4666512|NCT03451396|Dry eye|dry eye
4666513|NCT03451396|Tear osmolarity|tear osmolarity
4666514|NCT03451396|Lifitegrast|lifitegrast
4666515|NCT03451383|breast cancer|breast cancer
4666516|NCT03451383|cognitive decline|cognitive decline
4666517|NCT03451370|Bevacizumab|bevacizumab
4666518|NCT03451370|Capecitabine|capecitabine
4666519|NCT03451370|Oxaliplatin|oxaliplatin
4666520|NCT03451370|CRASH score|crash score
4666521|NCT03451370|ECOG PS|ecog ps
4666522|NCT03451370|G8 score|g8 score
4666523|NCT03451357|stroke|stroke
4666524|NCT03451357|dependence degree|dependence degree
4666525|NCT03451357|social care|social care
4666526|NCT03451357|health care|health care
4666527|NCT03451357|disability|disability
4666528|NCT03451344|Mobile Health|mobile health
4666529|NCT03451344|Illicit drug use|illicit drug use
4666530|NCT03451344|Rehabilitation|rehabilitation
4666531|NCT03451344|Community|community
4666532|NCT03451344|China|china
4666533|NCT03451331|cisplatin-ineligible|cisplatin-ineligible
4666534|NCT03451331|gemcitabine|gemcitabine
4666535|NCT03451331|carboplatin|carboplatin
4666536|NCT03451331|nivolumab|nivolumab
4666537|NCT03451331|oxaliplatin|oxaliplatin
4666538|NCT03451305|Compression fracture, postural reduction, vertebroplasty|compression fracture, postural reduction, vertebroplasty
4666539|NCT03451266|preeclampsia|preeclampsia
4666540|NCT03451266|vitamin C|vitamin c
4666541|NCT03451266|lung ultrasound|lung ultrasound
4666542|NCT03451240|Stress|stress
4666543|NCT03451240|Resilience|resilience
4666544|NCT03451227|Sedation, Analgesia|sedation, analgesia
4666545|NCT03451201|Exercise|exercise
4666546|NCT03451201|High-Intensity Interval Training|high-intensity interval training
4666547|NCT03451201|Type 1 diabetes|type 1 diabetes
4666548|NCT03451201|Endothelial Dysfunction|endothelial dysfunction
4666549|NCT03451175|Overactive Detrusor|overactive detrusor
4666550|NCT03451175|Multiple Sclerosis|multiple sclerosis
4666551|NCT03451175|Reproductibility|reproductibility
4666552|NCT03451175|Cystometry|cystometry
4666553|NCT03451149|TIPS|tips
4666554|NCT03451136|Placenta previa|placenta previa
4666555|NCT03451136|Cervical length|cervical length
4666556|NCT03451136|Antepartum haemorrhage|antepartum haemorrhage
4666557|NCT03451110|Drug-Drug Interactions|drug-drug interactions
4666558|NCT03451110|Lemborexant|lemborexant
4666559|NCT03451110|Oral Contraceptive|oral contraceptive
4666560|NCT03451110|Famotidine|famotidine
4666561|NCT03451110|Fluconazole|fluconazole
4666562|NCT03451110|Pharmacokinetics|pharmacokinetics
4666563|NCT03451110|Proton pump inhibitors|proton pump inhibitors
4666564|NCT03451110|CYP3A inhibitors|cyp3a inhibitors
4666565|NCT03451084|AML, ASLAN, DHODH|aml, aslan, dhodh
4666566|NCT03451058|Traumatic brain injury, eye tracking, EEG, cognition|traumatic brain injury, eye tracking, eeg, cognition
4666567|NCT03451045|Pulmonary exacerbation, lenabasum, JBT-101|pulmonary exacerbation, lenabasum, jbt-101
4666568|NCT03451032|HIV exposition treatment|hiv exposition treatment
4666569|NCT03451032|sexual risk|sexual risk
4666570|NCT03451032|blood risk|blood risk
4666571|NCT03451019|chronic kidney disease - mineral bone disorder, phosphate-binders|chronic kidney disease - mineral bone disorder, phosphate-binders
4666572|NCT03450993|Mind-Body|mind-body
4666573|NCT03450980|Double Vision, Amblyopia|double vision, amblyopia
4666574|NCT03450928|Peroral Endoscopic Myotomy|peroral endoscopic myotomy
4666575|NCT03450928|Endoscopy|endoscopy
4666576|NCT03450928|POEM|poem
4666577|NCT03450928|Submucosal endoscopy|submucosal endoscopy
4666578|NCT03450915|Influenza|influenza
4666579|NCT03450915|vaccine|vaccine
4666580|NCT03450915|universal|universal
4666581|NCT03450915|M-001|m-001
4666582|NCT03450915|Multimeric-001|multimeric-001
4666583|NCT03450915|Flu|flu
4666584|NCT03450902|Urinary incontinence, Chinese herb, Acupuncture|urinary incontinence, chinese herb, acupuncture
4666585|NCT03450837|Coronary artery disease; HDL; anabolic steroids|coronary artery disease; hdl; anabolic steroids
4666586|NCT03450824|Patellofemoral Pain Syndrome|patellofemoral pain syndrome
4666587|NCT03450824|Anterior Knee Pain|anterior knee pain
4666588|NCT03450824|Knee Varus|knee varus
4666589|NCT03450811|complication|complication
4666590|NCT03450811|uroflowmetry|uroflowmetry
4666591|NCT03450759|Heart failure.|heart failure.
4666592|NCT03450759|Mineralocorticoid receptor modulator.|mineralocorticoid receptor modulator.
4666593|NCT03450759|Heart failure with preserved ejection fraction (HFpEF).|heart failure with preserved ejection fraction (hfpef).
4666594|NCT03450733|Metal-on-Metal|metal-on-metal
4666595|NCT03450733|MOM|mom
4666596|NCT03450733|Total Hip Arthroplasty|total hip arthroplasty
4666597|NCT03450733|THA|tha
4666598|NCT03450707|cardiac arrest|cardiac arrest
4666599|NCT03450707|post-arrest|post-arrest
4666600|NCT03450681|Pain Management|pain management
4666601|NCT03450681|Knee Replacement Arthroplasty|knee replacement arthroplasty
4666602|NCT03450681|Postoperative Pain|postoperative pain
4666603|NCT03450681|Pulsed Radiofrequency Treatment|pulsed radiofrequency treatment
4666604|NCT03450668|neonatal, incubator, thermal-regulation|neonatal, incubator, thermal-regulation
4666605|NCT03450590|heart rate variability|heart rate variability
4666606|NCT03450590|intraarterial chemotherapy|intraarterial chemotherapy
4666607|NCT03450590|ophthalmic arterial chemotherapy|ophthalmic arterial chemotherapy
4666608|NCT03450538|Trauma|trauma
4666609|NCT03450538|Computed tomography|computed tomography
4666610|NCT03450538|India|india
4666611|NCT03450512|Neutropenic enterocolitis, acute myeloid leukemia, abdominal tomodensitometry|neutropenic enterocolitis, acute myeloid leukemia, abdominal tomodensitometry
4666612|NCT03450486|dynamic balance|dynamic balance
4666613|NCT03450486|star excursion balance test|star excursion balance test
4666614|NCT03450486|exercise|exercise
4666615|NCT03450473|Mesh|mesh
4666616|NCT03450460|peer support|peer support
4666617|NCT03450460|feasibility trial|feasibility trial
4666618|NCT03450460|mixed methods|mixed methods
4666619|NCT03450447|Head and Neck Cancer|head and neck cancer
4666620|NCT03450447|Esophageal Cancer|esophageal cancer
4666621|NCT03450447|endoscopic submucosal dissection|endoscopic submucosal dissection
4666622|NCT03450447|quality of life|quality of life
4666623|NCT03450447|median survival time|median survival time
4666624|NCT03450382|community health|community health
4666625|NCT03450382|mental health|mental health
4666626|NCT03450382|behavior change|behavior change
4666627|NCT03450382|social support|social support
4666628|NCT03450382|health promotion|health promotion
4666629|NCT03450304|Multidetector Computed Tomography|multidetector computed tomography
4666630|NCT03450304|Pulmonary Embolism|pulmonary embolism
4666631|NCT03450304|Hypertension Pulmonary Secondary|hypertension pulmonary secondary
4666632|NCT03450291|Computational|computational
4666633|NCT03450252|HCM|hcm
4666634|NCT03450252|Mid-cavity|mid-cavity
4666635|NCT03450252|Pacing|pacing
4666636|NCT03450239|MRI|mri
4666637|NCT03450200|Diabetic Peripheral Neuropathy, Exercises|diabetic peripheral neuropathy, exercises
4666638|NCT03450148|aversive therapy|aversive therapy
4666639|NCT03450135|puberty|puberty
4666640|NCT03450135|EEG|eeg
4666641|NCT03450135|estradiol|estradiol
4666642|NCT03450135|mood|mood
4666643|NCT03450135|stress|stress
4666644|NCT03450122|Malignant neoplasms of bone and articular cartilage|malignant neoplasms of bone and articular cartilage
4666645|NCT03450122|Malignant neoplasms of mesothelial and soft tissue|malignant neoplasms of mesothelial and soft tissue
4666646|NCT03450122|Synovial sarcoma|synovial sarcoma
4666647|NCT03450122|Myxoid liposarcoma|myxoid liposarcoma
4666648|NCT03450122|CD8+ antigen specific T cells|cd8+ antigen specific t cells
4666649|NCT03450122|Cyclophosphamide|cyclophosphamide
4666650|NCT03450122|Cytoxan|cytoxan
4666651|NCT03450122|Neosar|neosar
4666652|NCT03450122|IL-2|il-2
4666653|NCT03450122|Aldesleukin|aldesleukin
4666654|NCT03450122|Interleukin|interleukin
4666655|NCT03450122|Proleukin|proleukin
4666656|NCT03450122|LV305|lv305
4666657|NCT03450122|ID-LV305|id-lv305
4666658|NCT03450122|CMB305|cmb305
4666659|NCT03450044|Chemotherapy|chemotherapy
4666660|NCT03450044|Breast Cancer|breast cancer
4666661|NCT03450044|Dendritic cells|dendritic cells
4666662|NCT03450044|Immunotherapy|immunotherapy
4666663|NCT03450044|Doxorubicine|doxorubicine
4666664|NCT03450018|Gemcitabine|gemcitabine
4666665|NCT03450018|SLC-0111|slc-0111
4666666|NCT03450018|PDAC|pdac
4666667|NCT03449979|tACS|tacs
4666668|NCT03449979|transcranial alternating current stimulation|transcranial alternating current stimulation
4666669|NCT03449979|stimulation|stimulation
4666670|NCT03449979|heart rate variability|heart rate variability
4666671|NCT03449979|electroencephalogram|electroencephalogram
4666672|NCT03449979|EEG|eeg
4666673|NCT03449966|pCLE|pcle
4666674|NCT03449966|confocal|confocal
4666675|NCT03449966|Advanced gastric cancer|advanced gastric cancer
4666676|NCT03449966|chemotherapy|chemotherapy
4666677|NCT03449940|Penile fracture|penile fracture
4666678|NCT03449940|Delayed|delayed
4666679|NCT03449940|Localized|localized
4666680|NCT03449940|Repair|repair
4666681|NCT03449927|Nutrition Tool|nutrition tool
4666682|NCT03449927|Melphalan Autologous Transplant|melphalan autologous transplant
4666683|NCT03449914|ECOG PS|ecog ps
4666684|NCT03449914|Timed Up and Go test|timed up and go test
4666685|NCT03449914|G8 score|g8 score
4666686|NCT03449823|Renal Artery Doppler|renal artery doppler
4666687|NCT03449810|Muscles Energy Technique, Low Back Pain|muscles energy technique, low back pain
4666688|NCT03449797|aldosterone|aldosterone
4666689|NCT03449797|cortisol|cortisol
4666690|NCT03449797|adrenal vein sampling|adrenal vein sampling
4666691|NCT03449797|primary aldosteronism|primary aldosteronism
4666692|NCT03449784|dyslipidemia|dyslipidemia
4666693|NCT03449784|lipid-lowering therapy|lipid-lowering therapy
4666694|NCT03449784|cardiovascular risk|cardiovascular risk
4666695|NCT03449784|diabetes|diabetes
4666696|NCT03449784|low-density lipoprotein cholesterol|low-density lipoprotein cholesterol
4666697|NCT03449771|HIV|hiv
4666698|NCT03449771|Pre-exposure prophylaxis|pre-exposure prophylaxis
4666699|NCT03449771|Recreational drugs|recreational drugs
4666700|NCT03449771|Chemsex|chemsex
4666701|NCT03449771|Mental disorders|mental disorders
4666702|NCT03449745|Acute Myeloid Leukemia|acute myeloid leukemia
4666899|NCT03448510|male|male
4666703|NCT03449745|Immune Checkpoint Ligand|immune checkpoint ligand
4666704|NCT03449745|Flow Cytometry|flow cytometry
4666705|NCT03449706|Reservoir|reservoir
4666706|NCT03449680|hip arthroscopy|hip arthroscopy
4666707|NCT03449680|femoral articular branch block|femoral articular branch block
4666708|NCT03449615|Cutaneous melanoma|cutaneous melanoma
4666709|NCT03449615|Sentinel node biopsy|sentinel node biopsy
4666710|NCT03449602|thoracoscopy|thoracoscopy
4666711|NCT03449602|pleuroscopy|pleuroscopy
4666712|NCT03449602|metastatic cancer|metastatic cancer
4666713|NCT03449602|lung cancer|lung cancer
4666714|NCT03449602|malignant pleural effusion|malignant pleural effusion
4666715|NCT03449602|tuberculosis|tuberculosis
4666716|NCT03449576|PTSD|ptsd
4666717|NCT03449576|neuroimaging|neuroimaging
4666718|NCT03449576|fMRI|fmri
4666719|NCT03449576|veterans|veterans
4666720|NCT03449576|exposure therapy|exposure therapy
4666721|NCT03449576|treatment|treatment
4666722|NCT03449563|thoracic paravertebral block|thoracic paravertebral block
4666723|NCT03449563|postoperative analgesia|postoperative analgesia
4666724|NCT03449563|pulmonary lobectomy|pulmonary lobectomy
4666725|NCT03449550|Child obstructive sleep apnea|child obstructive sleep apnea
4666726|NCT03449550|Home Respiratory Polygraphy|home respiratory polygraphy
4666727|NCT03449550|Diagnosis|diagnosis
4666728|NCT03449550|Validity|validity
4666729|NCT03449550|Polysomnography|polysomnography
4666730|NCT03449524|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
4666731|NCT03449524|Pulmonary Hypertension|pulmonary hypertension
4666732|NCT03449524|PAH|pah
4666733|NCT03449524|Connective Tissue Disease-Associated|connective tissue disease-associated
4666734|NCT03449524|6 Minute Walk Test|6 minute walk test
4666735|NCT03449524|6 Minute Walk Distance|6 minute walk distance
4666736|NCT03449524|Pulmonary Vascular Resistance|pulmonary vascular resistance
4666737|NCT03449524|Cardiac MRI|cardiac mri
4666738|NCT03449524|Right Ventricular Function|right ventricular function
4666739|NCT03449524|Hypertension|hypertension
4666740|NCT03449524|Familial Primary Pulmonary Hypertension|familial primary pulmonary hypertension
4666741|NCT03449524|Connective Tissue Diseases|connective tissue diseases
4666742|NCT03449524|Vascular Diseases|vascular diseases
4666743|NCT03449524|Cardiovascular Diseases|cardiovascular diseases
4666744|NCT03449524|Hypertension, Pulmonary|hypertension, pulmonary
4666745|NCT03449524|Lung Diseases|lung diseases
4666746|NCT03449485|Bariatric surgery|bariatric surgery
4666747|NCT03449485|Gastrointestinal tract|gastrointestinal tract
4666748|NCT03449485|Biological availability|biological availability
4666749|NCT03449485|Pharmacokinetics|pharmacokinetics
4666750|NCT03449485|Chlorprothixene|chlorprothixene
4666751|NCT03449472|Bariatric surgery|bariatric surgery
4666752|NCT03449472|Gastrointestinal tract|gastrointestinal tract
4666753|NCT03449472|Biological availability|biological availability
4666754|NCT03449472|Pharmacokinetics|pharmacokinetics
4666755|NCT03449472|Quetiapine fumarate|quetiapine fumarate
4666756|NCT03449459|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
4666757|NCT03449459|aerosol inhaled amikacin|aerosol inhaled amikacin
4666758|NCT03449459|oral probiotics|oral probiotics
4666759|NCT03449459|combined influenza and pneumococcal vaccine inoculation|combined influenza and pneumococcal vaccine inoculation
4666760|NCT03449459|bacterial decolonization in lower respiratory tract|bacterial decolonization in lower respiratory tract
4666761|NCT03449420|thromboelastography|thromboelastography
4666762|NCT03449407|Auditory hallucinations|auditory hallucinations
4666763|NCT03449407|Psychosis|psychosis
4666764|NCT03449407|Mood|mood
4666765|NCT03449407|Brain imaging|brain imaging
4666766|NCT03449407|Experience sampling method|experience sampling method
4666767|NCT03449394|Psychosis|psychosis
4666768|NCT03449394|Depression|depression
4666769|NCT03449394|Metacognition|metacognition
4666770|NCT03449394|Attribution|attribution
4666771|NCT03449394|Emotions|emotions
4666772|NCT03449355|sexuality|sexuality
4666773|NCT03449355|mode of delivery|mode of delivery
4666774|NCT03449355|quality of life|quality of life
4666775|NCT03449316|Nebulizers and Vaporizers|nebulizers and vaporizers
4666776|NCT03449303|breast cancer|breast cancer
4666777|NCT03449303|CIPN|cipn
4666778|NCT03449303|Pain|pain
4666779|NCT03449303|QOL|qol
4666780|NCT03449303|Essential Oils|essential oils
4666781|NCT03449251|Apelin|apelin
4666782|NCT03449251|Relaxin|relaxin
4666783|NCT03449212|SOD1|sod1
4666784|NCT03449212|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
4666785|NCT03449212|ALS|als
4666786|NCT03449212|Kinetics|kinetics
4666787|NCT03449212|Amyotrophic Lateral Sclerosis, Familial|amyotrophic lateral sclerosis, familial
4666788|NCT03449212|Amyotrophic Lateral Sclerosis, Sporadic|amyotrophic lateral sclerosis, sporadic
4666789|NCT03449186|periodontitis|periodontitis
4666790|NCT03449186|postpartum|postpartum
4666791|NCT03449121|Breathing|breathing
4666792|NCT03449121|Mind-body|mind-body
4666793|NCT03449108|Malignant neoplasms of bone and articular cartilage|malignant neoplasms of bone and articular cartilage
4666794|NCT03449108|Malignant neoplasms of female genital organs|malignant neoplasms of female genital organs
4666795|NCT03449108|Cyclophosphamide|cyclophosphamide
4666796|NCT03449108|Cytoxan|cytoxan
4666797|NCT03449108|Neosar|neosar
4666798|NCT03449108|Fludarabine|fludarabine
4666799|NCT03449108|Fludarabine phosphate|fludarabine phosphate
4666800|NCT03449108|Fludara|fludara
4666801|NCT03449108|LN-145|ln-145
4666802|NCT03449108|IL-2|il-2
4666803|NCT03449108|Aldesleukin|aldesleukin
4666804|NCT03449108|Interleukin|interleukin
4666805|NCT03449108|Proleukin|proleukin
4666806|NCT03449108|Mesna|mesna
4666807|NCT03449108|Questionnaires|questionnaires
4666808|NCT03449108|Surveys|surveys
4666809|NCT03449082|adipose derived mesenchymal stem cell|adipose derived mesenchymal stem cell
4666810|NCT03449082|allogeneic stem cell|allogeneic stem cell
4666811|NCT03449030|Drug Therapy|drug therapy
4666812|NCT03449017|nicotine|nicotine
4666813|NCT03449017|alcohol|alcohol
4666814|NCT03449017|vape|vape
4666815|NCT03449017|electronic cigarette|electronic cigarette
4666816|NCT03449004|Validation|validation
4666817|NCT03449004|questionnaire|questionnaire
4666818|NCT03449004|satisfaction|satisfaction
4666819|NCT03449004|online information|online information
4666820|NCT03448991|NPO time|npo time
4666821|NCT03448991|Gastric content|gastric content
4666822|NCT03448991|Gastric pH|gastric ph
4666823|NCT03448939|papulopustular rosacea|papulopustular rosacea
4666824|NCT03448926|DCIS|dcis
4666825|NCT03448926|molecular testing|molecular testing
4666826|NCT03448926|risk of recurrence|risk of recurrence
4666827|NCT03448913|Anesthesia, Regional ;PECS block|anesthesia, regional ;pecs block
4666828|NCT03448900|Cessation|cessation
4666829|NCT03448900|College student|college student
4666830|NCT03448900|Motivational Interview|motivational interview
4666831|NCT03448900|Self-efficacy|self-efficacy
4666832|NCT03448900|Intention|intention
4666833|NCT03448900|Beliefs|beliefs
4666834|NCT03448900|Young adult|young adult
4666835|NCT03448887|End-stage renal disease|end-stage renal disease
4666836|NCT03448887|Medium cut-off dialyzer|medium cut-off dialyzer
4666837|NCT03448887|Hemodiafiltration|hemodiafiltration
4666838|NCT03448887|Cardiovascular|cardiovascular
4666839|NCT03448887|Pulse wave velocity|pulse wave velocity
4666840|NCT03448835|short term immunotherapy|short term immunotherapy
4666841|NCT03448835|surgical resection|surgical resection
4666842|NCT03448835|atezolizumab|atezolizumab
4666843|NCT03448835|capecitabine|capecitabine
4666844|NCT03448835|oxaliplatin|oxaliplatin
4666845|NCT03448835|docetaxel|docetaxel
4666846|NCT03448809|Cognitive and Behavioral Therapies|cognitive and behavioral therapies
4666847|NCT03448809|Children and Adolescents|children and adolescents
4666848|NCT03448809|Community Health Care|community health care
4666849|NCT03448809|Early Intervention|early intervention
4666850|NCT03448809|Feasibility Study|feasibility study
4666851|NCT03448796|High tibial osteotomy|high tibial osteotomy
4666852|NCT03448796|Osteoarthrosis|osteoarthrosis
4666853|NCT03448796|Tomofix|tomofix
4666854|NCT03448796|Randomized controlled trial|randomized controlled trial
4666855|NCT03448783|Bariatric surgery|bariatric surgery
4666856|NCT03448783|Gastrointestinal tract|gastrointestinal tract
4666857|NCT03448783|Biological availability|biological availability
4666858|NCT03448783|Pharmacokinetics|pharmacokinetics
4666859|NCT03448783|Apixaban|apixaban
4666860|NCT03448757|LEEF|leef
4666861|NCT03448757|hemodynamic parameters|hemodynamic parameters
4666862|NCT03448757|heart beat|heart beat
4666863|NCT03448757|biofeedback effect|biofeedback effect
4666864|NCT03448744|thymosin alpha|thymosin alpha
4666865|NCT03448744|entecavir|entecavir
4666866|NCT03448705|influenza|influenza
4666867|NCT03448679|glycocalyx|glycocalyx
4666868|NCT03448679|serum albumin|serum albumin
4666869|NCT03448679|orthotopic liver transplantation|orthotopic liver transplantation
4666870|NCT03448679|colloid osmotic pressure|colloid osmotic pressure
4666871|NCT03448679|endothelial dysfunction|endothelial dysfunction
4666872|NCT03448666|ECT|ect
4666873|NCT03448666|pembrolizumab|pembrolizumab
4666874|NCT03448666|advanced melanoma|advanced melanoma
4666875|NCT03448627|stem cell transplantation|stem cell transplantation
4666876|NCT03448627|Pulmonary Functions|pulmonary functions
4666877|NCT03448627|muscle strength|muscle strength
4666878|NCT03448627|exercise capacity|exercise capacity
4666879|NCT03448614|skull base reconstrction|skull base reconstrction
4666880|NCT03448601|Precision Medicine|precision medicine
4666881|NCT03448575|Youth|youth
4666882|NCT03448575|Mental Health|mental health
4666883|NCT03448575|Psychotropic|psychotropic
4666884|NCT03448575|Medication Safety|medication safety
4666885|NCT03448575|Quality Improvement|quality improvement
4666886|NCT03448562|Atrial Fibrillation|atrial fibrillation
4666887|NCT03448562|Pulmonary Vein Isolation|pulmonary vein isolation
4666888|NCT03448562|Catheter Ablation|catheter ablation
4666889|NCT03448562|Substrate Modification|substrate modification
4666890|NCT03448549|Tegafur，gimeracil and oteracil potassium|tegafur，gimeracil and oteracil potassium
4666891|NCT03448549|Capecitabine|capecitabine
4666892|NCT03448549|compliance|compliance
4666893|NCT03448549|quality of life|quality of life
4666894|NCT03448549|adverse reaction|adverse reaction
4666895|NCT03448549|disease free survival|disease free survival
4666896|NCT03448549|overall survival|overall survival
4666897|NCT03448536|Primary dysmenorrhea of at least moderate severity|primary dysmenorrhea of at least moderate severity
4666898|NCT03448510|lower urinary tract symptoms|lower urinary tract symptoms
4666900|NCT03448510|benign prostatic obstruction|benign prostatic obstruction
4666901|NCT03448510|irreversible electroporation|irreversible electroporation
4666902|NCT03448510|urodynamics|urodynamics
4666903|NCT03448471|stem cell transplantation|stem cell transplantation
4666904|NCT03448471|Fatigue|fatigue
4666905|NCT03448471|muscle strength|muscle strength
4666906|NCT03448471|exercise capacity|exercise capacity
4666907|NCT03448471|Depression|depression
4666908|NCT03448471|Quality of Life|quality of life
4666909|NCT03448445|High-risk|high-risk
4666910|NCT03448445|Low-risk|low-risk
4666911|NCT03448445|Alzheimer's disease|alzheimer's disease
4666912|NCT03448445|Observational study|observational study
4666913|NCT03448432|Pregnancy Anemia|pregnancy anemia
4666914|NCT03448393|CD-19 expressing tumor|cd-19 expressing tumor
4666915|NCT03448393|CD-22 Expressing Tumor|cd-22 expressing tumor
4666916|NCT03448393|Adoptive Immunotherapy|adoptive immunotherapy
4666917|NCT03448393|Philadelphia chromosome (Ph)+ ALL|philadelphia chromosome (ph)+ all
4666918|NCT03448393|Lymphoma|lymphoma
4666919|NCT03448354|HIPEC|hipec
4666920|NCT03448354|Interval debulking surgery|interval debulking surgery
4666921|NCT03448341|radiotherapy|radiotherapy
4666922|NCT03448341|IMRT|imrt
4666923|NCT03448341|dysphagia|dysphagia
4666924|NCT03448341|Oropharynx|oropharynx
4666925|NCT03448341|Nasopharynx|nasopharynx
4666926|NCT03448341|FEES|fees
4666927|NCT03448341|VFS|vfs
4666928|NCT03448328|muscular strength|muscular strength
4666929|NCT03448328|inflammation|inflammation
4666930|NCT03448328|protein|protein
4666931|NCT03448315|brain stimulation, tDCS, acute postoperative pain, chronic pain|brain stimulation, tdcs, acute postoperative pain, chronic pain
4666932|NCT03448289|Postpartum|postpartum
4666933|NCT03448289|Contraception|contraception
4666934|NCT03448276|Osteoporosis|osteoporosis
4666935|NCT03448276|Muscle Strength|muscle strength
4666936|NCT03448276|Postural Balance|postural balance
4666937|NCT03448276|Vibration|vibration
4666938|NCT03448276|Walking|walking
4666939|NCT03448263|pain|pain
4666940|NCT03448263|post endodontic pain|post endodontic pain
4666941|NCT03448263|root canal treatment|root canal treatment
4666942|NCT03448198|total knee arthroplasty|total knee arthroplasty
4666943|NCT03448198|patellar resurfacing|patellar resurfacing
4666944|NCT03448198|patellar tracking|patellar tracking
4666945|NCT03448198|patello-femoral joint kinematics|patello-femoral joint kinematics
4666946|NCT03448198|surgical navigation|surgical navigation
4666947|NCT03448198|computer-aided surgery|computer-aided surgery
4666948|NCT03448159|Stroke|stroke
4666949|NCT03448159|Exercise|exercise
4666950|NCT03448159|Fluoxetine|fluoxetine
4666951|NCT03448159|Randomized Control Trial|randomized control trial
4666952|NCT03448159|Rehabilitation|rehabilitation
4666953|NCT03448120|Muscle fatigue|muscle fatigue
4666954|NCT03448120|Thermography|thermography
4666955|NCT03448120|Acupuncture|acupuncture
4666956|NCT03448120|Dry needling|dry needling
4666957|NCT03448107|dental caries|dental caries
4666958|NCT03448107|caries arrest|caries arrest
4666959|NCT03448107|caries prevention|caries prevention
4666960|NCT03448107|silver diamine fluoride|silver diamine fluoride
4666961|NCT03448107|sealants|sealants
4666962|NCT03448107|interim therapeutic restorations|interim therapeutic restorations
4666963|NCT03448055|MCI, AD, MRI, GSH, Immunocal, brain health, neuropsychological evaluation|mci, ad, mri, gsh, immunocal, brain health, neuropsychological evaluation
4666964|NCT03448029|Vascular Diseases|vascular diseases
4666965|NCT03448029|Peripheral Artery Disease|peripheral artery disease
4666966|NCT03448029|Revascularisation|revascularisation
4666967|NCT03448029|Outcome|outcome
4666968|NCT03448029|Quality Management|quality management
4666969|NCT03448029|Registry|registry
4666970|NCT03448029|Endovascular Intervention|endovascular intervention
4666971|NCT03448029|Limb Amputation|limb amputation
4666972|NCT03448003|Benign Neoplasms|benign neoplasms
4666973|NCT03448003|Cancer prevention|cancer prevention
4666974|NCT03448003|Online counseling|online counseling
4666975|NCT03448003|Questionnaires|questionnaires
4666976|NCT03448003|Surveys|surveys
4666977|NCT03447977|neck pain|neck pain
4666978|NCT03447977|manual therapy|manual therapy
4666979|NCT03447977|respiratory function|respiratory function
4666980|NCT03447964|sphingolipids|sphingolipids
4666981|NCT03447964|hepatic steatosis|hepatic steatosis
4666982|NCT03447964|non-alcoholic fatty liver disease|non-alcoholic fatty liver disease
4666983|NCT03447964|macrovascular complications|macrovascular complications
4666984|NCT03447964|insulin resistance|insulin resistance
4666985|NCT03447964|microvasclar complications|microvasclar complications
4666986|NCT03447964|NAFLD|nafld
4666987|NCT03447925|callosities; keratosis; diabetes mellitus; plants, medicinal; herbal medicine; keratolytic agents|callosities; keratosis; diabetes mellitus; plants, medicinal; herbal medicine; keratolytic agents
4666988|NCT03447912|Behavioral intervention|behavioral intervention
4666989|NCT03447912|Social intervention|social intervention
4666990|NCT03447912|Public health|public health
4666991|NCT03447912|Smoking behavior|smoking behavior
4666992|NCT03447886|Breast Cancer|breast cancer
4666993|NCT03447873|Antiretroviral treatment|antiretroviral treatment
4666994|NCT03447873|Treatment simplification|treatment simplification
4666995|NCT03447873|Dual therapy|dual therapy
4666996|NCT03447873|Immune recovery|immune recovery
4666997|NCT03447834|intracoronary cooling|intracoronary cooling
4666998|NCT03447821|Infectious diarrhoea|infectious diarrhoea
4666999|NCT03447821|rifamycin SV|rifamycin sv
4667000|NCT03447821|rifamycin SV MMX|rifamycin sv mmx
4667001|NCT03447821|MMX|mmx
4667002|NCT03447782|New Daily Persistent Headache|new daily persistent headache
4667003|NCT03447782|Chronic Headache|chronic headache
4667004|NCT03447769|Non-Small Cell Lung Cancer|non-small cell lung cancer
4667005|NCT03447769|NSCLC|nsclc
4667006|NCT03447769|ACZ885|acz885
4667007|NCT03447769|canakinumab|canakinumab
4667008|NCT03447769|adjuvant|adjuvant
4667009|NCT03447769|AJCC/UICC v. 8 stages II-IIIA and IIIB (T>5cm N2)|ajcc/uicc v. 8 stages ii-iiia and iiib (t>5cm n2)
4667010|NCT03447717|hemiplegic gait|hemiplegic gait
4667011|NCT03447717|peroneal nerve stimulation|peroneal nerve stimulation
4667012|NCT03447717|gait analysis|gait analysis
4667013|NCT03447704|Ankylosing Spondylitis|ankylosing spondylitis
4667014|NCT03447704|interleukin 17|interleukin 17
4667015|NCT03447704|monoclonal antibody|monoclonal antibody
4667016|NCT03447665|Infant behavioral sleep intervention|infant behavioral sleep intervention
4667017|NCT03447665|Infant sleep|infant sleep
4667018|NCT03447665|Pediatric insomnia|pediatric insomnia
4667019|NCT03447665|Infant night wakings|infant night wakings
4667020|NCT03447639|Catheter associated UTI|catheter associated uti
4667021|NCT03447639|Povidine iodine|povidine iodine
4667022|NCT03447639|Bladder Irrigation|bladder irrigation
4667023|NCT03447613|retinal nerve fiber layer|retinal nerve fiber layer
4667024|NCT03447613|cerebrospinal fluid Aβ and Tau|cerebrospinal fluid aβ and tau
4667025|NCT03447587|Randomized controlled trial|randomized controlled trial
4667026|NCT03447587|Sleep|sleep
4667027|NCT03447587|Traditional Chinese medicine|traditional chinese medicine
4667028|NCT03447587|Oxidative stress|oxidative stress
4667029|NCT03447561|Dopamine|dopamine
4667030|NCT03447561|Food|food
4667031|NCT03447561|Reward|reward
4667032|NCT03447561|Anticipatory|anticipatory
4667033|NCT03447561|Consummatory|consummatory
4667034|NCT03447561|Positron Emission Tomography|positron emission tomography
4667035|NCT03447561|Magnetic Resonance|magnetic resonance
4667036|NCT03447561|Metabolic hormones|metabolic hormones
4667037|NCT03447548|Cognitive training|cognitive training
4667038|NCT03447548|Social function|social function
4667039|NCT03447548|Processing speed|processing speed
4667040|NCT03447535|Oppositional defiant disorder|oppositional defiant disorder
4667041|NCT03447535|Family|family
4667042|NCT03447535|Disruptive, impulse control and conduct disorders|disruptive, impulse control and conduct disorders
4667043|NCT03447535|Anxiety disorder|anxiety disorder
4667044|NCT03447535|Intrafamilial disruptive behaviours disorder|intrafamilial disruptive behaviours disorder
4667045|NCT03447509|Spinal cord injury|spinal cord injury
4667046|NCT03447509|neural control|neural control
4667047|NCT03447509|motor function|motor function
4667048|NCT03447509|hand movement|hand movement
4667049|NCT03447483|Solid tumor|solid tumor
4667050|NCT03447483|Immune Checkpoint Inhibitor|immune checkpoint inhibitor
4667051|NCT03447483|immune-related Adverse Event|immune-related adverse event
4667052|NCT03447444|dignity|dignity
4667053|NCT03447444|music therapy|music therapy
4667054|NCT03447444|physical activity|physical activity
4667055|NCT03447431|colorectal cancers|colorectal cancers
4667056|NCT03447431|Microsatellite Instability|microsatellite instability
4667057|NCT03447431|Tumor development|tumor development
4667058|NCT03447418|Lung Clearance Index|lung clearance index
4667059|NCT03447418|Breath Nitrogen Washout|breath nitrogen washout
4667060|NCT03447418|Healthy subjects|healthy subjects
4667061|NCT03447405|Music Therapy|music therapy
4667062|NCT03447405|NICU|nicu
4667063|NCT03447405|Infants|infants
4667064|NCT03447405|multisensory processing|multisensory processing
4667065|NCT03447392|Patient Education|patient education
4667066|NCT03447392|Chinese Medicine|chinese medicine
4667067|NCT03447353|driving|driving
4667068|NCT03447353|Xanax|xanax
4667069|NCT03447353|Norco|norco
4667070|NCT03447353|simulation|simulation
4667071|NCT03447314|GSK1795091|gsk1795091
4667072|NCT03447314|Dose-escalation|dose-escalation
4667073|NCT03447314|204686|204686
4667074|NCT03447314|Immunotherapies|immunotherapies
4667075|NCT03447314|Phase I|phase i
4667076|NCT03447314|anticancer agent|anticancer agent
4667077|NCT03447314|OX40|ox40
4667078|NCT03447314|201212|201212
4667079|NCT03447314|TLR4|tlr4
4667080|NCT03447314|GSK3174998|gsk3174998
4667081|NCT03447314|Advanced Solid Tumors|advanced solid tumors
4667082|NCT03447301|Saudi Arabia, Extra Virgin Olive Oil, Blood Glucose|saudi arabia, extra virgin olive oil, blood glucose
4667083|NCT03447288|Dyssynchrony|dyssynchrony
4667084|NCT03447288|Breath-stacking|breath-stacking
4667085|NCT03447288|Asynchrony|asynchrony
4667086|NCT03447288|Reverse Triggering|reverse triggering
4667087|NCT03447288|Mechanical Ventilation|mechanical ventilation
4667088|NCT03447288|Sedation|sedation
4667089|NCT03447236|Older people|older people
4667090|NCT03447236|Cognitive training|cognitive training
4667091|NCT03447236|MCI|mci
4667092|NCT03447223|Attention-deficit/hyperactivity disorder|attention-deficit/hyperactivity disorder
4667093|NCT03447223|circulating metabolites|circulating metabolites
4667094|NCT03447223|metagenome|metagenome
4667095|NCT03447210|Persons who inject drugs (PWID)|persons who inject drugs (pwid)
4667096|NCT03447210|Phylogenetics|phylogenetics
4667097|NCT03447210|HIV testing|hiv testing
4667098|NCT03447210|HCV testing|hcv testing
4667099|NCT03447210|HIV care cascade|hiv care cascade
4667100|NCT03447210|Assisted partner services|assisted partner services
4667101|NCT03447171|Amblyopia|amblyopia
4667102|NCT03447171|Myopia|myopia
4667103|NCT03447171|Hyperopia|hyperopia
4667104|NCT03447171|Risk Factors|risk factors
4667105|NCT03447171|Amblyopia Risk Factors|amblyopia risk factors
4667106|NCT03447171|Smartphone Application (App)|smartphone application (app)
4667107|NCT03447171|Photoscreening|photoscreening
4667108|NCT03447171|Vision Screening|vision screening
4667109|NCT03447171|Mobile Vision Screening|mobile vision screening
4667110|NCT03447171|Vision Screening App|vision screening app
4667111|NCT03447171|Preschool children|preschool children
4667112|NCT03447171|Objective vision screening|objective vision screening
4667113|NCT03447132|Breast Cancer|breast cancer
4667114|NCT03447132|Luminal|luminal
4667115|NCT03447132|Neoadjuvant|neoadjuvant
4667116|NCT03447132|pCR|pcr
4667117|NCT03447132|Surgery|surgery
4667118|NCT03447093|oral microbiota|oral microbiota
4667119|NCT03447093|16S rRNA gene|16s rrna gene
4667120|NCT03447093|Graves' disease|graves' disease
4667121|NCT03447093|Methimazole|methimazole
4667122|NCT03447093|Propylthiouracil|propylthiouracil
4667123|NCT03447093|Hashimoto's thyroiditis|hashimoto's thyroiditis
4667124|NCT03447054|Alcohol|alcohol
4667125|NCT03447054|tDCS|tdcs
4667126|NCT03447054|inhibition|inhibition
4667127|NCT03447054|cognitive training|cognitive training
4667128|NCT03447054|implicit cognition|implicit cognition
4667129|NCT03447054|relapse|relapse
4667130|NCT03447054|craving|craving
4667131|NCT03447041|Keratopathy|keratopathy
4667132|NCT03447041|Visual Quality|visual quality
4667133|NCT03447041|Contrast Sensitivity Function|contrast sensitivity function
4667134|NCT03447028|Triglyseride-Glucose index|triglyseride-glucose index
4667135|NCT03447028|prostate cancer|prostate cancer
4667136|NCT03447028|radical prostatectomy|radical prostatectomy
4667137|NCT03447028|metabolic syndrome|metabolic syndrome
4667138|NCT03447015|ambulation|ambulation
4667139|NCT03447015|labour|labour
4667140|NCT03447015|Randomized Controlled Trial|randomized controlled trial
4667141|NCT03447015|Jordan|jordan
4667142|NCT03447002|premature|premature
4667143|NCT03447002|pvc|pvc
4667144|NCT03446989|case management|case management
4667145|NCT03446989|rheumatoid arthritis|rheumatoid arthritis
4667146|NCT03446989|Effectiveness|effectiveness
4667147|NCT03446989|Generalized Estimating Equations|generalized estimating equations
4667148|NCT03446950|vaginal surgery|vaginal surgery
4667149|NCT03446950|patient position|patient position
4667150|NCT03446950|stirrups|stirrups
4667151|NCT03446950|functional status|functional status
4667152|NCT03446950|urogynecology|urogynecology
4667153|NCT03446937|Antenal corticosteroids|antenal corticosteroids
4667154|NCT03446937|Late preterm delivery|late preterm delivery
4667155|NCT03446937|Neonatal morbidity|neonatal morbidity
4667156|NCT03446924|Nutraceuticals|nutraceuticals
4667157|NCT03446924|Muscle anabolism|muscle anabolism
4667158|NCT03446924|Ageing|ageing
4667159|NCT03446911|SABR|sabr
4667160|NCT03446911|Immunotherapy|immunotherapy
4667161|NCT03446859|Transcutaneous nerve electrical stimulation,|transcutaneous nerve electrical stimulation,
4667162|NCT03446859|Pain intensity|pain intensity
4667163|NCT03446859|Primary dysmenorrhea|primary dysmenorrhea
4667164|NCT03446859|Female|female
4667165|NCT03446859|Undergraduates|undergraduates
4667166|NCT03446833|Parkinson's Disease|parkinson's disease
4667167|NCT03446833|Deep Brain Stimulation|deep brain stimulation
4667168|NCT03446807|fatigue|fatigue
4667169|NCT03446807|Droxidopa|droxidopa
4667170|NCT03446794|Left Atrial Appendage Closure|left atrial appendage closure
4667171|NCT03446794|Watchman device|watchman device
4667172|NCT03446768|COPD|copd
4667173|NCT03446768|OSA|osa
4667174|NCT03446742|Rehabilitation Service|rehabilitation service
4667175|NCT03446742|Signals and symptons|signals and symptons
4667176|NCT03446742|Heart Rate|heart rate
4667177|NCT03446742|Blood pressure|blood pressure
4667178|NCT03446742|Respiratory Muscles|respiratory muscles
4667179|NCT03446742|autonomic modulation|autonomic modulation
4667180|NCT03446742|exercise|exercise
4667181|NCT03446742|risk measurement|risk measurement
4667182|NCT03446742|muscle strength|muscle strength
4667183|NCT03446742|inflammation|inflammation
4667184|NCT03446742|cytosines|cytosines
4667185|NCT03446703|social cognition|social cognition
4667186|NCT03446703|psychotherapy|psychotherapy
4667187|NCT03446703|rehabilitation|rehabilitation
4667188|NCT03446703|theory of mind|theory of mind
4667189|NCT03446690|Enamel decalcification|enamel decalcification
4667190|NCT03446677|HIV|hiv
4667191|NCT03446677|Balance|balance
4667192|NCT03446677|Vestibular|vestibular
4667193|NCT03446677|Somatosensory|somatosensory
4667194|NCT03446677|postural stability|postural stability
4667195|NCT03446677|center of pressure|center of pressure
4667196|NCT03446651|Sodium Homeostasis|sodium homeostasis
4667197|NCT03446638|myelodysplastic syndromes|myelodysplastic syndromes
4667198|NCT03446638|MDS|mds
4667199|NCT03446638|computational biology|computational biology
4667200|NCT03446638|relapsed|relapsed
4667201|NCT03446638|refractory|refractory
4667202|NCT03446625|resveratrol|resveratrol
4667203|NCT03446625|OHSS|ohss
4667204|NCT03446625|PCOS|pcos
4667205|NCT03446612|darbepoetin alpha|darbepoetin alpha
4667206|NCT03446612|challenge agents|challenge agents
4667207|NCT03446612|daprodustat|daprodustat
4667208|NCT03446612|FBF-CKD|fbf-ckd
4667209|NCT03446599|cardiac surgery|cardiac surgery
4667210|NCT03446599|vasoplegia|vasoplegia
4667211|NCT03446599|cardiopulmonary bypass|cardiopulmonary bypass
4667212|NCT03446573|Switch study|switch study
4667213|NCT03446573|non-inferiority|non-inferiority
4667214|NCT03446573|HIV-1|hiv-1
4667215|NCT03446573|tenofovir alafenamide|tenofovir alafenamide
4667216|NCT03446573|dolutegravir plus lamivudine|dolutegravir plus lamivudine
4667217|NCT03446560|Compliance|compliance
4667218|NCT03446560|Telemedicine|telemedicine
4667219|NCT03446560|Patient related outcome measures|patient related outcome measures
4667220|NCT03446547|SBRT|sbrt
4667221|NCT03446547|Immunotherapy|immunotherapy
4667222|NCT03446534|pneumonia|pneumonia
4667223|NCT03446534|pre-school children|pre-school children
4667224|NCT03446534|antibiotics|antibiotics
4667225|NCT03446534|amoxicillin|amoxicillin
4667226|NCT03446508|High definition transcranial direct stimulation|high definition transcranial direct stimulation
4667227|NCT03446508|Mild Cognitive Impairment|mild cognitive impairment
4667228|NCT03446508|Memory|memory
4667229|NCT03446495|ovarian cancer, trabectedin, recurrent ovarian cancer|ovarian cancer, trabectedin, recurrent ovarian cancer
4667230|NCT03446469|Chronic ankle instability|chronic ankle instability
4667231|NCT03446469|Functional instability|functional instability
4667232|NCT03446469|Ankle sprain|ankle sprain
4667233|NCT03446469|postural sway|postural sway
4667234|NCT03446469|Fascial Manipulation|fascial manipulation
4667235|NCT03446456|Magnetic Resonance Imaging|magnetic resonance imaging
4667236|NCT03446456|Healthy Volunteers|healthy volunteers
4667237|NCT03446430|arterial stiffness|arterial stiffness
4667238|NCT03446430|pulse wave velocity|pulse wave velocity
4667239|NCT03446430|laser Doppler vibrometry|laser doppler vibrometry
4667240|NCT03446365|Asthma|asthma
4667241|NCT03446365|Latino children|latino children
4667242|NCT03446365|middle school|middle school
4667243|NCT03446365|peer models|peer models
4667244|NCT03446365|educational intervention|educational intervention
4667245|NCT03446365|high school students|high school students
4667246|NCT03446352|Falls|falls
4667247|NCT03446352|Elderly|elderly
4667248|NCT03446352|Psychomotor exercise program|psychomotor exercise program
4667249|NCT03446352|Whole body vibration|whole body vibration
4667250|NCT03446326|pacemaker|pacemaker
4667251|NCT03446326|stroke volume|stroke volume
4667252|NCT03446326|cardiac output|cardiac output
4667253|NCT03446326|heart rate|heart rate
4667254|NCT03446300|High Myopia, fundus structure, early visual impairment|high myopia, fundus structure, early visual impairment
4667255|NCT03446248|vibroacoustic stimulation|vibroacoustic stimulation
4667256|NCT03446235|Obesity|obesity
4667257|NCT03446235|Physical Activity|physical activity
4667258|NCT03446235|Exercise|exercise
4667259|NCT03446235|Wearable device|wearable device
4667260|NCT03446196|Transplantation, Fluid Balance|transplantation, fluid balance
4667261|NCT03446170|Young adults|young adults
4667262|NCT03446170|Cigarette smoking|cigarette smoking
4667263|NCT03446170|Warning labels|warning labels
4667264|NCT03446157|colon cancer|colon cancer
4667265|NCT03446157|metastatic colon cancer|metastatic colon cancer
4667266|NCT03446157|palbociclib|palbociclib
4667267|NCT03446157|cetuximab|cetuximab
4667268|NCT03446144|Geographic Atrophy|geographic atrophy
4667269|NCT03446144|Age Related Macular Degeneration|age related macular degeneration
4667270|NCT03446144|IONIS-FB-Lrx|ionis-fb-lrx
4667271|NCT03446144|Complement Factor B|complement factor b
4667272|NCT03446131|transfemoral amputation|transfemoral amputation
4667273|NCT03446131|limb salvage|limb salvage
4667274|NCT03446131|bilateral amputation|bilateral amputation
4667275|NCT03446131|Department of Defense|department of defense
4667276|NCT03446131|orthosis|orthosis
4667277|NCT03446131|prosthesis|prosthesis
4667278|NCT03446131|rehabilitation|rehabilitation
4667279|NCT03446131|military treatment facilities|military treatment facilities
4667280|NCT03446131|military|military
4667281|NCT03446131|injured lower extremity|injured lower extremity
4667282|NCT03446131|prevent falls|prevent falls
4667283|NCT03446131|trauma lower extremity|trauma lower extremity
4667284|NCT03446131|service members|service members
4667285|NCT03446131|retired service members|retired service members
4667286|NCT03446131|active service members|active service members
4667287|NCT03446131|unilateral lower extremity trauma|unilateral lower extremity trauma
4667288|NCT03446131|limb amputation|limb amputation
4667289|NCT03446131|limb preservation|limb preservation
4667290|NCT03446131|preserved limb|preserved limb
4667291|NCT03446131|trips|trips
4667292|NCT03446131|slips|slips
4667293|NCT03446131|transtibial amputation|transtibial amputation
4667294|NCT03446118|EoE|eoe
4667295|NCT03446105|Cancer survivor|cancer survivor
4667296|NCT03446105|App-based intervention|app-based intervention
4667297|NCT03446105|Behavioral intervention|behavioral intervention
4667298|NCT03446092|Cancer|cancer
4667299|NCT03446092|Mindfulness|mindfulness
4667300|NCT03446092|Palliative care|palliative care
4667301|NCT03446079|Genetic|genetic
4667302|NCT03446079|Skin|skin
4667303|NCT03446079|Anti Aging|anti aging
4667304|NCT03446079|SNP|snp
4667305|NCT03446053|Methicillin-Resistant Staphylococcus Aureus|methicillin-resistant staphylococcus aureus
4667306|NCT03446053|Methicillin-Sensitive Staphylococcus Aureus|methicillin-sensitive staphylococcus aureus
4667307|NCT03446053|N-Rephasin SAL200|n-rephasin sal200
4667308|NCT03445962|Autonomic nervous system|autonomic nervous system
4667309|NCT03445962|Heart rate variability|heart rate variability
4667310|NCT03445962|Physical Activity|physical activity
4667311|NCT03445962|exercise|exercise
4667312|NCT03445962|biological parameters|biological parameters
4667313|NCT03445962|cephalometry|cephalometry
4667314|NCT03445962|body composition|body composition
4667315|NCT03445962|actigraphy|actigraphy
4667316|NCT03445962|motor capacity|motor capacity
4667317|NCT03445962|physical fitness|physical fitness
4667318|NCT03445962|aerobic capacity|aerobic capacity
4667319|NCT03445962|seismocardiography|seismocardiography
4667320|NCT03445949|atrial fibrillation, stroke, bleeding, left atrial appendage|atrial fibrillation, stroke, bleeding, left atrial appendage
4667321|NCT03445936|loop-ileostomy reversal|loop-ileostomy reversal
4667322|NCT03445936|hernia prevention|hernia prevention
4667323|NCT03445910|human chorionic gonadotropin|human chorionic gonadotropin
4667324|NCT03445884|positron emission tomography|positron emission tomography
4667325|NCT03445884|nuclear medicine|nuclear medicine
4667326|NCT03445884|prognosis|prognosis
4667327|NCT03445871|Rheumatoid Arthritis|rheumatoid arthritis
4667328|NCT03445871|Methotrexate|methotrexate
4667329|NCT03445871|Erythrocyte polyglutamate|erythrocyte polyglutamate
4667330|NCT03445871|Compliance Questionnaire Rheumatology|compliance questionnaire rheumatology
4667331|NCT03445845|TNF blocker|tnf blocker
4667332|NCT03445845|change of biotherapy|change of biotherapy
4667333|NCT03445819|Patella Fracture, elderly|patella fracture, elderly
4667334|NCT03445806|IOP fluctuations|iop fluctuations
4667335|NCT03445806|iCare Home|icare home
4667336|NCT03445806|Trabeculectomy|trabeculectomy
4667337|NCT03445806|self-tonometry|self-tonometry
4667338|NCT03445793|DeltaF508deletion (F508del) mutation in 2 copies|deltaf508deletion (f508del) mutation in 2 copies
4667339|NCT03445767|Peri-operative care|peri-operative care
4667340|NCT03445767|Medication management|medication management
4667341|NCT03445741|Aerobic exercise|aerobic exercise
4667342|NCT03445741|Metabolic syndrome|metabolic syndrome
4667343|NCT03445741|Pedometer|pedometer
4667344|NCT03445676|Hand Hygiene|hand hygiene
4667345|NCT03445676|WHO 5-moments|who 5-moments
4667346|NCT03445663|Relapsed/ Refractory Multiple Myeloma|relapsed/ refractory multiple myeloma
4667347|NCT03445663|Multiple Myeloma|multiple myeloma
4667348|NCT03445663|Oncology/Hematology|oncology/hematology
4667349|NCT03445663|Immunotherapy|immunotherapy
4667350|NCT03445650|ADX-102, Sjögren-Larsson Syndrome|adx-102, sjögren-larsson syndrome
4667351|NCT03445637|Metastatic breast cancer, safety, ibrance|metastatic breast cancer, safety, ibrance
4667352|NCT03445598|depression|depression
4667353|NCT03445598|anxiety|anxiety
4667354|NCT03445598|CBT|cbt
4667355|NCT03445598|psychotherapy|psychotherapy
4667356|NCT03445598|e-health|e-health
4667357|NCT03445598|CCBT|ccbt
4667358|NCT03445572|Advanced Cancer|advanced cancer
4667359|NCT03445572|Meditative Slow Breathing|meditative slow breathing
4667360|NCT03445572|MSB|msb
4667361|NCT03445572|Isha Kriya Meditation|isha kriya meditation
4667362|NCT03445572|IK|ik
4667363|NCT03445572|Questionnaires|questionnaires
4667364|NCT03445572|Surveys|surveys
4667365|NCT03445559|Prostate Cancer|prostate cancer
4667366|NCT03445559|Imaging|imaging
4667367|NCT03445559|Veterans Affairs|veterans affairs
4667368|NCT03445559|Guideline Adherence|guideline adherence
4667369|NCT03445559|Implementation|implementation
4667370|NCT03445533|Melanoma|melanoma
4667371|NCT03445533|PD1|pd1
4667372|NCT03445533|PD-1|pd-1
4667373|NCT03445533|refractory|refractory
4667374|NCT03445533|metastatic|metastatic
4667375|NCT03445533|IMO-2125|imo-2125
4667376|NCT03445533|illuminate 301|illuminate 301
4667377|NCT03445533|TLR9 agonist|tlr9 agonist
4667378|NCT03445533|advanced melanoma|advanced melanoma
4667379|NCT03445533|CTLA4|ctla4
4667380|NCT03445533|CTLA-4|ctla-4
4667381|NCT03445533|immunotherapy|immunotherapy
4667382|NCT03445533|skin cancer|skin cancer
4667383|NCT03445533|ILLUMINATE-301|illuminate-301
4667384|NCT03445520|Transitions|transitions
4667385|NCT03445520|Passport|passport
4667386|NCT03445520|Building Better Bridges|building better bridges
4667387|NCT03445520|Snapshot|snapshot
4667388|NCT03445507|tobacco|tobacco
4667389|NCT03445507|cessation|cessation
4667390|NCT03445507|medical apps for smartphones|medical apps for smartphones
4667391|NCT03445468|Influenza vaccine|influenza vaccine
4667392|NCT03445468|Split influenza vaccine|split influenza vaccine
4667393|NCT03445468|Seasonal influenza vaccine|seasonal influenza vaccine
4667394|NCT03445442|Elderly|elderly
4667395|NCT03445442|Native tissue repair|native tissue repair
4667396|NCT03445442|Pelvic Organ Prolapse|pelvic organ prolapse
4667397|NCT03445442|Sacrocolpopexy|sacrocolpopexy
4667398|NCT03445442|Vaginal mesh repair|vaginal mesh repair
4667399|NCT03445403|Offset analgesia|offset analgesia
4667400|NCT03445403|Quantitive sensory testing|quantitive sensory testing
4667401|NCT03445364|Primary PCI|primary pci
4667402|NCT03445364|Coronary injection pressure|coronary injection pressure
4667403|NCT03445364|Reperfusion|reperfusion
4667404|NCT03445364|Resolution of ST elevation|resolution of st elevation
4667405|NCT03445364|Myocardial Blush Grade|myocardial blush grade
4667406|NCT03445351|Exercise Therapy;|exercise therapy;
4667407|NCT03445351|Sleep;|sleep;
4667408|NCT03445351|; Immune Markers;|; immune markers;
4667409|NCT03445351|HIV|hiv
4667410|NCT03445325|obesity|obesity
4667411|NCT03445325|physical activity|physical activity
4667412|NCT03445325|nutrition|nutrition
4667413|NCT03445325|adolescents|adolescents
4667414|NCT03445325|gamification|gamification
4667415|NCT03445325|sedentary activity|sedentary activity
4667416|NCT03445286|Gingivitis and geriatric patients|gingivitis and geriatric patients
4667417|NCT03445286|Silver Diamine Fluoride and gingivitis|silver diamine fluoride and gingivitis
4667418|NCT03445286|Sliver Diamine Fluoride|sliver diamine fluoride
4667419|NCT03445247|Diabetic Nephropathies|diabetic nephropathies
4667420|NCT03445247|Extracorporeal low intensity shockwave therapy|extracorporeal low intensity shockwave therapy
4667421|NCT03445247|Proteinuria|proteinuria
4667422|NCT03445234|exercise|exercise
4667423|NCT03445234|innate immune function|innate immune function
4667424|NCT03445234|metabolomics|metabolomics
4667425|NCT03445234|inflammation|inflammation
4667426|NCT03445221|Oral Immunonutrition|oral immunonutrition
4667427|NCT03445221|Cardiac Patient|cardiac patient
4667428|NCT03445221|Mitral Valve Replacement|mitral valve replacement
4667429|NCT03445182|pain control|pain control
4667430|NCT03445182|paediatric dental patients|paediatric dental patients
4667431|NCT03445182|local anaesthesia|local anaesthesia
4667432|NCT03445182|dentalvibe|dentalvibe
4667433|NCT03445156|First-person shooter (FPS)|first-person shooter (fps)
4667434|NCT03445156|Violent video game|violent video game
4667435|NCT03445156|Headshot|headshot
4667436|NCT03445156|Gun|gun
4667437|NCT03445156|Operant conditioning theory|operant conditioning theory
4667438|NCT03445130|Preoperative Anxiety|preoperative anxiety
4667439|NCT03445130|Breast Surgery|breast surgery
4667440|NCT03445130|Lavender Aromatherapy|lavender aromatherapy
4667441|NCT03445117|influenza|influenza
4667442|NCT03445117|pneumonia|pneumonia
4667443|NCT03445117|vaccination|vaccination
4667444|NCT03445117|education|education
4667445|NCT03445117|public health|public health
4667446|NCT03445104|Huperzine A|huperzine a
4667447|NCT03445104|acetylcholinesterase inhibitor|acetylcholinesterase inhibitor
4667448|NCT03445104|AChEI|achei
4667449|NCT03445104|exercise|exercise
4667450|NCT03445104|Physical performance|physical performance
4667451|NCT03445104|cognitive function|cognitive function
4667452|NCT03445104|rating of perceived exertion|rating of perceived exertion
4667453|NCT03445104|RPE|rpe
4667454|NCT03445091|compression socks|compression socks
4667455|NCT03445091|venous insufficiency|venous insufficiency
4667456|NCT03445091|compression stockings|compression stockings
4667457|NCT03445091|compression|compression
4667458|NCT03445091|compression therapy|compression therapy
4667459|NCT03445052|Adherence|adherence
4667460|NCT03445052|Behaviour change|behaviour change
4667461|NCT03445052|Intervention|intervention
4667462|NCT03445052|Photoprotection|photoprotection
4667463|NCT03445052|Ultraviolet radiation|ultraviolet radiation
4667464|NCT03445039|Dental implants, Trans-alveolar sinus floor elevation, Bone grafting|dental implants, trans-alveolar sinus floor elevation, bone grafting
4667465|NCT03445000|RET-rearrangement|ret-rearrangement
4667466|NCT03445000|advanced NSCLC|advanced nsclc
4667467|NCT03444987|Uterine fibroid|uterine fibroid
4667468|NCT03444987|FAP|fap
4667469|NCT03444987|Autophagy|autophagy
4667470|NCT03444974|drugs|drugs
4667471|NCT03444974|youth|youth
4667472|NCT03444974|adolescence|adolescence
4667473|NCT03444974|abuse|abuse
4667474|NCT03444974|dependency|dependency
4667475|NCT03444974|Tetrahydrocannabinol (THC)|tetrahydrocannabinol (thc)
4667476|NCT03444974|Methamphetamine (Crystal Meth)|methamphetamine (crystal meth)
4667477|NCT03444974|Marihuana|marihuana
4667478|NCT03444974|comorbidity|comorbidity
4667479|NCT03444974|treatment|treatment
4667480|NCT03444974|etiopathology|etiopathology
4667481|NCT03444974|sociodemographics|sociodemographics
4667482|NCT03444974|Saxony|saxony
4667483|NCT03444961|Argus II Retinal Prosthesis System|argus ii retinal prosthesis system
4667484|NCT03444961|Rehabilitation|rehabilitation
4667485|NCT03444935|Phone|phone
4667486|NCT03444935|Brief Contact Intervention|brief contact intervention
4667487|NCT03444935|Caring Contact|caring contact
4667488|NCT03444935|Follow-up|follow-up
4667489|NCT03444935|Suicide|suicide
4667490|NCT03444935|Suicidal Ideation|suicidal ideation
4667491|NCT03444935|Suicidal Behaviour|suicidal behaviour
4667492|NCT03444935|Suicide Attempt|suicide attempt
4667493|NCT03444909|Monitoring|monitoring
4667494|NCT03444857|Continuous Positive Airway Pressure|continuous positive airway pressure
4667495|NCT03444857|Myocardial Salvage|myocardial salvage
4667496|NCT03444857|Obstructive Sleep Apnea|obstructive sleep apnea
4667497|NCT03444857|ST Elevation Myocardial Infarction|st elevation myocardial infarction
4667498|NCT03444831|Functional Dyspepsia|functional dyspepsia
4667499|NCT03444818|E6007|e6007
4667500|NCT03444818|Pharmacokinetics|pharmacokinetics
4667501|NCT03444818|Radioactivity|radioactivity
4667502|NCT03444805|Autoimmune diseases|autoimmune diseases
4667503|NCT03444805|Systemic sclerosis|systemic sclerosis
4667504|NCT03444805|Autologous hematopoietic stem cell transplant (AHSCT)|autologous hematopoietic stem cell transplant (ahsct)
4667505|NCT03444805|Post-AHSCT management|post-ahsct management
4667506|NCT03444805|Immune reconstitution|immune reconstitution
4667507|NCT03444727|vulvar biopsy|vulvar biopsy
4667508|NCT03444727|ice|ice
4667509|NCT03444727|anesthesia|anesthesia
4667510|NCT03444727|pain|pain
4667511|NCT03444727|vulva|vulva
4667512|NCT03444714|intratumoral|intratumoral
4667513|NCT03444701|Solid tumors|solid tumors
4667514|NCT03444701|Her2-negative breast cancer|her2-negative breast cancer
4667515|NCT03444701|Squamous cell carcinoma of the head and neck|squamous cell carcinoma of the head and neck
4667516|NCT03444688|Robotic Walker|robotic walker
4667517|NCT03444675|Transplantation; intestine|transplantation; intestine
4667518|NCT03444675|endoscopy|endoscopy
4667519|NCT03444675|severity score|severity score
4667520|NCT03444675|transplant rejection|transplant rejection
4667521|NCT03444675|transplant; complications|transplant; complications
4667522|NCT03444649|AML|aml
4667523|NCT03444649|Epacadostat|epacadostat
4667524|NCT03444649|Idarubicin|idarubicin
4667525|NCT03444649|Cytarabine|cytarabine
4667526|NCT03444636|Multimodal analgesia|multimodal analgesia
4667527|NCT03444636|Thoracic epidural|thoracic epidural
4667528|NCT03444636|Postoperative pain|postoperative pain
4667529|NCT03444636|Postoperative Complications|postoperative complications
4667530|NCT03444636|Patient Satisfaction|patient satisfaction
4667531|NCT03444623|predictive factor|predictive factor
4667532|NCT03444623|prognostic factor|prognostic factor
4667533|NCT03444584|0382, T2DM|0382, t2dm
4667534|NCT03444558|metabolic parameters|metabolic parameters
4667535|NCT03444558|cardio-metabolic parameters|cardio-metabolic parameters
4667536|NCT03444545|Cardiac output|cardiac output
4667537|NCT03444545|Carbon dioxide|carbon dioxide
4667538|NCT03444545|Intraoperative monitoring|intraoperative monitoring
4667539|NCT03444545|Pulmonary blood flow|pulmonary blood flow
4667540|NCT03444519|brain relaxation|brain relaxation
4667541|NCT03444519|mannitol|mannitol
4667542|NCT03444519|supratentorial tumours|supratentorial tumours
4667543|NCT03444506|SAR|sar
4667544|NCT03444454|Telerehabilitation|telerehabilitation
4667545|NCT03444454|Virtual reality|virtual reality
4667546|NCT03444454|Quality of life|quality of life
4667547|NCT03444441|Foot|foot
4667548|NCT03444441|Ankle|ankle
4667549|NCT03444441|Finnish|finnish
4667550|NCT03444441|Validation|validation
4667551|NCT03444441|FAOS|faos
4667552|NCT03444441|EFAS|efas
4667553|NCT03444441|LEFS|lefs
4667554|NCT03444441|FAAM|faam
4667555|NCT03444441|VAS-FA|vas-fa
4667556|NCT03444441|MOxFA|moxfa
4667557|NCT03444415|Obesity|obesity
4667558|NCT03444415|Children|children
4667559|NCT03444415|Pregnancy|pregnancy
4667560|NCT03444415|Motivational interview|motivational interview
4667561|NCT03444415|Family Care|family care
4667562|NCT03444415|Primary Care|primary care
4667563|NCT03444402|CKD-381|ckd-381
4667564|NCT03444402|Nexium|nexium
4667565|NCT03444376|keytruda|keytruda
4667566|NCT03444376|pembrolizumab|pembrolizumab
4667567|NCT03444376|GX-188E|gx-188e
4667568|NCT03444376|TDS-IM device|tds-im device
4667569|NCT03444363|laser|laser
4667570|NCT03444363|periodontal treatment|periodontal treatment
4667571|NCT03444363|systemic inflammation|systemic inflammation
4667572|NCT03444363|glycemic control|glycemic control
4667573|NCT03444350|Periodontal treatment|periodontal treatment
4667574|NCT03444350|Ozone|ozone
4667575|NCT03444350|oxidative stress|oxidative stress
4667576|NCT03444337|ablation|ablation
4667577|NCT03444337|atrial fibrillation|atrial fibrillation
4667578|NCT03444337|FIRM|firm
4667579|NCT03444324|Fibrinogen|fibrinogen
4667580|NCT03444311|microbiota|microbiota
4667581|NCT03444311|ulcerative colitis|ulcerative colitis
4667582|NCT03444311|fiber|fiber
4667583|NCT03444311|probiotic|probiotic
4667584|NCT03444285|Thermotherapy|thermotherapy
4667585|NCT03444285|warm-up|warm-up
4667586|NCT03444285|extensibility|extensibility
4667587|NCT03444285|pain|pain
4667588|NCT03444285|athletes|athletes
4667589|NCT03444259|Atrial fibrillation|atrial fibrillation
4667590|NCT03444259|Aortic stenosis|aortic stenosis
4667591|NCT03444259|Coronary artery disease|coronary artery disease
4667592|NCT03444259|Cardiac surgery|cardiac surgery
4667593|NCT03444259|Atrial appendage|atrial appendage
4667594|NCT03444207|obesity|obesity
4667595|NCT03444207|inflammation|inflammation
4667596|NCT03444207|C-reactive protein|c-reactive protein
4667597|NCT03444207|training|training
4667598|NCT03444207|tumor necrosis factor alfa|tumor necrosis factor alfa
4667599|NCT03444194|liver metastasis|liver metastasis
4667600|NCT03444194|chemotherapy|chemotherapy
4667601|NCT03444194|liver biopsy|liver biopsy
4667602|NCT03444194|colorectal caner|colorectal caner
4667603|NCT03444168|lumbar spine surgery|lumbar spine surgery
4667604|NCT03444168|lumbar failed back surgery syndrome|lumbar failed back surgery syndrome
4667605|NCT03444142|Diabetes|diabetes
4667606|NCT03444142|Hyperglycemia|hyperglycemia
4667607|NCT03444142|ABPM|abpm
4667608|NCT03444142|Variability of blood pressure|variability of blood pressure
4667609|NCT03444142|Exenatide LAR or Dulaglutide 0.75mg|exenatide lar or dulaglutide 0.75mg
4667610|NCT03444142|Glucagon-like peptide analogues type 1 (GLP1).|glucagon-like peptide analogues type 1 (glp1).
4667611|NCT03444103|IL-6 blockade|il-6 blockade
4667612|NCT03444064|Islet transplantation|islet transplantation
4667613|NCT03444064|Diabetes treatment|diabetes treatment
4667614|NCT03444064|PolyTregs|polytregs
4667615|NCT03444064|Immunotherapy|immunotherapy
4667616|NCT03444051|EUS-FNB|eus-fnb
4667617|NCT03444051|comparative study|comparative study
4667618|NCT03443999|Coronary Artery Disease|coronary artery disease
4667619|NCT03443999|Sirolimus-eluting Stent|sirolimus-eluting stent
4667620|NCT03443999|Biodegradable Polymers|biodegradable polymers
4667621|NCT03443986|Diabetes Mellitus|diabetes mellitus
4667622|NCT03443986|Blood Flow Velocity|blood flow velocity
4667623|NCT03443986|Skin Temperature|skin temperature
4667624|NCT03443986|Postural Balance|postural balance
4667625|NCT03443986|Combined Modality Therapy|combined modality therapy
4667626|NCT03443986|Vibration|vibration
4667627|NCT03443986|Resistance Training|resistance training
4667628|NCT03443934|Hemodynamic assessments|hemodynamic assessments
4667629|NCT03443934|Echocardiography|echocardiography
4667630|NCT03443934|MR-Elastography|mr-elastography
4667631|NCT03443934|Liver vein catheterization|liver vein catheterization
4667632|NCT03443934|Liver Cirrhosis|liver cirrhosis
4667633|NCT03443934|Cirrhotic cardiomyopathy|cirrhotic cardiomyopathy
4667634|NCT03443934|Cirrhotic complications|cirrhotic complications
4667635|NCT03443934|Magnetic Resonance Imaging|magnetic resonance imaging
4667636|NCT03443921|Artery Divestment Technique|artery divestment technique
4667637|NCT03443921|Locally Advanced Pancreatic Cancer|locally advanced pancreatic cancer
4667638|NCT03443921|Neoadjuvant Therapy|neoadjuvant therapy
4667639|NCT03443921|Borderline Resectable Pancreatic Cancer|borderline resectable pancreatic cancer
4667640|NCT03443908|lung cancer|lung cancer
4667641|NCT03443908|non small cell lung cancer|non small cell lung cancer
4667642|NCT03443908|nsclc|nsclc
4667643|NCT03443908|small cell lung cancer|small cell lung cancer
4667644|NCT03443908|sclc|sclc
4667645|NCT03443908|metastic lung mass|metastic lung mass
4667646|NCT03443908|sleep disordered breathing|sleep disordered breathing
4667647|NCT03443908|sdb|sdb
4667648|NCT03443908|obstructive sleep apnea|obstructive sleep apnea
4667649|NCT03443830|Zika virus|zika virus
4667650|NCT03443830|Tyzivumab|tyzivumab
4667651|NCT03443830|Monoclonal antibody|monoclonal antibody
4667652|NCT03443830|Infectious diseases|infectious diseases
4667653|NCT03443830|Phase 1A first in human study|phase 1a first in human study
4667654|NCT03443830|Singapore|singapore
4667655|NCT03443817|Feasibility|feasibility
4667656|NCT03443817|tele-rehabilitation|tele-rehabilitation
4667657|NCT03443817|follow-up|follow-up
4667658|NCT03443817|COPD|copd
4667659|NCT03443791|CMV|cmv
4667660|NCT03443791|Congenital Birth|congenital birth
4667661|NCT03443791|Infectious Diseases|infectious diseases
4667662|NCT03443778|tonsillectomy pain|tonsillectomy pain
4667663|NCT03443778|dexamethasone|dexamethasone
4667664|NCT03443778|bupivacaine|bupivacaine
4667665|NCT03443739|Intermittent Fasting|intermittent fasting
4667666|NCT03443739|Religious Fast|religious fast
4667667|NCT03443739|Bahá'í|bahá'í
4667668|NCT03443739|Hydration|hydration
4667669|NCT03443739|Calorimetry|calorimetry
4667670|NCT03443739|Microdialysis|microdialysis
4667671|NCT03443739|circadian clock|circadian clock
4667672|NCT03443739|circadian rhythm|circadian rhythm
4667673|NCT03443739|spirituality|spirituality
4667674|NCT03443739|self-efficacy|self-efficacy
4667675|NCT03443726|Lower third molar extraction|lower third molar extraction
4667676|NCT03443726|Infiltration anesthesia|infiltration anesthesia
4667677|NCT03443726|Articaine|articaine
4667678|NCT03443700|SCI|sci
4667679|NCT03443700|gait|gait
4667680|NCT03443700|incomplete motor SCI|incomplete motor sci
4667681|NCT03443700|robotic gait training|robotic gait training
4667682|NCT03443700|locomotor training|locomotor training
4667683|NCT03443700|walking training|walking training
4667684|NCT03443700|rehabilitation|rehabilitation
4667685|NCT03443700|exoskeleton|exoskeleton
4667686|NCT03443700|EKSO|ekso
4667687|NCT03443700|EKSO-GT|ekso-gt
4667688|NCT03443700|neuroplasticity|neuroplasticity
4667689|NCT03443700|brain cortical plasticity|brain cortical plasticity
4667690|NCT03443661|5-Fluorouracil|5-fluorouracil
4667691|NCT03443661|rectal cancer|rectal cancer
4667692|NCT03443661|irinotecan|irinotecan
4667693|NCT03443661|oxaliplatin|oxaliplatin
4667694|NCT03443661|neoadjuvant chemotherapy|neoadjuvant chemotherapy
4667695|NCT03443622|SC-43|sc-43
4667696|NCT03443622|refractory solid tumor|refractory solid tumor
4667697|NCT03443622|Phase I|phase i
4667698|NCT03443609|occult prostate cancer recurrence|occult prostate cancer recurrence
4667699|NCT03443609|PSA|psa
4667700|NCT03443609|68Ga-HBED-CC-PSMA PET / CT|68ga-hbed-cc-psma pet / ct
4667701|NCT03443596|stroke|stroke
4667702|NCT03443596|blood pressure|blood pressure
4667703|NCT03443596|hemodynamic|hemodynamic
4667704|NCT03443570|immune thrombocytopenia|immune thrombocytopenia
4667705|NCT03443570|Thrombocytopenia|thrombocytopenia
4667706|NCT03443557|Oral nutrition supplement|oral nutrition supplement
4667707|NCT03443557|malnutrition|malnutrition
4667708|NCT03443557|mortality|mortality
4667709|NCT03443544|fournier's|fournier's
4667710|NCT03443544|gangrene|gangrene
4667711|NCT03443531|Bronchiectasis|bronchiectasis
4667712|NCT03443531|Traditional Chinese Medicine|traditional chinese medicine
4667713|NCT03443518|EVAR, analgesia|evar, analgesia
4667714|NCT03443505|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
4667715|NCT03443505|Acute exacerbation|acute exacerbation
4667716|NCT03443505|Neural respiratory drive|neural respiratory drive
4667717|NCT03443505|Parasternal electromyography|parasternal electromyography
4667718|NCT03443505|Respiratory physiology|respiratory physiology
4667719|NCT03443479|Non invasive ventilation|non invasive ventilation
4667720|NCT03443479|BiPAP|bipap
4667721|NCT03443479|High-Flow Oxygen Therapy|high-flow oxygen therapy
4667722|NCT03443479|High-Flow Nasal Cannula|high-flow nasal cannula
4667723|NCT03443479|COPD|copd
4667724|NCT03443479|Hypercapnia|hypercapnia
4667725|NCT03443479|Hypercapnic Respiratory failure|hypercapnic respiratory failure
4667726|NCT03443479|Chronic obstructive Pulmonary Disease|chronic obstructive pulmonary disease
4667727|NCT03443466|Electric stimulation|electric stimulation
4667728|NCT03443466|Cesarean section|cesarean section
4667729|NCT03443427|Non-typeable Haemophilus influenzae|non-typeable haemophilus influenzae
4667730|NCT03443427|Moraxella catarrhalis|moraxella catarrhalis
4667731|NCT03443427|Safety|safety
4667732|NCT03443427|Third vaccine dose|third vaccine dose
4667733|NCT03443427|Vaccination|vaccination
4667734|NCT03443427|Immunogenicity|immunogenicity
4667735|NCT03443414|COPD, bronchodilation, FEV1|copd, bronchodilation, fev1
4667736|NCT03443388|head injury from seizures|head injury from seizures
4667737|NCT03443388|seizures resulting in fall|seizures resulting in fall
4667738|NCT03443388|helmet for seizures|helmet for seizures
4667739|NCT03443388|novel helmet design|novel helmet design
4667740|NCT03443388|inflatable helmet|inflatable helmet
4667741|NCT03443388|Hovding Inc|hovding inc
4667742|NCT03443388|helmet|helmet
4667743|NCT03443388|device|device
4667744|NCT03443375|Older adults|older adults
4667745|NCT03443375|Physical function|physical function
4667746|NCT03443375|Muscle mass|muscle mass
4667747|NCT03443375|Short-term memory|short-term memory
4667748|NCT03443375|Executive function|executive function
4667749|NCT03443375|Blood Pressure|blood pressure
4667750|NCT03443375|Resistance training|resistance training
4667751|NCT03443375|Exercise training|exercise training
4667752|NCT03443375|Periodization|periodization
4667753|NCT03443362|Chronic Urticaria|chronic urticaria
4667754|NCT03443362|Endothelial cells|endothelial cells
4667755|NCT03443349|Delivering Women|delivering women
4667756|NCT03443323|Executive Function|executive function
4667757|NCT03443323|Behavioral Research|behavioral research
4667758|NCT03443323|Cost Analysis|cost analysis
4667759|NCT03443323|Students|students
4667760|NCT03443323|Schools|schools
4667761|NCT03443323|Randomized Controlled Trial|randomized controlled trial
4667762|NCT03443323|Behavior Therapy|behavior therapy
4667763|NCT03443310|DVT|dvt
4667764|NCT03443310|TKA|tka
4667765|NCT03443310|THA|tha
4667766|NCT03443310|Hip Fracture|hip fracture
4667767|NCT03443310|High risk|high risk
4667768|NCT03443310|Ultrasound|ultrasound
4667769|NCT03443310|U/S|u/s
4667770|NCT03443284|Total Knee Arthroplasty|total knee arthroplasty
4667771|NCT03443284|Total Hip Arthroplasty|total hip arthroplasty
4667772|NCT03443284|Total Knee Replacement|total knee replacement
4667773|NCT03443284|Total Hip Replacement|total hip replacement
4667774|NCT03443284|Hospital Care Plan|hospital care plan
4667775|NCT03443284|mHealth|mhealth
4667776|NCT03443271|transversus abdominis plane block|transversus abdominis plane block
4667777|NCT03443271|abdominal hysterectomy|abdominal hysterectomy
4667778|NCT03443271|stress response|stress response
4667779|NCT03443219|Airway Management|airway management
4667780|NCT03443219|Extraglottic airway device|extraglottic airway device
4667781|NCT03443219|Laryngeal mask airway|laryngeal mask airway
4667782|NCT03443219|Spritztube|spritztube
4667783|NCT03443206|adolescent|adolescent
4667784|NCT03443206|mental health|mental health
4667785|NCT03443206|social media|social media
4667786|NCT03443193|aerobic exercise training|aerobic exercise training
4667787|NCT03443193|periodization|periodization
4667788|NCT03443193|cerebral oxygenation and perfusion|cerebral oxygenation and perfusion
4667789|NCT03443193|cognition|cognition
4667790|NCT03443180|Siblings|siblings
4667791|NCT03443167|Cardiopulmonary Resuscitation|cardiopulmonary resuscitation
4667792|NCT03443167|Teaching Material|teaching material
4667793|NCT03443167|Primary education|primary education
4667794|NCT03443154|Cerclage|cerclage
4667795|NCT03443154|Preterm birth|preterm birth
4667796|NCT03443128|Anaplastic Large Cell Lymphoma|anaplastic large cell lymphoma
4667797|NCT03443128|Recurrent|recurrent
4667798|NCT03443128|Childhood|childhood
4667799|NCT03443128|Adolescent|adolescent
4667800|NCT03443128|Treatment|treatment
4667801|NCT03443089|medroxyprogesterone acetate|medroxyprogesterone acetate
4667802|NCT03443089|estradiol cypionate|estradiol cypionate
4667803|NCT03443089|bioavailability|bioavailability
4667804|NCT03443089|monthly contraceptive|monthly contraceptive
4667805|NCT03443063|severe renal impairment|severe renal impairment
4667806|NCT03443063|lemborexant|lemborexant
4667807|NCT03443063|normal renal function|normal renal function
4667808|NCT03443063|healthy participants|healthy participants
4667809|NCT03443063|metabolites|metabolites
4667810|NCT03443063|E2006|e2006
4667811|NCT03443063|pharmacokinetics|pharmacokinetics
4667812|NCT03443037|Coma|coma
4667813|NCT03443037|Disability|disability
4667814|NCT03443037|amantadine|amantadine
4667815|NCT03443024|Eczema|eczema
4667816|NCT03442985|Multiple osteochondromas|multiple osteochondromas
4667817|NCT03442985|Osteochondroma|osteochondroma
4667818|NCT03442985|Palovarotene|palovarotene
4667819|NCT03442985|Hereditary multiple exostoses|hereditary multiple exostoses
4667820|NCT03442985|HME|hme
4667821|NCT03442985|MO|mo
4667822|NCT03442985|Retinoic acid receptor gamma agonist|retinoic acid receptor gamma agonist
4667823|NCT03442985|Retinoic acid receptor agonist|retinoic acid receptor agonist
4667824|NCT03442972|Intestinal lipoprotein|intestinal lipoprotein
4667825|NCT03442972|Duodenal biopsy|duodenal biopsy
4667826|NCT03442972|Gut Peptide|gut peptide
4667827|NCT03442972|Chylomicrons|chylomicrons
4667828|NCT03442959|Small intestine neuroendocrine tumor|small intestine neuroendocrine tumor
4667829|NCT03442959|palliative surgery|palliative surgery
4667830|NCT03442946|nutrition guidelines|nutrition guidelines
4667831|NCT03442946|critical care|critical care
4667832|NCT03442946|cardiovascular|cardiovascular
4667833|NCT03442946|nutrition therapy|nutrition therapy
4667834|NCT03442933|Muscle Fatigue|muscle fatigue
4667835|NCT03442933|Cycling|cycling
4667836|NCT03442933|MTB|mtb
4667837|NCT03442933|Tensiomiography|tensiomiography
4667838|NCT03442920|obesity|obesity
4667839|NCT03442920|periodontal diseases|periodontal diseases
4667840|NCT03442920|gingival crevicular fluid|gingival crevicular fluid
4667841|NCT03442920|saliva|saliva
4667842|NCT03442920|serum|serum
4667843|NCT03442894|Shoulder pain|shoulder pain
4667844|NCT03442894|Subacromial|subacromial
4667845|NCT03442894|bursitis|bursitis
4667846|NCT03442894|rotator cuff|rotator cuff
4667847|NCT03442894|tendinopathy|tendinopathy
4667848|NCT03442894|dry needling|dry needling
4667849|NCT03442894|myofascial trigger point|myofascial trigger point
4667850|NCT03442855|Arthroplasty, Replacement, Hip|arthroplasty, replacement, hip
4667851|NCT03442829|sweet taste, food preferences, food intake|sweet taste, food preferences, food intake
4667852|NCT03442803|sedation|sedation
4667853|NCT03442803|Emergency Department|emergency department
4667854|NCT03442803|Target Controlled infusion|target controlled infusion
4667855|NCT03442803|propofol|propofol
4667856|NCT03442790|CVC confirmation|cvc confirmation
4667857|NCT03442790|Agitated Saline|agitated saline
4667858|NCT03442790|CXR|cxr
4667859|NCT03442738|ADR|adr
4667860|NCT03442738|adenoma|adenoma
4667861|NCT03442738|polyp|polyp
4667862|NCT03442738|colon|colon
4667863|NCT03442738|screening|screening
4667864|NCT03442738|colorectal carcinoma (CRC)|colorectal carcinoma (crc)
4667865|NCT03442738|cap|cap
4667866|NCT03442738|endoscopy|endoscopy
4667867|NCT03442738|colonoscopy|colonoscopy
4667868|NCT03442738|private practice|private practice
4667869|NCT03442712|obesity|obesity
4667870|NCT03442712|weight loss|weight loss
4667871|NCT03442712|ear acupressure|ear acupressure
4667872|NCT03442712|smartphone application|smartphone application
4667873|NCT03442699|cognitive behavioral therapy|cognitive behavioral therapy
4667874|NCT03442699|suicidal ideology|suicidal ideology
4667875|NCT03442699|suicidal behavior|suicidal behavior
4667876|NCT03442673|Multiple Myeloma|multiple myeloma
4667877|NCT03442673|Vinorelbine|vinorelbine
4667878|NCT03442673|Gemcitabine|gemcitabine
4667879|NCT03442673|G-CSF|g-csf
4667880|NCT03442673|ASCT|asct
4667881|NCT03442634|bowel movements|bowel movements
4667882|NCT03442634|cesarean section|cesarean section
4667883|NCT03442634|oral hydration|oral hydration
4667884|NCT03442543|sentinel lymph node biopsy|sentinel lymph node biopsy
4667885|NCT03442530|pregnancy, smoking cessation, tobacco, preterm birth, ToPIC|pregnancy, smoking cessation, tobacco, preterm birth, topic
4667886|NCT03442517|group-based counseling|group-based counseling
4667887|NCT03442517|phone counseling|phone counseling
4667888|NCT03442517|conference calls|conference calls
4667889|NCT03442504|metastatic Breast cancer|metastatic breast cancer
4667890|NCT03442504|FES PET/CT|fes pet/ct
4667891|NCT03442504|menopausal patients|menopausal patients
4667892|NCT03442504|recurrence after a 1st line of hormone therapy|recurrence after a 1st line of hormone therapy
4667893|NCT03442491|Postpartum Hemorrhage|postpartum hemorrhage
4667894|NCT03442491|Hayman's Haemostatic Suture|hayman's haemostatic suture
4667895|NCT03442465|18-014|18-014
4667896|NCT03442465|Memorial Sloan Kettering Cancer Center|memorial sloan kettering cancer center
4667897|NCT03442439|Family Nurture Intervention|family nurture intervention
4667898|NCT03442439|Martha G. Welch MD|martha g. welch md
4667899|NCT03442439|Randomized Controlled Trial|randomized controlled trial
4667900|NCT03442439|Preschool Intervention|preschool intervention
4667901|NCT03442439|Pre-school Intervention|pre-school intervention
4667902|NCT03442439|Multiple Family Group Intervention|multiple family group intervention
4667903|NCT03442439|Emotional Connection|emotional connection
4667904|NCT03442439|Co-regulation|co-regulation
4667905|NCT03442426|Primary Health Care|primary health care
4667906|NCT03442426|Frail Elderly|frail elderly
4667907|NCT03442426|Qualitative Methods|qualitative methods
4667908|NCT03442426|Quantitative Methods|quantitative methods
4667909|NCT03442426|Cost-Benefit Analysis|cost-benefit analysis
4667910|NCT03442426|Patient Participation|patient participation
4667911|NCT03442400|Coronary Artery Stenoses|coronary artery stenoses
4667912|NCT03442400|Aortic Stenosis|aortic stenosis
4667913|NCT03442374|Multifidus|multifidus
4667914|NCT03442374|Muscle|muscle
4667915|NCT03442374|Degeneration|degeneration
4667916|NCT03442374|Lumbar Spine|lumbar spine
4667917|NCT03442374|Disc|disc
4667918|NCT03442348|Omega 3|omega 3
4667919|NCT03442348|Fibre|fibre
4667920|NCT03442348|Gut microbiome|gut microbiome
4667921|NCT03442348|Metabolic profile|metabolic profile
4667922|NCT03442348|Dietary intervention|dietary intervention
4667923|NCT03442348|Randomised Control Trial|randomised control trial
4667924|NCT03442335|embryo implantation|embryo implantation
4667925|NCT03442335|endometrial receptivity|endometrial receptivity
4667926|NCT03442335|chromohysteroscopy|chromohysteroscopy
4667927|NCT03442335|transcriptomics|transcriptomics
4667928|NCT03442335|proteomics|proteomics
4667929|NCT03442335|metabolomics|metabolomics
4667930|NCT03442335|implantation window|implantation window
4667931|NCT03442335|luteal phase|luteal phase
4667932|NCT03442322|long term care residents|long term care residents
4667933|NCT03442322|nursing home care|nursing home care
4667934|NCT03442309|dental caries|dental caries
4667935|NCT03442309|caries arrest|caries arrest
4667936|NCT03442309|caries prevention|caries prevention
4667937|NCT03442309|quality of life|quality of life
4667938|NCT03442309|silver diamine fluoride|silver diamine fluoride
4667939|NCT03442309|sealants|sealants
4667940|NCT03442309|interim therapeutic restorations|interim therapeutic restorations
4667941|NCT03442309|student achievement|student achievement
4667942|NCT03442309|school attendance|school attendance
4667943|NCT03442283|Supplements, Cardiovascular Diseases, All-cause mortality, Meta-Analysis|supplements, cardiovascular diseases, all-cause mortality, meta-analysis
4667944|NCT03442270|Serrated Adenoma, Colonoscopy|serrated adenoma, colonoscopy
4667945|NCT03442257|Hypertension|hypertension
4667946|NCT03442257|Text Messaging|text messaging
4667947|NCT03442257|Primary Prevention|primary prevention
4667948|NCT03442257|Cardiovascular Risk Factor|cardiovascular risk factor
4667949|NCT03442257|Primary Health Care|primary health care
4667950|NCT03442257|Health Promotion|health promotion
4667951|NCT03442231|osteoarthritis|osteoarthritis
4667952|NCT03442231|traumatic arthritis|traumatic arthritis
4667953|NCT03442231|avascular necrosis|avascular necrosis
4667954|NCT03442218|Cesarean|cesarean
4667955|NCT03442218|Operative site infection|operative site infection
4667956|NCT03442218|Vaginal wash|vaginal wash
4667957|NCT03442218|Clorhexidine|clorhexidine
4667958|NCT03442218|Endometritis|endometritis
4667959|NCT03442205|Common Bile Duct Stone;|common bile duct stone;
4667960|NCT03442205|Laparoscopic Common Bile Duct Exploration;|laparoscopic common bile duct exploration;
4667961|NCT03442205|ERCP;|ercp;
4667962|NCT03442192|PrEP|prep
4667963|NCT03442192|virtual|virtual
4667964|NCT03442192|adherence|adherence
4667965|NCT03442192|retention|retention
4667966|NCT03442179|Aging|aging
4667967|NCT03442179|Anesthesia|anesthesia
4667968|NCT03442179|EEG monitoring|eeg monitoring
4667969|NCT03442179|Burst suppression|burst suppression
4667970|NCT03442140|COPD|copd
4667971|NCT03442140|Shortness of breath|shortness of breath
4667972|NCT03442140|Harmonica|harmonica
4667973|NCT03442114|shared decision making|shared decision making
4667974|NCT03442114|parent-provider communication|parent-provider communication
4667975|NCT03442114|hydroxyurea|hydroxyurea
4667976|NCT03442114|sickle cell disease|sickle cell disease
4667977|NCT03442075|Cancer of Prostate|cancer of prostate
4667978|NCT03442075|Analgesic method|analgesic method
4667979|NCT03442062|quality improvement|quality improvement
4667980|NCT03442062|HPV vaccine|hpv vaccine
4667981|NCT03442049|Multiple Sclerosis|multiple sclerosis
4667982|NCT03442049|Gait|gait
4667983|NCT03442049|Spinal Stabilization Exercises|spinal stabilization exercises
4667984|NCT03442049|Plantar Pressure Distribution|plantar pressure distribution
4667985|NCT03442049|Rehabilitation|rehabilitation
4667986|NCT03442036|Regional Anesthesia|regional anesthesia
4667987|NCT03442036|Sciatic Nerve Block|sciatic nerve block
4667988|NCT03442036|Continuous Nerve Block|continuous nerve block
4667989|NCT03442036|Perineural Catheter|perineural catheter
4667990|NCT03442023|Chlorhexidine|chlorhexidine
4667991|NCT03442023|Gram-negative|gram-negative
4667992|NCT03442023|Colonization|colonization
4667993|NCT03442010|Emergency department|emergency department
4667994|NCT03442010|Clinical Pharmacist|clinical pharmacist
4667995|NCT03442010|Adverse drug event|adverse drug event
4667996|NCT03441997|exercise|exercise
4667997|NCT03441997|low intensity exercise|low intensity exercise
4667998|NCT03441997|pain|pain
4667999|NCT03441997|fatigue|fatigue
4668000|NCT03441997|sleep problems|sleep problems
4668001|NCT03441984|Pediatric dispersible tablets|pediatric dispersible tablets
4668002|NCT03441984|Bioavailability|bioavailability
4668003|NCT03441958|hematopoietic stem cell transplant|hematopoietic stem cell transplant
4668004|NCT03441958|Expanded cord blood|expanded cord blood
4668005|NCT03441945|Magnetic|magnetic
4668006|NCT03441945|Capsule Endoscopy|capsule endoscopy
4668007|NCT03441945|enhance|enhance
4668008|NCT03441945|gastric emptying|gastric emptying
4668009|NCT03441932|Dysphagia|dysphagia
4668010|NCT03441932|Pharyngeal residue scale|pharyngeal residue scale
4668011|NCT03441932|Stroke|stroke
4668012|NCT03441932|Pneumonia|pneumonia
4668013|NCT03441893|ulcerative colitis, intestinal parasites, helminths, intestinal protozoan, nitazoxanide, mesalazine, combination therapy|ulcerative colitis, intestinal parasites, helminths, intestinal protozoan, nitazoxanide, mesalazine, combination therapy
4668014|NCT03441867|Cognitive Behavioral Therapy|cognitive behavioral therapy
4668015|NCT03441867|Veterans|veterans
4668016|NCT03441867|Quality of Life|quality of life
4668017|NCT03441867|Stress Disorders, Post-Traumatic|stress disorders, post-traumatic
4668018|NCT03441867|Convulsion, Non-Epileptic|convulsion, non-epileptic
4668019|NCT03441867|civilians|civilians
4668020|NCT03441854|Gas exchange|gas exchange
4668021|NCT03441854|Non invasive ventilation|non invasive ventilation
4668022|NCT03441854|Liver transplantation|liver transplantation
4668023|NCT03441841|local anesthetics|local anesthetics
4668024|NCT03441841|pharmacokinetics|pharmacokinetics
4668025|NCT03441841|nanotechnology|nanotechnology
4668026|NCT03441815|Healthy volunteers|healthy volunteers
4668027|NCT03441815|Phase I|phase i
4668028|NCT03441815|Histamine glutarimide|histamine glutarimide
4668029|NCT03441815|PHARMENTERPRISES|pharmenterprises
4668030|NCT03441776|TBI|tbi
4668031|NCT03441776|Rehabilitation|rehabilitation
4668032|NCT03441776|Vestibular|vestibular
4668033|NCT03441776|Dizziness|dizziness
4668034|NCT03441763|Foot pressure, Obese, and normal Subjects|foot pressure, obese, and normal subjects
4668035|NCT03441737|Aerobic exercise|aerobic exercise
4668036|NCT03441737|Antisaccades|antisaccades
4668037|NCT03441737|Urge to Smoke|urge to smoke
4668038|NCT03441737|Adults|adults
4668039|NCT03441672|Prenatal Screening|prenatal screening
4668040|NCT03441672|Interactive educational technology|interactive educational technology
4668041|NCT03441633|atrial fibrillation|atrial fibrillation
4668042|NCT03441633|apixaban|apixaban
4668043|NCT03441633|stroke|stroke
4668044|NCT03441594|Food Insecurity|food insecurity
4668045|NCT03441581|IBS-D|ibs-d
4668046|NCT03441581|BAM|bam
4668047|NCT03441555|Cancer|cancer
4668048|NCT03441555|Acute Myeloid Leukemia (AML)|acute myeloid leukemia (aml)
4668049|NCT03441555|relapsed Acute Myeloid Leukemia|relapsed acute myeloid leukemia
4668050|NCT03441555|refractory Acute Myeloid Leukemia|refractory acute myeloid leukemia
4668051|NCT03441542|Care cascade|care cascade
4668052|NCT03441542|Patient navigation services|patient navigation services
4668053|NCT03441542|Injection drug users|injection drug users
4668054|NCT03441542|Opioid substitution therapy|opioid substitution therapy
4668055|NCT03441490|Learning Support|learning support
4668056|NCT03441490|Chat|chat
4668057|NCT03441490|Adolescents|adolescents
4668058|NCT03441464|Fluorescence|fluorescence
4668059|NCT03441464|Prostate|prostate
4668060|NCT03441464|Cancer detection|cancer detection
4668061|NCT03441451|Bariatric Surgery|bariatric surgery
4668062|NCT03441438|alcohol sensitivity|alcohol sensitivity
4668063|NCT03441438|red wine|red wine
4668064|NCT03441438|aerd|aerd
4668065|NCT03441425|CRM Skills|crm skills
4668066|NCT03441425|ACLS|acls
4668067|NCT03441425|Simulation|simulation
4668068|NCT03441425|Stress|stress
4668069|NCT03441399|Medication Adherence|medication adherence
4668070|NCT03441360|eribulin mesylate|eribulin mesylate
4668071|NCT03441360|pediatric|pediatric
4668072|NCT03441347|Physical therapy|physical therapy
4668073|NCT03441347|Occupational therapy|occupational therapy
4668074|NCT03441347|Rehabilitation|rehabilitation
4668075|NCT03441347|Motor control|motor control
4668076|NCT03441308|Dieting|dieting
4668077|NCT03441308|learning to eat|learning to eat
4668078|NCT03441308|group treatment|group treatment
4668079|NCT03441295|ACL|acl
4668080|NCT03441269|Emergency Medicine|emergency medicine
4668081|NCT03441269|Acute Pain|acute pain
4668082|NCT03441269|Oral Ibuprofen|oral ibuprofen
4668083|NCT03441230|stomach|stomach
4668084|NCT03441230|motility|motility
4668085|NCT03441217|Duration of labor|duration of labor
4668086|NCT03441217|Hyoscine butylbromide|hyoscine butylbromide
4668087|NCT03441204|COPD|copd
4668088|NCT03441204|Long-term oxygen therapy (LTOT)|long-term oxygen therapy (ltot)
4668089|NCT03441204|Registry|registry
4668090|NCT03441204|Registry-based randomized controlled trial (R-RCT)|registry-based randomized controlled trial (r-rct)
4668091|NCT03441204|Treatment duration|treatment duration
4668092|NCT03441204|Mortality|mortality
4668093|NCT03441165|ACL|acl
4668094|NCT03441165|MAT|mat
4668095|NCT03441165|REVISION|revision
4668096|NCT03441165|LAXITY|laxity
4668097|NCT03441152|Mild Cognitive Impairment|mild cognitive impairment
4668098|NCT03441152|Neuromodulation|neuromodulation
4668099|NCT03441139|Randomized controlled trial|randomized controlled trial
4668100|NCT03441139|Musculoskeletal metastasis|musculoskeletal metastasis
4668101|NCT03441139|Cancer pain|cancer pain
4668102|NCT03441139|Percutaneous cryotherapy|percutaneous cryotherapy
4668103|NCT03441139|Medical supportive care|medical supportive care
4668104|NCT03441126|Diagnostic Stewardship|diagnostic stewardship
4668105|NCT03441126|Pediatric|pediatric
4668106|NCT03441126|Blood Culture Test|blood culture test
4668107|NCT03441100|T-Cell therapy|t-cell therapy
4668108|NCT03441100|Immunotherapy|immunotherapy
4668109|NCT03441100|Adoptive cellular therapy|adoptive cellular therapy
4668110|NCT03441100|T-Cell Receptor|t-cell receptor
4668111|NCT03441100|Cell Therapy|cell therapy
4668112|NCT03441100|Cytotherapy|cytotherapy
4668113|NCT03441100|IMA202|ima202
4668114|NCT03441087|transvaginal ultrasonography|transvaginal ultrasonography
4668115|NCT03441087|hysteroscopy|hysteroscopy
4668116|NCT03441087|abnormal uterine bleeding|abnormal uterine bleeding
4668117|NCT03441061|Malignant neoplasms stated as primary lymphoid haematopoietic|malignant neoplasms stated as primary lymphoid haematopoietic
4668118|NCT03441061|Acute Lymphocytic Leukemia|acute lymphocytic leukemia
4668119|NCT03441061|ALL|all
4668120|NCT03441061|Inotuzumab Ozogamicin|inotuzumab ozogamicin
4668121|NCT03441061|CMC-544|cmc-544
4668122|NCT03441048|Acute myeloid leukemia|acute myeloid leukemia
4668123|NCT03441048|Relapsed/refractory acute myeloid leukemia|relapsed/refractory acute myeloid leukemia
4668124|NCT03441048|CLAG-M|clag-m
4668125|NCT03441048|Lintuzumab|lintuzumab
4668126|NCT03441022|Cardioversion|cardioversion
4668127|NCT03441022|BodyGuardian|bodyguardian
4668128|NCT03441022|Amiigo Wristband|amiigo wristband
4668129|NCT03441009|PSH, Rehabilitation, Medication, ANS|psh, rehabilitation, medication, ans
4668130|NCT03440996|toothpaste|toothpaste
4668131|NCT03440983|optimize the imaging protocols|optimize the imaging protocols
4668132|NCT03440983|validate technical parameters in healthy volunteers|validate technical parameters in healthy volunteers
4668133|NCT03440970|Chloride homeostasisH|chloride homeostasish
4668134|NCT03440957|advanced cancer|advanced cancer
4668135|NCT03440957|osteopathy|osteopathy
4668136|NCT03440957|pain|pain
4668137|NCT03440957|bedridden|bedridden
4668138|NCT03440944|vascular access|vascular access
4668139|NCT03440944|midline cather|midline cather
4668140|NCT03440944|ultrasound guided IV|ultrasound guided iv
4668141|NCT03440918|Infection|infection
4668142|NCT03440892|survivin|survivin
4668143|NCT03440892|biomarker of pharmacological response|biomarker of pharmacological response
4668144|NCT03440892|antirheumatic treatment|antirheumatic treatment
4668145|NCT03440892|methotrexate|methotrexate
4668146|NCT03440892|sulfasalazin|sulfasalazin
4668147|NCT03440892|abatacept|abatacept
4668148|NCT03440892|tocilizumab|tocilizumab
4668149|NCT03440892|tofacitinib/baricitinib|tofacitinib/baricitinib
4668150|NCT03440827|low-flow vascular malformations, scale of life's quality|low-flow vascular malformations, scale of life's quality
4668151|NCT03440814|PWS|pws
4668152|NCT03440814|Prader-Willi Syndrome|prader-willi syndrome
4668153|NCT03440762|Screening|screening
4668154|NCT03440762|Education|education
4668155|NCT03440762|AFib Awareness|afib awareness
4668156|NCT03440762|Stroke prevention|stroke prevention
4668157|NCT03440749|rhythm|rhythm
4668158|NCT03440749|serial Reaction Time Task|serial reaction time task
4668159|NCT03440736|Psoriasis|psoriasis
4668160|NCT03440736|Metabolic syndrome|metabolic syndrome
4668161|NCT03440736|Diabetes|diabetes
4668162|NCT03440736|Obesity|obesity
4668163|NCT03440736|Life-style|life-style
4668164|NCT03440736|Life-style intervention|life-style intervention
4668165|NCT03440736|Secukinumab|secukinumab
4668166|NCT03440736|CAIN457A|cain457a
4668167|NCT03440736|CAIN457ADE08|cain457ade08
4668168|NCT03440736|AIN457A|ain457a
4668169|NCT03440736|Skin condition|skin condition
4668170|NCT03440736|skin disease|skin disease
4668171|NCT03440736|itching condition|itching condition
4668172|NCT03440736|psoriasis vulgaris|psoriasis vulgaris
4668173|NCT03440736|relapsing/remitting psoriasis|relapsing/remitting psoriasis
4668174|NCT03440736|immune-mediated systemic disease|immune-mediated systemic disease
4668175|NCT03440736|skin lesions|skin lesions
4668176|NCT03440736|red skin lesions|red skin lesions
4668177|NCT03440736|scaly patches|scaly patches
4668178|NCT03440736|papules|papules
4668179|NCT03440736|plaques|plaques
4668180|NCT03440736|itching|itching
4668181|NCT03440723|Cervical Dilation|cervical dilation
4668182|NCT03440723|Dilation|dilation
4668183|NCT03440723|Sterile vaginal examination|sterile vaginal examination
4668184|NCT03440697|Cardiovascular Disease|cardiovascular disease
4668185|NCT03440684|Core stability, hand, function, balance, strength|core stability, hand, function, balance, strength
4668186|NCT03440658|brachial plexus palsy|brachial plexus palsy
4668187|NCT03440658|isokinetics|isokinetics
4668188|NCT03440658|shoulder|shoulder
4668189|NCT03440658|strenght|strenght
4668190|NCT03440606|Randomized Wait-List Control Trial|randomized wait-list control trial
4668191|NCT03440606|Mindful-Compassion Art Therapy Supervision|mindful-compassion art therapy supervision
4668192|NCT03440606|End-of-Life Care|end-of-life care
4668193|NCT03440606|Self-Care|self-care
4668194|NCT03440593|sepsis|sepsis
4668195|NCT03440593|nutrition|nutrition
4668196|NCT03440593|indirect calorimetry|indirect calorimetry
4668197|NCT03440593|muscle thickness|muscle thickness
4668198|NCT03440580|physical activity|physical activity
4668199|NCT03440580|serious game|serious game
4668200|NCT03440580|school intervention|school intervention
4668201|NCT03440580|children|children
4668202|NCT03440554|Prostate Cancer|prostate cancer
4668203|NCT03440554|Restriction spectrum imaging|restriction spectrum imaging
4668204|NCT03440554|Magnetic resonance imaging|magnetic resonance imaging
4668205|NCT03440554|MRI|mri
4668206|NCT03440554|RSI|rsi
4668207|NCT03440541|Amniotic membrane|amniotic membrane
4668208|NCT03440541|Psoriasis|psoriasis
4668209|NCT03440541|Treatment|treatment
4668210|NCT03440528|Skin ulcer, Human amniotic membrane, Treatment|skin ulcer, human amniotic membrane, treatment
4668211|NCT03440515|gastrointestinal stromal tumor|gastrointestinal stromal tumor
4668212|NCT03440515|skin rash|skin rash
4668213|NCT03440515|imatinib|imatinib
4668214|NCT03440502|spinal anaesthesia|spinal anaesthesia
4668215|NCT03440502|cesarean section|cesarean section
4668216|NCT03440502|diabetes mellitus|diabetes mellitus
4668217|NCT03440450|Liposomal gemcitabine|liposomal gemcitabine
4668218|NCT03440437|FS118|fs118
4668219|NCT03440437|Immuno-oncology|immuno-oncology
4668220|NCT03440437|bispecific antibody|bispecific antibody
4668221|NCT03440437|check-point inhibitor|check-point inhibitor
4668222|NCT03440437|dose escalation|dose escalation
4668223|NCT03440437|cohort expansion|cohort expansion
4668224|NCT03440437|PK|pk
4668225|NCT03440437|PD|pd
4668226|NCT03440437|biomarker|biomarker
4668227|NCT03440424|mild hepatic impairment|mild hepatic impairment
4668228|NCT03440424|moderate hepatic impairment|moderate hepatic impairment
4668229|NCT03440424|lemborexant|lemborexant
4668230|NCT03440424|healthy participants|healthy participants
4668231|NCT03440424|metabolites|metabolites
4668232|NCT03440424|E2006|e2006
4668233|NCT03440424|pharmacokinetics|pharmacokinetics
4668234|NCT03440411|biochemical relapse|biochemical relapse
4668235|NCT03440398|Robotic Mastectomy|robotic mastectomy
4668236|NCT03440398|Nipple Sparing Mastectomy|nipple sparing mastectomy
4668237|NCT03440398|Conservative mastectomy|conservative mastectomy
4668238|NCT03440398|Breast reconstruction|breast reconstruction
4668239|NCT03440385|Crohn's Disease|crohn's disease
4668240|NCT03440385|Crohn Disease|crohn disease
4668241|NCT03440385|Oral|oral
4668242|NCT03440385|Ozanimod|ozanimod
4668243|NCT03440385|Moderately active|moderately active
4668244|NCT03440385|Severely active|severely active
4668245|NCT03440385|RPC01|rpc01
4668246|NCT03440385|RPC01-3202|rpc01-3202
4668247|NCT03440372|Crohn's Disease|crohn's disease
4668248|NCT03440372|Crohn Disease|crohn disease
4668249|NCT03440372|Oral|oral
4668250|NCT03440372|Ozanimod|ozanimod
4668251|NCT03440372|Moderately active|moderately active
4668252|NCT03440372|Severely active|severely active
4668253|NCT03440372|RPC01|rpc01
4668254|NCT03440372|RPC01-3201|rpc01-3201
4668255|NCT03440359|PCOS, crinone, vaginal progesterone, ovulation induction|pcos, crinone, vaginal progesterone, ovulation induction
4668256|NCT03440346|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
4668257|NCT03440346|ADHD|adhd
4668258|NCT03440346|child|child
4668259|NCT03440346|human|human
4668260|NCT03440346|diet|diet
4668261|NCT03440346|few-foods diet|few-foods diet
4668262|NCT03440346|brain|brain
4668263|NCT03440346|gut|gut
4668264|NCT03440346|microbiota|microbiota
4668265|NCT03440320|Caregiving Dyad|caregiving dyad
4668266|NCT03440320|Pain-related Disability|pain-related disability
4668267|NCT03440294|windsurfer|windsurfer
4668268|NCT03440294|neoprene suit|neoprene suit
4668269|NCT03440294|spirometry|spirometry
4668270|NCT03440294|cardiopulmonary exercise testing|cardiopulmonary exercise testing
4668271|NCT03440268|cardiac surgery|cardiac surgery
4668272|NCT03440268|post operatory complications|post operatory complications
4668273|NCT03440268|Acute kidney injury|acute kidney injury
4668274|NCT03440268|N-acetylcystein|n-acetylcystein
4668275|NCT03440255|Transcutaneous Vagus nerve Stimulation|transcutaneous vagus nerve stimulation
4668276|NCT03440255|Generalized Anxiety Disorder|generalized anxiety disorder
4668277|NCT03440255|Chronic Pain|chronic pain
4668278|NCT03440255|Irritable Bowel Syndrome|irritable bowel syndrome
4668279|NCT03440255|Private Practice|private practice
4668280|NCT03440216|temocillin|temocillin
4668281|NCT03440216|ceftriaxone|ceftriaxone
4668282|NCT03440216|meropenem|meropenem
4668283|NCT03440216|pharmacokinetics|pharmacokinetics
4668284|NCT03440216|pharmacodynamics|pharmacodynamics
4668285|NCT03440216|Intensive Care|intensive care
4668286|NCT03440216|dosing|dosing
4668287|NCT03440216|total concentration|total concentration
4668288|NCT03440216|free concentration|free concentration
4668289|NCT03440190|Bariatric surgery|bariatric surgery
4668290|NCT03440190|Gastrointestinal tract|gastrointestinal tract
4668291|NCT03440190|Biological availability|biological availability
4668292|NCT03440190|Pharmacokinetics|pharmacokinetics
4668293|NCT03440190|Methylphenidate|methylphenidate
4668294|NCT03440177|Bariatric surgery|bariatric surgery
4668295|NCT03440177|Gastrointestinal tract|gastrointestinal tract
4669690|NCT03431974|Anti-folate|anti-folate
4668296|NCT03440177|Biological availability|biological availability
4668297|NCT03440177|Pharmacokinetics|pharmacokinetics
4668298|NCT03440177|Ramipril|ramipril
4668299|NCT03440164|liver fibrosis|liver fibrosis
4668300|NCT03440164|Hepatoprotective|hepatoprotective
4668301|NCT03440164|Sylimarin|sylimarin
4668302|NCT03440151|Tongue Squamous Cell Carcinoma,|tongue squamous cell carcinoma,
4668303|NCT03440151|Contralateral Submental Flap|contralateral submental flap
4668304|NCT03440151|Submental Flap|submental flap
4668305|NCT03440151|oncological safety|oncological safety
4668306|NCT03440125|Low Back Pain|low back pain
4668307|NCT03440125|Capsicum|capsicum
4668308|NCT03440125|Physical Therapy|physical therapy
4668309|NCT03440125|Pain|pain
4668310|NCT03440112|Gait|gait
4668311|NCT03440112|Balance|balance
4668312|NCT03440112|GABA|gaba
4668313|NCT03440112|Clarithromycin|clarithromycin
4668314|NCT03440112|PET Imaging|pet imaging
4668315|NCT03440112|MRI|mri
4668316|NCT03440112|Mobility|mobility
4668317|NCT03440099|Resistance Training|resistance training
4668318|NCT03440099|Sex Differences|sex differences
4668319|NCT03440086|Laparoscopic surgery|laparoscopic surgery
4668320|NCT03440086|Pain|pain
4668321|NCT03440086|Jackson-Pratt drain|jackson-pratt drain
4668322|NCT03440073|pregnancy|pregnancy
4668323|NCT03440073|pain|pain
4668324|NCT03440073|pelvis|pelvis
4668325|NCT03440073|spine|spine
4668326|NCT03440073|manual therapy|manual therapy
4668327|NCT03440060|procalcitonin|procalcitonin
4668328|NCT03440060|mechanical ventilation|mechanical ventilation
4668329|NCT03440060|COPD exacerbation|copd exacerbation
4668330|NCT03440047|endoscopic image|endoscopic image
4668331|NCT03440047|Fujifilm|fujifilm
4668332|NCT03440047|Blue light imaging|blue light imaging
4668333|NCT03440034|IBM|ibm
4668334|NCT03440034|inclusion body myositis|inclusion body myositis
4668335|NCT03440021|Noradrenalin Agents|noradrenalin agents
4668336|NCT03440021|Physiological Effects of Drugs|physiological effects of drugs
4668337|NCT03440021|Mood disorders|mood disorders
4668338|NCT03440021|Behavioral Symptoms|behavioral symptoms
4668339|NCT03439982|Hepatic encephalopathy, fecal microbiota transplant|hepatic encephalopathy, fecal microbiota transplant
4668340|NCT03439969|Gingivitis|gingivitis
4668341|NCT03439969|SMS|sms
4668342|NCT03439969|Text messages|text messages
4668343|NCT03439969|Behavior change|behavior change
4668344|NCT03439969|HAPA|hapa
4668345|NCT03439969|Dental Hygiene|dental hygiene
4668346|NCT03439956|Obstetric outcomes|obstetric outcomes
4668347|NCT03439956|Transvaginal specimen extraction|transvaginal specimen extraction
4668348|NCT03439956|Gynecological laparoscopy|gynecological laparoscopy
4668349|NCT03439904|pharmaceutical care|pharmaceutical care
4668350|NCT03439904|adherence|adherence
4668351|NCT03439852|physical activity|physical activity
4668352|NCT03439839|Complement, alternative pathway, paroxysmal nocturnal hemoglobinuria,|complement, alternative pathway, paroxysmal nocturnal hemoglobinuria,
4668353|NCT03439839|hemolysis|hemolysis
4668354|NCT03439813|stroke|stroke
4668355|NCT03439813|transient ischemic attack|transient ischemic attack
4668356|NCT03439813|anxiety|anxiety
4668357|NCT03439813|psychotherapy|psychotherapy
4668358|NCT03439787|Arthroplasty, Replacement, Knee|arthroplasty, replacement, knee
4668359|NCT03439787|Anesthetics, Local|anesthetics, local
4668360|NCT03439787|Pain, Postoperative|pain, postoperative
4668361|NCT03439787|Nerve Block|nerve block
4668362|NCT03439787|Bupivacaine|bupivacaine
4668363|NCT03439787|Epinephrine|epinephrine
4668364|NCT03439735|Breast Cancer|breast cancer
4668365|NCT03439735|Metastatic Breast Cancer|metastatic breast cancer
4668366|NCT03439735|Aromatase Inhibitors|aromatase inhibitors
4668367|NCT03439735|Palbociclib|palbociclib
4668368|NCT03439735|Hormone Receptor Positive Metastatic Breast Cancer|hormone receptor positive metastatic breast cancer
4668369|NCT03439722|cluster headache|cluster headache
4668370|NCT03439722|sleep disturbances|sleep disturbances
4668371|NCT03439709|acromegaly|acromegaly
4668372|NCT03439709|pituitary adenoma|pituitary adenoma
4668373|NCT03439709|gamma knife radiosurgery|gamma knife radiosurgery
4668374|NCT03439709|adjuvant treatment|adjuvant treatment
4668375|NCT03439696|Thoracoscopy|thoracoscopy
4668376|NCT03439696|VATS|vats
4668377|NCT03439696|Needlescopy|needlescopy
4668378|NCT03439696|Uniportal|uniportal
4668379|NCT03439670|Duchenne Muscular Dystrophy|duchenne muscular dystrophy
4668380|NCT03439670|Vamorolone|vamorolone
4668381|NCT03439657|HZ|hz
4668382|NCT03439657|Safety|safety
4668383|NCT03439657|Immunogenicity|immunogenicity
4668384|NCT03439657|Shingles|shingles
4668385|NCT03439657|Adults|adults
4668386|NCT03439657|Prevenar 13|prevenar 13
4668387|NCT03439605|Troponin-T|troponin-t
4668388|NCT03439605|Haemolysis|haemolysis
4668389|NCT03439579|Telehealth|telehealth
4668390|NCT03439579|Remote weight loss|remote weight loss
4668391|NCT03439579|Self-monitoring|self-monitoring
4668392|NCT03439579|Diet|diet
4668393|NCT03439579|Physical activity|physical activity
4668394|NCT03439566|pain measures|pain measures
4668395|NCT03439566|prediction of pain|prediction of pain
4668396|NCT03439566|pain management|pain management
4668397|NCT03439540|Plantago major|plantago major
4668398|NCT03439540|obesity|obesity
4669792|NCT03430960|healthcare|healthcare
4668399|NCT03439540|mineral content|mineral content
4668400|NCT03439540|adipose tissue|adipose tissue
4668401|NCT03439527|Muscle Precursor Cells|muscle precursor cells
4668402|NCT03439514|cardiomyopathy|cardiomyopathy
4668403|NCT03439514|Lamin Type A|lamin type a
4668404|NCT03439514|heart failure|heart failure
4668405|NCT03439514|ARRY-797|arry-797
4668406|NCT03439488|First in Human|first in human
4668407|NCT03439488|Healthy Volunteers|healthy volunteers
4668408|NCT03439488|Hepatitis B Virus|hepatitis b virus
4668409|NCT03439488|JNJ-64530440|jnj-64530440
4668410|NCT03439449|History taking, Risk stratification|history taking, risk stratification
4668411|NCT03439410|Internal medicine|internal medicine
4668412|NCT03439410|Chronic disease|chronic disease
4668413|NCT03439410|Healthcare expenditure|healthcare expenditure
4668414|NCT03439371|Acute Myeloid Leukemia|acute myeloid leukemia
4668415|NCT03439371|Micro-transplantation|micro-transplantation
4668416|NCT03439371|Elderly|elderly
4668417|NCT03439371|Graft-versus-leukemia|graft-versus-leukemia
4668418|NCT03439358|Epidural top-up|epidural top-up
4668419|NCT03439358|Shivering|shivering
4668420|NCT03439358|Magnesium|magnesium
4668421|NCT03439332|Highly infiltrative|highly infiltrative
4668422|NCT03439332|Deeply invasive|deeply invasive
4668423|NCT03439332|Strong vascular proliferation|strong vascular proliferation
4668424|NCT03439332|Robust angiogenesis|robust angiogenesis
4668425|NCT03439332|Vascular heterogeneity|vascular heterogeneity
4668426|NCT03439332|Perfusion Biormarker|perfusion biormarker
4668427|NCT03439332|Non-Invasive Biomarker|non-invasive biomarker
4668428|NCT03439332|Predictor of overall survival|predictor of overall survival
4668429|NCT03439332|Predictor of progression-free survival|predictor of progression-free survival
4668430|NCT03439319|MyndMove|myndmove
4668431|NCT03439319|Electrical neuromodulation|electrical neuromodulation
4668432|NCT03439319|conventional therapy|conventional therapy
4668433|NCT03439293|Drug Therapy|drug therapy
4668434|NCT03439293|Ixazomib|ixazomib
4668435|NCT03439293|Daratumumab|daratumumab
4668436|NCT03439293|Dexamethasone|dexamethasone
4668437|NCT03439280|Drug therapy|drug therapy
4668438|NCT03439254|Compensated Cirrhosis|compensated cirrhosis
4668439|NCT03439254|Nonalcoholic Steatohepatitis|nonalcoholic steatohepatitis
4668440|NCT03439254|Fatty Liver Disease|fatty liver disease
4668441|NCT03439254|NASH|nash
4668442|NCT03439215|ROS1 positive, NSCLC|ros1 positive, nsclc
4668443|NCT03439202|Hypoxia|hypoxia
4668444|NCT03439202|Baro-reflex sensitivity|baro-reflex sensitivity
4668445|NCT03439202|Low-intensity exercise|low-intensity exercise
4668446|NCT03439202|Hear rate variability|hear rate variability
4668447|NCT03439202|EEG|eeg
4668448|NCT03439202|Concentration performance|concentration performance
4668449|NCT03439150|Absolute flow measurement|absolute flow measurement
4668450|NCT03439150|Microvascular resistance|microvascular resistance
4668451|NCT03439150|Left ventricular function|left ventricular function
4668452|NCT03439111|Lycium chinense fruit|lycium chinense fruit
4668453|NCT03439085|Malignant Neoplasms of Digestive Organs|malignant neoplasms of digestive organs
4668454|NCT03439085|Malignant neoplasms of female genital organs|malignant neoplasms of female genital organs
4668455|NCT03439085|Malignant neoplasms of male genital organs|malignant neoplasms of male genital organs
4668456|NCT03439085|Human Papilloma Virus|human papilloma virus
4668457|NCT03439085|MEDI0457|medi0457
4668458|NCT03439085|Durvalumab|durvalumab
4668459|NCT03439085|MEDI4736|medi4736
4668460|NCT03439085|Electroporation|electroporation
4668461|NCT03439085|EP|ep
4668462|NCT03439072|glucagon|glucagon
4668463|NCT03439072|hypoglycemia|hypoglycemia
4668464|NCT03439059|Older adults|older adults
4668465|NCT03439059|Sedentary behaviour|sedentary behaviour
4668466|NCT03439059|Assisted living facility|assisted living facility
4668467|NCT03439059|cognitive function|cognitive function
4668468|NCT03439046|HHR-positive HER2-negative|hhr-positive her2-negative
4668469|NCT03439046|advanced breast cancer|advanced breast cancer
4668470|NCT03439046|LEE011|lee011
4668471|NCT03439046|ribociclib|ribociclib
4668472|NCT03439046|letrozole|letrozole
4668473|NCT03439046|CDK|cdk
4668474|NCT03439046|CDK4|cdk4
4668475|NCT03439046|CDK6|cdk6
4668476|NCT03439046|CDK4/6|cdk4/6
4668477|NCT03439046|Phase IIIb|phase iiib
4668478|NCT03439046|ER-positive|er-positive
4668479|NCT03439046|PR-positivel|pr-positivel
4668480|NCT03439046|postmenopausal|postmenopausal
4668481|NCT03439046|biomarker|biomarker
4668483|NCT03439046|liquid biopsy|liquid biopsy
4668484|NCT03439033|prostate cancer|prostate cancer
4668485|NCT03439007|Dehydration|dehydration
4668486|NCT03438994|autism|autism
4668487|NCT03438994|movement|movement
4668488|NCT03438994|tablet|tablet
4668489|NCT03438994|gameplay|gameplay
4668490|NCT03438981|Pharmacokinetics|pharmacokinetics
4668491|NCT03438981|Ceftriaxone|ceftriaxone
4668492|NCT03438981|critical illness|critical illness
4668493|NCT03438981|capillary leak|capillary leak
4668494|NCT03438981|hypoalbuminemia|hypoalbuminemia
4668495|NCT03438942|iron|iron
4668496|NCT03438942|folate|folate
4668497|NCT03438942|childbearing age|childbearing age
4668498|NCT03438942|bioavailability|bioavailability
4668499|NCT03438916|Non-selective beta-blocker|non-selective beta-blocker
4668500|NCT03438916|Pharmacological respons|pharmacological respons
4668501|NCT03438916|Magnetic Resonance Imaging|magnetic resonance imaging
4668502|NCT03438916|Hemodynamic assessments|hemodynamic assessments
4668503|NCT03438916|Echocardiography|echocardiography
4668504|NCT03438916|MR-elastography|mr-elastography
4668505|NCT03438916|Propranolol|propranolol
4668506|NCT03438916|Liver vein catheterization|liver vein catheterization
4668507|NCT03438864|Radius fracture, Interferential current, edema, pain|radius fracture, interferential current, edema, pain
4668508|NCT03438838|Achalasia, LHM, Anterior fundoplication|achalasia, lhm, anterior fundoplication
4668509|NCT03438773|Hispanic|hispanic
4668510|NCT03438773|First time kidney recipients|first time kidney recipients
4668511|NCT03438760|Language Disorders|language disorders
4668512|NCT03438760|Communication Disorders|communication disorders
4668513|NCT03438760|Neurobehavioral Manifestations|neurobehavioral manifestations
4668514|NCT03438760|Developmental Language Disorder|developmental language disorder
4668515|NCT03438760|Randomized Controlled Trial|randomized controlled trial
4668516|NCT03438734|Bariatric surgery|bariatric surgery
4668517|NCT03438734|Low flow anesthesia|low flow anesthesia
4668518|NCT03438734|Bispectral index|bispectral index
4668519|NCT03438734|Regional cerebral oximetry|regional cerebral oximetry
4668520|NCT03438708|Renal Cell Carcinoma|renal cell carcinoma
4668521|NCT03438708|Axitinib|axitinib
4668522|NCT03438708|Nephrectomy|nephrectomy
4668523|NCT03438708|Neoadjuvant|neoadjuvant
4668524|NCT03438708|Clear Cell Renal Carcinoma|clear cell renal carcinoma
4668525|NCT03438695|endoscopy, motorized spiral enteroscopy|endoscopy, motorized spiral enteroscopy
4668526|NCT03438669|visual acuity|visual acuity
4668527|NCT03438669|ETDRS|etdrs
4668528|NCT03438669|quality of life|quality of life
4668529|NCT03438656|Depression|depression
4668530|NCT03438656|Childhood adversity|childhood adversity
4668531|NCT03438656|Behavioral Activation|behavioral activation
4668532|NCT03438656|Reward Processing|reward processing
4668533|NCT03438656|fMRI|fmri
4668534|NCT03438643|Graft versus host disease|graft versus host disease
4668535|NCT03438643|Extracorporeal photopheresis|extracorporeal photopheresis
4668536|NCT03438643|Immunomodulatory|immunomodulatory
4668537|NCT03438630|socioeconomic factors|socioeconomic factors
4668538|NCT03438630|comorbidity|comorbidity
4668539|NCT03438630|replacement surgery|replacement surgery
4668540|NCT03438617|Diabetes|diabetes
4668541|NCT03438617|Self-Management|self-management
4668542|NCT03438617|Primary Care|primary care
4668543|NCT03438617|Community Health Center|community health center
4668544|NCT03438617|Peer Support|peer support
4668545|NCT03438617|Group Support|group support
4668546|NCT03438617|Integrated Care|integrated care
4668547|NCT03438617|China|china
4668548|NCT03438617|Urban|urban
4668549|NCT03438591|cerclage pacing|cerclage pacing
4668550|NCT03438591|cerclage-CRT|cerclage-crt
4668551|NCT03438591|wide QRS|wide qrs
4668552|NCT03438578|Patient safety|patient safety
4668553|NCT03438578|Postoperative care|postoperative care
4668554|NCT03438578|Monitoring, physiologic|monitoring, physiologic
4668555|NCT03438578|Safety management|safety management
4668556|NCT03438565|Asahi Chikai Black 18 Neurovascular Guidewire|asahi chikai black 18 neurovascular guidewire
4668557|NCT03438565|Prospective|prospective
4668558|NCT03438565|Retrospective|retrospective
4668559|NCT03438513|Caregivers|caregivers
4668560|NCT03438513|Burden|burden
4668561|NCT03438513|Coping|coping
4668562|NCT03438513|Quality of life|quality of life
4668563|NCT03438513|Problem solving therapy|problem solving therapy
4668564|NCT03438448|Ultrasensitive Troponin T|ultrasensitive troponin t
4668565|NCT03438448|MINS|mins
4668566|NCT03438448|Cost-effectiveness|cost-effectiveness
4668567|NCT03438448|Myocardial Ischemia|myocardial ischemia
4668568|NCT03438383|Bi-PAP|bi-pap
4668569|NCT03438383|BiPAP|bipap
4668570|NCT03438383|morbid obesity|morbid obesity
4668571|NCT03438383|anesthesia|anesthesia
4668572|NCT03438383|bariatric surgery|bariatric surgery
4668573|NCT03438383|sham Bi-PAP|sham bi-pap
4668574|NCT03438383|sham BiPAP|sham bipap
4668575|NCT03438383|postoperative complications|postoperative complications
4668576|NCT03438331|Insomnia|insomnia
4668577|NCT03438331|Depression|depression
4668578|NCT03438331|Adolescents|adolescents
4668579|NCT03438331|Youth|youth
4668580|NCT03438292|Berberine|berberine
4668581|NCT03438292|TPGS|tpgs
4668582|NCT03438292|Pharmacokinetics|pharmacokinetics
4668583|NCT03438292|Human intervention study|human intervention study
4668584|NCT03438253|Intraoperative penile engorgement|intraoperative penile engorgement
4668585|NCT03438253|Anaesthesia|anaesthesia
4668586|NCT03438253|Urogenital surgery|urogenital surgery
4668587|NCT03438227|Iron Deficiency Anemia of Pregnancy|iron deficiency anemia of pregnancy
4668588|NCT03438227|oral iron supplementation|oral iron supplementation
4668589|NCT03438227|parenteral iron supplementation|parenteral iron supplementation
4668590|NCT03438227|maternal anemia|maternal anemia
4668591|NCT03438214|Vancomycin infusion|vancomycin infusion
4668592|NCT03438214|critical ill patients|critical ill patients
4668593|NCT03438214|MRSA|mrsa
4668594|NCT03438201|Cancer, ICU, Surgery, Protein, Physical Activity|cancer, icu, surgery, protein, physical activity
4668595|NCT03438188|Nicotine Addiction|nicotine addiction
4668596|NCT03438188|Quitting Smoking|quitting smoking
4668597|NCT03438175|Post-traumatic Stress Disorder|post-traumatic stress disorder
4668598|NCT03438175|Web-site|web-site
4668599|NCT03438175|Communication|communication
4668600|NCT03438175|Intensive Care Unit|intensive care unit
4668601|NCT03438175|Comprehension|comprehension
4668602|NCT03438149|microparticles|microparticles
4668603|NCT03438149|cardiovascular outcomes|cardiovascular outcomes
4668604|NCT03438110|Preterm birth|preterm birth
4668605|NCT03438110|Neonatal death|neonatal death
4668606|NCT03438110|Stillbirth|stillbirth
4668607|NCT03438110|Asia|asia
4668608|NCT03438110|Africa|africa
4668609|NCT03438097|Fluid therapy|fluid therapy
4668610|NCT03438097|Non-resuscitation fluids|non-resuscitation fluids
4668611|NCT03438097|Septic shock|septic shock
4668612|NCT03438084|Interesterified|interesterified
4668613|NCT03438084|Postprandial|postprandial
4668614|NCT03438084|Lipid|lipid
4668615|NCT03438058|Solid Organ Transplantation|solid organ transplantation
4668616|NCT03438058|Graft survival|graft survival
4668617|NCT03438058|Rejection|rejection
4668618|NCT03438058|Complement-activating anti-HLA DSA|complement-activating anti-hla dsa
4668619|NCT03438058|Meta-analysis|meta-analysis
4668620|NCT03438058|Prognosis|prognosis
4668621|NCT03438045|Chinese American|chinese american
4668622|NCT03438045|implementation science|implementation science
4668623|NCT03438045|feasibility|feasibility
4668624|NCT03438045|acceptability|acceptability
4668625|NCT03438045|oral health|oral health
4668626|NCT03438045|dental care|dental care
4668627|NCT03438045|health equity|health equity
4668628|NCT03438045|urban health|urban health
4668629|NCT03438019|Maximal Respiratory Pressures, Inspiratory Muscle Training, TIRE, COPD|maximal respiratory pressures, inspiratory muscle training, tire, copd
4668630|NCT03438006|Safety|safety
4668631|NCT03438006|Human Papillomavirus Vaccine|human papillomavirus vaccine
4668632|NCT03438006|Adverse Event Following Immunization|adverse event following immunization
4668633|NCT03437993|ADHD|adhd
4668634|NCT03437993|executive functioning|executive functioning
4668635|NCT03437993|game|game
4668636|NCT03437941|Prostate Cancer|prostate cancer
4668637|NCT03437941|Castration-Resistant Prostate Cancer|castration-resistant prostate cancer
4668638|NCT03437941|Glucocorticoid receptor|glucocorticoid receptor
4668639|NCT03437941|Antagonist|antagonist
4668640|NCT03437941|mCRPC|mcrpc
4668641|NCT03437941|enzalutamide|enzalutamide
4668642|NCT03437941|androgen receptor|androgen receptor
4668643|NCT03437928|Major Depressive Disorder (MDD)|major depressive disorder (mdd)
4668644|NCT03437928|MDD|mdd
4668645|NCT03437928|Neuromodulation|neuromodulation
4668646|NCT03437928|Deep Brain Stimulation (DBS)|deep brain stimulation (dbs)
4668647|NCT03437928|DBS|dbs
4668648|NCT03437928|Electrophysiology|electrophysiology
4668649|NCT03437928|Imaging|imaging
4668650|NCT03437902|Type 2 diabetes|type 2 diabetes
4668651|NCT03437902|Rutin|rutin
4668652|NCT03437902|Vitamin C|vitamin c
4668653|NCT03437902|oxidative stress|oxidative stress
4668654|NCT03437902|Insulin resistance|insulin resistance
4668655|NCT03437902|lipid profile|lipid profile
4668656|NCT03437889|epidural|epidural
4668657|NCT03437876|HBV induced cirrhosis|hbv induced cirrhosis
4668658|NCT03437876|intestinal microbiota transplantation|intestinal microbiota transplantation
4668659|NCT03437876|microbiota|microbiota
4668660|NCT03437863|self-management|self-management
4668661|NCT03437863|health assets|health assets
4668662|NCT03437863|Strengths|strengths
4668663|NCT03437863|mHealth|mhealth
4668664|NCT03437863|Feasibility|feasibility
4668665|NCT03437811|airway clearance system|airway clearance system
4668666|NCT03437811|cystic fibrosis|cystic fibrosis
4668667|NCT03437811|lung secretion clearance|lung secretion clearance
4668668|NCT03437798|Periodontal Disease|periodontal disease
4668669|NCT03437798|Diabetes|diabetes
4668670|NCT03437798|Osteoporosis|osteoporosis
4668671|NCT03437798|Cardiovascular Risk Factor|cardiovascular risk factor
4668672|NCT03437798|Genomic|genomic
4668673|NCT03437785|Acute Gastritis|acute gastritis
4668674|NCT03437785|Chronic Gastritis|chronic gastritis
4668675|NCT03437785|Cinnamic acid|cinnamic acid
4668676|NCT03437785|CKD-495|ckd-495
4668677|NCT03437759|macular hole (MH)|macular hole (mh)
4668678|NCT03437759|exosomes|exosomes
4668679|NCT03437759|mesenchymal stem cells|mesenchymal stem cells
4668680|NCT03437759|pars plana vitrectomy|pars plana vitrectomy
4668681|NCT03437733|Radiofrequency Ablation|radiofrequency ablation
4668682|NCT03437733|Paroxysmal Atrial Fibrillation|paroxysmal atrial fibrillation
4668683|NCT03437707|Postoperative pain|postoperative pain
4668684|NCT03437707|Intravenous ibuprofen|intravenous ibuprofen
4668685|NCT03437707|Intravenous paracetamol|intravenous paracetamol
4668686|NCT03437707|Lumbar disc surgery|lumbar disc surgery
4668687|NCT03437694|HIV|hiv
4668688|NCT03437694|AIDS|aids
4668689|NCT03437694|Diabetes Melliltus, Type 2|diabetes melliltus, type 2
4668690|NCT03437694|Hypertension|hypertension
4668691|NCT03437694|Pharmacist|pharmacist
4668692|NCT03437694|Medication optimization|medication optimization
4668693|NCT03437694|medication therapy management|medication therapy management
4668694|NCT03437681|Sleep|sleep
4668695|NCT03437681|Blood Sugar|blood sugar
4668696|NCT03437668|Schizophrenia|schizophrenia
4668697|NCT03437668|Withania Somnifera|withania somnifera
4668698|NCT03437616|Rehabilitation|rehabilitation
4668699|NCT03437616|Coronary heart disease|coronary heart disease
4668700|NCT03437616|Cardiovascular diseases|cardiovascular diseases
4668701|NCT03437616|Risk factors|risk factors
4668702|NCT03437616|Life-style changes|life-style changes
4668703|NCT03437616|Efficacy|efficacy
4668704|NCT03437603|Eltrombopag|eltrombopag
4668705|NCT03437603|Allogenetic Hematopoietic Stem Cell Transplantation|allogenetic hematopoietic stem cell transplantation
4668706|NCT03437603|Poor Graft Function|poor graft function
4668707|NCT03437577|Kidney|kidney
4668708|NCT03437577|Transplant|transplant
4668709|NCT03437551|Diabetes Mellitus 1|diabetes mellitus 1
4668710|NCT03437551|long-term intensified insulin therapy|long-term intensified insulin therapy
4668711|NCT03437551|diabetic retinopathy|diabetic retinopathy
4668712|NCT03437551|diabetic macular edema|diabetic macular edema
4668713|NCT03437538|Dialysis|dialysis
4668714|NCT03437538|MCO|mco
4668715|NCT03437538|Middle molecules|middle molecules
4668716|NCT03437538|High Retention Onset|high retention onset
4668717|NCT03437538|Medium Cut-Off|medium cut-off
4668718|NCT03437525|Diabetes|diabetes
4668719|NCT03437525|Self-Management|self-management
4668720|NCT03437525|Primary Care|primary care
4668721|NCT03437525|Community Health Center|community health center
4668722|NCT03437525|Peer Support|peer support
4668723|NCT03437525|Group Support|group support
4668724|NCT03437525|Integrated Care|integrated care
4668725|NCT03437525|Insulin|insulin
4668726|NCT03437525|China|china
4668727|NCT03437525|Urban|urban
4668728|NCT03437512|tDCS|tdcs
4668729|NCT03437512|MRI|mri
4668730|NCT03437512|Speech|speech
4668731|NCT03437512|fluency|fluency
4668732|NCT03437460|Productivity|productivity
4668733|NCT03437460|Cognitive Function|cognitive function
4668734|NCT03437460|Decision Making|decision making
4668735|NCT03437460|Well-Being|well-being
4668736|NCT03437460|Health|health
4668737|NCT03437460|Labor|labor
4668738|NCT03437447|Bioavailability|bioavailability
4668739|NCT03437447|Bioequivalence|bioequivalence
4668740|NCT03437447|Praziquantel|praziquantel
4668741|NCT03437447|Cysticide|cysticide
4668742|NCT03437447|Pharmacokinetics|pharmacokinetics
4668743|NCT03437421|myocardial function|myocardial function
4668744|NCT03437421|vitamin D|vitamin d
4668745|NCT03437421|stress echocardiography|stress echocardiography
4668746|NCT03437421|diabetes|diabetes
4668747|NCT03437408|Ventricular Tachycardia|ventricular tachycardia
4668748|NCT03437408|Catheter Ablation|catheter ablation
4668749|NCT03437408|Late Potential|late potential
4668750|NCT03437408|Ablation Index|ablation index
4668751|NCT03437408|Pacing|pacing
4668752|NCT03437395|Lumpectomy|lumpectomy
4668753|NCT03437395|Unifocal Disease|unifocal disease
4668754|NCT03437395|Stage 0 or 1 Disease|stage 0 or 1 disease
4668755|NCT03437382|Hepatocellular carcinoma|hepatocellular carcinoma
4668756|NCT03437382|Radiofrequency ablation (RFA)|radiofrequency ablation (rfa)
4668757|NCT03437382|Radioembolization|radioembolization
4668758|NCT03437382|Quirem Spheres|quirem spheres
4668759|NCT03437382|Selective internal radiation therapy|selective internal radiation therapy
4668760|NCT03437369|Ivabradine, heart rate, acute heart failure|ivabradine, heart rate, acute heart failure
4668761|NCT03437356|persistent atrial fibrillation|persistent atrial fibrillation
4668762|NCT03437356|pulmonary vein isolation|pulmonary vein isolation
4668763|NCT03437356|antiarrhythmic drug therapy|antiarrhythmic drug therapy
4668764|NCT03437343|EOS|eos
4668765|NCT03437343|total hip arthroplasty|total hip arthroplasty
4668766|NCT03437343|performance of surgeons|performance of surgeons
4668767|NCT03437343|leg length discrepancy|leg length discrepancy
4668768|NCT03437343|HOOS|hoos
4668769|NCT03437317|Social Anxiety|social anxiety
4668770|NCT03437317|Threat processing|threat processing
4668771|NCT03437317|Magnetoencephalography (MEG)|magnetoencephalography (meg)
4668772|NCT03437304|Vaccine|vaccine
4668773|NCT03437278|Anti-IgE|anti-ige
4668774|NCT03437278|Chronic spontaneous urticaria,|chronic spontaneous urticaria,
4668775|NCT03437252|COPD|copd
4668776|NCT03437252|COPD exacerbation|copd exacerbation
4668777|NCT03437252|COPD AE|copd ae
4668778|NCT03437252|Physical activity|physical activity
4668779|NCT03437252|Wearable arm device|wearable arm device
4668780|NCT03437239|Bicep tenodesis|bicep tenodesis
4668781|NCT03437226|Heart Failure, Levosimendan|heart failure, levosimendan
4668782|NCT03437200|œsophageal cancer nivolumab ipilimumab|œsophageal cancer nivolumab ipilimumab
4668783|NCT03437174|Hypoparathyroidism|hypoparathyroidism
4668784|NCT03437174|Parathyroid Disease|parathyroid disease
4668785|NCT03437174|Burden of Illness|burden of illness
4668786|NCT03437174|SF-36|sf-36
4668787|NCT03437174|Quality of Life|quality of life
4668788|NCT03437161|Radiation|radiation
4668789|NCT03437161|Prone position|prone position
4668790|NCT03437161|Supine position|supine position
4668791|NCT03437161|DIBH|dibh
4668792|NCT03437161|Invasive Breast Carcinoma|invasive breast carcinoma
4668793|NCT03437161|Ductal Breast Carcinoma In Situ|ductal breast carcinoma in situ
4668794|NCT03437148|Pulmonary to systemic blood flow|pulmonary to systemic blood flow
4668795|NCT03437148|Non-invasive measurement|non-invasive measurement
4668796|NCT03437148|Inert gas rebreathing|inert gas rebreathing
4668797|NCT03437148|Bioimpedance cardiograph|bioimpedance cardiograph
4668798|NCT03437148|Atrial Septal Defect|atrial septal defect
4668799|NCT03437148|Congenital heart disease|congenital heart disease
4668800|NCT03437148|Cardiac Output|cardiac output
4668801|NCT03437135|diabetes|diabetes
4668802|NCT03437135|hearing problems|hearing problems
4668803|NCT03437135|otoscopy|otoscopy
4668804|NCT03437122|lung, nasal mucosa, respiratory mucosa|lung, nasal mucosa, respiratory mucosa
4668805|NCT03437083|Breast neoplasms|breast neoplasms
4668806|NCT03437083|Metastatic breast cancer|metastatic breast cancer
4668807|NCT03437083|E7389|e7389
4668808|NCT03437070|Advanced Leiomyosarcoma|advanced leiomyosarcoma
4668809|NCT03437070|Recurrent Leiomyosarcoma|recurrent leiomyosarcoma
4668810|NCT03437057|ECL|ecl
4668811|NCT03437057|Hematoma|hematoma
4668812|NCT03437057|Antiplatelet|antiplatelet
4668813|NCT03437044|diabetes mellitus|diabetes mellitus
4668814|NCT03437044|percutaneous coronary intervention|percutaneous coronary intervention
4668815|NCT03437044|ticagrelor|ticagrelor
4668816|NCT03437044|clopidogrel|clopidogrel
4668817|NCT03437044|coronary artery disease|coronary artery disease
4668818|NCT03437031|Labor Pain|labor pain
4668819|NCT03437031|Virtual Reality|virtual reality
4668820|NCT03437031|Alternative Medicine|alternative medicine
4668821|NCT03437018|moderate diabetic retinopathy|moderate diabetic retinopathy
4668822|NCT03437018|tele-expertise|tele-expertise
4668823|NCT03437005|Human microbiome|human microbiome
4668824|NCT03437005|Topical|topical
4668825|NCT03437005|Steroid|steroid
4668826|NCT03437005|Anti-fungal|anti-fungal
4668827|NCT03436992|Estrogen, Diabetes|estrogen, diabetes
4668828|NCT03436979|prolapse|prolapse
4668829|NCT03436979|sacrospinous fixation|sacrospinous fixation
4668830|NCT03436979|minimally invasive|minimally invasive
4668831|NCT03436927|Multiple Sclerosis|multiple sclerosis
4668832|NCT03436927|rehabilitation|rehabilitation
4668833|NCT03436927|postural balance|postural balance
4668834|NCT03436927|exercise|exercise
4668835|NCT03436901|magnetic resonance imaging|magnetic resonance imaging
4668836|NCT03436901|diffusion weighted imaging|diffusion weighted imaging
4668837|NCT03436862|Nivolumab|nivolumab
4668838|NCT03436862|Autologous Stem Cell Transplant|autologous stem cell transplant
4668839|NCT03436862|Blood cancers|blood cancers
4668840|NCT03436849|ASP2693|asp2693
4668841|NCT03436849|Pharmacodynamics|pharmacodynamics
4668842|NCT03436849|Pharmacokinetics|pharmacokinetics
4668843|NCT03436849|ESN364|esn364
4668844|NCT03436849|Safety|safety
4668845|NCT03436810|Motor Imagery|motor imagery
4668846|NCT03436810|Task-Oriented Circuit Class Training|task-oriented circuit class training
4668847|NCT03436810|Health Education|health education
4668848|NCT03436771|long-term follow-up|long-term follow-up
4668849|NCT03436771|chimeric antigen receptor (CAR) T cells|chimeric antigen receptor (car) t cells
4668850|NCT03436771|JCAR017|jcar017
4668851|NCT03436771|JCARH125|jcarh125
4668852|NCT03436758|uterine fluids|uterine fluids
4668853|NCT03436758|Biobank|biobank
4668854|NCT03436758|culture medium|culture medium
4668855|NCT03436745|Insomnia|insomnia
4668856|NCT03436745|Enzyme Expression|enzyme expression
4668857|NCT03436745|PSA|psa
4668858|NCT03436745|TESTOSTERONE|testosterone
4668859|NCT03436745|Recommended Dose|recommended dose
4668860|NCT03436732|Immunotoxin|immunotoxin
4668861|NCT03436732|Rapamycin|rapamycin
4668862|NCT03436732|Targeted Therapy|targeted therapy
4668863|NCT03436732|Mesothelin|mesothelin
4668864|NCT03436719|Surgical Site Infection|surgical site infection
4668865|NCT03436719|Rectal Cancer Surgery|rectal cancer surgery
4668866|NCT03436719|Oral Antibiotic|oral antibiotic
4668867|NCT03436719|Antibiotic Prophylaxis|antibiotic prophylaxis
4668868|NCT03436693|Diabetic Nephropathy|diabetic nephropathy
4668869|NCT03436693|Canagliflozin|canagliflozin
4668870|NCT03436693|Canaglu|canaglu
4668871|NCT03436693|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
4668872|NCT03436680|Malignant neoplasms of independent (primary) multiple sites|malignant neoplasms of independent (primary) multiple sites
4668873|NCT03436680|Chemotherapy-induced peripheral neuropathy|chemotherapy-induced peripheral neuropathy
4668874|NCT03436680|CIPN|cipn
4668875|NCT03436680|Home-based neurofeedback|home-based neurofeedback
4668876|NCT03436680|HBNF|hbnf
4668877|NCT03436680|Questionnaires|questionnaires
4668878|NCT03436680|Surveys|surveys
4668879|NCT03436680|Electroencephalogram|electroencephalogram
4668880|NCT03436680|EEG|eeg
4668881|NCT03436654|prostate cancer|prostate cancer
4668882|NCT03436654|apalutamide|apalutamide
4668883|NCT03436654|abiraterone acetate|abiraterone acetate
4668884|NCT03436654|memorial sloan kettering cancer center|memorial sloan kettering cancer center
4668885|NCT03436654|17-646|17-646
4668886|NCT03436602|Personalized risk assessment|personalized risk assessment
4668887|NCT03436602|Risk stratification model|risk stratification model
4668888|NCT03436589|Supplemental Nutrition Assistance Program-Education|supplemental nutrition assistance program-education
4668889|NCT03436589|nutrition education intervention|nutrition education intervention
4668890|NCT03436576|Autologous serum|autologous serum
4668891|NCT03436576|Concentration|concentration
4668892|NCT03436576|Autologous serum 20%|autologous serum 20%
4668893|NCT03436576|Autologous serum 50%|autologous serum 50%
4668894|NCT03436576|Severe dry eye|severe dry eye
4668895|NCT03436563|Adenocarcinoma of the colon|adenocarcinoma of the colon
4668896|NCT03436563|Adenocarcinoma of the rectum|adenocarcinoma of the rectum
4668897|NCT03436563|Microsatellite instability-high metastatic colorectal cancer|microsatellite instability-high metastatic colorectal cancer
4668898|NCT03436563|Treatment-refractory, consensus molecular subtype 4 (CMS4) mCRC|treatment-refractory, consensus molecular subtype 4 (cms4) mcrc
4668899|NCT03436563|MSI-H non CRC solid tumors who have progressed on immune checkpoint blockade therapy|msi-h non crc solid tumors who have progressed on immune checkpoint blockade therapy
4668900|NCT03436563|M7824|m7824
4668901|NCT03436563|MSB0011359C|msb0011359c
4668902|NCT03436550|Hepatic Venous Pressure Gradient|hepatic venous pressure gradient
4668903|NCT03436550|Magnetic Resonance Imaging|magnetic resonance imaging
4668904|NCT03436550|Acoustic Radiation Force Impulse|acoustic radiation force impulse
4668905|NCT03436550|Elastography|elastography
4668906|NCT03436550|Ultrasound|ultrasound
4668907|NCT03436550|Liver Cirrhosis|liver cirrhosis
4668908|NCT03436537|aesthetic|aesthetic
4668909|NCT03436537|development|development
4668910|NCT03436537|periodontal|periodontal
4668911|NCT03436537|reliability|reliability
4668912|NCT03436537|validity|validity
4668913|NCT03436524|Early stage CLL|early stage cll
4668914|NCT03436524|Binet A|binet a
4668915|NCT03436524|Prognosis|prognosis
4668916|NCT03436511|Health resource utilization|health resource utilization
4668917|NCT03436511|Eosinophilic COPD|eosinophilic copd
4668918|NCT03436511|Mepolizumab|mepolizumab
4668919|NCT03436472|aged|aged
4668920|NCT03436472|operative|operative
4668921|NCT03436472|delirium|delirium
4668922|NCT03436472|dexmedetomidine|dexmedetomidine
4668923|NCT03436472|long-term outcome|long-term outcome
4668924|NCT03436459|extracorporeal shock wave therapy (ESWT)|extracorporeal shock wave therapy (eswt)
4668925|NCT03436459|Low level laser therapy (LLLT)|low level laser therapy (lllt)
4668926|NCT03436459|Myofascial Pain Syndrome|myofascial pain syndrome
4668927|NCT03436446|Patient Reported Outcomes (PRO)|patient reported outcomes (pro)
4668928|NCT03436446|Social Incentives|social incentives
4668929|NCT03436420|Pediatrics|pediatrics
4668930|NCT03436420|Lipids|lipids
4668931|NCT03436420|Liver Diseases|liver diseases
4668932|NCT03436420|Obesity|obesity
4668933|NCT03436394|Renal Impairment|renal impairment
4668934|NCT03436394|Evobrutinib|evobrutinib
4668935|NCT03436394|Pharmacokinetics|pharmacokinetics
4668936|NCT03436368|Continuous spinal anesthesia|continuous spinal anesthesia
4668937|NCT03436368|General anesthesia|general anesthesia
4668938|NCT03436368|Renal transplantation|renal transplantation
4668939|NCT03436368|Chronic renal failure|chronic renal failure
4668940|NCT03436355|Behavioral|behavioral
4668941|NCT03436355|Physical activity|physical activity
4668942|NCT03436355|Intervention|intervention
4668943|NCT03436355|School children|school children
4668944|NCT03436329|Lung cancer|lung cancer
4668945|NCT03436329|Surgical technique|surgical technique
4668946|NCT03436329|vessel ligation|vessel ligation
4668947|NCT03436329|Circulating tumor cell|circulating tumor cell
4668948|NCT03436316|Phosphoinositide 3-kinase (PI3K) inhibitor|phosphoinositide 3-kinase (pi3k) inhibitor
4668949|NCT03436316|First-in-human (FiH) study|first-in-human (fih) study
4668950|NCT03436303|Menopause Syndrome|menopause syndrome
4668951|NCT03436303|low dose estrogen|low dose estrogen
4668952|NCT03436303|progestin|progestin
4668953|NCT03436290|Palliative Care|palliative care
4668954|NCT03436277|Overweight|overweight
4668955|NCT03436277|Obesity|obesity
4668956|NCT03436277|L-Carnitine|l-carnitine
4668957|NCT03436277|Body weight|body weight
4668958|NCT03436277|Body fat percentage|body fat percentage
4668959|NCT03436251|hyperthermia|hyperthermia
4668960|NCT03436251|human papillomavirus virus|human papillomavirus virus
4668961|NCT03436251|cervical intraepithelial neoplasia|cervical intraepithelial neoplasia
4668962|NCT03436238|Perioperative|perioperative
4668963|NCT03436238|Biomarkers|biomarkers
4668964|NCT03436238|Troponin|troponin
4668965|NCT03436238|Prodrenomedullin|prodrenomedullin
4668966|NCT03436238|Endothelin|endothelin
4668967|NCT03436238|Perioperative Complications|perioperative complications
4668968|NCT03436225|steroid therapy.|steroid therapy.
4668969|NCT03436186|Thyroidectomy|thyroidectomy
4668970|NCT03436186|voice|voice
4668971|NCT03436186|swallowing problems|swallowing problems
4668972|NCT03436186|dysphagia|dysphagia
4668973|NCT03436147|vaginal hysterectomy|vaginal hysterectomy
4668974|NCT03436147|laparoscopic hysteropexy|laparoscopic hysteropexy
4668975|NCT03436147|pelvic organ prolapse quantification|pelvic organ prolapse quantification
4668976|NCT03436134|Donor-specific antibodies|donor-specific antibodies
4668977|NCT03436134|Double-Filtration PlasmaPheresis (DFPP)|double-filtration plasmapheresis (dfpp)
4668978|NCT03436134|Plasma Exchange (PE)|plasma exchange (pe)
4668979|NCT03436095|Bundle|bundle
4668980|NCT03436095|difficult ventilator weaning|difficult ventilator weaning
4668981|NCT03436069|Breast cancer|breast cancer
4668982|NCT03436069|biomarkers|biomarkers
4668983|NCT03436069|prognostic|prognostic
4668984|NCT03436069|ectopic gene expression|ectopic gene expression
4668985|NCT03436069|expression profile|expression profile
4668986|NCT03436069|tissue-specific genes|tissue-specific genes
4668987|NCT03436069|response to treatment|response to treatment
4668988|NCT03436056|Non-small-cell lunG cancer|non-small-cell lung cancer
4668989|NCT03436056|NSCLC|nsclc
4668990|NCT03436056|metastatic|metastatic
4668991|NCT03436056|pembrolizumab|pembrolizumab
4668992|NCT03436056|radiotherapy|radiotherapy
4668993|NCT03436043|Walled of necrosis|walled of necrosis
4668994|NCT03436017|adhd|adhd
4668995|NCT03436017|metabolomics|metabolomics
4668996|NCT03436017|child|child
4668997|NCT03436004|Colonoscopy|colonoscopy
4668998|NCT03436004|Adenoma|adenoma
4668999|NCT03436004|Adenoma detection rate|adenoma detection rate
4669000|NCT03435991|Experience Sampling Method|experience sampling method
4669001|NCT03435991|Ecological Momentary Assessment|ecological momentary assessment
4669002|NCT03435991|Momentary Symptom Assessment|momentary symptom assessment
4669003|NCT03435991|Patient Reported Outcome Measure|patient reported outcome measure
4669004|NCT03435978|diet|diet
4669005|NCT03435978|metabolic syndrome|metabolic syndrome
4669006|NCT03435978|obese children|obese children
4669007|NCT03435952|Pembrolizumab|pembrolizumab
4669008|NCT03435952|Keytruda|keytruda
4669009|NCT03435952|MK-3475|mk-3475
4669010|NCT03435952|SCH-900475|sch-900475
4669011|NCT03435952|Clostridium Novyi-NT|clostridium novyi-nt
4669012|NCT03435952|C. novyi-NT|c. novyi-nt
4669013|NCT03435952|Doxycycline|doxycycline
4669014|NCT03435952|Vibramycin|vibramycin
4669015|NCT03435952|Periostat|periostat
4669016|NCT03435952|Doryx|doryx
4669017|NCT03435952|Solid tumor malignancies|solid tumor malignancies
4669018|NCT03435913|Mechanical ventilation|mechanical ventilation
4669019|NCT03435913|Driving Pressure|driving pressure
4669020|NCT03435913|Protective Lung VEntilation|protective lung ventilation
4669021|NCT03435887|Point of Care Testing|point of care testing
4669022|NCT03435887|HIV|hiv
4669023|NCT03435887|Pediatric HIV-exposed infants|pediatric hiv-exposed infants
4669024|NCT03435887|at-birth testing|at-birth testing
4669025|NCT03435887|early infant diagnosis|early infant diagnosis
4669026|NCT03435887|Kenya|kenya
4669027|NCT03435848|Acute Myeloid Leukemia|acute myeloid leukemia
4669028|NCT03435848|Unfit for standard induction therapy|unfit for standard induction therapy
4669029|NCT03435848|Cytarabine|cytarabine
4669030|NCT03435822|asthma|asthma
4669031|NCT03435822|children|children
4669032|NCT03435822|action plan|action plan
4669033|NCT03435822|China|china
4669034|NCT03435822|CCAAP|ccaap
4669035|NCT03435796|Long-term follow up|long-term follow up
4669036|NCT03435796|Gene-Modified T Cells|gene-modified t cells
4669037|NCT03435796|CAR T Cell|car t cell
4669038|NCT03435770|EUS-guided RFA|eus-guided rfa
4669039|NCT03435770|Endoscopic ultrasound|endoscopic ultrasound
4669040|NCT03435770|radio frequency ablation|radio frequency ablation
4669041|NCT03435731|OSA|osa
4669042|NCT03435731|Continous Positive Airway Pressure (CPAP)|continous positive airway pressure (cpap)
4669043|NCT03435731|Mandibular Advancement Split (MAS)|mandibular advancement split (mas)
4669044|NCT03435731|Mandibular Advancement Oral Appliance|mandibular advancement oral appliance
4669045|NCT03435731|Dual Therapy|dual therapy
4669046|NCT03435718|oxfendazole|oxfendazole
4669047|NCT03435718|albendazole|albendazole
4669048|NCT03435718|Trichuris trichiura|trichuris trichiura
4669049|NCT03435679|infection|infection
4669050|NCT03435679|knee arthroplasty|knee arthroplasty
4669051|NCT03435679|surgical treatment|surgical treatment
4669052|NCT03435679|one-stage|one-stage
4669053|NCT03435679|two-stage|two-stage
4669054|NCT03435679|outcome|outcome
4669055|NCT03435640|NKTR-214|nktr-214
4669056|NCT03435640|NKTR-262|nktr-262
4669057|NCT03435640|Nivolumab|nivolumab
4669058|NCT03435640|Opdivo|opdivo
4669059|NCT03435640|Metastatic|metastatic
4669060|NCT03435640|Locally advanced|locally advanced
4669061|NCT03435640|Relapsed/Refractory|relapsed/refractory
4669062|NCT03435640|TLR7/8|tlr7/8
4669063|NCT03435640|CD122|cd122
4669064|NCT03435614|Opioid|opioid
4669065|NCT03435614|Withdrawal|withdrawal
4669066|NCT03435614|Critically ill adults|critically ill adults
4669067|NCT03435614|Cortisol|cortisol
4669068|NCT03435601|Rheumatoid Arthritis|rheumatoid arthritis
4669069|NCT03435601|RA|ra
4669070|NCT03435601|IFN-Signature|ifn-signature
4669071|NCT03435601|Anifrolumab|anifrolumab
4669072|NCT03435575|physical activity|physical activity
4669073|NCT03435575|serious game|serious game
4669074|NCT03435575|childhood obesity|childhood obesity
4669075|NCT03435536|circulating tumor DNA|circulating tumor dna
4669076|NCT03435536|kinetic|kinetic
4669077|NCT03435536|pancreatic cancer|pancreatic cancer
4669078|NCT03435536|pancreatoduodenectomy|pancreatoduodenectomy
4669079|NCT03435536|Next Generation Sequencing|next generation sequencing
4669080|NCT03435510|Live Donor Kidney Transplant|live donor kidney transplant
4669081|NCT03435510|Education|education
4669082|NCT03435510|Advocacy|advocacy
4669083|NCT03435510|Live Donor|live donor
4669084|NCT03435471|Prophylactic Swallowing Therapy|prophylactic swallowing therapy
4669085|NCT03435458|Induced labor|induced labor
4669086|NCT03435458|Maternal obesity|maternal obesity
4669087|NCT03435445|obesity|obesity
4669088|NCT03435445|overweight|overweight
4669089|NCT03435445|telemedicine|telemedicine
4669090|NCT03435445|ehealth|ehealth
4669091|NCT03435419|cutaneous leishmaniasis|cutaneous leishmaniasis
4669092|NCT03435419|RDT|rdt
4669093|NCT03435419|LAMP|lamp
4669094|NCT03435419|PCR|pcr
4669793|NCT03430960|application|application
4669095|NCT03435406|Hepatitis B, Chronic|hepatitis b, chronic
4669096|NCT03435406|Cirrhosis|cirrhosis
4669097|NCT03435406|Hepatopulmonary Syndrome|hepatopulmonary syndrome
4669098|NCT03435380|Cancer Survivors|cancer survivors
4669099|NCT03435380|Smartphone|smartphone
4669100|NCT03435380|Mobile Applications|mobile applications
4669101|NCT03435354|Physical activity|physical activity
4669102|NCT03435354|Quality of life|quality of life
4669103|NCT03435354|Activity motivation|activity motivation
4669104|NCT03435354|Children|children
4669105|NCT03435354|Adolescents|adolescents
4669106|NCT03435354|Cluster-randomized trial|cluster-randomized trial
4669107|NCT03435341|Acute Myeloid Leukemia (AML)|acute myeloid leukemia (aml)
4669108|NCT03435341|Observational|observational
4669109|NCT03435341|Standard Clinical Practice|standard clinical practice
4669110|NCT03435341|Survival|survival
4669111|NCT03435341|Tolerability|tolerability
4669112|NCT03435341|Spain|spain
4669113|NCT03435328|TENS|tens
4669114|NCT03435302|Mucosal Melanoma,Adjuvant Therapy,IFN-a2b,Temozolomide|mucosal melanoma,adjuvant therapy,ifn-a2b,temozolomide
4669115|NCT03435289|Advanced Pancreatic Cancer|advanced pancreatic cancer
4669116|NCT03435276|Heart failure.|heart failure.
4669117|NCT03435276|Oral selective mineralocorticoid receptor modulator.|oral selective mineralocorticoid receptor modulator.
4669118|NCT03435276|Heart failure with preserved ejection fraction (HFpEF).|heart failure with preserved ejection fraction (hfpef).
4669119|NCT03435263|premature rupture of membranes|premature rupture of membranes
4669120|NCT03435250|MTAP|mtap
4669121|NCT03435250|MTAP deletion|mtap deletion
4669122|NCT03435250|CDKN2A deletion|cdkn2a deletion
4669123|NCT03435250|MAT2A inhibitor|mat2a inhibitor
4669124|NCT03435250|Advanced solid tumors|advanced solid tumors
4669125|NCT03435250|Lymphoma|lymphoma
4669126|NCT03435237|Optical Coherence Tomography|optical coherence tomography
4669127|NCT03435237|Bronchial Thermoplasty|bronchial thermoplasty
4669128|NCT03435185|Pain|pain
4669129|NCT03435185|Nerve Blocks|nerve blocks
4669130|NCT03435185|Headache|headache
4669131|NCT03435185|Local Anaesthetics|local anaesthetics
4669132|NCT03435185|Migraine|migraine
4669133|NCT03435172|Thermal Burn|thermal burn
4669134|NCT03435172|Adipose Derived Regenerative Cells|adipose derived regenerative cells
4669135|NCT03435172|Skin Graft|skin graft
4669136|NCT03435159|Chiropractic, Manipulation, Vertebrobasilar Artery|chiropractic, manipulation, vertebrobasilar artery
4669137|NCT03435146|3HP|3hp
4669138|NCT03435146|LTBI|ltbi
4669139|NCT03435146|IMPAACT4TB|impaact4tb
4669140|NCT03435146|DDI|ddi
4669141|NCT03435146|Pharmacokinetics|pharmacokinetics
4669142|NCT03435146|Dolutegravir|dolutegravir
4669143|NCT03435133|Primary angioplasty|primary angioplasty
4669144|NCT03435133|Prasugrel|prasugrel
4669145|NCT03435133|Ticagrelor|ticagrelor
4669146|NCT03435133|STEMI|stemi
4669147|NCT03435133|cardiac magnetic resonance|cardiac magnetic resonance
4669148|NCT03435133|infarct size|infarct size
4669149|NCT03435133|infarct injury|infarct injury
4669150|NCT03435120|Breakthrough Cancer Pain|breakthrough cancer pain
4669151|NCT03435120|Quality of life|quality of life
4669152|NCT03435120|Medical Oncology|medical oncology
4669153|NCT03435081|eczema|eczema
4669154|NCT03435081|atopic eczema|atopic eczema
4669155|NCT03435068|rotary|rotary
4669156|NCT03435068|diode laser|diode laser
4669157|NCT03435068|gingivectomy|gingivectomy
4669158|NCT03435068|wound healing|wound healing
4669159|NCT03435029|aging|aging
4669160|NCT03435029|cognitive rehabilitation|cognitive rehabilitation
4669161|NCT03435029|REHACOP|rehacop
4669162|NCT03435003|Bariatric Procedure|bariatric procedure
4669163|NCT03434990|spinal manipulative therapy|spinal manipulative therapy
4669164|NCT03434990|Myofascial release|myofascial release
4669165|NCT03434990|Low back pain|low back pain
4669166|NCT03434938|Stroke|stroke
4669167|NCT03434938|Geriatric|geriatric
4669168|NCT03434938|Rehabilitation|rehabilitation
4669169|NCT03434938|Functional recovery|functional recovery
4669170|NCT03434938|Physical activity|physical activity
4669171|NCT03434938|Motivational interviewing|motivational interviewing
4669172|NCT03434938|Adherence|adherence
4669173|NCT03434938|Clinical trial|clinical trial
4669174|NCT03434925|colorectal neoplasia|colorectal neoplasia
4669175|NCT03434925|adenoma|adenoma
4669176|NCT03434925|colonoscopy|colonoscopy
4669177|NCT03434925|gene mutation|gene mutation
4669178|NCT03434925|follow-up|follow-up
4669179|NCT03434925|recurrence|recurrence
4669180|NCT03434925|multiparametric test|multiparametric test
4669181|NCT03434873|magnetic stimulation, multiple sclerosis|magnetic stimulation, multiple sclerosis
4669182|NCT03434821|Hyperoxemia|hyperoxemia
4669183|NCT03434821|ventilator-associated|ventilator-associated
4669184|NCT03434821|pneumonia|pneumonia
4669185|NCT03434821|critical illness|critical illness
4669186|NCT03434769|Cyclophosphamide|cyclophosphamide
4669187|NCT03434769|Fludarabine|fludarabine
4669188|NCT03434769|Chimeric antigen receptor T cells|chimeric antigen receptor t cells
4669189|NCT03434756|ultrasound imaging|ultrasound imaging
4669190|NCT03434756|propioception|propioception
4669191|NCT03434756|training|training
4669192|NCT03434743|oral feeding|oral feeding
4669193|NCT03434743|early intervention|early intervention
4670194|NCT03428542|biomarkers|biomarkers
4669194|NCT03434743|premature infant|premature infant
4669195|NCT03434743|sucking|sucking
4669196|NCT03434730|tocilizumab|tocilizumab
4669197|NCT03434730|17-616|17-616
4669198|NCT03434730|Memorial Sloan Kettering Cancer Center|memorial sloan kettering cancer center
4669199|NCT03434678|General Anesthesia|general anesthesia
4669200|NCT03434678|Epidural|epidural
4669201|NCT03434678|Pancreaticoduodenectomy|pancreaticoduodenectomy
4669202|NCT03434678|18-056|18-056
4669203|NCT03434665|Angiography|angiography
4669204|NCT03434665|Bariatric embolization|bariatric embolization
4669205|NCT03434665|Gastric artery|gastric artery
4669206|NCT03434665|Obesity|obesity
4669207|NCT03434665|Transradial|transradial
4669208|NCT03434639|Gut permeability|gut permeability
4669209|NCT03434639|Fluorescence|fluorescence
4669210|NCT03434639|Spectroscopy|spectroscopy
4669211|NCT03434639|Wearable sensor|wearable sensor
4669212|NCT03434639|Leaky gut|leaky gut
4669213|NCT03434587|fifth metacarpal neck, fracture, syndactyly, inmobilization, RCT|fifth metacarpal neck, fracture, syndactyly, inmobilization, rct
4669214|NCT03434574|(Poly)phenols|(poly)phenols
4669215|NCT03434574|Aronia berry|aronia berry
4669216|NCT03434574|Blood pressure|blood pressure
4669217|NCT03434574|Vascular function|vascular function
4669218|NCT03434561|hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
4669219|NCT03434509|Motor Control|motor control
4669220|NCT03434509|Attention|attention
4669221|NCT03434509|Cognitive Control|cognitive control
4669222|NCT03434496|PD; Gait training 3; treadmill.|pd; gait training 3; treadmill.
4669223|NCT03434483|Microbiota|microbiota
4669224|NCT03434483|Immunity|immunity
4669225|NCT03434483|Genetics|genetics
4669226|NCT03434483|Atherosclerosis|atherosclerosis
4669227|NCT03434470|Ultrasound|ultrasound
4669228|NCT03434470|Shear wave elastography|shear wave elastography
4669229|NCT03434470|SWE|swe
4669230|NCT03434470|Hepatitis C|hepatitis c
4669231|NCT03434470|HCV|hcv
4669232|NCT03434457|Fetal growth retardation|fetal growth retardation
4669233|NCT03434457|Early adversity|early adversity
4669234|NCT03434457|Depressive Symptoms|depressive symptoms
4669235|NCT03434444|propranolol|propranolol
4669236|NCT03434444|oxytocin|oxytocin
4669237|NCT03434444|uterine contraction|uterine contraction
4669238|NCT03434431|metabolic adaptation|metabolic adaptation
4669239|NCT03434431|weight regain|weight regain
4669240|NCT03434431|reverse dieting|reverse dieting
4669241|NCT03434418|EGFR Mutation|egfr mutation
4669242|NCT03434418|osimertinib|osimertinib
4669243|NCT03434418|exon 18 G719X|exon 18 g719x
4669244|NCT03434418|exon 20 S7681|exon 20 s7681
4669245|NCT03434418|exon 21 L861Q|exon 21 l861q
4669246|NCT03434405|schizophrenia|schizophrenia
4669247|NCT03434405|mindfulness|mindfulness
4669248|NCT03434405|social cognition|social cognition
4669249|NCT03434405|SocialMind|socialmind
4669250|NCT03434405|AGES-Mind|ages-mind
4669251|NCT03434392|Chronic Pain|chronic pain
4669252|NCT03434392|Chronic Pancreatitis|chronic pancreatitis
4669253|NCT03434392|Sphincter of Oddi Dysfunction|sphincter of oddi dysfunction
4669254|NCT03434392|Recurrent Acute Pancreatitis|recurrent acute pancreatitis
4669255|NCT03434392|Chronic Abdominal Pain|chronic abdominal pain
4669256|NCT03434392|Functional Dyspepsia|functional dyspepsia
4669257|NCT03434366|Autism Spectrum Disorder|autism spectrum disorder
4669258|NCT03434366|ketamine|ketamine
4669259|NCT03434366|dexmedetomidine|dexmedetomidine
4669260|NCT03434340|peppermint oil|peppermint oil
4669261|NCT03434340|morphine|morphine
4669262|NCT03434340|nausea and vomiting|nausea and vomiting
4669263|NCT03434340|lower segment cesarean section|lower segment cesarean section
4669264|NCT03434314|Paraplegia|paraplegia
4669265|NCT03434314|Aortic Aneurysm Repair|aortic aneurysm repair
4669266|NCT03434314|Staging|staging
4669267|NCT03434314|Embolization|embolization
4669268|NCT03434314|TAAA|taaa
4669269|NCT03434314|Thoracoabdominal aortic aneurysm|thoracoabdominal aortic aneurysm
4669270|NCT03434314|MISACE|misace
4669271|NCT03434314|Spinal cord ischemia|spinal cord ischemia
4669272|NCT03434314|Spinal cord ischaemia|spinal cord ischaemia
4669273|NCT03434314|Spinal cord injury|spinal cord injury
4669274|NCT03434314|Spinal cord ischemic injury|spinal cord ischemic injury
4669275|NCT03434314|Spinal cord ischaemic injury|spinal cord ischaemic injury
4669276|NCT03434314|Permanent paraplegia|permanent paraplegia
4669277|NCT03434314|Temporary paraplegia|temporary paraplegia
4669278|NCT03434314|Paraparesis|paraparesis
4669279|NCT03434314|SCI|sci
4669280|NCT03434314|TAAA repair|taaa repair
4669281|NCT03434314|Open TAAA repair|open taaa repair
4669282|NCT03434314|Open surgical TAAA repair|open surgical taaa repair
4669283|NCT03434314|Endovascular TAAA repair|endovascular taaa repair
4669284|NCT03434314|TEVAR|tevar
4669285|NCT03434314|Aortic surgery|aortic surgery
4669286|NCT03434314|Thoracoabdominal aortic surgery|thoracoabdominal aortic surgery
4669287|NCT03434314|Type B aortic dissection|type b aortic dissection
4669288|NCT03434314|Chronic type B aortic dissection|chronic type b aortic dissection
4669289|NCT03434314|Stanford type B aortic dissection|stanford type b aortic dissection
4669290|NCT03434314|Collateral network|collateral network
4669291|NCT03434314|Paraspinal collateral network|paraspinal collateral network
4669292|NCT03434314|Paraspinous collateral network|paraspinous collateral network
4669293|NCT03434314|Arteriogenesis|arteriogenesis
4669294|NCT03434314|Intercostal arteries|intercostal arteries
4669295|NCT03434301|Surgery|surgery
4669296|NCT03434301|Laparotomy|laparotomy
4669297|NCT03434301|Tack|tack
4669298|NCT03434301|Non-absorbable Tack|non-absorbable tack
4669299|NCT03434301|Absorbable Tack|absorbable tack
4669300|NCT03434301|Pain|pain
4669301|NCT03434288|Diabetes|diabetes
4669302|NCT03434288|Diabetic foot|diabetic foot
4669303|NCT03434288|Osteomyelitis|osteomyelitis
4669304|NCT03434275|Total Knee Arthroplasty|total knee arthroplasty
4669305|NCT03434275|Pain|pain
4669306|NCT03434275|Analgesia|analgesia
4669307|NCT03434275|N1539|n1539
4669308|NCT03434275|Phase 3b|phase 3b
4669309|NCT03434275|Knee Replacement|knee replacement
4669310|NCT03434262|ATRT|atrt
4669311|NCT03434262|Brain Tumors in Adolescents|brain tumors in adolescents
4669312|NCT03434262|Brain Tumors in Children|brain tumors in children
4669313|NCT03434262|Brain Tumors in Young Adults|brain tumors in young adults
4669314|NCT03434262|CDK4 amplification|cdk4 amplification
4669315|NCT03434262|CDK 4/6|cdk 4/6
4669316|NCT03434262|CDK 4/6 inhibitor|cdk 4/6 inhibitor
4669317|NCT03434262|CDK 4/6 pathway|cdk 4/6 pathway
4669318|NCT03434262|CDK 4/6/cyclin/RB/E2F pathway|cdk 4/6/cyclin/rb/e2f pathway
4669319|NCT03434262|CDK6 amplification|cdk6 amplification
4669320|NCT03434262|CyclinD1|cyclind1
4669321|NCT03434262|DAWN|dawn
4669322|NCT03434262|D-type Cyclins|d-type cyclins
4669323|NCT03434262|Hedgehog pathway inhibitor|hedgehog pathway inhibitor
4669324|NCT03434262|HGG|hgg
4669325|NCT03434262|MAPK pathway|mapk pathway
4669326|NCT03434262|MEK|mek
4669327|NCT03434262|MEK inhibitor|mek inhibitor
4669328|NCT03434262|MEK1|mek1
4669329|NCT03434262|MEK2|mek2
4669330|NCT03434262|Mekinist|mekinist
4669331|NCT03434262|Molecular|molecular
4669332|NCT03434262|Molecular therapy|molecular therapy
4669333|NCT03434262|MYC amplification|myc amplification
4669334|NCT03434262|PTCH1|ptch1
4669335|NCT03434262|Rare brain tumor|rare brain tumor
4669336|NCT03434262|Recurrent ATRT|recurrent atrt
4669337|NCT03434262|Recurrent brain tumor|recurrent brain tumor
4669338|NCT03434262|Recurrent ependymoma|recurrent ependymoma
4669339|NCT03434262|Recurrent high grade glioma|recurrent high grade glioma
4669340|NCT03434262|Recurrent malignant glioma|recurrent malignant glioma
4669341|NCT03434262|Recurrent medulloblastoma|recurrent medulloblastoma
4669342|NCT03434262|Refractory brain tumor|refractory brain tumor
4669343|NCT03434262|Small molecule inhibitor|small molecule inhibitor
4669344|NCT03434262|SMO antagonist|smo antagonist
4669345|NCT03434262|Smoothened protein|smoothened protein
4669346|NCT03434262|Sonic hedgehog|sonic hedgehog
4669347|NCT03434262|Combination therapy|combination therapy
4669348|NCT03434249|Bifidobacterium|bifidobacterium
4669349|NCT03434236|omega-3|omega-3
4669350|NCT03434236|specialized proresolving mediators|specialized proresolving mediators
4669351|NCT03434210|schizophrenia|schizophrenia
4669352|NCT03434210|violence risk|violence risk
4669353|NCT03434210|long-acting antipsychotics|long-acting antipsychotics
4669354|NCT03434210|community-based|community-based
4669355|NCT03434197|Osteoarthritis Knee Pain|osteoarthritis knee pain
4669356|NCT03434184|Walking analysis|walking analysis
4669357|NCT03434184|spinal surgery|spinal surgery
4669358|NCT03434184|scoliosis|scoliosis
4669359|NCT03434184|pelvic fixation|pelvic fixation
4669360|NCT03434158|Metastatic Prostate Cancer Resistant to Castration|metastatic prostate cancer resistant to castration
4669361|NCT03434132|Open Radical Cystectomy|open radical cystectomy
4669362|NCT03434132|Robotic Radical cystectomy|robotic radical cystectomy
4669363|NCT03434132|Intracorporeal urinary diversion|intracorporeal urinary diversion
4669364|NCT03434132|Prospective randdomized trial|prospective randdomized trial
4669365|NCT03434106|meibomian gland dysfunction|meibomian gland dysfunction
4669366|NCT03434106|Sjögren's syndrome|sjögren's syndrome
4669367|NCT03434106|dry eye disease|dry eye disease
4669368|NCT03434093|Paired Associative Stimulation (PAS)|paired associative stimulation (pas)
4669369|NCT03434093|Functional Magnetic Resonance Imaging (fMRI)|functional magnetic resonance imaging (fmri)
4669370|NCT03434093|Electrical Field Modeling|electrical field modeling
4669371|NCT03434093|Working Memory|working memory
4669372|NCT03434080|Pediatric|pediatric
4669373|NCT03434080|Neuroimaging|neuroimaging
4669374|NCT03434080|Brain Function|brain function
4669375|NCT03434080|Voluntary Movement|voluntary movement
4669376|NCT03434067|hyperthyroidism|hyperthyroidism
4669377|NCT03434067|thyroidectomy|thyroidectomy
4669378|NCT03434067|PTH|pth
4669379|NCT03434067|immunochromatographic assay|immunochromatographic assay
4669380|NCT03434054|losartan|losartan
4669381|NCT03434054|emotional processing|emotional processing
4669382|NCT03434054|anxiety|anxiety
4669383|NCT03434054|magnet resonance imaging|magnet resonance imaging
4669384|NCT03434054|MRI|mri
4669385|NCT03434028|Fluid management|fluid management
4669386|NCT03434028|Sepsis-induced hypotension|sepsis-induced hypotension
4669387|NCT03434028|vasopressors|vasopressors
4669388|NCT03434015|Atrial fibrillation|atrial fibrillation
4669389|NCT03434015|Left atrial septal closure|left atrial septal closure
4669390|NCT03434002|Virtual Reality Simulation|virtual reality simulation
4669391|NCT03434002|Teaching and Assessment|teaching and assessment
4669392|NCT03434002|Anesthesia Crisis Management|anesthesia crisis management
4669393|NCT03433989|Post-Traumatic Stress Disorder|post-traumatic stress disorder
4669394|NCT03433989|Pregnancy loss|pregnancy loss
4669395|NCT03433976|Caesarean section|caesarean section
4669396|NCT03433976|spinal anesthesia|spinal anesthesia
4669397|NCT03433976|Prilocaïne|prilocaïne
4669398|NCT03433976|motor block|motor block
4669399|NCT03433963|air pollution|air pollution
4669400|NCT03433963|blood pressure|blood pressure
4669401|NCT03433963|cardiac ischemia|cardiac ischemia
4669402|NCT03433963|L-arginine|l-arginine
4669403|NCT03433963|nitric oxide|nitric oxide
4669404|NCT03433950|antiparkinson|antiparkinson
4669405|NCT03433911|Permanent contraception|permanent contraception
4669406|NCT03433911|Birth control|birth control
4669407|NCT03433885|macular pigment optical density (MPOD)|macular pigment optical density (mpod)
4669408|NCT03433885|Age-related Macular Degeneration (AMD)|age-related macular degeneration (amd)
4669409|NCT03433885|drusen|drusen
4669410|NCT03433885|Chroidal neovascularization (CNV)|chroidal neovascularization (cnv)
4669411|NCT03433885|lutein|lutein
4669412|NCT03433885|zeaxanthin|zeaxanthin
4669413|NCT03433872|Infant-toddler care|infant-toddler care
4669414|NCT03433872|Early child development|early child development
4669415|NCT03433872|Professional development|professional development
4669416|NCT03433846|Sepsis|sepsis
4669417|NCT03433846|Prematurity|prematurity
4669418|NCT03433807|idebenone, DMD, Duchenne|idebenone, dmd, duchenne
4669419|NCT03433781|ASCORBIC ACID|ascorbic acid
4669420|NCT03433755|Evolocumab|evolocumab
4669421|NCT03433755|Repatha|repatha
4669422|NCT03433755|Statin|statin
4669423|NCT03433755|Chinese|chinese
4669424|NCT03433755|China|china
4669425|NCT03433755|Hypercholesterolemia|hypercholesterolemia
4669426|NCT03433755|Mixed Dyslipidemia|mixed dyslipidemia
4669427|NCT03433755|High Cholesterol|high cholesterol
4669428|NCT03433755|Lowering cholesterol|lowering cholesterol
4669429|NCT03433742|metal ion levels, total hip replacement, Trident II cup.|metal ion levels, total hip replacement, trident ii cup.
4669430|NCT03433729|Outpatient Clinics, Hospital|outpatient clinics, hospital
4669431|NCT03433729|Humans|humans
4669432|NCT03433729|Outcome Assessment (Health Care)|outcome assessment (health care)
4669433|NCT03433729|Patient Outcome Assessment|patient outcome assessment
4669434|NCT03433729|Patient satisfaction|patient satisfaction
4669435|NCT03433729|Hospitalists|hospitalists
4669436|NCT03433729|Secondary care|secondary care
4669437|NCT03433716|Percutaneous Neuromodulation, radial nerve, pain|percutaneous neuromodulation, radial nerve, pain
4669438|NCT03433703|Unresectable hepatocellular carcinoma|unresectable hepatocellular carcinoma
4669439|NCT03433703|Lenvatinib|lenvatinib
4669440|NCT03433703|E7080|e7080
4669441|NCT03433690|Child Obesity|child obesity
4669442|NCT03433690|Adolescents|adolescents
4669443|NCT03433690|High Intensity Interval Training|high intensity interval training
4669444|NCT03433690|Moderate training|moderate training
4669445|NCT03433677|insulin pump|insulin pump
4669446|NCT03433664|CO2 laser|co2 laser
4669447|NCT03433664|Ablative fractional laser|ablative fractional laser
4669448|NCT03433651|depression|depression
4669449|NCT03433638|Juvenile dermatomyositis|juvenile dermatomyositis
4669450|NCT03433638|Inflammatory myopathy|inflammatory myopathy
4669451|NCT03433638|Clinical features|clinical features
4669452|NCT03433638|Treatment|treatment
4669453|NCT03433625|Cognitive-behavioural therapy|cognitive-behavioural therapy
4669454|NCT03433612|Anatomical Landmarks|anatomical landmarks
4669455|NCT03433599|Intermittent Hypoxia|intermittent hypoxia
4669456|NCT03433599|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
4669457|NCT03433560|febrile neutropenia|febrile neutropenia
4669458|NCT03433560|neutropenia|neutropenia
4669459|NCT03433547|macular buckling|macular buckling
4669460|NCT03433547|full-thickness macular hole|full-thickness macular hole
4669461|NCT03433547|macular detachment|macular detachment
4669462|NCT03433547|internal limiting membrane peeling|internal limiting membrane peeling
4669463|NCT03433547|high myopia|high myopia
4669464|NCT03433534|nivolumab|nivolumab
4669465|NCT03433534|monoclonal antibody|monoclonal antibody
4669466|NCT03433534|Opdivo|opdivo
4669467|NCT03433534|antineoplastic agent|antineoplastic agent
4669468|NCT03433534|ELISA|elisa
4669469|NCT03433534|pharmacokinetic|pharmacokinetic
4669470|NCT03433521|Spatio-Temporal Diagnostic Pattern|spatio-temporal diagnostic pattern
4669471|NCT03433495|stroke|stroke
4669472|NCT03433495|aphasia|aphasia
4669473|NCT03433495|melodic intonation therapy|melodic intonation therapy
4669474|NCT03433482|Meningococcal disease|meningococcal disease
4669475|NCT03433482|Liquid formulation|liquid formulation
4669476|NCT03433482|Meningitis|meningitis
4669477|NCT03433456|obesity|obesity
4669478|NCT03433456|low-income|low-income
4669479|NCT03433456|health disparities|health disparities
4669480|NCT03433456|home visitation|home visitation
4669481|NCT03433456|prevention|prevention
4669482|NCT03433456|childhood obesity|childhood obesity
4669483|NCT03433456|habit|habit
4669484|NCT03433443|Spinal Fusion|spinal fusion
4669485|NCT03433443|Case Managers|case managers
4669486|NCT03433443|Rehabilitation|rehabilitation
4669487|NCT03433352|gut microbiota|gut microbiota
4669488|NCT03433352|16S rRNA gene|16s rrna gene
4669489|NCT03433352|Graves' disease|graves' disease
4669490|NCT03433352|Methimazole|methimazole
4669491|NCT03433352|Propylthiouracil|propylthiouracil
4669492|NCT03433339|depression|depression
4669493|NCT03433339|transcutaneous spinal direct current stimulation|transcutaneous spinal direct current stimulation
4669494|NCT03433339|non-invasive|non-invasive
4669495|NCT03433339|major depressive disorder|major depressive disorder
4669496|NCT03433248|Type 2 diabetes mellitus|type 2 diabetes mellitus
4669497|NCT03433248|Diabetic kidney disease|diabetic kidney disease
4669498|NCT03433248|Diabetic nephropathy|diabetic nephropathy
4669499|NCT03433248|Renoprotection|renoprotection
4669500|NCT03433248|SGLT2 inhibitor|sglt2 inhibitor
4669501|NCT03433248|Empagliflozin|empagliflozin
4669502|NCT03433248|DPP-4 inhibitor|dpp-4 inhibitor
4669503|NCT03433248|Linagliptin|linagliptin
4669504|NCT03433248|SU derivative|su derivative
4669505|NCT03433248|Gliclazide|gliclazide
4669506|NCT03433222|light emitting diode-red light|light emitting diode-red light
4669507|NCT03433222|high fluence|high fluence
4669508|NCT03433222|red light|red light
4669509|NCT03433222|RCT|rct
4669510|NCT03433209|Advanced bipolar energy devices|advanced bipolar energy devices
4669511|NCT03433209|ENSEAL|enseal
4669512|NCT03433209|LigaSure|ligasure
4669513|NCT03433209|Operative time|operative time
4669514|NCT03433209|Total laparoscopic hysterectomy|total laparoscopic hysterectomy
4669515|NCT03433157|stainless stain crowns|stainless stain crowns
4669516|NCT03433157|Hall technique|hall technique
4669517|NCT03433157|children|children
4669518|NCT03433118|fatigue|fatigue
4669519|NCT03433118|health-related quality of life|health-related quality of life
4669520|NCT03433105|oxygen uptake,prolonged mechanical ventilation,weaning|oxygen uptake,prolonged mechanical ventilation,weaning
4669521|NCT03433092|Serum carotenoids|serum carotenoids
4669522|NCT03433092|Gastrointestinal tract cancer|gastrointestinal tract cancer
4669523|NCT03433092|Meta-analysis|meta-analysis
4669524|NCT03433079|Acute Kidney Injury|acute kidney injury
4669525|NCT03433079|Severe Trauma|severe trauma
4669526|NCT03433079|NGAL|ngal
4669527|NCT03433079|Tissue Hypoxia|tissue hypoxia
4669528|NCT03433079|Inflammatory Response|inflammatory response
4669529|NCT03433079|Rhabdomyolysis|rhabdomyolysis
4669530|NCT03433066|advanced platelet-rich fibrin|advanced platelet-rich fibrin
4669531|NCT03432988|Nursing Solution-Focused|nursing solution-focused
4669532|NCT03432988|hemodialysis|hemodialysis
4669533|NCT03432988|Psychosocial intervention|psychosocial intervention
4669534|NCT03432988|Adherence|adherence
4669535|NCT03432949|Radium-223|radium-223
4669536|NCT03432949|Dexamethasone|dexamethasone
4669537|NCT03432949|mCRPC|mcrpc
4669538|NCT03432910|Forced Breath Technique|forced breath technique
4669539|NCT03432910|auto-CPAP|auto-cpap
4669540|NCT03432910|CPAP|cpap
4669541|NCT03432910|Obstructive sleep apnea|obstructive sleep apnea
4669542|NCT03432910|central sleep apnea|central sleep apnea
4669543|NCT03432897|High risk|high risk
4669544|NCT03432897|Defects|defects
4669545|NCT03432897|prostate|prostate
4669546|NCT03432884|Phase 1|phase 1
4669547|NCT03432884|pharmacokinetics|pharmacokinetics
4669548|NCT03432884|safety|safety
4669549|NCT03432871|Mitochondria|mitochondria
4669550|NCT03432871|Mitochondrial disease|mitochondrial disease
4669551|NCT03432871|Nicotinamide Riboside|nicotinamide riboside
4669552|NCT03432871|Niagen|niagen
4669553|NCT03432871|PEO|peo
4669554|NCT03432871|Single deletion|single deletion
4669555|NCT03432871|mtDNA deletion|mtdna deletion
4669556|NCT03432871|MELAS|melas
4669557|NCT03432871|m.3243A>G|m.3243a>g
4669558|NCT03432858|Endoscopic Carpal Tunnel Release|endoscopic carpal tunnel release
4669559|NCT03432858|Prophylactic Antibiotics|prophylactic antibiotics
4669560|NCT03432819|Latino, men who have sex with men|latino, men who have sex with men
4669561|NCT03432806|Tissue samples|tissue samples
4669562|NCT03432806|17-594|17-594
4669563|NCT03432793|DDI|ddi
4669564|NCT03432793|Itraconazole|itraconazole
4669565|NCT03432793|Fluvoxamine|fluvoxamine
4669566|NCT03432793|TD-9855|td-9855
4669567|NCT03432793|Smoking|smoking
4669568|NCT03432793|Caffeine|caffeine
4669569|NCT03432793|CYP1A2|cyp1a2
4669570|NCT03432793|CYP3A4|cyp3a4
4669571|NCT03432767|pregnancy|pregnancy
4669572|NCT03432767|postpartum hemorrhage|postpartum hemorrhage
4669573|NCT03432767|vaginal delivery|vaginal delivery
4669574|NCT03432767|shock index|shock index
4669575|NCT03432767|hemoglobin|hemoglobin
4669576|NCT03432754|Older adults|older adults
4669577|NCT03432754|Mindfulness|mindfulness
4669578|NCT03432754|Mind wandering|mind wandering
4669579|NCT03432754|Health education|health education
4669580|NCT03432754|Working memory|working memory
4669581|NCT03432754|Cognitive functioning|cognitive functioning
4669582|NCT03432754|Emotion regulation|emotion regulation
4669583|NCT03432754|Emotional functioning|emotional functioning
4669584|NCT03432728|Antioxidant Capacity|antioxidant capacity
4669585|NCT03432715|School|school
4669586|NCT03432715|Policy|policy
4669587|NCT03432715|Nutrition|nutrition
4669588|NCT03432715|Physical Activity|physical activity
4669589|NCT03432715|Local Wellness Policy|local wellness policy
4669590|NCT03432676|Pancreatic Adenocarcinoma|pancreatic adenocarcinoma
4670195|NCT03428503|paracetamol|paracetamol
4669591|NCT03432676|Homologous recombination repair deficiency|homologous recombination repair deficiency
4669592|NCT03432676|HRD|hrd
4669593|NCT03432676|Pembrolizumab|pembrolizumab
4669594|NCT03432676|Keytruda|keytruda
4669595|NCT03432676|MK-3475|mk-3475
4669596|NCT03432676|SCH-900475|sch-900475
4669597|NCT03432676|Epacadostat|epacadostat
4669598|NCT03432676|INCB024360|incb024360
4669599|NCT03432663|Atrial Fibrillation|atrial fibrillation
4669600|NCT03432663|Intravenous Amiodarone|intravenous amiodarone
4669601|NCT03432663|Drug safety profile|drug safety profile
4669602|NCT03432663|Chemical cardioversion|chemical cardioversion
4669603|NCT03432637|Complications, Postoperative/Perioperative|complications, postoperative/perioperative
4669604|NCT03432637|video assisted thoracic surgery|video assisted thoracic surgery
4669605|NCT03432637|non-intubated anaesthesia|non-intubated anaesthesia
4669606|NCT03432611|mHealth|mhealth
4669607|NCT03432611|dysmenorrhea|dysmenorrhea
4669608|NCT03432611|acupressure|acupressure
4669609|NCT03432611|self-management|self-management
4669610|NCT03432611|self-care|self-care
4669611|NCT03432585|feasibility|feasibility
4669612|NCT03432585|attendance|attendance
4669613|NCT03432585|conference|conference
4669614|NCT03432559|endoscopy|endoscopy
4669615|NCT03432533|Post-Menopausal osteoporosis|post-menopausal osteoporosis
4669616|NCT03432494|Transcather|transcather
4669617|NCT03432494|Transcaval|transcaval
4669618|NCT03432494|Bioprosthesis|bioprosthesis
4669619|NCT03432494|Closure Device|closure device
4669620|NCT03432494|Aortic Stenosis|aortic stenosis
4669621|NCT03432481|Osteoarthritis, Knee|osteoarthritis, knee
4669622|NCT03432468|Hypertension|hypertension
4669623|NCT03432468|Left Ventricular Hypertrophy|left ventricular hypertrophy
4669624|NCT03432468|Women|women
4669625|NCT03432455|Incidence|incidence
4669626|NCT03432455|prevalence|prevalence
4669627|NCT03432455|epidemiology|epidemiology
4669628|NCT03432455|juvenile dermatomyositis|juvenile dermatomyositis
4669629|NCT03432455|inflammatory myopathy|inflammatory myopathy
4669630|NCT03432429|Tumours|tumours
4669631|NCT03432429|Breast conserving surgery|breast conserving surgery
4669632|NCT03432429|Margin assessment technology|margin assessment technology
4669633|NCT03432429|Mass spectrometry|mass spectrometry
4669634|NCT03432416|Healthy Women|healthy women
4669635|NCT03432416|Female Contraception|female contraception
4669636|NCT03432416|Vaginal Ring|vaginal ring
4669637|NCT03432416|Contraceptive Vaginal Ring|contraceptive vaginal ring
4669638|NCT03432364|Beta thalassemia|beta thalassemia
4669639|NCT03432364|Beta-thalassemia|beta-thalassemia
4669640|NCT03432364|Thalassemia major|thalassemia major
4669641|NCT03432364|Cooley's anemia|cooley's anemia
4669642|NCT03432364|ZFN mediated genome editing|zfn mediated genome editing
4669643|NCT03432364|zinc finger nuclease|zinc finger nuclease
4669644|NCT03432351|EEG|eeg
4669645|NCT03432351|Electroencephalography|electroencephalography
4669646|NCT03432351|Pediatric anesthesia|pediatric anesthesia
4669647|NCT03432299|Thyroid Diseases|thyroid diseases
4669648|NCT03432299|Radiofrequency Ablation|radiofrequency ablation
4669649|NCT03432260|Alcoholic Hepatitis|alcoholic hepatitis
4669650|NCT03432260|acute alcoholic liver disease|acute alcoholic liver disease
4669651|NCT03432260|progressive inflammatory liver injury|progressive inflammatory liver injury
4669652|NCT03432260|IV infusion|iv infusion
4669653|NCT03432247|music therapy|music therapy
4669654|NCT03432247|bone pain|bone pain
4669655|NCT03432247|pain management|pain management
4669656|NCT03432247|advanced cancer|advanced cancer
4669657|NCT03432234|COPD|copd
4669658|NCT03432234|Microbiome|microbiome
4669659|NCT03432234|Exacerbation|exacerbation
4669660|NCT03432221|Cognition, antidepressants drugs, SNRI, hot cognition, functioning|cognition, antidepressants drugs, snri, hot cognition, functioning
4669661|NCT03432182|Premature infant|premature infant
4669662|NCT03432182|sleep state|sleep state
4669663|NCT03432182|body movement|body movement
4669664|NCT03432182|neurodevelopmental outcome|neurodevelopmental outcome
4669665|NCT03432156|immunotherapy|immunotherapy
4669666|NCT03432156|NSCLC|nsclc
4669667|NCT03432143|Peer Review|peer review
4669668|NCT03432143|Community-Based Research|community-based research
4669669|NCT03432143|Community Perspectives|community perspectives
4669670|NCT03432130|hip-hop dance, injuries, body fat|hip-hop dance, injuries, body fat
4669671|NCT03432117|respiratory rehabilitation|respiratory rehabilitation
4669672|NCT03432117|personalized mobile services|personalized mobile services
4669673|NCT03432091|melatonin|melatonin
4669674|NCT03432091|melatonin receptor agonist|melatonin receptor agonist
4669675|NCT03432091|circadian-clock-related genes|circadian-clock-related genes
4669676|NCT03432065|Autism Spectrum Disorders|autism spectrum disorders
4669677|NCT03432065|Anxiety|anxiety
4669678|NCT03432065|Pervasive Developmental Disorders|pervasive developmental disorders
4669679|NCT03432065|Buspar|buspar
4669680|NCT03432065|Buspirone|buspirone
4669681|NCT03432052|centralization|centralization
4669682|NCT03431987|Marijuana|marijuana
4669683|NCT03431987|Alcohol|alcohol
4669684|NCT03431987|THC|thc
4669685|NCT03431987|fMRI|fmri
4669686|NCT03431987|MRI|mri
4669687|NCT03431987|Driving Simulation|driving simulation
4669688|NCT03431987|Cannabis|cannabis
4669689|NCT03431987|Intoxication|intoxication
4669691|NCT03431935|Health Care Transition|health care transition
4669692|NCT03431935|Adolescent|adolescent
4669693|NCT03431935|Young Adult|young adult
4669694|NCT03431909|Human Urinary Kallidinogenase|human urinary kallidinogenase
4669695|NCT03431909|Acute ischemic stroke|acute ischemic stroke
4669696|NCT03431909|Magnetic resonance spectroscopy|magnetic resonance spectroscopy
4669697|NCT03431909|CT perfusion|ct perfusion
4669698|NCT03431857|Shoulder arthroplasty|shoulder arthroplasty
4669699|NCT03431857|Medical device|medical device
4669700|NCT03431857|Shoulder prosthesis|shoulder prosthesis
4669701|NCT03431857|Performance|performance
4669702|NCT03431805|Randomized|randomized
4669703|NCT03431805|double blind placebo controlled trial|double blind placebo controlled trial
4669704|NCT03431805|prevention|prevention
4669705|NCT03431805|tranexamic acid|tranexamic acid
4669706|NCT03431805|postpartum hemorrhage|postpartum hemorrhage
4669707|NCT03431805|cesarean|cesarean
4669708|NCT03431792|CDH, FETO, fetal surgery, long tail FETO|cdh, feto, fetal surgery, long tail feto
4669709|NCT03431766|chlorhexidine gel|chlorhexidine gel
4669710|NCT03431766|dental implant|dental implant
4669711|NCT03431753|STHLM3-test|sthlm3-test
4669712|NCT03431753|prostate cancer|prostate cancer
4669713|NCT03431753|MR-imaging|mr-imaging
4669714|NCT03431753|MR-targeted biopsy|mr-targeted biopsy
4669715|NCT03431753|MRI|mri
4669716|NCT03431753|Novel biomarkers|novel biomarkers
4669717|NCT03431753|Genetic screening|genetic screening
4669718|NCT03431636|sports for people with disabilities|sports for people with disabilities
4669719|NCT03431636|immersion therapy|immersion therapy
4669720|NCT03431636|cryotherapy|cryotherapy
4669721|NCT03431636|physiotherapy|physiotherapy
4669722|NCT03431571|ReLEx|relex
4669723|NCT03431571|SMILE|smile
4669724|NCT03431571|Hyperopia|hyperopia
4669725|NCT03431571|VisuMax|visumax
4669726|NCT03431571|Small Incision Lenticule Extraction|small incision lenticule extraction
4669727|NCT03431571|Lenticule|lenticule
4669728|NCT03431571|Farsightedness|farsightedness
4669729|NCT03431558|Bovine Lactoferrin, Neonatal infection, Low Birth Weight|bovine lactoferrin, neonatal infection, low birth weight
4669730|NCT03431532|anesthesia|anesthesia
4669731|NCT03431532|general anesthesia|general anesthesia
4669732|NCT03431532|neuraxial anesthesia|neuraxial anesthesia
4669733|NCT03431532|monocyte funtion|monocyte funtion
4669734|NCT03431532|CD 14, HLA-DR|cd 14, hla-dr
4669735|NCT03431532|Interleukines|interleukines
4669736|NCT03431519|Thoracolumbar fractures|thoracolumbar fractures
4669737|NCT03431519|PMMA|pmma
4669738|NCT03431519|KIVA|kiva
4669739|NCT03431519|PEEK|peek
4669740|NCT03431480|cord blood stem cell|cord blood stem cell
4669741|NCT03431480|Norwood heart surgery|norwood heart surgery
4669742|NCT03431480|congenital|congenital
4669743|NCT03431480|heart|heart
4669744|NCT03431467|ECMO|ecmo
4669745|NCT03431467|Heart Failure|heart failure
4669746|NCT03431467|RCT|rct
4669747|NCT03431467|Mechanical unloading|mechanical unloading
4669748|NCT03431415|Lung|lung
4669749|NCT03431415|Cancer|cancer
4669750|NCT03431415|Early-Stage|early-stage
4669751|NCT03431415|Video-assisted Thoracic Surgery|video-assisted thoracic surgery
4669752|NCT03431415|VATS|vats
4669753|NCT03431415|SBRT|sbrt
4669754|NCT03431415|Stereotactic Body Radiation Therapy|stereotactic body radiation therapy
4669755|NCT03431376|potato consumption|potato consumption
4669756|NCT03431376|hypertension|hypertension
4669757|NCT03431376|CHNS|chns
4669758|NCT03431311|MSI|msi
4669759|NCT03431298|Knee osteoarthritis|knee osteoarthritis
4669760|NCT03431298|Physical activity|physical activity
4669761|NCT03431298|Exercise|exercise
4669762|NCT03431272|contact lens, discomfort, dry eye|contact lens, discomfort, dry eye
4669763|NCT03431233|protein-enriched bar|protein-enriched bar
4669764|NCT03431233|food intake|food intake
4669765|NCT03431233|appetite|appetite
4669766|NCT03431233|satiety related hormones|satiety related hormones
4669767|NCT03431194|Acute Kidney Injury|acute kidney injury
4669768|NCT03431194|midodrine|midodrine
4669769|NCT03431194|intensive care unit|intensive care unit
4669770|NCT03431168|STI Prevention|sti prevention
4669771|NCT03431168|Cameroon|cameroon
4669772|NCT03431168|sub-Saharan Africa|sub-saharan africa
4669773|NCT03431168|HIV pregnancy|hiv pregnancy
4669774|NCT03431168|Malaria in pregnancy|malaria in pregnancy
4669775|NCT03431155|children|children
4669776|NCT03431155|cancer|cancer
4669777|NCT03431155|mother|mother
4669778|NCT03431155|uncertainty|uncertainty
4669779|NCT03431155|nursing intervention|nursing intervention
4669780|NCT03431155|education|education
4669781|NCT03431129|Xenon MRI, Lung, Radiation Induced Lung Injury,|xenon mri, lung, radiation induced lung injury,
4669782|NCT03431103|overlap|overlap
4669783|NCT03431103|exercise|exercise
4669784|NCT03431103|inflammation|inflammation
4669785|NCT03431051|Healthy Beverage Initiative, Sugar Sweetened Beverages|healthy beverage initiative, sugar sweetened beverages
4669786|NCT03431012|Adherence, medication|adherence, medication
4669787|NCT03431012|Pandemic Influenza|pandemic influenza
4669788|NCT03430973|aggressive driving; road rage|aggressive driving; road rage
4669789|NCT03430960|mCare|mcare
4669790|NCT03430960|post surgery|post surgery
4669791|NCT03430960|mobile|mobile
4669794|NCT03430947|Stereotactic radiosurgery|stereotactic radiosurgery
4669795|NCT03430947|BRAF inhibitor|braf inhibitor
4669796|NCT03430947|MEK inhibitor|mek inhibitor
4669797|NCT03430947|Vemurafenib|vemurafenib
4669798|NCT03430947|Cobimetinib|cobimetinib
4669799|NCT03430934|Mohs tumor|mohs tumor
4669800|NCT03430908|endotracheal tube|endotracheal tube
4669801|NCT03430908|gastric tube|gastric tube
4669802|NCT03430908|17-653|17-653
4669803|NCT03430908|Memorial Sloan Kettering Cancer Center|memorial sloan kettering cancer center
4669804|NCT03430895|Durvalumab (MEDI4736)|durvalumab (medi4736)
4669805|NCT03430895|Tremelimumab|tremelimumab
4669806|NCT03430895|immunotherapy|immunotherapy
4669807|NCT03430895|17-511|17-511
4669808|NCT03430882|Solid tumor malignancy|solid tumor malignancy
4669809|NCT03430882|TAK-228|tak-228
4669810|NCT03430882|MLN0128|mln0128
4669811|NCT03430882|TAK228|tak228
4669812|NCT03430882|Paclitaxel|paclitaxel
4669813|NCT03430882|Taxol|taxol
4669814|NCT03430882|Carboplatin|carboplatin
4669815|NCT03430882|Paraplatin|paraplatin
4669816|NCT03430869|late-life depression|late-life depression
4669817|NCT03430869|major depressive disorder|major depressive disorder
4669818|NCT03430869|Alzheimer's disease dementia|alzheimer's disease dementia
4669819|NCT03430869|neurodegeneration|neurodegeneration
4669820|NCT03430869|amyloid plague, tau protein|amyloid plague, tau protein
4669821|NCT03430856|Oral insulin|oral insulin
4669822|NCT03430843|Unresectable|unresectable
4669823|NCT03430843|metastatic|metastatic
4669824|NCT03430843|second-line|second-line
4669825|NCT03430843|squamous|squamous
4669826|NCT03430843|esophagus|esophagus
4669827|NCT03430843|chemotherapy|chemotherapy
4669828|NCT03430843|paclitaxel|paclitaxel
4669829|NCT03430843|docetaxel|docetaxel
4669830|NCT03430843|irinotecan|irinotecan
4669831|NCT03430791|bevacizumab-naïve|bevacizumab-naïve
4669832|NCT03430791|recurrent glioblastoma|recurrent glioblastoma
4669833|NCT03430739|Deformational Plagiocephaly, Orthotics, Helmet|deformational plagiocephaly, orthotics, helmet
4669834|NCT03430726|Probiotics; paediatrics; gut microbiota|probiotics; paediatrics; gut microbiota
4669835|NCT03430713|tooth color|tooth color
4669836|NCT03430713|measurement|measurement
4669837|NCT03430713|accuracy|accuracy
4669838|NCT03430713|shade guide|shade guide
4669839|NCT03430713|spectrophotometer|spectrophotometer
4669840|NCT03430700|platinum-resistant|platinum-resistant
4669841|NCT03430648|Tau protein|tau protein
4669842|NCT03430648|PET imaging|pet imaging
4669843|NCT03430648|Alzheimer's disease|alzheimer's disease
4669844|NCT03430609|endometrioma|endometrioma
4669845|NCT03430609|laparoscopy|laparoscopy
4669846|NCT03430609|ovarian reserve|ovarian reserve
4669847|NCT03430609|anti-mullerian hormone|anti-mullerian hormone
4669848|NCT03430583|Fontan|fontan
4669849|NCT03430583|Ultrasound|ultrasound
4669850|NCT03430583|Magnetic Resonance Imaging Elastography|magnetic resonance imaging elastography
4669851|NCT03430570|Adolescent risk behavior|adolescent risk behavior
4669852|NCT03430570|digital|digital
4669853|NCT03430570|early adolescence|early adolescence
4669854|NCT03430570|emotion regulation|emotion regulation
4669855|NCT03430570|prevention|prevention
4669856|NCT03430557|Endodontic surgery|endodontic surgery
4669857|NCT03430544|cariprazine|cariprazine
4669858|NCT03430544|fMRI|fmri
4669859|NCT03430544|D3 receptor|d3 receptor
4669860|NCT03430544|cocaine use disorder|cocaine use disorder
4669861|NCT03430544|urine|urine
4669862|NCT03430518|Durvalumab (MEDI4736) (Anti-PDL1)|durvalumab (medi4736) (anti-pdl1)
4669863|NCT03430518|Eribulin|eribulin
4669864|NCT03430518|Recurrent Ovarian cancer|recurrent ovarian cancer
4669865|NCT03430518|Her2-negative Metastatic Breast Cancer|her2-negative metastatic breast cancer
4669866|NCT03430518|Ovarian cancer|ovarian cancer
4669867|NCT03430518|Metastatic Breast Cancer|metastatic breast cancer
4669868|NCT03430505|Asthma, noninvasive ventilation|asthma, noninvasive ventilation
4669869|NCT03430492|Psychological Resilience|psychological resilience
4669870|NCT03430492|Biomarkers|biomarkers
4669871|NCT03430492|Molecular Fingerprint|molecular fingerprint
4669872|NCT03430492|Quality of Life (QoL)|quality of life (qol)
4669873|NCT03430492|Body and Mind|body and mind
4669874|NCT03430492|CD-RISC|cd-risc
4669875|NCT03430492|SF-36|sf-36
4669876|NCT03430453|Regional Anesthesia|regional anesthesia
4669877|NCT03430453|Ultrasound guidance|ultrasound guidance
4669878|NCT03430453|Nerve stimulation|nerve stimulation
4669879|NCT03430453|Orthopedic surgery|orthopedic surgery
4669880|NCT03430427|BNET|bnet
4669881|NCT03430427|Brain Networks|brain networks
4669882|NCT03430427|Mobility Function|mobility function
4669883|NCT03430427|SMCCS|smccs
4669884|NCT03430401|memory encoding|memory encoding
4669885|NCT03430401|functional performance|functional performance
4669886|NCT03430388|vaccine|vaccine
4669887|NCT03430388|Yellow Fever|yellow fever
4669888|NCT03430388|Rheumatic disease|rheumatic disease
4669889|NCT03430375|wheelchair cushion|wheelchair cushion
4669890|NCT03430375|pressure mapping|pressure mapping
4669891|NCT03430375|pressure wounds|pressure wounds
4669892|NCT03430349|IPV-primed|ipv-primed
4669893|NCT03430349|adults|adults
4669894|NCT03430349|vaccination|vaccination
4669895|NCT03430349|containment|containment
4669896|NCT03430349|shedding|shedding
4669897|NCT03430349|genetic stability|genetic stability
4669898|NCT03430349|safety|safety
4669899|NCT03430349|neurovirulence|neurovirulence
4669900|NCT03430349|novel polio vaccine candidates|novel polio vaccine candidates
4669901|NCT03430297|anti-PD-1 monoclonal antibody|anti-pd-1 monoclonal antibody
4669902|NCT03430297|the First Line Therapy|the first line therapy
4669903|NCT03430297|Dacarbazine|dacarbazine
4669904|NCT03430297|Melanoma|melanoma
4669905|NCT03430284|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
4669906|NCT03430284|Diabetic Vascular Complications|diabetic vascular complications
4669907|NCT03430284|Multifactorial Intervention|multifactorial intervention
4669908|NCT03430284|Digital and Network Management|digital and network management
4669909|NCT03430245|Circumference reduction|circumference reduction
4669910|NCT03430219|AccuFill|accufill
4669911|NCT03430219|Injectable Calcium Phosphate|injectable calcium phosphate
4669912|NCT03430219|Subchondroplasty|subchondroplasty
4669913|NCT03430206|high-flow|high-flow
4669914|NCT03430206|nasal cannula|nasal cannula
4669915|NCT03430206|laryngoscopy|laryngoscopy
4669916|NCT03430206|otolaryngology|otolaryngology
4669917|NCT03430206|oxygen|oxygen
4669918|NCT03430206|desaturation|desaturation
4669919|NCT03430206|anesthesia|anesthesia
4669920|NCT03430206|pediatric|pediatric
4669921|NCT03430193|rehabilitation|rehabilitation
4669922|NCT03430193|multi-disciplinary rehabilitation|multi-disciplinary rehabilitation
4669923|NCT03430193|clinical pathway|clinical pathway
4669924|NCT03430193|Fragility|fragility
4669925|NCT03430167|Reverse Total Shoulder Arthroplasty|reverse total shoulder arthroplasty
4669926|NCT03430167|post operative physical therapy|post operative physical therapy
4669927|NCT03430115|Obese|obese
4669928|NCT03430115|Exercise|exercise
4669929|NCT03430089|Influenza|influenza
4669930|NCT03430089|Flu|flu
4669931|NCT03430076|vascular prostheses|vascular prostheses
4669932|NCT03430076|heparin|heparin
4669933|NCT03430076|ischemia lesions|ischemia lesions
4669934|NCT03430076|vascular|vascular
4669935|NCT03430076|critical limb ischemia lesions|critical limb ischemia lesions
4669936|NCT03430063|Advanced non-squamous NSCLC|advanced non-squamous nsclc
4669937|NCT03430063|Advanced squamous NSCLC|advanced squamous nsclc
4669938|NCT03430063|Metastatic non-squamous NSCLC|metastatic non-squamous nsclc
4669939|NCT03430063|Metastatic squamous NSCLC|metastatic squamous nsclc
4669940|NCT03430050|Progesterone|progesterone
4669941|NCT03430050|Ovarian hormones|ovarian hormones
4669942|NCT03430050|Gender|gender
4669943|NCT03430050|Cannabis|cannabis
4669944|NCT03430050|Withdrawal|withdrawal
4669945|NCT03430050|Cognitive functioning|cognitive functioning
4669946|NCT03430037|Inflammation|inflammation
4669947|NCT03430037|Frailty|frailty
4669948|NCT03430024|Myosin VI|myosin vi
4669949|NCT03430024|Estrogen receptor|estrogen receptor
4669950|NCT03430011|JCARH125|jcarh125
4669951|NCT03430011|chimeric antigen receptor|chimeric antigen receptor
4669952|NCT03430011|multiple myeloma|multiple myeloma
4669953|NCT03430011|CAR T cells|car t cells
4669954|NCT03430011|B-cell maturation antigen|b-cell maturation antigen
4669955|NCT03430011|BCMA|bcma
4669956|NCT03430011|autologous T-cell therapy|autologous t-cell therapy
4669957|NCT03430011|immunotherapy|immunotherapy
4669958|NCT03429998|cardiovascular risk|cardiovascular risk
4669959|NCT03429998|evolocumab|evolocumab
4669960|NCT03429998|LDL-apheresis|ldl-apheresis
4669961|NCT03429985|Sexual and Reproductive Health|sexual and reproductive health
4669962|NCT03429985|Parent-based Intervention|parent-based intervention
4669963|NCT03429985|Sexual risk behavior|sexual risk behavior
4669964|NCT03429985|Adolescent males|adolescent males
4669965|NCT03429985|Father-son Intervention|father-son intervention
4669966|NCT03429972|Paclitaxel|paclitaxel
4669967|NCT03429972|Neuropathy|neuropathy
4669968|NCT03429920|Fermented Soy|fermented soy
4669969|NCT03429920|Cardiovascular Disease|cardiovascular disease
4669970|NCT03429920|Inflammation|inflammation
4669971|NCT03429920|DNA Methylation|dna methylation
4669972|NCT03429907|Malignant neoplasm of breast|malignant neoplasm of breast
4669973|NCT03429907|Mind-Body Exercises|mind-body exercises
4669974|NCT03429907|Questionnaires|questionnaires
4669975|NCT03429907|Surveys|surveys
4669976|NCT03429868|Nasopharyngeal carcinoma|nasopharyngeal carcinoma
4669977|NCT03429868|Nead neck cancer|nead neck cancer
4669978|NCT03429868|Prognosis|prognosis
4669979|NCT03429868|PET|pet
4669980|NCT03429868|MRI|mri
4669981|NCT03429855|Physiotherapy|physiotherapy
4669982|NCT03429855|Trunk control|trunk control
4669983|NCT03429855|Bobath concept|bobath concept
4669984|NCT03429855|Stroke rehabilitation|stroke rehabilitation
4669985|NCT03429829|Caries|caries
4669986|NCT03429829|Fluoride Varnish|fluoride varnish
4669987|NCT03429829|Dental Health|dental health
4669988|NCT03429803|low-grade glioma|low-grade glioma
4669989|NCT03429790|caesarean section|caesarean section
4669990|NCT03429790|cell salvage|cell salvage
4669991|NCT03429790|blood transfusion|blood transfusion
4669992|NCT03429777|Smartphone|smartphone
4669993|NCT03429777|Medical application|medical application
4669994|NCT03429777|Hearing-in-noise test|hearing-in-noise test
4669995|NCT03429777|Digits-in-noise test|digits-in-noise test
4669996|NCT03429777|Speech reception threshold|speech reception threshold
4669997|NCT03429777|Hearing Loss|hearing loss
4669998|NCT03429777|Hearing Disorders|hearing disorders
4669999|NCT03429777|Hearing Abnormalities|hearing abnormalities
4670000|NCT03429777|Tinnitus|tinnitus
4670001|NCT03429777|Hearing aids|hearing aids
4670002|NCT03429777|Cochlear implants|cochlear implants
4670003|NCT03429751|lung ultrasound, fluid, hysterectomy, B lines|lung ultrasound, fluid, hysterectomy, b lines
4670004|NCT03429738|Ibuprofen|ibuprofen
4670005|NCT03429738|phase-I-study|phase-i-study
4670006|NCT03429738|pharmacokinetic|pharmacokinetic
4670007|NCT03429738|combination therapy|combination therapy
4670008|NCT03429738|bioavailability|bioavailability
4670009|NCT03429738|bioequivalence|bioequivalence
4670010|NCT03429738|pseudoephedrine hydrochloride|pseudoephedrine hydrochloride
4670012|NCT03429686|dementia|dementia
4670013|NCT03429686|reminiscence therapy|reminiscence therapy
4670014|NCT03429686|touch screen technology|touch screen technology
4670015|NCT03429686|digital reminiscence therapy|digital reminiscence therapy
4670016|NCT03429673|Chinese|chinese
4670017|NCT03429673|real-world evidences|real-world evidences
4670018|NCT03429673|NSCLC|nsclc
4670019|NCT03429673|surgeries|surgeries
4670020|NCT03429660|Disease epidemiology|disease epidemiology
4670021|NCT03429660|Risk assessment|risk assessment
4670022|NCT03429660|Drug utilisation study|drug utilisation study
4670023|NCT03429660|Effectiveness evaluation|effectiveness evaluation
4670024|NCT03429582|Human Papilloma Virus|human papilloma virus
4670025|NCT03429582|Thermoablation|thermoablation
4670026|NCT03429582|Thermocoagulation|thermocoagulation
4670027|NCT03429582|Cryotherapy|cryotherapy
4670028|NCT03429582|Cervica Pre-cancer|cervica pre-cancer
4670029|NCT03429582|Low and Middle Income Countries (LMICs)|low and middle income countries (lmics)
4670030|NCT03429569|Keratoconus|keratoconus
4670031|NCT03429569|Cross-linking|cross-linking
4670032|NCT03429569|Confocal microscopy|confocal microscopy
4670033|NCT03429569|Postoperative morphological|postoperative morphological
4670034|NCT03429569|Iotonphoresis|iotonphoresis
4670035|NCT03429556|pain, neurotoxin|pain, neurotoxin
4670036|NCT03429517|HDL-C|hdl-c
4670037|NCT03429517|Triglycerides|triglycerides
4670038|NCT03429517|Non HDL-C and Acute coronary syndrome|non hdl-c and acute coronary syndrome
4670039|NCT03429504|Obesity|obesity
4670040|NCT03429504|Breast cancer|breast cancer
4670041|NCT03429504|Body mass index|body mass index
4670042|NCT03429478|Music|music
4670043|NCT03429478|Laparoscopic Surgery|laparoscopic surgery
4670044|NCT03429478|Sterile Inflammation|sterile inflammation
4670045|NCT03429465|Digital Health Intervention|digital health intervention
4670046|NCT03429465|Executive Function|executive function
4670047|NCT03429465|Depression|depression
4670048|NCT03429465|Anxiety|anxiety
4670049|NCT03429452|structural heart abnormality|structural heart abnormality
4670050|NCT03429452|spatial method|spatial method
4670051|NCT03429452|echocardiography|echocardiography
4670052|NCT03429452|electrocardiogram|electrocardiogram
4670053|NCT03429452|mediterranean diet|mediterranean diet
4670054|NCT03429452|exercise|exercise
4670055|NCT03429452|social status|social status
4670056|NCT03429452|rural|rural
4670057|NCT03429439|chronic hepatitis B|chronic hepatitis b
4670058|NCT03429439|intestinal microbiota transplantation|intestinal microbiota transplantation
4670059|NCT03429439|microbiota|microbiota
4670060|NCT03429439|antiviral therapy|antiviral therapy
4670061|NCT03429426|Rheumatoid Arthritis|rheumatoid arthritis
4670062|NCT03429426|High-resolution peripheral quantitative computed tomography|high-resolution peripheral quantitative computed tomography
4670063|NCT03429426|Radiography|radiography
4670064|NCT03429413|Health Information Technology (HIT)|health information technology (hit)
4670065|NCT03429387|Diagnosis|diagnosis
4670066|NCT03429348|Firefighter|firefighter
4670067|NCT03429348|Post-Fire Rehabilitation|post-fire rehabilitation
4670068|NCT03429348|Sauna|sauna
4670069|NCT03429335|Transition|transition
4670070|NCT03429335|Adolescents|adolescents
4670071|NCT03429335|Smart phone|smart phone
4670072|NCT03429322|traumatic brain injury|traumatic brain injury
4670073|NCT03429322|pragmatic clinical trial|pragmatic clinical trial
4670074|NCT03429322|telemedicine|telemedicine
4670075|NCT03429322|cost|cost
4670076|NCT03429309|telomere|telomere
4670077|NCT03429309|propofol|propofol
4670078|NCT03429309|anesthesia-induction|anesthesia-induction
4670079|NCT03429296|Cancer|cancer
4670080|NCT03429296|Autohypnosis|autohypnosis
4670081|NCT03429296|Quality of life|quality of life
4670082|NCT03429283|Epidemiology,|epidemiology,
4670083|NCT03429283|Achromobacter xylosoxidans,|achromobacter xylosoxidans,
4670084|NCT03429283|antibiotic resistance|antibiotic resistance
4670085|NCT03429257|Aflatoxin B1|aflatoxin b1
4670086|NCT03429257|Environmental Enteric Dysfunction|environmental enteric dysfunction
4670087|NCT03429257|L:M Test|l:m test
4670088|NCT03429257|Pregnancy|pregnancy
4670089|NCT03429257|Linear Growth Faltering|linear growth faltering
4670090|NCT03429257|Birth Outcomes|birth outcomes
4670091|NCT03429257|Uganda|uganda
4670092|NCT03429218|Tolero, Phase 1, First in Human, Solid Tumors, Advanced Malignancy, Cancer|tolero, phase 1, first in human, solid tumors, advanced malignancy, cancer
4670093|NCT03429205|Sleeve gastrectomy|sleeve gastrectomy
4670094|NCT03429205|Roux-Y gastric bypass|roux-y gastric bypass
4670095|NCT03429205|Single anastomosis gastric bypass|single anastomosis gastric bypass
4670096|NCT03429205|Hypothermia|hypothermia
4670097|NCT03429205|External heating blanket|external heating blanket
4670098|NCT03429192|Chinese, real-world evidences, NSCLC, lymph skip metastases|chinese, real-world evidences, nsclc, lymph skip metastases
4670099|NCT03429179|butorphanol|butorphanol
4670100|NCT03429179|preoperative anxiety|preoperative anxiety
4670101|NCT03429179|sedation|sedation
4670102|NCT03429179|Orthopedics|orthopedics
4670103|NCT03429153|endocarditis|endocarditis
4670104|NCT03429127|balanced fluids, neurosurgery, plasma osmolality|balanced fluids, neurosurgery, plasma osmolality
4670105|NCT03429101|Poziotinib|poziotinib
4670106|NCT03429101|HER2 Positive|her2 positive
4670107|NCT03429101|T-DM1|t-dm1
4670108|NCT03429075|depression|depression
4670109|NCT03429075|mdd|mdd
4670110|NCT03429075|major depression|major depression
4670111|NCT03429075|major depressive disorder|major depressive disorder
4670112|NCT03429075|unipolar depression|unipolar depression
4670113|NCT03429075|psilocybin|psilocybin
4670114|NCT03429075|psychedelics|psychedelics
4670115|NCT03429075|psychedelic|psychedelic
4670116|NCT03429075|escitalopram|escitalopram
4670117|NCT03429075|ssri|ssri
4670118|NCT03429062|balance|balance
4670119|NCT03429062|gait|gait
4670120|NCT03429062|Multiple Sclerosis|multiple sclerosis
4670121|NCT03429036|Genomic DNA|genomic dna
4670122|NCT03429036|DNA Banking|dna banking
4670123|NCT03429036|Tissue Sample|tissue sample
4670124|NCT03429036|Saliva|saliva
4670125|NCT03429036|Blood Collection|blood collection
4670126|NCT03429023|Mucormycosis|mucormycosis
4670127|NCT03429010|Anesthesia|anesthesia
4670128|NCT03429010|Hip Fracture|hip fracture
4670129|NCT03428971|atrial fibrillation|atrial fibrillation
4670130|NCT03428971|p-wave|p-wave
4670131|NCT03428971|hospitalization|hospitalization
4670132|NCT03428958|Relapsed metastatic adenocarcinoma of colon/rectum|relapsed metastatic adenocarcinoma of colon/rectum
4670133|NCT03428945|TrialNet|trialnet
4670134|NCT03428932|Insulin pump|insulin pump
4670135|NCT03428932|Closed loop|closed loop
4670136|NCT03428932|Brain development|brain development
4670137|NCT03428932|Pediatric|pediatric
4670138|NCT03428932|Type 1 Diabetes|type 1 diabetes
4670139|NCT03428932|MRI|mri
4670140|NCT03428932|Cognitive development|cognitive development
4670141|NCT03428919|ICSI|icsi
4670142|NCT03428919|Conventional IVF|conventional ivf
4670143|NCT03428919|Non-male factor|non-male factor
4670144|NCT03428906|intranasal oxytocin|intranasal oxytocin
4670145|NCT03428906|functional brain network|functional brain network
4670146|NCT03428906|multiple tasks|multiple tasks
4670147|NCT03428906|resting state|resting state
4670148|NCT03428893|Exercise, mhealth, physical therapy|exercise, mhealth, physical therapy
4670149|NCT03428880|quadratus lumborum block|quadratus lumborum block
4670150|NCT03428880|cesarean section|cesarean section
4670151|NCT03428880|spinal morphine|spinal morphine
4670152|NCT03428880|ultrasound guidance|ultrasound guidance
4670153|NCT03428841|audiometry|audiometry
4670154|NCT03428841|dural puncture|dural puncture
4670155|NCT03428841|epidural|epidural
4670156|NCT03428828|Neurofeedback|neurofeedback
4670157|NCT03428828|major depressive disorder|major depressive disorder
4670158|NCT03428828|treatment resistant|treatment resistant
4670159|NCT03428828|amygdala|amygdala
4670160|NCT03428789|breast reconstruction|breast reconstruction
4670161|NCT03428789|DIEP flap|diep flap
4670162|NCT03428789|Nerve coaptation|nerve coaptation
4670163|NCT03428789|Sensory recovery|sensory recovery
4670164|NCT03428763|Arthritis, Rheumatoid|arthritis, rheumatoid
4670165|NCT03428763|Telerehabilitation|telerehabilitation
4670166|NCT03428763|controlled randomised trial|controlled randomised trial
4670167|NCT03428737|: pressure support ventilation, pressure control ventilation, sleep, weaning, chronic obstructive respiratory disease, weaning duration period|: pressure support ventilation, pressure control ventilation, sleep, weaning, chronic obstructive respiratory disease, weaning duration period
4670168|NCT03428711|Superficial Venous Thrombosis of Leg|superficial venous thrombosis of leg
4670169|NCT03428711|secondary prevention|secondary prevention
4670170|NCT03428711|prophylaxis|prophylaxis
4670171|NCT03428698|third molar extraction|third molar extraction
4670172|NCT03428698|hyaluronic acid|hyaluronic acid
4670173|NCT03428659|Motor function|motor function
4670174|NCT03428659|Recovery|recovery
4670175|NCT03428659|Gait|gait
4670176|NCT03428659|Magnetic resonance imaging|magnetic resonance imaging
4670177|NCT03428646|Eczema|eczema
4670178|NCT03428620|Functional Performance|functional performance
4670179|NCT03428620|Rehabilitation|rehabilitation
4670180|NCT03428620|Manipulation|manipulation
4670181|NCT03428581|Axillary|axillary
4670182|NCT03428581|Lymph node|lymph node
4670183|NCT03428581|Dissection|dissection
4670184|NCT03428581|Reverse Mapping|reverse mapping
4670185|NCT03428581|Lympho-venous Bypass|lympho-venous bypass
4670186|NCT03428568|Herbal Melanin|herbal melanin
4670187|NCT03428568|H.Pylori|h.pylori
4670188|NCT03428542|yoga|yoga
4670189|NCT03428542|stress|stress
4670190|NCT03428542|anxiety|anxiety
4670191|NCT03428542|depression|depression
4670192|NCT03428542|sleep quality|sleep quality
4670193|NCT03428542|physiological stress|physiological stress
4670196|NCT03428503|dexketoprofen|dexketoprofen
4670197|NCT03428503|emergency department|emergency department
4670198|NCT03428503|musculoskeletal pain|musculoskeletal pain
4670199|NCT03428490|Integrated Treatment|integrated treatment
4670200|NCT03428490|Alcohol Use Disorder|alcohol use disorder
4670201|NCT03428490|Social Anxiety Disorder|social anxiety disorder
4670202|NCT03428490|Comorbidity|comorbidity
4670203|NCT03428490|Cognitive Behavioral Therapy|cognitive behavioral therapy
4670204|NCT03428477|Liver metastases|liver metastases
4670205|NCT03428477|Colon Cancer|colon cancer
4670206|NCT03428451|TURP|turp
4670207|NCT03428451|hypertonic saline|hypertonic saline
4670208|NCT03428451|TURP syndrome|turp syndrome
4670209|NCT03428451|hyponatraemia|hyponatraemia
4670210|NCT03428412|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
4670211|NCT03428412|Acute exacerbation|acute exacerbation
4670212|NCT03428412|Traditional Chinese medicine|traditional chinese medicine
4670213|NCT03428399|breast reconstruction|breast reconstruction
4670214|NCT03428399|mastectomy|mastectomy
4670215|NCT03428373|Multiple Myeloma|multiple myeloma
4670216|NCT03428360|Seizure|seizure
4670217|NCT03428347|Ebola|ebola
4670218|NCT03428347|Ebola Virus Disease|ebola virus disease
4670219|NCT03428347|Monoclonal antibody|monoclonal antibody
4670220|NCT03428334|Sputum leukocyte density|sputum leukocyte density
4670221|NCT03428321|Microwave ablation|microwave ablation
4670222|NCT03428321|Percutaneous thermalablation|percutaneous thermalablation
4670223|NCT03428321|High risk location|high risk location
4670224|NCT03428321|Articifial pneumothorax|articifial pneumothorax
4670225|NCT03428321|Lipiodol marked|lipiodol marked
4670226|NCT03428321|Prognostic factor|prognostic factor
4670227|NCT03428295|artificial pancreas|artificial pancreas
4670228|NCT03428295|automated insulin delivery|automated insulin delivery
4670229|NCT03428295|hybrid closed loop|hybrid closed loop
4670230|NCT03428295|APDS|apds
4670231|NCT03428295|fully automated closed loop|fully automated closed loop
4670232|NCT03428269|simulation|simulation
4670233|NCT03428269|clinical reasoning|clinical reasoning
4670234|NCT03428269|patient deterioration|patient deterioration
4670235|NCT03428217|Tumor Metabolism|tumor metabolism
4670236|NCT03428217|RCC|rcc
4670237|NCT03428217|Glutaminase Inhibitor|glutaminase inhibitor
4670238|NCT03428217|CB-839|cb-839
4670239|NCT03428217|CANTATA|cantata
4670240|NCT03428217|TKI|tki
4670241|NCT03428217|Tyrosine Kinase Inhibitor|tyrosine kinase inhibitor
4670242|NCT03428217|cabozantinib|cabozantinib
4670243|NCT03428217|Cabometyx|cabometyx
4670244|NCT03428217|Cometriq|cometriq
4670245|NCT03428217|glutaminase|glutaminase
4670246|NCT03428217|glutamine|glutamine
4670247|NCT03428217|renal cell|renal cell
4670248|NCT03428217|clear cell|clear cell
4670249|NCT03428217|kidney cancer|kidney cancer
4670250|NCT03428217|cMET|cmet
4670251|NCT03428217|MET|met
4670252|NCT03428217|HGFR|hgfr
4670253|NCT03428191|dexmedetomidine|dexmedetomidine
4670254|NCT03428191|remifentanil|remifentanil
4670255|NCT03428191|prostate puncture and biopsy|prostate puncture and biopsy
4670256|NCT03428178|Acute LHON|acute lhon
4670257|NCT03428178|onset within three months|onset within three months
4670258|NCT03428178|onset between 3 to 6 months|onset between 3 to 6 months
4670259|NCT03428178|onset between 6 to 12 months|onset between 6 to 12 months
4670260|NCT03428178|onset between 12 to 24 months|onset between 12 to 24 months
4670261|NCT03428178|onset between 24 to 60 months|onset between 24 to 60 months
4670262|NCT03428178|onset over 60 months|onset over 60 months
4670263|NCT03428152|superior hypogastric plexus block|superior hypogastric plexus block
4670264|NCT03428152|hysterectomy|hysterectomy
4670265|NCT03428152|postoperative pain|postoperative pain
4670266|NCT03428139|lumbosacral radicular pain|lumbosacral radicular pain
4670267|NCT03428139|pulsed radiofrequency|pulsed radiofrequency
4670268|NCT03428139|Alpha Lipoic acid|alpha lipoic acid
4670269|NCT03428126|Malignant neoplasms of digestive organs|malignant neoplasms of digestive organs
4670270|NCT03428126|Colorectal Cancer|colorectal cancer
4670271|NCT03428126|Colon Cancer|colon cancer
4670272|NCT03428126|Durvalumab|durvalumab
4670273|NCT03428126|MEDI4736|medi4736
4670274|NCT03428126|Trametinib|trametinib
4670275|NCT03428126|GSK1120212|gsk1120212
4670276|NCT03428100|eczema|eczema
4670277|NCT03428100|atopic eczema|atopic eczema
4670278|NCT03428074|Chinese, esophageal cancer, surgeries of Ivor-Lewis/Mckeown|chinese, esophageal cancer, surgeries of ivor-lewis/mckeown
4670279|NCT03428061|Prevention|prevention
4670280|NCT03428061|Disease Management|disease management
4670281|NCT03428061|Integrated care|integrated care
4670282|NCT03428061|Primary Health Care|primary health care
4670283|NCT03428035|Randomized controlled trial|randomized controlled trial
4670284|NCT03428035|package insert|package insert
4670285|NCT03428035|nocebo|nocebo
4670286|NCT03428022|Apatinib|apatinib
4670287|NCT03428022|EGFR-TKI resistance|egfr-tki resistance
4670288|NCT03428022|slowly progress|slowly progress
4670289|NCT03428009|Dystonia|dystonia
4670290|NCT03428009|Control|control
4670291|NCT03428009|Magnetic Resonance Imagine|magnetic resonance imagine
4670292|NCT03428009|Genotype|genotype
4670293|NCT03428009|Phenotype|phenotype
4670294|NCT03427996|rotational atherectomy|rotational atherectomy
4670295|NCT03427957|Hysteroscopy|hysteroscopy
4670296|NCT03427957|Endometrial biopsy|endometrial biopsy
4670297|NCT03427957|Menopause|menopause
4670298|NCT03427944|Calcium Dobesilate|calcium dobesilate
4670299|NCT03427944|Non Dialysis Patients With CKD(3-5)|non dialysis patients with ckd(3-5)
4670300|NCT03427944|Glomerular filtration rate|glomerular filtration rate
4670301|NCT03427944|serum creatinine|serum creatinine
4670302|NCT03427931|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
4670303|NCT03427931|Islet Transplantation|islet transplantation
4670304|NCT03427931|Continuous Glucose Monitor (CGM)|continuous glucose monitor (cgm)
4670305|NCT03427892|mood|mood
4670306|NCT03427892|bipolar|bipolar
4670307|NCT03427892|depression|depression
4670308|NCT03427866|Myelofibrosis|myelofibrosis
4670309|NCT03427840|Superior Hypogastric Plexus Block|superior hypogastric plexus block
4670310|NCT03427840|Hysterectomy|hysterectomy
4670311|NCT03427840|Minimally invasive surgery|minimally invasive surgery
4670312|NCT03427840|Laparoscopy|laparoscopy
4670313|NCT03427840|Pain|pain
4670314|NCT03427840|Gynecologic Disease|gynecologic disease
4670315|NCT03427827|PD-1 antibody|pd-1 antibody
4670316|NCT03427827|Adjuvant treatment|adjuvant treatment
4670317|NCT03427827|Immune checkpoint inhibitors|immune checkpoint inhibitors
4670318|NCT03427814|BGB-290|bgb-290
4670319|NCT03427814|PARP inhibitor|parp inhibitor
4670320|NCT03427814|Phase 3|phase 3
4670321|NCT03427814|maintenance therapy|maintenance therapy
4670322|NCT03427814|gastric cancer|gastric cancer
4670323|NCT03427814|oral treatment|oral treatment
4670324|NCT03427801|erythropoiesis-stimulating agent|erythropoiesis-stimulating agent
4670325|NCT03427775|multimodal analgesia, quality of recovery, quality of pain management|multimodal analgesia, quality of recovery, quality of pain management
4670326|NCT03427762|balance|balance
4670327|NCT03427762|postural controll|postural controll
4670328|NCT03427762|motor controll|motor controll
4670329|NCT03427762|posturgraphy|posturgraphy
4670330|NCT03427762|quality of life|quality of life
4670331|NCT03427749|Myocardial Blood Flow|myocardial blood flow
4670332|NCT03427749|SPECT|spect
4670333|NCT03427723|Peripheral intravenous cannulation|peripheral intravenous cannulation
4670334|NCT03427723|children|children
4670335|NCT03427723|near-infrared light|near-infrared light
4670336|NCT03427684|Gastric cancer|gastric cancer
4670337|NCT03427684|Chemo-radiotherapy|chemo-radiotherapy
4670338|NCT03427684|Phase I study|phase i study
4670339|NCT03427684|Hypo-fractionated radiotherapy|hypo-fractionated radiotherapy
4670340|NCT03427658|sweet taste|sweet taste
4670341|NCT03427658|food preferences|food preferences
4670342|NCT03427658|food intake|food intake
4670343|NCT03427645|surrogate decision maker|surrogate decision maker
4670344|NCT03427632|PVP|pvp
4670345|NCT03427632|bone tumor|bone tumor
4670346|NCT03427606|sacral colpopexy|sacral colpopexy
4670347|NCT03427606|laparoscopy|laparoscopy
4670348|NCT03427606|mesh fixation|mesh fixation
4670349|NCT03427593|CVID|cvid
4670350|NCT03427593|Neutropenia|neutropenia
4670351|NCT03427593|Autoimmunity|autoimmunity
4670352|NCT03427593|Lymphoproliferation|lymphoproliferation
4670353|NCT03427580|Schizophrenia|schizophrenia
4670354|NCT03427580|Psychotherapy|psychotherapy
4670355|NCT03427580|Metacognitive abilities|metacognitive abilities
4670356|NCT03427580|Session by session assessment|session by session assessment
4670357|NCT03427580|Outcome|outcome
4670358|NCT03427567|Chinese|chinese
4670359|NCT03427567|real-world evidences|real-world evidences
4670360|NCT03427567|NSCLC|nsclc
4670361|NCT03427567|sublobar dissection|sublobar dissection
4670362|NCT03427541|Chinese|chinese
4670363|NCT03427541|non-small cell lung cancer|non-small cell lung cancer
4670364|NCT03427541|oligometastases|oligometastases
4670365|NCT03427515|Psychobiotics|psychobiotics
4670366|NCT03427515|Probiotics|probiotics
4670367|NCT03427515|Examination|examination
4670368|NCT03427515|Stress|stress
4670369|NCT03427502|general anesthesia|general anesthesia
4670370|NCT03427502|nasal surgery|nasal surgery
4670371|NCT03427502|anterior ehtmoidal nerve block|anterior ehtmoidal nerve block
4670372|NCT03427502|bupivacaine|bupivacaine
4670373|NCT03427502|postoperative confusion|postoperative confusion
4670374|NCT03427489|Biomarkers|biomarkers
4670375|NCT03427489|Genetic Markers|genetic markers
4670376|NCT03427489|Controls|controls
4670377|NCT03427476|renal cell carcinoma|renal cell carcinoma
4670378|NCT03427476|RCC|rcc
4670379|NCT03427476|prostate specific membrane antigen|prostate specific membrane antigen
4670380|NCT03427476|PSMA|psma
4670381|NCT03427476|metastatic renal cancer|metastatic renal cancer
4670382|NCT03427476|positron emission tomography|positron emission tomography
4670383|NCT03427476|PET|pet
4670384|NCT03427450|circulating tumor cells|circulating tumor cells
4670385|NCT03427450|liquid biopsy|liquid biopsy
4670386|NCT03427450|microfluidics|microfluidics
4670387|NCT03427437|sacral canal|sacral canal
4670388|NCT03427437|sacral hiatus|sacral hiatus
4670389|NCT03427437|ultrasound|ultrasound
4670390|NCT03427424|Opioid use Disorder|opioid use disorder
4670391|NCT03427424|Alcohol use Disorder|alcohol use disorder
4670392|NCT03427424|Physician Health Program|physician health program
4670393|NCT03427424|Functional Magnetic Resonance Imaging (fMRI)|functional magnetic resonance imaging (fmri)
4670784|NCT03425045|hypacusion|hypacusion
4670394|NCT03427424|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
4670395|NCT03427411|TGFR1 pathway signaling and overexpression|tgfr1 pathway signaling and overexpression
4670396|NCT03427411|PD-1 inhibitors|pd-1 inhibitors
4670397|NCT03427411|Manageable Safety Profile|manageable safety profile
4670398|NCT03427411|Bifunctional Fusion Protein|bifunctional fusion protein
4670399|NCT03427411|Refractory/Recurrent HPV Associated Malignancies|refractory/recurrent hpv associated malignancies
4670400|NCT03427385|Neuromuscular blockade|neuromuscular blockade
4670401|NCT03427359|nasopharyngeal carcinoma|nasopharyngeal carcinoma
4670402|NCT03427359|induction chemotherapy|induction chemotherapy
4670403|NCT03427359|cisplatin|cisplatin
4670404|NCT03427359|capecitabine|capecitabine
4670405|NCT03427359|chemoradiotherapy|chemoradiotherapy
4670406|NCT03427346|Barrett Esophagus|barrett esophagus
4670407|NCT03427346|ESD|esd
4670408|NCT03427346|EMR|emr
4670409|NCT03427346|Esophagus Neoplasm|esophagus neoplasm
4670410|NCT03427346|endoscopic resection technique|endoscopic resection technique
4670411|NCT03427346|ablation of esophageal mucosa|ablation of esophageal mucosa
4670412|NCT03427333|VT|vt
4670413|NCT03427333|Pacemaker Lead Extraction|pacemaker lead extraction
4670414|NCT03427333|epicardial access|epicardial access
4670415|NCT03427333|pericardial access|pericardial access
4670416|NCT03427320|[131]I-IAZA Imaging study|[131]i-iaza imaging study
4670417|NCT03427307|Lipopolysaccharide-binding protein|lipopolysaccharide-binding protein
4670418|NCT03427307|inflammation|inflammation
4670419|NCT03427307|ASCVD|ascvd
4670420|NCT03427255|superficial dyspareunia; CBT|superficial dyspareunia; cbt
4670421|NCT03427242|biliary tract carcinoma|biliary tract carcinoma
4670422|NCT03427242|apatinib|apatinib
4670423|NCT03427229|fecal microbiota transplantation|fecal microbiota transplantation
4670424|NCT03427229|Clostridium difficile infection|clostridium difficile infection
4670425|NCT03427229|pseudomembranous colitis|pseudomembranous colitis
4670426|NCT03427190|Suicide|suicide
4670427|NCT03427190|Suicide attempted|suicide attempted
4670428|NCT03427190|Secondary Prevention|secondary prevention
4670429|NCT03427190|Relapse prevention|relapse prevention
4670430|NCT03427190|Case Management|case management
4670431|NCT03427190|Intervention Study|intervention study
4670432|NCT03427164|Transjugular Intrahepatic Portosystemic Shunt|transjugular intrahepatic portosystemic shunt
4670433|NCT03427164|TIPS|tips
4670434|NCT03427164|cirrhosis|cirrhosis
4670435|NCT03427164|hepatitis|hepatitis
4670436|NCT03427164|portal vein thrombosis|portal vein thrombosis
4670437|NCT03427164|Budd-Chiari Disease|budd-chiari disease
4670438|NCT03427164|Elastography|elastography
4670439|NCT03427086|Amyotrophic lateral sclerosis|amyotrophic lateral sclerosis
4670440|NCT03427086|Biotin|biotin
4670441|NCT03427034|Urine|urine
4670442|NCT03427034|Haematuria|haematuria
4670443|NCT03427034|Flexible cystoscopy|flexible cystoscopy
4670444|NCT03427034|Recurrence|recurrence
4670445|NCT03427034|Cytology|cytology
4670446|NCT03427008|mHealth|mhealth
4670447|NCT03427008|kidney transplantation|kidney transplantation
4670448|NCT03427008|medication adherence|medication adherence
4670449|NCT03427008|video directly observed therapy|video directly observed therapy
4670450|NCT03426969|Myelofibrosis|myelofibrosis
4670451|NCT03426969|MF|mf
4670452|NCT03426969|Haploidentical hematopoietic cell transplantation|haploidentical hematopoietic cell transplantation
4670453|NCT03426969|Haplo-HCT|haplo-hct
4670454|NCT03426969|Melphalan|melphalan
4670455|NCT03426969|Alkeran|alkeran
4670456|NCT03426969|Evomela|evomela
4670457|NCT03426969|Fludarabine|fludarabine
4670458|NCT03426969|Fludarabine phosphate|fludarabine phosphate
4670459|NCT03426969|Fludara|fludara
4670460|NCT03426969|Tacrolimus|tacrolimus
4670461|NCT03426969|Prograf|prograf
4670462|NCT03426969|Mycophenolate Mofetil|mycophenolate mofetil
4670463|NCT03426969|MMF|mmf
4670464|NCT03426969|CellCept|cellcept
4670465|NCT03426969|G-CSF|g-csf
4670466|NCT03426969|Filgrastim|filgrastim
4670467|NCT03426969|Neupogen|neupogen
4670468|NCT03426969|Total body irradiation|total body irradiation
4670469|NCT03426969|TBI|tbi
4670470|NCT03426969|External beam radiation therapy|external beam radiation therapy
4670471|NCT03426956|Glucagon-like Peptide-1|glucagon-like peptide-1
4670472|NCT03426956|Glucose|glucose
4670473|NCT03426956|Gastric bypass|gastric bypass
4670474|NCT03426956|Bariatric surgery|bariatric surgery
4670475|NCT03426956|Obesity|obesity
4670476|NCT03426956|Diabetes|diabetes
4670477|NCT03426891|Immunotherapy|immunotherapy
4670478|NCT03426891|Radiotherapy|radiotherapy
4670479|NCT03426891|Glioblastoma|glioblastoma
4670480|NCT03426878|Lynch syndrome|lynch syndrome
4670481|NCT03426878|Hereditary breast and ovarian cancer|hereditary breast and ovarian cancer
4670482|NCT03426865|retroperitoneal lymph node dissection|retroperitoneal lymph node dissection
4670483|NCT03426865|testicular cancer|testicular cancer
4670484|NCT03426865|testis cancer|testis cancer
4670485|NCT03426865|germ cell tumor|germ cell tumor
4670486|NCT03426865|PET scan|pet scan
4670487|NCT03426865|Axumin|axumin
4670488|NCT03426865|teratoma|teratoma
4670489|NCT03426852|Biomechanical Phenomenon|biomechanical phenomenon
4670490|NCT03426852|Gait|gait
4670491|NCT03426852|Lumbar Disc Degeneration|lumbar disc degeneration
4670785|NCT03425045|depression|depression
4670492|NCT03426839|hemostatic techniques|hemostatic techniques
4670493|NCT03426839|perioperative hemorrhage|perioperative hemorrhage
4670494|NCT03426839|platelet function test|platelet function test
4670495|NCT03426839|point of care technology|point of care technology
4670496|NCT03426839|thromboelastometry|thromboelastometry
4670497|NCT03426839|vascular surgical procedures|vascular surgical procedures
4670498|NCT03426826|FMT|fmt
4670499|NCT03426826|Gut Microbiome|gut microbiome
4670500|NCT03426826|Fecal Microbiata Transplantation|fecal microbiata transplantation
4670501|NCT03426826|Autism Spectrum Disorder|autism spectrum disorder
4670502|NCT03426826|16s rRNA|16s rrna
4670503|NCT03426826|Gastro-Intestinal Disorder|gastro-intestinal disorder
4670504|NCT03426813|mobilization|mobilization
4670505|NCT03426813|physiotherapy|physiotherapy
4670506|NCT03426813|community-acquired pneumonia|community-acquired pneumonia
4670507|NCT03426800|Acupuncture|acupuncture
4670508|NCT03426800|Training|training
4670509|NCT03426800|Children|children
4670510|NCT03426800|Effect|effect
4670511|NCT03426787|Patient Centered|patient centered
4670512|NCT03426787|Pre-Post Design|pre-post design
4670513|NCT03426787|Decision Support|decision support
4670514|NCT03426787|Health Literacy|health literacy
4670515|NCT03426748|Brachytherapy|brachytherapy
4670516|NCT03426748|Quality of life|quality of life
4670517|NCT03426748|High dose rate vs. low dose rate|high dose rate vs. low dose rate
4670518|NCT03426748|Intermediate risk group|intermediate risk group
4670519|NCT03426735|Iodine|iodine
4670520|NCT03426735|Iodized|iodized
4670521|NCT03426735|Computerized Tomography|computerized tomography
4670522|NCT03426735|Extravasation|extravasation
4670523|NCT03426735|contrast media|contrast media
4670524|NCT03426709|Depression|depression
4670525|NCT03426709|Multimorbidity|multimorbidity
4670526|NCT03426709|Computer-delivered psychotherapy|computer-delivered psychotherapy
4670527|NCT03426709|Randomized-controlled trial|randomized-controlled trial
4670528|NCT03426709|Cost-effectiveness|cost-effectiveness
4670529|NCT03426696|psychological status|psychological status
4670530|NCT03426696|Related Factors|related factors
4670531|NCT03426696|Thyroid Related Eye Disease|thyroid related eye disease
4670532|NCT03426683|Inflammatory Bowel Disease(IBD)|inflammatory bowel disease(ibd)
4670533|NCT03426683|Ulcerative colitis(UC)|ulcerative colitis(uc)
4670534|NCT03426683|Crohn's disease(CD)|crohn's disease(cd)
4670535|NCT03426683|intestinal microbiota transplantation|intestinal microbiota transplantation
4670536|NCT03426683|microbiota|microbiota
4670537|NCT03426670|HIV self-testing|hiv self-testing
4670538|NCT03426670|Pre-exposure prophylaxis|pre-exposure prophylaxis
4670539|NCT03426670|Sex workers|sex workers
4670540|NCT03426644|Childhood sleep promotion|childhood sleep promotion
4670541|NCT03426644|Sleep promotion|sleep promotion
4670542|NCT03426644|Sleep|sleep
4670543|NCT03426592|HIV|hiv
4670544|NCT03426592|Inflammation|inflammation
4670545|NCT03426592|Vitamin D|vitamin d
4670546|NCT03426592|Immunomodulation|immunomodulation
4670547|NCT03426592|Virus latency|virus latency
4670548|NCT03426566|diabetic foot|diabetic foot
4670549|NCT03426566|pedobarography|pedobarography
4670550|NCT03426566|diabetic neuropathy|diabetic neuropathy
4670551|NCT03426566|plantar pressure|plantar pressure
4670552|NCT03426553|Patogen inactivation|patogen inactivation
4670553|NCT03426553|Pathogen reduction|pathogen reduction
4670554|NCT03426553|clinical use|clinical use
4670555|NCT03426553|riboflavin+UV|riboflavin+uv
4670556|NCT03426553|RBC transfusion|rbc transfusion
4670557|NCT03426553|whole blood|whole blood
4670558|NCT03426514|Colorectal cancer|colorectal cancer
4670559|NCT03426514|Laparoscopic surgery|laparoscopic surgery
4670560|NCT03426514|Three-port|three-port
4670561|NCT03426501|heart rate variability|heart rate variability
4670562|NCT03426501|prognosis|prognosis
4670563|NCT03426475|nursing home residents|nursing home residents
4670564|NCT03426475|interprofessional collaboration|interprofessional collaboration
4670565|NCT03426475|reduction of hospitalisation|reduction of hospitalisation
4670566|NCT03426462|Pharmacodynamic|pharmacodynamic
4670567|NCT03426462|Permutation Entropy|permutation entropy
4670568|NCT03426462|EEG|eeg
4670569|NCT03426423|Gender|gender
4670570|NCT03426423|Metabolism|metabolism
4670571|NCT03426423|Microbiota|microbiota
4670572|NCT03426397|Complete response|complete response
4670573|NCT03426397|Organ preservation|organ preservation
4670574|NCT03426397|Wait-and-See|wait-and-see
4670575|NCT03426397|Watch-and-Wait|watch-and-wait
4670576|NCT03426397|Watchful Waiting|watchful waiting
4670577|NCT03426384|SLE|sle
4670578|NCT03426384|FLARE|flare
4670579|NCT03426384|Lupus|lupus
4670580|NCT03426384|Digital Therapeutics|digital therapeutics
4670581|NCT03426384|Health Coaching|health coaching
4670582|NCT03426384|Smartphone App|smartphone app
4670583|NCT03426358|Veno Occlusive Disease|veno occlusive disease
4670584|NCT03426358|Sinusoidal Obstruction Syndrome|sinusoidal obstruction syndrome
4670585|NCT03426358|HSCT|hsct
4670586|NCT03426358|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
4670587|NCT03426358|Stem Cell Transplant Complications|stem cell transplant complications
4670588|NCT03426358|Liver Stiffness Measurement|liver stiffness measurement
4670589|NCT03426358|Sinusoidal Obstructive Syndrome|sinusoidal obstructive syndrome
4670590|NCT03426358|Transient Elastography|transient elastography
4670591|NCT03426332|Adrenal Insufficiency|adrenal insufficiency
4670592|NCT03426332|Adrenal crisis|adrenal crisis
4670593|NCT03426332|Adrenal emergency|adrenal emergency
4670594|NCT03426332|Glucocorticoid injection|glucocorticoid injection
4670595|NCT03426319|Primary adrenal insufficiency|primary adrenal insufficiency
4670596|NCT03426319|Cardiovascular status|cardiovascular status
4670597|NCT03426319|Metabolic profile|metabolic profile
4670598|NCT03426306|4-Dimensional Computed Tomography|4-dimensional computed tomography
4670599|NCT03426293|heparin;ACT;non-cardiac vascular;peri-procedural|heparin;act;non-cardiac vascular;peri-procedural
4670600|NCT03426254|Subcutaneously Talazoparib|subcutaneously talazoparib
4670601|NCT03426241|chronic periodontitis|chronic periodontitis
4670602|NCT03426241|smoking|smoking
4670603|NCT03426241|mmp-2|mmp-2
4670604|NCT03426241|mmp-9|mmp-9
4670605|NCT03426228|IVF, Glucose Homeostasis, Metabolic Parameters|ivf, glucose homeostasis, metabolic parameters
4670606|NCT03426202|modafinil|modafinil
4670607|NCT03426202|emotion|emotion
4670608|NCT03426202|cognitive processing|cognitive processing
4670609|NCT03426189|HIV|hiv
4670610|NCT03426189|Latent reservoir|latent reservoir
4670611|NCT03426189|Leukapheresis|leukapheresis
4670612|NCT03426189|Inguinal lymph node biopsy|inguinal lymph node biopsy
4670613|NCT03426189|Immune checkpoint|immune checkpoint
4670615|NCT03426189|CTLA4|ctla4
4670616|NCT03426176|oxytocin|oxytocin
4670617|NCT03426176|acute tryptophan depletion|acute tryptophan depletion
4670618|NCT03426176|emotion|emotion
4670619|NCT03426163|virtual reality|virtual reality
4670620|NCT03426163|knee|knee
4670621|NCT03426137|Oxycodone|oxycodone
4670622|NCT03426137|Placebo|placebo
4670623|NCT03426137|Expectancy Induced Analgesia|expectancy induced analgesia
4670624|NCT03426137|NSAID|nsaid
4670625|NCT03426124|venous thromboembolism|venous thromboembolism
4670626|NCT03426111|Non-Alcoholic Fatty Liver Disease|non-alcoholic fatty liver disease
4670627|NCT03426111|NASH|nash
4670628|NCT03426111|Obesity|obesity
4670629|NCT03426111|Endoscopic gastric tubulization|endoscopic gastric tubulization
4670630|NCT03426111|Non-alcoholic steatohepatitis|non-alcoholic steatohepatitis
4670631|NCT03426072|quality improvement|quality improvement
4670632|NCT03426059|Phelan-McDermid Syndrome|phelan-mcdermid syndrome
4670633|NCT03426059|PMS|pms
4670634|NCT03426059|Genotype|genotype
4670635|NCT03426059|Phenotype|phenotype
4670636|NCT03426059|Mapping|mapping
4670637|NCT03426059|22q13 Deletion Syndrome|22q13 deletion syndrome
4670638|NCT03426059|SHANK3|shank3
4670639|NCT03426059|Autism Spectrum Disorder|autism spectrum disorder
4670640|NCT03426059|ASD|asd
4670641|NCT03426059|Intellectual Disability|intellectual disability
4670642|NCT03426059|ID|id
4670643|NCT03426046|Biodentine|biodentine
4670644|NCT03426046|Cariously exposed pulp|cariously exposed pulp
4670645|NCT03426046|MTA|mta
4670646|NCT03426046|Partial pulpotomy|partial pulpotomy
4670647|NCT03426046|Image J Software|image j software
4670648|NCT03426020|Premedication|premedication
4670649|NCT03426020|Pediatric patients|pediatric patients
4670650|NCT03426020|Emergence agitation|emergence agitation
4670651|NCT03426007|uterine lavage|uterine lavage
4670652|NCT03426007|intrauterine insemination|intrauterine insemination
4670653|NCT03426007|embryo|embryo
4670654|NCT03426007|blastocyst|blastocyst
4670655|NCT03426007|in vivo|in vivo
4670656|NCT03426007|superovulation|superovulation
4670657|NCT03425981|WB-EMS|wb-ems
4670658|NCT03425981|Running economy|running economy
4670659|NCT03425981|VO2max|vo2max
4670660|NCT03425968|Injury rate|injury rate
4670661|NCT03425942|Cognitive Behavioral Therapy|cognitive behavioral therapy
4670662|NCT03425942|Applied Relaxation Techniques|applied relaxation techniques
4670663|NCT03425942|Internet treatment|internet treatment
4670664|NCT03425929|amygdala, fear, intrusion, oxytocin, trauma disclosure|amygdala, fear, intrusion, oxytocin, trauma disclosure
4670665|NCT03425916|Hypopressive exercises|hypopressive exercises
4670666|NCT03425916|Ultrasonography|ultrasonography
4670667|NCT03425903|Fibromyalgia, Whole body cryotherapy|fibromyalgia, whole body cryotherapy
4670668|NCT03425890|Upper Limb|upper limb
4670669|NCT03425890|Self-exercise|self-exercise
4670670|NCT03425877|arousal, valence, emotion, heart rate variability, electrodermal activity, u-shape curve, performance, neurorehabilitation|arousal, valence, emotion, heart rate variability, electrodermal activity, u-shape curve, performance, neurorehabilitation
4670671|NCT03425851|Diaper need|diaper need
4670672|NCT03425851|Infants|infants
4670673|NCT03425851|Well baby visits|well baby visits
4670674|NCT03425851|Low-income families|low-income families
4670675|NCT03425851|Caregiver stress|caregiver stress
4670676|NCT03425838|CDK 4/6 inhibitor|cdk 4/6 inhibitor
4670677|NCT03425825|Small Cell Lung Cancer (SCLC)|small cell lung cancer (sclc)
4670678|NCT03425812|Axial Spondyloarthritis|axial spondyloarthritis
4670679|NCT03425812|Anti-Inflammatory Drugs|anti-inflammatory drugs
4670680|NCT03425812|Flare|flare
4670681|NCT03425773|HER2/neu|her2/neu
4670682|NCT03425773|IHC 1+|ihc 1+
4670683|NCT03425773|BVAC|bvac
4670684|NCT03425773|Cellid|cellid
4670685|NCT03425773|B-cell|b-cell
4670686|NCT03425773|Monocyte|monocyte
4670687|NCT03425773|Immunotherapeutic vaccine|immunotherapeutic vaccine
4670688|NCT03425773|Breast cancer|breast cancer
4670689|NCT03425773|Colorectal cancer|colorectal cancer
4670690|NCT03425773|Pancreatic cancer|pancreatic cancer
4670691|NCT03425747|calcium carbonate|calcium carbonate
4670692|NCT03425747|calcium citrate|calcium citrate
4670693|NCT03425747|quality of life|quality of life
4670694|NCT03425747|hypoparathyroidism|hypoparathyroidism
4670695|NCT03425747|hypocalcemia|hypocalcemia
4670696|NCT03425708|Uric Acid|uric acid
4670697|NCT03425708|Febuxostat|febuxostat
4670698|NCT03425708|Chronic Renal Disease|chronic renal disease
4670699|NCT03425695|Free gingival graft, Low level laser therapy, Shrinkage|free gingival graft, low level laser therapy, shrinkage
4670700|NCT03425682|Anterior Cervical Discectomy and Fusion (ACDF)|anterior cervical discectomy and fusion (acdf)
4670701|NCT03425682|Transforaminal Lumbar Interbody Fusion (TLIF)|transforaminal lumbar interbody fusion (tlif)
4670702|NCT03425682|Posterior Lumbar Interbody Fusion (PLIF)|posterior lumbar interbody fusion (plif)
4670703|NCT03425669|Acoustic and vestibular noise stimulation|acoustic and vestibular noise stimulation
4670704|NCT03425656|breast cancer|breast cancer
4670705|NCT03425656|AryoTrust™|aryotrust™
4670706|NCT03425656|Herceptin®|herceptin®
4670707|NCT03425656|non-Inferiority|non-inferiority
4670708|NCT03425578|Monosodium glutamate|monosodium glutamate
4670709|NCT03425578|Amino acids|amino acids
4670710|NCT03425578|Glucose tolerance|glucose tolerance
4670711|NCT03425526|Hematological Malignancies|hematological malignancies
4670712|NCT03425526|Immunocompromised Patients|immunocompromised patients
4670713|NCT03425526|Adenovirus Specific T Cells|adenovirus specific t cells
4670714|NCT03425513|Belgium|belgium
4670715|NCT03425513|Prevalence|prevalence
4670716|NCT03425513|Risk factor|risk factor
4670717|NCT03425513|Ethnicity|ethnicity
4670718|NCT03425513|Linkage of care|linkage of care
4670719|NCT03425487|Mindfulness|mindfulness
4670720|NCT03425487|Compassion|compassion
4670721|NCT03425487|Mental Health Services|mental health services
4670722|NCT03425422|Vagus nerve stimulation|vagus nerve stimulation
4670723|NCT03425383|Cardiovascular disease, FMD, c-IMT|cardiovascular disease, fmd, c-imt
4670724|NCT03425370|Surgical wounds|surgical wounds
4670725|NCT03425370|Tissue adhesive|tissue adhesive
4670726|NCT03425370|Sutures|sutures
4670727|NCT03425370|Wound healing|wound healing
4670728|NCT03425331|Non-Small Cell Lung Cancer|non-small cell lung cancer
4670729|NCT03425305|Serum uric acid|serum uric acid
4670730|NCT03425305|Cardiovascular disease|cardiovascular disease
4670731|NCT03425305|Atherosclerosis|atherosclerosis
4670732|NCT03425292|immunotherapy|immunotherapy
4670733|NCT03425292|nivolumab|nivolumab
4670734|NCT03425292|ipilimumab|ipilimumab
4670735|NCT03425266|shared decision-making|shared decision-making
4670736|NCT03425266|decision support tool|decision support tool
4670737|NCT03425266|patient-provider communication|patient-provider communication
4670738|NCT03425266|managing chronic pain|managing chronic pain
4670739|NCT03425266|patient preferences|patient preferences
4670740|NCT03425266|values clarification|values clarification
4670741|NCT03425253|Lower Face Contouring|lower face contouring
4670742|NCT03425240|Erectile Dysfunction|erectile dysfunction
4670743|NCT03425240|Prostate Cancer|prostate cancer
4670744|NCT03425240|Neuromodulation|neuromodulation
4670745|NCT03425227|Frailty|frailty
4670746|NCT03425227|Elderly People|elderly people
4670747|NCT03425227|Exergame|exergame
4670748|NCT03425227|Physical Activity|physical activity
4670749|NCT03425227|Kinect|kinect
4670750|NCT03425227|Biofeeback|biofeeback
4670751|NCT03425214|functional MRI|functional mri
4670752|NCT03425214|Reward system|reward system
4670753|NCT03425214|REM sleep behaviour disorder|rem sleep behaviour disorder
4670754|NCT03425214|Narco-cataplexy|narco-cataplexy
4670755|NCT03425175|Non-relevant conversation|non-relevant conversation
4670756|NCT03425175|Surgical safety|surgical safety
4670757|NCT03425175|Audio recording|audio recording
4670758|NCT03425162|quadratus lumborum block|quadratus lumborum block
4670759|NCT03425162|pain|pain
4670760|NCT03425162|ultrasound|ultrasound
4670761|NCT03425162|percutaneous nephrolithotomy|percutaneous nephrolithotomy
4670762|NCT03425149|vaccine|vaccine
4670763|NCT03425149|prevention|prevention
4670764|NCT03425136|Prevention of Mother-to-Child HIV Transmission|prevention of mother-to-child hiv transmission
4670765|NCT03425136|HIV|hiv
4670766|NCT03425136|PMTCT|pmtct
4670767|NCT03425123|Regenerative endodontic procedure (REP)|regenerative endodontic procedure (rep)
4670768|NCT03425123|Mineral Trioxide Aggregate (MTA) apexification|mineral trioxide aggregate (mta) apexification
4670769|NCT03425123|Calcium Hydroxide -Ca(OH)2|calcium hydroxide -ca(oh)2
4670770|NCT03425123|Permanent non-vital tooth|permanent non-vital tooth
4670771|NCT03425123|Children 7-18 years of age|children 7-18 years of age
4670772|NCT03425071|Tacrolimus|tacrolimus
4670773|NCT03425071|T Lymphocytes|t lymphocytes
4670774|NCT03425071|B lymphocytes|b lymphocytes
4670775|NCT03425071|Monitoring, Immunologic|monitoring, immunologic
4670776|NCT03425058|Molecular Evaluation|molecular evaluation
4670777|NCT03425058|Locally Advanced Gastric Cancer|locally advanced gastric cancer
4670778|NCT03425058|Neoadjuvant Chemotherapy|neoadjuvant chemotherapy
4670779|NCT03425058|ctDNA|ctdna
4670780|NCT03425058|CTC|ctc
4670781|NCT03425058|dMMR/MSI|dmmr/msi
4670782|NCT03425045|chronic tinnitus|chronic tinnitus
4670783|NCT03425045|repetitive transcranial magnetic stimulation|repetitive transcranial magnetic stimulation
4670786|NCT03425045|treatment|treatment
4670787|NCT03425045|placebo|placebo
4670788|NCT03425045|medication therapy|medication therapy
4670789|NCT03425019|Knee Osteoarthritis|knee osteoarthritis
4670790|NCT03425019|Chronic Pain|chronic pain
4670791|NCT03425019|Osteoarthritis|osteoarthritis
4670792|NCT03425019|Transcranial Direct Current Stimulation|transcranial direct current stimulation
4670793|NCT03425019|tDCS|tdcs
4670794|NCT03424993|Endothelium, vascular|endothelium, vascular
4670795|NCT03424993|Cardiovascular Disease|cardiovascular disease
4670796|NCT03424993|Hemodynamics|hemodynamics
4670797|NCT03424993|Oxidative Stress|oxidative stress
4670798|NCT03424993|Dietary Sodium|dietary sodium
4670799|NCT03424993|Dietary Counseling|dietary counseling
4670800|NCT03424980|Non-small cell lung cancer, Chinese, brain metastases|non-small cell lung cancer, chinese, brain metastases
4670801|NCT03424967|attention-bias modification|attention-bias modification
4670802|NCT03424967|statistical learning|statistical learning
4670803|NCT03424967|social anxiety disorder|social anxiety disorder
4670804|NCT03424967|treatment outcome|treatment outcome
4670805|NCT03424941|Aortic Stenosis (AS)|aortic stenosis (as)
4670806|NCT03424941|Multi Vessel Coronary Artery Disease (MVD)|multi vessel coronary artery disease (mvd)
4670807|NCT03424941|TransCatheter Aortic Valve Implantation (TAVI)|transcatheter aortic valve implantation (tavi)
4670808|NCT03424941|Coronary Artery By-pass Grafting (CABG)|coronary artery by-pass grafting (cabg)
4670809|NCT03424941|Percutaneous Coronary Intervention (PCI)|percutaneous coronary intervention (pci)
4670810|NCT03424941|Fractional Flow Reserve (FFR)|fractional flow reserve (ffr)
4670811|NCT03424941|Surgical Aortic Valve Replacement (SAVR)|surgical aortic valve replacement (savr)
4670812|NCT03424928|Pomalidomide|pomalidomide
4670813|NCT03424928|Multiple myeloma|multiple myeloma
4670814|NCT03424928|Bioequivalence|bioequivalence
4670815|NCT03424889|Bronchoscopy|bronchoscopy
4670816|NCT03424889|Lignocaine|lignocaine
4670817|NCT03424889|Anaesthesia|anaesthesia
4670818|NCT03424876|Sunitinib Imatinib|sunitinib imatinib
4670819|NCT03424798|mechanical ventilation|mechanical ventilation
4670820|NCT03424798|lung function|lung function
4670821|NCT03424798|cardiopulmonary monitoring|cardiopulmonary monitoring
4670822|NCT03424785|Aortic intramural hematoma|aortic intramural hematoma
4670823|NCT03424785|Chinese patients|chinese patients
4670824|NCT03424785|Clinical outcomes|clinical outcomes
4670825|NCT03424733|demyelination|demyelination
4670826|NCT03424733|relapse rate|relapse rate
4670827|NCT03424733|Pegylated interferon beta-1a|pegylated interferon beta-1a
4670828|NCT03424733|side effects|side effects
4670829|NCT03424733|flu-like symptoms|flu-like symptoms
4670830|NCT03424733|injection site reactions|injection site reactions
4670831|NCT03424733|prednisone|prednisone
4670832|NCT03424694|Brachytherapy|brachytherapy
4670833|NCT03424694|Monotherapy|monotherapy
4670834|NCT03424694|HDR Brachytherapy|hdr brachytherapy
4670835|NCT03424694|Toxicity|toxicity
4670836|NCT03424694|Quality of Life|quality of life
4670837|NCT03424694|Progression Free Survival|progression free survival
4670838|NCT03424668|nutrition|nutrition
4670839|NCT03424668|physical activity|physical activity
4670840|NCT03424668|lifestyle|lifestyle
4670841|NCT03424668|smoking|smoking
4670842|NCT03424655|post -endodontic pain|post -endodontic pain
4670843|NCT03424655|endodontic pain|endodontic pain
4670844|NCT03424655|pain|pain
4670845|NCT03424642|prenatal depression|prenatal depression
4670846|NCT03424642|prenatal anxiety|prenatal anxiety
4670847|NCT03424642|prenatal mental disorders|prenatal mental disorders
4670848|NCT03424642|interactive ultrasound examination|interactive ultrasound examination
4670849|NCT03424642|maternal-fetal relations|maternal-fetal relations
4670850|NCT03424629|psoriasis|psoriasis
4670851|NCT03424629|UC-MSCs|uc-mscs
4670852|NCT03424616|Opiate dependence|opiate dependence
4670853|NCT03424616|Deep brain stimulation|deep brain stimulation
4670854|NCT03424616|Nucleus accumbens|nucleus accumbens
4670855|NCT03424577|H3B-6527|h3b-6527
4670856|NCT03424577|Healthy Participants|healthy participants
4670857|NCT03424577|Pharmacokinetics|pharmacokinetics
4670858|NCT03424564|Perampanel|perampanel
4670859|NCT03424564|Pharmacokinetics|pharmacokinetics
4670861|NCT03424564|Chinese|chinese
4670862|NCT03424551|vibration|vibration
4670863|NCT03424551|muscle spindle|muscle spindle
4670864|NCT03424551|H reflex|h reflex
4670865|NCT03424551|tonic vibration reflex|tonic vibration reflex
4670866|NCT03424538|multiple sclerosis|multiple sclerosis
4670867|NCT03424538|posture|posture
4670868|NCT03424538|neurorehabilitation|neurorehabilitation
4670869|NCT03424538|balance|balance
4670870|NCT03424499|neurogenic bladder|neurogenic bladder
4670871|NCT03424499|intermittent urethral catheterization|intermittent urethral catheterization
4670872|NCT03424499|Clean intermittent catheterization|clean intermittent catheterization
4670873|NCT03424486|Cystic fibrosis|cystic fibrosis
4670874|NCT03424486|Anxiety|anxiety
4670875|NCT03424486|Depression|depression
4670876|NCT03424486|Adolescence|adolescence
4670877|NCT03424473|tucatinib|tucatinib
4670878|NCT03424473|Breast Cancer|breast cancer
4670879|NCT03424473|ARRY-380|arry-380
4670880|NCT03424473|ONT-380|ont-380
4670881|NCT03424473|HER2 Positive Breast Carcinoma|her2 positive breast carcinoma
4670977|NCT03423940|Treatment Relapse|treatment relapse
4670882|NCT03424473|HER2 Positive Locally Advanced Breast Cancer|her2 positive locally advanced breast cancer
4670883|NCT03424473|HER-2 Positive Breast Cancer|her-2 positive breast cancer
4670884|NCT03424473|HER-2 Positive Locally Advanced Breast Cancer|her-2 positive locally advanced breast cancer
4670885|NCT03424473|Recurrent Breast Carcinoma|recurrent breast carcinoma
4670886|NCT03424473|Stage IV Breast Cancer|stage iv breast cancer
4670887|NCT03424473|Metastatic Breast Cancer|metastatic breast cancer
4670888|NCT03424473|Breast Carcinoma|breast carcinoma
4670889|NCT03424473|Metastatic Malignant Neoplasm in the Brain|metastatic malignant neoplasm in the brain
4670890|NCT03424473|Brain Metastases in Breast Cancer|brain metastases in breast cancer
4670891|NCT03424473|Breast Neoplasms|breast neoplasms
4670892|NCT03424473|Neoplasms by Site|neoplasms by site
4670893|NCT03424473|Neoplasms|neoplasms
4670894|NCT03424473|Breast Diseases|breast diseases
4670895|NCT03424460|Myotonic dystrophy 1|myotonic dystrophy 1
4670896|NCT03424460|Venous thromboembolism|venous thromboembolism
4670897|NCT03424460|Pulmonary embolism|pulmonary embolism
4670898|NCT03424460|Deep vein thrombosis|deep vein thrombosis
4670899|NCT03424460|Hypercoagulability|hypercoagulability
4670900|NCT03424460|Thrombophilia|thrombophilia
4670901|NCT03424460|RNA alternative splicing|rna alternative splicing
4670902|NCT03424434|Occupational blood exposure|occupational blood exposure
4670903|NCT03424434|underreporting|underreporting
4670904|NCT03424434|medical|medical
4670905|NCT03424434|hospital|hospital
4670906|NCT03424421|Shoulder Joint|shoulder joint
4670907|NCT03424421|Orthopedics|orthopedics
4670908|NCT03424421|Arthroscopy|arthroscopy
4670909|NCT03424395|personalized dietary and wellness program|personalized dietary and wellness program
4670910|NCT03424395|oral protein glucose lipid tolerance test|oral protein glucose lipid tolerance test
4670911|NCT03424395|metabolism|metabolism
4670912|NCT03424395|behavior|behavior
4670913|NCT03424395|health|health
4670914|NCT03424395|body composition|body composition
4670915|NCT03424395|single nucleotide polymorphisms|single nucleotide polymorphisms
4670916|NCT03424395|genotype|genotype
4670917|NCT03424395|dietary and wellness coaching/advice|dietary and wellness coaching/advice
4670918|NCT03424395|liquid meal challenge test|liquid meal challenge test
4670919|NCT03424356|LMA|lma
4670920|NCT03424356|Rocuronium bromur|rocuronium bromur
4670921|NCT03424356|propofol|propofol
4670922|NCT03424343|survivors|survivors
4670923|NCT03424343|parents|parents
4670924|NCT03424343|sibling|sibling
4670925|NCT03424343|family environment|family environment
4670926|NCT03424343|psychosocial functioning|psychosocial functioning
4670927|NCT03424343|longitudinal|longitudinal
4670928|NCT03424343|cancer|cancer
4670929|NCT03424343|identity|identity
4670930|NCT03424343|adolescence|adolescence
4670931|NCT03424343|emerging adulthood|emerging adulthood
4670932|NCT03424278|Low back pain|low back pain
4670933|NCT03424278|Exercise|exercise
4670934|NCT03424252|Cystic Fibrosis|cystic fibrosis
4670935|NCT03424239|Roux-en-Y gastric bypass|roux-en-y gastric bypass
4670936|NCT03424174|TKA, cytokine, coating|tka, cytokine, coating
4670937|NCT03424122|Diffuse large B-cell lymphoma (DLBCL)|diffuse large b-cell lymphoma (dlbcl)
4670938|NCT03424122|follicular lymphoma (FL)|follicular lymphoma (fl)
4670939|NCT03424122|marginal zone lymphoma (MZL)|marginal zone lymphoma (mzl)
4670940|NCT03424122|mantle cell lymphoma (MCL)|mantle cell lymphoma (mcl)
4670941|NCT03424122|phosphatidylinositol 3-kinase delta (PI3Kδ) inhibitor|phosphatidylinositol 3-kinase delta (pi3kδ) inhibitor
4670942|NCT03424109|Emergency Department|emergency department
4670943|NCT03424109|Palliative Care|palliative care
4670944|NCT03424070|laryngoscopy|laryngoscopy
4670945|NCT03424070|pediatric|pediatric
4670946|NCT03424070|airway|airway
4670947|NCT03424070|gel roll|gel roll
4670948|NCT03424070|larynx|larynx
4670949|NCT03424070|glottis|glottis
4670950|NCT03424057|Karydakis modification|karydakis modification
4670951|NCT03424057|pilonidal sinus|pilonidal sinus
4670952|NCT03424057|seroma|seroma
4670953|NCT03424044|glucagon|glucagon
4670954|NCT03424044|closed-loop|closed-loop
4670955|NCT03424044|Omnipod|omnipod
4670956|NCT03424044|exercise|exercise
4670957|NCT03424018|ACH|ach
4670958|NCT03424018|Achondroplasia|achondroplasia
4670959|NCT03424018|Bone Diseases|bone diseases
4670960|NCT03424018|Bone Diseases, Developmental|bone diseases, developmental
4670961|NCT03424018|Dwarfism|dwarfism
4670962|NCT03424018|Genetic Diseases, Inborn|genetic diseases, inborn
4670963|NCT03424018|Musculoskeletal Diseases|musculoskeletal diseases
4670964|NCT03424018|Natriuretic Agents|natriuretic agents
4670965|NCT03424018|Natriuretic Peptide, C-Type|natriuretic peptide, c-type
4670966|NCT03424018|Osteochondrodysplasias|osteochondrodysplasias
4670967|NCT03424018|Physiological Effects of Drugs|physiological effects of drugs
4670968|NCT03424018|Skeletal Dysplasias|skeletal dysplasias
4670969|NCT03423979|BPH|bph
4670970|NCT03423953|osteoarthritis|osteoarthritis
4670971|NCT03423953|avascular necrosis|avascular necrosis
4670972|NCT03423953|rheumatoid arthritis|rheumatoid arthritis
4670973|NCT03423940|Functional communication training|functional communication training
4670974|NCT03423940|Reinforcement Schedule Thinning|reinforcement schedule thinning
4670975|NCT03423940|Resurgence|resurgence
4670976|NCT03423940|Treatment Dosage|treatment dosage
4670978|NCT03423914|writing|writing
4670979|NCT03423914|postraumatic stress|postraumatic stress
4670980|NCT03423914|coping|coping
4670981|NCT03423901|Complications|complications
4670982|NCT03423888|Dyspnea|dyspnea
4670983|NCT03423888|palliative care|palliative care
4670984|NCT03423888|high-flow nasal oxygen|high-flow nasal oxygen
4670985|NCT03423888|pilot study|pilot study
4670986|NCT03423875|Delirium, Delirium Recognition|delirium, delirium recognition
4670987|NCT03423823|Neovascularization|neovascularization
4670988|NCT03423797|silver nitrate|silver nitrate
4670989|NCT03423797|sodium fluoride|sodium fluoride
4670990|NCT03423797|dental caries|dental caries
4670991|NCT03423797|equivalence trial|equivalence trial
4670992|NCT03423784|teething in infants and children|teething in infants and children
4670993|NCT03423784|oral gels|oral gels
4670994|NCT03423784|paediatric dentistry|paediatric dentistry
4670995|NCT03423758|Pseudoexfoliation Glaucoma, Angle block glaucoma, Genetic|pseudoexfoliation glaucoma, angle block glaucoma, genetic
4670996|NCT03423745|intubation|intubation
4670997|NCT03423745|cardiopulmonary resuscitation|cardiopulmonary resuscitation
4670998|NCT03423745|number of endotracheal intubation experience|number of endotracheal intubation experience
4670999|NCT03423693|Small airway obstruction|small airway obstruction
4671000|NCT03423693|Asthma|asthma
4671001|NCT03423693|COPD|copd
4671002|NCT03423693|ACOS|acos
4671003|NCT03423667|N-acetylcysteine|n-acetylcysteine
4671004|NCT03423667|Craving|craving
4671005|NCT03423641|Drug-Related Side Effects and Adverse Reactions|drug-related side effects and adverse reactions
4671006|NCT03423641|Antiviral Agents / Adverse Effects|antiviral agents / adverse effects
4671007|NCT03423641|Antiviral Agents / Toxicity|antiviral agents / toxicity
4671008|NCT03423641|Simeprevir|simeprevir
4671009|NCT03423641|Sofosbuvir|sofosbuvir
4671010|NCT03423641|Ledipasvir|ledipasvir
4671011|NCT03423641|Ombitasvir|ombitasvir
4671012|NCT03423641|Paritaprevir|paritaprevir
4671013|NCT03423641|Ritonavir|ritonavir
4671014|NCT03423641|Dasabuvir|dasabuvir
4671015|NCT03423641|Daclatasvir|daclatasvir
4671016|NCT03423641|Elbasvir|elbasvir
4671017|NCT03423641|Grazoprevir|grazoprevir
4671018|NCT03423641|Velpatasvir|velpatasvir
4671019|NCT03423641|Ribavirin|ribavirin
4671020|NCT03423628|glioblastoma|glioblastoma
4671021|NCT03423628|brain metastases|brain metastases
4671022|NCT03423628|Ataxia-telangiectasia mutated kinase (ATM) inhibition|ataxia-telangiectasia mutated kinase (atm) inhibition
4671023|NCT03423628|radiation therapy|radiation therapy
4671024|NCT03423615|School Health Services|school health services
4671025|NCT03423615|Health Education|health education
4671026|NCT03423615|Primary Schools|primary schools
4671027|NCT03423615|Republic of India|republic of india
4671028|NCT03423602|Percutaneous vascular closure device|percutaneous vascular closure device
4671029|NCT03423602|Large hole closure device|large hole closure device
4671030|NCT03423602|Arteriotomy closure|arteriotomy closure
4671031|NCT03423602|Vascular closure device|vascular closure device
4671032|NCT03423589|Siblings|siblings
4671033|NCT03423576|health services|health services
4671034|NCT03423576|FEV1|fev1
4671035|NCT03423576|BMI|bmi
4671036|NCT03423576|quality of life|quality of life
4671037|NCT03423576|mental stress|mental stress
4671038|NCT03423524|Intraocular lens|intraocular lens
4671039|NCT03423524|Monofocal|monofocal
4671040|NCT03423524|Hydrophobic|hydrophobic
4671041|NCT03423511|MiStent|mistent
4671042|NCT03423511|Coronary Artery Disease|coronary artery disease
4671043|NCT03423511|Coronary Disease|coronary disease
4671044|NCT03423511|Myocardial Ischemia|myocardial ischemia
4671045|NCT03423511|Heart Disease|heart disease
4671046|NCT03423511|Cardiovascular Diseases|cardiovascular diseases
4671047|NCT03423511|Arteriosclerosis|arteriosclerosis
4671048|NCT03423511|Arterial Occlusive Diseases|arterial occlusive diseases
4671049|NCT03423511|Vascular Diseases|vascular diseases
4671050|NCT03423498|hallux valgus,|hallux valgus,
4671051|NCT03423498|toe-spread-out exercise|toe-spread-out exercise
4671052|NCT03423498|abductor hallucis muscle|abductor hallucis muscle
4671053|NCT03423498|surface electromyography|surface electromyography
4671054|NCT03423485|Colorectal Surgery|colorectal surgery
4671055|NCT03423472|Nutrition|nutrition
4671056|NCT03423472|Women|women
4671057|NCT03423472|Young children|young children
4671058|NCT03423472|Ethiopia|ethiopia
4671059|NCT03423472|Vitamin A|vitamin a
4671060|NCT03423472|Orange flesh sweet potato|orange flesh sweet potato
4671061|NCT03423433|Chronic|chronic
4671062|NCT03423433|Stroke|stroke
4671063|NCT03423433|Blood Pressure|blood pressure
4671064|NCT03423433|Oxygen Perfusion|oxygen perfusion
4671065|NCT03423433|Stroop|stroop
4671066|NCT03423433|Cognitive Performance|cognitive performance
4671067|NCT03423433|Cognition|cognition
4671068|NCT03423394|Motivational enhancement therapy|motivational enhancement therapy
4671069|NCT03423368|Libramed|libramed
4671070|NCT03423368|Policaptil Gel Retard|policaptil gel retard
4671071|NCT03423368|Overweight|overweight
4671072|NCT03423368|Obesity|obesity
4671073|NCT03423368|Medical Device|medical device
4671074|NCT03423368|glycemic profile|glycemic profile
4671075|NCT03423368|lipid profile|lipid profile
4671076|NCT03423342|nicotinamide riboside|nicotinamide riboside
4671280|NCT03422289|anovulation|anovulation
4671077|NCT03423342|Nicotinamide-Adenine Dinucleotide|nicotinamide-adenine dinucleotide
4671078|NCT03423303|Prostate cancer|prostate cancer
4671079|NCT03423303|Screening|screening
4671080|NCT03423303|Randomised trial|randomised trial
4671081|NCT03423303|Kallikrein|kallikrein
4671082|NCT03423303|Magnetic resonance imaging|magnetic resonance imaging
4671083|NCT03423303|Prostate-specific antigen|prostate-specific antigen
4671084|NCT03423264|HPV-related oropharyngeal cancer|hpv-related oropharyngeal cancer
4671085|NCT03423264|oropharyngeal cancer|oropharyngeal cancer
4671086|NCT03423264|HPV-related squamous cell carcinoma|hpv-related squamous cell carcinoma
4671087|NCT03423264|prophylactic gabapentin|prophylactic gabapentin
4671088|NCT03423264|Optima II study|optima ii study
4671089|NCT03423238|Cardiac|cardiac
4671090|NCT03423238|Rehab|rehab
4671091|NCT03423238|Diet|diet
4671092|NCT03423238|Exercise|exercise
4671093|NCT03423238|Obese|obese
4671094|NCT03423225|ADVAGRAF®|advagraf®
4671095|NCT03423225|Liver Transplantation|liver transplantation
4671096|NCT03423225|tacrolimus|tacrolimus
4671097|NCT03423199|breast Cancer|breast cancer
4671098|NCT03423199|palbociclib (PD-0332991)|palbociclib (pd-0332991)
4671099|NCT03423199|tamoxifen|tamoxifen
4671100|NCT03423199|goserelin|goserelin
4671101|NCT03423199|any menopausal status|any menopausal status
4671102|NCT03423199|hormone receptor positive|hormone receptor positive
4671103|NCT03423199|HER2 negative|her2 negative
4671104|NCT03423199|locally advanced|locally advanced
4671105|NCT03423199|metastatic|metastatic
4671106|NCT03423173|Vaccine|vaccine
4671107|NCT03423147|Cesarean section|cesarean section
4671108|NCT03423147|Labor|labor
4671109|NCT03423147|Surgical Site Infections|surgical site infections
4671110|NCT03423147|Chlorhexidine gluconate|chlorhexidine gluconate
4671111|NCT03423108|Exercise|exercise
4671112|NCT03423108|Aging|aging
4671113|NCT03423108|Elderly|elderly
4671114|NCT03423108|Physical Activity|physical activity
4671115|NCT03423108|Cardiovascular Disease|cardiovascular disease
4671116|NCT03423069|Irritable bowel syndrome|irritable bowel syndrome
4671117|NCT03423069|FODMAPs|fodmaps
4671118|NCT03423069|Dietary advice|dietary advice
4671119|NCT03423069|Gastrointestinal symptoms|gastrointestinal symptoms
4671120|NCT03423069|Intestinal permeability|intestinal permeability
4671121|NCT03423069|Gastrointestinal peptides|gastrointestinal peptides
4671122|NCT03423069|Microbiome|microbiome
4671123|NCT03423069|Lipidomic profile|lipidomic profile
4671124|NCT03423056|Gastrointestinal Neoplasms|gastrointestinal neoplasms
4671125|NCT03423056|Exercise|exercise
4671126|NCT03423056|Preoperative Period|preoperative period
4671127|NCT03423056|Preoperative Care|preoperative care
4671128|NCT03423017|Pierre Robin sequence|pierre robin sequence
4671129|NCT03423017|Brainstem|brainstem
4671130|NCT03423017|pathogenesis|pathogenesis
4671131|NCT03423017|swallowing|swallowing
4671132|NCT03423017|apnea|apnea
4671133|NCT03423004|psoriasis|psoriasis
4671134|NCT03423004|IL-22|il-22
4671135|NCT03423004|miR-21|mir-21
4671136|NCT03422991|Heart Failure|heart failure
4671137|NCT03422991|Heart Diseases|heart diseases
4671138|NCT03422991|Cardiovascular Diseases|cardiovascular diseases
4671139|NCT03422991|Vascular Diseases|vascular diseases
4671140|NCT03422991|Cohort|cohort
4671141|NCT03422978|Dexmedetomidine|dexmedetomidine
4671142|NCT03422965|Retina|retina
4671143|NCT03422965|OCT|oct
4671144|NCT03422965|Optical Coherence Tomography|optical coherence tomography
4671145|NCT03422965|Optical Coherence Tomography Angiography|optical coherence tomography angiography
4671146|NCT03422965|Systemic|systemic
4671147|NCT03422965|Blood|blood
4671148|NCT03422965|Diabetes Mellitus|diabetes mellitus
4671149|NCT03422965|Diabetic Retinopathy|diabetic retinopathy
4671150|NCT03422939|FBDG|fbdg
4671151|NCT03422939|dietitians|dietitians
4671152|NCT03422939|portion sizes|portion sizes
4671153|NCT03422939|time frame|time frame
4671154|NCT03422939|visual references|visual references
4671155|NCT03422887|postoperative pain|postoperative pain
4671156|NCT03422887|general anesthesia|general anesthesia
4671157|NCT03422887|postoperative discomfort|postoperative discomfort
4671158|NCT03422874|Advanced Solid Tumors|advanced solid tumors
4671159|NCT03422874|Lymphoma|lymphoma
4671160|NCT03422874|Nelfinavir|nelfinavir
4671161|NCT03422874|MLN9708|mln9708
4671162|NCT03422874|proteasome inhibitor|proteasome inhibitor
4671163|NCT03422861|Nabilone|nabilone
4671164|NCT03422861|Inflammatory Bowel Disease|inflammatory bowel disease
4671165|NCT03422861|Opioid|opioid
4671166|NCT03422848|hydration|hydration
4671167|NCT03422848|water|water
4671168|NCT03422848|vasopressin|vasopressin
4671169|NCT03422848|copeptin|copeptin
4671170|NCT03422848|glucose|glucose
4671171|NCT03422848|OGTT|ogtt
4671172|NCT03422848|insulin|insulin
4671173|NCT03422848|glucagon|glucagon
4671174|NCT03422835|transanal surgery|transanal surgery
4671175|NCT03422835|robotic surgery|robotic surgery
4671176|NCT03422835|total mesorectal excision|total mesorectal excision
4671177|NCT03422822|atopic dermatitis|atopic dermatitis
4671178|NCT03422822|atopic eczema|atopic eczema
4671179|NCT03422822|eczema|eczema
4671180|NCT03422822|JAK|jak
4671281|NCT03422289|infertility|infertility
4671181|NCT03422822|janus kinase|janus kinase
4671182|NCT03422809|Plasma volume, micronutrient, estrogen, progesterone|plasma volume, micronutrient, estrogen, progesterone
4671183|NCT03422783|Monitoring|monitoring
4671184|NCT03422783|Biomarker|biomarker
4671185|NCT03422783|Thoracoscopy|thoracoscopy
4671186|NCT03422770|Myocardium|myocardium
4671187|NCT03422770|Predictive Value of Tests|predictive value of tests
4671188|NCT03422770|Prognosis|prognosis
4671189|NCT03422770|Clinical Decision-making|clinical decision-making
4671190|NCT03422770|Heart Ventricles|heart ventricles
4671191|NCT03422770|Echocardiography|echocardiography
4671192|NCT03422718|stroke|stroke
4671193|NCT03422718|hypertension|hypertension
4671194|NCT03422692|Resorbable membrane, amnion-chorion membrane, collagen membrane, ridge preservation.|resorbable membrane, amnion-chorion membrane, collagen membrane, ridge preservation.
4671195|NCT03422679|advanced solid tumours|advanced solid tumours
4671196|NCT03422679|haematological malignancies|haematological malignancies
4671197|NCT03422679|phase I/II|phase i/ii
4671198|NCT03422679|NOTCH pathway|notch pathway
4671199|NCT03422679|pan-NOTCH inhibitor|pan-notch inhibitor
4671200|NCT03422666|Intestinal lipoprotein|intestinal lipoprotein
4671201|NCT03422666|Gut Peptide|gut peptide
4671202|NCT03422666|Chylomicrons|chylomicrons
4671203|NCT03422653|Hemodialysis|hemodialysis
4671204|NCT03422640|Frontal Fibrosing Alopecia|frontal fibrosing alopecia
4671205|NCT03422640|Apremilast|apremilast
4671206|NCT03422549|diaphragm|diaphragm
4671207|NCT03422549|non-invasive ventilation|non-invasive ventilation
4671208|NCT03422549|high-frequency oscillation|high-frequency oscillation
4671209|NCT03422549|CPAP|cpap
4671210|NCT03422536|Head and Neck Cancer|head and neck cancer
4671211|NCT03422536|Oropharyngeal Cancer|oropharyngeal cancer
4671212|NCT03422536|Squamous Cell Carcinoma|squamous cell carcinoma
4671213|NCT03422536|lip carcinoma|lip carcinoma
4671214|NCT03422536|oral cavity carcinoma|oral cavity carcinoma
4671215|NCT03422536|HNSCC|hnscc
4671216|NCT03422536|Head and Neck Squamous Cell Carcinoma|head and neck squamous cell carcinoma
4671217|NCT03422536|AVEO|aveo
4671218|NCT03422523|Refractory|refractory
4671219|NCT03422523|Relapsed|relapsed
4671220|NCT03422523|Hematological cancer|hematological cancer
4671221|NCT03422510|FSGS|fsgs
4671222|NCT03422510|Kidney Disease|kidney disease
4671223|NCT03422510|Proteinuria|proteinuria
4671224|NCT03422510|Nephrotic Syndrome|nephrotic syndrome
4671225|NCT03422510|FIRSTx|firstx
4671226|NCT03422510|Nitro fatty acids|nitro fatty acids
4671227|NCT03422510|OA-NO2|oa-no2
4671228|NCT03422510|10-nitro oleic acid|10-nitro oleic acid
4671229|NCT03422510|Nitro oleic acid|nitro oleic acid
4671230|NCT03422484|Internal medecine unit|internal medecine unit
4671231|NCT03422484|Medication Error|medication error
4671232|NCT03422484|Clinical Pharmacist|clinical pharmacist
4671233|NCT03422484|Medication reconciliation|medication reconciliation
4671234|NCT03422445|Apatinib|apatinib
4671235|NCT03422445|Temozolomide|temozolomide
4671236|NCT03422445|Advanced Melanoma|advanced melanoma
4671237|NCT03422406|Iodine excess|iodine excess
4671238|NCT03422406|Cause|cause
4671239|NCT03422406|Pregnancy|pregnancy
4671240|NCT03422406|Urinary iodine concentration|urinary iodine concentration
4671241|NCT03422406|Serum iodine concentration|serum iodine concentration
4671242|NCT03422406|Breast milk iodine concentration|breast milk iodine concentration
4671243|NCT03422393|venetoclax|venetoclax
4671244|NCT03422393|ibrutinib|ibrutinib
4671245|NCT03422393|high-dose ibrutinib|high-dose ibrutinib
4671246|NCT03422393|chronic lymphocytic leukemia|chronic lymphocytic leukemia
4671247|NCT03422393|progressive disease|progressive disease
4671248|NCT03422393|Small Lymphocytic Lymphoma|small lymphocytic lymphoma
4671249|NCT03422393|cancer|cancer
4671250|NCT03422380|energy expenditure|energy expenditure
4671251|NCT03422380|adaptive thermogenesis|adaptive thermogenesis
4671252|NCT03422380|metabolic adaptation|metabolic adaptation
4671253|NCT03422380|weight loss maintenance|weight loss maintenance
4671254|NCT03422367|autism|autism
4671255|NCT03422367|epilepsy|epilepsy
4671256|NCT03422367|asd|asd
4671257|NCT03422367|TSC|tsc
4671258|NCT03422367|UCLA|ucla
4671259|NCT03422367|Los Angeles|los angeles
4671260|NCT03422367|JASPER|jasper
4671261|NCT03422367|intervention|intervention
4671262|NCT03422367|Boston|boston
4671263|NCT03422367|BCH|bch
4671264|NCT03422367|MGH|mgh
4671265|NCT03422328|macitentan|macitentan
4671266|NCT03422328|long-term safety|long-term safety
4671267|NCT03422328|open-label|open-label
4671268|NCT03422328|single-arm|single-arm
4671269|NCT03422315|Propofol|propofol
4671270|NCT03422315|Population pharmacokinetics|population pharmacokinetics
4671271|NCT03422315|Individualized administration|individualized administration
4671272|NCT03422302|Malignant neoplasms of respiratory and intrathoracic organs|malignant neoplasms of respiratory and intrathoracic organs
4671273|NCT03422302|Lung cancer|lung cancer
4671274|NCT03422302|Continuous Positive Airway Pressure Device|continuous positive airway pressure device
4671275|NCT03422302|CPAP|cpap
4671276|NCT03422302|Deep inspiration breath hold|deep inspiration breath hold
4671277|NCT03422302|DIBH|dibh
4671278|NCT03422289|myo-inositol|myo-inositol
4671279|NCT03422289|alpha-lactalbumin|alpha-lactalbumin
4671282|NCT03422276|Transition|transition
4671283|NCT03422276|Rehabilitation Discharge|rehabilitation discharge
4671284|NCT03422263|Type 2 diabetes mellitus, SGLT-2-Inhibitors, Empagliflozin, Canagliflozin, Dapagliflozin, 6-minute walk test.|type 2 diabetes mellitus, sglt-2-inhibitors, empagliflozin, canagliflozin, dapagliflozin, 6-minute walk test.
4671285|NCT03422172|GSK1265744|gsk1265744
4671286|NCT03422172|Pre-Exposure Prophylaxis|pre-exposure prophylaxis
4671287|NCT03422172|Human immunodeficiency virus|human immunodeficiency virus
4671288|NCT03422172|Cabotegravir|cabotegravir
4671289|NCT03422172|Pharmacokinetics|pharmacokinetics
4671290|NCT03422120|Immune Suppression|immune suppression
4671291|NCT03422120|Natural Killer Cell Mediated Immunity|natural killer cell mediated immunity
4671292|NCT03422120|Natural Killer Cell Cytokine Production|natural killer cell cytokine production
4671293|NCT03422120|Perioperative/Postoperative Complications|perioperative/postoperative complications
4671294|NCT03422107|Peripheral Nerve Injuries|peripheral nerve injuries
4671295|NCT03422107|Thoracic Surgery|thoracic surgery
4671296|NCT03422107|Minimally invasive cardiac surgery|minimally invasive cardiac surgery
4671297|NCT03422081|endothelial dysfunction|endothelial dysfunction
4671298|NCT03422081|doppler ultrasound examination|doppler ultrasound examination
4671299|NCT03422081|nitric oxide|nitric oxide
4671300|NCT03422055|safety 99mTc-Fucoïdane scintigraphy|safety 99mtc-fucoïdane scintigraphy
4671301|NCT03422029|ORR|orr
4671302|NCT03422029|Safety|safety
4671303|NCT03422029|PFS|pfs
4671304|NCT03422016|electroretinogram|electroretinogram
4671305|NCT03422003|Breast Cancer|breast cancer
4671306|NCT03422003|Radiation|radiation
4671307|NCT03422003|Hypofractionation|hypofractionation
4671308|NCT03422003|Randomization|randomization
4671309|NCT03421951|spine|spine
4671310|NCT03421951|lower limb|lower limb
4671311|NCT03421938|total knee arthroplasty|total knee arthroplasty
4671312|NCT03421938|walking exercises|walking exercises
4671313|NCT03421938|uphill-downhill walking exercises|uphill-downhill walking exercises
4671314|NCT03421938|functional level|functional level
4671315|NCT03421912|Prevention strategy|prevention strategy
4671316|NCT03421912|Cutaneous toxicity|cutaneous toxicity
4671317|NCT03421912|Quality of life|quality of life
4671318|NCT03421912|Patient satisfaction|patient satisfaction
4671319|NCT03421912|Dermatology Life Quality Index (DLQI)|dermatology life quality index (dlqi)
4671320|NCT03421912|Epidermal Repair Score (SCOREPI)|epidermal repair score (scorepi)
4671321|NCT03421912|Topical treatment|topical treatment
4671322|NCT03421899|Mitochondria|mitochondria
4671323|NCT03421899|Mitochondrial dysfunction|mitochondrial dysfunction
4671324|NCT03421899|Parkin|parkin
4671325|NCT03421899|PINK1|pink1
4671326|NCT03421860|Spinal anesthesia|spinal anesthesia
4671327|NCT03421860|cardiac output|cardiac output
4671328|NCT03421860|vasopressor|vasopressor
4671329|NCT03421847|depression|depression
4671330|NCT03421847|vestibular disorder|vestibular disorder
4671331|NCT03421847|rotatory test|rotatory test
4671332|NCT03421847|electronystagmography|electronystagmography
4671333|NCT03421834|Ventricular Tachycardia|ventricular tachycardia
4671334|NCT03421834|Ischemic Cardiomyopathy|ischemic cardiomyopathy
4671335|NCT03421834|Primary prevention|primary prevention
4671336|NCT03421834|Heart Failure|heart failure
4671337|NCT03421821|quadratus lumborum block|quadratus lumborum block
4671338|NCT03421821|anterior thoracolumbar fascia|anterior thoracolumbar fascia
4671339|NCT03421821|subfascial injection|subfascial injection
4671340|NCT03421821|extrafascial injection|extrafascial injection
4671341|NCT03421808|TMS|tms
4671342|NCT03421808|transcranial magnetic stimulation|transcranial magnetic stimulation
4671343|NCT03421808|brain stimulation|brain stimulation
4671344|NCT03421795|pain assessment/management|pain assessment/management
4671345|NCT03421795|developmental disabilities|developmental disabilities
4671346|NCT03421795|children|children
4671347|NCT03421795|education|education
4671348|NCT03421795|respite workers|respite workers
4671349|NCT03421730|mild asthma|mild asthma
4671350|NCT03421730|budesonide|budesonide
4671351|NCT03421730|nebulizer|nebulizer
4671352|NCT03421730|pediatric|pediatric
4671353|NCT03421730|pharmacokinetics|pharmacokinetics
4671354|NCT03421665|titanium wedge|titanium wedge
4671355|NCT03421665|Evans|evans
4671356|NCT03421665|Cotton|cotton
4671357|NCT03421613|PHN, acute, herpes zoster|phn, acute, herpes zoster
4671358|NCT03421600|image enhanced endoscopy|image enhanced endoscopy
4671359|NCT03421600|colonoscopy|colonoscopy
4671360|NCT03421600|colonic polyp|colonic polyp
4671361|NCT03421600|colonic adenoma|colonic adenoma
4671362|NCT03421535|Glenohumeral internal rotational deficit|glenohumeral internal rotational deficit
4671363|NCT03421535|GIRD|gird
4671364|NCT03421535|Sleeper stretch|sleeper stretch
4671365|NCT03421535|SI joint stretch|si joint stretch
4671366|NCT03421522|PPSP|ppsp
4671367|NCT03421522|ICBN|icbn
4671368|NCT03421509|cutaneous silent period|cutaneous silent period
4671369|NCT03421509|spasticity|spasticity
4671370|NCT03421509|stroke|stroke
4671371|NCT03421483|Folate|folate
4671372|NCT03421483|Absorption|absorption
4671373|NCT03421483|Metabolism|metabolism
4671374|NCT03421483|Colon|colon
4671375|NCT03421483|Receptor|receptor
4671376|NCT03421483|Enzyme|enzyme
4671377|NCT03421457|Pelvic Organ Prolapse|pelvic organ prolapse
4671378|NCT03421457|Translabial ultrasound|translabial ultrasound
4671379|NCT03421457|Transperineal ultrasound|transperineal ultrasound
4671380|NCT03421457|Lateral Mesh Suspension|lateral mesh suspension
4671381|NCT03421457|Descensus uteri|descensus uteri
4671382|NCT03421457|Laparoscopic pelvic organ prolapse repair|laparoscopic pelvic organ prolapse repair
4671383|NCT03421457|Uterus preserving|uterus preserving
4671384|NCT03421457|hysteropexy|hysteropexy
4671385|NCT03421457|uterine-preserving|uterine-preserving
4671386|NCT03421457|fertility-sparing|fertility-sparing
4671387|NCT03421457|sacropexy|sacropexy
4671388|NCT03421457|cervicopexy|cervicopexy
4671389|NCT03421457|sacrocervicopexy|sacrocervicopexy
4671390|NCT03421457|sacrohysteropexy|sacrohysteropexy
4671391|NCT03421457|mesh prolapse surgery|mesh prolapse surgery
4671392|NCT03421444|Children|children
4671393|NCT03421444|Obesity|obesity
4671394|NCT03421444|Metabolic Disease|metabolic disease
4671395|NCT03421431|NASH|nash
4671396|NCT03421431|Non-Alcoholic Steatohepatitis (NASH)|non-alcoholic steatohepatitis (nash)
4671397|NCT03421392|constitutive thrombocytopenia|constitutive thrombocytopenia
4671398|NCT03421392|central thrombocytopenia|central thrombocytopenia
4671399|NCT03421392|platelets|platelets
4671400|NCT03421392|sialylation|sialylation
4671401|NCT03421392|flow cytometry|flow cytometry
4671402|NCT03421366|posaconazole|posaconazole
4671403|NCT03421353|AZD9150|azd9150
4671404|NCT03421353|Durvalumab|durvalumab
4671405|NCT03421353|NSCLC|nsclc
4671406|NCT03421353|Non-small-cell lung cancer|non-small-cell lung cancer
4671407|NCT03421353|Advanced solid malignancies|advanced solid malignancies
4671408|NCT03421340|ERCP|ercp
4671410|NCT03421340|Spy Glass|spy glass
4671411|NCT03421340|Biliary Stones|biliary stones
4671412|NCT03421340|Choledocholithiasis|choledocholithiasis
4671413|NCT03421340|Non-Complex|non-complex
4671414|NCT03421340|Stones|stones
4671415|NCT03421301|gut microbiota|gut microbiota
4671416|NCT03421301|functional foods|functional foods
4671417|NCT03421301|branched chain amino acids|branched chain amino acids
4671418|NCT03421301|TMAO|tmao
4671419|NCT03421301|type 2 diabetes|type 2 diabetes
4671420|NCT03421275|fentanyl|fentanyl
4671421|NCT03421275|esketamine|esketamine
4671422|NCT03421275|ketamine|ketamine
4671423|NCT03421275|analgesia|analgesia
4671424|NCT03421275|acute pain|acute pain
4671425|NCT03421275|minor trauma|minor trauma
4671426|NCT03421184|autoimmune disease|autoimmune disease
4671427|NCT03421184|endocrine disruptors|endocrine disruptors
4671428|NCT03421184|isoflavones|isoflavones
4671429|NCT03421184|lignans|lignans
4671430|NCT03421184|diet exposure|diet exposure
4671431|NCT03421184|risk factor|risk factor
4671432|NCT03421158|neonates|neonates
4671433|NCT03421158|Non-pharmacological|non-pharmacological
4671434|NCT03421119|type 2 diabetes|type 2 diabetes
4671435|NCT03421119|liraglutide|liraglutide
4671436|NCT03421119|efficacy|efficacy
4671437|NCT03421119|safety|safety
4671438|NCT03421106|Food insecurity|food insecurity
4671439|NCT03421106|Food pantries|food pantries
4671440|NCT03421093|Lung cancer|lung cancer
4671441|NCT03421093|Chinese|chinese
4671442|NCT03421093|surgeries|surgeries
4671443|NCT03421093|adjuvant therapies|adjuvant therapies
4671444|NCT03421015|localized prostate cancer|localized prostate cancer
4671445|NCT03421015|prostatectomy|prostatectomy
4671446|NCT03421015|biomarkers|biomarkers
4671447|NCT03421015|metastatic recurrence|metastatic recurrence
4671448|NCT03421015|genomic|genomic
4671449|NCT03421002|candida meningitis|candida meningitis
4671450|NCT03421002|Mycamine|mycamine
4671451|NCT03421002|candidiasis, systemic|candidiasis, systemic
4671452|NCT03421002|micafungin|micafungin
4671453|NCT03420989|carob|carob
4671454|NCT03420989|seaweed|seaweed
4671455|NCT03420989|snack food|snack food
4671456|NCT03420989|obese subjects|obese subjects
4671457|NCT03420976|Small Intestinal Bacterial Overgrowth|small intestinal bacterial overgrowth
4671458|NCT03420976|SIBO|sibo
4671459|NCT03420963|Natural killer cells|natural killer cells
4671460|NCT03420963|NK cells|nk cells
4671461|NCT03420963|Cyclophosphamide|cyclophosphamide
4671462|NCT03420963|Cytoxan|cytoxan
4671463|NCT03420963|Neosar|neosar
4671464|NCT03420963|Etoposide|etoposide
4671465|NCT03420963|VePesid|vepesid
4671466|NCT03420937|deep neuromuscular block|deep neuromuscular block
4671467|NCT03420937|laparoscopic surgery|laparoscopic surgery
4671468|NCT03420937|robotic surgery|robotic surgery
4671469|NCT03420937|lung protective ventilation|lung protective ventilation
4671470|NCT03420937|respiratory functions|respiratory functions
4671471|NCT03420937|post-operative recovery|post-operative recovery
4671472|NCT03420924|intraoperative hypothermia|intraoperative hypothermia
4671473|NCT03420924|thermal suit|thermal suit
4671474|NCT03420924|forced-air warming|forced-air warming
4671475|NCT03420911|pain|pain
4671476|NCT03420911|anxiety|anxiety
4671477|NCT03420911|emergency department|emergency department
4671478|NCT03420911|pain management|pain management
4671479|NCT03420885|Ba Duan Jin|ba duan jin
4671480|NCT03420885|Pulmonary Nodules|pulmonary nodules
4671481|NCT03420885|Clinical Intervention|clinical intervention
4671482|NCT03420872|Nutrition|nutrition
4671483|NCT03420872|Nutrients|nutrients
4671484|NCT03420872|Mixtures|mixtures
4671485|NCT03420872|Neurodevelopment|neurodevelopment
4671486|NCT03420872|Prenatal|prenatal
4671487|NCT03420872|Children|children
4671488|NCT03420820|intravitreal injection|intravitreal injection
4671489|NCT03420820|povidone-iodine|povidone-iodine
4671490|NCT03420820|ocular surface flora|ocular surface flora
4671491|NCT03420820|endophthalmitis|endophthalmitis
4671492|NCT03420820|betadine|betadine
4671493|NCT03420781|diabetic gastroparesis|diabetic gastroparesis
4671494|NCT03420781|vomiting|vomiting
4671495|NCT03420742|Drug therapy, brigatinib, lung cancer, ALK, ROS1|drug therapy, brigatinib, lung cancer, alk, ros1
4671496|NCT03420716|functional foods|functional foods
4671497|NCT03420716|dairy foods|dairy foods
4671498|NCT03420716|calcium absorption|calcium absorption
4671499|NCT03420716|prebiotics and probiotics|prebiotics and probiotics
4671500|NCT03420716|young women|young women
4671501|NCT03420716|bone health|bone health
4671502|NCT03420703|erector spinae plane block|erector spinae plane block
4671503|NCT03420703|laparoscopic cholecystectomy|laparoscopic cholecystectomy
4671504|NCT03420703|postoperative pain|postoperative pain
4671505|NCT03420664|cast|cast
4671506|NCT03420664|orthosis|orthosis
4671507|NCT03420664|immobilisation|immobilisation
4671508|NCT03420664|venous stasis|venous stasis
4671509|NCT03420664|circulation|circulation
4671510|NCT03420638|Adults|adults
4671511|NCT03420638|Pain|pain
4671512|NCT03420625|Intermittent Pneumatic Compression Devices|intermittent pneumatic compression devices
4671513|NCT03420625|Electric Stimulation Therapy|electric stimulation therapy
4671514|NCT03420625|Blood Flow Velocity|blood flow velocity
4671515|NCT03420625|Hemodynamics|hemodynamics
4671516|NCT03420599|Gut microbiota|gut microbiota
4671517|NCT03420599|Splenectomy|splenectomy
4671518|NCT03420599|Infection|infection
4671519|NCT03420599|Immune|immune
4671520|NCT03420599|Cytokines|cytokines
4671521|NCT03420586|Anesthetics, Inhalation|anesthetics, inhalation
4671522|NCT03420586|Anesthesia Recovery Period|anesthesia recovery period
4671523|NCT03420586|Postoperative Nausea and Vomiting|postoperative nausea and vomiting
4671524|NCT03420586|Pain, Postoperative|pain, postoperative
4671525|NCT03420508|Ensartinib|ensartinib
4671526|NCT03420508|ALK Inhibitor|alk inhibitor
4671527|NCT03420508|ALK Alterations|alk alterations
4671528|NCT03420508|Aberrant ALK Expression|aberrant alk expression
4671529|NCT03420508|17-471|17-471
4671530|NCT03420495|OCD|ocd
4671531|NCT03420495|Intolerance of Uncertainty|intolerance of uncertainty
4671532|NCT03420482|Microbiome|microbiome
4671533|NCT03420482|Fecal Microbiota Transplant|fecal microbiota transplant
4671534|NCT03420443|radiotherapy, probiotics|radiotherapy, probiotics
4671535|NCT03420417|Mechanical ventilation|mechanical ventilation
4671536|NCT03420391|phototherapy|phototherapy
4671537|NCT03420391|performance|performance
4671538|NCT03420391|muscular recovery|muscular recovery
4671539|NCT03420391|photobiomodulation therapy|photobiomodulation therapy
4671540|NCT03420391|time-window|time-window
4671541|NCT03420378|Central Sensitisation|central sensitisation
4671542|NCT03420378|Cutaneous Silent Period|cutaneous silent period
4671543|NCT03420378|Vitamin D Deficiency|vitamin d deficiency
4671544|NCT03420339|stimulant medication|stimulant medication
4671545|NCT03420339|behavioral function|behavioral function
4671546|NCT03420339|preferences|preferences
4671547|NCT03420339|delay discounting|delay discounting
4671548|NCT03420326|Atrial Fibrillation|atrial fibrillation
4671549|NCT03420326|Frailty status|frailty status
4671550|NCT03420326|Body composition|body composition
4671551|NCT03420326|Sarcopenia|sarcopenia
4671552|NCT03420313|buprenorphine|buprenorphine
4671553|NCT03420313|waitlist|waitlist
4671554|NCT03420313|interim treatment|interim treatment
4671555|NCT03420313|opioid use disorder|opioid use disorder
4671556|NCT03420300|Hepatitis C virus|hepatitis c virus
4671557|NCT03420300|Hemodialysis|hemodialysis
4671558|NCT03420300|Direct acting antiviral agent|direct acting antiviral agent
4671559|NCT03420274|Shared decision-making|shared decision-making
4671560|NCT03420274|Prenatal genetic testing|prenatal genetic testing
4671561|NCT03420274|Noninvasive prenatal testing (NIPT)|noninvasive prenatal testing (nipt)
4671562|NCT03420274|Cell free fetal DNA (cfDNA)|cell free fetal dna (cfdna)
4671563|NCT03420274|Informed consent|informed consent
4671564|NCT03420261|Goal-directed therapy|goal-directed therapy
4671565|NCT03420261|Fluid loading|fluid loading
4671566|NCT03420261|Abdominal surgery|abdominal surgery
4671567|NCT03420261|Postoperative morbidity|postoperative morbidity
4671568|NCT03420261|Postoperative mortality|postoperative mortality
4671569|NCT03420261|Individualized goal-directed fluid therapy|individualized goal-directed fluid therapy
4671570|NCT03420261|Elective or emergency abdominal surgery|elective or emergency abdominal surgery
4671571|NCT03420261|General Anesthesia|general anesthesia
4671572|NCT03420261|Moderate-to-high risk surgical patients|moderate-to-high risk surgical patients
4671573|NCT03420235|quality of life|quality of life
4671574|NCT03420235|eHealth|ehealth
4671575|NCT03420235|patient-reported outcomes|patient-reported outcomes
4671576|NCT03420235|home spirometry|home spirometry
4671577|NCT03420235|cost-effectiveness|cost-effectiveness
4671578|NCT03420235|home monitoring|home monitoring
4671579|NCT03420222|Intermittent Explosive Disorder|intermittent explosive disorder
4671580|NCT03420222|AVP-786|avp-786
4671581|NCT03420209|proprioceptive neuromuscular facilitation|proprioceptive neuromuscular facilitation
4671582|NCT03420209|respiratory functions|respiratory functions
4671583|NCT03420209|elastic band|elastic band
4671584|NCT03420209|posture|posture
4671585|NCT03420196|low back pain|low back pain
4671586|NCT03420196|physical therapy|physical therapy
4671587|NCT03420196|randomized clinical trial|randomized clinical trial
4671588|NCT03420196|exercise program|exercise program
4671589|NCT03420183|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
4671590|NCT03420183|Small Lymphocytic Lymphoma|small lymphocytic lymphoma
4671591|NCT03420183|Mantle cell lymphoma|mantle cell lymphoma
4671592|NCT03420183|Receptor Tyrosine Kinase-like Orphan Receptor 1 (ROR1)|receptor tyrosine kinase-like orphan receptor 1 (ror1)
4671593|NCT03420183|Bruton Tyrosine Kinase (BTK)|bruton tyrosine kinase (btk)
4671594|NCT03420183|Leukemia, lymphoid|leukemia, lymphoid
4671595|NCT03420183|Leukemia, Lymphocytic, Chronic, B-Cell|leukemia, lymphocytic, chronic, b-cell
4671596|NCT03420183|Leukemia|leukemia
4671597|NCT03420183|Lymphoma|lymphoma
4671598|NCT03420183|Lymphoma, mantle cell|lymphoma, mantle cell
4671599|NCT03420183|Neoplasms by histologic type|neoplasms by histologic type
4671600|NCT03420183|Neoplasms|neoplasms
4671601|NCT03420183|Lymphoproliferative Disorders|lymphoproliferative disorders
4671602|NCT03420183|Lymphatic Diseases|lymphatic diseases
4671603|NCT03420183|Immunoproliferative Disorders|immunoproliferative disorders
4671604|NCT03420183|Immune System Diseases|immune system diseases
4671605|NCT03420183|Lymphoma, Non-Hodgkin|lymphoma, non-hodgkin
4671606|NCT03420170|Spinal Cord Injuries|spinal cord injuries
4671607|NCT03420170|Physical Fitness|physical fitness
4671608|NCT03420170|Exercise Self-Efficacy|exercise self-efficacy
4671609|NCT03420170|Physical Activity|physical activity
4671610|NCT03420157|Cervical cancer screening|cervical cancer screening
4671611|NCT03420157|vaginal self-sampling|vaginal self-sampling
4671612|NCT03420157|Focus group|focus group
4671613|NCT03420157|communication|communication
4671614|NCT03420144|Growth hormone|growth hormone
4671615|NCT03420144|cirrhosis|cirrhosis
4671616|NCT03420131|instantaneous Flow Ratio|instantaneous flow ratio
4671617|NCT03420131|Quantitative Flow Ratio|quantitative flow ratio
4671618|NCT03420131|Fractional Flow Reserve|fractional flow reserve
4671619|NCT03420092|vasoactive leukotrienes by leukocytes|vasoactive leukotrienes by leukocytes
4671620|NCT03420092|bioavailability|bioavailability
4671621|NCT03420053|PfSPZ Vaccine|pfspz vaccine
4671622|NCT03420053|HIV+|hiv+
4671623|NCT03420053|Plasmodium falciparum|plasmodium falciparum
4671624|NCT03420053|Sporozoites|sporozoites
4671625|NCT03420040|Glargine Insulin|glargine insulin
4671626|NCT03420040|QS-M Needle Free Injector|qs-m needle free injector
4671627|NCT03420027|predictive score|predictive score
4671628|NCT03420027|difficult intubation|difficult intubation
4671629|NCT03420001|VBAC, levator ani avulsion, quality of life|vbac, levator ani avulsion, quality of life
4671630|NCT03419988|Nrf2|nrf2
4671631|NCT03419949|pain|pain
4671632|NCT03419936|Stomach Neoplasms|stomach neoplasms
4671633|NCT03419936|Helicobacter pylori|helicobacter pylori
4671634|NCT03419936|Subtotal gastrectomy|subtotal gastrectomy
4671635|NCT03419897|Advanced liver cancer|advanced liver cancer
4671636|NCT03419871|economically stressed communities|economically stressed communities
4671637|NCT03419858|Pain|pain
4671638|NCT03419858|Slow-Breathing|slow-breathing
4671639|NCT03419858|Mindfulness|mindfulness
4671640|NCT03419858|Opioids|opioids
4671641|NCT03419858|Placebo|placebo
4671642|NCT03419832|ARIC|aric
4671643|NCT03419819|Phenylketonuria|phenylketonuria
4671644|NCT03419819|GMP|gmp
4671645|NCT03419819|Sphere|sphere
4671646|NCT03419819|Child|child
4671647|NCT03419819|Adult|adult
4671648|NCT03419819|Phenylalanine|phenylalanine
4671649|NCT03419819|PKU|pku
4671650|NCT03419819|Glycomacropeptide|glycomacropeptide
4671651|NCT03419767|carotid stenosis|carotid stenosis
4671652|NCT03419767|melatonin|melatonin
4671653|NCT03419767|insulin resistance|insulin resistance
4671654|NCT03419767|inflammation|inflammation
4671655|NCT03419767|carotid revascularization|carotid revascularization
4671656|NCT03419767|antioxidants|antioxidants
4671657|NCT03419741|Cancer, Nicotine Addiction, Smoking Cessation|cancer, nicotine addiction, smoking cessation
4671658|NCT03419728|Teen pregnancy prevention|teen pregnancy prevention
4671659|NCT03419728|Long-acting reversible contraception (LARCs)|long-acting reversible contraception (larcs)
4671660|NCT03419728|Healthy Families Healthy Futures|healthy families healthy futures
4671661|NCT03419728|Home visiting|home visiting
4671662|NCT03419715|migraine|migraine
4671663|NCT03419715|headache|headache
4671664|NCT03419715|bimatoprost|bimatoprost
4671665|NCT03419676|Pancreatoduodenectomy|pancreatoduodenectomy
4671666|NCT03419676|Postoperative pancreatic fistula|postoperative pancreatic fistula
4671667|NCT03419676|Sealant|sealant
4671668|NCT03419676|Hemopatch|hemopatch
4671669|NCT03419663|cereal|cereal
4671670|NCT03419663|whole grain|whole grain
4671671|NCT03419663|refined grain|refined grain
4671672|NCT03419663|gastric cancer|gastric cancer
4671673|NCT03419663|meta analysis|meta analysis
4671674|NCT03419650|PsA|psa
4671675|NCT03419624|Dapagliflozin|dapagliflozin
4671676|NCT03419624|Exenatide|exenatide
4671677|NCT03419624|high-dose insulin therapy|high-dose insulin therapy
4671678|NCT03419624|SGLT-2 inhibitor|sglt-2 inhibitor
4671679|NCT03419624|GLP-1 receptor agonist|glp-1 receptor agonist
4671680|NCT03419611|Communication Intervention|communication intervention
4671681|NCT03419598|virtual clinical trial|virtual clinical trial
4671682|NCT03419598|high tibial osteotomy|high tibial osteotomy
4671683|NCT03419598|3D|3d
4671684|NCT03419598|computer simulation|computer simulation
4671685|NCT03419598|finite element analysis|finite element analysis
4671686|NCT03419598|medial unicompartmental knee osteoarthritis|medial unicompartmental knee osteoarthritis
4671687|NCT03419559|LN-145|ln-145
4671688|NCT03419559|Cell Therapy|cell therapy
4671689|NCT03419559|Autologous Adoptive Cell Transfer|autologous adoptive cell transfer
4671690|NCT03419559|Cellular Immuno-therapy|cellular immuno-therapy
4671691|NCT03419559|TIL|til
4671692|NCT03419559|IL-2|il-2
4671693|NCT03419559|Durvalumab|durvalumab
4671694|NCT03419520|Schoolchildren|schoolchildren
4671695|NCT03419520|Overweight|overweight
4671696|NCT03419520|Obesity|obesity
4671697|NCT03419520|Polymorphisms|polymorphisms
4671698|NCT03419520|Genetics|genetics
4671699|NCT03419520|Nutritional counseling|nutritional counseling
4671700|NCT03419520|Healthy strategies|healthy strategies
4671701|NCT03419507|endotracheal tube introducer|endotracheal tube introducer
4671702|NCT03419507|manikin|manikin
4671703|NCT03419507|chest compression|chest compression
4671704|NCT03419455|Obesity|obesity
4671705|NCT03419455|Lifelong Obesity|lifelong obesity
4671706|NCT03419455|Metabolic abnormalties|metabolic abnormalties
4671707|NCT03419455|Low-grade chronic inflammation|low-grade chronic inflammation
4671708|NCT03419455|Hyperinsulinemia|hyperinsulinemia
4671709|NCT03419455|IGF signalling|igf signalling
4671710|NCT03419455|Sex hormones|sex hormones
4671711|NCT03419455|Inflammatory response|inflammatory response
4671712|NCT03419455|Adipokines|adipokines
4671713|NCT03419455|Diet|diet
4671714|NCT03419442|Prostate cancer|prostate cancer
4671715|NCT03419442|Bone metastases|bone metastases
4671716|NCT03419442|Xofigo|xofigo
4671717|NCT03419429|Guided tissue membranes|guided tissue membranes
4671718|NCT03419429|EDTA|edta
4671719|NCT03419429|Simvastatin|simvastatin
4671720|NCT03419403|Glioblastoma Multiforme (GBM)|glioblastoma multiforme (gbm)
4671721|NCT03419403|cancer|cancer
4671722|NCT03419403|chemoradiation therapy|chemoradiation therapy
4671723|NCT03419403|epidermal growth factor receptor-amplified glioblastoma|epidermal growth factor receptor-amplified glioblastoma
4671724|NCT03419403|radiation|radiation
4671725|NCT03419403|temozolomide|temozolomide
4671726|NCT03419390|Hydra01|hydra01
4671727|NCT03419377|Treatment|treatment
4671728|NCT03419377|Quality of Life|quality of life
4671729|NCT03419377|Sexology|sexology
4671730|NCT03419377|Women|women
4671731|NCT03419338|Maxillary Sinus|maxillary sinus
4671732|NCT03419338|Sinus lifting|sinus lifting
4671733|NCT03419338|Bone graft|bone graft
4671734|NCT03419325|percutaneous coronary interventions (PCI)|percutaneous coronary interventions (pci)
4671735|NCT03419325|secondary stroke prevention|secondary stroke prevention
4671736|NCT03419325|dual antiplatelet therapy (DAPT)|dual antiplatelet therapy (dapt)
4671737|NCT03419312|Spinal Cord Stimulation|spinal cord stimulation
4671738|NCT03419312|Burst Spinal Cord Stimulation|burst spinal cord stimulation
4671739|NCT03419312|SCS|scs
4671740|NCT03419260|seizures|seizures
4671741|NCT03419260|status epilepticus|status epilepticus
4671742|NCT03419260|EEG monitoring|eeg monitoring
4671743|NCT03419221|Staphylococcus aureus|staphylococcus aureus
4671744|NCT03419221|bloodstream infection|bloodstream infection
4671745|NCT03419221|deep foci of infection|deep foci of infection
4671746|NCT03419221|18 FDG PET/CT|18 fdg pet/ct
4671747|NCT03419221|antibiotics|antibiotics
4671748|NCT03419208|Systemic Sclerosis|systemic sclerosis
4671749|NCT03419208|Scleroderma|scleroderma
4671750|NCT03419208|Hand Function|hand function
4671751|NCT03419208|Intervention|intervention
4671752|NCT03419208|Exercise|exercise
4671753|NCT03419208|Telerehabilitation|telerehabilitation
4671754|NCT03419208|eHealth|ehealth
4671755|NCT03419208|Physical Therapy|physical therapy
4671756|NCT03419195|Type 2 Diabetes|type 2 diabetes
4671757|NCT03419195|Overweight|overweight
4671758|NCT03419195|Exercise Training|exercise training
4671759|NCT03419195|Exercise Impairment|exercise impairment
4671760|NCT03419195|Healthy Control|healthy control
4671761|NCT03419195|Veteran|veteran
4671762|NCT03419195|Blood Flow|blood flow
4671763|NCT03419182|Geriatric|geriatric
4671764|NCT03419182|Acetabular|acetabular
4671765|NCT03419182|Arthroplasty|arthroplasty
4671766|NCT03419169|Patient|patient
4671767|NCT03419169|Rehabilitation|rehabilitation
4671768|NCT03419169|Ligament reconstruction|ligament reconstruction
4671769|NCT03419169|Surgery|surgery
4671770|NCT03419156|text message|text message
4671771|NCT03419156|telemedicine|telemedicine
4671772|NCT03419104|bariatric surgery|bariatric surgery
4671773|NCT03419104|extubation|extubation
4671774|NCT03419091|ureteroscopy|ureteroscopy
4671775|NCT03419091|lithovue|lithovue
4671776|NCT03419091|nephrolithiasis|nephrolithiasis
4671777|NCT03419091|single use ureteroscope|single use ureteroscope
4671778|NCT03419078|enteral nutrition|enteral nutrition
4671779|NCT03419078|parenteral nutrition|parenteral nutrition
4671780|NCT03419078|artificial nutrition support|artificial nutrition support
4671781|NCT03419078|non-relapse mortality|non-relapse mortality
4671782|NCT03419078|survival|survival
4671783|NCT03419039|Mild Cognitive Impairment|mild cognitive impairment
4671784|NCT03419000|GTCS|gtcs
4671785|NCT03419000|Epilepsies, Partial|epilepsies, partial
4671786|NCT03419000|Drug Resistant Epilepsy|drug resistant epilepsy
4671787|NCT03419000|Circulating MicroRNA|circulating microrna
4671788|NCT03419000|Diagnostic|diagnostic
4671789|NCT03418987|3D imaging|3d imaging
4671790|NCT03418987|vertebral vector|vertebral vector
4671791|NCT03418987|Scoliosis|scoliosis
4671792|NCT03418974|Dyslipidemia|dyslipidemia
4671793|NCT03418974|Cardiovascular Diseases|cardiovascular diseases
4671794|NCT03418974|Hypertension|hypertension
4671795|NCT03418974|LDL-C|ldl-c
4671796|NCT03418935|obstructive jaundice, non-malignant|obstructive jaundice, non-malignant
4671797|NCT03418935|mechanical jaundice, non-malignant|mechanical jaundice, non-malignant
4671798|NCT03418935|Methionine|methionine
4671799|NCT03418935|Succinic acid|succinic acid
4671800|NCT03418883|Stroke|stroke
4671801|NCT03418883|rehabilitation|rehabilitation
4671802|NCT03418883|mirror therapy|mirror therapy
4671803|NCT03418883|upper limb|upper limb
4671804|NCT03418870|Intensive Care Units, Neonatal|intensive care units, neonatal
4671805|NCT03418870|Parents|parents
4671806|NCT03418870|Mobile application|mobile application
4671807|NCT03418857|probiotics|probiotics
4671808|NCT03418857|Human|human
4671809|NCT03418857|obesity|obesity
4671810|NCT03418857|non-pharmacologic therapy|non-pharmacologic therapy
4671811|NCT03418857|gut health|gut health
4671812|NCT03418857|microbiome|microbiome
4671813|NCT03418857|inflammation|inflammation
4671814|NCT03418831|negtive symptoms|negtive symptoms
4671815|NCT03418831|cognitive function|cognitive function
4671816|NCT03418818|hypoxia|hypoxia
4671817|NCT03418818|sarcoma|sarcoma
4671818|NCT03418818|FAZA|faza
4671819|NCT03418818|PET Imaging|pet imaging
4671820|NCT03418805|Ibuprofen|ibuprofen
4671821|NCT03418805|Controlled-Release|controlled-release
4671822|NCT03418805|pain control|pain control
4671823|NCT03418805|Healthy Volunteers|healthy volunteers
4671824|NCT03418805|Food Effect|food effect
4671825|NCT03418779|IgA nephropathy|iga nephropathy
4671826|NCT03418779|immunosuppressive therapy|immunosuppressive therapy
4671827|NCT03418779|Yi-Qi-Qing-Jie herbal compound|yi-qi-qing-jie herbal compound
4671828|NCT03418779|high-risk IgAN|high-risk igan
4671829|NCT03418779|traditional chinese medicine|traditional chinese medicine
4671830|NCT03418766|Right-to-left Shunt|right-to-left shunt
4671831|NCT03418766|Brain White Matter Lesions|brain white matter lesions
4671832|NCT03418766|Migraine|migraine
4671833|NCT03418753|noninvasive diagnosis|noninvasive diagnosis
4671834|NCT03418740|Friedreich|friedreich
4671835|NCT03418740|Ataxia|ataxia
4671836|NCT03418740|FRDA|frda
4671837|NCT03418740|FA|fa
4671838|NCT03418740|Friedrich Ataxia (FRDA)|friedrich ataxia (frda)
4671839|NCT03418701|Women's health|women's health
4671840|NCT03418662|Colonoscopy|colonoscopy
4671841|NCT03418649|low back pain|low back pain
4671842|NCT03418649|radicular pain|radicular pain
4671843|NCT03418649|degenerative disc disease|degenerative disc disease
4671844|NCT03418636|People who inject drugs|people who inject drugs
4671845|NCT03418636|Hepatitis C prevention|hepatitis c prevention
4671846|NCT03418636|Young adults|young adults
4671847|NCT03418636|Behavioral interventions|behavioral interventions
4671848|NCT03418623|Glutamate|glutamate
4671849|NCT03418623|Alcohol use|alcohol use
4671850|NCT03418623|GABA|gaba
4671851|NCT03418623|GET73|get73
4671852|NCT03418623|Non-treatment seeking|non-treatment seeking
4671853|NCT03418610|Rosacea|rosacea
4671854|NCT03418597|Virtual reality|virtual reality
4671855|NCT03418597|Radio-guided biopsy|radio-guided biopsy
4671856|NCT03418597|Pain|pain
4671857|NCT03418597|Anxiety|anxiety
4671858|NCT03418597|Patient's satisfaction|patient's satisfaction
4671859|NCT03418584|argon plasma coagulation|argon plasma coagulation
4671860|NCT03418584|submucosal injection|submucosal injection
4671861|NCT03418584|Barrett Esophagus|barrett esophagus
4671862|NCT03418558|HER2 AMPLIFICATION|her2 amplification
4671863|NCT03418532|DARPin®protein|darpin®protein
4671864|NCT03418532|MP0250|mp0250
4671865|NCT03418532|VEGF|vegf
4671866|NCT03418532|HGF|hgf
4671867|NCT03418532|NSCLC|nsclc
4671868|NCT03418532|EGFR mutated|egfr mutated
4671869|NCT03418532|Osimertinib|osimertinib
4671870|NCT03418506|Smokeless tobacco|smokeless tobacco
4671871|NCT03418506|adolescent|adolescent
4671872|NCT03418506|oral cancer|oral cancer
4671873|NCT03418506|betal quid|betal quid
4671874|NCT03418506|areca nut|areca nut
4671875|NCT03418467|Tachycardiomyopathy|tachycardiomyopathy
4671876|NCT03418467|atrial fibrillation|atrial fibrillation
4671877|NCT03418467|EMID (enrichment of mitochondria at the intercalated discs)|emid (enrichment of mitochondria at the intercalated discs)
4671878|NCT03418467|Biopsy|biopsy
4671879|NCT03418467|empathy|empathy
4671880|NCT03418441|Nationwide prospective observational cohort study|nationwide prospective observational cohort study
4671881|NCT03418441|Epidemiology|epidemiology
4671882|NCT03418441|Central Nervous System Infections|central nervous system infections
4671883|NCT03418441|Meningitis|meningitis
4671884|NCT03418441|Encephalitis|encephalitis
4671885|NCT03418441|Brain abscess|brain abscess
4671886|NCT03418441|Lyme disease|lyme disease
4671887|NCT03418441|Neuroborreliosis|neuroborreliosis
4671888|NCT03418441|Neurosyphilis|neurosyphilis
4671889|NCT03418441|Tertiary syphilis|tertiary syphilis
4671890|NCT03418363|Oral contraceptives|oral contraceptives
4671891|NCT03418363|Venous thromboembolism|venous thromboembolism
4671892|NCT03418363|androgenic combined oral contraception|androgenic combined oral contraception
4671893|NCT03418337|cough, dexlansoprazole, GERD, globus, non-cardiac chest pain|cough, dexlansoprazole, gerd, globus, non-cardiac chest pain
4671894|NCT03418324|Prostate Cancer|prostate cancer
4671895|NCT03418324|Metastatic Prostate Cancer|metastatic prostate cancer
4671896|NCT03418324|Castration Resistant Prostate Cancer|castration resistant prostate cancer
4671897|NCT03418324|Metastatic Castration Resistant|metastatic castration resistant
4671898|NCT03418311|Twin pregnancy|twin pregnancy
4671899|NCT03418311|Cervical Pessary|cervical pessary
4671900|NCT03418311|short cervix|short cervix
4671901|NCT03418311|Prevention|prevention
4671902|NCT03418272|ICU|icu
4671903|NCT03418272|OR|or
4671904|NCT03418272|Pneumonia|pneumonia
4671905|NCT03418272|PICU|picu
4671906|NCT03418272|Pediatric|pediatric
4671907|NCT03418272|PCR|pcr
4671908|NCT03418246|gingiva|gingiva
4671909|NCT03418246|plaque|plaque
4671910|NCT03418246|pocket depth|pocket depth
4671911|NCT03418220|Age related Macular Degeneration|age related macular degeneration
4671912|NCT03418220|Atrophy|atrophy
4671913|NCT03418220|Inflammation|inflammation
4671914|NCT03418220|Cytokines|cytokines
4671915|NCT03418220|test LUMINEX®|test luminex®
4671916|NCT03418207|TPS system|tps system
4671917|NCT03418207|trans-perineal template-guided mapping biopsy|trans-perineal template-guided mapping biopsy
4671918|NCT03418207|prostate cancer|prostate cancer
4671919|NCT03418207|spatial distribution|spatial distribution
4671920|NCT03418207|large tissue slice|large tissue slice
4671921|NCT03418194|Anesthesia, General|anesthesia, general
4671922|NCT03418181|Residual Kidney Function|residual kidney function
4671923|NCT03418181|Haemodialysis|haemodialysis
4671924|NCT03418181|Preserve Residual Kidney Function|preserve residual kidney function
4671925|NCT03418129|Military Veterans|military veterans
4671926|NCT03418051|Ankle Instability|ankle instability
4671927|NCT03418051|Manual Therapy|manual therapy
4671928|NCT03418051|Massage|massage
4671929|NCT03418051|Ankle Joint Mobilization|ankle joint mobilization
4671930|NCT03418051|Biomechanics|biomechanics
4671931|NCT03418051|Neuromuscular|neuromuscular
4671932|NCT03418012|Cervical Pessary|cervical pessary
4671933|NCT03418012|Short Cervix|short cervix
4671934|NCT03418012|Recurrent Preterm Birth|recurrent preterm birth
4671935|NCT03418012|history of cervical surgery|history of cervical surgery
4671936|NCT03418012|history of conisation|history of conisation
4671937|NCT03417999|Intranasal|intranasal
4671938|NCT03417999|Pharmacokinetic|pharmacokinetic
4671939|NCT03417999|Pediatric|pediatric
4671940|NCT03417986|Thiethylperazine|thiethylperazine
4671941|NCT03417986|Alzheimer Disease|alzheimer disease
4671942|NCT03417973|dorsal root ganglion|dorsal root ganglion
4671943|NCT03417960|post partum depression|post partum depression
4671944|NCT03417960|theta burst|theta burst
4671945|NCT03417960|transcranial magnetic stimulation|transcranial magnetic stimulation
4671946|NCT03417947|Bolus supplementation|bolus supplementation
4671947|NCT03417947|Pilot randomised controlled trial|pilot randomised controlled trial
4671948|NCT03417947|Vitamin D|vitamin d
4671949|NCT03417908|Proprioceptive neuromuscular facilitation|proprioceptive neuromuscular facilitation
4671950|NCT03417908|Pulmonary Rehabilitation|pulmonary rehabilitation
4671951|NCT03417908|muscle activation|muscle activation
4671952|NCT03417908|COPD|copd
4671953|NCT03417882|PD-L1+|pd-l1+
4671954|NCT03417856|Ichthyosis|ichthyosis
4671955|NCT03417856|Netherton Syndrome|netherton syndrome
4671956|NCT03417843|ablation catheter|ablation catheter
4671957|NCT03417843|pancreatic premalignant and early malignant cystic lesion|pancreatic premalignant and early malignant cystic lesion
4671958|NCT03417830|miridesap|miridesap
4671959|NCT03417830|GSK2315698|gsk2315698
4671960|NCT03417830|89Zirconium labelled|89zirconium labelled
4671961|NCT03417830|Positron Emission Tomography|positron emission tomography
4671962|NCT03417830|Transthyretin cardiomyopathy|transthyretin cardiomyopathy
4671963|NCT03417830|GSK2398852|gsk2398852
4671964|NCT03417830|dezamizumab|dezamizumab
4671965|NCT03417791|recovery|recovery
4671966|NCT03417791|serum creatinine|serum creatinine
4671967|NCT03417765|gastrointestinal mucositis|gastrointestinal mucositis
4671968|NCT03417765|myeloablative chemotherapy|myeloablative chemotherapy
4671969|NCT03417765|autologous transplantation|autologous transplantation
4671970|NCT03417739|Uveal Melanoma|uveal melanoma
4671971|NCT03417726|Cerebral Palsy|cerebral palsy
4671972|NCT03417726|Balance|balance
4671973|NCT03417700|vitamin D|vitamin d
4671974|NCT03417700|exercise|exercise
4671975|NCT03417700|training|training
4671976|NCT03417700|aging|aging
4672274|NCT03416049|pulsed electromagnetic|pulsed electromagnetic
4671977|NCT03417648|Rheumatoid Arthritis, Diet, Fat-Restricted, Diet, Vegetarian|rheumatoid arthritis, diet, fat-restricted, diet, vegetarian
4671978|NCT03417635|Meditation|meditation
4671979|NCT03417635|Cognitive assessment|cognitive assessment
4671980|NCT03417635|Executive function|executive function
4671981|NCT03417635|Older adults|older adults
4671982|NCT03417635|Randomized control trial|randomized control trial
4671983|NCT03417635|Mobility|mobility
4671984|NCT03417622|resection margin|resection margin
4671985|NCT03417622|neoadjuvant therapy|neoadjuvant therapy
4671986|NCT03417622|breast conservative surgery|breast conservative surgery
4671987|NCT03417622|locally advanced breast cancer|locally advanced breast cancer
4671988|NCT03417609|Sarcopenia|sarcopenia
4671989|NCT03417609|Tongue strength|tongue strength
4671990|NCT03417544|HER2-positive metastatic Breast Cancer|her2-positive metastatic breast cancer
4671991|NCT03417544|Central Nervous System Metastases|central nervous system metastases
4671992|NCT03417531|Protein supplementation|protein supplementation
4671993|NCT03417531|Home exercise program|home exercise program
4671994|NCT03417531|Falls prevention|falls prevention
4671995|NCT03417531|Seniors|seniors
4671996|NCT03417531|Autonomy|autonomy
4671997|NCT03417518|Oxidative stress|oxidative stress
4671998|NCT03417518|Bariatric surgery|bariatric surgery
4671999|NCT03417505|Contact lens discomfort|contact lens discomfort
4672000|NCT03417505|Scleral lens|scleral lens
4672001|NCT03417505|Tangible Hydra-PEG|tangible hydra-peg
4672002|NCT03417492|TBI|tbi
4672003|NCT03417492|CVR|cvr
4672004|NCT03417492|Hypercapnia|hypercapnia
4672005|NCT03417492|fNIRS|fnirs
4672006|NCT03417492|functional magnetic resonance imaging (fMRI)|functional magnetic resonance imaging (fmri)
4672007|NCT03417492|American football|american football
4672008|NCT03417466|Diabetes Type I Type II|diabetes type i type ii
4672009|NCT03417453|normal patients|normal patients
4672010|NCT03417453|eye drops dispensers|eye drops dispensers
4672011|NCT03417453|aids|aids
4672012|NCT03417453|glacuoma|glacuoma
4672013|NCT03417453|cataract|cataract
4672014|NCT03417440|smartphone app, physical activity, older adults|smartphone app, physical activity, older adults
4672015|NCT03417427|acute myeloid leukemia|acute myeloid leukemia
4672016|NCT03417427|Intermediate-risk|intermediate-risk
4672017|NCT03417427|demethylation drug|demethylation drug
4672018|NCT03417427|complete remission|complete remission
4672019|NCT03417388|Coronary Angiography|coronary angiography
4672020|NCT03417388|Coronary CT Angiogram|coronary ct angiogram
4672021|NCT03417388|Ischemia|ischemia
4672022|NCT03417388|Non-obstructive CAD|non-obstructive cad
4672023|NCT03417362|education|education
4672024|NCT03417362|audiovisual|audiovisual
4672025|NCT03417362|information|information
4672026|NCT03417362|acceptability|acceptability
4672027|NCT03417349|Acute Ischemic Stroke|acute ischemic stroke
4672028|NCT03417349|Thrombectomy|thrombectomy
4672029|NCT03417349|Aspiration Thrombectomy|aspiration thrombectomy
4672030|NCT03417349|Observational study|observational study
4672031|NCT03417310|closed reduction|closed reduction
4672032|NCT03417310|locked intramedullary nailing|locked intramedullary nailing
4672033|NCT03417284|Multiple Myeloma|multiple myeloma
4672034|NCT03417284|MM|mm
4672035|NCT03417284|Evomela|evomela
4672036|NCT03417284|Melphalan|melphalan
4672037|NCT03417284|Alkeran|alkeran
4672038|NCT03417284|G-CSF|g-csf
4672039|NCT03417284|Filgrastim|filgrastim
4672040|NCT03417284|Neupogen|neupogen
4672041|NCT03417284|Stem cell transplant|stem cell transplant
4672042|NCT03417258|phytoestrogens|phytoestrogens
4672043|NCT03417258|isoflavones|isoflavones
4672044|NCT03417258|adenomatous polyps|adenomatous polyps
4672045|NCT03417258|microbiome|microbiome
4672046|NCT03417245|RNAi therapeutic|rnai therapeutic
4672047|NCT03417245|Hemophilia A|hemophilia a
4672048|NCT03417245|Hemophilia B|hemophilia b
4672049|NCT03417245|Hemophilia A, Severe|hemophilia a, severe
4672050|NCT03417245|Hemophilia B, Severe|hemophilia b, severe
4672051|NCT03417245|Blood Coagulation Disorders, Inherited|blood coagulation disorders, inherited
4672052|NCT03417245|Blood Coagulation Disorders|blood coagulation disorders
4672053|NCT03417245|Hematologic Diseases|hematologic diseases
4672054|NCT03417245|Coagulation Protein Disorders|coagulation protein disorders
4672055|NCT03417245|Hemorrhagic Disorders|hemorrhagic disorders
4672056|NCT03417245|Genetic Diseases, Inborn|genetic diseases, inborn
4672057|NCT03417245|Genetic Diseases, X-Linked|genetic diseases, x-linked
4672058|NCT03417245|Factor VIII|factor viii
4672059|NCT03417245|Factor IX|factor ix
4672060|NCT03417245|Coagulants|coagulants
4672061|NCT03417245|Fitusiran|fitusiran
4672062|NCT03417232|gingival recession|gingival recession
4672063|NCT03417232|coronally advanced flap|coronally advanced flap
4672064|NCT03417232|complete root coverage|complete root coverage
4672065|NCT03417232|flap elevation|flap elevation
4672066|NCT03417232|flap thickness|flap thickness
4672067|NCT03417219|Caregivers|caregivers
4672068|NCT03417219|Family|family
4672069|NCT03417219|Veterans|veterans
4672070|NCT03417219|Alzheimer Disease|alzheimer disease
4672071|NCT03417219|Memory|memory
4672072|NCT03417206|Pupillary Dilatation Reflex (PRD)|pupillary dilatation reflex (prd)
4672073|NCT03417206|Intraoperative Blood Loss (IBL)|intraoperative blood loss (ibl)
4672370|NCT03415529|Prognosis|prognosis
4672074|NCT03417206|Boezaart Bleeding Scale (BBS)|boezaart bleeding scale (bbs)
4672075|NCT03417206|Spectral Entropy (SE)|spectral entropy (se)
4672076|NCT03417206|Adequacy of Anaesthesia (AoA)|adequacy of anaesthesia (aoa)
4672077|NCT03417206|Total Intravenous Anaesthesia (TIVA)|total intravenous anaesthesia (tiva)
4672078|NCT03417206|Sevoflurane|sevoflurane
4672079|NCT03417206|Desflurane|desflurane
4672080|NCT03417193|Lidocaine|lidocaine
4672081|NCT03417193|Dexmedetomidine|dexmedetomidine
4672082|NCT03417193|Opioid-free|opioid-free
4672083|NCT03417180|Surgical Pleth Index (SPI)|surgical pleth index (spi)
4672084|NCT03417180|Intraoperative Blood Loss (IBL)|intraoperative blood loss (ibl)
4672085|NCT03417180|Boezaart Bleeding Scale (BBS)|boezaart bleeding scale (bbs)
4672086|NCT03417180|Spectral Entropy (SE)|spectral entropy (se)
4672087|NCT03417180|Adequacy of Anaesthesia (AoA)|adequacy of anaesthesia (aoa)
4672088|NCT03417180|Total Intravenous Anaesthesia (TIVA)|total intravenous anaesthesia (tiva)
4672089|NCT03417180|Sevoflurane|sevoflurane
4672090|NCT03417180|Desflurane|desflurane
4672091|NCT03417167|synovial biopsy|synovial biopsy
4672092|NCT03417167|US guided synovial biopsy|us guided synovial biopsy
4672093|NCT03417154|AML|aml
4672094|NCT03417154|MDS|mds
4672095|NCT03417141|Valchor|valchor
4672096|NCT03417115|Breast Cancer|breast cancer
4672097|NCT03417115|Epidemiology|epidemiology
4672098|NCT03417115|Registry|registry
4672099|NCT03417115|Health Services Research|health services research
4672100|NCT03417115|Germany|germany
4672101|NCT03417115|Palliative Treatment|palliative treatment
4672102|NCT03417102|RNAi therapeutic|rnai therapeutic
4672103|NCT03417102|Hemophilia A|hemophilia a
4672104|NCT03417102|Hemophilia B|hemophilia b
4672105|NCT03417102|Hemophilia A, Severe|hemophilia a, severe
4672106|NCT03417102|Hemophilia B, Severe|hemophilia b, severe
4672107|NCT03417102|Blood Coagulation Disorders, Inherited|blood coagulation disorders, inherited
4672108|NCT03417102|Blood Coagulation Disorders|blood coagulation disorders
4672109|NCT03417102|Hematologic Diseases|hematologic diseases
4672110|NCT03417102|Coagulation Protein Disorders|coagulation protein disorders
4672111|NCT03417102|Hemorrhagic Disorders|hemorrhagic disorders
4672112|NCT03417102|Genetic Diseases, Inborn|genetic diseases, inborn
4672113|NCT03417102|Genetic Diseases, X-Linked|genetic diseases, x-linked
4672114|NCT03417102|Factor VIII|factor viii
4672115|NCT03417102|Factor IX|factor ix
4672116|NCT03417102|Inhibitor|inhibitor
4672117|NCT03417102|Bypassing agents|bypassing agents
4672118|NCT03417102|Coagulants|coagulants
4672119|NCT03417102|Fitusiran|fitusiran
4672120|NCT03417063|Intracranial artery|intracranial artery
4672121|NCT03417063|Atherosclerosis|atherosclerosis
4672122|NCT03417063|Intracranial artery stenosis|intracranial artery stenosis
4672123|NCT03417063|High-Resolution Magnetic Resonance|high-resolution magnetic resonance
4672124|NCT03417050|coronary artery bypass grafting|coronary artery bypass grafting
4672125|NCT03417050|percutaneous coronary intervention|percutaneous coronary intervention
4672126|NCT03417050|drug eluting stent|drug eluting stent
4672127|NCT03417050|survival status|survival status
4672128|NCT03417050|long-term follow-up|long-term follow-up
4672129|NCT03417050|complex coronary artery disease|complex coronary artery disease
4672130|NCT03416998|Photherapy|photherapy
4672131|NCT03416998|Photobiomodulation|photobiomodulation
4672132|NCT03416998|Creatine Kinase|creatine kinase
4672133|NCT03416998|Soccer|soccer
4672134|NCT03416998|Muscle Recovery|muscle recovery
4672135|NCT03416946|Total knee replacement|total knee replacement
4672136|NCT03416933|ctDNA|ctdna
4672137|NCT03416933|MAPK inhibition|mapk inhibition
4672138|NCT03416933|BRAF(V600) mutated|braf(v600) mutated
4672139|NCT03416907|Informed consent|informed consent
4672140|NCT03416881|HIV infection|hiv infection
4672141|NCT03416881|antiretroviral|antiretroviral
4672142|NCT03416881|aging population|aging population
4672143|NCT03416881|drug interactions|drug interactions
4672144|NCT03416881|cross-sectional study|cross-sectional study
4672145|NCT03416881|SNIIRAM|sniiram
4672146|NCT03416868|Ambulatory|ambulatory
4672147|NCT03416868|Biofeedback|biofeedback
4672148|NCT03416868|Voice|voice
4672149|NCT03416842|outpatient|outpatient
4672150|NCT03416842|wearable sensors|wearable sensors
4672151|NCT03416842|home exercise|home exercise
4672152|NCT03416829|Ambulatory|ambulatory
4672153|NCT03416829|Biofeedback|biofeedback
4672154|NCT03416829|Voice|voice
4672155|NCT03416816|DSP-0337|dsp-0337
4672156|NCT03416790|Central Nervous System|central nervous system
4672157|NCT03416790|HIV Persistence|hiv persistence
4672158|NCT03416790|HIV Reservoirs|hiv reservoirs
4672159|NCT03416777|vegetarian|vegetarian
4672160|NCT03416777|meat|meat
4672161|NCT03416777|fish|fish
4672162|NCT03416764|PTSD, neurofeedback (NF)|ptsd, neurofeedback (nf)
4672163|NCT03416712|Social Determinants of Health|social determinants of health
4672164|NCT03416699|Transnal Total Mesorectal Excision|transnal total mesorectal excision
4672165|NCT03416699|Rectal Cancer|rectal cancer
4672166|NCT03416686|differentiated thyroid cancer|differentiated thyroid cancer
4672167|NCT03416686|Radiofrequency|radiofrequency
4672168|NCT03416660|Fractional laser|fractional laser
4672169|NCT03416660|Postburn scar|postburn scar
4672170|NCT03416660|Density|density
4672171|NCT03416647|Superior Mesenteric Artery Syndrome|superior mesenteric artery syndrome
4672172|NCT03416647|Chronic duodenal obstruction|chronic duodenal obstruction
4672173|NCT03416647|Duodenojejunostomy|duodenojejunostomy
4672174|NCT03416647|Wilkie's syndrome|wilkie's syndrome
4672175|NCT03416634|Health promotion|health promotion
4672176|NCT03416634|Behavioral research|behavioral research
4672177|NCT03416634|Preventive medicine|preventive medicine
4672178|NCT03416634|Obesity|obesity
4672179|NCT03416634|Cardiovascular disease|cardiovascular disease
4672180|NCT03416621|Light Smoker|light smoker
4672181|NCT03416608|ultrasound|ultrasound
4672182|NCT03416608|patient experience|patient experience
4672183|NCT03416608|diagnostic test|diagnostic test
4672184|NCT03416608|general practice|general practice
4672185|NCT03416608|family medicine|family medicine
4672186|NCT03416595|probiotic|probiotic
4672187|NCT03416595|Lactobacillus paracasei N1115|lactobacillus paracasei n1115
4672188|NCT03416595|young children|young children
4672189|NCT03416543|Rheumatoid arthritis|rheumatoid arthritis
4672190|NCT03416543|Dendritics cells|dendritics cells
4672191|NCT03416517|Ewing Sarcoma|ewing sarcoma
4672192|NCT03416517|Anlotinib|anlotinib
4672193|NCT03416517|Irinotecan|irinotecan
4672194|NCT03416517|Refractory|refractory
4672195|NCT03416517|Metastatic|metastatic
4672197|NCT03416491|Chronic hepatitis C|chronic hepatitis c
4672198|NCT03416491|Hepatitis C virus|hepatitis c virus
4672199|NCT03416491|KW-136|kw-136
4672200|NCT03416491|sofosbuvir|sofosbuvir
4672201|NCT03416491|nonstructural protein 5A|nonstructural protein 5a
4672202|NCT03416491|nonstructural protein 5B|nonstructural protein 5b
4672203|NCT03416491|panogentypic regimen|panogentypic regimen
4672204|NCT03416478|Colorectal Cancer|colorectal cancer
4672205|NCT03416478|ctDNA|ctdna
4672206|NCT03416478|Surveillance|surveillance
4672207|NCT03416465|hospitalization|hospitalization
4672208|NCT03416465|cancer|cancer
4672209|NCT03416465|general practitioner|general practitioner
4672210|NCT03416452|Gait|gait
4672211|NCT03416452|Parkinson's Disease|parkinson's disease
4672212|NCT03416426|patent foramen ovale|patent foramen ovale
4672213|NCT03416426|PFO closure|pfo closure
4672214|NCT03416426|residual shunt|residual shunt
4672215|NCT03416426|bubble contrast transesophageal echocardiography|bubble contrast transesophageal echocardiography
4672216|NCT03416400|Vitrification|vitrification
4672217|NCT03416400|In vitro maturation|in vitro maturation
4672218|NCT03416400|Cytoskeleton|cytoskeleton
4672219|NCT03416400|chromosomes|chromosomes
4672220|NCT03416400|High resolution imaging|high resolution imaging
4672221|NCT03416387|complex liver surgery|complex liver surgery
4672222|NCT03416387|3D printing|3d printing
4672223|NCT03416361|Left ventricular dysfunction|left ventricular dysfunction
4672224|NCT03416361|Vitamin D|vitamin d
4672225|NCT03416348|amputation|amputation
4672226|NCT03416348|amputations|amputations
4672227|NCT03416348|sweating|sweating
4672228|NCT03416348|residual limb|residual limb
4672229|NCT03416348|service members|service members
4672230|NCT03416348|civilians|civilians
4672231|NCT03416335|DSP-0509|dsp-0509
4672232|NCT03416322|Adenoma|adenoma
4672233|NCT03416322|Adenoma detection rate|adenoma detection rate
4672234|NCT03416322|Colorectal cancer|colorectal cancer
4672235|NCT03416309|pharmacokinetics|pharmacokinetics
4672236|NCT03416309|pharmacogenetics|pharmacogenetics
4672237|NCT03416309|Time To Positivity|time to positivity
4672238|NCT03416270|SGLT2 inhibtion|sglt2 inhibtion
4672239|NCT03416270|Ertugliflozin|ertugliflozin
4672240|NCT03416270|Type 2 Diabetes|type 2 diabetes
4672241|NCT03416270|Heart Failure|heart failure
4672242|NCT03416231|apatinib|apatinib
4672243|NCT03416231|Docetaxel|docetaxel
4672244|NCT03416218|STEM Skills|stem skills
4672245|NCT03416192|Dialysis|dialysis
4672247|NCT03416192|Middle molecules|middle molecules
4672248|NCT03416179|glasdegib;|glasdegib;
4672249|NCT03416179|untreated;|untreated;
4672250|NCT03416179|Hedgehog Inhibitor|hedgehog inhibitor
4672251|NCT03416166|Tricuspid Valve|tricuspid valve
4672252|NCT03416166|tricuspid regurgitation|tricuspid regurgitation
4672253|NCT03416166|transcatheter tricuspid regurgitation|transcatheter tricuspid regurgitation
4672254|NCT03416127|Diabetes Mellitus type 2|diabetes mellitus type 2
4672255|NCT03416127|Glycemic control|glycemic control
4672256|NCT03416127|Propolis|propolis
4672257|NCT03416127|Metformin|metformin
4672258|NCT03416114|rare headaches|rare headaches
4672259|NCT03416114|epidemiology|epidemiology
4672260|NCT03416101|esophageal cancer|esophageal cancer
4672261|NCT03416101|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
4672262|NCT03416101|esophageal surgery|esophageal surgery
4672263|NCT03416088|wine,coffee,reading,retinal microcirculation,optical coherence tomography angiography|wine,coffee,reading,retinal microcirculation,optical coherence tomography angiography
4672264|NCT03416062|Jaundice, obstructive|jaundice, obstructive
4672265|NCT03416062|Methionine|methionine
4672266|NCT03416062|Succinic acid|succinic acid
4672267|NCT03416049|ulcers|ulcers
4672268|NCT03416049|leg ulcers|leg ulcers
4672269|NCT03416049|venous stasis|venous stasis
4672270|NCT03416049|ulcer treatment|ulcer treatment
4672271|NCT03416049|leg ulcer treatment|leg ulcer treatment
4672272|NCT03416049|venous stasis treatment|venous stasis treatment
4672273|NCT03416049|non invasive treatment|non invasive treatment
4672275|NCT03416049|pulsed electromagnetic therapy|pulsed electromagnetic therapy
4672276|NCT03416049|pulsed electromagnetic treatment|pulsed electromagnetic treatment
4672277|NCT03416049|pulsed magnetic|pulsed magnetic
4672278|NCT03416049|pulsed magnetic therapy|pulsed magnetic therapy
4672279|NCT03416049|pulsed magnetic treatment|pulsed magnetic treatment
4672280|NCT03416049|varicose Ulcer|varicose ulcer
4672281|NCT03416049|ulcer pain|ulcer pain
4672282|NCT03416023|Implant|implant
4672283|NCT03416023|continence control|continence control
4672284|NCT03416023|titanium|titanium
4672285|NCT03416010|emotional distress pregnancy disparities minority depression|emotional distress pregnancy disparities minority depression
4672286|NCT03415984|Parkinson Disease|parkinson disease
4672287|NCT03415984|Age Related Macular Degeneration|age related macular degeneration
4672288|NCT03415984|L-DOPA|l-dopa
4672289|NCT03415958|prospective|prospective
4672290|NCT03415958|adolescent|adolescent
4672291|NCT03415958|displaced|displaced
4672292|NCT03415958|clavicle|clavicle
4672293|NCT03415958|fracture|fracture
4672294|NCT03415958|mid-shaft|mid-shaft
4672295|NCT03415906|angiotensin receptor blocker|angiotensin receptor blocker
4672296|NCT03415906|neprilysin inhibition|neprilysin inhibition
4672297|NCT03415906|sympathetic activity|sympathetic activity
4672298|NCT03415906|baroreflex|baroreflex
4672299|NCT03415906|microneurography|microneurography
4672300|NCT03415906|functional MRI|functional mri
4672301|NCT03415893|high-resolution manometry|high-resolution manometry
4672302|NCT03415893|esophageal atresia|esophageal atresia
4672303|NCT03415893|teenagers|teenagers
4672304|NCT03415880|Diabetes mellitus|diabetes mellitus
4672305|NCT03415880|Type2 Diabetes|type2 diabetes
4672306|NCT03415880|Sedentary Lifestyle|sedentary lifestyle
4672307|NCT03415880|Physical Activity|physical activity
4672308|NCT03415880|Pulse wave velocity|pulse wave velocity
4672309|NCT03415880|arterial stiffness|arterial stiffness
4672310|NCT03415880|aortic stiffness|aortic stiffness
4672311|NCT03415880|artery disease|artery disease
4672312|NCT03415880|light intensity physical activity|light intensity physical activity
4672313|NCT03415867|Graft-versus-host disease|graft-versus-host disease
4672314|NCT03415867|Bone marrow transplantation|bone marrow transplantation
4672315|NCT03415867|Hedgehog inhibitor|hedgehog inhibitor
4672316|NCT03415841|Post MI|post mi
4672317|NCT03415841|Cardiac Rehabilitation|cardiac rehabilitation
4672318|NCT03415841|Wearable Devices|wearable devices
4672319|NCT03415841|Smartphone-based Program|smartphone-based program
4672320|NCT03415815|Chinese, real-world evidences, T1-T3 esophageal cancer|chinese, real-world evidences, t1-t3 esophageal cancer
4672321|NCT03415802|Nab-Paclitaxel|nab-paclitaxel
4672322|NCT03415802|S-1|s-1
4672323|NCT03415802|Advanced Pancreatic Cancer|advanced pancreatic cancer
4672324|NCT03415789|Non ischemic dilated cardiomyopathy|non ischemic dilated cardiomyopathy
4672325|NCT03415789|Cardiac thrombosis|cardiac thrombosis
4672326|NCT03415789|Silent brain infarct|silent brain infarct
4672327|NCT03415789|Fluid dynamics|fluid dynamics
4672328|NCT03415789|Intracardiac blood flow|intracardiac blood flow
4672329|NCT03415789|Echocardiography|echocardiography
4672330|NCT03415776|Hemodialysis|hemodialysis
4672331|NCT03415776|Sessions frequency|sessions frequency
4672332|NCT03415776|Mortality|mortality
4672333|NCT03415776|Morbidity|morbidity
4672334|NCT03415763|Rectal Neoplasms|rectal neoplasms
4672335|NCT03415763|Adjuvant Chemotherapy|adjuvant chemotherapy
4672336|NCT03415763|Neoadjuvant Chemoradiotherapy|neoadjuvant chemoradiotherapy
4672337|NCT03415750|Renal transplant|renal transplant
4672338|NCT03415698|Regenerative medicine|regenerative medicine
4672339|NCT03415672|Interleukin-2|interleukin-2
4672340|NCT03415672|Hepatitis B Vaccines|hepatitis b vaccines
4672341|NCT03415672|Non-responders|non-responders
4672342|NCT03415672|Liver Diseases|liver diseases
4672343|NCT03415672|Digestive system|digestive system
4672344|NCT03415672|Vaccines|vaccines
4672345|NCT03415659|HWH340|hwh340
4672346|NCT03415659|pharmacokinetics|pharmacokinetics
4672347|NCT03415659|dose-escalation|dose-escalation
4672348|NCT03415659|safety|safety
4672349|NCT03415659|tolerability|tolerability
4672350|NCT03415646|erector spinae plane block|erector spinae plane block
4672351|NCT03415646|breast surgery|breast surgery
4672352|NCT03415646|postoperative pain|postoperative pain
4672353|NCT03415633|Home Respiratory Polygraphy|home respiratory polygraphy
4672354|NCT03415633|Standard Polysomnography|standard polysomnography
4672355|NCT03415633|Validity|validity
4672356|NCT03415633|Cost-effectiveness|cost-effectiveness
4672357|NCT03415568|Postprandial lipid metabolism|postprandial lipid metabolism
4672358|NCT03415568|Medium-chain triglycerides|medium-chain triglycerides
4672359|NCT03415568|Diacylglycerols|diacylglycerols
4672360|NCT03415568|Serum triglycerides|serum triglycerides
4672361|NCT03415568|Chylomicron triglycerides|chylomicron triglycerides
4672362|NCT03415555|Erector Spinae Plane blockade|erector spinae plane blockade
4672363|NCT03415555|patient control anlagesia|patient control anlagesia
4672364|NCT03415555|mitral valve replacement|mitral valve replacement
4672365|NCT03415542|Attitudes|attitudes
4672366|NCT03415542|Ecological momentary assessment|ecological momentary assessment
4672367|NCT03415529|Lung|lung
4672368|NCT03415529|ARDS|ards
4672369|NCT03415529|Acute Respiratory Syndrome|acute respiratory syndrome
4672371|NCT03415529|Outcome Research|outcome research
4672372|NCT03415529|Respiratory infection|respiratory infection
4672373|NCT03415529|Sepsis|sepsis
4672374|NCT03415529|Organ failure|organ failure
4672375|NCT03415529|Hypercapnia|hypercapnia
4672376|NCT03415503|anthocyanins|anthocyanins
4672377|NCT03415503|dyslipidemias|dyslipidemias
4672378|NCT03415503|Hyperglycemia|hyperglycemia
4672379|NCT03415490|general anesthesia|general anesthesia
4672380|NCT03415490|self-adherent wrap|self-adherent wrap
4672381|NCT03415490|pressure|pressure
4672382|NCT03415477|aneurysmal bone cyst, denosumab, surgical treatment, complication|aneurysmal bone cyst, denosumab, surgical treatment, complication
4672383|NCT03415451|cancer patients, Nutritional status|cancer patients, nutritional status
4672384|NCT03415438|thoracolumbar fascia|thoracolumbar fascia
4672385|NCT03415438|subacromial impingement syndrome|subacromial impingement syndrome
4672386|NCT03415412|non-caries cervical lesion|non-caries cervical lesion
4672387|NCT03415412|universal adhesives|universal adhesives
4672388|NCT03415399|relapsed/refractory CD19+ Lymphomas, B-Cell|relapsed/refractory cd19+ lymphomas, b-cell
4672389|NCT03415360|cryoablation|cryoablation
4672390|NCT03415347|Pilonidal abscess|pilonidal abscess
4672391|NCT03415347|Pilonidal disease|pilonidal disease
4672392|NCT03415347|Pilonidal sinus|pilonidal sinus
4672393|NCT03415334|Hepatitis C|hepatitis c
4672394|NCT03415334|social marketing|social marketing
4672395|NCT03415334|Communication for behavior development|communication for behavior development
4672396|NCT03415321|Postpartum, Sense of Security, Mobile Support Application|postpartum, sense of security, mobile support application
4672397|NCT03415308|Implicit Bias|implicit bias
4672398|NCT03415308|Healthcare Equity|healthcare equity
4672399|NCT03415295|Trimethylamine-N-oxide; Gestational diabetes mellitus|trimethylamine-n-oxide; gestational diabetes mellitus
4672400|NCT03415269|acute|acute
4672401|NCT03415191|ketamine, post-thoracotomy pain, analgesia|ketamine, post-thoracotomy pain, analgesia
4672402|NCT03415152|Omacor|omacor
4672403|NCT03415152|Omega-3-acid ethyl esters|omega-3-acid ethyl esters
4672404|NCT03415152|patient adherence|patient adherence
4672405|NCT03415152|patient reported outcomes|patient reported outcomes
4672406|NCT03415126|KRAS mutant|kras mutant
4672407|NCT03415126|NRAS mutant|nras mutant
4672408|NCT03415126|BRAF mutant|braf mutant
4672409|NCT03415126|HRAS mutant|hras mutant
4672410|NCT03415126|ERK 1/2 inhibitor|erk 1/2 inhibitor
4672411|NCT03415113|Medication reconciliation at discharge, potentially inappropriate medications, elderly.|medication reconciliation at discharge, potentially inappropriate medications, elderly.
4672412|NCT03415074|low protein diet|low protein diet
4672413|NCT03415074|Diabetic Kidney Disease|diabetic kidney disease
4672414|NCT03415035|Venetoclax|venetoclax
4672415|NCT03415035|Venclyxto|venclyxto
4672416|NCT03415035|Cancer|cancer
4672417|NCT03415035|Chronic Lymphocytic Leukemia (CLL)|chronic lymphocytic leukemia (cll)
4672418|NCT03415022|SAD|sad
4672419|NCT03415022|Social Anxiety|social anxiety
4672420|NCT03415022|Social Phobia|social phobia
4672421|NCT03415009|IL28B gene|il28b gene
4672422|NCT03414996|Interval training|interval training
4672423|NCT03414996|Autonomic nervous system|autonomic nervous system
4672424|NCT03414996|Post-acute coronary syndrome|post-acute coronary syndrome
4672425|NCT03414957|Malay women, PCOS, Metabolic Syndrome, Rotterdam criteria|malay women, pcos, metabolic syndrome, rotterdam criteria
4672426|NCT03414944|Non-small cell lung cancer|non-small cell lung cancer
4672427|NCT03414944|Brain metastases|brain metastases
4672428|NCT03414944|SIB|sib
4672429|NCT03414944|hippocampus avoidance|hippocampus avoidance
4672430|NCT03414944|inner ear avoidance|inner ear avoidance
4672431|NCT03414918|Macrolides, KCNJ5 potassium channel, aldosteronism|macrolides, kcnj5 potassium channel, aldosteronism
4672432|NCT03414892|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
4672433|NCT03414892|Glucokinase Activator|glucokinase activator
4672434|NCT03414866|Thoracic Aorta|thoracic aorta
4672435|NCT03414866|Dissection|dissection
4672436|NCT03414866|Aneurysm|aneurysm
4672437|NCT03414866|Frozen Elephant Trunk|frozen elephant trunk
4672438|NCT03414853|Appendicitis, abdominal pain, free text prediction|appendicitis, abdominal pain, free text prediction
4672439|NCT03414840|coronary artery disease|coronary artery disease
4672440|NCT03414840|coronary computed tomography angiography|coronary computed tomography angiography
4672441|NCT03414840|statins|statins
4672442|NCT03414840|coronary atherosclerosis|coronary atherosclerosis
4672443|NCT03414814|NSCLC|nsclc
4672444|NCT03414814|Osimertinib|osimertinib
4672445|NCT03414814|EGFR exon 20 insertion mutation|egfr exon 20 insertion mutation
4672446|NCT03414801|Environmental Exposure Unit|environmental exposure unit
4672447|NCT03414801|Cat Allergen|cat allergen
4672448|NCT03414801|Rhinitis|rhinitis
4672449|NCT03414801|Subject Validation|subject validation
4672450|NCT03414788|Positron Emission Tomography (PET), Ulcerative Colitis, Safety, PKPlasma|positron emission tomography (pet), ulcerative colitis, safety, pkplasma
4672451|NCT03414775|microbiome|microbiome
4672452|NCT03414775|gastrointestinal microbiome|gastrointestinal microbiome
4672453|NCT03414775|pediatrics|pediatrics
4672454|NCT03414775|critical illness|critical illness
4672455|NCT03414762|cesarean section|cesarean section
4672456|NCT03414762|negative-pressure wound therapy|negative-pressure wound therapy
4672457|NCT03414762|surgical wound dehiscence|surgical wound dehiscence
4672458|NCT03414762|hospital readmission|hospital readmission
4672459|NCT03414762|surgical site infection|surgical site infection
4672460|NCT03414710|uptake of voluntary medical male circumcision|uptake of voluntary medical male circumcision
4672461|NCT03414697|umbilical cord-derived mesenchymal stem cells|umbilical cord-derived mesenchymal stem cells
4672462|NCT03414697|cerebral palsy|cerebral palsy
4672463|NCT03414684|Breast Cancer|breast cancer
4672464|NCT03414671|apnea|apnea
4672465|NCT03414658|Breast Cancer|breast cancer
4672466|NCT03414632|Heart Failure|heart failure
4672467|NCT03414632|Diastolic Heart Failure|diastolic heart failure
4672468|NCT03414632|Heart Failure with Preserved Ejection Fraction|heart failure with preserved ejection fraction
4672469|NCT03414632|Transthyretin Cardiac Amyloidosis|transthyretin cardiac amyloidosis
4672470|NCT03414632|Amyloidosis|amyloidosis
4672471|NCT03414619|OCD|ocd
4672472|NCT03414619|GAD|gad
4672473|NCT03414619|MDD|mdd
4672474|NCT03414619|Rumination|rumination
4672475|NCT03414619|Obsession|obsession
4672476|NCT03414619|Worry|worry
4672477|NCT03414593|preemptive analgic effect|preemptive analgic effect
4672478|NCT03414593|popliteal sciatic nerve block|popliteal sciatic nerve block
4672479|NCT03414593|Bilateral Hallux Valgus|bilateral hallux valgus
4672480|NCT03414567|Follicular fluid|follicular fluid
4672481|NCT03414567|nicotine|nicotine
4672482|NCT03414567|cotinine|cotinine
4672483|NCT03414567|Benzo(a)pyrene|benzo(a)pyrene
4672484|NCT03414502|Methotrexate|methotrexate
4672485|NCT03414489|Clinical Trial, Phase II|clinical trial, phase ii
4672486|NCT03414489|Multicenter Trials|multicenter trials
4672487|NCT03414489|Clinical Study|clinical study
4672488|NCT03414489|Clinical Trials, Non-Randomized|clinical trials, non-randomized
4672489|NCT03414489|Oral capsule|oral capsule
4672490|NCT03414489|Single arm|single arm
4672491|NCT03414489|Anti-cancer|anti-cancer
4672492|NCT03414489|Anti-inflammatory|anti-inflammatory
4672493|NCT03414489|ABC294640|abc294640
4672494|NCT03414489|Expanded Access Program|expanded access program
4672495|NCT03414489|Compassionate Use|compassionate use
4672496|NCT03414489|Special Access Program|special access program
4672497|NCT03414489|Yeliva ®|yeliva ®
4672498|NCT03414463|Brain Injury|brain injury
4672499|NCT03414450|Mnk kinase inhibitor, Mnk kinase|mnk kinase inhibitor, mnk kinase
4672500|NCT03414424|transcutaneous electric nerve stimulation|transcutaneous electric nerve stimulation
4672501|NCT03414424|transcranial magnetic stimulation|transcranial magnetic stimulation
4672502|NCT03414411|HIV|hiv
4672503|NCT03414411|Alcohol Use|alcohol use
4672504|NCT03414411|Substance Use|substance use
4672505|NCT03414411|Bone Disease|bone disease
4672506|NCT03414411|Falls|falls
4672507|NCT03414411|Fractures|fractures
4672508|NCT03414372|MSM|msm
4672509|NCT03414372|HIV|hiv
4672510|NCT03414372|disclosure|disclosure
4672511|NCT03414372|eHealth|ehealth
4672512|NCT03414372|virtual reality|virtual reality
4672513|NCT03414346|Cryotherapy|cryotherapy
4672514|NCT03414346|Skin temperature|skin temperature
4672515|NCT03414346|Physical therapy modalities|physical therapy modalities
4672516|NCT03414346|Physical therapy|physical therapy
4672517|NCT03414346|Thermography|thermography
4672518|NCT03414346|Pain measurement|pain measurement
4672519|NCT03414333|obesity|obesity
4672520|NCT03414333|cognitive dysfunction|cognitive dysfunction
4672521|NCT03414320|type 1 diabetes|type 1 diabetes
4672522|NCT03414320|insulin pump|insulin pump
4672523|NCT03414320|bolus calculator|bolus calculator
4672524|NCT03414320|continuous glucose monitoring|continuous glucose monitoring
4672525|NCT03414320|carbohydrate to insulin ratio|carbohydrate to insulin ratio
4672526|NCT03414320|insulin sensitivity factor|insulin sensitivity factor
4672527|NCT03414281|quadratus lumborum block, thoracic paravertebral block, nephrectomy|quadratus lumborum block, thoracic paravertebral block, nephrectomy
4672528|NCT03414268|Chronic plantar fasciitis|chronic plantar fasciitis
4672529|NCT03414268|Heel pain|heel pain
4672530|NCT03414255|Chronic Achilles Tendonitis|chronic achilles tendonitis
4672531|NCT03414229|Epacadostat|epacadostat
4672532|NCT03414229|Pembrolizumab|pembrolizumab
4672533|NCT03414229|17-508|17-508
4672534|NCT03414203|Transcranial Direct Current Stimulation|transcranial direct current stimulation
4672535|NCT03414203|Migraine Disorders|migraine disorders
4672536|NCT03414203|Cognitive Symptoms|cognitive symptoms
4672537|NCT03414190|Acute Coronary Syndrome|acute coronary syndrome
4672538|NCT03414190|Text Messaging|text messaging
4672539|NCT03414190|Risk Factors|risk factors
4672540|NCT03414177|Telemedicine|telemedicine
4672541|NCT03414177|Clinical follow up visits|clinical follow up visits
4672542|NCT03414138|Pain|pain
4672543|NCT03414138|Mindfulness|mindfulness
4672544|NCT03414138|Meditation|meditation
4672545|NCT03414138|fMRI|fmri
4672546|NCT03414125|Colorectal Cancer|colorectal cancer
4672547|NCT03414125|Colon Cancer|colon cancer
4672548|NCT03414125|FIT Screening Strategy|fit screening strategy
4672549|NCT03414125|Colon Screening Strategy|colon screening strategy
4672550|NCT03414125|Colorectal Neoplasms|colorectal neoplasms
4672551|NCT03414125|Mass Screening|mass screening
4672552|NCT03414125|Health Services Research|health services research
4672553|NCT03414125|Comparative Effectiveness Research|comparative effectiveness research
4672554|NCT03414099|Pain|pain
4672555|NCT03414099|Kratom|kratom
4672556|NCT03414099|Ketum|ketum
4672557|NCT03414099|mitragynine|mitragynine
4672558|NCT03414086|PM|pm
4672559|NCT03414086|DM|dm
4672560|NCT03414073|dental floss|dental floss
4672561|NCT03414073|gingival embrasure|gingival embrasure
4672562|NCT03414073|oral hygiene|oral hygiene
4672563|NCT03414073|interdental brush|interdental brush
4672564|NCT03414060|obstetric fistula|obstetric fistula
4672565|NCT03414060|vesicovaginal fistula|vesicovaginal fistula
4672566|NCT03414060|menstrual cup|menstrual cup
4672567|NCT03414060|pad test|pad test
4672568|NCT03414060|non-surgical management|non-surgical management
4672569|NCT03414060|feasibility|feasibility
4672570|NCT03414060|acceptability|acceptability
4672571|NCT03414060|innovation|innovation
4672572|NCT03414047|DNA damage repair|dna damage repair
4672573|NCT03414047|replication stress|replication stress
4672574|NCT03414034|PLK1|plk1
4672575|NCT03414034|PLK Inhibitor|plk inhibitor
4672576|NCT03414021|Nuclear Medicine|nuclear medicine
4672577|NCT03414021|SPECT-CT Scan|spect-ct scan
4672578|NCT03414021|gamma-camera with semiconductor|gamma-camera with semiconductor
4672579|NCT03413995|metastatic hormone sensitive|metastatic hormone sensitive
4672580|NCT03413956|Chinese|chinese
4672581|NCT03413956|T1 non-small cell lung cancer|t1 non-small cell lung cancer
4672582|NCT03413956|Lymph metastases|lymph metastases
4672583|NCT03413930|TaTME|tatme
4672584|NCT03413930|Rectal cancer|rectal cancer
4672585|NCT03413930|Laparoscopic Surgery|laparoscopic surgery
4672586|NCT03413917|genomic markers|genomic markers
4672587|NCT03413904|taTME|tatme
4672588|NCT03413891|Anticoagulants|anticoagulants
4672589|NCT03413891|Tranexamic Acid|tranexamic acid
4672590|NCT03413878|snow|snow
4672591|NCT03413878|avalanche|avalanche
4672592|NCT03413878|hypercapnia|hypercapnia
4672593|NCT03413878|work of breathing|work of breathing
4672594|NCT03413839|Scoliosis|scoliosis
4672595|NCT03413839|PSSE|psse
4672596|NCT03413826|weight loss|weight loss
4672597|NCT03413826|exercise|exercise
4672598|NCT03413826|reinforcement|reinforcement
4672599|NCT03413826|compensation|compensation
4672600|NCT03413813|Magmaris|magmaris
4672601|NCT03413800|hematopoietic stem cell transplant|hematopoietic stem cell transplant
4672602|NCT03413800|lenalidomide|lenalidomide
4672604|NCT03413722|Liver transplant|liver transplant
4672605|NCT03413722|Cognitive function|cognitive function
4672606|NCT03413709|Parenting Time, Father Involvement|parenting time, father involvement
4672607|NCT03413696|HIV|hiv
4672608|NCT03413696|Health literacy|health literacy
4672609|NCT03413696|Hepatitis C|hepatitis c
4672610|NCT03413696|Hepatitis C knowledge|hepatitis c knowledge
4672611|NCT03413696|HIV knowledge|hiv knowledge
4672612|NCT03413696|Hepatitis C treatment|hepatitis c treatment
4672613|NCT03413644|Hematological diseases|hematological diseases
4672614|NCT03413631|prenatal substance abuse|prenatal substance abuse
4672615|NCT03413631|mentalization|mentalization
4672616|NCT03413631|prenatal depression|prenatal depression
4672617|NCT03413631|prenatal anxiety|prenatal anxiety
4672618|NCT03413631|maternal-fetal attachment|maternal-fetal attachment
4672619|NCT03413631|prenatal intervention|prenatal intervention
4672620|NCT03413631|ultrasound|ultrasound
4672621|NCT03413631|perinatal outcome|perinatal outcome
4672622|NCT03413631|fetal exposure|fetal exposure
4672623|NCT03413631|parenting|parenting
4672624|NCT03413631|parenthood|parenthood
4672625|NCT03413631|prenatal treatment|prenatal treatment
4672626|NCT03413618|deep vein thrombosis|deep vein thrombosis
4672627|NCT03413618|postthrombotic syndrome|postthrombotic syndrome
4672628|NCT03413618|anticoagulation|anticoagulation
4672629|NCT03413618|treatment|treatment
4672630|NCT03413618|prevention|prevention
4672631|NCT03413579|Cervix|cervix
4672632|NCT03413579|Oncology,|oncology,
4672633|NCT03413579|hR3,|hr3,
4672634|NCT03413579|Nimotuzumab,|nimotuzumab,
4672635|NCT03413579|Chemotherapy,|chemotherapy,
4672636|NCT03413579|Survival|survival
4672637|NCT03413579|Monoclonal antibody|monoclonal antibody
4672638|NCT03413579|RECIST|recist
4672639|NCT03413579|Cisplatin|cisplatin
4672640|NCT03413579|Vinorelbine|vinorelbine
4672641|NCT03413579|Paclitaxel|paclitaxel
4672642|NCT03413579|Carboplatine|carboplatine
4672643|NCT03413579|Randomisation|randomisation
4672644|NCT03413579|Placebo|placebo
4672645|NCT03413579|cancer|cancer
4672646|NCT03413566|Trends|trends
4672647|NCT03413566|Prevalence|prevalence
4672648|NCT03413566|Registries/statistics & numerical data|registries/statistics & numerical data
4672649|NCT03413566|Epidemiology|epidemiology
4672650|NCT03413553|immediate implant|immediate implant
4672651|NCT03413553|connective tissue graft|connective tissue graft
4672652|NCT03413540|jumping|jumping
4672653|NCT03413540|bone health|bone health
4672654|NCT03413527|rTMS|rtms
4672655|NCT03413514|shared decision making|shared decision making
4672656|NCT03413514|neoadjuvant chemotherapy|neoadjuvant chemotherapy
4672657|NCT03413514|cycle|cycle
4672658|NCT03413514|MRI|mri
4672659|NCT03413514|clinical response|clinical response
4672660|NCT03413488|Shoulder impingement syndrome|shoulder impingement syndrome
4672661|NCT03413488|Kinesio tape|kinesio tape
4672662|NCT03413488|Round shoulder posture|round shoulder posture
4672663|NCT03413475|Edentulism|edentulism
4672664|NCT03413475|complete removable prosthesis|complete removable prosthesis
4672665|NCT03413475|quality of life|quality of life
4672666|NCT03413436|adjuvant chemotherapy|adjuvant chemotherapy
4672667|NCT03413436|multicenter retrospective study|multicenter retrospective study
4672668|NCT03413423|smoking|smoking
4672669|NCT03413423|depression|depression
4672670|NCT03413423|Behavioral Activation|behavioral activation
4672671|NCT03413423|Mood management|mood management
4672672|NCT03413423|Secondary Prevention|secondary prevention
4672673|NCT03413384|Parkinson's Disease|parkinson's disease
4672674|NCT03413384|Parkinson's Disease Dementia|parkinson's disease dementia
4672675|NCT03413371|Surgical Pleth Index (SPI)|surgical pleth index (spi)
4672676|NCT03413371|General Anaesthesia (GA),|general anaesthesia (ga),
4672677|NCT03413371|Numerical Rating Scale (NRS)|numerical rating scale (nrs)
4672678|NCT03413371|Adequacy of Anaesthesia (AoA)|adequacy of anaesthesia (aoa)
4672679|NCT03413371|Peribulbar Block (PBB)|peribulbar block (pbb)
4672680|NCT03413371|bupivacaine|bupivacaine
4672681|NCT03413371|ropivacaine|ropivacaine
4672682|NCT03413371|lidocaine|lidocaine
4672683|NCT03413332|Chinese American Women|chinese american women
4672684|NCT03413332|Provider-patient Communication|provider-patient communication
4672685|NCT03413332|Survivorship Care|survivorship care
4672686|NCT03413306|aplastic anemia|aplastic anemia
4672687|NCT03413306|immunosupressive therapy|immunosupressive therapy
4672688|NCT03413306|ATG|atg
4672689|NCT03413306|eltrombopag|eltrombopag
4672690|NCT03413280|preemptive analgic effect|preemptive analgic effect
4672691|NCT03413280|Rectus Sheath Block|rectus sheath block
4672692|NCT03413280|laparoscopic cholecystectomy|laparoscopic cholecystectomy
4672693|NCT03413267|micronutrient|micronutrient
4672694|NCT03413267|bioavailability|bioavailability
4672695|NCT03413267|bioaccessibility|bioaccessibility
4672696|NCT03413267|food structure|food structure
4672697|NCT03413267|food texture|food texture
4672698|NCT03413254|pT4 colon cancer|pt4 colon cancer
4672699|NCT03413254|Peritoneal metastases|peritoneal metastases
4672700|NCT03413254|Early detection|early detection
4672701|NCT03413254|Diagnostic laparoscopy|diagnostic laparoscopy
4672702|NCT03413254|Second look surgery|second look surgery
4672703|NCT03413254|Third look surgery|third look surgery
4672704|NCT03413241|High functioning autism spectrum disorder|high functioning autism spectrum disorder
4672705|NCT03413202|butylphthalide(NBP)|butylphthalide(nbp)
4672706|NCT03413202|large-artery atherosclerosis acute ischemic stroke|large-artery atherosclerosis acute ischemic stroke
4672707|NCT03413202|dynamic Cerebral Autoregulation(dCA)|dynamic cerebral autoregulation(dca)
4672708|NCT03413189|Exercise|exercise
4672709|NCT03413189|Dosage|dosage
4672710|NCT03413189|Function|function
4672711|NCT03413176|VEGFR|vegfr
4672712|NCT03413176|VEGF|vegf
4672713|NCT03413176|antiangiogenics|antiangiogenics
4672714|NCT03413176|angiogenesis|angiogenesis
4672715|NCT03413163|Ultrasound Guided Erector Spinae Plane Block|ultrasound guided erector spinae plane block
4672716|NCT03413163|postoperative pain|postoperative pain
4672717|NCT03413163|retropubic radical prostatectomy|retropubic radical prostatectomy
4672718|NCT03413137|Prostate cancer|prostate cancer
4672719|NCT03413137|transperineal mp-MRI-fusion/TRUS biopsies|transperineal mp-mri-fusion/trus biopsies
4672720|NCT03413137|mp-MRI fusion/TRUS transrectal biopsy|mp-mri fusion/trus transrectal biopsy
4672721|NCT03413111|ERCP|ercp
4672722|NCT03413111|double guidewire technique|double guidewire technique
4672723|NCT03413085|Myopia control|myopia control
4672724|NCT03413046|Regulatory T cell|regulatory t cell
4672725|NCT03413046|Acute lymphoblastic leukemia|acute lymphoblastic leukemia
4672726|NCT03413046|Minimal residual disease|minimal residual disease
4672727|NCT03413033|Semi-occluded vocal tract|semi-occluded vocal tract
4672728|NCT03413033|resonance tubes|resonance tubes
4672729|NCT03413033|tongue trill|tongue trill
4672730|NCT03413033|voice therapy|voice therapy
4672731|NCT03413020|Helicobacter pylori|helicobacter pylori
4672732|NCT03413020|Rescue therapy|rescue therapy
4672733|NCT03413020|Tailored therapy|tailored therapy
4672734|NCT03413020|Antimicrobial susceptibility testing|antimicrobial susceptibility testing
4672735|NCT03412942|Comfort|comfort
4672736|NCT03412942|Confidence|confidence
4672737|NCT03412942|Usage outcomes|usage outcomes
4672738|NCT03412916|Orthopedic|orthopedic
4672739|NCT03412916|Chronic Pain|chronic pain
4672740|NCT03412916|Musculoskeletal|musculoskeletal
4672741|NCT03412916|Physical Activity|physical activity
4672742|NCT03412903|Acute geriatric treatment|acute geriatric treatment
4672743|NCT03412903|Inpatient treatment team|inpatient treatment team
4672744|NCT03412903|Elderly|elderly
4672745|NCT03412903|Pharmacist|pharmacist
4672746|NCT03412903|Comprehensive pharmaceutical assessment|comprehensive pharmaceutical assessment
4672747|NCT03412903|Medication history|medication history
4672748|NCT03412903|Medication reconciliation|medication reconciliation
4672749|NCT03412903|Adherence|adherence
4672750|NCT03412903|Medication therapy management|medication therapy management
4672751|NCT03412903|Pharmaceutical consultation|pharmaceutical consultation
4672752|NCT03412903|Drug-Related Side Effects and Adverse Reactions|drug-related side effects and adverse reactions
4672753|NCT03412903|Drug interactions|drug interactions
4672754|NCT03412903|Pharmaceutical Council|pharmaceutical council
4672755|NCT03412903|Drug regime acceptance|drug regime acceptance
4672756|NCT03412903|Patient Care Team|patient care team
4672757|NCT03412903|Hospital Pharmacy Service|hospital pharmacy service
4672758|NCT03412903|Polypharmacy|polypharmacy
4672759|NCT03412903|Hospitalization|hospitalization
4672760|NCT03412903|Pharmaceutical Services|pharmaceutical services
4672761|NCT03412877|Gene Therapy|gene therapy
4672762|NCT03412877|Immunotherapy|immunotherapy
4672763|NCT03412877|Cell Therapy|cell therapy
4672764|NCT03412877|Adoptive Cell Therapy|adoptive cell therapy
4672765|NCT03412864|chondrocyte cells|chondrocyte cells
4672766|NCT03412864|osteoarthritis|osteoarthritis
4672767|NCT03412864|gene therapy|gene therapy
4672768|NCT03412851|Thrombectomy|thrombectomy
4672769|NCT03412851|Stentriever|stentriever
4672770|NCT03412851|ADAPT|adapt
4672771|NCT03412838|Bone block allograft|bone block allograft
4672772|NCT03412838|Bone density|bone density
4672773|NCT03412838|Graft resorption|graft resorption
4672774|NCT03412838|PRP|prp
4672775|NCT03412838|RCT|rct
4672776|NCT03412812|Brain Metastases|brain metastases
4672777|NCT03412812|Stereotactic Radiosurgery|stereotactic radiosurgery
4672778|NCT03412773|Advanced liver cancer|advanced liver cancer
4672779|NCT03412760|hydrops fetalis|hydrops fetalis
4672780|NCT03412760|birth defect|birth defect
4672781|NCT03412760|fetal anomaly|fetal anomaly
4672782|NCT03412760|whole exome sequencing|whole exome sequencing
4672783|NCT03412747|Bimekizumab|bimekizumab
4672784|NCT03412747|PSO|pso
4672785|NCT03412747|Psoriasis|psoriasis
4672786|NCT03412721|laser analgesia|laser analgesia
4672787|NCT03412721|pediatric dentistry|pediatric dentistry
4672788|NCT03412695|Disease-related malnutrition|disease-related malnutrition
4672789|NCT03412695|eHealth|ehealth
4672790|NCT03412695|Decision support system|decision support system
4672791|NCT03412695|Clinical nutrition|clinical nutrition
4672792|NCT03412682|Ulcerative colitis|ulcerative colitis
4672793|NCT03412682|FE999315|fe999315
4672794|NCT03412682|Mesalazine|mesalazine
4672795|NCT03412682|Colitis|colitis
4672796|NCT03412682|Colitis, Ulcerative|colitis, ulcerative
4672797|NCT03412669|Addiction affected family members|addiction affected family members
4672798|NCT03412669|Counselling|counselling
4672799|NCT03412669|Psychosocial intervention|psychosocial intervention
4672800|NCT03412669|Low and Middle Income Countries|low and middle income countries
4672801|NCT03412669|India|india
4672802|NCT03412669|Pilot Randomised Controlled Trial|pilot randomised controlled trial
4672803|NCT03412656|CUFF|cuff
4672804|NCT03412656|Soft Hand Pro|soft hand pro
4672805|NCT03412656|SHP|shp
4672806|NCT03412656|SH Pro|sh pro
4672807|NCT03412656|SoftHand|softhand
4672808|NCT03412617|Healthy Eating|healthy eating
4672809|NCT03412617|Blood glucose|blood glucose
4672810|NCT03412617|Bifidobacterium|bifidobacterium
4672811|NCT03412617|Obese women|obese women
4672812|NCT03412604|Alzheimer Disease|alzheimer disease
4672813|NCT03412539|resistant pain|resistant pain
4672814|NCT03412513|Overactive Bladder|overactive bladder
4672815|NCT03412513|Parkinson Disease|parkinson disease
4672816|NCT03412500|Methicillin-Resistant Staphylococcus aureus|methicillin-resistant staphylococcus aureus
4672817|NCT03412500|Vancomycin|vancomycin
4672818|NCT03412474|suprazygomatic block, dexmedetomidine|suprazygomatic block, dexmedetomidine
4672819|NCT03412461|Transition-aged youth|transition-aged youth
4672820|NCT03412461|Mental Health|mental health
4672821|NCT03412461|Accessibility|accessibility
4672822|NCT03412448|chronic pain|chronic pain
4672823|NCT03412448|cardiac surgery|cardiac surgery
4672824|NCT03412448|opioids|opioids
4672825|NCT03412435|Acute myocardial infarction|acute myocardial infarction
4672826|NCT03412435|Myocardial infarction|myocardial infarction
4672827|NCT03412422|Passive Leg Raise|passive leg raise
4672828|NCT03412422|Fluid Challenge|fluid challenge
4672829|NCT03412422|Common carotid artery|common carotid artery
4672830|NCT03412409|RIC regimen|ric regimen
4672831|NCT03412409|comorbidity|comorbidity
4672832|NCT03412409|elderly|elderly
4672833|NCT03412409|haploidentical|haploidentical
4672834|NCT03412409|transplant-related mortality|transplant-related mortality
4672835|NCT03412396|Prostate Cancer|prostate cancer
4672836|NCT03412396|Apalutamide|apalutamide
4672837|NCT03412396|ARN-509|arn-509
4672838|NCT03412396|Prostatectomy|prostatectomy
4672839|NCT03412396|Questionnaires|questionnaires
4672840|NCT03412396|Surveys|surveys
4672841|NCT03412396|Adenocarcinoma of the prostate|adenocarcinoma of the prostate
4672842|NCT03412357|pleurectomy/decortication|pleurectomy/decortication
4672843|NCT03412357|indwelling pleural catheter|indwelling pleural catheter
4672844|NCT03412344|clinical trial|clinical trial
4672845|NCT03412344|patient|patient
4672846|NCT03412344|questionnaire|questionnaire
4672847|NCT03412305|Dental implants, antibiotic prophylaxis|dental implants, antibiotic prophylaxis
4672848|NCT03412279|Chronic Low Back Pain|chronic low back pain
4672971|NCT03411447|mortality|mortality
4672849|NCT03412279|Oswestry Disability Index|oswestry disability index
4672850|NCT03412279|Roland Morris Disability Questionnaire|roland morris disability questionnaire
4672851|NCT03412279|SF-12 Health Survey|sf-12 health survey
4672852|NCT03412279|Pain Catastrophizing Scale|pain catastrophizing scale
4672853|NCT03412279|Back Beliefs Questionnaire|back beliefs questionnaire
4672854|NCT03412266|RIC regimen; MDS; haplo-HSCT; survival|ric regimen; mds; haplo-hsct; survival
4672855|NCT03412253|metabolic surgery, BMI 25-30 kg/m2, SAGB, T2DM remission.|metabolic surgery, bmi 25-30 kg/m2, sagb, t2dm remission.
4672856|NCT03412227|Anxiety|anxiety
4672857|NCT03412227|Depression|depression
4672858|NCT03412227|Children|children
4672859|NCT03412227|Adolescents|adolescents
4672861|NCT03412201|Disease management|disease management
4672862|NCT03412201|Medication therapy management|medication therapy management
4672863|NCT03412201|Biomarkers|biomarkers
4672864|NCT03412188|Chronic ITP|chronic itp
4672865|NCT03412188|persistent ITP|persistent itp
4672866|NCT03412188|Eltrombopag|eltrombopag
4672867|NCT03412188|GPVI receptor|gpvi receptor
4672868|NCT03412162|Discrimination|discrimination
4672869|NCT03412162|Cortisol|cortisol
4672870|NCT03412162|Sleep|sleep
4672871|NCT03412162|Identity|identity
4672872|NCT03412149|Malabsorption, Mini Gastric Bypass, Roux en Y Gastric Bypass|malabsorption, mini gastric bypass, roux en y gastric bypass
4672873|NCT03412136|Testosterone|testosterone
4672874|NCT03412136|Food Intake|food intake
4672875|NCT03412136|Appetite|appetite
4672876|NCT03412110|chiropractic|chiropractic
4672877|NCT03412097|chiropractic|chiropractic
4672878|NCT03412084|Sedentary Lifestyle|sedentary lifestyle
4672879|NCT03412084|physical function|physical function
4672880|NCT03412058|PD-1|pd-1
4672881|NCT03412058|PD-L1|pd-l1
4672882|NCT03412019|Music|music
4672883|NCT03412019|Patient Satisfaction|patient satisfaction
4672884|NCT03412006|type II diabetes|type ii diabetes
4672885|NCT03412006|diabetic kidney disease|diabetic kidney disease
4672886|NCT03411980|Pharmacokinetics|pharmacokinetics
4672887|NCT03411954|hippocampus avoidance|hippocampus avoidance
4672888|NCT03411954|cognitive changes|cognitive changes
4672889|NCT03411954|intensity modulated radiotherapy|intensity modulated radiotherapy
4672890|NCT03411941|nAMD: neovascular Age-related Macular Degeneration|namd: neovascular age-related macular degeneration
4672891|NCT03411915|NET|net
4672892|NCT03411915|GIST|gist
4672893|NCT03411915|DUET-1|duet-1
4672894|NCT03411902|Bone Health|bone health
4672895|NCT03411876|IPF|ipf
4672896|NCT03411876|Oxymizer|oxymizer
4672897|NCT03411876|oxygen conserving device|oxygen conserving device
4672898|NCT03411876|pulmonary disease|pulmonary disease
4672899|NCT03411863|Transcutaneous Electric Nerve Stimulation|transcutaneous electric nerve stimulation
4672900|NCT03411863|transcranial magnetic stimulation|transcranial magnetic stimulation
4672901|NCT03411837|Atopic Dermatitis, dupilumab|atopic dermatitis, dupilumab
4672902|NCT03411824|diagnosis|diagnosis
4672903|NCT03411824|Point-of-Care-Ultrasound|point-of-care-ultrasound
4672904|NCT03411824|lung ultrasound|lung ultrasound
4672905|NCT03411811|tendinopathy|tendinopathy
4672906|NCT03411811|wrist|wrist
4672907|NCT03411811|chronic pain|chronic pain
4672908|NCT03411811|sprain|sprain
4672909|NCT03411798|ankylosing spondylitis(AS)|ankylosing spondylitis(as)
4672910|NCT03411798|TNFi|tnfi
4672911|NCT03411798|Yisaipu®|yisaipu®
4672912|NCT03411798|Disease modifying anti-rheumatic drugs (DMARDs)|disease modifying anti-rheumatic drugs (dmards)
4672913|NCT03411759|CYP2D6|cyp2d6
4672914|NCT03411759|Chronic pain|chronic pain
4672915|NCT03411759|Cytochrome P450|cytochrome p450
4672916|NCT03411759|Opioids|opioids
4672917|NCT03411733|acne vlugaris|acne vlugaris
4672918|NCT03411733|prevalence|prevalence
4672919|NCT03411733|Helicobacter Pylori|helicobacter pylori
4672920|NCT03411707|Colorectal cancer screening|colorectal cancer screening
4672921|NCT03411707|Stool DNA test|stool dna test
4672922|NCT03411707|Blood mRNA test|blood mrna test
4672923|NCT03411694|Survey|survey
4672924|NCT03411694|Anesthesia|anesthesia
4672925|NCT03411694|Anesthesiologist|anesthesiologist
4672926|NCT03411694|Patient perspective|patient perspective
4672927|NCT03411668|undergraduate nursing students|undergraduate nursing students
4672928|NCT03411668|evidence based practice beliefs|evidence based practice beliefs
4672929|NCT03411668|evidence based practice knowledge|evidence based practice knowledge
4672930|NCT03411668|evidence based practice implementation|evidence based practice implementation
4672931|NCT03411668|Evidence based practice Education programme|evidence based practice education programme
4672932|NCT03411642|Stroke, echocardiography|stroke, echocardiography
4672933|NCT03411629|Necrotizing Pancreatitis|necrotizing pancreatitis
4672934|NCT03411629|Critically ill|critically ill
4672935|NCT03411629|Mortality|mortality
4672936|NCT03411616|Eating behavior|eating behavior
4672937|NCT03411616|Excessive weight|excessive weight
4672938|NCT03411616|Food craving|food craving
4672939|NCT03411616|Liver transplantation|liver transplantation
4672940|NCT03411616|Obesity|obesity
4672941|NCT03411616|Weight gain|weight gain
4672942|NCT03411603|nutrient profiling|nutrient profiling
4672943|NCT03411564|dating violence|dating violence
4672944|NCT03411564|health promotion|health promotion
4672945|NCT03411564|educational intervention|educational intervention
4672946|NCT03411564|health assets|health assets
4672947|NCT03411564|participation action research|participation action research
4672948|NCT03411551|Intravenous anesthesia|intravenous anesthesia
4672949|NCT03411551|Nerve Block|nerve block
4672950|NCT03411551|Regional anesthesia|regional anesthesia
4672951|NCT03411538|antibiotic-resistant infections|antibiotic-resistant infections
4672952|NCT03411538|risk factors|risk factors
4672953|NCT03411538|prospective surveillance|prospective surveillance
4672954|NCT03411512|congenital heart defects|congenital heart defects
4672955|NCT03411512|near-infrared spectroscopy|near-infrared spectroscopy
4672956|NCT03411512|newborn|newborn
4672957|NCT03411512|tissue oxygenation|tissue oxygenation
4672958|NCT03411499|Adult|adult
4672959|NCT03411499|Endocarditis/surgery|endocarditis/surgery
4672960|NCT03411499|Embolism/prevention & control|embolism/prevention & control
4672961|NCT03411499|Cardiovascular Diseases|cardiovascular diseases
4672962|NCT03411499|Costs and Cost Analysis|costs and cost analysis
4672963|NCT03411499|Quality of life|quality of life
4672964|NCT03411447|vasoactive drug|vasoactive drug
4672965|NCT03411447|mechanical ventilation|mechanical ventilation
4672966|NCT03411447|early enteral nutrition|early enteral nutrition
4672967|NCT03411447|intensive care unit|intensive care unit
4672968|NCT03411447|early parenteral nutrition|early parenteral nutrition
4672969|NCT03411447|critical care medicine|critical care medicine
4672970|NCT03411447|nosocomial infection|nosocomial infection
4672972|NCT03411447|shock|shock
4672973|NCT03411434|oculomotor performances|oculomotor performances
4672974|NCT03411434|neurocognition|neurocognition
4672975|NCT03411434|methylphenidate|methylphenidate
4672976|NCT03411408|Hypofractionated radiotherapy|hypofractionated radiotherapy
4672977|NCT03411408|image - guided helical tomotherapy|image - guided helical tomotherapy
4672978|NCT03411408|hyperbaric oxygen therapy|hyperbaric oxygen therapy
4672979|NCT03411408|malignant glioma|malignant glioma
4672980|NCT03411408|high grade glioma|high grade glioma
4672981|NCT03411408|recurrent glioma|recurrent glioma
4672982|NCT03411395|Diabetes|diabetes
4672983|NCT03411395|Prediabetes|prediabetes
4672984|NCT03411395|Blood sugar regulation|blood sugar regulation
4672985|NCT03411369|Creatine, ribose, ischemic heart disease.|creatine, ribose, ischemic heart disease.
4672986|NCT03411343|Postoperative Shoulder Analgesia|postoperative shoulder analgesia
4672987|NCT03411343|Hemidiaphragmatic Paralysis|hemidiaphragmatic paralysis
4672988|NCT03411343|Alternative blocks|alternative blocks
4672989|NCT03411317|Aortic stenosis|aortic stenosis
4672990|NCT03411317|progression|progression
4672991|NCT03411317|Left ventricular remodeling|left ventricular remodeling
4672992|NCT03411304|Aortic valvular replacement|aortic valvular replacement
4672993|NCT03411304|Aortic stenosis|aortic stenosis
4672994|NCT03411304|Left ventricular remodeling|left ventricular remodeling
4672995|NCT03411304|biomarkers|biomarkers
4672996|NCT03411291|Alzheimer's, magnetic resonance imaging|alzheimer's, magnetic resonance imaging
4672997|NCT03411278|recovery|recovery
4672998|NCT03411278|deep oscillation|deep oscillation
4672999|NCT03411278|soccer|soccer
4673000|NCT03411278|sports|sports
4673001|NCT03411278|training|training
4673002|NCT03411278|electrotherapy|electrotherapy
4673003|NCT03411278|physical therapy|physical therapy
4673004|NCT03411239|Airway pressure|airway pressure
4673005|NCT03411239|Oesophageal pressure|oesophageal pressure
4673006|NCT03411239|transpulmonary pressure|transpulmonary pressure
4673007|NCT03411239|laparoscopic surgery|laparoscopic surgery
4673008|NCT03411226|Inguinal Hernia|inguinal hernia
4673009|NCT03411226|TREPP|trepp
4673010|NCT03411226|Recurrence|recurrence
4673011|NCT03411200|Older|older
4673012|NCT03411200|Advanced Cancer|advanced cancer
4673013|NCT03411200|Exercise|exercise
4673014|NCT03411200|Resistance training|resistance training
4673015|NCT03411200|Counseling|counseling
4673016|NCT03411200|Mobilization|mobilization
4673017|NCT03411187|Endoscopy|endoscopy
4673018|NCT03411187|Thyroidectomy|thyroidectomy
4673019|NCT03411187|Thyroid Cancer|thyroid cancer
4673020|NCT03411174|breast cancer|breast cancer
4673021|NCT03411174|hypofractionated partial breast irradiation|hypofractionated partial breast irradiation
4673022|NCT03411161|Mps1|mps1
4673023|NCT03411161|Mps1i|mps1i
4673024|NCT03411161|S81694|s81694
4673025|NCT03411161|breast cancer|breast cancer
4673026|NCT03411161|triple negative breast cancer|triple negative breast cancer
4673027|NCT03411161|phase I|phase i
4673028|NCT03411161|phase II|phase ii
4673029|NCT03411148|fear avoidance|fear avoidance
4673030|NCT03411148|cognitive behavioral therapy|cognitive behavioral therapy
4673031|NCT03411148|physical therapy|physical therapy
4673032|NCT03411148|prosthetic|prosthetic
4673033|NCT03411148|fear of falling|fear of falling
4673034|NCT03411148|gait|gait
4673035|NCT03411122|Enzyme Inhibitors|enzyme inhibitors
4673036|NCT03411122|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers
4673037|NCT03411109|intrathecal analgesia|intrathecal analgesia
4673038|NCT03411109|colorectal|colorectal
4673039|NCT03411109|enhanced recovery|enhanced recovery
4673040|NCT03411083|Rehabilitation|rehabilitation
4673041|NCT03411083|Recovery of function|recovery of function
4673042|NCT03411083|Outcome Assessment (Health Care)|outcome assessment (health care)
4673043|NCT03411083|Patient Reported outcome Measures|patient reported outcome measures
4673044|NCT03411083|Treatment Outcome|treatment outcome
4673045|NCT03411083|Pain, Postoperative|pain, postoperative
4673046|NCT03411083|Pain Management|pain management
4673047|NCT03411083|Orthopedic Surgery|orthopedic surgery
4673048|NCT03411057|Mindfulness|mindfulness
4673049|NCT03411057|Mindfulness Based Stress Reduction|mindfulness based stress reduction
4673050|NCT03411057|Rheumatoid Arthritis|rheumatoid arthritis
4673051|NCT03411057|Anxiety|anxiety
4673052|NCT03411057|Depression|depression
4673053|NCT03411057|Psoriatic Arthritis|psoriatic arthritis
4673054|NCT03411044|Total Hip Arthroplasty|total hip arthroplasty
4673055|NCT03411044|Fitmore|fitmore
4673056|NCT03411044|Minimal Invasive Surgery|minimal invasive surgery
4673057|NCT03411044|Short Stem|short stem
4673058|NCT03411031|lenalidomide maintenance|lenalidomide maintenance
4673059|NCT03411031|hematopoietic cell transplantation|hematopoietic cell transplantation
4673060|NCT03411031|serologic relapse|serologic relapse
4673061|NCT03411018|lung protective strategies|lung protective strategies
4673062|NCT03411018|Less invasive respiratory support|less invasive respiratory support
4673063|NCT03411018|preterm infant|preterm infant
4673064|NCT03411005|Lysine, Adult, Protein Quality|lysine, adult, protein quality
4673065|NCT03410992|Bimekizumab|bimekizumab
4673067|NCT03410992|Psoriasis|psoriasis
4673068|NCT03410940|Total Hip Arthroplasty|total hip arthroplasty
4673069|NCT03410940|CLS Brevius|cls brevius
4673070|NCT03410940|Kinectiv|kinectiv
4673071|NCT03410940|Medical Device|medical device
4673072|NCT03410940|Performance|performance
4673073|NCT03410940|Safety|safety
4673074|NCT03410940|Hip Prosthesis|hip prosthesis
4673075|NCT03410927|Phase I|phase i
4673076|NCT03410927|solid tumors|solid tumors
4673077|NCT03410927|pharmacokinetics|pharmacokinetics
4673078|NCT03410927|pharmacodynamics|pharmacodynamics
4673079|NCT03410927|MTD|mtd
4673080|NCT03410927|TAS0728|tas0728
4673081|NCT03410927|HER2|her2
4673082|NCT03410927|HER3 mutation|her3 mutation
4673083|NCT03410927|amplification or overexpression|amplification or overexpression
4673084|NCT03410927|Urothelial cancer with HER2 or HER3 mutation|urothelial cancer with her2 or her3 mutation
4673085|NCT03410927|Biliary tract cancer with HER2 or HER3 mutation|biliary tract cancer with her2 or her3 mutation
4673086|NCT03410927|MBC with HER2 amplification or overexpression or HER3 mutation|mbc with her2 amplification or overexpression or her3 mutation
4673087|NCT03410927|NSCLC with HER2 or HER3 mutation|nsclc with her2 or her3 mutation
4673088|NCT03410927|CRC with HER2 or HER3 mutation|crc with her2 or her3 mutation
4673089|NCT03410927|amplification|amplification
4673090|NCT03410914|Hemopatch|hemopatch
4673091|NCT03410888|sciatic nerve block|sciatic nerve block
4673092|NCT03410888|infragluteal approach|infragluteal approach
4673093|NCT03410888|popliteal approach|popliteal approach
4673094|NCT03410875|Leukemia|leukemia
4673095|NCT03410875|Hairy Cell Leukemia|hairy cell leukemia
4673096|NCT03410875|BRAF|braf
4673097|NCT03410875|vemurafenib|vemurafenib
4673098|NCT03410875|obinutuzumab|obinutuzumab
4673099|NCT03410875|Memorial Sloan Kettering Cancer Center|memorial sloan kettering cancer center
4673100|NCT03410875|17-513|17-513
4673101|NCT03410862|Elderberry|elderberry
4673102|NCT03410862|Influenza|influenza
4673103|NCT03410836|lidocaine|lidocaine
4673104|NCT03410836|colorectal cancer|colorectal cancer
4673105|NCT03410836|laparoscopy surgery|laparoscopy surgery
4673106|NCT03410836|anesthesia|anesthesia
4673107|NCT03410836|inflammation|inflammation
4673108|NCT03410836|cytokine|cytokine
4673109|NCT03410836|post-operative immunosuppression|post-operative immunosuppression
4673110|NCT03410823|hip fracture|hip fracture
4673111|NCT03410823|exercise|exercise
4673112|NCT03410823|protein|protein
4673113|NCT03410810|Prematurity|prematurity
4673114|NCT03410810|Neuroimaging|neuroimaging
4673115|NCT03410797|SOVT|sovt
4673116|NCT03410797|semi occluded vocal tract|semi occluded vocal tract
4673117|NCT03410797|voice disorder|voice disorder
4673118|NCT03410797|voice therapy|voice therapy
4673119|NCT03410797|muscle tension dysphonia|muscle tension dysphonia
4673120|NCT03410797|MTD|mtd
4673121|NCT03410797|vocal fold lesions|vocal fold lesions
4673122|NCT03410797|vocal fold atrophy|vocal fold atrophy
4673123|NCT03410784|PD-L1 Expression|pd-l1 expression
4673124|NCT03410784|prognostic factors|prognostic factors
4673125|NCT03410784|predictive factors|predictive factors
4673126|NCT03410784|Patient reported outcomes|patient reported outcomes
4673127|NCT03410771|Distribution Volume|distribution volume
4673128|NCT03410771|Antibiotics|antibiotics
4673129|NCT03410745|exercise|exercise
4673130|NCT03410745|cytokines|cytokines
4673131|NCT03410745|collagen|collagen
4673132|NCT03410732|dendritic cell|dendritic cell
4673133|NCT03410732|immunotherapy|immunotherapy
4673134|NCT03410732|tumor cell membrane proteins|tumor cell membrane proteins
4673135|NCT03410706|Venous thromboembolism|venous thromboembolism
4673136|NCT03410706|Anticoagulation|anticoagulation
4673137|NCT03410706|Rivaroxaban|rivaroxaban
4673138|NCT03410706|Observation study|observation study
4673139|NCT03410693|Urothelial carcinoma|urothelial carcinoma
4673140|NCT03410680|Antiretroviral Therapy|antiretroviral therapy
4673141|NCT03410680|Adherence|adherence
4673142|NCT03410680|HIV|hiv
4673143|NCT03410680|Men who have sex with men|men who have sex with men
4673144|NCT03410680|Sexual minorities|sexual minorities
4673145|NCT03410680|habit-formation|habit-formation
4673146|NCT03410680|gamification|gamification
4673147|NCT03410641|cancer risk|cancer risk
4673148|NCT03410641|randomised trial|randomised trial
4673149|NCT03410641|intervention|intervention
4673150|NCT03410641|smoking cessation|smoking cessation
4673151|NCT03410641|dietary intervention|dietary intervention
4673152|NCT03410641|weight loss|weight loss
4673153|NCT03410602|Nonsurgical periodontal therapy|nonsurgical periodontal therapy
4673154|NCT03410602|Orthodontic bands|orthodontic bands
4673155|NCT03410576|Matrix metalloproteinase|matrix metalloproteinase
4673156|NCT03410576|Carotid artery stenting|carotid artery stenting
4673157|NCT03410576|Carotid endarterectomy|carotid endarterectomy
4673158|NCT03410563|Pain|pain
4673159|NCT03410563|Auditory inputs|auditory inputs
4673160|NCT03410524|Bowel wall visualization|bowel wall visualization
4673161|NCT03410524|Intraluminal bubbles|intraluminal bubbles
4673162|NCT03410524|Intraluminal foam|intraluminal foam
4673163|NCT03410524|Simethicone|simethicone
4673164|NCT03410485|NoL index|nol index
4673165|NCT03410485|Bispectral index|bispectral index
4673166|NCT03410485|Intraoperative monitoring|intraoperative monitoring
4673167|NCT03410420|Thoracic Aortic Aneurysm|thoracic aortic aneurysm
4673168|NCT03410420|Hypoxia|hypoxia
4673169|NCT03410420|Ascending Aorta|ascending aorta
4673170|NCT03410420|Hypoxyprobe|hypoxyprobe
4673171|NCT03410420|Pimonidazole|pimonidazole
4673172|NCT03410407|Acute Myeloid Leukemia|acute myeloid leukemia
4673173|NCT03410407|Central Nervous System|central nervous system
4673174|NCT03410407|Relapse|relapse
4673175|NCT03410407|Prognostic factors|prognostic factors
4673176|NCT03410394|adrenal|adrenal
4673177|NCT03410394|thyroid|thyroid
4673178|NCT03410394|parathyroid|parathyroid
4673179|NCT03410394|endocrine pancreas|endocrine pancreas
4673180|NCT03410394|endocrine digestive tube|endocrine digestive tube
4673181|NCT03410381|Psychiatry|psychiatry
4673182|NCT03410381|Suicide|suicide
4673183|NCT03410381|Prediction|prediction
4673184|NCT03410381|Smartphone application|smartphone application
4673185|NCT03410381|Ecological Momentary Assessment|ecological momentary assessment
4673186|NCT03410368|maintenance therapy|maintenance therapy
4673187|NCT03410368|immunotherapy|immunotherapy
4673188|NCT03410368|adoptive cell transfer|adoptive cell transfer
4673189|NCT03410368|natural killer cell|natural killer cell
4673190|NCT03410316|Obesity, common diseases, epidemiology, etiology|obesity, common diseases, epidemiology, etiology
4673191|NCT03410225|Pregnancy Prevention|pregnancy prevention
4673192|NCT03410225|Male Involvement|male involvement
4673193|NCT03410212|Inferior alveolar nerve block|inferior alveolar nerve block
4673194|NCT03410212|ketorolac|ketorolac
4673195|NCT03410212|success|success
4673196|NCT03410160|adrenal crisis|adrenal crisis
4673197|NCT03410160|predisposing factors|predisposing factors
4673198|NCT03410134|Permanent teeth|permanent teeth
4673199|NCT03410134|Vital pulp therapy|vital pulp therapy
4673200|NCT03410134|MTA|mta
4673201|NCT03410043|Malignant neoplasms of respiratory and intrathoracic organs|malignant neoplasms of respiratory and intrathoracic organs
4673202|NCT03410043|Non-small cell lung cancer|non-small cell lung cancer
4673203|NCT03410043|NSCLC|nsclc
4673204|NCT03410043|Osimertinib|osimertinib
4673205|NCT03410043|AZD9291|azd9291
4673206|NCT03410043|Local consolidative therapy|local consolidative therapy
4673207|NCT03410043|LCT|lct
4673208|NCT03410043|Radiotherapy|radiotherapy
4673209|NCT03410043|Surgical resection|surgical resection
4673210|NCT03410017|Functional Listening Index|functional listening index
4673211|NCT03409991|Psychiatric Rehabilitation|psychiatric rehabilitation
4673212|NCT03409991|Career Counseling|career counseling
4673213|NCT03409978|Infants, newborn|infants, newborn
4673214|NCT03409978|General Movements|general movements
4673215|NCT03409978|Video Recording|video recording
4673216|NCT03409978|Mobile Applications|mobile applications
4673217|NCT03409978|Prognosis|prognosis
4673218|NCT03409978|Parents|parents
4673219|NCT03409939|nutrition|nutrition
4673220|NCT03409939|phenylalanine|phenylalanine
4673221|NCT03409939|tyrosine|tyrosine
4673222|NCT03409939|stable isotope|stable isotope
4673223|NCT03409926|Heart Disease|heart disease
4673224|NCT03409926|Cardiovascular Disease|cardiovascular disease
4673225|NCT03409926|Diet|diet
4673226|NCT03409926|Fiber|fiber
4673227|NCT03409926|Microbiome|microbiome
4673228|NCT03409913|positron emissions tomography|positron emissions tomography
4673229|NCT03409913|diagnostic accuracy|diagnostic accuracy
4673230|NCT03409913|case-control|case-control
4673231|NCT03409900|Lumbar Plexus Block|lumbar plexus block
4673232|NCT03409900|Quadratus Lumborum Block|quadratus lumborum block
4673233|NCT03409900|Direct Anterior Approach|direct anterior approach
4673234|NCT03409900|Post-Operative|post-operative
4673235|NCT03409900|Pain Management|pain management
4673236|NCT03409887|root canal treatment, intraorifice barrier.|root canal treatment, intraorifice barrier.
4673237|NCT03409809|Implementation Support|implementation support
4673238|NCT03409809|Eating Disorder|eating disorder
4673239|NCT03409809|Dissemination|dissemination
4673240|NCT03409809|Prevention|prevention
4673241|NCT03409809|Peer Leader|peer leader
4673242|NCT03409796|Gluten Challenge|gluten challenge
4673243|NCT03409757|microbiome|microbiome
4673244|NCT03409744|HoFH|hofh
4673245|NCT03409731|Drug eluting Bio-resolvable Scaffold (BRS)|drug eluting bio-resolvable scaffold (brs)
4673246|NCT03409731|Bio-resolvable Scaffold (BRS)|bio-resolvable scaffold (brs)
4673247|NCT03409731|Real world|real world
4673248|NCT03409718|Total Shoulder Arthroplasty|total shoulder arthroplasty
4673249|NCT03409718|Medical Device|medical device
4673250|NCT03409718|Performance|performance
4673251|NCT03409718|Safety|safety
4673252|NCT03409718|Shoulder Prosthesis|shoulder prosthesis
4673253|NCT03409666|Total Hip Arthroplasty|total hip arthroplasty
4673254|NCT03409666|Medical Device|medical device
4673255|NCT03409666|Performance|performance
4673256|NCT03409666|Safety|safety
4673257|NCT03409666|Hip prosthesis|hip prosthesis
4673258|NCT03409666|Roentgen Stereophotogrammetric Analysis|roentgen stereophotogrammetric analysis
4673259|NCT03409627|retrograde coronary sinus infusion|retrograde coronary sinus infusion
4673260|NCT03409627|DNA|dna
4673261|NCT03409627|non-viral|non-viral
4673262|NCT03409627|triple effector plasmid|triple effector plasmid
4673263|NCT03409627|gene therapy|gene therapy
4673264|NCT03409627|regenerative medicine|regenerative medicine
4673265|NCT03409627|non-stem cell|non-stem cell
4673266|NCT03409614|Stage IIIB|stage iiib
4673267|NCT03409614|Stage IV|stage iv
4673268|NCT03409614|Non-squamous NSCLC|non-squamous nsclc
4673269|NCT03409614|Squamous NSCLC|squamous nsclc
4673270|NCT03409601|Obesity, eating behavior, food, nutrition|obesity, eating behavior, food, nutrition
4673271|NCT03409588|Chronic Thromboembolic Disease|chronic thromboembolic disease
4673272|NCT03409588|CTED|cted
4673273|NCT03409588|Treatment Post PEA surgery|treatment post pea surgery
4673274|NCT03409575|neuromuscular electrical stimulation|neuromuscular electrical stimulation
4673275|NCT03409575|geriatric population|geriatric population
4673276|NCT03409575|physical function|physical function
4673277|NCT03409575|quadriceps|quadriceps
4673278|NCT03409575|fatigue|fatigue
4673279|NCT03409562|low back pain|low back pain
4673280|NCT03409562|pain neurophysiology education|pain neurophysiology education
4673281|NCT03409562|motor control|motor control
4673282|NCT03409536|SSEP Monitoring|ssep monitoring
4673283|NCT03409536|Diagnostic threshold|diagnostic threshold
4673284|NCT03409510|vitamin D|vitamin d
4673285|NCT03409510|25(OH)D|25(oh)d
4673286|NCT03409510|skin pigmentation|skin pigmentation
4673287|NCT03409510|UVB|uvb
4673288|NCT03409510|pigment genes|pigment genes
4673289|NCT03409471|Urine|urine
4673290|NCT03409471|Cervical Intraepithelial Neoplasia|cervical intraepithelial neoplasia
4673291|NCT03409471|Self-Sampling|self-sampling
4673292|NCT03409471|HPV Testing|hpv testing
4673293|NCT03409471|Cervical Cancer Screening|cervical cancer screening
4673294|NCT03409471|ASCUS|ascus
4673295|NCT03409471|LSIL|lsil
4673296|NCT03409458|Advanced Solid Tumors|advanced solid tumors
4673297|NCT03409458|NSCLC|nsclc
4673298|NCT03409458|mUC|muc
4673299|NCT03409458|mBC|mbc
4673300|NCT03409458|CRPC|crpc
4673301|NCT03409458|SCCHN|scchn
4673302|NCT03409419|Advanced|advanced
4673303|NCT03409419|Recurrent|recurrent
4673304|NCT03409419|Immune Therapy|immune therapy
4673305|NCT03409406|developmental disability|developmental disability
4673306|NCT03409406|speech and language disorder|speech and language disorder
4673307|NCT03409406|mobile health technology|mobile health technology
4673308|NCT03409406|parent training|parent training
4673309|NCT03409406|communication intervention|communication intervention
4673310|NCT03409393|Human|human
4673311|NCT03409393|Denmark|denmark
4673312|NCT03409393|Adult|adult
4673313|NCT03409393|Adolescent|adolescent
4673314|NCT03409393|Young Adult|young adult
4673315|NCT03409393|Male|male
4673316|NCT03409393|Female|female
4673317|NCT03409393|Physical Activity|physical activity
4673318|NCT03409393|Maximum Oxygen Consumption|maximum oxygen consumption
4673319|NCT03409393|Resistance Training|resistance training
4673320|NCT03409393|High-Intensity Functional Training|high-intensity functional training
4673321|NCT03409393|Aerobic Exercise|aerobic exercise
4673322|NCT03409393|Motivation|motivation
4673323|NCT03409393|Feasibility|feasibility
4673324|NCT03409393|Relevance|relevance
4673325|NCT03409393|Health Behavior|health behavior
4673326|NCT03409380|growth hormone|growth hormone
4673327|NCT03409367|Prevention|prevention
4673328|NCT03409367|Emollient|emollient
4673329|NCT03409367|Pragmatic clinical trial|pragmatic clinical trial
4673330|NCT03409315|Centralized Therapeutic Drug Monitoring|centralized therapeutic drug monitoring
4673331|NCT03409315|Fluoroquinolones|fluoroquinolones
4673332|NCT03409302|ACT|act
4673333|NCT03409302|digital intervention|digital intervention
4673334|NCT03409302|web-based|web-based
4673335|NCT03409302|adherence|adherence
4673336|NCT03409289|Spontaneous Circulation (ROSC)|spontaneous circulation (rosc)
4673337|NCT03409289|Shock and Hypotension (RUSH) exam|shock and hypotension (rush) exam
4673338|NCT03409263|Cirrhosis|cirrhosis
4673339|NCT03409263|Advanced chronic liver disease|advanced chronic liver disease
4673340|NCT03409263|Ascites|ascites
4673341|NCT03409263|Variceal hemorrhage|variceal hemorrhage
4673342|NCT03409263|Transjugular intrahepatic portosystemic shunt|transjugular intrahepatic portosystemic shunt
4673343|NCT03409250|CNV due to Age Related Macular Degeneration|cnv due to age related macular degeneration
4673344|NCT03409198|Neoplasms|neoplasms
4673345|NCT03409185|Cataract surgery|cataract surgery
4673346|NCT03409185|Intraocular lens|intraocular lens
4673347|NCT03409185|Glistenings|glistenings
4673348|NCT03409172|High intensity interval training|high intensity interval training
4673349|NCT03409172|Inflammation|inflammation
4673350|NCT03409172|Obesity|obesity
4673351|NCT03409172|adipokines|adipokines
4673352|NCT03409133|Prosthesis User|prosthesis user
4673353|NCT03409133|Phantom Sensation|phantom sensation
4673354|NCT03409133|Sensory Feedback|sensory feedback
4673355|NCT03409120|Dystonia|dystonia
4673356|NCT03409120|Parkinson's Disease|parkinson's disease
4673357|NCT03409107|Non-Dialysis|non-dialysis
4673358|NCT03409107|Anemia|anemia
4673359|NCT03409107|Chronic kidney disease|chronic kidney disease
4673360|NCT03409107|Recombinant human erythropoietin naïve|recombinant human erythropoietin naïve
4673361|NCT03409107|Hemoglobin|hemoglobin
4673362|NCT03409107|Daprodustat|daprodustat
4673363|NCT03409081|Expanded Access|expanded access
4673364|NCT03409081|FMS-like Tyrosine Kinase 3|fms-like tyrosine kinase 3
4673365|NCT03409081|Acute Myeloid Leukemia (AML)|acute myeloid leukemia (aml)
4673366|NCT03409081|gilteritinib|gilteritinib
4673367|NCT03409081|ASP2215|asp2215
4673368|NCT03409068|Carotid thromboendarterectomy|carotid thromboendarterectomy
4673369|NCT03409068|Carotidodynia|carotidodynia
4673370|NCT03409042|Caloric compensation|caloric compensation
4673371|NCT03409029|bladder|bladder
4673372|NCT03409029|radiotherapy|radiotherapy
4673373|NCT03409029|magnetic resonance imaging|magnetic resonance imaging
4673374|NCT03409016|Immune Checkpoint Inhibitors|immune checkpoint inhibitors
4673375|NCT03409016|Biomarkers|biomarkers
4673376|NCT03409016|Immune Related Adverse Event|immune related adverse event
4673377|NCT03409003|urea cycle disorder|urea cycle disorder
4673378|NCT03408977|meal ingestion|meal ingestion
4673379|NCT03408977|meal tolerance|meal tolerance
4673380|NCT03408977|postprandial responses|postprandial responses
4673381|NCT03408977|hedonic sensations|hedonic sensations
4673382|NCT03408977|homeostatic sensations|homeostatic sensations
4673383|NCT03408925|elite orienteering|elite orienteering
4673384|NCT03408899|Microbicides|microbicides
4673385|NCT03408886|fecal transplant|fecal transplant
4673386|NCT03408886|fecal microbiota transplant|fecal microbiota transplant
4673387|NCT03408886|microbiota transplant|microbiota transplant
4673388|NCT03408886|vancomycin|vancomycin
4673389|NCT03408886|moviprep|moviprep
4673390|NCT03408873|Antipsychotic Drugs|antipsychotic drugs
4673391|NCT03408873|Antipsychotics|antipsychotics
4673392|NCT03408873|Injectables|injectables
4673393|NCT03408873|Long Acting Injectable Antipsychotic|long acting injectable antipsychotic
4673394|NCT03408873|Bipolar Disorder|bipolar disorder
4673395|NCT03408873|Medication Adherence|medication adherence
4673396|NCT03408873|Medication Non-Adherence|medication non-adherence
4673397|NCT03408847|Ulcerative colitis|ulcerative colitis
4673398|NCT03408847|UC|uc
4673399|NCT03408847|Extra virgin olive oil|extra virgin olive oil
4673400|NCT03408847|Polyphenols|polyphenols
4673401|NCT03408834|NGAL|ngal
4673402|NCT03408834|PVI|pvi
4673403|NCT03408808|wrist|wrist
4673404|NCT03408808|ganglion|ganglion
4673405|NCT03408808|platelet rich plasma|platelet rich plasma
4673406|NCT03408808|aspiration|aspiration
4673407|NCT03408782|Surgical Site Infection|surgical site infection
4673408|NCT03408782|Surgical drains|surgical drains
4673409|NCT03408769|Cancer|cancer
4673410|NCT03408769|Sexuality|sexuality
4673411|NCT03408769|Quality of life|quality of life
4673412|NCT03408769|Intimacy|intimacy
4673413|NCT03408769|BISF-WBrief Index of Sexual Functioning for Women questionnaire|bisf-wbrief index of sexual functioning for women questionnaire
4673414|NCT03408769|Quality of life questionnaire (EORTC QLQ-BR23):|quality of life questionnaire (eortc qlq-br23):
4673415|NCT03408769|Partnership questionnaire (partnerschaftsfragebogen; PFB)|partnership questionnaire (partnerschaftsfragebogen; pfb)
4673416|NCT03408743|Multiphase optimization strategy|multiphase optimization strategy
4673417|NCT03408743|College students|college students
4673418|NCT03408730|Hepatitis B Vaccines|hepatitis b vaccines
4673419|NCT03408717|Breast cancer|breast cancer
4673420|NCT03408717|Chronic pain|chronic pain
4673421|NCT03408717|Acute Pain|acute pain
4673422|NCT03408717|Depression|depression
4673423|NCT03408717|Anxiety|anxiety
4673424|NCT03408704|Streptococcus Pyogenes Infection|streptococcus pyogenes infection
4673425|NCT03408704|Randomized Controlled Trial|randomized controlled trial
4673426|NCT03408691|probiotic|probiotic
4673427|NCT03408691|permeability|permeability
4673428|NCT03408691|stress|stress
4673429|NCT03408678|body composition|body composition
4673430|NCT03408678|glucocorticoids|glucocorticoids
4673431|NCT03408678|inflammation|inflammation
4673432|NCT03408678|black African|black african
4673433|NCT03408678|sex|sex
4673434|NCT03408678|gonadal steroid hormones|gonadal steroid hormones
4673435|NCT03408652|Bone Metastases|bone metastases
4673436|NCT03408639|End-Stage Renal Disease, Anemia, Erythropoietin, Hemoglobine|end-stage renal disease, anemia, erythropoietin, hemoglobine
4673437|NCT03408613|Obstructive Sleep Apnea|obstructive sleep apnea
4673438|NCT03408613|Glucose Metabolism|glucose metabolism
4673439|NCT03408600|Abdominal sepsis|abdominal sepsis
4673440|NCT03408600|Secondary peritonitis|secondary peritonitis
4673441|NCT03408600|Complicated intra-abdominal infections|complicated intra-abdominal infections
4673442|NCT03408587|CVA21|cva21
4673443|NCT03408587|CAVATAK|cavatak
4673444|NCT03408587|Coxsackievirus|coxsackievirus
4673445|NCT03408587|ocular|ocular
4673446|NCT03408587|eye|eye
4673447|NCT03408587|ipilimumab|ipilimumab
4673448|NCT03408587|yervoy|yervoy
4673449|NCT03408587|oncolytic|oncolytic
4673450|NCT03408587|virus|virus
4673451|NCT03408587|checkpoint|checkpoint
4673452|NCT03408587|CTLA-4|ctla-4
4673453|NCT03408574|nicotinic system|nicotinic system
4673454|NCT03408574|cognitive aging|cognitive aging
4673455|NCT03408574|working memory|working memory
4673456|NCT03408574|fMRI|fmri
4673457|NCT03408548|Bifidobacterium animalis subsp. lactis|bifidobacterium animalis subsp. lactis
4673458|NCT03408548|Probiotic|probiotic
4673459|NCT03408548|Periodontitis treatment|periodontitis treatment
4673460|NCT03408548|Periodontitis|periodontitis
4673461|NCT03408535|eHealth|ehealth
4673462|NCT03408535|Online Rehabilitation|online rehabilitation
4673463|NCT03408535|Hearing Problems|hearing problems
4673464|NCT03408535|Adult|adult
4673465|NCT03408535|Hearing Aids|hearing aids
4673466|NCT03408496|Myofascial release|myofascial release
4673467|NCT03408496|Pain|pain
4673468|NCT03408496|Manual therapy|manual therapy
4673469|NCT03408496|Muscle stretching|muscle stretching
4673470|NCT03408496|Quality of life|quality of life
4673471|NCT03408483|Quadratus Lumborum Block|quadratus lumborum block
4673472|NCT03408470|Absolute Bioavailability|absolute bioavailability
4673473|NCT03408470|ADME|adme
4673474|NCT03408470|Healthy Normal Males|healthy normal males
4673475|NCT03408457|Surgical wound infection|surgical wound infection
4673476|NCT03408457|antibiotic concentration|antibiotic concentration
4673477|NCT03408457|blood level|blood level
4673478|NCT03408418|Platelet-rich fibrin|platelet-rich fibrin
4673479|NCT03408418|Tooth Extraction|tooth extraction
4673480|NCT03408418|Alveolar Bone Grafting|alveolar bone grafting
4673481|NCT03408392|Single dose|single dose
4673482|NCT03408392|Oral suspension|oral suspension
4673483|NCT03408392|Bioequivalence|bioequivalence
4673484|NCT03408392|Cefixime|cefixime
4673485|NCT03408392|Two-way crossover|two-way crossover
4673486|NCT03408379|intracranial aneurysms|intracranial aneurysms
4673487|NCT03408379|ruptured aneurysm|ruptured aneurysm
4673488|NCT03408379|platelet activity|platelet activity
4673489|NCT03408366|Laparotomy|laparotomy
4673490|NCT03408366|Surgical Incisions|surgical incisions
4673491|NCT03408366|Wound Perfusion|wound perfusion
4673492|NCT03408366|17-650|17-650
4673493|NCT03408340|Anesthesiology|anesthesiology
4673494|NCT03408340|Pediatric surgery|pediatric surgery
4673495|NCT03408340|Anesthesia, Regional|anesthesia, regional
4673496|NCT03408340|Anesthesia, Cardiac Procedures|anesthesia, cardiac procedures
4673497|NCT03408340|Nerve Block|nerve block
4673498|NCT03408327|Schizophrenia|schizophrenia
4673499|NCT03408327|Physical Activity|physical activity
4673500|NCT03408327|Health Promotion|health promotion
4673501|NCT03408327|Wearable Technology|wearable technology
4673502|NCT03408327|Fitness Wristband|fitness wristband
4673503|NCT03408327|mobile health, mHealth|mobile health, mhealth
4673504|NCT03408314|Advanced Cancer|advanced cancer
4673505|NCT03408275|Dietary patterns|dietary patterns
4673506|NCT03408275|Pregnancy|pregnancy
4673507|NCT03408275|Woman|woman
4673508|NCT03408275|Diet|diet
4673509|NCT03408275|Lead|lead
4673510|NCT03408275|ALSPAC|alspac
4673511|NCT03408249|Crohn's disease, ulcerative colitis, fecal calprotectin|crohn's disease, ulcerative colitis, fecal calprotectin
4673512|NCT03408197|inadvertent, intraoperative hypothermia, prewarming|inadvertent, intraoperative hypothermia, prewarming
4673513|NCT03408171|liver biopsy|liver biopsy
4673514|NCT03408171|endoscopic ultrasound guided liver biopsy|endoscopic ultrasound guided liver biopsy
4673516|NCT03408171|FNB|fnb
4673517|NCT03408158|HPA|hpa
4673518|NCT03408158|Blood disease|blood disease
4673519|NCT03408145|Stem Cell Therapy|stem cell therapy
4673520|NCT03408145|Injection|injection
4673521|NCT03408145|Hyaluronic Acid|hyaluronic acid
4673522|NCT03408145|Synovial Fluid|synovial fluid
4673523|NCT03408119|prune|prune
4673524|NCT03408119|dried plum|dried plum
4673525|NCT03408119|osteoporosis|osteoporosis
4673526|NCT03408119|osteopenia|osteopenia
4673527|NCT03408119|men|men
4673528|NCT03408093|Interferon beta-1b (INFb-1b)|interferon beta-1b (infb-1b)
4673529|NCT03408093|Multiple Sclerosis (MS)|multiple sclerosis (ms)
4673530|NCT03408093|Relapsing-remitting MS (RRMS)|relapsing-remitting ms (rrms)
4673531|NCT03408093|Secondary progressive MS (SPMS)|secondary progressive ms (spms)
4673532|NCT03408093|Clinically isolated syndrome (CIS)|clinically isolated syndrome (cis)
4673533|NCT03408054|Uterine contraction|uterine contraction
4673534|NCT03408054|Oxytocin|oxytocin
4673535|NCT03408054|Nitroglycerin|nitroglycerin
4673536|NCT03408041|Alzheimer Disease|alzheimer disease
4673537|NCT03408041|Objective parameters|objective parameters
4673538|NCT03408041|Scheltens index|scheltens index
4673539|NCT03408028|Therapeutic code|therapeutic code
4673540|NCT03408028|Geriatry|geriatry
4673541|NCT03408015|dry eye disease|dry eye disease
4673542|NCT03408015|neutrophil|neutrophil
4673543|NCT03408015|T cell|t cell
4673544|NCT03408015|lifitegrast|lifitegrast
4673545|NCT03408015|contact lens discomfort|contact lens discomfort
4673546|NCT03408015|ocular surface homeostasis|ocular surface homeostasis
4673547|NCT03408002|preoperative anxiety|preoperative anxiety
4673548|NCT03408002|self-efficacy|self-efficacy
4673549|NCT03408002|psychophysiology|psychophysiology
4673550|NCT03408002|psychotherapy|psychotherapy
4673551|NCT03408002|pancreatic surgery|pancreatic surgery
4673552|NCT03407950|Deficit Schizophrenia|deficit schizophrenia
4673553|NCT03407950|long stay inpatients|long stay inpatients
4673554|NCT03407950|cognitive remediation|cognitive remediation
4673555|NCT03407950|negative symptoms|negative symptoms
4673556|NCT03407937|Hypnosis|hypnosis
4673557|NCT03407937|Meditation|meditation
4673558|NCT03407937|Conditioned pain modulation|conditioned pain modulation
4673559|NCT03407937|Placebo|placebo
4673560|NCT03407937|Endocannabinoids|endocannabinoids
4673561|NCT03407937|Opioid peptides|opioid peptides
4673562|NCT03407937|Norepinephrine|norepinephrine
4673563|NCT03407937|Pain|pain
4673564|NCT03407937|Analgesia|analgesia
4673565|NCT03407937|Genes|genes
4673566|NCT03407937|Heart rate variability|heart rate variability
4673567|NCT03407911|Peri-implant pocket microbiota|peri-implant pocket microbiota
4673568|NCT03407911|Periodontal pocket microbiota|periodontal pocket microbiota
4673569|NCT03407859|CD19-CART|cd19-cart
4673570|NCT03407859|CD20-CART|cd20-cart
4673571|NCT03407859|CD10-CART|cd10-cart
4673572|NCT03407859|CD22-CART|cd22-cart
4673573|NCT03407859|Relapsed/Refractory B-ALL|relapsed/refractory b-all
4673574|NCT03407859|MRD|mrd
4673575|NCT03407807|Fetal Splenic cyst|fetal splenic cyst
4673576|NCT03407807|Differential Diagnosis|differential diagnosis
4673577|NCT03407807|Evolution and complication|evolution and complication
4673578|NCT03407768|Premenopausal breast cancer|premenopausal breast cancer
4673579|NCT03407768|Individualized interventions|individualized interventions
4673580|NCT03407768|Exercise|exercise
4673581|NCT03407768|Combination hormone therapy|combination hormone therapy
4673582|NCT03407768|Massage therapy|massage therapy
4673583|NCT03407768|Yoga|yoga
4673584|NCT03407768|Acupuncture|acupuncture
4673585|NCT03407768|Treatment tolerance|treatment tolerance
4673586|NCT03407768|Treatment adherence|treatment adherence
4673587|NCT03407768|Adverse effects|adverse effects
4673588|NCT03407768|Quality of life|quality of life
4673589|NCT03407755|Intraocular gas|intraocular gas
4673590|NCT03407755|Positioning|positioning
4673591|NCT03407755|DMEK|dmek
4673592|NCT03407755|Endothelial keratoplasty|endothelial keratoplasty
4673593|NCT03407729|Hypoxia, Brain|hypoxia, brain
4673594|NCT03407729|Neural networks|neural networks
4673595|NCT03407729|Magnetic Resonance Imaging|magnetic resonance imaging
4673596|NCT03407729|EEG|eeg
4673597|NCT03407703|genotype 1|genotype 1
4673598|NCT03407703|genotype 4|genotype 4
4673599|NCT03407638|Opioid Use Disorder|opioid use disorder
4673600|NCT03407638|Primary Care|primary care
4673601|NCT03407638|Buprenorphine|buprenorphine
4673602|NCT03407638|Naltrexone|naltrexone
4673603|NCT03407625|Pregnancy|pregnancy
4673604|NCT03407625|Labor Induction|labor induction
4673605|NCT03407625|Cervical Ripening|cervical ripening
4673606|NCT03407612|continuous passive motion device|continuous passive motion device
4673608|NCT03407612|hip arthroscopy|hip arthroscopy
4673609|NCT03407586|point-of-care testing|point-of-care testing
4673610|NCT03407586|sexually transmitted infections|sexually transmitted infections
4673611|NCT03407586|expedited partner therapy|expedited partner therapy
4673612|NCT03407586|genital inflammation|genital inflammation
4673613|NCT03407560|bone substitute|bone substitute
4673614|NCT03407560|spinal fusion|spinal fusion
4673615|NCT03407560|lumbar spine disease|lumbar spine disease
4673616|NCT03407547|upper limb|upper limb
4673617|NCT03407547|recovery|recovery
4673618|NCT03407547|somatosensory|somatosensory
4673619|NCT03407547|impairment|impairment
4673620|NCT03407547|electroencephalography|electroencephalography
4673621|NCT03407547|acute phase|acute phase
4673622|NCT03407534|Exocrine|exocrine
4673623|NCT03407534|Pancreatic Insufficiency|pancreatic insufficiency
4673624|NCT03407534|Diarrhea|diarrhea
4673625|NCT03407534|Bloating|bloating
4673626|NCT03407534|Loose Stool|loose stool
4673627|NCT03407521|second trimester abortion|second trimester abortion
4673628|NCT03407495|Hepatocellular Carcinoma|hepatocellular carcinoma
4673629|NCT03407495|Magnetic Resonance Imaging|magnetic resonance imaging
4673630|NCT03407469|Questionnaires|questionnaires
4673631|NCT03407469|Surveys|surveys
4673632|NCT03407469|Cancer-related Venous Thromboembolism|cancer-related venous thromboembolism
4673633|NCT03407469|VTE|vte
4673634|NCT03407443|mental health promotion campaign|mental health promotion campaign
4673635|NCT03407443|veterans|veterans
4673636|NCT03407430|Pregabalin|pregabalin
4673637|NCT03407430|Bone pain|bone pain
4673638|NCT03407430|Pegfilgrastim|pegfilgrastim
4673639|NCT03407430|Supportive care|supportive care
4673640|NCT03407430|prevention|prevention
4673641|NCT03407391|Picky eater|picky eater
4673642|NCT03407391|Fussy eater|fussy eater
4673643|NCT03407391|Faddy eater|faddy eater
4673644|NCT03407391|Nutrition|nutrition
4673645|NCT03407352|Exercise|exercise
4673646|NCT03407352|Video Games|video games
4673647|NCT03407352|Physical Activity|physical activity
4673648|NCT03407352|Children|children
4673649|NCT03407352|Appetite|appetite
4673650|NCT03407326|severe acute malnutrition, SAM|severe acute malnutrition, sam
4673651|NCT03407313|Submental fullness|submental fullness
4673652|NCT03407313|Submental fat|submental fat
4673653|NCT03407313|Loose skin|loose skin
4673654|NCT03407300|Non-small Cell Lung Cancer (NSCLC), XH1|non-small cell lung cancer (nsclc), xh1
4673655|NCT03407222|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
4673656|NCT03407222|Physical Activity|physical activity
4673657|NCT03407222|Personal health record|personal health record
4673658|NCT03407222|Intervention|intervention
4673659|NCT03407209|Epidural analgesia|epidural analgesia
4673660|NCT03407209|Patient Controlled Epidural Analgesia (PCEA)|patient controlled epidural analgesia (pcea)
4673661|NCT03407209|Patient Epidural Intermittent Bolus (PEIB)|patient epidural intermittent bolus (peib)
4673662|NCT03407209|Local anesthetics|local anesthetics
4673663|NCT03407196|Diabetes|diabetes
4673664|NCT03407196|Dapagliflozin|dapagliflozin
4673665|NCT03407196|Endocrinology|endocrinology
4673666|NCT03407196|Internal diseases|internal diseases
4673667|NCT03407196|Type II diabetes mellitus|type ii diabetes mellitus
4673668|NCT03407196|HbA1c|hba1c
4673669|NCT03407196|BMI|bmi
4673670|NCT03407196|BP|bp
4673671|NCT03407170|Programmed Cell Death-1 (PD-1)|programmed cell death-1 (pd-1)
4673672|NCT03407170|PD1|pd1
4673673|NCT03407170|Programmed Cell Death-Ligand 1 (PD-L1)|programmed cell death-ligand 1 (pd-l1)
4673674|NCT03407170|Programmed Cell Death-Ligand 2 (PD-L2)|programmed cell death-ligand 2 (pd-l2)
4673675|NCT03407170|PDL1|pdl1
4673676|NCT03407170|PDL2|pdl2
4673677|NCT03407157|Probiotics|probiotics
4673678|NCT03407157|Pregnancy|pregnancy
4673679|NCT03407157|GBS|gbs
4673680|NCT03407157|Group B Streptococcus|group b streptococcus
4673681|NCT03407144|Programmed Death-1 (PD-1)|programmed death-1 (pd-1)
4673682|NCT03407144|PD1|pd1
4673683|NCT03407144|Programmed Death-Ligand 1 (PD-L1)|programmed death-ligand 1 (pd-l1)
4673684|NCT03407144|PDL1|pdl1
4673685|NCT03407131|Intertrochanteric fracture, Medical complications|intertrochanteric fracture, medical complications
4673686|NCT03407079|Drug Metabolism|drug metabolism
4673687|NCT03407079|Artificial Sweetner|artificial sweetner
4673688|NCT03407079|P-Glycoprotein|p-glycoprotein
4673689|NCT03407079|Cytochrome P 450|cytochrome p 450
4673690|NCT03407079|Microbiome|microbiome
4673691|NCT03407066|Magnetic Resonance Imaging (MRI)|magnetic resonance imaging (mri)
4673692|NCT03407066|MEG|meg
4673693|NCT03407066|Color Vision|color vision
4673694|NCT03407066|Neuroimaging|neuroimaging
4673695|NCT03407053|Calories|calories
4673696|NCT03407053|Food Intake|food intake
4673697|NCT03407053|Glucose|glucose
4673698|NCT03407053|Body Composition|body composition
4673699|NCT03407053|Body Weight Regulation|body weight regulation
4673700|NCT03407040|Blood|blood
4673701|NCT03407040|Tissue|tissue
4673702|NCT03407040|Immunotherapy|immunotherapy
4673703|NCT03407040|Tumor|tumor
4673704|NCT03407040|Somatic|somatic
4673705|NCT03407027|Quadratus lumborum syndrome; ultrasound- guided infiltration|quadratus lumborum syndrome; ultrasound- guided infiltration
4673706|NCT03407001|Diseases of liver|diseases of liver
4673707|NCT03407001|Hepatocellular carcinoma|hepatocellular carcinoma
4673708|NCT03407001|HCC|hcc
4673709|NCT03407001|Lumason|lumason
4673710|NCT03407001|Ultrasounds|ultrasounds
4673711|NCT03406988|Systemic Sclerosis|systemic sclerosis
4673712|NCT03406988|Digital Ulcer|digital ulcer
4673713|NCT03406988|Autologous fat grafting|autologous fat grafting
4673714|NCT03406988|Adipose tissue stem cells|adipose tissue stem cells
4673715|NCT03406962|inherited metabolic disorders|inherited metabolic disorders
4673716|NCT03406962|cerebral adrenoleukodystrophy|cerebral adrenoleukodystrophy
4673717|NCT03406962|Hurler syndrome|hurler syndrome
4673718|NCT03406962|globoid cell leukodystrophy|globoid cell leukodystrophy
4673719|NCT03406962|Krabbe disease|krabbe disease
4673720|NCT03406962|metachromatic leukodystrophy|metachromatic leukodystrophy
4673721|NCT03406962|hematopoietic stem cells|hematopoietic stem cells
4673722|NCT03406962|hematopoietic stem cell transplant|hematopoietic stem cell transplant
4673723|NCT03406962|umbilical cord blood|umbilical cord blood
4673724|NCT03406962|umbilical cord blood transplant|umbilical cord blood transplant
4673725|NCT03406962|MGTA-456|mgta-456
4673726|NCT03406962|myeloablative conditioning regimen|myeloablative conditioning regimen
4673727|NCT03406962|bone marrow transplant|bone marrow transplant
4673728|NCT03406962|mucopolysaccharidosis-1H|mucopolysaccharidosis-1h
4673729|NCT03406923|Health literacy|health literacy
4673730|NCT03406923|Self-efficacy|self-efficacy
4673731|NCT03406923|Beliefs about diabetes|beliefs about diabetes
4673732|NCT03406923|Beliefs in medicines|beliefs in medicines
4673734|NCT03406910|meat|meat
4673735|NCT03406910|western diet|western diet
4673736|NCT03406910|type 2 diabetes|type 2 diabetes
4673737|NCT03406910|Adventist Health Study|adventist health study
4673738|NCT03406910|Vegetarian cohort|vegetarian cohort
4673739|NCT03406910|Adventist|adventist
4673740|NCT03406884|stem cells|stem cells
4673741|NCT03406884|pediatric|pediatric
4673742|NCT03406871|Regorafenib|regorafenib
4673743|NCT03406871|Nivolumab|nivolumab
4673744|NCT03406871|Phase I clinical trial|phase i clinical trial
4673745|NCT03406832|Prevention|prevention
4673746|NCT03406832|Slow flow|slow flow
4673747|NCT03406832|No reflow|no reflow
4673748|NCT03406832|Nitroprusside|nitroprusside
4673749|NCT03406832|Tirofiban|tirofiban
4673750|NCT03406819|Prevention|prevention
4673751|NCT03406819|Slow flow|slow flow
4673752|NCT03406819|No reflow|no reflow
4673753|NCT03406819|Nitroprusside|nitroprusside
4673754|NCT03406819|Tirofiban|tirofiban
4673755|NCT03406793|Zinc|zinc
4673756|NCT03406793|Multiple micronutrient powders|multiple micronutrient powders
4673757|NCT03406793|Diarrhea|diarrhea
4673758|NCT03406793|Stunting|stunting
4673759|NCT03406780|Duchenne Muscular Dystrophy|duchenne muscular dystrophy
4673760|NCT03406780|Cell Therapy|cell therapy
4673761|NCT03406780|Performance of the Upper Limb|performance of the upper limb
4673762|NCT03406780|Pulmonary Function|pulmonary function
4673763|NCT03406780|Ambulatory|ambulatory
4673764|NCT03406780|Non-Ambulatory|non-ambulatory
4673765|NCT03406780|Glucocorticoids|glucocorticoids
4673766|NCT03406728|Parkinson's Disease|parkinson's disease
4673767|NCT03406728|Virtual Reality|virtual reality
4673768|NCT03406728|Training|training
4673769|NCT03406728|Balance|balance
4673770|NCT03406728|Falls|falls
4673771|NCT03406728|PDSAFEX|pdsafex
4673772|NCT03406715|SCLC|sclc
4673773|NCT03406715|Lung Cancer|lung cancer
4673774|NCT03406715|Lung Disease|lung disease
4673775|NCT03406715|Relapsed SCLC|relapsed sclc
4673776|NCT03406702|Epilepsy, Generalized Epileptic Syndromes, Absence Seizures|epilepsy, generalized epileptic syndromes, absence seizures
4673777|NCT03406689|Pain|pain
4673778|NCT03406689|Intravitreal Injection|intravitreal injection
4673779|NCT03406689|Anti-VEGF|anti-vegf
4673780|NCT03406689|Nepafenac eye drops|nepafenac eye drops
4673781|NCT03406689|Short Form McGill Pain Questionnaire|short form mcgill pain questionnaire
4673782|NCT03406676|Methylene blue; Peripheral vascular resistance|methylene blue; peripheral vascular resistance
4673783|NCT03406663|Insulin|insulin
4673784|NCT03406650|muscle invasive urothelial cancer|muscle invasive urothelial cancer
4673785|NCT03406650|cancer|cancer
4673786|NCT03406650|immunotherapy|immunotherapy
4673787|NCT03406650|durvalumab|durvalumab
4673788|NCT03406650|MEDI4736|medi4736
4673789|NCT03406650|adjuvant|adjuvant
4673790|NCT03406650|neoadjuvant|neoadjuvant
4673791|NCT03406650|radical cystectomy|radical cystectomy
4673792|NCT03406650|bladder|bladder
4673793|NCT03406624|Modic changes|modic changes
4673794|NCT03406624|biomarkers|biomarkers
4673795|NCT03406624|low back pain|low back pain
4673796|NCT03406598|Shock|shock
4673797|NCT03406598|Microcirculation|microcirculation
4673798|NCT03406598|Nurses|nurses
4673799|NCT03406572|Acute on chronic respiratory failure|acute on chronic respiratory failure
4673800|NCT03406572|High-Flow heated and humidified nasal oxygen therapy|high-flow heated and humidified nasal oxygen therapy
4673801|NCT03406520|peritoneal dialysis|peritoneal dialysis
4673802|NCT03406520|chlorhexidine|chlorhexidine
4673803|NCT03406520|exit site infection|exit site infection
4673804|NCT03406520|tunnel tract infection|tunnel tract infection
4673805|NCT03406494|sepsis|sepsis
4673806|NCT03406494|critical illness|critical illness
4673807|NCT03406494|intensive care unit|intensive care unit
4673808|NCT03406494|mechanical ventilation|mechanical ventilation
4673809|NCT03406494|rehabilitation|rehabilitation
4673810|NCT03406494|mortality|mortality
4673811|NCT03406494|physical function|physical function
4673812|NCT03406494|health-related quality of life|health-related quality of life
4673813|NCT03406468|non small cell lung cancer|non small cell lung cancer
4673814|NCT03406468|immune therapy|immune therapy
4673815|NCT03406468|radiotherapy|radiotherapy
4673816|NCT03406455|wearable|wearable
4673817|NCT03406455|mhealth|mhealth
4673818|NCT03406429|rTMS|rtms
4673819|NCT03406429|PPA|ppa
4673820|NCT03406390|contrast sensitivity|contrast sensitivity
4673821|NCT03406390|Pterygium|pterygium
4673822|NCT03406325|mast cell|mast cell
4673823|NCT03406325|allergy|allergy
4673824|NCT03406325|genomic|genomic
4673825|NCT03406325|biomarkers|biomarkers
4673826|NCT03406312|Roux en Y Gastric Bypass Surgery, Hypoglycemia, Postprandial|roux en y gastric bypass surgery, hypoglycemia, postprandial
4673827|NCT03406299|SLOG|slog
4673828|NCT03406286|Post Marketing Surveillance|post marketing surveillance
4673829|NCT03406208|Psychiatry|psychiatry
4673830|NCT03406208|Psychology|psychology
4673831|NCT03406208|Psychosocial|psychosocial
4673832|NCT03406208|Behavioral|behavioral
4673833|NCT03406195|transcranial magnetic stimulation|transcranial magnetic stimulation
4673834|NCT03406182|stunting|stunting
4673835|NCT03406182|under-weight|under-weight
4673836|NCT03406182|Pakistan|pakistan
4673837|NCT03406182|infant|infant
4673838|NCT03406182|time-use|time-use
4673839|NCT03406182|women|women
4673840|NCT03406182|body mass index|body mass index
4673841|NCT03406182|growth|growth
4673842|NCT03406169|penile rehabilitation|penile rehabilitation
4673843|NCT03406156|Cancer|cancer
4673844|NCT03406156|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
4673845|NCT03406156|17p Deletion|17p deletion
4673846|NCT03406156|debulking|debulking
4673847|NCT03406156|obinutuzumab|obinutuzumab
4673848|NCT03406156|bendamustine|bendamustine
4673849|NCT03406156|tumor lysis syndrome|tumor lysis syndrome
4673850|NCT03406156|venetoclax|venetoclax
4673851|NCT03406156|Small Lymphocytic Lymphoma|small lymphocytic lymphoma
4673852|NCT03406104|Heredity Optic Atrophy|heredity optic atrophy
4673853|NCT03406104|Leber Hereditary Optic Atrophy|leber hereditary optic atrophy
4673854|NCT03406104|Leber Hereditary Optic Neuropathy|leber hereditary optic neuropathy
4673855|NCT03406104|LHON|lhon
4673856|NCT03406104|Eye Diseases|eye diseases
4673857|NCT03406104|Hereditary Eye Diseases|hereditary eye diseases
4673858|NCT03406104|Inborn Genetic Disease|inborn genetic disease
4673859|NCT03406104|Gene Therapy|gene therapy
4673860|NCT03406104|Intravitreal Injections|intravitreal injections
4673861|NCT03406104|Mitochondrial Disease|mitochondrial disease
4673862|NCT03406104|AAV2 Vectors|aav2 vectors
4673863|NCT03406104|Nervous System Diseases|nervous system diseases
4673864|NCT03406104|Neurodegenerative Disease|neurodegenerative disease
4673865|NCT03406104|Heredodegenerative Disorders of the Nervous System|heredodegenerative disorders of the nervous system
4673866|NCT03406078|Asthma|asthma
4673867|NCT03406065|Sodium bicarbonate|sodium bicarbonate
4673868|NCT03406065|NaHCO3|nahco3
4673869|NCT03406065|Combat Sports|combat sports
4673870|NCT03406065|Physical capacity|physical capacity
4673871|NCT03406065|Dummy test|dummy test
4673872|NCT03406039|Alcohol Use Disorder|alcohol use disorder
4673873|NCT03406039|Emotional Disorder|emotional disorder
4673874|NCT03406039|Cognitive Behavioural Therapy|cognitive behavioural therapy
4673875|NCT03406039|Motivational Interviewing|motivational interviewing
4673876|NCT03406039|Online Intervention|online intervention
4673877|NCT03406039|Randomized Controlled Trial|randomized controlled trial
4673878|NCT03406026|Stroke|stroke
4673879|NCT03406026|Balance rehabilitation|balance rehabilitation
4673880|NCT03406026|Physiotherapy|physiotherapy
4673881|NCT03405974|Osteonecrosis|osteonecrosis
4673882|NCT03405974|Aspirin|aspirin
4673883|NCT03405961|PAR scoring|par scoring
4673884|NCT03405961|Digital study models|digital study models
4673885|NCT03405909|contrast-enhanced ultrasound|contrast-enhanced ultrasound
4673886|NCT03405909|non-invasive diagnosis|non-invasive diagnosis
4673887|NCT03405909|focal liver lesion|focal liver lesion
4673888|NCT03405909|liver cirrhosis|liver cirrhosis
4673889|NCT03405909|standardised diagnostic algorithm|standardised diagnostic algorithm
4673890|NCT03405909|intrahepatic cholangiocellular carcinoma|intrahepatic cholangiocellular carcinoma
4673891|NCT03405909|ESCULAP|esculap
4673892|NCT03405909|CEUS LI-RADS|ceus li-rads
4673893|NCT03405909|imaging|imaging
4673894|NCT03405909|hepatocellular carcinoma|hepatocellular carcinoma
4673895|NCT03405909|MRI|mri
4673896|NCT03405909|diagnostic accuracy|diagnostic accuracy
4673897|NCT03405909|interobserver agreement|interobserver agreement
4673898|NCT03405909|Erlanger Synopsis of CEUS for Liver lesion Assessment in Patients at risk|erlanger synopsis of ceus for liver lesion assessment in patients at risk
4673899|NCT03405909|CEUS Liver Imaging Reporting and Data System|ceus liver imaging reporting and data system
4673900|NCT03405870|cholesterol|cholesterol
4673901|NCT03405870|lipids|lipids
4673902|NCT03405870|total parenteral nutrition|total parenteral nutrition
4673903|NCT03405857|mild cognitive impairment|mild cognitive impairment
4673904|NCT03405857|cognitive training program|cognitive training program
4673905|NCT03405844|Shoulder|shoulder
4673906|NCT03405844|glenohumeral|glenohumeral
4673907|NCT03405844|stretching|stretching
4673908|NCT03405831|Heart transplantation|heart transplantation
4673909|NCT03405831|Exercise capacity|exercise capacity
4673910|NCT03405831|Heart rate|heart rate
4673911|NCT03405831|Cardiac allograft vasculopathy|cardiac allograft vasculopathy
4673912|NCT03405818|Fungal infection of the nail|fungal infection of the nail
4673913|NCT03405792|Tumor Treating Electric Fields (TTFields)|tumor treating electric fields (ttfields)
4673914|NCT03405714|Epilepsy|epilepsy
4673915|NCT03405714|Brivaracetam|brivaracetam
4673916|NCT03405714|Briviact|briviact
4673917|NCT03405714|Open-label|open-label
4673918|NCT03405714|pediatric|pediatric
4673919|NCT03405714|intravenous|intravenous
4673920|NCT03405688|Sickle cell|sickle cell
4673921|NCT03405688|Heterozygous|heterozygous
4673922|NCT03405688|Blood donor|blood donor
4673923|NCT03405675|Dementia|dementia
4673924|NCT03405675|Mild cognitive impairment|mild cognitive impairment
4673925|NCT03405675|Cognitive abilities and changes|cognitive abilities and changes
4673926|NCT03405675|Functional change and disabilities|functional change and disabilities
4673927|NCT03405675|Depression|depression
4673928|NCT03405675|Health and social services utilization|health and social services utilization
4673929|NCT03405675|Quality of life|quality of life
4673930|NCT03405675|Adverse drug effects|adverse drug effects
4673931|NCT03405675|Social network and support|social network and support
4673932|NCT03405675|Self-rated health|self-rated health
4673933|NCT03405675|Medical morbidities|medical morbidities
4673934|NCT03405675|Falls|falls
4673935|NCT03405675|Health risk behaviors|health risk behaviors
4673936|NCT03405675|Nutrition|nutrition
4673937|NCT03405675|Apo-E lipoprotein|apo-e lipoprotein
4673938|NCT03405675|Phytochemicals|phytochemicals
4673939|NCT03405675|B12|b12
4673940|NCT03405675|Folate|folate
4673941|NCT03405675|Homocysteine|homocysteine
4673942|NCT03405675|Lifestyle|lifestyle
4673943|NCT03405675|Physical activity|physical activity
4673944|NCT03405675|Leisure activity|leisure activity
4673945|NCT03405675|Successful ageing|successful ageing
4673946|NCT03405675|Mortality|mortality
4673947|NCT03405649|postpartum|postpartum
4673948|NCT03405649|exercise|exercise
4673949|NCT03405649|intervention|intervention
4673950|NCT03405610|Psychiatry|psychiatry
4673951|NCT03405610|Psychology|psychology
4673952|NCT03405610|Psychosocial|psychosocial
4673953|NCT03405610|Mind-Body|mind-body
4673954|NCT03405584|Helicobacter pylori|helicobacter pylori
4673955|NCT03405584|Therapy|therapy
4673956|NCT03405506|Fractional Flow Reserve|fractional flow reserve
4673957|NCT03405506|Quantitative Coronary Angiography|quantitative coronary angiography
4673958|NCT03405506|Coronary artery disease|coronary artery disease
4673959|NCT03405506|Quantitative Flow Ratio|quantitative flow ratio
4673960|NCT03405506|Tandem lesion|tandem lesion
4673961|NCT03405506|Virtual stenting|virtual stenting
4673962|NCT03405493|Circadian Rhythm|circadian rhythm
4673963|NCT03405493|Light Therapy|light therapy
4673964|NCT03405493|Wake Therapy|wake therapy
4673965|NCT03405493|Sleep Phase Advance|sleep phase advance
4673966|NCT03405493|Major Depression|major depression
4673967|NCT03405480|Pulmonary embolism|pulmonary embolism
4673968|NCT03405480|Dyspnea|dyspnea
4673969|NCT03405480|Post Pulmonary Embolism Syndrome|post pulmonary embolism syndrome
4673970|NCT03405480|PPS|pps
4673971|NCT03405480|Rehabilitation|rehabilitation
4673972|NCT03405480|Cardiac magnetic resonance imaging (CMR)|cardiac magnetic resonance imaging (cmr)
4673973|NCT03405428|Ultrasonography|ultrasonography
4673974|NCT03405428|Radial Artery Diameter|radial artery diameter
4673975|NCT03405428|Allen Test|allen test
4673976|NCT03405428|Arterial Cannulation|arterial cannulation
4673977|NCT03405428|Doppler Ultrasonography|doppler ultrasonography
4673978|NCT03405428|Ulnar Artery|ulnar artery
4673979|NCT03405402|Sickle cell disease|sickle cell disease
4673980|NCT03405402|Allo-immunization|allo-immunization
4673981|NCT03405402|Blood transfusion|blood transfusion
4673982|NCT03405389|mandibulo-maxillary fixation|mandibulo-maxillary fixation
4673983|NCT03405389|malocclusion|malocclusion
4673984|NCT03405324|brain stimulation, tDCS, nausea and vomiting|brain stimulation, tdcs, nausea and vomiting
4673985|NCT03405311|Labor analgesia|labor analgesia
4673986|NCT03405311|Ultrasound|ultrasound
4673987|NCT03405311|Obesity, Morbid|obesity, morbid
4673988|NCT03405311|Pregnancy|pregnancy
4673989|NCT03405311|Labor Epidural Analgesia|labor epidural analgesia
4673990|NCT03405285|Improved Bladder Management|improved bladder management
4673991|NCT03405285|Neurogenic Lower Urinary Tract Dysfunction|neurogenic lower urinary tract dysfunction
4673992|NCT03405285|Bladder function following Spinal Cord Injury|bladder function following spinal cord injury
4673993|NCT03405285|Urinary Retention|urinary retention
4673994|NCT03405272|Full human anti-EGFR monoclonal antibody (SCT200)|full human anti-egfr monoclonal antibody (sct200)
4673995|NCT03405272|metastatic colorectal cancer （mCRC）|metastatic colorectal cancer （mcrc）
4673996|NCT03405246|Childhood obesity|childhood obesity
4673997|NCT03405246|Weight gain in children|weight gain in children
4673998|NCT03405246|Diet intervention|diet intervention
4674000|NCT03405233|ePTFE|eptfe
4674001|NCT03405233|neointemal hyperplasia|neointemal hyperplasia
4674002|NCT03405220|smoking|smoking
4674003|NCT03405220|self-affirmation|self-affirmation
4674004|NCT03405220|mobile application|mobile application
4674005|NCT03405220|cessation|cessation
4674006|NCT03405194|HIV/AIDS|hiv/aids
4674007|NCT03405194|Same-Day ART|same-day art
4674008|NCT03405194|Genvoya|genvoya
4674009|NCT03405194|Efavirenz|efavirenz
4674010|NCT03405129|Smoking Cessation|smoking cessation
4674011|NCT03405129|Smartphone App|smartphone app
4674012|NCT03405129|Dynamic Treatment|dynamic treatment
4674013|NCT03405103|self-management|self-management
4674014|NCT03405103|m-Health|m-health
4674015|NCT03405077|interpersonal psychotherapy|interpersonal psychotherapy
4674016|NCT03405077|treatment|treatment
4674017|NCT03405077|training|training
4674018|NCT03405077|dissemination and implementation|dissemination and implementation
4674019|NCT03405077|eating disorders|eating disorders
4674020|NCT03405051|hypokalemia|hypokalemia
4674021|NCT03405051|cardiac failure|cardiac failure
4674022|NCT03404960|Platinum|platinum
4674023|NCT03404960|chemotherapy|chemotherapy
4674024|NCT03404960|Niraparib|niraparib
4674025|NCT03404960|Ipilimumab|ipilimumab
4674026|NCT03404960|Nivolumab|nivolumab
4674027|NCT03404960|Pancreatic adenocarcinoma|pancreatic adenocarcinoma
4674028|NCT03404960|PARP inhibitor|parp inhibitor
4674029|NCT03404960|Pancreatic ductal adenocarcinoma|pancreatic ductal adenocarcinoma
4674030|NCT03404960|DDR|ddr
4674031|NCT03404960|PDAC|pdac
4674032|NCT03404947|Exercise|exercise
4674033|NCT03404947|Metabolism|metabolism
4674034|NCT03404947|Nutrition|nutrition
4674035|NCT03404934|Adaptive anastomosis|adaptive anastomosis
4674036|NCT03404934|C-REX|c-rex
4674037|NCT03404934|Colorectal cancer|colorectal cancer
4674038|NCT03404921|Endoscopic submucosal dissection|endoscopic submucosal dissection
4674039|NCT03404921|Endoscopic submucosal tunnelling dissection|endoscopic submucosal tunnelling dissection
4674040|NCT03404921|procedure time|procedure time
4674041|NCT03404908|transversus abdominis plane block|transversus abdominis plane block
4674042|NCT03404908|quadratus lumborum block|quadratus lumborum block
4674043|NCT03404908|neuropathic pain|neuropathic pain
4674044|NCT03404895|DFU|dfu
4674045|NCT03404895|Vein|vein
4674046|NCT03404895|Stent|stent
4674047|NCT03404791|Bladder Cancer|bladder cancer
4674254|NCT03403530|IgM|igm
4674048|NCT03404791|Urothelial Carcinoma|urothelial carcinoma
4674049|NCT03404791|Cystectomy|cystectomy
4674050|NCT03404791|Radical Cystectomy|radical cystectomy
4674051|NCT03404778|Reverse Shoulder Arthroplasty|reverse shoulder arthroplasty
4674052|NCT03404778|Medical Device|medical device
4674053|NCT03404778|Performance|performance
4674054|NCT03404778|Safety|safety
4674055|NCT03404778|Shoulder Prosthesis|shoulder prosthesis
4674056|NCT03404778|Glenoid Erosion|glenoid erosion
4674057|NCT03404765|Tai Chi|tai chi
4674058|NCT03404765|Cognition|cognition
4674059|NCT03404765|Instrumental activities of daily living|instrumental activities of daily living
4674060|NCT03404765|Health-related Quality of Life|health-related quality of life
4674061|NCT03404752|breast cancer|breast cancer
4674062|NCT03404752|chemotherapy|chemotherapy
4674063|NCT03404752|Neutropenia|neutropenia
4674064|NCT03404752|Peg-filgrastim|peg-filgrastim
4674065|NCT03404752|biosimilar|biosimilar
4674066|NCT03404739|Antibiotic prophylaxis|antibiotic prophylaxis
4674067|NCT03404739|Infectious complications|infectious complications
4674068|NCT03404739|Peroral endoscopic myotomy|peroral endoscopic myotomy
4674069|NCT03404726|Acute myeloid leukemia|acute myeloid leukemia
4674070|NCT03404726|Myelodysplastic Syndromes|myelodysplastic syndromes
4674071|NCT03404726|Chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
4674072|NCT03404726|Dihydroorotate dehydrogenase (DHODH) inhibitor|dihydroorotate dehydrogenase (dhodh) inhibitor
4674073|NCT03404713|adolescence|adolescence
4674074|NCT03404713|adolescent|adolescent
4674075|NCT03404713|binge eating|binge eating
4674076|NCT03404713|loss-of-control eating|loss-of-control eating
4674077|NCT03404713|behavioral weight loss|behavioral weight loss
4674078|NCT03404713|weight management|weight management
4674079|NCT03404713|acceptance commitment therapy|acceptance commitment therapy
4674080|NCT03404713|overweight|overweight
4674081|NCT03404713|obesity|obesity
4674082|NCT03404700|Eggs, saturated fat, insulin resistance,|eggs, saturated fat, insulin resistance,
4674083|NCT03404674|ETEC|etec
4674084|NCT03404674|Escherichia coli|escherichia coli
4674085|NCT03404674|enteric|enteric
4674086|NCT03404648|high risk|high risk
4674087|NCT03404648|prostate cancer|prostate cancer
4674088|NCT03404648|C11-choline|c11-choline
4674089|NCT03404648|PET/MR|pet/mr
4674090|NCT03404648|mpMRI|mpmri
4674091|NCT03404596|cigarettes|cigarettes
4674092|NCT03404596|quit smoking|quit smoking
4674093|NCT03404596|nicotine|nicotine
4674094|NCT03404596|mindfulness|mindfulness
4674095|NCT03404596|mHealth|mhealth
4674096|NCT03404596|mobile health|mobile health
4674097|NCT03404583|Person-centred care|person-centred care
4674098|NCT03404570|Sweaty Hands|sweaty hands
4674099|NCT03404557|Crohn's Disease|crohn's disease
4674100|NCT03404557|Ulcerative colitis|ulcerative colitis
4674101|NCT03404557|Macrophages|macrophages
4674102|NCT03404557|Adherent-Invasive Escherichia coli|adherent-invasive escherichia coli
4674103|NCT03404557|Proteomic analysis|proteomic analysis
4674104|NCT03404518|Thyroidectomy|thyroidectomy
4674105|NCT03404518|Parotidectomy|parotidectomy
4674106|NCT03404518|Tympanoplasty|tympanoplasty
4674107|NCT03404518|Mastoidectomy|mastoidectomy
4674108|NCT03404518|Septoplasty|septoplasty
4674109|NCT03404518|Sinus Surgery|sinus surgery
4674110|NCT03404518|Postoperative pain|postoperative pain
4674111|NCT03404518|Outpatient surgery|outpatient surgery
4674112|NCT03404505|infant|infant
4674113|NCT03404505|play|play
4674114|NCT03404505|parents|parents
4674115|NCT03404479|Knee Osteoarthritis|knee osteoarthritis
4674116|NCT03404479|Diacerein|diacerein
4674117|NCT03404453|Airway prediction|airway prediction
4674118|NCT03404453|Difficult airway|difficult airway
4674119|NCT03404440|helicobacter pylori|helicobacter pylori
4674120|NCT03404440|L. Reuteri|l. reuteri
4674121|NCT03404440|Proton Pump Inhibitor|proton pump inhibitor
4674122|NCT03404375|scheduled cesarean section|scheduled cesarean section
4674123|NCT03404375|term pregnancy|term pregnancy
4674124|NCT03404375|estimated blood loss|estimated blood loss
4674125|NCT03404375|postpartum hemorrhage|postpartum hemorrhage
4674126|NCT03404362|Bone Metastases|bone metastases
4674127|NCT03404336|migraine|migraine
4674128|NCT03404336|chronic|chronic
4674129|NCT03404336|well-being therapy|well-being therapy
4674130|NCT03404336|psychotherapy|psychotherapy
4674131|NCT03404336|therapy|therapy
4674132|NCT03404323|central retinal thickness|central retinal thickness
4674133|NCT03404323|epiretinal membrane|epiretinal membrane
4674134|NCT03404323|cataract surgery|cataract surgery
4674135|NCT03404323|pseudophakic cystoid macular edema|pseudophakic cystoid macular edema
4674136|NCT03404310|HPV|hpv
4674137|NCT03404310|ASCUS|ascus
4674138|NCT03404310|LSIL|lsil
4674139|NCT03404310|Cervical Cancer|cervical cancer
4674140|NCT03404297|compression therapy|compression therapy
4674141|NCT03404297|Kenya|kenya
4674142|NCT03404297|Kaposi Sarcoma|kaposi sarcoma
4674143|NCT03404297|Locally sourced|locally sourced
4674144|NCT03404297|wrapping|wrapping
4674145|NCT03404297|chronic leg ulcers|chronic leg ulcers
4674146|NCT03404284|Immunization|immunization
4674147|NCT03404245|Physical Activity|physical activity
4674148|NCT03404245|Exercise|exercise
4674149|NCT03404245|Rheumatoid|rheumatoid
4674150|NCT03404245|Arthritis|arthritis
4674151|NCT03404245|Self-management|self-management
4674152|NCT03404245|Symptoms|symptoms
4674153|NCT03404206|Postsurgical pain|postsurgical pain
4674154|NCT03404193|Other diseases of blood and blood-forming organs|other diseases of blood and blood-forming organs
4674155|NCT03404193|Acute Myeloid Leukemia|acute myeloid leukemia
4674156|NCT03404193|AML|aml
4674157|NCT03404193|Myelodysplastic Syndrome|myelodysplastic syndrome
4674158|NCT03404193|MDS|mds
4674159|NCT03404193|Decitabine|decitabine
4674160|NCT03404193|Dacogen|dacogen
4674161|NCT03404193|Ventoclax|ventoclax
4674162|NCT03404193|ABT-199|abt-199
4674163|NCT03404193|GDC-0199|gdc-0199
4674164|NCT03404167|ETX0914|etx0914
4674165|NCT03404167|Plasma Pharmacokinetic|plasma pharmacokinetic
4674166|NCT03404167|Safety|safety
4674167|NCT03404167|Tolerability|tolerability
4674168|NCT03404167|Zoliflodacin|zoliflodacin
4674169|NCT03404141|Stress|stress
4674170|NCT03404141|pregnancy|pregnancy
4674171|NCT03404141|psychological therapy|psychological therapy
4674172|NCT03404141|cortisol|cortisol
4674173|NCT03404115|reproxalap|reproxalap
4674174|NCT03404089|device drug monitoring|device drug monitoring
4674175|NCT03404089|β-lactam antibiotic|β-lactam antibiotic
4674176|NCT03404089|health care-associated infection|health care-associated infection
4674177|NCT03404089|MON4STRAT|mon4strat
4674178|NCT03404076|Gastrointestinal Stromal Tumor (GIST)|gastrointestinal stromal tumor (gist)
4674179|NCT03404076|Dual Energy CT|dual energy ct
4674180|NCT03404076|Tyrosine Kinase Inhibitor (TKI)|tyrosine kinase inhibitor (tki)
4674181|NCT03404024|gene therapy|gene therapy
4674182|NCT03403998|Pain|pain
4674183|NCT03403998|Temporomandibular Disorders|temporomandibular disorders
4674184|NCT03403998|Therapeutic exercises|therapeutic exercises
4674185|NCT03403998|Musculoskeletal disorders|musculoskeletal disorders
4674186|NCT03403998|Randomized controlled trial|randomized controlled trial
4674187|NCT03403998|Imaging|imaging
4674188|NCT03403998|Brain plasticity|brain plasticity
4674189|NCT03403998|Clinical outcomes|clinical outcomes
4674190|NCT03403998|Chronic pain|chronic pain
4674191|NCT03403998|Neck|neck
4674192|NCT03403972|pharmacokinetics|pharmacokinetics
4674193|NCT03403972|simvastatin|simvastatin
4674194|NCT03403972|vancomycin|vancomycin
4674195|NCT03403972|gut microbiome|gut microbiome
4674196|NCT03403959|pupillometry|pupillometry
4674197|NCT03403959|light therapy|light therapy
4674198|NCT03403959|visual impairment|visual impairment
4674199|NCT03403959|melatonin|melatonin
4674200|NCT03403959|ipRGC|iprgc
4674201|NCT03403946|difficult airway|difficult airway
4674202|NCT03403946|carvical collar|carvical collar
4674203|NCT03403946|endotracheal intubation|endotracheal intubation
4674204|NCT03403920|validity|validity
4674205|NCT03403920|low back pain|low back pain
4674206|NCT03403920|functional|functional
4674207|NCT03403920|pain|pain
4674208|NCT03403920|questionnaire|questionnaire
4674209|NCT03403907|epilepsy|epilepsy
4674210|NCT03403907|microbiota|microbiota
4674211|NCT03403907|probiotics|probiotics
4674212|NCT03403881|Exercise|exercise
4674213|NCT03403881|Physical activity|physical activity
4674214|NCT03403881|Behavioral change|behavioral change
4674215|NCT03403881|Depression|depression
4674216|NCT03403881|Major Depressive Disorder|major depressive disorder
4674217|NCT03403881|Health promotion|health promotion
4674218|NCT03403803|Glioblastoma|glioblastoma
4674219|NCT03403803|Brain Tumor|brain tumor
4674220|NCT03403790|Bipresso|bipresso
4674221|NCT03403790|Drug use-results survey|drug use-results survey
4674222|NCT03403790|Quetiapine|quetiapine
4674223|NCT03403777|Multiple relapsed/refractory testicular germ cell tumors|multiple relapsed/refractory testicular germ cell tumors
4674224|NCT03403777|Avelumab|avelumab
4674225|NCT03403777|Anti PD-L1|anti pd-l1
4674226|NCT03403764|Intention|intention
4674227|NCT03403764|Distant Healing|distant healing
4674228|NCT03403764|Wellness|wellness
4674229|NCT03403764|Distant Intentionality|distant intentionality
4674230|NCT03403764|Distant Healing Intention|distant healing intention
4674231|NCT03403751|Abdominal sepsis|abdominal sepsis
4674232|NCT03403751|AKI|aki
4674233|NCT03403725|Solid Tumors|solid tumors
4674234|NCT03403725|Non-Hodgkin Lymphoma|non-hodgkin lymphoma
4674235|NCT03403725|NHL|nhl
4674236|NCT03403725|MEN1309|men1309
4674237|NCT03403725|CD205|cd205
4674238|NCT03403725|Relapsed|relapsed
4674239|NCT03403725|Refractory|refractory
4674240|NCT03403725|R-R NHL|r-r nhl
4674241|NCT03403725|ADC|adc
4674242|NCT03403725|Antibody-Drug Coniugate|antibody-drug coniugate
4674243|NCT03403725|Metastatic Tumors|metastatic tumors
4674244|NCT03403699|inducible pluripotent stem cells|inducible pluripotent stem cells
4674245|NCT03403686|Liver X receptor|liver x receptor
4674246|NCT03403686|Circulating angiogenic cells|circulating angiogenic cells
4674247|NCT03403660|Attire|attire
4674248|NCT03403660|White coat|white coat
4674249|NCT03403660|Patient physician communication|patient physician communication
4674250|NCT03403569|CD4 cell recovery|cd4 cell recovery
4674251|NCT03403569|immune activation|immune activation
4674252|NCT03403569|anti-inflammation|anti-inflammation
4674253|NCT03403556|High ASCVD risk patients with type 2 diabetes|high ascvd risk patients with type 2 diabetes
4674255|NCT03403530|Immunoglobulin|immunoglobulin
4674256|NCT03403530|Neonatal sepsis|neonatal sepsis
4674257|NCT03403530|very low birth weight preterm|very low birth weight preterm
4674258|NCT03403517|steroids|steroids
4674259|NCT03403517|glucocorticoids|glucocorticoids
4674260|NCT03403517|liver surgery|liver surgery
4674261|NCT03403517|hepatectomy|hepatectomy
4674262|NCT03403478|Hemodynamics|hemodynamics
4674263|NCT03403478|Aquatic exercise|aquatic exercise
4674264|NCT03403478|Elderly|elderly
4674265|NCT03403374|Evolocumab|evolocumab
4674266|NCT03403374|Hypercholesterolemia|hypercholesterolemia
4674267|NCT03403322|intervention|intervention
4674268|NCT03403322|children|children
4674269|NCT03403309|Multiple system atrophy|multiple system atrophy
4674270|NCT03403309|Uric acid|uric acid
4674271|NCT03403309|Inosine 5'-monophosphate|inosine 5'-monophosphate
4674272|NCT03403309|Inosine monophosphate|inosine monophosphate
4674273|NCT03403309|Inosinic acid|inosinic acid
4674274|NCT03403270|Mobile App|mobile app
4674275|NCT03403270|Sedentary Behaviour|sedentary behaviour
4674276|NCT03403270|Workplace Wellness|workplace wellness
4674277|NCT03403270|Sitting Time|sitting time
4674278|NCT03403257|Caregiving|caregiving
4674279|NCT03403257|Hispanic|hispanic
4674280|NCT03403257|Mexican American|mexican american
4674281|NCT03403257|Epidemiology|epidemiology
4674282|NCT03403257|Community|community
4674283|NCT03403231|Veterans|veterans
4674284|NCT03403231|Type 2 diabetes mellitus|type 2 diabetes mellitus
4674285|NCT03403231|Prediabetes|prediabetes
4674286|NCT03403231|Secure Messaging|secure messaging
4674287|NCT03403231|Health Promotion|health promotion
4674288|NCT03403231|Prevention and Control|prevention and control
4674289|NCT03403231|Motivation|motivation
4674290|NCT03403218|balance, risk of falling|balance, risk of falling
4674291|NCT03403192|EZ Blocker|ez blocker
4674292|NCT03403192|DLT|dlt
4674293|NCT03403192|Double Lumen Tube|double lumen tube
4674294|NCT03403192|Thoracic Surgery|thoracic surgery
4674295|NCT03403179|Cognition|cognition
4674296|NCT03403179|Cognitive Remediation|cognitive remediation
4674297|NCT03403179|Mood Disorder|mood disorder
4674298|NCT03403179|Functional Impairment|functional impairment
4674299|NCT03403179|Psychosocial intervention|psychosocial intervention
4674300|NCT03403153|Parent-Child Relationship|parent-child relationship
4674301|NCT03403153|military family|military family
4674302|NCT03403153|veterans health|veterans health
4674303|NCT03403153|stress disorders|stress disorders
4674304|NCT03403114|Vaccine hesitancy|vaccine hesitancy
4674305|NCT03403114|Hospital specialists (HS)|hospital specialists (hs)
4674306|NCT03403114|Vaccination survey|vaccination survey
4674307|NCT03403088|Non-carious cervical lesions|non-carious cervical lesions
4674308|NCT03403088|dentin hypersensitivity|dentin hypersensitivity
4674309|NCT03403075|blood cancer|blood cancer
4674310|NCT03403075|exercise|exercise
4674311|NCT03403075|therapeutic education|therapeutic education
4674312|NCT03403075|fatigue|fatigue
4674313|NCT03403075|feasibility|feasibility
4674314|NCT03403062|Sepsis|sepsis
4674315|NCT03403062|red cell distribution width (RDW)|red cell distribution width (rdw)
4674316|NCT03403062|Late onset sepsis (LOS)|late onset sepsis (los)
4674317|NCT03403062|Early onset sepsis (EOS)|early onset sepsis (eos)
4674318|NCT03403049|pancreatic cancer|pancreatic cancer
4674319|NCT03403049|pancreas|pancreas
4674320|NCT03403049|cancer|cancer
4674321|NCT03403049|locally advanced|locally advanced
4674322|NCT03403049|unresectable|unresectable
4674323|NCT03403049|radiation|radiation
4674324|NCT03403049|radiation therapy|radiation therapy
4674325|NCT03403049|radiotherapy|radiotherapy
4674326|NCT03403049|carbon|carbon
4674327|NCT03403049|carbon ion|carbon ion
4674328|NCT03403049|ion|ion
4674329|NCT03403036|Psoriasis|psoriasis
4674330|NCT03403036|brodalumab|brodalumab
4674331|NCT03403023|Dry Eye Disease|dry eye disease
4674332|NCT03403023|Tear Film Imager|tear film imager
4674333|NCT03403023|tear film|tear film
4674334|NCT03403023|Cyclosporine|cyclosporine
4674335|NCT03403023|dry eye syndrome|dry eye syndrome
4674336|NCT03403023|keratoconjunctivitis sicca|keratoconjunctivitis sicca
4674337|NCT03402984|Gastric motility|gastric motility
4674338|NCT03402984|Gastric emptying|gastric emptying
4674339|NCT03402971|right heart|right heart
4674340|NCT03402971|pregnancy|pregnancy
4674341|NCT03402971|echocardiography|echocardiography
4674342|NCT03402971|reference values|reference values
4674343|NCT03402945|negative pressure wound management system|negative pressure wound management system
4674344|NCT03402945|open-heart surgery|open-heart surgery
4674345|NCT03402945|antibiotic prophylaxis|antibiotic prophylaxis
4674346|NCT03402945|surgical site infection|surgical site infection
4674347|NCT03402854|pediatric|pediatric
4674348|NCT03402854|children|children
4674349|NCT03402854|non-invasive brain stimulation|non-invasive brain stimulation
4674350|NCT03402854|transcranial direct current stimulation|transcranial direct current stimulation
4674351|NCT03402854|bimanual training|bimanual training
4674352|NCT03402854|hand training|hand training
4674353|NCT03402841|Ovarian cancer|ovarian cancer
4674354|NCT03402841|non-gBRCA|non-gbrca
4674355|NCT03402841|Platinum|platinum
4674356|NCT03402841|Chemotherapy|chemotherapy
4674357|NCT03402828|Topicals|topicals
4674358|NCT03402828|Long-term|long-term
4674359|NCT03402815|HIV|hiv
4674360|NCT03402815|Maraviroc|maraviroc
4674361|NCT03402815|Atherosclerosis|atherosclerosis
4674362|NCT03402802|eye drop|eye drop
4674363|NCT03402789|Docosahexaenoic acid|docosahexaenoic acid
4674364|NCT03402789|Long chain fatty acid|long chain fatty acid
4674365|NCT03402776|haemopoietic stem cell transplantation|haemopoietic stem cell transplantation
4674366|NCT03402776|vaccine|vaccine
4674367|NCT03402776|diphteria|diphteria
4674368|NCT03402776|tetanus|tetanus
4674369|NCT03402776|haemophilus influenza|haemophilus influenza
4674370|NCT03402776|poliomyelitis|poliomyelitis
4674371|NCT03402776|hepatitis B|hepatitis b
4674372|NCT03402763|Advance care planning|advance care planning
4674373|NCT03402763|Older adults|older adults
4674374|NCT03402763|Emergency department|emergency department
4674375|NCT03402750|Adherence, Medication, Prescription|adherence, medication, prescription
4674376|NCT03402737|Stereotactic body radiotherapy|stereotactic body radiotherapy
4674377|NCT03402737|Immunomodulating systemic therapy|immunomodulating systemic therapy
4674378|NCT03402711|ACS|acs
4674379|NCT03402711|PCI|pci
4674380|NCT03402711|Bleeding risk|bleeding risk
4674381|NCT03402698|cholecalciferol|cholecalciferol
4674382|NCT03402698|BMI|bmi
4674383|NCT03402698|winter|winter
4674384|NCT03402607|Unresectable|unresectable
4674385|NCT03402594|High flow oxygen therapy|high flow oxygen therapy
4674386|NCT03402594|Oxygen desaturation index|oxygen desaturation index
4674387|NCT03402594|Acute ischemic stroke|acute ischemic stroke
4674388|NCT03402568|alcohol|alcohol
4674389|NCT03402568|targeted metabolomics|targeted metabolomics
4674390|NCT03402568|lipid metabolites|lipid metabolites
4674391|NCT03402568|amino acids|amino acids
4674392|NCT03402568|acylcarnitines|acylcarnitines
4674393|NCT03402529|Contrast Enhanced Spectral Mammography|contrast enhanced spectral mammography
4674394|NCT03402516|hysteroscopic myomectomy|hysteroscopic myomectomy
4674395|NCT03402516|26Fr resector|26fr resector
4674396|NCT03402516|18.5Fr resector|18.5fr resector
4674397|NCT03402490|Motivational interviewing|motivational interviewing
4674398|NCT03402490|physical activity|physical activity
4674399|NCT03402490|feasibility|feasibility
4674400|NCT03402490|HFpEF|hfpef
4674401|NCT03402477|locally advanced, neo-adjuvant treatment, Watch & Wait|locally advanced, neo-adjuvant treatment, watch & wait
4674402|NCT03402425|FET|fet
4674403|NCT03402425|PET/MRI|pet/mri
4674404|NCT03402425|child|child
4674405|NCT03402360|Virtual Reality|virtual reality
4674406|NCT03402360|Rehabilitation|rehabilitation
4674407|NCT03402360|Acquired Brain Injury|acquired brain injury
4674408|NCT03402347|Ex vivo|ex vivo
4674409|NCT03402347|Gastric bypass|gastric bypass
4674410|NCT03402321|alveogyl, gelatin sponge, free gingival graft, palate, pain|alveogyl, gelatin sponge, free gingival graft, palate, pain
4674411|NCT03402282|hemorrhoidal disease|hemorrhoidal disease
4674412|NCT03402282|embolization|embolization
4674413|NCT03402256|Mobile Technology|mobile technology
4674414|NCT03402256|Alcohol|alcohol
4674415|NCT03402256|Alcoholic Liver Disease|alcoholic liver disease
4674416|NCT03402256|Ethyl Glucuronide|ethyl glucuronide
4674417|NCT03402217|Contraception|contraception
4674418|NCT03402217|Post Partum Contraception|post partum contraception
4674419|NCT03402204|Simvastatin|simvastatin
4674420|NCT03402204|Plaque stability|plaque stability
4674421|NCT03402204|Acute ischemic stroke|acute ischemic stroke
4674422|NCT03402178|E2082|e2082
4674423|NCT03402178|male|male
4674424|NCT03402178|single ascending dose|single ascending dose
4674425|NCT03402178|multiple ascending dose|multiple ascending dose
4674426|NCT03402152|Biomarker|biomarker
4674427|NCT03402100|myopia|myopia
4674428|NCT03402100|schoolchildren|schoolchildren
4674429|NCT03402100|atropine|atropine
4674430|NCT03402100|allergy|allergy
4674431|NCT03402100|eye drops|eye drops
4674432|NCT03402100|outdoor|outdoor
4674433|NCT03402100|near work|near work
4674434|NCT03402048|Lung Cancer|lung cancer
4674435|NCT03402048|Elderly|elderly
4674436|NCT03402048|First line|first line
4674437|NCT03402048|Customized chemotherapy|customized chemotherapy
4674438|NCT03402048|Pharmacogenomic-driven|pharmacogenomic-driven
4674439|NCT03402048|NSCLC|nsclc
4674440|NCT03402035|Whole Blood Resuscitation|whole blood resuscitation
4674441|NCT03402022|Sport|sport
4674442|NCT03402022|competition|competition
4674443|NCT03402022|ultra-endurance|ultra-endurance
4674444|NCT03402022|trail running|trail running
4674445|NCT03402022|doping|doping
4674446|NCT03402009|meditation|meditation
4674447|NCT03402009|Mindfulness|mindfulness
4674448|NCT03402009|stress|stress
4674449|NCT03402009|anxiety|anxiety
4674450|NCT03401983|exercise|exercise
4674451|NCT03401983|pelvic floor|pelvic floor
4674452|NCT03401983|stress urinary incontinence|stress urinary incontinence
4674453|NCT03401970|Body composition|body composition
4674454|NCT03401970|Internal body fat|internal body fat
4674455|NCT03401970|Dietary pattern|dietary pattern
4674456|NCT03401970|Dietary carbohydrate|dietary carbohydrate
4674457|NCT03401957|colorectal cancer|colorectal cancer
4674458|NCT03401957|cetuximab resistance|cetuximab resistance
4674459|NCT03401957|liquid biopsy|liquid biopsy
4674460|NCT03401957|RAS mutation|ras mutation
4674461|NCT03401905|Percutaneous electrical nerve stimulation|percutaneous electrical nerve stimulation
4674462|NCT03401905|Myofascial trigger point|myofascial trigger point
4674463|NCT03401866|brain tumor|brain tumor
4674464|NCT03401840|Head and neck cancers|head and neck cancers
4674465|NCT03401840|Radiation oncology|radiation oncology
4674466|NCT03401840|Stereotactic radiotherapy|stereotactic radiotherapy
4674467|NCT03401827|pancreatic cancer|pancreatic cancer
4674468|NCT03401827|second line chemotherapy|second line chemotherapy
4674469|NCT03401827|nab-paclitaxel|nab-paclitaxel
4674470|NCT03401775|aging, computerized cognitive training|aging, computerized cognitive training
4674471|NCT03401762|rehabilitation|rehabilitation
4674472|NCT03401736|Sedatives and Hypnotics,Mechanical Ventilation|sedatives and hypnotics,mechanical ventilation
4674473|NCT03401723|Validation study|validation study
4674474|NCT03401723|Simulation|simulation
4674475|NCT03401723|Endoscopy|endoscopy
4674476|NCT03401710|Anemia, Acute Kidney injury, ESA, Erythropoietin|anemia, acute kidney injury, esa, erythropoietin
4674477|NCT03401684|firefighters|firefighters
4674478|NCT03401684|mental resiliency|mental resiliency
4674479|NCT03401684|peer support|peer support
4674480|NCT03401671|Lanadelumab|lanadelumab
4674481|NCT03401632|Enteral nutrition|enteral nutrition
4674482|NCT03401632|Vasoactive Drugs|vasoactive drugs
4674483|NCT03401632|Critical Care|critical care
4674484|NCT03401606|sedation|sedation
4674485|NCT03401606|dexmedetomidine|dexmedetomidine
4674486|NCT03401606|remifentanil|remifentanil
4674487|NCT03401606|cataract surgery|cataract surgery
4674488|NCT03401606|surgeon satisfaction|surgeon satisfaction
4674489|NCT03401606|patient satisfaction|patient satisfaction
4674490|NCT03401593|ablation|ablation
4674491|NCT03401593|atrial fibrillation|atrial fibrillation
4674492|NCT03401593|stroke|stroke
4674493|NCT03401567|blood flow restriction|blood flow restriction
4674494|NCT03401567|proprioception|proprioception
4674495|NCT03401567|functional performance|functional performance
4674496|NCT03401567|muscle strength|muscle strength
4674497|NCT03401541|Calcifediol (25(OH)D)|calcifediol (25(oh)d)
4674498|NCT03401541|Calciferol (Vitamin D)|calciferol (vitamin d)
4674499|NCT03401463|endotracheal tube cuff pressure|endotracheal tube cuff pressure
4674500|NCT03401463|Ventilator-Induced Lung Injury|ventilator-induced lung injury
4674501|NCT03401463|traning|traning
4674502|NCT03401437|adverse effects|adverse effects
4674503|NCT03401437|Salpingectomy|salpingectomy
4674504|NCT03401437|Essure® device ablation|essure® device ablation
4674505|NCT03401437|Cornual resection|cornual resection
4674506|NCT03401424|congenital cyst of common bile duct|congenital cyst of common bile duct
4674507|NCT03401424|Biliary enteric anastomosis|biliary enteric anastomosis
4674508|NCT03401411|ICU|icu
4674509|NCT03401411|ICU Triage Practices|icu triage practices
4674510|NCT03401411|Cancer Patients|cancer patients
4674511|NCT03401411|Oncology ICU|oncology icu
4674512|NCT03401398|hydrocortisone|hydrocortisone
4674513|NCT03401398|refractory septic shock|refractory septic shock
4674514|NCT03401398|sepsis|sepsis
4674515|NCT03401398|new/progressive MODS|new/progressive mods
4674516|NCT03401398|mortality|mortality
4674517|NCT03401398|health-related quality of life|health-related quality of life
4674518|NCT03401398|corticosteroid adverse events|corticosteroid adverse events
4674519|NCT03401398|sepsis biomarkers|sepsis biomarkers
4674520|NCT03401385|Non-small cell lung cancer|non-small cell lung cancer
4674521|NCT03401385|NSCLC|nsclc
4674522|NCT03401385|Other solid tumors|other solid tumors
4674523|NCT03401372|Primary light chain amyloidosis|primary light chain amyloidosis
4674524|NCT03401372|Doxycycline|doxycycline
4674525|NCT03401372|Bortezomib|bortezomib
4674526|NCT03401372|Prognosis|prognosis
4674527|NCT03401372|Progression-free survival|progression-free survival
4674528|NCT03401372|Overall survival|overall survival
4674529|NCT03401372|Organ response|organ response
4674530|NCT03401320|pharmacokinetics|pharmacokinetics
4674531|NCT03401320|letrozole|letrozole
4674532|NCT03401294|Metastatic colorectal cancer|metastatic colorectal cancer
4674533|NCT03401294|Conversion therapy|conversion therapy
4674534|NCT03401294|Liver Metastasectomy|liver metastasectomy
4674535|NCT03401268|hypogammaglobulinemia|hypogammaglobulinemia
4674536|NCT03401268|allogeneic hematopoietic cell transplantation|allogeneic hematopoietic cell transplantation
4674537|NCT03401255|Placental alpha microglobulin-1|placental alpha microglobulin-1
4674538|NCT03401255|PAMG-1|pamg-1
4674539|NCT03401255|preterm labor|preterm labor
4674540|NCT03401255|preterm delivery|preterm delivery
4674541|NCT03401255|preterm birth|preterm birth
4674542|NCT03401255|cervical length|cervical length
4674543|NCT03401255|transvaginal ultrasound|transvaginal ultrasound
4674544|NCT03401255|corticosteroid|corticosteroid
4674545|NCT03401242|Carbapenemase|carbapenemase
4674546|NCT03401242|Enterobacteriaceae|enterobacteriaceae
4674547|NCT03401242|extended spectrum beta-lactamases|extended spectrum beta-lactamases
4674548|NCT03401242|nursing homes|nursing homes
4674549|NCT03401242|prevalence|prevalence
4674550|NCT03401229|Polyps|polyps
4674551|NCT03401229|Nasal polyps|nasal polyps
4674552|NCT03401229|Nasal polyposis|nasal polyposis
4674553|NCT03401229|Nose diseases|nose diseases
4674554|NCT03401229|Respiratory tract diseases|respiratory tract diseases
4674555|NCT03401229|Otorhinolaryngologic diseases|otorhinolaryngologic diseases
4674556|NCT03401229|Benralizumab|benralizumab
4674557|NCT03401229|Mometasone furoate|mometasone furoate
4674558|NCT03401216|Optical coherence tomography|optical coherence tomography
4674559|NCT03401216|Healing score|healing score
4674560|NCT03401216|Neointimal coverage|neointimal coverage
4674561|NCT03401216|synergy 48|synergy 48
4674562|NCT03401216|long lesion|long lesion
4674563|NCT03401203|ISR|isr
4674564|NCT03401203|ROTA|rota
4674565|NCT03401203|DEB|deb
4674566|NCT03401203|PCI|pci
4674567|NCT03401151|Heart failure|heart failure
4674568|NCT03401151|Skeletal muscle|skeletal muscle
4674569|NCT03401151|Exercise capacity|exercise capacity
4674570|NCT03401151|Lung function|lung function
4674571|NCT03401151|Gene expression|gene expression
4674572|NCT03401138|Peripheral perfusion|peripheral perfusion
4674573|NCT03401138|Blood Volume|blood volume
4674574|NCT03401138|Tissue Prefusion|tissue prefusion
4674575|NCT03401138|Near-infrared spectroscopy|near-infrared spectroscopy
4674576|NCT03401138|Hemodynamic monitoring|hemodynamic monitoring
4674577|NCT03401138|Hemodynamic optimization|hemodynamic optimization
4674578|NCT03401138|Preoperative resuscitation|preoperative resuscitation
4674579|NCT03401125|Sickle cell disease|sickle cell disease
4674580|NCT03401125|Allo-immunization|allo-immunization
4674581|NCT03401099|Radiofrequency ablation|radiofrequency ablation
4674582|NCT03401099|Cavo-tricuspid isthmus|cavo-tricuspid isthmus
4674583|NCT03401099|Pulmonary Vein Isolation|pulmonary vein isolation
4674584|NCT03401099|Cryoballoon ablation|cryoballoon ablation
4674585|NCT03401073|small Fiber Neuropathy|small fiber neuropathy
4674586|NCT03401073|Idiopathic Peripheral Neuropathy|idiopathic peripheral neuropathy
4674587|NCT03401073|IVIg|ivig
4674588|NCT03401073|Gamunex-C|gamunex-c
4674589|NCT03401060|Systemic mastocytosis|systemic mastocytosis
4674590|NCT03401060|Osteoporosis|osteoporosis
4674591|NCT03401060|Bone mineral density (BMD)|bone mineral density (bmd)
4674592|NCT03401060|Denosumab|denosumab
4674593|NCT03401060|RANKL|rankl
4674594|NCT03401047|Polycystic ovary syndrome|polycystic ovary syndrome
4674595|NCT03401021|intention to quit smoking|intention to quit smoking
4674596|NCT03401021|male smoker|male smoker
4674597|NCT03401021|smoking cessation|smoking cessation
4674598|NCT03401021|planning for pregnancy|planning for pregnancy
4674599|NCT03401008|Acromegaly|acromegaly
4674600|NCT03401008|Oral manifestations|oral manifestations
4674601|NCT03400969|Palliative|palliative
4674602|NCT03400969|Moisturisers|moisturisers
4674603|NCT03400969|Dry mouth|dry mouth
4674604|NCT03400969|Xerostomia|xerostomia
4674605|NCT03400956|Uterine fibroids|uterine fibroids
4674606|NCT03400956|Heavy menstrual bleeding|heavy menstrual bleeding
4674607|NCT03400943|Uterine fibroids|uterine fibroids
4674608|NCT03400943|Heavy menstrual bleeding|heavy menstrual bleeding
4674609|NCT03400930|Severe Acute Malnutrition|severe acute malnutrition
4674610|NCT03400865|cabergoline|cabergoline
4674611|NCT03400865|prolactinomas|prolactinomas
4674612|NCT03400865|resistant|resistant
4674613|NCT03400865|hydroxychloroquine|hydroxychloroquine
4674614|NCT03400865|chloroquine|chloroquine
4674615|NCT03400852|Muscular Dystrophy|muscular dystrophy
4674616|NCT03400852|DMD|dmd
4674617|NCT03400852|Duchenne|duchenne
4674618|NCT03400839|Interstitial Lung disease|interstitial lung disease
4674619|NCT03400839|prognosis|prognosis
4674620|NCT03400839|clinical endpoints|clinical endpoints
4674621|NCT03400839|association|association
4674622|NCT03400826|simvastatin|simvastatin
4674623|NCT03400826|fibroids|fibroids
4674624|NCT03400826|medical management|medical management
4674625|NCT03400826|uterine fibroids|uterine fibroids
4674626|NCT03400826|leiomyoma|leiomyoma
4674627|NCT03400813|Eye-Movement Desensitization|eye-movement desensitization
4674628|NCT03400813|Reprocessing|reprocessing
4674629|NCT03400800|Inclisiran sodium|inclisiran sodium
4674630|NCT03400800|ASCVD|ascvd
4674631|NCT03400800|LDL-C|ldl-c
4674632|NCT03400748|Electrosurgery|electrosurgery
4674633|NCT03400748|RF ablation|rf ablation
4674634|NCT03400748|Minimally invasive|minimally invasive
4674635|NCT03400748|Lung cancer|lung cancer
4674636|NCT03400748|Lung metastasis|lung metastasis
4674637|NCT03400748|Lung tumor|lung tumor
4674638|NCT03400748|Primary|primary
4674639|NCT03400748|Metastatic|metastatic
4674640|NCT03400748|Endobronchial ultrasound|endobronchial ultrasound
4674641|NCT03400748|EBUS|ebus
4674642|NCT03400722|Suboptimal ovarian response|suboptimal ovarian response
4674643|NCT03400722|Ovarian Stimulation|ovarian stimulation
4674644|NCT03400722|Infertility, Female|infertility, female
4674645|NCT03400722|In Vitro Fertilisation|in vitro fertilisation
4674646|NCT03400709|Cisplatin|cisplatin
4674647|NCT03400709|Ototoxicity|ototoxicity
4674648|NCT03400709|N-acetylcisteine|n-acetylcisteine
4674649|NCT03400696|nutrition, diet, genetics, physical activity, weight loss|nutrition, diet, genetics, physical activity, weight loss
4674650|NCT03400670|NCPAP|ncpap
4674651|NCT03400670|Respiratory Distress Syndrome|respiratory distress syndrome
4674652|NCT03400644|open-door laminoplasty, laminoplasty, cervical collars|open-door laminoplasty, laminoplasty, cervical collars
4674653|NCT03400631|Cytokine|cytokine
4674654|NCT03400618|Carbohydrates|carbohydrates
4674655|NCT03400618|Diet|diet
4674656|NCT03400618|Diabetes Mellitus, Type 1|diabetes mellitus, type 1
4674657|NCT03400592|gastric adenocarcinoma|gastric adenocarcinoma
4674658|NCT03400592|EGFR|egfr
4674659|NCT03400592|Irinotecan|irinotecan
4674660|NCT03400592|Nimotuzumab|nimotuzumab
4674661|NCT03400592|biomarker|biomarker
4674662|NCT03400579|Emergency Medical Services|emergency medical services
4674663|NCT03400540|verbal instruction, pelvic diaphragm, muscle contraction|verbal instruction, pelvic diaphragm, muscle contraction
4674664|NCT03400514|Artificial intelligence|artificial intelligence
4674665|NCT03400514|concordance|concordance
4674666|NCT03400488|Coronary Artery Disease,|coronary artery disease,
4674667|NCT03400488|Cardiovascular disease (CAD),|cardiovascular disease (cad),
4674668|NCT03400488|5-lipoxygenase activating protein (FLAP) inhibitor,|5-lipoxygenase activating protein (flap) inhibitor,
4674669|NCT03400488|Leukotrienes.|leukotrienes.
4674670|NCT03400475|topical|topical
4674671|NCT03400475|subgingival|subgingival
4674672|NCT03400475|simvastatin|simvastatin
4674673|NCT03400462|Dry needling, occlusal splint, NSAID, nimesulide|dry needling, occlusal splint, nsaid, nimesulide
4674674|NCT03400423|Caffeine|caffeine
4674675|NCT03400423|Caffeine Withdrawal|caffeine withdrawal
4674676|NCT03400423|Acute Aerobic Exercise|acute aerobic exercise
4674677|NCT03400423|Cognition|cognition
4674678|NCT03400423|Working Memory|working memory
4674679|NCT03400410|Contraception|contraception
4674680|NCT03400410|Education|education
4674681|NCT03400410|Male adolescents|male adolescents
4674682|NCT03400410|Emergency Department|emergency department
4674683|NCT03400410|Unintended pregnancy|unintended pregnancy
4674684|NCT03400397|Anxiety|anxiety
4674685|NCT03400397|Child|child
4674686|NCT03400397|Cognitive behaviour therapy|cognitive behaviour therapy
4674687|NCT03400397|CBT|cbt
4674688|NCT03400397|effectiveness|effectiveness
4674689|NCT03400397|treatment|treatment
4674690|NCT03400397|Cool Kids|cool kids
4674691|NCT03400384|Deprescribing|deprescribing
4674692|NCT03400371|JME|jme
4674693|NCT03400371|Epilepsy|epilepsy
4674694|NCT03400371|Juvenile Myoclonic Epilepsy|juvenile myoclonic epilepsy
4674695|NCT03400371|Genomewide Association Study|genomewide association study
4674696|NCT03400371|Genetics|genetics
4674697|NCT03400358|uterocervical angle|uterocervical angle
4674698|NCT03400358|multiparous|multiparous
4674699|NCT03400345|Hand Transplant|hand transplant
4674700|NCT03400345|composite tissue allograft (CTA)|composite tissue allograft (cta)
4674701|NCT03400345|Vascularized Composite Allotransplantation (VCA)|vascularized composite allotransplantation (vca)
4674702|NCT03400345|Amputation|amputation
4674703|NCT03400345|Upper Limb|upper limb
4674704|NCT03400345|Immunosuppression|immunosuppression
4674705|NCT03400319|Thoracic Aortic Aneurysm|thoracic aortic aneurysm
4674706|NCT03400319|Obstructive Sleep Apnea|obstructive sleep apnea
4674707|NCT03400306|Cancer - Ovarian cancer|cancer - ovarian cancer
4674708|NCT03400306|Bioavailability|bioavailability
4674709|NCT03400306|Pharmacokinetics|pharmacokinetics
4674710|NCT03400306|Bioequivalence|bioequivalence
4674711|NCT03400293|Human Immunodeficiency virus|human immunodeficiency virus
4674712|NCT03400293|Health Related Quality of Life|health related quality of life
4674713|NCT03400293|Functional Assessment of HIV Infection|functional assessment of hiv infection
4674714|NCT03400293|Mobile app|mobile app
4674715|NCT03400280|Postoperative pancreatic fistula|postoperative pancreatic fistula
4674716|NCT03400280|Pancreatic resection|pancreatic resection
4674717|NCT03400228|Probiotics|probiotics
4674718|NCT03400228|Chronic kidney disease|chronic kidney disease
4674719|NCT03400228|Cardiovascular risk|cardiovascular risk
4674720|NCT03400176|Ibrutinib|ibrutinib
4674721|NCT03400176|VAY736|vay736
4674722|NCT03400176|Chronic lymphocytic leukemia|chronic lymphocytic leukemia
4674723|NCT03400176|CLL|cll
4674724|NCT03400176|Bruton's Tyrosine Kinase|bruton's tyrosine kinase
4674725|NCT03400176|BTK mutation|btk mutation
4674726|NCT03400163|First Line Therapy|first line therapy
4674727|NCT03400163|NASH|nash
4674728|NCT03400085|mHealth|mhealth
4674729|NCT03400085|living donor kidney transplant|living donor kidney transplant
4674730|NCT03400085|follow-up|follow-up
4674731|NCT03400085|health utilization|health utilization
4674732|NCT03400059|Prophylaxis, Headache, Preventative Treatment|prophylaxis, headache, preventative treatment
4674733|NCT03400033|CKD, EPO, rhEPO, Hemodialysis dependent, Daprodustat|ckd, epo, rhepo, hemodialysis dependent, daprodustat
4674734|NCT03400007|dynamic floor magnetic resonance imaging|dynamic floor magnetic resonance imaging
4674735|NCT03400007|colpocystodefecagraphy|colpocystodefecagraphy
4674736|NCT03400007|prolapse surgery|prolapse surgery
4674737|NCT03399968|shockwave|shockwave
4674738|NCT03399968|ESWT|eswt
4674739|NCT03399929|Rehabilitation|rehabilitation
4674740|NCT03399929|Long term outcome|long term outcome
4674741|NCT03399838|Procedural Sedation and Analgesia|procedural sedation and analgesia
4674742|NCT03399838|Pediatric Emergency Department|pediatric emergency department
4674743|NCT03399838|intranasal|intranasal
4674744|NCT03399838|dexmedetomidine|dexmedetomidine
4674745|NCT03399838|midazolam|midazolam
4674746|NCT03399838|anxiety relief|anxiety relief
4674747|NCT03399786|HoFH|hofh
4674748|NCT03399760|i-PRF (injectable platelet rich fibrin)|i-prf (injectable platelet rich fibrin)
4674749|NCT03399760|alveolar bone height|alveolar bone height
4674750|NCT03399760|canine root resorption|canine root resorption
4674751|NCT03399760|bone density|bone density
4674752|NCT03399760|cone-beam computed tomography|cone-beam computed tomography
4674753|NCT03399734|Perampanel|perampanel
4674754|NCT03399734|Bioequivalence|bioequivalence
4674755|NCT03399734|fine granules|fine granules
4674756|NCT03399734|E2007|e2007
4674757|NCT03399734|Japanese|japanese
4674758|NCT03399708|apremilast|apremilast
4674759|NCT03399708|PDE4 inhibition|pde4 inhibition
4674760|NCT03399708|cardiometabolic|cardiometabolic
4674761|NCT03399708|immune profile|immune profile
4674762|NCT03399695|preoxygenation|preoxygenation
4674763|NCT03399695|high flow oxygen|high flow oxygen
4674764|NCT03399682|cystography|cystography
4674765|NCT03399682|pediatry|pediatry
4674766|NCT03399682|urinary infection|urinary infection
4674767|NCT03399630|Osteo Arthritis Knee|osteo arthritis knee
4674768|NCT03399630|Autologous Adipose Tissue|autologous adipose tissue
4674769|NCT03399604|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
4674770|NCT03399604|Idiopathic Pulmonary Arterial Hypertension|idiopathic pulmonary arterial hypertension
4674771|NCT03399604|Heritable Pulmonary Arterial Hypertension|heritable pulmonary arterial hypertension
4674772|NCT03399604|Drug Induced Pulmonary Arterial Hypertension|drug induced pulmonary arterial hypertension
4674773|NCT03399604|Toxin Induced Pulmonary Arterial Hypertension|toxin induced pulmonary arterial hypertension
4674774|NCT03399604|Connective tissue disease|connective tissue disease
4674775|NCT03399591|Gait Disorders|gait disorders
4674776|NCT03399591|Spatio-temporal parameters of walking|spatio-temporal parameters of walking
4674777|NCT03399591|Alzheimer's disease|alzheimer's disease
4674778|NCT03399591|Lewy body disease|lewy body disease
4674779|NCT03399552|Stereotactic Body Radiation Therapy|stereotactic body radiation therapy
4674780|NCT03399552|Avelumab Immunotherapy|avelumab immunotherapy
4674781|NCT03399552|17-358|17-358
4674782|NCT03399513|Ibrutinib|ibrutinib
4674783|NCT03399500|Case Management|case management
4674784|NCT03399500|Homelessness|homelessness
4674785|NCT03399500|Smartphone|smartphone
4674786|NCT03399500|Health Related Quality of Life|health related quality of life
4674787|NCT03399500|Mental Health|mental health
4674788|NCT03399500|Substance Use Disorders|substance use disorders
4674789|NCT03399487|NSCLC|nsclc
4674790|NCT03399487|ROS1 rearrangement|ros1 rearrangement
4674791|NCT03399487|Ceritinib|ceritinib
4674792|NCT03399487|LDK378|ldk378
4674793|NCT03399474|Regional Anesthesia, Dexmedetomidine and lidocaine|regional anesthesia, dexmedetomidine and lidocaine
4674794|NCT03399461|United States|united states
4674795|NCT03399461|United Kingdom|united kingdom
4674796|NCT03399461|Wiskott-Aldrich Syndrome|wiskott-aldrich syndrome
4674797|NCT03399461|Caregiver|caregiver
4674798|NCT03399461|Interview|interview
4674799|NCT03399461|immune deficiency|immune deficiency
4674800|NCT03399461|France|france
4674801|NCT03399435|Regional anesthesia|regional anesthesia
4674802|NCT03399435|Brachial plexus blockade|brachial plexus blockade
4674803|NCT03399435|Sensory and motor function testing|sensory and motor function testing
4674804|NCT03399422|i-PRF (injectable platelet rich fibrin)|i-prf (injectable platelet rich fibrin)
4674805|NCT03399422|canine retraction|canine retraction
4674806|NCT03399422|pain and discomfort|pain and discomfort
4674807|NCT03399383|Adrenal Insufficiency|adrenal insufficiency
4674808|NCT03399383|Adrenal crisis|adrenal crisis
4674809|NCT03399383|Adherence|adherence
4674810|NCT03399383|Standardized patient education|standardized patient education
4674811|NCT03399370|Inclisiran sodium|inclisiran sodium
4674812|NCT03399370|ASCVD|ascvd
4674813|NCT03399370|LDL-C|ldl-c
4674814|NCT03399331|honey, olive oil, oral mucositis, pain|honey, olive oil, oral mucositis, pain
4674815|NCT03399318|HRP2|hrp2
4674816|NCT03399292|Lipid based eye drops|lipid based eye drops
4674817|NCT03399292|Tearfilm lipid layer thickness|tearfilm lipid layer thickness
4674818|NCT03399279|nanohydroxyapatite|nanohydroxyapatite
4674819|NCT03399279|Perforated membrane|perforated membrane
4674820|NCT03399279|occlusive membrane|occlusive membrane
4674821|NCT03399279|Aggressive periodontitis|aggressive periodontitis
4674822|NCT03399266|Induction of labor|induction of labor
4674823|NCT03399266|Previous cesarean delivery|previous cesarean delivery
4674824|NCT03399266|Trial of labor after cesarean|trial of labor after cesarean
4674825|NCT03399266|Prelabor rupture of membranes|prelabor rupture of membranes
4674826|NCT03399266|balloon induction|balloon induction
4674827|NCT03399253|Distal Gastric Cancer, Gastrectomy, Metastasectomy|distal gastric cancer, gastrectomy, metastasectomy
4674828|NCT03399227|Bone microarchitecture|bone microarchitecture
4674829|NCT03399188|Inflammatory Bowel Diseases, Fecal microbiota transplantation, microbiome|inflammatory bowel diseases, fecal microbiota transplantation, microbiome
4674830|NCT03399175|Vogt-Koyanagi-Harada disease|vogt-koyanagi-harada disease
4674831|NCT03399175|Immunosuppressive therapy|immunosuppressive therapy
4674832|NCT03399175|Indocyanine green angiography|indocyanine green angiography
4674833|NCT03399175|Enhanced depth imaging optical coherence tomography|enhanced depth imaging optical coherence tomography
4674834|NCT03399175|Electroretinogram|electroretinogram
4674835|NCT03399149|Respiratory Insufficiency|respiratory insufficiency
4674836|NCT03399149|Hematologic Malignancy|hematologic malignancy
4674837|NCT03399149|Intensive Care Unit|intensive care unit
4674838|NCT03399136|Exercise training|exercise training
4674839|NCT03399136|Intervention|intervention
4674840|NCT03399136|Aerobic capacity|aerobic capacity
4674841|NCT03399123|Laparoscopic hepatectomy|laparoscopic hepatectomy
4674842|NCT03399123|Low tidal volume|low tidal volume
4674843|NCT03399123|Blood loss|blood loss
4675212|NCT03396731|Leg Wound|leg wound
4674844|NCT03399110|Gastric cancer,Adjuvant chemtherapy|gastric cancer,adjuvant chemtherapy
4674845|NCT03399097|Obesity|obesity
4674846|NCT03399084|Ferric carboxymaltose|ferric carboxymaltose
4674847|NCT03399084|Anemia|anemia
4674848|NCT03399071|Gastric cancer|gastric cancer
4674849|NCT03399071|Oesophageal cancer|oesophageal cancer
4674850|NCT03399071|Gastro-oesophageal cancer|gastro-oesophageal cancer
4674851|NCT03399071|Perioperative|perioperative
4674852|NCT03399071|Immunotherapy|immunotherapy
4674853|NCT03399071|Anti PDL1|anti pdl1
4674854|NCT03399071|Avelumab|avelumab
4674855|NCT03399071|FLOT|flot
4674856|NCT03399032|caspofungin|caspofungin
4674857|NCT03399032|pharmacokinetics|pharmacokinetics
4674858|NCT03399019|Bispectral index monitor|bispectral index monitor
4674859|NCT03398980|Childhood and Adolescent|childhood and adolescent
4674860|NCT03398980|Survivors|survivors
4674861|NCT03398980|Radiotherapy|radiotherapy
4674862|NCT03398980|Late Sequelae|late sequelae
4674863|NCT03398941|Pancreatic fistula|pancreatic fistula
4674864|NCT03398915|robotic|robotic
4674865|NCT03398915|robot-guided|robot-guided
4674866|NCT03398915|navigated|navigated
4674867|NCT03398915|computer-assisted|computer-assisted
4674868|NCT03398915|pedicle screw|pedicle screw
4674869|NCT03398915|instrumentation|instrumentation
4674870|NCT03398915|thoracolumbar|thoracolumbar
4674871|NCT03398902|sleep|sleep
4674872|NCT03398902|sleep extension|sleep extension
4674873|NCT03398902|sleep patterns|sleep patterns
4674874|NCT03398902|type 2 diabetes|type 2 diabetes
4674875|NCT03398902|glucose regulation|glucose regulation
4674876|NCT03398902|behavioral intervention|behavioral intervention
4674877|NCT03398902|adults|adults
4674878|NCT03398889|intestinal microbiome|intestinal microbiome
4674879|NCT03398889|atherosclerosis|atherosclerosis
4674880|NCT03398889|nutrients|nutrients
4674881|NCT03398889|renal function|renal function
4674882|NCT03398850|spontaneous coronary artery dissection|spontaneous coronary artery dissection
4674883|NCT03398850|acute coronary syndrome|acute coronary syndrome
4674884|NCT03398850|coronary angiography|coronary angiography
4674885|NCT03398850|coronary tomography|coronary tomography
4674886|NCT03398837|Scleroderma|scleroderma
4674887|NCT03398837|cannabinoid receptor type 2 agonist|cannabinoid receptor type 2 agonist
4674888|NCT03398837|anabasum|anabasum
4674889|NCT03398837|JBT-101|jbt-101
4674890|NCT03398837|lenabasum|lenabasum
4674891|NCT03398824|Fanconi Anemia|fanconi anemia
4674892|NCT03398824|Metformin|metformin
4674893|NCT03398798|archwire dimension|archwire dimension
4674894|NCT03398798|ligation method|ligation method
4674895|NCT03398798|bracket type|bracket type
4674896|NCT03398785|Primary Aldosteronism|primary aldosteronism
4674897|NCT03398785|Hypertension|hypertension
4674898|NCT03398785|Ablation|ablation
4674899|NCT03398785|Adrenal Gland|adrenal gland
4674900|NCT03398759|Butorphanol|butorphanol
4674901|NCT03398759|Functional endoscopic sinus surgery|functional endoscopic sinus surgery
4674902|NCT03398759|Emergence agitation|emergence agitation
4674903|NCT03398746|soft tissue infection|soft tissue infection
4674904|NCT03398746|MRSA|mrsa
4674905|NCT03398733|Obstructive Sleep Apnea|obstructive sleep apnea
4674906|NCT03398733|heart valve replacement|heart valve replacement
4674907|NCT03398733|CPAP treatment|cpap treatment
4674908|NCT03398707|PICs|pics
4674909|NCT03398707|diagnosis|diagnosis
4674910|NCT03398707|prevention|prevention
4674911|NCT03398707|outcome|outcome
4674912|NCT03398681|Heart failure|heart failure
4674913|NCT03398681|Iron deficiency|iron deficiency
4674914|NCT03398681|Cardiac magnetic resonance|cardiac magnetic resonance
4674915|NCT03398681|Ferric carboxymaltose|ferric carboxymaltose
4674916|NCT03398681|Myocardial iron|myocardial iron
4674917|NCT03398655|Recurrent Ovarian cancer|recurrent ovarian cancer
4674918|NCT03398655|Platinum resistant ovarian cancer|platinum resistant ovarian cancer
4674919|NCT03398655|Ovarian cancer|ovarian cancer
4674920|NCT03398655|Ovarian carcinoma|ovarian carcinoma
4674921|NCT03398655|Epithelial ovarian cancer|epithelial ovarian cancer
4674922|NCT03398655|paclitaxel|paclitaxel
4674923|NCT03398642|Occupational therapy|occupational therapy
4674924|NCT03398642|Health promotion|health promotion
4674925|NCT03398642|Life Style|life style
4674926|NCT03398642|Quality of life|quality of life
4674927|NCT03398642|Aging|aging
4674928|NCT03398642|Aged|aged
4674929|NCT03398642|Community participation|community participation
4674930|NCT03398616|Retinal Bloodflow Pressure|retinal bloodflow pressure
4674931|NCT03398603|"AMH measurement ElecSys"|"amh measurement elecsys"
4674932|NCT03398590|Type 2 Diabetes|type 2 diabetes
4674933|NCT03398590|Obesity|obesity
4674934|NCT03398577|Coronary disease|coronary disease
4674935|NCT03398577|diabetes|diabetes
4674936|NCT03398577|SGLT2I|sglt2i
4674937|NCT03398577|Inflammation Mediators|inflammation mediators
4674938|NCT03398564|Erecror Spinae Plan Block|erecror spinae plan block
4674939|NCT03398564|postoperative pain|postoperative pain
4674940|NCT03398564|Laparoscopic cholecystectomy|laparoscopic cholecystectomy
4674941|NCT03398551|pregnancy|pregnancy
4674942|NCT03398551|machine learning|machine learning
4674943|NCT03398551|fetal Doppler echocardiography|fetal doppler echocardiography
4674944|NCT03398538|DFU|dfu
4674945|NCT03398538|Ulcer|ulcer
4674946|NCT03398525|central venous catheter|central venous catheter
4674947|NCT03398525|intensive care|intensive care
4674948|NCT03398525|music therapy|music therapy
4674949|NCT03398499|pain|pain
4674950|NCT03398499|orthognathic surgery|orthognathic surgery
4674951|NCT03398499|temporomandibular disorders (TMD)|temporomandibular disorders (tmd)
4674952|NCT03398499|Electromagnetic Therapy|electromagnetic therapy
4674953|NCT03398499|Light therapy|light therapy
4674954|NCT03398486|Kinesiotaping, Manual therapy|kinesiotaping, manual therapy
4674955|NCT03398486|Physiotherapy|physiotherapy
4674956|NCT03398473|Epoetin Hospira|epoetin hospira
4674957|NCT03398473|Pharmacokinetics|pharmacokinetics
4674958|NCT03398434|MAA868|maa868
4674959|NCT03398434|apixaban|apixaban
4674960|NCT03398434|atrial fibrillation|atrial fibrillation
4674961|NCT03398434|anticoagulant|anticoagulant
4674962|NCT03398434|Factor XI|factor xi
4674963|NCT03398434|D-dimer|d-dimer
4674964|NCT03398434|systemic thromboembolic events|systemic thromboembolic events
4674965|NCT03398421|Nemiralisib|nemiralisib
4674966|NCT03398421|Pharmacokinetics|pharmacokinetics
4674967|NCT03398421|Itraconazole|itraconazole
4674968|NCT03398421|Drug-drug Interaction|drug-drug interaction
4674969|NCT03398421|Cross-over|cross-over
4674970|NCT03398382|Magnesium citrate|magnesium citrate
4675213|NCT03396718|Head and neck cancer|head and neck cancer
4674971|NCT03398382|Trismus after surgical removal of the lower third molars|trismus after surgical removal of the lower third molars
4674972|NCT03398382|Local anesthesia|local anesthesia
4674973|NCT03398382|Analgesia after surgical removal of the lower third molars|analgesia after surgical removal of the lower third molars
4674974|NCT03398382|Swelling after surgical removal of the lower third molars|swelling after surgical removal of the lower third molars
4674975|NCT03398382|Surgical removal of the lower third molars|surgical removal of the lower third molars
4674976|NCT03398382|Oral surgical procedures|oral surgical procedures
4674977|NCT03398382|Placebo effect|placebo effect
4674978|NCT03398356|prediabetes|prediabetes
4674979|NCT03398356|impaired fasting glucose|impaired fasting glucose
4674980|NCT03398356|impaired glucose tolerance|impaired glucose tolerance
4674981|NCT03398356|metformin|metformin
4674982|NCT03398356|nitric oxide|nitric oxide
4674983|NCT03398317|SDF|sdf
4674984|NCT03398317|DFI|dfi
4674985|NCT03398317|sperm selection|sperm selection
4674986|NCT03398317|PICSI|picsi
4674987|NCT03398317|MACS|macs
4674988|NCT03398239|respiratory failure, hypercapnia, BPAP, AVAPS|respiratory failure, hypercapnia, bpap, avaps
4674989|NCT03398174|Rural individuals|rural individuals
4674990|NCT03398174|Patient Education|patient education
4674991|NCT03398174|Exercise|exercise
4674992|NCT03398161|Mycosis Fungoides|mycosis fungoides
4674993|NCT03398161|MF|mf
4674994|NCT03398161|Malignant neoplasms stated as primary lymphoid haematopoietic|malignant neoplasms stated as primary lymphoid haematopoietic
4674995|NCT03398161|Radiation therapy|radiation therapy
4674996|NCT03398161|XRT|xrt
4674997|NCT03398161|Questionnaire|questionnaire
4674998|NCT03398161|Survey|survey
4674999|NCT03398161|Photographs|photographs
4675000|NCT03398161|Microbiome Analysis|microbiome analysis
4675001|NCT03398148|ABBV-066|abbv-066
4675002|NCT03398148|BI 655066|bi 655066
4675003|NCT03398135|ABBV-066|abbv-066
4675004|NCT03398135|BI 655066|bi 655066
4675005|NCT03398122|Apatinib|apatinib
4675006|NCT03398122|advanced hepatocellular carcinoma|advanced hepatocellular carcinoma
4675007|NCT03398070|Functional Neurological Disorder|functional neurological disorder
4675008|NCT03398070|Functional Movement Disorder|functional movement disorder
4675009|NCT03398070|Psychogenic Nonepileptic Seizures|psychogenic nonepileptic seizures
4675010|NCT03398070|Functional Limb Weakness|functional limb weakness
4675011|NCT03398057|Breast cancer screening; health education; breast self-examination; clinical breast examination; mammography.|breast cancer screening; health education; breast self-examination; clinical breast examination; mammography.
4675012|NCT03398018|dry eye|dry eye
4675013|NCT03398018|corticotropin|corticotropin
4675014|NCT03398005|Omega-3 Fatty acids|omega-3 fatty acids
4675015|NCT03398005|Triglycerides|triglycerides
4675016|NCT03397979|atopic dermatitis|atopic dermatitis
4675017|NCT03397979|bathing|bathing
4675018|NCT03397979|baths|baths
4675019|NCT03397966|obesity|obesity
4675020|NCT03397966|Cardiovascular Physiological Phenomena|cardiovascular physiological phenomena
4675021|NCT03397966|metabolism|metabolism
4675022|NCT03397966|Energy Metabolism|energy metabolism
4675023|NCT03397953|Anaplastic Large Cell Lymphoma|anaplastic large cell lymphoma
4675024|NCT03397953|Childhood|childhood
4675025|NCT03397953|Adolescent|adolescent
4675026|NCT03397953|Recurrent|recurrent
4675027|NCT03397953|Treatment|treatment
4675028|NCT03397927|ballet shoe|ballet shoe
4675029|NCT03397927|orthosis|orthosis
4675030|NCT03397927|pain|pain
4675031|NCT03397901|chronic radiation proctitis|chronic radiation proctitis
4675032|NCT03397901|rectal bleeding|rectal bleeding
4675033|NCT03397901|transverse colostomy|transverse colostomy
4675034|NCT03397901|refractory|refractory
4675035|NCT03397901|moderate to severe anemia|moderate to severe anemia
4675036|NCT03397849|Primary prevention|primary prevention
4675037|NCT03397849|Lifestyle intervention|lifestyle intervention
4675038|NCT03397849|Digital health|digital health
4675039|NCT03397849|Cardiovascular disease prevention|cardiovascular disease prevention
4675040|NCT03397836|Older adults|older adults
4675041|NCT03397836|Optimal aging|optimal aging
4675042|NCT03397836|Primary health care|primary health care
4675043|NCT03397836|Randomized control trial|randomized control trial
4675044|NCT03397836|Integrated care|integrated care
4675045|NCT03397836|Health care volunteers|health care volunteers
4675046|NCT03397836|interdisciplinary health care teams|interdisciplinary health care teams
4675047|NCT03397836|Implementation|implementation
4675048|NCT03397836|Health services research|health services research
4675049|NCT03397836|Patient centered care|patient centered care
4675050|NCT03397810|cardiac amyloidosis|cardiac amyloidosis
4675051|NCT03397810|radiotherapy|radiotherapy
4675052|NCT03397797|muscle relaxant|muscle relaxant
4675053|NCT03397784|Tidal volume challenge|tidal volume challenge
4675054|NCT03397784|Fluid responsiveness|fluid responsiveness
4675055|NCT03397784|Preload responsiveness|preload responsiveness
4675056|NCT03397784|Functional hemodynamic monitoring|functional hemodynamic monitoring
4675057|NCT03397784|Cardiac surgery|cardiac surgery
4675058|NCT03397784|inferior vena cava variation|inferior vena cava variation
4675059|NCT03397771|urinary incontinence, SSRI|urinary incontinence, ssri
4675060|NCT03397745|bispectral index|bispectral index
4675061|NCT03397745|lateral decubitus position|lateral decubitus position
4675062|NCT03397745|one lung ventilation|one lung ventilation
4675063|NCT03397732|Matrix metalloproteinase|matrix metalloproteinase
4675064|NCT03397732|Tissue inhibitor of matrix metalloproteinase|tissue inhibitor of matrix metalloproteinase
4675065|NCT03397732|Vascular surgery|vascular surgery
4675066|NCT03397732|Aorta stent implantation|aorta stent implantation
4675067|NCT03397732|Aorto-bifemoral bypass surgery|aorto-bifemoral bypass surgery
4675068|NCT03397719|Autism Spectrum Disorder|autism spectrum disorder
4675069|NCT03397719|Early Intervention|early intervention
4675070|NCT03397719|Parent-Mediated Intervention|parent-mediated intervention
4675071|NCT03397706|EBV+ post-transplant lymphoproliferative malignancy|ebv+ post-transplant lymphoproliferative malignancy
4675072|NCT03397706|EBV-associated lymphoproliferative disorders associated with acquired immunodeficiency including HIV-positive|ebv-associated lymphoproliferative disorders associated with acquired immunodeficiency including hiv-positive
4675073|NCT03397706|Relapsed, refractory, EBV+ lymphoid malignancy|relapsed, refractory, ebv+ lymphoid malignancy
4675074|NCT03397693|PCOS|pcos
4675075|NCT03397693|Unexplained infertiltiy|unexplained infertiltiy
4675076|NCT03397693|3D Power Doppler|3d power doppler
4675077|NCT03397693|Endometrial thickness|endometrial thickness
4675078|NCT03397693|Subendometrial blood perfusion|subendometrial blood perfusion
4675079|NCT03397680|Helicobacter Pylori infection|helicobacter pylori infection
4675080|NCT03397680|Non-ulcer Dyspepsia|non-ulcer dyspepsia
4675081|NCT03397680|Rabeprazole-Levofloxacin|rabeprazole-levofloxacin
4675082|NCT03397602|atrial fibrillation|atrial fibrillation
4675083|NCT03397602|exercise|exercise
4675084|NCT03397576|Prisoner|prisoner
4675085|NCT03397563|Continuous Positive Airway Pressure|continuous positive airway pressure
4675214|NCT03396718|Oropharyngeal cancer|oropharyngeal cancer
4675086|NCT03397563|Sleep Apnea, Obstructive|sleep apnea, obstructive
4675087|NCT03397563|Polysomnography|polysomnography
4675088|NCT03397550|taste threshold|taste threshold
4675089|NCT03397550|salt restriction|salt restriction
4675090|NCT03397537|Breast Neoplasms Endocrine-responsive Neoadjuvant Duration Letrozole|breast neoplasms endocrine-responsive neoadjuvant duration letrozole
4675091|NCT03397498|computerized cognitive training|computerized cognitive training
4675092|NCT03397472|Insomnia|insomnia
4675093|NCT03397472|Treatment|treatment
4675094|NCT03397472|magnetic field modulation|magnetic field modulation
4675095|NCT03397459|cervicobrachial neuralgia|cervicobrachial neuralgia
4675096|NCT03397459|sagittal balance|sagittal balance
4675097|NCT03397459|lordosis|lordosis
4675098|NCT03397446|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate
4675099|NCT03397446|Lisdexamfetamine|lisdexamfetamine
4675100|NCT03397446|Vyvanse|vyvanse
4675101|NCT03397446|Eating Disorders|eating disorders
4675102|NCT03397446|Mental Disorders|mental disorders
4675103|NCT03397446|Central Nervous System Stimulants|central nervous system stimulants
4675104|NCT03397446|Dextroamphetamine|dextroamphetamine
4675105|NCT03397446|LDX|ldx
4675106|NCT03397446|Binge Eating|binge eating
4675107|NCT03397446|Purging|purging
4675108|NCT03397446|Bulimia Nervosa|bulimia nervosa
4675109|NCT03397433|Antibiotic Stewardship|antibiotic stewardship
4675110|NCT03397433|Information Technology|information technology
4675111|NCT03397433|Healthcare Outcomes|healthcare outcomes
4675112|NCT03397433|Antibiotic Resistance|antibiotic resistance
4675113|NCT03397433|Bacterial Infection|bacterial infection
4675114|NCT03397394|PARP inhibitor|parp inhibitor
4675115|NCT03397394|PARPi|parpi
4675116|NCT03397394|HRD|hrd
4675117|NCT03397394|ATLAS|atlas
4675118|NCT03397394|homologous recombination|homologous recombination
4675119|NCT03397394|DNA repair|dna repair
4675120|NCT03397394|LOH|loh
4675121|NCT03397394|DNA defect|dna defect
4675122|NCT03397394|DNA anomaly|dna anomaly
4675123|NCT03397394|Rucaparib|rucaparib
4675124|NCT03397394|MIBC|mibc
4675125|NCT03397355|Pulmonary Nodule; Lung Cancer; Biopsy; Biomarker.|pulmonary nodule; lung cancer; biopsy; biomarker.
4675126|NCT03397329|Healthy Volunteers|healthy volunteers
4675127|NCT03397316|immediate implant|immediate implant
4675128|NCT03397316|upper esthetic zone|upper esthetic zone
4675129|NCT03397316|marginal bone loss|marginal bone loss
4675130|NCT03397290|Chest X-ray|chest x-ray
4675131|NCT03397290|Ultrasound|ultrasound
4675132|NCT03397277|IPV|ipv
4675133|NCT03397238|myeloid cell|myeloid cell
4675134|NCT03397238|reprogramming|reprogramming
4675135|NCT03397238|monocyte|monocyte
4675136|NCT03397238|tumor-associated macrophage|tumor-associated macrophage
4675137|NCT03397212|NADA|nada
4675138|NCT03397173|Azacitidine|azacitidine
4675139|NCT03397173|Ascorbic Acid|ascorbic acid
4675140|NCT03397160|Prostate cancer|prostate cancer
4675141|NCT03397160|Transformative Impact Award|transformative impact award
4675142|NCT03397160|Early stage|early stage
4675143|NCT03397160|Active surveillance|active surveillance
4675144|NCT03397160|Decision aid|decision aid
4675145|NCT03397160|Coaching session|coaching session
4675146|NCT03397160|Personalized|personalized
4675147|NCT03397160|University of California, San Francisco (UCSF)|university of california, san francisco (ucsf)
4675148|NCT03397160|Validation|validation
4675149|NCT03397121|HeFH|hefh
4675150|NCT03397121|LDL-C|ldl-c
4675151|NCT03397121|Inclisiran|inclisiran
4675152|NCT03397108|Inflammatory Bowel Disease|inflammatory bowel disease
4675153|NCT03397108|Crohn disease|crohn disease
4675154|NCT03397108|Colitis|colitis
4675155|NCT03397108|TNF|tnf
4675156|NCT03397108|Breast milk|breast milk
4675157|NCT03397108|monoclonal antibody|monoclonal antibody
4675158|NCT03397095|stem cells, ischemic heart disease.|stem cells, ischemic heart disease.
4675159|NCT03397082|Endouterine manual aspiration|endouterine manual aspiration
4675160|NCT03397082|Paracervical blockade|paracervical blockade
4675161|NCT03397082|Lidocaine gel|lidocaine gel
4675162|NCT03397069|peribubar block - midazolam|peribubar block - midazolam
4675163|NCT03397056|Patient willingness|patient willingness
4675164|NCT03397056|Participation|participation
4675165|NCT03397030|Prostate Cancer|prostate cancer
4675166|NCT03397030|Biomarkers|biomarkers
4675167|NCT03397030|Exercise|exercise
4675168|NCT03397004|Hereditary hemorrhagic telangiectasia|hereditary hemorrhagic telangiectasia
4675169|NCT03397004|HHT|hht
4675170|NCT03397004|Doxycycline|doxycycline
4675171|NCT03396991|Analgesia technique|analgesia technique
4675172|NCT03396991|Pain control|pain control
4675173|NCT03396939|Stroke|stroke
4675174|NCT03396939|Rehabilitation|rehabilitation
4675175|NCT03396939|Task oriented training|task oriented training
4675176|NCT03396939|Motor recovery|motor recovery
4675177|NCT03396939|Hand function|hand function
4675178|NCT03396939|Arm function|arm function
4675179|NCT03396913|Intense Pulsed Light|intense pulsed light
4675180|NCT03396913|Meibomian Gland Dysfunction|meibomian gland dysfunction
4675181|NCT03396913|Dry Eye Disease|dry eye disease
4675182|NCT03396887|Alcohol Use Disorder|alcohol use disorder
4675183|NCT03396887|Smartphone Application|smartphone application
4675184|NCT03396861|macular edema|macular edema
4675185|NCT03396861|pseudophakia|pseudophakia
4675186|NCT03396861|pseudophakic macular edema|pseudophakic macular edema
4675187|NCT03396861|retinal swelling|retinal swelling
4675188|NCT03396861|aflibercept|aflibercept
4675189|NCT03396861|anti-vascular endothelial growth factor|anti-vascular endothelial growth factor
4675190|NCT03396861|subconjunctival injection|subconjunctival injection
4675191|NCT03396848|Rehabilitation|rehabilitation
4675192|NCT03396848|Online Clinic|online clinic
4675193|NCT03396822|multiple sclerosis|multiple sclerosis
4675194|NCT03396822|7T MRI|7t mri
4675195|NCT03396822|Meningeal inflammation|meningeal inflammation
4675196|NCT03396809|punctal plugs|punctal plugs
4675197|NCT03396809|dry eye|dry eye
4675198|NCT03396809|ocular surface disease index|ocular surface disease index
4675199|NCT03396796|Vagus nerve|vagus nerve
4675200|NCT03396796|Delayed gastric emptying|delayed gastric emptying
4675201|NCT03396796|Cirrhosis|cirrhosis
4675202|NCT03396796|Hypertension|hypertension
4675203|NCT03396796|laparoscopy|laparoscopy
4675204|NCT03396770|Urinary biomarkers|urinary biomarkers
4675205|NCT03396770|Intensive Care Unit|intensive care unit
4675206|NCT03396757|Acute Kidney Injury|acute kidney injury
4675207|NCT03396757|Critical Care|critical care
4675208|NCT03396757|Renal Replacement Therapy|renal replacement therapy
4675209|NCT03396731|VLU|vlu
4675210|NCT03396731|Venous Leg Ulcer|venous leg ulcer
4675211|NCT03396731|Leg Ulcer|leg ulcer
4675215|NCT03396718|postoperative|postoperative
4675216|NCT03396718|radiotherapy|radiotherapy
4675217|NCT03396718|radiochemotherapy|radiochemotherapy
4675218|NCT03396718|de-intensification|de-intensification
4675219|NCT03396718|HPV|hpv
4675220|NCT03396679|Psoriatic arthritis|psoriatic arthritis
4675221|NCT03396679|remission|remission
4675222|NCT03396679|ultrasound|ultrasound
4675223|NCT03396653|weight loss|weight loss
4675224|NCT03396653|weight maintenance|weight maintenance
4675225|NCT03396653|weight control|weight control
4675226|NCT03396653|peer support|peer support
4675227|NCT03396653|patient-provided care|patient-provided care
4675228|NCT03396640|anteromedial|anteromedial
4675229|NCT03396627|eyelid|eyelid
4675230|NCT03396627|Muller|muller
4675231|NCT03396588|Opiate use during pregnancy|opiate use during pregnancy
4675232|NCT03396588|Clonidine|clonidine
4675233|NCT03396588|Morphine|morphine
4675234|NCT03396588|Prenatal opiate|prenatal opiate
4675235|NCT03396588|Neonatal Abstinence Syndrome|neonatal abstinence syndrome
4675236|NCT03396588|Infant, Newborn, Diseases|infant, newborn, diseases
4675237|NCT03396588|Substance-Related Disorders|substance-related disorders
4675238|NCT03396588|Chemically-Induced Disorders|chemically-induced disorders
4675239|NCT03396588|Opiate Alkaloids|opiate alkaloids
4675240|NCT03396588|Mental Disorders|mental disorders
4675241|NCT03396588|Narcotics|narcotics
4675242|NCT03396588|Central Nervous System Depressants|central nervous system depressants
4675243|NCT03396588|Physiological Effects of Drugs|physiological effects of drugs
4675244|NCT03396588|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists
4675245|NCT03396588|Adrenergic alpha-Agonists|adrenergic alpha-agonists
4675246|NCT03396588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
4675247|NCT03396588|Antihypertensive Agents|antihypertensive agents
4675248|NCT03396588|Analgesics|analgesics
4675249|NCT03396588|Peripheral Nervous System Agents|peripheral nervous system agents
4675250|NCT03396588|Sympatholytics|sympatholytics
4675251|NCT03396588|Autonomic Agents|autonomic agents
4675252|NCT03396588|Neurotransmitter Agents|neurotransmitter agents
4675253|NCT03396575|Total tumor mRNA-pulsed autologous Dendritic Cells (DCs) (TTRNA-DCs)|total tumor mrna-pulsed autologous dendritic cells (dcs) (ttrna-dcs)
4675254|NCT03396575|Tumor-specific ex vivo expanded autologous lymphocyte transfer (TTRNA-xALT)|tumor-specific ex vivo expanded autologous lymphocyte transfer (ttrna-xalt)
4675255|NCT03396575|Autologous G-CSF mobilized HSCs|autologous g-csf mobilized hscs
4675256|NCT03396575|Temozolomide (TMZ)|temozolomide (tmz)
4675257|NCT03396575|Cyclophosphamide (CTX)|cyclophosphamide (ctx)
4675258|NCT03396575|Fludarabine (Flu)|fludarabine (flu)
4675259|NCT03396575|Granulocyte Colony Stimulating Factor (G-CSF)|granulocyte colony stimulating factor (g-csf)
4675260|NCT03396575|Granulocyte Macrophage Colony Stimulating Factor (GM-CSF)|granulocyte macrophage colony stimulating factor (gm-csf)
4675261|NCT03396575|Tetanus Toxoid|tetanus toxoid
4675262|NCT03396575|Mesna|mesna
4675263|NCT03396562|body composition|body composition
4675264|NCT03396562|klinefelter syndrome|klinefelter syndrome
4675265|NCT03396562|XXY|xxy
4675266|NCT03396562|Trisomy X|trisomy x
4675267|NCT03396562|XXX|xxx
4675268|NCT03396562|XYY|xyy
4675269|NCT03396562|XXYY|xxyy
4675270|NCT03396562|XXXY|xxxy
4675271|NCT03396562|XXXXY|xxxxy
4675272|NCT03396562|sex chromosome variation|sex chromosome variation
4675273|NCT03396562|sex chromosome aneuploidy|sex chromosome aneuploidy
4675274|NCT03396562|sex chromosome trisomy|sex chromosome trisomy
4675275|NCT03396562|testosterone|testosterone
4675276|NCT03396562|XYYY|xyyy
4675277|NCT03396562|XXXX|xxxx
4675278|NCT03396562|XXXXX|xxxxx
4675279|NCT03396562|XXXYY|xxxyy
4675280|NCT03396562|XXYYY|xxyyy
4675281|NCT03396562|XYYYY|xyyyy
4675282|NCT03396562|developmental delay|developmental delay
4675283|NCT03396562|speech development|speech development
4675284|NCT03396549|tDCS|tdcs
4675285|NCT03396549|food craving|food craving
4675286|NCT03396549|tDCS sham procedure|tdcs sham procedure
4675287|NCT03396549|montage|montage
4675288|NCT03396549|food intake|food intake
4675289|NCT03396536|implant|implant
4675290|NCT03396536|oral hygiene|oral hygiene
4675291|NCT03396536|discomfort|discomfort
4675292|NCT03396523|Losartan|losartan
4675293|NCT03396523|Fear extinction|fear extinction
4675294|NCT03396510|Cancer Care|cancer care
4675295|NCT03396484|TrialNet|trialnet
4675296|NCT03396458|Hepatitis B|hepatitis b
4675297|NCT03396458|Disease prevalence|disease prevalence
4675298|NCT03396458|Screening|screening
4675299|NCT03396458|Migrant|migrant
4675300|NCT03396458|Turkish|turkish
4675301|NCT03396458|Belgium|belgium
4675302|NCT03396432|laryngoscope|laryngoscope
4675303|NCT03396432|intubation|intubation
4675304|NCT03396432|first attempt success|first attempt success
4675305|NCT03396432|oxygen saturation|oxygen saturation
4675306|NCT03396432|airway management|airway management
4675307|NCT03396432|Videolaryngoscopy|videolaryngoscopy
4675308|NCT03396432|Direct laryngoscopy|direct laryngoscopy
4675309|NCT03396406|trigeminal neuralgia, radiofrequency|trigeminal neuralgia, radiofrequency
4675310|NCT03396393|Dihydroartemisinin;Systemic Lupus Erythematosus|dihydroartemisinin;systemic lupus erythematosus
4675311|NCT03396367|Relationships|relationships
4675312|NCT03396367|YMSM|ymsm
4675313|NCT03396367|HIV/AIDS|hiv/aids
4675314|NCT03396367|PrEP|prep
4675315|NCT03396367|Drug Use|drug use
4675316|NCT03396341|BRCA1/2 Mutations|brca1/2 mutations
4675317|NCT03396341|17-489|17-489
4675318|NCT03396315|premenopausal women|premenopausal women
4675319|NCT03396302|Exercise|exercise
4675320|NCT03396302|Nutrition|nutrition
4675321|NCT03396302|Internet|internet
4675322|NCT03396302|Obesity|obesity
4675323|NCT03396302|Hypertension|hypertension
4675324|NCT03396289|Cerebral Palsy|cerebral palsy
4675325|NCT03396289|Balance|balance
4675326|NCT03396289|Inspiratory Muscle Training|inspiratory muscle training
4675327|NCT03396289|6-Minute Walk Test|6-minute walk test
4675328|NCT03396289|Pulmonary Function Test|pulmonary function test
4675329|NCT03396289|Postural Stability|postural stability
4675330|NCT03396263|Personalised nutrition|personalised nutrition
4675331|NCT03396263|Mobile web application|mobile web application
4675332|NCT03396224|Total hip arthroplasty|total hip arthroplasty
4675333|NCT03396224|Hip implant|hip implant
4675334|NCT03396211|Metastatic|metastatic
4675335|NCT03396211|Unresectable|unresectable
4675336|NCT03396198|Gastrointestinal Microbiome|gastrointestinal microbiome
4675337|NCT03396198|Infants|infants
4675338|NCT03396172|COPD|copd
4675339|NCT03396172|Homecare|homecare
4675340|NCT03396172|Oxygen|oxygen
4675341|NCT03396172|Telemedicine|telemedicine
4675342|NCT03396172|Automated oxygen adjustment|automated oxygen adjustment
4675343|NCT03396172|Rehabilitation program|rehabilitation program
4675344|NCT03396159|liver transplantation|liver transplantation
4675345|NCT03396159|mini fluid challenge|mini fluid challenge
4675346|NCT03396146|Pancreatic polypeptide|pancreatic polypeptide
4675347|NCT03396146|Type 1 diabetes|type 1 diabetes
4675348|NCT03396146|Chronic pancreatitis|chronic pancreatitis
4675349|NCT03396133|Dyno|dyno
4675350|NCT03396133|symptomatic arrhythmia|symptomatic arrhythmia
4675351|NCT03396133|diagnosis|diagnosis
4675352|NCT03396133|follow-up|follow-up
4675353|NCT03396094|high flow oxygenation, rapid sequence intubation|high flow oxygenation, rapid sequence intubation
4675354|NCT03396081|Heart Failure|heart failure
4675355|NCT03396081|Care pathway|care pathway
4675356|NCT03396081|Transition program|transition program
4675357|NCT03396081|Efficiency|efficiency
4675358|NCT03396055|decompression surgery|decompression surgery
4675359|NCT03396055|functional outcome|functional outcome
4675360|NCT03396055|biomechanic|biomechanic
4675361|NCT03396055|rehabilitation|rehabilitation
4675362|NCT03396042|CEP290|cep290
4675363|NCT03396042|Leber congenital amaurosis (LCA)|leber congenital amaurosis (lca)
4675364|NCT03396042|LCA10|lca10
4675365|NCT03396042|Retinal degenerative diseases (RDD)|retinal degenerative diseases (rdd)
4675366|NCT03396029|Lifestyle intervention|lifestyle intervention
4675367|NCT03396029|Diet|diet
4675368|NCT03396029|Smoking cessation|smoking cessation
4675369|NCT03396029|Physical activity|physical activity
4675370|NCT03396029|Alcohol|alcohol
4675371|NCT03396029|Body mass index|body mass index
4675372|NCT03396029|colorectal cancer screening|colorectal cancer screening
4675373|NCT03396029|sigmoidoscopy|sigmoidoscopy
4675374|NCT03395990|femoral nerve block|femoral nerve block
4675375|NCT03395990|adductor canal block|adductor canal block
4675376|NCT03395990|analgesia|analgesia
4675377|NCT03395977|uric acid|uric acid
4675378|NCT03395977|xanthin oxydoreductase|xanthin oxydoreductase
4675379|NCT03395977|febuxostat|febuxostat
4675380|NCT03395977|uricase|uricase
4675381|NCT03395951|Mean Systemic Filling Pressure|mean systemic filling pressure
4675382|NCT03395951|Diuretics|diuretics
4675383|NCT03395951|Pressure for venous return|pressure for venous return
4675384|NCT03395951|Fluid Balance|fluid balance
4675385|NCT03395951|De-escalation fluid therapy|de-escalation fluid therapy
4675386|NCT03395951|De-resuscitation|de-resuscitation
4675387|NCT03395951|Guyton|guyton
4675388|NCT03395951|Guytonian Approach|guytonian approach
4675389|NCT03395951|Furosemide|furosemide
4675390|NCT03395951|Cardiac Output|cardiac output
4675391|NCT03395951|Cardiac Index|cardiac index
4675392|NCT03395938|SCREENING|screening
4675393|NCT03395925|Thyroid Nodule|thyroid nodule
4675394|NCT03395925|Bipolar coagulation electrode|bipolar coagulation electrode
4675395|NCT03395925|radiofrequency ablation|radiofrequency ablation
4675396|NCT03395912|local anesthetics infiltration|local anesthetics infiltration
4675397|NCT03395912|cesarean section pain relief|cesarean section pain relief
4675398|NCT03395899|Atezolizumab|atezolizumab
4675399|NCT03395899|Bevacizumab|bevacizumab
4675400|NCT03395899|Cobimetinib|cobimetinib
4675401|NCT03395899|Ipatasertib|ipatasertib
4675402|NCT03395899|pre-operative|pre-operative
4675403|NCT03395899|Window of opportunity|window of opportunity
4675404|NCT03395886|noninvasive ventilation|noninvasive ventilation
4675405|NCT03395886|remifentanil|remifentanil
4675406|NCT03395886|dexmedetomidine|dexmedetomidine
4675407|NCT03395886|cardiac surgery|cardiac surgery
4675408|NCT03395860|GVHD|gvhd
4675410|NCT03395860|PTCy|ptcy
4675411|NCT03395860|halo-HSCT|halo-hsct
4675412|NCT03395847|Diseases of oesophagus stomach and duodenum|diseases of oesophagus stomach and duodenum
4675413|NCT03395847|Advanced gastroesophageal adenocarcinoma|advanced gastroesophageal adenocarcinoma
4675414|NCT03395847|Pembrolizumab|pembrolizumab
4675415|NCT03395847|Keytruda|keytruda
4675416|NCT03395847|MK-3475|mk-3475
4675417|NCT03395847|Ramucirumab|ramucirumab
4675418|NCT03395847|Ramucirumab DP|ramucirumab dp
4675419|NCT03395847|IMC-1121B|imc-1121b
4675420|NCT03395847|SCH-900475|sch-900475
4675421|NCT03395821|competency-based education|competency-based education
4675422|NCT03395821|gynecology|gynecology
4675423|NCT03395821|laparoscopy|laparoscopy
4675424|NCT03395821|resident education|resident education
4675425|NCT03395821|simulation|simulation
4675726|NCT03393988|Fentanyl|fentanyl
4675426|NCT03395821|surgical curriculum|surgical curriculum
4675427|NCT03395795|Infantile Spinal Muscular Atrophy|infantile spinal muscular atrophy
4675428|NCT03395795|Respiratory Decompensations|respiratory decompensations
4675429|NCT03395756|Depot Medroxyprogesterone acetate|depot medroxyprogesterone acetate
4675430|NCT03395756|Injectable birth control|injectable birth control
4675431|NCT03395717|Stroke|stroke
4675432|NCT03395717|Robot|robot
4675433|NCT03395717|Hemiparesis|hemiparesis
4675434|NCT03395717|Gait Training|gait training
4675435|NCT03395717|Rehabilitation|rehabilitation
4675436|NCT03395717|Exoskeleton|exoskeleton
4675437|NCT03395717|Functional Recovery|functional recovery
4675438|NCT03395691|axillary vein|axillary vein
4675439|NCT03395691|central venous catheterization|central venous catheterization
4675440|NCT03395691|ultrasound|ultrasound
4675441|NCT03395691|cardiac surgery|cardiac surgery
4675442|NCT03395691|complication|complication
4675443|NCT03395678|Microneedling|microneedling
4675444|NCT03395678|Nonablative fractional lasers|nonablative fractional lasers
4675445|NCT03395678|Fitzpatrick skin types III-V|fitzpatrick skin types iii-v
4675446|NCT03395678|Arophic acne scarring|arophic acne scarring
4675447|NCT03395652|pregnancy, physical activity, fetal growth|pregnancy, physical activity, fetal growth
4675448|NCT03395639|Children|children
4675449|NCT03395639|Pediatrics|pediatrics
4675450|NCT03395639|Cardiac disease with potential for thromboembolic complications|cardiac disease with potential for thromboembolic complications
4675451|NCT03395639|Prophylactic treatment|prophylactic treatment
4675452|NCT03395639|Anticoagulant drugs|anticoagulant drugs
4675453|NCT03395587|glioblastoma,|glioblastoma,
4675454|NCT03395587|immunotherapy|immunotherapy
4675455|NCT03395587|dendritic cells|dendritic cells
4675456|NCT03395587|vaccination|vaccination
4675457|NCT03395535|Primary Open Angle Glaucoma|primary open angle glaucoma
4675458|NCT03395535|Glaucoma|glaucoma
4675459|NCT03395535|Ocular Hypertension|ocular hypertension
4675460|NCT03395535|POAG|poag
4675461|NCT03395535|SLT|slt
4675462|NCT03395535|Laser|laser
4675463|NCT03395509|Mass screening|mass screening
4675464|NCT03395509|cardiovascular disease|cardiovascular disease
4675465|NCT03395509|diabetes|diabetes
4675466|NCT03395496|pulpotomy|pulpotomy
4675467|NCT03395496|pediatric dentistry|pediatric dentistry
4675468|NCT03395496|primary molars|primary molars
4675469|NCT03395483|peripheral perfusion|peripheral perfusion
4675470|NCT03395483|Haemodynamic Instability|haemodynamic instability
4675471|NCT03395483|mesenteric bloodflow|mesenteric bloodflow
4675472|NCT03395431|Autologuous serum|autologuous serum
4675473|NCT03395431|dry eyes disease|dry eyes disease
4675474|NCT03395431|fingerprick blood|fingerprick blood
4675475|NCT03395418|COPD|copd
4675476|NCT03395418|Asthma|asthma
4675477|NCT03395418|Inhaled Therapeutics|inhaled therapeutics
4675478|NCT03395405|Efficacy|efficacy
4675479|NCT03395405|Nitazoxanide|nitazoxanide
4675480|NCT03395405|Norovirus|norovirus
4675481|NCT03395405|Safety|safety
4675482|NCT03395405|Treatment|treatment
4675483|NCT03395379|Radiofrequency|radiofrequency
4675484|NCT03395379|Thermal Protection|thermal protection
4675485|NCT03395379|Percutaneous thermal ablation|percutaneous thermal ablation
4675486|NCT03395379|Kidney neoplasms|kidney neoplasms
4675487|NCT03395366|Hemodialysis|hemodialysis
4675488|NCT03395366|End Stage Renal Disease|end stage renal disease
4675489|NCT03395340|cGVHD|cgvhd
4675490|NCT03395340|Epidermal|epidermal
4675491|NCT03395340|JAK Inhibitors|jak inhibitors
4675492|NCT03395340|Skin|skin
4675493|NCT03395340|JAK-STAT|jak-stat
4675494|NCT03395314|Borderline Personality Disorder|borderline personality disorder
4675495|NCT03395314|Ketamine|ketamine
4675496|NCT03395314|Suicide|suicide
4675497|NCT03395314|Social Cognition|social cognition
4675498|NCT03395301|hysteroscopy|hysteroscopy
4675499|NCT03395301|fiber platinum coil|fiber platinum coil
4675500|NCT03395301|tubal occlusion|tubal occlusion
4675501|NCT03395288|UTI|uti
4675502|NCT03395288|recurrent UTI|recurrent uti
4675503|NCT03395249|safety|safety
4675504|NCT03395249|tolerability|tolerability
4675505|NCT03395249|pharmacokinetics|pharmacokinetics
4675506|NCT03395249|SPR994|spr994
4675507|NCT03395223|Acquired Methaemoglobinemia|acquired methaemoglobinemia
4675508|NCT03395223|Methylene Blue|methylene blue
4675509|NCT03395197|DDR (DNA damage repair), mCRPc (metastatic castration-resistant prostate cancer)|ddr (dna damage repair), mcrpc (metastatic castration-resistant prostate cancer)
4675510|NCT03395119|Ozone exposure|ozone exposure
4675511|NCT03395119|Healthy Adults|healthy adults
4675512|NCT03395106|vaccine|vaccine
4675513|NCT03395106|public health|public health
4675514|NCT03395093|bronchoscopy|bronchoscopy
4675515|NCT03395093|conscious sedation|conscious sedation
4675516|NCT03395093|fentanyl|fentanyl
4675517|NCT03395093|Bispectral Index|bispectral index
4675518|NCT03395080|epithelial histology|epithelial histology
4675519|NCT03395080|Wnt pathway|wnt pathway
4675520|NCT03395080|DKK1|dkk1
4675521|NCT03395067|Obesity|obesity
4675522|NCT03395067|Infertility|infertility
4675523|NCT03395067|In vitro fertilization|in vitro fertilization
4675524|NCT03395054|neck pain|neck pain
4675525|NCT03395054|pulmonary function test|pulmonary function test
4677379|NCT03383692|Oncology|oncology
4675526|NCT03395054|respiratory muscle strength|respiratory muscle strength
4675527|NCT03395054|cervical stabilization exercises|cervical stabilization exercises
4675528|NCT03395041|vulnerable plaque, cardiac imaging, oral bacteria, inflammation|vulnerable plaque, cardiac imaging, oral bacteria, inflammation
4675529|NCT03395028|Biliary Atresia|biliary atresia
4675530|NCT03395028|Granulocyte Colony Stimulating Factor|granulocyte colony stimulating factor
4675531|NCT03395028|GCSF|gcsf
4675532|NCT03395015|Reconstructive surgical procedures|reconstructive surgical procedures
4675533|NCT03395015|Therapy, soft tissue|therapy, soft tissue
4675534|NCT03395015|Treatment outcome|treatment outcome
4675535|NCT03395015|Outcome Assessment (Health Care)|outcome assessment (health care)
4675536|NCT03395015|Photogrammetry|photogrammetry
4675537|NCT03395015|Physical Appearance, Body|physical appearance, body
4675538|NCT03395002|Tiotropium|tiotropium
4675539|NCT03395002|Salmeterol|salmeterol
4675540|NCT03395002|Fluticasone|fluticasone
4675541|NCT03395002|COPD|copd
4675542|NCT03395002|Bronchodilator effect|bronchodilator effect
4675543|NCT03395002|Discair|discair
4675544|NCT03395002|Diskus|diskus
4675545|NCT03395002|Spirometry|spirometry
4675546|NCT03394963|Food-Based Dietary guideline|food-based dietary guideline
4675547|NCT03394963|Healthy Eating Index|healthy eating index
4675548|NCT03394963|Healthy Diet|healthy diet
4675549|NCT03394963|Protocol|protocol
4675550|NCT03394963|Ethiopia|ethiopia
4675551|NCT03394950|thrombolysis|thrombolysis
4675552|NCT03394950|Butyphthalide|butyphthalide
4675553|NCT03394924|PBC|pbc
4675554|NCT03394924|Primary Ciliary Cholangitis (PBC)|primary ciliary cholangitis (pbc)
4675555|NCT03394898|Chronic Pain|chronic pain
4675556|NCT03394898|Body Mass Index|body mass index
4675557|NCT03394898|Eating Habits|eating habits
4675558|NCT03394872|Pleural effusion|pleural effusion
4675559|NCT03394872|Mechanical Ventilation|mechanical ventilation
4675560|NCT03394872|Ultrasonography|ultrasonography
4675561|NCT03394872|Drainage|drainage
4675562|NCT03394833|preoperative|preoperative
4675563|NCT03394833|fluid therapy|fluid therapy
4675564|NCT03394833|hemodynamics|hemodynamics
4675565|NCT03394833|anesthesia induction|anesthesia induction
4675566|NCT03394833|rapid sequence induction|rapid sequence induction
4675567|NCT03394833|TCI|tci
4675568|NCT03394820|Dexamethasone|dexamethasone
4675569|NCT03394820|Supraclavicular block|supraclavicular block
4675570|NCT03394794|anorectal physiology|anorectal physiology
4675571|NCT03394794|therapies|therapies
4675572|NCT03394794|quality fo life|quality fo life
4675573|NCT03394755|thrombocytopenia|thrombocytopenia
4675574|NCT03394755|bleeding|bleeding
4675575|NCT03394742|Peer Group|peer group
4675576|NCT03394742|Quality of Life|quality of life
4675577|NCT03394729|Propole|propole
4675578|NCT03394729|Xylitol|xylitol
4675579|NCT03394729|Saliva|saliva
4675580|NCT03394716|MRI|mri
4675581|NCT03394716|Radiotherapy|radiotherapy
4675582|NCT03394703|Lung cancer|lung cancer
4675583|NCT03394703|screening|screening
4675584|NCT03394703|Low-dose Computed Tomography|low-dose computed tomography
4675585|NCT03394703|Smokers|smokers
4675586|NCT03394664|Body composition|body composition
4675587|NCT03394664|Feeding study|feeding study
4675588|NCT03394664|Ketogenic diet|ketogenic diet
4675589|NCT03394664|Weight loss|weight loss
4675590|NCT03394664|Energy Expenditure|energy expenditure
4675591|NCT03394651|male|male
4675592|NCT03394651|lower urinary tract symptoms|lower urinary tract symptoms
4675593|NCT03394651|comorbidities|comorbidities
4675594|NCT03394651|chronic kidney diseases|chronic kidney diseases
4675595|NCT03394651|urodynamics|urodynamics
4675596|NCT03394651|medical therapy|medical therapy
4675597|NCT03394651|surgical treatment|surgical treatment
4675598|NCT03394638|eHealth|ehealth
4675599|NCT03394638|Bariatric surgery|bariatric surgery
4675600|NCT03394638|Obesity|obesity
4675601|NCT03394638|Telemedicine|telemedicine
4675602|NCT03394625|Socket Shield|socket shield
4675603|NCT03394625|immediate implant|immediate implant
4675604|NCT03394625|ridge preservation|ridge preservation
4675605|NCT03394612|Scar|scar
4675606|NCT03394612|Skin|skin
4675607|NCT03394612|Wound Healing|wound healing
4675608|NCT03394612|Tissue Engineering|tissue engineering
4675609|NCT03394612|Dermis|dermis
4675610|NCT03394612|Epidermis|epidermis
4675611|NCT03394599|Physical Activity|physical activity
4675612|NCT03394599|Rehabilitation|rehabilitation
4675613|NCT03394599|Exercise|exercise
4675614|NCT03394599|Engagement|engagement
4675615|NCT03394599|Older Adults|older adults
4675616|NCT03394586|Golimumab|golimumab
4675617|NCT03394586|TNF-inhibitors|tnf-inhibitors
4675618|NCT03394586|Clinical Response|clinical response
4675619|NCT03394586|Clinical Remission|clinical remission
4675620|NCT03394586|Ulcerative Colitis|ulcerative colitis
4675621|NCT03394573|Diabetic macular edema|diabetic macular edema
4675622|NCT03394560|Spinal Cord Injury|spinal cord injury
4675623|NCT03394560|transcranial magnetic stimulation|transcranial magnetic stimulation
4675624|NCT03394560|body weight-support treadmill training|body weight-support treadmill training
4675625|NCT03394560|gait|gait
4675626|NCT03394534|Comprehensive Geriatric Assessment|comprehensive geriatric assessment
4675627|NCT03394534|Frailty|frailty
4675628|NCT03394534|electronic Frailty Index|electronic frailty index
4675630|NCT03394534|Care and Support plan|care and support plan
4675631|NCT03394534|Primary Care|primary care
4675632|NCT03394521|glaucoma suspect|glaucoma suspect
4675633|NCT03394521|ocular hypertension|ocular hypertension
4675634|NCT03394521|progression|progression
4675635|NCT03394495|Fatigue|fatigue
4675636|NCT03394495|Frailty|frailty
4675637|NCT03394495|Cluster-RCT|cluster-rct
4675638|NCT03394495|Exercise|exercise
4675639|NCT03394495|Behavioral change|behavioral change
4675640|NCT03394469|Obesity|obesity
4675641|NCT03394469|Sarcopenia|sarcopenia
4675642|NCT03394430|sevoflurane|sevoflurane
4675643|NCT03394430|epileptiform EEG|epileptiform eeg
4675644|NCT03394430|midazolam|midazolam
4675645|NCT03394430|dexmedetomidine|dexmedetomidine
4675646|NCT03394404|ECG-I Mapping Pulmonary Vein Isolation|ecg-i mapping pulmonary vein isolation
4675647|NCT03394391|Adherence|adherence
4675648|NCT03394391|Adolescents|adolescents
4675649|NCT03394391|Antiretroviral therapy|antiretroviral therapy
4675650|NCT03394391|HIV|hiv
4675651|NCT03394391|Nigeria|nigeria
4675652|NCT03394391|Randomized controlled trial|randomized controlled trial
4675653|NCT03394391|Short message services|short message services
4675654|NCT03394365|Solid organ transplant|solid organ transplant
4675655|NCT03394365|EBV-PTLD|ebv-ptld
4675656|NCT03394365|Cytotoxic T Lymphocytes|cytotoxic t lymphocytes
4675657|NCT03394365|SOT|sot
4675658|NCT03394365|Lymphoproliferative disorders|lymphoproliferative disorders
4675659|NCT03394365|Post-transplant lymphoproliferative disease|post-transplant lymphoproliferative disease
4675660|NCT03394365|EBV-CTL|ebv-ctl
4675661|NCT03394365|Epstein-Barr Virus|epstein-barr virus
4675662|NCT03394365|Kidney transplant|kidney transplant
4675663|NCT03394365|Renal transplant|renal transplant
4675664|NCT03394365|Liver transplant|liver transplant
4675665|NCT03394365|Heart transplant|heart transplant
4675666|NCT03394365|Lung transplant|lung transplant
4675667|NCT03394365|Intestinal transplant|intestinal transplant
4675668|NCT03394365|Pancreas transplant|pancreas transplant
4675669|NCT03394365|Organ transplant complications|organ transplant complications
4675670|NCT03394365|Allogeneic, off-the-shelf T-cell immunotherapy|allogeneic, off-the-shelf t-cell immunotherapy
4675671|NCT03394365|EBV-LPD|ebv-lpd
4675672|NCT03394365|Post-transplant lymphoma|post-transplant lymphoma
4675673|NCT03394365|Cancer after transplant|cancer after transplant
4675674|NCT03394352|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
4675675|NCT03394352|Insulin pump|insulin pump
4675676|NCT03394352|Continuous Glucose Monitor (CGM)|continuous glucose monitor (cgm)
4675677|NCT03394352|Exercise|exercise
4675678|NCT03394352|Activity on Board|activity on board
4675679|NCT03394352|Decision Support System|decision support system
4675680|NCT03394339|Systematic review and meta-anaylsis|systematic review and meta-anaylsis
4675681|NCT03394339|Evidence-based nutrition (EBN)|evidence-based nutrition (ebn)
4675682|NCT03394339|Dietary guidelines|dietary guidelines
4675683|NCT03394339|Fruit|fruit
4675684|NCT03394339|Vegetables|vegetables
4675685|NCT03394313|Registry|registry
4675686|NCT03394274|transfusion|transfusion
4675687|NCT03394274|liberal|liberal
4675688|NCT03394274|restrictive|restrictive
4675689|NCT03394261|Opioid Use Disorder (OUD)|opioid use disorder (oud)
4675690|NCT03394261|Medication Assisted Therapy (MAT)|medication assisted therapy (mat)
4675691|NCT03394261|Patient Decision Aid|patient decision aid
4675692|NCT03394248|Subconcussive head injury|subconcussive head injury
4675693|NCT03394235|hair transplant|hair transplant
4675694|NCT03394235|hairline|hairline
4675695|NCT03394235|laser hair removal|laser hair removal
4675696|NCT03394209|Favipiravir, Influenza, Human, Critical Illness, Pharmacokinetics|favipiravir, influenza, human, critical illness, pharmacokinetics
4675697|NCT03394183|cardiac rehabilitation|cardiac rehabilitation
4675698|NCT03394183|cardiorespiratory fitness|cardiorespiratory fitness
4675699|NCT03394183|functional capacity|functional capacity
4675700|NCT03394183|acute exercise response|acute exercise response
4675701|NCT03394183|quality of life|quality of life
4675702|NCT03394157|sleeve gastrectomy , MGB , type 2 diabetes , obesity , SASI|sleeve gastrectomy , mgb , type 2 diabetes , obesity , sasi
4675703|NCT03394118|T790 mutation|t790 mutation
4675704|NCT03394118|Liquid biopsy|liquid biopsy
4675705|NCT03394105|Pleurodesis|pleurodesis
4675706|NCT03394092|immunoglobulin G|immunoglobulin g
4675707|NCT03394079|OCT|oct
4675708|NCT03394079|IVUS|ivus
4675709|NCT03394079|PCI|pci
4675710|NCT03394066|Repetitive TMS (rTMS)|repetitive tms (rtms)
4675711|NCT03394066|Simultaneous TMS and MRI|simultaneous tms and mri
4675712|NCT03394053|PID|pid
4675713|NCT03394053|Immune Deficiency|immune deficiency
4675714|NCT03394053|Molecular Biology|molecular biology
4675715|NCT03394053|T-Cell Lymphocytopenia|t-cell lymphocytopenia
4675716|NCT03394053|Genetic Biology|genetic biology
4675717|NCT03394040|Diarrhea|diarrhea
4675718|NCT03394040|Point-of-Need|point-of-need
4675719|NCT03394040|Pathogen Identification|pathogen identification
4675720|NCT03394027|Impiridones|impiridones
4675721|NCT03394027|TNBC|tnbc
4675722|NCT03394027|Metastatic|metastatic
4675723|NCT03394027|Male Breast Cancer|male breast cancer
4675724|NCT03393988|Transversus abdominis plane block,|transversus abdominis plane block,
4675725|NCT03393988|Dexmedetomidine|dexmedetomidine
4675727|NCT03393988|Live liver donor|live liver donor
4675728|NCT03393988|Liver transplantation|liver transplantation
4675729|NCT03393962|Ovarian cancer|ovarian cancer
4675730|NCT03393962|Cytotoxic lymphocyte|cytotoxic lymphocyte
4675731|NCT03393962|Cancer specific antigen|cancer specific antigen
4675732|NCT03393949|Methylprednisolone|methylprednisolone
4675733|NCT03393949|Postoperative cognitive function|postoperative cognitive function
4675734|NCT03393949|Immunological function|immunological function
4675735|NCT03393897|fluid responsiveness|fluid responsiveness
4675736|NCT03393897|cardiac surgery|cardiac surgery
4675737|NCT03393832|Oral care|oral care
4675738|NCT03393832|Oropharyngeal mother's milk|oropharyngeal mother's milk
4675739|NCT03393819|antimicrobial skin solution|antimicrobial skin solution
4675740|NCT03393819|skin preparation|skin preparation
4675741|NCT03393806|Asthma Control Questionnaire|asthma control questionnaire
4675742|NCT03393806|Allergic fungal airway disease|allergic fungal airway disease
4675743|NCT03393806|Asthma Quality of Life Questionnaire|asthma quality of life questionnaire
4675744|NCT03393806|Holter monitoring|holter monitoring
4675745|NCT03393806|Asthma|asthma
4675746|NCT03393793|Heart transplantation|heart transplantation
4675747|NCT03393767|CNV|cnv
4675748|NCT03393767|AMD|amd
4675749|NCT03393767|ranibizumab|ranibizumab
4675750|NCT03393754|Hepatitis B Vaccines|hepatitis b vaccines
4675751|NCT03393741|Metastatic breast cancer|metastatic breast cancer
4675752|NCT03393728|hyperthyroidism|hyperthyroidism
4675753|NCT03393728|heart rate variability|heart rate variability
4675754|NCT03393728|propanolol|propanolol
4675755|NCT03393728|Africa|africa
4675756|NCT03393715|Diabetes|diabetes
4675757|NCT03393715|Hypertension|hypertension
4675758|NCT03393715|Perindopril|perindopril
4675759|NCT03393715|chronobiology|chronobiology
4675760|NCT03393715|Africa|africa
4675761|NCT03393702|Postoperative pain|postoperative pain
4675762|NCT03393702|Anxiety|anxiety
4675763|NCT03393702|Postoperative Complications|postoperative complications
4675764|NCT03393702|Patient Satisfaction|patient satisfaction
4675765|NCT03393689|68Ga-NODAGA-E[c(RGDyK)]2|68ga-nodaga-e[c(rgdyk)]2
4675766|NCT03393689|Angiogenesis PET/MR|angiogenesis pet/mr
4675767|NCT03393689|Acoustic Neuroma|acoustic neuroma
4675768|NCT03393676|Postoperative Cognitive Dysfunction|postoperative cognitive dysfunction
4675769|NCT03393676|elderly patients|elderly patients
4675770|NCT03393676|Preoperative Pain|preoperative pain
4675771|NCT03393663|chronic kidney disease|chronic kidney disease
4675772|NCT03393663|cardiovascular disease|cardiovascular disease
4675773|NCT03393663|mortality|mortality
4675774|NCT03393663|end stage renal disease|end stage renal disease
4675775|NCT03393650|exercise|exercise
4675776|NCT03393650|protein|protein
4675777|NCT03393650|muscle function|muscle function
4675778|NCT03393650|aging|aging
4675779|NCT03393637|prenatal anxiety|prenatal anxiety
4675780|NCT03393637|pregnancy|pregnancy
4675781|NCT03393637|depression|depression
4675782|NCT03393637|military|military
4675783|NCT03393637|intervention|intervention
4675784|NCT03393624|Dark circles|dark circles
4675785|NCT03393624|Periorbital hyperchromia|periorbital hyperchromia
4675786|NCT03393624|Sleep Quality|sleep quality
4675787|NCT03393624|Facial aesthetics|facial aesthetics
4675788|NCT03393585|Respiratory Rates|respiratory rates
4675789|NCT03393546|pain|pain
4675790|NCT03393546|acupressure|acupressure
4675791|NCT03393546|alzheimer|alzheimer
4675792|NCT03393533|Third molar;|third molar;
4675793|NCT03393533|Oral surgery;|oral surgery;
4675794|NCT03393533|Pain;|pain;
4675795|NCT03393533|Edema;|edema;
4675796|NCT03393533|Trismus.|trismus.
4675797|NCT03393520|Agitation|agitation
4675798|NCT03393520|Dementia of the Alzheimer's type|dementia of the alzheimer's type
4675799|NCT03393520|Alzheimer's disease|alzheimer's disease
4675800|NCT03393520|AVP-786|avp-786
4675801|NCT03393520|Deudextromethorphan hydrobromide|deudextromethorphan hydrobromide
4675802|NCT03393520|Quinidine sulfate|quinidine sulfate
4675803|NCT03393507|ovarian cancer|ovarian cancer
4675804|NCT03393481|biologic,|biologic,
4675805|NCT03393481|venous thromboembolism,|venous thromboembolism,
4675806|NCT03393481|unilateral knee arthroplasty|unilateral knee arthroplasty
4675807|NCT03393455|Fetal pathology|fetal pathology
4675808|NCT03393455|Obstetrical outcome|obstetrical outcome
4675809|NCT03393455|Pediatric outcome|pediatric outcome
4675810|NCT03393442|Magnetic Resonance Imaging|magnetic resonance imaging
4675811|NCT03393442|Gd-based contrast media|gd-based contrast media
4675812|NCT03393442|Gd-deposits|gd-deposits
4675813|NCT03393442|brain imaging|brain imaging
4675814|NCT03393442|breast cancer screening|breast cancer screening
4675815|NCT03393416|MASCT-I|masct-i
4675816|NCT03393403|Subcostal transversus abdominis plane block|subcostal transversus abdominis plane block
4675817|NCT03393377|arterial stiffness|arterial stiffness
4675818|NCT03393377|endothelial dysfunction|endothelial dysfunction
4675819|NCT03393377|fluvastatin|fluvastatin
4675820|NCT03393377|valsartan|valsartan
4675821|NCT03393377|inflammatory markers|inflammatory markers
4675822|NCT03393377|oxidative stress|oxidative stress
4675823|NCT03393377|SIRT1|sirt1
4675824|NCT03393351|Shared Decision-Making|shared decision-making
4675825|NCT03393351|Decision Making|decision making
4677380|NCT03383692|HER2|her2
4675826|NCT03393351|Patient Participation|patient participation
4675827|NCT03393351|Patient Centeredness|patient centeredness
4675828|NCT03393351|Health Services Research|health services research
4675829|NCT03393351|Implementation Research|implementation research
4675830|NCT03393351|Oncology|oncology
4675831|NCT03393351|Stepped Wedge Design|stepped wedge design
4675832|NCT03393351|Mixed Methods|mixed methods
4675833|NCT03393338|Diabetes|diabetes
4675834|NCT03393338|African American|african american
4675835|NCT03393338|Emergency Department visits|emergency department visits
4675836|NCT03393312|Transcranial direct current stimulation|transcranial direct current stimulation
4675837|NCT03393312|Biological Psychiatry|biological psychiatry
4675838|NCT03393312|Depression|depression
4675839|NCT03393312|Decision-making|decision-making
4675840|NCT03393299|elderly people|elderly people
4675841|NCT03393299|geriatric short-stay|geriatric short-stay
4675842|NCT03393299|STOPP/START criteria|stopp/start criteria
4675843|NCT03393273|Stem Cell autologous graft|stem cell autologous graft
4675844|NCT03393273|Elotuzumab|elotuzumab
4675845|NCT03393273|Multiple myeloma|multiple myeloma
4675846|NCT03393273|Elderly|elderly
4675847|NCT03393260|cancer|cancer
4675848|NCT03393260|emergency departments (ED)|emergency departments (ed)
4675849|NCT03393247|infliximab|infliximab
4675850|NCT03393247|azathioprine|azathioprine
4675851|NCT03393234|Ultra-low rectal cancer|ultra-low rectal cancer
4675852|NCT03393234|Intersphincteric resection|intersphincteric resection
4675853|NCT03393234|IORT|iort
4675854|NCT03393208|Diabetes Mellitus|diabetes mellitus
4675855|NCT03393208|Glucophage Immediate Release (GIR)|glucophage immediate release (gir)
4675856|NCT03393208|Bioequivalence Study|bioequivalence study
4675857|NCT03393195|Weight loss|weight loss
4675858|NCT03393195|Diet|diet
4675859|NCT03393195|Time-restricted feeding|time-restricted feeding
4675860|NCT03393143|Primary Health Care; Analgesics, Opioid; Medicaid|primary health care; analgesics, opioid; medicaid
4675861|NCT03393130|Burns|burns
4675862|NCT03393130|Young Adult|young adult
4675863|NCT03393130|Cognitive Impairment|cognitive impairment
4675864|NCT03393130|Apolipoprotein E, Deficiency or Defect of|apolipoprotein e, deficiency or defect of
4675865|NCT03393130|Intensive Care Neurological Disorder|intensive care neurological disorder
4675866|NCT03393130|Quality of Life|quality of life
4675867|NCT03393130|Inflammation, Brain|inflammation, brain
4675868|NCT03393117|Reconstruction|reconstruction
4675869|NCT03393117|Bupivacaine|bupivacaine
4675870|NCT03393117|Liposomal Bupivacaine|liposomal bupivacaine
4675871|NCT03393104|Chronic Low Back Pain|chronic low back pain
4675872|NCT03393104|Motor Control Exercise|motor control exercise
4675873|NCT03393104|Patient Education|patient education
4675874|NCT03393065|lung ultrasounds|lung ultrasounds
4675875|NCT03393065|fluid managements|fluid managements
4675876|NCT03393065|critical care patients|critical care patients
4675877|NCT03393052|L-RECORD|l-record
4675878|NCT03393052|Radial|radial
4675879|NCT03393052|Femoral|femoral
4675880|NCT03393052|CABG|cabg
4675881|NCT03393052|coronary artery bypass graft|coronary artery bypass graft
4675882|NCT03393039|fMRI|fmri
4675883|NCT03393039|Reward|reward
4675884|NCT03393039|Food Choices|food choices
4675885|NCT03393039|Negative Affect|negative affect
4675886|NCT03393013|immunoproteasome inhibition|immunoproteasome inhibition
4675887|NCT03393013|selective proteasome inhibition|selective proteasome inhibition
4675888|NCT03393013|proteasome|proteasome
4675889|NCT03392987|GSK2696274|gsk2696274
4675890|NCT03392987|Cryopreserved formulation|cryopreserved formulation
4675891|NCT03392987|Gene therapy|gene therapy
4675892|NCT03392987|Metachromatic leukodystrophy|metachromatic leukodystrophy
4675893|NCT03392974|Hemophilia A|hemophilia a
4675894|NCT03392974|Gene Therapy|gene therapy
4675895|NCT03392974|Clotting Disorders|clotting disorders
4675896|NCT03392974|Blood Disorder|blood disorder
4675897|NCT03392974|Blood Coagulation Disorders|blood coagulation disorders
4675898|NCT03392974|Inherited Blood Coagulation Disorders|inherited blood coagulation disorders
4675899|NCT03392974|Hematologic Diseases|hematologic diseases
4675900|NCT03392974|Coagulation Protein Disorders|coagulation protein disorders
4675901|NCT03392974|Hemorrhagic Disorders|hemorrhagic disorders
4675902|NCT03392974|Genetic Diseases|genetic diseases
4675903|NCT03392974|Inborn|inborn
4675904|NCT03392974|Factor VIII|factor viii
4675905|NCT03392974|Coagulants|coagulants
4675906|NCT03392961|Oral insulin|oral insulin
4675907|NCT03392961|Dosing time|dosing time
4675908|NCT03392961|Insulin concentration|insulin concentration
4675909|NCT03392961|Prandial insulin|prandial insulin
4675910|NCT03392961|Post Prandial Glucose (PPG)|post prandial glucose (ppg)
4675911|NCT03392948|atrial fibrillation|atrial fibrillation
4675912|NCT03392948|prosthetic valves|prosthetic valves
4675913|NCT03392948|pulmonary embolism|pulmonary embolism
4675914|NCT03392948|venous thrombosis|venous thrombosis
4675915|NCT03392948|percutaneous coronary interventions|percutaneous coronary interventions
4675916|NCT03392948|chronic anticoagulant treatment|chronic anticoagulant treatment
4675917|NCT03392909|Nonsense Mutations|nonsense mutations
4675918|NCT03392883|Latin America|latin america
4675919|NCT03392883|Depression|depression
4675920|NCT03392883|mHealth|mhealth
4675921|NCT03392883|Problematic Alcohol Use|problematic alcohol use
4675922|NCT03392870|Autism Spectrum Disorder (ASD)|autism spectrum disorder (asd)
4675923|NCT03392870|Transition program|transition program
4675924|NCT03392857|Critical care|critical care
4675925|NCT03392831|Central Venous Catheters|central venous catheters
4675926|NCT03392831|Vascular Access Devices|vascular access devices
4675927|NCT03392831|Nursing|nursing
4675928|NCT03392831|Cost Effectiveness|cost effectiveness
4675929|NCT03392831|PICC|picc
4675930|NCT03392766|fibreoptic intubation|fibreoptic intubation
4675931|NCT03392766|double lumen tube|double lumen tube
4675932|NCT03392766|difficult intubation|difficult intubation
4675933|NCT03392714|Bendamustine|bendamustine
4675934|NCT03392714|CSF|csf
4675935|NCT03392714|Pharmacokinetics|pharmacokinetics
4675936|NCT03392714|PCNSL|pcnsl
4675937|NCT03392714|Salvage therapy|salvage therapy
4675938|NCT03392688|onset , hamstring muscles, patellofemoral pain|onset , hamstring muscles, patellofemoral pain
4675939|NCT03392675|Breast and Nipple Pain|breast and nipple pain
4675940|NCT03392675|Quantitative Sensory Testing|quantitative sensory testing
4675941|NCT03392675|Genotyping|genotyping
4675942|NCT03392675|Breastfeeding|breastfeeding
4675943|NCT03392649|Postoperative Atrial Fibrillation|postoperative atrial fibrillation
4675944|NCT03392649|Tragus Stimulation|tragus stimulation
4675945|NCT03392623|Epigenetics, Malar melasma,|epigenetics, malar melasma,
4675946|NCT03392610|Intratracheal intubation, bronchoscopy, bronchoalveolar lavage, endoscopy, pulmonary medicine, critical care, anesthesia department, disinfection|intratracheal intubation, bronchoscopy, bronchoalveolar lavage, endoscopy, pulmonary medicine, critical care, anesthesia department, disinfection
4675947|NCT03392584|Locally advanced rectal cancer|locally advanced rectal cancer
4675948|NCT03392584|Deep infection|deep infection
4675949|NCT03392584|Microdialysis|microdialysis
4675950|NCT03392584|Surgical site infection|surgical site infection
4675951|NCT03392571|Resectable pancreatic cancer, NGC-triple regimen|resectable pancreatic cancer, ngc-triple regimen
4675952|NCT03392545|recurrent GBM; radiation; immunotherapy|recurrent gbm; radiation; immunotherapy
4675953|NCT03392532|Astigmatism|astigmatism
4675954|NCT03392532|Axis orientation|axis orientation
4675955|NCT03392519|Brain connectivity|brain connectivity
4675956|NCT03392519|Magnetic resonance imaging|magnetic resonance imaging
4675957|NCT03392519|Brain plasticity|brain plasticity
4675958|NCT03392519|Recovery|recovery
4675959|NCT03392506|CP-EBUS|cp-ebus
4675960|NCT03392506|EBUS-TBNA|ebus-tbna
4675961|NCT03392506|Real time elasticity|real time elasticity
4675962|NCT03392506|Staging of lung cancer|staging of lung cancer
4675963|NCT03392493|Stroke|stroke
4675964|NCT03392493|Robotic rehabilitation|robotic rehabilitation
4675965|NCT03392493|Hand function|hand function
4675966|NCT03392493|Activities of Daily Living|activities of daily living
4675967|NCT03392454|Partial Trapeziectomy|partial trapeziectomy
4675968|NCT03392454|Tendon Interposition|tendon interposition
4675969|NCT03392454|Trapeziectomy|trapeziectomy
4675970|NCT03392454|Thumb Carpometacarpal Joint|thumb carpometacarpal joint
4675971|NCT03392441|dementia|dementia
4675972|NCT03392441|cognition|cognition
4675973|NCT03392441|insulin|insulin
4675974|NCT03392441|adolescent|adolescent
4675975|NCT03392415|chronic total occlusion|chronic total occlusion
4675976|NCT03392415|CTO|cto
4675977|NCT03392415|PCI|pci
4675978|NCT03392415|percutaneus coronary intervention|percutaneus coronary intervention
4675979|NCT03392402|Thyroid nodule|thyroid nodule
4675980|NCT03392402|Indeterminate thyroid nodule|indeterminate thyroid nodule
4675981|NCT03392402|Molecular biopsy|molecular biopsy
4675982|NCT03392402|Gene expression classifier|gene expression classifier
4675983|NCT03392389|mRNA-1653|mrna-1653
4675984|NCT03392389|human metapneumovirus|human metapneumovirus
4675985|NCT03392389|human parainfluenza vaccine|human parainfluenza vaccine
4675986|NCT03392376|ICU Delirium|icu delirium
4675987|NCT03392376|Haloperidol|haloperidol
4675988|NCT03392324|atrophic macular degeneration|atrophic macular degeneration
4675989|NCT03392324|geographic atrophy|geographic atrophy
4675990|NCT03392324|retina implant|retina implant
4675991|NCT03392324|retinal prosthesis|retinal prosthesis
4675992|NCT03392324|visual prosthesis|visual prosthesis
4675993|NCT03392324|macular degeneration|macular degeneration
4675994|NCT03392324|dry macular degeneration|dry macular degeneration
4675995|NCT03392324|AMD|amd
4675996|NCT03392298|Thalassemia|thalassemia
4675997|NCT03392298|Pregnancy|pregnancy
4675998|NCT03392298|Globin expression|globin expression
4675999|NCT03392298|Colla corii asini|colla corii asini
4676000|NCT03392272|Ptosis|ptosis
4676001|NCT03392272|Müller's Muscle-Conjunctival Resection (MMCR)|müller's muscle-conjunctival resection (mmcr)
4676002|NCT03392272|Fibrin Glue|fibrin glue
4676003|NCT03392246|Non-Small Cell Lung Cancer|non-small cell lung cancer
4676004|NCT03392233|spinal metastases|spinal metastases
4676005|NCT03392233|Stereotactic body radiation therapy(SBRT)|stereotactic body radiation therapy(sbrt)
4676006|NCT03392233|breast cancer|breast cancer
4676007|NCT03392233|prostate cancer|prostate cancer
4676008|NCT03392233|non small cell lung cancer|non small cell lung cancer
4676009|NCT03392220|clinically negative neck|clinically negative neck
4676010|NCT03392220|regional control rate|regional control rate
4676011|NCT03392194|Behavioral interventions|behavioral interventions
4676012|NCT03392194|Sleep hygiene|sleep hygiene
4676013|NCT03392194|Yoga|yoga
4676014|NCT03392194|Community research|community research
4676015|NCT03392194|Short sleep duration|short sleep duration
4676016|NCT03392194|Low-income population|low-income population
4676017|NCT03392168|Psoriasis|psoriasis
4676018|NCT03392168|Plaque Psoriasis|plaque psoriasis
4676019|NCT03392142|Allogeneic Hematopoietic Cell Transplant|allogeneic hematopoietic cell transplant
4676020|NCT03392142|EBV-LPD|ebv-lpd
4676021|NCT03392142|Lymphoproliferative Disorders|lymphoproliferative disorders
4676022|NCT03392142|Epstein-Barr Virus|epstein-barr virus
4676023|NCT03392142|EBV-PTLD|ebv-ptld
4676024|NCT03392142|alloHCT|allohct
4676025|NCT03392142|Post-transplant lymphoproliferative disease|post-transplant lymphoproliferative disease
4676026|NCT03392142|EBV-associated PTLD|ebv-associated ptld
4676027|NCT03392142|Post-transplant lymphoma|post-transplant lymphoma
4676028|NCT03392142|HCT|hct
4676029|NCT03392142|HSCT|hsct
4676030|NCT03392142|Cytotoxic T lymphocytes|cytotoxic t lymphocytes
4676031|NCT03392142|EBV-CTL|ebv-ctl
4676032|NCT03392142|Hematopoietic Cell Transplant|hematopoietic cell transplant
4676033|NCT03392142|Stem cell transplant|stem cell transplant
4676034|NCT03392142|Bone marrow transplant complications|bone marrow transplant complications
4676035|NCT03392142|Cancer after transplant|cancer after transplant
4676036|NCT03392142|Allogeneic, off-the-shelf T-cell immunotherapy|allogeneic, off-the-shelf t-cell immunotherapy
4676037|NCT03392129|Asthma|asthma
4676038|NCT03392129|Child|child
4676039|NCT03392129|respiratory exercises|respiratory exercises
4676040|NCT03392129|Hydrotherapy|hydrotherapy
4676041|NCT03392129|Physical Therapy Specialty|physical therapy specialty
4676042|NCT03392129|Sleep|sleep
4676043|NCT03392129|Quality of life|quality of life
4676044|NCT03392129|Anxiety|anxiety
4676045|NCT03392129|Spirometry|spirometry
4676046|NCT03392129|Clinical trial|clinical trial
4676047|NCT03392103|Raltitrexed|raltitrexed
4676048|NCT03392103|IMRT|imrt
4676049|NCT03392090|Cancer|cancer
4676050|NCT03392064|AMG 119|amg 119
4676051|NCT03392064|CART|cart
4676052|NCT03392064|DLL3|dll3
4676053|NCT03392012|anesthesia, patient safety, respiratory complications|anesthesia, patient safety, respiratory complications
4676054|NCT03391999|Mental Health, Physical Health|mental health, physical health
4676055|NCT03391973|CUP|cup
4676056|NCT03391973|Pembrolizumab|pembrolizumab
4676057|NCT03391973|KEYTRUDA|keytruda
4676058|NCT03391960|CLABSI|clabsi
4676059|NCT03391960|Septicemia|septicemia
4676060|NCT03391960|Bloodstream infection|bloodstream infection
4676061|NCT03391960|Central line associated bloodstream infection|central line associated bloodstream infection
4676062|NCT03391960|Catheter related bloodstream infection|catheter related bloodstream infection
4676063|NCT03391960|Intravascular device|intravascular device
4676064|NCT03391960|Catheter port|catheter port
4676065|NCT03391947|gingival recession|gingival recession
4676066|NCT03391947|semilunar coronally flap|semilunar coronally flap
4676067|NCT03391947|coronally advanced flap|coronally advanced flap
4676068|NCT03391934|RAS Wild-type|ras wild-type
4676069|NCT03391934|Cetuximab|cetuximab
4676070|NCT03391934|Metastatic Colorectal Cancer|metastatic colorectal cancer
4676071|NCT03391921|vaccine|vaccine
4676072|NCT03391921|woman|woman
4676073|NCT03391908|vulnerable plaques, acute coronary syndromes, NSTEMI, vulnerable patient|vulnerable plaques, acute coronary syndromes, nstemi, vulnerable patient
4676074|NCT03391895|Adolescent Idiopathic Scoliosis|adolescent idiopathic scoliosis
4676075|NCT03391895|Scoliosis|scoliosis
4676076|NCT03391895|Inspiratory Muscle Training|inspiratory muscle training
4676077|NCT03391895|Exercise Training|exercise training
4676078|NCT03391895|Respiratory Exercise Training|respiratory exercise training
4676079|NCT03391895|Pulmonary Function Test|pulmonary function test
4676080|NCT03391895|6-Minute Walk test|6-minute walk test
4676081|NCT03391895|Respiratory Muscle Strength|respiratory muscle strength
4676082|NCT03391882|Parkinson's Disease|parkinson's disease
4676083|NCT03391882|"Off Episodes"|"off episodes"
4676084|NCT03391882|motor fluctuations associated with Parkinson's Disease|motor fluctuations associated with parkinson's disease
4676334|NCT03390296|AML|aml
4676085|NCT03391869|Malignant neoplasms of respiratory and intrathoracic organs|malignant neoplasms of respiratory and intrathoracic organs
4676086|NCT03391869|Non-small cell lung cancer|non-small cell lung cancer
4676087|NCT03391869|NSCLC|nsclc
4676088|NCT03391869|Ipilimumab|ipilimumab
4676089|NCT03391869|Yervoy|yervoy
4676090|NCT03391869|BMS-734016|bms-734016
4676091|NCT03391869|MDX010|mdx010
4676092|NCT03391869|Nivolumab|nivolumab
4676093|NCT03391869|BMS-936558|bms-936558
4676094|NCT03391869|Opdivo|opdivo
4676095|NCT03391869|Local Consolidative Therapy|local consolidative therapy
4676096|NCT03391869|LCT|lct
4676097|NCT03391843|Local Advanced Rectal Cancer|local advanced rectal cancer
4676098|NCT03391843|Neoadjuvant Chemotherapy|neoadjuvant chemotherapy
4676099|NCT03391843|FOLFOXIRI|folfoxiri
4676100|NCT03391843|Cetuximab|cetuximab
4676101|NCT03391843|EGFR wild type|egfr wild type
4676102|NCT03391804|Oxalate|oxalate
4676103|NCT03391804|Kidney Stones|kidney stones
4676104|NCT03391804|oxalate nephropathy|oxalate nephropathy
4676105|NCT03391804|systemic oxalosis|systemic oxalosis
4676106|NCT03391791|Cell Therapy|cell therapy
4676107|NCT03391791|T Cell Therapy|t cell therapy
4676108|NCT03391791|SPEAR T Cell|spear t cell
4676109|NCT03391791|Immuno-oncology|immuno-oncology
4676110|NCT03391791|Metastatic|metastatic
4676111|NCT03391791|T Cell Receptor|t cell receptor
4676112|NCT03391791|Long Term Follow Up|long term follow up
4676113|NCT03391791|Genetically Engineered|genetically engineered
4676114|NCT03391778|Solid and Hematological Malignancies|solid and hematological malignancies
4676115|NCT03391778|Cell Therapy|cell therapy
4676116|NCT03391778|T Cell Therapy|t cell therapy
4676117|NCT03391778|SPEAR T Cell|spear t cell
4676118|NCT03391778|Immuno-oncology|immuno-oncology
4676119|NCT03391778|NY-ESO-1|ny-eso-1
4676120|NCT03391778|Metastatic|metastatic
4676121|NCT03391778|Previously Treated|previously treated
4676122|NCT03391778|T Cell Receptor|t cell receptor
4676123|NCT03391778|Safety|safety
4676124|NCT03391778|Long Term Follow Up|long term follow up
4676125|NCT03391778|Genetically engineered|genetically engineered
4676126|NCT03391765|tauopathy|tauopathy
4676127|NCT03391765|Steele-Richardson-Olszewski Syndrome|steele-richardson-olszewski syndrome
4676128|NCT03391765|PSP|psp
4676129|NCT03391752|malnutrition, screening, assessment, treatment|malnutrition, screening, assessment, treatment
4676130|NCT03391713|awareness|awareness
4676131|NCT03391713|poster|poster
4676132|NCT03391713|stroke|stroke
4676133|NCT03391700|muscle relaxant|muscle relaxant
4676134|NCT03391687|Gastric Cancer|gastric cancer
4676135|NCT03391687|Pancreatic Fistula|pancreatic fistula
4676136|NCT03391687|Gastrectomy|gastrectomy
4676137|NCT03391635|acupuncture|acupuncture
4676138|NCT03391635|functional constipation|functional constipation
4676139|NCT03391635|transcutaneous electric nerve stimulation|transcutaneous electric nerve stimulation
4676140|NCT03391635|randomized controlled trial|randomized controlled trial
4676141|NCT03391622|thrombin generation|thrombin generation
4676142|NCT03391622|calibrated automated thrombogram|calibrated automated thrombogram
4676143|NCT03391622|ischemic heart disease|ischemic heart disease
4676144|NCT03391622|Percutaneous Coronary Intervention|percutaneous coronary intervention
4676145|NCT03391596|Family caregivers|family caregivers
4676146|NCT03391596|Depressive symptoms|depressive symptoms
4676147|NCT03391596|Psychological wellbeing|psychological wellbeing
4676148|NCT03391596|Internet-based intervention|internet-based intervention
4676149|NCT03391596|Acceptance and Commitment Therapy|acceptance and commitment therapy
4676150|NCT03391583|Education|education
4676151|NCT03391583|Pain|pain
4676152|NCT03391570|Laparoscopic surgery|laparoscopic surgery
4676153|NCT03391570|COX-2 inhibitor|cox-2 inhibitor
4676154|NCT03391570|Celecoxib|celecoxib
4676155|NCT03391570|Prostanoid|prostanoid
4676156|NCT03391557|Elastography|elastography
4676157|NCT03391557|Lymph node|lymph node
4676158|NCT03391557|Diagnosis|diagnosis
4676159|NCT03391531|surgery: laparoscopic cholecystectomy|surgery: laparoscopic cholecystectomy
4676160|NCT03391531|analgesia: postoperative|analgesia: postoperative
4676161|NCT03391531|locoregional analgesia: transversus abdominis plane block|locoregional analgesia: transversus abdominis plane block
4676162|NCT03391531|opioid: side effects|opioid: side effects
4676163|NCT03391505|Cognition|cognition
4676164|NCT03391505|Physical activity|physical activity
4676165|NCT03391505|Memory|memory
4676166|NCT03391505|Health|health
4676167|NCT03391492|ICU|icu
4676168|NCT03391427|Lidocaine|lidocaine
4676169|NCT03391427|Ketamine|ketamine
4676170|NCT03391427|postoperative analgesia|postoperative analgesia
4676171|NCT03391414|thick mucus|thick mucus
4676172|NCT03391414|obstructive lung disease|obstructive lung disease
4676173|NCT03391362|Small Cell Lung Cancer|small cell lung cancer
4676174|NCT03391362|Brain Metastases|brain metastases
4676175|NCT03391362|Brain metastasis|brain metastasis
4676176|NCT03391362|Lung cancer|lung cancer
4676177|NCT03391362|Stereotactic radiation|stereotactic radiation
4676178|NCT03391362|Stereotactic radiosurgery|stereotactic radiosurgery
4676179|NCT03391362|SRS|srs
4676180|NCT03391362|Stereotactic|stereotactic
4676181|NCT03391362|Radiation|radiation
4676182|NCT03391362|Quality of life|quality of life
4676183|NCT03391362|Neurocognitive|neurocognitive
4676184|NCT03391362|Neurocognition|neurocognition
4676185|NCT03391349|proteomes, chronic periodontitis|proteomes, chronic periodontitis
4676186|NCT03391336|Carpal tunnel syndrome|carpal tunnel syndrome
4676187|NCT03391336|Median nerve injury|median nerve injury
4676188|NCT03391336|Steroids|steroids
4676189|NCT03391336|Ultrasound|ultrasound
4676190|NCT03391336|Injections|injections
4676191|NCT03391297|PTSD; prolonged exposure; posttraumatic growth|ptsd; prolonged exposure; posttraumatic growth
4676192|NCT03391258|Maxilary atrophy|maxilary atrophy
4676193|NCT03391258|Leucocyte-platelet-rich-fibrin|leucocyte-platelet-rich-fibrin
4676194|NCT03391258|bone resorption|bone resorption
4676195|NCT03391258|autologous growth factors|autologous growth factors
4676196|NCT03391258|guided-bone-regeneration|guided-bone-regeneration
4676197|NCT03391258|lip support|lip support
4676198|NCT03391206|Breast cancer related lymphedemas|breast cancer related lymphedemas
4676199|NCT03391206|Sentinel Lymph Node Biopsy|sentinel lymph node biopsy
4676200|NCT03391206|Axillary Lymph Node Dissection|axillary lymph node dissection
4676201|NCT03391206|Bioelectrical Impedance Analysis|bioelectrical impedance analysis
4676202|NCT03391206|Dietary Fat|dietary fat
4676203|NCT03391193|Influenza|influenza
4676304|NCT03390517|indocyanine green|indocyanine green
4676204|NCT03391193|Quadrivalent Inactivated Influenza Vaccine|quadrivalent inactivated influenza vaccine
4676205|NCT03391193|Multi-dose Presentation|multi-dose presentation
4676206|NCT03391141|obstructive sleep apnea|obstructive sleep apnea
4676207|NCT03391141|sleep endoscopy|sleep endoscopy
4676208|NCT03391141|drug induced sleep endoscopy|drug induced sleep endoscopy
4676209|NCT03391141|diagnostic validation|diagnostic validation
4676210|NCT03391115|Psychosocial|psychosocial
4676211|NCT03391115|Underserved|underserved
4676212|NCT03391115|Palliative|palliative
4676213|NCT03391115|Electronic Health Record|electronic health record
4676214|NCT03391115|Narrative|narrative
4676215|NCT03391102|Epidemiology|epidemiology
4676216|NCT03391102|Community-based study|community-based study
4676217|NCT03391050|Melanoma|melanoma
4676218|NCT03391050|Malignant melanoma|malignant melanoma
4676219|NCT03391050|Skin cancer|skin cancer
4676220|NCT03391050|Resistant cancer|resistant cancer
4676221|NCT03391050|Unresectable cancer|unresectable cancer
4676222|NCT03391050|Metastatic cancer|metastatic cancer
4676223|NCT03391050|BRAF mutant|braf mutant
4676224|NCT03390998|Pregnancy-related SCAD|pregnancy-related scad
4676225|NCT03390998|Myocardial Infarction|myocardial infarction
4676226|NCT03390972|Dexmedetomidine|dexmedetomidine
4676227|NCT03390972|Swallowing function|swallowing function
4676228|NCT03390972|Anesthetic sedation|anesthetic sedation
4676229|NCT03390959|Proprioception|proprioception
4676230|NCT03390959|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
4676231|NCT03390959|Postural Balance|postural balance
4676232|NCT03390959|Gait|gait
4676233|NCT03390959|Posture|posture
4676234|NCT03390946|four-drugs, interval-compression|four-drugs, interval-compression
4676235|NCT03390920|regenerative medicine|regenerative medicine
4676236|NCT03390920|arthritis|arthritis
4676237|NCT03390920|amniotic|amniotic
4676238|NCT03390920|stem cell|stem cell
4676239|NCT03390920|growth factor|growth factor
4676240|NCT03390920|cartilage|cartilage
4676241|NCT03390907|Colon polyp|colon polyp
4676242|NCT03390907|EMR|emr
4676243|NCT03390907|Hybrid-APC|hybrid-apc
4676244|NCT03390907|Laterally spreading tumor|laterally spreading tumor
4676245|NCT03390894|Long-term Follow-Up|long-term follow-up
4676246|NCT03390894|Invasive Breast Cancer Early Stages|invasive breast cancer early stages
4676247|NCT03390894|Previous Neoadjuvant treatment|previous neoadjuvant treatment
4676248|NCT03390894|Previous Adjuvant treatment|previous adjuvant treatment
4676249|NCT03390881|breath acetone|breath acetone
4676250|NCT03390881|energy balance|energy balance
4676251|NCT03390868|Interaction|interaction
4676252|NCT03390868|challenging behaviour|challenging behaviour
4676253|NCT03390868|training|training
4676254|NCT03390855|IL-6|il-6
4676255|NCT03390855|Glucosinolate|glucosinolate
4676256|NCT03390855|Brassica oleracea|brassica oleracea
4676257|NCT03390855|Sulphoraphane|sulphoraphane
4676258|NCT03390855|Biomarkers|biomarkers
4676259|NCT03390855|Bioavailability|bioavailability
4676260|NCT03390855|Inflammation|inflammation
4676261|NCT03390842|blood bicarbonate, kidney disease|blood bicarbonate, kidney disease
4676262|NCT03390816|malnutrition|malnutrition
4676263|NCT03390816|cancer|cancer
4676264|NCT03390816|elderly|elderly
4676265|NCT03390764|Incisional hernia|incisional hernia
4676266|NCT03390764|4:1-technique|4:1-technique
4676267|NCT03390764|RTL-suture|rtl-suture
4676268|NCT03390751|atropinic drugs|atropinic drugs
4676269|NCT03390751|confusion|confusion
4676270|NCT03390751|elderly patients|elderly patients
4676271|NCT03390725|Prevention, obesity, parenting, diet, physical activity|prevention, obesity, parenting, diet, physical activity
4676272|NCT03390712|Paliperidone palmitate|paliperidone palmitate
4676273|NCT03390712|Risperidone long-acting injection|risperidone long-acting injection
4676274|NCT03390712|mirror-image|mirror-image
4676275|NCT03390673|randomized|randomized
4676276|NCT03390673|double-blind|double-blind
4676277|NCT03390647|E6130|e6130
4676278|NCT03390647|Healthy adult male participants|healthy adult male participants
4676279|NCT03390647|Phase 1|phase 1
4676280|NCT03390647|Pharmacokinetics|pharmacokinetics
4676281|NCT03390621|parent feeding styles|parent feeding styles
4676282|NCT03390621|dietary quality|dietary quality
4676283|NCT03390621|dinner meal|dinner meal
4676284|NCT03390621|preschool|preschool
4676285|NCT03390621|low-income|low-income
4676286|NCT03390595|Urothelial carcinoma|urothelial carcinoma
4676287|NCT03390582|Gut Microbiota|gut microbiota
4676288|NCT03390582|Hashimoto Thyroiditis|hashimoto thyroiditis
4676289|NCT03390582|Graves' Disease|graves' disease
4676290|NCT03390582|Methimazole|methimazole
4676291|NCT03390582|Levothyroxine sodium|levothyroxine sodium
4676292|NCT03390582|16S rRNA gene|16s rrna gene
4676293|NCT03390582|Metabonomics|metabonomics
4676294|NCT03390569|GBM|gbm
4676295|NCT03390569|Glioblastoma|glioblastoma
4676296|NCT03390569|Brain Cancer|brain cancer
4676297|NCT03390569|High-Grade Glioma|high-grade glioma
4676298|NCT03390569|Glioma|glioma
4676299|NCT03390530|Thyroxine|thyroxine
4676300|NCT03390530|Intraventricular hemorrhage|intraventricular hemorrhage
4676301|NCT03390530|MRI with DTI,|mri with dti,
4676302|NCT03390530|Neurodevelopmental outcome|neurodevelopmental outcome
4676303|NCT03390517|fluorescence angiography|fluorescence angiography
4676305|NCT03390517|anastomotic leakage|anastomotic leakage
4676306|NCT03390478|Frailty|frailty
4676307|NCT03390478|Aged|aged
4676308|NCT03390478|Cognitive Stimulation|cognitive stimulation
4676309|NCT03390478|Technology|technology
4676310|NCT03390452|mHealth|mhealth
4676311|NCT03390452|Oral Health|oral health
4676312|NCT03390452|Primary School Children|primary school children
4676313|NCT03390452|Mobile Phone Messaging|mobile phone messaging
4676314|NCT03390439|Striae alba|striae alba
4676315|NCT03390439|Microneedling|microneedling
4676316|NCT03390439|Fractional nonablative laser|fractional nonablative laser
4676317|NCT03390439|dermaroller|dermaroller
4676318|NCT03390439|Nd-yap 1340nm laser|nd-yap 1340nm laser
4676319|NCT03390439|Percutaneous Collagen Induction Therapy|percutaneous collagen induction therapy
4676320|NCT03390426|Perifemoral|perifemoral
4676321|NCT03390426|Tourniquet|tourniquet
4676322|NCT03390426|Mepivacaine|mepivacaine
4676323|NCT03390426|Tourniquet Hypertension|tourniquet hypertension
4676324|NCT03390413|Cryoablation|cryoablation
4676325|NCT03390413|Robot-assisted surgical resection|robot-assisted surgical resection
4676326|NCT03390400|Laser Cataract Surgery|laser cataract surgery
4676327|NCT03390387|Acute lymphoblastic leukemia, children, adolescents, treatment|acute lymphoblastic leukemia, children, adolescents, treatment
4676328|NCT03390374|Nystatin|nystatin
4676329|NCT03390374|Fungal colonization|fungal colonization
4676330|NCT03390374|Systemic fungal infections|systemic fungal infections
4676331|NCT03390361|Laser Cataract Surgery|laser cataract surgery
4676332|NCT03390361|Prostaglandin|prostaglandin
4676333|NCT03390296|Acute Myeloid Leukemia|acute myeloid leukemia
4676335|NCT03390296|Relapsed/refractory|relapsed/refractory
4676337|NCT03390296|PF-04518600|pf-04518600
4676338|NCT03390296|Avelumab|avelumab
4676339|NCT03390296|MSB0010718C|msb0010718c
4676340|NCT03390296|Azacitidine|azacitidine
4676341|NCT03390296|5-azacytidine|5-azacytidine
4676342|NCT03390296|5-AZA|5-aza
4676343|NCT03390296|Vidaza|vidaza
4676344|NCT03390296|5-AZC|5-azc
4676345|NCT03390296|AZA-CR|aza-cr
4676346|NCT03390296|Ladakamycin|ladakamycin
4676347|NCT03390296|NSC-102816|nsc-102816
4676348|NCT03390296|Azacytidine|azacytidine
4676349|NCT03390296|Utomilumab|utomilumab
4676350|NCT03390296|PF-05082566|pf-05082566
4676351|NCT03390296|Anti-CD137|anti-cd137
4676352|NCT03390296|Gemtuzumab ozogamicin|gemtuzumab ozogamicin
4676353|NCT03390296|Gemtuzumab|gemtuzumab
4676354|NCT03390296|Mylotarg|mylotarg
4676355|NCT03390296|Glasdegib|glasdegib
4676356|NCT03390296|PF-04449913|pf-04449913
4676357|NCT03390283|Survey|survey
4676358|NCT03390283|Questionnaire|questionnaire
4676359|NCT03390270|intensive care units|intensive care units
4676360|NCT03390270|critical care|critical care
4676361|NCT03390270|risk assessment|risk assessment
4676362|NCT03390270|electronic health records|electronic health records
4676363|NCT03390257|Endoscopy, BSD|endoscopy, bsd
4676364|NCT03390231|Stem Cell Educator|stem cell educator
4676365|NCT03390231|Immune modulation|immune modulation
4676366|NCT03390231|Diabetes|diabetes
4676367|NCT03390231|Autoimmune|autoimmune
4676368|NCT03390231|Insulin resistance|insulin resistance
4676369|NCT03390231|Pancreatic islets|pancreatic islets
4676370|NCT03390192|Noninvasive brain stimulation|noninvasive brain stimulation
4676371|NCT03390192|Repetitive Transcranial Magnetic Stimulation|repetitive transcranial magnetic stimulation
4676372|NCT03390192|Transcranial Direct Current Stimulation|transcranial direct current stimulation
4676373|NCT03390179|diabetes|diabetes
4676374|NCT03390179|anesthesia|anesthesia
4676375|NCT03390179|surgery|surgery
4676376|NCT03390179|glucose|glucose
4676377|NCT03390166|GPO Tri Fluvac Vaccine|gpo tri fluvac vaccine
4676378|NCT03390166|Tri Fluvac vaccine|tri fluvac vaccine
4676379|NCT03390140|Spinal Cord Injuries|spinal cord injuries
4676380|NCT03390140|Group Intervention|group intervention
4676381|NCT03390140|Self Efficacy|self efficacy
4676382|NCT03390127|elderly|elderly
4676383|NCT03390127|lithotomy position|lithotomy position
4676384|NCT03390127|PEEP|peep
4676385|NCT03390127|laryngeal mask airway|laryngeal mask airway
4676386|NCT03390114|HIV|hiv
4676387|NCT03390114|Insomnia|insomnia
4676388|NCT03390114|Cognitive Behavioral Therapy|cognitive behavioral therapy
4676389|NCT03390088|Heart failure|heart failure
4676390|NCT03390075|shelf nutrition label, NuVal|shelf nutrition label, nuval
4676391|NCT03390049|SmartXide 2 V 2 LR|smartxide 2 v 2 lr
4676392|NCT03390049|MonaLisa Touch|monalisa touch
4676393|NCT03390049|DEKA|deka
4676394|NCT03390049|Fractional CO2 Laser|fractional co2 laser
4676395|NCT03390049|Sham Laser|sham laser
4676396|NCT03390049|Vulvodynia|vulvodynia
4676397|NCT03390049|PVD|pvd
4676398|NCT03390049|Provoked vestibulodynia|provoked vestibulodynia
4676399|NCT03390023|Prenatal Care|prenatal care
4676400|NCT03390023|Barriers|barriers
4676401|NCT03390023|Clinical Trials|clinical trials
4676402|NCT03389997|respiratory tract infections|respiratory tract infections
4676403|NCT03389997|virus shedding|virus shedding
4676404|NCT03389997|cancer|cancer
4676405|NCT03389997|Immunocompromised Host|immunocompromised host
4676406|NCT03389958|intrauterine device|intrauterine device
4676407|NCT03389958|postpartum contraception|postpartum contraception
4676408|NCT03389958|repeat pregnancy|repeat pregnancy
4676409|NCT03389958|adolescent pregnancy|adolescent pregnancy
4676410|NCT03389945|Labor analgesia|labor analgesia
4676411|NCT03389945|Dural puncture epidural|dural puncture epidural
4676412|NCT03389945|Postdural puncture headache|postdural puncture headache
4676413|NCT03389945|Neuraxial analgesia|neuraxial analgesia
4676414|NCT03389893|randomized double-masked (blind) placebo-controlled trial|randomized double-masked (blind) placebo-controlled trial
4676415|NCT03389893|Thelper2 (Th2) effect|thelper2 (th2) effect
4676416|NCT03389893|cutaneous microbial community|cutaneous microbial community
4676417|NCT03389893|skin barrier|skin barrier
4676418|NCT03389867|Male sexual health|male sexual health
4676419|NCT03389867|Erectile function|erectile function
4676420|NCT03389841|home care services|home care services
4676421|NCT03389841|comorbidity|comorbidity
4676422|NCT03389841|heart failure|heart failure
4676423|NCT03389841|caregivers|caregivers
4676424|NCT03389841|health education|health education
4676425|NCT03389841|patient admission|patient admission
4676426|NCT03389828|Focus Group|focus group
4676427|NCT03389828|Health Disparities|health disparities
4676428|NCT03389828|Occupational Health|occupational health
4676429|NCT03389828|Behaviors|behaviors
4676430|NCT03389789|pain|pain
4676431|NCT03389789|infant|infant
4676432|NCT03389789|near-infrared spectroscopy|near-infrared spectroscopy
4676433|NCT03389789|non pharmacological analgesia|non pharmacological analgesia
4676434|NCT03389763|Surgical Pleth Index (SPI)|surgical pleth index (spi)
4676435|NCT03389763|Pupillary Dilatation Reflex (PRD)|pupillary dilatation reflex (prd)
4676436|NCT03389763|Intraoperative Blood Loss (IBL)|intraoperative blood loss (ibl)
4676437|NCT03389763|Boezaart Bleeding Scale (BBS)|boezaart bleeding scale (bbs)
4676438|NCT03389763|Spectral Entropy (SE)|spectral entropy (se)
4676439|NCT03389763|Adequacy of Anaesthesia (AoA)|adequacy of anaesthesia (aoa)
4676440|NCT03389763|Total Intravenous Anaesthesia (TIVA)|total intravenous anaesthesia (tiva)
4676441|NCT03389711|Rheumatoid Arthritis Mexico|rheumatoid arthritis mexico
4676442|NCT03389711|Early Rheumatoid Arthritis Cohort Mexico|early rheumatoid arthritis cohort mexico
4676443|NCT03389685|Platelet Rich Plasma|platelet rich plasma
4676444|NCT03389672|patient safety|patient safety
4676445|NCT03389672|residency training|residency training
4676446|NCT03389659|mCRC|mcrc
4676447|NCT03389659|oxaliplatin plus fluoropyrimidine|oxaliplatin plus fluoropyrimidine
4676448|NCT03389620|CT-fluoroscopy|ct-fluoroscopy
4676449|NCT03389620|Corticosteroid injection|corticosteroid injection
4676450|NCT03389607|SCUBE-1|scube-1
4676451|NCT03389594|Surgical guide|surgical guide
4676452|NCT03389594|Computer guided implantology|computer guided implantology
4676453|NCT03389594|CBCT voxel size|cbct voxel size
4676454|NCT03389555|Sepsis|sepsis
4676455|NCT03389555|Metabolic Resuscitation|metabolic resuscitation
4676456|NCT03389503|Access site|access site
4676457|NCT03389503|Transradial access|transradial access
4676458|NCT03389503|Coronary artery disease|coronary artery disease
4676459|NCT03389503|Learning curve|learning curve
4676460|NCT03389451|68Ga-PSMA-11|68ga-psma-11
4676461|NCT03389451|(68Ga)Glu-urea-Lys(Ahx)-HBED-CC|(68ga)glu-urea-lys(ahx)-hbed-cc
4676462|NCT03389451|68Ga PSMA-HBED-CC|68ga psma-hbed-cc
4676463|NCT03389438|Immunotherapy|immunotherapy
4676464|NCT03389399|Brigatinib|brigatinib
4676465|NCT03389399|Early Onset Pulmonary Events|early onset pulmonary events
4676466|NCT03389386|Congestive Heart Failure|congestive heart failure
4676467|NCT03389386|Catestatin|catestatin
4676468|NCT03389386|Chromogranin A|chromogranin a
4676469|NCT03389386|Echocardiography|echocardiography
4676470|NCT03389386|Biomarkers|biomarkers
4676471|NCT03389386|Ventricular Dysfunction, Left|ventricular dysfunction, left
4676472|NCT03389386|Comorbidity|comorbidity
4676473|NCT03389373|Dental Caries|dental caries
4676474|NCT03389321|pharmacokinetics|pharmacokinetics
4676475|NCT03389321|macitentan|macitentan
4676476|NCT03389321|riociguat|riociguat
4676477|NCT03389308|Epidermolysis Bullosa Simplex|epidermolysis bullosa simplex
4676478|NCT03389308|Epidermolysis Bullosa|epidermolysis bullosa
4676479|NCT03389308|Skin Blister|skin blister
4676480|NCT03389308|Erosions|erosions
4676481|NCT03389295|Nasopharyngeal Carcinoma|nasopharyngeal carcinoma
4676482|NCT03389295|Reduced Target Delineation|reduced target delineation
4676483|NCT03389295|Sequential chemoradiotherapy|sequential chemoradiotherapy
4676484|NCT03389282|Tear, Metabolite|tear, metabolite
4676485|NCT03389256|apatinib|apatinib
4676486|NCT03389256|T790 negative|t790 negative
4676487|NCT03389256|NSCLC|nsclc
4676488|NCT03389243|Surgical Pleth Index (SPI)|surgical pleth index (spi)
4676489|NCT03389243|General Anaesthesia (GA),|general anaesthesia (ga),
4676490|NCT03389243|Numerical Rating Scale (NRS)|numerical rating scale (nrs)
4676491|NCT03389243|Adequacy of Anaesthesia (AoA)|adequacy of anaesthesia (aoa)
4676492|NCT03389243|Oculocardiac reflex (OCR)|oculocardiac reflex (ocr)
4676493|NCT03389243|paracetamol|paracetamol
4676494|NCT03389243|metamizole|metamizole
4676495|NCT03389230|chimeric antigen receptor|chimeric antigen receptor
4676496|NCT03389230|glioblastoma|glioblastoma
4676497|NCT03389217|Multiple Sclerosis|multiple sclerosis
4676498|NCT03389217|Pain|pain
4676499|NCT03389217|Transcranial Direct Current Stimulation|transcranial direct current stimulation
4676500|NCT03389217|tDCS|tdcs
4676501|NCT03389204|Breast surgery|breast surgery
4676502|NCT03389204|Physiotherapy|physiotherapy
4676503|NCT03389204|Breast Cancer|breast cancer
4676504|NCT03389204|Shoulder pain|shoulder pain
4676505|NCT03389204|Shoulder motion|shoulder motion
4676506|NCT03389178|prenatal stress|prenatal stress
4676507|NCT03389178|fetal autonomic nervous system|fetal autonomic nervous system
4676508|NCT03389178|multidimensional FHR variability assessment|multidimensional fhr variability assessment
4676509|NCT03389165|Wearable hip assist robot|wearable hip assist robot
4676510|NCT03389165|Elderly adult|elderly adult
4676511|NCT03389165|Metabolic energy expenditure|metabolic energy expenditure
4676512|NCT03389165|Stair ascent|stair ascent
4676513|NCT03389139|Cesarean|cesarean
4676514|NCT03389139|newborn|newborn
4676515|NCT03389139|cerebral and renal oxygenation|cerebral and renal oxygenation
4676516|NCT03389139|anesthesia|anesthesia
4676517|NCT03389100|diabetes|diabetes
4676518|NCT03389100|hyperglycemia|hyperglycemia
4676519|NCT03389100|tau|tau
4676520|NCT03389061|Epclusa|epclusa
4676521|NCT03389061|Pharmacokinetics|pharmacokinetics
4676522|NCT03389061|Crushing|crushing
4676523|NCT03389035|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
4676524|NCT03389035|CAR-T|car-t
4676525|NCT03389035|CARCIK|carcik
4676526|NCT03389035|Transposon|transposon
4676527|NCT03388983|Prehabilitation|prehabilitation
4676528|NCT03388983|Physical activity|physical activity
4676529|NCT03388983|Lumbar decompression surgery|lumbar decompression surgery
4676530|NCT03388983|Randomized controlled trial|randomized controlled trial
4676531|NCT03388970|vitamin K1|vitamin k1
4676532|NCT03388970|spontaneous intracerebral hemorrhage|spontaneous intracerebral hemorrhage
4676533|NCT03388970|effectiveness|effectiveness
4676534|NCT03388970|outcome|outcome
4676535|NCT03388931|Radiotherapy Dose Escalation|radiotherapy dose escalation
4676536|NCT03388918|Quality of life|quality of life
4676537|NCT03388918|Telerehabilitation|telerehabilitation
4676538|NCT03388918|Cardiac patients|cardiac patients
4676539|NCT03388918|Heart failure|heart failure
4676540|NCT03388905|LifeVest wearable|lifevest wearable
4676541|NCT03388905|cardioverter defibrillator|cardioverter defibrillator
4676542|NCT03388905|LVEF|lvef
4676543|NCT03388892|Angioplasty|angioplasty
4676544|NCT03388892|Drug Eluting Balloon|drug eluting balloon
4676545|NCT03388892|Arteriovenous Graft|arteriovenous graft
4676546|NCT03388866|inhaled aeroallergens|inhaled aeroallergens
4676547|NCT03388866|eczema|eczema
4676548|NCT03388866|pruritus|pruritus
4676549|NCT03388866|life quality|life quality
4676550|NCT03388866|immunotheraphy|immunotheraphy
4676551|NCT03388866|atopic dermatitis|atopic dermatitis
4676552|NCT03388853|Acetylcysteine/Doxofylline|acetylcysteine/doxofylline
4676553|NCT03388853|Acetylcysteine|acetylcysteine
4676554|NCT03388853|Doxofylline|doxofylline
4676555|NCT03388853|Effervescent Tablet|effervescent tablet
4676556|NCT03388853|COPD|copd
4676557|NCT03388840|platelet rich plasma|platelet rich plasma
4676558|NCT03388840|adipose derived stem cells|adipose derived stem cells
4676559|NCT03388840|follicular unit extraction|follicular unit extraction
4676560|NCT03388840|hair transplantation|hair transplantation
4676561|NCT03388814|PPBCS|ppbcs
4676562|NCT03388814|Acute|acute
4676563|NCT03388814|Postoperative|postoperative
4676564|NCT03388814|Mastectomy|mastectomy
4676565|NCT03388814|Breast Reconstruction|breast reconstruction
4676566|NCT03388775|deep vein thrombosis|deep vein thrombosis
4676567|NCT03388775|assessment|assessment
4676568|NCT03388775|risk factors|risk factors
4676569|NCT03388762|Hyperglycemia|hyperglycemia
4676570|NCT03388762|Prediabetes|prediabetes
4676571|NCT03388762|Botanical|botanical
4676572|NCT03388762|Phytochemicals|phytochemicals
4676573|NCT03388762|Dietary Supplements|dietary supplements
4676574|NCT03388762|Berberine|berberine
4676575|NCT03388762|Fenugreek|fenugreek
4676576|NCT03388762|American Ginseng|american ginseng
4676577|NCT03388762|Gymnema|gymnema
4676578|NCT03388762|Banaba|banaba
4676579|NCT03388762|Kudzu|kudzu
4676580|NCT03388762|Cinnamon|cinnamon
4676581|NCT03388762|Glycated hemoglobin|glycated hemoglobin
4676582|NCT03388762|Trigonella|trigonella
4676583|NCT03388762|Blood Glucose|blood glucose
4676584|NCT03388762|Panax|panax
4676585|NCT03388762|Plant Extracts|plant extracts
4676586|NCT03388762|Public Health|public health
4676587|NCT03388762|Chronic Disease|chronic disease
4676588|NCT03388736|preoperative|preoperative
4676589|NCT03388736|anxiety|anxiety
4676590|NCT03388736|orthognathic surgery|orthognathic surgery
4676591|NCT03388736|lavender oil|lavender oil
4676592|NCT03388723|Epigenetics|epigenetics
4676593|NCT03388723|Cardiometabolic risk factors|cardiometabolic risk factors
4676594|NCT03388710|airway, children, endotracheal tube, cuff|airway, children, endotracheal tube, cuff
4676595|NCT03388658|Atrial Fibrillation; Cryoballoon; Ablation;|atrial fibrillation; cryoballoon; ablation;
4676596|NCT03388645|RSV Shedding|rsv shedding
4676597|NCT03388645|Immune Responses|immune responses
4676598|NCT03388645|Neutralizing Antibody Titer|neutralizing antibody titer
4676599|NCT03388645|Upper Respiratory Tract Infection|upper respiratory tract infection
4676600|NCT03388632|Immunotherapy|immunotherapy
4676601|NCT03388632|T Cells|t cells
4676602|NCT03388632|Checkpoint Inhibitor|checkpoint inhibitor
4676603|NCT03388632|IL-15|il-15
4676604|NCT03388632|Combination Therapy|combination therapy
4676605|NCT03388619|Rising PSA|rising psa
4676606|NCT03388619|No evidence of metastatic disease|no evidence of metastatic disease
4676607|NCT03388619|Entire Prostate Bed|entire prostate bed
4676608|NCT03388619|Quality of Life|quality of life
4676609|NCT03388619|Irradiation|irradiation
4676610|NCT03388606|Mood Disorder|mood disorder
4676611|NCT03388606|Teenagers|teenagers
4676612|NCT03388606|Mechanism|mechanism
4676613|NCT03388593|chronic heart failure|chronic heart failure
4676614|NCT03388593|neuregulin|neuregulin
4676615|NCT03388593|mortality|mortality
4676616|NCT03388567|Dispensation|dispensation
4676617|NCT03388567|Health Education|health education
4676618|NCT03388567|Pharmacovigilance|pharmacovigilance
4676619|NCT03388567|Pharmacists|pharmacists
4676620|NCT03388528|Dysmotility|dysmotility
4676621|NCT03388528|Microbiome|microbiome
4676622|NCT03388528|Transit Time|transit time
4676623|NCT03388528|Gastrointestinal|gastrointestinal
4676624|NCT03388502|Total knee arthroplasty|total knee arthroplasty
4676625|NCT03388502|Total hip arthroplasty|total hip arthroplasty
4676626|NCT03388476|pulmonary hypertension|pulmonary hypertension
4676627|NCT03388476|endtidal co2|endtidal co2
4676628|NCT03388476|endtidal carbon dioxide|endtidal carbon dioxide
4676629|NCT03388476|pulmonary arterial hypertension|pulmonary arterial hypertension
4676630|NCT03388437|Non-invasive Neurally Adjusted Ventilatory Assist NI-NAVA|non-invasive neurally adjusted ventilatory assist ni-nava
4676631|NCT03388437|Nasal Intermittent Positive Pressure Ventilation NIPPV|nasal intermittent positive pressure ventilation nippv
4676632|NCT03388437|post extubation|post extubation
4676633|NCT03388424|bacterial DNA, RNA16S gene|bacterial dna, rna16s gene
4676634|NCT03388411|Microbiome|microbiome
4676636|NCT03388398|Mother-to-child transmission of HIV (MTCT)|mother-to-child transmission of hiv (mtct)
4676637|NCT03388398|Prevention of mother-to-child HIV transmission (PMTCT)|prevention of mother-to-child hiv transmission (pmtct)
4676638|NCT03388398|Antiretroviral therapy (ART)|antiretroviral therapy (art)
4676639|NCT03388398|Antenatal care (ANC)|antenatal care (anc)
4676640|NCT03388398|Pediatric infections|pediatric infections
4676641|NCT03388398|Pregnancy|pregnancy
4676642|NCT03388385|CKD, anemia, iron, endothelial dysfunction, oxidative stress|ckd, anemia, iron, endothelial dysfunction, oxidative stress
4676643|NCT03388372|glioma|glioma
4676644|NCT03388372|phase 2|phase 2
4676645|NCT03388372|nimotozumab|nimotozumab
4676646|NCT03388372|temozolomide|temozolomide
4676647|NCT03388372|radiotherapy|radiotherapy
4676648|NCT03388359|asthma|asthma
4676649|NCT03388359|eosinophils|eosinophils
4676650|NCT03388359|Extracellular matrix|extracellular matrix
4676651|NCT03388359|airway smooth muscle|airway smooth muscle
4676652|NCT03388359|airway remodelling|airway remodelling
4676653|NCT03388359|fibroblast|fibroblast
4676654|NCT03388346|68Ga-PSMA-11|68ga-psma-11
4676655|NCT03388346|(68Ga)Glu-urea-Lys(Ahx)-HBED-CC|(68ga)glu-urea-lys(ahx)-hbed-cc
4676656|NCT03388346|68Ga PSMA-HBED-CC|68ga psma-hbed-cc
4676657|NCT03388294|communication|communication
4676658|NCT03388294|sensory|sensory
4676659|NCT03388294|early intervention|early intervention
4676660|NCT03388294|parent coaching|parent coaching
4676661|NCT03388281|Pacemaker|pacemaker
4676662|NCT03388281|Gender differences|gender differences
4676663|NCT03388281|Survival|survival
4676664|NCT03388281|Retrospective|retrospective
4676665|NCT03388268|Clostridium difficile|clostridium difficile
4676666|NCT03388268|Diarrhea|diarrhea
4676667|NCT03388255|Polydeoxyribonucletide|polydeoxyribonucletide
4676668|NCT03388255|Placentex|placentex
4676669|NCT03388255|PDRN|pdrn
4676670|NCT03388229|Dietary pattern|dietary pattern
4676671|NCT03388229|glycemic control|glycemic control
4676672|NCT03388229|type 2 diabetes|type 2 diabetes
4676673|NCT03388229|UAE|uae
4676674|NCT03388203|25(OH)D|25(oh)d
4676675|NCT03388203|PTH|pth
4676676|NCT03388203|mass spectrometry|mass spectrometry
4676677|NCT03388203|data mining|data mining
4676678|NCT03388190|Colorectal|colorectal
4676679|NCT03388190|Cancer|cancer
4676680|NCT03388190|Neoplasm|neoplasm
4676681|NCT03388190|Nivolumab|nivolumab
4676682|NCT03388190|Fluorouracil|fluorouracil
4676683|NCT03388190|Metastatic|metastatic
4676684|NCT03388190|Oxaliplatin|oxaliplatin
4676685|NCT03388190|Leucovorin|leucovorin
4676686|NCT03388177|Depression|depression
4676687|NCT03388177|Young adult women|young adult women
4676688|NCT03388177|Yoga|yoga
4676689|NCT03388112|Probiotics,Gut Microbiome,Antibiotics,Infants|probiotics,gut microbiome,antibiotics,infants
4676690|NCT03388099|gonadotrophin receptor polymorphism|gonadotrophin receptor polymorphism
4676691|NCT03388099|antimüllerian hormone|antimüllerian hormone
4676692|NCT03388099|ovarian response|ovarian response
4676693|NCT03388099|ovarian stimulation|ovarian stimulation
4676694|NCT03388060|Oral Dissolution Therapy|oral dissolution therapy
4676695|NCT03388060|Kidney stone|kidney stone
4676696|NCT03388060|ESWL|eswl
4676697|NCT03388047|Barrett Esophagus|barrett esophagus
4676698|NCT03388047|Endoscopy|endoscopy
4676699|NCT03388047|Adenocarcinoma|adenocarcinoma
4676700|NCT03388021|limb ischemia|limb ischemia
4676701|NCT03388021|completion angiography|completion angiography
4676702|NCT03388021|thromboembolectomy|thromboembolectomy
4676803|NCT03387293|Pediatric Obesity|pediatric obesity
4676703|NCT03388008|donor-specific HLA antibodies|donor-specific hla antibodies
4676704|NCT03388008|lung transplantation|lung transplantation
4676705|NCT03387995|treatment outcome|treatment outcome
4676706|NCT03387956|Postoperative Nuasea|postoperative nuasea
4676707|NCT03387930|Low back pain|low back pain
4676708|NCT03387930|lumbar multifidus|lumbar multifidus
4676709|NCT03387930|Proprioception|proprioception
4676710|NCT03387930|Elastography|elastography
4676711|NCT03387930|Magnetic resonance imaging|magnetic resonance imaging
4676712|NCT03387917|Advanced Solid Tumors|advanced solid tumors
4676713|NCT03387917|doxorubicin|doxorubicin
4676714|NCT03387917|TLD-1|tld-1
4676715|NCT03387917|phase I|phase i
4676716|NCT03387917|Talidox|talidox
4676717|NCT03387917|Liposomal|liposomal
4676718|NCT03387904|Anlotinib|anlotinib
4676719|NCT03387865|banking, biological sampling, tumor tissue, tumor response|banking, biological sampling, tumor tissue, tumor response
4676720|NCT03387826|ticagrelor|ticagrelor
4676721|NCT03387826|prasugrel|prasugrel
4676722|NCT03387813|Heart Failure|heart failure
4676723|NCT03387813|Hemodynamic Monitoring|hemodynamic monitoring
4676724|NCT03387813|CardioMEMS|cardiomems
4676725|NCT03387813|Pulmonary Artery Pressure|pulmonary artery pressure
4676726|NCT03387800|randomized controlled trial|randomized controlled trial
4676727|NCT03387800|smoking cessation|smoking cessation
4676728|NCT03387800|social support|social support
4676729|NCT03387800|positive effect|positive effect
4676730|NCT03387800|online social networking|online social networking
4676731|NCT03387800|theory-based|theory-based
4676732|NCT03387787|GlucoTab, Tresiba, Type 2 Diabetes|glucotab, tresiba, type 2 diabetes
4676733|NCT03387774|Ulinastatin|ulinastatin
4676734|NCT03387774|Radiation-induced acute oral mucositis|radiation-induced acute oral mucositis
4676735|NCT03387774|Localregionally Advanced Nasopharyngeal Carcinoma|localregionally advanced nasopharyngeal carcinoma
4676736|NCT03387774|Intensity Modulated Radiation Therapy|intensity modulated radiation therapy
4676737|NCT03387761|Urothelial cancer|urothelial cancer
4676738|NCT03387761|Bladder cancer|bladder cancer
4676739|NCT03387761|Cancer|cancer
4676740|NCT03387761|Resectable|resectable
4676741|NCT03387761|Operable|operable
4676742|NCT03387761|immunotherapy|immunotherapy
4676743|NCT03387761|Ipilimumab|ipilimumab
4676744|NCT03387761|Nivolumab|nivolumab
4676745|NCT03387761|Neo-Adjuvant|neo-adjuvant
4676746|NCT03387735|Hypertension, Hyperlipidemia, Diabetes, Arthritis, Obesity|hypertension, hyperlipidemia, diabetes, arthritis, obesity
4676747|NCT03387709|Nondiabetic|nondiabetic
4676748|NCT03387709|Overweight|overweight
4676749|NCT03387709|Obesity|obesity
4676750|NCT03387709|Men|men
4676751|NCT03387709|Women|women
4676752|NCT03387709|San Diego|san diego
4676753|NCT03387709|Weight Loss|weight loss
4676754|NCT03387696|Mucormycosis|mucormycosis
4676755|NCT03387696|Intensive Care Medicine|intensive care medicine
4676756|NCT03387631|Efficacy safety uncomplicated malaria AL|efficacy safety uncomplicated malaria al
4676757|NCT03387592|Neuroendocrine Carcinoma|neuroendocrine carcinoma
4676758|NCT03387592|second line therapy|second line therapy
4676759|NCT03387592|PET imaging|pet imaging
4676760|NCT03387592|FOLFIRI|folfiri
4676761|NCT03387592|CAPTEM|captem
4676762|NCT03387553|Immunotherapy|immunotherapy
4676763|NCT03387553|Dendritic Cell Vaccine|dendritic cell vaccine
4676764|NCT03387553|DC1|dc1
4676765|NCT03387540|Anti-PD-1|anti-pd-1
4676766|NCT03387540|Anti-PD-L1|anti-pd-l1
4676767|NCT03387540|Anti CTLA-4|anti ctla-4
4676768|NCT03387540|Immune checkpoint inhibitors|immune checkpoint inhibitors
4676769|NCT03387527|Decision Aid|decision aid
4676770|NCT03387514|Clear Cell|clear cell
4676771|NCT03387514|Kidney Cancer|kidney cancer
4676772|NCT03387514|RCC|rcc
4676773|NCT03387475|efficacy|efficacy
4676774|NCT03387475|safety|safety
4676775|NCT03387462|Adherence|adherence
4676776|NCT03387462|PrEP|prep
4676777|NCT03387462|HIV Prevention|hiv prevention
4676778|NCT03387462|Truvada|truvada
4676779|NCT03387462|HIV Risk Reduction|hiv risk reduction
4676780|NCT03387462|Mobile App|mobile app
4676781|NCT03387436|Palliative care|palliative care
4676782|NCT03387436|Advance care planning|advance care planning
4676783|NCT03387436|psychological intervention|psychological intervention
4676784|NCT03387410|Laparoscopic surgery|laparoscopic surgery
4676785|NCT03387410|Fluorescence|fluorescence
4676786|NCT03387397|Co-morbidities|co-morbidities
4676787|NCT03387371|chronic periodontitis, laser|chronic periodontitis, laser
4676788|NCT03387358|intensive care unit|intensive care unit
4676789|NCT03387358|nasal bridle securement device|nasal bridle securement device
4676790|NCT03387358|small bore feeding tube|small bore feeding tube
4676791|NCT03387358|adverse events|adverse events
4676792|NCT03387358|enteral nutrition|enteral nutrition
4676793|NCT03387345|glucose|glucose
4676794|NCT03387345|dietary fiber|dietary fiber
4676795|NCT03387345|glycemia|glycemia
4676796|NCT03387345|whole grain|whole grain
4676797|NCT03387332|Bcl-2/Bcl-xL dual inhibitor|bcl-2/bcl-xl dual inhibitor
4676798|NCT03387319|Social stress|social stress
4676799|NCT03387319|Inflammation|inflammation
4676800|NCT03387306|serum bilirubin|serum bilirubin
4676801|NCT03387306|normal-tension glaucoma|normal-tension glaucoma
4676802|NCT03387306|oxidative stress|oxidative stress
4676804|NCT03387293|Insulin Resistance|insulin resistance
4676805|NCT03387293|Diet|diet
4676806|NCT03387280|acute myocardial infarction|acute myocardial infarction
4676807|NCT03387280|electrocardiogram|electrocardiogram
4676808|NCT03387280|coronary angiography|coronary angiography
4676809|NCT03387254|virtual reality|virtual reality
4676810|NCT03387254|brain stimulation|brain stimulation
4676811|NCT03387241|moderate|moderate
4676812|NCT03387241|severe|severe
4676813|NCT03387241|persistent|persistent
4676814|NCT03387241|reversible|reversible
4676815|NCT03387241|Seretide|seretide
4676816|NCT03387241|Flutiform|flutiform
4676817|NCT03387228|back pain|back pain
4676818|NCT03387228|low back pain|low back pain
4676819|NCT03387228|Explain Pain|explain pain
4676820|NCT03387228|Pain education|pain education
4676821|NCT03387202|Pelvic Organ Prolapse|pelvic organ prolapse
4676822|NCT03387202|Translabial ultrasound|translabial ultrasound
4676823|NCT03387202|Transperineal ultrasound|transperineal ultrasound
4676824|NCT03387202|Lateral Mesh Suspension|lateral mesh suspension
4676825|NCT03387202|Descensus uteri|descensus uteri
4676826|NCT03387202|Laparoscopic pelvic organ prolapse repair|laparoscopic pelvic organ prolapse repair
4676827|NCT03387163|Heart failure|heart failure
4676828|NCT03387163|Reduced left ventricular ejection fraction|reduced left ventricular ejection fraction
4676829|NCT03387163|Chronic Systolic Heart failure|chronic systolic heart failure
4676830|NCT03387163|Sacubitril /Valsartan|sacubitril /valsartan
4676831|NCT03387163|Patient reported outcomes (PRO)|patient reported outcomes (pro)
4676832|NCT03387163|Kansas City Cardiomyopathy Questionnaire (KCCQ)|kansas city cardiomyopathy questionnaire (kccq)
4676833|NCT03387163|Patient Centered Outcomes Research Network (PCORNeT)|patient centered outcomes research network (pcornet)
4676834|NCT03387163|Common Data Model (CDM)|common data model (cdm)
4676835|NCT03387072|Mental stress|mental stress
4676836|NCT03387072|Sudden cardiac death|sudden cardiac death
4676837|NCT03387072|arrhythmias|arrhythmias
4676838|NCT03387072|long QT syndrome|long qt syndrome
4676839|NCT03387059|Infertility|infertility
4676840|NCT03387059|Forielle|forielle
4676841|NCT03387059|Assisted Reproductive Technique (ART)|assisted reproductive technique (art)
4676842|NCT03387059|Controlled Ovarian Stimulation (COS)|controlled ovarian stimulation (cos)
4676843|NCT03387046|Relapsing remitting multiple sclerosis|relapsing remitting multiple sclerosis
4676844|NCT03387046|D-Aspartate|d-aspartate
4676845|NCT03387046|interferon beta-1a|interferon beta-1a
4676846|NCT03387007|adolescent|adolescent
4676847|NCT03387007|mental health|mental health
4676848|NCT03387007|hope|hope
4676849|NCT03387007|psycho-social support|psycho-social support
4676850|NCT03387007|school teachers|school teachers
4676851|NCT03387007|earthquake|earthquake
4676852|NCT03386981|Energy metabolism|energy metabolism
4676853|NCT03386981|Homeostasis|homeostasis
4676854|NCT03386981|Bone turnover markers|bone turnover markers
4676855|NCT03386968|virtual reality|virtual reality
4676856|NCT03386968|hemiplegia|hemiplegia
4676857|NCT03386968|diplegia|diplegia
4676858|NCT03386968|video gaming|video gaming
4676859|NCT03386968|active video games|active video games
4676860|NCT03386968|Playstation X-Box 360|playstation x-box 360
4676861|NCT03386968|Rutgers V-Step|rutgers v-step
4676862|NCT03386968|Microsoft Kinect|microsoft kinect
4676863|NCT03386955|non-small cell lung cancer|non-small cell lung cancer
4676864|NCT03386955|NSCLC|nsclc
4676865|NCT03386942|Solid Tumors|solid tumors
4676866|NCT03386942|Folate Receptor α (FRA)-Positive Triple Negative Breast Cancer|folate receptor α (fra)-positive triple negative breast cancer
4676867|NCT03386942|FRA-Positive Type 2 Endometrial Carcinoma|fra-positive type 2 endometrial carcinoma
4676868|NCT03386929|NSCLC|nsclc
4676869|NCT03386929|tri-therapy|tri-therapy
4676870|NCT03386929|avelumab|avelumab
4676871|NCT03386929|axitinib|axitinib
4676872|NCT03386929|palbociclib|palbociclib
4676873|NCT03386929|dual matched normal and tumor biopsies|dual matched normal and tumor biopsies
4676874|NCT03386929|SIMS algorithm|sims algorithm
4676875|NCT03386929|Sequencing|sequencing
4676876|NCT03386929|Gene expression|gene expression
4676877|NCT03386916|Technology, Radiologic - Radiography, Interventional - Image-Guided Biopsy - Early Detection of Cancer - Carcinoma, Bronchogenic / diagnosis - Outpatients|technology, radiologic - radiography, interventional - image-guided biopsy - early detection of cancer - carcinoma, bronchogenic / diagnosis - outpatients
4676878|NCT03386890|Non-invasive Assessment|non-invasive assessment
4676879|NCT03386890|Transient Elastography|transient elastography
4676880|NCT03386890|Controlled Attenuation Parameter|controlled attenuation parameter
4676881|NCT03386864|Heart Failure, Diabetes Mellitus, Mitochondrial Respiration|heart failure, diabetes mellitus, mitochondrial respiration
4676882|NCT03386825|Metastatic Colorectal Cancer|metastatic colorectal cancer
4676883|NCT03386812|androgen deprivation therapy|androgen deprivation therapy
4676884|NCT03386812|sarcopenia|sarcopenia
4676885|NCT03386812|bone loss|bone loss
4676886|NCT03386799|Power assistance device|power assistance device
4676887|NCT03386799|Wheelchair|wheelchair
4676888|NCT03386786|Total Knee Arthroplasty|total knee arthroplasty
4676889|NCT03386786|Total Hip Arthroplasty|total hip arthroplasty
4676890|NCT03386786|Total Knee Replacement|total knee replacement
4676891|NCT03386786|Total Hip Replacement|total hip replacement
4676892|NCT03386786|Hospital Care Plan|hospital care plan
4676893|NCT03386786|mHealth|mhealth
4676894|NCT03386773|patient generated health data|patient generated health data
4676895|NCT03386773|patient reported outcome measures|patient reported outcome measures
4676896|NCT03386773|health information technology|health information technology
4676897|NCT03386773|mobile health|mobile health
4676898|NCT03386773|consumer health informatics|consumer health informatics
4676899|NCT03386760|tattoo|tattoo
4676900|NCT03386747|child development|child development
4676901|NCT03386747|neonatal mortality|neonatal mortality
4676902|NCT03386708|Healing Poor After Uterus Injury, Mesenchymal Stem Cell|healing poor after uterus injury, mesenchymal stem cell
4676903|NCT03386695|Cervical Cancer and HPV infection|cervical cancer and hpv infection
4676904|NCT03386669|18F-THK5351 PET|18f-thk5351 pet
4676905|NCT03386669|Tauopathies|tauopathies
4676906|NCT03386656|Osteoarthritis|osteoarthritis
4676907|NCT03386656|Tranexamic acid|tranexamic acid
4676908|NCT03386643|Oral lichen planus|oral lichen planus
4676909|NCT03386643|Probiotics|probiotics
4676910|NCT03386643|Immunomodulation.|immunomodulation.
4676911|NCT03386604|Whey Protein|whey protein
4676912|NCT03386539|heart transplantation|heart transplantation
4676913|NCT03386539|children|children
4676914|NCT03386539|everolimus|everolimus
4676915|NCT03386539|tacrolimus|tacrolimus
4676916|NCT03386539|mycophenolate mofetil|mycophenolate mofetil
4676917|NCT03386539|randomized clinical trial|randomized clinical trial
4676918|NCT03386526|IAP inhibitor|iap inhibitor
4676919|NCT03386513|Antibody Drug Conjugate|antibody drug conjugate
4676920|NCT03386513|Other Hematologic Malignancies|other hematologic malignancies
4676921|NCT03386513|Myeloproliferative Neoplasms|myeloproliferative neoplasms
4676922|NCT03386513|CD123|cd123
4676923|NCT03386513|MDS|mds
4676924|NCT03386513|Relapsed, Refractory|relapsed, refractory
4676925|NCT03386513|Acute Lymphocytic Leukaemia|acute lymphocytic leukaemia
4676926|NCT03386513|Blastic Plasmacytoid Dendritic Cell Neoplasm|blastic plasmacytoid dendritic cell neoplasm
4676927|NCT03386513|Acute Myeloid Leukemia|acute myeloid leukemia
4676928|NCT03386474|double-masked, extension study|double-masked, extension study
4676929|NCT03386474|neovascular age-related macular degeneration|neovascular age-related macular degeneration
4676930|NCT03386474|intravitreal injection|intravitreal injection
4676931|NCT03386474|brolucizumab|brolucizumab
4676932|NCT03386474|aflibercept|aflibercept
4676933|NCT03386461|elderly|elderly
4676934|NCT03386461|exercise training|exercise training
4676935|NCT03386461|adipose tissue|adipose tissue
4676936|NCT03386461|omega-3 polyunsaturated fatty acids|omega-3 polyunsaturated fatty acids
4676937|NCT03386461|inflammation|inflammation
4676938|NCT03386461|diferentiation of preadipocytes|diferentiation of preadipocytes
4676939|NCT03386435|remote ischemic preconditioning|remote ischemic preconditioning
4676940|NCT03386435|liver donors|liver donors
4676941|NCT03386422|Mindfulness|mindfulness
4676942|NCT03386422|Self-Compassion|self-compassion
4676943|NCT03386422|Chronic Pain|chronic pain
4676944|NCT03386422|Psychological Intervention|psychological intervention
4676945|NCT03386422|Cognitive-Behavioural therapy|cognitive-behavioural therapy
4676946|NCT03386422|acceptance|acceptance
4676947|NCT03386422|catastrophising|catastrophising
4676948|NCT03386422|Self-Care|self-care
4676949|NCT03386422|Quality of life|quality of life
4676950|NCT03386409|Injury prevention|injury prevention
4676951|NCT03386383|adolescent and young adult|adolescent and young adult
4676952|NCT03386383|cancer survivor|cancer survivor
4676953|NCT03386370|Acute ischemia|acute ischemia
4676954|NCT03386370|Lower Limb|lower limb
4676955|NCT03386318|concentration|concentration
4676956|NCT03386292|prevalence|prevalence
4676957|NCT03386292|urinary incontinence|urinary incontinence
4676958|NCT03386292|anal incontinence|anal incontinence
4676959|NCT03386292|risk factors|risk factors
4676960|NCT03386292|women|women
4676961|NCT03386279|healthy volunteers|healthy volunteers
4676962|NCT03386266|Biomarkers|biomarkers
4676963|NCT03386266|CMT1A|cmt1a
4676964|NCT03386266|Charcot-Marie-Tooth disease|charcot-marie-tooth disease
4676965|NCT03386227|Assisted Reproductive Technology|assisted reproductive technology
4676966|NCT03386227|Antibiotic Prophylaxis|antibiotic prophylaxis
4676967|NCT03386227|Microbiome|microbiome
4676968|NCT03386201|Laparoscopic cholecystectomy|laparoscopic cholecystectomy
4676969|NCT03386201|Fluorescence|fluorescence
4676970|NCT03386162|Breast cancer, PI3K, alpelisib|breast cancer, pi3k, alpelisib
4676971|NCT03386149|Herniated Intervertebral Disc of Lumbar Spine|herniated intervertebral disc of lumbar spine
4676972|NCT03386149|Low Back Pain|low back pain
4676973|NCT03386149|Radiculopathy|radiculopathy
4676974|NCT03386149|Bosinji|bosinji
4676975|NCT03386149|Herbal Medicine|herbal medicine
4676976|NCT03386136|bowel ischemia|bowel ischemia
4676977|NCT03386136|bowel perforation|bowel perforation
4676978|NCT03386123|Tinnitus|tinnitus
4676979|NCT03386123|Insomnia|insomnia
4676980|NCT03386123|Cognitive Behaviour Therapy|cognitive behaviour therapy
4676981|NCT03386110|Couples|couples
4676983|NCT03386110|HIV|hiv
4676984|NCT03386110|Drug Use|drug use
4676985|NCT03386097|Cholesterol|cholesterol
4676986|NCT03386097|Interstitial fluid|interstitial fluid
4676987|NCT03386084|capacitive resistive diathermy|capacitive resistive diathermy
4676988|NCT03386084|motor control|motor control
4676989|NCT03386019|lymphatic massage|lymphatic massage
4677277|NCT03384355|ecchymosis|ecchymosis
4676990|NCT03386019|static stretching|static stretching
4676991|NCT03386019|cold water immersion|cold water immersion
4676992|NCT03386006|bariatric surgery|bariatric surgery
4676993|NCT03386006|mobile health (mHealth)|mobile health (mhealth)
4676994|NCT03386006|psychosocial functioning|psychosocial functioning
4676995|NCT03386006|obesity|obesity
4676996|NCT03386006|weight loss|weight loss
4676997|NCT03386006|behavioral activation|behavioral activation
4676998|NCT03385993|Delirium Prevention|delirium prevention
4676999|NCT03385993|Virtual Reality|virtual reality
4677000|NCT03385993|VR|vr
4677001|NCT03385967|upper extremity bone fracture|upper extremity bone fracture
4677002|NCT03385954|nursing|nursing
4677003|NCT03385954|distance|distance
4677004|NCT03385954|education|education
4677005|NCT03385954|RSI/WRMD|rsi/wrmd
4677006|NCT03385928|ICH|ich
4677007|NCT03385928|Stroke|stroke
4677008|NCT03385928|Cerebrovascular Disorders|cerebrovascular disorders
4677009|NCT03385928|Brain Diseases|brain diseases
4677010|NCT03385928|Central Nervous System Diseases|central nervous system diseases
4677011|NCT03385928|Nervous System Diseases|nervous system diseases
4677012|NCT03385928|Vascular Diseases|vascular diseases
4677013|NCT03385928|Cardiovascular Diseases|cardiovascular diseases
4677014|NCT03385928|Tranexamic Acid|tranexamic acid
4677015|NCT03385928|Antifibrinolytic Agents|antifibrinolytic agents
4677016|NCT03385928|Fibrin Modulating Agents|fibrin modulating agents
4677017|NCT03385928|Pharmacologic Actions|pharmacologic actions
4677018|NCT03385928|Cardiovascular Agents|cardiovascular agents
4677019|NCT03385928|Therapeutic Uses|therapeutic uses
4677020|NCT03385928|Hematologic Agents|hematologic agents
4677021|NCT03385928|Hemostatics|hemostatics
4677022|NCT03385928|Contrast Media|contrast media
4677023|NCT03385928|Angiography|angiography
4677024|NCT03385928|Cerebral Angiography|cerebral angiography
4677025|NCT03385928|Tomography, X-Ray Computed|tomography, x-ray computed
4677026|NCT03385915|Transcatheter aortic valve replacement|transcatheter aortic valve replacement
4677027|NCT03385915|Transcatheter aortic valve implantation|transcatheter aortic valve implantation
4677028|NCT03385915|TAVI|tavi
4677029|NCT03385915|TAVR|tavr
4677030|NCT03385915|Aortic valve replacement|aortic valve replacement
4677031|NCT03385915|Surgical aortic valve replacement|surgical aortic valve replacement
4677032|NCT03385915|Sutureless|sutureless
4677033|NCT03385902|advanced chronic kidney disease|advanced chronic kidney disease
4677034|NCT03385902|timing of dialysis initiation|timing of dialysis initiation
4677035|NCT03385902|hemodialysis|hemodialysis
4677036|NCT03385902|fuzzy mathematics|fuzzy mathematics
4677037|NCT03385902|glomerular filtration rate|glomerular filtration rate
4677038|NCT03385889|Cervicogenic Headache|cervicogenic headache
4677039|NCT03385889|Manual Therapy|manual therapy
4677040|NCT03385889|Joint Position Sense|joint position sense
4677041|NCT03385889|Balance|balance
4677042|NCT03385876|Rady Children's|rady children's
4677043|NCT03385876|Pediatric|pediatric
4677044|NCT03385876|Genomic|genomic
4677045|NCT03385876|Precision Medicine|precision medicine
4677046|NCT03385876|Biorepository|biorepository
4677047|NCT03385824|traumatic brain injury|traumatic brain injury
4677048|NCT03385824|advocacy|advocacy
4677049|NCT03385811|Professional quality of life, Medical Professionals, Job Involvement, Intention to Stay,|professional quality of life, medical professionals, job involvement, intention to stay,
4677050|NCT03385798|Endo-GIA Stapler|endo-gia stapler
4677051|NCT03385798|Endowrist Stapler|endowrist stapler
4677052|NCT03385785|Transcatheter aortic valve replacement|transcatheter aortic valve replacement
4677053|NCT03385785|Pressure Recording Analytical Method|pressure recording analytical method
4677054|NCT03385785|Ventriculo-arterial coupling|ventriculo-arterial coupling
4677055|NCT03385785|Monitoring|monitoring
4677056|NCT03385785|Hemodynamic|hemodynamic
4677057|NCT03385772|sphenopalatine block|sphenopalatine block
4677058|NCT03385759|unicompartmental knee|unicompartmental knee
4677059|NCT03385759|total knee arthroplasty|total knee arthroplasty
4677060|NCT03385759|osteoarthritis|osteoarthritis
4677061|NCT03385733|pulmonary hypertension|pulmonary hypertension
4677062|NCT03385733|inspiratory muscle training|inspiratory muscle training
4677063|NCT03385733|functional capacity|functional capacity
4677064|NCT03385733|physical activity|physical activity
4677065|NCT03385707|Post-bariatric hypoglycemia|post-bariatric hypoglycemia
4677066|NCT03385681|pediatric pain|pediatric pain
4677067|NCT03385681|postoperative pain|postoperative pain
4677068|NCT03385681|pain assessment|pain assessment
4677069|NCT03385681|pain management|pain management
4677070|NCT03385681|knowledge|knowledge
4677071|NCT03385681|children|children
4677072|NCT03385681|nurses|nurses
4677073|NCT03385668|Pulmonary fibrosis|pulmonary fibrosis
4677074|NCT03385668|Antibodies, Antineutrophil Cytoplasmic|antibodies, antineutrophil cytoplasmic
4677075|NCT03385668|Anti-Neutrophil Cytoplasmic Antibody (ANCA)-Associated Vasculitis|anti-neutrophil cytoplasmic antibody (anca)-associated vasculitis
4677076|NCT03385668|Pirfenidone|pirfenidone
4677077|NCT03385668|Microscopic Polyangiitis|microscopic polyangiitis
4677078|NCT03385668|Interstitial lung disease|interstitial lung disease
4677079|NCT03385629|Dental Care|dental care
4677080|NCT03385629|Dental Caries|dental caries
4677081|NCT03385629|Common Sense Model of Self-Regulation|common sense model of self-regulation
4677082|NCT03385590|healthy|healthy
4677083|NCT03385577|Gastrointestinal (GI)|gastrointestinal (gi)
4677084|NCT03385577|Fear of Cancer Recurrence (FCR)|fear of cancer recurrence (fcr)
4677085|NCT03385551|Vulvovaginal Atrophy|vulvovaginal atrophy
4677086|NCT03385525|Healthy Volunteer|healthy volunteer
4677087|NCT03385512|Virtual standardized patient coaching|virtual standardized patient coaching
4677088|NCT03385512|Standardized patient instructor coaching|standardized patient instructor coaching
4677089|NCT03385512|Patient centered communication|patient centered communication
4677090|NCT03385499|Congenital toxoplasmosis|congenital toxoplasmosis
4677091|NCT03385499|Neonatal biological diagnosis of congenital toxoplasmosis|neonatal biological diagnosis of congenital toxoplasmosis
4677092|NCT03385499|neonatal diagnosis|neonatal diagnosis
4677093|NCT03385499|ELISPOT|elispot
4677094|NCT03385499|IgG|igg
4677095|NCT03385486|Melanoma|melanoma
4677096|NCT03385486|Resistant|resistant
4677097|NCT03385486|Refractory|refractory
4677098|NCT03385460|Overactive bladder|overactive bladder
4677099|NCT03385460|Botulinum Toxin|botulinum toxin
4677100|NCT03385460|low energy shock waves|low energy shock waves
4677101|NCT03385460|Intravesical|intravesical
4677102|NCT03385434|Colonoscopy; adenoma detection rate; endorings-2; endorings; device-assisted colonoscopy|colonoscopy; adenoma detection rate; endorings-2; endorings; device-assisted colonoscopy
4677103|NCT03385369|MEDI0382|medi0382
4677104|NCT03385369|Safety|safety
4677105|NCT03385369|Tolerability|tolerability
4677106|NCT03385369|Pharmacokinetics|pharmacokinetics
4677107|NCT03385369|Immunogenicity|immunogenicity
4677108|NCT03385330|BPD|bpd
4677109|NCT03385330|Prematurity|prematurity
4677110|NCT03385330|Supplemental Oxygen|supplemental oxygen
4677111|NCT03385330|Oximetry|oximetry
4677112|NCT03385330|Infants|infants
4677113|NCT03385304|Surgical Site Infection|surgical site infection
4677114|NCT03385304|Open Fracture|open fracture
4677115|NCT03385304|Povidone-iodine|povidone-iodine
4677116|NCT03385304|Chlorhexidine gluconate|chlorhexidine gluconate
4677117|NCT03385304|Peri-operative Preparation Solutions|peri-operative preparation solutions
4677118|NCT03385291|EEG;DOC;auditory|eeg;doc;auditory
4677119|NCT03385278|TMS;DOC|tms;doc
4677120|NCT03385252|complementary feeding|complementary feeding
4677121|NCT03385252|eggs|eggs
4677122|NCT03385252|infant growth|infant growth
4677123|NCT03385252|stunting|stunting
4677124|NCT03385252|cognitive development|cognitive development
4677125|NCT03385252|choline|choline
4677126|NCT03385252|vitamin B12|vitamin b12
4677127|NCT03385252|microbiome|microbiome
4677128|NCT03385239|AKCEA-APOCIII-LRx|akcea-apociii-lrx
4677129|NCT03385239|IONIS-APOCIII-LRx|ionis-apociii-lrx
4677130|NCT03385239|Dyslipidemia|dyslipidemia
4677131|NCT03385239|Metabolic Disease|metabolic disease
4677132|NCT03385239|Hyperlipidemia|hyperlipidemia
4677133|NCT03385239|Cardiac Disease|cardiac disease
4677134|NCT03385239|Lipid Metabolism Disorders|lipid metabolism disorders
4677135|NCT03385239|Triglycerides High|triglycerides high
4677136|NCT03385239|Vascular Diseases|vascular diseases
4677137|NCT03385226|Relapsed|relapsed
4677138|NCT03385226|Refractory|refractory
4677139|NCT03385213|Microbiota|microbiota
4677140|NCT03385213|colorectal cancer|colorectal cancer
4677141|NCT03385213|relapse|relapse
4677142|NCT03385213|surveillance|surveillance
4677143|NCT03385200|breast cancer, neoadjuvant chemotherapy, ultrasound, microbubbles|breast cancer, neoadjuvant chemotherapy, ultrasound, microbubbles
4677144|NCT03385161|ethanol ablation of the prostate|ethanol ablation of the prostate
4677145|NCT03385161|Benign prostatic hyperplasia (BPH)|benign prostatic hyperplasia (bph)
4677146|NCT03385161|Prostate|prostate
4677147|NCT03385161|Ethanol|ethanol
4677148|NCT03385161|Transrectal|transrectal
4677149|NCT03385161|BPH|bph
4677150|NCT03385161|onaBoNT-A|onabont-a
4677151|NCT03385161|Botox|botox
4677152|NCT03385161|Lower urinary tract symptoms|lower urinary tract symptoms
4677153|NCT03385161|Botulinum toxin|botulinum toxin
4677154|NCT03385161|OnabotulinumtoxinA|onabotulinumtoxina
4677155|NCT03385161|Quality of life|quality of life
4677156|NCT03385161|IPSS|ipss
4677157|NCT03385161|Randomised controlled study|randomised controlled study
4677158|NCT03385135|allopurinol|allopurinol
4677159|NCT03385135|coronary artery disease|coronary artery disease
4677160|NCT03385135|diabetes|diabetes
4677161|NCT03385135|endothelial function|endothelial function
4677162|NCT03385122|Cardiovascular disease|cardiovascular disease
4677163|NCT03385109|Robotic|robotic
4677164|NCT03385109|Laparoscopic|laparoscopic
4677165|NCT03385044|Endotracheal tube|endotracheal tube
4677166|NCT03385044|Intracuff pressure|intracuff pressure
4677167|NCT03385044|Minimal occlusive volume technique|minimal occlusive volume technique
4677168|NCT03385044|Spirometer|spirometer
4677169|NCT03385044|Endotracheal sealing|endotracheal sealing
4677170|NCT03385031|Dose-guided radiation therapy|dose-guided radiation therapy
4677171|NCT03385031|CBCT|cbct
4677172|NCT03385005|Physical and Rehabilitation Medicine|physical and rehabilitation medicine
4677173|NCT03385005|Transcutaneous Electric Nerve Stimulation|transcutaneous electric nerve stimulation
4677174|NCT03385005|Healthy Volunteer|healthy volunteer
4677175|NCT03385005|Spinal Cord Injury|spinal cord injury
4677176|NCT03385005|Biomedical Engineering|biomedical engineering
4677177|NCT03384992|Fear of Cancer Recurrence|fear of cancer recurrence
4677278|NCT03384355|symptoms|symptoms
4677178|NCT03384992|ehealth interventions|ehealth interventions
4677179|NCT03384992|PROMIS|promis
4677180|NCT03384992|FoR|for
4677181|NCT03384940|Oncology|oncology
4677182|NCT03384940|HER2|her2
4677183|NCT03384940|Colorectal cancer|colorectal cancer
4677184|NCT03384940|Antibody drug conjugate|antibody drug conjugate
4677185|NCT03384940|ADC|adc
4677186|NCT03384927|Treatment diary|treatment diary
4677187|NCT03384914|axillary nodes|axillary nodes
4677188|NCT03384914|HER-2 directed treatment|her-2 directed treatment
4677189|NCT03384888|Fibromyalgia, Neurostimulation, TDCS|fibromyalgia, neurostimulation, tdcs
4677190|NCT03384875|CytoSorb device|cytosorb device
4677191|NCT03384875|Plasma free hemoglobin|plasma free hemoglobin
4677192|NCT03384875|inflammation|inflammation
4677193|NCT03384875|extracorporeal cardiopulmonary bypass|extracorporeal cardiopulmonary bypass
4677194|NCT03384875|cardiopulmonary bypass|cardiopulmonary bypass
4677195|NCT03384875|Acute Kidney Injury|acute kidney injury
4677196|NCT03384862|Arsenic exposure|arsenic exposure
4677197|NCT03384849|Fiber-optic sensor system|fiber-optic sensor system
4677198|NCT03384849|Magnetic resonance imaging|magnetic resonance imaging
4677199|NCT03384849|Medical monitoring|medical monitoring
4677200|NCT03384849|Physiological parameters|physiological parameters
4677201|NCT03384836|Melanoma|melanoma
4677202|NCT03384836|Immune Checkpoint Inhibitors|immune checkpoint inhibitors
4677203|NCT03384836|Beta Adrenergic Blockers|beta adrenergic blockers
4677204|NCT03384823|First-in-Human|first-in-human
4677205|NCT03384823|Single Ascending Dose|single ascending dose
4677206|NCT03384823|Multiple Ascending Dose|multiple ascending dose
4677207|NCT03384810|CPR|cpr
4677208|NCT03384810|cardiac arrest|cardiac arrest
4677209|NCT03384810|inhospital|inhospital
4677210|NCT03384797|blood|blood
4677211|NCT03384797|biomarker|biomarker
4677212|NCT03384797|Parkinson's disease|parkinson's disease
4677213|NCT03384784|HIV|hiv
4677214|NCT03384784|Neurocognition|neurocognition
4677215|NCT03384784|Inflammation|inflammation
4677216|NCT03384784|Galantamine|galantamine
4677217|NCT03384784|Nicotine|nicotine
4677218|NCT03384784|Tobacco Use|tobacco use
4677219|NCT03384771|mindfulness, MBSR, teaching|mindfulness, mbsr, teaching
4677220|NCT03384758|Compression therapy|compression therapy
4677221|NCT03384758|Microcirculation|microcirculation
4677222|NCT03384758|Diabetes mellitus|diabetes mellitus
4677223|NCT03384758|Peripheral Arterial Disease|peripheral arterial disease
4677224|NCT03384732|community-dwelling elderly|community-dwelling elderly
4677225|NCT03384732|ICF|icf
4677226|NCT03384732|core set development|core set development
4677227|NCT03384732|geriatric|geriatric
4677228|NCT03384732|functioning|functioning
4677229|NCT03384732|health|health
4677230|NCT03384732|ageing|ageing
4677231|NCT03384719|Growth factor|growth factor
4677232|NCT03384719|Protein|protein
4677233|NCT03384719|Milk protein|milk protein
4677234|NCT03384719|Plant protein|plant protein
4677235|NCT03384719|Insulin-like growth factor-1 (IGF-1)|insulin-like growth factor-1 (igf-1)
4677236|NCT03384719|Insulin|insulin
4677237|NCT03384719|Insulin-like growth factor-binding protein-3 (IGFBP-3)|insulin-like growth factor-binding protein-3 (igfbp-3)
4677238|NCT03384706|posttraumatic stress disorder (PTSD)|posttraumatic stress disorder (ptsd)
4677239|NCT03384706|Clinical Trial|clinical trial
4677240|NCT03384706|Psychotherapy|psychotherapy
4677241|NCT03384706|Assessment|assessment
4677242|NCT03384706|Effectiveness|effectiveness
4677243|NCT03384693|hematopoeitic stem cell transplant|hematopoeitic stem cell transplant
4677244|NCT03384693|prophylactic defibrotide|prophylactic defibrotide
4677245|NCT03384667|Maekmoondong-tang|maekmoondong-tang
4677246|NCT03384667|Mai-men-dong-tang|mai-men-dong-tang
4677247|NCT03384667|Bakumondo-to|bakumondo-to
4677248|NCT03384628|Contact lens|contact lens
4677249|NCT03384628|The Young Theory|the young theory
4677250|NCT03384602|subjective cognitive decline|subjective cognitive decline
4677251|NCT03384602|falls prevention|falls prevention
4677252|NCT03384602|cognitive function|cognitive function
4677253|NCT03384602|dalcroze eurhythmics|dalcroze eurhythmics
4677254|NCT03384602|home exercise program|home exercise program
4677255|NCT03384602|seniors|seniors
4677256|NCT03384576|Music|music
4677257|NCT03384576|Emergency|emergency
4677258|NCT03384576|caregivers|caregivers
4677259|NCT03384563|pediatric|pediatric
4677260|NCT03384563|anesthesia|anesthesia
4677261|NCT03384563|dexmedetomidine|dexmedetomidine
4677262|NCT03384537|intra-oral microorganisms.|intra-oral microorganisms.
4677263|NCT03384537|cariogenic microorganisms|cariogenic microorganisms
4677264|NCT03384511|RGD PET-CT|rgd pet-ct
4677265|NCT03384511|Apatinib|apatinib
4677266|NCT03384498|Genetic epidemiology|genetic epidemiology
4677267|NCT03384498|Antimalarial drug resistance|antimalarial drug resistance
4677268|NCT03384472|Malaria Genetic Surveillance|malaria genetic surveillance
4677269|NCT03384472|Cambodia|cambodia
4677270|NCT03384459|vitiligo|vitiligo
4677271|NCT03384459|308-nm excimer laser|308-nm excimer laser
4677272|NCT03384459|maintenance therapy|maintenance therapy
4677273|NCT03384459|recurrence|recurrence
4677274|NCT03384420|Autologous stem cell transplantation|autologous stem cell transplantation
4677275|NCT03384355|varicose veins|varicose veins
4677276|NCT03384355|chronic venous disease|chronic venous disease
4677279|NCT03384316|Combination Vaccine|combination vaccine
4677280|NCT03384316|Adenoviral|adenoviral
4677281|NCT03384316|ETBX-011|etbx-011
4677282|NCT03384316|ETBX-061|etbx-061
4677283|NCT03384316|ETBX-051|etbx-051
4677284|NCT03384303|Incretines|incretines
4677285|NCT03384303|Bile acids|bile acids
4677286|NCT03384303|Gut hormones|gut hormones
4677287|NCT03384303|Limb lengths|limb lengths
4677288|NCT03384303|Biliopancreatic limb|biliopancreatic limb
4677289|NCT03384303|Bariatric surgery|bariatric surgery
4677290|NCT03384303|Gastric bypass|gastric bypass
4677291|NCT03384290|Asthma|asthma
4677292|NCT03384290|Anticalin|anticalin
4677293|NCT03384290|PRS-060|prs-060
4677294|NCT03384290|Healthy Volunteers|healthy volunteers
4677295|NCT03384290|Pieris|pieris
4677296|NCT03384290|IL-4 receptor alpha|il-4 receptor alpha
4677297|NCT03384290|IL-13|il-13
4677298|NCT03384290|IL-4|il-4
4677299|NCT03384277|Acquired hemophilia A|acquired hemophilia a
4677300|NCT03384277|Cyclophosphamide|cyclophosphamide
4677301|NCT03384277|Rituximab|rituximab
4677302|NCT03384277|Steroid|steroid
4677303|NCT03384251|Adolescent pregnancy|adolescent pregnancy
4677304|NCT03384251|Teenage pregnancy|teenage pregnancy
4677305|NCT03384251|Prevention|prevention
4677306|NCT03384251|Ghana|ghana
4677307|NCT03384225|cladribine|cladribine
4677308|NCT03384225|fludarabine|fludarabine
4677309|NCT03384225|relapse|relapse
4677310|NCT03384212|cladribine|cladribine
4677311|NCT03384212|fludarabine|fludarabine
4677312|NCT03384212|relapse|relapse
4677313|NCT03384199|Localized Prostate|localized prostate
4677314|NCT03384199|VMAT|vmat
4677315|NCT03384199|Dose escalation|dose escalation
4677316|NCT03384199|Fiducial marker|fiducial marker
4677317|NCT03384199|Focal Lesion|focal lesion
4677318|NCT03384199|Random error during dose escalation radiotherapy|random error during dose escalation radiotherapy
4677319|NCT03384199|fiducial marker image guided technique|fiducial marker image guided technique
4677320|NCT03384173|Near Infrared Spectroscopy|near infrared spectroscopy
4677321|NCT03384173|Creatinine|creatinine
4677322|NCT03384173|Urine Output|urine output
4677323|NCT03384160|Pain|pain
4677324|NCT03384160|Third molar|third molar
4677325|NCT03384160|Articaine|articaine
4677326|NCT03384160|Mepivacaine|mepivacaine
4677327|NCT03384134|cancer|cancer
4677328|NCT03384134|cognitive and behavioral skills training intervention|cognitive and behavioral skills training intervention
4677329|NCT03384134|pain|pain
4677330|NCT03384134|symptoms|symptoms
4677331|NCT03384134|quality of life|quality of life
4677332|NCT03384121|CYP24A1|cyp24a1
4677333|NCT03384121|Nephrocalcinosis|nephrocalcinosis
4677334|NCT03384121|Hypercalcemia|hypercalcemia
4677335|NCT03384121|Hypercalcuria|hypercalcuria
4677336|NCT03384095|Aromatase Inhibitors|aromatase inhibitors
4677337|NCT03384069|Cognitive Impairment|cognitive impairment
4677338|NCT03384069|Cognitive- behavioral therapy|cognitive- behavioral therapy
4677339|NCT03384069|African Americans|african americans
4677340|NCT03384030|Malodor|malodor
4677341|NCT03384030|Stress|stress
4677342|NCT03384030|STMST|stmst
4677343|NCT03384004|Root Canal Treatment|root canal treatment
4677344|NCT03383991|Humeral Fracture, Proximal|humeral fracture, proximal
4677345|NCT03383991|Arthroplasty, Replacement, Shoulder|arthroplasty, replacement, shoulder
4677346|NCT03383991|Reverse Total Shoulder Arthroplasty|reverse total shoulder arthroplasty
4677347|NCT03383991|Shoulder Hemiarthroplasty|shoulder hemiarthroplasty
4677348|NCT03383939|bronchiectasis|bronchiectasis
4677349|NCT03383939|alpha1-antitrypsin|alpha1-antitrypsin
4677350|NCT03383939|neutrophilic elastase|neutrophilic elastase
4677351|NCT03383926|Longo|longo
4677352|NCT03383926|Hemorrhoids|hemorrhoids
4677353|NCT03383926|Rectal|rectal
4677354|NCT03383926|Prolapse|prolapse
4677355|NCT03383926|Anal|anal
4677356|NCT03383913|Heart Rate Variability Biofeedback|heart rate variability biofeedback
4677357|NCT03383913|Sickle Cell Disease|sickle cell disease
4677358|NCT03383835|Omega 3 supplement|omega 3 supplement
4677359|NCT03383835|pre-menopausal|pre-menopausal
4677360|NCT03383835|pregnancy|pregnancy
4677361|NCT03383809|Self-reported healthy adults|self-reported healthy adults
4677362|NCT03383796|Cholangiocarcinoma perihilar|cholangiocarcinoma perihilar
4677363|NCT03383796|three dimension laparoscopic|three dimension laparoscopic
4677364|NCT03383783|Caries|caries
4677365|NCT03383731|Operation mode|operation mode
4677366|NCT03383731|Air tamponade|air tamponade
4677367|NCT03383731|High myopia|high myopia
4677368|NCT03383731|Macular hole retinal detachment|macular hole retinal detachment
4677369|NCT03383718|Coronary Artery Disease|coronary artery disease
4677370|NCT03383718|Fractional Flow Reserve|fractional flow reserve
4677371|NCT03383718|Dobutamine Stress Echocardiography|dobutamine stress echocardiography
4677372|NCT03383718|Stable Coronary Artery Disease|stable coronary artery disease
4677373|NCT03383718|Bystander Coronary Artery Disease|bystander coronary artery disease
4677374|NCT03383718|Non-Culprit Lesions|non-culprit lesions
4677375|NCT03383718|Acute Myocardial Infarction|acute myocardial infarction
4677376|NCT03383705|Photoaged Skin|photoaged skin
4677377|NCT03383692|Unresectable or metastatic solid malignant tumors|unresectable or metastatic solid malignant tumors
4677378|NCT03383692|Solid malignant tumors|solid malignant tumors
4677381|NCT03383692|Antibody drug conjugate|antibody drug conjugate
4677382|NCT03383692|ADC|adc
4677383|NCT03383666|Unruptured|unruptured
4677384|NCT03383666|intracranial aneurysms|intracranial aneurysms
4677385|NCT03383666|Endovascular|endovascular
4677386|NCT03383653|Td Vaccine|td vaccine
4677387|NCT03383653|Safety|safety
4677388|NCT03383653|Pregnant|pregnant
4677389|NCT03383653|Pregnant Women|pregnant women
4677390|NCT03383627|Chronic Kidney Disease|chronic kidney disease
4677391|NCT03383601|COPD|copd
4677392|NCT03383601|Exacerbation of respiratory symptoms|exacerbation of respiratory symptoms
4677393|NCT03383601|Functional exercise capacity|functional exercise capacity
4677394|NCT03383601|Heated Tobacco Products|heated tobacco products
4677395|NCT03383601|Respiratory symptoms|respiratory symptoms
4677396|NCT03383575|Myelodysplastic Syndrome|myelodysplastic syndrome
4677397|NCT03383575|MDS|mds
4677398|NCT03383575|Enasidenib|enasidenib
4677399|NCT03383575|AG-221|ag-221
4677400|NCT03383575|IDHIFA|idhifa
4677401|NCT03383575|Azacitidine|azacitidine
4677402|NCT03383575|5-Azacytidine|5-azacytidine
4677403|NCT03383575|Azacytidine|azacytidine
4677404|NCT03383575|5-aza|5-aza
4677405|NCT03383575|Vidaza|vidaza
4677406|NCT03383575|5-AZC|5-azc
4677407|NCT03383575|AZA-CR|aza-cr
4677408|NCT03383575|Ladakamycin|ladakamycin
4677409|NCT03383575|NSC-102816|nsc-102816
4677410|NCT03383549|Telerehabilitation [E02.831.891]|telerehabilitation [e02.831.891]
4677411|NCT03383549|Cognitive Aging [G07.345.124.260]|cognitive aging [g07.345.124.260]
4677412|NCT03383549|Exercise Therapy [E02.760.169.063.500.387]|exercise therapy [e02.760.169.063.500.387]
4677413|NCT03383536|fMRI|fmri
4677414|NCT03383536|stress|stress
4677415|NCT03383536|peptide|peptide
4677416|NCT03383536|social|social
4677417|NCT03383536|neuroimaging|neuroimaging
4677418|NCT03383484|polycystic ovary syndrome|polycystic ovary syndrome
4677419|NCT03383484|hyperandrogenism|hyperandrogenism
4677420|NCT03383484|nonpharmacological|nonpharmacological
4677421|NCT03383484|yoga|yoga
4677422|NCT03383484|osteopathic manipulative medicine|osteopathic manipulative medicine
4677423|NCT03383471|chondrocyte cells|chondrocyte cells
4677424|NCT03383471|osteoarthritis|osteoarthritis
4677425|NCT03383471|gene therapy|gene therapy
4677426|NCT03383419|Heart Failure, Heart Transplant|heart failure, heart transplant
4677427|NCT03383380|Activated PI3K-delta Syndrome|activated pi3k-delta syndrome
4677428|NCT03383380|Immunodeficiency Primary|immunodeficiency primary
4677429|NCT03383380|Akt/mTOR pathway|akt/mtor pathway
4677430|NCT03383380|Rapamycin Therapy|rapamycin therapy
4677431|NCT03383380|Hyperphosphorylation|hyperphosphorylation
4677432|NCT03383367|mass screening|mass screening
4677433|NCT03383367|colonoscopy surveillance|colonoscopy surveillance
4677434|NCT03383367|high risk patients|high risk patients
4677435|NCT03383341|gut microbiota|gut microbiota
4677436|NCT03383341|cricket powder|cricket powder
4677437|NCT03383341|prebiotic fiber|prebiotic fiber
4677438|NCT03383341|inflammation|inflammation
4677439|NCT03383341|dietary intervention|dietary intervention
4677440|NCT03383328|Cataract|cataract
4677441|NCT03383328|Cataract Surgery|cataract surgery
4677442|NCT03383302|Non-small cell lung cancer|non-small cell lung cancer
4677443|NCT03383302|NSCLC|nsclc
4677444|NCT03383263|Humira®|humira®
4677445|NCT03383263|polyarticular juvenile arthritis|polyarticular juvenile arthritis
4677446|NCT03383263|Adalimumab|adalimumab
4677447|NCT03383250|meal ingestion|meal ingestion
4677448|NCT03383250|postprandial sensations|postprandial sensations
4677449|NCT03383250|circulating metabolites|circulating metabolites
4677450|NCT03383224|smoking cessation treatment|smoking cessation treatment
4677451|NCT03383211|RNAseq|rnaseq
4677452|NCT03383211|Next Generation Sequencing|next generation sequencing
4677453|NCT03383211|Transcriptome|transcriptome
4677454|NCT03383211|Peripheral blood transcripts|peripheral blood transcripts
4677455|NCT03383211|Tempus Blood RNA Tubes|tempus blood rna tubes
4677456|NCT03383185|contraception|contraception
4677457|NCT03383185|Body mass index|body mass index
4677458|NCT03383185|Metabolic Syndrome|metabolic syndrome
4677459|NCT03383185|obesity|obesity
4677460|NCT03383172|Prevention|prevention
4677461|NCT03383172|Promotion|promotion
4677462|NCT03383172|Mental Health|mental health
4677463|NCT03383159|Microbiota|microbiota
4677464|NCT03383159|Metachronous Adenoma|metachronous adenoma
4677465|NCT03383159|Colorectal Cancer|colorectal cancer
4677466|NCT03383159|Colonoscopy|colonoscopy
4677467|NCT03383146|diabetic gastroparesis|diabetic gastroparesis
4677468|NCT03383146|vomiting|vomiting
4677469|NCT03383133|sulfotransferase|sulfotransferase
4677470|NCT03383133|metabolism|metabolism
4677471|NCT03383133|acetaminophen|acetaminophen
4677472|NCT03383133|dehydroepiandrosterone|dehydroepiandrosterone
4677473|NCT03383133|mefenamic acid|mefenamic acid
4677474|NCT03383133|allostery|allostery
4677475|NCT03383120|Peri-implantitis|peri-implantitis
4677476|NCT03383120|Diode laser|diode laser
4677477|NCT03383120|Surgical debridement|surgical debridement
4677478|NCT03383094|cancer|cancer
4677479|NCT03383094|Head and Neck|head and neck
4677480|NCT03383094|Pembrolizumab|pembrolizumab
4677481|NCT03383094|Cisplatin|cisplatin
4677482|NCT03383094|Radiotherapy|radiotherapy
4677483|NCT03383094|Head and Neck Squamous Cell Carcinoma|head and neck squamous cell carcinoma
4677484|NCT03383094|p16+|p16+
4677485|NCT03383081|osteoarthritis, mesenchymal stem cell|osteoarthritis, mesenchymal stem cell
4677486|NCT03383068|PCOS|pcos
4677487|NCT03383068|imparied glucose tolerance|imparied glucose tolerance
4677488|NCT03383029|Nutrition|nutrition
4677489|NCT03383029|Behavioral|behavioral
4677490|NCT03383016|Prostate cancer risk|prostate cancer risk
4677491|NCT03383016|Environmental risk factors|environmental risk factors
4677492|NCT03383016|Biomarkers|biomarkers
4677493|NCT03383016|Inflammation and prostate cancer|inflammation and prostate cancer
4677494|NCT03383003|Helicobacter pylori eradication|helicobacter pylori eradication
4677495|NCT03383003|High dose proton pump inhibitor|high dose proton pump inhibitor
4677496|NCT03383003|High dose Amoxicillin|high dose amoxicillin
4677497|NCT03383003|Concomitant therapy|concomitant therapy
4677498|NCT03382990|Atrial fibrillation|atrial fibrillation
4677499|NCT03382990|Acute myocardial infarction|acute myocardial infarction
4677500|NCT03382990|Drug-eluting stent|drug-eluting stent
4677501|NCT03382977|GBM|gbm
4677502|NCT03382977|Glioblastoma|glioblastoma
4677503|NCT03382977|eVLP|evlp
4677504|NCT03382977|VBI-1901|vbi-1901
4677505|NCT03382977|vaccine|vaccine
4677506|NCT03382977|immunotherapy|immunotherapy
4677507|NCT03382977|CMV|cmv
4677508|NCT03382977|CNS|cns
4677509|NCT03382977|Brain|brain
4677510|NCT03382977|Cancer|cancer
4677511|NCT03382964|VLA1553|vla1553
4677512|NCT03382964|Chikungunya|chikungunya
4677513|NCT03382964|CHIKV|chikv
4677514|NCT03382964|Live-attenuated Chikungunya virus vaccine|live-attenuated chikungunya virus vaccine
4677515|NCT03382938|dexmedetomidine|dexmedetomidine
4677516|NCT03382938|ropivacaine|ropivacaine
4677517|NCT03382938|wound infiltration|wound infiltration
4677518|NCT03382938|ceasarean section|ceasarean section
4677519|NCT03382925|cervical epidural steroid injection|cervical epidural steroid injection
4677520|NCT03382925|local anesthetic|local anesthetic
4677521|NCT03382925|upper extremity weakness|upper extremity weakness
4677522|NCT03382886|Advanced and/or metastatic|advanced and/or metastatic
4677523|NCT03382873|Hyperglycemia|hyperglycemia
4677524|NCT03382873|Obese|obese
4677525|NCT03382873|Overweight|overweight
4677526|NCT03382860|Intracranial Hypertension|intracranial hypertension
4677527|NCT03382860|Intracranial pressure monitoring|intracranial pressure monitoring
4677528|NCT03382860|Non-invasive point-of-care device|non-invasive point-of-care device
4677529|NCT03382860|Normal pressure hydrocephalus|normal pressure hydrocephalus
4677530|NCT03382821|cervical epidural steroid injection|cervical epidural steroid injection
4677531|NCT03382821|transforaminal approach|transforaminal approach
4677532|NCT03382821|epidural catheter targeted|epidural catheter targeted
4677533|NCT03382821|interlaminar approach|interlaminar approach
4677534|NCT03382821|cervical radicular pain|cervical radicular pain
4677535|NCT03382795|Epidermal growth factor receptor tyrosine kinase inhibitor|epidermal growth factor receptor tyrosine kinase inhibitor
4677536|NCT03382795|Cytotoxic chemotherapy|cytotoxic chemotherapy
4677537|NCT03382795|Epidermal growth factor receptor mutation|epidermal growth factor receptor mutation
4677538|NCT03382782|Obesity|obesity
4677539|NCT03382782|Mental Disorder|mental disorder
4677540|NCT03382782|Peer Navigator|peer navigator
4677541|NCT03382782|Physical Health|physical health
4677542|NCT03382782|Overweight|overweight
4677543|NCT03382782|Serious Mental Illness|serious mental illness
4677544|NCT03382743|office hysteroscopy|office hysteroscopy
4677545|NCT03382743|Lidocaine spray|lidocaine spray
4677546|NCT03382704|Peri-ocular|peri-ocular
4677547|NCT03382678|Eosinophilic Gastrointestinal Disorders|eosinophilic gastrointestinal disorders
4677548|NCT03382665|Revision total hip arthroplasty|revision total hip arthroplasty
4677549|NCT03382665|Medical Device|medical device
4677550|NCT03382665|Post Market Surveillance Study|post market surveillance study
4677551|NCT03382665|Primary total hip arthroplasty|primary total hip arthroplasty
4677552|NCT03382652|Total hip arthroplasty|total hip arthroplasty
4677553|NCT03382652|Medical Device|medical device
4677554|NCT03382652|Post Market Surveillance Study|post market surveillance study
4677555|NCT03382652|Performance|performance
4677556|NCT03382652|Safety|safety
4677557|NCT03382639|Drug therapy|drug therapy
4677558|NCT03382626|Traumatic Brain Injury|traumatic brain injury
4677559|NCT03382626|Transcranial Direct Current Stimulation|transcranial direct current stimulation
4677560|NCT03382626|Computer-assisted training|computer-assisted training
4677561|NCT03382626|Cognitive training|cognitive training
4677562|NCT03382626|Cognitive function|cognitive function
4677563|NCT03382626|Executive function|executive function
4677564|NCT03382626|Working memory|working memory
4677565|NCT03382626|Attention|attention
4677566|NCT03382548|Ventilator Associated Pneumonia|ventilator associated pneumonia
4677567|NCT03382548|Pneumonia|pneumonia
4677568|NCT03382535|Voice disorder|voice disorder
4677569|NCT03382535|Teacher's voice|teacher's voice
4677570|NCT03382535|Voice SPL (Voice sound pressure level)|voice spl (voice sound pressure level)
4677571|NCT03382535|Voice F0 (Voice fundamental frequency)|voice f0 (voice fundamental frequency)
4677572|NCT03382535|Voice therapy|voice therapy
4677573|NCT03382535|Voice accumulator|voice accumulator
4677574|NCT03382535|Activity noise|activity noise
4677575|NCT03382535|Classroom|classroom
4677576|NCT03382522|bone scintigraphy|bone scintigraphy
4677577|NCT03382522|quantification|quantification
4677578|NCT03382522|prostate cancer|prostate cancer
4677579|NCT03382522|prognosis|prognosis
4677580|NCT03382457|Functional|functional
4677582|NCT03382457|FTR|ftr
4677583|NCT03382457|Transcatheter|transcatheter
4677584|NCT03382457|Reconstruction|reconstruction
4677585|NCT03382444|cognitive impairment|cognitive impairment
4677586|NCT03382444|hemodialysis|hemodialysis
4677587|NCT03382444|dementia|dementia
4677588|NCT03382444|end stage renal disease|end stage renal disease
4677589|NCT03382405|cytomegalovirus vaccine|cytomegalovirus vaccine
4677590|NCT03382405|mRNA-1647|mrna-1647
4677591|NCT03382405|mRNA-1443|mrna-1443
4677592|NCT03382392|Amyotrophic lateral sclerosis,|amyotrophic lateral sclerosis,
4677593|NCT03382392|Resting energy expenditure|resting energy expenditure
4677594|NCT03382392|Predictive equation|predictive equation
4677595|NCT03382379|methamphetamine|methamphetamine
4677596|NCT03382379|transcranial Direct Current Stimulation|transcranial direct current stimulation
4677597|NCT03382379|functional Magnetic Resonance Imaging|functional magnetic resonance imaging
4677598|NCT03382379|amphetamine|amphetamine
4677599|NCT03382379|drug craving|drug craving
4677600|NCT03382366|Sarcopenia|sarcopenia
4677601|NCT03382366|Risk of fall|risk of fall
4677602|NCT03382366|Osteoporosis|osteoporosis
4677603|NCT03382366|Muscle|muscle
4677604|NCT03382366|DXA|dxa
4677605|NCT03382366|MR|mr
4677606|NCT03382366|Muscle metabolism|muscle metabolism
4677607|NCT03382353|primary prevention|primary prevention
4677608|NCT03382353|Subjective Cognitive Decline|subjective cognitive decline
4677609|NCT03382353|Neuroimaging|neuroimaging
4677610|NCT03382353|Alzheimer's disease|alzheimer's disease
4677611|NCT03382353|nonpharmacological interventions|nonpharmacological interventions
4677612|NCT03382353|multidomain lifestyle interventions|multidomain lifestyle interventions
4677613|NCT03382327|Surgical planning|surgical planning
4677614|NCT03382327|CT-scan|ct-scan
4677615|NCT03382327|MRI|mri
4677616|NCT03382327|3D model|3d model
4677617|NCT03382327|Hepatocarcinoma eligible for surgical resection|hepatocarcinoma eligible for surgical resection
4677618|NCT03382301|Ischemia reperfusion injuries|ischemia reperfusion injuries
4677619|NCT03382301|Renal artery stenosis|renal artery stenosis
4677620|NCT03382301|Renal functional imaging|renal functional imaging
4677621|NCT03382262|Osteoarthritis|osteoarthritis
4677622|NCT03382262|Shoulder|shoulder
4677623|NCT03382262|Hip|hip
4677624|NCT03382262|Pain|pain
4677625|NCT03382262|Intra-articular|intra-articular
4677626|NCT03382262|Injection|injection
4677627|NCT03382262|Corticosteroid|corticosteroid
4677628|NCT03382210|Enhanced Recovery Program|enhanced recovery program
4677629|NCT03382197|aerosol therapy|aerosol therapy
4677630|NCT03382197|positive pressure|positive pressure
4677631|NCT03382197|electrical impedance tomography|electrical impedance tomography
4677632|NCT03382197|pulmonary scintigraphy|pulmonary scintigraphy
4677633|NCT03382158|pleuropulmonary blastoma|pleuropulmonary blastoma
4677634|NCT03382158|PPB|ppb
4677635|NCT03382158|DICER1|dicer1
4677636|NCT03382158|Sertoli-Leydig cell tumor|sertoli-leydig cell tumor
4677637|NCT03382158|cystic nephroma|cystic nephroma
4677638|NCT03382119|liver stiffness Fontan|liver stiffness fontan
4677639|NCT03382093|Anxiety Sensitivity|anxiety sensitivity
4677640|NCT03382093|Tobacco|tobacco
4677641|NCT03382093|Smoking|smoking
4677642|NCT03382093|Anxiety|anxiety
4677643|NCT03382093|Feedback|feedback
4677644|NCT03382093|Stress|stress
4677645|NCT03382080|randomized controlled trial|randomized controlled trial
4677646|NCT03382080|drop out|drop out
4677647|NCT03382080|upper secondary school|upper secondary school
4677648|NCT03382080|psychosocial learning environments|psychosocial learning environments
4677649|NCT03382028|developmental abnormalities|developmental abnormalities
4677650|NCT03382028|psychomotor development|psychomotor development
4677651|NCT03381989|TAVR|tavr
4677652|NCT03381989|Native Aortic Valve Failure|native aortic valve failure
4677653|NCT03381989|TAVR Associated Coronary Artery Obstruction|tavr associated coronary artery obstruction
4677654|NCT03381989|Electrosurgery|electrosurgery
4677655|NCT03381963|tamoxifen|tamoxifen
4677656|NCT03381963|aromatase inhibitors|aromatase inhibitors
4677657|NCT03381963|breast cancer|breast cancer
4677658|NCT03381963|venous thromboembolism|venous thromboembolism
4677659|NCT03381950|chronic kidney disease|chronic kidney disease
4677660|NCT03381950|prospective cohort study|prospective cohort study
4677661|NCT03381950|risk profile|risk profile
4677662|NCT03381950|patient-reported-outcomes|patient-reported-outcomes
4677663|NCT03381937|mechanical ventilation|mechanical ventilation
4677664|NCT03381937|noninvasive ventilation|noninvasive ventilation
4677665|NCT03381937|neuromuscular disorder|neuromuscular disorder
4677666|NCT03381937|phonation|phonation
4677667|NCT03381937|mouthpiece ventilation|mouthpiece ventilation
4677668|NCT03381924|Migraine disorders|migraine disorders
4677669|NCT03381924|Educational models|educational models
4677670|NCT03381924|Neuroscience|neuroscience
4677671|NCT03381898|Telehealth|telehealth
4677672|NCT03381898|Physical therapy exercise|physical therapy exercise
4677673|NCT03381898|Speech therapy Lee Silverman voice treatment|speech therapy lee silverman voice treatment
4677674|NCT03381898|Pharmacy medication management|pharmacy medication management
4677776|NCT03381248|genicular|genicular
4677675|NCT03381872|Intravascular Imaging|intravascular imaging
4677676|NCT03381872|Intravascular Ultrasound|intravascular ultrasound
4677677|NCT03381872|Optical Coherence Tomography|optical coherence tomography
4677678|NCT03381872|Complex Lesion|complex lesion
4677679|NCT03381872|Percutaneous Coronary Intervention|percutaneous coronary intervention
4677680|NCT03381859|Hepatitis C Virus|hepatitis c virus
4677681|NCT03381859|Genotype 4|genotype 4
4677682|NCT03381859|End Stage Renal Disease|end stage renal disease
4677683|NCT03381820|music therapy|music therapy
4677684|NCT03381820|hypertension|hypertension
4677685|NCT03381820|Asian|asian
4677686|NCT03381820|stage-2 hypertension|stage-2 hypertension
4677687|NCT03381794|Keratoplasty Registry, PKP, DSAEK, DMEK, DALK|keratoplasty registry, pkp, dsaek, dmek, dalk
4677688|NCT03381781|p53 mutation|p53 mutation
4677689|NCT03381781|acute myeloid leukemia|acute myeloid leukemia
4677690|NCT03381781|decitabine|decitabine
4677691|NCT03381781|Arsenic trioxide|arsenic trioxide
4677692|NCT03381781|cytarabine|cytarabine
4677693|NCT03381768|PD-L1|pd-l1
4677694|NCT03381768|PD-L2|pd-l2
4677695|NCT03381768|peptide vaccine|peptide vaccine
4677696|NCT03381729|Gene Transfer|gene transfer
4677697|NCT03381729|Gene Therapy|gene therapy
4677698|NCT03381729|Adeno-associated virus|adeno-associated virus
4677699|NCT03381729|Survival Motor Neuron|survival motor neuron
4677700|NCT03381729|SMN|smn
4677701|NCT03381729|AAV9|aav9
4677702|NCT03381716|aortic dissection|aortic dissection
4677703|NCT03381716|sex|sex
4677704|NCT03381716|treatment|treatment
4677705|NCT03381703|Accelerated Mass Spectrometry|accelerated mass spectrometry
4677706|NCT03381703|Microtracer|microtracer
4677707|NCT03381703|Microdose|microdose
4677708|NCT03381703|hAME|hame
4677709|NCT03381703|Absolute bioavailability|absolute bioavailability
4677710|NCT03381677|pedicle lengthening osteotomy|pedicle lengthening osteotomy
4677711|NCT03381677|spinal stenosis|spinal stenosis
4677712|NCT03381677|decompression|decompression
4677713|NCT03381664|bioavailability|bioavailability
4677714|NCT03381664|pharmacokinetics|pharmacokinetics
4677715|NCT03381664|safety|safety
4677716|NCT03381664|tolerability|tolerability
4677717|NCT03381664|AVP-923|avp-923
4677718|NCT03381664|dextromethorphan|dextromethorphan
4677719|NCT03381664|quinidine|quinidine
4677720|NCT03381651|Radiation dose|radiation dose
4677721|NCT03381638|Concussion|concussion
4677722|NCT03381638|TBI|tbi
4677723|NCT03381638|Sports|sports
4677724|NCT03381638|Medical Device|medical device
4677725|NCT03381638|Fast|fast
4677726|NCT03381612|Female circumcision, Young Women, Dysmenorrhea,Dysuria|female circumcision, young women, dysmenorrhea,dysuria
4677727|NCT03381586|ALT-803|alt-803
4677728|NCT03381586|PK|pk
4677729|NCT03381560|LASSYC; COPD symptoms.|lassyc; copd symptoms.
4677730|NCT03381534|vertebral artery origin|vertebral artery origin
4677731|NCT03381534|angioplasty|angioplasty
4677732|NCT03381534|distal embolic protection|distal embolic protection
4677733|NCT03381521|nerve hydrodissection|nerve hydrodissection
4677734|NCT03381508|CPAP|cpap
4677735|NCT03381508|masks|masks
4677736|NCT03381508|unintentional leak|unintentional leak
4677737|NCT03381508|leakage|leakage
4677738|NCT03381495|Epidural Labor Analgesia|epidural labor analgesia
4677739|NCT03381495|length of labor stage|length of labor stage
4677740|NCT03381495|fetal outcomes|fetal outcomes
4677741|NCT03381495|maternal outcomes|maternal outcomes
4677742|NCT03381495|postpartum depression|postpartum depression
4677743|NCT03381495|exercise|exercise
4677744|NCT03381482|Alzheimer disease|alzheimer disease
4677745|NCT03381482|Extracellular vesicles|extracellular vesicles
4677746|NCT03381482|Biomarker|biomarker
4677747|NCT03381482|Tau|tau
4677748|NCT03381482|CSF|csf
4677749|NCT03381482|Plasma|plasma
4677750|NCT03381404|Mass Balance Study with MT-8554|mass balance study with mt-8554
4677751|NCT03381378|Vitamin D|vitamin d
4677752|NCT03381378|s-25-hydroxyvitamin D|s-25-hydroxyvitamin d
4677753|NCT03381378|hand grip strength|hand grip strength
4677754|NCT03381378|myopathy|myopathy
4677755|NCT03381378|muscle|muscle
4677756|NCT03381352|Radiotherapy|radiotherapy
4677757|NCT03381352|Anal cancer|anal cancer
4677758|NCT03381352|IMRT|imrt
4677759|NCT03381339|power toothbrush, oscillating rotating|power toothbrush, oscillating rotating
4677760|NCT03381326|circulating tumor cells|circulating tumor cells
4677761|NCT03381326|Castration-resistant Prostate Cancer|castration-resistant prostate cancer
4677762|NCT03381326|cabazitaxel|cabazitaxel
4677763|NCT03381326|biomarker|biomarker
4677764|NCT03381326|free DNA|free dna
4677765|NCT03381326|stem cells|stem cells
4677766|NCT03381326|EMT related antigens|emt related antigens
4677767|NCT03381274|EGFR mutated, CD73, A2AR, oleclumab, MEDI9447, AZD4635, osimertinib, NSCLC, immunotherapy|egfr mutated, cd73, a2ar, oleclumab, medi9447, azd4635, osimertinib, nsclc, immunotherapy
4677768|NCT03381261|chronic migraine|chronic migraine
4677769|NCT03381261|trigeminal neuralgia|trigeminal neuralgia
4677770|NCT03381261|migraine surgery|migraine surgery
4677771|NCT03381261|nerve decompression|nerve decompression
4677772|NCT03381248|randomized clinical trial|randomized clinical trial
4677773|NCT03381248|osteoarthritis|osteoarthritis
4677774|NCT03381248|radiofrequency ablation|radiofrequency ablation
4677775|NCT03381248|knee|knee
4677777|NCT03381248|cross-over|cross-over
4677778|NCT03381248|viscosupplemention|viscosupplemention
4677779|NCT03381235|Exercise|exercise
4677780|NCT03381235|Quality of life|quality of life
4677781|NCT03381235|Progression of disease|progression of disease
4677782|NCT03381235|Retinitis|retinitis
4677783|NCT03381209|Sugammadex|sugammadex
4677784|NCT03381209|morbidly obese patients|morbidly obese patients
4677785|NCT03381209|bariatric surgery|bariatric surgery
4677786|NCT03381209|neuromuscular blockade|neuromuscular blockade
4677787|NCT03381170|Relapsing Multiple Sclerosis|relapsing multiple sclerosis
4677788|NCT03381157|general movements, fidgety movements, motor optimality score|general movements, fidgety movements, motor optimality score
4677789|NCT03381105|Diagnostics, over-diagnosis|diagnostics, over-diagnosis
4677790|NCT03381092|neoadjuvant chemotherapy|neoadjuvant chemotherapy
4677791|NCT03381092|sentinel lymph node biopsy|sentinel lymph node biopsy
4677792|NCT03381092|axillary lymph node dissection|axillary lymph node dissection
4677793|NCT03381092|Predictive model|predictive model
4677794|NCT03381066|NSCLC|nsclc
4677795|NCT03381066|EGFR|egfr
4677796|NCT03381066|adjuvant|adjuvant
4677797|NCT03381066|gefitinib|gefitinib
4677798|NCT03381066|intercalating|intercalating
4677799|NCT03381053|GIST|gist
4677800|NCT03381053|Grading and Staging|grading and staging
4677801|NCT03381027|Infant Sleep|infant sleep
4677802|NCT03381027|Baby Massage|baby massage
4677803|NCT03381027|Neurodevelopmental Disorders|neurodevelopmental disorders
4677804|NCT03381001|cryopreservation|cryopreservation
4677805|NCT03381001|human embryos|human embryos
4677806|NCT03381001|vitrification|vitrification
4677807|NCT03381001|embryo culture|embryo culture
4677808|NCT03381001|embryo transfer|embryo transfer
4677809|NCT03381001|pregnancy rate|pregnancy rate
4677810|NCT03380975|MAAP|maap
4677811|NCT03380975|Asthma|asthma
4677812|NCT03380975|Allergic rhinits|allergic rhinits
4677813|NCT03380962|Donor-Specific Anti-HLA Antibodies|donor-specific anti-hla antibodies
4677814|NCT03380962|Kidney Transplantation|kidney transplantation
4677815|NCT03380962|Donor Specific Antibody|donor specific antibody
4677816|NCT03380949|Analgesia|analgesia
4677817|NCT03380949|Monitoring|monitoring
4677818|NCT03380949|Opioid|opioid
4677819|NCT03380949|Sufentanil|sufentanil
4677820|NCT03380949|Sevoflurane|sevoflurane
4677821|NCT03380936|subclinical|subclinical
4677822|NCT03380936|graft rejection|graft rejection
4677823|NCT03380936|AMR (antibody-mediated rejection)|amr (antibody-mediated rejection)
4677824|NCT03380936|AMBR (acute antibody-mediated rejection)|ambr (acute antibody-mediated rejection)
4677825|NCT03380936|DSA (donor specific antibodies)|dsa (donor specific antibodies)
4677826|NCT03380923|epigenetics|epigenetics
4677827|NCT03380923|exercise dose-response|exercise dose-response
4677828|NCT03380923|inter-individual response heterogeneity|inter-individual response heterogeneity
4677829|NCT03380923|exercise training adaptations|exercise training adaptations
4677830|NCT03380897|induction of labor|induction of labor
4677831|NCT03380897|double balloon catheter|double balloon catheter
4677832|NCT03380897|mechanical ripening|mechanical ripening
4677833|NCT03380884|Distal Radius Fracture, Osteoporosis, Vibration Therapy|distal radius fracture, osteoporosis, vibration therapy
4677834|NCT03380871|Personal Vaccine|personal vaccine
4677835|NCT03380871|Neoantigen|neoantigen
4677836|NCT03380871|Immunotherapy|immunotherapy
4677837|NCT03380871|Poly-ICLC|poly-iclc
4677838|NCT03380871|Peptide|peptide
4677839|NCT03380871|Checkpoint Inhibitor|checkpoint inhibitor
4677840|NCT03380806|stereotactic body radiotherapy (SBRT)|stereotactic body radiotherapy (sbrt)
4677841|NCT03380806|conventional radiotherapy (CRT)|conventional radiotherapy (crt)
4677842|NCT03380806|High risk prostate cancer|high risk prostate cancer
4677843|NCT03380806|quality of life (QoL)|quality of life (qol)
4677844|NCT03380806|The Expanded Prostate cancer Index Composite (EPIC-26)|the expanded prostate cancer index composite (epic-26)
4677845|NCT03380806|International Prostate Symptom Score (IPSS)|international prostate symptom score (ipss)
4677846|NCT03380767|trauma-induced coagulopathy|trauma-induced coagulopathy
4677847|NCT03380754|Nausea|nausea
4677848|NCT03380754|Vomiting|vomiting
4677849|NCT03380754|Knee Arthroplasty|knee arthroplasty
4677850|NCT03380754|PONV|ponv
4677851|NCT03380754|TKA|tka
4677852|NCT03380715|Sinusitis|sinusitis
4677853|NCT03380715|Endoscopy|endoscopy
4677854|NCT03380715|Rhinitis|rhinitis
4677855|NCT03380702|colour|colour
4677856|NCT03380702|dental aesthetics|dental aesthetics
4677857|NCT03380702|perceptions|perceptions
4677858|NCT03380702|quality of life|quality of life
4677859|NCT03380702|tooth whitening|tooth whitening
4677860|NCT03380663|blood flow restricted resistance exercise|blood flow restricted resistance exercise
4677861|NCT03380663|remote ischemic conditioning|remote ischemic conditioning
4677862|NCT03380663|miRNA|mirna
4677863|NCT03380650|femoropopliteal occlusive disease|femoropopliteal occlusive disease
4677864|NCT03380650|directional atherectomy|directional atherectomy
4677865|NCT03380650|local drug delivery|local drug delivery
4677866|NCT03380650|endovascular treatment|endovascular treatment
4677867|NCT03380598|Mobile Health, Self-Monitoring, Behavioural Treatment|mobile health, self-monitoring, behavioural treatment
4677868|NCT03380572|Robotic Surgery|robotic surgery
4677869|NCT03380559|Epicondylitis|epicondylitis
4677870|NCT03380559|Botulinum toxin|botulinum toxin
4677871|NCT03380559|Corticoid|corticoid
4677872|NCT03380546|Diabetes|diabetes
4677873|NCT03380546|Pregnancy|pregnancy
4677874|NCT03380546|Gestational|gestational
4677875|NCT03380546|Acarbose|acarbose
4677876|NCT03380507|Septic Shock|septic shock
4677877|NCT03380507|Vitamin C|vitamin c
4677878|NCT03380507|Thiamine|thiamine
4677879|NCT03380507|Hydrocortisone|hydrocortisone
4677880|NCT03380507|Critically Ill|critically ill
4677881|NCT03380494|Overhead perturbation training; instability, glenohumeral joint|overhead perturbation training; instability, glenohumeral joint
4677882|NCT03380468|Lung adenocarcinoma|lung adenocarcinoma
4677883|NCT03380468|adjuvant chemotherapy|adjuvant chemotherapy
4677884|NCT03380442|fMRI|fmri
4677885|NCT03380442|psilocybin|psilocybin
4677886|NCT03380442|ketamine|ketamine
4677887|NCT03380442|biomarker|biomarker
4677888|NCT03380442|rapid-acting antidepressants|rapid-acting antidepressants
4677889|NCT03380429|Connected Inhaler System|connected inhaler system
4677890|NCT03380429|Metered Dose Inhaler|metered dose inhaler
4677891|NCT03380429|ELLIPTA|ellipta
4677892|NCT03380429|RELVAR/BREO|relvar/breo
4677893|NCT03380429|Dry Powder Inhaler|dry powder inhaler
4677894|NCT03380429|Salbutamol|salbutamol
4677895|NCT03380429|Asthma|asthma
4677896|NCT03380403|diabetic foot|diabetic foot
4677897|NCT03380403|Osteomyelitis|osteomyelitis
4677898|NCT03380403|PACT|pact
4677899|NCT03380403|PDT|pdt
4677900|NCT03380403|Singlet oxygen|singlet oxygen
4677901|NCT03380403|antimicrobial|antimicrobial
4677902|NCT03380403|diabetes|diabetes
4677903|NCT03380403|Wagner scale|wagner scale
4677904|NCT03380377|kidney transplant|kidney transplant
4677905|NCT03380377|Chronic antibody mediated rejection|chronic antibody mediated rejection
4677906|NCT03380377|donor specific antibody|donor specific antibody
4677907|NCT03380338|Gut microbiota|gut microbiota
4677908|NCT03380325|Capillary recruitment|capillary recruitment
4677909|NCT03380286|Firehawk|firehawk
4677910|NCT03380286|Coronary Artery Disease|coronary artery disease
4677911|NCT03380286|Drug Eluting Stent|drug eluting stent
4677912|NCT03380247|Emergency, trauma pain, analgesia, Methoxyfurane|emergency, trauma pain, analgesia, methoxyfurane
4677913|NCT03380234|Smoking|smoking
4677914|NCT03380234|Secondhand smoke|secondhand smoke
4677915|NCT03380234|Thirdhand smoke|thirdhand smoke
4677916|NCT03380234|Children|children
4677917|NCT03380234|Cluster randomised controlled trial|cluster randomised controlled trial
4677918|NCT03380182|acupuncture|acupuncture
4677919|NCT03380182|acupressure|acupressure
4677920|NCT03380143|Children|children
4677921|NCT03380143|Cancer Prevention|cancer prevention
4677922|NCT03380143|Population Health|population health
4677923|NCT03380143|Rural|rural
4677924|NCT03380143|Community|community
4677925|NCT03380143|School|school
4677926|NCT03380143|After School|after school
4677927|NCT03380143|Youth Sport|youth sport
4677928|NCT03380143|Intervention|intervention
4677929|NCT03380143|Multilevel|multilevel
4677930|NCT03380143|Systems|systems
4677931|NCT03380130|Hepatocellular Carcinoma|hepatocellular carcinoma
4677932|NCT03380130|Liver cancer|liver cancer
4677933|NCT03380130|Hepatoma|hepatoma
4677934|NCT03380117|Suicidal Ideation|suicidal ideation
4677935|NCT03380117|Suicide Attempt|suicide attempt
4677936|NCT03380117|Risk Screening|risk screening
4677937|NCT03380117|Online Intervention|online intervention
4677938|NCT03380117|Online Counseling|online counseling
4677939|NCT03380117|College Students|college students
4677940|NCT03380117|Motivational Interviewing|motivational interviewing
4677941|NCT03380117|Linkage to Care|linkage to care
4677942|NCT03380104|Percutaneous Electrical Nerve Stimulation|percutaneous electrical nerve stimulation
4677943|NCT03380091|PCOS|pcos
4677944|NCT03380091|Depression|depression
4677945|NCT03380091|Vitamin D|vitamin d
4677946|NCT03380091|Insulin Resistance|insulin resistance
4677947|NCT03380091|Anxiety|anxiety
4677948|NCT03380091|Quality of life|quality of life
4677949|NCT03380091|Mood disorders|mood disorders
4677950|NCT03380078|Implementation Mechanism|implementation mechanism
4677951|NCT03380078|Autism Spectrum Disorder|autism spectrum disorder
4677952|NCT03380078|Children's Mental Health Services|children's mental health services
4677953|NCT03380078|School Services|school services
4677954|NCT03380065|coronary angiogram|coronary angiogram
4677955|NCT03380065|radial artery|radial artery
4677956|NCT03380052|OLGA|olga
4677957|NCT03380052|OLGIM|olgim
4677958|NCT03380052|Helicobacter pylori|helicobacter pylori
4677959|NCT03380052|Gastric cancer|gastric cancer
4677960|NCT03380026|CTCL|ctcl
4677961|NCT03380026|topical mechlorethamine|topical mechlorethamine
4677962|NCT03380026|Valchlor|valchlor
4677963|NCT03380026|contact dermatitis|contact dermatitis
4677964|NCT03380026|triamcinolone|triamcinolone
4677966|NCT03380026|Cutaneous T-cell Lymphoma|cutaneous t-cell lymphoma
4677967|NCT03380013|hypothermia treatment|hypothermia treatment
4677968|NCT03380013|OMT in infants|omt in infants
4677969|NCT03380000|Dietary nitrate supplementation|dietary nitrate supplementation
4677970|NCT03380000|Beetroot juice|beetroot juice
4677971|NCT03379961|social categorization|social categorization
4677972|NCT03379961|nurse sorting|nurse sorting
4677973|NCT03379961|emergencies units|emergencies units
4677974|NCT03379909|metformin|metformin
4677975|NCT03379909|marker lesion|marker lesion
4677976|NCT03379870|cochlear implant|cochlear implant
4677977|NCT03379870|electric acoustic stimulation|electric acoustic stimulation
4677978|NCT03379870|EAS|eas
4677979|NCT03379870|hearing loss|hearing loss
4677980|NCT03379870|pediatric|pediatric
4677981|NCT03379831|systemic right ventricle|systemic right ventricle
4677982|NCT03379831|quality of life|quality of life
4677983|NCT03379831|VO2|vo2
4677984|NCT03379831|oxygen uptake|oxygen uptake
4677985|NCT03379831|exercise test|exercise test
4677986|NCT03379831|congenital heart disease|congenital heart disease
4677987|NCT03379818|Shape bias|shape bias
4677988|NCT03379818|Late Talkers|late talkers
4677989|NCT03379792|Obesity|obesity
4677990|NCT03379779|Microbiota|microbiota
4677991|NCT03379779|Respiratory Failure|respiratory failure
4677992|NCT03379779|Pneumonia|pneumonia
4677993|NCT03379779|Lower Respiratory Tract Infection|lower respiratory tract infection
4677994|NCT03379740|Reduced risk product|reduced risk product
4677995|NCT03379727|Midostaurin|midostaurin
4677996|NCT03379727|PKC412|pkc412
4677997|NCT03379727|FMS-like tyrosine kinase receptor|fms-like tyrosine kinase receptor
4677998|NCT03379727|FLT3|flt3
4677999|NCT03379727|Acute Myeloid Leukemia|acute myeloid leukemia
4678000|NCT03379727|AML|aml
4678001|NCT03379727|7+3 chemotherapy|7+3 chemotherapy
4678002|NCT03379727|5+2 chemotherapy|5+2 chemotherapy
4678003|NCT03379727|Daunorubicin|daunorubicin
4678004|NCT03379727|Idarubicin|idarubicin
4678005|NCT03379727|Cytarabine|cytarabine
4678006|NCT03379701|chronic rhinosinusitis, nasal polyposis|chronic rhinosinusitis, nasal polyposis
4678007|NCT03379662|Autism|autism
4678008|NCT03379662|Autistic Disorder|autistic disorder
4678009|NCT03379662|Autistic Spectrum Disorder|autistic spectrum disorder
4678010|NCT03379662|Irritability|irritability
4678011|NCT03379662|laser|laser
4678012|NCT03379662|light therapy|light therapy
4678013|NCT03379649|Recurrent implantation failure|recurrent implantation failure
4678014|NCT03379636|Athletic tape|athletic tape
4678015|NCT03379636|Electromyography|electromyography
4678016|NCT03379636|Rehabilitation|rehabilitation
4678017|NCT03379636|Shoulder|shoulder
4678018|NCT03379597|Schizophrenia|schizophrenia
4678019|NCT03379597|probiotics|probiotics
4678020|NCT03379597|cognitive impairment|cognitive impairment
4678021|NCT03379597|Metabolic syndrome|metabolic syndrome
4678022|NCT03379597|clinical trail|clinical trail
4678023|NCT03379597|Efficacy|efficacy
4678024|NCT03379597|Safety|safety
4678025|NCT03379584|Multiple myeloma|multiple myeloma
4678026|NCT03379584|Antibody-drug conjugate|antibody-drug conjugate
4678027|NCT03379571|Chronic kidney disease|chronic kidney disease
4678028|NCT03379571|Competing-risk analysis|competing-risk analysis
4678029|NCT03379571|Epidemiological study|epidemiological study
4678030|NCT03379571|Incidence|incidence
4678031|NCT03379571|Outcomes|outcomes
4678032|NCT03379571|Risk factors|risk factors
4678033|NCT03379493|relapsed/refractory CD19+ Lymphomas Non-Hodgkin's B-Cell|relapsed/refractory cd19+ lymphomas non-hodgkin's b-cell
4678034|NCT03379480|Schizophrenia, Yoga, fMRI, self reflection, efficacy|schizophrenia, yoga, fmri, self reflection, efficacy
4678035|NCT03379467|SMS Reminder|sms reminder
4678036|NCT03379467|Two-way Reminder|two-way reminder
4678037|NCT03379428|Breast Cancer|breast cancer
4678038|NCT03379428|Metastatic Breast Cancer|metastatic breast cancer
4678039|NCT03379428|HER2-amplified Metastatic Breast Cancer|her2-amplified metastatic breast cancer
4678040|NCT03379428|HER2-positive Metastatic Breast Cancer|her2-positive metastatic breast cancer
4678041|NCT03379415|Meniscectomy|meniscectomy
4678042|NCT03379415|Footwear|footwear
4678043|NCT03379415|Osteoarthritis|osteoarthritis
4678044|NCT03379402|causes of community-acquired sepsis|causes of community-acquired sepsis
4678045|NCT03379402|diagnostic tests|diagnostic tests
4678046|NCT03379363|cushing syndrome, hypercortisolism|cushing syndrome, hypercortisolism
4678047|NCT03379350|lung cancer|lung cancer
4678048|NCT03379350|surgery|surgery
4678049|NCT03379350|chest tube clamping|chest tube clamping
4678050|NCT03379350|duration of chest tube drainage|duration of chest tube drainage
4678051|NCT03379350|postoperative stay|postoperative stay
4678052|NCT03379337|Imaging|imaging
4678053|NCT03379324|Rotator Cuff|rotator cuff
4678054|NCT03379324|Human Amniotic Fluid|human amniotic fluid
4678055|NCT03379324|Amniotic Fluid Allograft|amniotic fluid allograft
4678056|NCT03379324|FlōGraft®|flōgraft®
4678057|NCT03379324|Amniotic Fluid Biologic|amniotic fluid biologic
4678058|NCT03379324|Fatty Atrophy|fatty atrophy
4678059|NCT03379324|Fat Degeneration|fat degeneration
4678060|NCT03379311|AKC|akc
4678061|NCT03379311|PAC|pac
4678062|NCT03379311|VKC|vkc
4678063|NCT03379285|Gastro Intestinal Bleeding;|gastro intestinal bleeding;
4678064|NCT03379285|Transfusion,|transfusion,
4678065|NCT03379285|Outcomes|outcomes
4678066|NCT03379272|Electroencephalography|electroencephalography
4678067|NCT03379272|Epilepsy|epilepsy
4678068|NCT03379272|EEG|eeg
4678069|NCT03379233|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
4678070|NCT03379233|Adherence|adherence
4678071|NCT03379233|Dose Tracking|dose tracking
4678072|NCT03379233|Concept2|concept2
4679149|NCT03372083|Asunra|asunra
4678073|NCT03379233|Digital Adherence System|digital adherence system
4678074|NCT03379233|Ultibro Breezhaler|ultibro breezhaler
4678075|NCT03379207|Community-acquired Pneumonia|community-acquired pneumonia
4678076|NCT03379207|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
4678077|NCT03379207|Innate Immunity|innate immunity
4678078|NCT03379207|Non Conventional T Lymphocytes|non conventional t lymphocytes
4678079|NCT03379194|antibiotic prescriptions|antibiotic prescriptions
4678080|NCT03379194|resistance|resistance
4678081|NCT03379194|feedback|feedback
4678082|NCT03379194|primary care|primary care
4678083|NCT03379181|Brown adipose tissue (BAT)|brown adipose tissue (bat)
4678084|NCT03379181|Hyperthyroidism|hyperthyroidism
4678085|NCT03379168|knee osteoarthritis|knee osteoarthritis
4678086|NCT03379168|mesenchymal stem cell|mesenchymal stem cell
4678087|NCT03379168|adipose tissue|adipose tissue
4678088|NCT03379168|injection|injection
4678089|NCT03379168|nonoperative treatment|nonoperative treatment
4678090|NCT03379142|Faith-Based; Community-engaged; Text messaging; Tobacco|faith-based; community-engaged; text messaging; tobacco
4678091|NCT03379103|Blood Loss, Surgical|blood loss, surgical
4678092|NCT03379103|Blood Transfusion|blood transfusion
4678093|NCT03379103|Arthroplasty, Replacement, Knee|arthroplasty, replacement, knee
4678094|NCT03379077|Mothers|mothers
4678095|NCT03379077|young children|young children
4678096|NCT03379077|Implementation|implementation
4678097|NCT03379077|Learning through play Plus|learning through play plus
4678098|NCT03379077|Cognitive Behavior Therapy|cognitive behavior therapy
4678099|NCT03379064|Irritable Bowel Syndrome, Low Income Country|irritable bowel syndrome, low income country
4678100|NCT03379038|Cerebral Palsy|cerebral palsy
4678101|NCT03379038|Spasticity|spasticity
4678102|NCT03379038|Constipation|constipation
4678103|NCT03379038|Gross Motor Functional Classification Scale|gross motor functional classification scale
4678104|NCT03379038|Defecation Frequency|defecation frequency
4678105|NCT03379038|Constipation Severity|constipation severity
4678106|NCT03379025|electronic cigarettes; e-cigarettes|electronic cigarettes; e-cigarettes
4678107|NCT03378973|motor evoked potentials|motor evoked potentials
4678108|NCT03378947|EBV, DLBCL|ebv, dlbcl
4678109|NCT03378934|Coronary Artery Disease|coronary artery disease
4678110|NCT03378934|Percutaneous Coronary Intervention|percutaneous coronary intervention
4678111|NCT03378934|Antiplatelet|antiplatelet
4678112|NCT03378934|Berberine|berberine
4678113|NCT03378921|FMT|fmt
4678114|NCT03378908|medical therapy nutrition|medical therapy nutrition
4678115|NCT03378908|meal|meal
4678116|NCT03378908|carbohydrates|carbohydrates
4678117|NCT03378908|intervention|intervention
4678118|NCT03378908|food intake|food intake
4678119|NCT03378882|Angiostrongylosis|angiostrongylosis
4678120|NCT03378882|Hypereosinophilia|hypereosinophilia
4678121|NCT03378882|Eosinophilic meningitis|eosinophilic meningitis
4678122|NCT03378882|Meningoencephalitis|meningoencephalitis
4678123|NCT03378882|Achatina fulica|achatina fulica
4678124|NCT03378882|Angiostrongylus cantonensis|angiostrongylus cantonensis
4678125|NCT03378882|Angiostrongylus costaricensis|angiostrongylus costaricensis
4678126|NCT03378843|Polyamine, cardiovascular disease, cancer|polyamine, cardiovascular disease, cancer
4678127|NCT03378830|Pain|pain
4678128|NCT03378830|Sleep Disordered Breathing|sleep disordered breathing
4678129|NCT03378817|Extended criteria donor|extended criteria donor
4678130|NCT03378817|Donation after brain death|donation after brain death
4678131|NCT03378817|HOPE|hope
4678132|NCT03378817|Kidney transplantation|kidney transplantation
4678133|NCT03378804|PCEA|pcea
4678134|NCT03378804|PIEB|pieb
4678135|NCT03378804|epidural analgesia|epidural analgesia
4678136|NCT03378752|Computer tomography|computer tomography
4678137|NCT03378752|Liver tumor thermoablation|liver tumor thermoablation
4678138|NCT03378739|cardiogenic|cardiogenic
4678139|NCT03378739|shock|shock
4678140|NCT03378713|Poor Ovarian Response|poor ovarian response
4678141|NCT03378700|CKD|ckd
4678142|NCT03378700|Hope Intervention|hope intervention
4678143|NCT03378700|decision making|decision making
4678144|NCT03378687|Status Epilepticus|status epilepticus
4678145|NCT03378687|Children|children
4678146|NCT03378687|Multi-center|multi-center
4678147|NCT03378687|etiology|etiology
4678148|NCT03378687|treatment|treatment
4678149|NCT03378687|outcome|outcome
4678150|NCT03378687|risk factor|risk factor
4678151|NCT03378661|Chronic, Indeterminate|chronic, indeterminate
4678152|NCT03378635|Glucagon|glucagon
4678153|NCT03378596|Post-Exercise Hypotension|post-exercise hypotension
4678154|NCT03378596|Exercise|exercise
4678155|NCT03378596|Arginine|arginine
4678156|NCT03378596|Citrulline|citrulline
4678157|NCT03378570|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
4678158|NCT03378570|rTMS|rtms
4678159|NCT03378570|TMS|tms
4678160|NCT03378570|F3|f3
4678161|NCT03378570|5.5cm rule|5.5cm rule
4678162|NCT03378570|Targeting|targeting
4678163|NCT03378518|In-hospital Cardiac Arrest, mortality|in-hospital cardiac arrest, mortality
4678164|NCT03378479|Influenza|influenza
4678165|NCT03378453|Narcolepsy|narcolepsy
4678166|NCT03378453|Alzheimer|alzheimer
4678167|NCT03378453|Orexin|orexin
4678168|NCT03378453|Amyloid|amyloid
4678169|NCT03378453|PET-amyloid imaging|pet-amyloid imaging
4678170|NCT03378427|Tedizolid|tedizolid
4678171|NCT03378427|Adverse effects|adverse effects
4678172|NCT03378427|Efficacy|efficacy
4678173|NCT03378427|prosthetic joint infection|prosthetic joint infection
4678174|NCT03378414|Spinocerebellar Ataxia,Mesenchymal Stem Cells|spinocerebellar ataxia,mesenchymal stem cells
4678175|NCT03378388|Drug therapy|drug therapy
4678176|NCT03378323|upper extremity surgery|upper extremity surgery
4678177|NCT03378297|Ovarian cancer|ovarian cancer
4678178|NCT03378297|Phase 0|phase 0
4678179|NCT03378297|Window-of-opportunity|window-of-opportunity
4678180|NCT03378297|Suregry|suregry
4678181|NCT03378297|Repurposing|repurposing
4678182|NCT03378297|Metformin|metformin
4678183|NCT03378297|Acetylsalicylic acid|acetylsalicylic acid
4678184|NCT03378297|Olaparib|olaparib
4678185|NCT03378297|Letrozol|letrozol
4678186|NCT03378271|Continuous Glucose Monitoring|continuous glucose monitoring
4678187|NCT03378271|Flash glucose Monitoring|flash glucose monitoring
4678188|NCT03378271|Renal Impairment|renal impairment
4678189|NCT03378271|Type 1 Diabetes|type 1 diabetes
4678190|NCT03378271|Type 2 Diabetes|type 2 diabetes
4678191|NCT03378258|meningococcal|meningococcal
4678192|NCT03378258|neisseria meningitidis|neisseria meningitidis
4678193|NCT03378258|sepsis|sepsis
4678194|NCT03378258|meningitis|meningitis
4678195|NCT03378258|procalcitonin|procalcitonin
4678196|NCT03378258|PCT|pct
4678197|NCT03378258|LAMP|lamp
4678198|NCT03378258|loop-mediated-isothermal AMPlification|loop-mediated-isothermal amplification
4678199|NCT03378232|DHA|dha
4678200|NCT03378232|EPA|epa
4678201|NCT03378232|fatty acids|fatty acids
4678202|NCT03378232|blood pressure|blood pressure
4678203|NCT03378232|resting metabolic rate|resting metabolic rate
4678204|NCT03378232|blood lipids|blood lipids
4678205|NCT03378232|muscle sympathetic nerve activity (MSNA)|muscle sympathetic nerve activity (msna)
4678206|NCT03378206|genu valgum or varum|genu valgum or varum
4678207|NCT03378206|eight-plate|eight-plate
4678208|NCT03378206|epiphysis arrest|epiphysis arrest
4678209|NCT03378206|hemiepiphysiodesis|hemiepiphysiodesis
4678210|NCT03378193|Squamous cell carcinoma|squamous cell carcinoma
4678211|NCT03378193|FDG PET/CT|fdg pet/ct
4678212|NCT03378193|Textural analysis|textural analysis
4678213|NCT03378167|Paediatrics|paediatrics
4678214|NCT03378167|Pediatrics|pediatrics
4678215|NCT03378167|Crohn's|crohn's
4678216|NCT03378167|Crohn|crohn
4678217|NCT03378167|Microbiome|microbiome
4678218|NCT03378167|Microbiota|microbiota
4678219|NCT03378167|FMT|fmt
4678220|NCT03378167|Fecal Transplant|fecal transplant
4678221|NCT03378167|Fecal Microbiota Transplant|fecal microbiota transplant
4678222|NCT03378167|IBD-U|ibd-u
4678223|NCT03378167|Inflammatory Bowel Disease Unclassified|inflammatory bowel disease unclassified
4678224|NCT03378167|Inflammatory Bowel Disease Indeterminate|inflammatory bowel disease indeterminate
4678225|NCT03378167|IBD|ibd
4678226|NCT03378167|Colitis|colitis
4678227|NCT03378154|King vision|king vision
4678228|NCT03378154|Difficult airway|difficult airway
4678229|NCT03378154|Videolaryngoscope|videolaryngoscope
4678230|NCT03378154|Paediatric intubation|paediatric intubation
4678231|NCT03378128|debulking surgery|debulking surgery
4678232|NCT03378128|Ovarian Cancer|ovarian cancer
4678233|NCT03378102|T Cell Therapy|t cell therapy
4678234|NCT03378102|Opportunistic Infection|opportunistic infection
4678235|NCT03378089|Music Therapy|music therapy
4678236|NCT03378076|Osteoarthritis|osteoarthritis
4678237|NCT03378076|Knee|knee
4678238|NCT03378076|Corticosteroid|corticosteroid
4678239|NCT03378076|Bilateral|bilateral
4678240|NCT03378076|Pain|pain
4678241|NCT03378076|Intra-articular|intra-articular
4678242|NCT03378076|Injection|injection
4678243|NCT03378037|Brain Injuries, Traumatic|brain injuries, traumatic
4678244|NCT03378037|Alzheimer's disease|alzheimer's disease
4678245|NCT03378037|Magnetic resonance imaging|magnetic resonance imaging
4678246|NCT03378037|white matter integrity|white matter integrity
4678247|NCT03378037|beta-Amyloid|beta-amyloid
4678248|NCT03378024|Oscillometric device|oscillometric device
4678249|NCT03378024|repetitive Active Pedal Plantarflexion (APP) exercise test|repetitive active pedal plantarflexion (app) exercise test
4678250|NCT03378024|brachial-ankle pulse wave velocity (baPWV)|brachial-ankle pulse wave velocity (bapwv)
4678251|NCT03377959|dance|dance
4678252|NCT03377959|ballet|ballet
4678253|NCT03377959|Exercise Movement Techniques|exercise movement techniques
4678254|NCT03377959|turnout|turnout
4678255|NCT03377946|pre-diabetes,diabetes,probiotics|pre-diabetes,diabetes,probiotics
4678256|NCT03377933|Helicobacter pylori|helicobacter pylori
4678257|NCT03377933|Probiotics|probiotics
4678258|NCT03377933|Efficacy|efficacy
4678259|NCT03377933|Safety|safety
4678260|NCT03377933|gastromicroecology|gastromicroecology
4678261|NCT03377907|IVRA|ivra
4678262|NCT03377907|hematoma block|hematoma block
4678263|NCT03377842|apatinib|apatinib
4678264|NCT03377829|Papillary Thyroid Microcarcinoma|papillary thyroid microcarcinoma
4678265|NCT03377829|Percutaneous Laser Ablation|percutaneous laser ablation
4678266|NCT03377829|thyroidectomy|thyroidectomy
4678267|NCT03377829|ultrasonography|ultrasonography
4678268|NCT03377829|double-blind|double-blind
4678269|NCT03377816|Emotion Processing|emotion processing
4678270|NCT03377816|Art Therapy|art therapy
4678271|NCT03377816|Breast Cancer|breast cancer
4678272|NCT03377816|Cholinergic anti-inflammatory pathway|cholinergic anti-inflammatory pathway
4678273|NCT03377803|Molluscum|molluscum
4678274|NCT03377803|Skin Diseases|skin diseases
4678275|NCT03377803|Poxviridae Infections|poxviridae infections
4678276|NCT03377803|Skin Diseases; Infectious|skin diseases; infectious
4678277|NCT03377803|Skin Diseases; Viral|skin diseases; viral
4678278|NCT03377803|DNA Poxvirus|dna poxvirus
4678279|NCT03377790|Molluscum|molluscum
4678280|NCT03377790|Skin Diseases|skin diseases
4678281|NCT03377790|Poxviridae Infections|poxviridae infections
4678282|NCT03377790|Skin Diseases; Infectious|skin diseases; infectious
4678283|NCT03377790|Skin Diseases; Viral|skin diseases; viral
4678284|NCT03377790|DNA Poxvirus|dna poxvirus
4678285|NCT03377777|Anemia|anemia
4678286|NCT03377777|Iron-deficiency|iron-deficiency
4678287|NCT03377777|Iron-deficiency anemia|iron-deficiency anemia
4678288|NCT03377777|Infants|infants
4678289|NCT03377777|Metabolomics|metabolomics
4678290|NCT03377777|Microbiome|microbiome
4678291|NCT03377764|Spinal Anesthetic,|spinal anesthetic,
4678292|NCT03377764|Ultrasound guided Neuroaxial block,|ultrasound guided neuroaxial block,
4678293|NCT03377764|Anesthesia Trainees|anesthesia trainees
4678294|NCT03377751|Catheter ablation|catheter ablation
4678295|NCT03377751|Atrial fibrillation|atrial fibrillation
4678296|NCT03377751|Low voltage area|low voltage area
4678297|NCT03377738|Spirometry|spirometry
4678298|NCT03377738|Primary care|primary care
4678299|NCT03377738|Smoking Cessations|smoking cessations
4678300|NCT03377725|Myelodysplastic Syndromes|myelodysplastic syndromes
4678301|NCT03377725|Decitabine|decitabine
4678302|NCT03377725|Arsenic Trioxide|arsenic trioxide
4678303|NCT03377725|P53 Mutations|p53 mutations
4678304|NCT03377686|paediatrics|paediatrics
4678305|NCT03377686|breath analysis|breath analysis
4678306|NCT03377686|volatile organic compounds|volatile organic compounds
4678307|NCT03377686|respiratory diseases|respiratory diseases
4678308|NCT03377660|Esophagectomy|esophagectomy
4678309|NCT03377660|Unintentional weight loss|unintentional weight loss
4678310|NCT03377660|Gut hormones|gut hormones
4678311|NCT03377634|Older Adults|older adults
4678312|NCT03377634|Physical Activity|physical activity
4678313|NCT03377634|MORPH|morph
4678314|NCT03377634|Telecoaching|telecoaching
4678315|NCT03377634|mHealth|mhealth
4678316|NCT03377634|Weight Loss|weight loss
4678317|NCT03377634|Sedentary Behavior|sedentary behavior
4678318|NCT03377634|Pain|pain
4678319|NCT03377634|Design|design
4678320|NCT03377634|RCT|rct
4678321|NCT03377634|Randomized Controlled Trial|randomized controlled trial
4678322|NCT03377621|whole body vibration|whole body vibration
4678323|NCT03377621|sleep|sleep
4678324|NCT03377621|apnea|apnea
4678325|NCT03377608|tenofovir|tenofovir
4678326|NCT03377608|microbiome|microbiome
4678327|NCT03377608|inflammation|inflammation
4678328|NCT03377582|cardiovascular diseases|cardiovascular diseases
4678329|NCT03377582|cardiac rehabilitation|cardiac rehabilitation
4678330|NCT03377582|sympathetic nervous system|sympathetic nervous system
4678331|NCT03377582|heart rate|heart rate
4678332|NCT03377582|blood pressure|blood pressure
4678333|NCT03377582|clinical trial|clinical trial
4678334|NCT03377582|virtual reality exposure therapy|virtual reality exposure therapy
4678335|NCT03377582|barriers to cardiac rehabilitation|barriers to cardiac rehabilitation
4678336|NCT03377582|motivation|motivation
4678337|NCT03377582|adherence patient|adherence patient
4678338|NCT03377582|engagement|engagement
4678339|NCT03377582|perceived exertion|perceived exertion
4678340|NCT03377582|oxygen saturation|oxygen saturation
4678341|NCT03377569|Deep Brain Stimulation|deep brain stimulation
4678342|NCT03377569|Polysomnography|polysomnography
4678343|NCT03377569|Actigraphy|actigraphy
4678344|NCT03377530|Bacillus Cereus|bacillus cereus
4678345|NCT03377530|Premature neonates|premature neonates
4678346|NCT03377504|complex regional pain syndrome|complex regional pain syndrome
4678347|NCT03377504|mirror therapy|mirror therapy
4678348|NCT03377504|rehabilitation|rehabilitation
4678349|NCT03377491|Locally Advanced Pancreatic Adenocarcinoma|locally advanced pancreatic adenocarcinoma
4678350|NCT03377491|TTFields|ttfields
4678351|NCT03377491|Tumor Treating Fields|tumor treating fields
4678352|NCT03377491|Gemcitabine|gemcitabine
4678353|NCT03377491|nab-Paclitaxel|nab-paclitaxel
4678354|NCT03377491|Minimal toxicity|minimal toxicity
4678355|NCT03377491|TTF|ttf
4678356|NCT03377491|Novocure|novocure
4678357|NCT03377439|Platelet function|platelet function
4678358|NCT03377439|Bleeding risk|bleeding risk
4678359|NCT03377439|Immune Thrombocytopenia|immune thrombocytopenia
4678360|NCT03377426|Urinary tract infection, LYS228, beta-lactam antibiotics, creatinine clearance, Enterobactericeae|urinary tract infection, lys228, beta-lactam antibiotics, creatinine clearance, enterobactericeae
4678361|NCT03377387|Capecitabine|capecitabine
4678362|NCT03377387|Neratinib|neratinib
4678363|NCT03377387|HER2-Positive|her2-positive
4678364|NCT03377387|17-585|17-585
4678365|NCT03377335|Dapagliflozin|dapagliflozin
4678366|NCT03377335|Type 2 diabetes mellitus|type 2 diabetes mellitus
4678367|NCT03377335|Carotid intima-media thickness|carotid intima-media thickness
4678368|NCT03377335|Endothelial dysfunction|endothelial dysfunction
4678369|NCT03377335|Atherogenic lipoproteins|atherogenic lipoproteins
4678370|NCT03377335|Inflammatory markers|inflammatory markers
4678371|NCT03377335|microRNAs|micrornas
4678372|NCT03377309|Safety|safety
4678373|NCT03377309|Tolerability|tolerability
4678374|NCT03377309|Perampanel|perampanel
4678375|NCT03377270|Oropharyngeal Head and Neck Cancer|oropharyngeal head and neck cancer
4678376|NCT03377270|dysphagia|dysphagia
4678377|NCT03377270|Respiratory Swallow Training|respiratory swallow training
4678378|NCT03377257|Cluster headache|cluster headache
4678379|NCT03377257|zolmitriptan|zolmitriptan
4678380|NCT03377257|Sublingual administration|sublingual administration
4678381|NCT03377231|Pregnancy, Striae gravidarum, Striae distensae, Women's health|pregnancy, striae gravidarum, striae distensae, women's health
4678382|NCT03377192|Impedance pneumography|impedance pneumography
4678383|NCT03377192|Respiratory function|respiratory function
4678384|NCT03377192|Asthma management|asthma management
4678385|NCT03377179|Clinical Trial, Phase II|clinical trial, phase ii
4678386|NCT03377179|Multicenter Trials|multicenter trials
4678387|NCT03377179|Clinical Study|clinical study
4678388|NCT03377179|Clinical Trials, Non-Randomized|clinical trials, non-randomized
4678389|NCT03377179|Oral capsule|oral capsule
4678390|NCT03377179|Single arm|single arm
4678391|NCT03377179|Anti-cancer|anti-cancer
4678392|NCT03377179|Anti-inflammatory|anti-inflammatory
4678393|NCT03377179|ABC294640|abc294640
4678394|NCT03377179|Yeliva ®|yeliva ®
4678395|NCT03377127|diabetes|diabetes
4678396|NCT03377127|pharmacy clinic|pharmacy clinic
4678397|NCT03377127|education|education
4678398|NCT03377127|diabetes complications|diabetes complications
4678399|NCT03377127|hemoglobin A1c|hemoglobin a1c
4678400|NCT03377127|health-care cost|health-care cost
4678401|NCT03377127|'no show' rate|'no show' rate
4678402|NCT03377127|compliance|compliance
4678403|NCT03377127|diabetes core measures|diabetes core measures
4678404|NCT03377114|Nasotracheal intubation|nasotracheal intubation
4678405|NCT03377049|acetazolamide challenge|acetazolamide challenge
4678406|NCT03377049|cerebral vasospasm|cerebral vasospasm
4678407|NCT03377049|aneurysmal subarachnoid hemorrhage|aneurysmal subarachnoid hemorrhage
4678408|NCT03377036|Breast Cancer|breast cancer
4678409|NCT03377036|Population-based Screening|population-based screening
4678410|NCT03377036|Digital Breast Tomosynthesis plus synthesized Mammography|digital breast tomosynthesis plus synthesized mammography
4678411|NCT03377036|Reconstructed Mammography|reconstructed mammography
4678412|NCT03377036|Full-Field Digital Mammography (FFDM)|full-field digital mammography (ffdm)
4678413|NCT03377036|Multicentric Randomized Controlled Trial|multicentric randomized controlled trial
4678414|NCT03377036|Diagnostic Performance|diagnostic performance
4678415|NCT03377036|Recall Rate|recall rate
4678416|NCT03377036|Interval Cancer|interval cancer
4678417|NCT03377023|Nivolumab|nivolumab
4678418|NCT03377023|Ipilimumab|ipilimumab
4678419|NCT03377023|Nintedanib|nintedanib
4678420|NCT03377023|Immunotherapy|immunotherapy
4678421|NCT03377023|Advanced stage non-small cell lung cancer|advanced stage non-small cell lung cancer
4678422|NCT03377023|Locally advanced non-small cell lung cancer|locally advanced non-small cell lung cancer
4678423|NCT03376997|Bioavailability|bioavailability
4678424|NCT03376997|Perampanel|perampanel
4678425|NCT03376984|Root Canal Therapy|root canal therapy
4678426|NCT03376971|Lesion|lesion
4678427|NCT03376971|Lung|lung
4678428|NCT03376971|Cancer|cancer
4678429|NCT03376971|Diagnosis|diagnosis
4678430|NCT03376971|Optical Biopsy|optical biopsy
4678431|NCT03376971|Biopsy|biopsy
4678432|NCT03376958|R/R DLBCL, DCR, OS, PFS|r/r dlbcl, dcr, os, pfs
4678433|NCT03376945|n-3|n-3
4678434|NCT03376945|Parenteral nutrition|parenteral nutrition
4678435|NCT03376945|Jaundice|jaundice
4678436|NCT03376945|Propensity score match|propensity score match
4678437|NCT03376932|Vilanterol|vilanterol
4678438|NCT03376932|Fluticasone furoate|fluticasone furoate
4678439|NCT03376932|Connected Inhaler System|connected inhaler system
4678440|NCT03376932|Dry powder inhaler|dry powder inhaler
4678441|NCT03376932|Umeclidinium|umeclidinium
4678442|NCT03376932|Asthma|asthma
4678443|NCT03376919|wearable robotics|wearable robotics
4678444|NCT03376919|Unilateral Lower Limb Amputation|unilateral lower limb amputation
4678445|NCT03376919|gait efficiency|gait efficiency
4678446|NCT03376906|Obesity|obesity
4678447|NCT03376906|aerobic exercise|aerobic exercise
4678448|NCT03376906|interval exercise|interval exercise
4678449|NCT03376867|conditioned pain modulation (CPM)|conditioned pain modulation (cpm)
4678450|NCT03376867|Diffuse Noxious Inhibitory Controls (DNIC)|diffuse noxious inhibitory controls (dnic)
4678451|NCT03376867|pressure pain threshold (PPT)|pressure pain threshold (ppt)
4678452|NCT03376867|reference values|reference values
4678453|NCT03376867|clinical decision rule|clinical decision rule
4678454|NCT03376854|ARDS, temperature management, neuromuscular blockade|ards, temperature management, neuromuscular blockade
4678455|NCT03376841|Liver insufficiency|liver insufficiency
4678456|NCT03376841|Hepatic Impairment|hepatic impairment
4678457|NCT03376841|Cenicriviroc|cenicriviroc
4678458|NCT03376841|Pharmacokinetics|pharmacokinetics
4678459|NCT03376828|laryngoscopy|laryngoscopy
4678460|NCT03376828|videolaryngoscopy|videolaryngoscopy
4678461|NCT03376828|hypertension|hypertension
4678462|NCT03376815|Tumor ,landscape ,pathological diagnosis|tumor ,landscape ,pathological diagnosis
4679150|NCT03372083|Jadenu|jadenu
4678463|NCT03376776|idiopathic macular hole|idiopathic macular hole
4678464|NCT03376763|aripiprazole|aripiprazole
4678465|NCT03376763|Long-Acting Injection|long-acting injection
4678466|NCT03376750|telerehabilitation|telerehabilitation
4678467|NCT03376750|occupational therapy|occupational therapy
4678468|NCT03376750|RCT|rct
4678469|NCT03376750|participation|participation
4678470|NCT03376750|quality of life|quality of life
4678471|NCT03376750|intervention|intervention
4678472|NCT03376750|older adults|older adults
4678473|NCT03376659|PD-L1|pd-l1
4678474|NCT03376633|Randomized Controlled Trial|randomized controlled trial
4678475|NCT03376633|RCT|rct
4678476|NCT03376633|Chicago Public Schools|chicago public schools
4678477|NCT03376633|high school|high school
4678478|NCT03376633|trauma-informed counseling|trauma-informed counseling
4678479|NCT03376633|group-based counseling|group-based counseling
4678480|NCT03376633|counseling|counseling
4678481|NCT03376633|mentoring|mentoring
4678482|NCT03376633|Cognitive Behavioral Therapy|cognitive behavioral therapy
4678483|NCT03376633|CBT|cbt
4678484|NCT03376633|adolescents|adolescents
4678485|NCT03376633|females|females
4678486|NCT03376633|trauma|trauma
4678487|NCT03376633|stress|stress
4678488|NCT03376633|PTSD|ptsd
4678489|NCT03376633|anxiety|anxiety
4678490|NCT03376633|depression|depression
4678491|NCT03376633|graduation|graduation
4678492|NCT03376620|Prevention of hypertrophic scar|prevention of hypertrophic scar
4678493|NCT03376607|Primary Health Care|primary health care
4678494|NCT03376607|Health Behavior|health behavior
4678495|NCT03376607|Quality of Life|quality of life
4678496|NCT03376607|Health Literacy|health literacy
4678497|NCT03376607|Global Health|global health
4678498|NCT03376607|Medication Adherence|medication adherence
4678499|NCT03376594|Benjakul Extract|benjakul extract
4678500|NCT03376594|Allergic Rhinitis|allergic rhinitis
4678501|NCT03376594|Herbal Medicine|herbal medicine
4678502|NCT03376568|polysomnographic|polysomnographic
4678503|NCT03376568|multiple sleep latency test|multiple sleep latency test
4678504|NCT03376568|fMRI|fmri
4678505|NCT03376555|Sodium|sodium
4678506|NCT03376555|Hypertension|hypertension
4678507|NCT03376555|Blood Pressure|blood pressure
4678508|NCT03376555|Cardiovascular Disease|cardiovascular disease
4678509|NCT03376555|Nitric Oxide|nitric oxide
4678510|NCT03376555|Skin|skin
4678511|NCT03376555|Dairy|dairy
4678512|NCT03376555|Cheese|cheese
4678513|NCT03376555|Oxidative Stress|oxidative stress
4678514|NCT03376555|Diet|diet
4678515|NCT03376555|Flow Mediated Vasodilation|flow mediated vasodilation
4678516|NCT03376555|Nitroglycerin|nitroglycerin
4678517|NCT03376555|Superoxide|superoxide
4678518|NCT03376555|Microcirculation|microcirculation
4678519|NCT03376529|safety|safety
4678520|NCT03376529|tolerability|tolerability
4678521|NCT03376529|pharmacokinetics|pharmacokinetics
4678522|NCT03376529|drug-drug interaction|drug-drug interaction
4678523|NCT03376529|SPR741|spr741
4678524|NCT03376529|antibiotic|antibiotic
4678525|NCT03376477|Lenalidomide|lenalidomide
4678526|NCT03376477|M-spike negative|m-spike negative
4678527|NCT03376477|GVax|gvax
4678528|NCT03376477|GM-CSF secreting myeloma vaccine|gm-csf secreting myeloma vaccine
4678529|NCT03376464|Xeomin Cosmetic;|xeomin cosmetic;
4678530|NCT03376464|Masseteric Hypertrophy|masseteric hypertrophy
4678531|NCT03376425|Chest ultrasound,Lung tumor|chest ultrasound,lung tumor
4678532|NCT03376399|Sleeve Gastrectomy|sleeve gastrectomy
4678533|NCT03376399|Gastric Emptying|gastric emptying
4678534|NCT03376399|Diabetic Gastroparesis|diabetic gastroparesis
4678535|NCT03376399|Bariatric Surgery Candidate|bariatric surgery candidate
4678536|NCT03376386|Adaptive|adaptive
4678537|NCT03376386|Image-guided|image-guided
4678538|NCT03376386|Radiotherapy|radiotherapy
4678539|NCT03376386|Head and Neck cancer|head and neck cancer
4678540|NCT03376360|prostate cancer|prostate cancer
4678541|NCT03376360|Fcholine|fcholine
4678542|NCT03376360|positron emission tomography|positron emission tomography
4678543|NCT03376360|MRI|mri
4678544|NCT03376347|intraoperative|intraoperative
4678545|NCT03376347|hypotension|hypotension
4678546|NCT03376347|Hypotension Probability Index|hypotension probability index
4678547|NCT03376347|HPI|hpi
4678548|NCT03376334|Mental motor imagery|mental motor imagery
4678549|NCT03376334|SEBT|sebt
4678550|NCT03376308|rocuronium|rocuronium
4678551|NCT03376308|propofol|propofol
4678552|NCT03376308|pain|pain
4678553|NCT03376308|withdrawal|withdrawal
4678554|NCT03376308|venous diameter|venous diameter
4678555|NCT03376282|HBO|hbo
4678556|NCT03376282|kidney functions|kidney functions
4678557|NCT03376282|markers|markers
4678558|NCT03376269|more than 1 year|more than 1 year
4678559|NCT03376256|thoracic epidural|thoracic epidural
4678560|NCT03376256|pressure measurement|pressure measurement
4678561|NCT03376256|device|device
4678562|NCT03376243|Atopic eczema, prevention|atopic eczema, prevention
4678563|NCT03376230|Environmental risk factors|environmental risk factors
4678564|NCT03376230|Xenobiotic detoxification|xenobiotic detoxification
4678565|NCT03376217|malaria|malaria
4678566|NCT03376217|malaria in pregnancy|malaria in pregnancy
4678854|NCT03374215|Adrenal Adenoma|adrenal adenoma
4678567|NCT03376217|intermittent preventive treatment in pregnancy (IPTp)|intermittent preventive treatment in pregnancy (iptp)
4678568|NCT03376217|community health workers|community health workers
4678569|NCT03376217|Sulfadoxine-pyrimethamine (SP)|sulfadoxine-pyrimethamine (sp)
4678570|NCT03376204|Bronchiectasis|bronchiectasis
4678571|NCT03376204|Pain mechanisms|pain mechanisms
4678572|NCT03376204|Pressure pain threshold|pressure pain threshold
4678573|NCT03376204|Referred pain|referred pain
4678574|NCT03376191|Apatinib|apatinib
4678575|NCT03376191|lung cancer|lung cancer
4678576|NCT03376191|angiogenesis inhibitors|angiogenesis inhibitors
4678577|NCT03376191|efficacy|efficacy
4678578|NCT03376191|safety|safety
4678579|NCT03376178|multiorifice or endhole femoral nerve catheter|multiorifice or endhole femoral nerve catheter
4678580|NCT03376165|prognosis|prognosis
4678581|NCT03376165|translational research|translational research
4678582|NCT03376139|Alcohol|alcohol
4678583|NCT03376139|Alcoholic|alcoholic
4678584|NCT03376139|Alcoholism|alcoholism
4678585|NCT03376139|Alcohol abuse|alcohol abuse
4678586|NCT03376139|Alcohol Use Disorder|alcohol use disorder
4678587|NCT03376139|Alcohol use|alcohol use
4678588|NCT03376139|Alcohol dependence|alcohol dependence
4678589|NCT03376139|Alcohol dependent|alcohol dependent
4678590|NCT03376139|PTSD|ptsd
4678591|NCT03376139|Post-Traumatic Stress Disorder|post-traumatic stress disorder
4678592|NCT03376139|Veteran|veteran
4678593|NCT03376126|isolated limb perfusion|isolated limb perfusion
4678594|NCT03376113|self-harm|self-harm
4678595|NCT03376113|psychological intervention|psychological intervention
4678596|NCT03376087|Epilepsy|epilepsy
4678597|NCT03376087|heart block|heart block
4678598|NCT03376087|sudden cardiac death|sudden cardiac death
4678599|NCT03376087|loop recorder|loop recorder
4678600|NCT03376074|liver transplantation|liver transplantation
4678601|NCT03376074|hypothermic machine liver perfusion|hypothermic machine liver perfusion
4678602|NCT03376074|extended criteria liver grafts|extended criteria liver grafts
4678603|NCT03376061|Tranexamic Acid|tranexamic acid
4678604|NCT03376061|Cardiac surgery|cardiac surgery
4678605|NCT03376022|Attitudes|attitudes
4678606|NCT03376022|Knowledge|knowledge
4678607|NCT03376022|Oral Health|oral health
4678608|NCT03376022|Nursing personnel|nursing personnel
4678609|NCT03376009|Biomarker|biomarker
4678610|NCT03375983|Advanced cancer|advanced cancer
4678611|NCT03375983|Plasmodium immunotherapy|plasmodium immunotherapy
4678612|NCT03375983|Plasmodiun vivax|plasmodiun vivax
4678613|NCT03375944|Cardiac tele-rehabilitation, Myocardial revascularization|cardiac tele-rehabilitation, myocardial revascularization
4678614|NCT03375931|Quality of Recovery 40 Questionaries|quality of recovery 40 questionaries
4678615|NCT03375918|Healthcare disparities|healthcare disparities
4678616|NCT03375918|Racial Bias|racial bias
4678617|NCT03375905|ethnic Japanese|ethnic japanese
4678618|NCT03375892|radiation|radiation
4678619|NCT03375892|Deep Inspiration Breath Hold|deep inspiration breath hold
4678620|NCT03375892|stage I|stage i
4678621|NCT03375892|stage II|stage ii
4678622|NCT03375892|stage IIa|stage iia
4678623|NCT03375879|Ptosis|ptosis
4678624|NCT03375879|Blepharoptosis|blepharoptosis
4678625|NCT03375879|bandage contact lens|bandage contact lens
4678626|NCT03375879|fasanella servat procedure|fasanella servat procedure
4678627|NCT03375853|Obesity|obesity
4678628|NCT03375853|Dissonance|dissonance
4678629|NCT03375853|Response Training|response training
4678630|NCT03375853|Eating Disorder|eating disorder
4678631|NCT03375853|Computer-based Training|computer-based training
4678632|NCT03375840|pictorial warning labels|pictorial warning labels
4678633|NCT03375840|risk knowledge|risk knowledge
4678634|NCT03375840|emotion|emotion
4678635|NCT03375840|memory|memory
4678636|NCT03375840|risk perceptions|risk perceptions
4678637|NCT03375840|quit intentions|quit intentions
4678638|NCT03375827|Breast Cancer|breast cancer
4678639|NCT03375814|Crocin, osteoarthritis, Inflammation, IL-17,T-helper,T-reg|crocin, osteoarthritis, inflammation, il-17,t-helper,t-reg
4678640|NCT03375788|tesamorelin|tesamorelin
4678641|NCT03375788|obesity|obesity
4678642|NCT03375788|fatty liver|fatty liver
4678643|NCT03375749|sitting|sitting
4678644|NCT03375736|whole body vibration|whole body vibration
4678645|NCT03375736|cerebral palsy|cerebral palsy
4678646|NCT03375736|functional abilities|functional abilities
4678647|NCT03375736|children|children
4678648|NCT03375736|adults|adults
4678649|NCT03375723|Pain measurement|pain measurement
4678650|NCT03375723|Pain|pain
4678651|NCT03375710|Heart Failure|heart failure
4678652|NCT03375710|Heart Diseases|heart diseases
4678653|NCT03375710|Cardiovascular Disease|cardiovascular disease
4678654|NCT03375684|Cystic Fibrosis|cystic fibrosis
4678655|NCT03375684|Inspiratory Muscle Training|inspiratory muscle training
4678656|NCT03375684|Chest Physiotherapy|chest physiotherapy
4678657|NCT03375684|Balance|balance
4678658|NCT03375684|Postural Stability|postural stability
4678659|NCT03375684|Pulmonary Function Test|pulmonary function test
4678660|NCT03375684|6-Minute Walk Test|6-minute walk test
4678661|NCT03375671|ketamine|ketamine
4678662|NCT03375671|aggressive behaviour|aggressive behaviour
4678663|NCT03375671|midazolam|midazolam
4678664|NCT03375671|haloperidol|haloperidol
4678665|NCT03375671|emergency department|emergency department
4678666|NCT03375658|Information Science: Algorithms|information science: algorithms
4678667|NCT03375658|Information Science: Informatics: Nursing Informatics|information science: informatics: nursing informatics
4678668|NCT03375658|Information Science: Data Display: Computer graphics|information science: data display: computer graphics
4678669|NCT03375658|Diagnosis: Diagnostic Techiques and Procedures: Monitoring, Physiologic|diagnosis: diagnostic techiques and procedures: monitoring, physiologic
4678670|NCT03375658|Health care facilities, Manpower and services: Health services: Emergency Medical Services: Triage|health care facilities, manpower and services: health services: emergency medical services: triage
4678671|NCT03375619|CAR-20/19 T-Cell Therapy|car-20/19 t-cell therapy
4678672|NCT03375593|pain management|pain management
4678673|NCT03375593|RCT|rct
4678674|NCT03375554|esophageal steothoscope, tracheal intubation|esophageal steothoscope, tracheal intubation
4678675|NCT03375528|Matrix metalloproteinase|matrix metalloproteinase
4678676|NCT03375528|neointimal hyperplasia|neointimal hyperplasia
4678677|NCT03375515|hydromorphone titration|hydromorphone titration
4678678|NCT03375489|Lung Cancer palliative care|lung cancer palliative care
4678679|NCT03375476|postoperative myocardial infraction|postoperative myocardial infraction
4678680|NCT03375476|myocardial injury|myocardial injury
4678681|NCT03375476|general anesthesia|general anesthesia
4678682|NCT03375476|vascular surgery|vascular surgery
4678683|NCT03375476|surgical stress|surgical stress
4678684|NCT03375476|surgical plethysmographic index|surgical plethysmographic index
4678685|NCT03375450|Epidemiology, Chronic Obstructive Disease, Comparative Effectiveness, Exacerbation|epidemiology, chronic obstructive disease, comparative effectiveness, exacerbation
4678686|NCT03375437|Clinical Trial|clinical trial
4678687|NCT03375437|Multicenter Trial|multicenter trial
4678688|NCT03375437|NTRK1|ntrk1
4678689|NCT03375437|NTRK2|ntrk2
4678690|NCT03375437|NTRK3|ntrk3
4678691|NCT03375437|ROS1|ros1
4678692|NCT03375437|ALK|alk
4678693|NCT03375437|RNAseq|rnaseq
4678694|NCT03375437|entrectinib|entrectinib
4678695|NCT03375437|STARTRK-2|startrk-2
4678822|NCT03374449|Major surgery|major surgery
4678696|NCT03375424|Vedolizumab, Crohns disease, Ulcerative colitis, safety|vedolizumab, crohns disease, ulcerative colitis, safety
4678697|NCT03375398|SUGARDOWN™|sugardown™
4678698|NCT03375398|Galactomannan|galactomannan
4678699|NCT03375398|Postprandial blood glucose|postprandial blood glucose
4678700|NCT03375398|Insulin|insulin
4678701|NCT03375346|Whole body vibration exercise|whole body vibration exercise
4678702|NCT03375333|ultrasound|ultrasound
4678703|NCT03375333|diagnostics|diagnostics
4678704|NCT03375333|general practice|general practice
4678705|NCT03375333|family medicine|family medicine
4678706|NCT03375294|PTSD|ptsd
4678707|NCT03375255|Duchenne Muscular Dystrophy|duchenne muscular dystrophy
4678708|NCT03375255|Exon Skipping|exon skipping
4678709|NCT03375255|DMD|dmd
4678710|NCT03375255|Exon 51|exon 51
4678711|NCT03375255|Ambulatory|ambulatory
4678712|NCT03375255|Pediatric|pediatric
4678713|NCT03375255|Nonambulatory|nonambulatory
4678714|NCT03375255|Peptide-conjugated phosphorodiamidate morpholino oligomer (PPMO)|peptide-conjugated phosphorodiamidate morpholino oligomer (ppmo)
4678715|NCT03375229|Myofascial Pain|myofascial pain
4678716|NCT03375229|Pain Pressure Threshold|pain pressure threshold
4678717|NCT03375229|Low-Level Laser Therapy|low-level laser therapy
4678718|NCT03375229|Dry Needling|dry needling
4678719|NCT03375177|multiple sclerosis|multiple sclerosis
4678720|NCT03375177|Argentina|argentina
4678721|NCT03375177|epidemiology|epidemiology
4678722|NCT03375177|registry|registry
4678723|NCT03375164|Duchenne|duchenne
4678724|NCT03375164|gene therapy|gene therapy
4678725|NCT03375164|DMD|dmd
4678726|NCT03375164|dystrophin|dystrophin
4678727|NCT03375138|Healthy volunteers|healthy volunteers
4678728|NCT03375112|Total Hip Arthroplasty|total hip arthroplasty
4678729|NCT03375112|Fascia Iliaca|fascia iliaca
4678730|NCT03375112|Nerve Block|nerve block
4678731|NCT03375112|Pain Control|pain control
4678732|NCT03375099|Firearms|firearms
4678733|NCT03375099|Guns|guns
4678734|NCT03375099|Suicide|suicide
4678735|NCT03375099|Means Safety|means safety
4678736|NCT03375099|Means Restriction|means restriction
4678737|NCT03375099|Lethal Means Counseling|lethal means counseling
4678738|NCT03375047|Cystic Fibrosis|cystic fibrosis
4678739|NCT03375047|CF|cf
4678740|NCT03375034|Chronic pain|chronic pain
4678741|NCT03375034|Benzodiazepine|benzodiazepine
4678742|NCT03375034|Central sensitization|central sensitization
4678743|NCT03375034|Selective compound|selective compound
4678744|NCT03375034|GABAA receptors|gabaa receptors
4678745|NCT03375034|Antihyperalgesia|antihyperalgesia
4678746|NCT03375034|RCT|rct
4678747|NCT03375021|ADHD, ampakine, Phase II clinical trial|adhd, ampakine, phase ii clinical trial
4678748|NCT03375008|Magnetic resonance imager(MRI)|magnetic resonance imager(mri)
4678749|NCT03375008|Nonalcoholic fatty liver disease(NAFLD)|nonalcoholic fatty liver disease(nafld)
4678750|NCT03375008|Imaging diagnostic|imaging diagnostic
4678751|NCT03374956|Pharmacological|pharmacological
4678752|NCT03374956|Obesity Management|obesity management
4678753|NCT03374956|Individualized|individualized
4678754|NCT03374917|carbidopa|carbidopa
4678755|NCT03374917|levodopa|levodopa
4678756|NCT03374904|Parenting|parenting
4678757|NCT03374904|Parental Mentalization|parental mentalization
4679148|NCT03372083|Deferasirox|deferasirox
4678758|NCT03374904|Parental Reflective Function|parental reflective function
4678759|NCT03374904|Child Psychopathology|child psychopathology
4678760|NCT03374891|Shared Decision Making;|shared decision making;
4678761|NCT03374891|Defibrillator|defibrillator
4678762|NCT03374878|exercise|exercise
4678763|NCT03374878|oral contraceptive|oral contraceptive
4678764|NCT03374878|strength training|strength training
4678765|NCT03374813|Bone graft substitutes|bone graft substitutes
4678766|NCT03374813|Synthetic graft|synthetic graft
4678767|NCT03374813|Xenograft|xenograft
4678768|NCT03374813|Ridge preservation|ridge preservation
4678769|NCT03374813|Alveolar defect|alveolar defect
4678770|NCT03374761|child abuse|child abuse
4678771|NCT03374761|parenting|parenting
4678772|NCT03374761|low and middle income countries|low and middle income countries
4678773|NCT03374761|child discipline|child discipline
4678774|NCT03374761|Indonesia|indonesia
4678775|NCT03374696|Chlamydia infections|chlamydia infections
4678776|NCT03374696|condoms|condoms
4678777|NCT03374696|theater,|theater,
4678778|NCT03374696|sex education|sex education
4678779|NCT03374683|Risky play|risky play
4678780|NCT03374683|Physical activity|physical activity
4678781|NCT03374683|Injury prevention|injury prevention
4678782|NCT03374683|Outdoor play|outdoor play
4678783|NCT03374670|Zimura|zimura
4678784|NCT03374670|ARC1905|arc1905
4678785|NCT03374670|Eylea|eylea
4678786|NCT03374670|aflibercept|aflibercept
4678787|NCT03374670|IPCV|ipcv
4678788|NCT03374670|avacincaptad pegol|avacincaptad pegol
4678789|NCT03374670|complement factor C5 inhibitor|complement factor c5 inhibitor
4678790|NCT03374657|Clinical trials, dark adaptation, gene therapy, RLBP1 mutation, retinitis pigmentosa.|clinical trials, dark adaptation, gene therapy, rlbp1 mutation, retinitis pigmentosa.
4678791|NCT03374644|Correlation|correlation
4678792|NCT03374644|ETCO2|etco2
4678793|NCT03374644|PaCO2|paco2
4678794|NCT03374644|nasal cannula|nasal cannula
4678795|NCT03374644|Sentri Nasal Cannula|sentri nasal cannula
4678796|NCT03374592|Intensity-modulated radiation therapy|intensity-modulated radiation therapy
4678797|NCT03374592|Volumetric intensity-modulated arc therapy|volumetric intensity-modulated arc therapy
4678798|NCT03374592|Radiotherapy|radiotherapy
4678799|NCT03374592|Pain|pain
4678800|NCT03374592|Metastasis|metastasis
4678801|NCT03374592|Quality of Life|quality of life
4678802|NCT03374592|Acute Toxicity|acute toxicity
4678803|NCT03374566|Epstein-Barr Virus Infections|epstein-barr virus infections
4678804|NCT03374566|Immunodeficiency|immunodeficiency
4678805|NCT03374566|Screening|screening
4678806|NCT03374566|Immunologic Function|immunologic function
4678807|NCT03374527|T-cells|t-cells
4678808|NCT03374527|circulation|circulation
4678809|NCT03374527|synovial fluid|synovial fluid
4678810|NCT03374527|psoriasis|psoriasis
4678811|NCT03374527|psoriatic arthritis|psoriatic arthritis
4678812|NCT03374514|corticosteroids|corticosteroids
4678813|NCT03374514|Electric impedance|electric impedance
4678814|NCT03374501|Sugardown™|sugardown™
4678815|NCT03374501|Galactomannan|galactomannan
4678816|NCT03374501|Postprandial blood glucose|postprandial blood glucose
4678817|NCT03374501|Insulin|insulin
4678818|NCT03374488|Urothelial carcinoma|urothelial carcinoma
4678819|NCT03374488|programmed cell death protein 1 (PD-1) inhibitor|programmed cell death protein 1 (pd-1) inhibitor
4678820|NCT03374488|indoleamine 2,3-dioxygenase (IDO) inhibitor|indoleamine 2,3-dioxygenase (ido) inhibitor
4678821|NCT03374462|Pediatrics|pediatrics
4678823|NCT03374449|Postoperative morbidity and mortality|postoperative morbidity and mortality
4678824|NCT03374449|Renin angiotensin system inhibitors|renin angiotensin system inhibitors
4678825|NCT03374397|Laparoscopic unilateral ovarian cystectomy|laparoscopic unilateral ovarian cystectomy
4678826|NCT03374397|SurgiGuard|surgiguard
4678827|NCT03374397|Hemostasis|hemostasis
4678828|NCT03374397|Ovarian function preservation|ovarian function preservation
4678829|NCT03374397|Bipolar electrocauterization|bipolar electrocauterization
4678830|NCT03374371|Staphylococcus epidermidis Infection|staphylococcus epidermidis infection
4678831|NCT03374371|Staphylococcus epidermidis Contamination|staphylococcus epidermidis contamination
4678832|NCT03374371|intravascular device|intravascular device
4678833|NCT03374371|implanted material|implanted material
4678834|NCT03374345|Cold Hypersensitivity|cold hypersensitivity
4678835|NCT03374345|Korean medicine|korean medicine
4678836|NCT03374345|Sipjeondaebo-tang|sipjeondaebo-tang
4678837|NCT03374345|Cold intolerance|cold intolerance
4678838|NCT03374332|Refractory|refractory
4678839|NCT03374332|progression|progression
4678840|NCT03374332|recurrence|recurrence
4678841|NCT03374306|Myopia|myopia
4678842|NCT03374306|Myopia control|myopia control
4678843|NCT03374306|Atropine|atropine
4678844|NCT03374306|Electroretinogram|electroretinogram
4678845|NCT03374306|Multifocal Electroretinogram|multifocal electroretinogram
4678846|NCT03374293|pancreatic cancer|pancreatic cancer
4678847|NCT03374293|Radiation|radiation
4678848|NCT03374293|Anti-PD-1 Antibody|anti-pd-1 antibody
4678849|NCT03374280|non small cell lung cancer|non small cell lung cancer
4678850|NCT03374280|Gefitinib|gefitinib
4678851|NCT03374280|EGFR negative|egfr negative
4678852|NCT03374280|Pemetrexed|pemetrexed
4678853|NCT03374254|CRC, MSS, non-MSI-H, PD-1, anti-PD-1, anti PD-1, MEK, MEK inhibitor|crc, mss, non-msi-h, pd-1, anti-pd-1, anti pd-1, mek, mek inhibitor
4678855|NCT03374215|Molecular Genetics|molecular genetics
4678856|NCT03374215|African-American|african-american
4678857|NCT03374215|Biomarkers|biomarkers
4678858|NCT03374215|Primary Aldosteronism|primary aldosteronism
4678859|NCT03374202|ARV Therapy|arv therapy
4678860|NCT03374202|Broadly Neutralizing|broadly neutralizing
4678861|NCT03374202|Gene Transfer|gene transfer
4678862|NCT03374202|Monoclonal Antibody|monoclonal antibody
4678863|NCT03374202|AAV8|aav8
4678864|NCT03374176|periodontitis|periodontitis
4678865|NCT03374176|diabetes mellitus|diabetes mellitus
4678866|NCT03374176|systemic antimicrobials|systemic antimicrobials
4678867|NCT03374163|infertility , implantion failure, intracytoplasmic sperm injection|infertility , implantion failure, intracytoplasmic sperm injection
4678868|NCT03374150|Low-Calorie Diet|low-calorie diet
4678869|NCT03374150|Diet, High-Protein|diet, high-protein
4678870|NCT03374150|Obesity|obesity
4678871|NCT03374150|weight cycling|weight cycling
4678872|NCT03374150|body composition|body composition
4678873|NCT03374150|high-sensitivity C-Reactive protein|high-sensitivity c-reactive protein
4678874|NCT03374150|malondialdehyde|malondialdehyde
4678875|NCT03374150|glutathione|glutathione
4678876|NCT03374124|Chronic rhinosinusitis|chronic rhinosinusitis
4678877|NCT03374124|Eosinophil|eosinophil
4678878|NCT03374124|Surgery|surgery
4678879|NCT03374124|Diagnosis|diagnosis
4678880|NCT03374111|Thalassemia;|thalassemia;
4678881|NCT03374111|the Syndrome of Blood Deficiency|the syndrome of blood deficiency
4678882|NCT03374111|Anemia|anemia
4678883|NCT03374111|Colla Corii Asini|colla corii asini
4678884|NCT03374098|Medicaid|medicaid
4678885|NCT03374098|Mississippi|mississippi
4678886|NCT03374085|Multiple Myeloma|multiple myeloma
4678887|NCT03374085|Safety|safety
4678888|NCT03374085|Efficacy|efficacy
4678889|NCT03374085|CC-92480|cc-92480
4678890|NCT03374085|Relapsed|relapsed
4678891|NCT03374085|Refractory|refractory
4678892|NCT03374033|Preterm infants, growth, nutrition, physical activity|preterm infants, growth, nutrition, physical activity
4678893|NCT03373994|FDG, perfusion, hypoxia, tumor, PET|fdg, perfusion, hypoxia, tumor, pet
4678894|NCT03373955|T Cell repertoire|t cell repertoire
4678895|NCT03373955|lung cancer|lung cancer
4678896|NCT03373955|tumor mutation burden|tumor mutation burden
4678897|NCT03373955|Circulating tumour DNA|circulating tumour dna
4678898|NCT03373942|glaucoma|glaucoma
4678899|NCT03373942|EDI OCT|edi oct
4678900|NCT03373942|pseudoexfoliation|pseudoexfoliation
4678901|NCT03373942|choroidal thickness|choroidal thickness
4678902|NCT03373916|Peer Mentorship|peer mentorship
4678903|NCT03373916|Psychiatric Hospitalization|psychiatric hospitalization
4678904|NCT03373916|Suicide Risk|suicide risk
4678905|NCT03373864|Unilateral spinal anesthesia|unilateral spinal anesthesia
4678906|NCT03373864|general anesthesia|general anesthesia
4678907|NCT03373864|hemodynamic stability|hemodynamic stability
4678908|NCT03373864|MINS|mins
4678909|NCT03373864|hip fracture|hip fracture
4678910|NCT03373864|elderly|elderly
4678911|NCT03373864|AKI|aki
4678912|NCT03373825|overdose prevention|overdose prevention
4678913|NCT03373825|opioid overdose|opioid overdose
4678914|NCT03373825|risk behavior|risk behavior
4678915|NCT03373825|harm reduction|harm reduction
4678916|NCT03373799|rotator cuff|rotator cuff
4678917|NCT03373799|physiotherapy|physiotherapy
4678918|NCT03373799|video-based rehabilitation|video-based rehabilitation
4678919|NCT03373799|exercise|exercise
4678920|NCT03373786|Kidney disease|kidney disease
4678921|NCT03373786|Nephritis|nephritis
4678922|NCT03373786|Hereditary kidney disease|hereditary kidney disease
4678923|NCT03373786|Hereditary nephritis|hereditary nephritis
4678924|NCT03373773|pelvic reconstructive surgery|pelvic reconstructive surgery
4678925|NCT03373773|foley catheter|foley catheter
4678926|NCT03373773|Foley removal|foley removal
4678927|NCT03373773|Urogynecology|urogynecology
4678928|NCT03373773|Urinary Retention|urinary retention
4678929|NCT03373773|Gynecologic surgery|gynecologic surgery
4678930|NCT03373734|Online Cognitive Behavioural Therapy|online cognitive behavioural therapy
4678931|NCT03373734|Pregnancy|pregnancy
4678932|NCT03373734|Self-help|self-help
4678933|NCT03373669|oral cholera vaccine|oral cholera vaccine
4678934|NCT03373669|OCV|ocv
4678935|NCT03373669|dose interval|dose interval
4678936|NCT03373656|Vaccination|vaccination
4678937|NCT03373656|Childhood|childhood
4678938|NCT03373656|Hematologic Malignancy|hematologic malignancy
4678939|NCT03373656|Solid Tumor|solid tumor
4678940|NCT03373656|Immune Deficiency|immune deficiency
4678941|NCT03373604|18F-MK-6240|18f-mk-6240
4678942|NCT03373604|Cognitive Impairment|cognitive impairment
4678943|NCT03373604|Alzheimer's|alzheimer's
4678944|NCT03373591|bariatric surgery|bariatric surgery
4678945|NCT03373591|liposomal bupivacaine|liposomal bupivacaine
4678946|NCT03373578|sleep;|sleep;
4678947|NCT03373578|Infant, Premature;|infant, premature;
4678948|NCT03373578|Polysomnography;|polysomnography;
4678949|NCT03373578|Ear Protective Devices|ear protective devices
4678950|NCT03373552|Coronary Artery Disease; Clopidogrel; Polymorphism, genetic|coronary artery disease; clopidogrel; polymorphism, genetic
4678951|NCT03373539|Biomarkers|biomarkers
4678952|NCT03373539|Neurotrophins|neurotrophins
4678953|NCT03373526|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
4678954|NCT03373526|Aerobic Exercise|aerobic exercise
4678955|NCT03373526|Breathing Exercises|breathing exercises
4678956|NCT03373526|Inspiratory Capacity|inspiratory capacity
4678957|NCT03373526|Muscle Strength|muscle strength
4678958|NCT03373526|Exercise Tolerance|exercise tolerance
4678959|NCT03373526|Autonomic Nervous System|autonomic nervous system
4678960|NCT03373513|Return-to-work, Visual analogue pain score, Cosmesis|return-to-work, visual analogue pain score, cosmesis
4678961|NCT03373461|glomerunephritis, complement driven, chronic kidney disease|glomerunephritis, complement driven, chronic kidney disease
4678962|NCT03373409|Dry Powder Inhaler|dry powder inhaler
4678963|NCT03373396|Chlordecone|chlordecone
4678964|NCT03373396|fibrosis|fibrosis
4678965|NCT03373396|cirrhosis|cirrhosis
4678966|NCT03373396|chronic hepatitis B, C|chronic hepatitis b, c
4678967|NCT03373396|alcohol|alcohol
4678968|NCT03373396|viral hepatitis|viral hepatitis
4678969|NCT03373396|transaminases|transaminases
4678970|NCT03373396|fibroscan|fibroscan
4678971|NCT03373383|Epilepsy|epilepsy
4678972|NCT03373383|Padsevonil|padsevonil
4678973|NCT03373357|sleep apnea|sleep apnea
4678974|NCT03373357|arterial hypertension|arterial hypertension
4678975|NCT03373357|cardiovascular risk|cardiovascular risk
4678976|NCT03373344|emotional processing|emotional processing
4678977|NCT03373344|multiple sclerosis|multiple sclerosis
4678978|NCT03373344|cognition|cognition
4678979|NCT03373331|Emotional Processing|emotional processing
4678980|NCT03373331|Cognition|cognition
4678981|NCT03373331|Traumatic Brain Injury|traumatic brain injury
4678982|NCT03373331|Intervention|intervention
4678983|NCT03373292|Stenting|stenting
4678984|NCT03373292|Jugular vein stenosis|jugular vein stenosis
4678985|NCT03373292|Intracranial hypertension|intracranial hypertension
4678986|NCT03373292|Headache|headache
4678987|NCT03373292|Tinnitus|tinnitus
4678988|NCT03373292|Papilledema|papilledema
4678989|NCT03373292|Visual impairment|visual impairment
4678990|NCT03373279|Heart Transplant|heart transplant
4678991|NCT03373240|Drug use Disorders|drug use disorders
4678992|NCT03373240|Cognitive Remediation|cognitive remediation
4678993|NCT03373227|Heart Transplant|heart transplant
4678994|NCT03373214|Human Hookworm|human hookworm
4678995|NCT03373214|Necator americanus|necator americanus
4678996|NCT03373214|Hookworm|hookworm
4678997|NCT03373214|Hookworm Disease|hookworm disease
4678998|NCT03373214|Iron-deficiency anemia|iron-deficiency anemia
4678999|NCT03373214|Soil-transmitted helminth infection|soil-transmitted helminth infection
4679000|NCT03373214|Neglected Tropical Disease|neglected tropical disease
4679001|NCT03373214|Na-GST-1|na-gst-1
4679002|NCT03373214|CpG|cpg
4679003|NCT03373175|Monitoring NIV, inspiratory muscular unloading, EMG|monitoring niv, inspiratory muscular unloading, emg
4679004|NCT03373149|IVF|ivf
4679005|NCT03373149|Growth hormone|growth hormone
4679006|NCT03373149|Poor responders|poor responders
4679007|NCT03373123|Esophageal Varices|esophageal varices
4679008|NCT03373123|Variceal Hemorrhage|variceal hemorrhage
4679009|NCT03373123|Endoscopy|endoscopy
4679010|NCT03373123|Radiomics|radiomics
4679011|NCT03373123|Hepatitis B Virus|hepatitis b virus
4679012|NCT03373110|Online Therapy|online therapy
4679013|NCT03373110|Fitbit|fitbit
4679014|NCT03373110|Depression|depression
4679015|NCT03373110|Cardiovascular Disease|cardiovascular disease
4679016|NCT03373097|Neuroblastoma|neuroblastoma
4679017|NCT03373097|GD2 CAR T cell|gd2 car t cell
4679018|NCT03373097|CAR T|car t
4679019|NCT03373084|Magnetic Resonance Imaging (MRI)|magnetic resonance imaging (mri)
4679020|NCT03373084|Ultrasound|ultrasound
4679021|NCT03373084|Sport|sport
4679022|NCT03373084|Hamstring muscle|hamstring muscle
4679023|NCT03373084|Injury|injury
4679024|NCT03373071|CD19-CAR T cell|cd19-car t cell
4679025|NCT03373071|CD19-malignancy|cd19-malignancy
4679026|NCT03373071|CAR T cell|car t cell
4679027|NCT03373071|CD19-ALL|cd19-all
4679028|NCT03373071|CD19-LNH|cd19-lnh
4679029|NCT03373058|Hyperthermic Intraperitoneal Chemotherapy|hyperthermic intraperitoneal chemotherapy
4679030|NCT03373058|Advanced-Stage Epithelial Ovarian Cancer|advanced-stage epithelial ovarian cancer
4679031|NCT03373058|Cytoreductive surgery|cytoreductive surgery
4679032|NCT03373058|Postoperative Chemotherapy|postoperative chemotherapy
4679033|NCT03373045|Severe asthma|severe asthma
4679034|NCT03373045|Monoclonal antibody|monoclonal antibody
4679035|NCT03373045|Corticosteroid|corticosteroid
4679036|NCT03373045|Non-interventional|non-interventional
4679037|NCT03373032|Physical Activity|physical activity
4679038|NCT03373032|Sensory Neuropathy|sensory neuropathy
4679039|NCT03373032|Acupuncture|acupuncture
4679040|NCT03373019|chidamide|chidamide
4679041|NCT03373019|R-GDP|r-gdp
4679042|NCT03373019|diffuse large B-cell lymphoma|diffuse large b-cell lymphoma
4679043|NCT03372980|Biomarkers|biomarkers
4679044|NCT03372967|preventable disease|preventable disease
4679045|NCT03372967|vaccine|vaccine
4679046|NCT03372967|public health|public health
4679047|NCT03372967|vaccine history|vaccine history
4679048|NCT03372967|point-of-care|point-of-care
4679049|NCT03372941|Acute bacterial skin and skin structure infections|acute bacterial skin and skin structure infections
4679050|NCT03372941|Hospital avoidance|hospital avoidance
4679051|NCT03372941|Antibiotic therapy|antibiotic therapy
4679052|NCT03372941|Dalbavancin|dalbavancin
4679053|NCT03372941|Emergency department|emergency department
4679054|NCT03372902|Breast imaging|breast imaging
4679055|NCT03372902|17-598|17-598
4679056|NCT03372889|Anterior Cruciate Ligament|anterior cruciate ligament
4679057|NCT03372889|On-Q Catheter|on-q catheter
4679058|NCT03372889|nerve block|nerve block
4679059|NCT03372889|ACL reconstruction|acl reconstruction
4679060|NCT03372889|patient education materials|patient education materials
4679061|NCT03372837|Diffuse large B-cell lymphoma, rituximab, SyB L-0501, combination therapy|diffuse large b-cell lymphoma, rituximab, syb l-0501, combination therapy
4679062|NCT03372824|mass screening|mass screening
4679063|NCT03372798|catheter ablation|catheter ablation
4679064|NCT03372798|intraprocedural left atrial wall thickness imaging|intraprocedural left atrial wall thickness imaging
4679065|NCT03372785|coronary artery disease|coronary artery disease
4679066|NCT03372785|Cardiac magnetic resonance (CMR) imaging|cardiac magnetic resonance (cmr) imaging
4679067|NCT03372785|Myocardial Stunning|myocardial stunning
4679068|NCT03372785|Percutaneous Coronary Intervention|percutaneous coronary intervention
4679069|NCT03372785|Chronic Total Occlusion of Coronary Artery|chronic total occlusion of coronary artery
4679070|NCT03372772|Fatigue, Levocarnitine,|fatigue, levocarnitine,
4679071|NCT03372746|Biopsy|biopsy
4679072|NCT03372733|Omega-7|omega-7
4679073|NCT03372733|Palmitoleic Acid|palmitoleic acid
4679074|NCT03372733|Monounsaturated Fatty Acids|monounsaturated fatty acids
4679075|NCT03372733|Lipoproteins|lipoproteins
4679076|NCT03372733|Satiety|satiety
4679077|NCT03372707|Cuff leak test|cuff leak test
4679078|NCT03372707|Post-extubation airway obstruction|post-extubation airway obstruction
4679079|NCT03372707|Laryngeal edema|laryngeal edema
4679080|NCT03372681|Distal Gastrectomy|distal gastrectomy
4679081|NCT03372681|Postoperative Reflux Rate|postoperative reflux rate
4679082|NCT03372681|Gastric Cance|gastric cance
4679083|NCT03372681|Laparoscopic Surgery|laparoscopic surgery
4679084|NCT03372668|lower limb amputation|lower limb amputation
4679085|NCT03372668|PLP|plp
4679086|NCT03372616|aortic blood pressure|aortic blood pressure
4679087|NCT03372616|diastolic dysfuntion|diastolic dysfuntion
4679088|NCT03372616|echocardiography|echocardiography
4679089|NCT03372616|left ventricular ejection fraction|left ventricular ejection fraction
4679090|NCT03372603|GSK2798745, efficacy, safety, chronic cough, crossover study|gsk2798745, efficacy, safety, chronic cough, crossover study
4679091|NCT03372590|general movement assessment|general movement assessment
4679092|NCT03372538|placenta accreta|placenta accreta
4679093|NCT03372499|Hepatic Encephalopathy|hepatic encephalopathy
4679094|NCT03372499|Diet Management|diet management
4679095|NCT03372499|Transjugular Intrahepatic Portosystemic Shunt|transjugular intrahepatic portosystemic shunt
4679096|NCT03372460|Transcranial Direct Current Stimulation|transcranial direct current stimulation
4679097|NCT03372460|Stress Disorders, Post-Traumatic|stress disorders, post-traumatic
4679098|NCT03372460|Virtual Reality|virtual reality
4679099|NCT03372460|Prefrontal Cortex|prefrontal cortex
4679100|NCT03372460|Veterans|veterans
4679101|NCT03372460|Quality of Life|quality of life
4679102|NCT03372395|probiotics implementation|probiotics implementation
4679103|NCT03372395|HPV infection|hpv infection
4679104|NCT03372395|vaginosis|vaginosis
4679105|NCT03372395|yeast vaginitis|yeast vaginitis
4679106|NCT03372382|postpartum|postpartum
4679107|NCT03372369|contraceptive knowledge|contraceptive knowledge
4679108|NCT03372369|contraceptive use|contraceptive use
4679109|NCT03372369|educational intervention|educational intervention
4679110|NCT03372369|poster|poster
4679111|NCT03372369|online survey|online survey
4679112|NCT03372356|DT|dt
4679113|NCT03372356|HADS|hads
4679114|NCT03372356|SPBS|spbs
4679115|NCT03372356|CD-RISC|cd-risc
4679116|NCT03372356|Psychosocial Screening|psychosocial screening
4679117|NCT03372330|peripheral artery disease|peripheral artery disease
4679118|NCT03372330|sepsis|sepsis
4679119|NCT03372317|Tau|tau
4679120|NCT03372317|MK-6240|mk-6240
4679121|NCT03372317|Cognition|cognition
4679122|NCT03372304|Peripheral regional anesthesia|peripheral regional anesthesia
4679123|NCT03372291|Acute Myeloid Leukemia|acute myeloid leukemia
4679124|NCT03372278|Total hip arthroplasty|total hip arthroplasty
4679125|NCT03372278|Medical Device|medical device
4679126|NCT03372278|Safety|safety
4679127|NCT03372278|Prothesis|prothesis
4679128|NCT03372265|Peripheral regional anesthesia|peripheral regional anesthesia
4679129|NCT03372239|Indoximod|indoximod
4679130|NCT03372226|Gambling|gambling
4679131|NCT03372226|Problematic Gambling|problematic gambling
4679132|NCT03372226|Pathological Gambling|pathological gambling
4679133|NCT03372187|diet|diet
4679134|NCT03372187|MS|ms
4679135|NCT03372187|Telehealth|telehealth
4679136|NCT03372174|cardiac surgery|cardiac surgery
4679137|NCT03372174|mechanical ventilation|mechanical ventilation
4679138|NCT03372174|postoperative infections|postoperative infections
4679139|NCT03372161|lumbosacral radicular pain|lumbosacral radicular pain
4679140|NCT03372161|sciatica|sciatica
4679141|NCT03372161|leg pain|leg pain
4679142|NCT03372135|POCD|pocd
4679143|NCT03372135|RARC|rarc
4679144|NCT03372135|Trendelenburg Position|trendelenburg position
4679145|NCT03372096|embolization|embolization
4679146|NCT03372096|prostate|prostate
4679147|NCT03372083|Iron Chelation Therapy|iron chelation therapy
4679151|NCT03372083|Exjade|exjade
4679152|NCT03372083|ICL 670|icl 670
4679153|NCT03372083|Pediatric|pediatric
4679154|NCT03372070|primary snoring|primary snoring
4679155|NCT03372070|bed partner|bed partner
4679156|NCT03372070|home sleep testing|home sleep testing
4679157|NCT03372057|Lymphoma|lymphoma
4679158|NCT03372057|T-cell Lymphoma|t-cell lymphoma
4679159|NCT03372057|Relapse|relapse
4679160|NCT03372057|Refractory|refractory
4679161|NCT03372057|PI3K-δ,γ|pi3k-δ,γ
4679162|NCT03372044|Relative bioavailability|relative bioavailability
4679163|NCT03372044|Modified release|modified release
4679164|NCT03372044|Pharmacokinetics|pharmacokinetics
4679165|NCT03372031|Music Supported Therapy|music supported therapy
4679166|NCT03372031|plasticity|plasticity
4679167|NCT03372031|multisensory integration|multisensory integration
4679168|NCT03372031|bimanual coupling|bimanual coupling
4679169|NCT03372031|auditory feedback|auditory feedback
4679170|NCT03372031|dexterity|dexterity
4679171|NCT03372031|piano therapy|piano therapy
4679172|NCT03371992|immunotherapy|immunotherapy
4679173|NCT03371992|anti-PD1|anti-pd1
4679174|NCT03371992|anti-PDL1|anti-pdl1
4679175|NCT03371992|biomarker|biomarker
4679176|NCT03371992|drug mechanism|drug mechanism
4679177|NCT03371966|Beetroot Juice|beetroot juice
4679178|NCT03371966|Older Adults|older adults
4679179|NCT03371966|Nitrate|nitrate
4679180|NCT03371966|Nitrite|nitrite
4679181|NCT03371966|Nitric Oxide|nitric oxide
4679182|NCT03371953|vecuronium|vecuronium
4679183|NCT03371953|atracurium|atracurium
4679184|NCT03371953|combination|combination
4679185|NCT03371927|Premature Infants|premature infants
4679186|NCT03371927|SINC feeding protocol|sinc feeding protocol
4679187|NCT03371914|costing|costing
4679188|NCT03371914|behavioral intervention|behavioral intervention
4679189|NCT03371914|management|management
4679190|NCT03371901|Menisci, Tibial|menisci, tibial
4679191|NCT03371901|Cartilage, Articular|cartilage, articular
4679192|NCT03371901|Blood Flow Restriction Training|blood flow restriction training
4679193|NCT03371901|Resistance training|resistance training
4679194|NCT03371901|Physical Therapy Modalities|physical therapy modalities
4679195|NCT03371901|Feasibility Studies|feasibility studies
4679196|NCT03371862|Liraglutide|liraglutide
4679197|NCT03371862|Victoza|victoza
4679198|NCT03371836|pediatrics|pediatrics
4679199|NCT03371823|Hypertension|hypertension
4679200|NCT03371823|Endothelin-1 receptor|endothelin-1 receptor
4679201|NCT03371810|attention-deficit / hyperactivity disorder|attention-deficit / hyperactivity disorder
4679202|NCT03371810|depression|depression
4679203|NCT03371810|obesity|obesity
4679204|NCT03371810|prevention|prevention
4679205|NCT03371810|bright light therapy|bright light therapy
4679206|NCT03371810|exercise|exercise
4679207|NCT03371810|mobile healthy system|mobile healthy system
4679208|NCT03371797|ALERT, MSSBP, MSDBP|alert, mssbp, msdbp
4679209|NCT03371784|Acute myocardial infarction|acute myocardial infarction
4679210|NCT03371784|Left ventricular remodeling|left ventricular remodeling
4679211|NCT03371784|Coronary wedge pressure|coronary wedge pressure
4679212|NCT03371784|Glucocorticoid therapy|glucocorticoid therapy
4679213|NCT03371732|Psychological intervention Alcohol|psychological intervention alcohol
4679214|NCT03371732|Tobacco consumption|tobacco consumption
4679215|NCT03371732|Substance use|substance use
4679216|NCT03371732|Health risk behavior|health risk behavior
4679217|NCT03371732|Oncology setting|oncology setting
4679218|NCT03371732|Women|women
4679219|NCT03371732|Supportive care|supportive care
4679220|NCT03371706|aphasia|aphasia
4679221|NCT03371706|primary progressive aphasia|primary progressive aphasia
4679222|NCT03371706|dementia|dementia
4679223|NCT03371706|communication|communication
4679224|NCT03371706|frontotemporal dementia|frontotemporal dementia
4679225|NCT03371706|Alzheimer's disease|alzheimer's disease
4679226|NCT03371693|hyperthermic intraperitoneal chemotherapy|hyperthermic intraperitoneal chemotherapy
4679227|NCT03371693|epithelial ovarian cancer|epithelial ovarian cancer
4679228|NCT03371667|Hematopoietic Stem Cell|hematopoietic stem cell
4679229|NCT03371667|Methotrexate|methotrexate
4679230|NCT03371667|Corticosteroids therapy|corticosteroids therapy
4679231|NCT03371667|Acute GVHD|acute gvhd
4679232|NCT03371667|Allogenic stem cell transplantation|allogenic stem cell transplantation
4679233|NCT03371641|Fetal Alcohol Syndrome|fetal alcohol syndrome
4679234|NCT03371641|Pregnancy|pregnancy
4679235|NCT03371641|Biomarker|biomarker
4679236|NCT03371641|PlGF|plgf
4679237|NCT03371641|Cognitive development|cognitive development
4679238|NCT03371641|Behavior troubles|behavior troubles
4679239|NCT03371576|toric IOL|toric iol
4679240|NCT03371550|Concurrent 3-D chemoradiotherapy,Docetaxel,Cisplatin,Chemotherapy ·|concurrent 3-d chemoradiotherapy,docetaxel,cisplatin,chemotherapy ·
4679241|NCT03371511|Microbiota|microbiota
4679242|NCT03371511|Microbiome|microbiome
4679243|NCT03371485|Non-small cell lung cancer|non-small cell lung cancer
4679244|NCT03371485|Immunotherapy|immunotherapy
4679245|NCT03371485|Cancer vaccine|cancer vaccine
4679246|NCT03371485|Dendritic cell vaccine|dendritic cell vaccine
4679247|NCT03371485|Allogeneic vaccine|allogeneic vaccine
4679248|NCT03371446|DNA Methylation. Smoking. SOCS-1 gene.|dna methylation. smoking. socs-1 gene.
4679249|NCT03371433|Osteoporosis|osteoporosis
4679250|NCT03371433|Hip Fractures|hip fractures
4679251|NCT03371433|Soft Drinks|soft drinks
4679252|NCT03371368|Obesity|obesity
4679253|NCT03371368|Insulin Resistance|insulin resistance
4679254|NCT03371368|Bariatric Surgery|bariatric surgery
4679255|NCT03371368|Gastric Bypass|gastric bypass
4679256|NCT03371368|Sleeve Gastrectomy|sleeve gastrectomy
4679257|NCT03371355|Type 2 Diabetes|type 2 diabetes
4679258|NCT03371355|Hepatic Steatosis|hepatic steatosis
4679259|NCT03371355|Triglycerides|triglycerides
4679260|NCT03371355|AKCEA-ANGPTL3-Lrx|akcea-angptl3-lrx
4679261|NCT03371355|IONIS-ANGPTL3-Lrx|ionis-angptl3-lrx
4679262|NCT03371355|Fatty Liver|fatty liver
4679263|NCT03371355|Fatty Liver Without Mention of Alcohol|fatty liver without mention of alcohol
4679264|NCT03371355|Liver Fat|liver fat
4679265|NCT03371355|Liver Diseases|liver diseases
4679266|NCT03371355|Diabetes Mellitus Type 2 in Nonobese|diabetes mellitus type 2 in nonobese
4679267|NCT03371355|Diabetes Mellitus|diabetes mellitus
4679268|NCT03371355|Triglycerides High|triglycerides high
4679269|NCT03371355|High Triglycerides|high triglycerides
4679270|NCT03371355|Metabolic Disease|metabolic disease
4679271|NCT03371355|Endocrine System Diseases|endocrine system diseases
4679272|NCT03371355|Digestive System Disease|digestive system disease
4679273|NCT03371355|Glucose Metabolism Disorders|glucose metabolism disorders
4679274|NCT03371329|mesenchymal stem cell|mesenchymal stem cell
4679275|NCT03371329|stroke|stroke
4679276|NCT03371329|intracerebral hemorrhage|intracerebral hemorrhage
4679277|NCT03371329|cell therapy|cell therapy
4679278|NCT03371264|Liver transplantation|liver transplantation
4679279|NCT03371264|Allocation process|allocation process
4679280|NCT03371264|Extended-criteria donors|extended-criteria donors
4679281|NCT03371264|Survival|survival
4679282|NCT03371251|Adults|adults
4679283|NCT03371251|BOS161721|bos161721
4679284|NCT03371251|standard of care|standard of care
4679285|NCT03371251|moderately to severely active Systemic Lupus Erythematosus|moderately to severely active systemic lupus erythematosus
4679286|NCT03371212|Dual Mobility|dual mobility
4679287|NCT03371212|Serum metal levels|serum metal levels
4679288|NCT03371186|Implementation Research|implementation research
4679289|NCT03371186|Maternal Mortality and Morbidity|maternal mortality and morbidity
4679290|NCT03371186|Neonatal Mortality and Morbidity|neonatal mortality and morbidity
4679291|NCT03371186|Infant Mortality and Morbidity|infant mortality and morbidity
4679292|NCT03371186|Child Mortality and Morbidity|child mortality and morbidity
4679293|NCT03371186|Community Health Workers|community health workers
4679294|NCT03371186|Health Systems Strengthening|health systems strengthening
4679295|NCT03371173|Pulmonary Hypertension|pulmonary hypertension
4679296|NCT03371173|Iron Deficiency|iron deficiency
4679297|NCT03371108|Diabetes|diabetes
4679298|NCT03371108|Diabetes Type 2|diabetes type 2
4679299|NCT03371108|Type 2|type 2
4679300|NCT03371108|Basal|basal
4679301|NCT03371108|Insulin|insulin
4679302|NCT03371108|Glargine|glargine
4679303|NCT03371108|T2DM|t2dm
4679304|NCT03371108|Diabetes Mellitus|diabetes mellitus
4679305|NCT03371095|Behcet's Disease|behcet's disease
4679306|NCT03371095|Vasculitis|vasculitis
4679307|NCT03371095|Biotherapy|biotherapy
4679308|NCT03371095|immunosuppressant|immunosuppressant
4679309|NCT03371095|Infliximab|infliximab
4679310|NCT03371082|Diabetes|diabetes
4679311|NCT03371082|Diabetes Type 1|diabetes type 1
4679312|NCT03371082|Type 1|type 1
4679313|NCT03371082|Basal|basal
4679314|NCT03371082|Insulin|insulin
4679315|NCT03371082|Glargine|glargine
4679316|NCT03371082|T1DM|t1dm
4679317|NCT03371082|Diabetes Mellitus|diabetes mellitus
4679318|NCT03371082|Insulin Dependent Diabetes|insulin dependent diabetes
4679319|NCT03371069|methylphenidate|methylphenidate
4679320|NCT03371069|drug utilisation study|drug utilisation study
4679321|NCT03371069|pediatrics|pediatrics
4679322|NCT03371056|Neonatal infections|neonatal infections
4679323|NCT03371056|maternal-fetal infection|maternal-fetal infection
4679324|NCT03371056|group B streptococcus|group b streptococcus
4679325|NCT03371056|vaginal sample|vaginal sample
4679326|NCT03371056|antibiotic prophylaxis|antibiotic prophylaxis
4679327|NCT03371056|bacterial resistance|bacterial resistance
4679328|NCT03371043|analgesics|analgesics
4679329|NCT03371043|opioids|opioids
4679330|NCT03371043|outpatient drug use|outpatient drug use
4679331|NCT03371043|pediatrics|pediatrics
4679332|NCT03371030|distal radius fractures|distal radius fractures
4679333|NCT03371030|pronator quadratus|pronator quadratus
4679334|NCT03371030|osteosynthesis|osteosynthesis
4679335|NCT03371004|DM-CHOC-PEN|dm-choc-pen
4679336|NCT03371004|Radiation|radiation
4679337|NCT03371004|Cancer|cancer
4679338|NCT03370991|Blueberries|blueberries
4679339|NCT03370991|Polyphenols|polyphenols
4679340|NCT03370991|Cardiovascular Disease|cardiovascular disease
4679341|NCT03370991|Atherosclerosis|atherosclerosis
4679342|NCT03370991|Oxidative Stress|oxidative stress
4679343|NCT03370991|Inflammmation|inflammmation
4679344|NCT03370991|Endothelium|endothelium
4679345|NCT03370991|Vasodilation|vasodilation
4679346|NCT03370991|Blood Pressure|blood pressure
4679347|NCT03370991|Menopause|menopause
4679348|NCT03370991|Women's Health|women's health
4679349|NCT03370991|Functional Food|functional food
4679350|NCT03370991|Bioactive Compounds|bioactive compounds
4679351|NCT03370991|Dietary Supplements|dietary supplements
4679352|NCT03370991|Aging|aging
4679353|NCT03370965|optic neuritis|optic neuritis
4679354|NCT03370965|neuromyelitis optica|neuromyelitis optica
4679355|NCT03370965|multiple sclerosis|multiple sclerosis
4679356|NCT03370965|emergent treatment of optic neuritis|emergent treatment of optic neuritis
4679357|NCT03370965|optic neuritis disease modifying therapy|optic neuritis disease modifying therapy
4679358|NCT03370965|optic neuritis treatment trial|optic neuritis treatment trial
4679359|NCT03370965|plasma exchange|plasma exchange
4679360|NCT03370939|ischemic stroke|ischemic stroke
4679361|NCT03370939|endovascular treatment|endovascular treatment
4679362|NCT03370939|workflow|workflow
4679363|NCT03370913|Gene Therapy|gene therapy
4679364|NCT03370913|Clotting Disorders|clotting disorders
4679365|NCT03370913|Blood Disorder|blood disorder
4679366|NCT03370913|Blood Coagulation Disorders|blood coagulation disorders
4679367|NCT03370913|Inherited Blood Coagulation disorders|inherited blood coagulation disorders
4679368|NCT03370913|Hematologic Diseases|hematologic diseases
4679369|NCT03370913|Coagulation Protein Disorders|coagulation protein disorders
4679370|NCT03370913|Hemorrhagic Disorders|hemorrhagic disorders
4679371|NCT03370913|Genetic Diseases|genetic diseases
4679372|NCT03370913|Inborn|inborn
4679373|NCT03370913|Factor VIII|factor viii
4679374|NCT03370913|Coagulants|coagulants
4679375|NCT03370900|Education (Medical); Retention;|education (medical); retention;
4679376|NCT03370848|Niacin|niacin
4679377|NCT03370848|Psyllium|psyllium
4679378|NCT03370848|Dietary fiber|dietary fiber
4679379|NCT03370835|Beta-Blocker|beta-blocker
4679380|NCT03370835|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
4679381|NCT03370835|COPD|copd
4679382|NCT03370835|Cardioselective|cardioselective
4679383|NCT03370822|Fetal monitoring|fetal monitoring
4679384|NCT03370822|Acceptability|acceptability
4679385|NCT03370822|Fetal Heart Rate|fetal heart rate
4679386|NCT03370809|Frailty|frailty
4679387|NCT03370809|Oncogeriatric|oncogeriatric
4679388|NCT03370809|PET 18F-FDG|pet 18f-fdg
4679389|NCT03370809|SPM (Statistical Parametric Mapping)|spm (statistical parametric mapping)
4679390|NCT03370809|Neurology|neurology
4679391|NCT03370796|dementia|dementia
4679392|NCT03370796|cognitive impairment|cognitive impairment
4679393|NCT03370796|cognition|cognition
4679394|NCT03370796|quality of life|quality of life
4679395|NCT03370796|depressive symptoms|depressive symptoms
4679396|NCT03370796|Reminiscence Therapy|reminiscence therapy
4679397|NCT03370744|subjective cognitive decline|subjective cognitive decline
4679398|NCT03370744|brain network|brain network
4679399|NCT03370744|multi-modality|multi-modality
4679400|NCT03370744|magnetic resonance imaging|magnetic resonance imaging
4679401|NCT03370731|pediatric|pediatric
4679402|NCT03370731|obstructive sleep apnea|obstructive sleep apnea
4679403|NCT03370731|polysomnography|polysomnography
4679404|NCT03370731|quality of life|quality of life
4679405|NCT03370731|adenotonsillectomy|adenotonsillectomy
4679406|NCT03370718|Adrenocortical carcinoma|adrenocortical carcinoma
4679407|NCT03370718|ACC|acc
4679408|NCT03370718|Cabozantinib|cabozantinib
4679409|NCT03370718|XL-184|xl-184
4679410|NCT03370718|XL184|xl184
4679411|NCT03370692|Outcome|outcome
4679412|NCT03370692|Survival|survival
4679413|NCT03370692|Prognostication|prognostication
4679414|NCT03370679|Premature|premature
4679415|NCT03370679|Ventricular|ventricular
4679416|NCT03370679|Complexes|complexes
4679417|NCT03370679|Beats|beats
4679418|NCT03370679|Prognosis|prognosis
4679419|NCT03370653|MPS VI|mps vi
4679420|NCT03370653|Lysosomal disease|lysosomal disease
4679421|NCT03370653|Glycoaminoglycans (GAG)|glycoaminoglycans (gag)
4679422|NCT03370653|Odiparcil|odiparcil
4679423|NCT03370627|Autoimmune Diseases|autoimmune diseases
4679424|NCT03370627|Plasmacytoid Dendritic Cells|plasmacytoid dendritic cells
4679425|NCT03370627|Type I Interferons|type i interferons
4679426|NCT03370627|Antibodies|antibodies
4679427|NCT03370627|Anti-CD303|anti-cd303
4679428|NCT03370614|PET|pet
4679429|NCT03370614|MRI|mri
4679430|NCT03370614|Irritable Bowel Syndrome|irritable bowel syndrome
4679431|NCT03370614|Irritable Bowel|irritable bowel
4679432|NCT03370614|Positron emission tomography|positron emission tomography
4679433|NCT03370614|Magnetic resonance imaging|magnetic resonance imaging
4679434|NCT03370614|FDG|fdg
4679435|NCT03370614|Fluorodeoxyglucose|fluorodeoxyglucose
4679436|NCT03370601|crohn's disease|crohn's disease
4679437|NCT03370601|ulcerative colitis|ulcerative colitis
4679438|NCT03370601|infliximab|infliximab
4679439|NCT03370601|loss of response|loss of response
4679440|NCT03370562|dexmedetomidine|dexmedetomidine
4679441|NCT03370562|cesarean|cesarean
4679442|NCT03370562|spinal anesthesia|spinal anesthesia
4679443|NCT03370549|Mental health|mental health
4679444|NCT03370549|Suicide|suicide
4679445|NCT03370549|Sexual risk behaviors|sexual risk behaviors
4679446|NCT03370536|Atrial Fibrillation|atrial fibrillation
4679447|NCT03370536|Persistent Atrial Fibrillation|persistent atrial fibrillation
4679448|NCT03370536|AFIB|afib
4679449|NCT03370536|Arrhythmia|arrhythmia
4679450|NCT03370471|aerobic exercise|aerobic exercise
4679451|NCT03370471|learning|learning
4679452|NCT03370471|language|language
4679453|NCT03370471|cognition|cognition
4679454|NCT03370432|Vitamin D|vitamin d
4679455|NCT03370432|GC|gc
4679456|NCT03370432|CYP2R1|cyp2r1
4679457|NCT03370432|Gene-environment interaction|gene-environment interaction
4679458|NCT03370432|prospective case-cohort study|prospective case-cohort study
4679459|NCT03370432|single nucleotide polymorphisms|single nucleotide polymorphisms
4679460|NCT03370432|colorectal cancer|colorectal cancer
4679461|NCT03370419|Metabolic syndrome|metabolic syndrome
4679462|NCT03370419|Habits|habits
4679463|NCT03370419|African American|african american
4679464|NCT03370419|Emergency Medicine|emergency medicine
4679465|NCT03370406|Squamous Cell|squamous cell
4679466|NCT03370406|Carcinoma|carcinoma
4679467|NCT03370406|Lower Extremities|lower extremities
4679468|NCT03370406|5-Fluorouracil|5-fluorouracil
4679469|NCT03370406|Imiquimod|imiquimod
4679470|NCT03370393|Reward-drive|reward-drive
4679471|NCT03370393|Cogntiive-control|cogntiive-control
4679472|NCT03370315|Parkinsonian Disorders|parkinsonian disorders
4679473|NCT03370315|Dance Therapy|dance therapy
4679474|NCT03370315|Rehabilitation|rehabilitation
4679475|NCT03370315|Kinematics|kinematics
4679476|NCT03370315|Locomotion|locomotion
4679477|NCT03370315|Quality of Life|quality of life
4679478|NCT03370302|Drug therapy|drug therapy
4679479|NCT03370263|Benlysta, systemic lupus erythematosus, safety, efficacy|benlysta, systemic lupus erythematosus, safety, efficacy
4679480|NCT03370250|immediate breast reconstruction|immediate breast reconstruction
4679481|NCT03370250|free greater omentum|free greater omentum
4679482|NCT03370250|breast-conserving surgery|breast-conserving surgery
4679483|NCT03370250|luminal breast cancer|luminal breast cancer
4679484|NCT03370237|Diabetic foot ulcer|diabetic foot ulcer
4679485|NCT03370237|type 2 diabetes|type 2 diabetes
4679486|NCT03370237|foot ulcer risk|foot ulcer risk
4679487|NCT03370224|Memory|memory
4679488|NCT03370224|Learning|learning
4679489|NCT03370224|Cognition|cognition
4679490|NCT03370224|Treatment|treatment
4679491|NCT03370211|resistance training|resistance training
4679492|NCT03370211|inflammatory markers|inflammatory markers
4679493|NCT03370211|functional capacity|functional capacity
4679494|NCT03370185|Leukemia|leukemia
4679495|NCT03370185|Lymphoma|lymphoma
4679496|NCT03370185|Refractory|refractory
4679497|NCT03370185|Relapse|relapse
4679498|NCT03370133|Bimekizumab|bimekizumab
4679499|NCT03370133|PSO|pso
4679500|NCT03370133|Psoriasis|psoriasis
4679501|NCT03370120|Drug-Resistant Epilepsy|drug-resistant epilepsy
4679502|NCT03370120|Padsevonil|padsevonil
4679503|NCT03370081|Capnometry|capnometry
4679504|NCT03370081|Capnography|capnography
4679505|NCT03370081|ETCO2|etco2
4679506|NCT03370081|Recovery room|recovery room
4679507|NCT03370081|Post-anesthesia care unit|post-anesthesia care unit
4679508|NCT03370068|ICSI|icsi
4679509|NCT03370068|IVF|ivf
4679510|NCT03370068|Infertility|infertility
4679511|NCT03370068|non-male factor|non-male factor
4679512|NCT03370068|intracytoplasmic sperm injection|intracytoplasmic sperm injection
4679513|NCT03370068|In vitro fertilization|in vitro fertilization
4679514|NCT03370055|Exposed tendon or bone|exposed tendon or bone
4679515|NCT03370055|LeucoPatch|leucopatch
4679516|NCT03370055|Plastic Surgery|plastic surgery
4679517|NCT03370055|Granulation tissue|granulation tissue
4679518|NCT03370055|Wound|wound
4679519|NCT03370042|aesthetics|aesthetics
4679520|NCT03370042|root coverage|root coverage
4679521|NCT03370042|semilunar coronally positioned flap|semilunar coronally positioned flap
4679522|NCT03370042|free gingival graft|free gingival graft
4679523|NCT03370042|width of keratinised tissue|width of keratinised tissue
4679524|NCT03370029|Exercise capacity|exercise capacity
4679525|NCT03370029|Respiratory muscle strength|respiratory muscle strength
4679526|NCT03370029|Physical inactivity|physical inactivity
4679527|NCT03370029|Quality of life|quality of life
4679528|NCT03370016|Radical Prostatectomy|radical prostatectomy
4679529|NCT03370016|Robotic Assisted Radical Prostatectomy|robotic assisted radical prostatectomy
4679530|NCT03369977|BioGlue Surgical Adhesive|bioglue surgical adhesive
4679531|NCT03369977|Type A Aortic Dissection|type a aortic dissection
4679532|NCT03369951|ACUMIN|acumin
4679533|NCT03369951|Infusion|infusion
4679534|NCT03369951|Injection|injection
4679535|NCT03369951|Minocycline|minocycline
4679536|NCT03369951|Pharmacokinetic|pharmacokinetic
4679537|NCT03369951|PK|pk
4679538|NCT03369938|left ventricular assist device|left ventricular assist device
4679539|NCT03369938|exercise training|exercise training
4679540|NCT03369912|Safety, efficacy|safety, efficacy
4679541|NCT03369912|pregnant women|pregnant women
4679542|NCT03369912|CSJ148|csj148
4679543|NCT03369912|HCMV infection|hcmv infection
4679544|NCT03369912|congenital HCMV|congenital hcmv
4679545|NCT03369886|OCTA|octa
4679546|NCT03369886|Angiography|angiography
4679547|NCT03369886|Artificial neural network|artificial neural network
4679548|NCT03369873|cardiac catheterization|cardiac catheterization
4679549|NCT03369873|anxiety|anxiety
4679550|NCT03369873|stress|stress
4679551|NCT03369873|nursing orientation|nursing orientation
4679552|NCT03369847|inhaled corticosteroids|inhaled corticosteroids
4679553|NCT03369847|budesonide|budesonide
4679554|NCT03369847|beclomethasone|beclomethasone
4680032|NCT03367026|heart rate|heart rate
4679555|NCT03369834|phototherapy|phototherapy
4679556|NCT03369834|diabetes mellitus|diabetes mellitus
4679557|NCT03369834|exercise|exercise
4679558|NCT03369821|type 1 diabetes|type 1 diabetes
4679559|NCT03369821|monogenic diabetes|monogenic diabetes
4679560|NCT03369821|autoimmune diabetes|autoimmune diabetes
4679561|NCT03369821|early-onset autoimmune diabetes|early-onset autoimmune diabetes
4679562|NCT03369821|beta cell (β-cell) destruction|beta cell (β-cell) destruction
4679563|NCT03369821|type 1 diabetes genetic risk|type 1 diabetes genetic risk
4679564|NCT03369821|extremely early-onset Type 1 diabetes|extremely early-onset type 1 diabetes
4679565|NCT03369821|neonatal diabetes|neonatal diabetes
4679566|NCT03369808|H7N9|h7n9
4679567|NCT03369795|methotrexate|methotrexate
4679568|NCT03369795|add-on|add-on
4679569|NCT03369795|schizophrenia|schizophrenia
4679570|NCT03369795|schizoaffective|schizoaffective
4679571|NCT03369782|Muscle Tension|muscle tension
4679572|NCT03369782|Skeletal Muscle Relaxants|skeletal muscle relaxants
4679573|NCT03369782|Arthroplasties, Hip Replacement|arthroplasties, hip replacement
4679574|NCT03369782|Rocuronium|rocuronium
4679575|NCT03369782|sugammadex|sugammadex
4679576|NCT03369730|Screening|screening
4679577|NCT03369730|Duration of Untreated Psychosis (DUP)|duration of untreated psychosis (dup)
4679578|NCT03369730|Coordinated Specialty Care (CSC)|coordinated specialty care (csc)
4679579|NCT03369730|First Episode Psychosis (FEP)|first episode psychosis (fep)
4679580|NCT03369730|At Risk Mental State (ARMS)|at risk mental state (arms)
4679581|NCT03369730|Clinical High Risk for Psychosis (CHR)|clinical high risk for psychosis (chr)
4679582|NCT03369717|endoscopic sinus surgery|endoscopic sinus surgery
4679583|NCT03369717|antibiotics|antibiotics
4679584|NCT03369704|cryptomeria, omalizumab, seasonal allergic rhinitis|cryptomeria, omalizumab, seasonal allergic rhinitis
4679585|NCT03369678|Cultural Safety|cultural safety
4679586|NCT03369678|Discrimination|discrimination
4679587|NCT03369678|Emergency Departments|emergency departments
4679588|NCT03369678|Health Equity|health equity
4679589|NCT03369678|Indigenous Populations|indigenous populations
4679590|NCT03369678|Marginalized Populations|marginalized populations
4679591|NCT03369678|Patient Experiences of Care|patient experiences of care
4679592|NCT03369678|Trauma- and Violence-Informed Care|trauma- and violence-informed care
4679593|NCT03369678|Staff Engagement|staff engagement
4679594|NCT03369678|Harm Reduction|harm reduction
4679595|NCT03369665|Multiple sclerosis|multiple sclerosis
4679596|NCT03369665|Mavenclad®|mavenclad®
4679597|NCT03369665|Cladribine|cladribine
4679598|NCT03369665|Health-related Quality of Life|health-related quality of life
4679599|NCT03369639|late life|late life
4679600|NCT03369639|THC|thc
4679601|NCT03369639|depression|depression
4679602|NCT03369639|anxiety|anxiety
4679603|NCT03369639|dronabinol|dronabinol
4679604|NCT03369587|Handwriting, Micrographia|handwriting, micrographia
4679605|NCT03369548|Bile acids|bile acids
4679606|NCT03369548|Lipid metabolism|lipid metabolism
4679607|NCT03369548|Cholesterol|cholesterol
4679608|NCT03369548|Probiotics|probiotics
4679609|NCT03369548|Polyphenols|polyphenols
4679610|NCT03369548|Prebiotics|prebiotics
4679611|NCT03369548|Gut bacteria|gut bacteria
4679612|NCT03369548|Gut microbiota|gut microbiota
4679613|NCT03369535|hypertension|hypertension
4679614|NCT03369522|seizure detection|seizure detection
4679615|NCT03369509|Drug hypersensitivity, drug allergy, cross reaction|drug hypersensitivity, drug allergy, cross reaction
4679616|NCT03369496|Social Capital|social capital
4679617|NCT03369496|Social Support|social support
4679618|NCT03369496|Neighborhood|neighborhood
4679619|NCT03369496|Population Health|population health
4679620|NCT03369496|Healthy Aging|healthy aging
4679621|NCT03369496|Adult|adult
4679622|NCT03369496|Canada|canada
4679623|NCT03369431|Autism|autism
4679624|NCT03369431|Gastrointestinal|gastrointestinal
4679625|NCT03369431|behaviour|behaviour
4679626|NCT03369431|constipation|constipation
4679627|NCT03369431|diarrhoea|diarrhoea
4679628|NCT03369431|probiotic|probiotic
4679629|NCT03369431|sociability|sociability
4679630|NCT03369405|periodontitis|periodontitis
4679631|NCT03369405|hypothyroidism|hypothyroidism
4679632|NCT03369379|Fibromyalgia|fibromyalgia
4679633|NCT03369379|D Vitamin|d vitamin
4679634|NCT03369366|Maxillofacial Defects|maxillofacial defects
4679635|NCT03369366|Benign, large tumors requiring surgical resection|benign, large tumors requiring surgical resection
4679636|NCT03369353|Bone Marrow Transplantation|bone marrow transplantation
4679637|NCT03369353|Graft Vs Host Disease|graft vs host disease
4679638|NCT03369353|Inflammatory Bowel Diseases|inflammatory bowel diseases
4679639|NCT03369353|Functional Gastrointestinal Disorders|functional gastrointestinal disorders
4679640|NCT03369340|Nicotine|nicotine
4679641|NCT03369340|Reduced risk product|reduced risk product
4679642|NCT03369340|Nicotine-containing product|nicotine-containing product
4679643|NCT03369275|Mesenchymal Stem Cells|mesenchymal stem cells
4679644|NCT03369275|Mesenchymal Stromal Cells|mesenchymal stromal cells
4679645|NCT03369275|Randomized Controlled Trial|randomized controlled trial
4679646|NCT03369275|Cryopreserved|cryopreserved
4679647|NCT03369275|Allogeneic|allogeneic
4679648|NCT03369275|Phase II|phase ii
4679649|NCT03369262|preterm labor|preterm labor
4679650|NCT03369262|preterm birth|preterm birth
4679651|NCT03369262|premature birth|premature birth
4679652|NCT03369262|tocolysis|tocolysis
4679653|NCT03369262|prostaglandin F2α antagonist|prostaglandin f2α antagonist
4679654|NCT03369262|PGF2α|pgf2α
4679655|NCT03369236|factor D|factor d
4679656|NCT03369236|fD|fd
4679657|NCT03369236|alternative pathway|alternative pathway
4679658|NCT03369236|complement mediated disease|complement mediated disease
4679659|NCT03369236|Membranoproliferative Glomerulonephritis|membranoproliferative glomerulonephritis
4679660|NCT03369236|Primary MPGN|primary mpgn
4679661|NCT03369236|MPGN|mpgn
4679662|NCT03369236|Mesangiocapillary Glomerulonephritis|mesangiocapillary glomerulonephritis
4679663|NCT03369236|idiopathic MPGN|idiopathic mpgn
4679664|NCT03369236|DDD|ddd
4679665|NCT03369236|C3GN|c3gn
4679666|NCT03369223|Antibodies|antibodies
4679667|NCT03369223|Antineoplastic Agents|antineoplastic agents
4679668|NCT03369223|Immunologic Factors|immunologic factors
4679669|NCT03369223|Nivolumab|nivolumab
4679670|NCT03369223|Antibodies, Monoclonal|antibodies, monoclonal
4679671|NCT03369223|Physiological Effects of Drugs|physiological effects of drugs
4679672|NCT03369197|procedural sedation|procedural sedation
4679673|NCT03369197|monitored anesthesia care|monitored anesthesia care
4679674|NCT03369197|endoscopy|endoscopy
4679675|NCT03369184|Coronary flow|coronary flow
4679676|NCT03369184|Coronary vascular resistance|coronary vascular resistance
4679677|NCT03369184|Supplemental oxygen|supplemental oxygen
4679678|NCT03369145|Hepatokines|hepatokines
4679679|NCT03369145|High Fat Diet|high fat diet
4679680|NCT03369145|Glycaemic Control|glycaemic control
4679681|NCT03369145|Fibroblast Growth Factor 21|fibroblast growth factor 21
4679682|NCT03369145|Leukocyte Cell-derived Chemotaxin 2|leukocyte cell-derived chemotaxin 2
4679683|NCT03369145|Fetuin-A|fetuin-a
4679684|NCT03369145|Appetite|appetite
4679685|NCT03369145|Ghrelin|ghrelin
4679686|NCT03369145|Peptide YY|peptide yy
4679687|NCT03369119|Acute asthma|acute asthma
4679688|NCT03369119|Montelukast|montelukast
4679689|NCT03369119|Hospitalized children|hospitalized children
4679690|NCT03369119|Preschool children|preschool children
4679691|NCT03369093|RCT|rct
4679692|NCT03369093|severe pneumonia|severe pneumonia
4679693|NCT03369093|amoxicillin|amoxicillin
4679694|NCT03369093|under five|under five
4679695|NCT03369080|Body Mass Index|body mass index
4679696|NCT03369067|Artificial Pancreas (AP)|artificial pancreas (ap)
4679697|NCT03369067|Continuous Glucose Monitor (CGM)|continuous glucose monitor (cgm)
4679698|NCT03369067|Closed Loop Control (CLC)|closed loop control (clc)
4679699|NCT03369067|Insulin Pump|insulin pump
4679700|NCT03369041|chemoembolization|chemoembolization
4679701|NCT03369015|Reward Learning|reward learning
4679702|NCT03369015|Decision Making|decision making
4679703|NCT03369002|Hepatic Impairment|hepatic impairment
4679704|NCT03368950|Anxiety|anxiety
4679705|NCT03368950|Depression|depression
4679706|NCT03368950|Stress|stress
4679707|NCT03368937|Artificial Pancreas (AP)|artificial pancreas (ap)
4679708|NCT03368937|Closed Loop Control (CLC)|closed loop control (clc)
4679709|NCT03368937|Continuous Glucose Monitor (CGM)|continuous glucose monitor (cgm)
4679710|NCT03368937|Insulin Pump|insulin pump
4679711|NCT03368924|sickle cell anemia red blood cell oxidation|sickle cell anemia red blood cell oxidation
4679712|NCT03368924|vaso-occlusive crises|vaso-occlusive crises
4679713|NCT03368924|anti bande 3 antibodies|anti bande 3 antibodies
4679714|NCT03368924|red blood cell oxidation|red blood cell oxidation
4679715|NCT03368911|Hoarseness|hoarseness
4679716|NCT03368911|Sore Throat|sore throat
4679717|NCT03368911|Thyroidectomy|thyroidectomy
4679718|NCT03368885|MIYCN -Maternal Infant Young Child Nutrition|miycn -maternal infant young child nutrition
4679719|NCT03368885|CGPP - Core Group Polio Project|cgpp - core group polio project
4679720|NCT03368885|A&T- Alive and Thrive|a&t- alive and thrive
4679721|NCT03368885|PCI- Project Concern International|pci- project concern international
4679722|NCT03368885|UP- Uttar Pradesh|up- uttar pradesh
4679723|NCT03368885|VHSNC -Village Health, Sanitation and Nutrition Committee|vhsnc -village health, sanitation and nutrition committee
4679724|NCT03368885|CMC- Community Mobilization Coordinator|cmc- community mobilization coordinator
4679725|NCT03368872|Sarcopenia, muscle function, muscle endurance, fatigue|sarcopenia, muscle function, muscle endurance, fatigue
4679726|NCT03368859|cancer|cancer
4679727|NCT03368859|colorectal cancer|colorectal cancer
4679728|NCT03368859|ABT-165|abt-165
4679729|NCT03368859|FOLFIRI|folfiri
4679730|NCT03368859|Bevacizumab|bevacizumab
4679731|NCT03368859|bowel cancer|bowel cancer
4679732|NCT03368859|metastatic colorectal cancer|metastatic colorectal cancer
4679733|NCT03368859|metastatic colorectal|metastatic colorectal
4679734|NCT03368820|lung neoplasms|lung neoplasms
4679735|NCT03368820|cardiovascular co-morbidity|cardiovascular co-morbidity
4679736|NCT03368781|Atrial Fibrillation|atrial fibrillation
4679737|NCT03368768|Antimicrobial-resistant bacterial infection|antimicrobial-resistant bacterial infection
4679738|NCT03368768|Questionaire|questionaire
4679739|NCT03368729|metastatic breast cancer|metastatic breast cancer
4679740|NCT03368729|HER2 positive|her2 positive
4679741|NCT03368729|Poly (ADP-Ribose) polymerase (PARP)|poly (adp-ribose) polymerase (parp)
4679742|NCT03368729|Niraparib|niraparib
4679743|NCT03368729|Trastuzumab|trastuzumab
4679744|NCT03368716|Pediatric Obesity|pediatric obesity
4680633|NCT03363425|Recovery|recovery
4679745|NCT03368716|Executive Function|executive function
4679746|NCT03368716|Behavioral Intervention|behavioral intervention
4679747|NCT03368703|COPD|copd
4679748|NCT03368703|Transcranial direct-current stimulation|transcranial direct-current stimulation
4679749|NCT03368703|Transcranial magnetic stimulation|transcranial magnetic stimulation
4679750|NCT03368703|Motor-evoked potentials|motor-evoked potentials
4679751|NCT03368703|Inhibition|inhibition
4679752|NCT03368703|Muscle weakness|muscle weakness
4679753|NCT03368690|Polyphenolic extract from pine bark, Antioxidant, Attention deficit/hyperactivity disorder.|polyphenolic extract from pine bark, antioxidant, attention deficit/hyperactivity disorder.
4679754|NCT03368638|Degenerative lumbar spinal stenosis|degenerative lumbar spinal stenosis
4679755|NCT03368638|Neural mobilization|neural mobilization
4679756|NCT03368638|Hip extension mobilization|hip extension mobilization
4679757|NCT03368638|Case series|case series
4679758|NCT03368638|Neurogenic claudication|neurogenic claudication
4679759|NCT03368625|Stereotactic Radiosurgery|stereotactic radiosurgery
4679760|NCT03368625|Radiation|radiation
4679761|NCT03368625|Surgery|surgery
4679762|NCT03368586|Flash Glucose Monitoring|flash glucose monitoring
4679763|NCT03368586|Children|children
4679764|NCT03368586|Adolescents|adolescents
4679765|NCT03368573|ADHD|adhd
4679766|NCT03368573|Cognitive Assessment|cognitive assessment
4679767|NCT03368573|QbTest|qbtest
4679768|NCT03368573|Medication|medication
4679769|NCT03368573|Feasibility|feasibility
4679770|NCT03368560|Treatment-resistant Late Life Depression|treatment-resistant late life depression
4679771|NCT03368560|Sudarshan Kriya Yoga|sudarshan kriya yoga
4679772|NCT03368560|Glutathione|glutathione
4679773|NCT03368508|Simulation|simulation
4679774|NCT03368508|Physiotherapy training|physiotherapy training
4679775|NCT03368508|360-degree video|360-degree video
4679776|NCT03368495|yellow fever vaccine|yellow fever vaccine
4679777|NCT03368495|MMR vaccine|mmr vaccine
4679778|NCT03368495|immunogenicity|immunogenicity
4679779|NCT03368482|cognition disorders|cognition disorders
4679780|NCT03368482|frail elderly|frail elderly
4679781|NCT03368482|human physical conditioning|human physical conditioning
4679782|NCT03368482|institutionalization|institutionalization
4679783|NCT03368482|physical activity|physical activity
4679784|NCT03368469|Transcranial|transcranial
4679785|NCT03368469|Stimulation|stimulation
4679786|NCT03368456|mhealth|mhealth
4679787|NCT03368456|preventive intervention|preventive intervention
4679788|NCT03368456|primary health care|primary health care
4679789|NCT03368443|Parkinson's disease|parkinson's disease
4679790|NCT03368443|context-dependent learning|context-dependent learning
4679791|NCT03368443|transcranial magnetic stimulation|transcranial magnetic stimulation
4679792|NCT03368443|cognitive function|cognitive function
4679793|NCT03368430|Melatonin; Chronic periodontitis; Host modulation therapy|melatonin; chronic periodontitis; host modulation therapy
4679794|NCT03368417|Hypertension|hypertension
4679795|NCT03368417|Wireless Home Blood Pressure Monitoring|wireless home blood pressure monitoring
4679796|NCT03368417|Medication Adherence|medication adherence
4679797|NCT03368417|Medication Titration|medication titration
4679798|NCT03368417|Financial Incentives|financial incentives
4679799|NCT03368417|Ambulatory Blood Pressure Monitoring|ambulatory blood pressure monitoring
4679800|NCT03368378|prostate cancer|prostate cancer
4679801|NCT03368378|radical prostatectomy|radical prostatectomy
4679802|NCT03368378|deep venous complex ligation|deep venous complex ligation
4679803|NCT03368365|Monitoring|monitoring
4679804|NCT03368365|Home|home
4679805|NCT03368365|Lung|lung
4679806|NCT03368365|Transplant|transplant
4679807|NCT03368365|Hospitalization|hospitalization
4679808|NCT03368365|Respiratory function at rest|respiratory function at rest
4679809|NCT03368365|Monitoring modem|monitoring modem
4679810|NCT03368352|Melatonin|melatonin
4679811|NCT03368352|Altitude|altitude
4679812|NCT03368352|Sleep|sleep
4679813|NCT03368352|Ventilation|ventilation
4679814|NCT03368352|Cognition|cognition
4679815|NCT03368313|Nonelastic compression theraphy|nonelastic compression theraphy
4679816|NCT03368313|Compression theraphy|compression theraphy
4679817|NCT03368313|Compression stockings|compression stockings
4679818|NCT03368300|progressive supranuclear palsy|progressive supranuclear palsy
4679819|NCT03368300|Caribbean atypical Parkinsonism|caribbean atypical parkinsonism
4679820|NCT03368300|Annona Muricata|annona muricata
4679821|NCT03368287|Total Knee Arthroplasty|total knee arthroplasty
4679822|NCT03368287|steps|steps
4679823|NCT03368287|rehabilitation|rehabilitation
4679824|NCT03368287|activity tracker|activity tracker
4679825|NCT03368261|Pulmonary arterial hypertension|pulmonary arterial hypertension
4679826|NCT03368261|SCD|scd
4679827|NCT03368261|Epidemiology|epidemiology
4679828|NCT03368248|Palliative care|palliative care
4679829|NCT03368248|Collegial meetings|collegial meetings
4679830|NCT03368248|Neonatal resuscitation services|neonatal resuscitation services
4679831|NCT03368248|Survey|survey
4679832|NCT03368248|Medico-caring staff of the NICUs|medico-caring staff of the nicus
4679833|NCT03368235|rheumatoid arthritis, swollen joints, tender joints, autoimmunity|rheumatoid arthritis, swollen joints, tender joints, autoimmunity
4679834|NCT03368222|Non Small Cell Lung Cancer|non small cell lung cancer
4679835|NCT03368222|NSCLC|nsclc
4679836|NCT03368209|Non-invasive glucose monitoring|non-invasive glucose monitoring
4679837|NCT03368196|Stomach cancer|stomach cancer
4679838|NCT03368196|Cancer where the esophagus meets the stomach|cancer where the esophagus meets the stomach
4679839|NCT03368196|Human epidermal growth factor 2|human epidermal growth factor 2
4679840|NCT03368196|HER2|her2
4679841|NCT03368196|Breast Cancer|breast cancer
4679842|NCT03368196|Adenocarcinoma, Gastroesophageal Junction (GEJ)|adenocarcinoma, gastroesophageal junction (gej)
4679843|NCT03368196|Gastric Cancer|gastric cancer
4679844|NCT03368196|Antibody drug conjugate (ADC)|antibody drug conjugate (adc)
4679845|NCT03368196|Oncology|oncology
4679846|NCT03368170|Levodopa induced dyskinesia|levodopa induced dyskinesia
4679847|NCT03368118|ABX464|abx464
4679848|NCT03368118|Ulcerative Colitis|ulcerative colitis
4679849|NCT03368105|Clostridium difficile Infection|clostridium difficile infection
4679850|NCT03368105|Lactobacillus plantarum 299v|lactobacillus plantarum 299v
4679851|NCT03368105|organ transplantation|organ transplantation
4679852|NCT03368105|antibiotic-associated diarrhoea|antibiotic-associated diarrhoea
4679853|NCT03368092|severe trauma|severe trauma
4679854|NCT03368092|acute respiratory distress syndrome|acute respiratory distress syndrome
4679855|NCT03368092|damage-associated molecular patterns|damage-associated molecular patterns
4679856|NCT03368092|neutrophil extracellular traps|neutrophil extracellular traps
4679857|NCT03368092|dornase alfa|dornase alfa
4679858|NCT03368079|Dysphagia|dysphagia
4679859|NCT03368079|Oropharyngeal dysphagia|oropharyngeal dysphagia
4679860|NCT03368079|Video Fluoroscopic Swallowing Exam (VFSE)|video fluoroscopic swallowing exam (vfse)
4679861|NCT03368053|gp120|gp120
4679862|NCT03368053|HIV infections|hiv infections
4679863|NCT03368053|RV144|rv144
4679864|NCT03368053|gp120-NefTat/AS01B vaccine candidate|gp120-neftat/as01b vaccine candidate
4679865|NCT03368053|V1V2|v1v2
4679866|NCT03368040|body core temperature|body core temperature
4679867|NCT03368027|Vision Disorders; Stress, Psychological|vision disorders; stress, psychological
4679868|NCT03368014|Sharing|sharing
4679869|NCT03368014|Mind|mind
4679870|NCT03368014|Enjoyment|enjoyment
4679871|NCT03368001|Autism|autism
4679872|NCT03367988|Opioid Dependence|opioid dependence
4679873|NCT03367988|Analagesia|analagesia
4679874|NCT03367988|Opioid-free Anesthesia|opioid-free anesthesia
4679875|NCT03367962|PET-CT scan|pet-ct scan
4679876|NCT03367962|[18F]F-AraG|[18f]f-arag
4679877|NCT03367949|Surgical guide|surgical guide
4679878|NCT03367949|impression inversion|impression inversion
4679879|NCT03367949|stereolithographic surgical guides|stereolithographic surgical guides
4679880|NCT03367936|mobile technology|mobile technology
4679881|NCT03367936|feedback message|feedback message
4679882|NCT03367936|self-monitoring|self-monitoring
4679883|NCT03367910|Urinary tract infection|urinary tract infection
4679884|NCT03367910|Multidrug resistant organism|multidrug resistant organism
4679885|NCT03367910|Fecal microbiota transplantation|fecal microbiota transplantation
4679886|NCT03367897|Helicobacter pylori|helicobacter pylori
4679887|NCT03367897|peptic ulcer|peptic ulcer
4679888|NCT03367897|erosions|erosions
4679889|NCT03367897|bleeding|bleeding
4679890|NCT03367897|Nsaids|nsaids
4679891|NCT03367897|Noac|noac
4679892|NCT03367884|Hypopharyngeal cancer|hypopharyngeal cancer
4679893|NCT03367884|Neck dissection|neck dissection
4679894|NCT03367884|Induction chemotherapy|induction chemotherapy
4679895|NCT03367884|Cervical lymph node metastasis|cervical lymph node metastasis
4679896|NCT03367884|definitive radiotherapy|definitive radiotherapy
4679897|NCT03367871|Recurrent Cervical Cancer|recurrent cervical cancer
4679898|NCT03367871|Persistent Cervical Cancer|persistent cervical cancer
4679899|NCT03367871|Metastatic Cervical Cancer|metastatic cervical cancer
4679900|NCT03367845|Parent sensitivity|parent sensitivity
4679901|NCT03367845|Fathers|fathers
4679902|NCT03367845|Attachment|attachment
4679903|NCT03367845|Marital communication|marital communication
4679904|NCT03367780|Head-neck tumours|head-neck tumours
4679905|NCT03367780|Radiotherapy|radiotherapy
4679906|NCT03367780|Salivary gland toxicity|salivary gland toxicity
4679907|NCT03367780|PSMA PET/CT|psma pet/ct
4679908|NCT03367767|Blood Sample|blood sample
4679909|NCT03367767|Medical History|medical history
4679910|NCT03367767|Optical Imaging|optical imaging
4679911|NCT03367754|Immunotherapy|immunotherapy
4679912|NCT03367754|Immunologic Non-Responder|immunologic non-responder
4679913|NCT03367754|Immunologic Response|immunologic response
4679914|NCT03367754|Randomized|randomized
4679915|NCT03367754|PD-1|pd-1
4679916|NCT03367728|Bariatric Surgery|bariatric surgery
4679917|NCT03367728|Bariatrics|bariatrics
4679918|NCT03367728|Ropivacaine|ropivacaine
4679919|NCT03367728|Randomized Controlled Trial|randomized controlled trial
4679920|NCT03367728|Enhanced Recovery After Bariatric Surgery|enhanced recovery after bariatric surgery
4679921|NCT03367728|TAP Block|tap block
4679922|NCT03367728|Rectus Sheath Block|rectus sheath block
4679923|NCT03367676|trastuzumab|trastuzumab
4679924|NCT03367676|adjuvant therapy|adjuvant therapy
4679925|NCT03367650|amyotrophic lateral sclerosis|amyotrophic lateral sclerosis
4679926|NCT03367650|epidemiology|epidemiology
4679927|NCT03367650|genetic|genetic
4679928|NCT03367650|environmental factor|environmental factor
4679929|NCT03367637|Cancer Pain, Palliative care, Mobile Applications, Rwanda|cancer pain, palliative care, mobile applications, rwanda
4679930|NCT03367624|influenza|influenza
4679931|NCT03367624|Staphylococcus Aureus|staphylococcus aureus
4679932|NCT03367624|Pneumonia|pneumonia
4679933|NCT03367624|PV leukocidin|pv leukocidin
4679934|NCT03367624|ICU|icu
4679935|NCT03367611|Immunochemical faecal occult blood test|immunochemical faecal occult blood test
4679936|NCT03367611|iFOBT|ifobt
4679937|NCT03367611|Cancer patient pathway|cancer patient pathway
4679938|NCT03367611|Colonoscopy|colonoscopy
4679939|NCT03367611|Colorectal cancer|colorectal cancer
4679940|NCT03367585|Supplementary Feeding|supplementary feeding
4679941|NCT03367585|vitamin D|vitamin d
4679942|NCT03367585|Muscle Strength|muscle strength
4679943|NCT03367585|postural balance|postural balance
4679944|NCT03367585|exercise|exercise
4679945|NCT03367585|aged|aged
4679946|NCT03367559|Rotavirus|rotavirus
4679947|NCT03367559|ROTAVAC|rotavac
4679948|NCT03367559|Vaccine|vaccine
4679949|NCT03367559|Vietnam|vietnam
4679950|NCT03367546|SCD|scd
4679951|NCT03367546|cALD|cald
4679952|NCT03367481|Gingival fissures|gingival fissures
4679953|NCT03367481|Gingival recession|gingival recession
4679954|NCT03367481|Risk factors|risk factors
4679955|NCT03367481|Traumatic toothbrusing|traumatic toothbrusing
4679956|NCT03367468|Plantar fascitis|plantar fascitis
4679957|NCT03367468|Pain|pain
4679958|NCT03367468|Exercise|exercise
4679959|NCT03367468|Physiotherapy|physiotherapy
4679960|NCT03367468|Quality of life|quality of life
4679961|NCT03367455|Potassium|potassium
4679962|NCT03367455|Genetic Variants|genetic variants
4679963|NCT03367442|Thoracic trauma|thoracic trauma
4679964|NCT03367442|mechanical ventilation|mechanical ventilation
4679965|NCT03367442|Acute respiratory distress syndrome|acute respiratory distress syndrome
4679966|NCT03367442|Esophageal pressure|esophageal pressure
4679967|NCT03367442|Pleural pressure|pleural pressure
4679968|NCT03367429|stroke|stroke
4679969|NCT03367429|spasticity|spasticity
4679970|NCT03367403|TRAILBLAZER-ALZ|trailblazer-alz
4679971|NCT03367364|Venous Thromboembolism, Deep Venous Thrombosis, Clots|venous thromboembolism, deep venous thrombosis, clots
4679972|NCT03367325|non-valvular atrial fibrillation|non-valvular atrial fibrillation
4679973|NCT03367325|time in therapeutic range|time in therapeutic range
4679974|NCT03367325|primary care|primary care
4679975|NCT03367299|Acute Lymphoid Leukemia|acute lymphoid leukemia
4679976|NCT03367299|Philadelphia Chromosome-Negative B-Cell Precursor|philadelphia chromosome-negative b-cell precursor
4679977|NCT03367299|Adults|adults
4679978|NCT03367299|Minimal residual disease|minimal residual disease
4679979|NCT03367299|Blinatumomab|blinatumomab
4679980|NCT03367260|patient preferences|patient preferences
4679981|NCT03367247|Ovarian Cancer|ovarian cancer
4679982|NCT03367247|Bowel blockage|bowel blockage
4679983|NCT03367247|Ascites|ascites
4679984|NCT03367247|Supportive care|supportive care
4679985|NCT03367247|Nursing|nursing
4679986|NCT03367247|Mobile health|mobile health
4679987|NCT03367247|m-Health|m-health
4679988|NCT03367247|Tele-health|tele-health
4679989|NCT03367247|Palliative Care|palliative care
4679990|NCT03367247|Symptom management|symptom management
4679991|NCT03367234|Federally Qualified Health Center|federally qualified health center
4679992|NCT03367234|Contingency Management|contingency management
4679993|NCT03367234|Cognitive Behavioral Therapy|cognitive behavioral therapy
4679994|NCT03367234|Cognitive Behavioral / Relapse Prevention|cognitive behavioral / relapse prevention
4679995|NCT03367234|Medication Assisted Treatment|medication assisted treatment
4679996|NCT03367234|Behavioral Health Consultant|behavioral health consultant
4679997|NCT03367234|Integrated Care|integrated care
4679998|NCT03367208|metabolomic|metabolomic
4679999|NCT03367195|GERD|gerd
4680000|NCT03367195|DLBS2411|dlbs2411
4680001|NCT03367195|omeprazole|omeprazole
4680002|NCT03367169|Pilon fractures|pilon fractures
4680003|NCT03367169|Osteosynthesis|osteosynthesis
4680004|NCT03367169|Mini invasive plate osteosynthesis|mini invasive plate osteosynthesis
4680005|NCT03367169|Locked plate|locked plate
4680006|NCT03367169|Open reduction|open reduction
4680007|NCT03367156|Dyspnea|dyspnea
4680008|NCT03367156|Questionnaires|questionnaires
4680009|NCT03367156|Surveys|surveys
4680010|NCT03367156|Dexamethasone|dexamethasone
4680011|NCT03367156|Decadron|decadron
4680012|NCT03367156|Placebo|placebo
4680013|NCT03367156|Sugar pill|sugar pill
4680014|NCT03367130|Antiretroviral therapy, clinic attendance, Nepal|antiretroviral therapy, clinic attendance, nepal
4680015|NCT03367091|Wearable Exoskeleton|wearable exoskeleton
4680016|NCT03367091|Stroke|stroke
4680017|NCT03367091|Energy Consumption|energy consumption
4680018|NCT03367091|Cardiorespiratory Load|cardiorespiratory load
4680019|NCT03367078|tDCS|tdcs
4680020|NCT03367078|transcranial direct current stimulation|transcranial direct current stimulation
4680021|NCT03367078|acquired brain injury|acquired brain injury
4680022|NCT03367078|coma|coma
4680023|NCT03367078|vigilance|vigilance
4680024|NCT03367052|ProDisc-C vivo|prodisc-c vivo
4680025|NCT03367052|Hybrid|hybrid
4680026|NCT03367052|Cervical degenerative disc disease|cervical degenerative disc disease
4680027|NCT03367039|ProDisc-C vivo|prodisc-c vivo
4680028|NCT03367039|ACDF|acdf
4680029|NCT03367039|Cervical degenerative disc disease|cervical degenerative disc disease
4680030|NCT03367026|ivabradine|ivabradine
4680031|NCT03367026|sepsis|sepsis
4680033|NCT03366935|labor analgesia|labor analgesia
4680034|NCT03366935|dural puncture epidural (DPE)|dural puncture epidural (dpe)
4680035|NCT03366935|standard Epidural (EPL)|standard epidural (epl)
4680036|NCT03366935|continuous epidural infusion (CEI)|continuous epidural infusion (cei)
4680037|NCT03366935|programmed intermittent epidural bolus (PIEB)|programmed intermittent epidural bolus (pieb)
4680038|NCT03366909|mindfulness|mindfulness
4680039|NCT03366909|cannabis use|cannabis use
4680040|NCT03366883|preoperative chemotherapy|preoperative chemotherapy
4680041|NCT03366883|preoperative chemoradiotherapy|preoperative chemoradiotherapy
4680042|NCT03366883|clinical trial|clinical trial
4680043|NCT03366883|phase III|phase iii
4680044|NCT03366883|Esophageal squamous cancer|esophageal squamous cancer
4680045|NCT03366870|CBT-I|cbt-i
4680046|NCT03366870|Insomnia|insomnia
4680047|NCT03366844|invasive adenocarcinoma of the breast|invasive adenocarcinoma of the breast
4680048|NCT03366844|ER-positive and HER2-negative breast cancer|er-positive and her2-negative breast cancer
4680049|NCT03366844|Triple negative breast cancer (TNBC)|triple negative breast cancer (tnbc)
4680050|NCT03366844|immunotherapy|immunotherapy
4680051|NCT03366844|checkpoint inhibitor|checkpoint inhibitor
4680052|NCT03366805|opioid|opioid
4680053|NCT03366805|analgesic|analgesic
4680054|NCT03366805|ambulatory|ambulatory
4680055|NCT03366805|orthopedic|orthopedic
4680056|NCT03366805|surgery|surgery
4680057|NCT03366805|patient education|patient education
4680058|NCT03366805|video|video
4680059|NCT03366805|medication diary|medication diary
4680060|NCT03366779|Lumbar disc herniation, reherniation|lumbar disc herniation, reherniation
4680061|NCT03366753|acute normovolemic hemodilution|acute normovolemic hemodilution
4680062|NCT03366753|coronary artery bypass graft surgery|coronary artery bypass graft surgery
4680063|NCT03366753|hydroxyethyl starch|hydroxyethyl starch
4680064|NCT03366753|blood viscosity|blood viscosity
4680065|NCT03366740|Persistent diarrhea|persistent diarrhea
4680066|NCT03366740|> 6 to 36 months aged children|> 6 to 36 months aged children
4680067|NCT03366740|green banana|green banana
4680068|NCT03366740|rice suji|rice suji
4680069|NCT03366740|milk suji|milk suji
4680070|NCT03366740|comminuted chicken|comminuted chicken
4680071|NCT03366727|drug eluting balloon|drug eluting balloon
4680072|NCT03366714|Noninvasive ventilation, respiratory distress syndrome|noninvasive ventilation, respiratory distress syndrome
4680073|NCT03366701|physical activity|physical activity
4680074|NCT03366701|sedentary behavior|sedentary behavior
4680075|NCT03366701|implicit attitudes|implicit attitudes
4680076|NCT03366701|self regulation|self regulation
4680077|NCT03366701|intention|intention
4680078|NCT03366701|chronic diseases|chronic diseases
4680079|NCT03366662|Electromyography|electromyography
4680080|NCT03366649|Bypass Surgery|bypass surgery
4680081|NCT03366649|Cardiology|cardiology
4680082|NCT03366649|Coronary Artery Bypass Surgery|coronary artery bypass surgery
4680083|NCT03366649|Mitral Valve Repair|mitral valve repair
4680084|NCT03366649|Mitral Valve Surgery|mitral valve surgery
4680085|NCT03366649|Coronary Revascularization|coronary revascularization
4680086|NCT03366636|Pregnancy|pregnancy
4680087|NCT03366636|Adolescents|adolescents
4680088|NCT03366636|STIs/STDs|stis/stds
4680089|NCT03366636|Self-sufficiency|self-sufficiency
4680090|NCT03366623|Pain assessment|pain assessment
4680091|NCT03366623|Self report|self report
4680092|NCT03366623|Hospital clown intervention|hospital clown intervention
4680093|NCT03366597|sevoflurane|sevoflurane
4680094|NCT03366597|S100β protein|s100β protein
4680095|NCT03366597|regional cerebral oxygen saturation|regional cerebral oxygen saturation
4680096|NCT03366597|infant|infant
4680097|NCT03366571|Liver Cirrhosis|liver cirrhosis
4680098|NCT03366558|motion detectors|motion detectors
4680099|NCT03366558|early stage Parkinson's disease|early stage parkinson's disease
4680100|NCT03366558|advanced Parkinson's disease|advanced parkinson's disease
4680101|NCT03366558|UPDRS|updrs
4680102|NCT03366558|observational study with non-diseased controls|observational study with non-diseased controls
4680103|NCT03366545|cardiac resynchronization therapy|cardiac resynchronization therapy
4680104|NCT03366545|CRT|crt
4680105|NCT03366545|clinical routine|clinical routine
4680106|NCT03366532|diet|diet
4680107|NCT03366532|food frequency questionnaire|food frequency questionnaire
4680108|NCT03366532|nutrient|nutrient
4680109|NCT03366519|Embolism, Pulmonary|embolism, pulmonary
4680110|NCT03366519|echocardiography|echocardiography
4680111|NCT03366519|emergency|emergency
4680112|NCT03366519|prognosis|prognosis
4680113|NCT03366467|dental treatment|dental treatment
4680114|NCT03366467|sensory adapted environment|sensory adapted environment
4680115|NCT03366428|HER2|her2
4680116|NCT03366428|Breast cancer|breast cancer
4680117|NCT03366428|Oncology|oncology
4680118|NCT03366428|Antibody drug conjugate|antibody drug conjugate
4680119|NCT03366428|ADC|adc
4680120|NCT03366415|Nasopharyngeal Carcinoma|nasopharyngeal carcinoma
4680121|NCT03366415|concurrent chemoradiotherapy|concurrent chemoradiotherapy
4680122|NCT03366415|sequential chemoradiotherapy|sequential chemoradiotherapy
4680123|NCT03366376|hippocampus|hippocampus
4680124|NCT03366376|radiotherapy|radiotherapy
4680125|NCT03366363|Knee osteoarthritis|knee osteoarthritis
4680126|NCT03366363|acupuncture|acupuncture
4680127|NCT03366363|electroacupuncture|electroacupuncture
4680128|NCT03366363|sham acupuncture|sham acupuncture
4680129|NCT03366337|IgA Nephropathy|iga nephropathy
4680130|NCT03366337|CKD associated with type 1 diabetes|ckd associated with type 1 diabetes
4680131|NCT03366337|Focal segmental glomerulosclerosis|focal segmental glomerulosclerosis
4680132|NCT03366337|Autosomal dominant polycystic kidney disease|autosomal dominant polycystic kidney disease
4680133|NCT03366337|IgAN|igan
4680134|NCT03366337|FSGS|fsgs
4680135|NCT03366337|ADPKD|adpkd
4680136|NCT03366337|Bardoxolone methyl|bardoxolone methyl
4680137|NCT03366337|CDDO-ME|cddo-me
4680138|NCT03366337|RTA 402|rta 402
4680139|NCT03366311|intubation|intubation
4680140|NCT03366311|epiglottis lift|epiglottis lift
4680141|NCT03366311|hold high position|hold high position
4680142|NCT03366285|Bonding|bonding
4680143|NCT03366285|Gene expression|gene expression
4680144|NCT03366285|Stress response|stress response
4680145|NCT03366285|Neurodevelopment|neurodevelopment
4680146|NCT03366246|topical anesthetic|topical anesthetic
4680147|NCT03366246|nanocapsules|nanocapsules
4680148|NCT03366246|nanotechnology|nanotechnology
4680149|NCT03366246|lidocaine|lidocaine
4680150|NCT03366246|prilocaine|prilocaine
4680151|NCT03366246|fractional CO2 laser resurfacing|fractional co2 laser resurfacing
4680152|NCT03366168|Diabetes|diabetes
4680153|NCT03366168|Fungiform Papillae|fungiform papillae
4680154|NCT03366168|Insulin|insulin
4680155|NCT03366155|Unresectable Liver Tumor|unresectable liver tumor
4680156|NCT03366155|Response Rates|response rates
4680157|NCT03366155|Progression-Free Survival|progression-free survival
4680158|NCT03366155|Patient Survival|patient survival
4680159|NCT03366142|Autosomal Recessive Disorder|autosomal recessive disorder
4680160|NCT03366142|Bacterial Infections|bacterial infections
4680161|NCT03366142|Gingival|gingival
4680162|NCT03366142|Oral Ulcer|oral ulcer
4680163|NCT03366142|Cytokine Expression|cytokine expression
4680164|NCT03366129|CEREBROVASCULAR DISEASE|cerebrovascular disease
4680165|NCT03366129|Vascular Cognitive Impairment|vascular cognitive impairment
4680166|NCT03366129|Stroke|stroke
4680167|NCT03366129|Permeability Imaging|permeability imaging
4680168|NCT03366116|Pharmacodynamics|pharmacodynamics
4680169|NCT03366116|DNA Methylation|dna methylation
4680170|NCT03366116|Pharmacokinetics|pharmacokinetics
4680171|NCT03366116|NUCLEOSIDE ANALOG|nucleoside analog
4680172|NCT03366116|Epigenetics|epigenetics
4680173|NCT03366064|Non-small cell lung cancer|non-small cell lung cancer
4680174|NCT03366064|Natural killer cells|natural killer cells
4680175|NCT03366064|HLA-haploidentical family donor|hla-haploidentical family donor
4680176|NCT03366051|Endometrial Cancer|endometrial cancer
4680177|NCT03366051|Sentinel Lymph Node|sentinel lymph node
4680178|NCT03366051|Lymphadenectomy|lymphadenectomy
4680179|NCT03366038|pancreaticoduodenectomy|pancreaticoduodenectomy
4680180|NCT03366038|pancreaticojejunostomy|pancreaticojejunostomy
4680181|NCT03366038|pancreatic fistula|pancreatic fistula
4680182|NCT03366012|Cytosponge|cytosponge
4680183|NCT03366012|GERD|gerd
4680184|NCT03365986|hereditary|hereditary
4680185|NCT03365986|colorectal cancer|colorectal cancer
4680186|NCT03365986|screening|screening
4680187|NCT03365973|Pathological Fracture|pathological fracture
4680188|NCT03365973|Indeterminate Instability|indeterminate instability
4680189|NCT03365973|Spinal Metastases|spinal metastases
4680190|NCT03365973|Breast Cancer|breast cancer
4680191|NCT03365960|Watermelon|watermelon
4680192|NCT03365960|Watermelon phytochemicals bioavailability|watermelon phytochemicals bioavailability
4680193|NCT03365960|Flow Mediated Vasodilation|flow mediated vasodilation
4680194|NCT03365960|Pharmacokinetics|pharmacokinetics
4680195|NCT03365934|Microflora|microflora
4680196|NCT03365934|Microbiome|microbiome
4680197|NCT03365934|skin physiology|skin physiology
4680198|NCT03365934|Fitzpatrick Skin Types I-III|fitzpatrick skin types i-iii
4680199|NCT03365934|Tape-stripped wounds|tape-stripped wounds
4680200|NCT03365908|ACL|acl
4680201|NCT03365895|diffusion|diffusion
4680202|NCT03365895|tensor|tensor
4680203|NCT03365895|imaging|imaging
4680204|NCT03365895|chemotherapy|chemotherapy
4680205|NCT03365895|peripheral neuropathy|peripheral neuropathy
4680206|NCT03365895|breast cancer|breast cancer
4680207|NCT03365895|MRI|mri
4680208|NCT03365895|Magnetic Resonance Imaging|magnetic resonance imaging
4680209|NCT03365895|Diffusion Tensor Imaging|diffusion tensor imaging
4680210|NCT03365843|Cardiac surgery|cardiac surgery
4680211|NCT03365843|Sternal closure|sternal closure
4680212|NCT03365817|cognitive function|cognitive function
4680213|NCT03365817|opioid dependence|opioid dependence
4680214|NCT03365817|opioid withdrawal|opioid withdrawal
4680215|NCT03365817|quality of life|quality of life
4680216|NCT03365817|side effect|side effect
4680217|NCT03365804|Ultrasound|ultrasound
4680218|NCT03365804|Scoliosis|scoliosis
4680219|NCT03365804|Orthoses|orthoses
4680220|NCT03365804|3D Printing|3d printing
4680221|NCT03365791|PDR001|pdr001
4680222|NCT03365791|LAG525|lag525
4680223|NCT03365791|Immune checkpoint blockade|immune checkpoint blockade
4680224|NCT03365791|Solid tumor malignancy|solid tumor malignancy
4680225|NCT03365791|lymphoma|lymphoma
4680226|NCT03365791|Small cell lung cancer (SCLC)|small cell lung cancer (sclc)
4680227|NCT03365791|Gastric/esophageal adenocarcinoma|gastric/esophageal adenocarcinoma
4680228|NCT03365791|Castration resistant prostate adenocarcinoma (CRPC)|castration resistant prostate adenocarcinoma (crpc)
4680229|NCT03365791|Soft tissue sarcoma|soft tissue sarcoma
4680230|NCT03365791|Ovarian adenocarcinoma|ovarian adenocarcinoma
4680231|NCT03365791|Advanced well-differentiated neuroendocrine tumors (NETs)|advanced well-differentiated neuroendocrine tumors (nets)
4680232|NCT03365791|Diffuse large B cell lymphoma (DLBCL)|diffuse large b cell lymphoma (dlbcl)
4680233|NCT03365778|educational intervention|educational intervention
4680234|NCT03365778|SLT|slt
4680235|NCT03365778|selective laser trabeculoplasty|selective laser trabeculoplasty
4680236|NCT03365739|Mango|mango
4680237|NCT03365739|Mango pulp phytochemicals bioavailability|mango pulp phytochemicals bioavailability
4680238|NCT03365739|Pharmacokinetics|pharmacokinetics
4680239|NCT03365713|COPD|copd
4680240|NCT03365713|Spirometry|spirometry
4680241|NCT03365713|COPD Diagnosis|copd diagnosis
4680242|NCT03365713|PEF|pef
4680243|NCT03365713|Case Finding|case finding
4680244|NCT03365713|LMIC|lmic
4680245|NCT03365700|Persistent atrial fibrillation|persistent atrial fibrillation
4680246|NCT03365700|Catheter ablation|catheter ablation
4680247|NCT03365687|Children|children
4680248|NCT03365687|Vitamin D|vitamin d
4680249|NCT03365687|Respiratory viral infection|respiratory viral infection
4680250|NCT03365687|Randomized controlled trial|randomized controlled trial
4680251|NCT03365687|Asthma exacerbations|asthma exacerbations
4680252|NCT03365674|Myofascial Pain Syndromes, Gastrocnemius, Trigger points, Injections, Vibration|myofascial pain syndromes, gastrocnemius, trigger points, injections, vibration
4680253|NCT03365661|AML|aml
4680254|NCT03365661|MDS|mds
4680255|NCT03365596|Brain connectivity|brain connectivity
4680256|NCT03365596|Magnetic resonance imaging|magnetic resonance imaging
4680257|NCT03365596|Recovery prediction|recovery prediction
4680258|NCT03365583|Vitamin B12|vitamin b12
4680259|NCT03365583|Microbiome|microbiome
4680260|NCT03365583|infant|infant
4680261|NCT03365570|hemoglobin, iron, oral lesions, oral manifestations,cross-sectional study|hemoglobin, iron, oral lesions, oral manifestations,cross-sectional study
4680262|NCT03365531|fasting|fasting
4680263|NCT03365518|Psychological Treatment|psychological treatment
4680264|NCT03365518|Intimacy|intimacy
4680265|NCT03365518|Cognitive Behavioural Therapy|cognitive behavioural therapy
4680266|NCT03365518|Cognitive Behavioral Therapy|cognitive behavioral therapy
4680267|NCT03365518|Mindfulness|mindfulness
4680268|NCT03365518|Group Therapy|group therapy
4680269|NCT03365518|Couples Therapy|couples therapy
4680270|NCT03365479|pulmonary hypertension|pulmonary hypertension
4680271|NCT03365479|iloprost|iloprost
4680272|NCT03365479|inhaled|inhaled
4680273|NCT03365479|breelib|breelib
4680274|NCT03365479|nebulizer|nebulizer
4680275|NCT03365479|pulmonary arterial hypertension|pulmonary arterial hypertension
4680276|NCT03365466|recurrent implantation failure|recurrent implantation failure
4680277|NCT03365466|aspirin|aspirin
4680278|NCT03365466|low molecular weight heparin|low molecular weight heparin
4680279|NCT03365440|ECG|ecg
4680280|NCT03365440|cardiac arrhythmia|cardiac arrhythmia
4680281|NCT03365440|heart rhythm|heart rhythm
4680282|NCT03365440|esophageal ECG|esophageal ecg
4680283|NCT03365440|non-invasive mapping|non-invasive mapping
4680284|NCT03365440|supraventricular tachycardia|supraventricular tachycardia
4680285|NCT03365440|atrial fibrillation|atrial fibrillation
4680286|NCT03365440|atrial flutter|atrial flutter
4680287|NCT03365440|extrasystole|extrasystole
4680288|NCT03365427|rehabilitation|rehabilitation
4680289|NCT03365427|application on smart phones|application on smart phones
4680290|NCT03365414|Postural Orthostatic Tachycardia Syndrome|postural orthostatic tachycardia syndrome
4680291|NCT03365414|POTS|pots
4680292|NCT03365414|Syncope|syncope
4680293|NCT03365414|Vasovagal|vasovagal
4680294|NCT03365414|Hypotension|hypotension
4680295|NCT03365414|Tachycardia|tachycardia
4680296|NCT03365401|surgery|surgery
4680297|NCT03365401|decompression|decompression
4680298|NCT03365375|Chest Pain|chest pain
4680299|NCT03365375|Anxiety|anxiety
4680300|NCT03365375|Mindfulness|mindfulness
4680301|NCT03365375|Emergency Service, Hospital|emergency service, hospital
4680302|NCT03365362|directly observed therapy|directly observed therapy
4680303|NCT03365362|varenicline|varenicline
4680304|NCT03365362|long-term pharmacotherapy|long-term pharmacotherapy
4680305|NCT03365323|Periprosthetic Joint Infection|periprosthetic joint infection
4680306|NCT03365284|total knee arthroplasty|total knee arthroplasty
4680307|NCT03365284|rehabilitation|rehabilitation
4680308|NCT03365284|Smart Kneebrace|smart kneebrace
4680309|NCT03365219|Surgical Site Infection|surgical site infection
4680310|NCT03365219|Cesarean delivery infection|cesarean delivery infection
4680311|NCT03365167|LANAP|lanap
4680312|NCT03365167|Periodontitis|periodontitis
4680313|NCT03365154|Peripheral Artery Disease|peripheral artery disease
4680314|NCT03365154|Atherectomy|atherectomy
4680315|NCT03365154|Orbital Atherectomy|orbital atherectomy
4680316|NCT03365141|vitiligo|vitiligo
4680317|NCT03365141|intralesional injection|intralesional injection
4680318|NCT03365141|corticosteroid|corticosteroid
4680319|NCT03365141|triamcinolone|triamcinolone
4680320|NCT03365115|spinal anesthesia|spinal anesthesia
4680321|NCT03365115|morphine|morphine
4680322|NCT03365115|fentanyl|fentanyl
4680323|NCT03365115|pain|pain
4680324|NCT03365115|knee|knee
4680325|NCT03365089|Hemodialysis fistula|hemodialysis fistula
4680326|NCT03365089|Failure to mature|failure to mature
4680327|NCT03365089|Collateral vein|collateral vein
4680328|NCT03365063|Knowledge Translation|knowledge translation
4680329|NCT03365063|Chronic Kidney Disease|chronic kidney disease
4680330|NCT03365063|Matched Cluster Randomized Trial|matched cluster randomized trial
4680331|NCT03365024|CBT-I|cbt-i
4680332|NCT03365024|Insomnia|insomnia
4680333|NCT03365011|Nitrous Oxide|nitrous oxide
4680334|NCT03364972|cataract|cataract
4680335|NCT03364972|cataract extraction|cataract extraction
4680336|NCT03364972|interocular lens implant|interocular lens implant
4680337|NCT03364972|glistenings|glistenings
4680338|NCT03364972|phacoemulsification|phacoemulsification
4680339|NCT03364972|hydrophobic acrylic|hydrophobic acrylic
4680340|NCT03364972|light scatter|light scatter
4680341|NCT03364972|patient related outcome measures|patient related outcome measures
4680342|NCT03364933|Child|child
4680343|NCT03364933|Critical Illness|critical illness
4680344|NCT03364933|Length of Stay|length of stay
4680345|NCT03364933|Satisfaction|satisfaction
4680346|NCT03364920|Maresin-1|maresin-1
4680347|NCT03364920|SAP|sap
4680348|NCT03364920|IPN|ipn
4680349|NCT03364920|MODS|mods
4680350|NCT03364920|Mortality|mortality
4680351|NCT03364907|HIPEC|hipec
4680352|NCT03364907|oxaliplatin|oxaliplatin
4680353|NCT03364907|flushing|flushing
4680354|NCT03364907|peritoneal carcinomatosis|peritoneal carcinomatosis
4680355|NCT03364894|Parkinson's Disease|parkinson's disease
4680356|NCT03364894|Biomarkers|biomarkers
4680357|NCT03364894|Wearable sensors|wearable sensors
4680358|NCT03364894|Imaging|imaging
4680359|NCT03364894|Disease progression|disease progression
4680360|NCT03364868|Type 1 diabetes|type 1 diabetes
4680361|NCT03364868|T1D|t1d
4680362|NCT03364868|diabetes mellitus|diabetes mellitus
4680363|NCT03364868|oral insulin|oral insulin
4680364|NCT03364868|oral tolerance|oral tolerance
4680365|NCT03364868|autoantigen|autoantigen
4680366|NCT03364868|self tolerance|self tolerance
4680367|NCT03364868|prevention|prevention
4680368|NCT03364868|at risk for developing type 1 diabetes|at risk for developing type 1 diabetes
4680369|NCT03364868|juvenile diabetes|juvenile diabetes
4680370|NCT03364868|autoimmune diabetes|autoimmune diabetes
4680371|NCT03364855|Balance|balance
4680372|NCT03364855|Patellofemoral pain syndrome|patellofemoral pain syndrome
4680373|NCT03364855|Star excursion balance test|star excursion balance test
4680374|NCT03364855|Kinesthetic Ability Trainer 2000|kinesthetic ability trainer 2000
4680375|NCT03364816|cervical spondylosis|cervical spondylosis
4680376|NCT03364816|artificial disc replacement|artificial disc replacement
4680377|NCT03364816|complications|complications
4680378|NCT03364816|photographic indicators|photographic indicators
4680379|NCT03364816|functional efficacy|functional efficacy
4680380|NCT03364803|Cushing Syndrome|cushing syndrome
4680381|NCT03364803|Cushing's Disease|cushing's disease
4680382|NCT03364803|Cushing Disease|cushing disease
4680383|NCT03364803|17-592|17-592
4680384|NCT03364803|Memorial Sloan Kettering Cancer Center|memorial sloan kettering cancer center
4680385|NCT03364790|knee - spine syndrome|knee - spine syndrome
4680386|NCT03364790|PLIF|plif
4680387|NCT03364790|TKA|tka
4680388|NCT03364790|sagittal parameters|sagittal parameters
4680389|NCT03364790|neuroelectrophysiology|neuroelectrophysiology
4680390|NCT03364777|lumbar surgery, emotional state|lumbar surgery, emotional state
4680391|NCT03364764|sirolimus|sirolimus
4680392|NCT03364764|refractory pure red cell aplasia|refractory pure red cell aplasia
4680393|NCT03364764|prospective study|prospective study
4680394|NCT03364751|Oral Health|oral health
4680395|NCT03364751|Smoking|smoking
4680396|NCT03364751|Cigarette|cigarette
4680397|NCT03364751|Reduced risk product|reduced risk product
4680398|NCT03364751|Tobacco heating system|tobacco heating system
4680399|NCT03364751|THS|ths
4680400|NCT03364751|Modified risk tobacco product|modified risk tobacco product
4680401|NCT03364751|Clinical attachment level|clinical attachment level
4680402|NCT03364699|strenuous exercise|strenuous exercise
4680403|NCT03364699|dietary supplementation|dietary supplementation
4680404|NCT03364699|immune system|immune system
4680405|NCT03364699|leucocyte function|leucocyte function
4680406|NCT03364699|inflammation|inflammation
4680407|NCT03364686|BioRBCs|biorbcs
4680408|NCT03364686|Biotin labeled red blood cells|biotin labeled red blood cells
4680409|NCT03364673|Ovarian Cancer|ovarian cancer
4680410|NCT03364673|Physical Activity|physical activity
4680411|NCT03364673|Mobile Health|mobile health
4680412|NCT03364673|Fitness Tracker|fitness tracker
4680413|NCT03364673|Survivorship|survivorship
4680414|NCT03364673|Quality of Life|quality of life
4680415|NCT03364660|Epidural Stimulation|epidural stimulation
4680416|NCT03364660|Spinal Cord Injury|spinal cord injury
4680417|NCT03364660|Task-Specific|task-specific
4680418|NCT03364634|decompressive craniectomy|decompressive craniectomy
4680419|NCT03364634|intracranial pressure|intracranial pressure
4680420|NCT03364634|icp|icp
4680421|NCT03364634|telemetry|telemetry
4680422|NCT03364634|telemetric|telemetric
4680423|NCT03364621|Liver resection|liver resection
4680424|NCT03364621|Metastasis|metastasis
4680425|NCT03364621|Molecular profiling|molecular profiling
4680426|NCT03364621|Epigenetic analysis|epigenetic analysis
4680427|NCT03364621|Genomic analysis|genomic analysis
4680428|NCT03364621|Sequencing|sequencing
4680429|NCT03364595|radial head fracture|radial head fracture
4680430|NCT03364595|replacement|replacement
4680431|NCT03364595|plate|plate
4680432|NCT03364582|Dietary patterns|dietary patterns
4680433|NCT03364582|Metabolomics|metabolomics
4680434|NCT03364582|Mortaltiy|mortaltiy
4680435|NCT03364582|Colorectal cancer|colorectal cancer
4680436|NCT03364569|Drainage|drainage
4680437|NCT03364569|Breast augmentation|breast augmentation
4680438|NCT03364569|Tranexamic acid|tranexamic acid
4680439|NCT03364517|Medical regulation|medical regulation
4680440|NCT03364517|SPIA|spia
4680441|NCT03364517|Imminent delivery|imminent delivery
4680442|NCT03364504|PXE|pxe
4680443|NCT03364504|renal cells|renal cells
4680444|NCT03364504|urine|urine
4680445|NCT03364504|calcification|calcification
4680446|NCT03364504|omics|omics
4680447|NCT03364504|drug screening|drug screening
4680448|NCT03364491|Tranexamic Acid|tranexamic acid
4680449|NCT03364491|Hemorrhage|hemorrhage
4680450|NCT03364491|Cesarean|cesarean
4680451|NCT03364478|Surgical approach|surgical approach
4680452|NCT03364478|Laparoscopic right hemicolectomy|laparoscopic right hemicolectomy
4680453|NCT03364452|Dietary Assessment Methodology|dietary assessment methodology
4680454|NCT03364452|beverages|beverages
4680455|NCT03364452|non-nutritive sweeteners|non-nutritive sweeteners
4680456|NCT03364439|DLBCL|dlbcl
4680457|NCT03364387|Acute Coronary Syndrome|acute coronary syndrome
4680458|NCT03364387|MINOCA|minoca
4680459|NCT03364387|Myocardial Infarction|myocardial infarction
4680460|NCT03364387|Atrial Fibrillation|atrial fibrillation
4680461|NCT03364374|Stroke rehabilitation|stroke rehabilitation
4680462|NCT03364374|Upper extremity|upper extremity
4680463|NCT03364374|Posture|posture
4680464|NCT03364309|plaque psoriasis|plaque psoriasis
4680465|NCT03364309|ixekizumab|ixekizumab
4680466|NCT03364309|skin condition|skin condition
4680467|NCT03364309|skin disease|skin disease
4680468|NCT03364309|itching|itching
4680469|NCT03364309|psoriasis vulgaris|psoriasis vulgaris
4680470|NCT03364309|immune-mediated systemic disease|immune-mediated systemic disease
4680471|NCT03364309|skin lesions|skin lesions
4680472|NCT03364309|scaly patches|scaly patches
4680473|NCT03364309|papules|papules
4680474|NCT03364296|Acute stroke, Biomarkers|acute stroke, biomarkers
4680475|NCT03364283|Posterior fossa|posterior fossa
4680476|NCT03364283|Pineal region|pineal region
4680477|NCT03364270|atherosclerosis|atherosclerosis
4680478|NCT03364257|metagenomic|metagenomic
4680479|NCT03364257|infection|infection
4680480|NCT03364257|diagnosis|diagnosis
4680481|NCT03364244|Revatio|revatio
4680482|NCT03364244|Pulmonary arterial hypertension|pulmonary arterial hypertension
4680483|NCT03364244|Pediatric patients|pediatric patients
4680484|NCT03364205|SFA interview technique|sfa interview technique
4680485|NCT03364205|adolescence|adolescence
4680486|NCT03364205|obesity|obesity
4680487|NCT03364205|nutrition|nutrition
4680488|NCT03364205|exercise|exercise
4680489|NCT03364192|Whole Health Coaching|whole health coaching
4680490|NCT03364192|Integrative Health Coaching|integrative health coaching
4680491|NCT03364192|Peer Support Specialist|peer support specialist
4680492|NCT03364192|Personalized Health Plan|personalized health plan
4680493|NCT03364179|dementia|dementia
4680494|NCT03364179|young onset dementia|young onset dementia
4680495|NCT03364179|quality of death|quality of death
4680496|NCT03364179|late onset dementia|late onset dementia
4680497|NCT03364179|palliative care|palliative care
4680498|NCT03364166|buccal squamous cell carcinoma|buccal squamous cell carcinoma
4680499|NCT03364153|Zimura|zimura
4680500|NCT03364153|ARC1905|arc1905
4680501|NCT03364153|complement factor C5 inhibitor|complement factor c5 inhibitor
4680502|NCT03364153|avacincaptad pegol|avacincaptad pegol
4680503|NCT03364153|STGD1|stgd1
4680504|NCT03364140|Peripartum Cardiomyopathy|peripartum cardiomyopathy
4680505|NCT03364140|Heart Failure|heart failure
4680506|NCT03364127|Vulvar Pain, Dyspareunia|vulvar pain, dyspareunia
4680507|NCT03364088|Total knee arthroplasty|total knee arthroplasty
4680508|NCT03364088|Anesthesia|anesthesia
4680509|NCT03364088|Surgical tourniquet|surgical tourniquet
4680510|NCT03364088|Pain|pain
4680511|NCT03364088|Postoperative nausea and vomiting|postoperative nausea and vomiting
4680512|NCT03364088|Quality of life|quality of life
4680513|NCT03364088|Length of stay|length of stay
4680514|NCT03364088|Knee function|knee function
4680515|NCT03364088|Bioelectrical impedance|bioelectrical impedance
4680516|NCT03364088|Knee endoprosthesis|knee endoprosthesis
4680517|NCT03364062|Blood Pressure|blood pressure
4680518|NCT03364062|shoulder replacement|shoulder replacement
4680519|NCT03364062|proximal humeral fracture|proximal humeral fracture
4680520|NCT03364036|Multiple sclerosis|multiple sclerosis
4680521|NCT03364036|Mavenclad ®|mavenclad ®
4680522|NCT03364036|Cladribine|cladribine
4680523|NCT03364010|Motor control|motor control
4680524|NCT03364010|Proprioception|proprioception
4680525|NCT03363997|estriol|estriol
4680526|NCT03363997|pharmacokinetic|pharmacokinetic
4680527|NCT03363997|pharmacodynamic|pharmacodynamic
4680528|NCT03363997|hormone replacement therapy|hormone replacement therapy
4680529|NCT03363997|vaginal ring administration|vaginal ring administration
4680530|NCT03363971|soft tissue, pain|soft tissue, pain
4680531|NCT03363958|myocardial protection|myocardial protection
4680532|NCT03363958|remote ischemic preconditioning|remote ischemic preconditioning
4680533|NCT03363958|remote ischemic postconditioning|remote ischemic postconditioning
4680534|NCT03363958|cardiac surgery|cardiac surgery
4680535|NCT03363945|kidney transplant|kidney transplant
4680536|NCT03363945|cellular therapy|cellular therapy
4680537|NCT03363945|anti-rejection therapy|anti-rejection therapy
4680538|NCT03363945|living donor|living donor
4680539|NCT03363945|HLA-matched|hla-matched
4680540|NCT03363945|hematopoietic stem cells (HSC)|hematopoietic stem cells (hsc)
4680541|NCT03363945|CD34+|cd34+
4680542|NCT03363945|CD3+|cd3+
4680543|NCT03363945|T cells|t cells
4680544|NCT03363932|Ventricular septal defect|ventricular septal defect
4680545|NCT03363932|Congenital heart disease|congenital heart disease
4680546|NCT03363932|Outcome|outcome
4680547|NCT03363919|adolescent|adolescent
4680548|NCT03363919|biomarkers|biomarkers
4680549|NCT03363880|Severe trauma|severe trauma
4680550|NCT03363880|Multiple trauma|multiple trauma
4680551|NCT03363880|Regional Trauma management system|regional trauma management system
4680552|NCT03363880|Trauma management team|trauma management team
4680553|NCT03363867|High grade serous|high grade serous
4680554|NCT03363867|C1 molecular subtype|c1 molecular subtype
4680555|NCT03363841|Candida auris|candida auris
4680556|NCT03363815|Healthy Volunteer|healthy volunteer
4680557|NCT03363815|CC-90001|cc-90001
4680558|NCT03363815|Pharmacokinetics|pharmacokinetics
4680559|NCT03363815|Omeprazole|omeprazole
4680560|NCT03363815|Midazolam|midazolam
4680561|NCT03363815|Warfarin|warfarin
4680562|NCT03363815|Rosuvastatin|rosuvastatin
4680563|NCT03363815|Metformin|metformin
4680564|NCT03363815|Digoxin|digoxin
4680565|NCT03363815|Nintedanib|nintedanib
4680566|NCT03363763|rash|rash
4680567|NCT03363763|fibroma|fibroma
4680568|NCT03363763|skin|skin
4680569|NCT03363763|facial|facial
4680570|NCT03363763|face|face
4680571|NCT03363763|bumps|bumps
4680572|NCT03363763|redness|redness
4680573|NCT03363763|erythema|erythema
4680574|NCT03363763|lesions|lesions
4680575|NCT03363763|papules|papules
4680576|NCT03363763|blood vessel|blood vessel
4680577|NCT03363763|cheeks|cheeks
4680578|NCT03363750|Depression|depression
4680579|NCT03363750|Adolescent|adolescent
4680580|NCT03363750|mind-body-skills|mind-body-skills
4680581|NCT03363750|group therapy|group therapy
4680582|NCT03363750|primary care|primary care
4680583|NCT03363724|Parkinson Disease|parkinson disease
4680584|NCT03363724|Deep Brain Stimulation|deep brain stimulation
4680585|NCT03363724|Microelectrodes recording|microelectrodes recording
4680586|NCT03363724|HaGuide|haguide
4680587|NCT03363724|Alpha Omega Engineering Ltd.|alpha omega engineering ltd.
4680588|NCT03363698|Chronic Cough|chronic cough
4680589|NCT03363698|Upper-Airway Cough Syndrome|upper-airway cough syndrome
4680590|NCT03363698|GERD|gerd
4680591|NCT03363698|Allergic Rhinitis|allergic rhinitis
4680592|NCT03363698|Methacholine Challenge Test|methacholine challenge test
4680593|NCT03363698|Cough Challenge|cough challenge
4680594|NCT03363698|Capsaicin|capsaicin
4680595|NCT03363685|Survival Prediction|survival prediction
4680596|NCT03363685|Spinal Metastases|spinal metastases
4680597|NCT03363685|Non Small Cell Lung Cancer Metastatic|non small cell lung cancer metastatic
4680598|NCT03363672|Chronic Postoperative Pain|chronic postoperative pain
4680599|NCT03363672|Daily Life|daily life
4680600|NCT03363672|Risk Factor|risk factor
4680601|NCT03363659|Glioblastoma|glioblastoma
4680602|NCT03363659|Glioblastoma Multiforme|glioblastoma multiforme
4680603|NCT03363659|Glioma|glioma
4680604|NCT03363659|Anaplastic Glioma|anaplastic glioma
4680605|NCT03363659|Unmethylated|unmethylated
4680606|NCT03363633|Venous Ulceration|venous ulceration
4680607|NCT03363633|Refluxing Perforator Veins|refluxing perforator veins
4680608|NCT03363620|maxillary expansion|maxillary expansion
4680609|NCT03363620|self ligating|self ligating
4680610|NCT03363620|arch form|arch form
4680611|NCT03363594|Diabetes, T2D|diabetes, t2d
4680612|NCT03363581|Food preferences|food preferences
4680613|NCT03363581|Fat|fat
4680614|NCT03363581|Weight loss|weight loss
4680615|NCT03363529|Dynamic lighting, ipRGC|dynamic lighting, iprgc
4680616|NCT03363503|COPD|copd
4680617|NCT03363503|Salmeterol/Fluticasone|salmeterol/fluticasone
4680618|NCT03363503|Discair|discair
4680619|NCT03363503|Diskus|diskus
4680620|NCT03363503|Spirometry|spirometry
4680621|NCT03363490|Self-Management|self-management
4680622|NCT03363490|Neuromuscular Exercise Therapy|neuromuscular exercise therapy
4680623|NCT03363490|Knee osteoarthritis|knee osteoarthritis
4680624|NCT03363477|antithrombotic|antithrombotic
4680625|NCT03363477|heparin|heparin
4680626|NCT03363477|anticoagulant|anticoagulant
4680627|NCT03363477|low molecular weight heparin|low molecular weight heparin
4680628|NCT03363477|pharmacodynamic equivalence|pharmacodynamic equivalence
4680629|NCT03363425|Dexmedetomidine|dexmedetomidine
4680630|NCT03363425|Lidocaine|lidocaine
4680631|NCT03363425|Postoperative Pain|postoperative pain
4680632|NCT03363425|Analgesic Consumption|analgesic consumption
4680634|NCT03363425|Abdominal Gynaecological Surgery|abdominal gynaecological surgery
4680635|NCT03363399|Diagnostic accuracy study|diagnostic accuracy study
4680636|NCT03363399|Flow cytometry analysis|flow cytometry analysis
4680637|NCT03363399|Myeloperoxidase|myeloperoxidase
4680638|NCT03363399|Peripheral blood sample|peripheral blood sample
4680639|NCT03363386|aerobic exercise|aerobic exercise
4680640|NCT03363386|dynamic balance|dynamic balance
4680641|NCT03363386|functional capacity|functional capacity
4680642|NCT03363386|HbA1c|hba1c
4680643|NCT03363386|proprioceptive exercise training|proprioceptive exercise training
4680644|NCT03363373|Antibody, Neuroblastoma, Pediatric, Adult|antibody, neuroblastoma, pediatric, adult
4680645|NCT03363334|ITP|itp
4680646|NCT03363334|Immune Thrombocytopenia|immune thrombocytopenia
4680647|NCT03363321|hemophilia|hemophilia
4680648|NCT03363295|endophthalmitis|endophthalmitis
4680649|NCT03363282|Crosslinking|crosslinking
4680650|NCT03363256|Digital therapeutics|digital therapeutics
4680651|NCT03363256|Adaptation|adaptation
4680652|NCT03363230|mindfulness|mindfulness
4680653|NCT03363230|emotion regulation|emotion regulation
4680654|NCT03363230|impulsivity|impulsivity
4680655|NCT03363217|Glioma|glioma
4680656|NCT03363217|Optic Pathway Glioma|optic pathway glioma
4680657|NCT03363217|Low grade glioma|low grade glioma
4680658|NCT03363217|MAPK/ERK|mapk/erk
4680659|NCT03363217|Plexiform Neurofibroma|plexiform neurofibroma
4680660|NCT03363217|Neurofibromatosis Type 1|neurofibromatosis type 1
4680661|NCT03363217|Central Nervous System|central nervous system
4680662|NCT03363217|CNS|cns
4680663|NCT03363217|Brain Tumor|brain tumor
4680664|NCT03363217|LGG|lgg
4680665|NCT03363217|NF1|nf1
4680666|NCT03363217|KIAA1549-BRAF|kiaa1549-braf
4680667|NCT03363217|Mitogen-activated Protein Kinase (MEK) inhibitor|mitogen-activated protein kinase (mek) inhibitor
4680668|NCT03363217|Trametinib|trametinib
4680669|NCT03363191|fluticasone furoate/vilanterol, efficacy, asthma, Chronic obstructive pulmonary disease|fluticasone furoate/vilanterol, efficacy, asthma, chronic obstructive pulmonary disease
4680670|NCT03363165|PAD|pad
4680671|NCT03363087|Atrial Scar|atrial scar
4680672|NCT03363087|Atrial Fibrillation Ablation|atrial fibrillation ablation
4680673|NCT03363087|Mapping|mapping
4680674|NCT03363087|Persistent Atrial Fibrillation|persistent atrial fibrillation
4680675|NCT03363087|Catheter Ablation|catheter ablation
4680676|NCT03363074|Low-Level Laser Therapy, Orthotic Insoles|low-level laser therapy, orthotic insoles
4680677|NCT03363048|Food restrictions/incentives|food restrictions/incentives
4680678|NCT03363048|Food Stamp program|food stamp program
4680679|NCT03363048|Policy change|policy change
4680680|NCT03363048|Supplemental Nutrition Assistance Program (SNAP)|supplemental nutrition assistance program (snap)
4680681|NCT03363009|prehabilitation|prehabilitation
4680682|NCT03363009|connected devices|connected devices
4680683|NCT03362996|extra virgin olive oil|extra virgin olive oil
4680684|NCT03362996|mild cognitive impairment|mild cognitive impairment
4680685|NCT03362996|randomized double blind clinical trial|randomized double blind clinical trial
4680686|NCT03362970|Bloody Diarrhea|bloody diarrhea
4680687|NCT03362970|STEC|stec
4680688|NCT03362970|Hematochezia|hematochezia
4680689|NCT03362970|BioFire FilmArray|biofire filmarray
4680690|NCT03362970|Child|child
4680691|NCT03362957|embolization|embolization
4680692|NCT03362957|vascular|vascular
4680693|NCT03362905|Lidocaine|lidocaine
4680694|NCT03362905|Dosage forms|dosage forms
4680695|NCT03362905|Pain scores|pain scores
4680696|NCT03362879|Advanced Parkinson's Disease|advanced parkinson's disease
4680697|NCT03362879|Levodopa-Carbidopa Intestinal Gel (LCIG)|levodopa-carbidopa intestinal gel (lcig)
4680698|NCT03362827|Low back pain|low back pain
4680699|NCT03362827|Long-term potentiation|long-term potentiation
4680700|NCT03362827|Hyperalgesia|hyperalgesia
4680701|NCT03362827|Allodynia|allodynia
4680702|NCT03362814|HCV|hcv
4680703|NCT03362814|Ravidasvir|ravidasvir
4680704|NCT03362814|SVR12|svr12
4680705|NCT03362801|physical activity|physical activity
4680706|NCT03362801|elderly|elderly
4680707|NCT03362788|Antithrombotics Antiplatelets Stents Angioplasty|antithrombotics antiplatelets stents angioplasty
4680708|NCT03362762|Type 2 diabetes|type 2 diabetes
4680709|NCT03362762|insulin|insulin
4680710|NCT03362762|Hb1Ac|hb1ac
4680711|NCT03362762|glycemia|glycemia
4680712|NCT03362762|Guadeloupe|guadeloupe
4680713|NCT03362671|OSA|osa
4680714|NCT03362671|Mandibular Advancement Splint|mandibular advancement splint
4680715|NCT03362671|Oral Appliance|oral appliance
4680716|NCT03362671|Treatment|treatment
4680717|NCT03362671|Orthodontic Implants|orthodontic implants
4680718|NCT03362658|Magnetic Resonance Imaging|magnetic resonance imaging
4680719|NCT03362658|MRI|mri
4680720|NCT03362658|Biomarker|biomarker
4680721|NCT03362619|Cervical cancer|cervical cancer
4680722|NCT03362619|Cytotoxic lymphocyte|cytotoxic lymphocyte
4680723|NCT03362619|CC-CTL|cc-ctl
4680724|NCT03362606|Ovarian cancer|ovarian cancer
4680725|NCT03362606|Cytotoxic lymphocyte|cytotoxic lymphocyte
4680726|NCT03362606|OC-CTL|oc-ctl
4680727|NCT03362580|Epiretinal Membrane|epiretinal membrane
4680728|NCT03362580|Diabetes|diabetes
4680729|NCT03362567|Cervical Radiculopathy|cervical radiculopathy
4680730|NCT03362567|Sustained Natural Apophyseal Glides|sustained natural apophyseal glides
4681311|NCT03359005|Irinotecan|irinotecan
4680731|NCT03362567|Mechanical Cervical Traction|mechanical cervical traction
4680732|NCT03362567|Pain Intensity|pain intensity
4680733|NCT03362567|Neck Disability|neck disability
4680734|NCT03362554|Insulin|insulin
4680735|NCT03362554|Glucose|glucose
4680736|NCT03362554|Rab3|rab3
4680737|NCT03362541|multiple sclerosis|multiple sclerosis
4680738|NCT03362541|fatigue|fatigue
4680739|NCT03362541|self-management|self-management
4680740|NCT03362541|rehabilitation|rehabilitation
4680741|NCT03362502|gene therapy, mini-dystrophin, AAV|gene therapy, mini-dystrophin, aav
4680742|NCT03362489|In Vitro Fertilization|in vitro fertilization
4680743|NCT03362489|Intra-Uterine Insemination|intra-uterine insemination
4680744|NCT03362489|Poor responders|poor responders
4680745|NCT03362476|HIV|hiv
4680746|NCT03362476|HCV|hcv
4680747|NCT03362476|Computer Intervention|computer intervention
4680748|NCT03362476|Alcoholism|alcoholism
4680749|NCT03362476|Women|women
4680750|NCT03362476|Russia|russia
4680751|NCT03362450|Midgut volvulus|midgut volvulus
4680752|NCT03362450|Fetal volvulus|fetal volvulus
4680753|NCT03362450|Whirlpool sign|whirlpool sign
4680754|NCT03362450|Pregnant women|pregnant women
4680755|NCT03362450|Position of mesenteric vessels|position of mesenteric vessels
4680756|NCT03362450|Post natal surgery|post natal surgery
4680757|NCT03362450|Foetopathology if performed|foetopathology if performed
4680758|NCT03362450|Hydro-meconium level in the dilated loops|hydro-meconium level in the dilated loops
4680759|NCT03362411|Healthy participants|healthy participants
4680760|NCT03362411|Healthy subjects|healthy subjects
4680761|NCT03362385|Obstructive sleep apnea|obstructive sleep apnea
4680762|NCT03362385|Acute coronary syndrome|acute coronary syndrome
4680763|NCT03362385|Continuous positive airway pressure|continuous positive airway pressure
4680764|NCT03362385|Outcome|outcome
4680765|NCT03362359|prostatectomy|prostatectomy
4680766|NCT03362359|68Ga-PSMA-11|68ga-psma-11
4680767|NCT03362359|EPLND|eplnd
4680768|NCT03362346|Wavelet transform|wavelet transform
4680769|NCT03362346|Deep learning|deep learning
4680770|NCT03362307|Low-Level Light Therapy, Osseointegration|low-level light therapy, osseointegration
4680771|NCT03362281|Peptic ulcer hemorrhage|peptic ulcer hemorrhage
4680772|NCT03362281|Proton Pump Inhibitor|proton pump inhibitor
4680773|NCT03362255|Optic Nerve Sheath Diameter Injection Speed|optic nerve sheath diameter injection speed
4680774|NCT03362216|soft tissue, pain|soft tissue, pain
4680775|NCT03362203|Conditioned pain modulation, neck pain|conditioned pain modulation, neck pain
4680776|NCT03362190|Zimura|zimura
4680777|NCT03362190|ARC1905|arc1905
4680778|NCT03362190|Lucentis|lucentis
4680779|NCT03362190|ranibizumab|ranibizumab
4680780|NCT03362190|Wet AMD|wet amd
4680781|NCT03362190|avacincaptad pegol|avacincaptad pegol
4680782|NCT03362190|complement factor C5 inhibitor|complement factor c5 inhibitor
4680783|NCT03362177|Chemotherapy Induced Thrombocytopenia|chemotherapy induced thrombocytopenia
4680784|NCT03362177|Gastrointestinal Cancer|gastrointestinal cancer
4680785|NCT03362177|Colorectal Cancer|colorectal cancer
4680786|NCT03362164|Fabry|fabry
4680787|NCT03362164|Fibrosis|fibrosis
4680788|NCT03362164|Dialysis|dialysis
4680789|NCT03362164|Stroke|stroke
4680790|NCT03362164|Chronic kidney disease|chronic kidney disease
4680791|NCT03362151|type 1 diabetes|type 1 diabetes
4680792|NCT03362151|pasta|pasta
4680793|NCT03362151|rice|rice
4680794|NCT03362151|protein|protein
4680795|NCT03362151|carbohydrate|carbohydrate
4680796|NCT03362138|melanoma|melanoma
4680797|NCT03362138|dysplastic nevus|dysplastic nevus
4680798|NCT03362138|artificial intelligence|artificial intelligence
4680799|NCT03362138|early diagnosis|early diagnosis
4680800|NCT03362112|lipoprotein-associated phospholipase A2|lipoprotein-associated phospholipase a2
4680801|NCT03362099|varenicline|varenicline
4680802|NCT03362099|bupropion|bupropion
4680803|NCT03362086|bone tumor osteosarcoma|bone tumor osteosarcoma
4680804|NCT03362073|Ketamine|ketamine
4680805|NCT03362073|Refractory cancer pain|refractory cancer pain
4680806|NCT03362073|Terminally ill cancer patients|terminally ill cancer patients
4680807|NCT03362073|Palliative care|palliative care
4680808|NCT03362060|Triple Negative Breast Cancer|triple negative breast cancer
4680809|NCT03362060|Vaccine|vaccine
4680810|NCT03362060|Immunotherapy|immunotherapy
4680811|NCT03362060|PD-1 Inhibitor|pd-1 inhibitor
4680812|NCT03362060|Metastatic Breast Cancer|metastatic breast cancer
4680813|NCT03362021|transvaginal oocyte retrieval|transvaginal oocyte retrieval
4680814|NCT03362021|sedation|sedation
4680815|NCT03362021|dexmedetomidine|dexmedetomidine
4680816|NCT03362021|fentanyl|fentanyl
4680817|NCT03362021|remifentanil|remifentanil
4680818|NCT03362021|midazolam|midazolam
4680819|NCT03361995|STEMI|stemi
4680820|NCT03361969|quality of life|quality of life
4680821|NCT03361969|hot flushes|hot flushes
4680822|NCT03361969|prostate cancer|prostate cancer
4680823|NCT03361969|testosterone|testosterone
4680824|NCT03361930|spastic unilateral cerebral palsy, ankle-foot orthosis, AFO, muscle activity, muscular activity, electromyography, EMG,|spastic unilateral cerebral palsy, ankle-foot orthosis, afo, muscle activity, muscular activity, electromyography, emg,
4680825|NCT03361917|Colonoscopy screening|colonoscopy screening
4680826|NCT03361917|Colonscopy procedure|colonscopy procedure
4680827|NCT03361878|Metformin|metformin
4680828|NCT03361878|Intolerance|intolerance
4680829|NCT03361878|Pharmacokinetics|pharmacokinetics
4680830|NCT03361865|Urothelial cancer, programmed cell death 1 (PD-1) inhibitor|urothelial cancer, programmed cell death 1 (pd-1) inhibitor
4680831|NCT03361865|indoleamine 2,3-dioxygenase (IDO) inhibitor|indoleamine 2,3-dioxygenase (ido) inhibitor
4680832|NCT03361852|Follicular Lymphoma|follicular lymphoma
4680833|NCT03361826|Magnetic seizure therapy (MST)|magnetic seizure therapy (mst)
4680834|NCT03361826|Treatment resistance|treatment resistance
4680835|NCT03361826|Open-label trial|open-label trial
4680836|NCT03361826|Borderline Personality Disorder|borderline personality disorder
4680837|NCT03361826|Suicidal Ideation|suicidal ideation
4680838|NCT03361826|Treatment-resistant depression|treatment-resistant depression
4680839|NCT03361826|Dialectical behavior therapy (DBT)|dialectical behavior therapy (dbt)
4680840|NCT03361826|MST + DBT|mst + dbt
4680841|NCT03361826|Neuroimaging-based biomarkers|neuroimaging-based biomarkers
4680842|NCT03361800|Breast Cancer|breast cancer
4680843|NCT03361800|ER Negative Breast Cancer|er negative breast cancer
4680844|NCT03361800|Triple Negative Breast Cancer|triple negative breast cancer
4680845|NCT03361800|PR Negative Breast Cancer|pr negative breast cancer
4680846|NCT03361800|ER Positive PR Positive Breast Cancer|er positive pr positive breast cancer
4680847|NCT03361787|adolescents|adolescents
4680848|NCT03361787|parents|parents
4680849|NCT03361787|coaching|coaching
4680850|NCT03361761|Chronic disease|chronic disease
4680851|NCT03361761|precariousness and vulnerability|precariousness and vulnerability
4680852|NCT03361761|Health education|health education
4680853|NCT03361748|Multiple Myeloma|multiple myeloma
4680854|NCT03361748|Efficacy and Safety|efficacy and safety
4680855|NCT03361748|BB2121|bb2121
4680856|NCT03361748|CAR T Cell|car t cell
4680857|NCT03361748|BCMA|bcma
4680858|NCT03361748|Relapsed and Refractory|relapsed and refractory
4680859|NCT03361735|PSA Level Greater than or Equal to 0.2|psa level greater than or equal to 0.2
4680860|NCT03361735|Stage IV Prostate Adenocarcinoma AJCC v7|stage iv prostate adenocarcinoma ajcc v7
4680861|NCT03361683|High-Flow nasal oxygen|high-flow nasal oxygen
4680862|NCT03361618|Uric acid|uric acid
4680863|NCT03361618|Adenosine deaminase|adenosine deaminase
4680864|NCT03361618|Zinc Sulfate|zinc sulfate
4680865|NCT03361618|5'-nucleotidase|5'-nucleotidase
4680866|NCT03361618|Asthenospermia.|asthenospermia.
4680867|NCT03361618|Xanthine oxidase|xanthine oxidase
4680868|NCT03361592|symmetry index, functional performance tests, SMT|symmetry index, functional performance tests, smt
4680869|NCT03361579|Placebo|placebo
4680870|NCT03361566|physical activity|physical activity
4680871|NCT03361566|energy balance|energy balance
4680872|NCT03361566|caloric restriction|caloric restriction
4680873|NCT03361566|overfeeding|overfeeding
4680874|NCT03361566|appetite regulation|appetite regulation
4680875|NCT03361540|Pharmacokinetics|pharmacokinetics
4680876|NCT03361540|Safety|safety
4680877|NCT03361540|ASP8302|asp8302
4680878|NCT03361514|antidepressants, discontinuation, primary care, MBCT|antidepressants, discontinuation, primary care, mbct
4680879|NCT03361501|Omega-3 Fatty acids|omega-3 fatty acids
4680880|NCT03361501|Triglycerides|triglycerides
4680881|NCT03361475|Sharing|sharing
4680882|NCT03361475|Mind|mind
4680883|NCT03361475|Enjoyment|enjoyment
4680884|NCT03361462|Sharing|sharing
4680885|NCT03361462|Mind|mind
4680886|NCT03361462|Enjoyment|enjoyment
4680887|NCT03361410|Mild Decline in Cognition|mild decline in cognition
4680888|NCT03361410|Mild Cognitive Decline|mild cognitive decline
4680889|NCT03361410|Mild Cognitive Impairment|mild cognitive impairment
4680890|NCT03361410|Dementia|dementia
4680891|NCT03361410|Positron Emission Tomography (PET)|positron emission tomography (pet)
4680892|NCT03361410|F-18 Fluorodeoxyglucose (FDG)|f-18 fluorodeoxyglucose (fdg)
4680893|NCT03361410|Cerebral Metabolism|cerebral metabolism
4680894|NCT03361410|Dietary Supplement|dietary supplement
4680895|NCT03361410|MCI|mci
4680896|NCT03361410|MDC|mdc
4680897|NCT03361410|Grape|grape
4680898|NCT03361410|Memory|memory
4680899|NCT03361410|Randomized|randomized
4680900|NCT03361410|Non-Drug|non-drug
4680901|NCT03361410|Supplement|supplement
4680902|NCT03361410|Non-Pharmacologic|non-pharmacologic
4680903|NCT03361410|Natural|natural
4680904|NCT03361410|Red Wine|red wine
4680905|NCT03361410|Free|free
4680906|NCT03361410|UCLA|ucla
4680907|NCT03361410|Brain Scan|brain scan
4680908|NCT03361410|Alzheimer's Disease|alzheimer's disease
4680909|NCT03361410|Brain Diseases|brain diseases
4680910|NCT03361410|Central Nervous System Diseases|central nervous system diseases
4680911|NCT03361410|Cognition|cognition
4680912|NCT03361410|Cognitive|cognitive
4680913|NCT03361410|Neurocognitive|neurocognitive
4680914|NCT03361410|Neurodegenerative|neurodegenerative
4680915|NCT03361384|men who have sex with men|men who have sex with men
4680916|NCT03361371|Nose suctioning|nose suctioning
4680917|NCT03361371|Pediatric|pediatric
4680918|NCT03361345|Postinflammatory hyperpigmentation|postinflammatory hyperpigmentation
4680919|NCT03361345|Acne|acne
4680920|NCT03361319|NSCLC|nsclc
4680921|NCT03361319|Non-Small Cell Lung Cancer|non-small cell lung cancer
4680922|NCT03361319|Adenocarcinoma of lung|adenocarcinoma of lung
4680923|NCT03361306|Relapsed|relapsed
4680924|NCT03361280|hemodialysis|hemodialysis
4680925|NCT03361280|dialytic clearance|dialytic clearance
4680926|NCT03361280|pharmacokinetics|pharmacokinetics
4680927|NCT03361241|Stroke|stroke
4680928|NCT03361241|Postural Balance|postural balance
4680929|NCT03361241|Motor Function|motor function
4680930|NCT03361241|Gait|gait
4680931|NCT03361241|Virtual Reality Exposure Therapy|virtual reality exposure therapy
4680932|NCT03361241|Physiotherapist|physiotherapist
4680933|NCT03361228|Non-small cell lung cancer (NSCLC)|non-small cell lung cancer (nsclc)
4680934|NCT03361228|melanoma|melanoma
4680935|NCT03361228|urothelial carcinoma|urothelial carcinoma
4680936|NCT03361228|squamous cell carcinoma of the head and neck (SCCHN)|squamous cell carcinoma of the head and neck (scchn)
4680937|NCT03361228|small cell lung cancer (SCLC)|small cell lung cancer (sclc)
4680938|NCT03361228|colorectal cancer (CRC)|colorectal cancer (crc)
4680939|NCT03361228|arginase 1 inhibitor|arginase 1 inhibitor
4680940|NCT03361228|indoleamine 2,3-dioxygenase 1 inhibitor|indoleamine 2,3-dioxygenase 1 inhibitor
4680941|NCT03361228|programmed death-1 receptor (PD-1) inhibitor|programmed death-1 receptor (pd-1) inhibitor
4680942|NCT03361215|Disease progression|disease progression
4680943|NCT03361215|Disease course|disease course
4680944|NCT03361215|Immunological characterization|immunological characterization
4680945|NCT03361189|Congenital heart disease|congenital heart disease
4680946|NCT03361189|Pacemaker|pacemaker
4680947|NCT03361189|Sinus node dysfunction|sinus node dysfunction
4680948|NCT03361163|Streptococcus pyogenes pharyngitis|streptococcus pyogenes pharyngitis
4680949|NCT03361163|Streptococcus Pharyngitis|streptococcus pharyngitis
4680950|NCT03361163|Strep Throat|strep throat
4680951|NCT03361163|Streptococcus pyogenes Infection|streptococcus pyogenes infection
4680952|NCT03361163|Group A Streptococcus: B Hemolytic Pharyngitis|group a streptococcus: b hemolytic pharyngitis
4680953|NCT03361163|Group A Streptococcal Infection|group a streptococcal infection
4680954|NCT03361163|Controlled human infection model|controlled human infection model
4680955|NCT03361163|Challenge study|challenge study
4680956|NCT03361150|prehabilitation|prehabilitation
4680957|NCT03361111|severe asthma|severe asthma
4680958|NCT03361111|anti-IgE|anti-ige
4680959|NCT03361111|periostin|periostin
4680960|NCT03361111|induced sputum,|induced sputum,
4680961|NCT03361111|exhaled breath condensate|exhaled breath condensate
4680962|NCT03361098|SGLT2 inhibition; dapagliflozin|sglt2 inhibition; dapagliflozin
4680963|NCT03361098|GLP-1 receptor agonist; exenatide|glp-1 receptor agonist; exenatide
4680964|NCT03361098|Central satiety and reward circuits|central satiety and reward circuits
4680965|NCT03361098|bodyweight|bodyweight
4680966|NCT03361098|brain|brain
4680967|NCT03361085|non-ventilator-associated hospital acquired pneumonia|non-ventilator-associated hospital acquired pneumonia
4680968|NCT03361085|Hospital-acquired Pneumonia|hospital-acquired pneumonia
4680969|NCT03361085|Healthcare Associated Infection|healthcare associated infection
4680970|NCT03361085|Adherence|adherence
4680971|NCT03361085|infection prevention|infection prevention
4680972|NCT03361085|implementation|implementation
4680973|NCT03361072|oral immunotherapy|oral immunotherapy
4680974|NCT03361072|milk|milk
4680975|NCT03361072|peanut|peanut
4680976|NCT03361072|egg|egg
4680977|NCT03361072|adult|adult
4680978|NCT03361059|risk factors|risk factors
4680979|NCT03361059|elderly patients|elderly patients
4680980|NCT03361059|risk of falling|risk of falling
4680981|NCT03361046|TAVI|tavi
4680982|NCT03361046|valve-in-valve|valve-in-valve
4680983|NCT03361046|aortic stenosis|aortic stenosis
4680984|NCT03361033|Survivorship|survivorship
4680985|NCT03361033|Social Functioning|social functioning
4680986|NCT03361033|Social Outcomes|social outcomes
4680987|NCT03361007|TAVI|tavi
4680988|NCT03361007|common carotid artery|common carotid artery
4680989|NCT03360955|Extubation|extubation
4680990|NCT03360955|Cardiac Surgery|cardiac surgery
4680991|NCT03360929|Lung Cancer|lung cancer
4680992|NCT03360916|high cholesterol|high cholesterol
4680993|NCT03360916|exercise|exercise
4680994|NCT03360916|statins|statins
4680995|NCT03360890|thyroid cancer|thyroid cancer
4680996|NCT03360890|salivary gland cancer|salivary gland cancer
4680997|NCT03360890|pembrolizumab|pembrolizumab
4680998|NCT03360890|docetaxel|docetaxel
4680999|NCT03360864|Therapeutic education|therapeutic education
4681000|NCT03360812|Medical Students|medical students
4681001|NCT03360812|Education|education
4681002|NCT03360812|Prognosis|prognosis
4681003|NCT03360812|Online training resource|online training resource
4681004|NCT03360799|Malignant neoplasms of independent (primary) multiple sites|malignant neoplasms of independent (primary) multiple sites
4681005|NCT03360799|Questionnaires|questionnaires
4681006|NCT03360799|Surveys|surveys
4681007|NCT03360786|sport concussion|sport concussion
4681008|NCT03360786|cervical spine|cervical spine
4681009|NCT03360786|youth|youth
4681010|NCT03360760|osteosarcoma|osteosarcoma
4681011|NCT03360760|pelvis|pelvis
4681012|NCT03360760|sacrum|sacrum
4681013|NCT03360747|Familial Lipoprotein Lipase Deficiency|familial lipoprotein lipase deficiency
4681014|NCT03360747|Hyperlipoproteinemias|hyperlipoproteinemias
4681015|NCT03360747|Familial Hyperlipoproteinemia Type 1|familial hyperlipoproteinemia type 1
4681016|NCT03360747|Hyperlipoproteinemia Type I|hyperlipoproteinemia type i
4681017|NCT03360747|Hyperchylomicronemia, Familial|hyperchylomicronemia, familial
4681018|NCT03360747|Lipoprotein Lipase Deficiency, Familial|lipoprotein lipase deficiency, familial
4681019|NCT03360747|Hyperlipidemias|hyperlipidemias
4681020|NCT03360747|Dyslipidemias|dyslipidemias
4681021|NCT03360747|Lipid Metabolism Disorders|lipid metabolism disorders
4681022|NCT03360747|Lipid Metabolism, Inborn Errors|lipid metabolism, inborn errors
4681023|NCT03360747|Metabolic Diseases|metabolic diseases
4681024|NCT03360747|Metabolism, Inborn Errors|metabolism, inborn errors
4681025|NCT03360747|Genetic Diseases, Inborn|genetic diseases, inborn
4681026|NCT03360721|mCRPC|mcrpc
4681027|NCT03360721|metastatic castration resistant prostate cancer|metastatic castration resistant prostate cancer
4681028|NCT03360721|nonsteroidal antiandrogen|nonsteroidal antiandrogen
4681029|NCT03360721|androgen signaling|androgen signaling
4681030|NCT03360695|Cancer Care|cancer care
4681031|NCT03360695|Major Depression and Cancer|major depression and cancer
4681032|NCT03360695|Schizophrenia and Cancer|schizophrenia and cancer
4681033|NCT03360695|Bipolar Disorder and Cancer|bipolar disorder and cancer
4681034|NCT03360695|Lung Cancer|lung cancer
4681035|NCT03360695|Breast Cancer|breast cancer
4681036|NCT03360695|Head and Neck Cancer|head and neck cancer
4681037|NCT03360695|Gastrointestinal Cancer|gastrointestinal cancer
4681038|NCT03360695|Schizophrenia|schizophrenia
4681039|NCT03360695|Bipolar Disorder|bipolar disorder
4681040|NCT03360695|Major Depression|major depression
4681041|NCT03360669|hypertension, blood pressure, systolic, diastolic, AOBP, Omron HEM-907, research, clinical|hypertension, blood pressure, systolic, diastolic, aobp, omron hem-907, research, clinical
4681042|NCT03360656|shivering, fever, normothermia|shivering, fever, normothermia
4681043|NCT03360643|Point-of-care ultrasound|point-of-care ultrasound
4681044|NCT03360643|Intussusception|intussusception
4681045|NCT03360643|Pediatric Emergency Medicine|pediatric emergency medicine
4681046|NCT03360643|Ultrasound|ultrasound
4681047|NCT03360617|IV|iv
4681048|NCT03360617|Intravenous|intravenous
4681049|NCT03360617|IV Push|iv push
4681050|NCT03360617|Piggyback|piggyback
4681051|NCT03360617|Antibiotics|antibiotics
4681052|NCT03360617|Beta Lactam|beta lactam
4681053|NCT03360617|Infection|infection
4681054|NCT03360604|glycaemic index|glycaemic index
4681055|NCT03360604|glycaemia|glycaemia
4681056|NCT03360604|diabetes mellitus|diabetes mellitus
4681057|NCT03360604|type 2 diabetes|type 2 diabetes
4681058|NCT03360565|Obstructive Sleep Apnea Syndrome (OSAS)|obstructive sleep apnea syndrome (osas)
4681059|NCT03360526|PICSI|picsi
4681060|NCT03360526|ORP|orp
4681061|NCT03360526|TESA|tesa
4681062|NCT03360526|seminal oxidation reduction potential|seminal oxidation reduction potential
4681063|NCT03360513|Orthodontics|orthodontics
4681064|NCT03360513|Dental arch|dental arch
4681065|NCT03360513|Orthodontic appliance design.|orthodontic appliance design.
4681066|NCT03360500|Osteoarthritis, Knee|osteoarthritis, knee
4681067|NCT03360500|Cryotherapy|cryotherapy
4681068|NCT03360500|Exercise|exercise
4681069|NCT03360500|Physiotherapy|physiotherapy
4681070|NCT03360500|Knee|knee
4681071|NCT03360448|Gene Transfer|gene transfer
4681072|NCT03360422|MSM, young adult|msm, young adult
4681073|NCT03360409|Cervical Disc Degeneration|cervical disc degeneration
4681074|NCT03360409|cervical anterior discectomy|cervical anterior discectomy
4681075|NCT03360409|Spinal alignment|spinal alignment
4681076|NCT03360396|severe heterogeneous emphysema|severe heterogeneous emphysema
4681077|NCT03360396|severe homogeneous emphysema|severe homogeneous emphysema
4681078|NCT03360383|Spinal Fractures/surgery|spinal fractures/surgery
4681079|NCT03360383|Vertebroplasty|vertebroplasty
4681080|NCT03360383|Quality-Adjusted Life Years|quality-adjusted life years
4681081|NCT03360370|Neurodevelopmental disorders,|neurodevelopmental disorders,
4681082|NCT03360370|Congenital heart disease|congenital heart disease
4681083|NCT03360370|Children|children
4681084|NCT03360344|carpal tunnel syndrome, forearm wrist hand pain, kinesio tape|carpal tunnel syndrome, forearm wrist hand pain, kinesio tape
4681085|NCT03360318|pediatric|pediatric
4681086|NCT03360318|elbow fractures|elbow fractures
4681087|NCT03360318|management|management
4681088|NCT03360305|emergency department|emergency department
4681089|NCT03360305|prevention|prevention
4681090|NCT03360305|transitions of care|transitions of care
4681091|NCT03360292|Neonatology|neonatology
4681092|NCT03360266|remineralization|remineralization
4681093|NCT03360266|fluoride varnish|fluoride varnish
4681094|NCT03360227|syncope|syncope
4681095|NCT03360227|bradycardia|bradycardia
4681096|NCT03360227|tachycardia|tachycardia
4681097|NCT03360227|sudden cardiac death|sudden cardiac death
4681098|NCT03360227|implantable cardioverter-defibrillator|implantable cardioverter-defibrillator
4681099|NCT03360227|ventricular tachycardia|ventricular tachycardia
4681100|NCT03360227|ventricular fibrillation|ventricular fibrillation
4681101|NCT03360227|biomarker|biomarker
4681102|NCT03360227|thyroid hormone|thyroid hormone
4681103|NCT03360214|Mastectomy|mastectomy
4681104|NCT03360214|Tissue expander|tissue expander
4681105|NCT03360214|PEMF|pemf
4681106|NCT03360214|PIB|pib
4681107|NCT03360201|Africa|africa
4681108|NCT03360201|Kenya|kenya
4681109|NCT03360201|Family relations|family relations
4681110|NCT03360201|Child mental health|child mental health
4681111|NCT03360201|Adolescent mental health|adolescent mental health
4681112|NCT03360201|Family therapy|family therapy
4681113|NCT03360201|Program evaluation|program evaluation
4681114|NCT03360201|Family Conflict|family conflict
4681115|NCT03360201|Marital Conflict|marital conflict
4681116|NCT03360201|Domestic Violence|domestic violence
4681117|NCT03360201|Parenting|parenting
4681118|NCT03360201|Parent-Child Relations|parent-child relations
4681119|NCT03360201|child abuse|child abuse
4681120|NCT03360201|low- and middle-income country|low- and middle-income country
4681121|NCT03360149|Hemophilia pregnant|hemophilia pregnant
4681122|NCT03360149|Hemophilia delivery|hemophilia delivery
4681123|NCT03360149|Hemophilia children|hemophilia children
4681124|NCT03360136|Exhaustion Disorder|exhaustion disorder
4681125|NCT03360136|Burnout|burnout
4681126|NCT03360136|Clinical Burnout|clinical burnout
4681127|NCT03360097|In vitro Fertilization|in vitro fertilization
4681128|NCT03360097|Slow Developing Blastocyst|slow developing blastocyst
4681129|NCT03360097|Fresh Embryo Transfer|fresh embryo transfer
4681130|NCT03360097|Frozen Embryo Transfer|frozen embryo transfer
4681131|NCT03360097|Live Birth Rate|live birth rate
4681132|NCT03360084|CT|ct
4681133|NCT03360084|Interventional radiology|interventional radiology
4681134|NCT03360084|Lung biopsy|lung biopsy
4681135|NCT03360084|Transthoracic biopsy|transthoracic biopsy
4681136|NCT03360084|Systemic air embolism|systemic air embolism
4681137|NCT03360058|motivational techniques|motivational techniques
4681138|NCT03360058|primary care|primary care
4681139|NCT03360032|Incremental shuttle walk test|incremental shuttle walk test
4681140|NCT03360032|Cardiopulmonary exercise test|cardiopulmonary exercise test
4681141|NCT03360032|VO2 peak|vo2 peak
4681142|NCT03360006|Castrate-Resistant Prostate Cancer (CRPC)|castrate-resistant prostate cancer (crpc)
4681143|NCT03360006|Metastatic Castrate-Resistant Prostate Cancer (CRPC)|metastatic castrate-resistant prostate cancer (crpc)
4681144|NCT03360006|Acute Myeloid Leukemia (AML)|acute myeloid leukemia (aml)
4681145|NCT03360006|Relapsing acute myeloid leukemia|relapsing acute myeloid leukemia
4681146|NCT03360006|Remitting acute myeloid leukemia|remitting acute myeloid leukemia
4681147|NCT03360006|Dose-limiting toxicity|dose-limiting toxicity
4681148|NCT03360006|Recommended phase two dose|recommended phase two dose
4681149|NCT03360006|Pharmacokinetics|pharmacokinetics
4681150|NCT03359993|Endotracheal intubation|endotracheal intubation
4681151|NCT03359993|Neonatal premedication|neonatal premedication
4681152|NCT03359993|Delivery room|delivery room
4681153|NCT03359954|Malignant neoplasm of breast|malignant neoplasm of breast
4681154|NCT03359954|Preoperative boost radiotherapy|preoperative boost radiotherapy
4681155|NCT03359954|RT|rt
4681156|NCT03359954|XRT|xrt
4681157|NCT03359954|HR+/HER2-|hr+/her2-
4681158|NCT03359954|Breast surgery|breast surgery
4681159|NCT03359941|Integrative Treatments|integrative treatments
4681160|NCT03359941|Korean Traditional medicine|korean traditional medicine
4681161|NCT03359915|COPD|copd
4681162|NCT03359915|Self-Management|self-management
4681163|NCT03359915|Action Plan|action plan
4681164|NCT03359915|SGRQ|sgrq
4681165|NCT03359915|LMIC|lmic
4681166|NCT03359915|COPD Diagnosis|copd diagnosis
4681167|NCT03359902|Mild Cognitive Impairment|mild cognitive impairment
4681168|NCT03359902|Vagal Nerve Stimulation|vagal nerve stimulation
4681169|NCT03359902|tVNS|tvns
4681170|NCT03359902|Alzheimer's disease|alzheimer's disease
4681171|NCT03359876|Real-world study|real-world study
4681172|NCT03359876|Atrial fibrillation|atrial fibrillation
4681173|NCT03359876|Renal dysfunction|renal dysfunction
4681174|NCT03359876|Rivaroxaban|rivaroxaban
4681175|NCT03359876|Warfarin|warfarin
4681176|NCT03359824|exercise, brown adipose tissue|exercise, brown adipose tissue
4681177|NCT03359811|Local Anesthetic Solution|local anesthetic solution
4681178|NCT03359811|Bupivacaine HCl|bupivacaine hcl
4681179|NCT03359811|Liposomal Bupivacaine|liposomal bupivacaine
4681180|NCT03359811|Peritoneal Cancer|peritoneal cancer
4681181|NCT03359785|Drug therapy|drug therapy
4681182|NCT03359772|Neuropathic Pain|neuropathic pain
4681183|NCT03359772|Balance|balance
4681184|NCT03359772|Kinesthetic Ability Trainer|kinesthetic ability trainer
4681185|NCT03359772|Quality of Life|quality of life
4681186|NCT03359759|Telemedicine|telemedicine
4681187|NCT03359759|Connected watches|connected watches
4681188|NCT03359759|Patient-Reported symptom monitoring|patient-reported symptom monitoring
4681189|NCT03359759|Secure Platform|secure platform
4681190|NCT03359733|Drug therapy|drug therapy
4681191|NCT03359694|breast cancer, neoadjuvant chemotherapy,susceptible gene|breast cancer, neoadjuvant chemotherapy,susceptible gene
4681192|NCT03359655|misoprostol|misoprostol
4681193|NCT03359655|hyoscine butyl bromide|hyoscine butyl bromide
4681194|NCT03359655|cervical dilatation|cervical dilatation
4681195|NCT03359655|cervical ripening|cervical ripening
4681196|NCT03359655|hysteroscopy|hysteroscopy
4681197|NCT03359655|pain|pain
4681198|NCT03359642|Microbiota|microbiota
4681199|NCT03359642|inflammatory bowel disease|inflammatory bowel disease
4681200|NCT03359642|inflammation|inflammation
4681201|NCT03359642|anti-TNF alpha|anti-tnf alpha
4681202|NCT03359629|Spectrophon|spectrophon
4681203|NCT03359629|Glucose|glucose
4681204|NCT03359629|Biosensor|biosensor
4681205|NCT03359629|Non-invasive testing|non-invasive testing
4681206|NCT03359616|rectal cancer|rectal cancer
4681207|NCT03359616|laparoscopic surgery|laparoscopic surgery
4681208|NCT03359616|total mesorectal excision|total mesorectal excision
4681209|NCT03359616|transanal surgery|transanal surgery
4681210|NCT03359603|Electro-acupuncture|electro-acupuncture
4681211|NCT03359603|Knee osteoarthritis|knee osteoarthritis
4681212|NCT03359603|Treatment frequency|treatment frequency
4681213|NCT03359577|Chronic plaque psoriasis|chronic plaque psoriasis
4681214|NCT03359577|Inflammation|inflammation
4681215|NCT03359577|Cardiovascular diseases|cardiovascular diseases
4681216|NCT03359564|Lumbar Disc Herniation|lumbar disc herniation
4681217|NCT03359564|Micro Endoscopic Discectomy|micro endoscopic discectomy
4681218|NCT03359551|Choroideremia|choroideremia
4681219|NCT03359551|REP1|rep1
4681220|NCT03359551|Retina|retina
4681221|NCT03359551|Retinal Degeneration|retinal degeneration
4681222|NCT03359551|Retinal Dystrophy|retinal dystrophy
4681223|NCT03359551|Natural History|natural history
4681224|NCT03359538|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
4681225|NCT03359538|Motor Neuron Disease|motor neuron disease
4681226|NCT03359538|Rapamycin|rapamycin
4681227|NCT03359512|anesthesia monitoring|anesthesia monitoring
4681228|NCT03359473|GSK2881078|gsk2881078
4681229|NCT03359473|COPD|copd
4681230|NCT03359473|muscle weakness|muscle weakness
4681231|NCT03359473|post-menopausal|post-menopausal
4681232|NCT03359473|selective androgen receptor modulator|selective androgen receptor modulator
4681233|NCT03359447|infant|infant
4681234|NCT03359447|primary prevention|primary prevention
4681235|NCT03359434|Acute Stroke|acute stroke
4681236|NCT03359434|Blood Pressure|blood pressure
4681237|NCT03359434|Cerebral Hemorrhage|cerebral hemorrhage
4681238|NCT03359421|prehospital|prehospital
4681239|NCT03359421|aeromedical|aeromedical
4681240|NCT03359421|trauma|trauma
4681241|NCT03359421|ems|ems
4681242|NCT03359421|helicopter|helicopter
4681243|NCT03359408|Health care|health care
4681244|NCT03359408|Dementia care|dementia care
4681245|NCT03359408|Collaborative care|collaborative care
4681246|NCT03359408|Discharge management|discharge management
4681247|NCT03359408|Hospital|hospital
4681248|NCT03359408|Primary care|primary care
4681249|NCT03359395|Anesthesia|anesthesia
4681250|NCT03359356|alopecia|alopecia
4681251|NCT03359356|alopecia areata|alopecia areata
4681252|NCT03359356|alopecia universalis|alopecia universalis
4681253|NCT03359356|alopecia totalis|alopecia totalis
4681254|NCT03359356|dupixent|dupixent
4681255|NCT03359356|dupilumab|dupilumab
4681256|NCT03359330|Peripheral nervous system diseases|peripheral nervous system diseases
4681257|NCT03359330|Wounds and injuries|wounds and injuries
4681258|NCT03359330|Nerve regeneration|nerve regeneration
4681259|NCT03359330|Biocompatible materials|biocompatible materials
4681260|NCT03359330|Surgical procedures|surgical procedures
4681261|NCT03359317|Osteoporosis|osteoporosis
4681262|NCT03359317|Bone Diseases|bone diseases
4681263|NCT03359304|bone tumor|bone tumor
4681264|NCT03359291|macitentan|macitentan
4681265|NCT03359291|rosuvastatin|rosuvastatin
4681266|NCT03359291|pharmacokinetics|pharmacokinetics
4681267|NCT03359278|distal radius fracture, sigmoid notch|distal radius fracture, sigmoid notch
4681268|NCT03359252|coil embolization|coil embolization
4681269|NCT03359252|headache|headache
4681270|NCT03359252|stent|stent
4681271|NCT03359239|PGV001|pgv001
4681272|NCT03359239|atezolizumab|atezolizumab
4681273|NCT03359239|urothelial cancer|urothelial cancer
4681274|NCT03359239|personalized neoantigen vaccine|personalized neoantigen vaccine
4681275|NCT03359187|Radiation- induced mucositis|radiation- induced mucositis
4681276|NCT03359187|Head and Neck Cancer|head and neck cancer
4681277|NCT03359187|Radiation therapy side effect|radiation therapy side effect
4681278|NCT03359161|ambulatory|ambulatory
4681279|NCT03359161|Subcutaneous|subcutaneous
4681280|NCT03359161|furosemide|furosemide
4681281|NCT03359148|Nosocomial infection|nosocomial infection
4681282|NCT03359148|Ventilator system|ventilator system
4681283|NCT03359148|Closed suction system|closed suction system
4681284|NCT03359148|Open suction system|open suction system
4681285|NCT03359148|Bacterial contamination|bacterial contamination
4681286|NCT03359135|Compression garment|compression garment
4681287|NCT03359096|Sleep apnea|sleep apnea
4681288|NCT03359096|Tongue stimulation|tongue stimulation
4681289|NCT03359096|Cardiovascular function|cardiovascular function
4681290|NCT03359083|foot-ankle characteristic|foot-ankle characteristic
4681291|NCT03359083|lumbopelvic control|lumbopelvic control
4681292|NCT03359083|balance|balance
4681293|NCT03359083|physical performance|physical performance
4681294|NCT03359070|Tinea cruris|tinea cruris
4681295|NCT03359070|dapaconazole|dapaconazole
4681296|NCT03359070|topical antifungal|topical antifungal
4681297|NCT03359070|dermatophytoses|dermatophytoses
4681298|NCT03359057|Folic acid|folic acid
4681299|NCT03359057|Supplementation|supplementation
4681300|NCT03359057|Ethinyl estradiol|ethinyl estradiol
4681301|NCT03359057|Levonorgestrel|levonorgestrel
4681302|NCT03359057|Oral contraceptive|oral contraceptive
4681303|NCT03359044|Fiberoptic bronchoscopy|fiberoptic bronchoscopy
4681304|NCT03359044|Neuropsychological Development|neuropsychological development
4681305|NCT03359044|general anesthesia|general anesthesia
4681306|NCT03359018|osteosarcoma|osteosarcoma
4681307|NCT03359018|advanced|advanced
4681308|NCT03359018|apatinib|apatinib
4681309|NCT03359018|PD-1|pd-1
4681310|NCT03359005|Ewing Sarcoma|ewing sarcoma
4681312|NCT03359005|Temozolomide|temozolomide
4681313|NCT03358992|CESOFB|cesofb
4681314|NCT03358992|clinical evaluation|clinical evaluation
4681315|NCT03358992|RECIST|recist
4681316|NCT03358992|histological response|histological response
4681317|NCT03358992|survival|survival
4681318|NCT03358992|osteosarcoma|osteosarcoma
4681319|NCT03358992|Ewing sarcoma|ewing sarcoma
4681320|NCT03358979|Conjunctival Diseases|conjunctival diseases
4681321|NCT03358979|Dry Eye Syndromes|dry eye syndromes
4681322|NCT03358979|Antigens|antigens
4681323|NCT03358979|CD147|cd147
4681324|NCT03358966|chronic kidney disease|chronic kidney disease
4681325|NCT03358966|energy expenditure|energy expenditure
4681326|NCT03358966|metabolic rate|metabolic rate
4681327|NCT03358953|electronic cigarettes|electronic cigarettes
4681328|NCT03358953|cardiovascular|cardiovascular
4681329|NCT03358953|nicotine replacement patches|nicotine replacement patches
4681330|NCT03358940|Non-medical abortion|non-medical abortion
4681331|NCT03358940|Misoprostol|misoprostol
4681332|NCT03358940|miscarriage complications|miscarriage complications
4681333|NCT03358940|Guadeloupe|guadeloupe
4681334|NCT03358927|HIV/AIDS|hiv/aids
4681335|NCT03358927|Fast-track care|fast-track care
4681336|NCT03358927|Behavioral economics|behavioral economics
4681337|NCT03358927|Differentiated care|differentiated care
4681338|NCT03358914|psoriasis, adolescents, quality of life, PRO (patient-reported outcome), validation|psoriasis, adolescents, quality of life, pro (patient-reported outcome), validation
4681339|NCT03358862|myopia|myopia
4681340|NCT03358862|progressive myopia|progressive myopia
4681341|NCT03358862|contact lenses|contact lenses
4681342|NCT03358862|extended depth of focus|extended depth of focus
4681343|NCT03358862|retrospective clinical series|retrospective clinical series
4681344|NCT03358862|axial length|axial length
4681345|NCT03358862|refractive error|refractive error
4681346|NCT03358836|Hemophilia B|hemophilia b
4681347|NCT03358836|FIX|fix
4681348|NCT03358836|Factor IX|factor ix
4681349|NCT03358836|Factor 9|factor 9
4681350|NCT03358823|AS database ; Brain Image;Neural-EEG Data|as database ; brain image;neural-eeg data
4681351|NCT03358797|Community-based Intervention|community-based intervention
4681352|NCT03358797|Lifestyle intervention|lifestyle intervention
4681353|NCT03358797|Women in East Jerusalem|women in east jerusalem
4681354|NCT03358797|Diabetes prevention|diabetes prevention
4681355|NCT03358797|Leadership|leadership
4681356|NCT03358784|Humeral Fractures, Proximal|humeral fractures, proximal
4681357|NCT03358784|Arthroplasty, Shoulder Replacement|arthroplasty, shoulder replacement
4681358|NCT03358784|Bone Plates|bone plates
4681359|NCT03358771|COPD|copd
4681360|NCT03358771|AECOPD|aecopd
4681361|NCT03358771|Discharge care bundle|discharge care bundle
4681362|NCT03358771|Patient Care Bundles|patient care bundles
4681363|NCT03358758|Trauma|trauma
4681364|NCT03358758|War-Related Injuries|war-related injuries
4681365|NCT03358758|Firearm|firearm
4681366|NCT03358758|Explosion|explosion
4681367|NCT03358758|Bomb|bomb
4681368|NCT03358758|Ordnance|ordnance
4681369|NCT03358758|IED|ied
4681370|NCT03358758|Epidemiology|epidemiology
4681371|NCT03358758|Public Health|public health
4681372|NCT03358745|Type 2 diabetes risk|type 2 diabetes risk
4681373|NCT03358745|Cardiovascular disease risk|cardiovascular disease risk
4681374|NCT03358732|embryo transfer, mock embryo transfer, endometrial receptivity, endometrial scratching, IVF|embryo transfer, mock embryo transfer, endometrial receptivity, endometrial scratching, ivf
4681375|NCT03358667|peri-implant soft tissue augmentation|peri-implant soft tissue augmentation
4681376|NCT03358654|Umbilical Cord Bleeding|umbilical cord bleeding
4681377|NCT03358654|Knee Osteoarthritis|knee osteoarthritis
4681378|NCT03358654|stem cells|stem cells
4681379|NCT03358641|exercise|exercise
4681380|NCT03358641|physical activity|physical activity
4681381|NCT03358641|radiographic osteoarthritis|radiographic osteoarthritis
4681382|NCT03358628|Osteosarcoma|osteosarcoma
4681383|NCT03358628|Patient-derived xenograft|patient-derived xenograft
4681384|NCT03358615|robson classification|robson classification
4681385|NCT03358615|Egypt|egypt
4681386|NCT03358602|Supraglottic cancer|supraglottic cancer
4681387|NCT03358602|Laryngeal cancer|laryngeal cancer
4681388|NCT03358602|Cervical lymph node|cervical lymph node
4681389|NCT03358602|Neck dissection|neck dissection
4681390|NCT03358563|Prostate Cancer|prostate cancer
4681391|NCT03358563|Prostatectomy|prostatectomy
4681392|NCT03358563|Chemohormonal therapy|chemohormonal therapy
4681393|NCT03358563|Androgen deprivation therapy|androgen deprivation therapy
4681394|NCT03358563|docetaxel chemotherapy|docetaxel chemotherapy
4681395|NCT03358550|accommodation|accommodation
4681396|NCT03358550|dark focus|dark focus
4681397|NCT03358550|night myopia|night myopia
4681398|NCT03358537|Dietary fiber|dietary fiber
4681399|NCT03358472|Head and neck squamous cell carcinoma|head and neck squamous cell carcinoma
4681400|NCT03358472|programmed cell death 1 (PD-1) inhibitor|programmed cell death 1 (pd-1) inhibitor
4681401|NCT03358472|indoleamine 2,3-dioxygenase 1 (IDO1) inhibitor|indoleamine 2,3-dioxygenase 1 (ido1) inhibitor
4681402|NCT03358459|phenotype; genotype|phenotype; genotype
4681403|NCT03358446|central catheterization|central catheterization
4681404|NCT03358446|femoral vein central catheterization|femoral vein central catheterization
4681405|NCT03358446|leg angulation|leg angulation
4681406|NCT03358407|Inflammatory Bowel disease|inflammatory bowel disease
4681407|NCT03358407|Pro-drug|pro-drug
4681408|NCT03358407|Double-blinded|double-blinded
4681409|NCT03358407|Crossover|crossover
4681410|NCT03358381|total knee arthroplasty|total knee arthroplasty
4681411|NCT03358381|CT scan|ct scan
4681412|NCT03358355|PAD|pad
4681413|NCT03358355|unacylated ghrelin|unacylated ghrelin
4681414|NCT03358355|Peripheral Artery Disease|peripheral artery disease
4681415|NCT03358316|Rotator Cuff Tear|rotator cuff tear
4681416|NCT03358316|Magnetic Resonance Imaging|magnetic resonance imaging
4681417|NCT03358316|humeral migration|humeral migration
4681418|NCT03358290|JTE-051|jte-051
4681419|NCT03358290|Psoriasis|psoriasis
4681420|NCT03358264|Vascular dysfunction, L-citrulline, arginase|vascular dysfunction, l-citrulline, arginase
4681421|NCT03358225|Hybrid surgery,ACDF,C-ADR,bi-level cervical spondylosis|hybrid surgery,acdf,c-adr,bi-level cervical spondylosis
4681422|NCT03358212|giant cell tumor of bone|giant cell tumor of bone
4681423|NCT03358212|Denosumab|denosumab
4681424|NCT03358212|post-operative|post-operative
4681425|NCT03358199|LOD|lod
4681426|NCT03358199|PCOS|pcos
4681427|NCT03358199|AMH|amh
4681428|NCT03358199|OHSS|ohss
4681429|NCT03358186|Periprosthetic Fractures|periprosthetic fractures
4681430|NCT03358186|Arthroplasty|arthroplasty
4681431|NCT03358186|Surgical procedures|surgical procedures
4681432|NCT03358173|Humeral Fractures|humeral fractures
4681433|NCT03358173|plate|plate
4681434|NCT03358173|Conservative Treatment|conservative treatment
4681435|NCT03358134|Peripheral Spondylarthropathies|peripheral spondylarthropathies
4681436|NCT03358134|Psoriatic arthritis|psoriatic arthritis
4681437|NCT03358134|Reactive arthritis|reactive arthritis
4681438|NCT03358056|Mindfulness|mindfulness
4681439|NCT03358056|Emotion|emotion
4681440|NCT03358056|Mindfulenss-based cognitive therapy|mindfulenss-based cognitive therapy
4681441|NCT03358043|respiratory failure|respiratory failure
4681442|NCT03358043|mechanical ventilation|mechanical ventilation
4681443|NCT03358043|prevalence|prevalence
4681444|NCT03358017|Triple negative breast cancer|triple negative breast cancer
4681445|NCT03358017|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
4681446|NCT03358017|p53|p53
4681447|NCT03358017|Zoledronate|zoledronate
4681448|NCT03358017|Atorvastatin|atorvastatin
4681449|NCT03358017|Mevalonate pathway inhibitors|mevalonate pathway inhibitors
4681450|NCT03358017|Hippo pathway|hippo pathway
4681451|NCT03358004|TNBC|tnbc
4681452|NCT03358004|metronomic chemotherapy|metronomic chemotherapy
4681453|NCT03358004|vinorelbine|vinorelbine
4681454|NCT03358004|capecitabine|capecitabine
4681455|NCT03357991|E6/E7 mRNA|e6/e7 mrna
4681456|NCT03357991|anal cancer screening|anal cancer screening
4681457|NCT03357991|men who have sex with men|men who have sex with men
4681458|NCT03357991|cost-effectiveness analysis|cost-effectiveness analysis
4681459|NCT03357991|High resolution anoscopy|high resolution anoscopy
4681460|NCT03357978|immunodeficiency|immunodeficiency
4681461|NCT03357978|liver disease|liver disease
4681462|NCT03357978|cancer risk|cancer risk
4681463|NCT03357965|maternal infant bonding|maternal infant bonding
4681464|NCT03357965|depression|depression
4681465|NCT03357965|anxiety|anxiety
4681466|NCT03357939|HLX03|hlx03
4681467|NCT03357939|adalimumab|adalimumab
4681468|NCT03357939|pharmacokinetics|pharmacokinetics
4681469|NCT03357939|biosimilar|biosimilar
4681470|NCT03357900|Consciousness Monitor|consciousness monitor
4681471|NCT03357900|Clinical Pharmacology|clinical pharmacology
4681472|NCT03357861|cancer|cancer
4681473|NCT03357861|intensive care unit|intensive care unit
4681474|NCT03357861|checkpoint inhibitors|checkpoint inhibitors
4681475|NCT03357861|adverse event|adverse event
4681476|NCT03357835|trauma|trauma
4681477|NCT03357835|triage|triage
4681478|NCT03357835|software|software
4681479|NCT03357835|emergency|emergency
4681480|NCT03357822|Chronic hepatitis B|chronic hepatitis b
4681481|NCT03357822|Nucleoside analog|nucleoside analog
4681482|NCT03357822|Pegylated Interferon|pegylated interferon
4681483|NCT03357822|Sequential combination therapy|sequential combination therapy
4681484|NCT03357822|HBsAg loss|hbsag loss
4681485|NCT03357796|Depressive Disorder, Major|depressive disorder, major
4681486|NCT03357796|Depressive Disorder|depressive disorder
4681487|NCT03357796|Mood Disorders|mood disorders
4681488|NCT03357796|Mental Disorders|mental disorders
4681489|NCT03357796|Desvenlafaxine Succinate|desvenlafaxine succinate
4681490|NCT03357796|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors
4681491|NCT03357796|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors
4681492|NCT03357796|Membrane Transport Modulators|membrane transport modulators
4681493|NCT03357796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
4681494|NCT03357796|Neurotransmitter Agents|neurotransmitter agents
4681495|NCT03357796|Physiological Effects of Drugs|physiological effects of drugs
4681496|NCT03357796|Antidepressive Agents|antidepressive agents
4681497|NCT03357796|Psychotropic Drugs|psychotropic drugs
4681498|NCT03357783|Frequency|frequency
4681499|NCT03357783|Macroscopic|macroscopic
4681500|NCT03357783|Deciduosis|deciduosis
4681501|NCT03357783|Ovarian|ovarian
4681502|NCT03357783|Neoplasm|neoplasm
4681503|NCT03357783|Pregnancy|pregnancy
4681504|NCT03357770|mesenchymal stem cells|mesenchymal stem cells
4681505|NCT03357770|Knee Osteoarthritis|knee osteoarthritis
4681506|NCT03357770|Umbilical Cord|umbilical cord
4681507|NCT03357744|distress|distress
4681508|NCT03357744|assessment methods|assessment methods
4681509|NCT03357718|premedication|premedication
4681510|NCT03357705|alveolar ridge preservation|alveolar ridge preservation
4681511|NCT03357692|all on four; piezoelectric; implant; trans-sinusal|all on four; piezoelectric; implant; trans-sinusal
4681512|NCT03357679|Bed up head elevated position|bed up head elevated position
4681513|NCT03357679|Glidescope assisted tracheal intubation|glidescope assisted tracheal intubation
4681514|NCT03357679|Laryngeal exposure|laryngeal exposure
4681515|NCT03357679|Time to intubation|time to intubation
4681516|NCT03357653|proteinuria|proteinuria
4681517|NCT03357653|progression|progression
4681518|NCT03357653|early immunoglobulin A (IgA) nephropathy|early immunoglobulin a (iga) nephropathy
4681519|NCT03357627|Drug therapy|drug therapy
4681520|NCT03357601|High Intensity Interval|high intensity interval
4681521|NCT03357601|Moderate Endurance Exercise|moderate endurance exercise
4681522|NCT03357601|Fat Loss|fat loss
4681523|NCT03357601|Endurance Capacity|endurance capacity
4681524|NCT03357575|Knee Osteoarthritis|knee osteoarthritis
4681525|NCT03357575|adipose|adipose
4681526|NCT03357575|mesenchymal stem cells|mesenchymal stem cells
4681527|NCT03357562|Cystic fibrosis|cystic fibrosis
4681528|NCT03357562|CT|ct
4681529|NCT03357562|MRI|mri
4681530|NCT03357562|radiation dose|radiation dose
4681531|NCT03357562|contrast agent|contrast agent
4681532|NCT03357549|Breast Feeding|breast feeding
4681533|NCT03357549|Motivational Interviewing|motivational interviewing
4681534|NCT03357549|Self Efficacy|self efficacy
4681535|NCT03357497|colorectal surgery, early mobilization, postoperative care|colorectal surgery, early mobilization, postoperative care
4681536|NCT03357484|impacted tooth|impacted tooth
4681537|NCT03357484|pain|pain
4681538|NCT03357484|platelet-rich fibrin|platelet-rich fibrin
4681539|NCT03357484|third molar|third molar
4681540|NCT03357484|tooth extraction|tooth extraction
4681541|NCT03357484|wound healing|wound healing
4681542|NCT03357471|Certolizumab Pegol|certolizumab pegol
4681543|NCT03357471|E-Device|e-device
4681544|NCT03357458|Family Integrated Care|family integrated care
4681545|NCT03357458|Parenting education|parenting education
4681546|NCT03357458|Nursing|nursing
4681547|NCT03357458|Cost effectiveness|cost effectiveness
4681548|NCT03357458|Patient engagement|patient engagement
4681549|NCT03357458|Randomized controlled trial|randomized controlled trial
4681550|NCT03357458|Neonatal intensive care unit|neonatal intensive care unit
4681551|NCT03357445|Total hip Arthroplasty|total hip arthroplasty
4681552|NCT03357445|Hip implant|hip implant
4681553|NCT03357432|collagen|collagen
4681554|NCT03357432|gelatin|gelatin
4681555|NCT03357432|PINP|pinp
4681556|NCT03357406|implant|implant
4681557|NCT03357406|piezoelectric|piezoelectric
4681558|NCT03357406|drills|drills
4681559|NCT03357406|immediate loading|immediate loading
4681560|NCT03357341|electronic health record|electronic health record
4681561|NCT03357341|Pilot|pilot
4681562|NCT03357341|COPD|copd
4681563|NCT03357341|Sensor|sensor
4681564|NCT03357341|Asthma|asthma
4681565|NCT03357328|Phototherapy|phototherapy
4681566|NCT03357328|Nursing home|nursing home
4681567|NCT03357328|Light therapy|light therapy
4681568|NCT03357250|biomarkers|biomarkers
4681569|NCT03357185|Femoral bifurcation|femoral bifurcation
4681570|NCT03357185|Peripheral arterial disease|peripheral arterial disease
4681571|NCT03357185|Vascular surgery|vascular surgery
4681572|NCT03357185|Eversion|eversion
4681573|NCT03357185|Open surgery|open surgery
4681574|NCT03357172|Immune recovery|immune recovery
4681575|NCT03357172|Immunomodulatory cells|immunomodulatory cells
4681576|NCT03357172|GVHD|gvhd
4681577|NCT03357172|GVL|gvl
4681578|NCT03357159|anti thymocyte globulin|anti thymocyte globulin
4681579|NCT03357159|cyclophospamide|cyclophospamide
4681580|NCT03357159|graft-versus-host disease|graft-versus-host disease
4681581|NCT03357159|stem cell transplantation|stem cell transplantation
4681582|NCT03357120|Breast Cancer|breast cancer
4681583|NCT03357120|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
4681584|NCT03357120|Circulating tumor DNA|circulating tumor dna
4681585|NCT03357094|Pulmonary ventilation|pulmonary ventilation
4681586|NCT03357094|Pulmonary perfusion|pulmonary perfusion
4681587|NCT03357094|Single Photon Emission Computed Tomography|single photon emission computed tomography
4681588|NCT03357055|tourniquet, pain, ketamine|tourniquet, pain, ketamine
4681589|NCT03357029|Chronic pancreatitis|chronic pancreatitis
4681590|NCT03357029|Vagal nerve stimulation|vagal nerve stimulation
4681591|NCT03357029|Visceral Pain|visceral pain
4681592|NCT03357016|interval training|interval training
4681593|NCT03357016|abdominal fat mass|abdominal fat mass
4681594|NCT03357016|postmenopausal women|postmenopausal women
4681595|NCT03357016|lipids oxidation|lipids oxidation
4681596|NCT03356964|endometrial receptivity progesterone elevation|endometrial receptivity progesterone elevation
4681597|NCT03356925|Xpert®MTB/RIF|xpert®mtb/rif
4681598|NCT03356925|Xpert®MTB/RIF Ultra|xpert®mtb/rif ultra
4681599|NCT03356886|Chronic Low Back Pain|chronic low back pain
4681600|NCT03356886|Pain Neuroscience Education|pain neuroscience education
4681601|NCT03356886|Spinal Manipulative Techniques|spinal manipulative techniques
4681602|NCT03356886|Psychosocial Factors|psychosocial factors
4681603|NCT03356860|breast cancer|breast cancer
4681604|NCT03356860|immunotherapy|immunotherapy
4681605|NCT03356860|anti-PD-L1|anti-pd-l1
4681606|NCT03356834|Chronic hepatitis B|chronic hepatitis b
4681607|NCT03356834|Efficacy, safety, and tolerability|efficacy, safety, and tolerability
4681608|NCT03356834|Tenofovir alafenamide|tenofovir alafenamide
4681609|NCT03356808|Lung cancer|lung cancer
4681610|NCT03356808|CAR-T|car-t
4681611|NCT03356808|mesothelin|mesothelin
4681612|NCT03356808|Muc1|muc1
4681613|NCT03356808|GD2|gd2
4681614|NCT03356808|MAGE-A4|mage-a4
4681615|NCT03356795|Cervical cancer|cervical cancer
4681616|NCT03356795|CAR-T|car-t
4681617|NCT03356795|GD2|gd2
4681618|NCT03356795|PSMA|psma
4681619|NCT03356795|Muc1|muc1
4681620|NCT03356795|Mesothelin|mesothelin
4681621|NCT03356795|HPV|hpv
4681622|NCT03356795|solid tumor|solid tumor
4681623|NCT03356782|CART|cart
4681624|NCT03356782|PD-1|pd-1
4681625|NCT03356782|PDL-1|pdl-1
4681626|NCT03356782|CTLA-4|ctla-4
4681627|NCT03356782|sarcoma|sarcoma
4681628|NCT03356782|solid tumor|solid tumor
4681629|NCT03356769|refractory seizure|refractory seizure
4681630|NCT03356769|cognitive impairment|cognitive impairment
4681631|NCT03356769|electroencephalography improvement|electroencephalography improvement
4681632|NCT03356769|seizure reduction|seizure reduction
4681633|NCT03356769|seizure free|seizure free
4681634|NCT03356769|aspirin|aspirin
4681635|NCT03356743|lobectomy|lobectomy
4681636|NCT03356730|Implants|implants
4681637|NCT03356730|Vitamin D|vitamin d
4681638|NCT03356730|Osseointegration|osseointegration
4681639|NCT03356730|Histomorphometric|histomorphometric
4681640|NCT03356717|simulation, high-fidelity, observer tool; learning outcomes|simulation, high-fidelity, observer tool; learning outcomes
4681641|NCT03356704|adults|adults
4681642|NCT03356691|Spiritist pass|spiritist pass
4681643|NCT03356691|adult|adult
4681644|NCT03356691|laying of hands|laying of hands
4681645|NCT03356665|diagnosis|diagnosis
4681646|NCT03356665|sensitivity|sensitivity
4681647|NCT03356665|specificity|specificity
4681648|NCT03356665|rapid diagnostic test|rapid diagnostic test
4681649|NCT03356665|molecular biology|molecular biology
4681650|NCT03356665|LAMP|lamp
4681651|NCT03356665|RT-PCR|rt-pcr
4681652|NCT03356665|serology|serology
4681653|NCT03356665|ELISA|elisa
4681654|NCT03356665|immune trypanolysis|immune trypanolysis
4681655|NCT03356665|clinical symptom|clinical symptom
4681656|NCT03356652|Cardiac resynchronizaton therapy|cardiac resynchronizaton therapy
4681657|NCT03356652|Electrical activation mapping|electrical activation mapping
4681658|NCT03356652|Noninvasive|noninvasive
4681659|NCT03356652|Electrical dyssynchrony|electrical dyssynchrony
4681660|NCT03356639|Schizophrenia|schizophrenia
4681661|NCT03356639|ASP6981|asp6981
4681662|NCT03356639|Safety|safety
4681663|NCT03356639|Phase 1|phase 1
4681664|NCT03356626|fever, inflammation|fever, inflammation
4681665|NCT03356600|Brain Metastases|brain metastases
4681666|NCT03356587|NGS|ngs
4681667|NCT03356587|Nanostring|nanostring
4681668|NCT03356587|Biomarker Driven Umbrella Trial|biomarker driven umbrella trial
4681669|NCT03356587|abemaciclib|abemaciclib
4681670|NCT03356535|targeted metabolomics|targeted metabolomics
4681671|NCT03356535|multivariate statistics|multivariate statistics
4681672|NCT03356535|metabolic signatures|metabolic signatures
4681673|NCT03356535|partial least squares|partial least squares
4681674|NCT03356535|healthy lifestyle index|healthy lifestyle index
4681675|NCT03356535|EPIC|epic
4681676|NCT03356483|Psilocybin|psilocybin
4681677|NCT03356470|melanoma|melanoma
4681678|NCT03356470|antimelanoma T cells|antimelanoma t cells
4681679|NCT03356444|abiraterone|abiraterone
4681680|NCT03356444|docetaxel|docetaxel
4681681|NCT03356444|Castration-resistant Prostate Cancer|castration-resistant prostate cancer
4681682|NCT03356431|Exercise therapy|exercise therapy
4681683|NCT03356431|Physical Therapy|physical therapy
4681684|NCT03356418|Exercise|exercise
4681685|NCT03356418|Vibration|vibration
4681686|NCT03356418|Torque|torque
4681687|NCT03356418|Aging|aging
4681688|NCT03356392|acute stroke, thrombectomy, endovascular treatment|acute stroke, thrombectomy, endovascular treatment
4681689|NCT03356379|Diagnosis|diagnosis
4681690|NCT03356379|Peripheral artery disease|peripheral artery disease
4681691|NCT03356379|sports|sports
4681692|NCT03356314|superior mesenteric artery|superior mesenteric artery
4681693|NCT03356314|superior mesenteric vein|superior mesenteric vein
4681694|NCT03356314|intestinal malrotation|intestinal malrotation
4681695|NCT03356314|volvulus|volvulus
4681696|NCT03356314|pregnant women|pregnant women
4681697|NCT03356314|mesenteric vessels position|mesenteric vessels position
4681698|NCT03356314|postnatal diagnosis|postnatal diagnosis
4681699|NCT03356314|prophylactic surgery|prophylactic surgery
4681700|NCT03356301|Aortic compliance|aortic compliance
4681701|NCT03356301|Aortic distensibility|aortic distensibility
4681702|NCT03356301|CMR|cmr
4681703|NCT03356301|Triathletes|triathletes
4681704|NCT03356301|Ventriculo-atrial coupling|ventriculo-atrial coupling
4682198|NCT03352869|Metformin|metformin
4681705|NCT03356288|Capnography, Diagnosis. Breathlessness, Exacerbations, Device|capnography, diagnosis. breathlessness, exacerbations, device
4681706|NCT03356262|Cohort study|cohort study
4681707|NCT03356249|Sepsis|sepsis
4681708|NCT03356249|Septic shock|septic shock
4681709|NCT03356249|Next-Generation Sequencing|next-generation sequencing
4681710|NCT03356249|Bacteremia|bacteremia
4681711|NCT03356223|Clinical Trial|clinical trial
4681712|NCT03356223|Phase II|phase ii
4681713|NCT03356223|Monotherapy|monotherapy
4681714|NCT03356223|Abemaciclib|abemaciclib
4681715|NCT03356223|Homozygous deletion of CDKN2A|homozygous deletion of cdkn2a
4681716|NCT03356223|Amplification of CCND1|amplification of ccnd1
4681717|NCT03356223|Amplification of CDK6|amplification of cdk6
4681718|NCT03356223|Multicenter Trial|multicenter trial
4681719|NCT03356158|Metastatic Colorectal Cancer,|metastatic colorectal cancer,
4681720|NCT03356158|Recombinant Anti-EGFR Monoclonal Antibody|recombinant anti-egfr monoclonal antibody
4681721|NCT03356145|paracervical block|paracervical block
4681722|NCT03356145|abortion|abortion
4681723|NCT03356145|dilation and evacuation|dilation and evacuation
4681724|NCT03356145|cervical preparation|cervical preparation
4681725|NCT03356132|breast implant|breast implant
4681726|NCT03356132|complication|complication
4681727|NCT03356132|satisfaction|satisfaction
4681728|NCT03356132|quality of life|quality of life
4681729|NCT03356132|augmentation|augmentation
4681730|NCT03356132|textured|textured
4681731|NCT03356132|polyurethane|polyurethane
4681732|NCT03356119|Contraceptive Implant|contraceptive implant
4681733|NCT03356106|Obstructive sleep apnea|obstructive sleep apnea
4681734|NCT03356106|Pre-Eclampsia|pre-eclampsia
4681735|NCT03356093|head and neck cancer, symptom cluster, change, radiotherapy|head and neck cancer, symptom cluster, change, radiotherapy
4681736|NCT03356080|decitabine|decitabine
4681737|NCT03356080|retinoid acid|retinoid acid
4681738|NCT03356080|cytarabine C|cytarabine c
4681739|NCT03356080|Granulocyte Colony Stimulating Factor|granulocyte colony stimulating factor
4681740|NCT03356080|acute myeloid leukemia|acute myeloid leukemia
4681741|NCT03356080|Myelodysplastic Syndrome|myelodysplastic syndrome
4681742|NCT03356028|Trauma|trauma
4681743|NCT03356028|Psychiatric Disorder|psychiatric disorder
4681744|NCT03356028|mass trauma|mass trauma
4681745|NCT03356015|Polyp detection rate|polyp detection rate
4681746|NCT03356015|Adenoma detection rate|adenoma detection rate
4681747|NCT03356015|Boston Bowel Preparation Scale|boston bowel preparation scale
4681748|NCT03355989|Conditional Cash Transfer|conditional cash transfer
4681749|NCT03355989|Immunization coverage|immunization coverage
4681750|NCT03355989|Immunization reminder|immunization reminder
4681751|NCT03355976|recurrent|recurrent
4681752|NCT03355976|advanced|advanced
4681753|NCT03355976|metastatitic|metastatitic
4681754|NCT03355937|unexplained infertility|unexplained infertility
4681755|NCT03355937|recurrent implantation failure|recurrent implantation failure
4681756|NCT03355885|early onset pneumonia|early onset pneumonia
4681757|NCT03355885|out-of-hospital cardiac arrest|out-of-hospital cardiac arrest
4681758|NCT03355885|prognosis|prognosis
4681759|NCT03355885|antibiotic|antibiotic
4681760|NCT03355859|Non Hodgkin Lymphoma|non hodgkin lymphoma
4681761|NCT03355859|CD19-targeted chimeric antigen receptor|cd19-targeted chimeric antigen receptor
4681762|NCT03355859|JWCAR029|jwcar029
4681763|NCT03355846|Anal Fissure|anal fissure
4681764|NCT03355846|local therapy|local therapy
4681765|NCT03355846|pain|pain
4681766|NCT03355846|defecation|defecation
4681767|NCT03355846|bleeding|bleeding
4681768|NCT03355820|Immune response|immune response
4681769|NCT03355820|Cervarix|cervarix
4681770|NCT03355820|Persistence|persistence
4681771|NCT03355820|Chinese|chinese
4681772|NCT03355820|Human papillomavirus|human papillomavirus
4681773|NCT03355807|sleeve gastrectomy|sleeve gastrectomy
4681774|NCT03355807|magnesium sulfate|magnesium sulfate
4681775|NCT03355807|postoperative pain|postoperative pain
4681776|NCT03355807|bariatric surgery|bariatric surgery
4681777|NCT03355794|DIPG|dipg
4681778|NCT03355794|High Grade Glioma|high grade glioma
4681779|NCT03355794|ribociclib|ribociclib
4681780|NCT03355794|everolimus|everolimus
4681781|NCT03355781|childhood trauma|childhood trauma
4681782|NCT03355781|candidate gene expression|candidate gene expression
4681783|NCT03355781|cerebral morphology|cerebral morphology
4681784|NCT03355781|schizophrenic symptomatology|schizophrenic symptomatology
4681785|NCT03355781|conceptual framework of stress vulnerability|conceptual framework of stress vulnerability
4681786|NCT03355768|Romidepsin|romidepsin
4681787|NCT03355768|Pralatrexate|pralatrexate
4681788|NCT03355768|PTCL|ptcl
4681789|NCT03355768|Peripheral T-cell Lymphoma|peripheral t-cell lymphoma
4681790|NCT03355742|XIENCE|xience
4681791|NCT03355742|High bleeding risk (HBR)|high bleeding risk (hbr)
4681792|NCT03355742|Dual antiplatelet therapy (DAPT)|dual antiplatelet therapy (dapt)
4681793|NCT03355742|Coronary Artery Disease|coronary artery disease
4681794|NCT03355742|Drug eluting stent (DES)|drug eluting stent (des)
4681795|NCT03355690|thrombectomy|thrombectomy
4681796|NCT03355690|thrombolysis|thrombolysis
4681797|NCT03355690|Health-economic status|health-economic status
4681798|NCT03355690|Outcome after stroke|outcome after stroke
4681799|NCT03355677|Case finding|case finding
4681800|NCT03355677|complex case management|complex case management
4681801|NCT03355664|Malaria, Falciparum|malaria, falciparum
4681802|NCT03355664|Malaria|malaria
4681803|NCT03355664|Protozoan Infections|protozoan infections
4681804|NCT03355664|Lumefantrine|lumefantrine
4681805|NCT03355664|Artemether|artemether
4681806|NCT03355664|Amodiaquine|amodiaquine
4681807|NCT03355664|Piperaquine|piperaquine
4681808|NCT03355664|Artemether-lumefantrine combination|artemether-lumefantrine combination
4681809|NCT03355664|Artemisinins|artemisinins
4681810|NCT03355664|Dihydroartemisinin|dihydroartemisinin
4681811|NCT03355664|Mefloquine|mefloquine
4681812|NCT03355664|Artemisinin|artemisinin
4681813|NCT03355664|Antimalarials|antimalarials
4681814|NCT03355664|Antiparasitic Agents|antiparasitic agents
4681815|NCT03355664|Anti-Infective Agents|anti-infective agents
4681816|NCT03355664|ACT|act
4681817|NCT03355664|TACT|tact
4681818|NCT03355664|Triple ACT(s)|triple act(s)
4681819|NCT03355664|Resistance|resistance
4681820|NCT03355664|Antimalarial resistance|antimalarial resistance
4681821|NCT03355664|Cardiotoxicity|cardiotoxicity
4681822|NCT03355664|Safety|safety
4681823|NCT03355664|Tolerability|tolerability
4681824|NCT03355664|Efficacy|efficacy
4681825|NCT03355651|Anterior Cruciate Ligament Tears|anterior cruciate ligament tears
4681826|NCT03355651|Dietary Supplementations|dietary supplementations
4681827|NCT03355651|Plasma Rich Proteins|plasma rich proteins
4681828|NCT03355651|Collagen|collagen
4681829|NCT03355651|Chondroitin Sulfate|chondroitin sulfate
4681830|NCT03355651|Hyaluronic Acid|hyaluronic acid
4681831|NCT03355625|Flow Cytometry|flow cytometry
4681832|NCT03355625|eCPR|ecpr
4681833|NCT03355625|Extracorporeal Life Support|extracorporeal life support
4681834|NCT03355586|Lung diseases|lung diseases
4681835|NCT03355586|Cancer|cancer
4681836|NCT03355586|Interventional pulmonology|interventional pulmonology
4681837|NCT03355586|Peripheral nodule|peripheral nodule
4681838|NCT03355573|Bimekizumab|bimekizumab
4681839|NCT03355573|Ankylosing Spondylitis|ankylosing spondylitis
4681840|NCT03355573|AS|as
4681841|NCT03355534|dexmedetomidine|dexmedetomidine
4681842|NCT03355534|general anesthesia|general anesthesia
4681843|NCT03355534|cerebral aneurysm|cerebral aneurysm
4681844|NCT03355521|functionality|functionality
4681845|NCT03355521|gait|gait
4681846|NCT03355521|kinematics|kinematics
4681847|NCT03355521|electromyographic activity|electromyographic activity
4681848|NCT03355521|depressive symptoms|depressive symptoms
4681849|NCT03355521|quality of life|quality of life
4681850|NCT03355495|Colonoscopy|colonoscopy
4681851|NCT03355495|Cecal Intubation Rate|cecal intubation rate
4681852|NCT03355456|Persistent atrial fibrillation|persistent atrial fibrillation
4681853|NCT03355456|Medication refractory atrial fibrillation|medication refractory atrial fibrillation
4681854|NCT03355456|Pulmonary vein isolation procedure|pulmonary vein isolation procedure
4681855|NCT03355456|Low voltage directed ablation|low voltage directed ablation
4681856|NCT03355443|Colonoscopy|colonoscopy
4681857|NCT03355443|Lower Gastrointestinal Tract|lower gastrointestinal tract
4681858|NCT03355443|Re-examination|re-examination
4681859|NCT03355443|Retroflexion|retroflexion
4681860|NCT03355391|SCREENING|screening
4681861|NCT03355391|RISK FACTOR|risk factor
4681862|NCT03355365|Mesenchymal Stem Cells|mesenchymal stem cells
4681863|NCT03355365|Neural Progenitors|neural progenitors
4681864|NCT03355365|Autologous|autologous
4681865|NCT03355365|Bone Marrow|bone marrow
4681866|NCT03355365|Multiple Sclerosis|multiple sclerosis
4681867|NCT03355352|Zalviso|zalviso
4681868|NCT03355352|sufentanyl|sufentanyl
4681869|NCT03355352|PCA|pca
4681870|NCT03355352|Dipidolor|dipidolor
4681871|NCT03355339|Balance|balance
4681872|NCT03355339|Dual-task|dual-task
4681873|NCT03355339|King-Devick Test|king-devick test
4681874|NCT03355339|Saccades|saccades
4681875|NCT03355339|Binasal Occlusion|binasal occlusion
4681876|NCT03355313|saliva|saliva
4681877|NCT03355313|Low-level light therapy|low-level light therapy
4681878|NCT03355313|salivary glands|salivary glands
4681879|NCT03355274|Transcutaneous Oximetry|transcutaneous oximetry
4681880|NCT03355248|postpartum|postpartum
4681881|NCT03355248|postoperative cesarean pain management|postoperative cesarean pain management
4681882|NCT03355248|opioid requirements|opioid requirements
4681883|NCT03355222|complementary feeding|complementary feeding
4681884|NCT03355222|calcium|calcium
4681885|NCT03355209|LGS|lgs
4681886|NCT03355196|Osteoarthritic patients|osteoarthritic patients
4681887|NCT03355196|Cartilage|cartilage
4681888|NCT03355196|Safety|safety
4681889|NCT03355183|isokinetics|isokinetics
4681890|NCT03355183|knee|knee
4681891|NCT03355157|Palbociclib|palbociclib
4681892|NCT03355157|Endocrine Therapy|endocrine therapy
4681893|NCT03355157|Chemotherapy|chemotherapy
4681894|NCT03355157|Real world setting|real world setting
4681895|NCT03355157|Electronic patient-reported outcome|electronic patient-reported outcome
4681896|NCT03355157|Daily Monitoring Treatment Impact|daily monitoring treatment impact
4681897|NCT03355157|Health care utilization (call tracking, geofencing)|health care utilization (call tracking, geofencing)
4681898|NCT03355105|Neuromuscular disease|neuromuscular disease
4681899|NCT03355066|Wnt pathway|wnt pathway
4681900|NCT03355066|Wnt inhibition|wnt inhibition
4681901|NCT03355066|SM08502|sm08502
4681902|NCT03355040|shoulder dystocia|shoulder dystocia
4681903|NCT03355040|maternal and neonatal morbidity|maternal and neonatal morbidity
4681904|NCT03355027|Low Density Lipoprotein Cholesterol (LDL)|low density lipoprotein cholesterol (ldl)
4681905|NCT03355027|PCSK9|pcsk9
4681906|NCT03355027|Alirocumab|alirocumab
4681907|NCT03355027|Flow Mediated Dilatation|flow mediated dilatation
4681908|NCT03355027|Arterial Stiffness|arterial stiffness
4681909|NCT03355027|Carotid Intima Media Thickness|carotid intima media thickness
4681910|NCT03355027|Inflammation|inflammation
4681911|NCT03355027|Endothelial function|endothelial function
4681912|NCT03355027|FDG PET-CT|fdg pet-ct
4681913|NCT03355027|PET-MR|pet-mr
4681914|NCT03355027|Ezetimibe|ezetimibe
4681915|NCT03354962|Melanoma|melanoma
4681916|NCT03354962|Immune checkpoint|immune checkpoint
4681917|NCT03354962|Nivolumab|nivolumab
4681918|NCT03354962|Ipilimumab|ipilimumab
4681919|NCT03354962|Abscopal effect|abscopal effect
4681920|NCT03354962|Stereotactic radiotherapy|stereotactic radiotherapy
4681921|NCT03354962|PD-1|pd-1
4681922|NCT03354962|CTLA-4|ctla-4
4681923|NCT03354949|Wheelchair|wheelchair
4681924|NCT03354949|Hemiplegia|hemiplegia
4681925|NCT03354949|Stroke|stroke
4681926|NCT03354949|Postural control|postural control
4681927|NCT03354949|Pain|pain
4681928|NCT03354910|Live Donor Kidney Transplantation|live donor kidney transplantation
4681929|NCT03354910|LDKT|ldkt
4681930|NCT03354910|Disparity|disparity
4681931|NCT03354910|African American|african american
4681932|NCT03354910|Education|education
4681933|NCT03354910|Patient Support|patient support
4681934|NCT03354897|stratified medicine, UMOD, torasemide|stratified medicine, umod, torasemide
4681935|NCT03354858|follicle flushing|follicle flushing
4681936|NCT03354858|direct follicle aspiration|direct follicle aspiration
4681937|NCT03354858|fertilization rate|fertilization rate
4681938|NCT03354858|maturation|maturation
4681939|NCT03354754|Intra-abdominal infection|intra-abdominal infection
4681940|NCT03354754|LYS228|lys228
4681941|NCT03354754|beta-lactam antibiotics|beta-lactam antibiotics
4681942|NCT03354754|creatinine clearance|creatinine clearance
4681943|NCT03354754|enterobacteriaceae|enterobacteriaceae
4681944|NCT03354676|adipokines, metabolic syndrome, obese children|adipokines, metabolic syndrome, obese children
4681945|NCT03354663|paroxysmal atrial fibrillation|paroxysmal atrial fibrillation
4681946|NCT03354663|PAF|paf
4681947|NCT03354663|ablation|ablation
4681948|NCT03354585|Mindfulness|mindfulness
4681949|NCT03354585|fMRI|fmri
4681950|NCT03354585|Pain|pain
4681951|NCT03354585|low back|low back
4681952|NCT03354585|radicular|radicular
4681953|NCT03354559|coagulopathy|coagulopathy
4681954|NCT03354559|trauma|trauma
4681955|NCT03354559|bleeding|bleeding
4681956|NCT03354559|fibrinogen|fibrinogen
4681957|NCT03354559|transfusion|transfusion
4681958|NCT03354507|topiramate|topiramate
4681959|NCT03354507|epilepsy|epilepsy
4681960|NCT03354507|sodium bicarbonate|sodium bicarbonate
4681961|NCT03354507|urine alkalinization|urine alkalinization
4681962|NCT03354494|Oocyte donors|oocyte donors
4681963|NCT03354494|Ovarian stimulation|ovarian stimulation
4681964|NCT03354494|Desogestrel|desogestrel
4681965|NCT03354494|Corifolitropina alfa|corifolitropina alfa
4681966|NCT03354494|Gonadotropins|gonadotropins
4681967|NCT03354481|Dyscalculia|dyscalculia
4681968|NCT03354468|Prevention and Control|prevention and control
4681969|NCT03354468|Patient Safety|patient safety
4681970|NCT03354468|Aged|aged
4681971|NCT03354468|Risk Management|risk management
4681972|NCT03354442|Class III treatment|class iii treatment
4681973|NCT03354442|Modified Fixed Mandibular Retractor Appliance|modified fixed mandibular retractor appliance
4681974|NCT03354442|RCT|rct
4681975|NCT03354429|Acute ischaemic stroke; Transient Ischaemic Attack (TIA); Stroke|acute ischaemic stroke; transient ischaemic attack (tia); stroke
4681976|NCT03354416|Imaging-Based Prognostic Markers|imaging-based prognostic markers
4681977|NCT03354416|Multiparametric MRI (mpMRI)|multiparametric mri (mpmri)
4681978|NCT03354416|Translation of Imaging into Treatment Decisions|translation of imaging into treatment decisions
4681979|NCT03354416|Decision-Support System|decision-support system
4681980|NCT03354416|Artificial Intelligence Research|artificial intelligence research
4681981|NCT03354403|XLRS|xlrs
4681982|NCT03354403|RS1|rs1
4681983|NCT03354403|Carrier|carrier
4681984|NCT03354390|genetically modified lymphocytes|genetically modified lymphocytes
4681985|NCT03354390|tumor antigens|tumor antigens
4681986|NCT03354390|T cell receptor immunotherapy|t cell receptor immunotherapy
4681987|NCT03354390|genomic retroviral elements|genomic retroviral elements
4681988|NCT03354351|Stepped-care model|stepped-care model
4681989|NCT03354351|Men's health|men's health
4681990|NCT03354351|Prevention|prevention
4681991|NCT03354351|Early treatment|early treatment
4681992|NCT03354351|Psychotherapy|psychotherapy
4681993|NCT03354338|Periodontal disease|periodontal disease
4681994|NCT03354338|Bacteremia|bacteremia
4681995|NCT03354338|Amoxicilline|amoxicilline
4681996|NCT03354338|Inflamatory markers|inflamatory markers
4681997|NCT03354325|Office Visits|office visits
4681998|NCT03354312|scaling and root planing|scaling and root planing
4681999|NCT03354312|topical anesthesia|topical anesthesia
4682000|NCT03354299|malnutrition|malnutrition
4682001|NCT03354299|liver cirrhosis|liver cirrhosis
4682002|NCT03354299|coconut milk|coconut milk
4682003|NCT03354286|670G|670g
4682004|NCT03354286|Hybrid closed-loop system|hybrid closed-loop system
4682005|NCT03354286|pediatric|pediatric
4682006|NCT03354234|Gz accelerations|gz accelerations
4682007|NCT03354234|Head up tilt (HUT) test|head up tilt (hut) test
4682008|NCT03354234|Lower body negative pressure (LBNP) method|lower body negative pressure (lbnp) method
4682009|NCT03354234|Physiological parameters|physiological parameters
4682010|NCT03354234|Variable gravitational stimuli|variable gravitational stimuli
4682011|NCT03354221|EoE|eoe
4682012|NCT03354208|biomarkers|biomarkers
4682013|NCT03354182|Mandibular type II furcations|mandibular type ii furcations
4682014|NCT03354182|Periodontal treatment|periodontal treatment
4682015|NCT03354182|Demineralized bovine bone mineral|demineralized bovine bone mineral
4682016|NCT03354182|Collagen membrane|collagen membrane
4682017|NCT03354169|Metabolism|metabolism
4682018|NCT03354169|Eating|eating
4682019|NCT03354169|Circadian Rhythms|circadian rhythms
4682020|NCT03354143|Dementia|dementia
4682021|NCT03354143|Alzheimer's Disease|alzheimer's disease
4682022|NCT03354143|Blood Pressure|blood pressure
4682023|NCT03354143|Cognitive Function|cognitive function
4682024|NCT03354143|Magnetic Resonance Imaging|magnetic resonance imaging
4682025|NCT03354078|Cesarean section|cesarean section
4682026|NCT03354078|Wound infection|wound infection
4682027|NCT03354078|Gapping|gapping
4682028|NCT03354065|pancreatitis|pancreatitis
4682029|NCT03354065|mild|mild
4682030|NCT03354065|biliary|biliary
4682031|NCT03354065|referring|referring
4682032|NCT03354052|Pain|pain
4682033|NCT03354052|rTMS|rtms
4682034|NCT03354052|Rehabilitation|rehabilitation
4682035|NCT03354039|DMD|dmd
4682036|NCT03354026|Blood-breaking Decotion|blood-breaking decotion
4682037|NCT03354013|AOA|aoa
4682038|NCT03354013|embryo developmental problems|embryo developmental problems
4682039|NCT03354013|genetic screening|genetic screening
4682040|NCT03354013|calcium pattern analysis|calcium pattern analysis
4682041|NCT03354000|Patient Portal|patient portal
4682042|NCT03354000|Healthcare disparities|healthcare disparities
4682043|NCT03354000|Safety net healthcare system|safety net healthcare system
4682044|NCT03353987|Post-op cognitive dysfunction|post-op cognitive dysfunction
4682045|NCT03353987|Cognitive training|cognitive training
4682046|NCT03353987|Logbook|logbook
4682047|NCT03353987|Elderly|elderly
4682048|NCT03353974|Multiple Sclerosis|multiple sclerosis
4682049|NCT03353974|Video game therapy|video game therapy
4682050|NCT03353974|Balance|balance
4682051|NCT03353974|Cognitive functions|cognitive functions
4682052|NCT03353961|NSSI|nssi
4682053|NCT03353948|Polycystic Ovary Syndrome|polycystic ovary syndrome
4682054|NCT03353948|Obesity|obesity
4682055|NCT03353948|Infertility|infertility
4682056|NCT03353948|IVF|ivf
4682057|NCT03353935|surgery|surgery
4682058|NCT03353935|pelvic function|pelvic function
4682059|NCT03353922|cognitive function|cognitive function
4682060|NCT03353909|Intrauterine adhesion|intrauterine adhesion
4682061|NCT03353909|Delayed miscarriage|delayed miscarriage
4682062|NCT03353909|hyaluronan gel|hyaluronan gel
4682063|NCT03353831|Recurrent Ovarian Cancer|recurrent ovarian cancer
4682064|NCT03353831|Atezolizumab|atezolizumab
4682065|NCT03353831|Bevacizumab|bevacizumab
4682066|NCT03353779|Percutaneous coronary intervention|percutaneous coronary intervention
4682067|NCT03353779|antiplatelet|antiplatelet
4682068|NCT03353779|platelet function|platelet function
4682069|NCT03353779|prognosis|prognosis
4682070|NCT03353766|Early Orthodontic treatment|early orthodontic treatment
4682071|NCT03353766|Orthodontic treatment outcome|orthodontic treatment outcome
4682072|NCT03353766|Crossbite treatment|crossbite treatment
4682073|NCT03353727|Orthoptic rehabilitation|orthoptic rehabilitation
4682074|NCT03353727|low vision|low vision
4682075|NCT03353727|eye tracker|eye tracker
4682076|NCT03353727|tactile device|tactile device
4682077|NCT03353688|Parkinson's|parkinson's
4682078|NCT03353688|Parkinson Disease|parkinson disease
4682079|NCT03353675|Nivolumab|nivolumab
4682080|NCT03353675|Therapeutic Vaccine|therapeutic vaccine
4682081|NCT03353662|bio fortification|bio fortification
4682082|NCT03353623|Immersive Virtual Environments|immersive virtual environments
4682083|NCT03353623|Wearable Haptic Devices|wearable haptic devices
4682084|NCT03353623|Neuromotor Impairments|neuromotor impairments
4682085|NCT03353623|Rehabilitation|rehabilitation
4682086|NCT03353623|Serious Game|serious game
4682087|NCT03353623|Randomized Controlled Trial|randomized controlled trial
4682088|NCT03353610|Tachycardia|tachycardia
4682089|NCT03353610|PSVT episodes|psvt episodes
4682090|NCT03353584|Virtual reality|virtual reality
4682091|NCT03353584|Pain|pain
4682092|NCT03353584|Nonpharmacological|nonpharmacological
4682093|NCT03353493|Mindfulness-Based Cognitive Therapy|mindfulness-based cognitive therapy
4682094|NCT03353493|Neural, psychological and molecular mechanisms|neural, psychological and molecular mechanisms
4682095|NCT03353480|Azithromycin tablet, Bioequivalence, Phase I, Chinese, Healthy Subjects|azithromycin tablet, bioequivalence, phase i, chinese, healthy subjects
4682096|NCT03353454|Cholestasis|cholestasis
4682097|NCT03353454|Maralixibat|maralixibat
4682098|NCT03353454|Mutation|mutation
4682299|NCT03352154|cochlear implant|cochlear implant
4682099|NCT03353441|Verbal Learning and Memory Test (VLMT)|verbal learning and memory test (vlmt)
4682100|NCT03353441|Stroop Test|stroop test
4682101|NCT03353441|Attention|attention
4682102|NCT03353441|Working Memory|working memory
4682103|NCT03353441|Learning and recognition|learning and recognition
4682104|NCT03353441|CogTrack|cogtrack
4682105|NCT03353428|Lung cancer|lung cancer
4682106|NCT03353428|Cytotoxic lymphocyte|cytotoxic lymphocyte
4682107|NCT03353428|LC-CTL|lc-ctl
4682108|NCT03353428|NSCLC|nsclc
4682109|NCT03353415|Post-bariatric Hypoglycemia;|post-bariatric hypoglycemia;
4682110|NCT03353402|Melanoma|melanoma
4682111|NCT03353402|Fecal Microbiota Transplantation|fecal microbiota transplantation
4682112|NCT03353402|Immunotherapy|immunotherapy
4682113|NCT03353389|Acute Kidney Injury|acute kidney injury
4682114|NCT03353389|Hospital-acquired Acute Kidney Injury|hospital-acquired acute kidney injury
4682115|NCT03353389|Community-acquired Acute Kidney Injury|community-acquired acute kidney injury
4682116|NCT03353389|Acute Renal Failure|acute renal failure
4682117|NCT03353363|cesarean delivery|cesarean delivery
4682118|NCT03353363|liposomal bupivacaine|liposomal bupivacaine
4682119|NCT03353363|Exparel|exparel
4682120|NCT03353363|bupivacaine|bupivacaine
4682121|NCT03353363|wound infiltration|wound infiltration
4682122|NCT03353337|neurocognition|neurocognition
4682123|NCT03353337|prognosis|prognosis
4682124|NCT03353337|aerobic exercise|aerobic exercise
4682125|NCT03353311|ERAS|eras
4682126|NCT03353311|Fast-track|fast-track
4682127|NCT03353311|colorectal surgery|colorectal surgery
4682128|NCT03353311|immuno-nutrition|immuno-nutrition
4682129|NCT03353298|Uric acid|uric acid
4682130|NCT03353298|Left ventricular mass|left ventricular mass
4682131|NCT03353298|Nephrectomy|nephrectomy
4682132|NCT03353298|Allopurinol|allopurinol
4682133|NCT03353298|Magnetic resonance imaging|magnetic resonance imaging
4682134|NCT03353233|iPACK|ipack
4682135|NCT03353233|Interspace between the Popliteal Artery and Capsule of the Knee|interspace between the popliteal artery and capsule of the knee
4682136|NCT03353233|Posterior Capsule block|posterior capsule block
4682137|NCT03353233|Nerve Block|nerve block
4682138|NCT03353220|Overweight|overweight
4682139|NCT03353220|Obesity|obesity
4682140|NCT03353220|Weight Loss|weight loss
4682141|NCT03353220|Lorcaserin|lorcaserin
4682142|NCT03353220|Healthy Volunteers|healthy volunteers
4682143|NCT03353207|REM Sleep Without Atonia|rem sleep without atonia
4682144|NCT03353207|Dopamine transmission|dopamine transmission
4682145|NCT03353207|Neurodegeneration|neurodegeneration
4682146|NCT03353194|Cerebral Palsy|cerebral palsy
4682147|NCT03353194|Canada|canada
4682148|NCT03353194|Registry|registry
4682149|NCT03353181|Endoscopic Retrograde Cholangiopancreatography|endoscopic retrograde cholangiopancreatography
4682150|NCT03353181|endoscopic drainage|endoscopic drainage
4682151|NCT03353181|endoscopic nasobiliary drainage|endoscopic nasobiliary drainage
4682152|NCT03353181|stent|stent
4682153|NCT03353168|fear|fear
4682154|NCT03353168|anxiety|anxiety
4682155|NCT03353168|childbirth|childbirth
4682156|NCT03353168|pregnancy|pregnancy
4682157|NCT03353129|Quality Improvement|quality improvement
4682158|NCT03353129|Patient Safety|patient safety
4682159|NCT03353129|Outcome Improvements|outcome improvements
4682160|NCT03353077|Skin SCC|skin scc
4682161|NCT03353077|Skin Carcinoma, Squamous|skin carcinoma, squamous
4682162|NCT03353038|assistive technology|assistive technology
4682163|NCT03353038|3 Dimensional Printing|3 dimensional printing
4682164|NCT03353038|Self-Management|self-management
4682165|NCT03353025|non-invasive prolactinoma|non-invasive prolactinoma
4682166|NCT03353012|Immediate postpartum implant|immediate postpartum implant
4682167|NCT03353012|postpartum implant|postpartum implant
4682168|NCT03353012|implant contraception|implant contraception
4682169|NCT03353012|Etonogestrel|etonogestrel
4682170|NCT03353012|Levonorgestrel|levonorgestrel
4682171|NCT03352999|Refractory out-hospital cardiac arrest|refractory out-hospital cardiac arrest
4682172|NCT03352999|Extracorporeal Life Support|extracorporeal life support
4682173|NCT03352986|Sickle cell disease|sickle cell disease
4682174|NCT03352986|anemia|anemia
4682175|NCT03352986|Africa|africa
4682176|NCT03352934|avelumab|avelumab
4682177|NCT03352934|anti-PD-L1|anti-pd-l1
4682178|NCT03352934|neuroendocrine tumor|neuroendocrine tumor
4682179|NCT03352934|NET G3|net g3
4682180|NCT03352934|neuroendocrine carcinoma|neuroendocrine carcinoma
4682181|NCT03352934|NEC G3|nec g3
4682182|NCT03352921|clinical pilates|clinical pilates
4682183|NCT03352921|exercise|exercise
4682184|NCT03352921|Sagital Cervical Disorientation|sagital cervical disorientation
4682185|NCT03352921|Disorientation|disorientation
4682186|NCT03352921|Forward Head Posture|forward head posture
4682187|NCT03352908|Dysphagia|dysphagia
4682188|NCT03352908|Aspiration|aspiration
4682189|NCT03352908|YSP|ysp
4682190|NCT03352908|FEES|fees
4682191|NCT03352908|Swallow Problems|swallow problems
4682192|NCT03352895|Resveratrol|resveratrol
4682193|NCT03352895|chronic kidney disease|chronic kidney disease
4682194|NCT03352869|Polycystic Ovary Syndrome|polycystic ovary syndrome
4682195|NCT03352869|Overweight and Obesity|overweight and obesity
4682196|NCT03352869|Impaired Glucose Regulation|impaired glucose regulation
4682197|NCT03352869|Exenatide|exenatide
4682199|NCT03352856|Cereal allergy; barley starch, DBPC|cereal allergy; barley starch, dbpc
4682200|NCT03352830|household air pollution|household air pollution
4682201|NCT03352830|health promotion|health promotion
4682202|NCT03352830|clean cookstove adoption|clean cookstove adoption
4682203|NCT03352830|clean cookstove sustained use|clean cookstove sustained use
4682204|NCT03352765|Rituximab|rituximab
4682205|NCT03352765|Bendamustine|bendamustine
4682206|NCT03352765|Melphalan|melphalan
4682207|NCT03352765|Autologous Stem Cell Transplantation (ASCT)|autologous stem cell transplantation (asct)
4682208|NCT03352765|17-373|17-373
4682209|NCT03352752|virtual reality|virtual reality
4682210|NCT03352752|fractional laser|fractional laser
4682211|NCT03352752|scars|scars
4682212|NCT03352752|acute pain|acute pain
4682213|NCT03352752|anxiety score|anxiety score
4682214|NCT03352726|EPIT|epit
4682215|NCT03352726|Epicutaneous|epicutaneous
4682216|NCT03352726|Immunotherapy|immunotherapy
4682217|NCT03352726|Viaskin|viaskin
4682218|NCT03352713|self-regulation|self-regulation
4682219|NCT03352713|binge eating|binge eating
4682220|NCT03352713|smoking|smoking
4682221|NCT03352713|ecological momentary assessment|ecological momentary assessment
4682222|NCT03352713|mobile sensing|mobile sensing
4682223|NCT03352713|mHealth|mhealth
4682224|NCT03352687|Shoulder surgery|shoulder surgery
4682225|NCT03352687|Local regional anesthesia|local regional anesthesia
4682226|NCT03352674|insulin glargine|insulin glargine
4682227|NCT03352674|diabetes mellitus|diabetes mellitus
4682228|NCT03352674|immunogenicity|immunogenicity
4682229|NCT03352635|Ethnic Differences|ethnic differences
4682230|NCT03352622|PHARMACOGENOMICS|pharmacogenomics
4682231|NCT03352622|POLYMORPHISM|polymorphism
4682232|NCT03352609|TMS|tms
4682233|NCT03352609|rTMS|rtms
4682234|NCT03352609|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
4682235|NCT03352609|Smoking|smoking
4682236|NCT03352609|Nicotine|nicotine
4682237|NCT03352570|anastomotic leakage|anastomotic leakage
4682238|NCT03352570|fistula|fistula
4682239|NCT03352557|Mild cognitive impairment|mild cognitive impairment
4682240|NCT03352557|Alzheimer's disease|alzheimer's disease
4682241|NCT03352531|Anti-PD-1 monoclonal antibody|anti-pd-1 monoclonal antibody
4682242|NCT03352531|immunotherapy|immunotherapy
4682243|NCT03352531|immuno-oncology|immuno-oncology
4682244|NCT03352531|advanced solid tumors|advanced solid tumors
4682245|NCT03352466|Anthrax|anthrax
4682246|NCT03352440|Cerebral Palsy|cerebral palsy
4682247|NCT03352440|Virtual Reality Exposure Therapy|virtual reality exposure therapy
4682248|NCT03352440|Learning|learning
4682249|NCT03352440|Motor Activity|motor activity
4682250|NCT03352440|Motor Skills|motor skills
4682251|NCT03352414|HIPEC|hipec
4682252|NCT03352414|peritoneal carcinomatosis|peritoneal carcinomatosis
4682253|NCT03352401|Pulmonary aspiration, full stomach, gastric content inhalation, Mendelson syndrom|pulmonary aspiration, full stomach, gastric content inhalation, mendelson syndrom
4682254|NCT03352388|Older people|older people
4682255|NCT03352388|Nutrition|nutrition
4682256|NCT03352388|Snack|snack
4682257|NCT03352388|Dairy|dairy
4682258|NCT03352388|Protein|protein
4682259|NCT03352388|Berries|berries
4682260|NCT03352349|Terlipressinum|terlipressinum
4682261|NCT03352349|Portal Vein Pressure|portal vein pressure
4682262|NCT03352349|Liver Tumor Resection|liver tumor resection
4682263|NCT03352336|Atelectasis|atelectasis
4682264|NCT03352336|Oxygenation|oxygenation
4682265|NCT03352336|Venous admixture|venous admixture
4682266|NCT03352336|Computed Tomography|computed tomography
4682267|NCT03352336|Oxygenation test|oxygenation test
4682268|NCT03352310|umbilical cord blood|umbilical cord blood
4682269|NCT03352297|Post burn scar face|post burn scar face
4682270|NCT03352297|Unfiltered nanofat|unfiltered nanofat
4682271|NCT03352297|Adipose tissue growth factors|adipose tissue growth factors
4682272|NCT03352297|Adipose stem cells|adipose stem cells
4682273|NCT03352297|POSAS|posas
4682274|NCT03352297|Image J|image j
4682275|NCT03352297|Face|face
4682276|NCT03352284|Zirconia implant|zirconia implant
4682277|NCT03352284|One-piece|one-piece
4682278|NCT03352284|Monoblock|monoblock
4682279|NCT03352284|Single tooth|single tooth
4682280|NCT03352271|Incremental hemodialysis|incremental hemodialysis
4682281|NCT03352271|Precision medicine|precision medicine
4682282|NCT03352271|Individualized care|individualized care
4682283|NCT03352258|Alzheimer's Disease|alzheimer's disease
4682284|NCT03352258|Amyloid|amyloid
4682285|NCT03352258|Radiotherapy|radiotherapy
4682286|NCT03352219|Human immunodeficiency virus|human immunodeficiency virus
4682287|NCT03352219|Sexually transmitted disease|sexually transmitted disease
4682288|NCT03352219|African Americans|african americans
4682289|NCT03352219|Young adults|young adults
4682290|NCT03352219|Behavioral intervention|behavioral intervention
4682291|NCT03352219|Entertainment-Education|entertainment-education
4682292|NCT03352219|Serial drama|serial drama
4682293|NCT03352219|Sexual behavior|sexual behavior
4682294|NCT03352219|HIV testing|hiv testing
4682295|NCT03352219|Homophobia|homophobia
4682296|NCT03352219|Social cognitive theory|social cognitive theory
4682297|NCT03352206|Mass drug administration|mass drug administration
4682298|NCT03352206|Effectiveness|effectiveness
4682300|NCT03352154|Evoked Potential P300|evoked potential p300
4682301|NCT03352102|Electric Stimulation|electric stimulation
4682302|NCT03352102|Intensive Care Units|intensive care units
4682303|NCT03352102|Mechanical Ventilation|mechanical ventilation
4682304|NCT03352102|Ventilator Weaning|ventilator weaning
4682305|NCT03352089|Magnetic resonance imaging|magnetic resonance imaging
4682306|NCT03352089|Positron emission tomography|positron emission tomography
4682307|NCT03352076|Danazol|danazol
4682308|NCT03352024|neuro degenerative diseases|neuro degenerative diseases
4682309|NCT03352024|Alzheimer's disease|alzheimer's disease
4682310|NCT03352024|lumbar puncture|lumbar puncture
4682312|NCT03352024|hypno analgesia|hypno analgesia
4682313|NCT03352024|no drug care|no drug care
4682314|NCT03352024|pain|pain
4682315|NCT03352024|anxiety|anxiety
4682316|NCT03352024|counseling|counseling
4682317|NCT03351998|insulin sensitivity|insulin sensitivity
4682318|NCT03351998|cardiorespiratory fitness|cardiorespiratory fitness
4682319|NCT03351998|skeletal muscle mitochondrial function|skeletal muscle mitochondrial function
4682320|NCT03351959|ypT0|ypt0
4682321|NCT03351946|Atelectasis|atelectasis
4682322|NCT03351946|Oxygenation|oxygenation
4682323|NCT03351946|Positive end-expiratory pressure|positive end-expiratory pressure
4682324|NCT03351946|Mechanical ventilation|mechanical ventilation
4682325|NCT03351946|General anesthesia|general anesthesia
4682326|NCT03351946|Computed tomography|computed tomography
4682327|NCT03351868|Fanconi anemia|fanconi anemia
4682328|NCT03351868|Lentiviral vector|lentiviral vector
4682329|NCT03351868|FANCA|fanca
4682330|NCT03351868|Gene|gene
4682331|NCT03351855|Human papilloma virus|human papilloma virus
4682332|NCT03351855|Cytotoxic lymphocyte|cytotoxic lymphocyte
4682333|NCT03351855|HPV-CTL|hpv-ctl
4682334|NCT03351842|Adjuvant chemotherapy|adjuvant chemotherapy
4682335|NCT03351842|Micropapillary Component|micropapillary component
4682336|NCT03351842|Early stage lung cancer|early stage lung cancer
4682337|NCT03351829|Beta Thalassemia|beta thalassemia
4682338|NCT03351829|Lentiviral vector|lentiviral vector
4682339|NCT03351829|Gene|gene
4682340|NCT03351803|BRCA|brca
4682341|NCT03351803|BFOR|bfor
4682342|NCT03351803|Ashkenazi|ashkenazi
4682343|NCT03351803|17-568|17-568
4682344|NCT03351764|Non-Invasive Brain Stimulation|non-invasive brain stimulation
4682345|NCT03351764|fMRI|fmri
4682346|NCT03351764|TMS-Evoked Potential|tms-evoked potential
4682347|NCT03351764|Transcranial Magnetic Stimulation (TMS)|transcranial magnetic stimulation (tms)
4682348|NCT03351764|EEG|eeg
4682349|NCT03351751|PF-06372865|pf-06372865
4682350|NCT03351751|Safety|safety
4682351|NCT03351751|Tolerability|tolerability
4682352|NCT03351751|Pharmacokinetics|pharmacokinetics
4682353|NCT03351751|Multiple dose|multiple dose
4682354|NCT03351751|Healthy subjects|healthy subjects
4682355|NCT03351738|coronary heart disease pharmacokinetic pharmacodynamics|coronary heart disease pharmacokinetic pharmacodynamics
4682356|NCT03351725|peripheral venous catheter|peripheral venous catheter
4682357|NCT03351725|catheter colonization|catheter colonization
4682358|NCT03351712|Wearables|wearables
4682359|NCT03351712|Activity Trackers|activity trackers
4682360|NCT03351712|ACT|act
4682361|NCT03351712|Health promotion|health promotion
4682362|NCT03351712|Obesity|obesity
4682363|NCT03351712|Chronic Health Condition|chronic health condition
4682364|NCT03351712|Psychological well-being|psychological well-being
4682365|NCT03351712|Quality of life|quality of life
4682366|NCT03351712|Behavior modification|behavior modification
4682367|NCT03351712|RCT|rct
4682368|NCT03351686|tranexamic acid|tranexamic acid
4682369|NCT03351647|Crohn Disease|crohn disease
4682370|NCT03351647|Ustekinumab|ustekinumab
4682371|NCT03351647|Vedolizumab|vedolizumab
4682372|NCT03351647|anti-TNF|anti-tnf
4682373|NCT03351647|CRP|crp
4682374|NCT03351647|calprotectin|calprotectin
4682375|NCT03351647|cohort|cohort
4682376|NCT03351595|Growth pattern|growth pattern
4682377|NCT03351595|Environmental and prenatal exposure|environmental and prenatal exposure
4682378|NCT03351582|family therapy|family therapy
4682379|NCT03351582|psychological health|psychological health
4682380|NCT03351569|Unverricht-Lundborg disease|unverricht-lundborg disease
4682381|NCT03351569|progressive myoclonus epilepsy|progressive myoclonus epilepsy
4682382|NCT03351569|pharmacoresistant epilepsy|pharmacoresistant epilepsy
4682383|NCT03351543|vaccine response|vaccine response
4682384|NCT03351543|immune system activity|immune system activity
4682385|NCT03351504|household air pollution|household air pollution
4682386|NCT03351504|fine particulate matter|fine particulate matter
4682387|NCT03351504|kerosene|kerosene
4682388|NCT03351491|Health mobile applications|health mobile applications
4682389|NCT03351491|Apps|apps
4682390|NCT03351491|mhealth|mhealth
4682391|NCT03351491|ehealth|ehealth
4682392|NCT03351491|France|france
4682393|NCT03351491|msanté|msanté
4682394|NCT03351491|applications mobiles|applications mobiles
4682395|NCT03351439|Hip Arthroscopy|hip arthroscopy
4682396|NCT03351426|obesity|obesity
4682397|NCT03351426|overweight|overweight
4682398|NCT03351426|neuromodulation|neuromodulation
4682399|NCT03351426|transcranial direct current stimulation (tDCS)|transcranial direct current stimulation (tdcs)
4682400|NCT03351413|Fall Prevention|fall prevention
4682401|NCT03351413|Older Adults|older adults
4682402|NCT03351400|cardiac stem cells|cardiac stem cells
4682403|NCT03351400|c-kit|c-kit
4682404|NCT03351387|amputation|amputation
4682405|NCT03351387|necrosis|necrosis
4682406|NCT03351387|high risk lower extremity wound|high risk lower extremity wound
4682407|NCT03351374|behavioral health|behavioral health
4682408|NCT03351374|software|software
4682409|NCT03351374|integration|integration
4682410|NCT03351348|Bupivacaine|bupivacaine
4682411|NCT03351348|Mastectomy|mastectomy
4682412|NCT03351348|17-576|17-576
4682413|NCT03351322|Alopecia|alopecia
4682414|NCT03351322|Hair Loss|hair loss
4682415|NCT03351322|Female Pattern Baldness|female pattern baldness
4682416|NCT03351270|CNM|cnm
4682417|NCT03351270|XLMTM|xlmtm
4682418|NCT03351270|Myotubular myopathy|myotubular myopathy
4682419|NCT03351205|Asherman syndrome|asherman syndrome
4682420|NCT03351205|hysteroscopy|hysteroscopy
4682421|NCT03351205|uterine stent|uterine stent
4682422|NCT03351205|Estrogen|estrogen
4682423|NCT03351205|Amnion|amnion
4682424|NCT03351205|Hysteroscopic Adhesiolysis|hysteroscopic adhesiolysis
4682425|NCT03351179|Heart Failure with Preserved Ejection Fraction|heart failure with preserved ejection fraction
4682426|NCT03351179|Acute MyocAcute Myocardial Infarction|acute myocacute myocardial infarction
4682427|NCT03351179|Predictive factors|predictive factors
4682428|NCT03351140|Multiple Myeloma|multiple myeloma
4682429|NCT03351140|Patient‐Reported Outcome Measurement Information System (PROMIS)|patient‐reported outcome measurement information system (promis)
4682430|NCT03351140|Non‐Small Cell Lung Cancer (NSCLC)|non‐small cell lung cancer (nsclc)
4682431|NCT03351140|Breast cancer|breast cancer
4682432|NCT03351140|Diffuse Large B‐Cell (DLBCL)|diffuse large b‐cell (dlbcl)
4682433|NCT03351140|Follicular Lymphoma|follicular lymphoma
4682434|NCT03351140|Prostate Cancer|prostate cancer
4682435|NCT03351140|Qualitative interview|qualitative interview
4682436|NCT03351114|Morphea, Localized Scleroderma|morphea, localized scleroderma
4682437|NCT03351062|premenopausal|premenopausal
4682438|NCT03351062|early breast cancer|early breast cancer
4682439|NCT03351062|estrogen receptor positive|estrogen receptor positive
4682440|NCT03351049|Acute care, support surface|acute care, support surface
4682441|NCT03351036|Hypothermia|hypothermia
4682442|NCT03351010|Mindfulness, Cancer, Pain Management|mindfulness, cancer, pain management
4682443|NCT03350997|Exercise|exercise
4682444|NCT03350971|virtual reality|virtual reality
4682445|NCT03350971|physical therapy|physical therapy
4682446|NCT03350971|myocardial revascualrization|myocardial revascualrization
4682447|NCT03350932|sensory imagination; foods|sensory imagination; foods
4682448|NCT03350906|Exercise|exercise
4682449|NCT03350906|muscle function|muscle function
4682450|NCT03350880|Passive|passive
4682451|NCT03350880|Stretching|stretching
4682452|NCT03350880|Water|water
4682453|NCT03350880|Proprioceptive Neuromuscular Facilitation (PNF)|proprioceptive neuromuscular facilitation (pnf)
4682454|NCT03350867|Posture|posture
4682455|NCT03350867|Orthosis|orthosis
4682456|NCT03350867|Foot|foot
4682457|NCT03350867|Biomechanical Phenomena|biomechanical phenomena
4682458|NCT03350854|early stage breast cancer;|early stage breast cancer;
4682459|NCT03350854|treatment decision making|treatment decision making
4682460|NCT03350854|newly diagnosed breast cancer|newly diagnosed breast cancer
4682461|NCT03350828|CF|cf
4682462|NCT03350828|Cystic Fibrosis|cystic fibrosis
4682463|NCT03350828|Sweat|sweat
4682464|NCT03350828|Sweat chloride|sweat chloride
4682465|NCT03350828|CFTR Modulator|cftr modulator
4682466|NCT03350815|Ankylosing spondylitis, ASDAS inactive disease, secukinumab|ankylosing spondylitis, asdas inactive disease, secukinumab
4682467|NCT03350789|acupuncture|acupuncture
4682468|NCT03350789|sciatica|sciatica
4682469|NCT03350789|MRI, functional|mri, functional
4682470|NCT03350776|Neoplasm|neoplasm
4682471|NCT03350776|Chronic disease|chronic disease
4682472|NCT03350776|Complex cases|complex cases
4682473|NCT03350776|Care coordination|care coordination
4682474|NCT03350776|Oncologic nursing|oncologic nursing
4682475|NCT03350776|Theoretical model|theoretical model
4682476|NCT03350763|Pancreatic Cancer|pancreatic cancer
4682477|NCT03350763|Biliary decompression|biliary decompression
4682478|NCT03350737|No-option patients|no-option patients
4682479|NCT03350711|Microbiota composition|microbiota composition
4682480|NCT03350711|Microbiota Enrichment Program|microbiota enrichment program
4682481|NCT03350711|Fecal microbiota transplant (FMT)|fecal microbiota transplant (fmt)
4682482|NCT03350698|Human papilloma virus|human papilloma virus
4682483|NCT03350672|HIV prevention|hiv prevention
4682484|NCT03350672|PrEP|prep
4682485|NCT03350672|Descovy|descovy
4682486|NCT03350659|orthostatic hypotension|orthostatic hypotension
4682487|NCT03350659|midodrine|midodrine
4682488|NCT03350659|atomoxetine|atomoxetine
4682489|NCT03350659|treatment|treatment
4682490|NCT03350646|embryo transfer|embryo transfer
4682491|NCT03350646|volume|volume
4682492|NCT03350646|culture medium|culture medium
4682493|NCT03350646|loading the catheter|loading the catheter
4682494|NCT03350646|clinical pregnancy rate|clinical pregnancy rate
4682495|NCT03350620|child, myopia, nearsightedness|child, myopia, nearsightedness
4682496|NCT03350607|Epiretinal membrane, sweeper, forceps, microperimetry|epiretinal membrane, sweeper, forceps, microperimetry
4682497|NCT03350594|Anorexia Nervosa|anorexia nervosa
4682498|NCT03350594|Multiple Family Therapy|multiple family therapy
4682499|NCT03350594|Systemic Family Therapy|systemic family therapy
4682500|NCT03350594|Adolescence|adolescence
4682501|NCT03350594|Randomised controled trial|randomised controled trial
4682502|NCT03350581|Catheter ablation|catheter ablation
4682503|NCT03350581|Fast anatomical mapping (FAM)|fast anatomical mapping (fam)
4682504|NCT03350581|Computed tomography (CT)|computed tomography (ct)
4682505|NCT03350581|Magnetic resonance image (MRI)|magnetic resonance image (mri)
4682506|NCT03350581|Contact force|contact force
4682507|NCT03350581|Atrial fibrillation|atrial fibrillation
4682508|NCT03350568|Antioxidants|antioxidants
4682509|NCT03350568|Oxidative Stress|oxidative stress
4682510|NCT03350568|Atherosclerosis|atherosclerosis
4682511|NCT03350568|Epidemiology|epidemiology
4682512|NCT03350542|Drug-Eluting Stents|drug-eluting stents
4682513|NCT03350529|prostate cancer|prostate cancer
4682514|NCT03350529|benign prostatic hyperplasia|benign prostatic hyperplasia
4682515|NCT03350529|benign prostatic obstruction|benign prostatic obstruction
4682516|NCT03350529|high intensity focused ultrasound|high intensity focused ultrasound
4682517|NCT03350529|real-time temperature feedback control|real-time temperature feedback control
4682518|NCT03350529|magnetic resonance imaging|magnetic resonance imaging
4682519|NCT03350503|phacoemulsification|phacoemulsification
4682520|NCT03350503|intraocular lens|intraocular lens
4682521|NCT03350503|vision|vision
4682522|NCT03350503|toric|toric
4682523|NCT03350490|Cancer ablation|cancer ablation
4682524|NCT03350490|Life information rehabilitation therapy|life information rehabilitation therapy
4682525|NCT03350477|Cancer ablation|cancer ablation
4682526|NCT03350477|Life information rehabilitation therapy|life information rehabilitation therapy
4682527|NCT03350451|Hyperoxaluria, Primary|hyperoxaluria, primary
4682528|NCT03350451|Hyperoxaluria|hyperoxaluria
4682529|NCT03350451|Kidney Diseases|kidney diseases
4682530|NCT03350451|Urologic Diseases|urologic diseases
4682531|NCT03350451|Metabolism, Inborn Errors|metabolism, inborn errors
4682532|NCT03350451|Genetic Diseases, Inborn|genetic diseases, inborn
4682533|NCT03350451|Metabolic Diseases|metabolic diseases
4682534|NCT03350438|participation|participation
4682535|NCT03350438|quality of life|quality of life
4682536|NCT03350438|occupational therapy|occupational therapy
4682537|NCT03350425|hemodialysis|hemodialysis
4682538|NCT03350425|pneumococcal vaccination|pneumococcal vaccination
4682539|NCT03350347|Renal anemia|renal anemia
4682540|NCT03350334|Duloxetine|duloxetine
4682541|NCT03350334|laparoscopic hysterectomy|laparoscopic hysterectomy
4682542|NCT03350334|postoperative pain|postoperative pain
4682543|NCT03350334|postoperative recovery|postoperative recovery
4682544|NCT03350295|Relative bioavailability|relative bioavailability
4682545|NCT03350295|In vitro dissolution|in vitro dissolution
4682546|NCT03350269|Living kidney donation|living kidney donation
4682547|NCT03350269|Kidney transplant|kidney transplant
4682548|NCT03350269|Lost Wage Reimbursement|lost wage reimbursement
4682549|NCT03350243|Neonatal Intensive Care Unit|neonatal intensive care unit
4682550|NCT03350243|Mindfulness|mindfulness
4682551|NCT03350243|Care coordination|care coordination
4682552|NCT03350243|Anticipatory guidance|anticipatory guidance
4682553|NCT03350243|Parental support|parental support
4682554|NCT03350243|Neonatal follow-up|neonatal follow-up
4682555|NCT03350152|Chemotherapy, Low-intensity therapy, elderly, prognosis,|chemotherapy, low-intensity therapy, elderly, prognosis,
4682556|NCT03350126|MSI or MMR|msi or mmr
4682557|NCT03350113|prognosis|prognosis
4682558|NCT03350113|diagnosis|diagnosis
4682559|NCT03350087|repetitive transcranial magnetic stimulation|repetitive transcranial magnetic stimulation
4682560|NCT03350087|stroke|stroke
4682561|NCT03350087|optimal treatment protocol|optimal treatment protocol
4682562|NCT03350087|VR-based cycling training (VCT)|vr-based cycling training (vct)
4682563|NCT03350087|randomized controlled trial|randomized controlled trial
4682564|NCT03350087|motor control|motor control
4682565|NCT03350087|clinical predictors|clinical predictors
4682566|NCT03350074|Hepatitis B virus|hepatitis b virus
4682567|NCT03350074|PreS/S variability|pres/s variability
4682568|NCT03350074|Anti-HBV treatment|anti-hbv treatment
4682569|NCT03350048|Tuberculosis|tuberculosis
4682570|NCT03350048|Point-of-care test|point-of-care test
4682571|NCT03350048|Diagnostics|diagnostics
4682572|NCT03350048|Biomarkers|biomarkers
4682573|NCT03349957|TACE|tace
4682574|NCT03349944|exercise|exercise
4682575|NCT03349931|Aspergillosis,|aspergillosis,
4682576|NCT03349931|qPCR|qpcr
4682577|NCT03349931|allogenic haemopoietic stem-cell transplantation|allogenic haemopoietic stem-cell transplantation
4682578|NCT03349931|leukemia|leukemia
4682579|NCT03349905|Freeze all|freeze all
4682580|NCT03349905|IVF|ivf
4682581|NCT03349905|deferred embryo transfer|deferred embryo transfer
4682582|NCT03349905|endometriosis|endometriosis
4682583|NCT03349853|Palliative care; Acetaminophen; Subcutaneous route; Pain treatment|palliative care; acetaminophen; subcutaneous route; pain treatment
4682584|NCT03349840|type 2 diabetes|type 2 diabetes
4682585|NCT03349840|insulin|insulin
4682586|NCT03349840|glargine u100|glargine u100
4682587|NCT03349840|degludec|degludec
4682588|NCT03349840|Ramadan|ramadan
4682589|NCT03349814|appendicitis|appendicitis
4682989|NCT03347630|MRI|mri
4682590|NCT03349814|appendectomy|appendectomy
4682591|NCT03349814|yersinia|yersinia
4682592|NCT03349801|iAMD|iamd
4682593|NCT03349801|biomarker|biomarker
4682594|NCT03349801|clinical endpoint|clinical endpoint
4682595|NCT03349788|Left colic artery|left colic artery
4682596|NCT03349788|Laparoscopic Surgery|laparoscopic surgery
4682597|NCT03349788|Anterior resection of rectum|anterior resection of rectum
4682598|NCT03349788|Rectum cancer|rectum cancer
4682599|NCT03349775|Pulmonary Hypertension|pulmonary hypertension
4682600|NCT03349775|BMI|bmi
4682601|NCT03349775|Echocardiography|echocardiography
4682602|NCT03349775|CPET|cpet
4682603|NCT03349775|6-minute walk test|6-minute walk test
4682604|NCT03349775|Cardio Metabolic disease|cardio metabolic disease
4682605|NCT03349762|Huaier Granule|huaier granule
4682606|NCT03349762|multisite|multisite
4682607|NCT03349762|open-label|open-label
4682608|NCT03349762|prospective|prospective
4682609|NCT03349749|intensive care units|intensive care units
4682610|NCT03349749|resuscitation|resuscitation
4682611|NCT03349749|fluid therapy|fluid therapy
4682612|NCT03349749|Vascular Access Devices|vascular access devices
4682613|NCT03349749|cardiac output|cardiac output
4682614|NCT03349749|monitoring, physiologic|monitoring, physiologic
4682615|NCT03349736|Pelvic floor muscle|pelvic floor muscle
4682616|NCT03349697|Liver Health|liver health
4682617|NCT03349697|Hangover|hangover
4682618|NCT03349697|Herbal supplement|herbal supplement
4682619|NCT03349697|Liver function|liver function
4682620|NCT03349658|total hip arthroplasty|total hip arthroplasty
4682621|NCT03349658|cerebral oxygen saturation|cerebral oxygen saturation
4682622|NCT03349658|general anesthesia|general anesthesia
4682623|NCT03349658|spinal anesthesia|spinal anesthesia
4682624|NCT03349593|Heart failure, diastolic dysfunction, venous return|heart failure, diastolic dysfunction, venous return
4682625|NCT03349593|Left ventricular filling pressures|left ventricular filling pressures
4682626|NCT03349580|rehabilitation|rehabilitation
4682627|NCT03349580|randomized controlled trial|randomized controlled trial
4682628|NCT03349580|strength training|strength training
4682629|NCT03349580|early initiation|early initiation
4682630|NCT03349580|intra-abdominal pressure|intra-abdominal pressure
4682631|NCT03349554|Parkinson's disease|parkinson's disease
4682632|NCT03349554|anxiety|anxiety
4682633|NCT03349554|meditation|meditation
4682634|NCT03349554|in-patients|in-patients
4682635|NCT03349528|bipolar disorder|bipolar disorder
4682636|NCT03349528|bipolar depression|bipolar depression
4682637|NCT03349528|depressive episode|depressive episode
4682638|NCT03349528|probiotic supplement|probiotic supplement
4682639|NCT03349528|probiotics|probiotics
4682640|NCT03349528|relapse prevention|relapse prevention
4682641|NCT03349528|rehospitalization|rehospitalization
4682642|NCT03349502|Allogeneic natural killer cell, MG4101|allogeneic natural killer cell, mg4101
4682643|NCT03349489|Type 1 diabetes|type 1 diabetes
4682644|NCT03349489|Exercise|exercise
4682645|NCT03349489|Hypoglycemia|hypoglycemia
4682646|NCT03349489|Insulin pump|insulin pump
4682647|NCT03349476|Atrial Fibrillation|atrial fibrillation
4682648|NCT03349476|AFIB|afib
4682649|NCT03349476|Ablation|ablation
4682650|NCT03349476|Paroxysmal|paroxysmal
4682651|NCT03349476|Persistent|persistent
4682652|NCT03349450|Lymphoma|lymphoma
4682653|NCT03349450|DLBCL|dlbcl
4682654|NCT03349450|Lymphoma, B-Cell|lymphoma, b-cell
4682655|NCT03349450|Lymphoma, Large B-Cell, Diffuse|lymphoma, large b-cell, diffuse
4682656|NCT03349450|Neoplasms by Histologic Type|neoplasms by histologic type
4682657|NCT03349450|Neoplasms|neoplasms
4682658|NCT03349450|Lymphoproliferative Disorders|lymphoproliferative disorders
4682659|NCT03349450|Lymphatic Diseases|lymphatic diseases
4682660|NCT03349450|Immunoproliferative Disorders|immunoproliferative disorders
4682661|NCT03349450|Immune System Diseases|immune system diseases
4682662|NCT03349450|Lymphoma, Non-Hodgkin|lymphoma, non-hodgkin
4682663|NCT03349450|Cyclophosphamide|cyclophosphamide
4682664|NCT03349450|Pembrolizumab|pembrolizumab
4682665|NCT03349450|Immunosuppressive Agents|immunosuppressive agents
4682666|NCT03349450|Immunologic Factors|immunologic factors
4682667|NCT03349450|Physiological Effects of Drugs|physiological effects of drugs
4682668|NCT03349450|Antirheumatic Agents|antirheumatic agents
4682669|NCT03349450|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating
4682670|NCT03349450|Alkylating Agents|alkylating agents
4682671|NCT03349450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
4682672|NCT03349450|Antineoplastic Agents|antineoplastic agents
4682673|NCT03349450|Myeloablative Agonists|myeloablative agonists
4682674|NCT03349450|Canada|canada
4682675|NCT03349450|Ontario|ontario
4682676|NCT03349450|Diffuse Large B Cell Lymphoma|diffuse large b cell lymphoma
4682677|NCT03349450|refractory|refractory
4682678|NCT03349450|relapsed|relapsed
4682679|NCT03349450|checkpoint inhibitor|checkpoint inhibitor
4682680|NCT03349450|vaccine|vaccine
4682681|NCT03349450|DPX-Survivac|dpx-survivac
4682682|NCT03349450|Survivin|survivin
4682683|NCT03349450|Immunotherapy|immunotherapy
4682684|NCT03349450|Transformed Lymphoma|transformed lymphoma
4682685|NCT03349450|Double Hit|double hit
4682686|NCT03349450|Large Cell Lymphoma|large cell lymphoma
4682687|NCT03349450|Keytruda|keytruda
4682688|NCT03349424|Somatostatin|somatostatin
4682689|NCT03349424|Pancreatic Fistula|pancreatic fistula
4682690|NCT03349424|Intermediate Risk|intermediate risk
4682691|NCT03349424|Pancreaticoduodenectomy|pancreaticoduodenectomy
4682692|NCT03349398|Uncut Roux-en-Y|uncut roux-en-y
4682693|NCT03349398|Roux-en-Y|roux-en-y
4682694|NCT03349385|Secondary revascularization|secondary revascularization
4682695|NCT03349385|Repeat revascularization|repeat revascularization
4682696|NCT03349385|Coronary revascularization|coronary revascularization
4682697|NCT03349385|Coronary artery bypass graft|coronary artery bypass graft
4682698|NCT03349333|FOT12-CN-301|fot12-cn-301
4682699|NCT03349333|PTCL (peripheral T-cell lymphoma)|ptcl (peripheral t-cell lymphoma)
4682700|NCT03349333|pralatrexate|pralatrexate
4682701|NCT03349333|vitamin B12|vitamin b12
4682702|NCT03349333|folic acid|folic acid
4682703|NCT03349320|Alzheimer|alzheimer
4682704|NCT03349320|APOE|apoe
4682705|NCT03349320|CYP2D6|cyp2d6
4682706|NCT03349320|Donepezil|donepezil
4682707|NCT03349320|Genetics|genetics
4682708|NCT03349307|lobectomy|lobectomy
4682709|NCT03349294|Thyroid|thyroid
4682710|NCT03349294|Thyroidectomy|thyroidectomy
4682711|NCT03349294|Iodine|iodine
4682712|NCT03349294|Biokinetic|biokinetic
4682713|NCT03349294|Ablation|ablation
4682714|NCT03349255|alpha-fetoprotein|alpha-fetoprotein
4682715|NCT03349255|AFP|afp
4682716|NCT03349255|HCC|hcc
4682717|NCT03349255|CAR T cell therapy|car t cell therapy
4682718|NCT03349229|care practices|care practices
4682719|NCT03349229|geriatry|geriatry
4682720|NCT03349229|oncology|oncology
4682721|NCT03349151|Postoperative maternal feeding, cesarean section|postoperative maternal feeding, cesarean section
4682722|NCT03349138|rehabilitation|rehabilitation
4682723|NCT03349138|functional electrical stimulation|functional electrical stimulation
4682724|NCT03349138|electrode array|electrode array
4682725|NCT03349138|upper limb|upper limb
4682726|NCT03349138|chronic|chronic
4682727|NCT03349138|motor relearning|motor relearning
4682728|NCT03349125|Cervical Brace|cervical brace
4682729|NCT03349125|Elderly|elderly
4682730|NCT03349125|Dysphagia|dysphagia
4682731|NCT03349125|VFSS|vfss
4682732|NCT03349125|Videoflouroscopy|videoflouroscopy
4682733|NCT03349125|Swallow Problems|swallow problems
4682734|NCT03349112|Manometry|manometry
4682735|NCT03349112|Lidocaine|lidocaine
4682736|NCT03349112|Pharyngeal|pharyngeal
4682737|NCT03349112|High Resolution Pharyngeal Manometry (HRPM)|high resolution pharyngeal manometry (hrpm)
4682738|NCT03349112|Pressure|pressure
4682739|NCT03349086|Botox Injection|botox injection
4682740|NCT03349086|Spasmodic|spasmodic
4682741|NCT03349086|Dysphonia|dysphonia
4682742|NCT03349086|Voice Therapy|voice therapy
4682743|NCT03349086|Speech Therapy|speech therapy
4682744|NCT03349086|Voice Rest|voice rest
4682745|NCT03349060|atopic dermatitis|atopic dermatitis
4682746|NCT03349060|atopic eczema|atopic eczema
4682747|NCT03349060|eczema|eczema
4682748|NCT03349060|JAK|jak
4682749|NCT03349060|janus kinase|janus kinase
4682750|NCT03349047|Food Allergy|food allergy
4682751|NCT03349047|Anxiety|anxiety
4682752|NCT03349047|Casual Exposure|casual exposure
4682753|NCT03349047|Peanut Hypersensitivity|peanut hypersensitivity
4682754|NCT03349047|Tree nut Hypersensitivity|tree nut hypersensitivity
4682755|NCT03349047|Adolescents|adolescents
4682756|NCT03349034|Local anesthetics|local anesthetics
4682757|NCT03349034|Randomized Control Trial|randomized control trial
4682758|NCT03349034|Free tissue transfer|free tissue transfer
4682759|NCT03349034|Head and neck|head and neck
4682760|NCT03349034|Microvascular|microvascular
4682761|NCT03349034|Postoperative Pain|postoperative pain
4682762|NCT03349021|esophagus|esophagus
4682763|NCT03349021|stenosis|stenosis
4682764|NCT03349021|bougienage|bougienage
4682765|NCT03349008|necro-inflammatory|necro-inflammatory
4682766|NCT03349008|glycyrrhizin|glycyrrhizin
4682767|NCT03349008|entecavir|entecavir
4682768|NCT03349008|hepatic biological parameters|hepatic biological parameters
4682769|NCT03349008|liver fibrosis|liver fibrosis
4682770|NCT03348982|Physical activity|physical activity
4682771|NCT03348982|Sleep|sleep
4682772|NCT03348982|Children|children
4682773|NCT03348982|Autism Spectrum Disorder|autism spectrum disorder
4682774|NCT03348982|Melatonin|melatonin
4682775|NCT03348969|Mitomycin C|mitomycin c
4682776|NCT03348969|Neoadjuvant|neoadjuvant
4682777|NCT03348904|Non-small cell lung cancer|non-small cell lung cancer
4682778|NCT03348904|programmed cell death protein 1 (PD-1) antibody|programmed cell death protein 1 (pd-1) antibody
4682779|NCT03348904|indoleamine 2,3-dioxygenase (IDO) inhibitor|indoleamine 2,3-dioxygenase (ido) inhibitor
4682780|NCT03348891|Melanoma|melanoma
4682781|NCT03348891|TNF|tnf
4682782|NCT03348891|Immune checkpoints|immune checkpoints
4682783|NCT03348891|Tumor-infiltrating lymphocytes|tumor-infiltrating lymphocytes
4682784|NCT03348891|Cytokines|cytokines
4682785|NCT03348891|Circulating leukocytes|circulating leukocytes
4682786|NCT03348878|drug compliance|drug compliance
4682787|NCT03348878|hypertension|hypertension
4682788|NCT03348878|anti-hypertensive agents|anti-hypertensive agents
4682789|NCT03348865|Cognitive Behavioural Therapy|cognitive behavioural therapy
4682790|NCT03348839|telemedicine|telemedicine
4682791|NCT03348839|telemonitoring|telemonitoring
4682792|NCT03348839|educational therapy|educational therapy
4682793|NCT03348813|Black|black
4682794|NCT03348813|Adolescents|adolescents
4682795|NCT03348813|Community-based research|community-based research
4682796|NCT03348813|Randomized controlled trial|randomized controlled trial
4682797|NCT03348813|Intervention|intervention
4682798|NCT03348813|Behavioral science|behavioral science
4682799|NCT03348800|Child|child
4682800|NCT03348800|RCT|rct
4682801|NCT03348800|Anesthesia|anesthesia
4682802|NCT03348800|Tooth extraction|tooth extraction
4682803|NCT03348787|Behavioral and Cognitive Therapies|behavioral and cognitive therapies
4682804|NCT03348774|Disease Course|disease course
4682805|NCT03348761|Repetitive Transcranial Magnetic Stimulation|repetitive transcranial magnetic stimulation
4682806|NCT03348761|resting-state Functional magnetic resonance imaging|resting-state functional magnetic resonance imaging
4682807|NCT03348761|treatment response trajectories|treatment response trajectories
4682808|NCT03348722|Active surveillance|active surveillance
4682809|NCT03348722|Low risk prostate cancer|low risk prostate cancer
4682810|NCT03348722|Prostatic neoplasm/therapy (MESH)|prostatic neoplasm/therapy (mesh)
4682811|NCT03348722|Prostatic neoplasm/surgery (MESH)|prostatic neoplasm/surgery (mesh)
4682812|NCT03348722|Prostatic neoplasm/radiotherapy (MESH)|prostatic neoplasm/radiotherapy (mesh)
4682813|NCT03348722|Prostatectomy (MESH)|prostatectomy (mesh)
4682814|NCT03348722|Quality of life (MESH)|quality of life (mesh)
4682815|NCT03348722|Costs and Cost Analysis (MESH)|costs and cost analysis (mesh)
4682816|NCT03348683|Induction|induction
4682817|NCT03348683|Labor|labor
4682818|NCT03348683|Propranolol|propranolol
4682819|NCT03348670|SCLC|sclc
4682820|NCT03348670|SNP|snp
4682821|NCT03348670|Oncology|oncology
4682822|NCT03348670|Drug|drug
4682823|NCT03348670|Etoposide|etoposide
4682824|NCT03348670|Methotrexate|methotrexate
4682825|NCT03348670|Lung|lung
4682826|NCT03348670|Cancer|cancer
4682827|NCT03348670|Topotecan|topotecan
4682828|NCT03348670|Everolimus|everolimus
4682829|NCT03348618|Obsessive-Compulsive Disorder|obsessive-compulsive disorder
4682830|NCT03348618|Anxiety|anxiety
4682831|NCT03348618|PANS|pans
4682832|NCT03348618|PANDAS|pandas
4682833|NCT03348618|Children|children
4682834|NCT03348605|Amputation|amputation
4682835|NCT03348605|Phantom Pain|phantom pain
4682836|NCT03348605|Gait analysis|gait analysis
4682837|NCT03348592|Microbiome, p-inulin|microbiome, p-inulin
4682838|NCT03348579|Intensive care unit|intensive care unit
4682839|NCT03348579|Pneumonia|pneumonia
4682840|NCT03348579|Ventilator associated|ventilator associated
4682841|NCT03348579|Hospital acquired pneumonia|hospital acquired pneumonia
4682842|NCT03348579|Guidelines|guidelines
4682843|NCT03348553|Omega-fatty-acids|omega-fatty-acids
4682844|NCT03348553|Absorption|absorption
4682845|NCT03348553|Bioavailability|bioavailability
4682846|NCT03348553|Fruit & Vegetable concentrate|fruit & vegetable concentrate
4682847|NCT03348553|Lipid Metabolism|lipid metabolism
4682848|NCT03348475|Guided self-help|guided self-help
4682849|NCT03348475|Group-based intervention|group-based intervention
4682850|NCT03348475|Binge Focused Therapy|binge focused therapy
4682851|NCT03348475|Brain Over Binge|brain over binge
4682852|NCT03348475|Non-expert guided|non-expert guided
4682853|NCT03348475|Minimally intensive|minimally intensive
4682854|NCT03348462|psoriasis|psoriasis
4682855|NCT03348462|anthralin|anthralin
4682856|NCT03348462|ethosome|ethosome
4682857|NCT03348462|liposome|liposome
4682858|NCT03348449|HIV|hiv
4682859|NCT03348449|Dual therapy|dual therapy
4682860|NCT03348449|Comorbidities|comorbidities
4682861|NCT03348449|Nucleoside analogues sparing-regimens|nucleoside analogues sparing-regimens
4682862|NCT03348436|paroxysmal supraventricular tachycardia|paroxysmal supraventricular tachycardia
4682863|NCT03348436|Left Atrial Function|left atrial function
4682864|NCT03348423|Peri-procedural pain|peri-procedural pain
4682865|NCT03348423|Pain|pain
4682866|NCT03348423|Anxiety|anxiety
4682867|NCT03348423|Analgesia|analgesia
4682868|NCT03348423|Anxiolysis|anxiolysis
4682869|NCT03348371|Incretin effect|incretin effect
4682870|NCT03348371|Ethanol|ethanol
4682871|NCT03348345|eating disorders|eating disorders
4682872|NCT03348345|prevention|prevention
4682873|NCT03348345|yoga|yoga
4682874|NCT03348345|mindfulness|mindfulness
4682875|NCT03348345|embodiment|embodiment
4682876|NCT03348345|self-regulation|self-regulation
4682877|NCT03348345|functional action|functional action
4682878|NCT03348345|interoceptive awareness|interoceptive awareness
4682879|NCT03348332|exercise|exercise
4682880|NCT03348332|intrapartum|intrapartum
4682881|NCT03348332|aerobic exercise|aerobic exercise
4682882|NCT03348332|resistance exercise|resistance exercise
4682883|NCT03348332|wellbeing|wellbeing
4682884|NCT03348293|biodegradable scaffold|biodegradable scaffold
4682885|NCT03348293|immediate breast reconstruction|immediate breast reconstruction
4682886|NCT03348293|3D printing|3d printing
4682887|NCT03348241|Gum Arabic|gum arabic
4682888|NCT03348241|Cancer patients|cancer patients
4682889|NCT03348241|Chemotherapy|chemotherapy
4682890|NCT03348241|Oral mucositis|oral mucositis
4682891|NCT03348228|Hydroxycitrate Supplements|hydroxycitrate supplements
4682892|NCT03348215|Gait rehabilitation|gait rehabilitation
4682893|NCT03348163|Transgender women|transgender women
4682894|NCT03348163|Bictegravir|bictegravir
4682895|NCT03348150|HIPEC|hipec
4682896|NCT03348150|Hyperthermic Intraperitoneal Chemotherapy|hyperthermic intraperitoneal chemotherapy
4682897|NCT03348150|gastrectomy|gastrectomy
4682898|NCT03348150|cytoreductive surgery|cytoreductive surgery
4682899|NCT03348150|oxaliplatin|oxaliplatin
4682900|NCT03348150|docetaxel|docetaxel
4682901|NCT03348124|Intellectual disability|intellectual disability
4682902|NCT03348124|Parenthood|parenthood
4682903|NCT03348124|Reproduction|reproduction
4682904|NCT03348124|Intervention|intervention
4682905|NCT03348124|Adolescents|adolescents
4682906|NCT03348111|Mucositis|mucositis
4682907|NCT03348111|Peri-Implantitis|peri-implantitis
4682908|NCT03348111|Air-Flow Master Piezon®|air-flow master piezon®
4682909|NCT03348098|Triple negative breast cancer|triple negative breast cancer
4682910|NCT03348046|Infliximab|infliximab
4682911|NCT03348046|Remsima|remsima
4682912|NCT03348046|Biosimilar|biosimilar
4682913|NCT03348046|Autoimmune Disease|autoimmune disease
4682914|NCT03348046|Rheumatoid Arthritis|rheumatoid arthritis
4682915|NCT03348046|Cohort Study|cohort study
4682916|NCT03348046|Disease modifying anti-rheumatic drugs|disease modifying anti-rheumatic drugs
4682917|NCT03348046|Tumor necrosis factor-alpha inhibitors|tumor necrosis factor-alpha inhibitors
4682918|NCT03347994|Acute Myeloid Leukemia|acute myeloid leukemia
4682919|NCT03347994|AML|aml
4682920|NCT03347994|Refractory AML|refractory aml
4682921|NCT03347994|Relapsed AML|relapsed aml
4682922|NCT03347994|Refractory Acute Myeloid Leukemia|refractory acute myeloid leukemia
4682923|NCT03347994|Relapsed Acute Myeloid Leukemia|relapsed acute myeloid leukemia
4682924|NCT03347981|Intraocular Lens|intraocular lens
4682925|NCT03347981|trifocal|trifocal
4682926|NCT03347981|hydrophobic|hydrophobic
4682927|NCT03347981|hydrophilic|hydrophilic
4682928|NCT03347968|type 2 Diabetes Mellitus, MEDI0382|type 2 diabetes mellitus, medi0382
4682929|NCT03347955|placebo effect|placebo effect
4682930|NCT03347942|Overweight|overweight
4682931|NCT03347942|Obesity|obesity
4682932|NCT03347942|Satiety|satiety
4682933|NCT03347942|Cardiovascular risk|cardiovascular risk
4682934|NCT03347903|esophagus|esophagus
4682935|NCT03347903|motility|motility
4682936|NCT03347890|GLP-1|glp-1
4682937|NCT03347890|fMRI|fmri
4682938|NCT03347877|autologous osteo-periosteal cylinder graft|autologous osteo-periosteal cylinder graft
4682939|NCT03347877|autologous osteochondral graft|autologous osteochondral graft
4682940|NCT03347877|randomized controlled trial|randomized controlled trial
4682941|NCT03347877|Hepple V osteochondral lesions of the talus|hepple v osteochondral lesions of the talus
4682942|NCT03347851|mechanical heart valve|mechanical heart valve
4682943|NCT03347851|On-X|on-x
4682944|NCT03347838|PD-1|pd-1
4682945|NCT03347838|Precancerous Conditions|precancerous conditions
4682946|NCT03347838|Nivolumab|nivolumab
4682947|NCT03347838|Lung Cancer Immunoprevention|lung cancer immunoprevention
4682948|NCT03347812|Aortic Arch|aortic arch
4682949|NCT03347812|Endovascular Treatment|endovascular treatment
4682950|NCT03347812|Traditional Open Surgery|traditional open surgery
4682951|NCT03347812|Chimney Technique|chimney technique
4682952|NCT03347812|Fenestration Technique|fenestration technique
4682953|NCT03347812|Branched Stent-grafts Technique|branched stent-grafts technique
4682954|NCT03347799|very premature infants|very premature infants
4682955|NCT03347799|screening|screening
4682956|NCT03347799|retinopathy|retinopathy
4682957|NCT03347773|Oral nutritional supplement|oral nutritional supplement
4682958|NCT03347773|Sarcopenic obesity|sarcopenic obesity
4682959|NCT03347773|Body composition|body composition
4682960|NCT03347760|68-Ga-DOTATOC PET|68-ga-dotatoc pet
4682961|NCT03347760|Myocarditis|myocarditis
4682962|NCT03347734|eye exercises|eye exercises
4682963|NCT03347734|convergence exercise|convergence exercise
4682964|NCT03347734|hyperopia|hyperopia
4682965|NCT03347734|oculomotor exercise|oculomotor exercise
4682966|NCT03347734|school-age children|school-age children
4682967|NCT03347708|Lumbar disc degeneration|lumbar disc degeneration
4682968|NCT03347708|Low back pain|low back pain
4682969|NCT03347708|Intervertebral disc degeneration|intervertebral disc degeneration
4682970|NCT03347695|modified Cox-Maze|modified cox-maze
4682971|NCT03347695|atrial fibrillation|atrial fibrillation
4682972|NCT03347695|surgery|surgery
4682973|NCT03347682|Amputation, prosthesis,psychometrics, questionnaires|amputation, prosthesis,psychometrics, questionnaires
4682974|NCT03347669|Fibromyalgia|fibromyalgia
4682975|NCT03347669|Small fiber neuropathy|small fiber neuropathy
4682976|NCT03347669|Sudoscan®|sudoscan®
4682977|NCT03347656|Mobilization Therapy|mobilization therapy
4682978|NCT03347656|Clitical Illness|clitical illness
4682979|NCT03347656|Stroke|stroke
4682980|NCT03347656|Intensive Care|intensive care
4682981|NCT03347656|Functional Mobility|functional mobility
4682982|NCT03347656|Quality of Life|quality of life
4682983|NCT03347643|Internet game addiction|internet game addiction
4682984|NCT03347643|Internet gaming disorder|internet gaming disorder
4682985|NCT03347643|transcranial direct current stimulation|transcranial direct current stimulation
4682986|NCT03347643|response inhibition|response inhibition
4682987|NCT03347643|craving|craving
4682988|NCT03347643|cue reactivity|cue reactivity
4682990|NCT03347630|oesophagus cancer|oesophagus cancer
4682991|NCT03347630|Staging|staging
4682992|NCT03347591|Fibrinogen|fibrinogen
4682993|NCT03347591|Factor II|factor ii
4682994|NCT03347591|Factor V|factor v
4682995|NCT03347591|Factor V & VIII|factor v & viii
4682996|NCT03347591|Factor VII|factor vii
4682997|NCT03347591|Factor X|factor x
4682998|NCT03347591|Factor XI|factor xi
4682999|NCT03347591|Factor XIII|factor xiii
4683000|NCT03347591|α2-antiplasmin|α2-antiplasmin
4683001|NCT03347591|Plasminogen activator inhibitor 1|plasminogen activator inhibitor 1
4683002|NCT03347591|Epidemiology|epidemiology
4683003|NCT03347591|Genetics|genetics
4683004|NCT03347591|Phenotype|phenotype
4683005|NCT03347565|adolescents, healthy controls|adolescents, healthy controls
4683006|NCT03347552|treatment engagement|treatment engagement
4683007|NCT03347526|Vigabatrin|vigabatrin
4683008|NCT03347526|Cosyntropin|cosyntropin
4683009|NCT03347513|H-pylori|h-pylori
4683010|NCT03347513|iron deficiency anemia|iron deficiency anemia
4683011|NCT03347513|Pregnancy|pregnancy
4683012|NCT03347513|iron therapy|iron therapy
4683013|NCT03347487|Bilateral Habenula|bilateral habenula
4683014|NCT03347487|Treatment Resistant Major Depressive Disorder|treatment resistant major depressive disorder
4683015|NCT03347474|Bilateral Ventral Capsule/ Ventral Striatum|bilateral ventral capsule/ ventral striatum
4683016|NCT03347474|Methamphetamine Addiction|methamphetamine addiction
4683017|NCT03347461|Tympanostomy tube placement|tympanostomy tube placement
4683018|NCT03347461|Otiprio|otiprio
4683019|NCT03347461|Ciprodex drops|ciprodex drops
4683020|NCT03347461|Ear drops|ear drops
4683021|NCT03347461|Middle ear|middle ear
4683022|NCT03347448|Psychology|psychology
4683023|NCT03347448|Skin|skin
4683024|NCT03347435|clopidogrel|clopidogrel
4683025|NCT03347435|pharmacogenetics|pharmacogenetics
4683026|NCT03347435|antiplatelet therapy|antiplatelet therapy
4683027|NCT03347435|acute coronary syndromes|acute coronary syndromes
4683028|NCT03347409|ERAS, Fast-track surgery, gynecology|eras, fast-track surgery, gynecology
4683029|NCT03347370|subcutaneous interferon beta therapy multiple sclerosis (MS)|subcutaneous interferon beta therapy multiple sclerosis (ms)
4683030|NCT03347370|injection site reactions (ISR)|injection site reactions (isr)
4683031|NCT03347370|flu-like symptoms (FLS)|flu-like symptoms (fls)
4683032|NCT03347370|non-interventional study (NIS)|non-interventional study (nis)
4683033|NCT03347370|SC Peginterferon beta-1a|sc peginterferon beta-1a
4683034|NCT03347370|SC interferon beta-1a|sc interferon beta-1a
4683035|NCT03347370|SC interferon beta-1b|sc interferon beta-1b
4683036|NCT03347370|Plegridy®|plegridy®
4683037|NCT03347370|Betaferon®|betaferon®
4683038|NCT03347370|Extavia®|extavia®
4683039|NCT03347370|Rebif®|rebif®
4683040|NCT03347344|Spinocerebellar ataxia-SCA2|spinocerebellar ataxia-sca2
4683041|NCT03347344|SARA (Scale for the Assessment and Rating of Ataxia) score|sara (scale for the assessment and rating of ataxia) score
4683042|NCT03347344|Riluzole (Rilutek)|riluzole (rilutek)
4683043|NCT03347331|PET imaging- Serotonin-Radiotracer|pet imaging- serotonin-radiotracer
4683044|NCT03347305|Energy expenditure|energy expenditure
4683045|NCT03347305|Peritoneal dialysis|peritoneal dialysis
4683046|NCT03347292|Liver cell carcinoma|liver cell carcinoma
4683047|NCT03347292|Liver cancer|liver cancer
4683048|NCT03347279|Asthma, Uncontrolled Asthma, Severe Uncontrolled Asthma|asthma, uncontrolled asthma, severe uncontrolled asthma
4683049|NCT03347227|AF ablation|af ablation
4683050|NCT03347227|Pulmonary vein isolation|pulmonary vein isolation
4683051|NCT03347227|Atrial scar ablation|atrial scar ablation
4683052|NCT03347214|dbGaP|dbgap
4683053|NCT03347201|Cardiopulmonary bypass, Heparin, Protamine|cardiopulmonary bypass, heparin, protamine
4683054|NCT03347188|persistent posttraumatic headache (PPTH)|persistent posttraumatic headache (ppth)
4683055|NCT03347175|Respiration, Artificial|respiration, artificial
4683056|NCT03347175|Advanced Cardiac Life Support|advanced cardiac life support
4683057|NCT03347175|Heart Massage|heart massage
4683058|NCT03347175|Emergency Service, Hospital|emergency service, hospital
4683059|NCT03347162|Cancer|cancer
4683060|NCT03347162|Muscle mass|muscle mass
4683061|NCT03347162|Muscle strength|muscle strength
4683062|NCT03347162|Complications|complications
4683063|NCT03347162|Patient reported outcomes|patient reported outcomes
4683065|NCT03347162|Physical function|physical function
4683066|NCT03347149|Alarms|alarms
4683067|NCT03347149|Alarm Fatigue|alarm fatigue
4683068|NCT03347149|Alarm Nuisance|alarm nuisance
4683069|NCT03347149|Alarm Reduction|alarm reduction
4683070|NCT03347149|Patient Monitoring|patient monitoring
4683071|NCT03347149|Intensive Care|intensive care
4683072|NCT03347123|Epacadostat|epacadostat
4683073|NCT03347123|nivolumab|nivolumab
4683074|NCT03347123|ipilimumab|ipilimumab
4683075|NCT03347123|lirilumab|lirilumab
4683076|NCT03347123|solid tumor|solid tumor
4683077|NCT03347123|melanoma|melanoma
4683078|NCT03347123|non-small cell lung cancer (NSCLC)|non-small cell lung cancer (nsclc)
4683079|NCT03347123|squamous cell carcinoma of the head and neck (SCCHN)|squamous cell carcinoma of the head and neck (scchn)
4683080|NCT03347123|IDO inhibitor|ido inhibitor
4683081|NCT03347110|Bimekizumab|bimekizumab
4683082|NCT03347110|Psoriatic Arthritis|psoriatic arthritis
4683083|NCT03347110|PsA|psa
4683084|NCT03347097|glioma|glioma
4683085|NCT03347097|pd-1|pd-1
4683086|NCT03347097|pd-L1|pd-l1
4683087|NCT03347097|immunotherapy|immunotherapy
4683088|NCT03347084|DBS|dbs
4683089|NCT03347084|brain imaging|brain imaging
4683090|NCT03347084|Memory|memory
4683091|NCT03347084|fMRI|fmri
4683092|NCT03347071|prevention|prevention
4683093|NCT03347071|collegiate athletes|collegiate athletes
4683094|NCT03347071|yoga|yoga
4683095|NCT03347058|immunotherapy|immunotherapy
4683096|NCT03347045|cystectomy|cystectomy
4683097|NCT03347045|nutrition|nutrition
4683098|NCT03347045|physiotherapy|physiotherapy
4683099|NCT03347045|prehabilitation|prehabilitation
4683100|NCT03347045|enhanced recovery after surgery|enhanced recovery after surgery
4683101|NCT03347019|bankart repair|bankart repair
4683102|NCT03347019|accelerated rehabilitation|accelerated rehabilitation
4683103|NCT03347019|shoulder|shoulder
4683104|NCT03346993|Bupivacaine|bupivacaine
4683105|NCT03346993|Brachial Plexus Block|brachial plexus block
4683106|NCT03346993|Ultrasound|ultrasound
4683107|NCT03346980|Spigelman|spigelman
4683108|NCT03346967|AD mesenchymal stem cells;sexual hormone deficiency|ad mesenchymal stem cells;sexual hormone deficiency
4683109|NCT03346954|: Cushing's disease, [11C]-Methionine PET/MRI, Sensitivity|: cushing's disease, [11c]-methionine pet/mri, sensitivity
4683110|NCT03346915|HPV vaccinaton|hpv vaccinaton
4683111|NCT03346915|Cervical cancer screening|cervical cancer screening
4683112|NCT03346915|Web-based mobile health education|web-based mobile health education
4683113|NCT03346915|brief negotiated interview (BNI|brief negotiated interview (bni
4683114|NCT03346889|vestibular evoked myogenic potentials|vestibular evoked myogenic potentials
4683115|NCT03346889|head impulse testing|head impulse testing
4683116|NCT03346889|quality of life|quality of life
4683117|NCT03346876|Pectus excavatum, heart rate variability|pectus excavatum, heart rate variability
4683118|NCT03346863|Electrical Cardioversion|electrical cardioversion
4683119|NCT03346824|Levosimendan|levosimendan
4683120|NCT03346824|Veno-arterial ECMO|veno-arterial ecmo
4683121|NCT03346824|Weaning|weaning
4683122|NCT03346798|External eating|external eating
4683123|NCT03346798|Technology|technology
4683124|NCT03346798|Photography|photography
4683125|NCT03346798|Social media|social media
4683126|NCT03346785|External eating|external eating
4683127|NCT03346785|Technology|technology
4683128|NCT03346785|Photography|photography
4683129|NCT03346785|Social media|social media
4683130|NCT03346759|tampon|tampon
4683131|NCT03346759|menstruation|menstruation
4683132|NCT03346759|menstrual period|menstrual period
4683133|NCT03346746|cognition|cognition
4683134|NCT03346746|glycaemic|glycaemic
4683135|NCT03346746|mood|mood
4683136|NCT03346746|diet|diet
4683137|NCT03346733|psyllium|psyllium
4683138|NCT03346733|viscous fibre|viscous fibre
4683139|NCT03346720|Data Sharing|data sharing
4683140|NCT03346655|Treatment|treatment
4683141|NCT03346642|Relapsed/Refractory|relapsed/refractory
4683142|NCT03346642|primary mediastinal large B-cell lymphoma|primary mediastinal large b-cell lymphoma
4683143|NCT03346642|PD-1 antibody|pd-1 antibody
4683144|NCT03346642|Decitabine|decitabine
4683145|NCT03346642|GVD chemotherapy|gvd chemotherapy
4683146|NCT03346564|Head and neck cancer|head and neck cancer
4683147|NCT03346564|Ritual training|ritual training
4683148|NCT03346564|disfigurement|disfigurement
4683149|NCT03346564|body image|body image
4683150|NCT03346551|Postnatal depression|postnatal depression
4683151|NCT03346551|Attachment|attachment
4683152|NCT03346551|Self-defining memories|self-defining memories
4683153|NCT03346525|echocardiography|echocardiography
4683154|NCT03346525|penicillin prophylaxis|penicillin prophylaxis
4683155|NCT03346525|intramuscular benzathine penicillin G|intramuscular benzathine penicillin g
4683156|NCT03346525|benzathine penicillin G|benzathine penicillin g
4683157|NCT03346525|low-resource setting|low-resource setting
4683158|NCT03346499|HIV|hiv
4683159|NCT03346486|Diet|diet
4683160|NCT03346486|Metabolites|metabolites
4683161|NCT03346486|Cognitive function|cognitive function
4683162|NCT03346486|Physiology|physiology
4683163|NCT03346486|LDL|ldl
4683164|NCT03346486|Diet Habit|diet habit
4683165|NCT03346486|Diet Modification|diet modification
4683166|NCT03346434|Eczema|eczema
4683167|NCT03346408|Analgesics|analgesics
4683168|NCT03346395|Adjustment disorders|adjustment disorders
4683169|NCT03346395|Anxiety disorders|anxiety disorders
4683170|NCT03346395|Depression|depression
4683171|NCT03346395|Mental disorders|mental disorders
4683172|NCT03346395|Interventional study|interventional study
4683173|NCT03346395|Primary health care|primary health care
4683174|NCT03346395|Problem solving|problem solving
4683175|NCT03346395|Randomized controlled trial|randomized controlled trial
4683176|NCT03346395|Return to work|return to work
4683177|NCT03346395|Sick leave|sick leave
4683178|NCT03346382|Epilepsy|epilepsy
4683179|NCT03346382|Emergency medical services|emergency medical services
4683180|NCT03346369|Nephrolithiasis|nephrolithiasis
4683181|NCT03346369|Urolithiasis|urolithiasis
4683182|NCT03346369|Secondary Hyperoxaluria|secondary hyperoxaluria
4683183|NCT03346369|Hyperoxaluria|hyperoxaluria
4683184|NCT03346369|Lanthanum Carbonate|lanthanum carbonate
4683185|NCT03346369|Phosphate Binder|phosphate binder
4683186|NCT03346330|Chronic pain|chronic pain
4683187|NCT03346330|Neuropathic pain|neuropathic pain
4683188|NCT03346317|Asherman syndrome|asherman syndrome
4683189|NCT03346317|hysteroscopy|hysteroscopy
4683190|NCT03346317|Uterine stent|uterine stent
4683191|NCT03346317|Estrogen|estrogen
4683192|NCT03346317|Amnion|amnion
4683193|NCT03346317|Hysteroscopic Adhesiolysis|hysteroscopic adhesiolysis
4683194|NCT03346304|Autofluorescence Broncoscopy (AFB)|autofluorescence broncoscopy (afb)
4683195|NCT03346304|Photodynamic Therapy (PDT)|photodynamic therapy (pdt)
4683196|NCT03346304|High Grade Lesions (HGLs)|high grade lesions (hgls)
4683197|NCT03346304|lung cancer|lung cancer
4683198|NCT03346304|photosensitiser|photosensitiser
4683199|NCT03346304|Fotolon|fotolon
4683200|NCT03346278|Cardiac Rehabilitation|cardiac rehabilitation
4683201|NCT03346278|Text Messaging|text messaging
4683202|NCT03346265|progressive modular rebalancing|progressive modular rebalancing
4683203|NCT03346265|PMR|pmr
4683204|NCT03346265|visual sensory cues|visual sensory cues
4683205|NCT03346265|SC|sc
4683206|NCT03346265|Parkinson Disease|parkinson disease
4683207|NCT03346265|Movement Disorders|movement disorders
4683208|NCT03346265|Parkinson rehabilitation|parkinson rehabilitation
4683209|NCT03346265|neurocognitive method|neurocognitive method
4683210|NCT03346265|motor performance|motor performance
4683211|NCT03346265|improving gait|improving gait
4683212|NCT03346265|physiotherapy|physiotherapy
4683213|NCT03346265|3D motion analysis system|3d motion analysis system
4683214|NCT03346265|improvements|improvements
4683215|NCT03346226|Delirium Dexmedetomidine elderly|delirium dexmedetomidine elderly
4683216|NCT03346213|Cardiopulmonary exercise testing|cardiopulmonary exercise testing
4683217|NCT03346213|Intravenous iron|intravenous iron
4683218|NCT03346213|Total haemoglobin mass|total haemoglobin mass
4683219|NCT03346148|Food Allergy, Restaurant staff|food allergy, restaurant staff
4683220|NCT03346109|Nasopharyngeal Carcinoma|nasopharyngeal carcinoma
4683221|NCT03346109|medial group retropharyngeal node|medial group retropharyngeal node
4683222|NCT03346096|TEAM (Thiotepa, Etoposide, Cytosar, Melphalan )|team (thiotepa, etoposide, cytosar, melphalan )
4683223|NCT03346096|autologous stem-cell transplantation (ASCT)|autologous stem-cell transplantation (asct)
4683224|NCT03346096|malignant lymphoma|malignant lymphoma
4683225|NCT03346057|arrhythmia, bradycardia, neuromuscular blocking agents, surgery, tachycardia|arrhythmia, bradycardia, neuromuscular blocking agents, surgery, tachycardia
4683226|NCT03346031|music therapy, pain, oxidative stress parameters|music therapy, pain, oxidative stress parameters
4683227|NCT03345992|Macrolides|macrolides
4683228|NCT03345979|Alkermes|alkermes
4683229|NCT03345979|schizophrenia|schizophrenia
4683230|NCT03345979|aripiprazole lauroxil|aripiprazole lauroxil
4683231|NCT03345979|ARISTADA|aristada
4683232|NCT03345940|Multiple Sclerosis|multiple sclerosis
4683233|NCT03345927|S-adenosylhomocysteine|s-adenosylhomocysteine
4683234|NCT03345927|Endothelial function|endothelial function
4683235|NCT03345914|Eczema|eczema
4683236|NCT03345901|pemafibrate|pemafibrate
4683237|NCT03345875|human papillomavirus|human papillomavirus
4683238|NCT03345875|cervical cancer|cervical cancer
4683239|NCT03345875|self-collection|self-collection
4683240|NCT03345862|Social isolation, Loneliness, Health Related Quality of Life|social isolation, loneliness, health related quality of life
4683241|NCT03345849|Upadacitinib|upadacitinib
4683242|NCT03345849|ABT-494|abt-494
4683243|NCT03345849|Efficacy|efficacy
4683244|NCT03345849|Safety|safety
4683245|NCT03345849|Crohn's Disease|crohn's disease
4683246|NCT03345836|Upadacitinib|upadacitinib
4683247|NCT03345836|Crohn's Disease|crohn's disease
4683248|NCT03345836|Efficacy|efficacy
4683249|NCT03345836|Safety|safety
4683250|NCT03345823|Upadacitinib|upadacitinib
4683251|NCT03345823|ABT-494|abt-494
4683252|NCT03345823|Extension Study|extension study
4683253|NCT03345823|Efficacy|efficacy
4683254|NCT03345823|Safety|safety
4683255|NCT03345823|Crohn's Disease|crohn's disease
4683256|NCT03345823|Maintenance Study|maintenance study
4683257|NCT03345810|NSCLC|nsclc
4683258|NCT03345810|Non small cell lung cancer|non small cell lung cancer
4683259|NCT03345797|Paediatric|paediatric
4683260|NCT03345758|respiratory failure, circulatory failure|respiratory failure, circulatory failure
4683261|NCT03345745|Fetuin-A|fetuin-a
4683262|NCT03345745|S100A12|s100a12
4683263|NCT03345745|C-Reactive Protein|c-reactive protein
4683264|NCT03345745|Chronic Periodontitis|chronic periodontitis
4683265|NCT03345706|Hypothermia,ECPR|hypothermia,ecpr
4683266|NCT03345693|Rehabilitation|rehabilitation
4683267|NCT03345693|MoTrack Therapy|motrack therapy
4683268|NCT03345693|Telemedicine|telemedicine
4683269|NCT03345693|Computer Vision|computer vision
4683270|NCT03345693|Compliance|compliance
4683271|NCT03345680|Dental visits|dental visits
4683272|NCT03345680|School-based program|school-based program
4683273|NCT03345680|Dental screening|dental screening
4683274|NCT03345680|Dental Caries|dental caries
4683275|NCT03345641|premature birth|premature birth
4683276|NCT03345641|mother's post-traumatic reaction|mother's post-traumatic reaction
4683277|NCT03345641|mother-infant interactions|mother-infant interactions
4683278|NCT03345628|sedation|sedation
4683279|NCT03345628|critical care|critical care
4683280|NCT03345628|infant|infant
4683281|NCT03345628|neurodevelopment|neurodevelopment
4683282|NCT03345615|atrial fibrillation|atrial fibrillation
4683283|NCT03345615|myocardial infarction|myocardial infarction
4683284|NCT03345615|intensive monitoring|intensive monitoring
4683285|NCT03345615|oral anticoagulation|oral anticoagulation
4683286|NCT03345615|hospitalization|hospitalization
4683287|NCT03345589|Ursodeoxycholic Acid|ursodeoxycholic acid
4683288|NCT03345576|Electric Stimulation|electric stimulation
4683289|NCT03345576|Spinal Cord Injuries|spinal cord injuries
4683290|NCT03345576|Muscle Denervation|muscle denervation
4683291|NCT03345576|carbohydrate metabolism|carbohydrate metabolism
4683292|NCT03345576|Lipids metabolism|lipids metabolism
4683293|NCT03345576|Basal Metabolic Rate|basal metabolic rate
4683294|NCT03345576|Muscle Proteins|muscle proteins
4683295|NCT03345576|Mitochondria, Muscle|mitochondria, muscle
4683296|NCT03345576|RNA|rna
4683297|NCT03345576|Rehabilitation|rehabilitation
4683298|NCT03345563|Prostate Cancer|prostate cancer
4683299|NCT03345563|Fatigue|fatigue
4683300|NCT03345563|Elderly|elderly
4683301|NCT03345563|Supportive Care|supportive care
4683302|NCT03345563|Light Exercise|light exercise
4683303|NCT03345563|Quality of Life|quality of life
4683304|NCT03345537|Inflammatory|inflammatory
4683305|NCT03345537|Optic neuritis|optic neuritis
4683306|NCT03345537|autoantibodies anti MOG|autoantibodies anti mog
4683307|NCT03345524|Obstructive Sleep Apnea|obstructive sleep apnea
4683308|NCT03345524|OSA|osa
4683309|NCT03345524|Peer-Buddies|peer-buddies
4683310|NCT03345524|CPAP|cpap
4683311|NCT03345524|CPAP Adherence|cpap adherence
4683312|NCT03345511|ultrasound guided caudal block|ultrasound guided caudal block
4683313|NCT03345511|anal surgery|anal surgery
4683314|NCT03345485|Phase 1 clinical trial|phase 1 clinical trial
4683315|NCT03345485|Solid Tumor|solid tumor
4683316|NCT03345485|Small Cell Lung Cancer|small cell lung cancer
4683317|NCT03345485|Breast Cancer|breast cancer
4683318|NCT03345485|Ovarian Cancer|ovarian cancer
4683319|NCT03345485|Soft Tissue Sarcoma|soft tissue sarcoma
4683320|NCT03345485|Relapsed/Refractory|relapsed/refractory
4683321|NCT03345485|Triple Negative|triple negative
4683322|NCT03345485|GIST|gist
4683323|NCT03345485|Epithelial cancer|epithelial cancer
4683324|NCT03345485|Peritoneal cancer|peritoneal cancer
4683325|NCT03345485|Fallopian tube cancer|fallopian tube cancer
4683326|NCT03345485|Metastatic|metastatic
4683327|NCT03345485|Advanced|advanced
4683328|NCT03345459|Internet-based treatment|internet-based treatment
4683329|NCT03345407|Nemiralisib|nemiralisib
4683330|NCT03345407|Dose-Finding|dose-finding
4683331|NCT03345407|GSK2269557|gsk2269557
4683332|NCT03345407|Acute Moderate or Severe Exacerbation of Chronic Obstructive Pulmonary Disease|acute moderate or severe exacerbation of chronic obstructive pulmonary disease
4683333|NCT03345394|crack cocaine|crack cocaine
4683334|NCT03345394|contingency management|contingency management
4683335|NCT03345394|ambulatory treatment|ambulatory treatment
4683336|NCT03345394|Brazil|brazil
4683337|NCT03345368|transcranial magnetic stimulation|transcranial magnetic stimulation
4683338|NCT03345368|obesity|obesity
4683339|NCT03345368|diet|diet
4683340|NCT03345303|Bortezomib|bortezomib
4683341|NCT03345290|Aging|aging
4683342|NCT03345290|Central pressure|central pressure
4683343|NCT03345290|FDG PET|fdg pet
4683344|NCT03345290|Quantita|quantita
4683345|NCT03345277|Termperature|termperature
4683346|NCT03345277|Fever|fever
4683347|NCT03345277|Vital Signs|vital signs
4683348|NCT03345264|Sexual Dysfunction|sexual dysfunction
4683349|NCT03345264|Fertility Disorders|fertility disorders
4683350|NCT03345264|Cancer|cancer
4683351|NCT03345251|ICSI - physical - Manipulation - scratching|icsi - physical - manipulation - scratching
4683352|NCT03345238|Dry Needling|dry needling
4683353|NCT03345238|Myofascial Pain Syndrome|myofascial pain syndrome
4683354|NCT03345238|Neurophysiological effects|neurophysiological effects
4683355|NCT03345238|Autonomic Nervous System|autonomic nervous system
4683356|NCT03345225|Chemoembolization (TACE)|chemoembolization (tace)
4683357|NCT03345225|HCC|hcc
4683358|NCT03345225|Liver Cancer|liver cancer
4683359|NCT03345199|Multiple Sclerosis, Inspiratory Muscle Training|multiple sclerosis, inspiratory muscle training
4683360|NCT03345186|Outcome|outcome
4683361|NCT03345186|Gout|gout
4683362|NCT03345147|Vitamin A|vitamin a
4683363|NCT03345147|Isotopic dilution|isotopic dilution
4683364|NCT03345147|dietary assessment|dietary assessment
4683365|NCT03345095|Marizomib|marizomib
4683366|NCT03345095|Temozolomide|temozolomide
4683367|NCT03345095|Glioblastoma|glioblastoma
4683368|NCT03345095|Phase III|phase iii
4683369|NCT03345069|Premature|premature
4683370|NCT03345069|Magnetic resonance imaging (MRI)|magnetic resonance imaging (mri)
4683371|NCT03345069|Neurodevelopmental impairment|neurodevelopmental impairment
4683372|NCT03345069|Cerebral Palsy|cerebral palsy
4683373|NCT03345069|Cognitive Impairment|cognitive impairment
4683374|NCT03345069|Diffusion MRI|diffusion mri
4683375|NCT03345069|Functional MRI|functional mri
4683376|NCT03345069|Infant|infant
4683377|NCT03345069|Magnetic resonance spectroscopy|magnetic resonance spectroscopy
4683378|NCT03345043|VAL-339851|val-339851
4683379|NCT03345043|H7N9 antigen mRNA|h7n9 antigen mrna
4683380|NCT03345043|Influenza vaccine|influenza vaccine
4683381|NCT03345030|comet assay|comet assay
4683382|NCT03345030|DNA damage|dna damage
4683383|NCT03345030|granulosa|granulosa
4683384|NCT03345030|IVF outcome|ivf outcome
4683385|NCT03345004|Diamyd|diamyd
4683386|NCT03345004|Diabetes|diabetes
4683387|NCT03345004|Juvenile Diabetes|juvenile diabetes
4683388|NCT03345004|Diabetes Type 1|diabetes type 1
4683389|NCT03345004|Type 1 Diabetes|type 1 diabetes
4683390|NCT03345004|Autoimmune Diabetes|autoimmune diabetes
4683391|NCT03345004|Insulin Dependent Diabetes|insulin dependent diabetes
4683392|NCT03345004|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
4683393|NCT03345004|rhGAD65|rhgad65
4683394|NCT03345004|GAD65|gad65
4683395|NCT03345004|GAD-Alum|gad-alum
4683396|NCT03345004|Diabetes Mellitus|diabetes mellitus
4683397|NCT03345004|Diabetes Mellitus Type 1|diabetes mellitus type 1
4683398|NCT03345004|Glucose Metabolism Disorders|glucose metabolism disorders
4683399|NCT03345004|Metabolic Diseases|metabolic diseases
4683400|NCT03345004|Vitamin D|vitamin d
4683401|NCT03345004|Vitamins|vitamins
4683402|NCT03345004|Micronutrients|micronutrients
4683403|NCT03345004|Cholecalciferol|cholecalciferol
4683404|NCT03345004|Ergocalciferols|ergocalciferols
4683405|NCT03344991|Hypothermia|hypothermia
4683406|NCT03344991|Newborn|newborn
4683407|NCT03344978|Neonate|neonate
4683408|NCT03344978|Premature|premature
4683409|NCT03344978|Hypothermia|hypothermia
4683410|NCT03344978|Cardboard|cardboard
4683411|NCT03344978|Cot|cot
4683412|NCT03344965|Metastatic Breast Cancer|metastatic breast cancer
4683413|NCT03344965|Invasive Breast Cancer|invasive breast cancer
4683414|NCT03344965|Somatic Mutation Breast Cancer (BRCA1)|somatic mutation breast cancer (brca1)
4683415|NCT03344965|Somatic Mutation Breast Cancer (BRCA2)|somatic mutation breast cancer (brca2)
4683416|NCT03344926|Acceptance and Commitment therapy|acceptance and commitment therapy
4683417|NCT03344926|ACT|act
4683418|NCT03344926|CBT|cbt
4683419|NCT03344926|Smart phone|smart phone
4683420|NCT03344926|Internet|internet
4683421|NCT03344926|Intervention|intervention
4683422|NCT03344900|mHealth|mhealth
4683423|NCT03344900|Medication adherence|medication adherence
4683424|NCT03344900|Barriers to adherence|barriers to adherence
4683425|NCT03344887|anemia|anemia
4683426|NCT03344887|donor sex|donor sex
4683427|NCT03344887|prospective blinded pragmatic randomized|prospective blinded pragmatic randomized
4683428|NCT03344874|heart sounds|heart sounds
4683429|NCT03344874|Stethee|stethee
4683430|NCT03344874|electronic stethoscope|electronic stethoscope
4683431|NCT03344861|lung cancer|lung cancer
4683432|NCT03344861|lung carcinoma|lung carcinoma
4683433|NCT03344861|lung metastases|lung metastases
4683434|NCT03344835|Prostate Cancer|prostate cancer
4683435|NCT03344835|Disease Outcome|disease outcome
4683436|NCT03344822|68Ga-PSMA PET|68ga-psma pet
4683437|NCT03344809|lymphoma|lymphoma
4683438|NCT03344809|unclassifiable|unclassifiable
4683439|NCT03344809|next|next
4683440|NCT03344809|generation|generation
4683441|NCT03344809|sequencing|sequencing
4683442|NCT03344796|Skin Cancer|skin cancer
4683443|NCT03344796|Sunburn, erythema|sunburn, erythema
4683444|NCT03344796|UV Exposure, Sunburn|uv exposure, sunburn
4683445|NCT03344796|Wearable UV Device|wearable uv device
4683446|NCT03344757|prostate cancer|prostate cancer
4683447|NCT03344757|localized prostate cancer|localized prostate cancer
4683448|NCT03344757|spanish|spanish
4683449|NCT03344757|latino|latino
4683450|NCT03344757|hispanic|hispanic
4683451|NCT03344757|stress management|stress management
4683452|NCT03344744|Subarachnoid Haemorrhage|subarachnoid haemorrhage
4683453|NCT03344679|Pectoral nerve block|pectoral nerve block
4683454|NCT03344679|Adenosine|adenosine
4683455|NCT03344679|Magnesium sulphate|magnesium sulphate
4683456|NCT03344640|Overuse tendinopathy, shoulder, rotator cuff, IL-17A-Ab|overuse tendinopathy, shoulder, rotator cuff, il-17a-ab
4683457|NCT03344614|third-line treatment|third-line treatment
4683458|NCT03344614|apatinib|apatinib
4683459|NCT03344614|raltitrexed|raltitrexed
4683460|NCT03344549|eHealth|ehealth
4683461|NCT03344549|Nutrition Therapy|nutrition therapy
4683462|NCT03344549|Telehealth|telehealth
4683463|NCT03344549|Diabetic Kidney Disease|diabetic kidney disease
4683464|NCT03344549|Chronic Kidney Disease|chronic kidney disease
4683465|NCT03344536|Debio 1347|debio 1347
4683466|NCT03344536|Fulvestrant|fulvestrant
4683467|NCT03344536|17-379|17-379
4683468|NCT03344510|lidocaine|lidocaine
4683469|NCT03344510|vibration|vibration
4683470|NCT03344510|anesthesia|anesthesia
4683471|NCT03344510|injection|injection
4683472|NCT03344510|pain|pain
4683473|NCT03344510|discomfort|discomfort
4683474|NCT03344510|dermatology|dermatology
4683475|NCT03344510|dermatologic surgery|dermatologic surgery
4683476|NCT03344510|local|local
4683477|NCT03344510|device|device
4683478|NCT03344471|preterm delivery|preterm delivery
4683479|NCT03344471|PTSD|ptsd
4683480|NCT03344471|prematurity|prematurity
4683481|NCT03344471|birth|birth
4683482|NCT03344471|personality|personality
4683483|NCT03344458|Human Growth Hormone|human growth hormone
4683484|NCT03344458|hGH|hgh
4683485|NCT03344458|GHD|ghd
4683486|NCT03344458|rhGH|rhgh
4683487|NCT03344458|Pediatric Growth Hormone Deficiency|pediatric growth hormone deficiency
4683488|NCT03344458|Long Acting Growth Hormone|long acting growth hormone
4683489|NCT03344458|Somatropin|somatropin
4683490|NCT03344458|Prodrug|prodrug
4683491|NCT03344458|Growth Failure|growth failure
4683492|NCT03344458|Growth Hormone Replacement Therapy|growth hormone replacement therapy
4683493|NCT03344458|Sustained Release Growth Hormone|sustained release growth hormone
4683494|NCT03344458|Growth Hormone Deficiency|growth hormone deficiency
4683495|NCT03344458|TransCon GH|transcon gh
4683496|NCT03344419|cocaine|cocaine
4683497|NCT03344419|mindfulness based relapse prevention|mindfulness based relapse prevention
4683498|NCT03344419|motivational enhancement therapy|motivational enhancement therapy
4683499|NCT03344406|Asthma|asthma
4683500|NCT03344406|Telephone interview|telephone interview
4683501|NCT03344406|Cross-sectional|cross-sectional
4683502|NCT03344406|Qualitative research|qualitative research
4683503|NCT03344406|E-RS: COPD|e-rs: copd
4683504|NCT03344380|Gene polymorphism|gene polymorphism
4683505|NCT03344380|acute kidney injury|acute kidney injury
4683506|NCT03344380|liver transplantation|liver transplantation
4683507|NCT03344367|Non Hodgkin Lymphoma|non hodgkin lymphoma
4683508|NCT03344367|CD19-targeted chimeric antigen receptor|cd19-targeted chimeric antigen receptor
4683509|NCT03344367|JWCAR029|jwcar029
4683510|NCT03344341|T2DM|t2dm
4683511|NCT03344328|Chemotherapy|chemotherapy
4683512|NCT03344328|Bortezomib|bortezomib
4683513|NCT03344328|Multiple myeloma|multiple myeloma
4683514|NCT03344315|Gingival recession|gingival recession
4683515|NCT03344315|Collagen matrix|collagen matrix
4683516|NCT03344315|Connective tissue graft|connective tissue graft
4683517|NCT03344315|Coronally advanced flap|coronally advanced flap
4683518|NCT03344315|Root coverage|root coverage
4683519|NCT03344315|keratinized tissue|keratinized tissue
4683520|NCT03344315|Periodontal disease|periodontal disease
4683521|NCT03344289|Linked-color-imaging|linked-color-imaging
4683522|NCT03344289|Advanced Imaging Techniques|advanced imaging techniques
4683523|NCT03344276|carotid stenosis|carotid stenosis
4683524|NCT03344276|neurocognition|neurocognition
4683525|NCT03344276|carotid stenting|carotid stenting
4683526|NCT03344276|circle of willis|circle of willis
4683527|NCT03344250|Adoptive Cell Therapy|adoptive cell therapy
4683528|NCT03344250|Armed Activated T-cells|armed activated t-cells
4683529|NCT03344250|Bispecific Antibodies|bispecific antibodies
4683530|NCT03344250|Immunotherapy|immunotherapy
4683531|NCT03344185|glycaemic index|glycaemic index
4683532|NCT03344185|mood|mood
4683533|NCT03344185|glucose|glucose
4683534|NCT03344185|diet|diet
4683535|NCT03344159|Mineralocorticoid receptor antagonist|mineralocorticoid receptor antagonist
4683536|NCT03344159|Brain natriuretic peptide (BNP)|brain natriuretic peptide (bnp)
4683537|NCT03344159|Sympathetic Nervous System|sympathetic nervous system
4683538|NCT03344159|Positron Emissions Tomography|positron emissions tomography
4683539|NCT03344146|ischemic stroke, direct oral anticoagulants, adherence, electronic monitoring, adherence-improving intervention, polypharmacy|ischemic stroke, direct oral anticoagulants, adherence, electronic monitoring, adherence-improving intervention, polypharmacy
4683540|NCT03344133|Obesity|obesity
4683541|NCT03344133|Exercise|exercise
4683542|NCT03344133|CVD risk factors|cvd risk factors
4683543|NCT03344133|Appetite Regulation|appetite regulation
4683544|NCT03344133|Gut Microbiota|gut microbiota
4683545|NCT03344120|Symptoms and Signs|symptoms and signs
4683546|NCT03344120|Pain|pain
4683547|NCT03344120|Ureteral Calculi|ureteral calculi
4683548|NCT03344120|Ureteroscopy|ureteroscopy
4683549|NCT03344120|Ureteral Stents|ureteral stents
4683550|NCT03344107|Symptoms and Signs|symptoms and signs
4683551|NCT03344107|Pain|pain
4683552|NCT03344107|Renal Calculi|renal calculi
4683553|NCT03344107|Ureteral Stent|ureteral stent
4683554|NCT03344107|Ureteroscopy|ureteroscopy
4683555|NCT03344081|attention|attention
4683556|NCT03344081|interoception|interoception
4683557|NCT03344081|meditation|meditation
4683558|NCT03344081|mind wandering|mind wandering
4683559|NCT03344068|nasopharyngeal carcinoma|nasopharyngeal carcinoma
4683560|NCT03344068|nutritional support|nutritional support
4683561|NCT03344068|early and whole course|early and whole course
4683562|NCT03344068|efficacy and safety|efficacy and safety
4683563|NCT03344055|Adenoma Detection Rate|adenoma detection rate
4683564|NCT03344055|Endocuff|endocuff
4683565|NCT03344055|Colonoscopy|colonoscopy
4683566|NCT03344029|Influenza|influenza
4683567|NCT03344029|Flu|flu
4683568|NCT03343964|aEEG, cEEG|aeeg, ceeg
4683569|NCT03343951|Physical Therapists|physical therapists
4683570|NCT03343951|Diagnosis|diagnosis
4683571|NCT03343951|Clinical Competence|clinical competence
4683572|NCT03343951|Interprofessional Relations|interprofessional relations
4683573|NCT03343951|Cost Analysis|cost analysis
4683574|NCT03343938|Group embryo culture|group embryo culture
4683575|NCT03343938|Low oxygen tension|low oxygen tension
4683576|NCT03343938|Closed station|closed station
4683577|NCT03343938|Embryo handling|embryo handling
4683578|NCT03343925|Reinfection|reinfection
4683579|NCT03343912|Estriol|estriol
4683580|NCT03343912|Trimegestone|trimegestone
4683581|NCT03343912|Vaginal Ring|vaginal ring
4683582|NCT03343886|Health Status|health status
4683583|NCT03343886|Well-being|well-being
4683584|NCT03343886|Mental Health|mental health
4683585|NCT03343886|Risk Factors|risk factors
4683586|NCT03343886|Aging|aging
4683587|NCT03343873|anesthetics; fMRI; EEG; functional connectivity|anesthetics; fmri; eeg; functional connectivity
4683588|NCT03343834|Allogenic cell stem transplant (HSCT)|allogenic cell stem transplant (hsct)
4683589|NCT03343834|EBV-induced lymphoproliferation|ebv-induced lymphoproliferation
4683590|NCT03343834|Epigenetic|epigenetic
4683591|NCT03343808|Cooled radiofrequency|cooled radiofrequency
4683592|NCT03343808|chronic knee pain|chronic knee pain
4683593|NCT03343808|knee arthroplasty|knee arthroplasty
4683594|NCT03343808|genicular nerve|genicular nerve
4683595|NCT03343782|Diabetes|diabetes
4683596|NCT03343782|BM mesenchymal stem cell|bm mesenchymal stem cell
4683597|NCT03343717|Pneumonia, Ventilator-Associated|pneumonia, ventilator-associated
4683598|NCT03343717|Mechanical ventilation|mechanical ventilation
4683599|NCT03343717|Physical therapy|physical therapy
4683600|NCT03343665|Nivolumab|nivolumab
4683601|NCT03343652|Hodgkin's Lymphoma|hodgkin's lymphoma
4683602|NCT03343652|Nivolumab|nivolumab
4683603|NCT03343652|Bendamustine Hydrochloride|bendamustine hydrochloride
4683604|NCT03343626|Drug therapy|drug therapy
4683605|NCT03343613|IDO-1 Inhibitor|ido-1 inhibitor
4683606|NCT03343613|IDO1 Inhibitor|ido1 inhibitor
4683607|NCT03343613|IDO Inhibitor|ido inhibitor
4683608|NCT03343574|Parkinson's Disease|parkinson's disease
4683609|NCT03343574|Neurogenic orthostatic hypotension|neurogenic orthostatic hypotension
4683610|NCT03343574|Orthostatic intolerance|orthostatic intolerance
4683611|NCT03343574|Exercise|exercise
4683612|NCT03343574|Abdominal binder|abdominal binder
4683613|NCT03343574|Autonomic dysfunction|autonomic dysfunction
4683614|NCT03343574|Dizziness|dizziness
4683615|NCT03343574|Physical Therapy|physical therapy
4683616|NCT03343574|Blood pressure|blood pressure
4683617|NCT03343574|Heart rate|heart rate
4683618|NCT03343574|Autonomic function testing|autonomic function testing
4683619|NCT03343574|Neurology|neurology
4683620|NCT03343574|Falls risk|falls risk
4683621|NCT03343574|Autonomic Nervous System|autonomic nervous system
4683622|NCT03343574|Autonomic reflex screening|autonomic reflex screening
4683623|NCT03343574|Cerebral blood flow|cerebral blood flow
4683624|NCT03343574|Cerebral perfusion|cerebral perfusion
4683625|NCT03343574|Activities of Daily Living|activities of daily living
4683626|NCT03343535|portable ex-vivo lung perfusion|portable ex-vivo lung perfusion
4683627|NCT03343535|breathing lung transplant|breathing lung transplant
4683628|NCT03343535|portable OCS Lung System|portable ocs lung system
4683629|NCT03343522|Vascular function|vascular function
4683630|NCT03343522|Physical training|physical training
4683631|NCT03343522|Laser Speckle Contrast Imaging|laser speckle contrast imaging
4683632|NCT03343509|Hemorrhoidectomy|hemorrhoidectomy
4683633|NCT03343509|Metronidazole|metronidazole
4683634|NCT03343509|Postoperative analgesia|postoperative analgesia
4683635|NCT03343496|awake fiberoptic intubation|awake fiberoptic intubation
4683636|NCT03343483|Volunteerism|volunteerism
4683637|NCT03343483|Aged|aged
4683638|NCT03343483|Loneliness|loneliness
4683639|NCT03343483|Quality of Life|quality of life
4683640|NCT03343470|Cushing Syndrome|cushing syndrome
4683641|NCT03343470|Adrenal Insufficiency|adrenal insufficiency
4683642|NCT03343470|Peripheral blood mononuclear cells|peripheral blood mononuclear cells
4683643|NCT03343470|Melatonin|melatonin
4683644|NCT03343470|Cortisol|cortisol
4683645|NCT03343470|Immunological profile|immunological profile
4683646|NCT03343470|Cushing Disease|cushing disease
4683647|NCT03343457|Anxiety|anxiety
4683648|NCT03343457|Chronic Pain|chronic pain
4683649|NCT03343431|Hepatitis B|hepatitis b
4683650|NCT03343431|Hepatitis B eAg|hepatitis b eag
4683651|NCT03343431|Pregnancy|pregnancy
4683652|NCT03343418|Bleeding|bleeding
4683653|NCT03343418|Valve Cardiac Surgery|valve cardiac surgery
4683654|NCT03343418|Desmopressin|desmopressin
4683655|NCT03343405|Mind/Body|mind/body
4683656|NCT03343392|Hydrogen Peroxide, Tooth Bleaching, Analgesics.|hydrogen peroxide, tooth bleaching, analgesics.
4683657|NCT03343379|Abdominal muscles|abdominal muscles
4683658|NCT03343379|Back muscles|back muscles
4683659|NCT03343379|Core stability|core stability
4683660|NCT03343379|Field test|field test
4683661|NCT03343379|Muscle strength dynamometer|muscle strength dynamometer
4683662|NCT03343379|Lower extremity injury|lower extremity injury
4683663|NCT03343379|Risk assessment|risk assessment
4683664|NCT03343379|Prospective studies|prospective studies
4683665|NCT03343366|fasting plasma glucose|fasting plasma glucose
4683666|NCT03343366|fasting plasma insulin|fasting plasma insulin
4683667|NCT03343366|HOMA-IR insulin resistance|homa-ir insulin resistance
4683668|NCT03343366|clinical attachment loss|clinical attachment loss
4683669|NCT03343353|burn injury, phototherapy, wound healing|burn injury, phototherapy, wound healing
4683670|NCT03343301|gastrointestinal cancer|gastrointestinal cancer
4683671|NCT03343288|Silver Hydroxiapatite Coating|silver hydroxiapatite coating
4683672|NCT03343288|Antimicrobial|antimicrobial
4683673|NCT03343288|Medical Device|medical device
4683674|NCT03343275|Stent, incrustation, pH Control|stent, incrustation, ph control
4683675|NCT03343236|Head and neck cancer|head and neck cancer
4683676|NCT03343236|Observational study|observational study
4683677|NCT03343236|Three tertiary hospitals|three tertiary hospitals
4683678|NCT03343236|Long-term follow-up|long-term follow-up
4683679|NCT03343236|Survival|survival
4683680|NCT03343236|Immune response|immune response
4683681|NCT03343236|Metabolomics|metabolomics
4683682|NCT03343197|Glioma|glioma
4683683|NCT03343197|IDH1|idh1
4683684|NCT03343197|AG-120|ag-120
4683685|NCT03343197|AG-881|ag-881
4683686|NCT03343184|dentin bonding agents|dentin bonding agents
4683687|NCT03343184|tooth sensitivity|tooth sensitivity
4683688|NCT03343184|composite resin restoration|composite resin restoration
4683689|NCT03343171|total hip arthroplasty|total hip arthroplasty
4683690|NCT03343145|Neutropenia|neutropenia
4683691|NCT03343106|Acceptance and Commitment Therapy|acceptance and commitment therapy
4683692|NCT03343106|Exposure and Response Prevention|exposure and response prevention
4683693|NCT03343106|Psychotherapy|psychotherapy
4683694|NCT03343106|Obsessive-Compulsive Disorder|obsessive-compulsive disorder
4683695|NCT03343106|Treatment Acceptability|treatment acceptability
4683696|NCT03343106|Treatment Adherence|treatment adherence
4683697|NCT03343093|Erectile Dysfunction|erectile dysfunction
4683698|NCT03343080|Cardiac Surgery|cardiac surgery
4683699|NCT03343067|Endometriosis associated pain|endometriosis associated pain
4683700|NCT03343067|Elagolix|elagolix
4683701|NCT03343067|Non-menstrual pelvic pain (NMPP)|non-menstrual pelvic pain (nmpp)
4683702|NCT03343067|Dysmenorrhea (DYS)|dysmenorrhea (dys)
4683703|NCT03343054|Phase 1|phase 1
4683704|NCT03343054|talazoparib|talazoparib
4683705|NCT03343054|PF-06944076|pf-06944076
4683706|NCT03343054|MDV3800|mdv3800
4683707|NCT03343054|BMN673|bmn673
4683708|NCT03343054|PARP inhibitor|parp inhibitor
4683709|NCT03343054|Japanese|japanese
4683710|NCT03343054|solid tumors|solid tumors
4683711|NCT03343054|C3441030|c3441030
4683712|NCT03343028|veterans|veterans
4683713|NCT03343028|post traumatic stress disorder|post traumatic stress disorder
4683714|NCT03343028|depression|depression
4683715|NCT03343015|TMD, centric relation, complete dentures|tmd, centric relation, complete dentures
4683716|NCT03342989|delirium|delirium
4683717|NCT03342989|speed of processing|speed of processing
4683718|NCT03342989|cognitive decline|cognitive decline
4683719|NCT03342976|Frailty|frailty
4683720|NCT03342976|Physical impairment|physical impairment
4683721|NCT03342976|Cognitive decline|cognitive decline
4683722|NCT03342976|ICT|ict
4683723|NCT03342937|pembrolizumab|pembrolizumab
4683724|NCT03342937|XELOX|xelox
4683725|NCT03342937|gastric cancer|gastric cancer
4683726|NCT03342924|cognitive control|cognitive control
4683727|NCT03342924|physical fitness|physical fitness
4683728|NCT03342924|minority|minority
4683729|NCT03342898|Drug Therapy|drug therapy
4683730|NCT03342885|Low Back Pain|low back pain
4683731|NCT03342885|Sleep ergonomics|sleep ergonomics
4683732|NCT03342872|Adolescents|adolescents
4683733|NCT03342872|Substance Use Disorders|substance use disorders
4683734|NCT03342859|Uterine fibroids|uterine fibroids
4683735|NCT03342859|Bleeding reduction|bleeding reduction
4683736|NCT03342859|Vilaprisan|vilaprisan
4683737|NCT03342859|Mode of action|mode of action
4683738|NCT03342859|Hysterectomy|hysterectomy
4683739|NCT03342859|Myomectomy|myomectomy
4683740|NCT03342859|Pharmacodynamic|pharmacodynamic
4683741|NCT03342807|Hypertriglyceridemia-induced acute pancreatitis|hypertriglyceridemia-induced acute pancreatitis
4683742|NCT03342807|insulin|insulin
4683743|NCT03342807|triglyceride|triglyceride
4683744|NCT03342807|treatment|treatment
4683745|NCT03342781|bronchiolitis|bronchiolitis
4683746|NCT03342781|diffuser mask|diffuser mask
4683747|NCT03342781|high-flow nasal oxygen|high-flow nasal oxygen
4683748|NCT03342781|pediatric intensive-care unit|pediatric intensive-care unit
4683749|NCT03342716|Pancreatitis|pancreatitis
4683750|NCT03342716|Multiple Organ Dysfunction Syndrome|multiple organ dysfunction syndrome
4683751|NCT03342690|Selara|selara
4683752|NCT03342690|Chronic Heart Failure|chronic heart failure
4683753|NCT03342677|Cirrhosis|cirrhosis
4683754|NCT03342677|HCC|hcc
4683755|NCT03342677|Primovist|primovist
4683756|NCT03342664|ICH|ich
4683757|NCT03342651|Vitamin D|vitamin d
4683758|NCT03342651|general anesthesia|general anesthesia
4683759|NCT03342651|respiratory complications|respiratory complications
4683760|NCT03342638|Autologous Stem Cell Transplantation|autologous stem cell transplantation
4683761|NCT03342638|Stem Cells|stem cells
4683762|NCT03342638|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
4683763|NCT03342625|High intensity focused ultrasound|high intensity focused ultrasound
4683764|NCT03342599|Alpha Lipoic Acid|alpha lipoic acid
4683765|NCT03342586|resting state functional Magnetic Resonance Imaging|resting state functional magnetic resonance imaging
4683766|NCT03342586|rsfMRI|rsfmri
4683767|NCT03342586|17-403|17-403
4683768|NCT03342560|Liver Fibrosis|liver fibrosis
4683769|NCT03342560|Ultrasound Elastography|ultrasound elastography
4683770|NCT03342560|Liver Steatosis|liver steatosis
4683771|NCT03342560|Shear wave speed|shear wave speed
4683772|NCT03342560|Stiffness|stiffness
4683773|NCT03342560|Liver Biopsy|liver biopsy
4683774|NCT03342547|Norovirus|norovirus
4683775|NCT03342521|myocardial infarction|myocardial infarction
4683776|NCT03342521|optical coherence tomography|optical coherence tomography
4683777|NCT03342521|intracoronary thrombus|intracoronary thrombus
4683778|NCT03342521|VerifyNow|verifynow
4683779|NCT03342508|Maternal outcomes|maternal outcomes
4683780|NCT03342508|Neonatal Outcomes|neonatal outcomes
4683781|NCT03342495|transition, young adults, transfer|transition, young adults, transfer
4683782|NCT03342482|MSG|msg
4683783|NCT03342482|Gulf War Syndrome|gulf war syndrome
4683784|NCT03342482|Diet|diet
4683785|NCT03342482|Glutamate|glutamate
4683786|NCT03342469|ADHD|adhd
4683787|NCT03342469|Food Additives|food additives
4683788|NCT03342469|Artificial Food Coloring|artificial food coloring
4683789|NCT03342469|Diet|diet
4683790|NCT03342456|Helicobacter pylori eradication|helicobacter pylori eradication
4683791|NCT03342456|Duodenal Ulcer|duodenal ulcer
4683792|NCT03342456|Ilaprazole/Doxycycline-based Bismuth-containing quadruple therapy|ilaprazole/doxycycline-based bismuth-containing quadruple therapy
4683793|NCT03342443|memantine|memantine
4683794|NCT03342443|radiotherapy-related cognitive impairment|radiotherapy-related cognitive impairment
4683795|NCT03342417|breast cancer|breast cancer
4683796|NCT03342417|ovarian cancer|ovarian cancer
4683797|NCT03342417|gastric cancer|gastric cancer
4683798|NCT03342404|(β)-Thalassemia|(β)-thalassemia
4683799|NCT03342404|Beta-Thalassemia|beta-thalassemia
4683800|NCT03342404|Phase 2|phase 2
4683801|NCT03342404|Luspatercept|luspatercept
4683802|NCT03342404|ACE-536|ace-536
4683803|NCT03342404|Safety|safety
4683804|NCT03342404|Efficacy|efficacy
4683805|NCT03342404|Placebo|placebo
4683806|NCT03342404|Red Blood Cell Transfusions|red blood cell transfusions
4683807|NCT03342404|Erythrocyte transfusion|erythrocyte transfusion
4683808|NCT03342404|Hb increase|hb increase
4683810|NCT03342378|HPV|hpv
4683811|NCT03342378|HPV-positive|hpv-positive
4683812|NCT03342378|Oropharynx Cancer|oropharynx cancer
4683813|NCT03342352|Squamous cell carcinoma of the head and neck|squamous cell carcinoma of the head and neck
4683814|NCT03342352|programmed cell death protein 1 (PD-1) antibody|programmed cell death protein 1 (pd-1) antibody
4683815|NCT03342352|indoleamine 2,3-dioxygenase (IDO) inhibitor|indoleamine 2,3-dioxygenase (ido) inhibitor
4683816|NCT03342339|influence of emotions|influence of emotions
4683817|NCT03342339|positif emotional induction|positif emotional induction
4683818|NCT03342339|decision making|decision making
4683819|NCT03342339|Iowa Gambling Task|iowa gambling task
4683820|NCT03342326|Lexical priming|lexical priming
4683821|NCT03342326|Healthy Aging|healthy aging
4683822|NCT03342300|soft tissue sarcoma|soft tissue sarcoma
4683823|NCT03342300|pegylated liposomal doxorubicin|pegylated liposomal doxorubicin
4683824|NCT03342300|pirarubicin|pirarubicin
4683825|NCT03342300|toxicity for heart|toxicity for heart
4683826|NCT03342300|cumulative dose|cumulative dose
4683827|NCT03342287|gut microbiome|gut microbiome
4683828|NCT03342287|anxiety|anxiety
4683829|NCT03342287|depression|depression
4683830|NCT03342287|cognition|cognition
4683831|NCT03342235|Excimer Laser Surgery|excimer laser surgery
4683832|NCT03342235|Photorefractive Keratectomy|photorefractive keratectomy
4683833|NCT03342235|Anisometropic Amblyopia|anisometropic amblyopia
4683834|NCT03342235|Visual Acuity|visual acuity
4683835|NCT03342235|Refractive Surgical Procedures|refractive surgical procedures
4683836|NCT03342235|PRK|prk
4683837|NCT03342222|PEEK Interference Screw; Fixation; Anterior Cruciate Ligament Reconstruction|peek interference screw; fixation; anterior cruciate ligament reconstruction
4683838|NCT03342209|carbon monoxide toxicity|carbon monoxide toxicity
4683839|NCT03342209|high flow nasal cannula|high flow nasal cannula
4683840|NCT03342209|emergency department|emergency department
4683841|NCT03342196|Thiotepa|thiotepa
4683842|NCT03342196|Fludarabine|fludarabine
4683843|NCT03342196|Melphalan|melphalan
4683844|NCT03342183|Dialysis|dialysis
4683845|NCT03342183|Hemodialysis|hemodialysis
4683846|NCT03342183|Remote Ischemic Preconditioning|remote ischemic preconditioning
4683847|NCT03342144|Chronic Lymphocytic Leukemia (CLL)|chronic lymphocytic leukemia (cll)
4683848|NCT03342144|Cancer|cancer
4683849|NCT03342144|Leukemia|leukemia
4683850|NCT03342144|venetoclax|venetoclax
4683851|NCT03342131|Wnt signaling|wnt signaling
4683852|NCT03342105|Rhinitis, Allergic|rhinitis, allergic
4683853|NCT03342105|Moxibustion|moxibustion
4683854|NCT03342053|Huntington's Disease|huntington's disease
4683855|NCT03342053|HTTRx|httrx
4683856|NCT03342040|TAP block|tap block
4683857|NCT03342040|laparoscopic IPOM|laparoscopic ipom
4683858|NCT03342040|post operative pain|post operative pain
4683859|NCT03341962|Ulcerative Colitis|ulcerative colitis
4683860|NCT03341962|IMU-838|imu-838
4683861|NCT03341962|vidofludimus calcium|vidofludimus calcium
4683862|NCT03341936|Squamous Cell Carcinoma|squamous cell carcinoma
4683863|NCT03341923|contact lenses|contact lenses
4683864|NCT03341923|lens centration|lens centration
4683865|NCT03341923|multifocal|multifocal
4683866|NCT03341897|embolization|embolization
4683867|NCT03341897|coiling|coiling
4683868|NCT03341897|varicocele|varicocele
4683869|NCT03341871|chronic hepatitis C virus (HCV)|chronic hepatitis c virus (hcv)
4683870|NCT03341871|Genotype|genotype
4683871|NCT03341871|glecaprevir|glecaprevir
4683872|NCT03341871|pibrentasvir|pibrentasvir
4683873|NCT03341871|sustained virologic response|sustained virologic response
4683874|NCT03341871|chronic hepatitis C virus genotype 1|chronic hepatitis c virus genotype 1
4683875|NCT03341871|chronic hepatitis C virus genotype 2|chronic hepatitis c virus genotype 2
4683876|NCT03341871|chronic hepatitis C virus genotype 3|chronic hepatitis c virus genotype 3
4683877|NCT03341871|chronic hepatitis C virus genotype 4|chronic hepatitis c virus genotype 4
4683977|NCT03341130|Oral Appliance|oral appliance
4683878|NCT03341871|chronic hepatitis C virus genotype 5|chronic hepatitis c virus genotype 5
4683879|NCT03341871|chronic hepatitis C virus genotype 6|chronic hepatitis c virus genotype 6
4683880|NCT03341806|GBM|gbm
4683881|NCT03341806|LITT|litt
4683882|NCT03341806|Laser Interstitial Thermal Therapy|laser interstitial thermal therapy
4683883|NCT03341806|Bavencio|bavencio
4683884|NCT03341806|immunotherapy|immunotherapy
4683885|NCT03341767|HIV|hiv
4683886|NCT03341767|Cryptosporidium|cryptosporidium
4683887|NCT03341767|Clofazimine|clofazimine
4683888|NCT03341754|Malaria Infection|malaria infection
4683889|NCT03341741|chronic pulmonary infection|chronic pulmonary infection
4683890|NCT03341702|jail|jail
4683891|NCT03341702|violence|violence
4683892|NCT03341702|predictive factors|predictive factors
4683893|NCT03341702|prevention|prevention
4683894|NCT03341689|Psilocybin|psilocybin
4683895|NCT03341663|Stable Angina Pectoris|stable angina pectoris
4683896|NCT03341663|Acupoint sensitization|acupoint sensitization
4683897|NCT03341663|Correlation analysis|correlation analysis
4683898|NCT03341663|Diagnostic value|diagnostic value
4683899|NCT03341650|Mediterranean Diet|mediterranean diet
4683900|NCT03341650|BMI|bmi
4683901|NCT03341650|weight loss|weight loss
4683902|NCT03341650|pasta|pasta
4683903|NCT03341650|obesity|obesity
4683904|NCT03341637|Drug Therapy|drug therapy
4683905|NCT03341624|persistent fetal vasculature|persistent fetal vasculature
4683906|NCT03341624|congenital cataract|congenital cataract
4683907|NCT03341533|Analgesia|analgesia
4683908|NCT03341533|Laparoscopy|laparoscopy
4683909|NCT03341533|Pain|pain
4683910|NCT03341507|laryngoscopy|laryngoscopy
4683911|NCT03341507|retromolar|retromolar
4683912|NCT03341481|galactagogues, lactogenesis, preterm labor|galactagogues, lactogenesis, preterm labor
4683913|NCT03341468|Urethral catheter discomfort|urethral catheter discomfort
4683914|NCT03341468|Urethral catheter pain|urethral catheter pain
4683915|NCT03341468|Urethral catheter immobilization device|urethral catheter immobilization device
4683916|NCT03341468|Prolonged urethral catheterization|prolonged urethral catheterization
4683917|NCT03341468|Foley catheter|foley catheter
4683918|NCT03341468|Urinary catheter|urinary catheter
4683919|NCT03341468|Indwelling urethral catheter support|indwelling urethral catheter support
4683920|NCT03341455|Sri Lanka|sri lanka
4683921|NCT03341455|preschool|preschool
4683922|NCT03341455|randomized control trial|randomized control trial
4683923|NCT03341429|obesity|obesity
4683924|NCT03341429|GLP-1|glp-1
4683925|NCT03341429|liraglutide|liraglutide
4683926|NCT03341429|diabetes|diabetes
4683927|NCT03341429|bariatric surgery|bariatric surgery
4683928|NCT03341416|cerebellar ataxia|cerebellar ataxia
4683929|NCT03341416|stroke|stroke
4683930|NCT03341416|Spinocerebellar ataxia|spinocerebellar ataxia
4683931|NCT03341416|deep brain stimulation|deep brain stimulation
4683932|NCT03341416|dentate nucleus|dentate nucleus
4683933|NCT03341403|severe asthma|severe asthma
4683934|NCT03341403|synbiotic|synbiotic
4683935|NCT03341403|immunomodulation|immunomodulation
4683936|NCT03341403|sputum|sputum
4683937|NCT03341390|Healthy participants|healthy participants
4683938|NCT03341390|Healthy subjects|healthy subjects
4683939|NCT03341390|Strokes|strokes
4683940|NCT03341351|Fourth-degree laceration|fourth-degree laceration
4683941|NCT03341351|Beef tongue model|beef tongue model
4683942|NCT03341325|animal-assisted therapy|animal-assisted therapy
4683943|NCT03341273|Antibiotic Therapy|antibiotic therapy
4683944|NCT03341273|Lower Respiratory Tract Infection|lower respiratory tract infection
4683945|NCT03341273|Procalcitonin|procalcitonin
4683946|NCT03341260|Pulpitis, irreversible Pulpitis,|pulpitis, irreversible pulpitis,
4683947|NCT03341260|Diclofenac Potassium|diclofenac potassium
4683948|NCT03341260|Premedication, Preoperative Analgesic|premedication, preoperative analgesic
4683949|NCT03341260|Postoperative pain|postoperative pain
4683950|NCT03341247|Obesity|obesity
4683951|NCT03341247|Portion Size Effect|portion size effect
4683952|NCT03341247|fMRI|fmri
4683953|NCT03341247|Functional Magnetic Resonance Imaging|functional magnetic resonance imaging
4683954|NCT03341247|Inhibition|inhibition
4683955|NCT03341247|Decision Making|decision making
4683956|NCT03341247|Satiety Responsiveness|satiety responsiveness
4683957|NCT03341247|Anthropometrics|anthropometrics
4683958|NCT03341247|DXA|dxa
4683959|NCT03341247|Reward Processing|reward processing
4683960|NCT03341234|Superficial Serratus Plane Block|superficial serratus plane block
4683961|NCT03341234|Modified Radical Mastectomy|modified radical mastectomy
4683962|NCT03341234|Axillary Lymph Node Disection|axillary lymph node disection
4683963|NCT03341234|bupivacaine|bupivacaine
4683964|NCT03341195|SMS|sms
4683965|NCT03341195|Automated calls|automated calls
4683966|NCT03341195|Routine immunization|routine immunization
4683967|NCT03341195|mHealth|mhealth
4683968|NCT03341182|epidural steroid injection|epidural steroid injection
4683969|NCT03341182|radiation exposure|radiation exposure
4683970|NCT03341182|mirror|mirror
4683971|NCT03341156|Heart transplantation|heart transplantation
4683972|NCT03341143|Unresectable|unresectable
4683973|NCT03341143|Stage III|stage iii
4683974|NCT03341143|Stage IV|stage iv
4683975|NCT03341130|OSA|osa
4683976|NCT03341130|Mandibular Advancement Splint|mandibular advancement splint
4683978|NCT03341130|Treatment|treatment
4683979|NCT03341130|Repositioning Splint|repositioning splint
4683980|NCT03341117|acetylsalicylic acid|acetylsalicylic acid
4683981|NCT03341117|antioxidant enzyme system|antioxidant enzyme system
4683982|NCT03341117|stress oxidative|stress oxidative
4683983|NCT03341117|type 2 diabetes mellitus.|type 2 diabetes mellitus.
4683984|NCT03341091|Tai-chi|tai-chi
4683985|NCT03341091|Dementia|dementia
4683986|NCT03341091|Dyad approach|dyad approach
4683987|NCT03341091|Fall prevention|fall prevention
4683988|NCT03341091|Mobility|mobility
4683989|NCT03341078|Ibudilast|ibudilast
4683990|NCT03341078|Methamphetamine|methamphetamine
4683991|NCT03341078|Neuroinflammation|neuroinflammation
4683992|NCT03341013|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
4683993|NCT03341013|GLP-1 receptor agonists|glp-1 receptor agonists
4683994|NCT03340987|vestibular incision subperiosteal tunnel access|vestibular incision subperiosteal tunnel access
4683995|NCT03340987|coronally advanced flap|coronally advanced flap
4683996|NCT03340987|subepithelial connective tissue graft|subepithelial connective tissue graft
4683997|NCT03340987|multiple gingival recessions|multiple gingival recessions
4683998|NCT03340974|Super Oxide Dismutase|super oxide dismutase
4683999|NCT03340948|Mindfulness Based Stress Reduction|mindfulness based stress reduction
4684000|NCT03340948|Depressive symptoms|depressive symptoms
4684001|NCT03340948|Coronary Artery Disease|coronary artery disease
4684002|NCT03340948|Mastery|mastery
4684003|NCT03340935|fasting mimicking diet|fasting mimicking diet
4684004|NCT03340935|malignant neoplasm|malignant neoplasm
4684005|NCT03340935|metabolism|metabolism
4684006|NCT03340935|metabolic effects|metabolic effects
4684007|NCT03340935|adjuvant treatment|adjuvant treatment
4684008|NCT03340935|metastatic setting|metastatic setting
4684009|NCT03340922|premature ventricular complex|premature ventricular complex
4684010|NCT03340922|catheter ablation|catheter ablation
4684011|NCT03340922|activation mapping|activation mapping
4684012|NCT03340922|wavefront|wavefront
4684013|NCT03340896|Larynx, hypopharynx|larynx, hypopharynx
4684014|NCT03340857|Post-cancer retraining|post-cancer retraining
4684015|NCT03340857|Physical activity|physical activity
4684016|NCT03340857|Intelligent electric bicycle|intelligent electric bicycle
4684017|NCT03340818|Low back pain, bone marrow concentrate, disc degeneration|low back pain, bone marrow concentrate, disc degeneration
4684018|NCT03340805|Sepsis|sepsis
4684019|NCT03340805|Septic shock|septic shock
4684020|NCT03340805|Pediatric|pediatric
4684021|NCT03340805|Fluid resuscitation|fluid resuscitation
4684022|NCT03340805|Saline|saline
4684023|NCT03340805|Lactated Ringer's|lactated ringer's
4684024|NCT03340805|Crystalloid|crystalloid
4684025|NCT03340805|Mortality|mortality
4684026|NCT03340805|Pragmatic trial|pragmatic trial
4684027|NCT03340805|Feasibility|feasibility
4684028|NCT03340792|Exoskeleton Device|exoskeleton device
4684029|NCT03340792|Rehabilitation|rehabilitation
4684030|NCT03340792|Body composition|body composition
4684031|NCT03340792|Quality of Life|quality of life
4684032|NCT03340779|Norepinephrine|norepinephrine
4684033|NCT03340779|Dobutamine|dobutamine
4684034|NCT03340779|Shock|shock
4684035|NCT03340766|DLBCL Relapsed post-autologous hematopoietic stem cell transplantation (HSCT)|dlbcl relapsed post-autologous hematopoietic stem cell transplantation (hsct)
4684036|NCT03340766|Antibodies|antibodies
4684037|NCT03340766|Bispecific in combination with PD-1/PD-L1 inhibitor|bispecific in combination with pd-1/pd-l1 inhibitor
4684038|NCT03340727|Moderate preterm infant|moderate preterm infant
4684039|NCT03340727|Caffeine citrate|caffeine citrate
4684040|NCT03340701|progesterone|progesterone
4684041|NCT03340701|pharmacology|pharmacology
4684042|NCT03340701|pharmacokinetics|pharmacokinetics
4684043|NCT03340662|Healthy Volunteer|healthy volunteer
4684044|NCT03340662|CC-122|cc-122
4684045|NCT03340662|Adult|adult
4684046|NCT03340662|Phase 1|phase 1
4684047|NCT03340662|CYTOCHROME P450|cytochrome p450
4684048|NCT03340623|DIEP|diep
4684049|NCT03340623|Venous coupler|venous coupler
4684050|NCT03340584|Total Knee Replacement|total knee replacement
4684051|NCT03340584|Taping|taping
4684052|NCT03340584|Rehabilitation|rehabilitation
4684053|NCT03340584|Edema|edema
4684054|NCT03340584|Pain|pain
4684055|NCT03340571|Alzheimer's Disease|alzheimer's disease
4684056|NCT03340571|biomarkers|biomarkers
4684057|NCT03340571|blood|blood
4684058|NCT03340519|Crohn|crohn
4684059|NCT03340519|MRI|mri
4684060|NCT03340506|Tafinlar|tafinlar
4684061|NCT03340506|Mekinist|mekinist
4684062|NCT03340506|Dabrafenib|dabrafenib
4684063|NCT03340506|Trametinib|trametinib
4684064|NCT03340506|Adult|adult
4684065|NCT03340506|Pediatric|pediatric
4684066|NCT03340506|Melanoma|melanoma
4684067|NCT03340506|Melanoma Stage IV|melanoma stage iv
4684068|NCT03340506|Metastatic Melanoma|metastatic melanoma
4684069|NCT03340506|Advanced Melanoma|advanced melanoma
4684070|NCT03340506|Lung Cancer|lung cancer
4684071|NCT03340506|NSLC|nslc
4684072|NCT03340506|Non Small Cell Lung Cancer|non small cell lung cancer
4684073|NCT03340506|BRAF V600 Mutation|braf v600 mutation
4684074|NCT03340506|BRAF Gene Mutation|braf gene mutation
4684075|NCT03340506|Solid tumor|solid tumor
4684076|NCT03340506|Rare cancers|rare cancers
4684077|NCT03340506|High Grade Glioma|high grade glioma
4684078|NCT03340493|Stroke|stroke
4684079|NCT03340493|Ischemia|ischemia
4684080|NCT03340493|Cerebral Infarction|cerebral infarction
4684081|NCT03340493|Cerebrovascular Disorders|cerebrovascular disorders
4684082|NCT03340493|Brain Diseases|brain diseases
4684083|NCT03340493|Central Nervous System Diseases|central nervous system diseases
4684084|NCT03340493|Nervous System Diseases|nervous system diseases
4684085|NCT03340493|Vascular Diseases|vascular diseases
4684086|NCT03340493|Cardiovascular Diseases|cardiovascular diseases
4684087|NCT03340493|Pathologic Processes|pathologic processes
4684088|NCT03340493|Brain Infarction|brain infarction
4684089|NCT03340493|Brain Ischemia|brain ischemia
4684090|NCT03340493|Tenecteplase|tenecteplase
4684091|NCT03340493|Fibrinolytic agents|fibrinolytic agents
4684092|NCT03340493|Fibrin Modulating agents|fibrin modulating agents
4684093|NCT03340493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
4684094|NCT03340493|Plasminogen|plasminogen
4684095|NCT03340493|Tissue Plasminogen Activator|tissue plasminogen activator
4684096|NCT03340454|Diabetes Management|diabetes management
4684097|NCT03340454|H. pylori|h. pylori
4684098|NCT03340415|Hallux Valgus|hallux valgus
4684099|NCT03340415|Bunion|bunion
4684100|NCT03340415|Post-operative|post-operative
4684101|NCT03340415|Rehabilitation|rehabilitation
4684102|NCT03340415|Weight Bearing Status|weight bearing status
4684103|NCT03340402|Breast Cancer|breast cancer
4684104|NCT03340350|Minocycline|minocycline
4684105|NCT03340350|PTSD|ptsd
4684106|NCT03340337|electrical stimulation|electrical stimulation
4684107|NCT03340337|Muscle Strength|muscle strength
4684108|NCT03340337|Fatigue|fatigue
4684109|NCT03340337|assessments, pain|assessments, pain
4684110|NCT03340324|inflammation|inflammation
4684111|NCT03340324|autoimmunity|autoimmunity
4684112|NCT03340324|immunotherapy|immunotherapy
4684113|NCT03340324|infertility|infertility
4684114|NCT03340324|pelvic pain|pelvic pain
4684115|NCT03340311|M-Health, GDM, Bluetooth, SMBG|m-health, gdm, bluetooth, smbg
4684116|NCT03340272|prostate cancer|prostate cancer
4684117|NCT03340272|pelvic irradiation|pelvic irradiation
4684118|NCT03340272|hormonal treatment|hormonal treatment
4684119|NCT03340259|Congenital malformations of the gastrointestinal tract|congenital malformations of the gastrointestinal tract
4684120|NCT03340259|Enterostomy|enterostomy
4684121|NCT03340259|Microbiota|microbiota
4684122|NCT03340259|Necrotizing enterocolitis|necrotizing enterocolitis
4684123|NCT03340259|Newborn Infants|newborn infants
4684124|NCT03340259|Spontaneous intestinal perforation|spontaneous intestinal perforation
4684125|NCT03340246|Varicose veins, phlebectomy|varicose veins, phlebectomy
4684126|NCT03340233|diastolic dysfunction|diastolic dysfunction
4684127|NCT03340233|mechanism|mechanism
4684128|NCT03340233|MRI magnetic resonance imaging|mri magnetic resonance imaging
4684129|NCT03340233|ejection fraction|ejection fraction
4684130|NCT03340220|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
4684131|NCT03340207|intubation|intubation
4684132|NCT03340207|anesthesiology|anesthesiology
4684133|NCT03340194|Systemic sclerosis|systemic sclerosis
4684134|NCT03340194|Calcinosis cutis|calcinosis cutis
4684135|NCT03340181|RIPC, myocardial protective effect|ripc, myocardial protective effect
4684136|NCT03340168|Bisphenol S, toxicokinetics|bisphenol s, toxicokinetics
4684137|NCT03340129|Immunotherapy|immunotherapy
4684138|NCT03340129|Radiotherapy|radiotherapy
4684139|NCT03340129|Brain metastases|brain metastases
4684140|NCT03340103|Lutein/Zeaxanthin|lutein/zeaxanthin
4684141|NCT03340103|Antioxidant|antioxidant
4684142|NCT03340103|Oxidative stress|oxidative stress
4684143|NCT03340103|Carotenoid|carotenoid
4684144|NCT03340103|Preterm newborn|preterm newborn
4684145|NCT03340064|Epilepsy|epilepsy
4684146|NCT03340064|Partial Seizures|partial seizures
4684147|NCT03340064|Levetiracetam|levetiracetam
4684148|NCT03340064|Monotherapy|monotherapy
4684149|NCT03340064|Adjunctive Treatment|adjunctive treatment
4684150|NCT03340038|free flap reconstructive surgery, head and neck|free flap reconstructive surgery, head and neck
4684151|NCT03340025|negative pressure wound therapy|negative pressure wound therapy
4684152|NCT03340025|split thickness skin graft|split thickness skin graft
4684153|NCT03339986|Portion Size|portion size
4684154|NCT03339986|Feasibility|feasibility
4684155|NCT03339986|Acceptability|acceptability
4684156|NCT03339986|Snacking|snacking
4684157|NCT03339986|Preschool children|preschool children
4684158|NCT03339973|Peripheral Arterial Occlusive Disease|peripheral arterial occlusive disease
4684159|NCT03339973|ABCB5|abcb5
4684160|NCT03339973|allogeneic|allogeneic
4684161|NCT03339973|mesenchymal stem cells|mesenchymal stem cells
4684162|NCT03339973|advanced therapy medicinal product|advanced therapy medicinal product
4684163|NCT03339973|somatic cell therapy|somatic cell therapy
4684164|NCT03339973|phase I/IIa|phase i/iia
4684165|NCT03339973|non-healing ulcers|non-healing ulcers
4684166|NCT03339947|Multidrug-resistant Enterobacteriaceae acquisition|multidrug-resistant enterobacteriaceae acquisition
4684167|NCT03339947|travellers' diarrhoea|travellers' diarrhoea
4684168|NCT03339947|international travel|international travel
4684169|NCT03339934|Hypofractionation|hypofractionation
4684170|NCT03339934|Proton therapy|proton therapy
4684171|NCT03339934|3D conformal radiation|3d conformal radiation
4684172|NCT03339934|Randomized|randomized
4684173|NCT03339934|Phase II|phase ii
4684174|NCT03339895|COLORECTAL SURGERY|colorectal surgery
4684175|NCT03339895|PVI GUIDED FLUID MANAGEMENT|pvi guided fluid management
4684176|NCT03339895|GOAL DIRECTED THERAPY|goal directed therapy
4684177|NCT03339882|remifemin|remifemin
4684178|NCT03339882|preventive effect|preventive effect
4684179|NCT03339882|LHRH-a|lhrh-a
4684180|NCT03339882|breast cancer|breast cancer
4684181|NCT03339843|cancer|cancer
4684182|NCT03339830|SMA|sma
4684183|NCT03339830|Spinal Muscular Atrophy|spinal muscular atrophy
4684184|NCT03339830|Neuromuscular disease|neuromuscular disease
4684185|NCT03339830|Spinraza|spinraza
4684186|NCT03339804|Chemotherapy|chemotherapy
4684187|NCT03339804|Muscle sympathetic nervous activity|muscle sympathetic nervous activity
4684188|NCT03339804|Blood flow|blood flow
4684189|NCT03339804|Endothelial microparticles|endothelial microparticles
4684190|NCT03339765|Self-advocacy|self-advocacy
4684191|NCT03339765|Advanced cancer|advanced cancer
4684192|NCT03339765|Serious games|serious games
4684193|NCT03339765|Self-management|self-management
4684194|NCT03339739|Musculoskeletal Pain|musculoskeletal pain
4684195|NCT03339739|Orofacial Pain|orofacial pain
4684196|NCT03339739|Physical Therapy Modalities|physical therapy modalities
4684197|NCT03339739|Oral Contraceptives|oral contraceptives
4684198|NCT03339739|Mandibular Diseases|mandibular diseases
4684199|NCT03339739|Muscular Diseases|muscular diseases
4684200|NCT03339739|Risk factors|risk factors
4684201|NCT03339739|Contraceptive Usage|contraceptive usage
4684202|NCT03339739|Pain, Chronic|pain, chronic
4684203|NCT03339739|Craniomandibular Disorders|craniomandibular disorders
4684204|NCT03339661|CMV infection|cmv infection
4684205|NCT03339661|kidney transplant|kidney transplant
4684206|NCT03339661|γδ T cells monitoring|γδ t cells monitoring
4684207|NCT03339648|School Resource Officer|school resource officer
4684208|NCT03339648|Trauma Informed Care|trauma informed care
4684209|NCT03339648|Cultural Competency|cultural competency
4684210|NCT03339648|Restorative Problem Solving|restorative problem solving
4684211|NCT03339648|Social Emotional Learning|social emotional learning
4684212|NCT03339648|Professional Development|professional development
4684213|NCT03339648|School Violence|school violence
4684214|NCT03339622|uncontrollable cancer pain|uncontrollable cancer pain
4684215|NCT03339622|incurable malignancy,|incurable malignancy,
4684216|NCT03339596|electroconvulsive therapy|electroconvulsive therapy
4684217|NCT03339596|depression|depression
4684218|NCT03339596|cognition|cognition
4684219|NCT03339596|cognitive side-effects|cognitive side-effects
4684220|NCT03339596|erythropoietin|erythropoietin
4684221|NCT03339596|functional magnetic resonance imaging|functional magnetic resonance imaging
4684222|NCT03339583|chronic insomnia|chronic insomnia
4684223|NCT03339583|brief behavioral treatment|brief behavioral treatment
4684224|NCT03339583|behavioral treatment|behavioral treatment
4684225|NCT03339583|insomnia severity index|insomnia severity index
4684226|NCT03339583|predictors|predictors
4684227|NCT03339583|treatment response|treatment response
4684228|NCT03339531|2D|2d
4684229|NCT03339531|prostate neoplasms|prostate neoplasms
4684230|NCT03339531|radiotherapy|radiotherapy
4684231|NCT03339531|simulation|simulation
4684232|NCT03339492|rotator cuff|rotator cuff
4684233|NCT03339492|PEMF|pemf
4684234|NCT03339492|Pulsed Electromagnetic Field|pulsed electromagnetic field
4684235|NCT03339492|Rotator Cuff Repair|rotator cuff repair
4684236|NCT03339492|adjunctive therapy|adjunctive therapy
4684237|NCT03339479|dielectric property|dielectric property
4684238|NCT03339479|lung nodules|lung nodules
4684239|NCT03339479|differential diagnosis|differential diagnosis
4684240|NCT03339479|frozen pathological examination|frozen pathological examination
4684241|NCT03339427|vitamin D|vitamin d
4684242|NCT03339427|cardiovascular|cardiovascular
4684243|NCT03339427|muscle power|muscle power
4684244|NCT03339362|low back pain|low back pain
4684245|NCT03339362|lumbar facet joint pain|lumbar facet joint pain
4684246|NCT03339362|feasibility|feasibility
4684247|NCT03339362|lumbar facet joint injection|lumbar facet joint injection
4684248|NCT03339310|CCM Therapy|ccm therapy
4684249|NCT03339310|2-Lead|2-lead
4684250|NCT03339310|FIX-HF-5C2|fix-hf-5c2
4684251|NCT03339310|Optimizer|optimizer
4684252|NCT03339258|Posttraumatic Stress Disorder|posttraumatic stress disorder
4684253|NCT03339258|Post-traumatic Stress Disorder|post-traumatic stress disorder
4684254|NCT03339258|PTSD|ptsd
4684255|NCT03339258|Doxazosin|doxazosin
4684256|NCT03339258|Nightmares|nightmares
4684257|NCT03339258|Sleep Disturbance|sleep disturbance
4684258|NCT03339245|obesity|obesity
4684259|NCT03339245|fructose|fructose
4684260|NCT03339245|glucose|glucose
4684261|NCT03339245|fecal microbiota|fecal microbiota
4684262|NCT03339245|intestinal permiability|intestinal permiability
4684263|NCT03339245|fecal metabolites|fecal metabolites
4684264|NCT03339193|atrial fibrillation|atrial fibrillation
4684265|NCT03339193|stroke|stroke
4684266|NCT03339193|atrial appendage|atrial appendage
4684267|NCT03339180|cardiac troponin|cardiac troponin
4684268|NCT03339167|Lysine, Adult, Protein Quality|lysine, adult, protein quality
4684269|NCT03339154|Healthy|healthy
4684270|NCT03339154|Men|men
4684271|NCT03339154|Adults|adults
4684272|NCT03339154|Methionine|methionine
4684273|NCT03339141|Intubation conditions|intubation conditions
4684274|NCT03339141|Anaesthetic techniques|anaesthetic techniques
4684275|NCT03339141|Laryngoscopy|laryngoscopy
4684276|NCT03339128|Irritable Bowel Syndrome with Diarrhea|irritable bowel syndrome with diarrhea
4684277|NCT03339128|IBSD|ibsd
4684278|NCT03339128|IBS-D|ibs-d
4684279|NCT03339128|Irritable Bowel Syndrome|irritable bowel syndrome
4684280|NCT03339128|Pediatric|pediatric
4684281|NCT03339102|Non-infectious intermediate, posterior and panuveitis|non-infectious intermediate, posterior and panuveitis
4684282|NCT03339102|Post-Marketing Surveillance|post-marketing surveillance
4684283|NCT03339102|Humira®|humira®
4684284|NCT03339089|rheumatoid arthritis|rheumatoid arthritis
4684285|NCT03339089|plaque psoriasis|plaque psoriasis
4684286|NCT03339089|ankylosing spondylitis|ankylosing spondylitis
4684287|NCT03339089|Immune-Mediated Inflammatory Diseases|immune-mediated inflammatory diseases
4684288|NCT03339089|Chinese Patients|chinese patients
4684289|NCT03339063|Nontuberculous Mycobacteria|nontuberculous mycobacteria
4684290|NCT03339063|Non-tuberculous mycobacteria|non-tuberculous mycobacteria
4684291|NCT03339063|NTM-PD|ntm-pd
4684292|NCT03339063|NTM-LD|ntm-ld
4684293|NCT03339063|MAC|mac
4684294|NCT03339063|M. avium|m. avium
4684295|NCT03339063|M. intracellulare|m. intracellulare
4684296|NCT03339063|M. abscessus|m. abscessus
4684297|NCT03339063|Atypical mycobacteria|atypical mycobacteria
4684298|NCT03339063|NTM|ntm
4684299|NCT03339050|church-based health promotion|church-based health promotion
4684300|NCT03339050|African Americans|african americans
4684301|NCT03339037|HBOT|hbot
4684302|NCT03339037|TBI|tbi
4684303|NCT03339037|pediatrics|pediatrics
4684304|NCT03339037|PCS|pcs
4684306|NCT03339037|concussion|concussion
4684307|NCT03339037|traumatic brain injury|traumatic brain injury
4684308|NCT03339037|hyperbaric oxygen|hyperbaric oxygen
4684309|NCT03339024|Oxytocin|oxytocin
4684310|NCT03339024|Administration, Intranasal|administration, intranasal
4684311|NCT03339024|Ethanol|ethanol
4684312|NCT03339024|Follow-up Studies|follow-up studies
4684313|NCT03338998|stroke|stroke
4684314|NCT03338998|intracerebral hemorrhage|intracerebral hemorrhage
4684315|NCT03338998|ICH|ich
4684316|NCT03338998|BAF312|baf312
4684317|NCT03338998|siponimod|siponimod
4684318|NCT03338998|sphingosine-1-phosphate receptor|sphingosine-1-phosphate receptor
4684319|NCT03338946|Remote monitoring|remote monitoring
4684320|NCT03338920|acute migraine|acute migraine
4684321|NCT03338920|aura|aura
4684322|NCT03338920|sumatriptan nasal powder|sumatriptan nasal powder
4684323|NCT03338920|AVP-825|avp-825
4684324|NCT03338920|adolescents|adolescents
4684325|NCT03338907|cerebral hypoxia|cerebral hypoxia
4684326|NCT03338907|CO2|co2
4684327|NCT03338907|cerebral perfusion|cerebral perfusion
4684328|NCT03338907|hypoxia|hypoxia
4684329|NCT03338881|Drug therapy|drug therapy
4684330|NCT03338868|physical activity|physical activity
4684331|NCT03338868|pain|pain
4684332|NCT03338868|uric acid|uric acid
4684333|NCT03338855|T2DM, insulin resistance, skeletal muscle, mitochondrial function, Phase 4 trial, dapagliflozin|t2dm, insulin resistance, skeletal muscle, mitochondrial function, phase 4 trial, dapagliflozin
4684334|NCT03338816|Acute Intermittent Porphyria (AIP)|acute intermittent porphyria (aip)
4684335|NCT03338816|Acute Hepatic Porphyria (AHP)|acute hepatic porphyria (ahp)
4684336|NCT03338816|Hereditary Coproporphyria (HCP)|hereditary coproporphyria (hcp)
4684337|NCT03338816|Variegate Porphyria (VP)|variegate porphyria (vp)
4684338|NCT03338816|ALA dehydratase deficient porphyria (ADP) (ALAD)|ala dehydratase deficient porphyria (adp) (alad)
4684339|NCT03338816|RNAi therapeutic|rnai therapeutic
4684340|NCT03338816|Porphyria|porphyria
4684341|NCT03338777|melanoma|melanoma
4684342|NCT03338777|lipoplexes|lipoplexes
4684343|NCT03338777|plasmid|plasmid
4684344|NCT03338777|herpes simplex thymidine kinase|herpes simplex thymidine kinase
4684345|NCT03338777|interleukin-2|interleukin-2
4684346|NCT03338777|granulocyte-macrophage colony-stimulating factor|granulocyte-macrophage colony-stimulating factor
4684347|NCT03338777|tumor vaccine|tumor vaccine
4684348|NCT03338777|suicide gene|suicide gene
4684349|NCT03338764|Transient insomnia|transient insomnia
4684350|NCT03338764|Insomnia|insomnia
4684351|NCT03338764|Sleep initiation and maintenance disorder|sleep initiation and maintenance disorder
4684352|NCT03338699|Early infant male circumcision|early infant male circumcision
4684353|NCT03338699|ShangRing|shangring
4684354|NCT03338699|sub-Saharan Africa|sub-saharan africa
4684355|NCT03338699|HIV|hiv
4684356|NCT03338699|WHO|who
4684357|NCT03338686|Keratinized tissue|keratinized tissue
4684358|NCT03338686|Keratinized mucosa|keratinized mucosa
4684359|NCT03338686|Attached mucosa|attached mucosa
4684360|NCT03338686|Dental implants|dental implants
4684361|NCT03338686|Free gingival graft|free gingival graft
4684362|NCT03338686|Connective tissue graft|connective tissue graft
4684363|NCT03338686|Patient-centered outcomes|patient-centered outcomes
4684364|NCT03338647|Stereotactic body radiation therapy|stereotactic body radiation therapy
4684365|NCT03338647|transarterial chemoembolization|transarterial chemoembolization
4684366|NCT03338647|SBRT|sbrt
4684367|NCT03338647|TACE|tace
4684368|NCT03338634|Portion Size Effect|portion size effect
4684369|NCT03338634|Childhood Obesity|childhood obesity
4684370|NCT03338634|fMRI|fmri
4684371|NCT03338621|tuberculosis|tuberculosis
4684372|NCT03338621|drug-resistant tuberculosis|drug-resistant tuberculosis
4684373|NCT03338621|TB|tb
4684374|NCT03338621|DR-TB|dr-tb
4684375|NCT03338621|pretomanid|pretomanid
4684376|NCT03338621|PA-824|pa-824
4684377|NCT03338621|bedaquiline|bedaquiline
4684378|NCT03338621|TMC207|tmc207
4684379|NCT03338621|moxifloxacin|moxifloxacin
4684380|NCT03338621|pyrazinamide|pyrazinamide
4684381|NCT03338621|HRZE|hrze
4684382|NCT03338621|TB Alliance|tb alliance
4684383|NCT03338621|NC-008|nc-008
4684384|NCT03338621|drug-sensitive tuberculosis|drug-sensitive tuberculosis
4684385|NCT03338621|DS-TB|ds-tb
4684386|NCT03338608|Cosmesis|cosmesis
4684387|NCT03338608|Wound Healing|wound healing
4684388|NCT03338608|Anterior Cervical Decompression and Fusion|anterior cervical decompression and fusion
4684389|NCT03338608|ACDF|acdf
4684390|NCT03338608|Platysma|platysma
4684391|NCT03338595|arterial stiffness|arterial stiffness
4684392|NCT03338595|flow-mediated dilation|flow-mediated dilation
4684393|NCT03338595|endothelial function|endothelial function
4684394|NCT03338595|Orkambi|orkambi
4684395|NCT03338595|exercise capacity|exercise capacity
4684396|NCT03338582|Pacemaker|pacemaker
4684397|NCT03338582|Conduction disturbance|conduction disturbance
4684398|NCT03338582|TAVI|tavi
4684399|NCT03338556|Rhinovirus|rhinovirus
4684400|NCT03338556|Healthy volunteer|healthy volunteer
4684401|NCT03338556|Outpatient|outpatient
4684402|NCT03338556|Cold virus|cold virus
4684403|NCT03338556|HRV-16|hrv-16
4684404|NCT03338543|percutaneous electrical nerve stimulation|percutaneous electrical nerve stimulation
4684405|NCT03338543|transcutaneous electrical nerve stimulation|transcutaneous electrical nerve stimulation
4684406|NCT03338543|pain|pain
4684407|NCT03338543|liver cancer|liver cancer
4684408|NCT03338543|hepatocellular carcinoma|hepatocellular carcinoma
4684409|NCT03338530|Psychosocial treatment|psychosocial treatment
4684410|NCT03338530|School intervention|school intervention
4684411|NCT03338530|Autism Spectrum Disorder|autism spectrum disorder
4684412|NCT03338504|type 2 myocardial infarction|type 2 myocardial infarction
4684413|NCT03338465|Greater Trochanteric Pain Syndrome,|greater trochanteric pain syndrome,
4684414|NCT03338465|Gluteal|gluteal
4684415|NCT03338465|Tendinopathy|tendinopathy
4684416|NCT03338465|ESWT|eswt
4684417|NCT03338465|shockwave|shockwave
4684418|NCT03338452|ketogenic diet|ketogenic diet
4684419|NCT03338452|body composition|body composition
4684420|NCT03338452|metabolism|metabolism
4684421|NCT03338452|body dissatisfaction|body dissatisfaction
4684422|NCT03338452|cognition|cognition
4684423|NCT03338413|Rehabilitation|rehabilitation
4684424|NCT03338400|Quality of Recovery, Dexamethasone, Same day surgery|quality of recovery, dexamethasone, same day surgery
4684425|NCT03338387|neuropeptides|neuropeptides
4684426|NCT03338387|microdialysis|microdialysis
4684427|NCT03338374|Cardiac chronotropy|cardiac chronotropy
4684428|NCT03338374|Cardiac resynchronisation therapy|cardiac resynchronisation therapy
4684429|NCT03338374|Rate responsive pacemaker|rate responsive pacemaker
4684430|NCT03338374|Heart failure with preserved ejection fraction|heart failure with preserved ejection fraction
4684431|NCT03338361|approach avoidance training|approach avoidance training
4684432|NCT03338361|attentional bias training|attentional bias training
4684433|NCT03338361|alcohol depencence|alcohol depencence
4684434|NCT03338361|relapse|relapse
4684435|NCT03338348|Vosaroxin|vosaroxin
4684436|NCT03338322|postoperative pain|postoperative pain
4684437|NCT03338322|reciproc|reciproc
4684438|NCT03338322|twisted file adaptive|twisted file adaptive
4684439|NCT03338309|Fractional flow reserve|fractional flow reserve
4684440|NCT03338309|Instantaneous wave-free ratio|instantaneous wave-free ratio
4684441|NCT03338309|Ischemic heart disease|ischemic heart disease
4684442|NCT03338296|body mass index|body mass index
4684443|NCT03338296|weight loss|weight loss
4684444|NCT03338296|adolescents|adolescents
4684445|NCT03338296|lifestyle modification|lifestyle modification
4684446|NCT03338270|MRI|mri
4684447|NCT03338270|Neuroradiology|neuroradiology
4684448|NCT03338270|minute-MRI|minute-mri
4684449|NCT03338270|multi EPI-mix|multi epi-mix
4684450|NCT03338270|Clinical Validation|clinical validation
4684451|NCT03338257|Pre-school children|pre-school children
4684452|NCT03338257|fruit and vegetable acceptance|fruit and vegetable acceptance
4684453|NCT03338257|service-learning|service-learning
4684454|NCT03338257|pre-school nutrition education|pre-school nutrition education
4684455|NCT03338257|childhood obesity|childhood obesity
4684456|NCT03338244|Childhood mortality|childhood mortality
4684457|NCT03338244|Mass treatment|mass treatment
4684458|NCT03338244|Azithromycin|azithromycin
4684459|NCT03338244|Infection|infection
4684460|NCT03338231|Immunity duration|immunity duration
4684461|NCT03338218|Hydroxyethylstarch (HES)|hydroxyethylstarch (hes)
4684462|NCT03338205|ketamine|ketamine
4684463|NCT03338205|pediatric status asthmaticus|pediatric status asthmaticus
4684464|NCT03338192|Low back pain|low back pain
4684465|NCT03338192|Chronic pain|chronic pain
4684466|NCT03338192|Health disparities in chronic low back pain|health disparities in chronic low back pain
4684467|NCT03338179|Metamemory|metamemory
4684468|NCT03338179|Schizophrenia|schizophrenia
4684469|NCT03338114|ALS|als
4684470|NCT03338114|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
4684471|NCT03338114|Fasciculation|fasciculation
4684472|NCT03338114|FLX-787|flx-787
4684473|NCT03338062|Radiation Treatment|radiation treatment
4684474|NCT03338036|Concussion|concussion
4684475|NCT03338036|Post-Concussion Syndrome|post-concussion syndrome
4684476|NCT03338036|Biofeedback|biofeedback
4684477|NCT03338036|Heart Rate Variability|heart rate variability
4684478|NCT03338036|Neurofeedback|neurofeedback
4684479|NCT03338023|Insulin Glargine|insulin glargine
4684480|NCT03338010|Insulin glargine|insulin glargine
4684481|NCT03337997|Irreversible Electroporation|irreversible electroporation
4684482|NCT03337997|Pancreatic Adenocarcinoma|pancreatic adenocarcinoma
4684483|NCT03337984|Diverticulitis|diverticulitis
4684484|NCT03337984|Damage Control Surgery|damage control surgery
4684485|NCT03337971|Post-menopausal|post-menopausal
4684486|NCT03337971|Osteoporosis|osteoporosis
4684487|NCT03337971|Bone Turnover Markers|bone turnover markers
4684488|NCT03337971|Dairy Products|dairy products
4684489|NCT03337958|Education|education
4684490|NCT03337958|Dry Powder Inhalers|dry powder inhalers
4684491|NCT03337958|Metered Dose Inhalers|metered dose inhalers
4684492|NCT03337958|Pulmonary Disease|pulmonary disease
4684493|NCT03337958|Chronic Obstructive|chronic obstructive
4684494|NCT03337945|CYP450 phenotyping in patients with liver cirrhosis|cyp450 phenotyping in patients with liver cirrhosis
4684495|NCT03337906|HIV|hiv
4684496|NCT03337867|Recurrent stroke|recurrent stroke
4684497|NCT03337867|Stroke|stroke
4684498|NCT03337867|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
4684499|NCT03337867|Theta-Burst-Stimulation|theta-burst-stimulation
4684500|NCT03337854|prognostic|prognostic
4684501|NCT03337854|phenotype|phenotype
4684502|NCT03337854|Computed tomography|computed tomography
4684503|NCT03337854|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
4684504|NCT03337841|Hepatocellular carcinoma|hepatocellular carcinoma
4684505|NCT03337841|Neo adjuvant chemotherapy|neo adjuvant chemotherapy
4684506|NCT03337841|Adjuvant chemotherapy|adjuvant chemotherapy
4684507|NCT03337841|Immune checkpoint inhibitor|immune checkpoint inhibitor
4684508|NCT03337841|Pembrolizumab|pembrolizumab
4684509|NCT03337828|Alcohol-free beer|alcohol-free beer
4684510|NCT03337828|Carbohydrates|carbohydrates
4684511|NCT03337828|Overweight|overweight
4684512|NCT03337828|Obesity|obesity
4684513|NCT03337828|Diabetes mellitus type 2|diabetes mellitus type 2
4684514|NCT03337828|Microbiota|microbiota
4684515|NCT03337828|Glucose metabolism|glucose metabolism
4684516|NCT03337776|WhatsApp messenger|whatsapp messenger
4684517|NCT03337776|crc screening|crc screening
4684518|NCT03337776|screening update rate|screening update rate
4684519|NCT03337763|LV-LV conduction delay|lv-lv conduction delay
4684520|NCT03337750|Combat|combat
4684521|NCT03337750|Psychological Treatment|psychological treatment
4684522|NCT03337750|Military|military
4684523|NCT03337750|Psychotherapy|psychotherapy
4684524|NCT03337750|Trauma|trauma
4684525|NCT03337750|Posttraumatic Stress|posttraumatic stress
4684526|NCT03337750|Posttraumatic Stress Disorder|posttraumatic stress disorder
4684527|NCT03337711|NSCLC;ctDNA;IIA-IIIA|nsclc;ctdna;iia-iiia
4684528|NCT03337659|Family-integrated care|family-integrated care
4684529|NCT03337659|neonatal intensive care unit|neonatal intensive care unit
4684530|NCT03337659|premature|premature
4684531|NCT03337659|infant development|infant development
4684532|NCT03337646|vyvanse|vyvanse
4684533|NCT03337646|executive function|executive function
4684534|NCT03337646|safety|safety
4684535|NCT03337633|cognitive load|cognitive load
4684536|NCT03337633|galvanic skin response|galvanic skin response
4684537|NCT03337633|meal size|meal size
4684538|NCT03337633|kilocalories|kilocalories
4684539|NCT03337633|menu design|menu design
4684540|NCT03337620|chronic|chronic
4684541|NCT03337607|Extracorporeal shock wave therapy|extracorporeal shock wave therapy
4684542|NCT03337607|ESWT|eswt
4684543|NCT03337607|Radial extracorporeal shock wave therapy|radial extracorporeal shock wave therapy
4684544|NCT03337607|rESWT|reswt
4684545|NCT03337607|Chronic non-specific low back pain|chronic non-specific low back pain
4684546|NCT03337607|Non-steroidal anti-inflammatory drug|non-steroidal anti-inflammatory drug
4684547|NCT03337594|Gadolinium|gadolinium
4684548|NCT03337594|MultiHance|multihance
4684549|NCT03337594|Dotarem|dotarem
4684550|NCT03337594|Contrast agents|contrast agents
4684551|NCT03337594|Magnetic Resonance Imaging|magnetic resonance imaging
4684552|NCT03337594|Gadolinium retention|gadolinium retention
4684553|NCT03337594|Pediatric|pediatric
4684555|NCT03337581|Dexmedetomidine|dexmedetomidine
4684556|NCT03337581|pediatrics|pediatrics
4684557|NCT03337581|Pharmacodynamics|pharmacodynamics
4684558|NCT03337581|Pharmacokinetics|pharmacokinetics
4684559|NCT03337568|AML CR|aml cr
4684560|NCT03337568|allogeneic hematopoietic cell transplantation|allogeneic hematopoietic cell transplantation
4684561|NCT03337568|busulfan|busulfan
4684562|NCT03337568|fludarabine|fludarabine
4684563|NCT03337568|ATG|atg
4684564|NCT03337542|AR101|ar101
4684565|NCT03337542|Characterized Peanut Allergen|characterized peanut allergen
4684566|NCT03337542|CPNA (Characterized Peanut Allergen)|cpna (characterized peanut allergen)
4684567|NCT03337542|OIT (oral immunotherapy)|oit (oral immunotherapy)
4684568|NCT03337542|Peanut Allergy|peanut allergy
4684569|NCT03337542|Peanut-Allergic Children|peanut-allergic children
4684570|NCT03337542|Desensitization|desensitization
4684571|NCT03337542|Food Allergy|food allergy
4684572|NCT03337464|exercise|exercise
4684573|NCT03337464|EEG|eeg
4684574|NCT03337464|EMG|emg
4684575|NCT03337464|Motor function|motor function
4684576|NCT03337464|Mood|mood
4684577|NCT03337464|Cognition|cognition
4684578|NCT03337425|Psychotherapy, group|psychotherapy, group
4684579|NCT03337425|Adults|adults
4684580|NCT03337412|Therapeutic Education|therapeutic education
4684581|NCT03337412|physical activity|physical activity
4684582|NCT03337412|overweight|overweight
4684583|NCT03337412|obesity|obesity
4684584|NCT03337399|Lung Cancer|lung cancer
4684585|NCT03337373|Critical care|critical care
4684586|NCT03337373|Neuromuscular Blocking Agents|neuromuscular blocking agents
4684587|NCT03337373|Pharmacodynamics|pharmacodynamics
4684588|NCT03337373|Pharmacokinetics|pharmacokinetics
4684589|NCT03337373|Physiological Effects of Drugs|physiological effects of drugs
4684590|NCT03337360|fertility|fertility
4684591|NCT03337360|male subfertility|male subfertility
4684592|NCT03337360|foodsupplement|foodsupplement
4684593|NCT03337360|oxidative stress|oxidative stress
4684594|NCT03337347|Prognostic significance|prognostic significance
4684595|NCT03337321|pregnancy|pregnancy
4684596|NCT03337321|emotions|emotions
4684597|NCT03337321|patient experience|patient experience
4684598|NCT03337321|maternal care|maternal care
4684599|NCT03337308|hyperlipidemia|hyperlipidemia
4684600|NCT03337308|heterozygous familial hypercholesterolemia|heterozygous familial hypercholesterolemia
4684601|NCT03337308|atherosclerotic cardiovascular disease|atherosclerotic cardiovascular disease
4684602|NCT03337308|high cholesterol|high cholesterol
4684603|NCT03337308|ASCVD|ascvd
4684604|NCT03337308|HeFH|hefh
4684605|NCT03337308|LDL|ldl
4684606|NCT03337295|Meibomian Gland Dysfunction|meibomian gland dysfunction
4684607|NCT03337295|Lipid Layer Thickness|lipid layer thickness
4684608|NCT03337282|anesthesia|anesthesia
4684609|NCT03337282|noncardiac surgery|noncardiac surgery
4684610|NCT03337282|major surgery|major surgery
4684611|NCT03337282|POCD|pocd
4684612|NCT03337243|Stem Cell Injection|stem cell injection
4684613|NCT03337243|Cytokine|cytokine
4684614|NCT03337243|Wharton's Jelly|wharton's jelly
4684615|NCT03337243|Stem Cells|stem cells
4684616|NCT03337230|Cancer|cancer
4684617|NCT03337230|Weight-Loss|weight-loss
4684618|NCT03337230|Social Media|social media
4684619|NCT03337217|colonoscopy|colonoscopy
4684620|NCT03337191|ultrasound guided caudal injection|ultrasound guided caudal injection
4684621|NCT03337191|sacral hiatus|sacral hiatus
4684622|NCT03337191|sacral canal|sacral canal
4684623|NCT03337165|Rheumatoid arthritis|rheumatoid arthritis
4684624|NCT03337165|Auto-immune disorders|auto-immune disorders
4684625|NCT03337165|Tolerogenic Dendritic Cells|tolerogenic dendritic cells
4684626|NCT03337139|Weight Loss|weight loss
4684627|NCT03337139|Obesity|obesity
4684628|NCT03337139|Overweight|overweight
4684629|NCT03337139|Behavioral Weight Loss|behavioral weight loss
4684630|NCT03337100|Opioids|opioids
4684631|NCT03337100|Naloxone|naloxone
4684632|NCT03337100|Co-dispensing|co-dispensing
4684633|NCT03337100|Cluster randomized trial|cluster randomized trial
4684634|NCT03337100|Opioid antagonist|opioid antagonist
4684635|NCT03337035|Probiotics, Oxytocin|probiotics, oxytocin
4684636|NCT03337022|Psoriasis|psoriasis
4684637|NCT03337022|CC-90006|cc-90006
4684638|NCT03337022|Mild to moderate plaque-type psoriasis|mild to moderate plaque-type psoriasis
4684639|NCT03337022|Safety|safety
4684640|NCT03337022|Pharmacokinetics|pharmacokinetics
4684641|NCT03337022|Pharmacodynamics|pharmacodynamics
4684642|NCT03337009|Opioid antagonist|opioid antagonist
4684643|NCT03337009|Naloxone|naloxone
4684644|NCT03337009|Opioids|opioids
4684645|NCT03337009|Web-based intervention|web-based intervention
4684646|NCT03336996|Motor nerve injury|motor nerve injury
4684647|NCT03336996|umbilical cord interstitial stem cell|umbilical cord interstitial stem cell
4684648|NCT03336996|bold-DTI|bold-dti
4684649|NCT03336996|reconstruction of motor circuits|reconstruction of motor circuits
4684650|NCT03336983|prostate cancer|prostate cancer
4684651|NCT03336983|bone metastasis|bone metastasis
4684652|NCT03336983|enzalutamide|enzalutamide
4684653|NCT03336983|zoledronic acid|zoledronic acid
4684654|NCT03336970|single visit root canal treatment, chlorhexidine|single visit root canal treatment, chlorhexidine
4684655|NCT03336957|chromogranin A, stress, gingivitis, pregnancy|chromogranin a, stress, gingivitis, pregnancy
4684656|NCT03336931|children|children
4684657|NCT03336931|precision medicine|precision medicine
4684658|NCT03336931|personalised medicine|personalised medicine
4684659|NCT03336931|high-risk cancer|high-risk cancer
4684660|NCT03336931|refractory|refractory
4684661|NCT03336931|recurrent|recurrent
4684662|NCT03336931|sequencing|sequencing
4684663|NCT03336931|patient derived xenograft|patient derived xenograft
4684664|NCT03336931|molecular profiling|molecular profiling
4684665|NCT03336931|paediatric|paediatric
4684666|NCT03336918|Bipolar Disorder|bipolar disorder
4684667|NCT03336918|Bipolar I and II Depression|bipolar i and ii depression
4684668|NCT03336918|Lithium|lithium
4684669|NCT03336918|Depression|depression
4684670|NCT03336905|Adolescent and young adult|adolescent and young adult
4684671|NCT03336892|Care Coordination|care coordination
4684672|NCT03336879|Gambling Disorder|gambling disorder
4684673|NCT03336879|Mental Disorder|mental disorder
4684674|NCT03336879|Behavioral Addiction|behavioral addiction
4684675|NCT03336827|Emotion Regulation|emotion regulation
4684676|NCT03336827|Post-Treatment Breast Cancer Care|post-treatment breast cancer care
4684677|NCT03336827|Cognitive-Behavioral Therapy|cognitive-behavioral therapy
4684678|NCT03336827|CBT|cbt
4684679|NCT03336827|Hypnosis|hypnosis
4684680|NCT03336814|Terlipressin|terlipressin
4684681|NCT03336814|norepinephrine|norepinephrine
4684682|NCT03336801|sevoflurane|sevoflurane
4684683|NCT03336801|propofol|propofol
4684684|NCT03336775|acupuncure|acupuncure
4684685|NCT03336775|dysphagia|dysphagia
4684686|NCT03336775|radiation|radiation
4684687|NCT03336749|Stroke, upper limb, sensory training, rehabilitation|stroke, upper limb, sensory training, rehabilitation
4684688|NCT03336736|Physical Activity|physical activity
4684689|NCT03336736|Diet|diet
4684690|NCT03336736|Exercise|exercise
4684691|NCT03336736|Sarcoidosis|sarcoidosis
4684692|NCT03336736|Pulmonary sarcoidosis|pulmonary sarcoidosis
4684693|NCT03336736|Lung Function|lung function
4684694|NCT03336736|Fitness|fitness
4684695|NCT03336736|Strength|strength
4684696|NCT03336736|Endurance|endurance
4684697|NCT03336710|Self-control|self-control
4684698|NCT03336710|Ecological Momentary Assessment|ecological momentary assessment
4684699|NCT03336710|Attentional bias|attentional bias
4684700|NCT03336710|Respiratory Sinus Arrhythmia|respiratory sinus arrhythmia
4684701|NCT03336710|Affect|affect
4684702|NCT03336710|Emotion Regulation|emotion regulation
4684703|NCT03336710|Well-being|well-being
4684704|NCT03336710|Decentering|decentering
4684705|NCT03336710|Affective disorders|affective disorders
4684706|NCT03336684|Patient education|patient education
4684707|NCT03336684|Rheumatoid arthritis|rheumatoid arthritis
4684708|NCT03336684|Knowledge|knowledge
4684709|NCT03336684|Attitudes|attitudes
4684710|NCT03336684|Practice|practice
4684711|NCT03336671|Pediatric|pediatric
4684712|NCT03336671|Chronic Sinusitis|chronic sinusitis
4684713|NCT03336645|Seizure|seizure
4684714|NCT03336645|Midazolam hydrochloride|midazolam hydrochloride
4684715|NCT03336645|Convulsive|convulsive
4684716|NCT03336632|PBSCT|pbsct
4684717|NCT03336632|myeloablative conditioning|myeloablative conditioning
4684718|NCT03336632|HDACi|hdaci
4684719|NCT03336632|chidamide|chidamide
4684720|NCT03336619|Influenza|influenza
4684721|NCT03336606|immunotherapy|immunotherapy
4684722|NCT03336606|OX40|ox40
4684723|NCT03336606|antibodies|antibodies
4684724|NCT03336606|HNSCC|hnscc
4684725|NCT03336606|melanoma|melanoma
4684726|NCT03336606|phase 1|phase 1
4684727|NCT03336606|squamous cell|squamous cell
4684728|NCT03336567|telephonic interview|telephonic interview
4684729|NCT03336567|TCR Therapy|tcr therapy
4684730|NCT03336567|cross-sectional|cross-sectional
4684731|NCT03336567|CGT|cgt
4684732|NCT03336567|qualitative|qualitative
4684733|NCT03336554|osteosarcoma|osteosarcoma
4684734|NCT03336554|epigenetic biomarker|epigenetic biomarker
4684735|NCT03336554|hMe-Seal technique|hme-seal technique
4684736|NCT03336541|Prenatal depression|prenatal depression
4684737|NCT03336541|Ketamine|ketamine
4684738|NCT03336541|Cesarean delivery|cesarean delivery
4684739|NCT03336541|Postpartum depression|postpartum depression
4684740|NCT03336528|Long-acting insulin analog|long-acting insulin analog
4684741|NCT03336515|Positional Obstructive Sleep Apnea|positional obstructive sleep apnea
4684742|NCT03336515|Postural Device|postural device
4684743|NCT03336515|Treatment|treatment
4684744|NCT03336476|Direct laryngoscopy|direct laryngoscopy
4684745|NCT03336476|Videolaryngoscopy|videolaryngoscopy
4684746|NCT03336476|Diabetes Mellitus|diabetes mellitus
4684747|NCT03336476|Intubation|intubation
4684748|NCT03336476|Anesthesia|anesthesia
4684749|NCT03336463|Thrombophilia screening|thrombophilia screening
4684750|NCT03336463|Genetic risk score|genetic risk score
4684751|NCT03336437|Menopause|menopause
4684752|NCT03336437|Vaginal dryness|vaginal dryness
4684753|NCT03336437|Vaginal atrophy|vaginal atrophy
4684754|NCT03336437|Postmenopause|postmenopause
4684755|NCT03336437|Estrogen|estrogen
4684756|NCT03336437|Urinary microbiome|urinary microbiome
4684757|NCT03336437|Estradiol vaginal ring|estradiol vaginal ring
4684758|NCT03336437|Genitourinary Syndrome of Menopause|genitourinary syndrome of menopause
4684759|NCT03336437|Vaginal microbiome|vaginal microbiome
4684760|NCT03336424|MS|ms
4684761|NCT03336424|Multiple sclerosis|multiple sclerosis
4684762|NCT03336424|urinary Bladder, Neurogenic|urinary bladder, neurogenic
4684763|NCT03336424|Urodynamics|urodynamics
4684764|NCT03336424|Randomized controlled trial|randomized controlled trial
4684765|NCT03336385|Older adults|older adults
4684766|NCT03336385|Prebiotics|prebiotics
4684767|NCT03336385|Intestinal permeability|intestinal permeability
4684768|NCT03336385|NSAIDS|nsaids
4684769|NCT03336359|colonoscopy|colonoscopy
4684770|NCT03336359|image enhanced endoscopy|image enhanced endoscopy
4684771|NCT03336346|DTG|dtg
4684772|NCT03336346|Dolutegravir|dolutegravir
4684773|NCT03336346|Efavirenz|efavirenz
4684774|NCT03336346|Etonogestrel|etonogestrel
4684775|NCT03336333|BGB-3111|bgb-3111
4684776|NCT03336333|BTK inhibitor|btk inhibitor
4684777|NCT03336333|bendamustine|bendamustine
4684778|NCT03336333|rituximab|rituximab
4684779|NCT03336333|Phase 3|phase 3
4684780|NCT03336307|Parkinson disease|parkinson disease
4684781|NCT03336307|movement Disorders|movement disorders
4684782|NCT03336307|gait disturbance|gait disturbance
4684783|NCT03336307|Parkinson|parkinson
4684784|NCT03336307|Parkinson gait|parkinson gait
4684785|NCT03336307|3D motion analysis systems|3d motion analysis systems
4684786|NCT03336307|motion analysis|motion analysis
4684787|NCT03336307|Parkinson rehabilitation|parkinson rehabilitation
4684788|NCT03336307|rehabilitation gait improvement|rehabilitation gait improvement
4684789|NCT03336307|gait improvement|gait improvement
4684790|NCT03336307|SMART Capture|smart capture
4684791|NCT03336307|MATLAB software|matlab software
4684792|NCT03336294|Sarcopenia|sarcopenia
4684793|NCT03336294|Muscle strength|muscle strength
4684794|NCT03336294|SRM P31|srm p31
4684795|NCT03336294|Phosphocreatine|phosphocreatine
4684796|NCT03336229|cancer|cancer
4684797|NCT03336229|colorectal|colorectal
4684798|NCT03336229|exercise|exercise
4684799|NCT03336229|physical fitness|physical fitness
4684800|NCT03336203|eGFR, gout, CKD, uric acid, uric acid lowering therapy, hyperuricemia, allopurinol, febuxostat|egfr, gout, ckd, uric acid, uric acid lowering therapy, hyperuricemia, allopurinol, febuxostat
4684801|NCT03336190|military|military
4684802|NCT03336190|caregiver|caregiver
4684803|NCT03336177|gynecology|gynecology
4684804|NCT03336177|cancer|cancer
4684806|NCT03336177|delay|delay
4684807|NCT03336177|help-seeking behavior|help-seeking behavior
4684808|NCT03336177|qualitative research|qualitative research
4684809|NCT03336177|semiopragmatic analysis|semiopragmatic analysis
4684810|NCT03336177|psychodynamic analysis|psychodynamic analysis
4684811|NCT03336112|Non-cardiac chest pain|non-cardiac chest pain
4684812|NCT03336112|Psychological distress|psychological distress
4684813|NCT03336112|I-CBT|i-cbt
4684814|NCT03336047|Exercise|exercise
4684815|NCT03336047|Actigraphy|actigraphy
4684816|NCT03336047|Prevention and Control|prevention and control
4684817|NCT03336047|Cardiorespiratory Fitness|cardiorespiratory fitness
4684818|NCT03336034|IBS-C|ibs-c
4684819|NCT03336034|Experience sampling method|experience sampling method
4684820|NCT03336034|Ecological momentary assessment|ecological momentary assessment
4684821|NCT03336034|Abdominal pain|abdominal pain
4684822|NCT03336034|Constipation|constipation
4684823|NCT03335995|mechanical invasive ventilation|mechanical invasive ventilation
4684824|NCT03335995|course of the care|course of the care
4684825|NCT03335995|prognosis|prognosis
4684826|NCT03335995|stroke|stroke
4684827|NCT03335982|transendoscopic enteral tubing|transendoscopic enteral tubing
4684828|NCT03335982|mid-gut|mid-gut
4684829|NCT03335982|endoscopy|endoscopy
4684830|NCT03335982|nasal-jejunal tube|nasal-jejunal tube
4684831|NCT03335982|fecal microbiota transplantation|fecal microbiota transplantation
4684832|NCT03335982|enteral nutrition|enteral nutrition
4684833|NCT03335956|Glucocorticoid receptor; antagonist|glucocorticoid receptor; antagonist
4684834|NCT03335943|CDA-2, MDS|cda-2, mds
4684835|NCT03335930|exercise|exercise
4684836|NCT03335930|blood glucose response|blood glucose response
4684837|NCT03335930|metabolic control|metabolic control
4684838|NCT03335930|type 2 diabetes.|type 2 diabetes.
4684839|NCT03335904|Angiotensin receptor blockade|angiotensin receptor blockade
4684840|NCT03335904|control of breathing|control of breathing
4684841|NCT03335904|breath-holding|breath-holding
4684842|NCT03335891|asthma education program|asthma education program
4684843|NCT03335891|balance|balance
4684844|NCT03335891|core stabilization exercises|core stabilization exercises
4684845|NCT03335839|tPA|tpa
4684846|NCT03335826|Elderly|elderly
4684847|NCT03335826|Cancer surgery|cancer surgery
4684848|NCT03335826|Epidural anesthesia and analgesia|epidural anesthesia and analgesia
4684849|NCT03335826|Long-term survival|long-term survival
4684850|NCT03335826|Quality of life|quality of life
4684851|NCT03335813|brachytherapy|brachytherapy
4684852|NCT03335813|multichannel balloon applicator|multichannel balloon applicator
4684853|NCT03335787|Athletic Tape|athletic tape
4684854|NCT03335787|Proprioception|proprioception
4684855|NCT03335787|Hemiplegia|hemiplegia
4684856|NCT03335787|Gait|gait
4684857|NCT03335761|Urinary|urinary
4684858|NCT03335761|Incontinence|incontinence
4684859|NCT03335748|ADHD|adhd
4684860|NCT03335748|Combined type|combined type
4684861|NCT03335748|Cognitive training|cognitive training
4684862|NCT03335748|Intervention|intervention
4684863|NCT03335748|Youths|youths
4684864|NCT03335735|alcohol|alcohol
4684865|NCT03335735|driving|driving
4684866|NCT03335735|breathalyzers|breathalyzers
4684867|NCT03335735|smartphone|smartphone
4684868|NCT03335722|stammering|stammering
4684869|NCT03335722|speech motor disorder|speech motor disorder
4684870|NCT03335722|electrical current stimulation|electrical current stimulation
4684871|NCT03335722|metronome-timed speech|metronome-timed speech
4684872|NCT03335709|Occupational therapy|occupational therapy
4684873|NCT03335696|Epidemiology|epidemiology
4685270|NCT03333460|addiction|addiction
4684874|NCT03335696|Magnetic resonance imaging|magnetic resonance imaging
4684875|NCT03335696|Diffusion tensor imaging|diffusion tensor imaging
4684876|NCT03335696|White matter|white matter
4684877|NCT03335696|Functional MRI|functional mri
4684878|NCT03335696|Connectome|connectome
4684879|NCT03335696|Resting state brain networks|resting state brain networks
4684880|NCT03335696|Neuropsychology|neuropsychology
4684881|NCT03335670|68Ga-pentixafor|68ga-pentixafor
4684882|NCT03335670|(68Ga)pentixafor|(68ga)pentixafor
4684883|NCT03335670|Gallium Radioisotopes|gallium radioisotopes
4684884|NCT03335670|CXCR4|cxcr4
4684885|NCT03335644|determinants of dietary patterns and nutritional status|determinants of dietary patterns and nutritional status
4684886|NCT03335618|Activity|activity
4684887|NCT03335618|Mood|mood
4684888|NCT03335605|primary immunodeficiency|primary immunodeficiency
4684889|NCT03335527|Aged|aged
4684890|NCT03335527|Postoperative period|postoperative period
4684891|NCT03335527|Intensive Care Unit|intensive care unit
4684892|NCT03335527|Mechanical ventilation|mechanical ventilation
4684893|NCT03335527|Sleep quality|sleep quality
4684894|NCT03335527|Dexmedetomidine|dexmedetomidine
4684895|NCT03335514|GALNT4|galnt4
4684896|NCT03335501|Closed-loop control|closed-loop control
4684897|NCT03335501|Artificial pancreas|artificial pancreas
4684898|NCT03335501|Postprandial glucose control|postprandial glucose control
4684899|NCT03335501|Insulin|insulin
4684900|NCT03335488|Urea|urea
4684901|NCT03335488|Hyperammonemic crisis (HAC)|hyperammonemic crisis (hac)
4684902|NCT03335475|congenital heart disease|congenital heart disease
4684903|NCT03335475|physical activity|physical activity
4684904|NCT03335436|buprenorphine maintenance|buprenorphine maintenance
4684905|NCT03335397|education|education
4684906|NCT03335397|health science|health science
4684907|NCT03335397|app|app
4684908|NCT03335397|m-learning|m-learning
4684909|NCT03335358|couples|couples
4684910|NCT03335358|positive psychology|positive psychology
4684911|NCT03335358|behavioral intervention|behavioral intervention
4684912|NCT03335358|stroke|stroke
4684913|NCT03335358|depression|depression
4684914|NCT03335358|wellbeing|wellbeing
4684915|NCT03335358|caregiver|caregiver
4684916|NCT03335345|Airway Extubation/adverse effects/ Methods|airway extubation/adverse effects/ methods
4684917|NCT03335345|Nutrition|nutrition
4684918|NCT03335345|Ventilator Weaning/methods|ventilator weaning/methods
4684919|NCT03335345|Intensive care Unit|intensive care unit
4684920|NCT03335345|Enteral Nutrition|enteral nutrition
4684921|NCT03335332|High intensity exercise|high intensity exercise
4684922|NCT03335332|Cardiorespiratory fitness|cardiorespiratory fitness
4684923|NCT03335332|Stroke volume reserve|stroke volume reserve
4684924|NCT03335332|Arrhythmia burden|arrhythmia burden
4684925|NCT03335319|Cardiovascular Disease|cardiovascular disease
4684926|NCT03335319|Coronary Artery Disease|coronary artery disease
4684927|NCT03335319|Cardiopulmonary Exercise Testing|cardiopulmonary exercise testing
4684928|NCT03335319|Oxygen Uptake Kinetics|oxygen uptake kinetics
4684929|NCT03335319|Skeletal Muscle Oxygenation|skeletal muscle oxygenation
4684930|NCT03335319|Exercise Training|exercise training
4684931|NCT03335319|Periodized Exercise|periodized exercise
4684932|NCT03335306|Body constitution|body constitution
4684933|NCT03335306|Chinese Medicine|chinese medicine
4684934|NCT03335306|Validation|validation
4684935|NCT03335293|pregnancy|pregnancy
4684936|NCT03335293|repeat cesarean section|repeat cesarean section
4684937|NCT03335293|spinal anesthesia|spinal anesthesia
4684938|NCT03335293|bupivacaine|bupivacaine
4684939|NCT03335293|epinephrine|epinephrine
4684940|NCT03335293|intrathecal|intrathecal
4684941|NCT03335293|analgesia|analgesia
4684942|NCT03335254|Hypogonadism|hypogonadism
4684943|NCT03335254|Testosterone|testosterone
4684944|NCT03335254|Testosterone undecanoate|testosterone undecanoate
4684945|NCT03335241|Ovarian Cancer|ovarian cancer
4684946|NCT03335241|Fludarabine|fludarabine
4684947|NCT03335241|Pegylated Liposomal Doxorubicin|pegylated liposomal doxorubicin
4684948|NCT03335241|Chemotherapy|chemotherapy
4684949|NCT03335228|platelet rich plasma, frontal fibrosing alopecia|platelet rich plasma, frontal fibrosing alopecia
4684950|NCT03335202|respiratory and intestinal microbiome|respiratory and intestinal microbiome
4684951|NCT03335202|antibiotic therapy|antibiotic therapy
4684952|NCT03335202|cftr modifier|cftr modifier
4684953|NCT03335202|diversity|diversity
4684954|NCT03335189|E-Health|e-health
4684955|NCT03335189|Smartphone technology|smartphone technology
4684956|NCT03335189|Real-time symptom assessment|real-time symptom assessment
4684957|NCT03335189|Self-care|self-care
4684958|NCT03335189|Symptom management|symptom management
4684959|NCT03335150|Parkinson's disease|parkinson's disease
4684960|NCT03335150|Rehabilitation|rehabilitation
4684961|NCT03335150|Cognition|cognition
4684962|NCT03335124|Sepsis|sepsis
4684963|NCT03335124|Vitamin C|vitamin c
4684964|NCT03335124|Hydrocortisone|hydrocortisone
4684965|NCT03335124|Thiamine|thiamine
4684966|NCT03335124|Critical Illness|critical illness
4684967|NCT03335124|Fluid Responsiveness|fluid responsiveness
4684968|NCT03335124|Hemodynamics|hemodynamics
4684969|NCT03335111|Remote Ischemic Postconditioning|remote ischemic postconditioning
4684970|NCT03335111|Peripheral Immunity|peripheral immunity
4685471|NCT03332342|tears|tears
4684971|NCT03335098|Waldenstrom's macroglobulinemia|waldenstrom's macroglobulinemia
4684972|NCT03335098|Lymphoplasmacytic lymphoma|lymphoplasmacytic lymphoma
4684973|NCT03335098|Bortezomib|bortezomib
4684974|NCT03335098|Thalidomide|thalidomide
4684975|NCT03335072|Azithromycin|azithromycin
4684976|NCT03335072|Mass Drug Administration|mass drug administration
4684977|NCT03335072|Antibiotic Resistance|antibiotic resistance
4684978|NCT03335059|BCG|bcg
4684979|NCT03335059|Bacillus Calmette-Guérin|bacillus calmette-guérin
4684980|NCT03335059|CIS|cis
4684981|NCT03335059|BCG-unresponsive|bcg-unresponsive
4684982|NCT03335059|Synergo|synergo
4684983|NCT03335059|chemohyperthermia|chemohyperthermia
4684984|NCT03335059|thermochemotherapy|thermochemotherapy
4684985|NCT03335059|RF|rf
4684986|NCT03335059|radio frequency|radio frequency
4684987|NCT03335059|RITE|rite
4684988|NCT03335046|Home Visit|home visit
4684989|NCT03335046|School Absenteeism|school absenteeism
4684990|NCT03335033|Carotid Plaque|carotid plaque
4684991|NCT03335033|Contrast Enhanced Ultrasound|contrast enhanced ultrasound
4684992|NCT03335033|Shear Wave Elastography|shear wave elastography
4684993|NCT03335033|Endarterectomy|endarterectomy
4684994|NCT03335033|Stenosis|stenosis
4684995|NCT03335020|Ultrasound|ultrasound
4684996|NCT03335020|3D ultrasonography|3d ultrasonography
4684997|NCT03335020|Contrast-enhanced ultrasound|contrast-enhanced ultrasound
4684998|NCT03335020|Shear wave elastography|shear wave elastography
4684999|NCT03335007|Aceclofenac|aceclofenac
4685000|NCT03335007|pain|pain
4685001|NCT03335007|irreversible pulpitis|irreversible pulpitis
4685002|NCT03334994|Immediate dental implant, Connective tissue graft, Esthetic zone.|immediate dental implant, connective tissue graft, esthetic zone.
4685003|NCT03334981|meconium concentration|meconium concentration
4685004|NCT03334981|buprenorphine|buprenorphine
4685005|NCT03334981|methadone|methadone
4685006|NCT03334981|pregnant|pregnant
4685007|NCT03334981|liquid chromatography-tandem mass spectrometry|liquid chromatography-tandem mass spectrometry
4685008|NCT03334981|opioid-dependant woman|opioid-dependant woman
4685009|NCT03334968|Stroke|stroke
4685010|NCT03334968|prolidase|prolidase
4685011|NCT03334968|prognosis|prognosis
4685012|NCT03334968|biomarker|biomarker
4685013|NCT03334955|Polycystic Ovary Syndrome|polycystic ovary syndrome
4685014|NCT03334955|Laparoscopic ovarian drilling|laparoscopic ovarian drilling
4685015|NCT03334955|subendometrial blood flow|subendometrial blood flow
4685016|NCT03334942|youth|youth
4685017|NCT03334942|parents|parents
4685018|NCT03334942|posttraumatic stress|posttraumatic stress
4685019|NCT03334942|violence|violence
4685020|NCT03334942|violent injuries|violent injuries
4685021|NCT03334929|virtual reality|virtual reality
4685022|NCT03334929|trigger point injections|trigger point injections
4685023|NCT03334903|Total Knee Arthroplasty|total knee arthroplasty
4685024|NCT03334903|Neurontin|neurontin
4685025|NCT03334903|Gabapentin|gabapentin
4685026|NCT03334903|Opioid Tapering|opioid tapering
4685027|NCT03334890|colorectal cancer|colorectal cancer
4685028|NCT03334890|septin 9|septin 9
4685029|NCT03334890|SEPT9|sept9
4685030|NCT03334890|methylation|methylation
4685031|NCT03334890|CEA|cea
4685032|NCT03334864|Advanced non-small cell lung cancer|advanced non-small cell lung cancer
4685033|NCT03334838|Food effect|food effect
4685034|NCT03334838|Dose proportionality|dose proportionality
4685035|NCT03334825|HIV|hiv
4685036|NCT03334825|housing|housing
4685037|NCT03334825|homelessness|homelessness
4685038|NCT03334812|cartilage lesion, ACI|cartilage lesion, aci
4685039|NCT03334799|sacroiliac belt|sacroiliac belt
4685040|NCT03334799|kinematics|kinematics
4685041|NCT03334799|stability|stability
4685042|NCT03334799|pelvic girdle pain|pelvic girdle pain
4685043|NCT03334799|sacroiliac instability|sacroiliac instability
4685044|NCT03334786|ALS|als
4685045|NCT03334786|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
4685046|NCT03334786|Fasciculation|fasciculation
4685047|NCT03334786|FLX-787|flx-787
4685048|NCT03334773|Type 2 diabetes, nutrition education programme, intervention, South Africa|type 2 diabetes, nutrition education programme, intervention, south africa
4685049|NCT03334760|Cohort study|cohort study
4685050|NCT03334760|Infant feeding|infant feeding
4685051|NCT03334760|Overweight|overweight
4685052|NCT03334760|Child BMI|child bmi
4685053|NCT03334760|Breastfeeding|breastfeeding
4685054|NCT03334760|Intake of protein|intake of protein
4685055|NCT03334747|uncomplicated Plasmodium falciparum Malaria.|uncomplicated plasmodium falciparum malaria.
4685056|NCT03334734|Tuberculosis|tuberculosis
4685057|NCT03334734|PBTZ169|pbtz169
4685058|NCT03334734|antimycobacterial|antimycobacterial
4685059|NCT03334708|17-257|17-257
4685060|NCT03334669|Childhood obesity|childhood obesity
4685061|NCT03334669|Preschool|preschool
4685062|NCT03334669|Head Start|head start
4685063|NCT03334669|Family Interventions|family interventions
4685064|NCT03334669|Community Based Participatory Research (CBPR)|community based participatory research (cbpr)
4685065|NCT03334669|Empowerment Theory|empowerment theory
4685066|NCT03334669|Family Ecological Theory|family ecological theory
4685067|NCT03334669|Step Wedge Design|step wedge design
4685068|NCT03334669|Low Income|low income
4685069|NCT03334656|Split thickness skin graft donor site|split thickness skin graft donor site
4685070|NCT03334656|wound healing|wound healing
4685071|NCT03334656|Fetal skin bioconstruct|fetal skin bioconstruct
4685072|NCT03334656|Fibroblasts|fibroblasts
4685073|NCT03334656|Keratinocytes|keratinocytes
4685074|NCT03334643|Type 2 Diabetes|type 2 diabetes
4685075|NCT03334643|Dietary fiber|dietary fiber
4685076|NCT03334643|Glycemic response|glycemic response
4685077|NCT03334630|ablation|ablation
4685078|NCT03334630|electrophysiology|electrophysiology
4685079|NCT03334630|atrial fibrillation|atrial fibrillation
4685080|NCT03334630|catheter|catheter
4685081|NCT03334630|paroxysmal|paroxysmal
4685082|NCT03334617|Non-small cell lung cancer|non-small cell lung cancer
4685083|NCT03334617|NSCLC|nsclc
4685084|NCT03334617|anti-PD-1/PD-L1|anti-pd-1/pd-l1
4685085|NCT03334617|umbrella study|umbrella study
4685086|NCT03334617|Durvalumab|durvalumab
4685087|NCT03334617|MEDI4736|medi4736
4685088|NCT03334617|Olaparib|olaparib
4685089|NCT03334617|AZD2281|azd2281
4685090|NCT03334617|AZD9150|azd9150
4685091|NCT03334617|AZD6738|azd6738
4685092|NCT03334617|Vistusertib|vistusertib
4685093|NCT03334617|AZD2014|azd2014
4685094|NCT03334604|antibiotic-associated diarrhea|antibiotic-associated diarrhea
4685095|NCT03334604|probiotics|probiotics
4685096|NCT03334513|Bevacizumab|bevacizumab
4685097|NCT03334513|Biometry|biometry
4685098|NCT03334513|Ranibizumab|ranibizumab
4685099|NCT03334513|Refractive error|refractive error
4685100|NCT03334513|Retinopathy of prematurity|retinopathy of prematurity
4685101|NCT03334487|Cancer|cancer
4685102|NCT03334487|Small Cell Lung Cancer|small cell lung cancer
4685103|NCT03334487|Relapsed Small Cell Lung Cancer|relapsed small cell lung cancer
4685104|NCT03334487|Remitting Small Cell Lung Cancer|remitting small cell lung cancer
4685105|NCT03334487|Delta-like protein 3 (DLL3)|delta-like protein 3 (dll3)
4685106|NCT03334487|DLL3 Expressing Small Cell Lung Cancer|dll3 expressing small cell lung cancer
4685107|NCT03334487|Rovalpituzumab Tesirine|rovalpituzumab tesirine
4685108|NCT03334461|Oral antiseptics|oral antiseptics
4685109|NCT03334461|remineralisation agents|remineralisation agents
4685110|NCT03334435|eczema|eczema
4685111|NCT03334435|atopic eczema|atopic eczema
4685112|NCT03334422|eczema|eczema
4685113|NCT03334422|atopic eczema|atopic eczema
4685114|NCT03334396|eczema|eczema
4685115|NCT03334396|atopic eczema|atopic eczema
4685116|NCT03334383|Laparoscopic colorectal surgery|laparoscopic colorectal surgery
4685117|NCT03334383|Retractor sponge|retractor sponge
4685118|NCT03334383|Trendelenburg position|trendelenburg position
4685119|NCT03334383|Postoperative complications|postoperative complications
4685120|NCT03334370|Diabetes mellitus|diabetes mellitus
4685121|NCT03334357|Physical fitness|physical fitness
4685122|NCT03334357|Klotho|klotho
4685123|NCT03334357|Training|training
4685124|NCT03334357|HIIT|hiit
4685125|NCT03334357|WB-EMS|wb-ems
4685126|NCT03334292|Wilson Disease|wilson disease
4685127|NCT03334266|sugar|sugar
4685128|NCT03334266|sweetened|sweetened
4685129|NCT03334266|beverages|beverages
4685130|NCT03334266|responsive|responsive
4685131|NCT03334253|Myopia|myopia
4685132|NCT03334253|atropine|atropine
4685133|NCT03334240|HPV|hpv
4685134|NCT03334240|Digoxin|digoxin
4685135|NCT03334240|Furosemide|furosemide
4685136|NCT03334240|Vulvar HSIL|vulvar hsil
4685137|NCT03334227|High-Flow Nasal Cannula|high-flow nasal cannula
4685138|NCT03334227|Severe Sepsis|severe sepsis
4685139|NCT03334227|qSOFA|qsofa
4685140|NCT03334214|Hepatic Steatosis|hepatic steatosis
4685141|NCT03334214|IONIS-DGAT2Rx|ionis-dgat2rx
4685142|NCT03334214|Type 2 Diabetes|type 2 diabetes
4685143|NCT03334162|Children|children
4685144|NCT03334162|Adolescents|adolescents
4685145|NCT03334162|Cancer|cancer
4685146|NCT03334162|brain Tumor|brain tumor
4685147|NCT03334162|exercise|exercise
4685148|NCT03334162|Chemotherapy-induced Peripheral Neuropathy|chemotherapy-induced peripheral neuropathy
4685149|NCT03334162|CIPN|cipn
4685150|NCT03334162|Sensorimotor Training|sensorimotor training
4685151|NCT03334123|exercise|exercise
4685152|NCT03334123|aerobic exercise|aerobic exercise
4685153|NCT03334123|functional training|functional training
4685154|NCT03334123|strength training|strength training
4685155|NCT03334123|resistance training|resistance training
4685156|NCT03334123|kidney failure|kidney failure
4685157|NCT03334123|rehabilitation|rehabilitation
4685158|NCT03334123|physical activity|physical activity
4685159|NCT03334123|hemodialysis|hemodialysis
4685160|NCT03334123|dialysis patients|dialysis patients
4685161|NCT03334123|chronic renal failure|chronic renal failure
4685162|NCT03334123|chronic kidney disease|chronic kidney disease
4685163|NCT03334123|end-stage renal disease|end-stage renal disease
4685164|NCT03334123|intradialytic exercise|intradialytic exercise
4685165|NCT03334097|Pregnancy|pregnancy
4685166|NCT03334097|fear|fear
4685167|NCT03334097|Parturition|parturition
4685168|NCT03334097|Prenatal Education|prenatal education
4685169|NCT03334045|Neurobiology|neurobiology
4685170|NCT03334045|Occupational Stress|occupational stress
4685171|NCT03334045|Dopamine|dopamine
4685172|NCT03334032|Body composition|body composition
4685173|NCT03334032|Total body protein|total body protein
4685174|NCT03334032|nutritional recovery|nutritional recovery
4685175|NCT03334032|Exercise status|exercise status
4685176|NCT03334032|In-vivo neutron activation analysis|in-vivo neutron activation analysis
4685177|NCT03334032|Protein depletion|protein depletion
4685178|NCT03334006|Pentaglobin®|pentaglobin®
4685179|NCT03334006|Personalised Medicine|personalised medicine
4685180|NCT03333993|Pilates exercise|pilates exercise
4685181|NCT03333993|Fatigue|fatigue
4685182|NCT03333993|Quality of Life|quality of life
4685183|NCT03333967|apatinib|apatinib
4685184|NCT03333954|atrophic macular degeneration|atrophic macular degeneration
4685185|NCT03333954|geographic atrophy|geographic atrophy
4685186|NCT03333954|macular degeneration|macular degeneration
4685187|NCT03333954|dry macular degeneration|dry macular degeneration
4685188|NCT03333954|AMD|amd
4685189|NCT03333954|retina implant|retina implant
4685190|NCT03333954|retinal prosthesis|retinal prosthesis
4685191|NCT03333954|visual prosthesis|visual prosthesis
4685192|NCT03333902|quadratus lumborum block|quadratus lumborum block
4685193|NCT03333902|transversus abdominis plane block|transversus abdominis plane block
4685194|NCT03333902|anesthesia|anesthesia
4685195|NCT03333837|Improvisation|improvisation
4685196|NCT03333837|Memory loss|memory loss
4685197|NCT03333837|Caregivers|caregivers
4685198|NCT03333837|Quality of Life|quality of life
4685199|NCT03333837|Dance|dance
4685200|NCT03333837|Social Group|social group
4685201|NCT03333837|MRI|mri
4685202|NCT03333837|mild cognitive impairment|mild cognitive impairment
4685203|NCT03333837|MCI|mci
4685204|NCT03333837|Social engagement|social engagement
4685205|NCT03333824|Pharmacokinetics, Cardiac Conduction, Mitotic Checkpoint inhibitor, QTc interval|pharmacokinetics, cardiac conduction, mitotic checkpoint inhibitor, qtc interval
4685206|NCT03333798|Intimate Partner Violence|intimate partner violence
4685207|NCT03333798|Domestic Violence|domestic violence
4685208|NCT03333798|Mental Health|mental health
4685209|NCT03333798|Cognitive- Behavioral Therapy|cognitive- behavioral therapy
4685210|NCT03333798|Community Lay Workers|community lay workers
4685211|NCT03333785|Primary Care|primary care
4685212|NCT03333785|Oncology|oncology
4685213|NCT03333785|Continuity of care|continuity of care
4685214|NCT03333785|Integration of care|integration of care
4685215|NCT03333785|Communication|communication
4685216|NCT03333759|laser|laser
4685217|NCT03333759|Er:YAG laser|er:yag laser
4685218|NCT03333759|acne|acne
4685219|NCT03333759|acne vulgaris|acne vulgaris
4685220|NCT03333759|optical coherence tomography|optical coherence tomography
4685221|NCT03333720|Phenylketonuria|phenylketonuria
4685222|NCT03333720|Inherited Metabolic Disorders|inherited metabolic disorders
4685223|NCT03333694|Cutaneous Squamous Cell Carcinoma (cSCC) in situ, mTOR kinase inhibitors, PI3K inhibitor.|cutaneous squamous cell carcinoma (cscc) in situ, mtor kinase inhibitors, pi3k inhibitor.
4685224|NCT03333681|Rheumatoid arthritis|rheumatoid arthritis
4685225|NCT03333681|Stem Cells|stem cells
4685226|NCT03333681|Cellular immunity|cellular immunity
4685227|NCT03333681|Humoral immunity|humoral immunity
4685228|NCT03333681|chemokines|chemokines
4685229|NCT03333681|homing of immune cells|homing of immune cells
4685230|NCT03333668|Lisdexamfetamine|lisdexamfetamine
4685231|NCT03333668|Guanfacine|guanfacine
4685232|NCT03333668|functional Magnetic Resonance Imaging|functional magnetic resonance imaging
4685233|NCT03333668|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
4685234|NCT03333655|Metastatic Cancer|metastatic cancer
4685235|NCT03333642|diabetes|diabetes
4685236|NCT03333642|metabolic surgery|metabolic surgery
4685237|NCT03333642|ileal interposition|ileal interposition
4685238|NCT03333629|Autistic Disorder|autistic disorder
4685239|NCT03333629|Early Detection|early detection
4685240|NCT03333629|Early Intervention|early intervention
4685241|NCT03333616|Genitourinary Cancer|genitourinary cancer
4685242|NCT03333603|Schizophrenia|schizophrenia
4685243|NCT03333590|DMD|dmd
4685244|NCT03333590|Duchenne Muscular Dystrophy|duchenne muscular dystrophy
4685245|NCT03333564|Vitamin D3|vitamin d3
4685246|NCT03333564|Vitamin D deficiency|vitamin d deficiency
4685247|NCT03333564|estradiol|estradiol
4685248|NCT03333564|omega-3 fatty acids|omega-3 fatty acids
4685249|NCT03333564|menopausal|menopausal
4685250|NCT03333551|AL Cardiac Amyloidosis|al cardiac amyloidosis
4685251|NCT03333551|18F-Florbetapir (Amyvid)|18f-florbetapir (amyvid)
4685252|NCT03333538|Hemorrhagic Fever, Ebola|hemorrhagic fever, ebola
4685253|NCT03333538|Ebola Virus Disease|ebola virus disease
4685254|NCT03333538|Ebola Virus Vaccines|ebola virus vaccines
4685255|NCT03333538|Hemorrhagic Fevers, Viral|hemorrhagic fevers, viral
4685256|NCT03333538|GP protein, Ebola virus|gp protein, ebola virus
4685257|NCT03333538|Filoviridae Infections|filoviridae infections
4685258|NCT03333538|RNA Virus Infections|rna virus infections
4685259|NCT03333525|Fat-protein counting|fat-protein counting
4685260|NCT03333525|Type 1 diabetes|type 1 diabetes
4685261|NCT03333525|Postprandial glucose level|postprandial glucose level
4685262|NCT03333512|Nap|nap
4685263|NCT03333512|Recovery Sleep|recovery sleep
4685264|NCT03333512|Cognitive Functions|cognitive functions
4685265|NCT03333512|Glucose Metabolism|glucose metabolism
4685266|NCT03333512|Neurobehavioral Functions|neurobehavioral functions
4685267|NCT03333512|Mood|mood
4685268|NCT03333512|Subjective Sleepiness|subjective sleepiness
4685269|NCT03333460|cocaine|cocaine
4685271|NCT03333460|transcranial magnetic stimulation|transcranial magnetic stimulation
4685272|NCT03333460|neuromodulation|neuromodulation
4685273|NCT03333460|neuroimaging|neuroimaging
4685274|NCT03333460|brain stimulation|brain stimulation
4685275|NCT03333395|Mechanical ventilation|mechanical ventilation
4685276|NCT03333395|Acute Exacerbation of chronic obstructive airway disease (AECOPD)|acute exacerbation of chronic obstructive airway disease (aecopd)
4685277|NCT03333395|Nebulized heparin|nebulized heparin
4685278|NCT03333395|C-Reactive Protein (CRP|c-reactive protein (crp
4685279|NCT03333369|resting-state functional MRI|resting-state functional mri
4685280|NCT03333369|Dopamine|dopamine
4685281|NCT03333369|functional connectivity|functional connectivity
4685282|NCT03333343|EGFR-mutant NSCLC|egfr-mutant nsclc
4685283|NCT03333343|EGF816|egf816
4685284|NCT03333343|LXH254|lxh254
4685285|NCT03333343|INC280|inc280
4685286|NCT03333343|ribociclib|ribociclib
4685287|NCT03333343|trametinib|trametinib
4685288|NCT03333343|gefitinib|gefitinib
4685289|NCT03333343|EGFR T790M|egfr t790m
4685290|NCT03333343|BRAF mutation|braf mutation
4685291|NCT03333343|BRAF fusion|braf fusion
4685292|NCT03333343|BRAF rearrangement|braf rearrangement
4685293|NCT03333343|MET amplification|met amplification
4685294|NCT03333330|Carotid atherosclerosis|carotid atherosclerosis
4685295|NCT03333330|Carotid plaque|carotid plaque
4685296|NCT03333330|Brain magnetic resonance imaging|brain magnetic resonance imaging
4685297|NCT03333330|Contrast enhanced ultrasound|contrast enhanced ultrasound
4685298|NCT03333330|Carotid CT angiography|carotid ct angiography
4685299|NCT03333330|Silent brain ischemia|silent brain ischemia
4685300|NCT03333330|Vascular cognitive impairment|vascular cognitive impairment
4685301|NCT03333304|Procalcitonin|procalcitonin
4685302|NCT03333278|Critical Care|critical care
4685303|NCT03333278|Shock, Septic|shock, septic
4685304|NCT03333278|Ascorbic Acid|ascorbic acid
4685305|NCT03333278|Adult|adult
4685306|NCT03333252|Caregiver|caregiver
4685307|NCT03333252|Psycho-social intervention|psycho-social intervention
4685308|NCT03333252|Cognitive training|cognitive training
4685309|NCT03333252|Quality of life|quality of life
4685310|NCT03333252|Early on-set Alzheimer's Disease|early on-set alzheimer's disease
4685311|NCT03333239|childhood and adolescence|childhood and adolescence
4685312|NCT03333226|Breast Neoplasms|breast neoplasms
4685313|NCT03333226|Sentinel Lymph Node Biopsy|sentinel lymph node biopsy
4685314|NCT03333226|Lymph Node Excision|lymph node excision
4685315|NCT03333226|Technetium Tc 99m|technetium tc 99m
4685316|NCT03333226|Indocyanine Green|indocyanine green
4685317|NCT03333226|Lymphatic System|lymphatic system
4685318|NCT03333226|Secondary Prevention|secondary prevention
4685319|NCT03333200|Pediatric|pediatric
4685320|NCT03333200|Rare|rare
4685321|NCT03333200|Neurodegenerative|neurodegenerative
4685322|NCT03333200|Genetic|genetic
4685323|NCT03333200|Neurodevelopment|neurodevelopment
4685324|NCT03333200|Brain|brain
4685325|NCT03333200|MRI|mri
4685326|NCT03333200|Biorepository|biorepository
4685327|NCT03333200|NDRD|ndrd
4685328|NCT03333200|Longitudinal|longitudinal
4685329|NCT03333200|Cognitive|cognitive
4685330|NCT03333200|Motor|motor
4685331|NCT03333200|Language|language
4685332|NCT03333200|Adaptive behavior|adaptive behavior
4685333|NCT03333187|Myelofibrosis, Myeloproliferative Disease|myelofibrosis, myeloproliferative disease
4685334|NCT03333174|apnea of prematurity|apnea of prematurity
4685335|NCT03333174|bradycardia|bradycardia
4685336|NCT03333174|hypoxemic episode|hypoxemic episode
4685337|NCT03333174|oxygen delivery|oxygen delivery
4685338|NCT03333161|apnea of prematurity|apnea of prematurity
4685339|NCT03333161|bradycardia|bradycardia
4685340|NCT03333161|hypoxemic episode|hypoxemic episode
4685341|NCT03333161|permissive hypercapnia|permissive hypercapnia
4685342|NCT03333148|Colorectal Surgery|colorectal surgery
4685343|NCT03333148|Immunonutrition|immunonutrition
4685344|NCT03333148|Complications|complications
4685345|NCT03333148|Microbiome|microbiome
4685346|NCT03333148|Preoperative nutrition|preoperative nutrition
4685347|NCT03333135|Ultramarathons|ultramarathons
4685348|NCT03333135|Electromagnetic field therapy|electromagnetic field therapy
4685349|NCT03333135|Endurance|endurance
4685350|NCT03333135|Exercise|exercise
4685351|NCT03333135|Environmental conditions|environmental conditions
4685352|NCT03333109|AMG 334, erenumab, migraine, episodic, headache, CGRP|amg 334, erenumab, migraine, episodic, headache, cgrp
4685353|NCT03333096|Glaucoma|glaucoma
4685354|NCT03333096|Mild Cognitive Impairment|mild cognitive impairment
4685355|NCT03333096|Ocusweep|ocusweep
4685356|NCT03333096|Reaction Time|reaction time
4685357|NCT03333096|Neuropsychology|neuropsychology
4685358|NCT03333096|Dementia|dementia
4685359|NCT03333096|Alzheimer's Disease|alzheimer's disease
4685360|NCT03333096|Brain Diseases|brain diseases
4685361|NCT03333083|Lamivudine|lamivudine
4685362|NCT03333083|Raltegravir|raltegravir
4685363|NCT03333031|cancer|cancer
4685364|NCT03333031|imaging agent|imaging agent
4685365|NCT03333031|HSP90|hsp90
4685366|NCT03333018|COPD|copd
4685367|NCT03332979|pre-death grief|pre-death grief
4685368|NCT03332979|palliative care|palliative care
4685369|NCT03332979|dementia|dementia
4685370|NCT03332979|caregiver|caregiver
4685371|NCT03332979|preparation for end of life|preparation for end of life
4685372|NCT03332966|adolescent|adolescent
4685373|NCT03332966|outpatients|outpatients
4685374|NCT03332966|questionnaire|questionnaire
4685375|NCT03332966|psychotic-like symptoms|psychotic-like symptoms
4685376|NCT03332966|psychosis risk|psychosis risk
4685377|NCT03332940|Tc99m-tilmanocept|tc99m-tilmanocept
4685378|NCT03332940|Tilmanocept|tilmanocept
4685379|NCT03332940|NASH|nash
4685380|NCT03332940|Nonalcoholic Steatohepatitis|nonalcoholic steatohepatitis
4685381|NCT03332914|Osteoarthritis|osteoarthritis
4685382|NCT03332914|microcurrent|microcurrent
4685383|NCT03332914|knee|knee
4685384|NCT03332914|electrotherapy|electrotherapy
4685385|NCT03332875|OurRelationship|ourrelationship
4685386|NCT03332875|Couple therapy|couple therapy
4685387|NCT03332875|Internet|internet
4685388|NCT03332875|Marriage Counseling|marriage counseling
4685389|NCT03332862|Catheter Ablation|catheter ablation
4685390|NCT03332862|Atrial Fibrillation|atrial fibrillation
4685391|NCT03332862|Contact Force|contact force
4685392|NCT03332862|Continuous Ablation|continuous ablation
4685393|NCT03332823|Mental health|mental health
4685394|NCT03332823|Mental well-being|mental well-being
4685395|NCT03332823|Community-based engagement|community-based engagement
4685396|NCT03332823|Positive psychology|positive psychology
4685397|NCT03332823|Public health approach|public health approach
4685398|NCT03332810|Mental health|mental health
4685399|NCT03332810|Mental well-being|mental well-being
4685400|NCT03332810|Community-based engagement|community-based engagement
4685401|NCT03332810|Positive psychology|positive psychology
4685402|NCT03332810|Public health approach|public health approach
4685403|NCT03332758|retinal detachment|retinal detachment
4685404|NCT03332758|inflammasome|inflammasome
4685405|NCT03332758|macular hole|macular hole
4685406|NCT03332745|Troponin|troponin
4685407|NCT03332732|Healthy Volunteers|healthy volunteers
4685408|NCT03332732|Pharmacokinetics|pharmacokinetics
4685409|NCT03332654|Urinary Incontinence, Stress|urinary incontinence, stress
4685410|NCT03332654|Multiple Sclerosis|multiple sclerosis
4685411|NCT03332654|Lower Urinary Tract Symptoms|lower urinary tract symptoms
4685412|NCT03332628|Peer Reviewed Research|peer reviewed research
4685413|NCT03332615|Palliative Care|palliative care
4685414|NCT03332602|Iron deficiency|iron deficiency
4685415|NCT03332602|Iron fortification|iron fortification
4685416|NCT03332602|Iron encapsulation|iron encapsulation
4685417|NCT03332589|Melanoma|melanoma
4685418|NCT03332589|CNS metastases|cns metastases
4685419|NCT03332589|BRAF mutation|braf mutation
4685420|NCT03332589|MEK mutation|mek mutation
4685421|NCT03332589|E6201|e6201
4685422|NCT03332576|vaccine|vaccine
4685423|NCT03332576|immunotherapy|immunotherapy
4685424|NCT03332576|combination therapy|combination therapy
4685425|NCT03332563|Adolescent|adolescent
4685426|NCT03332563|Cognitive Behavioral Therapy|cognitive behavioral therapy
4685427|NCT03332563|Chronic Pain|chronic pain
4685428|NCT03332563|smartphone application|smartphone application
4685429|NCT03332563|internet-delivered|internet-delivered
4685430|NCT03332550|laparoscopic lavage|laparoscopic lavage
4685431|NCT03332537|Young Adults|young adults
4685432|NCT03332537|IBS|ibs
4685433|NCT03332537|Self Management|self management
4685434|NCT03332537|Pain|pain
4685435|NCT03332537|Gut microbiome|gut microbiome
4685436|NCT03332537|Genetics|genetics
4685437|NCT03332537|Online education|online education
4685438|NCT03332524|1st degree burn|1st degree burn
4685439|NCT03332498|colon|colon
4685440|NCT03332498|rectum|rectum
4685441|NCT03332498|advanced|advanced
4685442|NCT03332498|refractory|refractory
4685443|NCT03332472|type 1 diabetes|type 1 diabetes
4685444|NCT03332446|cold water immersion, strength training, training effect|cold water immersion, strength training, training effect
4685445|NCT03332433|Hypoxia|hypoxia
4685446|NCT03332433|Gastroscope|gastroscope
4685447|NCT03332433|High-flow nasal cannula|high-flow nasal cannula
4685448|NCT03332420|Huaiqihuang granule|huaiqihuang granule
4685449|NCT03332420|primary nephrotic syndrome|primary nephrotic syndrome
4685450|NCT03332420|multisite|multisite
4685451|NCT03332420|prospective|prospective
4685452|NCT03332420|open-label|open-label
4685453|NCT03332407|Postoperative delirium|postoperative delirium
4685454|NCT03332407|Sleep quality|sleep quality
4685455|NCT03332407|Pediatric anesthesia|pediatric anesthesia
4685456|NCT03332407|Strabismus surgery|strabismus surgery
4685457|NCT03332394|Care Model|care model
4685458|NCT03332394|COPD|copd
4685459|NCT03332394|Exacerbations|exacerbations
4685460|NCT03332394|Health Confidence Score|health confidence score
4685461|NCT03332368|Triple-negative breast cancer|triple-negative breast cancer
4685462|NCT03332368|Traditional Chinese Medicine|traditional chinese medicine
4685463|NCT03332355|glioblastoma multiforme|glioblastoma multiforme
4685464|NCT03332355|anaplastic astrocytoma|anaplastic astrocytoma
4685465|NCT03332355|high grade glioma|high grade glioma
4685466|NCT03332355|temozolomide|temozolomide
4685467|NCT03332355|PROCASPASE ACTIVATING COMPOUND-1 (PAC-1)|procaspase activating compound-1 (pac-1)
4685468|NCT03332355|advanced malignancy|advanced malignancy
4685469|NCT03332355|maximal tolerated dose (MTD)|maximal tolerated dose (mtd)
4685470|NCT03332342|dry eye disease|dry eye disease
4685472|NCT03332342|inflammation|inflammation
4685473|NCT03332342|ocular surface|ocular surface
4685474|NCT03332329|HBsAg|hbsag
4685475|NCT03332329|PegIFN|pegifn
4685476|NCT03332329|ETV|etv
4685477|NCT03332329|Chronic Hepatitis B (CHB)|chronic hepatitis b (chb)
4685478|NCT03332329|HBV|hbv
4685479|NCT03332329|GMCSF|gmcsf
4685480|NCT03332303|Vaginal Dryness|vaginal dryness
4685481|NCT03332303|Vaginal and/or Vulvar Irritation/Itching|vaginal and/or vulvar irritation/itching
4685482|NCT03332303|Dysuria|dysuria
4685483|NCT03332303|Vaginal Pain and Bleeding|vaginal pain and bleeding
4685484|NCT03332277|Active Bodysuits|active bodysuits
4685485|NCT03332264|PAOD|paod
4685486|NCT03332264|drug coated balloon|drug coated balloon
4685487|NCT03332264|drug coated stent|drug coated stent
4685488|NCT03332264|percutaneous transluminal angioplasty (PTA)|percutaneous transluminal angioplasty (pta)
4685489|NCT03332251|Posture Correction Girdle|posture correction girdle
4685490|NCT03332225|sepsis|sepsis
4685491|NCT03332225|macrophage activation syndrome|macrophage activation syndrome
4685492|NCT03332225|immunoparalysis|immunoparalysis
4685493|NCT03332225|anakinra|anakinra
4685494|NCT03332225|recombinant human interferon-gamma|recombinant human interferon-gamma
4685495|NCT03332225|HLA-DR|hla-dr
4685496|NCT03332199|symptom cluster|symptom cluster
4685497|NCT03332199|oncology|oncology
4685498|NCT03332199|psychoeducation|psychoeducation
4685499|NCT03332199|symptom management|symptom management
4685500|NCT03332199|fatigue|fatigue
4685501|NCT03332199|pain|pain
4685502|NCT03332199|sleep disturbance|sleep disturbance
4685503|NCT03332160|Lymphedema|lymphedema
4685504|NCT03332160|Cancer|cancer
4685505|NCT03332160|Head Cancer|head cancer
4685506|NCT03332160|Neck Cancer|neck cancer
4685507|NCT03332160|Head and Neck Cancer|head and neck cancer
4685508|NCT03332108|mobile health (mHealth)|mobile health (mhealth)
4685509|NCT03332108|electronic health (eHealth)|electronic health (ehealth)
4685510|NCT03332108|breastfeeding|breastfeeding
4685511|NCT03332108|infant nutrition|infant nutrition
4685512|NCT03332108|text messaging intervention|text messaging intervention
4685513|NCT03332069|Hyperthermia|hyperthermia
4685514|NCT03332069|cervix|cervix
4685515|NCT03332069|HIV|hiv
4685516|NCT03332056|Ureteral stent pain|ureteral stent pain
4685517|NCT03332056|nephrolithiasis|nephrolithiasis
4685518|NCT03332056|kidney stone|kidney stone
4685519|NCT03332043|HIRREM|hirrem
4685520|NCT03332043|Neurotechnology|neurotechnology
4685521|NCT03332043|Closed-loop|closed-loop
4685522|NCT03332043|Acoustic stimulation|acoustic stimulation
4685523|NCT03332043|Allostatic|allostatic
4685524|NCT03332043|Heart rate variability|heart rate variability
4685525|NCT03332043|Baroreflex sensitivity|baroreflex sensitivity
4685526|NCT03332043|Blood pressure management|blood pressure management
4685527|NCT03332043|Autocalibration|autocalibration
4685528|NCT03332043|Neural oscillations|neural oscillations
4685529|NCT03332043|Relaxation|relaxation
4685530|NCT03332043|Electroencephalic|electroencephalic
4685531|NCT03332017|Relapsed/Refractory Follicular non-Hodgkin Lymphoma|relapsed/refractory follicular non-hodgkin lymphoma
4685532|NCT03332004|Indocyanine Green|indocyanine green
4685533|NCT03332004|Deep Infiltrating Endometriosis|deep infiltrating endometriosis
4685534|NCT03332004|Near-Infrared Vision|near-infrared vision
4685535|NCT03332004|Occult endometriosis|occult endometriosis
4685536|NCT03332004|Invisible endometriosis|invisible endometriosis
4685537|NCT03331978|Adherence|adherence
4685538|NCT03331978|Antiretroviral treatment|antiretroviral treatment
4685539|NCT03331978|Black/ AfricanAmerican|black/ africanamerican
4685540|NCT03331965|Interventional Radiology|interventional radiology
4685541|NCT03331965|Metoclopramide|metoclopramide
4685542|NCT03331965|Gastrojejenostomy|gastrojejenostomy
4685543|NCT03331952|Streptococcal Pneumonia|streptococcal pneumonia
4685544|NCT03331952|Pneumococcal Conjugate Vaccine|pneumococcal conjugate vaccine
4685545|NCT03331887|endodontically treate teeth|endodontically treate teeth
4685546|NCT03331887|Emax crowns|emax crowns
4685547|NCT03331887|Fiber reinforced composite post|fiber reinforced composite post
4685548|NCT03331887|Endocrowns|endocrowns
4685549|NCT03331874|confocal|confocal
4685550|NCT03331874|basal|basal
4685551|NCT03331874|carcinoma|carcinoma
4685552|NCT03331848|Levodopa-Induced Dyskinesia (LID)|levodopa-induced dyskinesia (lid)
4685553|NCT03331848|Foliglurax|foliglurax
4685554|NCT03331848|Parkinson's Disease|parkinson's disease
4685555|NCT03331848|mGlu4 PAM|mglu4 pam
4685556|NCT03331822|circadian|circadian
4685557|NCT03331822|light therapy|light therapy
4685558|NCT03331822|ICU nurse|icu nurse
4685559|NCT03331809|intubation|intubation
4685560|NCT03331809|pharyngitis|pharyngitis
4685561|NCT03331796|mild cognitive impairment|mild cognitive impairment
4685562|NCT03331796|tms|tms
4685563|NCT03331796|rtms|rtms
4685564|NCT03331796|transcranial magnetic stimulation|transcranial magnetic stimulation
4685565|NCT03331796|noninvasive brain stimulation|noninvasive brain stimulation
4685566|NCT03331796|non-pharmacological|non-pharmacological
4685567|NCT03331770|Benzalkonium Chloride|benzalkonium chloride
4685568|NCT03331770|Latanoprost|latanoprost
4685569|NCT03331770|BAK-free|bak-free
4685570|NCT03331770|Glaucoma|glaucoma
4685571|NCT03331770|Ocular hypertension|ocular hypertension
4685668|NCT03331042|Insomnia|insomnia
4685572|NCT03331770|conjunctival hyperemia|conjunctival hyperemia
4685573|NCT03331770|BUT|but
4685574|NCT03331770|OSDI|osdi
4685575|NCT03331770|Schirmer I|schirmer i
4685576|NCT03331770|Corneal staining|corneal staining
4685577|NCT03331770|Tear meniscus height|tear meniscus height
4685578|NCT03331744|Infantile hemanioma|infantile hemanioma
4685579|NCT03331744|Infantile hepatic hemangioma|infantile hepatic hemangioma
4685580|NCT03331744|Ulcerated infantile hemangioma|ulcerated infantile hemangioma
4685581|NCT03331744|Clinical characteristics|clinical characteristics
4685582|NCT03331744|Demographic characteristics|demographic characteristics
4685583|NCT03331718|pancreatoduodenectomy|pancreatoduodenectomy
4685584|NCT03331718|pancreaticojejunostomy|pancreaticojejunostomy
4685585|NCT03331718|polyglycolic acid|polyglycolic acid
4685586|NCT03331718|Neoveil|neoveil
4685587|NCT03331718|pancreatic fistula|pancreatic fistula
4685588|NCT03331718|pancreas|pancreas
4685589|NCT03331666|Hyperlipidemia, Hypercholesterolemia, atherothrombosis|hyperlipidemia, hypercholesterolemia, atherothrombosis
4685590|NCT03331653|Cervical Pain|cervical pain
4685591|NCT03331653|Motor Control|motor control
4685592|NCT03331653|Sternocleidomastoid|sternocleidomastoid
4685593|NCT03331653|Dry Needling|dry needling
4685594|NCT03331601|Brain metastasis|brain metastasis
4685595|NCT03331601|HER2|her2
4685596|NCT03331588|Lung cancer|lung cancer
4685597|NCT03331588|Pain|pain
4685598|NCT03331588|Quality of life|quality of life
4685599|NCT03331562|Pembrolizumab|pembrolizumab
4685600|NCT03331562|Paricalcitol|paricalcitol
4685601|NCT03331562|Pancreatic cancer|pancreatic cancer
4685602|NCT03331562|Metastatic Pancreatic Cancer|metastatic pancreatic cancer
4685603|NCT03331562|Vitamin D|vitamin d
4685604|NCT03331562|Immune Checkpoint Inhibitor|immune checkpoint inhibitor
4685605|NCT03331562|VDR agonist|vdr agonist
4685606|NCT03331562|PD1 Inhibitor|pd1 inhibitor
4685607|NCT03331510|Shoulder, Instability, Latarjet, Dislocation, Strength|shoulder, instability, latarjet, dislocation, strength
4685608|NCT03331484|percutaneous coronary intervention|percutaneous coronary intervention
4685609|NCT03331484|bleeding|bleeding
4685610|NCT03331458|physical activity|physical activity
4685611|NCT03331445|inhaled nitric oxide|inhaled nitric oxide
4685612|NCT03331445|non tuberculous mycobacteria|non tuberculous mycobacteria
4685613|NCT03331445|drug resistant pneumonia|drug resistant pneumonia
4685614|NCT03331406|Metastatic gastrointestinal cancer|metastatic gastrointestinal cancer
4685615|NCT03331406|Physical Activity|physical activity
4685616|NCT03331380|1.5 T CMR|1.5 t cmr
4685617|NCT03331380|Low SAR CMR|low sar cmr
4685618|NCT03331380|Gadolinium|gadolinium
4685619|NCT03331380|Regadenoson|regadenoson
4685620|NCT03331380|Adenosine|adenosine
4685621|NCT03331367|Cryotherapy|cryotherapy
4685622|NCT03331367|Radiation|radiation
4685623|NCT03331367|Prostatectomy|prostatectomy
4685624|NCT03331367|Immune Response|immune response
4685625|NCT03331354|employment|employment
4685626|NCT03331354|distance learning|distance learning
4685627|NCT03331354|incarceration|incarceration
4685628|NCT03331328|MonaLisa|monalisa
4685629|NCT03331328|Genitourinary syndrome of menopause (GSM)|genitourinary syndrome of menopause (gsm)
4685630|NCT03331250|Epithelioid hemangioendothelioma (EHE)|epithelioid hemangioendothelioma (ehe)
4685631|NCT03331250|Angiosarcoma|angiosarcoma
4685632|NCT03331211|Leukemia, Lymphoblastic, Acute|leukemia, lymphoblastic, acute
4685633|NCT03331198|JCAR017|jcar017
4685634|NCT03331198|chimeric antigen receptor|chimeric antigen receptor
4685635|NCT03331198|CLL|cll
4685636|NCT03331198|SLL|sll
4685637|NCT03331198|chronic lymphocytic leukemia|chronic lymphocytic leukemia
4685638|NCT03331198|small lymphocytic lymphoma|small lymphocytic lymphoma
4685639|NCT03331198|CAR|car
4685640|NCT03331198|CAR T cells|car t cells
4685641|NCT03331198|autologous T cell therapy|autologous t cell therapy
4685642|NCT03331198|immunotherapy|immunotherapy
4685643|NCT03331185|Extraction|extraction
4685644|NCT03331185|Alveolar Ridge Augmentation|alveolar ridge augmentation
4685645|NCT03331185|Freeze Dried Bone Allograft|freeze dried bone allograft
4685646|NCT03331185|Leukocytic Platelet Rich Fibrin|leukocytic platelet rich fibrin
4685647|NCT03331185|Volumetric Changes|volumetric changes
4685648|NCT03331185|Dense Polytetrafluoroethylene Membrane|dense polytetrafluoroethylene membrane
4685649|NCT03331172|HIFU|hifu
4685650|NCT03331172|thyroid nodule|thyroid nodule
4685651|NCT03331172|Benign|benign
4685652|NCT03331172|Reapplication|reapplication
4685653|NCT03331159|Lumbar Fusion|lumbar fusion
4685654|NCT03331159|Hydroxyapatite|hydroxyapatite
4685655|NCT03331146|Nitric Oxide|nitric oxide
4685656|NCT03331146|Sodium Nitrite|sodium nitrite
4685657|NCT03331146|Cardiopulmonary bypass|cardiopulmonary bypass
4685658|NCT03331146|cardioplegic cardiac arrest|cardioplegic cardiac arrest
4685659|NCT03331146|coronary revacularization|coronary revacularization
4685660|NCT03331133|Twin|twin
4685661|NCT03331133|Early Development|early development
4685662|NCT03331133|Cohort|cohort
4685663|NCT03331081|Overactive Bladder Syndrome|overactive bladder syndrome
4685664|NCT03331055|percutaneous electrical nerve stimulation|percutaneous electrical nerve stimulation
4685665|NCT03331055|transcutaneous electrical nerve stimulation|transcutaneous electrical nerve stimulation
4685666|NCT03331055|pain|pain
4685667|NCT03331055|pancreatic cancer|pancreatic cancer
4685669|NCT03331042|Transient Insomnia|transient insomnia
4685670|NCT03331042|Sleep initiation and maintenance disorder|sleep initiation and maintenance disorder
4685671|NCT03331029|3 D Ultrasound, left atrium, Mitral inflow velocity, systolic and diastolic ventricular function|3 d ultrasound, left atrium, mitral inflow velocity, systolic and diastolic ventricular function
4685672|NCT03331016|Foster caregiver|foster caregiver
4685673|NCT03331016|Kinship caregiver|kinship caregiver
4685674|NCT03331016|Foster youth|foster youth
4685675|NCT03331016|Unintended pregnancy|unintended pregnancy
4685676|NCT03331016|Curriculum|curriculum
4685677|NCT03331016|Intervention|intervention
4685678|NCT03331016|sexually transmitted infections|sexually transmitted infections
4685679|NCT03331016|Behaviorism|behaviorism
4685680|NCT03331016|Monitoring|monitoring
4685681|NCT03331016|Communication|communication
4685682|NCT03331016|Adolescent development|adolescent development
4685683|NCT03331016|sexually transmitted diseases|sexually transmitted diseases
4685684|NCT03330951|HbA1c|hba1c
4685685|NCT03330951|Glycated albumin|glycated albumin
4685686|NCT03330938|Hemodialysis|hemodialysis
4685687|NCT03330938|Resilience|resilience
4685688|NCT03330938|Cognitive Behavioral Therapy|cognitive behavioral therapy
4685689|NCT03330873|Asherman syndrome|asherman syndrome
4685690|NCT03330873|disposable balloon uterine stent|disposable balloon uterine stent
4685691|NCT03330873|hysteroscopy|hysteroscopy
4685692|NCT03330873|Foley catheter|foley catheter
4685693|NCT03330847|Germline BRCA mutation|germline brca mutation
4685694|NCT03330847|Human epidermal growth factor receptor 2|human epidermal growth factor receptor 2
4685695|NCT03330847|Olaparib|olaparib
4685696|NCT03330847|Homologous Recombinant Repair (HRR)-related Genes|homologous recombinant repair (hrr)-related genes
4685697|NCT03330834|CAR-T|car-t
4685698|NCT03330834|advanced lung cancer|advanced lung cancer
4685699|NCT03330834|single-arm|single-arm
4685700|NCT03330834|phase I clinical study|phase i clinical study
4685701|NCT03330795|end-stage lung disease|end-stage lung disease
4685702|NCT03330795|Bilateral Orthotopic Lung Transplant (BOLT) candidate|bilateral orthotopic lung transplant (bolt) candidate
4685703|NCT03330795|CD3/CD19 negative allogeneic hematopoietic stem cells (HSCT)|cd3/cd19 negative allogeneic hematopoietic stem cells (hsct)
4685704|NCT03330795|CD3+/CD19+ depleted Bone Marrow Transplant (BMT)|cd3+/cd19+ depleted bone marrow transplant (bmt)
4685705|NCT03330795|Cadaveric (Deceased) Donor|cadaveric (deceased) donor
4685706|NCT03330795|Unrelated (Deceased) Donor|unrelated (deceased) donor
4685707|NCT03330782|pain|pain
4685708|NCT03330782|propofol|propofol
4685709|NCT03330782|remifentanil|remifentanil
4685710|NCT03330769|Psoriatic Arthritis|psoriatic arthritis
4685711|NCT03330769|Ultrasonography|ultrasonography
4685712|NCT03330769|Minimal disease activity|minimal disease activity
4685713|NCT03330756|Roux-en-Y gastric bypass|roux-en-y gastric bypass
4685714|NCT03330756|Mini gastric bypass|mini gastric bypass
4685715|NCT03330756|Type 2 diabetes mellitus|type 2 diabetes mellitus
4685716|NCT03330756|Morbid Obesity|morbid obesity
4685717|NCT03330691|CD19|cd19
4685718|NCT03330691|CD22|cd22
4685719|NCT03330691|CAR T-cell|car t-cell
4685720|NCT03330678|Probiotic|probiotic
4685721|NCT03330678|Gut microbiome|gut microbiome
4685722|NCT03330678|VSL#3|vsl#3
4685723|NCT03330652|Quality of life|quality of life
4685724|NCT03330652|Cognitive function|cognitive function
4685725|NCT03330652|Mental state|mental state
4685726|NCT03330652|Functional capacity|functional capacity
4685727|NCT03330652|EQ5D|eq5d
4685728|NCT03330652|HADS|hads
4685729|NCT03330652|Barthel Index|barthel index
4685730|NCT03330652|mRS|mrs
4685731|NCT03330626|Fluid management|fluid management
4685732|NCT03330626|conventional method|conventional method
4685733|NCT03330626|InBody S10|inbody s10
4685734|NCT03330626|CRRT|crrt
4685735|NCT03330574|Glaucoma|glaucoma
4685736|NCT03330561|HER2-positive breast cancer|her2-positive breast cancer
4685737|NCT03330561|HER2 -positive gastric cancer|her2 -positive gastric cancer
4685738|NCT03330561|HER2-positive bladder cancer|her2-positive bladder cancer
4685739|NCT03330561|Pieris|pieris
4685740|NCT03330561|PRS-343|prs-343
4685741|NCT03330561|Anticalin|anticalin
4685742|NCT03330561|Bi-specific|bi-specific
4685743|NCT03330561|4-1BB|4-1bb
4685744|NCT03330561|CD137|cd137
4685745|NCT03330561|HER2|her2
4685746|NCT03330548|Plant-based diet|plant-based diet
4685747|NCT03330548|Hyperlipidemia|hyperlipidemia
4685748|NCT03330548|Diabetes|diabetes
4685749|NCT03330548|Overweight|overweight
4685750|NCT03330548|Veterans|veterans
4685751|NCT03330509|Palliative care|palliative care
4685752|NCT03330509|Consultation model|consultation model
4685753|NCT03330496|infant-newborn|infant-newborn
4685754|NCT03330496|infant-premature|infant-premature
4685755|NCT03330496|pain|pain
4685756|NCT03330496|acute pain|acute pain
4685757|NCT03330496|repetitive pain|repetitive pain
4685758|NCT03330483|pain|pain
4685759|NCT03330483|discomfort|discomfort
4685760|NCT03330483|hydrophylic catheter|hydrophylic catheter
4685761|NCT03330483|urodynamic study|urodynamic study
4685762|NCT03330444|Endometrial microbiota|endometrial microbiota
4685763|NCT03330444|Bacterial pathogens|bacterial pathogens
4685764|NCT03330444|Assisted reproductive techniques|assisted reproductive techniques
4685765|NCT03330444|Dysbiosis|dysbiosis
4685766|NCT03330444|Endometrial receptivity|endometrial receptivity
4685767|NCT03330444|Endometrial diagnosis|endometrial diagnosis
4685768|NCT03330405|NSCLC, TNBC, hormone receptor positive (HR+) breast cancer, recurrent epithelial ovarian cancer, UC, and castration resistant prostate cancer (CRPC).|nsclc, tnbc, hormone receptor positive (hr+) breast cancer, recurrent epithelial ovarian cancer, uc, and castration resistant prostate cancer (crpc).
4685769|NCT03330379|Endotracheal tube|endotracheal tube
4685770|NCT03330379|ventilator's associated pneumonia|ventilator's associated pneumonia
4685771|NCT03330379|intensive care unit|intensive care unit
4685772|NCT03330379|orotracheal intubation|orotracheal intubation
4685773|NCT03330340|vertebral compression fracture|vertebral compression fracture
4685774|NCT03330340|osteoporosis|osteoporosis
4685775|NCT03330340|glucocorticoids|glucocorticoids
4685776|NCT03330340|vertebroplasty|vertebroplasty
4685777|NCT03330262|Postural Instability|postural instability
4685778|NCT03330262|Balance Disorder|balance disorder
4685779|NCT03330262|Balance Prosthesis|balance prosthesis
4685780|NCT03330262|Dizziness|dizziness
4685781|NCT03330210|LAAC|laac
4685782|NCT03330210|3D printing|3d printing
4685783|NCT03330210|Procedure success|procedure success
4685784|NCT03330210|Procedure-related complications|procedure-related complications
4685785|NCT03330197|DIPG|dipg
4685786|NCT03330197|Glioblastoma|glioblastoma
4685787|NCT03330197|Anaplastic Astrocytoma|anaplastic astrocytoma
4685788|NCT03330197|High Grade Glioma (HGG) Not Otherwise Specified (NOS)|high grade glioma (hgg) not otherwise specified (nos)
4685789|NCT03330197|Supratentorial Tumor NOS|supratentorial tumor nos
4685790|NCT03330184|Bifidobacterium|bifidobacterium
4685791|NCT03330184|People With Abnormal Glucose Level|people with abnormal glucose level
4685792|NCT03330171|Immunogenicity|immunogenicity
4685793|NCT03330171|Safety|safety
4685794|NCT03330171|Vaccine|vaccine
4685795|NCT03330145|Complicated Grief|complicated grief
4685796|NCT03330145|Risk Factors|risk factors
4685797|NCT03330145|Cancer|cancer
4685798|NCT03330145|Children|children
4685799|NCT03330119|Pregnancy|pregnancy
4685800|NCT03330119|cesarean section|cesarean section
4685801|NCT03330119|enhanced recovery|enhanced recovery
4685802|NCT03330119|narcotic use|narcotic use
4685803|NCT03330106|Drug therapy|drug therapy
4685804|NCT03330093|Children|children
4685805|NCT03330080|Ecological momentary assessment|ecological momentary assessment
4685806|NCT03330080|Sleepiness|sleepiness
4685807|NCT03330080|Fatigue|fatigue
4685808|NCT03330080|Endocrinopathy|endocrinopathy
4685809|NCT03330080|Family functioning|family functioning
4685810|NCT03330067|laparoscope|laparoscope
4685811|NCT03330041|Cutaneous Sutures|cutaneous sutures
4685812|NCT03330041|Scar Cosmesis|scar cosmesis
4685813|NCT03330041|Linear Wound Closure|linear wound closure
4685814|NCT03330041|Wound Cosmesis|wound cosmesis
4685815|NCT03330028|Diseases of oesophagus stomach and duodenum|diseases of oesophagus stomach and duodenum
4685816|NCT03330028|Gastric cancer|gastric cancer
4685817|NCT03330028|Gastroesophageal cancer|gastroesophageal cancer
4685818|NCT03330028|Adenocarcinoma of the stomach or gastroesophageal junction|adenocarcinoma of the stomach or gastroesophageal junction
4685819|NCT03330028|Hyperthermic intraperitoneal chemotherapy|hyperthermic intraperitoneal chemotherapy
4685820|NCT03330028|HIPEC|hipec
4685821|NCT03330028|Paclitaxel|paclitaxel
4685822|NCT03330028|Taxol|taxol
4685823|NCT03330028|Dexamethasone|dexamethasone
4685824|NCT03330028|Decadron|decadron
4685825|NCT03330028|Diphenhydramine|diphenhydramine
4685826|NCT03330028|Benadryl|benadryl
4685827|NCT03330028|Cisplatin|cisplatin
4685828|NCT03330028|Platinol-AQ|platinol-aq
4685829|NCT03330028|Platinol|platinol
4685830|NCT03330028|CDDP|cddp
4685831|NCT03330028|Mitomycin-C|mitomycin-c
4685832|NCT03330028|Mitomycin|mitomycin
4685833|NCT03330028|Famotidine|famotidine
4685834|NCT03330028|Pepcid|pepcid
4685835|NCT03330015|postmenopausal bleeding|postmenopausal bleeding
4685836|NCT03330015|endometrial cancer|endometrial cancer
4685837|NCT03330015|Patient's experience|patient's experience
4685838|NCT03330015|Patient's choice|patient's choice
4685839|NCT03330002|Arterial Closure Device|arterial closure device
4685840|NCT03330002|Large Bore Closure Device|large bore closure device
4685841|NCT03329950|CDX-1140|cdx-1140
4685842|NCT03329950|Solid Tumors|solid tumors
4685843|NCT03329950|Liver Cancer|liver cancer
4685844|NCT03329950|GI Cancer|gi cancer
4685845|NCT03329950|Kidney Cancer|kidney cancer
4685846|NCT03329950|Celldex|celldex
4685847|NCT03329950|Monoclonal|monoclonal
4685848|NCT03329950|Antibody|antibody
4685849|NCT03329950|CD40|cd40
4685850|NCT03329950|CD-40|cd-40
4685851|NCT03329950|Flt3l|flt3l
4685852|NCT03329950|CDX-301|cdx-301
4685853|NCT03329950|Lung Cancer|lung cancer
4685854|NCT03329950|Bile duct cancer|bile duct cancer
4685855|NCT03329950|TNBC|tnbc
4685856|NCT03329950|RCC|rcc
4685857|NCT03329898|Asherman syndrome|asherman syndrome
4685858|NCT03329898|uterine stent|uterine stent
4685859|NCT03329898|hysteroscopy|hysteroscopy
4685860|NCT03329872|Neuro-Orthopedics|neuro-orthopedics
4685861|NCT03329872|Register|register
4685862|NCT03329833|Parkinson's Disease|parkinson's disease
4685863|NCT03329833|Parkinson's|parkinson's
4685864|NCT03329833|Motivational Interviewing|motivational interviewing
4685865|NCT03329833|Exercise|exercise
4685866|NCT03329833|Motivation|motivation
4685867|NCT03329820|Chronic hepatitis B infection|chronic hepatitis b infection
4685868|NCT03329820|Health-related quality of life|health-related quality of life
4685869|NCT03329820|Cost-effectiveness|cost-effectiveness
4685870|NCT03329820|Treatment|treatment
4685871|NCT03329820|Chinese|chinese
4685872|NCT03329781|Endotoxaemia, Curcumin.|endotoxaemia, curcumin.
4685873|NCT03329755|Advanced melanoma|advanced melanoma
4685874|NCT03329755|Immune checkpoint|immune checkpoint
4685875|NCT03329755|E-follow-up|e-follow-up
4685876|NCT03329716|brace-weaning, cost-effectiveness|brace-weaning, cost-effectiveness
4685877|NCT03329703|PNES|pnes
4685878|NCT03329703|UPLIFT|uplift
4685879|NCT03329703|Depression|depression
4685880|NCT03329703|Mindfulness|mindfulness
4685881|NCT03329703|CBT|cbt
4685882|NCT03329703|Managing Epilepsy Well (MEW) Network|managing epilepsy well (mew) network
4685883|NCT03329703|Psychogenic Seizures|psychogenic seizures
4685884|NCT03329703|Non-Epileptic Seizures|non-epileptic seizures
4685885|NCT03329690|Adenocarcinoma Metastatic|adenocarcinoma metastatic
4685886|NCT03329690|Adenocarcinoma of the Stomach|adenocarcinoma of the stomach
4685887|NCT03329690|Adenocarcinoma of the Gastroesophageal Junction|adenocarcinoma of the gastroesophageal junction
4685888|NCT03329690|HER2 Overexpression|her2 overexpression
4685889|NCT03329690|Adenocarcinoma, Locally Advanced|adenocarcinoma, locally advanced
4685890|NCT03329625|Triple P|triple p
4685891|NCT03329625|RCT|rct
4685892|NCT03329625|parent management training|parent management training
4685893|NCT03329625|Child welfare|child welfare
4685894|NCT03329625|child behavior problems|child behavior problems
4685895|NCT03329586|maximum oxygen consumption|maximum oxygen consumption
4685896|NCT03329586|organ transplantation|organ transplantation
4685897|NCT03329586|physical fitness|physical fitness
4685898|NCT03329586|rehabilitation|rehabilitation
4685899|NCT03329573|Cross-over|cross-over
4685900|NCT03329573|Chinese|chinese
4685901|NCT03329573|GSKT|gskt
4685902|NCT03329573|Mississauga|mississauga
4685903|NCT03329573|Healthy|healthy
4685904|NCT03329573|Bioequivalence|bioequivalence
4685905|NCT03329573|Paroxetine|paroxetine
4685906|NCT03329547|Bioequivalence|bioequivalence
4685907|NCT03329547|Pharmacokinetics|pharmacokinetics
4685908|NCT03329547|SKF101804|skf101804
4685909|NCT03329547|Crossover|crossover
4685910|NCT03329547|Cefixime|cefixime
4685911|NCT03329521|Cluster Randomized Controlled Trial|cluster randomized controlled trial
4685912|NCT03329521|Kidney Transplant|kidney transplant
4685913|NCT03329521|Living Kidney Donation|living kidney donation
4685914|NCT03329521|Kidney Disease|kidney disease
4685915|NCT03329508|Parkinson disease|parkinson disease
4685916|NCT03329495|right colon cancer|right colon cancer
4685917|NCT03329495|superior mesenteric artery|superior mesenteric artery
4685918|NCT03329495|superior mesenteric vein|superior mesenteric vein
4685919|NCT03329482|Ultrasound|ultrasound
4685920|NCT03329482|kneading-massage|kneading-massage
4685921|NCT03329482|low back pain|low back pain
4685922|NCT03329482|pain intensity|pain intensity
4685923|NCT03329482|disability|disability
4685924|NCT03329469|Computed Tomography Fractional Flow Reserve (CT-FFR),|computed tomography fractional flow reserve (ct-ffr),
4685925|NCT03329469|Computed Coronary Tomography Angiography (CCTA)|computed coronary tomography angiography (ccta)
4685926|NCT03329469|Invasive Fractional Flow Reserve (iFFR)|invasive fractional flow reserve (iffr)
4685927|NCT03329469|Fractional Flow Reserve (FFR)|fractional flow reserve (ffr)
4686299|NCT03326804|Ceramic|ceramic
4685928|NCT03329469|Emergency Department (ED)|emergency department (ed)
4685929|NCT03329469|Emergency Room (ER)|emergency room (er)
4685930|NCT03329443|spironolactone|spironolactone
4685931|NCT03329404|Thalassemia|thalassemia
4685932|NCT03329404|pathogen reduction therapy|pathogen reduction therapy
4685933|NCT03329391|Psychosocial model,nursing intervention|psychosocial model,nursing intervention
4685934|NCT03329378|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
4685935|NCT03329378|locally advanced breast cancer|locally advanced breast cancer
4685936|NCT03329378|Her2neu|her2neu
4685937|NCT03329365|Flow cytometry|flow cytometry
4685938|NCT03329365|Lactate dehydrogenase (LDH) release|lactate dehydrogenase (ldh) release
4685939|NCT03329365|Anemia|anemia
4685940|NCT03329365|Cytopenia|cytopenia
4685941|NCT03329339|diet|diet
4685942|NCT03329326|standardized test|standardized test
4685943|NCT03329326|prosthesis|prosthesis
4685944|NCT03329326|upper limb amputation|upper limb amputation
4685945|NCT03329326|rehabilitation outcome|rehabilitation outcome
4685946|NCT03329313|Intensive care unit|intensive care unit
4685947|NCT03329313|SLEDD-f|sledd-f
4685948|NCT03329313|intermittent hemodialysis/diafiltration|intermittent hemodialysis/diafiltration
4685949|NCT03329300|Pediatric Obesity|pediatric obesity
4685950|NCT03329300|Executive Function|executive function
4685951|NCT03329300|Behavioral Intervention|behavioral intervention
4685952|NCT03329287|Simplified Cognitive Behavioral Therapy (SCBT)|simplified cognitive behavioral therapy (scbt)
4685953|NCT03329287|Generalized Anxiety Disorder|generalized anxiety disorder
4685954|NCT03329287|Depression|depression
4685955|NCT03329287|Operating manual|operating manual
4685956|NCT03329287|Efficacy|efficacy
4685957|NCT03329274|registry|registry
4685958|NCT03329209|Drug therapy|drug therapy
4685959|NCT03329183|Irinotecan|irinotecan
4685960|NCT03329183|UGT1A1|ugt1a1
4685961|NCT03329183|Advanced Colorectal Cancer|advanced colorectal cancer
4685962|NCT03329170|Oral health|oral health
4685963|NCT03329170|Dental caries|dental caries
4685964|NCT03329170|Heart Defects|heart defects
4685965|NCT03329170|Congenital|congenital
4685966|NCT03329144|Young mother|young mother
4685967|NCT03329144|Depression|depression
4685968|NCT03329144|Anxiety|anxiety
4685969|NCT03329144|Resilience|resilience
4685970|NCT03329144|Emotion regulation|emotion regulation
4685971|NCT03329144|Parenting|parenting
4685972|NCT03329144|CBT|cbt
4685973|NCT03329118|SHR3824,simvastatin, drug-drug interaction|shr3824,simvastatin, drug-drug interaction
4685974|NCT03329105|Gingival Health|gingival health
4685975|NCT03329105|Biofilm Formation|biofilm formation
4685976|NCT03329092|Complicated intra-abdominal infection|complicated intra-abdominal infection
4685977|NCT03329092|Hosptial acquired pneumonia|hosptial acquired pneumonia
4685978|NCT03329092|Ventilator associated pneumonia|ventilator associated pneumonia
4685979|NCT03329092|Gram negative infections|gram negative infections
4685980|NCT03329092|Metallo-beta lactamase|metallo-beta lactamase
4685981|NCT03329092|Multi drug resistant pathogens|multi drug resistant pathogens
4685982|NCT03329079|rural|rural
4685983|NCT03329079|men|men
4685984|NCT03329079|community-based participatory research|community-based participatory research
4685985|NCT03329079|weight loss|weight loss
4685986|NCT03329079|mobile applications|mobile applications
4685987|NCT03329079|text messaging|text messaging
4685988|NCT03329066|Asthma|asthma
4685989|NCT03329066|Sleep|sleep
4685990|NCT03329066|Adolescents|adolescents
4685991|NCT03329066|Urban|urban
4685992|NCT03329066|Intervention|intervention
4685993|NCT03329066|High school|high school
4685994|NCT03329053|exercise prescription|exercise prescription
4685995|NCT03329053|digital exercise prescription tool|digital exercise prescription tool
4685996|NCT03329040|Hyperbilirubinemia|hyperbilirubinemia
4685997|NCT03329040|Primiparity|primiparity
4685998|NCT03329040|multiparity|multiparity
4685999|NCT03329001|PARP inhibitor|parp inhibitor
4686000|NCT03329001|niraparib|niraparib
4686001|NCT03329001|Zejula|zejula
4686002|NCT03328988|bladder cancer|bladder cancer
4686003|NCT03328988|radical cystectomy|radical cystectomy
4686004|NCT03328988|epidural analgesia|epidural analgesia
4686005|NCT03328988|quadratus lumborum block|quadratus lumborum block
4686006|NCT03328988|postoperative pain|postoperative pain
4686007|NCT03328923|post-prandial cognition|post-prandial cognition
4686008|NCT03328923|brown seaweed|brown seaweed
4686009|NCT03328910|Emergence Delirium|emergence delirium
4686010|NCT03328910|pulse oximetry|pulse oximetry
4686011|NCT03328910|Children, Preschool|children, preschool
4686012|NCT03328897|Chronic spontaneous urticarial|chronic spontaneous urticarial
4686013|NCT03328897|ISS7|iss7
4686014|NCT03328897|UAS7|uas7
4686015|NCT03328897|omalizumab, China|omalizumab, china
4686016|NCT03328871|Striae Gravidarum|striae gravidarum
4686017|NCT03328871|Fractional Laser|fractional laser
4686018|NCT03328871|Platelet-Rich Plasma (PRP)|platelet-rich plasma (prp)
4686019|NCT03328871|Nanofat Graft|nanofat graft
4686020|NCT03328871|Combination Therapy|combination therapy
4686021|NCT03328858|Ketogenic Diet, brain tumors|ketogenic diet, brain tumors
4686022|NCT03328845|Oxidation|oxidation
4686023|NCT03328845|Insulin analogues|insulin analogues
4686024|NCT03328845|Type 1 diabetes mellitus|type 1 diabetes mellitus
4686025|NCT03328832|Thrombin-gelatin matrix|thrombin-gelatin matrix
4686026|NCT03328832|Floseal|floseal
4686027|NCT03328832|Tranexamic Acid|tranexamic acid
4686028|NCT03328832|Total Knee Arthroplasty|total knee arthroplasty
4686029|NCT03328819|Acupuncture|acupuncture
4686030|NCT03328819|Chronic pain|chronic pain
4686031|NCT03328819|Major depressive disorder|major depressive disorder
4686032|NCT03328819|Biomarkers|biomarkers
4686033|NCT03328819|Gene|gene
4686034|NCT03328819|Comorbidity|comorbidity
4686035|NCT03328806|low back pain|low back pain
4686036|NCT03328806|outcome measures|outcome measures
4686037|NCT03328806|cross culture adaptation|cross culture adaptation
4686038|NCT03328806|Core Outcome Measure Index|core outcome measure index
4686039|NCT03328793|music|music
4686040|NCT03328793|gait|gait
4686041|NCT03328793|emotions|emotions
4686042|NCT03328793|communication|communication
4686043|NCT03328780|preoperative|preoperative
4686044|NCT03328780|orthopedic surgery|orthopedic surgery
4686045|NCT03328754|Pitchfork|pitchfork
4686046|NCT03328754|Class II malocclusion|class ii malocclusion
4686047|NCT03328754|PowerScope|powerscope
4686048|NCT03328741|Clinical Trials, Randomized|clinical trials, randomized
4686049|NCT03328741|Telemedicine|telemedicine
4686050|NCT03328702|Dysphagia|dysphagia
4686051|NCT03328702|Oropharyngeal dysphagia|oropharyngeal dysphagia
4686052|NCT03328702|Total Laryngectomy|total laryngectomy
4686053|NCT03328702|Video Fluoroscopic Swallowing Exam (VFSE)|video fluoroscopic swallowing exam (vfse)
4686054|NCT03328689|prevention|prevention
4686055|NCT03328689|exercise|exercise
4686056|NCT03328689|randomized controlled trial|randomized controlled trial
4686057|NCT03328689|physical activity|physical activity
4686058|NCT03328663|Cancer Care|cancer care
4686059|NCT03328637|Smartphone Addiction|smartphone addiction
4686060|NCT03328637|CBT|cbt
4686061|NCT03328637|Evidence based intervention|evidence based intervention
4686062|NCT03328585|CBT-I|cbt-i
4686063|NCT03328585|Telemedicine|telemedicine
4686064|NCT03328494|Paclitaxel|paclitaxel
4686065|NCT03328494|BOS172722|bos172722
4686066|NCT03328494|triple-negative breast cancer|triple-negative breast cancer
4686067|NCT03328468|Stroke|stroke
4686068|NCT03328429|bartholin|bartholin
4686069|NCT03328429|marsupialisation|marsupialisation
4686070|NCT03328429|abscess|abscess
4686071|NCT03328416|Image-Guided Biopsy|image-guided biopsy
4686072|NCT03328416|Multidetector Computed Tomography|multidetector computed tomography
4686073|NCT03328416|Diagnostic Imaging|diagnostic imaging
4686074|NCT03328416|Cryosurgery|cryosurgery
4686075|NCT03328416|Ablation Techniques|ablation techniques
4686076|NCT03328403|Endovascular therapy|endovascular therapy
4686077|NCT03328403|Mechanical thrombectomy|mechanical thrombectomy
4686078|NCT03328403|Acute ischaemic stroke treatment|acute ischaemic stroke treatment
4686079|NCT03328364|enzalutamide|enzalutamide
4686080|NCT03328364|metastatic castration-resistant prostate cancer|metastatic castration-resistant prostate cancer
4686081|NCT03328364|Xtandi|xtandi
4686082|NCT03328364|registry based study|registry based study
4686083|NCT03328364|MDV3100|mdv3100
4686084|NCT03328364|mCRPC|mcrpc
4686085|NCT03328351|Manual therapy|manual therapy
4686086|NCT03328351|cervical radiculopathy|cervical radiculopathy
4686087|NCT03328351|pressure pain threshold|pressure pain threshold
4686088|NCT03328351|physiotherapy|physiotherapy
4686089|NCT03328338|Mitochondria|mitochondria
4686090|NCT03328338|Oxidative phosphorylation (mitochondrial respiration)|oxidative phosphorylation (mitochondrial respiration)
4686091|NCT03328338|Subcutaneous abdominal adipose tissue|subcutaneous abdominal adipose tissue
4686092|NCT03328338|Heart.|heart.
4686093|NCT03328325|Influenza|influenza
4686094|NCT03328325|PCR|pcr
4686095|NCT03328325|Seasonal Vaccination|seasonal vaccination
4686096|NCT03328221|Heart rate variability|heart rate variability
4686097|NCT03328221|Observational study|observational study
4686098|NCT03328221|Physical activity|physical activity
4686099|NCT03328221|Rehabilitation|rehabilitation
4686100|NCT03328208|Nonpharmacologic analgesia|nonpharmacologic analgesia
4686101|NCT03328208|Medical app|medical app
4686102|NCT03328208|Relaxation|relaxation
4686103|NCT03328143|Craniotomy, anxiety, malignant, cancer, brain tumor|craniotomy, anxiety, malignant, cancer, brain tumor
4686104|NCT03328130|Adeno-associated virus|adeno-associated virus
4686105|NCT03328130|AAV|aav
4686106|NCT03328130|Retinitis Pigmentosa|retinitis pigmentosa
4686107|NCT03328130|PDE6B|pde6b
4686108|NCT03328130|Gene Therapy|gene therapy
4686109|NCT03328130|Gene Transfer|gene transfer
4686110|NCT03328130|Retinal Dystrophy|retinal dystrophy
4686111|NCT03328130|Eye Diseases|eye diseases
4686112|NCT03328130|Vision Disorders|vision disorders
4686113|NCT03328130|Eye Diseases, Hereditary|eye diseases, hereditary
4686114|NCT03328130|Retinal Diseases|retinal diseases
4686115|NCT03328130|Retinal Degeneration|retinal degeneration
4686116|NCT03328104|T- cell acute lymphoblastic leukemia|t- cell acute lymphoblastic leukemia
4686117|NCT03328104|T-ALL|t-all
4686118|NCT03328104|T-cell lymphoblastic lymphoma|t-cell lymphoblastic lymphoma
4686119|NCT03328104|T-LLy|t-lly
4686120|NCT03328104|Everolimus|everolimus
4686121|NCT03328104|Maximum tolerated dose|maximum tolerated dose
4686122|NCT03328091|Prostate Cancer|prostate cancer
4686123|NCT03328091|Genetics|genetics
4686124|NCT03328078|DLBCL|dlbcl
4686125|NCT03328078|MCL|mcl
4686126|NCT03328078|WM|wm
4686127|NCT03328078|LPL|lpl
4686128|NCT03328078|MYD88|myd88
4686129|NCT03328078|IRAK4|irak4
4686130|NCT03327987|vaccine immunogenicity|vaccine immunogenicity
4686131|NCT03327987|vaccine safety|vaccine safety
4686132|NCT03327974|Aged between 18 and 65|aged between 18 and 65
4686133|NCT03327974|Major depressive disorder|major depressive disorder
4686134|NCT03327974|Suicide|suicide
4686135|NCT03327974|Ecological momentary assessment|ecological momentary assessment
4686136|NCT03327974|Smartphone application|smartphone application
4686137|NCT03327948|Sacral neuromodulation (SNM)|sacral neuromodulation (snm)
4686138|NCT03327948|SNM|snm
4686139|NCT03327922|Subdermal|subdermal
4686140|NCT03327922|Suture|suture
4686141|NCT03327922|Wound Closure|wound closure
4686142|NCT03327922|Wound Cosmesis|wound cosmesis
4686143|NCT03327909|Intradialytic Hypotension, Hypertension, Ambulatory Blood Pressure|intradialytic hypotension, hypertension, ambulatory blood pressure
4686144|NCT03327896|Quality Measures, Social Determinants of Health|quality measures, social determinants of health
4686145|NCT03327883|Diagnostic Imaging|diagnostic imaging
4686146|NCT03327883|Review of Patients Records|review of patients records
4686147|NCT03327883|PET MRI|pet mri
4686148|NCT03327883|Treatment Responses|treatment responses
4686149|NCT03327870|Sjogren's Syndrome|sjogren's syndrome
4686150|NCT03327870|Sicca|sicca
4686151|NCT03327844|Regenerative Endodontic Therapy|regenerative endodontic therapy
4686152|NCT03327844|Infected immature permanent teeth|infected immature permanent teeth
4686153|NCT03327831|aminolevulinic acid|aminolevulinic acid
4686154|NCT03327831|pdt|pdt
4686155|NCT03327831|photodynamic therapy|photodynamic therapy
4686156|NCT03327831|Photochemotherapy|photochemotherapy
4686157|NCT03327805|Choline|choline
4686158|NCT03327805|Trimethylamine N-Oxide|trimethylamine n-oxide
4686159|NCT03327805|Vascular health|vascular health
4686160|NCT03327766|vitamin D and recurrent pregnancy loss|vitamin d and recurrent pregnancy loss
4686161|NCT03327753|exercise|exercise
4686162|NCT03327753|mobility|mobility
4686163|NCT03327753|physiotherapy|physiotherapy
4686164|NCT03327753|validation|validation
4686165|NCT03327740|Hypersensitivity reactions (HSR)|hypersensitivity reactions (hsr)
4686166|NCT03327740|HIV|hiv
4686167|NCT03327740|Dolutegravir|dolutegravir
4686168|NCT03327727|IA|ia
4686169|NCT03327714|mindfulness|mindfulness
4686170|NCT03327714|children|children
4686171|NCT03327714|anxiety|anxiety
4686172|NCT03327714|depression|depression
4686173|NCT03327714|mental disorder|mental disorder
4686174|NCT03327714|risk factor|risk factor
4686175|NCT03327701|Exercise-induced bronchoconstriction|exercise-induced bronchoconstriction
4686176|NCT03327701|Benralizumab|benralizumab
4686177|NCT03327701|Antiinterleukin 5 receptor α monoclonal antibody|antiinterleukin 5 receptor α monoclonal antibody
4686178|NCT03327688|Focus assesment with sonography for trauma|focus assesment with sonography for trauma
4686179|NCT03327688|POCUS|pocus
4686180|NCT03327688|LOS|los
4686181|NCT03327688|Point-of-care ultrasound|point-of-care ultrasound
4686182|NCT03327688|length of stay|length of stay
4686183|NCT03327688|cost-minimization|cost-minimization
4686184|NCT03327688|primary health care|primary health care
4686185|NCT03327688|Ultrasound|ultrasound
4686186|NCT03327688|Emergency department|emergency department
4686187|NCT03327675|prostate-specific membrane antigen|prostate-specific membrane antigen
4686188|NCT03327675|Lymph Node Dissection|lymph node dissection
4686189|NCT03327675|Prostatectomy|prostatectomy
4686190|NCT03327675|Positron-Emission Tomography|positron-emission tomography
4686191|NCT03327662|Cabazitaxel|cabazitaxel
4686192|NCT03327662|Docetaxel|docetaxel
4686193|NCT03327662|Circulating Tumour Cells|circulating tumour cells
4686194|NCT03327649|heart failure with preserved ejection fraction|heart failure with preserved ejection fraction
4686195|NCT03327649|inflammation|inflammation
4686196|NCT03327636|Papillary Thyroid Microcarcinoma|papillary thyroid microcarcinoma
4686197|NCT03327636|High intensity focused ultrasound|high intensity focused ultrasound
4686198|NCT03327636|Active surveillance|active surveillance
4686199|NCT03327623|sleep apnea|sleep apnea
4686200|NCT03327623|arrhythmia|arrhythmia
4686201|NCT03327610|Respiratory Therapy|respiratory therapy
4686202|NCT03327610|Positive Pressure Respiration|positive pressure respiration
4686203|NCT03327610|Physical Therapy Modalities|physical therapy modalities
4686204|NCT03327597|MGUS|mgus
4686205|NCT03327597|Screening|screening
4686206|NCT03327597|Population-based|population-based
4686207|NCT03327571|Drug therapy|drug therapy
4686208|NCT03327545|Trigger points|trigger points
4686209|NCT03327545|Trigegeminal nerve|trigegeminal nerve
4686210|NCT03327545|Pain|pain
4686211|NCT03327532|Acute Heart Failure|acute heart failure
4686212|NCT03327532|Congestion|congestion
4686213|NCT03327532|Ultrasound|ultrasound
4686214|NCT03327519|Asthma|asthma
4686215|NCT03327519|Insomnia|insomnia
4686216|NCT03327506|Premedication/ Hypnosis/ Anxiety/Surgery|premedication/ hypnosis/ anxiety/surgery
4686217|NCT03327493|Cardiogenic shock|cardiogenic shock
4686218|NCT03327493|Extra-Corporeal-Life-Support (ECLS)|extra-corporeal-life-support (ecls)
4686219|NCT03327493|inflammation|inflammation
4686220|NCT03327493|adrenergic system|adrenergic system
4686221|NCT03327480|osteoarthritis thumb|osteoarthritis thumb
4686222|NCT03327480|orthosis|orthosis
4686223|NCT03327480|functioning|functioning
4686224|NCT03327454|Rheumatoid arthritis|rheumatoid arthritis
4686225|NCT03327454|Ankylosing spondylitis|ankylosing spondylitis
4686226|NCT03327454|Axial spondyloarthritis|axial spondyloarthritis
4686227|NCT03327454|Benepali pen|benepali pen
4686228|NCT03327454|Etanercept|etanercept
4686229|NCT03327454|Patient questionnaire|patient questionnaire
4686230|NCT03327454|Pre-filled pen|pre-filled pen
4686231|NCT03327454|Biological DMARDs|biological dmards
4686232|NCT03327454|Antirheumatic drug|antirheumatic drug
4686233|NCT03327428|Anemia, Sickle Cell|anemia, sickle cell
4686234|NCT03327428|Sickle Cell disease|sickle cell disease
4686235|NCT03327415|Children|children
4686236|NCT03327415|Food practice|food practice
4686237|NCT03327415|Food consumption|food consumption
4686238|NCT03327415|Nutrient intake|nutrient intake
4686239|NCT03327402|SHP465|shp465
4686240|NCT03327402|ADHD|adhd
4686241|NCT03327402|Hyperactivity|hyperactivity
4686242|NCT03327376|central venous catheters|central venous catheters
4686243|NCT03327376|venous thrombosis|venous thrombosis
4686244|NCT03327376|ultrasound|ultrasound
4686245|NCT03327376|critical care|critical care
4686246|NCT03327363|ICT based clinical trial,|ict based clinical trial,
4686247|NCT03327363|eCRF|ecrf
4686248|NCT03327363|electronic -institutional review board (eIRB),|electronic -institutional review board (eirb),
4686249|NCT03327363|Centralized monitoring|centralized monitoring
4686250|NCT03327363|contract research organization (CRO)|contract research organization (cro)
4686251|NCT03327311|No condition|no condition
4686252|NCT03327298|Pedicle screw. Free hand. Lumbar fixation|pedicle screw. free hand. lumbar fixation
4687243|NCT03321175|infection|infection
4686253|NCT03327285|Acute lymphoblastic leukemia|acute lymphoblastic leukemia
4686254|NCT03327285|Hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
4686255|NCT03327285|Anti-CD19 chimeric antigen receptor T-cell|anti-cd19 chimeric antigen receptor t-cell
4686256|NCT03327181|short chain fatty acid metabolism|short chain fatty acid metabolism
4686257|NCT03327168|Adipose Tissue, Brown|adipose tissue, brown
4686258|NCT03327155|HIV prevention|hiv prevention
4686259|NCT03327155|PrEP|prep
4686260|NCT03327142|Adrenal Gland|adrenal gland
4686261|NCT03327142|Endoscopic Ultrasound Guided FNA|endoscopic ultrasound guided fna
4686262|NCT03327116|atopic dermatitis|atopic dermatitis
4686263|NCT03327116|pruritus|pruritus
4686264|NCT03327116|methotrexate|methotrexate
4686265|NCT03327116|inflamation|inflamation
4686266|NCT03327116|IL-31|il-31
4686267|NCT03327103|decision making|decision making
4686268|NCT03327103|advanced prostate cancer|advanced prostate cancer
4686269|NCT03327103|decision aid|decision aid
4686270|NCT03327103|minorities|minorities
4686271|NCT03327103|mHealth|mhealth
4686272|NCT03327103|community patient navigator|community patient navigator
4686273|NCT03327090|Olympic Weightlifting|olympic weightlifting
4686274|NCT03327090|Taping|taping
4686275|NCT03327090|Muscles Facilitation|muscles facilitation
4686276|NCT03327090|Jumps|jumps
4686277|NCT03326999|adductor canal regional block|adductor canal regional block
4686278|NCT03326999|obturator nerve regional block|obturator nerve regional block
4686279|NCT03326999|total knee arthroplasty|total knee arthroplasty
4686280|NCT03326999|knee replacement surgery|knee replacement surgery
4686281|NCT03326999|Knee rheumatoid arthritis|knee rheumatoid arthritis
4686282|NCT03326973|Quality of Life (QoL)|quality of life (qol)
4686283|NCT03326973|17-518|17-518
4686284|NCT03326960|general anesthesia|general anesthesia
4686285|NCT03326960|postoperative delirium|postoperative delirium
4686286|NCT03326960|postoperative cognitive dysfunction|postoperative cognitive dysfunction
4686287|NCT03326960|biomarker|biomarker
4686288|NCT03326947|TPF induction chemotherapy, randomized, trial,OSCC|tpf induction chemotherapy, randomized, trial,oscc
4686289|NCT03326921|HA-1|ha-1
4686290|NCT03326921|TCR|tcr
4686291|NCT03326921|Immunotherapy|immunotherapy
4686292|NCT03326921|Leukemia|leukemia
4686293|NCT03326843|low platelet count|low platelet count
4686294|NCT03326843|ITP|itp
4686295|NCT03326830|Respiratory Insufficiency|respiratory insufficiency
4686296|NCT03326830|Oxygen Inhalation Therapy|oxygen inhalation therapy
4686297|NCT03326817|Degenerative Arthritis, Rheumatic Diseases|degenerative arthritis, rheumatic diseases
4686298|NCT03326804|Hip Resurfacing Arthroplasty|hip resurfacing arthroplasty
4686300|NCT03326804|H1|h1
4686301|NCT03326791|Acetylsalicylic acid|acetylsalicylic acid
4686302|NCT03326791|Aspirin|aspirin
4686303|NCT03326791|Trombyl|trombyl
4686304|NCT03326791|Secondary prevention|secondary prevention
4686305|NCT03326778|Aortic Valve Stenosis|aortic valve stenosis
4686306|NCT03326778|Rapid deployment Valve|rapid deployment valve
4686307|NCT03326778|CABG|cabg
4686308|NCT03326778|Edwards Intuity Elite|edwards intuity elite
4686309|NCT03326765|tuberous sclerosis complex (TSC)|tuberous sclerosis complex (tsc)
4686310|NCT03326765|Children|children
4686311|NCT03326765|Adults|adults
4686312|NCT03326752|Cancer|cancer
4686313|NCT03326752|Lung Cancer|lung cancer
4686314|NCT03326752|NSCLC|nsclc
4686315|NCT03326752|Anti-PD-1 inhibitor|anti-pd-1 inhibitor
4686316|NCT03326752|Immuno-oncology|immuno-oncology
4686317|NCT03326752|Toll-Like Receptor (TLR) agonist|toll-like receptor (tlr) agonist
4686318|NCT03326713|Genetic Testing|genetic testing
4686319|NCT03326713|Prevention|prevention
4686320|NCT03326687|Language|language
4686321|NCT03326687|Anomia|anomia
4686322|NCT03326687|Therapy|therapy
4686323|NCT03326674|Tesetaxel|tesetaxel
4686324|NCT03326674|Capecitabine|capecitabine
4686325|NCT03326674|HER2 negative|her2 negative
4686326|NCT03326674|Hormone Receptor positive|hormone receptor positive
4686327|NCT03326674|Locally advanced or metastatic breast cancer|locally advanced or metastatic breast cancer
4686328|NCT03326674|Combination of tesetaxel and capecitabine|combination of tesetaxel and capecitabine
4686329|NCT03326674|Taxanes|taxanes
4686330|NCT03326674|Metastatic breast cancer|metastatic breast cancer
4686331|NCT03326674|Breast cancer|breast cancer
4686332|NCT03326661|Tonsillectomy|tonsillectomy
4686333|NCT03326661|Aspiration|aspiration
4686334|NCT03326661|Quinsy|quinsy
4686335|NCT03326648|Sarcopenia|sarcopenia
4686336|NCT03326648|Frailty|frailty
4686337|NCT03326648|Strength training|strength training
4686338|NCT03326648|Autophagy|autophagy
4686339|NCT03326635|Resuscitation|resuscitation
4686340|NCT03326635|Frailty|frailty
4686341|NCT03326635|ICU|icu
4686342|NCT03326635|Ageing|ageing
4686343|NCT03326635|Rehabilitation|rehabilitation
4686344|NCT03326635|Elderly|elderly
4686345|NCT03326622|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
4686346|NCT03326622|aerobic exercise|aerobic exercise
4686347|NCT03326622|functional outcome|functional outcome
4686348|NCT03326622|non-invasive ventilation|non-invasive ventilation
4686349|NCT03326622|oxygen uptake|oxygen uptake
4686350|NCT03326596|Hemorrhage|hemorrhage
4686351|NCT03326596|Tranexamic acid (TXA)|tranexamic acid (txa)
4688114|NCT03315559|Excretion|excretion
4686352|NCT03326596|Estimated Blood Loss (EBL)|estimated blood loss (ebl)
4686353|NCT03326583|End Stage Renal Disease|end stage renal disease
4686354|NCT03326583|ESRD|esrd
4686355|NCT03326583|Hyperkalemia|hyperkalemia
4686356|NCT03326570|Lung cancer|lung cancer
4686357|NCT03326570|Data collection post bronchoscopy|data collection post bronchoscopy
4686358|NCT03326557|Induction of Labour|induction of labour
4686359|NCT03326557|Previous Caesarean delivery|previous caesarean delivery
4686360|NCT03326557|Foley|foley
4686361|NCT03326557|Membrane sweeping|membrane sweeping
4686362|NCT03326557|Vaginal delivery|vaginal delivery
4686363|NCT03326505|Umbilical Cord Mesenchymal Stem Cells|umbilical cord mesenchymal stem cells
4686364|NCT03326505|Multiple Sclerosis|multiple sclerosis
4686365|NCT03326505|Neuroimmunology|neuroimmunology
4686366|NCT03326505|Autoimmune disease|autoimmune disease
4686367|NCT03326505|Physical therapy|physical therapy
4686368|NCT03326492|Snake bites|snake bites
4686369|NCT03326492|Antivenom serum|antivenom serum
4686370|NCT03326492|Snake venoms|snake venoms
4686371|NCT03326479|Molecular Profiling|molecular profiling
4686372|NCT03326479|Biomarker Analysis|biomarker analysis
4686373|NCT03326479|Outcomes Database|outcomes database
4686374|NCT03326466|Subacromial Impingement Syndrome|subacromial impingement syndrome
4686375|NCT03326466|Central Nervous System Sensitization|central nervous system sensitization
4686376|NCT03326466|Muscle Function|muscle function
4686377|NCT03326466|EMG|emg
4686378|NCT03326466|Force Steadiness|force steadiness
4686379|NCT03326466|CUFF Algometry|cuff algometry
4686380|NCT03326466|Manual Algometry|manual algometry
4686381|NCT03326466|Pain|pain
4686382|NCT03326466|Maximal Voluntary Isometric Contraction|maximal voluntary isometric contraction
4686383|NCT03326453|mini dental implant|mini dental implant
4686384|NCT03326453|overdenture|overdenture
4686385|NCT03326453|Patient satisfaction|patient satisfaction
4686386|NCT03326427|Attention Deficit Hyperactive Disorder|attention deficit hyperactive disorder
4686387|NCT03326427|Skill Training Group|skill training group
4686388|NCT03326427|Dialectical Behavior Therapy|dialectical behavior therapy
4686389|NCT03326401|dietary total antioxidant activity|dietary total antioxidant activity
4686390|NCT03326401|nutritional status|nutritional status
4686391|NCT03326401|macular degeneration|macular degeneration
4686392|NCT03326401|glycemic load|glycemic load
4686393|NCT03326401|glycemic index|glycemic index
4686394|NCT03326401|nutrient intake|nutrient intake
4686395|NCT03326375|TACE|tace
4686396|NCT03326375|SBRT|sbrt
4686397|NCT03326362|chronic low back pain|chronic low back pain
4686398|NCT03326362|strength training|strength training
4686399|NCT03326362|biomechanics|biomechanics
4686400|NCT03326362|inflammatory biomarkers|inflammatory biomarkers
4686401|NCT03326349|computerized cognitive rehabilitation|computerized cognitive rehabilitation
4686402|NCT03326336|Eye Diseases|eye diseases
4686403|NCT03326336|Hereditary Eye Diseases|hereditary eye diseases
4686404|NCT03326336|Retinal degeneration|retinal degeneration
4686405|NCT03326336|Inherited retinal diseases|inherited retinal diseases
4686406|NCT03326336|Rod & cone dystrophies|rod & cone dystrophies
4686407|NCT03326336|Retinitis Pigmentosa|retinitis pigmentosa
4686408|NCT03326336|Gene Therapy|gene therapy
4686409|NCT03326336|Optogenetic|optogenetic
4686410|NCT03326336|Intravitreal Injections|intravitreal injections
4686411|NCT03326336|AAV Vectors|aav vectors
4686412|NCT03326336|Medical device|medical device
4686413|NCT03326336|Visual Interface|visual interface
4686414|NCT03326323|acute normovolemic hemodilution|acute normovolemic hemodilution
4686415|NCT03326310|Chronic Myeloid Leukemia|chronic myeloid leukemia
4686416|NCT03326310|Myelofibrosis|myelofibrosis
4686417|NCT03326310|selumetinib|selumetinib
4686418|NCT03326310|azacitidine|azacitidine
4686419|NCT03326297|Infant Colic|infant colic
4686420|NCT03326297|Osteopathy|osteopathy
4686421|NCT03326297|Stress|stress
4686422|NCT03326297|Physiotherapy|physiotherapy
4686423|NCT03326284|Hypocaloric diet|hypocaloric diet
4686424|NCT03326284|Dietary protein|dietary protein
4686425|NCT03326245|Pharmacological MRI|pharmacological mri
4686426|NCT03326245|C-11 Raclopride|c-11 raclopride
4686427|NCT03326245|PET Imaging|pet imaging
4686428|NCT03326245|Neuropsychological Testing|neuropsychological testing
4686429|NCT03326219|MOCA|moca
4686430|NCT03326219|VSM|vsm
4686431|NCT03326219|Clarivein|clarivein
4686432|NCT03326219|Histological|histological
4686433|NCT03326206|Navajo|navajo
4686434|NCT03326206|Community Health Workers|community health workers
4686435|NCT03326206|Community Health Representatives|community health representatives
4686436|NCT03326206|Tribal health systems|tribal health systems
4686437|NCT03326206|American Indian|american indian
4686438|NCT03326206|Rural|rural
4686439|NCT03326206|Health disparities|health disparities
4686440|NCT03326193|Stage IIIb - IV|stage iiib - iv
4686441|NCT03326193|gBRCAmut|gbrcamut
4686442|NCT03326193|BRCA|brca
4686443|NCT03326193|PARP inhibitor|parp inhibitor
4686444|NCT03326193|Ovarian|ovarian
4686445|NCT03326193|Primary Peritoneal|primary peritoneal
4686446|NCT03326193|Fallopian Tube|fallopian tube
4686447|NCT03326193|VEGF inhibitor|vegf inhibitor
4686448|NCT03326193|Bevacizumab|bevacizumab
4686449|NCT03326193|Niraparib|niraparib
4686450|NCT03326193|Angiogenesis Inhibitors|angiogenesis inhibitors
4686451|NCT03326193|Angiogenesis Modulating Agents|angiogenesis modulating agents
4686452|NCT03326193|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors
4686453|NCT03326154|cholecystectomy|cholecystectomy
4686454|NCT03326154|quality of life|quality of life
4686455|NCT03326128|Bupropion XL|bupropion xl
4686456|NCT03326128|Anhedonia|anhedonia
4686457|NCT03326128|Heavy Smokers|heavy smokers
4686458|NCT03326128|Smoking cessation|smoking cessation
4686459|NCT03326115|patient activation|patient activation
4686460|NCT03326115|peer visitation|peer visitation
4686461|NCT03326115|amputee|amputee
4686462|NCT03326102|Breast Cancer|breast cancer
4686463|NCT03326102|DHP107|dhp107
4686464|NCT03326102|Paclitaxel|paclitaxel
4686465|NCT03326102|Liporaxel|liporaxel
4686466|NCT03326089|pulmonary rehabilitation|pulmonary rehabilitation
4686467|NCT03326050|Rhinoscleroma|rhinoscleroma
4686468|NCT03326050|Gemifloxacin|gemifloxacin
4686469|NCT03326050|Ciprofloxacin|ciprofloxacin
4686470|NCT03326037|Nephrotic Syndrome|nephrotic syndrome
4686471|NCT03326037|NPHS2 gene mutation|nphs2 gene mutation
4686472|NCT03326037|disease association|disease association
4686473|NCT03326011|Exoskeleton Device|exoskeleton device
4686474|NCT03326011|Gait rehabilitation|gait rehabilitation
4686475|NCT03326011|Chronic storke|chronic storke
4686476|NCT03325998|Exoskeleton Device|exoskeleton device
4686477|NCT03325998|Elderly|elderly
4686478|NCT03325998|Gait rehabilitation|gait rehabilitation
4686479|NCT03325959|hyperbaric oxygen|hyperbaric oxygen
4686480|NCT03325959|HBOT|hbot
4686481|NCT03325959|fibromyalgia|fibromyalgia
4686482|NCT03325959|pain|pain
4686483|NCT03325933|insulin sensitivity|insulin sensitivity
4686484|NCT03325933|muscle|muscle
4686485|NCT03325933|strength|strength
4686486|NCT03325933|resistance training|resistance training
4686487|NCT03325933|strength training|strength training
4686488|NCT03325933|vascular function|vascular function
4686489|NCT03325933|arterial stiffness|arterial stiffness
4686490|NCT03325933|glucose tolerance|glucose tolerance
4686491|NCT03325920|sleep bruxism|sleep bruxism
4686492|NCT03325920|diagnosis|diagnosis
4686493|NCT03325920|validation study|validation study
4686494|NCT03325920|assessment|assessment
4686495|NCT03325907|Biopsy, Needle|biopsy, needle
4686496|NCT03325907|Printing, Three-Dimensional|printing, three-dimensional
4686497|NCT03325907|Image-Guided Biopsy|image-guided biopsy
4686498|NCT03325894|ADHD|adhd
4686499|NCT03325894|SHP465|shp465
4686500|NCT03325894|Hyperactivity|hyperactivity
4686501|NCT03325881|ADHD|adhd
4686502|NCT03325881|Hyperactivity|hyperactivity
4686503|NCT03325881|SHP465|shp465
4686504|NCT03325868|heavy periods, painful periods, adenomyosis|heavy periods, painful periods, adenomyosis
4686505|NCT03325855|FMT|fmt
4686506|NCT03325855|CDI|cdi
4686507|NCT03325855|Fecal Matter Transplant|fecal matter transplant
4686508|NCT03325842|Cross-cultural comparison|cross-cultural comparison
4686509|NCT03325842|Disability evaluation|disability evaluation
4686510|NCT03325842|Self-assessment|self-assessment
4686511|NCT03325842|Child|child
4686512|NCT03325842|Adolescent|adolescent
4686513|NCT03325829|Registry|registry
4686514|NCT03325829|Diverticular Disease|diverticular disease
4686515|NCT03325829|Diverticulitis|diverticulitis
4686516|NCT03325829|Uncomplicated Diverticular Disease|uncomplicated diverticular disease
4686517|NCT03325816|nivolumab|nivolumab
4686518|NCT03325816|177Lu-DOTA0-Tyr3-Octreotate|177lu-dota0-tyr3-octreotate
4686519|NCT03325816|Lutathera|lutathera
4686520|NCT03325803|actinic keratosis|actinic keratosis
4686521|NCT03325803|ablative fractional laser|ablative fractional laser
4686522|NCT03325803|photodynamic therapy|photodynamic therapy
4686523|NCT03325803|ablative depth|ablative depth
4686524|NCT03325803|protoporphyrin IX|protoporphyrin ix
4686525|NCT03325790|Meniere's disease|meniere's disease
4686526|NCT03325790|Hearing Loss|hearing loss
4686527|NCT03325790|Vertigo|vertigo
4686528|NCT03325790|Tinnitus|tinnitus
4686529|NCT03325790|Ebselen|ebselen
4686530|NCT03325790|Pharmacokinetics|pharmacokinetics
4686531|NCT03325790|Safety|safety
4686532|NCT03325790|Efficacy|efficacy
4686533|NCT03325790|Speech|speech
4686534|NCT03325777|Cigarettes|cigarettes
4686535|NCT03325777|Tobacco Use|tobacco use
4686536|NCT03325764|Obesity|obesity
4686537|NCT03325764|bariatric surgery|bariatric surgery
4686538|NCT03325764|sleeve gastrectomy|sleeve gastrectomy
4686539|NCT03325764|physical activity|physical activity
4686540|NCT03325764|movement analysis|movement analysis
4686541|NCT03325725|severe aspiration|severe aspiration
4686542|NCT03325699|Mild dementia|mild dementia
4686543|NCT03325699|Cognitive impairment|cognitive impairment
4686544|NCT03325699|Informal caregiver|informal caregiver
4686545|NCT03325699|Aging|aging
4686546|NCT03325699|Quality of life|quality of life
4686547|NCT03325699|Health application|health application
4686548|NCT03325699|Information and communication technology (ICT)|information and communication technology (ict)
4686549|NCT03325686|vitamin D|vitamin d
4686550|NCT03325686|atletes|atletes
4686551|NCT03325686|physical performance|physical performance
4686552|NCT03325660|Whole body vibration, Pelvic floor muscle|whole body vibration, pelvic floor muscle
4686553|NCT03325647|body composition|body composition
4686554|NCT03325647|klinefelter syndrome|klinefelter syndrome
4686556|NCT03325647|sex chromosome variation|sex chromosome variation
4686557|NCT03325647|sex chromosome aneuploidy|sex chromosome aneuploidy
4686558|NCT03325647|testosterone|testosterone
4686559|NCT03325621|Hepcidin|hepcidin
4686560|NCT03325621|Hemoglobin|hemoglobin
4686561|NCT03325621|Iron|iron
4686562|NCT03325621|Anemia of chronic disease|anemia of chronic disease
4686563|NCT03325582|Perianal Fistula Crohn's disease, MRI|perianal fistula crohn's disease, mri
4686564|NCT03325556|Dementia|dementia
4686565|NCT03325556|Dementia-related psychosis|dementia-related psychosis
4686566|NCT03325556|Dementia associated with Parkinson's disease|dementia associated with parkinson's disease
4686567|NCT03325556|Dementia with Lewy bodies|dementia with lewy bodies
4686568|NCT03325556|Alzheimer's disease|alzheimer's disease
4686569|NCT03325556|Behavioral variant frontotemporal dementia|behavioral variant frontotemporal dementia
4686570|NCT03325556|Progressive supranuclear palsy|progressive supranuclear palsy
4686571|NCT03325556|Corticobasal degeneration|corticobasal degeneration
4686572|NCT03325556|Vascular dementia|vascular dementia
4686573|NCT03325556|Hallucinations|hallucinations
4686574|NCT03325556|Delusions|delusions
4686575|NCT03325556|Psychosis|psychosis
4686576|NCT03325543|Urinary Incontinence, Stress|urinary incontinence, stress
4686577|NCT03325543|Pelvic Floor|pelvic floor
4686578|NCT03325543|Exercise|exercise
4686579|NCT03325530|Adolescent|adolescent
4686580|NCT03325530|Nutrition|nutrition
4686581|NCT03325530|Physical Activity|physical activity
4686582|NCT03325465|squamous cell carcinoma of the head and neck|squamous cell carcinoma of the head and neck
4686583|NCT03325465|head and neck cancer|head and neck cancer
4686584|NCT03325465|neoadjuvant pembrolizumab|neoadjuvant pembrolizumab
4686585|NCT03325465|epacadostat|epacadostat
4686586|NCT03325439|Electroencephalographic neonatal seizures|electroencephalographic neonatal seizures
4686587|NCT03325439|Brivaracetam|brivaracetam
4686588|NCT03325439|Epilepsy|epilepsy
4686589|NCT03325439|ENS|ens
4686590|NCT03325439|Newborns|newborns
4686591|NCT03325439|Pharmacokinetic|pharmacokinetic
4686592|NCT03325413|Perioperative geriatric care|perioperative geriatric care
4686593|NCT03325413|Geriatric assessment|geriatric assessment
4686594|NCT03325413|Postoperative cognitive dysfunction|postoperative cognitive dysfunction
4686595|NCT03325413|POCD|pocd
4686596|NCT03325413|Frailty|frailty
4686597|NCT03325413|Depression|depression
4686598|NCT03325413|Physical fitness|physical fitness
4686599|NCT03325413|Geriatric anesthesia|geriatric anesthesia
4686600|NCT03325413|IADL|iadl
4686601|NCT03325413|Postoperative functional status|postoperative functional status
4686602|NCT03325413|Quality of life|quality of life
4686603|NCT03325400|Fluoride toothpaste|fluoride toothpaste
4686604|NCT03325400|Cytogenetic damage|cytogenetic damage
4686605|NCT03325400|Exfoliated buccal cells|exfoliated buccal cells
4686606|NCT03325400|Micronucleus assay|micronucleus assay
4686607|NCT03325348|Severe Pre eclampsia|severe pre eclampsia
4686608|NCT03325348|Nifidepine|nifidepine
4686609|NCT03325348|Labetalol|labetalol
4686610|NCT03325335|midazolam premedication|midazolam premedication
4686611|NCT03325322|Frailty|frailty
4686612|NCT03325322|Inflammation|inflammation
4686613|NCT03325322|Mesenchymal stem cell|mesenchymal stem cell
4686614|NCT03325322|Mesenchymal stromal cell|mesenchymal stromal cell
4686615|NCT03325309|Lumbar spinal stenosis|lumbar spinal stenosis
4686616|NCT03325309|Cycling|cycling
4686617|NCT03325309|Lumbar-flexion-based training|lumbar-flexion-based training
4686618|NCT03325283|stroke prevention|stroke prevention
4686619|NCT03325283|embolic protection|embolic protection
4686620|NCT03325283|cognition|cognition
4686621|NCT03325270|prebiotics|prebiotics
4686622|NCT03325270|Galacto-oligosaccharides|galacto-oligosaccharides
4686623|NCT03325270|Iron-deficiency|iron-deficiency
4686624|NCT03325257|Unresectable melanoma|unresectable melanoma
4686625|NCT03325257|metastatic melanoma|metastatic melanoma
4686626|NCT03325257|Immunotherapy|immunotherapy
4686627|NCT03325257|Nivolumab|nivolumab
4686628|NCT03325257|Temporary Auhorization for Use (ATU)|temporary auhorization for use (atu)
4686629|NCT03325205|Transcranial direct current stimulation|transcranial direct current stimulation
4686630|NCT03325205|Neuromodulation|neuromodulation
4686631|NCT03325205|Individualizing brain stimulation|individualizing brain stimulation
4686632|NCT03325205|Neuropsychology|neuropsychology
4686633|NCT03325192|Indwelling Pleural Catheter|indwelling pleural catheter
4686634|NCT03325192|Pleurodesis|pleurodesis
4686635|NCT03325192|Iodopovidone|iodopovidone
4686636|NCT03325192|Pleural Effusion, Malignant|pleural effusion, malignant
4686637|NCT03325179|Simple Obesity|simple obesity
4686638|NCT03325179|Thread-embedding Therapy|thread-embedding therapy
4686639|NCT03325179|Acupuncture|acupuncture
4686640|NCT03325153|Obstructive Sleep Apnea|obstructive sleep apnea
4686641|NCT03325153|Bronchoscopy|bronchoscopy
4686642|NCT03325153|STOP-Bang questionnaire|stop-bang questionnaire
4686643|NCT03325153|Cardiopulmonary events|cardiopulmonary events
4686644|NCT03325127|Prostate Cancer, Bone metastases, Xofigo, Zytiga, Xtandi.|prostate cancer, bone metastases, xofigo, zytiga, xtandi.
4686645|NCT03325114|type 1 diabetes|type 1 diabetes
4686646|NCT03325114|hypercalciuria|hypercalciuria
4686647|NCT03325088|Severe Asthma|severe asthma
4688211|NCT03315052|Graft loss|graft loss
4686648|NCT03325088|airway smooth muscle cells|airway smooth muscle cells
4686649|NCT03325088|Rac1 protein|rac1 protein
4686650|NCT03325075|VAL-181388|val-181388
4686651|NCT03325075|Chikungunya vaccine|chikungunya vaccine
4686652|NCT03325049|Family Relations|family relations
4686653|NCT03325049|Family Health|family health
4686654|NCT03325049|Intervention study|intervention study
4686655|NCT03325049|Social support|social support
4686656|NCT03325049|Intensive care unit|intensive care unit
4686657|NCT03325023|PCOS, microbiota, probiotic,obesity|pcos, microbiota, probiotic,obesity
4686658|NCT03324984|Spinal anesthesia|spinal anesthesia
4686659|NCT03324984|Pain|pain
4686660|NCT03324984|Chloroprocaine|chloroprocaine
4686661|NCT03324958|Endometrial cancer|endometrial cancer
4686662|NCT03324958|Brachytherapy|brachytherapy
4686663|NCT03324958|Virtual reality|virtual reality
4686664|NCT03324958|Pain|pain
4686665|NCT03324958|Anxiety|anxiety
4686666|NCT03324932|bone health|bone health
4686667|NCT03324932|hormone-sensitive breast cancer|hormone-sensitive breast cancer
4686668|NCT03324932|postmenopausal|postmenopausal
4686669|NCT03324932|aromatase inhibitor|aromatase inhibitor
4686670|NCT03324932|bone mineral density|bone mineral density
4686671|NCT03324919|Psoriasis|psoriasis
4686672|NCT03324919|Urticaria|urticaria
4686673|NCT03324919|Lupus erythematodes|lupus erythematodes
4686674|NCT03324919|qualtiy of life|qualtiy of life
4686675|NCT03324906|Prader-Willi Syndrome|prader-willi syndrome
4686676|NCT03324906|Obesity|obesity
4686677|NCT03324906|Depressive disorder|depressive disorder
4686678|NCT03324906|Obsessive-compulsive disorder|obsessive-compulsive disorder
4686679|NCT03324906|noninvasive brain stimulation|noninvasive brain stimulation
4686680|NCT03324880|rhPTH[1-84)|rhpth[1-84)
4686681|NCT03324880|Parathyroid hormone|parathyroid hormone
4686682|NCT03324880|Hypocalcemia|hypocalcemia
4686683|NCT03324880|Hypoparathyroidism|hypoparathyroidism
4686684|NCT03324854|Mosquito net|mosquito net
4686685|NCT03324854|Mesh|mesh
4686686|NCT03324854|Polypropylene mesh|polypropylene mesh
4686687|NCT03324854|Prolene mesh|prolene mesh
4686688|NCT03324854|ventral hernia|ventral hernia
4686689|NCT03324854|hernia|hernia
4686690|NCT03324841|Molecular Profiling|molecular profiling
4686691|NCT03324841|Biomarker Analysis|biomarker analysis
4686692|NCT03324841|Next Generation Sequencing|next generation sequencing
4686693|NCT03324828|anxiety|anxiety
4686694|NCT03324828|surgery|surgery
4686695|NCT03324828|clown|clown
4686696|NCT03324815|Morphine|morphine
4686697|NCT03324815|Methadone|methadone
4686698|NCT03324815|Pain|pain
4686699|NCT03324789|Single implant|single implant
4686700|NCT03324789|Anterior edentulism|anterior edentulism
4686701|NCT03324789|partial denture|partial denture
4686702|NCT03324776|inhaled insulin|inhaled insulin
4686703|NCT03324750|corticotherapy|corticotherapy
4686704|NCT03324750|qualitative study|qualitative study
4686705|NCT03324750|therapeutic education|therapeutic education
4686706|NCT03324750|lifestyle change|lifestyle change
4686707|NCT03324750|diet|diet
4686708|NCT03324737|Prevention|prevention
4686709|NCT03324737|Smartphone application|smartphone application
4686710|NCT03324737|Randomized control trial|randomized control trial
4686711|NCT03324711|Cognitive disorders|cognitive disorders
4686712|NCT03324711|Alzheimer's disease|alzheimer's disease
4686713|NCT03324711|Mini Mental State Examination|mini mental state examination
4686714|NCT03324711|Geriatry|geriatry
4686715|NCT03324685|Oral Contraceptive, Healthy Volunteers, Ethinyl Estradiol,|oral contraceptive, healthy volunteers, ethinyl estradiol,
4686716|NCT03324685|Levonorgestrel|levonorgestrel
4686717|NCT03324672|lumbar pain; pregnancy;|lumbar pain; pregnancy;
4686718|NCT03324659|Mindfulness|mindfulness
4686719|NCT03324659|Exercise|exercise
4686720|NCT03324659|Meditation|meditation
4686721|NCT03324659|Back pain|back pain
4686722|NCT03324646|PET Imaging|pet imaging
4686723|NCT03324633|HIV|hiv
4686724|NCT03324633|HCV|hcv
4686725|NCT03324633|cohort|cohort
4686726|NCT03324633|natural history|natural history
4686727|NCT03324633|cure|cure
4686728|NCT03324620|physiotherapy|physiotherapy
4686729|NCT03324620|nurse|nurse
4686730|NCT03324620|Cost effectiveness|cost effectiveness
4686731|NCT03324620|Activities of Daily Living|activities of daily living
4686732|NCT03324620|exercise tolerance|exercise tolerance
4686733|NCT03324620|Allogeneic|allogeneic
4686734|NCT03324620|Quality of Life|quality of life
4686735|NCT03324620|Rehabilitation|rehabilitation
4686736|NCT03324620|Physical Activity|physical activity
4686737|NCT03324594|functional performance|functional performance
4686738|NCT03324594|synthetic male condom|synthetic male condom
4686739|NCT03324581|ADHD|adhd
4686740|NCT03324581|ADD|add
4686741|NCT03324516|pterional incision|pterional incision
4686742|NCT03324516|Temporal hollowing|temporal hollowing
4686743|NCT03324503|Pulmonary Sarcoidosis|pulmonary sarcoidosis
4686744|NCT03324503|HRCT|hrct
4686745|NCT03324503|Glucocorticoid|glucocorticoid
4686746|NCT03324503|Prednisone|prednisone
4686747|NCT03324503|FRI|fri
4686748|NCT03324503|Prednisolone|prednisolone
4686749|NCT03324490|Mid-thoracic spinal anesthesia|mid-thoracic spinal anesthesia
4686750|NCT03324490|Mid-thoracic epidural anesthesia|mid-thoracic epidural anesthesia
4686751|NCT03324490|Nephrectomy|nephrectomy
4686752|NCT03324490|Lung disease|lung disease
4686753|NCT03324438|pediatrics|pediatrics
4686754|NCT03324425|breast cancer|breast cancer
4686755|NCT03324425|metastatic breast cancer|metastatic breast cancer
4686756|NCT03324399|ALS|als
4686757|NCT03324399|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
4686758|NCT03324386|Hypertension|hypertension
4686759|NCT03324386|Tecnology|tecnology
4686760|NCT03324386|Nursing|nursing
4686761|NCT03324386|Education|education
4686762|NCT03324347|Animal-Assisted Intervention|animal-assisted intervention
4686763|NCT03324347|Dog-Assisted Intervention|dog-assisted intervention
4686764|NCT03324347|Dental Care|dental care
4686765|NCT03324347|Questionnaire|questionnaire
4686766|NCT03324347|Pilot Project|pilot project
4686767|NCT03324347|Dental Clinic|dental clinic
4686768|NCT03324321|Cerebral Haemodynamics|cerebral haemodynamics
4686769|NCT03324321|Carbon Dioxide|carbon dioxide
4686770|NCT03324321|Cerebral Autoregulation|cerebral autoregulation
4686771|NCT03324308|Coronary Artery Disease|coronary artery disease
4686772|NCT03324308|Ischemia|ischemia
4686773|NCT03324308|Computed Tomography|computed tomography
4686774|NCT03324308|Myocardial perfusion|myocardial perfusion
4686775|NCT03324308|Dynamic Imaging|dynamic imaging
4686776|NCT03324282|Anti PD1|anti pd1
4686777|NCT03324282|Bladder carcinoma|bladder carcinoma
4686778|NCT03324282|Chemotherapy|chemotherapy
4686779|NCT03324282|Immunological monitoring|immunological monitoring
4686780|NCT03324256|Energy drink consumption|energy drink consumption
4686781|NCT03324230|Monoclonal antibody|monoclonal antibody
4686782|NCT03324230|Mepolizumab|mepolizumab
4686783|NCT03324230|Eosinophil|eosinophil
4686784|NCT03324217|motor imagery|motor imagery
4686785|NCT03324217|action observation|action observation
4686786|NCT03324191|Tea extract|tea extract
4686787|NCT03324191|Triglycerides|triglycerides
4686788|NCT03324191|Energy metabolism|energy metabolism
4686789|NCT03324178|Neurofeedback|neurofeedback
4686790|NCT03324178|Attention|attention
4686791|NCT03324165|Computed Tomography|computed tomography
4686792|NCT03324165|Algorithm|algorithm
4686793|NCT03324165|Alvarado Score|alvarado score
4686794|NCT03324152|High-intensity interval training|high-intensity interval training
4686795|NCT03324152|Exercise|exercise
4686796|NCT03324152|Muscle function|muscle function
4686797|NCT03324152|Inflammation|inflammation
4686798|NCT03324126|Preterm infants|preterm infants
4686799|NCT03324126|very low birth weight|very low birth weight
4686800|NCT03324126|breast milk|breast milk
4686801|NCT03324126|individualized fortification|individualized fortification
4686802|NCT03324126|targeted protein fortification|targeted protein fortification
4686803|NCT03324126|adjustable protein fortification|adjustable protein fortification
4686804|NCT03324126|growth|growth
4686805|NCT03324087|HRQoL|hrqol
4686806|NCT03324087|Immune Thrombocytopenia|immune thrombocytopenia
4686807|NCT03324048|Preoperative anxiety|preoperative anxiety
4686808|NCT03324048|Relaxation|relaxation
4686809|NCT03324048|Autonomous nervous system|autonomous nervous system
4686810|NCT03324048|Surgery|surgery
4686811|NCT03324048|Visual Analogue Scale (VAS)|visual analogue scale (vas)
4686812|NCT03324048|State-Trait Anxiety Inventory (STAI-Y)|state-trait anxiety inventory (stai-y)
4686813|NCT03324022|Fibroblast growth factors|fibroblast growth factors
4686814|NCT03324022|Fibroblast growth factors receptors|fibroblast growth factors receptors
4686815|NCT03324022|Thyroid orbitopathy|thyroid orbitopathy
4686816|NCT03323944|metastatic adenocarcinoma, pancreas|metastatic adenocarcinoma, pancreas
4686817|NCT03323931|autism spectrum disorder|autism spectrum disorder
4686818|NCT03323931|robot-enhanced intervention|robot-enhanced intervention
4686819|NCT03323931|imitation|imitation
4686820|NCT03323931|joint attention|joint attention
4686821|NCT03323931|turn-taking|turn-taking
4686822|NCT03323892|preimplantation development|preimplantation development
4686823|NCT03323892|DNA fragmentation|dna fragmentation
4686824|NCT03323892|abstinence duration|abstinence duration
4686825|NCT03323879|brachytherapy|brachytherapy
4686827|NCT03323879|HDR|hdr
4686828|NCT03323879|monotherapy|monotherapy
4686829|NCT03323879|focal|focal
4686830|NCT03323801|Infertility|infertility
4686831|NCT03323762|Pre-Eclampsia; Mild|pre-eclampsia; mild
4686832|NCT03323762|Pre-Eclampsia; Moderate|pre-eclampsia; moderate
4686833|NCT03323762|Gestational Hypertension|gestational hypertension
4686834|NCT03323762|Remote ischemic conditioning|remote ischemic conditioning
4686835|NCT03323749|Myopathy|myopathy
4686836|NCT03323749|PMD|pmd
4686837|NCT03323749|Primary Mitochondrial Disease|primary mitochondrial disease
4686838|NCT03323749|MTP-131|mtp-131
4686839|NCT03323749|elamipretide|elamipretide
4686840|NCT03323710|Metastatic|metastatic
4686841|NCT03323710|Renal Cell Carcinoma|renal cell carcinoma
4686842|NCT03323710|Kidney Cancer|kidney cancer
4686843|NCT03323710|Sunitinib|sunitinib
4686844|NCT03323710|Sutent|sutent
4686845|NCT03323710|Tyrosine Kinase Inhibitor|tyrosine kinase inhibitor
4686846|NCT03323710|Angiogenesis Inhibitor|angiogenesis inhibitor
4686847|NCT03323710|Propranolol|propranolol
4686848|NCT03323710|Beta-blocker|beta-blocker
4686849|NCT03323710|First-line|first-line
4686850|NCT03323697|Depression|depression
4686851|NCT03323697|Anxiety|anxiety
4686852|NCT03323697|Herbal Medicine|herbal medicine
4686853|NCT03323697|Chinese Medicine|chinese medicine
4686854|NCT03323697|Hamilton Scale|hamilton scale
4686855|NCT03323697|SSRI|ssri
4686856|NCT03323671|primary dysmenorrhea|primary dysmenorrhea
4686857|NCT03323671|preemptive analgesia|preemptive analgesia
4686858|NCT03323645|prostate cancer|prostate cancer
4686859|NCT03323645|erectile dysfunction|erectile dysfunction
4686860|NCT03323645|penile prosthesis|penile prosthesis
4686861|NCT03323632|Stroke|stroke
4686862|NCT03323632|Cerebrovascular accident|cerebrovascular accident
4686863|NCT03323632|Upper extremity|upper extremity
4686864|NCT03323632|Cerebral Infarction|cerebral infarction
4686865|NCT03323632|Brain Infarction|brain infarction
4686866|NCT03323632|Brain Ischemia|brain ischemia
4686867|NCT03323632|Cerebrovascular Disorders|cerebrovascular disorders
4686868|NCT03323632|Cardiovascular Diseases|cardiovascular diseases
4686869|NCT03323632|Nervous System Diseases|nervous system diseases
4686870|NCT03323632|Central Nervous System Diseases|central nervous system diseases
4686871|NCT03323619|Transcatheter aortic valve replacement|transcatheter aortic valve replacement
4686872|NCT03323619|Anesthesia technique|anesthesia technique
4686873|NCT03323619|Delirium|delirium
4686874|NCT03323567|TMD, collagen, intramuscular injection, trigger point|tmd, collagen, intramuscular injection, trigger point
4686875|NCT03323554|radical prostatectomy , Device,|radical prostatectomy , device,
4686876|NCT03323541|biosimilars|biosimilars
4686877|NCT03323541|filgrastim|filgrastim
4686878|NCT03323541|Stem cell transplantation|stem cell transplantation
4686879|NCT03323541|lymphoma|lymphoma
4686880|NCT03323541|multiple myeloma|multiple myeloma
4686881|NCT03323528|Dorithricin|dorithricin
4686882|NCT03323528|Tyrothricin|tyrothricin
4686883|NCT03323528|Benzalkonium chloride|benzalkonium chloride
4686884|NCT03323528|Benzocaine|benzocaine
4686885|NCT03323528|placebo-controlled|placebo-controlled
4686886|NCT03323528|Pharyngitis|pharyngitis
4686887|NCT03323528|sore throat|sore throat
4686888|NCT03323528|throat pain|throat pain
4686889|NCT03323528|difficulty swallowing|difficulty swallowing
4686890|NCT03323528|complete responder|complete responder
4686891|NCT03323528|lozenge|lozenge
4686892|NCT03323528|Non-streptococcal Infections|non-streptococcal infections
4686893|NCT03323502|Nursing Homes|nursing homes
4686894|NCT03323502|Skilled Nursing Facilities|skilled nursing facilities
4686895|NCT03323502|Advance Care Planning|advance care planning
4686896|NCT03323502|Advance Directives|advance directives
4686897|NCT03323502|Alzheimer Disease|alzheimer disease
4686898|NCT03323502|Dementia|dementia
4686899|NCT03323502|Do Not Resuscitate Orders|do not resuscitate orders
4686900|NCT03323502|Physician Orders for Life-Sustaining Treatment|physician orders for life-sustaining treatment
4686901|NCT03323502|Artificial Nutrition|artificial nutrition
4686902|NCT03323502|Hospitalization|hospitalization
4686903|NCT03323502|Intubation|intubation
4686904|NCT03323502|Pragmatic Clinical Trials|pragmatic clinical trials
4686905|NCT03323502|Randomized Controlled Trials|randomized controlled trials
4686906|NCT03323502|Patient Preferences|patient preferences
4686907|NCT03323502|Resuscitation Orders|resuscitation orders
4686908|NCT03323489|celiac|celiac
4686909|NCT03323489|radiosurgery|radiosurgery
4686910|NCT03323489|sbrt|sbrt
4686911|NCT03323489|radiotherapy|radiotherapy
4686912|NCT03323489|pain|pain
4686913|NCT03323463|squamous cell carcinoma of the neck of unknown primary|squamous cell carcinoma of the neck of unknown primary
4686914|NCT03323463|HPV-Associated Oropharyngeal Squamous Cell Carcinoma|hpv-associated oropharyngeal squamous cell carcinoma
4686915|NCT03323463|Oropharyngeal Squamous Cell Carcinoma|oropharyngeal squamous cell carcinoma
4686916|NCT03323463|17-409|17-409
4686917|NCT03323463|Hypoxia negative|hypoxia negative
4686918|NCT03323463|T1-2n1-2b oropharyngeal squamous cell carcinoma|t1-2n1-2b oropharyngeal squamous cell carcinoma
4686919|NCT03323450|High grade gliomas (WHO grade III or IV)|high grade gliomas (who grade iii or iv)
4686920|NCT03323450|Low grade gliomas (WHO Grade II)|low grade gliomas (who grade ii)
4686921|NCT03323424|Metastatic cancer|metastatic cancer
4686922|NCT03323424|Abscopal effect|abscopal effect
4686923|NCT03323424|Ionizing radiation|ionizing radiation
4686924|NCT03323424|Antibody-Dependant Cell Cytotoxicity (ADCC)|antibody-dependant cell cytotoxicity (adcc)
4686925|NCT03323424|Immuno-Radiation effect|immuno-radiation effect
4686926|NCT03323424|Stereotactic Body Radio-Therapy (SBRT)|stereotactic body radio-therapy (sbrt)
4686927|NCT03323424|Targeted therapies|targeted therapies
4686928|NCT03323398|mRNA-2416|mrna-2416
4686929|NCT03323398|OX40 ligand|ox40 ligand
4686930|NCT03323398|OX40L|ox40l
4686931|NCT03323385|Colorectal surgery|colorectal surgery
4686932|NCT03323385|Pain|pain
4686933|NCT03323385|Analgesia|analgesia
4686934|NCT03323385|N1539|n1539
4686935|NCT03323385|Phase 3b|phase 3b
4686936|NCT03323359|Hemopatch|hemopatch
4686937|NCT03323359|Hepatic resection|hepatic resection
4686938|NCT03323359|Hemostasis|hemostasis
4686939|NCT03323359|Surgery|surgery
4686940|NCT03323346|metastatic breast cancer|metastatic breast cancer
4686941|NCT03323346|disulfiram|disulfiram
4686942|NCT03323346|cooper|cooper
4686943|NCT03323294|Obesity|obesity
4686944|NCT03323294|Pediatric Health|pediatric health
4686945|NCT03323294|Type 2 Diabetes|type 2 diabetes
4686946|NCT03323294|Insulin Resistance|insulin resistance
4686947|NCT03323294|Metformin Therapy|metformin therapy
4686948|NCT03323281|Diabetic foot|diabetic foot
4686949|NCT03323281|Cognitive functions|cognitive functions
4686950|NCT03323281|Psychiatric disorders|psychiatric disorders
4686951|NCT03323281|Neurology|neurology
4686952|NCT03323281|Psychiatry|psychiatry
4686953|NCT03323268|Intensive care|intensive care
4686954|NCT03323268|Cardiogenic shock|cardiogenic shock
4686955|NCT03323268|Peripheral veno-arterial extracorporeal membrane oxygenation|peripheral veno-arterial extracorporeal membrane oxygenation
4686956|NCT03323268|Left ventricular overload|left ventricular overload
4686957|NCT03323268|Native cardiac output|native cardiac output
4686958|NCT03323268|Pulmonary artery blood flow|pulmonary artery blood flow
4686959|NCT03323268|End-tidal carbon dioxide|end-tidal carbon dioxide
4686960|NCT03323268|Swan Ganz catheter|swan ganz catheter
4686961|NCT03323268|Blood gaz|blood gaz
4686962|NCT03323242|Vessel Sealing Devices|vessel sealing devices
4686963|NCT03323242|Liver Transplantation|liver transplantation
4686964|NCT03323229|Ultrasonography|ultrasonography
4686965|NCT03323229|Ambulances|ambulances
4686966|NCT03323229|Satellite Communications|satellite communications
4686967|NCT03323229|Telemedicine|telemedicine
4686968|NCT03323151|Relapsed Mantle-Cell Lymphoma|relapsed mantle-cell lymphoma
4686969|NCT03323151|Refractory Mantle-Cell Lymphoma|refractory mantle-cell lymphoma
4686970|NCT03323151|Ixazomib|ixazomib
4686971|NCT03323151|Ibrutinib|ibrutinib
4686972|NCT03323151|Proteasome Inhibitor|proteasome inhibitor
4686973|NCT03323151|Bruton's Tyrosine Kinase Inhibitor|bruton's tyrosine kinase inhibitor
4686974|NCT03323138|Ex-PRESS|ex-press
4686975|NCT03323138|glaucoma|glaucoma
4686976|NCT03323138|filtration surgery|filtration surgery
4686977|NCT03323138|phacoemulsification|phacoemulsification
4686978|NCT03323112|influenza|influenza
4686979|NCT03323112|vaccination|vaccination
4686980|NCT03323112|health care workers|health care workers
4686981|NCT03323112|immune responses|immune responses
4686982|NCT03323112|humoral immunity|humoral immunity
4686983|NCT03323112|cellular immunity|cellular immunity
4686984|NCT03323073|unipolar|unipolar
4686985|NCT03323073|bipolar|bipolar
4686986|NCT03323073|depression|depression
4686987|NCT03323073|resting state fMRI|resting state fmri
4686988|NCT03323073|neural network|neural network
4686989|NCT03323073|connectivity|connectivity
4686990|NCT03323047|tonsillectomy|tonsillectomy
4686991|NCT03323047|acetaminophen|acetaminophen
4686992|NCT03323047|dexamethasone|dexamethasone
4686993|NCT03323008|Prisoners|prisoners
4686994|NCT03323008|End-of-life Care|end-of-life care
4686995|NCT03323008|Geriatric Care|geriatric care
4686996|NCT03323008|Palliative Care|palliative care
4686997|NCT03323008|Hospice Care|hospice care
4686998|NCT03323008|Prison|prison
4686999|NCT03323008|Corrections|corrections
4687000|NCT03323008|Inmates|inmates
4687001|NCT03322995|Neoadjuvant Therapy|neoadjuvant therapy
4687002|NCT03322982|diet, low-fat|diet, low-fat
4687003|NCT03322956|Low back/lumbar spine|low back/lumbar spine
4687004|NCT03322956|Multimodal Physical therapy|multimodal physical therapy
4687005|NCT03322956|Quality of life|quality of life
4687006|NCT03322956|Range of Motion|range of motion
4687007|NCT03322956|Pain|pain
4687008|NCT03322943|Ursodeoxycholic Acid|ursodeoxycholic acid
4687009|NCT03322943|Response|response
4687010|NCT03322930|microperimetry|microperimetry
4687011|NCT03322930|rod visual fields|rod visual fields
4687012|NCT03322917|dry eye|dry eye
4687013|NCT03322917|PRP|prp
4687014|NCT03322917|autologous|autologous
4687015|NCT03322917|after LASIK|after lasik
4687016|NCT03322917|ocular surface|ocular surface
4687017|NCT03322904|iris collarette; autonomous nervous system|iris collarette; autonomous nervous system
4687018|NCT03322891|Urology|urology
4687019|NCT03322878|postoperative pain , pediatrics , magnesium sulfate|postoperative pain , pediatrics , magnesium sulfate
4687020|NCT03322839|Guideline-adherence|guideline-adherence
4687021|NCT03322839|Implementation|implementation
4687022|NCT03322839|Implementation-strategies|implementation-strategies
4687023|NCT03322839|Randomized-controlled-trial|randomized-controlled-trial
4687024|NCT03322839|Organisational risk-factors|organisational risk-factors
4687025|NCT03322839|Schools|schools
4687026|NCT03322839|Social risk-factors|social risk-factors
4687027|NCT03322813|Glioblastoma|glioblastoma
4687028|NCT03322813|Blood Brain Barrier|blood brain barrier
4687029|NCT03322813|BBB|bbb
4687030|NCT03322813|ExAblate|exablate
4687031|NCT03322813|Blood Brain Barrier Disruption|blood brain barrier disruption
4687032|NCT03322774|Stepped Care|stepped care
4687033|NCT03322761|Multiple sclerosis|multiple sclerosis
4687034|NCT03322761|Exercise|exercise
4687035|NCT03322761|Disease-modifying treatment|disease-modifying treatment
4687036|NCT03322761|Early treatment|early treatment
4687037|NCT03322683|Neck Pain|neck pain
4687038|NCT03322683|Physical Therapy Modalities|physical therapy modalities
4687039|NCT03322683|Massage|massage
4687040|NCT03322683|Manual Therapy|manual therapy
4687041|NCT03322670|community-acquired pneumonia|community-acquired pneumonia
4687042|NCT03322670|family practice|family practice
4687043|NCT03322670|streptococcus pneumoniae|streptococcus pneumoniae
4687044|NCT03322657|Sugammadex|sugammadex
4687045|NCT03322657|Neostigmine|neostigmine
4687046|NCT03322657|Reversal of neuromuscular block|reversal of neuromuscular block
4687047|NCT03322644|Pancreatitis|pancreatitis
4687048|NCT03322644|Pain|pain
4687049|NCT03322644|Internet Intervention|internet intervention
4687050|NCT03322644|Behavioral Intervention|behavioral intervention
4687051|NCT03322566|Non-small cell lung cancer|non-small cell lung cancer
4687052|NCT03322566|programmed cell death 1 (PD-1) inhibitor|programmed cell death 1 (pd-1) inhibitor
4687053|NCT03322566|indoleamine 2|indoleamine 2
4687054|NCT03322566|3-dioxygenase 1 (IDO1) inhibitor|3-dioxygenase 1 (ido1) inhibitor
4687055|NCT03322566|chemotherapy|chemotherapy
4687056|NCT03322540|non-small cell lung cancer|non-small cell lung cancer
4687057|NCT03322540|programmed cell death 1 (PD-1) inhibitor|programmed cell death 1 (pd-1) inhibitor
4687058|NCT03322540|indoleamine 2|indoleamine 2
4687059|NCT03322540|3-dioxygenase 1 (IDO1) inhibitor|3-dioxygenase 1 (ido1) inhibitor
4687060|NCT03322514|gut hormones, obesity, appetite, propionate,fermentation|gut hormones, obesity, appetite, propionate,fermentation
4687061|NCT03322449|APOA2|apoa2
4687062|NCT03322449|Inflammation|inflammation
4687063|NCT03322449|gene|gene
4687064|NCT03322449|diet|diet
4687065|NCT03322410|Fluid overload|fluid overload
4687066|NCT03322410|Hydratation statud|hydratation statud
4687067|NCT03322410|Peritoneal hypepermeability|peritoneal hypepermeability
4687068|NCT03322410|Peritoneal dialysis|peritoneal dialysis
4687069|NCT03322410|Impedancemetry|impedancemetry
4687070|NCT03322397|adolescence|adolescence
4687071|NCT03322397|immune function|immune function
4687072|NCT03322397|gene expression|gene expression
4687073|NCT03322397|psychological well-being|psychological well-being
4687074|NCT03322397|social connection|social connection
4687075|NCT03322397|kindness|kindness
4687076|NCT03322345|lymph flow|lymph flow
4687077|NCT03322345|Fontan|fontan
4687078|NCT03322332|adiponectin|adiponectin
4687079|NCT03322332|omentin-1|omentin-1
4687080|NCT03322332|resistin|resistin
4687081|NCT03322332|RBP4|rbp4
4687082|NCT03322332|epicardial fat|epicardial fat
4687083|NCT03322332|Coronary artery disease|coronary artery disease
4687084|NCT03322319|Cardiac amyloidosis|cardiac amyloidosis
4687085|NCT03322319|Caribbean|caribbean
4687086|NCT03322319|Diagnosis|diagnosis
4687087|NCT03322319|Transthyretin|transthyretin
4687088|NCT03322306|genetic screening|genetic screening
4687089|NCT03322306|neuro-degenerative disease|neuro-degenerative disease
4687090|NCT03322293|Actinic Keratoses|actinic keratoses
4687091|NCT03322293|photodynamic therapy|photodynamic therapy
4687092|NCT03322293|aminolevulinic acid|aminolevulinic acid
4687093|NCT03322293|precancerous skin lesion|precancerous skin lesion
4687094|NCT03322280|Hepatocellular carcinoma|hepatocellular carcinoma
4687095|NCT03322280|Portal vein tumor thrombus|portal vein tumor thrombus
4687096|NCT03322280|Transcatheter arterial chemoembolization|transcatheter arterial chemoembolization
4687097|NCT03322280|iodine-125 seed|iodine-125 seed
4687098|NCT03322267|Adjuvant pembrolizumab|adjuvant pembrolizumab
4687099|NCT03322267|Chemoradiotherapy|chemoradiotherapy
4687100|NCT03322228|Hospice|hospice
4687101|NCT03322228|Palliative Care|palliative care
4687102|NCT03322228|Integrative Medicine|integrative medicine
4687103|NCT03322228|Music Therapy|music therapy
4687104|NCT03322228|Inpatient|inpatient
4687105|NCT03322228|Caregiver|caregiver
4687106|NCT03322215|palbociclib|palbociclib
4687107|NCT03322215|fulvestrant|fulvestrant
4687108|NCT03322215|capecitabine|capecitabine
4687109|NCT03322202|Spinal Cord Injury|spinal cord injury
4687110|NCT03322202|Motivational Interviewing|motivational interviewing
4687111|NCT03322150|Atropine|atropine
4687112|NCT03322150|glycopyrrolate|glycopyrrolate
4687113|NCT03322150|bradycardia|bradycardia
4687114|NCT03322150|dexmedetomidine|dexmedetomidine
4687115|NCT03322150|spinal anesthesia|spinal anesthesia
4687116|NCT03322098|Atropine|atropine
4687117|NCT03322098|glycopyrrolate|glycopyrrolate
4687118|NCT03322098|bradycardia|bradycardia
4687119|NCT03322098|dexmedetomidine|dexmedetomidine
4687120|NCT03322098|spinal anesthesia|spinal anesthesia
4687121|NCT03322085|atrial fibrillation|atrial fibrillation
4687122|NCT03322085|atrial electrical remodeling|atrial electrical remodeling
4687123|NCT03322046|Therapeutic Lifestyle Change|therapeutic lifestyle change
4687124|NCT03322046|Cardiovascular Disease|cardiovascular disease
4687125|NCT03322046|First Responders|first responders
4687126|NCT03322046|Firefighters|firefighters
4687127|NCT03322046|CVD|cvd
4687128|NCT03322007|pain|pain
4687129|NCT03322007|pancreas cancer|pancreas cancer
4687130|NCT03322007|Scrambler Therapy|scrambler therapy
4687131|NCT03321981|Bispecific Antibody IgG1, HER2 HER3|bispecific antibody igg1, her2 her3
4687132|NCT03321981|MCLA-128|mcla-128
4687133|NCT03321981|Antibodies, bispecific|antibodies, bispecific
4687134|NCT03321981|Immunologic Factors|immunologic factors
4687135|NCT03321981|Cytokines|cytokines
4687136|NCT03321981|combination Trastuzumab with and without Vinorelbine|combination trastuzumab with and without vinorelbine
4687137|NCT03321968|Influenza|influenza
4687138|NCT03321968|Human|human
4687139|NCT03321968|RNA Virus Infections|rna virus infections
4687140|NCT03321968|Lot Consistency|lot consistency
4687141|NCT03321968|Immunologic|immunologic
4687142|NCT03321968|Orthomyxoviridae Infections|orthomyxoviridae infections
4687143|NCT03321968|Infection|infection
4687144|NCT03321968|Virus Diseases|virus diseases
4687145|NCT03321942|Adipose Tissue-derived Mesenchymal Stem Cells|adipose tissue-derived mesenchymal stem cells
4687146|NCT03321942|Chronic Kidney Diseases|chronic kidney diseases
4687147|NCT03321916|MacTel|mactel
4687148|NCT03321903|Oxygen|oxygen
4687149|NCT03321903|Oximetry|oximetry
4687150|NCT03321903|Electron Spin Resonance Spectroscopy|electron spin resonance spectroscopy
4687151|NCT03321903|Carbon|carbon
4687152|NCT03321903|Charcoal|charcoal
4687153|NCT03321903|Radiotherapy|radiotherapy
4687154|NCT03321903|India Ink|india ink
4687155|NCT03321903|EPR|epr
4687156|NCT03321903|ESR|esr
4687157|NCT03321903|Immunotherapy|immunotherapy
4687158|NCT03321890|relapsed or refractory|relapsed or refractory
4687159|NCT03321890|peripheral T-cell lymphoma|peripheral t-cell lymphoma
4687160|NCT03321890|Combination therapy|combination therapy
4687161|NCT03321864|Transperineal biopsy|transperineal biopsy
4687162|NCT03321864|Prostate cancer|prostate cancer
4687163|NCT03321864|Transrectal ultrasound|transrectal ultrasound
4687164|NCT03321864|Fusion biopsy techniques|fusion biopsy techniques
4687165|NCT03321812|decalcification bone scaffold|decalcification bone scaffold
4687166|NCT03321812|microfracture|microfracture
4687167|NCT03321812|randomized controlled trial|randomized controlled trial
4687168|NCT03321812|cartilage lesions of the knee|cartilage lesions of the knee
4687169|NCT03321773|Helicobacter pylori|helicobacter pylori
4687170|NCT03321773|Eradication rate|eradication rate
4687171|NCT03321734|Caffeine|caffeine
4687172|NCT03321734|Prematurity|prematurity
4687173|NCT03321721|hand|hand
4687174|NCT03321721|feet lacerations|feet lacerations
4687175|NCT03321721|children|children
4687176|NCT03321721|conservative management|conservative management
4687177|NCT03321682|Cardiopulmonary Capacity|cardiopulmonary capacity
4687178|NCT03321682|Quality of Life|quality of life
4687179|NCT03321682|Functional Capacity|functional capacity
4687180|NCT03321682|Functional Training|functional training
4687181|NCT03321630|Pebrolizumab|pebrolizumab
4687182|NCT03321630|Lenvatinib|lenvatinib
4687183|NCT03321604|hemodialysis|hemodialysis
4687184|NCT03321604|kidney|kidney
4687185|NCT03321604|dialysis|dialysis
4687186|NCT03321578|nosocomial|nosocomial
4687187|NCT03321578|hospital acquired|hospital acquired
4687188|NCT03321578|clostridium difficile|clostridium difficile
4687189|NCT03321565|obesity|obesity
4687190|NCT03321552|Desert foot|desert foot
4687191|NCT03321552|No-option patients|no-option patients
4687192|NCT03321552|Venous arterialization|venous arterialization
4687193|NCT03321539|Nasopharyngeal carcinoma;adjuvant chemotherapy|nasopharyngeal carcinoma;adjuvant chemotherapy
4687194|NCT03321513|Diabetic Macular Edema|diabetic macular edema
4687195|NCT03321513|anti-vascular endothelial growth factor|anti-vascular endothelial growth factor
4687196|NCT03321487|Blood-Brain Barrier disruption|blood-brain barrier disruption
4687197|NCT03321487|Blood-Brain Barrier opening|blood-brain barrier opening
4687198|NCT03321487|magnetic resonance-guided focused ultrasound|magnetic resonance-guided focused ultrasound
4687199|NCT03321409|Somatic symptom|somatic symptom
4687200|NCT03321409|SSS-Ch|sss-ch
4687201|NCT03321409|PHQ-15|phq-15
4687202|NCT03321409|Suspected CAD|suspected cad
4687203|NCT03321409|Coronary angiography|coronary angiography
4687204|NCT03321396|Sodium Alginate|sodium alginate
4687205|NCT03321396|Calcium Lactate|calcium lactate
4687206|NCT03321396|Gel|gel
4687207|NCT03321383|dyspepsia|dyspepsia
4687208|NCT03321383|health related quality of life|health related quality of life
4687209|NCT03321331|Mobile Health|mobile health
4687210|NCT03321331|mobile apps|mobile apps
4687211|NCT03321331|weight control|weight control
4687212|NCT03321331|weight management|weight management
4687213|NCT03321331|self-directed intervention|self-directed intervention
4687214|NCT03321331|behavioral intervention|behavioral intervention
4687215|NCT03321266|Fistula plug|fistula plug
4687216|NCT03321253|Posterior Capsule Opacification|posterior capsule opacification
4687217|NCT03321253|Macular Pigment Optical Density|macular pigment optical density
4687218|NCT03321253|Anterior Chamber Parameters|anterior chamber parameters
4687219|NCT03321253|Nd: YAG Laser Posterior Capsulotomy|nd: yag laser posterior capsulotomy
4687220|NCT03321253|Posterior Capsulotomy|posterior capsulotomy
4687221|NCT03321253|Cystoid Macular Edema|cystoid macular edema
4687222|NCT03321253|Choroidal Thickness|choroidal thickness
4687223|NCT03321240|focal cortical dysplasia|focal cortical dysplasia
4687224|NCT03321240|Pronostic|pronostic
4687225|NCT03321240|Epilepsy surgery|epilepsy surgery
4687226|NCT03321240|Epiletogenicity index|epiletogenicity index
4687227|NCT03321240|SEEG|seeg
4687228|NCT03321227|Children|children
4687229|NCT03321227|Nutrition|nutrition
4687230|NCT03321227|Eggs|eggs
4687231|NCT03321227|Cognitive performance|cognitive performance
4687232|NCT03321227|Glycemic response|glycemic response
4687233|NCT03321227|Appetite|appetite
4687234|NCT03321227|Emotion|emotion
4687235|NCT03321214|Gluten Free diet|gluten free diet
4687236|NCT03321188|Heated intraperitoneal chemotherapy|heated intraperitoneal chemotherapy
4687237|NCT03321188|HIPEC|hipec
4687238|NCT03321188|cisplatin|cisplatin
4687239|NCT03321188|paclitaxel|paclitaxel
4687240|NCT03321188|carboplatin|carboplatin
4687241|NCT03321188|adjuvant IV chemotherapy|adjuvant iv chemotherapy
4687242|NCT03321175|Wound|wound
4687244|NCT03321175|cesarean section|cesarean section
4687245|NCT03321162|surgical guide , double scan , triple scan protocol|surgical guide , double scan , triple scan protocol
4687246|NCT03321149|Web-based intervention|web-based intervention
4687247|NCT03321149|Sedentary behavior|sedentary behavior
4687248|NCT03321149|Lifestyle intervention|lifestyle intervention
4687249|NCT03321149|Feasibility|feasibility
4687250|NCT03321123|B cell Acute Lymphoblastic Leukemia|b cell acute lymphoblastic leukemia
4687251|NCT03321123|relapsed or refractory|relapsed or refractory
4687252|NCT03321123|CD-19 Positive|cd-19 positive
4687253|NCT03321097|stroke rehabilitation|stroke rehabilitation
4687254|NCT03321097|spasticity|spasticity
4687255|NCT03321097|Botulinum toxin type A injection|botulinum toxin type a injection
4687256|NCT03321097|robot-assisted therapy|robot-assisted therapy
4687257|NCT03321097|massed therapy|massed therapy
4687258|NCT03321097|distributed therapy|distributed therapy
4687259|NCT03321084|Osteoarthrosis|osteoarthrosis
4687260|NCT03321084|Exercise Movement Techniques|exercise movement techniques
4687261|NCT03321084|Pilates|pilates
4687262|NCT03321084|Elderly|elderly
4687263|NCT03321084|Physiotherapy|physiotherapy
4687264|NCT03321058|Drug Substitution|drug substitution
4687265|NCT03321058|Multicompartment Compliance Aid|multicompartment compliance aid
4687266|NCT03321045|89Zr-Trastuzumab, HER2 Imaging|89zr-trastuzumab, her2 imaging
4687267|NCT03321032|Coronary Artery Disease|coronary artery disease
4687268|NCT03321032|Diabetes Mellitus|diabetes mellitus
4687269|NCT03321032|Drug-eluting stents|drug-eluting stents
4687270|NCT03321032|Restenosis|restenosis
4687271|NCT03320993|post-prandial glucose control|post-prandial glucose control
4687272|NCT03320993|alcohol|alcohol
4687273|NCT03320980|ALPPS|alpps
4687274|NCT03320980|RALPPS|ralpps
4687275|NCT03320980|Portal Vein Embolization|portal vein embolization
4687276|NCT03320980|Hilar Cholangiocarcinoma|hilar cholangiocarcinoma
4687277|NCT03320980|Intrahepatic Cholangiocarcinoma|intrahepatic cholangiocarcinoma
4687278|NCT03320954|Language|language
4687279|NCT03320954|Anomia|anomia
4687280|NCT03320941|Obesity disease|obesity disease
4687281|NCT03320941|Over weight|over weight
4687282|NCT03320941|T2DM|t2dm
4687283|NCT03320941|interventional study|interventional study
4687284|NCT03320941|Weight loss|weight loss
4687285|NCT03320902|Family members|family members
4687286|NCT03320902|sudden death|sudden death
4687287|NCT03320902|sudden death counseling|sudden death counseling
4687288|NCT03320902|depression|depression
4687289|NCT03320837|metabolomics|metabolomics
4687290|NCT03320837|microbiome|microbiome
4687291|NCT03320837|infant formula|infant formula
4687292|NCT03320837|synbiotics|synbiotics
4687293|NCT03320837|urine samples|urine samples
4687294|NCT03320837|NMR analysis|nmr analysis
4687295|NCT03320811|Celiac disease|celiac disease
4687296|NCT03320811|serological tests|serological tests
4687297|NCT03320811|anti-deamidated gliadin peptide antibodies|anti-deamidated gliadin peptide antibodies
4687298|NCT03320798|Bullous pemphigoid|bullous pemphigoid
4687299|NCT03320798|neurologic disorders|neurologic disorders
4687300|NCT03320785|preterm infants|preterm infants
4687301|NCT03320785|sepsis|sepsis
4687302|NCT03320785|chorioamnionitis|chorioamnionitis
4687303|NCT03320785|circulating markers|circulating markers
4687304|NCT03320746|Physical activity|physical activity
4687305|NCT03320746|Sedentary time|sedentary time
4687306|NCT03320746|Intervention|intervention
4687307|NCT03320746|Retiree|retiree
4687308|NCT03320733|dual energy CT|dual energy ct
4687309|NCT03320694|Gestational Diabetes Mellitus, Metformin, Insulin|gestational diabetes mellitus, metformin, insulin
4687310|NCT03320681|Neurostimulator|neurostimulator
4687311|NCT03320668|Falls Prevention|falls prevention
4687312|NCT03320668|Otago Program|otago program
4687313|NCT03320668|Community-Dwelling|community-dwelling
4687314|NCT03320655|Chronic Heart Failure|chronic heart failure
4687315|NCT03320655|Fragility|fragility
4687316|NCT03320642|Acute leukemia|acute leukemia
4687317|NCT03320642|chronic myelogenous leukemia|chronic myelogenous leukemia
4687318|NCT03320642|myelodysplasia|myelodysplasia
4687319|NCT03320642|chronic lymphocytic leukemia/small lymphocytic lymphoma|chronic lymphocytic leukemia/small lymphocytic lymphoma
4687320|NCT03320642|follicular|follicular
4687321|NCT03320642|marginal zone|marginal zone
4687322|NCT03320642|diffuse large B-cell|diffuse large b-cell
4687323|NCT03320642|Hodgkin's lymphoma|hodgkin's lymphoma
4687324|NCT03320642|mantle cell lymphoma|mantle cell lymphoma
4687325|NCT03320642|Janus kinase inhibitor|janus kinase inhibitor
4687326|NCT03320642|graft-versus-host disease|graft-versus-host disease
4687327|NCT03320590|Time lapse Primovision|time lapse primovision
4687328|NCT03320590|Spermatic nuclear quality|spermatic nuclear quality
4687329|NCT03320590|intracytoplasmic sperm injection (ICSI)|intracytoplasmic sperm injection (icsi)
4687330|NCT03320590|Embryonic kinetics|embryonic kinetics
4687331|NCT03320564|injections, intravenous|injections, intravenous
4687332|NCT03320564|fluorodeoxyglucose F-18|fluorodeoxyglucose f-18
4687333|NCT03320551|Education|education
4687334|NCT03320538|Jiangzhong Hou Gu® Mi Xi™|jiangzhong hou gu® mi xi™
4687335|NCT03320538|Shen Ling Bai Zhu San|shen ling bai zhu san
4687336|NCT03320538|peptic ulcer disease|peptic ulcer disease
4687337|NCT03320538|traditional Chinese medicine|traditional chinese medicine
4688410|NCT03314038|Syndrome|syndrome
4687338|NCT03320538|randomized controlled trial|randomized controlled trial
4687339|NCT03320525|YKL-40|ykl-40
4687340|NCT03320525|Pharmacokinetic|pharmacokinetic
4687341|NCT03320525|Solid tumors|solid tumors
4687342|NCT03320525|T-ChOS|t-chos
4687343|NCT03320525|Benecta|benecta
4687344|NCT03320525|chitinase 3 like-1 protein (CHI3L1)|chitinase 3 like-1 protein (chi3l1)
4687345|NCT03320512|PrEP|prep
4687346|NCT03320512|gamification|gamification
4687347|NCT03320512|mHealth|mhealth
4687348|NCT03320512|HIV prevention|hiv prevention
4687349|NCT03320512|truvada|truvada
4687350|NCT03320512|eHealth|ehealth
4687351|NCT03320512|app|app
4687352|NCT03320512|adherence|adherence
4687353|NCT03320512|ymsm|ymsm
4687354|NCT03320512|transgender women|transgender women
4687355|NCT03320486|Mycoses|mycoses
4687356|NCT03320486|Dermatomycoses|dermatomycoses
4687357|NCT03320486|Antifugal Agents|antifugal agents
4687358|NCT03320486|Dapaconazole|dapaconazole
4687359|NCT03320460|oral lichen planus; photobiomodulation; inflammation|oral lichen planus; photobiomodulation; inflammation
4687360|NCT03320447|ablative fractional laser|ablative fractional laser
4687361|NCT03320447|photodynamic therapy|photodynamic therapy
4687362|NCT03320447|protoporphyrin IX|protoporphyrin ix
4687363|NCT03320447|methy-aminolevulinate|methy-aminolevulinate
4687364|NCT03320421|hypofractionated radiation|hypofractionated radiation
4687365|NCT03320421|breast cancer|breast cancer
4687366|NCT03320421|breast conserving surgery|breast conserving surgery
4687367|NCT03320421|simultaneous boost radiation|simultaneous boost radiation
4687368|NCT03320408|biobank|biobank
4687369|NCT03320408|pathogenesis|pathogenesis
4687370|NCT03320408|Aortic Aneurysm|aortic aneurysm
4687371|NCT03320304|Difficult to Treat Depression|difficult to treat depression
4687372|NCT03320304|TRD|trd
4687373|NCT03320304|VNS Therapy|vns therapy
4687374|NCT03320304|Vagus Nerve Stimulation|vagus nerve stimulation
4687375|NCT03320304|VNS|vns
4687376|NCT03320291|Rhizarthrosis|rhizarthrosis
4687377|NCT03320291|Regjoint|regjoint
4687378|NCT03320291|Trapeziectomy|trapeziectomy
4687379|NCT03320278|endotracheal intubation|endotracheal intubation
4687380|NCT03320278|airway management|airway management
4687381|NCT03320265|Phosphorylcholine human monoclonal antibody|phosphorylcholine human monoclonal antibody
4687382|NCT03320265|Lipoprotein a|lipoprotein a
4687383|NCT03320252|CHEVAR|chevar
4687384|NCT03320252|Chimney|chimney
4687385|NCT03320252|Juxtarenal|juxtarenal
4687386|NCT03320252|Short Infrarenal /neck|short infrarenal /neck
4687387|NCT03320252|Endurant|endurant
4687388|NCT03320239|HIV|hiv
4687389|NCT03320239|risk assessment|risk assessment
4687390|NCT03320239|HIV testing|hiv testing
4687391|NCT03320239|unprotected anal intercourse|unprotected anal intercourse
4687392|NCT03320239|Social medica|social medica
4687393|NCT03320213|CA125|ca125
4687394|NCT03320213|Yolk sac morphology|yolk sac morphology
4687395|NCT03320213|Threatened miscarriage|threatened miscarriage
4687396|NCT03320174|tafenoquine|tafenoquine
4687397|NCT03320174|australia|australia
4687398|NCT03320161|Supportive care|supportive care
4687399|NCT03320161|Cancer|cancer
4687400|NCT03320161|Health-related quality of life|health-related quality of life
4687401|NCT03320161|Consensus|consensus
4687402|NCT03320161|Participative approach|participative approach
4687403|NCT03320161|Patient involvement|patient involvement
4687404|NCT03320161|DELPHI method|delphi method
4687405|NCT03320135|enamel matrix derivative|enamel matrix derivative
4687406|NCT03320135|proximal furcation|proximal furcation
4687407|NCT03320135|randomized clinical trial|randomized clinical trial
4687408|NCT03320122|Telemedicine|telemedicine
4687409|NCT03320083|sleep, infants, behavioural insomnia, breastfeeding|sleep, infants, behavioural insomnia, breastfeeding
4687410|NCT03320057|medication abortion|medication abortion
4687411|NCT03320057|mifepristone|mifepristone
4687412|NCT03320044|Circulating Tumor DNA|circulating tumor dna
4687413|NCT03320044|Lung cancer Surgery|lung cancer surgery
4687414|NCT03320044|early diagnosis|early diagnosis
4687415|NCT03320044|immuno-sequencing|immuno-sequencing
4687416|NCT03320031|Linagliptin|linagliptin
4687417|NCT03320031|premixedinsulin therapy|premixedinsulin therapy
4687418|NCT03320031|peritoneal dialysis|peritoneal dialysis
4687419|NCT03320031|glycemic variability|glycemic variability
4687420|NCT03320018|neuroprotection|neuroprotection
4687421|NCT03320018|antioxidant|antioxidant
4687422|NCT03320005|respiratory performance|respiratory performance
4687423|NCT03320005|quality of life|quality of life
4687424|NCT03320005|physical performance|physical performance
4687425|NCT03319992|Robotics [H01.671.293.643]|robotics [h01.671.293.643]
4687426|NCT03319992|Exoskeleton Device [E07.341]|exoskeleton device [e07.341]
4687427|NCT03319992|Rehabilitation Research [H01.770.644.145.472]|rehabilitation research [h01.770.644.145.472]
4687428|NCT03319992|Physical and Rehabilitation Medicine [H02.403.680]|physical and rehabilitation medicine [h02.403.680]
4687429|NCT03319992|Exercise Therapy [E02.779.483]|exercise therapy [e02.779.483]
4687430|NCT03319992|Patient Outcome Assessment [N05.715.360.575.575.399]|patient outcome assessment [n05.715.360.575.575.399]
4687431|NCT03319979|Folate, DHFR|folate, dhfr
4687432|NCT03319953|Drug therapy|drug therapy
4687433|NCT03319940|Half Life Extended (HLE) Bispecific T cell engager (BiTE®)|half life extended (hle) bispecific t cell engager (bite®)
4688607|NCT03312452|Pediatric|pediatric
4687434|NCT03319940|Delta-like protein 3 (DLL3)|delta-like protein 3 (dll3)
4687435|NCT03319927|integrated pest management|integrated pest management
4687436|NCT03319927|environmental health|environmental health
4687437|NCT03319927|child care|child care
4687438|NCT03319927|preschool children|preschool children
4687439|NCT03319927|pesticides|pesticides
4687440|NCT03319914|calciphylaxis, calcific uremic arteriolopathy,|calciphylaxis, calcific uremic arteriolopathy,
4687441|NCT03319914|calcium metabolism disorders|calcium metabolism disorders
4687442|NCT03319914|metabolic diseases|metabolic diseases
4687443|NCT03319914|sodium thiosulfate|sodium thiosulfate
4687444|NCT03319901|Leukemia|leukemia
4687445|NCT03319888|CPAP, Chronic kidney disease, sleep apnea|cpap, chronic kidney disease, sleep apnea
4687446|NCT03319875|Epiduroscopy|epiduroscopy
4687447|NCT03319875|Discectomy|discectomy
4687448|NCT03319875|Holmium Yag laser|holmium yag laser
4687449|NCT03319875|Lumbar disc herniation|lumbar disc herniation
4687450|NCT03319875|Minimally invasive treatment|minimally invasive treatment
4687451|NCT03319849|Ciliary Neurotrophic Factor (CNTF)|ciliary neurotrophic factor (cntf)
4687452|NCT03319849|Macular Telangiectasia (MacTel)|macular telangiectasia (mactel)
4687453|NCT03319810|MCI, Alzheimer Disease, AD|mci, alzheimer disease, ad
4687454|NCT03319797|Autologous chondrocyte transplantation ACT|autologous chondrocyte transplantation act
4687455|NCT03319771|exercise|exercise
4687456|NCT03319771|neuroimaging|neuroimaging
4687457|NCT03319771|walking|walking
4687458|NCT03319771|multiple sclerosis|multiple sclerosis
4687459|NCT03319758|bone augmentation|bone augmentation
4687460|NCT03319758|esthetics|esthetics
4687461|NCT03319758|immediate implant|immediate implant
4687462|NCT03319758|buccal bone defects|buccal bone defects
4687463|NCT03319745|Malignant neoplasms of urinary tract|malignant neoplasms of urinary tract
4687464|NCT03319745|Urothelial carcinoma of the bladder|urothelial carcinoma of the bladder
4687465|NCT03319745|Pembrolizumab|pembrolizumab
4687466|NCT03319745|Keytruda|keytruda
4687467|NCT03319745|MK-3475|mk-3475
4687468|NCT03319745|SCH-900475|sch-900475
4687469|NCT03319654|Unexplained Infertility|unexplained infertility
4687470|NCT03319654|Idiopathic Infertility|idiopathic infertility
4687471|NCT03319654|DNA damage|dna damage
4687472|NCT03319654|DNA fragmentation|dna fragmentation
4687473|NCT03319654|Insemination|insemination
4687474|NCT03319641|68Ga-PSMA|68ga-psma
4687475|NCT03319641|Positron-Emission Tomography|positron-emission tomography
4687476|NCT03319641|Immunohistochemistry|immunohistochemistry
4687477|NCT03319615|Appetite|appetite
4687478|NCT03319615|Energy Intake|energy intake
4687479|NCT03319615|Body Composition|body composition
4687480|NCT03319615|Energy Expenditure|energy expenditure
4687481|NCT03319602|oxygen mask|oxygen mask
4687482|NCT03319602|high-flow oxygen therapy|high-flow oxygen therapy
4687483|NCT03319602|acute respiratory failure|acute respiratory failure
4687484|NCT03319576|Gastrostomy|gastrostomy
4687485|NCT03319576|Feeding|feeding
4687486|NCT03319576|G-tube|g-tube
4687487|NCT03319550|milk protein, endotoxemia, muscle protein synthesis, whey, casein|milk protein, endotoxemia, muscle protein synthesis, whey, casein
4687488|NCT03319537|Pevonedistat|pevonedistat
4687489|NCT03319537|Pemetrexed|pemetrexed
4687490|NCT03319537|Cisplatin|cisplatin
4687491|NCT03319537|17-361|17-361
4687492|NCT03319511|thoracic spinal|thoracic spinal
4687493|NCT03319511|awake mastectomy|awake mastectomy
4687494|NCT03319511|paravertebral block|paravertebral block
4687495|NCT03319511|analgesia|analgesia
4687496|NCT03319511|ultrasound|ultrasound
4687497|NCT03319511|breast cancer|breast cancer
4687498|NCT03319485|ExAblate|exablate
4687499|NCT03319485|TcMRgFUS|tcmrgfus
4687500|NCT03319485|Pallidotomy|pallidotomy
4687501|NCT03319472|malignant|malignant
4687502|NCT03319472|cancer|cancer
4687503|NCT03319472|simple bedside test|simple bedside test
4687504|NCT03319472|rapid|rapid
4687505|NCT03319472|score|score
4687506|NCT03319472|widely available|widely available
4687507|NCT03319472|feasible|feasible
4687508|NCT03319459|Solid Tumor|solid tumor
4687509|NCT03319459|HER2|her2
4687510|NCT03319459|EGFR|egfr
4687511|NCT03319459|Advanced Solid Tumor|advanced solid tumor
4687512|NCT03319459|Breast Cancer|breast cancer
4687513|NCT03319459|Head and Neck Cancer|head and neck cancer
4687514|NCT03319459|Head and Neck Squamous Cell Carcinoma|head and neck squamous cell carcinoma
4687515|NCT03319459|Colorectal Cancer|colorectal cancer
4687516|NCT03319459|Gastric Cancer|gastric cancer
4687517|NCT03319459|HER2 Positive|her2 positive
4687518|NCT03319459|EGFR Positive|egfr positive
4687519|NCT03319459|EGFR+|egfr+
4687520|NCT03319459|HER2+|her2+
4687521|NCT03319459|Immunotherapy|immunotherapy
4687522|NCT03319459|NK cell therapy|nk cell therapy
4687523|NCT03319459|Natural killer cell therapy|natural killer cell therapy
4687524|NCT03319459|antibody-dependent cell-mediated cytotoxicity|antibody-dependent cell-mediated cytotoxicity
4687525|NCT03319459|ADCC|adcc
4687526|NCT03319433|spinal hypotension|spinal hypotension
4687527|NCT03319433|perfusion index|perfusion index
4687528|NCT03319433|caesarean section|caesarean section
4687529|NCT03319394|Firefighters|firefighters
4687530|NCT03319394|Exercise Training|exercise training
4687531|NCT03319394|Resistance Training|resistance training
4687532|NCT03319394|Exercise Test|exercise test
4687533|NCT03319394|High-Intensity Interval Training|high-intensity interval training
4687534|NCT03319381|Algorithm|algorithm
4687535|NCT03319381|In-hospital mortality|in-hospital mortality
4687536|NCT03319381|Multiple trauma|multiple trauma
4687537|NCT03319381|Standard of care|standard of care
4687538|NCT03319355|multicomponent therapy|multicomponent therapy
4687539|NCT03319264|Spondylarthropathy|spondylarthropathy
4687540|NCT03319264|Sarcopenia|sarcopenia
4687541|NCT03319264|lean mass|lean mass
4687542|NCT03319264|fat mass|fat mass
4687543|NCT03319238|Chronic pain|chronic pain
4687544|NCT03319238|Neuropathic pain|neuropathic pain
4687545|NCT03319238|Ketamine|ketamine
4687546|NCT03319238|Concomitant treatment|concomitant treatment
4687547|NCT03319238|Adverse effect|adverse effect
4687548|NCT03319173|Mild Cognitive Impairment|mild cognitive impairment
4687549|NCT03319173|AMPK activation|ampk activation
4687550|NCT03319173|DNA global hypo-methylation|dna global hypo-methylation
4687551|NCT03319173|Metabolic Syndrome|metabolic syndrome
4687552|NCT03319173|Ketogenic diet|ketogenic diet
4687553|NCT03319147|exercise|exercise
4687554|NCT03319147|recovery|recovery
4687556|NCT03319147|protein|protein
4687557|NCT03319121|Non cardiac chest pain|non cardiac chest pain
4687558|NCT03319121|Empirical therapy|empirical therapy
4687559|NCT03319121|Guided therapy|guided therapy
4687560|NCT03319095|pelvic floor, muscle, electrical stimulation, physiotherapy|pelvic floor, muscle, electrical stimulation, physiotherapy
4687561|NCT03319043|Cough Variant Asthma|cough variant asthma
4687562|NCT03319043|impedance|impedance
4687563|NCT03319043|inflammation|inflammation
4687564|NCT03319043|Chanqin granules|chanqin granules
4687565|NCT03319030|exercise|exercise
4687566|NCT03319030|Aerobic Exercise|aerobic exercise
4687567|NCT03319017|Hypoxia|hypoxia
4687568|NCT03319017|Hyperinflammatory|hyperinflammatory
4687569|NCT03319017|Hyperoxia|hyperoxia
4687570|NCT03319017|Apoptosis|apoptosis
4687571|NCT03319017|Oxygenation|oxygenation
4687572|NCT03319017|Polymorphonuclear Cells|polymorphonuclear cells
4687573|NCT03319017|Tumor necrosis factor(TNF)-α|tumor necrosis factor(tnf)-α
4687574|NCT03319017|Cytokine|cytokine
4687575|NCT03318991|thulium laser|thulium laser
4687576|NCT03318991|GreenLight laser|greenlight laser
4687577|NCT03318991|laser therapy|laser therapy
4687578|NCT03318991|resection of the prostate|resection of the prostate
4687579|NCT03318991|prostate hyperplasia|prostate hyperplasia
4687580|NCT03318978|Benzo[a]pyrene|benzo[a]pyrene
4687581|NCT03318978|Accelerator Mass Spectrometry|accelerator mass spectrometry
4687582|NCT03318978|Polycyclic Aromatic Hydrocarbons|polycyclic aromatic hydrocarbons
4687583|NCT03318965|Mortality|mortality
4687584|NCT03318965|Anthropometry|anthropometry
4687585|NCT03318965|Nutrition Assessment|nutrition assessment
4687586|NCT03318965|Caliper|caliper
4687587|NCT03318952|lidocaine injection|lidocaine injection
4687588|NCT03318952|articaine injections|articaine injections
4687589|NCT03318952|pediatric dental anesthesia|pediatric dental anesthesia
4687590|NCT03318952|post dental procedure pain|post dental procedure pain
4687591|NCT03318939|EGFR|egfr
4687592|NCT03318939|HER2|her2
4687593|NCT03318939|Exon 20 insertion mutation|exon 20 insertion mutation
4687594|NCT03318926|tea, cup-year, renal stone disease|tea, cup-year, renal stone disease
4687595|NCT03318913|Vascular function|vascular function
4687596|NCT03318913|Type 2 diabetes mellitus|type 2 diabetes mellitus
4687597|NCT03318913|Fish protein hydrolysates|fish protein hydrolysates
4687598|NCT03318900|adoptively transferred central memory-type CTL targeting ovarian cancer antigens|adoptively transferred central memory-type ctl targeting ovarian cancer antigens
4687599|NCT03318900|in vivo persistence|in vivo persistence
4687600|NCT03318900|Adoptive Cellular Therapy|adoptive cellular therapy
4687601|NCT03318900|IL-21-Primed CD8+ Tumor Antigen-Specific T Cells|il-21-primed cd8+ tumor antigen-specific t cells
4687602|NCT03318900|epithelial ovarian cancer|epithelial ovarian cancer
4687603|NCT03318887|Cirrhosis|cirrhosis
4687604|NCT03318887|Direct acting antiviral agents|direct acting antiviral agents
4687605|NCT03318887|Hepatitis C|hepatitis c
4687606|NCT03318887|Pharmacological monitoring|pharmacological monitoring
4687607|NCT03318874|Dry Eye Disease|dry eye disease
4687608|NCT03318874|Meibomian Gland Dysfunction|meibomian gland dysfunction
4687609|NCT03318874|Blephasteam|blephasteam
4687610|NCT03318874|THERA°PEARL Eye Mask|thera°pearl eye mask
4687611|NCT03318848|students, nursing|students, nursing
4687612|NCT03318848|simulation training|simulation training
4687613|NCT03318848|Instructional Films and Videos|instructional films and videos
4687614|NCT03318848|Aptitude|aptitude
4687615|NCT03318835|Thalidomide|thalidomide
4687616|NCT03318835|R-CHOP|r-chop
4687617|NCT03318835|diffuse large B-cell lymphoma|diffuse large b-cell lymphoma
4687618|NCT03318822|brain injury|brain injury
4687619|NCT03318809|Cardiovascular Diseases|cardiovascular diseases
4687620|NCT03318809|Renal Impairment|renal impairment
4687621|NCT03318809|Heart Diseases|heart diseases
4687622|NCT03318796|Bifurcation lesions|bifurcation lesions
4687623|NCT03318783|Eicosanoids|eicosanoids
4687624|NCT03318783|Epoxyeicosatrienoic Acids|epoxyeicosatrienoic acids
4687625|NCT03318770|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
4687626|NCT03318770|adult|adult
4687627|NCT03318770|dasatinib|dasatinib
4687628|NCT03318770|blinatumomab|blinatumomab
4687629|NCT03318770|LAL2116|lal2116
4687630|NCT03318757|bupivacaine liposomal injectable|bupivacaine liposomal injectable
4687631|NCT03318757|post operative pain|post operative pain
4687632|NCT03318757|post operative narcotic use|post operative narcotic use
4687633|NCT03318757|bupivacaine hydrochloride|bupivacaine hydrochloride
4687634|NCT03318744|Silent Brain Infarction|silent brain infarction
4687635|NCT03318744|Antithrombotics|antithrombotics
4687636|NCT03318744|Antiplatelet|antiplatelet
4687637|NCT03318744|Aspirin|aspirin
4687638|NCT03318744|Asymptomatic|asymptomatic
4687639|NCT03318731|fenugreek extract|fenugreek extract
4687640|NCT03318731|non-resistance trained|non-resistance trained
4687641|NCT03318666|Adolescent|adolescent
4687642|NCT03318666|Adolescent Medicine|adolescent medicine
4687643|NCT03318666|Mental Health Services|mental health services
4687644|NCT03318666|eHealth|ehealth
4687645|NCT03318666|Online systems|online systems
4687646|NCT03318666|Primary Health Care|primary health care
4687647|NCT03318666|Social media|social media
4687648|NCT03318666|Social support|social support
4687649|NCT03318653|Blood pressure|blood pressure
4687650|NCT03318653|Dialysis|dialysis
4687651|NCT03318640|schizophrenia|schizophrenia
4687652|NCT03318640|mindfulness|mindfulness
4687653|NCT03318640|parasympathetic system|parasympathetic system
4687654|NCT03318614|Gut Microbiota|gut microbiota
4687655|NCT03318614|Probiotics|probiotics
4687656|NCT03318614|Abdominal Pain|abdominal pain
4687657|NCT03318614|Small Intestinal Bacterial Overgrowth|small intestinal bacterial overgrowth
4687658|NCT03318614|Mental|mental
4687659|NCT03318601|cirrhotic|cirrhotic
4687660|NCT03318601|ascite|ascite
4687661|NCT03318601|copeptin|copeptin
4687662|NCT03318588|Retinal detachment|retinal detachment
4687663|NCT03318588|Photoreceptor apoptosis|photoreceptor apoptosis
4687664|NCT03318588|Cytokine|cytokine
4687665|NCT03318575|remote ischemic conditioning (RIC)|remote ischemic conditioning (ric)
4687666|NCT03318575|percutaneous coronary intervention|percutaneous coronary intervention
4687667|NCT03318575|PCI|pci
4687668|NCT03318575|cardiac troponin I|cardiac troponin i
4687669|NCT03318575|cardiac catheterization|cardiac catheterization
4687670|NCT03318575|myocardial injury|myocardial injury
4687671|NCT03318575|myocardial necrosis|myocardial necrosis
4687672|NCT03318575|autoRIC|autoric
4687673|NCT03318575|Ischemia-Reperfusion Injury (IRI)|ischemia-reperfusion injury (iri)
4687674|NCT03318575|Automated Remote Ischemic Conditioning|automated remote ischemic conditioning
4687675|NCT03318549|virtual reality|virtual reality
4687676|NCT03318549|glaucoma|glaucoma
4687677|NCT03318549|age related macular degeneration|age related macular degeneration
4687678|NCT03318549|quality of life|quality of life
4687679|NCT03318549|visual field|visual field
4687680|NCT03318549|optical coherence tomography|optical coherence tomography
4687681|NCT03318536|Serotonin Antagonists|serotonin antagonists
4687682|NCT03318536|Sympathomimetics|sympathomimetics
4687683|NCT03318523|BIIB054|biib054
4687684|NCT03318523|Parkinson's Disease|parkinson's disease
4687685|NCT03318523|Alpha-synuclein|alpha-synuclein
4687686|NCT03318523|Alpha synuclein|alpha synuclein
4687687|NCT03318497|Pancreatic adenocarcinoma|pancreatic adenocarcinoma
4687688|NCT03318497|18F-FLT|18f-flt
4687689|NCT03318497|FLT|flt
4687690|NCT03318497|Locally advanced pancreatic adenocarcinoma|locally advanced pancreatic adenocarcinoma
4687691|NCT03318497|Borderline resectable pancreatic adenocarcinoma|borderline resectable pancreatic adenocarcinoma
4687692|NCT03318471|MgSo4, Mayfield clamp, pressor effect|mgso4, mayfield clamp, pressor effect
4687693|NCT03318445|DNA repair mutation|dna repair mutation
4687694|NCT03318432|Stroke|stroke
4687695|NCT03318432|Acute Stroke|acute stroke
4687696|NCT03318432|Ischemic Stroke|ischemic stroke
4687697|NCT03318432|Hemorrhagic Stroke|hemorrhagic stroke
4687698|NCT03318432|Cerebral Ischemia|cerebral ischemia
4687699|NCT03318432|Cerebral Infarction|cerebral infarction
4687700|NCT03318432|Cerebral Stroke|cerebral stroke
4687701|NCT03318432|Cerebral Vascular Accident|cerebral vascular accident
4687702|NCT03318432|Stroke Recovery|stroke recovery
4687703|NCT03318406|registry|registry
4687704|NCT03318406|vapor ablation|vapor ablation
4687705|NCT03318406|InterVapor|intervapor
4687706|NCT03318406|BTVA|btva
4687707|NCT03318315|AS03-adjuvanted Inactivated Influenza Vaccine|as03-adjuvanted inactivated influenza vaccine
4687708|NCT03318315|Co-Administered|co-administered
4687709|NCT03318315|Healthy Adults|healthy adults
4687710|NCT03318315|Immunogenicity|immunogenicity
4687711|NCT03318315|Inactivated Seasonal Influenza Vaccine|inactivated seasonal influenza vaccine
4687712|NCT03318315|Phase II|phase ii
4687713|NCT03318315|Safety|safety
4687714|NCT03318263|Estrogen-receptor-positive breast cancer|estrogen-receptor-positive breast cancer
4687715|NCT03318263|aromatase inhibitor,|aromatase inhibitor,
4687716|NCT03318263|ESR1,|esr1,
4687717|NCT03318263|PIK3CA|pik3ca
4687718|NCT03318263|AKT|akt
4687719|NCT03318263|endocrine resistance|endocrine resistance
4687720|NCT03318263|circulating tumor DNA|circulating tumor dna
4687721|NCT03318250|DRG Stimulation|drg stimulation
4687722|NCT03318211|preeclampsia|preeclampsia
4687723|NCT03318211|Magnisium sulfate|magnisium sulfate
4687724|NCT03318198|Graduate Medical Education|graduate medical education
4687919|NCT03316716|neonatal hypothermia|neonatal hypothermia
4687725|NCT03318198|Attending Supervision of Residents|attending supervision of residents
4687726|NCT03318198|Patient Safety|patient safety
4687727|NCT03318185|gasless single-port laparoscopic surgery;rectal carcinoma|gasless single-port laparoscopic surgery;rectal carcinoma
4687728|NCT03318172|Spinal Cord Stimulation|spinal cord stimulation
4687729|NCT03318172|High Density Stimulation|high density stimulation
4687730|NCT03318146|Plugged Tear Duct|plugged tear duct
4687731|NCT03318133|general anesthesia|general anesthesia
4687732|NCT03318133|sacral plexus block|sacral plexus block
4687733|NCT03318133|lumbar plexus block|lumbar plexus block
4687734|NCT03318133|hip fracture|hip fracture
4687735|NCT03318133|elderly|elderly
4687736|NCT03318094|insulin resistance|insulin resistance
4687737|NCT03318094|phentolamine|phentolamine
4687738|NCT03318094|microvascular recruitment|microvascular recruitment
4687739|NCT03318094|autonomic nervous system|autonomic nervous system
4687740|NCT03318081|Amphetamine-type stimulants|amphetamine-type stimulants
4687741|NCT03318081|prefrontal-striatal circuits|prefrontal-striatal circuits
4687742|NCT03318081|cognitive rehabilitation therapy|cognitive rehabilitation therapy
4687743|NCT03318068|Cancer|cancer
4687744|NCT03318068|Pediatric cancer|pediatric cancer
4687745|NCT03318068|Yoga|yoga
4687746|NCT03318068|Psychological distress|psychological distress
4687747|NCT03318068|Outpatient chemotherapy|outpatient chemotherapy
4687748|NCT03318029|Vitamin D|vitamin d
4687749|NCT03318029|Supplementation|supplementation
4687750|NCT03318029|Sunlight|sunlight
4687751|NCT03318016|Arsenic Trioxide|arsenic trioxide
4687752|NCT03318016|Cyclophosphamide|cyclophosphamide
4687753|NCT03317990|Prostate Cancer|prostate cancer
4687754|NCT03317990|Nerve sparing|nerve sparing
4687755|NCT03317990|NeuroSAFE|neurosafe
4687756|NCT03317990|Frozen section|frozen section
4687757|NCT03317977|Asthma management, adolescents|asthma management, adolescents
4687758|NCT03317925|Pediatric Renal Transplant|pediatric renal transplant
4687759|NCT03317925|Renal Allograft|renal allograft
4687760|NCT03317925|Angiotensin II|angiotensin ii
4687761|NCT03317925|Angiotensin-(1-7)|angiotensin-(1-7)
4687762|NCT03317925|ACE|ace
4687763|NCT03317925|ACE2|ace2
4687764|NCT03317860|perceptual disorders|perceptual disorders
4687765|NCT03317860|cerebrovascular disorders|cerebrovascular disorders
4687766|NCT03317860|neurobehavioral manifestations|neurobehavioral manifestations
4687767|NCT03317860|neurologic manifestations|neurologic manifestations
4687768|NCT03317860|neglect|neglect
4687769|NCT03317860|non-invasive brain stimulation|non-invasive brain stimulation
4687770|NCT03317860|rehabilitation|rehabilitation
4687771|NCT03317860|tDCS|tdcs
4687772|NCT03317860|paresis|paresis
4687773|NCT03317795|Menorrhagia|menorrhagia
4687774|NCT03317795|FIbroids|fibroids
4687775|NCT03317795|Menstrual Bleeding|menstrual bleeding
4687776|NCT03317795|Heavy Bleeding|heavy bleeding
4687777|NCT03317795|Menses|menses
4687778|NCT03317795|Uterine Fibroids|uterine fibroids
4687779|NCT03317730|Xtampza ER|xtampza er
4687780|NCT03317730|LAHNC|lahnc
4687781|NCT03317730|Head and neck cancer|head and neck cancer
4687782|NCT03317730|Pain management|pain management
4687783|NCT03317691|myocardial infarction|myocardial infarction
4687784|NCT03317691|artificial Intelligence|artificial intelligence
4687785|NCT03317691|12 lead electrocardiogram|12 lead electrocardiogram
4687786|NCT03317665|biologic|biologic
4687787|NCT03317665|prosthetic|prosthetic
4687788|NCT03317665|mesh|mesh
4687789|NCT03317613|Neuropathic Pain|neuropathic pain
4687790|NCT03317613|Qutenza|qutenza
4687791|NCT03317613|Capsaicin|capsaicin
4687792|NCT03317613|Cancer patient|cancer patient
4687793|NCT03317561|troponin|troponin
4687794|NCT03317561|major surgery|major surgery
4687795|NCT03317535|Anesthesia Methods|anesthesia methods
4687796|NCT03317535|Acute Ischemic Stroke|acute ischemic stroke
4687797|NCT03317535|Endovascular Treatment|endovascular treatment
4687798|NCT03317522|Pregnancy|pregnancy
4687799|NCT03317522|teratogenesis|teratogenesis
4687800|NCT03317496|Avelumab, immunotherapy, PD-L1 inhibitor, non-small cell lung cancer (NSCLC), urothelial cancer (UC), carboplatin, pemetrexed, gemcitabine, cisplatin|avelumab, immunotherapy, pd-l1 inhibitor, non-small cell lung cancer (nsclc), urothelial cancer (uc), carboplatin, pemetrexed, gemcitabine, cisplatin
4687801|NCT03317444|blood bicarbonate, kidney disease|blood bicarbonate, kidney disease
4687802|NCT03317431|dopamine,mechanical ventilation,lung injury|dopamine,mechanical ventilation,lung injury
4687803|NCT03317366|ARQ 092|arq 092
4687804|NCT03317366|ArQule|arqule
4687805|NCT03317366|AKT|akt
4687806|NCT03317366|PIK3CA|pik3ca
4687807|NCT03317366|Overgrowth|overgrowth
4687808|NCT03317366|Congenital malformations|congenital malformations
4687809|NCT03317353|Vestibular Rehabilitation|vestibular rehabilitation
4687810|NCT03317353|Falls in elderly|falls in elderly
4687811|NCT03317353|Computerized Dynamic Posturography|computerized dynamic posturography
4687812|NCT03317353|Optokinetic stimuli|optokinetic stimuli
4687813|NCT03317327|HNSCC|hnscc
4687814|NCT03317327|Nivolumab|nivolumab
4687815|NCT03317327|immunotherapy|immunotherapy
4687816|NCT03317301|Pruritus cutaneus|pruritus cutaneus
4687817|NCT03317288|spinal cord injury|spinal cord injury
4687818|NCT03317288|pressure ulcer|pressure ulcer
4687819|NCT03317288|laser Doppler flowmetry|laser doppler flowmetry
4688112|NCT03315559|Radiolabel|radiolabel
4687820|NCT03317262|quality of life, citalopram, quetiapine, pregabalin|quality of life, citalopram, quetiapine, pregabalin
4687821|NCT03317249|Inappropriate Sinus Tachycardia|inappropriate sinus tachycardia
4687822|NCT03317249|Pregnancy Related|pregnancy related
4687823|NCT03317249|IST|ist
4687824|NCT03317236|Bioequivalence|bioequivalence
4687825|NCT03317236|Quetiapine|quetiapine
4687826|NCT03317197|Out-of-Hospital Cardiac Arrest|out-of-hospital cardiac arrest
4687827|NCT03317197|Vasopressin-steroid-epinephrine (VSE)|vasopressin-steroid-epinephrine (vse)
4687828|NCT03317197|Treatment Outcome|treatment outcome
4687829|NCT03317197|prognosis|prognosis
4687830|NCT03317197|Return of spontaneous circulation|return of spontaneous circulation
4687831|NCT03317184|Physical Activity|physical activity
4687832|NCT03317184|Pfannenstiel incision|pfannenstiel incision
4687833|NCT03317184|Periumbilical incision|periumbilical incision
4687834|NCT03317171|dietary supplementation|dietary supplementation
4687835|NCT03317171|flavonoids|flavonoids
4687836|NCT03317171|omega 3|omega 3
4687837|NCT03317158|non-muscle invasive bladder cancer|non-muscle invasive bladder cancer
4687838|NCT03317158|BCG|bcg
4687839|NCT03317158|immunotherapy|immunotherapy
4687840|NCT03317145|venous thromboembolism|venous thromboembolism
4687841|NCT03317145|deep vein thrombosis|deep vein thrombosis
4687842|NCT03317145|pulmonary embolism|pulmonary embolism
4687843|NCT03317145|neuromuscular electrostimulation|neuromuscular electrostimulation
4687844|NCT03317145|foot compression|foot compression
4687845|NCT03317145|hip replacement|hip replacement
4687846|NCT03317132|Vocational, First-episode psychosis|vocational, first-episode psychosis
4687847|NCT03317080|lung cancer|lung cancer
4687848|NCT03317080|circulating tumor DNA|circulating tumor dna
4687849|NCT03317080|molecular classification|molecular classification
4687850|NCT03317080|dynamic monitoring|dynamic monitoring
4687851|NCT03317080|next generation sequencing|next generation sequencing
4687852|NCT03317080|diagnosis|diagnosis
4687853|NCT03317080|postoperative relapse|postoperative relapse
4687854|NCT03317067|Dexmdetomidine|dexmdetomidine
4687855|NCT03317067|Haloperidol|haloperidol
4687856|NCT03317067|Delirium|delirium
4687857|NCT03317067|Productive Delirium|productive delirium
4687858|NCT03317067|Agitation|agitation
4687859|NCT03317067|Intubation|intubation
4687860|NCT03317067|Ventilatory free days|ventilatory free days
4687861|NCT03317067|Sedation|sedation
4687862|NCT03317067|ICU patients|icu patients
4687863|NCT03317067|Mechanical Ventilation|mechanical ventilation
4687864|NCT03317054|Gambing|gambing
4687865|NCT03317054|occupational health services|occupational health services
4687866|NCT03317054|psychosocial risks|psychosocial risks
4687867|NCT03317041|Capacitive-resistive electric transfer therapy|capacitive-resistive electric transfer therapy
4687868|NCT03317041|Radiofrequency therapy|radiofrequency therapy
4687869|NCT03317041|Recovery intervention|recovery intervention
4687870|NCT03317041|Fatigue|fatigue
4687871|NCT03317041|Running|running
4687872|NCT03316976|Drug therapy|drug therapy
4687873|NCT03316963|Neostigmine|neostigmine
4687874|NCT03316963|Nerve stimulant medication|nerve stimulant medication
4687875|NCT03316963|Treatments for snoring|treatments for snoring
4687876|NCT03316950|postmenopause|postmenopause
4687877|NCT03316950|rejuvenation|rejuvenation
4687878|NCT03316950|radiofrequency|radiofrequency
4687879|NCT03316950|diva|diva
4687880|NCT03316859|opioid-induced constipation (OIC)|opioid-induced constipation (oic)
4687881|NCT03316846|Chronic Pain|chronic pain
4687882|NCT03316846|Depression|depression
4687883|NCT03316846|Anxiety|anxiety
4687884|NCT03316846|Stress|stress
4687885|NCT03316846|iCBT|icbt
4687886|NCT03316846|Cognitive behavioral therapy|cognitive behavioral therapy
4687887|NCT03316846|Internet delivered|internet delivered
4687888|NCT03316846|Tailored treatment|tailored treatment
4687889|NCT03316807|Hepatitis B, Vaccine|hepatitis b, vaccine
4687890|NCT03316807|Randomized Controlled Trial|randomized controlled trial
4687891|NCT03316807|HIV|hiv
4687892|NCT03316807|Immunogenicity|immunogenicity
4687893|NCT03316794|Triple Negative Breast Cancer|triple negative breast cancer
4687894|NCT03316794|Cancer|cancer
4687895|NCT03316794|Breast Cancer|breast cancer
4687896|NCT03316794|Maximum tolerated dose (MTD)|maximum tolerated dose (mtd)
4687897|NCT03316794|Pharmacokinetics|pharmacokinetics
4687898|NCT03316768|grip|grip
4687899|NCT03316768|pinch|pinch
4687900|NCT03316768|forces|forces
4687901|NCT03316768|pressure|pressure
4687902|NCT03316768|Tekscan|tekscan
4687903|NCT03316768|sensor|sensor
4687904|NCT03316768|ADL|adl
4687905|NCT03316768|activities of daily living|activities of daily living
4687906|NCT03316768|work requirements|work requirements
4687907|NCT03316768|hand biomechanics|hand biomechanics
4687908|NCT03316768|forceful precision grip|forceful precision grip
4687909|NCT03316768|power grip|power grip
4687910|NCT03316768|hominid|hominid
4687911|NCT03316768|hominin|hominin
4687912|NCT03316768|prehistoric|prehistoric
4687913|NCT03316742|Obese|obese
4687914|NCT03316742|Overweight|overweight
4687915|NCT03316742|Weight loss|weight loss
4687916|NCT03316742|West Africa|west africa
4687917|NCT03316729|Sub-massive acute pulmonary embolism|sub-massive acute pulmonary embolism
4687918|NCT03316716|caesarean section|caesarean section
4688113|NCT03315559|Healthy|healthy
4687920|NCT03316716|maternal hypothermia|maternal hypothermia
4687921|NCT03316716|active warming|active warming
4687922|NCT03316716|skin-to-skin contact|skin-to-skin contact
4687923|NCT03316703|Spine, Spinal injuries, Fractures, Bone|spine, spinal injuries, fractures, bone
4687924|NCT03316677|anastomotic leak|anastomotic leak
4687925|NCT03316677|colorectal|colorectal
4687926|NCT03316677|anastomosis testing|anastomosis testing
4687927|NCT03316677|Intraoperative testing|intraoperative testing
4687928|NCT03316664|cognitive behavioural therapy|cognitive behavioural therapy
4687929|NCT03316664|psychotic disorder|psychotic disorder
4687930|NCT03316664|schizophrenia|schizophrenia
4687931|NCT03316664|schizoaffective disorder|schizoaffective disorder
4687932|NCT03316664|psychological intervention|psychological intervention
4687933|NCT03316651|pulmonary alveolar proteinosis|pulmonary alveolar proteinosis
4687934|NCT03316651|granulocyte-macrophage colony-stimulating factor|granulocyte-macrophage colony-stimulating factor
4687935|NCT03316651|whole lung lavage|whole lung lavage
4687936|NCT03316612|Advanced Glycation End Products, Metabolites, Gut Microbiota|advanced glycation end products, metabolites, gut microbiota
4687937|NCT03316599|Pancreatic Cancer|pancreatic cancer
4687938|NCT03316586|Breast Cancer|breast cancer
4687939|NCT03316573|Lymphoma|lymphoma
4687940|NCT03316573|Histiocyte sarcoma|histiocyte sarcoma
4687941|NCT03316573|Follicular Dendritic Cell Saroma|follicular dendritic cell saroma
4687942|NCT03316573|Interdigitating dendritic cell sarcoma|interdigitating dendritic cell sarcoma
4687943|NCT03316560|XLRP|xlrp
4687944|NCT03316560|retinal degeneration|retinal degeneration
4687945|NCT03316560|RPGR|rpgr
4687946|NCT03316560|ORF15|orf15
4687947|NCT03316560|adeno-associated virus|adeno-associated virus
4687948|NCT03316560|gene therapy|gene therapy
4687949|NCT03316560|AAV|aav
4687950|NCT03316547|preterm|preterm
4687951|NCT03316521|complement inhibition|complement inhibition
4687952|NCT03316521|C3 complement inhibitor|c3 complement inhibitor
4687953|NCT03316521|AMY-101|amy-101
4687954|NCT03316521|Compstatin Cp40|compstatin cp40
4687955|NCT03316521|Paroxysmal Nocturnal Hemoglobinuria (PNH)|paroxysmal nocturnal hemoglobinuria (pnh)
4687956|NCT03316521|C3 glomerulopathy (C3G)|c3 glomerulopathy (c3g)
4687957|NCT03316521|Periodontal disease|periodontal disease
4687958|NCT03316521|Age-related macular degeneration (AMD)|age-related macular degeneration (amd)
4687959|NCT03316521|ABO incompatible kidney transplantation|abo incompatible kidney transplantation
4687960|NCT03316508|copeptin|copeptin
4687961|NCT03316508|pediatric cardiac surgery|pediatric cardiac surgery
4687962|NCT03316508|heart lung machine|heart lung machine
4687963|NCT03316469|Anti-mullerian hormone|anti-mullerian hormone
4687964|NCT03316456|AL|al
4687965|NCT03316443|Glidescope,Macintosh, Laryngscope, intubation,Hypertension.|glidescope,macintosh, laryngscope, intubation,hypertension.
4687966|NCT03316404|Multiple Sclerosis|multiple sclerosis
4687967|NCT03316404|MS|ms
4687968|NCT03316378|Human|human
4687969|NCT03316378|Pain|pain
4687970|NCT03316378|Biomechanics|biomechanics
4687971|NCT03316378|Anesthetics|anesthetics
4687972|NCT03316313|Public Health|public health
4687973|NCT03316313|Patient Education as Topic|patient education as topic
4687974|NCT03316313|Hepatitis C|hepatitis c
4687975|NCT03316300|Ciliary Neurotrophic Factor (CNTF)|ciliary neurotrophic factor (cntf)
4687976|NCT03316300|Macular Telangiectasia (MacTel)|macular telangiectasia (mactel)
4687977|NCT03316261|infants|infants
4687978|NCT03316261|type 1 diabetes|type 1 diabetes
4687979|NCT03316261|Freder1k|freder1k
4687980|NCT03316248|Transtibial amputation|transtibial amputation
4687981|NCT03316248|visual feedback|visual feedback
4687982|NCT03316248|rehabilitation|rehabilitation
4687983|NCT03316196|trauma|trauma
4687984|NCT03316196|PTSD|ptsd
4687985|NCT03316196|cognition|cognition
4687986|NCT03316183|cerebral oximetry|cerebral oximetry
4687987|NCT03316183|near-infrared spectroscopy (NIRS)|near-infrared spectroscopy (nirs)
4687988|NCT03316183|metabolomic profiling|metabolomic profiling
4687989|NCT03316183|neurocognitive outcomes|neurocognitive outcomes
4687990|NCT03316183|Cerebral protection|cerebral protection
4687991|NCT03316144|immunotherapy|immunotherapy
4687992|NCT03316144|check point inhibitor|check point inhibitor
4687993|NCT03316144|PD-1 antibody|pd-1 antibody
4687994|NCT03316144|phase 1 trial|phase 1 trial
4687995|NCT03316144|Malignant Lymphoma|malignant lymphoma
4687996|NCT03316131|Gout|gout
4687997|NCT03316131|Uric acid|uric acid
4687998|NCT03316131|Hyperuricemia|hyperuricemia
4687999|NCT03316131|Asymptomatic gout|asymptomatic gout
4688000|NCT03316131|Febuxostat|febuxostat
4688001|NCT03316131|Dapagliflozin|dapagliflozin
4688002|NCT03316131|Uric acid transporter 1 (URAT1) Inhibitor|uric acid transporter 1 (urat1) inhibitor
4688003|NCT03316131|Xanthine Oxidase Inhibitor|xanthine oxidase inhibitor
4688004|NCT03316131|Sodium-glucose cotransporter 2 (SGLT2) Inhibitor|sodium-glucose cotransporter 2 (sglt2) inhibitor
4688005|NCT03316118|anesthesiology|anesthesiology
4688006|NCT03316118|pain|pain
4688007|NCT03316118|arthroplasty|arthroplasty
4688008|NCT03316079|intensive care|intensive care
4688009|NCT03316079|invasive mechanical ventilation|invasive mechanical ventilation
4688010|NCT03316079|mechanical insufflation-exsufflation|mechanical insufflation-exsufflation
4688011|NCT03316079|airway mucus clearance|airway mucus clearance
4688012|NCT03316079|chest physiotherapy|chest physiotherapy
4688013|NCT03316079|peak expiratory flow|peak expiratory flow
4688014|NCT03316079|pulmonary mechanics|pulmonary mechanics
4688015|NCT03316066|Stellate Ganglion|stellate ganglion
4688016|NCT03316066|Local Anesthetic|local anesthetic
4688017|NCT03316040|HIV/AIDS|hiv/aids
4688018|NCT03316040|Join-in-Circuit|join-in-circuit
4688019|NCT03316014|Pediatry; Adverse drug reactions; Pharmacovigilance|pediatry; adverse drug reactions; pharmacovigilance
4688020|NCT03315988|type 2 diabetes|type 2 diabetes
4688021|NCT03315988|vegan diet|vegan diet
4688022|NCT03315988|TMAO|tmao
4688023|NCT03315988|cardiovascular disease|cardiovascular disease
4688024|NCT03315975|Influenza vaccine|influenza vaccine
4688025|NCT03315923|Active progressive Multiple Sclerosis|active progressive multiple sclerosis
4688026|NCT03315923|Glatiramer acetate|glatiramer acetate
4688027|NCT03315923|Rituximab|rituximab
4688028|NCT03315923|Comparative study|comparative study
4688029|NCT03315923|Annualized relapse rate|annualized relapse rate
4688030|NCT03315923|Disability|disability
4688031|NCT03315923|Randomized clinical trial|randomized clinical trial
4688032|NCT03315910|Tobacco Treatment|tobacco treatment
4688033|NCT03315910|Lung CT|lung ct
4688034|NCT03315910|Cancer Screening|cancer screening
4688035|NCT03315910|17-500|17-500
4688036|NCT03315897|bipolar disorder|bipolar disorder
4688037|NCT03315897|cognition|cognition
4688038|NCT03315897|cognitive dysfunction|cognitive dysfunction
4688039|NCT03315897|erythropoietin|erythropoietin
4688040|NCT03315897|pro-cognitive efficacy|pro-cognitive efficacy
4688041|NCT03315897|prefrontal cortex|prefrontal cortex
4688042|NCT03315897|functional magnetic resonance imaging|functional magnetic resonance imaging
4688043|NCT03315897|biomarker|biomarker
4688044|NCT03315884|TASC C, D|tasc c, d
4688045|NCT03315884|CFA|cfa
4688046|NCT03315884|Supera|supera
4688047|NCT03315884|iliac arteries|iliac arteries
4688048|NCT03315884|common femoral artery|common femoral artery
4688049|NCT03315884|plasty of the common femoral artery|plasty of the common femoral artery
4688050|NCT03315884|stenting Supera|stenting supera
4688051|NCT03315871|Vaccine|vaccine
4688052|NCT03315871|PSA|psa
4688053|NCT03315871|Immunotherapy|immunotherapy
4688054|NCT03315871|Immune Response|immune response
4688055|NCT03315871|Checkpoint Inhibitor|checkpoint inhibitor
4688056|NCT03315858|NFAT|nfat
4688057|NCT03315858|gene expression|gene expression
4688058|NCT03315858|tacrolimus|tacrolimus
4688059|NCT03315845|BMI|bmi
4688060|NCT03315845|obstetric anaesthesia|obstetric anaesthesia
4688061|NCT03315845|neuraxial anaesthesia|neuraxial anaesthesia
4688062|NCT03315845|neuraxial ultrasound|neuraxial ultrasound
4688063|NCT03315845|difficult neuraxial anaesthesia|difficult neuraxial anaesthesia
4688064|NCT03315832|Aortic Valve Stenosis|aortic valve stenosis
4688065|NCT03315832|Valsartan|valsartan
4688066|NCT03315832|Angiotensin Receptor Antagonists|angiotensin receptor antagonists
4688067|NCT03315832|Transcatheter Aortic Valve Replacement|transcatheter aortic valve replacement
4688068|NCT03315832|Heart Valve Prosthesis Implantation|heart valve prosthesis implantation
4688069|NCT03315832|double-blind phase II study|double-blind phase ii study
4688070|NCT03315832|left ventricular mass|left ventricular mass
4688071|NCT03315819|glenohumeral dislocation|glenohumeral dislocation
4688072|NCT03315819|Arthroscopic|arthroscopic
4688073|NCT03315819|capsular lesions|capsular lesions
4688074|NCT03315806|Dietary nitrate|dietary nitrate
4688075|NCT03315806|Nitrate|nitrate
4688076|NCT03315806|Flow-mediated dilation|flow-mediated dilation
4688077|NCT03315806|Tissue oxygen saturation|tissue oxygen saturation
4688078|NCT03315767|HVPG|hvpg
4688079|NCT03315767|portal hypertension|portal hypertension
4688080|NCT03315767|ARFI|arfi
4688081|NCT03315767|portal vein flow|portal vein flow
4688082|NCT03315767|advanced liver chronic disease (ACLD)|advanced liver chronic disease (acld)
4688083|NCT03315741|Bronchiolitis obliterans syndrome|bronchiolitis obliterans syndrome
4688084|NCT03315728|Quality improvement|quality improvement
4688085|NCT03315728|Indigenous|indigenous
4688086|NCT03315728|First Nation|first nation
4688087|NCT03315728|Participatory|participatory
4688088|NCT03315728|Diabetes|diabetes
4688089|NCT03315728|Chronic Disease|chronic disease
4688090|NCT03315702|R-spondin proteins, mechanical ventilation, lung injury|r-spondin proteins, mechanical ventilation, lung injury
4688091|NCT03315663|Mobile Health|mobile health
4688092|NCT03315650|Non-valvular AF|non-valvular af
4688093|NCT03315650|ACS|acs
4688094|NCT03315650|PCI|pci
4688095|NCT03315650|NOAC|noac
4688096|NCT03315650|Rivaroxaban|rivaroxaban
4688097|NCT03315624|Hemodialysis|hemodialysis
4688098|NCT03315624|Hemodiafiltration|hemodiafiltration
4688099|NCT03315624|Renal replacement therapy|renal replacement therapy
4688100|NCT03315598|Neuralgia, Acupuncture Treatment|neuralgia, acupuncture treatment
4688101|NCT03315585|focal therapy|focal therapy
4688102|NCT03315585|IRE|ire
4688103|NCT03315585|Composite Steep-pulse Treatment Apparatus|composite steep-pulse treatment apparatus
4688104|NCT03315585|prostate cancer|prostate cancer
4688105|NCT03315572|caregiver|caregiver
4688106|NCT03315572|ELLIPTA|ellipta
4688107|NCT03315572|Asthma|asthma
4688108|NCT03315572|Dry Powder Inhaler|dry powder inhaler
4688109|NCT03315572|pediatric|pediatric
4688110|NCT03315559|GSK2269557|gsk2269557
4688111|NCT03315559|Pharmacokinetics|pharmacokinetics
4688115|NCT03315559|Bioavailability|bioavailability
4688116|NCT03315546|deep inspiration breath-hold|deep inspiration breath-hold
4688117|NCT03315546|radiotherapy|radiotherapy
4688118|NCT03315546|late effects|late effects
4688119|NCT03315546|pediatric cancer|pediatric cancer
4688120|NCT03315520|Hodgkin Lymphoma|hodgkin lymphoma
4688121|NCT03315520|Non-Hodgkin lymphoma|non-hodgkin lymphoma
4688122|NCT03315520|autologous hematopoietic stem-cell transplantation|autologous hematopoietic stem-cell transplantation
4688123|NCT03315520|conditioning regimen|conditioning regimen
4688124|NCT03315494|rheumatoid arthritis|rheumatoid arthritis
4688125|NCT03315494|healthy volunteers|healthy volunteers
4688126|NCT03315494|moderate to severe|moderate to severe
4688127|NCT03315468|melanoma|melanoma
4688128|NCT03315468|database|database
4688129|NCT03315468|cohort|cohort
4688130|NCT03315442|Fluid|fluid
4688131|NCT03315442|Balance|balance
4688132|NCT03315416|Speech Disorder|speech disorder
4688133|NCT03315416|Breast Feeding|breast feeding
4688134|NCT03315416|Infant Feeding|infant feeding
4688135|NCT03315416|Bottle Feeding|bottle feeding
4688136|NCT03315416|Speech Development|speech development
4688137|NCT03315416|Speech Sound Development|speech sound development
4688138|NCT03315416|Speech Sound Disorder|speech sound disorder
4688139|NCT03315416|Non-nutritive Sucking|non-nutritive sucking
4688140|NCT03315403|quantitative polymerase chain reaction|quantitative polymerase chain reaction
4688141|NCT03315403|qPCR|qpcr
4688142|NCT03315403|autolysin|autolysin
4688143|NCT03315403|lytA|lyta
4688144|NCT03315403|Pneumococcal pneumonia|pneumococcal pneumonia
4688145|NCT03315403|Diagnostics|diagnostics
4688146|NCT03315403|Community-acquired Pneumonia|community-acquired pneumonia
4688147|NCT03315403|Antibiotic resistance|antibiotic resistance
4688148|NCT03315390|Narrative Exposure Therapy, ICU Survival, post-traumatic stress disorders, primary health care, randomized controlled trial|narrative exposure therapy, icu survival, post-traumatic stress disorders, primary health care, randomized controlled trial
4688149|NCT03315364|Recurrent breast cancer|recurrent breast cancer
4688150|NCT03315364|Metastatic breast cancer|metastatic breast cancer
4688151|NCT03315364|MBC|mbc
4688152|NCT03315364|Firstline chemotherapy|firstline chemotherapy
4688153|NCT03315364|Paclitaxel|paclitaxel
4688154|NCT03315364|Liporaxel|liporaxel
4688155|NCT03315364|Taxol|taxol
4688156|NCT03315351|PET-scan|pet-scan
4688157|NCT03315351|Brachytherapy|brachytherapy
4688158|NCT03315351|Cervical Cancer|cervical cancer
4688159|NCT03315325|Aging|aging
4688160|NCT03315286|ultraviolet light|ultraviolet light
4688161|NCT03315286|dosimetry|dosimetry
4688162|NCT03315286|actinic keratosis|actinic keratosis
4688163|NCT03315286|skin cancer|skin cancer
4688164|NCT03315286|sun counseling|sun counseling
4688165|NCT03315286|wearable device|wearable device
4688166|NCT03315273|Traumatic brain injury, motor imagery ability, validation|traumatic brain injury, motor imagery ability, validation
4688167|NCT03315260|Castration resistant prostate cancer|castration resistant prostate cancer
4688168|NCT03315260|Patient reported outcome|patient reported outcome
4688169|NCT03315247|Obesity|obesity
4688170|NCT03315247|Bariatric Surgery|bariatric surgery
4688171|NCT03315247|Bariatrics|bariatrics
4688172|NCT03315247|Cognitive Therapy|cognitive therapy
4688173|NCT03315247|Binge Eating|binge eating
4688174|NCT03315234|SYNTAX score|syntax score
4688175|NCT03315234|Coronary Atherosclerosis|coronary atherosclerosis
4688176|NCT03315234|Coronary Artery Disease|coronary artery disease
4688177|NCT03315234|SNPs|snps
4688178|NCT03315234|Genetics|genetics
4688179|NCT03315234|Genetic Risk Score|genetic risk score
4688180|NCT03315234|Personalized Medicine|personalized medicine
4688181|NCT03315208|transdiagnostic treatment|transdiagnostic treatment
4688182|NCT03315208|cognitive-behavioral therapy|cognitive-behavioral therapy
4688183|NCT03315208|Unified Protocol|unified protocol
4688184|NCT03315208|young adults|young adults
4688185|NCT03315208|substance use disorder|substance use disorder
4688186|NCT03315208|emotional disorder|emotional disorder
4688187|NCT03315208|depression|depression
4688188|NCT03315208|anxiety|anxiety
4688189|NCT03315208|emotion dysregulation|emotion dysregulation
4688190|NCT03315208|self-injurious thoughts and behaviors|self-injurious thoughts and behaviors
4688191|NCT03315182|MPS IIIB|mps iiib
4688192|NCT03315182|Sanfilippo Syndrome B|sanfilippo syndrome b
4688193|NCT03315169|Incision and Drainage|incision and drainage
4688194|NCT03315169|Packing|packing
4688195|NCT03315156|Acute otitis media|acute otitis media
4688196|NCT03315156|AOM|aom
4688197|NCT03315156|Electrogustometer|electrogustometer
4688198|NCT03315156|EGM|egm
4688199|NCT03315156|Taste threshold|taste threshold
4688200|NCT03315104|influenza A|influenza a
4688201|NCT03315104|hospitalized|hospitalized
4688202|NCT03315104|H1N1|h1n1
4688203|NCT03315104|H3N2|h3n2
4688204|NCT03315104|human flu|human flu
4688205|NCT03315104|respiratory tract infection|respiratory tract infection
4688206|NCT03315104|serious illness|serious illness
4688207|NCT03315104|flu|flu
4688208|NCT03315091|Pharmacokinetics, WEE1 inhibitor, food effect, safety assessments|pharmacokinetics, wee1 inhibitor, food effect, safety assessments
4688209|NCT03315065|thoracic Radiation therapy|thoracic radiation therapy
4688210|NCT03315065|Lung Function|lung function
4688212|NCT03315052|Renal failure|renal failure
4688213|NCT03315052|Infection|infection
4688214|NCT03315052|Diabetes|diabetes
4688215|NCT03315052|Hypertension|hypertension
4688216|NCT03315026|Siltuximab|siltuximab
4688217|NCT03315026|Autologous Stem Cell Transplantation (AST)|autologous stem cell transplantation (ast)
4688218|NCT03315026|17-365|17-365
4688219|NCT03315013|Antiretroviral therapy initiation|antiretroviral therapy initiation
4688220|NCT03315013|Sub-Sahara Africa|sub-sahara africa
4688221|NCT03315013|ART|art
4688222|NCT03315000|methacholine|methacholine
4688223|NCT03315000|airway hyperresponsiveness|airway hyperresponsiveness
4688224|NCT03314987|air pollution|air pollution
4688225|NCT03314987|oxidative stress|oxidative stress
4688226|NCT03314987|intervention|intervention
4688227|NCT03314974|AML|aml
4688228|NCT03314974|ALL|all
4688229|NCT03314974|MDS|mds
4688230|NCT03314974|NHL|nhl
4688231|NCT03314974|CLL|cll
4688232|NCT03314974|CML|cml
4688233|NCT03314974|SLL|sll
4688234|NCT03314961|rectal cancer|rectal cancer
4688235|NCT03314935|INCB001158|incb001158
4688236|NCT03314935|arginase inhibitor|arginase inhibitor
4688237|NCT03314935|oxaliplatin|oxaliplatin
4688238|NCT03314935|leucovorin|leucovorin
4688239|NCT03314935|5 fluorouracil|5 fluorouracil
4688240|NCT03314935|gemcitabine|gemcitabine
4688241|NCT03314935|cisplatin|cisplatin
4688242|NCT03314935|paclitaxel|paclitaxel
4688243|NCT03314935|solid tumors|solid tumors
4688244|NCT03314935|colorectal cancer|colorectal cancer
4688245|NCT03314935|biliary tract cancer|biliary tract cancer
4688246|NCT03314935|gastroesophageal cancer|gastroesophageal cancer
4688247|NCT03314935|endometrial cancer|endometrial cancer
4688248|NCT03314935|ovarian cancer|ovarian cancer
4688249|NCT03314922|Diffuse large B-cell lymphoma (DLBCL)|diffuse large b-cell lymphoma (dlbcl)
4688250|NCT03314922|follicular lymphoma (FL)|follicular lymphoma (fl)
4688251|NCT03314922|marginal zone lymphoma (MZL)|marginal zone lymphoma (mzl)
4688252|NCT03314922|mantle cell lymphoma (MCL)|mantle cell lymphoma (mcl)
4688253|NCT03314922|phosphatidylinositol 3-kinase (PI3K)|phosphatidylinositol 3-kinase (pi3k)
4688254|NCT03314909|Renal Dialysis|renal dialysis
4688255|NCT03314909|Hemoperfusion|hemoperfusion
4688256|NCT03314909|Paraquat|paraquat
4688257|NCT03314896|Colonic Neoplasms|colonic neoplasms
4688258|NCT03314896|Laparoscopic Surgery|laparoscopic surgery
4688259|NCT03314896|T4|t4
4688260|NCT03314883|Ultrasound|ultrasound
4688261|NCT03314883|Diaphragm|diaphragm
4688262|NCT03314883|Non Invasive Ventilation|non invasive ventilation
4688263|NCT03314857|TAVI|tavi
4688264|NCT03314857|TAVR|tavr
4688265|NCT03314857|CHINA|china
4688266|NCT03314857|SAPIEN XT|sapien xt
4688267|NCT03314857|High Risk|high risk
4688268|NCT03314857|Transcatheter aortic valve implantation|transcatheter aortic valve implantation
4688269|NCT03314857|Transcatheter aortic valve replacement|transcatheter aortic valve replacement
4688270|NCT03314831|sepsis|sepsis
4688271|NCT03314831|septic shock|septic shock
4688272|NCT03314831|systemic inflammatory response syndrome|systemic inflammatory response syndrome
4688273|NCT03314831|tetradecanoic acid|tetradecanoic acid
4688274|NCT03314831|myristic acid|myristic acid
4688275|NCT03314818|carotid atherosclerosis|carotid atherosclerosis
4688276|NCT03314818|plaque progression|plaque progression
4688277|NCT03314818|Framingham Risk Score|framingham risk score
4688278|NCT03314805|astragalus polysaccharides|astragalus polysaccharides
4688279|NCT03314805|breast cancer|breast cancer
4688280|NCT03314805|adjuvant chemotherapy|adjuvant chemotherapy
4688281|NCT03314792|pain|pain
4688282|NCT03314792|postoperative pain|postoperative pain
4688283|NCT03314792|postoperative pain management|postoperative pain management
4688284|NCT03314792|opioid|opioid
4688285|NCT03314792|analgesia|analgesia
4688286|NCT03314792|oxycodone|oxycodone
4688287|NCT03314792|tapentadol|tapentadol
4688288|NCT03314792|hysterectomy|hysterectomy
4688289|NCT03314792|respiratory depression|respiratory depression
4688290|NCT03314727|Osmolar Concentration|osmolar concentration
4688291|NCT03314727|Oxidative Stress|oxidative stress
4688292|NCT03314727|Salt|salt
4688293|NCT03314727|Inflammation|inflammation
4688294|NCT03314727|Endothelial Function|endothelial function
4688295|NCT03314727|Hypertension|hypertension
4688296|NCT03314701|Resting Energy Expenditure|resting energy expenditure
4688297|NCT03314701|Multiple Fracture Ribs|multiple fracture ribs
4688298|NCT03314701|Ventilation|ventilation
4688299|NCT03314675|CRT-D, LV Latency|crt-d, lv latency
4688300|NCT03314649|Peritoneal Lavage, Gene Mutation, Peritoneal Metastasis,Gastric Cancer|peritoneal lavage, gene mutation, peritoneal metastasis,gastric cancer
4688301|NCT03314584|TBI|tbi
4688302|NCT03314584|traumatic brain injury|traumatic brain injury
4688303|NCT03314584|transcranial magnetic stimulation|transcranial magnetic stimulation
4688304|NCT03314584|headache|headache
4688305|NCT03314571|Epidural analgesia|epidural analgesia
4688306|NCT03314571|Labor pain|labor pain
4688307|NCT03314571|Satisfaction|satisfaction
4688308|NCT03314571|Care assessment|care assessment
4688309|NCT03314571|Psychometry|psychometry
4688310|NCT03314558|COPD|copd
4688311|NCT03314558|pulmonary rehabilitation|pulmonary rehabilitation
4688312|NCT03314558|insomnia|insomnia
4688313|NCT03314558|sleep quality|sleep quality
4688314|NCT03314558|physical activity|physical activity
4688315|NCT03314545|endocrown|endocrown
4688316|NCT03314545|laminate veneer with coronal post|laminate veneer with coronal post
4688317|NCT03314545|post and core|post and core
4688318|NCT03314545|crown|crown
4688319|NCT03314532|Surgical Resection|surgical resection
4688320|NCT03314532|TILA-TACE|tila-tace
4688321|NCT03314532|Hepatocellular carcinoma|hepatocellular carcinoma
4688322|NCT03314519|Lung ultrasonography|lung ultrasonography
4688323|NCT03314519|Lung collapse|lung collapse
4688324|NCT03314519|fiberoptic bronchoscopy|fiberoptic bronchoscopy
4688325|NCT03314519|double lumen tube|double lumen tube
4688326|NCT03314506|exercise|exercise
4688327|NCT03314493|Vascular calcification|vascular calcification
4688328|NCT03314493|Coronary calcification|coronary calcification
4688329|NCT03314493|Peritoneal Dialysis|peritoneal dialysis
4688330|NCT03314493|Spironolactone|spironolactone
4688331|NCT03314480|Multidetector Computed Tomography|multidetector computed tomography
4688332|NCT03314480|Cone Beam Computed Tomography|cone beam computed tomography
4688333|NCT03314480|Maxillofacial fractures|maxillofacial fractures
4688334|NCT03314480|zygomaticomaxillary fractures|zygomaticomaxillary fractures
4688335|NCT03314467|diabetic retinopathy|diabetic retinopathy
4688336|NCT03314467|diabetes|diabetes
4688337|NCT03314467|arterial hypertension|arterial hypertension
4688338|NCT03314467|obstructive sleep apnea syndrome|obstructive sleep apnea syndrome
4688339|NCT03314441|yoga|yoga
4688340|NCT03314441|sleep quality|sleep quality
4688341|NCT03314441|sleep quantity|sleep quantity
4688342|NCT03314441|sleep efficiency|sleep efficiency
4688343|NCT03314441|insomnia|insomnia
4688344|NCT03314415|overweight|overweight
4688345|NCT03314415|obesity|obesity
4688346|NCT03314415|weight loss|weight loss
4688347|NCT03314415|robot|robot
4688348|NCT03314402|JAK2 inhibitor|jak2 inhibitor
4688349|NCT03314402|Tolerance|tolerance
4688350|NCT03314402|Pharmacokinetics|pharmacokinetics
4688351|NCT03314402|Dose-escalated|dose-escalated
4688352|NCT03314389|Cochet bonnet esthesiometer|cochet bonnet esthesiometer
4688353|NCT03314376|prehabilitation|prehabilitation
4688354|NCT03314376|surgery|surgery
4688355|NCT03314376|exercise program|exercise program
4688356|NCT03314376|transplant|transplant
4688357|NCT03314376|postoperative|postoperative
4688358|NCT03314363|Calorimetry, Indirect|calorimetry, indirect
4688359|NCT03314363|respiratory dialysis|respiratory dialysis
4688360|NCT03314350|Geriatrics|geriatrics
4688361|NCT03314350|Frailty|frailty
4688362|NCT03314337|Distal Pancreatectomy|distal pancreatectomy
4688363|NCT03314337|Pancreatic stent|pancreatic stent
4688364|NCT03314337|Post-operative pancreatic fistula|post-operative pancreatic fistula
4688365|NCT03314311|Rehabilitation|rehabilitation
4688366|NCT03314311|Exercise|exercise
4688367|NCT03314311|Nutrition Therapy|nutrition therapy
4688368|NCT03314311|Patient Education as Topic|patient education as topic
4688369|NCT03314285|Cervicalgia|cervicalgia
4688370|NCT03314246|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
4688371|NCT03314246|Ramadan Fasting|ramadan fasting
4688372|NCT03314246|Randomized controlled trial|randomized controlled trial
4688373|NCT03314207|XLRP|xlrp
4688374|NCT03314207|retinal degeneration|retinal degeneration
4688375|NCT03314207|RPGR|rpgr
4688376|NCT03314207|ORF15|orf15
4688377|NCT03314181|t(11,14) positive relapsed/refractory (R/R) multiple myeloma|t(11,14) positive relapsed/refractory (r/r) multiple myeloma
4688378|NCT03314181|Non-refractory Relapsed Multiple Myeloma|non-refractory relapsed multiple myeloma
4688379|NCT03314181|Non-refractory Refractory Multiple Myeloma|non-refractory refractory multiple myeloma
4688380|NCT03314181|Relapsed Multiple Myeloma|relapsed multiple myeloma
4688381|NCT03314181|Refractory Multiple Myeloma|refractory multiple myeloma
4688382|NCT03314181|Multiple Myeloma|multiple myeloma
4688383|NCT03314181|Cancer|cancer
4688384|NCT03314168|Breast Cancer|breast cancer
4688385|NCT03314168|Combined training|combined training
4688386|NCT03314168|Fatigue|fatigue
4688387|NCT03314155|Depressive disorder|depressive disorder
4688388|NCT03314155|Treatment Resistant Depression|treatment resistant depression
4688389|NCT03314155|[18 F ] DPA- 714|[18 f ] dpa- 714
4688390|NCT03314155|PET|pet
4688391|NCT03314155|MRI|mri
4688392|NCT03314155|Inflammation|inflammation
4688393|NCT03314142|blood glucose|blood glucose
4688394|NCT03314142|bran particle size|bran particle size
4688395|NCT03314142|glucemic index|glucemic index
4688396|NCT03314116|hearing loss During basic training, otoacoustic emission|hearing loss during basic training, otoacoustic emission
4688397|NCT03314090|Cleft lip|cleft lip
4688398|NCT03314090|Scar|scar
4688399|NCT03314090|Silicone sheet|silicone sheet
4688400|NCT03314090|Silicone gel|silicone gel
4688401|NCT03314064|Phase 4|phase 4
4688402|NCT03314064|Russian Federation|russian federation
4688403|NCT03314064|dolutegravir|dolutegravir
4688404|NCT03314064|long-term safety|long-term safety
4688405|NCT03314064|Human Immunodeficiency Virus|human immunodeficiency virus
4688406|NCT03314051|Nasopharyngeal Carcinoma|nasopharyngeal carcinoma
4688407|NCT03314051|plasma EBV DNA|plasma ebv dna
4688408|NCT03314038|Chronic Atrophic Gastritis|chronic atrophic gastritis
4688409|NCT03314038|Malignant Transformation|malignant transformation
4688411|NCT03314038|Traditional Chinese Medicine|traditional chinese medicine
4688412|NCT03314038|Cross-sectional Study|cross-sectional study
4688413|NCT03313999|Lymphedema indentometer|lymphedema indentometer
4688414|NCT03313999|Durometer|durometer
4688415|NCT03313986|penile curvature|penile curvature
4688416|NCT03313986|Peyronie's disease|peyronie's disease
4688418|NCT03313960|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
4688419|NCT03313960|Afrezza|afrezza
4688420|NCT03313934|Hyaluronic Acid Filler|hyaluronic acid filler
4688421|NCT03313934|Platelet Rich Fibrin (PRF)|platelet rich fibrin (prf)
4688422|NCT03313934|Tear Trough Filler|tear trough filler
4688423|NCT03313921|myopia|myopia
4688424|NCT03313921|astigmatism|astigmatism
4688425|NCT03313921|online assessment|online assessment
4688426|NCT03313921|refractive error|refractive error
4688427|NCT03313895|cognitive impairment, Alzheimer's disease, exercise, cognitive training, imaging|cognitive impairment, alzheimer's disease, exercise, cognitive training, imaging
4688428|NCT03313882|RNA Stability|rna stability
4688429|NCT03313882|HuR protein|hur protein
4688430|NCT03313882|SCN5A|scn5a
4688431|NCT03313869|Metabolism|metabolism
4688432|NCT03313869|Lipid oxidation|lipid oxidation
4688433|NCT03313869|micronutrient cocktail supplementation|micronutrient cocktail supplementation
4688434|NCT03313869|physical inactivity|physical inactivity
4688435|NCT03313869|glucose intolerance|glucose intolerance
4688436|NCT03313869|oxidative stress|oxidative stress
4688437|NCT03313843|Optical Coherence Tomography|optical coherence tomography
4688438|NCT03313830|Whey|whey
4688439|NCT03313830|Muscle Protein Synthesis|muscle protein synthesis
4688440|NCT03313778|mRNA-4157|mrna-4157
4688441|NCT03313778|Personalized cancer vaccine|personalized cancer vaccine
4688442|NCT03313778|PCV|pcv
4688443|NCT03313778|pembrolizumab|pembrolizumab
4688444|NCT03313752|diabetes, heart, dapagliflozin,|diabetes, heart, dapagliflozin,
4688445|NCT03313726|PSMA-PET|psma-pet
4688446|NCT03313700|Stomach Neoplasm|stomach neoplasm
4688447|NCT03313700|Robotic Surgery|robotic surgery
4688448|NCT03313700|Distal Gastrectomy|distal gastrectomy
4688449|NCT03313648|Recurrent HCC|recurrent hcc
4688450|NCT03313648|Laparoscopic Hepatectomy|laparoscopic hepatectomy
4688451|NCT03313648|RFA|rfa
4688452|NCT03313648|RCT|rct
4688453|NCT03313635|Prealbumin|prealbumin
4688454|NCT03313622|OCD|ocd
4688455|NCT03313622|Obsessive Compulsive Disorder|obsessive compulsive disorder
4688456|NCT03313557|Continued access, safety assessments|continued access, safety assessments
4688457|NCT03313531|Thrombin generation|thrombin generation
4688458|NCT03313531|variability|variability
4688459|NCT03313531|level of agreement|level of agreement
4688460|NCT03313531|hemophilia|hemophilia
4688461|NCT03313518|tDCS, Alzheimer Disease|tdcs, alzheimer disease
4688462|NCT03313479|Nausea, vomiting|nausea, vomiting
4688463|NCT03313440|Fibre|fibre
4688464|NCT03313440|diet|diet
4688465|NCT03313440|fecal bulk|fecal bulk
4688466|NCT03313414|HCV|hcv
4688467|NCT03313414|Needlestick|needlestick
4688468|NCT03313375|hemodynamics|hemodynamics
4688469|NCT03313375|exercise|exercise
4688470|NCT03313349|ADHD, Behavioral Problems, Children and Adolescents|adhd, behavioral problems, children and adolescents
4688471|NCT03313336|Dermal anesthesia.|dermal anesthesia.
4688472|NCT03313336|Venipuncture and intravenous cannulation.|venipuncture and intravenous cannulation.
4688473|NCT03313336|Skin blanching or erythema.|skin blanching or erythema.
4688474|NCT03313336|Phase I.|phase i.
4688475|NCT03313336|Therapeutic equivalence.|therapeutic equivalence.
4688476|NCT03313336|Eutectic Mixture of Local anaesthetics (EMLA)|eutectic mixture of local anaesthetics (emla)
4688477|NCT03313323|Immuno-PET|immuno-pet
4688478|NCT03313323|Ipilimumab|ipilimumab
4688479|NCT03313323|Immunotherapy|immunotherapy
4688480|NCT03313310|Youth Empowerment|youth empowerment
4688481|NCT03313310|Employment Intervention|employment intervention
4688482|NCT03313310|Young Men Who Have Sex With Men|young men who have sex with men
4688483|NCT03313310|Young Transgender Women|young transgender women
4688484|NCT03313297|skin|skin
4688485|NCT03313297|wound healing|wound healing
4688486|NCT03313297|11 beta-hydroxysteroid dehydrogenase type 1|11 beta-hydroxysteroid dehydrogenase type 1
4688487|NCT03313271|lymphoma|lymphoma
4688488|NCT03313271|CLAP|clap
4688489|NCT03313271|China|china
4688490|NCT03313271|patient registry|patient registry
4688491|NCT03313193|nausea|nausea
4688492|NCT03313193|vomiting|vomiting
4688493|NCT03313193|pain|pain
4688494|NCT03313193|fatigue|fatigue
4688495|NCT03313193|depression|depression
4688496|NCT03313193|anxiety|anxiety
4688497|NCT03313193|PTSD|ptsd
4688498|NCT03313154|Quality of Life|quality of life
4688499|NCT03313154|Psychiatric comorbidity|psychiatric comorbidity
4688500|NCT03313154|Cognitive impairment|cognitive impairment
4688501|NCT03313154|Chronic Hepatitis HCV-related|chronic hepatitis hcv-related
4688502|NCT03313089|micronutrient powders|micronutrient powders
4688503|NCT03313089|spinkles|spinkles
4688504|NCT03313089|nutrition|nutrition
4688505|NCT03313089|food security program|food security program
4688506|NCT03313089|nutritional program|nutritional program
4688507|NCT03313089|hemoglobin|hemoglobin
4688508|NCT03313089|anemia|anemia
4688509|NCT03313076|burn injury|burn injury
4688510|NCT03313076|thermal burn injury|thermal burn injury
4688511|NCT03313076|omega 3 fatty acids|omega 3 fatty acids
4688512|NCT03313076|vitamin D|vitamin d
4688513|NCT03313076|fish oil|fish oil
4688514|NCT03313076|chronic pain|chronic pain
4688515|NCT03313076|chronic pain due to trauma|chronic pain due to trauma
4688516|NCT03313063|magnetic resonance imaging|magnetic resonance imaging
4688517|NCT03313063|myocard|myocard
4688518|NCT03313063|preeclampsia|preeclampsia
4688519|NCT03313011|apraxia of speech|apraxia of speech
4688520|NCT03312972|Cancer|cancer
4688521|NCT03312972|HDR Brachytherapy|hdr brachytherapy
4688522|NCT03312972|Prostate Cancer|prostate cancer
4688523|NCT03312920|tDCS, accelerated learning, memory|tdcs, accelerated learning, memory
4688524|NCT03312907|immunosuppressants|immunosuppressants
4688525|NCT03312907|Systemic Lupus Erythematosus Disease Activity Index|systemic lupus erythematosus disease activity index
4688526|NCT03312907|Belimumab|belimumab
4688527|NCT03312907|Lupus Low Disease Activity State|lupus low disease activity state
4688528|NCT03312907|Systemic Lupus Erythematosus|systemic lupus erythematosus
4688529|NCT03312894|Drug therapy|drug therapy
4688530|NCT03312881|pain|pain
4688531|NCT03312881|neuropathic|neuropathic
4688532|NCT03312881|children|children
4688533|NCT03312881|QST|qst
4688534|NCT03312868|Stereotactic Body Radiotherapy|stereotactic body radiotherapy
4688535|NCT03312855|coronary artery disease|coronary artery disease
4688536|NCT03312855|platelet inhibition|platelet inhibition
4688537|NCT03312790|augmented reality|augmented reality
4688538|NCT03312790|fatigue|fatigue
4688539|NCT03312790|muscle|muscle
4688540|NCT03312790|heart rate|heart rate
4688541|NCT03312790|mental function|mental function
4688542|NCT03312777|analgesia, Cytochrome P450 2D6|analgesia, cytochrome p450 2d6
4688543|NCT03312764|Prediabetes|prediabetes
4688544|NCT03312764|Obesity|obesity
4688545|NCT03312764|Intensive behavioral counseling|intensive behavioral counseling
4688546|NCT03312764|Type 2 Diabetes|type 2 diabetes
4688547|NCT03312751|Interferon-gamma|interferon-gamma
4688548|NCT03312751|NI-0501|ni-0501
4688549|NCT03312751|primary HLH|primary hlh
4688550|NCT03312738|everolimus|everolimus
4688551|NCT03312738|exemestane|exemestane
4688552|NCT03312738|advanced Breast Cancer|advanced breast cancer
4688553|NCT03312738|non-steroidal aromatase inhibitors|non-steroidal aromatase inhibitors
4688554|NCT03312738|breast carcinoma|breast carcinoma
4688555|NCT03312738|breast cancer|breast cancer
4688556|NCT03312738|breast lump|breast lump
4688557|NCT03312738|HER2 negative|her2 negative
4688558|NCT03312738|breast cancer progression|breast cancer progression
4688559|NCT03312712|FDG|fdg
4688560|NCT03312712|PET|pet
4688561|NCT03312712|CT|ct
4688562|NCT03312712|Sarcoidosis|sarcoidosis
4688563|NCT03312699|Inactivated, quadrivalent influenza vaccine|inactivated, quadrivalent influenza vaccine
4688564|NCT03312699|Inactivated Hepatitis A vaccine|inactivated hepatitis a vaccine
4688565|NCT03312699|Inactivated, trivalent high-dose influenza vaccine|inactivated, trivalent high-dose influenza vaccine
4688566|NCT03312699|Typhoid Vi Polysaccharide Vaccine|typhoid vi polysaccharide vaccine
4688567|NCT03312699|Typhoid Vaccine Live Oral Ty21a|typhoid vaccine live oral ty21a
4688568|NCT03312699|Influenza Vaccine, Adjuvanted|influenza vaccine, adjuvanted
4688569|NCT03312686|endoflip|endoflip
4688570|NCT03312660|Prebiotics|prebiotics
4688571|NCT03312660|kefir|kefir
4688572|NCT03312647|Adverse Drug Reaction|adverse drug reaction
4688573|NCT03312647|Latent Tuberculosis Infection|latent tuberculosis infection
4688574|NCT03312647|Tuberculosis|tuberculosis
4688575|NCT03312634|Interventional study|interventional study
4688576|NCT03312634|Clinical trial phase 3|clinical trial phase 3
4688577|NCT03312634|Efficacy and safety|efficacy and safety
4688578|NCT03312634|Heterotopic ossification|heterotopic ossification
4688579|NCT03312634|Flare-up|flare-up
4688580|NCT03312634|Palovarotene|palovarotene
4688581|NCT03312634|Retinoic acid receptor agonist|retinoic acid receptor agonist
4688582|NCT03312634|Retinoic acid receptor gamma agonist|retinoic acid receptor gamma agonist
4688583|NCT03312634|Clementia|clementia
4688584|NCT03312634|Myositis Ossificans Progressiva|myositis ossificans progressiva
4688585|NCT03312634|Munchmeyer's Disease|munchmeyer's disease
4688586|NCT03312634|FOP|fop
4688587|NCT03312634|FOP variants|fop variants
4688588|NCT03312621|Adolescent Health|adolescent health
4688589|NCT03312608|cerebral reorganization, TMS|cerebral reorganization, tms
4688590|NCT03312556|hypertension|hypertension
4688591|NCT03312556|supine hypertension|supine hypertension
4688592|NCT03312556|autonomic failure|autonomic failure
4688593|NCT03312556|pure autonomic failure|pure autonomic failure
4688594|NCT03312556|multiple system atrophy|multiple system atrophy
4688595|NCT03312556|cpap|cpap
4688596|NCT03312543|Photoaging of Skin, Skin Wrinkling, Solar Aging of Skin, light therapy|photoaging of skin, skin wrinkling, solar aging of skin, light therapy
4688597|NCT03312517|insomnia|insomnia
4688598|NCT03312517|belsomra|belsomra
4688599|NCT03312517|suvorexant|suvorexant
4688600|NCT03312504|sport injury|sport injury
4688601|NCT03312504|injury prevention|injury prevention
4688602|NCT03312504|fitness|fitness
4688603|NCT03312504|neuromuscular training|neuromuscular training
4688604|NCT03312504|implementation|implementation
4688605|NCT03312465|Total Shoulder Arthroplasty|total shoulder arthroplasty
4688606|NCT03312465|Hemi Shoulder Arthroplasty|hemi shoulder arthroplasty
4688608|NCT03312452|Perioperative|perioperative
4688609|NCT03312452|Intravenous fluid|intravenous fluid
4688610|NCT03312439|Myocardial infarction|myocardial infarction
4688611|NCT03312439|Stroke|stroke
4688612|NCT03312439|Diabetes|diabetes
4688613|NCT03312439|Depression|depression
4688614|NCT03312439|Dementia|dementia
4688615|NCT03312439|Fractures|fractures
4688616|NCT03312426|Cancer|cancer
4688617|NCT03312426|Tumor|tumor
4688618|NCT03312426|Healthy Participants|healthy participants
4688619|NCT03312426|Healthy Subjects|healthy subjects
4688620|NCT03312426|Neoplasm|neoplasm
4688621|NCT03312413|dexmedetomidine|dexmedetomidine
4688622|NCT03312413|coughing during anesthetic emergence|coughing during anesthetic emergence
4688623|NCT03312413|thyroid surgery|thyroid surgery
4688624|NCT03312400|Telomeres|telomeres
4688625|NCT03312400|Aplastic Anemia|aplastic anemia
4688626|NCT03312400|Pulmonary Fibrosis|pulmonary fibrosis
4688627|NCT03312400|Androgens|androgens
4688628|NCT03312400|Hepatic Fibrosis|hepatic fibrosis
4688629|NCT03312335|Lupus Erythematosus, Systemic|lupus erythematosus, systemic
4688630|NCT03312335|SLE|sle
4688631|NCT03312335|Interleukin-2|interleukin-2
4688632|NCT03312335|IL-2|il-2
4688633|NCT03312335|T-Lymphocytes, Regulatory|t-lymphocytes, regulatory
4688634|NCT03312335|Treg|treg
4688635|NCT03312296|Stent Thrombosis|stent thrombosis
4688636|NCT03312270|aphasia|aphasia
4688637|NCT03312270|comprehension|comprehension
4688638|NCT03312270|text-to-speech|text-to-speech
4688639|NCT03312270|social validity|social validity
4688640|NCT03312231|A/H7N9|a/h7n9
4688641|NCT03312231|Immunogenicity|immunogenicity
4688642|NCT03312231|Influenza|influenza
4688643|NCT03312231|Safety|safety
4688644|NCT03312231|Sanofi Pasteur|sanofi pasteur
4688645|NCT03312231|Vaccine|vaccine
4688646|NCT03312192|Anterior Cervical Discectomy and Fusion|anterior cervical discectomy and fusion
4688647|NCT03312192|Stand-Alone Cage|stand-alone cage
4688648|NCT03312192|Anterior Plating|anterior plating
4688649|NCT03312166|ear lobe|ear lobe
4688650|NCT03312166|compression|compression
4688651|NCT03312166|medical device|medical device
4688652|NCT03312166|recurrence|recurrence
4688653|NCT03312101|exercise program|exercise program
4688654|NCT03312062|elbow|elbow
4688655|NCT03312062|foam rolling|foam rolling
4688656|NCT03312062|proprioception|proprioception
4688657|NCT03312062|motor performance|motor performance
4688658|NCT03312062|strength|strength
4688659|NCT03312049|Aflatoxin B1|aflatoxin b1
4688660|NCT03312049|Aflatoxin M1|aflatoxin m1
4688661|NCT03312049|Aflatoxin|aflatoxin
4688662|NCT03312049|Mycotoxin|mycotoxin
4688663|NCT03312049|Stunting|stunting
4688664|NCT03312049|Linear growth|linear growth
4688665|NCT03312049|Pregnancy|pregnancy
4688666|NCT03312049|Birth outcomes|birth outcomes
4688667|NCT03312049|Nepal|nepal
4688668|NCT03312036|CPFA|cpfa
4688669|NCT03312036|Liver failure|liver failure
4688670|NCT03312036|Resin|resin
4688671|NCT03312036|detoxification|detoxification
4688672|NCT03312023|Hepatitis B|hepatitis b
4688673|NCT03312023|HBsAg|hbsag
4688674|NCT03312023|Ledipasvir/Sofosbuvir|ledipasvir/sofosbuvir
4688675|NCT03312023|Hepatitis B treatment|hepatitis b treatment
4688676|NCT03311997|RCT|rct
4688677|NCT03311997|Hamstring|hamstring
4688678|NCT03311997|Suture|suture
4688679|NCT03311945|Raltegravir|raltegravir
4688680|NCT03311945|Lamivudine|lamivudine
4688681|NCT03311776|Pancreatic cancer|pancreatic cancer
4688682|NCT03311776|Biomarkers|biomarkers
4688683|NCT03311776|Biobank|biobank
4688684|NCT03311776|Diagnostic biomarkers|diagnostic biomarkers
4688685|NCT03311776|Predictive biomarkers|predictive biomarkers
4688686|NCT03311776|Prognostic biomarkers|prognostic biomarkers
4688687|NCT03311763|implementation|implementation
4688688|NCT03311711|Dementia|dementia
4688689|NCT03311711|Aging|aging
4688690|NCT03311711|Behavioral Research|behavioral research
4688691|NCT03311659|Diphtheria|diphtheria
4688692|NCT03311659|Pertussis|pertussis
4688693|NCT03311659|Tetanus|tetanus
4688694|NCT03311659|Immunogenicity|immunogenicity
4688695|NCT03311633|Radius Fracture Distal|radius fracture distal
4688696|NCT03311633|Radius Fracture Distal Therapy|radius fracture distal therapy
4688697|NCT03311633|Fracture fixation|fracture fixation
4688698|NCT03311633|Closed Fracture Reduction|closed fracture reduction
4688699|NCT03311607|Post-kala-azar Dermal Leishmaniasis|post-kala-azar dermal leishmaniasis
4688700|NCT03311607|Visceral Leishmaniasis|visceral leishmaniasis
4688701|NCT03311607|AmBisome|ambisome
4688702|NCT03311607|Liposomal amphotericin B|liposomal amphotericin b
4688703|NCT03311607|Bangladesh|bangladesh
4688704|NCT03311607|Kala azar|kala azar
4688705|NCT03311594|Alcohol|alcohol
4688706|NCT03311594|Pain|pain
4688707|NCT03311568|Ultrasonography|ultrasonography
4688708|NCT03311568|Microvessels|microvessels
4688709|NCT03311568|Physiopathology|physiopathology
4688710|NCT03311568|Diagnostic Imaging|diagnostic imaging
4688711|NCT03311568|Critical Care|critical care
4688712|NCT03311555|Recurrent PSA-only prostate cancer following prostatectomy|recurrent psa-only prostate cancer following prostatectomy
4688713|NCT03311542|GBM|gbm
4688714|NCT03311542|Glioma|glioma
4688715|NCT03311516|insulin therapy|insulin therapy
4688716|NCT03311503|lentiviral|lentiviral
4688717|NCT03311503|Gene therapy|gene therapy
4688718|NCT03311503|busulfan|busulfan
4688719|NCT03311490|Ankle Sprain|ankle sprain
4688720|NCT03311490|Prophylaxis|prophylaxis
4688721|NCT03311490|Indoor Sports|indoor sports
4688722|NCT03311490|Ligamentous sprain|ligamentous sprain
4688723|NCT03311490|Prevention|prevention
4688724|NCT03311477|ABBV-399|abbv-399
4688725|NCT03311477|Maximum tolerated dose (MTD)|maximum tolerated dose (mtd)
4688726|NCT03311477|Maximally administered dose (MAD)|maximally administered dose (mad)
4688727|NCT03311477|Dose escalation|dose escalation
4688728|NCT03311477|Pharmacokinetics|pharmacokinetics
4688729|NCT03311477|Advanced solid tumors|advanced solid tumors
4688730|NCT03311477|Cancer|cancer
4688731|NCT03311477|Solid tumors|solid tumors
4688732|NCT03311464|Pyoderma Gangrenosum|pyoderma gangrenosum
4688733|NCT03311464|Ulcer|ulcer
4688734|NCT03311464|Efficacy|efficacy
4688735|NCT03311464|Safety|safety
4688736|NCT03311464|Adalimumab|adalimumab
4688737|NCT03311464|Humira®|humira®
4688738|NCT03311464|Japan|japan
4688739|NCT03311425|Anterior cervical discectomy and fusion|anterior cervical discectomy and fusion
4688740|NCT03311425|prevertebral swelling|prevertebral swelling
4688741|NCT03311425|swallowing|swallowing
4688742|NCT03311425|methylprednisolone|methylprednisolone
4688743|NCT03311425|intraoperative steroid|intraoperative steroid
4688744|NCT03311412|Locally advanced/unresectable|locally advanced/unresectable
4688745|NCT03311412|Metastatic solid tumor|metastatic solid tumor
4688746|NCT03311412|Lymphoma|lymphoma
4688747|NCT03311412|Anti-PD-1|anti-pd-1
4688748|NCT03311412|PD-1|pd-1
4688749|NCT03311412|PD1|pd1
4688750|NCT03311399|Surgical Site Infection|surgical site infection
4688751|NCT03311399|mHealth|mhealth
4688752|NCT03311399|Cesarean Section|cesarean section
4688753|NCT03311373|COPD|copd
4688754|NCT03311360|vertebral artery origin stenosis|vertebral artery origin stenosis
4688755|NCT03311360|drug-coated balloon|drug-coated balloon
4688756|NCT03311360|stenting|stenting
4688757|NCT03311360|medical treatment|medical treatment
4688758|NCT03311347|pulmonary ultrasound|pulmonary ultrasound
4688759|NCT03311347|hypergravity|hypergravity
4688760|NCT03311347|human physiology|human physiology
4688761|NCT03311347|oxygen|oxygen
4688762|NCT03311347|lung ventilation|lung ventilation
4688763|NCT03311347|lung perfusion|lung perfusion
4688764|NCT03311347|computed tomography|computed tomography
4688765|NCT03311347|electrical impedance tomography|electrical impedance tomography
4688766|NCT03311347|altitude chamber|altitude chamber
4688767|NCT03311334|DSP-7888|dsp-7888
4688768|NCT03311334|nivolumab|nivolumab
4688769|NCT03311334|atezolizumab|atezolizumab
4688770|NCT03311334|immune checkpoint inhibitor|immune checkpoint inhibitor
4688771|NCT03311334|cancer vaccine|cancer vaccine
4688772|NCT03311334|Wilms Tumor 1|wilms tumor 1
4688773|NCT03311334|ICI|ici
4688774|NCT03311321|Arterial Stiffness|arterial stiffness
4688775|NCT03311321|Endothelial Function|endothelial function
4688776|NCT03311321|Vitamin K|vitamin k
4688777|NCT03311308|Melanoma|melanoma
4688778|NCT03311308|Unresectable|unresectable
4688779|NCT03311308|Stage III|stage iii
4688780|NCT03311308|Stage IV|stage iv
4688781|NCT03311282|breastfeeding|breastfeeding
4688782|NCT03311282|infants|infants
4688783|NCT03311282|squeezing|squeezing
4688784|NCT03311282|breathing|breathing
4688785|NCT03311256|Tissue Transit Time|tissue transit time
4688786|NCT03311243|cytokines|cytokines
4688787|NCT03311243|scaling root planing|scaling root planing
4688788|NCT03311243|oral hygiene|oral hygiene
4688789|NCT03311243|systemic inflammation|systemic inflammation
4688790|NCT03311204|Eyelid margin|eyelid margin
4688791|NCT03311204|tear film|tear film
4688792|NCT03311204|debridement|debridement
4688793|NCT03311204|contact lens and ocular discomfort|contact lens and ocular discomfort
4688794|NCT03311178|Shock|shock
4688795|NCT03311178|Preterm infant|preterm infant
4688796|NCT03311178|Dobutamine|dobutamine
4688797|NCT03311165|neonate|neonate
4688798|NCT03311165|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
4688799|NCT03311165|prognosis|prognosis
4688800|NCT03311165|risk factor|risk factor
4688801|NCT03311165|clinical course|clinical course
4688802|NCT03311152|Hepatocellular carcinoma|hepatocellular carcinoma
4688803|NCT03311152|Cirrhosis|cirrhosis
4688804|NCT03311152|Circulating epigenetic biomarker|circulating epigenetic biomarker
4688805|NCT03311152|Plasma biomarker|plasma biomarker
4688806|NCT03311152|SEPT9|sept9
4688807|NCT03311152|Septin9|septin9
4688808|NCT03311152|DNA methylation biomarker|dna methylation biomarker
4688809|NCT03311152|Circulating DNA methylation biomarker|circulating dna methylation biomarker
4688810|NCT03311152|Alpha-fetoprotein|alpha-fetoprotein
4688811|NCT03311139|Atrial Fibrillation|atrial fibrillation
4688812|NCT03311139|Acute Coronary Syndrome|acute coronary syndrome
4688813|NCT03311139|Anticoagulation|anticoagulation
4688814|NCT03311087|high flow nasal oxygen|high flow nasal oxygen
4688815|NCT03311087|acute hypoxemic respiratory failure|acute hypoxemic respiratory failure
4688816|NCT03311087|adults|adults
4688817|NCT03311087|intensive care unit|intensive care unit
4688818|NCT03311074|Sonication Linker Medicated Polymerase Chain Reaction|sonication linker medicated polymerase chain reaction
4688819|NCT03311074|GSK2696273|gsk2696273
4688820|NCT03311074|Gene therapy|gene therapy
4688821|NCT03311074|Adenosine deaminase deficiency|adenosine deaminase deficiency
4688822|NCT03311074|Retroviral insertion site|retroviral insertion site
4688823|NCT03311074|Severe combined immunodeficiency|severe combined immunodeficiency
4688824|NCT03311061|Teen Pregnancy|teen pregnancy
4688825|NCT03311061|Prevention|prevention
4688826|NCT03311061|Positive Youth Development|positive youth development
4688827|NCT03311061|Financial Literacy|financial literacy
4688828|NCT03311061|College and Career Readiness|college and career readiness
4688829|NCT03311061|School Based Intervention|school based intervention
4688830|NCT03311061|Age 13-19|age 13-19
4688831|NCT03311061|Behavior Modification|behavior modification
4688832|NCT03311048|Cleaning workers|cleaning workers
4688833|NCT03311048|Work-related asthma|work-related asthma
4688834|NCT03311048|Work-related rhinitis|work-related rhinitis
4688835|NCT03311048|Respiratory symptoms|respiratory symptoms
4688836|NCT03311048|Nasal swab|nasal swab
4688837|NCT03310996|working memory|working memory
4688838|NCT03310983|Fat mass|fat mass
4688839|NCT03310983|Gestational weight gain|gestational weight gain
4688840|NCT03310983|Fetal adipose tissue|fetal adipose tissue
4688841|NCT03310970|Peer Reviewed Research|peer reviewed research
4688842|NCT03310957|Breast cancer|breast cancer
4688843|NCT03310957|Breast carcinoma|breast carcinoma
4688844|NCT03310957|Triple negative breast cancer|triple negative breast cancer
4688845|NCT03310957|Locally-advanced breast cancer|locally-advanced breast cancer
4688846|NCT03310957|Metastatic breast cancer|metastatic breast cancer
4688847|NCT03310957|Tumors, breast|tumors, breast
4688848|NCT03310957|Breast tumors|breast tumors
4688849|NCT03310957|pembrolizumab|pembrolizumab
4688850|NCT03310957|LIV-1 protein, human|liv-1 protein, human
4688851|NCT03310918|AML|aml
4688852|NCT03310905|Research|research
4688853|NCT03310905|Transplant|transplant
4688854|NCT03310905|Abdominal Wall|abdominal wall
4688855|NCT03310905|Hernia|hernia
4688856|NCT03310892|Colorectal cancer screening|colorectal cancer screening
4688857|NCT03310879|Cancer|cancer
4688858|NCT03310853|probiotics|probiotics
4688859|NCT03310853|infections|infections
4688860|NCT03310853|bacterial vaginosis|bacterial vaginosis
4688861|NCT03310827|Nutrition|nutrition
4688862|NCT03310827|Nutrigenomics|nutrigenomics
4688863|NCT03310801|left atrial appendage occlusion|left atrial appendage occlusion
4688864|NCT03310801|antithrombotic therapy|antithrombotic therapy
4688865|NCT03310801|atrial fibrillation|atrial fibrillation
4688866|NCT03310801|percutaneous coronary intervention|percutaneous coronary intervention
4688867|NCT03310801|drug eluting stent|drug eluting stent
4688868|NCT03310788|IOP fluctuations|iop fluctuations
4688869|NCT03310788|iCare Home|icare home
4688870|NCT03310788|SLT|slt
4688871|NCT03310788|self-tonometry|self-tonometry
4688872|NCT03310775|Social skill training|social skill training
4688873|NCT03310775|PEERS|peers
4688874|NCT03310762|immunization coverage|immunization coverage
4688875|NCT03310762|silicon bracelet|silicon bracelet
4688876|NCT03310762|immunization reminders|immunization reminders
4688877|NCT03310749|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
4688878|NCT03310749|DPP-IV inhibitor|dpp-iv inhibitor
4688879|NCT03310749|Drug-Drug Interactions|drug-drug interactions
4688880|NCT03310749|Ethnicity|ethnicity
4688881|NCT03310736|iron deficiency|iron deficiency
4688882|NCT03310736|anemia|anemia
4688883|NCT03310736|hepcidin|hepcidin
4688884|NCT03310697|Afebrile seizure|afebrile seizure
4688885|NCT03310697|Toxicological screening|toxicological screening
4688886|NCT03310697|Chromatography|chromatography
4688887|NCT03310697|Mass spectrometry|mass spectrometry
4688888|NCT03310697|Children|children
4688889|NCT03310684|Renin-Angiotensin system|renin-angiotensin system
4688890|NCT03310684|Hypertension|hypertension
4688891|NCT03310684|Obesity|obesity
4688892|NCT03310684|Angiotensin-(1-7)|angiotensin-(1-7)
4688893|NCT03310684|Angiotensin II|angiotensin ii
4688894|NCT03310684|FGF23|fgf23
4688895|NCT03310684|Klotho|klotho
4688896|NCT03310684|Uric acid|uric acid
4688897|NCT03310684|Left ventricular hypertrophy|left ventricular hypertrophy
4688898|NCT03310645|Refractory chronic cough|refractory chronic cough
4688899|NCT03310645|healthy volunteers|healthy volunteers
4688900|NCT03310632|Antroquinonol|antroquinonol
4688901|NCT03310632|Hocena|hocena
4688902|NCT03310632|metastatic pancreatic cancer|metastatic pancreatic cancer
4688903|NCT03310619|JCAR017|jcar017
4688904|NCT03310619|B-Cell Malignancies|b-cell malignancies
4688905|NCT03310619|NHL|nhl
4688906|NCT03310619|non-Hodgkin lymphoma|non-hodgkin lymphoma
4688907|NCT03310619|CAR T cells|car t cells
4688908|NCT03310619|chimeric antigen receptor|chimeric antigen receptor
4688909|NCT03310606|Therapeutic drug monitoring|therapeutic drug monitoring
4688910|NCT03310593|bipolar disorder|bipolar disorder
4688911|NCT03310593|bipolar depression|bipolar depression
4688912|NCT03310593|cannabidiol|cannabidiol
4688913|NCT03310593|endocannabinoids|endocannabinoids
4688914|NCT03310541|AZD5363|azd5363
4688915|NCT03310541|AKT Mutations|akt mutations
4688916|NCT03310541|17-322|17-322
4688917|NCT03310528|Aspiration risk|aspiration risk
4688918|NCT03310528|GI Endoscopy|gi endoscopy
4688919|NCT03310528|Fasting guidelines|fasting guidelines
4688920|NCT03310528|Delayed gastric emptying|delayed gastric emptying
4688921|NCT03310515|PrEP|prep
4688923|NCT03310515|seroincidence|seroincidence
4688924|NCT03310515|HIV-1|hiv-1
4688925|NCT03310515|TGW|tgw
4688926|NCT03310515|STIs|stis
4688927|NCT03310502|positron emission tomography|positron emission tomography
4688928|NCT03310502|skeletal muscle|skeletal muscle
4688929|NCT03310502|liver|liver
4688930|NCT03310502|adipose tissue|adipose tissue
4688931|NCT03310502|brain|brain
4688932|NCT03310502|genetics|genetics
4688933|NCT03310463|infection|infection
4688934|NCT03310463|gram-negative bacterium|gram-negative bacterium
4688935|NCT03310463|renal impairment|renal impairment
4688936|NCT03310450|troponin-I|troponin-i
4688937|NCT03310450|hs-CRP|hs-crp
4688938|NCT03310450|Malondialdehyde|malondialdehyde
4688939|NCT03310450|predictors|predictors
4688940|NCT03310385|Acute Bronchitis, Herbal Medicine|acute bronchitis, herbal medicine
4688941|NCT03310333|PROM|prom
4688942|NCT03310333|Dinoprostone|dinoprostone
4688943|NCT03310333|cervical ripening device|cervical ripening device
4688944|NCT03310333|oxytocin|oxytocin
4688945|NCT03310320|Plaque psoriasis|plaque psoriasis
4688946|NCT03310320|PASI|pasi
4688947|NCT03310320|BSA|bsa
4688948|NCT03310320|sPGA|spga
4688949|NCT03310320|P-VAS|p-vas
4688950|NCT03310320|IL17A-|il17a-
4688951|NCT03310320|CCL20|ccl20
4688952|NCT03310320|PK|pk
4688953|NCT03310307|Homocysteine|homocysteine
4688954|NCT03310307|Overweight|overweight
4688955|NCT03310307|vitamin D3|vitamin d3
4688956|NCT03310307|Reproductive women|reproductive women
4688957|NCT03310307|RCT|rct
4688958|NCT03310294|Lactobacillus|lactobacillus
4688959|NCT03310294|Herpes Labial|herpes labial
4688960|NCT03310294|Immune repsonse|immune repsonse
4688961|NCT03310281|Depression|depression
4688962|NCT03310229|cardiovascular complications|cardiovascular complications
4688963|NCT03310216|artificial intelligent|artificial intelligent
4688964|NCT03310216|visual inspection|visual inspection
4688965|NCT03310190|Chronic Lymphocytic Leukemia (CLL)|chronic lymphocytic leukemia (cll)
4688966|NCT03310190|Deletion of the short arm of chromosome 17 (Del[17p])|deletion of the short arm of chromosome 17 (del[17p])
4688967|NCT03310190|Relapse Chronic Lymphocytic Leukemia|relapse chronic lymphocytic leukemia
4688968|NCT03310190|Refractory Chronic Lymphocytic Leukemia|refractory chronic lymphocytic leukemia
4688969|NCT03310190|Chronic Lymphocytic Leukemia with deletion of the short arm of chromosome 17|chronic lymphocytic leukemia with deletion of the short arm of chromosome 17
4688970|NCT03310190|Cancer|cancer
4688971|NCT03310177|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
4688972|NCT03310177|Metabolomics|metabolomics
4688973|NCT03310138|treatment|treatment
4688974|NCT03310138|brain stimulation|brain stimulation
4688975|NCT03310125|Atrial Fibrillation|atrial fibrillation
4688976|NCT03310125|Inflammation|inflammation
4688977|NCT03310125|Thoracic Surgery|thoracic surgery
4688978|NCT03310125|Randomized|randomized
4688979|NCT03310125|Colchicine|colchicine
4688980|NCT03310099|Obesity|obesity
4688981|NCT03310099|Heart failure with preserved ejection fraction|heart failure with preserved ejection fraction
4688982|NCT03310099|HFpEF|hfpef
4688983|NCT03310099|unsaturated fatty acids|unsaturated fatty acids
4688984|NCT03310099|cardiorespiratory fitness|cardiorespiratory fitness
4688985|NCT03310099|dietary intervention|dietary intervention
4688986|NCT03310086|corticision|corticision
4688987|NCT03310086|CBCT|cbct
4688988|NCT03310086|Crowding|crowding
4688989|NCT03309995|Cough|cough
4688990|NCT03309995|Laryngitis|laryngitis
4688991|NCT03309995|Pharyngitis|pharyngitis
4688992|NCT03309995|Rhinitis|rhinitis
4688993|NCT03309995|Zinc Acetate|zinc acetate
4688994|NCT03309995|Zinc Lozenge|zinc lozenge
4688995|NCT03309956|Ambulatory Electrocardiography|ambulatory electrocardiography
4688996|NCT03309956|Holter Monitor|holter monitor
4688997|NCT03309956|Zio Patch Monitor|zio patch monitor
4688998|NCT03309956|Pediatrics|pediatrics
4688999|NCT03309930|comprehension|comprehension
4689000|NCT03309930|Strategies|strategies
4689001|NCT03309930|repeated exposure|repeated exposure
4689002|NCT03309865|semi-vegetarian diet|semi-vegetarian diet
4689003|NCT03309865|vedolizumab|vedolizumab
4689004|NCT03309865|ulcerative colitis|ulcerative colitis
4689005|NCT03309839|HLA-DR expression|hla-dr expression
4689006|NCT03309839|cardiopulmonary bypass|cardiopulmonary bypass
4689007|NCT03309839|neonate|neonate
4689008|NCT03309826|gestational hypertension|gestational hypertension
4689009|NCT03309826|pre-eclampsia|pre-eclampsia
4689010|NCT03309826|eclampsia|eclampsia
4689011|NCT03309826|obstructive sleep apnea-hypopnea|obstructive sleep apnea-hypopnea
4689012|NCT03309826|positive airway pressure|positive airway pressure
4689013|NCT03309826|polysomnography|polysomnography
4689014|NCT03309826|blood pressure|blood pressure
4689015|NCT03309826|arterial stiffness|arterial stiffness
4689016|NCT03309813|ExAblate|exablate
4689017|NCT03309813|TcMRgFUS|tcmrgfus
4689018|NCT03309813|Thalamotomy|thalamotomy
4689019|NCT03309800|Acute Bronchitis|acute bronchitis
4689020|NCT03309774|Children|children
4689021|NCT03309774|Complex Regional Pain Syndrome|complex regional pain syndrome
4689022|NCT03309774|Relaxation|relaxation
4689023|NCT03309774|Bergès relaxation|bergès relaxation
4689024|NCT03309774|Pain|pain
4689025|NCT03309748|photodynamic therapy|photodynamic therapy
4689026|NCT03309748|black-stain|black-stain
4689027|NCT03309748|Pigmented bacteria|pigmented bacteria
4689028|NCT03309748|Tannerella forsythia|tannerella forsythia
4689029|NCT03309735|threatened miscarriage|threatened miscarriage
4689030|NCT03309735|miscarriage|miscarriage
4689031|NCT03309735|micronized progesterone|micronized progesterone
4689032|NCT03309735|dydrogesterone|dydrogesterone
4689033|NCT03309670|psychiatric outcome|psychiatric outcome
4689034|NCT03309670|psychosocial outcome|psychosocial outcome
4689035|NCT03309670|young|young
4689036|NCT03309644|Unplanned admissions|unplanned admissions
4689037|NCT03309644|Visits to the ED|visits to the ed
4689038|NCT03309644|Readmissions|readmissions
4689039|NCT03309644|Death|death
4689040|NCT03309631|Gene classifier|gene classifier
4689041|NCT03309618|myocardial infarction|myocardial infarction
4689042|NCT03309618|arterial stiffness|arterial stiffness
4689043|NCT03309618|pulse wave velocity|pulse wave velocity
4689044|NCT03309618|flow mediated dilatation|flow mediated dilatation
4689045|NCT03309618|fluvastatin|fluvastatin
4689046|NCT03309618|valsartan|valsartan
4689047|NCT03309605|Translational read through|translational read through
4689048|NCT03309579|Aneurysmal subarachnoid hemorrhage (aSAH)|aneurysmal subarachnoid hemorrhage (asah)
4689049|NCT03309579|Red Blood Cell Transfusion (RBC)|red blood cell transfusion (rbc)
4689050|NCT03309579|Vasospasm|vasospasm
4689051|NCT03309579|Intracranial Hemorrhages|intracranial hemorrhages
4689052|NCT03309579|Cardiovascular Diseases|cardiovascular diseases
4689053|NCT03309540|Low back/lumbar spine|low back/lumbar spine
4689054|NCT03309540|Multimodal Physical therapy|multimodal physical therapy
4689055|NCT03309540|Quality of life|quality of life
4689056|NCT03309540|Range of Motion|range of motion
4689057|NCT03309540|Pain|pain
4689058|NCT03309527|insomia|insomia
4689059|NCT03309527|Depression|depression
4689060|NCT03309527|Self Harm|self harm
4689061|NCT03309527|Suicide|suicide
4689062|NCT03309527|guided self-help|guided self-help
4689063|NCT03309527|psychological treatment|psychological treatment
4689064|NCT03309527|eCBTI|ecbti
4689065|NCT03309527|internet|internet
4689066|NCT03309527|Psychotherapy|psychotherapy
4689067|NCT03309501|Knee osteoarthritis|knee osteoarthritis
4689068|NCT03309501|Randomised Double-blind Controlled trial|randomised double-blind controlled trial
4689069|NCT03309501|Tong-Luo-Qu-Tong Plaster|tong-luo-qu-tong plaster
4689070|NCT03309488|Food allergy|food allergy
4689071|NCT03309488|Milk allergy|milk allergy
4689072|NCT03309488|Egg allergy|egg allergy
4689073|NCT03309488|Nut allergy|nut allergy
4689074|NCT03309488|Basophil activation test|basophil activation test
4689075|NCT03309488|Diagnosis|diagnosis
4689076|NCT03309488|Specific IgE|specific ige
4689077|NCT03309488|Skin prick test|skin prick test
4689078|NCT03309475|first episode psychosis|first episode psychosis
4689079|NCT03309475|early psychosis|early psychosis
4689080|NCT03309475|schizophrenia|schizophrenia
4689081|NCT03309475|mindfulness|mindfulness
4689082|NCT03309475|social cognition|social cognition
4689083|NCT03309475|social functioning|social functioning
4689084|NCT03309475|AGES-Mind|ages-mind
4689085|NCT03309475|SocialMind|socialmind
4689086|NCT03309462|Next generation sequencing|next generation sequencing
4689087|NCT03309462|Re-biopsy|re-biopsy
4689088|NCT03309462|Acquired resistance|acquired resistance
4689089|NCT03309462|Tissue sample|tissue sample
4689090|NCT03309462|Peripheral blood|peripheral blood
4689091|NCT03309423|Blood gas analysis|blood gas analysis
4689092|NCT03309423|Critical care|critical care
4689093|NCT03309423|venus to arterial conversion|venus to arterial conversion
4689094|NCT03309410|Blood Gas Analysis|blood gas analysis
4689095|NCT03309410|Emergency Service, Hospital|emergency service, hospital
4689096|NCT03309410|Venous to arterial conversion|venous to arterial conversion
4689097|NCT03309410|Matched-Pair Analysis|matched-pair analysis
4689098|NCT03309397|adolescent sports|adolescent sports
4689099|NCT03309358|Cystic Fibrosis|cystic fibrosis
4689100|NCT03309358|Pulmonary exacerbation|pulmonary exacerbation
4689101|NCT03309358|Pulmonary inflammation|pulmonary inflammation
4689102|NCT03309358|Respiratory tract disease|respiratory tract disease
4689103|NCT03309358|Pulmonary disease|pulmonary disease
4689104|NCT03309358|Biofilms|biofilms
4689105|NCT03309267|pain, thoracotomy|pain, thoracotomy
4689106|NCT03309228|elderly people|elderly people
4689107|NCT03309228|polymedication,|polymedication,
4689108|NCT03309228|ethics|ethics
4689109|NCT03309228|qualitative research|qualitative research
4689110|NCT03309150|Ataxia telangiectasia mutated and Rad3-related protein inhibitor (ATRi)|ataxia telangiectasia mutated and rad3-related protein inhibitor (atri)
4689111|NCT03309150|M6620|m6620
4689112|NCT03309150|Solid tumors|solid tumors
4689113|NCT03309137|Blood stream infections|blood stream infections
4689114|NCT03309137|Prospective|prospective
4689115|NCT03309137|Preventative|preventative
4689116|NCT03309137|Randomized|randomized
4689117|NCT03309124|White potatoes|white potatoes
4689118|NCT03309124|Older adults|older adults
4689119|NCT03309124|Satiety|satiety
4689120|NCT03309124|Glycaemia|glycaemia
4689121|NCT03309072|transcranial Direct Current Stimulation (tDCS)|transcranial direct current stimulation (tdcs)
4689122|NCT03309072|accelerated learning|accelerated learning
4689123|NCT03309072|memory|memory
4689124|NCT03309059|Nursing care|nursing care
4689125|NCT03309059|diaper rash|diaper rash
4689126|NCT03309059|fecal incontinence|fecal incontinence
4689127|NCT03309059|urinary incontinence|urinary incontinence
4689128|NCT03309046|Parents|parents
4689129|NCT03309046|Caregivers|caregivers
4689130|NCT03309046|Veterans|veterans
4689131|NCT03309033|Vaccine Efficacy|vaccine efficacy
4689132|NCT03309033|Immune Response|immune response
4689133|NCT03309033|Long-Term Protection|long-term protection
4689134|NCT03309020|OCT|oct
4689135|NCT03309020|Cataracts|cataracts
4689136|NCT03309020|Visual Acuity|visual acuity
4689137|NCT03309007|Autophagy|autophagy
4689138|NCT03308994|Multiple sclerosis|multiple sclerosis
4689139|NCT03308994|Epidemiology|epidemiology
4689140|NCT03308994|Oral disease modifying treatments|oral disease modifying treatments
4689141|NCT03308994|Therapeutical delays|therapeutical delays
4689142|NCT03308994|Socio-Economical Status|socio-economical status
4689143|NCT03308981|therapeutic online game|therapeutic online game
4689144|NCT03308981|resilience|resilience
4689145|NCT03308981|prevention|prevention
4689146|NCT03308981|emotional disorders|emotional disorders
4689147|NCT03308981|child|child
4689148|NCT03308981|adolescent|adolescent
4689149|NCT03308942|Niraparib|niraparib
4689150|NCT03308942|Zejula|zejula
4689151|NCT03308942|PARP Inhibitor|parp inhibitor
4689152|NCT03308942|PD-1 Inhibitor|pd-1 inhibitor
4689153|NCT03308916|elastography|elastography
4689154|NCT03308916|screening|screening
4689155|NCT03308916|non-invasive markers|non-invasive markers
4689156|NCT03308916|microbiome|microbiome
4689157|NCT03308916|gut-liver-axis|gut-liver-axis
4689158|NCT03308916|cost-benefit|cost-benefit
4689159|NCT03308916|fibroscan|fibroscan
4689160|NCT03308916|aixplorer|aixplorer
4689161|NCT03308916|ultrasound elastography|ultrasound elastography
4689162|NCT03308916|liver fibrosis|liver fibrosis
4689163|NCT03308916|alcoholic liver disease|alcoholic liver disease
4689164|NCT03308916|advanced fibrosis|advanced fibrosis
4689165|NCT03308916|enhanced liver fibrosis test|enhanced liver fibrosis test
4689166|NCT03308916|direct liver fibrosis markers|direct liver fibrosis markers
4689167|NCT03308916|ELF|elf
4689168|NCT03308916|cytokeratin-18|cytokeratin-18
4689169|NCT03308916|neoepitopes|neoepitopes
4689170|NCT03308916|collagen|collagen
4689171|NCT03308916|NAFLD|nafld
4689172|NCT03308916|ALD|ald
4689173|NCT03308916|metabolomics|metabolomics
4689174|NCT03308916|non-alcoholic fatty liver disease|non-alcoholic fatty liver disease
4689175|NCT03308825|Influenza|influenza
4689176|NCT03308825|Flu|flu
4689177|NCT03308812|Cardiovascular health|cardiovascular health
4689178|NCT03308812|Health coach|health coach
4689179|NCT03308812|Cardiovascular risk factors|cardiovascular risk factors
4689180|NCT03308812|Ethnic disparities|ethnic disparities
4689181|NCT03308812|Behavioral intervention|behavioral intervention
4689182|NCT03308812|E-health lifestyle intervention|e-health lifestyle intervention
4689183|NCT03308812|Health360x|health360x
4689184|NCT03308812|eHealthyStrides|ehealthystrides
4689185|NCT03308773|Prediabetes|prediabetes
4689186|NCT03308773|insulin resistance|insulin resistance
4689187|NCT03308773|T2DM|t2dm
4689188|NCT03308773|Carotid IMT/Plaque|carotid imt/plaque
4689189|NCT03308747|Low-grade systemic inflammation|low-grade systemic inflammation
4689190|NCT03308747|Muscle protein synthesis|muscle protein synthesis
4689191|NCT03308747|Proteasome activation|proteasome activation
4689192|NCT03308747|Anabolic signaling|anabolic signaling
4689193|NCT03308747|Aging|aging
4689194|NCT03308747|Sarcopenia|sarcopenia
4689195|NCT03308734|High-intensity interval training|high-intensity interval training
4689196|NCT03308734|REHIT|rehit
4689197|NCT03308734|Prostate cancer|prostate cancer
4689198|NCT03308734|cardiorespiratory fitness|cardiorespiratory fitness
4689199|NCT03308656|uterocervical angle, labor induction|uterocervical angle, labor induction
4689200|NCT03308643|myomectomy|myomectomy
4689201|NCT03308643|oxytocin|oxytocin
4689202|NCT03308643|blood loss|blood loss
4689203|NCT03308617|sonication|sonication
4689204|NCT03308578|Obsructive sleep apnea|obsructive sleep apnea
4689205|NCT03308578|Adipose tissue|adipose tissue
4689206|NCT03308565|AIS grade A or B|ais grade a or b
4689207|NCT03308513|Prolonged acute mechanical ventilation|prolonged acute mechanical ventilation
4689208|NCT03308500|HIIT|hiit
4689209|NCT03308500|Children|children
4689210|NCT03308500|Cardiorespiratory fitness|cardiorespiratory fitness
4689211|NCT03308500|Body composition|body composition
4689212|NCT03308487|Vitamin D|vitamin d
4689213|NCT03308487|pregnancy|pregnancy
4689214|NCT03308461|difficult defecation|difficult defecation
4689215|NCT03308461|fecal microbiota transplantation|fecal microbiota transplantation
4689216|NCT03308461|stool pattern|stool pattern
4689217|NCT03308448|Traumatic optic neuropathy|traumatic optic neuropathy
4689218|NCT03308448|Erythropoietin|erythropoietin
4689219|NCT03308448|EPO|epo
4689220|NCT03308448|Eprex|eprex
4689221|NCT03308422|screens|screens
4689222|NCT03308422|preschool children|preschool children
4689223|NCT03308422|parenting education|parenting education
4689224|NCT03308422|social perceptions|social perceptions
4689225|NCT03308396|Durvalumab|durvalumab
4689226|NCT03308396|Guadecitabine|guadecitabine
4689227|NCT03308357|drug monitoring|drug monitoring
4689228|NCT03308331|HIV|hiv
4689229|NCT03308331|nicotine|nicotine
4689230|NCT03308331|brain|brain
4689231|NCT03308331|smoking|smoking
4689232|NCT03308318|Deep temporal fascia|deep temporal fascia
4689233|NCT03308318|Deep layer of the deep temporal fascia|deep layer of the deep temporal fascia
4689234|NCT03308318|Superficial layer of the deep temporal fascia|superficial layer of the deep temporal fascia
4689235|NCT03308318|Temporal fascial layers|temporal fascial layers
4689236|NCT03308318|Temporal anatomy|temporal anatomy
4689237|NCT03308279|dry needling|dry needling
4689238|NCT03308279|median nerve|median nerve
4689239|NCT03308279|Pronator Teres|pronator teres
4689240|NCT03308253|Vascular Surgery|vascular surgery
4689241|NCT03308253|Surgical Site Infection|surgical site infection
4689242|NCT03308253|Prophylactic Antibiotics|prophylactic antibiotics
4689243|NCT03308253|Implantable Beads|implantable beads
4689244|NCT03308240|Magic|magic
4689245|NCT03308240|Anxiety|anxiety
4689246|NCT03308240|Pediatric|pediatric
4689247|NCT03308227|Linezolid; PK/PD; Septic shock|linezolid; pk/pd; septic shock
4689248|NCT03308214|septic shock; imipenem; VD ;pharmacokinetics|septic shock; imipenem; vd ;pharmacokinetics
4689249|NCT03308188|Opioid therapy|opioid therapy
4689250|NCT03308188|web-based intervention|web-based intervention
4689251|NCT03308188|self-management|self-management
4689252|NCT03308162|Integrated Behavioral Health Care|integrated behavioral health care
4689253|NCT03308136|epidural steroid injection|epidural steroid injection
4689254|NCT03308136|procedural pain|procedural pain
4689255|NCT03308136|local Anesthetic Injection|local anesthetic injection
4689256|NCT03308097|PrEP|prep
4689257|NCT03308097|Uptake|uptake
4689258|NCT03308097|MSM|msm
4689259|NCT03308097|Black|black
4689260|NCT03308084|transforaminal lumbar interbody fusion, methylprednisolone|transforaminal lumbar interbody fusion, methylprednisolone
4689261|NCT03308071|Hypnosis|hypnosis
4689262|NCT03308071|Hypnotherapy|hypnotherapy
4689263|NCT03308071|Perioperative Pain Management|perioperative pain management
4689264|NCT03308071|Narcotic reduction|narcotic reduction
4689265|NCT03308071|Perioperative Outcomes|perioperative outcomes
4689266|NCT03308071|Total knee replacement|total knee replacement
4689267|NCT03308071|Total knee arthroplasty|total knee arthroplasty
4689268|NCT03308058|Breastfeeding Rural Hispanic Pregnant|breastfeeding rural hispanic pregnant
4689269|NCT03308045|plasmid|plasmid
4689270|NCT03308045|electrotransfer|electrotransfer
4689271|NCT03308045|ciliary muscle|ciliary muscle
4689272|NCT03308045|uveitis|uveitis
4689273|NCT03307993|Lu AE58054|lu ae58054
4689274|NCT03307980|gene therapy|gene therapy
4689275|NCT03307928|Obstructive Sleep Apnea Syndrome|obstructive sleep apnea syndrome
4689276|NCT03307928|Aged|aged
4689277|NCT03307928|Hypertension|hypertension
4689278|NCT03307928|Oxygen Consumption|oxygen consumption
4689279|NCT03307928|Exercise|exercise
4689280|NCT03307902|Vaccination|vaccination
4689281|NCT03307889|perioperative monitoring|perioperative monitoring
4689282|NCT03307876|biologic,|biologic,
4689283|NCT03307876|Alpha 2 Macroglobulin|alpha 2 macroglobulin
4689284|NCT03307876|A2M|a2m
4689285|NCT03307876|back pain|back pain
4689286|NCT03307876|APIC|apic
4689287|NCT03307876|FAC|fac
4689288|NCT03307876|FACT|fact
4689289|NCT03307863|etonogestrel implant|etonogestrel implant
4689290|NCT03307863|anti-epileptic drugs|anti-epileptic drugs
4689291|NCT03307863|pharmacokinetics|pharmacokinetics
4689292|NCT03307850|type 1 diabetes|type 1 diabetes
4689293|NCT03307850|hypoglycemia|hypoglycemia
4689294|NCT03307850|exercise|exercise
4689295|NCT03307850|stress|stress
4689296|NCT03307850|artificial pancreas|artificial pancreas
4689297|NCT03307850|cortisol|cortisol
4689298|NCT03307837|nilateral Transpositional First Metatarsal Osteotomy|nilateral transpositional first metatarsal osteotomy
4689299|NCT03307824|Laparoscopic Surgery|laparoscopic surgery
4689300|NCT03307824|synthetic glue IFABONDTM|synthetic glue ifabondtm
4689301|NCT03307824|time of surgery|time of surgery
4689302|NCT03307811|liver|liver
4689303|NCT03307811|biopsy|biopsy
4689304|NCT03307811|hepatic|hepatic
4689305|NCT03307811|EUS|eus
4689306|NCT03307811|fine needle biopsy|fine needle biopsy
4689307|NCT03307798|dental implant,bone quality,tactile sensation|dental implant,bone quality,tactile sensation
4689308|NCT03307772|lactobacillus|lactobacillus
4689309|NCT03307772|Herpes Labialis|herpes labialis
4689310|NCT03307772|immune response|immune response
4689311|NCT03307720|agonist trigger|agonist trigger
4689312|NCT03307720|Ovulation induction|ovulation induction
4689313|NCT03307720|Controlled ovarian stimulation (COS)|controlled ovarian stimulation (cos)
4689314|NCT03307720|Poor responder|poor responder
4689315|NCT03307707|FGF23|fgf23
4689316|NCT03307707|klotho|klotho
4689317|NCT03307707|Mineral Bone Disorder|mineral bone disorder
4689318|NCT03307694|Cancer|cancer
4689319|NCT03307694|Thyroid nodule|thyroid nodule
4689320|NCT03307694|Imaging|imaging
4689321|NCT03307694|Radiology|radiology
4689322|NCT03307681|White potatoes|white potatoes
4689323|NCT03307681|Children|children
4689324|NCT03307681|Satiety|satiety
4689325|NCT03307681|Glycaemia|glycaemia
4689326|NCT03307655|nitric oxide|nitric oxide
4689327|NCT03307655|follicular fluid|follicular fluid
4689328|NCT03307655|sperm|sperm
4689329|NCT03307655|capacitation|capacitation
4689330|NCT03307655|fertilization|fertilization
4689331|NCT03307655|phosphorylation|phosphorylation
4689332|NCT03307655|nitrosylation|nitrosylation
4689333|NCT03307642|Influenza vaccination rates|influenza vaccination rates
4689334|NCT03307642|Respiratory Tract Diseases|respiratory tract diseases
4689335|NCT03307616|Systemic connective tissue disorders|systemic connective tissue disorders
4689336|NCT03307616|Undifferentiated pleomorphic sarcoma|undifferentiated pleomorphic sarcoma
4689337|NCT03307616|Dedifferentiated liposarcoma|dedifferentiated liposarcoma
4689338|NCT03307616|Dedifferentiated liposarcoma of the retroperitoneum|dedifferentiated liposarcoma of the retroperitoneum
4689339|NCT03307616|DDLPS|ddlps
4689340|NCT03307616|Undifferentiated pleomorphic sarcoma of the trunk or extremities|undifferentiated pleomorphic sarcoma of the trunk or extremities
4689341|NCT03307616|UPS|ups
4689342|NCT03307616|Nivolumab|nivolumab
4689343|NCT03307616|BMS-936558|bms-936558
4689344|NCT03307616|Opdivo|opdivo
4689345|NCT03307616|Ipilimumab|ipilimumab
4689346|NCT03307616|Yervoy|yervoy
4689347|NCT03307616|BMS-734016|bms-734016
4689348|NCT03307616|MDX010|mdx010
4689349|NCT03307616|Radiation therapy|radiation therapy
4689350|NCT03307616|XRT|xrt
4689351|NCT03307603|Yttrium-90 radioembolization|yttrium-90 radioembolization
4689352|NCT03307603|Nivolumab|nivolumab
4689353|NCT03307551|propofol, automated, manual|propofol, automated, manual
4689354|NCT03307538|Perihilar cholangiocarcinoma|perihilar cholangiocarcinoma
4689355|NCT03307538|Klatskin tumor|klatskin tumor
4689356|NCT03307538|Stereotactic body radiation therapy|stereotactic body radiation therapy
4689357|NCT03307512|inhaled insulin|inhaled insulin
4689358|NCT03307512|asthma|asthma
4689359|NCT03307512|COPD|copd
4689360|NCT03307486|Gestational diabetes|gestational diabetes
4689361|NCT03307486|Type 2 DM after GDM|type 2 dm after gdm
4689362|NCT03307473|Physical activity|physical activity
4689363|NCT03307473|Bicycling|bicycling
4689364|NCT03307473|Transportation|transportation
4689365|NCT03307473|Public health|public health
4689366|NCT03307447|optical coherence tomography|optical coherence tomography
4689367|NCT03307434|Program|program
4689368|NCT03307434|Prevention|prevention
4689369|NCT03307434|Injury|injury
4689370|NCT03307434|Athletics|athletics
4689371|NCT03307421|simulation|simulation
4689372|NCT03307421|debriefing|debriefing
4689373|NCT03307421|team score|team score
4689374|NCT03307421|multidisciplinarity|multidisciplinarity
4689375|NCT03307421|DEBRIEF sim II|debrief sim ii
4689376|NCT03307395|Chronic Subdural Hematoma|chronic subdural hematoma
4689377|NCT03307395|Embolization|embolization
4689378|NCT03307395|Middle meningeal artery|middle meningeal artery
4689379|NCT03307382|Biliary stricture, cholangioscopy|biliary stricture, cholangioscopy
4689380|NCT03307369|Severe malaria|severe malaria
4689381|NCT03307369|plasmodium vivax|plasmodium vivax
4689382|NCT03307356|Uterine Transplant|uterine transplant
4689383|NCT03307356|MRKH|mrkh
4689384|NCT03307343|sedentary behavior|sedentary behavior
4689385|NCT03307343|light intensity physical activity|light intensity physical activity
4689386|NCT03307343|behavioral intervention|behavioral intervention
4689387|NCT03307343|office workers|office workers
4689388|NCT03307343|blood pressure|blood pressure
4689389|NCT03307343|pulse wave velocity|pulse wave velocity
4689390|NCT03307343|randomized clinical trial|randomized clinical trial
4689391|NCT03307330|Obstructive Sleep Apnea|obstructive sleep apnea
4689392|NCT03307330|Adipose Tissue|adipose tissue
4689393|NCT03307317|Near Infrared Spectroscopy|near infrared spectroscopy
4689394|NCT03307317|EEG|eeg
4689395|NCT03307317|Functional Brain Activity|functional brain activity
4689396|NCT03307317|Neurodevelopment|neurodevelopment
4689397|NCT03307304|Batten Disease|batten disease
4689398|NCT03307304|Neurodegenerative|neurodegenerative
4689399|NCT03307304|Lysosomal Storage|lysosomal storage
4689400|NCT03307304|Biomarkers|biomarkers
4689401|NCT03307304|Longitudinal Study|longitudinal study
4689402|NCT03307265|Weighted Jacket|weighted jacket
4689403|NCT03307265|Balance disorder|balance disorder
4689404|NCT03307265|Equilibrium disorder|equilibrium disorder
4689405|NCT03307226|Suubi|suubi
4689406|NCT03307226|Adolescent Girls|adolescent girls
4689407|NCT03307226|Poverty|poverty
4689408|NCT03307226|Economic Empowement Interventions|economic empowement interventions
4689409|NCT03307226|Adherence to HIV antiretroviral therapy|adherence to hiv antiretroviral therapy
4689410|NCT03307226|HIV/AIDS-impacted girls|hiv/aids-impacted girls
4689411|NCT03307226|Uganda|uganda
4689412|NCT03307226|Cost-effectiveness|cost-effectiveness
4689413|NCT03307200|Supportive care|supportive care
4689414|NCT03307200|Prospective observational study|prospective observational study
4689415|NCT03307161|manual therapy|manual therapy
4689416|NCT03307161|heart rate|heart rate
4689417|NCT03307148|Locally Advanced or Metastatic|locally advanced or metastatic
4689418|NCT03307135|Spasticity|spasticity
4689419|NCT03307135|electrophysiology|electrophysiology
4689420|NCT03307135|biomechanics|biomechanics
4689421|NCT03307135|objective assessment|objective assessment
4689422|NCT03307096|FURS|furs
4689423|NCT03307096|microperc|microperc
4689424|NCT03307096|renal calculus|renal calculus
4689425|NCT03307096|Randomized Controlled Trial|randomized controlled trial
4689426|NCT03307096|Retrograde Intrarenal Surgery|retrograde intrarenal surgery
4689427|NCT03307057|Pediatrics|pediatrics
4689428|NCT03307057|Behavioral Research|behavioral research
4689429|NCT03307031|training volume|training volume
4689430|NCT03307031|elderly|elderly
4689431|NCT03307031|lipid profile|lipid profile
4689432|NCT03307031|postmenopausal|postmenopausal
4689433|NCT03307018|Bronchoscopy|bronchoscopy
4689434|NCT03307018|Respiratory Complications|respiratory complications
4689435|NCT03307018|Anatomical Lung Resection|anatomical lung resection
4689436|NCT03306992|Exercise|exercise
4689437|NCT03306966|Ascending colon|ascending colon
4689438|NCT03306940|botulinum toxin A|botulinum toxin a
4689439|NCT03306927|blood sugar|blood sugar
4689440|NCT03306927|insulin|insulin
4689441|NCT03306927|appetite|appetite
4689442|NCT03306927|peas|peas
4689443|NCT03306875|multiple sclerosis|multiple sclerosis
4689444|NCT03306875|cognitive training|cognitive training
4689445|NCT03306875|telerehabilitation|telerehabilitation
4689446|NCT03306875|personality|personality
4689447|NCT03306875|Conscientiousness|conscientiousness
4689448|NCT03306875|predict|predict
4689449|NCT03306862|blood sugar|blood sugar
4689450|NCT03306862|insulin|insulin
4689451|NCT03306862|peas|peas
4689452|NCT03306836|Hybrid operation|hybrid operation
4689453|NCT03306836|Cerebral Aneurysm|cerebral aneurysm
4689454|NCT03306836|Arteriovenous Malformations|arteriovenous malformations
4689455|NCT03306836|Anticoagulation|anticoagulation
4689456|NCT03306823|Cerebral Aneurysm|cerebral aneurysm
4689457|NCT03306823|Arteriovenous Malformations|arteriovenous malformations
4689458|NCT03306823|Hybrid operation|hybrid operation
4689459|NCT03306823|Anticoagulation|anticoagulation
4689460|NCT03306810|Perioperative complications|perioperative complications
4689461|NCT03306810|Dysglycemia management team|dysglycemia management team
4689462|NCT03306810|Nurse Practitioner|nurse practitioner
4689463|NCT03306810|Hospital|hospital
4689464|NCT03306797|Music therapy|music therapy
4689465|NCT03306797|Sonification technique|sonification technique
4689466|NCT03306797|Rehabilitation|rehabilitation
4689467|NCT03306784|RAPID3|rapid3
4689468|NCT03306784|pain catastrophizing|pain catastrophizing
4689469|NCT03306771|Morbid Obesity|morbid obesity
4689470|NCT03306771|Carotid Stenosis|carotid stenosis
4689471|NCT03306771|Metabolic Syndrome|metabolic syndrome
4689472|NCT03306745|Polycystic Ovary Syndrome|polycystic ovary syndrome
4689473|NCT03306745|Anti-Mullerian Hormone|anti-mullerian hormone
4689474|NCT03306745|Androgens|androgens
4689475|NCT03306745|Micronutrient Supplementation|micronutrient supplementation
4689476|NCT03306732|Thiamine|thiamine
4689477|NCT03306732|Thiamine Supplementation|thiamine supplementation
4689478|NCT03306732|Vasoplegia Syndrome|vasoplegia syndrome
4689479|NCT03306732|Inotropic support|inotropic support
4689480|NCT03306732|Cardiac surgery|cardiac surgery
4689481|NCT03306732|Renal Failure|renal failure
4689482|NCT03306706|blood sugar|blood sugar
4689483|NCT03306706|insulin|insulin
4689484|NCT03306706|appetite|appetite
4689485|NCT03306706|peas|peas
4689486|NCT03306693|Emotional Intelligence|emotional intelligence
4689487|NCT03306693|Quality of Life|quality of life
4689488|NCT03306628|Skin Scarring|skin scarring
4689489|NCT03306628|keloids|keloids
4689490|NCT03306628|hypertrophic scars|hypertrophic scars
4689491|NCT03306628|CO2 laser therapy|co2 laser therapy
4689492|NCT03306615|Muscle Stiffness|muscle stiffness
4689493|NCT03306615|Muscle Spasticity|muscle spasticity
4689494|NCT03306615|Stroke|stroke
4689495|NCT03306615|Cerebral Palsy|cerebral palsy
4689496|NCT03306615|Hyperreflexia|hyperreflexia
4689497|NCT03306602|Composite Resins|composite resins
4689498|NCT03306602|Dental Restorations|dental restorations
4689499|NCT03306589|Inflammation|inflammation
4689500|NCT03306589|GM-CSF|gm-csf
4689501|NCT03306589|LPS|lps
4689502|NCT03306589|Skin blisters|skin blisters
4689503|NCT03306589|Healthy subjects|healthy subjects
4689504|NCT03306589|cantharidin|cantharidin
4689505|NCT03306576|composite restoration|composite restoration
4689506|NCT03306563|TBI|tbi
4689507|NCT03306563|Mild traumatic brain injury|mild traumatic brain injury
4689508|NCT03306563|Concussion|concussion
4689509|NCT03306563|Diagnostics|diagnostics
4689510|NCT03306563|Rapid test|rapid test
4689511|NCT03306563|Traumatic Brain Injury|traumatic brain injury
4689512|NCT03306563|mTBI|mtbi
4689513|NCT03306550|drug-drug interaction|drug-drug interaction
4689514|NCT03306550|Asprin|asprin
4689515|NCT03306550|salvianolate injection|salvianolate injection
4689516|NCT03306550|PK-PD model|pk-pd model
4689517|NCT03306550|metabolic enzymes|metabolic enzymes
4689518|NCT03306524|mechanical ventilation|mechanical ventilation
4689519|NCT03306524|SIPPV|sippv
4689520|NCT03306524|PSV|psv
4689521|NCT03306524|Device flow|device flow
4689522|NCT03306524|Circuit flow|circuit flow
4689523|NCT03306524|Slope time|slope time
4689524|NCT03306524|neonatal intensive care|neonatal intensive care
4689525|NCT03306498|plasma free amino acids|plasma free amino acids
4689526|NCT03306459|PCOS|pcos
4689527|NCT03306459|Quality of life|quality of life
4689528|NCT03306459|Sexuality|sexuality
4689529|NCT03306459|Psychological traits|psychological traits
4689530|NCT03306433|dental caries|dental caries
4689531|NCT03306433|white spot lesion|white spot lesion
4689532|NCT03306433|prevention|prevention
4689533|NCT03306433|smooth surface sealant|smooth surface sealant
4689534|NCT03306420|MS201408-0005A|ms201408-0005a
4689535|NCT03306420|MS201408-0005B|ms201408-0005b
4689536|NCT03306420|MS201408-0005C|ms201408-0005c
4689537|NCT03306420|First-in-Human|first-in-human
4689538|NCT03306420|Advanced solid tumors|advanced solid tumors
4689539|NCT03306394|metastatic|metastatic
4689540|NCT03306394|colorectal|colorectal
4689541|NCT03306394|cancer|cancer
4689542|NCT03306394|trifluridine/tipiracil|trifluridine/tipiracil
4689543|NCT03306394|early access|early access
4689544|NCT03306381|IBS|ibs
4689545|NCT03306381|Epigenetics|epigenetics
4689546|NCT03306381|Dietary intervention|dietary intervention
4689547|NCT03306381|Gut Microbiota|gut microbiota
4689548|NCT03306381|Inflammation|inflammation
4689549|NCT03306381|Genetics|genetics
4689550|NCT03306368|OUD|oud
4689551|NCT03306368|XR-NTX|xr-ntx
4689552|NCT03306368|assertive outreach|assertive outreach
4689553|NCT03306368|youth|youth
4689554|NCT03306355|Intraocular Lens|intraocular lens
4689555|NCT03306355|trifocal|trifocal
4689556|NCT03306355|hydrophobic|hydrophobic
4689557|NCT03306355|hydrophilic|hydrophilic
4689558|NCT03306342|Intraocular Lens|intraocular lens
4689559|NCT03306342|trifocal|trifocal
4689560|NCT03306342|hydrophobic|hydrophobic
4689561|NCT03306342|hydrophilic|hydrophilic
4689562|NCT03306303|melatonin|melatonin
4689563|NCT03306303|STEMI|stemi
4689564|NCT03306303|No-reflow|no-reflow
4689565|NCT03306290|Obese|obese
4689566|NCT03306290|Bariatric surgery|bariatric surgery
4689567|NCT03306290|Antibiotic prophylaxis|antibiotic prophylaxis
4689568|NCT03306290|Cefoxitin|cefoxitin
4689569|NCT03306264|MDS|mds
4689570|NCT03306264|CMML|cmml
4689571|NCT03306264|decitabine|decitabine
4689572|NCT03306264|Myelodysplastic Syndromes|myelodysplastic syndromes
4689573|NCT03306264|Chronic Myelomonocytic Leukemia|chronic myelomonocytic leukemia
4689574|NCT03306251|HIV|hiv
4689575|NCT03306251|Pregnancy|pregnancy
4689576|NCT03306251|Prevention of mother-to-child transmission|prevention of mother-to-child transmission
4689577|NCT03306238|laparoscopy/ key-hole|laparoscopy/ key-hole
4689578|NCT03306238|renal surgery|renal surgery
4689579|NCT03306238|open/hasson|open/hasson
4689580|NCT03306238|closed/veress|closed/veress
4689581|NCT03306212|cerebral palsy|cerebral palsy
4689582|NCT03306212|casting|casting
4689583|NCT03306212|Botulinum toxin A|botulinum toxin a
4689584|NCT03306186|diagnosis|diagnosis
4689585|NCT03306186|prognosis|prognosis
4689586|NCT03306160|central blood pressure|central blood pressure
4689587|NCT03306160|ambulatory blood pressure monitoring|ambulatory blood pressure monitoring
4689588|NCT03306160|blood pressure variability|blood pressure variability
4689589|NCT03306147|Pain|pain
4689590|NCT03306147|Opioid|opioid
4689591|NCT03306147|Drug monitoring|drug monitoring
4689592|NCT03306147|Pain education|pain education
4689593|NCT03306121|Nasopharyngeal carcinoma;Induction chemotherapy|nasopharyngeal carcinoma;induction chemotherapy
4689594|NCT03306069|Aerobic exercise|aerobic exercise
4689595|NCT03306069|Interval training|interval training
4689596|NCT03306069|VO2max|vo2max
4689597|NCT03306069|Health Promotion|health promotion
4689598|NCT03306069|Inflammation|inflammation
4689599|NCT03306069|Body Composition|body composition
4689600|NCT03306056|Exercise|exercise
4689601|NCT03306056|Strength Training|strength training
4689602|NCT03306056|Health Promotion|health promotion
4689603|NCT03306056|Inflammation|inflammation
4689604|NCT03306056|Body Composition|body composition
4689605|NCT03306043|hypereosinophilic syndrome|hypereosinophilic syndrome
4689606|NCT03306043|hypereosinophilic syndrome flare|hypereosinophilic syndrome flare
4689607|NCT03306043|open-label extension study|open-label extension study
4689608|NCT03306043|Mepolizumab|mepolizumab
4689609|NCT03306043|SB240563|sb240563
4689610|NCT03306043|Long-term safety|long-term safety
4689611|NCT03306030|PEG|peg
4689612|NCT03306030|Bowel preparation|bowel preparation
4689613|NCT03306030|Colonoscopy|colonoscopy
4689614|NCT03306030|split-does|split-does
4689615|NCT03306017|left ventricular assist device|left ventricular assist device
4689616|NCT03306017|platelet-leukocyte conjugates|platelet-leukocyte conjugates
4689617|NCT03306017|lipo-oxygenase products|lipo-oxygenase products
4689618|NCT03305991|tuberculosis|tuberculosis
4689619|NCT03305991|pregnancy|pregnancy
4689620|NCT03305991|ethiopia|ethiopia
4689621|NCT03305978|Ultra low dose chest CT|ultra low dose chest ct
4689622|NCT03305978|lung cancer screening|lung cancer screening
4689623|NCT03305939|Gestational diabetes,Lifestyle,Type 2 DM|gestational diabetes,lifestyle,type 2 dm
4689624|NCT03305913|mCRC|mcrc
4689625|NCT03305900|formate|formate
4689626|NCT03305900|one-carbon metabolism|one-carbon metabolism
4689627|NCT03305887|TKA|tka
4689628|NCT03305887|Barbed suture|barbed suture
4689629|NCT03305887|Surgical time|surgical time
4689630|NCT03305874|contrast-induced nephropathy (CIN)|contrast-induced nephropathy (cin)
4689631|NCT03305874|percutaneous coronary intervention (PCI)|percutaneous coronary intervention (pci)
4689632|NCT03305874|computer-based risk tool|computer-based risk tool
4689633|NCT03305861|Thulium Laser Enucleation of the Prostate (ThuLEP)|thulium laser enucleation of the prostate (thulep)
4689634|NCT03305861|Greenlight Laser Enucleation of the Prostate (Green LEP)|greenlight laser enucleation of the prostate (green lep)
4689635|NCT03305861|Holmium Laser Enucleation of Prostate (HoLEP)|holmium laser enucleation of prostate (holep)
4689636|NCT03305835|Primary Hyperoxaluria (PH)|primary hyperoxaluria (ph)
4689637|NCT03305835|Hyperoxaluria|hyperoxaluria
4689638|NCT03305835|PH|ph
4689639|NCT03305835|PH 1|ph 1
4689640|NCT03305835|PH 2|ph 2
4689641|NCT03305835|PH 3|ph 3
4689642|NCT03305835|Dent Disease|dent disease
4689643|NCT03305835|Dent 1|dent 1
4689644|NCT03305835|Dent 2|dent 2
4689645|NCT03305835|Cystinuria|cystinuria
4689646|NCT03305835|APRT Deficiency|aprt deficiency
4689647|NCT03305835|24-Hydroxylase Deficiency|24-hydroxylase deficiency
4689648|NCT03305835|CYP24A1|cyp24a1
4689649|NCT03305809|Parkinson disease dementia|parkinson disease dementia
4689650|NCT03305809|Parkinson disease|parkinson disease
4689651|NCT03305809|Dopamine|dopamine
4689652|NCT03305809|Cognition|cognition
4689653|NCT03305744|Athlete|athlete
4689654|NCT03305744|Middle-aged|middle-aged
4689655|NCT03305744|Endurance training|endurance training
4689656|NCT03305744|Cardiac Function|cardiac function
4689657|NCT03305744|Atrial Fibrillation|atrial fibrillation
4689658|NCT03305731|Rehabilitation|rehabilitation
4689659|NCT03305731|Disability|disability
4689660|NCT03305692|cardiac resynchronization therapy|cardiac resynchronization therapy
4689661|NCT03305692|pacing|pacing
4689662|NCT03305692|echocardiography|echocardiography
4689663|NCT03305692|optimization|optimization
4689664|NCT03305692|heart failure|heart failure
4689665|NCT03305653|Pediatrics|pediatrics
4689666|NCT03305588|essential tremor (ET)|essential tremor (et)
4689667|NCT03305588|stereotactic radiosurgery (SRS)|stereotactic radiosurgery (srs)
4689668|NCT03305588|radiosurgery (RS)|radiosurgery (rs)
4689669|NCT03305588|deep brain stimulation (DBS)|deep brain stimulation (dbs)
4689670|NCT03305588|Parkinson's Disease (PD)|parkinson's disease (pd)
4689671|NCT03305588|tremor-dominant Parkinson's disease (TDPD)|tremor-dominant parkinson's disease (tdpd)
4689672|NCT03305575|Cervical Cerclage|cervical cerclage
4689673|NCT03305575|Bupivacaine|bupivacaine
4689674|NCT03305575|Chloroprocaine|chloroprocaine
4689675|NCT03305575|spinal anesthesia|spinal anesthesia
4689676|NCT03305562|Hypertension|hypertension
4689803|NCT03304704|Parasite|parasite
4689677|NCT03305549|Dialysis-requiring Acute Kidney Injury|dialysis-requiring acute kidney injury
4689678|NCT03305549|Renal Recovery|renal recovery
4689679|NCT03305536|AVD|avd
4689680|NCT03305523|circumcision; Thermocautery; Complication|circumcision; thermocautery; complication
4689681|NCT03305497|Opioid Overdose; Naloxone|opioid overdose; naloxone
4689682|NCT03305484|contact lenses|contact lenses
4689683|NCT03305484|red eye|red eye
4689684|NCT03305484|corneal infiltrate|corneal infiltrate
4689685|NCT03305471|Chronic hemodialysis|chronic hemodialysis
4689686|NCT03305471|Investigational drug|investigational drug
4689687|NCT03305445|Immunotransplant|immunotransplant
4689688|NCT03305445|Relapsed Diffuse Large B-Cell Lymphoma|relapsed diffuse large b-cell lymphoma
4689689|NCT03305445|Refractory Diffuse Large B-Cell Lymphoma|refractory diffuse large b-cell lymphoma
4689690|NCT03305445|Nivolumab|nivolumab
4689691|NCT03305445|Ipilimumab|ipilimumab
4689692|NCT03305419|Crossover|crossover
4689693|NCT03305419|Sequential|sequential
4689694|NCT03305419|GSK2982772|gsk2982772
4689695|NCT03305419|Safety|safety
4689696|NCT03305419|Pharmacokinetics|pharmacokinetics
4689697|NCT03305419|Healthy subjects|healthy subjects
4689698|NCT03305393|Heart Failure|heart failure
4689699|NCT03305393|CRT|crt
4689700|NCT03305393|Cardiac Recynchronization Therapy|cardiac recynchronization therapy
4689701|NCT03305393|left bundle branch block|left bundle branch block
4689702|NCT03305393|atrio-ventricular conduction|atrio-ventricular conduction
4689703|NCT03305380|anti-PD1|anti-pd1
4689704|NCT03305380|anti-PD-L1|anti-pd-l1
4689705|NCT03305354|mobile health|mobile health
4689706|NCT03305354|physical activity|physical activity
4689707|NCT03305341|SCLC|sclc
4689708|NCT03305341|SNP|snp
4689709|NCT03305341|Oncology|oncology
4689710|NCT03305341|Drug|drug
4689711|NCT03305341|Etoposide|etoposide
4689712|NCT03305341|Methotrexate|methotrexate
4689713|NCT03305341|Lung|lung
4689714|NCT03305341|Cancer|cancer
4689715|NCT03305328|Oscillations|oscillations
4689716|NCT03305328|Non-invasive Brain Stimulation|non-invasive brain stimulation
4689717|NCT03305328|Transcranial Alternating Current Stimulation|transcranial alternating current stimulation
4689718|NCT03305276|diet;|diet;
4689719|NCT03305276|exercise;|exercise;
4689720|NCT03305276|hypertension;|hypertension;
4689721|NCT03305276|vitamin d|vitamin d
4689722|NCT03305237|Weight loss|weight loss
4689723|NCT03305237|Chrono-nutrition|chrono-nutrition
4689724|NCT03305237|Diet|diet
4689725|NCT03305237|energy expenditure|energy expenditure
4689726|NCT03305224|castration-resistant prostate cancer|castration-resistant prostate cancer
4689727|NCT03305224|bone metastasis|bone metastasis
4689728|NCT03305185|AIS|ais
4689729|NCT03305107|Child|child
4689730|NCT03305107|Exercise|exercise
4689731|NCT03305107|Chocolate milk|chocolate milk
4689732|NCT03305107|Blood glucose|blood glucose
4689733|NCT03305107|Cognition|cognition
4689734|NCT03305107|Appetite|appetite
4689735|NCT03305107|Emotions|emotions
4689736|NCT03305107|Cortisol|cortisol
4689737|NCT03305094|Remote ischemic preconditioning|remote ischemic preconditioning
4689738|NCT03305094|Myocardial infarction|myocardial infarction
4689739|NCT03305094|Cardiac surgery|cardiac surgery
4689740|NCT03305055|opioid|opioid
4689741|NCT03305055|ketamine|ketamine
4689742|NCT03305042|aging|aging
4689743|NCT03305042|alpha-retinol|alpha-retinol
4689744|NCT03305042|hypervitaminosis A|hypervitaminosis a
4689745|NCT03305042|vitamin A biomarkers|vitamin a biomarkers
4689746|NCT03305042|serum retinol|serum retinol
4689747|NCT03305029|Age related macular degeneration|age related macular degeneration
4689748|NCT03305029|embryonic stem cells|embryonic stem cells
4689749|NCT03305029|somatic cell nuclear transfer|somatic cell nuclear transfer
4689750|NCT03305016|Human Growth Hormone|human growth hormone
4689751|NCT03305016|hGH|hgh
4689752|NCT03305016|GHD|ghd
4689753|NCT03305016|rhGH|rhgh
4689754|NCT03305016|Pediatric Growth Hormone Deficiency|pediatric growth hormone deficiency
4689755|NCT03305016|Long Acting Growth Hormone|long acting growth hormone
4689756|NCT03305016|Somatropin|somatropin
4689757|NCT03305016|Prodrug|prodrug
4689758|NCT03305016|Growth Failure|growth failure
4689759|NCT03305016|Growth Hormone Replacement Therapy|growth hormone replacement therapy
4689760|NCT03305016|Sustained Release Growth Hormone|sustained release growth hormone
4689761|NCT03305016|Growth Hormone Deficiency|growth hormone deficiency
4689762|NCT03305016|TransCon GH|transcon gh
4689763|NCT03304964|FP-025, MMP-12 inhibitor|fp-025, mmp-12 inhibitor
4689764|NCT03304912|Pre-Exposure Prophylaxis|pre-exposure prophylaxis
4689765|NCT03304912|Injection Drug Use|injection drug use
4689766|NCT03304873|rectal MRSA|rectal mrsa
4689767|NCT03304873|mupirocin-resistant nasal MRSA|mupirocin-resistant nasal mrsa
4689768|NCT03304834|HIFU|hifu
4689769|NCT03304834|High intensity focused ultrasound|high intensity focused ultrasound
4689770|NCT03304821|Atherosclerotic peripheral artery disease|atherosclerotic peripheral artery disease
4689771|NCT03304821|Granulocyte-macrophage colony stimulating factor (GM-CSF)|granulocyte-macrophage colony stimulating factor (gm-csf)
4689772|NCT03304821|Atherosclerosis|atherosclerosis
4689773|NCT03304821|Cardiology|cardiology
4689774|NCT03304821|Vascular disease|vascular disease
4689775|NCT03304808|premature ejaculation|premature ejaculation
4689776|NCT03304808|cognitive-behavior|cognitive-behavior
4689777|NCT03304808|treatment|treatment
4689778|NCT03304808|device|device
4689779|NCT03304795|Vitamin D|vitamin d
4689780|NCT03304795|Asia|asia
4689781|NCT03304795|Trend|trend
4689782|NCT03304795|KNHANES|knhanes
4689783|NCT03304795|Temporal change|temporal change
4689784|NCT03304782|Preterm Birth|preterm birth
4689785|NCT03304782|FitBit|fitbit
4689786|NCT03304782|Preterm Delivery|preterm delivery
4689787|NCT03304769|Virtual Reality Distraction|virtual reality distraction
4689788|NCT03304769|Pediatric IV placement|pediatric iv placement
4689789|NCT03304756|locally advanced breast cancer|locally advanced breast cancer
4689790|NCT03304756|triple negative|triple negative
4689791|NCT03304756|cisplatin|cisplatin
4689792|NCT03304743|dental panoramic radiographs|dental panoramic radiographs
4689793|NCT03304743|osteoporosis|osteoporosis
4689794|NCT03304743|feasibility study|feasibility study
4689795|NCT03304730|Zygapophyseal Joint|zygapophyseal joint
4689796|NCT03304730|Low Back Pain|low back pain
4689797|NCT03304730|Spine Osteoarthritis|spine osteoarthritis
4689798|NCT03304717|Leukodystrophy|leukodystrophy
4689799|NCT03304717|Antiretroviral Drugs|antiretroviral drugs
4689800|NCT03304704|Assays|assays
4689801|NCT03304704|Direct Skin Feeds|direct skin feeds
4689802|NCT03304704|Infection|infection
4689804|NCT03304704|Gametocyte|gametocyte
4689806|NCT03304691|Parasitemia|parasitemia
4689807|NCT03304691|Anemia|anemia
4689808|NCT03304691|Ligand|ligand
4689809|NCT03304691|Anopheles gambiae|anopheles gambiae
4689810|NCT03304678|mTORC1 Inhibition|mtorc1 inhibition
4689811|NCT03304678|VEGF-D|vegf-d
4689812|NCT03304678|MicroRNA|microrna
4689813|NCT03304665|Healthy Volunteers|healthy volunteers
4689814|NCT03304665|Mental Health|mental health
4689815|NCT03304665|Common Data Elements|common data elements
4689816|NCT03304600|OCD|ocd
4689817|NCT03304600|tDCS|tdcs
4689818|NCT03304561|knee|knee
4689819|NCT03304561|rehabilitation|rehabilitation
4689820|NCT03304561|ACL|acl
4689821|NCT03304561|Contralateral training|contralateral training
4689822|NCT03304548|Telephone interviews|telephone interviews
4689823|NCT03304548|Subcutaneous|subcutaneous
4689824|NCT03304548|Low-interventional|low-interventional
4689825|NCT03304548|Qualitative research|qualitative research
4689826|NCT03304548|PAH|pah
4689827|NCT03304535|Glaucoma|glaucoma
4689828|NCT03304535|Social Worker|social worker
4689829|NCT03304496|Nitroglycerin|nitroglycerin
4689830|NCT03304496|Vasodilator Agents|vasodilator agents
4689831|NCT03304496|Subcutaneous Injection|subcutaneous injection
4689832|NCT03304496|Radial Artery|radial artery
4689833|NCT03304496|Coronary Angiography|coronary angiography
4689834|NCT03304496|Cardiac Catheterization|cardiac catheterization
4689835|NCT03304496|Coronary Angioplasty|coronary angioplasty
4689836|NCT03304496|Percutaneous Coronary Intervention|percutaneous coronary intervention
4689837|NCT03304457|Lurasidone|lurasidone
4689838|NCT03304457|Olanzapine|olanzapine
4689839|NCT03304457|Brain derived neurotrophic factor|brain derived neurotrophic factor
4689840|NCT03304457|Nerve growth factor|nerve growth factor
4689841|NCT03304457|Neurotrophin 3|neurotrophin 3
4689842|NCT03304431|QT dispersion|qt dispersion
4689843|NCT03304431|topical lidocaine|topical lidocaine
4689844|NCT03304431|P-wave values|p-wave values
4689845|NCT03304405|ASD|asd
4689846|NCT03304392|anxiety|anxiety
4689847|NCT03304392|depression|depression
4689848|NCT03304392|internet-delivered cognitive behaviour therapy|internet-delivered cognitive behaviour therapy
4689849|NCT03304392|randomized controlled trial|randomized controlled trial
4689850|NCT03304392|patient-centered|patient-centered
4689851|NCT03304392|knowledge implementation|knowledge implementation
4689852|NCT03304392|mental health system|mental health system
4689853|NCT03304392|therapist-assistance|therapist-assistance
4689854|NCT03304353|Plantar heel pain|plantar heel pain
4689855|NCT03304353|Resistance training|resistance training
4689856|NCT03304340|acute stroke,TENS ,posture stability, function|acute stroke,tens ,posture stability, function
4689857|NCT03304327|Yoga|yoga
4689858|NCT03304327|Mindfulness|mindfulness
4689859|NCT03304314|PTC|ptc
4689860|NCT03304314|EYES|eyes
4689861|NCT03304314|Pseudotumor cerebri|pseudotumor cerebri
4689862|NCT03304314|increased Intracranial pressure|increased intracranial pressure
4689863|NCT03304314|ICP|icp
4689864|NCT03304301|sunlight exposure|sunlight exposure
4689865|NCT03304301|institutionalized elderly|institutionalized elderly
4689866|NCT03304301|depression|depression
4689867|NCT03304301|quality of life|quality of life
4689868|NCT03304301|cognition function|cognition function
4689869|NCT03304288|all-trans retinoid acid|all-trans retinoid acid
4689870|NCT03304288|rituximab|rituximab
4689871|NCT03304288|steroid-resistant|steroid-resistant
4689872|NCT03304288|refractory|refractory
4689873|NCT03304288|low-dose|low-dose
4689874|NCT03304275|Pertussis|pertussis
4689875|NCT03304275|Vaccination|vaccination
4689876|NCT03304275|Emergency Department|emergency department
4689877|NCT03304262|Metaplasticity|metaplasticity
4689878|NCT03304262|Motor excitability|motor excitability
4689879|NCT03304262|rTMS|rtms
4689880|NCT03304262|tDCS|tdcs
4689881|NCT03304236|Cervical Myelopahty|cervical myelopahty
4689882|NCT03304236|sEMG|semg
4689883|NCT03304236|Motion capture analysis|motion capture analysis
4689884|NCT03304210|PIPAC|pipac
4689885|NCT03304210|Peritoneal carcinomatosis|peritoneal carcinomatosis
4689886|NCT03304210|Ovarian cancer|ovarian cancer
4689887|NCT03304210|Pharmacokinetics|pharmacokinetics
4689888|NCT03304210|Pharmacodynamics|pharmacodynamics
4689889|NCT03304210|Safety and efficacy|safety and efficacy
4689890|NCT03304210|Abraxane|abraxane
4689891|NCT03304210|Breast cancer|breast cancer
4689892|NCT03304210|Pancreas cancer|pancreas cancer
4689893|NCT03304210|Stomach cancer|stomach cancer
4689894|NCT03304158|Diabetes|diabetes
4689895|NCT03304158|Non-communicable disease|non-communicable disease
4689896|NCT03304158|Primary health care|primary health care
4689897|NCT03304158|Nepal|nepal
4689898|NCT03304145|Treatment Care Planning|treatment care planning
4689899|NCT03304132|Oral Microbiome|oral microbiome
4689900|NCT03304132|reflux disorders|reflux disorders
4689901|NCT03304132|esophageal microbiome|esophageal microbiome
4689902|NCT03304132|Alcohol Use|alcohol use
4689903|NCT03304132|Tobacco Use|tobacco use
4689904|NCT03304119|Tipping of tibial tuberosity|tipping of tibial tuberosity
4689905|NCT03304119|Torsion of tibial tuberosity|torsion of tibial tuberosity
4689906|NCT03304119|Recurrent patellar dislocation|recurrent patellar dislocation
4689907|NCT03304119|MRI Measurements|mri measurements
4689908|NCT03304119|Patellar instability|patellar instability
4689909|NCT03304119|Patellar dislocation|patellar dislocation
4689910|NCT03304119|Tibial tubercle position|tibial tubercle position
4689911|NCT03304119|Tibial tubercle torsion|tibial tubercle torsion
4689912|NCT03304093|IFCT|ifct
4689913|NCT03304093|VIH|vih
4689914|NCT03304093|Nivolumab|nivolumab
4689915|NCT03304093|NSCLC|nsclc
4689916|NCT03304080|Breast Neoplasms|breast neoplasms
4689917|NCT03304080|Breast Diseases|breast diseases
4689918|NCT03304080|Palbociclib|palbociclib
4689919|NCT03304080|Trastuzumab|trastuzumab
4689920|NCT03304080|Pertuzumab|pertuzumab
4689921|NCT03304080|Hormone Antagonists|hormone antagonists
4689922|NCT03304054|MuSK antibody positive|musk antibody positive
4689923|NCT03304041|low-FODMAP|low-fodmap
4689924|NCT03304041|Irritable Bowel Syndrome|irritable bowel syndrome
4689925|NCT03304041|stool fermentation|stool fermentation
4689926|NCT03304041|Breath test|breath test
4689927|NCT03304028|Connected Devices|connected devices
4689928|NCT03304028|Pulmonary Exacerbations|pulmonary exacerbations
4689929|NCT03304028|Cumulative Sum (CUSUM) Chart|cumulative sum (cusum) chart
4689930|NCT03304015|Intervention|intervention
4689931|NCT03304015|Violence against Women|violence against women
4689932|NCT03304015|Female Garment Workers|female garment workers
4689933|NCT03304015|Bangladesh|bangladesh
4689934|NCT03303976|pneumococcal vaccine|pneumococcal vaccine
4689935|NCT03303976|bioconjugate|bioconjugate
4689936|NCT03303963|culture-free|culture-free
4689937|NCT03303963|tuberculosis|tuberculosis
4689938|NCT03303963|multidrug resistant|multidrug resistant
4689939|NCT03303963|diagnosis|diagnosis
4689940|NCT03303963|follow-up|follow-up
4689941|NCT03303963|africa|africa
4689942|NCT03303963|molecular tools|molecular tools
4689943|NCT03303937|virulence factor genes;|virulence factor genes;
4689944|NCT03303937|phenotyping|phenotyping
4689945|NCT03303937|genotyping|genotyping
4689946|NCT03303937|antimicrobial susceptibility|antimicrobial susceptibility
4689947|NCT03303924|Pharmacokinetic|pharmacokinetic
4689948|NCT03303924|Bronchoalveolar Lavage|bronchoalveolar lavage
4689949|NCT03303924|Epithelial Lining Fluid|epithelial lining fluid
4689950|NCT03303924|Alveolar Macrophage|alveolar macrophage
4689951|NCT03303924|Gram-negative bacterium|gram-negative bacterium
4689952|NCT03303924|Acinetobacter baumannii|acinetobacter baumannii
4689953|NCT03303872|atrial high rate episode|atrial high rate episode
4689954|NCT03303872|pacemaker|pacemaker
4689955|NCT03303872|atrial fibrillation|atrial fibrillation
4689956|NCT03303872|stroke|stroke
4689957|NCT03303859|Bacterial vaginosis, preterm delivery, Martinique, stress|bacterial vaginosis, preterm delivery, martinique, stress
4689958|NCT03303833|Lifestyle|lifestyle
4689959|NCT03303833|Nutrition|nutrition
4689960|NCT03303807|Extracorporeal CO2 removal (ECCO2-R)|extracorporeal co2 removal (ecco2-r)
4689961|NCT03303807|ARDS|ards
4689962|NCT03303794|Total Knee arthroplasty|total knee arthroplasty
4689963|NCT03303794|bupivacaine|bupivacaine
4689964|NCT03303794|anesthesia|anesthesia
4689965|NCT03303729|Carbohydrate|carbohydrate
4689966|NCT03303729|Cluster Dextrin|cluster dextrin
4689967|NCT03303729|Exercise training|exercise training
4689968|NCT03303729|Protein supplement|protein supplement
4689969|NCT03303703|cardiac rehabilitation|cardiac rehabilitation
4689970|NCT03303677|endoscopic sinus surgery|endoscopic sinus surgery
4689971|NCT03303677|topical nasal therapy|topical nasal therapy
4689972|NCT03303664|opioid|opioid
4689973|NCT03303664|inpatient|inpatient
4689974|NCT03303664|pain|pain
4689975|NCT03303664|multimodal|multimodal
4689976|NCT03303651|Analgesia, Monitoring, Opioid, Sufentanil, Sevoflurane|analgesia, monitoring, opioid, sufentanil, sevoflurane
4689977|NCT03303638|Multi-sensory environment|multi-sensory environment
4689978|NCT03303638|Snoezelen|snoezelen
4689979|NCT03303638|Bathing|bathing
4689980|NCT03303638|Showering|showering
4689981|NCT03303638|Tub Bathing|tub bathing
4689982|NCT03303599|Chronic Hepatitis C|chronic hepatitis c
4689983|NCT03303599|Sustained Virological Response|sustained virological response
4689984|NCT03303599|Chronic Hepatitis C genotype 1|chronic hepatitis c genotype 1
4689985|NCT03303599|Chronic Hepatitis C genotype 2|chronic hepatitis c genotype 2
4689986|NCT03303599|Chronic Hepatitis C genotype 3|chronic hepatitis c genotype 3
4689987|NCT03303599|Chronic Hepatitis C genotype 4|chronic hepatitis c genotype 4
4689988|NCT03303599|Chronic Hepatitis C genotype 5|chronic hepatitis c genotype 5
4689989|NCT03303599|Chronic Hepatitis C genotype 6|chronic hepatitis c genotype 6
4689990|NCT03303599|Hepatitis C|hepatitis c
4689991|NCT03303586|Asthma|asthma
4689992|NCT03303586|Fluid Shift|fluid shift
4689993|NCT03303586|Compression stockings|compression stockings
4689994|NCT03303586|intrathoracic airway narrowing|intrathoracic airway narrowing
4689995|NCT03303573|Erythropoeitin|erythropoeitin
4689996|NCT03303547|MRI|mri
4689997|NCT03303547|Tissue|tissue
4689998|NCT03303547|Imaging|imaging
4689999|NCT03303547|Pathology|pathology
4690000|NCT03303547|Rectal|rectal
4690001|NCT03303547|Cancer|cancer
4690002|NCT03303534|inflammation|inflammation
4690003|NCT03303534|hydrogen sulfide|hydrogen sulfide
4690004|NCT03303534|caloric restriction|caloric restriction
4690005|NCT03303534|vascular surgery|vascular surgery
4690006|NCT03303495|FOLFIRI|folfiri
4690007|NCT03303495|CPT-11|cpt-11
4690008|NCT03303495|Bevacizumab|bevacizumab
4690009|NCT03303495|2nd-line metastatic colorectal cancer|2nd-line metastatic colorectal cancer
4690010|NCT03303456|early psychosis|early psychosis
4690011|NCT03303456|clinical high risk|clinical high risk
4690012|NCT03303456|mobile health|mobile health
4690013|NCT03303430|cerebral microembolisation|cerebral microembolisation
4690014|NCT03303430|plaque characteristics|plaque characteristics
4690015|NCT03303417|Kiwifruit|kiwifruit
4690016|NCT03303378|melatonin|melatonin
4690017|NCT03303378|Reperfusion Injury|reperfusion injury
4690018|NCT03303378|myocardial infarction|myocardial infarction
4690019|NCT03303365|Brain Metastases|brain metastases
4690020|NCT03303365|WBRT (whole brain radiotherapy)|wbrt (whole brain radiotherapy)
4690021|NCT03303365|SRS (stereotactic radiosurgery)|srs (stereotactic radiosurgery)
4690022|NCT03303365|CYBER-Knife|cyber-knife
4690023|NCT03303339|PLK1|plk1
4690024|NCT03303339|PLK Inhibitor|plk inhibitor
4690025|NCT03303326|sexual health|sexual health
4690026|NCT03303313|RNAi therapeutic|rnai therapeutic
4690221|NCT03301922|Sick leave|sick leave
4690027|NCT03303313|Atypical Hemolytic Uremic Syndrome|atypical hemolytic uremic syndrome
4690028|NCT03303313|Hemolysis|hemolysis
4690029|NCT03303313|Thrombocytopenia|thrombocytopenia
4690030|NCT03303313|Renal insufficiency|renal insufficiency
4690031|NCT03303313|Thrombotic Microangiopathy|thrombotic microangiopathy
4690032|NCT03303313|aHUS|ahus
4690033|NCT03303313|TMA|tma
4690034|NCT03303287|health education|health education
4690035|NCT03303235|methylergonovine|methylergonovine
4690036|NCT03303209|opioid|opioid
4690037|NCT03303209|opioids|opioids
4690038|NCT03303209|taper|taper
4690039|NCT03303209|chronic pain|chronic pain
4690040|NCT03303196|Post-Pancreatectomy Diabetes|post-pancreatectomy diabetes
4690041|NCT03303196|Insulin Therapy|insulin therapy
4690042|NCT03303144|Pharmacokinetics|pharmacokinetics
4690043|NCT03303144|Equivalence|equivalence
4690044|NCT03303118|Hypoxia|hypoxia
4690045|NCT03303118|Brain|brain
4690046|NCT03303118|Cerebral vaso-reactivity|cerebral vaso-reactivity
4690047|NCT03303118|EEG|eeg
4690048|NCT03303118|Concentration performance|concentration performance
4690049|NCT03303118|Cerebral oxygenation|cerebral oxygenation
4690050|NCT03303118|Cerebral blood-flow|cerebral blood-flow
4690051|NCT03303118|Heart rate variability|heart rate variability
4690052|NCT03303066|Myelodysplastic Syndromes|myelodysplastic syndromes
4690053|NCT03303066|Anemia|anemia
4690054|NCT03303066|Hemoglobin (Hb)|hemoglobin (hb)
4690055|NCT03303066|Low Risk Myelodysplastic Syndrome|low risk myelodysplastic syndrome
4690178|NCT03302195|Bleeding|bleeding
4690056|NCT03303053|Hyperthyroidism,Graves disease,Cholestyramine,Prednisolone|hyperthyroidism,graves disease,cholestyramine,prednisolone
4690057|NCT03303040|Mechanical ventilation|mechanical ventilation
4690058|NCT03303040|Diaphragm weakness|diaphragm weakness
4690059|NCT03303040|Difficulty weaning from mechanical ventilation|difficulty weaning from mechanical ventilation
4690060|NCT03303040|Diaphragm stimulation|diaphragm stimulation
4690061|NCT03303027|Cosmesis|cosmesis
4690062|NCT03303027|Surgical Wound|surgical wound
4690063|NCT03303027|Fast Absorbing Gut|fast absorbing gut
4690064|NCT03303027|Linear Cutaneous Wound|linear cutaneous wound
4690065|NCT03303014|Suture|suture
4690066|NCT03303014|Absorbable|absorbable
4690067|NCT03303014|Non-absorbable|non-absorbable
4690068|NCT03303014|Split wound|split wound
4690069|NCT03303014|Cutaneous Wound|cutaneous wound
4690070|NCT03303001|subacromial infiltration|subacromial infiltration
4690071|NCT03303001|high volumen|high volumen
4690072|NCT03303001|shoulder pain|shoulder pain
4690073|NCT03302988|Wound Edge Eversion|wound edge eversion
4690074|NCT03302988|Dermal Sutures|dermal sutures
4690075|NCT03302975|Running|running
4690076|NCT03302975|Biomechanics|biomechanics
4690077|NCT03302975|Kinetics|kinetics
4690078|NCT03302962|asthma|asthma
4690079|NCT03302962|pediatric|pediatric
4690080|NCT03302962|american indian|american indian
4690081|NCT03302962|children|children
4690082|NCT03302949|Nutritional Supplement|nutritional supplement
4690083|NCT03302949|Health-related Quality of Life|health-related quality of life
4690084|NCT03302949|Dietary Intake|dietary intake
4690085|NCT03302936|Midurethral sling|midurethral sling
4690086|NCT03302936|Pyridium|pyridium
4690087|NCT03302923|Nursing home residents|nursing home residents
4690088|NCT03302923|Brisk walking|brisk walking
4690089|NCT03302910|Acute Heart Failure, Chronic Heart Failure, Heart Failure, Heart conditions, nitroglycerin|acute heart failure, chronic heart failure, heart failure, heart conditions, nitroglycerin
4690090|NCT03302897|Leprosy, vaccine, adjuvant, GLA, GLA-SE|leprosy, vaccine, adjuvant, gla, gla-se
4690091|NCT03302871|cerebral palsy|cerebral palsy
4690092|NCT03302871|botulinum toxin A|botulinum toxin a
4690093|NCT03302871|constraint induced movement therapy|constraint induced movement therapy
4690094|NCT03302871|transcranial direct current stimulation|transcranial direct current stimulation
4690095|NCT03302832|Total Knee Arthroplasty|total knee arthroplasty
4690096|NCT03302832|Total Knee Replacement|total knee replacement
4690097|NCT03302806|disability|disability
4690098|NCT03302806|EDSS|edss
4690099|NCT03302767|Oncology|oncology
4690100|NCT03302767|Work Keeping|work keeping
4690101|NCT03302767|Social difficulties|social difficulties
4690102|NCT03302767|Cognitive Disorders|cognitive disorders
4690103|NCT03302741|stroke|stroke
4690104|NCT03302728|CD 30 positive, relapsed, refractory|cd 30 positive, relapsed, refractory
4690105|NCT03302702|exercise|exercise
4690106|NCT03302702|duration|duration
4690107|NCT03302689|TAP-block|tap-block
4690108|NCT03302689|VAS of pain|vas of pain
4690109|NCT03302689|Cesarean section|cesarean section
4690110|NCT03302689|Postoperative analgesia|postoperative analgesia
4690111|NCT03302676|Saliva substitute|saliva substitute
4690112|NCT03302663|Fetal bone heart abnormality|fetal bone heart abnormality
4690113|NCT03302624|acute kidney injury|acute kidney injury
4690114|NCT03302624|quality of life|quality of life
4690115|NCT03302624|Renal replacement therapy|renal replacement therapy
4690116|NCT03302624|Intensive care unit|intensive care unit
4690117|NCT03302611|major depressive disorder|major depressive disorder
4690118|NCT03302611|military|military
4690119|NCT03302611|surf therapy|surf therapy
4690120|NCT03302611|hike therapy|hike therapy
4690121|NCT03302611|randomized controlled trial|randomized controlled trial
4690222|NCT03301896|Phase I|phase i
4690122|NCT03302598|enterocutaneous fistula - C-reactive protein- surgical repair|enterocutaneous fistula - c-reactive protein- surgical repair
4690123|NCT03302585|Optic Neuritis|optic neuritis
4690124|NCT03302585|Vitamin D|vitamin d
4690125|NCT03302572|primary care|primary care
4690126|NCT03302572|advance directives|advance directives
4690127|NCT03302572|randomized controlled trial|randomized controlled trial
4690128|NCT03302533|distal humerus fracture|distal humerus fracture
4690129|NCT03302533|total elbow arthroplasty|total elbow arthroplasty
4690130|NCT03302533|elbow prosthesis|elbow prosthesis
4690131|NCT03302533|delayed arthroplasty|delayed arthroplasty
4690132|NCT03302533|revision surgery|revision surgery
4690133|NCT03302494|Non-valvular Atrial Fibrillation|non-valvular atrial fibrillation
4690134|NCT03302494|Left Atrial Appendage|left atrial appendage
4690135|NCT03302481|Obesity surgery|obesity surgery
4690136|NCT03302481|liver|liver
4690137|NCT03302481|mitochondria|mitochondria
4690138|NCT03302481|steatosis|steatosis
4690139|NCT03302455|insomia|insomia
4690140|NCT03302455|eCBTI|ecbti
4690141|NCT03302455|internet|internet
4690142|NCT03302455|psychotherapy|psychotherapy
4690143|NCT03302455|guided self-help|guided self-help
4690144|NCT03302455|psychological treatment|psychological treatment
4690145|NCT03302429|Alveolar cleft -Platelet rich fibrin- calcium phosphate|alveolar cleft -platelet rich fibrin- calcium phosphate
4690146|NCT03302377|Feasibility|feasibility
4690147|NCT03302338|Feeding intolerance|feeding intolerance
4690148|NCT03302338|Simulated amniotic fluid like solution|simulated amniotic fluid like solution
4690149|NCT03302338|Necrotizing enterocolitis|necrotizing enterocolitis
4690150|NCT03302325|stage IV solid tumor|stage iv solid tumor
4690151|NCT03302312|Posttraumatic Stress Disorder|posttraumatic stress disorder
4690152|NCT03302312|Generalized Anxiety Disorder|generalized anxiety disorder
4690153|NCT03302312|Depression|depression
4690154|NCT03302312|Distress|distress
4690155|NCT03302312|Alcohol Use|alcohol use
4690156|NCT03302312|Pain|pain
4690157|NCT03302299|Adherence|adherence
4690158|NCT03302299|Hepatotoxicity|hepatotoxicity
4690159|NCT03302299|Phosphatidtylethanol|phosphatidtylethanol
4690160|NCT03302286|Heart-Lung Machine|heart-lung machine
4690161|NCT03302286|Cardiopulmonary Bypass|cardiopulmonary bypass
4690162|NCT03302273|stem cell therapy|stem cell therapy
4690163|NCT03302273|dry eye disease|dry eye disease
4690164|NCT03302260|maternal health|maternal health
4690165|NCT03302260|pregnancy|pregnancy
4690166|NCT03302260|pre-eclampsia|pre-eclampsia
4690167|NCT03302234|Programmed Cell Death Receptor 1 (PD-1)|programmed cell death receptor 1 (pd-1)
4690168|NCT03302234|Programmed Cell Death Receptor Ligand 1 (PD-L1)|programmed cell death receptor ligand 1 (pd-l1)
4690169|NCT03302234|Cytotoxic T-lymphocyte-associated protein 4 (CTLA4)|cytotoxic t-lymphocyte-associated protein 4 (ctla4)
4690170|NCT03302234|PD1|pd1
4690171|NCT03302234|PD-1|pd-1
4690172|NCT03302234|PDL1|pdl1
4690173|NCT03302234|PD-L1|pd-l1
4690174|NCT03302234|CTLA4|ctla4
4690175|NCT03302208|General Anesthesia|general anesthesia
4690176|NCT03302195|Heparin|heparin
4690177|NCT03302195|Allogeneic blood product transfusions|allogeneic blood product transfusions
4690179|NCT03302195|Cardiac surgery|cardiac surgery
4690180|NCT03302195|Obesity|obesity
4690181|NCT03302169|Prostate Cancer|prostate cancer
4690182|NCT03302169|Urinary incontinence|urinary incontinence
4690183|NCT03302169|Radical prostatectomy|radical prostatectomy
4690184|NCT03302169|Rhabdosphincter|rhabdosphincter
4690185|NCT03302169|Robotic Surgery|robotic surgery
4690186|NCT03302156|Uterine cancer|uterine cancer
4690187|NCT03302156|Ovarian cancer|ovarian cancer
4690188|NCT03302156|Hysterectomy|hysterectomy
4690189|NCT03302156|Salpingo-oophorectomy|salpingo-oophorectomy
4690190|NCT03302143|Dental Implant|dental implant
4690191|NCT03302143|Guided Bone Regeneration|guided bone regeneration
4690192|NCT03302143|Contour Augmentation|contour augmentation
4690193|NCT03302117|Wood smoke|wood smoke
4690194|NCT03302117|Bronchoscopy|bronchoscopy
4690195|NCT03302065|inhalation|inhalation
4690196|NCT03302065|anticholinergic|anticholinergic
4690197|NCT03302026|nicotine treatment|nicotine treatment
4690198|NCT03302026|real time fMRI|real time fmri
4690199|NCT03302013|Arthroplasty|arthroplasty
4690200|NCT03302013|Knee|knee
4690201|NCT03302013|Bicruciate retaining|bicruciate retaining
4690202|NCT03302013|Vanguard XP|vanguard xp
4690203|NCT03302013|Vanguard CR|vanguard cr
4690204|NCT03302013|Surgery|surgery
4690205|NCT03302013|Zimmer Biomet|zimmer biomet
4690206|NCT03302013|Joint Replacement|joint replacement
4690207|NCT03302013|Osteoarthritis|osteoarthritis
4690208|NCT03302000|prematurity|prematurity
4690209|NCT03302000|sensory stimulation|sensory stimulation
4690210|NCT03302000|rehabilitation|rehabilitation
4690211|NCT03302000|infant|infant
4690212|NCT03301961|Circulating Tumor DNA|circulating tumor dna
4690213|NCT03301961|Early diagnosis|early diagnosis
4690214|NCT03301961|Surveillance|surveillance
4690215|NCT03301961|Methylation|methylation
4690216|NCT03301961|Somatic mutation|somatic mutation
4690217|NCT03301935|Risk assessment|risk assessment
4690218|NCT03301922|Occupational Health Services|occupational health services
4690219|NCT03301922|Metacognitive therapy|metacognitive therapy
4690220|NCT03301922|Work focused therapy|work focused therapy
4690223|NCT03301896|LHC165|lhc165
4690224|NCT03301896|PDR001|pdr001
4690225|NCT03301896|intratumoral injection|intratumoral injection
4690226|NCT03301896|abscopal|abscopal
4690227|NCT03301896|checkpoint inhibitor|checkpoint inhibitor
4690228|NCT03301896|programmed cell death|programmed cell death
4690229|NCT03301896|PD-1|pd-1
4690230|NCT03301896|TLR-7|tlr-7
4690231|NCT03301896|toll-like receptor|toll-like receptor
4690232|NCT03301896|melanoma|melanoma
4690233|NCT03301896|head and neck|head and neck
4690234|NCT03301831|Parents|parents
4690235|NCT03301831|Technology-Dependent Child|technology-dependent child
4690236|NCT03301831|Resourcefulness|resourcefulness
4690237|NCT03301792|Group prenatal care|group prenatal care
4690238|NCT03301792|Diabetes|diabetes
4690239|NCT03301779|Red Blood Cells|red blood cells
4690240|NCT03301766|lidocaine|lidocaine
4690241|NCT03301740|Ultrafiltration profiling|ultrafiltration profiling
4690242|NCT03301740|Hemodialysis|hemodialysis
4690243|NCT03301740|Dialysis|dialysis
4690244|NCT03301740|Cardiovascular outcomes|cardiovascular outcomes
4690245|NCT03301740|Patient-reported outcomes|patient-reported outcomes
4690246|NCT03301740|Crossover study design|crossover study design
4690247|NCT03301740|End Stage Renal Disease|end stage renal disease
4690248|NCT03301740|Ultrafiltration|ultrafiltration
4690249|NCT03301740|Echocardiogram|echocardiogram
4690250|NCT03301740|Blood pressure|blood pressure
4690251|NCT03301740|Hypotension|hypotension
4690252|NCT03301740|Symptoms|symptoms
4690253|NCT03301714|motivational interviewing|motivational interviewing
4690254|NCT03301714|elderly|elderly
4690255|NCT03301714|oral health|oral health
4690256|NCT03301688|PD-1 antibody|pd-1 antibody
4690257|NCT03301688|phase 1 trial|phase 1 trial
4690258|NCT03301675|Orange juice|orange juice
4690259|NCT03301675|Healthy diet|healthy diet
4690260|NCT03301675|Metabolic syndrome|metabolic syndrome
4690261|NCT03301675|Cardiometabolic risk factors|cardiometabolic risk factors
4690262|NCT03301675|Body composition|body composition
4690263|NCT03301662|atrial fibrillation|atrial fibrillation
4690264|NCT03301662|cryptogenic stroke|cryptogenic stroke
4690265|NCT03301662|ECG screening|ecg screening
4690266|NCT03301662|health-related quality of life|health-related quality of life
4690267|NCT03301662|Short Form-36|short form-36
4690268|NCT03301662|stroke|stroke
4690269|NCT03301662|thumb-ECG|thumb-ecg
4690270|NCT03301636|Melanoma, Metastaic Melanoma|melanoma, metastaic melanoma
4690271|NCT03301623|Clinical Decision Support|clinical decision support
4690272|NCT03301623|Patient Education Materials|patient education materials
4690273|NCT03301623|Opioid Use|opioid use
4690274|NCT03301623|Chronic Pain|chronic pain
4690275|NCT03301610|Pain Education|pain education
4690276|NCT03301610|Information Delivery|information delivery
4690277|NCT03301610|Mobile Application|mobile application
4690278|NCT03301597|Chemotherapy-induced Neutropenia|chemotherapy-induced neutropenia
4690279|NCT03301597|Bacterial Infections|bacterial infections
4690280|NCT03301597|Fungal Infections|fungal infections
4690281|NCT03301584|Hip fracture|hip fracture
4690282|NCT03301584|ADL|adl
4690283|NCT03301584|patient participation|patient participation
4690284|NCT03301584|functional balance|functional balance
4690285|NCT03301584|physical performance|physical performance
4690286|NCT03301571|Coronary artery bypass graft|coronary artery bypass graft
4690287|NCT03301571|Echocardiography|echocardiography
4690288|NCT03301545|Bariatric surgery|bariatric surgery
4690289|NCT03301545|Obesity|obesity
4690290|NCT03301545|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
4690291|NCT03301545|Indigenous Population|indigenous population
4690292|NCT03301545|Randomized Control Trial|randomized control trial
4690293|NCT03301545|Glycoslyated Hemoglobin A1C|glycoslyated hemoglobin a1c
4690294|NCT03301545|Anthropometric measurements|anthropometric measurements
4690295|NCT03301545|Medication Use|medication use
4690296|NCT03301532|G1D, glucose, transporter|g1d, glucose, transporter
4690297|NCT03301506|PBC|pbc
4690298|NCT03301506|Primary Biliary Cholangitis (PBC)|primary biliary cholangitis (pbc)
4690299|NCT03301467|C3 Glomerulonephritis|c3 glomerulonephritis
4690300|NCT03301467|C3 glomerulopathy|c3 glomerulopathy
4690301|NCT03301467|C3G|c3g
4690302|NCT03301467|DDD|ddd
4690303|NCT03301467|dense deposit disease|dense deposit disease
4690304|NCT03301467|membranoproliferative glomerulonephritis|membranoproliferative glomerulonephritis
4690305|NCT03301467|MPGN|mpgn
4690307|NCT03301467|idiopathic MPGN|idiopathic mpgn
4690308|NCT03301441|migraine|migraine
4690309|NCT03301441|migraine with aura|migraine with aura
4690310|NCT03301441|migraine without aura|migraine without aura
4690311|NCT03301441|ischemic stroke|ischemic stroke
4690312|NCT03301441|Mismatch|mismatch
4690313|NCT03301415|Asymptomatic|asymptomatic
4690314|NCT03301415|Congenital CMV Infection|congenital cmv infection
4690315|NCT03301415|Valganciclovir Therapy|valganciclovir therapy
4690316|NCT03301337|Amino acid uptake|amino acid uptake
4690317|NCT03301337|Aging|aging
4690318|NCT03301337|Meat protein|meat protein
4690319|NCT03301324|intubation|intubation
4690320|NCT03301272|Parkinson, Botox, Tremor|parkinson, botox, tremor
4690321|NCT03301259|Necrotic pulp|necrotic pulp
4690322|NCT03301259|wave-one|wave-one
4690323|NCT03301259|one-shape|one-shape
4690324|NCT03301259|periapical lesion|periapical lesion
4690325|NCT03301194|Hypertension|hypertension
4690326|NCT03301194|Effectiveness|effectiveness
4690327|NCT03301194|Cost Effectiveness|cost effectiveness
4690328|NCT03301194|Cost|cost
4690329|NCT03301194|Multi-disciplinary|multi-disciplinary
4690330|NCT03301194|Risk Stratification|risk stratification
4690331|NCT03301168|ALL|all
4690332|NCT03301168|AML|aml
4690333|NCT03301168|hematologic neoplasms|hematologic neoplasms
4690334|NCT03301168|hematologic malignancies|hematologic malignancies
4690335|NCT03301168|primary immune deficiences|primary immune deficiences
4690336|NCT03301168|allogeneic stem cell transplant|allogeneic stem cell transplant
4690337|NCT03301142|urinary stress incontinence|urinary stress incontinence
4690338|NCT03301142|urinary incontinence,stress|urinary incontinence,stress
4690339|NCT03301142|laser|laser
4690340|NCT03301142|physiotherapy|physiotherapy
4690341|NCT03301142|kinesiotherapy|kinesiotherapy
4690342|NCT03301116|Exercise|exercise
4690343|NCT03301116|Frail Elderly|frail elderly
4690344|NCT03301116|Homebound Persons|homebound persons
4690345|NCT03301116|Activities of Daily Living|activities of daily living
4690346|NCT03301116|Mobility Limitation|mobility limitation
4690347|NCT03301116|Home Care Services|home care services
4690348|NCT03301116|Long-Term Care|long-term care
4690349|NCT03301116|Dual MEDICAID MEDICARE Eligibility|dual medicaid medicare eligibility
4690350|NCT03301103|Nutrition|nutrition
4690351|NCT03301103|Gastroenteritis|gastroenteritis
4690352|NCT03301103|Traveler's diarrhea|traveler's diarrhea
4690353|NCT03301103|E. coli|e. coli
4690354|NCT03301090|Adults|adults
4690355|NCT03301090|Evaluate|evaluate
4690356|NCT03301090|Healthy|healthy
4690357|NCT03301090|Immunogenicity|immunogenicity
4690358|NCT03301090|MERS-CoV|mers-cov
4690359|NCT03301090|Pharmacokinetics|pharmacokinetics
4690360|NCT03301090|Phase I|phase i
4690361|NCT03301090|Placebo|placebo
4690362|NCT03301090|REGN MERS|regn mers
4690363|NCT03301090|Safety|safety
4690364|NCT03301090|Tolerability|tolerability
4690365|NCT03301077|children and adolescents|children and adolescents
4690366|NCT03301077|mental health|mental health
4690367|NCT03301077|epidemiology|epidemiology
4690368|NCT03301077|psychiatric disorders|psychiatric disorders
4690369|NCT03301064|alcohol, intervention, Latino, community|alcohol, intervention, latino, community
4690370|NCT03301051|Influenza|influenza
4690371|NCT03301051|Human|human
4690372|NCT03301051|RNA Virus Infections|rna virus infections
4690373|NCT03301051|Efficacy|efficacy
4690374|NCT03301051|Immunologic|immunologic
4690375|NCT03301051|Immunogenic Factors|immunogenic factors
4690376|NCT03301051|Physiological Effects of Drug|physiological effects of drug
4690377|NCT03301051|Virus Diseases|virus diseases
4690378|NCT03301051|Orthomyxoviridae Infections|orthomyxoviridae infections
4690379|NCT03301051|Infection|infection
4690380|NCT03301038|hypercalcemia|hypercalcemia
4690381|NCT03301038|nephrocalcinosis|nephrocalcinosis
4690382|NCT03301038|CYP24A1|cyp24a1
4690383|NCT03301038|hypercalciuria|hypercalciuria
4690384|NCT03301025|Pregabalin, hypotensive anesthesia, blood loss, analgesia|pregabalin, hypotensive anesthesia, blood loss, analgesia
4690385|NCT03301012|Adolescent|adolescent
4690386|NCT03301012|Relapse Prevention|relapse prevention
4690387|NCT03301012|Smartphone|smartphone
4690388|NCT03301012|Recovery Support|recovery support
4690389|NCT03300999|ginger tea|ginger tea
4690390|NCT03300973|urodynamic study|urodynamic study
4690391|NCT03300973|stress urinary incontinence|stress urinary incontinence
4690392|NCT03300882|Study co-enrollment (CTOT-20 and CTOT-22)|study co-enrollment (ctot-20 and ctot-22)
4690393|NCT03300882|cytomegalovirus (CMV)|cytomegalovirus (cmv)
4690394|NCT03300882|CMV seropositive positive recipient|cmv seropositive positive recipient
4690395|NCT03300882|CMV infection|cmv infection
4690396|NCT03300882|CMV-specific immunity|cmv-specific immunity
4690397|NCT03300882|immunologic monitoring|immunologic monitoring
4690398|NCT03300869|Spinal Muscular Atrophy|spinal muscular atrophy
4690399|NCT03300869|Natural History|natural history
4690400|NCT03300856|Transcranial Magnetic Stimulation (TMS)|transcranial magnetic stimulation (tms)
4690401|NCT03300856|Electrophysiology|electrophysiology
4690402|NCT03300843|Cell Therapy|cell therapy
4690403|NCT03300843|Immunotherapy|immunotherapy
4690404|NCT03300843|Vaccines|vaccines
4690405|NCT03300830|Immunodeficiency|immunodeficiency
4690406|NCT03300830|Viral-Associated Cancer|viral-associated cancer
4690407|NCT03300830|Kaposi Sarcoma Herpes Virus|kaposi sarcoma herpes virus
4690408|NCT03300830|Idiopathic Castleman Disease|idiopathic castleman disease
4690409|NCT03300830|Endogenous Retroviruses|endogenous retroviruses
4690410|NCT03300804|IBS|ibs
4690411|NCT03300791|heart failure|heart failure
4690412|NCT03300791|readmission|readmission
4690413|NCT03300791|predictive models|predictive models
4690414|NCT03300778|neurocognition|neurocognition
4690415|NCT03300778|high-risk|high-risk
4690416|NCT03300778|prognosis|prognosis
4690417|NCT03300765|Thyroid Cancer|thyroid cancer
4690418|NCT03300765|Apatinib|apatinib
4690419|NCT03300765|Intensity modulated radiation therapy|intensity modulated radiation therapy
4690420|NCT03300726|Synaptic injury|synaptic injury
4690421|NCT03300713|Mass screening|mass screening
4690422|NCT03300713|Pediatrician training|pediatrician training
4690423|NCT03300648|coma|coma
4690424|NCT03300648|pediatrics|pediatrics
4690425|NCT03300583|Interstitial lung disease|interstitial lung disease
4690426|NCT03300583|Self-Management|self-management
4690427|NCT03300583|Service provision|service provision
4690428|NCT03300531|Pure Platelet-rich Plasma|pure platelet-rich plasma
4690429|NCT03300531|Randomized Controlled Trial|randomized controlled trial
4690430|NCT03300518|GnRH antagonist|gnrh antagonist
4690431|NCT03300518|Estrogen pretreatment|estrogen pretreatment
4690432|NCT03300518|Poor response patient|poor response patient
4690433|NCT03300492|Natural Killer cells|natural killer cells
4690434|NCT03300492|NK cells|nk cells
4690435|NCT03300492|Immunotherapy|immunotherapy
4690436|NCT03300492|haploidentical hematopoietic stem cell transplantation|haploidentical hematopoietic stem cell transplantation
4690437|NCT03300479|nontraumatic intracerebral hemorrhage|nontraumatic intracerebral hemorrhage
4690438|NCT03300479|Cleviprex®|cleviprex®
4690439|NCT03300479|Ebrantil®|ebrantil®
4690440|NCT03300479|Systolic blood pressure|systolic blood pressure
4690441|NCT03300466|Hyaluronic Acid, Lidocaine|hyaluronic acid, lidocaine
4690442|NCT03300427|Heart failure with reduced left ventricular ejection fraction|heart failure with reduced left ventricular ejection fraction
4690443|NCT03300427|LVEF|lvef
4690444|NCT03300427|Cardiac dysfunction|cardiac dysfunction
4690445|NCT03300427|Heart muscle dysfunction|heart muscle dysfunction
4690446|NCT03300427|Left ventricular (LV) dilation|left ventricular (lv) dilation
4690447|NCT03300427|Left ventricular hypertrophy|left ventricular hypertrophy
4690448|NCT03300427|HF|hf
4690449|NCT03300427|AHF|ahf
4690450|NCT03300427|CHF|chf
4690451|NCT03300427|CCF|ccf
4690452|NCT03300427|acute heart failure|acute heart failure
4690453|NCT03300427|chronic heart failure|chronic heart failure
4690454|NCT03300427|congestive heart failure|congestive heart failure
4690455|NCT03300427|congestive cardiac failure|congestive cardiac failure
4690456|NCT03300388|Insulin resistance|insulin resistance
4690457|NCT03300388|Exercise|exercise
4690458|NCT03300388|Omega-3 fatty acids|omega-3 fatty acids
4690459|NCT03300388|Adipose tissue|adipose tissue
4690460|NCT03300349|Breast cancer|breast cancer
4690461|NCT03300349|Breast cancer-related lymphedema|breast cancer-related lymphedema
4690462|NCT03300349|Shoulder injury|shoulder injury
4690463|NCT03300349|Prevention|prevention
4690464|NCT03300349|Educational activity|educational activity
4690465|NCT03300349|Physiotherapy|physiotherapy
4690466|NCT03300336|Walking|walking
4690467|NCT03300336|Inpatients|inpatients
4690468|NCT03300336|Veterans|veterans
4690469|NCT03300336|Early Ambulation|early ambulation
4690470|NCT03300336|Quality of Life|quality of life
4690471|NCT03300323|peri-operative|peri-operative
4690472|NCT03300323|fluid|fluid
4690473|NCT03300323|microcirculation|microcirculation
4690474|NCT03300297|Temporomandibular joint|temporomandibular joint
4690475|NCT03300297|Physical Therapy|physical therapy
4690476|NCT03300297|Cervical spine thrust joint manipulation|cervical spine thrust joint manipulation
4690477|NCT03300297|therapy, exercise|therapy, exercise
4690478|NCT03300297|Temporomandibular Disorders|temporomandibular disorders
4690479|NCT03300284|Quality of Life|quality of life
4690480|NCT03300284|Decision Making|decision making
4690481|NCT03300284|17-382|17-382
4690482|NCT03300219|telerehabilitation|telerehabilitation
4690483|NCT03300219|occupational therapy|occupational therapy
4690484|NCT03300219|rct|rct
4690485|NCT03300219|participation|participation
4690486|NCT03300219|quality of life|quality of life
4690487|NCT03300219|intervention|intervention
4690488|NCT03300219|older adults|older adults
4690489|NCT03300206|Breast Biopsy|breast biopsy
4690490|NCT03300206|Breast Biopsy Imaging|breast biopsy imaging
4690491|NCT03300206|Stereotactic Biopsy|stereotactic biopsy
4690492|NCT03300193|Magnetic Resonance guided Focused Ultrasound|magnetic resonance guided focused ultrasound
4690493|NCT03300193|Tremor|tremor
4690494|NCT03300193|Essential Tremor|essential tremor
4690495|NCT03300193|Parkinson's Disease|parkinson's disease
4690496|NCT03300154|Cardiovascular risk|cardiovascular risk
4690497|NCT03300154|Behavioral economics|behavioral economics
4690498|NCT03300154|Text messages|text messages
4690499|NCT03300154|Financial incentives|financial incentives
4690500|NCT03300141|Upper Extremity|upper extremity
4690501|NCT03300141|Rehabilitation|rehabilitation
4690502|NCT03300141|Arm|arm
4690503|NCT03300141|Robotics|robotics
4690504|NCT03300141|Stroke Rehabilitation|stroke rehabilitation
4690505|NCT03300141|Virtual Reality Thearpy|virtual reality thearpy
4690506|NCT03300128|autism|autism
4690507|NCT03300128|parenting|parenting
4690508|NCT03300128|Incredible Years|incredible years
4690509|NCT03300102|personalised medicine|personalised medicine
4690510|NCT03300050|live attenuated influenza vaccine|live attenuated influenza vaccine
4690511|NCT03300050|inactivated influenza vaccine|inactivated influenza vaccine
4690512|NCT03300024|Hemodialysis|hemodialysis
4690513|NCT03300024|Arteriovenous|arteriovenous
4690514|NCT03300024|Graft|graft
4690515|NCT03300024|polytetrafluoroethylene|polytetrafluoroethylene
4690516|NCT03300024|Bovine|bovine
4690517|NCT03300011|ultrasonic|ultrasonic
4690518|NCT03300011|chronic total occlusion|chronic total occlusion
4690519|NCT03300011|heart function|heart function
4691218|NCT03295240|MCL|mcl
4690520|NCT03299985|Gastroesophageal reflux Disease|gastroesophageal reflux disease
4690521|NCT03299985|Myofascial release|myofascial release
4690522|NCT03299985|Diaphragm|diaphragm
4690523|NCT03299972|Sarcopenia|sarcopenia
4690524|NCT03299972|Resistance exercise|resistance exercise
4690525|NCT03299972|Protein|protein
4690526|NCT03299946|Nivolumab|nivolumab
4690527|NCT03299946|Cabozantinib|cabozantinib
4690528|NCT03299946|Neoadjuvant|neoadjuvant
4690529|NCT03299946|Immunotherapy|immunotherapy
4690530|NCT03299946|Liver Cancer|liver cancer
4690531|NCT03299946|Borderline Resectable|borderline resectable
4690532|NCT03299946|Advance Resectable|advance resectable
4690533|NCT03299946|Neoplasms|neoplasms
4690534|NCT03299946|Hepatocellular Carcinoma|hepatocellular carcinoma
4690535|NCT03299946|HCC|hcc
4690536|NCT03299946|Resection|resection
4690537|NCT03299894|Sepsis|sepsis
4690538|NCT03299894|Shock, septic|shock, septic
4690539|NCT03299894|Emergency service, hospital|emergency service, hospital
4690540|NCT03299894|Anti-infective agents|anti-infective agents
4690541|NCT03299894|Outcome assessment|outcome assessment
4690542|NCT03299868|Peripherally inserted central catheter|peripherally inserted central catheter
4690543|NCT03299868|Terminally ill cancer patients|terminally ill cancer patients
4690544|NCT03299868|Palliative care|palliative care
4690545|NCT03299855|oncogeriatric|oncogeriatric
4690546|NCT03299855|MMS|mms
4690547|NCT03299855|MoCA|moca
4690548|NCT03299842|seizure|seizure
4690549|NCT03299842|tonic clonic|tonic clonic
4690550|NCT03299842|epilepsy|epilepsy
4690551|NCT03299842|myoclonic|myoclonic
4690552|NCT03299842|encephalopathy|encephalopathy
4690553|NCT03299829|trientine|trientine
4690554|NCT03299829|Wilson's disease|wilson's disease
4690555|NCT03299816|Chronic Kidney Disease|chronic kidney disease
4690556|NCT03299816|Hypertension|hypertension
4690557|NCT03299816|Albuminuria|albuminuria
4690558|NCT03299816|African Americans|african americans
4690559|NCT03299790|Type 2 diabetes|type 2 diabetes
4690560|NCT03299790|Diabetic cardiomyopathy|diabetic cardiomyopathy
4690561|NCT03299790|Cardiac function|cardiac function
4690562|NCT03299790|Exercise echocardiography|exercise echocardiography
4690563|NCT03299790|Exercise training|exercise training
4690564|NCT03299751|neonatal sepsis|neonatal sepsis
4690565|NCT03299751|biomarker combination|biomarker combination
4690566|NCT03299751|diagnostic|diagnostic
4690567|NCT03299751|antibiotic use|antibiotic use
4690568|NCT03299751|newborn|newborn
4690569|NCT03299751|preterm neonates|preterm neonates
4690570|NCT03299751|NICU|nicu
4690571|NCT03299686|Asthma, allergic, eosinophilic, non-T2 high|asthma, allergic, eosinophilic, non-t2 high
4690572|NCT03299647|Attention-deficit/hyperactivity disorder|attention-deficit/hyperactivity disorder
4690573|NCT03299647|behavioral deficits|behavioral deficits
4690574|NCT03299647|cognitive function|cognitive function
4690575|NCT03299647|polyunsaturated fatty acids|polyunsaturated fatty acids
4690576|NCT03299647|visual memory|visual memory
4690577|NCT03299582|paclitaxel|paclitaxel
4690578|NCT03299582|neuropathy|neuropathy
4690579|NCT03299582|hypothermia|hypothermia
4690580|NCT03299582|cryocompression|cryocompression
4690581|NCT03299556|Wearable Health Technology|wearable health technology
4690582|NCT03299556|iPhone|iphone
4690583|NCT03299556|Apple Watch|apple watch
4690584|NCT03299556|Pain Medication|pain medication
4690585|NCT03299543|beta-hydroxybutyrate|beta-hydroxybutyrate
4690586|NCT03299543|breath acetone|breath acetone
4690587|NCT03299530|Corneal Astigmatism|corneal astigmatism
4690588|NCT03299530|Scheimpflug|scheimpflug
4690589|NCT03299530|pupil size|pupil size
4690590|NCT03299530|Toric|toric
4690591|NCT03299517|lidocaine|lidocaine
4690592|NCT03299517|amiodarone|amiodarone
4690593|NCT03299491|Maternity Waiting Area|maternity waiting area
4690594|NCT03299491|Ethiopia|ethiopia
4690595|NCT03299491|Community Leader|community leader
4690596|NCT03299491|Religious Leader|religious leader
4690597|NCT03299491|Skilled birth attendance|skilled birth attendance
4690598|NCT03299491|Postnatal care|postnatal care
4690599|NCT03299491|Information, Education, Communication|information, education, communication
4690600|NCT03299491|Safe Motherhood|safe motherhood
4690601|NCT03299491|Health Extension Worker|health extension worker
4690602|NCT03299491|Antenatal Care|antenatal care
4690603|NCT03299465|bone marrow transplantation|bone marrow transplantation
4690604|NCT03299465|yoga|yoga
4690605|NCT03299452|ex vivo high-throughput drug screening assay|ex vivo high-throughput drug screening assay
4690606|NCT03299426|Typhoid|typhoid
4690607|NCT03299426|Typhoid in Malawi|typhoid in malawi
4690608|NCT03299426|Typhoid Vaccine|typhoid vaccine
4690609|NCT03299413|Inflammatory Bowel Disease|inflammatory bowel disease
4690610|NCT03299413|Mesenchymal stem cells|mesenchymal stem cells
4690611|NCT03299413|Ulcerative colitis|ulcerative colitis
4690612|NCT03299413|Neutrophils|neutrophils
4690614|NCT03299387|urinary tract|urinary tract
4690615|NCT03299387|infection|infection
4690616|NCT03299387|recurrent|recurrent
4690617|NCT03299387|women|women
4690618|NCT03299374|Pilates|pilates
4690619|NCT03299374|Balance|balance
4690620|NCT03299374|Falls|falls
4690621|NCT03299374|Older people|older people
4690622|NCT03299361|Carpal tunnel syndrome|carpal tunnel syndrome
4690623|NCT03299361|Corticosteroid|corticosteroid
4690624|NCT03299361|Diffusion tensor imaging|diffusion tensor imaging
4690625|NCT03299361|Injection|injection
4690626|NCT03299361|Magnetic resonance image|magnetic resonance image
4690627|NCT03299361|Ultrasound|ultrasound
4690628|NCT03299348|Psychological Mechanisms|psychological mechanisms
4690629|NCT03299348|Social-Cognitive Mechanisms|social-cognitive mechanisms
4690630|NCT03299322|Bronchial Asthma，TCM，microorganism|bronchial asthma，tcm，microorganism
4690631|NCT03299309|Glioma|glioma
4690632|NCT03299309|Medulloblastoma|medulloblastoma
4690633|NCT03299309|PRiME|prime
4690634|NCT03299309|Pro00079843|pro00079843
4690635|NCT03299309|Thompson|thompson
4690636|NCT03299309|Pediatric|pediatric
4690637|NCT03299309|Landi|landi
4690638|NCT03299296|Thromboprophylaxis|thromboprophylaxis
4690639|NCT03299296|orthopedic|orthopedic
4690640|NCT03299296|rivaroxaban|rivaroxaban
4690641|NCT03299296|enoxaparin|enoxaparin
4690642|NCT03299270|Surgery|surgery
4690643|NCT03299270|Solid malignancy|solid malignancy
4690644|NCT03299270|Elderly|elderly
4690645|NCT03299270|Functional recovery|functional recovery
4690646|NCT03299257|OSA|osa
4690647|NCT03299257|CPAP|cpap
4690648|NCT03299257|sleepiness|sleepiness
4690649|NCT03299257|donepezil|donepezil
4690650|NCT03299231|COPD|copd
4690651|NCT03299231|acute exacerbation|acute exacerbation
4690652|NCT03299231|OPEP|opep
4690653|NCT03299218|Specialized Nutritious Food (SNF)|specialized nutritious food (snf)
4690654|NCT03299218|Behaviour change communication (BCC)|behaviour change communication (bcc)
4690655|NCT03299218|Cash-based transfers|cash-based transfers
4690656|NCT03299140|Bipolar disorder|bipolar disorder
4690657|NCT03299140|Children|children
4690658|NCT03299140|Family Focused Therapy|family focused therapy
4690659|NCT03299140|CBT|cbt
4690660|NCT03299114|Neuropathic Pain|neuropathic pain
4690661|NCT03299114|Whirlpool|whirlpool
4690662|NCT03299114|Osteoarthritis|osteoarthritis
4690663|NCT03299114|Sleep|sleep
4690664|NCT03299101|Frailty|frailty
4690665|NCT03299101|Prehabilitation|prehabilitation
4690666|NCT03299101|Exercise therapy|exercise therapy
4690667|NCT03299101|Surgery|surgery
4690668|NCT03299101|Nutrition support|nutrition support
4690669|NCT03299075|External eating|external eating
4690670|NCT03299075|Technology|technology
4690671|NCT03299075|Photography|photography
4690672|NCT03299075|Social media|social media
4690673|NCT03299049|Long acting Cabotegravir|long acting cabotegravir
4690674|NCT03299049|Safety|safety
4690675|NCT03299049|HIV-1|hiv-1
4690676|NCT03299049|Efficacy|efficacy
4690677|NCT03299049|Tolerability|tolerability
4690678|NCT03299049|ATLAS-2M|atlas-2m
4690679|NCT03299049|Long acting Rilpivirine|long acting rilpivirine
4690680|NCT03299036|Hepatoma|hepatoma
4690681|NCT03299036|Transcatheter Arterial chemo-embolization|transcatheter arterial chemo-embolization
4690682|NCT03299036|Microsphere|microsphere
4690683|NCT03299036|Doxorubicin|doxorubicin
4690684|NCT03299023|Obstructive Sleep Apnea|obstructive sleep apnea
4690685|NCT03299023|Orthodontics|orthodontics
4690686|NCT03299023|Tooth Movement|tooth movement
4690687|NCT03299023|Medibyte|medibyte
4690688|NCT03299023|Apnea|apnea
4690689|NCT03299023|Hypopnea|hypopnea
4690690|NCT03299023|Sleep|sleep
4690691|NCT03299023|Disturbed Breathing|disturbed breathing
4690692|NCT03299010|Diabetes Mellitus|diabetes mellitus
4690693|NCT03299010|Risk|risk
4690694|NCT03299010|Complications|complications
4690695|NCT03299010|Mortality|mortality
4690696|NCT03299010|Cardiovascular Diseases|cardiovascular diseases
4690697|NCT03299010|Chinese|chinese
4690698|NCT03299010|Prediction|prediction
4690699|NCT03298997|Hemorrhoids|hemorrhoids
4690700|NCT03298997|Ligation|ligation
4690701|NCT03298997|Ultrasound|ultrasound
4690702|NCT03298997|Prospective|prospective
4690703|NCT03298997|Randomized Controlled Trial|randomized controlled trial
4690704|NCT03298945|colonoscopy|colonoscopy
4690705|NCT03298945|colorectal cancer|colorectal cancer
4690706|NCT03298945|bowel preparation regimen|bowel preparation regimen
4690707|NCT03298945|pragmatic trial|pragmatic trial
4690708|NCT03298932|Transesophageal echography|transesophageal echography
4690709|NCT03298932|Perioperative cardiac surgery|perioperative cardiac surgery
4690710|NCT03298932|Aortic valve replacement|aortic valve replacement
4690711|NCT03298932|2D strain of right ventricle|2d strain of right ventricle
4690712|NCT03298893|cervical cancer|cervical cancer
4690713|NCT03298893|nivolumab|nivolumab
4690714|NCT03298893|cisplatin|cisplatin
4690715|NCT03298893|radiotherapy|radiotherapy
4690716|NCT03298880|Valsalva manoeuvre|valsalva manoeuvre
4690717|NCT03298880|Vagal tone|vagal tone
4690718|NCT03298880|Modified Valsalva|modified valsalva
4690719|NCT03298880|Valsalva Assist Device|valsalva assist device
4690720|NCT03298867|Proptosis|proptosis
4690721|NCT03298867|Human monoclonal antibody|human monoclonal antibody
4690722|NCT03298867|insulin-like growth factor-1 receptor|insulin-like growth factor-1 receptor
4690723|NCT03298867|Thyroid-Associated Ophthalmopathy|thyroid-associated ophthalmopathy
4690724|NCT03298867|Hyperthyroidism|hyperthyroidism
4690725|NCT03298867|Autoimmune Thyroid Disease|autoimmune thyroid disease
4690726|NCT03298802|readmission|readmission
4690727|NCT03298802|triage visit for pregnancy related hypertension|triage visit for pregnancy related hypertension
4690728|NCT03298802|hydrochlorothiazide|hydrochlorothiazide
4690729|NCT03298789|static stretching|static stretching
4690730|NCT03298789|muscle power|muscle power
4690731|NCT03298789|countermovement jump|countermovement jump
4690732|NCT03298789|dynamometry|dynamometry
4690733|NCT03298789|warm up|warm up
4690734|NCT03298789|force plate|force plate
4690735|NCT03298750|Mechanical Laboratory Ovarian Stimulation Poor responders|mechanical laboratory ovarian stimulation poor responders
4690736|NCT03298711|Central Nervous System Sensitization|central nervous system sensitization
4690737|NCT03298711|Neuropeptides|neuropeptides
4690738|NCT03298698|Idiopathic nephrotic syndrome|idiopathic nephrotic syndrome
4690739|NCT03298698|Minimal change disease|minimal change disease
4690740|NCT03298698|Focal segmental glomerulosclerosis|focal segmental glomerulosclerosis
4690741|NCT03298698|Rituximab|rituximab
4690742|NCT03298698|Randomized clinical trial|randomized clinical trial
4690743|NCT03298685|transition|transition
4690744|NCT03298685|care program|care program
4690745|NCT03298685|needs|needs
4690746|NCT03298672|Alzheimer's Disease|alzheimer's disease
4690747|NCT03298672|Dementia|dementia
4690748|NCT03298672|Brain Diseases|brain diseases
4690749|NCT03298672|Central Nervous System Diseases|central nervous system diseases
4690750|NCT03298672|Cognition|cognition
4690751|NCT03298672|Neurodegenerative Diseases|neurodegenerative diseases
4690752|NCT03298672|Neurocognitive Disorders|neurocognitive disorders
4690753|NCT03298672|Mental Disorders|mental disorders
4690754|NCT03298633|Male infertility|male infertility
4690755|NCT03298633|In vitro fertilization|in vitro fertilization
4690756|NCT03298633|Intracytoplasmic sperm injection|intracytoplasmic sperm injection
4690757|NCT03298620|nursing home|nursing home
4690758|NCT03298620|gerodontology|gerodontology
4690759|NCT03298620|oral hygiene|oral hygiene
4690760|NCT03298568|food intolerance|food intolerance
4690761|NCT03298568|histamine intolerance|histamine intolerance
4690762|NCT03298568|diamine oxidase|diamine oxidase
4690763|NCT03298568|DAO|dao
4690764|NCT03298568|DAOsin|daosin
4690765|NCT03298529|Glycemic index|glycemic index
4690766|NCT03298529|Insulinemic index|insulinemic index
4690767|NCT03298529|Traditional egg pasta|traditional egg pasta
4690768|NCT03298503|Parkinson's disease|parkinson's disease
4690769|NCT03298503|posture balance|posture balance
4690770|NCT03298503|attention|attention
4690771|NCT03298490|validity|validity
4690772|NCT03298490|reliability|reliability
4690773|NCT03298490|low back pain|low back pain
4690774|NCT03298451|Hepatocellular Carcinoma Non-Resectable|hepatocellular carcinoma non-resectable
4690775|NCT03298399|Hematopoietic cell transplantation (HCT)|hematopoietic cell transplantation (hct)
4690776|NCT03298399|Haploidentical|haploidentical
4690777|NCT03298399|Mesenchymal stromal cells|mesenchymal stromal cells
4690778|NCT03298386|Elderly|elderly
4690779|NCT03298386|Multimorbidity|multimorbidity
4690780|NCT03298386|Polypharmacy|polypharmacy
4690781|NCT03298373|Healthy Men|healthy men
4690782|NCT03298373|Male Contraception|male contraception
4690783|NCT03298373|Androgen|androgen
4690784|NCT03298360|HIV cell reservoir|hiv cell reservoir
4690785|NCT03298295|Diabetes Mellitus|diabetes mellitus
4690786|NCT03298295|Insulin Pump Therapy|insulin pump therapy
4690787|NCT03298295|Continuous Subcutaneous Insulin Infusion|continuous subcutaneous insulin infusion
4690788|NCT03298256|AIS|ais
4690789|NCT03298243|stroke|stroke
4690790|NCT03298243|proprioception|proprioception
4690791|NCT03298243|sensory substitution|sensory substitution
4690792|NCT03298217|Inspiratory flow|inspiratory flow
4690793|NCT03298217|High flow nasal cannula, spirometry|high flow nasal cannula, spirometry
4690794|NCT03298217|spirometry|spirometry
4690795|NCT03298217|physiologic study|physiologic study
4690796|NCT03298217|Bronchiolitis patients sverity score mWCAS/ 3-5.|bronchiolitis patients sverity score mwcas/ 3-5.
4690797|NCT03298178|TAVR|tavr
4690798|NCT03298178|TAVI|tavi
4690799|NCT03298178|SAVR|savr
4690800|NCT03298152|lithium disilicate endocrowns|lithium disilicate endocrowns
4690801|NCT03298152|cerasmart endocrowns|cerasmart endocrowns
4690802|NCT03298126|Radial artery occlusion|radial artery occlusion
4690803|NCT03298126|TR band|tr band
4690804|NCT03298126|Transradial catheterization|transradial catheterization
4690805|NCT03298087|oligometastatic|oligometastatic
4690806|NCT03298087|SBRT|sbrt
4690807|NCT03298087|abiraterone|abiraterone
4690808|NCT03298087|apalutamide|apalutamide
4690809|NCT03298074|platinum-resistant|platinum-resistant
4690810|NCT03298074|recurrent|recurrent
4690811|NCT03298061|Eosinophilic Granulomatosis|eosinophilic granulomatosis
4690812|NCT03298061|MEA115921|mea115921
4690813|NCT03298061|Polyangiitis|polyangiitis
4690814|NCT03298061|Long-term access program|long-term access program
4690815|NCT03298061|mepolizumab|mepolizumab
4690816|NCT03298022|Ulcerative Colitis|ulcerative colitis
4690817|NCT03297983|M7583|m7583
4690818|NCT03297983|Healthy Subjects|healthy subjects
4690819|NCT03297983|Cross-over|cross-over
4690820|NCT03297931|Pulse|pulse
4690821|NCT03297931|Snack|snack
4690822|NCT03297931|Post-prandial glycemia|post-prandial glycemia
4690823|NCT03297931|Appetite|appetite
4690824|NCT03297931|Food intake|food intake
4690825|NCT03297931|Young adults|young adults
4690826|NCT03297931|Satiety|satiety
4690827|NCT03297905|Chronic Pain|chronic pain
4690828|NCT03297905|Military|military
4690829|NCT03297853|Descriptive|descriptive
4690830|NCT03297853|Support|support
4690831|NCT03297853|Retrospective|retrospective
4690832|NCT03297853|survey|survey
4690833|NCT03297827|diagnosis|diagnosis
4690834|NCT03297827|inflammatory biomarkers|inflammatory biomarkers
4690835|NCT03297827|cytokines|cytokines
4690836|NCT03297827|interleukin|interleukin
4690837|NCT03297827|interferons|interferons
4690838|NCT03297814|Peripheral arterial disease|peripheral arterial disease
4690839|NCT03297814|Platelet lysate|platelet lysate
4690840|NCT03297788|SCLC|sclc
4690841|NCT03297788|Brain Metastases|brain metastases
4690842|NCT03297788|SRS (stereotactic radiosurgery)|srs (stereotactic radiosurgery)
4690843|NCT03297788|WBRT (whole brain radiotherapy)|wbrt (whole brain radiotherapy)
4690844|NCT03297775|Rheumatoid Arthritis|rheumatoid arthritis
4690846|NCT03297775|Interstitial Lung Disease|interstitial lung disease
4690847|NCT03297775|ILD|ild
4690848|NCT03297775|lung disease|lung disease
4690849|NCT03297775|connective tissue disease|connective tissue disease
4690850|NCT03297775|CTD|ctd
4690851|NCT03297775|idiopathic pulmonary fibrosis|idiopathic pulmonary fibrosis
4690852|NCT03297775|IPF|ipf
4690853|NCT03297775|airways disease|airways disease
4690854|NCT03297593|renal cell carcinoma|renal cell carcinoma
4690855|NCT03297593|Nivolumab|nivolumab
4690856|NCT03297593|Ipilimumab|ipilimumab
4690857|NCT03297593|metastatic renal cell carcinoma|metastatic renal cell carcinoma
4690858|NCT03297593|immunotherapy|immunotherapy
4690859|NCT03297593|Opdivo|opdivo
4690860|NCT03297593|Yervoy|yervoy
4690861|NCT03297567|Elderly|elderly
4690862|NCT03297567|Hospitalization|hospitalization
4690863|NCT03297567|Immobilization|immobilization
4690864|NCT03297567|Exercise|exercise
4690865|NCT03297567|Accelerometry|accelerometry
4690866|NCT03297515|Omega-3|omega-3
4690867|NCT03297515|dry AMD|dry amd
4690868|NCT03297515|Stargardt|stargardt
4690869|NCT03297515|visual acuity|visual acuity
4690870|NCT03297424|PLX2853|plx2853
4690871|NCT03297424|Small cell lung cancer (SCLC)|small cell lung cancer (sclc)
4690872|NCT03297424|Uveal Melanoma|uveal melanoma
4690873|NCT03297424|Ovarian Clear Cell Carcinoma|ovarian clear cell carcinoma
4690874|NCT03297424|Non-Hodgkin Lymphoma|non-hodgkin lymphoma
4690875|NCT03297424|Advanced Malignancies|advanced malignancies
4690876|NCT03297424|Solid Tumor|solid tumor
4690877|NCT03297424|Diffuse Large B Cell Lymphoma (DLBCL)|diffuse large b cell lymphoma (dlbcl)
4690878|NCT03297424|Follicular Lymphoma (FL)|follicular lymphoma (fl)
4690879|NCT03297424|ARID1A|arid1a
4690880|NCT03297411|electroconvulsive therapy|electroconvulsive therapy
4690881|NCT03297411|computer modelling|computer modelling
4690882|NCT03297385|Prostate Cancer|prostate cancer
4690883|NCT03297385|Androgen Receptor Genomics|androgen receptor genomics
4690884|NCT03297385|Enzalutamide|enzalutamide
4690885|NCT03297385|Prostatectomy|prostatectomy
4690886|NCT03297385|Neoadjuvant androgen ablation|neoadjuvant androgen ablation
4690887|NCT03297372|Intraocular lens|intraocular lens
4690888|NCT03297372|monofocal|monofocal
4690889|NCT03297372|cataract|cataract
4690890|NCT03297372|PhysIOL|physiol
4690891|NCT03297359|Dalteparin|dalteparin
4690892|NCT03297359|Fragmin|fragmin
4690893|NCT03297346|radiotherapy|radiotherapy
4690894|NCT03297346|cardiovascular changes|cardiovascular changes
4690895|NCT03297346|cardiac imaging|cardiac imaging
4690896|NCT03297346|circulating biomarkers|circulating biomarkers
4690897|NCT03297346|dosimetry|dosimetry
4690898|NCT03297333|Obesity|obesity
4690899|NCT03297333|Exercise|exercise
4690900|NCT03297333|Cardiac Fat|cardiac fat
4690901|NCT03297333|Cardiac Magnetic Resonance|cardiac magnetic resonance
4690902|NCT03297333|Vascular Health|vascular health
4690903|NCT03297320|Advance Care Planning, End of life, CPR|advance care planning, end of life, cpr
4690904|NCT03297294|Painful diabetic neuropathy|painful diabetic neuropathy
4690905|NCT03297294|Neuropathic pain|neuropathic pain
4690906|NCT03297294|Angiotensin II type 2 receptor antagonist|angiotensin ii type 2 receptor antagonist
4690907|NCT03297281|Photovaporization|photovaporization
4690908|NCT03297281|Laser|laser
4690909|NCT03297281|Benign prostatic hyperplasia|benign prostatic hyperplasia
4690910|NCT03297281|Oral anticoagulation|oral anticoagulation
4690911|NCT03297281|Complication|complication
4690912|NCT03297268|Dementia Caregiver Empowerment|dementia caregiver empowerment
4690913|NCT03297268|Caregiver Burden|caregiver burden
4690914|NCT03297268|Agitation in Dementia|agitation in dementia
4690915|NCT03297268|Environmental Sensors|environmental sensors
4690916|NCT03297268|Wearable Technology|wearable technology
4690917|NCT03297255|Primary Liver Cancer; Cohort Study|primary liver cancer; cohort study
4690918|NCT03297242|Helicobacter Pylori eradication|helicobacter pylori eradication
4690919|NCT03297229|Peer mentoring|peer mentoring
4690920|NCT03297229|Self-monitoring|self-monitoring
4690921|NCT03297229|Behavioral economics|behavioral economics
4690922|NCT03297229|Hypertension|hypertension
4690923|NCT03297216|PreTerm Birth|preterm birth
4690924|NCT03297216|HIV-1-infection|hiv-1-infection
4690925|NCT03297216|Antiretroviral Treatment|antiretroviral treatment
4690926|NCT03297164|acute myocardial infarction|acute myocardial infarction
4690927|NCT03297164|heart failure|heart failure
4690928|NCT03297164|optimized treatment|optimized treatment
4690929|NCT03297151|Resistance Training|resistance training
4690930|NCT03297151|Muscle Function|muscle function
4690931|NCT03297151|Protein Synthesis|protein synthesis
4690932|NCT03297125|Optune Therapy|optune therapy
4690933|NCT03297125|MRI|mri
4690934|NCT03297125|NovoCure-TTF-200A|novocure-ttf-200a
4690935|NCT03297099|robot-assisted laparosocpic|robot-assisted laparosocpic
4690936|NCT03297099|hepatectomy|hepatectomy
4690937|NCT03297086|multifocal intraocular lens, angle kappa, presbyopia|multifocal intraocular lens, angle kappa, presbyopia
4690938|NCT03297060|Alcohol Screening|alcohol screening
4690939|NCT03297047|cast, fracture, immobilization, displacement, child|cast, fracture, immobilization, displacement, child
4690940|NCT03297034|Late effects|late effects
4690941|NCT03297034|Childhood cancer survivors|childhood cancer survivors
4690942|NCT03297034|Swiss Childhood Cancer Registry|swiss childhood cancer registry
4690943|NCT03297034|Europe|europe
4690944|NCT03297021|ambulatory surgery|ambulatory surgery
4690945|NCT03297021|post-operative nausea and vomiting|post-operative nausea and vomiting
4690946|NCT03297021|general anesthesia|general anesthesia
4690947|NCT03297008|healthy|healthy
4690948|NCT03297008|saliva|saliva
4690949|NCT03297008|stool|stool
4690950|NCT03297008|biomarkers|biomarkers
4690951|NCT03297008|Respiratory Syncytial Virus|respiratory syncytial virus
4690952|NCT03297008|Rotavirus|rotavirus
4690953|NCT03297008|Immunoglobulin|immunoglobulin
4690954|NCT03297008|Antibody|antibody
4690955|NCT03296995|glucose|glucose
4690956|NCT03296995|systemic lupus erythematosus|systemic lupus erythematosus
4690957|NCT03296982|Whole blood clotting time|whole blood clotting time
4690958|NCT03296956|Postpartum|postpartum
4690959|NCT03296956|Dietary Supplement|dietary supplement
4690960|NCT03296956|Mood Symptoms|mood symptoms
4690961|NCT03296930|Direct Acting Antiviral Agents (DAAs)|direct acting antiviral agents (daas)
4690962|NCT03296904|Lower limb amputation|lower limb amputation
4690963|NCT03296904|Wearable robotics|wearable robotics
4690964|NCT03296891|Ultrasonography|ultrasonography
4690965|NCT03296891|Point-of-care ultrasound|point-of-care ultrasound
4690966|NCT03296891|Resuscitation|resuscitation
4690967|NCT03296891|Critical Care|critical care
4690968|NCT03296878|low income|low income
4690969|NCT03296865|taping|taping
4690970|NCT03296865|functionality|functionality
4690971|NCT03296865|rehabilitation|rehabilitation
4690972|NCT03296865|muscle activity|muscle activity
4690973|NCT03296865|electromyography|electromyography
4690974|NCT03296839|colorectal cancer|colorectal cancer
4690975|NCT03296839|liver metastases|liver metastases
4690976|NCT03296839|SBRT|sbrt
4690977|NCT03296813|loop diuretic|loop diuretic
4690978|NCT03296787|Drug therapy|drug therapy
4690979|NCT03296748|asymptomatic cystocele.|asymptomatic cystocele.
4690980|NCT03296748|stress urinary incontinence|stress urinary incontinence
4690981|NCT03296696|Phase 1|phase 1
4690982|NCT03296696|EGFRvIII-positive glioblastoma|egfrviii-positive glioblastoma
4690983|NCT03296696|safety and tolerability|safety and tolerability
4690984|NCT03296696|AMG 596|amg 596
4690985|NCT03296670|STEMI|stemi
4690986|NCT03296670|CSFP|csfp
4690987|NCT03296670|Alprostadil|alprostadil
4690988|NCT03296670|targeted perfusion microcatheter|targeted perfusion microcatheter
4690989|NCT03296631|microbiome|microbiome
4690990|NCT03296631|gut|gut
4690991|NCT03296631|infant gut|infant gut
4690992|NCT03296631|phages|phages
4690993|NCT03296631|phages-bacteria interactions|phages-bacteria interactions
4690994|NCT03296631|microbiome development|microbiome development
4690995|NCT03296618|chronic stroke|chronic stroke
4690996|NCT03296618|neural stem cell|neural stem cell
4690997|NCT03296618|transplant|transplant
4690998|NCT03296618|paralysis|paralysis
4690999|NCT03296605|Obesity|obesity
4691000|NCT03296592|myelopathy|myelopathy
4691001|NCT03296592|diffusion MRI|diffusion mri
4691002|NCT03296592|spinal cord injury|spinal cord injury
4691003|NCT03296592|spinal cord compression|spinal cord compression
4691004|NCT03296592|spondylosis|spondylosis
4691005|NCT03296592|cervical|cervical
4691006|NCT03296540|STEMI|stemi
4691007|NCT03296501|ALS|als
4691008|NCT03296501|ADRC|adrc
4691009|NCT03296501|adipose derived regenerative cells|adipose derived regenerative cells
4691010|NCT03296501|intraspinal transplantation|intraspinal transplantation
4691011|NCT03296501|mesenchymal cells|mesenchymal cells
4691012|NCT03296488|post-laparotomy wound pain|post-laparotomy wound pain
4691013|NCT03296488|NALDEBAIN (150 mg Nalbuphine Sebacate)|naldebain (150 mg nalbuphine sebacate)
4691014|NCT03296488|PCA (patient-control-ed alagesia)|pca (patient-control-ed alagesia)
4691015|NCT03296449|Hypoxia|hypoxia
4691016|NCT03296449|High-Frequency Jet Ventilation|high-frequency jet ventilation
4691017|NCT03296449|Continuous Positive Airway Pressure|continuous positive airway pressure
4691018|NCT03296423|BCG vaccination|bcg vaccination
4691019|NCT03296410|Hand, Foot and Mouth Disease (HFMD)|hand, foot and mouth disease (hfmd)
4691020|NCT03296410|immunogenicity|immunogenicity
4691021|NCT03296410|safety|safety
4691022|NCT03296397|Genital warts|genital warts
4691023|NCT03296397|HPV vaccine|hpv vaccine
4691024|NCT03296397|Relapse|relapse
4691025|NCT03296384|schizophrenia|schizophrenia
4691026|NCT03296384|environmental factors|environmental factors
4691027|NCT03296358|Acute urticaria|acute urticaria
4691028|NCT03296358|Emergency department|emergency department
4691029|NCT03296358|Acute allergic syndrome|acute allergic syndrome
4691030|NCT03296358|Corticosteroid|corticosteroid
4691031|NCT03296358|H1-Antihistamines|h1-antihistamines
4691032|NCT03296358|Chronic urticaria|chronic urticaria
4691033|NCT03296345|Ketamine|ketamine
4691034|NCT03296345|Sickle Cell Disease|sickle cell disease
4691035|NCT03296345|Vaso-Occlusive Crisis|vaso-occlusive crisis
4691036|NCT03296332|Evaluation|evaluation
4691037|NCT03296332|Population-based Intervention|population-based intervention
4691038|NCT03296332|Salt intake|salt intake
4691039|NCT03296332|Hypertension|hypertension
4691040|NCT03296306|urothelial carcinoma|urothelial carcinoma
4691041|NCT03296306|cisplatin|cisplatin
4691042|NCT03296306|first-line chemotherapy|first-line chemotherapy
4691043|NCT03296293|Positive end-expiratory pressure(PEEP)|positive end-expiratory pressure(peep)
4691044|NCT03296293|intracranial pressure(ICP)|intracranial pressure(icp)
4691045|NCT03296293|central venous pressure(CVP)|central venous pressure(cvp)
4691046|NCT03296293|intracranial central venous pressure difference(IVPD)|intracranial central venous pressure difference(ivpd)
4691047|NCT03296280|ultrasound|ultrasound
4691048|NCT03296280|ultrasonography|ultrasonography
4691049|NCT03296280|point of care|point of care
4691050|NCT03296280|Doppler ultrasound|doppler ultrasound
4691051|NCT03296280|ultrasound imaging|ultrasound imaging
4691052|NCT03296280|diagnostic ultrasound|diagnostic ultrasound
4691053|NCT03296267|bile acid|bile acid
4691054|NCT03296267|bacterial uptake|bacterial uptake
4691055|NCT03296254|mindfulness|mindfulness
4691056|NCT03296254|meditation|meditation
4691057|NCT03296254|stress|stress
4691058|NCT03296254|burn-out|burn-out
4691059|NCT03296254|personality|personality
4691060|NCT03296254|randomized controlled trial|randomized controlled trial
4691061|NCT03296241|stress urinary incontinence|stress urinary incontinence
4691062|NCT03296241|sexual dysfunction|sexual dysfunction
4691063|NCT03296241|laser|laser
4691064|NCT03296241|Er:YAG|er:yag
4691065|NCT03296241|vaginal laser|vaginal laser
4691066|NCT03296241|vaginal tightening|vaginal tightening
4691067|NCT03296241|non-ablative|non-ablative
4691068|NCT03296241|minimally-invasive|minimally-invasive
4691069|NCT03296228|AIS|ais
4691070|NCT03296202|HIV|hiv
4691071|NCT03296202|cohort studies|cohort studies
4691072|NCT03296202|antiretroviral treatment|antiretroviral treatment
4691073|NCT03296189|ureteroscopy|ureteroscopy
4691074|NCT03296189|ureteric stent|ureteric stent
4691075|NCT03296189|intraluminal|intraluminal
4691076|NCT03296189|local anaesthetic/anesthetic|local anaesthetic/anesthetic
4691077|NCT03296189|steroid/glucocorticoid|steroid/glucocorticoid
4691078|NCT03296150|therapeutic educational program|therapeutic educational program
4691079|NCT03296150|adherence|adherence
4691080|NCT03296150|quality of life|quality of life
4691081|NCT03296150|elderly|elderly
4691082|NCT03296150|cancer|cancer
4691083|NCT03296137|immune therapy|immune therapy
4691084|NCT03296137|TILs|tils
4691085|NCT03296137|Adoptive cell therapy|adoptive cell therapy
4691086|NCT03296124|Prostate Cancer|prostate cancer
4691087|NCT03296124|Proton Radiation|proton radiation
4691088|NCT03296098|Contraception|contraception
4691089|NCT03296098|Healthy Female|healthy female
4691090|NCT03296098|Progestin|progestin
4691091|NCT03296098|ulipristal acetate|ulipristal acetate
4691092|NCT03296033|enoxaparin|enoxaparin
4691093|NCT03296033|thromboembolism|thromboembolism
4691094|NCT03296033|coagulation|coagulation
4691095|NCT03296033|factor Xa|factor xa
4691096|NCT03295994|arthroscopy|arthroscopy
4691097|NCT03295994|physical therapy|physical therapy
4691098|NCT03295994|rehabilitation|rehabilitation
4691099|NCT03295994|surgery|surgery
4691100|NCT03295994|rotator cuff tear|rotator cuff tear
4691101|NCT03295929|3D model|3d model
4691102|NCT03295929|Inner ear|inner ear
4691103|NCT03295903|Vascular function|vascular function
4691104|NCT03295903|Cannabidiol supplementation|cannabidiol supplementation
4691105|NCT03295890|myofascial trigger point, tinnitus, dry needling|myofascial trigger point, tinnitus, dry needling
4691106|NCT03295864|Arnold-Chiari Malformation, Type 1|arnold-chiari malformation, type 1
4691107|NCT03295864|Multifrequency tympanometry|multifrequency tympanometry
4691108|NCT03295864|Inner ear pressure|inner ear pressure
4691109|NCT03295851|Anemia|anemia
4691110|NCT03295851|Pre-operative|pre-operative
4691111|NCT03295851|Intravenous Iron|intravenous iron
4691112|NCT03295851|Ferric carboxymaltose|ferric carboxymaltose
4691113|NCT03295851|abdominal surgery|abdominal surgery
4691114|NCT03295838|Borderline personality disorder|borderline personality disorder
4691115|NCT03295838|Psychotherapy|psychotherapy
4691116|NCT03295838|Treatment outcome|treatment outcome
4691117|NCT03295838|Pragmatic clinical trials as topic|pragmatic clinical trials as topic
4691118|NCT03295838|Mentalization-based treatment|mentalization-based treatment
4691119|NCT03295838|Alexithymia|alexithymia
4691120|NCT03295825|Heparin binding protein|heparin binding protein
4691121|NCT03295825|Mortality|mortality
4691122|NCT03295786|Parkinson|parkinson
4691123|NCT03295786|CDNF|cdnf
4691219|NCT03295240|Lymphoma|lymphoma
4691124|NCT03295786|Drug Delivery System|drug delivery system
4691125|NCT03295786|Intracerebral|intracerebral
4691126|NCT03295773|Ischemic Stroke|ischemic stroke
4691127|NCT03295773|3D-rotational angiography|3d-rotational angiography
4691128|NCT03295773|Morphology|morphology
4691129|NCT03295773|Atherosclerosis|atherosclerosis
4691130|NCT03295721|bunion|bunion
4691131|NCT03295721|bunionectomy|bunionectomy
4691132|NCT03295721|bunion surgery|bunion surgery
4691133|NCT03295721|postoperative pain|postoperative pain
4691134|NCT03295708|Major depressive disorder,Fish Oil|major depressive disorder,fish oil
4691135|NCT03295695|Chemotherapy induced cardiotoxicity|chemotherapy induced cardiotoxicity
4691136|NCT03295695|Tumor blood perfusion|tumor blood perfusion
4691137|NCT03295630|Accelerometry|accelerometry
4691138|NCT03295630|Validity|validity
4691139|NCT03295617|spinal thoracic herniation|spinal thoracic herniation
4691140|NCT03295617|surgery|surgery
4691141|NCT03295617|endoscopic approach|endoscopic approach
4691142|NCT03295617|thoracic spine|thoracic spine
4691143|NCT03295617|minimal invasive access|minimal invasive access
4691144|NCT03295604|Gingival recession|gingival recession
4691145|NCT03295604|Subepithelial connective tissue grafts|subepithelial connective tissue grafts
4691146|NCT03295604|CAD/CAM|cad/cam
4691147|NCT03295591|Metastatic colorectal cancer|metastatic colorectal cancer
4691148|NCT03295591|Liver resection|liver resection
4691149|NCT03295591|Circulating tumor cells|circulating tumor cells
4691150|NCT03295578|employees|employees
4691151|NCT03295578|continuous glucose monitoring|continuous glucose monitoring
4691152|NCT03295578|personalized feedback|personalized feedback
4691153|NCT03295578|cognition|cognition
4691154|NCT03295578|wellbeing|wellbeing
4691155|NCT03295565|Sequencing|sequencing
4691156|NCT03295565|cabazitaxel|cabazitaxel
4691157|NCT03295565|abiraterone|abiraterone
4691158|NCT03295565|enzalutamide|enzalutamide
4691159|NCT03295565|clinical benefit rate|clinical benefit rate
4691160|NCT03295565|docetaxel|docetaxel
4691161|NCT03295565|second line treatment|second line treatment
4691162|NCT03295552|decitabine|decitabine
4691163|NCT03295552|triple negative breast cancer|triple negative breast cancer
4691164|NCT03295552|carboplatin|carboplatin
4691165|NCT03295552|metastatic|metastatic
4691166|NCT03295526|Cervical Cancer, Lymph nodes debulking surgery|cervical cancer, lymph nodes debulking surgery
4691167|NCT03295513|mutilated, root canal treated teeth, and coronal fracture|mutilated, root canal treated teeth, and coronal fracture
4691168|NCT03295500|CyberKnife|cyberknife
4691169|NCT03295500|hepatocellular|hepatocellular
4691170|NCT03295500|dose fraction|dose fraction
4691171|NCT03295500|ICG R15|icg r15
4691172|NCT03295487|post menopausal stress incontinence|post menopausal stress incontinence
4691173|NCT03295487|local estrogen|local estrogen
4691174|NCT03295448|fatty acids|fatty acids
4691175|NCT03295448|biomarker|biomarker
4691176|NCT03295448|carbohydrate|carbohydrate
4691177|NCT03295448|lipogenesis|lipogenesis
4691178|NCT03295435|Diet|diet
4691179|NCT03295435|Oral Health|oral health
4691180|NCT03295435|Nutrition|nutrition
4691181|NCT03295435|Dentition|dentition
4691182|NCT03295422|Persistent Atrial Fibrillation|persistent atrial fibrillation
4691183|NCT03295422|Radiofrequency ablation|radiofrequency ablation
4691184|NCT03295422|Catheter ablation|catheter ablation
4691185|NCT03295383|cyclophosphamide|cyclophosphamide
4691186|NCT03295383|Rituximab|rituximab
4691187|NCT03295370|Pain mechanisms|pain mechanisms
4691188|NCT03295370|Cortical activation|cortical activation
4691189|NCT03295370|fNIRS|fnirs
4691190|NCT03295370|Accessory spinal nerve|accessory spinal nerve
4691191|NCT03295370|Autonomic response|autonomic response
4691192|NCT03295370|Muscular perfusion|muscular perfusion
4691193|NCT03295318|Neisseria meningitidis|neisseria meningitidis
4691194|NCT03295318|conjugate meningococcal vaccine|conjugate meningococcal vaccine
4691195|NCT03295318|meningococcal serogroup X|meningococcal serogroup x
4691196|NCT03295305|Biomarker|biomarker
4691197|NCT03295305|Bipolar Disorder|bipolar disorder
4691198|NCT03295305|Cognition|cognition
4691199|NCT03295305|Cognitive Impairment|cognitive impairment
4691200|NCT03295305|cognitive remediation|cognitive remediation
4691201|NCT03295305|functional magnetic resonance imaging|functional magnetic resonance imaging
4691202|NCT03295305|pro-cognitive effect|pro-cognitive effect
4691203|NCT03295305|Relatives|relatives
4691204|NCT03295292|Phototherapeutic Keratectomy (PTK)|phototherapeutic keratectomy (ptk)
4691205|NCT03295292|photorefractive Keratectomy (PRK)|photorefractive keratectomy (prk)
4691206|NCT03295292|Collagen Cross-linking (CXL)|collagen cross-linking (cxl)
4691207|NCT03295292|Stem Cell Therapy|stem cell therapy
4691208|NCT03295279|World Trade Center|world trade center
4691209|NCT03295279|Quantitative computerized tomography|quantitative computerized tomography
4691210|NCT03295279|Qualitative computerized tomography of the chest|qualitative computerized tomography of the chest
4691211|NCT03295279|Chronic airway disease|chronic airway disease
4691212|NCT03295279|Interstitial lung disease|interstitial lung disease
4691213|NCT03295279|Occupational pulmonology|occupational pulmonology
4691214|NCT03295253|urinary incontinence|urinary incontinence
4691215|NCT03295253|stress urinary incontinence|stress urinary incontinence
4691216|NCT03295253|stress incontinence|stress incontinence
4691217|NCT03295240|Mantle Cell Lymphoma|mantle cell lymphoma
4691220|NCT03295240|Venetoclax|venetoclax
4691221|NCT03295240|17-216|17-216
4691222|NCT03295227|Thymoma|thymoma
4691223|NCT03295227|Thymic cancer|thymic cancer
4691224|NCT03295227|Pembrolizumab|pembrolizumab
4691225|NCT03295227|Keytruda|keytruda
4691226|NCT03295227|MK-3475|mk-3475
4691227|NCT03295227|SCH-900475|sch-900475
4691228|NCT03295214|Acetaminophen|acetaminophen
4691229|NCT03295214|Functional Endoscopic Sinus Surgery|functional endoscopic sinus surgery
4691230|NCT03295201|Cystic Fibrosis|cystic fibrosis
4691231|NCT03295201|Postural exercise|postural exercise
4691232|NCT03295201|Pulmonary rehabilitation|pulmonary rehabilitation
4691233|NCT03295175|Congenital Abnormalities|congenital abnormalities
4691234|NCT03295175|Hypospadias|hypospadias
4691235|NCT03295175|Congenital megaprepuce|congenital megaprepuce
4691236|NCT03295175|Histology|histology
4691237|NCT03295110|Alzheimer's disease and Related Disorders (ADRD)|alzheimer's disease and related disorders (adrd)
4691238|NCT03295110|natural caregiver|natural caregiver
4691239|NCT03295110|non-medical connected device|non-medical connected device
4691240|NCT03295110|caregiver's burden|caregiver's burden
4691241|NCT03295110|anxiety|anxiety
4691242|NCT03295110|costs|costs
4691243|NCT03295110|quality of life|quality of life
4691244|NCT03295110|depressive symptoms|depressive symptoms
4691245|NCT03295110|independence|independence
4691246|NCT03295097|pharmacogenomics|pharmacogenomics
4691247|NCT03295071|Heredity Optic Atrophy|heredity optic atrophy
4691248|NCT03295071|Leber Hereditary Optic Atrophy|leber hereditary optic atrophy
4691249|NCT03295071|Leber Hereditary Optic Neuropathy|leber hereditary optic neuropathy
4691250|NCT03295071|Eye Diseases|eye diseases
4691251|NCT03295071|Hereditary Eye Diseases|hereditary eye diseases
4691252|NCT03295071|Inherited retinal dystrophies or degeneration|inherited retinal dystrophies or degeneration
4691253|NCT03295071|Inborn Genetic Disease|inborn genetic disease
4691254|NCT03295071|Gene Therapy|gene therapy
4691255|NCT03295071|Intravitreal Injections|intravitreal injections
4691256|NCT03295071|Mitochondrial Disease|mitochondrial disease
4691257|NCT03295071|AAV2 Vectors|aav2 vectors
4691258|NCT03295071|Nervous System Diseases|nervous system diseases
4691259|NCT03295071|Neurodegenerative Disease|neurodegenerative disease
4691260|NCT03295071|Heredodegenerative Disorders of the Nervous System|heredodegenerative disorders of the nervous system
4691261|NCT03295006|TheraSphere, hepatocellular carcinoma, dosimetry|therasphere, hepatocellular carcinoma, dosimetry
4691262|NCT03294980|Chronic lymphocytic leukemia|chronic lymphocytic leukemia
4691263|NCT03294980|Observational study|observational study
4691264|NCT03294967|High Myopia|high myopia
4691265|NCT03294967|Caffeine|caffeine
4691266|NCT03294967|Choroidal Thickness|choroidal thickness
4691267|NCT03294967|Choroidal Volume|choroidal volume
4691268|NCT03294967|Optical Coherence Tomography|optical coherence tomography
4691269|NCT03294967|Optical Coherence Tomography Angiography|optical coherence tomography angiography
4691270|NCT03294954|Neuroblastoma|neuroblastoma
4691271|NCT03294954|Natural Killer T-Cells|natural killer t-cells
4691272|NCT03294954|Chimerical Antigen Receptor|chimerical antigen receptor
4691273|NCT03294915|prediabetes|prediabetes
4691274|NCT03294915|resistant starch|resistant starch
4691275|NCT03294915|insulin sensitivity|insulin sensitivity
4691276|NCT03294889|Prostate cancer|prostate cancer
4691277|NCT03294889|Stereotactic body radiation therapy|stereotactic body radiation therapy
4691278|NCT03294889|Calypso® beacon system|calypso® beacon system
4691279|NCT03294876|Glucocorticoid|glucocorticoid
4691280|NCT03294876|HPA axis|hpa axis
4691281|NCT03294863|Scar|scar
4691282|NCT03294863|Cosmesis|cosmesis
4691283|NCT03294863|Embrace Device|embrace device
4691284|NCT03294863|Split Wound|split wound
4691285|NCT03294863|Wound Closure|wound closure
4691286|NCT03294863|Cutaneous Wound|cutaneous wound
4691287|NCT03294824|NK cells|nk cells
4691288|NCT03294824|Cytomegalovirus|cytomegalovirus
4691289|NCT03294824|adenovirus|adenovirus
4691290|NCT03294824|Allogeneic transplantation|allogeneic transplantation
4691291|NCT03294772|Respiratory Tract Infections|respiratory tract infections
4691292|NCT03294772|gastroenteritis|gastroenteritis
4691293|NCT03294772|hand sanitizer|hand sanitizer
4691294|NCT03294772|handwashing|handwashing
4691295|NCT03294772|day care|day care
4691296|NCT03294759|amion|amion
4691297|NCT03294759|stem cell|stem cell
4691298|NCT03294759|acl|acl
4691299|NCT03294746|Drug induced interstitial lung disease (DIILD)|drug induced interstitial lung disease (diild)
4691300|NCT03294694|Metastatic Hormone-Receptor-Positive (HR+) Breast Cancer|metastatic hormone-receptor-positive (hr+) breast cancer
4691301|NCT03294694|HER2-Negative Breast Cancer|her2-negative breast cancer
4691302|NCT03294694|Metastatic Epithelial Ovarian Cancer|metastatic epithelial ovarian cancer
4691303|NCT03294668|social skills group training|social skills group training
4691304|NCT03294668|Adolescents|adolescents
4691305|NCT03294668|Active control group|active control group
4691306|NCT03294668|Australian|australian
4691307|NCT03294642|exercise|exercise
4691308|NCT03294642|FODMAP|fodmap
4691309|NCT03294642|gastrointestinal|gastrointestinal
4691310|NCT03294642|endurance|endurance
4691311|NCT03294642|cycling|cycling
4691312|NCT03294629|cPAP|cpap
4691313|NCT03294629|SenseAwake|senseawake
4691314|NCT03294616|transcutaneous electroacupuncture|transcutaneous electroacupuncture
4691315|NCT03294603|Healthy Volunteer|healthy volunteer
4691316|NCT03294603|CC-220|cc-220
4691317|NCT03294603|Male|male
4691318|NCT03294590|Child oral health behaviors|child oral health behaviors
4691319|NCT03294590|Text messages|text messages
4691320|NCT03294590|Motivation|motivation
4691321|NCT03294590|Self efficacy|self efficacy
4691322|NCT03294590|Outcome Expectations|outcome expectations
4691323|NCT03294590|Bottle/sippy cup use|bottle/sippy cup use
4691324|NCT03294590|Sugar sweetened beverage consumption|sugar sweetened beverage consumption
4691325|NCT03294590|Fluoride varnish|fluoride varnish
4691326|NCT03294590|Healthy eating|healthy eating
4691327|NCT03294590|Parent oral health behaviors|parent oral health behaviors
4691328|NCT03294590|Parent oral health attitudes|parent oral health attitudes
4691329|NCT03294590|Fluoride|fluoride
4691330|NCT03294577|Plinabulin|plinabulin
4691331|NCT03294577|Pegfilgrastim|pegfilgrastim
4691332|NCT03294577|bone pain|bone pain
4691333|NCT03294577|Chemotherapy induced neutropenia|chemotherapy induced neutropenia
4691334|NCT03294564|Inflammation|inflammation
4691335|NCT03294564|Threat sensitivity|threat sensitivity
4691336|NCT03294564|Reward sensitivity|reward sensitivity
4691337|NCT03294551|HPV Vaccine|hpv vaccine
4691338|NCT03294551|immunization registry|immunization registry
4691339|NCT03294551|Reminder recall (R/R)|reminder recall (r/r)
4691340|NCT03294486|Glioblastoma|glioblastoma
4691341|NCT03294486|Oncolytic viruses|oncolytic viruses
4691342|NCT03294473|reminder recall (R/R), influenza vaccines|reminder recall (r/r), influenza vaccines
4691343|NCT03294460|Functional Magnetic Resonance Imaging (fMRI)|functional magnetic resonance imaging (fmri)
4691344|NCT03294460|Alcohol Use|alcohol use
4691345|NCT03294460|Polymorphism, Genetic|polymorphism, genetic
4691346|NCT03294460|Magnetic Resonance Imaging (MRI)|magnetic resonance imaging (mri)
4691347|NCT03294447|Fear of falling|fear of falling
4691348|NCT03294408|fractal analysis|fractal analysis
4691349|NCT03294408|trabecular bone texture|trabecular bone texture
4691350|NCT03294408|knee osteoarthritis|knee osteoarthritis
4691351|NCT03294408|subchondral bone|subchondral bone
4691352|NCT03294408|Medical Resonnance Imaging|medical resonnance imaging
4691353|NCT03294395|Antimicrobial resistance|antimicrobial resistance
4691354|NCT03294395|Antibiotics|antibiotics
4691355|NCT03294395|Fosfomycin|fosfomycin
4691356|NCT03294395|Ertapenem|ertapenem
4691357|NCT03294395|Gentamicin|gentamicin
4691358|NCT03294395|Neisseria Gonorrhoeae|neisseria gonorrhoeae
4691359|NCT03294382|epicanthoplasty|epicanthoplasty
4691360|NCT03294382|Botulinum Toxins|botulinum toxins
4691361|NCT03294382|scar|scar
4691362|NCT03294382|intercanthal distance|intercanthal distance
4691363|NCT03294382|blepharoplasty|blepharoplasty
4691364|NCT03294369|Hypertension|hypertension
4691365|NCT03294369|Diabetes|diabetes
4691366|NCT03294369|Dyslipidemia|dyslipidemia
4691367|NCT03294369|Smoking|smoking
4691368|NCT03294369|Cardiovascular|cardiovascular
4691369|NCT03294369|Toledo|toledo
4691370|NCT03294317|His bundle pacing|his bundle pacing
4691371|NCT03294317|Pacemaker|pacemaker
4691372|NCT03294304|MIBC|mibc
4691373|NCT03294304|UC|uc
4691374|NCT03294304|Immunotherapy|immunotherapy
4691375|NCT03294304|Bladder Cancer|bladder cancer
4691376|NCT03294304|Neoadjuvant|neoadjuvant
4691377|NCT03294304|Nivolumab|nivolumab
4691378|NCT03294304|Cisplatin|cisplatin
4691379|NCT03294304|Gemcitabine|gemcitabine
4691380|NCT03294265|Diabetes|diabetes
4691381|NCT03294265|Peer support|peer support
4691382|NCT03294265|WhatsApp|whatsapp
4691383|NCT03294252|PIPAC|pipac
4691384|NCT03294252|oxaliplatin|oxaliplatin
4691385|NCT03294252|peritoneal metastases|peritoneal metastases
4691386|NCT03294187|Upper Extremity|upper extremity
4691387|NCT03294187|Feedback|feedback
4691388|NCT03294187|Rehabilitation|rehabilitation
4691389|NCT03294187|Randomized Controlled Trial|randomized controlled trial
4691390|NCT03294161|Meglumine antimoniate|meglumine antimoniate
4691391|NCT03294161|L.Braziliensis|l.braziliensis
4691392|NCT03294161|Immunotherapy|immunotherapy
4691393|NCT03294161|Immucillin|immucillin
4691394|NCT03294148|Placebo|placebo
4691395|NCT03294148|Back|back
4691396|NCT03294148|Pain|pain
4691397|NCT03294148|Chronic|chronic
4691398|NCT03294148|Mind-Body|mind-body
4691399|NCT03294135|Encepur|encepur
4691400|NCT03294135|Adults|adults
4691401|NCT03294135|Long term immunogenicity|long term immunogenicity
4691402|NCT03294135|Tick-borne Encephalitis vaccine|tick-borne encephalitis vaccine
4691403|NCT03294135|Booster|booster
4691404|NCT03294122|Radiotherapy|radiotherapy
4691405|NCT03294122|Adverse effects|adverse effects
4691406|NCT03294122|Prostate cancer|prostate cancer
4691407|NCT03294122|Head and neck cancer|head and neck cancer
4691408|NCT03294122|Patient risk stratification|patient risk stratification
4691409|NCT03294122|Mathematical models|mathematical models
4691410|NCT03294122|Microbiome|microbiome
4691411|NCT03294122|Inflammatory cytokines|inflammatory cytokines
4691412|NCT03294122|Magnetic Resonance Imaging|magnetic resonance imaging
4691413|NCT03294109|TQL block, TAP block, donor nephrectomy, pain, patient satisfaction|tql block, tap block, donor nephrectomy, pain, patient satisfaction
4691414|NCT03294083|Cancer|cancer
4691415|NCT03294083|Renal cell carcinoma|renal cell carcinoma
4691416|NCT03294083|Clear cell renal cell carcinoma|clear cell renal cell carcinoma
4691417|NCT03294070|hemodynamic parameters|hemodynamic parameters
4691418|NCT03294070|arterial stiffness|arterial stiffness
4691419|NCT03294057|Self-Management IT Program|self-management it program
4691420|NCT03294044|Self-Management IT Program|self-management it program
4691421|NCT03294031|Parkinson Disease|parkinson disease
4691422|NCT03294031|Neurodegenerative Disorder|neurodegenerative disorder
4691423|NCT03294031|Physical Activity|physical activity
4691424|NCT03294031|Pilates Method|pilates method
4691425|NCT03294031|Stabilometer|stabilometer
4691426|NCT03293953|HCV|hcv
4691427|NCT03293953|HIV|hiv
4691428|NCT03293953|Liver Fibrosis|liver fibrosis
4691429|NCT03293953|Liver Iron Overload|liver iron overload
4691430|NCT03293940|Breast Pain|breast pain
4691431|NCT03293940|Nerve Pain|nerve pain
4691432|NCT03293940|Mastectomy|mastectomy
4691433|NCT03293940|Lumpectomy|lumpectomy
4691434|NCT03293940|Breast Reconstruction|breast reconstruction
4691435|NCT03293927|children, mechanically ventilated, fentanyl, dexmedetomidine, delirium, polypharmacy|children, mechanically ventilated, fentanyl, dexmedetomidine, delirium, polypharmacy
4691436|NCT03293888|Spectral Diagnosis Probe|spectral diagnosis probe
4691437|NCT03293888|Chaos Wand|chaos wand
4691438|NCT03293888|Spectral Analysis|spectral analysis
4691439|NCT03293888|Optical Spectroscopy|optical spectroscopy
4691440|NCT03293862|laparotomy|laparotomy
4691441|NCT03293862|emergency surgery|emergency surgery
4691442|NCT03293862|abdominal wound dehiscence|abdominal wound dehiscence
4691443|NCT03293862|prophylactic mesh|prophylactic mesh
4691444|NCT03293836|Varicose ulcer|varicose ulcer
4691445|NCT03293836|Venous ulcer|venous ulcer
4691446|NCT03293836|Radiofrequency ablation|radiofrequency ablation
4691447|NCT03293836|Perforating veins insufficiency|perforating veins insufficiency
4691448|NCT03293836|Varicose veins treatment|varicose veins treatment
4691449|NCT03293797|Mindfulness-based Therapy|mindfulness-based therapy
4691450|NCT03293797|Wellbeing|wellbeing
4691451|NCT03293797|Treatment|treatment
4691452|NCT03293784|Melanoma|melanoma
4691453|NCT03293784|Immune checkpoint|immune checkpoint
4691454|NCT03293784|Nivolumab|nivolumab
4691455|NCT03293784|Ipilimumab|ipilimumab
4691456|NCT03293784|Infliximab|infliximab
4691457|NCT03293784|Certolizumab|certolizumab
4691458|NCT03293784|PD-1|pd-1
4691459|NCT03293784|TNFa|tnfa
4691460|NCT03293784|CTLA-4|ctla-4
4691461|NCT03293771|Transgender women|transgender women
4691462|NCT03293771|Male-to-female|male-to-female
4691463|NCT03293771|Gender confirmation surgery|gender confirmation surgery
4691464|NCT03293771|Voiding disorder|voiding disorder
4691465|NCT03293771|Vaginal dysfunction|vaginal dysfunction
4691466|NCT03293693|beta-glucan|beta-glucan
4691467|NCT03293693|Blood glucose|blood glucose
4691468|NCT03293693|Gut microbiota|gut microbiota
4691469|NCT03293693|Satiety|satiety
4691470|NCT03293693|Dietary intervention|dietary intervention
4691471|NCT03293667|Rheumatoid Arthritis|rheumatoid arthritis
4691472|NCT03293667|Regulatory T Cells|regulatory t cells
4691473|NCT03293641|Children, Sickle Cell Disease, Zinc|children, sickle cell disease, zinc
4691474|NCT03293628|cervical intraepithelial neoplasia|cervical intraepithelial neoplasia
4691475|NCT03293628|haemostasis|haemostasis
4691476|NCT03293628|vaginal pack|vaginal pack
4691477|NCT03293628|Loop electrical excision procedure|loop electrical excision procedure
4691478|NCT03293628|randomized clinical trials|randomized clinical trials
4691479|NCT03293628|uterine cervical neoplasm|uterine cervical neoplasm
4691480|NCT03293602|prostate cancer|prostate cancer
4691481|NCT03293602|MRI|mri
4691482|NCT03293602|BOLD|bold
4691483|NCT03293602|18F-MISO|18f-miso
4691484|NCT03293602|PET|pet
4691485|NCT03293589|end-stage renal disease|end-stage renal disease
4691486|NCT03293589|critical limb ischemia|critical limb ischemia
4691487|NCT03293589|surgical revascularisation|surgical revascularisation
4691488|NCT03293589|endovascular therapy|endovascular therapy
4691489|NCT03293576|Behavioural Medicine|behavioural medicine
4691490|NCT03293576|Health Psychology|health psychology
4691491|NCT03293576|Psychosocial Intervention|psychosocial intervention
4691492|NCT03293576|People Who Inject Drugs|people who inject drugs
4691493|NCT03293563|Kidney cancer|kidney cancer
4691494|NCT03293563|Surgical approaches|surgical approaches
4691495|NCT03293563|Medical treatment|medical treatment
4691496|NCT03293563|Multicentric and multidisciplinary network|multicentric and multidisciplinary network
4691497|NCT03293537|Dementia|dementia
4691498|NCT03293537|Aphathy|aphathy
4691499|NCT03293537|Emotion|emotion
4691500|NCT03293537|Images|images
4691501|NCT03293537|Skin conductance|skin conductance
4691502|NCT03293537|Heart rate|heart rate
4691503|NCT03293524|Heredity Optic Atrophy|heredity optic atrophy
4691504|NCT03293524|Leber Hereditary Optic Atrophy|leber hereditary optic atrophy
4691505|NCT03293524|Leber Hereditary Optic Neuropathy|leber hereditary optic neuropathy
4691506|NCT03293524|LHON|lhon
4691507|NCT03293524|Eye Diseases|eye diseases
4691508|NCT03293524|Hereditary Eye Diseases|hereditary eye diseases
4691509|NCT03293524|Inherited retinal dystrophies or degeneration|inherited retinal dystrophies or degeneration
4691510|NCT03293524|Inborn Genetic Disease|inborn genetic disease
4691511|NCT03293524|Gene Therapy|gene therapy
4691610|NCT03292991|SIR Spheres|sir spheres
4691512|NCT03293524|Intravitreal Injections|intravitreal injections
4691513|NCT03293524|Mitochondrial Disease|mitochondrial disease
4691514|NCT03293524|AAV2 Vectors|aav2 vectors
4691515|NCT03293524|Nervous System Diseases|nervous system diseases
4691516|NCT03293524|Neurodegenerative Disease|neurodegenerative disease
4691517|NCT03293524|Heredodegenerative Disorders of the Nervous System|heredodegenerative disorders of the nervous system
4691518|NCT03293524|Atrophy|atrophy
4691519|NCT03293524|Pathological Conditions, Anatomical|pathological conditions, anatomical
4691520|NCT03293524|Anesthetics|anesthetics
4691521|NCT03293524|Central Nervous System Depressants|central nervous system depressants
4691522|NCT03293524|Physiological Effects of Drugs|physiological effects of drugs
4691523|NCT03293511|Oxytocin|oxytocin
4691524|NCT03293511|Eye tracking|eye tracking
4691525|NCT03293511|Autistic trait|autistic trait
4691526|NCT03293407|Pulmonary arterial hypertension|pulmonary arterial hypertension
4691527|NCT03293407|PAH|pah
4691528|NCT03293394|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
4691529|NCT03293394|Motor Neuron Disease|motor neuron disease
4691530|NCT03293394|Transcranial Direct Current Stimulation|transcranial direct current stimulation
4691531|NCT03293368|Oral|oral
4691532|NCT03293368|Lichen planus|lichen planus
4691533|NCT03293368|PRP|prp
4691534|NCT03293355|People Living with HIV Who Use Drugs (PLHWUD)|people living with hiv who use drugs (plhwud)
4691535|NCT03293355|Community Health Workers (CHW)|community health workers (chw)
4691536|NCT03293355|Multilevel Service Integration|multilevel service integration
4691537|NCT03293355|HIV/AIDS|hiv/aids
4691538|NCT03293355|Vietnam|vietnam
4691539|NCT03293329|rotator cuff injury|rotator cuff injury
4691540|NCT03293329|diaphragm|diaphragm
4691541|NCT03293329|physical therapy|physical therapy
4691542|NCT03293329|manual therapy|manual therapy
4691543|NCT03293316|Transcranial electrical stimulation; random noise;|transcranial electrical stimulation; random noise;
4691544|NCT03293316|cognitive interventions; electroencephalography;|cognitive interventions; electroencephalography;
4691545|NCT03293316|inter-individual variability; stochastic resonance;|inter-individual variability; stochastic resonance;
4691546|NCT03293303|Prevention|prevention
4691547|NCT03293303|Physical activity|physical activity
4691548|NCT03293303|Sedentary behaviour|sedentary behaviour
4691549|NCT03293303|Daily activities|daily activities
4691550|NCT03293303|Homecare|homecare
4691551|NCT03293303|Nursing|nursing
4691552|NCT03293303|Primary care|primary care
4691553|NCT03293303|Older adults|older adults
4691554|NCT03293303|Function Focused Care|function focused care
4691555|NCT03293303|Reablement|reablement
4691556|NCT03293303|Restorative Care|restorative care
4691557|NCT03293290|HIV pre-exposure prophylaxis|hiv pre-exposure prophylaxis
4691558|NCT03293290|criminal justice|criminal justice
4691559|NCT03293290|women|women
4691560|NCT03293290|risk networks|risk networks
4691561|NCT03293264|metabolic syndrome|metabolic syndrome
4691562|NCT03293264|exercise training|exercise training
4691563|NCT03293264|employees|employees
4691564|NCT03293264|workplace|workplace
4691565|NCT03293264|operational health service|operational health service
4691566|NCT03293238|knee|knee
4691567|NCT03293238|osteoarthritis|osteoarthritis
4691568|NCT03293238|ultrasound|ultrasound
4691569|NCT03293238|sonography|sonography
4691570|NCT03293238|injection|injection
4691571|NCT03293225|cu|cu
4691572|NCT03293212|Postoperative pain|postoperative pain
4691573|NCT03293212|Failed back surgery syndrome|failed back surgery syndrome
4691574|NCT03293212|Korean medicine|korean medicine
4691575|NCT03293173|DLBCL|dlbcl
4691576|NCT03293173|Chemoimmunotherapy|chemoimmunotherapy
4691577|NCT03293173|High risk|high risk
4691578|NCT03293173|CNS prophylaxis|cns prophylaxis
4691579|NCT03293173|Biomarker-driven|biomarker-driven
4691580|NCT03293147|Blood pressure|blood pressure
4691581|NCT03293147|Antihypertensive treatment|antihypertensive treatment
4691582|NCT03293147|Adherence|adherence
4691583|NCT03293147|Biomarker|biomarker
4691584|NCT03293147|Urine|urine
4691585|NCT03293147|HPLC-MS/MS|hplc-ms/ms
4691586|NCT03293134|Fowler syndrome|fowler syndrome
4691587|NCT03293121|running related injuries|running related injuries
4691588|NCT03293108|Osteoporosis|osteoporosis
4691589|NCT03293108|Denosumab|denosumab
4691590|NCT03293095|musculoskeletal pathology|musculoskeletal pathology
4691591|NCT03293095|motion sensor|motion sensor
4691592|NCT03293095|motion capture|motion capture
4691593|NCT03293095|functional task|functional task
4691594|NCT03293095|biomarker|biomarker
4691595|NCT03293069|Conservative Iron Chelation|conservative iron chelation
4691596|NCT03293069|Disease-modifying Strategy|disease-modifying strategy
4691597|NCT03293056|aerobic exercises|aerobic exercises
4691598|NCT03293056|training|training
4691599|NCT03293056|aquatic|aquatic
4691600|NCT03293030|atopic dermatitis|atopic dermatitis
4691601|NCT03293030|eczema|eczema
4691602|NCT03293030|dupilumab|dupilumab
4691603|NCT03293004|collagen|collagen
4691604|NCT03293004|tendon|tendon
4691605|NCT03293004|procollagen type I N-terminal|procollagen type i n-terminal
4691606|NCT03293004|athletes|athletes
4691607|NCT03293004|vitamin C|vitamin c
4691608|NCT03293004|hydrolyzed collagen|hydrolyzed collagen
4691609|NCT03292991|Hepatocellular Carcinoma|hepatocellular carcinoma
4691611|NCT03292991|SIRT|sirt
4691612|NCT03292939|progestrone|progestrone
4691613|NCT03292939|doppler indices|doppler indices
4691614|NCT03292913|HIV|hiv
4691615|NCT03292887|Mucopolysaccharidosis II|mucopolysaccharidosis ii
4691616|NCT03292887|Hunter Syndrome|hunter syndrome
4691617|NCT03292887|Enzyme Replacement Therapy|enzyme replacement therapy
4691618|NCT03292887|Lysosomal|lysosomal
4691619|NCT03292887|Glycosaminoglycans|glycosaminoglycans
4691620|NCT03292874|prostate cancer|prostate cancer
4691621|NCT03292874|MRI|mri
4691622|NCT03292848|CNS Disorders|cns disorders
4691623|NCT03292848|Brexpiprazole|brexpiprazole
4691624|NCT03292835|complex|complex
4691625|NCT03292835|zoonotic|zoonotic
4691626|NCT03292835|medical device|medical device
4691627|NCT03292796|Open Angle Glaucoma|open angle glaucoma
4691628|NCT03292796|Cataract|cataract
4691629|NCT03292796|Phacoemulsification,|phacoemulsification,
4691630|NCT03292796|Cystoid Macular Oedema,|cystoid macular oedema,
4691631|NCT03292796|Prostaglandin Analogues|prostaglandin analogues
4691632|NCT03292783|VEGF|vegf
4691633|NCT03292783|DLL4|dll4
4691634|NCT03292783|Solid Tumors|solid tumors
4691635|NCT03292783|bispecific antibody|bispecific antibody
4691636|NCT03292783|anti-angiogenic|anti-angiogenic
4691637|NCT03292770|Embryo Transfer|embryo transfer
4691638|NCT03292770|Flushing catheter|flushing catheter
4691639|NCT03292770|Pregnancy rate|pregnancy rate
4691640|NCT03292770|Frozen Embryo Tranfer|frozen embryo tranfer
4691641|NCT03292757|Fluorescence|fluorescence
4691642|NCT03292744|immunosenescence|immunosenescence
4691643|NCT03292718|PERT|pert
4691644|NCT03292718|mobile application|mobile application
4691645|NCT03292705|cognitive training|cognitive training
4691646|NCT03292705|person-centered approach|person-centered approach
4691647|NCT03292614|Multifocal Intraocular Lens|multifocal intraocular lens
4691648|NCT03292614|Postoperative Measurements of refraction|postoperative measurements of refraction
4691649|NCT03292601|Spinal Orthosis|spinal orthosis
4691650|NCT03292601|Spinal Brace|spinal brace
4691651|NCT03292588|urban setting|urban setting
4691652|NCT03292588|children and adolescents|children and adolescents
4691653|NCT03292588|double-masked, placebo-controlled randomized trial|double-masked, placebo-controlled randomized trial
4691654|NCT03292588|asthma exacerbations (attacks)|asthma exacerbations (attacks)
4691655|NCT03292588|mepolizumab adjunctive therapy|mepolizumab adjunctive therapy
4691656|NCT03292588|asthma exacerbations prevention|asthma exacerbations prevention
4691657|NCT03292588|difficult-to-control exacerbation-prone asthma|difficult-to-control exacerbation-prone asthma
4691658|NCT03292549|Urology|urology
4691659|NCT03292549|Robotic surgery|robotic surgery
4691660|NCT03292549|Haemostasis|haemostasis
4691661|NCT03292549|Partial Nephrectomy|partial nephrectomy
4691662|NCT03292523|Hyperventilation syndrome|hyperventilation syndrome
4691663|NCT03292523|Work productivity|work productivity
4691664|NCT03292523|Absenteeism|absenteeism
4691665|NCT03292523|Presenteeism|presenteeism
4691666|NCT03292484|AR101|ar101
4691667|NCT03292484|Characterized Peanut Allergen|characterized peanut allergen
4691668|NCT03292484|OIT (oral immunotherapy)|oit (oral immunotherapy)
4691669|NCT03292484|Peanut Allergy|peanut allergy
4691670|NCT03292484|Allergy|allergy
4691671|NCT03292484|Peanut-Allergic Children|peanut-allergic children
4691672|NCT03292484|Peanut-Allergic Adults|peanut-allergic adults
4691673|NCT03292484|Desensitization|desensitization
4691674|NCT03292484|CPNA (Characterized Peanut Allergen)|cpna (characterized peanut allergen)
4691675|NCT03292471|Aphasia|aphasia
4691676|NCT03292471|Rehabilitation|rehabilitation
4691677|NCT03292471|Stroke|stroke
4691678|NCT03292458|spasmodic dysphonia|spasmodic dysphonia
4691679|NCT03292458|laryngeal dystonia|laryngeal dystonia
4691680|NCT03292458|functional MRI|functional mri
4691681|NCT03292458|Xyrem|xyrem
4691682|NCT03292432|Adherence, Medication|adherence, medication
4691683|NCT03292406|T-Cell|t-cell
4691684|NCT03292406|Lymphoma|lymphoma
4691685|NCT03292406|Cutaneous|cutaneous
4691686|NCT03292406|CTCL|ctcl
4691687|NCT03292393|Hypertension|hypertension
4691688|NCT03292393|Medication|medication
4691689|NCT03292393|Adherence|adherence
4691690|NCT03292380|Caffeine|caffeine
4691691|NCT03292380|Dietary intake|dietary intake
4691692|NCT03292380|Validation|validation
4691693|NCT03292380|Dietary methods|dietary methods
4691694|NCT03292354|Coronary Computed Tomography Angiography|coronary computed tomography angiography
4691695|NCT03292354|Image Quality|image quality
4691696|NCT03292354|Contrast Media Reduction|contrast media reduction
4691697|NCT03292354|Personalised Injection Protocols|personalised injection protocols
4691698|NCT03292328|breast cancer|breast cancer
4691699|NCT03292328|neuropathy|neuropathy
4691700|NCT03292328|peripheral neuropathy|peripheral neuropathy
4691701|NCT03292328|yoga|yoga
4691702|NCT03292328|17-449|17-449
4691703|NCT03292315|Glucagon-Like Peptide-1|glucagon-like peptide-1
4691704|NCT03292302|Translational read through|translational read through
4691705|NCT03292289|proctectomy|proctectomy
4691706|NCT03292289|coloanal continuity reconstruction|coloanal continuity reconstruction
4691707|NCT03292263|Multiple Myeloma|multiple myeloma
4691708|NCT03292263|Nivolumab|nivolumab
4691709|NCT03292263|Melphalan|melphalan
4691897|NCT03290937|C225|c225
4691710|NCT03292263|Autologous hematopoietic stem cell transplantation|autologous hematopoietic stem cell transplantation
4691711|NCT03292250|NGS|ngs
4691712|NCT03292250|Nanostring|nanostring
4691713|NCT03292250|Biomarker Driven Umbrella Trial|biomarker driven umbrella trial
4691714|NCT03292250|BYL719,poziotinib, abemaciclib, nintedanib|byl719,poziotinib, abemaciclib, nintedanib
4691715|NCT03292250|Durvalumab + Tremelimumab Combination Treatment|durvalumab + tremelimumab combination treatment
4691716|NCT03292237|Energy|energy
4691717|NCT03292237|Nutrition|nutrition
4691718|NCT03292237|Critical illness|critical illness
4691719|NCT03292237|Parenteral nutrition|parenteral nutrition
4691720|NCT03292237|Intensive care unit|intensive care unit
4691721|NCT03292237|Ward|ward
4691722|NCT03292237|Randomised Controlled Trial|randomised controlled trial
4691723|NCT03292237|Intensive Nutrition|intensive nutrition
4691724|NCT03292211|Early mobilization|early mobilization
4691725|NCT03292211|Acute stroke|acute stroke
4691726|NCT03292211|Early intervention|early intervention
4691727|NCT03292211|Early mobilization therapy|early mobilization therapy
4691728|NCT03292198|Subclinical lymphedema|subclinical lymphedema
4691729|NCT03292198|bioimpedance|bioimpedance
4691730|NCT03292198|breast cancer|breast cancer
4691731|NCT03292159|stroke|stroke
4691732|NCT03292159|vagus nerve stimulation|vagus nerve stimulation
4691733|NCT03292159|upper extremity paresis|upper extremity paresis
4691734|NCT03292133|Lung Cancer|lung cancer
4691735|NCT03292081|Intracoronary Imaging|intracoronary imaging
4691736|NCT03292081|Optical Frequency Domain Imaging|optical frequency domain imaging
4691737|NCT03292081|Intravascular Ultrasound|intravascular ultrasound
4691738|NCT03292081|Percutaneous Coronary Intervention|percutaneous coronary intervention
4691739|NCT03292081|Drug Eluting Stent|drug eluting stent
4691740|NCT03292055|food frequency questionnaire; psychometric properties|food frequency questionnaire; psychometric properties
4691741|NCT03292042|metabolic syndrome|metabolic syndrome
4691742|NCT03292042|lifestyle intervention|lifestyle intervention
4691743|NCT03292042|health promotion|health promotion
4691744|NCT03292042|mental health nurse|mental health nurse
4691745|NCT03292042|serious mental illness|serious mental illness
4691746|NCT03292029|Renal replacement therapy|renal replacement therapy
4691747|NCT03292029|Haemodialsysis|haemodialsysis
4691748|NCT03292029|Calcification Inhibition Test|calcification inhibition test
4691749|NCT03292016|Off Episodes|off episodes
4691750|NCT03292016|Parkinson Disease|parkinson disease
4691751|NCT03292003|rheumatoid arthritis|rheumatoid arthritis
4691752|NCT03292003|post-traumatic arthritis|post-traumatic arthritis
4691753|NCT03292003|osteoarthritis|osteoarthritis
4691754|NCT03292003|degenerative arthritis|degenerative arthritis
4691755|NCT03292003|failed osteotomy|failed osteotomy
4691756|NCT03291977|surgery - glioblastoma - fluorescein|surgery - glioblastoma - fluorescein
4691757|NCT03291938|Malignant neoplasm of breast|malignant neoplasm of breast
4691758|NCT03291938|Malignant neoplasms of bone and articular cartilage|malignant neoplasms of bone and articular cartilage
4691759|NCT03291938|Malignant neoplasms of digestive organs|malignant neoplasms of digestive organs
4691760|NCT03291938|Malignant neoplasms of female genital organs|malignant neoplasms of female genital organs
4691761|NCT03291938|Malignant neoplasms of lip oral cavity and pharynx|malignant neoplasms of lip oral cavity and pharynx
4691762|NCT03291938|Malignant neoplasms of male genital organs|malignant neoplasms of male genital organs
4691763|NCT03291938|Malignant neoplasms of mesothelial and soft tissue|malignant neoplasms of mesothelial and soft tissue
4691764|NCT03291938|Malignant neoplasms of respiratory and intrathoracic organs|malignant neoplasms of respiratory and intrathoracic organs
4691765|NCT03291938|Malignant neoplasms of thyroid and other endocrine glands|malignant neoplasms of thyroid and other endocrine glands
4691766|NCT03291938|Malignant neoplasms of urinary tract|malignant neoplasms of urinary tract
4691767|NCT03291938|Malignant neoplasms stated as primary lymphoid haematopoietic|malignant neoplasms stated as primary lymphoid haematopoietic
4691768|NCT03291938|IACS-010759|iacs-010759
4691769|NCT03291847|maternal opioid use|maternal opioid use
4691770|NCT03291847|neonatal abstinence syndrome|neonatal abstinence syndrome
4691771|NCT03291847|buprenorphine-naloxone|buprenorphine-naloxone
4691772|NCT03291834|type 1 diabetes mellitus|type 1 diabetes mellitus
4691773|NCT03291834|sports|sports
4691774|NCT03291834|child|child
4691775|NCT03291834|adolescent|adolescent
4691776|NCT03291821|DuoStim|duostim
4691777|NCT03291821|MitoScore|mitoscore
4691778|NCT03291821|Preimplantation genetic diagnosis|preimplantation genetic diagnosis
4691779|NCT03291821|MII oocyte|mii oocyte
4691780|NCT03291808|Obesity; asthma; Weight loss|obesity; asthma; weight loss
4691781|NCT03291743|Crohn's|crohn's
4691782|NCT03291743|Capsule endoscopy|capsule endoscopy
4691783|NCT03291743|IBD|ibd
4691784|NCT03291730|Anxiety|anxiety
4691785|NCT03291717|Mental Illness|mental illness
4691786|NCT03291717|Community Participation|community participation
4691787|NCT03291717|Stigma|stigma
4691788|NCT03291717|Photovoice|photovoice
4691789|NCT03291704|Dry Eye|dry eye
4691790|NCT03291704|Thermal Therapy|thermal therapy
4691791|NCT03291704|Meibomian Gland Dysfunction|meibomian gland dysfunction
4691792|NCT03291691|Protective Nerve Stimulation|protective nerve stimulation
4691793|NCT03291691|Regional Anesthesia|regional anesthesia
4691794|NCT03291691|Sciatic nerve block|sciatic nerve block
4691795|NCT03291691|femoral nerve block|femoral nerve block
4691796|NCT03291691|brachial plexus block|brachial plexus block
4691797|NCT03291665|Plantar Fasciitis|plantar fasciitis
4691798|NCT03291665|Plantar heel pain|plantar heel pain
4691799|NCT03291652|Ischemic Stroke|ischemic stroke
4691800|NCT03291652|atherosclerosis|atherosclerosis
4691801|NCT03291652|Plaque morphology|plaque morphology
4691802|NCT03291652|DSA/3DRA|dsa/3dra
4691803|NCT03291613|Sickle Cell Disease|sickle cell disease
4691804|NCT03291613|Adolescence|adolescence
4691805|NCT03291613|Pain Assessment|pain assessment
4691806|NCT03291613|Tablet Application|tablet application
4691808|NCT03291613|mHealth|mhealth
4691809|NCT03291548|Quinoa|quinoa
4691810|NCT03291548|Functional food|functional food
4691811|NCT03291548|Cardiovascular disease|cardiovascular disease
4691812|NCT03291548|Cholesterol|cholesterol
4691813|NCT03291548|Lipid profile|lipid profile
4691814|NCT03291548|Randomised Control Trial|randomised control trial
4691815|NCT03291522|Testicular sperm extraction|testicular sperm extraction
4691816|NCT03291509|weight loss|weight loss
4691817|NCT03291509|weight management|weight management
4691818|NCT03291483|Whole body vibration|whole body vibration
4691819|NCT03291483|mesh id D000072797|mesh id d000072797
4691820|NCT03291483|Plyometric exercise|plyometric exercise
4691821|NCT03291483|Muscle strength|muscle strength
4691822|NCT03291483|Physical fitness|physical fitness
4691823|NCT03291483|Balance|balance
4691824|NCT03291470|knee|knee
4691825|NCT03291431|alcohol use disorder|alcohol use disorder
4691826|NCT03291431|intermittent theta burst|intermittent theta burst
4691827|NCT03291431|Veterans|veterans
4691828|NCT03291431|depressive disorder|depressive disorder
4691829|NCT03291431|cigarette smoking|cigarette smoking
4691830|NCT03291418|Healthy Volunteers, ATB-346, Naproxen sodium, GI safety|healthy volunteers, atb-346, naproxen sodium, gi safety
4691831|NCT03291392|Genetics|genetics
4691832|NCT03291392|Stroke|stroke
4691833|NCT03291392|Biobank|biobank
4691834|NCT03291392|Atherosclerosis|atherosclerosis
4691835|NCT03291379|mCRC, HCC, radiopaque beads, vandetanib|mcrc, hcc, radiopaque beads, vandetanib
4691836|NCT03291301|Insomnia|insomnia
4691837|NCT03291301|Cognitive Behavioral Therapy|cognitive behavioral therapy
4691838|NCT03291301|CBT-I|cbt-i
4691839|NCT03291301|Acupressure|acupressure
4691840|NCT03291301|Traditional Chinese Medicine|traditional chinese medicine
4691841|NCT03291288|Tenosynovial Giant Cell Tumors (TGCT)|tenosynovial giant cell tumors (tgct)
4691842|NCT03291288|Kit-mutant melanoma|kit-mutant melanoma
4691843|NCT03291288|Kit-mutant gastrointestinal stromal tumor (GIST)|kit-mutant gastrointestinal stromal tumor (gist)
4691844|NCT03291288|Cocktail drug-drug interaction (DDI)|cocktail drug-drug interaction (ddi)
4691845|NCT03291210|hyperoxemia|hyperoxemia
4691846|NCT03291210|myocardial injury|myocardial injury
4691847|NCT03291210|transcatheter aortic valve replacement|transcatheter aortic valve replacement
4691848|NCT03291197|Suprascapular nerve block|suprascapular nerve block
4691849|NCT03291197|Median nerve block|median nerve block
4691850|NCT03291197|CRPS|crps
4691851|NCT03291197|Shoulder hand syndrome|shoulder hand syndrome
4691852|NCT03291184|neuromuscular blockade|neuromuscular blockade
4691853|NCT03291184|neuromuscular monitoring|neuromuscular monitoring
4691854|NCT03291171|physical activity|physical activity
4691855|NCT03291171|sedentary behaviour|sedentary behaviour
4691856|NCT03291171|type 2 diabetes|type 2 diabetes
4691857|NCT03291171|eHealth|ehealth
4691858|NCT03291171|mHealth|mhealth
4691859|NCT03291171|self-regulation|self-regulation
4691860|NCT03291171|behaviour change techniques|behaviour change techniques
4691861|NCT03291158|Bacterial Infections|bacterial infections
4691862|NCT03291145|Long QT Syndrome|long qt syndrome
4691863|NCT03291132|Smoke-free|smoke-free
4691864|NCT03291132|Teens|teens
4691865|NCT03291119|Cervico-medullary, Extubation Failure, Risk Predictors|cervico-medullary, extubation failure, risk predictors
4691866|NCT03291093|PET/MRI|pet/mri
4691867|NCT03291093|Amyloid|amyloid
4691868|NCT03291093|Flutemetamol|flutemetamol
4691869|NCT03291054|Gastrointestinal Stromal Tumors|gastrointestinal stromal tumors
4691870|NCT03291054|GIST|gist
4691871|NCT03291054|Pembrolizumab|pembrolizumab
4691872|NCT03291054|Epacadostat|epacadostat
4691873|NCT03291054|Columbia|columbia
4691874|NCT03291015|arthroscopy|arthroscopy
4691875|NCT03291015|radiographic(plain X ray)|radiographic(plain x ray)
4691876|NCT03290963|depression|depression
4691877|NCT03290963|bipolar I disorder|bipolar i disorder
4691878|NCT03290963|bipolar II disorder|bipolar ii disorder
4691879|NCT03290950|Daratumumab|daratumumab
4691880|NCT03290950|Carfilzomib|carfilzomib
4691881|NCT03290950|Lenalidomide|lenalidomide
4691882|NCT03290950|Dexamethasone|dexamethasone
4691883|NCT03290950|17-352|17-352
4691884|NCT03290937|Malignant neoplasms of digestive organs|malignant neoplasms of digestive organs
4691885|NCT03290937|Colorectal cancer|colorectal cancer
4691886|NCT03290937|Metastatic|metastatic
4691887|NCT03290937|Refractory to standard therapy|refractory to standard therapy
4691888|NCT03290937|Wild type RAS tumor|wild type ras tumor
4691889|NCT03290937|Mutated RAS tumor|mutated ras tumor
4691890|NCT03290937|Irinotecan|irinotecan
4691891|NCT03290937|CPT-11|cpt-11
4691892|NCT03290937|Camptosar|camptosar
4691893|NCT03290937|PF-05082566|pf-05082566
4691894|NCT03290937|Utomilumab|utomilumab
4691895|NCT03290937|Anti-CD137|anti-cd137
4691896|NCT03290937|Cetuximab|cetuximab
4691898|NCT03290937|Erbitux|erbitux
4691899|NCT03290937|IMC-C225|imc-c225
4691900|NCT03290937|MOAB C225|moab c225
4691901|NCT03290924|institutional delivery|institutional delivery
4691902|NCT03290911|low responders|low responders
4691903|NCT03290898|Asthma|asthma
4691904|NCT03290898|Exercise|exercise
4691905|NCT03290898|Asthma treatment|asthma treatment
4691906|NCT03290898|Inhaled corticosteroid|inhaled corticosteroid
4691907|NCT03290898|Rehabilitation|rehabilitation
4691908|NCT03290859|Procedural Sedation|procedural sedation
4691909|NCT03290833|Robotics|robotics
4691910|NCT03290833|Stroke|stroke
4691911|NCT03290833|Hand|hand
4691912|NCT03290833|neurorehabilitation|neurorehabilitation
4691913|NCT03290820|nasopharyngeal carcinoma|nasopharyngeal carcinoma
4691914|NCT03290820|N2-3 disease|n2-3 disease
4691915|NCT03290820|distant metastasis|distant metastasis
4691916|NCT03290820|aspirin|aspirin
4691917|NCT03290820|survival|survival
4691918|NCT03290781|Ulcerative colitis|ulcerative colitis
4691919|NCT03290755|Hepatitis C|hepatitis c
4691920|NCT03290755|sexual network|sexual network
4691921|NCT03290755|sexual transmitted|sexual transmitted
4691922|NCT03290755|men who have sex with men|men who have sex with men
4691923|NCT03290755|HIV positive|hiv positive
4691924|NCT03290755|sexual behaviour|sexual behaviour
4691925|NCT03290729|wedge implants; atrophic bone|wedge implants; atrophic bone
4691926|NCT03290664|AML|aml
4691927|NCT03290638|Guided Bone Regeneration|guided bone regeneration
4691928|NCT03290638|Dehydrated Human Amnion Chorion Membrane|dehydrated human amnion chorion membrane
4691929|NCT03290638|Type I Bovine Collagen Membrane|type i bovine collagen membrane
4691930|NCT03290638|Ridge Preservation|ridge preservation
4691931|NCT03290638|Ridge Healing|ridge healing
4691932|NCT03290638|Teeth Extraction|teeth extraction
4691933|NCT03290612|Sleep|sleep
4691934|NCT03290612|Vitamin C|vitamin c
4691935|NCT03290599|Cognitive dysfunction|cognitive dysfunction
4691936|NCT03290599|Hip Surgery|hip surgery
4691937|NCT03290599|Mini mental Test,|mini mental test,
4691938|NCT03290599|Preoperative Hospitalisation|preoperative hospitalisation
4691939|NCT03290599|Spinal Anesthesia|spinal anesthesia
4691940|NCT03290534|wedge resection|wedge resection
4691941|NCT03290534|sublobar resection|sublobar resection
4691942|NCT03290534|brachytherapy|brachytherapy
4691943|NCT03290534|CivaSheet|civasheet
4691944|NCT03290534|Pd-103|pd-103
4691945|NCT03290534|CivaTech Oncology|civatech oncology
4691946|NCT03290521|pain|pain
4691947|NCT03290521|laparoscopy|laparoscopy
4691948|NCT03290521|washing|washing
4691949|NCT03290521|intraperitoneal irrigation|intraperitoneal irrigation
4691950|NCT03290508|Prolaris|prolaris
4691951|NCT03290508|Prostate Cancer|prostate cancer
4691952|NCT03290508|Cell Cycle Progression Test|cell cycle progression test
4691953|NCT03290495|ketamine|ketamine
4691954|NCT03290495|isoflurane|isoflurane
4691955|NCT03290495|electroencephalography|electroencephalography
4691956|NCT03290495|maintenance|maintenance
4691957|NCT03290495|recovery|recovery
4691958|NCT03290495|anesthesia|anesthesia
4691959|NCT03290469|ICU|icu
4691960|NCT03290469|Intensive Care Unit|intensive care unit
4691961|NCT03290456|Vasculitis|vasculitis
4691962|NCT03290456|GPA|gpa
4691963|NCT03290456|Granulomatosis with Polyangitis|granulomatosis with polyangitis
4691964|NCT03290456|MPA|mpa
4691965|NCT03290456|Microscopic Polyangitis|microscopic polyangitis
4691966|NCT03290456|Systemic anti-neutrophil cytoplasmic antibodies (ANCA)|systemic anti-neutrophil cytoplasmic antibodies (anca)
4691967|NCT03290456|Prednisone|prednisone
4691968|NCT03290456|glucocorticoids|glucocorticoids
4691969|NCT03290456|Remission Maintenance|remission maintenance
4691970|NCT03290456|Rituximab|rituximab
4691971|NCT03290456|Cyclophosphamide|cyclophosphamide
4691972|NCT03290443|Hepatic|hepatic
4691973|NCT03290443|Pharmacokinetics|pharmacokinetics
4691974|NCT03290443|Phase 1|phase 1
4691975|NCT03290443|Enasidenib|enasidenib
4691976|NCT03290443|CC-90007|cc-90007
4691977|NCT03290430|Nicotine Dependence|nicotine dependence
4691978|NCT03290430|applied behavioral research|applied behavioral research
4691979|NCT03290417|Active Surveillance|active surveillance
4691980|NCT03290417|Vitamin D|vitamin d
4691981|NCT03290417|Omega-3 Fatty Acid|omega-3 fatty acid
4691982|NCT03290417|tumeric curcumin|tumeric curcumin
4691983|NCT03290404|Axillary Block|axillary block
4691984|NCT03290404|LidocaÏne 1% adrenaliné|lidocaïne 1% adrenaliné
4691985|NCT03290391|Russia|russia
4691986|NCT03290391|Substance use|substance use
4691987|NCT03290391|Peer case managers|peer case managers
4691988|NCT03290391|ART|art
4691989|NCT03290391|HIV|hiv
4691990|NCT03290365|Platelet rich plasma|platelet rich plasma
4691991|NCT03290365|Osteoarthritis of knee|osteoarthritis of knee
4691992|NCT03290365|Hyaluronic acid|hyaluronic acid
4691993|NCT03290339|one-day surgery|one-day surgery
4691994|NCT03290339|hysterectomy|hysterectomy
4691995|NCT03290339|ambulatory|ambulatory
4691996|NCT03290326|Alzheimer|alzheimer
4691997|NCT03290326|Memory Problems|memory problems
4691998|NCT03290313|Depression|depression
4691999|NCT03290313|erectile dysfunction|erectile dysfunction
4692000|NCT03290313|shu gan yi yang|shu gan yi yang
4692001|NCT03290300|Nasal valve|nasal valve
4692002|NCT03290300|Nasal airway obstruction|nasal airway obstruction
4692003|NCT03290300|Quality of Life|quality of life
4692004|NCT03290287|COPD|copd
4692005|NCT03290274|Deep brain stimulation|deep brain stimulation
4692006|NCT03290274|Alzheimer´s Disease|alzheimer´s disease
4692007|NCT03290274|Fornix|fornix
4692008|NCT03290274|Basal nucleus of Meynert|basal nucleus of meynert
4692009|NCT03290222|Respiratory symptoms|respiratory symptoms
4692010|NCT03290222|Children|children
4692011|NCT03290209|Stomach Neoplasm|stomach neoplasm
4692012|NCT03290209|Elderly Patients|elderly patients
4692013|NCT03290209|Laparoscopic D1 Lymphadenectomy|laparoscopic d1 lymphadenectomy
4692014|NCT03290196|Shoulder|shoulder
4692015|NCT03290196|Rotator cuff|rotator cuff
4692016|NCT03290183|Confocal laser endomicroscopy|confocal laser endomicroscopy
4692017|NCT03290157|Colonoscopy|colonoscopy
4692018|NCT03290157|preparation|preparation
4692019|NCT03290157|new media|new media
4692020|NCT03290157|SPA|spa
4692021|NCT03290157|APP|app
4692022|NCT03290144|Cystic fibrosis - Pregnancy - Diabetes|cystic fibrosis - pregnancy - diabetes
4692023|NCT03290105|oropharyngeal colonization|oropharyngeal colonization
4692024|NCT03290079|metastatic progressive high-grade neuroendocrine|metastatic progressive high-grade neuroendocrine
4692025|NCT03290079|progressive high-grade neuroendocrine|progressive high-grade neuroendocrine
4692026|NCT03290079|high grade neuroendocrine|high grade neuroendocrine
4692027|NCT03290079|carcinoma originating outside of the lung|carcinoma originating outside of the lung
4692028|NCT03290079|poorly differentiated neuroendocrine|poorly differentiated neuroendocrine
4692029|NCT03290066|Primary Dysmenorrhea|primary dysmenorrhea
4692030|NCT03290066|Kinesio Taping|kinesio taping
4692031|NCT03289962|Cancer vaccine|cancer vaccine
4692032|NCT03289962|Neoantigen|neoantigen
4692033|NCT03289962|Personalized|personalized
4692034|NCT03289962|Atezolizumab|atezolizumab
4692035|NCT03289962|Vaccine|vaccine
4692036|NCT03289962|Immunotherapy|immunotherapy
4692037|NCT03289962|Anti-PDL1|anti-pdl1
4692038|NCT03289962|Checkpoint Inhibitor|checkpoint inhibitor
4692039|NCT03289962|Personalized vaccine|personalized vaccine
4692040|NCT03289936|preterm|preterm
4692041|NCT03289936|ventilation|ventilation
4692042|NCT03289936|nasal intermittent positive pressure ventilation|nasal intermittent positive pressure ventilation
4692043|NCT03289936|synchronization|synchronization
4692044|NCT03289936|cardio-respiratory events|cardio-respiratory events
4692045|NCT03289936|newborn|newborn
4692046|NCT03289923|Transcranial Magnetic Stimulation (TMS)|transcranial magnetic stimulation (tms)
4692047|NCT03289923|Major Depressive Disorder|major depressive disorder
4692048|NCT03289923|Cognitive Therapy|cognitive therapy
4692049|NCT03289832|Sulforaphane|sulforaphane
4692050|NCT03289832|Curcumin|curcumin
4692051|NCT03289832|Crucera-SGS|crucera-sgs
4692052|NCT03289832|Meriva-SF|meriva-sf
4692053|NCT03289832|Skin|skin
4692054|NCT03289832|erythema|erythema
4692055|NCT03289832|UV|uv
4692056|NCT03289832|Sunburn|sunburn
4692057|NCT03289832|Inflammation|inflammation
4692058|NCT03289832|Redness|redness
4692059|NCT03289832|ultra-violet|ultra-violet
4692060|NCT03289832|sunlight|sunlight
4692061|NCT03289819|TNBC|tnbc
4692062|NCT03289819|neoadjuvant chemotherapy|neoadjuvant chemotherapy
4692063|NCT03289819|triple negative breast cancer|triple negative breast cancer
4692064|NCT03289793|Attention Deficit Disorder with Hyperactivity|attention deficit disorder with hyperactivity
4692065|NCT03289793|ADHD|adhd
4692066|NCT03289793|Children|children
4692067|NCT03289793|Inattention|inattention
4692068|NCT03289793|Hyperactivity|hyperactivity
4692069|NCT03289793|Neurofeedback|neurofeedback
4692070|NCT03289793|Neuropsychology|neuropsychology
4692071|NCT03289754|knee implant|knee implant
4692072|NCT03289754|osteoarthritis|osteoarthritis
4692073|NCT03289754|patient-specific|patient-specific
4692074|NCT03289754|knee osteoarthritis|knee osteoarthritis
4692075|NCT03289741|Octreotide|octreotide
4692076|NCT03289741|Lanreotide|lanreotide
4692077|NCT03289741|17-422|17-422
4692078|NCT03289728|elderly patients|elderly patients
4692079|NCT03289728|myocardial infarction|myocardial infarction
4692080|NCT03289728|myocardial revascularization strategy|myocardial revascularization strategy
4692081|NCT03289728|ischemia imaging|ischemia imaging
4692082|NCT03289728|coronary artery disease|coronary artery disease
4692083|NCT03289663|synergistic combination|synergistic combination
4692084|NCT03289663|insecticide resistance|insecticide resistance
4692085|NCT03289663|vectors|vectors
4692086|NCT03289650|immunosuppression|immunosuppression
4692087|NCT03289624|Care Planning|care planning
4692088|NCT03289624|Care Values and Preferences|care values and preferences
4692089|NCT03289611|Preeclampsia|preeclampsia
4692090|NCT03289611|pregnancy|pregnancy
4692091|NCT03289611|biomarkers|biomarkers
4692092|NCT03289611|prediction|prediction
4692093|NCT03289611|safety|safety
4692094|NCT03289611|cost|cost
4692095|NCT03289585|Hidradenitis Suppurativa|hidradenitis suppurativa
4692096|NCT03289585|Registry|registry
4692097|NCT03289546|mindfulness|mindfulness
4692098|NCT03289546|exercise|exercise
4692099|NCT03289546|cognitive function|cognitive function
4692100|NCT03289533|Cancer|cancer
4692795|NCT03285139|CBT|cbt
4692101|NCT03289533|Hepatocellular carcinoma|hepatocellular carcinoma
4692102|NCT03289533|Liver disease|liver disease
4692103|NCT03289533|Avelumab|avelumab
4692104|NCT03289533|Axitinib|axitinib
4692105|NCT03289520|Access Blood Flow Monitoring|access blood flow monitoring
4692106|NCT03289520|Clinical Trial Vascular Access|clinical trial vascular access
4692107|NCT03289520|Fistula Failure|fistula failure
4692108|NCT03289520|Hemodialysis|hemodialysis
4692109|NCT03289520|Vascular Access|vascular access
4692110|NCT03289507|Longvida Curcumin|longvida curcumin
4692111|NCT03289507|Pharmacokinetics|pharmacokinetics
4692112|NCT03289494|Slowly Digestible Starch|slowly digestible starch
4692113|NCT03289494|SDS|sds
4692114|NCT03289494|Type 2 diabetes|type 2 diabetes
4692115|NCT03289494|T2D|t2d
4692116|NCT03289494|Glycemic response|glycemic response
4692117|NCT03289494|Continuous Glucose Monitoring System|continuous glucose monitoring system
4692118|NCT03289494|CGMS|cgms
4692119|NCT03289481|Heart failure|heart failure
4692120|NCT03289481|HFpEF|hfpef
4692121|NCT03289481|Nitrate supplement|nitrate supplement
4692122|NCT03289455|Acute Lymphoblastic Leukaemia|acute lymphoblastic leukaemia
4692123|NCT03289455|CD19 Positive|cd19 positive
4692124|NCT03289455|CD22 Positive|cd22 positive
4692125|NCT03289455|Relapsed Acute Lymphoblastic Leukaemia|relapsed acute lymphoblastic leukaemia
4692126|NCT03289455|Refractory Acute Lymphoblastic Leukaemia|refractory acute lymphoblastic leukaemia
4692127|NCT03289455|AUTO3|auto3
4692128|NCT03289429|Atorvastatin|atorvastatin
4692129|NCT03289429|Magnesium sulfate|magnesium sulfate
4692130|NCT03289429|POAF|poaf
4692131|NCT03289429|Cardiac|cardiac
4692132|NCT03289429|Valve|valve
4692133|NCT03289416|knee|knee
4692134|NCT03289416|osteoarthritis|osteoarthritis
4692135|NCT03289416|platelet rich plasma (PRP)|platelet rich plasma (prp)
4692136|NCT03289416|bone marrow concentrate (BMC)|bone marrow concentrate (bmc)
4692137|NCT03289364|Breast Cancer|breast cancer
4692138|NCT03289364|Alopecia|alopecia
4692139|NCT03289364|Hair Loss|hair loss
4692140|NCT03289364|Scalp Cooling|scalp cooling
4692141|NCT03289364|Penguin Cold Caps|penguin cold caps
4692142|NCT03289338|Zoledronic acid|zoledronic acid
4692143|NCT03289338|Methylprednisolone|methylprednisolone
4692144|NCT03289338|Active Charcot's disease|active charcot's disease
4692145|NCT03289325|Cardiac surgery|cardiac surgery
4692146|NCT03289325|Dexmedetomidine|dexmedetomidine
4692147|NCT03289325|Long-term outcome|long-term outcome
4692148|NCT03289325|Mortality|mortality
4692149|NCT03289325|Quality of life|quality of life
4692150|NCT03289312|sepsis, lymphocyte|sepsis, lymphocyte
4692151|NCT03289299|myeloma|myeloma
4692152|NCT03289299|MRD|mrd
4692153|NCT03289299|smoldering|smoldering
4692154|NCT03289286|Breast Cancer|breast cancer
4692155|NCT03289286|Ambulatory surgery|ambulatory surgery
4692156|NCT03289286|Electronic tool|electronic tool
4692157|NCT03289286|e-follow-up|e-follow-up
4692158|NCT03289273|Liver cancer|liver cancer
4692159|NCT03289273|unresectable hepatocellular carcinoma|unresectable hepatocellular carcinoma
4692160|NCT03289273|real-world practice conditions|real-world practice conditions
4692161|NCT03289273|safety and effectiveness|safety and effectiveness
4692162|NCT03289273|management and treatment of liver cancer|management and treatment of liver cancer
4692163|NCT03289260|Condylomata acuminata, Fulguration, Imiquimod|condylomata acuminata, fulguration, imiquimod
4692164|NCT03289195|MRI|mri
4692165|NCT03289195|Biopsy|biopsy
4692166|NCT03289195|17-390|17-390
4692167|NCT03289143|Alzheimer Disease|alzheimer disease
4692168|NCT03289143|Brain Diseases|brain diseases
4692169|NCT03289143|Dementia|dementia
4692170|NCT03289143|Neurodegenerative Diseases|neurodegenerative diseases
4692171|NCT03289143|Neurocognitive Disorders|neurocognitive disorders
4692172|NCT03289117|Urinary catheterization|urinary catheterization
4692173|NCT03289117|Gel installation|gel installation
4692174|NCT03289117|Novel medical device|novel medical device
4692175|NCT03289117|Indwelling urinary catheter|indwelling urinary catheter
4692176|NCT03289117|Long-term urinary catheter|long-term urinary catheter
4692177|NCT03289117|Male patients|male patients
4692178|NCT03289091|aerobic training|aerobic training
4692179|NCT03289091|aquatic exercise|aquatic exercise
4692181|NCT03289065|Genetic|genetic
4692182|NCT03289065|Fabry Disease|fabry disease
4692183|NCT03289065|Glycolipid|glycolipid
4692184|NCT03289065|lysosomal|lysosomal
4692185|NCT03289052|Hyaluronic acid, midface|hyaluronic acid, midface
4692186|NCT03289039|Breast Cancer|breast cancer
4692187|NCT03289026|Aripiprazole; Acute schizophrenia episode; positive symptoms|aripiprazole; acute schizophrenia episode; positive symptoms
4692188|NCT03289000|osteoarthritis|osteoarthritis
4692189|NCT03289000|knee arthroplasty|knee arthroplasty
4692190|NCT03289000|knee replacement|knee replacement
4692191|NCT03289000|patient specific|patient specific
4692192|NCT03288974|Multiple Myeloma|multiple myeloma
4692193|NCT03288974|POMALYST®|pomalyst®
4692194|NCT03288974|Pomalidomide|pomalidomide
4692195|NCT03288974|Observational|observational
4692196|NCT03288974|Korea|korea
4692197|NCT03288974|Post Marketing Surveillance[PMS]|post marketing surveillance[pms]
4692198|NCT03288974|Relapsed and Refractory Multiple Myeloma|relapsed and refractory multiple myeloma
4692199|NCT03288935|refugee|refugee
4692200|NCT03288935|trauma-informed case management (TICM)|trauma-informed case management (ticm)
4692201|NCT03288935|trauma-informed cultural orientation (TICO)|trauma-informed cultural orientation (tico)
4692202|NCT03288935|PTSD|ptsd
4692203|NCT03288935|depression|depression
4692204|NCT03288935|refugee resettlement|refugee resettlement
4692205|NCT03288922|Online Hemodiafiltration|online hemodiafiltration
4692206|NCT03288922|Super high-flux dialyzer|super high-flux dialyzer
4692207|NCT03288922|Protein-bound uremic toxin|protein-bound uremic toxin
4692208|NCT03288922|P-cresol|p-cresol
4692209|NCT03288896|Adolescence|adolescence
4692210|NCT03288896|Alcohol Drinking|alcohol drinking
4692211|NCT03288896|Binge Drinking|binge drinking
4692212|NCT03288896|I-Change model|i-change model
4692213|NCT03288896|Web-based interventions|web-based interventions
4692214|NCT03288896|Computer-tailoring|computer-tailoring
4692215|NCT03288857|Naspira|naspira
4692216|NCT03288857|Suctioning|suctioning
4692217|NCT03288857|Nasal suction device|nasal suction device
4692218|NCT03288857|Children|children
4692219|NCT03288844|LSCD, Holoclar, follow-up|lscd, holoclar, follow-up
4692220|NCT03288831|Randomized, double-blinded, placebo-controlled trial|randomized, double-blinded, placebo-controlled trial
4692221|NCT03288831|Oral food challenge|oral food challenge
4692222|NCT03288753|Cochlear implant|cochlear implant
4692223|NCT03288714|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
4692224|NCT03288714|TMS|tms
4692225|NCT03288714|sTMS|stms
4692226|NCT03288701|heart failure|heart failure
4692227|NCT03288701|cardial decompensation|cardial decompensation
4692228|NCT03288701|smart scale|smart scale
4692229|NCT03288701|bioimpedance analysis|bioimpedance analysis
4692230|NCT03288701|whole body water|whole body water
4692231|NCT03288675|Major depressive disorder|major depressive disorder
4692232|NCT03288675|Treatment resistant depression|treatment resistant depression
4692233|NCT03288675|Accelerated intermittent thetaburst stimulation|accelerated intermittent thetaburst stimulation
4692234|NCT03288675|Cognitive control training|cognitive control training
4692235|NCT03288675|Neuroimaging|neuroimaging
4692236|NCT03288662|Computed tomography|computed tomography
4692237|NCT03288662|thymic epithelial tumors|thymic epithelial tumors
4692238|NCT03288610|Copeptin|copeptin
4692239|NCT03288610|Vasopressin|vasopressin
4692240|NCT03288610|Microcirculation|microcirculation
4692241|NCT03288610|Inflammation|inflammation
4692242|NCT03288610|Vasodilation|vasodilation
4692243|NCT03288610|Cardiopulmonary bypass|cardiopulmonary bypass
4692244|NCT03288597|positive rate|positive rate
4692245|NCT03288597|SUVmax|suvmax
4692246|NCT03288597|relationship|relationship
4692247|NCT03288584|Arterial stiffness|arterial stiffness
4692248|NCT03288584|Endothelial function|endothelial function
4692249|NCT03288584|Endothelial glycocalyx|endothelial glycocalyx
4692250|NCT03288584|Left ventricular function|left ventricular function
4692251|NCT03288584|Apoptosis|apoptosis
4692252|NCT03288584|Oxidative stress|oxidative stress
4692253|NCT03288571|Diabetes|diabetes
4692254|NCT03288571|nephropathy|nephropathy
4692255|NCT03288571|Kidney|kidney
4692256|NCT03288571|parenchyma|parenchyma
4692257|NCT03288571|Wharton Jelly|wharton jelly
4692258|NCT03288571|Mesenchymal stem cells|mesenchymal stem cells
4692259|NCT03288545|ASG-22ME|asg-22me
4692260|NCT03288545|ASG-22CE|asg-22ce
4692261|NCT03288545|Antibody-drug conjugate|antibody-drug conjugate
4692262|NCT03288545|Antineoplastic agents|antineoplastic agents
4692263|NCT03288545|CPI|cpi
4692264|NCT03288545|Enfortumab vedotin|enfortumab vedotin
4692265|NCT03288545|Locally advanced urothelial cancer|locally advanced urothelial cancer
4692266|NCT03288545|Drug therapy|drug therapy
4692267|NCT03288545|Metastatic urothelial cancer|metastatic urothelial cancer
4692268|NCT03288545|Nectin-4|nectin-4
4692269|NCT03288545|Atezolizumab|atezolizumab
4692270|NCT03288545|Checkpoint Inhibitors|checkpoint inhibitors
4692271|NCT03288545|Pembrolizumab|pembrolizumab
4692272|NCT03288532|Renal Cell Carcinoma|renal cell carcinoma
4692273|NCT03288532|Immunotherapy|immunotherapy
4692274|NCT03288532|Multi-Arm Multi-Stage|multi-arm multi-stage
4692275|NCT03288519|Cerebral aneurysm|cerebral aneurysm
4692276|NCT03288519|Endovascular therapy|endovascular therapy
4692277|NCT03288519|Classic laryngeal mask airway|classic laryngeal mask airway
4692278|NCT03288519|Hemodynamic changes|hemodynamic changes
4692279|NCT03288493|CAR-T cells|car-t cells
4692280|NCT03288454|Ciraparantag|ciraparantag
4692281|NCT03288454|PER977|per977
4692282|NCT03288454|Apixaban|apixaban
4692283|NCT03288454|Whole Blood Clotting Time (WBCT)|whole blood clotting time (wbct)
4692284|NCT03288441|Hematologic Neoplasms|hematologic neoplasms
4692285|NCT03288441|Thrombocytopenia|thrombocytopenia
4692286|NCT03288441|Anticoagulants|anticoagulants
4692287|NCT03288441|Platelet Aggregation Inhibitors|platelet aggregation inhibitors
4692288|NCT03288415|Integrated prognostic model|integrated prognostic model
4692289|NCT03288389|Membrane Lipid Replacement|membrane lipid replacement
4692290|NCT03288389|NTFactor Lipids|ntfactor lipids
4692291|NCT03288389|Fibromyalgia|fibromyalgia
4692292|NCT03288389|Pain|pain
4692293|NCT03288389|Faigue|faigue
4692294|NCT03288389|Gastrointestinal symptoms|gastrointestinal symptoms
4692295|NCT03288376|obstructive sleep apnea|obstructive sleep apnea
4692296|NCT03288376|polysomnography|polysomnography
4692297|NCT03288363|tDCS|tdcs
4692298|NCT03288363|cognition|cognition
4692299|NCT03288350|Phase II Trial|phase ii trial
4692300|NCT03288350|Esophago-Gastric Adenocarcinoma|esophago-gastric adenocarcinoma
4692301|NCT03288350|Avelumab|avelumab
4692302|NCT03288337|Hidradenitis Suppurativa|hidradenitis suppurativa
4692303|NCT03288337|Quality of Life|quality of life
4692304|NCT03288298|TSCC|tscc
4692305|NCT03288298|OSCC|oscc
4692306|NCT03288298|luteolin|luteolin
4692307|NCT03288298|nanoluteolin|nanoluteolin
4692308|NCT03288298|nanotechnology|nanotechnology
4692309|NCT03288298|oral cancer|oral cancer
4692310|NCT03288298|apoptosis|apoptosis
4692312|NCT03288298|MTT|mtt
4692313|NCT03288298|ELISA reader|elisa reader
4692314|NCT03288285|hemodiafiltration|hemodiafiltration
4692315|NCT03288285|pre-dilution|pre-dilution
4692316|NCT03288285|post-dilution|post-dilution
4692317|NCT03288285|uremic toxins|uremic toxins
4692318|NCT03288259|Transnasal endoscopy - Obesity - endoscopy without sedation|transnasal endoscopy - obesity - endoscopy without sedation
4692319|NCT03288246|adolescent|adolescent
4692320|NCT03288246|HIV|hiv
4692321|NCT03288246|point-of-care|point-of-care
4692322|NCT03288246|viral load|viral load
4692323|NCT03288233|Hemoglobin A1c|hemoglobin a1c
4692324|NCT03288233|HbA1c|hba1c
4692325|NCT03288233|End tidal carbon monoxide|end tidal carbon monoxide
4692326|NCT03288220|Stroke|stroke
4692327|NCT03288207|Community-Based Participatory Research|community-based participatory research
4692328|NCT03288207|Obesity|obesity
4692329|NCT03288207|Cardiovascular Disease Risk|cardiovascular disease risk
4692330|NCT03288207|Social Determinants of Health|social determinants of health
4692331|NCT03288168|Observation|observation
4692332|NCT03288168|Molecular Subgroup|molecular subgroup
4692333|NCT03288168|NanoString|nanostring
4692334|NCT03288155|Parkinson's|parkinson's
4692335|NCT03288155|Fatigue|fatigue
4692336|NCT03288155|Flavonoid|flavonoid
4692337|NCT03288155|Cocoa|cocoa
4692338|NCT03288129|monotherapy|monotherapy
4692339|NCT03288129|adjunctive therapy|adjunctive therapy
4692340|NCT03288129|open-label|open-label
4692341|NCT03288129|multicenter|multicenter
4692342|NCT03288064|raisins|raisins
4692343|NCT03288064|carbohydrates|carbohydrates
4692344|NCT03288064|antioxidant capacity|antioxidant capacity
4692345|NCT03288064|substrate oxidation|substrate oxidation
4692346|NCT03288064|prolonged cycling|prolonged cycling
4692347|NCT03288025|Insulin Resistance|insulin resistance
4692348|NCT03288025|Inflammation|inflammation
4692349|NCT03288025|Right Ventricular Function|right ventricular function
4692350|NCT03288025|Metabolism|metabolism
4692351|NCT03288025|Glucose|glucose
4692352|NCT03287986|Elderly|elderly
4692353|NCT03287986|MRI|mri
4692354|NCT03287960|LEPR deficiency obesity|lepr deficiency obesity
4692355|NCT03287960|setmelanotide|setmelanotide
4692356|NCT03287960|RM-493|rm-493
4692357|NCT03287960|Leptin receptor|leptin receptor
4692358|NCT03287960|Obesity|obesity
4692359|NCT03287960|Melanocortin 4 receptor|melanocortin 4 receptor
4692360|NCT03287934|selective laser sintering, stereolithography stents|selective laser sintering, stereolithography stents
4692361|NCT03287921|pulmonary care|pulmonary care
4692362|NCT03287921|COPD|copd
4692363|NCT03287921|small airway disease|small airway disease
4692364|NCT03287921|hyperinflation|hyperinflation
4692365|NCT03287908|Amgen|amgen
4692366|NCT03287908|Phase 1|phase 1
4692367|NCT03287908|Clinical Trial|clinical trial
4692368|NCT03287908|Oncology/Hematology|oncology/hematology
4692369|NCT03287908|Relapsed/Refractory Multiple Myeloma|relapsed/refractory multiple myeloma
4692370|NCT03287908|Immunotherapy|immunotherapy
4692371|NCT03287895|Cardio-pulmonary resuscitation|cardio-pulmonary resuscitation
4692372|NCT03287895|CPR|cpr
4692373|NCT03287895|Decision-making|decision-making
4692374|NCT03287895|Advance Care Planning|advance care planning
4692375|NCT03287895|End of life|end of life
4692376|NCT03287895|Code Status|code status
4692377|NCT03287895|Goals of Care|goals of care
4692378|NCT03287895|Communication|communication
4692379|NCT03287882|preconception supplementation|preconception supplementation
4692380|NCT03287882|multiple micronutrients|multiple micronutrients
4692381|NCT03287882|low birth weight|low birth weight
4692382|NCT03287869|Bipolar|bipolar
4692383|NCT03287869|Mania|mania
4692384|NCT03287869|Brexpiprazole|brexpiprazole
4692385|NCT03287856|Valve-in-valve|valve-in-valve
4692386|NCT03287856|TAVI|tavi
4692387|NCT03287843|Locally advanced rectal cancer|locally advanced rectal cancer
4692388|NCT03287843|Neoadjuvant chemoradiation|neoadjuvant chemoradiation
4692389|NCT03287830|text message|text message
4692390|NCT03287830|Short message service (SMS)|short message service (sms)
4692391|NCT03287830|mHealth|mhealth
4692392|NCT03287817|Diffuse Large B Cell Lymphoma|diffuse large b cell lymphoma
4692393|NCT03287817|CD19 Positive|cd19 positive
4692394|NCT03287817|CD22 Positive|cd22 positive
4692395|NCT03287817|Relapsed Diffuse Large B Cell Lymphoma|relapsed diffuse large b cell lymphoma
4692396|NCT03287817|Refractory Diffuse Large B Cell Lymphoma|refractory diffuse large b cell lymphoma
4692397|NCT03287817|AUTO3|auto3
4692398|NCT03287817|PD-1|pd-1
4692399|NCT03287817|Anti PD-1 antibody|anti pd-1 antibody
4692400|NCT03287804|Multiple Myeloma|multiple myeloma
4692401|NCT03287804|Relapsed Multiple Myeloma|relapsed multiple myeloma
4692402|NCT03287804|Refractory Multiple Myeloma|refractory multiple myeloma
4692403|NCT03287804|AUTO2|auto2
4692404|NCT03287778|Pyridoxine|pyridoxine
4692405|NCT03287778|Vitamin B6|vitamin b6
4692406|NCT03287778|Neurologic Manifestations|neurologic manifestations
4692407|NCT03287778|Involuntary Movements|involuntary movements
4692408|NCT03287778|Movement Disorder|movement disorder
4692409|NCT03287778|Dyskinesias|dyskinesias
4692410|NCT03287778|Physiological Effects of Drugs|physiological effects of drugs
4692411|NCT03287778|Psychotic Disorders|psychotic disorders
4692412|NCT03287778|Schizophrenia Spectrum and Other Psychotic Disorders|schizophrenia spectrum and other psychotic disorders
4692413|NCT03287778|Signs and Symptoms|signs and symptoms
4692414|NCT03287765|Dementia|dementia
4692415|NCT03287765|Tauopathies|tauopathies
4692416|NCT03287765|cognitive impairment|cognitive impairment
4692417|NCT03287765|CNS Diseases|cns diseases
4692418|NCT03287765|neurodegenerative disease|neurodegenerative disease
4692419|NCT03287739|Upper Extremity|upper extremity
4692420|NCT03287739|Cohort Studies|cohort studies
4692421|NCT03287739|Prognosis|prognosis
4692422|NCT03287726|Probiotics|probiotics
4692423|NCT03287726|Appetite Regulation|appetite regulation
4692424|NCT03287726|Gastrointestinal microbiome|gastrointestinal microbiome
4692425|NCT03287726|Caloric Restriction|caloric restriction
4692426|NCT03287726|Body weight maintenance|body weight maintenance
4692427|NCT03287726|Body composition|body composition
4692428|NCT03287661|chronic pain|chronic pain
4692429|NCT03287661|online treatment|online treatment
4692430|NCT03287661|acceptance-based therapy|acceptance-based therapy
4692431|NCT03287648|optical coherence tomography|optical coherence tomography
4692432|NCT03287648|blue fundus autofluorescence|blue fundus autofluorescence
4692433|NCT03287596|Spondylarthropathy|spondylarthropathy
4692434|NCT03287596|Tendinopathy|tendinopathy
4692435|NCT03287596|MRI|mri
4692436|NCT03287596|Healthy Volunteer|healthy volunteer
4692437|NCT03287570|Osteoarthritis, Knee|osteoarthritis, knee
4692438|NCT03287570|Moxibustion|moxibustion
4692439|NCT03287544|Aphasia|aphasia
4692440|NCT03287544|Rehabilitation|rehabilitation
4692441|NCT03287544|Communication|communication
4692442|NCT03287544|Linguistics|linguistics
4692443|NCT03287531|conventional therapy|conventional therapy
4692444|NCT03287518|Endothelial function|endothelial function
4692445|NCT03287518|Blood pressure|blood pressure
4692446|NCT03287518|Lipid metabolism|lipid metabolism
4692447|NCT03287518|EndoPAT score RHI|endopat score rhi
4692448|NCT03287492|Malignant neoplasms of independent (primary) multiple sites|malignant neoplasms of independent (primary) multiple sites
4692449|NCT03287492|Neoplasms of uncertain or unknown behavior|neoplasms of uncertain or unknown behavior
4692450|NCT03287492|Information Materials|information materials
4692451|NCT03287492|Questionnaires|questionnaires
4692452|NCT03287492|Surveys|surveys
4692453|NCT03287479|vitrification|vitrification
4692454|NCT03287479|semi-automated|semi-automated
4692455|NCT03287479|manual|manual
4692456|NCT03287466|oxygen|oxygen
4692457|NCT03287466|oxygen saturation|oxygen saturation
4692458|NCT03287466|oxygen concentration|oxygen concentration
4692459|NCT03287440|Health Disparities|health disparities
4692460|NCT03287440|Lung Diseases|lung diseases
4692461|NCT03287440|Self-management|self-management
4692462|NCT03287440|Chronic Disease|chronic disease
4692463|NCT03287440|Socio-economic status|socio-economic status
4692464|NCT03287427|Advanced|advanced
4692465|NCT03287427|Metastatic|metastatic
4692466|NCT03287401|EEG|eeg
4692467|NCT03287401|PACU Delirium|pacu delirium
4692468|NCT03287388|Laparoscopic surgery|laparoscopic surgery
4692469|NCT03287388|Abdominal working space|abdominal working space
4692470|NCT03287388|Moderate neuromuscular blockade|moderate neuromuscular blockade
4692471|NCT03287388|Deep neuromuscular blockade|deep neuromuscular blockade
4692472|NCT03287388|MRI measurement|mri measurement
4692473|NCT03287362|major depressive disorder|major depressive disorder
4692474|NCT03287362|cognitive behavioral therapy|cognitive behavioral therapy
4692475|NCT03287362|supportive therapy|supportive therapy
4692476|NCT03287362|schema therapy|schema therapy
4692477|NCT03287362|biomarkers|biomarkers
4692478|NCT03287362|neuropsychology|neuropsychology
4692479|NCT03287362|circadian rhythm|circadian rhythm
4692480|NCT03287336|tranexamic acid|tranexamic acid
4692481|NCT03287336|postpartum hemorrhage|postpartum hemorrhage
4692482|NCT03287323|palliative care|palliative care
4692483|NCT03287323|surgical intensive care|surgical intensive care
4692484|NCT03287323|family satisfaction|family satisfaction
4692485|NCT03287323|ICU decision-making|icu decision-making
4692486|NCT03287323|end-of-life care|end-of-life care
4692487|NCT03287310|eosinophils|eosinophils
4692488|NCT03287310|pharmacokinetics|pharmacokinetics
4692489|NCT03287310|First time in Human|first time in human
4692490|NCT03287310|GSK3511294|gsk3511294
4692491|NCT03287310|pharmacodynamics|pharmacodynamics
4692492|NCT03287310|asthma|asthma
4692493|NCT03287271|ovarian cancer|ovarian cancer
4692494|NCT03287271|cancer|cancer
4692495|NCT03287271|ovary|ovary
4692496|NCT03287271|carboplatin|carboplatin
4692497|NCT03287271|paclitaxel|paclitaxel
4692498|NCT03287271|VS-6063|vs-6063
4692499|NCT03287271|primary peritoneal carcinoma|primary peritoneal carcinoma
4692500|NCT03287271|fallopian tube|fallopian tube
4692501|NCT03287271|defactinib|defactinib
4692502|NCT03287258|perineal massage|perineal massage
4692503|NCT03287258|health education|health education
4692504|NCT03287258|perineal tear|perineal tear
4692505|NCT03287258|episiotomy|episiotomy
4692506|NCT03287258|pelvic floor muscle exercise|pelvic floor muscle exercise
4692507|NCT03287245|polycythemia vera|polycythemia vera
4692508|NCT03287245|PV|pv
4692509|NCT03287245|P vera|p vera
4692510|NCT03287245|myeloproliferative diseases|myeloproliferative diseases
4692511|NCT03287245|hematologic diseases|hematologic diseases
4692512|NCT03287245|myeloproliferative neoplasm|myeloproliferative neoplasm
4692513|NCT03287245|MPN|mpn
4692514|NCT03287232|Prasterone|prasterone
4692515|NCT03287232|DHEA|dhea
4692516|NCT03287232|Menopause|menopause
4692517|NCT03287232|Sexual Disorder|sexual disorder
4692518|NCT03287180|Adolescent Community Reinforcement Approach|adolescent community reinforcement approach
4692519|NCT03287180|A-CRA|a-cra
4692520|NCT03287180|Opioid-Related Disorders|opioid-related disorders
4692521|NCT03287180|Behavior|behavior
4692522|NCT03287180|Psychosocial treatment|psychosocial treatment
4692523|NCT03287180|Pharmacotherapy|pharmacotherapy
4692524|NCT03287180|Randomized controlled|randomized controlled
4692525|NCT03287180|Adolescent|adolescent
4692526|NCT03287180|Young adult|young adult
4692527|NCT03287154|Alcohol Abstinence|alcohol abstinence
4692528|NCT03287154|Alcohol Addiction|alcohol addiction
4692529|NCT03287154|Alcohol Consumption|alcohol consumption
4692530|NCT03287154|Alcohol Dependence|alcohol dependence
4692531|NCT03287141|noninvasive ventilation|noninvasive ventilation
4692532|NCT03287141|continuous positive airway pressure|continuous positive airway pressure
4692533|NCT03287141|intermittent positive-pressure breathing|intermittent positive-pressure breathing
4692534|NCT03287141|exercise test|exercise test
4692535|NCT03287141|physical endurance|physical endurance
4692536|NCT03287141|physical fitness|physical fitness
4692537|NCT03287089|Nitrofurantoin|nitrofurantoin
4692538|NCT03287089|Prolapse|prolapse
4692539|NCT03287089|Pelvic Organ Prolapse|pelvic organ prolapse
4692540|NCT03287089|Anti-incontinence procedure|anti-incontinence procedure
4692541|NCT03287089|Urinary retention|urinary retention
4692542|NCT03287089|Urinary Tract Infection|urinary tract infection
4692543|NCT03287089|Short-term catheterization|short-term catheterization
4692544|NCT03287076|stroke|stroke
4692545|NCT03287076|glucose|glucose
4692546|NCT03287076|exenatide|exenatide
4692547|NCT03287037|Unipolar depression|unipolar depression
4692548|NCT03287037|bipolar depression|bipolar depression
4692549|NCT03287037|Transcranial direct current stimulation|transcranial direct current stimulation
4692550|NCT03287011|dental plaque|dental plaque
4692551|NCT03287011|tooth pastes|tooth pastes
4692552|NCT03287011|oral hygiene|oral hygiene
4692553|NCT03286998|placenta previa|placenta previa
4692554|NCT03286998|color doppler|color doppler
4692555|NCT03286998|placenta accreta|placenta accreta
4692556|NCT03286998|ultrasonography|ultrasonography
4692557|NCT03286933|yoga therapy|yoga therapy
4692559|NCT03286933|quality of life|quality of life
4692560|NCT03286933|pain management|pain management
4692561|NCT03286920|home nutrition|home nutrition
4692562|NCT03286920|BMI|bmi
4692563|NCT03286920|postoperative|postoperative
4692564|NCT03286920|body weight|body weight
4692565|NCT03286907|Uptake of HPV vaccination|uptake of hpv vaccination
4692566|NCT03286881|Common Mental Disorders|common mental disorders
4692567|NCT03286881|Brief Psychological Treatments|brief psychological treatments
4692568|NCT03286881|Primary Care|primary care
4692569|NCT03286881|Randomized Clinical Trial|randomized clinical trial
4692570|NCT03286842|HER2-ve metastatic breast cancer|her2-ve metastatic breast cancer
4692571|NCT03286842|Germline BRCA1/2 mutations|germline brca1/2 mutations
4692572|NCT03286842|Somatic BRCA1/2 mutations|somatic brca1/2 mutations
4692573|NCT03286842|BRCA1|brca1
4692574|NCT03286842|BRCA2|brca2
4692575|NCT03286816|type 1 diabetes mellitus|type 1 diabetes mellitus
4692576|NCT03286816|impaired awareness of hypoglycemia|impaired awareness of hypoglycemia
4692577|NCT03286816|lactate|lactate
4692578|NCT03286816|MR spectroscopy|mr spectroscopy
4692579|NCT03286790|elderly|elderly
4692580|NCT03286777|6-prenylnaringenin|6-prenylnaringenin
4692581|NCT03286777|Bioavailability|bioavailability
4692582|NCT03286777|Pharmacokinetics|pharmacokinetics
4692583|NCT03286777|PBMC|pbmc
4692584|NCT03286712|Flow mediated dilatation|flow mediated dilatation
4692585|NCT03286712|Brachial artery|brachial artery
4692586|NCT03286712|Anemia|anemia
4692587|NCT03286712|Chronic kidney disease|chronic kidney disease
4692588|NCT03286712|Renogen|renogen
4692589|NCT03286712|Erythropoietin Alpha|erythropoietin alpha
4692590|NCT03286686|optic ataxia|optic ataxia
4692591|NCT03286686|posterior parietal cortex functions|posterior parietal cortex functions
4692592|NCT03286686|multisensory integration|multisensory integration
4692593|NCT03286673|calcium carbonate|calcium carbonate
4692594|NCT03286673|calcium phosphate|calcium phosphate
4692595|NCT03286673|metabolic effects|metabolic effects
4692596|NCT03286673|human study|human study
4692597|NCT03286673|calcium and phosphorus metabolism|calcium and phosphorus metabolism
4692598|NCT03286660|Exercise tests|exercise tests
4692599|NCT03286660|COPD|copd
4692600|NCT03286660|Rehabilitation|rehabilitation
4692601|NCT03286647|grief, periodontal disease|grief, periodontal disease
4692602|NCT03286621|eye tracking|eye tracking
4692603|NCT03286621|visual preference|visual preference
4692604|NCT03286595|early psychosis|early psychosis
4692605|NCT03286595|clinical high risk|clinical high risk
4692606|NCT03286595|mobile health|mobile health
4692607|NCT03286556|Acute Exacerbation of Idiopathic Pulmonary Fibrosis|acute exacerbation of idiopathic pulmonary fibrosis
4692608|NCT03286543|electrical stimulation|electrical stimulation
4692609|NCT03286543|neurostimulation|neurostimulation
4692610|NCT03286543|TKA pain|tka pain
4692611|NCT03286543|pain following total knee replacement|pain following total knee replacement
4692612|NCT03286543|total knee arthroplasty|total knee arthroplasty
4692613|NCT03286530|Acute Myeloid Leukemia|acute myeloid leukemia
4692614|NCT03286530|Acute Myeloid Leukemia in Remission|acute myeloid leukemia in remission
4692615|NCT03286530|Allogenic Stem Cell Transplantation|allogenic stem cell transplantation
4692616|NCT03286517|Puberty, Sexuality|puberty, sexuality
4692617|NCT03286491|acute coronary syndrome, risk classification, 30 day adverse event, clinical decision support system|acute coronary syndrome, risk classification, 30 day adverse event, clinical decision support system
4692618|NCT03286478|body image|body image
4692619|NCT03286478|school|school
4692620|NCT03286478|adolescence|adolescence
4692621|NCT03286478|intervention|intervention
4692622|NCT03286478|task-shifting|task-shifting
4692623|NCT03286465|blood transfusion|blood transfusion
4692624|NCT03286452|Antimicrobial|antimicrobial
4692625|NCT03286452|Collagen|collagen
4692626|NCT03286452|Bioburden|bioburden
4692627|NCT03286452|Biofilm|biofilm
4692628|NCT03286452|PHMB|phmb
4692629|NCT03286452|Chronic wounds|chronic wounds
4692630|NCT03286452|Acute wounds|acute wounds
4692631|NCT03286426|vision screening|vision screening
4692632|NCT03286426|portable fundus camera|portable fundus camera
4692633|NCT03286426|acne medication|acne medication
4692634|NCT03286400|CTAG|ctag
4692635|NCT03286400|TEVAR|tevar
4692636|NCT03286387|Memory|memory
4692637|NCT03286387|naturalistic|naturalistic
4692638|NCT03286387|context|context
4692639|NCT03286387|fMRI|fmri
4692640|NCT03286387|Attention|attention
4692641|NCT03286374|Obesity|obesity
4692642|NCT03286374|Occupational rehabilitation|occupational rehabilitation
4692643|NCT03286374|Sick leave|sick leave
4692644|NCT03286374|Life style treatment|life style treatment
4692645|NCT03286335|Brain Tumor|brain tumor
4692646|NCT03286283|Rhytides|rhytides
4692647|NCT03286283|Wrinkle Reduction|wrinkle reduction
4692648|NCT03286283|J-Plasma|j-plasma
4692649|NCT03286283|Dermal Resurfacing|dermal resurfacing
4692650|NCT03286270|mRUS|mrus
4692651|NCT03286270|validation tool|validation tool
4692652|NCT03286270|Impaired fractures|impaired fractures
4692653|NCT03286257|Vascular function|vascular function
4692654|NCT03286257|Vascular structure|vascular structure
4692655|NCT03286257|Thermoregulation|thermoregulation
4692656|NCT03286257|Hot flushes|hot flushes
4692657|NCT03286257|Cerebral blood flow|cerebral blood flow
4692658|NCT03286257|Exercise training|exercise training
4692659|NCT03286231|gluteal venous vasculature|gluteal venous vasculature
4692660|NCT03286231|prone position|prone position
4692661|NCT03286231|jackknife position|jackknife position
4692662|NCT03286153|Hemophilia A|hemophilia a
4692663|NCT03286153|FVIII|fviii
4692664|NCT03286153|Ideal body weight|ideal body weight
4692665|NCT03286153|Actual body weight|actual body weight
4692666|NCT03286140|endovenous ablation|endovenous ablation
4692667|NCT03286075|DLPFC, tDCS, emotional processing|dlpfc, tdcs, emotional processing
4692668|NCT03286036|Biomarkers, early detection|biomarkers, early detection
4692669|NCT03286023|brain metastases|brain metastases
4692670|NCT03286023|stereotactic radiation|stereotactic radiation
4692671|NCT03286023|cyberknife|cyberknife
4692672|NCT03285997|Quadrivalent Influenza Vaccines|quadrivalent influenza vaccines
4692673|NCT03285945|Positron-Emission Tomography|positron-emission tomography
4692674|NCT03285932|Brain Metastase|brain metastase
4692675|NCT03285932|Radiation of resection cavity|radiation of resection cavity
4692676|NCT03285932|WBRT (whole brain radiotherapy)|wbrt (whole brain radiotherapy)
4692677|NCT03285932|SRS (stereotactic radiosurgery)|srs (stereotactic radiosurgery)
4692678|NCT03285919|perturbed walking|perturbed walking
4692679|NCT03285919|stepping response|stepping response
4692680|NCT03285854|CKD|ckd
4692681|NCT03285854|Dialysis|dialysis
4692682|NCT03285854|calcium|calcium
4692683|NCT03285854|mineral and bone disorder (MBD)|mineral and bone disorder (mbd)
4692684|NCT03285854|calcification|calcification
4692685|NCT03285854|DEXA|dexa
4692686|NCT03285854|peripheral quantitative CT scan (pqCT)|peripheral quantitative ct scan (pqct)
4692687|NCT03285841|cervical cancer|cervical cancer
4692688|NCT03285841|vulvar cancer|vulvar cancer
4692689|NCT03285841|optical coherence tomography|optical coherence tomography
4692690|NCT03285841|autofluorescence imaging|autofluorescence imaging
4692691|NCT03285828|medical education, motivational interviewing, medical empathy|medical education, motivational interviewing, medical empathy
4692692|NCT03285789|Dyslexia|dyslexia
4692693|NCT03285789|Visual Fields|visual fields
4692694|NCT03285789|visual attention span|visual attention span
4692695|NCT03285789|visual search|visual search
4692696|NCT03285789|visual attention field|visual attention field
4692697|NCT03285750|GRP120|grp120
4692698|NCT03285750|Adipose tissue|adipose tissue
4692699|NCT03285750|Type 2 diabetes|type 2 diabetes
4692700|NCT03285737|Protein ingestion|protein ingestion
4692701|NCT03285737|Muscle protein synthesis|muscle protein synthesis
4692702|NCT03285685|Analgesia|analgesia
4692703|NCT03285685|Facial pain|facial pain
4692704|NCT03285685|Transcranial Direct Current Stimulation|transcranial direct current stimulation
4692705|NCT03285685|Temporomandibular disorders|temporomandibular disorders
4692706|NCT03285672|Hot Flashes, vasomotor symptoms, postmenopausal|hot flashes, vasomotor symptoms, postmenopausal
4692707|NCT03285659|depression|depression
4692708|NCT03285659|Primary Health Care|primary health care
4692709|NCT03285659|Health Plan Implementation|health plan implementation
4692710|NCT03285659|Collaborative care|collaborative care
4692711|NCT03285659|Patient-Centered Care|patient-centered care
4692712|NCT03285646|Knee|knee
4692713|NCT03285646|Hip|hip
4692714|NCT03285555|barbed suture|barbed suture
4692715|NCT03285555|knoteless suture|knoteless suture
4692716|NCT03285555|closure|closure
4692717|NCT03285555|wound|wound
4692718|NCT03285555|time|time
4692719|NCT03285555|total hip arthroplasty|total hip arthroplasty
4692720|NCT03285542|adhesive|adhesive
4692721|NCT03285542|total knee arthroplasty|total knee arthroplasty
4692722|NCT03285542|wound|wound
4692723|NCT03285542|closure|closure
4692724|NCT03285542|time|time
4692725|NCT03285542|barbed suture|barbed suture
4692726|NCT03285542|knoteless suture|knoteless suture
4692727|NCT03285529|barbed suture|barbed suture
4692728|NCT03285529|knoteless suture|knoteless suture
4692729|NCT03285529|total knee arthroplasty|total knee arthroplasty
4692730|NCT03285529|wound|wound
4692731|NCT03285529|closure|closure
4692732|NCT03285529|time|time
4692733|NCT03285516|transdiagnostic treatment|transdiagnostic treatment
4692734|NCT03285516|emotional disorders|emotional disorders
4692735|NCT03285516|veterans|veterans
4692736|NCT03285516|rural|rural
4692737|NCT03285490|Actinic Keratosis|actinic keratosis
4692738|NCT03285490|Keratosis|keratosis
4692739|NCT03285490|Keratosis, Actinic|keratosis, actinic
4692740|NCT03285490|Precancerous Conditions|precancerous conditions
4692741|NCT03285490|Neoplasms|neoplasms
4692742|NCT03285490|Sun Damaged Skin|sun damaged skin
4692743|NCT03285490|Actinic Keratoses|actinic keratoses
4692744|NCT03285477|Actinic Keratosis|actinic keratosis
4692745|NCT03285477|Keratosis|keratosis
4692746|NCT03285477|Keratosis, Actinic|keratosis, actinic
4692747|NCT03285477|Skin Diseases|skin diseases
4692748|NCT03285477|Actinic Keratoses|actinic keratoses
4692749|NCT03285477|Precancerous Conditions|precancerous conditions
4692750|NCT03285477|Neoplasms|neoplasms
4692751|NCT03285464|knee|knee
4692752|NCT03285464|hip|hip
4692753|NCT03285464|exercise|exercise
4692754|NCT03285464|proximal control|proximal control
4692755|NCT03285464|PFPS|pfps
4692756|NCT03285451|Submental ultrasound, Obstructive sleep apnea|submental ultrasound, obstructive sleep apnea
4692757|NCT03285438|Venous Thromboembolism|venous thromboembolism
4692758|NCT03285438|Anticoagulant|anticoagulant
4692759|NCT03285438|Direct oral anticoagulant|direct oral anticoagulant
4692760|NCT03285438|risk of recurrent venous thromboembolism|risk of recurrent venous thromboembolism
4692761|NCT03285438|anticoagulant-related bleeding|anticoagulant-related bleeding
4692762|NCT03285425|Batten's disease|batten's disease
4692763|NCT03285425|Neuronal Ceroid Lipofuscinosis|neuronal ceroid lipofuscinosis
4692764|NCT03285412|Breast Cancer|breast cancer
4692765|NCT03285399|Nepal|nepal
4692766|NCT03285399|Breastfeeding|breastfeeding
4692767|NCT03285399|Micronutrients|micronutrients
4692768|NCT03285399|Women|women
4692769|NCT03285399|Infants|infants
4692770|NCT03285360|Bifluoride, sylc, hypersensitivity,|bifluoride, sylc, hypersensitivity,
4692771|NCT03285347|parkinson|parkinson
4692772|NCT03285347|executive dysfunction|executive dysfunction
4692773|NCT03285347|attention|attention
4692774|NCT03285347|computer-based cognitive training|computer-based cognitive training
4692775|NCT03285321|Nivolumab|nivolumab
4692776|NCT03285321|Ipilimumab|ipilimumab
4692777|NCT03285321|immunotherapy|immunotherapy
4692778|NCT03285269|shock|shock
4692779|NCT03285269|ultrasound|ultrasound
4692780|NCT03285256|Prospective memory, working memory, substance abuse|prospective memory, working memory, substance abuse
4692781|NCT03285243|Delirium, anesthesia, pediatrics|delirium, anesthesia, pediatrics
4692782|NCT03285217|HMB|hmb
4692783|NCT03285204|optical coherence tomography|optical coherence tomography
4692784|NCT03285204|amyotrophic lateral sclerosis|amyotrophic lateral sclerosis
4692785|NCT03285191|NRS|nrs
4692786|NCT03285191|Concept elicitation|concept elicitation
4692787|NCT03285191|Real-time data capture|real-time data capture
4692788|NCT03285191|Rheumatoid arthritis|rheumatoid arthritis
4692789|NCT03285191|GSK3196165|gsk3196165
4692790|NCT03285178|Sickle Cell Disease|sickle cell disease
4692791|NCT03285178|SCD|scd
4692792|NCT03285152|Ketogenic Diet|ketogenic diet
4692793|NCT03285152|17-396|17-396
4692794|NCT03285139|Postpartum depression|postpartum depression
4692796|NCT03285139|Lay Peer|lay peer
4692797|NCT03285074|Diagnostic discordance of obesity|diagnostic discordance of obesity
4692798|NCT03285074|all-cause mortality|all-cause mortality
4692799|NCT03285048|cognitive impairment|cognitive impairment
4692800|NCT03285035|Cryotherapy|cryotherapy
4692801|NCT03285035|Palliation|palliation
4692802|NCT03285035|Dysphagia|dysphagia
4692803|NCT03285022|Incomplete caries removel|incomplete caries removel
4692804|NCT03285022|Partial caries removel|partial caries removel
4692805|NCT03284970|Interferon beta-1a|interferon beta-1a
4692806|NCT03284970|Dimethyl fumarate|dimethyl fumarate
4692807|NCT03284970|Rebif|rebif
4692808|NCT03284970|Tecfidera|tecfidera
4692809|NCT03284970|Relapsing-Remitting Multiple Sclerosis|relapsing-remitting multiple sclerosis
4692810|NCT03284892|postextubation dysphagia|postextubation dysphagia
4692811|NCT03284892|endotracheal intubation|endotracheal intubation
4692812|NCT03284892|randomized controlled trial|randomized controlled trial
4692813|NCT03284892|dysphagia intervention|dysphagia intervention
4692814|NCT03284892|dysphagia screening|dysphagia screening
4692815|NCT03284879|Psoriasis vulgaris|psoriasis vulgaris
4692816|NCT03284879|Psoriasis arthropathica|psoriasis arthropathica
4692817|NCT03284879|Serious infections|serious infections
4692818|NCT03284879|Gastrointestinal Disorders|gastrointestinal disorders
4692819|NCT03284879|Serious Hypersensitivity|serious hypersensitivity
4692820|NCT03284879|Weight Decrease|weight decrease
4692821|NCT03284879|Vasculitis|vasculitis
4692822|NCT03284879|Malignancies|malignancies
4692823|NCT03284879|Depression and Suicidal Ideation|depression and suicidal ideation
4692824|NCT03284840|dietary intake|dietary intake
4692825|NCT03284840|nutritional status|nutritional status
4692826|NCT03284840|micronutrients|micronutrients
4692827|NCT03284840|thyroid health|thyroid health
4692828|NCT03284827|edoxaban|edoxaban
4692829|NCT03284827|dual antiplatelet therapy|dual antiplatelet therapy
4692830|NCT03284827|cerebral embolization|cerebral embolization
4692831|NCT03284827|leaflet thrombosis|leaflet thrombosis
4692832|NCT03284814|coenzyme q10|coenzyme q10
4692833|NCT03284814|single dose bioavailability|single dose bioavailability
4692834|NCT03284814|multiple dose bioavailability|multiple dose bioavailability
4692835|NCT03284788|acceptance-based therapy|acceptance-based therapy
4692836|NCT03284788|adolescents|adolescents
4692837|NCT03284788|weight|weight
4692838|NCT03284788|weight loss|weight loss
4692839|NCT03284788|obesity|obesity
4692840|NCT03284788|overweight|overweight
4692841|NCT03284749|Copper Oxide|copper oxide
4692842|NCT03284749|Antibiotic Resistance|antibiotic resistance
4692843|NCT03284723|HER2|her2
4692844|NCT03284723|PF-06804103|pf-06804103
4692845|NCT03284723|ADC|adc
4692846|NCT03284723|breast cancer|breast cancer
4692847|NCT03284723|gastric cancer|gastric cancer
4692848|NCT03284723|esophagogastric cancer|esophagogastric cancer
4692849|NCT03284723|non-small cell lung cancer|non-small cell lung cancer
4692850|NCT03284723|neoplasms|neoplasms
4692851|NCT03284723|solid tumors|solid tumors
4692852|NCT03284723|human epidermal growth receptor 2|human epidermal growth receptor 2
4692853|NCT03284710|HIV|hiv
4692854|NCT03284671|Transcranial Direct Current Stimulation|transcranial direct current stimulation
4692855|NCT03284671|Supplementary motor area|supplementary motor area
4692856|NCT03284671|Orbitofrontal cortex|orbitofrontal cortex
4692857|NCT03284658|Tyrosinemia Type 1|tyrosinemia type 1
4692858|NCT03284658|Biomarker|biomarker
4692859|NCT03284632|Tobacco|tobacco
4692860|NCT03284632|E-Cigarettes|e-cigarettes
4692861|NCT03284632|Toxicants|toxicants
4692862|NCT03284632|Formaldehyde DNA Adducts|formaldehyde dna adducts
4692863|NCT03284632|Oxidative Damage|oxidative damage
4692864|NCT03284567|Breast cancer|breast cancer
4692865|NCT03284567|Football|football
4692866|NCT03284567|Late effects|late effects
4692867|NCT03284567|Physical exercise|physical exercise
4692868|NCT03284567|Soccer training|soccer training
4692869|NCT03284567|Rehabilitation|rehabilitation
4692870|NCT03284567|Bone mineralization|bone mineralization
4692871|NCT03284567|Body composition|body composition
4692872|NCT03284567|Fitness|fitness
4692873|NCT03284567|Aerobic capacity|aerobic capacity
4692874|NCT03284554|Satiety|satiety
4692875|NCT03284554|Nutrients|nutrients
4692876|NCT03284554|Appetite|appetite
4692877|NCT03284554|Encapsulation|encapsulation
4692878|NCT03284554|Lipid|lipid
4692879|NCT03284554|Amino acid|amino acid
4692880|NCT03284554|Probiotic bacteria|probiotic bacteria
4692881|NCT03284489|Pancreatitis|pancreatitis
4692882|NCT03284476|Nosocomial Peritonitis|nosocomial peritonitis
4692883|NCT03284476|Community-acquired Peritonitis|community-acquired peritonitis
4692884|NCT03284476|Post-operative Peritonitis|post-operative peritonitis
4692885|NCT03284463|acute ischemic stroke|acute ischemic stroke
4692886|NCT03284463|glibenclamide|glibenclamide
4692887|NCT03284463|rt-PA|rt-pa
4692888|NCT03284463|blood-brain barrier|blood-brain barrier
4692889|NCT03284463|brain edema|brain edema
4692890|NCT03284450|Dance|dance
4692891|NCT03284450|Sprint|sprint
4692892|NCT03284450|Females|females
4692893|NCT03284450|Recovery|recovery
4692894|NCT03284424|PD1|pd1
4692895|NCT03284424|PD-1|pd-1
4692896|NCT03284424|PDL1|pdl1
4692897|NCT03284424|PD-L1|pd-l1
4692898|NCT03284398|parenteral nutrition|parenteral nutrition
4692899|NCT03284398|ICU|icu
4692900|NCT03284398|3-chamber bags|3-chamber bags
4692901|NCT03284398|ICD-9-CM|icd-9-cm
4692902|NCT03284398|BSI|bsi
4692903|NCT03284398|Medical records system|medical records system
4692904|NCT03284398|computerized|computerized
4692905|NCT03284359|Critical Illness|critical illness
4692906|NCT03284359|Mechanical Ventilation|mechanical ventilation
4692907|NCT03284359|Economics, Behavioral|economics, behavioral
4692908|NCT03284359|Surrogate decision maker|surrogate decision maker
4692909|NCT03284307|Sedation|sedation
4692910|NCT03284307|Propofol|propofol
4692911|NCT03284307|Dexmedetomidine|dexmedetomidine
4692912|NCT03284307|Ketamine|ketamine
4692913|NCT03284307|Sevoflurane|sevoflurane
4692914|NCT03284307|Electroencephalogram|electroencephalogram
4692915|NCT03284268|Gene therapy|gene therapy
4692916|NCT03284255|Bioresorbable Vascular Scaffold System|bioresorbable vascular scaffold system
4692917|NCT03284255|Percutaneous Coronary Intervention|percutaneous coronary intervention
4692918|NCT03284255|Cardiac Catheterization|cardiac catheterization
4692919|NCT03284255|Tomography, Optical Coherence|tomography, optical coherence
4692920|NCT03284242|Kidney|kidney
4692921|NCT03284242|Transplant|transplant
4692922|NCT03284229|ELCA|elca
4692923|NCT03284229|Coronary Artery Disease|coronary artery disease
4692924|NCT03284229|India|india
4692925|NCT03284151|prostate cancer|prostate cancer
4692926|NCT03284151|good prognosis|good prognosis
4692927|NCT03284151|focused treatment|focused treatment
4692928|NCT03284151|Cyberknife|cyberknife
4692929|NCT03284138|Schizophrenia|schizophrenia
4692930|NCT03284138|rTMS|rtms
4692931|NCT03284138|first rank symptoms|first rank symptoms
4692932|NCT03284112|Dementia, Schools, Nutrition, Health|dementia, schools, nutrition, health
4692933|NCT03284086|Oxygen consumption|oxygen consumption
4692934|NCT03284086|Physical endurance|physical endurance
4692935|NCT03284073|uterus|uterus
4692936|NCT03284073|transplantation|transplantation
4692937|NCT03284073|infertility|infertility
4692938|NCT03284060|Cognitive remediation, 22q11.2 deletion syndrome|cognitive remediation, 22q11.2 deletion syndrome
4692939|NCT03284008|Breast Neoplasm|breast neoplasm
4692940|NCT03284008|Physiotherapy|physiotherapy
4692941|NCT03284008|Rehabilitation|rehabilitation
4692942|NCT03283982|Ventral Hernia|ventral hernia
4692943|NCT03283982|Robotic|robotic
4692944|NCT03283982|Laparoscopic|laparoscopic
4692945|NCT03283982|Pain scores|pain scores
4692946|NCT03283930|anxiety, cbt, abmt|anxiety, cbt, abmt
4692947|NCT03283917|Amyloid light chain (AL) amyloidosis|amyloid light chain (al) amyloidosis
4692948|NCT03283917|Daratumumab|daratumumab
4692949|NCT03283917|Ixazomib|ixazomib
4692950|NCT03283917|Dexamethasone|dexamethasone
4692951|NCT03283917|MLN 9708|mln 9708
4692952|NCT03283917|MLN9708|mln9708
4692953|NCT03283917|Decadron|decadron
4692954|NCT03283904|Children|children
4692955|NCT03283904|Schools|schools
4692956|NCT03283891|Educational intervention|educational intervention
4692957|NCT03283891|Watson's theory of human caring|watson's theory of human caring
4692958|NCT03283891|Quality of working life of haemodialysis nurses|quality of working life of haemodialysis nurses
4692959|NCT03283891|Quality of life of haemodialysis patients|quality of life of haemodialysis patients
4692960|NCT03283839|Temporo-mandibular dysfunction|temporo-mandibular dysfunction
4692961|NCT03283839|Balance control|balance control
4692962|NCT03283839|Orientation function|orientation function
4692963|NCT03283826|Multiple Sclerosis|multiple sclerosis
4692964|NCT03283826|Relapsing Remitting Multiple Sclerosis|relapsing remitting multiple sclerosis
4692965|NCT03283826|Primary Progressive Multiple Sclerosis|primary progressive multiple sclerosis
4692966|NCT03283826|Secondary Progressive Multiple Sclerosis|secondary progressive multiple sclerosis
4692967|NCT03283826|Epstein-Barr Virus (EBV)|epstein-barr virus (ebv)
4692968|NCT03283826|EBV-associated Multiple Sclerosis|ebv-associated multiple sclerosis
4692969|NCT03283826|Inflammation|inflammation
4692970|NCT03283826|Central Nervous System|central nervous system
4692971|NCT03283826|Autoimmune Disease|autoimmune disease
4692972|NCT03283826|Autoimmunity|autoimmunity
4692973|NCT03283826|Demyelination|demyelination
4692974|NCT03283826|Cell Therapy|cell therapy
4692975|NCT03283826|T-cell|t-cell
4692976|NCT03283826|Allogeneic|allogeneic
4692977|NCT03283813|Paediatric Obesity|paediatric obesity
4692978|NCT03283813|Insulin resistance|insulin resistance
4692979|NCT03283813|Zinc|zinc
4692980|NCT03283813|Myo-inositol|myo-inositol
4692981|NCT03283800|Copper Oxide|copper oxide
4692982|NCT03283800|Compression Therapy|compression therapy
4692983|NCT03283800|Chronic Venous Disease|chronic venous disease
4692984|NCT03283800|Randomised Controlled Trial|randomised controlled trial
4692985|NCT03283800|Lipodermatosclerosis|lipodermatosclerosis
4692986|NCT03283787|Pressure Ulcer|pressure ulcer
4692987|NCT03283787|ACell|acell
4692988|NCT03283787|ACell MicroMatrix®|acell micromatrix®
4692989|NCT03283787|ACell Cytal™|acell cytal™
4692990|NCT03283787|Extracellular Matrix|extracellular matrix
4692991|NCT03283787|Urinary Bladder Matrix|urinary bladder matrix
4692992|NCT03283787|Wound|wound
4692993|NCT03283761|FOLFOX|folfox
4692994|NCT03283761|Nab-Paclitaxel|nab-paclitaxel
4692995|NCT03283735|Deprescribing|deprescribing
4692996|NCT03283735|Polypharmacy|polypharmacy
4692997|NCT03283735|Elderly|elderly
4692998|NCT03283735|Enablement|enablement
4692999|NCT03283735|Quality of Life|quality of life
4693000|NCT03283683|rest-activity rhythm|rest-activity rhythm
4693001|NCT03283683|survival|survival
4693002|NCT03283683|actigraphy|actigraphy
4693003|NCT03283670|Depression|depression
4693004|NCT03283670|treatment-resistant|treatment-resistant
4693005|NCT03283644|gastric bypass|gastric bypass
4693006|NCT03283644|Obesity|obesity
4693007|NCT03283644|Morbid obesity|morbid obesity
4693008|NCT03283644|Matched Healthy Controls|matched healthy controls
4693009|NCT03283631|Malignant Glioma|malignant glioma
4693010|NCT03283631|INTERCEPT|intercept
4693011|NCT03283631|Pro00083828|pro00083828
4693012|NCT03283631|Adult|adult
4693013|NCT03283631|Chimeric Antigen Receptor|chimeric antigen receptor
4693014|NCT03283631|CAR T cell|car t cell
4693015|NCT03283631|EGFRvIII|egfrviii
4693016|NCT03283618|Weight loss|weight loss
4693017|NCT03283618|Video conferencing|video conferencing
4693018|NCT03283618|Health coaching|health coaching
4693019|NCT03283618|Telemedicine|telemedicine
4693020|NCT03283618|mHealth|mhealth
4693021|NCT03283618|Obesity|obesity
4693022|NCT03283566|Pancreatectomy|pancreatectomy
4693023|NCT03283566|Autologous Islet Transplantation|autologous islet transplantation
4693024|NCT03283566|Pancreatitis|pancreatitis
4693025|NCT03283566|Diabetes|diabetes
4693026|NCT03283566|Hydroxychloroquine|hydroxychloroquine
4693027|NCT03283553|breast cancer|breast cancer
4693028|NCT03283540|Low Anterior Resection|low anterior resection
4693029|NCT03283501|TAVI|tavi
4693030|NCT03283501|PCI|pci
4693031|NCT03283488|anorexia|anorexia
4693032|NCT03283488|cachexia|cachexia
4693033|NCT03283488|mirtazapine|mirtazapine
4693034|NCT03283488|megestrol|megestrol
4693035|NCT03283488|palliative care|palliative care
4693036|NCT03283436|Laparoscopy|laparoscopy
4693037|NCT03283436|Superior hypogastric plexus block|superior hypogastric plexus block
4693038|NCT03283410|propofol|propofol
4693039|NCT03283410|dose-response|dose-response
4693040|NCT03283410|elderly|elderly
4693041|NCT03283410|young adults|young adults
4693042|NCT03283384|Breast cancer|breast cancer
4693043|NCT03283384|Ribociclib|ribociclib
4693044|NCT03283384|Letrozole|letrozole
4693045|NCT03283384|Chemotherapy|chemotherapy
4693046|NCT03283384|CDK4|cdk4
4693047|NCT03283384|CDK6|cdk6
4693048|NCT03283384|Ki67|ki67
4693049|NCT03283384|NEOLBC|neolbc
4693050|NCT03283371|Drug Resistant Focal Epilepsy, Natalizumab, Seizure|drug resistant focal epilepsy, natalizumab, seizure
4693051|NCT03283358|Prevention and control|prevention and control
4693052|NCT03283345|breast cancer|breast cancer
4693053|NCT03283345|menstrual cycle|menstrual cycle
4693054|NCT03283345|breast surgery|breast surgery
4693055|NCT03283345|systemic responses to trauma|systemic responses to trauma
4693056|NCT03283332|Ethnicity|ethnicity
4693057|NCT03283332|adolescents|adolescents
4693058|NCT03283332|cohort|cohort
4693059|NCT03283332|longitudinal|longitudinal
4693060|NCT03283332|health inequalities|health inequalities
4693061|NCT03283319|Influenza|influenza
4693062|NCT03283319|human|human
4693063|NCT03283319|Influenza in Birds|influenza in birds
4693064|NCT03283319|Orthomyxoviridae Infections|orthomyxoviridae infections
4693065|NCT03283319|RNA Virus Infections|rna virus infections
4693066|NCT03283319|Virus Diseases|virus diseases
4693067|NCT03283319|Respiratory Tract Infections|respiratory tract infections
4693068|NCT03283319|Respiratory Tract Diseases|respiratory tract diseases
4693069|NCT03283319|MF59|mf59
4693070|NCT03283319|AS03|as03
4693071|NCT03283319|Adjuvants|adjuvants
4693072|NCT03283319|Immunologic|immunologic
4693073|NCT03283293|Neoadjuvant Chemotherapy|neoadjuvant chemotherapy
4693074|NCT03283293|Intensity-modulated Radiation Therapy|intensity-modulated radiation therapy
4693075|NCT03283293|Target Volume Delineation|target volume delineation
4693076|NCT03283293|Locoregional Failure Pattern|locoregional failure pattern
4693077|NCT03283293|Nasopharyngeal Carcinoma|nasopharyngeal carcinoma
4693078|NCT03283280|Short fiber reinforced resin composite|short fiber reinforced resin composite
4693079|NCT03283280|Nanohybrid resin composite|nanohybrid resin composite
4693080|NCT03283280|Indirect resin composite restoration|indirect resin composite restoration
4693081|NCT03283267|Healthy Chinese Subjects, Pharmacodynamic Study|healthy chinese subjects, pharmacodynamic study
4693082|NCT03283254|Postpartum Depression Treatment|postpartum depression treatment
4693083|NCT03283202|Diffuse B-Cell Lymphoma|diffuse b-cell lymphoma
4693084|NCT03283202|R-CHOP-21|r-chop-21
4693085|NCT03283202|International Prognostic Index (IPI)|international prognostic index (ipi)
4693086|NCT03283189|Use of cosmetics|use of cosmetics
4693087|NCT03283189|Pregnant women|pregnant women
4693088|NCT03283189|Risk perception|risk perception
4693089|NCT03283189|Preventive attitude|preventive attitude
4693090|NCT03283189|Qualitative study|qualitative study
4693091|NCT03283150|Deep Brain Stimulation(DBS)|deep brain stimulation(dbs)
4693092|NCT03283150|Sedation|sedation
4693093|NCT03283150|DBS Implantation|dbs implantation
4693094|NCT03283150|Microelectrode recording(MER)|microelectrode recording(mer)
4693095|NCT03283137|CLL|cll
4693096|NCT03283137|B-cell Non Hodgkin Lymphoma|b-cell non hodgkin lymphoma
4693097|NCT03283137|pembrolizumab|pembrolizumab
4693098|NCT03283137|TGR-1202|tgr-1202
4693099|NCT03283098|Secondary hyperparathyroidism|secondary hyperparathyroidism
4693100|NCT03283098|Chronic kidney disease CKD|chronic kidney disease ckd
4693101|NCT03283098|Intact parathyroid hormone iPTH|intact parathyroid hormone ipth
4693102|NCT03283098|Hemodialysis|hemodialysis
4693103|NCT03283085|Immunosuppressants|immunosuppressants
4693104|NCT03283085|Mesalamine|mesalamine
4693105|NCT03283085|Ulcerative Colitis|ulcerative colitis
4693106|NCT03283085|Crohn's disease|crohn's disease
4693107|NCT03283085|Gastroenteritis|gastroenteritis
4693108|NCT03283072|thermal threshold|thermal threshold
4693109|NCT03283072|pressure pain threshold|pressure pain threshold
4693110|NCT03283072|temporal summation|temporal summation
4693111|NCT03283046|Multiple myeloma|multiple myeloma
4693112|NCT03283046|Newly diagnosed|newly diagnosed
4693113|NCT03283046|Nivolumab|nivolumab
4693114|NCT03283046|BMS-936558|bms-936558
4693115|NCT03283046|Opdivo|opdivo
4693116|NCT03283046|Lenalidomide|lenalidomide
4693117|NCT03283046|CC-5013|cc-5013
4693118|NCT03283046|Revlimid|revlimid
4693119|NCT03283046|Dexamethasone|dexamethasone
4693120|NCT03283046|Decadron|decadron
4693121|NCT03283046|Ipilimumab|ipilimumab
4693122|NCT03283046|Yervoy|yervoy
4693123|NCT03283046|BMS-734016|bms-734016
4693124|NCT03283046|MDX010|mdx010
4693125|NCT03283033|Children|children
4693126|NCT03283033|Plate Waste|plate waste
4693127|NCT03283033|Fruit and vegetable intake|fruit and vegetable intake
4693128|NCT03283033|School lunch|school lunch
4693129|NCT03283033|social marketing|social marketing
4693130|NCT03283020|Remifentanil|remifentanil
4693131|NCT03283020|Methylnaltrexone|methylnaltrexone
4693132|NCT03283020|Pharyngeal dysfunction|pharyngeal dysfunction
4693133|NCT03283020|Anesthetic sedation|anesthetic sedation
4693134|NCT03283007|Nintedanib, lung transplantation, bronchiolitis obliterans syndrome|nintedanib, lung transplantation, bronchiolitis obliterans syndrome
4693135|NCT03282968|exergaming|exergaming
4693136|NCT03282968|physiotherapy|physiotherapy
4693137|NCT03282968|balance|balance
4693138|NCT03282942|hypertension|hypertension
4693139|NCT03282942|Aerobic training|aerobic training
4693140|NCT03282942|Strength training|strength training
4693141|NCT03282916|Valacyclovir|valacyclovir
4693142|NCT03282916|Anti-viral treatment|anti-viral treatment
4693143|NCT03282890|HIV|hiv
4693144|NCT03282890|Substance Abuse|substance abuse
4693145|NCT03282890|Pre-Exposure Prophylaxis|pre-exposure prophylaxis
4693146|NCT03282890|HIV Risk Behavior|hiv risk behavior
4693147|NCT03282890|Methadone Maintenance|methadone maintenance
4693148|NCT03282864|asthma|asthma
4693149|NCT03282864|air pollution|air pollution
4693150|NCT03282864|air filtration|air filtration
4693151|NCT03282864|indoor air quality|indoor air quality
4693152|NCT03282864|respiratory health|respiratory health
4693153|NCT03282851|MSB11456|msb11456
4693154|NCT03282851|Actemra®|actemra®
4693155|NCT03282851|RoActemra®|roactemra®
4693156|NCT03282799|etonogestrel|etonogestrel
4693157|NCT03282799|efavirenz|efavirenz
4693158|NCT03282799|antiretroviral therapy|antiretroviral therapy
4693159|NCT03282799|HIV|hiv
4693160|NCT03282786|Inflammatory Bowel Disease|inflammatory bowel disease
4693161|NCT03282786|Crohn's Disease|crohn's disease
4693162|NCT03282786|Ulcerative Colitis|ulcerative colitis
4693163|NCT03282786|Carbon Dioxide (CO2)|carbon dioxide (co2)
4693164|NCT03282786|Colonoscopy|colonoscopy
4693165|NCT03282773|acute myocardial infarction|acute myocardial infarction
4693166|NCT03282773|percutaneous coronary intervention|percutaneous coronary intervention
4693167|NCT03282773|deferred stent implantation|deferred stent implantation
4693168|NCT03282760|Cell Transplantation|cell transplantation
4693169|NCT03282760|Neural Stem Cells|neural stem cells
4693170|NCT03282708|intestinal microbiome|intestinal microbiome
4693171|NCT03282708|captive great apes|captive great apes
4693172|NCT03282708|human beings|human beings
4693173|NCT03282695|Disc Herniation|disc herniation
4693174|NCT03282695|Lumbar Herniated Disc|lumbar herniated disc
4693175|NCT03282695|Ozone Therapy|ozone therapy
4693176|NCT03282682|hypogonadism|hypogonadism
4693177|NCT03282682|aging male|aging male
4693178|NCT03282682|strength training|strength training
4693179|NCT03282682|physical activity|physical activity
4693180|NCT03282682|testosterone|testosterone
4693181|NCT03282669|Pregnancy|pregnancy
4693182|NCT03282669|Transcutaneous Carbon Dioxide Monitoring|transcutaneous carbon dioxide monitoring
4693183|NCT03282669|Pulse Oximetry|pulse oximetry
4693184|NCT03282669|Cesarean Section|cesarean section
4693185|NCT03282669|Postoperative pain control|postoperative pain control
4693186|NCT03282669|High BMI|high bmi
4693187|NCT03282669|Hypercarbia|hypercarbia
4693188|NCT03282669|Hypoxemia|hypoxemia
4693189|NCT03282656|Gene therapy|gene therapy
4693190|NCT03282656|lentivirus vector|lentivirus vector
4693191|NCT03282656|BCL11A|bcl11a
4693192|NCT03282656|Fetal Hemoglobin|fetal hemoglobin
4693193|NCT03282630|Acupuncture|acupuncture
4693194|NCT03282630|Sphenopalatine ganglion|sphenopalatine ganglion
4693195|NCT03282630|Allergic rhinitis|allergic rhinitis
4693196|NCT03282630|Randomized Trial|randomized trial
4693197|NCT03282604|Intubation|intubation
4693198|NCT03282604|Intratracheal|intratracheal
4693199|NCT03282604|Nasopharynx|nasopharynx
4693200|NCT03282578|sternum|sternum
4693201|NCT03282578|bone healing|bone healing
4693202|NCT03282578|recovery|recovery
4693203|NCT03282565|ACL|acl
4693204|NCT03282565|Quadriceps|quadriceps
4693205|NCT03282565|Muscle|muscle
4693206|NCT03282565|Resistance Training|resistance training
4693207|NCT03282539|Lumen apposing metal stents|lumen apposing metal stents
4693208|NCT03282539|Double pigtail stents|double pigtail stents
4693209|NCT03282539|Endoscopic ultrasonography|endoscopic ultrasonography
4693210|NCT03282513|AG-120|ag-120
4693211|NCT03282513|Healthy Volunteer|healthy volunteer
4693212|NCT03282513|Clinical Pharmacology|clinical pharmacology
4693213|NCT03282513|Hepatic Impairment|hepatic impairment
4693214|NCT03282487|cortisol|cortisol
4693215|NCT03282487|adrenal insufficiency|adrenal insufficiency
4693216|NCT03282487|hypopituitarism|hypopituitarism
4693217|NCT03282487|hydrocortisone|hydrocortisone
4693218|NCT03282474|Hepatitis E|hepatitis e
4693219|NCT03282422|Cerebral palsy|cerebral palsy
4693220|NCT03282422|Hemiplegia|hemiplegia
4693221|NCT03282422|Upper-limb splint|upper-limb splint
4693222|NCT03282422|Home-based|home-based
4693223|NCT03282422|Social Participation|social participation
4693224|NCT03282409|Prediction|prediction
4693225|NCT03282409|Chronic Renal Disease|chronic renal disease
4693226|NCT03282409|Acute Kidney Injury|acute kidney injury
4693227|NCT03282396|Hematopoietic/Lymphoid Cancer|hematopoietic/lymphoid cancer
4693228|NCT03282396|Mantle Cell Lymphoma|mantle cell lymphoma
4693229|NCT03282396|MCL|mcl
4693230|NCT03282396|Newly-diagnosed|newly-diagnosed
4693231|NCT03282396|Ibrutinib|ibrutinib
4693232|NCT03282396|PCI-32765|pci-32765
4693233|NCT03282396|Imbruvica|imbruvica
4693234|NCT03282383|biomarkers pneumonia severity|biomarkers pneumonia severity
4693235|NCT03282370|Japanese Encephalitis|japanese encephalitis
4693236|NCT03282370|JECEVAX|jecevax
4693237|NCT03282370|Vietnam|vietnam
4693238|NCT03282344|NKTR-214|nktr-214
4693239|NCT03282344|NIVOLUMAB|nivolumab
4693240|NCT03282344|17-366|17-366
4693241|NCT03282331|Preoxygenation|preoxygenation
4693242|NCT03282331|Intubation|intubation
4693243|NCT03282331|Electrical Impedance Tomography|electrical impedance tomography
4693244|NCT03282331|Lung aeration|lung aeration
4693245|NCT03282331|Alveolar recruitment|alveolar recruitment
4693246|NCT03282318|Bladder Pain Syndrome|bladder pain syndrome
4693247|NCT03282318|Interstitial Cystitis|interstitial cystitis
4693248|NCT03282318|ASP6294|asp6294
4693249|NCT03282279|oocyte retrieval|oocyte retrieval
4693250|NCT03282279|surgical complications|surgical complications
4693251|NCT03282240|Influenza|influenza
4693252|NCT03282227|migraine|migraine
4693253|NCT03282227|migraine headache|migraine headache
4693254|NCT03282227|acute migraine|acute migraine
4693255|NCT03282227|acute migraine headache|acute migraine headache
4693256|NCT03282214|Energy conservation|energy conservation
4693257|NCT03282214|Self management|self management
4693258|NCT03282175|BDNF|bdnf
4693259|NCT03282175|interleukin-15|interleukin-15
4693260|NCT03282175|interleukin-8|interleukin-8
4693261|NCT03282175|resistin|resistin
4693262|NCT03282175|SPPB|sppb
4693263|NCT03282162|Oxytocin|oxytocin
4693264|NCT03282162|affective touch|affective touch
4693265|NCT03282162|trait autism|trait autism
4693266|NCT03282149|inflammation|inflammation
4693267|NCT03282149|cytokine|cytokine
4693268|NCT03282149|anti-inflammatory|anti-inflammatory
4693269|NCT03282149|pain|pain
4693270|NCT03282123|MDMA|mdma
4693271|NCT03282123|methylenedioxymethamphetamine|methylenedioxymethamphetamine
4693272|NCT03282123|psychotherapy|psychotherapy
4693273|NCT03282071|Mental health|mental health
4693274|NCT03282071|Mental well-being|mental well-being
4693275|NCT03282071|Community-based engagement|community-based engagement
4693276|NCT03282071|Positive psychology|positive psychology
4693277|NCT03282071|Public health approach|public health approach
4693278|NCT03282058|Silastic Stenting|silastic stenting
4693279|NCT03282058|Trans-nasal Endoscopic Surgery|trans-nasal endoscopic surgery
4693280|NCT03282058|Post-operative Intra-nasal Re-mucosalization|post-operative intra-nasal re-mucosalization
4693281|NCT03282045|acute sore throat|acute sore throat
4693282|NCT03282045|lysobact|lysobact
4693283|NCT03282019|myAIRVO2|myairvo2
4693284|NCT03282019|high-flow nasal cannula therapy|high-flow nasal cannula therapy
4693285|NCT03282019|home oxygen therapy|home oxygen therapy
4693286|NCT03282019|HOT|hot
4693287|NCT03282019|COPD|copd
4693288|NCT03282006|Pivmecillinam|pivmecillinam
4693289|NCT03281993|apnea test, brain death, pupillometry|apnea test, brain death, pupillometry
4693290|NCT03281980|Bangladesh|bangladesh
4693291|NCT03281980|Child development|child development
4693292|NCT03281980|Poor mothers|poor mothers
4693293|NCT03281980|Psycho social stimulation|psycho social stimulation
4693294|NCT03281980|Unconditional cash transfer|unconditional cash transfer
4693295|NCT03281954|anti-PD-L1 antibody|anti-pd-l1 antibody
4693296|NCT03281954|TNBC|tnbc
4693297|NCT03281915|infertility|infertility
4693298|NCT03281915|pain|pain
4693299|NCT03281915|pregnancy|pregnancy
4693300|NCT03281889|Brain Tumor|brain tumor
4693301|NCT03281876|Immunogenicity|immunogenicity
4693302|NCT03281876|Vaccination|vaccination
4693303|NCT03281876|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
4693304|NCT03281876|Non-typeable Haemophilus influenzae|non-typeable haemophilus influenzae
4693305|NCT03281876|Acute exacerbation of COPD|acute exacerbation of copd
4693306|NCT03281876|Moraxella catarrhalis|moraxella catarrhalis
4693307|NCT03281876|Efficacy|efficacy
4693308|NCT03281876|Safety|safety
4693309|NCT03281837|osteoarthritis|osteoarthritis
4693310|NCT03281837|knee osteoarthritis|knee osteoarthritis
4693311|NCT03281837|patellofemoral osteoarthritis|patellofemoral osteoarthritis
4693312|NCT03281837|tibiofemoral osteoarthritis|tibiofemoral osteoarthritis
4693313|NCT03281837|hyaluronan|hyaluronan
4693314|NCT03281837|hyaluronic acid|hyaluronic acid
4693315|NCT03281837|intra-articular|intra-articular
4693316|NCT03281837|arthritis|arthritis
4693317|NCT03281837|joint disease|joint disease
4693318|NCT03281837|active|active
4693319|NCT03281837|viscosupplements|viscosupplements
4693320|NCT03281837|Hymovis|hymovis
4693321|NCT03281824|HER2 Positive Breast Cancer|her2 positive breast cancer
4693322|NCT03281824|ALT-P7|alt-p7
4693323|NCT03281824|Antibody-Drug Conjugate|antibody-drug conjugate
4693324|NCT03281772|hypertension|hypertension
4693325|NCT03281772|clinical decision support software|clinical decision support software
4693326|NCT03281772|renin|renin
4693327|NCT03281772|aldosterone|aldosterone
4693328|NCT03281759|Brain Injuries, Traumatic;|brain injuries, traumatic;
4693329|NCT03281759|Diffuse Axonal Injury|diffuse axonal injury
4693330|NCT03281759|Low-Level Light Therapy|low-level light therapy
4693331|NCT03281759|Neurologic Manifestations|neurologic manifestations
4693332|NCT03281759|Quality of Life|quality of life
4693333|NCT03281759|Rehabilitation|rehabilitation
4693334|NCT03281733|malnutrition|malnutrition
4693335|NCT03281733|adult|adult
4693336|NCT03281733|hospitalized patients|hospitalized patients
4693337|NCT03281733|dietitian|dietitian
4693338|NCT03281733|communication|communication
4693339|NCT03281733|discharge|discharge
4693340|NCT03281733|nutrition|nutrition
4693341|NCT03281707|NIRS|nirs
4693342|NCT03281707|DO2|do2
4693343|NCT03281694|nicotine|nicotine
4693344|NCT03281694|positive allosteric modulator|positive allosteric modulator
4693345|NCT03281694|attention|attention
4693346|NCT03281694|cognition|cognition
4693347|NCT03281681|adenocarcinoma of the ovary|adenocarcinoma of the ovary
4693348|NCT03281681|ovarian adenocarcinoma|ovarian adenocarcinoma
4693349|NCT03281681|ovarian cancer|ovarian cancer
4693350|NCT03281681|cancer of the ovary|cancer of the ovary
4693351|NCT03281681|ovarian neoplasm|ovarian neoplasm
4693352|NCT03281681|AO|ao
4693353|NCT03281681|ovarian carcinoma|ovarian carcinoma
4693354|NCT03281668|Knee osteoarthritis|knee osteoarthritis
4693355|NCT03281655|Visnadine|visnadine
4693356|NCT03281655|Prenylflavonoids|prenylflavonoids
4693357|NCT03281655|Bovine colostrum|bovine colostrum
4693358|NCT03281655|Sexual wellbeing|sexual wellbeing
4693359|NCT03281629|Transcranial magnetic stimulation|transcranial magnetic stimulation
4693360|NCT03281629|schizophrenia|schizophrenia
4693361|NCT03281629|MRI|mri
4693362|NCT03281629|smoking|smoking
4693363|NCT03281603|Patient satisfaction|patient satisfaction
4693364|NCT03281603|Retention|retention
4693365|NCT03281590|identification|identification
4693366|NCT03281590|diagnosis|diagnosis
4693367|NCT03281590|management|management
4693368|NCT03281590|investigation|investigation
4693369|NCT03281590|prevalence|prevalence
4693370|NCT03281590|incidence|incidence
4693371|NCT03281590|quality of care|quality of care
4693372|NCT03281590|hospitalization|hospitalization
4693373|NCT03281590|morbidity|morbidity
4693374|NCT03281590|disability|disability
4693375|NCT03281577|Drug Therapy|drug therapy
4693376|NCT03281525|cardiotransplant|cardiotransplant
4693377|NCT03281512|Saturated fatty acids|saturated fatty acids
4693378|NCT03281512|CHNS|chns
4693379|NCT03281473|ARDS; esophageal pressure; Mechanical ventilation|ards; esophageal pressure; mechanical ventilation
4693380|NCT03281460|Hysterectomy, Vaginal|hysterectomy, vaginal
4693381|NCT03281460|Uterine Myomatosis|uterine myomatosis
4693382|NCT03281460|Morcellation|morcellation
4693383|NCT03281460|Laparoscopy|laparoscopy
4693384|NCT03281460|in-bag morcellation|in-bag morcellation
4693385|NCT03281447|Nurse navigation|nurse navigation
4693386|NCT03281447|Family|family
4693387|NCT03281447|Self Efficacy|self efficacy
4693388|NCT03281447|Needs assessment|needs assessment
4693389|NCT03281447|Quality of Life|quality of life
4693390|NCT03281447|Colorectal Neoplasms|colorectal neoplasms
4693391|NCT03281447|Case Management|case management
4693392|NCT03281434|Skeletal muscle|skeletal muscle
4693393|NCT03281434|Protein synthesis|protein synthesis
4693394|NCT03281434|Protein ingestion|protein ingestion
4693395|NCT03281434|Resistance exercise|resistance exercise
4693396|NCT03281356|Pilot Study|pilot study
4693397|NCT03281356|Early childhood development|early childhood development
4693398|NCT03281343|PrEP|prep
4693399|NCT03281343|Women|women
4693400|NCT03281343|Linkage to Care|linkage to care
4693401|NCT03281317|vasoplegicsyndrome|vasoplegicsyndrome
4693402|NCT03281317|cardiac surgery|cardiac surgery
4693403|NCT03281317|predictive risk score|predictive risk score
4693404|NCT03281304|ulcerative colitis|ulcerative colitis
4693405|NCT03281304|inflammatory bowel disease|inflammatory bowel disease
4693406|NCT03281291|malaria vaccine|malaria vaccine
4693407|NCT03281291|infants|infants
4693408|NCT03281291|Malaria|malaria
4693409|NCT03281291|RTS,S/AS01|rts,s/as01
4693410|NCT03281291|falciparum|falciparum
4693411|NCT03281291|genomics|genomics
4693412|NCT03281291|efficacy|efficacy
4693413|NCT03281278|Thrombelastography,acute on chronic liver failure, platelet|thrombelastography,acute on chronic liver failure, platelet
4693414|NCT03281265|pre-acute-on-chronic liver failure|pre-acute-on-chronic liver failure
4693415|NCT03281265|hepatitis B|hepatitis b
4693416|NCT03281252|liver failure|liver failure
4693417|NCT03281239|welder, airport agent, Welding fumes|welder, airport agent, welding fumes
4693418|NCT03281226|Pulmonary tuberculosis|pulmonary tuberculosis
4693419|NCT03281226|HIV/AIDS|hiv/aids
4693420|NCT03281226|Glutathione|glutathione
4693421|NCT03281226|N-acetylcysteine|n-acetylcysteine
4693422|NCT03281226|Oxidative stress|oxidative stress
4693423|NCT03281187|Hormonal reposition, Testosterone nasal, Nasotestt|hormonal reposition, testosterone nasal, nasotestt
4693424|NCT03281174|Inactivated Enterovirus Type 71 (EV71) Vaccine|inactivated enterovirus type 71 (ev71) vaccine
4693425|NCT03281174|5-year Immune Persistence|5-year immune persistence
4693426|NCT03281161|skin cancer|skin cancer
4693427|NCT03281161|prevention|prevention
4693428|NCT03281161|worksite|worksite
4693429|NCT03281161|policy|policy
4693430|NCT03281161|cost and effectiveness|cost and effectiveness
4693431|NCT03281161|implementation|implementation
4693432|NCT03281148|immediate implants, accuracy,extraction sockets|immediate implants, accuracy,extraction sockets
4693433|NCT03281135|Cervical cancer screening|cervical cancer screening
4693434|NCT03281135|Adherance|adherance
4693435|NCT03281135|HPV typing|hpv typing
4693437|NCT03281135|Ethiopia|ethiopia
4693438|NCT03281109|menstrual cycle|menstrual cycle
4693439|NCT03281109|gingivitis|gingivitis
4693440|NCT03281109|interleukin 1|interleukin 1
4693441|NCT03281109|tumor necrosis factor alpha|tumor necrosis factor alpha
4693442|NCT03281083|Non-Alcoholic Fatty Liver Disease|non-alcoholic fatty liver disease
4693443|NCT03281083|Diabetes Mellitus, type 2|diabetes mellitus, type 2
4693444|NCT03281083|Thyroid hormone|thyroid hormone
4693445|NCT03281083|Levothyroxine|levothyroxine
4693446|NCT03281070|Anastomotic leakage|anastomotic leakage
4693447|NCT03281070|Anterior resection|anterior resection
4693448|NCT03281070|Risk factors|risk factors
4693449|NCT03281070|Incidence|incidence
4693450|NCT03281070|Rectal Cancer|rectal cancer
4693451|NCT03281031|MRI|mri
4693452|NCT03281031|Acute abdominal pain|acute abdominal pain
4693453|NCT03281031|Pelvic pain|pelvic pain
4693454|NCT03281031|Diagnostic performance|diagnostic performance
4693455|NCT03281031|Young women|young women
4693456|NCT03281018|hypnosis|hypnosis
4693457|NCT03281018|preoperative anxiety|preoperative anxiety
4693458|NCT03281018|hysterectomy|hysterectomy
4693459|NCT03281018|hospitalisation|hospitalisation
4693460|NCT03281005|Retinitis pigmentosa|retinitis pigmentosa
4693461|NCT03281005|Visual function evaluation|visual function evaluation
4693462|NCT03280940|Inflammation|inflammation
4693463|NCT03280940|Immune activation|immune activation
4693464|NCT03280940|Integrase Inhibitors|integrase inhibitors
4693465|NCT03280940|Naive patients|naive patients
4693466|NCT03280927|Onychomycosis|onychomycosis
4693467|NCT03280914|obstructive sleep apnea|obstructive sleep apnea
4693468|NCT03280914|real world|real world
4693469|NCT03280914|community|community
4693470|NCT03280901|renal replacement therapy|renal replacement therapy
4693471|NCT03280901|haemodialysis|haemodialysis
4693472|NCT03280901|haemodiafiltration|haemodiafiltration
4693473|NCT03280862|Heart Failure|heart failure
4693474|NCT03280862|Branch Block|branch block
4693475|NCT03280862|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
4693476|NCT03280849|chitosan|chitosan
4693477|NCT03280849|endoscopic|endoscopic
4693478|NCT03280849|sellar tumor|sellar tumor
4693479|NCT03280849|biomaterials|biomaterials
4693480|NCT03280849|transphenoidal|transphenoidal
4693481|NCT03280823|complement system|complement system
4693482|NCT03280810|Schizophrenia|schizophrenia
4693483|NCT03280810|Postural|postural
4693484|NCT03280810|Cognitive|cognitive
4693485|NCT03280810|task|task
4693486|NCT03280758|Resistance training|resistance training
4693487|NCT03280758|Diabetes Mellitus|diabetes mellitus
4693488|NCT03280758|blood-glucose control|blood-glucose control
4693489|NCT03280758|Muscle|muscle
4693490|NCT03280758|Function|function
4693491|NCT03280732|Lung Ultrasound|lung ultrasound
4693492|NCT03280732|Chest X-Ray|chest x-ray
4693493|NCT03280732|Pneumonia|pneumonia
4693494|NCT03280732|Pneumothorax|pneumothorax
4693495|NCT03280732|Pleural effusion|pleural effusion
4693496|NCT03280719|Prone position|prone position
4693497|NCT03280719|Supine position|supine position
4693498|NCT03280719|Hypofractionation|hypofractionation
4693499|NCT03280719|Accelerated radiotherapy|accelerated radiotherapy
4693500|NCT03280719|Regional nodal irradiation|regional nodal irradiation
4693501|NCT03280706|Gastric Emptying|gastric emptying
4693502|NCT03280706|labor|labor
4693503|NCT03280706|maltodextrin|maltodextrin
4693504|NCT03280706|orange juice|orange juice
4693505|NCT03280706|coffee|coffee
4693506|NCT03280706|ultrasound|ultrasound
4693507|NCT03280693|Body mass index,|body mass index,
4693508|NCT03280693|Bone density|bone density
4693509|NCT03280693|Balance|balance
4693510|NCT03280693|Postmenopause|postmenopause
4693511|NCT03280680|Violence against young women and girls|violence against young women and girls
4693512|NCT03280680|Sexual and reproductive health and rights|sexual and reproductive health and rights
4693513|NCT03280680|Consent|consent
4693514|NCT03280680|Health services|health services
4693515|NCT03280680|Legal services|legal services
4693516|NCT03280680|Awareness raising|awareness raising
4693517|NCT03280680|Community mobilization|community mobilization
4693518|NCT03280654|Obesity|obesity
4693519|NCT03280654|Overactive Bladder|overactive bladder
4693520|NCT03280654|Urinary incontinence|urinary incontinence
4693521|NCT03280654|Visceral Adiposity Index|visceral adiposity index
4693522|NCT03280654|Waist Circumference|waist circumference
4693523|NCT03280615|Albuminuria|albuminuria
4693524|NCT03280615|Carotid Intima-Media Thickness|carotid intima-media thickness
4693525|NCT03280615|Pulse Wave Velocity|pulse wave velocity
4693526|NCT03280615|Inflammation|inflammation
4693527|NCT03280589|Heart Rate Variability|heart rate variability
4693528|NCT03280589|EEG|eeg
4693529|NCT03280589|Respiration|respiration
4693530|NCT03280576|Postoperative|postoperative
4693531|NCT03280576|Dysfunction Following Cardiac Surgery|dysfunction following cardiac surgery
4693532|NCT03280524|Reflexology,diabetes, quality of life|reflexology,diabetes, quality of life
4693533|NCT03280485|TBI|tbi
4693534|NCT03280485|management|management
4693535|NCT03280485|S100B|s100b
4693536|NCT03280485|biomarkers|biomarkers
4693537|NCT03280485|mild head injury|mild head injury
4693538|NCT03280485|intracranial complication|intracranial complication
4693539|NCT03280472|Interpretation Bias|interpretation bias
4693540|NCT03280472|Interpretation Modification Program|interpretation modification program
4693541|NCT03280433|Epicardial adipose tissue|epicardial adipose tissue
4693542|NCT03280433|Coronary artery disease|coronary artery disease
4693543|NCT03280433|Atrial fibrillation|atrial fibrillation
4693544|NCT03280433|Severe aortic stenosis|severe aortic stenosis
4693545|NCT03280433|Proteome|proteome
4693546|NCT03280433|Mass spectrometry|mass spectrometry
4693547|NCT03280433|Computed tomography|computed tomography
4693548|NCT03280420|Acute urinary retention|acute urinary retention
4693549|NCT03280420|BPH|bph
4693550|NCT03280420|TWOC|twoc
4693551|NCT03280420|Tamsulosin|tamsulosin
4693552|NCT03280407|Neoadjuvant chemotherapy,|neoadjuvant chemotherapy,
4693553|NCT03280407|locally advanced rectal cancer,|locally advanced rectal cancer,
4693554|NCT03280407|chemotherapy|chemotherapy
4693555|NCT03280407|CAPOX (oxaliplatin/capecitabine)|capox (oxaliplatin/capecitabine)
4693556|NCT03280407|FOLFOX (oxaliplatin/leucovorin/5FU)|folfox (oxaliplatin/leucovorin/5fu)
4693557|NCT03280394|Liquid biopsy|liquid biopsy
4693558|NCT03280394|Classical Hodgkin Lymphoma|classical hodgkin lymphoma
4693559|NCT03280394|Diffuse Large B Cell Lymphoma|diffuse large b cell lymphoma
4693560|NCT03280394|Follicular Lymphoma|follicular lymphoma
4693561|NCT03280394|Mantle Cell Lymphoma|mantle cell lymphoma
4693562|NCT03280394|Mutations|mutations
4693563|NCT03280381|Nifty Cup|nifty cup
4693564|NCT03280381|breastfeeding difficulties|breastfeeding difficulties
4693565|NCT03280381|preterm infant|preterm infant
4693566|NCT03280381|cup feeding|cup feeding
4693567|NCT03280355|COPD|copd
4693568|NCT03280355|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
4693569|NCT03280355|Randomised controlled trial (RCT)|randomised controlled trial (rct)
4693570|NCT03280355|Rehabilitation|rehabilitation
4693571|NCT03280355|Singing Training|singing training
4693572|NCT03280342|Migraine|migraine
4693573|NCT03280342|Headache|headache
4693574|NCT03280316|Spinal Vascular Disorder|spinal vascular disorder
4693575|NCT03280316|Overactive Bladder|overactive bladder
4693576|NCT03280290|Lymphocytes CD4|lymphocytes cd4
4693577|NCT03280290|Lymphocytes CCR7|lymphocytes ccr7
4693578|NCT03280290|ALLOGRAFT|allograft
4693579|NCT03280290|Hematopoietic Stem Cells|hematopoietic stem cells
4693580|NCT03280251|Cognitive disorders|cognitive disorders
4693581|NCT03280251|cognitive training|cognitive training
4693582|NCT03280251|symptomatic treatment|symptomatic treatment
4693583|NCT03280251|Methylphenidate|methylphenidate
4693584|NCT03280251|elderly|elderly
4693585|NCT03280225|Suicide|suicide
4693586|NCT03280225|Prevention|prevention
4693587|NCT03280225|Implementation|implementation
4693588|NCT03280225|Facilitation|facilitation
4693589|NCT03280212|Chronic subdural hematoma|chronic subdural hematoma
4693590|NCT03280212|Tranexamic acid|tranexamic acid
4693591|NCT03280212|TXA|txa
4693592|NCT03280186|Spinal Vascular Malformations|spinal vascular malformations
4693593|NCT03280186|Bladder|bladder
4693594|NCT03280186|Surgical intervention|surgical intervention
4693595|NCT03280186|Urodynamics|urodynamics
4693596|NCT03280147|Neonate|neonate
4693597|NCT03280147|Sepsis|sepsis
4693598|NCT03280147|Antibiotics|antibiotics
4693599|NCT03280147|Duration|duration
4693600|NCT03280134|non-sentinel lymph node|non-sentinel lymph node
4693601|NCT03280134|breast cancer|breast cancer
4693602|NCT03280134|prediction|prediction
4693603|NCT03280134|CK19|ck19
4693604|NCT03280134|contrast-enhanced ultrasound|contrast-enhanced ultrasound
4693605|NCT03280121|transoral incisionless|transoral incisionless
4693606|NCT03280056|MSC|msc
4693607|NCT03280056|Autologous|autologous
4693608|NCT03280056|Neurotrophic factors|neurotrophic factors
4693609|NCT03280043|Breast reduction|breast reduction
4693610|NCT03280043|Reduction mammoplasty|reduction mammoplasty
4693611|NCT03280043|Hematoma|hematoma
4693612|NCT03280043|Hemorrhage|hemorrhage
4693613|NCT03280043|Ketorolac|ketorolac
4693614|NCT03280043|Toradol|toradol
4693615|NCT03280030|midostaurin|midostaurin
4693616|NCT03280030|PKC412|pkc412
4693617|NCT03280030|cytarabine|cytarabine
4693618|NCT03280030|daunorubicin|daunorubicin
4693619|NCT03280030|acute myeloid leukemia|acute myeloid leukemia
4693620|NCT03280030|combination treatment|combination treatment
4693621|NCT03280030|FLT3|flt3
4693622|NCT03280030|acute myeloid leukemia (AML)|acute myeloid leukemia (aml)
4693623|NCT03280030|acute myelogenous leukemia (AML)|acute myelogenous leukemia (aml)
4693624|NCT03280017|anesthesia|anesthesia
4693625|NCT03280017|thoracic surgery|thoracic surgery
4693626|NCT03280017|thoracic paravertebral block|thoracic paravertebral block
4693627|NCT03280017|ketamine|ketamine
4693628|NCT03279991|biobank|biobank
4693629|NCT03279991|chronic disease|chronic disease
4693630|NCT03279991|omics|omics
4693631|NCT03279991|big data|big data
4693632|NCT03279991|4 P medicine|4 p medicine
4693633|NCT03279965|Lung MRI cystic fibrosis primary ciliary dyskinesia|lung mri cystic fibrosis primary ciliary dyskinesia
4693634|NCT03279913|Depression, neurofeedback, TMS|depression, neurofeedback, tms
4693635|NCT03279874|decision-making|decision-making
4693636|NCT03279874|repair behavior|repair behavior
4693637|NCT03279874|interviews|interviews
4693638|NCT03279796|Adipose-drived mesenchymal stem cells|adipose-drived mesenchymal stem cells
4693639|NCT03279796|Rotator cuff injury|rotator cuff injury
4693640|NCT03279796|Lateral Epicondylitis|lateral epicondylitis
4693641|NCT03279796|Randomized controlled trials|randomized controlled trials
4693642|NCT03279770|lnRNA|lnrna
4693643|NCT03279770|CV disease|cv disease
4693644|NCT03279757|Fractional laser|fractional laser
4693645|NCT03279757|Topical anesthesia|topical anesthesia
4693646|NCT03279757|Drug delivery|drug delivery
4693647|NCT03279757|CO2 laser|co2 laser
4693648|NCT03279744|Oral Verrucous Hyperplasia|oral verrucous hyperplasia
4693649|NCT03279744|Oral Erythroleukoplakia|oral erythroleukoplakia
4693650|NCT03279731|eating disorder, pharmacotherapy|eating disorder, pharmacotherapy
4693651|NCT03279705|water exchange|water exchange
4693652|NCT03279705|water jet channel colonoscopy|water jet channel colonoscopy
4693653|NCT03279705|colonoscopy|colonoscopy
4693654|NCT03279705|cecal insertion time|cecal insertion time
4693655|NCT03279705|adenoma detection rate|adenoma detection rate
4693656|NCT03279692|Meningioma|meningioma
4693657|NCT03279679|costoclavicular|costoclavicular
4693658|NCT03279679|paracoracoid|paracoracoid
4693659|NCT03279679|brachial plexus|brachial plexus
4693660|NCT03279640|Motor Network|motor network
4693661|NCT03279640|Resting-state fMRI|resting-state fmri
4693662|NCT03279640|Repetitive Transcranial Magnetic Stimulation|repetitive transcranial magnetic stimulation
4693663|NCT03279640|Transcranial Direct Current Stimulation|transcranial direct current stimulation
4693664|NCT03279627|inpatient|inpatient
4693665|NCT03279627|hypoglycemia|hypoglycemia
4693666|NCT03279627|hyperglycemia|hyperglycemia
4693667|NCT03279627|hospital readmission|hospital readmission
4693668|NCT03279627|discharge planning|discharge planning
4693669|NCT03279614|ORR|orr
4693670|NCT03279614|OS|os
4693671|NCT03279614|PFS|pfs
4693672|NCT03279614|safety|safety
4693673|NCT03279601|chemotherapy|chemotherapy
4693674|NCT03279601|OS|os
4693675|NCT03279601|ORR|orr
4693676|NCT03279601|PFS|pfs
4693677|NCT03279601|safety|safety
4693678|NCT03279588|Ultrasound diagnosis|ultrasound diagnosis
4693679|NCT03279588|Abdominal Ultrasound|abdominal ultrasound
4693680|NCT03279588|Emergency Department|emergency department
4693681|NCT03279523|Dementia|dementia
4693682|NCT03279523|HIV|hiv
4693683|NCT03279523|Brain Disease|brain disease
4693684|NCT03279523|CNS Diseases|cns diseases
4693685|NCT03279523|Mild Cognitive Impairment|mild cognitive impairment
4693686|NCT03279523|Neurodegenerative Disease|neurodegenerative disease
4693687|NCT03279523|Tauopathies|tauopathies
4693688|NCT03279510|auditory perception|auditory perception
4693689|NCT03279510|hearing|hearing
4693690|NCT03279484|safety , electrical performance|safety , electrical performance
4693691|NCT03279471|autism spectrum disorder|autism spectrum disorder
4693692|NCT03279471|anxiety|anxiety
4693693|NCT03279471|cognitive behavior therapy|cognitive behavior therapy
4693694|NCT03279471|functional neuroimaging|functional neuroimaging
4693695|NCT03279458|Capnography|capnography
4693696|NCT03279432|VDR, MEGALIN, haplotypes, obesity, metabolic syndrome|vdr, megalin, haplotypes, obesity, metabolic syndrome
4693697|NCT03279406|Atrial fibrillation|atrial fibrillation
4693698|NCT03279406|Stroke|stroke
4693699|NCT03279406|Thrombus|thrombus
4693700|NCT03279406|Left atrial appendage|left atrial appendage
4693701|NCT03279406|Bleeding|bleeding
4693702|NCT03279393|Post-Traumatic Stress Disorder|post-traumatic stress disorder
4693703|NCT03279393|PTSD|ptsd
4693704|NCT03279393|trauma|trauma
4693705|NCT03279393|stress|stress
4693706|NCT03279393|atherosclerosis|atherosclerosis
4693707|NCT03279393|macrophage|macrophage
4693708|NCT03279393|plaque burden|plaque burden
4693709|NCT03279393|vascular inflammation|vascular inflammation
4693710|NCT03279393|atherosclerotic inflammation|atherosclerotic inflammation
4693711|NCT03279393|PET/MRI|pet/mri
4693712|NCT03279393|18F-FDG-PET|18f-fdg-pet
4693713|NCT03279380|genetic polymorphism|genetic polymorphism
4693714|NCT03279380|sport performance|sport performance
4693715|NCT03279380|myokines|myokines
4693716|NCT03279354|Health-related quality of life|health-related quality of life
4693717|NCT03279354|Physical activity|physical activity
4693718|NCT03279354|Smartphone application|smartphone application
4693719|NCT03279341|laxatives|laxatives
4693720|NCT03279341|constipation|constipation
4693721|NCT03279315|Iodine|iodine
4693722|NCT03279315|Balance experiment|balance experiment
4693723|NCT03279315|EAR|ear
4693724|NCT03279315|Chinese women|chinese women
4693725|NCT03279315|Euthyroid|euthyroid
4693726|NCT03279289|FOLFIRI|folfiri
4693727|NCT03279289|aflibercept|aflibercept
4693728|NCT03279289|5-FU|5-fu
4693729|NCT03279289|oxaliplatin|oxaliplatin
4693730|NCT03279289|elderly|elderly
4693731|NCT03279289|metastatic colorectal cancer|metastatic colorectal cancer
4693732|NCT03279276|Hip arthroplasty|hip arthroplasty
4693733|NCT03279250|Diseases of Male Genital Organs|diseases of male genital organs
4693734|NCT03279250|Prostate Cancer|prostate cancer
4693735|NCT03279250|Adenocarcinoma of the prostate|adenocarcinoma of the prostate
4693736|NCT03279250|LHRH Agonist|lhrh agonist
4693737|NCT03279250|Apalutamide|apalutamide
4693738|NCT03279250|ARN-509|arn-509
4693739|NCT03279250|Abiraterone Acetate|abiraterone acetate
4693740|NCT03279250|Zytiga|zytiga
4693741|NCT03279250|Prednisone|prednisone
4693742|NCT03279237|GastroEsophageal Cancer|gastroesophageal cancer
4693743|NCT03279224|Bipolar, Depression, FMT, Microbiome|bipolar, depression, fmt, microbiome
4693744|NCT03279211|digestibility|digestibility
4693745|NCT03279211|whey protein|whey protein
4693746|NCT03279211|zein|zein
4693747|NCT03279211|bioavailability|bioavailability
4693748|NCT03279198|breast cancer screening|breast cancer screening
4693749|NCT03279198|colorectal cancer screening|colorectal cancer screening
4693750|NCT03279198|cervical cancer screening|cervical cancer screening
4693751|NCT03279198|cancer screening beliefs|cancer screening beliefs
4693752|NCT03279198|cost-effectiveness|cost-effectiveness
4693753|NCT03279198|demographics|demographics
4693754|NCT03279198|tailored intervention|tailored intervention
4693755|NCT03279185|HIV/AIDS, perinatal HIV infection|hiv/aids, perinatal hiv infection
4693756|NCT03279172|videolaryngoscope|videolaryngoscope
4693757|NCT03279172|intraocular pressure|intraocular pressure
4693758|NCT03279172|Direct laryngoscope|direct laryngoscope
4693759|NCT03279120|HIV|hiv
4693760|NCT03279120|LNG|lng
4693761|NCT03279120|TFV|tfv
4693762|NCT03279120|IVR|ivr
4693763|NCT03279120|Contraception|contraception
4693764|NCT03279120|Prevention|prevention
4693765|NCT03279094|Sickle Cell Disease|sickle cell disease
4693766|NCT03279094|Hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
4693767|NCT03279094|Haploidentical stem cell transplantation|haploidentical stem cell transplantation
4693768|NCT03279094|Post-transplant Cytoxan|post-transplant cytoxan
4693769|NCT03279081|Crohn's disease|crohn's disease
4693770|NCT03279081|complex perianal fistula(s)|complex perianal fistula(s)
4693771|NCT03279068|electronic fetal monitoring|electronic fetal monitoring
4693772|NCT03279055|Insomnia|insomnia
4693773|NCT03279042|En masse retraction|en masse retraction
4693774|NCT03279042|Corticotomy|corticotomy
4693775|NCT03279042|Acceleration of tooth movement|acceleration of tooth movement
4693776|NCT03279042|Piezocision|piezocision
4693777|NCT03279042|Flapless corticotomy|flapless corticotomy
4693778|NCT03279042|Class II division 1 malocclusion|class ii division 1 malocclusion
4693779|NCT03279042|Protrusion of upper incisors|protrusion of upper incisors
4693780|NCT03279042|Sliding mechanics|sliding mechanics
4693781|NCT03279042|mini-implant based anchorage|mini-implant based anchorage
4693782|NCT03279042|temporary anchorage devices|temporary anchorage devices
4693783|NCT03278990|PrEP|prep
4693784|NCT03278990|Prevention|prevention
4693785|NCT03278990|Value Affirmation|value affirmation
4693786|NCT03278990|Future Selves|future selves
4693787|NCT03278990|Behavioral Intervention|behavioral intervention
4693788|NCT03278977|Apparent Life-Threatening Event|apparent life-threatening event
4693789|NCT03278977|ALTE|alte
4693790|NCT03278977|Sudden Infant Death|sudden infant death
4693791|NCT03278964|Graves Disease|graves disease
4693792|NCT03278964|Orbital decompression|orbital decompression
4693793|NCT03278964|Graves Orbitopathy|graves orbitopathy
4693794|NCT03278964|Exophthalmos|exophthalmos
4693795|NCT03278964|Diplopia|diplopia
4693796|NCT03278964|Restrictive Strabismus|restrictive strabismus
4693797|NCT03278951|Weight loss|weight loss
4693798|NCT03278951|video conferencing|video conferencing
4693799|NCT03278951|mHealth|mhealth
4693800|NCT03278951|Telemedicine|telemedicine
4693801|NCT03278951|glycemic control|glycemic control
4693802|NCT03278938|depression|depression
4693803|NCT03278938|citalopram|citalopram
4693804|NCT03278938|bupropion|bupropion
4693805|NCT03278938|combination therapy|combination therapy
4693806|NCT03278912|Inflammatory Bowel Disease|inflammatory bowel disease
4693807|NCT03278912|Chronic Granulomatous Disease|chronic granulomatous disease
4693808|NCT03278912|Dysbiosis|dysbiosis
4693809|NCT03278912|Microbiome|microbiome
4693810|NCT03278912|Immunodeficiency|immunodeficiency
4693811|NCT03278899|Adrenoleukodystropy|adrenoleukodystropy
4693812|NCT03278899|X-ALD|x-ald
4693813|NCT03278899|ALD|ald
4693814|NCT03278886|Alcohol Use|alcohol use
4693815|NCT03278886|Pain|pain
4693816|NCT03278886|HIV|hiv
4693817|NCT03278886|Low-dose naltrexone|low-dose naltrexone
4693818|NCT03278886|Nalmefene|nalmefene
4693819|NCT03278860|Oxytocin|oxytocin
4693820|NCT03278860|social touch|social touch
4693821|NCT03278847|NNRD|nnrd
4693822|NCT03278847|matching|matching
4693823|NCT03278847|propensity score|propensity score
4693824|NCT03278821|Informed choice|informed choice
4693825|NCT03278821|Alcohol use disorder|alcohol use disorder
4693826|NCT03278821|Addiction treatment|addiction treatment
4693827|NCT03278795|Weaning, ventilatory support, assisted ventilation modes|weaning, ventilatory support, assisted ventilation modes
4693828|NCT03278782|Refractory Peripheral T-Cell Lymphoma|refractory peripheral t-cell lymphoma
4693829|NCT03278782|Cutaneous T-cell lymphoma|cutaneous t-cell lymphoma
4693830|NCT03278782|Pembrolizumab|pembrolizumab
4693831|NCT03278782|Keytruda|keytruda
4693832|NCT03278782|MK-3475|mk-3475
4693833|NCT03278782|SCH-900475|sch-900475
4693834|NCT03278782|Romidepsin|romidepsin
4693835|NCT03278782|Istodax|istodax
4693836|NCT03278782|Depsipeptide|depsipeptide
4693837|NCT03278782|FK228|fk228
4693838|NCT03278756|Depression|depression
4693839|NCT03278756|Remission|remission
4693840|NCT03278756|Relapse prevention|relapse prevention
4693841|NCT03278756|Cognitive control training|cognitive control training
4693842|NCT03278756|Internet intervention|internet intervention
4693843|NCT03278743|tea|tea
4693844|NCT03278743|cognition|cognition
4693845|NCT03278743|very old|very old
4693846|NCT03278743|Newcastle 85+|newcastle 85+
4693847|NCT03278743|epidemiology|epidemiology
4693848|NCT03278730|sepsis|sepsis
4693849|NCT03278730|para-Tyrosine|para-tyrosine
4693850|NCT03278730|ortho-Tyrosine|ortho-tyrosine
4693851|NCT03278730|meta-Tyrosine|meta-tyrosine
4693852|NCT03278704|Concurrent training|concurrent training
4693853|NCT03278704|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
4693854|NCT03278704|Resistance exercise|resistance exercise
4693855|NCT03278704|High-Intensity Interval Training (HIIT)|high-intensity interval training (hiit)
4693856|NCT03278704|Muscle hypertrophy|muscle hypertrophy
4693857|NCT03278704|Interference effect|interference effect
4693858|NCT03278678|Nutritional screening MNA-SF malnutrition Case Management|nutritional screening mna-sf malnutrition case management
4693859|NCT03278665|Cutaneous melanoma|cutaneous melanoma
4693860|NCT03278639|gait disorders|gait disorders
4693861|NCT03278639|balance disorders|balance disorders
4693862|NCT03278639|music|music
4693863|NCT03278639|tango|tango
4693864|NCT03278639|rhythmic auditory stimulation|rhythmic auditory stimulation
4693865|NCT03278639|health-related quality of life|health-related quality of life
4693866|NCT03278626|Locally Advanced Esophageal Squamous Cell Carcinoma|locally advanced esophageal squamous cell carcinoma
4693867|NCT03278561|asthma|asthma
4693868|NCT03278561|age of onset|age of onset
4693869|NCT03278561|inflammation|inflammation
4693870|NCT03278561|comorbidity|comorbidity
4693871|NCT03278561|microbiome|microbiome
4693872|NCT03278548|HES|hes
4693873|NCT03278548|Hydroxyethylstarch|hydroxyethylstarch
4693874|NCT03278522|ramosetron|ramosetron
4693875|NCT03278496|addiction|addiction
4693876|NCT03278496|substance abuse treatment|substance abuse treatment
4693877|NCT03278496|aftercare|aftercare
4693878|NCT03278496|outpatient counseling|outpatient counseling
4693879|NCT03278496|opiates|opiates
4693880|NCT03278496|cocaine|cocaine
4693881|NCT03278483|Latent tuberculosis, ,|latent tuberculosis, ,
4693882|NCT03278483|isoniazid, rifampin,|isoniazid, rifampin,
4693883|NCT03278483|rifampin,|rifampin,
4693884|NCT03278483|adverse,|adverse,
4693885|NCT03278483|diabetes mellitus|diabetes mellitus
4693886|NCT03278457|hypertrophic cardiomyopathy|hypertrophic cardiomyopathy
4693887|NCT03278457|implantable cardioverter defibrillator|implantable cardioverter defibrillator
4693888|NCT03278457|positron emission tomography|positron emission tomography
4693889|NCT03278392|pregnancy|pregnancy
4693890|NCT03278392|metabolism|metabolism
4693891|NCT03278392|stress|stress
4693892|NCT03278392|emotional state|emotional state
4693893|NCT03278392|diet|diet
4693894|NCT03278392|glycemic response|glycemic response
4693895|NCT03278353|Expectation|expectation
4693896|NCT03278353|Conservative Intervention|conservative intervention
4693897|NCT03278340|Skin Cancer|skin cancer
4693898|NCT03278340|Prevention|prevention
4693899|NCT03278340|Policy|policy
4693900|NCT03278340|Worksite|worksite
4693901|NCT03278340|Scale-up|scale-up
4693902|NCT03278340|Cost and Effectiveness|cost and effectiveness
4693903|NCT03278275|urokinase plasminogen activator receptor|urokinase plasminogen activator receptor
4693904|NCT03278275|uPAR PET/CT|upar pet/ct
4693905|NCT03278275|positron emission tomography|positron emission tomography
4693906|NCT03278275|neuroendocrine tumors|neuroendocrine tumors
4693907|NCT03278249|brain tumor|brain tumor
4693908|NCT03278223|Multipurpose Contact Lens Care System|multipurpose contact lens care system
4693909|NCT03278210|EEG-fMRI|eeg-fmri
4693910|NCT03278210|brain imaging|brain imaging
4693911|NCT03278210|presurgical evaluation|presurgical evaluation
4693912|NCT03278210|epilepsy surgery|epilepsy surgery
4693913|NCT03278158|safety|safety
4693914|NCT03278158|tolerability|tolerability
4693915|NCT03278132|Inactivated Enterovirus Type 71 (EV71) Vaccine|inactivated enterovirus type 71 (ev71) vaccine
4693916|NCT03278132|Safety|safety
4693917|NCT03278132|Immunogenicity|immunogenicity
4693918|NCT03278132|Infant|infant
4693919|NCT03278093|Physiotherapy|physiotherapy
4693920|NCT03278093|Physical therapy|physical therapy
4693921|NCT03278093|Balance|balance
4693922|NCT03278093|Posturography|posturography
4693923|NCT03278067|England|england
4693924|NCT03278067|Adverse Event of Interest|adverse event of interest
4693925|NCT03278067|Seasonal influenza vaccines|seasonal influenza vaccines
4693926|NCT03278067|Pilot study|pilot study
4693927|NCT03278067|Prospective passive enhanced safety surveillance|prospective passive enhanced safety surveillance
4693928|NCT03278054|apical periodontitis|apical periodontitis
4693929|NCT03278054|hybrid|hybrid
4693930|NCT03278054|ProTaper|protaper
4693931|NCT03278054|rotary|rotary
4693932|NCT03278015|S-1|s-1
4693933|NCT03278015|nab-paclitaxel|nab-paclitaxel
4693934|NCT03277976|atrial fibrillation;|atrial fibrillation;
4693935|NCT03277976|catheter ablation;|catheter ablation;
4693936|NCT03277976|pulmonary vein isolation|pulmonary vein isolation
4693937|NCT03277976|ablation index|ablation index
4693938|NCT03277963|Obesity|obesity
4693939|NCT03277963|Obstructive sleep apnea syndrome|obstructive sleep apnea syndrome
4693940|NCT03277950|virtual reality|virtual reality
4693941|NCT03277950|feedback|feedback
4693942|NCT03277937|gastric varices|gastric varices
4693943|NCT03277937|endoscopic ultrasound|endoscopic ultrasound
4693944|NCT03277937|coils|coils
4693945|NCT03277937|cyanoacrylate|cyanoacrylate
4693946|NCT03277898|Breast Neoplasms|breast neoplasms
4693947|NCT03277898|"Exercis* OR Aerobic Exercise"|"exercis* or aerobic exercise"
4693948|NCT03277898|Cognitive Function*|cognitive function*
4693949|NCT03277898|"Antineoplastic therapy OR Antineoplastic agent"|"antineoplastic therapy or antineoplastic agent"
4693950|NCT03277898|Chemotherapy, Adjuvant|chemotherapy, adjuvant
4693951|NCT03277885|Work related chronic pain|work related chronic pain
4693952|NCT03277885|Preventive care|preventive care
4693953|NCT03277859|Yoga|yoga
4693954|NCT03277859|Veterans|veterans
4693955|NCT03277859|Traumatic Brain Injury|traumatic brain injury
4693956|NCT03277859|Post-concussive Headaches|post-concussive headaches
4693957|NCT03277859|Post-concussive Symptoms|post-concussive symptoms
4693958|NCT03277768|Premature infant|premature infant
4693959|NCT03277768|Tissue Oxygenation|tissue oxygenation
4693960|NCT03277768|Patent Ductus Arteriosus|patent ductus arteriosus
4693961|NCT03277716|Huge hepatocellular carcinoma|huge hepatocellular carcinoma
4693962|NCT03277716|Microwave ablation|microwave ablation
4693963|NCT03277716|TACE|tace
4693964|NCT03277716|Safety|safety
4693965|NCT03277716|Non-resectable|non-resectable
4693966|NCT03277716|Treatment|treatment
4693967|NCT03277703|Influenza vaccine|influenza vaccine
4693968|NCT03277703|Booster dose|booster dose
4693969|NCT03277703|immunocompromised|immunocompromised
4693970|NCT03277703|Biologic therapy|biologic therapy
4693971|NCT03277703|Rheumatologic disease|rheumatologic disease
4693972|NCT03277703|inflammatory bowel disease|inflammatory bowel disease
4693973|NCT03277690|Cushing Syndrome, Adrenocortical Hyperfunction|cushing syndrome, adrenocortical hyperfunction
4693974|NCT03277664|pediatric|pediatric
4693975|NCT03277664|asthma adherence|asthma adherence
4693976|NCT03277664|electronic device|electronic device
4693977|NCT03277651|noninvasive|noninvasive
4693978|NCT03277651|Hemodynamics|hemodynamics
4693979|NCT03277638|recurrent glioblastoma|recurrent glioblastoma
4693980|NCT03277638|brain cancer|brain cancer
4693981|NCT03277625|pancreaticoduodenectomy|pancreaticoduodenectomy
4693982|NCT03277573|Salsalate|salsalate
4693983|NCT03277560|Major Trauma Centre|major trauma centre
4693984|NCT03277560|ISS|iss
4693985|NCT03277560|Outcome Measures|outcome measures
4693986|NCT03277534|electrical stimulation|electrical stimulation
4693987|NCT03277508|Brain-computer integration|brain-computer integration
4693988|NCT03277482|Recurrent gynecological cancer|recurrent gynecological cancer
4693989|NCT03277482|Metastatic Cervical Cancer|metastatic cervical cancer
4693990|NCT03277482|Metastatic Ovarian Cancer|metastatic ovarian cancer
4693991|NCT03277482|Metastatic Vaginal Cancer|metastatic vaginal cancer
4693992|NCT03277482|Metastatic Vulvar Cancer|metastatic vulvar cancer
4693993|NCT03277482|Metastatic Endometrial Cancer|metastatic endometrial cancer
4693994|NCT03277482|Recurrent Cervical Carcinoma|recurrent cervical carcinoma
4693995|NCT03277482|Recurrent Ovarian Carcinoma|recurrent ovarian carcinoma
4693996|NCT03277482|Recurrent Vaginal Cancer|recurrent vaginal cancer
4693997|NCT03277482|Recurrent Vulvar Cancer|recurrent vulvar cancer
4693998|NCT03277482|Recurrent Endometrial Cancer|recurrent endometrial cancer
4693999|NCT03277469|Gynecologic Cancer|gynecologic cancer
4694000|NCT03277443|Skeletal open bite|skeletal open bite
4694001|NCT03277430|uterus transplantation, absolute uterine factor infertility|uterus transplantation, absolute uterine factor infertility
4694002|NCT03277404|EDTA|edta
4694003|NCT03277404|Postoperative pain|postoperative pain
4694004|NCT03277404|Pulp necrosis|pulp necrosis
4694005|NCT03277404|Smear layer|smear layer
4694006|NCT03277352|cervical cancer|cervical cancer
4694007|NCT03277352|endometrial cancer|endometrial cancer
4694008|NCT03277352|gastric cancer (including stomach and gastroesophageal junction (GEJ))|gastric cancer (including stomach and gastroesophageal junction (gej))
4694009|NCT03277352|esophageal cancer|esophageal cancer
4694010|NCT03277352|hepatocellular carcinoma (HCC)|hepatocellular carcinoma (hcc)
4694011|NCT03277352|melanoma (mucosal or cutaneous)|melanoma (mucosal or cutaneous)
4694012|NCT03277352|Merkel cell carcinoma|merkel cell carcinoma
4694013|NCT03277352|mesothelioma|mesothelioma
4694014|NCT03277352|microsatellite instability-high (MSI-H)|microsatellite instability-high (msi-h)
4694015|NCT03277352|solid tumors|solid tumors
4694016|NCT03277352|non-small cell lung cancer (NSCLC)|non-small cell lung cancer (nsclc)
4694017|NCT03277352|ovarian cancer|ovarian cancer
4694018|NCT03277352|squamous cell carcinoma of the head and neck (SCCHN)|squamous cell carcinoma of the head and neck (scchn)
4694019|NCT03277352|small cell lung cancer (SCLC)|small cell lung cancer (sclc)
4694020|NCT03277352|renal cell carcinoma (RCC)|renal cell carcinoma (rcc)
4694021|NCT03277352|triple-negative breast cancer (TNBC)|triple-negative breast cancer (tnbc)
4694022|NCT03277352|urothelial carcinoma|urothelial carcinoma
4694023|NCT03277352|glucocorticoid-induced tumor necrosis factor receptor (GITR)|glucocorticoid-induced tumor necrosis factor receptor (gitr)
4694024|NCT03277339|Generalized anxious disorders|generalized anxious disorders
4694025|NCT03277339|Thermal cure|thermal cure
4694026|NCT03277339|paroxetine|paroxetine
4694027|NCT03277274|Drug therapy|drug therapy
4694028|NCT03277235|fatigue|fatigue
4694029|NCT03277235|colon cancer|colon cancer
4694030|NCT03277235|quality of life|quality of life
4694031|NCT03277222|Neurocognitive impairment|neurocognitive impairment
4694032|NCT03277222|HIV-1|hiv-1
4694033|NCT03277222|Intranasal insulin|intranasal insulin
4694034|NCT03277222|Neurocognitive Disorder|neurocognitive disorder
4694035|NCT03277222|Cognition|cognition
4694036|NCT03277222|Memory|memory
4694037|NCT03277183|erythropoietin|erythropoietin
4694038|NCT03277170|acute asthma exacerbation|acute asthma exacerbation
4694039|NCT03277170|pediatric asthma|pediatric asthma
4694040|NCT03277170|leukotriene receptor antagonist|leukotriene receptor antagonist
4694041|NCT03277170|montelukast|montelukast
4694042|NCT03277144|linear stapler|linear stapler
4694043|NCT03277092|Child, blood drawing procedure, near Infrared light|child, blood drawing procedure, near infrared light
4694044|NCT03277079|coronary artery disease|coronary artery disease
4694045|NCT03277079|LDL cholesterol|ldl cholesterol
4694046|NCT03277079|therapeutic target|therapeutic target
4694047|NCT03277053|colorectal|colorectal
4694048|NCT03277053|laparoscopic|laparoscopic
4694049|NCT03277053|application|application
4694050|NCT03277053|ERP|erp
4694051|NCT03277053|adherence|adherence
4694052|NCT03277053|mobile|mobile
4694053|NCT03277027|cerebral palsy|cerebral palsy
4694054|NCT03277027|Health-Related Quality Of Life|health-related quality of life
4694055|NCT03277027|Physical Activity|physical activity
4694056|NCT03277014|Nutritional monitoring|nutritional monitoring
4694057|NCT03277014|insulin-like growth factor-1|insulin-like growth factor-1
4694058|NCT03277001|AECOPD|aecopd
4694059|NCT03277001|VTE prevention|vte prevention
4694060|NCT03277001|Rivaroxaban|rivaroxaban
4694061|NCT03277001|LMWHs|lmwhs
4694062|NCT03276988|Thyroid cancer|thyroid cancer
4694063|NCT03276988|Thyroidectomy|thyroidectomy
4694064|NCT03276988|rhTSH|rhtsh
4694065|NCT03276988|GX-30|gx-30
4694066|NCT03276975|CT fluoroscopy|ct fluoroscopy
4694067|NCT03276975|epidural patching|epidural patching
4694068|NCT03276975|spontaneous intracranial hypotension|spontaneous intracranial hypotension
4694069|NCT03276962|falciparum, efficacy|falciparum, efficacy
4694070|NCT03276962|RTS,S/AS01|rts,s/as01
4694071|NCT03276962|malaria vaccine|malaria vaccine
4694072|NCT03276962|safety|safety
4694073|NCT03276962|Malaria|malaria
4694074|NCT03276962|immunogenicity|immunogenicity
4694075|NCT03276962|infants|infants
4694076|NCT03276949|Blood glucose|blood glucose
4694077|NCT03276949|non-invasive|non-invasive
4694078|NCT03276949|Raman spectroscopy|raman spectroscopy
4694079|NCT03276910|antidoping|antidoping
4694080|NCT03276871|Balloon dissection|balloon dissection
4694081|NCT03276871|Telescopic dissection|telescopic dissection
4694082|NCT03276871|Inguinal hernia|inguinal hernia
4694084|NCT03276845|Ultrasound|ultrasound
4694085|NCT03276845|Elastography|elastography
4694086|NCT03276845|Doppler Ultrasound|doppler ultrasound
4694087|NCT03276845|Contrast enhanced Ultrasound|contrast enhanced ultrasound
4694088|NCT03276845|Three-dimensional Ultrasound|three-dimensional ultrasound
4694089|NCT03276819|Oral potentially malignant lesions (OPML)|oral potentially malignant lesions (opml)
4694090|NCT03276819|Head and neck squamous cell carcinoma (HNSCC)|head and neck squamous cell carcinoma (hnscc)
4694091|NCT03276819|Biomarkers|biomarkers
4694092|NCT03276819|Smoking cessation program|smoking cessation program
4694093|NCT03276819|Loss of heterozigoty (LOH)|loss of heterozigoty (loh)
4694094|NCT03276819|Medico-economics|medico-economics
4694095|NCT03276819|Sociology|sociology
4694096|NCT03276819|Psychology|psychology
4694097|NCT03276806|CT low dose|ct low dose
4694098|NCT03276806|nurse led intervention|nurse led intervention
4694099|NCT03276806|safety net hospital|safety net hospital
4694100|NCT03276806|lung cancer screening with CTLD|lung cancer screening with ctld
4694101|NCT03276767|online intervention|online intervention
4694102|NCT03276767|e-Health|e-health
4694103|NCT03276767|reminder|reminder
4694104|NCT03276767|SMS-textmessage|sms-textmessage
4694105|NCT03276767|e-mail|e-mail
4694106|NCT03276767|mobile phone|mobile phone
4694107|NCT03276767|cell phone|cell phone
4694108|NCT03276754|Pneumococcal infections|pneumococcal infections
4694109|NCT03276754|COPD exacerbations|copd exacerbations
4694110|NCT03276741|labor|labor
4694111|NCT03276741|anesthesia|anesthesia
4694112|NCT03276741|oral intake|oral intake
4694113|NCT03276741|maternal satisfaction|maternal satisfaction
4694114|NCT03276741|newborn complications|newborn complications
4694115|NCT03276728|Heart Failure|heart failure
4694116|NCT03276728|Cardiovascular Diseases|cardiovascular diseases
4694117|NCT03276728|Heart Diseases|heart diseases
4694118|NCT03276728|Ejection fraction|ejection fraction
4694119|NCT03276728|Heart Failure with reduced ejection fraction|heart failure with reduced ejection fraction
4694120|NCT03276728|Heart Failure with preserved ejection fraction|heart failure with preserved ejection fraction
4694121|NCT03276715|malignant pleural effusion|malignant pleural effusion
4694122|NCT03276715|lung cancer|lung cancer
4694123|NCT03276637|Genome Sequencing|genome sequencing
4694124|NCT03276637|Exome Sequencing|exome sequencing
4694125|NCT03276637|Military|military
4694126|NCT03276637|Air Force|air force
4694127|NCT03276611|Assessment|assessment
4694128|NCT03276611|pulmonary|pulmonary
4694129|NCT03276611|artery|artery
4694130|NCT03276611|right|right
4694131|NCT03276611|sided|sided
4694132|NCT03276611|hemodynamics|hemodynamics
4694133|NCT03276611|patients|patients
4694134|NCT03276611|sleep|sleep
4694135|NCT03276611|apnea|apnea
4694136|NCT03276611|syndrome|syndrome
4694137|NCT03276611|contionous|contionous
4694138|NCT03276611|positive|positive
4694139|NCT03276611|air|air
4694140|NCT03276611|way|way
4694141|NCT03276611|pressure|pressure
4694142|NCT03276611|treatment|treatment
4694143|NCT03276585|home sleep monitor|home sleep monitor
4694144|NCT03276585|Sleep Apnea Syndromes|sleep apnea syndromes
4694145|NCT03276585|questionnaire|questionnaire
4694146|NCT03276559|critically ill|critically ill
4694147|NCT03276559|ICU|icu
4694148|NCT03276559|uncommunicative|uncommunicative
4694149|NCT03276559|caregivers|caregivers
4694150|NCT03276533|dexmedetomidine; lidocaine; cytokine|dexmedetomidine; lidocaine; cytokine
4694151|NCT03276520|ethyl glucuronide, biomarker, diagnostic randomized trial|ethyl glucuronide, biomarker, diagnostic randomized trial
4694152|NCT03276481|melphalan|melphalan
4694153|NCT03276481|stem cell transplantation|stem cell transplantation
4694154|NCT03276481|17-404|17-404
4694155|NCT03276481|hematopoietic cell transplantation|hematopoietic cell transplantation
4694156|NCT03276481|HCT|hct
4694157|NCT03276468|venetoclax; obinutuzumab; atezolizumab; lymphoma|venetoclax; obinutuzumab; atezolizumab; lymphoma
4694158|NCT03276455|Beta thalassemia|beta thalassemia
4694159|NCT03276455|Gene therapy|gene therapy
4694160|NCT03276455|Beta-globin|beta-globin
4694161|NCT03276455|Hematopoietic stem cells|hematopoietic stem cells
4694162|NCT03276455|Lentiviral vector|lentiviral vector
4694163|NCT03276429|NSCLC|nsclc
4694164|NCT03276429|SCLC|sclc
4694165|NCT03276429|MOLECULAR BIOMARKERS|molecular biomarkers
4694166|NCT03276390|health disparities|health disparities
4694167|NCT03276390|living donation|living donation
4694168|NCT03276312|Lipogems|lipogems
4694169|NCT03276312|Adipose-derived Mesenchymal Stem Cells|adipose-derived mesenchymal stem cells
4694170|NCT03276312|Lipofilling|lipofilling
4694171|NCT03276312|Diabetic foot|diabetic foot
4694172|NCT03276208|Pregnancy|pregnancy
4694173|NCT03276208|Tobacco|tobacco
4694174|NCT03276208|Massage Therapy|massage therapy
4694175|NCT03276208|Mindfulness|mindfulness
4694176|NCT03276195|Neurodevelopmental Disorder|neurodevelopmental disorder
4694177|NCT03276195|Genomics|genomics
4694178|NCT03276195|Genetics|genetics
4694179|NCT03276169|atrial fibrillation|atrial fibrillation
4694180|NCT03276169|left atrial appendage closure|left atrial appendage closure
4694181|NCT03276169|left atrial function|left atrial function
4694182|NCT03276130|Blood coagulation disorder|blood coagulation disorder
4694183|NCT03276130|Haematologic diseases|haematologic diseases
4694184|NCT03276130|Coagulation protein disorder|coagulation protein disorder
4694185|NCT03276130|Hemorrhagic disorder|hemorrhagic disorder
4694186|NCT03276130|Genetic diseases, inborn|genetic diseases, inborn
4694187|NCT03276130|Pain|pain
4694188|NCT03276130|Anxiety|anxiety
4694189|NCT03276130|Pain medication|pain medication
4694190|NCT03276130|Anxiety medication|anxiety medication
4694191|NCT03276117|pregnancy.obstructed labour|pregnancy.obstructed labour
4694192|NCT03276104|IOL dislocation|iol dislocation
4694193|NCT03276104|Cataract|cataract
4694194|NCT03276104|Cataract surgery|cataract surgery
4694896|NCT03271307|self-test|self-test
4694195|NCT03276104|Scleral suturing|scleral suturing
4694196|NCT03276104|Verisyse|verisyse
4694197|NCT03276104|Iris-claw|iris-claw
4694198|NCT03276104|Late in-the-bag IOL dislocation|late in-the-bag iol dislocation
4694199|NCT03276091|colonoscopy|colonoscopy
4694200|NCT03276091|immunochemical fecal test|immunochemical fecal test
4694201|NCT03276091|screening|screening
4694202|NCT03276078|COPD|copd
4694203|NCT03276052|COPD, Pharmacokinetics|copd, pharmacokinetics
4694204|NCT03276026|sugammadex|sugammadex
4694205|NCT03276026|post anesthesia care unit recovery|post anesthesia care unit recovery
4694206|NCT03276013|Oncology|oncology
4694207|NCT03276013|Endometrial Cancer|endometrial cancer
4694208|NCT03276013|Pembrolizumab|pembrolizumab
4694209|NCT03276013|Doxorubicin|doxorubicin
4694210|NCT03276013|Metastatic Endometrial Cancer|metastatic endometrial cancer
4694211|NCT03276000|Misoprostol ,office hysteroscopy|misoprostol ,office hysteroscopy
4694212|NCT03275987|cancer screening|cancer screening
4694213|NCT03275935|ACOS|acos
4694214|NCT03275935|Asthma|asthma
4694215|NCT03275935|COPD|copd
4694216|NCT03275935|inhalation technique|inhalation technique
4694217|NCT03275922|Migraine|migraine
4694218|NCT03275922|Headache|headache
4694219|NCT03275922|Pain|pain
4694220|NCT03275922|Efficacy|efficacy
4694221|NCT03275922|Pediatric|pediatric
4694222|NCT03275909|Chronic schizophrenia|chronic schizophrenia
4694223|NCT03275909|Emotional Management Therapy|emotional management therapy
4694224|NCT03275909|Integrated Psychological Therapy|integrated psychological therapy
4694225|NCT03275844|Physical activity|physical activity
4694226|NCT03275844|Physical capacity|physical capacity
4694227|NCT03275844|Children|children
4694228|NCT03275818|sarcoma|sarcoma
4694229|NCT03275818|Desmoid tumor|desmoid tumor
4694230|NCT03275818|Desmoplastic small round cell tumor|desmoplastic small round cell tumor
4694231|NCT03275818|Ewing sarcoma|ewing sarcoma
4694232|NCT03275818|relapsed|relapsed
4694233|NCT03275818|refractory|refractory
4694234|NCT03275805|Residual dysplasia|residual dysplasia
4694235|NCT03275805|Pavlik Harness|pavlik harness
4694236|NCT03275792|Shiga-Toxigenic Escherichia coli|shiga-toxigenic escherichia coli
4694237|NCT03275792|Child|child
4694238|NCT03275753|Visual function|visual function
4694239|NCT03275753|Critical flicker fusion|critical flicker fusion
4694240|NCT03275753|Dark adaptation|dark adaptation
4694241|NCT03275753|Reading test|reading test
4694242|NCT03275727|Breast Cancer|breast cancer
4694243|NCT03275727|Survivors|survivors
4694244|NCT03275727|Internet intervention|internet intervention
4694245|NCT03275727|Psychosocial intervention|psychosocial intervention
4694246|NCT03275727|Acceptance and Commitment Therapy (ACT)|acceptance and commitment therapy (act)
4694247|NCT03275727|Randomized controlled trial|randomized controlled trial
4694248|NCT03275688|lung cancer|lung cancer
4694249|NCT03275688|volatile organic compound|volatile organic compound
4694250|NCT03275688|screening|screening
4694251|NCT03275688|VOC|voc
4694252|NCT03275688|clinical trial|clinical trial
4694253|NCT03275675|Cancer|cancer
4694254|NCT03275675|Oral chemotherapy|oral chemotherapy
4694255|NCT03275675|Community Pharmacy|community pharmacy
4694256|NCT03275675|Satisfaction|satisfaction
4694257|NCT03275636|Haploidentical|haploidentical
4694258|NCT03275636|mismatched unrelated donor|mismatched unrelated donor
4694259|NCT03275636|hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
4694260|NCT03275636|donor comparison|donor comparison
4694261|NCT03275584|positron emission tomography|positron emission tomography
4694262|NCT03275584|NH3|nh3
4694263|NCT03275571|Cognition|cognition
4694264|NCT03275571|Intervention|intervention
4694265|NCT03275571|Therapy|therapy
4694266|NCT03275558|Nasal Spray|nasal spray
4694267|NCT03275558|Gliosarcoma|gliosarcoma
4694268|NCT03275558|Glioblastoma|glioblastoma
4694269|NCT03275558|Gliomas|gliomas
4694270|NCT03275519|distal hypospadias repair|distal hypospadias repair
4694271|NCT03275519|urinary tract infection|urinary tract infection
4694272|NCT03275519|prophylactic antibiotic use|prophylactic antibiotic use
4694273|NCT03275506|neoadjuvant|neoadjuvant
4694274|NCT03275506|debulking surgery|debulking surgery
4694275|NCT03275493|CD19+ ,CAR-T, CRS|cd19+ ,car-t, crs
4694276|NCT03275454|Autoimmune Diseases|autoimmune diseases
4694277|NCT03275454|Hematologic Diseases|hematologic diseases
4694278|NCT03275454|Immune System Diseases|immune system diseases
4694279|NCT03275454|Blood Platelet Disorders|blood platelet disorders
4694280|NCT03275441|electroretinogram|electroretinogram
4694281|NCT03275441|ERG|erg
4694282|NCT03275441|dark-adaptation|dark-adaptation
4694283|NCT03275441|ophthalmology|ophthalmology
4694284|NCT03275441|electrophysiology|electrophysiology
4694285|NCT03275441|ISCEV|iscev
4694286|NCT03275441|electroretinography|electroretinography
4694287|NCT03275441|scotopic|scotopic
4694288|NCT03275428|THRIVE|thrive
4694289|NCT03275428|Non-intubated thoracic surgery|non-intubated thoracic surgery
4694290|NCT03275415|BPD|bpd
4694291|NCT03275415|surfactant|surfactant
4694292|NCT03275415|budesonide|budesonide
4694293|NCT03275415|respiratory distress syndrome|respiratory distress syndrome
4694294|NCT03275402|Radioimmunotherapy|radioimmunotherapy
4694295|NCT03275402|Neuroblastoma|neuroblastoma
4694296|NCT03275402|CNS Metastases|cns metastases
4694297|NCT03275402|Leptomeningeal Metastases|leptomeningeal metastases
4694298|NCT03275402|Pediatric|pediatric
4694299|NCT03275389|Safety|safety
4694300|NCT03275389|Healthy adults|healthy adults
4694301|NCT03275389|Immunogenicity|immunogenicity
4694302|NCT03275389|Supra-seasonal universal influenza vaccines - inactivated (SUIVs)|supra-seasonal universal influenza vaccines - inactivated (suivs)
4694303|NCT03275363|Subjective cognitive decline|subjective cognitive decline
4694304|NCT03275363|Mild Cognitive Impairment|mild cognitive impairment
4694305|NCT03275363|Dementia|dementia
4694306|NCT03275363|Cerebral aging|cerebral aging
4694307|NCT03275337|Social Phobia|social phobia
4694308|NCT03275337|Anxiety|anxiety
4694309|NCT03275337|Cerebellum|cerebellum
4694310|NCT03275337|rTMS|rtms
4694311|NCT03275337|Neuromodulation|neuromodulation
4694312|NCT03275337|Fear Extinction|fear extinction
4694313|NCT03275311|metastatic breast cancer|metastatic breast cancer
4694314|NCT03275311|observational study|observational study
4694315|NCT03275311|survival|survival
4694316|NCT03275311|real world data|real world data
4694317|NCT03275311|real life setting|real life setting
4694318|NCT03275298|ovarian cancer|ovarian cancer
4694319|NCT03275298|observational study|observational study
4694320|NCT03275298|survival|survival
4694321|NCT03275298|real world data|real world data
4694322|NCT03275298|real life setting|real life setting
4694323|NCT03275259|Shock wave|shock wave
4694324|NCT03275259|Gynoid lipodystrophy|gynoid lipodystrophy
4694325|NCT03275259|Cellulits|cellulits
4694326|NCT03275246|Primary total knee replacement|primary total knee replacement
4694327|NCT03275207|Chronic pain|chronic pain
4694328|NCT03275207|CPSP|cpsp
4694329|NCT03275207|Dexmedetomidine|dexmedetomidine
4694330|NCT03275207|Surgery|surgery
4694331|NCT03275155|Autonomic Dysfunction|autonomic dysfunction
4694332|NCT03275155|Inflammation|inflammation
4694333|NCT03275155|Cognitive impairment|cognitive impairment
4694334|NCT03275155|Interoception|interoception
4694335|NCT03275155|Gait impairment|gait impairment
4694336|NCT03275129|ultrasound assessment|ultrasound assessment
4694337|NCT03275116|Bronchodilation|bronchodilation
4694338|NCT03275116|Hyperinflation|hyperinflation
4694339|NCT03275116|Physical activity|physical activity
4694340|NCT03275116|Sleep quality|sleep quality
4694341|NCT03275090|lipid emulsions; preterm; sepsis|lipid emulsions; preterm; sepsis
4694342|NCT03275077|End stage renal disease|end stage renal disease
4694343|NCT03275077|ESRD|esrd
4694344|NCT03275077|Thromboelastography|thromboelastography
4694345|NCT03275077|Fibrinogen|fibrinogen
4694346|NCT03275064|Articular cartilage, partial thickness cartilage lesion, knee, cartilage|articular cartilage, partial thickness cartilage lesion, knee, cartilage
4694347|NCT03275064|regeneration|regeneration
4694348|NCT03275051|Beta Thalassaemia|beta thalassaemia
4694349|NCT03275051|GSK2696277|gsk2696277
4694350|NCT03275051|Lentiviral vector|lentiviral vector
4694351|NCT03275051|TIGET-BTHAL|tiget-bthal
4694352|NCT03275051|Gene therapy|gene therapy
4694353|NCT03275038|Neuroimage|neuroimage
4694354|NCT03275038|Training|training
4694355|NCT03275038|Aging|aging
4694356|NCT03275038|Brain|brain
4694357|NCT03275038|Cardiovascular risks|cardiovascular risks
4694358|NCT03274960|asymptomati bacteriuria, Griess nitrite test, preterm birth|asymptomati bacteriuria, griess nitrite test, preterm birth
4694359|NCT03274947|Oropharyngeal Dysphagia|oropharyngeal dysphagia
4694360|NCT03274947|Stroke|stroke
4694361|NCT03274934|Adolescents|adolescents
4694362|NCT03274934|Web- and mobile-based intervention|web- and mobile-based intervention
4694363|NCT03274934|Acceptance and Commitment therapy|acceptance and commitment therapy
4694364|NCT03274934|Psychological well-being|psychological well-being
4694365|NCT03274934|Career preparation|career preparation
4694366|NCT03274934|Lifecontrol|lifecontrol
4694367|NCT03274934|Successful educational transitions|successful educational transitions
4694368|NCT03274934|Learning difficulties|learning difficulties
4694369|NCT03274934|Psychological flexibility and mindfulness skills|psychological flexibility and mindfulness skills
4694370|NCT03274921|cardiovascular complications|cardiovascular complications
4694371|NCT03274921|biomarkers|biomarkers
4694372|NCT03274882|metastatic|metastatic
4694373|NCT03274882|colorectal|colorectal
4694374|NCT03274882|cancer|cancer
4694375|NCT03274882|Lonsurf|lonsurf
4694376|NCT03274882|S95005|s95005
4694377|NCT03274882|Russia|russia
4694378|NCT03274869|Scrub typhus|scrub typhus
4694379|NCT03274869|Cardiovascular Complication|cardiovascular complication
4694380|NCT03274830|primary osteoarthritis|primary osteoarthritis
4694381|NCT03274830|secondary osteoarthritis|secondary osteoarthritis
4694382|NCT03274830|femoral head fracture|femoral head fracture
4694383|NCT03274830|necrosis|necrosis
4694384|NCT03274817|Alzheimer's Disease|alzheimer's disease
4694385|NCT03274817|Depression|depression
4694386|NCT03274817|Escitalopram|escitalopram
4694387|NCT03274817|Venlafaxine|venlafaxine
4694388|NCT03274791|COPD|copd
4694389|NCT03274791|smoking|smoking
4694390|NCT03274791|induced sputum|induced sputum
4694391|NCT03274791|clinical features|clinical features
4694392|NCT03274765|ovarian stimulation|ovarian stimulation
4694393|NCT03274765|blood test|blood test
4694897|NCT03271307|testing|testing
4694394|NCT03274765|Medically Assisted Procreation|medically assisted procreation
4694395|NCT03274752|Paroxetine|paroxetine
4694397|NCT03274674|I-PRF|i-prf
4694398|NCT03274674|Microneedle|microneedle
4694399|NCT03274674|Gingival Thickness|gingival thickness
4694400|NCT03274674|Injectable-Platelet-Rich-Fibrin|injectable-platelet-rich-fibrin
4694401|NCT03274674|Platelet Rich Fibrin|platelet rich fibrin
4694402|NCT03274661|solid tumor, Pembrolizumab,|solid tumor, pembrolizumab,
4694403|NCT03274609|Lung diseases|lung diseases
4694404|NCT03274609|cancer|cancer
4694405|NCT03274609|Interventional pulmonology|interventional pulmonology
4694406|NCT03274609|peripheral nodule|peripheral nodule
4694407|NCT03274596|Oxidative Damage|oxidative damage
4694408|NCT03274596|Vitamin E|vitamin e
4694409|NCT03274596|Total Antioxidant Capacity|total antioxidant capacity
4694410|NCT03274596|Retinopathy of Prematurity|retinopathy of prematurity
4694411|NCT03274583|atrial fibrillation|atrial fibrillation
4694412|NCT03274583|smartphone|smartphone
4694413|NCT03274583|detection|detection
4694414|NCT03274557|Achilles, tendinose, tendinopathy, pain|achilles, tendinose, tendinopathy, pain
4694415|NCT03274544|Idiopathic Pulmonary Fibrosis|idiopathic pulmonary fibrosis
4694416|NCT03274544|Chinese Medicine|chinese medicine
4694417|NCT03274544|Herbal Medicine|herbal medicine
4694418|NCT03274518|Hemodialysis|hemodialysis
4694419|NCT03274518|Hemodiafiltration|hemodiafiltration
4694420|NCT03274518|fluid status|fluid status
4694421|NCT03274518|hemodynamics|hemodynamics
4694422|NCT03274479|adenosine receptors|adenosine receptors
4694423|NCT03274479|checkpoint inhibitors|checkpoint inhibitors
4694424|NCT03274479|immune system activator|immune system activator
4694425|NCT03274440|OCD|ocd
4694426|NCT03274440|Marijuana|marijuana
4694427|NCT03274440|THC|thc
4694428|NCT03274440|Cannabis|cannabis
4694429|NCT03274440|CBD|cbd
4694430|NCT03274440|Cannabinoid|cannabinoid
4694431|NCT03274414|squamous cell carcinoma|squamous cell carcinoma
4694432|NCT03274414|esthesioneuroblastoma|esthesioneuroblastoma
4694433|NCT03274414|adenoid cystic carcinoma|adenoid cystic carcinoma
4694434|NCT03274414|adenocarcinoma|adenocarcinoma
4694435|NCT03274414|cisplatin|cisplatin
4694436|NCT03274414|17-442|17-442
4694437|NCT03274401|Atrial fibrillation|atrial fibrillation
4694438|NCT03274401|Pulmonary embolism|pulmonary embolism
4694439|NCT03274401|Screening|screening
4694440|NCT03274375|Anti-NMDAR encephalitis|anti-nmdar encephalitis
4694441|NCT03274375|IA adsorption|ia adsorption
4694442|NCT03274375|Paediatric|paediatric
4694443|NCT03274336|patient satisfaction|patient satisfaction
4694444|NCT03274336|preanesthesia|preanesthesia
4694445|NCT03274336|movie|movie
4694446|NCT03274336|brochure|brochure
4694447|NCT03274336|face-to-face interview|face-to-face interview
4694448|NCT03274310|Influenza|influenza
4694449|NCT03274310|Text message|text message
4694450|NCT03274310|Influenza-like Illness|influenza-like illness
4694451|NCT03274310|Acute Respiratory Infection|acute respiratory infection
4694452|NCT03274284|chemoradiation for|chemoradiation for
4694453|NCT03274284|T1G3 BC|t1g3 bc
4694454|NCT03274271|physical activity|physical activity
4694455|NCT03274271|sedentary behaviour|sedentary behaviour
4694456|NCT03274271|eHealth|ehealth
4694457|NCT03274271|mHealth|mhealth
4694458|NCT03274271|self-regulation|self-regulation
4694459|NCT03274271|behaviour change techniques|behaviour change techniques
4694460|NCT03274271|action planning|action planning
4694461|NCT03274271|coping planning|coping planning
4694462|NCT03274271|self-monitoring|self-monitoring
4694463|NCT03274271|prevention|prevention
4694464|NCT03274258|Renal Medullary Carcinoma|renal medullary carcinoma
4694465|NCT03274258|RMC|rmc
4694466|NCT03274258|Locally advanced or metastatic|locally advanced or metastatic
4694467|NCT03274258|Nivolumab|nivolumab
4694468|NCT03274258|BMS-936558|bms-936558
4694469|NCT03274258|Opdivo|opdivo
4694470|NCT03274258|Ipilimumab|ipilimumab
4694471|NCT03274258|Yervoy|yervoy
4694472|NCT03274258|BMS-734016|bms-734016
4694473|NCT03274258|MDX010|mdx010
4694474|NCT03274245|Public Health|public health
4694475|NCT03274206|Cervical Intraepithelian Neoplasia Grade 2/3|cervical intraepithelian neoplasia grade 2/3
4694476|NCT03274206|CIN 2/3|cin 2/3
4694477|NCT03274206|HPV|hpv
4694478|NCT03274180|Travel consultation|travel consultation
4694479|NCT03274102|Inactivated Enterovirus Type 71 (EV71) Vaccine|inactivated enterovirus type 71 (ev71) vaccine
4694480|NCT03274102|Concomitant vaccination|concomitant vaccination
4694481|NCT03274102|Safety|safety
4694482|NCT03274102|Immunogenicity|immunogenicity
4694483|NCT03274102|Infant|infant
4694484|NCT03274076|diffuse|diffuse
4694485|NCT03274076|scleroderma|scleroderma
4694486|NCT03274076|systemic sclerosis|systemic sclerosis
4694487|NCT03274050|robot|robot
4694488|NCT03274050|surgery|surgery
4694489|NCT03274050|pediatry|pediatry
4694490|NCT03273998|coagulation|coagulation
4694491|NCT03273998|bleeding|bleeding
4694492|NCT03273972|Healthy Volunteers|healthy volunteers
4694493|NCT03273972|Low Density Lipoprotein Cholesterol (LDL)|low density lipoprotein cholesterol (ldl)
4694494|NCT03273972|PCSK9|pcsk9
4694495|NCT03273972|Alirocumab|alirocumab
4694496|NCT03273972|Forearm Blood Flow|forearm blood flow
4694497|NCT03273972|Arterial Stiffness|arterial stiffness
4694993|NCT03270709|Vitamin D3|vitamin d3
4694498|NCT03273972|Carotid Intima Media Thickness|carotid intima media thickness
4694499|NCT03273972|Inflammation|inflammation
4694500|NCT03273972|Endothelial function|endothelial function
4694501|NCT03273959|Physiotherapy|physiotherapy
4694502|NCT03273959|Physical Therapy|physical therapy
4694503|NCT03273959|Exercise|exercise
4694504|NCT03273959|Hospitalization|hospitalization
4694505|NCT03273959|Pediatric|pediatric
4694506|NCT03273959|Adolescents|adolescents
4694507|NCT03273946|CCI18781|cci18781
4694508|NCT03273946|Observational|observational
4694509|NCT03273946|Post-marketing|post-marketing
4694510|NCT03273946|Fluticasone propionate|fluticasone propionate
4694511|NCT03273946|Asthma|asthma
4694512|NCT03273920|laparoscopy-assisted gastrectomy|laparoscopy-assisted gastrectomy
4694513|NCT03273920|robot-assisted gastrectomy|robot-assisted gastrectomy
4694514|NCT03273920|advanced gastric cancer|advanced gastric cancer
4694515|NCT03273920|D2 Lymphadenectomy|d2 lymphadenectomy
4694516|NCT03273907|CyPass Micro-Stent|cypass micro-stent
4694517|NCT03273894|Hypothermia, temperature management|hypothermia, temperature management
4694518|NCT03273881|Gestational diabetes mellitus|gestational diabetes mellitus
4694519|NCT03273881|Pre-gestational diabetes mellitus|pre-gestational diabetes mellitus
4694520|NCT03273881|Treatment|treatment
4694521|NCT03273881|Neonatal hypoglycemia|neonatal hypoglycemia
4694522|NCT03273803|Heart sounds, smartphone, application|heart sounds, smartphone, application
4694523|NCT03273777|Cesarean section|cesarean section
4694524|NCT03273777|Skin incision|skin incision
4694525|NCT03273777|Skewness|skewness
4694526|NCT03273777|Line drawing|line drawing
4694527|NCT03273764|Preterm, RDS, Surfactant, CPAP|preterm, rds, surfactant, cpap
4694528|NCT03273751|Remote Ischemic Preconditioning|remote ischemic preconditioning
4694529|NCT03273751|Partial nephrectomy|partial nephrectomy
4694530|NCT03273751|Acute kidney injury|acute kidney injury
4694531|NCT03273738|type 2 diabetes|type 2 diabetes
4694532|NCT03273738|postmenopausal|postmenopausal
4694533|NCT03273725|Oral Health|oral health
4694534|NCT03273725|Vitamin D|vitamin d
4694535|NCT03273686|Esophageal Cancer|esophageal cancer
4694536|NCT03273686|Nasogastric Tube|nasogastric tube
4694537|NCT03273673|Secondary ACL Injury Prevention|secondary acl injury prevention
4694538|NCT03273673|Visual Biofeedback|visual biofeedback
4694539|NCT03273673|Tactile Biofeedback|tactile biofeedback
4694540|NCT03273634|Palpitations|palpitations
4694541|NCT03273608|Hepatocellular Carcinoma|hepatocellular carcinoma
4694542|NCT03273608|Advanced HCC|advanced hcc
4694543|NCT03273608|Unresectable|unresectable
4694544|NCT03273608|deTACE|detace
4694545|NCT03273608|HepaSphere|hepasphere
4694546|NCT03273517|Glycemia|glycemia
4694547|NCT03273517|Preoperative fasting|preoperative fasting
4694548|NCT03273517|Pediatric patients|pediatric patients
4694549|NCT03273517|Anesthesia|anesthesia
4694550|NCT03273517|Knowledge of the resident|knowledge of the resident
4694551|NCT03273491|self-weighing|self-weighing
4694552|NCT03273491|weight gain|weight gain
4694553|NCT03273491|Ecological Momentary Assessment|ecological momentary assessment
4694554|NCT03273491|mood|mood
4694555|NCT03273491|emerging adulthood|emerging adulthood
4694556|NCT03273491|obesity|obesity
4694557|NCT03273491|eating disorders|eating disorders
4694558|NCT03273478|Bifurcation aneurysm|bifurcation aneurysm
4694559|NCT03273478|Unruptured bifurcation aneurysm|unruptured bifurcation aneurysm
4694560|NCT03273478|Ruptured bifurcation aneurysm|ruptured bifurcation aneurysm
4694561|NCT03273478|Stent-assisted coiling|stent-assisted coiling
4694562|NCT03273478|pCONUS2 Bifurcation Aneurysm Implant|pconus2 bifurcation aneurysm implant
4694564|NCT03273465|Colitis|colitis
4694565|NCT03273465|fecal|fecal
4694566|NCT03273465|FMT|fmt
4694567|NCT03273465|microbiota|microbiota
4694568|NCT03273465|transplantation|transplantation
4694569|NCT03273439|Repetitive transcranial magnetic stimulation|repetitive transcranial magnetic stimulation
4694570|NCT03273439|Negative symptoms|negative symptoms
4694571|NCT03273439|randomized controlled trial|randomized controlled trial
4694572|NCT03273439|Schizophrenia|schizophrenia
4694573|NCT03273439|cognition|cognition
4694574|NCT03273413|Pravastatin|pravastatin
4694575|NCT03273413|Statin|statin
4694576|NCT03273400|Lumbar, Hamstring, Mobilisation|lumbar, hamstring, mobilisation
4694577|NCT03273322|Left atrial appendage closure|left atrial appendage closure
4694578|NCT03273322|Rivaroxaban|rivaroxaban
4694579|NCT03273322|Dual antiplatelet therapy|dual antiplatelet therapy
4694580|NCT03273322|Anticoagulation|anticoagulation
4694581|NCT03273322|Stroke prevention|stroke prevention
4694582|NCT03273296|microbiota|microbiota
4694583|NCT03273296|metabolize|metabolize
4694584|NCT03273257|Pulmonary endarterectomy|pulmonary endarterectomy
4694585|NCT03273257|PEA|pea
4694586|NCT03273257|Medical therapy|medical therapy
4694587|NCT03273218|coronary angiography, diagnostic, transradial, catheter|coronary angiography, diagnostic, transradial, catheter
4694588|NCT03273205|Transcranial direct current stimulation (tDCS)|transcranial direct current stimulation (tdcs)
4694589|NCT03273192|healthy subjects|healthy subjects
4694590|NCT03273192|adalimumab|adalimumab
4694591|NCT03273192|single dose|single dose
4694592|NCT03273192|Phase 1|phase 1
4694593|NCT03273192|PK|pk
4694594|NCT03273179|cerebral venous sinus thrombosis|cerebral venous sinus thrombosis
4694595|NCT03273179|CSF pressure|csf pressure
4694596|NCT03273179|modified Rankin Scale|modified rankin scale
4694597|NCT03273179|papilledema|papilledema
4694598|NCT03273179|NIHSS|nihss
4694599|NCT03273127|Asthma, placebo, abediterol, DPI, corticosteroids|asthma, placebo, abediterol, dpi, corticosteroids
4694600|NCT03273114|back pain|back pain
4694601|NCT03273114|physiotherapy|physiotherapy
4694602|NCT03273114|exercise therapy|exercise therapy
4694603|NCT03273114|cognitive functional therapy|cognitive functional therapy
4694604|NCT03273114|low back pain|low back pain
4694605|NCT03273114|backache|backache
4694606|NCT03273114|lower back pain|lower back pain
4694607|NCT03273114|lumbago|lumbago
4694608|NCT03273114|multidimensional|multidimensional
4694609|NCT03273114|biopsychosocial|biopsychosocial
4694610|NCT03273088|healthy subjects|healthy subjects
4694611|NCT03273088|Pharmacokinetics|pharmacokinetics
4694612|NCT03273088|etanercept|etanercept
4694613|NCT03273088|single dose|single dose
4694614|NCT03273088|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal
4694615|NCT03273075|P2Y12r inhibitor|p2y12r inhibitor
4694616|NCT03273075|Cardiac Arrest|cardiac arrest
4694617|NCT03273075|STEMI|stemi
4694618|NCT03273075|HTPR|htpr
4694619|NCT03273062|Brain Injury|brain injury
4694620|NCT03273062|Traumatic Brain Injury|traumatic brain injury
4694621|NCT03273062|Acquired Brain Injury|acquired brain injury
4694622|NCT03273062|Cognition|cognition
4694623|NCT03273062|Neuropsychiatric Symptopms|neuropsychiatric symptopms
4694624|NCT03273062|COMT|comt
4694625|NCT03272997|Positron emission thomography|positron emission thomography
4694626|NCT03272997|Computed tomography|computed tomography
4694627|NCT03272997|Sensitivity|sensitivity
4694628|NCT03272997|Specificity|specificity
4694629|NCT03272971|lung cancer|lung cancer
4694630|NCT03272971|radiofrequency ablation|radiofrequency ablation
4694631|NCT03272971|bronchoscopy|bronchoscopy
4694632|NCT03272971|NSCLC|nsclc
4694633|NCT03272958|Pruritus|pruritus
4694634|NCT03272958|Bullous pemphigoid|bullous pemphigoid
4694635|NCT03272919|Breast Cancer, Peripheral neuropathy, Taxol, carboplatin|breast cancer, peripheral neuropathy, taxol, carboplatin
4694636|NCT03272906|aphasia|aphasia
4694637|NCT03272906|stroke|stroke
4694638|NCT03272906|tDCS|tdcs
4694639|NCT03272906|language|language
4694640|NCT03272906|stimulation|stimulation
4694641|NCT03272906|brain|brain
4694642|NCT03272906|speech therapy|speech therapy
4694643|NCT03272893|psychoneuroimmunology|psychoneuroimmunology
4694644|NCT03272880|Art Therapy|art therapy
4694645|NCT03272880|Music Therapy|music therapy
4694646|NCT03272815|pneumothorax|pneumothorax
4694647|NCT03272815|chest tube removal|chest tube removal
4694648|NCT03272815|percussion|percussion
4694649|NCT03272802|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
4694650|NCT03272802|Edaravone|edaravone
4694651|NCT03272776|LMA Protector|lma protector
4694652|NCT03272776|Second Generation Laryngeal Masks|second generation laryngeal masks
4694653|NCT03272776|Airway|airway
4694654|NCT03272776|Dual Gastric Acces|dual gastric acces
4694655|NCT03272776|Teleflex|teleflex
4694656|NCT03272776|Supraglottic Devices|supraglottic devices
4694657|NCT03272776|Ambulatory Surgery|ambulatory surgery
4694658|NCT03272737|KAATSU|kaatsu
4694659|NCT03272737|Cardiovascular system|cardiovascular system
4694660|NCT03272737|Elderly|elderly
4694661|NCT03272711|Vortioxetine|vortioxetine
4694662|NCT03272711|Elderly|elderly
4694663|NCT03272711|Online cognitive training|online cognitive training
4694664|NCT03272698|ketamine|ketamine
4694665|NCT03272698|treatment-resistant depression|treatment-resistant depression
4694666|NCT03272698|electroconvulsive therapy|electroconvulsive therapy
4694667|NCT03272685|Reduced nicotine cigarettes|reduced nicotine cigarettes
4694668|NCT03272685|Alternative nicotine products|alternative nicotine products
4694669|NCT03272685|Biomarkers of tobacco exposure|biomarkers of tobacco exposure
4694670|NCT03272659|Fluorescence Sigmoidoscopy|fluorescence sigmoidoscopy
4694671|NCT03272659|PDD|pdd
4694672|NCT03272659|Photodynamic Diagnosis|photodynamic diagnosis
4694673|NCT03272646|Gastric Cancer|gastric cancer
4694674|NCT03272607|Adverse Drug Event|adverse drug event
4694675|NCT03272607|Choosing Wisely Canada|choosing wisely canada
4694676|NCT03272607|Deprescribing|deprescribing
4694677|NCT03272607|Elderly|elderly
4694678|NCT03272607|Frailty|frailty
4694679|NCT03272607|High value healthcare|high value healthcare
4694680|NCT03272607|Medication rationalization|medication rationalization
4694681|NCT03272607|Medication stewardship|medication stewardship
4694682|NCT03272607|Polypharmacy|polypharmacy
4694683|NCT03272594|Neonatal pain|neonatal pain
4694684|NCT03272594|Pediatric pain|pediatric pain
4694685|NCT03272594|Pain assessment|pain assessment
4694686|NCT03272594|Breastfeeding|breastfeeding
4694687|NCT03272594|Sucrose|sucrose
4694688|NCT03272594|Randomized controlled trial|randomized controlled trial
4694689|NCT03272594|Behavioural pain response|behavioural pain response
4694690|NCT03272594|Neurophysiological pain response|neurophysiological pain response
4694691|NCT03272581|Functional|functional
4694692|NCT03272581|Training|training
4694693|NCT03272581|Performance|performance
4694694|NCT03272568|Extended Life Plasma Derived Factor Products|extended life plasma derived factor products
4694695|NCT03272568|Female hemophilia A and B carriers|female hemophilia a and b carriers
4694696|NCT03272568|Menorrhagia|menorrhagia
4694697|NCT03272542|gastric bypass|gastric bypass
4694698|NCT03272542|calcium absorption|calcium absorption
4694699|NCT03272542|postmenopausal women|postmenopausal women
4694700|NCT03272516|Mild to moderate Depression|mild to moderate depression
4694701|NCT03272516|Mild to moderate Anxiety|mild to moderate anxiety
4694702|NCT03272516|Mindfulness based cognitive therapy|mindfulness based cognitive therapy
4694703|NCT03272516|Primary care|primary care
4694704|NCT03272516|PHQ-9|phq-9
4694705|NCT03272516|GAD-7|gad-7
4694706|NCT03272516|Antidepressants|antidepressants
4694707|NCT03272516|Anxiolytica|anxiolytica
4694708|NCT03272516|Subjective wellbeing|subjective wellbeing
4694709|NCT03272503|Pimozide|pimozide
4694710|NCT03272490|locking plate|locking plate
4694711|NCT03272490|anatomical preshaped|anatomical preshaped
4694712|NCT03272490|polyaxial|polyaxial
4694713|NCT03272490|outcome|outcome
4694714|NCT03272477|hormone receptor positive|hormone receptor positive
4694715|NCT03272477|human epidermal growth factor receptor 2 positive|human epidermal growth factor receptor 2 positive
4694716|NCT03272477|Early breast cancer|early breast cancer
4694717|NCT03272477|HR+/HER2+|hr+/her2+
4694718|NCT03272464|Melanoma|melanoma
4694719|NCT03272438|steps|steps
4694720|NCT03272438|goals|goals
4694721|NCT03272386|pelvic floor muscles|pelvic floor muscles
4694722|NCT03272386|instruction|instruction
4694723|NCT03272386|assessment|assessment
4694724|NCT03272386|acceptability|acceptability
4694725|NCT03272386|understanding|understanding
4694726|NCT03272334|Metastatic Breast Cancer|metastatic breast cancer
4694727|NCT03272334|Adoptive Cell Therapy|adoptive cell therapy
4694728|NCT03272334|Armed Activated T-cells|armed activated t-cells
4694729|NCT03272334|Bispecific Antibodies|bispecific antibodies
4694730|NCT03272334|Immunotherapy|immunotherapy
4694731|NCT03272321|biomedical intervention|biomedical intervention
4694732|NCT03272321|oxytocin|oxytocin
4694733|NCT03272321|EEG|eeg
4694734|NCT03272321|skin conductance response|skin conductance response
4694735|NCT03272321|heart rate|heart rate
4694736|NCT03272321|gaze direction|gaze direction
4694737|NCT03272321|eye contact|eye contact
4694738|NCT03272282|WHO PARTOGRAPG.OBSTRUCTED LABOUR. managment of labour|who partograpg.obstructed labour. managment of labour
4694739|NCT03272269|Diabetes Mellitus type 1|diabetes mellitus type 1
4694740|NCT03272269|Autoimmune disease|autoimmune disease
4694741|NCT03272269|Immunotherapy|immunotherapy
4694742|NCT03272269|Diabetes treatment|diabetes treatment
4694743|NCT03272269|Residual beta cell function|residual beta cell function
4694744|NCT03272269|Adult patients|adult patients
4694745|NCT03272243|thoracolumbar fracture|thoracolumbar fracture
4694746|NCT03272243|short segment fixation|short segment fixation
4694747|NCT03272243|long segment fixation|long segment fixation
4694748|NCT03272243|index level|index level
4694749|NCT03272230|Apathy|apathy
4694750|NCT03272230|Goal-directed behavior|goal-directed behavior
4694751|NCT03272230|Assessment|assessment
4694752|NCT03272230|Diagnosis|diagnosis
4694753|NCT03272230|Sensor|sensor
4694754|NCT03272230|Ecological condition|ecological condition
4694755|NCT03272230|Neurological disease|neurological disease
4694756|NCT03272217|Atezolizumab|atezolizumab
4694757|NCT03272217|MPDL3280A|mpdl3280a
4694758|NCT03272217|Bevacizumab|bevacizumab
4694759|NCT03272217|Avastin|avastin
4694760|NCT03272217|Cisplatin-Ineligible|cisplatin-ineligible
4694761|NCT03272217|Anti-PD-L1 Antibodies|anti-pd-l1 antibodies
4694762|NCT03272204|pubic hair; grooming; urinary tract symptoms; vaginitis|pubic hair; grooming; urinary tract symptoms; vaginitis
4694763|NCT03272191|MI|mi
4694764|NCT03272191|Infarction|infarction
4694765|NCT03272191|Infarct|infarct
4694766|NCT03272191|Subacute MI|subacute mi
4694767|NCT03272191|stem cell|stem cell
4694768|NCT03272165|Healthy Volunteers|healthy volunteers
4694769|NCT03272165|Safety|safety
4694770|NCT03272165|Tolerability|tolerability
4694771|NCT03272165|Pharmacokinetics|pharmacokinetics
4694772|NCT03272165|Pharmacodynamics|pharmacodynamics
4694773|NCT03272165|Immunogenicity|immunogenicity
4694774|NCT03272126|vitamin D|vitamin d
4694775|NCT03272100|lateral approach|lateral approach
4694776|NCT03272100|bone augmentation|bone augmentation
4694777|NCT03272100|sinus lift|sinus lift
4694778|NCT03272100|flap|flap
4694779|NCT03272087|Thoracoscopy|thoracoscopy
4694780|NCT03272048|Firearms|firearms
4694781|NCT03272035|General practice|general practice
4694782|NCT03272035|death|death
4694783|NCT03272035|bereavement|bereavement
4694784|NCT03272022|cobalamin, folate|cobalamin, folate
4694785|NCT03271996|Pilonidal sinus|pilonidal sinus
4694786|NCT03271996|Bascom|bascom
4694787|NCT03271996|Cleft lift|cleft lift
4694788|NCT03271996|Fistulectomy|fistulectomy
4694789|NCT03271996|Karydakis|karydakis
4694790|NCT03271918|Pituitary Adenoma|pituitary adenoma
4694791|NCT03271918|Dopaminergic Agonist|dopaminergic agonist
4694792|NCT03271918|Nonfunctioning Pituitary Adenoma|nonfunctioning pituitary adenoma
4694793|NCT03271918|Cabergoline|cabergoline
4694794|NCT03271879|Diabetes|diabetes
4694795|NCT03271879|Heart|heart
4694796|NCT03271879|Arrhythmia|arrhythmia
4694797|NCT03271866|Schizophrenia|schizophrenia
4694798|NCT03271866|Metabolic syndrome|metabolic syndrome
4694799|NCT03271866|Metformin|metformin
4694800|NCT03271866|Cognitive impairment|cognitive impairment
4694801|NCT03271866|Clinical trial|clinical trial
4694802|NCT03271827|Apnoeic oxygenation|apnoeic oxygenation
4694803|NCT03271827|Airway management|airway management
4694804|NCT03271827|Oxygen insufflation|oxygen insufflation
4694805|NCT03271827|Paediatric general anaesthesia|paediatric general anaesthesia
4694806|NCT03271775|Dizziness|dizziness
4694807|NCT03271775|Instability|instability
4694808|NCT03271762|MITRACLIP|mitraclip
4694809|NCT03271762|primary Mitral Regurgitation|primary mitral regurgitation
4694810|NCT03271762|high surgical risks|high surgical risks
4694811|NCT03271749|Fast Track surgical recovery|fast track surgical recovery
4694812|NCT03271749|Surgical recovery|surgical recovery
4694813|NCT03271749|Thoracic surgery|thoracic surgery
4694814|NCT03271736|Parkinson's disease|parkinson's disease
4694815|NCT03271736|Auditory cues|auditory cues
4694816|NCT03271736|step in place|step in place
4694817|NCT03271736|transcranial magnetic stimulation|transcranial magnetic stimulation
4694818|NCT03271736|cortical excitability|cortical excitability
4694819|NCT03271723|cohort studies|cohort studies
4694820|NCT03271723|infant development|infant development
4694821|NCT03271723|pregnancy|pregnancy
4694822|NCT03271723|Brazil|brazil
4694823|NCT03271723|observational studies|observational studies
4694824|NCT03271723|epidemiology|epidemiology
4694825|NCT03271723|maternal health|maternal health
4694826|NCT03271710|Distal embolization|distal embolization
4694827|NCT03271710|Percutaneous transluminal angioplasty|percutaneous transluminal angioplasty
4694828|NCT03271710|Integrated embolic protection|integrated embolic protection
4694829|NCT03271684|stroke, self-management, Bridges, participation, function, self-efficacy|stroke, self-management, bridges, participation, function, self-efficacy
4694830|NCT03271671|neurally adjusted ventilator assist|neurally adjusted ventilator assist
4694831|NCT03271671|Pressure support ventilation|pressure support ventilation
4694832|NCT03271671|non invasive ventilation|non invasive ventilation
4694833|NCT03271671|niv|niv
4694834|NCT03271658|patient decision aid|patient decision aid
4694835|NCT03271658|end-of-life care|end-of-life care
4694836|NCT03271658|shared decision making|shared decision making
4694837|NCT03271658|informed decision|informed decision
4694838|NCT03271658|decision-making|decision-making
4694839|NCT03271658|clinical decision-making|clinical decision-making
4694840|NCT03271658|web-based decision aid|web-based decision aid
4694841|NCT03271658|palliative|palliative
4694842|NCT03271658|critical care|critical care
4694843|NCT03271658|nursing|nursing
4694844|NCT03271645|Depression|depression
4694845|NCT03271645|Anxiety|anxiety
4694846|NCT03271645|Stress|stress
4694847|NCT03271645|Internet-delivered interventions|internet-delivered interventions
4694848|NCT03271632|multiple myeloma|multiple myeloma
4694849|NCT03271632|chimeric antigen receptor|chimeric antigen receptor
4694850|NCT03271632|BCMA|bcma
4694851|NCT03271632|CD38|cd38
4694852|NCT03271632|CD56|cd56
4694853|NCT03271632|CD138|cd138
4694854|NCT03271619|Safety Issues|safety issues
4694855|NCT03271580|Wound healing|wound healing
4694856|NCT03271580|Diabetes|diabetes
4694857|NCT03271580|Inflammatory cells|inflammatory cells
4694858|NCT03271580|Macrophage|macrophage
4694859|NCT03271528|Lacosamide|lacosamide
4694860|NCT03271528|Alcohol craving|alcohol craving
4694861|NCT03271528|Alcohol Urge Questionnaire|alcohol urge questionnaire
4694862|NCT03271528|Obsessive-Compulsive Drinking Scale|obsessive-compulsive drinking scale
4694863|NCT03271515|leukemia|leukemia
4694864|NCT03271515|lymphoma|lymphoma
4694865|NCT03271515|CAR-T|car-t
4694866|NCT03271515|bispecific|bispecific
4694867|NCT03271515|CD20|cd20
4694868|NCT03271515|CD19|cd19
4694869|NCT03271489|Elagolix Sodium|elagolix sodium
4694870|NCT03271489|Heavy Menstrual Bleeding (HMB)|heavy menstrual bleeding (hmb)
4694871|NCT03271489|Heavy Uterine Bleeding|heavy uterine bleeding
4694872|NCT03271489|Leiomyomata|leiomyomata
4694873|NCT03271489|Menorrhagia|menorrhagia
4694874|NCT03271489|Elagolix + Norethindrone Acetate|elagolix + norethindrone acetate
4694875|NCT03271489|Elagolix + E2/NETA|elagolix + e2/neta
4694876|NCT03271489|Elagolix|elagolix
4694877|NCT03271489|Safety|safety
4694878|NCT03271489|Efficacy|efficacy
4694879|NCT03271489|ABT-620|abt-620
4694880|NCT03271476|Breast Cancer|breast cancer
4694881|NCT03271476|EMDR|emdr
4694882|NCT03271463|stroke|stroke
4694883|NCT03271463|selective voluntary motor control|selective voluntary motor control
4694884|NCT03271450|dabigatran|dabigatran
4694885|NCT03271450|warfarin|warfarin
4694886|NCT03271450|apixaban|apixaban
4694887|NCT03271450|edoxaban|edoxaban
4694888|NCT03271450|extended treatment|extended treatment
4694889|NCT03271450|oral anticoagulant|oral anticoagulant
4694890|NCT03271450|rivaroxaban|rivaroxaban
4694891|NCT03271450|comparative safety|comparative safety
4694892|NCT03271450|comparative effectiveness|comparative effectiveness
4694893|NCT03271385|hypertrophic Cardiomyopathy|hypertrophic cardiomyopathy
4694894|NCT03271385|hypertensive Heart Disease|hypertensive heart disease
4694895|NCT03271385|cardiac magnetic resonance|cardiac magnetic resonance
4694898|NCT03271307|cost-effectiveness|cost-effectiveness
4694899|NCT03271294|pelvic organ prolapse|pelvic organ prolapse
4694900|NCT03271294|Exair|exair
4694901|NCT03271294|Transvaginal mesh|transvaginal mesh
4694902|NCT03271281|68Ga-NODAGA-E[c(RGDyK)]2|68ga-nodaga-e[c(rgdyk)]2
4694903|NCT03271281|Angiogenesis PET/CT|angiogenesis pet/ct
4694904|NCT03271281|Neuroendocrine tumors|neuroendocrine tumors
4694905|NCT03271268|Vascular filling|vascular filling
4694906|NCT03271268|Fluid overload|fluid overload
4694907|NCT03271268|Biomarkers|biomarkers
4694908|NCT03271268|Lung edema|lung edema
4694909|NCT03271255|apatinib|apatinib
4694910|NCT03271255|bevacizumab|bevacizumab
4694911|NCT03271255|FOLFIRI|folfiri
4694912|NCT03271255|colorectal cancer|colorectal cancer
4694913|NCT03271229|Platelet rich plasma|platelet rich plasma
4694914|NCT03271229|bone marrow|bone marrow
4694915|NCT03271229|stem cell|stem cell
4694916|NCT03271203|Michigan Hand Outcomes Questionnaire|michigan hand outcomes questionnaire
4694917|NCT03271203|Real-time data capture|real-time data capture
4694918|NCT03271203|Cognitive debriefing|cognitive debriefing
4694919|NCT03271203|Hand Osteoarthritis|hand osteoarthritis
4694920|NCT03271203|Concept elicitation|concept elicitation
4694921|NCT03271190|aging|aging
4694922|NCT03271190|memory complaint|memory complaint
4694923|NCT03271177|transradial percutaneous coronary intervention|transradial percutaneous coronary intervention
4694924|NCT03271138|Celiac Disease|celiac disease
4694925|NCT03271138|Gluten-Free Diet|gluten-free diet
4694926|NCT03271138|Bifidobacterium infantis NLS super strain|bifidobacterium infantis nls super strain
4694927|NCT03271138|gastrointestinal symptoms|gastrointestinal symptoms
4694928|NCT03271138|quality of life|quality of life
4694929|NCT03271138|microbiota|microbiota
4694930|NCT03271138|IgA TTG|iga ttg
4694931|NCT03271138|IgA DGP|iga dgp
4694932|NCT03271125|Intervention|intervention
4694933|NCT03271125|Multiple sclerosis|multiple sclerosis
4694934|NCT03271125|Treadmill|treadmill
4694935|NCT03271125|Mobility|mobility
4694936|NCT03271099|survivorship; navigation|survivorship; navigation
4694937|NCT03271086|Relaxation training|relaxation training
4694938|NCT03271086|Pediatric clinic|pediatric clinic
4694939|NCT03271086|Children 6-11 years|children 6-11 years
4694940|NCT03271086|Text messaging|text messaging
4694941|NCT03271073|gastric cancer|gastric cancer
4694942|NCT03271073|gastroesophageal junction cancer|gastroesophageal junction cancer
4694943|NCT03271073|Apatinib|apatinib
4694944|NCT03271073|S1|s1
4694945|NCT03271047|cancer|cancer
4694946|NCT03271034|Lipedema|lipedema
4694947|NCT03271034|Metabolism|metabolism
4694948|NCT03271034|Body Composition|body composition
4694949|NCT03271034|Fat Distribution|fat distribution
4694950|NCT03271034|Immunology|immunology
4694951|NCT03270995|breast cancer|breast cancer
4694952|NCT03270995|gynecological cancer|gynecological cancer
4694953|NCT03270995|fear of cancer recurrence|fear of cancer recurrence
4694954|NCT03270995|clinical trial|clinical trial
4694955|NCT03270995|randomized controlled trial|randomized controlled trial
4694956|NCT03270995|group therapy|group therapy
4694957|NCT03270995|intervention|intervention
4694958|NCT03270995|cognitive-existential|cognitive-existential
4694959|NCT03270982|Non Inflammatory Degenerative Joint Disease|non inflammatory degenerative joint disease
4694960|NCT03270982|Rheumatoid Arthritis|rheumatoid arthritis
4694961|NCT03270982|Revision where other devices have failed|revision where other devices have failed
4694962|NCT03270982|Correction of functional deformity|correction of functional deformity
4694963|NCT03270982|Oncology Applications|oncology applications
4694964|NCT03270982|Treatment of acute or Chronic fractures|treatment of acute or chronic fractures
4694965|NCT03270930|Operative duration|operative duration
4694966|NCT03270930|Pediatric surgery|pediatric surgery
4694967|NCT03270930|Emergency laparotomy|emergency laparotomy
4694968|NCT03270930|Mortality rate|mortality rate
4694969|NCT03270930|Survival|survival
4694970|NCT03270930|Kaplan-Meier analysis|kaplan-meier analysis
4694971|NCT03270930|ROC curve analysis|roc curve analysis
4694972|NCT03270930|Senior resident|senior resident
4694973|NCT03270917|Parenchymal preserving|parenchymal preserving
4694974|NCT03270917|Postero-superior|postero-superior
4694975|NCT03270917|Laparoscopy|laparoscopy
4694976|NCT03270891|Pharmacogenomics|pharmacogenomics
4694977|NCT03270891|Primary care physicians|primary care physicians
4694978|NCT03270878|Glasdegib|glasdegib
4694979|NCT03270878|PF-04449913|pf-04449913
4694980|NCT03270878|Pharmacokinetics|pharmacokinetics
4694981|NCT03270878|Bioavailability|bioavailability
4694982|NCT03270813|Child|child
4694983|NCT03270813|Adolescent|adolescent
4694984|NCT03270787|Acute Mountain sickness|acute mountain sickness
4694985|NCT03270787|Compound Danshen Dripping Pills|compound danshen dripping pills
4694986|NCT03270748|Allogeneic hematopoietic stem cell transplantation|allogeneic hematopoietic stem cell transplantation
4694987|NCT03270748|acute graft-versus-host disease|acute graft-versus-host disease
4694988|NCT03270748|Unrelated donors|unrelated donors
4694989|NCT03270748|Post-transplant cyclophosphamide|post-transplant cyclophosphamide
4694990|NCT03270748|Myeloid Malignancies|myeloid malignancies
4694991|NCT03270748|unrelated hematopoietic cell transplantation|unrelated hematopoietic cell transplantation
4694992|NCT03270748|GITMO|gitmo
4694994|NCT03270709|Pulmonary disease|pulmonary disease
4694995|NCT03270709|Immunosuppression|immunosuppression
4694996|NCT03270709|HIV|hiv
4694997|NCT03270709|Smoking|smoking
4694998|NCT03270683|Out-of-hospital cardiac arrest|out-of-hospital cardiac arrest
4694999|NCT03270683|transcranial Doppler sonography|transcranial doppler sonography
4695000|NCT03270683|cerebrovascular circulation|cerebrovascular circulation
4695001|NCT03270683|prognosis|prognosis
4695002|NCT03270657|Deep Brain Stimulation|deep brain stimulation
4695003|NCT03270592|Service dogs|service dogs
4695004|NCT03270592|Alert dogs|alert dogs
4695005|NCT03270592|Costs|costs
4695006|NCT03270592|Quality of Life|quality of life
4695007|NCT03270592|Cost-effectiveness|cost-effectiveness
4695008|NCT03270566|Water hardness|water hardness
4695009|NCT03270566|Atopic eczema prevention|atopic eczema prevention
4695010|NCT03270566|Skin barrier function|skin barrier function
4695011|NCT03270566|Skin microbiome|skin microbiome
4695012|NCT03270527|Dietary fat modification|dietary fat modification
4695013|NCT03270527|Lipids|lipids
4695014|NCT03270527|LDL cholesterol|ldl cholesterol
4695015|NCT03270527|Dietary fatty acids|dietary fatty acids
4695016|NCT03270527|Saturated fat|saturated fat
4695017|NCT03270514|cardiac surgery|cardiac surgery
4695018|NCT03270514|sternotomy|sternotomy
4695019|NCT03270514|post-operative pain|post-operative pain
4695020|NCT03270514|sternal wound infiltration|sternal wound infiltration
4695021|NCT03270488|Thumb|thumb
4695022|NCT03270488|Osteoarthritis|osteoarthritis
4695023|NCT03270488|Physical Therapy|physical therapy
4695024|NCT03270488|Pain|pain
4695025|NCT03270449|fibromyalgia|fibromyalgia
4695026|NCT03270449|community-based|community-based
4695027|NCT03270449|multidisciplinary|multidisciplinary
4695028|NCT03270410|neonates|neonates
4695029|NCT03270410|non invasive monitoring|non invasive monitoring
4695030|NCT03270397|Self Esteem|self esteem
4695031|NCT03270397|Body Image|body image
4695032|NCT03270397|Eating disorders|eating disorders
4695033|NCT03270384|early feasibility|early feasibility
4695034|NCT03270384|non-randomized|non-randomized
4695035|NCT03270345|Decubitus|decubitus
4695036|NCT03270345|Pressure|pressure
4695037|NCT03270345|Ulcer|ulcer
4695038|NCT03270345|Injuries|injuries
4695039|NCT03270345|Sores|sores
4695040|NCT03270345|Intensive care|intensive care
4695041|NCT03270319|Measurement of cardiac output|measurement of cardiac output
4695042|NCT03270280|Chronic Periodontitis|chronic periodontitis
4695043|NCT03270280|Phytomedicines|phytomedicines
4695044|NCT03270280|Nigella sativa|nigella sativa
4695045|NCT03270241|Vitiligo|vitiligo
4695046|NCT03270241|Dermatology|dermatology
4695047|NCT03270241|Johns Hopkins|johns hopkins
4695048|NCT03270241|Compensation|compensation
4695049|NCT03270241|Paid|paid
4695050|NCT03270241|Phototherapy|phototherapy
4695051|NCT03270241|NB-UVB|nb-uvb
4695052|NCT03270241|Light treatment|light treatment
4695053|NCT03270241|Skin|skin
4695054|NCT03270241|Biopsies|biopsies
4695055|NCT03270241|Money|money
4695056|NCT03270241|Short-term|short-term
4695057|NCT03270228|Incidence of cancer|incidence of cancer
4695058|NCT03270228|Survival|survival
4695059|NCT03270215|Computed Tomography|computed tomography
4695060|NCT03270215|Specificity|specificity
4695061|NCT03270215|Sensitivity|sensitivity
4695062|NCT03270202|Exercise|exercise
4695063|NCT03270202|Cardiorespiratory fitness|cardiorespiratory fitness
4695064|NCT03270202|Risk factors|risk factors
4695065|NCT03270202|Monitoring, physiologic|monitoring, physiologic
4695066|NCT03270202|Monitoring, ambulatory|monitoring, ambulatory
4695067|NCT03270202|Prognosis|prognosis
4695068|NCT03270202|Norway|norway
4695069|NCT03270163|Intensive care unit acquired muscle weakness|intensive care unit acquired muscle weakness
4695070|NCT03270163|Transcutaneous electrical stimulation|transcutaneous electrical stimulation
4695071|NCT03270137|Alzheimer Disease|alzheimer disease
4695072|NCT03270137|rTMS|rtms
4695073|NCT03270137|Cognition|cognition
4695074|NCT03270137|Behavioral Symptoms|behavioral symptoms
4695075|NCT03270137|Functionality|functionality
4695076|NCT03270124|Aortic Valve Stenosis|aortic valve stenosis
4695077|NCT03270124|Fitbit|fitbit
4695078|NCT03270124|iPAD|ipad
4695079|NCT03270124|Physical Exercises|physical exercises
4695080|NCT03270124|Quality of Life|quality of life
4695081|NCT03270111|breast cancer survivor|breast cancer survivor
4695082|NCT03270111|weight loss program|weight loss program
4695083|NCT03270098|Schizophrenia|schizophrenia
4695084|NCT03270098|Aerobic Exercise|aerobic exercise
4695085|NCT03270098|Cognition|cognition
4695086|NCT03270098|Daily Functioning|daily functioning
4695087|NCT03270098|Biomarkers|biomarkers
4695088|NCT03270098|Brain Derived Neurotrophic Factor|brain derived neurotrophic factor
4695089|NCT03270046|Bowel preparation|bowel preparation
4695090|NCT03270046|CRC screening|crc screening
4695091|NCT03270033|Shoulder Joint|shoulder joint
4695092|NCT03270033|Arthroscopy|arthroscopy
4695093|NCT03270033|Ambulatory surgical procedures|ambulatory surgical procedures
4695094|NCT03270033|Pain, Postoperative|pain, postoperative
4695095|NCT03270033|Brachial Plexus Block|brachial plexus block
4695096|NCT03270033|Corticosteroid|corticosteroid
4695097|NCT03270033|Dexamethasone|dexamethasone
4695098|NCT03270033|Dexmedetomidine|dexmedetomidine
4695099|NCT03270033|Bupivacaine|bupivacaine
4695100|NCT03270033|Alpha 2 agonist|alpha 2 agonist
4695101|NCT03270033|Postoperative analgesia|postoperative analgesia
4695102|NCT03270020|treatment|treatment
4695103|NCT03270020|denosumab|denosumab
4695104|NCT03270020|Positron Emission Tomography (PET) CT scan|positron emission tomography (pet) ct scan
4695105|NCT03269994|pancreatoduodenectomy|pancreatoduodenectomy
4695106|NCT03269994|17-418|17-418
4695107|NCT03269994|cefoxitin|cefoxitin
4695108|NCT03269994|piperacillin-tazobactam|piperacillin-tazobactam
4695109|NCT03269981|Adjuvant radiotherapy|adjuvant radiotherapy
4695110|NCT03269981|Lymphatic irradiation|lymphatic irradiation
4695111|NCT03269981|Taxane|taxane
4695112|NCT03269981|Anthracycline|anthracycline
4695113|NCT03269981|Prospective study|prospective study
4695114|NCT03269942|Intracranial Aneurysm|intracranial aneurysm
4695115|NCT03269942|Flow Diverter|flow diverter
4695116|NCT03269942|Cerebral Revascularization|cerebral revascularization
4695117|NCT03269851|neurological deficit|neurological deficit
4695118|NCT03269799|uncontrolled type 2 diabetes mellitus|uncontrolled type 2 diabetes mellitus
4695119|NCT03269799|periodontitis|periodontitis
4695120|NCT03269799|non surgical periodontal treatment|non surgical periodontal treatment
4695121|NCT03269799|vitamin C|vitamin c
4695122|NCT03269773|Atopic Dermatitis|atopic dermatitis
4695123|NCT03269773|Stem cell|stem cell
4695124|NCT03269773|Cell therapy|cell therapy
4695125|NCT03269773|skin disease|skin disease
4695126|NCT03269773|Umbilical cord Blood|umbilical cord blood
4695127|NCT03269773|UCB-MSC|ucb-msc
4695128|NCT03269773|hUCB-MSC|hucb-msc
4695130|NCT03269773|furestem|furestem
4695131|NCT03269773|dermatitis|dermatitis
4695132|NCT03269773|eczema|eczema
4695133|NCT03269747|glucocorticoids|glucocorticoids
4695134|NCT03269747|brown adipose tissue|brown adipose tissue
4695135|NCT03269747|cold induced thermogenesis|cold induced thermogenesis
4695136|NCT03269734|Vascular Diseases|vascular diseases
4695137|NCT03269734|Cerebrovascular Diseases|cerebrovascular diseases
4695138|NCT03269734|Cardiovascular Diseases|cardiovascular diseases
4695139|NCT03269734|Aortic aneurysm|aortic aneurysm
4695140|NCT03269734|Arteriovenous malformations|arteriovenous malformations
4695141|NCT03269734|Catheterization|catheterization
4695142|NCT03269721|Cognition|cognition
4695143|NCT03269721|Pulmonary|pulmonary
4695144|NCT03269721|COPD|copd
4695145|NCT03269721|Lung|lung
4695146|NCT03269656|Vitamin D|vitamin d
4695147|NCT03269656|Cancer|cancer
4695148|NCT03269656|Survival|survival
4695149|NCT03269617|dysbiosis|dysbiosis
4695150|NCT03269617|gut microbiota|gut microbiota
4695151|NCT03269617|bacteriophage|bacteriophage
4695152|NCT03269617|irritable bowel syndrome|irritable bowel syndrome
4695153|NCT03269617|gastrointestinal distress|gastrointestinal distress
4695154|NCT03269617|prebiotic|prebiotic
4695155|NCT03269604|Urological Surgery|urological surgery
4695156|NCT03269604|Bacterial resistance|bacterial resistance
4695157|NCT03269591|Dysmenorrhea|dysmenorrhea
4695158|NCT03269591|Pulsed electromagnetic field|pulsed electromagnetic field
4695159|NCT03269591|Diclofenac|diclofenac
4695160|NCT03269578|Pharmacodynamics|pharmacodynamics
4695161|NCT03269578|Tissue Collection|tissue collection
4695162|NCT03269578|Tissue Biopsies|tissue biopsies
4695163|NCT03269578|Biospecimen|biospecimen
4695164|NCT03269578|Assay Development|assay development
4695165|NCT03269526|Pancreatic Cancer|pancreatic cancer
4695166|NCT03269526|Pancreatic Adenocarcinoma|pancreatic adenocarcinoma
4695167|NCT03269526|Adoptive cell therapy|adoptive cell therapy
4695168|NCT03269526|Armed activated T-cells|armed activated t-cells
4695169|NCT03269526|Bispecific antibody|bispecific antibody
4695170|NCT03269526|Immunotherapy|immunotherapy
4695171|NCT03269474|epidermolysis bullosa simplex|epidermolysis bullosa simplex
4695172|NCT03269474|genetic expression|genetic expression
4695173|NCT03269474|drug repurposing|drug repurposing
4695174|NCT03269474|computational approaches|computational approaches
4695175|NCT03269474|drug discovery|drug discovery
4695176|NCT03269461|stent, DES, INSPIRON, OCT, tissue repair|stent, des, inspiron, oct, tissue repair
4695177|NCT03269448|partial pressure of carbon dioxide|partial pressure of carbon dioxide
4695178|NCT03269448|carbon dioxide|carbon dioxide
4695179|NCT03269448|peripheral venous blood|peripheral venous blood
4695180|NCT03269448|central venous blood|central venous blood
4695181|NCT03269448|venous blood gas|venous blood gas
4695182|NCT03269448|blood gas analysis|blood gas analysis
4695183|NCT03269422|17-407|17-407
4695184|NCT03269422|Intermediate Risk Prostate Cancer|intermediate risk prostate cancer
4695185|NCT03269422|DIL|dil
4695186|NCT03269422|Dominant Intra-Prostatic Lesion|dominant intra-prostatic lesion
4695187|NCT03269396|severe laryngotracheal dysfunction|severe laryngotracheal dysfunction
4695188|NCT03269383|stellate ganglion block|stellate ganglion block
4695189|NCT03269383|cardiac surgery|cardiac surgery
4695190|NCT03269383|atrial fibrillation|atrial fibrillation
4695191|NCT03269370|CBT|cbt
4695192|NCT03269370|Self-Help|self-help
4695193|NCT03269370|Family|family
4695194|NCT03269357|LARC|larc
4695195|NCT03269357|contraception|contraception
4695196|NCT03269357|counselling|counselling
4695197|NCT03269357|unplanned pregnancy|unplanned pregnancy
4695198|NCT03269331|nursing practice|nursing practice
4695199|NCT03269331|evidence-based practice models|evidence-based practice models
4695200|NCT03269331|military nursing|military nursing
4695201|NCT03269331|clinical inquiry|clinical inquiry
4695202|NCT03269266|Scrub Typhus|scrub typhus
4695203|NCT03269266|Positive Rapid Diagnostic Test|positive rapid diagnostic test
4695204|NCT03269253|ALSPAC|alspac
4695205|NCT03269253|longitudinal|longitudinal
4695206|NCT03269227|Malignant Pleural Mesothelioma|malignant pleural mesothelioma
4695207|NCT03269227|Radiotherapy|radiotherapy
4695208|NCT03269227|Tomotherapy|tomotherapy
4695209|NCT03269227|Hypofractionation|hypofractionation
4695210|NCT03269214|osteonecrosis|osteonecrosis
4695211|NCT03269214|mandible|mandible
4695212|NCT03269201|parkinsonism|parkinsonism
4695213|NCT03269201|ataxia|ataxia
4695214|NCT03269201|tremor|tremor
4695215|NCT03269201|dystonia|dystonia
4695216|NCT03269175|Clinically Isolated Syndrome suggestive of Multiple Sclerosis or Multiple Sclerosis|clinically isolated syndrome suggestive of multiple sclerosis or multiple sclerosis
4695217|NCT03269149|Alzheimer's disease|alzheimer's disease
4695218|NCT03269149|African-American Women|african-american women
4695219|NCT03269149|Caregivers|caregivers
4695220|NCT03269149|Tango|tango
4695221|NCT03269149|Dance-based intervention|dance-based intervention
4695222|NCT03269136|Multiple Myeloma|multiple myeloma
4695223|NCT03269136|relapse/ refractory multiple myeloma|relapse/ refractory multiple myeloma
4695224|NCT03269136|bispecific antibody|bispecific antibody
4695225|NCT03269136|bispecific|bispecific
4695226|NCT03269136|BCMA|bcma
4695227|NCT03269136|BCMA- CD3 bispecific|bcma- cd3 bispecific
4695228|NCT03269136|Phase 1|phase 1
4695229|NCT03269136|PF-06863135|pf-06863135
4695230|NCT03269123|Sensory trick|sensory trick
4695231|NCT03269123|Geste Antagoniste|geste antagoniste
4695232|NCT03269110|neurological|neurological
4695233|NCT03269110|autism|autism
4695234|NCT03269110|ASD|asd
4695235|NCT03269110|behaviour|behaviour
4695236|NCT03269110|folic acid|folic acid
4695237|NCT03269110|pre-eclampsia|pre-eclampsia
4695238|NCT03269110|asthma|asthma
4695239|NCT03269110|executive function|executive function
4695240|NCT03269071|Multiple Sclerosis|multiple sclerosis
4695241|NCT03269071|Cell Therapy|cell therapy
4695242|NCT03269071|Human Neural Stem Cells|human neural stem cells
4695243|NCT03269032|Mediterranean diet|mediterranean diet
4695244|NCT03269032|gut microbiome|gut microbiome
4695245|NCT03269032|gastrointestinal|gastrointestinal
4695246|NCT03269019|Heparin-induced thrombocytopenia|heparin-induced thrombocytopenia
4695247|NCT03269019|Thrombosis|thrombosis
4695248|NCT03269019|thrombin-antithrombin|thrombin-antithrombin
4695249|NCT03269019|d-dimer|d-dimer
4695250|NCT03269019|Thrombelastograghy|thrombelastograghy
4695251|NCT03269006|Visceral leishmaniasis|visceral leishmaniasis
4695252|NCT03269006|Vector control|vector control
4695253|NCT03269006|Sand fly,|sand fly,
4695254|NCT03269006|Bangladesh|bangladesh
4695255|NCT03268993|prevention|prevention
4695256|NCT03268993|dietary supplement|dietary supplement
4695257|NCT03268993|broccoli|broccoli
4695258|NCT03268967|intensive care|intensive care
4695259|NCT03268967|crisis resource management|crisis resource management
4695260|NCT03268967|simulation training|simulation training
4695261|NCT03268967|before and after study|before and after study
4695262|NCT03268954|Drug therapy|drug therapy
4695263|NCT03268941|Drug therapy|drug therapy
4695264|NCT03268928|Shared Book Reading|shared book reading
4695265|NCT03268928|Language Development|language development
4695266|NCT03268928|Syntax|syntax
4695267|NCT03268928|Vocabulary|vocabulary
4695268|NCT03268928|Phonological Awareness|phonological awareness
4695269|NCT03268928|Young Children|young children
4695270|NCT03268928|Randomised Control Trial|randomised control trial
4695271|NCT03268928|Language Intervention|language intervention
4695272|NCT03268915|Idiopathic pulmonary fibrosis|idiopathic pulmonary fibrosis
4695273|NCT03268915|3 minutes sit-to-stand test|3 minutes sit-to-stand test
4695274|NCT03268915|Interindividual reproductibility|interindividual reproductibility
4695275|NCT03268889|Chidamide, CHOP regimen|chidamide, chop regimen
4695276|NCT03268876|Epithelial ovarian cancer|epithelial ovarian cancer
4695277|NCT03268876|Surgery|surgery
4695278|NCT03268876|Quality of life|quality of life
4695279|NCT03268863|pain tolerance|pain tolerance
4695280|NCT03268863|perioperative pain|perioperative pain
4695281|NCT03268863|virtual reality therapy|virtual reality therapy
4695282|NCT03268850|LDKT|ldkt
4695283|NCT03268850|Live donor transplantation|live donor transplantation
4695284|NCT03268850|Kidney transplantation|kidney transplantation
4695285|NCT03268798|stroke|stroke
4695286|NCT03268798|strength training|strength training
4695287|NCT03268798|rehabilitation|rehabilitation
4695288|NCT03268785|Parathyroid glands|parathyroid glands
4695289|NCT03268785|Needle puncture|needle puncture
4695290|NCT03268785|Diff-quik staining|diff-quik staining
4695291|NCT03268785|PTH test assay|pth test assay
4695292|NCT03268785|Thyroid cancer|thyroid cancer
4695293|NCT03268759|substance abuse|substance abuse
4695294|NCT03268733|Folic acid|folic acid
4695295|NCT03268733|PCOS|pcos
4695296|NCT03268733|Insulin resistance|insulin resistance
4695297|NCT03268733|Infertility|infertility
4695298|NCT03268720|gluten sensitivity|gluten sensitivity
4695299|NCT03268720|gluten-free diet|gluten-free diet
4695300|NCT03268720|FODMAP diet|fodmap diet
4695301|NCT03268720|microbiome|microbiome
4695302|NCT03268707|Paroxysmal Atrial Fibrillation|paroxysmal atrial fibrillation
4695303|NCT03268707|Pulmonary Vein Isolation|pulmonary vein isolation
4695304|NCT03268707|Telemetry Monitoring|telemetry monitoring
4695305|NCT03268707|Cryoballoon ablation|cryoballoon ablation
4695306|NCT03268655|gingerol|gingerol
4695307|NCT03268655|microbiome|microbiome
4695308|NCT03268655|gut|gut
4695309|NCT03268655|ginger|ginger
4695310|NCT03268642|Fulminant Myocarditis|fulminant myocarditis
4695311|NCT03268642|Retrospective cohort study|retrospective cohort study
4695312|NCT03268629|Insomnia|insomnia
4695313|NCT03268629|Mindfulness-based Intervention|mindfulness-based intervention
4695314|NCT03268629|Mindfulness Meditation|mindfulness meditation
4695315|NCT03268629|Tai Chi|tai chi
4695316|NCT03268629|Inflammation|inflammation
4695317|NCT03268629|NF-κB|nf-κb
4695318|NCT03268616|neural respiratory drive|neural respiratory drive
4695319|NCT03268616|noninvasive positive pressure ventilation|noninvasive positive pressure ventilation
4695320|NCT03268616|electromyography|electromyography
4695321|NCT03268590|Hyperoxia|hyperoxia
4695322|NCT03268590|Hypoxia, Brain|hypoxia, brain
4695323|NCT03268512|leucocyte- and platelet rich fibrin|leucocyte- and platelet rich fibrin
4695324|NCT03268512|ridge preservation|ridge preservation
4695325|NCT03268512|growth factors|growth factors
4695326|NCT03268512|platelet concentrates|platelet concentrates
4695327|NCT03268486|Fetal monitoring|fetal monitoring
4695328|NCT03268486|cardiotocography|cardiotocography
4695329|NCT03268473|OSAS|osas
4695330|NCT03268473|Obstructive Sleep Apnea|obstructive sleep apnea
4695331|NCT03268473|Periodontitis|periodontitis
4695332|NCT03268434|Depression|depression
4695333|NCT03268434|Metacognition|metacognition
4695334|NCT03268434|CBT|cbt
4695335|NCT03268434|D-MCT|d-mct
4695336|NCT03268434|cognitive bias|cognitive bias
4695337|NCT03268421|juvenile fibromyalgia|juvenile fibromyalgia
4695338|NCT03268421|pain in children|pain in children
4695339|NCT03268421|musculoskeletal pain|musculoskeletal pain
4695340|NCT03268421|cognitive behavioral therapy|cognitive behavioral therapy
4695341|NCT03268421|coping skills training|coping skills training
4695342|NCT03268421|neuromuscular exercise|neuromuscular exercise
4695343|NCT03268421|graded aerobic exercise|graded aerobic exercise
4695344|NCT03268408|community intervention|community intervention
4695345|NCT03268408|newsletter|newsletter
4695346|NCT03268382|Ovarian Cancer|ovarian cancer
4695347|NCT03268382|Ovarian Carcinoma|ovarian carcinoma
4695348|NCT03268382|High Grade Serous Ovarian Cancer|high grade serous ovarian cancer
4695349|NCT03268382|Recurrent Cancer|recurrent cancer
4695350|NCT03268382|Resistant Cancer|resistant cancer
4695351|NCT03268304|Upper Limb Motor Function Deficit|upper limb motor function deficit
4695352|NCT03268304|Neurorehabilitation|neurorehabilitation
4695353|NCT03268304|Virtual Reality|virtual reality
4695354|NCT03268304|Action Research Arm Test|action research arm test
4695355|NCT03268291|Adherence to therapy|adherence to therapy
4695356|NCT03268291|Myocardial Infarction|myocardial infarction
4695357|NCT03268291|Coronary Artery Disease|coronary artery disease
4695358|NCT03268291|Communicational program|communicational program
4695359|NCT03268278|analgesia|analgesia
4695360|NCT03268278|endodontic|endodontic
4695361|NCT03268278|postoperative|postoperative
4695362|NCT03268187|Cognitive Fatigue|cognitive fatigue
4695363|NCT03268187|Multiple Sclerosis|multiple sclerosis
4695364|NCT03268187|Biofeedback|biofeedback
4695365|NCT03268187|Self-Alert Training|self-alert training
4695366|NCT03268187|Vigilance|vigilance
4695367|NCT03268187|Autonomic potentials|autonomic potentials
4695368|NCT03268161|anti-MAG neuropathy|anti-mag neuropathy
4695369|NCT03268161|Waldenström disease|waldenström disease
4695370|NCT03268161|Mutational analysis|mutational analysis
4695371|NCT03268148|neonates|neonates
4695372|NCT03268148|pain|pain
4695373|NCT03268148|low level laser|low level laser
4695374|NCT03268135|miRNA|mirna
4695375|NCT03268135|lncRNAs|lncrnas
4695376|NCT03268135|transcriptome|transcriptome
4695377|NCT03268135|heart failure|heart failure
4695378|NCT03268135|aortic stenosis|aortic stenosis
4695379|NCT03268135|biomarkers|biomarkers
4695380|NCT03268122|Patient Isolation|patient isolation
4695381|NCT03268122|Methicillin-Resistant Staphylococcus aureus|methicillin-resistant staphylococcus aureus
4695382|NCT03268122|Vancomycin-Resistant Enterococci|vancomycin-resistant enterococci
4695383|NCT03268083|Foot-and-Mouth Disease|foot-and-mouth disease
4695384|NCT03268083|Vaccines|vaccines
4695385|NCT03268083|Hand, Foot and Mouth Disease|hand, foot and mouth disease
4695386|NCT03268083|EV71 vaccine|ev71 vaccine
4695387|NCT03268070|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
4695388|NCT03268070|Neurophysiology|neurophysiology
4695389|NCT03268070|Neuroscience|neuroscience
4695390|NCT03268070|Stroke Rehabilitation|stroke rehabilitation
4695391|NCT03268057|Non-Small-Cell Lung|non-small-cell lung
4695392|NCT03268057|Carcinoma|carcinoma
4695393|NCT03268057|Advanced|advanced
4695394|NCT03268057|VX15/2503|vx15/2503
4695395|NCT03268057|Semaphorin 4D|semaphorin 4d
4695396|NCT03268057|SEMA4D|sema4d
4695397|NCT03268057|safety tolerability|safety tolerability
4695398|NCT03268057|pharmacokinetics|pharmacokinetics
4695399|NCT03268057|monoclonal antibody|monoclonal antibody
4695400|NCT03268031|artificial intelligence|artificial intelligence
4695401|NCT03268031|glaucoma|glaucoma
4695402|NCT03268018|calcium|calcium
4695403|NCT03268018|peripheral arterial disease|peripheral arterial disease
4695404|NCT03267992|COPD|copd
4695405|NCT03267992|Coils|coils
4695406|NCT03267992|App|app
4695407|NCT03267979|pain assessment|pain assessment
4695408|NCT03267979|pupillary diameter|pupillary diameter
4695409|NCT03267979|variation coefficient of pupillary diameter|variation coefficient of pupillary diameter
4695410|NCT03267979|pain self assessment|pain self assessment
4695411|NCT03267979|video-pupillometer|video-pupillometer
4695412|NCT03267979|electrocardiogram|electrocardiogram
4695413|NCT03267979|analgesic treatment|analgesic treatment
4695414|NCT03267966|periampullary cancer|periampullary cancer
4695415|NCT03267966|margin status|margin status
4695416|NCT03267966|R1 resection|r1 resection
4695417|NCT03267966|clearance margin|clearance margin
4695418|NCT03267953|Stress management, e-Health, cardiovascular disease, adaptive design, lay coaching, motivational interviewing|stress management, e-health, cardiovascular disease, adaptive design, lay coaching, motivational interviewing
4695419|NCT03267940|Extrahepatic Cholangiocarcinoma|extrahepatic cholangiocarcinoma
4695420|NCT03267940|Intrahepatic Cholangiocarcinoma|intrahepatic cholangiocarcinoma
4695421|NCT03267940|Gallbladder Adenocarcinoma|gallbladder adenocarcinoma
4695422|NCT03267940|PEGylated Recombinant Human Hyaluronidase|pegylated recombinant human hyaluronidase
4695423|NCT03267940|PEGylated Recombinant Human Hyaluronidase with atezolizumab|pegylated recombinant human hyaluronidase with atezolizumab
4695424|NCT03267927|OSA|osa
4695425|NCT03267927|Polysomnography|polysomnography
4695426|NCT03267927|Rapid palatal expansion|rapid palatal expansion
4695427|NCT03267927|Mandibular advancement|mandibular advancement
4695428|NCT03267927|Sleep position|sleep position
4695429|NCT03267862|biomarker|biomarker
4695430|NCT03267849|biomarker|biomarker
4695431|NCT03267823|Bleeding|bleeding
4695432|NCT03267823|heart surgery|heart surgery
4695433|NCT03267823|coagulation|coagulation
4695434|NCT03267823|coagulopathy|coagulopathy
4695435|NCT03267823|INR|inr
4695436|NCT03267810|Neuropathic Pain|neuropathic pain
4695437|NCT03267810|Transcutaneous Electrical Nerve Stimulation|transcutaneous electrical nerve stimulation
4695438|NCT03267797|Recurrent Implantation Failure|recurrent implantation failure
4695439|NCT03267797|Pregnancy Rate|pregnancy rate
4695440|NCT03267797|Lymphocyte Therapy|lymphocyte therapy
4695441|NCT03267784|diabetic neuropathic ulcer|diabetic neuropathic ulcer
4695442|NCT03267784|ABCB5|abcb5
4695443|NCT03267784|allogeneic|allogeneic
4695444|NCT03267784|mesenchymal stem cells|mesenchymal stem cells
4695445|NCT03267784|skin ulcer|skin ulcer
4695446|NCT03267784|advanced therapy medicinal product|advanced therapy medicinal product
4695447|NCT03267784|somatic cell therapy|somatic cell therapy
4695448|NCT03267784|phase I/IIa|phase i/iia
4695449|NCT03267784|Diabetic Foot Ulcer|diabetic foot ulcer
4695450|NCT03267745|protein|protein
4695451|NCT03267745|skeletal muscle|skeletal muscle
4695452|NCT03267745|immobilization|immobilization
4695453|NCT03267706|Primary care|primary care
4695454|NCT03267706|Palliative care|palliative care
4695455|NCT03267641|Intra-tumour heterogeneity|intra-tumour heterogeneity
4695456|NCT03267641|Cancer immunotherapy|cancer immunotherapy
4695457|NCT03267641|Tumour microenvironment|tumour microenvironment
4695458|NCT03267641|Driver mutations|driver mutations
4695459|NCT03267641|Precision Medicine|precision medicine
4695460|NCT03267628|intrathecal morphine|intrathecal morphine
4695461|NCT03267628|quadratus lumborum type 2 block|quadratus lumborum type 2 block
4695462|NCT03267628|cesarean section|cesarean section
4695463|NCT03267628|pain|pain
4695464|NCT03267615|Liver Cirrhosis|liver cirrhosis
4695465|NCT03267615|Portal Hypertension|portal hypertension
4695466|NCT03267589|immunotherapy|immunotherapy
4695467|NCT03267589|ovarian cancer|ovarian cancer
4695468|NCT03267589|durvalumab|durvalumab
4695469|NCT03267589|tremelilumab|tremelilumab
4695470|NCT03267589|MEDI 9447|medi 9447
4695471|NCT03267589|MEDI 0562|medi 0562
4695472|NCT03267563|prevention|prevention
4695473|NCT03267563|implementation|implementation
4695474|NCT03267563|sustainment|sustainment
4695475|NCT03267563|perinatal|perinatal
4695476|NCT03267563|pregnancy|pregnancy
4695477|NCT03267563|postpartum|postpartum
4695478|NCT03267537|Insomnia|insomnia
4695479|NCT03267537|Sleep|sleep
4695480|NCT03267537|Telemedicine|telemedicine
4695481|NCT03267368|Comprehensive Care Program|comprehensive care program
4695482|NCT03267368|Stereotactic Radiotherapy|stereotactic radiotherapy
4695483|NCT03267316|First-in-Human|first-in-human
4695484|NCT03267316|Phase 1|phase 1
4695485|NCT03267316|Phase 2|phase 2
4695486|NCT03267316|Antibody, Monoclonal|antibody, monoclonal
4695487|NCT03267316|IL1RAP|il1rap
4695488|NCT03267316|Safety|safety
4695489|NCT03267316|Tolerability|tolerability
4695490|NCT03267316|Cancer|cancer
4695491|NCT03267316|Solid tumor|solid tumor
4695492|NCT03267316|Malignant|malignant
4695493|NCT03267316|Dose escalation|dose escalation
4695494|NCT03267316|Dose expansion|dose expansion
4695495|NCT03267316|CAN04|can04
4695496|NCT03267316|Immunoglobulin|immunoglobulin
4695497|NCT03267316|Clinical Trial|clinical trial
4695498|NCT03267316|Infusion|infusion
4695499|NCT03267316|Antineoplastic|antineoplastic
4695500|NCT03267316|Anticancer|anticancer
4695501|NCT03267303|Narcolepsy|narcolepsy
4695502|NCT03267277|Calcinosis|calcinosis
4695503|NCT03267277|Dermatomyositis|dermatomyositis
4695504|NCT03267277|Juvenile Dermatomyositis|juvenile dermatomyositis
4695505|NCT03267277|Idiopathic Inflammatory Myopathies|idiopathic inflammatory myopathies
4695506|NCT03267277|Sodium Thiosulfate|sodium thiosulfate
4695507|NCT03267251|Vaccine Decision Making|vaccine decision making
4695508|NCT03267251|Public Health|public health
4695509|NCT03267251|Health Communication|health communication
4695510|NCT03267251|Digital Interventions|digital interventions
4695511|NCT03267225|drug interaction|drug interaction
4695512|NCT03267225|genetic polymorphism|genetic polymorphism
4695513|NCT03267212|Functional Electrical Stimulation (FES)-Rowing|functional electrical stimulation (fes)-rowing
4695514|NCT03267212|Ventilatory support|ventilatory support
4695515|NCT03267173|Pancreatic Cancer|pancreatic cancer
4695516|NCT03267173|CAR-T|car-t
4695517|NCT03267173|Mesothelin|mesothelin
4695518|NCT03267173|CEA|cea
4695519|NCT03267173|HER2|her2
4695520|NCT03267147|Anti-CCP|anti-ccp
4695521|NCT03267147|rheumatoid arthritis|rheumatoid arthritis
4695522|NCT03267121|head and neck cancer|head and neck cancer
4695523|NCT03267121|Apatinib|apatinib
4695524|NCT03267121|Tegafur Gimeracil Oteracil|tegafur gimeracil oteracil
4695525|NCT03267121|induction chemotherapy|induction chemotherapy
4695526|NCT03267108|Pulmonary Fibrosis|pulmonary fibrosis
4695527|NCT03267108|PF|pf
4695528|NCT03267108|Pulmonary Hypertension|pulmonary hypertension
4695529|NCT03267108|Inhaled Nitric Oxide|inhaled nitric oxide
4695530|NCT03267108|iNO|ino
4695531|NCT03267108|Long Term Oxygen Therapy|long term oxygen therapy
4695532|NCT03267108|Oxygen|oxygen
4695533|NCT03267056|drug-coated balloon|drug-coated balloon
4695534|NCT03267043|preterm birth|preterm birth
4695535|NCT03267043|NICU|nicu
4695536|NCT03267043|neonatal|neonatal
4695537|NCT03267043|skin to skin|skin to skin
4695538|NCT03267043|kangaroo care|kangaroo care
4695539|NCT03267043|separation stress|separation stress
4695540|NCT03267043|family nurture|family nurture
4695541|NCT03267043|maternal confidence|maternal confidence
4695542|NCT03267043|maternal competence|maternal competence
4695543|NCT03267043|calming cycle|calming cycle
4695544|NCT03267043|infant neurodevelopment|infant neurodevelopment
4695545|NCT03267043|infant psychological development|infant psychological development
4695546|NCT03267043|mother-infant co-regulation|mother-infant co-regulation
4695547|NCT03267043|postpartum depression|postpartum depression
4695548|NCT03267030|Hypersensitivity to PEG-asparaginase|hypersensitivity to peg-asparaginase
4695549|NCT03266965|Fatigue|fatigue
4695550|NCT03266965|Histamine|histamine
4695551|NCT03266952|stroke|stroke
4695552|NCT03266952|race|race
4695553|NCT03266952|diet|diet
4695554|NCT03266952|diabetes|diabetes
4695555|NCT03266952|ethnicity|ethnicity
4695556|NCT03266952|myocardial infarction|myocardial infarction
4695557|NCT03266874|total hip arthroplasty|total hip arthroplasty
4695558|NCT03266848|Magnetic Resonance Imaging|magnetic resonance imaging
4695559|NCT03266848|Ferumoxytol|ferumoxytol
4695560|NCT03266835|Chronic Total Occlusion|chronic total occlusion
4695561|NCT03266835|Peripheral|peripheral
4695562|NCT03266835|SoundBite™ Crossing System|soundbite™ crossing system
4695563|NCT03266835|CTO|cto
4695564|NCT03266835|intra-luminal|intra-luminal
4695565|NCT03266835|Active wire|active wire
4695566|NCT03266835|Device|device
4695567|NCT03266835|Procedure|procedure
4695568|NCT03266809|Cardiac function|cardiac function
4695569|NCT03266809|Cardio-toxicity|cardio-toxicity
4695570|NCT03266770|ureteral stent|ureteral stent
4695571|NCT03266744|Metastatic Breast Cancer|metastatic breast cancer
4695572|NCT03266744|Whole Body MRI|whole body mri
4695573|NCT03266744|Computerised Tomography|computerised tomography
4695574|NCT03266744|Bone scan|bone scan
4695575|NCT03266718|cancer survivor|cancer survivor
4695576|NCT03266718|breast cancer|breast cancer
4695577|NCT03266718|prostate cancer|prostate cancer
4695578|NCT03266718|couples|couples
4695579|NCT03266692|BCMA|bcma
4695580|NCT03266692|SEA-BCMA|sea-bcma
4695581|NCT03266692|B Cell Maturation Antigen|b cell maturation antigen
4695582|NCT03266692|ACTR|actr
4695583|NCT03266692|ACTR087|actr087
4695584|NCT03266692|T cell|t cell
4695585|NCT03266692|T cell product|t cell product
4695586|NCT03266692|relapsed|relapsed
4695587|NCT03266692|refractory|refractory
4695588|NCT03266692|multiple myeloma|multiple myeloma
4695589|NCT03266692|adoptive T cells|adoptive t cells
4695590|NCT03266692|autologous|autologous
4695591|NCT03266692|gene therapy|gene therapy
4695592|NCT03266692|cell therapy|cell therapy
4695593|NCT03266679|bipolar disorder|bipolar disorder
4695594|NCT03266679|metacognition|metacognition
4695595|NCT03266679|reflective functioning|reflective functioning
4695596|NCT03266679|metacognition-based intervention|metacognition-based intervention
4695597|NCT03266679|sense of self|sense of self
4695598|NCT03266679|insight|insight
4695599|NCT03266666|grocery|grocery
4695600|NCT03266666|lifestyle|lifestyle
4695601|NCT03266666|lifestyle change|lifestyle change
4695602|NCT03266666|behavior|behavior
4695603|NCT03266666|nutrition|nutrition
4695604|NCT03266640|Cytomegalovirus|cytomegalovirus
4695605|NCT03266640|CMV|cmv
4695606|NCT03266640|cytotoxic t-lymphocytes|cytotoxic t-lymphocytes
4695607|NCT03266627|adenovirus|adenovirus
4695608|NCT03266627|primary immune deficiency disorder|primary immune deficiency disorder
4695609|NCT03266627|cytotoxic t-lymphocytes|cytotoxic t-lymphocytes
4695610|NCT03266614|Mental Illness|mental illness
4695611|NCT03266614|Loneliness|loneliness
4695612|NCT03266614|Hope|hope
4695613|NCT03266614|Community|community
4695614|NCT03266614|Social Media|social media
4695615|NCT03266601|Aged 1-7 years old, within 72 hours of onset patients with herpangina|aged 1-7 years old, within 72 hours of onset patients with herpangina
4695616|NCT03266588|migraine|migraine
4695617|NCT03266588|acute|acute
4695618|NCT03266575|Frailty|frailty
4695619|NCT03266575|Sarcopenia|sarcopenia
4695620|NCT03266575|Pulmonary Rehabilitation|pulmonary rehabilitation
4695621|NCT03266562|Positron Emission Mammography|positron emission mammography
4695622|NCT03266549|botulinum toxin|botulinum toxin
4695623|NCT03266549|infantile esotropia|infantile esotropia
4695624|NCT03266536|Gut microbiota|gut microbiota
4695625|NCT03266523|CT|ct
4695626|NCT03266523|MRI|mri
4695627|NCT03266523|Anxiety-state|anxiety-state
4695628|NCT03266523|Anxiety State-Trait|anxiety state-trait
4695629|NCT03266510|Inspiratory muscle strength training|inspiratory muscle strength training
4695630|NCT03266497|diet quality|diet quality
4695631|NCT03266497|health disparities|health disparities
4695632|NCT03266497|immigrants|immigrants
4695633|NCT03266497|foreign-born|foreign-born
4695634|NCT03266497|Blacks/African Americans|blacks/african americans
4695635|NCT03266497|place of birth/nativity|place of birth/nativity
4695636|NCT03266497|length of residency|length of residency
4695637|NCT03266497|NHANES|nhanes
4695638|NCT03266497|acculturation|acculturation
4695639|NCT03266484|Microbiome|microbiome
4695640|NCT03266484|Fatigue|fatigue
4695641|NCT03266484|Probiotics|probiotics
4695642|NCT03266471|Cytokines|cytokines
4695643|NCT03266471|Pharmacogenetics|pharmacogenetics
4695644|NCT03266445|relapse|relapse
4695645|NCT03266445|buprenorphine/naloxone|buprenorphine/naloxone
4695646|NCT03266445|opioids|opioids
4695647|NCT03266445|narcotics|narcotics
4695648|NCT03266445|post-surgical pain|post-surgical pain
4695649|NCT03266393|Envarsus XR|envarsus xr
4695650|NCT03266393|Kidney transplantation|kidney transplantation
4695651|NCT03266393|Grafting, Kidney|grafting, kidney
4695652|NCT03266393|Tacrolimus|tacrolimus
4695653|NCT03266393|Rejection|rejection
4695654|NCT03266393|Adherence|adherence
4695655|NCT03266393|Quality of Life|quality of life
4695656|NCT03266393|post-transplant immunosuppression|post-transplant immunosuppression
4695657|NCT03266354|Artisan|artisan
4695658|NCT03266302|vasodilatory shock|vasodilatory shock
4695659|NCT03266302|hemoadsorption|hemoadsorption
4695660|NCT03266302|cardiac surgery|cardiac surgery
4695661|NCT03266302|cytokines|cytokines
4695662|NCT03266250|inferior vena caca ultrasound|inferior vena caca ultrasound
4695663|NCT03266237|Influenza|influenza
4695664|NCT03266237|Influenza Virus Vaccines|influenza virus vaccines
4695665|NCT03266237|Vaxigrip|vaxigrip
4695666|NCT03266237|Respiratory Tract Infections|respiratory tract infections
4695667|NCT03266237|Orthomyxoviridae Infections|orthomyxoviridae infections
4695668|NCT03266237|Frailty|frailty
4695669|NCT03266237|Aging|aging
4695670|NCT03266237|Safety|safety
4695671|NCT03266237|Immunogenicity|immunogenicity
4695672|NCT03266224|congenital muscular torticollis|congenital muscular torticollis
4695673|NCT03266224|wryneck|wryneck
4695674|NCT03266224|sternocleidomastoid|sternocleidomastoid
4695675|NCT03266224|ultrasonography|ultrasonography
4695676|NCT03266224|digital analysis|digital analysis
4695677|NCT03266185|paclitaxel-containing chemotherapy|paclitaxel-containing chemotherapy
4695678|NCT03266172|immediate release tablet|immediate release tablet
4695679|NCT03266172|GSK2982772|gsk2982772
4695680|NCT03266172|Modified release|modified release
4695681|NCT03266172|minitablet|minitablet
4695682|NCT03266159|Dose escalation|dose escalation
4695683|NCT03266159|Small cell lung cancer|small cell lung cancer
4695684|NCT03266159|Trametinib|trametinib
4695685|NCT03266159|GSK525762|gsk525762
4695686|NCT03266159|Ras-mutations|ras-mutations
4695687|NCT03266159|BET inhibitor|bet inhibitor
4695688|NCT03266146|Drug-induced Liver Injury|drug-induced liver injury
4695689|NCT03266146|Recurrence|recurrence
4695690|NCT03266146|Methylprednisolone|methylprednisolone
4695691|NCT03266146|Short-term|short-term
4695692|NCT03266133|Gestational Diabetes Mellitus|gestational diabetes mellitus
4695693|NCT03266133|Sleep education|sleep education
4695694|NCT03266120|Gardening|gardening
4695695|NCT03266120|Therapeutic Arts|therapeutic arts
4695821|NCT03265002|psyllium|psyllium
4695696|NCT03266120|Therapeutic Horticulture|therapeutic horticulture
4695697|NCT03266120|Anxiety|anxiety
4695698|NCT03266120|Depression|depression
4695699|NCT03266120|Mood States|mood states
4695700|NCT03266120|Quality of Life|quality of life
4695701|NCT03266120|Social Interactions|social interactions
4695702|NCT03266120|Stress|stress
4695703|NCT03266120|Wellness|wellness
4695704|NCT03266055|Blueberry|blueberry
4695705|NCT03266055|Diet|diet
4695706|NCT03266003|Tuberculosis|tuberculosis
4695707|NCT03266003|Directly observed therapy|directly observed therapy
4695708|NCT03266003|Adherence|adherence
4695709|NCT03266003|Video assisted directly observed therapy|video assisted directly observed therapy
4695710|NCT03266003|Electronic directly observed therapy|electronic directly observed therapy
4695711|NCT03266003|Mobile health|mobile health
4695712|NCT03265964|Suicidal Ideation|suicidal ideation
4695713|NCT03265964|Veteran|veteran
4695714|NCT03265964|Uridine|uridine
4695715|NCT03265964|Neuroimaging|neuroimaging
4695716|NCT03265951|sleep apnea, PTSD|sleep apnea, ptsd
4695717|NCT03265938|Head and Neck cancer|head and neck cancer
4695718|NCT03265938|Cancer of oral cavity|cancer of oral cavity
4695719|NCT03265938|Ear, Nose and Throat|ear, nose and throat
4695720|NCT03265938|Indirect laryngoscopy|indirect laryngoscopy
4695721|NCT03265938|Awake intubation|awake intubation
4695722|NCT03265938|Expected difficult intubation|expected difficult intubation
4695723|NCT03265847|intimate partner violence|intimate partner violence
4695724|NCT03265847|safety planning|safety planning
4695725|NCT03265847|immigrant, refugee|immigrant, refugee
4695726|NCT03265847|Native American|native american
4695727|NCT03265847|risk for future violence|risk for future violence
4695728|NCT03265847|risk for intimate partner homicide|risk for intimate partner homicide
4695729|NCT03265821|Smoking|smoking
4695730|NCT03265821|Periodontal treatment|periodontal treatment
4695731|NCT03265821|Periodontal disease|periodontal disease
4695732|NCT03265821|Healing|healing
4695733|NCT03265808|stem cells|stem cells
4695734|NCT03265782|efficacy|efficacy
4695735|NCT03265782|safety|safety
4695736|NCT03265782|paracetamol|paracetamol
4695737|NCT03265782|ibuprofen|ibuprofen
4695738|NCT03265782|PDA|pda
4695739|NCT03265782|preterms|preterms
4695740|NCT03265769|Femoral approach|femoral approach
4695741|NCT03265769|Radial approach|radial approach
4695742|NCT03265769|Chronic total occlusion|chronic total occlusion
4695743|NCT03265730|Outpatient clinics|outpatient clinics
4695744|NCT03265730|oral antibiotics|oral antibiotics
4695745|NCT03265730|diarrhea|diarrhea
4695746|NCT03265704|Maternal PIH|maternal pih
4695747|NCT03265704|Neonatal thrombocytopenia|neonatal thrombocytopenia
4695748|NCT03265704|Neonatal neutropenia|neonatal neutropenia
4695749|NCT03265691|Accidental Falls|accidental falls
4695750|NCT03265691|Hyponatremia|hyponatremia
4695751|NCT03265691|Elderly|elderly
4695752|NCT03265691|Risk factors|risk factors
4695753|NCT03265691|Nurse|nurse
4695754|NCT03265665|walking|walking
4695755|NCT03265665|African American women|african american women
4695756|NCT03265665|community-based|community-based
4695757|NCT03265652|Intense Pulsed Light|intense pulsed light
4695758|NCT03265652|Meibomian Gland Dysfunction|meibomian gland dysfunction
4695759|NCT03265652|Dry Eye Disease|dry eye disease
4695760|NCT03265587|Feng Shui|feng shui
4695761|NCT03265587|Inner harmony|inner harmony
4695762|NCT03265587|Chi|chi
4695763|NCT03265522|Mediterranean diet|mediterranean diet
4695764|NCT03265522|Lifestyle|lifestyle
4695765|NCT03265483|Personalized prevention trial|personalized prevention trial
4695766|NCT03265483|Magnesium|magnesium
4695767|NCT03265483|Vitamin D metabolism and synthesis|vitamin d metabolism and synthesis
4695768|NCT03265483|Magnesium-vitamin D interaction|magnesium-vitamin d interaction
4695769|NCT03265444|MSA|msa
4695770|NCT03265405|pulmonary sarcoidosis|pulmonary sarcoidosis
4695771|NCT03265405|corticosteroids|corticosteroids
4695772|NCT03265405|glucocorticoids|glucocorticoids
4695773|NCT03265405|relapse|relapse
4695774|NCT03265405|interstitial lung disease|interstitial lung disease
4695775|NCT03265405|diffuse parenchymal lung disease|diffuse parenchymal lung disease
4695776|NCT03265405|immunosuppression|immunosuppression
4695777|NCT03265405|mediastinal lymphadenopathy|mediastinal lymphadenopathy
4695778|NCT03265366|Ultrashort echo time magnetic resonance imaging|ultrashort echo time magnetic resonance imaging
4695779|NCT03265353|Potassium|potassium
4695780|NCT03265353|Sodium|sodium
4695781|NCT03265353|Vascular function|vascular function
4695782|NCT03265340|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
4695783|NCT03265288|Inflammation|inflammation
4695784|NCT03265288|Essential Fatty Acids|essential fatty acids
4695785|NCT03265288|Inflammation resolution|inflammation resolution
4695786|NCT03265288|Docosahexaenoic acid|docosahexaenoic acid
4695787|NCT03265288|Lung function|lung function
4695788|NCT03265275|Fast track|fast track
4695789|NCT03265223|Ropivacaine|ropivacaine
4695790|NCT03265223|local anesthesia|local anesthesia
4695791|NCT03265223|intraincisional infiltration|intraincisional infiltration
4695792|NCT03265223|intraperitoneal instillation|intraperitoneal instillation
4695793|NCT03265223|post-laparoscopic cholecystectomy pain|post-laparoscopic cholecystectomy pain
4695794|NCT03265223|shoulder pain|shoulder pain
4695795|NCT03265223|rescue analgesia|rescue analgesia
4695796|NCT03265223|triple blinding|triple blinding
4695797|NCT03265210|Middle-aged and Older Adults|middle-aged and older adults
4695798|NCT03265210|Primary Care|primary care
4695799|NCT03265197|Tinnitus|tinnitus
4695800|NCT03265197|Intra-tympanic|intra-tympanic
4695801|NCT03265197|Lidocaine|lidocaine
4695802|NCT03265197|Dexamethasone|dexamethasone
4695803|NCT03265132|Interleukin 1 receptor antagonist|interleukin 1 receptor antagonist
4695804|NCT03265132|IL-1 receptor antagonist|il-1 receptor antagonist
4695805|NCT03265132|Kineret|kineret
4695806|NCT03265132|anakinra|anakinra
4695807|NCT03265132|Adult-Onset Still's Disease|adult-onset still's disease
4695808|NCT03265132|Systemic Juvenile Idiopathic Arthritis|systemic juvenile idiopathic arthritis
4695809|NCT03265093|Pain Measurement|pain measurement
4695810|NCT03265093|Platelet Activation|platelet activation
4695811|NCT03265093|Quality of Life|quality of life
4695812|NCT03265028|primary care|primary care
4695813|NCT03265028|antibiotics|antibiotics
4695814|NCT03265028|communication skills|communication skills
4695815|NCT03265028|general practice|general practice
4695816|NCT03265028|outpatient|outpatient
4695817|NCT03265028|ambulatory care|ambulatory care
4695818|NCT03265028|anti-bacterial agents|anti-bacterial agents
4695819|NCT03265002|fibre|fibre
4695820|NCT03265002|inulin|inulin
4695822|NCT03265002|small bowel MRI|small bowel mri
4695823|NCT03264989|Sickle cell disease|sickle cell disease
4695824|NCT03264989|sickle cell anemia|sickle cell anemia
4695825|NCT03264989|vaso-occlusive crisis|vaso-occlusive crisis
4695826|NCT03264989|P-selectin|p-selectin
4695827|NCT03264989|SEG101|seg101
4695828|NCT03264989|crizanlizumab|crizanlizumab
4695829|NCT03264989|monoclonal antibody|monoclonal antibody
4695830|NCT03264989|Anemia, Sickle Cell|anemia, sickle cell
4695831|NCT03264989|HbS Disease|hbs disease
4695832|NCT03264989|Hemoglobin SC Disease|hemoglobin sc disease
4695833|NCT03264989|Sickle Cell Disorders|sickle cell disorders
4695834|NCT03264989|Sickling Disorder Due to Hemoglobin S|sickling disorder due to hemoglobin s
4695835|NCT03264976|diabetic retinopathy|diabetic retinopathy
4695836|NCT03264976|miRNA|mirna
4695837|NCT03264976|serum exosomes|serum exosomes
4695838|NCT03264976|prognostic biomarker|prognostic biomarker
4695839|NCT03264963|Upper airway exercises|upper airway exercises
4695840|NCT03264963|Smart phone application|smart phone application
4695841|NCT03264937|TTR|ttr
4695842|NCT03264937|INR|inr
4695843|NCT03264937|Warfarin|warfarin
4695844|NCT03264937|social software|social software
4695845|NCT03264924|physical activity|physical activity
4695846|NCT03264924|motivation|motivation
4695847|NCT03264924|behaviour change|behaviour change
4695848|NCT03264911|pharyngitis|pharyngitis
4695849|NCT03264911|amoxicillin|amoxicillin
4695850|NCT03264872|Motivational Interviewing|motivational interviewing
4695851|NCT03264859|NGAL|ngal
4695852|NCT03264859|STEMI|stemi
4695853|NCT03264859|no-reflow|no-reflow
4695854|NCT03264859|PCI (Percutaneous Coronary Intervention)|pci (percutaneous coronary intervention)
4695855|NCT03264820|digital obstructive arterial disease, DOAD|digital obstructive arterial disease, doad
4695856|NCT03264807|Lymph Node 14v|lymph node 14v
4695857|NCT03264807|D2 lymphadenectomy|d2 lymphadenectomy
4695858|NCT03264781|Cyclofem®|cyclofem®
4695859|NCT03264781|Implant|implant
4695860|NCT03264781|Jadelle|jadelle
4695861|NCT03264781|Implanon|implanon
4695862|NCT03264781|irregular uterine bleeding|irregular uterine bleeding
4695863|NCT03264781|randomized controlled trial|randomized controlled trial
4695864|NCT03264768|valves|valves
4695865|NCT03264768|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
4695866|NCT03264768|endoscopic long volume reduction|endoscopic long volume reduction
4695867|NCT03264742|ghreline, stroke|ghreline, stroke
4695868|NCT03264729|plantar heel pain|plantar heel pain
4695869|NCT03264716|TACE (transarterial chemoembolization)|tace (transarterial chemoembolization)
4695870|NCT03264716|colorectal liver metastasis|colorectal liver metastasis
4695871|NCT03264703|Joint pain|joint pain
4695872|NCT03264703|Joint stiffness|joint stiffness
4695873|NCT03264703|Joint redness|joint redness
4695874|NCT03264703|Loss of joint function|loss of joint function
4695875|NCT03264703|Swollen joints|swollen joints
4695876|NCT03264690|Crohn's disease|crohn's disease
4695877|NCT03264690|Ulcerative colitis|ulcerative colitis
4695878|NCT03264677|8-week HUT|8-week hut
4695879|NCT03264677|Hydro Boost|hydro boost
4695880|NCT03264677|Skin healthy signs|skin healthy signs
4695881|NCT03264677|Environmental aggressors|environmental aggressors
4695882|NCT03264677|Cosmetic|cosmetic
4695883|NCT03264664|E7386|e7386
4695884|NCT03264664|dose escalation|dose escalation
4695885|NCT03264664|advanced or recurrent neoplasms|advanced or recurrent neoplasms
4695886|NCT03264651|Selective androgen receptor modulator|selective androgen receptor modulator
4695887|NCT03264651|Aromatase inhibitor|aromatase inhibitor
4695888|NCT03264638|PCOS|pcos
4695889|NCT03264638|Dingkundan|dingkundan
4695890|NCT03264638|Diane-35|diane-35
4695891|NCT03264625|Cholecalciferol|cholecalciferol
4695892|NCT03264625|Peritoneal dialysis|peritoneal dialysis
4695893|NCT03264625|Peritonitis|peritonitis
4695894|NCT03264573|Atrophic scar|atrophic scar
4695895|NCT03264573|PRP|prp
4695896|NCT03264573|ADSCs|adscs
4695897|NCT03264560|Telepsychiatry|telepsychiatry
4695898|NCT03264560|Synchronous|synchronous
4695899|NCT03264560|Asynchronous|asynchronous
4695900|NCT03264560|SNF|snf
4695901|NCT03264521|Crowdsourcing|crowdsourcing
4695902|NCT03264521|Patient Engagement|patient engagement
4695903|NCT03264521|Chiropractic|chiropractic
4695904|NCT03264508|endothelial function|endothelial function
4695905|NCT03264508|arterial stiffness|arterial stiffness
4695906|NCT03264508|heat|heat
4695907|NCT03264508|hot water immersion|hot water immersion
4695908|NCT03264443|physical activity|physical activity
4695909|NCT03264443|exercise|exercise
4695910|NCT03264443|aging|aging
4695911|NCT03264443|older|older
4695912|NCT03264430|Perianal fistula|perianal fistula
4695913|NCT03264430|Hemorrhoids|hemorrhoids
4695914|NCT03264404|Pancreas|pancreas
4695915|NCT03264404|pembrolizumab|pembrolizumab
4695916|NCT03264404|azacitidine|azacitidine
4695917|NCT03264404|metastatic pancreatic cancer|metastatic pancreatic cancer
4695918|NCT03264404|first-line|first-line
4695919|NCT03264391|OCT-A|oct-a
4695920|NCT03264391|Retinal vasculitis|retinal vasculitis
4695921|NCT03264391|Behcet's disease|behcet's disease
4695922|NCT03264365|Health-related quality of life|health-related quality of life
4695923|NCT03264365|Anxiety|anxiety
4695924|NCT03264365|Depression|depression
4695925|NCT03264365|Post-traumatic stress disorder|post-traumatic stress disorder
4695926|NCT03264365|Recovery programme|recovery programme
4695927|NCT03264365|Rehabilitation|rehabilitation
4695928|NCT03264365|Follow-up programme|follow-up programme
4695929|NCT03264365|Aftercare|aftercare
4695930|NCT03264365|Randomized controlled Trial|randomized controlled trial
4695931|NCT03264365|Multicentre|multicentre
4695932|NCT03264339|Infant|infant
4695933|NCT03264339|Hand/Growth & Development|hand/growth & development
4695934|NCT03264339|Motor activity|motor activity
4695935|NCT03264339|Exercise|exercise
4695936|NCT03264339|Communication|communication
4695937|NCT03264313|tobacco|tobacco
4695938|NCT03264313|Smoking Cessation|smoking cessation
4695939|NCT03264313|TMS|tms
4695940|NCT03264313|Neuromodulation|neuromodulation
4695941|NCT03264313|transcranial magnetic stimulation|transcranial magnetic stimulation
4695942|NCT03264300|brain tumor, MRI|brain tumor, mri
4695943|NCT03264287|acne vulgaris|acne vulgaris
4695944|NCT03264287|acupuncture|acupuncture
4695945|NCT03264287|cupping|cupping
4695946|NCT03264287|ear point tapping|ear point tapping
4695947|NCT03264287|randomized controlled trial|randomized controlled trial
4695948|NCT03264274|Colorectal|colorectal
4695949|NCT03264274|Metastatic|metastatic
4695950|NCT03264274|Chemorefractory|chemorefractory
4695951|NCT03264274|Ultrasound|ultrasound
4695952|NCT03264274|Aflibercept|aflibercept
4695953|NCT03264261|stroke, locomotion|stroke, locomotion
4695954|NCT03264248|obesity|obesity
4695955|NCT03264248|overweight|overweight
4695956|NCT03264248|wheelchair|wheelchair
4695957|NCT03264235|Powered-Knee Exoskeleton|powered-knee exoskeleton
4695958|NCT03264235|Stair Training|stair training
4695959|NCT03264235|Keeogo|keeogo
4695960|NCT03264196|condylar hear|condylar hear
4695961|NCT03264196|fracture|fracture
4695962|NCT03264196|randomised controlled trial|randomised controlled trial
4695963|NCT03264144|Social norms|social norms
4695964|NCT03264144|Adolescent|adolescent
4695965|NCT03264144|Smoking|smoking
4695966|NCT03264144|Randomised controlled trial|randomised controlled trial
4695967|NCT03264131|Brentuximab Vedotin|brentuximab vedotin
4695968|NCT03264131|Adcetris|adcetris
4695969|NCT03264131|Lymphoma|lymphoma
4695970|NCT03264131|Leukemia|leukemia
4695971|NCT03264131|CD30|cd30
4695972|NCT03264118|Periodontal Guided Tissue Regeneration|periodontal guided tissue regeneration
4695973|NCT03264118|Photochemotherapy|photochemotherapy
4695974|NCT03264079|RTA 402|rta 402
4695975|NCT03264079|Bardoxolone methyl|bardoxolone methyl
4695976|NCT03264079|Itraconazole|itraconazole
4695977|NCT03264079|Sporanox|sporanox
4695978|NCT03264079|CYP3A4|cyp3a4
4695979|NCT03264053|socket shield technique|socket shield technique
4695980|NCT03264053|crestal bone loss|crestal bone loss
4695981|NCT03264053|immediate implanation|immediate implanation
4695982|NCT03264040|Mannosidosis|mannosidosis
4695983|NCT03264040|Biomarker|biomarker
4695984|NCT03263988|pulse contour analysis|pulse contour analysis
4695985|NCT03263988|capton|capton
4695986|NCT03263988|intraoperative monitoring|intraoperative monitoring
4695987|NCT03263962|CHF|chf
4695988|NCT03263962|Canrenone|canrenone
4695989|NCT03263949|risk prediction|risk prediction
4695990|NCT03263949|ventricular arrhythmia|ventricular arrhythmia
4695991|NCT03263949|myocardial infarction|myocardial infarction
4695992|NCT03263936|Relapse|relapse
4695993|NCT03263936|Myelogenous|myelogenous
4695994|NCT03263936|Leukemia|leukemia
4695995|NCT03263936|Refractory|refractory
4695996|NCT03263936|Acute|acute
4695997|NCT03263936|Pediatric|pediatric
4695998|NCT03263923|grandmother caregivers|grandmother caregivers
4695999|NCT03263923|grandfamily|grandfamily
4696000|NCT03263923|grandfamilies|grandfamilies
4696001|NCT03263923|custodial grandparent|custodial grandparent
4696002|NCT03263923|custodial grandmother|custodial grandmother
4696003|NCT03263923|multigenerational family|multigenerational family
4696004|NCT03263923|Grandmothers raising or living with grandchildren|grandmothers raising or living with grandchildren
4696005|NCT03263897|abortive effect|abortive effect
4696006|NCT03263897|mobile interface|mobile interface
4696007|NCT03263884|nerve growth factor|nerve growth factor
4696008|NCT03263884|repetitive transcranial magnetic stimulation|repetitive transcranial magnetic stimulation
4696009|NCT03263884|dorsolateral prefrontal cortex|dorsolateral prefrontal cortex
4696010|NCT03263871|nutrition|nutrition
4696011|NCT03263832|Antibiogramme|antibiogramme
4696012|NCT03263832|Antibiofilmogramme|antibiofilmogramme
4696013|NCT03263819|Postural Orthostatic Tachycardia Syndrome, gastrointestinal hormones|postural orthostatic tachycardia syndrome, gastrointestinal hormones
4696014|NCT03263806|angina|angina
4696015|NCT03263806|coronary artery disease|coronary artery disease
4696016|NCT03263806|coronary artery catheterization|coronary artery catheterization
4696017|NCT03263806|coronary CT angiography|coronary ct angiography
4696018|NCT03263806|fractional flow reserve CT|fractional flow reserve ct
4696019|NCT03263806|emergency department|emergency department
4696020|NCT03263793|singing|singing
4696021|NCT03263780|Diagnostic imaging|diagnostic imaging
4696022|NCT03263780|High-Intensity Focused Ultrasound|high-intensity focused ultrasound
4696023|NCT03263780|HIFU|hifu
4696024|NCT03263780|18F-Fluciclovine|18f-fluciclovine
4696025|NCT03263780|high resolution diffusion-weighted imaging|high resolution diffusion-weighted imaging
4696026|NCT03263767|Peripheral haemopoietic stem cell transplant|peripheral haemopoietic stem cell transplant
4696027|NCT03263767|High dose cyclophosphamide|high dose cyclophosphamide
4696028|NCT03263767|acute GVHD|acute gvhd
4696029|NCT03263767|allogenic transplantation|allogenic transplantation
4696030|NCT03263767|RIC (reduced-intensity conditioning)|ric (reduced-intensity conditioning)
4696031|NCT03263741|Paclitaxel|paclitaxel
4696032|NCT03263741|S-1|s-1
4696033|NCT03263741|Oxaliplatin|oxaliplatin
4696034|NCT03263741|Efficiency|efficiency
4696035|NCT03263741|safety|safety
4696036|NCT03263728|Stress Cardiac Magnetic Resonance|stress cardiac magnetic resonance
4696037|NCT03263715|Polymyalgia Rheumatica|polymyalgia rheumatica
4696038|NCT03263715|Tocilizumab|tocilizumab
4696039|NCT03263715|Glucocorticoid|glucocorticoid
4696040|NCT03263715|Glucocorticoid-Sparing|glucocorticoid-sparing
4696041|NCT03263702|Persistent Atrial Fibrillation|persistent atrial fibrillation
4696042|NCT03263702|mapping|mapping
4696043|NCT03263663|colorectal cancer|colorectal cancer
4696044|NCT03263663|adjuvant|adjuvant
4696045|NCT03263650|prostate cancer|prostate cancer
4696046|NCT03263650|genomic alterations|genomic alterations
4696047|NCT03263650|DNA damage repair|dna damage repair
4696048|NCT03263650|DDR pathway gene expression|ddr pathway gene expression
4696049|NCT03263650|aggressive-variant prostate carcinomas|aggressive-variant prostate carcinomas
4696050|NCT03263650|small cell prostate carcinoma|small cell prostate carcinoma
4696051|NCT03263650|neuroendocrine prostate carcinoma|neuroendocrine prostate carcinoma
4696052|NCT03263637|Relapsed or refractory haematological malignancies|relapsed or refractory haematological malignancies
4696053|NCT03263637|AZD4573|azd4573
4696054|NCT03263637|Acute Myeloid Leukemia (AML)|acute myeloid leukemia (aml)
4696055|NCT03263637|Acute Lymphocytic Leukemia (ALL)|acute lymphocytic leukemia (all)
4696056|NCT03263637|Chronic lymphocytic Leukemia (CLL)|chronic lymphocytic leukemia (cll)
4696057|NCT03263637|High risk Myelodysplastic syndrome (MDS)|high risk myelodysplastic syndrome (mds)
4696058|NCT03263637|Chronic Myelomonocytic Leukemia (CML)|chronic myelomonocytic leukemia (cml)
4696059|NCT03263637|Richter's syndrome|richter's syndrome
4696060|NCT03263637|B-cell Non-Hodgkin Lymphoma (B-cell NHL)|b-cell non-hodgkin lymphoma (b-cell nhl)
4696061|NCT03263637|T-cell Non-Hodgkin Lymphoma (T-cell NHL)|t-cell non-hodgkin lymphoma (t-cell nhl)
4696062|NCT03263637|Small lymphocytic Lymphoma (SLL)|small lymphocytic lymphoma (sll)
4696063|NCT03263637|Multiple Myeloma (MM)|multiple myeloma (mm)
4696064|NCT03263624|psoriasis|psoriasis
4696065|NCT03263624|laser|laser
4696066|NCT03263624|nail|nail
4696067|NCT03263611|disc degeneration|disc degeneration
4696068|NCT03263611|Intervertebral disc|intervertebral disc
4696069|NCT03263611|discogenic pain|discogenic pain
4696070|NCT03263611|chronic discogenic lumbar back pain|chronic discogenic lumbar back pain
4696071|NCT03263598|liver cirrhosis|liver cirrhosis
4696072|NCT03263598|ascites|ascites
4696073|NCT03263585|Osteoporosis|osteoporosis
4696074|NCT03263585|Vertebral Fracture|vertebral fracture
4696075|NCT03263585|Back Pain|back pain
4696076|NCT03263585|Spinal orthosis|spinal orthosis
4696077|NCT03263585|Elderly women|elderly women
4696078|NCT03263572|Malignant neoplasms stated as primary lymphoid haematopoietic|malignant neoplasms stated as primary lymphoid haematopoietic
4696079|NCT03263572|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
4696080|NCT03263572|ALL|all
4696081|NCT03263572|Philadelphia chromosome-positive acute lymphoblastic leukemia|philadelphia chromosome-positive acute lymphoblastic leukemia
4696082|NCT03263572|Ph+ ALL|ph+ all
4696083|NCT03263572|BCR-ABL-positive ALL|bcr-abl-positive all
4696084|NCT03263572|ALL relapsed or refractory|all relapsed or refractory
4696085|NCT03263572|Methotrexate|methotrexate
4696086|NCT03263572|Cytarabine|cytarabine
4696087|NCT03263572|Ara-C|ara-c
4696088|NCT03263572|Cytosar|cytosar
4696089|NCT03263572|DepoCyt|depocyt
4696090|NCT03263572|Cytosine arabinosine hydrochloride|cytosine arabinosine hydrochloride
4696091|NCT03263572|Blinatumomab|blinatumomab
4696092|NCT03263572|Dexamethasone|dexamethasone
4696093|NCT03263572|Decadron|decadron
4696094|NCT03263572|Ponatinib|ponatinib
4696095|NCT03263572|Iclusig|iclusig
4696096|NCT03263572|AP24534|ap24534
4696097|NCT03263559|Reduced Intensity Conditioning|reduced intensity conditioning
4696098|NCT03263559|Haploidentical|haploidentical
4696099|NCT03263559|Bone Marrow|bone marrow
4696100|NCT03263559|Transplant|transplant
4696101|NCT03263559|Sickle Cell Disease|sickle cell disease
4696102|NCT03263533|schizophrenia|schizophrenia
4696103|NCT03263533|clozapine|clozapine
4696104|NCT03263533|vorinostat|vorinostat
4696105|NCT03263533|HDAC|hdac
4696106|NCT03263533|histone deacetylase inhibitor|histone deacetylase inhibitor
4696107|NCT03263507|IONIS PKK-LRx|ionis pkk-lrx
4696108|NCT03263455|neglect,|neglect,
4696109|NCT03263455|stroke,|stroke,
4696110|NCT03263455|rehabilitation,|rehabilitation,
4696111|NCT03263455|range of motion|range of motion
4696112|NCT03263416|Metastatic solid tumor|metastatic solid tumor
4696113|NCT03263416|Oral Targeted Therapy|oral targeted therapy
4696114|NCT03263416|Treatment adherence|treatment adherence
4696115|NCT03263403|Meningococcal Vaccine|meningococcal vaccine
4696116|NCT03263403|Ingovax ACWY|ingovax acwy
4696117|NCT03263403|adults|adults
4696118|NCT03263403|Bangladeshi|bangladeshi
4696119|NCT03263403|immunogenicity|immunogenicity
4696120|NCT03263390|Obesity|obesity
4696121|NCT03263390|Bariatric Surgery|bariatric surgery
4696122|NCT03263390|Anti Obesity Medications|anti obesity medications
4696123|NCT03263390|Weight Regulation|weight regulation
4696124|NCT03263390|Pluripotent Stem Cells|pluripotent stem cells
4696125|NCT03263377|School feeding|school feeding
4696126|NCT03263377|Fortified Biscuits|fortified biscuits
4696127|NCT03263377|Bangladesh|bangladesh
4696128|NCT03263312|myocardial fibrosis|myocardial fibrosis
4696129|NCT03263312|exercise training|exercise training
4696130|NCT03263312|Fontan|fontan
4696131|NCT03263273|Minocycline|minocycline
4696132|NCT03263273|Topical|topical
4696133|NCT03263273|Tetracycline|tetracycline
4696134|NCT03263273|Doxycycline|doxycycline
4696135|NCT03263273|Rosacea|rosacea
4696136|NCT03263273|Skin Disease|skin disease
4696137|NCT03263273|Anti-Bacterial Agent|anti-bacterial agent
4696138|NCT03263273|Anti-Inflammatory Agent|anti-inflammatory agent
4696139|NCT03263260|stent, DES, Inspiron|stent, des, inspiron
4696140|NCT03263195|HIV|hiv
4696141|NCT03263195|Zika Virus|zika virus
4696142|NCT03263195|Pregnancy|pregnancy
4696143|NCT03263195|MTCT|mtct
4696144|NCT03263182|childbirth|childbirth
4696145|NCT03263182|delivery|delivery
4696146|NCT03263169|e-health, community networks, pragmatic RCT|e-health, community networks, pragmatic rct
4696147|NCT03263156|sleep|sleep
4696148|NCT03263156|ADHD|adhd
4696149|NCT03263156|behavioural intervention|behavioural intervention
4696150|NCT03263156|insomnia|insomnia
4696151|NCT03263130|COPD, Emphysema, Asthma COPD Overlap|copd, emphysema, asthma copd overlap
4696152|NCT03263117|Acute stroke|acute stroke
4696153|NCT03263117|Cerebral Stroke|cerebral stroke
4696154|NCT03263091|Myelodysplastic Syndromes|myelodysplastic syndromes
4696155|NCT03263091|Anemia|anemia
4696156|NCT03263091|Hemoglobin (Hb)|hemoglobin (hb)
4696157|NCT03263091|Low Risk Myelodysplastic Syndrome|low risk myelodysplastic syndrome
4696158|NCT03263091|Low Risk MDS|low risk mds
4696159|NCT03263078|inhalation,intravenous anesthesia|inhalation,intravenous anesthesia
4696160|NCT03263065|Nopal|nopal
4696161|NCT03263065|Bran|bran
4696162|NCT03263065|Psyllium|psyllium
4696163|NCT03263052|kidney transplant|kidney transplant
4696164|NCT03263052|immunosuppression|immunosuppression
4696165|NCT03263052|tacrolimus XR|tacrolimus xr
4696166|NCT03263052|elderly|elderly
4696167|NCT03263052|quality of life|quality of life
4696168|NCT03263052|neurological adverse events|neurological adverse events
4696169|NCT03263039|Programmed Cell Death 1 Receptor|programmed cell death 1 receptor
4696170|NCT03263039|Pembrolizumab|pembrolizumab
4696171|NCT03263039|Keytruda|keytruda
4696172|NCT03263039|MK-3475|mk-3475
4696173|NCT03263039|Urothelial Carcinoma|urothelial carcinoma
4696174|NCT03263026|Lymphoma|lymphoma
4696175|NCT03263026|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
4696176|NCT03263026|enzastaurin|enzastaurin
4696177|NCT03263013|Functional (BOLD) MRI|functional (bold) mri
4696178|NCT03263000|Belpharospasm|belpharospasm
4696179|NCT03263000|Blink Reflex|blink reflex
4696180|NCT03263000|Eyeblink|eyeblink
4696181|NCT03262974|Imatinib|imatinib
4696182|NCT03262974|Pharmacogenetics|pharmacogenetics
4696183|NCT03262974|CML|cml
4696184|NCT03262974|Plasma level|plasma level
4696185|NCT03262961|Mild pre-eclampsia Sildenafil Citrate|mild pre-eclampsia sildenafil citrate
4696186|NCT03262922|systemic scleroderma|systemic scleroderma
4696187|NCT03262922|environmental and professional toxics|environmental and professional toxics
4696188|NCT03262896|Brain Death|brain death
4696189|NCT03262896|Spinal Reflex|spinal reflex
4696190|NCT03262896|Electromyography|electromyography
4696191|NCT03262883|Prolonged akut mechanical ventilation|prolonged akut mechanical ventilation
4696192|NCT03262883|Tracheotomy|tracheotomy
4696193|NCT03262857|magnesium sulfate|magnesium sulfate
4696194|NCT03262857|pulpitis|pulpitis
4696195|NCT03262857|anesthesia|anesthesia
4696196|NCT03262805|Knee OA|knee oa
4696197|NCT03262805|Joint Pain|joint pain
4696301|NCT03262051|phenotyping|phenotyping
4696198|NCT03262805|Dietary supplement|dietary supplement
4696199|NCT03262805|WOMAC|womac
4696200|NCT03262805|Lequesne index|lequesne index
4696201|NCT03262805|hs-CRP|hs-crp
4696202|NCT03262766|Acute Intermittent Hypoxia|acute intermittent hypoxia
4696203|NCT03262766|Upper Extremity Training|upper extremity training
4696204|NCT03262714|Dance, walking, cardiovascular risk, functional capacity.|dance, walking, cardiovascular risk, functional capacity.
4696205|NCT03262688|INL-001|inl-001
4696206|NCT03262688|Bupivacaine|bupivacaine
4696207|NCT03262688|Collagen|collagen
4696208|NCT03262688|Children|children
4696209|NCT03262688|Pediatric|pediatric
4696210|NCT03262688|Inguinal hernia|inguinal hernia
4696211|NCT03262675|Heart Failure|heart failure
4696212|NCT03262675|Acute Heart Failure|acute heart failure
4696213|NCT03262675|Chronic Heat Failure|chronic heat failure
4696214|NCT03262675|Cardiovascular diseases|cardiovascular diseases
4696215|NCT03262675|Heart diseases|heart diseases
4696216|NCT03262675|Registry|registry
4696217|NCT03262675|Tunisia|tunisia
4696218|NCT03262597|fluid balance|fluid balance
4696219|NCT03262597|dehydration|dehydration
4696220|NCT03262597|rehydration|rehydration
4696221|NCT03262597|electrolytes|electrolytes
4696222|NCT03262597|urine|urine
4696223|NCT03262571|Heart failure|heart failure
4696224|NCT03262571|Lung ultrasound|lung ultrasound
4696225|NCT03262571|B-lines|b-lines
4696226|NCT03262558|staphylococcus aureus|staphylococcus aureus
4696227|NCT03262558|nosocomial infection|nosocomial infection
4696228|NCT03262532|Interactive web-base simulation|interactive web-base simulation
4696229|NCT03262493|intubation, gastrointestinal|intubation, gastrointestinal
4696230|NCT03262493|nursing|nursing
4696231|NCT03262493|clinical trial|clinical trial
4696232|NCT03262493|enteral nutrition|enteral nutrition
4696233|NCT03262441|HIV|hiv
4696234|NCT03262441|Antiretroviral treatment|antiretroviral treatment
4696235|NCT03262441|Mycophenolate mofetil|mycophenolate mofetil
4696236|NCT03262441|Cure|cure
4696237|NCT03262441|Latency|latency
4696238|NCT03262441|Reservoir|reservoir
4696239|NCT03262441|CD4 T cell|cd4 t cell
4696240|NCT03262441|Anti-proliferation|anti-proliferation
4696241|NCT03262415|LabPatch Continuous Glucose Monitoring (CGM)|labpatch continuous glucose monitoring (cgm)
4696242|NCT03262402|Chronic periodontitis|chronic periodontitis
4696243|NCT03262402|Candida spp|candida spp
4696244|NCT03262402|Histatin-5|histatin-5
4696245|NCT03262402|Lactoferrin|lactoferrin
4696246|NCT03262389|positron emission tomography (PET)|positron emission tomography (pet)
4696247|NCT03262389|computerized tomography (CT)|computerized tomography (ct)
4696248|NCT03262389|Magnetic resonance imaging (MRI)|magnetic resonance imaging (mri)
4696249|NCT03262389|Fludeoxyglucose (F-18 FDG)|fludeoxyglucose (f-18 fdg)
4696250|NCT03262389|C-11 acetate|c-11 acetate
4696251|NCT03262376|Stress|stress
4696252|NCT03262376|Anxiety|anxiety
4696253|NCT03262376|Cortisol|cortisol
4696254|NCT03262376|Vitamins|vitamins
4696255|NCT03262376|Botanicals|botanicals
4696256|NCT03262376|Minerals|minerals
4696257|NCT03262363|nutrigenomics|nutrigenomics
4696258|NCT03262363|Diet-gene interaction,|diet-gene interaction,
4696259|NCT03262363|Curcumin,|curcumin,
4696260|NCT03262363|Antioxidants,|antioxidants,
4696261|NCT03262363|Human NFE2L2 protein,|human nfe2l2 protein,
4696262|NCT03262363|Polymorphism,|polymorphism,
4696263|NCT03262363|Diabetes,|diabetes,
4696264|NCT03262363|Chronic kidney disease|chronic kidney disease
4696265|NCT03262324|Foot and Ankle|foot and ankle
4696266|NCT03262324|Disorders|disorders
4696267|NCT03262324|Outcome Measure|outcome measure
4696268|NCT03262298|CD22|cd22
4696269|NCT03262298|CAR-T|car-t
4696270|NCT03262298|Leukemia|leukemia
4696271|NCT03262298|Lymphoma|lymphoma
4696272|NCT03262220|Haematological malignancy|haematological malignancy
4696273|NCT03262220|Total Marrow Irradiation|total marrow irradiation
4696274|NCT03262220|Volumetric Arc Therapy|volumetric arc therapy
4696275|NCT03262181|Exercise|exercise
4696276|NCT03262181|Physical Activity|physical activity
4696277|NCT03262181|Biomechanics|biomechanics
4696278|NCT03262168|Exercise|exercise
4696279|NCT03262168|Physical Activity|physical activity
4696280|NCT03262142|COPD|copd
4696281|NCT03262142|Pseudomonas Aeruginosa|pseudomonas aeruginosa
4696282|NCT03262116|bionic pancreas|bionic pancreas
4696283|NCT03262116|insulin|insulin
4696284|NCT03262116|continuous glucose monitor|continuous glucose monitor
4696285|NCT03262116|type 1 diabetes|type 1 diabetes
4696286|NCT03262116|insulin pharmacokinetics|insulin pharmacokinetics
4696287|NCT03262103|Prostate Cancer|prostate cancer
4696288|NCT03262103|Gleason 8-10|gleason 8-10
4696289|NCT03262103|Immunotherapy|immunotherapy
4696290|NCT03262103|Neoadjuvant|neoadjuvant
4696291|NCT03262090|Emergence Delirium|emergence delirium
4696292|NCT03262090|desoflurane|desoflurane
4696293|NCT03262090|general anesthesia|general anesthesia
4696294|NCT03262077|photodynamic therapy|photodynamic therapy
4696295|NCT03262077|periodontal disease|periodontal disease
4696296|NCT03262077|dosimetry|dosimetry
4696297|NCT03262077|methylene blue|methylene blue
4696298|NCT03262051|cytochrome|cytochrome
4696299|NCT03262051|chronic inflammation|chronic inflammation
4696300|NCT03262051|genotyping|genotyping
4696302|NCT03262051|acute inflammation|acute inflammation
4696303|NCT03262051|rheumatoid arthritis|rheumatoid arthritis
4696304|NCT03262038|intrathecal morphine|intrathecal morphine
4696305|NCT03262025|Primary cecal pathology|primary cecal pathology
4696306|NCT03262025|Emergency laparotomy|emergency laparotomy
4696307|NCT03262025|Ruptured liver abscess|ruptured liver abscess
4696308|NCT03262025|Right hemicolectomy|right hemicolectomy
4696309|NCT03262025|Conservative colonic resection|conservative colonic resection
4696310|NCT03262025|Fulminant amoebic colitis|fulminant amoebic colitis
4696311|NCT03262025|Ileocecal resection|ileocecal resection
4696312|NCT03262025|Ileoascending anastomosis|ileoascending anastomosis
4696313|NCT03262025|Ileotransverse anastomosis|ileotransverse anastomosis
4696314|NCT03262025|Cecal diverticulitis|cecal diverticulitis
4696315|NCT03262025|Amoebic typhilitis|amoebic typhilitis
4696316|NCT03262025|Idiopathic typhilitis|idiopathic typhilitis
4696317|NCT03261999|Prostate Neoplasm Cancer Carcinoma|prostate neoplasm cancer carcinoma
4696318|NCT03261986|Trident|trident
4696319|NCT03261986|RSA|rsa
4696320|NCT03261986|THA|tha
4696321|NCT03261947|Drug therapy|drug therapy
4696322|NCT03261934|Chronic Atrophic Gastritis|chronic atrophic gastritis
4696323|NCT03261934|Malignant Transformation|malignant transformation
4696324|NCT03261934|Risk Assessment|risk assessment
4696325|NCT03261934|Syndrome Evolution|syndrome evolution
4696326|NCT03261934|Traditional Chinese Medicine|traditional chinese medicine
4696327|NCT03261934|Registry Study|registry study
4696328|NCT03261869|Ice pack therapy, third molar surgery, swelling, pain, trismus|ice pack therapy, third molar surgery, swelling, pain, trismus
4696329|NCT03261856|Breath test|breath test
4696330|NCT03261856|SIBO|sibo
4696331|NCT03261856|GI|gi
4696332|NCT03261843|platelet rich plasma , posterior lumbar interbody fusion|platelet rich plasma , posterior lumbar interbody fusion
4696333|NCT03261830|Antibiotic|antibiotic
4696334|NCT03261830|Pediatric|pediatric
4696335|NCT03261817|web|web
4696336|NCT03261817|brain imaging|brain imaging
4696337|NCT03261817|heart rate variability|heart rate variability
4696338|NCT03261817|circadian cycles|circadian cycles
4696339|NCT03261817|cognition|cognition
4696340|NCT03261817|well-being|well-being
4696341|NCT03261817|hippocampus|hippocampus
4696342|NCT03261817|N acetyl aspartate|n acetyl aspartate
4696343|NCT03261817|white matter|white matter
4696344|NCT03261817|physical activity|physical activity
4696345|NCT03261791|hepatocellular carcinoma|hepatocellular carcinoma
4696346|NCT03261791|apatinib|apatinib
4696347|NCT03261791|portal vein invasion|portal vein invasion
4696348|NCT03261791|adjuvant therapy|adjuvant therapy
4696349|NCT03261791|resection|resection
4696350|NCT03261739|NAFLD, CB1 receptor blockade, anti-CB1 monoclonal antibody|nafld, cb1 receptor blockade, anti-cb1 monoclonal antibody
4696351|NCT03261726|unilateral deafness|unilateral deafness
4696352|NCT03261726|acoustic neuroma|acoustic neuroma
4696353|NCT03261726|cochlear implant|cochlear implant
4696354|NCT03261713|rehabilitation|rehabilitation
4696355|NCT03261713|telerehabilitation|telerehabilitation
4696356|NCT03261713|feasibility studies|feasibility studies
4696357|NCT03261713|virtual reality|virtual reality
4696358|NCT03261700|women Veterans|women veterans
4696359|NCT03261700|interpersonal violence|interpersonal violence
4696360|NCT03261687|pregnancy|pregnancy
4696361|NCT03261687|pelvic girdle pain|pelvic girdle pain
4696362|NCT03261687|hydrotherapy|hydrotherapy
4696363|NCT03261687|quality of life|quality of life
4696364|NCT03261687|physical therapy|physical therapy
4696365|NCT03261674|Insomnia|insomnia
4696366|NCT03261674|Traumatic Brain Injury|traumatic brain injury
4696367|NCT03261674|Cognitive Behavioral Therapy|cognitive behavioral therapy
4696368|NCT03261674|Veterans|veterans
4696369|NCT03261622|Sacral Nerve Stimulation|sacral nerve stimulation
4696370|NCT03261622|Sacral Nerve Modulation|sacral nerve modulation
4696371|NCT03261609|extremely preterm|extremely preterm
4696372|NCT03261609|young adults|young adults
4696373|NCT03261609|CVD risks factors|cvd risks factors
4696374|NCT03261609|inflammation|inflammation
4696375|NCT03261609|chronic health conditions|chronic health conditions
4696376|NCT03261609|term|term
4696377|NCT03261596|Soil-transmitted helminth|soil-transmitted helminth
4696378|NCT03261596|hookworm|hookworm
4696379|NCT03261596|hookworm infections|hookworm infections
4696380|NCT03261596|necator americanus|necator americanus
4696381|NCT03261596|ancylostoma duodenale|ancylostoma duodenale
4696382|NCT03261570|Postural Orthostatic Tachycardia Syndrome (POTS)|postural orthostatic tachycardia syndrome (pots)
4696383|NCT03261570|POTS|pots
4696384|NCT03261570|Orthostatic Intolerance|orthostatic intolerance
4696385|NCT03261570|Digoxin|digoxin
4696386|NCT03261570|Pyridostigmine|pyridostigmine
4696387|NCT03261570|Mestinon|mestinon
4696388|NCT03261531|Overweight|overweight
4696389|NCT03261531|Class I Obesity|class i obesity
4696390|NCT03261518|ileus|ileus
4696391|NCT03261518|Contrast-induced Nephropathy|contrast-induced nephropathy
4696392|NCT03261518|vena cava inferior|vena cava inferior
4696393|NCT03261505|fMRI|fmri
4696394|NCT03261505|acupuncture|acupuncture
4696395|NCT03261505|osteoarthritis|osteoarthritis
4696396|NCT03261479|pneumonia|pneumonia
4696397|NCT03261479|thermal imaging|thermal imaging
4697079|NCT03257579|Medication|medication
4696398|NCT03261479|respiratory distress|respiratory distress
4696399|NCT03261479|x-ray|x-ray
4696400|NCT03261479|thermal|thermal
4696401|NCT03261466|obesity|obesity
4696402|NCT03261466|paediatric|paediatric
4696403|NCT03261466|probiotic|probiotic
4696404|NCT03261401|Healthy Subjects|healthy subjects
4696405|NCT03261401|M5717|m5717
4696406|NCT03261401|Malaria|malaria
4696407|NCT03261401|Plasmodium falciparum|plasmodium falciparum
4696408|NCT03261349|Follicular lymphoma|follicular lymphoma
4696409|NCT03261349|MALT lymphoma|malt lymphoma
4696410|NCT03261349|Waldenström's macroglobulinemia|waldenström's macroglobulinemia
4696411|NCT03261349|Hepatitis C virus|hepatitis c virus
4696412|NCT03261323|Breast Reconstruction|breast reconstruction
4696413|NCT03261323|Mastectomy|mastectomy
4696414|NCT03261310|acetaminophen|acetaminophen
4696415|NCT03261310|pain|pain
4696416|NCT03261310|laminectomy|laminectomy
4696417|NCT03261310|craniotomy|craniotomy
4696418|NCT03261284|D-dimer|d-dimer
4696419|NCT03261284|Nonvalvular atrial fibrillation|nonvalvular atrial fibrillation
4696420|NCT03261284|Direct thrombin inhibitor|direct thrombin inhibitor
4696421|NCT03261284|INR|inr
4696422|NCT03261193|quadratus lumborum block|quadratus lumborum block
4696423|NCT03261193|post-operative pain|post-operative pain
4696424|NCT03261193|cesarean section pain|cesarean section pain
4696425|NCT03261193|analgesia|analgesia
4696426|NCT03261193|nerve block|nerve block
4696427|NCT03261167|Botulinum toxin A|botulinum toxin a
4696428|NCT03261167|Safety|safety
4696429|NCT03261167|post-stroke upper limb spasticity|post-stroke upper limb spasticity
4696430|NCT03261167|Efficacy|efficacy
4696431|NCT03261167|GSK1358820|gsk1358820
4696432|NCT03261167|double blind|double blind
4696433|NCT03261154|Serum iPTH|serum ipth
4696434|NCT03261154|Calcium|calcium
4696435|NCT03261154|Phosphate|phosphate
4696436|NCT03261128|cancer|cancer
4696437|NCT03261128|chemotherapy|chemotherapy
4696438|NCT03261115|Pain, Benzocaine, Clinical trial|pain, benzocaine, clinical trial
4696439|NCT03261102|IBD|ibd
4696440|NCT03261102|Crohn|crohn
4696441|NCT03261102|adalimumab|adalimumab
4696442|NCT03261102|ADAL|adal
4696443|NCT03261089|coma, prognosis, cardiac arrest|coma, prognosis, cardiac arrest
4696444|NCT03261076|Specific Learning Disorder|specific learning disorder
4696445|NCT03261076|Learning Disorders|learning disorders
4696446|NCT03261076|Neurodevelopmental Disorders|neurodevelopmental disorders
4696447|NCT03261076|Mental Disorders|mental disorders
4696448|NCT03261076|Developmental Reading Disability|developmental reading disability
4696449|NCT03261076|Reading Disorder|reading disorder
4696450|NCT03261076|Conduct Disorder|conduct disorder
4696451|NCT03261050|Eating disorder|eating disorder
4696452|NCT03261050|Counter attitudinal therapy|counter attitudinal therapy
4696453|NCT03261050|fMRI|fmri
4696454|NCT03261024|En-masse retraction , Class I bimaxillary protrusion|en-masse retraction , class i bimaxillary protrusion
4696455|NCT03261011|immunotherapy|immunotherapy
4696456|NCT03261011|immuno-oncology|immuno-oncology
4696457|NCT03261011|advanced solid tumors|advanced solid tumors
4696458|NCT03260920|oxytocin|oxytocin
4696459|NCT03260920|frontotemporal dementia|frontotemporal dementia
4696460|NCT03260920|apathy|apathy
4696461|NCT03260920|empathy|empathy
4696462|NCT03260907|Overactive bladder|overactive bladder
4696463|NCT03260907|menopause|menopause
4696464|NCT03260907|Postmenopausal overactive bladder|postmenopausal overactive bladder
4696465|NCT03260907|Electroacupuncture|electroacupuncture
4696466|NCT03260894|Renal cell carcinoma|renal cell carcinoma
4696467|NCT03260894|programmed cell death 1 (PD-1) inhibitor|programmed cell death 1 (pd-1) inhibitor
4696468|NCT03260894|indoleamine 2|indoleamine 2
4696469|NCT03260894|3-dioxygenase 1 (IDO1) inhibitor|3-dioxygenase 1 (ido1) inhibitor
4696470|NCT03260881|Epicardial Fat|epicardial fat
4696471|NCT03260855|Lymphoma|lymphoma
4696472|NCT03260855|Cancer survivorship|cancer survivorship
4696473|NCT03260855|Fear|fear
4696474|NCT03260842|early detection|early detection
4696475|NCT03260842|biomarkers|biomarkers
4696476|NCT03260842|pancreas cancer|pancreas cancer
4696477|NCT03260829|vitamin C|vitamin c
4696478|NCT03260829|palatally impacted canines|palatally impacted canines
4696479|NCT03260829|intraepidermal injection|intraepidermal injection
4696480|NCT03260816|Preschoolers|preschoolers
4696481|NCT03260816|Developmental Delay|developmental delay
4696482|NCT03260816|Disruptive Behavior|disruptive behavior
4696483|NCT03260816|Early Intervention|early intervention
4696484|NCT03260816|Parent-Child Interaction Therapy (PCIT)|parent-child interaction therapy (pcit)
4696485|NCT03260816|Telehealth|telehealth
4696486|NCT03260816|Telemental Health|telemental health
4696487|NCT03260816|Telepsychiatry|telepsychiatry
4696488|NCT03260803|osteopenia|osteopenia
4696489|NCT03260803|oligopin|oligopin
4696490|NCT03260803|postmenopause|postmenopause
4696491|NCT03260803|antioxidant|antioxidant
4696492|NCT03260803|bone|bone
4696493|NCT03260790|Vaccine|vaccine
4696494|NCT03260790|Pneumococcal|pneumococcal
4696495|NCT03260790|Pneumonia|pneumonia
4696496|NCT03260764|Multifocal Contact Lenses|multifocal contact lenses
4696497|NCT03260764|Bifocal Spectacles|bifocal spectacles
4696498|NCT03260764|Congenital Cataracts|congenital cataracts
4696499|NCT03260738|Chronic Low Back Pain|chronic low back pain
4696500|NCT03260738|Rehabilitation|rehabilitation
4696501|NCT03260738|Robot Poppy|robot poppy
4696502|NCT03260712|biliary tract cancer|biliary tract cancer
4696503|NCT03260712|metastitic cancer|metastitic cancer
4696504|NCT03260712|advanced cancer|advanced cancer
4696505|NCT03260712|pembrolizumab|pembrolizumab
4696506|NCT03260712|cisplatin|cisplatin
4696507|NCT03260712|gemcitabine|gemcitabine
4696508|NCT03260712|gallbladder cancer|gallbladder cancer
4696509|NCT03260673|cataract|cataract
4696510|NCT03260673|phacoemulsification|phacoemulsification
4696511|NCT03260673|type 2 diabetes mellitus|type 2 diabetes mellitus
4696512|NCT03260673|corneal endothelial cells|corneal endothelial cells
4696513|NCT03260634|voriconazole|voriconazole
4696514|NCT03260634|therapeutic drug monitoring|therapeutic drug monitoring
4696515|NCT03260608|dementia, deficits, burden, caregivers, telemedicine.|dementia, deficits, burden, caregivers, telemedicine.
4696516|NCT03260582|cardiac rehabilitation|cardiac rehabilitation
4696517|NCT03260582|eHealth|ehealth
4696518|NCT03260582|smartphone application|smartphone application
4696519|NCT03260569|Mechanical ventilation|mechanical ventilation
4696520|NCT03260569|Inhaled nitric oxide|inhaled nitric oxide
4696521|NCT03260556|pulmonary fibrosis|pulmonary fibrosis
4696522|NCT03260543|ginseng powder|ginseng powder
4696523|NCT03260543|Fatty Liver|fatty liver
4696524|NCT03260543|Clinical Trial|clinical trial
4696525|NCT03260491|Oncology|oncology
4696526|NCT03260491|Advanced Non-small Cell Lung Cancer|advanced non-small cell lung cancer
4696527|NCT03260491|Inoperable Non-small Cell Lung Cancer|inoperable non-small cell lung cancer
4696528|NCT03260491|Metastatic|metastatic
4696529|NCT03260491|Unresectable|unresectable
4696530|NCT03260491|Epidermal growth factor receptor|epidermal growth factor receptor
4696531|NCT03260491|EGFR|egfr
4696532|NCT03260478|Traumatic Brain Injury (TBI)|traumatic brain injury (tbi)
4696533|NCT03260478|Red Blood Cells (RBC) Transfusion|red blood cells (rbc) transfusion
4696534|NCT03260478|Intensive Care Unit (ICU)|intensive care unit (icu)
4696535|NCT03260478|Transfusion Threshold|transfusion threshold
4696536|NCT03260478|Anemia|anemia
4696537|NCT03260478|Oxygen Delivery|oxygen delivery
4696538|NCT03260478|Neurocritical Care|neurocritical care
4696539|NCT03260478|Critical Care Neurology and Trauma|critical care neurology and trauma
4696540|NCT03260465|total hip replacement|total hip replacement
4696541|NCT03260465|roentgen stereophotogrammetric analysis|roentgen stereophotogrammetric analysis
4696542|NCT03260452|Type 2 diabetes|type 2 diabetes
4696543|NCT03260452|Adipose tissue|adipose tissue
4696544|NCT03260452|Hematopoiesis|hematopoiesis
4696545|NCT03260452|Inflammation|inflammation
4696546|NCT03260452|Macrophages|macrophages
4696547|NCT03260439|tramadol-penile block -circumcision surgery-anesthesia-child|tramadol-penile block -circumcision surgery-anesthesia-child
4696548|NCT03260426|Tolerability diet after surgery|tolerability diet after surgery
4696549|NCT03260400|RPNI|rpni
4696550|NCT03260400|Regenerative Peripheral Nerve Interface|regenerative peripheral nerve interface
4696551|NCT03260335|Challenging behaviour|challenging behaviour
4696552|NCT03260335|Biofeedback|biofeedback
4696553|NCT03260335|Anxiety management|anxiety management
4696554|NCT03260322|Pembrolizumab|pembrolizumab
4696555|NCT03260322|Oncology|oncology
4696556|NCT03260322|Tumors|tumors
4696557|NCT03260322|ASP8374|asp8374
4696558|NCT03260322|Locally advanced or metastatic solid tumor malignancies|locally advanced or metastatic solid tumor malignancies
4696559|NCT03260296|smartphones addiction|smartphones addiction
4696560|NCT03260283|pethidine|pethidine
4696561|NCT03260257|Neurofeedback, Gamma band response|neurofeedback, gamma band response
4696562|NCT03260244|atrial fibrillation|atrial fibrillation
4696563|NCT03260244|atrial flutter|atrial flutter
4696564|NCT03260244|supraventricular tachycardia|supraventricular tachycardia
4696565|NCT03260244|ventricular tachycardia|ventricular tachycardia
4696566|NCT03260244|premature ventricular contractions|premature ventricular contractions
4696567|NCT03260244|cardiac mapping system|cardiac mapping system
4696568|NCT03260218|postoperative delirium|postoperative delirium
4696569|NCT03260218|elderly|elderly
4696570|NCT03260218|total joint replacement|total joint replacement
4696571|NCT03260218|risk factors for delirium|risk factors for delirium
4696572|NCT03260218|postoperative confusion|postoperative confusion
4696573|NCT03260205|SPD489|spd489
4696574|NCT03260205|Lisdexamfetamine dimesylate|lisdexamfetamine dimesylate
4696575|NCT03260205|ADHD|adhd
4696576|NCT03260205|hyperactivity|hyperactivity
4696577|NCT03260205|Neurobehavioral disorder|neurobehavioral disorder
4696578|NCT03260192|circulating tumor DNA|circulating tumor dna
4696579|NCT03260166|nicotinamide|nicotinamide
4696580|NCT03260166|lupus-associated skin lesion|lupus-associated skin lesion
4696581|NCT03260166|lupus erythematosus|lupus erythematosus
4696582|NCT03260153|Intracerebral Hemorrhage|intracerebral hemorrhage
4696583|NCT03260153|Perihematomal edema|perihematomal edema
4696584|NCT03260153|Deproteinised Calf Blood Serum Injection|deproteinised calf blood serum injection
4696585|NCT03260140|weight loss|weight loss
4696586|NCT03260140|lifestyle|lifestyle
4696587|NCT03260140|diet|diet
4696588|NCT03260140|exercise|exercise
4696589|NCT03260140|randomized controlled trial|randomized controlled trial
4696590|NCT03260127|PTSD|ptsd
4696591|NCT03260127|treatment|treatment
4696592|NCT03260127|posttraumatic stress disorder|posttraumatic stress disorder
4696593|NCT03260127|therapy|therapy
4696594|NCT03260127|cognition|cognition
4696595|NCT03260127|thinking|thinking
4696596|NCT03260127|executive function|executive function
4696597|NCT03260127|computer|computer
4696598|NCT03260127|training|training
4696599|NCT03260114|Physical activity|physical activity
4696600|NCT03260114|Body weight|body weight
4696601|NCT03260114|Obesity|obesity
4696602|NCT03260062|cochlear implants|cochlear implants
4696603|NCT03260062|language development|language development
4696604|NCT03260062|parenting intervention|parenting intervention
4696605|NCT03260062|maternal sensitivity|maternal sensitivity
4696606|NCT03260062|facilitative language techniques|facilitative language techniques
4696607|NCT03260036|Urea synthesis|urea synthesis
4696608|NCT03260036|Ammonia|ammonia
4696609|NCT03260036|Bariatric surgery|bariatric surgery
4696610|NCT03260023|Avelumab|avelumab
4696611|NCT03260023|Cancer|cancer
4696612|NCT03260023|Anti PD-L1|anti pd-l1
4696613|NCT03260023|Therapeutic Vaccine|therapeutic vaccine
4696614|NCT03259971|Rett syndrome|rett syndrome
4696615|NCT03259971|Tourette syndrome|tourette syndrome
4696616|NCT03259971|Probiotic|probiotic
4696617|NCT03259919|Metformin|metformin
4696618|NCT03259919|Pregnancy outcome|pregnancy outcome
4696619|NCT03259919|Androgens|androgens
4696620|NCT03259893|Proctor Conceptual Model of Implementation Research|proctor conceptual model of implementation research
4696621|NCT03259893|Prevention|prevention
4696622|NCT03259893|Safety net hospital|safety net hospital
4696623|NCT03259893|Diverse inner city patients|diverse inner city patients
4696624|NCT03259880|evaluation|evaluation
4696625|NCT03259867|Hepatocellular carcinoma|hepatocellular carcinoma
4696626|NCT03259867|Colorectal cancer|colorectal cancer
4696627|NCT03259867|Immune checkpoint inhibitor|immune checkpoint inhibitor
4696628|NCT03259867|Gastric cancer|gastric cancer
4696629|NCT03259867|Non-small cell lung cancer|non-small cell lung cancer
4696630|NCT03259828|Sigmoid colon cancer|sigmoid colon cancer
4696631|NCT03259828|Internal organ motion|internal organ motion
4696632|NCT03259828|Radiotherapy|radiotherapy
4696633|NCT03259815|FFR Targeted PCI|ffr targeted pci
4696634|NCT03259815|Post-PCI FFR|post-pci ffr
4696635|NCT03259776|Intensive Care|intensive care
4696636|NCT03259776|Patient- and Family-Centred Care|patient- and family-centred care
4696637|NCT03259776|Patient and Public Involvement|patient and public involvement
4696638|NCT03259776|South West London Major Trauma Network|south west london major trauma network
4696639|NCT03259776|Service Improvement|service improvement
4696640|NCT03259776|Survey Questionnaire|survey questionnaire
4696641|NCT03259776|Visitor Experiences|visitor experiences
4696642|NCT03259763|Gastroenterostomy|gastroenterostomy
4696643|NCT03259763|Gastric Outlet Obstruction|gastric outlet obstruction
4696644|NCT03259763|Cancer|cancer
4696645|NCT03259763|Endosonography|endosonography
4696646|NCT03259750|Self-reported outcome instrument|self-reported outcome instrument
4696647|NCT03259750|Sport|sport
4696648|NCT03259750|Ankle and foot|ankle and foot
4696649|NCT03259750|Injury|injury
4696650|NCT03259711|Cardiotoxicity|cardiotoxicity
4696651|NCT03259711|selective estrogen receptor modulators|selective estrogen receptor modulators
4696652|NCT03259711|aromatase inhibitors|aromatase inhibitors
4696653|NCT03259711|hormone replacement therapy|hormone replacement therapy
4696654|NCT03259711|estrogen|estrogen
4696655|NCT03259685|Non-nutritive sweeteners|non-nutritive sweeteners
4696656|NCT03259685|High Sugar Sweetened Beverages|high sugar sweetened beverages
4696657|NCT03259685|Diet|diet
4696658|NCT03259672|intubation|intubation
4696659|NCT03259672|pharyngitis|pharyngitis
4696660|NCT03259672|remifentanil|remifentanil
4696661|NCT03259633|Neurofibromatosis type1,|neurofibromatosis type1,
4696662|NCT03259633|Plexiform Neurofibromas|plexiform neurofibromas
4696663|NCT03259633|inoperable, progressive/symptomatic plexiform neurofibromas (PN) without any alternative therapeutic options|inoperable, progressive/symptomatic plexiform neurofibromas (pn) without any alternative therapeutic options
4696664|NCT03259633|mutation in the NF1 gene|mutation in the nf1 gene
4696665|NCT03259633|Selumetinib|selumetinib
4696666|NCT03259633|Early Access|early access
4696667|NCT03259633|Intermediate Access Protocol|intermediate access protocol
4696668|NCT03259607|Bioequivalence|bioequivalence
4696669|NCT03259594|Renal functional reserve|renal functional reserve
4696670|NCT03259594|Simple renal cysts|simple renal cysts
4696671|NCT03259594|Laparoscopic deroofing|laparoscopic deroofing
4696672|NCT03259581|transarterial chemoembolization|transarterial chemoembolization
4696673|NCT03259568|TMS|tms
4696674|NCT03259555|Brexpiprazole|brexpiprazole
4696675|NCT03259555|Bipolar|bipolar
4696676|NCT03259555|Manic episode|manic episode
4696677|NCT03259529|Diffuse Large B-cell Lymphoma|diffuse large b-cell lymphoma
4696678|NCT03259529|Nivolumab|nivolumab
4696679|NCT03259529|Bendamustine Hydrochloride|bendamustine hydrochloride
4696680|NCT03259529|Gemcitabine|gemcitabine
4696681|NCT03259529|Rituximab|rituximab
4696682|NCT03259516|myelodysplastic syndrome|myelodysplastic syndrome
4696683|NCT03259516|nivolumab|nivolumab
4696684|NCT03259516|5-azacitidine|5-azacitidine
4696685|NCT03259516|cytarabine|cytarabine
4696686|NCT03259516|melphalan|melphalan
4697080|NCT03257540|bunion|bunion
4696687|NCT03259516|all-trans retinoic acid|all-trans retinoic acid
4696688|NCT03259516|lymphodepletion|lymphodepletion
4696689|NCT03259503|Malignant neoplasms stated as primary lymphoid haematopoietic|malignant neoplasms stated as primary lymphoid haematopoietic
4696690|NCT03259503|Lymphoma|lymphoma
4696691|NCT03259503|Refractory|refractory
4696692|NCT03259503|Diffuse large B-cell lymphoma|diffuse large b-cell lymphoma
4696693|NCT03259503|DLBCL|dlbcl
4696694|NCT03259503|Palifermin|palifermin
4696695|NCT03259503|Kepivance|kepivance
4696696|NCT03259503|Olaparib|olaparib
4696697|NCT03259503|Lynparza|lynparza
4696698|NCT03259503|Vorinostat|vorinostat
4696699|NCT03259503|SAHA|saha
4696700|NCT03259503|Suberoylanilide Hydroxamic Acid|suberoylanilide hydroxamic acid
4696701|NCT03259503|MSK-390|msk-390
4696702|NCT03259503|Zolinza|zolinza
4696703|NCT03259503|Dexamethasone|dexamethasone
4696704|NCT03259503|Decadron|decadron
4696705|NCT03259503|Rituximab|rituximab
4696706|NCT03259503|Rituxan|rituxan
4696707|NCT03259503|Caphosol|caphosol
4696708|NCT03259503|Melphalan|melphalan
4696709|NCT03259503|Alkeran|alkeran
4696710|NCT03259503|Evomela|evomela
4696711|NCT03259503|Glutamine|glutamine
4696712|NCT03259503|Enterex|enterex
4696713|NCT03259503|Glutapak-10|glutapak-10
4696714|NCT03259503|NutreStore|nutrestore
4696715|NCT03259503|Resource|resource
4696716|NCT03259503|GlutaSolve|glutasolve
4696717|NCT03259503|Sympt-X G.I|sympt-x g.i
4696718|NCT03259503|Sympt-X|sympt-x
4696719|NCT03259503|Gemcitabine|gemcitabine
4696720|NCT03259503|Gemcitabine Hydrochloride|gemcitabine hydrochloride
4696721|NCT03259503|Gemzar|gemzar
4696722|NCT03259503|Busulfan|busulfan
4696723|NCT03259503|Busulfex|busulfex
4696724|NCT03259503|Myleran|myleran
4696725|NCT03259503|Pyridoxine|pyridoxine
4696726|NCT03259503|Autologous Stem-Cell Transplant|autologous stem-cell transplant
4696727|NCT03259503|ASCT|asct
4696728|NCT03259503|G-CSF|g-csf
4696729|NCT03259503|Filgrastim|filgrastim
4696730|NCT03259503|Neupogen|neupogen
4696731|NCT03259477|laparoscopic partial nephrectomy|laparoscopic partial nephrectomy
4696732|NCT03259477|precise segmental renal arterial clamping|precise segmental renal arterial clamping
4696733|NCT03259477|renal cell carcinoma|renal cell carcinoma
4696734|NCT03259477|renal functional reserve|renal functional reserve
4696735|NCT03259438|Qigong|qigong
4696736|NCT03259438|Comprehensive Health Improvement Program (CHIP)|comprehensive health improvement program (chip)
4696737|NCT03259438|Pre-Train Injury Prevention Program|pre-train injury prevention program
4696738|NCT03259438|Cancer Related Fatigue|cancer related fatigue
4696739|NCT03259438|Cancer Survivorship|cancer survivorship
4696740|NCT03259438|Inflammation|inflammation
4696741|NCT03259438|Flowmetry|flowmetry
4696742|NCT03259438|Corticomuscular coherence|corticomuscular coherence
4696743|NCT03259438|Heart Rate Variability|heart rate variability
4696744|NCT03259438|Neuroimmune Interactions|neuroimmune interactions
4696745|NCT03259438|Complex Systems Analysis|complex systems analysis
4696746|NCT03259438|Female|female
4696747|NCT03259425|Resectable Stage IIIB, IIIC, and IVM1a|resectable stage iiib, iiic, and ivm1a
4696748|NCT03259373|AF|af
4696749|NCT03259373|AFib|afib
4696750|NCT03259373|OAC|oac
4696751|NCT03259373|Atrial fibrillation|atrial fibrillation
4696752|NCT03259373|Oral anticoagulant|oral anticoagulant
4696753|NCT03259373|Education|education
4696754|NCT03259360|Tobacco|tobacco
4696755|NCT03259360|Gender Identity Minority|gender identity minority
4696756|NCT03259360|Sexual Identity Minority|sexual identity minority
4696757|NCT03259360|Cessation|cessation
4696758|NCT03259360|Intervention|intervention
4696759|NCT03259360|Young Adults|young adults
4696760|NCT03259360|Social Media|social media
4696761|NCT03259360|Internet|internet
4696762|NCT03259360|Cigarette|cigarette
4696763|NCT03259321|Fish|fish
4696764|NCT03259321|Polyunsaturated fatty acids|polyunsaturated fatty acids
4696765|NCT03259321|CHNS|chns
4696766|NCT03259295|skin tag|skin tag
4696767|NCT03259243|Bupivacaine, Port site infiltration ,Postoperative pain ,Gynecologic laparoscopy|bupivacaine, port site infiltration ,postoperative pain ,gynecologic laparoscopy
4696768|NCT03259230|Hemophagocytic Lymphohistiocytosis|hemophagocytic lymphohistiocytosis
4696769|NCT03259230|Malignancy-Associated Hemophagocytic Lymphohistiocytosis|malignancy-associated hemophagocytic lymphohistiocytosis
4696770|NCT03259230|M-HLH|m-hlh
4696771|NCT03259230|Patients with known diagnosis of malignancy without HLH|patients with known diagnosis of malignancy without hlh
4696772|NCT03259230|Interferon Gamma|interferon gamma
4696773|NCT03259230|IFNγ|ifnγ
4696774|NCT03259230|Biomarkers|biomarkers
4696775|NCT03259230|Inflammatory Markers|inflammatory markers
4696776|NCT03259230|Blood draws|blood draws
4696777|NCT03259230|Data collection|data collection
4696778|NCT03259204|Achilles tendon|achilles tendon
4696779|NCT03259204|Microdialysis|microdialysis
4696780|NCT03259204|Immobilization|immobilization
4696781|NCT03259204|Wound healing|wound healing
4696782|NCT03259204|Intermittent Pneumatic Compression|intermittent pneumatic compression
4696783|NCT03259204|Ultrasonography|ultrasonography
4696784|NCT03259191|Anti-reflux mucosectomy,refractory gastroesophageal reflux disease,safety,efficacy|anti-reflux mucosectomy,refractory gastroesophageal reflux disease,safety,efficacy
4697187|NCT03256903|emergency|emergency
4696785|NCT03259178|Binocular vision test|binocular vision test
4696786|NCT03259165|Heart Failure|heart failure
4696787|NCT03259165|Acute Heart Failure|acute heart failure
4696788|NCT03259165|Pulmonary Edema|pulmonary edema
4696789|NCT03259165|Lung Ultrasound|lung ultrasound
4696790|NCT03259165|Extra vascular lung water|extra vascular lung water
4696791|NCT03259165|B-lines|b-lines
4696792|NCT03259165|Diuretics|diuretics
4696793|NCT03259165|Nitrates|nitrates
4696794|NCT03259152|Giant cell tumor of bone|giant cell tumor of bone
4696795|NCT03259152|Denousmab|denousmab
4696796|NCT03259152|Pathologic|pathologic
4696797|NCT03259152|Clinical|clinical
4696798|NCT03259152|Mechansim|mechansim
4696799|NCT03259139|adolescent|adolescent
4696800|NCT03259139|gun|gun
4696801|NCT03259139|violence|violence
4696802|NCT03259139|media|media
4696803|NCT03259126|Transradial|transradial
4696804|NCT03259126|Coronary|coronary
4696805|NCT03259126|X-ray|x-ray
4696806|NCT03259126|Radiation|radiation
4696807|NCT03259126|Curtain|curtain
4696808|NCT03259113|insertable cardiac monitor|insertable cardiac monitor
4696809|NCT03259113|atrial fibrillation|atrial fibrillation
4696810|NCT03259113|non-sustained ventricular tachycardia|non-sustained ventricular tachycardia
4696811|NCT03259074|ankylosing spondylitis, AS, secukinumab, GP2017, adalimumab biosimilar, mSASSS, ASAS20|ankylosing spondylitis, as, secukinumab, gp2017, adalimumab biosimilar, msasss, asas20
4696812|NCT03259009|colorectal cancer|colorectal cancer
4696813|NCT03259009|anti-EGFR therapy|anti-egfr therapy
4696814|NCT03259009|rechallenge|rechallenge
4696815|NCT03259009|circulating tumor DNA|circulating tumor dna
4696816|NCT03259009|biomarker|biomarker
4696817|NCT03259009|RAS mutations|ras mutations
4696818|NCT03258996|Gingival recession|gingival recession
4696819|NCT03258996|Class III gingival recession|class iii gingival recession
4696820|NCT03258996|Multiples gingival recessions|multiples gingival recessions
4696821|NCT03258996|Periodontitis|periodontitis
4696822|NCT03258996|Mucogingival surgery|mucogingival surgery
4696823|NCT03258996|Modified vestibular incision subperiosteal tunnel access|modified vestibular incision subperiosteal tunnel access
4696824|NCT03258996|Coronally advanced flap|coronally advanced flap
4696825|NCT03258996|Connective tissue graft|connective tissue graft
4696826|NCT03258996|Post-surgical pain|post-surgical pain
4696827|NCT03258983|Alpha-linolenic acid|alpha-linolenic acid
4696828|NCT03258983|Dietary intake|dietary intake
4696829|NCT03258983|Adipose tissue|adipose tissue
4696830|NCT03258983|Nutritional epidemiology|nutritional epidemiology
4696831|NCT03258970|vitamin supplement|vitamin supplement
4696832|NCT03258970|Vitamin C|vitamin c
4696833|NCT03258970|Vitamin E|vitamin e
4696834|NCT03258905|transition-age youth|transition-age youth
4696835|NCT03258905|mobile app|mobile app
4696836|NCT03258905|grounding|grounding
4696837|NCT03258905|Seeking Safety|seeking safety
4696838|NCT03258879|Combined spinal epidural analgesia, dural puncture epidural|combined spinal epidural analgesia, dural puncture epidural
4696839|NCT03258866|thrombocytopenia|thrombocytopenia
4696840|NCT03258866|Immune Thrombocytopenia|immune thrombocytopenia
4696841|NCT03258866|purpura|purpura
4696842|NCT03258853|cystic fibrosis|cystic fibrosis
4696843|NCT03258853|insulin|insulin
4696844|NCT03258853|glucagon|glucagon
4696845|NCT03258853|continuous glucose monitor|continuous glucose monitor
4696846|NCT03258853|bionic pancreas|bionic pancreas
4696847|NCT03258840|EPA|epa
4696848|NCT03258840|Paraoxonase 1|paraoxonase 1
4696849|NCT03258840|Paraoxonase 2|paraoxonase 2
4696850|NCT03258840|Type 2 diabetes|type 2 diabetes
4696851|NCT03258827|elderly|elderly
4696852|NCT03258827|sarcopenia|sarcopenia
4696853|NCT03258827|strengthening exercise|strengthening exercise
4696854|NCT03258814|axial spondyloarthritis|axial spondyloarthritis
4696855|NCT03258814|active supervised training|active supervised training
4696856|NCT03258814|physical training|physical training
4696857|NCT03258814|adalimumab|adalimumab
4696858|NCT03258814|spinal mobility|spinal mobility
4696859|NCT03258814|physiotherapy|physiotherapy
4696860|NCT03258814|physical function|physical function
4696861|NCT03258814|health-related quality of life|health-related quality of life
4696862|NCT03258814|pain|pain
4696863|NCT03258814|disease activity|disease activity
4696864|NCT03258814|psychosocial risk factors|psychosocial risk factors
4696865|NCT03258814|workability|workability
4696866|NCT03258814|Bath Ankylosing Spondylitis Metrology Index (BASMI)|bath ankylosing spondylitis metrology index (basmi)
4696867|NCT03258775|RMR|rmr
4696868|NCT03258775|hydration|hydration
4696869|NCT03258775|substrate oxidation|substrate oxidation
4696870|NCT03258762|Japanese|japanese
4696871|NCT03258762|Caucasian|caucasian
4696872|NCT03258762|pharmacokinetics|pharmacokinetics
4696873|NCT03258762|pyrimethamine|pyrimethamine
4696874|NCT03258762|toxoplasmosis|toxoplasmosis
4696875|NCT03258749|COPD|copd
4696876|NCT03258749|GOLD|gold
4696877|NCT03258749|formoterol|formoterol
4696878|NCT03258749|tiotropium|tiotropium
4696879|NCT03258736|pediatric, inguinal hernia, caudal, ilioinguinal/ilioihypogastric|pediatric, inguinal hernia, caudal, ilioinguinal/ilioihypogastric
4696880|NCT03258710|Tenofovir Disoproxil Fumarate|tenofovir disoproxil fumarate
4696881|NCT03258710|safety|safety
4696882|NCT03258710|chronic hepatitis B|chronic hepatitis b
4696883|NCT03258710|virological effect|virological effect
4696884|NCT03258697|Local analgesia, Pharmacokinetics, Total joint replacement|local analgesia, pharmacokinetics, total joint replacement
4696885|NCT03258684|corticosteroid|corticosteroid
4696886|NCT03258684|hydrocortisone|hydrocortisone
4696887|NCT03258684|septic shock|septic shock
4696888|NCT03258684|thiamine|thiamine
4696889|NCT03258684|vitamin C|vitamin c
4696890|NCT03258658|Urethral Stricture|urethral stricture
4696891|NCT03258632|Alcohol Use Disorder|alcohol use disorder
4696892|NCT03258606|Research Participants|research participants
4696893|NCT03258606|Retrospective Review|retrospective review
4696894|NCT03258606|Capacity Assignment|capacity assignment
4696895|NCT03258606|Cognitive Impairment|cognitive impairment
4696896|NCT03258606|Assent|assent
4696897|NCT03258593|Carcinoma-in-situ|carcinoma-in-situ
4696898|NCT03258593|High-grade Ta or T1 disease|high-grade ta or t1 disease
4696899|NCT03258593|Papillary Tumors|papillary tumors
4696900|NCT03258580|Pain|pain
4696901|NCT03258580|Visual Analogue Pain Scale|visual analogue pain scale
4696902|NCT03258580|Healthy Volunteer|healthy volunteer
4696903|NCT03258580|Social Cognition|social cognition
4696904|NCT03258580|Eye Movement|eye movement
4696905|NCT03258567|Monoclonal Antibody|monoclonal antibody
4696906|NCT03258541|TraceIT®|traceit®
4696907|NCT03258541|Hydrogel spacer|hydrogel spacer
4696908|NCT03258541|Rectal cancer|rectal cancer
4696909|NCT03258515|Mesenchymal epithelial transition (MET) receptor|mesenchymal epithelial transition (met) receptor
4696910|NCT03258515|Small molecule kinase inhibitors|small molecule kinase inhibitors
4696911|NCT03258515|Moxifloxacin (Avelox)|moxifloxacin (avelox)
4696912|NCT03258515|QT prolongation|qt prolongation
4696913|NCT03258437|sperm motility, Clinical Trial , DA-9401|sperm motility, clinical trial , da-9401
4696914|NCT03258385|Vitamin B12, Fortified milk, Immunity, Child development|vitamin b12, fortified milk, immunity, child development
4696915|NCT03258359|MDS|mds
4696916|NCT03258346|Pomegranate Juice|pomegranate juice
4696917|NCT03258346|Functional Tasks of Living|functional tasks of living
4696918|NCT03258333|aortic stenosis, aortic valve replacement, pericardium|aortic stenosis, aortic valve replacement, pericardium
4696919|NCT03258320|Cabazitaxel|cabazitaxel
4696920|NCT03258320|Docetaxel|docetaxel
4696921|NCT03258320|Mitoxantrone|mitoxantrone
4696922|NCT03258320|Satraplatin|satraplatin
4696923|NCT03258320|Surgery|surgery
4696924|NCT03258320|Prostate Cancer|prostate cancer
4696925|NCT03258320|Localized|localized
4696926|NCT03258320|High Risk|high risk
4696927|NCT03258294|melatonin|melatonin
4696928|NCT03258294|sleep disturbances|sleep disturbances
4696929|NCT03258229|Angelica gigas N. extract|angelica gigas n. extract
4696930|NCT03258229|Glucose|glucose
4696931|NCT03258229|Clinical Trial|clinical trial
4696932|NCT03258216|Upper gastrointestinal disorders|upper gastrointestinal disorders
4696933|NCT03258216|Automatic tongue diagnosis system|automatic tongue diagnosis system
4696934|NCT03258216|Panendoscopy|panendoscopy
4696935|NCT03258190|Urolithaisis|urolithaisis
4696936|NCT03258190|Recurrence|recurrence
4696937|NCT03258190|Citrate|citrate
4696938|NCT03258190|Antioxidants|antioxidants
4696939|NCT03258190|Lime Powder Regimen|lime powder regimen
4696940|NCT03258177|Virtual Visits|virtual visits
4696941|NCT03258177|Telehealth|telehealth
4696942|NCT03258138|Pragmatic|pragmatic
4696943|NCT03258138|Pilot study|pilot study
4696944|NCT03258138|Mixed methods|mixed methods
4696945|NCT03258138|Randomized controlled trial|randomized controlled trial
4696946|NCT03258138|Implementation research|implementation research
4696947|NCT03258138|Person-centered care|person-centered care
4696948|NCT03258138|Multidisciplinary|multidisciplinary
4696949|NCT03258138|Ecological approach|ecological approach
4696950|NCT03258073|maternal|maternal
4696951|NCT03258073|newborn|newborn
4696952|NCT03258073|resuscitation|resuscitation
4696953|NCT03258073|emergencies|emergencies
4696954|NCT03258073|medical simulation|medical simulation
4696955|NCT03258060|Heart Failure|heart failure
4696956|NCT03258060|Pacing|pacing
4696957|NCT03258060|Resynchronization|resynchronization
4696958|NCT03258060|Electrophysiology|electrophysiology
4696959|NCT03258060|Imaging|imaging
4696960|NCT03258060|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
4696961|NCT03258034|Conversion therapy|conversion therapy
4696962|NCT03258021|Glioblastoma|glioblastoma
4696963|NCT03258021|GBM|gbm
4696964|NCT03258021|Tumor-treating fields|tumor-treating fields
4696965|NCT03258021|TTFields|ttfields
4696966|NCT03258008|Malignant neoplasms of lip oral cavity and pharynx|malignant neoplasms of lip oral cavity and pharynx
4696967|NCT03258008|Malignant neoplasms of ill-defined secondary and unspecified sites|malignant neoplasms of ill-defined secondary and unspecified sites
4696968|NCT03258008|Oropharyngeal Cancer|oropharyngeal cancer
4696969|NCT03258008|Oropharyngeal squamous cell carcinoma|oropharyngeal squamous cell carcinoma
4696970|NCT03258008|OPSCC|opscc
4696971|NCT03258008|Human Papillomavirus - positive (HPV+)|human papillomavirus - positive (hpv+)
4696972|NCT03258008|Utomilumab|utomilumab
4696973|NCT03258008|PF-05082566|pf-05082566
4696974|NCT03258008|Anti-CD137|anti-cd137
4696975|NCT03258008|ISA101b|isa101b
4697076|NCT03257605|Medication Therapy Management|medication therapy management
4697077|NCT03257579|Myocardial Infarction|myocardial infarction
4696976|NCT03257995|asthma, asthma attack, difficulty breathing, bronchial diseases, lung, lung diseases, inhaled drugs, bronchodilator, inhaled corticosteriod|asthma, asthma attack, difficulty breathing, bronchial diseases, lung, lung diseases, inhaled drugs, bronchodilator, inhaled corticosteriod
4696977|NCT03257982|Brain-computer interface|brain-computer interface
4696978|NCT03257982|Functional electrical stimulation|functional electrical stimulation
4696979|NCT03257969|Oral chemotherapy|oral chemotherapy
4696980|NCT03257969|Health related program|health related program
4696981|NCT03257969|Secured drug intake|secured drug intake
4696982|NCT03257969|Pharmacist intervention|pharmacist intervention
4696983|NCT03257969|Cancer outpatient|cancer outpatient
4696984|NCT03257917|Financial Burden|financial burden
4696985|NCT03257917|Out of Pocket expenses|out of pocket expenses
4696986|NCT03257917|Time spent on Healthcare|time spent on healthcare
4696987|NCT03257917|Metastatic Breast Cancer|metastatic breast cancer
4696988|NCT03257904|intracranial pressure|intracranial pressure
4696989|NCT03257891|Adrenocortical Carcinoma|adrenocortical carcinoma
4696990|NCT03257891|Cabazitaxel|cabazitaxel
4696991|NCT03257865|Brexpiprazole|brexpiprazole
4696992|NCT03257865|Bipolar|bipolar
4696993|NCT03257865|Manic episode|manic episode
4696994|NCT03257852|Methotrexate|methotrexate
4696995|NCT03257852|Arthritis, Rheumatoid|arthritis, rheumatoid
4696996|NCT03257852|ASP5094|asp5094
4696997|NCT03257839|SoftVue|softvue
4696998|NCT03257839|Dense Breast Tissue|dense breast tissue
4696999|NCT03257839|Breast Screening|breast screening
4697000|NCT03257839|Abnormal Breast|abnormal breast
4697001|NCT03257839|Normal Breast|normal breast
4697002|NCT03257839|Breast Imaging|breast imaging
4697003|NCT03257839|Breast Biopsy|breast biopsy
4697004|NCT03257839|Mammography|mammography
4697005|NCT03257839|Tomosynthesis|tomosynthesis
4697006|NCT03257839|Automated Breast Ultrasound|automated breast ultrasound
4697007|NCT03257839|Breast Cancer|breast cancer
4697008|NCT03257839|Breast Carcinoma|breast carcinoma
4697009|NCT03257839|Breast Tumors|breast tumors
4697010|NCT03257839|Mammary Carcinoma|mammary carcinoma
4697011|NCT03257839|Malignant Breast Tumor|malignant breast tumor
4697012|NCT03257839|Mammary Neoplasm|mammary neoplasm
4697013|NCT03257839|Mammary Cancer|mammary cancer
4697014|NCT03257839|ABUS|abus
4697015|NCT03257839|AWBUS|awbus
4697016|NCT03257839|Breast Tomography|breast tomography
4697017|NCT03257839|ATUS|atus
4697018|NCT03257839|ABTUS|abtus
4697019|NCT03257839|Mammogram|mammogram
4697020|NCT03257839|3D Mammogram|3d mammogram
4697021|NCT03257839|3D ABUS|3d abus
4697022|NCT03257839|3D Breast Ultrasound|3d breast ultrasound
4697023|NCT03257839|DBT|dbt
4697024|NCT03257839|FFDM|ffdm
4697025|NCT03257839|Digital Mammography|digital mammography
4697026|NCT03257839|Breast Ultrasound|breast ultrasound
4697027|NCT03257839|Dense Breasts|dense breasts
4697028|NCT03257839|Breast Density|breast density
4697029|NCT03257839|Dense Parenchyma|dense parenchyma
4697030|NCT03257839|Asymptomatic|asymptomatic
4697031|NCT03257839|Delphinus|delphinus
4697032|NCT03257839|Delphinus Medical Technologies|delphinus medical technologies
4697033|NCT03257839|Screening Breast Ultrasound|screening breast ultrasound
4697034|NCT03257826|congenital pseudarthrosis of the tibia|congenital pseudarthrosis of the tibia
4697035|NCT03257826|age of surgery|age of surgery
4697036|NCT03257826|Percutaneous Kirschner wire|percutaneous kirschner wire
4697037|NCT03257813|timolol|timolol
4697038|NCT03257813|dorzolamide|dorzolamide
4697039|NCT03257813|brimonidine|brimonidine
4697040|NCT03257813|Glaucoma|glaucoma
4697041|NCT03257813|Ocular hypertension|ocular hypertension
4697042|NCT03257800|ketamine|ketamine
4697043|NCT03257800|Propofol|propofol
4697044|NCT03257800|laryngeal masks|laryngeal masks
4697045|NCT03257800|anesthesia|anesthesia
4697046|NCT03257800|child|child
4697047|NCT03257722|Non Small Cell Lung Cancer|non small cell lung cancer
4697048|NCT03257722|Metastasis|metastasis
4697049|NCT03257722|Recurrence|recurrence
4697050|NCT03257722|Immunotherapy|immunotherapy
4697051|NCT03257670|Dyspareunia|dyspareunia
4697052|NCT03257670|Laser|laser
4697053|NCT03257670|CO2|co2
4697054|NCT03257670|Breast Cancer|breast cancer
4697055|NCT03257670|Vaginal Atrophy|vaginal atrophy
4697056|NCT03257670|Lidocaine|lidocaine
4697057|NCT03257644|Atopic dermatitis|atopic dermatitis
4697058|NCT03257644|Janus kinase (JAK) inhibitor|janus kinase (jak) inhibitor
4697059|NCT03257644|pediatric|pediatric
4697060|NCT03257644|inflammation|inflammation
4697061|NCT03257631|Pediatric|pediatric
4697062|NCT03257631|Brain Tumor|brain tumor
4697063|NCT03257631|Central Nervous System Neoplasms|central nervous system neoplasms
4697064|NCT03257631|Glioma|glioma
4697065|NCT03257631|High-grade glioma|high-grade glioma
4697066|NCT03257631|HGG|hgg
4697067|NCT03257631|Ependymoma|ependymoma
4697068|NCT03257631|Medulloblastoma|medulloblastoma
4697069|NCT03257631|DIPG|dipg
4697070|NCT03257631|Diffuse intrinsic pontine gliomaProgressive|diffuse intrinsic pontine gliomaprogressive
4697071|NCT03257631|RecurrentPomalidomide|recurrentpomalidomide
4697072|NCT03257631|PomalystImnovid|pomalystimnovid
4697073|NCT03257631|CC-4047|cc-4047
4697074|NCT03257631|Children|children
4697075|NCT03257605|Pharmacogenomics|pharmacogenomics
4697078|NCT03257579|Adherence|adherence
4697081|NCT03257540|early weight-bearing|early weight-bearing
4697082|NCT03257540|Lapidus|lapidus
4697083|NCT03257540|arthrodesis|arthrodesis
4697084|NCT03257540|intramedullary nail|intramedullary nail
4697085|NCT03257540|Hallux Valgus|hallux valgus
4697086|NCT03257527|Well-being|well-being
4697087|NCT03257527|Comparative Clinical Trial|comparative clinical trial
4697088|NCT03257527|Positive Psychology Intervention|positive psychology intervention
4697089|NCT03257527|Mindfulness Based Stress Reduction (MBSR)|mindfulness based stress reduction (mbsr)
4697090|NCT03257527|Group Therapy|group therapy
4697091|NCT03257527|Happiness|happiness
4697092|NCT03257527|Bibliotherapy|bibliotherapy
4697093|NCT03257475|cervical cance|cervical cance
4697094|NCT03257475|vaginal radiation injury|vaginal radiation injury
4697095|NCT03257475|PIBS|pibs
4697096|NCT03257475|R-V|r-v
4697097|NCT03257475|VRL|vrl
4697098|NCT03257462|17-hydroxyprogesterone|17-hydroxyprogesterone
4697099|NCT03257449|Body Weight|body weight
4697100|NCT03257449|Weight loss|weight loss
4697101|NCT03257449|BMI|bmi
4697102|NCT03257449|Waist Circumference|waist circumference
4697103|NCT03257449|Body Fat Percentage|body fat percentage
4697104|NCT03257449|Viscofiber|viscofiber
4697105|NCT03257449|Viscous Fibres|viscous fibres
4697106|NCT03257449|supplement|supplement
4697107|NCT03257436|Pacing|pacing
4697108|NCT03257423|Uncomplicated acute appendicitis|uncomplicated acute appendicitis
4697109|NCT03257423|Complicated acute appendicitis|complicated acute appendicitis
4697110|NCT03257423|Antibiotic therapy|antibiotic therapy
4697111|NCT03257423|Microbiological etiology|microbiological etiology
4697112|NCT03257358|Relapsing Multiple Sclerosis|relapsing multiple sclerosis
4697113|NCT03257358|RMS|rms
4697114|NCT03257358|Relapsing Multiple Sclerosis (RMS)|relapsing multiple sclerosis (rms)
4697115|NCT03257358|Multiple Sclerosis|multiple sclerosis
4697116|NCT03257358|MS|ms
4697117|NCT03257358|Multiple Sclerosis (MS)|multiple sclerosis (ms)
4697118|NCT03257358|Fingolimod|fingolimod
4697119|NCT03257358|FLUENT|fluent
4697120|NCT03257358|Immune Phenotype|immune phenotype
4697121|NCT03257345|Real world outcomes|real world outcomes
4697122|NCT03257332|Rectum cancer|rectum cancer
4697123|NCT03257332|Low Anterior Rectal Syndrome|low anterior rectal syndrome
4697124|NCT03257332|Anorectal muscle function|anorectal muscle function
4697125|NCT03257306|Urinary tract stone|urinary tract stone
4697126|NCT03257306|ureter double-J stent|ureter double-j stent
4697127|NCT03257254|GSV|gsv
4697128|NCT03257254|AASV|aasv
4697129|NCT03257254|Vein|vein
4697130|NCT03257254|Venous|venous
4697131|NCT03257254|Ulcer|ulcer
4697132|NCT03257254|Vericose Vein|vericose vein
4697133|NCT03257254|VLU|vlu
4697134|NCT03257254|venous insufficiency|venous insufficiency
4697135|NCT03257254|venous disease|venous disease
4697136|NCT03257254|chronic VLU|chronic vlu
4697137|NCT03257241|aml|aml
4697138|NCT03257241|acute myeloid leukemia|acute myeloid leukemia
4697139|NCT03257241|DAC|dac
4697140|NCT03257241|DA-90|da-90
4697141|NCT03257241|FLAG-IDA|flag-ida
4697142|NCT03257241|CLAG-M|clag-m
4697143|NCT03257241|Ara-C|ara-c
4697144|NCT03257241|HiDAC|hidac
4697145|NCT03257215|Vitamin D|vitamin d
4697146|NCT03257202|Propionibacterium Acnes|propionibacterium acnes
4697147|NCT03257202|Surgical Site Infection|surgical site infection
4697148|NCT03257202|Shoulder|shoulder
4697149|NCT03257137|sleep|sleep
4697150|NCT03257137|macronutrients|macronutrients
4697151|NCT03257137|dietary patterns|dietary patterns
4697152|NCT03257137|sleep quality|sleep quality
4697153|NCT03257137|diet quality|diet quality
4697154|NCT03257137|polysomnography|polysomnography
4697155|NCT03257137|appetite|appetite
4697156|NCT03257137|mood|mood
4697157|NCT03257137|hunger|hunger
4697158|NCT03257111|rehabilitation outcomes|rehabilitation outcomes
4697159|NCT03257111|activity level|activity level
4697160|NCT03257098|Chronic Venous Ulcer|chronic venous ulcer
4697161|NCT03257098|ABCB5|abcb5
4697162|NCT03257098|Allogeneic|allogeneic
4697163|NCT03257098|Mesenchymal stem cells|mesenchymal stem cells
4697164|NCT03257098|varicose ulcer|varicose ulcer
4697165|NCT03257098|skin ulcer|skin ulcer
4697166|NCT03257098|advanced therapy medicinal product|advanced therapy medicinal product
4697167|NCT03257098|somatic cell therapy|somatic cell therapy
4697168|NCT03257098|phase I/IIa|phase i/iia
4697169|NCT03257072|hookworm|hookworm
4697170|NCT03257072|controlled human infection model|controlled human infection model
4697171|NCT03257020|OCT|oct
4697172|NCT03257020|RNFL|rnfl
4697173|NCT03257020|BMO-MRW|bmo-mrw
4697174|NCT03257020|Glaucoma|glaucoma
4697175|NCT03256981|SBRT|sbrt
4697176|NCT03256981|Oligoprogressive disease|oligoprogressive disease
4697177|NCT03256981|NSCLC|nsclc
4697178|NCT03256981|TKI|tki
4697179|NCT03256955|Validation study for a neuromuscular monitoring device|validation study for a neuromuscular monitoring device
4697180|NCT03256929|Personalized Diet|personalized diet
4697181|NCT03256929|Microbiota|microbiota
4697182|NCT03256929|Depression|depression
4697183|NCT03256929|Elderly|elderly
4697184|NCT03256929|Gut flora|gut flora
4697185|NCT03256916|Cervical cancer|cervical cancer
4697186|NCT03256903|Methoxyflurane|methoxyflurane
4697188|NCT03256903|trauma pain|trauma pain
4697189|NCT03256903|inhaled analgesia|inhaled analgesia
4697190|NCT03256890|mindfulness|mindfulness
4697191|NCT03256890|blood pressure|blood pressure
4697192|NCT03256890|hypertension|hypertension
4697193|NCT03256890|prehypertension|prehypertension
4697194|NCT03256890|self regulation|self regulation
4697195|NCT03256890|Science of Behavior Change|science of behavior change
4697196|NCT03256890|attention control|attention control
4697197|NCT03256890|self awareness|self awareness
4697198|NCT03256890|emotion regulation|emotion regulation
4697199|NCT03256838|Citric Acid|citric acid
4697200|NCT03256838|Ferric Compounds|ferric compounds
4697201|NCT03256838|Renal Insufficiency|renal insufficiency
4697202|NCT03256838|Anticoagulants|anticoagulants
4697203|NCT03256838|Calcium Chelating Agents|calcium chelating agents
4697204|NCT03256838|Chelating Agents|chelating agents
4697205|NCT03256838|Sequestering Agents|sequestering agents
4697206|NCT03256838|Hemodialysis|hemodialysis
4697207|NCT03256838|Dialysis|dialysis
4697208|NCT03256838|Renal Failure|renal failure
4697209|NCT03256838|Kidney Failure|kidney failure
4697210|NCT03256838|Urologic Diseases|urologic diseases
4697211|NCT03256838|Metabolic Disease|metabolic disease
4697212|NCT03256838|Kidney Diseases|kidney diseases
4697213|NCT03256838|Renal Insufficiency, Chronic|renal insufficiency, chronic
4697214|NCT03256825|Diagnostic accuracy|diagnostic accuracy
4697215|NCT03256825|Anti-bacterial agents|anti-bacterial agents
4697216|NCT03256825|Decision support systems, clinical|decision support systems, clinical
4697217|NCT03256812|Arrhythmias, Atrial Fibrillation|arrhythmias, atrial fibrillation
4697218|NCT03256786|cesarean delivery with spinal anesthesia|cesarean delivery with spinal anesthesia
4697219|NCT03256786|Hypothermia and shivering|hypothermia and shivering
4697220|NCT03256786|Active warming|active warming
4697221|NCT03256760|Insomnia, depression|insomnia, depression
4697222|NCT03256747|Diabetes Mellitus|diabetes mellitus
4697223|NCT03256747|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
4697224|NCT03256747|Glucose Metabolism Disorders|glucose metabolism disorders
4697225|NCT03256747|Metabolic Diseases|metabolic diseases
4697226|NCT03256747|Endocrine System Diseases|endocrine system diseases
4697227|NCT03256721|apatinib docetaxel pemetrexed|apatinib docetaxel pemetrexed
4697228|NCT03256708|antibiotic-associated diarrhea|antibiotic-associated diarrhea
4697229|NCT03256708|probiotic|probiotic
4697230|NCT03256708|prebiotic|prebiotic
4697231|NCT03256708|placebo|placebo
4697232|NCT03256708|synbiotic|synbiotic
4697233|NCT03256682|Resilience|resilience
4697234|NCT03256682|Mobile video counseling|mobile video counseling
4697235|NCT03256682|Emotiona labor|emotiona labor
4697236|NCT03256643|traumatic brain injury|traumatic brain injury
4697237|NCT03256643|brain contusion|brain contusion
4697238|NCT03256643|craniocerebral trauma|craniocerebral trauma
4697239|NCT03256643|exercise therapy|exercise therapy
4697240|NCT03256643|chronic brain injury|chronic brain injury
4697241|NCT03256643|environment impact|environment impact
4697242|NCT03256643|cognitive therapy|cognitive therapy
4697243|NCT03256643|health facility environment|health facility environment
4697244|NCT03256630|Active Surveillance|active surveillance
4697245|NCT03256630|Radical Prostatectomy|radical prostatectomy
4697246|NCT03256617|low back pain|low back pain
4697247|NCT03256617|cognitive reassurance|cognitive reassurance
4697248|NCT03256617|physical therapist training|physical therapist training
4697249|NCT03256604|point of care, HGF, innate immunity|point of care, hgf, innate immunity
4697250|NCT03256578|Resuscitation|resuscitation
4697251|NCT03256578|Neonatal Prematurity|neonatal prematurity
4697252|NCT03256578|Positive-Pressure Ventilation|positive-pressure ventilation
4697253|NCT03256578|Respiratory Function Monitor|respiratory function monitor
4697254|NCT03256461|sepsis|sepsis
4697255|NCT03256461|lactate clearance|lactate clearance
4697256|NCT03256461|protocolized resuscitation|protocolized resuscitation
4697257|NCT03256422|Controlled, virological and therapeutic success, treatment discontinution, 4 days per week|controlled, virological and therapeutic success, treatment discontinution, 4 days per week
4697258|NCT03256409|biomaterials|biomaterials
4697259|NCT03256409|methacrylates|methacrylates
4697260|NCT03256409|microbiology|microbiology
4697261|NCT03256409|implant dentistry/implantology|implant dentistry/implantology
4697262|NCT03256409|removable prosthodontics|removable prosthodontics
4697263|NCT03256409|clinical studies/trials|clinical studies/trials
4697264|NCT03256396|Intraoperative mechanical ventilation|intraoperative mechanical ventilation
4697265|NCT03256396|Positive-end expiratory pressure|positive-end expiratory pressure
4697266|NCT03256396|Esophageal pressure|esophageal pressure
4697267|NCT03256396|Transpulmonary pressure|transpulmonary pressure
4697268|NCT03256396|Laparoscopic gynecologic surgery|laparoscopic gynecologic surgery
4697269|NCT03256370|Allergic manifestation, Human milk oligosaccharides, Breast Milk|allergic manifestation, human milk oligosaccharides, breast milk
4697270|NCT03256357|unilateral cerebral palsy|unilateral cerebral palsy
4697271|NCT03256357|upper limb rehabilitation|upper limb rehabilitation
4697272|NCT03256344|Liver Metastases|liver metastases
4697273|NCT03256305|Repetitive transcranial magnetic stimulation|repetitive transcranial magnetic stimulation
4697274|NCT03256279|Orthodontic Wires|orthodontic wires
4697275|NCT03256279|Alloys/therapeutic use|alloys/therapeutic use
4697276|NCT03256279|Orthodontics, corrective|orthodontics, corrective
4697277|NCT03256253|alcohol use disorder|alcohol use disorder
4697278|NCT03256253|alcohol abuse|alcohol abuse
4697279|NCT03256253|treatment|treatment
4697280|NCT03256253|lyrica|lyrica
4697281|NCT03256240|Crohn's recurrence|crohn's recurrence
4697282|NCT03256227|Posttraumatic Stress Disorder|posttraumatic stress disorder
4697283|NCT03256227|family therapy|family therapy
4697284|NCT03256227|patient adherence|patient adherence
4697285|NCT03256227|Prolonged Exposure Therapy|prolonged exposure therapy
4697286|NCT03256201|Cancer|cancer
4697287|NCT03256201|prehabilitation|prehabilitation
4697288|NCT03256201|sarcopenia|sarcopenia
4697289|NCT03256188|classroom|classroom
4697290|NCT03256188|prolonged sitting|prolonged sitting
4697291|NCT03256188|sedentary time|sedentary time
4697292|NCT03256188|time-on-task|time-on-task
4697293|NCT03256188|children|children
4697294|NCT03256175|Myocardial Protection|myocardial protection
4697295|NCT03256175|Oxygen|oxygen
4697296|NCT03256175|Exercise Test|exercise test
4697297|NCT03256162|ketamine|ketamine
4697298|NCT03256162|glutamate|glutamate
4697299|NCT03256136|Lung Cancer|lung cancer
4697300|NCT03256123|Vitamin A Deficiency|vitamin a deficiency
4697301|NCT03256123|Iron Deficiency|iron deficiency
4697302|NCT03256123|Parasite|parasite
4697303|NCT03256123|Gut Microbiota|gut microbiota
4697304|NCT03256123|Red palm oil|red palm oil
4697305|NCT03256110|Advance Care Planning|advance care planning
4697306|NCT03256110|Palliative Care|palliative care
4697307|NCT03256110|Indians, North American|indians, north american
4697308|NCT03256110|Alaska Natives|alaska natives
4697309|NCT03256110|Health Communication|health communication
4697310|NCT03256110|Primary Health Care|primary health care
4697311|NCT03256097|Sound processing strategy|sound processing strategy
4697312|NCT03256019|intubation|intubation
4697313|NCT03256019|Cardiopulmonary Resuscitation|cardiopulmonary resuscitation
4697314|NCT03256006|sport exercise|sport exercise
4697315|NCT03256006|ultra endurance|ultra endurance
4697316|NCT03255954|Interpersonal Counseling|interpersonal counseling
4697317|NCT03255941|LHV (Lady Health Visitor)|lhv (lady health visitor)
4697318|NCT03255941|LHW (Lady Health Worker|lhw (lady health worker
4697319|NCT03255941|DMPA (Depot medroxyprogesterone acetate or Depo Provera)|dmpa (depot medroxyprogesterone acetate or depo provera)
4697320|NCT03255941|DMPA IM (Depo Provera intramuscular injection)|dmpa im (depo provera intramuscular injection)
4697321|NCT03255941|SP (Sayana Press subcutaneous injection)|sp (sayana press subcutaneous injection)
4697322|NCT03255941|Contraception|contraception
4697323|NCT03255941|CBA2I (Community-based access to injectables)|cba2i (community-based access to injectables)
4697324|NCT03255941|Sayana (Sayana Press)|sayana (sayana press)
4697325|NCT03255941|JHPIEGO (Johns Hopkins Program for International Education in Gynaecology and Obstetrics)|jhpiego (johns hopkins program for international education in gynaecology and obstetrics)
4697326|NCT03255941|Sayana|sayana
4697327|NCT03255928|Platelet activation|platelet activation
4697328|NCT03255928|Ventricular Assist Device|ventricular assist device
4697329|NCT03255928|Thrombosis|thrombosis
4697330|NCT03255928|Bleeding|bleeding
4697331|NCT03255928|Antithrombotic Pharmacological Therapy|antithrombotic pharmacological therapy
4697332|NCT03255928|Mechanical Circulatory Support|mechanical circulatory support
4697333|NCT03255915|HIV Prevention|hiv prevention
4697334|NCT03255915|Intravaginal Ring|intravaginal ring
4697335|NCT03255915|Tenofovir Disoproxil Fumarate|tenofovir disoproxil fumarate
4697336|NCT03255915|Emtricitabine|emtricitabine
4697337|NCT03255889|Safety|safety
4697338|NCT03255889|Tolerability|tolerability
4697339|NCT03255889|Pharmacokinetics|pharmacokinetics
4697340|NCT03255889|Absorption|absorption
4697341|NCT03255876|Polyphenols|polyphenols
4697342|NCT03255876|Hyperglycemia|hyperglycemia
4697343|NCT03255876|Postprandial|postprandial
4697344|NCT03255876|Starch|starch
4697345|NCT03255876|Alpha-amylase|alpha-amylase
4697346|NCT03255863|Psychological Theory|psychological theory
4697347|NCT03255850|adolescents|adolescents
4697348|NCT03255850|quality of life|quality of life
4697349|NCT03255850|psychological well-being|psychological well-being
4697350|NCT03255837|Transcranial Stimulation|transcranial stimulation
4697351|NCT03255837|Memory|memory
4697352|NCT03255824|Oral Surgery|oral surgery
4697353|NCT03255824|Third Molars|third molars
4697354|NCT03255824|Intravenous Sedation|intravenous sedation
4697355|NCT03255824|Dexmedetomidine|dexmedetomidine
4697356|NCT03255811|Advanced gastric cancer apatinib Maintenance therapy|advanced gastric cancer apatinib maintenance therapy
4697357|NCT03255772|Magnetocardiography|magnetocardiography
4697358|NCT03255772|Chest pain|chest pain
4697359|NCT03255733|Chronic Lateral Epicondylitis|chronic lateral epicondylitis
4697360|NCT03255733|Tennis Elbow|tennis elbow
4697361|NCT03255733|Intense Therapeutic Ultrasound (ITU)|intense therapeutic ultrasound (itu)
4697362|NCT03255733|Guided Therapy Systems (GTS)|guided therapy systems (gts)
4697363|NCT03255733|Ardent Sound, Inc.|ardent sound, inc.
4697364|NCT03255733|Actisound|actisound
4697365|NCT03255707|Amblyopia|amblyopia
4697366|NCT03255707|Interactive Binocular Treatment|interactive binocular treatment
4697367|NCT03255707|Dissociative Treatment|dissociative treatment
4697368|NCT03255707|Occlusion|occlusion
4697369|NCT03255707|Patching|patching
4697370|NCT03255681|Cosmetics|cosmetics
4697371|NCT03255681|Filler|filler
4697372|NCT03255668|Mercaptopurine, acute lymphoblastic leukemia, hematotoxicity|mercaptopurine, acute lymphoblastic leukemia, hematotoxicity
4697373|NCT03255655|Chronic Plantar Fasciitis|chronic plantar fasciitis
4697374|NCT03255655|Plantar Fascia Pain|plantar fascia pain
4697375|NCT03255655|Intense Therapeutic Ultrasound (ITU)|intense therapeutic ultrasound (itu)
4697376|NCT03255655|Guided Therapy Systems (GTS)|guided therapy systems (gts)
4697377|NCT03255655|Ardent Sound, Inc.|ardent sound, inc.
4697378|NCT03255655|Actisound|actisound
4697379|NCT03255642|Clonazepam|clonazepam
4697380|NCT03255642|Melatonin|melatonin
4697381|NCT03255642|Treatment|treatment
4697382|NCT03255642|REM Sleep Behavior Disorder|rem sleep behavior disorder
4697383|NCT03255603|Resistant Starch|resistant starch
4697384|NCT03255603|Dietary Fiber|dietary fiber
4697385|NCT03255603|Gastrointestinal Microbiome|gastrointestinal microbiome
4697386|NCT03255603|Gastrointestinal Tolerance|gastrointestinal tolerance
4697387|NCT03255590|motor recovery|motor recovery
4697388|NCT03255590|transcranial magnetic stimulation|transcranial magnetic stimulation
4697389|NCT03255590|motor learning|motor learning
4697390|NCT03255590|ischemic Stroke|ischemic stroke
4697391|NCT03255577|Sentinel Lymph Node Biopsy|sentinel lymph node biopsy
4697392|NCT03255577|17-384|17-384
4697393|NCT03255538|patellar tendon|patellar tendon
4697394|NCT03255499|cognitive training|cognitive training
4697395|NCT03255499|physical exercise|physical exercise
4697396|NCT03255499|brain dynamics|brain dynamics
4697397|NCT03255499|cognitive abilities|cognitive abilities
4697398|NCT03255499|physiological markers|physiological markers
4697399|NCT03255460|Multiple Sclerosis|multiple sclerosis
4697400|NCT03255460|Fatigue|fatigue
4697401|NCT03255460|Physical Activity|physical activity
4697402|NCT03255460|Exercise|exercise
4697403|NCT03255447|Idiopathic Membranous Nephropathy|idiopathic membranous nephropathy
4697404|NCT03255447|Primary Membranous Nephropathy|primary membranous nephropathy
4697405|NCT03255447|Immunoadsorption|immunoadsorption
4697406|NCT03255447|Apharesis|apharesis
4697407|NCT03255421|urodynamic|urodynamic
4697408|NCT03255421|backwards cystometry|backwards cystometry
4697409|NCT03255421|reverse cystometry|reverse cystometry
4697410|NCT03255421|follow-up|follow-up
4697411|NCT03255395|MRI|mri
4697412|NCT03255395|Ultrasound|ultrasound
4697413|NCT03255395|Phantom Limb Pain|phantom limb pain
4697414|NCT03255395|Residual Limb Pain|residual limb pain
4697415|NCT03255395|Neuroma|neuroma
4697416|NCT03255382|ABBV-0066|abbv-0066
4697417|NCT03255382|BI 655066|bi 655066
4697418|NCT03255382|risankizumab|risankizumab
4697419|NCT03255369|Zika virus|zika virus
4697420|NCT03255369|Microcephaly|microcephaly
4697421|NCT03255369|Child|child
4697422|NCT03255369|pregnancy|pregnancy
4697423|NCT03255356|Postoperative pulmonary complications|postoperative pulmonary complications
4697424|NCT03255356|Protective mechanical ventilation|protective mechanical ventilation
4697425|NCT03255356|Alveolar lung recruitment manoeuvres|alveolar lung recruitment manoeuvres
4697426|NCT03255356|Cardiac Surgery Procedures|cardiac surgery procedures
4697427|NCT03255317|Substance use, youth, mobile health, data collection adherence, user engagement|substance use, youth, mobile health, data collection adherence, user engagement
4697428|NCT03255278|Tuberculosis|tuberculosis
4697429|NCT03255278|Recombinant vaccine|recombinant vaccine
4697430|NCT03255278|Mycobacterium tuberculosis|mycobacterium tuberculosis
4697431|NCT03255265|organ transplantation|organ transplantation
4697432|NCT03255265|cfDNA|cfdna
4697433|NCT03255265|microchimerism|microchimerism
4697434|NCT03255265|acute rejection|acute rejection
4697435|NCT03255239|ventral hernia|ventral hernia
4697436|NCT03255239|Open mesh repair|open mesh repair
4697437|NCT03255239|Polyester mesh|polyester mesh
4697438|NCT03255239|Preperitoneal|preperitoneal
4697439|NCT03255239|Retromuscular|retromuscular
4697440|NCT03255187|Biomarker|biomarker
4697441|NCT03255187|Fish oil|fish oil
4697442|NCT03255187|Oxidative stress|oxidative stress
4697443|NCT03255187|Air pollution|air pollution
4697444|NCT03255187|Cardiopulmonary system|cardiopulmonary system
4697445|NCT03255174|Bleeding, hemostasis, re-bleeding, hemostatic|bleeding, hemostasis, re-bleeding, hemostatic
4697446|NCT03255148|resting state|resting state
4697447|NCT03255148|EEG|eeg
4697448|NCT03255148|skin conductance|skin conductance
4697449|NCT03255148|heart rate|heart rate
4697450|NCT03255148|oxytocin|oxytocin
4697451|NCT03255109|Lung|lung
4697452|NCT03255109|acute|acute
4697453|NCT03255109|respiratory|respiratory
4697454|NCT03255109|distress|distress
4697455|NCT03255109|weaning|weaning
4697456|NCT03255109|mechanical ventilation|mechanical ventilation
4697457|NCT03255109|respiratory infection|respiratory infection
4697458|NCT03255083|Oncology|oncology
4697459|NCT03255083|Advanced Non-small Cell Lung Cancer|advanced non-small cell lung cancer
4697460|NCT03255083|Inoperable Non-small Cell Lung Cancer|inoperable non-small cell lung cancer
4697461|NCT03255083|Metastatic|metastatic
4697462|NCT03255083|Non-resectable|non-resectable
4697463|NCT03255083|Epidermal growth factor receptor|epidermal growth factor receptor
4697464|NCT03255083|EGFR|egfr
4697465|NCT03255070|HER2|her2
4697466|NCT03255070|Breast Cancer|breast cancer
4697467|NCT03255070|ADC|adc
4697671|NCT03254095|Neuropathy|neuropathy
4697468|NCT03255070|antibody drug conjugate|antibody drug conjugate
4697469|NCT03255070|elevated HER2 expression|elevated her2 expression
4697470|NCT03255070|breast neoplasm|breast neoplasm
4697471|NCT03255070|stomach neoplasm|stomach neoplasm
4697472|NCT03255070|gastrointestinal neoplasm|gastrointestinal neoplasm
4697473|NCT03255070|digestive system|digestive system
4697474|NCT03255070|breast diseases|breast diseases
4697475|NCT03255070|digestive system neoplasm|digestive system neoplasm
4697476|NCT03255070|digestive system diseases|digestive system diseases
4697477|NCT03255070|stomach diseases|stomach diseases
4697478|NCT03255044|statin|statin
4697479|NCT03255044|hydrophilic|hydrophilic
4697480|NCT03255044|lipophilic|lipophilic
4697481|NCT03255031|Ketogenic Diet|ketogenic diet
4697482|NCT03255031|Detoxification|detoxification
4697483|NCT03255031|Functional MRI|functional mri
4697484|NCT03255031|MRI/MRS|mri/mrs
4697485|NCT03255031|Alcoholism|alcoholism
4697486|NCT03255018|Monoclonal Antibody|monoclonal antibody
4697487|NCT03255018|PD-1 Receptor|pd-1 receptor
4697488|NCT03255005|obesity|obesity
4697489|NCT03255005|endoscopy|endoscopy
4697490|NCT03255005|endoscopic sleeve gastroplasty|endoscopic sleeve gastroplasty
4697491|NCT03254953|digital health|digital health
4697492|NCT03254953|eHealth|ehealth
4697493|NCT03254953|technology|technology
4697494|NCT03254953|smartphone|smartphone
4697495|NCT03254953|obesity|obesity
4697496|NCT03254953|overweight|overweight
4697497|NCT03254953|weight loss|weight loss
4697498|NCT03254953|behavioral intervention|behavioral intervention
4697499|NCT03254953|self-monitoring|self-monitoring
4697500|NCT03254953|tracking|tracking
4697501|NCT03254953|engagement|engagement
4697502|NCT03254953|adherence|adherence
4697503|NCT03254953|weight change|weight change
4697504|NCT03254953|e-mail|e-mail
4697505|NCT03254953|mobile application|mobile application
4697506|NCT03254953|goal setting|goal setting
4697507|NCT03254953|action plan|action plan
4697508|NCT03254953|feedback|feedback
4697509|NCT03254953|electronic health|electronic health
4697510|NCT03254940|text message|text message
4697511|NCT03254940|digital health|digital health
4697512|NCT03254940|weight loss|weight loss
4697513|NCT03254940|personalized|personalized
4697514|NCT03254927|Erbitux|erbitux
4697515|NCT03254927|Cetuximab|cetuximab
4697516|NCT03254927|Oral Cancer|oral cancer
4697517|NCT03254927|Oropharyngeal cancer|oropharyngeal cancer
4697518|NCT03254927|Laryngeal cancer|laryngeal cancer
4697519|NCT03254927|Head and Neck Squamous Cell Carcinoma|head and neck squamous cell carcinoma
4697520|NCT03254914|Home Blood Pressure|home blood pressure
4697521|NCT03254914|Fimasartan|fimasartan
4697522|NCT03254875|Breast cancer, Psychosocial intervention|breast cancer, psychosocial intervention
4697523|NCT03254862|Functional electrical stimulation|functional electrical stimulation
4697524|NCT03254836|Actigraphy|actigraphy
4697525|NCT03254836|Major Depression Inventory (MDI)|major depression inventory (mdi)
4697526|NCT03254836|Insomnia Severity Index (ISI)|insomnia severity index (isi)
4697527|NCT03254797|Rehabilitation|rehabilitation
4697528|NCT03254797|Neurological condition|neurological condition
4697529|NCT03254797|Walking ability|walking ability
4697530|NCT03254797|Feedback|feedback
4697531|NCT03254797|External information|external information
4697532|NCT03254771|Knee ostheoartritis|knee ostheoartritis
4697533|NCT03254771|Arthroplasty|arthroplasty
4697534|NCT03254771|Clinical trial|clinical trial
4697535|NCT03254771|Decision aids|decision aids
4697536|NCT03254745|Rheumatoid Arthritis|rheumatoid arthritis
4697537|NCT03254745|Pakistan|pakistan
4697538|NCT03254745|Pharmacist|pharmacist
4697539|NCT03254745|Intervention|intervention
4697540|NCT03254745|Treatment outcome|treatment outcome
4697541|NCT03254719|Low Back Pain|low back pain
4697542|NCT03254719|Chiropractic|chiropractic
4697543|NCT03254719|Veterans|veterans
4697544|NCT03254719|PTSD|ptsd
4697545|NCT03254719|Depression|depression
4697546|NCT03254719|Anxiety|anxiety
4697547|NCT03254706|Dentin adhesive; Non-carious cervical lesions; Longevity.|dentin adhesive; non-carious cervical lesions; longevity.
4697548|NCT03254693|Non-carious cervical lesions; Universal system; Longevity.|non-carious cervical lesions; universal system; longevity.
4697549|NCT03254680|Turmeric Oil|turmeric oil
4697550|NCT03254680|antiseizure medications|antiseizure medications
4697551|NCT03254680|ar-turmerone|ar-turmerone
4697552|NCT03254615|Plain water|plain water
4697553|NCT03254615|Educative strategies|educative strategies
4697554|NCT03254615|Effectiveness|effectiveness
4697555|NCT03254589|Methotrexate|methotrexate
4697556|NCT03254589|Rheumatoid arthritis|rheumatoid arthritis
4697557|NCT03254589|Blood pressure|blood pressure
4697558|NCT03254589|Arterial stiffness|arterial stiffness
4697559|NCT03254589|Cardiovascular risk|cardiovascular risk
4697560|NCT03254576|Overweight|overweight
4697561|NCT03254576|Obesity|obesity
4697562|NCT03254576|Body Mass Index|body mass index
4697563|NCT03254576|Weight|weight
4697564|NCT03254576|Brain imaging|brain imaging
4697565|NCT03254576|Child|child
4697566|NCT03254576|Learning|learning
4697567|NCT03254550|PrEP|prep
4697568|NCT03254524|Epidemiology Research|epidemiology research
4697569|NCT03254511|neoadjuvant chemoradiation|neoadjuvant chemoradiation
4697570|NCT03254511|pathologic response|pathologic response
4697571|NCT03254511|low molecular weight heparin|low molecular weight heparin
4697572|NCT03254498|colonic adenoma|colonic adenoma
4697573|NCT03254498|serrated polyps|serrated polyps
4697574|NCT03254498|caecal intubation time|caecal intubation time
4697575|NCT03254498|withdrawal time|withdrawal time
4697576|NCT03254498|polyp miss rate|polyp miss rate
4697577|NCT03254485|Heart Failure|heart failure
4697578|NCT03254485|Cardiovascular|cardiovascular
4697579|NCT03254485|HF|hf
4697580|NCT03254485|HFpEF|hfpef
4697581|NCT03254472|Biological markers|biological markers
4697582|NCT03254472|Professional practice|professional practice
4697583|NCT03254472|Big data analysis|big data analysis
4697584|NCT03254472|Measured concentrations|measured concentrations
4697585|NCT03254472|Cardiac markers|cardiac markers
4697586|NCT03254472|Troponin|troponin
4697587|NCT03254472|NTproBNP|ntprobnp
4697588|NCT03254472|Creatinin|creatinin
4697589|NCT03254472|INR|inr
4697590|NCT03254472|Hemogram|hemogram
4697591|NCT03254472|Lipid profile|lipid profile
4697592|NCT03254446|Diabetes|diabetes
4697593|NCT03254446|Hypertension|hypertension
4697594|NCT03254446|Dyslipidemia|dyslipidemia
4697595|NCT03254446|Cardiovascular Risk|cardiovascular risk
4697596|NCT03254433|Neuroimaging|neuroimaging
4697597|NCT03254433|Smoking Cessation|smoking cessation
4697598|NCT03254433|Weight Loss|weight loss
4697599|NCT03254407|bioequivalent|bioequivalent
4697600|NCT03254407|IV/PO switch|iv/po switch
4697601|NCT03254407|appropriateness|appropriateness
4697602|NCT03254407|clinical pharmacy|clinical pharmacy
4697603|NCT03254394|Oxaliplatin|oxaliplatin
4697604|NCT03254394|Cold hypersensitivity|cold hypersensitivity
4697605|NCT03254394|Neuropathy|neuropathy
4697606|NCT03254394|Colorectal cancer|colorectal cancer
4697607|NCT03254394|CIPN|cipn
4697608|NCT03254394|Neuropathic Pain|neuropathic pain
4697609|NCT03254381|cognitive assessment|cognitive assessment
4697610|NCT03254381|cognitive function|cognitive function
4697611|NCT03254381|community dwelling older people|community dwelling older people
4697612|NCT03254381|pre-diabetes|pre-diabetes
4697613|NCT03254381|randomized control trial|randomized control trial
4697614|NCT03254381|exercise|exercise
4697615|NCT03254381|pilot study|pilot study
4697616|NCT03254381|feasibility study|feasibility study
4697617|NCT03254368|Methionine Aminopeptidase 2 Inhibitor|methionine aminopeptidase 2 inhibitor
4697618|NCT03254368|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
4697619|NCT03254368|Blood Glucose|blood glucose
4697620|NCT03254368|Overweight|overweight
4697621|NCT03254368|Obesity|obesity
4697622|NCT03254355|avulsion injury|avulsion injury
4697623|NCT03254355|urinary incontinence|urinary incontinence
4697624|NCT03254355|multimodal physiotherapy|multimodal physiotherapy
4697625|NCT03254329|human milk|human milk
4697626|NCT03254329|micronutrients|micronutrients
4697627|NCT03254329|lactation|lactation
4697628|NCT03254329|milk volume|milk volume
4697629|NCT03254329|milk composition|milk composition
4697630|NCT03254329|reference values|reference values
4697631|NCT03254303|Sevoflurane, Catheterization, Anesthetics Inhalation, child|sevoflurane, catheterization, anesthetics inhalation, child
4697632|NCT03254277|Broadly Neutralizing Antibody|broadly neutralizing antibody
4697633|NCT03254277|3BNC117-LS|3bnc117-ls
4697634|NCT03254277|First in Human|first in human
4697635|NCT03254277|Dose Escalation|dose escalation
4697636|NCT03254225|Hypertension|hypertension
4697637|NCT03254225|Elderly|elderly
4697638|NCT03254225|Resistance training|resistance training
4697639|NCT03254225|Heart rate variability|heart rate variability
4697640|NCT03254212|Heart failure|heart failure
4697641|NCT03254212|Central sleep apnea|central sleep apnea
4697642|NCT03254212|oxygen therapy|oxygen therapy
4697643|NCT03254199|Charcot-Marie-Tooth|charcot-marie-tooth
4697644|NCT03254199|CMT|cmt
4697645|NCT03254199|Muscle Cramps|muscle cramps
4697646|NCT03254199|Muscle Cramping|muscle cramping
4697647|NCT03254199|FLX-787|flx-787
4697648|NCT03254199|Hereditary Sensory and Motor Neuropathy|hereditary sensory and motor neuropathy
4697649|NCT03254199|Neurogenetic disorder|neurogenetic disorder
4697650|NCT03254199|Nervous System Malformations|nervous system malformations
4697651|NCT03254199|Nervous System Diseases|nervous system diseases
4697652|NCT03254199|Neurodegenerative Diseases|neurodegenerative diseases
4697653|NCT03254199|Neuromuscular Diseases|neuromuscular diseases
4697654|NCT03254186|Propranolol|propranolol
4697655|NCT03254186|Safety|safety
4697656|NCT03254186|Efficacy|efficacy
4697657|NCT03254186|Tardive Dyskinesia treatment|tardive dyskinesia treatment
4697658|NCT03254173|Mirtazapine|mirtazapine
4697659|NCT03254173|Anorexia - Cachexia|anorexia - cachexia
4697660|NCT03254173|Advanced Cancer|advanced cancer
4697661|NCT03254173|Appetite|appetite
4697662|NCT03254160|Stroke|stroke
4697663|NCT03254160|Rehabilitation|rehabilitation
4697664|NCT03254160|Ischemic|ischemic
4697665|NCT03254121|Sustained virological response|sustained virological response
4697666|NCT03254121|Whole genome sequencing|whole genome sequencing
4697667|NCT03254095|Skin temperature|skin temperature
4697668|NCT03254095|Plantar pressure|plantar pressure
4697669|NCT03254095|Diabetic foot|diabetic foot
4697670|NCT03254095|Tissue hardness|tissue hardness
4697672|NCT03254095|Peripheral artery disease|peripheral artery disease
4697673|NCT03254082|sorghum health|sorghum health
4697674|NCT03254056|fascial closure device|fascial closure device
4697675|NCT03254056|laparoscopic surgery|laparoscopic surgery
4697676|NCT03254056|postoperative pain|postoperative pain
4697677|NCT03254030|Adenoma|adenoma
4697678|NCT03254030|Sessile serrated adenoma|sessile serrated adenoma
4697679|NCT03254017|Bilateral Habeluna|bilateral habeluna
4697680|NCT03254017|Remote Deep Brain Stimulation|remote deep brain stimulation
4697681|NCT03254017|Treatment Resistant Major Depressive Disorder|treatment resistant major depressive disorder
4697682|NCT03253900|wobble board|wobble board
4697683|NCT03253900|slides|slides
4697684|NCT03253900|rowing stroke|rowing stroke
4697685|NCT03253900|rowing biomechanics|rowing biomechanics
4697686|NCT03253900|power output|power output
4697687|NCT03253887|Ethanol lock therapy|ethanol lock therapy
4697688|NCT03253887|Pediatrics|pediatrics
4697689|NCT03253887|Central Venous Catheter|central venous catheter
4697690|NCT03253887|Bloodstream Infection|bloodstream infection
4697691|NCT03253874|Pre-operative Testing|pre-operative testing
4697692|NCT03253874|Cataract Surgery|cataract surgery
4697693|NCT03253874|Health Service Research|health service research
4697694|NCT03253874|Low-Value Care|low-value care
4697695|NCT03253874|Safety-Net Hospital|safety-net hospital
4697696|NCT03253861|Acute necrotizing pancreatitis|acute necrotizing pancreatitis
4697697|NCT03253861|Acute pancreatitis|acute pancreatitis
4697698|NCT03253861|Sepsis/complications|sepsis/complications
4697699|NCT03253861|Infection|infection
4697700|NCT03253861|Organ Dysfunction Scores|organ dysfunction scores
4697701|NCT03253861|Drainage|drainage
4697702|NCT03253861|Catheters|catheters
4697703|NCT03253861|Antibiotics|antibiotics
4697704|NCT03253861|Multiresistant organism|multiresistant organism
4697705|NCT03253861|Pancreatitis/complications|pancreatitis/complications
4697706|NCT03253861|Pancreatitis/diagnosis|pancreatitis/diagnosis
4697707|NCT03253861|Pancreatitis/surgery|pancreatitis/surgery
4697708|NCT03253861|Pancreatitis/therapy|pancreatitis/therapy
4697709|NCT03253861|Pancreatitis, Acute Necrotizing/complications|pancreatitis, acute necrotizing/complications
4697710|NCT03253861|Pancreatitis, Acute Necrotizing/surgery|pancreatitis, acute necrotizing/surgery
4697711|NCT03253861|Pancreatitis, Acute Necrotizing/therapy|pancreatitis, acute necrotizing/therapy
4697712|NCT03253822|Colorectal Neoplasms|colorectal neoplasms
4697713|NCT03253822|Decision Support Techniques|decision support techniques
4697714|NCT03253822|Early Detection of Cancer|early detection of cancer
4697715|NCT03253822|Educational Status|educational status
4697716|NCT03253822|Decision Making|decision making
4697717|NCT03253822|Knowledge, Attitudes, Practice|knowledge, attitudes, practice
4697718|NCT03253770|Cognitive Aid|cognitive aid
4697719|NCT03253757|PrEP|prep
4697720|NCT03253757|HIV|hiv
4697721|NCT03253744|Image Guidance|image guidance
4697722|NCT03253744|Dose Escalation|dose escalation
4697723|NCT03253744|Radiotherapy|radiotherapy
4697724|NCT03253744|Re-irradiation|re-irradiation
4697725|NCT03253744|Quality of Life|quality of life
4697726|NCT03253731|Brain Plasticity|brain plasticity
4697727|NCT03253731|Healthy Volunteers|healthy volunteers
4697728|NCT03253718|Healthy Volunteers|healthy volunteers
4697729|NCT03253705|Assay Development|assay development
4697730|NCT03253705|Gene Expression|gene expression
4697731|NCT03253705|Metabolomics|metabolomics
4697732|NCT03253705|Induced Pluripotent Stem Cell (iPS)|induced pluripotent stem cell (ips)
4697733|NCT03253705|PBMCs/DNA/RNA|pbmcs/dna/rna
4697734|NCT03253692|Cardiac Computed Tomography|cardiac computed tomography
4697735|NCT03253692|Radiation|radiation
4697736|NCT03253692|Iterative Reconstruction|iterative reconstruction
4697737|NCT03253653|waterpipe|waterpipe
4697738|NCT03253653|hookah|hookah
4697739|NCT03253653|NNAL|nnal
4697740|NCT03253653|SPMA|spma
4697741|NCT03253653|1-HOP|1-hop
4697742|NCT03253653|Furan-BDA-NAL|furan-bda-nal
4697743|NCT03253653|Carbon monoxide|carbon monoxide
4697744|NCT03253653|Pulmonary Function|pulmonary function
4697745|NCT03253640|Costs and Cost Analysis|costs and cost analysis
4697746|NCT03253640|Quality of Life|quality of life
4697747|NCT03253640|Length of Stay|length of stay
4697748|NCT03253640|Cohort study|cohort study
4697749|NCT03253601|Rehabilitation|rehabilitation
4697750|NCT03253601|Disability|disability
4697751|NCT03253601|Mobile Health Technology|mobile health technology
4697752|NCT03253575|Head and Neck Squamous Cell Carcinoma|head and neck squamous cell carcinoma
4697753|NCT03253575|Breast Cancer|breast cancer
4697754|NCT03253575|Non-Small Cell Lung Cancer|non-small cell lung cancer
4697755|NCT03253575|Epithelial Ovarian Cancer|epithelial ovarian cancer
4697756|NCT03253575|Colorectal Cancer|colorectal cancer
4697757|NCT03253575|Local Recurrent Cancer|local recurrent cancer
4697758|NCT03253575|Late Stage Cancer|late stage cancer
4697759|NCT03253575|Clinical Utility|clinical utility
4697760|NCT03253575|Outcomes Study|outcomes study
4697761|NCT03253562|diabetes|diabetes
4697762|NCT03253562|Metformin|metformin
4697763|NCT03253562|vildagliptin|vildagliptin
4697764|NCT03253562|hypertension|hypertension
4697765|NCT03253562|cardiovascular risk|cardiovascular risk
4697766|NCT03253549|remote automated monitoring|remote automated monitoring
4697863|NCT03252756|Alcohol Use Disorder|alcohol use disorder
4697767|NCT03253549|hospital to home virtual care|hospital to home virtual care
4697768|NCT03253549|cardiac surgery|cardiac surgery
4697769|NCT03253549|major vascular surgery|major vascular surgery
4697770|NCT03253549|self-management|self-management
4697771|NCT03253536|Hepatocellular Cancer|hepatocellular cancer
4697772|NCT03253536|Quality of Life|quality of life
4697773|NCT03253536|stereotactic body radiation therapy|stereotactic body radiation therapy
4697774|NCT03253536|observational|observational
4697775|NCT03253497|chlorhexidine, benzidamine, laryngeal mask|chlorhexidine, benzidamine, laryngeal mask
4697776|NCT03253484|scar NAFL laser|scar nafl laser
4697777|NCT03253458|Optical coherence tomography|optical coherence tomography
4697778|NCT03253458|Confocal Laser Endomicroscopy|confocal laser endomicroscopy
4697779|NCT03253458|Histology|histology
4697780|NCT03253445|smoking cessation|smoking cessation
4697781|NCT03253445|acceptance and commitment therapy|acceptance and commitment therapy
4697782|NCT03253445|ACT|act
4697783|NCT03253445|schizophrenic patients|schizophrenic patients
4697784|NCT03253445|hostel setting|hostel setting
4697785|NCT03253445|randomised controlled trial|randomised controlled trial
4697786|NCT03253419|Falls|falls
4697787|NCT03253419|Hip Replacement|hip replacement
4697788|NCT03253419|Home Safety|home safety
4697789|NCT03253367|Schizophrenia Spectrum and Other Psychotic Disorders|schizophrenia spectrum and other psychotic disorders
4697790|NCT03253341|exercise program|exercise program
4697791|NCT03253341|lifestyle changes|lifestyle changes
4697792|NCT03253341|fitness program|fitness program
4697793|NCT03253341|lifestyle intervention|lifestyle intervention
4697794|NCT03253302|transanal surgery|transanal surgery
4697795|NCT03253302|total mesorectal excision|total mesorectal excision
4697796|NCT03253302|rectal cancer|rectal cancer
4697797|NCT03253289|Hepatocellular carcinoma, HCC, Liver cancer|hepatocellular carcinoma, hcc, liver cancer
4697798|NCT03253276|Bile Acid Transporter|bile acid transporter
4697799|NCT03253237|Glycemic variability|glycemic variability
4697800|NCT03253237|Hypoglycemia|hypoglycemia
4697801|NCT03253211|Co-management model of care|co-management model of care
4697802|NCT03253211|Primary Care|primary care
4697803|NCT03253211|Specialty Care|specialty care
4697804|NCT03253211|Decision support tools|decision support tools
4697805|NCT03253211|Emergency Department Clinicians|emergency department clinicians
4697806|NCT03253211|Co-management|co-management
4697807|NCT03253185|Cancer|cancer
4697808|NCT03253185|Advanced cancer|advanced cancer
4697809|NCT03253185|Esophagogastric junction (EGJ) cancers|esophagogastric junction (egj) cancers
4697810|NCT03253185|Maximum tolerated dose (MTD)|maximum tolerated dose (mtd)
4697811|NCT03253185|Maximum Tolerated Dose|maximum tolerated dose
4697812|NCT03253185|Pharmacokinetics|pharmacokinetics
4697813|NCT03253146|Vimentin|vimentin
4697815|NCT03253146|immune cells|immune cells
4697816|NCT03253146|apoptosis|apoptosis
4697817|NCT03253107|gastric cancer|gastric cancer
4697818|NCT03253107|RNA sequencing|rna sequencing
4697819|NCT03253107|chemotherapy response|chemotherapy response
4697820|NCT03253107|miRNA sequencing|mirna sequencing
4697821|NCT03253055|Physical Performance|physical performance
4697822|NCT03253055|Bone|bone
4697823|NCT03253055|Illness|illness
4697824|NCT03253055|Injury|injury
4697825|NCT03253042|Exercise|exercise
4697826|NCT03253042|Vibration|vibration
4697827|NCT03253042|Torque|torque
4697828|NCT03253042|Aging|aging
4697829|NCT03253029|oncology, cancer cachexia, cachexia anorexia,|oncology, cancer cachexia, cachexia anorexia,
4697830|NCT03252977|fentanyl|fentanyl
4697831|NCT03252977|Pain Threshold|pain threshold
4697832|NCT03252977|predicted|predicted
4697833|NCT03252938|solid tumor|solid tumor
4697834|NCT03252938|peritoneal carcinomatosis|peritoneal carcinomatosis
4697835|NCT03252886|intubation|intubation
4697836|NCT03252886|Cardiopulmonary Resuscitation|cardiopulmonary resuscitation
4697837|NCT03252886|neck injury|neck injury
4697838|NCT03252873|adherence|adherence
4697839|NCT03252873|pulmonary rehabilitation|pulmonary rehabilitation
4697840|NCT03252873|copd|copd
4697841|NCT03252847|XLRP RPGR|xlrp rpgr
4697842|NCT03252808|Unresectable pancreatic cancer|unresectable pancreatic cancer
4697843|NCT03252808|Metastatic pancreatic cancer|metastatic pancreatic cancer
4697844|NCT03252808|Pancreatic adenocarcinoma|pancreatic adenocarcinoma
4697845|NCT03252808|TBI-1401(HF10)|tbi-1401(hf10)
4697846|NCT03252808|HF10|hf10
4697847|NCT03252808|Oncolytic virus|oncolytic virus
4697848|NCT03252808|Oncolytic viral immunotherapy|oncolytic viral immunotherapy
4697849|NCT03252808|Gemcitabine|gemcitabine
4697850|NCT03252808|Nab-paclitaxel|nab-paclitaxel
4697851|NCT03252808|Albumin-bound paclitaxel|albumin-bound paclitaxel
4697852|NCT03252808|Abraxane|abraxane
4697853|NCT03252808|Tegafur-gimeracil-oteracil potassium|tegafur-gimeracil-oteracil potassium
4697854|NCT03252808|TS-1|ts-1
4697855|NCT03252808|canerpaturev|canerpaturev
4697856|NCT03252795|Infertility, female|infertility, female
4697857|NCT03252795|Mayer Rokitansky Kuster Hauser Syndrome|mayer rokitansky kuster hauser syndrome
4697858|NCT03252795|Transplantation; Deceased donor|transplantation; deceased donor
4697859|NCT03252782|Soft Tissue|soft tissue
4697860|NCT03252782|Functional Appliance|functional appliance
4697861|NCT03252782|Maxillary Molar Distalization|maxillary molar distalization
4697862|NCT03252756|Cannabidiol|cannabidiol
4697864|NCT03252730|Dry scalp|dry scalp
4697865|NCT03252730|Itchy scalp|itchy scalp
4697866|NCT03252704|postprandial glucose insulin|postprandial glucose insulin
4697867|NCT03252678|Advanced Care Planning|advanced care planning
4697868|NCT03252665|STEMI|stemi
4697869|NCT03252665|myocardial perfusion|myocardial perfusion
4697870|NCT03252665|TMPFC|tmpfc
4697871|NCT03252665|Nicorandil|nicorandil
4697872|NCT03252665|Alprostadil|alprostadil
4697873|NCT03252652|Cranial vessels|cranial vessels
4697874|NCT03252652|Normal parameters|normal parameters
4697875|NCT03252652|Carotid Duplex|carotid duplex
4697876|NCT03252652|Egyptian|egyptian
4697877|NCT03252639|Renal Artery Stenosis|renal artery stenosis
4697878|NCT03252639|Renal Blood Perfusion|renal blood perfusion
4697879|NCT03252613|septic cardiomyopathy|septic cardiomyopathy
4697880|NCT03252613|cytokine|cytokine
4697881|NCT03252613|iPSC|ipsc
4697882|NCT03252613|Inducible pluripotent stem cell|inducible pluripotent stem cell
4697883|NCT03252561|TAP block|tap block
4697884|NCT03252561|Acute Appendicitis|acute appendicitis
4697885|NCT03252561|Post-operative analgesia|post-operative analgesia
4697886|NCT03252535|Huntington disease|huntington disease
4697887|NCT03252535|Stem cell therapy|stem cell therapy
4697888|NCT03252535|Dental pulp stem cell|dental pulp stem cell
4697889|NCT03252509|percutaneous radiologic gastrostomy|percutaneous radiologic gastrostomy
4697890|NCT03252509|Head and Neck Neoplasms|head and neck neoplasms
4697891|NCT03252470|2D laparoscopic surgery|2d laparoscopic surgery
4697892|NCT03252470|3D laparascopic surgery|3d laparascopic surgery
4697893|NCT03252470|laparoscopic roux-en-y gastric bypass|laparoscopic roux-en-y gastric bypass
4697894|NCT03252457|Purpura|purpura
4697895|NCT03252457|Thrombocytopenia|thrombocytopenia
4697896|NCT03252457|immune throbocytopenia|immune throbocytopenia
4697897|NCT03252444|Shoulder dyskinesis|shoulder dyskinesis
4697898|NCT03252444|EMG biofeedback training|emg biofeedback training
4697899|NCT03252444|Intensive Scapula-focused intervention|intensive scapula-focused intervention
4697900|NCT03252418|ascorbic acid|ascorbic acid
4697901|NCT03252418|diode laser|diode laser
4697902|NCT03252418|gingival hyperpigmentation|gingival hyperpigmentation
4697903|NCT03252392|hearing and communication abnormalities|hearing and communication abnormalities
4697904|NCT03252366|MAXILLARY SINUS ELEVATION ,Simultaneous implant placement|maxillary sinus elevation ,simultaneous implant placement
4697905|NCT03252353|Octreotide Capsules, Acromegaly, OPTIMAL, MYCAPSSA|octreotide capsules, acromegaly, optimal, mycapssa
4697906|NCT03252301|pain|pain
4697907|NCT03252301|post operative|post operative
4697908|NCT03252301|surgery|surgery
4697909|NCT03252301|objective|objective
4697910|NCT03252236|Stroke|stroke
4697911|NCT03252236|Tai Chi|tai chi
4697912|NCT03252236|Dual-tasking|dual-tasking
4697913|NCT03252236|Arterial compliance|arterial compliance
4697914|NCT03252236|Arterial stiffness|arterial stiffness
4697915|NCT03252236|Autonomic nervous system|autonomic nervous system
4697916|NCT03252236|Heart rate variability|heart rate variability
4697917|NCT03252223|polycystic ovary syndrome|polycystic ovary syndrome
4697918|NCT03252223|anovulation|anovulation
4697919|NCT03252223|hyperandrogenism|hyperandrogenism
4697920|NCT03252210|Preoperative localization|preoperative localization
4697921|NCT03252210|Stereoscopic Localization|stereoscopic localization
4697922|NCT03252210|Wedge Resection|wedge resection
4697923|NCT03252210|Ground Glass Opacity|ground glass opacity
4697924|NCT03252197|Ultrasound guided central venous cannulation|ultrasound guided central venous cannulation
4697925|NCT03252197|new device|new device
4697926|NCT03252197|first attempt success|first attempt success
4697927|NCT03252184|Phototherapy|phototherapy
4697928|NCT03252184|Laser Therapy|laser therapy
4697929|NCT03252184|Endothelium-Dependent|endothelium-dependent
4697930|NCT03252184|Vascular Endothelium|vascular endothelium
4697931|NCT03252184|Low Intensity Light Therapy|low intensity light therapy
4697932|NCT03252184|Relaxing Factors|relaxing factors
4697933|NCT03252171|CAR-T cell immunotherapy|car-t cell immunotherapy
4697934|NCT03252171|GD2|gd2
4697935|NCT03252171|glioma|glioma
4697936|NCT03252080|type 2 diabetes|type 2 diabetes
4697937|NCT03252080|holistic management|holistic management
4697938|NCT03252067|Azithromycin eyedrops, pharmacokinetics, tears|azithromycin eyedrops, pharmacokinetics, tears
4697939|NCT03252041|PCS|pcs
4697940|NCT03252028|Hepatocyte growth factor, Nosocomial infections, VAP, Meningitis, In vitro, point of care, rapid test|hepatocyte growth factor, nosocomial infections, vap, meningitis, in vitro, point of care, rapid test
4697941|NCT03252002|Chronic kidney disease|chronic kidney disease
4697942|NCT03251989|Brain Tumor|brain tumor
4697943|NCT03251989|Central Nervous System|central nervous system
4697944|NCT03251989|CNS|cns
4697945|NCT03251976|ovarian cancer|ovarian cancer
4697946|NCT03251976|cardiopulmonary resuscitation|cardiopulmonary resuscitation
4697947|NCT03251976|end of life care|end of life care
4697948|NCT03251976|endometrial cancer|endometrial cancer
4697949|NCT03251976|cervical cancer|cervical cancer
4697950|NCT03251950|Vegetable and fruit intake|vegetable and fruit intake
4697951|NCT03251937|Chronic Pain|chronic pain
4697952|NCT03251937|Back Pain|back pain
4697953|NCT03251937|Leg Pain|leg pain
4697954|NCT03251937|Pain|pain
4697955|NCT03251937|Stimulation|stimulation
4697956|NCT03251937|Spinal Cord Stimulator|spinal cord stimulator
4698054|NCT03251157|Europe|europe
4697957|NCT03251937|Implantable Pulse Generator|implantable pulse generator
4697958|NCT03251872|pulmonary arterial hypertension|pulmonary arterial hypertension
4697959|NCT03251872|PAH|pah
4697960|NCT03251872|poly (ADP-ribose) polymerases inhibition|poly (adp-ribose) polymerases inhibition
4697961|NCT03251872|PARP-1 inhibition|parp-1 inhibition
4697962|NCT03251872|DNA damage|dna damage
4697963|NCT03251872|Early-phase clinical trial pilot study|early-phase clinical trial pilot study
4697964|NCT03251872|Olaparib|olaparib
4697965|NCT03251872|Safety and efficacy|safety and efficacy
4697966|NCT03251859|platelet reactivity|platelet reactivity
4697967|NCT03251859|ticagrelor|ticagrelor
4697968|NCT03251859|myocardial infarction|myocardial infarction
4697969|NCT03251859|pharmacodynamics|pharmacodynamics
4697970|NCT03251859|antiplatelet therapy|antiplatelet therapy
4697971|NCT03251846|Diabetes Mellitus, Type 1|diabetes mellitus, type 1
4697972|NCT03251846|self-monitoring blood glucose|self-monitoring blood glucose
4697973|NCT03251846|diabetes mobile application|diabetes mobile application
4697974|NCT03251846|diabetes management device|diabetes management device
4697975|NCT03251820|electrical status epilepticus during slow wave sleep|electrical status epilepticus during slow wave sleep
4697976|NCT03251820|seizure|seizure
4697977|NCT03251820|cognition|cognition
4697978|NCT03251820|continuous spikes and waves during sleep|continuous spikes and waves during sleep
4697979|NCT03251807|Low-intensity pulsed ultrasound|low-intensity pulsed ultrasound
4697980|NCT03251807|Twin-block|twin-block
4697981|NCT03251807|Functional treatment|functional treatment
4697982|NCT03251781|Minimal Clinically Important Difference|minimal clinically important difference
4697983|NCT03251781|Exercise Test|exercise test
4697984|NCT03251781|Rehabilitation|rehabilitation
4697985|NCT03251781|Disability Evaluation|disability evaluation
4697986|NCT03251768|Chemotherapy|chemotherapy
4697987|NCT03251768|Neutropenia|neutropenia
4697988|NCT03251768|breast cancer|breast cancer
4697989|NCT03251755|type 2 diabetes mellitus|type 2 diabetes mellitus
4697990|NCT03251755|insomnia|insomnia
4697991|NCT03251755|Dao-in|dao-in
4697992|NCT03251742|Fontan operation|fontan operation
4697993|NCT03251742|Negative pressure ventilation|negative pressure ventilation
4697994|NCT03251742|MRI|mri
4697995|NCT03251729|cerclage, preterm birth, short cervix|cerclage, preterm birth, short cervix
4697996|NCT03251716|Metabolic syndrome|metabolic syndrome
4697997|NCT03251716|Schizophrenia|schizophrenia
4697998|NCT03251716|Efficacy|efficacy
4697999|NCT03251716|Female|female
4698000|NCT03251716|Berberine|berberine
4698001|NCT03251638|NHS( newborn hearing screening )|nhs( newborn hearing screening )
4698002|NCT03251599|peak temperature|peak temperature
4698003|NCT03251599|rewarming rate|rewarming rate
4698004|NCT03251599|surgical outcomes|surgical outcomes
4698005|NCT03251560|Fuke Qianjin capsule|fuke qianjin capsule
4698006|NCT03251560|chronic pelvic pain|chronic pelvic pain
4698007|NCT03251547|rFVIIa|rfviia
4698008|NCT03251547|Massive Hemorrhage|massive hemorrhage
4698009|NCT03251547|non-hemophilia|non-hemophilia
4698010|NCT03251534|Eos imaging stereography|eos imaging stereography
4698011|NCT03251534|Centromedullary nailing|centromedullary nailing
4698012|NCT03251534|Quantification of malunions|quantification of malunions
4698013|NCT03251521|pain|pain
4698014|NCT03251521|spasticity|spasticity
4698015|NCT03251521|stroke|stroke
4698016|NCT03251521|injection|injection
4698017|NCT03251521|botulinum toxin A|botulinum toxin a
4698018|NCT03251508|Peanut|peanut
4698019|NCT03251495|Vaccination|vaccination
4698020|NCT03251495|Contagious Diseases|contagious diseases
4698021|NCT03251495|Tropical Medicine|tropical medicine
4698022|NCT03251495|Infectious Diseases|infectious diseases
4698023|NCT03251469|tranexamic acid|tranexamic acid
4698024|NCT03251469|blood tranfusion|blood tranfusion
4698025|NCT03251469|hip fractures|hip fractures
4698026|NCT03251469|elderly|elderly
4698027|NCT03251469|blood loss|blood loss
4698028|NCT03251456|myopia|myopia
4698029|NCT03251456|Tertiary Care|tertiary care
4698030|NCT03251456|Pre-school Children|pre-school children
4698031|NCT03251417|Irinotecan|irinotecan
4698032|NCT03251417|Apatinib|apatinib
4698033|NCT03251391|revascularization|revascularization
4698034|NCT03251391|blocked arteries|blocked arteries
4698035|NCT03251391|leg arteries|leg arteries
4698036|NCT03251391|leg pain|leg pain
4698037|NCT03251365|Pancreatic cancer|pancreatic cancer
4698038|NCT03251365|Gemcitabine|gemcitabine
4698039|NCT03251365|Pancreatic carcinomatosis|pancreatic carcinomatosis
4698040|NCT03251365|Intrabdominal hyperthermic chemotherapy|intrabdominal hyperthermic chemotherapy
4698041|NCT03251352|TKI, CML, discontinuation|tki, cml, discontinuation
4698042|NCT03251339|Healthy Subjects|healthy subjects
4698043|NCT03251339|MSB11455|msb11455
4698044|NCT03251274|bath machine|bath machine
4698045|NCT03251274|sleep quality|sleep quality
4698046|NCT03251274|nursing home|nursing home
4698047|NCT03251274|heart rate variability|heart rate variability
4698048|NCT03251248|MSB11455|msb11455
4698049|NCT03251248|Healthy subjects|healthy subjects
4698050|NCT03251235|cognitive behaviour therapy|cognitive behaviour therapy
4698051|NCT03251222|conscious sedation, vitroretinal procedures|conscious sedation, vitroretinal procedures
4698052|NCT03251157|Asthma|asthma
4698053|NCT03251157|Adults|adults
4698055|NCT03251157|Lung function|lung function
4698056|NCT03251157|Allergy|allergy
4698057|NCT03251157|Atopy|atopy
4698058|NCT03251157|IgE|ige
4698059|NCT03251157|Sensitisation|sensitisation
4698060|NCT03251157|Diet|diet
4698061|NCT03251157|Dietary patterns|dietary patterns
4698062|NCT03251157|Dietary antioxidants|dietary antioxidants
4698063|NCT03251157|Flavonoids|flavonoids
4698064|NCT03251157|Fruits and vegetables|fruits and vegetables
4698065|NCT03251157|Food frequency questionnaire (FFQ)|food frequency questionnaire (ffq)
4698066|NCT03251157|Fatty acids|fatty acids
4698067|NCT03251144|HIV/AIDS|hiv/aids
4698068|NCT03251144|Tenofovir disoproxil fumarate (TDF)|tenofovir disoproxil fumarate (tdf)
4698069|NCT03251144|Tenofovir alafenamide (TAF)|tenofovir alafenamide (taf)
4698070|NCT03251144|mitochondria|mitochondria
4698071|NCT03251144|toxicity|toxicity
4698072|NCT03251118|Crohn's Disease|crohn's disease
4698073|NCT03251118|Ulcerative colitis|ulcerative colitis
4698074|NCT03251118|Indeterminate colitis|indeterminate colitis
4698075|NCT03251118|Digestive System Diseases|digestive system diseases
4698076|NCT03251066|Nose Saline Solution Irrigation Nasal Spray|nose saline solution irrigation nasal spray
4698077|NCT03251066|Sodium propionate Locke-Ringer Solution|sodium propionate locke-ringer solution
4698078|NCT03251040|Esophagogastric anastomosis|esophagogastric anastomosis
4698079|NCT03251040|Fibrin sealant|fibrin sealant
4698080|NCT03251040|Sealing|sealing
4698081|NCT03251014|Thrombosis|thrombosis
4698082|NCT03251014|Yellowstripe scad|yellowstripe scad
4698083|NCT03251014|Salmon|salmon
4698084|NCT03251014|Healthy overweight subjects|healthy overweight subjects
4698085|NCT03251014|Randomized crossover trial|randomized crossover trial
4698086|NCT03251001|gingiva|gingiva
4698087|NCT03251001|keratinized mucosa|keratinized mucosa
4698088|NCT03251001|gingival graft|gingival graft
4698089|NCT03250975|Intubation injury|intubation injury
4698090|NCT03250975|Acute laryngeal injury|acute laryngeal injury
4698091|NCT03250975|Chronic Laryngeal Injury|chronic laryngeal injury
4698092|NCT03250962|Relapsed/Refractory; Hodgkin Lymphoma；Decitabine; SHR-1210|relapsed/refractory; hodgkin lymphoma；decitabine; shr-1210
4698093|NCT03250936|trampoline|trampoline
4698094|NCT03250923|Oral Candidiasis, Thrush, Oral Moniliasis|oral candidiasis, thrush, oral moniliasis
4698095|NCT03250910|hepatitis C virus|hepatitis c virus
4698096|NCT03250910|human immunodeficiency virus|human immunodeficiency virus
4698097|NCT03250910|Direct acting antiviral agent|direct acting antiviral agent
4698098|NCT03250897|Alveolar macrophages|alveolar macrophages
4698099|NCT03250897|Blood monocyte-derived macrophages|blood monocyte-derived macrophages
4698100|NCT03250897|FACS analysis|facs analysis
4698101|NCT03250897|Broncho-alveolar lavage fluids|broncho-alveolar lavage fluids
4698102|NCT03250897|Non-infectious lung diseases|non-infectious lung diseases
4698103|NCT03250858|Personalised nutrition|personalised nutrition
4698104|NCT03250858|Mobile web application|mobile web application
4698105|NCT03250845|Multigam|multigam
4698106|NCT03250845|Immunoglobulin|immunoglobulin
4698107|NCT03250845|Secondary immunodeficiency|secondary immunodeficiency
4698108|NCT03250832|advanced solid tumors|advanced solid tumors
4698109|NCT03250832|endometrioid ovarian cancer|endometrioid ovarian cancer
4698110|NCT03250832|fallopian tube cancer|fallopian tube cancer
4698111|NCT03250832|primary peritoneal cancer|primary peritoneal cancer
4698112|NCT03250832|breast cancer|breast cancer
4698113|NCT03250832|bladder cancer|bladder cancer
4698114|NCT03250832|urothelial carcinoma|urothelial carcinoma
4698115|NCT03250832|TNBC|tnbc
4698116|NCT03250832|triple-negative breast cancer|triple-negative breast cancer
4698117|NCT03250832|LAG-3|lag-3
4698118|NCT03250806|aortic stenosis, auscultation, target echocardiography|aortic stenosis, auscultation, target echocardiography
4698119|NCT03250793|Hernia, DIaphragmatic, Congenital|hernia, diaphragmatic, congenital
4698120|NCT03250793|Respiration, Artificial|respiration, artificial
4698121|NCT03250793|physiologic pilot study|physiologic pilot study
4698122|NCT03250793|NAVA|nava
4698123|NCT03250793|Neurally Adjusted Ventilatory Assist|neurally adjusted ventilatory assist
4698124|NCT03250793|esophageal transducer|esophageal transducer
4698125|NCT03250793|Work of Breathing|work of breathing
4698126|NCT03250754|Acupuncture|acupuncture
4698127|NCT03250754|Migraine|migraine
4698128|NCT03250754|Tension-type headache|tension-type headache
4698129|NCT03250741|Rotigotine|rotigotine
4698130|NCT03250741|Dopamine|dopamine
4698131|NCT03250728|CDG|cdg
4698132|NCT03250728|Stroke-like|stroke-like
4698133|NCT03250728|Endothelial progenitor cells (EPCs)|endothelial progenitor cells (epcs)
4698134|NCT03250728|Protein C|protein c
4698135|NCT03250728|Congenital Disorders og Glycosylation|congenital disorders og glycosylation
4698136|NCT03250702|Tanzania|tanzania
4698137|NCT03250702|Observational|observational
4698138|NCT03250702|Sub-Saharan Africa|sub-saharan africa
4698139|NCT03250702|Treatment|treatment
4698140|NCT03250689|Danirixin|danirixin
4698141|NCT03250689|CXCR2|cxcr2
4698142|NCT03250689|NETs|nets
4698143|NCT03250689|GSK1325756|gsk1325756
4698144|NCT03250689|COPD|copd
4698145|NCT03250689|HBr|hbr
4698146|NCT03250676|HER2|her2
4698147|NCT03250676|estrogen receptor|estrogen receptor
4698148|NCT03250676|H3B-6545|h3b-6545
4698149|NCT03250676|breast cancer|breast cancer
4698740|NCT03246854|DBPR112|dbpr112
4698150|NCT03250676|Endocrine Therapy|endocrine therapy
4698151|NCT03250663|topical therapy, atopic dermatitis,|topical therapy, atopic dermatitis,
4698152|NCT03250650|Overactive Bladder|overactive bladder
4698153|NCT03250650|Electric Stimulation|electric stimulation
4698154|NCT03250650|Physical Therapy Modalities|physical therapy modalities
4698155|NCT03250637|Gene-environment interaction|gene-environment interaction
4698156|NCT03250637|Candidate gene|candidate gene
4698157|NCT03250637|Western style diet|western style diet
4698158|NCT03250637|Toll-like receptors|toll-like receptors
4698159|NCT03250637|Prospective study|prospective study
4698160|NCT03250637|Nested case-cohort|nested case-cohort
4698161|NCT03250611|Occipital condyle|occipital condyle
4698162|NCT03250611|Occipital condyle screw|occipital condyle screw
4698163|NCT03250598|Healthy|healthy
4698164|NCT03250598|Japanese|japanese
4698165|NCT03250585|acute chest syndrome|acute chest syndrome
4698166|NCT03250585|secretory phospholipases A2|secretory phospholipases a2
4698167|NCT03250585|exhaled breath condensate|exhaled breath condensate
4698168|NCT03250585|sickle cell disease|sickle cell disease
4698169|NCT03250559|Stone disease|stone disease
4698170|NCT03250533|Wound healing|wound healing
4698171|NCT03250533|Phototherapy|phototherapy
4698172|NCT03250533|Electrotherapy|electrotherapy
4698173|NCT03250507|TAP block|tap block
4698174|NCT03250507|Liposomal bupivicaine|liposomal bupivicaine
4698175|NCT03250494|Duloxetine, Dexamethasone, Postoperative pain, side effects.|duloxetine, dexamethasone, postoperative pain, side effects.
4698176|NCT03250481|Sedation, Responsiveness Index, Electromyogram|sedation, responsiveness index, electromyogram
4698177|NCT03250390|Lung cancer|lung cancer
4698178|NCT03250390|diagnosis|diagnosis
4698179|NCT03250390|volatile organic compounds|volatile organic compounds
4698180|NCT03250377|Brivaracetam|brivaracetam
4698181|NCT03250377|Epilepsy|epilepsy
4698182|NCT03250377|Partial seizures with or without secondary generalization|partial seizures with or without secondary generalization
4698183|NCT03250377|Asian subjects|asian subjects
4698184|NCT03250325|Adoptive cell transfer|adoptive cell transfer
4698185|NCT03250325|Cell therapy|cell therapy
4698186|NCT03250325|Immunotherapy|immunotherapy
4698187|NCT03250325|NY-ESO-1|ny-eso-1
4698188|NCT03250325|T cell receptor gene therapy|t cell receptor gene therapy
4698189|NCT03250325|Synovial sarcoma|synovial sarcoma
4698190|NCT03250312|Osteopathic manipulation|osteopathic manipulation
4698191|NCT03250312|low back pain|low back pain
4698192|NCT03250312|immune cells|immune cells
4698193|NCT03250273|Immunotherapy|immunotherapy
4698194|NCT03250273|Nivolumab|nivolumab
4698195|NCT03250273|Entinostat|entinostat
4698196|NCT03250273|Pancreatic Adenocarcinoma|pancreatic adenocarcinoma
4698197|NCT03250273|Cholangiocarcinoma|cholangiocarcinoma
4698198|NCT03250273|Unresectable|unresectable
4698199|NCT03250273|Metastatic|metastatic
4698200|NCT03250273|PD-1|pd-1
4698201|NCT03250273|Antibody|antibody
4698202|NCT03250260|3-dimensional imaging|3-dimensional imaging
4698203|NCT03250260|Breast Conserving Treatment|breast conserving treatment
4698204|NCT03250260|Simulation|simulation
4698205|NCT03250247|deep vein thrombosis|deep vein thrombosis
4698206|NCT03250247|superficial venous reflux|superficial venous reflux
4698207|NCT03250247|blood clot|blood clot
4698208|NCT03250247|post thrombotic syndrome|post thrombotic syndrome
4698209|NCT03250247|iliac vein obstruction|iliac vein obstruction
4698210|NCT03250234|microRNA, carbohydrate oxidation|microrna, carbohydrate oxidation
4698211|NCT03250208|Microbiome|microbiome
4698212|NCT03250208|Lactobacillus|lactobacillus
4698213|NCT03250208|Probiotic|probiotic
4698214|NCT03250208|Fem-Dophilus|fem-dophilus
4698215|NCT03250156|Mindfulness|mindfulness
4698216|NCT03250156|Attention|attention
4698217|NCT03250156|Working Memory|working memory
4698218|NCT03250156|Psychological Well-Being|psychological well-being
4698219|NCT03250156|Proctored Practice|proctored practice
4698220|NCT03250117|Parkinson Disease|parkinson disease
4698221|NCT03250117|Dyskinesia|dyskinesia
4698222|NCT03250117|ropinirole|ropinirole
4698223|NCT03250117|implant|implant
4698224|NCT03250117|ProNeura|proneura
4698225|NCT03250117|movement disorders|movement disorders
4698226|NCT03250117|dopamine agonist|dopamine agonist
4698227|NCT03250117|extended-release|extended-release
4698228|NCT03250117|Parkinsonian disorders|parkinsonian disorders
4698229|NCT03250117|brain diseases|brain diseases
4698230|NCT03250117|central nervous system diseases|central nervous system diseases
4698231|NCT03250117|Neurodegenerative Diseases|neurodegenerative diseases
4698232|NCT03250117|Antiparkinson agents|antiparkinson agents
4698233|NCT03250117|Anti-dyskinesia agents|anti-dyskinesia agents
4698234|NCT03250117|dopamine agents|dopamine agents
4698235|NCT03250117|neurotransmitter agents|neurotransmitter agents
4698236|NCT03250117|REQUIP|requip
4698237|NCT03250117|subdermal|subdermal
4698238|NCT03250104|antimicrobial stewardship|antimicrobial stewardship
4698239|NCT03250104|infection control|infection control
4698240|NCT03250104|nosocomial infection|nosocomial infection
4698241|NCT03250104|clostridium difficile|clostridium difficile
4698242|NCT03250104|MRGN bacteria|mrgn bacteria
4698243|NCT03250104|health-care associated pathogens|health-care associated pathogens
4698244|NCT03250104|VRE|vre
4698937|NCT03245645|IBS|ibs
4698245|NCT03250091|gastric precancerous lesions|gastric precancerous lesions
4698246|NCT03250091|gastric cancer|gastric cancer
4698247|NCT03250091|gastric intestinal Metaplasia|gastric intestinal metaplasia
4698248|NCT03250091|gastric atrophy|gastric atrophy
4698249|NCT03250091|gastric dysplasia|gastric dysplasia
4698250|NCT03250078|Pancreas|pancreas
4698251|NCT03250078|Cancer|cancer
4698252|NCT03250078|Diabetes Mellitus|diabetes mellitus
4698253|NCT03250078|MRI|mri
4698254|NCT03250078|BRCA|brca
4698255|NCT03250078|Early Detection|early detection
4698256|NCT03250078|Genetics|genetics
4698257|NCT03250052|Fimasartan|fimasartan
4698258|NCT03250039|Absorption, Metabolism, Excretion, Absolute Bioavailability|absorption, metabolism, excretion, absolute bioavailability
4698259|NCT03250026|primary care|primary care
4698260|NCT03250026|convergence dialogue|convergence dialogue
4698261|NCT03250026|sick leave|sick leave
4698262|NCT03250026|care manager|care manager
4698263|NCT03249974|Enlite glucose monitoring|enlite glucose monitoring
4698264|NCT03249974|accuracy|accuracy
4698265|NCT03249974|usability|usability
4698266|NCT03249974|skin reactions|skin reactions
4698267|NCT03249974|type 1 diabetes mellitus|type 1 diabetes mellitus
4698268|NCT03249961|motor|motor
4698269|NCT03249961|transcranial direct current stimulation|transcranial direct current stimulation
4698270|NCT03249961|transcranial magnetic stimulation|transcranial magnetic stimulation
4698271|NCT03249935|Azithromycin|azithromycin
4698272|NCT03249935|Chlamydia|chlamydia
4698273|NCT03249935|Correctional|correctional
4698274|NCT03249935|Facilities|facilities
4698275|NCT03249935|Symptoms|symptoms
4698276|NCT03249935|Urethral|urethral
4698277|NCT03249935|Urogenital|urogenital
4698278|NCT03249935|Youth|youth
4698279|NCT03249922|spinal cord stimulation|spinal cord stimulation
4698280|NCT03249896|Gestational Diabetes|gestational diabetes
4698281|NCT03249896|RCT|rct
4698282|NCT03249896|Lifestyle coaching program|lifestyle coaching program
4698283|NCT03249896|Smartphone app|smartphone app
4698284|NCT03249896|Gestational weight gain|gestational weight gain
4698285|NCT03249883|prosthetic feet|prosthetic feet
4698286|NCT03249883|double blind study|double blind study
4698287|NCT03249883|limited ambulators|limited ambulators
4698288|NCT03249883|SACH foot|sach foot
4698289|NCT03249883|prosthetic components comparison|prosthetic components comparison
4698290|NCT03249857|Bipolar affective disorders|bipolar affective disorders
4698291|NCT03249857|Cognition|cognition
4698292|NCT03249857|Emotion|emotion
4698293|NCT03249857|Embodiment|embodiment
4698294|NCT03249857|Sensorimotor|sensorimotor
4698295|NCT03249857|Simulation|simulation
4698296|NCT03249844|arterial ischemic stroke|arterial ischemic stroke
4698297|NCT03249844|children|children
4698298|NCT03249844|steroids|steroids
4698299|NCT03249844|aspirin|aspirin
4698300|NCT03249844|Methylprednisolone|methylprednisolone
4698301|NCT03249844|Prednisolone|prednisolone
4698302|NCT03249831|Sickle Cell Disease|sickle cell disease
4698303|NCT03249831|Sickle Cell Disorders|sickle cell disorders
4698304|NCT03249831|Hemoglobinopathies|hemoglobinopathies
4698305|NCT03249831|Thalassemia|thalassemia
4698306|NCT03249831|Anemia, Sickle Cell|anemia, sickle cell
4698307|NCT03249831|Haploidentical Transplant|haploidentical transplant
4698308|NCT03249831|Nonmyeloablative Conditioning|nonmyeloablative conditioning
4698309|NCT03249831|CD4+ T cell|cd4+ t cell
4698310|NCT03249831|CD4+ T cell-depleted Hematopoietic Cell Transplant|cd4+ t cell-depleted hematopoietic cell transplant
4698311|NCT03249831|Mixed Chimerism|mixed chimerism
4698313|NCT03249805|Medical device efficacy|medical device efficacy
4698314|NCT03249740|Age-related macular degeneration|age-related macular degeneration
4698315|NCT03249740|Choroidal neovascularization|choroidal neovascularization
4698316|NCT03249727|natural killer cells|natural killer cells
4698317|NCT03249727|natural killer cell activity|natural killer cell activity
4698318|NCT03249714|double-blind, placebo controlled, ofatumumab, relapsing multiple sclerosis, Japanese patients|double-blind, placebo controlled, ofatumumab, relapsing multiple sclerosis, japanese patients
4698319|NCT03249701|Acupoint Stimulation|acupoint stimulation
4698320|NCT03249701|postoperative recovery|postoperative recovery
4698321|NCT03249701|Postoperative Complications|postoperative complications
4698322|NCT03249701|Peri-operation|peri-operation
4698323|NCT03249688|Lifestyle intervention|lifestyle intervention
4698324|NCT03249688|Medical food|medical food
4698325|NCT03249688|Randomized controlled trial|randomized controlled trial
4698326|NCT03249688|Prodromal Alzheimer's disease|prodromal alzheimer's disease
4698327|NCT03249688|Prevention|prevention
4698328|NCT03249688|Intervention|intervention
4698329|NCT03249688|Multidomain|multidomain
4698330|NCT03249688|Multimodal|multimodal
4698331|NCT03249675|mild Traumatic Brain Injury|mild traumatic brain injury
4698332|NCT03249675|Concussion|concussion
4698333|NCT03249662|periarticular infiltration|periarticular infiltration
4698334|NCT03249662|postoperative pain management|postoperative pain management
4698335|NCT03249662|plasma level of bupivacaine|plasma level of bupivacaine
4698336|NCT03249649|defibulation|defibulation
4698337|NCT03249649|healthcare needs assessment|healthcare needs assessment
4698338|NCT03249649|CBPR|cbpr
4698339|NCT03249623|Weaning|weaning
4698340|NCT03249623|Intensive Care|intensive care
4698341|NCT03249623|Individualised Care|individualised care
4698342|NCT03249623|Open-Loop Decision Support System|open-loop decision support system
4698343|NCT03249623|Respiratory Failure|respiratory failure
4698344|NCT03249623|Mechanical Ventilation|mechanical ventilation
4698345|NCT03249623|Spontaneous breathing Tests|spontaneous breathing tests
4698346|NCT03249623|Extubation|extubation
4698347|NCT03249597|Sepsis|sepsis
4698348|NCT03249597|Emergency Medical Services|emergency medical services
4698349|NCT03249597|Prehospital|prehospital
4698350|NCT03249597|Emergency Care|emergency care
4698351|NCT03249597|Emergency Medicine|emergency medicine
4698352|NCT03249571|exercise|exercise
4698353|NCT03249571|flavonoids|flavonoids
4698354|NCT03249571|gut permeability|gut permeability
4698355|NCT03249571|gut-derived phenolics|gut-derived phenolics
4698356|NCT03249558|Pain|pain
4698357|NCT03249558|Pain Management|pain management
4698358|NCT03249519|Radiation therapy|radiation therapy
4698359|NCT03249519|Chemoradiation|chemoradiation
4698360|NCT03249519|Brachytherapy|brachytherapy
4698361|NCT03249519|Hyperthermia|hyperthermia
4698362|NCT03249519|Cervical cancer|cervical cancer
4698363|NCT03249519|Multimodality treatment of advanced cervical cancer|multimodality treatment of advanced cervical cancer
4698364|NCT03249493|Decentralised Area|decentralised area
4698365|NCT03249467|HAQ-II|haq-ii
4698366|NCT03249467|Rheumatoid arthritis|rheumatoid arthritis
4698367|NCT03249454|Incomplete SCI|incomplete sci
4698368|NCT03249415|Platelet-Rich Plasma|platelet-rich plasma
4698369|NCT03249415|Cell therapy|cell therapy
4698370|NCT03249415|Regenerative factors|regenerative factors
4698371|NCT03249415|Autologous treatment|autologous treatment
4698372|NCT03249415|Paracrine factors|paracrine factors
4698373|NCT03249363|Pulse Irrigation Povidone Iodine Spine Surgery|pulse irrigation povidone iodine spine surgery
4698374|NCT03249350|Substance Use Disorders|substance use disorders
4698375|NCT03249350|Adolescents|adolescents
4698376|NCT03249350|Treatment|treatment
4698377|NCT03249350|Mediation|mediation
4698378|NCT03249324|Pregnancy|pregnancy
4698379|NCT03249324|Overweight|overweight
4698380|NCT03249324|Obesity|obesity
4698381|NCT03249324|Prevention|prevention
4698382|NCT03249324|Positive-gain counseling|positive-gain counseling
4698383|NCT03249311|Levomilnacipran|levomilnacipran
4698384|NCT03249311|Antidepressant|antidepressant
4698385|NCT03249311|Ottawa|ottawa
4698386|NCT03249311|Selective Norepinephrine Reuptake Inhibitor|selective norepinephrine reuptake inhibitor
4698387|NCT03249311|Healthy males|healthy males
4698388|NCT03249311|Tyramine response|tyramine response
4698389|NCT03249311|Serotonin|serotonin
4698390|NCT03249311|Norepinephrine|norepinephrine
4698391|NCT03249285|hypertension|hypertension
4698392|NCT03249285|pharmacogenomics|pharmacogenomics
4698393|NCT03249285|anti-hypertensive therapy|anti-hypertensive therapy
4698394|NCT03249246|Sepsis|sepsis
4698395|NCT03249246|ICU|icu
4698396|NCT03249246|Point prevalence|point prevalence
4698397|NCT03249207|Aneurysmal|aneurysmal
4698398|NCT03249181|MTCT|mtct
4698399|NCT03249181|Antiretroviral|antiretroviral
4698400|NCT03249181|Pregnancy|pregnancy
4698401|NCT03249181|Africa|africa
4698402|NCT03249155|Freezing of Gait, Action Observation|freezing of gait, action observation
4698403|NCT03249142|Ovarian Cancer|ovarian cancer
4698404|NCT03249142|Anti-PD-L1|anti-pd-l1
4698405|NCT03249142|Anti-CLA-4|anti-cla-4
4698406|NCT03249142|Neo-adjuvant|neo-adjuvant
4698407|NCT03249129|Trauma|trauma
4698408|NCT03249129|spinal cord|spinal cord
4698409|NCT03249129|autoimmunity|autoimmunity
4698410|NCT03249129|antibody|antibody
4698411|NCT03249116|human-animal interaction|human-animal interaction
4698412|NCT03249116|animal-assisted intervention|animal-assisted intervention
4698413|NCT03249103|Fibromyalgia|fibromyalgia
4698414|NCT03249077|Prevention|prevention
4698415|NCT03249077|Medicare|medicare
4698416|NCT03249064|TREGS|tregs
4698417|NCT03249064|CD91|cd91
4698418|NCT03249064|LRP1|lrp1
4698419|NCT03249025|lidocaine|lidocaine
4698420|NCT03249025|ketamine|ketamine
4698421|NCT03249025|infusion|infusion
4698422|NCT03248999|multidrug resistance|multidrug resistance
4698423|NCT03248999|nursing home|nursing home
4698424|NCT03248999|ESBL|esbl
4698425|NCT03248999|CRE|cre
4698426|NCT03248947|opioid use disorder|opioid use disorder
4698427|NCT03248947|Medication-assisted treatment|medication-assisted treatment
4698428|NCT03248947|Buprenorphine treatment|buprenorphine treatment
4698429|NCT03248947|Collaborative care model|collaborative care model
4698430|NCT03248908|pupillary reflex|pupillary reflex
4698431|NCT03248908|nociception|nociception
4698432|NCT03248908|heart rate|heart rate
4698433|NCT03248908|intraoperative monitoring|intraoperative monitoring
4698434|NCT03248895|Inhaler assessment|inhaler assessment
4698435|NCT03248895|Direct observation of therapy|direct observation of therapy
4698436|NCT03248882|PF-05221304|pf-05221304
4698437|NCT03248882|NAFLD|nafld
4698438|NCT03248882|NASH|nash
4698439|NCT03248882|features of metabolic syndrome|features of metabolic syndrome
4698440|NCT03248882|Dose-Ranging Study|dose-ranging study
4698441|NCT03248869|asthma|asthma
4698442|NCT03248869|mobile application|mobile application
4698443|NCT03248869|mobile app|mobile app
4698938|NCT03245645|Diet|diet
4698444|NCT03248869|mobile health applications|mobile health applications
4698445|NCT03248869|asthma mobile health application|asthma mobile health application
4698446|NCT03248843|KN035|kn035
4698447|NCT03248843|Solid tumors|solid tumors
4698448|NCT03248843|Phase 1|phase 1
4698449|NCT03248804|Overweight|overweight
4698450|NCT03248804|Obesity|obesity
4698451|NCT03248804|Weight Loss|weight loss
4698452|NCT03248778|disclosure|disclosure
4698453|NCT03248752|Behavioural|behavioural
4698454|NCT03248739|Catheter|catheter
4698455|NCT03248739|Ventricular|ventricular
4698456|NCT03248739|External Ventricular Drain Catheter|external ventricular drain catheter
4698457|NCT03248739|EVD Catheter|evd catheter
4698458|NCT03248739|Occlusion|occlusion
4698459|NCT03248739|Ventriculostomy|ventriculostomy
4698460|NCT03248739|Clear Bactiseal catheter|clear bactiseal catheter
4698461|NCT03248739|Orange Bactiseal catheter|orange bactiseal catheter
4698462|NCT03248739|Ventriculostomy Occlusion|ventriculostomy occlusion
4698463|NCT03248739|Neurosurgery|neurosurgery
4698464|NCT03248726|Polyethylene Glycol|polyethylene glycol
4698465|NCT03248726|Bisacodyl|bisacodyl
4698466|NCT03248726|Colonoscopy|colonoscopy
4698467|NCT03248726|Bowel preparation|bowel preparation
4698468|NCT03248726|Ottawa bowel preparation scale|ottawa bowel preparation scale
4698469|NCT03248635|Survey|survey
4698470|NCT03248635|Pre-Test|pre-test
4698471|NCT03248622|Incidence|incidence
4698472|NCT03248622|Hepatitis B Surface Antigen|hepatitis b surface antigen
4698473|NCT03248622|Decompensation|decompensation
4698474|NCT03248596|Extracorporeal Membrane Oxygenation (ECMO)|extracorporeal membrane oxygenation (ecmo)
4698475|NCT03248596|Primary hemostasis|primary hemostasis
4698476|NCT03248583|Proof-of-principle|proof-of-principle
4698477|NCT03248583|Feasibility|feasibility
4698478|NCT03248557|resuscitation|resuscitation
4698479|NCT03248557|wavelet analysis|wavelet analysis
4698480|NCT03248557|spectral analysis|spectral analysis
4698481|NCT03248557|post-cardiac arrest syndrome|post-cardiac arrest syndrome
4698482|NCT03248544|vitamin D|vitamin d
4698483|NCT03248544|Brain Neoplasms|brain neoplasms
4698484|NCT03248544|perioperative complications|perioperative complications
4698485|NCT03248544|clinical outcomes|clinical outcomes
4698486|NCT03248544|craniotomy|craniotomy
4698487|NCT03248544|Immune System|immune system
4698488|NCT03248531|Hidradenitis Suppurativa|hidradenitis suppurativa
4698489|NCT03248531|Bimekizumab|bimekizumab
4698490|NCT03248531|HS|hs
4698491|NCT03248531|Moderate to Severe HS|moderate to severe hs
4698492|NCT03248518|Inflammatory Rheumatic Disease|inflammatory rheumatic disease
4698493|NCT03248518|Fatigue|fatigue
4698494|NCT03248518|Exercise|exercise
4698495|NCT03248518|Behavioural Intervention|behavioural intervention
4698496|NCT03248518|Rheumatoid Arthritis|rheumatoid arthritis
4698497|NCT03248518|Systemic Lupus Erythematosus|systemic lupus erythematosus
4698498|NCT03248518|Axial Spondyloarthritis|axial spondyloarthritis
4698499|NCT03248492|HER-2 positive breast cancer|her-2 positive breast cancer
4698500|NCT03248492|Metastatic or Unresectable|metastatic or unresectable
4698501|NCT03248492|Resistant or refractory to T-DM1|resistant or refractory to t-dm1
4698502|NCT03248479|Hu5F9-G4|hu5f9-g4
4698503|NCT03248479|CD47|cd47
4698504|NCT03248479|azacitidine|azacitidine
4698505|NCT03248466|platelet rich gel|platelet rich gel
4698506|NCT03248466|BMMSCs|bmmscs
4698507|NCT03248466|diabetic foot ulcer|diabetic foot ulcer
4698508|NCT03248453|Simulated colonoscopy|simulated colonoscopy
4698509|NCT03248453|Self-regulated learning|self-regulated learning
4698510|NCT03248427|Breast Cancer|breast cancer
4698511|NCT03248427|Neoadjuvant|neoadjuvant
4698512|NCT03248427|Luminal B tumors|luminal b tumors
4698513|NCT03248427|Ribociclib|ribociclib
4698514|NCT03248375|Unresectable Hepatocellular Carcinoma|unresectable hepatocellular carcinoma
4698515|NCT03248375|Radioembolization|radioembolization
4698516|NCT03248375|Radiation Segmentectomy|radiation segmentectomy
4698517|NCT03248349|Critically ill children|critically ill children
4698518|NCT03248349|Pharmacokinetics|pharmacokinetics
4698519|NCT03248349|Anti-Bacterial agents|anti-bacterial agents
4698520|NCT03248310|Quality of Life (QoL)|quality of life (qol)
4698521|NCT03248310|17-377|17-377
4698522|NCT03248271|Diabetes|diabetes
4698523|NCT03248271|Sarcopenia|sarcopenia
4698524|NCT03248271|Hypotension|hypotension
4698525|NCT03248271|Tilt Table Test|tilt table test
4698526|NCT03248258|Metastatic Breast Cancer|metastatic breast cancer
4698527|NCT03248258|Treatment Decision Making|treatment decision making
4698528|NCT03248258|Shared Decision Making|shared decision making
4698529|NCT03248245|interprofessional team collaboration|interprofessional team collaboration
4698530|NCT03248245|primary school|primary school
4698531|NCT03248245|learning environment|learning environment
4698532|NCT03248245|teacher's self-efficacy|teacher's self-efficacy
4698533|NCT03248245|teachers working ours|teachers working ours
4698534|NCT03248245|pupils learning outcome|pupils learning outcome
4698535|NCT03248245|cluster-randomized|cluster-randomized
4698536|NCT03248232|Transcatheter aortic valve implantation|transcatheter aortic valve implantation
4698537|NCT03248193|paclitaxel|paclitaxel
4698538|NCT03248193|neuropathy|neuropathy
4698539|NCT03248193|hypothermia|hypothermia
4698540|NCT03248193|cryocompression|cryocompression
4698541|NCT03248193|alopecia|alopecia
4698542|NCT03248180|antipsychotic|antipsychotic
4698543|NCT03248180|guided dose reduction|guided dose reduction
4698544|NCT03248180|maintenance treatment|maintenance treatment
4698545|NCT03248180|remitted psychosis|remitted psychosis
4698546|NCT03248180|relapse|relapse
4698547|NCT03248167|Cannabidiol|cannabidiol
4698548|NCT03248154|Biofilm|biofilm
4698549|NCT03248154|Procellera|procellera
4698550|NCT03248141|Hemophilia A Factor VIII|hemophilia a factor viii
4698551|NCT03248141|Hemophilia B Factor IX|hemophilia b factor ix
4698552|NCT03248141|Cross-sectional|cross-sectional
4698553|NCT03248141|Epidemiological|epidemiological
4698554|NCT03248141|Clinical practice|clinical practice
4698555|NCT03248141|United States|united states
4698556|NCT03248128|Fluticasone furoate|fluticasone furoate
4698557|NCT03248128|Efficacy|efficacy
4698558|NCT03248128|Vilanterol|vilanterol
4698559|NCT03248128|Asthma|asthma
4698560|NCT03248128|Safety|safety
4698561|NCT03248128|GW642444|gw642444
4698562|NCT03248128|GW685698|gw685698
4698563|NCT03248115|polyphenols|polyphenols
4698564|NCT03248115|green tea catechins|green tea catechins
4698565|NCT03248115|coffee caffeoylquinic acids|coffee caffeoylquinic acids
4698566|NCT03248115|metabolism|metabolism
4698567|NCT03248115|inter-individual variability|inter-individual variability
4698568|NCT03248115|colonic microbiota|colonic microbiota
4698569|NCT03248102|paediatric|paediatric
4698570|NCT03248063|Staphylococcus aureus|staphylococcus aureus
4698571|NCT03248063|bacteremia|bacteremia
4698572|NCT03248063|cloxacillin|cloxacillin
4698573|NCT03248063|cefazolin|cefazolin
4698574|NCT03248024|Chronic Disease|chronic disease
4698575|NCT03248024|Ulcerative Colitis|ulcerative colitis
4698576|NCT03248011|hamstring|hamstring
4698577|NCT03248011|ultrasound|ultrasound
4698578|NCT03248011|intervention|intervention
4698579|NCT03247998|Stroke|stroke
4698580|NCT03247998|endovascular repair|endovascular repair
4698581|NCT03247998|general anesthesia|general anesthesia
4698582|NCT03247998|conscious sedation|conscious sedation
4698583|NCT03247985|Mesh|mesh
4698584|NCT03247985|Repair|repair
4698585|NCT03247985|Peritoneal|peritoneal
4698586|NCT03247959|oral health education, distraction, videogame|oral health education, distraction, videogame
4698587|NCT03247946|infant|infant
4698588|NCT03247946|feeding position|feeding position
4698589|NCT03247946|respiratory|respiratory
4698590|NCT03247946|ear|ear
4698591|NCT03247933|COPD|copd
4698592|NCT03247933|RESPIRATORY REHABILITATION TELEMEDICINE|respiratory rehabilitation telemedicine
4698593|NCT03247920|Antibiotic switch therapy|antibiotic switch therapy
4698594|NCT03247920|Amoxicillin/clavulanic acid|amoxicillin/clavulanic acid
4698595|NCT03247894|Multiple sclerosis, anesthesia|multiple sclerosis, anesthesia
4698596|NCT03247842|post mastectomy pain|post mastectomy pain
4698597|NCT03247829|CardioMEMS|cardiomems
4698598|NCT03247829|Left Ventricular Assist Device|left ventricular assist device
4698599|NCT03247829|Hemodynamic Management|hemodynamic management
4698600|NCT03247803|Air-Q® SP|air-q® sp
4698601|NCT03247803|Williams Airway Intubator (WA)|williams airway intubator (wa)
4698602|NCT03247803|Flexible Bronchoscopic intubation (FBI)|flexible bronchoscopic intubation (fbi)
4698603|NCT03247803|Fiberoptic Intubation (FOI)|fiberoptic intubation (foi)
4698604|NCT03247803|Fiberoptic Intubating Airway(FIA)|fiberoptic intubating airway(fia)
4698605|NCT03247803|Laryngeal Mask Airway|laryngeal mask airway
4698606|NCT03247777|golf|golf
4698607|NCT03247777|strength training|strength training
4698608|NCT03247777|physical performance tests|physical performance tests
4698609|NCT03247777|body composition|body composition
4698610|NCT03247738|ticagrelor|ticagrelor
4698611|NCT03247738|cangrelor|cangrelor
4698612|NCT03247712|HNSCC|hnscc
4698613|NCT03247712|radiation|radiation
4698614|NCT03247712|surgery|surgery
4698615|NCT03247712|phase 1|phase 1
4698616|NCT03247712|immunotherapy|immunotherapy
4698617|NCT03247712|nivolumab|nivolumab
4698618|NCT03247712|antibodies|antibodies
4698619|NCT03247673|safety|safety
4698620|NCT03247673|Pharmacokinetics|pharmacokinetics
4698621|NCT03247673|Immunogenicity|immunogenicity
4698622|NCT03247647|Alcohol Intervention|alcohol intervention
4698623|NCT03247647|College Students|college students
4698624|NCT03247634|getting ahead|getting ahead
4698625|NCT03247634|vulnerable population|vulnerable population
4698626|NCT03247634|safety net practice network|safety net practice network
4698627|NCT03247621|external eating, technology|external eating, technology
4698628|NCT03247608|Ambio Health|ambio health
4698629|NCT03247595|Colonoscopy preparation|colonoscopy preparation
4698630|NCT03247595|Magnesium Citrate Capsules|magnesium citrate capsules
4698631|NCT03247582|Real World Evidence|real world evidence
4698632|NCT03247582|Non-valvular Atrial Fibrillation|non-valvular atrial fibrillation
4698633|NCT03247582|Observational Safety|observational safety
4698634|NCT03247569|Non-valvular Atrial Fibrillation|non-valvular atrial fibrillation
4698635|NCT03247569|Real World Evidence|real world evidence
4698636|NCT03247569|Observational Safety|observational safety
4698637|NCT03247491|Mindfulness|mindfulness
4698638|NCT03247491|Compassion|compassion
4698639|NCT03247491|Depression during Pregnancy and Postpartum|depression during pregnancy and postpartum
4698640|NCT03247491|Prevention|prevention
4698641|NCT03247491|Stress|stress
4698642|NCT03247478|Computed tomography (CT) reconstruction|computed tomography (ct) reconstruction
4698643|NCT03247478|axillary lymph node status|axillary lymph node status
4698644|NCT03247452|Low fiber diet|low fiber diet
4698645|NCT03247452|Colonoscopy|colonoscopy
4698646|NCT03247452|Bowel Cleansing|bowel cleansing
4698647|NCT03247439|CMC Joint|cmc joint
4698648|NCT03247439|Osteoarthritis|osteoarthritis
4698649|NCT03247439|Cartilage Replacement|cartilage replacement
4698650|NCT03247439|First CMC Joint Osteoarthritis|first cmc joint osteoarthritis
4698651|NCT03247439|Damaged Articular Surface|damaged articular surface
4698652|NCT03247439|LRTI|lrti
4698653|NCT03247439|Ligament Reconstruction Tendon Interposition|ligament reconstruction tendon interposition
4698654|NCT03247387|Wearable device|wearable device
4698655|NCT03247387|Patient monitor|patient monitor
4698656|NCT03247374|rehabilitation|rehabilitation
4698657|NCT03247374|treatment|treatment
4698658|NCT03247374|biofeedback|biofeedback
4698659|NCT03247374|bio-feedback|bio-feedback
4698660|NCT03247374|dysphagia|dysphagia
4698661|NCT03247374|swallowing disorders|swallowing disorders
4698662|NCT03247374|post-stroke|post-stroke
4698663|NCT03247374|deglutition disorders|deglutition disorders
4698664|NCT03247361|Heart Failure; Rehabilitation|heart failure; rehabilitation
4698665|NCT03247322|Medication Safety|medication safety
4698666|NCT03247322|Mobile Health Technology|mobile health technology
4698667|NCT03247309|T-cell therapy|t-cell therapy
4698668|NCT03247309|immunotherapy|immunotherapy
4698669|NCT03247309|adoptive cellular therapy|adoptive cellular therapy
4698670|NCT03247309|T-Cell Receptor|t-cell receptor
4698671|NCT03247309|IMA201|ima201
4698672|NCT03247309|Cytotherapy|cytotherapy
4698673|NCT03247309|Cell Therapy|cell therapy
4698674|NCT03247309|Gene Therapy|gene therapy
4698675|NCT03247296|Daclatasvir|daclatasvir
4698676|NCT03247296|HCC|hcc
4698677|NCT03247296|HCV|hcv
4698678|NCT03247296|Sofosbuvir|sofosbuvir
4698679|NCT03247244|Cannabis|cannabis
4698680|NCT03247244|Tics|tics
4698681|NCT03247244|Tourette Syndrome|tourette syndrome
4698682|NCT03247231|SUBEPITHELIAL TUMORS|subepithelial tumors
4698683|NCT03247231|SUBMUCOSAL TUMORS|submucosal tumors
4698684|NCT03247231|ENDOSCOPIC BAND LIGATION|endoscopic band ligation
4698685|NCT03247205|hip fracture|hip fracture
4698686|NCT03247205|cognitive impairment|cognitive impairment
4698687|NCT03247205|physical therapy|physical therapy
4698688|NCT03247192|resistance training|resistance training
4698689|NCT03247192|protein supplementation|protein supplementation
4698690|NCT03247192|aging|aging
4698691|NCT03247192|Randomized Controlled Trial|randomized controlled trial
4698692|NCT03247127|hippocampal avoidance whole brain radiotherapy (HA-WBRT)|hippocampal avoidance whole brain radiotherapy (ha-wbrt)
4698693|NCT03247127|brain metastases|brain metastases
4698694|NCT03247127|memory preservation|memory preservation
4698695|NCT03247127|neurocognitive function|neurocognitive function
4698696|NCT03247088|Malignant neoplasms stated as primary lymphoid haematopoietic|malignant neoplasms stated as primary lymphoid haematopoietic
4698697|NCT03247088|Acute Myeloid Leukemia|acute myeloid leukemia
4698698|NCT03247088|AML|aml
4698699|NCT03247088|flt3 positive and negative|flt3 positive and negative
4698700|NCT03247088|Stem cell transplant|stem cell transplant
4698701|NCT03247088|Sorafenib|sorafenib
4698702|NCT03247088|Nexavar|nexavar
4698703|NCT03247088|BAY 43-9006|bay 43-9006
4698704|NCT03247088|Busulfan|busulfan
4698705|NCT03247088|Busulfex|busulfex
4698706|NCT03247088|Myleran|myleran
4698707|NCT03247088|Fludarabine|fludarabine
4698708|NCT03247088|Fludarabine Phosphate|fludarabine phosphate
4698709|NCT03247088|Fludara|fludara
4698710|NCT03247088|Tacrolimus|tacrolimus
4698711|NCT03247088|Prograf|prograf
4698712|NCT03247088|Filgrastim|filgrastim
4698713|NCT03247088|G-CSF|g-csf
4698714|NCT03247088|Neupogen|neupogen
4698715|NCT03247088|Mycophenolate mofetil|mycophenolate mofetil
4698716|NCT03247088|MMF|mmf
4698717|NCT03247088|CellCept|cellcept
4698718|NCT03247075|Social anxiety disorder|social anxiety disorder
4698719|NCT03247075|Cognitive Behavior Therapy|cognitive behavior therapy
4698720|NCT03247075|Internet-delivered treatments|internet-delivered treatments
4698721|NCT03247075|Children and adolescents|children and adolescents
4698722|NCT03247075|Randomized controlled trial|randomized controlled trial
4698723|NCT03247062|agitation, sleep deprivation, bundle|agitation, sleep deprivation, bundle
4698724|NCT03246997|Food Insecure|food insecure
4698725|NCT03246958|Thyroid Cancer|thyroid cancer
4698726|NCT03246932|peer expert or specialist|peer expert or specialist
4698727|NCT03246932|psycho-education|psycho-education
4698728|NCT03246932|schizophrenia|schizophrenia
4698729|NCT03246932|outpatients|outpatients
4698730|NCT03246893|Sepsis|sepsis
4698731|NCT03246893|Septic shock|septic shock
4698732|NCT03246893|Severe sepsis|severe sepsis
4698733|NCT03246893|Extubation|extubation
4698734|NCT03246893|Reintubation|reintubation
4698735|NCT03246893|Noninvasive positive pressure ventilation|noninvasive positive pressure ventilation
4698736|NCT03246893|High flow oxygen nasal cannula|high flow oxygen nasal cannula
4698737|NCT03246867|isolytic stretching|isolytic stretching
4698738|NCT03246867|static stretching|static stretching
4698739|NCT03246867|Glenohumeral Internal Rotation Deficit|glenohumeral internal rotation deficit
4698741|NCT03246854|EGFR mutated NSCLC|egfr mutated nsclc
4698742|NCT03246854|squamous cell cancer of head and neck|squamous cell cancer of head and neck
4698743|NCT03246854|maximum tolerated dose|maximum tolerated dose
4698744|NCT03246854|recommended Phase 2 dose|recommended phase 2 dose
4698745|NCT03246841|Oncogeneticists|oncogeneticists
4698746|NCT03246841|Mutations|mutations
4698747|NCT03246841|Breast Cancer|breast cancer
4698748|NCT03246841|Ovarian cancer|ovarian cancer
4698749|NCT03246828|gliclazide|gliclazide
4698750|NCT03246828|glucagon|glucagon
4698751|NCT03246828|diabetes|diabetes
4698752|NCT03246802|recurrent prostate cancer|recurrent prostate cancer
4698753|NCT03246802|mpMRI|mpmri
4698754|NCT03246802|salvage HDR brachytherapy|salvage hdr brachytherapy
4698755|NCT03246763|childhood obesity|childhood obesity
4698756|NCT03246750|Brentuximab Vedotin|brentuximab vedotin
4698757|NCT03246724|Ocular surgery|ocular surgery
4698758|NCT03246724|Intravenous sedation|intravenous sedation
4698759|NCT03246724|Oral sedation|oral sedation
4698760|NCT03246698|Stretching|stretching
4698761|NCT03246698|Subacromial Impingement Syndrome|subacromial impingement syndrome
4698762|NCT03246698|Glenohumeral Internal Rotation Deficit|glenohumeral internal rotation deficit
4698763|NCT03246672|obesity, morbid|obesity, morbid
4698764|NCT03246659|medullary thyroid carcinoma|medullary thyroid carcinoma
4698765|NCT03246659|MTC|mtc
4698766|NCT03246659|new gastrin analog|new gastrin analog
4698767|NCT03246659|111In-CP04|111in-cp04
4698768|NCT03246659|CP04 indium|cp04 indium
4698769|NCT03246659|personalised diagnostics|personalised diagnostics
4698770|NCT03246659|personalised therapy|personalised therapy
4698771|NCT03246659|theranostics|theranostics
4698772|NCT03246659|advanced MTC|advanced mtc
4698773|NCT03246659|CCK-2/gastrin receptor|cck-2/gastrin receptor
4698774|NCT03246646|Substance Abuse|substance abuse
4698775|NCT03246646|Alcohol Abuse|alcohol abuse
4698776|NCT03246620|emergency|emergency
4698777|NCT03246620|emergency medicine|emergency medicine
4698778|NCT03246620|sedation|sedation
4698779|NCT03246620|acute agitation|acute agitation
4698780|NCT03246594|atrial fibrillation|atrial fibrillation
4698781|NCT03246594|esophageal probe|esophageal probe
4698782|NCT03246594|thermolesion|thermolesion
4698783|NCT03246581|inhalation|inhalation
4698784|NCT03246581|anticholinergic|anticholinergic
4698785|NCT03246568|Ablation|ablation
4698786|NCT03246568|Renal Denervation|renal denervation
4698787|NCT03246568|Cryoballoon|cryoballoon
4698788|NCT03246477|maxillomandibular advancement osteotomy|maxillomandibular advancement osteotomy
4698789|NCT03246477|long-term results|long-term results
4698790|NCT03246477|quality of life|quality of life
4698791|NCT03246477|polysomnographic measurements|polysomnographic measurements
4698792|NCT03246477|skeletal stability|skeletal stability
4698793|NCT03246464|Contact lenses|contact lenses
4698794|NCT03246464|Children|children
4698795|NCT03246464|Myopia|myopia
4698796|NCT03246451|GLP-1|glp-1
4698797|NCT03246451|glucagon-like peptide-1|glucagon-like peptide-1
4698798|NCT03246451|Metformin|metformin
4698799|NCT03246451|Exendin(9-39)|exendin(9-39)
4698800|NCT03246399|SM04690|sm04690
4698801|NCT03246399|Wnt pathway|wnt pathway
4698802|NCT03246399|Samumed|samumed
4698803|NCT03246373|cognitive impairment|cognitive impairment
4698804|NCT03246334|Cohort study|cohort study
4698805|NCT03246334|Critical Care|critical care
4698806|NCT03246334|Follow-up study|follow-up study
4698807|NCT03246334|Intensive care units|intensive care units
4698808|NCT03246334|Long-term outcome|long-term outcome
4698809|NCT03246334|Outcome assessment|outcome assessment
4698810|NCT03246334|Quality of life|quality of life
4698811|NCT03246321|Colorectal Neoplasms|colorectal neoplasms
4698812|NCT03246321|Peritoneal Neoplasms|peritoneal neoplasms
4698813|NCT03246321|Intraperitoneal Injections|intraperitoneal injections
4698814|NCT03246321|Laparoscopy|laparoscopy
4698815|NCT03246321|Aerosols|aerosols
4698816|NCT03246321|Chemotherapy, Cancer, Regional Perfusion|chemotherapy, cancer, regional perfusion
4698817|NCT03246321|Antineoplastic Agents|antineoplastic agents
4698818|NCT03246321|Leucovorin|leucovorin
4698819|NCT03246321|Fluorouracil|fluorouracil
4698820|NCT03246321|Platinum|platinum
4698821|NCT03246321|Intraoperative Complications|intraoperative complications
4698822|NCT03246321|Postoperative Complications|postoperative complications
4698823|NCT03246321|Drug-Related Side Effects and Adverse Reactions|drug-related side effects and adverse reactions
4698824|NCT03246321|Metabolic Side Effects of Drugs and Substances|metabolic side effects of drugs and substances
4698825|NCT03246321|Disease-free survival|disease-free survival
4698826|NCT03246321|Survival|survival
4698827|NCT03246321|Mortality|mortality
4698828|NCT03246321|Quality of Life|quality of life
4698829|NCT03246321|Costs and Cost Analysis|costs and cost analysis
4698830|NCT03246321|Translational Medical Research|translational medical research
4698831|NCT03246321|Clinical Trials, Phase II as topic|clinical trials, phase ii as topic
4698832|NCT03246321|PIPAC|pipac
4698833|NCT03246321|Pressurized Intraperitoneal Aerosol Chemotherapy|pressurized intraperitoneal aerosol chemotherapy
4698834|NCT03246321|Pressurised Intraperitoneal Aerosol Chemotherapy|pressurised intraperitoneal aerosol chemotherapy
4698835|NCT03246321|Peritoneum|peritoneum
4698836|NCT03246321|Cecal Neoplasms|cecal neoplasms
4698837|NCT03246321|Clinical Trials, Phase I as topic|clinical trials, phase i as topic
4698838|NCT03246295|Proteomics|proteomics
4698839|NCT03246295|Metabolomics|metabolomics
4698840|NCT03246256|acute|acute
4698841|NCT03246256|informed consent|informed consent
4698842|NCT03246256|thrombolysis|thrombolysis
4698843|NCT03246243|Hypoxic Ischemic Encephalopathy|hypoxic ischemic encephalopathy
4698844|NCT03246243|Bottle Feeding|bottle feeding
4698845|NCT03246230|newborn vaccine responses|newborn vaccine responses
4698846|NCT03246178|Haploidentical|haploidentical
4698847|NCT03246178|Hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
4698848|NCT03246178|Severe aplastic anemia|severe aplastic anemia
4698849|NCT03246152|Anti-VEGF safety|anti-vegf safety
4698850|NCT03246152|Ischemic Maculopathy|ischemic maculopathy
4698851|NCT03246152|Diabetic Macular Edema|diabetic macular edema
4698852|NCT03246152|OCTA|octa
4698853|NCT03246139|stroke|stroke
4698854|NCT03246139|neurorehabilitation|neurorehabilitation
4698855|NCT03246139|mirror neuron system|mirror neuron system
4698856|NCT03246139|action observation|action observation
4698857|NCT03246139|motor imagery|motor imagery
4698858|NCT03246139|MEG|meg
4698859|NCT03246113|GBM WHO Grade IV|gbm who grade iv
4698860|NCT03246100|centralized reminder/recall|centralized reminder/recall
4698861|NCT03246100|influenza vaccine reminders|influenza vaccine reminders
4698862|NCT03246100|childhood influenza vaccines|childhood influenza vaccines
4698863|NCT03246087|acupuncture|acupuncture
4698864|NCT03246087|plantar fasiosis|plantar fasiosis
4698865|NCT03246074|Phase I|phase i
4698866|NCT03246074|Ovarian Cancer|ovarian cancer
4698867|NCT03246074|Fostamatinib and Paclitaxel|fostamatinib and paclitaxel
4698868|NCT03246035|Acute Decompensated Heart Failure|acute decompensated heart failure
4698869|NCT03246035|Heart Failure|heart failure
4698870|NCT03246035|Frailty|frailty
4698871|NCT03246035|Geriatrics|geriatrics
4698872|NCT03246035|Self-care|self-care
4698873|NCT03246035|Emergency Medicine|emergency medicine
4698874|NCT03246035|Cardiology|cardiology
4698875|NCT03246035|Patient Oriented Research|patient oriented research
4698876|NCT03246022|blood pressure fluctuation|blood pressure fluctuation
4698877|NCT03246022|hypertension|hypertension
4698878|NCT03246022|continuous positive airway pressure|continuous positive airway pressure
4698879|NCT03246009|Neutropenia|neutropenia
4698880|NCT03246009|Chemotherapy|chemotherapy
4698881|NCT03246009|rHSA/GCSF|rhsa/gcsf
4698882|NCT03245996|sick sinus syndrome|sick sinus syndrome
4698883|NCT03245996|heart rate|heart rate
4698884|NCT03245996|aortic blood pressure|aortic blood pressure
4698885|NCT03245996|artificial pacemaker|artificial pacemaker
4698886|NCT03245996|beta-blockers|beta-blockers
4698887|NCT03245996|ivabradine|ivabradine
4698888|NCT03245944|immature AVF|immature avf
4698889|NCT03245944|percutaneous intervention|percutaneous intervention
4698890|NCT03245892|Nivolumab|nivolumab
4698891|NCT03245892|Paclitaxel|paclitaxel
4698892|NCT03245892|Carboplatin|carboplatin
4698893|NCT03245892|17-182|17-182
4698894|NCT03245866|Subarachnoid Hemorrhage|subarachnoid hemorrhage
4698895|NCT03245866|Intracranial Aneurysm|intracranial aneurysm
4698896|NCT03245866|Ruptured Intracranial Aneurysm|ruptured intracranial aneurysm
4698897|NCT03245866|Neurosurgery|neurosurgery
4698898|NCT03245866|Interventional Neuroradiology|interventional neuroradiology
4698899|NCT03245866|Neurointensive Care Medicine|neurointensive care medicine
4698900|NCT03245866|Switzerland|switzerland
4698901|NCT03245853|Keratoconus|keratoconus
4698902|NCT03245853|Corneal Crosslinking|corneal crosslinking
4698903|NCT03245853|CXL|cxl
4698904|NCT03245814|service dogs|service dogs
4698905|NCT03245814|human-animal interaction|human-animal interaction
4698906|NCT03245801|Juvenile idiopathic arthritis|juvenile idiopathic arthritis
4698907|NCT03245801|Canada|canada
4698908|NCT03245801|Registry|registry
4698909|NCT03245801|Clinical outcomes|clinical outcomes
4698910|NCT03245801|Adverse events|adverse events
4698911|NCT03245801|CAPRI|capri
4698912|NCT03245788|Lay Navigator|lay navigator
4698913|NCT03245788|Quality of Care|quality of care
4698914|NCT03245788|High-Need Cancer Treatment Regimen|high-need cancer treatment regimen
4698915|NCT03245775|health disparities|health disparities
4698916|NCT03245775|community-based participatory research|community-based participatory research
4698917|NCT03245749|omega-3 status|omega-3 status
4698918|NCT03245749|blood lipids|blood lipids
4698919|NCT03245749|Eicosapentaenoic acid (EPA)|eicosapentaenoic acid (epa)
4698920|NCT03245749|Docosahexaenoic acid (DHA)|docosahexaenoic acid (dha)
4698921|NCT03245723|premature adults|premature adults
4698922|NCT03245723|premature|premature
4698923|NCT03245723|premature lung function|premature lung function
4698924|NCT03245723|premature cardiac function|premature cardiac function
4698925|NCT03245723|MRI|mri
4698926|NCT03245723|PET|pet
4698927|NCT03245697|breast milk|breast milk
4698928|NCT03245697|composition|composition
4698929|NCT03245697|Galicia|galicia
4698930|NCT03245697|diet|diet
4698931|NCT03245697|lactation|lactation
4698932|NCT03245684|ARDS|ards
4698933|NCT03245684|Ventilator-induced Lung Injury|ventilator-induced lung injury
4698934|NCT03245684|cytokines|cytokines
4698935|NCT03245684|mechanical ventilation|mechanical ventilation
4698936|NCT03245645|FODMAP|fodmap
4698939|NCT03245645|Re-introduction|re-introduction
4698940|NCT03245645|Fructose|fructose
4698941|NCT03245619|3-hydroxykynurenine|3-hydroxykynurenine
4698942|NCT03245619|Acute pancreatitis|acute pancreatitis
4698943|NCT03245619|Dose-escalation|dose-escalation
4698944|NCT03245619|Healthy subjects|healthy subjects
4698945|NCT03245619|GSK3335065|gsk3335065
4698946|NCT03245606|NAFLD|nafld
4698947|NCT03245606|steatosis|steatosis
4698948|NCT03245606|fibrosis|fibrosis
4698949|NCT03245606|transient elastography|transient elastography
4698950|NCT03245554|Gastrointestinal Cancer|gastrointestinal cancer
4698951|NCT03245554|Propranolol|propranolol
4698952|NCT03245541|SBRT/SABR; Durvalumab; Locally advanced; Borderline resectable|sbrt/sabr; durvalumab; locally advanced; borderline resectable
4698953|NCT03245502|tissue oxygenation|tissue oxygenation
4698954|NCT03245450|eribulin mesilate|eribulin mesilate
4698955|NCT03245450|irinotecan|irinotecan
4698956|NCT03245450|combination therapy|combination therapy
4698957|NCT03245450|children|children
4698958|NCT03245437|Social Cognition|social cognition
4698959|NCT03245437|Oxytocin|oxytocin
4698960|NCT03245372|cardiac output|cardiac output
4698961|NCT03245372|perioperative care|perioperative care
4698962|NCT03245372|postoperative complications|postoperative complications
4698963|NCT03245359|Total Knee Arthroplasty|total knee arthroplasty
4698964|NCT03245359|Intra-articular Analgesia|intra-articular analgesia
4698965|NCT03245359|Bupivacaine Hydrochloride|bupivacaine hydrochloride
4698966|NCT03245294|cervical epidural space|cervical epidural space
4698967|NCT03245294|abrupt pressure decrease|abrupt pressure decrease
4698968|NCT03245281|Heart Failure|heart failure
4698969|NCT03245268|Balloon pulmonary angioplasty|balloon pulmonary angioplasty
4698970|NCT03245268|BPA|bpa
4698971|NCT03245255|pressure measurements|pressure measurements
4698972|NCT03245255|blood pressure|blood pressure
4698973|NCT03245255|contrast echocardiography|contrast echocardiography
4698974|NCT03245255|ventricular pressures|ventricular pressures
4698975|NCT03245255|catheterization|catheterization
4698976|NCT03245242|enhanced recovery after surgery|enhanced recovery after surgery
4698977|NCT03245242|urologic reconstruction|urologic reconstruction
4698978|NCT03245242|pediatric urology|pediatric urology
4698979|NCT03245242|bladder augmentation|bladder augmentation
4698980|NCT03245242|Mitrofanoff|mitrofanoff
4698981|NCT03245242|Malone antegrade continence enema channel|malone antegrade continence enema channel
4698982|NCT03245242|appendicovesicostomy|appendicovesicostomy
4698983|NCT03245242|ileovesicostomy|ileovesicostomy
4698984|NCT03245242|appendicocecostomy|appendicocecostomy
4698985|NCT03245216|Parkinson's Disease|parkinson's disease
4698986|NCT03245216|motor learning|motor learning
4698987|NCT03245216|aerobic exercise|aerobic exercise
4698988|NCT03245216|cardiovascular exercise|cardiovascular exercise
4698989|NCT03245216|balance|balance
4698990|NCT03245216|postural instability|postural instability
4698991|NCT03245216|motor skill|motor skill
4698992|NCT03245203|neoadjuvant chemotherapy|neoadjuvant chemotherapy
4698993|NCT03245164|obese children|obese children
4698994|NCT03245164|motor skills|motor skills
4698995|NCT03245164|physiotherapy|physiotherapy
4698996|NCT03245164|basketball|basketball
4698997|NCT03245151|pediatrics|pediatrics
4698998|NCT03245151|central nervous system tumors|central nervous system tumors
4698999|NCT03245151|lenvatinib|lenvatinib
4699000|NCT03245151|E7080|e7080
4699001|NCT03245151|everolimus|everolimus
4699002|NCT03245151|Ewing sarcoma/peripheral primitive neuroectodermal tumor|ewing sarcoma/peripheral primitive neuroectodermal tumor
4699003|NCT03245151|rhabdomyosarcoma|rhabdomyosarcoma
4699004|NCT03245151|high grade glioma|high grade glioma
4699005|NCT03245151|solid tumors|solid tumors
4699006|NCT03245138|endoscopic third ventriculostomy|endoscopic third ventriculostomy
4699007|NCT03245138|ventricular peritoneal shunt|ventricular peritoneal shunt
4699008|NCT03245138|communicating hydrocephalus|communicating hydrocephalus
4699009|NCT03245060|psychosocial well-being|psychosocial well-being
4699010|NCT03245060|solution focused brief therapy|solution focused brief therapy
4699011|NCT03245034|Medical Residents|medical residents
4699012|NCT03245034|Well-Being|well-being
4699013|NCT03245034|Stress/Burnout in Medical Residents|stress/burnout in medical residents
4699014|NCT03244995|Malignant neoplasms of eye brain and other parts of central nervous system|malignant neoplasms of eye brain and other parts of central nervous system
4699015|NCT03244995|High grade glioma|high grade glioma
4699016|NCT03244995|HGG|hgg
4699017|NCT03244995|Couple-based mind-body program|couple-based mind-body program
4699018|NCT03244995|CBMB|cbmb
4699019|NCT03244995|Waitlist Control Group|waitlist control group
4699020|NCT03244995|Questionnaires|questionnaires
4699021|NCT03244995|Surveys|surveys
4699022|NCT03244995|Mind-Body Intervention|mind-body intervention
4699023|NCT03244995|Compact Discs (CD's)|compact discs (cd's)
4699024|NCT03244995|Printed Materials|printed materials
4699025|NCT03244995|Phone calls|phone calls
4699026|NCT03244982|fluorescein|fluorescein
4699027|NCT03244982|angiography|angiography
4699028|NCT03244969|Hematoma fracture, angiogenesis, bone formation|hematoma fracture, angiogenesis, bone formation
4699029|NCT03244917|Nursing home|nursing home
4699030|NCT03244917|Palliative Care|palliative care
4699031|NCT03244917|Dementia|dementia
4699032|NCT03244917|Infection|infection
4699429|NCT03241992|IBD|ibd
4699033|NCT03244917|Antimicrobials|antimicrobials
4699034|NCT03244904|NGS,SCLC, ctDNA|ngs,sclc, ctdna
4699035|NCT03244878|Cognitive Behavior Therapy|cognitive behavior therapy
4699036|NCT03244852|OCD|ocd
4699037|NCT03244852|deep brain stimulation|deep brain stimulation
4699038|NCT03244852|treatment-resistant OCD|treatment-resistant ocd
4699039|NCT03244826|Cancer|cancer
4699040|NCT03244800|0382, T2DM|0382, t2dm
4699041|NCT03244761|high flow tracheal oxygen|high flow tracheal oxygen
4699042|NCT03244761|modified interface|modified interface
4699043|NCT03244735|Ketogenic Diet|ketogenic diet
4699044|NCT03244709|Giant cell arteritis,|giant cell arteritis,
4699045|NCT03244709|Tocilizumab|tocilizumab
4699046|NCT03244709|Aortitis|aortitis
4699047|NCT03244709|Remission|remission
4699048|NCT03244696|Multiple Sclerosis|multiple sclerosis
4699049|NCT03244696|Sclerosis|sclerosis
4699050|NCT03244696|Demyelinating Autoimmune Diseases, Central Nervous System|demyelinating autoimmune diseases, central nervous system
4699051|NCT03244696|Autoimmune Diseases of the Nervous System|autoimmune diseases of the nervous system
4699052|NCT03244696|Nervous System Diseases|nervous system diseases
4699053|NCT03244696|Demyelinating Diseases|demyelinating diseases
4699054|NCT03244696|Immune System Diseases|immune system diseases
4699055|NCT03244696|Physical Activity|physical activity
4699057|NCT03244696|Hydration|hydration
4699058|NCT03244696|Lifestyle Intervention|lifestyle intervention
4699059|NCT03244696|Health Behavior Tracking|health behavior tracking
4699060|NCT03244696|Inflammatory Biomarkers|inflammatory biomarkers
4699061|NCT03244696|Neurodegenerative Disease|neurodegenerative disease
4699062|NCT03244670|Myopia|myopia
4699063|NCT03244644|C Difficile Colitis|c difficile colitis
4699064|NCT03244644|Clostridium Difficile|clostridium difficile
4699065|NCT03244644|CDI|cdi
4699066|NCT03244644|C.Difficile Diarrhea|c.difficile diarrhea
4699067|NCT03244644|Fecal Transplant|fecal transplant
4699068|NCT03244644|Fecal Microbiota Transplant|fecal microbiota transplant
4699069|NCT03244644|Microbiota Restoration Therapy|microbiota restoration therapy
4699070|NCT03244644|Diarrhea|diarrhea
4699071|NCT03244644|FMT|fmt
4699072|NCT03244644|Microbial Suspension|microbial suspension
4699073|NCT03244592|Minocycline|minocycline
4699074|NCT03244566|positron emission tomography|positron emission tomography
4699075|NCT03244566|cervical lymphatic metastasis|cervical lymphatic metastasis
4699076|NCT03244540|postoperative pain|postoperative pain
4699077|NCT03244540|transversus abdominis plane block|transversus abdominis plane block
4699078|NCT03244540|quadratus lumborum block|quadratus lumborum block
4699079|NCT03244540|neuropathic pain|neuropathic pain
4699080|NCT03244527|BCAA|bcaa
4699081|NCT03244527|stroke|stroke
4699082|NCT03244527|mobility|mobility
4699083|NCT03244514|cardiac surgery|cardiac surgery
4699084|NCT03244514|KDIGO-Guideline|kdigo-guideline
4699085|NCT03244501|tSMS|tsms
4699086|NCT03244501|Transcranial Static Magnetic Field Stimulation|transcranial static magnetic field stimulation
4699087|NCT03244501|healthy control|healthy control
4699088|NCT03244475|mild Traumatic Brain Injury|mild traumatic brain injury
4699089|NCT03244475|transcranial electrical stimulation|transcranial electrical stimulation
4699090|NCT03244475|neurofeedback|neurofeedback
4699091|NCT03244475|magnetoencephalography|magnetoencephalography
4699092|NCT03244475|post-traumatic stress disorder|post-traumatic stress disorder
4699093|NCT03244449|biomarker|biomarker
4699094|NCT03244449|insulin resistance|insulin resistance
4699095|NCT03244449|myokine|myokine
4699096|NCT03244449|clamp|clamp
4699097|NCT03244423|Pediatric|pediatric
4699098|NCT03244423|Cyanotic heart disease|cyanotic heart disease
4699099|NCT03244423|Tranexamic acid|tranexamic acid
4699100|NCT03244423|Postoperative blood loss|postoperative blood loss
4699101|NCT03244358|Triple Negative Breast Cancer|triple negative breast cancer
4699102|NCT03244358|Epalrestat|epalrestat
4699103|NCT03244306|leukemia|leukemia
4699104|NCT03244306|CD 22|cd 22
4699105|NCT03244306|CAR T cell|car t cell
4699106|NCT03244306|pediatric|pediatric
4699107|NCT03244306|young adult|young adult
4699108|NCT03244306|chimeric antigen receptor|chimeric antigen receptor
4699109|NCT03244267|Orthopedics|orthopedics
4699110|NCT03244254|Celiac Disease|celiac disease
4699111|NCT03244254|Children|children
4699112|NCT03244254|I-FABP|i-fabp
4699113|NCT03244241|Type 2 diabetes, inpatient diabetes management, basal-bolus insulin|type 2 diabetes, inpatient diabetes management, basal-bolus insulin
4699114|NCT03244228|First in human|first in human
4699115|NCT03244228|Multiple ascending dose|multiple ascending dose
4699116|NCT03244228|Single ascending dose|single ascending dose
4699117|NCT03244215|Recurrence of stroke|recurrence of stroke
4699118|NCT03244215|Corneal Confocal Microscopy|corneal confocal microscopy
4699119|NCT03244215|High performance liquid chromatography,|high performance liquid chromatography,
4699120|NCT03244215|Inflammatory biomarkers|inflammatory biomarkers
4699121|NCT03244215|modified Rankin scale ( mRS)|modified rankin scale ( mrs)
4699122|NCT03244202|Incidental Findings|incidental findings
4699123|NCT03244202|Decision Aids|decision aids
4699124|NCT03244202|Genomic Sequencing|genomic sequencing
4699125|NCT03244202|Randomized Controlled Trail|randomized controlled trail
4699126|NCT03244202|Genetic Counselling|genetic counselling
4699127|NCT03244189|Urinary Stone Disease|urinary stone disease
4699128|NCT03244189|Kidney Stone|kidney stone
4699129|NCT03244189|Urinary Calculi|urinary calculi
4699130|NCT03244176|DLBCL|dlbcl
4699131|NCT03244163|Spyglass DS|spyglass ds
4699132|NCT03244163|Laser lithotripsy|laser lithotripsy
4699133|NCT03244163|Endoscopic retrograde cholangiopancreatography|endoscopic retrograde cholangiopancreatography
4699134|NCT03244150|Physical activity|physical activity
4699135|NCT03244150|Obesity|obesity
4699136|NCT03244150|Overweight|overweight
4699137|NCT03244150|Lifestyle|lifestyle
4699138|NCT03244150|Diet|diet
4699139|NCT03244124|dentin bonding agents|dentin bonding agents
4699140|NCT03244124|tooth sensitivity|tooth sensitivity
4699141|NCT03244124|composite resin restoration|composite resin restoration
4699142|NCT03244059|COPD|copd
4699143|NCT03244059|belimumab|belimumab
4699144|NCT03244059|biologic agent|biologic agent
4699145|NCT03244059|GRP78|grp78
4699146|NCT03244046|Low Back pain|low back pain
4699147|NCT03244046|Pain|pain
4699148|NCT03244046|Posttraumatic Stress Disorder|posttraumatic stress disorder
4699149|NCT03244046|PTSD|ptsd
4699150|NCT03244046|Somatic Experiencing|somatic experiencing
4699151|NCT03244046|SE|se
4699152|NCT03244033|context|context
4699153|NCT03244033|contextual error|contextual error
4699154|NCT03244033|contextual care|contextual care
4699155|NCT03244033|electronic medical record|electronic medical record
4699156|NCT03244033|clinical decision support|clinical decision support
4699157|NCT03244007|macular hole|macular hole
4699158|NCT03244007|lamellar macular hole|lamellar macular hole
4699159|NCT03243994|Cor pulmonale|cor pulmonale
4699160|NCT03243994|COPD|copd
4699161|NCT03243994|Malabsorption|malabsorption
4699162|NCT03243994|D-xylose|d-xylose
4699163|NCT03243994|Zinc|zinc
4699164|NCT03243955|acupuncture|acupuncture
4699165|NCT03243955|TENS|tens
4699166|NCT03243955|TEAS|teas
4699167|NCT03243955|constipation|constipation
4699168|NCT03243955|transcutaneous|transcutaneous
4699169|NCT03243942|pressure measurements|pressure measurements
4699170|NCT03243942|blood pressure|blood pressure
4699171|NCT03243942|contrast echocardiography|contrast echocardiography
4699172|NCT03243942|ventricular pressures|ventricular pressures
4699173|NCT03243942|catheterization|catheterization
4699174|NCT03243916|interventional therapy|interventional therapy
4699175|NCT03243916|TACE|tace
4699176|NCT03243916|Cyberknife|cyberknife
4699177|NCT03243903|T2DM|t2dm
4699178|NCT03243903|QS-M needle free injector|qs-m needle free injector
4699179|NCT03243903|insulin pen|insulin pen
4699180|NCT03243903|effective|effective
4699181|NCT03243903|safety|safety
4699182|NCT03243877|Screening|screening
4699183|NCT03243877|Mammography|mammography
4699184|NCT03243851|Glioblastoma|glioblastoma
4699185|NCT03243838|Triple-Negative Breast Cancer|triple-negative breast cancer
4699186|NCT03243838|apatinib|apatinib
4699187|NCT03243838|pCR|pcr
4699188|NCT03243838|OS|os
4699189|NCT03243838|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
4699190|NCT03243825|neoadjuvant chemotherapy|neoadjuvant chemotherapy
4699191|NCT03243825|brachytherapy|brachytherapy
4699192|NCT03243825|radiotherapy|radiotherapy
4699193|NCT03243812|Sickle Cell Disease|sickle cell disease
4699194|NCT03243812|Muscle function|muscle function
4699195|NCT03243812|Hemorheological disorders|hemorheological disorders
4699196|NCT03243760|CCI15106|cci15106
4699197|NCT03243760|pharmacokinetics|pharmacokinetics
4699198|NCT03243760|BAL|bal
4699199|NCT03243760|COPD|copd
4699200|NCT03243734|spray cryotherapy|spray cryotherapy
4699201|NCT03243734|quality of life|quality of life
4699202|NCT03243734|symptom reduction|symptom reduction
4699203|NCT03243734|esophageal malignancies|esophageal malignancies
4699204|NCT03243734|liquid nitrogen|liquid nitrogen
4699205|NCT03243734|ablation|ablation
4699206|NCT03243721|multiple sclerosis|multiple sclerosis
4699207|NCT03243721|thalamus|thalamus
4699208|NCT03243721|high field MRI|high field mri
4699209|NCT03243721|cognition|cognition
4699210|NCT03243708|Venous Thromboembolism Risk Calculator|venous thromboembolism risk calculator
4699211|NCT03243695|immediate implants, implant failure, angled abutments|immediate implants, implant failure, angled abutments
4699212|NCT03243682|Shock wave lithotripsy|shock wave lithotripsy
4699213|NCT03243682|Bidirectional|bidirectional
4699214|NCT03243682|Stones|stones
4699215|NCT03243669|Colonoscopy|colonoscopy
4699216|NCT03243669|High-definition endoscopy|high-definition endoscopy
4699217|NCT03243669|Virtual chromoendoscopy|virtual chromoendoscopy
4699218|NCT03243669|Adenoma detection rate (ADR)|adenoma detection rate (adr)
4699219|NCT03243604|Cardiotoxicity|cardiotoxicity
4699220|NCT03243604|abiraterone acetate|abiraterone acetate
4699221|NCT03243604|androgen antagonist|androgen antagonist
4699222|NCT03243565|adenoid hypertrophy|adenoid hypertrophy
4699223|NCT03243565|Adenoid Hyperplasia|adenoid hyperplasia
4699224|NCT03243565|children|children
4699225|NCT03243565|respiratory tract infection|respiratory tract infection
4699226|NCT03243565|adenotonsillectomy|adenotonsillectomy
4699227|NCT03243565|OM-85|om-85
4699228|NCT03243539|lung protective ventilation|lung protective ventilation
4699229|NCT03243500|atracurium|atracurium
4699230|NCT03243500|high myopes|high myopes
4699231|NCT03243500|percaruncular|percaruncular
4700116|NCT03237923|fluid|fluid
4699232|NCT03243500|phacoemulsification|phacoemulsification
4699233|NCT03243500|medial canthal|medial canthal
4699234|NCT03243500|ophthalmic regional anesthesia|ophthalmic regional anesthesia
4699235|NCT03243461|Glioblastoma|glioblastoma
4699236|NCT03243461|high grade glioma|high grade glioma
4699237|NCT03243461|brain tumor|brain tumor
4699238|NCT03243461|Anaplastic astrocytoma|anaplastic astrocytoma
4699239|NCT03243461|DIPG|dipg
4699240|NCT03243461|Gliomatosis cerebri|gliomatosis cerebri
4699241|NCT03243461|Diffuse midline glioma|diffuse midline glioma
4699242|NCT03243409|reversed shoulder arthroplasties|reversed shoulder arthroplasties
4699243|NCT03243409|clinical complications|clinical complications
4699244|NCT03243409|complex proximal humeral fractures|complex proximal humeral fractures
4699245|NCT03243396|Mental health|mental health
4699246|NCT03243396|Cognitive behavioral therapy|cognitive behavioral therapy
4699247|NCT03243396|Task-shifting|task-shifting
4699248|NCT03243396|Global health|global health
4699249|NCT03243396|Teacher|teacher
4699250|NCT03243396|Community health volunteer|community health volunteer
4699251|NCT03243396|Children|children
4699252|NCT03243396|Orphans|orphans
4699253|NCT03243396|Abandoned children|abandoned children
4699254|NCT03243396|TF-CBT|tf-cbt
4699255|NCT03243396|Mental health policy|mental health policy
4699256|NCT03243396|Ministry of Education|ministry of education
4699257|NCT03243396|Ministry of Health|ministry of health
4699258|NCT03243396|Delivery|delivery
4699259|NCT03243396|Implementation science|implementation science
4699260|NCT03243396|Qualitative comparative analysis|qualitative comparative analysis
4699261|NCT03243396|Implementation practices and policies|implementation practices and policies
4699262|NCT03243396|Youth|youth
4699263|NCT03243396|Adoption|adoption
4699264|NCT03243396|Fidelity|fidelity
4699265|NCT03243396|Kenya|kenya
4699266|NCT03243396|Bungoma|bungoma
4699267|NCT03243396|Kanduyi|kanduyi
4699268|NCT03243396|East Africa|east africa
4699269|NCT03243396|Posttraumatic stress|posttraumatic stress
4699270|NCT03243396|Childhood traumatic grief|childhood traumatic grief
4699271|NCT03243396|Grief|grief
4699272|NCT03243396|Trauma|trauma
4699273|NCT03243383|readmission|readmission
4699274|NCT03243370|Validate the Clock'nTest|validate the clock'ntest
4699275|NCT03243357|Endodontics, molars, instrumentation, obturation, anatomy|endodontics, molars, instrumentation, obturation, anatomy
4699276|NCT03243331|Breast Cancer|breast cancer
4699277|NCT03243292|Bronchial Thermoplasty|bronchial thermoplasty
4699278|NCT03243292|Alair|alair
4699279|NCT03243292|Registry|registry
4699280|NCT03243227|carpal tunnel syndrome|carpal tunnel syndrome
4699281|NCT03243227|neurodynamics|neurodynamics
4699282|NCT03243227|median nerve gliding exercise|median nerve gliding exercise
4699283|NCT03243214|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
4699284|NCT03243188|Palliative Care|palliative care
4699285|NCT03243175|intracerebral hemorrhage|intracerebral hemorrhage
4699286|NCT03243175|atrial fibrillation|atrial fibrillation
4699287|NCT03243175|microhemorrhage|microhemorrhage
4699288|NCT03243175|oral anticoagulation|oral anticoagulation
4699289|NCT03243175|left atrial appendage closure|left atrial appendage closure
4699290|NCT03243084|tACS|tacs
4699291|NCT03243084|transcranial alternating current stimulation|transcranial alternating current stimulation
4699292|NCT03243084|low back pain|low back pain
4699293|NCT03243084|chronic pain|chronic pain
4699294|NCT03243084|alpha oscillations|alpha oscillations
4699295|NCT03243084|heart rate variability|heart rate variability
4699296|NCT03243071|Medical Care|medical care
4699297|NCT03243071|Racial Discrimination|racial discrimination
4699298|NCT03243071|Poor Health Literacy|poor health literacy
4699299|NCT03243071|Medical Care Disparities|medical care disparities
4699300|NCT03243045|Arterial hypertension|arterial hypertension
4699301|NCT03243045|Microcirculation|microcirculation
4699302|NCT03243045|Sympathetic nervous system|sympathetic nervous system
4699303|NCT03243019|cervico-facial|cervico-facial
4699304|NCT03243019|rapamycin|rapamycin
4699305|NCT03243006|acute pain|acute pain
4699306|NCT03243006|emergency department|emergency department
4699307|NCT03243006|opioid consumption|opioid consumption
4699308|NCT03242980|HIV|hiv
4699309|NCT03242980|Adherence|adherence
4699310|NCT03242980|Viral re-suppression|viral re-suppression
4699311|NCT03242980|Step-wedgged randomized trial|step-wedgged randomized trial
4699312|NCT03242967|Anemia|anemia
4699313|NCT03242967|hemoglobin|hemoglobin
4699314|NCT03242967|darbepoetin alfa|darbepoetin alfa
4699315|NCT03242967|TIW|tiw
4699316|NCT03242967|hypoxia-inducible factor prolyl-hydroxylase inhibitor|hypoxia-inducible factor prolyl-hydroxylase inhibitor
4699317|NCT03242967|HIF-PHI|hif-phi
4699318|NCT03242967|AKB-6548|akb-6548
4699319|NCT03242967|vadadustat|vadadustat
4699320|NCT03242967|renal|renal
4699321|NCT03242967|hypoxia-inducible factor|hypoxia-inducible factor
4699322|NCT03242967|HIF|hif
4699323|NCT03242967|dialysis-dependent chronic kidney disease|dialysis-dependent chronic kidney disease
4699324|NCT03242967|CKD|ckd
4699325|NCT03242967|DD-CKD|dd-ckd
4699326|NCT03242967|kidney|kidney
4699327|NCT03242967|erythropoiesis stimulating agent|erythropoiesis stimulating agent
4699328|NCT03242967|ESA|esa
4699428|NCT03241992|Inflammatory Bowel Disease|inflammatory bowel disease
4699329|NCT03242928|Cocaine Use Disorder; cocaine dependence|cocaine use disorder; cocaine dependence
4699330|NCT03242902|light therapy|light therapy
4699331|NCT03242902|cancer related fatigue|cancer related fatigue
4699332|NCT03242902|sleep quality|sleep quality
4699333|NCT03242902|biological rhythms|biological rhythms
4699334|NCT03242850|Reading|reading
4699335|NCT03242850|Text Messages|text messages
4699336|NCT03242850|Video|video
4699337|NCT03242850|Cognitive Development|cognitive development
4699338|NCT03242850|Child Development|child development
4699339|NCT03242850|Infants|infants
4699340|NCT03242811|Medical age assessment|medical age assessment
4699341|NCT03242798|liver cirrhosis|liver cirrhosis
4699342|NCT03242798|malnutrition|malnutrition
4699343|NCT03242798|nutritional status|nutritional status
4699344|NCT03242798|nutritional assessment|nutritional assessment
4699345|NCT03242785|Self-monitoring|self-monitoring
4699346|NCT03242785|Education|education
4699347|NCT03242785|Self-titration|self-titration
4699348|NCT03242785|antihypertensives|antihypertensives
4699349|NCT03242746|LEEP|leep
4699350|NCT03242746|Loop Electrosurgical Excision Procedure|loop electrosurgical excision procedure
4699351|NCT03242746|Cervical Intraepithelial Neoplasia|cervical intraepithelial neoplasia
4699352|NCT03242746|pregnancy outcome|pregnancy outcome
4699353|NCT03242733|Gastroparesis|gastroparesis
4699354|NCT03242694|persistent atrial fibrillation|persistent atrial fibrillation
4699355|NCT03242694|pulmonary vein isolation|pulmonary vein isolation
4699356|NCT03242694|catheter ablation|catheter ablation
4699357|NCT03242694|left atrial function|left atrial function
4699358|NCT03242694|left atrial pressure|left atrial pressure
4699359|NCT03242694|voltage map|voltage map
4699360|NCT03242694|strain|strain
4699361|NCT03242694|scar|scar
4699362|NCT03242694|success|success
4699363|NCT03242694|biomarker|biomarker
4699364|NCT03242668|paravertebral block,PVC,PCA|paravertebral block,pvc,pca
4699365|NCT03242642|Heart disease|heart disease
4699366|NCT03242642|valve disease|valve disease
4699367|NCT03242642|heart valve disease|heart valve disease
4699368|NCT03242642|mitral regurgitation|mitral regurgitation
4699369|NCT03242642|cardiovascular disease|cardiovascular disease
4699370|NCT03242642|mitral insufficiency|mitral insufficiency
4699371|NCT03242629|pediatric ophthalmic examination|pediatric ophthalmic examination
4699372|NCT03242629|chloral hydrate|chloral hydrate
4699373|NCT03242629|Effects Comparison|effects comparison
4699374|NCT03242603|Relapsed, Refractory, Neuroblastoma|relapsed, refractory, neuroblastoma
4699375|NCT03242603|Anti-GD2|anti-gd2
4699376|NCT03242603|Natural Killer (NK) Cells|natural killer (nk) cells
4699377|NCT03242603|Immunotherapy|immunotherapy
4699378|NCT03242538|Exercise|exercise
4699379|NCT03242512|RANKL|rankl
4699380|NCT03242512|osteoporosis|osteoporosis
4699381|NCT03242512|bone resorption|bone resorption
4699382|NCT03242512|post-menopausal women|post-menopausal women
4699383|NCT03242512|TK006|tk006
4699384|NCT03242434|Mannitol|mannitol
4699385|NCT03242434|Intestinal permeability|intestinal permeability
4699386|NCT03242434|Thermal injury|thermal injury
4699387|NCT03242434|HESTIA|hestia
4699388|NCT03242434|Sucralose|sucralose
4699389|NCT03242434|Lactulose|lactulose
4699390|NCT03242421|test-retest reliability|test-retest reliability
4699391|NCT03242421|Binocular vision tests|binocular vision tests
4699392|NCT03242395|Neuroinflammation|neuroinflammation
4699393|NCT03242395|fMRI|fmri
4699394|NCT03242395|Post-operative cognitive dysfunction|post-operative cognitive dysfunction
4699395|NCT03242395|Systemic inflammation|systemic inflammation
4699396|NCT03242395|Severe burns|severe burns
4699397|NCT03242382|advanced|advanced
4699398|NCT03242382|sarcoma|sarcoma
4699399|NCT03242382|cdk4|cdk4
4699400|NCT03242369|colorectal neoplasia|colorectal neoplasia
4699401|NCT03242369|colonoscopy|colonoscopy
4699402|NCT03242369|quality of bowel cleansing|quality of bowel cleansing
4699403|NCT03242369|bowel preparation|bowel preparation
4699404|NCT03242330|Implant survival|implant survival
4699405|NCT03242330|Patient satisfaction|patient satisfaction
4699406|NCT03242278|Non-valvular atrial fibrillation (NVAF)|non-valvular atrial fibrillation (nvaf)
4699407|NCT03242278|Prevention|prevention
4699408|NCT03242278|Stroke|stroke
4699409|NCT03242239|HER2 Positive Breast Cancer|her2 positive breast cancer
4699410|NCT03242239|Trastuzumab|trastuzumab
4699411|NCT03242239|Biosimilar|biosimilar
4699412|NCT03242226|+3.00ADD|+3.00add
4699413|NCT03242226|single vision spectacle|single vision spectacle
4699414|NCT03242200|survivors of childhood cancer|survivors of childhood cancer
4699415|NCT03242200|young adult female|young adult female
4699416|NCT03242200|mobile app|mobile app
4699417|NCT03242200|questionnaire|questionnaire
4699418|NCT03242200|health tracking|health tracking
4699419|NCT03242187|Minimally invasive surgery|minimally invasive surgery
4699420|NCT03242187|trans-anal total mesorectal excision|trans-anal total mesorectal excision
4699421|NCT03242187|Laparoscopic total mesoretal excision|laparoscopic total mesoretal excision
4699422|NCT03242070|Patient Portals|patient portals
4699423|NCT03242070|Chronic Disease|chronic disease
4699424|NCT03242070|Older Adults|older adults
4699425|NCT03242057|NAVA|nava
4699426|NCT03242057|Extubation|extubation
4699427|NCT03242057|NIPPV|nippv
4699430|NCT03241992|Electronic Health Record|electronic health record
4699431|NCT03241992|Patient Portal|patient portal
4699432|NCT03241992|Quality of Life|quality of life
4699433|NCT03241966|Parkinson's Disease|parkinson's disease
4699434|NCT03241966|Online Study|online study
4699435|NCT03241966|Quality of Life|quality of life
4699436|NCT03241966|Activities of Daily Living|activities of daily living
4699437|NCT03241966|Perception|perception
4699438|NCT03241966|Cognition|cognition
4699439|NCT03241966|Gait|gait
4699440|NCT03241927|Pembrolizumab|pembrolizumab
4699441|NCT03241927|NK Cell Exhaustion|nk cell exhaustion
4699442|NCT03241927|PD-1|pd-1
4699443|NCT03241927|Unresectable|unresectable
4699444|NCT03241927|Stage III|stage iii
4699445|NCT03241927|Stage IV|stage iv
4699446|NCT03241901|Artemether-Lumefantrine, Primaquine|artemether-lumefantrine, primaquine
4699447|NCT03241888|Levonorgestrel-releasing intrauterine system|levonorgestrel-releasing intrauterine system
4699448|NCT03241888|megestrol acetate|megestrol acetate
4699449|NCT03241888|Atypical Endometrial Hyperplasia|atypical endometrial hyperplasia
4699450|NCT03241875|pregabalin|pregabalin
4699451|NCT03241875|gabapentin|gabapentin
4699452|NCT03241875|post operative pain|post operative pain
4699453|NCT03241875|laparoscopic cholecystectomy|laparoscopic cholecystectomy
4699454|NCT03241810|Breast Cancer, HER2 Negative, Hormone receptor positive, heregulin|breast cancer, her2 negative, hormone receptor positive, heregulin
4699455|NCT03241797|AIP|aip
4699456|NCT03241797|EUS-FNA|eus-fna
4699457|NCT03241784|ALS|als
4699458|NCT03241784|T-Regulatory Cells|t-regulatory cells
4699459|NCT03241745|Nivolumab|nivolumab
4699460|NCT03241745|17-180|17-180
4699461|NCT03241732|Traumatic Brain Injury|traumatic brain injury
4699462|NCT03241732|TBI|tbi
4699463|NCT03241732|Brain Trauma|brain trauma
4699464|NCT03241732|N-acetyl cysteine|n-acetyl cysteine
4699465|NCT03241732|Concussion|concussion
4699466|NCT03241732|NAC|nac
4699467|NCT03241732|Integrative Medicine|integrative medicine
4699468|NCT03241732|EEG|eeg
4699469|NCT03241732|electroencephalogram|electroencephalogram
4699470|NCT03241732|Functional magnetic resonance imaging or functional MRI|functional magnetic resonance imaging or functional mri
4699471|NCT03241732|fMRI|fmri
4699472|NCT03241732|PET|pet
4699473|NCT03241732|Positron emission tomography|positron emission tomography
4699474|NCT03241732|MRI|mri
4699475|NCT03241732|magnetic resonance imaging|magnetic resonance imaging
4699476|NCT03241706|hypoglycemia|hypoglycemia
4699477|NCT03241706|type 1 diabetes|type 1 diabetes
4699478|NCT03241706|liver glucose metabolism|liver glucose metabolism
4699479|NCT03241628|Skin blisters|skin blisters
4699480|NCT03241628|Finger webbing|finger webbing
4699481|NCT03241628|Finger contracture|finger contracture
4699482|NCT03241628|Hand contracture|hand contracture
4699483|NCT03241589|Teledermatology|teledermatology
4699484|NCT03241589|Telehealth|telehealth
4699485|NCT03241589|Dermatology|dermatology
4699486|NCT03241589|Telemedicine|telemedicine
4699487|NCT03241589|Mobile Application|mobile application
4699488|NCT03241550|invasive fungal disease|invasive fungal disease
4699489|NCT03241550|Cresemba®|cresemba®
4699490|NCT03241550|Hematological malignancy|hematological malignancy
4699491|NCT03241550|isavuconazonium sulfate|isavuconazonium sulfate
4699492|NCT03241550|ASP9766|asp9766
4699493|NCT03241550|isavuconazole|isavuconazole
4699494|NCT03241550|pediatric population|pediatric population
4699495|NCT03241524|Pelvic Floor muscles|pelvic floor muscles
4699496|NCT03241524|Physical Therapy|physical therapy
4699497|NCT03241524|Sexual function evaluation|sexual function evaluation
4699498|NCT03241511|Periodontitis, End Stage Renal Disease, Periodontal treatment|periodontitis, end stage renal disease, periodontal treatment
4699499|NCT03241498|Medicines optimisation|medicines optimisation
4699500|NCT03241498|Healthcare resource utilisation|healthcare resource utilisation
4699501|NCT03241498|HRQOL|hrqol
4699502|NCT03241498|Pharmacist-led|pharmacist-led
4699503|NCT03241498|GP based|gp based
4699504|NCT03241459|Percutaneous Transluminal Angioplasty|percutaneous transluminal angioplasty
4699505|NCT03241459|PTA|pta
4699506|NCT03241459|Peripheral Artery Disease|peripheral artery disease
4699507|NCT03241459|PAD|pad
4699508|NCT03241459|Paclitaxel|paclitaxel
4699509|NCT03241433|Exercise|exercise
4699510|NCT03241394|Monocyte subsets|monocyte subsets
4699511|NCT03241394|Obesity|obesity
4699512|NCT03241394|Metabolic Syndrome|metabolic syndrome
4699513|NCT03241381|observational sample|observational sample
4699514|NCT03241368|Irritable Bowel Disease|irritable bowel disease
4699515|NCT03241368|IBD|ibd
4699516|NCT03241368|Mucosal Disease|mucosal disease
4699517|NCT03241329|Endometriosis|endometriosis
4699518|NCT03241329|Metabolomics|metabolomics
4699519|NCT03241329|Transcriptomics|transcriptomics
4699520|NCT03241329|Follicular fluid|follicular fluid
4699521|NCT03241329|Cumulus cells|cumulus cells
4699522|NCT03241329|Oocyte quality|oocyte quality
4699523|NCT03241316|qualitative and survey research|qualitative and survey research
4699524|NCT03241303|Glp-1|glp-1
4699525|NCT03241303|alpha-glucosidase inhibitor|alpha-glucosidase inhibitor
4699526|NCT03241303|acarbose|acarbose
4699527|NCT03241290|C-arm|c-arm
4699528|NCT03241290|Medical Imaging Device|medical imaging device
4699529|NCT03241290|Radiological|radiological
4699530|NCT03241277|social phobia|social phobia
4699531|NCT03241277|anxiety disorders|anxiety disorders
4699532|NCT03241277|DSM-IV TR|dsm-iv tr
4699533|NCT03241277|periodontal disease|periodontal disease
4699534|NCT03241277|non surgical periodontal treatment|non surgical periodontal treatment
4699535|NCT03241251|psychosocial risk|psychosocial risk
4699536|NCT03241225|Elder abuse|elder abuse
4699537|NCT03241225|Depression|depression
4699538|NCT03241225|Mental health|mental health
4699539|NCT03241212|adolescent|adolescent
4699540|NCT03241212|young adult|young adult
4699541|NCT03241212|knowledge|knowledge
4699542|NCT03241212|self-care|self-care
4699543|NCT03241186|Ipilimumab|ipilimumab
4699544|NCT03241186|Nivolumab|nivolumab
4699545|NCT03241186|OPDIVO|opdivo
4699546|NCT03241186|IgG4 kappa immunoglobulin|igg4 kappa immunoglobulin
4699547|NCT03241173|advanced or metastatic cervical cancer|advanced or metastatic cervical cancer
4699548|NCT03241173|endometrial cancer|endometrial cancer
4699549|NCT03241173|esophageal cancer|esophageal cancer
4699550|NCT03241173|hepatocellular carcinoma (HCC)|hepatocellular carcinoma (hcc)
4699551|NCT03241173|melanoma|melanoma
4699552|NCT03241173|Merkel cell carcinoma|merkel cell carcinoma
4699553|NCT03241173|mesothelioma|mesothelioma
4699554|NCT03241173|microsatellite instability-high colorectal cancer|microsatellite instability-high colorectal cancer
4699555|NCT03241173|non-small cell lung cancer (NSCLC)|non-small cell lung cancer (nsclc)
4699556|NCT03241173|ovarian cancer|ovarian cancer
4699557|NCT03241173|squamous cell carcinoma of the head and neck|squamous cell carcinoma of the head and neck
4699558|NCT03241173|small cell lung cancer (SLCL)|small cell lung cancer (slcl)
4699559|NCT03241173|renal cell carcinoma (RCC)|renal cell carcinoma (rcc)
4699560|NCT03241173|triple-negative breast cancer|triple-negative breast cancer
4699561|NCT03241173|TNBC|tnbc
4699562|NCT03241173|urothelial carcinoma|urothelial carcinoma
4699563|NCT03241173|OX40 ligand (OX40)|ox40 ligand (ox40)
4699564|NCT03241173|SCCHN|scchn
4699565|NCT03241173|MSI-H CRC|msi-h crc
4699566|NCT03241173|gastric cancer (including stomach and gastroesophageal junction [GEJ])|gastric cancer (including stomach and gastroesophageal junction [gej])
4699567|NCT03241134|Dry needling|dry needling
4699568|NCT03241134|Sham needling|sham needling
4699569|NCT03241134|Office workers|office workers
4699570|NCT03241134|Myofascial pain|myofascial pain
4699571|NCT03241134|Surface electromyography|surface electromyography
4699572|NCT03241121|Time Restricted Feeding|time restricted feeding
4699573|NCT03241121|Eating patterns|eating patterns
4699574|NCT03241095|Osteopathic Manipulation Treatment|osteopathic manipulation treatment
4699575|NCT03241095|Golf|golf
4699576|NCT03241069|bio-impedance|bio-impedance
4699577|NCT03241069|BIOPAC system|biopac system
4699578|NCT03241069|dyspnea|dyspnea
4699579|NCT03241069|acute heart failure|acute heart failure
4699580|NCT03241043|Pharmacokinetic study|pharmacokinetic study
4699581|NCT03241043|Comparing Envarsus versus Advagraf|comparing envarsus versus advagraf
4699582|NCT03241017|Diffuse Large B-Cell Lymphoma|diffuse large b-cell lymphoma
4699583|NCT03241017|Double-hit Lymphomas|double-hit lymphomas
4699584|NCT03241017|Grey Zone Lymphomas|grey zone lymphomas
4699585|NCT03241017|Double or Triple Expressor Lymphomas|double or triple expressor lymphomas
4699586|NCT03241017|Unclassifiable Aggressive Lymphoma types|unclassifiable aggressive lymphoma types
4699587|NCT03241017|Aggressive Lymphomas|aggressive lymphomas
4699588|NCT03240991|bradykinin-mediated angiodema|bradykinin-mediated angiodema
4699589|NCT03240991|quality of life|quality of life
4699590|NCT03240939|Dutasteride|dutasteride
4699591|NCT03240939|Tadalafil|tadalafil
4699592|NCT03240926|COPD|copd
4699593|NCT03240926|COPD Exacerbation|copd exacerbation
4699594|NCT03240926|COPD Asthma|copd asthma
4699595|NCT03240926|COPD Bronchitis|copd bronchitis
4699596|NCT03240926|COPD, Severe Early-Onset|copd, severe early-onset
4699597|NCT03240887|Teen pregnancy prevention|teen pregnancy prevention
4699598|NCT03240874|Gestational Diabetes|gestational diabetes
4699599|NCT03240874|Diabetes Type 2 in Pregnancy|diabetes type 2 in pregnancy
4699600|NCT03240861|T cells|t cells
4699601|NCT03240861|stem cells|stem cells
4699602|NCT03240861|gene therapy|gene therapy
4699603|NCT03240861|NYESO|nyeso
4699604|NCT03240848|congenital cataract|congenital cataract
4699605|NCT03240848|artificial intelligent clinic|artificial intelligent clinic
4699606|NCT03240835|pre-Albumin|pre-albumin
4699607|NCT03240835|Retinol Conjugated Protein|retinol conjugated protein
4699608|NCT03240835|Transferrin|transferrin
4699609|NCT03240835|Locoregionally Advanced Nasopharyngeal Carcinoma|locoregionally advanced nasopharyngeal carcinoma
4699610|NCT03240835|nutrition|nutrition
4699611|NCT03240822|Penile Trauma|penile trauma
4699612|NCT03240822|Allotransplantation|allotransplantation
4699613|NCT03240822|Vascularized Composite Allotransplantation|vascularized composite allotransplantation
4699614|NCT03240822|VCA|vca
4699615|NCT03240822|Genital Trauma|genital trauma
4699616|NCT03240822|Penile Transplantation|penile transplantation
4699617|NCT03240822|Amputation|amputation
4699618|NCT03240822|Penile Injury|penile injury
4699619|NCT03240796|dense cataract|dense cataract
4699620|NCT03240796|intraocular lens implantation|intraocular lens implantation
4699621|NCT03240796|traditional cataract surgery|traditional cataract surgery
4699719|NCT03240185|deep breathing|deep breathing
4700979|NCT03232801|low libido|low libido
4699622|NCT03240783|CT-Fluoroscopic Selective Transforaminal Epidural Steroid|ct-fluoroscopic selective transforaminal epidural steroid
4699623|NCT03240783|Oral Dexamethasone|oral dexamethasone
4699624|NCT03240783|Acute Lumbar Radiculopathy|acute lumbar radiculopathy
4699625|NCT03240783|Sciatic Neuropathy|sciatic neuropathy
4699626|NCT03240783|Betamethasone injectable|betamethasone injectable
4699627|NCT03240783|Dexamethasone injectable|dexamethasone injectable
4699628|NCT03240783|Acute Lumbar radicular pain|acute lumbar radicular pain
4699629|NCT03240783|Randomized Controlled Trial (RCT)|randomized controlled trial (rct)
4699630|NCT03240783|Comparative Effectiveness Controlled Trial|comparative effectiveness controlled trial
4699631|NCT03240770|HFV|hfv
4699632|NCT03240770|HFA|hfa
4699633|NCT03240770|High Frequency Vibration|high frequency vibration
4699634|NCT03240757|meal absorption|meal absorption
4699635|NCT03240757|exercise|exercise
4699636|NCT03240757|energy balance|energy balance
4699637|NCT03240757|lipolysis|lipolysis
4699638|NCT03240744|immunogenicity|immunogenicity
4699639|NCT03240744|safety|safety
4699640|NCT03240744|Hand, Foot and Mouth Disease (HFMD)|hand, foot and mouth disease (hfmd)
4699641|NCT03240731|sickle cell disease|sickle cell disease
4699642|NCT03240731|haploidentical|haploidentical
4699643|NCT03240731|graft|graft
4699644|NCT03240731|marrow|marrow
4699645|NCT03240705|Stress|stress
4699646|NCT03240705|Medical education|medical education
4699647|NCT03240692|Major Depressive Disorder|major depressive disorder
4699648|NCT03240692|Treatment Resistant Depression|treatment resistant depression
4699649|NCT03240692|Transcranial Magnetic Stimulation (TMS)|transcranial magnetic stimulation (tms)
4699650|NCT03240692|Theta Burst|theta burst
4699651|NCT03240679|Barrett's esophagus|barrett's esophagus
4699652|NCT03240679|Endoscopic Mucosal Resection|endoscopic mucosal resection
4699653|NCT03240640|Inspiratory muscle training|inspiratory muscle training
4699654|NCT03240640|COPD|copd
4699655|NCT03240640|Dyspnea|dyspnea
4699656|NCT03240640|Balance|balance
4699657|NCT03240562|serratus anterior plane block|serratus anterior plane block
4699658|NCT03240562|ultrasound-guided|ultrasound-guided
4699659|NCT03240562|regional anesthesia|regional anesthesia
4699660|NCT03240562|thoracic surgery|thoracic surgery
4699661|NCT03240562|postoperative pain|postoperative pain
4699662|NCT03240549|advanced pulmonary adenocarcinoma|advanced pulmonary adenocarcinoma
4699663|NCT03240549|Bevacizumab|bevacizumab
4699664|NCT03240549|First line chemotherapy|first line chemotherapy
4699665|NCT03240549|Stable disease|stable disease
4699666|NCT03240536|Rheumatology Referral|rheumatology referral
4699667|NCT03240536|Choosing Wisely|choosing wisely
4699668|NCT03240510|Breast cancer|breast cancer
4699669|NCT03240510|Male|male
4699670|NCT03240471|Distal radius fracture|distal radius fracture
4699671|NCT03240471|Conservative treatment|conservative treatment
4699672|NCT03240471|Patient rated outcome (PRO)|patient rated outcome (pro)
4699673|NCT03240419|Obesity|obesity
4699674|NCT03240419|Inflammation|inflammation
4699675|NCT03240419|Pregnancy|pregnancy
4699676|NCT03240419|Programming|programming
4699677|NCT03240393|Non Small Cell Lung Cancer|non small cell lung cancer
4699678|NCT03240393|NSCLC|nsclc
4699679|NCT03240393|INC280|inc280
4699680|NCT03240393|EGFR wild-type (wt)|egfr wild-type (wt)
4699681|NCT03240393|advanced non-small cell lung cancer|advanced non-small cell lung cancer
4699682|NCT03240393|advanced/metastatic disease|advanced/metastatic disease
4699683|NCT03240393|Non-small cell lung carcinoma (NSCLC)|non-small cell lung carcinoma (nsclc)
4699684|NCT03240393|treatment of lung cancer after first metastasis|treatment of lung cancer after first metastasis
4699685|NCT03240393|lung cancer|lung cancer
4699686|NCT03240393|lung adenocarcinoma|lung adenocarcinoma
4699687|NCT03240393|Non small cell lung carcinoma|non small cell lung carcinoma
4699688|NCT03240393|Non-small cell lung cancer|non-small cell lung cancer
4699689|NCT03240393|MET exon 14 deletion|met exon 14 deletion
4699690|NCT03240393|MET exon 14 skipping|met exon 14 skipping
4699691|NCT03240393|MET exon 14 mutation|met exon 14 mutation
4699692|NCT03240393|MET mutation|met mutation
4699693|NCT03240393|MET amplification|met amplification
4699694|NCT03240393|MET inhibitor|met inhibitor
4699695|NCT03240393|MET dysregulation|met dysregulation
4699696|NCT03240393|MET activation|met activation
4699697|NCT03240393|MET signaling|met signaling
4699698|NCT03240393|MET pathway|met pathway
4699699|NCT03240393|MET|met
4699700|NCT03240393|cMET|cmet
4699701|NCT03240328|CAR-T HIV therapy|car-t hiv therapy
4699702|NCT03240250|VATS|vats
4699703|NCT03240250|Pulmonary lobectomy|pulmonary lobectomy
4699704|NCT03240250|Uniportal|uniportal
4699705|NCT03240250|Postoperative pain|postoperative pain
4699706|NCT03240250|Thoracic surgery|thoracic surgery
4699707|NCT03240237|HFpEF|hfpef
4699708|NCT03240224|Cancer ablation|cancer ablation
4699709|NCT03240224|Life information rehabilitation therapy|life information rehabilitation therapy
4699710|NCT03240211|Pembrolizumab|pembrolizumab
4699711|NCT03240211|Decitabine|decitabine
4699712|NCT03240211|Pralatrexate|pralatrexate
4699713|NCT03240211|T-cell lymphoma|t-cell lymphoma
4699714|NCT03240198|occupational|occupational
4699715|NCT03240198|cohort|cohort
4699716|NCT03240198|biomarkers|biomarkers
4699717|NCT03240185|hemorrhoid|hemorrhoid
4699718|NCT03240185|pain|pain
4701380|NCT03229928|Behavior|behavior
4699720|NCT03240185|multimodal pain control|multimodal pain control
4699721|NCT03240133|HAE|hae
4699722|NCT03240133|hereditary angioedema|hereditary angioedema
4699723|NCT03240133|kallikrein inhibitor|kallikrein inhibitor
4699724|NCT03240133|plasma kallikrein|plasma kallikrein
4699725|NCT03240107|levator resection|levator resection
4699726|NCT03240107|levator tucking|levator tucking
4699727|NCT03240107|Fair levator function|fair levator function
4699728|NCT03240107|Eyelid contour|eyelid contour
4699729|NCT03240094|Ehealth|ehealth
4699730|NCT03240094|Older adults|older adults
4699731|NCT03240094|Undernutrition|undernutrition
4699732|NCT03240081|Post-menopause dyspareunia|post-menopause dyspareunia
4699733|NCT03240081|Vulvar vestibular pain|vulvar vestibular pain
4699734|NCT03240081|Genitourinary syndrome of menopause|genitourinary syndrome of menopause
4699735|NCT03240081|Sexual pain|sexual pain
4699736|NCT03240068|Renin-Angiotensin System|renin-angiotensin system
4699737|NCT03240068|Inflammation|inflammation
4699738|NCT03240068|Cardiovascular|cardiovascular
4699739|NCT03240068|Atherosclerosis|atherosclerosis
4699740|NCT03240055|spinal anesthesia|spinal anesthesia
4699741|NCT03240055|etomidate|etomidate
4699742|NCT03240055|median effective dose|median effective dose
4699743|NCT03240055|BIS50|bis50
4699744|NCT03240042|anterior cervical spine surgery|anterior cervical spine surgery
4699745|NCT03240042|cuff pressure|cuff pressure
4699746|NCT03240042|nasotracheal|nasotracheal
4699747|NCT03240042|orotracheal|orotracheal
4699748|NCT03240029|children|children
4699749|NCT03240029|life quality|life quality
4699750|NCT03240029|school reintegration|school reintegration
4699751|NCT03240003|Social Anxiety|social anxiety
4699752|NCT03240003|Social Anxiety Disorder|social anxiety disorder
4699753|NCT03240003|SAD|sad
4699754|NCT03239990|Children's mental health|children's mental health
4699755|NCT03239990|Conduct disorders|conduct disorders
4699756|NCT03239990|Conduct problems|conduct problems
4699757|NCT03239990|Externalizing problems|externalizing problems
4699758|NCT03239990|Parental Intervention|parental intervention
4699759|NCT03239990|Groups based intervention|groups based intervention
4699760|NCT03239990|Finland|finland
4699761|NCT03239990|Social learning theory|social learning theory
4699762|NCT03239990|Cognitive-behavioral theory|cognitive-behavioral theory
4699763|NCT03239977|social intelligence|social intelligence
4699764|NCT03239977|quality of life|quality of life
4699765|NCT03239977|social competence|social competence
4699766|NCT03239964|recurrent keloid|recurrent keloid
4699767|NCT03239964|surgical excision|surgical excision
4699768|NCT03239964|steroids injection|steroids injection
4699769|NCT03239938|chronic whiplash associated disorders|chronic whiplash associated disorders
4699770|NCT03239938|central sensitization|central sensitization
4699771|NCT03239938|electroencephalography|electroencephalography
4699772|NCT03239938|physiotherapy|physiotherapy
4699773|NCT03239938|chronic pain|chronic pain
4699774|NCT03239938|functionality|functionality
4699775|NCT03239938|quality of life|quality of life
4699776|NCT03239938|stress management|stress management
4699777|NCT03239938|randomized controlled trial|randomized controlled trial
4699778|NCT03239938|modern neuroscience approach|modern neuroscience approach
4699779|NCT03239938|pain neuroscience education|pain neuroscience education
4699780|NCT03239938|neck school|neck school
4699781|NCT03239938|exercise therapy|exercise therapy
4699782|NCT03239938|pain cognitions|pain cognitions
4699783|NCT03239925|Cell phones, Electromagnetic Radiation|cell phones, electromagnetic radiation
4699784|NCT03239912|Low-level laser|low-level laser
4699785|NCT03239912|functional treatment|functional treatment
4699786|NCT03239912|twin-block|twin-block
4699787|NCT03239912|RCT|rct
4699788|NCT03239899|HIV|hiv
4699789|NCT03239899|Brain|brain
4699790|NCT03239899|Immunotherapy|immunotherapy
4699791|NCT03239860|Multiple Sclerosis|multiple sclerosis
4699792|NCT03239860|Multiple Sclerosis Relapsing-Remitting|multiple sclerosis relapsing-remitting
4699793|NCT03239860|GNbAC1|gnbac1
4699794|NCT03239860|MRI|mri
4699795|NCT03239860|Monoclonal antibody|monoclonal antibody
4699921|NCT03239119|rE-4|re-4
4699796|NCT03239860|Multiple Sclerosis associated retrovirus MSRV|multiple sclerosis associated retrovirus msrv
4699797|NCT03239860|MS|ms
4699798|NCT03239860|RRMS|rrms
4699799|NCT03239860|HERV-W|herv-w
4699800|NCT03239808|once-weekly haemodialysis|once-weekly haemodialysis
4699801|NCT03239808|incremental haemodialysis|incremental haemodialysis
4699802|NCT03239808|randomized clinical trial|randomized clinical trial
4699803|NCT03239795|Posters|posters
4699804|NCT03239795|Pamphlets|pamphlets
4699805|NCT03239795|Primary Health Care|primary health care
4699806|NCT03239795|Health Facilities|health facilities
4699807|NCT03239769|Thyroid surgery|thyroid surgery
4699808|NCT03239769|Thyroidectomy|thyroidectomy
4699809|NCT03239769|Minimally invasive access|minimally invasive access
4699810|NCT03239769|Aesthetic principle|aesthetic principle
4699811|NCT03239769|POSAS|posas
4699812|NCT03239743|virtual reality|virtual reality
4699813|NCT03239743|adenoidectomy|adenoidectomy
4699814|NCT03239743|induction of anesthesia|induction of anesthesia
4699815|NCT03239743|pre-operative anxiety|pre-operative anxiety
4699816|NCT03239730|dyspnea|dyspnea
4699817|NCT03239730|pH|ph
4701885|NCT03226626|Sepsis|sepsis
4699818|NCT03239730|blood gas analysis|blood gas analysis
4699819|NCT03239730|emergency department|emergency department
4699820|NCT03239730|Intensive care unit|intensive care unit
4699821|NCT03239704|Inflammatory Bowel Disease|inflammatory bowel disease
4699822|NCT03239704|Ulcerative Colitis|ulcerative colitis
4699823|NCT03239704|Crohn Disease|crohn disease
4699824|NCT03239704|Quality Improvement|quality improvement
4699825|NCT03239704|Telemedicine|telemedicine
4699826|NCT03239678|Preoxygenation|preoxygenation
4699827|NCT03239678|Oxygen Concentration|oxygen concentration
4699828|NCT03239665|Vaccine|vaccine
4699829|NCT03239665|Educational intervention|educational intervention
4699830|NCT03239665|Senior Center Model of Care|senior center model of care
4699831|NCT03239665|Older adults|older adults
4699832|NCT03239652|Microsphere|microsphere
4699833|NCT03239652|Transcatheter Arterial chemo-embolization|transcatheter arterial chemo-embolization
4699834|NCT03239639|Substitute decision makers of patient|substitute decision makers of patient
4699835|NCT03239600|Anti-IL-7 Receptor-alpha Monoclonal Antibody|anti-il-7 receptor-alpha monoclonal antibody
4699836|NCT03239600|Safety|safety
4699837|NCT03239600|GSK2618960|gsk2618960
4699838|NCT03239600|Primary Sjögren's Syndrome|primary sjögren's syndrome
4699839|NCT03239587|Symptoms and signs involving cognition perception emotion & behaviour|symptoms and signs involving cognition perception emotion & behaviour
4699840|NCT03239587|Abdominal cancer patients|abdominal cancer patients
4699841|NCT03239587|Musical preop intervention|musical preop intervention
4699842|NCT03239587|Surveys|surveys
4699843|NCT03239587|Questionnaires|questionnaires
4699844|NCT03239587|Blood draws|blood draws
4699845|NCT03239548|Opinion,|opinion,
4699846|NCT03239548|Doctors,|doctors,
4699847|NCT03239548|Nurses,|nurses,
4699848|NCT03239548|Key informants,|key informants,
4699849|NCT03239548|Independent Nurse Midwifery Practitioner|independent nurse midwifery practitioner
4699850|NCT03239522|GSK1278863|gsk1278863
4699851|NCT03239522|pharmacokinetics|pharmacokinetics
4699852|NCT03239522|mass balance|mass balance
4699853|NCT03239522|daprodustat|daprodustat
4699854|NCT03239509|long-term survival|long-term survival
4699855|NCT03239509|bioprosthesis|bioprosthesis
4699856|NCT03239509|complications|complications
4699857|NCT03239509|anticoagulation|anticoagulation
4699858|NCT03239509|mechanichal prosthesis|mechanichal prosthesis
4699859|NCT03239470|autologous polyclonal regulatory T cell therapy|autologous polyclonal regulatory t cell therapy
4699860|NCT03239470|PolyTregs|polytregs
4699861|NCT03239470|open-label|open-label
4699862|NCT03239470|Phase 1 (safety)|phase 1 (safety)
4699863|NCT03239444|ICE|ice
4699864|NCT03239444|Ablation|ablation
4699865|NCT03239444|Trans-septal|trans-septal
4699866|NCT03239444|Septum|septum
4699867|NCT03239444|Echocardiography|echocardiography
4699868|NCT03239431|asthma|asthma
4699869|NCT03239431|lung function|lung function
4699870|NCT03239431|forced oscillometry technique|forced oscillometry technique
4699871|NCT03239431|exacerbation|exacerbation
4699872|NCT03239418|NMES|nmes
4699873|NCT03239405|laparoscopic|laparoscopic
4699874|NCT03239405|sleeve|sleeve
4699875|NCT03239405|gastrectomy|gastrectomy
4699876|NCT03239392|BNZ-1|bnz-1
4699877|NCT03239392|Cytokine|cytokine
4699878|NCT03239392|IL-2|il-2
4699879|NCT03239392|IL-15|il-15
4699880|NCT03239379|cytokine inhibitor|cytokine inhibitor
4699881|NCT03239379|IL-2|il-2
4699882|NCT03239379|IL-9|il-9
4699883|NCT03239379|IL-15|il-15
4699884|NCT03239366|T2D|t2d
4699885|NCT03239340|EGFR, NSCLC, Lung Cancer, Biopsy, Molecular Profiling|egfr, nsclc, lung cancer, biopsy, molecular profiling
4699886|NCT03239327|Misoprostol|misoprostol
4699887|NCT03239327|neonatal|neonatal
4699888|NCT03239327|respiratory distress|respiratory distress
4699889|NCT03239327|cesarean section|cesarean section
4699890|NCT03239288|Fiber|fiber
4699891|NCT03239288|Postprandial glucose|postprandial glucose
4699892|NCT03239288|Insulin|insulin
4699893|NCT03239288|Resistant Starch Type 4|resistant starch type 4
4699894|NCT03239275|en masse retraction|en masse retraction
4699895|NCT03239275|biocreative therapy|biocreative therapy
4699896|NCT03239275|class II|class ii
4699897|NCT03239275|skeletal anchorage|skeletal anchorage
4699898|NCT03239262|Atrial Fibrillation|atrial fibrillation
4699899|NCT03239262|Left Atrial Cryoablation|left atrial cryoablation
4699900|NCT03239262|Ganglionated Plexi|ganglionated plexi
4699901|NCT03239262|Open-Heart Surgery|open-heart surgery
4699902|NCT03239249|school dropout prevention|school dropout prevention
4699903|NCT03239249|intervention study|intervention study
4699904|NCT03239249|cluster-randomized|cluster-randomized
4699905|NCT03239210|Brain Function|brain function
4699906|NCT03239210|functional magnetic resonance imaging (fMRI)|functional magnetic resonance imaging (fmri)
4699907|NCT03239210|Sensory processing|sensory processing
4699908|NCT03239210|Obsessive-Compulsive Disorder|obsessive-compulsive disorder
4699909|NCT03239210|OCD|ocd
4699910|NCT03239184|Cancer ablation|cancer ablation
4699911|NCT03239184|Life information rehabilitation therapy|life information rehabilitation therapy
4699912|NCT03239171|Cancer ablation|cancer ablation
4699913|NCT03239171|Life information rehabilitation therapy|life information rehabilitation therapy
4699914|NCT03239158|Cancer ablation|cancer ablation
4700023|NCT03238456|Tobacco Smoking|tobacco smoking
4699915|NCT03239158|Life information rehabilitation therapy|life information rehabilitation therapy
4699916|NCT03239145|Advanced Solid Tumor|advanced solid tumor
4699917|NCT03239145|Melanoma|melanoma
4699918|NCT03239145|Ovarian Cancer|ovarian cancer
4699919|NCT03239145|Renal Cancer|renal cancer
4699920|NCT03239145|Colorectal Cancer|colorectal cancer
4699922|NCT03239119|Exenatide|exenatide
4699923|NCT03239119|Metformin|metformin
4699924|NCT03239119|Sulfonylurea|sulfonylurea
4699925|NCT03239106|itch|itch
4699926|NCT03239106|pruritus|pruritus
4699927|NCT03239106|CIP|cip
4699928|NCT03239080|Rheumatoid Arthritis|rheumatoid arthritis
4699929|NCT03239080|HR-pQCT|hr-pqct
4699930|NCT03239080|erosion|erosion
4699931|NCT03239080|denosumab|denosumab
4699932|NCT03239067|Ticagrelor|ticagrelor
4699933|NCT03239067|Clopidogrel|clopidogrel
4699934|NCT03239067|Acute Coronary Syndrome|acute coronary syndrome
4699935|NCT03239067|Percutaneous Coronary Intervention|percutaneous coronary intervention
4699936|NCT03239028|diet quality|diet quality
4699937|NCT03239028|pregnancy|pregnancy
4699938|NCT03239028|adolescence|adolescence
4699939|NCT03239028|longitudinal study|longitudinal study
4699940|NCT03239028|food frequency questionnaire|food frequency questionnaire
4699941|NCT03238989|Interstitial lung disease|interstitial lung disease
4699942|NCT03238976|breast core biopsy|breast core biopsy
4699943|NCT03238976|core needle biopsies|core needle biopsies
4699944|NCT03238924|posttraumatic stress disorder|posttraumatic stress disorder
4699945|NCT03238924|oxytocin|oxytocin
4699946|NCT03238924|Prolonged Exposure|prolonged exposure
4699947|NCT03238898|muscle cramps|muscle cramps
4699948|NCT03238898|diabetic neuropathy|diabetic neuropathy
4699949|NCT03238898|botulinum toxin|botulinum toxin
4699950|NCT03238872|Anxiety|anxiety
4699951|NCT03238872|Depression|depression
4699952|NCT03238872|CBT|cbt
4699953|NCT03238872|Outcome monitoring|outcome monitoring
4699954|NCT03238872|Dissemination|dissemination
4699955|NCT03238872|Routine services|routine services
4699956|NCT03238833|In vitro fertilization|in vitro fertilization
4699957|NCT03238833|Poor ovarian responder|poor ovarian responder
4699958|NCT03238833|Luteal ovarian stimulation|luteal ovarian stimulation
4699959|NCT03238833|Antagonist protocol|antagonist protocol
4699960|NCT03238833|Cumulus cells|cumulus cells
4699961|NCT03238820|Gastrointestinal stromal tumors|gastrointestinal stromal tumors
4699962|NCT03238820|Robot|robot
4699963|NCT03238820|manual suture|manual suture
4699964|NCT03238807|hCG|hcg
4699965|NCT03238807|Intrauterine hCG|intrauterine hcg
4699966|NCT03238807|IVF|ivf
4699967|NCT03238807|ICSI|icsi
4699968|NCT03238794|Body Mass Index|body mass index
4699969|NCT03238794|gastric|gastric
4699970|NCT03238794|bypass|bypass
4699971|NCT03238794|bariatric surgery|bariatric surgery
4699972|NCT03238794|bile acid|bile acid
4699973|NCT03238794|weight loss|weight loss
4699974|NCT03238794|diet|diet
4699975|NCT03238794|low calorie|low calorie
4699976|NCT03238781|Migraine|migraine
4699977|NCT03238781|Headache|headache
4699978|NCT03238781|Prevention|prevention
4699979|NCT03238781|Prophylaxis|prophylaxis
4699980|NCT03238768|Nutrition|nutrition
4699981|NCT03238768|Body Composition|body composition
4699982|NCT03238768|Preterm|preterm
4699983|NCT03238768|Neonate|neonate
4699984|NCT03238755|HIV|hiv
4699985|NCT03238755|Diastolic Dysfunction|diastolic dysfunction
4699986|NCT03238755|Myocardial fibrosis|myocardial fibrosis
4699987|NCT03238755|Statin|statin
4699988|NCT03238742|Xuebijing Injection, morality, sepsis|xuebijing injection, morality, sepsis
4699989|NCT03238690|LVAD|lvad
4699990|NCT03238690|Cardiac Recovery|cardiac recovery
4699991|NCT03238677|speech sound disorder|speech sound disorder
4699992|NCT03238651|Drug therapy|drug therapy
4699993|NCT03238638|Epacadostat|epacadostat
4699994|NCT03238638|Pembrolizumab|pembrolizumab
4699995|NCT03238638|PD-1|pd-1
4699996|NCT03238638|PD-L1|pd-l1
4699997|NCT03238612|influenza|influenza
4699998|NCT03238612|FFA|ffa
4699999|NCT03238612|clarithromycin|clarithromycin
4700000|NCT03238612|mortality|mortality
4700001|NCT03238612|hospitalisation|hospitalisation
4700002|NCT03238586|hiv|hiv
4700003|NCT03238586|aids|aids
4700004|NCT03238586|alcohol|alcohol
4700005|NCT03238586|health|health
4700006|NCT03238586|knowledge|knowledge
4700007|NCT03238586|motivation|motivation
4700008|NCT03238586|skills|skills
4700009|NCT03238586|behavior|behavior
4700010|NCT03238573|Colorectal Sessile Serrated Adenomas/Polyps optical enhancement endoscopy|colorectal sessile serrated adenomas/polyps optical enhancement endoscopy
4700011|NCT03238508|Deferred stenting|deferred stenting
4700012|NCT03238508|Microvascular dysfunction|microvascular dysfunction
4700013|NCT03238495|Operable breast cancer|operable breast cancer
4700014|NCT03238495|Neo-adjuvant chemotherapy|neo-adjuvant chemotherapy
4700015|NCT03238469|Microwave Ablation|microwave ablation
4700016|NCT03238469|Hair Follicle|hair follicle
4700017|NCT03238469|Sweat gland|sweat gland
4700018|NCT03238456|Pacific Islander|pacific islander
4700019|NCT03238456|Native Hawaiian|native hawaiian
4700020|NCT03238456|NHPI|nhpi
4700021|NCT03238456|Tobacco Health|tobacco health
4700022|NCT03238456|Tobacco Use|tobacco use
4700024|NCT03238456|Tobacco Use Cessation|tobacco use cessation
4700025|NCT03238456|Smoking Cessation|smoking cessation
4700026|NCT03238456|Smoking|smoking
4700027|NCT03238456|Cigarette Use|cigarette use
4700028|NCT03238456|Young Adult|young adult
4700029|NCT03238443|DSA|dsa
4700030|NCT03238430|Intrathecal morphine, continuous wound infiltration|intrathecal morphine, continuous wound infiltration
4700031|NCT03238417|women's health|women's health
4700032|NCT03238417|primary health care|primary health care
4700033|NCT03238417|mental health|mental health
4700034|NCT03238417|Veterans|veterans
4700035|NCT03238417|quality improvement|quality improvement
4700036|NCT03238404|gastric cancer|gastric cancer
4700037|NCT03238404|neoadjuvant chemotherapy|neoadjuvant chemotherapy
4700038|NCT03238404|enhanced recovery after surgery|enhanced recovery after surgery
4700039|NCT03238404|gastrectomy|gastrectomy
4700040|NCT03238391|Contrast-induced nephropathy|contrast-induced nephropathy
4700041|NCT03238391|Ischemic preconditioning|ischemic preconditioning
4700042|NCT03238378|head and neck cancer|head and neck cancer
4700043|NCT03238378|Locally recurrent head and neck cancer|locally recurrent head and neck cancer
4700044|NCT03238378|Brachytherapy|brachytherapy
4700045|NCT03238378|Hyperthermia|hyperthermia
4700046|NCT03238339|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
4700047|NCT03238339|Respiratory Insufficiency|respiratory insufficiency
4700048|NCT03238339|Oxygen Inhalation Therapy|oxygen inhalation therapy
4700049|NCT03238339|Noninvasive Ventilation|noninvasive ventilation
4700050|NCT03238326|Brexpiprazole|brexpiprazole
4700051|NCT03238326|Schizophrenia|schizophrenia
4700052|NCT03238300|adolescent|adolescent
4700053|NCT03238287|Emergency|emergency
4700054|NCT03238287|Mechanical chest compression|mechanical chest compression
4700055|NCT03238287|Cerebral oximetry|cerebral oximetry
4700056|NCT03238222|Walking|walking
4700057|NCT03238222|Six-Minute Walk Distance|six-minute walk distance
4700058|NCT03238222|Illness Perceptions|illness perceptions
4700059|NCT03238222|Theory of Planned Behaviour|theory of planned behaviour
4700060|NCT03238209|neural respiratory drive|neural respiratory drive
4700061|NCT03238209|transesophageal diaphragmatic EMG|transesophageal diaphragmatic emg
4700062|NCT03238209|surface diaphragmatic EMG|surface diaphragmatic emg
4700063|NCT03238209|surface sternocleidomastoid EMG|surface sternocleidomastoid emg
4700064|NCT03238209|surface parasternal intercostal muscle EMG|surface parasternal intercostal muscle emg
4700065|NCT03238196|FGFR inhibitor|fgfr inhibitor
4700066|NCT03238196|ER+ metastatic breast cancer|er+ metastatic breast cancer
4700067|NCT03238196|CDK4/6 inhibitor|cdk4/6 inhibitor
4700068|NCT03238196|Endocrine therapy|endocrine therapy
4700069|NCT03238183|knee osteoarthritis|knee osteoarthritis
4700070|NCT03238183|hyaluronic acid|hyaluronic acid
4700071|NCT03238183|dextrose|dextrose
4700072|NCT03238183|therapeutic effects|therapeutic effects
4700073|NCT03238118|irritability|irritability
4700074|NCT03238118|severe mood dysregulation|severe mood dysregulation
4700075|NCT03238118|disruptive mood dysregulation disorder|disruptive mood dysregulation disorder
4700076|NCT03238105|Dark circles|dark circles
4700077|NCT03238105|Periorbital hyperchromia|periorbital hyperchromia
4700078|NCT03238105|Facial aesthetics|facial aesthetics
4700079|NCT03238092|in vitro fertilization|in vitro fertilization
4700080|NCT03238092|estradiol|estradiol
4700081|NCT03238092|gnrh antagonist|gnrh antagonist
4700082|NCT03238092|testosterone|testosterone
4700083|NCT03238053|laser treatment, randomized trial, menopause, vaginal symptoms|laser treatment, randomized trial, menopause, vaginal symptoms
4700084|NCT03238040|Critical illness|critical illness
4700085|NCT03238040|PICU|picu
4700086|NCT03238040|biomarkers|biomarkers
4700087|NCT03238027|SNDX-6352|sndx-6352
4700088|NCT03238027|CSF-1R inhibitor|csf-1r inhibitor
4700089|NCT03238027|Colony Stimulating factor 1 receptor inhibitor|colony stimulating factor 1 receptor inhibitor
4700090|NCT03238027|Solid Tumor|solid tumor
4700091|NCT03238027|Recurrent locally advanced tumor|recurrent locally advanced tumor
4700092|NCT03238027|unresectable solid tumor|unresectable solid tumor
4700093|NCT03238027|Metastatic tumor|metastatic tumor
4700094|NCT03238027|durvalumab|durvalumab
4700095|NCT03238001|Cognitive assessment|cognitive assessment
4700096|NCT03238001|Cognition|cognition
4700097|NCT03238001|Clock Test|clock test
4700098|NCT03237975|type 2 diabetes|type 2 diabetes
4700099|NCT03237975|sense of coherence|sense of coherence
4700100|NCT03237975|self-care|self-care
4700101|NCT03237975|strengths-based intervention|strengths-based intervention
4700102|NCT03237962|High flow nasal cannula|high flow nasal cannula
4700103|NCT03237962|Pulmonary rehab|pulmonary rehab
4700104|NCT03237962|Pulmonary rehabilitation|pulmonary rehabilitation
4700105|NCT03237962|Nasal cannula|nasal cannula
4700106|NCT03237962|Exercise endurance|exercise endurance
4700107|NCT03237962|Oxygen Therapy|oxygen therapy
4700108|NCT03237962|COPD|copd
4700109|NCT03237962|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
4700110|NCT03237949|Tobacco Use Disorder|tobacco use disorder
4700111|NCT03237949|Hospitalized patients|hospitalized patients
4700112|NCT03237949|Text message|text message
4700113|NCT03237949|Motivational Interview|motivational interview
4700114|NCT03237949|Substance-Related Disorders|substance-related disorders
4700115|NCT03237949|Behaviors and Mental Disorders|behaviors and mental disorders
4700117|NCT03237910|amplitude spectrum area|amplitude spectrum area
4700118|NCT03237910|defibrillation|defibrillation
4700119|NCT03237910|waveform analysis|waveform analysis
4700120|NCT03237910|cardiopulmonary resuscitation|cardiopulmonary resuscitation
4700121|NCT03237910|cardiac arrest|cardiac arrest
4700122|NCT03237897|ERAS|eras
4700123|NCT03237897|Enhanced recovery after surgery|enhanced recovery after surgery
4700124|NCT03237884|Palliative Care|palliative care
4700125|NCT03237884|Oncology|oncology
4700126|NCT03237884|advanced incurable cancer (any type)|advanced incurable cancer (any type)
4700127|NCT03237884|integration|integration
4700128|NCT03237884|development|development
4700129|NCT03237884|palliative care interventions|palliative care interventions
4700130|NCT03237884|process indicators|process indicators
4700131|NCT03237884|Romania|romania
4700132|NCT03237858|heart failure|heart failure
4700133|NCT03237858|diagnostics|diagnostics
4700134|NCT03237858|heart sounds|heart sounds
4700135|NCT03237858|CRT-D|crt-d
4700136|NCT03237858|ICD|icd
4700137|NCT03237858|remote monitoring|remote monitoring
4700138|NCT03237819|Thrombotic Thrombocytopenic Purpura|thrombotic thrombocytopenic purpura
4700139|NCT03237819|Intensive care|intensive care
4700140|NCT03237806|ARDS,|ards,
4700141|NCT03237806|Transpulmonary pressure,|transpulmonary pressure,
4700142|NCT03237806|Sedation|sedation
4700143|NCT03237754|migraine|migraine
4700144|NCT03237754|neurostimulation|neurostimulation
4700145|NCT03237754|neuroimaging|neuroimaging
4700146|NCT03237754|tDCS|tdcs
4700147|NCT03237754|MRI|mri
4700148|NCT03237702|prostate cancer|prostate cancer
4700149|NCT03237702|prostate biopsy|prostate biopsy
4700150|NCT03237702|biomarkers|biomarkers
4700151|NCT03237702|metabolomics|metabolomics
4700152|NCT03237702|overtreatment|overtreatment
4700153|NCT03237702|cancer screening|cancer screening
4700154|NCT03237702|urine|urine
4700155|NCT03237702|lycopene|lycopene
4700156|NCT03237676|cognitive rehabilitation|cognitive rehabilitation
4700157|NCT03237676|diffusion tensor imaging|diffusion tensor imaging
4700158|NCT03237676|neuropsychology|neuropsychology
4700159|NCT03237676|functional outcome|functional outcome
4700160|NCT03237650|Painful cutaneous electrical stimulation|painful cutaneous electrical stimulation
4700161|NCT03237650|Conditioned Pain Modulation|conditioned pain modulation
4700162|NCT03237624|gingivitis|gingivitis
4700163|NCT03237611|emesis|emesis
4700164|NCT03237611|aprepitant|aprepitant
4700165|NCT03237611|carboplatin|carboplatin
4700166|NCT03237611|chemotherapy-induced nausea and vomiting|chemotherapy-induced nausea and vomiting
4700167|NCT03237585|gender based violence|gender based violence
4700168|NCT03237585|violence against women|violence against women
4700169|NCT03237585|intimate partner violence|intimate partner violence
4700170|NCT03237585|impact assessment|impact assessment
4700171|NCT03237585|rural response system|rural response system
4700172|NCT03237585|cluster randomised controlled trial|cluster randomised controlled trial
4700173|NCT03237572|breast cancer|breast cancer
4700174|NCT03237572|pembrolizumab|pembrolizumab
4700175|NCT03237572|focused ultrasound|focused ultrasound
4700176|NCT03237572|immunotherapy|immunotherapy
4700177|NCT03237559|Eugenics|eugenics
4700178|NCT03237559|Eligible Couples|eligible couples
4700179|NCT03237559|Knowledge|knowledge
4700180|NCT03237559|Attitude|attitude
4700181|NCT03237559|Practice|practice
4700182|NCT03237546|Robotic Cardiac Surgery|robotic cardiac surgery
4700183|NCT03237494|Peripheral Nervous System Diseases|peripheral nervous system diseases
4700184|NCT03237494|Nervous System Diseases|nervous system diseases
4700185|NCT03237494|Metabolism, Inborn Errors|metabolism, inborn errors
4700186|NCT03237494|Genetic Diseases, Inborn|genetic diseases, inborn
4700187|NCT03237481|inguinal hernia|inguinal hernia
4700188|NCT03237481|hernia|hernia
4700189|NCT03237481|hernia surgery|hernia surgery
4700190|NCT03237481|postoperative pain|postoperative pain
4700191|NCT03237481|herniorrhaphy|herniorrhaphy
4700192|NCT03237468|concussion|concussion
4700193|NCT03237468|football|football
4700194|NCT03237468|student|student
4700195|NCT03237468|athlete|athlete
4700196|NCT03237468|sports|sports
4700197|NCT03237429|bioimpedance spectroscopy|bioimpedance spectroscopy
4700198|NCT03237429|arterial stiffness|arterial stiffness
4700199|NCT03237416|Drug-drug interaction|drug-drug interaction
4700200|NCT03237403|Sepsis|sepsis
4700201|NCT03237403|Adults|adults
4700202|NCT03237403|Pre hospital settings|pre hospital settings
4700203|NCT03237403|Triage|triage
4700204|NCT03237403|Hospital orientation|hospital orientation
4700205|NCT03237403|Outcome|outcome
4700206|NCT03237364|deployed in Iraq and/or Afghanistan|deployed in iraq and/or afghanistan
4700207|NCT03237351|goal-directed fluid therapy|goal-directed fluid therapy
4700208|NCT03237351|thoracic surgery, video-assisted|thoracic surgery, video-assisted
4700209|NCT03237351|acute lung injury|acute lung injury
4700210|NCT03237325|OM|om
4700211|NCT03237325|Head and Neck Cancer|head and neck cancer
4700212|NCT03237325|SGX942|sgx942
4700213|NCT03237325|Dusquetide|dusquetide
4700214|NCT03237325|Squamous Cell Carcinoma|squamous cell carcinoma
4700215|NCT03237299|Pharyngitis|pharyngitis
4700216|NCT03237299|case-control study|case-control study
4701886|NCT03226626|Prevention|prevention
4700217|NCT03237299|loco-regional complications of pharyngitis|loco-regional complications of pharyngitis
4700218|NCT03237286|depression|depression
4700219|NCT03237286|ketamine|ketamine
4700220|NCT03237286|neurocognitive|neurocognitive
4700221|NCT03237286|fMRI|fmri
4700222|NCT03237286|cognitive training|cognitive training
4700223|NCT03237247|extrahepatic cholestasis, CBC|extrahepatic cholestasis, cbc
4700224|NCT03237208|Transcutaneous electrical nerve stimulation|transcutaneous electrical nerve stimulation
4700225|NCT03237208|emergency medicine|emergency medicine
4700226|NCT03237182|whole genome sequencing;|whole genome sequencing;
4700227|NCT03237130|esophagus cancer; radiomics; computed tomograpy|esophagus cancer; radiomics; computed tomograpy
4700228|NCT03237104|Adolescent|adolescent
4700229|NCT03237104|Athlete|athlete
4700230|NCT03237091|non-invasive brain stimulation|non-invasive brain stimulation
4700231|NCT03237078|probiotics|probiotics
4700232|NCT03237078|major depressive disorder|major depressive disorder
4700233|NCT03237078|gut-brain axis|gut-brain axis
4700234|NCT03237078|inflammation|inflammation
4700235|NCT03237039|Roussouly type|roussouly type
4700236|NCT03237039|spine alignment|spine alignment
4700237|NCT03237039|fall-risk|fall-risk
4700238|NCT03237039|gait cycle analysis|gait cycle analysis
4700239|NCT03237026|prostate cancer, prostatectomy, prostate radiotherapy, chemotherapy, immunotherapy, biomarkers, metabolomics, urine|prostate cancer, prostatectomy, prostate radiotherapy, chemotherapy, immunotherapy, biomarkers, metabolomics, urine
4700240|NCT03237013|Sunbathing|sunbathing
4700241|NCT03237013|Indoor Tanning|indoor tanning
4700242|NCT03237013|Facial Morphing|facial morphing
4700243|NCT03237013|Skin Cancer Risk|skin cancer risk
4700244|NCT03237000|Preeclampsia|preeclampsia
4700245|NCT03237000|MgSO4|mgso4
4700246|NCT03236987|MAC|mac
4700247|NCT03236987|Clarithromycin|clarithromycin
4700248|NCT03236987|Azithromycin|azithromycin
4700249|NCT03236987|Efficacy|efficacy
4700250|NCT03236987|Safety|safety
4700251|NCT03236961|uncomplicated acute appendicitis|uncomplicated acute appendicitis
4700252|NCT03236961|complicated acute appendicitis|complicated acute appendicitis
4700253|NCT03236961|antibiotic therapy|antibiotic therapy
4700254|NCT03236922|obstetric fistula, anti-incontinence techniques|obstetric fistula, anti-incontinence techniques
4700255|NCT03236896|Menopause|menopause
4700256|NCT03236896|Hot Flash|hot flash
4700257|NCT03236896|MENQOL|menqol
4700258|NCT03236896|Mobile exercise device|mobile exercise device
4700259|NCT03236870|psoriasis|psoriasis
4700260|NCT03236870|effectiveness|effectiveness
4700261|NCT03236870|safety|safety
4700262|NCT03236870|adalimumab|adalimumab
4700263|NCT03236857|Cancer|cancer
4700264|NCT03236857|Venetoclax|venetoclax
4700265|NCT03236857|pediatric|pediatric
4700266|NCT03236857|relapsed or refractory|relapsed or refractory
4700267|NCT03236831|Ventricular Assist Device|ventricular assist device
4700268|NCT03236818|pulmonary arterial hypertension|pulmonary arterial hypertension
4700269|NCT03236818|right ventricle|right ventricle
4700270|NCT03236818|MRI|mri
4700271|NCT03236818|medical combination therapy|medical combination therapy
4700272|NCT03236805|Morphine|morphine
4700273|NCT03236805|Ketamine|ketamine
4700274|NCT03236805|Acute pain|acute pain
4700275|NCT03236805|prehospital|prehospital
4700276|NCT03236792|Newly Diagnosed|newly diagnosed
4700277|NCT03236792|AL Amyloidosis|al amyloidosis
4700278|NCT03236792|Amyloid|amyloid
4700279|NCT03236792|Light chain Amyloidosis|light chain amyloidosis
4700280|NCT03236753|Thread-Embedding Acupuncture|thread-embedding acupuncture
4700281|NCT03236753|Herniated Intervertebral Disc of Lumbar Spine|herniated intervertebral disc of lumbar spine
4700282|NCT03236753|Low Back Pain|low back pain
4700283|NCT03236753|Radiculopathy|radiculopathy
4700284|NCT03236727|Dexmedetomidine, spinal fusion, SSEP|dexmedetomidine, spinal fusion, ssep
4700285|NCT03236701|hyperphosphatemia|hyperphosphatemia
4700286|NCT03236701|hemodialysis|hemodialysis
4700287|NCT03236701|dietary treatment|dietary treatment
4700288|NCT03236701|egg white|egg white
4700289|NCT03236701|protein energy wasting|protein energy wasting
4700290|NCT03236662|BMD|bmd
4700291|NCT03236662|Becker muscular dystrophy|becker muscular dystrophy
4700292|NCT03236662|epicatechin|epicatechin
4700293|NCT03236662|clinical trial|clinical trial
4700294|NCT03236662|neuromuscular disease|neuromuscular disease
4700295|NCT03236623|Surgical Patient|surgical patient
4700296|NCT03236623|Menthol|menthol
4700297|NCT03236623|Clinical Study|clinical study
4700298|NCT03236571|Marfan syndrome|marfan syndrome
4700299|NCT03236571|Personal Training Program|personal training program
4700300|NCT03236571|Cardiorespiratory rehabilitation|cardiorespiratory rehabilitation
4700301|NCT03236571|Muscular rehabilitation|muscular rehabilitation
4700302|NCT03236558|Type 1 diabetes|type 1 diabetes
4700303|NCT03236558|Juvenile diabetes|juvenile diabetes
4700304|NCT03236558|Immune-tolerance|immune-tolerance
4700305|NCT03236558|Regulatory T lymphocyte|regulatory t lymphocyte
4700306|NCT03236558|Treg|treg
4700307|NCT03236558|TCR|tcr
4700308|NCT03236558|Repertoire|repertoire
4700309|NCT03236532|HIV/AIDS; Resistance training, supplementation|hiv/aids; resistance training, supplementation
4700310|NCT03236506|Illicit drug|illicit drug
4700311|NCT03236506|Injecting drug|injecting drug
4700312|NCT03236467|Fibromyalgia and PTSD|fibromyalgia and ptsd
4701887|NCT03226626|Prophylaxis|prophylaxis
4700313|NCT03236454|brain stimulation|brain stimulation
4700314|NCT03236454|cognitive training|cognitive training
4700315|NCT03236454|cognition|cognition
4700316|NCT03236454|treatment|treatment
4700317|NCT03236441|remote ischemic conditioning|remote ischemic conditioning
4700318|NCT03236441|contrast-induced nephropathy|contrast-induced nephropathy
4700319|NCT03236441|cardiac catheterization|cardiac catheterization
4700320|NCT03236441|coronary artery disease|coronary artery disease
4700321|NCT03236428|Smoldering Multiple Myeloma|smoldering multiple myeloma
4700322|NCT03236428|Monoclonal Gammopathy|monoclonal gammopathy
4700323|NCT03236402|Knowledge|knowledge
4700324|NCT03236402|Opinion|opinion
4700325|NCT03236402|Adoption|adoption
4700326|NCT03236402|Adults|adults
4700327|NCT03236402|Cross-Sectional|cross-sectional
4700328|NCT03236363|Physical activity|physical activity
4700329|NCT03236363|Obesity|obesity
4700330|NCT03236363|Children|children
4700331|NCT03236363|Cognitive function|cognitive function
4700332|NCT03236363|Academic achievement|academic achievement
4700333|NCT03236363|Cardiorespiratory fitness|cardiorespiratory fitness
4700334|NCT03236363|Adiposity|adiposity
4700335|NCT03236363|Cardiovascular fitness|cardiovascular fitness
4700336|NCT03236363|Aerobic capacity|aerobic capacity
4700337|NCT03236350|Chronic Kidney Disease|chronic kidney disease
4700338|NCT03236350|Hypertension|hypertension
4700339|NCT03236350|Cardiovascular Disease|cardiovascular disease
4700340|NCT03236350|Central Aortic Systolic Pressure|central aortic systolic pressure
4700341|NCT03236350|Proteinuria|proteinuria
4700342|NCT03236350|Remote Ischemic Conditioning|remote ischemic conditioning
4700343|NCT03236350|Left Ventricular Hypertrophy|left ventricular hypertrophy
4700344|NCT03236337|Physical activity|physical activity
4700345|NCT03236337|Obesity|obesity
4700346|NCT03236337|Children|children
4700347|NCT03236337|Cognitive function|cognitive function
4700348|NCT03236337|Academic achievement|academic achievement
4700349|NCT03236337|Cardiorespiratory fitness|cardiorespiratory fitness
4700350|NCT03236337|Adiposity|adiposity
4700351|NCT03236337|Cardiovascular fitness|cardiovascular fitness
4700352|NCT03236337|Atherosclerosis|atherosclerosis
4700353|NCT03236337|Aerobic capacity|aerobic capacity
4700354|NCT03236298|Epidural|epidural
4700355|NCT03236298|Labor analgesia|labor analgesia
4700356|NCT03236298|Programmed intermittent epidural bolus|programmed intermittent epidural bolus
4700357|NCT03236285|Obesity|obesity
4700358|NCT03236285|Microcirculation|microcirculation
4700359|NCT03236285|Endothelial function|endothelial function
4700360|NCT03236285|Laser speckle imaging|laser speckle imaging
4700361|NCT03236285|Capillary density|capillary density
4700362|NCT03236272|Biomarkers|biomarkers
4700363|NCT03236272|High-Throughput Screening Assays|high-throughput screening assays
4700364|NCT03236272|Respiratory Distress Syndrome, Adult|respiratory distress syndrome, adult
4700365|NCT03236220|haploidentical hematopoietic stem cell transplantation|haploidentical hematopoietic stem cell transplantation
4700366|NCT03236220|poor graft function|poor graft function
4700367|NCT03236220|prolonged isolated thrombocytopenia|prolonged isolated thrombocytopenia
4700368|NCT03236220|bone marrow endothelial cells|bone marrow endothelial cells
4700369|NCT03236220|N-acetyl-L-cysteine|n-acetyl-l-cysteine
4700370|NCT03236220|Acute leukemia|acute leukemia
4700371|NCT03236181|Energy Expenditure|energy expenditure
4700372|NCT03236181|Appetite|appetite
4700373|NCT03236181|Satiety|satiety
4700374|NCT03236155|Opioids|opioids
4700375|NCT03236142|bariatric|bariatric
4700376|NCT03236142|duodenal switch|duodenal switch
4700377|NCT03236142|DS|ds
4700378|NCT03236142|weight loss surgery|weight loss surgery
4700379|NCT03236142|SIPS|sips
4700380|NCT03236142|Single Anastomosis|single anastomosis
4700381|NCT03236129|DLI|dli
4700382|NCT03236129|Regulatory T cells depletion|regulatory t cells depletion
4700383|NCT03236129|Hematological malignancies|hematological malignancies
4700384|NCT03236129|Relapse|relapse
4700385|NCT03236103|Ventricular assist device|ventricular assist device
4700386|NCT03236090|Cirrhosis|cirrhosis
4700387|NCT03236090|Probiotics|probiotics
4700388|NCT03236090|Systemic inflammation|systemic inflammation
4700389|NCT03236090|neuroinflammation|neuroinflammation
4700390|NCT03236090|Cognitive function|cognitive function
4700391|NCT03236090|Bacterial translocation|bacterial translocation
4700392|NCT03236077|obesity, women, exercise, physical activity,|obesity, women, exercise, physical activity,
4700393|NCT03236051|gastric cancer|gastric cancer
4700394|NCT03236051|gastrectomy|gastrectomy
4700395|NCT03236051|multimodal analgesia|multimodal analgesia
4700396|NCT03236051|parecoxib|parecoxib
4700397|NCT03236038|exocrine pancreatic insufficiency|exocrine pancreatic insufficiency
4700398|NCT03236038|liver cirrhosis|liver cirrhosis
4700399|NCT03236038|decompensated cirrhosis|decompensated cirrhosis
4700400|NCT03236038|malnutrition|malnutrition
4700401|NCT03236038|prevalence|prevalence
4700402|NCT03236025|smoking cessation|smoking cessation
4700403|NCT03236025|video|video
4700404|NCT03236025|male smoker|male smoker
4700405|NCT03235986|RDS|rds
4700406|NCT03235973|refractory acute leukemia|refractory acute leukemia
4700407|NCT03235973|refractory myelodysplastic syndrome|refractory myelodysplastic syndrome
4700408|NCT03235973|cladribine dose escalation|cladribine dose escalation
4702185|NCT03225040|Acromegaly|acromegaly
4700409|NCT03235947|Renal transplant|renal transplant
4700410|NCT03235947|Antimicrobian prophylaxis|antimicrobian prophylaxis
4700411|NCT03235947|Fosfomycin|fosfomycin
4700412|NCT03235947|Urinary tract infection|urinary tract infection
4700413|NCT03235947|Asymptomatic bacteriuria|asymptomatic bacteriuria
4700414|NCT03235934|glucose monitoring|glucose monitoring
4700415|NCT03235921|hemorrhagic shock|hemorrhagic shock
4700416|NCT03235921|perfusion index|perfusion index
4700417|NCT03235921|lactate|lactate
4700418|NCT03235921|nitroglycerin|nitroglycerin
4700419|NCT03235908|Copeptin|copeptin
4700420|NCT03235908|Outcome prediction|outcome prediction
4700421|NCT03235882|Lung surfactant|lung surfactant
4700422|NCT03235882|Mid-infrared spectroscopy|mid-infrared spectroscopy
4700423|NCT03235882|Prematurity|prematurity
4700424|NCT03235882|Respiratory distress syndrome|respiratory distress syndrome
4700425|NCT03235882|gastric aspirate|gastric aspirate
4700426|NCT03235843|Chronotropic Incompetence|chronotropic incompetence
4700427|NCT03235843|Rate Adaptive Pacing|rate adaptive pacing
4700428|NCT03235843|Minute Ventilation Sensor|minute ventilation sensor
4700429|NCT03235843|Primary Prevention ICD Therapy|primary prevention icd therapy
4700430|NCT03235843|Implantable Cardioverter Defibrillator|implantable cardioverter defibrillator
4700431|NCT03235843|Heart Failure|heart failure
4700432|NCT03235843|Exercise Intolerance|exercise intolerance
4700433|NCT03235830|Healthcare utilization|healthcare utilization
4700434|NCT03235830|Health literacy|health literacy
4700435|NCT03235817|Proseal™ LMA|proseal™ lma
4700436|NCT03235817|infants|infants
4700437|NCT03235817|ventilation|ventilation
4700438|NCT03235817|general anesthesia|general anesthesia
4700439|NCT03235817|outpatient surgery|outpatient surgery
4700440|NCT03235804|High-protein diet|high-protein diet
4700441|NCT03235804|Inflammation|inflammation
4700442|NCT03235804|Gut microbiota|gut microbiota
4700443|NCT03235804|Energy metabolism|energy metabolism
4700444|NCT03235804|Body composition|body composition
4700445|NCT03235778|Tolerance; Pharmacokinetic characteristics|tolerance; pharmacokinetic characteristics
4700446|NCT03235765|NSCLC|nsclc
4700447|NCT03235765|Cancer panel|cancer panel
4700448|NCT03235765|NGS|ngs
4700449|NCT03235765|Actionable mutation|actionable mutation
4700450|NCT03235765|Immune checkpoint inhibitor|immune checkpoint inhibitor
4700451|NCT03235752|Randomized|randomized
4700452|NCT03235752|Double-blind|double-blind
4700453|NCT03235752|Placebo-controlled|placebo-controlled
4700454|NCT03235752|Safety|safety
4700455|NCT03235752|Efficacy|efficacy
4700456|NCT03235752|Active Ulcerative Colitis|active ulcerative colitis
4700457|NCT03235726|bystander|bystander
4700458|NCT03235726|inhalation powder|inhalation powder
4700459|NCT03235726|monodose device|monodose device
4700460|NCT03235726|COPD|copd
4700461|NCT03235726|pharmacokinetics|pharmacokinetics
4700462|NCT03235726|safety|safety
4700463|NCT03235726|Healthy|healthy
4700464|NCT03235726|CCI15106|cci15106
4700465|NCT03235726|tolerability|tolerability
4700466|NCT03235713|Ecological momentary assessments|ecological momentary assessments
4700467|NCT03235700|heart failure with reduced ejection fraction|heart failure with reduced ejection fraction
4700468|NCT03235700|intermediate coronary stenosis|intermediate coronary stenosis
4700469|NCT03235700|adenosine|adenosine
4700470|NCT03235700|hyperemia|hyperemia
4700471|NCT03235674|Cardiac rehabilitation|cardiac rehabilitation
4700472|NCT03235674|interval exercise|interval exercise
4700473|NCT03235635|microbiome|microbiome
4700474|NCT03235635|preterm|preterm
4700475|NCT03235635|newborn|newborn
4700476|NCT03235635|gut microbiome|gut microbiome
4700477|NCT03235635|allergic predisposition|allergic predisposition
4700478|NCT03235596|executive functions|executive functions
4700479|NCT03235596|tDCS|tdcs
4700480|NCT03235583|Energy expenditure|energy expenditure
4700481|NCT03235583|physical activity|physical activity
4700482|NCT03235583|accelerometer|accelerometer
4700483|NCT03235583|magnetometer|magnetometer
4700484|NCT03235583|monitoring|monitoring
4700485|NCT03235583|free-living conditions|free-living conditions
4700486|NCT03235583|doubly labelled water|doubly labelled water
4700487|NCT03235570|Solid tumor|solid tumor
4700488|NCT03235570|malignancy|malignancy
4700489|NCT03235570|fibroblast growth factor receptor (FGFR)|fibroblast growth factor receptor (fgfr)
4700490|NCT03235570|fibroblast growth factor (FGF)/FGFR alteration|fibroblast growth factor (fgf)/fgfr alteration
4700491|NCT03235557|prostate|prostate
4700492|NCT03235557|cancer|cancer
4700493|NCT03235557|radiation|radiation
4700494|NCT03235557|stereotactic|stereotactic
4700495|NCT03235557|CyberKnife|cyberknife
4700496|NCT03235557|elderly|elderly
4700497|NCT03235544|Mantle cell lymphoma|mantle cell lymphoma
4700498|NCT03235544|non-Hodgkin lymphoma|non-hodgkin lymphoma
4700499|NCT03235544|Bruton's tyrosine kinase (BTK)|bruton's tyrosine kinase (btk)
4700500|NCT03235544|phosphatidylinositol 3-kinase (PI3K)|phosphatidylinositol 3-kinase (pi3k)
4700501|NCT03235531|alcohol withdrawal syndrome|alcohol withdrawal syndrome
4700502|NCT03235531|trauma|trauma
4700503|NCT03235531|alcohol use disorder|alcohol use disorder
4700504|NCT03235531|alcohol|alcohol
4700505|NCT03235531|lorazepam|lorazepam
4700506|NCT03235531|benzodiazepine|benzodiazepine
4700507|NCT03235531|valproate|valproate
4700508|NCT03235518|HIV Prevention|hiv prevention
4700509|NCT03235518|Female sex workers|female sex workers
4700510|NCT03235505|Smoking Cessation|smoking cessation
4700511|NCT03235505|Electronic cigarette|electronic cigarette
4700512|NCT03235505|Adults|adults
4700513|NCT03235492|diabetes|diabetes
4700514|NCT03235492|salivary glycated albumin|salivary glycated albumin
4700515|NCT03235492|HbA1c|hba1c
4700516|NCT03235453|Parkinson|parkinson
4700517|NCT03235453|Quality of Life|quality of life
4700518|NCT03235453|Sleep Disorder|sleep disorder
4700519|NCT03235453|Gait Disorders|gait disorders
4700520|NCT03235453|Mobility|mobility
4700521|NCT03235427|Coronary|coronary
4700522|NCT03235427|Coronary Disease|coronary disease
4700523|NCT03235427|Coronary Arteriosclerosis|coronary arteriosclerosis
4700524|NCT03235427|Heart Disease|heart disease
4700525|NCT03235427|Cardiotoxicity|cardiotoxicity
4700526|NCT03235427|Breast Cancer|breast cancer
4700527|NCT03235427|Carcinoma|carcinoma
4700528|NCT03235427|Coronary Vessels|coronary vessels
4700529|NCT03235427|Radiation|radiation
4700530|NCT03235427|Radiation Therapy|radiation therapy
4700531|NCT03235427|Coronary Artery Disease|coronary artery disease
4700532|NCT03235427|CAD|cad
4700533|NCT03235427|RT|rt
4700534|NCT03235427|CT|ct
4700535|NCT03235427|Cardiac toxicity|cardiac toxicity
4700536|NCT03235427|Cardiac calcium score|cardiac calcium score
4700537|NCT03235427|Chest RT|chest rt
4700538|NCT03235427|Lung Cancer|lung cancer
4700539|NCT03235427|Lymphoma|lymphoma
4700540|NCT03235427|Cardiac CT Scan|cardiac ct scan
4700541|NCT03235427|Coronary Artery|coronary artery
4700542|NCT03235427|Coronary arteries|coronary arteries
4700543|NCT03235427|Cardiac Side Effect|cardiac side effect
4700544|NCT03235427|Cardiac tissue|cardiac tissue
4700545|NCT03235427|Cardiac|cardiac
4700546|NCT03235401|Questionnaire|questionnaire
4700547|NCT03235401|Disability assessment|disability assessment
4700548|NCT03235401|Bothersomeness|bothersomeness
4700549|NCT03235401|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
4700550|NCT03235401|patient-reported outcome measure|patient-reported outcome measure
4700551|NCT03235401|New York Heart Association (NYHA) functional class|new york heart association (nyha) functional class
4700552|NCT03235388|Trauma|trauma
4700553|NCT03235388|Injury|injury
4700554|NCT03235388|Audit filter|audit filter
4700555|NCT03235388|Quality improvement|quality improvement
4700556|NCT03235388|India|india
4700557|NCT03235375|Kidney Failure, Kidney Insufficiency, Renal Failure, Renal Insufficiency, MEDI0382|kidney failure, kidney insufficiency, renal failure, renal insufficiency, medi0382
4700558|NCT03235349|Chronic Hepatitis C Virus (HCV)|chronic hepatitis c virus (hcv)
4700559|NCT03235349|Genotype 1 to 6|genotype 1 to 6
4700560|NCT03235349|Cirrhosis|cirrhosis
4700561|NCT03235349|Compensated Cirrhosis|compensated cirrhosis
4700562|NCT03235349|Human Immunodeficiency Virus|human immunodeficiency virus
4700563|NCT03235349|co-infection|co-infection
4700564|NCT03235349|Treatment-naïve|treatment-naïve
4700565|NCT03235349|treatment-experienced|treatment-experienced
4700566|NCT03235349|interferon|interferon
4700567|NCT03235323|Vein Graft Failure|vein graft failure
4700568|NCT03235323|Coronary Artery Bypass|coronary artery bypass
4700569|NCT03235323|External Counterpulsation|external counterpulsation
4700570|NCT03235310|HIV|hiv
4700571|NCT03235310|Pregnancy|pregnancy
4700572|NCT03235310|Prevention of mother-to-child transmission|prevention of mother-to-child transmission
4700573|NCT03235297|Altitude|altitude
4700574|NCT03235297|Diffusing capacity for carbon monoxide|diffusing capacity for carbon monoxide
4700575|NCT03235297|COPD|copd
4700576|NCT03235297|Pulmonary function testing|pulmonary function testing
4700577|NCT03235258|HIV Infection|hiv infection
4700578|NCT03235258|Adolescent|adolescent
4700579|NCT03235245|cutaneous melanoma|cutaneous melanoma
4700580|NCT03235245|mucosal melanoma|mucosal melanoma
4700581|NCT03235245|BRAF mutation|braf mutation
4700582|NCT03235206|Police Officers|police officers
4700583|NCT03235154|HCV|hcv
4700584|NCT03235154|suboxone|suboxone
4700585|NCT03235154|epclusa|epclusa
4700586|NCT03235154|psychiatrist|psychiatrist
4700587|NCT03235141|Azithromycin eye drops|azithromycin eye drops
4700588|NCT03235141|Local Pharmacokinetics|local pharmacokinetics
4700589|NCT03235063|Dilated cardiomyopathy|dilated cardiomyopathy
4700590|NCT03235063|registry|registry
4700591|NCT03235063|heart failure|heart failure
4700592|NCT03235063|pregnancy|pregnancy
4700593|NCT03234959|Early Intervention|early intervention
4700594|NCT03234959|Cerebral Palsy|cerebral palsy
4700595|NCT03234959|CareToy Intervention|caretoy intervention
4700596|NCT03234959|Infant Massage|infant massage
4700597|NCT03234959|Information Communication Technology|information communication technology
4700598|NCT03234946|Diabetes|diabetes
4700599|NCT03234946|Family|family
4700600|NCT03234946|Impaired fasting-glucose|impaired fasting-glucose
4700601|NCT03234946|Carbohydrate intolerance|carbohydrate intolerance
4700602|NCT03234933|Cancer|cancer
4700603|NCT03234920|cirrhosis|cirrhosis
4700604|NCT03234920|liver transplantation|liver transplantation
4700605|NCT03234920|HMB|hmb
4700606|NCT03234907|Drug therapy|drug therapy
4700607|NCT03234881|Recurrent Binge Eating|recurrent binge eating
4700608|NCT03234881|Cognitive Behavioral Therapist|cognitive behavioral therapist
4700609|NCT03234881|Weight reduction|weight reduction
4700610|NCT03234842|Esophagus|esophagus
4700611|NCT03234842|Proton|proton
4700612|NCT03234842|Radiation|radiation
4700613|NCT03234829|arch lengths, space analysis, arch prediction|arch lengths, space analysis, arch prediction
4700614|NCT03234790|Diesel Exhaust|diesel exhaust
4700615|NCT03234790|Air Pollution|air pollution
4700616|NCT03234790|Airway Responsiveness|airway responsiveness
4700617|NCT03234790|Proteomics|proteomics
4700618|NCT03234790|Urine PAH Metabolites|urine pah metabolites
4700619|NCT03234764|IgE|ige
4700620|NCT03234764|Allergy|allergy
4700621|NCT03234764|Tolerance|tolerance
4700622|NCT03234764|Immunotherapy|immunotherapy
4700623|NCT03234764|Desensitization|desensitization
4700624|NCT03234751|human B-type natriuretic peptide|human b-type natriuretic peptide
4700625|NCT03234725|Blue light imaging|blue light imaging
4700626|NCT03234725|Linked color imaging|linked color imaging
4700627|NCT03234725|Optical histology|optical histology
4700628|NCT03234725|Adenoma detection rate|adenoma detection rate
4700629|NCT03234725|Variable stiffness|variable stiffness
4700630|NCT03234725|Deep learning|deep learning
4700631|NCT03234712|Advanced Solid Tumors|advanced solid tumors
4700632|NCT03234712|Epidermal Growth Factor Receptor (EGFR)|epidermal growth factor receptor (egfr)
4700633|NCT03234712|EGFR ligands|egfr ligands
4700634|NCT03234712|Colorectal carcinoma (CRC)|colorectal carcinoma (crc)
4700635|NCT03234712|Squamous cell carcinoma of the head and neck (HNSCC)|squamous cell carcinoma of the head and neck (hnscc)
4700636|NCT03234712|non-small cell lung cancer (NSCLC)|non-small cell lung cancer (nsclc)
4700637|NCT03234712|Glioblastoma (GBM)|glioblastoma (gbm)
4700638|NCT03234712|Cancer|cancer
4700639|NCT03234712|overexpression of Epidermal Growth Factor Receptor (EGFR) or EGFR Ligands|overexpression of epidermal growth factor receptor (egfr) or egfr ligands
4700640|NCT03234686|Dementia|dementia
4700641|NCT03234686|Alzheimer's Disease|alzheimer's disease
4700642|NCT03234621|protective ventilation strategy|protective ventilation strategy
4700643|NCT03234608|Healthcare services|healthcare services
4700644|NCT03234608|Adults|adults
4700645|NCT03234595|Cerebraca wafer|cerebraca wafer
4700646|NCT03234595|Recurrent high grade glioma|recurrent high grade glioma
4700647|NCT03234595|anaplastic astrocytoma|anaplastic astrocytoma
4700648|NCT03234595|glioblastoma multiforme|glioblastoma multiforme
4700649|NCT03234569|sonohysterosalpingography|sonohysterosalpingography
4700650|NCT03234569|hysterosalpingogagraphy|hysterosalpingogagraphy
4700651|NCT03234543|Abdominal Surgery|abdominal surgery
4700652|NCT03234543|Pre-conditioning|pre-conditioning
4700653|NCT03234543|Remote Ischemic Conditioning|remote ischemic conditioning
4700654|NCT03234543|Post-Operative Complications|post-operative complications
4700655|NCT03234543|Acute Phase Response|acute phase response
4700656|NCT03234530|albuminuria|albuminuria
4700657|NCT03234530|sleep apnea|sleep apnea
4700658|NCT03234530|particulate matter|particulate matter
4700659|NCT03234530|renal injury|renal injury
4700660|NCT03234491|Diabetes|diabetes
4700661|NCT03234491|Insulin|insulin
4700662|NCT03234478|deep brain stimulation|deep brain stimulation
4700663|NCT03234478|cognition|cognition
4700664|NCT03234478|young onset Parkinson disease|young onset parkinson disease
4700665|NCT03234452|Lactoflorene plus|lactoflorene plus
4700666|NCT03234452|Bifidobacterium animalis subsp. lactis, BB-12®|bifidobacterium animalis subsp. lactis, bb-12®
4700667|NCT03234452|Lactobacillus acidophilus, LA-5®|lactobacillus acidophilus, la-5®
4701031|NCT03232203|Human leukocyte antigen|human leukocyte antigen
4700668|NCT03234452|Lactobacillus paracasei subsp. paracasei, L. CASEI 431®|lactobacillus paracasei subsp. paracasei, l. casei 431®
4700669|NCT03234452|Inflammation|inflammation
4700670|NCT03234452|gut permeability|gut permeability
4700671|NCT03234452|disbiosis|disbiosis
4700672|NCT03234452|probiotic|probiotic
4700673|NCT03234452|IgA|iga
4700674|NCT03234452|IL10|il10
4700675|NCT03234439|digital behavioral health|digital behavioral health
4700676|NCT03234413|Botulinum Toxin-A|botulinum toxin-a
4700677|NCT03234374|Pharmacokinetics|pharmacokinetics
4700678|NCT03234374|Bioavailability|bioavailability
4700679|NCT03234374|Safety|safety
4700680|NCT03234374|Bupivacaine|bupivacaine
4700681|NCT03234374|Collagen|collagen
4700682|NCT03234374|Implant|implant
4700683|NCT03234374|Marcaine|marcaine
4700684|NCT03234374|Hernioplasty|hernioplasty
4700685|NCT03234361|Hypertension|hypertension
4700686|NCT03234361|High phosphorus diet|high phosphorus diet
4700687|NCT03234361|FGF 23|fgf 23
4700688|NCT03234361|24 hour ambulatory blood pressure|24 hour ambulatory blood pressure
4700689|NCT03234361|Muscle sympathetic nerve|muscle sympathetic nerve
4700690|NCT03234348|biodegradable stent|biodegradable stent
4700691|NCT03234348|STEMI|stemi
4700692|NCT03234348|Magnesium bioresorbable|magnesium bioresorbable
4700693|NCT03234348|Vasomotion|vasomotion
4700694|NCT03234335|Multiple Myeloma|multiple myeloma
4700695|NCT03234335|Renal Failure|renal failure
4700696|NCT03234335|Autologous Hematopoietic Stem Cell Transplantation (ASCT)|autologous hematopoietic stem cell transplantation (asct)
4700697|NCT03234335|Melphalan|melphalan
4700698|NCT03234322|prevention|prevention
4700699|NCT03234322|risk score|risk score
4700700|NCT03234322|behaviour|behaviour
4700701|NCT03234322|physical activity|physical activity
4700702|NCT03234296|uncomplicated acute appendicitis|uncomplicated acute appendicitis
4700703|NCT03234296|complicated acute appendicitis|complicated acute appendicitis
4700704|NCT03234296|antibiotic therapy|antibiotic therapy
4700705|NCT03234296|spontaneous resolution|spontaneous resolution
4700706|NCT03234283|Intubation|intubation
4700707|NCT03234270|Heat stress, pilots|heat stress, pilots
4700708|NCT03234257|Carotid stenosis|carotid stenosis
4700709|NCT03234257|stiffness|stiffness
4700710|NCT03234257|ultrafast ultrasound imaging|ultrafast ultrasound imaging
4700711|NCT03234257|Plaque stability|plaque stability
4700712|NCT03234218|vitamin D, liver transplantation|vitamin d, liver transplantation
4700713|NCT03234192|extensor carpi radialis brevis|extensor carpi radialis brevis
4700714|NCT03234192|Therapeutic Ultrasound|therapeutic ultrasound
4700715|NCT03234192|Astym Treatment Technique|astym treatment technique
4700716|NCT03234192|Graston Treatment Technique|graston treatment technique
4700717|NCT03234179|Non small cell lung cancer|non small cell lung cancer
4700718|NCT03234179|Genetic study|genetic study
4700719|NCT03234166|Acute necrotizing pancreatitis Acute pancreatitis Pancreas disease Sepsis Infection Drainage Catheters Antibiotics Multiresistant organism|acute necrotizing pancreatitis acute pancreatitis pancreas disease sepsis infection drainage catheters antibiotics multiresistant organism
4700720|NCT03234153|Muscle-invasive Bladder Cancer|muscle-invasive bladder cancer
4700721|NCT03234153|Ineligible for Cisplatin-based Chemotherapy|ineligible for cisplatin-based chemotherapy
4700722|NCT03234153|Durvalumab|durvalumab
4700723|NCT03234153|Tremelimumab|tremelimumab
4700724|NCT03234114|new generation drug eluting stent (DES)|new generation drug eluting stent (des)
4700725|NCT03234114|triple antithrombotic therapy (TT)|triple antithrombotic therapy (tt)
4700726|NCT03234114|pragmatic clinical trial (PCT)|pragmatic clinical trial (pct)
4700727|NCT03234101|Systematic review and meta-analysis|systematic review and meta-analysis
4700728|NCT03234101|Evidence-based medicine (EBM)|evidence-based medicine (ebm)
4700729|NCT03234101|Evidence-based nutrition (EBN)|evidence-based nutrition (ebn)
4700730|NCT03234101|Clinical practice guidelines|clinical practice guidelines
4700731|NCT03234101|Prospective cohort studies|prospective cohort studies
4700732|NCT03234101|Low-risk lifestyle behaviours|low-risk lifestyle behaviours
4700733|NCT03234101|Healthy Diet|healthy diet
4700734|NCT03234101|Exercise|exercise
4700735|NCT03234101|Physical activity|physical activity
4700736|NCT03234101|Body weight|body weight
4700737|NCT03234101|Sleep|sleep
4700738|NCT03234101|alcohol|alcohol
4700739|NCT03234101|Smoking|smoking
4700740|NCT03234101|Cardiovascular disease|cardiovascular disease
4700741|NCT03234101|Coronary heart disease|coronary heart disease
4700742|NCT03234101|Stroke|stroke
4700743|NCT03234101|Diabetes|diabetes
4700744|NCT03234101|Cancer|cancer
4700745|NCT03234101|Cardiovascular disease mortality|cardiovascular disease mortality
4700746|NCT03234101|Coronary heart disease mortality|coronary heart disease mortality
4700747|NCT03234101|Stroke mortality|stroke mortality
4700748|NCT03234101|All-cause mortality|all-cause mortality
4700749|NCT03234088|Congestive Heart Failure|congestive heart failure
4700750|NCT03234088|Heart Failure|heart failure
4700751|NCT03234088|Home telemonitoring|home telemonitoring
4700752|NCT03234088|Telehealth|telehealth
4700753|NCT03234088|HF Disease Management|hf disease management
4700754|NCT03234088|Heart failure remote self management|heart failure remote self management
4700755|NCT03234049|pediatric|pediatric
4700756|NCT03234049|checklist|checklist
4700757|NCT03234049|cognitive aid|cognitive aid
4700758|NCT03234036|GSK2838232|gsk2838232
4700759|NCT03234036|safety|safety
4700760|NCT03234036|food effect|food effect
4700761|NCT03234036|capsule|capsule
4700762|NCT03234036|healthy|healthy
4700763|NCT03234036|PK|pk
4700764|NCT03234036|tablet|tablet
4700765|NCT03233984|bisphenol-A|bisphenol-a
4700766|NCT03233984|prevention|prevention
4700767|NCT03233984|endocrine disruptors|endocrine disruptors
4700768|NCT03233932|CKD-841|ckd-841
4700769|NCT03233932|Leuplin|leuplin
4700770|NCT03233932|Postmenopausal|postmenopausal
4700771|NCT03233919|Remote Ischemic Conditioning|remote ischemic conditioning
4700772|NCT03233893|based dentin substitute|based dentin substitute
4700773|NCT03233893|dentin bridge|dentin bridge
4700774|NCT03233893|tertiary dentin|tertiary dentin
4700775|NCT03233893|indirect pulp treatment|indirect pulp treatment
4700776|NCT03233880|chlamydia|chlamydia
4700777|NCT03233880|prevention|prevention
4700778|NCT03233841|Natural History Study|natural history study
4700779|NCT03233841|Observational Study|observational study
4700780|NCT03233841|Prospective Study|prospective study
4700781|NCT03233841|Retrospective Study|retrospective study
4700782|NCT03233841|Farber Disease|farber disease
4700783|NCT03233841|Farber's Disease|farber's disease
4700784|NCT03233841|ASAH1|asah1
4700785|NCT03233841|Subcutaneous Nodules|subcutaneous nodules
4700786|NCT03233841|Lysosomal Storage Disease|lysosomal storage disease
4700787|NCT03233841|Lysosomal Storage Disease, Nervous System|lysosomal storage disease, nervous system
4700788|NCT03233841|Metabolic Diseases|metabolic diseases
4700789|NCT03233841|Lipid Metabolism Disorders|lipid metabolism disorders
4700790|NCT03233841|Lipidoses|lipidoses
4700791|NCT03233841|Sphingolipidoses|sphingolipidoses
4700792|NCT03233841|Genetic Disease, Inborn|genetic disease, inborn
4700793|NCT03233841|Musculoskeletal Diseases|musculoskeletal diseases
4700794|NCT03233841|Connective Tissue Diseases|connective tissue diseases
4700795|NCT03233841|Central Nervous System Diseases|central nervous system diseases
4700796|NCT03233841|Brain Diseases, Metabolic, Inborn|brain diseases, metabolic, inborn
4700797|NCT03233841|Brain Diseases, Metabolic|brain diseases, metabolic
4700798|NCT03233841|Brain Diseases, Inborn|brain diseases, inborn
4700799|NCT03233841|Brain Diseases|brain diseases
4700800|NCT03233841|Infant, Newborn Diseases|infant, newborn diseases
4700801|NCT03233841|Inborn Errors of Metabolism|inborn errors of metabolism
4700802|NCT03233841|Inherited Metabolic Disease|inherited metabolic disease
4700803|NCT03233828|Intralesional Injection|intralesional injection
4700804|NCT03233828|Immunotherapy|immunotherapy
4700805|NCT03233828|Immune Response|immune response
4700806|NCT03233828|Interleukin-2 (Aldesleukin)|interleukin-2 (aldesleukin)
4700807|NCT03233828|Tumor Infiltration|tumor infiltration
4700808|NCT03233828|Metastasis Prevention|metastasis prevention
4700809|NCT03233815|Inhaled anesthesia|inhaled anesthesia
4700810|NCT03233815|Total intravenous anesthesia|total intravenous anesthesia
4700811|NCT03233802|Alcohol Use Disorder|alcohol use disorder
4700812|NCT03233802|Treatment|treatment
4700813|NCT03233802|Cognitive-Behavioral Treatment|cognitive-behavioral treatment
4700814|NCT03233802|Individualized Treatment|individualized treatment
4700815|NCT03233776|Anakinra|anakinra
4700816|NCT03233776|Mucositis|mucositis
4700817|NCT03233776|Hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
4700818|NCT03233776|Febrile neutropenia|febrile neutropenia
4700819|NCT03233737|local anesthesia|local anesthesia
4700820|NCT03233737|pain tolerance|pain tolerance
4700821|NCT03233737|experimental pain|experimental pain
4700822|NCT03233724|PD-L1|pd-l1
4700823|NCT03233724|Demethylating Agents and Histone Deacetylase (HDAC) Inhibitors|demethylating agents and histone deacetylase (hdac) inhibitors
4700824|NCT03233724|DNA Hypomethylating Agent|dna hypomethylating agent
4700825|NCT03233724|Cytidine Deaminase|cytidine deaminase
4700826|NCT03233724|Checkpoint Inhibitor|checkpoint inhibitor
4700827|NCT03233685|Tennis|tennis
4700828|NCT03233685|Reaction Time|reaction time
4700829|NCT03233685|Visual training|visual training
4700830|NCT03233672|adjuvant|adjuvant
4700831|NCT03233672|hypofractionation|hypofractionation
4700832|NCT03233672|IMRT|imrt
4700833|NCT03233672|phase I-II|phase i-ii
4700834|NCT03233672|prostate neoplasms|prostate neoplasms
4700835|NCT03233672|radiotherapy|radiotherapy
4700836|NCT03233659|Allogeneic Stem Cell Transplantation, APCs, GVHD|allogeneic stem cell transplantation, apcs, gvhd
4700837|NCT03233646|OCT angiography|oct angiography
4700838|NCT03233646|Optical Coherence Tomography|optical coherence tomography
4700839|NCT03233646|Vessel Density|vessel density
4700840|NCT03233646|Superficial Capillary Plexus|superficial capillary plexus
4700841|NCT03233646|retinal microvasculature|retinal microvasculature
4700842|NCT03233646|OCTA|octa
4700843|NCT03233633|pain management|pain management
4700844|NCT03233633|terminally ill|terminally ill
4700845|NCT03233620|knee arthroplasty|knee arthroplasty
4700846|NCT03233620|working-age|working-age
4700847|NCT03233620|patient related outcome measures|patient related outcome measures
4700848|NCT03233607|Postpartum|postpartum
4700849|NCT03233607|Hemoglobin|hemoglobin
4700850|NCT03233594|Chronic Pain Syndrome|chronic pain syndrome
4700851|NCT03233594|Chronic Pain|chronic pain
4700852|NCT03233594|Chiropractic|chiropractic
4700853|NCT03233594|PET|pet
4700854|NCT03233594|MRI|mri
4700855|NCT03233594|Positron emission tomography|positron emission tomography
4700856|NCT03233594|Magnetic resonance imaging|magnetic resonance imaging
4700857|NCT03233542|Cognitive biases|cognitive biases
4700858|NCT03233542|Associations|associations
4700859|NCT03233542|Interpretations|interpretations
4700860|NCT03233542|Physiological and biological markers|physiological and biological markers
4700861|NCT03233529|atopic dermatitis|atopic dermatitis
4700862|NCT03233529|atopic eczema|atopic eczema
4700863|NCT03233529|eczema|eczema
4700864|NCT03233529|topical treatment|topical treatment
4700865|NCT03233529|skin diseases|skin diseases
4700866|NCT03233529|phosphodiesterase-4 inhibitor|phosphodiesterase-4 inhibitor
4700867|NCT03233529|PDE-4 inhibitor|pde-4 inhibitor
4700868|NCT03233529|crisaborole|crisaborole
4700869|NCT03233516|Community-acquired pneumonia|community-acquired pneumonia
4700870|NCT03233516|Pediatrics|pediatrics
4700871|NCT03233516|Etiology|etiology
4700872|NCT03233516|Point-of-care test|point-of-care test
4700873|NCT03233516|MxA|mxa
4700874|NCT03233516|CRP|crp
4700875|NCT03233516|Procalcitonin|procalcitonin
4700876|NCT03233516|Infectious diseases|infectious diseases
4700877|NCT03233516|Respiratory viruses|respiratory viruses
4700878|NCT03233516|Pediatric asthma|pediatric asthma
4700879|NCT03233490|CPR training|cpr training
4700880|NCT03233490|students|students
4700881|NCT03233490|willingness|willingness
4700882|NCT03233477|Posner Schlossman Syndrome|posner schlossman syndrome
4700883|NCT03233477|cytokine expression|cytokine expression
4700884|NCT03233477|cytomegalovirus|cytomegalovirus
4700885|NCT03233438|Critical Pathways|critical pathways
4700886|NCT03233438|Health Facilities|health facilities
4700887|NCT03233438|Clinical Protocols|clinical protocols
4702186|NCT03225040|Pegvisomant|pegvisomant
4700888|NCT03233438|Patient Satisfaction|patient satisfaction
4700889|NCT03233438|Absenteeism|absenteeism
4700890|NCT03233438|Anti-Bacterial Agents|anti-bacterial agents
4700891|NCT03233438|Quality of Life|quality of life
4700892|NCT03233438|Economics, Medical|economics, medical
4700893|NCT03233438|Health Resources|health resources
4700894|NCT03233438|Health resource utilization|health resource utilization
4700895|NCT03233438|Acute bacterial skin and skin structure infection (ABSSSI)|acute bacterial skin and skin structure infection (absssi)
4700896|NCT03233425|Child|child
4700897|NCT03233425|adolescent|adolescent
4700898|NCT03233425|co-morbidity|co-morbidity
4700899|NCT03233425|psychology|psychology
4700900|NCT03233425|motivation|motivation
4700901|NCT03233425|physical activity|physical activity
4700902|NCT03233425|eating disorders|eating disorders
4700903|NCT03233425|quality of life|quality of life
4700904|NCT03233425|therapy|therapy
4700905|NCT03233425|predictors|predictors
4700906|NCT03233412|high grade cervical intraepithelial neoplasia|high grade cervical intraepithelial neoplasia
4700907|NCT03233412|Immunomodulatory treatment|immunomodulatory treatment
4700908|NCT03233399|Electroencephalography|electroencephalography
4700909|NCT03233399|Magnetoencephalography|magnetoencephalography
4701032|NCT03232203|Key Risk Message|key risk message
4700910|NCT03233399|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
4700911|NCT03233373|Nasal Airway Obstruction|nasal airway obstruction
4700912|NCT03233373|Devices|devices
4700913|NCT03233373|Imaging, Diagnostic|imaging, diagnostic
4700914|NCT03233373|Computer-Assisted Image Processing|computer-assisted image processing
4700915|NCT03233373|Thermal Analysis, Differential|thermal analysis, differential
4700916|NCT03233321|Dry cold application|dry cold application
4700917|NCT03233321|Pain|pain
4700918|NCT03233321|Bruise|bruise
4700919|NCT03233321|Subcutaneous injection|subcutaneous injection
4700920|NCT03233243|Rosuvastatin|rosuvastatin
4700921|NCT03233243|Sodium fluoride|sodium fluoride
4700922|NCT03233243|Positron-emission tomography|positron-emission tomography
4700923|NCT03233230|Rheumatoid Arthritis|rheumatoid arthritis
4700924|NCT03233230|American College of Rheumatology|american college of rheumatology
4700925|NCT03233230|High-sensitivity C-reactive protein|high-sensitivity c-reactive protein
4700926|NCT03233230|Bruton's tyrosine kinase|bruton's tyrosine kinase
4700927|NCT03233217|Influenza|influenza
4700928|NCT03233191|Digital Mammography|digital mammography
4700929|NCT03233191|Breast Tomography|breast tomography
4700930|NCT03233191|Screening Mammography|screening mammography
4700931|NCT03233191|TMIST|tmist
4700932|NCT03233165|laser therapy|laser therapy
4700933|NCT03233165|recurrence|recurrence
4700934|NCT03233165|leukoplakia|leukoplakia
4700935|NCT03233165|precancerous lesion|precancerous lesion
4700936|NCT03233152|recurrence|recurrence
4700937|NCT03233139|Japanese patients|japanese patients
4700938|NCT03233113|Exposure therapy|exposure therapy
4700939|NCT03233113|Cognitive-behavioral therapy|cognitive-behavioral therapy
4700940|NCT03233113|Anxiety disorders|anxiety disorders
4700941|NCT03233100|FMT|fmt
4700942|NCT03233100|gut microbiota|gut microbiota
4700943|NCT03233100|gut-brain disorder|gut-brain disorder
4700944|NCT03233100|constipation|constipation
4700945|NCT03233100|depression|depression
4700946|NCT03233100|anxiety|anxiety
4700947|NCT03233074|Myelodysplastic Syndromes|myelodysplastic syndromes
4700948|NCT03233074|Acute Myeloid Leukemia|acute myeloid leukemia
4700949|NCT03233074|Bone Marrow|bone marrow
4700950|NCT03233074|Mesenchymal stromal cell|mesenchymal stromal cell
4700951|NCT03233074|Healthy donor|healthy donor
4700952|NCT03233061|Obesity; cardiorespiratory fitness; oxygen uptake; household activities; physical activity; sedentary; intensity; obese women|obesity; cardiorespiratory fitness; oxygen uptake; household activities; physical activity; sedentary; intensity; obese women
4700953|NCT03233035|Ketamine-Intranasal-Acute pain-Emergency departement|ketamine-intranasal-acute pain-emergency departement
4700954|NCT03232996|Balance|balance
4700955|NCT03232996|Gait|gait
4700956|NCT03232957|Intrathecal morphine, total knee arthroplasty|intrathecal morphine, total knee arthroplasty
4700957|NCT03232931|auditory|auditory
4700958|NCT03232931|tactile|tactile
4700959|NCT03232931|mother's voice|mother's voice
4700960|NCT03232931|multisensory|multisensory
4700961|NCT03232892|NSCLC|nsclc
4700962|NCT03232892|NF-1 mutant|nf-1 mutant
4700963|NCT03232879|Motor Imagery|motor imagery
4700964|NCT03232879|Action Observation|action observation
4700965|NCT03232879|Heart Rate|heart rate
4700966|NCT03232879|Respiration Rate|respiration rate
4700967|NCT03232879|Electrodermal Activity|electrodermal activity
4700968|NCT03232866|Exercise Movement Techniques|exercise movement techniques
4700969|NCT03232866|Exercise|exercise
4700970|NCT03232866|Monitoring, Physiologic|monitoring, physiologic
4700971|NCT03232866|Heart Rate|heart rate
4700972|NCT03232866|Autonomic Nervous System|autonomic nervous system
4700973|NCT03232866|Heart rate variability|heart rate variability
4700974|NCT03232853|medical error in anesthesia|medical error in anesthesia
4700975|NCT03232853|drug error in anesthesia|drug error in anesthesia
4700976|NCT03232840|wrong site surgery in regional anesthesia|wrong site surgery in regional anesthesia
4700977|NCT03232801|hypoactive sexual desire disorder|hypoactive sexual desire disorder
4700978|NCT03232801|female sexual dysfunction|female sexual dysfunction
4700980|NCT03232801|female sexual interest-arousal disorder|female sexual interest-arousal disorder
4700981|NCT03232801|low desire|low desire
4700982|NCT03232801|sexual dysfunction|sexual dysfunction
4700983|NCT03232788|Periodontal disease|periodontal disease
4700984|NCT03232788|Recession|recession
4700985|NCT03232788|Black space|black space
4700986|NCT03232775|visual pedagogy|visual pedagogy
4700987|NCT03232723|Magnetoencephalography|magnetoencephalography
4700988|NCT03232723|Whole-cortex MEG System (with optional EEG)|whole-cortex meg system (with optional eeg)
4700989|NCT03232554|Iron-Deficiency Anemia|iron-deficiency anemia
4700990|NCT03232554|Buxue Yimu Pills|buxue yimu pills
4700991|NCT03232554|Ferrous Sulfate|ferrous sulfate
4700992|NCT03232554|clinical observations|clinical observations
4700993|NCT03232554|adult women|adult women
4700994|NCT03232554|Metabonomics|metabonomics
4700995|NCT03232515|Bioimpedance Vector Analysis (BIVA)|bioimpedance vector analysis (biva)
4700996|NCT03232515|Chronic Renal Failure|chronic renal failure
4700997|NCT03232515|Dialysis|dialysis
4700998|NCT03232515|Dry weight|dry weight
4700999|NCT03232515|Blood Pressure|blood pressure
4701000|NCT03232437|HbA1c|hba1c
4701001|NCT03232411|prostate disease|prostate disease
4701002|NCT03232411|prostatic neoplasm|prostatic neoplasm
4701003|NCT03232411|biobank|biobank
4701004|NCT03232411|prostate cancer in black males|prostate cancer in black males
4701005|NCT03232411|biospecimen|biospecimen
4701006|NCT03232411|smoking and the aggressiveness of prostate cancer|smoking and the aggressiveness of prostate cancer
4701007|NCT03232372|Bone loss, dental implant desing|bone loss, dental implant desing
4701008|NCT03232346|buprenorphine|buprenorphine
4701009|NCT03232346|naltrexone|naltrexone
4701010|NCT03232346|Vivitrol|vivitrol
4701011|NCT03232346|opioid dependence|opioid dependence
4701012|NCT03232307|Hematopoietic/Lymphoid Cancer|hematopoietic/lymphoid cancer
4701013|NCT03232307|Mantle Cell Lymphoma|mantle cell lymphoma
4701014|NCT03232307|MCL|mcl
4701015|NCT03232307|Newly-diagnosed|newly-diagnosed
4701016|NCT03232307|Ibrutinib|ibrutinib
4701017|NCT03232307|PCI-32765|pci-32765
4701018|NCT03232307|Imbruvica|imbruvica
4701019|NCT03232307|Rituximab|rituximab
4701020|NCT03232307|Rituxan|rituxan
4701021|NCT03232307|Lenalidomide|lenalidomide
4701022|NCT03232307|CC-5013|cc-5013
4701023|NCT03232307|Revlimid|revlimid
4701024|NCT03232307|Dexamethasone|dexamethasone
4701025|NCT03232307|Decadron|decadron
4701026|NCT03232294|fetal macrosomia|fetal macrosomia
4701027|NCT03232294|fetal abdominal wall thickness|fetal abdominal wall thickness
4701028|NCT03232294|subcutaneous adipose tissue|subcutaneous adipose tissue
4701029|NCT03232268|Microtransplantation|microtransplantation
4701030|NCT03232268|Myeloid Hemopathy|myeloid hemopathy
4701033|NCT03232203|ADA-SCID|ada-scid
4701034|NCT03232203|Health care providers|health care providers
4701035|NCT03232190|prematurity|prematurity
4701036|NCT03232190|psychomotor development|psychomotor development
4701037|NCT03232190|parent empowerment|parent empowerment
4701038|NCT03232190|e-health|e-health
4701039|NCT03232190|parental support|parental support
4701040|NCT03232190|post discharge follow-up|post discharge follow-up
4701041|NCT03232164|Prostate Cancer|prostate cancer
4701042|NCT03232164|Prostate neoplasm|prostate neoplasm
4701043|NCT03232151|Stroke|stroke
4701044|NCT03232138|Sulforaphane|sulforaphane
4701045|NCT03232138|Chemoprevention|chemoprevention
4701046|NCT03232138|Former Smokers|former smokers
4701047|NCT03232112|Alcohol|alcohol
4701048|NCT03232112|Addiction|addiction
4701049|NCT03232112|Glucagon Like Peptide-1|glucagon like peptide-1
4701050|NCT03232112|GLP-1|glp-1
4701051|NCT03232099|trimethylamine-N-oxide|trimethylamine-n-oxide
4701052|NCT03232099|TMAO|tmao
4701053|NCT03232099|Gut Microbiota|gut microbiota
4701054|NCT03232099|Gut Flora|gut flora
4701055|NCT03232099|Atherosclerosis|atherosclerosis
4701056|NCT03232099|Wine|wine
4701057|NCT03232099|Red Wine|red wine
4701058|NCT03232086|Controlled Human Exposure Study|controlled human exposure study
4701059|NCT03232086|Cardiovascular|cardiovascular
4701060|NCT03232047|Computerized Working Memory Training|computerized working memory training
4701061|NCT03232047|Mild Cognitive Impairment|mild cognitive impairment
4701062|NCT03232034|Calcium citrate, dairy product, whey protein, appetite, metabolism|calcium citrate, dairy product, whey protein, appetite, metabolism
4701063|NCT03232021|urinary bladder|urinary bladder
4701064|NCT03232021|urinary catheters|urinary catheters
4701065|NCT03232021|pregabalin|pregabalin
4701066|NCT03232008|Blood glucose|blood glucose
4701067|NCT03232008|Appetite|appetite
4701068|NCT03231995|Severe influenza|severe influenza
4701069|NCT03231995|biomarkers|biomarkers
4701070|NCT03231995|respiratory microbiome|respiratory microbiome
4701071|NCT03231995|prognosis|prognosis
4701072|NCT03231943|FTIH|ftih
4701073|NCT03231943|Healthy|healthy
4701074|NCT03231943|Tolerability|tolerability
4701075|NCT03231943|Dose-escalation|dose-escalation
4701076|NCT03231943|HIV-1|hiv-1
4701077|NCT03231943|Safety|safety
4701079|NCT03231943|GSK3640254|gsk3640254
4701080|NCT03231943|Maturation inhibitor|maturation inhibitor
4701081|NCT03231930|Diagnosis|diagnosis
4701082|NCT03231930|Point of Care Diagnostics|point of care diagnostics
4701083|NCT03231930|Hepatitis|hepatitis
4701084|NCT03231826|Home monitoring|home monitoring
4701085|NCT03231826|ECG|ecg
4701086|NCT03231826|Myocardial Infarction|myocardial infarction
4701087|NCT03231826|Arrythmia|arrythmia
4701088|NCT03231813|irritant contact dermatitis|irritant contact dermatitis
4701089|NCT03231813|sodium lauryl sulphate|sodium lauryl sulphate
4701090|NCT03231813|emollients|emollients
4701091|NCT03231813|transepidermal water loss|transepidermal water loss
4701092|NCT03231800|Attention-Deficit Hyperactivity Disorder (ADHD)|attention-deficit hyperactivity disorder (adhd)
4701093|NCT03231774|Echocardiography|echocardiography
4701094|NCT03231774|Right heart catheterization|right heart catheterization
4701095|NCT03231722|mFOLFOXIRI + Panitumumab|mfolfoxiri + panitumumab
4701096|NCT03231722|RAS and BRAF wt|ras and braf wt
4701097|NCT03231696|nerve block|nerve block
4701098|NCT03231696|peripheral nerve stimulation|peripheral nerve stimulation
4701099|NCT03231657|preeclampsia|preeclampsia
4701100|NCT03231657|intrauterine growth restriction|intrauterine growth restriction
4701101|NCT03231657|angiogenic factors|angiogenic factors
4701102|NCT03231644|Fibrous Dysplasia|fibrous dysplasia
4701103|NCT03231644|McCune-Albright Syndrome|mccune-albright syndrome
4701104|NCT03231644|Mazabrauds|mazabrauds
4701105|NCT03231644|FD/MAS|fd/mas
4701106|NCT03231631|Exercise|exercise
4701107|NCT03231631|Education|education
4701108|NCT03231631|Stents|stents
4701109|NCT03231631|Angioplasty|angioplasty
4701110|NCT03231631|Cardiac Rehabilitation|cardiac rehabilitation
4701111|NCT03231631|Cholesterol, HDL|cholesterol, hdl
4701112|NCT03231631|Metabolic Equivalent|metabolic equivalent
4701113|NCT03231618|dietary intake|dietary intake
4701114|NCT03231618|cross-over intervention|cross-over intervention
4701115|NCT03231618|energy expenditure|energy expenditure
4701116|NCT03231540|Critical care|critical care
4701117|NCT03231540|nutrition|nutrition
4701118|NCT03231540|whey protein|whey protein
4701119|NCT03231540|mechanical ventilation|mechanical ventilation
4701120|NCT03231540|muscle function|muscle function
4701121|NCT03231514|body composition|body composition
4701122|NCT03231514|exercise performance|exercise performance
4701123|NCT03231514|keto-adaptation|keto-adaptation
4701124|NCT03231475|NSCLC|nsclc
4701125|NCT03231475|EGFR-TKI|egfr-tki
4701126|NCT03231449|routine care, evaluation, Africa, observatory|routine care, evaluation, africa, observatory
4701127|NCT03231436|intrathecal bupivacaine|intrathecal bupivacaine
4701128|NCT03231436|hyperbaric bupivacaine|hyperbaric bupivacaine
4701129|NCT03231436|failed spinal|failed spinal
4701130|NCT03231423|Obesity|obesity
4701131|NCT03231423|VAS|vas
4701132|NCT03231423|Pain|pain
4701133|NCT03231423|Laparoscopy|laparoscopy
4701134|NCT03231423|Bypass|bypass
4701135|NCT03231410|arteriovenous fistula|arteriovenous fistula
4701136|NCT03231410|maturation|maturation
4701137|NCT03231410|monocyte adhesion|monocyte adhesion
4701138|NCT03231410|vascular access|vascular access
4701139|NCT03231397|Abdominal Aortic Aneurysm (AAA)|abdominal aortic aneurysm (aaa)
4701140|NCT03231371|Orthotopic Heart Transplant|orthotopic heart transplant
4701141|NCT03231345|Peripheral IV|peripheral iv
4701142|NCT03231345|Internal jugular vein|internal jugular vein
4701143|NCT03231345|IJ|ij
4701144|NCT03231345|Peripheral IJ|peripheral ij
4701145|NCT03231345|Ultrasound-guided IJ|ultrasound-guided ij
4701146|NCT03231332|Helicobacter pylori|helicobacter pylori
4701147|NCT03231332|Eradication|eradication
4701148|NCT03231332|Microbiome|microbiome
4701149|NCT03231332|ESBL|esbl
4701150|NCT03231332|GIT|git
4701151|NCT03231306|Neurofibroma, Plexiform|neurofibroma, plexiform
4701152|NCT03231306|Genes, Neurofibromatosis|genes, neurofibromatosis
4701153|NCT03231306|Peripheral nerve tumors|peripheral nerve tumors
4701154|NCT03231306|Neurofibromatosis 1|neurofibromatosis 1
4701155|NCT03231306|Neurofibromas|neurofibromas
4701156|NCT03231280|knee|knee
4701157|NCT03231267|Multiresistant enterobacteriaceae|multiresistant enterobacteriaceae
4701158|NCT03231267|digestive colonization|digestive colonization
4701159|NCT03231267|bacteriophages|bacteriophages
4701160|NCT03231267|Admission in intensive care unit >72h|admission in intensive care unit >72h
4701161|NCT03231267|Presence of at least 2 consecutive stools|presence of at least 2 consecutive stools
4701162|NCT03231241|Headaches|headaches
4701163|NCT03231241|Tension-Type Headache|tension-type headache
4701164|NCT03231241|New Daily Persistent Headache (NDPH)|new daily persistent headache (ndph)
4701165|NCT03231241|Migraine|migraine
4701166|NCT03231202|Non-operative management|non-operative management
4701167|NCT03231202|Splenic Injury|splenic injury
4701168|NCT03231202|Blunt|blunt
4701169|NCT03231202|Splenic artery embolization|splenic artery embolization
4701170|NCT03231202|Trauma|trauma
4701171|NCT03231189|Coronary artery disease|coronary artery disease
4701172|NCT03231189|cardiac MRI|cardiac mri
4701173|NCT03231189|heart failure|heart failure
4701174|NCT03231176|Biliary Tract Neoplasms|biliary tract neoplasms
4701175|NCT03231176|Bile Duct Neoplasms|bile duct neoplasms
4701176|NCT03231176|Gallbladder Neoplasms|gallbladder neoplasms
4701177|NCT03231085|Craniosynostosis|craniosynostosis
4701178|NCT03231085|hemoglobin|hemoglobin
4701179|NCT03231085|iron peros|iron peros
4701180|NCT03231085|iron intravenous|iron intravenous
4701181|NCT03231072|mechanical ventilation|mechanical ventilation
4702676|NCT03222076|Nivolumab|nivolumab
4701182|NCT03231072|pleural effusion|pleural effusion
4701184|NCT03231059|Coronary artery disease|coronary artery disease
4701185|NCT03231059|Percutaneous coronary intervention|percutaneous coronary intervention
4701186|NCT03231059|Drug-eluting stent|drug-eluting stent
4701187|NCT03231059|Antiplatelet drugs|antiplatelet drugs
4701188|NCT03231059|Clinical event committee|clinical event committee
4701189|NCT03231020|single ventricle|single ventricle
4701190|NCT03231020|pediatric cardiology|pediatric cardiology
4701191|NCT03231020|interstage|interstage
4701192|NCT03231020|home monitoring|home monitoring
4701193|NCT03231020|mHealth|mhealth
4701194|NCT03230994|adenomyosis|adenomyosis
4701195|NCT03230994|diagnosis|diagnosis
4701196|NCT03230994|treatment|treatment
4701197|NCT03230994|epidemiology|epidemiology
4701198|NCT03230994|Complications|complications
4701199|NCT03230981|biomechanics|biomechanics
4701200|NCT03230981|cornea|cornea
4701201|NCT03230981|optical coherence tomography|optical coherence tomography
4701202|NCT03230981|vibrography|vibrography
4701203|NCT03230981|brillouin microscopy|brillouin microscopy
4701204|NCT03230968|Practical Approach to Lung Health|practical approach to lung health
4701205|NCT03230968|Respiratory diseases|respiratory diseases
4701206|NCT03230968|Mexico|mexico
4701207|NCT03230955|Randomized clinical trial|randomized clinical trial
4701208|NCT03230955|Hotlines|hotlines
4701209|NCT03230942|patient education|patient education
4701210|NCT03230942|arthritis|arthritis
4701211|NCT03230942|knee|knee
4701212|NCT03230942|arthroplasty|arthroplasty
4701213|NCT03230942|gait|gait
4701214|NCT03230929|EMG, BIS, phase lag entropy|emg, bis, phase lag entropy
4701215|NCT03230903|Multiple Sclerosis|multiple sclerosis
4701216|NCT03230903|Telerehabilitation|telerehabilitation
4701217|NCT03230903|Physical rehabilitation|physical rehabilitation
4701218|NCT03230890|PTSD|ptsd
4701219|NCT03230890|military|military
4701220|NCT03230890|neurotechnology|neurotechnology
4701221|NCT03230890|HIRREM|hirrem
4701222|NCT03230890|allostasis|allostasis
4701223|NCT03230890|heart rate variability|heart rate variability
4701224|NCT03230890|baroreflex sensitivity|baroreflex sensitivity
4701225|NCT03230890|closed loop|closed loop
4701226|NCT03230890|acoustic stimulation|acoustic stimulation
4701227|NCT03230890|neural oscillations|neural oscillations
4701228|NCT03230890|autonomic|autonomic
4701229|NCT03230890|hyperarousal|hyperarousal
4701230|NCT03230864|Treatment-resistant schizophrenia|treatment-resistant schizophrenia
4701231|NCT03230864|Lu AF35700|lu af35700
4701232|NCT03230851|Light Transmittance Aggregometry|light transmittance aggregometry
4701233|NCT03230851|Indobufen|indobufen
4701234|NCT03230851|Aspirin|aspirin
4701235|NCT03230851|Plasma Thromboxane|plasma thromboxane
4701236|NCT03230851|Urine 11-dehydro thromboxane|urine 11-dehydro thromboxane
4701237|NCT03230825|incomplete abortion|incomplete abortion
4701238|NCT03230825|retained products of conception|retained products of conception
4701239|NCT03230825|combined oral contraceptives|combined oral contraceptives
4701240|NCT03230825|ultrasound|ultrasound
4701241|NCT03230812|Insulin sensitivity|insulin sensitivity
4701242|NCT03230812|Metabolic flexibility|metabolic flexibility
4701243|NCT03230799|dense cataract|dense cataract
4701244|NCT03230799|lens-shell technique|lens-shell technique
4701245|NCT03230799|secondary intraocular lens implantation|secondary intraocular lens implantation
4701246|NCT03230786|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
4701247|NCT03230786|KBP-042|kbp-042
4701248|NCT03230760|acupuncture|acupuncture
4701249|NCT03230760|breast engorgement|breast engorgement
4701250|NCT03230760|lactation|lactation
4701251|NCT03230734|prostate cancer|prostate cancer
4701252|NCT03230734|castration-resistant prostate cancer|castration-resistant prostate cancer
4701253|NCT03230734|metastatic prostate cancer|metastatic prostate cancer
4701254|NCT03230734|bone only metastatic prostate cancer|bone only metastatic prostate cancer
4701255|NCT03230734|radium-223|radium-223
4701256|NCT03230734|Docetaxel|docetaxel
4701257|NCT03230721|laser|laser
4701258|NCT03230721|HoLEP|holep
4701259|NCT03230721|ThuLEP|thulep
4701260|NCT03230721|Thulium|thulium
4701261|NCT03230721|Thulium-fiber|thulium-fiber
4701262|NCT03230721|BPH|bph
4701263|NCT03230721|EEP|eep
4701264|NCT03230721|monopolar enucleation|monopolar enucleation
4701265|NCT03230708|Microparticles|microparticles
4701266|NCT03230708|Erythrocytes|erythrocytes
4701267|NCT03230708|Methotrexate|methotrexate
4701268|NCT03230695|stroke|stroke
4701269|NCT03230695|robotic therapy|robotic therapy
4701270|NCT03230695|transcranial direct current stimulation|transcranial direct current stimulation
4701271|NCT03230682|early improvement|early improvement
4701272|NCT03230682|antidepressants|antidepressants
4701273|NCT03230682|major depression diorder|major depression diorder
4701274|NCT03230682|resting-state fMRI|resting-state fmri
4701275|NCT03230669|substance abuse|substance abuse
4701276|NCT03230669|addiction|addiction
4701277|NCT03230669|etherapy|etherapy
4701278|NCT03230591|Fabry's disease|fabry's disease
4701279|NCT03230591|Agalsidase Alfa|agalsidase alfa
4701280|NCT03230591|Cardiomyopathy|cardiomyopathy
4701281|NCT03230591|Enzyme replacement therapy|enzyme replacement therapy
4701282|NCT03230591|Diastolic stress echocardiography|diastolic stress echocardiography
4701283|NCT03230591|LV vortex flow|lv vortex flow
4701284|NCT03230591|Cardiac MRI|cardiac mri
4701285|NCT03230578|Pharmacists|pharmacists
4701286|NCT03230578|Prescriptions|prescriptions
4701287|NCT03230513|vertigo|vertigo
4701288|NCT03230513|benign paroxysmal positional vertigo|benign paroxysmal positional vertigo
4701289|NCT03230513|particle repositioning manoeuvre|particle repositioning manoeuvre
4701290|NCT03230500|computer guided|computer guided
4701291|NCT03230500|immediate implant|immediate implant
4701292|NCT03230500|patient satisfaction|patient satisfaction
4701293|NCT03230461|CPR|cpr
4701294|NCT03230461|Basic life support|basic life support
4701295|NCT03230448|Acute alcoholism|acute alcoholism
4701296|NCT03230435|anorexia nervosa, health-related quality of life|anorexia nervosa, health-related quality of life
4701297|NCT03230422|infant, laryngoscopes, pediatrics|infant, laryngoscopes, pediatrics
4701298|NCT03230409|Tuberculosis, Latent Tuberculosis Infection, Adherence, Nursing, Pediatrics, Public Health.|tuberculosis, latent tuberculosis infection, adherence, nursing, pediatrics, public health.
4701299|NCT03230396|vitamins|vitamins
4701300|NCT03230396|dietary supplements|dietary supplements
4701301|NCT03230396|chewing gum|chewing gum
4701302|NCT03230396|pharmacokinetics|pharmacokinetics
4701303|NCT03230396|healthy human subjects|healthy human subjects
4701304|NCT03230370|intensity|intensity
4701305|NCT03230370|rehabilitation|rehabilitation
4701306|NCT03230318|iCCA|icca
4701307|NCT03230318|intrahepatic cholangiocarcinoma|intrahepatic cholangiocarcinoma
4701308|NCT03230318|FGFR2 gene fusion|fgfr2 gene fusion
4701309|NCT03230318|ARQ 087|arq 087
4701310|NCT03230318|biliary cancer|biliary cancer
4701311|NCT03230318|bile duct cancer|bile duct cancer
4701312|NCT03230318|FGFR2 gene rearrangement|fgfr2 gene rearrangement
4701313|NCT03230318|liver cancer|liver cancer
4701314|NCT03230318|targeted therapy|targeted therapy
4701315|NCT03230318|combined hepatocellular and cholangiocarcinoma|combined hepatocellular and cholangiocarcinoma
4701316|NCT03230318|cHCC-CCA|chcc-cca
4701317|NCT03230305|Elderly|elderly
4701318|NCT03230305|Cancer|cancer
4701319|NCT03230305|Ethnographic interview|ethnographic interview
4701320|NCT03230305|Social representation|social representation
4701321|NCT03230305|Clinical trials|clinical trials
4701322|NCT03230305|Reasons of non-participation|reasons of non-participation
4701323|NCT03230305|Qualitative method|qualitative method
4701324|NCT03230292|Psoriasis|psoriasis
4701325|NCT03230292|Chronic Plaque Psoriasis|chronic plaque psoriasis
4701326|NCT03230292|Bimekizumab|bimekizumab
4701327|NCT03230279|Sacroiliac pain|sacroiliac pain
4701328|NCT03230279|Low back pain|low back pain
4701329|NCT03230188|asthma|asthma
4701330|NCT03230188|neurocircuitry|neurocircuitry
4701331|NCT03230188|severe asthma|severe asthma
4701332|NCT03230188|mild to moderate asthma|mild to moderate asthma
4701333|NCT03230188|neurocircuitry patterns|neurocircuitry patterns
4701334|NCT03230149|Fabry|fabry
4701335|NCT03230149|Stroke|stroke
4701336|NCT03230149|Cerebrovascular Accident|cerebrovascular accident
4701337|NCT03230149|small fiber neuropathy|small fiber neuropathy
4701338|NCT03230136|Myocardial injury|myocardial injury
4701339|NCT03230136|Ischemia reperfusion|ischemia reperfusion
4701340|NCT03230136|cardiac surgery|cardiac surgery
4701341|NCT03230136|cardioprotection|cardioprotection
4701342|NCT03230123|Diabetes Mellitus|diabetes mellitus
4701343|NCT03230123|green banana|green banana
4701344|NCT03230123|resistant starch|resistant starch
4701345|NCT03230123|glucose|glucose
4701346|NCT03230123|prebiotics|prebiotics
4701347|NCT03230123|insulin|insulin
4701348|NCT03230123|incretins|incretins
4701349|NCT03230110|Sleep disordered breathing|sleep disordered breathing
4701350|NCT03230110|Obstructive sleep apnea|obstructive sleep apnea
4701351|NCT03230110|Hypertension|hypertension
4701352|NCT03230110|Pregnancy|pregnancy
4701353|NCT03230084|Infertility|infertility
4701354|NCT03230084|Ovulation|ovulation
4701355|NCT03230084|Pregnanediol 3-glucuronide|pregnanediol 3-glucuronide
4701356|NCT03230084|Progesterone|progesterone
4701357|NCT03230084|Urine dipstick test|urine dipstick test
4701358|NCT03230084|Feasibility study|feasibility study
4701359|NCT03230084|Fertile period|fertile period
4701360|NCT03230084|Menstrual cycle|menstrual cycle
4701361|NCT03230084|Natural family planning|natural family planning
4701362|NCT03230084|Fertility awareness methods|fertility awareness methods
4701363|NCT03230071|Herbal therapy|herbal therapy
4701364|NCT03230071|Randomized controlled trial|randomized controlled trial
4701365|NCT03230071|Vascular Dementia|vascular dementia
4701366|NCT03230045|acupoint stimulation|acupoint stimulation
4701367|NCT03230045|elderly patients|elderly patients
4701368|NCT03230045|postoperative pulmonary complications|postoperative pulmonary complications
4701369|NCT03230019|wedge resection|wedge resection
4701370|NCT03230019|tubeless|tubeless
4701371|NCT03229980|myocardial protection|myocardial protection
4701372|NCT03229980|potassium cardioplegia|potassium cardioplegia
4701373|NCT03229980|tropinin|tropinin
4701374|NCT03229980|Custodiol|custodiol
4701375|NCT03229967|Bronchopulmonary dysplasia|bronchopulmonary dysplasia
4701376|NCT03229967|Microbiome|microbiome
4701377|NCT03229967|Microbiota|microbiota
4701378|NCT03229967|Premature infant|premature infant
4701379|NCT03229967|Observational cohort study|observational cohort study
4701381|NCT03229928|Outcome Measures|outcome measures
4701382|NCT03229928|Intellectual/Developmental Disabilities|intellectual/developmental disabilities
4701383|NCT03229902|stroke|stroke
4701384|NCT03229889|Access Sheath|access sheath
4701385|NCT03229889|PCNL|pcnl
4701386|NCT03229889|Percutaneous Nephrolithotomy|percutaneous nephrolithotomy
4701387|NCT03229889|Ureteroscopy|ureteroscopy
4701388|NCT03229889|Alpha Blocker|alpha blocker
4701389|NCT03229889|Flomax|flomax
4701390|NCT03229889|PDE-5 Inhibitor|pde-5 inhibitor
4701391|NCT03229889|Cialis|cialis
4701392|NCT03229889|Phosphodiesterase Inhibitor|phosphodiesterase inhibitor
4701393|NCT03229863|Breastfeeding|breastfeeding
4701394|NCT03229863|First foods|first foods
4701395|NCT03229850|Diabetes|diabetes
4701396|NCT03229850|Insulin|insulin
4701397|NCT03229850|Lipohypertrophy|lipohypertrophy
4701398|NCT03229850|Euglycemic Clamp|euglycemic clamp
4701399|NCT03229837|Construct validity|construct validity
4701400|NCT03229837|Minimally important differences|minimally important differences
4701401|NCT03229837|Patient-reported outcomes|patient-reported outcomes
4701402|NCT03229837|Pediatric cancer survivors|pediatric cancer survivors
4701403|NCT03229837|PROMIS pediatric measures|promis pediatric measures
4701404|NCT03229824|Drain antisepsis|drain antisepsis
4701405|NCT03229824|Bacterial colonization|bacterial colonization
4701406|NCT03229824|Surgical site infection|surgical site infection
4701407|NCT03229733|Stroke|stroke
4701408|NCT03229733|Kinect|kinect
4701409|NCT03229733|Rehabilitation|rehabilitation
4701410|NCT03229733|Upper limbs|upper limbs
4701411|NCT03229720|Audio Visual Distraction|audio visual distraction
4701412|NCT03229681|Baduanjin; CHF; 6MWT; CPET|baduanjin; chf; 6mwt; cpet
4701413|NCT03229668|urinary bladder|urinary bladder
4701414|NCT03229668|urinary catheters|urinary catheters
4701415|NCT03229668|pregabalin|pregabalin
4701416|NCT03229642|repetitive transcranial magnetic stimulation|repetitive transcranial magnetic stimulation
4701417|NCT03229642|opioid use disorder|opioid use disorder
4701418|NCT03229642|craving|craving
4701419|NCT03229642|functional magnetic resonance imaging|functional magnetic resonance imaging
4701420|NCT03229642|neuropsychological tests|neuropsychological tests
4701421|NCT03229629|Behavior change communication|behavior change communication
4701422|NCT03229629|Ethiopia|ethiopia
4701423|NCT03229629|Food voucher|food voucher
4701424|NCT03229629|complementary feeding practice|complementary feeding practice
4701425|NCT03229629|affordability|affordability
4701426|NCT03229629|accessibility|accessibility
4701427|NCT03229629|gender|gender
4701428|NCT03229603|HPV infection and Cervical cancer|hpv infection and cervical cancer
4701429|NCT03229564|Burns|burns
4701430|NCT03229564|Scar|scar
4701431|NCT03229564|Skin|skin
4701432|NCT03229564|Wound healing|wound healing
4701433|NCT03229564|Tissue Engineering|tissue engineering
4701434|NCT03229564|Dermis|dermis
4701435|NCT03229564|Epidermis|epidermis
4701436|NCT03229564|Thermal Injuries|thermal injuries
4701437|NCT03229512|Hand Foot Skin Reaction|hand foot skin reaction
4701438|NCT03229512|Sildenafil|sildenafil
4701439|NCT03229499|Randomized Controlled Trial|randomized controlled trial
4701440|NCT03229499|clinical trial|clinical trial
4701441|NCT03229499|anastrozole|anastrozole
4701442|NCT03229499|pulmonary hypertension|pulmonary hypertension
4701443|NCT03229499|pulmonary arterial hypertension|pulmonary arterial hypertension
4701445|NCT03229486|emergence delirium|emergence delirium
4701446|NCT03229486|tonsillectomy|tonsillectomy
4701447|NCT03229473|Balance|balance
4701448|NCT03229473|Falls|falls
4701449|NCT03229473|Screening|screening
4701450|NCT03229473|COPD|copd
4701451|NCT03229434|affective responses|affective responses
4701452|NCT03229434|stress-related parameters|stress-related parameters
4701453|NCT03229434|green exercise|green exercise
4701454|NCT03229421|Zika Virus|zika virus
4701455|NCT03229408|Inflammation|inflammation
4701456|NCT03229408|Hyperandrogenism|hyperandrogenism
4701457|NCT03229408|Anovulation|anovulation
4701458|NCT03229408|Insulin Resistance|insulin resistance
4701459|NCT03229395|skeletal muscle|skeletal muscle
4701460|NCT03229395|muscle mass|muscle mass
4701461|NCT03229395|glucocorticoids|glucocorticoids
4701462|NCT03229395|biomarkers|biomarkers
4701463|NCT03229382|MCL, obinutuzumab|mcl, obinutuzumab
4701464|NCT03229369|ACL|acl
4701465|NCT03229369|ALL|all
4701466|NCT03229369|Ligament injury|ligament injury
4701467|NCT03229369|Reconstruction|reconstruction
4701468|NCT03229343|idiopathic pulmonary fibrosis, palliative care|idiopathic pulmonary fibrosis, palliative care
4701469|NCT03229330|Wound Healing|wound healing
4701470|NCT03229330|Outcome Assessment (Health Care)|outcome assessment (health care)
4701471|NCT03229317|Lung function|lung function
4701472|NCT03229317|Children|children
4701473|NCT03229317|Vitamin D|vitamin d
4701474|NCT03229317|COPD|copd
4701475|NCT03229291|SM04755|sm04755
4701476|NCT03229291|topical|topical
4701477|NCT03229291|Samumed|samumed
4701478|NCT03229291|Wnt inhibitor|wnt inhibitor
4701479|NCT03229226|Simulation|simulation
4701480|NCT03229226|Task Trainer|task trainer
4701481|NCT03229213|cystic fibrosis|cystic fibrosis
4701482|NCT03229213|video games|video games
4701483|NCT03229213|exercise|exercise
4702677|NCT03222076|BMS-936558|bms-936558
4701484|NCT03229213|maximal oxygen consumption|maximal oxygen consumption
4701485|NCT03229148|Anesthesia or Conscious sedation for Thrombectomy for Stroke|anesthesia or conscious sedation for thrombectomy for stroke
4701486|NCT03229148|Thrombectomy|thrombectomy
4701487|NCT03229148|Anesthesia|anesthesia
4701488|NCT03229148|Conscious sedation|conscious sedation
4701489|NCT03229148|Stroke|stroke
4701490|NCT03229122|ovarian cancer, gBRCAm|ovarian cancer, gbrcam
4701491|NCT03229109|dehydration|dehydration
4701492|NCT03229109|spectrophon|spectrophon
4701493|NCT03229109|device|device
4701494|NCT03229109|perspiration|perspiration
4701495|NCT03229096|gastric cancer|gastric cancer
4701496|NCT03229096|neoadjuvant chemotherapy|neoadjuvant chemotherapy
4701497|NCT03229096|apatinib|apatinib
4701498|NCT03229070|Thoracic Surgery|thoracic surgery
4701499|NCT03229070|Postoperative Period|postoperative period
4701500|NCT03229070|Rehabilitation|rehabilitation
4701501|NCT03229070|Early mobilization|early mobilization
4701502|NCT03229070|Cycle-ergometer|cycle-ergometer
4701503|NCT03229044|adipokine, tetranectin, lipid metabolism, body mass index|adipokine, tetranectin, lipid metabolism, body mass index
4701504|NCT03229031|spinal cord, spinal cord injury|spinal cord, spinal cord injury
4701505|NCT03229005|soft tissue; implant; abutment;|soft tissue; implant; abutment;
4701506|NCT03228966|Pediatric|pediatric
4701507|NCT03228953|Pharmacogenomic testing|pharmacogenomic testing
4701508|NCT03228953|Depression|depression
4701509|NCT03228940|Cardiovascular Disease, Renal Disease|cardiovascular disease, renal disease
4701510|NCT03228901|Oxytocin|oxytocin
4701511|NCT03228901|Affiliation|affiliation
4701512|NCT03228888|Rhythm|rhythm
4701513|NCT03228888|Ecological sounds|ecological sounds
4701514|NCT03228888|Auditory stimuli|auditory stimuli
4701515|NCT03228888|rhythmic auditory stimulation|rhythmic auditory stimulation
4701516|NCT03228888|Parkinson's Disease|parkinson's disease
4701517|NCT03228888|Gait|gait
4701518|NCT03228888|Gait analysis|gait analysis
4701519|NCT03228888|Spatio-temporal parameters|spatio-temporal parameters
4701520|NCT03228875|pregnancy outcomes, birth outcomes|pregnancy outcomes, birth outcomes
4701521|NCT03228849|Bony mallet injury|bony mallet injury
4701522|NCT03228849|Anchor suture|anchor suture
4701523|NCT03228849|Conservative treatment|conservative treatment
4701524|NCT03228849|DIP joint|dip joint
4701525|NCT03228823|Premature Ventricular contractions|premature ventricular contractions
4701526|NCT03228823|Cardiomyopathy|cardiomyopathy
4701527|NCT03228797|pain|pain
4701528|NCT03228771|PRGF|prgf
4701529|NCT03228771|Statins|statins
4701530|NCT03228771|socket augmentation|socket augmentation
4701531|NCT03228758|POEM|poem
4701532|NCT03228745|mindfulness based stress reduction|mindfulness based stress reduction
4701533|NCT03228745|total knee arthroplasty|total knee arthroplasty
4701534|NCT03228745|pre-operative|pre-operative
4701535|NCT03228719|Total Knee Replacement|total knee replacement
4701536|NCT03228719|Physical Therapy|physical therapy
4701537|NCT03228706|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
4701538|NCT03228706|Medication Adherence|medication adherence
4701539|NCT03228706|Malay patients|malay patients
4701540|NCT03228706|Structured Group-Based Intervention|structured group-based intervention
4701541|NCT03228706|Randomised controlled trial|randomised controlled trial
4701542|NCT03228693|Keloid|keloid
4701543|NCT03228667|Pembrolizumab|pembrolizumab
4701544|NCT03228667|Nivolumab|nivolumab
4701545|NCT03228667|Non-Small Cell Lung Cancer|non-small cell lung cancer
4701546|NCT03228667|Immunotherapy|immunotherapy
4701547|NCT03228667|Interleukin-15|interleukin-15
4701548|NCT03228667|PD-1 Checkpoint Inhibitor|pd-1 checkpoint inhibitor
4701549|NCT03228667|ALT-803|alt-803
4701550|NCT03228641|skin rejuvenation|skin rejuvenation
4701551|NCT03228641|wrinkle removal|wrinkle removal
4701552|NCT03228641|skin laxity reduction|skin laxity reduction
4701553|NCT03228628|Spinal puncture|spinal puncture
4701554|NCT03228628|Pain|pain
4701555|NCT03228628|Anxiety|anxiety
4701556|NCT03228628|Nitrous oxyde|nitrous oxyde
4701557|NCT03228615|shared decision making|shared decision making
4701558|NCT03228576|Tacrolimus|tacrolimus
4701559|NCT03228576|Envarsus|envarsus
4701560|NCT03228576|Everolimus|everolimus
4701561|NCT03228576|kidney|kidney
4701562|NCT03228576|Transplant|transplant
4701563|NCT03228550|omega-3 fatty acid|omega-3 fatty acid
4701564|NCT03228550|B vitamins|b vitamins
4701565|NCT03228550|vitamin E|vitamin e
4701566|NCT03228550|Phosphatidylserine|phosphatidylserine
4701567|NCT03228550|Gingko biloba|gingko biloba
4701568|NCT03228550|Gait|gait
4701569|NCT03228550|Aerobic Exercise|aerobic exercise
4701570|NCT03228550|Memory|memory
4701571|NCT03228550|Cognitive function|cognitive function
4701572|NCT03228485|Smartphone|smartphone
4701573|NCT03228485|Application|application
4701574|NCT03228485|Pilot|pilot
4701575|NCT03228485|mhealth|mhealth
4701576|NCT03228459|Kidney Diseases|kidney diseases
4701577|NCT03228459|Subclinical Disease and/or Syndrome|subclinical disease and/or syndrome
4701578|NCT03228459|Atherosclerosis|atherosclerosis
4701579|NCT03228459|Biomarkers|biomarkers
4701580|NCT03228459|Prevention|prevention
4701581|NCT03228459|Lung capacity|lung capacity
4701582|NCT03228459|Early diagnosis|early diagnosis
4701583|NCT03228459|Advanced glycation end products|advanced glycation end products
4701584|NCT03228459|Atrial fibrillation|atrial fibrillation
4701585|NCT03228459|Diabetes|diabetes
4701586|NCT03228459|Arterial ultrasound|arterial ultrasound
4701587|NCT03228446|training intervention|training intervention
4701588|NCT03228446|filter training|filter training
4701589|NCT03228446|distractor inhibition|distractor inhibition
4701590|NCT03228433|Drug Therapy|drug therapy
4701591|NCT03228394|Postpartum Care|postpartum care
4701592|NCT03228394|Postpartum Depression|postpartum depression
4701593|NCT03228381|Functional Mitral Regurgitation|functional mitral regurgitation
4701594|NCT03228381|Heart Failure|heart failure
4701595|NCT03228355|Levcromakalim|levcromakalim
4701596|NCT03228342|Rheumatoid Arthritis|rheumatoid arthritis
4701597|NCT03228342|Ultrasound|ultrasound
4701598|NCT03228342|Impact|impact
4701599|NCT03228329|cardiometry|cardiometry
4701600|NCT03228329|stroke volume|stroke volume
4701601|NCT03228329|liver transplantation|liver transplantation
4701602|NCT03228290|Cirrhosis|cirrhosis
4701603|NCT03228290|Liver|liver
4701604|NCT03228290|Liver Transplant|liver transplant
4701605|NCT03228290|Frailty|frailty
4701606|NCT03228290|end stage|end stage
4701607|NCT03228277|Extracellular vesicles|extracellular vesicles
4701608|NCT03228277|Bronchoalveolar lavage fluid|bronchoalveolar lavage fluid
4701609|NCT03228277|Liquid biopsy|liquid biopsy
4701610|NCT03228277|T790M|t790m
4701611|NCT03228277|NSCLC|nsclc
4701612|NCT03228277|Exosomes|exosomes
4701613|NCT03228277|EGFR mutation testing|egfr mutation testing
4701614|NCT03228199|Randomised Control Trial|randomised control trial
4701615|NCT03228199|Productivity|productivity
4701616|NCT03228199|Agricultural workers|agricultural workers
4701617|NCT03228199|India|india
4701618|NCT03228199|Vision correction|vision correction
4701619|NCT03228173|Cognition|cognition
4701620|NCT03228173|Executive functioning|executive functioning
4701621|NCT03228173|Depression|depression
4701622|NCT03228173|Affect|affect
4701623|NCT03228173|adult females|adult females
4701624|NCT03228160|Sympathetically Maintained Pain|sympathetically maintained pain
4701625|NCT03228160|Linear-Polarized Near-Infrared Irradiation|linear-polarized near-infrared irradiation
4701626|NCT03228160|Stellate Ganglion|stellate ganglion
4701627|NCT03228160|Heart Rate Variability|heart rate variability
4701628|NCT03228160|Autonomic Dysfunction Outcome|autonomic dysfunction outcome
4701629|NCT03228134|treatment； bronchial asthma|treatment； bronchial asthma
4701630|NCT03228108|Culture-guided|culture-guided
4701631|NCT03228108|Targeted prophylaxis|targeted prophylaxis
4701632|NCT03228108|Prostate biopsy|prostate biopsy
4701633|NCT03228108|Antibiotic prophylaxis|antibiotic prophylaxis
4701634|NCT03228095|Volatile Organic Compounds|volatile organic compounds
4701635|NCT03228095|Tuberculosis|tuberculosis
4701636|NCT03228095|Nano-sensors|nano-sensors
4701637|NCT03228095|Electronic nose|electronic nose
4701638|NCT03228095|Digestive cancers|digestive cancers
4701639|NCT03228082|Patient empowerment|patient empowerment
4701640|NCT03228082|Women's Health|women's health
4701641|NCT03228082|Home Blood Pressure Monitoring|home blood pressure monitoring
4701642|NCT03228069|rabies vaccination|rabies vaccination
4701643|NCT03228056|postoperative pain|postoperative pain
4701644|NCT03228056|videothoracoscopic surgery|videothoracoscopic surgery
4701645|NCT03228056|thoracic epidural analgesia|thoracic epidural analgesia
4701646|NCT03228056|lung lobectomy|lung lobectomy
4701647|NCT03228043|Apatinib|apatinib
4701648|NCT03228043|Outcome, Fatal|outcome, fatal
4701649|NCT03228043|Colorectal Cancer|colorectal cancer
4701650|NCT03228043|surgery|surgery
4701651|NCT03228043|adjuvant chemotherapy|adjuvant chemotherapy
4701652|NCT03228030|thiamine|thiamine
4701653|NCT03228030|heart failure|heart failure
4701654|NCT03228030|heart failure with reduced ejection fraction|heart failure with reduced ejection fraction
4701655|NCT03228030|geriatric|geriatric
4701656|NCT03228030|thiamin|thiamin
4701657|NCT03228030|vitamin b1|vitamin b1
4701658|NCT03228030|congestive heart failure|congestive heart failure
4701659|NCT03228017|cardiovascular disease|cardiovascular disease
4701660|NCT03228017|CVD|cvd
4701661|NCT03227991|Suicide|suicide
4701662|NCT03227978|pleurodesis|pleurodesis
4701663|NCT03227978|PCL|pcl
4701664|NCT03227965|cancer|cancer
4701665|NCT03227926|RAS|ras
4701666|NCT03227926|Panitumumab|panitumumab
4701667|NCT03227926|EGFR|egfr
4701668|NCT03227926|Clonal evolution|clonal evolution
4701669|NCT03227835|contrast-induced nephropathy|contrast-induced nephropathy
4701670|NCT03227835|contrast-induced acute kidney injury|contrast-induced acute kidney injury
4701671|NCT03227835|prophylaxis|prophylaxis
4701672|NCT03227835|intravenous hydration|intravenous hydration
4701673|NCT03227809|College student risk behavior prevention|college student risk behavior prevention
4701674|NCT03227809|Substance use|substance use
4701675|NCT03227809|Alcohol|alcohol
4701676|NCT03227809|Marijuana|marijuana
4701677|NCT03227809|Illicit drugs|illicit drugs
4701678|NCT03227809|Prescription drug misuse|prescription drug misuse
4701679|NCT03227809|Risky sexual behaviors|risky sexual behaviors
4701680|NCT03227796|osteoarthritis|osteoarthritis
4701681|NCT03227796|knee|knee
4701682|NCT03227796|healthy|healthy
4701683|NCT03227796|volunteer|volunteer
4701684|NCT03227796|LEVI-04|levi-04
4701685|NCT03227770|Hemoperfusion|hemoperfusion
4701686|NCT03227770|Hemodialysis|hemodialysis
4701687|NCT03227770|Mortality|mortality
4701688|NCT03227757|TRILUMINATE|triluminate
4701689|NCT03227757|Percutaneous transcatheter intervention|percutaneous transcatheter intervention
4701690|NCT03227757|Tricuspid regurgitation|tricuspid regurgitation
4701691|NCT03227757|Tricuspid Valve Repair System|tricuspid valve repair system
4701692|NCT03227744|Prostate Cancer, Anxiety|prostate cancer, anxiety
4701693|NCT03227731|Preexposure prophylaxis|preexposure prophylaxis
4701694|NCT03227731|safety|safety
4701695|NCT03227731|HIV prevention|hiv prevention
4701696|NCT03227731|pregnant women|pregnant women
4701697|NCT03227731|lactating women|lactating women
4701698|NCT03227718|VOR|vor
4701699|NCT03227705|Preterm birth|preterm birth
4701700|NCT03227705|Short cervix|short cervix
4701701|NCT03227705|Pessary|pessary
4701702|NCT03227705|Progesterone|progesterone
4701703|NCT03227679|Personalized Medicine|personalized medicine
4701704|NCT03227679|Nicotine Metabolite Ratio (NMR)|nicotine metabolite ratio (nmr)
4701705|NCT03227679|Varenicline|varenicline
4701706|NCT03227679|Nicotine Replacement Therapy (NRT)|nicotine replacement therapy (nrt)
4701707|NCT03227679|Smoking Cessation|smoking cessation
4701708|NCT03227679|Pharmacotherapy|pharmacotherapy
4701709|NCT03227666|Postural sway|postural sway
4701710|NCT03227666|Progressive balance exercise|progressive balance exercise
4701711|NCT03227666|RCT|rct
4701712|NCT03227666|Functional balance|functional balance
4701713|NCT03227653|Efavirenz|efavirenz
4701714|NCT03227653|Child Behavior|child behavior
4701715|NCT03227653|Cognition|cognition
4701716|NCT03227653|Medication Adherence|medication adherence
4701717|NCT03227653|Drug-Related Side Effects|drug-related side effects
4701718|NCT03227614|abortion|abortion
4701719|NCT03227614|social support|social support
4701720|NCT03227614|Anxiety|anxiety
4701721|NCT03227614|Pain|pain
4701722|NCT03227588|Fractional Flow Reserve|fractional flow reserve
4701723|NCT03227588|Percutaneous Coronary Intervention|percutaneous coronary intervention
4701724|NCT03227562|risperidone|risperidone
4701725|NCT03227562|anxiety|anxiety
4701726|NCT03227562|cognition|cognition
4701727|NCT03227562|stress|stress
4701728|NCT03227536|Neonatal asphyxia|neonatal asphyxia
4701729|NCT03227536|neonatal acidosis|neonatal acidosis
4701730|NCT03227536|fetal ECG|fetal ecg
4701731|NCT03227536|umbilical cord acid-base status|umbilical cord acid-base status
4701732|NCT03227523|low back pain|low back pain
4701733|NCT03227523|respiratory disorders|respiratory disorders
4701734|NCT03227523|pulmonary disease, chronic obstructive|pulmonary disease, chronic obstructive
4701735|NCT03227523|postural balance|postural balance
4701736|NCT03227523|functional laterality|functional laterality
4701737|NCT03227523|diaphragm|diaphragm
4701738|NCT03227510|Hepatocellular Carcinoma , MicroRNAs, Somalia|hepatocellular carcinoma , micrornas, somalia
4701739|NCT03227497|Blood Pressure|blood pressure
4701740|NCT03227497|Cholesterol|cholesterol
4701741|NCT03227497|Triglycerides|triglycerides
4701742|NCT03227497|Walnuts|walnuts
4701743|NCT03227458|areal bone mineral density|areal bone mineral density
4701744|NCT03227458|dehydroepiandrosterone (DHEA)|dehydroepiandrosterone (dhea)
4701745|NCT03227458|postmenopause|postmenopause
4701746|NCT03227458|exercise|exercise
4701747|NCT03227458|sex hormones|sex hormones
4701748|NCT03227445|DISKUS|diskus
4701749|NCT03227445|HandiHaler|handihaler
4701750|NCT03227445|COPD|copd
4701751|NCT03227445|Placebo|placebo
4701752|NCT03227445|Cross-over|cross-over
4701753|NCT03227445|Dry powder inhaler|dry powder inhaler
4701754|NCT03227445|ELLIPTA|ellipta
4701755|NCT03227432|Multiple Myeloma|multiple myeloma
4701756|NCT03227406|sleep|sleep
4701757|NCT03227406|memory|memory
4701758|NCT03227406|REM sleep|rem sleep
4701759|NCT03227406|slow wave sleep|slow wave sleep
4701760|NCT03227406|cognition|cognition
4701761|NCT03227406|sleep spindles|sleep spindles
4701762|NCT03227393|Heart Failure, Systolic|heart failure, systolic
4701763|NCT03227393|Defibrillators, Implantable|defibrillators, implantable
4701764|NCT03227393|Pacemaker, Artificial|pacemaker, artificial
4701765|NCT03227367|biomaterials|biomaterials
4701766|NCT03227367|apoptosis|apoptosis
4701767|NCT03227367|bone regeneration|bone regeneration
4701768|NCT03227354|Medical Device|medical device
4701769|NCT03227341|asthma control|asthma control
4701770|NCT03227341|pulmonary rehabilitation|pulmonary rehabilitation
4701771|NCT03227328|luminal B breast cancer|luminal b breast cancer
4701772|NCT03227328|metastatic breast cancer|metastatic breast cancer
4701773|NCT03227328|First line treatment|first line treatment
4701774|NCT03227328|endocrine therapy|endocrine therapy
4701775|NCT03227328|chemotherapy|chemotherapy
4701776|NCT03227328|randomized phase III trial|randomized phase iii trial
4701777|NCT03227328|aromatase inhibitor|aromatase inhibitor
4701778|NCT03227276|Litramine|litramine
4701779|NCT03227276|Opuntia ficus-indica|opuntia ficus-indica
4701780|NCT03227276|weight loss|weight loss
4701781|NCT03227263|Hemorrhagic Hereditary Telangiectasia (HHT)|hemorrhagic hereditary telangiectasia (hht)
4701782|NCT03227263|VEGF therapy|vegf therapy
4701783|NCT03227263|Bevacizumab|bevacizumab
4701784|NCT03227250|freezing of gait|freezing of gait
4702678|NCT03222076|Opdivo|opdivo
4701785|NCT03227250|Parkinson disease|parkinson disease
4701786|NCT03227250|GPi|gpi
4701787|NCT03227237|Impact, Interpersonal Relationship, Juvenile delinquency|impact, interpersonal relationship, juvenile delinquency
4701788|NCT03227211|COPD exacerbated|copd exacerbated
4701789|NCT03227211|Readmission|readmission
4701790|NCT03227211|Prospective cohort study|prospective cohort study
4701791|NCT03227211|Nested case control study|nested case control study
4701792|NCT03227211|Clinical prediction rules|clinical prediction rules
4701793|NCT03227159|Acute Myocardial Infarction|acute myocardial infarction
4701794|NCT03227159|Troponin|troponin
4701795|NCT03227159|Emergency department|emergency department
4701796|NCT03227146|Burns|burns
4701797|NCT03227146|Scar|scar
4701798|NCT03227146|Skin|skin
4701799|NCT03227146|Wound healing|wound healing
4701800|NCT03227146|Tissue Engineering|tissue engineering
4701801|NCT03227146|Dermis|dermis
4701802|NCT03227146|Epidermis|epidermis
4701803|NCT03227146|Thermal Injuries|thermal injuries
4701804|NCT03227120|Exercise Therapy|exercise therapy
4701805|NCT03227094|Diabetes|diabetes
4701806|NCT03227094|Screening test|screening test
4701807|NCT03227094|Continuous glucose monitoring|continuous glucose monitoring
4701808|NCT03227094|Oral glucose tolerance test|oral glucose tolerance test
4701809|NCT03227068|pediatric oncology|pediatric oncology
4701810|NCT03227068|parent|parent
4701811|NCT03227055|Arterial stiffness, children, chronic kidney disease, hypertension, microRNA|arterial stiffness, children, chronic kidney disease, hypertension, microrna
4701812|NCT03227042|Sanfilippo Syndrome Type B|sanfilippo syndrome type b
4701813|NCT03227042|MPS IIIB|mps iiib
4701814|NCT03227042|MPS 3 B|mps 3 b
4701815|NCT03226990|pressure area|pressure area
4701816|NCT03226990|polyether elastomeric impression|polyether elastomeric impression
4701817|NCT03226990|wax spacer|wax spacer
4701818|NCT03226964|endobronchial ultrasound|endobronchial ultrasound
4701819|NCT03226964|high flow nasal oxygen|high flow nasal oxygen
4701820|NCT03226938|dietary patterns|dietary patterns
4701821|NCT03226938|dietary adherence|dietary adherence
4701822|NCT03226938|popular diets|popular diets
4701823|NCT03226938|Paleo|paleo
4701824|NCT03226938|vegan|vegan
4701825|NCT03226938|behavior change|behavior change
4701826|NCT03226938|adherence|adherence
4701827|NCT03226938|compliance|compliance
4701828|NCT03226938|vegetarian|vegetarian
4701829|NCT03226938|low carb|low carb
4701830|NCT03226938|low-carb|low-carb
4701831|NCT03226938|whole food plant-based|whole food plant-based
4701832|NCT03226938|social ecological model|social ecological model
4701833|NCT03226925|thoracic tumors|thoracic tumors
4701834|NCT03226925|motion management|motion management
4701835|NCT03226925|radiotherapy|radiotherapy
4701836|NCT03226925|ventilator|ventilator
4701837|NCT03226873|HIV prevention|hiv prevention
4701838|NCT03226873|PrEP|prep
4701839|NCT03226873|peer navigation|peer navigation
4701840|NCT03226873|women|women
4701841|NCT03226847|Atrial Fibrillation, Athletes, Pulmonary Vein Isolation|atrial fibrillation, athletes, pulmonary vein isolation
4701842|NCT03226821|HIV Lipodystrophy|hiv lipodystrophy
4701843|NCT03226821|Tesamorelin|tesamorelin
4701844|NCT03226821|Body Composition|body composition
4701845|NCT03226821|Visceral Adiposity|visceral adiposity
4701846|NCT03226795|Cystic fibrosis|cystic fibrosis
4701847|NCT03226795|Therapeutic adherence|therapeutic adherence
4701848|NCT03226795|Co-constructed intervention|co-constructed intervention
4701849|NCT03226795|Patient involvement|patient involvement
4701850|NCT03226743|stepped and collaborative care|stepped and collaborative care
4701851|NCT03226743|cluster-randomized controlled trial|cluster-randomized controlled trial
4701852|NCT03226743|health services research|health services research
4701853|NCT03226743|evidence-based medicine|evidence-based medicine
4701854|NCT03226743|complex intervention|complex intervention
4701855|NCT03226743|guideline implementation|guideline implementation
4701856|NCT03226743|collaborative network|collaborative network
4701857|NCT03226730|Female Adolescent|female adolescent
4701858|NCT03226730|Married|married
4701859|NCT03226730|West Africa|west africa
4701860|NCT03226730|Family Planning|family planning
4701861|NCT03226730|Contraceptive Use|contraceptive use
4701862|NCT03226730|Birth Spacing|birth spacing
4701863|NCT03226704|CD19|cd19
4701864|NCT03226704|CD22|cd22
4701865|NCT03226704|CD19/22|cd19/22
4701866|NCT03226704|Immunotherapy|immunotherapy
4701867|NCT03226704|Apheresis|apheresis
4701868|NCT03226691|Plerixafor|plerixafor
4701869|NCT03226691|Leukapheresis|leukapheresis
4701870|NCT03226691|Mobilization|mobilization
4701871|NCT03226691|Stem Cells|stem cells
4701872|NCT03226691|Sickle Cell Disease|sickle cell disease
4701873|NCT03226665|obstruction|obstruction
4701874|NCT03226665|small bowel|small bowel
4701875|NCT03226665|ultrasound|ultrasound
4701876|NCT03226639|Atrial Fibrillation|atrial fibrillation
4701877|NCT03226639|First Ablation|first ablation
4701878|NCT03226626|Tumescent|tumescent
4701879|NCT03226626|Lidocaine|lidocaine
4701880|NCT03226626|Epinephrine|epinephrine
4701881|NCT03226626|Cefazolin|cefazolin
4701882|NCT03226626|Metronidazole|metronidazole
4701883|NCT03226626|Surgical Site Infection|surgical site infection
4701884|NCT03226626|Thrombosis|thrombosis
4701888|NCT03226613|Human Papillomavirus|human papillomavirus
4701889|NCT03226613|Oropharyngeal Cancer|oropharyngeal cancer
4701890|NCT03226613|Base of Tongue Cancer|base of tongue cancer
4701891|NCT03226613|Tonsil Cancer|tonsil cancer
4701892|NCT03226600|Gingival Recession|gingival recession
4701893|NCT03226600|Connective Tissue Graft|connective tissue graft
4701894|NCT03226600|OrACELL|oracell
4701895|NCT03226600|Decellularized Dermis|decellularized dermis
4701896|NCT03226600|Periodontics|periodontics
4701897|NCT03226587|blue light|blue light
4701898|NCT03226587|blood pressure|blood pressure
4701899|NCT03226587|vascular function|vascular function
4701900|NCT03226587|endothelial function|endothelial function
4701901|NCT03226587|health volunteers|health volunteers
4701902|NCT03226574|Resiniferatoxin|resiniferatoxin
4701903|NCT03226574|RTX|rtx
4701904|NCT03226574|Cancer pain|cancer pain
4701905|NCT03226548|Earned Income Tax Credit (EITC)|earned income tax credit (eitc)
4701906|NCT03226548|Tax Credit|tax credit
4701907|NCT03226548|Paycheck Plus|paycheck plus
4701908|NCT03226535|Computer Assisted Instrument Guidance (CAIG)|computer assisted instrument guidance (caig)
4701909|NCT03226535|Ultrasound-CT Fusion|ultrasound-ct fusion
4701910|NCT03226535|Image Fusion|image fusion
4701911|NCT03226535|Clear Guide SCENERGY|clear guide scenergy
4701912|NCT03226535|Needle path|needle path
4701913|NCT03226535|Needle Guidance|needle guidance
4701914|NCT03226535|CT|ct
4701915|NCT03226535|Ultrasound|ultrasound
4701916|NCT03226509|cascade of care|cascade of care
4701917|NCT03226483|Brain Metastases|brain metastases
4701918|NCT03226483|Intraoperative Radiotherapy|intraoperative radiotherapy
4701919|NCT03226483|Neurosurgery|neurosurgery
4701920|NCT03226470|Transcription Activator-like Effector Nucleases|transcription activator-like effector nucleases
4701921|NCT03226470|Human papillomavirus|human papillomavirus
4701922|NCT03226470|cervical intraepithelial neoplasia|cervical intraepithelial neoplasia
4701923|NCT03226457|Heart Failure|heart failure
4701924|NCT03226457|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
4701925|NCT03226457|Sodium-Glucose co-Transporter 2 (SGLT2) inhibitors|sodium-glucose co-transporter 2 (sglt2) inhibitors
4701926|NCT03226457|Natriuresis|natriuresis
4701927|NCT03226457|Diuresis|diuresis
4701928|NCT03226444|Dry Eye|dry eye
4701929|NCT03226444|Primary Sjogren's Syndrome|primary sjogren's syndrome
4701930|NCT03226444|Sjogren's Syndrome|sjogren's syndrome
4701931|NCT03226405|Cancer|cancer
4701932|NCT03226392|QAW039, uncontrolled asthma|qaw039, uncontrolled asthma
4701933|NCT03226366|door-to-antibiotic time|door-to-antibiotic time
4701934|NCT03226366|emergency department care|emergency department care
4701935|NCT03226366|antimicrobial|antimicrobial
4701936|NCT03226366|care reorganization|care reorganization
4701937|NCT03226366|severe sepsis|severe sepsis
4701938|NCT03226366|swarming|swarming
4701939|NCT03226314|bacterial multi-resitance|bacterial multi-resitance
4701940|NCT03226288|Plantar Fascitis|plantar fascitis
4701941|NCT03226288|orthopedic|orthopedic
4701942|NCT03226288|3D surface scanning|3d surface scanning
4701943|NCT03226275|Concor AM®|concor am®
4701944|NCT03226275|Concor®|concor®
4701945|NCT03226275|Norvasc®|norvasc®
4701946|NCT03226275|Bisoprolol|bisoprolol
4701947|NCT03226275|Amlodipine|amlodipine
4701948|NCT03226275|Bisoprolol-Amlodipine fixed dose combination|bisoprolol-amlodipine fixed dose combination
4701949|NCT03226275|Chinese Subjects|chinese subjects
4701950|NCT03226236|Carcinoma, Renal Cell|carcinoma, renal cell
4701951|NCT03226236|vaccination|vaccination
4701952|NCT03226236|dendritic cells|dendritic cells
4701953|NCT03226236|autologous tumor homogenate|autologous tumor homogenate
4701954|NCT03226236|High Dose -IL2|high dose -il2
4701955|NCT03226236|immunomodulating radiotherapy|immunomodulating radiotherapy
4701956|NCT03226236|secondary|secondary
4701957|NCT03226210|Diabetes Mellitus|diabetes mellitus
4701958|NCT03226210|Rapid-acting insulin analogues|rapid-acting insulin analogues
4701959|NCT03226210|Continuous glucose monitoring system (CGMS)|continuous glucose monitoring system (cgms)
4701960|NCT03226210|Continuous subcutaneous insulin infusion (CSII)|continuous subcutaneous insulin infusion (csii)
4701961|NCT03226184|Er:YAG laser, laser, biofilm removal, biofilm, disinfection, septic revision surgery|er:yag laser, laser, biofilm removal, biofilm, disinfection, septic revision surgery
4701962|NCT03226158|Next generation pathogen sequencing (NGPS)|next generation pathogen sequencing (ngps)
4701963|NCT03226158|Pediatric|pediatric
4701964|NCT03226158|Cancer|cancer
4701965|NCT03226158|Bloodstream infection (BSI)|bloodstream infection (bsi)
4701966|NCT03226119|HTLV|htlv
4701967|NCT03226119|Confirmatory|confirmatory
4701968|NCT03226119|Supplemental|supplemental
4701969|NCT03226119|Blot|blot
4701970|NCT03226119|HTLV-I|htlv-i
4701971|NCT03226119|HTLV-II|htlv-ii
4701972|NCT03226106|Rehabilitation|rehabilitation
4701973|NCT03226106|Total Knee Arthroplasty|total knee arthroplasty
4701974|NCT03226106|Telemedicine|telemedicine
4701975|NCT03226106|Physical Activity|physical activity
4701976|NCT03226054|Proton Pump Inhibitor|proton pump inhibitor
4701977|NCT03226041|transcutaneous carbon dioxide|transcutaneous carbon dioxide
4701978|NCT03226041|retroperitoneoscopic|retroperitoneoscopic
4701979|NCT03226041|urologic surgery|urologic surgery
4701980|NCT03226041|anesthesia|anesthesia
4701981|NCT03226015|Limbal Stem-cell Deficiency|limbal stem-cell deficiency
4701982|NCT03226015|Oral mucosa transplantation|oral mucosa transplantation
4701983|NCT03226015|Amniotic membrane|amniotic membrane
4701984|NCT03226015|Mesenchymal stem cells|mesenchymal stem cells
4701985|NCT03226002|Airtraq NT|airtraq nt
4701986|NCT03226002|nasotracheal intubation|nasotracheal intubation
4701987|NCT03226002|right|right
4701988|NCT03226002|left|left
4701989|NCT03225976|Phototherapy|phototherapy
4701990|NCT03225976|Athletic Performance|athletic performance
4701991|NCT03225976|Muscle Strength|muscle strength
4701992|NCT03225976|Fatigue|fatigue
4701993|NCT03225963|Glioblastoma|glioblastoma
4701994|NCT03225963|Bevacizumab|bevacizumab
4701995|NCT03225950|Periodontal disease|periodontal disease
4701996|NCT03225950|Periodontitis|periodontitis
4701997|NCT03225950|Aggressive periodontitis|aggressive periodontitis
4701998|NCT03225950|Dysbiosis|dysbiosis
4701999|NCT03225950|Inflammation|inflammation
4702000|NCT03225950|Regulation|regulation
4702001|NCT03225950|Cytokines|cytokines
4702002|NCT03225950|Bacteria|bacteria
4702003|NCT03225950|Porphyromonas gingivalis|porphyromonas gingivalis
4702004|NCT03225950|Saliva|saliva
4702005|NCT03225950|Anti-CCP|anti-ccp
4702006|NCT03225950|Peptidyl arginine deiminases|peptidyl arginine deiminases
4702007|NCT03225950|Single nucleotide polymorphisms|single nucleotide polymorphisms
4702008|NCT03225898|blood flow restriction|blood flow restriction
4702009|NCT03225898|resistance exercise|resistance exercise
4702010|NCT03225885|gestational age|gestational age
4702011|NCT03225885|multi-media|multi-media
4702012|NCT03225885|mobile application|mobile application
4702013|NCT03225885|anxiety|anxiety
4702014|NCT03225885|clinical trial|clinical trial
4702015|NCT03225885|random allocation|random allocation
4702016|NCT03225872|Osteosarcoma|osteosarcoma
4702017|NCT03225872|Bone cancer|bone cancer
4702018|NCT03225872|Family-based study|family-based study
4702019|NCT03225859|Stress Disorders, Posttraumatic|stress disorders, posttraumatic
4702020|NCT03225859|Self-Management|self-management
4702021|NCT03225820|pharmacogenomic information|pharmacogenomic information
4702022|NCT03225807|Intubated|intubated
4702023|NCT03225807|Intubation|intubation
4702024|NCT03225807|Ventilator|ventilator
4702025|NCT03225807|Ventilator-free days|ventilator-free days
4702026|NCT03225807|Ventilator free days|ventilator free days
4702027|NCT03225807|Mechanical Ventilation|mechanical ventilation
4702028|NCT03225807|Meta-Analysis|meta-analysis
4702029|NCT03225807|Tidal Volume|tidal volume
4702030|NCT03225807|Tidal Volumes|tidal volumes
4702031|NCT03225807|inflammation|inflammation
4702032|NCT03225807|cytokines|cytokines
4702033|NCT03225807|Pulmonary Infiltrate|pulmonary infiltrate
4702034|NCT03225807|Pulmonary Infiltrates|pulmonary infiltrates
4702035|NCT03225807|Low Tidal Volumes|low tidal volumes
4702036|NCT03225807|Protective Ventilation|protective ventilation
4702037|NCT03225794|Retrovirus|retrovirus
4702038|NCT03225794|Viral emergence|viral emergence
4702039|NCT03225755|Growth Hormone Deficiency|growth hormone deficiency
4702040|NCT03225755|Adipose Tissue|adipose tissue
4702041|NCT03225755|Inflammation|inflammation
4702042|NCT03225716|Waldenstrom's Macroglobulinemia|waldenstrom's macroglobulinemia
4702043|NCT03225703|Exercise|exercise
4702044|NCT03225703|Osteoporosis|osteoporosis
4702045|NCT03225703|Osteoarthritis|osteoarthritis
4702047|NCT03225703|DXA|dxa
4702048|NCT03225703|High Impact|high impact
4702049|NCT03225703|Cartilage|cartilage
4702050|NCT03225703|Bone|bone
4702051|NCT03225664|Non-Small Cell Lung Cancer|non-small cell lung cancer
4702052|NCT03225664|NSCLC|nsclc
4702053|NCT03225664|Trametinib|trametinib
4702054|NCT03225664|GSK1120212|gsk1120212
4702055|NCT03225664|Pembrolizumab|pembrolizumab
4702056|NCT03225664|Keytruda|keytruda
4702057|NCT03225664|MK-3475|mk-3475
4702058|NCT03225664|SCH-900475|sch-900475
4702059|NCT03225664|Metastatic|metastatic
4702060|NCT03225664|Unresectable|unresectable
4702061|NCT03225664|Locally advanced|locally advanced
4702062|NCT03225664|Recurrent|recurrent
4702063|NCT03225651|Stem cell|stem cell
4702064|NCT03225651|Autism|autism
4702065|NCT03225651|Psychological|psychological
4702066|NCT03225651|Rehabilitation|rehabilitation
4702067|NCT03225625|spinal cord injury|spinal cord injury
4702068|NCT03225625|spinal cord compression|spinal cord compression
4702069|NCT03225625|spinal cord ischemia|spinal cord ischemia
4702070|NCT03225625|spinal cord diseases|spinal cord diseases
4702071|NCT03225625|spinal paralysis|spinal paralysis
4702072|NCT03225625|paraplegia|paraplegia
4702073|NCT03225625|paraparesis|paraparesis
4702074|NCT03225586|Non-communicable Diseases, Risk Factors|non-communicable diseases, risk factors
4702075|NCT03225573|second mesiobuccal canal CBCT prevalence population|second mesiobuccal canal cbct prevalence population
4702076|NCT03225560|Smart Phone Application|smart phone application
4702077|NCT03225560|Bowel Preparation|bowel preparation
4702078|NCT03225560|Colorectal Cancer Screening|colorectal cancer screening
4702079|NCT03225547|HER-2 negative breast cancer|her-2 negative breast cancer
4702080|NCT03225547|breast cancer|breast cancer
4702081|NCT03225547|pembrolizumab|pembrolizumab
4702082|NCT03225547|mifepristone|mifepristone
4702083|NCT03225534|Asthma|asthma
4702084|NCT03225534|Allergy|allergy
4702085|NCT03225534|Epidemiology|epidemiology
4702086|NCT03225534|Environment|environment
4702087|NCT03225534|Exposures|exposures
4702088|NCT03225521|Physical Activity|physical activity
4702089|NCT03225521|Mobile Health|mobile health
4702090|NCT03225521|Self Monitoring|self monitoring
4702091|NCT03225521|Wearable Sensors|wearable sensors
4702092|NCT03225521|Tailored Health Communication|tailored health communication
4702093|NCT03225521|Implementation Intentions|implementation intentions
4702094|NCT03225521|Mobile Apps|mobile apps
4702095|NCT03225521|Anti-Sedentary Behavior|anti-sedentary behavior
4702096|NCT03225521|Opportunistic Physical Activity|opportunistic physical activity
4702097|NCT03225521|Health Belief Model|health belief model
4702098|NCT03225482|Mild Cognitive Impairment|mild cognitive impairment
4702099|NCT03225482|Cognitive rehabilitation|cognitive rehabilitation
4702100|NCT03225482|Cognitive training|cognitive training
4702101|NCT03225482|Cognitive remediation|cognitive remediation
4702102|NCT03225469|Bowel Preparation|bowel preparation
4702103|NCT03225469|Colonoscopy|colonoscopy
4702104|NCT03225469|Quality|quality
4702105|NCT03225469|Family Support|family support
4702106|NCT03225469|Education|education
4702107|NCT03225456|appetite regulation|appetite regulation
4702108|NCT03225456|obesity|obesity
4702109|NCT03225456|oxytocin|oxytocin
4702110|NCT03225443|Locally advanced cervical cancer|locally advanced cervical cancer
4702111|NCT03225443|Particle radiotherapy|particle radiotherapy
4702112|NCT03225443|Neoadjuvant Chemotherapy|neoadjuvant chemotherapy
4702113|NCT03225417|Ixazomib|ixazomib
4702114|NCT03225404|Tendinopathy|tendinopathy
4702115|NCT03225404|Electrolysis|electrolysis
4702116|NCT03225404|Exercise|exercise
4702117|NCT03225404|Dry needing|dry needing
4702118|NCT03225391|Residents|residents
4702119|NCT03225391|Naps|naps
4702120|NCT03225391|decision making|decision making
4702121|NCT03225378|Fluid responsiveness|fluid responsiveness
4702122|NCT03225378|Passive leg raising|passive leg raising
4702123|NCT03225378|Pulse pressure variation|pulse pressure variation
4702124|NCT03225365|Melanoma|melanoma
4702125|NCT03225365|Nivolumab|nivolumab
4702126|NCT03225365|Ipilimumab|ipilimumab
4702127|NCT03225365|Immune modulation|immune modulation
4702128|NCT03225326|articaine|articaine
4702129|NCT03225326|local anesthesia|local anesthesia
4702130|NCT03225326|AMSA|amsa
4702131|NCT03225300|Glioblastoma|glioblastoma
4702132|NCT03225300|Chemoradiation|chemoradiation
4702133|NCT03225300|Simultaneous integrated boost|simultaneous integrated boost
4702134|NCT03225274|Breathing exercises|breathing exercises
4702135|NCT03225274|Respiratory status|respiratory status
4702136|NCT03225274|Nebulization therapy|nebulization therapy
4702137|NCT03225274|lower respiratory tract disorders|lower respiratory tract disorders
4702138|NCT03225235|Prostate cancer, SBRT, Ultrafractionation, CyberKnife|prostate cancer, sbrt, ultrafractionation, cyberknife
4702139|NCT03225222|Prostate cancer|prostate cancer
4702140|NCT03225222|multivariate risk assessment|multivariate risk assessment
4702141|NCT03225222|MRI|mri
4702142|NCT03225222|biopsy|biopsy
4702143|NCT03225222|screening|screening
4702144|NCT03225222|multicenter|multicenter
4702145|NCT03225209|Roux-en-y gastric bypass|roux-en-y gastric bypass
4702146|NCT03225209|GLP-1|glp-1
4702147|NCT03225209|Liraglutide|liraglutide
4702148|NCT03225209|OPTIFAST|optifast
4702149|NCT03225196|Extracellular RNA|extracellular rna
4702150|NCT03225196|MicroRNA|microrna
4702151|NCT03225183|TOPMed|topmed
4702152|NCT03225183|Blood Pressure|blood pressure
4702153|NCT03225183|Long Noncoding RNA|long noncoding rna
4702154|NCT03225183|Gene Expression|gene expression
4702155|NCT03225183|MicroRNA|microrna
4702156|NCT03225170|BRCA1|brca1
4702157|NCT03225170|BRCA2|brca2
4702158|NCT03225170|Clinical Decision-Making|clinical decision-making
4702159|NCT03225157|Audiogram|audiogram
4702160|NCT03225157|Statins|statins
4702161|NCT03225157|Drug Response|drug response
4702162|NCT03225157|Cancer Treatment|cancer treatment
4702163|NCT03225157|Head and Neck Cancer|head and neck cancer
4702164|NCT03225144|Motor Neuron Disease|motor neuron disease
4702165|NCT03225144|Frontotemporal Dementia|frontotemporal dementia
4702166|NCT03225144|Corticobasal Syndrome|corticobasal syndrome
4702167|NCT03225131|Age Related Macular Degeneration|age related macular degeneration
4702168|NCT03225131|Dark Adaptation|dark adaptation
4702169|NCT03225118|Rebound|rebound
4702170|NCT03225118|Reinitiation|reinitiation
4702171|NCT03225118|ART|art
4702172|NCT03225118|Reservoirs|reservoirs
4702173|NCT03225118|Immune Exhaustion|immune exhaustion
4702174|NCT03225105|Solid Tumors|solid tumors
4702175|NCT03225105|M3541|m3541
4702176|NCT03225105|Palliative radiotherapy|palliative radiotherapy
4702177|NCT03225105|Adenosine triphosphate-competitive inhibitor|adenosine triphosphate-competitive inhibitor
4702178|NCT03225092|Chronic Knee Pain|chronic knee pain
4702179|NCT03225092|Status-Post Total Knee Arthroplasty|status-post total knee arthroplasty
4702180|NCT03225092|Platelet Rich Plasma|platelet rich plasma
4702181|NCT03225079|Pentaglobin® use|pentaglobin® use
4702182|NCT03225079|severe bacterial infection|severe bacterial infection
4702183|NCT03225053|Percutaneous microelectrolysis|percutaneous microelectrolysis
4702184|NCT03225053|Physiotherapy|physiotherapy
4702187|NCT03225040|Osteoporosis|osteoporosis
4702188|NCT03225027|Emotional prosody, schizophrenia|emotional prosody, schizophrenia
4702189|NCT03225001|Sapien XT|sapien xt
4702190|NCT03225001|Partner II|partner ii
4702191|NCT03225001|cardiovascular disease|cardiovascular disease
4702192|NCT03225001|heart disease|heart disease
4702193|NCT03225001|aortic disease|aortic disease
4702194|NCT03225001|SAVR|savr
4702195|NCT03225001|TAVR|tavr
4702196|NCT03225001|failing surgical valve|failing surgical valve
4702197|NCT03225001|failing valve|failing valve
4702198|NCT03225001|failing bioprosthetic valve|failing bioprosthetic valve
4702199|NCT03224988|Alzheimer's Disease|alzheimer's disease
4702200|NCT03224988|AD|ad
4702201|NCT03224988|MCI-AD|mci-ad
4702202|NCT03224988|MCI|mci
4702203|NCT03224988|Memory|memory
4702204|NCT03224988|TMS|tms
4702205|NCT03224988|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
4702206|NCT03224988|Neuropsychological evaluation|neuropsychological evaluation
4702207|NCT03224988|MRI|mri
4702208|NCT03224988|DTI|dti
4702209|NCT03224988|EEG|eeg
4702210|NCT03224975|Pain|pain
4702211|NCT03224975|Brain responses|brain responses
4702212|NCT03224975|Neuroimaging|neuroimaging
4702213|NCT03224975|fMRI|fmri
4702214|NCT03224975|Burn|burn
4702215|NCT03224975|Memory|memory
4702216|NCT03224962|pit and fissure caries|pit and fissure caries
4702217|NCT03224936|DISE|dise
4702218|NCT03224936|OSAS|osas
4702219|NCT03224936|PSI|psi
4702220|NCT03224910|FNA, smears, imprints, ROSE|fna, smears, imprints, rose
4702221|NCT03224897|Reappraisal|reappraisal
4702222|NCT03224897|Emotion Regulation|emotion regulation
4702223|NCT03224897|tDCS|tdcs
4702224|NCT03224897|Reinterpretation|reinterpretation
4702225|NCT03224858|Patient-Centered Care|patient-centered care
4702226|NCT03224858|Comorbidity|comorbidity
4702227|NCT03224754|Atypia, thyroid, malignancy|atypia, thyroid, malignancy
4702228|NCT03224741|Behavioral Economics|behavioral economics
4702229|NCT03224702|M6495|m6495
4702230|NCT03224702|anti-A disintegrin and metalloproteinase with thrombospondin motifs-5 nanobody|anti-a disintegrin and metalloproteinase with thrombospondin motifs-5 nanobody
4702231|NCT03224702|Osteoarthritis|osteoarthritis
4702232|NCT03224676|Quality of sleep|quality of sleep
4702233|NCT03224676|Perceived sleep distractors|perceived sleep distractors
4702234|NCT03224676|Adult patients|adult patients
4702235|NCT03224663|Effectiveness|effectiveness
4702236|NCT03224663|Module based learning|module based learning
4702237|NCT03224663|Mobile application based learning|mobile application based learning
4702238|NCT03224663|Facility based newborn care|facility based newborn care
4702239|NCT03224663|Knowledge|knowledge
4702240|NCT03224663|Practices|practices
4702241|NCT03224663|Nursing students|nursing students
4702242|NCT03224585|anakinra|anakinra
4702243|NCT03224585|Kineret|kineret
4702244|NCT03224585|pericarditis|pericarditis
4702245|NCT03224572|vitamin C|vitamin c
4702246|NCT03224572|quality of life|quality of life
4702247|NCT03224572|terminal cancer|terminal cancer
4702248|NCT03224533|nut consumption|nut consumption
4702249|NCT03224533|NHANES|nhanes
4702250|NCT03224533|epidemiology|epidemiology
4702251|NCT03224533|plasma glucose|plasma glucose
4702252|NCT03224533|hemoglobin A1c|hemoglobin a1c
4702253|NCT03224507|multiple myeloma|multiple myeloma
4702254|NCT03224507|induction therapy|induction therapy
4702255|NCT03224507|autologous hematopoietic cell transplantation|autologous hematopoietic cell transplantation
4702256|NCT03224507|KRdD|krdd
4702257|NCT03224507|Daratumumab|daratumumab
4702258|NCT03224507|Carfilzomib|carfilzomib
4702259|NCT03224507|Lenalidomide|lenalidomide
4702260|NCT03224468|medical marijuana|medical marijuana
4702261|NCT03224468|cannabis|cannabis
4702262|NCT03224468|pain|pain
4702263|NCT03224468|insomnia|insomnia
4702264|NCT03224468|depression|depression
4702265|NCT03224468|anxiety|anxiety
4702266|NCT03224468|addiction|addiction
4702267|NCT03224468|dependence|dependence
4702268|NCT03224468|neurocognition|neurocognition
4702269|NCT03224468|MRI|mri
4702270|NCT03224455|sleep|sleep
4702271|NCT03224455|sleep in children|sleep in children
4702272|NCT03224455|children and sleep|children and sleep
4702273|NCT03224455|environment|environment
4702274|NCT03224455|environment and sleep|environment and sleep
4702275|NCT03224455|environment and children|environment and children
4702276|NCT03224416|Alcohol|alcohol
4702277|NCT03224416|Delay Discounting|delay discounting
4702278|NCT03224416|Risky Sexual Behavior|risky sexual behavior
4702279|NCT03224416|Decision Making|decision making
4702280|NCT03224416|MSM|msm
4702281|NCT03224390|Contraception|contraception
4702282|NCT03224390|Family Planning|family planning
4702283|NCT03224390|Digital Health|digital health
4702284|NCT03224390|Kenya|kenya
4702285|NCT03224390|Unmet Need|unmet need
4702286|NCT03224364|Solo surgery|solo surgery
4702287|NCT03224364|Camera holder|camera holder
4702288|NCT03224364|Laparoscopic Appendectomy|laparoscopic appendectomy
4702289|NCT03224325|Drug therapy|drug therapy
4702290|NCT03224312|Primary aldosteronism|primary aldosteronism
4702291|NCT03224312|cardiovascular events|cardiovascular events
4702292|NCT03224312|cerebrovascular events|cerebrovascular events
4702293|NCT03224286|Pressure sensitive mat|pressure sensitive mat
4702294|NCT03224273|proximal box design preparation|proximal box design preparation
4702295|NCT03224247|vertical splitting|vertical splitting
4702296|NCT03224247|Cesarean Section Complications|cesarean section complications
4702297|NCT03224247|uterine vessels|uterine vessels
4702298|NCT03224247|injury|injury
4702299|NCT03224234|Uncontrolled Type 2 Diabetes|uncontrolled type 2 diabetes
4702300|NCT03224234|Insulclock|insulclock
4702301|NCT03224234|Electronic device|electronic device
4702302|NCT03224234|Alarm system|alarm system
4702303|NCT03224221|esophageal squamous cell carcinoma|esophageal squamous cell carcinoma
4702304|NCT03224221|apatinib|apatinib
4702305|NCT03224208|melanoma|melanoma
4702306|NCT03224208|advanced|advanced
4702307|NCT03224208|vemurafenib|vemurafenib
4702308|NCT03224208|cobimetinib|cobimetinib
4702309|NCT03224195|rehabilitation|rehabilitation
4702310|NCT03224195|patient perspective|patient perspective
4702311|NCT03224195|semi-structured interview|semi-structured interview
4702312|NCT03224143|dementia|dementia
4702313|NCT03224143|doll therapy|doll therapy
4702314|NCT03224143|attachment|attachment
4702315|NCT03224130|transitions of care|transitions of care
4702316|NCT03224130|reutilization|reutilization
4702317|NCT03224130|nurse phone call|nurse phone call
4702318|NCT03224104|elderly|elderly
4702319|NCT03224104|TG02|tg02
4702320|NCT03224104|newly diagnosed|newly diagnosed
4702321|NCT03224104|first relapse|first relapse
4702322|NCT03224091|Eating disorders|eating disorders
4702323|NCT03224091|psychopathology|psychopathology
4702324|NCT03224091|pathophysiology|pathophysiology
4702325|NCT03224091|prospective|prospective
4702326|NCT03224091|longitudinal|longitudinal
4702327|NCT03224052|Anti-Bacterial Agents|anti-bacterial agents
4702328|NCT03224052|Falciparum|falciparum
4702329|NCT03224052|Vivax|vivax
4702330|NCT03224000|Malignant neoplasms of lip oral cavity and pharynx|malignant neoplasms of lip oral cavity and pharynx
4702331|NCT03224000|Oropharyngeal Cancer|oropharyngeal cancer
4702332|NCT03224000|Human papilloma virus positive|human papilloma virus positive
4702333|NCT03224000|HPV+|hpv+
4702334|NCT03224000|Squamous cell carcinoma of the oropharynx|squamous cell carcinoma of the oropharynx
4702335|NCT03224000|Squamous cell carcinoma of the tonsil|squamous cell carcinoma of the tonsil
4702336|NCT03224000|Squamous cell carcinoma of the base of tongue|squamous cell carcinoma of the base of tongue
4702337|NCT03224000|Squamous cell carcinoma of the soft palate|squamous cell carcinoma of the soft palate
4702338|NCT03224000|Squamous cell carcinoma of the oropharyngeal walls|squamous cell carcinoma of the oropharyngeal walls
4702339|NCT03224000|Magnetic Resonance Imaging Guided Radiotherapy|magnetic resonance imaging guided radiotherapy
4702340|NCT03224000|Standard of Care Radiotherapy Planning|standard of care radiotherapy planning
4702341|NCT03224000|Radiation Therapy|radiation therapy
4702342|NCT03224000|Intensity modulated radiotherapy|intensity modulated radiotherapy
4702343|NCT03224000|IMRT|imrt
4702344|NCT03224000|Modified Barium Swallow|modified barium swallow
4702345|NCT03224000|MBS|mbs
4702346|NCT03224000|Swallowing questionnaire|swallowing questionnaire
4702347|NCT03224000|The M.D. Anderson Dysphagia Inventory (MDADI)|the m.d. anderson dysphagia inventory (mdadi)
4702348|NCT03224000|Symptom questionnaire|symptom questionnaire
4702349|NCT03224000|The M.D. Anderson Symptom Inventory for Head and Neck Cancer (MDASI-HN)|the m.d. anderson symptom inventory for head and neck cancer (mdasi-hn)
4702350|NCT03224000|Video-Strobe Procedure|video-strobe procedure
4702351|NCT03223987|16S rRNA|16s rrna
4702352|NCT03223987|Microbiome|microbiome
4702353|NCT03223987|Strath Herbal Yeast Preparation|strath herbal yeast preparation
4702354|NCT03223974|Angioplasty|angioplasty
4702355|NCT03223974|drug-coated balloon|drug-coated balloon
4702356|NCT03223974|bifurcation|bifurcation
4702357|NCT03223961|myelodysplastic syndrome|myelodysplastic syndrome
4702358|NCT03223961|erythropoetin|erythropoetin
4702359|NCT03223922|whole brain radiation therapy|whole brain radiation therapy
4702360|NCT03223922|genu of corpus callosum|genu of corpus callosum
4702361|NCT03223922|cognitive function|cognitive function
4702362|NCT03223909|dry eye|dry eye
4702363|NCT03223909|Chondroitin sulfate|chondroitin sulfate
4702364|NCT03223909|Ocular lubricants|ocular lubricants
4702365|NCT03223896|antagonist|antagonist
4702366|NCT03223896|nasal|nasal
4702367|NCT03223857|visual outcomes|visual outcomes
4702368|NCT03223857|multifocal intraocular lens|multifocal intraocular lens
4702369|NCT03223857|patient satisfaction|patient satisfaction
4702370|NCT03223857|spectacle independence|spectacle independence
4702371|NCT03223844|Dopamine|dopamine
4702372|NCT03223844|Amphetamine|amphetamine
4702373|NCT03223844|Positron Emission Tomography|positron emission tomography
4702374|NCT03223844|Magnetic Resonance Imaging|magnetic resonance imaging
4702375|NCT03223844|Schizophrenia|schizophrenia
4702376|NCT03223844|Psychosis|psychosis
4702377|NCT03223844|[18F]FDOPA|[18f]fdopa
4702378|NCT03223844|[11C]-(+)-PHNO|[11c]-(+)-phno
4702379|NCT03223831|unresectable malignant gastric outlet obstruction|unresectable malignant gastric outlet obstruction
4702380|NCT03223831|Partially covered pyloro-duodenal stents|partially covered pyloro-duodenal stents
4702381|NCT03223831|uncovered pyloro-duodenal stents|uncovered pyloro-duodenal stents
4702382|NCT03223818|Liver|liver
4702383|NCT03223818|Digestive system|digestive system
4702384|NCT03223779|Colorectal Cancer|colorectal cancer
4702385|NCT03223766|Proton therapy|proton therapy
4702386|NCT03223766|Long-term effects|long-term effects
4702387|NCT03223727|Radium-223|radium-223
4702388|NCT03223714|Conbercept ophthalmic injection|conbercept ophthalmic injection
4702389|NCT03223714|ME|me
4702390|NCT03223714|CRVO|crvo
4702391|NCT03223662|Neoadjuvant Chemoradiotherapy (nCRT)|neoadjuvant chemoradiotherapy (ncrt)
4702392|NCT03223662|Esophagectomy|esophagectomy
4702393|NCT03223662|Tissue or serologic biomarkers|tissue or serologic biomarkers
4702394|NCT03223649|Metabolism|metabolism
4702395|NCT03223649|Children|children
4702396|NCT03223649|Walking Bouts|walking bouts
4702397|NCT03223649|Glucose|glucose
4702398|NCT03223649|Insulin|insulin
4702399|NCT03223636|Transcranial Magnetic Stimulation (TMS)|transcranial magnetic stimulation (tms)
4702400|NCT03223636|Magnetic Resonance Imaging (MRI)|magnetic resonance imaging (mri)
4702401|NCT03223636|Electroencephalogram (EEG)|electroencephalogram (eeg)
4702402|NCT03223636|Magnetoencephalogram|magnetoencephalogram
4702403|NCT03223636|Transcranial Electrical Stimulation (TES)|transcranial electrical stimulation (tes)
4702404|NCT03223623|Complex Regional Pain Syndrome|complex regional pain syndrome
4702405|NCT03223623|CRPS|crps
4702406|NCT03223623|Dystonia|dystonia
4702407|NCT03223610|Monoclonal Antibody|monoclonal antibody
4702408|NCT03223610|Dose-Finding|dose-finding
4702409|NCT03223597|Radium-223|radium-223
4702410|NCT03223597|quality of life|quality of life
4702411|NCT03223597|Pain|pain
4702412|NCT03223571|stroke|stroke
4702413|NCT03223571|Upper arm|upper arm
4702414|NCT03223571|Cerebral plasticity|cerebral plasticity
4702415|NCT03223571|Functional connectivity|functional connectivity
4702416|NCT03223571|Rehabilitation|rehabilitation
4702417|NCT03223558|cardiac rehabilitation|cardiac rehabilitation
4702418|NCT03223545|mindfulness-based cognitive therapy|mindfulness-based cognitive therapy
4702419|NCT03223545|Meditation|meditation
4702420|NCT03223519|DOMS|doms
4702421|NCT03223519|Exercise|exercise
4702422|NCT03223519|Ibuprofen|ibuprofen
4702423|NCT03223519|Magnesium|magnesium
4702424|NCT03223519|Vitamin C|vitamin c
4702425|NCT03223519|Muscle pain|muscle pain
4702426|NCT03223467|Obesity|obesity
4702427|NCT03223467|Obstructive sleep apnea|obstructive sleep apnea
4702428|NCT03223467|Bariatric surgery candidate|bariatric surgery candidate
4702429|NCT03223467|Metabolic syndrome|metabolic syndrome
4702430|NCT03223441|Pulse wave velocity|pulse wave velocity
4702431|NCT03223441|anesthesia|anesthesia
4702432|NCT03223415|Clostridium difficile infection|clostridium difficile infection
4702433|NCT03223415|Infection Control|infection control
4702434|NCT03223415|Prevention|prevention
4702435|NCT03223415|Asymptomatic carriage|asymptomatic carriage
4702436|NCT03223415|Colonization|colonization
4702437|NCT03223415|Pilot Study|pilot study
4702438|NCT03223415|Contact Precaution|contact precaution
4702439|NCT03223415|Detection|detection
4702440|NCT03223363|Birth weight Prediction|birth weight prediction
4702441|NCT03223363|Two-dimensional Ultrasonography|two-dimensional ultrasonography
4702442|NCT03223363|Three-dimensional Ultrasonography|three-dimensional ultrasonography
4702443|NCT03223337|GSK1278863|gsk1278863
4702444|NCT03223337|Daprodustat|daprodustat
4702445|NCT03223337|Healthy control|healthy control
4702446|NCT03223337|Single dose|single dose
4702447|NCT03223337|Hepatic Impairment|hepatic impairment
4702448|NCT03223324|Threatened Premature Labor|threatened premature labor
4702449|NCT03223324|Abdominal Fetal ECG|abdominal fetal ecg
4702450|NCT03223298|Myofascial Pain|myofascial pain
4702451|NCT03223298|Myofascial Pain Disorder|myofascial pain disorder
4702452|NCT03223298|Maxillofacial Pain|maxillofacial pain
4702453|NCT03223298|Masseter Muscle|masseter muscle
4702454|NCT03223298|Temporalis Muscle|temporalis muscle
4702455|NCT03223298|Botulinum Toxin|botulinum toxin
4702456|NCT03223285|Cervical spine;|cervical spine;
4702457|NCT03223285|Diaphragm;|diaphragm;
4702458|NCT03223285|Manual Therapy|manual therapy
4702459|NCT03223285|Pain|pain
4702460|NCT03223285|Range of Motion|range of motion
4702461|NCT03223272|hypertension|hypertension
4702462|NCT03223272|sympathetic tone|sympathetic tone
4702463|NCT03223272|resperpine|resperpine
4702464|NCT03223259|Dance Injuries|dance injuries
4702465|NCT03223259|Injury Prevention Workshops|injury prevention workshops
4702466|NCT03223259|Motor Skill Theory|motor skill theory
4702467|NCT03223259|Gross Motor Skills|gross motor skills
4702468|NCT03223220|Stroke, Neuroprotection, Ketamine|stroke, neuroprotection, ketamine
4702469|NCT03223194|Crigler-Najjar|crigler-najjar
4702470|NCT03223194|CN|cn
4702471|NCT03223194|AAV8 Delivered Gene Transfer|aav8 delivered gene transfer
4702472|NCT03223194|Adeno Associated Virus|adeno associated virus
4702473|NCT03223181|Comiss|comiss
4702474|NCT03223155|Small cell lung cancer|small cell lung cancer
4702475|NCT03223155|ipilimumab|ipilimumab
4702476|NCT03223155|nivolumab|nivolumab
4702477|NCT03223155|stereotactic body radiotherapy|stereotactic body radiotherapy
4702478|NCT03223129|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
4702479|NCT03223129|Impaired glucose tolerance|impaired glucose tolerance
4702480|NCT03223129|Metabolomics|metabolomics
4702481|NCT03223116|heartburn|heartburn
4702482|NCT03223116|regurgitation|regurgitation
4702483|NCT03223103|Brain cancer|brain cancer
4702484|NCT03223103|Glioblastoma|glioblastoma
4702485|NCT03223103|Personalized vaccine|personalized vaccine
4702486|NCT03223103|Poly-ICLC|poly-iclc
4702487|NCT03223103|Immunotherapy|immunotherapy
4702488|NCT03223103|Cancer|cancer
4702489|NCT03223103|NovoTTF-200A|novottf-200a
4702490|NCT03223103|Optune|optune
4702491|NCT03223103|GBM|gbm
4702492|NCT03223103|immunogenicity|immunogenicity
4702493|NCT03223090|Language|language
4702494|NCT03223090|learning|learning
4702495|NCT03223090|plasticity|plasticity
4702496|NCT03223051|Spinal Muscular Atrophy|spinal muscular atrophy
4702497|NCT03223051|Children|children
4702498|NCT03223051|Motor assessment|motor assessment
4702499|NCT03223051|Space exploration|space exploration
4702500|NCT03223051|Upper limbs|upper limbs
4702501|NCT03223038|Nutrition|nutrition
4702502|NCT03223025|IGHD|ighd
4702503|NCT03223025|somatropin|somatropin
4702504|NCT03223012|Adalimumab|adalimumab
4702505|NCT03223012|Humira®|humira®
4702506|NCT03223012|AbbVie patient care support program|abbvie patient care support program
4702507|NCT03223012|Psoriasis and ankylosing spondylitis|psoriasis and ankylosing spondylitis
4702508|NCT03223012|Rheumatoid Arthritis|rheumatoid arthritis
4702509|NCT03223012|Ulcerative Colitis|ulcerative colitis
4702510|NCT03222999|Out-of-Hospital Cardiac Arrest|out-of-hospital cardiac arrest
4702511|NCT03222986|sepsis, nanoparticle tracking analysis|sepsis, nanoparticle tracking analysis
4702512|NCT03222973|Remyelination|remyelination
4702513|NCT03222973|Re-myelination|re-myelination
4702514|NCT03222973|DMT|dmt
4702515|NCT03222973|LINGO-1|lingo-1
4702516|NCT03222973|Anti-LINGO-1|anti-lingo-1
4702517|NCT03222973|Opicinumab|opicinumab
4702518|NCT03222921|high tibial osteotomy|high tibial osteotomy
4702519|NCT03222908|Behavior|behavior
4702520|NCT03222908|Perioperative/Postoperative Complications|perioperative/postoperative complications
4702521|NCT03222908|contract agreement|contract agreement
4702522|NCT03222908|implementation intentions|implementation intentions
4702523|NCT03222908|precommitment|precommitment
4702524|NCT03222908|smoking cessation|smoking cessation
4702525|NCT03222895|Esophageal Neoplasms|esophageal neoplasms
4702526|NCT03222895|Lymph node metastases|lymph node metastases
4702527|NCT03222895|Esophagectomy|esophagectomy
4702528|NCT03222843|ITP|itp
4702529|NCT03222804|Infants|infants
4702530|NCT03222804|Probiotic|probiotic
4702531|NCT03222804|B. Infantis|b. infantis
4702532|NCT03222791|Diabetes|diabetes
4702533|NCT03222778|fluid responsiveness|fluid responsiveness
4702534|NCT03222778|tissue doppler|tissue doppler
4702535|NCT03222778|off-pump coronary bypass surgery|off-pump coronary bypass surgery
4702536|NCT03222765|prediabetes lifestyle drugs microvascular complications|prediabetes lifestyle drugs microvascular complications
4702537|NCT03222752|Alpha-Stim|alpha-stim
4702538|NCT03222752|Cranial Electrotherapy Stimulation|cranial electrotherapy stimulation
4702539|NCT03222752|CES|ces
4702540|NCT03222726|exercise, diabetic kidney disease, complications|exercise, diabetic kidney disease, complications
4702541|NCT03222687|tacrolimus, Henoch-Schönlein purpura nephritis, children|tacrolimus, henoch-schönlein purpura nephritis, children
4702542|NCT03222674|AML|aml
4702543|NCT03222674|CAR T|car t
4702544|NCT03222674|Muc1, CD33, CD38, CD56, and/or CD123|muc1, cd33, cd38, cd56, and/or cd123
4702545|NCT03222648|Idiopathic Pulmonary Fibrosis|idiopathic pulmonary fibrosis
4702546|NCT03222648|Exercise training|exercise training
4702547|NCT03222648|Health related quality of life|health related quality of life
4702548|NCT03222648|Biomarkers|biomarkers
4702549|NCT03222635|Barrett's esophagus|barrett's esophagus
4702550|NCT03222635|Submucosal esophageal adenocarcinoma|submucosal esophageal adenocarcinoma
4702551|NCT03222635|Endoscopic treatment|endoscopic treatment
4702552|NCT03222635|Endoscopic follow-up|endoscopic follow-up
4702553|NCT03222622|EGFR inhibitor, topical agent, psoriasis, phase 2|egfr inhibitor, topical agent, psoriasis, phase 2
4702554|NCT03222609|Post-polycythemia vera MF (PPV-MF)|post-polycythemia vera mf (ppv-mf)
4702555|NCT03222609|Post-essential thrombocythemia (PET-MF)|post-essential thrombocythemia (pet-mf)
4702556|NCT03222609|ruxolitinib|ruxolitinib
4702557|NCT03222609|navitoclax|navitoclax
4702558|NCT03222609|splenic volume|splenic volume
4702559|NCT03222609|Primary Myelofibrosis|primary myelofibrosis
4702560|NCT03222609|Jakafi|jakafi
4702561|NCT03222609|enlarged spleen|enlarged spleen
4702562|NCT03222609|splenomegaly|splenomegaly
4702563|NCT03222609|ABT 263|abt 263
4702564|NCT03222609|bone marrow fibrosis|bone marrow fibrosis
4702565|NCT03222596|Quality of Life|quality of life
4702566|NCT03222596|Fatigue|fatigue
4702567|NCT03222596|Physical Disability|physical disability
4702568|NCT03222596|Disabilities Psychological|disabilities psychological
4702569|NCT03222596|Pain|pain
4702570|NCT03222596|Motivation|motivation
4702571|NCT03222596|Multiple sclerosis|multiple sclerosis
4702572|NCT03222583|Chronic Hepatitis C Virus (HCV)|chronic hepatitis c virus (hcv)
4702573|NCT03222583|Genotype 1 to 6|genotype 1 to 6
4702574|NCT03222583|Asian|asian
4702575|NCT03222583|non-cirrhotic|non-cirrhotic
4702576|NCT03222583|Human Immunodeficiency Virus|human immunodeficiency virus
4702577|NCT03222583|co-infection|co-infection
4702578|NCT03222583|Treatment-naïve|treatment-naïve
4702579|NCT03222583|Treatment-experienced|treatment-experienced
4702580|NCT03222583|interferon|interferon
4702581|NCT03222544|Indocyanine Green|indocyanine green
4702582|NCT03222544|Photodynamics Therapy|photodynamics therapy
4702583|NCT03222518|acute pain, trauma, paracetamol, NSAID|acute pain, trauma, paracetamol, nsaid
4702584|NCT03222505|Stroke|stroke
4702585|NCT03222505|Gait Stride Management Assist|gait stride management assist
4702586|NCT03222505|Stroke, post 1 year or longer|stroke, post 1 year or longer
4702587|NCT03222492|Diffuse Cutaneous Systemic Sclerosis (dcSSc)|diffuse cutaneous systemic sclerosis (dcssc)
4702588|NCT03222492|Phase 1/2 clinical trial|phase 1/2 clinical trial
4702589|NCT03222492|dose escalation randomized trial|dose escalation randomized trial
4702590|NCT03222492|Brentuximab vedotin|brentuximab vedotin
4702591|NCT03222466|Patient educational materials; prostate cancer; co-creation|patient educational materials; prostate cancer; co-creation
4702592|NCT03222453|thalassemia|thalassemia
4702593|NCT03222453|stem cell|stem cell
4702594|NCT03222388|IIEF|iief
4702595|NCT03222388|electronic validation|electronic validation
4702596|NCT03222375|Yaroshuk's MEGA-DISCOVERY · DIAGNOSTICS · TREATMENT|yaroshuk's mega-discovery · diagnostics · treatment
4702597|NCT03222375|Yaroshuk's Scientific Medical School|yaroshuk's scientific medical school
4702598|NCT03222375|Center of Synergetics|center of synergetics
4702599|NCT03222375|Controlling spatiotemporal chaos/Dr. Synergetic|controlling spatiotemporal chaos/dr. synergetic
4702600|NCT03222375|Autowave processes in Medicine|autowave processes in medicine
4702601|NCT03222375|Autowave Reverberator|autowave reverberator
4702602|NCT03222375|Bifurcation of Dynamic systems on a plane|bifurcation of dynamic systems on a plane
4702603|NCT03222375|Spiral Autowaves|spiral autowaves
4702604|NCT03222375|Drift of Spiral Autowaves|drift of spiral autowaves
4702605|NCT03222375|Excitable medium and Cellular Automata|excitable medium and cellular automata
4702606|NCT03222375|Stochastic Resonance and Coherence Resonance|stochastic resonance and coherence resonance
4702607|NCT03222375|Autowaves/SQUED|autowaves/squed
4702608|NCT03222375|Theory of Semiconducting QUantum Excitonic Device|theory of semiconducting quantum excitonic device
4702609|NCT03222362|retinal detachment|retinal detachment
4702610|NCT03222362|trauma|trauma
4702611|NCT03222362|age related macular degeneration|age related macular degeneration
4702612|NCT03222349|interictal state|interictal state
4702613|NCT03222349|ictal/peri-ictal state|ictal/peri-ictal state
4702614|NCT03222323|volunteers|volunteers
4702615|NCT03222284|diabetes|diabetes
4702616|NCT03222284|type 2 diabetes|type 2 diabetes
4702617|NCT03222284|type ii diabetes|type ii diabetes
4702618|NCT03222284|insulin|insulin
4702619|NCT03222284|mobile applications|mobile applications
4702620|NCT03222284|Diabetes Mellitus|diabetes mellitus
4702621|NCT03222284|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
4702622|NCT03222284|smartphone application|smartphone application
4702623|NCT03222284|health application|health application
4702624|NCT03222271|NIV weaning strategy|niv weaning strategy
4702625|NCT03222258|Palliative Care|palliative care
4702626|NCT03222258|Quality of Life|quality of life
4702627|NCT03222258|Prospective Cohort Study|prospective cohort study
4702628|NCT03222258|Treatment decision|treatment decision
4702629|NCT03222258|Utilization of health care|utilization of health care
4702630|NCT03222232|intestinal failure|intestinal failure
4702631|NCT03222232|catheter-related bloodstream infections|catheter-related bloodstream infections
4702632|NCT03222232|catheter salvage|catheter salvage
4702633|NCT03222232|recurrent infections|recurrent infections
4702634|NCT03222232|home parenteral support|home parenteral support
4702635|NCT03222219|dental implant insertional torque stability|dental implant insertional torque stability
4702636|NCT03222206|Hepatokine|hepatokine
4702637|NCT03222206|Adipokine|adipokine
4702638|NCT03222206|Saccharometabolism|saccharometabolism
4702639|NCT03222206|Lipid metabolism|lipid metabolism
4702640|NCT03222193|Medical device|medical device
4702641|NCT03222193|Retraining|retraining
4702642|NCT03222193|Snoring|snoring
4702643|NCT03222193|TRP|trp
4702644|NCT03222193|Tongue|tongue
4702645|NCT03222167|Elbasvir|elbasvir
4702646|NCT03222167|Grazoprevir|grazoprevir
4702647|NCT03222167|SVR12|svr12
4702648|NCT03222167|hepatitis C|hepatitis c
4702649|NCT03222167|metabolic syndrome|metabolic syndrome
4702650|NCT03222154|High Energy Shock Waves|high energy shock waves
4702651|NCT03222154|physiotherapy|physiotherapy
4702652|NCT03222141|Sapien 3|sapien 3
4702653|NCT03222141|Transfemoral|transfemoral
4702654|NCT03222141|Transapical|transapical
4702655|NCT03222141|Transaortic|transaortic
4702656|NCT03222141|TAVI|tavi
4702657|NCT03222141|Aortic Stenosis|aortic stenosis
4702658|NCT03222141|THV|thv
4702659|NCT03222141|Aortic Valve|aortic valve
4702660|NCT03222141|Transcatheter Heart Valve|transcatheter heart valve
4702661|NCT03222141|TAVR|tavr
4702662|NCT03222128|SAPIEN 3|sapien 3
4702663|NCT03222128|Transfemoral|transfemoral
4702664|NCT03222128|Transapical|transapical
4702665|NCT03222128|Transaortic|transaortic
4702666|NCT03222128|NovaFlex|novaflex
4702667|NCT03222128|TAVI|tavi
4702668|NCT03222128|Aortic Stenosis|aortic stenosis
4702669|NCT03222128|THV|thv
4702670|NCT03222128|Aortic Valve|aortic valve
4702671|NCT03222128|Transcatheter Heart Valve|transcatheter heart valve
4702672|NCT03222128|TAVR|tavr
4702673|NCT03222076|Hepatocellular carcinoma|hepatocellular carcinoma
4702674|NCT03222076|Resectable|resectable
4702675|NCT03222076|Potentially resectable|potentially resectable
4702679|NCT03222076|Ipilimumab|ipilimumab
4702680|NCT03222076|Yervoy|yervoy
4702681|NCT03222076|BMS-734016|bms-734016
4702682|NCT03222076|MDX010|mdx010
4702683|NCT03222063|Play interventions, anxiety|play interventions, anxiety
4702684|NCT03222024|ischaemic stroke|ischaemic stroke
4702685|NCT03222024|severe|severe
4702686|NCT03222024|malignant|malignant
4702687|NCT03222024|courses|courses
4702688|NCT03222024|risk factors|risk factors
4702689|NCT03222024|clinical course|clinical course
4702690|NCT03222024|management|management
4702691|NCT03222024|prognosis|prognosis
4702692|NCT03222011|Crohn Disease|crohn disease
4702693|NCT03222011|Inflammatory Bowel Disease|inflammatory bowel disease
4702694|NCT03222011|Intestinal stricture|intestinal stricture
4702695|NCT03221998|morbidly obese|morbidly obese
4702696|NCT03221998|,elective sleeve|,elective sleeve
4702697|NCT03221998|gastrectomy|gastrectomy
4702698|NCT03221998|paracetamol|paracetamol
4702699|NCT03221998|IV Perfelgan|iv perfelgan
4702700|NCT03221985|experience sampling method|experience sampling method
4702701|NCT03221972|25 hydroxyvitamin D|25 hydroxyvitamin d
4702702|NCT03221972|6-17 years old|6-17 years old
4702703|NCT03221972|vitamin D deficiency|vitamin d deficiency
4702704|NCT03221959|malignant middle cerebral artery infarction|malignant middle cerebral artery infarction
4702705|NCT03221920|Very Low Carbohydrate Diet|very low carbohydrate diet
4702706|NCT03221920|Colorectal Adenocarcinoma|colorectal adenocarcinoma
4702707|NCT03221894|Complementary therapies|complementary therapies
4702708|NCT03221868|motor activity|motor activity
4702709|NCT03221868|women|women
4702710|NCT03221842|Antibody-mediated kidney transplant rejection|antibody-mediated kidney transplant rejection
4702711|NCT03221842|Renal|renal
4702712|NCT03221829|spinal anaesthesia|spinal anaesthesia
4702713|NCT03221829|elderly patients|elderly patients
4702714|NCT03221829|transurethral resection of bladder tumour|transurethral resection of bladder tumour
4702715|NCT03221816|Menopause|menopause
4702716|NCT03221816|homocysteine|homocysteine
4702717|NCT03221816|lipid profile|lipid profile
4702718|NCT03221790|Irritable bowel syndrome|irritable bowel syndrome
4702719|NCT03221790|Low FODMAP diet|low fodmap diet
4702720|NCT03221790|Mucosal Inflammation|mucosal inflammation
4702721|NCT03221751|randomized controlled trial|randomized controlled trial
4702722|NCT03221738|BDD|bdd
4702723|NCT03221725|sacrospinous ligament fixation|sacrospinous ligament fixation
4702724|NCT03221725|stress urinary incontinence|stress urinary incontinence
4702725|NCT03221712|cardiopulmonary exercise test|cardiopulmonary exercise test
4702726|NCT03221712|chronic total occlusion|chronic total occlusion
4702727|NCT03221712|cardiac rehabilitation|cardiac rehabilitation
4702728|NCT03221673|Exercise|exercise
4702729|NCT03221673|Children|children
4702730|NCT03221673|Arkansas|arkansas
4702731|NCT03221673|Physical activity|physical activity
4702732|NCT03221673|Sedentary|sedentary
4702733|NCT03221660|filling material, polymerization|filling material, polymerization
4702734|NCT03221647|Celiac Disease; P31-43; Loxorubine; TLR7.|celiac disease; p31-43; loxorubine; tlr7.
4702735|NCT03221634|Programmed cell death 1 receptor (PD1)|programmed cell death 1 receptor (pd1)
4702736|NCT03221634|PD-1|pd-1
4702737|NCT03221634|Programmed cell death ligand 1 receptor (PDL1)|programmed cell death ligand 1 receptor (pdl1)
4702738|NCT03221634|PD-L1|pd-l1
4702739|NCT03221621|Acne inversa|acne inversa
4702740|NCT03221621|Adalimumab|adalimumab
4702741|NCT03221621|Cost-effectiveness|cost-effectiveness
4702742|NCT03221608|Colorectal Cancer|colorectal cancer
4702743|NCT03221608|HIPEC|hipec
4702744|NCT03221608|Peritoneal Carcinomatosis|peritoneal carcinomatosis
4702745|NCT03221608|Lobaplatin|lobaplatin
4702746|NCT03221556|Comparative effectiveness research|comparative effectiveness research
4702747|NCT03221556|Patient-centered medical home|patient-centered medical home
4702748|NCT03221556|Shared decision-making|shared decision-making
4702749|NCT03221530|suicidal ideation|suicidal ideation
4702750|NCT03221530|mental health|mental health
4702751|NCT03221530|adolescent|adolescent
4702752|NCT03221530|Latino|latino
4702753|NCT03221530|immigrant|immigrant
4702754|NCT03221504|urinary tract infections|urinary tract infections
4702755|NCT03221504|pyelonephritis|pyelonephritis
4702756|NCT03221504|cefuroxime|cefuroxime
4702757|NCT03221504|children|children
4702758|NCT03221491|Analgesia|analgesia
4702759|NCT03221491|Colorectal Surgery|colorectal surgery
4702760|NCT03221491|Background Infusion|background infusion
4702761|NCT03221439|back pain|back pain
4702762|NCT03221439|physiotherapy|physiotherapy
4702763|NCT03221439|exercise therapy|exercise therapy
4702764|NCT03221439|cognitive functional therapy|cognitive functional therapy
4702765|NCT03221439|low back pain|low back pain
4702766|NCT03221439|backache|backache
4702767|NCT03221439|lower back pain|lower back pain
4702768|NCT03221439|lumbago|lumbago
4702769|NCT03221439|multidimensional|multidimensional
4702770|NCT03221439|biopsychosocial|biopsychosocial
4702771|NCT03221426|PD1|pd1
4702772|NCT03221426|PD-1|pd-1
4702773|NCT03221426|PDL1|pdl1
4702774|NCT03221426|PD-L1|pd-l1
4702775|NCT03221413|transcranial alternating current stimulation|transcranial alternating current stimulation
4702776|NCT03221413|Neuroimaging|neuroimaging
4702777|NCT03221413|EEG|eeg
4702778|NCT03221387|Therapy|therapy
4702779|NCT03221387|Noninvasive Ventilation|noninvasive ventilation
4702780|NCT03221335|EUS-guided RFA|eus-guided rfa
4702781|NCT03221335|liver|liver
4702782|NCT03221335|stomach|stomach
4702783|NCT03221335|adrenal|adrenal
4702784|NCT03221335|kidney tumour|kidney tumour
4702785|NCT03221283|Music therapy|music therapy
4702786|NCT03221283|Depression|depression
4702787|NCT03221283|Emotion|emotion
4702788|NCT03221283|Motivation|motivation
4702789|NCT03221270|tACS|tacs
4702790|NCT03221270|Sham|sham
4702791|NCT03221270|Auditory Hallucinations|auditory hallucinations
4702792|NCT03221270|Schizophrenia|schizophrenia
4702793|NCT03221270|Schizo Affective Disorder|schizo affective disorder
4702794|NCT03221270|EEG|eeg
4702795|NCT03221244|Distractibility|distractibility
4702796|NCT03221244|Virtual Reality|virtual reality
4702797|NCT03221244|Attention|attention
4702798|NCT03221244|Child|child
4702799|NCT03221244|Pediatric|pediatric
4702800|NCT03221205|sleep apnea, obstructive|sleep apnea, obstructive
4702801|NCT03221205|obesity|obesity
4702802|NCT03221205|DM2|dm2
4702803|NCT03221205|TEI index|tei index
4702804|NCT03221205|CPAP|cpap
4702805|NCT03221192|Real-time data capture|real-time data capture
4702806|NCT03221192|Concept elicitation|concept elicitation
4702807|NCT03221192|Nasal polyps|nasal polyps
4702808|NCT03221192|Cognitive debriefing|cognitive debriefing
4702809|NCT03221192|Patient-reported outcomes|patient-reported outcomes
4702810|NCT03221192|HRQoL|hrqol
4702811|NCT03221166|Children|children
4702812|NCT03221166|Crohn disease|crohn disease
4702813|NCT03221166|Thalidomide|thalidomide
4702814|NCT03221166|Mucosal healing|mucosal healing
4702815|NCT03221153|Patient Safety|patient safety
4702816|NCT03221153|Quality|quality
4702817|NCT03221153|Simulation|simulation
4702818|NCT03221153|Undergraduate|undergraduate
4702819|NCT03221153|Medical Student|medical student
4702820|NCT03221114|Hispanics/Latinos|hispanics/latinos
4702821|NCT03221114|Underserved Population|underserved population
4702822|NCT03221075|Invasive Aspergillosis|invasive aspergillosis
4702823|NCT03221075|Azole resistance|azole resistance
4702824|NCT03221075|Aspergillus fumigatus|aspergillus fumigatus
4702825|NCT03221075|Efficacy of antifungal therapy|efficacy of antifungal therapy
4702826|NCT03221075|Patient registry|patient registry
4702827|NCT03221049|diagnosis performance|diagnosis performance
4702828|NCT03221049|hepatocellular carcinoma|hepatocellular carcinoma
4702829|NCT03221049|liver fibrosis|liver fibrosis
4702830|NCT03221049|progression|progression
4702831|NCT03221036|Drug therapy|drug therapy
4702832|NCT03221023|Vancomycin|vancomycin
4702833|NCT03221023|Implantable Neural Stimulator|implantable neural stimulator
4702834|NCT03221023|Deep Brain Stimulation|deep brain stimulation
4702835|NCT03221023|Surgical Site Infection|surgical site infection
4702836|NCT03221010|Smoking|smoking
4702837|NCT03221010|Smoking cessation|smoking cessation
4702838|NCT03221010|Motivational Interviewing|motivational interviewing
4702839|NCT03221010|Primary health care|primary health care
4702840|NCT03221010|Randomized clinical trial|randomized clinical trial
4702841|NCT03220997|Sequela|sequela
4702842|NCT03220997|Ketosis|ketosis
4702843|NCT03220971|Lipoprotein and Apolipoproteins metabolism|lipoprotein and apolipoproteins metabolism
4702844|NCT03220932|Epithelial Ovarian Cancer - Platinum-resistant - Cytoreductive surgery - HIPEC - Quality of Life|epithelial ovarian cancer - platinum-resistant - cytoreductive surgery - hipec - quality of life
4702845|NCT03220919|Insulin|insulin
4702846|NCT03220919|Type 2 diabetes|type 2 diabetes
4702847|NCT03220880|Dexmedetomidine|dexmedetomidine
4702848|NCT03220880|Sedation|sedation
4702849|NCT03220880|Pediatric|pediatric
4702850|NCT03220841|Crohn Disease|crohn disease
4702851|NCT03220841|Inflammatory Bowel Disease|inflammatory bowel disease
4702852|NCT03220841|Intestinal stricture|intestinal stricture
4702853|NCT03220698|endotracheal intubation|endotracheal intubation
4702854|NCT03220698|confirmation|confirmation
4702855|NCT03220698|ultrasonography|ultrasonography
4702856|NCT03220685|Microbiota|microbiota
4702857|NCT03220672|Pelvic floor muscles|pelvic floor muscles
4702858|NCT03220672|pelvic floor muscle training|pelvic floor muscle training
4702859|NCT03220672|motor control|motor control
4702860|NCT03220672|Educational intervention|educational intervention
4702861|NCT03220672|menopause|menopause
4702862|NCT03220646|Abemaciclib (LY2835219)|abemaciclib (ly2835219)
4702863|NCT03220646|17-261|17-261
4702864|NCT03220620|fluid therapy|fluid therapy
4702865|NCT03220620|perioperative|perioperative
4702866|NCT03220620|hemodilution|hemodilution
4702867|NCT03220607|uterocervical angle, second trimester abortion|uterocervical angle, second trimester abortion
4702868|NCT03220594|hypogastric artery|hypogastric artery
4702869|NCT03220594|anti-mullerian hormone|anti-mullerian hormone
4702870|NCT03220594|ovarian reserve|ovarian reserve
4702871|NCT03220594|postpartum|postpartum
4702872|NCT03220555|Buzzy|buzzy
4702873|NCT03220555|anesthetic cream|anesthetic cream
4702874|NCT03220555|pediatric|pediatric
4702875|NCT03220555|pain|pain
4702876|NCT03220555|venipuncture|venipuncture
4702877|NCT03220555|vaccination|vaccination
4702878|NCT03220555|vibration|vibration
4702879|NCT03220555|cold|cold
4702880|NCT03220555|distraction|distraction
4702881|NCT03220555|vaccination center|vaccination center
4702882|NCT03220542|Helicobacter Pylori|helicobacter pylori
4702883|NCT03220542|Probiotics|probiotics
4702884|NCT03220542|Sulforaphane|sulforaphane
4702885|NCT03220477|Pembrolizumab|pembrolizumab
4702886|NCT03220477|guadecitabine|guadecitabine
4702887|NCT03220477|mocetinostat|mocetinostat
4702888|NCT03220477|17-241|17-241
4702889|NCT03220451|pressure ulcer|pressure ulcer
4702890|NCT03220451|pressure sore|pressure sore
4702891|NCT03220451|decubitus ulcer|decubitus ulcer
4702892|NCT03220451|spinal cord injury|spinal cord injury
4702893|NCT03220451|adhesive elastic bandage|adhesive elastic bandage
4702894|NCT03220451|taping|taping
4702895|NCT03220451|kinesio taping|kinesio taping
4702896|NCT03220451|neuro taping|neuro taping
4702897|NCT03220412|adolescent|adolescent
4702898|NCT03220412|gun|gun
4702899|NCT03220412|violence|violence
4702900|NCT03220412|media|media
4702901|NCT03220386|staphylococcus aureus|staphylococcus aureus
4702902|NCT03220386|nosocomial infection|nosocomial infection
4702903|NCT03220386|decolonization|decolonization
4702904|NCT03220386|emergency department|emergency department
4702905|NCT03220373|Neuropsychology|neuropsychology
4702906|NCT03220373|Cognition|cognition
4702907|NCT03220373|Drop-out|drop-out
4702908|NCT03220373|Follow-up|follow-up
4702909|NCT03220347|Non-Hodgkin's Lymphomas|non-hodgkin's lymphomas
4702910|NCT03220347|Safety|safety
4702911|NCT03220347|Efficacy|efficacy
4702912|NCT03220347|CC-90010|cc-90010
4702913|NCT03220347|Solid Tumors|solid tumors
4702914|NCT03220347|Relapsed/Refractory|relapsed/refractory
4702915|NCT03220308|Self-control|self-control
4702916|NCT03220308|Well-being|well-being
4702917|NCT03220269|Utstein|utstein
4702918|NCT03220269|Resuscitation|resuscitation
4702919|NCT03220269|Epidemiology|epidemiology
4702920|NCT03220269|Emergency medicine|emergency medicine
4702921|NCT03220269|Resuscitation Registry|resuscitation registry
4702922|NCT03220230|Next generation sequencing|next generation sequencing
4702923|NCT03220230|Lung cancer|lung cancer
4702924|NCT03220230|target therapies|target therapies
4702925|NCT03220204|Heart Failure|heart failure
4702926|NCT03220204|Positive Psychology|positive psychology
4702927|NCT03220204|Adherence to Health Behaviors|adherence to health behaviors
4702928|NCT03220178|breast cancer|breast cancer
4702929|NCT03220178|HER2 negative|her2 negative
4702930|NCT03220178|hormone receptor positive|hormone receptor positive
4702931|NCT03220178|advanced|advanced
4702932|NCT03220178|metastatic|metastatic
4702933|NCT03220113|Migraine|migraine
4702934|NCT03220113|Craniofacial Neuralgia|craniofacial neuralgia
4702935|NCT03220100|Lung Cancer|lung cancer
4702936|NCT03219983|interscalene block|interscalene block
4702937|NCT03219983|liposomal bupivacaine|liposomal bupivacaine
4702938|NCT03219957|HCV|hcv
4702939|NCT03219957|Hepatitis C Virus|hepatitis c virus
4702940|NCT03219957|RNA Viruses|rna viruses
4702941|NCT03219957|Flavivirus|flavivirus
4702942|NCT03219957|Liver Diseases|liver diseases
4702943|NCT03219957|Hepatitis, Viral, Human|hepatitis, viral, human
4702944|NCT03219957|Flaviviridae Infections|flaviviridae infections
4702945|NCT03219931|infant colics|infant colics
4702946|NCT03219931|probiotic|probiotic
4702947|NCT03219931|gut microbiome|gut microbiome
4702948|NCT03219931|bifidobacterium breve|bifidobacterium breve
4702949|NCT03219931|crying time|crying time
4702950|NCT03219918|Colorectal adenoma|colorectal adenoma
4702951|NCT03219918|Colonoscopy|colonoscopy
4702952|NCT03219918|Caps|caps
4702953|NCT03219918|Adenoma detection rate|adenoma detection rate
4702954|NCT03219892|freezing of gait|freezing of gait
4702955|NCT03219892|rTMS|rtms
4702956|NCT03219892|fMRI|fmri
4702957|NCT03219879|Relapse prevention|relapse prevention
4702958|NCT03219879|Persistent depressive disorder|persistent depressive disorder
4702959|NCT03219879|Recurrent depressive disorder|recurrent depressive disorder
4702960|NCT03219879|Telephone-based intervention|telephone-based intervention
4702961|NCT03219879|Cognitive behavioral therapy|cognitive behavioral therapy
4702962|NCT03219866|Nebulizer|nebulizer
4702963|NCT03219866|Inhaler|inhaler
4702964|NCT03219840|Cetylpyridium Chloride (CPC)|cetylpyridium chloride (cpc)
4702965|NCT03219840|Chewing Gum|chewing gum
4702966|NCT03219814|body-image|body-image
4702967|NCT03219814|attention|attention
4702968|NCT03219814|cognitive dissonance|cognitive dissonance
4702969|NCT03219814|eating disorder prevention|eating disorder prevention
4702970|NCT03219788|emergence|emergence
4702971|NCT03219788|remifentanil|remifentanil
4702972|NCT03219788|recovery|recovery
4702973|NCT03219788|desflurene|desflurene
4702974|NCT03219775|tailored immuno therapy|tailored immuno therapy
4702975|NCT03219775|Nivolumab|nivolumab
4702976|NCT03219775|Ipilimumab|ipilimumab
4702977|NCT03219775|boost|boost
4702978|NCT03219749|obstructive sleep apnea|obstructive sleep apnea
4702979|NCT03219749|exercise training|exercise training
4702980|NCT03219749|vascular function|vascular function
4702981|NCT03219710|Chemotherapy induced nausea and vomiting|chemotherapy induced nausea and vomiting
4702982|NCT03219710|olanzapine|olanzapine
4702983|NCT03219697|Childhood obesity prevention;|childhood obesity prevention;
4702984|NCT03219658|Parenting|parenting
4702985|NCT03219658|Home visiting|home visiting
4702986|NCT03219658|Childhood obesity treatment|childhood obesity treatment
4702987|NCT03219606|Systemic sclerosis|systemic sclerosis
4702988|NCT03219606|Education|education
4702989|NCT03219606|Modified Rodnan skin score|modified rodnan skin score
4702990|NCT03219528|Irritable Bowel Syndrome|irritable bowel syndrome
4702991|NCT03219528|Diarrhea|diarrhea
4702992|NCT03219528|Small Intestinal Bacterial Overgrowth|small intestinal bacterial overgrowth
4702993|NCT03219528|Gut Microbiota|gut microbiota
4702994|NCT03219502|Malignant neoplasms of independent (primary) multiple sites|malignant neoplasms of independent (primary) multiple sites
4702995|NCT03219502|Repetitive transcranial magnetic stimulation|repetitive transcranial magnetic stimulation
4702996|NCT03219502|rTMS|rtms
4702997|NCT03219502|Chemotherapy-induced peripheral neuropathy|chemotherapy-induced peripheral neuropathy
4702998|NCT03219502|CIPN|cipn
4702999|NCT03219502|Electroencephalogram|electroencephalogram
4703000|NCT03219502|EEG|eeg
4703001|NCT03219502|Assessment Questionnaires|assessment questionnaires
4703002|NCT03219502|Pain Questionnaires|pain questionnaires
4703003|NCT03219502|Surveys|surveys
4703004|NCT03219489|Electronic Medical Record|electronic medical record
4703005|NCT03219489|Progesterone|progesterone
4703006|NCT03219476|aromatase inhibitor|aromatase inhibitor
4703007|NCT03219476|breast cancer|breast cancer
4703008|NCT03219476|estrogen receptor|estrogen receptor
4703009|NCT03219476|progesterone receptor|progesterone receptor
4703010|NCT03219476|endocrine-targeted therapy|endocrine-targeted therapy
4703011|NCT03219476|Anti-estrogen therapy|anti-estrogen therapy
4703012|NCT03219476|HR+|hr+
4703013|NCT03219476|HER2-negative|her2-negative
4703014|NCT03219476|Neoadjuvant Treatment|neoadjuvant treatment
4703015|NCT03219450|Leukemia|leukemia
4703016|NCT03219450|Lymphocytic Leukemia|lymphocytic leukemia
4703017|NCT03219437|ABBV-066|abbv-066
4703018|NCT03219437|BI 655066|bi 655066
4703019|NCT03219424|Return to work status|return to work status
4703020|NCT03219424|Functional outcome|functional outcome
4703021|NCT03219424|Quality of life|quality of life
4703022|NCT03219398|Living donor laparoscopic nephrectomy|living donor laparoscopic nephrectomy
4703023|NCT03219398|Pneumoperitoneum|pneumoperitoneum
4703024|NCT03219398|Renal resistive index|renal resistive index
4703025|NCT03219398|Syndecan-1|syndecan-1
4703026|NCT03219398|soluble VEGF-R2|soluble vegf-r2
4703027|NCT03219398|Occludin|occludin
4703028|NCT03219398|KIM-1|kim-1
4703029|NCT03219398|Interleukin-6|interleukin-6
4703030|NCT03219385|uterine leiomyoma|uterine leiomyoma
4703031|NCT03219385|uterine fibroid|uterine fibroid
4703032|NCT03219385|uterine myoma|uterine myoma
4703033|NCT03219385|abnormal menstrual bleeding|abnormal menstrual bleeding
4703034|NCT03219385|heavy menstrual bleeding|heavy menstrual bleeding
4703035|NCT03219385|menorrhagia|menorrhagia
4703036|NCT03219385|high-intensity focused ultrasound|high-intensity focused ultrasound
4703037|NCT03219385|ultrasound imaging|ultrasound imaging
4703038|NCT03219359|IBD|ibd
4703039|NCT03219359|Inflammatory Bowel Diseases|inflammatory bowel diseases
4703040|NCT03219359|Gastroenteritis|gastroenteritis
4703041|NCT03219359|Crohn's disease|crohn's disease
4703042|NCT03219359|Colitis|colitis
4703043|NCT03219359|Vedolizumab|vedolizumab
4703044|NCT03219346|stroke , swallowing function ,oral health quality of life|stroke , swallowing function ,oral health quality of life
4703045|NCT03219333|Enfortumab vedotin|enfortumab vedotin
4703046|NCT03219333|Metastatic Urothelial Cancer|metastatic urothelial cancer
4703047|NCT03219333|ASG-22CE|asg-22ce
4703048|NCT03219333|Locally Advanced Urothelial Cancer|locally advanced urothelial cancer
4703049|NCT03219333|Antibody-Drug Conjugate|antibody-drug conjugate
4703050|NCT03219333|Nectin-4|nectin-4
4703051|NCT03219333|Platinum-naïve|platinum-naïve
4703052|NCT03219333|Cisplatin-ineligible|cisplatin-ineligible
4703053|NCT03219333|Antineoplastic Agents|antineoplastic agents
4703054|NCT03219333|Drug Therapy|drug therapy
4703055|NCT03219333|ASG-22ME|asg-22me
4703056|NCT03219320|Type 2 Diabetes|type 2 diabetes
4703057|NCT03219320|Neuropathic Pain|neuropathic pain
4703058|NCT03219320|Peripheral Nervous System|peripheral nervous system
4703059|NCT03219307|cartilage repair|cartilage repair
4703060|NCT03219307|cartilage regeneration|cartilage regeneration
4703061|NCT03219307|cartilage reconstruction|cartilage reconstruction
4703062|NCT03219307|cartilage restoration|cartilage restoration
4703063|NCT03219307|autologous chondrocyte implantation|autologous chondrocyte implantation
4703064|NCT03219307|matrix associated chondrocyte implantation|matrix associated chondrocyte implantation
4703065|NCT03219294|neuromuscular blockade|neuromuscular blockade
4703066|NCT03219294|sugammadex|sugammadex
4703067|NCT03219255|Post-marketing|post-marketing
4703068|NCT03219255|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
4703069|NCT03219255|Drug use investigation|drug use investigation
4703070|NCT03219255|RELVAR 100 ELLIPTA|relvar 100 ellipta
4703071|NCT03219242|Advanced ovarian cancer|advanced ovarian cancer
4703072|NCT03219229|Fat-free mass|fat-free mass
4703073|NCT03219229|Tanner stage 1|tanner stage 1
4703074|NCT03219229|Pre-pubertal|pre-pubertal
4703075|NCT03219216|Chronic Hepatitis C Virus (HCV)|chronic hepatitis c virus (hcv)
4703076|NCT03219216|Genotype 1 - 6|genotype 1 - 6
4703376|NCT03217604|PF-06852231|pf-06852231
4703077|NCT03219216|Metavir System Fibrosis Score|metavir system fibrosis score
4703078|NCT03219216|Glecaprevir|glecaprevir
4703079|NCT03219216|Pibrentasvir|pibrentasvir
4703080|NCT03219216|Treatment naïve|treatment naïve
4703081|NCT03219216|Cirrhosis|cirrhosis
4703082|NCT03219216|Compensated cirrhosis|compensated cirrhosis
4703083|NCT03219203|HBV vaccination|hbv vaccination
4703084|NCT03219203|immunity|immunity
4703085|NCT03219138|muscle function tests|muscle function tests
4703086|NCT03219125|marrow adipose tissue|marrow adipose tissue
4703087|NCT03219125|bone marrow adiposity|bone marrow adiposity
4703088|NCT03219112|balance|balance
4703089|NCT03219112|rehabilitation|rehabilitation
4703090|NCT03219112|exergaming|exergaming
4703091|NCT03219112|virtual reality|virtual reality
4703092|NCT03219086|combined spinal epidural anesthesia|combined spinal epidural anesthesia
4703093|NCT03219086|caesarian section|caesarian section
4703094|NCT03219086|prilocaine|prilocaine
4703095|NCT03219086|bupivacaine|bupivacaine
4703096|NCT03219073|multiple sclerosis|multiple sclerosis
4703097|NCT03219073|neuropathic pain|neuropathic pain
4703098|NCT03219073|[18F] FDG-PET CT|[18f] fdg-pet ct
4703099|NCT03219073|tDCS|tdcs
4703100|NCT03219073|transcranial direct current stimulation|transcranial direct current stimulation
4703101|NCT03219060|Cognitive dissonance|cognitive dissonance
4703102|NCT03219060|Motivational interviewing|motivational interviewing
4703103|NCT03219060|Health Professional role|health professional role
4703104|NCT03219060|Nurses|nurses
4703105|NCT03219060|Health Promotion|health promotion
4703106|NCT03219060|Lifestyle|lifestyle
4703107|NCT03219060|Smoking cessation|smoking cessation
4703108|NCT03219047|Mantle Cell Lymphoma|mantle cell lymphoma
4703109|NCT03219047|MCL|mcl
4703110|NCT03219047|Relapsed/refractory|relapsed/refractory
4703111|NCT03219047|Xenograft|xenograft
4703112|NCT03219047|PDX|pdx
4703113|NCT03219047|Ibrutinib|ibrutinib
4703114|NCT03219047|PCI-32765|pci-32765
4703115|NCT03219047|Imbruvica|imbruvica
4703116|NCT03219034|oral appliance|oral appliance
4703117|NCT03219034|sleep quality|sleep quality
4703118|NCT03219034|sleep apnea|sleep apnea
4703119|NCT03219021|Cleft lip and Palate|cleft lip and palate
4703120|NCT03219021|unilateral cleft lip and palate|unilateral cleft lip and palate
4703121|NCT03219021|surgically repaired cleft lip and palate|surgically repaired cleft lip and palate
4703122|NCT03219021|arch dimensions|arch dimensions
4703123|NCT03219021|arch discrepancies|arch discrepancies
4703124|NCT03219021|dental arch dimensions|dental arch dimensions
4703125|NCT03219021|arch parameter|arch parameter
4703126|NCT03219021|arch circumference|arch circumference
4703127|NCT03219021|intercanine width|intercanine width
4703128|NCT03219021|first deciduous molar width|first deciduous molar width
4703129|NCT03219021|second deciduous molar width|second deciduous molar width
4703130|NCT03219021|permanent first molar width|permanent first molar width
4703131|NCT03219008|depressive disorder|depressive disorder
4703132|NCT03219008|multi-dimensional diagnosis technique|multi-dimensional diagnosis technique
4703133|NCT03219008|individualized therapy|individualized therapy
4703134|NCT03219008|management technique|management technique
4703135|NCT03219008|e-MBC|e-mbc
4703136|NCT03219008|MBC|mbc
4703137|NCT03218995|DMD|dmd
4703138|NCT03218995|Duchenne|duchenne
4703139|NCT03218995|Eteplirsen|eteplirsen
4703140|NCT03218995|dystrophy|dystrophy
4703141|NCT03218995|dystrophin|dystrophin
4703142|NCT03218995|exon 51|exon 51
4703143|NCT03218982|Caregiver|caregiver
4703144|NCT03218982|Vietnamese|vietnamese
4703145|NCT03218982|Alzheimer's Disease|alzheimer's disease
4703146|NCT03218956|Protein requirement|protein requirement
4703147|NCT03218943|BiPAP|bipap
4703148|NCT03218943|APRV|aprv
4703149|NCT03218943|Physiological dead space|physiological dead space
4703150|NCT03218943|volumetric capnography|volumetric capnography
4703151|NCT03218943|ARDS|ards
4703152|NCT03218943|impaired oxygenation|impaired oxygenation
4703153|NCT03218943|ICU|icu
4703154|NCT03218943|Mechanical ventilation|mechanical ventilation
4703155|NCT03218930|General Practice|general practice
4703156|NCT03218930|Social Marketing|social marketing
4703157|NCT03218930|Behavior Change|behavior change
4703158|NCT03218930|Antibiotic Prescribing|antibiotic prescribing
4703159|NCT03218917|P aeruginosa|p aeruginosa
4703160|NCT03218917|bronchiectasis|bronchiectasis
4703161|NCT03218917|active neutrophil elastase|active neutrophil elastase
4703162|NCT03218904|Glucose Breath Test|glucose breath test
4703163|NCT03218891|Refractory Angina|refractory angina
4703164|NCT03218891|Rehabilitation|rehabilitation
4703165|NCT03218839|PrePex|prepex
4703166|NCT03218839|HIV Seropositivity|hiv seropositivity
4703167|NCT03218800|subcutaneous|subcutaneous
4703168|NCT03218800|ertapenem|ertapenem
4703169|NCT03218800|urinary tract infection|urinary tract infection
4703170|NCT03218800|advanced cancer|advanced cancer
4703171|NCT03218800|palliative care|palliative care
4703172|NCT03218787|Coronary Artery Lesions|coronary artery lesions
4703173|NCT03218787|XIENCE|xience
4703174|NCT03218787|Dual Antiplatelet Therapy (DAPT)|dual antiplatelet therapy (dapt)
4703175|NCT03218787|Reduced DAPT|reduced dapt
4703176|NCT03218787|Risk of bleeding|risk of bleeding
4703177|NCT03218787|Drug-eluting stents|drug-eluting stents
4703178|NCT03218761|norepinephrine|norepinephrine
4703179|NCT03218761|norepinephrine transporter|norepinephrine transporter
4703180|NCT03218748|Mental illness|mental illness
4703181|NCT03218748|Disclosure|disclosure
4703182|NCT03218748|stigma|stigma
4703183|NCT03218748|soldiers|soldiers
4703184|NCT03218748|secrecy|secrecy
4703185|NCT03218735|large for gestational age fetal growth|large for gestational age fetal growth
4703186|NCT03218722|Acute traumatic coagulopathy|acute traumatic coagulopathy
4703187|NCT03218722|Hemostasis|hemostasis
4703188|NCT03218722|Severe hemorrhage|severe hemorrhage
4703189|NCT03218696|cough|cough
4703190|NCT03218696|children|children
4703191|NCT03218696|Acute Upper Respiratory Tract Infection|acute upper respiratory tract infection
4703192|NCT03218683|relapsed|relapsed
4703193|NCT03218683|refractory|refractory
4703194|NCT03218683|AZD5991|azd5991
4703195|NCT03218683|Non-Hodgkin lymphoma|non-hodgkin lymphoma
4703196|NCT03218683|Richter syndrome|richter syndrome
4703197|NCT03218683|Chronic lymphocytic leukemia|chronic lymphocytic leukemia
4703198|NCT03218683|Small lymphocytic lymphoma|small lymphocytic lymphoma
4703199|NCT03218683|T-cell lymphoma, Multiple myeloma|t-cell lymphoma, multiple myeloma
4703200|NCT03218657|Aplastic Anemia|aplastic anemia
4703201|NCT03218657|levamisole hydrochloride|levamisole hydrochloride
4703202|NCT03218657|clinical study|clinical study
4703203|NCT03218644|Proprioception|proprioception
4703204|NCT03218631|oxandrolone, cardiac|oxandrolone, cardiac
4703205|NCT03218605|Achilles tendon|achilles tendon
4703206|NCT03218605|Warming-up|warming-up
4703207|NCT03218605|Vascularisation|vascularisation
4703208|NCT03218605|Physical activity|physical activity
4703209|NCT03218605|Oxygen-to-See (O2C)|oxygen-to-see (o2c)
4703210|NCT03218592|Adherence|adherence
4703211|NCT03218592|Hair|hair
4703212|NCT03218579|microbiome|microbiome
4703213|NCT03218579|intestinal bacteria|intestinal bacteria
4703214|NCT03218566|pulmonary embolism|pulmonary embolism
4703215|NCT03218566|clot|clot
4703216|NCT03218540|stroke volume variation|stroke volume variation
4703217|NCT03218540|central venous pressure|central venous pressure
4703218|NCT03218540|serum lactate|serum lactate
4703219|NCT03218540|serum creatinine|serum creatinine
4703220|NCT03218514|Obesity|obesity
4703221|NCT03218514|Venous thromboembolism|venous thromboembolism
4703222|NCT03218514|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight
4703223|NCT03218514|Body Composition|body composition
4703224|NCT03218514|Glomerular filtration rate|glomerular filtration rate
4703225|NCT03218514|Bariatric Surgery|bariatric surgery
4703226|NCT03218501|Uremic Pruritus|uremic pruritus
4703227|NCT03218462|sensory adapted environment|sensory adapted environment
4703228|NCT03218462|pediatric dentistry|pediatric dentistry
4703229|NCT03218462|oral health|oral health
4703230|NCT03218462|Developmental Disability|developmental disability
4703231|NCT03218462|Intellectual Disability|intellectual disability
4703232|NCT03218462|dental anxiety|dental anxiety
4703233|NCT03218462|autism spectrum|autism spectrum
4703234|NCT03218423|screening|screening
4703235|NCT03218423|plasma|plasma
4703236|NCT03218423|DNA methylation|dna methylation
4703237|NCT03218410|surgical embolectomy|surgical embolectomy
4703238|NCT03218410|catheter-directed therapy|catheter-directed therapy
4703239|NCT03218397|Gram-negative Bacteremia|gram-negative bacteremia
4703240|NCT03218397|ICU|icu
4703241|NCT03218397|Critically ill|critically ill
4703242|NCT03218397|Intensive Care Unit|intensive care unit
4703243|NCT03218397|Rapid identification|rapid identification
4703244|NCT03218397|Rapid susceptibility|rapid susceptibility
4703245|NCT03218397|Accelerate PhenoTest™ BC Kit|accelerate phenotest™ bc kit
4703246|NCT03218397|Accelerate Pheno™ System (AXDX)|accelerate pheno™ system (axdx)
4703247|NCT03218397|Antimicrobial stewardship|antimicrobial stewardship
4703248|NCT03218397|Antimicrobial use|antimicrobial use
4703249|NCT03218384|Injectafer|injectafer
4703250|NCT03218384|ferric carboxymaltose|ferric carboxymaltose
4703251|NCT03218384|Supplemental Iron|supplemental iron
4703252|NCT03218371|scleral indentation|scleral indentation
4703253|NCT03218371|chandelier light|chandelier light
4703254|NCT03218371|air vitrectomy|air vitrectomy
4703255|NCT03218371|rhegmatogenous retinal detachment|rhegmatogenous retinal detachment
4703256|NCT03218345|EUS-guided RFA|eus-guided rfa
4703257|NCT03218345|pancreatic ca|pancreatic ca
4703258|NCT03218345|interventional EUS|interventional eus
4703259|NCT03218306|SPI|spi
4703260|NCT03218306|Remifentanil|remifentanil
4703261|NCT03218306|Target controlled infusion|target controlled infusion
4703262|NCT03218280|trauma|trauma
4703263|NCT03218280|antioxidant|antioxidant
4703264|NCT03218280|oxidative stress|oxidative stress
4703265|NCT03218280|Vitamin C|vitamin c
4703266|NCT03218280|Ascorbic Acid|ascorbic acid
4703267|NCT03218267|total hip replacement|total hip replacement
4703268|NCT03218267|static disbalance|static disbalance
4703269|NCT03218254|hematological cancer, fatigue, quality of life|hematological cancer, fatigue, quality of life
4703270|NCT03218241|Healthy Volunteers|healthy volunteers
4703271|NCT03218228|aggressive periodontitis|aggressive periodontitis
4703272|NCT03218215|cough assits|cough assits
4703273|NCT03218202|Inflammatory Bowel Disease|inflammatory bowel disease
4703274|NCT03218202|Crohn Disease|crohn disease
4703377|NCT03217604|Safety|safety
4703275|NCT03218202|Ulcerative Colitis|ulcerative colitis
4703276|NCT03218202|Intestinal stricture|intestinal stricture
4703277|NCT03218189|Essential medicines lists|essential medicines lists
4703278|NCT03218163|bone marrow|bone marrow
4703279|NCT03218163|bone marrow transplant|bone marrow transplant
4703280|NCT03218163|allogeneic|allogeneic
4703281|NCT03218163|Medi-551|medi-551
4703282|NCT03218137|Subjects|subjects
4703283|NCT03218137|diagnosed|diagnosed
4703284|NCT03218124|Thyroidectomy|thyroidectomy
4703285|NCT03218124|Remifentanil|remifentanil
4703286|NCT03218124|Extubation|extubation
4703287|NCT03218124|Cough|cough
4703288|NCT03218124|Target controlled infusion|target controlled infusion
4703289|NCT03218111|Glymphatic network|glymphatic network
4703290|NCT03218111|healthy|healthy
4703291|NCT03218111|central nervous system|central nervous system
4703292|NCT03218085|tenofovir|tenofovir
4703293|NCT03218085|prevention|prevention
4703294|NCT03218085|microbiome|microbiome
4703295|NCT03218085|cervicovaginal|cervicovaginal
4703296|NCT03218085|biopsy|biopsy
4703297|NCT03218085|swab|swab
4703298|NCT03218085|cytokines|cytokines
4703299|NCT03218085|inflammation|inflammation
4703300|NCT03218085|pharmacology|pharmacology
4703301|NCT03218059|Cesarean Scar Pregnancy|cesarean scar pregnancy
4703302|NCT03218033|systemic lupus|systemic lupus
4703303|NCT03218033|self-management|self-management
4703304|NCT03218033|social media|social media
4703305|NCT03217942|Muscle soreness|muscle soreness
4703306|NCT03217942|NGF-induced pain|ngf-induced pain
4703307|NCT03217942|Pain model|pain model
4703308|NCT03217942|Long-lasting sensitization|long-lasting sensitization
4703309|NCT03217929|vagus nerve|vagus nerve
4703310|NCT03217929|obesity|obesity
4703311|NCT03217929|craving|craving
4703312|NCT03217929|food|food
4703313|NCT03217916|podocyte glycoprotein|podocyte glycoprotein
4703314|NCT03217916|kidney injury|kidney injury
4703315|NCT03217916|preeclampsia|preeclampsia
4703316|NCT03217903|Myelodysplastic syndromes|myelodysplastic syndromes
4703317|NCT03217877|noninvasive stress testing|noninvasive stress testing
4703318|NCT03217877|high risk|high risk
4703319|NCT03217877|unstable angina|unstable angina
4703320|NCT03217877|PCI|pci
4703321|NCT03217864|Cancer|cancer
4703322|NCT03217864|palliative care|palliative care
4703323|NCT03217864|hospitalization at home|hospitalization at home
4703324|NCT03217864|home health care provider|home health care provider
4703325|NCT03217851|Plasmodium falciparum|plasmodium falciparum
4703326|NCT03217851|Prevalence Survey|prevalence survey
4703327|NCT03217851|Antimalarial Drug|antimalarial drug
4703328|NCT03217838|AML|aml
4703329|NCT03217838|Acute Myeloid Leukaemia|acute myeloid leukaemia
4703330|NCT03217838|High-Risk Myelodysplastic Syndrome|high-risk myelodysplastic syndrome
4703331|NCT03217838|AZD2811|azd2811
4703332|NCT03217838|AZD1152|azd1152
4703333|NCT03217838|AZD1152 hQPA|azd1152 hqpa
4703334|NCT03217838|barasertib|barasertib
4703335|NCT03217786|Macrovascular Disease|macrovascular disease
4703336|NCT03217786|Microvascular Coronary Artery Disease|microvascular coronary artery disease
4703337|NCT03217786|Cardiac Transplant Rejection|cardiac transplant rejection
4703338|NCT03217786|Transplant; Failure, Heart|transplant; failure, heart
4703339|NCT03217786|Intravascular ultrasound (IVUS)|intravascular ultrasound (ivus)
4703340|NCT03217786|Optical Coherence Tomography|optical coherence tomography
4703341|NCT03217786|Index of Microcirculatory Resistance|index of microcirculatory resistance
4703342|NCT03217786|Fractional Flow Reserve|fractional flow reserve
4703343|NCT03217786|Coronary Flow Reserve|coronary flow reserve
4703344|NCT03217786|Positron Emission Tomography|positron emission tomography
4703345|NCT03217786|Endomyocardial Biopsies|endomyocardial biopsies
4703346|NCT03217760|Induced stress, dental anxiety, endodontic treatment, salivary cortisol, cardiovascular parameters, pain, discomfort.|induced stress, dental anxiety, endodontic treatment, salivary cortisol, cardiovascular parameters, pain, discomfort.
4703347|NCT03217747|Metastatic solid tumors|metastatic solid tumors
4703348|NCT03217747|Advanced solid tumors|advanced solid tumors
4703349|NCT03217747|Avelumab|avelumab
4703350|NCT03217747|MSBOO10718C|msboo10718c
4703351|NCT03217747|Utomilumab|utomilumab
4703352|NCT03217747|PF-05082566|pf-05082566
4703353|NCT03217747|Anti-CD137|anti-cd137
4703354|NCT03217747|PF-04518600|pf-04518600
4703355|NCT03217747|Cisplatin|cisplatin
4703356|NCT03217747|Platinol-AQ|platinol-aq
4703357|NCT03217747|Platinol|platinol
4703358|NCT03217747|CDDP|cddp
4703359|NCT03217747|Radiation Therapy|radiation therapy
4703360|NCT03217747|XRT|xrt
4703361|NCT03217695|Heart rate variability|heart rate variability
4703362|NCT03217695|Self-efficacy|self-efficacy
4703363|NCT03217695|Pediatrics|pediatrics
4703364|NCT03217695|Mindfulness-based yoga|mindfulness-based yoga
4703365|NCT03217695|Symptoms|symptoms
4703366|NCT03217682|Hospice|hospice
4703367|NCT03217682|Palliative Care|palliative care
4703368|NCT03217682|Integrative Medicine|integrative medicine
4703369|NCT03217682|Massage Therapy|massage therapy
4703370|NCT03217682|Music Therapy|music therapy
4703371|NCT03217682|Caregivers|caregivers
4703372|NCT03217669|epacadostat|epacadostat
4703373|NCT03217669|sirolimus|sirolimus
4703374|NCT03217617|SCID-X1|scid-x1
4703375|NCT03217617|lentiviral vector|lentiviral vector
4703378|NCT03217604|Tolerability|tolerability
4703379|NCT03217604|Pharmacokinetics|pharmacokinetics
4703380|NCT03217604|First-in-human|first-in-human
4703381|NCT03217604|Healthy subjects|healthy subjects
4703382|NCT03217578|Spinal Muscular Atrophy|spinal muscular atrophy
4703383|NCT03217578|Newborn Screening|newborn screening
4703384|NCT03217526|Burn injury|burn injury
4703385|NCT03217526|Gait|gait
4703386|NCT03217526|Physical Function|physical function
4703387|NCT03217513|osteoporosis|osteoporosis
4703388|NCT03217513|osteoarthritis|osteoarthritis
4703389|NCT03217513|knee|knee
4703390|NCT03217422|Type 1, Type 2, autoimmune hepatitis, AIH,|type 1, type 2, autoimmune hepatitis, aih,
4703391|NCT03217396|synaptic plasticity|synaptic plasticity
4703392|NCT03217396|neuroinflammation|neuroinflammation
4703393|NCT03217396|neurodegeneration|neurodegeneration
4703394|NCT03217383|Oral appliance therapy|oral appliance therapy
4703395|NCT03217383|mandibular protrusion|mandibular protrusion
4703396|NCT03217370|patient blood management|patient blood management
4703397|NCT03217370|restrictive transfusion|restrictive transfusion
4703398|NCT03217357|tDCS, non invasive brain stimulation|tdcs, non invasive brain stimulation
4703399|NCT03217318|ureteral stent|ureteral stent
4703400|NCT03217305|EIT. NAVA. Endexpiratory Lung Impedance.|eit. nava. endexpiratory lung impedance.
4703401|NCT03217279|stroke-participation|stroke-participation
4703402|NCT03217279|restriction-needs-cohort-patients-caregivers|restriction-needs-cohort-patients-caregivers
4703403|NCT03217201|Breast Cancer|breast cancer
4703404|NCT03217201|Oncology|oncology
4703405|NCT03217201|Circadian Rhythm|circadian rhythm
4703406|NCT03217201|Light Therapy|light therapy
4703407|NCT03217201|Chemotherapy side effects|chemotherapy side effects
4703408|NCT03217188|Proton Re-Irradiation|proton re-irradiation
4703409|NCT03217188|17-300|17-300
4703410|NCT03217175|bionic pancreas|bionic pancreas
4703411|NCT03217175|type 1 diabetes|type 1 diabetes
4703412|NCT03217123|OCD, DBS, fMRI, Y-BOCS, tractography|ocd, dbs, fmri, y-bocs, tractography
4703413|NCT03217110|Cerebellum|cerebellum
4703414|NCT03217097|Neuroendocrine tumors|neuroendocrine tumors
4703415|NCT03217097|Methylation MGMT status|methylation mgmt status
4703416|NCT03217097|Alkylating agents|alkylating agents
4703417|NCT03217097|Oxaliplatin|oxaliplatin
4703418|NCT03217084|White spot lesion ,fluoride varnish|white spot lesion ,fluoride varnish
4703419|NCT03217071|non small cell lung cancer, resectable|non small cell lung cancer, resectable
4703420|NCT03217058|digital health|digital health
4703421|NCT03217058|implementation|implementation
4703422|NCT03217058|primary care|primary care
4703423|NCT03217032|Hemophilia A|hemophilia a
4703424|NCT03217032|Hemophilia B|hemophilia b
4703425|NCT03217032|factor VIII|factor viii
4703426|NCT03217032|factor IX|factor ix
4703427|NCT03217032|Gene therapy|gene therapy
4703428|NCT03217032|lentiviral vector|lentiviral vector
4703429|NCT03217019|Radial Artery|radial artery
4703430|NCT03217019|Vascular Catheters|vascular catheters
4703431|NCT03217006|coronary artery bypass surgery|coronary artery bypass surgery
4703432|NCT03217006|multiple arterial graft|multiple arterial graft
4703433|NCT03217006|radial artery graft|radial artery graft
4703434|NCT03216993|feeding protocol|feeding protocol
4703435|NCT03216980|cardiovascular disease|cardiovascular disease
4703436|NCT03216980|vascular function|vascular function
4703437|NCT03216980|PTSD|ptsd
4703438|NCT03216941|Psychomotor agitation; Tranquilizing agents|psychomotor agitation; tranquilizing agents
4703439|NCT03216928|Reverse Signaling|reverse signaling
4703440|NCT03216928|Anti-TNF|anti-tnf
4703441|NCT03216915|Heart Rhythm|heart rhythm
4703442|NCT03216915|Fingolimod|fingolimod
4703443|NCT03216915|autonomic nervous system|autonomic nervous system
4703444|NCT03216915|Effects of Medicinal Substance|effects of medicinal substance
4703445|NCT03216902|Glaucoma|glaucoma
4703446|NCT03216889|Multiple Sclerosis|multiple sclerosis
4703447|NCT03216837|Perinatal stroke|perinatal stroke
4703448|NCT03216837|hemiplegia|hemiplegia
4703449|NCT03216837|hemiplegic cerebral palsy|hemiplegic cerebral palsy
4703450|NCT03216772|Gynecologic Surgery|gynecologic surgery
4703451|NCT03216772|larscopy|larscopy
4703452|NCT03216772|morcellation|morcellation
4703453|NCT03216759|Comprehensive intestinal protection strategy|comprehensive intestinal protection strategy
4703454|NCT03216759|Intestinal complications|intestinal complications
4703455|NCT03216759|laparotomy|laparotomy
4703456|NCT03216746|oral health|oral health
4703457|NCT03216746|knowledge|knowledge
4703458|NCT03216746|adolescent|adolescent
4703460|NCT03216733|Angina pectoris|angina pectoris
4703461|NCT03216733|Stent|stent
4703462|NCT03216720|Coronary artery bypass grafting|coronary artery bypass grafting
4703463|NCT03216720|Miniaturized extracorporeal circulation|miniaturized extracorporeal circulation
4703464|NCT03216720|Thrombin generation|thrombin generation
4703465|NCT03216655|congenital cataract|congenital cataract
4703466|NCT03216655|anxiety|anxiety
4703467|NCT03216655|guardian|guardian
4703468|NCT03216642|Dacryocystitis|dacryocystitis
4703469|NCT03216642|Bacteriology|bacteriology
4703470|NCT03216642|Microbial Sensitivity Tests|microbial sensitivity tests
4703471|NCT03216629|Pain|pain
4703472|NCT03216629|Empathy|empathy
4703473|NCT03216629|Dressing change|dressing change
4703474|NCT03216616|fatigue|fatigue
4703475|NCT03216616|Inflammatory Rheumatism|inflammatory rheumatism
4703476|NCT03216616|Coping|coping
4703477|NCT03216616|self-efficacy|self-efficacy
4703478|NCT03216603|Health literacy|health literacy
4703479|NCT03216590|Shoulder Arthroscopy|shoulder arthroscopy
4703480|NCT03216590|Soft Tissue Swelling|soft tissue swelling
4703481|NCT03216590|Rotator Cuff Repair|rotator cuff repair
4703482|NCT03216590|Shoulder Arthroscopy Complications|shoulder arthroscopy complications
4703483|NCT03216577|health-related quality of life|health-related quality of life
4703484|NCT03216551|selective mediastinal lymphadenectomy|selective mediastinal lymphadenectomy
4703485|NCT03216551|minimally invasive surgery|minimally invasive surgery
4703486|NCT03216460|T1D, Omnipod|t1d, omnipod
4703487|NCT03216447|adherence|adherence
4703488|NCT03216447|conversion|conversion
4703489|NCT03216447|advagraf|advagraf
4703490|NCT03216447|prograf|prograf
4703491|NCT03216434|post-traumatic stress disorder|post-traumatic stress disorder
4703492|NCT03216434|dopamine|dopamine
4703493|NCT03216434|biomarker|biomarker
4703494|NCT03216421|DCIS|dcis
4703495|NCT03216421|Intraoperative Radiation (IORT)|intraoperative radiation (iort)
4703496|NCT03216421|Lumpectomy|lumpectomy
4703497|NCT03216421|Breast Conserving Surgery|breast conserving surgery
4703498|NCT03216382|High worry|high worry
4703499|NCT03216382|Anxiety|anxiety
4703500|NCT03216382|Attention Training Technique|attention training technique
4703501|NCT03216382|Attention Control|attention control
4703502|NCT03216382|Attention|attention
4703503|NCT03216382|Mindfulness|mindfulness
4703504|NCT03216382|Attention Bias|attention bias
4703505|NCT03216382|Worry|worry
4703506|NCT03216382|Pathological Worry|pathological worry
4703507|NCT03216382|Anxiety Disorder|anxiety disorder
4703508|NCT03216369|Arterial Spin Labeling|arterial spin labeling
4703509|NCT03216369|MRI|mri
4703510|NCT03216369|Perfusion|perfusion
4703511|NCT03216369|Carotid artery stenting|carotid artery stenting
4703512|NCT03216369|Carotid endarterectomy|carotid endarterectomy
4703513|NCT03216330|Quantitative sensory test (QST)|quantitative sensory test (qst)
4703514|NCT03216330|Deep dyspareunia|deep dyspareunia
4703515|NCT03216330|Electronic Thimble Algometer|electronic thimble algometer
4703516|NCT03216317|Hypertension|hypertension
4703517|NCT03216317|Hypotension|hypotension
4703518|NCT03216317|Cardiovascular system|cardiovascular system
4703519|NCT03216278|healthy,|healthy,
4703520|NCT03216278|fasted,|fasted,
4703521|NCT03216278|fed|fed
4703522|NCT03216226|Glucagon|glucagon
4703523|NCT03216148|FET PET|fet pet
4703524|NCT03216135|Microbiome|microbiome
4703525|NCT03216109|Supportive Care|supportive care
4703526|NCT03216109|Quality of Life|quality of life
4703527|NCT03216083|colpocleisis|colpocleisis
4703528|NCT03216083|vaginectomy|vaginectomy
4703529|NCT03216083|tranexamic acid|tranexamic acid
4703530|NCT03216070|Dasatinib|dasatinib
4703531|NCT03216057|hypertriglyceridemia|hypertriglyceridemia
4703532|NCT03216057|pediatric obesity|pediatric obesity
4703533|NCT03216057|omega 3|omega 3
4703534|NCT03216044|childbirth|childbirth
4703535|NCT03216044|caesarean delivery|caesarean delivery
4703536|NCT03216044|vaginal delivery|vaginal delivery
4703537|NCT03216044|chronic pain|chronic pain
4703538|NCT03216044|painful sexual intercourse|painful sexual intercourse
4703539|NCT03216031|Falls prevention|falls prevention
4703540|NCT03216031|Gardening|gardening
4703541|NCT03216018|resilience|resilience
4703542|NCT03216018|prevention program|prevention program
4703543|NCT03216018|body-image|body-image
4703544|NCT03216018|self-esteem|self-esteem
4703545|NCT03215992|Diffuse Optical Tomography|diffuse optical tomography
4703546|NCT03215966|bioequivalence|bioequivalence
4703547|NCT03215953|offloading|offloading
4703548|NCT03215953|plantar pressure|plantar pressure
4703549|NCT03215953|Diabetic Foot Ulcer|diabetic foot ulcer
4703550|NCT03215953|cast shoe|cast shoe
4703551|NCT03215953|forefoot offloading shoe|forefoot offloading shoe
4703552|NCT03215927|ILD|ild
4703553|NCT03215914|Closed loop insulin delivery system|closed loop insulin delivery system
4703554|NCT03215914|Insulin Pump|insulin pump
4703555|NCT03215914|Glycemic control|glycemic control
4703556|NCT03215914|Glucose Counterregulation|glucose counterregulation
4703557|NCT03215901|Population-based survey|population-based survey
4703558|NCT03215901|HIV treatment|hiv treatment
4703559|NCT03215901|HIV testing|hiv testing
4703560|NCT03215901|Survival expectations|survival expectations
4703561|NCT03215901|Condom use|condom use
4703562|NCT03215901|Life plans|life plans
4703563|NCT03215901|South African young adults|south african young adults
4703564|NCT03215862|Post-ERCP Acute Pancreatitis|post-ercp acute pancreatitis
4703565|NCT03215862|Normal Saline|normal saline
4703566|NCT03215862|Lactated Ringer's|lactated ringer's
4703567|NCT03215823|Intubation|intubation
4703568|NCT03215823|videolaryngoscope|videolaryngoscope
4703569|NCT03215810|Stage IV|stage iv
4703570|NCT03215810|NSCLC|nsclc
4703571|NCT03215810|Recurrent|recurrent
4703572|NCT03215810|TIL|til
4703573|NCT03215810|Tumor-infiltrating Lymphocyte Therapy (TIL)|tumor-infiltrating lymphocyte therapy (til)
4703574|NCT03215797|svv|svv
4703575|NCT03215797|norepinephrine|norepinephrine
4703576|NCT03215797|phenylephrine|phenylephrine
4703577|NCT03215797|elderly|elderly
4703578|NCT03215784|obesity|obesity
4703579|NCT03215784|placenta|placenta
4703580|NCT03215784|inflammation|inflammation
4703581|NCT03215784|fish oil|fish oil
4703582|NCT03215784|probiotics|probiotics
4703583|NCT03215758|QAW039, uncontrolled asthma|qaw039, uncontrolled asthma
4703584|NCT03215745|Delirium|delirium
4703585|NCT03215745|Critical Care|critical care
4703586|NCT03215745|Prevention & control|prevention & control
4703587|NCT03215745|Clinical Trial|clinical trial
4703588|NCT03215732|prevalence|prevalence
4703589|NCT03215732|vaccine coverage|vaccine coverage
4703590|NCT03215732|risk factors|risk factors
4703591|NCT03215732|morbidity|morbidity
4703592|NCT03215732|mortality|mortality
4703593|NCT03215732|quality of life|quality of life
4703594|NCT03215732|economic vulnerability|economic vulnerability
4703595|NCT03215732|food security|food security
4703596|NCT03215732|treatment needs|treatment needs
4703597|NCT03215732|decentralized care|decentralized care
4703598|NCT03215732|health costs|health costs
4703599|NCT03215732|caregivers training|caregivers training
4703600|NCT03215719|Radiation Therapy|radiation therapy
4703601|NCT03215680|Urinary iodine concentration|urinary iodine concentration
4703602|NCT03215654|mental health|mental health
4703603|NCT03215654|promotion|promotion
4703604|NCT03215654|prevention|prevention
4703605|NCT03215654|adolescence|adolescence
4703606|NCT03215654|school programs|school programs
4703607|NCT03215654|intervention|intervention
4703608|NCT03215641|obesity|obesity
4703609|NCT03215641|pediatrics|pediatrics
4703610|NCT03215641|weight management program|weight management program
4703611|NCT03215641|Fitbit|fitbit
4703612|NCT03215641|personal activity tracker|personal activity tracker
4703613|NCT03215628|CEUS|ceus
4703614|NCT03215628|TCEUS|tceus
4703615|NCT03215628|contrast enhanced ultrasound|contrast enhanced ultrasound
4703616|NCT03215628|perfusion|perfusion
4703617|NCT03215628|cerebral perfusion|cerebral perfusion
4703618|NCT03215628|sulphur hexafluoride|sulphur hexafluoride
4703619|NCT03215628|SonoVue|sonovue
4703620|NCT03215602|knee|knee
4703621|NCT03215602|osteoarthritis|osteoarthritis
4703622|NCT03215602|exercise|exercise
4703623|NCT03215602|quadriceps|quadriceps
4703624|NCT03215602|strength|strength
4703625|NCT03215602|activities of daily living|activities of daily living
4703626|NCT03215602|treatment outcome|treatment outcome
4703627|NCT03215589|Near-infrared spectroscopy-derived cerebral oximetry|near-infrared spectroscopy-derived cerebral oximetry
4703628|NCT03215563|atherosclerosis, imaging|atherosclerosis, imaging
4703629|NCT03215550|atherosclerosis, imaging|atherosclerosis, imaging
4703630|NCT03215537|physical activity|physical activity
4703631|NCT03215537|cardiopulmonary function|cardiopulmonary function
4703632|NCT03215537|quality of life|quality of life
4703633|NCT03215537|Perioperative management|perioperative management
4703634|NCT03215537|comprehensive intervention|comprehensive intervention
4703635|NCT03215537|health behavior model|health behavior model
4703636|NCT03215511|NTRK Fusion Positive|ntrk fusion positive
4703637|NCT03215511|LOXO-195|loxo-195
4703638|NCT03215511|Loxo|loxo
4703639|NCT03215511|TRK|trk
4703640|NCT03215511|TRK Fusion|trk fusion
4703641|NCT03215511|NTRK1|ntrk1
4703642|NCT03215511|NTRK2|ntrk2
4703643|NCT03215511|NTRK3|ntrk3
4703644|NCT03215511|TRKA|trka
4703645|NCT03215511|TRKB|trkb
4703646|NCT03215511|TRKC|trkc
4703647|NCT03215511|NTRK|ntrk
4703648|NCT03215511|ETV6|etv6
4703649|NCT03215511|fusion|fusion
4703650|NCT03215511|tumors|tumors
4703651|NCT03215511|CNS tumors|cns tumors
4703652|NCT03215511|solid tumors|solid tumors
4703653|NCT03215511|central nervous system tumors|central nervous system tumors
4703654|NCT03215511|advanced cancer|advanced cancer
4703655|NCT03215511|primary CNS tumor|primary cns tumor
4703656|NCT03215511|Advanced CNS tumor|advanced cns tumor
4703657|NCT03215511|Metastatic CNS tumor|metastatic cns tumor
4703658|NCT03215511|NTRK1 fusion|ntrk1 fusion
4703659|NCT03215511|NTRK2 fusion|ntrk2 fusion
4703660|NCT03215511|NTRK3 fusion|ntrk3 fusion
4703661|NCT03215511|ETV6-NTRK3|etv6-ntrk3
4703662|NCT03215511|ETV6 fusion|etv6 fusion
4703663|NCT03215511|Metastatic cancer|metastatic cancer
4703664|NCT03215511|Cancer of Unknown Primary Site|cancer of unknown primary site
4703665|NCT03215511|Pediatric|pediatric
4703666|NCT03215511|NTRK1 gene rearrangement|ntrk1 gene rearrangement
4703667|NCT03215511|NTRK2 gene rearrangement|ntrk2 gene rearrangement
4703668|NCT03215511|NTRK3 gene rearrangement|ntrk3 gene rearrangement
4703669|NCT03215511|ETV6 gene rearrangement|etv6 gene rearrangement
4703670|NCT03215511|NTRK gene rearragements|ntrk gene rearragements
4703671|NCT03215511|Congenital Nephroma|congenital nephroma
4703672|NCT03215511|Metastatic Infantile Fibrosarcoma|metastatic infantile fibrosarcoma
4703673|NCT03215511|Advanced Infantile Fibrosarcoma|advanced infantile fibrosarcoma
4703674|NCT03215485|adolescent|adolescent
4703675|NCT03215485|sports|sports
4703676|NCT03215485|nutrition|nutrition
4703677|NCT03215485|physical activity|physical activity
4703678|NCT03215485|body mass index|body mass index
4703679|NCT03215485|virtual world|virtual world
4703781|NCT03214731|artesunate|artesunate
4703680|NCT03215459|Cardiopulmonary Exercise Testing|cardiopulmonary exercise testing
4703681|NCT03215394|Social ABCs|social abcs
4703682|NCT03215394|autism|autism
4703683|NCT03215394|autism spectrum disorder|autism spectrum disorder
4703684|NCT03215394|Early Intervention|early intervention
4703685|NCT03215394|Toddler|toddler
4703686|NCT03215394|Early Identification|early identification
4703687|NCT03215394|Pivotal Response Treatment|pivotal response treatment
4703688|NCT03215394|ASD|asd
4703689|NCT03215394|PRT|prt
4703690|NCT03215394|Control Group|control group
4703691|NCT03215394|treatment Group|treatment group
4703692|NCT03215394|At Risk|at risk
4703693|NCT03215394|Social Communication|social communication
4703694|NCT03215394|Positive Affect|positive affect
4703695|NCT03215394|Smiling|smiling
4703696|NCT03215394|Social Orienting|social orienting
4703697|NCT03215394|Attentional Control|attentional control
4703698|NCT03215394|Attentional Disengagement|attentional disengagement
4703699|NCT03215394|Naturalistic Developmental Behaviour Intervention|naturalistic developmental behaviour intervention
4703700|NCT03215394|NDBI|ndbi
4703701|NCT03215381|Healthy Volunteer Male Subjects|healthy volunteer male subjects
4703702|NCT03215355|Adaptive radiotherapy|adaptive radiotherapy
4703703|NCT03215355|Contrast media|contrast media
4703704|NCT03215355|Cone-beam computed tomography|cone-beam computed tomography
4703705|NCT03215355|Stereotactic body radiation therapy|stereotactic body radiation therapy
4703706|NCT03215342|Child|child
4703707|NCT03215342|Rehabilitation|rehabilitation
4703708|NCT03215342|Psychotherapy, groups|psychotherapy, groups
4703709|NCT03215303|Asthma|asthma
4703710|NCT03215303|Continuous positive airway pressure|continuous positive airway pressure
4703711|NCT03215303|Oxygen consumption|oxygen consumption
4703712|NCT03215277|Ankylosing Spondylitis|ankylosing spondylitis
4703713|NCT03215277|Bimekizumab|bimekizumab
4703714|NCT03215277|AS|as
4703715|NCT03215277|Certolizumab Pegol|certolizumab pegol
4703716|NCT03215277|Cimzia|cimzia
4703717|NCT03215251|Thirst, Dry Mouth, Intervention Bundle|thirst, dry mouth, intervention bundle
4703718|NCT03215225|Endodontology|endodontology
4703719|NCT03215225|Endodontics|endodontics
4703720|NCT03215212|ear plug|ear plug
4703721|NCT03215212|eye mask|eye mask
4703722|NCT03215212|ocean sound|ocean sound
4703723|NCT03215212|sleep quality|sleep quality
4703724|NCT03215212|intensive care unit|intensive care unit
4703725|NCT03215186|congenital cataract|congenital cataract
4703726|NCT03215186|risk factor|risk factor
4703727|NCT03215186|mathematic model|mathematic model
4703728|NCT03215160|Mobilization|mobilization
4703729|NCT03215160|Manual Therapies|manual therapies
4703730|NCT03215160|Exercise|exercise
4703731|NCT03215147|Idiopathic Pulmonary Fibrosis|idiopathic pulmonary fibrosis
4703732|NCT03215147|Airway Disease|airway disease
4703733|NCT03215134|Improving Access to Psychological Therapies (IAPT)|improving access to psychological therapies (iapt)
4703734|NCT03215134|Primary mental health service|primary mental health service
4703735|NCT03215134|Compassion Focused Therapy (CFT)|compassion focused therapy (cft)
4703736|NCT03215095|Radioiodine (RAI)|radioiodine (rai)
4703737|NCT03215095|Durvalumab (Medi4736)|durvalumab (medi4736)
4703738|NCT03215095|RAI-avid|rai-avid
4703739|NCT03215095|17-218|17-218
4703740|NCT03215043|Eriocitrin|eriocitrin
4703741|NCT03215043|Intermediate hyperglycemia|intermediate hyperglycemia
4703742|NCT03215043|Citrus bioflavonoids|citrus bioflavonoids
4703743|NCT03215030|Drug therapy|drug therapy
4703744|NCT03215004|Volunteer|volunteer
4703745|NCT03215004|HIV|hiv
4703746|NCT03215004|Leukapheresis|leukapheresis
4703747|NCT03214978|thyroid|thyroid
4703748|NCT03214965|Kidney transplantation|kidney transplantation
4703749|NCT03214965|Facebook|facebook
4703750|NCT03214965|Education|education
4703751|NCT03214965|Adolescent|adolescent
4703752|NCT03214965|Social Networking|social networking
4703753|NCT03214939|dendritic cell, IL-12, IL-18, cytotoxicity|dendritic cell, il-12, il-18, cytotoxicity
4703754|NCT03214926|Parkinson's disease|parkinson's disease
4703755|NCT03214926|Dance|dance
4703756|NCT03214926|Google Glass|google glass
4703757|NCT03214926|Mobility|mobility
4703758|NCT03214926|Balance|balance
4703759|NCT03214913|resuscitation|resuscitation
4703760|NCT03214913|fluid therapy|fluid therapy
4703761|NCT03214887|Hyaluronan|hyaluronan
4703762|NCT03214887|Bone marrow mononuclear cells|bone marrow mononuclear cells
4703763|NCT03214848|Long-acting reversible contraceptive|long-acting reversible contraceptive
4703764|NCT03214848|Post Abortion|post abortion
4703765|NCT03214848|Iintrauterine device|iintrauterine device
4703766|NCT03214848|Contraceptive implant|contraceptive implant
4703767|NCT03214848|LARC|larc
4703768|NCT03214848|IUD|iud
4703769|NCT03214835|Larynx|larynx
4703770|NCT03214835|reflux|reflux
4703771|NCT03214835|LPR|lpr
4703772|NCT03214835|tumor|tumor
4703773|NCT03214835|lesion|lesion
4703774|NCT03214822|Microbiome|microbiome
4703775|NCT03214809|ultrasound|ultrasound
4703776|NCT03214809|MET team|met team
4703777|NCT03214809|Concordance|concordance
4703778|NCT03214783|artificial intelligence|artificial intelligence
4703779|NCT03214783|facial recognition|facial recognition
4703780|NCT03214783|facial characteristic|facial characteristic
4703782|NCT03214705|CT perfusion|ct perfusion
4703783|NCT03214705|Subarachnoid hemorrhage|subarachnoid hemorrhage
4703784|NCT03214705|Vasospasm|vasospasm
4703785|NCT03214705|Delayed cerebral ischemia|delayed cerebral ischemia
4703786|NCT03214692|Gum Arabic|gum arabic
4703787|NCT03214692|Renal failure|renal failure
4703788|NCT03214692|Hemodialysis|hemodialysis
4703789|NCT03214692|Antioxidant and anti-inflammatory|antioxidant and anti-inflammatory
4703790|NCT03214679|Hepatitis C|hepatitis c
4703791|NCT03214679|HCV|hcv
4703792|NCT03214679|People who inject drugs|people who inject drugs
4703793|NCT03214666|MDS|mds
4703794|NCT03214666|AML|aml
4703795|NCT03214640|neuraxial analgesia|neuraxial analgesia
4703796|NCT03214640|spinal block|spinal block
4703797|NCT03214640|epidural block|epidural block
4703798|NCT03214588|Drug Therapy|drug therapy
4703799|NCT03214575|Central Venous Vascular Access|central venous vascular access
4703800|NCT03214575|Intensive Care Unit|intensive care unit
4703801|NCT03214575|Needle Navigation Technology|needle navigation technology
4703802|NCT03214562|Other diseases of blood and blood-forming organs|other diseases of blood and blood-forming organs
4703803|NCT03214562|Acute Myeloid Leukemia|acute myeloid leukemia
4703804|NCT03214562|AML|aml
4703805|NCT03214562|Newly diagnosed|newly diagnosed
4703806|NCT03214562|Relapsed/refractory|relapsed/refractory
4703807|NCT03214562|Fludarabine|fludarabine
4703808|NCT03214562|Fludarabine phosphate|fludarabine phosphate
4703809|NCT03214562|Fludara|fludara
4703810|NCT03214562|Cytarabine|cytarabine
4703811|NCT03214562|Ara-C|ara-c
4703812|NCT03214562|Cytosar|cytosar
4703813|NCT03214562|DepoCyt|depocyt
4703814|NCT03214562|Cytosine arabinosine hydrochloride|cytosine arabinosine hydrochloride
4703815|NCT03214562|Idarubicin|idarubicin
4703816|NCT03214562|Idamycin|idamycin
4703817|NCT03214562|Filgrastim|filgrastim
4703818|NCT03214562|G-CSF|g-csf
4703819|NCT03214562|Neupogen|neupogen
4703820|NCT03214562|Pegylated filgrastim|pegylated filgrastim
4703821|NCT03214562|Neulasta|neulasta
4703822|NCT03214562|Venetoclax|venetoclax
4703823|NCT03214562|ABT-199|abt-199
4703824|NCT03214562|GDC-0199|gdc-0199
4703825|NCT03214536|spine surgery|spine surgery
4703826|NCT03214536|regional anaesthesia|regional anaesthesia
4703827|NCT03214536|opioid consumption|opioid consumption
4703828|NCT03214536|acute postoperative pain|acute postoperative pain
4703829|NCT03214523|sleep|sleep
4703830|NCT03214523|actigraphy|actigraphy
4703831|NCT03214510|Diseases of liver|diseases of liver
4703832|NCT03214510|Thoracic epidural analgesia|thoracic epidural analgesia
4703833|NCT03214510|TEA|tea
4703834|NCT03214510|Transversus abdominus plane|transversus abdominus plane
4703835|NCT03214510|TAP|tap
4703836|NCT03214510|Liver resection|liver resection
4703837|NCT03214510|Bupivacaine|bupivacaine
4703838|NCT03214510|Liposomal Bupivacaine|liposomal bupivacaine
4703839|NCT03214510|Hydromorphone|hydromorphone
4703840|NCT03214510|Questionnaires|questionnaires
4703841|NCT03214510|Surveys|surveys
4703842|NCT03214497|laryngeal mask|laryngeal mask
4703843|NCT03214497|Supreme|supreme
4703844|NCT03214497|Protector|protector
4703845|NCT03214471|bariatric surgery|bariatric surgery
4703846|NCT03214471|healthy lifestyle|healthy lifestyle
4703847|NCT03214458|Therapy|therapy
4703848|NCT03214458|Noninvasive Ventilation|noninvasive ventilation
4703849|NCT03214432|Mild traumatic brain injury|mild traumatic brain injury
4703850|NCT03214432|Concussion|concussion
4703851|NCT03214432|Labour market affiliation|labour market affiliation
4703852|NCT03214432|Return to work|return to work
4703853|NCT03214432|Sickness absence|sickness absence
4703854|NCT03214432|Long-term sickness absence|long-term sickness absence
4703855|NCT03214432|Disability pension|disability pension
4703856|NCT03214419|Breast cancer|breast cancer
4703857|NCT03214419|3D Optical scanning|3d optical scanning
4703858|NCT03214419|Preoperative MRI|preoperative mri
4703859|NCT03214419|Tumor localization|tumor localization
4703860|NCT03214354|sickle cell disease|sickle cell disease
4703861|NCT03214354|stem cell transplant|stem cell transplant
4703862|NCT03214354|red blood cell engraftment|red blood cell engraftment
4703863|NCT03214354|nonmyeloablative|nonmyeloablative
4703864|NCT03214354|pure red cell aplasia|pure red cell aplasia
4703865|NCT03214341|mediastinal masses|mediastinal masses
4703866|NCT03214341|MRI diffusion|mri diffusion
4703867|NCT03214315|Prostatectomy|prostatectomy
4703868|NCT03214302|antiviral treatment|antiviral treatment
4703869|NCT03214302|hepatitis B virus|hepatitis b virus
4703870|NCT03214302|pregnant woman|pregnant woman
4703871|NCT03214302|Postpartum hepatitis|postpartum hepatitis
4703872|NCT03214289|Fecal Microbiota Transplantation|fecal microbiota transplantation
4703873|NCT03214289|Intestinal Acute Graft Versus Host Disease|intestinal acute graft versus host disease
4703874|NCT03214289|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
4703875|NCT03214276|polyphenols|polyphenols
4703876|NCT03214276|cycling|cycling
4703877|NCT03214276|endurance|endurance
4703878|NCT03214276|aerobic|aerobic
4703879|NCT03214276|pain|pain
4703880|NCT03214263|Inflammatory rheumatic diseases|inflammatory rheumatic diseases
4703881|NCT03214263|Biomarkers|biomarkers
4703882|NCT03214263|Tailored treatment|tailored treatment
4703883|NCT03214263|Personalised medicine|personalised medicine
4703884|NCT03214263|DANBIO|danbio
4703885|NCT03214263|Danish Rheumatologic Biobank|danish rheumatologic biobank
4703886|NCT03214263|clinical data|clinical data
4703887|NCT03214250|Nivolumab|nivolumab
4703888|NCT03214250|APX005M|apx005m
4703889|NCT03214250|previously untreated metastatic pancreatic adenocarcinoma|previously untreated metastatic pancreatic adenocarcinoma
4703890|NCT03214250|Gemcitabine|gemcitabine
4703891|NCT03214250|nab-Paclitaxel|nab-paclitaxel
4703892|NCT03214224|Telemedicine|telemedicine
4703893|NCT03214224|Pulmonary Function Testing|pulmonary function testing
4703894|NCT03214224|Telehealth|telehealth
4703895|NCT03214185|unexplained recurrent pregnancy loss|unexplained recurrent pregnancy loss
4703896|NCT03214185|infertility, female|infertility, female
4703897|NCT03214185|preimplantation genetic screening|preimplantation genetic screening
4703898|NCT03214185|in vitro fertilization|in vitro fertilization
4703899|NCT03214185|intracytoplasmic sperm injection|intracytoplasmic sperm injection
4703900|NCT03214146|ALS|als
4703901|NCT03214146|Motor Neuron Disease|motor neuron disease
4703902|NCT03214146|Neuromuscular Disease|neuromuscular disease
4703903|NCT03214146|Neurodegenerative Disease|neurodegenerative disease
4703904|NCT03214146|Central Nervous System Disease|central nervous system disease
4703905|NCT03214146|HLA-haplo matched allogenic bone marrow derived stem cells|hla-haplo matched allogenic bone marrow derived stem cells
4703906|NCT03214120|thromboelastography, modified ultrafiltration|thromboelastography, modified ultrafiltration
4703907|NCT03214107|Exercise|exercise
4703908|NCT03214107|Hypoglycemia|hypoglycemia
4703909|NCT03214107|Carbohydrates|carbohydrates
4703910|NCT03214029|troponin|troponin
4703911|NCT03214029|high-sensitivity cardiac troponin|high-sensitivity cardiac troponin
4703912|NCT03214029|acute myocardial infarction|acute myocardial infarction
4703913|NCT03214016|Pilates Training|pilates training
4703914|NCT03214016|Aerobic Exercises|aerobic exercises
4703915|NCT03214016|Hypertension|hypertension
4703916|NCT03214016|Clinical trial|clinical trial
4703917|NCT03214003|small cell lung cancer limited stage|small cell lung cancer limited stage
4703918|NCT03214003|twice-daily radiotherapy|twice-daily radiotherapy
4703919|NCT03214003|simultaneous integrated boosting technique|simultaneous integrated boosting technique
4703920|NCT03213990|Sepsis|sepsis
4703921|NCT03213990|Beta-lactam antibiotics|beta-lactam antibiotics
4703922|NCT03213977|DLBCL, R-DA-EPOCH, R-CEOP90, auto-HSCT|dlbcl, r-da-epoch, r-ceop90, auto-hsct
4703923|NCT03213964|Recurrent|recurrent
4703924|NCT03213964|Platinum Resistant|platinum resistant
4703925|NCT03213964|Platinum Sensitive|platinum sensitive
4703926|NCT03213951|Surgical resection|surgical resection
4703927|NCT03213951|Margins of resection|margins of resection
4703928|NCT03213951|Beta radiopharmaceutical|beta radiopharmaceutical
4703929|NCT03213951|Beta probe device|beta probe device
4703931|NCT03213938|Chronic prostatitis|chronic prostatitis
4703932|NCT03213938|chronic pelvic pain syndrome|chronic pelvic pain syndrome
4703933|NCT03213938|acupuncture|acupuncture
4703934|NCT03213938|randomized controlled trial|randomized controlled trial
4703935|NCT03213912|effective concentration|effective concentration
4703936|NCT03213899|Subjective Global Assessment|subjective global assessment
4703937|NCT03213899|Nutritional Status|nutritional status
4703938|NCT03213899|Hospital Mortality|hospital mortality
4703939|NCT03213899|Length of Stay|length of stay
4703940|NCT03213899|Malnutrition|malnutrition
4703941|NCT03213886|hip fracture|hip fracture
4703942|NCT03213886|elderly|elderly
4703943|NCT03213886|vitamin D|vitamin d
4703944|NCT03213886|rehabilitation|rehabilitation
4703945|NCT03213873|Balance control|balance control
4703946|NCT03213873|Exercise|exercise
4703947|NCT03213873|Magnetic Resonance Imaging|magnetic resonance imaging
4703948|NCT03213873|Functional Magnetic Resonance Imaging|functional magnetic resonance imaging
4703949|NCT03213847|Carpal Tunnel Syndrome|carpal tunnel syndrome
4703950|NCT03213847|Superb microvascular imaging|superb microvascular imaging
4703951|NCT03213847|Doppler ultrasound|doppler ultrasound
4703952|NCT03213847|Ultrasound|ultrasound
4703953|NCT03213847|Median Nerve Entrapment|median nerve entrapment
4703954|NCT03213847|Diagnoses Disease|diagnoses disease
4703955|NCT03213808|Allergic diseases|allergic diseases
4703956|NCT03213808|hypersensitivity|hypersensitivity
4703957|NCT03213808|International Classification of Diseases (ICD)|international classification of diseases (icd)
4703958|NCT03213808|World Health Organization (WHO)|world health organization (who)
4703959|NCT03213782|Nature Based Sounds|nature based sounds
4703960|NCT03213782|Agitation|agitation
4703961|NCT03213782|Anxiety|anxiety
4703962|NCT03213782|Patients|patients
4703963|NCT03213782|Intensive Care Units|intensive care units
4703964|NCT03213769|oral minor aphthous ulcer|oral minor aphthous ulcer
4703965|NCT03213769|topical Q10 gel|topical q10 gel
4703966|NCT03213769|topical antioxidant|topical antioxidant
4703967|NCT03213769|oral recurrent aphthous ulcer|oral recurrent aphthous ulcer
4703968|NCT03213769|oral aphthous stomatitis|oral aphthous stomatitis
4703969|NCT03213756|doppler ultrasound|doppler ultrasound
4703970|NCT03213756|physical exercise|physical exercise
4703971|NCT03213756|arteriovenous fistula maturation|arteriovenous fistula maturation
4703972|NCT03213717|Obesity|obesity
4703973|NCT03213717|Loading|loading
4703974|NCT03213717|Edema|edema
4703975|NCT03213717|Urine|urine
4703976|NCT03213613|Teen health|teen health
4703977|NCT03213613|Teen development|teen development
4703978|NCT03213613|Adolescent development|adolescent development
4703979|NCT03213613|Memory|memory
4703980|NCT03213613|Attention|attention
4703981|NCT03213613|Reward processing|reward processing
4703982|NCT03213574|Goal directed fluid therapy|goal directed fluid therapy
4703983|NCT03213548|alar base reduction|alar base reduction
4703984|NCT03213548|alar facial groove|alar facial groove
4703985|NCT03213548|alectomy|alectomy
4703986|NCT03213548|Flare|flare
4703987|NCT03213548|Nose|nose
4703988|NCT03213535|PROM|prom
4703989|NCT03213496|clinical trial, non cardiac surgery, walking.|clinical trial, non cardiac surgery, walking.
4703990|NCT03213483|gingival recession|gingival recession
4703991|NCT03213483|connective tissue graft|connective tissue graft
4703992|NCT03213483|deepithelialized free gingival graft|deepithelialized free gingival graft
4703993|NCT03213483|free gingival graft|free gingival graft
4703994|NCT03213457|Elagolix|elagolix
4703995|NCT03213457|Endometriosis associated pain|endometriosis associated pain
4703996|NCT03213457|Dysmenorrhea (DYS)|dysmenorrhea (dys)
4703997|NCT03213457|Non-menstrual pelvic pain (NMPP)|non-menstrual pelvic pain (nmpp)
4703998|NCT03213444|Colon cancer|colon cancer
4703999|NCT03213444|adjuvant chemotherapy|adjuvant chemotherapy
4704000|NCT03213444|sympathetic nerve activity|sympathetic nerve activity
4704001|NCT03213444|peripheral vascular function|peripheral vascular function
4704002|NCT03213431|Cancer survivors|cancer survivors
4704003|NCT03213431|Instrument development|instrument development
4704004|NCT03213431|Neurocognitive functioning|neurocognitive functioning
4704005|NCT03213431|Patient-reported outcomes|patient-reported outcomes
4704006|NCT03213431|Qualitative interview|qualitative interview
4704007|NCT03213405|human Respiratory Syncytial Virus|human respiratory syncytial virus
4704008|NCT03213405|Phase I|phase i
4704009|NCT03213405|Recombinant BCG vaccine|recombinant bcg vaccine
4704010|NCT03213379|actimeter|actimeter
4704011|NCT03213379|apomorphin pump|apomorphin pump
4704012|NCT03213366|PrEP|prep
4704013|NCT03213366|HIV prevention|hiv prevention
4704014|NCT03213366|Public Health Social Media Campaign|public health social media campaign
4704015|NCT03213366|Peer Intervention|peer intervention
4704016|NCT03213327|mental health|mental health
4704017|NCT03213327|assessment|assessment
4704018|NCT03213327|health promotion|health promotion
4704019|NCT03213327|case management|case management
4704020|NCT03213327|health insurance|health insurance
4704021|NCT03213314|LiverMultiScan|livermultiscan
4704022|NCT03213314|multiparameter MRI|multiparameter mri
4704023|NCT03213314|functional liver remnant|functional liver remnant
4704024|NCT03213314|liver resection|liver resection
4704025|NCT03213314|hepatic resection|hepatic resection
4704026|NCT03213314|portal vein embolisation|portal vein embolisation
4704027|NCT03213314|preoperative liver function|preoperative liver function
4704028|NCT03213314|postoperative liver failure|postoperative liver failure
4704029|NCT03213301|Progressive Malignant Pleural Mesothelioma|progressive malignant pleural mesothelioma
4704030|NCT03213301|Lurbinectedin|lurbinectedin
4704031|NCT03213301|Mesothelioma|mesothelioma
4704032|NCT03213301|Phase II Trial|phase ii trial
4704033|NCT03213275|Extremely premature infants|extremely premature infants
4704034|NCT03213275|gut-immune-brain axis|gut-immune-brain axis
4704035|NCT03213275|neonatal brain injury|neonatal brain injury
4704036|NCT03213275|gut microbiome|gut microbiome
4704037|NCT03213275|neurodevelopmental outcome|neurodevelopmental outcome
4704038|NCT03213275|neonatal immunity|neonatal immunity
4704039|NCT03213223|retention|retention
4704040|NCT03213223|attrition|attrition
4704041|NCT03213223|PMTCT|pmtct
4704042|NCT03213223|elimination of mother to child transmission of HIV|elimination of mother to child transmission of hiv
4704043|NCT03213184|Birth cohort|birth cohort
4704044|NCT03213184|asthma|asthma
4704045|NCT03213184|allergies|allergies
4704046|NCT03213171|organ donation|organ donation
4704047|NCT03213171|family physician|family physician
4704048|NCT03213171|primary care|primary care
4704049|NCT03213171|clinical trial|clinical trial
4704050|NCT03213171|registry trial|registry trial
4704051|NCT03213171|cluster trial|cluster trial
4704052|NCT03213171|stepped-wedge|stepped-wedge
4704053|NCT03213145|drug-drug interaction|drug-drug interaction
4704054|NCT03213132|sleep|sleep
4704055|NCT03213132|insomnia|insomnia
4704056|NCT03213132|CBT|cbt
4704057|NCT03213119|Caloric Vestibular Stimulation Reward|caloric vestibular stimulation reward
4704058|NCT03213119|Brain Stimulation|brain stimulation
4704059|NCT03213119|Reward|reward
4704060|NCT03213119|Vestibular System|vestibular system
4704061|NCT03213119|Cingulate Cortex|cingulate cortex
4704062|NCT03213119|Cancellation Tasks|cancellation tasks
4704063|NCT03213106|TMS|tms
4704064|NCT03213106|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
4704065|NCT03213106|Cerebellar Ataxia|cerebellar ataxia
4704066|NCT03213093|Diabetes|diabetes
4704067|NCT03213093|Diabetic Foot Ulcer|diabetic foot ulcer
4704068|NCT03213093|Plantar pressure|plantar pressure
4704069|NCT03213080|Targeted Lung Denervation|targeted lung denervation
4704070|NCT03213080|TLD|tld
4704071|NCT03213054|esophageal cancer|esophageal cancer
4704072|NCT03213054|OBP-301|obp-301
4704073|NCT03213054|radiation|radiation
4704074|NCT03213054|Telomelysin|telomelysin
4704075|NCT03213054|radiotherapy|radiotherapy
4704076|NCT03213054|oncolytic|oncolytic
4704077|NCT03213054|virotherapy|virotherapy
4704078|NCT03213054|loco regional|loco regional
4704079|NCT03213015|confiability|confiability
4704080|NCT03213015|ankle|ankle
4704081|NCT03213015|patellofemoral pain syndrome|patellofemoral pain syndrome
4704082|NCT03212989|HIV|hiv
4704083|NCT03212989|HXTC|hxtc
4704084|NCT03212989|Antiretroviral Therapy|antiretroviral therapy
4704085|NCT03212989|HIV-Infected|hiv-infected
4704086|NCT03212989|Vorinostat|vorinostat
4704087|NCT03212989|AIDS|aids
4704088|NCT03212976|Non-Invasive|non-invasive
4704089|NCT03212976|Magnetic Resonance Imaging|magnetic resonance imaging
4704090|NCT03212976|Ventricular catheters|ventricular catheters
4704091|NCT03212924|cochlear implant|cochlear implant
4704092|NCT03212924|Listening effort|listening effort
4704093|NCT03212924|pupillometry|pupillometry
4704094|NCT03212911|HBV vaccination, HIV, isolated anti-HBc|hbv vaccination, hiv, isolated anti-hbc
4704095|NCT03212898|pharmacist interventions, warfarin, elderly rural patients|pharmacist interventions, warfarin, elderly rural patients
4704096|NCT03212885|Deep Brain Stimulation|deep brain stimulation
4704097|NCT03212872|Ammonia|ammonia
4704098|NCT03212872|bleeding risk factors|bleeding risk factors
4704099|NCT03212872|endoscopic risk signs for bleeding|endoscopic risk signs for bleeding
4704100|NCT03212872|esophageal varices|esophageal varices
4704101|NCT03212859|older adults|older adults
4704102|NCT03212859|physiotherapy|physiotherapy
4704103|NCT03212859|physical activity|physical activity
4704104|NCT03212846|hippotherapy|hippotherapy
4704105|NCT03212846|cerebral palsy|cerebral palsy
4704106|NCT03212846|spasticity|spasticity
4704107|NCT03212807|Checkpoint inhibition|checkpoint inhibition
4704108|NCT03212807|PDL1|pdl1
4704109|NCT03212807|EBV DLBCL|ebv dlbcl
4704110|NCT03212807|PCNSL|pcnsl
4704111|NCT03212716|Infectiology|infectiology
4704112|NCT03212716|Biology of infectious agents|biology of infectious agents
4704113|NCT03212716|Flu|flu
4704114|NCT03212716|Intensive care|intensive care
4704115|NCT03212703|Mindfulness training|mindfulness training
4704116|NCT03212703|Parents and families|parents and families
4704117|NCT03212703|Pediatric OCD|pediatric ocd
4704118|NCT03212690|mechanical ventilation|mechanical ventilation
4704119|NCT03212690|echocardiography|echocardiography
4704120|NCT03212690|right ventricular function|right ventricular function
4704121|NCT03212690|Ang (1-7)|ang (1-7)
4704122|NCT03212690|Ang II|ang ii
4704123|NCT03212690|Renin-angiotensin system|renin-angiotensin system
4704124|NCT03212625|Urea Cream|urea cream
4704125|NCT03212625|Sorafenib|sorafenib
4704126|NCT03212612|Galectin-3 ,endometrosis|galectin-3 ,endometrosis
4704127|NCT03212599|APP-processing|app-processing
4704128|NCT03212599|Disulfiram|disulfiram
4704129|NCT03212599|ADAM10|adam10
4704130|NCT03212599|Alzheimer's disease|alzheimer's disease
4704131|NCT03212599|blood|blood
4704132|NCT03212560|Exercise capacity|exercise capacity
4704133|NCT03212560|Physical activity|physical activity
4704134|NCT03212560|Quality of life|quality of life
4704135|NCT03212560|Pulmonary functions|pulmonary functions
4704136|NCT03212560|Muscle strength|muscle strength
4704137|NCT03212560|Respiratory muscle strength|respiratory muscle strength
4704138|NCT03212560|Respiratory muscle endurance|respiratory muscle endurance
4704139|NCT03212560|Dyspnea|dyspnea
4704140|NCT03212560|Anxiety|anxiety
4704141|NCT03212560|Fatigue|fatigue
4704142|NCT03212547|Social withdrawal|social withdrawal
4704143|NCT03212547|Preterm Infant|preterm infant
4704144|NCT03212547|Parent's mental health|parent's mental health
4704145|NCT03212534|Dascena|dascena
4704146|NCT03212534|patient mortality|patient mortality
4704147|NCT03212534|machine learning|machine learning
4704148|NCT03212534|algorithm|algorithm
4704149|NCT03212534|diagnostic|diagnostic
4704150|NCT03212521|chronic hepatitis C virus (HCV)|chronic hepatitis c virus (hcv)
4704151|NCT03212521|Hepatitis|hepatitis
4704152|NCT03212521|HCV genotype|hcv genotype
4704153|NCT03212521|aspartate aminotransferase|aspartate aminotransferase
4704154|NCT03212521|platelet|platelet
4704155|NCT03212521|Aspartate aminotransferase to Platelet Ratio Index (APRI)|aspartate aminotransferase to platelet ratio index (apri)
4704156|NCT03212521|glecaprevir|glecaprevir
4704157|NCT03212521|pibrentasvir|pibrentasvir
4704158|NCT03212521|Sustained Virologic Response 12 weeks post dosing (SVR12)|sustained virologic response 12 weeks post dosing (svr12)
4704159|NCT03212508|Continuous positive airway pressure, preterm|continuous positive airway pressure, preterm
4704160|NCT03212495|knee arthroscopy|knee arthroscopy
4704161|NCT03212495|dexmedetomidine|dexmedetomidine
4704162|NCT03212495|neostigmine|neostigmine
4704163|NCT03212482|brain-injured patients, patient-ventilator asychrony|brain-injured patients, patient-ventilator asychrony
4704164|NCT03212456|general anesthesia|general anesthesia
4704165|NCT03212456|cancer recurrence|cancer recurrence
4704166|NCT03212456|opioids analgesics|opioids analgesics
4704167|NCT03212456|neoplasm|neoplasm
4704168|NCT03212430|L-kynurenine|l-kynurenine
4704169|NCT03212430|Cerebral hemodynamic|cerebral hemodynamic
4704170|NCT03212430|Headache|headache
4704171|NCT03212430|Mohammad Al-Mahdi Al-Karagholi|mohammad al-mahdi al-karagholi
4704172|NCT03212404|Cancer|cancer
4704173|NCT03212404|PD-L1|pd-l1
4704174|NCT03212404|PDL1|pdl1
4704175|NCT03212404|PD-1|pd-1
4704176|NCT03212404|PD1|pd1
4704177|NCT03212404|Solid tumors|solid tumors
4704178|NCT03212404|Anti PD-L1|anti pd-l1
4704179|NCT03212352|miscarriage|miscarriage
4704180|NCT03212352|mifepristone|mifepristone
4704181|NCT03212352|misoprostol|misoprostol
4704182|NCT03212352|medical treatment|medical treatment
4704183|NCT03212352|patient satisfaction|patient satisfaction
4704184|NCT03212352|abortifacient agents|abortifacient agents
4704185|NCT03212339|parent-child interactions|parent-child interactions
4704186|NCT03212339|mental health care|mental health care
4704187|NCT03212339|child health services|child health services
4704188|NCT03212339|parenting confidence|parenting confidence
4704189|NCT03212339|adverse childhood events|adverse childhood events
4704190|NCT03212339|dyadic care model|dyadic care model
4704191|NCT03212313|Adults|adults
4704192|NCT03212313|Liver Disease|liver disease
4704193|NCT03212300|aerobic exercise training|aerobic exercise training
4704194|NCT03212300|delirium|delirium
4704195|NCT03212261|Lymphoma|lymphoma
4704196|NCT03212222|screening|screening
4704197|NCT03212222|cell phone application|cell phone application
4704198|NCT03212209|Sleep Apnea|sleep apnea
4704199|NCT03212209|CPAP|cpap
4704200|NCT03212196|Pancreaticoduodenectomy|pancreaticoduodenectomy
4704201|NCT03212196|Pancreaticogastrostomy|pancreaticogastrostomy
4704202|NCT03212196|Pancreaticojejunostomy|pancreaticojejunostomy
4704203|NCT03212196|Stent|stent
4704204|NCT03212196|Transanastomotic drain|transanastomotic drain
4704205|NCT03212183|web-based intervention|web-based intervention
4704206|NCT03212183|self-management|self-management
4704207|NCT03212183|nursing|nursing
4704208|NCT03212183|epilepsy|epilepsy
4704209|NCT03212183|seizures|seizures
4704210|NCT03212170|Invasive Breast Cancer|invasive breast cancer
4704211|NCT03212170|Metastatic Breast Cancer|metastatic breast cancer
4704212|NCT03212170|PR Positive Breast Cancer|pr positive breast cancer
4704213|NCT03212144|nuts|nuts
4704214|NCT03212144|exercise|exercise
4704215|NCT03212144|vagal activity|vagal activity
4704216|NCT03212144|peanuts|peanuts
4704217|NCT03212144|heart rate variability|heart rate variability
4704218|NCT03212118|Sick Leave|sick leave
4704219|NCT03212118|Return to work|return to work
4704220|NCT03212118|Motivational interviewing|motivational interviewing
4704221|NCT03212118|Absenteeism|absenteeism
4704222|NCT03212118|Occupational Health|occupational health
4704223|NCT03212092|Aggression|aggression
4704224|NCT03212092|aggressive behavior|aggressive behavior
4704225|NCT03212092|nutritional supplements|nutritional supplements
4704226|NCT03212092|dietary supplements|dietary supplements
4704227|NCT03212092|vitamin, mineral|vitamin, mineral
4704228|NCT03212092|omega-3|omega-3
4704229|NCT03212092|n-3 fatty acids|n-3 fatty acids
4704230|NCT03212092|intellectual disability|intellectual disability
4704231|NCT03212079|Cancer Survivors|cancer survivors
4704232|NCT03212079|Physical Activities|physical activities
4704233|NCT03212079|Baltimore|baltimore
4704234|NCT03212079|State of Maryland|state of maryland
4704235|NCT03212053|Essential thrombocythemia|essential thrombocythemia
4704236|NCT03212053|Multiplate|multiplate
4704237|NCT03212053|ROTEM|rotem
4704238|NCT03212053|haemorrhage|haemorrhage
4704239|NCT03212053|thrombosis|thrombosis
4704240|NCT03212053|Vasodilatator Stimulated Phosphoprotein (VASP)|vasodilatator stimulated phosphoprotein (vasp)
4704241|NCT03212027|apparent diffusion coefficient|apparent diffusion coefficient
4704242|NCT03212027|aquaporins|aquaporins
4704243|NCT03212014|Parkinson Disease|parkinson disease
4704244|NCT03212014|intelligent|intelligent
4704245|NCT03212014|Rehabilitaion|rehabilitaion
4704246|NCT03211988|abdominal|abdominal
4704247|NCT03211988|neuroendocrine tumor|neuroendocrine tumor
4704248|NCT03211988|columbia|columbia
4704249|NCT03211988|relapsed|relapsed
4704250|NCT03211988|refractory|refractory
4704251|NCT03211949|axillary nerve block|axillary nerve block
4704252|NCT03211923|muscle relaxation|muscle relaxation
4704253|NCT03211923|transcranial magnetic stimulation|transcranial magnetic stimulation
4704254|NCT03211923|myopathy|myopathy
4704255|NCT03211910|Sacral and trochenteric pressure ulcers|sacral and trochenteric pressure ulcers
4704256|NCT03211884|Problem solving therapy|problem solving therapy
4704257|NCT03211884|Military family caregivers|military family caregivers
4704258|NCT03211884|Cognitive impariment|cognitive impariment
4704259|NCT03211884|Traumatic brain injury|traumatic brain injury
4704260|NCT03211871|pain management, dexmedetomidine|pain management, dexmedetomidine
4704261|NCT03211845|Ehealth|ehealth
4704262|NCT03211845|Older adults|older adults
4704263|NCT03211845|Undernutrition|undernutrition
4704264|NCT03211845|Feasibility study|feasibility study
4704265|NCT03211832|Dissemination research|dissemination research
4704266|NCT03211832|Public health workforce|public health workforce
4704267|NCT03211832|Diabetes prevention|diabetes prevention
4704268|NCT03211832|Diabetes control|diabetes control
4704269|NCT03211832|Chronic disease prevention|chronic disease prevention
4704270|NCT03211832|Evidence-based public health|evidence-based public health
4704271|NCT03211832|Public health accreditation|public health accreditation
4704272|NCT03211819|immediate|immediate
4704273|NCT03211819|esthetics|esthetics
4704274|NCT03211793|systemic sclerosis|systemic sclerosis
4704275|NCT03211793|scleroderma|scleroderma
4704276|NCT03211793|digital ulcer|digital ulcer
4704277|NCT03211793|vasculopathy|vasculopathy
4704278|NCT03211793|mesenchymal stromal cell|mesenchymal stromal cell
4704279|NCT03211793|mesenchymal stem cell|mesenchymal stem cell
4704280|NCT03211754|Walnuts|walnuts
4704281|NCT03211754|almonds|almonds
4704282|NCT03211754|adiponectin|adiponectin
4704283|NCT03211754|lipocalin-2|lipocalin-2
4704284|NCT03211754|obesity|obesity
4704285|NCT03211741|Bevacizumab|bevacizumab
4704286|NCT03211702|geriatric assessments|geriatric assessments
4704287|NCT03211702|diffuse large B-cell lymphoma|diffuse large b-cell lymphoma
4704288|NCT03211702|activity of daily living|activity of daily living
4704289|NCT03211702|instrumental activity of daily living|instrumental activity of daily living
4704290|NCT03211702|Charlson's comorbidity index|charlson's comorbidity index
4704291|NCT03211689|Exercise|exercise
4704292|NCT03211689|Stress|stress
4704293|NCT03211689|Fatigue|fatigue
4704294|NCT03211689|Quality of Life|quality of life
4704295|NCT03211676|dialyzer|dialyzer
4704296|NCT03211676|beta2-microglobilin|beta2-microglobilin
4704297|NCT03211676|myoglobin|myoglobin
4704298|NCT03211637|nursing care|nursing care
4704299|NCT03211637|skin lesions|skin lesions
4704300|NCT03211637|wound healing|wound healing
4704301|NCT03211637|varicose ulcers|varicose ulcers
4704302|NCT03211611|BRCA1/2 Mutation|brca1/2 mutation
4704303|NCT03211611|Breast cancer|breast cancer
4704304|NCT03211611|General practitionner|general practitionner
4704305|NCT03211572|breast|breast
4704306|NCT03211559|ankylosing spondylitis|ankylosing spondylitis
4704307|NCT03211559|clinical pilates exercise|clinical pilates exercise
4704308|NCT03211559|aerobic exercise|aerobic exercise
4704309|NCT03211559|functional exercise capacity|functional exercise capacity
4704310|NCT03211559|pulmonary function|pulmonary function
4704311|NCT03211546|Pediatric femur fracture|pediatric femur fracture
4704312|NCT03211546|Spica casting|spica casting
4704313|NCT03211546|Traction|traction
4704314|NCT03211546|Intramedullary nailing|intramedullary nailing
4704315|NCT03211546|Children|children
4704316|NCT03211546|Internal fixation|internal fixation
4704317|NCT03211546|External fixation|external fixation
4704318|NCT03211533|infants at risk of cerebral palsy|infants at risk of cerebral palsy
4704319|NCT03211533|MRI|mri
4704320|NCT03211533|general movements|general movements
4704321|NCT03211520|Cancer treatment|cancer treatment
4704322|NCT03211520|Anthracyclines|anthracyclines
4704323|NCT03211520|Cardiac MRI|cardiac mri
4704324|NCT03211494|Mechanical ventilation|mechanical ventilation
4704325|NCT03211494|Driving pressure|driving pressure
4704326|NCT03211494|Closed-loop ventilation|closed-loop ventilation
4704327|NCT03211494|Esophageal catheter|esophageal catheter
4704328|NCT03211455|bariatric surgery|bariatric surgery
4704329|NCT03211455|rehabilitation|rehabilitation
4704330|NCT03211455|lidocaine|lidocaine
4704331|NCT03211442|Breast cancer|breast cancer
4704332|NCT03211442|Radiotherapy|radiotherapy
4704333|NCT03211442|Cardiac complications|cardiac complications
4704334|NCT03211442|Acute coronary events|acute coronary events
4704335|NCT03211442|NTCP model|ntcp model
4704336|NCT03211325|Transient Receptor Potential Channels|transient receptor potential channels
4704337|NCT03211325|Raynaud's Phenomenon Isolated Primary|raynaud's phenomenon isolated primary
4704338|NCT03211325|Raynaud's Phenomenon (Secondary)|raynaud's phenomenon (secondary)
4704339|NCT03211286|Hip fracture|hip fracture
4704340|NCT03211286|Tranexamic acid|tranexamic acid
4704341|NCT03211286|Perioperative blood loss|perioperative blood loss
4704342|NCT03211286|Blood Transfusion|blood transfusion
4704343|NCT03211260|Parkinson Disease|parkinson disease
4704344|NCT03211260|Freezing of gait|freezing of gait
4704345|NCT03211260|Equistasi|equistasi
4704346|NCT03211247|EPIT|epit
4704347|NCT03211247|Epicutaneous|epicutaneous
4704348|NCT03211247|Immunotherapy|immunotherapy
4704349|NCT03211247|Viaskin|viaskin
4704350|NCT03211221|OCD|ocd
4704351|NCT03211221|TMS|tms
4704352|NCT03211182|lifestyle intervention|lifestyle intervention
4704353|NCT03211182|prediabetes|prediabetes
4704354|NCT03211156|Amoxicillin|amoxicillin
4704355|NCT03211156|Gardnerella vaginalis|gardnerella vaginalis
4704356|NCT03211156|Vaginal Colonization|vaginal colonization
4704357|NCT03211143|GERD|gerd
4704358|NCT03211143|CKD-381|ckd-381
4704359|NCT03211143|Nexium|nexium
4704360|NCT03211143|Bioequivalence|bioequivalence
4704361|NCT03211130|medication adherence|medication adherence
4704362|NCT03211130|self-management|self-management
4704363|NCT03211130|antithrombotic|antithrombotic
4704364|NCT03211104|intermittent androgen deprivation therapy|intermittent androgen deprivation therapy
4704365|NCT03211104|curcumin|curcumin
4704366|NCT03211078|Early lung cancer|early lung cancer
4704367|NCT03211078|Photodynamic therapy|photodynamic therapy
4704368|NCT03211078|ENB|enb
4704369|NCT03211065|Rituximab|rituximab
4704370|NCT03211065|Non Hodgkin's Lymphoma|non hodgkin's lymphoma
4704371|NCT03211065|Subcutaneous Immunoglobulin|subcutaneous immunoglobulin
4704372|NCT03211039|Rady Children's|rady children's
4704373|NCT03211039|Pediatric|pediatric
4704374|NCT03211039|Genomic|genomic
4704375|NCT03211039|Precision Medicine|precision medicine
4704376|NCT03211039|Neonate|neonate
4704377|NCT03211026|Urinary tract infection|urinary tract infection
4704378|NCT03211026|Multidrug resistant bacteria|multidrug resistant bacteria
4704379|NCT03211026|Candiduria|candiduria
4704380|NCT03211026|Epidemiology|epidemiology
4704381|NCT03211026|Graft rejection|graft rejection
4704382|NCT03211026|Solid organ transplantation|solid organ transplantation
4704383|NCT03211013|oxytocin|oxytocin
4704384|NCT03211013|PTSD|ptsd
4704385|NCT03211013|attention bias|attention bias
4704386|NCT03211013|startle|startle
4704387|NCT03211000|aortic aneurysm|aortic aneurysm
4704388|NCT03211000|autophagy|autophagy
4704389|NCT03211000|oxidative stress|oxidative stress
4704390|NCT03211000|Hippo pathway|hippo pathway
4704391|NCT03210987|ward round|ward round
4704392|NCT03210987|patient case presentation|patient case presentation
4704393|NCT03210987|communication|communication
4704394|NCT03210987|patient-centered care|patient-centered care
4704395|NCT03210935|Adnexal cutaneous carcinoma|adnexal cutaneous carcinoma
4704396|NCT03210935|Merkel cell carcinoma|merkel cell carcinoma
4704397|NCT03210935|Advanced basal cell carcinoma requiring systemic treatment|advanced basal cell carcinoma requiring systemic treatment
4704398|NCT03210922|cervical collar, nasoendotracheal intubation, glidescope|cervical collar, nasoendotracheal intubation, glidescope
4704399|NCT03210870|Maternal health|maternal health
4704400|NCT03210870|maternal nutrition|maternal nutrition
4704401|NCT03210870|fetal health related to maternal nutrition|fetal health related to maternal nutrition
4704402|NCT03210857|apnea|apnea
4704403|NCT03210857|neck extension|neck extension
4704404|NCT03210857|syncope|syncope
4704405|NCT03210857|diving blackout|diving blackout
4704406|NCT03210857|right internal carotid arteria|right internal carotid arteria
4704407|NCT03210857|pulsatility index|pulsatility index
4704408|NCT03210857|healthy trained apnoea divers|healthy trained apnoea divers
4704409|NCT03210857|doppler ultrasonography|doppler ultrasonography
4704410|NCT03210844|total hip arthroplasty|total hip arthroplasty
4704411|NCT03210844|direct anterior|direct anterior
4704412|NCT03210844|posterior approach|posterior approach
4704413|NCT03210831|NEC, tissue oxygenation, gut inflammation|nec, tissue oxygenation, gut inflammation
4704414|NCT03210779|oral wound healing|oral wound healing
4704415|NCT03210779|probiotics|probiotics
4704416|NCT03210766|Cannabinoids, nabilone, FBSS, THC/CBD, refractory pain|cannabinoids, nabilone, fbss, thc/cbd, refractory pain
4704417|NCT03210753|Multiple Myeloma|multiple myeloma
4704418|NCT03210753|Peripheral neuropathy|peripheral neuropathy
4704419|NCT03210753|Subcutaneous injection|subcutaneous injection
4704420|NCT03210753|Bortezomib|bortezomib
4704421|NCT03210753|Risk factors|risk factors
4704422|NCT03210701|pharmacy|pharmacy
4704423|NCT03210701|pharmacist|pharmacist
4704424|NCT03210701|POCT|poct
4704425|NCT03210701|Implementation science|implementation science
4704426|NCT03210688|Prednisolone|prednisolone
4704427|NCT03210688|alfacalcidol|alfacalcidol
4704428|NCT03210688|Minimal change nephropathy|minimal change nephropathy
4704429|NCT03210662|Malignant neoplasms stated as primary lymphoid haematopoietic|malignant neoplasms stated as primary lymphoid haematopoietic
4704430|NCT03210662|Non-Hodgkin Lymphoma|non-hodgkin lymphoma
4704431|NCT03210662|NHL|nhl
4704432|NCT03210662|Relapsed|relapsed
4704433|NCT03210662|Refractory|refractory
4704434|NCT03210662|Pembrolizumab|pembrolizumab
4704435|NCT03210662|Keytruda|keytruda
4704436|NCT03210662|MK-3475|mk-3475
4704437|NCT03210662|SCH-900475|sch-900475
4704438|NCT03210662|External Beam Radiotherapy|external beam radiotherapy
4704439|NCT03210662|EBRT|ebrt
4704440|NCT03210662|Radiation therapy|radiation therapy
4704441|NCT03210649|Dyslipidemia|dyslipidemia
4704442|NCT03210597|water-base exercise|water-base exercise
4704443|NCT03210584|Knee joint|knee joint
4704444|NCT03210584|Cartilage degeneration|cartilage degeneration
4704445|NCT03210584|Ultrasound imaging|ultrasound imaging
4704446|NCT03210584|Full-Field Optical Coherence Tomography|full-field optical coherence tomography
4704447|NCT03210584|9,4 Tesla MRI|9,4 tesla mri
4704448|NCT03210584|Multimodal evaluation|multimodal evaluation
4704449|NCT03210558|female athletes, testosterone, physical performance, body composition|female athletes, testosterone, physical performance, body composition
4704450|NCT03210545|Biomarker|biomarker
4704451|NCT03210545|Glucocorticoids|glucocorticoids
4704452|NCT03210545|Metabolism|metabolism
4704453|NCT03210506|chronic hepatitis B|chronic hepatitis b
4704454|NCT03210506|hepatitis B virus|hepatitis b virus
4704455|NCT03210506|Cytokines|cytokines
4704456|NCT03210506|Pegylated Interferon α-2a|pegylated interferon α-2a
4704457|NCT03210506|Nucleoside Analogues|nucleoside analogues
4704458|NCT03210493|chronic hepatitis B|chronic hepatitis b
4704459|NCT03210493|hepatitis B virus|hepatitis b virus
4704460|NCT03210493|Treg Cells|treg cells
4704461|NCT03210493|Pegylated Interferon α-2a|pegylated interferon α-2a
4704462|NCT03210493|Nucleoside Analogues|nucleoside analogues
4704463|NCT03210480|Lithium Sulphate|lithium sulphate
4704464|NCT03210480|Prolonged release formulation|prolonged release formulation
4704465|NCT03210480|Lithium carbonate|lithium carbonate
4704466|NCT03210480|Immediate release formulation|immediate release formulation
4704467|NCT03210480|Bipolar Disorder|bipolar disorder
4704468|NCT03210480|Tremor|tremor
4704469|NCT03210467|chronic hepatitis B|chronic hepatitis b
4704470|NCT03210467|hepatitis B virus|hepatitis b virus
4704471|NCT03210467|Pegylated Interferon α-2a|pegylated interferon α-2a
4704472|NCT03210467|entecavir|entecavir
4704473|NCT03210467|Plasmacytoid Dendritic Cells|plasmacytoid dendritic cells
4704474|NCT03210415|Preterm Labor|preterm labor
4704475|NCT03210415|China|china
4704476|NCT03210415|Pregnant Women|pregnant women
4704477|NCT03210415|≥35 Years Old|≥35 years old
4704478|NCT03210389|Recurrent Nasopharyngeal Carcinoma|recurrent nasopharyngeal carcinoma
4704479|NCT03210389|lobaptin|lobaptin
4704480|NCT03210376|Malignant neoplasms of digestive organs|malignant neoplasms of digestive organs
4704481|NCT03210376|Malignant neoplasms of female genital organs|malignant neoplasms of female genital organs
4704482|NCT03210376|Malignant neoplasms of male genital organs|malignant neoplasms of male genital organs
4704483|NCT03210376|Malignant neoplasms of urinary tract|malignant neoplasms of urinary tract
4704484|NCT03210376|Neuromuscular blockade|neuromuscular blockade
4704485|NCT03210376|NMB|nmb
4704486|NCT03210376|Sugammadex|sugammadex
4704487|NCT03210376|Neostigmine|neostigmine
4704488|NCT03210376|Pain Assessment|pain assessment
4704489|NCT03210376|Survey|survey
4704490|NCT03210324|mifepristone antiprogestins|mifepristone antiprogestins
4704491|NCT03210298|Pressurized IntraPeritoneal Aerosol Chemotherapy|pressurized intraperitoneal aerosol chemotherapy
4704492|NCT03210298|PIPAC|pipac
4704493|NCT03210298|Pressurized IntraThoracic Aerosol Chemotherapy|pressurized intrathoracic aerosol chemotherapy
4704494|NCT03210298|PITAC|pitac
4704495|NCT03210298|Cisplatin|cisplatin
4704496|NCT03210298|Oxaliplatin|oxaliplatin
4704497|NCT03210298|Gemcitabine|gemcitabine
4704498|NCT03210298|Paclitaxel|paclitaxel
4704499|NCT03210298|nab-Paclitaxel|nab-paclitaxel
4704500|NCT03210298|Doxorubicine|doxorubicine
4704501|NCT03210298|Mitomycin|mitomycin
4704502|NCT03210285|Whole exome sequencing|whole exome sequencing
4704503|NCT03210285|Neurofibromatosis Type 2|neurofibromatosis type 2
4704504|NCT03210285|Acoustic Neuroma|acoustic neuroma
4704505|NCT03210285|Vestibular schwannoma|vestibular schwannoma
4704506|NCT03210194|Inservice Training|inservice training
4704507|NCT03210194|Neonatal Resuscitation|neonatal resuscitation
4704508|NCT03210194|Randomized Cluster Trial|randomized cluster trial
4704509|NCT03210155|Cranial Electrotherapy Stimulation (CES)|cranial electrotherapy stimulation (ces)
4704510|NCT03210155|Efficacy|efficacy
4704511|NCT03210155|Post Partum|post partum
4704512|NCT03210155|Anxiety|anxiety
4704513|NCT03210155|Depression|depression
4704514|NCT03210155|Insomnia|insomnia
4704515|NCT03210155|Sleep Quality|sleep quality
4704516|NCT03210155|Maternal Functioning|maternal functioning
4704517|NCT03210142|Sleep Apnea, Neural Stimulation|sleep apnea, neural stimulation
4704518|NCT03210129|Motivation|motivation
4704519|NCT03210129|Behavior|behavior
4704520|NCT03210129|Exercise|exercise
4704521|NCT03210129|Motivational interview|motivational interview
4704522|NCT03210129|Cancer|cancer
4704523|NCT03210129|economic evaluation|economic evaluation
4704524|NCT03210103|Transoral Surgery|transoral surgery
4704525|NCT03210103|Head and Neck Cancer|head and neck cancer
4704526|NCT03210090|Stem cells transplantation|stem cells transplantation
4704527|NCT03210090|Cytomegalovirus infection|cytomegalovirus infection
4704528|NCT03210090|CMV-Specific Immune response|cmv-specific immune response
4704529|NCT03210090|Immune reconstitution|immune reconstitution
4704530|NCT03210090|Humoral/Cellular mismatch|humoral/cellular mismatch
4704531|NCT03210090|Interferon-gamma|interferon-gamma
4704532|NCT03210077|general anesthesia|general anesthesia
4704533|NCT03210077|Entropy|entropy
4704534|NCT03210077|Hypnosis|hypnosis
4704535|NCT03210064|Apatinib|apatinib
4704536|NCT03210051|Acute ischemic stroke|acute ischemic stroke
4704537|NCT03210051|Endovascular treatment|endovascular treatment
4704538|NCT03210051|Remote ischemic conditioning|remote ischemic conditioning
4704539|NCT03210051|Reperfusion therapy|reperfusion therapy
4704540|NCT03210051|Neuroprotection|neuroprotection
4704541|NCT03210038|Cystoscopy|cystoscopy
4704542|NCT03209986|Liver Cirrhosis|liver cirrhosis
4704543|NCT03209986|Mesenchymal Sem Cells|mesenchymal sem cells
4704544|NCT03209947|Ulnar Neuropathies|ulnar neuropathies
4704545|NCT03209947|Ultrasound|ultrasound
4704546|NCT03209934|Bone and Joint Infection|bone and joint infection
4704547|NCT03209934|Daptomycin|daptomycin
4704548|NCT03209934|Eosinophilic pneumonia|eosinophilic pneumonia
4704549|NCT03209921|Bone and Joint Infection|bone and joint infection
4704550|NCT03209921|Daptomycin|daptomycin
4704551|NCT03209908|antiviral treatment|antiviral treatment
4704552|NCT03209908|hepatitis B virus|hepatitis b virus
4704553|NCT03209908|mother-to-child transmission|mother-to-child transmission
4704554|NCT03209908|Tenofovir Disoproxil Fumarate|tenofovir disoproxil fumarate
4704555|NCT03209882|Transcranial infrared laser stimulation (TILS)|transcranial infrared laser stimulation (tils)
4704556|NCT03209882|Near-infrared spectroscopy (NIRS)|near-infrared spectroscopy (nirs)
4704557|NCT03209830|mental fatigue|mental fatigue
4704558|NCT03209830|drug therapy|drug therapy
4704559|NCT03209830|subarachnoid hemorrhage|subarachnoid hemorrhage
4704560|NCT03209830|stroke|stroke
4704858|NCT03207685|EMU|emu
4704561|NCT03209804|Intracranial Arteriovenous Malformations|intracranial arteriovenous malformations
4704562|NCT03209752|3D analysis|3d analysis
4704563|NCT03209752|Brace|brace
4704564|NCT03209752|EOS imagind system|eos imagind system
4704565|NCT03209752|Anatomical transfer|anatomical transfer
4704566|NCT03209713|Mexican|mexican
4704567|NCT03209713|Mexican-American|mexican-american
4704568|NCT03209713|17-336|17-336
4704569|NCT03209674|Cardiac surgery|cardiac surgery
4704570|NCT03209674|Thoracic surgery|thoracic surgery
4704571|NCT03209661|vascular function|vascular function
4704572|NCT03209622|Smoking Cessation|smoking cessation
4704573|NCT03209622|Acute Coronary Syndrome|acute coronary syndrome
4704574|NCT03209622|Cardiology|cardiology
4704575|NCT03209609|Coronary artery bypass|coronary artery bypass
4704576|NCT03209596|Athletes|athletes
4704577|NCT03209596|Food intake|food intake
4704578|NCT03209596|Supplementation|supplementation
4704579|NCT03209596|Biochemical biomarkers|biochemical biomarkers
4704580|NCT03209596|Soccer Players|soccer players
4704581|NCT03209570|urinary incontinence, nursing home|urinary incontinence, nursing home
4704582|NCT03209557|Mobile Technology|mobile technology
4704583|NCT03209557|Sociobehavioral|sociobehavioral
4704584|NCT03209544|Suicidal ideation|suicidal ideation
4704585|NCT03209544|Suicide|suicide
4704586|NCT03209544|Cognitive behavioral therapy|cognitive behavioral therapy
4704587|NCT03209544|Online intervention|online intervention
4704588|NCT03209531|Quadriceps activation deficits|quadriceps activation deficits
4704589|NCT03209531|ACL|acl
4704590|NCT03209531|Surgery|surgery
4704591|NCT03209531|Quadrcieps weakness|quadrcieps weakness
4704592|NCT03209531|Operant conditioning|operant conditioning
4704593|NCT03209531|Cortical excitability|cortical excitability
4704594|NCT03209505|Lid Wiper Epitheliopahty|lid wiper epitheliopahty
4704595|NCT03209505|Coefficient of Friction|coefficient of friction
4704596|NCT03209466|Chlorhexidine gluconate|chlorhexidine gluconate
4704597|NCT03209466|Diabetic foot ulcer syndrome|diabetic foot ulcer syndrome
4704598|NCT03209466|Wound healing|wound healing
4704599|NCT03209453|family work shop|family work shop
4704600|NCT03209427|morphine, pruritus, serotonin|morphine, pruritus, serotonin
4704601|NCT03209414|Frailty syndrome|frailty syndrome
4704602|NCT03209414|Coronary heart disease|coronary heart disease
4704603|NCT03209414|Coronary revascularization|coronary revascularization
4704604|NCT03209414|Major adverse cardiovascular events|major adverse cardiovascular events
4704605|NCT03209414|Arterial stiffness|arterial stiffness
4704606|NCT03209414|Applanation tonometry|applanation tonometry
4704607|NCT03209414|Lean body mass|lean body mass
4704608|NCT03209414|ST2 biomarker|st2 biomarker
4704609|NCT03209401|Niraparib|niraparib
4704610|NCT03209401|Carboplatin|carboplatin
4704611|NCT03209375|triage|triage
4704612|NCT03209375|early warning system|early warning system
4704613|NCT03209362|Knee|knee
4704614|NCT03209362|Osteoarthritis|osteoarthritis
4704615|NCT03209362|Intra-articular injection|intra-articular injection
4704616|NCT03209349|Sigmoidoscopy|sigmoidoscopy
4704617|NCT03209336|Ultra-low rectal cancer|ultra-low rectal cancer
4704618|NCT03209336|Intersphincteric resection|intersphincteric resection
4704619|NCT03209336|IORT|iort
4704620|NCT03209323|Epileptiform patterns|epileptiform patterns
4704621|NCT03209323|sevoflurane|sevoflurane
4704622|NCT03209323|propofol|propofol
4704623|NCT03209323|bispectral index|bispectral index
4704624|NCT03209323|state entropy|state entropy
4704625|NCT03209323|response entropy|response entropy
4704626|NCT03209323|A-line Auto Regressive Index|a-line auto regressive index
4704627|NCT03209323|middle latency auditory evoked potentials|middle latency auditory evoked potentials
4704628|NCT03209284|maxillary atrophy|maxillary atrophy
4704629|NCT03209284|transcrestal sinus floor elevation|transcrestal sinus floor elevation
4704630|NCT03209271|Fluid therapy|fluid therapy
4704631|NCT03209258|Stroke|stroke
4704632|NCT03209258|Intracerebral Hemorrhage|intracerebral hemorrhage
4704633|NCT03209258|Care Bundle|care bundle
4704634|NCT03209258|Clinical Trial|clinical trial
4704635|NCT03209258|Stepped-wedge Cluster|stepped-wedge cluster
4704636|NCT03209258|Management|management
4704637|NCT03209258|Blood Pressure|blood pressure
4704638|NCT03209219|effectiveness, safety|effectiveness, safety
4704639|NCT03209206|Intravesical Chemotherapy|intravesical chemotherapy
4704640|NCT03209206|Docetaxel|docetaxel
4704641|NCT03209206|Radical Nephroureterectomy|radical nephroureterectomy
4704642|NCT03209193|off-pump coronary artery bypass|off-pump coronary artery bypass
4704643|NCT03209193|sevoflurane|sevoflurane
4704644|NCT03209193|desflurane|desflurane
4704645|NCT03209193|tissue oxygen saturation|tissue oxygen saturation
4704646|NCT03209180|HFrEF|hfref
4704647|NCT03209180|Carvedilol|carvedilol
4704648|NCT03209180|Slow Release|slow release
4704649|NCT03209180|NT-proBNP|nt-probnp
4704650|NCT03209167|Breast reconstruction; abdominoplasty; patient satisfaction|breast reconstruction; abdominoplasty; patient satisfaction
4704651|NCT03209154|Adherence|adherence
4704652|NCT03209154|Therapeutic Drug Monitoring|therapeutic drug monitoring
4704653|NCT03209154|Patient perspective|patient perspective
4704654|NCT03209141|hypertension|hypertension
4704655|NCT03209141|Diastolic Dysfunction|diastolic dysfunction
4704656|NCT03209141|impedance cardiography|impedance cardiography
4704657|NCT03209141|echocardiography|echocardiography
4704658|NCT03209076|rectal neoplasms|rectal neoplasms
4704659|NCT03209076|sexual dysfunctions|sexual dysfunctions
4704660|NCT03209076|Urinary incontinence|urinary incontinence
4704661|NCT03209076|Quality of life|quality of life
4704662|NCT03209076|robotic surgical procedures|robotic surgical procedures
4704663|NCT03209076|laparoscopy|laparoscopy
4704664|NCT03209037|chronic hepatitis B|chronic hepatitis b
4704665|NCT03209037|hepatitis B virus|hepatitis b virus
4704666|NCT03209037|CD8+T Cells|cd8+t cells
4704667|NCT03209037|Pegylated Interferon α-2a|pegylated interferon α-2a
4704668|NCT03209037|Nucleoside Analogues|nucleoside analogues
4704669|NCT03209024|hypertension|hypertension
4704670|NCT03209024|home blood pressure monitoring|home blood pressure monitoring
4704671|NCT03209024|self blood pressure monitoring|self blood pressure monitoring
4704672|NCT03209024|telemedicine|telemedicine
4704673|NCT03209024|health apps|health apps
4704674|NCT03209024|informatics|informatics
4704675|NCT03209024|data collection|data collection
4704676|NCT03209024|personal health records|personal health records
4704677|NCT03209024|smartphone|smartphone
4704678|NCT03209024|self care|self care
4704679|NCT03209024|blood pressure monitors|blood pressure monitors
4704680|NCT03209011|chronic hepatitis B|chronic hepatitis b
4704681|NCT03209011|hepatitis B virus|hepatitis b virus
4704682|NCT03209011|CD4+T Cells|cd4+t cells
4704683|NCT03209011|Pegylated Interferon α-2a|pegylated interferon α-2a
4704684|NCT03209011|Nucleoside Analogues|nucleoside analogues
4704685|NCT03208998|hepatitis B virus|hepatitis b virus
4704686|NCT03208998|Chronic Hepatitis B Infection|chronic hepatitis b infection
4704687|NCT03208998|Pegylated Interferon α-2a|pegylated interferon α-2a
4704688|NCT03208998|Nucleoside Analogues|nucleoside analogues
4704689|NCT03208998|Natural Killer Cells|natural killer cells
4704690|NCT03208985|Emergency contraception|emergency contraception
4704691|NCT03208972|IVF|ivf
4704692|NCT03208972|ovarian stimulation|ovarian stimulation
4704693|NCT03208972|low dose hCG|low dose hcg
4704694|NCT03208972|hp-FSH|hp-fsh
4704695|NCT03208972|Corifollitropin Alfa|corifollitropin alfa
4704696|NCT03208972|costs of IVF|costs of ivf
4704697|NCT03208946|Advanced glycation end products|advanced glycation end products
4704698|NCT03208946|Absorption|absorption
4704699|NCT03208946|Excretion|excretion
4704700|NCT03208933|Pirfenidone, UIP, IPF, FVC|pirfenidone, uip, ipf, fvc
4704701|NCT03208907|Vivax malaria|vivax malaria
4704702|NCT03208907|Radical cure|radical cure
4704703|NCT03208907|Elimination|elimination
4704704|NCT03208881|Osteoarthritis, Obesity, Liraglutide, Ultrasound|osteoarthritis, obesity, liraglutide, ultrasound
4704705|NCT03208855|Cognitive Behavioral Therapy|cognitive behavioral therapy
4704706|NCT03208816|pain|pain
4704707|NCT03208816|constipation|constipation
4704708|NCT03208803|Myelofibrosis|myelofibrosis
4704709|NCT03208803|Erythropoiesis-stimulating Agents|erythropoiesis-stimulating agents
4704710|NCT03208803|Janus Kinase 2 inhibitors|janus kinase 2 inhibitors
4704711|NCT03208803|Ruxolitinib|ruxolitinib
4704712|NCT03208725|Malnutrition|malnutrition
4704713|NCT03208725|Hospitalization|hospitalization
4704714|NCT03208725|Acute Illness|acute illness
4704715|NCT03208725|Pediatric|pediatric
4704716|NCT03208725|Post-discharge mortality|post-discharge mortality
4704717|NCT03208725|Mortality|mortality
4704718|NCT03208725|Cohort|cohort
4704719|NCT03208725|Nested case control|nested case control
4704720|NCT03208725|Antimicrobial resistance|antimicrobial resistance
4704721|NCT03208725|Antibiotic|antibiotic
4704722|NCT03208725|Feeding|feeding
4704723|NCT03208725|Undernutrition|undernutrition
4704724|NCT03208699|anorexia|anorexia
4704725|NCT03208699|bulimia|bulimia
4704726|NCT03208686|Gender|gender
4704727|NCT03208686|Men|men
4704728|NCT03208686|Black/African American|black/african american
4704729|NCT03208686|Self-management|self-management
4704730|NCT03208660|seizure|seizure
4704731|NCT03208660|Fycompa|fycompa
4704732|NCT03208647|case-control study|case-control study
4704733|NCT03208647|Multiple risk factors|multiple risk factors
4704734|NCT03208634|robotics|robotics
4704735|NCT03208634|motor performance|motor performance
4704736|NCT03208634|stroke patient|stroke patient
4704737|NCT03208634|upper limb|upper limb
4704738|NCT03208634|rehabilitation|rehabilitation
4704739|NCT03208608|RBANS-H|rbans-h
4704740|NCT03208608|Older adults|older adults
4704741|NCT03208608|Normal hearing|normal hearing
4704742|NCT03208608|Cognition|cognition
4704743|NCT03208608|Age-related hearing loss|age-related hearing loss
4704744|NCT03208569|anticholinergic|anticholinergic
4704745|NCT03208569|alzheimer|alzheimer
4704746|NCT03208569|cognition|cognition
4704747|NCT03208569|MMSE|mmse
4704748|NCT03208569|anticholinergic cognitive burden scale|anticholinergic cognitive burden scale
4704749|NCT03208543|thermotherapy|thermotherapy
4704750|NCT03208543|Pakistan|pakistan
4704751|NCT03208504|Thoracic Aortic Disease|thoracic aortic disease
4704752|NCT03208504|Thoracic Aneurysm|thoracic aneurysm
4704753|NCT03208465|Empagliflozin|empagliflozin
4704754|NCT03208465|Sitagliptin|sitagliptin
4704755|NCT03208465|Myocardial perfusion reserve|myocardial perfusion reserve
4704756|NCT03208426|Efficacy, Self|efficacy, self
4704757|NCT03208413|thalidomide|thalidomide
4704758|NCT03208413|radiation-induced brain injury|radiation-induced brain injury
4704759|NCT03208387|17-338|17-338
4704760|NCT03208387|Cognitive function|cognitive function
4704761|NCT03208387|Behavioral function|behavioral function
4704762|NCT03208374|Histologically confirmed cancer|histologically confirmed cancer
4704763|NCT03208374|IMPACT testing|impact testing
4704764|NCT03208374|17-327|17-327
4704765|NCT03208335|rh-endostatin|rh-endostatin
4704766|NCT03208335|radiotherapy|radiotherapy
4704767|NCT03208296|Basal Cell Nevus Syndrome|basal cell nevus syndrome
4704768|NCT03208296|Basal Cell Carcinoma|basal cell carcinoma
4704769|NCT03208257|esmolol|esmolol
4704770|NCT03208257|adrenergic storm|adrenergic storm
4704771|NCT03208257|septic shock|septic shock
4704772|NCT03208244|Heart Disease|heart disease
4704773|NCT03208244|Heart Transplant|heart transplant
4704774|NCT03208244|HCV|hcv
4704775|NCT03208244|Hepatitis C|hepatitis c
4704776|NCT03208218|Evaluation of the pharmacokinetics equivalence|evaluation of the pharmacokinetics equivalence
4704777|NCT03208218|Healthy volunteers|healthy volunteers
4704778|NCT03208218|Single dose over the period I and II(crossover)|single dose over the period i and ii(crossover)
4704779|NCT03208218|Healthy male volunteers|healthy male volunteers
4704780|NCT03208192|colorectal liver metastases|colorectal liver metastases
4704781|NCT03208192|hepatocellular carcinoma|hepatocellular carcinoma
4704782|NCT03208192|intrahepatic cholangiocellular carcinoma|intrahepatic cholangiocellular carcinoma
4704783|NCT03208192|tumor of liver|tumor of liver
4704784|NCT03208192|focal nodular hyperplasia liver|focal nodular hyperplasia liver
4704785|NCT03208192|hemangioma liver|hemangioma liver
4704786|NCT03208140|intubation to supraglottic devices|intubation to supraglottic devices
4704787|NCT03208140|intubation device|intubation device
4704788|NCT03208140|laryngeal vision|laryngeal vision
4704789|NCT03208140|success intubation|success intubation
4704790|NCT03208140|videolaryngoscope|videolaryngoscope
4704791|NCT03208140|direct intubation|direct intubation
4704792|NCT03208127|HCV|hcv
4704793|NCT03208127|Epclusa|epclusa
4704794|NCT03208127|ESLD|esld
4704795|NCT03208114|breastfeeding, support, promotion|breastfeeding, support, promotion
4704796|NCT03208075|phosphorus,diet|phosphorus,diet
4704797|NCT03208075|phosphorus|phosphorus
4704798|NCT03208075|healthy subject|healthy subject
4704799|NCT03208062|Biobank|biobank
4704800|NCT03208062|Waste material|waste material
4704801|NCT03208062|Orthopaedic|orthopaedic
4704802|NCT03208049|Insomnia|insomnia
4704803|NCT03208049|CBT|cbt
4704804|NCT03208049|Gulf War Veterans|gulf war veterans
4704805|NCT03208036|schizophrenia|schizophrenia
4704806|NCT03208036|tdcs|tdcs
4704807|NCT03208036|working memory|working memory
4704808|NCT03208036|cognitive remediation|cognitive remediation
4704809|NCT03208036|cognition|cognition
4704810|NCT03207997|Scleroderma|scleroderma
4704811|NCT03207997|Pulmonary fibrosis|pulmonary fibrosis
4704812|NCT03207997|MRI|mri
4704813|NCT03207997|quantification|quantification
4704814|NCT03207984|Gingival Recession|gingival recession
4704815|NCT03207984|Collagen Matrix|collagen matrix
4704816|NCT03207984|Periodontics|periodontics
4704817|NCT03207971|Gingival recession|gingival recession
4704818|NCT03207971|Laser-Doppler Flowmetry|laser-doppler flowmetry
4704819|NCT03207971|Periodontics|periodontics
4704820|NCT03207919|maternal-fetal attachment|maternal-fetal attachment
4704821|NCT03207919|maternal health|maternal health
4704822|NCT03207919|maternal stress|maternal stress
4704823|NCT03207919|Lullaby Project|lullaby project
4704824|NCT03207880|pregnancy test|pregnancy test
4704825|NCT03207867|Immunotherapy, A2aR, PDR001, NIR178, NSCLC, solid tumors|immunotherapy, a2ar, pdr001, nir178, nsclc, solid tumors
4704826|NCT03207841|SCI|sci
4704827|NCT03207841|High Protein|high protein
4704828|NCT03207841|Low Carbohydrate|low carbohydrate
4704829|NCT03207841|Metabolic Health|metabolic health
4704830|NCT03207841|Microbiome|microbiome
4704831|NCT03207828|Behavioral activation|behavioral activation
4704832|NCT03207763|Safety|safety
4704833|NCT03207763|Reactogenicity|reactogenicity
4704834|NCT03207763|Acceptability|acceptability
4704835|NCT03207763|Microneedle patch|microneedle patch
4704836|NCT03207750|Immunogenicity|immunogenicity
4704837|NCT03207750|lyophilized formulation|lyophilized formulation
4704838|NCT03207750|United States|united states
4704839|NCT03207750|Reactogenicity|reactogenicity
4704840|NCT03207750|Safety|safety
4704841|NCT03207750|Porcine circovirus -free|porcine circovirus -free
4704842|NCT03207750|Human rotavirus vaccine|human rotavirus vaccine
4704843|NCT03207750|liquid formulation|liquid formulation
4704844|NCT03207750|Healthy infants|healthy infants
4704845|NCT03207737|Spinal Cord Injuries|spinal cord injuries
4704846|NCT03207737|SCI|sci
4704847|NCT03207737|Telehealth|telehealth
4704848|NCT03207737|Mindfulness|mindfulness
4704849|NCT03207737|Nutrition|nutrition
4704850|NCT03207737|Exercise|exercise
4704851|NCT03207724|advanced pancreatic cancer|advanced pancreatic cancer
4704852|NCT03207724|locally advanced pancreatic cancer|locally advanced pancreatic cancer
4704853|NCT03207724|recurrent diagnosis|recurrent diagnosis
4704854|NCT03207724|new diagnosis|new diagnosis
4704855|NCT03207724|adenocarcinoma|adenocarcinoma
4704856|NCT03207685|Epilepsy|epilepsy
4704857|NCT03207685|Epilepsy Monitoring Unit|epilepsy monitoring unit
4704859|NCT03207685|Seizure|seizure
4704860|NCT03207685|Seizure Detection|seizure detection
4704861|NCT03207672|E7389 liposomal formulation|e7389 liposomal formulation
4704862|NCT03207672|dose escalation|dose escalation
4704863|NCT03207672|maximum tolerated dose|maximum tolerated dose
4704864|NCT03207672|pharmacokinetics|pharmacokinetics
4704865|NCT03207659|RIRS|rirs
4704866|NCT03207659|Renal stones|renal stones
4704867|NCT03207659|Efficacy|efficacy
4704868|NCT03207659|Safety|safety
4704869|NCT03207646|Cardiac Rehabiliation|cardiac rehabiliation
4704870|NCT03207646|Percutaneous Coronary Intervention|percutaneous coronary intervention
4704871|NCT03207646|Cardiovascular Risk Factor|cardiovascular risk factor
4704872|NCT03207646|Digital Health Solution|digital health solution
4704873|NCT03207646|Medication Adherence|medication adherence
4704874|NCT03207633|OCD, rTMS, right orbitofrontal cortex|ocd, rtms, right orbitofrontal cortex
4704875|NCT03207607|Adults|adults
4704876|NCT03207607|Snacks|snacks
4704877|NCT03207607|Appetite|appetite
4704878|NCT03207607|Blood glucose|blood glucose
4704879|NCT03207607|Insulin|insulin
4704880|NCT03207555|Malignant neoplasms stated as primary lymphoid haematopoietic|malignant neoplasms stated as primary lymphoid haematopoietic
4704881|NCT03207555|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
4704882|NCT03207555|CLL|cll
4704883|NCT03207555|Small Lymphocytic Leukemia|small lymphocytic leukemia
4704884|NCT03207555|SLL|sll
4704885|NCT03207555|Ibrutinib|ibrutinib
4704886|NCT03207555|PCI-32765|pci-32765
4704887|NCT03207555|Imbruvica|imbruvica
4704888|NCT03207542|Malignant neoplasms stated as primary lymphoid haematopoietic|malignant neoplasms stated as primary lymphoid haematopoietic
4704889|NCT03207542|B-Cell Precursor Acute Lymphoblastic Leukemia|b-cell precursor acute lymphoblastic leukemia
4704890|NCT03207542|T-Cell Precursor Acute Lymphoblastic Leukemia|t-cell precursor acute lymphoblastic leukemia
4704891|NCT03207542|ALL|all
4704892|NCT03207542|Daratumumab|daratumumab
4704893|NCT03207529|Malignant neoplasm of breast|malignant neoplasm of breast
4704894|NCT03207529|Metastatic breast cancer|metastatic breast cancer
4704895|NCT03207529|Androgen receptor (AR)-positive and PTEN positive|androgen receptor (ar)-positive and pten positive
4704896|NCT03207529|Alpelisib|alpelisib
4704897|NCT03207529|BY719|by719
4704898|NCT03207529|Enzalutamide|enzalutamide
4704899|NCT03207529|MDV3100|mdv3100
4704900|NCT03207529|XTANDI|xtandi
4704901|NCT03207516|sourdough; leavening process; fermentation; brewer's yeast|sourdough; leavening process; fermentation; brewer's yeast
4704902|NCT03207490|Hand|hand
4704903|NCT03207490|Rehabilitation|rehabilitation
4704904|NCT03207490|sEMG|semg
4704905|NCT03207477|Infant|infant
4704906|NCT03207477|Prematurely born|prematurely born
4704907|NCT03207477|maturation|maturation
4704908|NCT03207451|Anti-Platelet Therapy|anti-platelet therapy
4704909|NCT03207425|Hepatic Impairment|hepatic impairment
4704910|NCT03207386|Sexual Violence|sexual violence
4704911|NCT03207386|Prevention|prevention
4704912|NCT03207386|Mixed-Methods|mixed-methods
4704913|NCT03207386|Outcome Evaluation|outcome evaluation
4704914|NCT03207386|Process Evaluation|process evaluation
4704915|NCT03207386|Adolescence|adolescence
4704916|NCT03207347|BAP1|bap1
4704917|NCT03207347|niraparib|niraparib
4704918|NCT03207347|DNA repair|dna repair
4704919|NCT03207347|PARP inhibitor|parp inhibitor
4704920|NCT03207347|homologous repair deficiency|homologous repair deficiency
4704921|NCT03207347|renal cell carcinoma|renal cell carcinoma
4704922|NCT03207347|cholangiocarcinoma|cholangiocarcinoma
4704923|NCT03207347|mesothelioma|mesothelioma
4704924|NCT03207347|uveal melanoma|uveal melanoma
4704925|NCT03207334|acute myeloid leukemia|acute myeloid leukemia
4704926|NCT03207334|genomic signatures|genomic signatures
4704927|NCT03207334|midostaurin|midostaurin
4704928|NCT03207334|relapsed|relapsed
4704929|NCT03207334|refractory|refractory
4704930|NCT03207334|PKC412|pkc412
4704931|NCT03207308|Vitamin A Status|vitamin a status
4704932|NCT03207308|Retinol Isotope dilution|retinol isotope dilution
4704933|NCT03207308|Total body vitamin A stores|total body vitamin a stores
4704934|NCT03207308|Children|children
4704935|NCT03207308|Senegal|senegal
4704936|NCT03207295|Nesiritide|nesiritide
4704937|NCT03207295|Total Cavo-Pulmonary Connection|total cavo-pulmonary connection
4704938|NCT03207295|Congenital Heart Disease|congenital heart disease
4704939|NCT03207243|Severe asthma|severe asthma
4704940|NCT03207243|Safety|safety
4704941|NCT03207243|GSK3772847|gsk3772847
4704942|NCT03207243|Efficacy|efficacy
4704943|NCT03207217|Safety Planning|safety planning
4704944|NCT03207217|Access to Lethal Means|access to lethal means
4704945|NCT03207217|Zero Suicide|zero suicide
4704946|NCT03207204|Dental bleaching|dental bleaching
4704947|NCT03207204|Color|color
4704948|NCT03207204|Sensitivity|sensitivity
4704949|NCT03207204|violet LED|violet led
4704950|NCT03207204|Quality of life|quality of life
4704951|NCT03207165|Cardiogenic shock|cardiogenic shock
4704952|NCT03207165|Inotropes|inotropes
4704953|NCT03207165|Low cardiac output syndrome|low cardiac output syndrome
4704954|NCT03207139|cancer prostate|cancer prostate
4704955|NCT03207139|Ga-68 PSMA Ligand|ga-68 psma ligand
4704956|NCT03207139|staging|staging
4704957|NCT03207139|biochemical failure|biochemical failure
4704958|NCT03207126|Ultrasound|ultrasound
4704959|NCT03207126|Biopsy|biopsy
4704960|NCT03207126|Endometrial cancer|endometrial cancer
4704961|NCT03207113|prostate-specific antigen|prostate-specific antigen
4704962|NCT03207113|prostate cancer survivorship|prostate cancer survivorship
4704963|NCT03207113|mobile health|mobile health
4704964|NCT03207113|realist evaluation|realist evaluation
4704965|NCT03207113|case study|case study
4704966|NCT03207100|Intracerebral hemorrhage|intracerebral hemorrhage
4704967|NCT03207100|Early antihypertensive treatment|early antihypertensive treatment
4704968|NCT03207100|Analgesia-first|analgesia-first
4704969|NCT03207100|Sedation|sedation
4704970|NCT03207074|iKnife|iknife
4704971|NCT03207074|Mass Spectrometry|mass spectrometry
4704972|NCT03207074|Point-of-care|point-of-care
4704973|NCT03207074|Diagnosis|diagnosis
4704974|NCT03207074|Endometrial Cancer|endometrial cancer
4704975|NCT03207061|endometrial cancer|endometrial cancer
4704976|NCT03207061|staging|staging
4704977|NCT03207061|3 Dimensional|3 dimensional
4704978|NCT03207061|Ultrasound|ultrasound
4704979|NCT03207061|Myometrial invasion|myometrial invasion
4704980|NCT03206996|autism|autism
4704981|NCT03206996|sensory over-responsiveness|sensory over-responsiveness
4704982|NCT03206996|auditory hyper-sensitivity|auditory hyper-sensitivity
4704983|NCT03206996|auditory processing|auditory processing
4704984|NCT03206996|exposure therapy|exposure therapy
4704985|NCT03206996|exposure and response prevention|exposure and response prevention
4704986|NCT03206996|cognitive behavior therapy|cognitive behavior therapy
4704987|NCT03206996|occupational therapy|occupational therapy
4704988|NCT03206983|Small pupil|small pupil
4704989|NCT03206944|standardized tomato extract|standardized tomato extract
4704990|NCT03206944|anti-aggregation|anti-aggregation
4704991|NCT03206944|high cardiovascular risk|high cardiovascular risk
4704992|NCT03206944|diet supplement|diet supplement
4704993|NCT03206892|LESS surgery|less surgery
4704994|NCT03206892|conventional multi-port laparoscopy|conventional multi-port laparoscopy
4704995|NCT03206892|SILS|sils
4704996|NCT03206892|Single-site surgery|single-site surgery
4704997|NCT03206892|Covidien|covidien
4704998|NCT03206892|laparoscopy|laparoscopy
4704999|NCT03206892|minimally invasive surgery|minimally invasive surgery
4705000|NCT03206892|ovarian drilling|ovarian drilling
4705001|NCT03206892|PCOS|pcos
4705002|NCT03206892|Diagnostic laparoscopy|diagnostic laparoscopy
4705003|NCT03206879|ESBL|esbl
4705004|NCT03206879|Enterobacteriaceae|enterobacteriaceae
4705005|NCT03206879|multidrug-resistance|multidrug-resistance
4705006|NCT03206840|mindfulness meditation|mindfulness meditation
4705007|NCT03206840|hypnosis|hypnosis
4705008|NCT03206840|meta-awareness|meta-awareness
4705009|NCT03206840|absorption|absorption
4705010|NCT03206840|consciousness|consciousness
4705011|NCT03206840|self|self
4705012|NCT03206827|colorectal cancer|colorectal cancer
4705013|NCT03206827|type 2 diabetes|type 2 diabetes
4705014|NCT03206827|diet|diet
4705015|NCT03206827|plant protein|plant protein
4705016|NCT03206827|animal protein|animal protein
4705017|NCT03206814|Hypertension|hypertension
4705018|NCT03206814|Ambulatory Systolic Blood Pressure|ambulatory systolic blood pressure
4705019|NCT03206814|Home Blood Pressure|home blood pressure
4705020|NCT03206814|ESH-CARE APP|esh-care app
4705021|NCT03206801|Urine biomarker|urine biomarker
4705022|NCT03206801|CXCL10 chemokine|cxcl10 chemokine
4705023|NCT03206801|Post-transplant monitoring|post-transplant monitoring
4705024|NCT03206801|Protocol biopsy|protocol biopsy
4705025|NCT03206723|corneal abrasion|corneal abrasion
4705026|NCT03206723|contact lens|contact lens
4705027|NCT03206723|eye trauma|eye trauma
4705028|NCT03206710|vitamin C|vitamin c
4705029|NCT03206710|ascorbic acid|ascorbic acid
4705030|NCT03206710|wheeze|wheeze
4705031|NCT03206710|nicotine|nicotine
4705032|NCT03206710|smoke exposure|smoke exposure
4705033|NCT03206710|long term follow up|long term follow up
4705034|NCT03206710|pulmonary function testing|pulmonary function testing
4705035|NCT03206710|forced expiratory flows|forced expiratory flows
4705036|NCT03206697|mitochondrial copy, number and energy|mitochondrial copy, number and energy
4705037|NCT03206658|acute kidney injury|acute kidney injury
4705038|NCT03206658|prevention|prevention
4705039|NCT03206658|severity|severity
4705040|NCT03206658|biomarker|biomarker
4705041|NCT03206619|smoking|smoking
4705042|NCT03206619|habit|habit
4705043|NCT03206619|preference|preference
4705044|NCT03206619|behavior|behavior
4705045|NCT03206619|tailoring|tailoring
4705046|NCT03206619|cessation|cessation
4705047|NCT03206619|engagement|engagement
4705048|NCT03206619|digital|digital
4705049|NCT03206619|mobile app|mobile app
4705050|NCT03206619|recommender system|recommender system
4705051|NCT03206606|COPD|copd
4705052|NCT03206606|Spirometry|spirometry
4705053|NCT03206606|Mobile application|mobile application
4705054|NCT03206580|aging|aging
4705055|NCT03206580|strength training|strength training
4705056|NCT03206580|functionality|functionality
4705057|NCT03206567|Hair thinning, Hair loss, Women, Nutraceutical supplement|hair thinning, hair loss, women, nutraceutical supplement
4705058|NCT03206541|Neurological syndromes|neurological syndromes
4705059|NCT03206541|Arbovirus infection|arbovirus infection
4705060|NCT03206515|Renal Pelvic Pressure|renal pelvic pressure
4705061|NCT03206476|Food Habits|food habits
4705062|NCT03206476|Adolescents|adolescents
4705063|NCT03206476|Educative Intervention|educative intervention
4705064|NCT03206476|Nutrition Assessment|nutrition assessment
4705065|NCT03206476|Behavior Modifications|behavior modifications
4705066|NCT03206437|mindfulness|mindfulness
4705067|NCT03206437|meditation|meditation
4705068|NCT03206359|Unfolded Protein Response|unfolded protein response
4705069|NCT03206359|GADD34|gadd34
4705070|NCT03206359|Type I IFN|type i ifn
4705071|NCT03206359|IFN response genes|ifn response genes
4705072|NCT03206359|Type II IFN|type ii ifn
4705073|NCT03206359|anti-DNA autoantibodies|anti-dna autoantibodies
4705074|NCT03206333|Breast cancer|breast cancer
4705075|NCT03206333|Cardiovascular diseases|cardiovascular diseases
4705076|NCT03206333|Coronary artery calcium|coronary artery calcium
4705077|NCT03206333|Prediction|prediction
4705078|NCT03206333|Risk stratification|risk stratification
4705079|NCT03206333|Deep learning technique|deep learning technique
4705080|NCT03206333|Software development|software development
4705081|NCT03206333|Computed tomography scan|computed tomography scan
4705082|NCT03206307|Return to work|return to work
4705083|NCT03206307|medical rehabilitation|medical rehabilitation
4705084|NCT03206281|clinical weight estimation|clinical weight estimation
4705085|NCT03206268|retinal nerve fiber layer thickness|retinal nerve fiber layer thickness
4705086|NCT03206268|uveitis|uveitis
4705087|NCT03206268|SD-OCT|sd-oct
4705088|NCT03206268|GDx VCC|gdx vcc
4705089|NCT03206255|Human Papilloma Virus 16|human papilloma virus 16
4705090|NCT03206255|Human Papilloma Virus 18|human papilloma virus 18
4705091|NCT03206255|adolescent girl|adolescent girl
4705092|NCT03206255|non-inferiority|non-inferiority
4705093|NCT03206255|immuno-persistence|immuno-persistence
4705094|NCT03206242|Rehabilitation|rehabilitation
4705095|NCT03206242|Physiotherapy|physiotherapy
4705096|NCT03206242|Trismus|trismus
4705097|NCT03206242|Pain|pain
4705098|NCT03206242|Return to work|return to work
4705099|NCT03206242|Quality of life|quality of life
4705100|NCT03206190|SPG4|spg4
4705101|NCT03206190|presymptomatic|presymptomatic
4705102|NCT03206190|at risk|at risk
4705103|NCT03206190|mutation carriers|mutation carriers
4705104|NCT03206190|biomarkers|biomarkers
4705105|NCT03206190|longitudinal progression|longitudinal progression
4705106|NCT03206164|Health Services Research|health services research
4705107|NCT03206138|Investigator trial|investigator trial
4705108|NCT03206138|Cervical Intraepithelial Neoplasia|cervical intraepithelial neoplasia
4705109|NCT03206125|Esophageal Squamous Cell Carcinoma|esophageal squamous cell carcinoma
4705110|NCT03206125|Case-Control Study|case-control study
4705111|NCT03206125|Risk Factors|risk factors
4705112|NCT03206125|Epidemiology|epidemiology
4705113|NCT03206112|Focal Dystonia|focal dystonia
4705114|NCT03206112|Healthy Volunteers|healthy volunteers
4705115|NCT03206112|Paired Associative Stimulation (PAS)|paired associative stimulation (pas)
4705116|NCT03206099|Genetic Disorders and Defects|genetic disorders and defects
4705117|NCT03206099|Novel Clinical Phenotypes|novel clinical phenotypes
4705118|NCT03206099|Immune Diseases|immune diseases
4705119|NCT03206099|Proband|proband
4705120|NCT03206099|Mendelian Disorders|mendelian disorders
4705121|NCT03206086|DNA Repair|dna repair
4705122|NCT03206086|Bone Marrow|bone marrow
4705123|NCT03206086|Hematopoiesis|hematopoiesis
4705124|NCT03206086|Pancytopenia|pancytopenia
4705125|NCT03206086|Thrombocytopenia|thrombocytopenia
4705126|NCT03206073|Oncolytic Vaccinia Virus|oncolytic vaccinia virus
4705127|NCT03206073|Tumor Cell Death|tumor cell death
4705128|NCT03206073|Viral Therapy|viral therapy
4705129|NCT03206073|Anti-Tumor Immunity|anti-tumor immunity
4705130|NCT03206060|Hypertension|hypertension
4705131|NCT03206060|Catecholamine|catecholamine
4705132|NCT03206060|Familial Syndromes|familial syndromes
4705133|NCT03206060|Somatostatin Receptors|somatostatin receptors
4705134|NCT03206060|Ionizing Radiation|ionizing radiation
4705135|NCT03206034|Memory|memory
4705136|NCT03206034|Cognition|cognition
4705137|NCT03205995|TMA|tma
4705138|NCT03205995|aHUS|ahus
4705139|NCT03205982|Wisepill|wisepill
4705140|NCT03205982|ART|art
4705141|NCT03205982|PLWH|plwh
4705142|NCT03205969|Breast Cancer|breast cancer
4705143|NCT03205969|chemotherapy side effect|chemotherapy side effect
4705144|NCT03205969|mobile game|mobile game
4705145|NCT03205956|Parkinson's disease|parkinson's disease
4705146|NCT03205956|PD|pd
4705147|NCT03205956|levodopa|levodopa
4705148|NCT03205943|ICON|icon
4705149|NCT03205904|cystic fibrosis related diabetes|cystic fibrosis related diabetes
4705150|NCT03205891|Malignant neoplasms stated as primary lymphoid haematopoietic|malignant neoplasms stated as primary lymphoid haematopoietic
4705151|NCT03205891|Anaplastic Large Cell Lymphoma|anaplastic large cell lymphoma
4705152|NCT03205891|Classical Hodgkin Lymphoma|classical hodgkin lymphoma
4705153|NCT03205891|CD30+ peripheral T-cell lymphoma|cd30+ peripheral t-cell lymphoma
4705154|NCT03205891|Brentuximab Vedotin|brentuximab vedotin
4705155|NCT03205891|SGN-35|sgn-35
4705156|NCT03205891|Adcetris|adcetris
4705157|NCT03205891|TAK228|tak228
4705158|NCT03205891|TAK-228|tak-228
4705159|NCT03205891|MLN0128|mln0128
4705160|NCT03205891|Glucose Monitor|glucose monitor
4705161|NCT03205891|Glucometer|glucometer
4705162|NCT03205826|Emphysema|emphysema
4705163|NCT03205826|Bronchoscopic intervention|bronchoscopic intervention
4705164|NCT03205826|CHARTIS measurement|chartis measurement
4705165|NCT03205813|Pain, Postoperative|pain, postoperative
4705166|NCT03205813|Cesarean delivery|cesarean delivery
4705167|NCT03205813|Intrathecal morphine|intrathecal morphine
4705168|NCT03205761|Advanced Breast Cancer|advanced breast cancer
4705169|NCT03205761|Triple Negative|triple negative
4705170|NCT03205761|olaparib|olaparib
4705171|NCT03205761|lynparza|lynparza
4705173|NCT03205761|Methylation|methylation
4705174|NCT03205709|memory|memory
4705175|NCT03205709|computerized training|computerized training
4705176|NCT03205709|cognition|cognition
4705177|NCT03205709|MRI|mri
4705178|NCT03205709|mci|mci
4705179|NCT03205709|memory problems|memory problems
4705180|NCT03205709|memory complaints|memory complaints
4705181|NCT03205670|Autologous Cells|autologous cells
4705182|NCT03205670|Buccal Mucosa|buccal mucosa
4705183|NCT03205670|Urethroplasty|urethroplasty
4705184|NCT03205670|Tissue-engineered Construct|tissue-engineered construct
4705185|NCT03205670|Hybrid matrix|hybrid matrix
4705186|NCT03205670|Collagen|collagen
4705187|NCT03205670|Polylactoglycolide Fibers|polylactoglycolide fibers
4705188|NCT03205540|Continuous epidural analgesia|continuous epidural analgesia
4705189|NCT03205540|Bilateral single-shot adductor canal blocks|bilateral single-shot adductor canal blocks
4705190|NCT03205527|Fall risk|fall risk
4705191|NCT03205527|Stroke survivors|stroke survivors
4705192|NCT03205527|Perturbation training|perturbation training
4705193|NCT03205501|BE|be
4705194|NCT03205501|EAC|eac
4705195|NCT03205501|HGD|hgd
4705196|NCT03205501|Esophagus|esophagus
4705197|NCT03205488|Northwestern|northwestern
4705198|NCT03205488|Nilotinib|nilotinib
4705199|NCT03205488|USA|usa
4705200|NCT03205488|NILO-PD|nilo-pd
4705201|NCT03205488|Parkinson Disease|parkinson disease
4705202|NCT03205475|Training|training
4705203|NCT03205475|Intervention|intervention
4705204|NCT03205475|Social Communication|social communication
4705205|NCT03205475|Play|play
4705206|NCT03205462|Pseudomanas Aeruginosa|pseudomanas aeruginosa
4705207|NCT03205462|antibiotic resistance|antibiotic resistance
4705208|NCT03205462|nosocomial infection|nosocomial infection
4705209|NCT03205462|factors of pathogenicity of bacteria|factors of pathogenicity of bacteria
4705210|NCT03205462|the system of secretion of type III pathogenic bacteria|the system of secretion of type iii pathogenic bacteria
4705211|NCT03205462|chronic infection|chronic infection
4705212|NCT03205410|remote ischemic preconditioning|remote ischemic preconditioning
4705213|NCT03205410|cardiac surgery-associated acute kidney injury|cardiac surgery-associated acute kidney injury
4705214|NCT03205410|neutrophil gelatinase-associated lipocalin|neutrophil gelatinase-associated lipocalin
4705215|NCT03205384|Urgent abdominal surgery|urgent abdominal surgery
4705216|NCT03205358|Meningitis|meningitis
4705217|NCT03205358|Meningococcal Meningitis|meningococcal meningitis
4705218|NCT03205358|MenACYW conjugate vaccine|menacyw conjugate vaccine
4705219|NCT03205358|NIMENRIX®|nimenrix®
4705220|NCT03205345|Cirrhosis|cirrhosis
4705221|NCT03205345|NASH Cirrhosis|nash cirrhosis
4705222|NCT03205345|Decompensated NASH cirrhosis|decompensated nash cirrhosis
4705223|NCT03205345|Cirrhosis, Liver|cirrhosis, liver
4705224|NCT03205345|Non-Alcoholic Fatty Liver Disease|non-alcoholic fatty liver disease
4705225|NCT03205332|Worry|worry
4705226|NCT03205332|Anxiety|anxiety
4705227|NCT03205319|Oesophagoduodenoscopy|oesophagoduodenoscopy
4705228|NCT03205319|E-learning|e-learning
4705229|NCT03205319|Appropriate use of healthcare|appropriate use of healthcare
4705230|NCT03205319|Deimplementation|deimplementation
4705231|NCT03205306|Myasthenia Gravis|myasthenia gravis
4705232|NCT03205306|Psyche|psyche
4705233|NCT03205306|Depression|depression
4705234|NCT03205306|Anxiety Disorder|anxiety disorder
4705235|NCT03205306|Posttraumatic Stress Disorder|posttraumatic stress disorder
4705236|NCT03205306|Disease Processing|disease processing
4705237|NCT03205293|School-Based Intervention|school-based intervention
4705238|NCT03205293|Ecological Model|ecological model
4705239|NCT03205293|Participatory Approach|participatory approach
4705240|NCT03205293|Palestinian Female Schoolchildren|palestinian female schoolchildren
4705241|NCT03205280|Multiple Sclerosis, Relapsing-Remitting, Computer-Assisted Diagnosis, MRI, Diagnosis, Treatment Efficacy|multiple sclerosis, relapsing-remitting, computer-assisted diagnosis, mri, diagnosis, treatment efficacy
4705242|NCT03205254|Mediterranean diet|mediterranean diet
4705243|NCT03205254|HDL|hdl
4705244|NCT03205254|Fast food|fast food
4705245|NCT03205254|Gut microbiota|gut microbiota
4705246|NCT03205254|Inflammation|inflammation
4705247|NCT03205241|Exercise|exercise
4705248|NCT03205241|Fish Oil|fish oil
4705249|NCT03205241|Cycling|cycling
4705250|NCT03205241|Inflammation|inflammation
4705251|NCT03205241|Oxidative stress|oxidative stress
4705252|NCT03205215|Hyperbaric oxygen|hyperbaric oxygen
4705253|NCT03205215|Pressurized oxygen|pressurized oxygen
4705254|NCT03205215|Concussion|concussion
4705255|NCT03205215|Post concussive syndrome|post concussive syndrome
4705256|NCT03205215|Oxygen therapy|oxygen therapy
4705257|NCT03205189|postoperative pain|postoperative pain
4705258|NCT03205189|ambulatory surgery|ambulatory surgery
4705259|NCT03205189|general anesthesia|general anesthesia
4705260|NCT03205189|anesthesia consultation|anesthesia consultation
4705261|NCT03205189|post-op prescription|post-op prescription
4705262|NCT03205176|AZD5153|azd5153
4705263|NCT03205176|Malignant solid tumors|malignant solid tumors
4705264|NCT03205176|Lymphoma|lymphoma
4705265|NCT03205176|Ovarian Cancer|ovarian cancer
4705266|NCT03205176|BRD4|brd4
4705267|NCT03205150|non-alcoholic steatohepatitis|non-alcoholic steatohepatitis
4705268|NCT03205150|NASH|nash
4705269|NCT03205150|Obese|obese
4705270|NCT03205150|Type 2 diabetes mellitus|type 2 diabetes mellitus
4705271|NCT03205150|non-alcoholic fatty liver disease|non-alcoholic fatty liver disease
4705272|NCT03205098|biological markers|biological markers
4705273|NCT03205098|mesenteric ischemia|mesenteric ischemia
4705274|NCT03205098|ultratrail|ultratrail
4705275|NCT03205072|ERCP|ercp
4705276|NCT03205072|Per-Oral Cholangioscopy|per-oral cholangioscopy
4705277|NCT03205072|Liver Transplantation|liver transplantation
4705278|NCT03205072|Spy Glass|spy glass
4705279|NCT03205033|Melatonin|melatonin
4705280|NCT03205033|Breast cancer|breast cancer
4705281|NCT03205033|Chemotherapy|chemotherapy
4705282|NCT03205033|Sleep-wake rhytms|sleep-wake rhytms
4705283|NCT03205033|Circadian rhythms|circadian rhythms
4705284|NCT03205007|Health Promotion|health promotion
4705285|NCT03205007|Nutrition|nutrition
4705286|NCT03205007|Older Adults|older adults
4705287|NCT03204994|Colorectal surgery|colorectal surgery
4705288|NCT03204994|Fluorescence guided surgery|fluorescence guided surgery
4705289|NCT03204981|intramural needle ablation|intramural needle ablation
4705290|NCT03204981|ventricular arrhythmia|ventricular arrhythmia
4705291|NCT03204968|vagus nerve|vagus nerve
4705292|NCT03204968|Lung lobectomy|lung lobectomy
4705293|NCT03204955|Osmolar therapy|osmolar therapy
4705294|NCT03204955|Acetate|acetate
4705295|NCT03204942|Bone metastasis,Thoracic secondary, Cancer Pain,|bone metastasis,thoracic secondary, cancer pain,
4705296|NCT03204903|Dry eye|dry eye
4705297|NCT03204903|Laser acupuncture|laser acupuncture
4705298|NCT03204903|Traditional Chinese medicine|traditional chinese medicine
4705299|NCT03204877|Melatonin|melatonin
4705300|NCT03204877|Insulin sensitivity|insulin sensitivity
4705301|NCT03204877|Insulin secretion|insulin secretion
4705302|NCT03204877|Incretin response|incretin response
4705303|NCT03204838|IDH1, IDH2, MUTATION, AML|idh1, idh2, mutation, aml
4705304|NCT03204825|Patient education|patient education
4705305|NCT03204825|Pain management|pain management
4705306|NCT03204825|Transcutaneous electrical nerve stimulation|transcutaneous electrical nerve stimulation
4705307|NCT03204825|Physical activity|physical activity
4705308|NCT03204825|Feasibility|feasibility
4705309|NCT03204812|prostate cancer|prostate cancer
4705310|NCT03204812|metastatic disease|metastatic disease
4705311|NCT03204812|Immune responses|immune responses
4705312|NCT03204812|Immunotherapies|immunotherapies
4705313|NCT03204812|PD-L1-dependent immunosuppressive effects|pd-l1-dependent immunosuppressive effects
4705314|NCT03204812|cytotoxic activity|cytotoxic activity
4705315|NCT03204812|anti-tumor T-cells|anti-tumor t-cells
4705316|NCT03204786|Autism Spectrum Disorder (ASD)|autism spectrum disorder (asd)
4705317|NCT03204786|Autism|autism
4705318|NCT03204747|Gait speed|gait speed
4705319|NCT03204747|multiple sclerosis|multiple sclerosis
4705320|NCT03204747|lower urinary tract symptoms|lower urinary tract symptoms
4705321|NCT03204747|overactive bladder|overactive bladder
4705322|NCT03204734|therapy|therapy
4705323|NCT03204734|Capecitabine|capecitabine
4705324|NCT03204734|breast cancer|breast cancer
4705325|NCT03204708|postoperative analgsia|postoperative analgsia
4705326|NCT03204708|peripheral block catheter|peripheral block catheter
4705327|NCT03204708|modified radical mastectomy|modified radical mastectomy
4705328|NCT03204695|Non-valvular atrial fibrillation|non-valvular atrial fibrillation
4705329|NCT03204695|Atrial Fibrillation|atrial fibrillation
4705330|NCT03204695|Stroke|stroke
4705331|NCT03204695|Left Atrial Appendage (LAA)|left atrial appendage (laa)
4705332|NCT03204695|LAA Closure|laa closure
4705333|NCT03204695|LAA Occlusion|laa occlusion
4705334|NCT03204695|WaveCrest|wavecrest
4705335|NCT03204682|Endometriosis|endometriosis
4705336|NCT03204682|Magnetic transcranial stimulation|magnetic transcranial stimulation
4705337|NCT03204682|Chronic pain|chronic pain
4705338|NCT03204682|Analgesic|analgesic
4705339|NCT03204669|Copper|copper
4705340|NCT03204669|Selenium|selenium
4705341|NCT03204669|Zinc|zinc
4705342|NCT03204669|Continuous renal replacement therapy|continuous renal replacement therapy
4705343|NCT03204656|difficult orotracheal intubation|difficult orotracheal intubation
4705344|NCT03204656|selective lung intubation|selective lung intubation
4705345|NCT03204656|unexpected difficult selective lung intubation|unexpected difficult selective lung intubation
4705346|NCT03204630|infant nutrition|infant nutrition
4705347|NCT03204630|probiotic|probiotic
4705348|NCT03204617|HIV infection|hiv infection
4705349|NCT03204617|First in Human|first in human
4705350|NCT03204617|Therapeutic Vaccines|therapeutic vaccines
4705351|NCT03204617|HTI|hti
4705352|NCT03204617|HIV reservoir|hiv reservoir
4705353|NCT03204604|Memory|memory
4705354|NCT03204604|Dietary Treatment|dietary treatment
4705355|NCT03204565|gingival recession, clinical trial(s).|gingival recession, clinical trial(s).
4705356|NCT03204539|inhibitor|inhibitor
4705357|NCT03204539|Factor VIII inhibitor|factor viii inhibitor
4705358|NCT03204513|Prosthesis|prosthesis
4705359|NCT03204513|Powered Prosthesis|powered prosthesis
4705360|NCT03204500|Amyotrophic lateral sclerosis|amyotrophic lateral sclerosis
4705361|NCT03204500|Dual therapy|dual therapy
4705362|NCT03204500|Randomized controlled trial|randomized controlled trial
4705363|NCT03204500|ALSFRS-R|alsfrs-r
4705364|NCT03204487|tear film thickness|tear film thickness
4705365|NCT03204487|ocular surface disease|ocular surface disease
4705366|NCT03204487|OCT|oct
4705367|NCT03204474|Lacosamide|lacosamide
4705368|NCT03204474|Bioequivalence|bioequivalence
4705369|NCT03204474|Intravenous solution|intravenous solution
4705370|NCT03204474|Tablet|tablet
4705371|NCT03204422|urinary sodium excretion|urinary sodium excretion
4705372|NCT03204422|24-hout urine|24-hout urine
4705373|NCT03204422|salt intakes|salt intakes
4705374|NCT03204422|hypertension|hypertension
4705375|NCT03204409|CHIKV|chikv
4705376|NCT03204409|DENGUE|dengue
4705377|NCT03204409|Chikungunya|chikungunya
4705378|NCT03204409|DENV|denv
4705379|NCT03204357|Cardiac surgery|cardiac surgery
4705380|NCT03204344|Gastrointestinal surgery|gastrointestinal surgery
4705381|NCT03204344|Preoperative oral carbohydrate|preoperative oral carbohydrate
4705382|NCT03204344|Diabetic patients|diabetic patients
4705383|NCT03204344|Postoperative recovery|postoperative recovery
4705384|NCT03204331|Endometriosis|endometriosis
4705385|NCT03204331|Pain|pain
4705386|NCT03204331|Dysmenorrhea|dysmenorrhea
4705387|NCT03204318|Endometriosis|endometriosis
4705388|NCT03204318|Pain|pain
4705389|NCT03204318|Dysmenorrhea|dysmenorrhea
4705390|NCT03204305|Marijuana|marijuana
4705391|NCT03204305|cannabis|cannabis
4705392|NCT03204305|cannabinoid receptor|cannabinoid receptor
4705393|NCT03204292|Inferior vena cava|inferior vena cava
4705394|NCT03204292|Fluid responsiveness|fluid responsiveness
4705395|NCT03204292|Central venous pressure|central venous pressure
4705396|NCT03204266|urinary tract|urinary tract
4705397|NCT03204266|Bladder cancer|bladder cancer
4705398|NCT03204266|Radical cystectomy|radical cystectomy
4705399|NCT03204266|Omega-3 Fatty Acids|omega-3 fatty acids
4705400|NCT03204240|Spinal Cord Injury|spinal cord injury
4705401|NCT03204240|Skeletal Muscle|skeletal muscle
4705402|NCT03204240|Functional Electrical Stimulation|functional electrical stimulation
4705403|NCT03204240|Diabetes|diabetes
4705404|NCT03204227|Japanese Encephalitis|japanese encephalitis
4705405|NCT03204227|JECEVAX|jecevax
4705406|NCT03204227|Vietnam|vietnam
4705407|NCT03204214|binge drinking|binge drinking
4705408|NCT03204201|Fluorescence|fluorescence
4705409|NCT03204188|BTK Inhibitor|btk inhibitor
4705410|NCT03204188|Checkpoint Inhibitor|checkpoint inhibitor
4705411|NCT03204123|prostate cancer|prostate cancer
4705412|NCT03204123|prostatectomy|prostatectomy
4705413|NCT03204123|biochemical recurrence|biochemical recurrence
4705414|NCT03204123|Ga-HBED-iPSMA|ga-hbed-ipsma
4705415|NCT03204123|16-306|16-306
4705416|NCT03204110|Reversible cerebral vasoconstriction syndrome|reversible cerebral vasoconstriction syndrome
4705417|NCT03204110|Anatomic and morphological retinal network analysis|anatomic and morphological retinal network analysis
4705418|NCT03204110|Retinal vessel analyser|retinal vessel analyser
4705419|NCT03204110|retinography|retinography
4705420|NCT03204110|Prospective analysis|prospective analysis
4705421|NCT03204084|pterygium,Low temperature plasma|pterygium,low temperature plasma
4705422|NCT03204045|oxycodone, fentanyl, tracheal extubation|oxycodone, fentanyl, tracheal extubation
4705423|NCT03204032|Tegafur|tegafur
4705424|NCT03204032|Temozolomide|temozolomide
4705425|NCT03204032|Thalidomide|thalidomide
4705426|NCT03204032|Extrapancreatic Neuroendocrine Tumor|extrapancreatic neuroendocrine tumor
4705427|NCT03204019|Tegafur|tegafur
4705428|NCT03204019|Temozolomide|temozolomide
4705429|NCT03204019|Thalidomide|thalidomide
4705430|NCT03204019|Pancreatic Neuroendocrine Tumor|pancreatic neuroendocrine tumor
4705431|NCT03203993|BRCA mutation|brca mutation
4705432|NCT03203967|Adults|adults
4705433|NCT03203967|Unilateral TKA|unilateral tka
4705434|NCT03203967|Single femoral nerve block|single femoral nerve block
4705435|NCT03203967|Low-dose epidural morphine|low-dose epidural morphine
4705436|NCT03203967|Effect of postoperative analgesia|effect of postoperative analgesia
4705437|NCT03203967|Quality of life|quality of life
4705438|NCT03203941|Autologous Cord Blood Stem Cells|autologous cord blood stem cells
4705439|NCT03203928|ADHD|adhd
4705440|NCT03203928|Occupational Therapy|occupational therapy
4705441|NCT03203915|cholesterol|cholesterol
4705442|NCT03203915|triglyceride|triglyceride
4705443|NCT03203915|grape seed extract|grape seed extract
4705444|NCT03203915|chardonnay pomace powder|chardonnay pomace powder
4705445|NCT03203915|polyphenol|polyphenol
4705446|NCT03203915|gut microbiome|gut microbiome
4705447|NCT03203902|Therapeutic touch|therapeutic touch
4705448|NCT03203902|Post-traumatic Stress Disorder|post-traumatic stress disorder
4705449|NCT03203902|Homeless|homeless
4705450|NCT03203889|American Indians|american indians
4705451|NCT03203889|Native Americans|native americans
4705559|NCT03203447|Microneedle|microneedle
4705452|NCT03203889|Community Reinforcement Approach and Family Training|community reinforcement approach and family training
4705453|NCT03203889|Nar-Anonymous Facilitation|nar-anonymous facilitation
4705454|NCT03203889|Treatment Entry|treatment entry
4705455|NCT03203889|Cultural adaptations|cultural adaptations
4705456|NCT03203889|Spirituality|spirituality
4705457|NCT03203850|hereditary hemochromatosis|hereditary hemochromatosis
4705458|NCT03203850|ICL670|icl670
4705459|NCT03203850|deferasirox FCT|deferasirox fct
4705460|NCT03203850|iron overload|iron overload
4705461|NCT03203837|Radioembolization|radioembolization
4705463|NCT03203837|TheraSphere|therasphere
4705464|NCT03203837|HCC|hcc
4705465|NCT03203837|Biomarker|biomarker
4705466|NCT03203837|Prognostic factor|prognostic factor
4705467|NCT03203837|Angiogenesis|angiogenesis
4705468|NCT03203837|Inflammatory|inflammatory
4705469|NCT03203837|Liver|liver
4705470|NCT03203811|Healthy Subjects|healthy subjects
4705471|NCT03203746|Lycopene|lycopene
4705472|NCT03203746|Chronic periodontitis|chronic periodontitis
4705473|NCT03203746|Protein carbonyl|protein carbonyl
4705474|NCT03203733|Oral Mucositis , cooling, cryotherapy|oral mucositis , cooling, cryotherapy
4705475|NCT03203720|adherence|adherence
4705476|NCT03203720|adolescent|adolescent
4705477|NCT03203720|Motivational Intervention|motivational intervention
4705478|NCT03203707|IPSRT|ipsrt
4705479|NCT03203707|early intervention|early intervention
4705480|NCT03203707|bipolar disorder|bipolar disorder
4705481|NCT03203668|Hyperparathyroidism|hyperparathyroidism
4705482|NCT03203668|Imaging|imaging
4705483|NCT03203668|Scintigraphy|scintigraphy
4705484|NCT03203668|18F-choline|18f-choline
4705485|NCT03203668|18F-fluorocholine|18f-fluorocholine
4705486|NCT03203668|PET|pet
4705487|NCT03203668|PET/CT|pet/ct
4705488|NCT03203655|Mobile text|mobile text
4705489|NCT03203655|Obesity|obesity
4705490|NCT03203655|Hispanic|hispanic
4705491|NCT03203655|Women|women
4705492|NCT03203642|ADPKD|adpkd
4705493|NCT03203642|Autosomal Dominant Polycystic Kidney Disease|autosomal dominant polycystic kidney disease
4705494|NCT03203642|Polycystic Kidney|polycystic kidney
4705495|NCT03203642|Tesevatinib|tesevatinib
4705496|NCT03203642|Polycystic Kidney Disease|polycystic kidney disease
4705497|NCT03203642|PKD|pkd
4705498|NCT03203603|asthma|asthma
4705499|NCT03203603|pulmonary function testing|pulmonary function testing
4705500|NCT03203603|wheeze|wheeze
4705501|NCT03203603|vitamin C|vitamin c
4705502|NCT03203603|antioxidants|antioxidants
4705503|NCT03203603|forced expiratory flows|forced expiratory flows
4705504|NCT03203551|Dentures|dentures
4705505|NCT03203551|Biofilms|biofilms
4705506|NCT03203551|Disinfection|disinfection
4705507|NCT03203551|Candidiasis|candidiasis
4705508|NCT03203551|Candida|candida
4705509|NCT03203538|night work|night work
4705510|NCT03203538|shift work|shift work
4705511|NCT03203538|light|light
4705512|NCT03203538|bright light|bright light
4705513|NCT03203538|sleep|sleep
4705514|NCT03203538|cognitive performance|cognitive performance
4705515|NCT03203538|circadian rhythm|circadian rhythm
4705516|NCT03203525|Liver Cancer|liver cancer
4705517|NCT03203525|Hepatic metastases|hepatic metastases
4705518|NCT03203525|Advanced liver cancer|advanced liver cancer
4705519|NCT03203525|Eloxatin|eloxatin
4705520|NCT03203525|Oxaliplatin|oxaliplatin
4705521|NCT03203525|Leucovorin|leucovorin
4705522|NCT03203525|Citrovorum|citrovorum
4705523|NCT03203525|Wellcovorin|wellcovorin
4705524|NCT03203525|5-fluorouracil|5-fluorouracil
4705525|NCT03203525|Fluorouracil|fluorouracil
4705526|NCT03203525|5-FU|5-fu
4705527|NCT03203525|Adrucil|adrucil
4705528|NCT03203525|Efudex|efudex
4705529|NCT03203525|Bevacizumab|bevacizumab
4705530|NCT03203525|Avastin|avastin
4705531|NCT03203525|Anti-VEGF monoclonal antibody|anti-vegf monoclonal antibody
4705532|NCT03203525|rhuMab-VEGF|rhumab-vegf
4705533|NCT03203525|Liposomal Doxorubicin|liposomal doxorubicin
4705534|NCT03203525|Doxil|doxil
4705535|NCT03203525|Doxorubicin Hydrochloride (Liposomal)|doxorubicin hydrochloride (liposomal)
4705536|NCT03203525|Temsirolimus|temsirolimus
4705537|NCT03203525|CCI-779|cci-779
4705538|NCT03203525|Torisel|torisel
4705539|NCT03203525|NovoTTF-100L System|novottf-100l system
4705540|NCT03203512|Fish oil; N-3 polyunsaturated fatty acids|fish oil; n-3 polyunsaturated fatty acids
4705541|NCT03203499|Substance abuse disorder|substance abuse disorder
4705542|NCT03203486|NAFLD|nafld
4705543|NCT03203486|no fibrosis|no fibrosis
4705544|NCT03203486|Mediterranean diet|mediterranean diet
4705545|NCT03203486|STAT3|stat3
4705546|NCT03203486|GCKR|gckr
4705547|NCT03203486|visfatin|visfatin
4705548|NCT03203486|oxidized LDL|oxidized ldl
4705549|NCT03203486|fasting glucose|fasting glucose
4705550|NCT03203486|inflammation|inflammation
4705551|NCT03203473|Renal Cancer|renal cancer
4705552|NCT03203460|Prostate Cancer|prostate cancer
4705553|NCT03203460|Active Surveillance|active surveillance
4705554|NCT03203460|Exercise|exercise
4705555|NCT03203460|High-Intensity Interval Training|high-intensity interval training
4705556|NCT03203460|Randomized Controlled Trial|randomized controlled trial
4705557|NCT03203447|RVO|rvo
4705558|NCT03203447|ME|me
4705560|NCT03203447|Microinjection|microinjection
4705561|NCT03203447|Triamcinolone|triamcinolone
4705562|NCT03203447|Choroid|choroid
4705563|NCT03203447|Choroid injection|choroid injection
4705564|NCT03203447|Suprachoroidal|suprachoroidal
4705565|NCT03203447|Anti-VEGF|anti-vegf
4705566|NCT03203447|Subretinal Fluid|subretinal fluid
4705567|NCT03203447|Cystoid Macular Edema|cystoid macular edema
4705568|NCT03203447|Optical Coherence Tomography|optical coherence tomography
4705569|NCT03203447|OCT|oct
4705570|NCT03203447|Central Subfield Thickness|central subfield thickness
4705571|NCT03203447|Lucentis|lucentis
4705572|NCT03203447|Avastin|avastin
4705573|NCT03203447|Ranibizumab|ranibizumab
4705574|NCT03203447|Bevacizumab|bevacizumab
4705575|NCT03203434|Pancreatic cancer|pancreatic cancer
4705576|NCT03203434|Esophageal cancer|esophageal cancer
4705577|NCT03203434|volatile organic compounds|volatile organic compounds
4705578|NCT03203434|Field asymmetric ion mobility spectrometry|field asymmetric ion mobility spectrometry
4705579|NCT03203395|Depression|depression
4705580|NCT03203395|Anxiety|anxiety
4705581|NCT03203395|Panic Attacks|panic attacks
4705582|NCT03203395|Collaborative Care|collaborative care
4705583|NCT03203395|Heart disease and depression|heart disease and depression
4705584|NCT03203395|Heart disease and anxiety|heart disease and anxiety
4705585|NCT03203395|Heart disease and panic attacks|heart disease and panic attacks
4705586|NCT03203369|Blastic plasmacytoid dendritic cell neoplasm|blastic plasmacytoid dendritic cell neoplasm
4705587|NCT03203369|Natural Killer (NK) cell blastic lymphoma|natural killer (nk) cell blastic lymphoma
4705588|NCT03203369|Hematologic malignancies|hematologic malignancies
4705589|NCT03203369|Cluster of differentiation (CD) CD4+CD56+ hematodermic tumor|cluster of differentiation (cd) cd4+cd56+ hematodermic tumor
4705590|NCT03203369|Acute leukemia and myeloid neoplasms|acute leukemia and myeloid neoplasms
4705591|NCT03203369|Chimeric Antigen Receptor T-cell (CAR-T) therapy|chimeric antigen receptor t-cell (car-t) therapy
4705592|NCT03203369|Allogeneic|allogeneic
4705593|NCT03203369|Cluster of differentiation 4 (CD4)|cluster of differentiation 4 (cd4)
4705594|NCT03203369|Cluster of differentiation 56 (CD56)|cluster of differentiation 56 (cd56)
4705595|NCT03203356|growth hormone|growth hormone
4705596|NCT03203356|children|children
4705597|NCT03203356|adrenal function|adrenal function
4705598|NCT03203343|Inguinal Hernia, Indirect|inguinal hernia, indirect
4705599|NCT03203343|Children, Only|children, only
4705600|NCT03203343|Inflammatory Response|inflammatory response
4705601|NCT03203343|Surgery|surgery
4705602|NCT03203343|Interleukin-6|interleukin-6
4705603|NCT03203343|Tumor necrosis factor alpha|tumor necrosis factor alpha
4705604|NCT03203343|C reactive protein|c reactive protein
4705605|NCT03203343|Leukocytes|leukocytes
4705606|NCT03203304|hepatocellular carcinoma|hepatocellular carcinoma
4705607|NCT03203304|nivolumab|nivolumab
4705608|NCT03203304|ipilimumab|ipilimumab
4705609|NCT03203304|stereotactic body radiotherapy|stereotactic body radiotherapy
4705610|NCT03203304|SBRT|sbrt
4705611|NCT03203291|stroke|stroke
4705612|NCT03203291|robotic training|robotic training
4705613|NCT03203291|gait|gait
4705614|NCT03203278|South Asian|south asian
4705615|NCT03203265|HIV home testing|hiv home testing
4705616|NCT03203239|red light|red light
4705617|NCT03203239|vasodilation|vasodilation
4705618|NCT03203239|nitric oxide|nitric oxide
4705619|NCT03203226|Intellectual Disability|intellectual disability
4705620|NCT03203226|Feldenkrais Method|feldenkrais method
4705621|NCT03203226|Short Physical Performance Battery|short physical performance battery
4705622|NCT03203226|Stabilometry|stabilometry
4705623|NCT03203226|Supported employment|supported employment
4705624|NCT03203213|Poisoning|poisoning
4705625|NCT03203213|Psychoactive substances|psychoactive substances
4705626|NCT03203174|microneedle|microneedle
4705627|NCT03203174|botulinum toxin|botulinum toxin
4705628|NCT03203174|botox|botox
4705629|NCT03203174|palmar hyperhidrosis|palmar hyperhidrosis
4705630|NCT03203174|sweating|sweating
4705631|NCT03203174|hyperhidrosis|hyperhidrosis
4705632|NCT03203148|Cardiopulmonary Bypass|cardiopulmonary bypass
4705633|NCT03203148|Blood Coagulation Testing|blood coagulation testing
4705634|NCT03203148|Point-of-Care Testing|point-of-care testing
4705635|NCT03203109|lateropulsion|lateropulsion
4705636|NCT03203109|pusher syndrome|pusher syndrome
4705637|NCT03203109|posture|posture
4705638|NCT03203109|balance|balance
4705639|NCT03203109|PASS|pass
4705640|NCT03203109|verticality perception|verticality perception
4705641|NCT03203109|gait|gait
4705642|NCT03203096|magnesium, stress, metabolomics, heart rate variability|magnesium, stress, metabolomics, heart rate variability
4705643|NCT03203083|Reproducibility of Results|reproducibility of results
4705644|NCT03203083|Clinical Assessment|clinical assessment
4705645|NCT03203044|Dietary Intervention|dietary intervention
4705646|NCT03203031|pain|pain
4705647|NCT03203031|neonate|neonate
4705648|NCT03203031|regional anesthesia|regional anesthesia
4705649|NCT03203031|postoperative|postoperative
4705650|NCT03203018|Cardiovascular Diseases (CVD)|cardiovascular diseases (cvd)
4705651|NCT03203018|Community-based intervention|community-based intervention
4705652|NCT03203018|Socio-economic status (SES)|socio-economic status (ses)
4705653|NCT03203018|Health literacy (HL)|health literacy (hl)
4705654|NCT03202979|Trazodone|trazodone
4705655|NCT03202979|Placebo|placebo
4705656|NCT03202979|Gabapentin|gabapentin
4705657|NCT03202979|Neuropathic pain|neuropathic pain
4705658|NCT03202940|Lung Cancer|lung cancer
4705659|NCT03202901|knee-pain, curcuma, inflammation|knee-pain, curcuma, inflammation
4705660|NCT03202862|fulvestrant|fulvestrant
4705661|NCT03202862|ESR1|esr1
4705662|NCT03202849|hematopoietic stem cell transplant|hematopoietic stem cell transplant
4705663|NCT03202849|vitamin a|vitamin a
4705664|NCT03202849|vitamin d|vitamin d
4705665|NCT03202810|optical imaging technology, loss of heterozygosity, prevention, miRNA, cost-effectiveness|optical imaging technology, loss of heterozygosity, prevention, mirna, cost-effectiveness
4705666|NCT03202758|Durvalumab|durvalumab
4705667|NCT03202758|Tremelimumab|tremelimumab
4705668|NCT03202758|FOLFOX|folfox
4705669|NCT03202758|metastatic colorectal cancer|metastatic colorectal cancer
4705670|NCT03202732|Self-management|self-management
4705671|NCT03202732|Patient Activeted measure|patient activeted measure
4705672|NCT03202732|Patient-reported outcome|patient-reported outcome
4705673|NCT03202732|Type 1 diabetes Mellitus|type 1 diabetes mellitus
4705674|NCT03202732|Non-inferiority study|non-inferiority study
4705675|NCT03202719|Inactivated polio vaccine|inactivated polio vaccine
4705676|NCT03202719|Polio|polio
4705677|NCT03202719|oral polio vaccine|oral polio vaccine
4705678|NCT03202693|Tuberculosis, PA-824|tuberculosis, pa-824
4705679|NCT03202667|SGLT2-inhibitor|sglt2-inhibitor
4705680|NCT03202667|Treatment|treatment
4705681|NCT03202641|ARDS|ards
4705682|NCT03202641|PEEP titration|peep titration
4705683|NCT03202641|Open Lung Strategy|open lung strategy
4705684|NCT03202641|Right heart function|right heart function
4705685|NCT03202641|Lung recruitment maneuver|lung recruitment maneuver
4705686|NCT03202641|Esophageal Pressure|esophageal pressure
4705687|NCT03202641|Respiratory system compliance|respiratory system compliance
4705688|NCT03202615|lactoferrin|lactoferrin
4705689|NCT03202615|iron deficiency anemia in pregnancy|iron deficiency anemia in pregnancy
4705690|NCT03202602|Obstructive sleep apnea|obstructive sleep apnea
4705691|NCT03202602|Continuous positive airway pressure|continuous positive airway pressure
4705692|NCT03202602|Telemoedicine|telemoedicine
4705693|NCT03202589|Preoperative assessement for geriatric patients|preoperative assessement for geriatric patients
4705694|NCT03202589|FOCUS Echocardiography|focus echocardiography
4705695|NCT03202589|Orthopedic|orthopedic
4705696|NCT03202589|Surgery|surgery
4705697|NCT03202589|Geriatric|geriatric
4705698|NCT03202576|nasogastric tube|nasogastric tube
4705699|NCT03202576|microbridle|microbridle
4705700|NCT03202550|Oral Sedation|oral sedation
4705701|NCT03202550|Lorazepam|lorazepam
4705702|NCT03202550|Oxycodone|oxycodone
4705703|NCT03202524|Paracentesis|paracentesis
4705704|NCT03202524|Albumin|albumin
4705705|NCT03202524|Plasma|plasma
4705706|NCT03202498|Cirrhosis, Liver|cirrhosis, liver
4705707|NCT03202498|Fibrosis, Liver|fibrosis, liver
4705708|NCT03202498|Hepatic Cirrhosis|hepatic cirrhosis
4705709|NCT03202498|Liver Fibrosis|liver fibrosis
4705710|NCT03202485|astigmatism|astigmatism
4705711|NCT03202485|high myopia|high myopia
4705712|NCT03202485|phakic intraocular lens|phakic intraocular lens
4705713|NCT03202485|astigmatic keratotomy|astigmatic keratotomy
4705714|NCT03202485|toric|toric
4705715|NCT03202459|Anesthesia|anesthesia
4705716|NCT03202459|Complications|complications
4705717|NCT03202459|Nausea|nausea
4705718|NCT03202459|Vomiting|vomiting
4705719|NCT03202433|Virtual Reality|virtual reality
4705720|NCT03202433|Stress Reduction|stress reduction
4705721|NCT03202433|Needle Aspiration|needle aspiration
4705722|NCT03202433|Blood Donors|blood donors
4705723|NCT03202433|Intervention|intervention
4705724|NCT03202394|intubation|intubation
4705725|NCT03202394|aerosol|aerosol
4705726|NCT03202394|sepsis|sepsis
4705727|NCT03202394|edema|edema
4705728|NCT03202381|Androgen deprivation therapy|androgen deprivation therapy
4705729|NCT03202381|GnRH antagonist|gnrh antagonist
4705730|NCT03202355|Alignment phase|alignment phase
4705731|NCT03202355|Photobiomodulation|photobiomodulation
4705732|NCT03202355|Orthodontic treatment|orthodontic treatment
4705733|NCT03202355|Malocclusion|malocclusion
4705734|NCT03202355|OrthoPulse™|orthopulse™
4705735|NCT03202316|Malignant neoplasm of breast|malignant neoplasm of breast
4705736|NCT03202316|Metastatic inflammatory breast cancer|metastatic inflammatory breast cancer
4705737|NCT03202316|mIBC|mibc
4705738|NCT03202316|Cobimetinib|cobimetinib
4705739|NCT03202316|Atezolizumab|atezolizumab
4705740|NCT03202316|MPDL3280A|mpdl3280a
4705741|NCT03202316|Eribulin|eribulin
4705742|NCT03202316|E7389|e7389
4705743|NCT03202303|Autism|autism
4705744|NCT03202303|Irritability|irritability
4705745|NCT03202303|cannabinoids|cannabinoids
4705746|NCT03202277|physical activity, sleep, sedentary behavior, dietary intake, smartphone|physical activity, sleep, sedentary behavior, dietary intake, smartphone
4705747|NCT03202264|Polypharmacy|polypharmacy
4705748|NCT03202264|Mobility|mobility
4705749|NCT03202264|Multimorbidity|multimorbidity
4705750|NCT03202264|Drug Discontinuation|drug discontinuation
4705751|NCT03202264|Patient Preference|patient preference
4705752|NCT03202264|eHealth|ehealth
4705753|NCT03202251|overactive bladder|overactive bladder
4705754|NCT03202251|underactive bladder|underactive bladder
4705755|NCT03202251|urinary incontinence|urinary incontinence
4705756|NCT03202199|Adenocarcinoma, pancreas, PET/MRI|adenocarcinoma, pancreas, pet/mri
4705757|NCT03202173|Probe-based confocal laser endomicroscopy|probe-based confocal laser endomicroscopy
4705758|NCT03202173|Optical biopsy|optical biopsy
4705759|NCT03202160|Goiter|goiter
4705760|NCT03202147|Ischemic stroke, post-stroke cognitive impairment, PSCI|ischemic stroke, post-stroke cognitive impairment, psci
4705761|NCT03202108|Ketogenic|ketogenic
4705762|NCT03202108|Diet|diet
4705763|NCT03202108|Epilepsy|epilepsy
4705764|NCT03202108|Glut-1 DS|glut-1 ds
4705765|NCT03202108|Krio|krio
4705766|NCT03202095|Depression|depression
4705767|NCT03202095|Type 2 Diabetes|type 2 diabetes
4705768|NCT03202095|Creatine|creatine
4705769|NCT03202095|Diabetes|diabetes
4705770|NCT03202069|Protein|protein
4705771|NCT03202069|Weight Loss|weight loss
4705772|NCT03202056|hip osteoarthritis|hip osteoarthritis
4705773|NCT03202056|physiotherapy|physiotherapy
4705774|NCT03202056|manual therapy|manual therapy
4705775|NCT03202030|immediate dentoalveolar restoration|immediate dentoalveolar restoration
4705776|NCT03202030|bio-oss|bio-oss
4705777|NCT03202030|immediate dental implant|immediate dental implant
4705778|NCT03202030|bovine bone|bovine bone
4705779|NCT03202004|PGA|pga
4705780|NCT03202004|efficacy|efficacy
4705781|NCT03202004|PASI|pasi
4705782|NCT03202004|GSK2894512|gsk2894512
4705783|NCT03202004|NRS|nrs
4705784|NCT03202004|Topical|topical
4705785|NCT03202004|psoriasis|psoriasis
4705786|NCT03201991|ALS|als
4705787|NCT03201978|Healthy adults|healthy adults
4705788|NCT03201978|GSK2894512|gsk2894512
4705789|NCT03201978|Topical|topical
4705790|NCT03201978|Psoriasis|psoriasis
4705791|NCT03201978|Pharmacokinetics|pharmacokinetics
4705792|NCT03201952|Glucose|glucose
4705793|NCT03201952|Ileostomy|ileostomy
4705794|NCT03201939|HIV/AIDS|hiv/aids
4705795|NCT03201939|sub-Saharan Africa|sub-saharan africa
4705796|NCT03201939|Kidney disease|kidney disease
4705797|NCT03201939|Albuminuria|albuminuria
4705798|NCT03201939|Genetic risk|genetic risk
4705799|NCT03201900|perampanel|perampanel
4705800|NCT03201848|Huaiqihuang granule|huaiqihuang granule
4705801|NCT03201848|immune thrombocytopenia|immune thrombocytopenia
4705802|NCT03201848|randomized|randomized
4705803|NCT03201848|double-blind|double-blind
4705804|NCT03201848|placebo-controlled,|placebo-controlled,
4705805|NCT03201822|flavanol|flavanol
4705806|NCT03201822|ADME|adme
4705807|NCT03201822|cocoa flavanols|cocoa flavanols
4705808|NCT03201822|polyphenols|polyphenols
4705809|NCT03201796|Bacterial prostatitis|bacterial prostatitis
4705810|NCT03201796|CBP|cbp
4705811|NCT03201796|Levofloxacin|levofloxacin
4705812|NCT03201796|Prulifloxacin|prulifloxacin
4705813|NCT03201783|frozen-thawed embryo transfer|frozen-thawed embryo transfer
4705814|NCT03201783|time interval|time interval
4705815|NCT03201770|Uncomplicated Malaria|uncomplicated malaria
4705816|NCT03201770|Pyramax|pyramax
4705817|NCT03201770|Pyronaridine artesunate|pyronaridine artesunate
4705818|NCT03201757|Alkermes|alkermes
4705819|NCT03201757|ALKS 3831|alks 3831
4705820|NCT03201757|Olanzapine|olanzapine
4705821|NCT03201757|Samidorphan|samidorphan
4705822|NCT03201757|Schizophrenia|schizophrenia
4705823|NCT03201757|Schizophreniform|schizophreniform
4705824|NCT03201757|Bipolar I|bipolar i
4705825|NCT03201718|Hepatitis C|hepatitis c
4705826|NCT03201718|Paritaprevir|paritaprevir
4705827|NCT03201718|Ritonavir|ritonavir
4705828|NCT03201718|Ombitasvir|ombitasvir
4705829|NCT03201718|Dasabuvir|dasabuvir
4705830|NCT03201705|Failed Back Surgery Syndrome|failed back surgery syndrome
4705831|NCT03201705|Spinal Cord Stimulation|spinal cord stimulation
4705832|NCT03201705|Pain Management|pain management
4705833|NCT03201705|Implantable Neurostimulator|implantable neurostimulator
4705834|NCT03201679|SIRS, systemic inflammatory response syndrome|sirs, systemic inflammatory response syndrome
4705835|NCT03201679|Hip Fracture Surgery|hip fracture surgery
4705836|NCT03201679|Sepsis|sepsis
4705837|NCT03201679|Mortality|mortality
4705838|NCT03201666|prenatal diagnosis|prenatal diagnosis
4705839|NCT03201666|non-invasive prenatal tests|non-invasive prenatal tests
4705840|NCT03201666|chromosome microarray analysis|chromosome microarray analysis
4705841|NCT03201653|Distal Pancreatectomy|distal pancreatectomy
4705842|NCT03201653|Pancreatic Fistula|pancreatic fistula
4705843|NCT03201653|Oxidized Regenerated Cellulose|oxidized regenerated cellulose
4705844|NCT03201653|Pancreatectomy|pancreatectomy
4705845|NCT03201601|Polycystic ovarian syndrome|polycystic ovarian syndrome
4705846|NCT03201601|D-chiro-inositol|d-chiro-inositol
4705847|NCT03201601|Fertility|fertility
4705848|NCT03201588|Retinopathy of Prematurity|retinopathy of prematurity
4705849|NCT03201575|Intensive care|intensive care
4705850|NCT03201575|septic shock|septic shock
4705851|NCT03201575|multiple organ failure|multiple organ failure
4705852|NCT03201575|Ischemia-reperfusion|ischemia-reperfusion
4705853|NCT03201575|ischemic conditioning|ischemic conditioning
4705854|NCT03201575|remote conditioning|remote conditioning
4705855|NCT03201575|SOFA score|sofa score
4705856|NCT03201536|ZipLine3 device vs. conventional sutures|zipline3 device vs. conventional sutures
4705857|NCT03201523|Community-based Intervention|community-based intervention
4705858|NCT03201523|Socio-ecological Model|socio-ecological model
4705859|NCT03201523|Participatory Approach|participatory approach
4705860|NCT03201523|Ultra-Orthodox Jewish women|ultra-orthodox jewish women
4705861|NCT03201432|Vertebral Artery Stenosis|vertebral artery stenosis
4705862|NCT03201432|Ischemic Stroke|ischemic stroke
4705863|NCT03201432|Stent|stent
4705864|NCT03201406|Renal biopsy, Chronic kidney disease,Diabetic nephropathy,Lupus Nephritis|renal biopsy, chronic kidney disease,diabetic nephropathy,lupus nephritis
4705865|NCT03201393|Back pain|back pain
4705866|NCT03201393|Neuropathic Pain|neuropathic pain
4705867|NCT03201393|Radiculopathy|radiculopathy
4705868|NCT03201393|Allodynia|allodynia
4705869|NCT03201367|Portal vein|portal vein
4705870|NCT03201367|thrombosis|thrombosis
4705871|NCT03201367|acute|acute
4705872|NCT03201367|rivaroxaban|rivaroxaban
4705873|NCT03201354|Glaucoma|glaucoma
4705874|NCT03201354|Ocular hypertension|ocular hypertension
4705875|NCT03201354|Filtration surgery|filtration surgery
4705876|NCT03201354|Trabeculectomy with Ex-PRESS|trabeculectomy with ex-press
4705877|NCT03201354|Non penetrating deep sclerectomy|non penetrating deep sclerectomy
4705878|NCT03201354|Phacoemulsification|phacoemulsification
4705879|NCT03201354|Combined surgery|combined surgery
4705880|NCT03201341|Stroke|stroke
4705881|NCT03201341|Multisensory|multisensory
4705882|NCT03201341|Plasticity|plasticity
4705883|NCT03201341|Body|body
4705884|NCT03201341|Space|space
4705885|NCT03201341|MRI|mri
4705886|NCT03201315|Fentanyl, opioids|fentanyl, opioids
4705887|NCT03201302|bone|bone
4705888|NCT03201302|childhood|childhood
4705889|NCT03201302|pre-adolescence|pre-adolescence
4705890|NCT03201302|bone turnover markers|bone turnover markers
4705891|NCT03201302|sclerostin|sclerostin
4705892|NCT03201302|sports|sports
4705893|NCT03201302|physical activity|physical activity
4705894|NCT03201302|nutrition|nutrition
4705895|NCT03201276|glucosamine sulfate|glucosamine sulfate
4705896|NCT03201276|individual differences|individual differences
4705897|NCT03201276|gene polymorphism|gene polymorphism
4705898|NCT03201250|carfilzomib|carfilzomib
4705899|NCT03201250|cabozantinib|cabozantinib
4705900|NCT03201250|proteasome inhibitor|proteasome inhibitor
4705901|NCT03201250|resistance|resistance
4705902|NCT03201237|Cerebral palsy|cerebral palsy
4705903|NCT03201211|Safety|safety
4705904|NCT03201211|Immunogenicity|immunogenicity
4705905|NCT03201198|physical activity|physical activity
4705906|NCT03201198|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
4705907|NCT03201185|Cardiovascular events|cardiovascular events
4705908|NCT03201185|Ventricular remodeling|ventricular remodeling
4705909|NCT03201159|ASH|ash
4705910|NCT03201081|elderly|elderly
4705911|NCT03201081|motivation|motivation
4705912|NCT03201081|adherence|adherence
4705913|NCT03201081|resistance-training|resistance-training
4705914|NCT03201081|health|health
4705915|NCT03201029|center for ethnic skin|center for ethnic skin
4705916|NCT03201029|skin of color clinic|skin of color clinic
4705917|NCT03201029|ethnic skin center|ethnic skin center
4705918|NCT03201016|cirrhosis|cirrhosis
4705919|NCT03201003|AR101|ar101
4705920|NCT03201003|Characterized Peanut Allergen|characterized peanut allergen
4705921|NCT03201003|CPNA (Characterized Peanut Allergen)|cpna (characterized peanut allergen)
4705922|NCT03201003|OIT (oral immunotherapy)|oit (oral immunotherapy)
4705923|NCT03201003|Peanut Allergy|peanut allergy
4705924|NCT03201003|Peanut-Allergic Children|peanut-allergic children
4705925|NCT03201003|Desensitization|desensitization
4705926|NCT03201003|ARTEMIS|artemis
4705927|NCT03201003|Allergy|allergy
4705928|NCT03200990|pressure-volume loops|pressure-volume loops
4705929|NCT03200990|cardiac mechanics|cardiac mechanics
4705930|NCT03200990|high-risk PCI|high-risk pci
4705931|NCT03200938|pulpotomy|pulpotomy
4705932|NCT03200938|Biological cement|biological cement
4705933|NCT03200938|Deciduous tooth|deciduous tooth
4705934|NCT03200925|video|video
4705935|NCT03200925|skin-to-skin|skin-to-skin
4705936|NCT03200925|kangaroo care|kangaroo care
4705937|NCT03200925|prenatal education|prenatal education
4705938|NCT03200899|cognitive rehabilitation|cognitive rehabilitation
4705939|NCT03200886|hyaluronic acid|hyaluronic acid
4705940|NCT03200886|intra-articular injections|intra-articular injections
4705941|NCT03200886|triamcinolone|triamcinolone
4705942|NCT03200886|osteoarthritis of the thumb|osteoarthritis of the thumb
4705943|NCT03200873|transcranial magnetic stimulation|transcranial magnetic stimulation
4705944|NCT03200873|theta burst stimulation|theta burst stimulation
4705945|NCT03200873|impulsivity|impulsivity
4705946|NCT03200860|heart failure|heart failure
4705947|NCT03200860|diuretic response|diuretic response
4705948|NCT03200860|empagliflozin|empagliflozin
4705949|NCT03200847|Pembrolizumab|pembrolizumab
4705950|NCT03200847|All-Trans Retinoic Acid|all-trans retinoic acid
4705951|NCT03200834|Right colon cancer|right colon cancer
4705952|NCT03200834|D3 dissection|d3 dissection
4705953|NCT03200834|complete mesocolic excision|complete mesocolic excision
4705954|NCT03200834|Hemicolectomy|hemicolectomy
4705955|NCT03200808|Nonneoplastic Epithelial Disorders|nonneoplastic epithelial disorders
4705956|NCT03200808|methylene blue|methylene blue
4705957|NCT03200808|treatment|treatment
4705958|NCT03200795|Diabetes|diabetes
4705959|NCT03200795|Musculoskelatal pain|musculoskelatal pain
4705960|NCT03200795|Rebound exercises|rebound exercises
4705961|NCT03200795|Depression|depression
4705962|NCT03200795|Glucose|glucose
4705963|NCT03200795|Quality of life|quality of life
4705964|NCT03200782|postprandial hypoglycemia|postprandial hypoglycemia
4705965|NCT03200782|bariatric surgery|bariatric surgery
4705966|NCT03200782|late dumping syndrome|late dumping syndrome
4705967|NCT03200782|anakinra|anakinra
4705968|NCT03200782|empagliflozin|empagliflozin
4705969|NCT03200782|SGLT2 inhibitor|sglt2 inhibitor
4705970|NCT03200782|IL-1Beta|il-1beta
4705971|NCT03200782|IL1|il1
4705972|NCT03200769|CPAP|cpap
4705973|NCT03200769|Sleep Apnea Syndrome|sleep apnea syndrome
4705974|NCT03200769|Pharmacoresistant Epilepsy|pharmacoresistant epilepsy
4705975|NCT03200769|Apnea Hypopnea-Index|apnea hypopnea-index
4705976|NCT03200756|sedentary behavior|sedentary behavior
4705977|NCT03200743|Hypertension|hypertension
4705978|NCT03200743|Pregnancy|pregnancy
4705979|NCT03200743|Catestatin|catestatin
4705980|NCT03200730|Family Dignity Intervention|family dignity intervention
4705981|NCT03200730|Multicentre Randomized Control Trial|multicentre randomized control trial
4705982|NCT03200730|Palliative Care|palliative care
4705983|NCT03200730|End-of-Life Care|end-of-life care
4705984|NCT03200717|renal cell carcinoma|renal cell carcinoma
4705985|NCT03200717|metastatic renal cell|metastatic renal cell
4705986|NCT03200717|pazopanib|pazopanib
4705987|NCT03200717|checkpoint inhibitor therapy|checkpoint inhibitor therapy
4705988|NCT03200717|RCC|rcc
4705989|NCT03200717|hypernephroma|hypernephroma
4705990|NCT03200717|renal adenocarcinoma|renal adenocarcinoma
4705991|NCT03200717|kidney cancer|kidney cancer
4705992|NCT03200717|renal cancer|renal cancer
4705993|NCT03200717|adult|adult
4705994|NCT03200691|Esophageal Squamous Cell Carcinoma|esophageal squamous cell carcinoma
4705995|NCT03200691|PD-1|pd-1
4705996|NCT03200691|Neoadjuvant treatment|neoadjuvant treatment
4705997|NCT03200678|knee muscle|knee muscle
4705998|NCT03200678|strength|strength
4705999|NCT03200678|fatigue|fatigue
4706000|NCT03200678|MRI|mri
4706001|NCT03200678|ACL|acl
4706002|NCT03200652|Lysine|lysine
4706003|NCT03200652|Adult|adult
4706004|NCT03200652|Protein Quality|protein quality
4706005|NCT03200639|Breast Cancer Female|breast cancer female
4706006|NCT03200639|Gynecologic Cancer|gynecologic cancer
4706007|NCT03200639|Menopause|menopause
4706008|NCT03200639|Physical Activity|physical activity
4706009|NCT03200613|Spinal cord injury|spinal cord injury
4706010|NCT03200613|Venous thromboembolism|venous thromboembolism
4706011|NCT03200613|Hemorrhage|hemorrhage
4706012|NCT03200600|Carcinoma, Non-Small-Cell Lung|carcinoma, non-small-cell lung
4706013|NCT03200600|Surgery|surgery
4706014|NCT03200600|Dexamethasone|dexamethasone
4706015|NCT03200600|Flubiprofen Axetil|flubiprofen axetil
4706016|NCT03200600|Delirium|delirium
4706017|NCT03200587|Metastatic|metastatic
4706018|NCT03200574|Perceval|perceval
4706019|NCT03200574|Mitroflow|mitroflow
4706020|NCT03200574|CROWN PRT|crown prt
4706021|NCT03200574|Freedom Solo|freedom solo
4706022|NCT03200574|Solo Smart|solo smart
4706023|NCT03200522|Asthma, Diet|asthma, diet
4706024|NCT03200509|nonspecific low back pain|nonspecific low back pain
4706025|NCT03200509|chronic pain|chronic pain
4706026|NCT03200483|Autonomic Nervous System|autonomic nervous system
4706027|NCT03200483|Aerobic exercise|aerobic exercise
4706028|NCT03200483|Recuperation|recuperation
4706029|NCT03200483|Music|music
4706030|NCT03200457|Liver iron|liver iron
4706031|NCT03200457|Liver steatosis|liver steatosis
4706032|NCT03200457|MRI|mri
4706033|NCT03200405|umbilical hernia|umbilical hernia
4706034|NCT03200405|mesh repair|mesh repair
4706035|NCT03200405|MRI-visibility|mri-visibility
4706036|NCT03200405|underlay|underlay
4706037|NCT03200405|NANEP|nanep
4706038|NCT03200405|DynaMeshCICAT|dynameshcicat
4706039|NCT03200405|DynaMeshVisible|dynameshvisible
4706040|NCT03200405|preperitoneal|preperitoneal
4706041|NCT03200392|Er,Cr:YSGG laser|er,cr:ysgg laser
4706042|NCT03200392|connective tissue graft|connective tissue graft
4706043|NCT03200392|root coverage|root coverage
4706044|NCT03200392|mucogingival surgery|mucogingival surgery
4706045|NCT03200392|gingival recession|gingival recession
4706046|NCT03200366|Cancer Screening Tests|cancer screening tests
4706047|NCT03200366|Colonoscopy|colonoscopy
4706048|NCT03200275|Legionella urine antigen test|legionella urine antigen test
4706049|NCT03200249|dose escalation, chemo-radiation, rectum cancer, phase 2|dose escalation, chemo-radiation, rectum cancer, phase 2
4706050|NCT03200236|Lung Cancer Screening|lung cancer screening
4706051|NCT03200236|Smoking Cessation|smoking cessation
4706052|NCT03200236|Tobacco Use|tobacco use
4706053|NCT03200210|Continuous Ambulatory Peritoneal Dialysis (CAPD)|continuous ambulatory peritoneal dialysis (capd)
4706054|NCT03200210|Hyperuricemia|hyperuricemia
4706055|NCT03200210|Cardiovascular events|cardiovascular events
4706056|NCT03200210|Treatment|treatment
4706057|NCT03200197|Chewing gum|chewing gum
4706058|NCT03200197|Artificial saliva|artificial saliva
4706059|NCT03200197|Saliva|saliva
4706060|NCT03200197|Mastication|mastication
4706061|NCT03200197|Salivary glands|salivary glands
4706062|NCT03200197|Xerostomia|xerostomia
4706063|NCT03200184|Hepatitis C|hepatitis c
4706064|NCT03200184|sofosbuvir|sofosbuvir
4706065|NCT03200184|daclatasvir|daclatasvir
4706066|NCT03200171|Carcinoma, Hepatocellular|carcinoma, hepatocellular
4706067|NCT03200171|Hepatitis C|hepatitis c
4706068|NCT03200158|Stress related mucosal disease (SRMD)|stress related mucosal disease (srmd)
4706069|NCT03200158|APACHEII score|apacheii score
4706070|NCT03200158|C-reactive protein|c-reactive protein
4706071|NCT03200158|Malondialdehyde (MDA)|malondialdehyde (mda)
4706072|NCT03200158|transforming growth factor (TGF)|transforming growth factor (tgf)
4706073|NCT03200158|interleukin (IL)|interleukin (il)
4706074|NCT03200093|Clostridium difficile|clostridium difficile
4706075|NCT03200093|C diff|c diff
4706076|NCT03200093|Oral Vancomycin|oral vancomycin
4706077|NCT03200093|Prophylaxis|prophylaxis
4706078|NCT03200054|therapy|therapy
4706079|NCT03200054|postnatal|postnatal
4706080|NCT03200002|Lupus Nephritis, cyclophosphamide, Mycophenolate mofetil|lupus nephritis, cyclophosphamide, mycophenolate mofetil
4706081|NCT03199989|colon cancer|colon cancer
4706082|NCT03199989|adjuvant chemotherapy|adjuvant chemotherapy
4706083|NCT03199989|high risk|high risk
4706084|NCT03199976|wheeze|wheeze
4706085|NCT03199976|shortness of breath|shortness of breath
4706086|NCT03199963|Mammographic|mammographic
4706087|NCT03199963|Breast|breast
4706088|NCT03199963|Density|density
4706089|NCT03199963|BIRADS C or D|birads c or d
4706090|NCT03199950|Delirium|delirium
4706091|NCT03199950|Haloperidol|haloperidol
4706092|NCT03199950|Prophylactic|prophylactic
4706093|NCT03199950|High-risk|high-risk
4706094|NCT03199937|Autism Spectrum Disorder|autism spectrum disorder
4706095|NCT03199937|Executive Functioning|executive functioning
4706096|NCT03199937|Intervention|intervention
4706097|NCT03199937|Flexible|flexible
4706098|NCT03199937|Unstuck|unstuck
4706099|NCT03199937|Transition|transition
4706100|NCT03199937|Behavior|behavior
4706101|NCT03199937|High school|high school
4706102|NCT03199937|Problem Solving|problem solving
4706103|NCT03199937|Self-Control|self-control
4706104|NCT03199937|Coping|coping
4706105|NCT03199924|acute pain|acute pain
4706106|NCT03199924|Renal colic|renal colic
4706107|NCT03199924|Diclofenac|diclofenac
4706108|NCT03199924|Lidocain|lidocain
4706109|NCT03199924|Magnesium sulfate|magnesium sulfate
4706110|NCT03199898|Lung/Growth & Development|lung/growth & development
4706111|NCT03199898|Respiration, artificial|respiration, artificial
4706112|NCT03199898|Reproducibility of Results|reproducibility of results
4706113|NCT03199898|Observer Variation|observer variation
4706114|NCT03199859|gastric cancer|gastric cancer
4706115|NCT03199859|postoperative|postoperative
4706116|NCT03199859|subsyndromal delirium|subsyndromal delirium
4706117|NCT03199859|quality of life|quality of life
4706118|NCT03199833|rehabilitation|rehabilitation
4706119|NCT03199833|orthosis|orthosis
4706120|NCT03199833|functional electrical stimulation|functional electrical stimulation
4706121|NCT03199833|electrode array|electrode array
4706122|NCT03199833|upper limb|upper limb
4706123|NCT03199833|sub-acute|sub-acute
4706124|NCT03199833|motor relearning|motor relearning
4706125|NCT03199807|HCC|hcc
4706126|NCT03199807|NRT|nrt
4706127|NCT03199807|TOMO radiotherapy|tomo radiotherapy
4706128|NCT03199781|cellulits of leg|cellulits of leg
4706129|NCT03199781|Motorized power massage|motorized power massage
4706130|NCT03199781|massage|massage
4706131|NCT03199768|architecture|architecture
4706132|NCT03199768|delirium|delirium
4706133|NCT03199768|environment|environment
4706134|NCT03199768|hospital design and construction|hospital design and construction
4706135|NCT03199755|therapeutic|therapeutic
4706136|NCT03199755|ACT|act
4706137|NCT03199755|gametocyte|gametocyte
4706138|NCT03199729|Overground training|overground training
4706139|NCT03199729|Dynamic Stability|dynamic stability
4706140|NCT03199729|Fall risk|fall risk
4706141|NCT03199703|PVI Ablation|pvi ablation
4706142|NCT03199703|Cryoballoon|cryoballoon
4706143|NCT03199677|apatinib,refractory thyroid cancer|apatinib,refractory thyroid cancer
4706144|NCT03199638|Continuous Glucose Monitoring|continuous glucose monitoring
4706145|NCT03199638|Children|children
4706146|NCT03199638|Exercise|exercise
4706147|NCT03199638|Glycated hemoglobin|glycated hemoglobin
4706148|NCT03199638|Adolescents|adolescents
4706149|NCT03199638|Insulin sensitivity|insulin sensitivity
4706150|NCT03199638|Glutamine|glutamine
4706151|NCT03199625|cognitive-behavior therapy|cognitive-behavior therapy
4706152|NCT03199625|magnetic resonance imaging|magnetic resonance imaging
4706153|NCT03199625|Panic Disorder|panic disorder
4706154|NCT03199612|Thrombosis during Continuous Flow Pump Support|thrombosis during continuous flow pump support
4706155|NCT03199599|PET/CT|pet/ct
4706156|NCT03199599|image processing|image processing
4706157|NCT03199599|outcome|outcome
4706158|NCT03199573|sunscreen|sunscreen
4706159|NCT03199534|Pelvic Pain|pelvic pain
4706160|NCT03199534|Dyspareunia|dyspareunia
4706161|NCT03199534|Pelvic Floor Dysfunction|pelvic floor dysfunction
4706162|NCT03199534|Pelvic Floor Physical Therapy|pelvic floor physical therapy
4706163|NCT03199534|Chemodenervation|chemodenervation
4706164|NCT03199534|Botulinum Toxin A|botulinum toxin a
4706165|NCT03199534|Vaginismus|vaginismus
4706166|NCT03199521|apixaban|apixaban
4706167|NCT03199521|endogenous fibrinolysis|endogenous fibrinolysis
4706168|NCT03199521|warfarin|warfarin
4706169|NCT03199521|aspirin|aspirin
4706170|NCT03199521|thrombotic status|thrombotic status
4706171|NCT03199508|Nocturnal Enuresis|nocturnal enuresis
4706172|NCT03199508|Voiding Diary|voiding diary
4706173|NCT03199495|traditional Chinese medicine|traditional chinese medicine
4706174|NCT03199495|electroacupuncture|electroacupuncture
4706175|NCT03199495|abdominal pain|abdominal pain
4706176|NCT03199469|AAV8-Delivered Gene Therapy|aav8-delivered gene therapy
4706178|NCT03199469|Adeno Associated Virus|adeno associated virus
4706179|NCT03199443|Sacral neuromodulation|sacral neuromodulation
4706180|NCT03199443|Electromyography|electromyography
4706181|NCT03199443|Pelvic floor|pelvic floor
4706182|NCT03199430|catecholamines|catecholamines
4706183|NCT03199430|Exercise|exercise
4706184|NCT03199430|lipid metabolism|lipid metabolism
4706185|NCT03199365|Cancer Prevention|cancer prevention
4706186|NCT03199365|Latino Families|latino families
4706187|NCT03199365|Healthy eating|healthy eating
4706188|NCT03199365|Physical activity|physical activity
4706189|NCT03199365|PA|pa
4706190|NCT03199365|Food inventory|food inventory
4706191|NCT03199365|Questionnaires|questionnaires
4706192|NCT03199365|Surveys|surveys
4706193|NCT03199365|Interviews|interviews
4706194|NCT03199365|Accelerometer|accelerometer
4706195|NCT03199339|tuberculosis|tuberculosis
4706196|NCT03199339|TBA7371|tba7371
4706197|NCT03199339|TBA-7371|tba-7371
4706198|NCT03199339|TB Alliance|tb alliance
4706199|NCT03199339|TB|tb
4706200|NCT03199339|Pulmonary Tuberculosis|pulmonary tuberculosis
4706201|NCT03199313|tuberculosis|tuberculosis
4706202|NCT03199313|TB|tb
4706203|NCT03199313|Sutezolid|sutezolid
4706204|NCT03199313|pulmonary tuberculosis|pulmonary tuberculosis
4706205|NCT03199300|bleomycin|bleomycin
4706206|NCT03199300|cisplatin|cisplatin
4706207|NCT03199300|trastuzumab|trastuzumab
4706208|NCT03199300|anthracyclines|anthracyclines
4706209|NCT03199300|toxicity|toxicity
4706210|NCT03199287|metagenomics|metagenomics
4706211|NCT03199287|next-generation sequencing|next-generation sequencing
4706212|NCT03199287|bioinformatics|bioinformatics
4706213|NCT03199287|antibiotic susceptibility|antibiotic susceptibility
4706214|NCT03199248|Digital Mucous Cyst|digital mucous cyst
4706215|NCT03199248|capsulotomy|capsulotomy
4706216|NCT03199235|iron intake|iron intake
4706217|NCT03199235|iron bioavailability|iron bioavailability
4706218|NCT03199222|amputation|amputation
4706219|NCT03199222|transtibial|transtibial
4706220|NCT03199222|socket|socket
4706221|NCT03199222|pressure|pressure
4706222|NCT03199209|Physical Activity and Nutrition|physical activity and nutrition
4706223|NCT03199209|Latino adults|latino adults
4706224|NCT03199209|Questionnaires|questionnaires
4706225|NCT03199209|Surveys|surveys
4706226|NCT03199209|Community Health Worker|community health worker
4706227|NCT03199209|CHW|chw
4706228|NCT03199209|Accelerometer|accelerometer
4706229|NCT03199196|Cancer Prevention|cancer prevention
4706230|NCT03199196|African-American woman|african-american woman
4706231|NCT03199196|Hispanic woman|hispanic woman
4706232|NCT03199196|Sedentary|sedentary
4706233|NCT03199196|Activity Tracker|activity tracker
4706234|NCT03199196|Smartphone Application|smartphone application
4706235|NCT03199196|Questionnaires|questionnaires
4706236|NCT03199196|Surveys|surveys
4706237|NCT03199196|Focus Group|focus group
4706238|NCT03199196|Electronic Newsletters|electronic newsletters
4706239|NCT03199196|Telephone Counseling|telephone counseling
4706240|NCT03199183|Takayasu Arteritis|takayasu arteritis
4706241|NCT03199183|registry|registry
4706242|NCT03199170|Caesarean Section|caesarean section
4706243|NCT03199170|Spinal anesthesia|spinal anesthesia
4706244|NCT03199170|Quadratus lumborum block|quadratus lumborum block
4706245|NCT03199170|Postoperative pain|postoperative pain
4706246|NCT03199170|Intrathecal morphine|intrathecal morphine
4706247|NCT03199144|Pancreatic Neoplasms|pancreatic neoplasms
4706248|NCT03199144|Borderline resectable|borderline resectable
4706249|NCT03199144|Neoadjuvant treatment|neoadjuvant treatment
4706250|NCT03199144|Chemotherapy|chemotherapy
4706251|NCT03199144|Stereotactic radiation|stereotactic radiation
4706252|NCT03199118|root coverage|root coverage
4706253|NCT03199092|Reading|reading
4706254|NCT03199092|Developmental Dyslexia|developmental dyslexia
4706255|NCT03199092|Music|music
4706256|NCT03199092|Rhythm|rhythm
4706257|NCT03199092|Intervention|intervention
4706258|NCT03199066|survival|survival
4706259|NCT03199066|therapy|therapy
4706260|NCT03199066|epidemiology|epidemiology
4706261|NCT03199053|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
4706262|NCT03199027|Adherence|adherence
4706263|NCT03199001|Fabry Disease|fabry disease
4706264|NCT03199001|T1 Mapping|t1 mapping
4706265|NCT03199001|Cardiovascular Magnetic Resonance|cardiovascular magnetic resonance
4706266|NCT03198975|magnetic resonance image features|magnetic resonance image features
4706267|NCT03198975|pathological differentiation|pathological differentiation
4706268|NCT03198975|machine learning-based model|machine learning-based model
4706269|NCT03198962|ATS, Thai MSM TG, Use of amphetamine-type stimulants, HIV, adherence|ats, thai msm tg, use of amphetamine-type stimulants, hiv, adherence
4706270|NCT03198923|Non-small Cell Lung Cancer|non-small cell lung cancer
4706271|NCT03198897|high cholesterol levels|high cholesterol levels
4706272|NCT03198897|low-density lipoprotein|low-density lipoprotein
4706273|NCT03198897|xanthelasma palpebrarum|xanthelasma palpebrarum
4706274|NCT03198897|atherosclerosis|atherosclerosis
4706275|NCT03198897|arcus senilis corneae|arcus senilis corneae
4706276|NCT03198897|Primary hyperlipoproteinemia|primary hyperlipoproteinemia
4706277|NCT03198871|Post-operative pain|post-operative pain
4706278|NCT03198871|Major abdominal surgery|major abdominal surgery
4706279|NCT03198871|Colorectal surgery|colorectal surgery
4706280|NCT03198871|Gastric surgery|gastric surgery
4706281|NCT03198858|Paroxysmal Atrial Fibrillation|paroxysmal atrial fibrillation
4706282|NCT03198845|knee osteoarthritis|knee osteoarthritis
4706283|NCT03198845|video game|video game
4706284|NCT03198845|therapeutic effects|therapeutic effects
4706285|NCT03198832|Periodontal Disease|periodontal disease
4706286|NCT03198832|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
4706287|NCT03198832|Z-scan|z-scan
4706288|NCT03198832|Atherosclerosis|atherosclerosis
4706289|NCT03198819|Topical rifampicin, neural tube defects, infection, newborn|topical rifampicin, neural tube defects, infection, newborn
4706290|NCT03198806|Autonomic Nervous System|autonomic nervous system
4706291|NCT03198806|Fluid Therapy|fluid therapy
4706292|NCT03198806|Heart Rate|heart rate
4706293|NCT03198806|Exercise|exercise
4706294|NCT03198767|obesity|obesity
4706295|NCT03198767|overweight|overweight
4706296|NCT03198767|body mass index|body mass index
4706297|NCT03198767|BMI|bmi
4706298|NCT03198767|diarrhea|diarrhea
4706299|NCT03198754|Autologous Stem Cell Transplant|autologous stem cell transplant
4706300|NCT03198754|Multiple Myeloma|multiple myeloma
4706301|NCT03198754|oncology|oncology
4706302|NCT03198754|circadian rhythms|circadian rhythms
4706303|NCT03198754|light therapy|light therapy
4706304|NCT03198754|Hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
4706305|NCT03198715|Fibrinolysis enhancer|fibrinolysis enhancer
4706306|NCT03198715|TAFIa inhibitor|tafia inhibitor
4706307|NCT03198715|Developmental Phase I|developmental phase i
4706308|NCT03198702|physiotherapy|physiotherapy
4706309|NCT03198702|children|children
4706310|NCT03198702|shoulder deformation|shoulder deformation
4706311|NCT03198702|obstetrical brachial plexus palsy|obstetrical brachial plexus palsy
4706312|NCT03198689|systemic sclerosis|systemic sclerosis
4706313|NCT03198689|scleroderma|scleroderma
4706314|NCT03198689|brentuximab vedotin|brentuximab vedotin
4706315|NCT03198689|CD30-directed antibody-drug conjugate|cd30-directed antibody-drug conjugate
4706316|NCT03198689|antirheumatic agents|antirheumatic agents
4706317|NCT03198689|antineoplastic agents|antineoplastic agents
4706318|NCT03198689|connective tissue diseases|connective tissue diseases
4706319|NCT03198689|skin diseases|skin diseases
4706320|NCT03198689|immunologic factors|immunologic factors
4706321|NCT03198637|efficient|efficient
4706322|NCT03198637|neuromuscular|neuromuscular
4706323|NCT03198637|blockade|blockade
4706324|NCT03198572|Non-alcoholic steatohepatitis|non-alcoholic steatohepatitis
4706325|NCT03198559|HIV latency|hiv latency
4706326|NCT03198559|Disulfiram|disulfiram
4706327|NCT03198559|Vorinostat|vorinostat
4706328|NCT03198559|Latency Reversing Agents|latency reversing agents
4706329|NCT03198559|Histone Deacetylase Inhibitors (HDACi)|histone deacetylase inhibitors (hdaci)
4706330|NCT03198546|Hepatocellular carcinoma|hepatocellular carcinoma
4706331|NCT03198546|immunotherapy|immunotherapy
4706332|NCT03198546|CAR-T cell therapy|car-t cell therapy
4706333|NCT03198546|GPC3 targeting|gpc3 targeting
4706334|NCT03198546|Phase I clinical study|phase i clinical study
4706335|NCT03198546|squamous cell lung cancer|squamous cell lung cancer
4706336|NCT03198546|interventional radiology|interventional radiology
4706337|NCT03198533|Knee|knee
4706338|NCT03198533|Arthrosis|arthrosis
4706339|NCT03198533|Implant|implant
4706340|NCT03198481|midurethral sling|midurethral sling
4706341|NCT03198481|movie|movie
4706342|NCT03198481|preparedness|preparedness
4706343|NCT03198481|Video Counseling|video counseling
4706344|NCT03198468|Non Small Cell Lung Cancer|non small cell lung cancer
4706345|NCT03198468|Metastatic Lung Cancer|metastatic lung cancer
4706346|NCT03198468|Lung Cancer|lung cancer
4706347|NCT03198468|Vapor Ablation|vapor ablation
4706348|NCT03198468|BTVA|btva
4706349|NCT03198429|domestic violence|domestic violence
4706350|NCT03198429|dyadic mother-child intervention|dyadic mother-child intervention
4706351|NCT03198429|fathers|fathers
4706352|NCT03198429|parenting|parenting
4706353|NCT03198429|young children|young children
4706354|NCT03198377|Pain Threshold|pain threshold
4706355|NCT03198377|Transcutaneous Electrical Nerve Stimulation|transcutaneous electrical nerve stimulation
4706356|NCT03198377|Habituation|habituation
4706357|NCT03198325|HIV-1|hiv-1
4706358|NCT03198299|therapeutic effects|therapeutic effects
4706359|NCT03198299|insoles|insoles
4706360|NCT03198299|children|children
4706361|NCT03198273|clinical pilates|clinical pilates
4706362|NCT03198273|exercise|exercise
4706363|NCT03198273|lumbar disc herniation|lumbar disc herniation
4706364|NCT03198273|chronic low back pain|chronic low back pain
4706365|NCT03198234|Pediatric|pediatric
4706366|NCT03198234|GvHD|gvhd
4706367|NCT03198234|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
4706368|NCT03198234|Stem Cells|stem cells
4706369|NCT03198234|Transplant|transplant
4706370|NCT03198234|BMT - bone marrow transplant|bmt - bone marrow transplant
4706371|NCT03198221|Golytely, Clenpiq, bowel prep|golytely, clenpiq, bowel prep
4706372|NCT03198156|Transcranial Direct Current Stimulation|transcranial direct current stimulation
4706373|NCT03198156|Without Cataplexy|without cataplexy
4706374|NCT03198143|Decision-making|decision-making
4706375|NCT03198143|Ghrelin|ghrelin
4706376|NCT03198143|Healthy Volunteers|healthy volunteers
4706377|NCT03198143|Obese|obese
4706378|NCT03198104|Multiparametric MR Imaging|multiparametric mr imaging
4706379|NCT03198104|Paediatric|paediatric
4706380|NCT03198091|stable angina pectoris|stable angina pectoris
4706381|NCT03198091|Dun Ye Guan Xin Ning|dun ye guan xin ning
4706382|NCT03198078|Brexpiprazole|brexpiprazole
4706383|NCT03198078|Schizophrenia|schizophrenia
4706384|NCT03198078|Adolescent|adolescent
4706385|NCT03198065|Laparoscopic appendectomy|laparoscopic appendectomy
4706386|NCT03198065|Single-incision laparoscopic appendectomy|single-incision laparoscopic appendectomy
4706387|NCT03198065|Single-incision laparoscopic surgery setting|single-incision laparoscopic surgery setting
4706388|NCT03198065|Simple appendicitis|simple appendicitis
4706389|NCT03198065|Complicated appendicitis|complicated appendicitis
4706390|NCT03198052|Lung Cancer|lung cancer
4706391|NCT03198052|Immunotherapy|immunotherapy
4706392|NCT03198052|CAR-T Cell Therapy|car-t cell therapy
4706393|NCT03198052|PSCA|psca
4706394|NCT03198052|MUC1|muc1
4706395|NCT03198052|PD-L1|pd-l1
4706396|NCT03198052|CD80/86|cd80/86
4706397|NCT03198052|Cancer expressing PSCA,MUC1,PD-L1,or/and CD80/86|cancer expressing psca,muc1,pd-l1,or/and cd80/86
4706398|NCT03198039|Meditation|meditation
4706399|NCT03198039|Cognitive Dysfunction|cognitive dysfunction
4706400|NCT03198039|Postoperative Period|postoperative period
4706401|NCT03198039|Cardiac Surgery|cardiac surgery
4706402|NCT03198000|Eye Redness|eye redness
4706403|NCT03198000|Eye Comfort|eye comfort
4706404|NCT03198000|Red Eyes|red eyes
4706405|NCT03197987|adenoma detection rate|adenoma detection rate
4706406|NCT03197987|cap-assisted colonoscopy|cap-assisted colonoscopy
4706407|NCT03197987|endocuff|endocuff
4706408|NCT03197974|stage|stage
4706409|NCT03197974|online|online
4706410|NCT03197974|self-help|self-help
4706411|NCT03197974|coaching support|coaching support
4706412|NCT03197974|quality of life|quality of life
4706413|NCT03197974|mindfulness|mindfulness
4706414|NCT03197974|psychoeducation|psychoeducation
4706415|NCT03197974|persuasive systems design|persuasive systems design
4706416|NCT03197974|psychosocial|psychosocial
4706417|NCT03197922|Autism Spectrum Disorder|autism spectrum disorder
4706418|NCT03197922|Constipation|constipation
4706419|NCT03197909|COPD (Chronic Obstructive Pulmonary Patients)|copd (chronic obstructive pulmonary patients)
4706420|NCT03197909|Atrophy|atrophy
4706421|NCT03197909|cell cultur|cell cultur
4706422|NCT03197909|systemic inflammation|systemic inflammation
4706423|NCT03197909|Catabolism|catabolism
4706424|NCT03197857|Bariatric surgery|bariatric surgery
4706425|NCT03197857|Morbid obesity|morbid obesity
4706426|NCT03197857|Physical condition|physical condition
4706427|NCT03197857|Muscle|muscle
4706428|NCT03197857|6-minute walking test|6-minute walking test
4706429|NCT03197857|Protein supplementation|protein supplementation
4706430|NCT03197857|Physical activity program|physical activity program
4706431|NCT03197831|Medicaid Expansion, Affordable Care Act, Health Care Reform|medicaid expansion, affordable care act, health care reform
4706432|NCT03197818|COPD|copd
4706433|NCT03197818|Anticholinergics|anticholinergics
4706434|NCT03197818|Triple Combination|triple combination
4706435|NCT03197805|Equivocal Her 2|equivocal her 2
4706436|NCT03197805|Genomic test|genomic test
4706437|NCT03197792|Transesophageal ultrasound|transesophageal ultrasound
4706438|NCT03197792|TEE|tee
4706439|NCT03197792|Portal vein pulsatility|portal vein pulsatility
4706440|NCT03197792|Splenic vein pulsatility|splenic vein pulsatility
4706441|NCT03197792|Venous congestion|venous congestion
4706442|NCT03197792|Strain|strain
4706443|NCT03197792|Right ventricular dysfunction|right ventricular dysfunction
4706444|NCT03197792|Pulmonary hypertension|pulmonary hypertension
4706445|NCT03197792|Venous hypertension|venous hypertension
4706446|NCT03197766|Achondroplasia|achondroplasia
4706447|NCT03197766|Dwarfism|dwarfism
4706448|NCT03197766|Bone Diseases|bone diseases
4706449|NCT03197766|Bone Diseases, Developmental|bone diseases, developmental
4706450|NCT03197766|ACH|ach
4706451|NCT03197766|Natriuretic Peptide, C-Type|natriuretic peptide, c-type
4706452|NCT03197766|Musculoskeletal Diseases|musculoskeletal diseases
4706453|NCT03197766|Natriuretic Agents|natriuretic agents
4706454|NCT03197766|Physiological Effects of Drugs|physiological effects of drugs
4706455|NCT03197766|Skeletal Dysplasias|skeletal dysplasias
4706456|NCT03197766|Genetic Diseases, Inborn|genetic diseases, inborn
4706457|NCT03197766|Osteochondrodysplasias|osteochondrodysplasias
4706458|NCT03197753|laryngeal mask airway|laryngeal mask airway
4706459|NCT03197753|nasotracheal intubation|nasotracheal intubation
4706460|NCT03197753|dental treatment|dental treatment
4706461|NCT03197727|Tooth wear, risk factors, saliva, diet, oral hygiene|tooth wear, risk factors, saliva, diet, oral hygiene
4706462|NCT03197714|Myeloid Leukemia|myeloid leukemia
4706463|NCT03197701|Lung function|lung function
4706464|NCT03197701|Inspiratory flow rates|inspiratory flow rates
4706465|NCT03197675|Chronic pain|chronic pain
4706466|NCT03197675|Acupuncture|acupuncture
4706467|NCT03197662|Prader-Willi Syndrome|prader-willi syndrome
4706468|NCT03197662|Hyperphagia|hyperphagia
4706469|NCT03197636|Vitamin D|vitamin d
4706470|NCT03197636|Soluble PD-1|soluble pd-1
4706471|NCT03197623|Glucocorticoids|glucocorticoids
4706472|NCT03197610|gingival recession|gingival recession
4706473|NCT03197610|sub epithelial connective tissue graft|sub epithelial connective tissue graft
4706474|NCT03197610|enamel matrix derivatives|enamel matrix derivatives
4706475|NCT03197610|root coverage aesthetic score|root coverage aesthetic score
4706476|NCT03197597|B. pertussis|b. pertussis
4706477|NCT03197597|Acellular vaccination|acellular vaccination
4706478|NCT03197597|Strain variation|strain variation
4706479|NCT03197532|fertility|fertility
4706480|NCT03197532|hormones|hormones
4706481|NCT03197532|healthy|healthy
4706482|NCT03197532|chemotherapy|chemotherapy
4706483|NCT03197532|oncofertility|oncofertility
4706484|NCT03197532|alkylating agent|alkylating agent
4706485|NCT03197532|fertility after cancer|fertility after cancer
4706486|NCT03197532|late effects|late effects
4706487|NCT03197532|survivorship|survivorship
4706488|NCT03197532|healthy volunteers|healthy volunteers
4706489|NCT03197532|perimenopause|perimenopause
4706490|NCT03197532|middle age|middle age
4706491|NCT03197519|mHealth|mhealth
4706492|NCT03197519|Eating Disorders|eating disorders
4706493|NCT03197519|Randomised Controlled Trial|randomised controlled trial
4706494|NCT03197519|Cognitive Behavioural Therapy|cognitive behavioural therapy
4706495|NCT03197519|cost effectiveness|cost effectiveness
4706496|NCT03197480|Anti-Vascular Endothelial Growth Factor|anti-vascular endothelial growth factor
4706497|NCT03197480|Aflibercept|aflibercept
4706498|NCT03197480|Intravitreal injection|intravitreal injection
4706499|NCT03197480|Diabetic Macular Edema|diabetic macular edema
4706500|NCT03197441|Platelet-rich plasma|platelet-rich plasma
4706501|NCT03197441|Osteoarthritis Knee|osteoarthritis knee
4706502|NCT03197428|Platelet-Rich Plasma|platelet-rich plasma
4706503|NCT03197428|Ankle Injuries|ankle injuries
4706504|NCT03197428|Lateral Ligament, Ankle|lateral ligament, ankle
4706505|NCT03197415|Platelet-rich plasma|platelet-rich plasma
4706506|NCT03197415|Intervertebral Disc Degeneration|intervertebral disc degeneration
4706507|NCT03197415|Low Back Pain|low back pain
4706508|NCT03197402|Leucine|leucine
4706509|NCT03197402|Protein|protein
4706510|NCT03197402|Supplementation|supplementation
4706511|NCT03197389|Biomarker|biomarker
4706512|NCT03197363|Civilization diseases|civilization diseases
4706513|NCT03197363|Cardiovascular Risk Factor|cardiovascular risk factor
4706514|NCT03197363|Population study|population study
4706515|NCT03197363|Intestinal microbiome|intestinal microbiome
4706516|NCT03197363|Oral microbiome|oral microbiome
4706517|NCT03197350|heart failure with preserved ejection fraction|heart failure with preserved ejection fraction
4706518|NCT03197350|Imaging|imaging
4706519|NCT03197350|Prognosis|prognosis
4706520|NCT03197337|Vulvodynia|vulvodynia
4706521|NCT03197337|Localized Provoked Vulvodynia (LPV)|localized provoked vulvodynia (lpv)
4706522|NCT03197337|Referred pain|referred pain
4706523|NCT03197337|Utero-Sacral ligaments laxity|utero-sacral ligaments laxity
4706524|NCT03197311|Oral surgery|oral surgery
4706525|NCT03197311|Medication adherence|medication adherence
4706526|NCT03197298|Acute Coronary Syndrome|acute coronary syndrome
4706527|NCT03197298|Percutaneous Coronary Intervention|percutaneous coronary intervention
4706528|NCT03197298|Drug-Eluting Stents|drug-eluting stents
4706529|NCT03197298|Platelet Aggregation Inhibitors|platelet aggregation inhibitors
4706530|NCT03197298|Ticagrelor|ticagrelor
4706531|NCT03197298|clopidogrel|clopidogrel
4706532|NCT03197298|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists
4706533|NCT03197285|neck pain|neck pain
4706534|NCT03197285|eye|eye
4706535|NCT03197285|propioception|propioception
4706536|NCT03197285|range of motion|range of motion
4706537|NCT03197285|pain|pain
4706538|NCT03197272|Myopia|myopia
4706539|NCT03197272|corneal Crosslinking|corneal crosslinking
4706540|NCT03197259|CLL, del(17p)|cll, del(17p)
4706541|NCT03197246|PICC line|picc line
4706542|NCT03197246|ECG|ecg
4706543|NCT03197246|chest x-ray|chest x-ray
4706544|NCT03197246|IVECG|ivecg
4706545|NCT03197246|ICECG|icecg
4706673|NCT03196453|weight management|weight management
4706546|NCT03197194|Central retinal artery occlusion|central retinal artery occlusion
4706547|NCT03197194|visual acuity|visual acuity
4706548|NCT03197194|visual field|visual field
4706549|NCT03197194|mRs|mrs
4706550|NCT03197194|NEI-VFQ-25|nei-vfq-25
4706551|NCT03197168|stigma|stigma
4706552|NCT03197168|psychosocial intervention|psychosocial intervention
4706553|NCT03197168|low-and-middle income countries|low-and-middle income countries
4706554|NCT03197142|cardiac arrest|cardiac arrest
4706555|NCT03197142|resuscitation|resuscitation
4706556|NCT03197142|Out-Of-Hospital Cardiac Arrest|out-of-hospital cardiac arrest
4706557|NCT03197142|CPR|cpr
4706558|NCT03197103|Autologous fat grafting|autologous fat grafting
4706559|NCT03197103|Breast|breast
4706560|NCT03197103|Deformity|deformity
4706561|NCT03197103|Asymmetry|asymmetry
4706562|NCT03197103|Tuberous breast|tuberous breast
4706563|NCT03197103|Acetylcysteine|acetylcysteine
4706564|NCT03197090|Screening|screening
4706565|NCT03197090|Zenicor|zenicor
4706566|NCT03197051|Endothelial glycocalyx|endothelial glycocalyx
4706567|NCT03197051|Acute kidney injury|acute kidney injury
4706568|NCT03197051|Valvular heart disease|valvular heart disease
4706569|NCT03197038|Cognitive function|cognitive function
4706570|NCT03197038|Kidney Disease|kidney disease
4706571|NCT03197038|Exercise|exercise
4706572|NCT03197038|Older adults|older adults
4706573|NCT03197025|HPV-16|hpv-16
4706574|NCT03197025|premalignancy|premalignancy
4706575|NCT03197025|T Cell Therapy|t cell therapy
4706576|NCT03197012|neuroendocrine tumor (NET)|neuroendocrine tumor (net)
4706577|NCT03197012|Peptide Receptor Radionuclide Therapy (PRRT)|peptide receptor radionuclide therapy (prrt)
4706578|NCT03197012|somatostatin receptor (SSTR)|somatostatin receptor (sstr)
4706579|NCT03196999|PTSD|ptsd
4706580|NCT03196999|Attention bias modification|attention bias modification
4706581|NCT03196999|Remote app-based study|remote app-based study
4706582|NCT03196999|Digital Health|digital health
4706583|NCT03196960|Mobilization Therapy|mobilization therapy
4706584|NCT03196960|Critical Illness|critical illness
4706585|NCT03196960|Muscle Strength|muscle strength
4706586|NCT03196960|Functional Mobility|functional mobility
4706587|NCT03196960|Outcome|outcome
4706588|NCT03196960|Intensive Care Unit|intensive care unit
4706589|NCT03196960|Quality of Life|quality of life
4706590|NCT03196947|multiple myeloma|multiple myeloma
4706591|NCT03196947|APO010|apo010
4706592|NCT03196947|Drug Response Predictor|drug response predictor
4706593|NCT03196947|DRP|drp
4706594|NCT03196921|amphotericin B|amphotericin b
4706595|NCT03196921|cryptococcal|cryptococcal
4706596|NCT03196908|ECG|ecg
4706597|NCT03196908|Blood Pressure|blood pressure
4706598|NCT03196908|Energy Drinks|energy drinks
4706599|NCT03196895|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
4706600|NCT03196895|Continuous Glucose Monitoring|continuous glucose monitoring
4706601|NCT03196895|Lifestyle Modification|lifestyle modification
4706602|NCT03196882|pregnancy|pregnancy
4706603|NCT03196882|iron|iron
4706604|NCT03196882|hemoglobin|hemoglobin
4706605|NCT03196882|supplementation|supplementation
4706606|NCT03196882|neurodevelopment|neurodevelopment
4706607|NCT03196882|newborn|newborn
4706608|NCT03196882|anemia|anemia
4706609|NCT03196882|clinical trial|clinical trial
4706610|NCT03196869|NPC peripheral blood dendritic cell chronic-chemotherap|npc peripheral blood dendritic cell chronic-chemotherap
4706611|NCT03196856|Greek Yogurt|greek yogurt
4706612|NCT03196856|Muscle Size|muscle size
4706613|NCT03196856|Bone Health|bone health
4706614|NCT03196856|Body Composition|body composition
4706615|NCT03196856|Exercise|exercise
4706616|NCT03196843|raltitrexed|raltitrexed
4706617|NCT03196843|radiotherapy|radiotherapy
4706618|NCT03196843|older patient|older patient
4706619|NCT03196843|head and neck squamous cell carcinoma|head and neck squamous cell carcinoma
4706620|NCT03196830|Relapse/refractory non-Hodgkin lymphoma|relapse/refractory non-hodgkin lymphoma
4706621|NCT03196830|CAR - T CD19/CD20/CD22/CD30|car - t cd19/cd20/cd22/cd30
4706622|NCT03196817|Random Allocation|random allocation
4706623|NCT03196817|Injections|injections
4706624|NCT03196817|Orthotic Devices|orthotic devices
4706625|NCT03196765|X-ALD|x-ald
4706626|NCT03196752|cricothyroid membrane|cricothyroid membrane
4706627|NCT03196726|cognitive-behavioral therapy|cognitive-behavioral therapy
4706628|NCT03196713|Allegiance|allegiance
4706629|NCT03196713|Knowledge|knowledge
4706630|NCT03196713|Supervision|supervision
4706631|NCT03196713|Early intervention|early intervention
4706632|NCT03196713|Autism|autism
4706633|NCT03196700|palliative care|palliative care
4706634|NCT03196700|head and neck cancer|head and neck cancer
4706635|NCT03196700|radiotherapy|radiotherapy
4706636|NCT03196700|pain|pain
4706637|NCT03196700|quality of life|quality of life
4706638|NCT03196687|diastolic dysfunction|diastolic dysfunction
4706639|NCT03196661|safety investigation|safety investigation
4706640|NCT03196648|Gingivitis|gingivitis
4706641|NCT03196648|Periodontal disease|periodontal disease
4706642|NCT03196648|Inflammation|inflammation
4706643|NCT03196648|Teeth whitening|teeth whitening
4706644|NCT03196648|Breath freshening|breath freshening
4706645|NCT03196648|Periodontal pathogens|periodontal pathogens
4706646|NCT03196648|Bleeding on probing|bleeding on probing
4706647|NCT03196622|Sarcopenia|sarcopenia
4706648|NCT03196622|Elderly people|elderly people
4706649|NCT03196622|Hospitalization|hospitalization
4706650|NCT03196609|Intestinal microbiota, microbial genes, oncology|intestinal microbiota, microbial genes, oncology
4706651|NCT03196596|TAVI|tavi
4706652|NCT03196596|Computer simulation|computer simulation
4706653|NCT03196583|obstructive sleep apnea syndrome|obstructive sleep apnea syndrome
4706654|NCT03196583|video-polysomnography|video-polysomnography
4706655|NCT03196583|mandibular advancement device|mandibular advancement device
4706656|NCT03196583|oral device|oral device
4706657|NCT03196583|cephalometry|cephalometry
4706658|NCT03196518|PET Imaging|pet imaging
4706659|NCT03196518|18F-TFB|18f-tfb
4706660|NCT03196518|17-315|17-315
4706661|NCT03196505|Anesthetics, Local|anesthetics, local
4706662|NCT03196505|Liposomal Bupivacaine|liposomal bupivacaine
4706663|NCT03196505|Bupivacaine|bupivacaine
4706664|NCT03196505|Postoperative Complications|postoperative complications
4706665|NCT03196505|Roux-en-Y Gastric Bypass|roux-en-y gastric bypass
4706666|NCT03196505|Sleeve Gastrectomy|sleeve gastrectomy
4706667|NCT03196505|Laparoscopic Bariatric Surgery|laparoscopic bariatric surgery
4706668|NCT03196466|antiepileptics|antiepileptics
4706669|NCT03196466|pharmacokinetics|pharmacokinetics
4706670|NCT03196466|children|children
4706671|NCT03196453|overweight|overweight
4706672|NCT03196453|probiotic|probiotic
4706674|NCT03196440|elderly|elderly
4706675|NCT03196440|taste|taste
4706676|NCT03196440|thresholds|thresholds
4706677|NCT03196427|Drug Therapy|drug therapy
4706678|NCT03196401|Durvalumb|durvalumb
4706679|NCT03196401|Radiation Therapy|radiation therapy
4706680|NCT03196401|Clonal Bone Marrow Plasmacytosis|clonal bone marrow plasmacytosis
4706681|NCT03196401|MEDI4736|medi4736
4706682|NCT03196401|17-269|17-269
4706683|NCT03196388|ENZALUTAMIDE|enzalutamide
4706684|NCT03196388|External Beam Hypofractionated Radiotherapy Intermediate Risk Prostate Cancer|external beam hypofractionated radiotherapy intermediate risk prostate cancer
4706685|NCT03196375|Motor Neuron Disease|motor neuron disease
4706686|NCT03196375|Neurodegenerative Diseases|neurodegenerative diseases
4706687|NCT03196375|Nervous System Diseases|nervous system diseases
4706688|NCT03196375|Neuromuscular Diseases|neuromuscular diseases
4706689|NCT03196375|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
4706690|NCT03196375|Primary Lateral Sclerosis|primary lateral sclerosis
4706691|NCT03196375|Progressive Muscular Atrophy|progressive muscular atrophy
4706692|NCT03196375|Muscle cramps|muscle cramps
4706693|NCT03196375|Muscle cramping|muscle cramping
4706694|NCT03196375|ALS|als
4706695|NCT03196375|MND|mnd
4706696|NCT03196375|PMA|pma
4706697|NCT03196375|PLS|pls
4706698|NCT03196375|FLX-787|flx-787
4706699|NCT03196362|short-term intensive insulin therapy|short-term intensive insulin therapy
4706700|NCT03196362|pioglitazone|pioglitazone
4706701|NCT03196362|metformin|metformin
4706702|NCT03196362|remission|remission
4706703|NCT03196362|sequential therapy|sequential therapy
4706704|NCT03196258|fracture|fracture
4706705|NCT03196258|persistent pain|persistent pain
4706706|NCT03196258|cognitive behavioural therapy|cognitive behavioural therapy
4706707|NCT03196258|post surgical pain|post surgical pain
4706708|NCT03196258|health-related quality of life|health-related quality of life
4706709|NCT03196167|sugammadex|sugammadex
4706710|NCT03196167|extubation|extubation
4706711|NCT03196167|CABG, AVR, CABG/AVR combination|cabg, avr, cabg/avr combination
4706712|NCT03196154|Homeostasis Model Assessment|homeostasis model assessment
4706713|NCT03196154|Insulin Resistance|insulin resistance
4706714|NCT03196154|Beta Cell Function|beta cell function
4706715|NCT03196154|Liquid Chromatography Tandem Mass Spectrometry|liquid chromatography tandem mass spectrometry
4706716|NCT03196115|Autosomal Recessive Disorder|autosomal recessive disorder
4706717|NCT03196115|Gingival Hypertrophy|gingival hypertrophy
4706718|NCT03196115|Skin and Connective Tissue Diseases|skin and connective tissue diseases
4706719|NCT03196102|tobacco prevention; tobacco intervention; military; brief intervention|tobacco prevention; tobacco intervention; military; brief intervention
4706720|NCT03196063|Exercise Therapy|exercise therapy
4706721|NCT03196063|Heavy Slow Resistance Program|heavy slow resistance program
4706722|NCT03196063|Rehabilitation|rehabilitation
4706723|NCT03196024|Diabetes; CVD; Lifestyle; Hispanic; Promotora|diabetes; cvd; lifestyle; hispanic; promotora
4706724|NCT03196024|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
4706725|NCT03196024|Cardiovascular Diseases|cardiovascular diseases
4706726|NCT03196024|Risk Reduction Behavior|risk reduction behavior
4706727|NCT03196024|Hispanic Americans; Latinos|hispanic americans; latinos
4706728|NCT03196024|Community Health Workers|community health workers
4706729|NCT03195972|Adherence, Patient, oncology, oral therapy|adherence, patient, oncology, oral therapy
4706730|NCT03195959|Pulmonary arterial hypertension|pulmonary arterial hypertension
4706731|NCT03195959|Chronic thromboembolic pulmonary hypertension|chronic thromboembolic pulmonary hypertension
4706732|NCT03195959|Hypoxia|hypoxia
4706733|NCT03195959|Hyperoxia|hyperoxia
4706734|NCT03195933|Depression|depression
4706735|NCT03195933|Childhood Adversity|childhood adversity
4706736|NCT03195933|Childhood Abuse|childhood abuse
4706737|NCT03195933|Cortisol|cortisol
4706738|NCT03195933|Emotional Memory|emotional memory
4706739|NCT03195933|Magnetic Resonance Imaging (MRI)|magnetic resonance imaging (mri)
4706740|NCT03195907|Stroke|stroke
4706741|NCT03195907|Mortality|mortality
4706742|NCT03195907|Intensive care unit|intensive care unit
4706743|NCT03195907|Pulmonary rehabilitation|pulmonary rehabilitation
4706744|NCT03195894|Alcohol abuse, Alcoholometer, Medical Device, App|alcohol abuse, alcoholometer, medical device, app
4706745|NCT03195868|chemotherapy|chemotherapy
4706746|NCT03195868|chemo-induced|chemo-induced
4706747|NCT03195868|CIPN|cipn
4706748|NCT03195829|Mild Cognitive Impairment|mild cognitive impairment
4706749|NCT03195829|Computerized Cognitive Stimulation|computerized cognitive stimulation
4706750|NCT03195829|Cognition|cognition
4706751|NCT03195829|Psychosocial factors|psychosocial factors
4706752|NCT03195816|Mild Cognitive Impairment|mild cognitive impairment
4706753|NCT03195816|white matter hyperintensities|white matter hyperintensities
4706754|NCT03195816|computerized cognitive training|computerized cognitive training
4706755|NCT03195816|brain plasticity|brain plasticity
4706756|NCT03195751|telemonitoring|telemonitoring
4706757|NCT03195738|pediatrics|pediatrics
4706758|NCT03195738|case series|case series
4706759|NCT03195738|feasibility|feasibility
4706760|NCT03195712|BMI|bmi
4706761|NCT03195712|Obesity|obesity
4706762|NCT03195699|STAT3, cancer, inhibitor, advanced cancer|stat3, cancer, inhibitor, advanced cancer
4706763|NCT03195673|Carotid artery stenting|carotid artery stenting
4706764|NCT03195673|Silent embolism|silent embolism
4706765|NCT03195673|Terazosin|terazosin
4706766|NCT03195660|adaptive servo-ventilation|adaptive servo-ventilation
4706767|NCT03195660|ASV|asv
4706768|NCT03195660|HFpEF|hfpef
4706769|NCT03195647|cardiovascular|cardiovascular
4706770|NCT03195647|potassium supplementation|potassium supplementation
4706771|NCT03195647|coronary artery by pass surgery|coronary artery by pass surgery
4706772|NCT03195634|Cirrhosis|cirrhosis
4706773|NCT03195634|Portal Hypertension|portal hypertension
4706774|NCT03195621|Coronary Artery Disease|coronary artery disease
4706775|NCT03195621|Critical lesion|critical lesion
4706776|NCT03195608|In-vehicle technologies|in-vehicle technologies
4706777|NCT03195608|Parkinson's disease|parkinson's disease
4706778|NCT03195608|Driving performance|driving performance
4706779|NCT03195569|QL1101 Avastin® Non Small Cell Lung Cancer|ql1101 avastin® non small cell lung cancer
4706780|NCT03195543|Blood coagulation disorders|blood coagulation disorders
4706781|NCT03195543|Platelets|platelets
4706782|NCT03195543|Thrombin|thrombin
4706783|NCT03195543|Treatment|treatment
4706784|NCT03195517|Osteopenia|osteopenia
4706785|NCT03195517|Physical activity|physical activity
4706786|NCT03195517|Bone turnover markers|bone turnover markers
4706787|NCT03195517|Osteoprogenitor cells|osteoprogenitor cells
4706788|NCT03195517|Quality of life|quality of life
4706789|NCT03195452|HIV|hiv
4706790|NCT03195452|Antiretrovirals|antiretrovirals
4706791|NCT03195452|Raltegravir|raltegravir
4706792|NCT03195413|Hand blast injury|hand blast injury
4706793|NCT03195413|Nerve block|nerve block
4706794|NCT03195413|Hand injury|hand injury
4706795|NCT03195413|Forearm nerve block|forearm nerve block
4706796|NCT03195413|Ultrasound guided nerve block|ultrasound guided nerve block
4706797|NCT03195413|Ultrasound nerve block|ultrasound nerve block
4706798|NCT03195413|Emergency department|emergency department
4706799|NCT03195413|Emergency physician|emergency physician
4706800|NCT03195413|Emergency room|emergency room
4706801|NCT03195387|malaria, P. falciparum, chemoprotection, Phase Ib|malaria, p. falciparum, chemoprotection, phase ib
4706802|NCT03195374|Analgesic opioids|analgesic opioids
4706803|NCT03195374|Misuse|misuse
4706804|NCT03195374|Use disorder|use disorder
4706805|NCT03195374|Pain|pain
4706806|NCT03195335|Cerebral Palsy|cerebral palsy
4706807|NCT03195335|Participation|participation
4706808|NCT03195335|LIFE Habits (life-H)|life habits (life-h)
4706809|NCT03195335|Validity|validity
4706810|NCT03195335|Reliability|reliability
4706811|NCT03195322|Immediate Breast Reconstruction|immediate breast reconstruction
4706812|NCT03195322|Pain Control|pain control
4706813|NCT03195322|Post Mastectomy Pain Control|post mastectomy pain control
4706814|NCT03195322|Acellular Dermal Matrix|acellular dermal matrix
4706815|NCT03195309|Cesarean Delivery|cesarean delivery
4706816|NCT03195309|Ropivacaine|ropivacaine
4706817|NCT03195309|Fentanyl|fentanyl
4706818|NCT03195309|Patient-controlled Epidural Analgesia|patient-controlled epidural analgesia
4706819|NCT03195283|meal service|meal service
4706820|NCT03195283|protein intake|protein intake
4706821|NCT03195283|satisfaction|satisfaction
4706822|NCT03195283|hospitalized patients|hospitalized patients
4706823|NCT03195270|Positron emission tomography|positron emission tomography
4706824|NCT03195270|Magnetic Resonance Imaging|magnetic resonance imaging
4706825|NCT03195270|PET/MRI|pet/mri
4706826|NCT03195270|Fluorodeoxyglucose|fluorodeoxyglucose
4706827|NCT03195270|FDG|fdg
4706828|NCT03195270|Pain|pain
4706829|NCT03195270|Chronic Pain|chronic pain
4706830|NCT03195270|Neuropathic Pain|neuropathic pain
4706831|NCT03195270|Inflammatory Pain|inflammatory pain
4706832|NCT03195270|Nociceptive Pain|nociceptive pain
4706833|NCT03195244|aquatic therapy, hydrotherapy|aquatic therapy, hydrotherapy
4706834|NCT03195231|Parkinson`s disease|parkinson`s disease
4706835|NCT03195231|Depression|depression
4706836|NCT03195231|Wuling Powder|wuling powder
4706837|NCT03195218|Cancer prevention|cancer prevention
4706838|NCT03195218|Diagnosis|diagnosis
4706839|NCT03195218|Microendoscope|microendoscope
4706840|NCT03195218|High Resolution Microendoscope|high resolution microendoscope
4706841|NCT03195179|pelvic fracture urethral injury|pelvic fracture urethral injury
4706842|NCT03195179|urethra|urethra
4706843|NCT03195179|disruption|disruption
4706844|NCT03195179|trauma|trauma
4706845|NCT03195166|elderly spinal anesthesia|elderly spinal anesthesia
4706846|NCT03195140|Diabetes Mellitus|diabetes mellitus
4706847|NCT03195140|Diabetes|diabetes
4706848|NCT03195140|Sensor Augmented Pump|sensor augmented pump
4706849|NCT03195140|Hypoglycemia|hypoglycemia
4706850|NCT03195127|Physical Therapy Modalities|physical therapy modalities
4706851|NCT03195127|Rehabilitation|rehabilitation
4706852|NCT03195127|Exercise Therapy|exercise therapy
4706853|NCT03195127|Critical Illness|critical illness
4706854|NCT03195127|Respiration, Artificial|respiration, artificial
4706855|NCT03195127|Chronic Disease|chronic disease
4706856|NCT03195114|post TAVR quantification|post tavr quantification
4706857|NCT03195114|cardiac MRI|cardiac mri
4706858|NCT03195114|echocardiography|echocardiography
4706859|NCT03195114|biomarkers|biomarkers
4706860|NCT03195101|orbital tumors|orbital tumors
4706861|NCT03195101|transconjunctival approach|transconjunctival approach
4706862|NCT03195062|Fructose|fructose
4706863|NCT03195062|Obesity|obesity
4706864|NCT03195062|Metabolism|metabolism
4706865|NCT03195062|Post-prandial kinetics|post-prandial kinetics
4706866|NCT03195049|hyperbilirubinemia|hyperbilirubinemia
4706867|NCT03195049|kernicterus|kernicterus
4706868|NCT03195036|HIV-exposed|hiv-exposed
4706869|NCT03195036|Early Childhood Development|early childhood development
4706870|NCT03195036|Cameroon|cameroon
4706871|NCT03195023|Renal Insufficiency, Chronic|renal insufficiency, chronic
4706872|NCT03194997|Breast Cancer|breast cancer
4706873|NCT03194997|Quality of life|quality of life
4706874|NCT03194997|Lymphedema|lymphedema
4706875|NCT03194997|Fatigue|fatigue
4706876|NCT03194997|Depressive symptoms|depressive symptoms
4706877|NCT03194997|Body image|body image
4706878|NCT03194997|Self Esteem|self esteem
4706879|NCT03194997|Optimism|optimism
4706880|NCT03194997|Sexual function|sexual function
4706881|NCT03194997|Stress|stress
4706882|NCT03194997|Sleep quality|sleep quality
4706883|NCT03194997|Pain|pain
4706884|NCT03194997|Muscular strength|muscular strength
4706885|NCT03194997|Postural|postural
4706886|NCT03194997|Balance|balance
4706887|NCT03194997|Range of motion|range of motion
4706888|NCT03194997|Cardiorespiratory fitness|cardiorespiratory fitness
4706889|NCT03194984|dental whitening|dental whitening
4706890|NCT03194984|Dental office whitening|dental office whitening
4706891|NCT03194971|glioblastoma|glioblastoma
4706892|NCT03194971|brain tumor autopsy|brain tumor autopsy
4706893|NCT03194971|autopsy|autopsy
4706894|NCT03194971|Optune therapy|optune therapy
4706895|NCT03194971|tumor treatment fields|tumor treatment fields
4706896|NCT03194971|TTFields|ttfields
4706897|NCT03194971|Recurrent glioblastoma|recurrent glioblastoma
4706898|NCT03194971|grade IV|grade iv
4706899|NCT03194971|brain tumor|brain tumor
4706900|NCT03194971|newly diagnosed glioblastoma|newly diagnosed glioblastoma
4706901|NCT03194945|Type 2 diabetes mellitus|type 2 diabetes mellitus
4706902|NCT03194945|Continuous subcutaneous insulin infusion|continuous subcutaneous insulin infusion
4706903|NCT03194945|Metformin|metformin
4706904|NCT03194945|Linagliptin|linagliptin
4706905|NCT03194919|online intervention|online intervention
4706906|NCT03194919|e-Health|e-health
4706907|NCT03194919|negotiating quit date|negotiating quit date
4706908|NCT03194906|Pediatric oncology|pediatric oncology
4706909|NCT03194906|Brain tumor|brain tumor
4706910|NCT03194906|Low grade glioma|low grade glioma
4706911|NCT03194906|Cognitive late effects|cognitive late effects
4706912|NCT03194906|Radiation therapy|radiation therapy
4706913|NCT03194906|Neuroprotection|neuroprotection
4706914|NCT03194906|Memantine|memantine
4706915|NCT03194893|Non−small cell lung cancer (NSCLC)|non−small cell lung cancer (nsclc)
4706916|NCT03194893|Anaplastic lymphoma kinase (ALK)|anaplastic lymphoma kinase (alk)
4706917|NCT03194893|Rearranged during transfection (RET)|rearranged during transfection (ret)
4706918|NCT03194893|Alectinib|alectinib
4706919|NCT03194893|Crizotinib|crizotinib
4706920|NCT03194854|e-Health|e-health
4706921|NCT03194854|self-efficacy theory|self-efficacy theory
4706922|NCT03194854|mixture modeling|mixture modeling
4706923|NCT03194854|mobile health|mobile health
4706924|NCT03194854|complier average causal effect estimation|complier average causal effect estimation
4706925|NCT03194828|Adherence|adherence
4706926|NCT03194828|Mobile health|mobile health
4706927|NCT03194828|Real-time data|real-time data
4706928|NCT03194815|Psychosis|psychosis
4706929|NCT03194815|Immunotherapy|immunotherapy
4706930|NCT03194815|Autoantibodies|autoantibodies
4706931|NCT03194789|FGBMM|fgbmm
4706932|NCT03194789|LPSE|lpse
4706933|NCT03194789|UDI - 6|udi - 6
4706934|NCT03194789|UIQ - 7|uiq - 7
4706935|NCT03194776|PAD|pad
4706936|NCT03194776|peripheral artery/arterial disease|peripheral artery/arterial disease
4706937|NCT03194776|peripheral vascular disease|peripheral vascular disease
4706938|NCT03194776|leg pain|leg pain
4706939|NCT03194776|claudication|claudication
4706940|NCT03194776|leg pain with exercise|leg pain with exercise
4706941|NCT03194776|exercise test|exercise test
4706942|NCT03194776|walk test|walk test
4706943|NCT03194737|Benign prostatic hyperplasia|benign prostatic hyperplasia
4706944|NCT03194737|BPH|bph
4706945|NCT03194737|Urinary retention|urinary retention
4706946|NCT03194737|prostate|prostate
4706947|NCT03194737|hypertrophy|hypertrophy
4706948|NCT03194711|Percutaneous Coronary Revascularization|percutaneous coronary revascularization
4706949|NCT03194711|Optical Coherence Tomography|optical coherence tomography
4706950|NCT03194711|Stents, Drug-Eluting|stents, drug-eluting
4706951|NCT03194698|Intense Pulsed Light|intense pulsed light
4706952|NCT03194685|Acute Myeloid Leukemia|acute myeloid leukemia
4706953|NCT03194659|Nutrition|nutrition
4706954|NCT03194659|choline|choline
4706955|NCT03194659|pregnancy|pregnancy
4706956|NCT03194659|docosahexaenoic acid|docosahexaenoic acid
4706957|NCT03194659|DHA|dha
4706958|NCT03194659|fatty acids|fatty acids
4706959|NCT03194646|Uterine Fibroid|uterine fibroid
4706960|NCT03194620|Flavanols|flavanols
4706961|NCT03194620|Cocoa Flavanols|cocoa flavanols
4706962|NCT03194620|Epicatechins|epicatechins
4706963|NCT03194620|Polyphenols|polyphenols
4706964|NCT03194620|Procyanidins|procyanidins
4706965|NCT03194620|EGCG|egcg
4706966|NCT03194620|EGC|egc
4706967|NCT03194620|ECG|ecg
4706968|NCT03194620|Theaflavins|theaflavins
4706969|NCT03194620|Thearubigins|thearubigins
4706970|NCT03194594|Ketamine, dexamethasone, mood|ketamine, dexamethasone, mood
4706971|NCT03194568|Scoliosis|scoliosis
4706972|NCT03194568|Idiopathic Scoliosis|idiopathic scoliosis
4706973|NCT03194568|Adolescent Idiopathic Scoliosis|adolescent idiopathic scoliosis
4706974|NCT03194555|Innate Immune System|innate immune system
4706975|NCT03194555|Cytokines|cytokines
4706976|NCT03194555|Cox-2|cox-2
4706977|NCT03194555|Headache|headache
4706978|NCT03194555|Migraine|migraine
4706979|NCT03194555|Migraine Prevention|migraine prevention
4706980|NCT03194542|Luspatercept|luspatercept
4706981|NCT03194542|ACE-536|ace-536
4706982|NCT03194542|Myeloproliferative Neoplasm-Associated Myelofibrosis|myeloproliferative neoplasm-associated myelofibrosis
4706983|NCT03194542|Primary Myelofibrosis|primary myelofibrosis
4706984|NCT03194542|Post-Polycythemia Vera Myelofibrosis|post-polycythemia vera myelofibrosis
4706985|NCT03194542|Post-Essential Thrombocythemia|post-essential thrombocythemia
4706986|NCT03194542|Anemia|anemia
4706987|NCT03194542|Red Blood Cell (RBC) Transfusion|red blood cell (rbc) transfusion
4706988|NCT03194542|Ruxolitinib|ruxolitinib
4706989|NCT03194529|Crohn's Disease|crohn's disease
4706990|NCT03194529|PCDAI|pcdai
4706991|NCT03194529|16s rRNA|16s rrna
4706992|NCT03194529|Fecal Microbiota Transplantation|fecal microbiota transplantation
4706993|NCT03194529|Gut Microbiome|gut microbiome
4706994|NCT03194529|FMT|fmt
4706995|NCT03194516|prostate cancer|prostate cancer
4706996|NCT03194516|ketogenic diet|ketogenic diet
4706997|NCT03194516|overweight, obese|overweight, obese
4706998|NCT03194503|Intubation|intubation
4706999|NCT03194503|Video Laryngoscope|video laryngoscope
4707000|NCT03194503|Coaching/training|coaching/training
4707001|NCT03194477|HIV young Black men who have sex with men substance use|hiv young black men who have sex with men substance use
4707002|NCT03194464|hemiparesis|hemiparesis
4707003|NCT03194451|bone tissue engineering, dental stem cell differentiation|bone tissue engineering, dental stem cell differentiation
4707004|NCT03194438|Pulmonary Hypertension|pulmonary hypertension
4707005|NCT03194438|Symptom Management|symptom management
4707006|NCT03194438|Behavioral Intervention|behavioral intervention
4707007|NCT03194438|Integrative Therapy|integrative therapy
4707008|NCT03194438|Quality of Life|quality of life
4707009|NCT03194425|Sacral neuromodulation|sacral neuromodulation
4707010|NCT03194425|Electromyography|electromyography
4707011|NCT03194425|Pelvic floor|pelvic floor
4707012|NCT03194412|Frail Elderly|frail elderly
4707013|NCT03194412|Geriatric Assessment|geriatric assessment
4707014|NCT03194412|Humans|humans
4707015|NCT03194412|Aged|aged
4707016|NCT03194386|Post-Traumatic Syndrome|post-traumatic syndrome
4707017|NCT03194386|Eye-Movement Desensitization and Reprocessing|eye-movement desensitization and reprocessing
4707018|NCT03194334|vegetarianism|vegetarianism
4707019|NCT03194334|creatine|creatine
4707020|NCT03194334|carnosine|carnosine
4707021|NCT03194334|carnitine|carnitine
4707022|NCT03194308|HIV risk reduction|hiv risk reduction
4707023|NCT03194308|Safer Conception|safer conception
4707024|NCT03194308|Pre-exposure prophylaxis|pre-exposure prophylaxis
4707025|NCT03194308|South Africa|south africa
4707026|NCT03194308|Women|women
4707027|NCT03194308|Reproductive Health|reproductive health
4707028|NCT03194295|Drug-free community support|drug-free community support
4707029|NCT03194295|Methadone maintenance|methadone maintenance
4707030|NCT03194295|Social networks|social networks
4707031|NCT03194256|Smoking|smoking
4707032|NCT03194256|Cigarettes|cigarettes
4707033|NCT03194256|E-Cigarettes|e-cigarettes
4707034|NCT03194243|acute dyspnea|acute dyspnea
4707035|NCT03194243|acute heart failure|acute heart failure
4707036|NCT03194243|emergency|emergency
4707037|NCT03194230|Cervical dilators|cervical dilators
4707038|NCT03194230|induction of labor|induction of labor
4707039|NCT03194230|cervical ripening|cervical ripening
4707040|NCT03194230|medical termination of pregnancy|medical termination of pregnancy
4707041|NCT03194230|second-trimester of pregnancy.|second-trimester of pregnancy.
4707042|NCT03194191|Insomnia|insomnia
4707043|NCT03194191|Pregnancy|pregnancy
4707044|NCT03194191|Acupuncture|acupuncture
4707045|NCT03194191|Insomnia severity index|insomnia severity index
4707046|NCT03194191|Pittsburgh Sleep Quality Index|pittsburgh sleep quality index
4707047|NCT03194191|Anxiety|anxiety
4707048|NCT03194191|Depression|depression
4707049|NCT03194165|antiretroviral|antiretroviral
4707050|NCT03194165|children|children
4707051|NCT03194165|pharmacokinetics|pharmacokinetics
4707052|NCT03194139|Healthy Adult|healthy adult
4707053|NCT03194139|Superoxide Dismutase|superoxide dismutase
4707054|NCT03194139|First in Human|first in human
4707055|NCT03194139|Free Radical Dismutase|free radical dismutase
4707056|NCT03194087|Secondary Hyperparathyroidism|secondary hyperparathyroidism
4707057|NCT03194087|Low parathyroid hormone|low parathyroid hormone
4707058|NCT03194087|Hemodialysis|hemodialysis
4707059|NCT03194074|Laser Laryngeal Surgery|laser laryngeal surgery
4707060|NCT03194074|Desflurane|desflurane
4707061|NCT03194074|Propofol|propofol
4707062|NCT03194061|chemotherapy|chemotherapy
4707063|NCT03194061|complication|complication
4707064|NCT03194048|drooling|drooling
4707065|NCT03194048|tongue thrust|tongue thrust
4707066|NCT03194035|inflammation|inflammation
4707067|NCT03194035|exercise|exercise
4707068|NCT03194035|ultra endurance|ultra endurance
4707069|NCT03194009|diabetes|diabetes
4707070|NCT03194009|prevention|prevention
4707071|NCT03194009|metformin|metformin
4707072|NCT03194009|Mexico City|mexico city
4707073|NCT03193983|occlusive dressing|occlusive dressing
4707074|NCT03193970|Bladder Cancer|bladder cancer
4707075|NCT03193970|Registry|registry
4707076|NCT03193970|Post‐surgical outcomes|post‐surgical outcomes
4707077|NCT03193970|Radical cystectomy|radical cystectomy
4707078|NCT03193970|MD Anderson Symptom inventory|md anderson symptom inventory
4707079|NCT03193970|MDASI|mdasi
4707080|NCT03193892|registry|registry
4707081|NCT03193892|China|china
4707082|NCT03193892|lymphangioleiomyomatosis|lymphangioleiomyomatosis
4707083|NCT03193879|Pulmonary function|pulmonary function
4707084|NCT03193879|Particulate matter|particulate matter
4707085|NCT03193879|COPD|copd
4707086|NCT03193879|Asthma|asthma
4707087|NCT03193866|Immunomodulating treatment|immunomodulating treatment
4707088|NCT03193866|Cohort study|cohort study
4707089|NCT03193866|Dimethyl fumarate|dimethyl fumarate
4707090|NCT03193866|Fingolimod|fingolimod
4707091|NCT03193866|Interferon-beta|interferon-beta
4707092|NCT03193866|Natalizumab|natalizumab
4707093|NCT03193866|Rituximab|rituximab
4707094|NCT03193866|Glatiramer acetate|glatiramer acetate
4707095|NCT03193840|old acetabular fracture; posterior wall osteotomy|old acetabular fracture; posterior wall osteotomy
4707096|NCT03193827|vip score|vip score
4707097|NCT03193827|peripheral venous cannulation|peripheral venous cannulation
4707098|NCT03193827|particles|particles
4707099|NCT03193801|SAPIEN 3|sapien 3
4707100|NCT03193801|PARTNER 3|partner 3
4707101|NCT03193801|cardiovascular disease|cardiovascular disease
4707102|NCT03193801|TMVR|tmvr
4707103|NCT03193801|failing valve|failing valve
4707104|NCT03193801|failing bioprosthetic valve|failing bioprosthetic valve
4707105|NCT03193775|HBV vaccine|hbv vaccine
4707106|NCT03193775|persistent|persistent
4707107|NCT03193775|HBsAg|hbsag
4707108|NCT03193775|IP-10|ip-10
4707109|NCT03193762|pain|pain
4707110|NCT03193762|pain management|pain management
4707111|NCT03193762|anxiety|anxiety
4707112|NCT03193749|Chagas disease, cardiomyopathy, amiodarone, clinical trial|chagas disease, cardiomyopathy, amiodarone, clinical trial
4707113|NCT03193723|Hernia|hernia
4707114|NCT03193723|Local anesthesia|local anesthesia
4707115|NCT03193723|ultrasound|ultrasound
4707116|NCT03193710|Intravenous anesthesia|intravenous anesthesia
4707117|NCT03193710|Inhalational anesthesia|inhalational anesthesia
4707118|NCT03193710|Colorectal cancer resection|colorectal cancer resection
4707119|NCT03193710|Lymphocytes|lymphocytes
4707120|NCT03193710|Metastasis|metastasis
4707121|NCT03193710|Survival|survival
4707122|NCT03193710|Molecular mechanism|molecular mechanism
4707124|NCT03193671|CA125|ca125
4707125|NCT03193671|RMI|rmi
4707126|NCT03193671|ROMA|roma
4707127|NCT03193658|spine surgery|spine surgery
4707128|NCT03193658|Thoracolumbar Interfascial Plane block|thoracolumbar interfascial plane block
4707129|NCT03193658|regional anesthesia|regional anesthesia
4707130|NCT03193658|postoperative analgesia|postoperative analgesia
4707131|NCT03193658|opioid consumption|opioid consumption
4707132|NCT03193632|lean body mass|lean body mass
4707133|NCT03193632|resting energy expenditure|resting energy expenditure
4707134|NCT03193632|oxygen consumption|oxygen consumption
4707135|NCT03193632|Indirect calorimetry|indirect calorimetry
4707136|NCT03193632|carbon dioxide excretion|carbon dioxide excretion
4707137|NCT03193632|respiratory quotient|respiratory quotient
4707138|NCT03193580|Anodal Stimulation Transcranial Direct Current Stimulation|anodal stimulation transcranial direct current stimulation
4707139|NCT03193580|High-Definition Transcranial Direct Current Stimulation|high-definition transcranial direct current stimulation
4707140|NCT03193580|tDCS|tdcs
4707141|NCT03193580|Non-invasive brain stimulation|non-invasive brain stimulation
4707142|NCT03193580|Pediatrics|pediatrics
4707143|NCT03193489|Balance|balance
4707144|NCT03193489|Posturograpy|posturograpy
4707145|NCT03193489|quality of life|quality of life
4707146|NCT03193463|Topotecan|topotecan
4707147|NCT03193463|Convection-Enhanced Delivery|convection-enhanced delivery
4707148|NCT03193450|helicobactor pylori|helicobactor pylori
4707149|NCT03193437|Thymus|thymus
4707150|NCT03193437|Selinexor|selinexor
4707151|NCT03193437|KPT-330|kpt-330
4707859|NCT03189056|bladder|bladder
4707152|NCT03193398|Major Depressive Disorder|major depressive disorder
4707153|NCT03193398|Anhedonia|anhedonia
4707154|NCT03193398|antidepressant|antidepressant
4707155|NCT03193398|Nociceptin|nociceptin
4707156|NCT03193398|NOPR|nopr
4707157|NCT03193333|glaucoma|glaucoma
4707158|NCT03193333|primary open-angle glaucoma|primary open-angle glaucoma
4707159|NCT03193333|Ophthalmic antihypertensives|ophthalmic antihypertensives
4707160|NCT03193333|Krytantek Ofteno®.|krytantek ofteno®.
4707161|NCT03193333|timolol|timolol
4707162|NCT03193333|brimonidine|brimonidine
4707163|NCT03193333|dorzolamide|dorzolamide
4707164|NCT03193320|plethysmographic variability index|plethysmographic variability index
4707165|NCT03193320|PVI|pvi
4707166|NCT03193281|Dasatinib|dasatinib
4707167|NCT03193281|Imatinib|imatinib
4707168|NCT03193268|sensorimotor training|sensorimotor training
4707169|NCT03193268|quality of life|quality of life
4707170|NCT03193268|posture|posture
4707171|NCT03193242|Asthma|asthma
4707172|NCT03193242|Asthma Action Plan|asthma action plan
4707173|NCT03193216|Barrett's|barrett's
4707174|NCT03193216|GERD|gerd
4707175|NCT03193216|reflux|reflux
4707176|NCT03193216|alginate solution|alginate solution
4707177|NCT03193216|proton pump inhibitor|proton pump inhibitor
4707178|NCT03193177|fasting-like diet|fasting-like diet
4707179|NCT03193177|chronic diseases|chronic diseases
4707180|NCT03193177|autoimmune diseases|autoimmune diseases
4707181|NCT03193177|metabolic disorder|metabolic disorder
4707182|NCT03193164|Electric Stimulation Therapy; Endothelial Progenitor Cells.|electric stimulation therapy; endothelial progenitor cells.
4707183|NCT03193151|Liver transplant|liver transplant
4707184|NCT03193151|global gene expression|global gene expression
4707185|NCT03193151|molecular diagnostics|molecular diagnostics
4707186|NCT03193138|Cardiotoxicity|cardiotoxicity
4707187|NCT03193138|Androgens|androgens
4707188|NCT03193138|Hormone Replacement Therapy|hormone replacement therapy
4707189|NCT03193138|Testosterone|testosterone
4707190|NCT03193138|Androgen Antagonists|androgen antagonists
4707191|NCT03193112|Agomelatine|agomelatine
4707192|NCT03193112|Depression|depression
4707193|NCT03193112|Intraocular pressure|intraocular pressure
4707194|NCT03193086|Multiple Sclerosis|multiple sclerosis
4707195|NCT03193086|Blood-Brain-Barrier|blood-brain-barrier
4707196|NCT03193086|Treatment response|treatment response
4707197|NCT03193086|Metabolism|metabolism
4707198|NCT03193086|Alemtuzumab|alemtuzumab
4707199|NCT03193086|Perfusion|perfusion
4707200|NCT03193086|Oxygen consumption|oxygen consumption
4707201|NCT03193047|Cholesterol|cholesterol
4707202|NCT03193047|PCSK9|pcsk9
4707203|NCT03193047|Repatha|repatha
4707204|NCT03193047|evolocumab|evolocumab
4707205|NCT03193047|LDL-C|ldl-c
4707206|NCT03193034|Arthroplasty|arthroplasty
4707207|NCT03193034|replacement|replacement
4707208|NCT03193034|Knee|knee
4707209|NCT03193034|function|function
4707210|NCT03193034|radiographic|radiographic
4707211|NCT03193034|survivorship|survivorship
4707212|NCT03193021|vessel closure|vessel closure
4707213|NCT03193021|venous access site|venous access site
4707214|NCT03193021|femoral venotomy|femoral venotomy
4707215|NCT03193021|medium bore|medium bore
4707216|NCT03193021|multiple access sites|multiple access sites
4707217|NCT03193008|Breast Cancer|breast cancer
4707218|NCT03193008|Axillary ultrasound|axillary ultrasound
4707219|NCT03193008|Sentinel lymph node biopsy|sentinel lymph node biopsy
4707220|NCT03193008|Axillary management|axillary management
4707221|NCT03192995|HIV|hiv
4707222|NCT03192995|sexual behavior|sexual behavior
4707223|NCT03192956|Hyperbaric|hyperbaric
4707224|NCT03192956|Decompression sickness|decompression sickness
4707225|NCT03192956|Decompression injury|decompression injury
4707226|NCT03192956|Inflammation|inflammation
4707227|NCT03192956|Central nervous injury|central nervous injury
4707228|NCT03192956|Hybervaric oxygen therapy|hybervaric oxygen therapy
4707229|NCT03192930|Hyperbaric|hyperbaric
4707230|NCT03192930|Saturation|saturation
4707231|NCT03192930|Decompression injury|decompression injury
4707232|NCT03192930|Decompression sickness|decompression sickness
4707233|NCT03192930|Inflammation|inflammation
4707234|NCT03192930|Central nervous system injury|central nervous system injury
4707235|NCT03192930|Diving medicine|diving medicine
4707236|NCT03192917|Shock wave therapy|shock wave therapy
4707237|NCT03192917|erectile dysfunction|erectile dysfunction
4707238|NCT03192904|Lung cancer|lung cancer
4707239|NCT03192904|Segmentectomy|segmentectomy
4707240|NCT03192904|Postoperative Complication|postoperative complication
4707241|NCT03192904|Stapling Device|stapling device
4707242|NCT03192904|Energy Device|energy device
4707243|NCT03192878|infliximab|infliximab
4707244|NCT03192878|biosimilars|biosimilars
4707245|NCT03192878|treatment|treatment
4707246|NCT03192852|Tooth bleaching color|tooth bleaching color
4707247|NCT03192852|dental esthetic|dental esthetic
4707248|NCT03192852|Clinical Trial|clinical trial
4707249|NCT03192852|Violet LED light|violet led light
4707250|NCT03192852|Violet LED|violet led
4707251|NCT03192852|color|color
4707252|NCT03192852|sensibility|sensibility
4707253|NCT03192852|dental aesthetic|dental aesthetic
4707254|NCT03192826|Nd-YAG capsulotomy|nd-yag capsulotomy
4707959|NCT03188380|preterm|preterm
4707255|NCT03192826|ocular hypertension|ocular hypertension
4707256|NCT03192826|brimonidine|brimonidine
4707257|NCT03192826|brinzolamide|brinzolamide
4707258|NCT03192800|clinical outcome|clinical outcome
4707259|NCT03192800|prognositic factor|prognositic factor
4707260|NCT03192800|spinal dural arteriovenous fistula|spinal dural arteriovenous fistula
4707261|NCT03192722|Filters|filters
4707262|NCT03192722|Illumination|illumination
4707263|NCT03192722|Low vision|low vision
4707264|NCT03192722|Reading|reading
4707265|NCT03192709|Sildenafil IVF ICI failure|sildenafil ivf ici failure
4707266|NCT03192631|financial incentive|financial incentive
4707267|NCT03192579|neoatherosclerosis|neoatherosclerosis
4707268|NCT03192566|Acetaminophen|acetaminophen
4707269|NCT03192566|Anesthesia|anesthesia
4707270|NCT03192566|Adolescent|adolescent
4707271|NCT03192566|Obesity|obesity
4707272|NCT03192553|donning|donning
4707273|NCT03192553|doffing|doffing
4707274|NCT03192553|self-contamination|self-contamination
4707275|NCT03192553|healthcare workers|healthcare workers
4707276|NCT03192540|Exercise|exercise
4707277|NCT03192527|KN015|kn015
4707278|NCT03192527|Long-acting FSH|long-acting fsh
4707279|NCT03192514|Polypharmacy|polypharmacy
4707280|NCT03192514|Benzodiazepine use|benzodiazepine use
4707281|NCT03192501|lung cancer|lung cancer
4707282|NCT03192501|iCAGES|icages
4707283|NCT03192501|gene mutation|gene mutation
4707284|NCT03192501|precision medicine|precision medicine
4707285|NCT03192501|advanced cancers|advanced cancers
4707286|NCT03192462|Pancreatic Cancer|pancreatic cancer
4707287|NCT03192462|Immune-based therapies|immune-based therapies
4707288|NCT03192462|CytotoxicT Lymphocytes|cytotoxict lymphocytes
4707289|NCT03192423|Stress|stress
4707290|NCT03192423|Performance of procedures|performance of procedures
4707291|NCT03192423|Lumbar Puncture|lumbar puncture
4707292|NCT03192410|myocardial infarction|myocardial infarction
4707293|NCT03192410|cardiovascular diseases|cardiovascular diseases
4707294|NCT03192410|mortality|mortality
4707295|NCT03192410|post-myocardial infarction patients|post-myocardial infarction patients
4707296|NCT03192410|risk prediction|risk prediction
4707297|NCT03192410|kidney function|kidney function
4707298|NCT03192410|mental well-being|mental well-being
4707299|NCT03192410|cardiovascular drug treatment|cardiovascular drug treatment
4707300|NCT03192384|Hospital falls|hospital falls
4707301|NCT03192371|Zagreb regimen|zagreb regimen
4707302|NCT03192371|Encephalitis|encephalitis
4707303|NCT03192371|Antibody persistence|antibody persistence
4707304|NCT03192371|Essen regimen|essen regimen
4707305|NCT03192371|Post-Exposure Prophylaxis (PEP)|post-exposure prophylaxis (pep)
4707306|NCT03192371|Rabies|rabies
4707307|NCT03192358|Thickened Liquids|thickened liquids
4707308|NCT03192358|Dysphagia Management|dysphagia management
4707309|NCT03192358|Videofluoroscopy|videofluoroscopy
4707310|NCT03192358|Swallowing Physiology|swallowing physiology
4707311|NCT03192332|Intravenous thrombolysis|intravenous thrombolysis
4707312|NCT03192332|Endovascular treatment|endovascular treatment
4707313|NCT03192332|Mechanical thrombectomy|mechanical thrombectomy
4707314|NCT03192332|Bridging thrombolysis|bridging thrombolysis
4707315|NCT03192332|Acute ischemic stroke|acute ischemic stroke
4707316|NCT03192319|Herpes zoster vaccine|herpes zoster vaccine
4707317|NCT03192319|Cell-mediated immunity|cell-mediated immunity
4707318|NCT03192319|hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
4707319|NCT03192306|Herpes Labialis|herpes labialis
4707320|NCT03192306|Cold Sore|cold sore
4707321|NCT03192267|newly diagnosed rheumatoid arthritis|newly diagnosed rheumatoid arthritis
4707322|NCT03192267|lung disease|lung disease
4707323|NCT03192241|reading|reading
4707324|NCT03192228|Diabetes Mellitus, Type 2 +|diabetes mellitus, type 2 +
4707325|NCT03192228|Patient Education|patient education
4707326|NCT03192215|Atrial Cardiopathy|atrial cardiopathy
4707327|NCT03192215|Cryptogenic stroke|cryptogenic stroke
4707328|NCT03192215|Ischemic stroke|ischemic stroke
4707329|NCT03192215|Apixaban|apixaban
4707330|NCT03192215|Aspirin|aspirin
4707331|NCT03192202|Lymphoma|lymphoma
4707332|NCT03192202|Cutaneous Lymphoma|cutaneous lymphoma
4707333|NCT03192202|cutaneous T-cell lymphoma (CTCL)|cutaneous t-cell lymphoma (ctcl)
4707334|NCT03192202|CD30-Positive Cutaneous Lymphoma|cd30-positive cutaneous lymphoma
4707335|NCT03192176|Menopause|menopause
4707336|NCT03192176|Hot flashes|hot flashes
4707337|NCT03192176|Perimenopause|perimenopause
4707338|NCT03192176|Vasomotor symptoms|vasomotor symptoms
4707339|NCT03192124|primary total knee|primary total knee
4707340|NCT03192124|infection|infection
4707341|NCT03192111|Healthy Volunteers|healthy volunteers
4707342|NCT03192111|Mild Renal Impairment|mild renal impairment
4707343|NCT03192111|Moderate Renal Impairment|moderate renal impairment
4707344|NCT03192111|Severe Renal Impairment|severe renal impairment
4707345|NCT03192111|Entinostat|entinostat
4707346|NCT03192111|Histone Deacetylase Inhibitor|histone deacetylase inhibitor
4707347|NCT03192111|HDAC|hdac
4707348|NCT03192059|Immunotherapy|immunotherapy
4707349|NCT03192059|Radiotherapy|radiotherapy
4707350|NCT03192059|Immune-modulatory cocktail|immune-modulatory cocktail
4707351|NCT03192020|Hand dysfunction|hand dysfunction
4707352|NCT03192020|Xiapex|xiapex
4707353|NCT03192020|Xiaflex|xiaflex
4708253|NCT03186781|Protein|protein
4707354|NCT03192020|Aponeurectomy|aponeurectomy
4707355|NCT03192020|Aponeurotomy|aponeurotomy
4707356|NCT03192020|Dupuytren disease|dupuytren disease
4707357|NCT03192020|Joint contracture|joint contracture
4707358|NCT03192020|Surgery|surgery
4707359|NCT03191968|Behavior change|behavior change
4707360|NCT03191968|Prostate cancer|prostate cancer
4707361|NCT03191968|Behavioral counseling|behavioral counseling
4707362|NCT03191968|Physical Activity|physical activity
4707363|NCT03191968|Randomized controlled trial|randomized controlled trial
4707364|NCT03191942|Myopia control|myopia control
4707365|NCT03191942|Orthokeratology|orthokeratology
4707366|NCT03191942|Children|children
4707367|NCT03191942|Treatment zone|treatment zone
4707368|NCT03191929|Depression|depression
4707369|NCT03191929|Post-traumatic Stress Disorder|post-traumatic stress disorder
4707370|NCT03191929|Health Information Technology (HIT)|health information technology (hit)
4707371|NCT03191929|Primary Care Provider|primary care provider
4707372|NCT03191929|Mental Health Screening|mental health screening
4707373|NCT03191916|Parkinson's Disease|parkinson's disease
4707374|NCT03191916|Mild Cognitive Impairment|mild cognitive impairment
4707375|NCT03191916|tDCS|tdcs
4707376|NCT03191916|Cognitive function|cognitive function
4707377|NCT03191890|in vivo culture|in vivo culture
4707378|NCT03191877|coffee consumption|coffee consumption
4707379|NCT03191877|Cesarean section|cesarean section
4707380|NCT03191877|intestinal motility|intestinal motility
4707381|NCT03191864|Esophagitis|esophagitis
4707382|NCT03191864|Eosinophilic Esophagitis|eosinophilic esophagitis
4707383|NCT03191864|Fluticasone|fluticasone
4707384|NCT03191864|Dysphagia|dysphagia
4707385|NCT03191864|Safety|safety
4707386|NCT03191864|Efficacy|efficacy
4707387|NCT03191864|Pharmacokinetics|pharmacokinetics
4707388|NCT03191864|Esophageal Diseases|esophageal diseases
4707389|NCT03191864|Gastrointestinal Diseases|gastrointestinal diseases
4707390|NCT03191864|Digestive System Diseases|digestive system diseases
4707391|NCT03191864|Glucocorticoids|glucocorticoids
4707392|NCT03191864|Orally Disintegrating Tablet|orally disintegrating tablet
4707393|NCT03191825|online intervention|online intervention
4707394|NCT03191825|mHealth m-Health|mhealth m-health
4707395|NCT03191825|eHealth e-Health|ehealth e-health
4707396|NCT03191825|smoking cessation|smoking cessation
4707397|NCT03191825|lapse management|lapse management
4707398|NCT03191825|relapse prevention|relapse prevention
4707399|NCT03191812|Falls|falls
4707400|NCT03191812|transcranial Direct Current Stimulation|transcranial direct current stimulation
4707401|NCT03191812|Mobility|mobility
4707402|NCT03191812|Dual Task|dual task
4707403|NCT03191760|Posttraumatic Stress Disorder|posttraumatic stress disorder
4707404|NCT03191760|Social Support|social support
4707405|NCT03191760|Primary Care|primary care
4707406|NCT03191747|Masculine Norms|masculine norms
4707407|NCT03191747|Skin Care|skin care
4707408|NCT03191747|Gender|gender
4707409|NCT03191734|Lower Urinary Tract Symptoms (LUTS)|lower urinary tract symptoms (luts)
4707410|NCT03191734|Benign Prostatic Hyperplasia (BPH)|benign prostatic hyperplasia (bph)
4707411|NCT03191734|AQUABEAM|aquabeam
4707412|NCT03191734|Aquablation|aquablation
4707413|NCT03191721|Peri-implantitis|peri-implantitis
4707414|NCT03191721|Triclosan|triclosan
4707415|NCT03191721|Toothpastes|toothpastes
4707416|NCT03191721|Therapeutics|therapeutics
4707417|NCT03191721|Periodontal Diseases|periodontal diseases
4707418|NCT03191721|Periodontitis|periodontitis
4707419|NCT03191721|Dentifrices|dentifrices
4707420|NCT03191708|Fractional Flow Reserve|fractional flow reserve
4707421|NCT03191708|Quantitative Coronary Angiography|quantitative coronary angiography
4707422|NCT03191708|Coronary artery disease|coronary artery disease
4707423|NCT03191708|Angina pectoris|angina pectoris
4707424|NCT03191708|Quantitative Flow Ratio|quantitative flow ratio
4707425|NCT03191695|Participation|participation
4707426|NCT03191695|Activity|activity
4707427|NCT03191695|Cerebral Palsy|cerebral palsy
4707428|NCT03191695|LIFE Habits (life-H)|life habits (life-h)
4707429|NCT03191695|Gross Motor Function|gross motor function
4707430|NCT03191695|Health-related Quality of Life|health-related quality of life
4707431|NCT03191695|Family|family
4707432|NCT03191630|Kidney transplant|kidney transplant
4707433|NCT03191630|SystemCHANGE|systemchange
4707434|NCT03191630|physical activity|physical activity
4707435|NCT03191630|smart phone|smart phone
4707436|NCT03191630|Fitbit|fitbit
4707437|NCT03191630|activity monitor|activity monitor
4707438|NCT03191630|step count|step count
4707439|NCT03191630|post-surgery|post-surgery
4707440|NCT03191630|quality of life|quality of life
4707441|NCT03191630|cardiovascular|cardiovascular
4707442|NCT03191604|Endoscopy|endoscopy
4707443|NCT03191604|Narrow band imaging|narrow band imaging
4707444|NCT03191604|Dysplasia|dysplasia
4707445|NCT03191591|Overweight|overweight
4707446|NCT03191591|Obesity|obesity
4707447|NCT03191591|Maternal-child|maternal-child
4707448|NCT03191591|Social Determinants of Health|social determinants of health
4707449|NCT03191578|NMIBC|nmibc
4707450|NCT03191578|Immunotherapy|immunotherapy
4707451|NCT03191578|RUTI|ruti
4707452|NCT03191578|Non-muscle invasive bladder cancer|non-muscle invasive bladder cancer
4707453|NCT03191565|mhealth|mhealth
4707454|NCT03191565|self-monitoring|self-monitoring
4707455|NCT03191565|Outcome monitoring|outcome monitoring
4707456|NCT03191552|Cerebral palsy|cerebral palsy
4707457|NCT03191552|lycra garments|lycra garments
4707458|NCT03191552|orthosis|orthosis
4707459|NCT03191552|suit therapy|suit therapy
4707460|NCT03191552|trunk control|trunk control
4707461|NCT03191513|Interesterified|interesterified
4707462|NCT03191513|Postprandial|postprandial
4707463|NCT03191513|Lipid|lipid
4707464|NCT03191474|PrEP|prep
4707465|NCT03191474|Pre-exposure Prophylaxis|pre-exposure prophylaxis
4707466|NCT03191474|Truvada|truvada
4707467|NCT03191474|Client-centered case management|client-centered case management
4707468|NCT03191474|Transgender|transgender
4707469|NCT03191474|Gender non-conforming|gender non-conforming
4707470|NCT03191461|Anthracycline-based chemotherapy|anthracycline-based chemotherapy
4707471|NCT03191461|Anth-bC|anth-bc
4707472|NCT03191461|Chemotherapy|chemotherapy
4707473|NCT03191461|Myocardial Perfusion|myocardial perfusion
4707474|NCT03191435|Diabetes mellitus, type 2|diabetes mellitus, type 2
4707475|NCT03191435|Inspiratory muscle training|inspiratory muscle training
4707476|NCT03191435|Glycemic control|glycemic control
4707477|NCT03191435|Glucose|glucose
4707478|NCT03191435|Exercise|exercise
4707479|NCT03191435|Diaphragm exercise|diaphragm exercise
4707480|NCT03191435|Inspiratory loading|inspiratory loading
4707481|NCT03191422|Rehabilitation|rehabilitation
4707482|NCT03191422|Occupational Performance|occupational performance
4707483|NCT03191409|cognitive impairment|cognitive impairment
4707484|NCT03191409|ESRD|esrd
4707485|NCT03191409|functional MRI|functional mri
4707486|NCT03191383|Maternal immunization|maternal immunization
4707487|NCT03191383|Immunogenicity|immunogenicity
4707488|NCT03191383|Vaccines|vaccines
4707489|NCT03191383|Safety|safety
4707490|NCT03191383|Reactogenicity|reactogenicity
4707491|NCT03191383|Respiratory Syncytial Virus|respiratory syncytial virus
4707492|NCT03191370|pain during laryngoscopy, Flexible nasal endoscopy|pain during laryngoscopy, flexible nasal endoscopy
4707493|NCT03191357|traumatic brain injury,posttraumatic stress,service member|traumatic brain injury,posttraumatic stress,service member
4707494|NCT03191344|Intraoperative Parathyroid Scores System|intraoperative parathyroid scores system
4707495|NCT03191344|total thyroidectomy|total thyroidectomy
4707496|NCT03191344|thyroid cancer|thyroid cancer
4707497|NCT03191344|hypoparathyroidism|hypoparathyroidism
4707498|NCT03191344|prediction|prediction
4707499|NCT03191331|dietary intervention|dietary intervention
4707500|NCT03191331|gestational weight gain|gestational weight gain
4707501|NCT03191331|gestational diabetes|gestational diabetes
4707502|NCT03191331|overweight|overweight
4707503|NCT03191331|obesity|obesity
4707504|NCT03191318|ERAS|eras
4707505|NCT03191318|Enhanced recovery after sugery in bariatric surgery|enhanced recovery after sugery in bariatric surgery
4707506|NCT03191318|sleeve gastrectomy|sleeve gastrectomy
4707507|NCT03191292|probabilistic antibiotherapy|probabilistic antibiotherapy
4707508|NCT03191292|prosthetic joint infection|prosthetic joint infection
4707509|NCT03191292|treatment failure|treatment failure
4707510|NCT03191279|Wounds and injury|wounds and injury
4707511|NCT03191279|Trauma|trauma
4707512|NCT03191279|First aid|first aid
4707513|NCT03191279|Bystander|bystander
4707514|NCT03191279|Laypersons|laypersons
4707515|NCT03191266|repetitive transcranial magnetic stimulation|repetitive transcranial magnetic stimulation
4707516|NCT03191266|alcohol use disorder|alcohol use disorder
4707517|NCT03191266|neuroimaging|neuroimaging
4707518|NCT03191266|relapse|relapse
4707519|NCT03191266|Veterans|veterans
4707520|NCT03191253|food insecurity|food insecurity
4707521|NCT03191253|community-based|community-based
4707522|NCT03191253|food assistance|food assistance
4707523|NCT03191253|food support|food support
4707524|NCT03191253|intervention|intervention
4707525|NCT03191253|medically tailored|medically tailored
4707526|NCT03191253|nutrition|nutrition
4707527|NCT03191240|Out-of-Hospital Cardiac Arrest|out-of-hospital cardiac arrest
4707528|NCT03191240|Vasopressin|vasopressin
4707529|NCT03191214|Infra-red thermography|infra-red thermography
4707530|NCT03191201|Metabolomics, Transcriptomics, Ironomics|metabolomics, transcriptomics, ironomics
4707531|NCT03191175|HIV|hiv
4707532|NCT03191175|Inflammasome|inflammasome
4707533|NCT03191162|Benznidazole|benznidazole
4707534|NCT03191162|PCR|pcr
4707535|NCT03191123|Hepatocellular Carcinoma|hepatocellular carcinoma
4707536|NCT03191123|Hepatic Resection|hepatic resection
4707537|NCT03191123|TACE|tace
4707538|NCT03191123|Solitary Huge Tumor|solitary huge tumor
4707539|NCT03191123|Overall Survival|overall survival
4707540|NCT03191110|COLON|colon
4707541|NCT03191110|colorectal cancer|colorectal cancer
4707542|NCT03191110|nutrition|nutrition
4707543|NCT03191110|lifestyle|lifestyle
4707544|NCT03191110|survival|survival
4707545|NCT03191110|recurrence|recurrence
4707546|NCT03191110|quality of life|quality of life
4707547|NCT03191084|marijuana|marijuana
4707548|NCT03191084|THC|thc
4707549|NCT03191084|cannabis|cannabis
4707550|NCT03191084|driving|driving
4707551|NCT03191084|impairment|impairment
4707552|NCT03191084|intoxication|intoxication
4707553|NCT03191071|pneumonia|pneumonia
4707554|NCT03191071|procalcitonin|procalcitonin
4707555|NCT03191071|lung ultrassound|lung ultrassound
4707556|NCT03191071|point of care testing|point of care testing
4707557|NCT03191071|antibiotic prescription|antibiotic prescription
4707558|NCT03191071|respiratory pathogens|respiratory pathogens
4707559|NCT03191071|host biomarkers|host biomarkers
4707560|NCT03191058|Depression|depression
4707561|NCT03191058|Unipolar Depression|unipolar depression
4707562|NCT03191058|Treatment Resistant Depression|treatment resistant depression
4707563|NCT03191058|Magnetic Seizure Therapy|magnetic seizure therapy
4707564|NCT03191058|Suicidal Ideation|suicidal ideation
4707565|NCT03191058|Electroconvulsive Therapy|electroconvulsive therapy
4707567|NCT03191045|motility|motility
4707568|NCT03191045|perfused manometry|perfused manometry
4707569|NCT03191045|stomach|stomach
4707570|NCT03191045|bowel|bowel
4707571|NCT03191045|water|water
4707572|NCT03191032|Peripheral nerves/lesions; hands; rehabilitation; fMRI|peripheral nerves/lesions; hands; rehabilitation; fmri
4707573|NCT03191019|Cell phones|cell phones
4707574|NCT03191019|Women|women
4707575|NCT03191006|effect|effect
4707576|NCT03191006|insoles|insoles
4707577|NCT03191006|children|children
4707578|NCT03190967|Ado-trastuzumab Emtansine|ado-trastuzumab emtansine
4707579|NCT03190967|Systemic Control of Disease|systemic control of disease
4707580|NCT03190967|Maximum Tolerated Dose|maximum tolerated dose
4707581|NCT03190967|Preventing the Formation of a Metastasis|preventing the formation of a metastasis
4707582|NCT03190954|C-11 Raclopride|c-11 raclopride
4707583|NCT03190954|[11C] NNC-112|[11c] nnc-112
4707584|NCT03190954|Functional Magnetic Resonance Imaging (fMRI)|functional magnetic resonance imaging (fmri)
4707585|NCT03190954|Dopamine D1 Receptor|dopamine d1 receptor
4707586|NCT03190954|D2 Receptors|d2 receptors
4707587|NCT03190941|KRAS|kras
4707588|NCT03190941|HRAS|hras
4707589|NCT03190941|NRAS|nras
4707590|NCT03190941|Cell Therapy|cell therapy
4707591|NCT03190941|Immunotherapy|immunotherapy
4707592|NCT03190928|Disease Monitoring|disease monitoring
4707593|NCT03190928|Molecular Monitoring|molecular monitoring
4707594|NCT03190928|Novel Biomarker Identification|novel biomarker identification
4707595|NCT03190928|Gene Expression Analyses|gene expression analyses
4707596|NCT03190928|Watchful-Waiting|watchful-waiting
4707597|NCT03190889|ACL Reconstruction|acl reconstruction
4707598|NCT03190889|Rehabilitation|rehabilitation
4707599|NCT03190889|Sports Injury|sports injury
4707600|NCT03190889|Neuromuscular Intervention|neuromuscular intervention
4707601|NCT03190889|Knee Injury|knee injury
4707602|NCT03190876|Drain usage|drain usage
4707603|NCT03190863|Tenodesis grasp|tenodesis grasp
4707604|NCT03190863|Neurofeedback|neurofeedback
4707605|NCT03190863|Motor imagery|motor imagery
4707606|NCT03190863|Reach-to-grasp|reach-to-grasp
4707607|NCT03190863|Rehabilitation|rehabilitation
4707608|NCT03190863|Physical therapy|physical therapy
4707609|NCT03190863|Cervical spinal cord injury|cervical spinal cord injury
4707610|NCT03190863|Tetraplegia|tetraplegia
4707611|NCT03190863|AIS A|ais a
4707612|NCT03190863|AIS B|ais b
4707613|NCT03190850|Sleep Apnea|sleep apnea
4707614|NCT03190850|Elderly|elderly
4707615|NCT03190850|Inspiratory training|inspiratory training
4707616|NCT03190837|gaucher|gaucher
4707617|NCT03190837|gaucher disease|gaucher disease
4707618|NCT03190824|melanoma|melanoma
4707619|NCT03190824|immunotherapy|immunotherapy
4707620|NCT03190824|immune oncology|immune oncology
4707621|NCT03190824|loco regional therapy|loco regional therapy
4707622|NCT03190824|adenovirus|adenovirus
4707623|NCT03190824|oncolytic virus|oncolytic virus
4707624|NCT03190824|unresectable|unresectable
4707625|NCT03190824|telomerase|telomerase
4707626|NCT03190811|advanced solid tumor|advanced solid tumor
4707627|NCT03190811|DC-CIK|dc-cik
4707628|NCT03190811|anti-PD-1 antibody|anti-pd-1 antibody
4707629|NCT03190811|immunotherapy|immunotherapy
4707630|NCT03190785|benzoic acid|benzoic acid
4707631|NCT03190785|endocrine disrupting chemicals|endocrine disrupting chemicals
4707632|NCT03190785|leptin|leptin
4707633|NCT03190785|metabolic rate|metabolic rate
4707634|NCT03190733|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
4707635|NCT03190733|ATG|atg
4707636|NCT03190733|chronic GVHD|chronic gvhd
4707637|NCT03190733|leukemia relapse|leukemia relapse
4707638|NCT03190694|chronic kidney disease|chronic kidney disease
4707639|NCT03190694|non diabetic|non diabetic
4707640|NCT03190668|tissue microdialysis|tissue microdialysis
4707641|NCT03190668|spinal fusion|spinal fusion
4707642|NCT03190668|surgical site infection|surgical site infection
4707643|NCT03190642|Orthognathic Surgery|orthognathic surgery
4707644|NCT03190642|Swelling|swelling
4707645|NCT03190629|body composition|body composition
4707646|NCT03190629|bioimpedance|bioimpedance
4707647|NCT03190629|hemodialysis|hemodialysis
4707648|NCT03190629|hemodiafiltration|hemodiafiltration
4707649|NCT03190629|nutritional status|nutritional status
4707650|NCT03190629|protein energy wasting|protein energy wasting
4707651|NCT03190590|transcranial magnetic stimulation|transcranial magnetic stimulation
4707652|NCT03190577|Transthyretin mutation|transthyretin mutation
4707653|NCT03190551|infraclavicular brachial plexus block|infraclavicular brachial plexus block
4707654|NCT03190551|retroclavicular approach|retroclavicular approach
4707655|NCT03190551|costoclavicular approach|costoclavicular approach
4707656|NCT03190551|upper limb surgery|upper limb surgery
4707657|NCT03190551|needle shaft visibility|needle shaft visibility
4707658|NCT03190512|Periodontal disease|periodontal disease
4707659|NCT03190512|depression|depression
4707660|NCT03190512|body image|body image
4707661|NCT03190512|self-esteem|self-esteem
4707662|NCT03190499|Cancer|cancer
4707663|NCT03190499|Leukemia|leukemia
4707664|NCT03190486|Baby cries|baby cries
4707665|NCT03190486|pain|pain
4707666|NCT03190486|brain responses|brain responses
4707667|NCT03190486|neuroimaging|neuroimaging
4707668|NCT03190486|fMRI|fmri
4707669|NCT03190395|Paroxysmal Atrial Fibrillation|paroxysmal atrial fibrillation
4707670|NCT03190395|Circumferential Pulmonary Vein Isolation(CPVI)|circumferential pulmonary vein isolation(cpvi)
4707671|NCT03190395|Leftatrium Roofline Ablation(LARA)|leftatrium roofline ablation(lara)
4707672|NCT03190395|Longterm success rate|longterm success rate
4707673|NCT03190317|electronic medical record|electronic medical record
4707674|NCT03190317|personal health record|personal health record
4707675|NCT03190317|Veteran|veteran
4707676|NCT03190317|self-management|self-management
4707677|NCT03190278|Acute Myeloid Leukemia|acute myeloid leukemia
4707678|NCT03190278|Relapsed/Refractory Acute Myeloid Leukemia|relapsed/refractory acute myeloid leukemia
4707679|NCT03190278|Newly diagnosed AML|newly diagnosed aml
4707680|NCT03190278|ELN adverse genetic risk group|eln adverse genetic risk group
4707681|NCT03190278|Chimeric Antigen Receptor T-Cell (CAR-T) therapy|chimeric antigen receptor t-cell (car-t) therapy
4707682|NCT03190278|Allogeneic|allogeneic
4707684|NCT03190265|Cyclophosphamide|cyclophosphamide
4707685|NCT03190265|Pancreatic Vaccine|pancreatic vaccine
4707686|NCT03190265|GVAX|gvax
4707687|NCT03190265|Nivolumab|nivolumab
4707688|NCT03190265|Vaccine|vaccine
4707689|NCT03190265|Ipilimumab|ipilimumab
4707690|NCT03190265|CRS-207|crs-207
4707691|NCT03190265|Immunotherapy|immunotherapy
4707692|NCT03190265|PD-1|pd-1
4707693|NCT03190265|Adenocarcinoma|adenocarcinoma
4707694|NCT03190265|Carcinoma|carcinoma
4707695|NCT03190265|Neoplasms|neoplasms
4707696|NCT03190252|Diving medicine|diving medicine
4707697|NCT03190252|Inflammation|inflammation
4707698|NCT03190252|Central nervous system injury|central nervous system injury
4707699|NCT03190252|Trimix|trimix
4707700|NCT03190252|Decompression sickness|decompression sickness
4707701|NCT03190252|Venous gas emboli|venous gas emboli
4707702|NCT03190226|L-PRF|l-prf
4707703|NCT03190226|keratinised tissues|keratinised tissues
4707704|NCT03190226|implant|implant
4707705|NCT03190226|free gingival graft|free gingival graft
4707706|NCT03190213|high grade|high grade
4707707|NCT03190161|Schizophrenia|schizophrenia
4707708|NCT03190148|GLP-1|glp-1
4707709|NCT03190148|Ectopic Lipids|ectopic lipids
4707710|NCT03190135|Overweight|overweight
4707711|NCT03190135|Obesity|obesity
4707712|NCT03190135|School|school
4707713|NCT03190135|Physical Activity|physical activity
4707714|NCT03190109|bone age measurement|bone age measurement
4707715|NCT03190109|skeletal age measurement|skeletal age measurement
4707716|NCT03190109|ultrasound|ultrasound
4707717|NCT03190109|x-Ray|x-ray
4707718|NCT03190083|mastectomy|mastectomy
4707719|NCT03190083|lumpectomy|lumpectomy
4707720|NCT03190083|3-Dimensional Mammogram|3-dimensional mammogram
4707721|NCT03190083|digital breast tomosynthesis|digital breast tomosynthesis
4707722|NCT03190070|Renal reserve, physiological study, diagnostic testing|renal reserve, physiological study, diagnostic testing
4707723|NCT03190057|BioFreedom|biofreedom
4707724|NCT03190057|Drug Eluting Stent|drug eluting stent
4707725|NCT03190057|Coronary Artery Disease|coronary artery disease
4707726|NCT03190031|training|training
4707727|NCT03190031|exercise|exercise
4707728|NCT03190031|quality of life|quality of life
4707729|NCT03190005|PRU|pru
4707730|NCT03190005|P2Y12 receptor|p2y12 receptor
4707731|NCT03189979|community based participatory research|community based participatory research
4707732|NCT03189979|Childhood obesity|childhood obesity
4707733|NCT03189966|transversalis fascia plane block|transversalis fascia plane block
4707734|NCT03189966|quadratus lumborum block|quadratus lumborum block
4707735|NCT03189966|ultrasound-guided|ultrasound-guided
4707736|NCT03189966|Developmental Dysplasia of the Hip|developmental dysplasia of the hip
4707737|NCT03189966|postoperative analgesia|postoperative analgesia
4707738|NCT03189914|pancreatic cancer|pancreatic cancer
4707739|NCT03189914|Abraxane|abraxane
4707740|NCT03189914|first line|first line
4707741|NCT03189875|Systemic Lupus Erythematosus Disease|systemic lupus erythematosus disease
4707742|NCT03189849|Farming environment|farming environment
4707743|NCT03189836|CD20+|cd20+
4707744|NCT03189836|B cell|b cell
4707745|NCT03189836|ACTR|actr
4707746|NCT03189836|ACTR707|actr707
4707747|NCT03189836|relapsed|relapsed
4707748|NCT03189836|refractory|refractory
4707749|NCT03189836|T cell|t cell
4707750|NCT03189836|T cell product|t cell product
4707751|NCT03189836|adoptive T cells|adoptive t cells
4707752|NCT03189836|gene therapy|gene therapy
4707753|NCT03189810|Sham Repetitive Transcranial Magnetic Stimulation (rTMS)|sham repetitive transcranial magnetic stimulation (rtms)
4707754|NCT03189810|Schizophrenia|schizophrenia
4707755|NCT03189810|Cannabis Use Disorder|cannabis use disorder
4707756|NCT03189810|Cognitive Function|cognitive function
4707757|NCT03189758|chronic kidney disease|chronic kidney disease
4707758|NCT03189758|hemodialysis|hemodialysis
4707759|NCT03189758|sodium restriction|sodium restriction
4707760|NCT03189758|MRI|mri
4707761|NCT03189732|lipolysis|lipolysis
4707762|NCT03189732|adipose tissue|adipose tissue
4707763|NCT03189732|exercise|exercise
4707764|NCT03189719|PD1|pd1
4707765|NCT03189719|PD-1|pd-1
4707766|NCT03189719|PDL1|pdl1
4707767|NCT03189719|PD-L1|pd-l1
4707768|NCT03189706|Hu3F8|hu3f8
4707769|NCT03189706|Irinotecan|irinotecan
4707770|NCT03189706|Temozolomide|temozolomide
4707771|NCT03189706|Sargramostim|sargramostim
4707772|NCT03189706|Chemoimmunotherapy|chemoimmunotherapy
4707773|NCT03189706|17-251|17-251
4707774|NCT03189680|sensorimotor training|sensorimotor training
4707775|NCT03189680|exergaming|exergaming
4707776|NCT03189680|posture|posture
4707777|NCT03189680|quality of life|quality of life
4707778|NCT03189641|Drug eluting stents|drug eluting stents
4707779|NCT03189641|Coronary artery disease|coronary artery disease
4707780|NCT03189641|Coronary artery stenosis|coronary artery stenosis
4707781|NCT03189641|Myocardial ischemia|myocardial ischemia
4707782|NCT03189641|Angioplasty|angioplasty
4707783|NCT03189628|stromal vascular fraction|stromal vascular fraction
4707784|NCT03189628|skin regeneration|skin regeneration
4707785|NCT03189628|skin texture|skin texture
4707786|NCT03189628|anti-aging|anti-aging
4707787|NCT03189602|Takayasu Arteritis|takayasu arteritis
4707788|NCT03189602|Pulmonary artery hypertension|pulmonary artery hypertension
4707789|NCT03189589|Pharmacokinetics|pharmacokinetics
4707790|NCT03189589|Healthy|healthy
4707791|NCT03189589|ELLIPTA|ellipta
4707792|NCT03189589|Safety|safety
4707793|NCT03189589|GSK2269557|gsk2269557
4707794|NCT03189589|Inhalation|inhalation
4707795|NCT03189589|Tolerability|tolerability
4707796|NCT03189537|Profilaxis|profilaxis
4707797|NCT03189537|Ingavirin|ingavirin
4707798|NCT03189511|Brown Adipose Tissue|brown adipose tissue
4707799|NCT03189511|Brown Fat|brown fat
4707800|NCT03189511|Fluvastatin|fluvastatin
4707801|NCT03189511|Prospective Clinical Trial|prospective clinical trial
4707802|NCT03189446|Endometrial Cancer|endometrial cancer
4707803|NCT03189446|Gynecologic Cancer|gynecologic cancer
4707804|NCT03189420|glioma|glioma
4707805|NCT03189420|glioblastoma|glioblastoma
4707806|NCT03189420|low grade tumor|low grade tumor
4707807|NCT03189407|Moringa Oleifera tea|moringa oleifera tea
4707808|NCT03189407|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
4707809|NCT03189407|Metformin Steady state concentrations|metformin steady state concentrations
4707810|NCT03189407|Herb-drug interaction|herb-drug interaction
4707812|NCT03189394|gay couples|gay couples
4707813|NCT03189394|relationships|relationships
4707814|NCT03189394|dyads|dyads
4707815|NCT03189381|Whole Brain Radiation|whole brain radiation
4707816|NCT03189381|Simultaneous Integrated Boost|simultaneous integrated boost
4707817|NCT03189368|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
4707818|NCT03189368|Multi-site Pacing|multi-site pacing
4707819|NCT03189368|Ventriculoarterial Coupling|ventriculoarterial coupling
4707820|NCT03189368|Energy Efficiency|energy efficiency
4707821|NCT03189342|Balance|balance
4707822|NCT03189342|Dual-task interference|dual-task interference
4707823|NCT03189342|Falls|falls
4707824|NCT03189342|Gait|gait
4707825|NCT03189342|Older Adults|older adults
4707826|NCT03189329|NIR spectroscopy, cognitive function, eye, nerve block|nir spectroscopy, cognitive function, eye, nerve block
4707827|NCT03189316|Peritoneal fluid|peritoneal fluid
4707828|NCT03189316|B cells|b cells
4707829|NCT03189316|Regulatory B cells|regulatory b cells
4707830|NCT03189316|Human|human
4707831|NCT03189264|Percutaneous Nephrolithotomy|percutaneous nephrolithotomy
4707832|NCT03189264|Postoperative Complications|postoperative complications
4707833|NCT03189264|Renal Stone|renal stone
4707834|NCT03189264|Surgical Success|surgical success
4707835|NCT03189264|Surgical Complications|surgical complications
4707836|NCT03189264|Pneumatic Dilation|pneumatic dilation
4707837|NCT03189212|Telemedicine|telemedicine
4707838|NCT03189186|Kidney Cancer|kidney cancer
4707839|NCT03189186|Immunotherapy|immunotherapy
4707840|NCT03189186|Renal Cell Carcinoma|renal cell carcinoma
4707841|NCT03189186|Cryoablation|cryoablation
4707842|NCT03189186|Metastatic Renal Cancer|metastatic renal cancer
4707843|NCT03189173|Obstructive Sleep Apnea|obstructive sleep apnea
4707844|NCT03189173|Ventilatory Control Instability|ventilatory control instability
4707845|NCT03189173|Complex Sleep Apnea|complex sleep apnea
4707846|NCT03189121|Metabolism|metabolism
4707847|NCT03189121|Macronutrients|macronutrients
4707848|NCT03189121|Obesity|obesity
4707849|NCT03189121|Energy Expenditure|energy expenditure
4707850|NCT03189121|Glucose|glucose
4707851|NCT03189108|Paracentesis|paracentesis
4707852|NCT03189108|Thoracentesis|thoracentesis
4707853|NCT03189095|exercise|exercise
4707854|NCT03189095|physical activity|physical activity
4707855|NCT03189095|SCI|sci
4707856|NCT03189095|spinal cord injury|spinal cord injury
4707857|NCT03189095|online|online
4707858|NCT03189056|chronic Chagas disease|chronic chagas disease
4707860|NCT03189056|lower urinary tract|lower urinary tract
4707861|NCT03189056|urodynamic|urodynamic
4707862|NCT03189030|metastatic|metastatic
4707863|NCT03189030|microsatellite stable (MSS)|microsatellite stable (mss)
4707864|NCT03189004|mHealth, health services, technology, smartphones, Bangladesh|mhealth, health services, technology, smartphones, bangladesh
4707865|NCT03188991|pancreatic cystic neoplasm|pancreatic cystic neoplasm
4707866|NCT03188991|pancreatic cyst|pancreatic cyst
4707867|NCT03188991|pancreatic mucinous cyst|pancreatic mucinous cyst
4707868|NCT03188991|pancreatic neoplasms|pancreatic neoplasms
4707869|NCT03188991|digestive system neoplasms|digestive system neoplasms
4707870|NCT03188991|pancreatic diseases|pancreatic diseases
4707871|NCT03188991|mucinous cystic neoplasm|mucinous cystic neoplasm
4707872|NCT03188965|First in human|first in human
4707873|NCT03188965|Solid tumors|solid tumors
4707874|NCT03188965|Lymphomas|lymphomas
4707875|NCT03188965|Dose escalation|dose escalation
4707876|NCT03188965|Dose expansion|dose expansion
4707877|NCT03188913|Burns|burns
4707878|NCT03188913|Coagulation|coagulation
4707879|NCT03188913|Factor XIII|factor xiii
4707880|NCT03188913|Glycocalix|glycocalix
4707881|NCT03188913|Cicatrization|cicatrization
4707882|NCT03188900|Preeclampsia|preeclampsia
4707883|NCT03188900|apheresis|apheresis
4707884|NCT03188900|sflt-1|sflt-1
4707885|NCT03188887|NIgA|niga
4707886|NCT03188887|Kidney biopsy|kidney biopsy
4707887|NCT03188887|GFR|gfr
4707888|NCT03188887|Corticotherapy|corticotherapy
4707889|NCT03188861|mental health conditions in ACSC patients|mental health conditions in acsc patients
4707890|NCT03188861|multimorbidity|multimorbidity
4707891|NCT03188861|health care utilization|health care utilization
4707892|NCT03188809|Postoperative Pain|postoperative pain
4707893|NCT03188809|Functional Outcomes|functional outcomes
4707894|NCT03188809|Total Knee Arthroplasty|total knee arthroplasty
4707895|NCT03188809|Adductor Canal Block|adductor canal block
4707896|NCT03188809|Femoral Nerve Block|femoral nerve block
4707897|NCT03188796|vitamin D|vitamin d
4707898|NCT03188796|critical care|critical care
4707899|NCT03188770|Middle-income countries|middle-income countries
4707900|NCT03188744|Cervical cancer|cervical cancer
4707901|NCT03188744|Pelvic floor muscles|pelvic floor muscles
4707902|NCT03188744|Physiotherapy|physiotherapy
4707903|NCT03188744|Quality of life|quality of life
4707904|NCT03188731|ZIKA|zika
4707905|NCT03188731|Dengue|dengue
4707906|NCT03188731|Chikungunya|chikungunya
4707907|NCT03188731|Pregnant Women|pregnant women
4707908|NCT03188731|Pregnant Woman|pregnant woman
4707909|NCT03188731|ZIKV|zikv
4707910|NCT03188718|Polysomnogram|polysomnogram
4707911|NCT03188718|Sleep Disordered Breathing|sleep disordered breathing
4707912|NCT03188705|pharmacogenetics|pharmacogenetics
4707913|NCT03188705|carboxylesterase|carboxylesterase
4707914|NCT03188705|Personalized Medicine|personalized medicine
4707915|NCT03188692|Haemophilus influenza type b|haemophilus influenza type b
4707916|NCT03188692|Adsorbed Diphtheria-Purified Pertussis-Tetanus-Inactivate|adsorbed diphtheria-purified pertussis-tetanus-inactivate
4707917|NCT03188692|poliovirus combined vaccine|poliovirus combined vaccine
4707918|NCT03188692|Hib|hib
4707919|NCT03188692|DPT-IPV|dpt-ipv
4707920|NCT03188692|Intramuscular|intramuscular
4707921|NCT03188679|CMV|cmv
4707922|NCT03188679|neurological impairment|neurological impairment
4707923|NCT03188679|outcome prediction|outcome prediction
4707924|NCT03188679|amniotic fluid biomarkers|amniotic fluid biomarkers
4707925|NCT03188640|Bariatric surgery|bariatric surgery
4707926|NCT03188640|Sex hormones|sex hormones
4707927|NCT03188640|Women|women
4707928|NCT03188640|Quality of life|quality of life
4707929|NCT03188614|shock|shock
4707930|NCT03188614|crystalloid|crystalloid
4707931|NCT03188614|acute kidney injury|acute kidney injury
4707932|NCT03188601|Graft vs Host Disease|graft vs host disease
4707933|NCT03188601|Immune System Diseases|immune system diseases
4707934|NCT03188601|Protease Inhibitors|protease inhibitors
4707935|NCT03188601|Alpha 1-Antitrypsin|alpha 1-antitrypsin
4707936|NCT03188601|Enzyme Inhibitors|enzyme inhibitors
4707937|NCT03188601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
4707938|NCT03188601|Trypsin Inhibitors|trypsin inhibitors
4707939|NCT03188601|Serine Proteinase Inhibitors|serine proteinase inhibitors
4707940|NCT03188484|Atrial Fibrillation|atrial fibrillation
4707941|NCT03188484|Electrocardiography|electrocardiography
4707942|NCT03188484|Biological Markers|biological markers
4707943|NCT03188484|Risk Assessment|risk assessment
4707944|NCT03188458|Infants|infants
4707945|NCT03188458|Cord blood sample|cord blood sample
4707946|NCT03188458|Acellular pertussis|acellular pertussis
4707947|NCT03188458|Boostrix|boostrix
4707948|NCT03188458|Colombia|colombia
4707949|NCT03188458|Pregnant women|pregnant women
4707950|NCT03188419|Prospective Donors|prospective donors
4707951|NCT03188419|Immunodeficiency|immunodeficiency
4707952|NCT03188406|Intestinal Metaplasia|intestinal metaplasia
4707953|NCT03188406|Epidemiology|epidemiology
4707954|NCT03188406|Risk Stratification|risk stratification
4707955|NCT03188406|Helicobacter Pylori|helicobacter pylori
4707956|NCT03188380|nec|nec
4707957|NCT03188380|abdominal ultrasound|abdominal ultrasound
4707958|NCT03188380|abdominal radiograph|abdominal radiograph
4707960|NCT03188367|dose-finding|dose-finding
4707961|NCT03188367|extraintestinal symptoms|extraintestinal symptoms
4707962|NCT03188367|gluten|gluten
4707963|NCT03188367|intestinal symptoms|intestinal symptoms
4707964|NCT03188367|placebo|placebo
4707965|NCT03188354|Positron-Emission Tomography|positron-emission tomography
4707966|NCT03188354|Magnetic Resonance Imaging|magnetic resonance imaging
4707967|NCT03188341|vascular surgery|vascular surgery
4707968|NCT03188341|repolarization disturbances|repolarization disturbances
4707969|NCT03188341|cardiac complications|cardiac complications
4707970|NCT03188341|high risk patient|high risk patient
4707971|NCT03188341|high risk procedure|high risk procedure
4707972|NCT03188302|Stool consistency|stool consistency
4707973|NCT03188302|Texture Analyser|texture analyser
4707974|NCT03188302|Bristol Stool Form Scale|bristol stool form scale
4707975|NCT03188289|chitosan|chitosan
4707976|NCT03188289|clorhexidine|clorhexidine
4707977|NCT03188289|suture|suture
4707978|NCT03188289|bacteria|bacteria
4707979|NCT03188289|wisdom|wisdom
4707980|NCT03188276|Chronic Hepatitis C|chronic hepatitis c
4707981|NCT03188276|direct-acting antiviral agents|direct-acting antiviral agents
4707982|NCT03188276|Myeloid-Derived Suppressor Cells|myeloid-derived suppressor cells
4707983|NCT03188276|NK cells|nk cells
4707984|NCT03188263|diabetes|diabetes
4707985|NCT03188263|sleep|sleep
4707986|NCT03188263|circadian rhythm|circadian rhythm
4707987|NCT03188263|light treatment|light treatment
4707988|NCT03188224|Transition|transition
4707989|NCT03188224|Improved patient outcomes|improved patient outcomes
4707990|NCT03188224|RCT|rct
4707991|NCT03188224|Child health|child health
4707992|NCT03188224|Empower youth|empower youth
4707993|NCT03188185|Alkermes|alkermes
4707994|NCT03188185|Major Depressive Disorder|major depressive disorder
4707995|NCT03188185|Treatment Refractory MDD|treatment refractory mdd
4707996|NCT03188185|ALKS 5461|alks 5461
4707997|NCT03188133|Schizophrenia|schizophrenia
4707998|NCT03188133|Visual Hallucination|visual hallucination
4707999|NCT03188133|False Perception|false perception
4708000|NCT03188133|emotional priming|emotional priming
4708001|NCT03188107|Risky Infant|risky infant
4708002|NCT03188107|Cerebral Palsy|cerebral palsy
4708003|NCT03188107|Down Syndrome|down syndrome
4708004|NCT03188107|Spina Bifida|spina bifida
4708005|NCT03188107|Infant Motor Profile|infant motor profile
4708006|NCT03188068|Kaposiform Hemangioendothelioma|kaposiform hemangioendothelioma
4708007|NCT03188068|Kasabach Merritt Phenomenon|kasabach merritt phenomenon
4708008|NCT03188068|Sirolimus|sirolimus
4708009|NCT03188068|Prednisolone|prednisolone
4708010|NCT03188055|patient decision making|patient decision making
4708011|NCT03188055|surgical decision making|surgical decision making
4708012|NCT03188055|shared decision making|shared decision making
4708013|NCT03188055|decision support techniques|decision support techniques
4708014|NCT03188042|Transorbital Alternating Current Stimulation|transorbital alternating current stimulation
4708015|NCT03188042|Glaucoma|glaucoma
4708016|NCT03188029|ethomidate adrenocortical insufficiency|ethomidate adrenocortical insufficiency
4708017|NCT03188016|"music therapy"|"music therapy"
4708018|NCT03188016|"Intensive Interaction"|"intensive interaction"
4708019|NCT03188016|"non-verbal communication"|"non-verbal communication"
4708020|NCT03188016|"musical improvisation"|"musical improvisation"
4708021|NCT03188016|"feasibility study"|"feasibility study"
4708022|NCT03188016|"randomised controlled trial"|"randomised controlled trial"
4708023|NCT03188003|Exercise Movement Techniques|exercise movement techniques
4708024|NCT03188003|Low Back Pain|low back pain
4708025|NCT03188003|Exercise|exercise
4708026|NCT03187990|PSMA PET/MRI|psma pet/mri
4708027|NCT03187990|Guided Biopsy|guided biopsy
4708028|NCT03187990|Prostate Cancer|prostate cancer
4708029|NCT03187977|Cognitive intervention|cognitive intervention
4708030|NCT03187977|Survivors|survivors
4708031|NCT03187977|Childhood ALL|childhood all
4708032|NCT03187964|People Living with HIV (PLHIV)|people living with hiv (plhiv)
4708033|NCT03187964|Xpert HIV-1 Viral Load (Xpert VL)|xpert hiv-1 viral load (xpert vl)
4708034|NCT03187964|Xpert Ultra|xpert ultra
4708035|NCT03187964|Antiretroviral treatment (ART)|antiretroviral treatment (art)
4708036|NCT03187951|Other disorders of glucose regulation and pancreatic internal secretion|other disorders of glucose regulation and pancreatic internal secretion
4708037|NCT03187951|Pancreatic cancer|pancreatic cancer
4708038|NCT03187951|Questionnaires|questionnaires
4708039|NCT03187951|Surveys|surveys
4708040|NCT03187951|Nutritional Questionnaire|nutritional questionnaire
4708041|NCT03187951|Nutritional Counseling|nutritional counseling
4708042|NCT03187951|Booklet|booklet
4708043|NCT03187951|Pamphlet|pamphlet
4708044|NCT03187951|Educational materials|educational materials
4708045|NCT03187951|Aerobic Exercise|aerobic exercise
4708046|NCT03187951|Strength Training Exercises|strength training exercises
4708047|NCT03187951|Physical Assessments|physical assessments
4708048|NCT03187951|Walk Test|walk test
4708049|NCT03187938|Alkaline Phosphatase|alkaline phosphatase
4708050|NCT03187938|Pregnancy|pregnancy
4708051|NCT03187938|Suboptimal fetal growth|suboptimal fetal growth
4708052|NCT03187938|Placental insufficiency|placental insufficiency
4708053|NCT03187938|Low birth weight|low birth weight
4708054|NCT03187938|IUGR|iugr
4708055|NCT03187899|cervical plexus block|cervical plexus block
4708056|NCT03187899|clavicle fracture|clavicle fracture
4708057|NCT03187899|interscalene brachial plexus block|interscalene brachial plexus block
4708058|NCT03187886|Cerebral amyloid angiopathy|cerebral amyloid angiopathy
4708059|NCT03187886|CAA-RI|caa-ri
4708060|NCT03187886|MRI|mri
4708061|NCT03187886|Intracerebral hemorrhage|intracerebral hemorrhage
4708062|NCT03187873|community participation|community participation
4708063|NCT03187873|Maternal and child health|maternal and child health
4708064|NCT03187873|Kenya|kenya
4708065|NCT03187860|Bronchial epithelial cell|bronchial epithelial cell
4708066|NCT03187860|mucus|mucus
4708067|NCT03187860|Air Liquid Interface|air liquid interface
4708068|NCT03187847|Physical Activity|physical activity
4708069|NCT03187847|Fatigue|fatigue
4708070|NCT03187847|Rehabilitation|rehabilitation
4708071|NCT03187834|infection|infection
4708072|NCT03187834|azithromycin|azithromycin
4708073|NCT03187834|amoxicillin|amoxicillin
4708074|NCT03187834|co-trimoxazole|co-trimoxazole
4708075|NCT03187834|trachoma|trachoma
4708076|NCT03187834|mass treatment|mass treatment
4708077|NCT03187808|Neck pain, Thoracic manipulation, special massage|neck pain, thoracic manipulation, special massage
4708078|NCT03187795|Spinal Cord Injuries|spinal cord injuries
4708079|NCT03187795|Randomized Controlled Trial|randomized controlled trial
4708080|NCT03187795|Neurogenic Bladder|neurogenic bladder
4708081|NCT03187795|Rehabilitation|rehabilitation
4708082|NCT03187769|Alkermes|alkermes
4708083|NCT03187769|ALKS 3831|alks 3831
4708084|NCT03187769|Olanzapine|olanzapine
4708085|NCT03187769|Samidorphan|samidorphan
4708086|NCT03187769|Schizophrenia|schizophrenia
4708087|NCT03187769|Schizophreniform|schizophreniform
4708088|NCT03187769|Bipolar I|bipolar i
4708089|NCT03187756|Hematopoietic Malignancies|hematopoietic malignancies
4708090|NCT03187756|Nonmyeloablative Peripheral Blood Stem Cell Transplant|nonmyeloablative peripheral blood stem cell transplant
4708091|NCT03187756|Posttransplantation|posttransplantation
4708092|NCT03187743|Lupus erythematosus|lupus erythematosus
4708093|NCT03187743|Systemic|systemic
4708094|NCT03187743|Corticosteroid|corticosteroid
4708095|NCT03187743|Prednisone|prednisone
4708096|NCT03187743|Pharmacokinetics|pharmacokinetics
4708097|NCT03187730|Smoking Cassation|smoking cassation
4708098|NCT03187730|Immigrants|immigrants
4708099|NCT03187730|Economic Disparity|economic disparity
4708100|NCT03187717|Postoperative pain|postoperative pain
4708101|NCT03187717|Recovery period|recovery period
4708102|NCT03187717|Total intravenous anesthesia|total intravenous anesthesia
4708103|NCT03187717|Inhalation anesthesia|inhalation anesthesia
4708104|NCT03187704|air filtration, HEPA, In-home,|air filtration, hepa, in-home,
4708105|NCT03187678|switch|switch
4708106|NCT03187678|intravenous|intravenous
4708107|NCT03187678|selexipag|selexipag
4708108|NCT03187665|Pediatric|pediatric
4708109|NCT03187665|Pulse Oximeter|pulse oximeter
4708110|NCT03187665|Wireless|wireless
4708111|NCT03187665|Motion|motion
4708112|NCT03187665|False Alarm|false alarm
4708113|NCT03187639|Coronary artery disease|coronary artery disease
4708114|NCT03187639|CT coronary angiography|ct coronary angiography
4708115|NCT03187639|FFRct|ffrct
4708116|NCT03187639|Rapid access chest pain clinic|rapid access chest pain clinic
4708117|NCT03187639|Stable chest pain|stable chest pain
4708118|NCT03187639|Resource utilisation|resource utilisation
4708119|NCT03187639|Quality of life|quality of life
4708120|NCT03187626|Base-of-thumb osteoarthritis|base-of-thumb osteoarthritis
4708121|NCT03187626|Botulinum toxin A|botulinum toxin a
4708122|NCT03187626|Intra-articular therapy|intra-articular therapy
4708123|NCT03187626|Randomized trial|randomized trial
4708124|NCT03187613|Retinal shift|retinal shift
4708125|NCT03187613|Aniseikonia|aniseikonia
4708126|NCT03187613|Metamorphopsia|metamorphopsia
4708127|NCT03187613|Autofluorescence|autofluorescence
4708128|NCT03187587|Hyperthermia, Induced|hyperthermia, induced
4708129|NCT03187587|Laser Coagulation|laser coagulation
4708130|NCT03187587|Laser Therapy|laser therapy
4708131|NCT03187574|vaginal prolapse, mesh kit, anatomic assessment, quality of life|vaginal prolapse, mesh kit, anatomic assessment, quality of life
4708132|NCT03187561|Sleep|sleep
4708133|NCT03187561|Parenting|parenting
4708134|NCT03187561|Marital relationship|marital relationship
4708135|NCT03187561|Parent-child relations|parent-child relations
4708136|NCT03187548|WSL|wsl
4708137|NCT03187548|CPP-ACP|cpp-acp
4708138|NCT03187535|Transcutaneous Electrical Acupoint Stimulation|transcutaneous electrical acupoint stimulation
4708139|NCT03187522|AAA|aaa
4708140|NCT03187522|Abdominal Aortic Aneurysms|abdominal aortic aneurysms
4708141|NCT03187509|Torsemide, loop diuretics, weight-based|torsemide, loop diuretics, weight-based
4708142|NCT03187496|drug-drug interaction|drug-drug interaction
4708143|NCT03187444|Cardiovascular risk|cardiovascular risk
4708144|NCT03187444|Chronic inflammatory rheumatism|chronic inflammatory rheumatism
4708145|NCT03187444|Rheumatoid arthritis|rheumatoid arthritis
4708146|NCT03187444|Spondyloarthritis|spondyloarthritis
4708147|NCT03187444|Inflammation|inflammation
4708148|NCT03187431|Stem cell|stem cell
4708149|NCT03187431|Therapy|therapy
4708150|NCT03187431|IPF|ipf
4708151|NCT03187418|Cyclophotocoagulation|cyclophotocoagulation
4708152|NCT03187418|Micropulse TSCPC|micropulse tscpc
4708153|NCT03187418|Laser ablation|laser ablation
4708154|NCT03187418|Laser therapy|laser therapy
4708155|NCT03187405|Subarachnoid Hemorrhage|subarachnoid hemorrhage
4708156|NCT03187405|Intracranial Aneurysm|intracranial aneurysm
4708157|NCT03187405|Cerebral Ischemia|cerebral ischemia
4708158|NCT03187405|Ventriculostomy|ventriculostomy
4708159|NCT03187405|Tissue Plasminogen Activator|tissue plasminogen activator
4708160|NCT03187353|Cognitive complaints|cognitive complaints
4708161|NCT03187353|RRSO|rrso
4708162|NCT03187353|Oophorectomy|oophorectomy
4708163|NCT03187353|Memory|memory
4708164|NCT03187353|Cognition|cognition
4708165|NCT03187353|Early menopause|early menopause
4708166|NCT03187327|prophylactic salpingectomy|prophylactic salpingectomy
4708167|NCT03187327|vaginal hysterectomy|vaginal hysterectomy
4708168|NCT03187327|p53 expression|p53 expression
4708169|NCT03187327|ovarian cancers|ovarian cancers
4708170|NCT03187314|Esophageal cancer|esophageal cancer
4708171|NCT03187314|Radiation|radiation
4708172|NCT03187314|Anti-PD-1 Antibody|anti-pd-1 antibody
4708173|NCT03187301|Parkinson's Disease|parkinson's disease
4708174|NCT03187301|Off episodes|off episodes
4708175|NCT03187275|Cancer Related Fatigue (CRF)|cancer related fatigue (crf)
4708176|NCT03187275|Prostate Cancer|prostate cancer
4708301|NCT03186430|Health Promotion|health promotion
4708177|NCT03187275|Swedish Massage Therapy (SMT)|swedish massage therapy (smt)
4708178|NCT03187275|Cancer|cancer
4708179|NCT03187275|Quality of Life (QOL)|quality of life (qol)
4708180|NCT03187262|Waldenström Macroglobulinemia|waldenström macroglobulinemia
4708181|NCT03187223|Multiple Myeloma|multiple myeloma
4708182|NCT03187223|Bendamustine|bendamustine
4708183|NCT03187223|Melphalan|melphalan
4708184|NCT03187223|ASCT|asct
4708185|NCT03187210|CD30+ Lymphoma|cd30+ lymphoma
4708186|NCT03187210|ASCT|asct
4708187|NCT03187210|Brentuximab Vedotin|brentuximab vedotin
4708188|NCT03187171|Anterior Cervical Spine Fusion|anterior cervical spine fusion
4708189|NCT03187132|virtual reality|virtual reality
4708190|NCT03187132|transcutaneous electrical nerve stimulation|transcutaneous electrical nerve stimulation
4708191|NCT03187132|analgesia|analgesia
4708192|NCT03187119|Pediatric|pediatric
4708193|NCT03187119|Education|education
4708194|NCT03187119|Technology-supported intervention|technology-supported intervention
4708195|NCT03187119|Asthma Action Plan|asthma action plan
4708196|NCT03187119|Health literacy|health literacy
4708197|NCT03187093|MDD|mdd
4708198|NCT03187093|Vortioxetine|vortioxetine
4708199|NCT03187093|IGF-1|igf-1
4708200|NCT03187093|Cognitive dysfunction|cognitive dysfunction
4708201|NCT03187067|pneumonia|pneumonia
4708202|NCT03187067|diagnostic|diagnostic
4708203|NCT03187067|ultrasound|ultrasound
4708204|NCT03187067|Pakistan|pakistan
4708205|NCT03187067|Mozambique|mozambique
4708206|NCT03187041|blood draw tourniquets|blood draw tourniquets
4708207|NCT03187041|skin surface pressure|skin surface pressure
4708208|NCT03187041|blood draw band|blood draw band
4708209|NCT03187041|elastic tourniquet|elastic tourniquet
4708210|NCT03187041|phlebotomy|phlebotomy
4708211|NCT03187041|tourniquet pressure|tourniquet pressure
4708212|NCT03187028|Cancer of Pancreas|cancer of pancreas
4708213|NCT03187028|Neoplasms, Pancreatic|neoplasms, pancreatic
4708214|NCT03187028|Pancreas Cancer|pancreas cancer
4708215|NCT03187028|Pancreas Neoplasms|pancreas neoplasms
4708216|NCT03187028|Cancer of the Pancreas|cancer of the pancreas
4708217|NCT03187028|Pancreatic Cancer|pancreatic cancer
4708218|NCT03187015|Healthy Volunteers|healthy volunteers
4708219|NCT03187015|Entinostat|entinostat
4708220|NCT03187015|Histone Deacetylase Inhibitor|histone deacetylase inhibitor
4708221|NCT03187015|HDAC|hdac
4708222|NCT03186989|Mild Alzheimer's Disease|mild alzheimer's disease
4708223|NCT03186989|ISIS 814907|isis 814907
4708224|NCT03186976|Risk Factor Modification|risk factor modification
4708225|NCT03186976|Catheter ablation|catheter ablation
4708226|NCT03186963|distal radius fracture|distal radius fracture
4708227|NCT03186963|volar plate|volar plate
4708228|NCT03186963|immobilization|immobilization
4708229|NCT03186898|hepatocellular carcinoma|hepatocellular carcinoma
4708230|NCT03186898|HCC|hcc
4708231|NCT03186898|Proton Therapy|proton therapy
4708232|NCT03186898|Photon Therapy|photon therapy
4708233|NCT03186898|Liver cancer|liver cancer
4708234|NCT03186859|non-alcoholic fatty liver disease|non-alcoholic fatty liver disease
4708235|NCT03186859|bariatric surgery|bariatric surgery
4708236|NCT03186846|cognitive decline|cognitive decline
4708237|NCT03186846|hemodynamic monitoring|hemodynamic monitoring
4708238|NCT03186846|LIDCO|lidco
4708239|NCT03186846|INVOS|invos
4708240|NCT03186846|BIS|bis
4708241|NCT03186846|brain injury biomarkers|brain injury biomarkers
4708242|NCT03186820|Endometriosis|endometriosis
4708243|NCT03186820|Magnetic resonance imaging (MRI)|magnetic resonance imaging (mri)
4708244|NCT03186820|Susceptibility-weighted imaging (SWI)|susceptibility-weighted imaging (swi)
4708245|NCT03186807|normogram|normogram
4708246|NCT03186807|brain lumination|brain lumination
4708247|NCT03186807|fetal cortex|fetal cortex
4708248|NCT03186807|ultrasound|ultrasound
4708249|NCT03186794|Fatigue|fatigue
4708250|NCT03186781|Flu Virus|flu virus
4708251|NCT03186781|Flu Shot|flu shot
4708252|NCT03186781|H2N2|h2n2
4708254|NCT03186781|Immune Response|immune response
4708255|NCT03186742|Eplerenone|eplerenone
4708256|NCT03186742|Concentric hypertrophy|concentric hypertrophy
4708257|NCT03186729|Intracerebral hemorrhage|intracerebral hemorrhage
4708258|NCT03186716|Colostrum|colostrum
4708259|NCT03186716|Enteral Nutrition|enteral nutrition
4708260|NCT03186716|Intestinal Permeability|intestinal permeability
4708261|NCT03186716|Intensive Care Unit|intensive care unit
4708262|NCT03186703|Cancer prevention|cancer prevention
4708263|NCT03186703|Knowledge translation|knowledge translation
4708264|NCT03186703|Physical activity|physical activity
4708265|NCT03186703|Diet|diet
4708266|NCT03186703|Alcohol|alcohol
4708267|NCT03186703|Smoking|smoking
4708268|NCT03186690|vital pulp therapy|vital pulp therapy
4708269|NCT03186690|Biodentine|biodentine
4708270|NCT03186690|Mineral Trioxide Aggregate|mineral trioxide aggregate
4708271|NCT03186677|ISU304|isu304
4708272|NCT03186677|previously treated hemophilia B patients|previously treated hemophilia b patients
4708273|NCT03186677|FIX|fix
4708274|NCT03186677|Factor IX|factor ix
4708275|NCT03186677|CB2679d|cb2679d
4708276|NCT03186651|Vaginal|vaginal
4708277|NCT03186651|Medical Device|medical device
4708278|NCT03186651|Female Stress Urinary Incontinence|female stress urinary incontinence
4708279|NCT03186625|acute coronary syndrome|acute coronary syndrome
4708280|NCT03186625|gut microbiota|gut microbiota
4708281|NCT03186625|Trimethylamine N-oxide|trimethylamine n-oxide
4708282|NCT03186625|percutaneous coronary intervention|percutaneous coronary intervention
4708283|NCT03186612|Video games; Virtual reality; Occupational therapy, Manual dexterity; Multiple sclerosis.|video games; virtual reality; occupational therapy, manual dexterity; multiple sclerosis.
4708284|NCT03186599|Medication Event Monitoring System|medication event monitoring system
4708285|NCT03186599|adherence|adherence
4708286|NCT03186586|Heavy Menstrual Bleeding|heavy menstrual bleeding
4708287|NCT03186586|Levonorgestrel relesing intrauterine system|levonorgestrel relesing intrauterine system
4708288|NCT03186560|Leg ulcers and use of geko device|leg ulcers and use of geko device
4708289|NCT03186508|obesity prevention|obesity prevention
4708290|NCT03186508|sleep|sleep
4708291|NCT03186508|behavioral intervention|behavioral intervention
4708292|NCT03186456|acute cerebral infarction|acute cerebral infarction
4708293|NCT03186456|umbilical cord mesenchymal stem cells|umbilical cord mesenchymal stem cells
4708294|NCT03186443|herpetic neuralgia|herpetic neuralgia
4708295|NCT03186443|post-herpetic neuralgia|post-herpetic neuralgia
4708296|NCT03186443|pregabalin|pregabalin
4708297|NCT03186430|Vaccine|vaccine
4708298|NCT03186430|Vaccination|vaccination
4708299|NCT03186430|Behavioral Research|behavioral research
4708300|NCT03186430|Adolescent|adolescent
4708302|NCT03186430|Public Health|public health
4708303|NCT03186417|Arthritis, Rheumatoid, Stem Cells, Mesenchymal, Autoimmune|arthritis, rheumatoid, stem cells, mesenchymal, autoimmune
4708304|NCT03186352|photodynamic therapy|photodynamic therapy
4708305|NCT03186352|photoactivated disinfection|photoactivated disinfection
4708306|NCT03186352|primary root caries lesion|primary root caries lesion
4708307|NCT03186352|cavity disinfection|cavity disinfection
4708308|NCT03186352|lasers|lasers
4708309|NCT03186352|root caries|root caries
4708310|NCT03186339|QoL|qol
4708311|NCT03186339|TAVI|tavi
4708312|NCT03186339|surgical aortic valve replacement|surgical aortic valve replacement
4708313|NCT03186339|Aortic stenosis|aortic stenosis
4708314|NCT03186326|immunotherapy|immunotherapy
4708315|NCT03186326|second line|second line
4708316|NCT03186313|HCV|hcv
4708317|NCT03186313|Sofosbuvir|sofosbuvir
4708318|NCT03186313|Ribavirin|ribavirin
4708319|NCT03186300|bolus advisor|bolus advisor
4708320|NCT03186248|Achalasia cardia|achalasia cardia
4708321|NCT03186248|myotomy|myotomy
4708322|NCT03186248|Per oral endoscopic myotomy|per oral endoscopic myotomy
4708323|NCT03186248|laparoscopic fundoplication|laparoscopic fundoplication
4708324|NCT03186209|Asthma,|asthma,
4708325|NCT03186209|Bronchial Diseases,|bronchial diseases,
4708326|NCT03186209|Respiratory Tract Diseases,|respiratory tract diseases,
4708327|NCT03186209|Lung Diseases,|lung diseases,
4708328|NCT03186209|Obstructive Lung Diseases|obstructive lung diseases
4708329|NCT03186196|Folate|folate
4708330|NCT03186196|Polymorphism|polymorphism
4708331|NCT03186196|Overweight and Obesity|overweight and obesity
4708332|NCT03186196|Inflammatory markers|inflammatory markers
4708333|NCT03186183|HIV prevention|hiv prevention
4708334|NCT03186183|Sexual health|sexual health
4708335|NCT03186183|Motivational interviewing|motivational interviewing
4708336|NCT03186183|Information-Motivation-Behavioural skills model|information-motivation-behavioural skills model
4708337|NCT03186183|Health promotion|health promotion
4708338|NCT03186157|trephined syndrome|trephined syndrome
4708339|NCT03186157|sinking skin flap syndrome|sinking skin flap syndrome
4708340|NCT03186157|craniectomy|craniectomy
4708341|NCT03186157|decompressive craniectomy|decompressive craniectomy
4708342|NCT03186157|neurosurgical complications|neurosurgical complications
4708343|NCT03186118|pediatric|pediatric
4708344|NCT03186118|young adult|young adult
4708345|NCT03186118|acute lymphoblastic leukemia|acute lymphoblastic leukemia
4708346|NCT03186118|CD 19|cd 19
4708347|NCT03186118|leukemia|leukemia
4708348|NCT03186118|chimeric antigen receptor|chimeric antigen receptor
4708349|NCT03186118|T cell|t cell
4708549|NCT03184779|Ski|ski
4708350|NCT03186105|Appendicitis Acute|appendicitis acute
4708351|NCT03186105|AMBULATORY|ambulatory
4708352|NCT03186092|Respiratory muscle strength|respiratory muscle strength
4708353|NCT03186092|Pulmonary hypertension|pulmonary hypertension
4708354|NCT03186092|Respiratory muscle training|respiratory muscle training
4708355|NCT03186027|chronic fatigue|chronic fatigue
4708356|NCT03186027|Sleep problems|sleep problems
4708357|NCT03186027|Autonomic dysfunction|autonomic dysfunction
4708358|NCT03186027|Health-Related Quality of Life|health-related quality of life
4708359|NCT03186027|Coenzyme Q10|coenzyme q10
4708360|NCT03186027|NADH|nadh
4708361|NCT03186014|Malignant dysphagia|malignant dysphagia
4708362|NCT03186014|Stent|stent
4708363|NCT03186014|Esophageal neoplasms|esophageal neoplasms
4708364|NCT03186014|Brachytherapy|brachytherapy
4708365|NCT03186001|frontalis|frontalis
4708366|NCT03186001|frontal line|frontal line
4708367|NCT03186001|glabellar line|glabellar line
4708368|NCT03186001|botulinum toxin|botulinum toxin
4708369|NCT03186001|abobotulinum|abobotulinum
4708370|NCT03185988|Human epidermal growth factor receptor 2|human epidermal growth factor receptor 2
4708371|NCT03185988|Biliary tract cancer|biliary tract cancer
4708372|NCT03185988|Esophageal squamous cell carcinoma|esophageal squamous cell carcinoma
4708373|NCT03185988|Targeted therapy|targeted therapy
4708374|NCT03185975|HIV|hiv
4708375|NCT03185975|transgender|transgender
4708376|NCT03185975|trans|trans
4708377|NCT03185975|youth|youth
4708378|NCT03185975|home testing|home testing
4708379|NCT03185936|optic disc pit|optic disc pit
4708380|NCT03185936|retinal detachment|retinal detachment
4708381|NCT03185936|maculopathy|maculopathy
4708382|NCT03185923|Community-Acquired Infections|community-acquired infections
4708383|NCT03185923|Humans|humans
4708384|NCT03185923|Medicine, Chinese Traditional|medicine, chinese traditional
4708385|NCT03185871|Invasive breast carcinoma|invasive breast carcinoma
4708386|NCT03185871|breast carcinoma stage T1cN0 to N3N0|breast carcinoma stage t1cn0 to n3n0
4708387|NCT03185858|secondary prevention|secondary prevention
4708388|NCT03185858|primary healthcare|primary healthcare
4708389|NCT03185858|village doctors|village doctors
4708390|NCT03185858|rural China|rural china
4708391|NCT03185858|medication adherence|medication adherence
4708392|NCT03185858|physical activity|physical activity
4708393|NCT03185832|Hear failure|hear failure
4708394|NCT03185832|Sudden Cardiac Death|sudden cardiac death
4708395|NCT03185832|Arrhythmia|arrhythmia
4708396|NCT03185832|Implanted device|implanted device
4708397|NCT03185832|ICD|icd
4708398|NCT03185832|CRT|crt
4708399|NCT03185806|severe acute pancreatitis|severe acute pancreatitis
4708400|NCT03185806|sterile acute peripancreatic fluid collections|sterile acute peripancreatic fluid collections
4708401|NCT03185806|percutaneous catheter drainage|percutaneous catheter drainage
4708402|NCT03185793|SHR4640, Phase II, monotherapy, dose-finding|shr4640, phase ii, monotherapy, dose-finding
4708403|NCT03185780|complementary/integrative medicine|complementary/integrative medicine
4708404|NCT03185780|glioblastoma|glioblastoma
4708405|NCT03185780|quality of life|quality of life
4708406|NCT03185780|adherence|adherence
4708407|NCT03185754|lung cancer|lung cancer
4708408|NCT03185754|surgery|surgery
4708409|NCT03185754|lobectomy|lobectomy
4708410|NCT03185754|sublobar resection|sublobar resection
4708411|NCT03185728|Child Abuse|child abuse
4708412|NCT03185728|Mandated Reporting|mandated reporting
4708413|NCT03185728|Online Learning|online learning
4708414|NCT03185728|Child Protection|child protection
4708415|NCT03185728|GAMIFICATION|gamification
4708416|NCT03185728|Early Childhood Education|early childhood education
4708417|NCT03185715|oocyte donation|oocyte donation
4708418|NCT03185715|recipient counselling|recipient counselling
4708419|NCT03185715|single embryo transfer (SET)|single embryo transfer (set)
4708420|NCT03185715|double embryo transfer (DET)|double embryo transfer (det)
4708421|NCT03185715|decision-making|decision-making
4708422|NCT03185689|Glycemic control|glycemic control
4708423|NCT03185689|Diabetes self-management education|diabetes self-management education
4708424|NCT03185650|Healthy Volunteers|healthy volunteers
4708425|NCT03185637|Outcomes|outcomes
4708426|NCT03185637|Mortality|mortality
4708427|NCT03185637|Complications|complications
4708428|NCT03185637|Neonatal surgery|neonatal surgery
4708429|NCT03185637|Paediatric surgery|paediatric surgery
4708430|NCT03185637|Childrens surgery|childrens surgery
4708431|NCT03185637|Sub-Saharan Africa|sub-saharan africa
4708432|NCT03185637|Research Collaboration|research collaboration
4708433|NCT03185637|Gastroschisis|gastroschisis
4708434|NCT03185637|Anorectal malformation|anorectal malformation
4708435|NCT03185637|Appendicitis|appendicitis
4708436|NCT03185637|Intussuception|intussuception
4708437|NCT03185637|Inguinal hernia|inguinal hernia
4708438|NCT03185585|Nutritional screenings|nutritional screenings
4708439|NCT03185546|smoking|smoking
4708440|NCT03185546|vaping|vaping
4708441|NCT03185520|Stroke|stroke
4708442|NCT03185520|Ischemic Stroke|ischemic stroke
4708443|NCT03185520|Cryptogenic Stroke|cryptogenic stroke
4708444|NCT03185520|Embolic stroke of undetermined source|embolic stroke of undetermined source
4708445|NCT03185520|ESUS|esus
4708446|NCT03185520|Cerebrovascular Disease|cerebrovascular disease
4708447|NCT03185481|Parkinson's Disease|parkinson's disease
4708448|NCT03185481|Motor Fluctuations|motor fluctuations
4708449|NCT03185481|D1 partial agonist|d1 partial agonist
4708450|NCT03185468|CAR T|car t
4708451|NCT03185468|Bladder|bladder
4708452|NCT03185455|Hypertension|hypertension
4708453|NCT03185455|Pregnancy|pregnancy
4708454|NCT03185455|Text|text
4708455|NCT03185442|fMRI|fmri
4708456|NCT03185442|PRF|prf
4708457|NCT03185416|Quality of Life|quality of life
4708458|NCT03185416|Caregiver|caregiver
4708459|NCT03185416|Quality Improvement|quality improvement
4708460|NCT03185403|hemodynamic effect|hemodynamic effect
4708461|NCT03185403|para vertebral block|para vertebral block
4708462|NCT03185390|periampullary lesions|periampullary lesions
4708463|NCT03185351|midazolam|midazolam
4708464|NCT03185351|brachial plexus block|brachial plexus block
4708465|NCT03185338|physical activity, promotion, school|physical activity, promotion, school
4708466|NCT03185299|Polyp detection rate|polyp detection rate
4708467|NCT03185299|Adenoma detection rate|adenoma detection rate
4708468|NCT03185299|Boston Bowel Preparation Scale|boston bowel preparation scale
4708469|NCT03185286|3D printing, metal implant, bone defect|3d printing, metal implant, bone defect
4708470|NCT03185260|Cardio-Pulmonary Resuscitation|cardio-pulmonary resuscitation
4708471|NCT03185260|Cardiac Arrest|cardiac arrest
4708472|NCT03185260|Training|training
4708473|NCT03185247|Transdiagnostic|transdiagnostic
4708474|NCT03185247|POTS (Postural Orthostatic Tachycardia Syndrome)|pots (postural orthostatic tachycardia syndrome)
4708475|NCT03185247|Therapy|therapy
4708476|NCT03185234|tDCS|tdcs
4708477|NCT03185221|Stents Coronary Artery Disease|stents coronary artery disease
4708478|NCT03185208|Lithium|lithium
4708479|NCT03185208|Mild Cognitive Impairment|mild cognitive impairment
4708480|NCT03185208|MCI|mci
4708481|NCT03185208|Dementia|dementia
4708482|NCT03185208|Alzheimer|alzheimer
4708483|NCT03185208|Alzheimer's Disease|alzheimer's disease
4708484|NCT03185208|Cognition|cognition
4708485|NCT03185208|Memory|memory
4708486|NCT03185208|Thinking|thinking
4708487|NCT03185208|Prevention|prevention
4708488|NCT03185208|amyloid|amyloid
4708489|NCT03185208|imaging|imaging
4708490|NCT03185208|MRI|mri
4708491|NCT03185208|PET|pet
4708492|NCT03185208|tau|tau
4708493|NCT03185208|plaques|plaques
4708494|NCT03185208|tangles|tangles
4708495|NCT03185182|Diagnosis|diagnosis
4708496|NCT03185182|Imaging|imaging
4708497|NCT03185169|breast cancer survivor|breast cancer survivor
4708498|NCT03185169|postmenopausal|postmenopausal
4708499|NCT03185169|dysuria|dysuria
4708500|NCT03185169|dyspareunia|dyspareunia
4708501|NCT03185169|vaginal dryness|vaginal dryness
4708502|NCT03185169|urinary tract infections|urinary tract infections
4708503|NCT03185169|urinary frequency|urinary frequency
4708504|NCT03185169|urinary urgency|urinary urgency
4708505|NCT03185169|genital burning|genital burning
4708506|NCT03185169|genital itching|genital itching
4708507|NCT03185169|genital dryness|genital dryness
4708508|NCT03185156|nausea and vomiting|nausea and vomiting
4708509|NCT03185156|hemabate|hemabate
4708510|NCT03185156|propofol|propofol
4708511|NCT03185130|Headache|headache
4708512|NCT03185130|Benign Headache|benign headache
4708513|NCT03185117|opioid consumption|opioid consumption
4708514|NCT03185117|postdischarge|postdischarge
4708515|NCT03185117|major orthopedic surgery|major orthopedic surgery
4708516|NCT03185104|removable partial denture|removable partial denture
4708517|NCT03185104|silver diamine fluoride|silver diamine fluoride
4708518|NCT03185078|physical therapy|physical therapy
4708519|NCT03185078|ESWT|eswt
4708520|NCT03185026|Psychiatry|psychiatry
4708521|NCT03185026|Suicide|suicide
4708522|NCT03185026|Psychoeducation|psychoeducation
4708523|NCT03185026|Randomized controlled trial|randomized controlled trial
4708524|NCT03185026|current suicidal behavior disorder|current suicidal behavior disorder
4708525|NCT03185026|DSM-5|dsm-5
4708526|NCT03185013|Cervical intraepithelial neoplasia (CIN)|cervical intraepithelial neoplasia (cin)
4708527|NCT03185013|Human papillomavirus (HPV)|human papillomavirus (hpv)
4708528|NCT03185013|High grade squamous intraepithelial lesion (HSIL)|high grade squamous intraepithelial lesion (hsil)
4708529|NCT03185013|CIN 2|cin 2
4708530|NCT03185013|CIN 3|cin 3
4708531|NCT03185013|papillomavirus|papillomavirus
4708532|NCT03184987|fluticasone furoate|fluticasone furoate
4708533|NCT03184987|fixed dose combination|fixed dose combination
4708534|NCT03184987|Japanese subjects|japanese subjects
4708535|NCT03184987|vilanterol|vilanterol
4708536|NCT03184987|asthma|asthma
4708537|NCT03184987|umeclidinium bromide|umeclidinium bromide
4708538|NCT03184987|closed triple therapy|closed triple therapy
4708539|NCT03184935|Myelodysplastic Syndromes|myelodysplastic syndromes
4708540|NCT03184935|mesenchymal stem cells|mesenchymal stem cells
4708541|NCT03184922|femoral suspensory loops|femoral suspensory loops
4708542|NCT03184857|maxillary sinus|maxillary sinus
4708543|NCT03184857|augmentation|augmentation
4708544|NCT03184857|bovine bone|bovine bone
4708545|NCT03184857|Nano hydroxy appatite|nano hydroxy appatite
4708546|NCT03184844|Thalidomide TI|thalidomide ti
4708547|NCT03184831|sinus lift, injectable platelet rich fibrin, sticky bone, bovine bone|sinus lift, injectable platelet rich fibrin, sticky bone, bovine bone
4708548|NCT03184792|Spinal electrical stimulation|spinal electrical stimulation
4708550|NCT03184779|Snowboard|snowboard
4708551|NCT03184779|Snow Sport|snow sport
4708552|NCT03184779|Injury|injury
4708553|NCT03184779|Injury Prevention|injury prevention
4708554|NCT03184779|Safety|safety
4708555|NCT03184779|Safety Video|safety video
4708556|NCT03184779|Video Intervention|video intervention
4708557|NCT03184779|Youth|youth
4708558|NCT03184779|Children|children
4708559|NCT03184779|Adolescent|adolescent
4708560|NCT03184779|Education|education
4708561|NCT03184779|Knowledge|knowledge
4708562|NCT03184753|Autologous|autologous
4708563|NCT03184753|IgT|igt
4708564|NCT03184753|Ovarian Cancer|ovarian cancer
4708565|NCT03184753|CART|cart
4708566|NCT03184701|Telehealth|telehealth
4708567|NCT03184701|Quality of Life|quality of life
4708568|NCT03184688|platelet rich plasma|platelet rich plasma
4708569|NCT03184688|Perineural injection therapy|perineural injection therapy
4708570|NCT03184688|hydrodissection|hydrodissection
4708571|NCT03184662|High-intensity physical activity|high-intensity physical activity
4708572|NCT03184662|Diabetes|diabetes
4708573|NCT03184662|Renal function decline|renal function decline
4708574|NCT03184636|ACLF|aclf
4708575|NCT03184636|SOFA|sofa
4708576|NCT03184636|Zagazig university|zagazig university
4708577|NCT03184610|Keratoconus|keratoconus
4708578|NCT03184610|Optical Coherence Tomography|optical coherence tomography
4708579|NCT03184610|Corneal Epithelium Thickness Maps|corneal epithelium thickness maps
4708580|NCT03184597|HLA screening|hla screening
4708581|NCT03184597|SJS/TEN|sjs/ten
4708582|NCT03184597|MPE|mpe
4708583|NCT03184597|AEDs|aeds
4708584|NCT03184571|bemcentinib|bemcentinib
4708585|NCT03184571|NSCLC|nsclc
4708586|NCT03184571|pembrolizumab|pembrolizumab
4708587|NCT03184571|Keytruda|keytruda
4708588|NCT03184571|BGB324|bgb324
4708589|NCT03184558|bemcentinib|bemcentinib
4708590|NCT03184558|TNBC|tnbc
4708591|NCT03184558|pembrolizumab|pembrolizumab
4708592|NCT03184558|Keytruda|keytruda
4708593|NCT03184558|BGB324|bgb324
4708594|NCT03184545|anterior knee pain|anterior knee pain
4708595|NCT03184480|Drug Use Investigation|drug use investigation
4708596|NCT03184480|GW685698|gw685698
4708597|NCT03184480|asthma|asthma
4708598|NCT03184480|Post-marketing surveillance|post-marketing surveillance
4708599|NCT03184480|ARNUITY ELLIPTA|arnuity ellipta
4708600|NCT03184467|GV1001|gv1001
4708601|NCT03184467|Alzheimer Disease|alzheimer disease
4708602|NCT03184454|OCD|ocd
4708603|NCT03184454|deep brain stimulation|deep brain stimulation
4708604|NCT03184454|treatment-resistant OCD|treatment-resistant ocd
4708605|NCT03184428|YAG-Laser Capsulotomy|yag-laser capsulotomy
4708606|NCT03184389|Behavioral Counseling|behavioral counseling
4708607|NCT03184389|Cigarette Smoking|cigarette smoking
4708608|NCT03184389|Mobile Health|mobile health
4708609|NCT03184389|Heart Rate Variability Monitoring|heart rate variability monitoring
4708610|NCT03184389|Mindfulness-Based Exercises|mindfulness-based exercises
4708611|NCT03184389|Mobile Apps|mobile apps
4708612|NCT03184389|Physiological Monitoring|physiological monitoring
4708613|NCT03184389|Respiratory Pattern Monitoring|respiratory pattern monitoring
4708614|NCT03184389|Stress-Management Interventions|stress-management interventions
4708615|NCT03184389|Sensor-Triggered Stress Intervention|sensor-triggered stress intervention
4708616|NCT03184389|Smartphone Apps|smartphone apps
4708617|NCT03184389|Smoking Cessation|smoking cessation
4708618|NCT03184389|Wearable Sensors|wearable sensors
4708619|NCT03184389|Eating Behavior|eating behavior
4708620|NCT03184389|Stress-Related Eating|stress-related eating
4708621|NCT03184376|Gut microbiota|gut microbiota
4708622|NCT03184376|Prebiotic|prebiotic
4708623|NCT03184376|Liver biopsy|liver biopsy
4708624|NCT03184376|Oligofructose|oligofructose
4708625|NCT03184350|cervical cancer|cervical cancer
4708626|NCT03184350|endometrial cancer|endometrial cancer
4708627|NCT03184350|proton therapy|proton therapy
4708628|NCT03184337|Weight loss|weight loss
4708629|NCT03184337|Women|women
4708630|NCT03184337|Sleep|sleep
4708631|NCT03184337|Intervention|intervention
4708632|NCT03184337|Diet|diet
4708633|NCT03184337|Physical activity|physical activity
4708634|NCT03184337|Fitbit|fitbit
4708635|NCT03184311|Iron deficiency|iron deficiency
4708636|NCT03184311|Therapy response prediction|therapy response prediction
4708637|NCT03184311|Exercise tolerance|exercise tolerance
4708638|NCT03184298|Military Personnel|military personnel
4708639|NCT03184298|Sexual Assault|sexual assault
4708640|NCT03184298|Military Sexual Trauma|military sexual trauma
4708641|NCT03184298|Alcohol and Substance Abuse|alcohol and substance abuse
4708642|NCT03184285|limitation in conventional monitoring|limitation in conventional monitoring
4708643|NCT03184272|limitation in conventional monitoring|limitation in conventional monitoring
4708644|NCT03184246|Videolaryngoscopy (GlideScope)|videolaryngoscopy (glidescope)
4708645|NCT03184246|Direct laryngoscopy|direct laryngoscopy
4708646|NCT03184220|Neck Pain|neck pain
4708647|NCT03184220|Physical Therapy Modalities|physical therapy modalities
4708648|NCT03184220|Fascia|fascia
4708649|NCT03184220|Manual Therapy|manual therapy
4708650|NCT03184220|Massage|massage
4708651|NCT03184194|daratumumab|daratumumab
4708652|NCT03184194|nivolumab|nivolumab
4708653|NCT03184194|cyclophosphamide|cyclophosphamide
4708654|NCT03184181|tendinopathy|tendinopathy
4708655|NCT03184181|electrolysis|electrolysis
4708656|NCT03184181|exercise|exercise
4708657|NCT03184181|dry needling|dry needling
4708658|NCT03184168|healthy volunteers, lorlatinib, PF-06463922, ADME, NSCLC, radiolabel, metabolism|healthy volunteers, lorlatinib, pf-06463922, adme, nsclc, radiolabel, metabolism
4708659|NCT03184155|Nicardipine|nicardipine
4708660|NCT03184155|Percutaneous Coronary Intervention|percutaneous coronary intervention
4708661|NCT03184155|Coronary Artery Disease|coronary artery disease
4708662|NCT03184142|Intimidation|intimidation
4708663|NCT03184142|Simulation|simulation
4708664|NCT03184142|Medical education|medical education
4708665|NCT03184142|Surgical education|surgical education
4708666|NCT03184077|Postpartum dyspareunia|postpartum dyspareunia
4708667|NCT03184077|Obestric laceration|obestric laceration
4708668|NCT03184064|Blackcurrant|blackcurrant
4708669|NCT03184064|Citrus|citrus
4708670|NCT03184064|Polyphenols|polyphenols
4708671|NCT03184064|Glucose|glucose
4708672|NCT03184064|Postprandial|postprandial
4708673|NCT03184064|Metabolism|metabolism
4708674|NCT03184051|Knee|knee
4708675|NCT03184051|Osteoarthritis|osteoarthritis
4708676|NCT03184051|Ultrasonography evaluation/ultrasound|ultrasonography evaluation/ultrasound
4708677|NCT03184051|Articular cartilage|articular cartilage
4708678|NCT03184051|UltraSound Speed Of Sound (US-SOS)|ultrasound speed of sound (us-sos)
4708679|NCT03184051|UltraSound Time of Flight (US-TOF)|ultrasound time of flight (us-tof)
4708680|NCT03184012|caries|caries
4708681|NCT03184012|full coverage|full coverage
4708682|NCT03184012|strip crown|strip crown
4708683|NCT03184012|Zirconia crown|zirconia crown
4708684|NCT03184012|primary anterior teeth|primary anterior teeth
4708685|NCT03184012|crown|crown
4708686|NCT03183960|Self-management|self-management
4708687|NCT03183960|Quality of Life|quality of life
4708688|NCT03183960|Self-efficacy|self-efficacy
4708689|NCT03183960|Support|support
4708690|NCT03183960|Stroke|stroke
4708691|NCT03183960|Older adults|older adults
4708692|NCT03183947|fMRI|fmri
4708693|NCT03183947|neurofeedback|neurofeedback
4708694|NCT03183947|emotion regulation|emotion regulation
4708695|NCT03183947|schizophrenia|schizophrenia
4708696|NCT03183947|cognitive reappraisal|cognitive reappraisal
4708697|NCT03183947|depression|depression
4708698|NCT03183934|Epidermolysis Bullosa|epidermolysis bullosa
4708699|NCT03183934|Stem cell|stem cell
4708700|NCT03183908|influenza vaccine|influenza vaccine
4708701|NCT03183908|fever following vaccination|fever following vaccination
4708702|NCT03183908|pain following vaccination|pain following vaccination
4708703|NCT03183908|quality of life|quality of life
4708704|NCT03183869|microbiome|microbiome
4708705|NCT03183869|multiple sclerosis|multiple sclerosis
4708706|NCT03183869|microbiota|microbiota
4708707|NCT03183869|gut|gut
4708708|NCT03183843|Atrial Fibrillation|atrial fibrillation
4708709|NCT03183843|Mitral Valve Stenosis|mitral valve stenosis
4708710|NCT03183843|Mitral Valve Insufficiency|mitral valve insufficiency
4708711|NCT03183843|Dabigatran|dabigatran
4708712|NCT03183843|Biological Prosthesis|biological prosthesis
4708713|NCT03183843|Mitral Valve Replacement|mitral valve replacement
4708714|NCT03183843|Cox-Maze Procedure|cox-maze procedure
4708715|NCT03183830|Cardiovascular Disease|cardiovascular disease
4708716|NCT03183830|Inorganic nitrate|inorganic nitrate
4708717|NCT03183830|Nitric Oxide|nitric oxide
4708718|NCT03183830|Inflammation|inflammation
4708719|NCT03183817|Person-centred care|person-centred care
4708720|NCT03183778|Chronic kidney disease, stages 3B-4|chronic kidney disease, stages 3b-4
4708721|NCT03183752|thyroid|thyroid
4708722|NCT03183752|insulin|insulin
4708723|NCT03183752|thyroid nodule|thyroid nodule
4708724|NCT03183752|insulin resistance|insulin resistance
4708725|NCT03183752|thyroid volume|thyroid volume
4708726|NCT03183752|metformin|metformin
4708727|NCT03183739|ASP8062|asp8062
4708728|NCT03183739|Pharmacokinetics|pharmacokinetics
4708729|NCT03183739|Safety|safety
4708730|NCT03183700|Screening HPV|screening hpv
4708731|NCT03183700|Self sampling|self sampling
4708732|NCT03183700|DNA Methylation|dna methylation
4708733|NCT03183687|neurosurgery|neurosurgery
4708734|NCT03183687|resident wellness|resident wellness
4708735|NCT03183687|health|health
4708736|NCT03183687|mental health|mental health
4708737|NCT03183687|physical activity|physical activity
4708738|NCT03183687|physician health|physician health
4708739|NCT03183622|Deep Second-Degree Burn Wound|deep second-degree burn wound
4708740|NCT03183596|Deep Serratus Block|deep serratus block
4708741|NCT03183596|Reconstructive Breast Surgery|reconstructive breast surgery
4708742|NCT03183596|Superficial Serratus block|superficial serratus block
4708743|NCT03183583|Tissue Adhesive|tissue adhesive
4708744|NCT03183492|Israel|israel
4708745|NCT03183492|Universal Mass Vaccination|universal mass vaccination
4708746|NCT03183492|Havrix®|havrix®
4708747|NCT03183492|Hepatitis A|hepatitis a
4708748|NCT03183492|Healthy adults|healthy adults
4708749|NCT03183492|Long term persistence|long term persistence
4708750|NCT03183492|Toddlers|toddlers
4708751|NCT03183479|adolescent idiopathic scoliosis|adolescent idiopathic scoliosis
4708752|NCT03183479|fibrinogen concentrate|fibrinogen concentrate
4708753|NCT03183479|perioperative blood loss|perioperative blood loss
4708754|NCT03183479|transfusion|transfusion
4708755|NCT03183453|Confabulations|confabulations
4708756|NCT03183453|Neuropsychological rehabilitation|neuropsychological rehabilitation
4708757|NCT03183453|Memory|memory
4708758|NCT03183440|Atopic dermatitis|atopic dermatitis
4708759|NCT03183440|Prevention|prevention
4708760|NCT03183440|Prebiotics|prebiotics
4708761|NCT03183440|Pregnancy|pregnancy
4708762|NCT03183414|cardiac surgery|cardiac surgery
4708763|NCT03183414|transoesophageal echocardiography|transoesophageal echocardiography
4708764|NCT03183401|childhood cancer survivor|childhood cancer survivor
4708765|NCT03183388|psychotherapy|psychotherapy
4708766|NCT03183362|Barbed sutures,Cesarean Section, adhesions|barbed sutures,cesarean section, adhesions
4708767|NCT03183323|hfpef|hfpef
4708768|NCT03183323|hfref|hfref
4708769|NCT03183323|cardiorenal syndrome|cardiorenal syndrome
4708770|NCT03183323|exercise|exercise
4708771|NCT03183323|telerehabilitation|telerehabilitation
4708772|NCT03183323|rehabilitation|rehabilitation
4708773|NCT03183284|dexamethazone|dexamethazone
4708774|NCT03183284|prednislone|prednislone
4708775|NCT03183284|severe ITP|severe itp
4708776|NCT03183232|Immunotherapy, γδ T Cell, Lung Cancer|immunotherapy, γδ t cell, lung cancer
4708777|NCT03183219|Immunotherapy, γδ T Cell, Liver Cancer|immunotherapy, γδ t cell, liver cancer
4708778|NCT03183206|Immunotherapy, γδ T Cell, Breast Cancer|immunotherapy, γδ t cell, breast cancer
4708779|NCT03183193|NAFLD|nafld
4708780|NCT03183193|NASH|nash
4708781|NCT03183193|Obesity|obesity
4708782|NCT03183193|AASLD|aasld
4708783|NCT03183193|AHA|aha
4708784|NCT03183193|Energy-restricted diet|energy-restricted diet
4708785|NCT03183193|Lifestyle intervention|lifestyle intervention
4708786|NCT03183193|Mediterranean diet|mediterranean diet
4708787|NCT03183193|Weight loss|weight loss
4708788|NCT03183193|Liver damage|liver damage
4708789|NCT03183193|Inflammation|inflammation
4708790|NCT03183193|Oxidative stress|oxidative stress
4708791|NCT03183193|Microbiota composition|microbiota composition
4708792|NCT03183193|Eating behaviour|eating behaviour
4708793|NCT03183193|Satiety|satiety
4708794|NCT03183193|Physical activity|physical activity
4708795|NCT03183193|Sedentary behaviours|sedentary behaviours
4708796|NCT03183193|Sleep quality|sleep quality
4708797|NCT03183193|Sleep duration|sleep duration
4708798|NCT03183193|Psychological factors|psychological factors
4708799|NCT03183193|Nutrigenomics|nutrigenomics
4708800|NCT03183193|Nutrigenetics|nutrigenetics
4708801|NCT03183193|Transcriptomics|transcriptomics
4708802|NCT03183193|Epigenetics|epigenetics
4708803|NCT03183193|Metabolomics|metabolomics
4708804|NCT03183193|miRNAs|mirnas
4708805|NCT03183193|Lipidomics|lipidomics
4708806|NCT03183115|Early esophageal squamous cell neoplasm|early esophageal squamous cell neoplasm
4708807|NCT03183115|Radiofrequency ablation|radiofrequency ablation
4708808|NCT03183115|Endoscopic submucosal dissection|endoscopic submucosal dissection
4708809|NCT03183115|Esophageal cancer|esophageal cancer
4708810|NCT03183115|Recurrence|recurrence
4708811|NCT03183115|Field cancerization|field cancerization
4708812|NCT03183076|epilepsy|epilepsy
4708813|NCT03183076|Diet, Carbohydrate-Restricted|diet, carbohydrate-restricted
4708814|NCT03183076|Drug Resistance|drug resistance
4708815|NCT03183037|Acupuncture|acupuncture
4708817|NCT03183011|cardiac resynchronization therapy|cardiac resynchronization therapy
4708818|NCT03183011|implantable cardioverter defibrillator|implantable cardioverter defibrillator
4708819|NCT03183011|heart failure|heart failure
4708820|NCT03183011|magnetic resonance imaging|magnetic resonance imaging
4708821|NCT03182972|medication reconciliation|medication reconciliation
4708822|NCT03182972|implementation|implementation
4708823|NCT03182972|pharmacists|pharmacists
4708824|NCT03182972|southwestern Nigeria|southwestern nigeria
4708825|NCT03182959|Nrf2 pathway|nrf2 pathway
4708826|NCT03182959|Oral mucosa|oral mucosa
4708827|NCT03182959|HNSCC|hnscc
4708828|NCT03182959|Head and Neck Cancer|head and neck cancer
4708829|NCT03182959|Head and Neck Squamous Cell Carcinoma|head and neck squamous cell carcinoma
4708830|NCT03182959|Avmacol|avmacol
4708831|NCT03182959|Tobacco-related Head and Neck Cancer|tobacco-related head and neck cancer
4708832|NCT03182959|broccoli sprout powder|broccoli sprout powder
4708833|NCT03182959|broccoli seed extract powder|broccoli seed extract powder
4708834|NCT03182933|10 meter walk test|10 meter walk test
4708835|NCT03182933|Opioid consumption|opioid consumption
4708836|NCT03182894|chemo-refractory|chemo-refractory
4708837|NCT03182894|pembrolizumab|pembrolizumab
4708838|NCT03182894|epacadostat|epacadostat
4708839|NCT03182894|azacitidine|azacitidine
4708840|NCT03182894|recommended phase 2 dose (RP2D)|recommended phase 2 dose (rp2d)
4708841|NCT03182894|microsatellite-stable (MSS) Metastatic Colorectal Cancer|microsatellite-stable (mss) metastatic colorectal cancer
4708842|NCT03182881|Myofascial-reléase|myofascial-reléase
4708843|NCT03182881|Fibromyalgia|fibromyalgia
4708844|NCT03182881|Lymphatic drainage|lymphatic drainage
4708845|NCT03182881|Breast cancer|breast cancer
4708846|NCT03182855|Acute Coronary Syndrome|acute coronary syndrome
4708847|NCT03182855|STEMI|stemi
4708848|NCT03182855|Platelet reactivity|platelet reactivity
4708849|NCT03182855|Anti-thrombotic therapy|anti-thrombotic therapy
4708850|NCT03182829|direct oral anticoagulants|direct oral anticoagulants
4708851|NCT03182829|apixaban|apixaban
4708852|NCT03182829|dabigatran|dabigatran
4708853|NCT03182829|edoxaban|edoxaban
4708854|NCT03182829|rivaroxaban|rivaroxaban
4708855|NCT03182829|urine|urine
4708856|NCT03182829|LC-MS/MS|lc-ms/ms
4708857|NCT03182829|evaluation study|evaluation study
4708858|NCT03182829|point of care test|point of care test
4708859|NCT03182816|epidermal growth factor receptor|epidermal growth factor receptor
4708860|NCT03182816|CTLA-4|ctla-4
4708861|NCT03182816|PD-1|pd-1
4708862|NCT03182816|chimeric antigen receptor T cells|chimeric antigen receptor t cells
4708863|NCT03182816|solid tumor|solid tumor
4708864|NCT03182803|mesothelin|mesothelin
4708865|NCT03182803|CTLA-4|ctla-4
4708866|NCT03182803|PD-1|pd-1
4708867|NCT03182803|chimeric antigen receptor T cells|chimeric antigen receptor t cells
4708868|NCT03182803|solid tumor|solid tumor
4708869|NCT03182790|Smoking Cessation|smoking cessation
4708870|NCT03182790|Quit to Win|quit to win
4708871|NCT03182790|Brief intervention|brief intervention
4708872|NCT03182790|Semi-personalized Instant messaging|semi-personalized instant messaging
4708873|NCT03182790|Incentives|incentives
4708874|NCT03182790|AWARD model|award model
4708875|NCT03182790|Smoking Cessation Intervention|smoking cessation intervention
4708876|NCT03182790|Regular messages|regular messages
4708877|NCT03182777|arrhythmias, cardiac|arrhythmias, cardiac
4708878|NCT03182777|channelopathies|channelopathies
4708879|NCT03182777|death, sudden|death, sudden
4708880|NCT03182777|genetic testing|genetic testing
4708881|NCT03182777|electrocardiography, ambulatory|electrocardiography, ambulatory
4708882|NCT03182777|anesthesia, local|anesthesia, local
4708883|NCT03182777|dentistry|dentistry
4708884|NCT03182738|HIV/AIDS Health Management App|hiv/aids health management app
4708885|NCT03182738|HIV/AIDS symptoms|hiv/aids symptoms
4708886|NCT03182725|POTS|pots
4708887|NCT03182725|tachycardia|tachycardia
4708888|NCT03182725|ivabradine|ivabradine
4708889|NCT03182699|Secondary Hyperparathyroidism|secondary hyperparathyroidism
4708890|NCT03182699|Hemodialysis|hemodialysis
4708891|NCT03182699|Left Ventricular Hypertrophy|left ventricular hypertrophy
4708892|NCT03182699|FGF 23|fgf 23
4708893|NCT03182699|Etelcalcetide|etelcalcetide
4708894|NCT03182699|Alfacalcidol|alfacalcidol
4708895|NCT03182686|osteoarthritis|osteoarthritis
4708896|NCT03182686|osteoarthritis of the knee|osteoarthritis of the knee
4708897|NCT03182686|OA|oa
4708898|NCT03182686|OAK|oak
4708899|NCT03182686|Kellgren Lawrence (KL)|kellgren lawrence (kl)
4708900|NCT03182673|advanced solid tumor|advanced solid tumor
4708901|NCT03182673|Protein Kinase MEK inhibitor (MEKi)|protein kinase mek inhibitor (meki)
4708902|NCT03182673|Programmed Death 1(PD-1)|programmed death 1(pd-1)
4708903|NCT03182673|Safety|safety
4708904|NCT03182673|Pharmacokinetics|pharmacokinetics
4708905|NCT03182621|Physical Fitness|physical fitness
4708906|NCT03182621|Body Composition|body composition
4708907|NCT03182621|Executive Cognitive Function|executive cognitive function
4708908|NCT03182582|Laser Debridement|laser debridement
4708909|NCT03182582|Debridement|debridement
4708910|NCT03182556|Dance Therapy|dance therapy
4708911|NCT03182556|Exercise|exercise
4708912|NCT03182556|Myofeedback|myofeedback
4708913|NCT03182556|Fibromyalgia|fibromyalgia
4708914|NCT03182543|Exercise|exercise
4708915|NCT03182543|Oxidative stress|oxidative stress
4708916|NCT03182543|Antioxidant|antioxidant
4708917|NCT03182491|Platelet activating factor|platelet activating factor
4708918|NCT03182491|Basophil activation test|basophil activation test
4708919|NCT03182491|Anaphylatoxins|anaphylatoxins
4708920|NCT03182478|skin picking|skin picking
4708921|NCT03182478|SPD|spd
4708922|NCT03182478|Cognitive-Behavioral Therapy|cognitive-behavioral therapy
4708923|NCT03182478|CBT|cbt
4708924|NCT03182478|Group treatment|group treatment
4708925|NCT03182478|Rothbaum protocol|rothbaum protocol
4708926|NCT03182452|Alarms|alarms
4708927|NCT03182452|Alarm Fatigue|alarm fatigue
4708928|NCT03182452|Alarm Nuisance|alarm nuisance
4708929|NCT03182452|Alarm Reduction|alarm reduction
4708930|NCT03182452|Patient Monitoring|patient monitoring
4708931|NCT03182452|Intensive Care|intensive care
4708932|NCT03182439|WEARABLE HEART RATE MONITORS, ACCURACY|wearable heart rate monitors, accuracy
4708933|NCT03182413|modafinil|modafinil
4708934|NCT03182413|connexin|connexin
4708935|NCT03182413|sleep deprivation|sleep deprivation
4708936|NCT03182413|cognitive performance|cognitive performance
4708937|NCT03182387|Bronchoalveolar lavage|bronchoalveolar lavage
4708938|NCT03182387|amylase assay|amylase assay
4708939|NCT03182387|aspiration pneumonia|aspiration pneumonia
4708940|NCT03182374|Autologous Protein Solution (APS)|autologous protein solution (aps)
4708941|NCT03182374|Intra-articular Injection|intra-articular injection
4708942|NCT03182374|Osteoarthritis|osteoarthritis
4708943|NCT03182361|Auricular, nasal, orbital, extraoral prostheses, extraoral implants, peri-implant reactions, Holgers|auricular, nasal, orbital, extraoral prostheses, extraoral implants, peri-implant reactions, holgers
4708944|NCT03182348|Microvessels|microvessels
4708945|NCT03182348|Cardiovascular disease|cardiovascular disease
4708946|NCT03182348|OCT|oct
4708947|NCT03182322|Type 1 diabetes|type 1 diabetes
4708948|NCT03182322|T1D|t1d
4708949|NCT03182322|diabetes mellitus|diabetes mellitus
4708950|NCT03182322|intranasal insulin|intranasal insulin
4708951|NCT03182322|mucosal tolerance|mucosal tolerance
4708952|NCT03182322|autoantigen|autoantigen
4708953|NCT03182322|self tolerance|self tolerance
4708954|NCT03182322|prevention|prevention
4708955|NCT03182322|at risk for developing type 1 diabetes|at risk for developing type 1 diabetes
4708956|NCT03182322|juvenile diabetes|juvenile diabetes
4708957|NCT03182296|beta cell mass|beta cell mass
4708958|NCT03182296|exendin|exendin
4708959|NCT03182296|GLP-1 PET|glp-1 pet
4708960|NCT03182283|Person-centered care|person-centered care
4708961|NCT03182283|Psychosis care|psychosis care
4708962|NCT03182283|Integrated care|integrated care
4708963|NCT03182257|TRK|trk
4708964|NCT03182257|TRKA|trka
4708965|NCT03182257|TRKB|trkb
4708966|NCT03182257|TRKC|trkc
4708967|NCT03182257|NTRK1|ntrk1
4708968|NCT03182257|NTRK2|ntrk2
4708969|NCT03182257|NTRK3|ntrk3
4708970|NCT03182257|NTRK fusion positive|ntrk fusion positive
4708971|NCT03182257|NTRK1 fusion|ntrk1 fusion
4708972|NCT03182257|NTRK2 fusion|ntrk2 fusion
4708973|NCT03182257|NTRK3 fusion|ntrk3 fusion
4708974|NCT03182257|NTRK1 gene rearrangement|ntrk1 gene rearrangement
4708975|NCT03182257|NTRK2 gene rearrangement|ntrk2 gene rearrangement
4708976|NCT03182257|NTRK3 gene fusion|ntrk3 gene fusion
4708977|NCT03182257|ETV6-NTRK3|etv6-ntrk3
4708978|NCT03182257|fusion|fusion
4708979|NCT03182257|tumors|tumors
4708980|NCT03182257|solid tumors|solid tumors
4708981|NCT03182257|CNS tumors|cns tumors
4708982|NCT03182257|central nervous system tumors|central nervous system tumors
4708983|NCT03182257|TRK fusion|trk fusion
4708984|NCT03182257|ETV6|etv6
4708985|NCT03182257|ETV6 fusion|etv6 fusion
4708986|NCT03182257|solid CNS tumor|solid cns tumor
4708987|NCT03182257|advanced CNS tumor|advanced cns tumor
4708988|NCT03182257|primary CNS tumor|primary cns tumor
4708989|NCT03182244|gilteritinib|gilteritinib
4708990|NCT03182244|Acute Myeloid Leukemia (AML)|acute myeloid leukemia (aml)
4708991|NCT03182244|ASP2215|asp2215
4708992|NCT03182231|exendin|exendin
4708993|NCT03182231|GLP1|glp1
4708994|NCT03182231|beta cell mass|beta cell mass
4708995|NCT03182218|Periprocedural|periprocedural
4708996|NCT03182218|Anticoagulation|anticoagulation
4708997|NCT03182218|Dabigatran|dabigatran
4708998|NCT03182218|Rivaroxaban|rivaroxaban
4708999|NCT03182218|Apixaban|apixaban
4709000|NCT03182218|Edoxaban|edoxaban
4709001|NCT03182218|Direct oral anticoagulant|direct oral anticoagulant
4709002|NCT03182218|Surgery|surgery
4709003|NCT03182218|Anaesthesia|anaesthesia
4709004|NCT03182218|Novel oral anticoagulant|novel oral anticoagulant
4709005|NCT03182218|Perioperative medicine|perioperative medicine
4709006|NCT03182205|Breathing Exercises|breathing exercises
4709007|NCT03182205|Autonomic Nervous System|autonomic nervous system
4709008|NCT03182205|Hemodynamics|hemodynamics
4709009|NCT03182192|Betal cells|betal cells
4709010|NCT03182192|Roux- and Y gastic bypass|roux- and y gastic bypass
4709011|NCT03182192|exendin|exendin
4709012|NCT03182192|GLP1|glp1
4709013|NCT03182166|golimumab|golimumab
4709014|NCT03182166|clinical response|clinical response
4709015|NCT03182166|mayo score|mayo score
4709016|NCT03182166|rectosigmoidoscopy|rectosigmoidoscopy
4709017|NCT03182166|ulcerative colitis|ulcerative colitis
4709018|NCT03182140|long-acting contraception,|long-acting contraception,
4709019|NCT03182140|unintended pregnancy|unintended pregnancy
4709020|NCT03182140|satisfaction|satisfaction
4709021|NCT03182140|bleeding profile|bleeding profile
4709022|NCT03182140|amenorrhea|amenorrhea
4709023|NCT03182075|Obsessive-Compulsive Disorder|obsessive-compulsive disorder
4709024|NCT03182075|OCD|ocd
4709025|NCT03182075|Obsessive Personality Disorder|obsessive personality disorder
4709026|NCT03182075|Compulsive Behavior|compulsive behavior
4709027|NCT03182075|Personality Disorders|personality disorders
4709028|NCT03182075|Mental Disorders|mental disorders
4709029|NCT03182075|Anxiety Disorders|anxiety disorders
4709030|NCT03182075|Impulsive Behavior|impulsive behavior
4709031|NCT03182075|Cognition|cognition
4709032|NCT03182075|Emotion|emotion
4709033|NCT03182075|Emotional Regulation|emotional regulation
4709034|NCT03182062|one lung ventilation|one lung ventilation
4709035|NCT03182062|postoperative pulmonary complication|postoperative pulmonary complication
4709036|NCT03182062|perioperative lung protective ventilation|perioperative lung protective ventilation
4709037|NCT03182049|GPA|gpa
4709038|NCT03182049|Granulomatosis with polyangiitis|granulomatosis with polyangiitis
4709039|NCT03182049|Wegener's granulomatosis|wegener's granulomatosis
4709040|NCT03182049|Subglottic Stenosis|subglottic stenosis
4709041|NCT03182049|Bronchial Stenosis|bronchial stenosis
4709042|NCT03182023|outcome,ECMO,Respiratory Failure,Circulatory Failure|outcome,ecmo,respiratory failure,circulatory failure
4709043|NCT03182010|Cesarean section scar, Barbed suture, Conventional suture|cesarean section scar, barbed suture, conventional suture
4709044|NCT03181997|Aortic Valve Stenosis|aortic valve stenosis
4709045|NCT03181997|Transcatheter Aortic Valve Implantation|transcatheter aortic valve implantation
4709046|NCT03181997|Cancer|cancer
4709047|NCT03181997|Malignancy|malignancy
4709048|NCT03181971|water|water
4709049|NCT03181971|sugar-sweetened beverages|sugar-sweetened beverages
4709050|NCT03181971|schools|schools
4709150|NCT03181334|neoplasm|neoplasm
4709051|NCT03181958|nasal high frequency oscillation ventilation(NHFOV)|nasal high frequency oscillation ventilation(nhfov)
4709052|NCT03181958|nasal continuous positive airway pressure(NCPAP)|nasal continuous positive airway pressure(ncpap)
4709053|NCT03181958|nasal intermittent positive pressure ventilation（NIPPV）|nasal intermittent positive pressure ventilation（nippv）
4709054|NCT03181958|neonatal respiratory distress syndrome(NRDS)|neonatal respiratory distress syndrome(nrds)
4709055|NCT03181958|preterm infants|preterm infants
4709056|NCT03181906|medication discrepancy|medication discrepancy
4709057|NCT03181906|primary care|primary care
4709058|NCT03181906|transition of care|transition of care
4709060|NCT03181880|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
4709061|NCT03181880|Randomised|randomised
4709062|NCT03181880|Pragmatic|pragmatic
4709063|NCT03181880|Standard of Care|standard of care
4709064|NCT03181880|Aclidinium bromide/formoterol fumarate fixed-dose combination|aclidinium bromide/formoterol fumarate fixed-dose combination
4709065|NCT03181880|Duaklir|duaklir
4709066|NCT03181880|Genuair|genuair
4709067|NCT03181867|PET/ CT|pet/ ct
4709068|NCT03181867|Endorectal MRI|endorectal mri
4709069|NCT03181867|Imaging|imaging
4709070|NCT03181867|PSMA|psma
4709071|NCT03181867|Prostate Cancer Relapse|prostate cancer relapse
4709072|NCT03181854|Integrated Early Palliative Care|integrated early palliative care
4709073|NCT03181828|CPSI deficiency|cpsi deficiency
4709074|NCT03181828|OTC Deficiency|otc deficiency
4709075|NCT03181828|AS Deficiency|as deficiency
4709076|NCT03181828|AL Deficiency|al deficiency
4709077|NCT03181815|CLADRIBINE|cladribine
4709078|NCT03181815|ACUTE MYELOID LEUKEMIA|acute myeloid leukemia
4709079|NCT03181789|HIV vaccine|hiv vaccine
4709080|NCT03181789|DNA vaccine|dna vaccine
4709081|NCT03181789|IL-12|il-12
4709082|NCT03181789|Electroporation|electroporation
4709083|NCT03181789|p24|p24
4709084|NCT03181789|Gag|gag
4709085|NCT03181789|Adjuvant|adjuvant
4709086|NCT03181789|Healthy|healthy
4709087|NCT03181763|MDMA|mdma
4709088|NCT03181763|Startle response|startle response
4709089|NCT03181763|sleep|sleep
4709090|NCT03181750|Palliative Care|palliative care
4709091|NCT03181750|Latino|latino
4709092|NCT03181750|Patient Navigation|patient navigation
4709093|NCT03181737|diabetes mellitus typ 2, adherence, psychological online-intervention, randomized controlled study|diabetes mellitus typ 2, adherence, psychological online-intervention, randomized controlled study
4709094|NCT03181711|Dental caries|dental caries
4709095|NCT03181711|Tooth, deciduous|tooth, deciduous
4709096|NCT03181711|Children|children
4709097|NCT03181711|Radiography/bitewing|radiography/bitewing
4709098|NCT03181711|diagnostic imaging|diagnostic imaging
4709099|NCT03181685|Progesterone supplementation|progesterone supplementation
4709100|NCT03181685|IVF|ivf
4709101|NCT03181685|Preference expressed by the patient|preference expressed by the patient
4709102|NCT03181672|Stellate ganglion block Tourniquet reaction|stellate ganglion block tourniquet reaction
4709103|NCT03181659|Musculoskeletal Manipulations|musculoskeletal manipulations
4709104|NCT03181659|Exercise|exercise
4709105|NCT03181659|Patient Education|patient education
4709106|NCT03181659|Low back pain|low back pain
4709107|NCT03181633|PNH|pnh
4709108|NCT03181633|Paroxysmal|paroxysmal
4709109|NCT03181633|Hemoglobinuria|hemoglobinuria
4709110|NCT03181633|ACH-0144471|ach-0144471
4709111|NCT03181581|ultrasonography|ultrasonography
4709112|NCT03181581|ultrasonics|ultrasonics
4709113|NCT03181581|brain|brain
4709114|NCT03181581|surgery|surgery
4709115|NCT03181555|Pregnant|pregnant
4709116|NCT03181555|Obese|obese
4709117|NCT03181555|Omic|omic
4709118|NCT03181490|Pulmonary Nodule|pulmonary nodule
4709119|NCT03181490|Solitary|solitary
4709120|NCT03181477|Phase II|phase ii
4709121|NCT03181477|Radiotherapy with SIB-IMRT|radiotherapy with sib-imrt
4709122|NCT03181477|Tomozolomide|tomozolomide
4709123|NCT03181438|Renal Transplantation|renal transplantation
4709124|NCT03181438|Acute pain|acute pain
4709125|NCT03181438|Regional Anesthesia|regional anesthesia
4709126|NCT03181438|TAP Block|tap block
4709127|NCT03181425|Knee cartilage|knee cartilage
4709128|NCT03181425|Early Osteoarthritis|early osteoarthritis
4709129|NCT03181425|MRI tractography|mri tractography
4709130|NCT03181425|Diffusion Tensor Imaging|diffusion tensor imaging
4709131|NCT03181386|Dabigatran|dabigatran
4709132|NCT03181386|Rivaroxaban|rivaroxaban
4709133|NCT03181386|Apixaban|apixaban
4709134|NCT03181386|Warfarin|warfarin
4709135|NCT03181386|Tooth Extraction|tooth extraction
4709136|NCT03181373|Craniocerebral injury|craniocerebral injury
4709137|NCT03181373|Mild and severe brain traumatic injury|mild and severe brain traumatic injury
4709138|NCT03181373|Neuropsychological abilities|neuropsychological abilities
4709139|NCT03181373|Clinical assessment|clinical assessment
4709140|NCT03181373|Anatomical and functional imaging|anatomical and functional imaging
4709141|NCT03181360|ischemic stroke|ischemic stroke
4709142|NCT03181360|wake-up|wake-up
4709143|NCT03181360|thrombolysis|thrombolysis
4709144|NCT03181360|tenecteplase|tenecteplase
4709145|NCT03181360|computed tomography|computed tomography
4709146|NCT03181347|Bariatrics|bariatrics
4709147|NCT03181347|Microbiology|microbiology
4709148|NCT03181334|colorectal|colorectal
4709149|NCT03181334|cancer|cancer
4709151|NCT03181334|CRC screening|crc screening
4709152|NCT03181334|FIT|fit
4709153|NCT03181334|Fecal Immunochemical Test|fecal immunochemical test
4709154|NCT03181321|nutrition|nutrition
4709155|NCT03181321|fitness|fitness
4709156|NCT03181321|cardiovascular disease|cardiovascular disease
4709157|NCT03181321|firefighters|firefighters
4709158|NCT03181321|obesity|obesity
4709159|NCT03181321|injury|injury
4709160|NCT03181295|Family Medicine|family medicine
4709161|NCT03181295|Primary Care|primary care
4709162|NCT03181295|Exercise prescriptions|exercise prescriptions
4709163|NCT03181295|Technology|technology
4709164|NCT03181282|Deep brain stimulation|deep brain stimulation
4709165|NCT03181282|Balance|balance
4709166|NCT03181282|Gait|gait
4709167|NCT03181282|Physical Therapy|physical therapy
4709168|NCT03181282|Parkinson disease|parkinson disease
4709169|NCT03181230|Turner syndrome|turner syndrome
4709170|NCT03181230|45,XO|45,xo
4709171|NCT03181230|body composition|body composition
4709172|NCT03181230|cardiometabolism|cardiometabolism
4709173|NCT03181230|quality of life|quality of life
4709174|NCT03181230|fitness|fitness
4709175|NCT03181178|Complementary food supplement|complementary food supplement
4709176|NCT03181178|Protein quality and linear growth|protein quality and linear growth
4709177|NCT03181178|Intervention targeting complementary foods and growth|intervention targeting complementary foods and growth
4709178|NCT03181165|Low-carbohydrate|low-carbohydrate
4709179|NCT03181165|Low calorie|low calorie
4709180|NCT03181165|Energy restricted|energy restricted
4709181|NCT03181139|Enhanced Recovery after Surgery (ERAS)|enhanced recovery after surgery (eras)
4709182|NCT03181139|Fast-track surgery|fast-track surgery
4709183|NCT03181139|Pec Blocks|pec blocks
4709184|NCT03181139|Mastectomy|mastectomy
4709185|NCT03181126|Relapsed of Refractory Acute Lymphoblastic Leukemia|relapsed of refractory acute lymphoblastic leukemia
4709186|NCT03181126|Cancer|cancer
4709187|NCT03181126|Venetoclax|venetoclax
4709188|NCT03181126|Navitoclax|navitoclax
4709189|NCT03181113|peginterferon alpha|peginterferon alpha
4709190|NCT03181113|HBeAg seroconversion|hbeag seroconversion
4709191|NCT03181113|immune control|immune control
4709192|NCT03181100|Malignant neoplasms of thyroid and other endocrine glands|malignant neoplasms of thyroid and other endocrine glands
4709193|NCT03181100|Anaplastic thyroid carcinoma|anaplastic thyroid carcinoma
4709194|NCT03181100|ATC|atc
4709195|NCT03181100|Poorly differentiated thyroid cancer|poorly differentiated thyroid cancer
4709196|NCT03181100|PDTC|pdtc
4709197|NCT03181100|Nab-paclitaxel|nab-paclitaxel
4709198|NCT03181100|Paclitaxel (protein bound)|paclitaxel (protein bound)
4709199|NCT03181100|Abraxane|abraxane
4709200|NCT03181100|ABI-007|abi-007
4709201|NCT03181100|Paclitaxel|paclitaxel
4709202|NCT03181100|Taxol|taxol
4709203|NCT03181100|Vemurafenib|vemurafenib
4709204|NCT03181100|PLX4032|plx4032
4709205|NCT03181100|R05185426|r05185426
4709206|NCT03181100|Cobimetinib|cobimetinib
4709207|NCT03181100|Atezolizumab|atezolizumab
4709208|NCT03181100|MPDL3280A|mpdl3280a
4709209|NCT03181100|Bevacizumab|bevacizumab
4709210|NCT03181100|Avastin|avastin
4709211|NCT03181100|Anti-VEGF monoclonal antibody|anti-vegf monoclonal antibody
4709212|NCT03181100|rhuMAb-VEGF|rhumab-vegf
4709213|NCT03181100|BRAF|braf
4709214|NCT03181100|BRAF inhibitor|braf inhibitor
4709215|NCT03181100|MEK|mek
4709216|NCT03181100|MEK inhibitor|mek inhibitor
4709217|NCT03181100|Immunotherapy|immunotherapy
4709218|NCT03181100|Targeted therapy|targeted therapy
4709219|NCT03181087|Mesenchymal Stem Cells|mesenchymal stem cells
4709220|NCT03181087|Cesarean Section|cesarean section
4709221|NCT03181087|Uterine Scar|uterine scar
4709222|NCT03181035|Oral Tongue Cancer|oral tongue cancer
4709223|NCT03181035|Tumor Hypoxia|tumor hypoxia
4709224|NCT03181022|Patient-Provider Communication|patient-provider communication
4709225|NCT03181022|Motivational Interviewing|motivational interviewing
4709226|NCT03181022|Medication Adherence|medication adherence
4709227|NCT03181009|Oral Immunotherapy|oral immunotherapy
4709228|NCT03181009|Omalizumab|omalizumab
4709229|NCT03181009|OIT|oit
4709230|NCT03181009|Xolair|xolair
4709231|NCT03180996|FEVAR|fevar
4709232|NCT03180996|Fenestrated|fenestrated
4709233|NCT03180996|Endovascular|endovascular
4709234|NCT03180996|AAA|aaa
4709235|NCT03180996|Custom device|custom device
4709236|NCT03180957|Dupuytren|dupuytren
4709237|NCT03180957|adalimumab|adalimumab
4709238|NCT03180957|anti TNF|anti tnf
4709239|NCT03180957|phase II clinical trial|phase ii clinical trial
4709240|NCT03180957|randomized controlled trial|randomized controlled trial
4709241|NCT03180957|double-blind method|double-blind method
4709242|NCT03180957|Dupuytren's|dupuytren's
4709243|NCT03180957|Dupuytren's contracture|dupuytren's contracture
4709244|NCT03180892|Iodine|iodine
4709245|NCT03180892|thyroid peroxidase antibody|thyroid peroxidase antibody
4709246|NCT03180840|Enzyme-Replacement Therapy|enzyme-replacement therapy
4709247|NCT03180840|pegunigalsidase alfa|pegunigalsidase alfa
4709248|NCT03180840|Fabry Disease|fabry disease
4709249|NCT03180801|broad|broad
4709250|NCT03180801|universal|universal
4709251|NCT03180801|vaccine|vaccine
4709252|NCT03180801|influenza|influenza
4709253|NCT03180801|peptide|peptide
4709254|NCT03180801|T cell|t cell
4709255|NCT03180801|H1N1|h1n1
4709256|NCT03180801|human challenge|human challenge
4709257|NCT03180788|ESD|esd
4709258|NCT03180788|Traction assisted ESD|traction assisted esd
4709259|NCT03180788|Polypectomy|polypectomy
4709260|NCT03180788|Clip and thread ESD|clip and thread esd
4709261|NCT03180775|Amino acids|amino acids
4709262|NCT03180775|Macrophage atherogenicity|macrophage atherogenicity
4709263|NCT03180775|Triglycerides|triglycerides
4709264|NCT03180775|Cholesterol|cholesterol
4709265|NCT03180775|Lipoproteins|lipoproteins
4709266|NCT03180697|Amide Proton Transfer|amide proton transfer
4709267|NCT03180697|bevacizumab|bevacizumab
4709268|NCT03180697|recurrent malignant gliomas|recurrent malignant gliomas
4709269|NCT03180697|efficacy|efficacy
4709270|NCT03180684|HPV-16|hpv-16
4709271|NCT03180684|HPV-18|hpv-18
4709272|NCT03180671|anterior deprogrammer|anterior deprogrammer
4709273|NCT03180671|muscle pain|muscle pain
4709274|NCT03180671|centric relation|centric relation
4709275|NCT03180606|Elderly|elderly
4709276|NCT03180606|Frail|frail
4709277|NCT03180606|Primary care|primary care
4709278|NCT03180580|Childhood, Overweight, Obesity|childhood, overweight, obesity
4709279|NCT03180554|Vagal nerve stimulation|vagal nerve stimulation
4709280|NCT03180554|diaphragmatic breathing|diaphragmatic breathing
4709281|NCT03180554|chronic widespread pain|chronic widespread pain
4709282|NCT03180554|parasympathetic nervous system|parasympathetic nervous system
4709283|NCT03180554|heart rate variability|heart rate variability
4709284|NCT03180463|Osteonecrosis of Femoral Head|osteonecrosis of femoral head
4709285|NCT03180463|umbilical cord mesenchymal stem cells|umbilical cord mesenchymal stem cells
4709286|NCT03180450|Heart Failure|heart failure
4709287|NCT03180450|Human Umbilical Cord Mesenchymal Stem Cells|human umbilical cord mesenchymal stem cells
4709288|NCT03180437|Immunotherapy|immunotherapy
4709289|NCT03180437|γδ T Cell|γδ t cell
4709290|NCT03180437|Pancreatic Cancer|pancreatic cancer
4709291|NCT03180424|carnitine|carnitine
4709292|NCT03180424|elderly|elderly
4709293|NCT03180424|functional status|functional status
4709294|NCT03180411|Colorectal Cancer|colorectal cancer
4709295|NCT03180411|CRC|crc
4709296|NCT03180411|Colorectal cancer surveillance|colorectal cancer surveillance
4709297|NCT03180411|Decision support tool|decision support tool
4709298|NCT03180411|Interviews|interviews
4709299|NCT03180411|Questionnaire|questionnaire
4709300|NCT03180411|Survey|survey
4709301|NCT03180385|NAVA|nava
4709302|NCT03180385|BiPAP|bipap
4709303|NCT03180385|Pediatrics|pediatrics
4709304|NCT03180385|Cardiac Surgery|cardiac surgery
4709305|NCT03180359|solid transplant|solid transplant
4709306|NCT03180359|grafted children|grafted children
4709307|NCT03180359|vaccine recommendation|vaccine recommendation
4709308|NCT03180359|immunization efficacy|immunization efficacy
4709309|NCT03180359|solid grafted children|solid grafted children
4709433|NCT03179436|PD1|pd1
4709310|NCT03180359|solid transplant candidate children|solid transplant candidate children
4709311|NCT03180333|Chronic Hepatitis B|chronic hepatitis b
4709312|NCT03180320|chronic heart failure|chronic heart failure
4709313|NCT03180320|exercise-based cardiac rehabilitation|exercise-based cardiac rehabilitation
4709314|NCT03180320|Baduanjin|baduanjin
4709315|NCT03180203|INTELLiVENT-ASV|intellivent-asv
4709316|NCT03180203|Fully closed-loop ventilation|fully closed-loop ventilation
4709317|NCT03180203|Wean|wean
4709318|NCT03180177|Hyperthermic Intraperitoneal Chemotherapy|hyperthermic intraperitoneal chemotherapy
4709319|NCT03180177|Neoadjuvant Chemotherapy|neoadjuvant chemotherapy
4709320|NCT03180177|Interval Debulking Surgery|interval debulking surgery
4709321|NCT03180177|Advanced-Stage Epithelial Ovarian Cancer|advanced-stage epithelial ovarian cancer
4709322|NCT03180177|Postoperative Chemotherapy|postoperative chemotherapy
4709323|NCT03180151|corticotomy|corticotomy
4709324|NCT03180151|enmass retraction|enmass retraction
4709325|NCT03180151|mini implant|mini implant
4709326|NCT03180138|mobile phone|mobile phone
4709327|NCT03180138|Children's Health|children's health
4709328|NCT03180125|hydrodissection|hydrodissection
4709329|NCT03180125|sodium hyaluorinate|sodium hyaluorinate
4709330|NCT03180099|Lumbar Disk Hernia|lumbar disk hernia
4709331|NCT03180099|Thoracolumbar Interfascial Plane Block|thoracolumbar interfascial plane block
4709332|NCT03180099|Lumbar Disk Surgery|lumbar disk surgery
4709333|NCT03180086|Breast cancer risk|breast cancer risk
4709334|NCT03180086|Primary Care|primary care
4709335|NCT03180086|Women|women
4709336|NCT03180060|Likelihood Ratio|likelihood ratio
4709337|NCT03180060|Cardiovascular Magnetic Resonance|cardiovascular magnetic resonance
4709338|NCT03180060|CMR|cmr
4709339|NCT03180060|Myocardial Perfusion|myocardial perfusion
4709340|NCT03180060|Predictive Values|predictive values
4709341|NCT03180060|Computed Tomography Perfusion|computed tomography perfusion
4709342|NCT03180060|CTP|ctp
4709343|NCT03180060|SPECT|spect
4709344|NCT03180060|PET|pet
4709345|NCT03180060|Diagnostic Accuracy|diagnostic accuracy
4709346|NCT03180060|Quantitative Coronary Angiography|quantitative coronary angiography
4709347|NCT03180060|Area Under the Curve|area under the curve
4709348|NCT03180060|ROC Curve|roc curve
4709349|NCT03180034|Human Papillomavirus|human papillomavirus
4709350|NCT03180034|Cervical Cancer|cervical cancer
4709351|NCT03180034|Costa Rica|costa rica
4709352|NCT03180034|Fewer Doses|fewer doses
4709353|NCT03180034|HPV-Associated Cancers|hpv-associated cancers
4709354|NCT03179995|Octreotide, Major Liver Resection|octreotide, major liver resection
4709355|NCT03179943|bladder cancer|bladder cancer
4709356|NCT03179943|Ureteral Cancer|ureteral cancer
4709357|NCT03179943|Urothelial cancer|urothelial cancer
4709358|NCT03179943|Urethral cancer|urethral cancer
4709359|NCT03179930|Entinostat|entinostat
4709360|NCT03179930|Pembrolizumab|pembrolizumab
4709361|NCT03179930|17-073|17-073
4709362|NCT03179917|Pembrolizumab|pembrolizumab
4709363|NCT03179917|Radiation Therapy|radiation therapy
4709364|NCT03179917|17-054|17-054
4709365|NCT03179891|Interictal Period A|interictal period a
4709366|NCT03179891|Icta/peri-ictal Period B|icta/peri-ictal period b
4709367|NCT03179839|Mindfulness-Based Cognitive Therapy|mindfulness-based cognitive therapy
4709368|NCT03179813|hydrocortisone|hydrocortisone
4709369|NCT03179813|third molar|third molar
4709370|NCT03179813|oral surgery|oral surgery
4709371|NCT03179813|postoperative pain|postoperative pain
4709372|NCT03179813|edema|edema
4709373|NCT03179800|Hypertension|hypertension
4709374|NCT03179800|Resistant Hypertension|resistant hypertension
4709375|NCT03179800|Baroreceptor|baroreceptor
4709376|NCT03179800|BAT|bat
4709377|NCT03179722|Aging|aging
4709378|NCT03179722|Drug-related problems|drug-related problems
4709379|NCT03179722|Medication review|medication review
4709380|NCT03179722|Community pharmacist|community pharmacist
4709381|NCT03179722|Medication use|medication use
4709382|NCT03179709|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
4709383|NCT03179709|Neuromuscular Blockade|neuromuscular blockade
4709384|NCT03179709|Interviews|interviews
4709385|NCT03179709|Implementation Science|implementation science
4709386|NCT03179696|Schizophrenia|schizophrenia
4709387|NCT03179696|CBSST|cbsst
4709388|NCT03179696|mobile CBT|mobile cbt
4709389|NCT03179696|negative symptoms|negative symptoms
4709390|NCT03179683|aluminum step-wedge|aluminum step-wedge
4709391|NCT03179683|demineralized bone matrix|demineralized bone matrix
4709392|NCT03179683|dental implant|dental implant
4709393|NCT03179683|digital densitometry|digital densitometry
4709394|NCT03179683|low level laser therapy|low level laser therapy
4709395|NCT03179683|maxillary sinus augmentation.|maxillary sinus augmentation.
4709396|NCT03179657|Prospective Cohort study|prospective cohort study
4709397|NCT03179657|Nutrition|nutrition
4709398|NCT03179657|Diet|diet
4709399|NCT03179657|Guangzhou|guangzhou
4709400|NCT03179657|Chinese|chinese
4709401|NCT03179631|Duchenne Muscular Dystrophy|duchenne muscular dystrophy
4709402|NCT03179631|Dystrophinopathy|dystrophinopathy
4709403|NCT03179631|Nonsense Mutation|nonsense mutation
4709404|NCT03179631|Premature Stop Codon|premature stop codon
4709405|NCT03179631|Becker Muscular Dystrophy|becker muscular dystrophy
4709406|NCT03179631|DMD/BMD|dmd/bmd
4709407|NCT03179631|PTC124|ptc124
4709408|NCT03179631|Ataluren|ataluren
4709409|NCT03179618|Unstable Angina|unstable angina
4709410|NCT03179618|Xuefu Zhuyu Decoction|xuefu zhuyu decoction
4709411|NCT03179592|Computed Tomography|computed tomography
4709412|NCT03179579|Gastric Cancer|gastric cancer
4709413|NCT03179579|Peritoneal Carcinomatosis|peritoneal carcinomatosis
4709414|NCT03179579|Hyperthermic Intraperitoneal Chemotherapy|hyperthermic intraperitoneal chemotherapy
4709415|NCT03179579|Systemic Chemotherapy|systemic chemotherapy
4709416|NCT03179579|Cytoreductive Surgery|cytoreductive surgery
4709417|NCT03179566|drug disposal|drug disposal
4709418|NCT03179540|Low Rectal Cancer|low rectal cancer
4709419|NCT03179540|Complete Clinical Response|complete clinical response
4709420|NCT03179540|Non-operative Management|non-operative management
4709421|NCT03179527|Unstable Angina|unstable angina
4709422|NCT03179527|Shuanghe Decoction|shuanghe decoction
4709423|NCT03179514|Unstable Angina|unstable angina
4709424|NCT03179514|Gualou Xiebai Banxia Decoction|gualou xiebai banxia decoction
4709425|NCT03179514|Danshen Decoction|danshen decoction
4709426|NCT03179475|Spinal Cord Injury|spinal cord injury
4709427|NCT03179475|Traumatic Spinal Cord Injury|traumatic spinal cord injury
4709428|NCT03179475|Targin®|targin®
4709429|NCT03179475|Opioids|opioids
4709430|NCT03179475|Naloxone|naloxone
4709431|NCT03179475|Opioid Induced Constipation|opioid induced constipation
4709432|NCT03179475|Oxycodone-Naloxone|oxycodone-naloxone
4709434|NCT03179436|PD-1|pd-1
4709435|NCT03179436|PDL1|pdl1
4709436|NCT03179436|PD-L1|pd-l1
4709437|NCT03179423|Diabetes Mellitus, Type 1|diabetes mellitus, type 1
4709438|NCT03179423|T1D|t1d
4709439|NCT03179423|Monoclonal antibody|monoclonal antibody
4709440|NCT03179423|Multiple Sclerosis associated retrovirus MSRV|multiple sclerosis associated retrovirus msrv
4709441|NCT03179423|Human Endogenous Retrovirus Type W (HERV-W)|human endogenous retrovirus type w (herv-w)
4709442|NCT03179423|GNbAC1|gnbac1
4709443|NCT03179410|metastatic castrate-resistant prostate cancer (mCRPC)|metastatic castrate-resistant prostate cancer (mcrpc)
4709444|NCT03179410|neuroendocrine prostate cancer (NEPC)|neuroendocrine prostate cancer (nepc)
4709445|NCT03179345|Volunteer|volunteer
4709446|NCT03179345|Pharmacodynamics|pharmacodynamics
4709447|NCT03179345|Pharmacokinetics|pharmacokinetics
4709448|NCT03179319|PrEP|prep
4709449|NCT03179319|HIV testing|hiv testing
4709552|NCT03178669|DIMS0150|dims0150
4709450|NCT03179319|Sexually transmitted disease (STD) testing|sexually transmitted disease (std) testing
4709451|NCT03179319|Mobile app|mobile app
4709452|NCT03179319|Young men who have sex with men|young men who have sex with men
4709453|NCT03179319|Technology|technology
4709454|NCT03179306|Cervix|cervix
4709455|NCT03179306|HPV|hpv
4709456|NCT03179306|Imaging|imaging
4709457|NCT03179306|Costa Rica|costa rica
4709458|NCT03179280|Type 1 diabetes|type 1 diabetes
4709459|NCT03179280|Dual-wave bolus|dual-wave bolus
4709460|NCT03179280|Postprandial euglycaemia|postprandial euglycaemia
4709461|NCT03179267|vital signs|vital signs
4709462|NCT03179267|monitoring|monitoring
4709463|NCT03179267|early warning score|early warning score
4709464|NCT03179202|Electrical Stimulation|electrical stimulation
4709465|NCT03179202|Neurostimulation|neurostimulation
4709466|NCT03179202|Neuromodulation|neuromodulation
4709467|NCT03179202|Back Pain|back pain
4709468|NCT03179202|Low Back Pain|low back pain
4709469|NCT03179163|Hypertension|hypertension
4709470|NCT03179163|Blood Pressure|blood pressure
4709471|NCT03179163|Cardiovascular Disease|cardiovascular disease
4709472|NCT03179163|ACE Inhibitor|ace inhibitor
4709473|NCT03179163|Diuretic|diuretic
4709474|NCT03179163|Nitric Oxide|nitric oxide
4709475|NCT03179163|Hydrogen Sulfide|hydrogen sulfide
4709476|NCT03179163|Captopril|captopril
4709477|NCT03179163|Enalapril|enalapril
4709478|NCT03179163|Hydrochlorothiazide|hydrochlorothiazide
4709479|NCT03179163|Microcirculation|microcirculation
4709480|NCT03179163|Skin|skin
4709481|NCT03179150|computer-aided diagnosis|computer-aided diagnosis
4709482|NCT03179150|Web|web
4709483|NCT03179150|Cloud computing|cloud computing
4709484|NCT03179150|lung cancer|lung cancer
4709485|NCT03179124|cerebral palsy|cerebral palsy
4709486|NCT03179124|trunk control|trunk control
4709487|NCT03179124|upper extremity|upper extremity
4709488|NCT03179098|Elbow|elbow
4709489|NCT03179098|Stretching|stretching
4709490|NCT03179098|Joint amplitude|joint amplitude
4709491|NCT03179098|Electromyography|electromyography
4709492|NCT03179098|Surface heat|surface heat
4709493|NCT03179098|Orthosis|orthosis
4709494|NCT03179098|Posttraumatic|posttraumatic
4709495|NCT03179085|Diabetes|diabetes
4709496|NCT03179085|American Indians|american indians
4709497|NCT03179085|Disparity|disparity
4709498|NCT03179085|microalbuminuria|microalbuminuria
4709499|NCT03179085|Telemedicine|telemedicine
4709500|NCT03179085|Community health representative (CHR)|community health representative (chr)
4709501|NCT03179085|Patient Activation Measure (PAM)|patient activation measure (pam)
4709502|NCT03179085|Home base kidney care|home base kidney care
4709503|NCT03179059|Reproductive Health|reproductive health
4709504|NCT03179059|Family Planning|family planning
4709505|NCT03179059|Randomization Trial|randomization trial
4709506|NCT03179059|Uganda|uganda
4709507|NCT03179033|LVAD|lvad
4709508|NCT03179033|Passive leg raising|passive leg raising
4709509|NCT03179020|Intensive Care Units|intensive care units
4709510|NCT03179020|Brain Death|brain death
4709511|NCT03179020|Organ Donation|organ donation
4709512|NCT03179020|Family interview|family interview
4709513|NCT03179007|MUC1|muc1
4709514|NCT03179007|CTLA-4|ctla-4
4709515|NCT03179007|PD-1|pd-1
4709516|NCT03179007|chimeric antigen receptor T cells|chimeric antigen receptor t cells
4709517|NCT03179007|solid tumor|solid tumor
4709518|NCT03178994|Post - adolescence acne|post - adolescence acne
4709519|NCT03178994|Topical 2% ketoconazole cream|topical 2% ketoconazole cream
4709520|NCT03178877|IBS, Rome IV criteria, anxiety|ibs, rome iv criteria, anxiety
4709521|NCT03178864|cerebral venous thrombosis|cerebral venous thrombosis
4709522|NCT03178864|anticoagulation|anticoagulation
4709523|NCT03178799|Fractures|fractures
4709524|NCT03178799|Osteoporosis|osteoporosis
4709525|NCT03178799|Care management|care management
4709526|NCT03178799|cost-effeciveness|cost-effeciveness
4709527|NCT03178799|Randomized controlled trial|randomized controlled trial
4709528|NCT03178786|Art Therapy|art therapy
4709529|NCT03178773|mobile health|mobile health
4709530|NCT03178773|social support|social support
4709531|NCT03178773|health disparity|health disparity
4709532|NCT03178773|Latino|latino
4709533|NCT03178760|Optic nerve sheath diameter|optic nerve sheath diameter
4709534|NCT03178760|average optic nerve sheath diameter for healthy children|average optic nerve sheath diameter for healthy children
4709535|NCT03178747|Methylene blue|methylene blue
4709536|NCT03178747|Giemsa|giemsa
4709537|NCT03178747|Tzanck smear|tzanck smear
4709538|NCT03178695|Infertility|infertility
4709539|NCT03178695|Pregnancy|pregnancy
4709540|NCT03178695|Menopause|menopause
4709541|NCT03178695|Perimenopause|perimenopause
4709542|NCT03178695|Premature Ovarian Failure|premature ovarian failure
4709543|NCT03178669|Colitis, Ulcerative|colitis, ulcerative
4709544|NCT03178669|Gastrointestinal Diseases|gastrointestinal diseases
4709545|NCT03178669|Inflammatory Bowel Disease|inflammatory bowel disease
4709546|NCT03178669|Immunomodulator Therapy|immunomodulator therapy
4709547|NCT03178669|Glucocorticoids|glucocorticoids
4709548|NCT03178669|Anti-Inflammatory Agents|anti-inflammatory agents
4709549|NCT03178669|Therapeutic uses|therapeutic uses
4709550|NCT03178669|Kappaproct|kappaproct
4709551|NCT03178669|IDX0150|idx0150
4709553|NCT03178656|sorafenib, operation|sorafenib, operation
4709554|NCT03178578|Fluid therapy|fluid therapy
4709555|NCT03178565|Respiratory Failure|respiratory failure
4709556|NCT03178565|Mechanical Ventilation|mechanical ventilation
4709557|NCT03178565|Mechanical insufflation-exsufflation|mechanical insufflation-exsufflation
4709558|NCT03178565|Airway mucus clearance|airway mucus clearance
4709559|NCT03178539|tonsillectomy|tonsillectomy
4709560|NCT03178539|post operative analgesia|post operative analgesia
4709561|NCT03178539|diklofanic|diklofanic
4709562|NCT03178539|ketorolac|ketorolac
4709563|NCT03178500|clomiphene citrate|clomiphene citrate
4709564|NCT03178500|stair- step|stair- step
4709565|NCT03178500|poly cystic ovary|poly cystic ovary
4709566|NCT03178487|Upadacitinib|upadacitinib
4709567|NCT03178487|ABT-494|abt-494
4709568|NCT03178487|Ankylosing Spondylitis (AS)|ankylosing spondylitis (as)
4709569|NCT03178487|Safety|safety
4709570|NCT03178487|Efficacy|efficacy
4709571|NCT03178474|infant formula|infant formula
4709572|NCT03178474|Clinical trial|clinical trial
4709573|NCT03178474|Chinese infant|chinese infant
4709574|NCT03178474|body growth|body growth
4709575|NCT03178474|gut microbiota|gut microbiota
4709576|NCT03178474|Stool characteristics|stool characteristics
4709577|NCT03178461|Caesarean Section|caesarean section
4709578|NCT03178461|Delivery|delivery
4709579|NCT03178435|risk score|risk score
4709580|NCT03178435|Acute kidney injury|acute kidney injury
4709581|NCT03178435|critical care|critical care
4709582|NCT03178422|tobacco use cessation|tobacco use cessation
4709583|NCT03178422|smoking prevention|smoking prevention
4709584|NCT03178422|NRT|nrt
4709585|NCT03178370|Gastroparesis|gastroparesis
4709586|NCT03178370|Nausea and Vomiting|nausea and vomiting
4709587|NCT03178370|Abdominal Pain|abdominal pain
4709588|NCT03178370|Gastric Emptying|gastric emptying
4709589|NCT03178370|Electrophysiology|electrophysiology
4709590|NCT03178370|Hormones|hormones
4709591|NCT03178370|Inflammation|inflammation
4709592|NCT03178370|Enteric Nervous System|enteric nervous system
4709593|NCT03178370|Autonomic Nervous System|autonomic nervous system
4709594|NCT03178331|Children|children
4709595|NCT03178331|Student|student
4709596|NCT03178331|Questionnaires|questionnaires
4709597|NCT03178331|Screening|screening
4709598|NCT03178331|Health check|health check
4709599|NCT03178331|School health services|school health services
4709600|NCT03178279|physical health|physical health
4709601|NCT03178201|Relapsed follicular lymphoma|relapsed follicular lymphoma
4709602|NCT03178201|Refractory follicular lymphoma|refractory follicular lymphoma
4709603|NCT03178188|lupus erythematosus, Discoid|lupus erythematosus, discoid
4709604|NCT03178188|Pulsed-dye Laser|pulsed-dye laser
4709605|NCT03178175|Scalp acupuncture|scalp acupuncture
4709606|NCT03178175|Parkinson's disease|parkinson's disease
4709607|NCT03178175|Balance|balance
4709608|NCT03178162|limitation in conventional monitoring|limitation in conventional monitoring
4709609|NCT03178149|Age-related Macular Degeneration|age-related macular degeneration
4709610|NCT03178149|ASP7317|asp7317
4709611|NCT03178136|HR-HPV opportunistic screening|hr-hpv opportunistic screening
4709612|NCT03178136|virus load|virus load
4709613|NCT03178136|multi-site|multi-site
4709614|NCT03178123|anti-PD-1 monoclonal antibody|anti-pd-1 monoclonal antibody
4709615|NCT03178123|Mucosal Melanoma|mucosal melanoma
4709616|NCT03178123|Interferons|interferons
4709617|NCT03178110|physical therapy|physical therapy
4709618|NCT03178110|cancer rehabilitation|cancer rehabilitation
4709619|NCT03178097|limitation in conventional monitoring|limitation in conventional monitoring
4709620|NCT03178084|HIV|hiv
4709621|NCT03178084|CD4/CD8 ratio|cd4/cd8 ratio
4709622|NCT03178084|immune recovery|immune recovery
4709623|NCT03178084|maraviroc|maraviroc
4709624|NCT03178084|efavirenz|efavirenz
4709625|NCT03178071|NSCLC|nsclc
4709626|NCT03178032|Diffuse intrinsic pontine gliomas|diffuse intrinsic pontine gliomas
4709627|NCT03178032|Oncolytic adenovirus|oncolytic adenovirus
4709628|NCT03177980|Term infants|term infants
4709629|NCT03177980|Analgesia|analgesia
4709630|NCT03177980|fentanyl|fentanyl
4709631|NCT03177980|clonidine|clonidine
4709632|NCT03177980|pharmacokinetics|pharmacokinetics
4709633|NCT03177980|sedation|sedation
4709634|NCT03177980|pharmacodynamics|pharmacodynamics
4709635|NCT03177980|neurophysiology|neurophysiology
4709636|NCT03177980|pharmacogenetics|pharmacogenetics
4709637|NCT03177980|asphyxia|asphyxia
4709638|NCT03177980|hypothermia|hypothermia
4709639|NCT03177967|Insomnia|insomnia
4709640|NCT03177967|Cognitive behavioral treatment for insomnia (CBT-I)|cognitive behavioral treatment for insomnia (cbt-i)
4709641|NCT03177941|Melanoma|melanoma
4709642|NCT03177941|Skin Self-Examination|skin self-examination
4709643|NCT03177941|First-degree Relative|first-degree relative
4709644|NCT03177941|Mobile Application|mobile application
4709645|NCT03177876|tenting Hydroxyapetite nano particles implant immediate|tenting hydroxyapetite nano particles implant immediate
4709646|NCT03177863|neoplasm|neoplasm
4709647|NCT03177863|uterine cervix|uterine cervix
4709648|NCT03177850|sleep related breathing disturbances|sleep related breathing disturbances
4709649|NCT03177850|respiratory polygraphy|respiratory polygraphy
4709650|NCT03177850|airway disease|airway disease
4709651|NCT03177850|emphysema|emphysema
4709652|NCT03177850|acetazolamide|acetazolamide
4709653|NCT03177850|altitude|altitude
4709654|NCT03177850|nocturnal pulse oxymetry|nocturnal pulse oxymetry
4709655|NCT03177837|exercise performance|exercise performance
4709656|NCT03177837|maximal spiroergometry|maximal spiroergometry
4709657|NCT03177837|airway disease|airway disease
4709658|NCT03177837|emphysema|emphysema
4709659|NCT03177837|prevention|prevention
4709660|NCT03177837|acetazolamide|acetazolamide
4709661|NCT03177837|altitude|altitude
4709662|NCT03177811|postural control|postural control
4709663|NCT03177811|balance performance|balance performance
4709664|NCT03177811|airway disease|airway disease
4709665|NCT03177811|altitude|altitude
4709666|NCT03177811|prevention|prevention
4709667|NCT03177811|acetazolamide|acetazolamide
4709668|NCT03177772|caregivers|caregivers
4709669|NCT03177772|grief|grief
4709670|NCT03177772|dementia|dementia
4709671|NCT03177772|long-term care|long-term care
4709672|NCT03177772|psychotherapy group|psychotherapy group
4709673|NCT03177733|breast surgery|breast surgery
4709674|NCT03177733|acute pain|acute pain
4709675|NCT03177733|regional anesthesia|regional anesthesia
4709676|NCT03177694|cough|cough
4709677|NCT03177694|exacerbation|exacerbation
4709678|NCT03177694|connected device|connected device
4709679|NCT03177681|Malignant neoplasms of independent (primary) multiple sites|malignant neoplasms of independent (primary) multiple sites
4709680|NCT03177681|Gastrointestinal symptoms|gastrointestinal symptoms
4709681|NCT03177681|Probiotics|probiotics
4709682|NCT03177681|Yogurt|yogurt
4709683|NCT03177681|Stool sample|stool sample
4709684|NCT03177681|Questionnaires|questionnaires
4709685|NCT03177681|Surveys|surveys
4709686|NCT03177681|Holter monitor|holter monitor
4709687|NCT03177629|Immune Thrombocytopenic Purpura|immune thrombocytopenic purpura
4709688|NCT03177629|Helicobacter pylori|helicobacter pylori
4709689|NCT03177616|Migraine|migraine
4709690|NCT03177616|Women|women
4709691|NCT03177616|Adult|adult
4709692|NCT03177616|Feasibility|feasibility
4709693|NCT03177616|Safety|safety
4709694|NCT03177616|Pilot Randomized Trial|pilot randomized trial
4709695|NCT03177616|Randomized Control Trial|randomized control trial
4709696|NCT03177616|Chiropractic|chiropractic
4709697|NCT03177603|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
4709698|NCT03177603|Dose-escalation|dose-escalation
4709699|NCT03177603|Safety|safety
4709700|NCT03177603|Tolerability|tolerability
4709701|NCT03177603|GSK2586881|gsk2586881
4709702|NCT03177590|autism|autism
4709703|NCT03177590|Pervasive Developmental Disorder|pervasive developmental disorder
4709704|NCT03177564|driving pressure|driving pressure
4709705|NCT03177564|one-lung ventilation|one-lung ventilation
4709706|NCT03177551|Prostatic Neoplasms|prostatic neoplasms
4709707|NCT03177551|Nomograms|nomograms
4709708|NCT03177551|Drug Resistance, Neoplasm|drug resistance, neoplasm
4709709|NCT03177538|suboptimal response|suboptimal response
4709710|NCT03177538|Corifollitropin alfa|corifollitropin alfa
4709711|NCT03177538|IVF|ivf
4709712|NCT03177538|Ovarian stimulation|ovarian stimulation
4709713|NCT03177525|parent training|parent training
4709714|NCT03177525|social skills|social skills
4709715|NCT03177512|PrEP|prep
4709716|NCT03177512|HIV Testing|hiv testing
4709717|NCT03177512|STI Testing|sti testing
4709718|NCT03177512|Mobile app|mobile app
4709719|NCT03177512|Technology|technology
4709720|NCT03177512|Young men who have sex with men|young men who have sex with men
4709721|NCT03177499|Portal pressure gradient|portal pressure gradient
4709722|NCT03177499|Transjugular intrahepatic portosystemic shunt|transjugular intrahepatic portosystemic shunt
4709723|NCT03177499|Virtual imaging-based portal pressure gradient|virtual imaging-based portal pressure gradient
4709724|NCT03177486|Syntax score|syntax score
4709725|NCT03177486|Frank sign|frank sign
4709726|NCT03177486|Coronary angiography|coronary angiography
4709727|NCT03177473|degenerative disc disease|degenerative disc disease
4709728|NCT03177473|CervicalStim devic|cervicalstim devic
4709729|NCT03177473|cervical|cervical
4709730|NCT03177473|cervical fusion|cervical fusion
4709731|NCT03177460|Malignant neoplasms of male genital organs|malignant neoplasms of male genital organs
4709732|NCT03177460|Prostate Cancer|prostate cancer
4709733|NCT03177460|Adenocarcinoma of the Prostate|adenocarcinoma of the prostate
4709734|NCT03177460|High-risk|high-risk
4709735|NCT03177460|Localized|localized
4709736|NCT03177460|Daratumumab|daratumumab
4709737|NCT03177460|Prostatectomy|prostatectomy
4709738|NCT03177447|Cardiac Failure|cardiac failure
4709739|NCT03177447|Congestive Heart Failure|congestive heart failure
4709740|NCT03177447|Heart Decompensation|heart decompensation
4709741|NCT03177447|Heart Failure, Congestive|heart failure, congestive
4709742|NCT03177434|constipation|constipation
4709743|NCT03177434|children|children
4709744|NCT03177434|polyethylene glycols (PEG)|polyethylene glycols (peg)
4709745|NCT03177434|lactulose|lactulose
4709746|NCT03177408|Diastolic Dysfunction|diastolic dysfunction
4709747|NCT03177408|Hypertension|hypertension
4709748|NCT03177408|HMGB1|hmgb1
4709749|NCT03177382|Total Neoadjuvant Treatment|total neoadjuvant treatment
4709750|NCT03177382|Rectal Cancer|rectal cancer
4709947|NCT03176147|Hepcidine|hepcidine
4709751|NCT03177382|High Risk Factors|high risk factors
4709752|NCT03177382|Chemoradiotherapy|chemoradiotherapy
4709753|NCT03177369|Bone and joint infection|bone and joint infection
4709754|NCT03177369|Staphylococcus aureus|staphylococcus aureus
4709755|NCT03177369|Teicoplanin|teicoplanin
4709756|NCT03177369|Subcutaneous administration|subcutaneous administration
4709757|NCT03177356|Platelet rich fibrin,xenograft|platelet rich fibrin,xenograft
4709758|NCT03177343|Pristinamycin|pristinamycin
4709759|NCT03177343|Staphylococcus aureus|staphylococcus aureus
4709760|NCT03177343|Bone and joint infection|bone and joint infection
4709761|NCT03177304|Interpersonal Psychotherapy|interpersonal psychotherapy
4709762|NCT03177304|Internet|internet
4709763|NCT03177304|Training|training
4709764|NCT03177304|Depression|depression
4709765|NCT03177304|Dissemination|dissemination
4709766|NCT03177291|NSCLC|nsclc
4709767|NCT03177291|SCLC|sclc
4709768|NCT03177265|nicotine dependence|nicotine dependence
4709769|NCT03177265|tobacco cessation|tobacco cessation
4709770|NCT03177174|locally advanced nasopharyngeal carcinoma|locally advanced nasopharyngeal carcinoma
4709771|NCT03177174|Concurrent chemoradiotherapy|concurrent chemoradiotherapy
4709772|NCT03177174|Toxic reaction|toxic reaction
4709773|NCT03177161|PROM|prom
4709774|NCT03177161|Patient Reported Outcome Measure|patient reported outcome measure
4709775|NCT03177161|PROMIS|promis
4709776|NCT03177161|PROMIS-10|promis-10
4709777|NCT03177161|PROMIS Global Health|promis global health
4709778|NCT03177161|RiksStroke|riksstroke
4709779|NCT03177161|ICHOM|ichom
4709780|NCT03177161|International Consortium for Health Outcomes Measurement|international consortium for health outcomes measurement
4709781|NCT03177161|Wales|wales
4709782|NCT03177161|Administration|administration
4709783|NCT03177161|Method|method
4709784|NCT03177161|Delivery|delivery
4709785|NCT03177122|Polycystic Ovary Syndrome|polycystic ovary syndrome
4709786|NCT03177122|Myo-Inositol|myo-inositol
4709787|NCT03177122|Assisted Reproductive Technology|assisted reproductive technology
4709788|NCT03177122|oocyte performance|oocyte performance
4709789|NCT03177122|pregnancy|pregnancy
4709790|NCT03177109|Dentine Hypersensitivity|dentine hypersensitivity
4709791|NCT03177109|Fluoride varnish|fluoride varnish
4709792|NCT03177109|Desensitizing agents|desensitizing agents
4709793|NCT03177096|Type 1 diabetes children,School,Childcare facilities,Sensor|type 1 diabetes children,school,childcare facilities,sensor
4709794|NCT03177070|Ureteric injury|ureteric injury
4709795|NCT03177070|Colorectal Surgery|colorectal surgery
4709796|NCT03177044|Inflammatory bowel disease, pelvic floor exercise|inflammatory bowel disease, pelvic floor exercise
4709797|NCT03176992|ablation|ablation
4709798|NCT03176992|surgicel|surgicel
4709799|NCT03176953|PTSD|ptsd
4709800|NCT03176953|alcohol use disorder|alcohol use disorder
4709801|NCT03176953|Veterans|veterans
4709802|NCT03176940|Escalating Dosage|escalating dosage
4709803|NCT03176927|magnetogastrogram|magnetogastrogram
4709804|NCT03176927|gastroparesis|gastroparesis
4709805|NCT03176927|electrogastrogram|electrogastrogram
4709806|NCT03176927|gastric slow wave|gastric slow wave
4709807|NCT03176914|Community mobilisation|community mobilisation
4709808|NCT03176901|urinary urge incontinence|urinary urge incontinence
4709809|NCT03176901|urinary incontinence|urinary incontinence
4709810|NCT03176901|older adult women|older adult women
4709811|NCT03176901|older adults|older adults
4709812|NCT03176901|mindfulness-based stress reduction|mindfulness-based stress reduction
4709813|NCT03176901|health enhancement program|health enhancement program
4709814|NCT03176901|feasibility|feasibility
4709815|NCT03176901|randomized controlled trial|randomized controlled trial
4709816|NCT03176901|complementary|complementary
4709817|NCT03176901|integrative|integrative
4709818|NCT03176901|therapies|therapies
4709819|NCT03176888|Exercise|exercise
4709820|NCT03176888|Aerobic capacity|aerobic capacity
4709821|NCT03176888|Rehabilitation|rehabilitation
4709822|NCT03176810|percutaneous coronary intervention|percutaneous coronary intervention
4709823|NCT03176810|optical coherence tomography|optical coherence tomography
4709824|NCT03176797|Liver Fibrosis, multiparametric magnetic resonance imaging|liver fibrosis, multiparametric magnetic resonance imaging
4709825|NCT03176784|Varenicline|varenicline
4709826|NCT03176784|Nicotine Patch|nicotine patch
4709827|NCT03176784|Quit Smoking|quit smoking
4709828|NCT03176784|Tobacco|tobacco
4709829|NCT03176784|Cigarettes|cigarettes
4709830|NCT03176732|Sleep Apnea|sleep apnea
4709831|NCT03176732|Hypertension|hypertension
4709832|NCT03176732|Positive Airway Pressure|positive airway pressure
4709833|NCT03176732|Blood Pressure|blood pressure
4709834|NCT03176680|Anesthesia,Esophagectomy,Esophageal cancer,Treatment outcome|anesthesia,esophagectomy,esophageal cancer,treatment outcome
4709835|NCT03176667|regional, erector spinae block, lobectomy, video-assisted|regional, erector spinae block, lobectomy, video-assisted
4709836|NCT03176641|Platelet-Rich Plasma|platelet-rich plasma
4709837|NCT03176641|Meniscus|meniscus
4709838|NCT03176641|Knee Injuries|knee injuries
4709839|NCT03176628|Pharmacokinetics|pharmacokinetics
4709840|NCT03176628|Pharmacodynamics|pharmacodynamics
4709841|NCT03176615|Gastric Bypass|gastric bypass
4709842|NCT03176602|Subjective Global Assessment|subjective global assessment
4709948|NCT03176147|Iron|iron
4709843|NCT03176602|Nutrition Risk in Critically ill Score|nutrition risk in critically ill score
4709844|NCT03176602|Critical Illness|critical illness
4709845|NCT03176589|positive expiratory pressure|positive expiratory pressure
4709846|NCT03176589|oxygen saturation|oxygen saturation
4709847|NCT03176589|abdominal surgery|abdominal surgery
4709848|NCT03176589|carbon dioxide|carbon dioxide
4709849|NCT03176576|cancer among adolescents|cancer among adolescents
4709850|NCT03176576|cancer among young adults|cancer among young adults
4709851|NCT03176576|adolescents and young adults (AYA)|adolescents and young adults (aya)
4709852|NCT03176576|quality of life|quality of life
4709853|NCT03176576|reduce stress|reduce stress
4709854|NCT03176576|patient navigation|patient navigation
4709855|NCT03176576|questionnaire|questionnaire
4709856|NCT03176576|supportive care|supportive care
4709857|NCT03176576|distress levels|distress levels
4709858|NCT03176576|support resources|support resources
4709859|NCT03176576|satisfaction survey|satisfaction survey
4709860|NCT03176576|teen cancer|teen cancer
4709861|NCT03176563|herbal treatment|herbal treatment
4709862|NCT03176563|antibiotics|antibiotics
4709863|NCT03176563|uncomplicated urinary tract infection|uncomplicated urinary tract infection
4709864|NCT03176511|older adults|older adults
4709865|NCT03176511|dual task|dual task
4709866|NCT03176511|A Matter of Balance|a matter of balance
4709867|NCT03176498|cerebral Infarction|cerebral infarction
4709868|NCT03176498|umbilical cord mesenchymal stem cells|umbilical cord mesenchymal stem cells
4709869|NCT03176485|metastatic|metastatic
4709870|NCT03176485|melanoma|melanoma
4709871|NCT03176485|cancer|cancer
4709872|NCT03176485|colon|colon
4709873|NCT03176485|thyroid|thyroid
4709874|NCT03176485|Differentiated|differentiated
4709875|NCT03176485|Hepatocellular Carcinoma|hepatocellular carcinoma
4709876|NCT03176485|HCC|hcc
4709877|NCT03176485|RCC|rcc
4709878|NCT03176485|Renal Cell Carcinoma|renal cell carcinoma
4709879|NCT03176472|Diabetic Neuropathic Pain|diabetic neuropathic pain
4709880|NCT03176472|Neuropathic Pain|neuropathic pain
4709881|NCT03176472|HDAC6|hdac6
4709882|NCT03176472|ricolinostat|ricolinostat
4709883|NCT03176459|bupvacaine|bupvacaine
4709884|NCT03176459|exparel|exparel
4709885|NCT03176459|analgesic|analgesic
4709886|NCT03176459|TAP Block|tap block
4709887|NCT03176407|sensor capsule|sensor capsule
4709888|NCT03176394|Foley, UTI, Biofilm, DNA|foley, uti, biofilm, dna
4709889|NCT03176381|Prostatic Neoplasms|prostatic neoplasms
4709890|NCT03176381|Abiraterone Acetate|abiraterone acetate
4709891|NCT03176381|FK506 binding protein 5|fk506 binding protein 5
4709892|NCT03176381|Neurotensin|neurotensin
4709893|NCT03176381|yes-associated protein 1|yes-associated protein 1
4709894|NCT03176381|AKR1C3 protein|akr1c3 protein
4709895|NCT03176381|Proliferating Cell Nuclear Antigen|proliferating cell nuclear antigen
4709896|NCT03176368|dry mouth|dry mouth
4709897|NCT03176368|coconut oil|coconut oil
4709898|NCT03176368|radiation|radiation
4709899|NCT03176342|Drug patch tests|drug patch tests
4709900|NCT03176329|Full closed-loop ventilation control|full closed-loop ventilation control
4709901|NCT03176329|Critical care|critical care
4709902|NCT03176316|ileus|ileus
4709903|NCT03176316|fusion of spine|fusion of spine
4709904|NCT03176277|Leukemia|leukemia
4709905|NCT03176277|Leukemia, Myeloid|leukemia, myeloid
4709906|NCT03176277|Leukemia, Myeloid, Acute|leukemia, myeloid, acute
4709907|NCT03176277|MER|mer
4709908|NCT03176277|MERTK|mertk
4709909|NCT03176277|TYRO3|tyro3
4709910|NCT03176277|AXL|axl
4709911|NCT03176277|AML|aml
4709912|NCT03176277|de novo AML|de novo aml
4709913|NCT03176277|Relapsed/ Refractory AML|relapsed/ refractory aml
4709914|NCT03176277|TAM|tam
4709915|NCT03176264|PDR001|pdr001
4709916|NCT03176264|immunotherapy|immunotherapy
4709917|NCT03176264|bevacizumab|bevacizumab
4709918|NCT03176264|mFOLFOX6|mfolfox6
4709919|NCT03176264|CRC|crc
4709920|NCT03176264|MMS|mms
4709921|NCT03176264|CMS4|cms4
4709922|NCT03176264|ElevatION;CRC-101|elevation;crc-101
4709923|NCT03176238|post menopausal|post menopausal
4709924|NCT03176238|advanced breast cancer|advanced breast cancer
4709925|NCT03176238|metastatic breast cancer|metastatic breast cancer
4709926|NCT03176238|everolimus|everolimus
4709927|NCT03176238|exemestane|exemestane
4709928|NCT03176238|mTor inhibitor|mtor inhibitor
4709929|NCT03176238|endocrine therapy|endocrine therapy
4709930|NCT03176212|Gut permeability|gut permeability
4709931|NCT03176212|Cytokine|cytokine
4709932|NCT03176212|Endotoxin|endotoxin
4709933|NCT03176199|control-released oxycodone|control-released oxycodone
4709934|NCT03176199|immediate-released oxycodone|immediate-released oxycodone
4709935|NCT03176199|cancer pain|cancer pain
4709936|NCT03176199|opioid-naive|opioid-naive
4709937|NCT03176186|ischemic-reperfusion injury|ischemic-reperfusion injury
4709938|NCT03176186|out of hospital cardiac arrest|out of hospital cardiac arrest
4709939|NCT03176160|LITT|litt
4709940|NCT03176160|Fecci|fecci
4709941|NCT03176160|Pro00079623|pro00079623
4709942|NCT03176160|Glioblastoma|glioblastoma
4709943|NCT03176160|Laser Interstitial Thermal Therapy|laser interstitial thermal therapy
4709944|NCT03176160|Palliative|palliative
4709945|NCT03176147|Anemia|anemia
4709946|NCT03176147|Pregnancy|pregnancy
4709949|NCT03176121|Oxycodone|oxycodone
4709950|NCT03176121|Cancer Pain|cancer pain
4709951|NCT03176121|Long-term use|long-term use
4709952|NCT03176082|colorectal cancer screening|colorectal cancer screening
4709953|NCT03176082|colorectal cancer|colorectal cancer
4709954|NCT03176069|Vaginismus|vaginismus
4709955|NCT03176069|Muscle Tone|muscle tone
4709956|NCT03176069|Sexual dysfunctions|sexual dysfunctions
4709957|NCT03176056|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
4709958|NCT03176056|Low carbohydrate diet|low carbohydrate diet
4709959|NCT03176017|Transurethral Incision Of The Prostate|transurethral incision of the prostate
4709960|NCT03176017|Prostate|prostate
4709961|NCT03176017|Holmium Laser|holmium laser
4709962|NCT03176017|Ejaculatory Sparing|ejaculatory sparing
4709963|NCT03175965|Heart arrest, hypothermia, SEP, prognosis|heart arrest, hypothermia, sep, prognosis
4709964|NCT03175939|adjuvant chemotherapy|adjuvant chemotherapy
4709965|NCT03175939|NPC|npc
4709966|NCT03175926|Asthma|asthma
4709967|NCT03175926|inhaler device|inhaler device
4709968|NCT03175926|handling|handling
4709969|NCT03175900|Migraine|migraine
4709970|NCT03175900|Naoan dripping pills|naoan dripping pills
4709971|NCT03175900|Traditional Chinese Medicine|traditional chinese medicine
4709972|NCT03175900|fMRI|fmri
4709973|NCT03175900|Randomized Controlled trial|randomized controlled trial
4709974|NCT03175887|depression|depression
4709975|NCT03175887|trd|trd
4709976|NCT03175887|treatment-resistant depression|treatment-resistant depression
4709977|NCT03175887|TMS|tms
4709978|NCT03175874|Osteoporosis|osteoporosis
4709979|NCT03175874|Alzheimer Disease|alzheimer disease
4709980|NCT03175848|Cervical Cancer|cervical cancer
4709981|NCT03175848|Radiotherapy|radiotherapy
4709982|NCT03175848|Chemotherapy|chemotherapy
4709983|NCT03175848|stage IVB cervical cancer|stage ivb cervical cancer
4709984|NCT03175835|Dyslipidemia|dyslipidemia
4709985|NCT03175835|CKD-519|ckd-519
4709986|NCT03175835|Rosuvastatin|rosuvastatin
4709987|NCT03175835|Drug-Drug Interaction|drug-drug interaction
4709988|NCT03175809|Chronic pelvic pain|chronic pelvic pain
4709989|NCT03175809|Pain|pain
4709990|NCT03175809|Dry needling|dry needling
4709991|NCT03175809|Biofeedback|biofeedback
4709992|NCT03175809|Pelvic pain|pelvic pain
4709993|NCT03175731|Esophageal and gastric varices|esophageal and gastric varices
4709994|NCT03175731|Hemorrhage|hemorrhage
4709995|NCT03175718|Sarcoma|sarcoma
4709996|NCT03175718|Wound|wound
4709997|NCT03175718|Therapy|therapy
4709998|NCT03175627|Dental caries|dental caries
4709999|NCT03175627|Proximal surfaces|proximal surfaces
4710000|NCT03175627|Posterior teeth|posterior teeth
4710001|NCT03175627|Carious lesions|carious lesions
4710002|NCT03175627|Tooth diseases|tooth diseases
4710003|NCT03175627|Dental restorations|dental restorations
4710004|NCT03175627|Composite resin|composite resin
4710005|NCT03175614|Physical activity|physical activity
4710006|NCT03175614|Food Habits|food habits
4710007|NCT03175614|Information and communiation Technology|information and communiation technology
4710008|NCT03175614|Health education|health education
4710009|NCT03175601|Sleep disturbances|sleep disturbances
4710010|NCT03175601|Biomarkers|biomarkers
4710011|NCT03175601|Prefrailty|prefrailty
4710012|NCT03175601|Insulin resistance|insulin resistance
4710013|NCT03175601|Olfactory impairment|olfactory impairment
4710014|NCT03175601|Multiplex array|multiplex array
4710015|NCT03175601|Gait speed|gait speed
4710016|NCT03175536|high-deductible health plan|high-deductible health plan
4710017|NCT03175536|medication adherence|medication adherence
4710018|NCT03175536|out-of-pocket costs|out-of-pocket costs
4710019|NCT03175536|preventive drug list|preventive drug list
4710020|NCT03175536|value-based insurance design|value-based insurance design
4710021|NCT03175523|BioResorbable Scaffold|bioresorbable scaffold
4710022|NCT03175523|Quantitative Coronary Angiography|quantitative coronary angiography
4710023|NCT03175523|Intravascular Imaging|intravascular imaging
4710024|NCT03175510|validity, reliability, low back pain|validity, reliability, low back pain
4710025|NCT03175497|Gastric Cancer, VEGFR inhibitor|gastric cancer, vegfr inhibitor
4710026|NCT03175484|High Fidelity Simulation|high fidelity simulation
4710027|NCT03175484|Cognitive Load|cognitive load
4710028|NCT03175484|Simulation Training/methods*|simulation training/methods*
4710029|NCT03175484|Task Performance and Analysis*|task performance and analysis*
4710030|NCT03175484|Students, Medical|students, medical
4710031|NCT03175484|Prospective Studies|prospective studies
4710032|NCT03175458|tenting|tenting
4710033|NCT03175458|grafting|grafting
4710034|NCT03175458|implant placement|implant placement
4710035|NCT03175432|Melanoma and other malignant neoplasms of skin|melanoma and other malignant neoplasms of skin
4710036|NCT03175432|Untreated Melanoma Brain Metastases|untreated melanoma brain metastases
4710037|NCT03175432|Bevacizumab|bevacizumab
4710038|NCT03175432|rhuMA-VEGF|rhuma-vegf
4710039|NCT03175432|Avastin|avastin
4710040|NCT03175432|ANTI-VEGF monoclonal antibody|anti-vegf monoclonal antibody
4710041|NCT03175432|Atezolizumab|atezolizumab
4710042|NCT03175432|MPDL3280A|mpdl3280a
4710043|NCT03175432|Questionnaires|questionnaires
4710044|NCT03175432|Surveys|surveys
4710045|NCT03175432|Neurocognitive Exam|neurocognitive exam
4710046|NCT03175419|laparoscopic liver resection|laparoscopic liver resection
4710047|NCT03175341|breast cancer|breast cancer
4710048|NCT03175341|ascorbic acid|ascorbic acid
4710049|NCT03175341|vitamin C|vitamin c
4710050|NCT03175341|vitamin supplementation|vitamin supplementation
4710051|NCT03175341|quality of life|quality of life
4710052|NCT03175315|psychoeducation|psychoeducation
4710053|NCT03175315|treatment and education programme|treatment and education programme
4710054|NCT03175315|self-management|self-management
4710055|NCT03175315|diabetes education|diabetes education
4710056|NCT03175315|flash glucose monitoring|flash glucose monitoring
4710057|NCT03175302|cognitive processes|cognitive processes
4710058|NCT03175302|perioperative cognition|perioperative cognition
4710059|NCT03175302|neurocognitive impairment|neurocognitive impairment
4710060|NCT03175276|Delirium|delirium
4710061|NCT03175276|Cognitive decline|cognitive decline
4710062|NCT03175276|IQCODE|iqcode
4710063|NCT03175263|onabotulinumtoxinA, chronic migraine, myofascial pain|onabotulinumtoxina, chronic migraine, myofascial pain
4710064|NCT03175224|Advanced Solid Tumor|advanced solid tumor
4710065|NCT03175224|Relapsed Solid Tumor|relapsed solid tumor
4710066|NCT03175224|Recurrent Solid Tumor|recurrent solid tumor
4710067|NCT03175159|Risk Reduction|risk reduction
4710068|NCT03175159|Crystal Methamphetamine|crystal methamphetamine
4710069|NCT03175159|Cocaine|cocaine
4710070|NCT03175159|Stimulant Abuse|stimulant abuse
4710071|NCT03175159|HIV|hiv
4710072|NCT03175159|Behavioral Activation|behavioral activation
4710073|NCT03175133|rehabilitation|rehabilitation
4710074|NCT03175133|physical therapy|physical therapy
4710075|NCT03175107|exergaming|exergaming
4710076|NCT03175107|physiotherapy|physiotherapy
4710077|NCT03175107|upper extremities|upper extremities
4710078|NCT03175107|telerehabilitation|telerehabilitation
4710079|NCT03175094|women|women
4710080|NCT03175094|HIV prevention|hiv prevention
4710081|NCT03175094|criminal justice|criminal justice
4710082|NCT03175081|Intraperitoneal local anesthetic|intraperitoneal local anesthetic
4710083|NCT03175081|Ropivacaine|ropivacaine
4710084|NCT03175081|Postoperative pain|postoperative pain
4710085|NCT03175081|Bariatric surgery|bariatric surgery
4710086|NCT03175068|Functional magnetic resonance imaging|functional magnetic resonance imaging
4710087|NCT03175068|Electroencephalography|electroencephalography
4710088|NCT03175068|Cognitive Behavioral Therapy|cognitive behavioral therapy
4710089|NCT03175068|Supportive Therapy|supportive therapy
4710090|NCT03175029|Lower Urinary Tract Symptoms|lower urinary tract symptoms
4710091|NCT03174990|aspirin|aspirin
4710092|NCT03174990|clopidogrel|clopidogrel
4710093|NCT03174990|peripheral arterial disease|peripheral arterial disease
4710094|NCT03174990|genetics|genetics
4710095|NCT03174964|Recurrent Implantation Failure|recurrent implantation failure
4710096|NCT03174964|IVIg|ivig
4710097|NCT03174964|Pregnancy Rate|pregnancy rate
4710098|NCT03174951|Recurrent Pregnancy Loss|recurrent pregnancy loss
4710099|NCT03174951|IVIg|ivig
4710100|NCT03174951|Pregnancy Rate|pregnancy rate
4710101|NCT03174938|Early diagnosis, biomarker, PET, MRI, β-amyloid, tau, CSF, cognitive test|early diagnosis, biomarker, pet, mri, β-amyloid, tau, csf, cognitive test
4710102|NCT03174912|EORTC|eortc
4710103|NCT03174912|CUETO|cueto
4710104|NCT03174912|bladder neoplasm|bladder neoplasm
4710105|NCT03174912|disease progression|disease progression
4710106|NCT03174912|recurrence|recurrence
4710107|NCT03174886|tau|tau
4710108|NCT03174886|neurofibrillary|neurofibrillary
4710109|NCT03174886|degeneration|degeneration
4710110|NCT03174886|primary progressive aphasia|primary progressive aphasia
4710111|NCT03174886|agrammatic|agrammatic
4710112|NCT03174886|tauopathy|tauopathy
4710113|NCT03174886|immunotherapy|immunotherapy
4710114|NCT03174886|immunization|immunization
4710115|NCT03174860|Pulpitis, irreversible Pulpitis, Hot tooth|pulpitis, irreversible pulpitis, hot tooth
4710116|NCT03174860|Cataflam, Diclofenac Potassium, Preoperative, Premedication, Analgesic|cataflam, diclofenac potassium, preoperative, premedication, analgesic
4710117|NCT03174860|Local anesthesia, Articaine, Buccal infiltration|local anesthesia, articaine, buccal infiltration
4710118|NCT03174847|Primary aldosteronism|primary aldosteronism
4710119|NCT03174847|Blood pressure|blood pressure
4710120|NCT03174847|Adrenalectomy|adrenalectomy
4710121|NCT03174847|Mineralocorticoid-receptor Antagonists|mineralocorticoid-receptor antagonists
4710122|NCT03174847|Cardiovascular|cardiovascular
4710123|NCT03174847|Endothelial|endothelial
4710124|NCT03174847|Renal|renal
4710125|NCT03174834|Bladder Stimulation Technique|bladder stimulation technique
4710126|NCT03174834|Clean Catch Urine|clean catch urine
4710127|NCT03174834|UTI in infants less than 6 months|uti in infants less than 6 months
4710128|NCT03174821|Diabetic nephropathy|diabetic nephropathy
4710129|NCT03174821|Insulin pump intensive therapy|insulin pump intensive therapy
4710130|NCT03174808|cutaneous T-cell lymphoma|cutaneous t-cell lymphoma
4710131|NCT03174756|Hypochlorous Acid|hypochlorous acid
4710132|NCT03174756|Chlorhexidine|chlorhexidine
4710133|NCT03174756|Antiplaque agents|antiplaque agents
4710134|NCT03174756|Substantivity|substantivity
4710135|NCT03174730|smoking|smoking
4710136|NCT03174730|smartphone|smartphone
4710137|NCT03174730|technology|technology
4710138|NCT03174730|addiction|addiction
4710139|NCT03174678|Dexmedetomidine|dexmedetomidine
4710140|NCT03174678|child|child
4710141|NCT03174678|premedication|premedication
4710142|NCT03174678|emergence delirium|emergence delirium
4710143|NCT03174678|dental treatment|dental treatment
4710144|NCT03174626|caregiver|caregiver
4710145|NCT03174626|stress management|stress management
4710146|NCT03174600|Stroke|stroke
4710147|NCT03174600|Lower urinary tract dysfunction|lower urinary tract dysfunction
4710148|NCT03174600|Functional status|functional status
4710149|NCT03174600|Mini mental test|mini mental test
4710150|NCT03174587|Systemic lupus erythematosus|systemic lupus erythematosus
4710151|NCT03174587|HLA-haplo-matching|hla-haplo-matching
4710152|NCT03174587|allogenic bone marrow derived mesenchymal stem cell|allogenic bone marrow derived mesenchymal stem cell
4710153|NCT03174587|Phase 1 clinical trial|phase 1 clinical trial
4710154|NCT03174535|Ischemic Stroke|ischemic stroke
4710155|NCT03174535|Secondary Prevention|secondary prevention
4710156|NCT03174535|Endpoint Events|endpoint events
4710157|NCT03174535|Risk Assessment|risk assessment
4710158|NCT03174535|Traditional Chinese Medicine|traditional chinese medicine
4710159|NCT03174535|Registry Study|registry study
4710160|NCT03174522|Autologous|autologous
4710161|NCT03174522|Bone Marrow-derived Mononuclear Cells (BM-MNCs)|bone marrow-derived mononuclear cells (bm-mncs)
4710162|NCT03174522|Advanced Therapy Medicinal Product (ATMP)|advanced therapy medicinal product (atmp)
4710163|NCT03174522|Tissue-engineered Medicinal Product|tissue-engineered medicinal product
4710164|NCT03174522|Revascularization|revascularization
4710165|NCT03174522|Angiogenesis|angiogenesis
4710166|NCT03174522|Vasculogenesis|vasculogenesis
4710167|NCT03174522|Arteriogenesis|arteriogenesis
4710168|NCT03174509|airway extubation|airway extubation
4710169|NCT03174509|positive-pressure respiration|positive-pressure respiration
4710170|NCT03174509|suction|suction
4710171|NCT03174509|ventilator weaning|ventilator weaning
4710172|NCT03174457|Oesophageal Candidiasis|oesophageal candidiasis
4710173|NCT03174457|Paediatric|paediatric
4710174|NCT03174457|Invasive Candidiasis|invasive candidiasis
4710175|NCT03174457|Prophylaxis of Candida Infections|prophylaxis of candida infections
4710176|NCT03174457|Candidemia|candidemia
4710177|NCT03174457|Aspergillosis|aspergillosis
4710178|NCT03174457|Micafungin|micafungin
4710179|NCT03174444|Chinese American|chinese american
4710180|NCT03174444|Asian American|asian american
4710181|NCT03174444|Colorectal cancer screening|colorectal cancer screening
4710182|NCT03174444|Print materials|print materials
4710183|NCT03174418|Optical coherence tomography|optical coherence tomography
4710184|NCT03174418|Percutaneous coronary interventions|percutaneous coronary interventions
4710185|NCT03174418|Coronary atherosclerosis in bifurcations|coronary atherosclerosis in bifurcations
4710186|NCT03174392|Exercise|exercise
4710187|NCT03174392|Multimodal|multimodal
4710188|NCT03174392|Balance|balance
4710189|NCT03174392|Resistance|resistance
4710190|NCT03174392|Mobility|mobility
4710191|NCT03174314|Visual Impairment|visual impairment
4710192|NCT03174275|squamous cell carcinoma of the head and neck (SCCHN)|squamous cell carcinoma of the head and neck (scchn)
4710193|NCT03174275|durvalumab|durvalumab
4710194|NCT03174275|neoadjuvant induction|neoadjuvant induction
4710195|NCT03174275|post-operative treatment|post-operative treatment
4710196|NCT03174262|Ergonomics|ergonomics
4710197|NCT03174262|Computer Workstation|computer workstation
4710198|NCT03174262|Habit|habit
4710199|NCT03174262|Self-efficacy|self-efficacy
4710200|NCT03174262|Knowledge|knowledge
4710201|NCT03174249|Behavioural therapy|behavioural therapy
4710202|NCT03174249|Exposure in vivo|exposure in vivo
4710203|NCT03174249|Cortical reorganisation|cortical reorganisation
4710204|NCT03174249|Mirror therapy|mirror therapy
4710205|NCT03174210|COPD|copd
4710206|NCT03174210|supplemental oxygen|supplemental oxygen
4710207|NCT03174210|oxygen concentrator|oxygen concentrator
4710208|NCT03174197|Malignant neoplasms of eye brain and other parts of central nervous system|malignant neoplasms of eye brain and other parts of central nervous system
4710209|NCT03174197|Glioblastoma (GBM)|glioblastoma (gbm)
4710210|NCT03174197|GBM|gbm
4710211|NCT03174197|Gliosarcoma|gliosarcoma
4710212|NCT03174197|Temozolomide|temozolomide
4710213|NCT03174197|Temodar|temodar
4710214|NCT03174197|TMZ|tmz
4710215|NCT03174197|Atezolizumab|atezolizumab
4710216|NCT03174197|MPDL3280A|mpdl3280a
4710217|NCT03174197|Radiation therapy|radiation therapy
4710218|NCT03174197|External beam|external beam
4710219|NCT03174197|XRT|xrt
4710220|NCT03174171|Everolimus, mTor inhibitor|everolimus, mtor inhibitor
4710221|NCT03174158|text messaging|text messaging
4710222|NCT03174093|Mobile Health|mobile health
4710223|NCT03174080|Positron-Emission|positron-emission
4710224|NCT03174080|PET Scan Tomography|pet scan tomography
4710225|NCT03174067|buprenorphine|buprenorphine
4710226|NCT03174067|emergency department|emergency department
4710227|NCT03174054|Men aged 40 and over|men aged 40 and over
4710228|NCT03174054|multi parametric MRI|multi parametric mri
4710229|NCT03174015|Sanitation|sanitation
4710230|NCT03174015|Demand|demand
4710231|NCT03174015|Peri-urban|peri-urban
4710232|NCT03174015|Behavior Change|behavior change
4710233|NCT03174015|Lusaka|lusaka
4710234|NCT03174015|Zambia|zambia
4710235|NCT03174002|Oxygenation|oxygenation
4710236|NCT03174002|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
4710237|NCT03174002|Mechanical ventilation|mechanical ventilation
4710238|NCT03174002|Critical illness|critical illness
4710239|NCT03174002|Critical care|critical care
4710240|NCT03173989|osteoarthritis|osteoarthritis
4710241|NCT03173989|hand deformities|hand deformities
4710242|NCT03173989|hand strength|hand strength
4710243|NCT03173989|assistive technology|assistive technology
4710244|NCT03173989|exercise|exercise
4710245|NCT03173989|health education|health education
4710246|NCT03173963|Sodium Glucose Co-Transporter 2 (SGLT2) Inhibitor|sodium glucose co-transporter 2 (sglt2) inhibitor
4710247|NCT03173963|Kidney Biopsy|kidney biopsy
4710248|NCT03173963|Morphometry|morphometry
4710249|NCT03173963|American Indians|american indians
4710250|NCT03173963|Glomerular Filtration Rate|glomerular filtration rate
4710251|NCT03173950|Immunotherapy|immunotherapy
4710252|NCT03173950|Anti-PD-1 Antibody|anti-pd-1 antibody
4710253|NCT03173950|Brain Tumors|brain tumors
4710254|NCT03173950|MDASI-BT|mdasi-bt
4710255|NCT03173950|Spinal Cord Tumors|spinal cord tumors
4710256|NCT03173937|Haploidentical|haploidentical
4710257|NCT03173937|Nonmyeloablative|nonmyeloablative
4710258|NCT03173924|Small Molecule|small molecule
4710259|NCT03173924|Radiolabeled|radiolabeled
4710260|NCT03173924|PSA|psa
4710261|NCT03173924|Diagnostic|diagnostic
4710262|NCT03173924|PMSA|pmsa
4710263|NCT03173911|Balance|balance
4710264|NCT03173911|Postural control|postural control
4710265|NCT03173911|Elastic Bandages|elastic bandages
4710266|NCT03173911|Force plate|force plate
4710267|NCT03173898|PDL Injection; Infiltration; Anesthesia; Extraction|pdl injection; infiltration; anesthesia; extraction
4710268|NCT03173872|Reiki|reiki
4710269|NCT03173872|Chronic Pain|chronic pain
4710270|NCT03173872|Military|military
4710271|NCT03173859|prostate cancer, abiraterone, apalutamide|prostate cancer, abiraterone, apalutamide
4710272|NCT03173846|neurofeedback|neurofeedback
4710273|NCT03173846|episodic memory|episodic memory
4710274|NCT03173846|real-time functional MRI|real-time functional mri
4710275|NCT03173833|cancer patients, quality of life|cancer patients, quality of life
4710276|NCT03173820|tacrolimus|tacrolimus
4710277|NCT03173820|transplantation|transplantation
4710278|NCT03173820|CYP3A5|cyp3a5
4710279|NCT03173820|genotype|genotype
4710280|NCT03173768|intravenous antibiotics|intravenous antibiotics
4710281|NCT03173768|appropriateness|appropriateness
4710282|NCT03173768|outpatient antimicrobial therapy|outpatient antimicrobial therapy
4710283|NCT03173716|DEFINITY contrast|definity contrast
4710284|NCT03173677|Mononuclear cells|mononuclear cells
4710285|NCT03173677|Whey proteins|whey proteins
4710286|NCT03173677|Metabolically-Activated Macrophage|metabolically-activated macrophage
4710287|NCT03173677|Macrophage Polarization|macrophage polarization
4710288|NCT03173677|Macronutrients|macronutrients
4710289|NCT03173638|acute non arteritic anterior ischemic optic neuropathy|acute non arteritic anterior ischemic optic neuropathy
4710290|NCT03173638|mesenchymal stem cells|mesenchymal stem cells
4710291|NCT03173638|intravitreal injection|intravitreal injection
4710292|NCT03173638|safety|safety
4710293|NCT03173599|Chronic Hepatitis B|chronic hepatitis b
4710294|NCT03173586|Sugar sweetened beverage, biomarker|sugar sweetened beverage, biomarker
4710295|NCT03173573|Cystic Fibrosis|cystic fibrosis
4710296|NCT03173560|Renal Cell Carcinoma|renal cell carcinoma
4710297|NCT03173560|lenvatinib|lenvatinib
4710298|NCT03173560|everolimus|everolimus
4710299|NCT03173560|E7080|e7080
4710300|NCT03173560|VEGF-targeted treatment|vegf-targeted treatment
4710301|NCT03173508|right ventricular function|right ventricular function
4710302|NCT03173508|echocardiography|echocardiography
4710303|NCT03173508|obstructive airway disease|obstructive airway disease
4710304|NCT03173508|emphysema|emphysema
4710305|NCT03173508|acetazolamide|acetazolamide
4710306|NCT03173508|altitude|altitude
4710307|NCT03173495|fat metabolism|fat metabolism
4710308|NCT03173495|fructose|fructose
4710309|NCT03173495|exercise|exercise
4710310|NCT03173456|acute pain|acute pain
4710311|NCT03173456|musculoskeletal pain|musculoskeletal pain
4710312|NCT03173456|emergency medicine|emergency medicine
4710313|NCT03173456|Emergency Service, Hospital|emergency service, hospital
4710314|NCT03173456|analgesics|analgesics
4710315|NCT03173456|Acetaminophen|acetaminophen
4710316|NCT03173456|Ibuprofen|ibuprofen
4710317|NCT03173456|oxycodone|oxycodone
4710318|NCT03173456|hydrocodone|hydrocodone
4710319|NCT03173456|codeine|codeine
4710320|NCT03173456|adult|adult
4710321|NCT03173443|Fiberoptic intubation|fiberoptic intubation
4710322|NCT03173443|double lumen tube|double lumen tube
4710324|NCT03173391|T2DM|t2dm
4710325|NCT03173391|HMS5552|hms5552
4710326|NCT03173391|mono therapy|mono therapy
4710327|NCT03173365|Hand-foot Syndrome|hand-foot syndrome
4710328|NCT03173365|Brimonidine|brimonidine
4710329|NCT03173365|Mirvaso|mirvaso
4710330|NCT03173365|palmar-plantar erythrodysesthesia syndrome|palmar-plantar erythrodysesthesia syndrome
4710331|NCT03173365|Brimonidine Tartrate|brimonidine tartrate
4710332|NCT03173352|Hemangioma|hemangioma
4710333|NCT03173339|intubation|intubation
4710334|NCT03173339|pharyngitis|pharyngitis
4710335|NCT03173339|remifentanil|remifentanil
4710336|NCT03173313|Hypothermia|hypothermia
4710337|NCT03173313|Acute Myocardial Infarction|acute myocardial infarction
4710338|NCT03173313|AMI|ami
4710339|NCT03173313|PCI|pci
4710340|NCT03173313|Therapeutic Hypothermia|therapeutic hypothermia
4710341|NCT03173300|PMM2-CDG|pmm2-cdg
4710342|NCT03173300|CDG-Ia|cdg-ia
4710343|NCT03173287|Hepatic fibrosis|hepatic fibrosis
4710344|NCT03173287|IVIM|ivim
4710345|NCT03173287|1.5T MRI|1.5t mri
4710346|NCT03173248|Acute Myeloid Leukemia|acute myeloid leukemia
4710347|NCT03173248|Leukemia|leukemia
4710348|NCT03173248|Azacitidine|azacitidine
4710349|NCT03173248|AG-120|ag-120
4710350|NCT03173248|ivosidenib|ivosidenib
4710351|NCT03173209|school|school
4710352|NCT03173196|severe sepsis|severe sepsis
4710353|NCT03173196|encephalopathy|encephalopathy
4710354|NCT03173170|Drug Therapy|drug therapy
4710355|NCT03173144|Life Style|life style
4710356|NCT03173144|Diet|diet
4710357|NCT03173144|Food|food
4710358|NCT03173144|Exercise|exercise
4710359|NCT03173144|Treatment Outcome|treatment outcome
4710360|NCT03173144|Biomarkers|biomarkers
4710361|NCT03173144|Smoking|smoking
4710362|NCT03173105|Visually Impaired Persons|visually impaired persons
4710363|NCT03173105|Postural Balance|postural balance
4710364|NCT03173105|Rehabilitation|rehabilitation
4710365|NCT03173105|Transcranial Direct Current Stimulation|transcranial direct current stimulation
4710366|NCT03173092|Drug therapy|drug therapy
4710367|NCT03173053|S. aureus|s. aureus
4710368|NCT03173053|Home Parenteral Nutrition|home parenteral nutrition
4710369|NCT03173053|Intestinal failure|intestinal failure
4710370|NCT03173053|Eradication|eradication
4710371|NCT03173053|Decolonization|decolonization
4710372|NCT03173040|Traditional Chinese medicine|traditional chinese medicine
4710373|NCT03173040|Niu Bang Zi pill|niu bang zi pill
4710374|NCT03173040|methotrexate|methotrexate
4710375|NCT03173040|active rheumatoid arthritis|active rheumatoid arthritis
4710376|NCT03173001|intestinal helminths; protozoan infections;|intestinal helminths; protozoan infections;
4710377|NCT03173001|colorectal cancer; chemotherapy; cancer pathogenesis;|colorectal cancer; chemotherapy; cancer pathogenesis;
4710378|NCT03172988|Carcinoma, Non-Small-Cell Lung|carcinoma, non-small-cell lung
4710379|NCT03172988|Surgery|surgery
4710380|NCT03172988|Dexamethasone|dexamethasone
4710381|NCT03172988|Flurbiprofen axetil|flurbiprofen axetil
4710382|NCT03172988|Long-term survival|long-term survival
4710383|NCT03172975|Controlled infection|controlled infection
4710384|NCT03172975|Na-GST-1|na-gst-1
4710385|NCT03172975|Hookworm vaccine|hookworm vaccine
4710386|NCT03172936|injected lesion|injected lesion
4710387|NCT03172936|distal lesion|distal lesion
4710388|NCT03172936|abscopal activity|abscopal activity
4710389|NCT03172936|intratumoral|intratumoral
4710390|NCT03172936|checkpoint inhibitor|checkpoint inhibitor
4710391|NCT03172936|cyclic dinucleotide|cyclic dinucleotide
4710392|NCT03172936|programmed cell death|programmed cell death
4710393|NCT03172910|PER977|per977
4710394|NCT03172910|Ciraparantag|ciraparantag
4710395|NCT03172910|Whole Blood Clotting Time (WBCT)|whole blood clotting time (wbct)
4710396|NCT03172910|Rivaroxaban|rivaroxaban
4710397|NCT03172897|Adult|adult
4710398|NCT03172897|Intensive care unit|intensive care unit
4710399|NCT03172897|Mechanical ventilation|mechanical ventilation
4710400|NCT03172897|Delirium|delirium
4710401|NCT03172897|Dexmedetomidine|dexmedetomidine
4710402|NCT03172884|Renal Impairment|renal impairment
4710403|NCT03172884|Pharmacokinetics|pharmacokinetics
4710404|NCT03172884|Hepatic impairment|hepatic impairment
4710405|NCT03172871|Schizophrenia|schizophrenia
4710406|NCT03172871|Aripiprazole Intramuscular Depot|aripiprazole intramuscular depot
4710407|NCT03172871|Acute treatment|acute treatment
4710408|NCT03172858|cervical ripening|cervical ripening
4710409|NCT03172858|term premature rupture of membrane|term premature rupture of membrane
4710410|NCT03172858|intracervical balloon catheter|intracervical balloon catheter
4710411|NCT03172845|coronary bifurcation lesion|coronary bifurcation lesion
4710412|NCT03172845|optical coherence tomography|optical coherence tomography
4710413|NCT03172845|vulnerable plaque|vulnerable plaque
4710414|NCT03172793|telavancin|telavancin
4710415|NCT03172793|lipoglycopeptide|lipoglycopeptide
4710416|NCT03172793|MRSA|mrsa
4710417|NCT03172793|pharmacokinetics|pharmacokinetics
4710418|NCT03172767|Preterm|preterm
4710419|NCT03172767|Sensory processing|sensory processing
4710420|NCT03172767|School Readiness|school readiness
4710421|NCT03172741|Cannabis|cannabis
4710422|NCT03172715|Open reduction internal fixation|open reduction internal fixation
4710423|NCT03172715|Arthroplasty|arthroplasty
4710424|NCT03172715|Surgery|surgery
4710425|NCT03172715|Randomized controlled trial|randomized controlled trial
4710426|NCT03172663|obesity|obesity
4710427|NCT03172624|Nivolumab|nivolumab
4710428|NCT03172624|Ipilimumab|ipilimumab
4710429|NCT03172624|17-219|17-219
4710430|NCT03172572|minimally invasive surgical procedures|minimally invasive surgical procedures
4710431|NCT03172572|pancreas surgery|pancreas surgery
4710432|NCT03172572|pancreatoduodenectomy|pancreatoduodenectomy
4710433|NCT03172559|Stereotactic body radiotherapy|stereotactic body radiotherapy
4710434|NCT03172559|SBRT|sbrt
4710435|NCT03172559|Radiotherapy|radiotherapy
4710436|NCT03172559|Bridging therapy|bridging therapy
4710437|NCT03172559|Transplant|transplant
4710438|NCT03172546|direct oral anticoagulant|direct oral anticoagulant
4710439|NCT03172546|hemorrhagic complication|hemorrhagic complication
4710440|NCT03172546|thrombotic complication|thrombotic complication
4710441|NCT03172546|genetic polymorphisms|genetic polymorphisms
4710442|NCT03172533|anorexia nervosa|anorexia nervosa
4710443|NCT03172533|estrogen|estrogen
4710444|NCT03172533|psychotherapy|psychotherapy
4710445|NCT03172533|cortisol|cortisol
4710446|NCT03172533|appetite regulation|appetite regulation
4710447|NCT03172533|neurocognitive performance|neurocognitive performance
4710448|NCT03172533|eating disorder|eating disorder
4710449|NCT03172533|sexual hormone|sexual hormone
4710450|NCT03172520|Parotidectomy|parotidectomy
4710451|NCT03172507|Hematopoietic Stem Cells|hematopoietic stem cells
4710452|NCT03172442|Class III treatment|class iii treatment
4710453|NCT03172442|orthodontic removable traction appliance|orthodontic removable traction appliance
4710454|NCT03172442|RCT|rct
4710455|NCT03172429|pulmonary hypertension|pulmonary hypertension
4710456|NCT03172429|cerebral tissue oxygenation|cerebral tissue oxygenation
4710457|NCT03172429|disease progression|disease progression
4710458|NCT03172429|hypoxia|hypoxia
4710459|NCT03172416|Gastric Cancer|gastric cancer
4710460|NCT03172416|Unresectable Peritoneal Carcinomatosis|unresectable peritoneal carcinomatosis
4710461|NCT03172416|Oxaliplatin|oxaliplatin
4710462|NCT03172416|Pressurized intraperitoneal aerosol chemotherapy|pressurized intraperitoneal aerosol chemotherapy
4710463|NCT03172403|Cachexia|cachexia
4710464|NCT03172403|Colon cancer|colon cancer
4710465|NCT03172403|Myostatin|myostatin
4710466|NCT03172403|Skeletal muscle|skeletal muscle
4710467|NCT03172390|Ascending aorta aneurysm|ascending aorta aneurysm
4710468|NCT03172390|Aortic wall shear stress|aortic wall shear stress
4710469|NCT03172390|4D phase contrast Cardiovascular Magnetic Resonance|4d phase contrast cardiovascular magnetic resonance
4710470|NCT03172390|Aortic dissection|aortic dissection
4710471|NCT03172377|adalimumab|adalimumab
4710472|NCT03172377|anti-TNF|anti-tnf
4710473|NCT03172377|Humira|humira
4710474|NCT03172377|interval lengthening|interval lengthening
4710475|NCT03172377|dosing interval|dosing interval
4710476|NCT03172377|inflammatory bowel disease|inflammatory bowel disease
4710477|NCT03172377|antidrug antibodies|antidrug antibodies
4710478|NCT03172377|trough levels|trough levels
4710479|NCT03172377|pharmacokinetics|pharmacokinetics
4710480|NCT03172377|immunogenicity|immunogenicity
4710481|NCT03172377|cost-effectiveness|cost-effectiveness
4710482|NCT03172377|dose reduction|dose reduction
4710483|NCT03172312|Intraoperative Parathyroid Scores System|intraoperative parathyroid scores system
4710484|NCT03172312|total thyroidectomy|total thyroidectomy
4710485|NCT03172312|thyroid cancer|thyroid cancer
4710486|NCT03172312|hypoparathyroidism|hypoparathyroidism
4710487|NCT03172312|prediction|prediction
4710488|NCT03172273|Liver Cirrhosis|liver cirrhosis
4710489|NCT03172273|Transjugular Intrahepatic Portosystemic shunt|transjugular intrahepatic portosystemic shunt
4710490|NCT03172273|Refractory ascites|refractory ascites
4710491|NCT03172247|cardiology diabetes|cardiology diabetes
4710492|NCT03172234|β-endorphins,laryngoscopy and tracheal intubation|β-endorphins,laryngoscopy and tracheal intubation
4710493|NCT03172221|malaria|malaria
4710494|NCT03172221|pregnancy|pregnancy
4710495|NCT03172221|diagnosis|diagnosis
4710496|NCT03172221|low-transmission|low-transmission
4710497|NCT03172221|Plasmodium falciparum|plasmodium falciparum
4710498|NCT03172221|rapid diagnostic test|rapid diagnostic test
4710499|NCT03172195|ulcerative colitis|ulcerative colitis
4710500|NCT03172195|inflammation|inflammation
4710501|NCT03172195|immunosuppressive drugs|immunosuppressive drugs
4710502|NCT03172195|herpesvirus|herpesvirus
4710503|NCT03172195|qPCR|qpcr
4710504|NCT03172195|colonic mucosa|colonic mucosa
4710505|NCT03172156|NSCLC|nsclc
4710506|NCT03172156|stage I|stage i
4710507|NCT03172156|The next generation of high-throughput gene sequencing (NGS)|the next generation of high-throughput gene sequencing (ngs)
4710508|NCT03172156|ctDNA|ctdna
4710509|NCT03172143|Ileocolic|ileocolic
4710510|NCT03172143|Crohn's|crohn's
4710511|NCT03172143|Terminal ilium|terminal ilium
4710512|NCT03172143|Ileocecal|ileocecal
4710513|NCT03172130|Obstructive Sleep Apnea|obstructive sleep apnea
4710514|NCT03172130|CPAP|cpap
4710515|NCT03172091|Lung transplant|lung transplant
4710516|NCT03172091|Acute resection|acute resection
4710517|NCT03172091|Volatile Organic Compounds|volatile organic compounds
4710518|NCT03172078|advanced endoscopic procedure|advanced endoscopic procedure
4710519|NCT03172078|ERCP|ercp
4710520|NCT03172078|EUS|eus
4710521|NCT03172078|target-controlled infusion|target-controlled infusion
4710522|NCT03172078|sedation|sedation
4710523|NCT03172078|propofol|propofol
4710524|NCT03172039|hemodialysis|hemodialysis
4710525|NCT03172039|antimicrobial stewardship|antimicrobial stewardship
4710526|NCT03172039|antimicrobial agents|antimicrobial agents
4710527|NCT03172039|bacterial infections|bacterial infections
4710528|NCT03172039|ambulatory care|ambulatory care
4710529|NCT03172026|Telerehabilitation|telerehabilitation
4710530|NCT03172026|Maraviroc|maraviroc
4710531|NCT03171987|lidocaine patch|lidocaine patch
4710532|NCT03171987|flurbiprofen patch|flurbiprofen patch
4710533|NCT03171987|acute back pain|acute back pain
4710534|NCT03171974|breast capsular contructure|breast capsular contructure
4710535|NCT03171961|weight loss|weight loss
4710536|NCT03171961|Diet|diet
4710537|NCT03171961|online visit|online visit
4710538|NCT03171961|clinic visit|clinic visit
4710539|NCT03171948|almond|almond
4710540|NCT03171948|weight loss|weight loss
4710541|NCT03171948|Weight maintenance|weight maintenance
4710542|NCT03171948|hypoenergetic diet|hypoenergetic diet
4710543|NCT03171922|weight loss|weight loss
4710544|NCT03171922|internet-based diet|internet-based diet
4710545|NCT03171922|online dietary coach|online dietary coach
4710546|NCT03171922|clinic visit approach|clinic visit approach
4710547|NCT03171922|Diet|diet
4710548|NCT03171792|Musculoskeletal pain|musculoskeletal pain
4710549|NCT03171792|Adolescent|adolescent
4710550|NCT03171792|Qualitative research|qualitative research
4710551|NCT03171792|Attitude|attitude
4710552|NCT03171792|Health professionals|health professionals
4710553|NCT03171740|Emergence Delirium|emergence delirium
4710554|NCT03171740|Emergence Agitation|emergence agitation
4710555|NCT03171740|premedication|premedication
4710556|NCT03171740|dexmedetomidine|dexmedetomidine
4710557|NCT03171740|midazolam|midazolam
4710558|NCT03171714|Drainage Catheter|drainage catheter
4710559|NCT03171688|Postoperative Nausea and Vomiting|postoperative nausea and vomiting
4710560|NCT03171688|cesarean|cesarean
4710561|NCT03171688|risk factors|risk factors
4710562|NCT03171675|Chronic Periodontitis|chronic periodontitis
4710563|NCT03171675|Preterm Labor|preterm labor
4710564|NCT03171675|Preterm Birth|preterm birth
4710565|NCT03171675|Interleukin-17|interleukin-17
4710566|NCT03171675|IL-17|il-17
4710567|NCT03171675|Periodontal Disease|periodontal disease
4710568|NCT03171675|Periodontitis|periodontitis
4710569|NCT03171675|Periodontal risk factors|periodontal risk factors
4710570|NCT03171675|Medical risk factors|medical risk factors
4710571|NCT03171649|rehabilitation|rehabilitation
4710572|NCT03171649|exoskeleton|exoskeleton
4710573|NCT03171649|functional electrical stimulation|functional electrical stimulation
4710574|NCT03171649|upper limb|upper limb
4710575|NCT03171649|sub-acute|sub-acute
4710576|NCT03171649|motor re-learning|motor re-learning
4710577|NCT03171623|T2DM|t2dm
4710578|NCT03171623|Diabetes|diabetes
4710579|NCT03171623|GKA|gka
4710580|NCT03171610|laparoscopic nephrectomy|laparoscopic nephrectomy
4710581|NCT03171610|Patient-controlled analgesia (PCA)|patient-controlled analgesia (pca)
4710582|NCT03171610|sufentanil|sufentanil
4710583|NCT03171610|fentanyl|fentanyl
4710584|NCT03171597|Unstable Angina|unstable angina
4710585|NCT03171597|Traditional Chinese Medicine|traditional chinese medicine
4710586|NCT03171571|eating Behavior|eating behavior
4710587|NCT03171571|Volunteers|volunteers
4710588|NCT03171545|Peer Mentoring|peer mentoring
4710589|NCT03171545|Team Training|team training
4710590|NCT03171545|Checklist|checklist
4710591|NCT03171532|ACL|acl
4710592|NCT03171519|Physical activity|physical activity
4710593|NCT03171519|Disorders of onset and maintenance of sleep|disorders of onset and maintenance of sleep
4710594|NCT03171519|non-pharmacological treatment|non-pharmacological treatment
4710595|NCT03171519|Acupuncture|acupuncture
4710596|NCT03171506|ketogenic diet|ketogenic diet
4710597|NCT03171506|carbohydrate-restricted diet|carbohydrate-restricted diet
4710598|NCT03171493|Bladder cancer, Radical cystectomy|bladder cancer, radical cystectomy
4710599|NCT03171480|Preeclampsia|preeclampsia
4710600|NCT03171480|Induction|induction
4710601|NCT03171454|hysteroscopic operation|hysteroscopic operation
4710602|NCT03171454|intrauterine balloon|intrauterine balloon
4710603|NCT03171454|adhesions|adhesions
4710604|NCT03171415|Obesity|obesity
4710605|NCT03171415|Overweight|overweight
4710606|NCT03171415|Thermogenesis|thermogenesis
4710607|NCT03171415|Fat reduction|fat reduction
4710608|NCT03171389|GIST|gist
4710609|NCT03171389|KIT secondary mutation|kit secondary mutation
4710610|NCT03171389|ponatinib|ponatinib
4710611|NCT03171376|Root canal treatment|root canal treatment
4710612|NCT03171376|Coronal leakage|coronal leakage
4710613|NCT03171376|Intraorifice barrier|intraorifice barrier
4710614|NCT03171363|Attention bias modification treatment|attention bias modification treatment
4710615|NCT03171363|Anxiety disorders|anxiety disorders
4710616|NCT03171363|Attention training|attention training
4710617|NCT03171337|Chronic tension-type headache|chronic tension-type headache
4710618|NCT03171337|Acupuncture|acupuncture
4710619|NCT03171337|Fu's subcutaneous needling(FSN)|fu's subcutaneous needling(fsn)
4710620|NCT03171337|fMRI|fmri
4710621|NCT03171337|Regional homogeneity (ReHo)|regional homogeneity (reho)
4710622|NCT03171246|dietary intervention|dietary intervention
4710623|NCT03171220|Neoantigen|neoantigen
4710624|NCT03171220|Neoantigen Reactive T cells (NRTs)|neoantigen reactive t cells (nrts)
4710625|NCT03171220|PD-1 Inhibitor|pd-1 inhibitor
4710626|NCT03171220|Advanced Solid Tumor|advanced solid tumor
4710627|NCT03171220|Adoptive Cell Therapy(ACT)|adoptive cell therapy(act)
4710628|NCT03171220|PD-1 antibody|pd-1 antibody
4710629|NCT03171220|SHR1210|shr1210
4710630|NCT03171207|Gait Therapy|gait therapy
4710631|NCT03171194|Lupus|lupus
4710632|NCT03171194|Stem Cell|stem cell
4710633|NCT03171194|Systemic Lupus Erythematosus|systemic lupus erythematosus
4710634|NCT03171181|Spatial cognition, vestibular system, motor control|spatial cognition, vestibular system, motor control
4710635|NCT03171168|Gait Analysis|gait analysis
4710636|NCT03171168|WOMAC|womac
4710637|NCT03171168|SF-36|sf-36
4710638|NCT03171142|Heliox|heliox
4710639|NCT03171129|Respiratory Distress|respiratory distress
4710640|NCT03171129|Nasal CPAP|nasal cpap
4710641|NCT03171129|high flow nasal canula|high flow nasal canula
4710642|NCT03171116|ghrelin|ghrelin
4710643|NCT03171116|obestatin|obestatin
4710644|NCT03171116|children|children
4710645|NCT03171064|Exercise|exercise
4710646|NCT03171064|Cancer|cancer
4710647|NCT03171064|Melanoma|melanoma
4710648|NCT03171064|Feasibility|feasibility
4710649|NCT03171064|PD-1 antibodies|pd-1 antibodies
4710650|NCT03171064|Checkpoint inhibitors|checkpoint inhibitors
4710651|NCT03171064|Immune system|immune system
4710652|NCT03171038|Telemonitoring|telemonitoring
4710653|NCT03171038|Chronic Heart Failure|chronic heart failure
4710654|NCT03171038|eHealth|ehealth
4710655|NCT03171038|Mortality|mortality
4710656|NCT03171025|Muscle Invasive|muscle invasive
4710657|NCT03171012|Muscle Stretching Exercises|muscle stretching exercises
4710658|NCT03170999|China|china
4710659|NCT03170999|Cognitive testing|cognitive testing
4710660|NCT03170999|COPD exacerbation|copd exacerbation
4710661|NCT03170999|CERT|cert
4710662|NCT03170973|Obesity|obesity
4710663|NCT03170973|Motor Activity|motor activity
4710664|NCT03170973|Fatty acids|fatty acids
4710665|NCT03170973|Lipid|lipid
4710666|NCT03170960|Kidney|kidney
4710667|NCT03170960|Bladder|bladder
4710668|NCT03170960|Renal pelvis|renal pelvis
4710669|NCT03170960|Ureter|ureter
4710670|NCT03170960|Urethra|urethra
4710671|NCT03170960|Cancer|cancer
4710672|NCT03170960|Prostate|prostate
4710673|NCT03170960|Castration-resistant|castration-resistant
4710674|NCT03170960|Lung|lung
4710675|NCT03170947|Rheumatoid arthritis|rheumatoid arthritis
4710676|NCT03170947|Foot|foot
4710677|NCT03170947|Insoles|insoles
4710678|NCT03170947|Quality of life|quality of life
4710679|NCT03170947|Physical Activity|physical activity
4710680|NCT03170895|FLT3-ITD (+) Acute Myeloid Leukemia (AML)|flt3-itd (+) acute myeloid leukemia (aml)
4710681|NCT03170882|Drug therapy|drug therapy
4710682|NCT03170778|Congenital Heart Disease|congenital heart disease
4710683|NCT03170778|CHD|chd
4710684|NCT03170778|Fontan|fontan
4710685|NCT03170752|RCT, Cardiovascular Risk Factors, Screening|rct, cardiovascular risk factors, screening
4710686|NCT03170739|dexmedetomidine|dexmedetomidine
4710687|NCT03170739|dopamine|dopamine
4710688|NCT03170739|surgery|surgery
4710689|NCT03170726|Preemptive intravenous ibuprofen|preemptive intravenous ibuprofen
4710690|NCT03170726|Intraoperative analgesia|intraoperative analgesia
4710691|NCT03170726|Third molar tooth surgery|third molar tooth surgery
4710692|NCT03170713|Preemptive intravenous ibuprofen|preemptive intravenous ibuprofen
4710693|NCT03170713|trismus|trismus
4710694|NCT03170713|edema|edema
4710695|NCT03170713|Third molar tooth extraction|third molar tooth extraction
4710696|NCT03170713|Antiinflammatory effect|antiinflammatory effect
4710697|NCT03170700|preschool|preschool
4710698|NCT03170700|eating behaviors|eating behaviors
4710699|NCT03170700|family|family
4710700|NCT03170648|Acupuncture|acupuncture
4710701|NCT03170648|Breast Cancer|breast cancer
4710702|NCT03170635|recess, occupational therapy|recess, occupational therapy
4710703|NCT03170622|children|children
4710704|NCT03170622|paediatrics|paediatrics
4710705|NCT03170622|faecal volitile organic compounds|faecal volitile organic compounds
4710706|NCT03170622|diagnosis|diagnosis
4710707|NCT03170622|pathogenesis|pathogenesis
4710708|NCT03170583|bradycardia, pacemaker, MRI scan|bradycardia, pacemaker, mri scan
4710709|NCT03170570|recurrent cervical cancer|recurrent cervical cancer
4710710|NCT03170570|re-irradiation|re-irradiation
4710711|NCT03170570|intensity-modulated raditherapy|intensity-modulated raditherapy
4710712|NCT03170557|Persistent pain|persistent pain
4710713|NCT03170557|Spinal cord injury|spinal cord injury
4710714|NCT03170557|Acupuncture|acupuncture
4710715|NCT03170557|Randomized Controlled Trial|randomized controlled trial
4710716|NCT03170557|RCT|rct
4710717|NCT03170531|MRI|mri
4710718|NCT03170531|MR imaging|mr imaging
4710719|NCT03170531|17-267|17-267
4710720|NCT03170505|cleft palate|cleft palate
4710721|NCT03170466|Palliative care|palliative care
4710722|NCT03170453|Autism|autism
4710723|NCT03170453|Autism Spectrum Disorder|autism spectrum disorder
4710724|NCT03170453|Asperger's Syndrome|asperger's syndrome
4710725|NCT03170453|Pervasive Developmental Disorder|pervasive developmental disorder
4710726|NCT03170453|Cognition|cognition
4710727|NCT03170453|Social Cognition|social cognition
4710728|NCT03170453|Psychosocial Treatment|psychosocial treatment
4710729|NCT03170453|Cognitive Enhancement Therapy|cognitive enhancement therapy
4710730|NCT03170453|Enriched Supportive Therapy|enriched supportive therapy
4710731|NCT03170453|Therapy|therapy
4710732|NCT03170453|Psychotherapy|psychotherapy
4710733|NCT03170440|Nerve stimulation|nerve stimulation
4710734|NCT03170414|HIV|hiv
4710735|NCT03170414|Kidney Transplant|kidney transplant
4710736|NCT03170414|Liver Transplant|liver transplant
4710737|NCT03170414|Transplant|transplant
4710738|NCT03170414|HOPE Act|hope act
4710739|NCT03170375|obesity|obesity
4710740|NCT03170375|sodium|sodium
4710741|NCT03170375|DASH diet|dash diet
4710742|NCT03170375|hypertension|hypertension
4710743|NCT03170375|vascular stiffness|vascular stiffness
4710744|NCT03170375|diastolic function|diastolic function
4710745|NCT03170362|Treatment|treatment
4710746|NCT03170362|Pharmacogenetics|pharmacogenetics
4710747|NCT03170362|Depression|depression
4710748|NCT03170271|Asthma, Bronchial Diseases, Respiratory Tract Diseases, Lung Diseases, Obstructive Lung Diseases|asthma, bronchial diseases, respiratory tract diseases, lung diseases, obstructive lung diseases
4710749|NCT03170271|Additional relevant MeSH terms:|additional relevant mesh terms:
4710750|NCT03170271|Asthma|asthma
4710751|NCT03170271|Inflammation|inflammation
4710752|NCT03170271|Bronchial Diseases|bronchial diseases
4710753|NCT03170271|Respiratory Tract Diseases|respiratory tract diseases
4710754|NCT03170271|Lung Diseases, Obstructive|lung diseases, obstructive
4710755|NCT03170271|Lung Diseases Respiratory Hypersensitivity|lung diseases respiratory hypersensitivity
4710756|NCT03170271|Hypersensitivity, Immediate|hypersensitivity, immediate
4710757|NCT03170271|Hypersensitivity|hypersensitivity
4710758|NCT03170271|Immune System Diseases|immune system diseases
4710759|NCT03170271|Pathologic Processes|pathologic processes
4710760|NCT03170258|real-time fMRI|real-time fmri
4710761|NCT03170258|reward|reward
4710762|NCT03170258|motivation|motivation
4710763|NCT03170258|dopamine|dopamine
4710764|NCT03170258|EEG|eeg
4710765|NCT03170232|HRQoL|hrqol
4710766|NCT03170232|Disease Progression|disease progression
4710767|NCT03170232|Danirixin|danirixin
4710768|NCT03170232|COPD|copd
4710769|NCT03170206|Lung Cancer|lung cancer
4710770|NCT03170141|CAR T|car t
4710771|NCT03170141|Gene Therapy|gene therapy
4710772|NCT03170141|GBM|gbm
4710773|NCT03170141|PD-L1|pd-l1
4710774|NCT03170141|PD1|pd1
4710775|NCT03170115|Rectal Cancer|rectal cancer
4710776|NCT03170115|Total neoadjuvant therapy|total neoadjuvant therapy
4710777|NCT03170115|Induction chemotherapy|induction chemotherapy
4710778|NCT03170115|Aspirin colorectal cancer|aspirin colorectal cancer
4710779|NCT03170102|occupational therapy|occupational therapy
4710780|NCT03170089|oral-health-awareness, Diabetes|oral-health-awareness, diabetes
4710781|NCT03170076|skin manifestations - hepatitis c virus|skin manifestations - hepatitis c virus
4710782|NCT03170063|Parkinson's Disease|parkinson's disease
4710783|NCT03170063|Alpha-Synuclein|alpha-synuclein
4710784|NCT03170063|Biomarker|biomarker
4710785|NCT03170011|Cardiac rehabilitation|cardiac rehabilitation
4710786|NCT03170011|Sit to Stand|sit to stand
4710787|NCT03170011|Function|function
4710788|NCT03169985|Rosuvastatin|rosuvastatin
4710789|NCT03169985|Ezetimibe|ezetimibe
4710790|NCT03169985|Atherosclerotic plaque|atherosclerotic plaque
4710791|NCT03169985|Intravascular ultrasound|intravascular ultrasound
4710792|NCT03169959|Anti-diabetic|anti-diabetic
4710793|NCT03169959|Anti-hyperglycemic agents|anti-hyperglycemic agents
4710794|NCT03169959|Bioequivalence|bioequivalence
4710795|NCT03169959|Fixed-Combination Drug Product (FCDP) of saxagliptin / dapagliflozin / metformin extended-release (XR).|fixed-combination drug product (fcdp) of saxagliptin / dapagliflozin / metformin extended-release (xr).
4710796|NCT03169959|Fed-state bioequivalence (BE)|fed-state bioequivalence (be)
4710797|NCT03169959|XIGDUO® XR|xigduo® xr
4710798|NCT03169959|ONGLYZA®|onglyza®
4710799|NCT03169933|adjuvant|adjuvant
4710800|NCT03169933|androgen suppressive therapy|androgen suppressive therapy
4710801|NCT03169933|literature review|literature review
4710802|NCT03169933|phase II|phase ii
4710803|NCT03169933|prostate neoplasms|prostate neoplasms
4710804|NCT03169933|radiotherapy|radiotherapy
4710805|NCT03169907|Cardiac functions|cardiac functions
4710806|NCT03169907|Intrauterine fetal anemia|intrauterine fetal anemia
4710807|NCT03169907|Intrauterine Fetal blood transfusion|intrauterine fetal blood transfusion
4710808|NCT03169907|Myocardial performance index|myocardial performance index
4710809|NCT03169907|spatiotemporal imaging correlation|spatiotemporal imaging correlation
4710810|NCT03169868|clinical decision support|clinical decision support
4710811|NCT03169868|drug levels in blood|drug levels in blood
4710812|NCT03169868|therapeutic drug monitoring|therapeutic drug monitoring
4710813|NCT03169868|medication adherence|medication adherence
4710814|NCT03169868|medication therapy management|medication therapy management
4710815|NCT03169855|Traffic Ophthalmology|traffic ophthalmology
4710817|NCT03169855|Cataract|cataract
4710818|NCT03169855|Nighttime driving|nighttime driving
4710819|NCT03169855|contrast sensitivity|contrast sensitivity
4710820|NCT03169855|mesopic vision|mesopic vision
4710821|NCT03169829|Hemodialysis|hemodialysis
4710822|NCT03169829|Renal Disease|renal disease
4710823|NCT03169803|Electrical Stimulation Therapy|electrical stimulation therapy
4710824|NCT03169803|Electrodes|electrodes
4710825|NCT03169803|Parasympathetic Nervous System|parasympathetic nervous system
4710826|NCT03169803|Sympathetic Fibers|sympathetic fibers
4710827|NCT03169803|Post Ganglionic|post ganglionic
4710828|NCT03169803|Congestive Heart Failure|congestive heart failure
4710829|NCT03169803|Heart Failure|heart failure
4710830|NCT03169673|Magnetic Resonance Imaging|magnetic resonance imaging
4710831|NCT03169673|Pulmonary Function|pulmonary function
4710832|NCT03169634|Failed knee replacement|failed knee replacement
4710833|NCT03169634|loosening|loosening
4710834|NCT03169634|wear|wear
4710835|NCT03169634|reoperation|reoperation
4710836|NCT03169621|Chronic Endometritis|chronic endometritis
4710837|NCT03169621|Endometrial pathogens|endometrial pathogens
4710838|NCT03169621|Microbiological diagnosis|microbiological diagnosis
4710839|NCT03169621|Next Generation Sequencing|next generation sequencing
4710840|NCT03169621|Metagenomics|metagenomics
4710841|NCT03169621|Endometrial receptivity|endometrial receptivity
4710842|NCT03169608|autonomic nervous system|autonomic nervous system
4710843|NCT03169608|atrial fibrillation|atrial fibrillation
4710844|NCT03169608|acute kidney injury|acute kidney injury
4710845|NCT03169608|baroreflex sensitivity|baroreflex sensitivity
4710846|NCT03169608|microcirculation|microcirculation
4710847|NCT03169608|coronary artery bypass graft|coronary artery bypass graft
4710848|NCT03169569|hemostatic powder|hemostatic powder
4710849|NCT03169569|post-ESD bleeding|post-esd bleeding
4710850|NCT03169569|antithrombotic therapy|antithrombotic therapy
4710851|NCT03169569|high risk of bleeding|high risk of bleeding
4710852|NCT03169569|endoscopic submucosal dissection|endoscopic submucosal dissection
4710853|NCT03169569|adverse event|adverse event
4710854|NCT03169556|Intubation|intubation
4710855|NCT03169556|light wand|light wand
4710856|NCT03169556|video laryngoscopy|video laryngoscopy
4710857|NCT03169556|cervical spine immobilization|cervical spine immobilization
4710858|NCT03169530|cardiovascular, alcohol, diabetes|cardiovascular, alcohol, diabetes
4710859|NCT03169517|Peripheral nerve block|peripheral nerve block
4710860|NCT03169517|laser speckle contrast imaging|laser speckle contrast imaging
4710861|NCT03169517|blood flow index|blood flow index
4710862|NCT03169504|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
4710863|NCT03169504|Acupuncture Therapy|acupuncture therapy
4710864|NCT03169504|Humans|humans
4710865|NCT03169491|Sleep Apnea, Obstructive|sleep apnea, obstructive
4710866|NCT03169491|Child|child
4710867|NCT03169491|Continuous Positive Airway Pressure|continuous positive airway pressure
4710868|NCT03169491|Perioperative management|perioperative management
4710869|NCT03169491|Adenotonsillectomy|adenotonsillectomy
4710870|NCT03169491|Acoustic pharyngometry|acoustic pharyngometry
4710871|NCT03169478|hysteroscopic myomectomy|hysteroscopic myomectomy
4710872|NCT03169478|balloon dilatation|balloon dilatation
4710873|NCT03169478|adhesions|adhesions
4710874|NCT03169426|remote ischemic conditioning|remote ischemic conditioning
4710875|NCT03169426|beta-blocker|beta-blocker
4710876|NCT03169400|vascular calcification|vascular calcification
4710877|NCT03169400|haemodialysis|haemodialysis
4710878|NCT03169400|dialysis membrane|dialysis membrane
4710879|NCT03169387|Virtual Reality Exposure Therapy|virtual reality exposure therapy
4710880|NCT03169374|Virtual Reality|virtual reality
4710881|NCT03169374|Mechanical Ventilation|mechanical ventilation
4710882|NCT03169374|Anxiety|anxiety
4710883|NCT03169309|complementary and alternative medicine|complementary and alternative medicine
4710884|NCT03169309|military|military
4710885|NCT03169309|binaural beat technology|binaural beat technology
4710886|NCT03169309|brain entrainment technology|brain entrainment technology
4710887|NCT03169309|sleep|sleep
4710888|NCT03169296|Myelodysplastic syndrome|myelodysplastic syndrome
4710889|NCT03169296|Mutations|mutations
4710890|NCT03169296|Next-generation sequencing|next-generation sequencing
4710891|NCT03169270|Exercise training|exercise training
4710892|NCT03169270|Muscle dysfunction|muscle dysfunction
4710893|NCT03169270|COPD|copd
4710894|NCT03169257|paediatric obesity|paediatric obesity
4710895|NCT03169257|cardiovascular dysfunction|cardiovascular dysfunction
4710896|NCT03169257|metabolic syndrome|metabolic syndrome
4710897|NCT03169257|adipokines|adipokines
4710898|NCT03169257|inflammation|inflammation
4710899|NCT03169257|oxidative stress|oxidative stress
4710900|NCT03169218|Adult|adult
4710901|NCT03169218|Chronic pain|chronic pain
4710902|NCT03169218|Entrapment neuropathy. Carpal tunnel|entrapment neuropathy. carpal tunnel
4710903|NCT03169218|Exercise therapy|exercise therapy
4710904|NCT03169218|Humans|humans
4710905|NCT03169218|Neuronal plasticity|neuronal plasticity
4710906|NCT03169218|Mirror neurons|mirror neurons
4710907|NCT03169218|Pain/cognitive aspects|pain/cognitive aspects
4710908|NCT03169218|Physiotherapy|physiotherapy
4710909|NCT03169218|Somatosensory cortex|somatosensory cortex
4710910|NCT03169179|Physical activity|physical activity
4710911|NCT03169179|Mobile health|mobile health
4710912|NCT03169179|Wearable fitness technology|wearable fitness technology
4710913|NCT03169179|Organisational wellness|organisational wellness
4710914|NCT03169179|Occupational health|occupational health
4710915|NCT03169179|Police force|police force
4710916|NCT03169166|GnRH agonist|gnrh agonist
4710917|NCT03169166|In Vitro fertilization|in vitro fertilization
4710918|NCT03169166|Assisted Reproductive Technology|assisted reproductive technology
4710919|NCT03169166|Follicule Maturation|follicule maturation
4710920|NCT03169166|Pregnancy|pregnancy
4710921|NCT03169153|contact lenses|contact lenses
4710922|NCT03169153|lipids|lipids
4710923|NCT03169153|deposits|deposits
4710924|NCT03169140|pain management|pain management
4710925|NCT03169140|topical analgesic|topical analgesic
4710926|NCT03169140|acute low back pain|acute low back pain
4710927|NCT03169140|kinesiology tape|kinesiology tape
4710928|NCT03169127|Ibuprofen|ibuprofen
4710929|NCT03169127|Lower third molar|lower third molar
4710930|NCT03169127|Oral Surgery|oral surgery
4710931|NCT03169114|Appendicitis|appendicitis
4710932|NCT03169114|Surgery|surgery
4710933|NCT03169114|Antibiotic therapy|antibiotic therapy
4710934|NCT03169114|RIPASA Score|ripasa score
4710935|NCT03169101|Smoking Cessation|smoking cessation
4710936|NCT03169101|HIV|hiv
4710937|NCT03169101|Cognition|cognition
4710938|NCT03169088|eating Behavior|eating behavior
4710939|NCT03169088|Volunteers|volunteers
4710940|NCT03169075|Adapted physical ctivity|adapted physical ctivity
4710941|NCT03169075|Oral targeted thérapy|oral targeted thérapy
4710942|NCT03169075|Advanced cancer|advanced cancer
4710943|NCT03169075|Fatigue|fatigue
4710944|NCT03169075|Quality of life|quality of life
4710945|NCT03169075|Randomized Study|randomized study
4710946|NCT03169049|nerve conduction block|nerve conduction block
4710947|NCT03169049|high frequency stimulation|high frequency stimulation
4710948|NCT03169049|handgrip|handgrip
4710949|NCT03169010|registry|registry
4710950|NCT03169010|pulmonary hypertension|pulmonary hypertension
4710951|NCT03169010|survival|survival
4710952|NCT03169010|biomarker|biomarker
4710953|NCT03169010|whole genome sequencing|whole genome sequencing
4710954|NCT03168997|Alzheimer Disease Memantine|alzheimer disease memantine
4710955|NCT03168984|Healthy Japanese subjects|healthy japanese subjects
4710956|NCT03168984|Healthy Caucasian subjects|healthy caucasian subjects
4710957|NCT03168984|UCB0942|ucb0942
4710958|NCT03168971|Cancer|cancer
4710959|NCT03168971|Anxiety|anxiety
4710960|NCT03168971|Cognitive behavior therapy|cognitive behavior therapy
4710961|NCT03168971|Elderly|elderly
4710962|NCT03168971|Caregivers|caregivers
4710963|NCT03168945|Active Case Finding|active case finding
4710964|NCT03168906|Amyloidosis|amyloidosis
4710965|NCT03168906|NEOD001|neod001
4710966|NCT03168906|RAIN|rain
4710967|NCT03168893|deep brain stimulation|deep brain stimulation
4710968|NCT03168867|insulin dependent diabetes mellitus|insulin dependent diabetes mellitus
4710969|NCT03168867|adolescents/young adults|adolescents/young adults
4710970|NCT03168867|e-health intervention|e-health intervention
4710971|NCT03168867|parental monitoring|parental monitoring
4710972|NCT03168854|Anopheles stephensi|anopheles stephensi
4710973|NCT03168854|GAP3KO|gap3ko
4710974|NCT03168854|Malaria|malaria
4710975|NCT03168854|Mosquitoes|mosquitoes
4710976|NCT03168854|Plasmodium falciparum|plasmodium falciparum
4710977|NCT03168815|HFNC|hfnc
4710978|NCT03168815|Bronchoscopy|bronchoscopy
4710979|NCT03168815|Hypoxia|hypoxia
4710980|NCT03168815|Immunocompromised|immunocompromised
4710981|NCT03168815|Hematological malignancy|hematological malignancy
4710982|NCT03168802|Focused ultrasound Ablation|focused ultrasound ablation
4710983|NCT03168802|Radiofrequency Ablation|radiofrequency ablation
4710984|NCT03168802|Facet joint syndrome|facet joint syndrome
4710985|NCT03168802|Chronic low back pain|chronic low back pain
4710986|NCT03168789|Breathing Awareness Meditation,|breathing awareness meditation,
4710987|NCT03168776|Drug-eluting stent|drug-eluting stent
4710988|NCT03168763|Malignant neoplasms of independent (primary) multiple sites|malignant neoplasms of independent (primary) multiple sites
4710989|NCT03168763|Advanced Cancer|advanced cancer
4710990|NCT03168763|Videos|videos
4710991|NCT03168763|Questionnaires|questionnaires
4710992|NCT03168763|Surveys|surveys
4710993|NCT03168737|Malignant neoplasms of independent (primary) multiple sites|malignant neoplasms of independent (primary) multiple sites
4710994|NCT03168737|Solid tumors|solid tumors
4710995|NCT03168737|PET-CT|pet-ct
4710996|NCT03168737|18F-fluoroazomycin arabinoside|18f-fluoroazomycin arabinoside
4710997|NCT03168737|18F-FAZA|18f-faza
4710998|NCT03168724|Cognition|cognition
4710999|NCT03168724|Intervention|intervention
4711000|NCT03168724|Self-management|self-management
4711001|NCT03168724|Rehabilitation|rehabilitation
4711002|NCT03168711|ALS|als
4711003|NCT03168711|Inosine|inosine
4711004|NCT03168711|Uric acid|uric acid
4711005|NCT03168711|Urate|urate
4711006|NCT03168711|Glutathione|glutathione
4711007|NCT03168711|Biomarker|biomarker
4711008|NCT03168711|Oxidative stress|oxidative stress
4711009|NCT03168711|Oxidative damage|oxidative damage
4711010|NCT03168698|pregnancy|pregnancy
4711011|NCT03168698|postpartum hemorrhage|postpartum hemorrhage
4711012|NCT03168698|cesarean delivery|cesarean delivery
4711013|NCT03168698|carbetocin|carbetocin
4711014|NCT03168698|duratocin|duratocin
4711015|NCT03168698|oxytocin|oxytocin
4711016|NCT03168685|smartphones|smartphones
4711017|NCT03168685|clinical trials|clinical trials
4711018|NCT03168685|weight|weight
4711019|NCT03168685|actigraph|actigraph
4711020|NCT03168685|tracking|tracking
4711021|NCT03168685|hemophilia|hemophilia
4711022|NCT03168633|: Type 2 Diabetes Mellitus|: type 2 diabetes mellitus
4711023|NCT03168633|Web-based intervention|web-based intervention
4711024|NCT03168633|medication adherence|medication adherence
4711025|NCT03168633|lifestyle changes|lifestyle changes
4711026|NCT03168607|ORR|orr
4711027|NCT03168607|OS|os
4711028|NCT03168607|PFS|pfs
4711029|NCT03168607|safety|safety
4711030|NCT03168594|chemotherapy|chemotherapy
4711031|NCT03168594|OS|os
4711032|NCT03168594|ORR|orr
4711033|NCT03168594|PFS|pfs
4711034|NCT03168594|safety|safety
4711035|NCT03168529|Acute Heart Failure|acute heart failure
4711036|NCT03168529|Observation|observation
4711037|NCT03168529|Ivabradine|ivabradine
4711038|NCT03168516|Oxygen|oxygen
4711039|NCT03168516|closed-loop automatic control|closed-loop automatic control
4711040|NCT03168516|Oxygen saturation|oxygen saturation
4711041|NCT03168516|preterm infants|preterm infants
4711042|NCT03168451|text messaging|text messaging
4711043|NCT03168438|Cell Therapy|cell therapy
4711044|NCT03168438|Multiple Myeloma|multiple myeloma
4711045|NCT03168438|Immuno-oncology|immuno-oncology
4711046|NCT03168438|T Cell Therapy|t cell therapy
4711047|NCT03168438|Metastatic|metastatic
4711048|NCT03168438|SPEAR T Cell|spear t cell
4711049|NCT03168438|T Cell Receptor|t cell receptor
4711050|NCT03168438|Previously Treated|previously treated
4711051|NCT03168438|NY-ESO-1|ny-eso-1
4711052|NCT03168425|safe opioid prescribing|safe opioid prescribing
4711053|NCT03168412|Hepatitis E|hepatitis e
4711054|NCT03168399|Phenylketonuria|phenylketonuria
4711055|NCT03168399|PKU|pku
4711056|NCT03168399|Metabolism|metabolism
4711057|NCT03168399|Metabolic|metabolic
4711058|NCT03168399|Control|control
4711059|NCT03168399|Acceptability|acceptability
4711060|NCT03168347|Decision making|decision making
4711061|NCT03168269|CCTA interpretation|ccta interpretation
4711062|NCT03168269|technicians|technicians
4711063|NCT03168269|experts|experts
4711064|NCT03168269|comparison|comparison
4711065|NCT03168243|nutrition support, home enteral feeding|nutrition support, home enteral feeding
4711066|NCT03168217|Periodontitis|periodontitis
4711067|NCT03168217|classification|classification
4711068|NCT03168217|Cluster analysis|cluster analysis
4711069|NCT03168139|Metastatic colorectal cancer|metastatic colorectal cancer
4711070|NCT03168139|Metastatic pancreatic cancer|metastatic pancreatic cancer
4711071|NCT03168139|NOX-A12|nox-a12
4711072|NCT03168139|Olaptesed pegol|olaptesed pegol
4711073|NCT03168139|Spiegelmer|spiegelmer
4711074|NCT03168139|Pembrolizumab|pembrolizumab
4711075|NCT03168139|PD-1 inhibitor|pd-1 inhibitor
4711076|NCT03168139|Stromal cell-derived factor-1 (SDF-1)|stromal cell-derived factor-1 (sdf-1)
4711077|NCT03168139|CXCL12|cxcl12
4711078|NCT03168139|Tumor microenvironment|tumor microenvironment
4711079|NCT03168139|Immunotherapy|immunotherapy
4711080|NCT03168139|Checkpoint inhibition|checkpoint inhibition
4711081|NCT03168113|skin barrier function|skin barrier function
4711082|NCT03168113|microbiome|microbiome
4711083|NCT03168113|transepidermal water loss (TEWL)|transepidermal water loss (tewl)
4711084|NCT03168113|epidermal transcriptome|epidermal transcriptome
4711085|NCT03168113|epidermal lipid composition|epidermal lipid composition
4711086|NCT03168061|advanced solid tumor|advanced solid tumor
4711087|NCT03168061|unresectable soft tissue sarcoma|unresectable soft tissue sarcoma
4711088|NCT03168048|mobile application|mobile application
4711089|NCT03168048|radiotherapy|radiotherapy
4711090|NCT03168048|patient-care|patient-care
4711091|NCT03168048|mhealth|mhealth
4711092|NCT03168048|follow-up|follow-up
4711093|NCT03168048|patient satisfaction|patient satisfaction
4711094|NCT03168048|quality of life|quality of life
4711095|NCT03168009|BAT|bat
4711096|NCT03168009|Bariatric Surgery|bariatric surgery
4711097|NCT03168009|Energy Metabolism|energy metabolism
4711098|NCT03167996|South Asian|south asian
4711099|NCT03167996|Cardiovascular Risk Reduction|cardiovascular risk reduction
4711100|NCT03167996|Metabolic Disorders|metabolic disorders
4711101|NCT03167996|Lifestyle modifications|lifestyle modifications
4711102|NCT03167957|fluconazole|fluconazole
4711103|NCT03167957|fluconazole-resistant|fluconazole-resistant
4711104|NCT03167944|Mastectomy|mastectomy
4711105|NCT03167944|Seroma|seroma
4711106|NCT03167931|non-invasive brain stimulation|non-invasive brain stimulation
4711107|NCT03167931|neuromodulation|neuromodulation
4711108|NCT03167931|semantic tasks|semantic tasks
4711109|NCT03167918|calcium dobesilate|calcium dobesilate
4711110|NCT03167918|Xuefuzhuyu Decoction|xuefuzhuyu decoction
4711111|NCT03167918|pulmonary function|pulmonary function
4711112|NCT03167905|Anesthesia, Obstetrical|anesthesia, obstetrical
4711113|NCT03167905|Epidural anesthesia|epidural anesthesia
4711114|NCT03167905|Postnatal depression|postnatal depression
4711115|NCT03167905|Persistent pain|persistent pain
4711116|NCT03167879|family planning|family planning
4711117|NCT03167879|safer conception|safer conception
4711118|NCT03167879|HIV|hiv
4711119|NCT03167879|serodiscordant couples|serodiscordant couples
4711120|NCT03167879|Uganda|uganda
4711121|NCT03167879|contraception|contraception
4711122|NCT03167840|falls prevention, older adults, mild cognitive impairment|falls prevention, older adults, mild cognitive impairment
4711123|NCT03167827|pelvic floor|pelvic floor
4711124|NCT03167827|climateric|climateric
4711125|NCT03167827|exercise|exercise
4711126|NCT03167827|Supplementation of Isoflavone|supplementation of isoflavone
4711127|NCT03167801|tetraplegia|tetraplegia
4711128|NCT03167801|spinal cord injury|spinal cord injury
4711129|NCT03167801|melatonin|melatonin
4711130|NCT03167801|sleep quality|sleep quality
4711131|NCT03167801|sleepiness|sleepiness
4711132|NCT03167723|Chest tube size|chest tube size
4711133|NCT03167723|Hemothorax|hemothorax
4711134|NCT03167723|Empyema|empyema
4711135|NCT03167697|Phenylketonuria|phenylketonuria
4711136|NCT03167697|Hyperphenylalaninaemia|hyperphenylalaninaemia
4711137|NCT03167697|Inherited Metabolic Disorders|inherited metabolic disorders
4711138|NCT03167671|Oswestry|oswestry
4711139|NCT03167671|SF 36|sf 36
4711140|NCT03167671|Promis Pain and Function|promis pain and function
4711141|NCT03167671|Berg Balance|berg balance
4711142|NCT03167658|Wellness|wellness
4711143|NCT03167658|Prevention|prevention
4711144|NCT03167619|Mestastic|mestastic
4711145|NCT03167619|Platinum Sensitive|platinum sensitive
4711146|NCT03167619|Advanced|advanced
4711147|NCT03167619|PARP inhibitor|parp inhibitor
4711148|NCT03167606|myPEEPS|mypeeps
4711149|NCT03167606|Mobile Intervention|mobile intervention
4711150|NCT03167606|Human Immunodeficiency Virus (HIV)|human immunodeficiency virus (hiv)
4711151|NCT03167606|Men who have sex with men (MSM)|men who have sex with men (msm)
4711152|NCT03167593|Lactobacillus coryniformis|lactobacillus coryniformis
4711153|NCT03167593|Flu|flu
4711154|NCT03167593|Vaccine|vaccine
4711155|NCT03167528|Pain|pain
4711156|NCT03167528|Quality of life|quality of life
4711157|NCT03167476|miRNA|mirna
4711158|NCT03167476|biomarker|biomarker
4711159|NCT03167450|CRISPR|crispr
4711160|NCT03167450|Gene Editing|gene editing
4711161|NCT03167450|Qualitative|qualitative
4711162|NCT03167450|Participation Clinical Trials|participation clinical trials
4711163|NCT03167450|Genetic Literacy|genetic literacy
4711164|NCT03167437|Reduce Symptoms of Crohn's Disease|reduce symptoms of crohn's disease
4711165|NCT03167437|HDAC Inhibitors|hdac inhibitors
4711166|NCT03167424|In-stent restenosis|in-stent restenosis
4711167|NCT03167424|Bioresorbable vascular scaffold|bioresorbable vascular scaffold
4711168|NCT03167424|Coronary angiography|coronary angiography
4711169|NCT03167398|fecal microbiota transplantation|fecal microbiota transplantation
4711170|NCT03167398|carbapenem-resistant enterobacteriaceae|carbapenem-resistant enterobacteriaceae
4711171|NCT03167398|multidrug resistant bacteria|multidrug resistant bacteria
4711172|NCT03167398|carrier|carrier
4711173|NCT03167385|locally advanced differentiated thyroid carcinoma|locally advanced differentiated thyroid carcinoma
4711174|NCT03167385|radioiodine refractory thyroid carcinoma|radioiodine refractory thyroid carcinoma
4711175|NCT03167372|Light Therapy|light therapy
4711176|NCT03167372|N-of-1|n-of-1
4711177|NCT03167359|Psychiatry|psychiatry
4711178|NCT03167359|Radiation Therapy|radiation therapy
4711179|NCT03167346|stroke|stroke
4711180|NCT03167346|core symptoms|core symptoms
4711181|NCT03167346|public awareness|public awareness
4711182|NCT03167346|FAST|fast
4711183|NCT03167307|omega-3 fatty acids|omega-3 fatty acids
4711184|NCT03167307|eicosapentaenoic acid|eicosapentaenoic acid
4711185|NCT03167307|docosahexaenoic acid|docosahexaenoic acid
4711186|NCT03167307|antidepressants|antidepressants
4711187|NCT03167307|suicidality|suicidality
4711188|NCT03167307|cognition|cognition
4711189|NCT03167307|childhood depression|childhood depression
4711190|NCT03167307|pediatric depression|pediatric depression
4711191|NCT03167294|Aquablation|aquablation
4711192|NCT03167294|AQUABEAM|aquabeam
4711193|NCT03167294|BPH|bph
4711194|NCT03167294|LUTS|luts
4711195|NCT03167281|Chest tube|chest tube
4711196|NCT03167281|Thoracostomy|thoracostomy
4711197|NCT03167281|Pleural Diseases|pleural diseases
4711198|NCT03167281|Lung Neoplasms|lung neoplasms
4711199|NCT03167281|Pulmonary Embolism|pulmonary embolism
4711200|NCT03167281|Pneumothorax|pneumothorax
4711201|NCT03167281|Thoracic Surgery|thoracic surgery
4711202|NCT03167281|Deoxyribonucleases|deoxyribonucleases
4711203|NCT03167281|Fibrinolytic Agents|fibrinolytic agents
4711204|NCT03167281|Drainage|drainage
4711205|NCT03167281|Pleural Effusion|pleural effusion
4711206|NCT03167268|Lycopene|lycopene
4711207|NCT03167268|Anti EGFR therapy|anti egfr therapy
4711208|NCT03167216|chronic pain|chronic pain
4711209|NCT03167216|prostatitis|prostatitis
4711210|NCT03167216|pelvic pain|pelvic pain
4711211|NCT03167203|hESC-RPE|hesc-rpe
4711212|NCT03167203|Macular Degenerative Disease|macular degenerative disease
4711213|NCT03167190|Point of Care Ultrasound|point of care ultrasound
4711214|NCT03167151|Recurrent intermediate risk NMIBC|recurrent intermediate risk nmibc
4711215|NCT03167151|Intravesical Pembrolizumab|intravesical pembrolizumab
4711216|NCT03167151|Intravenous Pembrolizumab|intravenous pembrolizumab
4711217|NCT03167151|Phase I/II|phase i/ii
4711218|NCT03167151|Marker-lesion|marker-lesion
4711219|NCT03167151|Non-muscle invasive bladder cancer (NMIBC)|non-muscle invasive bladder cancer (nmibc)
4711220|NCT03167138|Shoulder pain|shoulder pain
4711221|NCT03167138|Rotator cuff disease|rotator cuff disease
4711222|NCT03167138|Spinal cord injuries|spinal cord injuries
4711223|NCT03167138|Mesenchymal stromal cells|mesenchymal stromal cells
4711224|NCT03167138|Regenerative medicine|regenerative medicine
4711225|NCT03167138|Rehabilitation|rehabilitation
4711226|NCT03167125|colorectal cancer screening|colorectal cancer screening
4711227|NCT03167125|cancer screening|cancer screening
4711228|NCT03167125|pragmatic trial|pragmatic trial
4711229|NCT03167125|boot camp translation|boot camp translation
4711230|NCT03167112|Potentially Curable|potentially curable
4711231|NCT03167112|Preoperative|preoperative
4711232|NCT03167112|FOLFIRINOX|folfirinox
4711233|NCT03167073|smartphone application|smartphone application
4711234|NCT03167073|low-income women|low-income women
4711235|NCT03167073|breastfeeding|breastfeeding
4711236|NCT03167073|health education|health education
4711237|NCT03167073|health disparities|health disparities
4711238|NCT03167073|postpartum weight loss|postpartum weight loss
4711239|NCT03167034|exercise|exercise
4711240|NCT03167034|echocardiography|echocardiography
4711241|NCT03167034|right ventricular function|right ventricular function
4711242|NCT03167034|obstructive airway disease|obstructive airway disease
4711243|NCT03167034|emphysema|emphysema
4711244|NCT03167034|acetazolamide|acetazolamide
4711245|NCT03167034|altitude|altitude
4711246|NCT03167021|Cannabis|cannabis
4711247|NCT03167021|Community pharmacy|community pharmacy
4711248|NCT03167021|Prevention|prevention
4711249|NCT03167021|Students|students
4711250|NCT03166995|Fibromyalgia,postural exercises|fibromyalgia,postural exercises
4711251|NCT03166982|Tubo-ovarian abscess|tubo-ovarian abscess
4711252|NCT03166982|Transvaginal drainage|transvaginal drainage
4711253|NCT03166982|Laparoscopic treatment|laparoscopic treatment
4711254|NCT03166956|Vitamin C|vitamin c
4711255|NCT03166956|Glutamine|glutamine
4711256|NCT03166956|Interleukin-6|interleukin-6
4711257|NCT03166956|Clinical outcomes|clinical outcomes
4711258|NCT03166930|Muscle Spasticity|muscle spasticity
4711259|NCT03166930|Muscle Stretching Exercises|muscle stretching exercises
4711260|NCT03166891|ovarian cancer, relapsed or refractory,chiauranib|ovarian cancer, relapsed or refractory,chiauranib
4711261|NCT03166878|CAR-T|car-t
4711262|NCT03166878|Cancer treatment|cancer treatment
4711263|NCT03166878|Immunotherapy|immunotherapy
4711264|NCT03166878|Adoptive cell therapy|adoptive cell therapy
4711265|NCT03166878|Chimeric antigen receptor|chimeric antigen receptor
4711266|NCT03166878|Universal CAR-T|universal car-t
4711267|NCT03166865|osteoarthritis (OA)|osteoarthritis (oa)
4711268|NCT03166865|mesenchymal stem cells(MSC)|mesenchymal stem cells(msc)
4711269|NCT03166839|maternal health|maternal health
4711270|NCT03166839|statistical analysis plan|statistical analysis plan
4711271|NCT03166813|remote ischaemic preconditioning|remote ischaemic preconditioning
4711272|NCT03166813|childhood cancer|childhood cancer
4711273|NCT03166813|cardio-oncology|cardio-oncology
4711274|NCT03166813|anthracycline|anthracycline
4711275|NCT03166813|myocardial reperfusion injury|myocardial reperfusion injury
4711276|NCT03166800|mitoquinone|mitoquinone
4711277|NCT03166800|Fatigue|fatigue
4711278|NCT03166800|Multiple Sclerosis|multiple sclerosis
4711279|NCT03166748|Incomplete lower first molar|incomplete lower first molar
4711280|NCT03166748|Immature permanent molar|immature permanent molar
4711281|NCT03166748|Potassium nitrate in polycarboxylate|potassium nitrate in polycarboxylate
4711282|NCT03166748|Mineral trioxide aggregate .Mineral trioxid|mineral trioxide aggregate .mineral trioxid
4711283|NCT03166644|Analgesia Nociception Index (ANI)|analgesia nociception index (ani)
4711284|NCT03166644|Postoperative Analgesia|postoperative analgesia
4711285|NCT03166644|Postoperative Hypoxemia|postoperative hypoxemia
4711286|NCT03166566|glaucoma|glaucoma
4711287|NCT03166566|glaucoma surgery|glaucoma surgery
4711288|NCT03166566|glaucoma drainage device|glaucoma drainage device
4711289|NCT03166566|glaucoma implant|glaucoma implant
4711290|NCT03166566|blindness|blindness
4711291|NCT03166540|coffee|coffee
4711292|NCT03166540|cocoa|cocoa
4711293|NCT03166540|bioavailability|bioavailability
4711294|NCT03166540|pharmacokinetics|pharmacokinetics
4711295|NCT03166540|cardiometabolic risk factors|cardiometabolic risk factors
4711296|NCT03166540|caffeoylquinic acids|caffeoylquinic acids
4711297|NCT03166540|flavan-3-ol|flavan-3-ol
4711298|NCT03166540|caffeine|caffeine
4711299|NCT03166540|trigonelline|trigonelline
4711300|NCT03166540|diterpene|diterpene
4711301|NCT03166449|Traumatic Brain injury|traumatic brain injury
4711302|NCT03166449|Immunonutrition|immunonutrition
4711303|NCT03166384|electrosurgical bipolar sealing devices, breast cancer|electrosurgical bipolar sealing devices, breast cancer
4711304|NCT03166371|Endocrinology|endocrinology
4711305|NCT03166371|Nutrition|nutrition
4711306|NCT03166371|Aging|aging
4711307|NCT03166332|Mindfulness|mindfulness
4711308|NCT03166332|Mediterranean diet|mediterranean diet
4711309|NCT03166332|Neurodevelopment|neurodevelopment
4711310|NCT03166332|Epigenetics|epigenetics
4711311|NCT03166332|Fetal growth restriction|fetal growth restriction
4711312|NCT03166306|pulmonary vascular disease|pulmonary vascular disease
4711313|NCT03166306|pulmonary vascular imaging|pulmonary vascular imaging
4711314|NCT03166293|Cerebral Palsy|cerebral palsy
4711315|NCT03166293|Physical Therapy|physical therapy
4711316|NCT03166293|Rehabilitation|rehabilitation
4711317|NCT03166280|hepatitis C|hepatitis c
4711318|NCT03166280|vitamin D|vitamin d
4711319|NCT03166280|iron|iron
4711320|NCT03166280|hepcidin|hepcidin
4711321|NCT03166215|Drug therapy|drug therapy
4711322|NCT03166202|age-related macular degeneration|age-related macular degeneration
4711323|NCT03166189|Repeated IVF failure|repeated ivf failure
4711324|NCT03166189|Stem cell|stem cell
4711325|NCT03166163|bleeding on brushing|bleeding on brushing
4711326|NCT03166150|Urinary Incontinence, pelvic floor muscle training|urinary incontinence, pelvic floor muscle training
4711327|NCT03166137|Warts,Laser,Cryotherapy|warts,laser,cryotherapy
4711328|NCT03166098|Psychotic Spectrum Disorders|psychotic spectrum disorders
4711329|NCT03166085|HER2-Negative|her2-negative
4711330|NCT03166085|PU-H71|pu-h71
4711331|NCT03166085|Nab-paclitaxel (Abraxane)|nab-paclitaxel (abraxane)
4711332|NCT03166085|17-093|17-093
4711333|NCT03166072|Low-vision|low-vision
4711334|NCT03166072|health related quality of life|health related quality of life
4711335|NCT03166072|visual aids|visual aids
4711336|NCT03166072|randomized controlled trial|randomized controlled trial
4711337|NCT03166059|Catheter directed thrombolysis (CDT)|catheter directed thrombolysis (cdt)
4711338|NCT03166033|Carpal Tunnel Syndrome|carpal tunnel syndrome
4711339|NCT03166033|etiology|etiology
4711340|NCT03166033|risk factor|risk factor
4711341|NCT03166020|Serious Game|serious game
4711342|NCT03166020|Stroke|stroke
4711343|NCT03166020|Rehabilitation|rehabilitation
4711344|NCT03166020|Connected objects|connected objects
4711345|NCT03166007|Multiple Sclerosis|multiple sclerosis
4711346|NCT03166007|Neurogenic Bowel Dysfunction|neurogenic bowel dysfunction
4711347|NCT03166007|Abdominal massage|abdominal massage
4711348|NCT03165994|esophagus|esophagus
4711349|NCT03165994|gastroesoophageal (GE) junction|gastroesoophageal (ge) junction
4711350|NCT03165994|T1-3N0-1|t1-3n0-1
4711351|NCT03165981|Influenza vaccine|influenza vaccine
4711352|NCT03165981|fever following vaccination|fever following vaccination
4711353|NCT03165981|PCV13 vaccine|pcv13 vaccine
4711354|NCT03165981|DTaP vaccine|dtap vaccine
4711355|NCT03165981|pneumococcal vaccine|pneumococcal vaccine
4711356|NCT03165955|breast cancer|breast cancer
4711357|NCT03165955|paclitaxel|paclitaxel
4711358|NCT03165929|free gingival grafts|free gingival grafts
4711359|NCT03165929|connective tissue grafts|connective tissue grafts
4711360|NCT03165929|flurbiprofen|flurbiprofen
4711361|NCT03165890|cognition|cognition
4711362|NCT03165890|visuomotor learning|visuomotor learning
4711363|NCT03165890|airway disease|airway disease
4711364|NCT03165890|altitude|altitude
4711365|NCT03165890|prevention|prevention
4711366|NCT03165890|acetazolamide|acetazolamide
4711367|NCT03165877|GLYCEMIC INDEX|glycemic index
4711368|NCT03165877|NAFLD|nafld
4711369|NCT03165877|METABOLIC PARAMETERS|metabolic parameters
4711370|NCT03165877|SATIETY|satiety
4711371|NCT03165864|Thalassaemia, IONIS TMPRSS6-Lrx|thalassaemia, ionis tmprss6-lrx
4711372|NCT03165838|postpartum|postpartum
4711373|NCT03165838|pregnancy|pregnancy
4711374|NCT03165838|contraception|contraception
4711375|NCT03165838|RROP|rrop
4711376|NCT03165812|Sleeve Gastrectomy|sleeve gastrectomy
4711377|NCT03165812|Duodeno Jejunal Bypass|duodeno jejunal bypass
4711378|NCT03165812|Single Anastomosis|single anastomosis
4711379|NCT03165812|Intensive Medical Therapy|intensive medical therapy
4711380|NCT03165812|Diabetes Mellitus|diabetes mellitus
4711381|NCT03165786|fear of hypoglycemia|fear of hypoglycemia
4711382|NCT03165786|self-management|self-management
4711383|NCT03165786|glycemic control|glycemic control
4711384|NCT03165786|glycemic variability|glycemic variability
4711385|NCT03165760|protective mechanical ventilation|protective mechanical ventilation
4711386|NCT03165747|Probiotics|probiotics
4711387|NCT03165747|Menopausal Osteoporosis|menopausal osteoporosis
4711388|NCT03165734|myelofibrosis|myelofibrosis
4711389|NCT03165734|pacritinib|pacritinib
4711390|NCT03165734|Post-polycythemia Vera Myelofibrosis|post-polycythemia vera myelofibrosis
4711391|NCT03165734|Post-essential Thrombocythemia Myelofibrosis|post-essential thrombocythemia myelofibrosis
4711392|NCT03165734|Ruxolitinib|ruxolitinib
4711393|NCT03165734|Bone Marrow Disease|bone marrow disease
4711394|NCT03165734|Hematologic Diseases|hematologic diseases
4711395|NCT03165734|Blood Platelet Disorders|blood platelet disorders
4711396|NCT03165734|Hemorrhagic Disorders|hemorrhagic disorders
4711397|NCT03165734|Splenomegaly|splenomegaly
4711398|NCT03165734|Anemia|anemia
4711399|NCT03165734|Spleen volume|spleen volume
4711400|NCT03165734|Spleen|spleen
4711401|NCT03165721|Renal Cancer|renal cancer
4711402|NCT03165721|DNA Hypermethylation|dna hypermethylation
4711403|NCT03165721|Gastrointestinal Stromal Tumors|gastrointestinal stromal tumors
4711404|NCT03165721|DNA Methyltransferase (DNMT) Inhibitor|dna methyltransferase (dnmt) inhibitor
4711405|NCT03165721|Succinate Dehydrogenase (SDH) Deficiency|succinate dehydrogenase (sdh) deficiency
4711406|NCT03165708|Epidural technique|epidural technique
4711407|NCT03165695|Delirium|delirium
4711408|NCT03165695|Insomnia|insomnia
4711409|NCT03165695|Ramelteon|ramelteon
4711410|NCT03165682|fatigue|fatigue
4711411|NCT03165682|depression|depression
4711412|NCT03165682|cortical excitability|cortical excitability
4711413|NCT03165669|education|education
4711414|NCT03165669|sleep|sleep
4711415|NCT03165669|pillow|pillow
4711416|NCT03165669|neck|neck
4711417|NCT03165656|Echocardiography|echocardiography
4711418|NCT03165656|right ventricular function|right ventricular function
4711419|NCT03165656|pulmonary hypertension|pulmonary hypertension
4711420|NCT03165656|disease progression|disease progression
4711421|NCT03165656|hypoxia|hypoxia
4711422|NCT03165617|Influenza vaccine|influenza vaccine
4711423|NCT03165604|Physical fitness|physical fitness
4711424|NCT03165604|Exercise|exercise
4711425|NCT03165604|Childhood Obesity|childhood obesity
4711426|NCT03165604|Information|information
4711427|NCT03165539|Postoperative|postoperative
4711428|NCT03165539|One-lung ventilation|one-lung ventilation
4711429|NCT03165539|Cerebral oximetry|cerebral oximetry
4711430|NCT03165539|Cerebral desaturation|cerebral desaturation
4711431|NCT03165513|Traditional healer|traditional healer
4711432|NCT03165513|faith healer|faith healer
4711433|NCT03165513|depression|depression
4711434|NCT03165513|mhGAP|mhgap
4711435|NCT03165513|Kenya|kenya
4711436|NCT03165500|Exodontia|exodontia
4711437|NCT03165500|Sedation|sedation
4711438|NCT03165500|Nitrous Oxide|nitrous oxide
4711439|NCT03165500|Benzodiazepines|benzodiazepines
4711440|NCT03165487|Triple Negative Breast Cancer|triple negative breast cancer
4711441|NCT03165487|microenvironment|microenvironment
4711442|NCT03165487|IORT|iort
4711443|NCT03165487|Hormone Receptor Positive, HER 2 negative|hormone receptor positive, her 2 negative
4711444|NCT03165474|childhood obesity|childhood obesity
4711445|NCT03165474|mhealth|mhealth
4711446|NCT03165474|digital health|digital health
4711447|NCT03165474|nutrition|nutrition
4711448|NCT03165474|intervention|intervention
4711449|NCT03165461|intubation to supraglottic devices|intubation to supraglottic devices
4711450|NCT03165461|intubating laryngeal tube|intubating laryngeal tube
4711451|NCT03165448|oral surgery|oral surgery
4711452|NCT03165448|psychology|psychology
4711453|NCT03165448|fear|fear
4711454|NCT03165448|pain|pain
4711455|NCT03165448|dentistry|dentistry
4711456|NCT03165396|mild cognitive impairment|mild cognitive impairment
4711457|NCT03165383|Transverse Abdominis Plane (TAP) Block|transverse abdominis plane (tap) block
4711458|NCT03165383|Patient Control Analgesia (PCA)|patient control analgesia (pca)
4711459|NCT03165357|Crossfit|crossfit
4711460|NCT03165357|Sodium bicarbonate|sodium bicarbonate
4711461|NCT03165357|Physical capacity|physical capacity
4711462|NCT03165318|Pulsed electromagnetic field|pulsed electromagnetic field
4711463|NCT03165318|Anterior cruciate ligament reconstruction|anterior cruciate ligament reconstruction
4711464|NCT03165318|Muscle|muscle
4711465|NCT03165253|Helicobacter pylori infection|helicobacter pylori infection
4711466|NCT03165253|Children|children
4711467|NCT03165253|Synbiotic|synbiotic
4711468|NCT03165253|Standard Triple Therapy|standard triple therapy
4711469|NCT03165201|Liver transplantation and Biopsy|liver transplantation and biopsy
4711470|NCT03165201|Liver transplantation and LiverMultiScan|liver transplantation and livermultiscan
4711471|NCT03165175|prescription drug abuse|prescription drug abuse
4711472|NCT03165175|prescription drug misuse|prescription drug misuse
4711473|NCT03165175|risk reduction|risk reduction
4711474|NCT03165175|education|education
4711475|NCT03165175|military|military
4711476|NCT03165175|mobile application|mobile application
4711477|NCT03165175|substance misuse|substance misuse
4711478|NCT03165175|substance abuse|substance abuse
4711479|NCT03165162|natural|natural
4711480|NCT03165162|Food Label Choices|food label choices
4711481|NCT03165136|Unexplained Recurrent Miscarriage|unexplained recurrent miscarriage
4711482|NCT03165136|First trimester abortion|first trimester abortion
4711483|NCT03165136|Hydroxychloroquine|hydroxychloroquine
4711484|NCT03165136|Antiphospholipid antibody|antiphospholipid antibody
4711485|NCT03165097|tolerability|tolerability
4711486|NCT03165097|safety|safety
4711487|NCT03165084|Self-management|self-management
4711488|NCT03165084|Primary Health Care|primary health care
4711489|NCT03165084|eHealth|ehealth
4711490|NCT03165032|exercise|exercise
4711491|NCT03165032|echocardiography|echocardiography
4711492|NCT03165032|right ventricular function|right ventricular function
4711493|NCT03165032|pulmonary hypertension|pulmonary hypertension
4711494|NCT03165032|hypoxia|hypoxia
4711495|NCT03165019|high altitude illness|high altitude illness
4711496|NCT03165019|pulmonary hypertension|pulmonary hypertension
4711497|NCT03165019|sleep apnea|sleep apnea
4711498|NCT03165019|disease progression|disease progression
4711499|NCT03165019|hypoxia|hypoxia
4711500|NCT03165006|Breast cancer, screening, survival|breast cancer, screening, survival
4711501|NCT03164993|Neoplasms|neoplasms
4711502|NCT03164980|Quality of life|quality of life
4711503|NCT03164980|ovarian cancer|ovarian cancer
4711504|NCT03164980|platinum sensitive|platinum sensitive
4711505|NCT03164980|recurrent|recurrent
4711506|NCT03164941|selective laser trabeculoplasty|selective laser trabeculoplasty
4711507|NCT03164941|practice|practice
4711508|NCT03164941|treatment|treatment
4711509|NCT03164941|intraocular pressure|intraocular pressure
4711510|NCT03164928|Denosumab|denosumab
4711511|NCT03164928|Pediatric GIOP|pediatric giop
4711512|NCT03164928|Glucocorticoid-induced|glucocorticoid-induced
4711513|NCT03164928|Osteoporosis|osteoporosis
4711514|NCT03164889|Chronic hepatitis B, antiviral treatment|chronic hepatitis b, antiviral treatment
4711515|NCT03164863|Neoadjuvant Chemotherapy, Triple Negative Breast Cancer|neoadjuvant chemotherapy, triple negative breast cancer
4711516|NCT03164824|Questionnaire|questionnaire
4711517|NCT03164824|Functional Rating Index|functional rating index
4711518|NCT03164824|Cross-cultural adaptation|cross-cultural adaptation
4711519|NCT03164824|Psychometric properties testing|psychometric properties testing
4711520|NCT03164772|mRNA Vaccine|mrna vaccine
4711521|NCT03164772|Durvalumab|durvalumab
4711522|NCT03164772|MEDI4736|medi4736
4711523|NCT03164772|anti-PD-L1|anti-pd-l1
4711524|NCT03164772|tremelimumab|tremelimumab
4711525|NCT03164772|anti-CTLA-4|anti-ctla-4
4711526|NCT03164772|BI 1361849|bi 1361849
4711527|NCT03164746|Autism|autism
4711528|NCT03164746|Therapeutic body wraps|therapeutic body wraps
4711529|NCT03164681|sheerly|sheerly
4711530|NCT03164642|Depressive Symptoms|depressive symptoms
4711531|NCT03164642|Developmental Disabilities|developmental disabilities
4711532|NCT03164642|Early Intervention|early intervention
4711533|NCT03164642|Language Development|language development
4711534|NCT03164642|Communication|communication
4711535|NCT03164642|Maternal Empowerment|maternal empowerment
4711536|NCT03164629|BPH|bph
4711537|NCT03164629|Lower Urinary Track Infection|lower urinary track infection
4711538|NCT03164629|Urine Retention|urine retention
4711539|NCT03164616|NSCLC|nsclc
4711540|NCT03164616|PD-L1|pd-l1
4711541|NCT03164616|Durvalumab|durvalumab
4711542|NCT03164616|Tremelimumab|tremelimumab
4711543|NCT03164616|PFS|pfs
4711544|NCT03164551|GERI+|geri+
4711545|NCT03164551|TICON|ticon
4711546|NCT03164551|EEVA|eeva
4711547|NCT03164551|Embryo culture|embryo culture
4711548|NCT03164551|In Vitro Fertilization|in vitro fertilization
4711549|NCT03164551|Intracytoplasmic Sperm Injection|intracytoplasmic sperm injection
4711550|NCT03164525|Thai version|thai version
4711551|NCT03164525|validated|validated
4711552|NCT03164525|Critical Care Pain Observation Tool|critical care pain observation tool
4711553|NCT03164525|Behavioral Pain Scale|behavioral pain scale
4711554|NCT03164525|adult ICU patients|adult icu patients
4711555|NCT03164499|Health education|health education
4711556|NCT03164499|Life style|life style
4711557|NCT03164499|Risk factors|risk factors
4711558|NCT03164499|Cardiovascular diseases|cardiovascular diseases
4711559|NCT03164499|Cognitive performance|cognitive performance
4711560|NCT03164499|Quality of life|quality of life
4711561|NCT03164473|Eosinophilic granulomatosis with polyangiitis in remission|eosinophilic granulomatosis with polyangiitis in remission
4711562|NCT03164473|double-blind randomized controlled trial|double-blind randomized controlled trial
4711563|NCT03164473|maintenance therapy|maintenance therapy
4711564|NCT03164473|rituximab versus azathioprine|rituximab versus azathioprine
4711565|NCT03164473|vasculitis remission|vasculitis remission
4711566|NCT03164473|asthma control|asthma control
4711567|NCT03164473|rhinosinusal manifestations control|rhinosinusal manifestations control
4711568|NCT03164473|glucocorticoid therapy reduction/withdrawal|glucocorticoid therapy reduction/withdrawal
4711569|NCT03164473|steroid sparing effect|steroid sparing effect
4711570|NCT03164473|damage|damage
4711571|NCT03164460|Head and Neck Cancer|head and neck cancer
4711572|NCT03164460|Stereotactic ablative radiotherapy|stereotactic ablative radiotherapy
4711573|NCT03164460|SBRT|sbrt
4711574|NCT03164460|Intensity modulated radiation therapy|intensity modulated radiation therapy
4711575|NCT03164460|IMRT|imrt
4711576|NCT03164460|Intensity modulated proton therapy|intensity modulated proton therapy
4711577|NCT03164460|IMPT|impt
4711578|NCT03164460|Questionnaires|questionnaires
4711579|NCT03164460|Surveys|surveys
4711580|NCT03164434|intracranial pressure|intracranial pressure
4711581|NCT03164434|cerebrospinal fluid drainage|cerebrospinal fluid drainage
4711582|NCT03164434|waveform analysis|waveform analysis
4711583|NCT03164395|atrial fibrillation|atrial fibrillation
4711584|NCT03164395|implantable cardiac defibrillator|implantable cardiac defibrillator
4711585|NCT03164395|cardioversion|cardioversion
4711586|NCT03164369|epidural block, ultrasound|epidural block, ultrasound
4711587|NCT03164356|Limb Fluid Volume Management|limb fluid volume management
4711588|NCT03164356|Prosthetic Socket Modification|prosthetic socket modification
4711589|NCT03164343|Pain Neuroscience Education|pain neuroscience education
4711590|NCT03164330|Health Care|health care
4711591|NCT03164330|Workplace Wellness|workplace wellness
4711592|NCT03164330|Preventative Health Care|preventative health care
4711593|NCT03164330|Health Costs|health costs
4711594|NCT03164317|Hypertension|hypertension
4711595|NCT03164317|High blood pressure|high blood pressure
4711596|NCT03164317|Task shifting|task shifting
4711597|NCT03164317|Decision support system|decision support system
4711598|NCT03164291|MAC and NTM|mac and ntm
4711599|NCT03164278|Wheelchair|wheelchair
4711600|NCT03164278|Biomechanics|biomechanics
4711601|NCT03164278|Transfer|transfer
4711602|NCT03164278|Participation|participation
4711603|NCT03164278|Training|training
4711604|NCT03164265|Regulatory Dendritic Cells|regulatory dendritic cells
4711605|NCT03164252|Third molar;|third molar;
4711606|NCT03164252|Third molar surgery;|third molar surgery;
4711607|NCT03164252|Laser;|laser;
4711608|NCT03164252|Tissue Repair.|tissue repair.
4711609|NCT03164226|endothelial function|endothelial function
4711610|NCT03164226|acute coronary syndrome|acute coronary syndrome
4711611|NCT03164213|tDCS|tdcs
4711612|NCT03164213|aphasia|aphasia
4711613|NCT03164161|Pain Sensitivity|pain sensitivity
4711614|NCT03164161|Measurement|measurement
4711615|NCT03164161|Cold Pressor|cold pressor
4711616|NCT03164161|β-endorphins|β-endorphins
4711617|NCT03164161|saliva|saliva
4711618|NCT03164161|oral surgery|oral surgery
4711619|NCT03164109|Healthy Adult|healthy adult
4711620|NCT03164109|Superoxide Dismutase|superoxide dismutase
4711621|NCT03164109|Free Radical Dismutase|free radical dismutase
4711821|NCT03162913|Strawberry|strawberry
4711622|NCT03164109|Cardiodynamic Assessment|cardiodynamic assessment
4711623|NCT03164083|Joint Diseases|joint diseases
4711624|NCT03164083|Musculoskeletal Diseases|musculoskeletal diseases
4711625|NCT03164083|Arthritis|arthritis
4711626|NCT03164070|Osteoarthritis|osteoarthritis
4711627|NCT03164070|Flow cytometry|flow cytometry
4711628|NCT03164070|Synovial fluid|synovial fluid
4711629|NCT03164057|DNA methyltransferase inhibitors|dna methyltransferase inhibitors
4711630|NCT03164057|Acute myeloid leukemia|acute myeloid leukemia
4711631|NCT03164044|Allergy|allergy
4711632|NCT03164044|Drug allergy|drug allergy
4711633|NCT03164044|Basophil activation test|basophil activation test
4711634|NCT03164044|Flow cytometry|flow cytometry
4711635|NCT03164005|VEGF-B|vegf-b
4711636|NCT03163979|locally advanced cervical cancer; radiotherapy|locally advanced cervical cancer; radiotherapy
4711637|NCT03163953|Physical Activity|physical activity
4711638|NCT03163953|Sedentary Lifestyle|sedentary lifestyle
4711639|NCT03163953|Office Workers|office workers
4711640|NCT03163940|Laughter Yoga|laughter yoga
4711641|NCT03163940|Major Depressive Disorder|major depressive disorder
4711642|NCT03163940|Anxiety|anxiety
4711643|NCT03163940|Stress|stress
4711644|NCT03163940|Depression|depression
4711645|NCT03163940|Quality of Life|quality of life
4711646|NCT03163940|Mood Disorder|mood disorder
4711647|NCT03163914|vasopressor|vasopressor
4711648|NCT03163914|spinal anaesthesia|spinal anaesthesia
4711649|NCT03163901|traumatic brain injury|traumatic brain injury
4711650|NCT03163875|erythema|erythema
4711651|NCT03163875|wheal formation|wheal formation
4711652|NCT03163875|vascular reaction of the skin|vascular reaction of the skin
4711653|NCT03163862|IVF|ivf
4711654|NCT03163836|Double Valve Replacement|double valve replacement
4711655|NCT03163836|Atrial Fibrillation Ablation|atrial fibrillation ablation
4711656|NCT03163797|Oropharyngeal cancer|oropharyngeal cancer
4711657|NCT03163797|integrated PET/MR|integrated pet/mr
4711658|NCT03163797|diffusion-weighted imaging|diffusion-weighted imaging
4711659|NCT03163797|perfusion-weighted imaging|perfusion-weighted imaging
4711660|NCT03163758|Ischemic stroke|ischemic stroke
4711661|NCT03163758|Functional magnetic resonance imaging (fMRI)|functional magnetic resonance imaging (fmri)
4711662|NCT03163758|Repetitive transcranial magnetic stimulation (rTMS)|repetitive transcranial magnetic stimulation (rtms)
4711663|NCT03163758|Brain Reorganization|brain reorganization
4711664|NCT03163732|Solid tumor|solid tumor
4711665|NCT03163732|Advanced tumor|advanced tumor
4711666|NCT03163732|Profiling panel|profiling panel
4711667|NCT03163719|Seizure|seizure
4711668|NCT03163719|Generalized convulsive seizure|generalized convulsive seizure
4711669|NCT03163719|Convulsions|convulsions
4711670|NCT03163719|Creatine Kinase|creatine kinase
4711671|NCT03163719|Lactate|lactate
4711672|NCT03163719|Lactacidaemia|lactacidaemia
4711673|NCT03163719|Diagnostic|diagnostic
4711674|NCT03163719|Losing consciousness|losing consciousness
4711675|NCT03163719|Epilepsy|epilepsy
4711676|NCT03163719|Epileptic generalized tonic-clonic seizure|epileptic generalized tonic-clonic seizure
4711677|NCT03163706|Schizophrenia|schizophrenia
4711678|NCT03163706|Stroop effect|stroop effect
4711679|NCT03163706|Semantic conflict|semantic conflict
4711680|NCT03163706|Response conflict|response conflict
4711681|NCT03163693|Dexmedetomidine|dexmedetomidine
4711682|NCT03163693|Cardiac Troponin I|cardiac troponin i
4711683|NCT03163693|Glycogen Phosphorylase Isoenzyme BB|glycogen phosphorylase isoenzyme bb
4711684|NCT03163680|Gastroduodenal Ulcer|gastroduodenal ulcer
4711685|NCT03163680|Marginal Ulcer|marginal ulcer
4711686|NCT03163680|Peptic Ulcer Hemorrhage|peptic ulcer hemorrhage
4711687|NCT03163680|Peptic Ulcer|peptic ulcer
4711688|NCT03163667|advanced, metastatic RCC|advanced, metastatic rcc
4711689|NCT03163667|RCC|rcc
4711690|NCT03163667|CB-839|cb-839
4711691|NCT03163667|Everolimus|everolimus
4711692|NCT03163667|CBE|cbe
4711693|NCT03163667|Glutaminase Inhibitor|glutaminase inhibitor
4711694|NCT03163667|Glutaminase|glutaminase
4711695|NCT03163667|Tumor Metabolism|tumor metabolism
4711696|NCT03163667|Glutamine|glutamine
4711697|NCT03163654|multiple gingival recessions|multiple gingival recessions
4711698|NCT03163654|collagen matrix|collagen matrix
4711699|NCT03163654|connective tissue graft|connective tissue graft
4711700|NCT03163654|tunnel technique|tunnel technique
4711701|NCT03163628|severe bacterial infection|severe bacterial infection
4711702|NCT03163628|acute infection|acute infection
4711703|NCT03163628|infection viral|infection viral
4711704|NCT03163628|biomarker combination|biomarker combination
4711705|NCT03163628|diagnostic|diagnostic
4711706|NCT03163628|child|child
4711707|NCT03163602|Peri-Implantitis|peri-implantitis
4711708|NCT03163602|Infection|infection
4711709|NCT03163602|Bone substitutes|bone substitutes
4711710|NCT03163524|family planning|family planning
4711711|NCT03163524|reproductive health|reproductive health
4711712|NCT03163524|m-health|m-health
4711713|NCT03163498|Hypertension|hypertension
4711714|NCT03163498|Exercise|exercise
4711715|NCT03163498|Sleep|sleep
4711716|NCT03163485|epilepsy|epilepsy
4711717|NCT03163485|multimodal neuromonitoring|multimodal neuromonitoring
4711718|NCT03163485|depth EEG|depth eeg
4711719|NCT03163485|microdialysis|microdialysis
4711720|NCT03163485|brain injury|brain injury
4711721|NCT03163485|brain tissue at risk|brain tissue at risk
4711722|NCT03163485|NCSE|ncse
4711723|NCT03163485|short time monitoring|short time monitoring
4711724|NCT03163485|neurologic ICU|neurologic icu
4711725|NCT03163459|mechanical thrombectomy|mechanical thrombectomy
4711726|NCT03163459|selective brain cooling|selective brain cooling
4711727|NCT03163446|Staphylococcus aureus|staphylococcus aureus
4711728|NCT03163446|bacteremia|bacteremia
4711729|NCT03163446|staphylococcal endocarditis|staphylococcal endocarditis
4711730|NCT03163433|Patient activation measure|patient activation measure
4711731|NCT03163433|Self-efficacy|self-efficacy
4711732|NCT03163433|Patient participation in research|patient participation in research
4711733|NCT03163433|Patient reported outcome measures|patient reported outcome measures
4711734|NCT03163420|Anesthetic efficacy|anesthetic efficacy
4711735|NCT03163420|Diclofenac|diclofenac
4711736|NCT03163420|Irreversible pulpitis|irreversible pulpitis
4711737|NCT03163381|first-line treatment failure|first-line treatment failure
4711738|NCT03163381|one measurable lesion|one measurable lesion
4711739|NCT03163368|metastatic tumor|metastatic tumor
4711740|NCT03163368|brain lesion|brain lesion
4711741|NCT03163368|stereotactic radiosurgery|stereotactic radiosurgery
4711742|NCT03163368|neoadjuvant|neoadjuvant
4711743|NCT03163368|maximum tolerated dose|maximum tolerated dose
4711744|NCT03163368|dose escalation|dose escalation
4711745|NCT03163368|neurosurgical resection|neurosurgical resection
4711746|NCT03163355|pureed diet|pureed diet
4711747|NCT03163355|dysphasia|dysphasia
4711748|NCT03163342|Seasonal|seasonal
4711749|NCT03163303|Tobacco|tobacco
4711750|NCT03163303|Cigarettes|cigarettes
4711751|NCT03163303|Alcohol|alcohol
4711752|NCT03163303|Cessation|cessation
4711753|NCT03163303|Intervention|intervention
4711754|NCT03163303|Young adults|young adults
4711755|NCT03163303|Internet|internet
4711756|NCT03163303|Social media|social media
4711757|NCT03163264|obesity|obesity
4711758|NCT03163264|weight loss|weight loss
4711759|NCT03163264|weight gain|weight gain
4711760|NCT03163264|weight management|weight management
4711761|NCT03163264|primary care|primary care
4711762|NCT03163264|health coach|health coach
4711763|NCT03163251|READ-SG|read-sg
4711764|NCT03163251|Burnout|burnout
4711765|NCT03163251|Professional identity|professional identity
4711766|NCT03163251|Empathy|empathy
4711767|NCT03163251|Emotional intelligence|emotional intelligence
4711768|NCT03163238|Dexmedetomidine|dexmedetomidine
4711769|NCT03163238|Congenital Heart Disease|congenital heart disease
4711770|NCT03163238|Cardiopulmonary Bypass|cardiopulmonary bypass
4711771|NCT03163238|Interleukin|interleukin
4711772|NCT03163225|outpatient care|outpatient care
4711773|NCT03163225|emergency department visits|emergency department visits
4711774|NCT03163212|Lactoferrin/FOS Supplementation|lactoferrin/fos supplementation
4711775|NCT03163173|Healthy Adult|healthy adult
4711776|NCT03163173|Superoxide Dismutase|superoxide dismutase
4711777|NCT03163173|Absorption|absorption
4711778|NCT03163173|Metabolism|metabolism
4711779|NCT03163173|Elimination|elimination
4711780|NCT03163173|Mass Balance|mass balance
4711781|NCT03163173|Male Subjects|male subjects
4711782|NCT03163160|pelvic floor muscles|pelvic floor muscles
4711783|NCT03163160|pelvic floor myalgia|pelvic floor myalgia
4711784|NCT03163160|manual therapy|manual therapy
4711785|NCT03163160|electrolysis|electrolysis
4711786|NCT03163160|galvanic|galvanic
4711787|NCT03163147|frequency|frequency
4711788|NCT03163134|Lumbar Drain, CSF Leak|lumbar drain, csf leak
4711789|NCT03163121|Plasmodium falciparum|plasmodium falciparum
4711790|NCT03163121|PfSPZ Vaccine|pfspz vaccine
4711791|NCT03163121|PfSPZ-GA1 Vaccine|pfspz-ga1 vaccine
4711792|NCT03163121|Controlled human malaria infection (CHMI)|controlled human malaria infection (chmi)
4711793|NCT03163121|Genetically attenuated sporozoites|genetically attenuated sporozoites
4711794|NCT03163121|Plasmodium falciparum sporozoites (PfSPZ)|plasmodium falciparum sporozoites (pfspz)
4711795|NCT03163108|controller|controller
4711796|NCT03163108|hyperoxia|hyperoxia
4711797|NCT03163108|hypoxia|hypoxia
4711798|NCT03163108|ventilation|ventilation
4711799|NCT03163108|cerebral oxygenation|cerebral oxygenation
4711800|NCT03163095|sepsis|sepsis
4711801|NCT03163095|abdominal infection|abdominal infection
4711802|NCT03163095|open abdomen management|open abdomen management
4711803|NCT03163095|Negative pressure peritoneal therapy|negative pressure peritoneal therapy
4711804|NCT03163082|Coercion theory|coercion theory
4711805|NCT03163082|Corrosive Couple Coercion|corrosive couple coercion
4711806|NCT03163069|tooth bleaching|tooth bleaching
4711807|NCT03163069|dentifrice|dentifrice
4711808|NCT03163056|Smoking cessation|smoking cessation
4711809|NCT03163056|Depression|depression
4711810|NCT03163056|Clinical trial|clinical trial
4711811|NCT03163030|Heart Failure|heart failure
4711812|NCT03163030|Preserved Ejection Fraction|preserved ejection fraction
4711813|NCT03163030|VNS|vns
4711814|NCT03163030|Vagus Nerve|vagus nerve
4711815|NCT03163030|Autonomic Regulation Therapy|autonomic regulation therapy
4711816|NCT03163017|3D Fluoroscopy|3d fluoroscopy
4711817|NCT03163004|Sedentary behavior|sedentary behavior
4711818|NCT03162978|Exercise|exercise
4711819|NCT03162978|behavior economics|behavior economics
4711820|NCT03162952|Chronic pain|chronic pain
4711822|NCT03162913|Cognition|cognition
4711823|NCT03162913|Gait|gait
4711824|NCT03162913|Posture|posture
4711825|NCT03162900|Glasdegib|glasdegib
4711826|NCT03162900|PF-04449913|pf-04449913
4711827|NCT03162900|Pharmacokinetics|pharmacokinetics
4711828|NCT03162900|QTc|qtc
4711829|NCT03162900|TQT|tqt
4711830|NCT03162874|Levodopa-Induced Dyskinesia (LID)|levodopa-induced dyskinesia (lid)
4711831|NCT03162874|Wearing-off|wearing-off
4711832|NCT03162874|Foliglurax|foliglurax
4711833|NCT03162874|Parkinson's Disease|parkinson's disease
4711834|NCT03162874|mGluR4 PAM|mglur4 pam
4711835|NCT03162835|Pain Neuroscience Education|pain neuroscience education
4711836|NCT03162822|Caregiver-Child Coercion|caregiver-child coercion
4711837|NCT03162822|Early Childhood Caries|early childhood caries
4711838|NCT03162809|infertility|infertility
4711839|NCT03162809|in vitro fertilization|in vitro fertilization
4711840|NCT03162809|Estradiol|estradiol
4711841|NCT03162809|Progesterone|progesterone
4711842|NCT03162783|Aldeyra|aldeyra
4711843|NCT03162770|mindfulness meditation|mindfulness meditation
4711844|NCT03162770|hemodialysis|hemodialysis
4711845|NCT03162770|quality of life|quality of life
4711846|NCT03162770|stress|stress
4711847|NCT03162718|lung cancer|lung cancer
4711848|NCT03162718|exercise|exercise
4711849|NCT03162718|pre-operative exercise program|pre-operative exercise program
4711850|NCT03162679|trauma treatment|trauma treatment
4711851|NCT03162679|Refugees|refugees
4711852|NCT03162679|Emotion regulation|emotion regulation
4711853|NCT03162679|Group therapy|group therapy
4711854|NCT03162679|randomized controlled|randomized controlled
4711855|NCT03162679|PTSD|ptsd
4711856|NCT03162653|Allopurinol|allopurinol
4711857|NCT03162653|hypothermia therapy|hypothermia therapy
4711858|NCT03162653|hypoxic-ischemic encephalopathy|hypoxic-ischemic encephalopathy
4711859|NCT03162653|neonatal oxygen deficiency|neonatal oxygen deficiency
4711860|NCT03162653|childbirth outcome|childbirth outcome
4711861|NCT03162653|perinatal asphyxia|perinatal asphyxia
4711862|NCT03162640|Early onset of cannabis use|early onset of cannabis use
4711863|NCT03162640|Addiction|addiction
4711864|NCT03162640|Time perception|time perception
4711865|NCT03162627|Malignant neoplasm of breast|malignant neoplasm of breast
4711866|NCT03162627|Malignant neoplasms of digestive organs|malignant neoplasms of digestive organs
4711867|NCT03162627|Malignant neoplasms of female genital organs|malignant neoplasms of female genital organs
4711868|NCT03162627|Malignant neoplasms of male genital organs|malignant neoplasms of male genital organs
4711869|NCT03162627|Malignant neoplasms of thyroid and other endocrine glands|malignant neoplasms of thyroid and other endocrine glands
4711870|NCT03162627|Solid tumors|solid tumors
4711871|NCT03162627|Ras Pathway Alterations|ras pathway alterations
4711872|NCT03162627|Ovarian Tumors with PARP Resistance|ovarian tumors with parp resistance
4711873|NCT03162627|Selumetinib|selumetinib
4711874|NCT03162627|AZD6244|azd6244
4711875|NCT03162627|Olaparib|olaparib
4711876|NCT03162627|Lynparza|lynparza
4711877|NCT03162614|healthy volunteers|healthy volunteers
4711878|NCT03162614|Malaria|malaria
4711879|NCT03162614|malaria vaccine|malaria vaccine
4711880|NCT03162614|controlled human challenge|controlled human challenge
4711881|NCT03162614|RTS,S/AS01|rts,s/as01
4711882|NCT03162536|ARQ 531|arq 531
4711883|NCT03162536|Hematologic Malignancies|hematologic malignancies
4711884|NCT03162536|SLL|sll
4711885|NCT03162536|CLL|cll
4711886|NCT03162536|B-cell NHL|b-cell nhl
4711887|NCT03162536|WM|wm
4711888|NCT03162536|BTK|btk
4711889|NCT03162536|cancer|cancer
4711890|NCT03162536|refractory|refractory
4711891|NCT03162536|relapsed|relapsed
4711892|NCT03162510|SOLAR regimen|solar regimen
4711893|NCT03162471|Corneal astigmatism|corneal astigmatism
4711894|NCT03162471|Cataract surgery|cataract surgery
4711895|NCT03162471|Corneal hysteresis|corneal hysteresis
4711896|NCT03162471|Corneal resistance factor|corneal resistance factor
4711897|NCT03162471|Intraocular pressure|intraocular pressure
4711898|NCT03162445|bone mineral density|bone mineral density
4711899|NCT03162445|Autism Spectrum Disorder|autism spectrum disorder
4711900|NCT03162445|Autism|autism
4711901|NCT03162432|IBD|ibd
4711902|NCT03162393|brachial plexus; avulsion injury|brachial plexus; avulsion injury
4711903|NCT03162380|Bipolar Disorder|bipolar disorder
4711904|NCT03162380|occupational stress|occupational stress
4711905|NCT03162367|Burn|burn
4711906|NCT03162367|Epidermal cell suspension|epidermal cell suspension
4711907|NCT03162341|Dual-Energy Computed Tomography|dual-energy computed tomography
4711908|NCT03162341|UltraSonography|ultrasonography
4711909|NCT03162341|Gout|gout
4711910|NCT03162341|Urate deposition|urate deposition
4711911|NCT03162302|MRI|mri
4711912|NCT03162302|magnetic resonance imaging|magnetic resonance imaging
4711913|NCT03162302|fat quantification|fat quantification
4711914|NCT03162302|iron quantification|iron quantification
4711915|NCT03162289|Fasting|fasting
4711916|NCT03162289|Vegan|vegan
4711917|NCT03162276|BRCA 1/2 Carriers|brca 1/2 carriers
4711918|NCT03162276|The Work|the work
4711919|NCT03162276|RCT|rct
4711920|NCT03162276|IBSR|ibsr
4711921|NCT03162263|Ekso|ekso
4711922|NCT03162263|neuroplasticity|neuroplasticity
4711923|NCT03162263|functional recovery|functional recovery
4711924|NCT03162237|Type1 diabetes|type1 diabetes
4711925|NCT03162237|porcine islets|porcine islets
4711926|NCT03162237|treg cells|treg cells
4711927|NCT03162237|immunosuppress|immunosuppress
4711928|NCT03162237|xenotransplantation|xenotransplantation
4711929|NCT03162224|Head and Neck Squamous Cell Carcinoma|head and neck squamous cell carcinoma
4711930|NCT03162224|Oropharyngeal Cancer|oropharyngeal cancer
4711931|NCT03162224|HPV|hpv
4711932|NCT03162224|Human Papilloma Virus|human papilloma virus
4711933|NCT03162224|Cancer Immunotherapy|cancer immunotherapy
4711934|NCT03162224|Check point inhibitors|check point inhibitors
4711935|NCT03162224|PD-L1 inhibitor|pd-l1 inhibitor
4711936|NCT03162224|Recurrent or Metastatic Cancer|recurrent or metastatic cancer
4711937|NCT03162224|Durvalumab|durvalumab
4711938|NCT03162224|MEDI0457|medi0457
4711939|NCT03162224|Antineoplastic agents|antineoplastic agents
4711940|NCT03162224|Neoplasms|neoplasms
4711941|NCT03162185|Neuroplasticity|neuroplasticity
4711942|NCT03162185|SSRI|ssri
4711943|NCT03162185|Motor Learning|motor learning
4711944|NCT03162172|congenital adrenal hyperplasia|congenital adrenal hyperplasia
4711945|NCT03162172|short stature|short stature
4711946|NCT03162172|growth hormone treatment|growth hormone treatment
4711947|NCT03162133|Breast Cancer|breast cancer
4711948|NCT03162133|Aromatase Inhibitor Therapy|aromatase inhibitor therapy
4711949|NCT03162133|Baduanjin Exercise|baduanjin exercise
4711950|NCT03162107|adherence|adherence
4711951|NCT03162107|HIV|hiv
4711952|NCT03162107|MDR/XDR TB|mdr/xdr tb
4711953|NCT03162107|Health Care Worker|health care worker
4711954|NCT03162081|addiction|addiction
4711955|NCT03162081|cognition|cognition
4711956|NCT03162081|impulsivity|impulsivity
4711957|NCT03162081|neuropsychology|neuropsychology
4711958|NCT03162081|prescription drug misuse|prescription drug misuse
4711959|NCT03162081|dependence|dependence
4711960|NCT03162068|Cushing's syndrome|cushing's syndrome
4711961|NCT03162068|Osteoporosis|osteoporosis
4711962|NCT03162068|peripheral Quantitative Computed|peripheral quantitative computed
4711963|NCT03162068|volumetric Bone Mineral Density|volumetric bone mineral density
4711964|NCT03162068|Cortical and trabecular bone|cortical and trabecular bone
4711965|NCT03162068|Bone Strength|bone strength
4711966|NCT03162055|COPD|copd
4711967|NCT03162042|Activin A|activin a
4711968|NCT03162042|Myostatin|myostatin
4711969|NCT03162042|Follistatin|follistatin
4711970|NCT03162042|Cachexia|cachexia
4711971|NCT03162042|Squamous cell carcinoma|squamous cell carcinoma
4711972|NCT03162029|CBCT|cbct
4711973|NCT03162029|Bone quality|bone quality
4711974|NCT03162029|Renal failure|renal failure
4711975|NCT03161990|DAIR|dair
4711976|NCT03161990|Transgluteal approach|transgluteal approach
4711977|NCT03161990|Posterior approach|posterior approach
4711978|NCT03161964|Hypoglycemia|hypoglycemia
4711979|NCT03161964|Impaired Awareness of Hypoglycemia|impaired awareness of hypoglycemia
4711980|NCT03161964|Propranolol|propranolol
4711981|NCT03161951|acute Infections, flow cytometry, cell activation|acute infections, flow cytometry, cell activation
4711982|NCT03161912|Diabetes|diabetes
4711983|NCT03161912|Retinal Diseases|retinal diseases
4711984|NCT03161912|Diabetic Retinopathy|diabetic retinopathy
4711985|NCT03161912|Diabetic macular edema|diabetic macular edema
4711986|NCT03161912|Retinal vein occlusion|retinal vein occlusion
4711987|NCT03161912|Macular edema secondary to retinal vein occlusion|macular edema secondary to retinal vein occlusion
4711988|NCT03161912|Intravitreal anti-VEGF (vascular endothelial growth factor)|intravitreal anti-vegf (vascular endothelial growth factor)
4711989|NCT03161912|VEGF inhibitor|vegf inhibitor
4711990|NCT03161912|aflibercept|aflibercept
4711991|NCT03161912|real world data|real world data
4711992|NCT03161912|treatment pattern|treatment pattern
4711993|NCT03161899|thalassemia - nutrition -growth|thalassemia - nutrition -growth
4711994|NCT03161886|colon capsule endoscopy|colon capsule endoscopy
4711995|NCT03161860|Program evaluation|program evaluation
4711996|NCT03161860|Cost-effectiveness|cost-effectiveness
4711997|NCT03161860|Community participation|community participation
4711998|NCT03161860|empowerment|empowerment
4711999|NCT03161847|OPMD|opmd
4712000|NCT03161834|DNA|dna
4712001|NCT03161834|Circulating tumor cells|circulating tumor cells
4712002|NCT03161795|Chemical coping|chemical coping
4712003|NCT03161795|Long-term opioid therapy|long-term opioid therapy
4712004|NCT03161795|Risk factors|risk factors
4712005|NCT03161795|Predictive tools|predictive tools
4712006|NCT03161795|Frequency|frequency
4712007|NCT03161782|pain|pain
4712008|NCT03161782|exercise|exercise
4712009|NCT03161782|proprioceptive neuromuscular facilitation stretching|proprioceptive neuromuscular facilitation stretching
4712010|NCT03161782|static stretching|static stretching
4712011|NCT03161743|platelet-rich plasma|platelet-rich plasma
4712012|NCT03161743|platelet|platelet
4712013|NCT03161730|videolaryngoscope, novice|videolaryngoscope, novice
4712014|NCT03161717|electrical stimulation|electrical stimulation
4712015|NCT03161717|vaginal delivery|vaginal delivery
4712016|NCT03161678|Pharmacogenetics|pharmacogenetics
4712017|NCT03161678|Carboxylesterase 1 (CES1)|carboxylesterase 1 (ces1)
4712018|NCT03161678|Antiplatelet therapy|antiplatelet therapy
4712019|NCT03161652|diabetic retinopathy|diabetic retinopathy
4712020|NCT03161652|blindness|blindness
4712021|NCT03161652|eye|eye
4712022|NCT03161652|macular edema|macular edema
4712023|NCT03161652|prolactin|prolactin
4712024|NCT03161652|dopamine antagonists|dopamine antagonists
4712025|NCT03161652|peptide hormones|peptide hormones
4712026|NCT03161639|Pulpectomy|pulpectomy
4712027|NCT03161639|Primary teeth|primary teeth
4712028|NCT03161639|Working length|working length
4712029|NCT03161639|Apex locator|apex locator
4712030|NCT03161587|FEV1|fev1
4712031|NCT03161587|COPD|copd
4712032|NCT03161587|CAT|cat
4712033|NCT03161587|treatment modality|treatment modality
4712034|NCT03161587|FVC|fvc
4712035|NCT03161587|GOLD 2016|gold 2016
4712036|NCT03161587|mMRC|mmrc
4712037|NCT03161574|neochemotherapy|neochemotherapy
4712038|NCT03161574|CRM|crm
4712039|NCT03161522|Malignant neoplasms of digestive organs|malignant neoplasms of digestive organs
4712040|NCT03161522|Esophageal Cancer|esophageal cancer
4712041|NCT03161522|Gastric Cancer|gastric cancer
4712042|NCT03161522|Oligometastatic|oligometastatic
4712043|NCT03161522|Chemotherapy|chemotherapy
4712044|NCT03161522|Radiation therapy|radiation therapy
4712045|NCT03161522|Surgery|surgery
4712046|NCT03161522|Questionnaires|questionnaires
4712047|NCT03161522|Surveys|surveys
4712048|NCT03161483|CC-220|cc-220
4712049|NCT03161483|Safety|safety
4712050|NCT03161483|Efficacy|efficacy
4712051|NCT03161483|Active Systemic Lupus Erythematosus|active systemic lupus erythematosus
4712052|NCT03161457|RA|ra
4712053|NCT03161457|Moderate RA|moderate ra
4712054|NCT03161457|Moderate Rheumatoid Arthritis|moderate rheumatoid arthritis
4712055|NCT03161457|Severe RA|severe ra
4712056|NCT03161457|Severe Rheumatoid Arthritis|severe rheumatoid arthritis
4712057|NCT03161457|Moderate to Severe RA|moderate to severe ra
4712058|NCT03161457|Moderate to Severe Rheumatoid Arthritis|moderate to severe rheumatoid arthritis
4712059|NCT03161431|Immunotherapy|immunotherapy
4712060|NCT03161431|Chemokine receptor blockade|chemokine receptor blockade
4712061|NCT03161431|Myeloid-derived suppressor cells|myeloid-derived suppressor cells
4712062|NCT03161405|Drug Therapy|drug therapy
4712063|NCT03161392|mammography|mammography
4712064|NCT03161392|ductal ectasia|ductal ectasia
4712065|NCT03161392|breast neoplasm/diagnostic imaging|breast neoplasm/diagnostic imaging
4712066|NCT03161392|mammary Glands, Human/pathology|mammary glands, human/pathology
4712067|NCT03161392|female|female
4712068|NCT03161379|Neoadjuvant therapy|neoadjuvant therapy
4712069|NCT03161379|immunotherapy|immunotherapy
4712070|NCT03161379|Cytoxan|cytoxan
4712071|NCT03161379|Cyclophosphamide|cyclophosphamide
4712072|NCT03161379|Pancreatic Vaccine|pancreatic vaccine
4712073|NCT03161379|SBRT|sbrt
4712074|NCT03161379|GVAX|gvax
4712075|NCT03161379|Nivolumab|nivolumab
4712076|NCT03161379|borderline resectable|borderline resectable
4712077|NCT03161379|Radioimmunotherapy|radioimmunotherapy
4712078|NCT03161379|Vaccine|vaccine
4712079|NCT03161379|Antibody|antibody
4712080|NCT03161379|Anti-PD-1|anti-pd-1
4712081|NCT03161366|Ebola Zaire Outbreak|ebola zaire outbreak
4712082|NCT03161366|Safety of rVSVΔG-ZEBOV-GP vaccine|safety of rvsvδg-zebov-gp vaccine
4712083|NCT03161366|Effectiveness of rVSVΔG-ZEBOV-GP vaccine|effectiveness of rvsvδg-zebov-gp vaccine
4712084|NCT03161340|Recurrent Implantation Failure|recurrent implantation failure
4712085|NCT03161340|Rapamycin|rapamycin
4712086|NCT03161340|Pregnancy Rate|pregnancy rate
4712087|NCT03161327|ankle brachial index|ankle brachial index
4712088|NCT03161327|peripheral arterial disease|peripheral arterial disease
4712089|NCT03161314|Plantar Fasciitis|plantar fasciitis
4712090|NCT03161314|Plantar Heel Pain|plantar heel pain
4712091|NCT03161314|Multisegment Foot Motion|multisegment foot motion
4712092|NCT03161314|EMG|emg
4712093|NCT03161314|Gait|gait
4712094|NCT03161275|cerebral saturation|cerebral saturation
4712095|NCT03161275|epidural anaesthesia|epidural anaesthesia
4712096|NCT03161275|Near Infrared Spectroscopy (NIRS)|near infrared spectroscopy (nirs)
4712097|NCT03161275|Regional cerebral oxygen saturation|regional cerebral oxygen saturation
4712098|NCT03161262|Text-message reminder|text-message reminder
4712099|NCT03161262|Post-operative medication|post-operative medication
4712100|NCT03161262|Behavioral Research|behavioral research
4712101|NCT03161262|Social Research|social research
4712102|NCT03161262|Short Message Service (SMS)|short message service (sms)
4712103|NCT03161249|first psychotic episode, mobile app intervention|first psychotic episode, mobile app intervention
4712104|NCT03161197|CKD, Dialysis, ESRD|ckd, dialysis, esrd
4712105|NCT03161197|Mindfulness-Based Stress Reduction (MBSR)|mindfulness-based stress reduction (mbsr)
4712106|NCT03161184|maternal health|maternal health
4712107|NCT03161184|community health|community health
4712108|NCT03161184|health services|health services
4712109|NCT03161184|Tanzania|tanzania
4712110|NCT03161184|evaluation|evaluation
4712111|NCT03161184|cluster randomized trial|cluster randomized trial
4712112|NCT03161158|Cardio-Renal Syndrome type 1|cardio-renal syndrome type 1
4712113|NCT03161158|Acutely decompensated chronic heart failure|acutely decompensated chronic heart failure
4712114|NCT03161158|Ultrafiltration|ultrafiltration
4712115|NCT03161067|Tetraplegia|tetraplegia
4712116|NCT03161067|Rehabilitation|rehabilitation
4712117|NCT03161067|Brain Computer Interface|brain computer interface
4712118|NCT03161067|Intracortical Microstimulation|intracortical microstimulation
4712119|NCT03161067|Upper extremity prosthetics|upper extremity prosthetics
4712120|NCT03161054|Metronomic Chemotherapy|metronomic chemotherapy
4712121|NCT03161054|Elderly non-fit patients|elderly non-fit patients
4712122|NCT03161054|Aggressive B-Cell lymphomas|aggressive b-cell lymphomas
4712123|NCT03161041|Cytoreductive surgery, HIPEC, perioperative chemotherapy, peritoneal carcinomatosis, bevacizumab, colorectal surgery|cytoreductive surgery, hipec, perioperative chemotherapy, peritoneal carcinomatosis, bevacizumab, colorectal surgery
4712124|NCT03161028|multiple sclerosis|multiple sclerosis
4712125|NCT03161028|magnetic resonance imaging|magnetic resonance imaging
4712126|NCT03161028|gait|gait
4712127|NCT03161028|neuroprotective agents|neuroprotective agents
4712128|NCT03161028|thioctic acid|thioctic acid
4712129|NCT03161028|alpha-lipoic acid|alpha-lipoic acid
4712130|NCT03161028|mobility|mobility
4712131|NCT03161028|chronic progressive multiple sclerosis|chronic progressive multiple sclerosis
4712132|NCT03160989|Blood pressure variability|blood pressure variability
4712133|NCT03160989|Combined physical exercise|combined physical exercise
4712134|NCT03160989|Hypertension|hypertension
4712135|NCT03160963|elderly|elderly
4712136|NCT03160937|pain|pain
4712137|NCT03160924|Enhanced recovery after surgery|enhanced recovery after surgery
4712138|NCT03160924|ERAS|eras
4712139|NCT03160924|Fast track recovery|fast track recovery
4712140|NCT03160924|Laparoscopic gastrectomy|laparoscopic gastrectomy
4712141|NCT03160924|Gastric Cancer|gastric cancer
4712142|NCT03160911|Over-the-scope clip|over-the-scope clip
4712143|NCT03160911|endoscopic haemostasis|endoscopic haemostasis
4712144|NCT03160898|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
4712145|NCT03160898|ALS|als
4712146|NCT03160898|CK-2127107|ck-2127107
4712147|NCT03160872|Donor sperm insemination|donor sperm insemination
4712148|NCT03160872|Anti Mullerian Hormone|anti mullerian hormone
4712149|NCT03160872|Ovarian reserve|ovarian reserve
4712150|NCT03160872|Antral follicle count|antral follicle count
4712151|NCT03160859|unsedated colonoscopy|unsedated colonoscopy
4712152|NCT03160859|water exchange colonoscopy|water exchange colonoscopy
4712153|NCT03160859|cap|cap
4712154|NCT03160859|colonoscopy pain|colonoscopy pain
4712155|NCT03160846|Inotrope|inotrope
4712156|NCT03160846|Milrinone|milrinone
4712157|NCT03160846|Dopamine|dopamine
4712158|NCT03160846|Dobutamine|dobutamine
4712159|NCT03160833|HMPL453|hmpl453
4712160|NCT03160833|solid tumor|solid tumor
4712161|NCT03160833|dose escalation|dose escalation
4712162|NCT03160794|Prostate cancer|prostate cancer
4712163|NCT03160794|stereotactic ablative radiotherpy|stereotactic ablative radiotherpy
4712164|NCT03160794|PET/MR|pet/mr
4712165|NCT03160768|p16|p16
4712166|NCT03160768|T cell isolation|t cell isolation
4712167|NCT03160768|physiologic age|physiologic age
4712168|NCT03160703|Dental stain, stannous fluoride, dentifrice|dental stain, stannous fluoride, dentifrice
4712169|NCT03160690|Choroidal thickness|choroidal thickness
4712170|NCT03160690|Open Angle Glaucoma|open angle glaucoma
4712171|NCT03160690|Non penetrating deep sclerectomy|non penetrating deep sclerectomy
4712172|NCT03160677|Acute Stroke|acute stroke
4712173|NCT03160677|Blood Pressure|blood pressure
4712174|NCT03160677|Cerebral Hemorrhage|cerebral hemorrhage
4712175|NCT03160664|magnetic seizure therapy|magnetic seizure therapy
4712176|NCT03160664|electroconvulsive therapy|electroconvulsive therapy
4712177|NCT03160664|bipolar mania|bipolar mania
4712178|NCT03160664|cognition|cognition
4712179|NCT03160664|randomized controlled trial|randomized controlled trial
4712180|NCT03160651|alcoholic hepatitis|alcoholic hepatitis
4712181|NCT03160651|spontaneous improvement|spontaneous improvement
4712182|NCT03160651|corticosteroids|corticosteroids
4712183|NCT03160638|Azithromycin|azithromycin
4712184|NCT03160638|Immunomodulation|immunomodulation
4712185|NCT03160638|Pharmacokinetics|pharmacokinetics
4712186|NCT03160638|Tissue degradation|tissue degradation
4712187|NCT03160638|Tissue remodelling|tissue remodelling
4712188|NCT03160612|Wheelchair|wheelchair
4712189|NCT03160612|Biomechanics|biomechanics
4712190|NCT03160612|Transfer|transfer
4712191|NCT03160612|Training|training
4712192|NCT03160586|Stuttering|stuttering
4712193|NCT03160586|Anxiety|anxiety
4712194|NCT03160495|PET/MR|pet/mr
4712195|NCT03160495|Squamous cell carcinoma|squamous cell carcinoma
4712196|NCT03160495|Heterogeneity|heterogeneity
4712197|NCT03160482|Thyroid Neoplasm|thyroid neoplasm
4712198|NCT03160482|Papillary Carcinoma|papillary carcinoma
4712199|NCT03160482|Follicular Carcinoma|follicular carcinoma
4712200|NCT03160482|Colloid Nodule|colloid nodule
4712201|NCT03160482|Hyperplastic Nodule|hyperplastic nodule
4712202|NCT03160482|Adenomatoid Nodule|adenomatoid nodule
4712203|NCT03160482|Follicular Adenoma|follicular adenoma
4712204|NCT03160482|Thyroid Cancer|thyroid cancer
4712205|NCT03160482|Bethesda Classification|bethesda classification
4712206|NCT03160482|Biomarkers|biomarkers
4712207|NCT03160482|Protein convertase|protein convertase
4712208|NCT03160469|obesity|obesity
4712209|NCT03160456|upper airway|upper airway
4712210|NCT03160456|genioglossus|genioglossus
4712211|NCT03160456|CPAP|cpap
4712212|NCT03160456|electrical stimulation|electrical stimulation
4712213|NCT03160456|sleep|sleep
4712214|NCT03160456|sleep disordered breathing|sleep disordered breathing
4712215|NCT03160443|Anorexia nervosa|anorexia nervosa
4712216|NCT03160443|Bulimia|bulimia
4712217|NCT03160443|Binge eating disorders|binge eating disorders
4712218|NCT03160443|Neuropsychology|neuropsychology
4712219|NCT03160443|Neurocognition|neurocognition
4712220|NCT03160443|Daily functioning|daily functioning
4712221|NCT03160430|Chronic Kidney Failure|chronic kidney failure
4712222|NCT03160430|ESRD|esrd
4712223|NCT03160430|End-Stage Kidney Disease|end-stage kidney disease
4712224|NCT03160430|End-Stage Renal Disease|end-stage renal disease
4712225|NCT03160430|Renal Disease, End-Stage|renal disease, end-stage
4712226|NCT03160430|Renal Failure, Chronic|renal failure, chronic
4712227|NCT03160430|Renal Failure, End-Stage|renal failure, end-stage
4712228|NCT03160404|Exercise|exercise
4712229|NCT03160404|Zolpidem|zolpidem
4712230|NCT03160404|Sleep|sleep
4712231|NCT03160326|chronic kidney disease|chronic kidney disease
4712232|NCT03160326|ultrasound|ultrasound
4712233|NCT03160326|muscle loss|muscle loss
4712234|NCT03160313|Social engagement|social engagement
4712235|NCT03160313|Physical Activity|physical activity
4712236|NCT03160313|Sleep Quality|sleep quality
4712237|NCT03160313|Traumatic Brain Injury|traumatic brain injury
4712238|NCT03160313|Veteran|veteran
4712239|NCT03160287|mobile, sleep, physical activity, older adults|mobile, sleep, physical activity, older adults
4712240|NCT03160274|tumor suppressor gene|tumor suppressor gene
4712241|NCT03160274|oncogene|oncogene
4712242|NCT03160274|mutation|mutation
4712243|NCT03160274|susceptibility gene|susceptibility gene
4712244|NCT03160222|reliability|reliability
4712245|NCT03160222|bioelectrical impedance analysis|bioelectrical impedance analysis
4712246|NCT03160222|computed tomography|computed tomography
4712247|NCT03160222|strength|strength
4712248|NCT03160222|mobility|mobility
4712249|NCT03160209|risk factors|risk factors
4712250|NCT03160209|case-control study|case-control study
4712251|NCT03160196|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
4712252|NCT03160196|Hemoglobin A, Glycosylated|hemoglobin a, glycosylated
4712253|NCT03160183|initiating chemotherapy|initiating chemotherapy
4712254|NCT03160183|prospective, open label, single arm, cohort|prospective, open label, single arm, cohort
4712255|NCT03160183|non randomized, non interventional|non randomized, non interventional
4712256|NCT03160170|open lumbar spine surgery|open lumbar spine surgery
4712257|NCT03160170|operative time and efficiency|operative time and efficiency
4712258|NCT03160170|Suction-Integrated Surgical Tissue Elevator and Retractor|suction-integrated surgical tissue elevator and retractor
4712259|NCT03160144|laparoscopic resection of colorectal cancer|laparoscopic resection of colorectal cancer
4712260|NCT03160144|open lung approach|open lung approach
4712261|NCT03160131|Stroke|stroke
4712262|NCT03160131|Visual impairment|visual impairment
4712263|NCT03160131|Hemianopia|hemianopia
4712264|NCT03160131|Neuro Vision Technology|neuro vision technology
4712265|NCT03160131|Rehabilitation|rehabilitation
4712266|NCT03160079|blinatumomab|blinatumomab
4712267|NCT03160079|pembrolizumab|pembrolizumab
4712268|NCT03160079|MK-3475|mk-3475
4712269|NCT03160079|relapsed|relapsed
4712270|NCT03160079|refractory|refractory
4712271|NCT03160079|B-lineage acute lymphoblastic leukemia|b-lineage acute lymphoblastic leukemia
4712272|NCT03160079|ALL|all
4712273|NCT03160066|Psychobiotic|psychobiotic
4712274|NCT03160066|Brain-gut axis|brain-gut axis
4712275|NCT03160066|Stress|stress
4712276|NCT03160066|Cognition|cognition
4712277|NCT03160066|EEG|eeg
4712278|NCT03160001|Niclosamide|niclosamide
4712279|NCT03160001|Rheumatoid arthritis|rheumatoid arthritis
4712280|NCT03160001|diseases activity|diseases activity
4712281|NCT03160001|Efficacy|efficacy
4712282|NCT03160001|Safety|safety
4712283|NCT03159975|Tuberculosis|tuberculosis
4712284|NCT03159975|DNA vaccine|dna vaccine
4712285|NCT03159975|Electroporation|electroporation
4712286|NCT03159975|GX-70|gx-70
4712287|NCT03159962|Rapid maxillary expansion|rapid maxillary expansion
4712288|NCT03159962|Mandibular response|mandibular response
4712289|NCT03159962|Class II malocclusion|class ii malocclusion
4712290|NCT03159962|Growing subjects|growing subjects
4712291|NCT03159949|VO2max, maximal oxygen uptake|vo2max, maximal oxygen uptake
4712292|NCT03159910|Shoulder Pain|shoulder pain
4712293|NCT03159910|Occupational Exposure|occupational exposure
4712294|NCT03159910|Clinical Trial|clinical trial
4712295|NCT03159897|advanced stage (IIB-IV)|advanced stage (iib-iv)
4712296|NCT03159897|ABVD DD-DI|abvd dd-di
4712297|NCT03159897|PET|pet
4712298|NCT03159871|Cesarean section|cesarean section
4712299|NCT03159871|C- section|c- section
4712300|NCT03159871|Suture|suture
4712301|NCT03159858|Complex Abdominal Aortic Aneurysm|complex abdominal aortic aneurysm
4712302|NCT03159845|zinc|zinc
4712303|NCT03159832|Efficacy|efficacy
4712304|NCT03159832|PK/PD study|pk/pd study
4712305|NCT03159832|Renal Insufficiency|renal insufficiency
4712306|NCT03159832|Type 2 Diabetes|type 2 diabetes
4712307|NCT03159728|Ability Care|ability care
4712308|NCT03159728|Caregiver overload|caregiver overload
4712309|NCT03159728|Family caregiver|family caregiver
4712310|NCT03159715|Internet, Behavioral Activation, Positive Psychology|internet, behavioral activation, positive psychology
4712311|NCT03159702|hematological malignancy|hematological malignancy
4712312|NCT03159702|EVOMELA|evomela
4712313|NCT03159702|Melphalan HCl|melphalan hcl
4712314|NCT03159702|Total Body Irradiation|total body irradiation
4712315|NCT03159702|Reduced Intensity Conditioning|reduced intensity conditioning
4712316|NCT03159702|Haploidentical Transplantation|haploidentical transplantation
4712317|NCT03159702|Fludarabine|fludarabine
4712318|NCT03159702|Hematologic Diseases|hematologic diseases
4712319|NCT03159702|Neoplasms, Plasma Cell|neoplasms, plasma cell
4712320|NCT03159702|Neoplasms by Histologic Type|neoplasms by histologic type
4712321|NCT03159702|Lymphoproliferative Disorders|lymphoproliferative disorders
4712322|NCT03159676|Prostate cancer|prostate cancer
4712323|NCT03159676|Radiation therapy|radiation therapy
4712324|NCT03159676|Radiotherapy|radiotherapy
4712325|NCT03159676|Proton|proton
4712326|NCT03159676|Proton beam|proton beam
4712327|NCT03159676|Stereotactic ablative body radiotherapy|stereotactic ablative body radiotherapy
4712328|NCT03159676|Stereotactic body radiotherapy|stereotactic body radiotherapy
4712329|NCT03159676|SABR|sabr
4712330|NCT03159676|SBRT|sbrt
4712331|NCT03159676|Localized|localized
4712332|NCT03159676|Low risk|low risk
4712333|NCT03159676|Intermediate risk|intermediate risk
4712334|NCT03159637|Pneumoperitoneum|pneumoperitoneum
4712335|NCT03159637|Trendelenburg position|trendelenburg position
4712336|NCT03159637|intra-abdominal pressure|intra-abdominal pressure
4712337|NCT03159624|nasoseptal flap|nasoseptal flap
4712338|NCT03159624|tissue repair|tissue repair
4712339|NCT03159624|wound healing|wound healing
4712340|NCT03159624|remucosalization|remucosalization
4712341|NCT03159624|upper airway|upper airway
4712342|NCT03159624|granulation tissue|granulation tissue
4712343|NCT03159624|tissue graft|tissue graft
4712344|NCT03159598|A-BR|a-br
4712345|NCT03159598|Abdominal-based breast reconstruction|abdominal-based breast reconstruction
4712346|NCT03159598|Seroma|seroma
4712347|NCT03159572|Ovarian cancer|ovarian cancer
4712348|NCT03159572|Fallopian tube cancer|fallopian tube cancer
4712349|NCT03159572|Primary peritoneal cancer|primary peritoneal cancer
4712350|NCT03159572|Germline Breast Cancer Susceptibility Gene (BRCA1/2 gene)|germline breast cancer susceptibility gene (brca1/2 gene)
4712351|NCT03159572|Homologous Recombination Deficiency (HRD)|homologous recombination deficiency (hrd)
4712352|NCT03159520|Pain|pain
4712353|NCT03159507|Omega-3 Index|omega-3 index
4712354|NCT03159507|Cellular metabolism|cellular metabolism
4712355|NCT03159507|EPA Monoglyceride|epa monoglyceride
4712356|NCT03159507|Quality of life|quality of life
4712357|NCT03159442|Chronic obstructive pulmonary disease (COPD)|chronic obstructive pulmonary disease (copd)
4712358|NCT03159442|Asthma|asthma
4712359|NCT03159442|AZD8871|azd8871
4712360|NCT03159442|muscarinic receptor antagonist and β2 adrenoceptor agonist (MABA)|muscarinic receptor antagonist and β2 adrenoceptor agonist (maba)
4712361|NCT03159442|Phase I|phase i
4712362|NCT03159442|Safety|safety
4712363|NCT03159442|Tolerability|tolerability
4712364|NCT03159442|Pharmacokinetics|pharmacokinetics
4712365|NCT03159442|long-acting muscarinic antagonist (LAMA)|long-acting muscarinic antagonist (lama)
4712366|NCT03159442|long-acting β2-agonist (LABA)|long-acting β2-agonist (laba)
4712367|NCT03159442|Japanese|japanese
4712368|NCT03159390|dietary supplements|dietary supplements
4712369|NCT03159377|pulmonary nodule, CT, low dose|pulmonary nodule, ct, low dose
4712371|NCT03159364|Virus CTL|virus ctl
4712372|NCT03159364|Fungus CTL|fungus ctl
4712373|NCT03159364|TB CTL|tb ctl
4712374|NCT03159325|internet|internet
4712375|NCT03159325|chronic disease management|chronic disease management
4712376|NCT03159325|technology|technology
4712377|NCT03159325|telehealth|telehealth
4712378|NCT03159325|application|application
4712379|NCT03159312|obesity,bariatric surgery,physical activity|obesity,bariatric surgery,physical activity
4712380|NCT03159299|mHealth|mhealth
4712381|NCT03159299|Hispanic/Latinos|hispanic/latinos
4712382|NCT03159299|Diabetes Self-Management Education|diabetes self-management education
4712383|NCT03159273|Dietary nitrate supplementation|dietary nitrate supplementation
4712384|NCT03159273|Cold symptoms|cold symptoms
4712385|NCT03159273|Stress|stress
4712386|NCT03159273|Immunity|immunity
4712387|NCT03159273|Exhaled nitric oxide|exhaled nitric oxide
4712388|NCT03159273|Lung function|lung function
4712389|NCT03159273|Cardiovascular activity|cardiovascular activity
4712390|NCT03159260|night-time leg cramps|night-time leg cramps
4712391|NCT03159260|topical|topical
4712392|NCT03159260|spasm|spasm
4712393|NCT03159247|education|education
4712394|NCT03159247|counseling|counseling
4712395|NCT03159247|motivational interviewing|motivational interviewing
4712396|NCT03159247|tailoring|tailoring
4712397|NCT03159221|type 2 diabetes in adolescents|type 2 diabetes in adolescents
4712398|NCT03159221|obesity in adolescents|obesity in adolescents
4712399|NCT03159221|behavioral family systems therapy|behavioral family systems therapy
4712400|NCT03159208|Prognosis|prognosis
4712401|NCT03159208|Critical Illness|critical illness
4712402|NCT03159208|Ventilation, Mechanical|ventilation, mechanical
4712403|NCT03159208|Disease Attributes|disease attributes
4712404|NCT03159208|Socioeconomic Factors|socioeconomic factors
4712405|NCT03159208|Activities of Daily LIving|activities of daily living
4712406|NCT03159208|Cognition|cognition
4712407|NCT03159195|metastatic breast cancer|metastatic breast cancer
4712408|NCT03159195|advanced breast cancer|advanced breast cancer
4712409|NCT03159195|HR+/ HER2-|hr+/ her2-
4712410|NCT03159182|Hypertrophic scarring|hypertrophic scarring
4712411|NCT03159182|Silicone Material|silicone material
4712412|NCT03159182|Pressure garments|pressure garments
4712413|NCT03159169|Neck Pain|neck pain
4712414|NCT03159169|Upper Limb Pain|upper limb pain
4712415|NCT03159130|Pain pump catheters|pain pump catheters
4712416|NCT03159130|bariatric surgery|bariatric surgery
4712417|NCT03159130|OnQ pump|onq pump
4712418|NCT03159130|sleeve gastrectomy|sleeve gastrectomy
4712419|NCT03159130|continuous infusion catheter|continuous infusion catheter
4712420|NCT03159117|GD3 ADC (Pfizer PF-06688992)|gd3 adc (pfizer pf-06688992)
4712421|NCT03159117|Stage III Melanoma|stage iii melanoma
4712422|NCT03159117|Stage IV Melanoma|stage iv melanoma
4712423|NCT03159117|17-165|17-165
4712424|NCT03159078|Acinetobacter|acinetobacter
4712425|NCT03159078|Polymyxins|polymyxins
4712426|NCT03159078|Imipenem|imipenem
4712427|NCT03159078|Pseudomona|pseudomona
4712428|NCT03159078|Klebsiella|klebsiella
4712429|NCT03159026|Amish/Mennonite variant|amish/mennonite variant
4712430|NCT03159013|Pyrethroids|pyrethroids
4712431|NCT03159013|Lambda-cyhalothrin|lambda-cyhalothrin
4712432|NCT03159013|Biomarkers|biomarkers
4712433|NCT03159013|Toxicokinetics|toxicokinetics
4712434|NCT03158974|External Genital Warts|external genital warts
4712435|NCT03158961|Thyroid|thyroid
4712436|NCT03158961|Thyroidectomy|thyroidectomy
4712437|NCT03158961|Transoral|transoral
4712438|NCT03158961|Endoscopic|endoscopic
4712439|NCT03158961|Surgery|surgery
4712440|NCT03158948|Sepsis|sepsis
4712441|NCT03158948|LR12|lr12
4712442|NCT03158948|TREM1|trem1
4712443|NCT03158948|TREM-1|trem-1
4712444|NCT03158935|adoptive cell therapy|adoptive cell therapy
4712445|NCT03158935|melanoma|melanoma
4712446|NCT03158935|ovarian|ovarian
4712447|NCT03158935|cyclophosphamide|cyclophosphamide
4712448|NCT03158935|fludarabine|fludarabine
4712449|NCT03158935|tumor-infiltrating lymphocytes (TILs)|tumor-infiltrating lymphocytes (tils)
4712450|NCT03158935|pembrolizumab|pembrolizumab
4712451|NCT03158935|interleukin-2|interleukin-2
4712452|NCT03158935|anti-PD-1|anti-pd-1
4712453|NCT03158935|immune checkpoint|immune checkpoint
4712454|NCT03158909|Eyemask|eyemask
4712455|NCT03158909|Earplugs|earplugs
4712456|NCT03158896|mesenchymal stem cell|mesenchymal stem cell
4712457|NCT03158896|hematopoietic stem cell transplant|hematopoietic stem cell transplant
4712458|NCT03158896|Allogeneic hematopoietic stem cell transplant|allogeneic hematopoietic stem cell transplant
4712459|NCT03158896|Autologous hematopoietic stem cell transplant|autologous hematopoietic stem cell transplant
4712460|NCT03158896|Wharton's jelly|wharton's jelly
4712461|NCT03158896|umbilical cord blood|umbilical cord blood
4712462|NCT03158896|steroid refractory graft versus host disease|steroid refractory graft versus host disease
4712463|NCT03158883|Avelumab|avelumab
4712464|NCT03158883|NSCLC|nsclc
4712465|NCT03158883|Stereotactic ablative radiotherapy (SAR)|stereotactic ablative radiotherapy (sar)
4712466|NCT03158857|Myanmar|myanmar
4712467|NCT03158857|HIV|hiv
4712468|NCT03158831|Drug Allergy|drug allergy
4712469|NCT03158831|Penicillin Allergy|penicillin allergy
4712470|NCT03158831|Antibiotic Allergy|antibiotic allergy
4712471|NCT03158831|Graded Drug Challenge|graded drug challenge
4712472|NCT03158792|Anticoagulation|anticoagulation
4712473|NCT03158792|Thromboprophylaxis|thromboprophylaxis
4712474|NCT03158792|Anti-Xa levels|anti-xa levels
4712475|NCT03158792|Elderly|elderly
4712476|NCT03158792|Prevention|prevention
4712477|NCT03158792|Enoxaparin|enoxaparin
4712478|NCT03158792|Low molecular weight heparin|low molecular weight heparin
4712479|NCT03158766|infection|infection
4712480|NCT03158766|intervertebral disc|intervertebral disc
4712481|NCT03158766|Propionibacterium acnes|propionibacterium acnes
4712482|NCT03158766|spine|spine
4712483|NCT03158727|intensive care|intensive care
4712484|NCT03158701|evaluation|evaluation
4712485|NCT03158675|fractional co2 laser, topical steroid,UVB narrow band|fractional co2 laser, topical steroid,uvb narrow band
4712486|NCT03158662|Epidermolysis Bullosa|epidermolysis bullosa
4712487|NCT03158662|Recessive Dystrophic|recessive dystrophic
4712488|NCT03158662|Simplex|simplex
4712489|NCT03158662|Junctional Non-Herlitz|junctional non-herlitz
4712490|NCT03158649|Pregnancy|pregnancy
4712491|NCT03158649|Prenatal well-being|prenatal well-being
4712492|NCT03158649|Mental maternal prenatal well-being|mental maternal prenatal well-being
4712493|NCT03158649|Positive Psychology|positive psychology
4712494|NCT03158649|Positive Psychology Intervention|positive psychology intervention
4712495|NCT03158649|Web-based intervention|web-based intervention
4712496|NCT03158623|total joint arthroplasty|total joint arthroplasty
4712497|NCT03158623|platelet-rich plasma|platelet-rich plasma
4712498|NCT03158623|activated collagen|activated collagen
4712499|NCT03158571|Gastric Cancer|gastric cancer
4712500|NCT03158571|gastric adenocarcinoma|gastric adenocarcinoma
4712501|NCT03158571|cancer subtypes|cancer subtypes
4712502|NCT03158571|prognosis|prognosis
4712503|NCT03158571|survival|survival
4712504|NCT03158571|molecular classification|molecular classification
4712505|NCT03158571|chemotherapy|chemotherapy
4712506|NCT03158571|immunotherapy|immunotherapy
4712507|NCT03158519|Physical activity|physical activity
4712508|NCT03158480|DC-CIK|dc-cik
4712509|NCT03158480|interferon|interferon
4712510|NCT03158441|MRI|mri
4712511|NCT03158441|Diffusion|diffusion
4712512|NCT03158441|DTI|dti
4712513|NCT03158415|mHealth|mhealth
4712514|NCT03158402|Inspiratory muscle training|inspiratory muscle training
4712515|NCT03158402|Systemic Inflammatory Response Syndrome|systemic inflammatory response syndrome
4712516|NCT03158389|MGMT methylation|mgmt methylation
4712517|NCT03158389|targeted therapy|targeted therapy
4712518|NCT03158389|umbrella protocol|umbrella protocol
4712519|NCT03158376|gabapentin|gabapentin
4712520|NCT03158376|thoracotomy|thoracotomy
4712521|NCT03158376|chronic post-thoracotomy pain|chronic post-thoracotomy pain
4712522|NCT03158376|acute post-thoracotomy pain|acute post-thoracotomy pain
4712523|NCT03158376|quality of life|quality of life
4712524|NCT03158376|neuropathic pain|neuropathic pain
4712525|NCT03158363|immobilization|immobilization
4712526|NCT03158363|fasting|fasting
4712527|NCT03158363|endotoxemia|endotoxemia
4712528|NCT03158363|LPS|lps
4712529|NCT03158363|metabolism|metabolism
4712530|NCT03158363|model of disease|model of disease
4712531|NCT03158337|Exercise|exercise
4712532|NCT03158337|Physical Activity|physical activity
4712533|NCT03158337|Brain blood flow|brain blood flow
4712534|NCT03158337|Cognition|cognition
4712535|NCT03158337|Fitness|fitness
4712536|NCT03158311|QVM149|qvm149
4712537|NCT03158311|asthma|asthma
4712538|NCT03158311|adult|adult
4712539|NCT03158259|IS|is
4712540|NCT03158259|ICH|ich
4712541|NCT03158259|rtPa|rtpa
4712542|NCT03158259|Prehospital|prehospital
4712543|NCT03158259|MSU|msu
4712544|NCT03158246|zoledronic acid|zoledronic acid
4712545|NCT03158246|Yigu|yigu
4712546|NCT03158246|Aclasta|aclasta
4712547|NCT03158246|Osteoporosis|osteoporosis
4712548|NCT03158246|Postmenopausal|postmenopausal
4712549|NCT03158246|BMD|bmd
4712550|NCT03158246|fracture|fracture
4712551|NCT03158246|Biochemical markers|biochemical markers
4712552|NCT03158233|Zika virus disease|zika virus disease
4712553|NCT03158194|Anxiety|anxiety
4712554|NCT03158194|Stress|stress
4712555|NCT03158194|Asthma|asthma
4712556|NCT03158181|Behavior; Operational block; Monitoring; Social Sciences ; New technologies|behavior; operational block; monitoring; social sciences ; new technologies
4712557|NCT03158129|Non-Small Cell Lung Cancer|non-small cell lung cancer
4712558|NCT03158129|NSCLC|nsclc
4712559|NCT03158129|Nivolumab|nivolumab
4712560|NCT03158129|BMS-936558|bms-936558
4712561|NCT03158129|Opdivo|opdivo
4712562|NCT03158129|Ipilimumab|ipilimumab
4712563|NCT03158129|Yervoy|yervoy
4712564|NCT03158129|BMS-734016|bms-734016
4712565|NCT03158129|MDX010|mdx010
4712566|NCT03158129|Amenable For Surgical Resection|amenable for surgical resection
4712567|NCT03158116|tracheostomy tube|tracheostomy tube
4712568|NCT03158116|Pseudomonas aeruginosa|pseudomonas aeruginosa
4712569|NCT03158103|MEK162 (Binimetinib)|mek162 (binimetinib)
4712570|NCT03158103|Pexidartinib|pexidartinib
4712571|NCT03158103|17-056|17-056
4712572|NCT03158090|Acromegaly|acromegaly
4712573|NCT03158064|17-160|17-160
4712574|NCT03158064|durvalumab|durvalumab
4712575|NCT03158064|tremelimumab|tremelimumab
4712576|NCT03158064|MEDI4736|medi4736
4712577|NCT03158051|Hypertension|hypertension
4712578|NCT03158051|Young Adult|young adult
4712579|NCT03158051|Self-Management|self-management
4712580|NCT03158051|Health coach|health coach
4712581|NCT03158038|Trivalent|trivalent
4712582|NCT03158038|Influenza|influenza
4712583|NCT03158038|FluMist Quadrivalent|flumist quadrivalent
4712584|NCT03158038|Vaccine|vaccine
4712585|NCT03158038|Prevention|prevention
4712586|NCT03158038|Healthy|healthy
4712587|NCT03158038|Monovalent|monovalent
4712588|NCT03158025|Recreational sedatives|recreational sedatives
4712589|NCT03158025|Healthy participants|healthy participants
4712590|NCT03158025|Lemborexant|lemborexant
4712591|NCT03158025|E2006|e2006
4712592|NCT03158025|Zolpidem|zolpidem
4712593|NCT03158025|Suvorexant|suvorexant
4712594|NCT03157999|Older Adults|older adults
4712595|NCT03157999|Transitional Care|transitional care
4712596|NCT03157999|Caregiver|caregiver
4712597|NCT03157999|Intervention|intervention
4712598|NCT03157986|COPD|copd
4712599|NCT03157986|Balance|balance
4712600|NCT03157986|Whole Body Vibration Training|whole body vibration training
4712601|NCT03157986|pulmonary rehabilitation|pulmonary rehabilitation
4712602|NCT03157986|exercise|exercise
4712603|NCT03157973|Information Literacy|information literacy
4712604|NCT03157973|Nursing Care|nursing care
4712605|NCT03157973|Social Support|social support
4712606|NCT03157960|Fructose|fructose
4712607|NCT03157960|Uric acid|uric acid
4712608|NCT03157960|Oxidised LDL|oxidised ldl
4712609|NCT03157960|Interleukin 6|interleukin 6
4712610|NCT03157947|decision aid|decision aid
4712611|NCT03157947|focus group|focus group
4712612|NCT03157934|stroke network|stroke network
4712613|NCT03157934|acute stroke care|acute stroke care
4712614|NCT03157934|emergency medical services|emergency medical services
4712615|NCT03157934|integrated care|integrated care
4712616|NCT03157908|South Africa|south africa
4712617|NCT03157908|Retention in care|retention in care
4712618|NCT03157908|Pregnancy|pregnancy
4712619|NCT03157908|Mobile health|mobile health
4712620|NCT03157895|Foster Families|foster families
4712621|NCT03157882|pediatric|pediatric
4712622|NCT03157882|children|children
4712623|NCT03157882|Faces Pain Scale Revised|faces pain scale revised
4712624|NCT03157882|Wong Baker FACES|wong baker faces
4712625|NCT03157882|pain scales|pain scales
4712626|NCT03157882|BRIGANCE|brigance
4712627|NCT03157869|Learning, Automatism, Motor Activity, Electric Stimulation|learning, automatism, motor activity, electric stimulation
4712628|NCT03157856|Fluorescence imaging technique|fluorescence imaging technique
4712629|NCT03157856|Biopsies from resected prostate|biopsies from resected prostate
4712630|NCT03157856|Medical device|medical device
4712631|NCT03157830|Multiple Sclerosis|multiple sclerosis
4712632|NCT03157830|MS|ms
4712633|NCT03157830|ocrelizumab|ocrelizumab
4712634|NCT03157830|OCREVUS|ocrevus
4712635|NCT03157830|Natalizumab|natalizumab
4712636|NCT03157830|Tysabri|tysabri
4712637|NCT03157791|simethicone|simethicone
4712638|NCT03157778|pregnenolone|pregnenolone
4712639|NCT03157778|endocannabinoid|endocannabinoid
4712640|NCT03157778|food intake|food intake
4712641|NCT03157778|type-1 cannabinoid receptor|type-1 cannabinoid receptor
4712642|NCT03157765|recurrent implantation failure|recurrent implantation failure
4712643|NCT03157765|frozen embryo transfer|frozen embryo transfer
4712644|NCT03157765|IVF|ivf
4712645|NCT03157765|endometrial scratch|endometrial scratch
4712646|NCT03157765|endometrial injury|endometrial injury
4712647|NCT03157739|Migraine|migraine
4712648|NCT03157726|benign prostatic hyperplasia|benign prostatic hyperplasia
4712649|NCT03157726|multicenter randomized control clinical trial|multicenter randomized control clinical trial
4712650|NCT03157726|transurethral plasmakinetic enucleation of prostate|transurethral plasmakinetic enucleation of prostate
4712651|NCT03157726|transurethral resection of prostate|transurethral resection of prostate
4712652|NCT03157713|Obesity|obesity
4712653|NCT03157713|Weight-loss|weight-loss
4712654|NCT03157713|Financial Incentives|financial incentives
4712655|NCT03157713|Behavioral Economics|behavioral economics
4712656|NCT03157648|Shivering temperature|shivering temperature
4712657|NCT03157622|Chronic Low Back Pain|chronic low back pain
4712658|NCT03157622|Cognitive-Behavioural Therapy|cognitive-behavioural therapy
4712659|NCT03157622|Exposure|exposure
4712660|NCT03157622|Therapeutic processes|therapeutic processes
4712661|NCT03157622|Single-case study|single-case study
4712662|NCT03157609|Thermometry|thermometry
4712663|NCT03157609|SpotOn|spoton
4712664|NCT03157596|disability|disability
4712665|NCT03157596|developmental disability|developmental disability
4712666|NCT03157596|special healthcare needs|special healthcare needs
4712667|NCT03157557|Treatment|treatment
4712668|NCT03157557|Sheltered Housing|sheltered housing
4712669|NCT03157544|Chronic Neck Pain|chronic neck pain
4712670|NCT03157544|Chronic Back Pain|chronic back pain
4712671|NCT03157544|non-pharmacological|non-pharmacological
4712672|NCT03157544|pain relief|pain relief
4712673|NCT03157518|Asthma|asthma
4712674|NCT03157518|obesity|obesity
4712675|NCT03157518|micorbiome|micorbiome
4712676|NCT03157518|probiotics|probiotics
4712677|NCT03157492|Adult|adult
4712678|NCT03157492|Post-lingual|post-lingual
4712679|NCT03157492|Auditory training|auditory training
4712680|NCT03157492|Communication strategies|communication strategies
4712681|NCT03157492|Speech tracking|speech tracking
4712682|NCT03157492|Speech recognition|speech recognition
4712683|NCT03157492|Quality of Life|quality of life
4712684|NCT03157479|Mechanical ventilation|mechanical ventilation
4712685|NCT03157453|Evaluation scale|evaluation scale
4712686|NCT03157453|Brain injury|brain injury
4712687|NCT03157453|Severity of Brain Injury|severity of brain injury
4712688|NCT03157453|Initial Evaluation|initial evaluation
4712689|NCT03157427|Solar Lentigo, Cryotherapy, Difluoroethane|solar lentigo, cryotherapy, difluoroethane
4712690|NCT03157388|inflammation|inflammation
4712691|NCT03157388|Macrophages|macrophages
4712692|NCT03157388|CD163|cd163
4712693|NCT03157375|IOL, IOL Rotation, Axial Rotation|iol, iol rotation, axial rotation
4712694|NCT03157349|Biofreeze|biofreeze
4712695|NCT03157349|Acute Neck Pain|acute neck pain
4712696|NCT03157349|Placebo|placebo
4712697|NCT03157349|chiropractic|chiropractic
4712698|NCT03157336|Cassava|cassava
4712699|NCT03157336|Konzo|konzo
4712700|NCT03157336|Cyanide|cyanide
4712701|NCT03157336|Cyanate|cyanate
4712702|NCT03157336|Thiocyanate|thiocyanate
4712703|NCT03157336|Carbamoylation|carbamoylation
4712704|NCT03157336|Isoprostanes|isoprostanes
4712705|NCT03157336|Oxidative Damage|oxidative damage
4712706|NCT03157323|Glycemic Index|glycemic index
4712707|NCT03157323|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
4712708|NCT03157323|Dietary Change|dietary change
4712709|NCT03157323|Pediatric Oncology|pediatric oncology
4712710|NCT03157284|Lactobacillus, Probiotics|lactobacillus, probiotics
4712711|NCT03157219|Heart failure|heart failure
4712712|NCT03157219|Institutional level registry|institutional level registry
4712713|NCT03157219|Systolic heart failure|systolic heart failure
4712714|NCT03157219|Acute heart failure|acute heart failure
4712715|NCT03157219|Heart failure India|heart failure india
4712716|NCT03157193|Peri-Implantitis|peri-implantitis
4712717|NCT03157193|Dental Implants|dental implants
4712718|NCT03157193|Hyaluronic Acid|hyaluronic acid
4712719|NCT03157193|Clinical Trial|clinical trial
4712720|NCT03157167|Kaposi Sarcoma, KS, HIV|kaposi sarcoma, ks, hiv
4712721|NCT03157154|Haemophilia|haemophilia
4712722|NCT03157154|Atherosclerosis|atherosclerosis
4712723|NCT03157154|Atrial fibrillation|atrial fibrillation
4712724|NCT03157154|Antiplatelets|antiplatelets
4712725|NCT03157154|Anticoagulant|anticoagulant
4712726|NCT03157141|Ankle osteoarthritis|ankle osteoarthritis
4712727|NCT03157141|total ankle replacement|total ankle replacement
4712728|NCT03157141|ankle arthrodesis|ankle arthrodesis
4712729|NCT03157141|kinematics|kinematics
4712730|NCT03157141|kinetics|kinetics
4712731|NCT03157141|plantar pressure measurements|plantar pressure measurements
4712732|NCT03157141|functional compensatory adaptations|functional compensatory adaptations
4712733|NCT03157128|LOXO-292|loxo-292
4712734|NCT03157128|KIF5B-RET|kif5b-ret
4712735|NCT03157128|M918T|m918t
4712736|NCT03157128|CCDC6-RET|ccdc6-ret
4712737|NCT03157128|RET-PTC1|ret-ptc1
4712738|NCT03157128|NCOA4-RET|ncoa4-ret
4712739|NCT03157128|RET-PTC|ret-ptc
4712740|NCT03157128|RET-PTC3|ret-ptc3
4712741|NCT03157128|RET-PTC4|ret-ptc4
4712742|NCT03157128|PRKAR1A-RET|prkar1a-ret
4712743|NCT03157128|RET-PTC2|ret-ptc2
4712744|NCT03157128|GOLGA5-RET|golga5-ret
4712745|NCT03157128|RET-PTC5|ret-ptc5
4712746|NCT03157128|ERC1-RET|erc1-ret
4712747|NCT03157128|KTN1-RET|ktn1-ret
4712748|NCT03157128|RET-PTC8|ret-ptc8
4712749|NCT03157128|HOOK3-RET|hook3-ret
4712750|NCT03157128|PCM1-RET|pcm1-ret
4712751|NCT03157128|TRIM24-RET|trim24-ret
4712752|NCT03157128|RET-PTC6|ret-ptc6
4712753|NCT03157128|TRIM27-RET|trim27-ret
4712754|NCT03157128|TRIM33-RET|trim33-ret
4712755|NCT03157128|RET-PTC7|ret-ptc7
4712756|NCT03157128|AKAP13-RET|akap13-ret
4712757|NCT03157128|FKBP15-RET|fkbp15-ret
4712758|NCT03157128|SPECC1L-RET|specc1l-ret
4712759|NCT03157128|TBL1XR1-RET|tbl1xr1-ret
4712760|NCT03157128|BCR-RET|bcr-ret
4712761|NCT03157128|FGRF1OP-RET|fgrf1op-ret
4712762|NCT03157128|RFG8-RET|rfg8-ret
4712763|NCT03157128|RET-PTC9|ret-ptc9
4712764|NCT03157128|ACBD5-RET|acbd5-ret
4712765|NCT03157128|MYH13-RET|myh13-ret
4712766|NCT03157128|CUX1-RET|cux1-ret
4712767|NCT03157128|KIAA1468-RET|kiaa1468-ret
4712768|NCT03157128|FRMD4A-RET|frmd4a-ret
4712769|NCT03157128|SQSTM1-RET|sqstm1-ret
4712770|NCT03157128|AFAP1L2-RET|afap1l2-ret
4712771|NCT03157128|PPFIBP2-RET|ppfibp2-ret
4712772|NCT03157128|EML4-RET|eml4-ret
4712773|NCT03157128|PARD3-RET|pard3-ret
4712774|NCT03157128|G533C|g533c
4712775|NCT03157128|C609F|c609f
4712776|NCT03157128|C609G|c609g
4712777|NCT03157128|C609R|c609r
4712778|NCT03157128|C609S|c609s
4712779|NCT03157128|C609Y|c609y
4712780|NCT03157128|C611F|c611f
4712781|NCT03157128|C611G|c611g
4712782|NCT03157128|C611S|c611s
4712783|NCT03157128|C611Y|c611y
4712784|NCT03157128|C611W|c611w
4712785|NCT03157128|C618F|c618f
4712786|NCT03157128|C618R|c618r
4712787|NCT03157128|C618S|c618s
4712788|NCT03157128|C620F|c620f
4712789|NCT03157128|C620R|c620r
4712790|NCT03157128|C620S|c620s
4712791|NCT03157128|C630R|c630r
4712792|NCT03157128|C630Y|c630y
4712793|NCT03157128|D631Y|d631y
4712794|NCT03157128|C634F|c634f
4712795|NCT03157128|C634G|c634g
4712796|NCT03157128|C634R|c634r
4712797|NCT03157128|C634S|c634s
4712798|NCT03157128|C634W|c634w
4712799|NCT03157128|C634Y|c634y
4712800|NCT03157128|K666E|k666e
4712801|NCT03157128|E768D|e768d
4712802|NCT03157128|L790F|l790f
4712803|NCT03157128|V804L|v804l
4712804|NCT03157128|V804M|v804m
4712805|NCT03157128|A883F|a883f
4712806|NCT03157128|S891A|s891a
4712807|NCT03157128|R912P|r912p
4712808|NCT03157128|CLIP1-RET|clip1-ret
4712809|NCT03157128|Y806C|y806c
4712810|NCT03157128|RET fusion|ret fusion
4712811|NCT03157128|RET alteration|ret alteration
4712812|NCT03157128|RET mutation|ret mutation
4712813|NCT03157128|RET rearrangement|ret rearrangement
4712814|NCT03157128|RET translocation|ret translocation
4712815|NCT03157128|Neoplasms by Site|neoplasms by site
4712816|NCT03157128|Neoplasms|neoplasms
4712817|NCT03157128|Non-Small Cell Lung Cancer|non-small cell lung cancer
4712818|NCT03157128|Lung Neoplasms|lung neoplasms
4712819|NCT03157128|Carcinoma, Non-Small-Cell Lung|carcinoma, non-small-cell lung
4712820|NCT03157128|Cancer of Lung|cancer of lung
4712821|NCT03157128|Cancer of the Lung|cancer of the lung
4712822|NCT03157128|Lung Cancer|lung cancer
4712823|NCT03157128|Neoplasms, Lung|neoplasms, lung
4712824|NCT03157128|Neoplasms, Pulmonary|neoplasms, pulmonary
4712825|NCT03157128|Pulmonary Cancer|pulmonary cancer
4712826|NCT03157128|Pulmonary Neoplasms|pulmonary neoplasms
4712827|NCT03157128|Respiratory Tract Neoplasms|respiratory tract neoplasms
4712828|NCT03157128|Lung Diseases|lung diseases
4712829|NCT03157128|Respiratory Tract Diseases|respiratory tract diseases
4712830|NCT03157128|Carcinoma, Bronchogenic|carcinoma, bronchogenic
4712831|NCT03157128|Bronchial Neoplasms|bronchial neoplasms
4712832|NCT03157128|Medullary Thyroid Cancer|medullary thyroid cancer
4712833|NCT03157128|Papillary Thyroid Cancer|papillary thyroid cancer
4712834|NCT03157128|Thyroid Diseases|thyroid diseases
4712835|NCT03157128|Thyroid Neoplasms|thyroid neoplasms
4712836|NCT03157128|Cancer of the Thyroid|cancer of the thyroid
4712837|NCT03157128|Cancer of Thyroid|cancer of thyroid
4712838|NCT03157128|Neoplasms, Thyroid|neoplasms, thyroid
4712839|NCT03157128|Thyroid Ademona|thyroid ademona
4712840|NCT03157128|Thyroid Cancer|thyroid cancer
4712841|NCT03157128|Thyroid Carcinoma|thyroid carcinoma
4712842|NCT03157128|Endocrine System Diseases|endocrine system diseases
4712843|NCT03157128|Endocrine Gland Neoplasms|endocrine gland neoplasms
4712844|NCT03157128|Head and Neck Neoplasms|head and neck neoplasms
4712845|NCT03157128|Thoracic Neoplasms|thoracic neoplasms
4712846|NCT03157128|CNS tumor|cns tumor
4712847|NCT03157128|Primary CNS tumor|primary cns tumor
4712848|NCT03157128|Cancer of Colon|cancer of colon
4712849|NCT03157128|Cancer of the Colon|cancer of the colon
4712850|NCT03157128|Colon Cancer|colon cancer
4712851|NCT03157128|Colon Neoplasms|colon neoplasms
4712852|NCT03157128|Colonic Cancer|colonic cancer
4712853|NCT03157128|Neoplasms, Colonic|neoplasms, colonic
4712854|NCT03157128|Malignant tumor of Breast|malignant tumor of breast
4712855|NCT03157128|Mammary Cancer|mammary cancer
4712856|NCT03157128|Mammary Carcinoma, Human|mammary carcinoma, human
4712857|NCT03157128|Mammary Neoplasm, Human|mammary neoplasm, human
4712858|NCT03157128|Neoplasms, Breast|neoplasms, breast
4712859|NCT03157128|Tumors, Breast|tumors, breast
4712860|NCT03157128|Human Mammary Carcinoma|human mammary carcinoma
4712861|NCT03157128|Malignant Neoplasm of Breast|malignant neoplasm of breast
4712862|NCT03157128|Breast Carcinoma|breast carcinoma
4712863|NCT03157128|Breast Tumors|breast tumors
4712864|NCT03157128|Cancer of the Breast|cancer of the breast
4712865|NCT03157128|Breast Neoplasms|breast neoplasms
4712866|NCT03157128|Breast Cancer|breast cancer
4712867|NCT03157128|RET Inhibitor|ret inhibitor
4712868|NCT03157128|MTC|mtc
4712869|NCT03157128|NSCLC|nsclc
4712870|NCT03157115|Kinocardiography|kinocardiography
4712871|NCT03157115|Cardiac contractility|cardiac contractility
4712872|NCT03157115|Heart kinetic energy|heart kinetic energy
4712873|NCT03157102|children|children
4712874|NCT03157102|status asthmaticus|status asthmaticus
4712875|NCT03157102|HFNC|hfnc
4712876|NCT03157011|Primary Sjögren syndrome - Digestive symptoms|primary sjögren syndrome - digestive symptoms
4712877|NCT03156998|CARE|care
4712878|NCT03156998|Paediatric asthma|paediatric asthma
4712879|NCT03156998|Compliance|compliance
4712880|NCT03156998|Home nebulizer|home nebulizer
4712881|NCT03156959|Eating disorders|eating disorders
4712882|NCT03156959|Cognitive Behavioral Therapy|cognitive behavioral therapy
4712883|NCT03156959|Eye Movement Desensitization and Processing|eye movement desensitization and processing
4712884|NCT03156946|breastfeeding|breastfeeding
4712885|NCT03156946|mother-to-mother support|mother-to-mother support
4712886|NCT03156946|lactation consultant|lactation consultant
4712887|NCT03156946|stepped wedge cluster randomized trial|stepped wedge cluster randomized trial
4712888|NCT03156946|peer counseling|peer counseling
4712889|NCT03156907|High dosage Buprenorphine (HDB)|high dosage buprenorphine (hdb)
4712890|NCT03156907|Chronic pain|chronic pain
4712891|NCT03156907|Analgesics opioids|analgesics opioids
4712892|NCT03156907|Withdrawal symptoms|withdrawal symptoms
4712893|NCT03156894|Graft Dysfunction|graft dysfunction
4712894|NCT03156894|Primary Graft Dysfunction|primary graft dysfunction
4712895|NCT03156894|heart transplant|heart transplant
4712896|NCT03156894|heart failure|heart failure
4712897|NCT03156894|Hemodynamic parameters|hemodynamic parameters
4712898|NCT03156894|Incidence of PDG|incidence of pdg
4712899|NCT03156855|efficacy|efficacy
4712900|NCT03156855|safety|safety
4712901|NCT03156855|H. pylori eradication|h. pylori eradication
4712902|NCT03156842|Hypertension|hypertension
4712903|NCT03156842|Dyslipidemia|dyslipidemia
4712904|NCT03156842|Fimasartan|fimasartan
4712905|NCT03156842|Rosuvastatin|rosuvastatin
4712906|NCT03156829|splinting|splinting
4712907|NCT03156829|steroid|steroid
4712908|NCT03156829|cortisone|cortisone
4712909|NCT03156829|trigger digit|trigger digit
4712910|NCT03156816|Myocardial Infarction|myocardial infarction
4712911|NCT03156816|STEMI|stemi
4712912|NCT03156816|Inflammation|inflammation
4712913|NCT03156816|Left ventricular remodeling|left ventricular remodeling
4712914|NCT03156816|Colchicine|colchicine
4712915|NCT03156816|CMR|cmr
4712916|NCT03156790|recombinant L-Asparaginase|recombinant l-asparaginase
4712917|NCT03156790|Spectrila®|spectrila®
4712918|NCT03156790|Lymphoblastic Leukaemia|lymphoblastic leukaemia
4712919|NCT03156790|BRALL 2014|brall 2014
4712920|NCT03156777|Gastric cancer; Circulating tumor cells; Prognosis|gastric cancer; circulating tumor cells; prognosis
4712921|NCT03156764|Qp/Qs ratio|qp/qs ratio
4712922|NCT03156764|Pediatric congenital heart disease|pediatric congenital heart disease
4712923|NCT03156751|Syphilis screening|syphilis screening
4712924|NCT03156751|antenatal care|antenatal care
4712925|NCT03156751|prenatal diagnosis|prenatal diagnosis
4712926|NCT03156751|rapid diagnosis test|rapid diagnosis test
4712927|NCT03156751|Burkina Faso|burkina faso
4712928|NCT03156751|feasibility|feasibility
4712929|NCT03156725|Iron Bioavailability|iron bioavailability
4712930|NCT03156725|hepcidin|hepcidin
4712931|NCT03156725|ferritin|ferritin
4712932|NCT03156725|iron absorption|iron absorption
4712933|NCT03156725|iron status|iron status
4712934|NCT03156712|Anemia|anemia
4712935|NCT03156712|Iron deficiency anemia|iron deficiency anemia
4712936|NCT03156712|Iron fortification|iron fortification
4712937|NCT03156712|ferrous sulfate|ferrous sulfate
4712938|NCT03156712|aspergillus oryzae|aspergillus oryzae
4712939|NCT03156712|iron supplementation|iron supplementation
4712940|NCT03156712|AUC|auc
4712941|NCT03156686|Acute Heart Failure|acute heart failure
4712942|NCT03156686|Chronic Heart Failure|chronic heart failure
4712943|NCT03156686|Home care services|home care services
4712944|NCT03156686|Cost-Benefit Analysis|cost-benefit analysis
4712945|NCT03156686|Quality of life|quality of life
4712946|NCT03156634|Patient education|patient education
4712947|NCT03156634|Internet|internet
4712948|NCT03156608|External Fetal Heart Rate Monitor|external fetal heart rate monitor
4712949|NCT03156608|Fetal Heart Rate Monitor|fetal heart rate monitor
4712950|NCT03156582|liver transplantation, hepatocellular carcinoma, alpha-foetoproteins, AFP|liver transplantation, hepatocellular carcinoma, alpha-foetoproteins, afp
4712951|NCT03156569|saliva , dental , oral health|saliva , dental , oral health
4712952|NCT03156530|Acupunture|acupunture
4712953|NCT03156530|Acupunture Therapy|acupunture therapy
4712954|NCT03156530|Acupunture Points|acupunture points
4712955|NCT03156530|Acupunture Ear|acupunture ear
4712956|NCT03156530|Postural Balance|postural balance
4712957|NCT03156517|Treatment|treatment
4712958|NCT03156517|Deep Brain Stimulation|deep brain stimulation
4712959|NCT03156517|VIM Nucleus of the Thalamus|vim nucleus of the thalamus
4712960|NCT03156517|Posterior Subthalamic Area|posterior subthalamic area
4712961|NCT03156517|Zona Incerta|zona incerta
4712962|NCT03156517|Efficacy|efficacy
4712963|NCT03156517|Safety|safety
4712964|NCT03156491|recurrent miscarriages (RM)|recurrent miscarriages (rm)
4712965|NCT03156491|recurrent pregnancy loss (RPL)|recurrent pregnancy loss (rpl)
4712966|NCT03156491|fetal-maternal interface|fetal-maternal interface
4712967|NCT03156491|decidualization|decidualization
4712968|NCT03156491|co-culture|co-culture
4712969|NCT03156491|implantation|implantation
4712970|NCT03156491|immune regulation|immune regulation
4712971|NCT03156478|Prevention|prevention
4712972|NCT03156478|Digital solutions|digital solutions
4712973|NCT03156478|Type 2 diabetes|type 2 diabetes
4712974|NCT03156478|Life style modification|life style modification
4712975|NCT03156478|Physical activity|physical activity
4712976|NCT03156478|Healthy diet|healthy diet
4712977|NCT03156478|Health economics|health economics
4712978|NCT03156478|Environmental choice architecture|environmental choice architecture
4712979|NCT03156478|Socio-economic facilitators|socio-economic facilitators
4712980|NCT03156478|Socio-economic barriers|socio-economic barriers
4712981|NCT03156478|Wellbeing|wellbeing
4712982|NCT03156387|diode laser|diode laser
4712983|NCT03156387|scalpel surgery|scalpel surgery
4712984|NCT03156387|frenectomy|frenectomy
4712985|NCT03156387|postoperative complications|postoperative complications
4712986|NCT03156348|Pharmaceutical intervention|pharmaceutical intervention
4712987|NCT03156348|Older adult|older adult
4712988|NCT03156348|Internal medicine|internal medicine
4712989|NCT03156348|Adverse drug event|adverse drug event
4712990|NCT03156322|cesarean section|cesarean section
4712991|NCT03156322|combined spinal epidural anesthesia|combined spinal epidural anesthesia
4712992|NCT03156322|patient controlled epidural analgesia|patient controlled epidural analgesia
4712993|NCT03156322|postoperative pain|postoperative pain
4712994|NCT03156296|transversus abdominis plane block , Dexmedetomidine|transversus abdominis plane block , dexmedetomidine
4712995|NCT03156283|smartphone|smartphone
4712996|NCT03156283|obstructive sleep apnea|obstructive sleep apnea
4712997|NCT03156283|adherence|adherence
4712998|NCT03156270|nasal valve|nasal valve
4712999|NCT03156270|nasal airway obstruction|nasal airway obstruction
4713000|NCT03156257|Microgravity Effects on Vascular Cells|microgravity effects on vascular cells
4713001|NCT03156244|PROMIS|promis
4713002|NCT03156231|airway disease|airway disease
4713003|NCT03156231|bronchitis|bronchitis
4713004|NCT03156231|emphysema|emphysema
4713005|NCT03156231|altitude|altitude
4713006|NCT03156231|prevention|prevention
4713007|NCT03156231|acetazolamide|acetazolamide
4713008|NCT03156218|PaO2/FiO2 ratio, hyperoxia, mechanical ventilation, ARDS|pao2/fio2 ratio, hyperoxia, mechanical ventilation, ards
4713009|NCT03156205|critically ill patients|critically ill patients
4713010|NCT03156205|music therapy|music therapy
4713011|NCT03156205|sleep|sleep
4713012|NCT03156205|delirium|delirium
4713013|NCT03156205|melatonin|melatonin
4713014|NCT03156205|elderly|elderly
4713015|NCT03156192|Caregivers|caregivers
4713016|NCT03156192|Family-centered care|family-centered care
4713017|NCT03156192|Music use|music use
4713018|NCT03156192|Psycho-social benefits of music|psycho-social benefits of music
4713019|NCT03156088|Predictors|predictors
4713020|NCT03156088|Sacral neuromodulation|sacral neuromodulation
4713021|NCT03156088|Outcomes|outcomes
4713022|NCT03156088|Overactive bladder|overactive bladder
4713023|NCT03156075|hip fracture, intervention, mortality, mobility|hip fracture, intervention, mortality, mobility
4713024|NCT03156036|Temozolomide|temozolomide
4713025|NCT03156036|Capecitabine|capecitabine
4713026|NCT03156036|MGMT|mgmt
4713324|NCT03153904|trauma|trauma
4713027|NCT03156010|oculomotor testing|oculomotor testing
4713028|NCT03155997|early stage breast cancer|early stage breast cancer
4713029|NCT03155997|cyclin-dependent kinase (CDK)|cyclin-dependent kinase (cdk)
4713030|NCT03155971|Drug-Coated Balloon|drug-coated balloon
4713031|NCT03155971|Main Coronary Artery|main coronary artery
4713032|NCT03155971|De Novo Lesion|de novo lesion
4713033|NCT03155919|taurine|taurine
4713034|NCT03155919|triathletes|triathletes
4713035|NCT03155919|oxidative stress|oxidative stress
4713036|NCT03155919|chocolate milk|chocolate milk
4713037|NCT03155906|Chronic hepatitis C|chronic hepatitis c
4713038|NCT03155906|Opiate Substitution Treatment|opiate substitution treatment
4713039|NCT03155906|Integrated Delivery of Health Care|integrated delivery of health care
4713040|NCT03155906|Substance Abuse Treatment Centers|substance abuse treatment centers
4713041|NCT03155841|Prevention|prevention
4713042|NCT03155841|Internet|internet
4713043|NCT03155841|Adolescence|adolescence
4713044|NCT03155841|LGBT|lgbt
4713045|NCT03155841|Sexuality|sexuality
4713046|NCT03155828|PCOS, OSA, CPAP|pcos, osa, cpap
4713047|NCT03155763|kidney transplantation|kidney transplantation
4713048|NCT03155763|implantation biopsy|implantation biopsy
4713049|NCT03155763|histology|histology
4713050|NCT03155763|allograft function|allograft function
4713051|NCT03155763|allograft survival|allograft survival
4713052|NCT03155750|insomnia|insomnia
4713053|NCT03155737|Knee Osteoarthritis|knee osteoarthritis
4713054|NCT03155685|antipsychotic|antipsychotic
4713055|NCT03155685|palliative care|palliative care
4713056|NCT03155659|Fish|fish
4713057|NCT03155659|Polyunsaturated fatty acids|polyunsaturated fatty acids
4713058|NCT03155659|Mortality|mortality
4713059|NCT03155659|CHNS|chns
4713060|NCT03155659|NHANES|nhanes
4713061|NCT03155646|TAP block|tap block
4713062|NCT03155646|Dexmedetomidine|dexmedetomidine
4713063|NCT03155646|Clonidine|clonidine
4713064|NCT03155633|Marathon, runners, biomarkers, recovery|marathon, runners, biomarkers, recovery
4713065|NCT03155594|Diabetes|diabetes
4713066|NCT03155594|Diabetes Mellitus|diabetes mellitus
4713067|NCT03155594|Diabetes Type 1|diabetes type 1
4713068|NCT03155594|Diabetes Type 2|diabetes type 2
4713070|NCT03155594|Continuous Glucose Monitoring|continuous glucose monitoring
4713071|NCT03155594|Inpatient|inpatient
4713072|NCT03155594|Outpatient|outpatient
4713073|NCT03155594|Transition of care|transition of care
4713074|NCT03155594|DM-1|dm-1
4713075|NCT03155594|DM-2|dm-2
4713076|NCT03155594|Freestyle Libre|freestyle libre
4713077|NCT03155555|Fluid Responsiveness|fluid responsiveness
4713078|NCT03155555|Pediatric surgery|pediatric surgery
4713079|NCT03155555|General endotracheal anaesthesia|general endotracheal anaesthesia
4713080|NCT03155542|alcohol|alcohol
4713081|NCT03155542|gene polymorphisms|gene polymorphisms
4713082|NCT03155542|Colorectal cancer|colorectal cancer
4713083|NCT03155529|cervical cancer|cervical cancer
4713084|NCT03155529|radical hysterectomy|radical hysterectomy
4713085|NCT03155529|Postoperative pelvic floor dysfunction|postoperative pelvic floor dysfunction
4713086|NCT03155529|the injure of pelvic floor|the injure of pelvic floor
4713087|NCT03155529|Three-dimensional reconstruction|three-dimensional reconstruction
4713088|NCT03155529|structural destruction of pelvic organs|structural destruction of pelvic organs
4713089|NCT03155529|structural destruction of pelvoic floor|structural destruction of pelvoic floor
4713090|NCT03155516|Cancer pain|cancer pain
4713091|NCT03155516|GPM|gpm
4713092|NCT03155516|pain assessment|pain assessment
4713093|NCT03155503|SUVN-911|suvn-911
4713094|NCT03155503|Depression|depression
4713095|NCT03155503|single dose|single dose
4713096|NCT03155503|multiple dose|multiple dose
4713097|NCT03155503|alpha4 beta2 receptor|alpha4 beta2 receptor
4713098|NCT03155503|first in human|first in human
4713099|NCT03155503|safety|safety
4713100|NCT03155503|pharmacokinetics|pharmacokinetics
4713101|NCT03155503|tolerability|tolerability
4713102|NCT03155490|Hospital medical emergency team|hospital medical emergency team
4713103|NCT03155490|Leadership|leadership
4713104|NCT03155490|Simulation training|simulation training
4713105|NCT03155477|SLE, vitamin D, SLEDAI, IL-6, TGF- β1|sle, vitamin d, sledai, il-6, tgf- β1
4713106|NCT03155464|indocyanine-green|indocyanine-green
4713107|NCT03155464|systemic scerlosis|systemic scerlosis
4713108|NCT03155438|Oxidative stress|oxidative stress
4713109|NCT03155438|Cumulus cell|cumulus cell
4713110|NCT03155438|Controlled ovarian hyperstimulation|controlled ovarian hyperstimulation
4713111|NCT03155438|In vitro fertilization|in vitro fertilization
4713112|NCT03155438|Low responder|low responder
4713113|NCT03155412|Type 2 Diabetes|type 2 diabetes
4713114|NCT03155412|adipose tissue|adipose tissue
4713115|NCT03155412|preadipocytes|preadipocytes
4713116|NCT03155412|expandability|expandability
4713117|NCT03155412|hypertrophy|hypertrophy
4713118|NCT03155412|hyperplasia|hyperplasia
4713119|NCT03155412|lipogenesis|lipogenesis
4713120|NCT03155412|adipogenesis|adipogenesis
4713121|NCT03155412|insulin sensitivity|insulin sensitivity
4713122|NCT03155399|Stroke|stroke
4713123|NCT03155399|Neurorehabilitation|neurorehabilitation
4713124|NCT03155399|Proprioceptive Training|proprioceptive training
4713125|NCT03155399|Bilateral Arm Training|bilateral arm training
4713126|NCT03155399|Intracortical Inhibition|intracortical inhibition
4713127|NCT03155373|Cardiopulmonary exercise testing|cardiopulmonary exercise testing
4713128|NCT03155360|Colics|colics
4713129|NCT03155360|infant colics|infant colics
4713130|NCT03155360|Migraine equivalent|migraine equivalent
4713131|NCT03155360|Migraine|migraine
4713132|NCT03155360|Episodic symptoms associated to migraine|episodic symptoms associated to migraine
4713133|NCT03155360|Colic|colic
4713134|NCT03155334|Multiple Sclerosis; Patient Information Sheet; User Testing|multiple sclerosis; patient information sheet; user testing
4713135|NCT03155256|EUS, cyanoacrylate, coils, gastric varices|eus, cyanoacrylate, coils, gastric varices
4713136|NCT03155243|Humira®|humira®
4713137|NCT03155243|Adalimumab|adalimumab
4713138|NCT03155243|Ocular inflammation|ocular inflammation
4713139|NCT03155243|Active non-infectious intermediate, posterior and panuveitis|active non-infectious intermediate, posterior and panuveitis
4713140|NCT03155230|Inguinal hernia|inguinal hernia
4713141|NCT03155217|melanoma|melanoma
4713142|NCT03155217|elderly|elderly
4713143|NCT03155217|tolerance|tolerance
4713144|NCT03155217|adverse effects|adverse effects
4713145|NCT03155217|targeted therapies|targeted therapies
4713146|NCT03155204|inhalation|inhalation
4713147|NCT03155204|LABA|laba
4713148|NCT03155204|corticosteroid|corticosteroid
4713149|NCT03155191|Acute lymphoblastic leukemia|acute lymphoblastic leukemia
4713150|NCT03155191|Leukemia|leukemia
4713151|NCT03155191|Lymphoblastic|lymphoblastic
4713152|NCT03155191|TBI-1501|tbi-1501
4713153|NCT03155191|Anti-CD19 CAR Expressing T cells Therapy|anti-cd19 car expressing t cells therapy
4713154|NCT03155191|CD19 CAR Gene-Transduced Lymphocyte|cd19 car gene-transduced lymphocyte
4713155|NCT03155191|Adoptive Immunotherapy|adoptive immunotherapy
4713156|NCT03155191|Genetically Engineered Lymphocyte Therapy|genetically engineered lymphocyte therapy
4713157|NCT03155191|Retroviral Vector|retroviral vector
4713158|NCT03155191|Neoplasms by Histologic Type|neoplasms by histologic type
4713159|NCT03155191|Neoplasms|neoplasms
4713160|NCT03155191|Neoplasms, Experimental|neoplasms, experimental
4713161|NCT03155191|Immune System Diseases|immune system diseases
4713162|NCT03155191|Chimeric antigen receptor|chimeric antigen receptor
4713163|NCT03155165|Colonoscopy, Retroview™ colonoscope, retrofex colonoscopy|colonoscopy, retroview™ colonoscope, retrofex colonoscopy
4713164|NCT03155139|prevalence|prevalence
4713165|NCT03155139|primary aldosteronism|primary aldosteronism
4713166|NCT03155139|hypertension|hypertension
4713167|NCT03155139|nationwide|nationwide
4713168|NCT03155126|shock|shock
4713169|NCT03155126|acute kidney injury|acute kidney injury
4713170|NCT03155126|crystalloid|crystalloid
4713171|NCT03155113|Chronic infection|chronic infection
4713172|NCT03155113|HCV|hcv
4713173|NCT03155113|DAA therapy|daa therapy
4713174|NCT03155113|immune response|immune response
4713175|NCT03155087|T2DM|t2dm
4713176|NCT03155087|genetic polymorphism|genetic polymorphism
4713177|NCT03155087|diabetic nephropathy|diabetic nephropathy
4713178|NCT03155035|deworming|deworming
4713179|NCT03155035|STH|sth
4713180|NCT03155022|ST-elevation myocardial infarction|st-elevation myocardial infarction
4713181|NCT03154996|Gliomas|gliomas
4713182|NCT03154996|Recurrent|recurrent
4713183|NCT03154996|Chronic Convection|chronic convection
4713184|NCT03154996|High Grade Gliomas|high grade gliomas
4713185|NCT03154983|Mesylate Apatinib|mesylate apatinib
4713186|NCT03154983|The First-line Treatment|the first-line treatment
4713187|NCT03154983|Metastatic Gastric Cancer|metastatic gastric cancer
4713188|NCT03154970|Physical Therapy Specialty|physical therapy specialty
4713189|NCT03154931|PTSD|ptsd
4713190|NCT03154931|CBT|cbt
4713191|NCT03154931|CFT|cft
4713192|NCT03154931|compassion|compassion
4713193|NCT03154931|shame|shame
4713194|NCT03154931|guilty|guilty
4713195|NCT03154931|self-criticism|self-criticism
4713196|NCT03154879|Heart arrest|heart arrest
4713197|NCT03154879|Hypothermia|hypothermia
4713198|NCT03154879|EEG|eeg
4713199|NCT03154879|Prognosis|prognosis
4713200|NCT03154866|Lactobacillus kefiri LKF01 DSM32079|lactobacillus kefiri lkf01 dsm32079
4713201|NCT03154866|Microbial Colonization|microbial colonization
4713202|NCT03154853|Electromyography,Excessive Foot Pronation,exercise,neurology,physical therapy|electromyography,excessive foot pronation,exercise,neurology,physical therapy
4713203|NCT03154814|ulinastatin|ulinastatin
4713204|NCT03154814|cardiopulmonary bypass|cardiopulmonary bypass
4713205|NCT03154814|cardiac surgery|cardiac surgery
4713206|NCT03154788|Falls prevention|falls prevention
4713207|NCT03154788|Community-Based Participatory Research|community-based participatory research
4713208|NCT03154749|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
4713209|NCT03154749|Triple-Negative Breast Cancer|triple-negative breast cancer
4713210|NCT03154736|CVD|cvd
4713211|NCT03154736|FDRCV|fdrcv
4713212|NCT03154736|Developing countries|developing countries
4713213|NCT03154736|Rcih countries|rcih countries
4713214|NCT03154710|Web-mediated follow up|web-mediated follow up
4713215|NCT03154710|Lymphoma|lymphoma
4713216|NCT03154710|Personalized medicine|personalized medicine
4713217|NCT03154684|Autonomy|autonomy
4713218|NCT03154684|Rehabilitation|rehabilitation
4713219|NCT03154684|Falls|falls
4713220|NCT03154684|Quality of life|quality of life
4713221|NCT03154684|Senior|senior
4713222|NCT03154671|older adult;|older adult;
4713425|NCT03153371|Young-onset|young-onset
4713223|NCT03154671|comprehensive geriatric assessment|comprehensive geriatric assessment
4713224|NCT03154671|chemotherapy|chemotherapy
4713225|NCT03154671|integrated care|integrated care
4713226|NCT03154671|randomized controlled trial|randomized controlled trial
4713227|NCT03154632|Myofascial trigger point|myofascial trigger point
4713228|NCT03154632|Trapezius Muscle|trapezius muscle
4713229|NCT03154632|Diathermy|diathermy
4713230|NCT03154632|Ultrasound|ultrasound
4713231|NCT03154593|Prevalence|prevalence
4713232|NCT03154541|Chronic Rhinosinusitis (CRS), Cystic Fibrosis related CRS|chronic rhinosinusitis (crs), cystic fibrosis related crs
4713233|NCT03154515|Respiratory Tract Infections|respiratory tract infections
4713234|NCT03154515|Acute Respiratory Viral Infection|acute respiratory viral infection
4713235|NCT03154502|Sodium intake|sodium intake
4713236|NCT03154502|Urinary sodium excretion|urinary sodium excretion
4713237|NCT03154411|ABY-029|aby-029
4713238|NCT03154411|Affibody|affibody
4713239|NCT03154411|molecular fluorescence-guided surgery|molecular fluorescence-guided surgery
4713240|NCT03154411|Epidermal Growth Factor Receptor (EGFR)|epidermal growth factor receptor (egfr)
4713241|NCT03154398|evaluation of thyroid function in diabetes patients|evaluation of thyroid function in diabetes patients
4713242|NCT03154385|ITP|itp
4713243|NCT03154346|Baseline|baseline
4713244|NCT03154346|Project Baseline|project baseline
4713245|NCT03154346|Baseline Study|baseline study
4713246|NCT03154346|Project Baseline Study|project baseline study
4713247|NCT03154333|Epidermolysis|epidermolysis
4713248|NCT03154333|bullosa|bullosa
4713249|NCT03154333|simplex|simplex
4713250|NCT03154333|blister|blister
4713251|NCT03154333|EBS|ebs
4713252|NCT03154333|topical|topical
4713253|NCT03154333|ointment|ointment
4713254|NCT03154333|lesion|lesion
4713255|NCT03154281|Breast|breast
4713256|NCT03154281|Ovarian|ovarian
4713257|NCT03154268|Gestational weight gain|gestational weight gain
4713258|NCT03154268|Chinese pregnant women|chinese pregnant women
4713259|NCT03154268|Retrospective longitudinal study|retrospective longitudinal study
4713260|NCT03154268|China|china
4713261|NCT03154268|IOM guideline|iom guideline
4713262|NCT03154268|Adverse outcome|adverse outcome
4713263|NCT03154268|Model|model
4713264|NCT03154255|Obesity|obesity
4713265|NCT03154255|Paediatric|paediatric
4713266|NCT03154255|Mediterranean diet|mediterranean diet
4713267|NCT03154255|Gamification|gamification
4713268|NCT03154255|Insulin-resistance|insulin-resistance
4713269|NCT03154242|non small cell lung cancer|non small cell lung cancer
4713270|NCT03154242|NSCLC|nsclc
4713271|NCT03154242|Platinum|platinum
4713272|NCT03154151|PTSD|ptsd
4713273|NCT03154151|Post-Traumatic Stress Disorder|post-traumatic stress disorder
4713274|NCT03154151|Post-Traumatic Stress Disorder symptoms|post-traumatic stress disorder symptoms
4713275|NCT03154151|World Trade Center|world trade center
4713276|NCT03154151|9/11|9/11
4713277|NCT03154151|first responder|first responder
4713278|NCT03154151|rescue/recovery/clean-up worker|rescue/recovery/clean-up worker
4713279|NCT03154151|trauma|trauma
4713280|NCT03154151|9/11 survivor|9/11 survivor
4713281|NCT03154138|Stroke|stroke
4713282|NCT03154138|hemiplegia|hemiplegia
4713283|NCT03154138|rehabilitation|rehabilitation
4713284|NCT03154138|prismatic adaptation|prismatic adaptation
4713285|NCT03154138|postural imbalance|postural imbalance
4713286|NCT03154138|posture|posture
4713287|NCT03154138|spatial cognition|spatial cognition
4713288|NCT03154099|CIRCI|circi
4713289|NCT03154086|REarranged during Transfection|rearranged during transfection
4713290|NCT03154073|Exercise|exercise
4713291|NCT03154073|Physical activity|physical activity
4713292|NCT03154073|Blood glucose|blood glucose
4713293|NCT03154073|Sleep|sleep
4713294|NCT03154060|Flash glucose monitoring|flash glucose monitoring
4713295|NCT03154060|Accuracy|accuracy
4713296|NCT03154060|Precision|precision
4713297|NCT03154034|Stress echocardiography|stress echocardiography
4713298|NCT03154034|Cardiopulmonary exercise testing|cardiopulmonary exercise testing
4713299|NCT03154034|ergospirometry|ergospirometry
4713300|NCT03154021|Gingival Index|gingival index
4713301|NCT03154021|Plaque Index|plaque index
4713302|NCT03154021|Bleeding|bleeding
4713303|NCT03154021|Pocket Depth|pocket depth
4713304|NCT03154008|reward|reward
4713305|NCT03154008|emotion regulation|emotion regulation
4713306|NCT03154008|electroencephalogram|electroencephalogram
4713307|NCT03154008|event-related potentials|event-related potentials
4713308|NCT03154008|cognitive behavior therapy|cognitive behavior therapy
4713309|NCT03153995|expander|expander
4713310|NCT03153982|HNSCC|hnscc
4713311|NCT03153956|AposTherapy® System|apostherapy® system
4713312|NCT03153956|Osteoarthritis|osteoarthritis
4713313|NCT03153956|Total knee arthroplasties|total knee arthroplasties
4713314|NCT03153956|Degenerative joint disease|degenerative joint disease
4713315|NCT03153930|sedentary behavior|sedentary behavior
4713316|NCT03153930|youth|youth
4713317|NCT03153930|moderating factors|moderating factors
4713318|NCT03153930|metabolic outcomes|metabolic outcomes
4713319|NCT03153917|shift work|shift work
4713320|NCT03153917|melatonin|melatonin
4713321|NCT03153917|sleep|sleep
4713322|NCT03153904|anxiety|anxiety
4713323|NCT03153904|depression|depression
4713325|NCT03153904|behavior problems|behavior problems
4713326|NCT03153904|evidence-based treatments|evidence-based treatments
4713327|NCT03153904|manualized treatments|manualized treatments
4713328|NCT03153904|cognitive-behavioral therapy|cognitive-behavioral therapy
4713329|NCT03153904|youth|youth
4713330|NCT03153904|mental health|mental health
4713331|NCT03153891|environment|environment
4713332|NCT03153891|nature|nature
4713333|NCT03153878|Unruptured Intracranial Aneurysm|unruptured intracranial aneurysm
4713334|NCT03153878|Benefit-risk|benefit-risk
4713335|NCT03153878|Ischemic heart disease|ischemic heart disease
4713336|NCT03153878|Ischemic cerebrovascular disease|ischemic cerebrovascular disease
4713337|NCT03153878|Antithrombotic|antithrombotic
4713338|NCT03153878|Anticoagulant|anticoagulant
4713339|NCT03153878|People's Republic of China|people's republic of china
4713340|NCT03153878|Multicenter Studies|multicenter studies
4713341|NCT03153839|Children|children
4713342|NCT03153839|Babies|babies
4713343|NCT03153839|Infant|infant
4713344|NCT03153839|Swimming pool|swimming pool
4713345|NCT03153839|Aquatic physical activity|aquatic physical activity
4713346|NCT03153839|Motor development|motor development
4713347|NCT03153839|Neurodevelopment|neurodevelopment
4713348|NCT03153826|COPD Exacerbation|copd exacerbation
4713349|NCT03153826|Muscle atrophy|muscle atrophy
4713350|NCT03153826|Inflammation|inflammation
4713351|NCT03153826|Oxidative stress|oxidative stress
4713352|NCT03153813|pain|pain
4713353|NCT03153813|knee osteoarthritis|knee osteoarthritis
4713354|NCT03153813|obesity|obesity
4713355|NCT03153813|capsaicin|capsaicin
4713356|NCT03153787|implantation failure|implantation failure
4713357|NCT03153787|fertility|fertility
4713358|NCT03153787|microbiome|microbiome
4713359|NCT03153787|Assisted reproduction|assisted reproduction
4713360|NCT03153774|Sarcopenia|sarcopenia
4713361|NCT03153774|Heart failure (HF)|heart failure (hf)
4713362|NCT03153774|The trans aortic valvular implantation (TAVI)|the trans aortic valvular implantation (tavi)
4713363|NCT03153748|Treatment strategy|treatment strategy
4713364|NCT03153735|Hyaluronic acid|hyaluronic acid
4713365|NCT03153735|Small Penis|small penis
4713366|NCT03153735|Penile Enhancement|penile enhancement
4713367|NCT03153722|pediatric|pediatric
4713368|NCT03153722|hospital discharge|hospital discharge
4713369|NCT03153722|quality improvement|quality improvement
4713370|NCT03153722|transition of care|transition of care
4713371|NCT03153709|Pregnancy rates|pregnancy rates
4713372|NCT03153709|pharmacokinetic interactions|pharmacokinetic interactions
4713373|NCT03153709|Women on efavirenz|women on efavirenz
4713374|NCT03153709|initiating the Levonorgestrel Implant|initiating the levonorgestrel implant
4713375|NCT03153709|initiating the Depot Medroxyprogesterone Acetate Injectable|initiating the depot medroxyprogesterone acetate injectable
4713376|NCT03153683|Acute|acute
4713377|NCT03153683|Ischemic|ischemic
4713378|NCT03153683|Stroke|stroke
4713379|NCT03153683|Biomarkers|biomarkers
4713380|NCT03153683|Proteins|proteins
4713381|NCT03153683|Leukocyte|leukocyte
4713382|NCT03153683|Inflammatory Cells|inflammatory cells
4713383|NCT03153683|Acid/Base Balance|acid/base balance
4713384|NCT03153657|Tooth Bleaching|tooth bleaching
4713385|NCT03153644|Qualitative Research|qualitative research
4713386|NCT03153644|Medical conditions|medical conditions
4713387|NCT03153644|Birth control methods|birth control methods
4713388|NCT03153644|Intrauterine Devices|intrauterine devices
4713389|NCT03153644|Physicians, Primary Care|physicians, primary care
4713390|NCT03153644|Long-acting reversible contraceptives (LARC)|long-acting reversible contraceptives (larc)
4713391|NCT03153540|Aphasia|aphasia
4713392|NCT03153540|Agrammatism|agrammatism
4713393|NCT03153540|Frontotemporal Dementia|frontotemporal dementia
4713394|NCT03153540|Tauopathies|tauopathies
4713395|NCT03153540|Neurodegenerative Diseases|neurodegenerative diseases
4713396|NCT03153540|Language Disorders|language disorders
4713397|NCT03153540|Frontotemporal Lobar Degeneration|frontotemporal lobar degeneration
4713398|NCT03153514|CLL|cll
4713399|NCT03153488|ADHD|adhd
4713400|NCT03153488|Methylphenidate|methylphenidate
4713401|NCT03153488|Amphetamine|amphetamine
4713402|NCT03153488|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
4713403|NCT03153488|Treatment|treatment
4713404|NCT03153475|Revision knee surgery, implant replacement|revision knee surgery, implant replacement
4713405|NCT03153449|complex primary, deformity, ligamentous laxity|complex primary, deformity, ligamentous laxity
4713406|NCT03153410|Pancreas vaccine|pancreas vaccine
4713407|NCT03153410|immunotherapy|immunotherapy
4713408|NCT03153410|antibody|antibody
4713409|NCT03153410|PD-1|pd-1
4713410|NCT03153410|IMC-CS4|imc-cs4
4713411|NCT03153410|Pembrolizumab|pembrolizumab
4713412|NCT03153410|GVAX|gvax
4713413|NCT03153410|Borderline Resectable|borderline resectable
4713414|NCT03153397|trauma|trauma
4713415|NCT03153397|brain|brain
4713416|NCT03153397|neurological|neurological
4713417|NCT03153397|injury|injury
4713418|NCT03153397|enteral|enteral
4713419|NCT03153397|tube|tube
4713420|NCT03153397|feeding|feeding
4713421|NCT03153397|nutrition|nutrition
4713422|NCT03153384|Diagnosis|diagnosis
4713423|NCT03153384|Blood Culture|blood culture
4713424|NCT03153371|Alzheimer's disease|alzheimer's disease
4713426|NCT03153371|variant|variant
4713427|NCT03153371|visuospatial|visuospatial
4713428|NCT03153371|language|language
4713429|NCT03153371|apraxia|apraxia
4713430|NCT03153371|control|control
4713431|NCT03153371|dementia|dementia
4713432|NCT03153371|memory|memory
4713433|NCT03153371|MRI|mri
4713434|NCT03153371|neurology|neurology
4713435|NCT03153371|neuropsychology|neuropsychology
4713436|NCT03153371|brain|brain
4713437|NCT03153358|EGFR mutation icotinib SBRT|egfr mutation icotinib sbrt
4713438|NCT03153306|Albumin|albumin
4713439|NCT03153293|LHON,G11778A mutation, rAAV2-ND4，gene therapy|lhon,g11778a mutation, raav2-nd4，gene therapy
4713440|NCT03153254|Upper extremity|upper extremity
4713441|NCT03153254|Rehabilitation|rehabilitation
4713442|NCT03153254|Robot assisted therapy|robot assisted therapy
4713443|NCT03153254|Robotics|robotics
4713444|NCT03153254|Devices|devices
4713445|NCT03153254|Orthosis|orthosis
4713446|NCT03153228|E-cigarettes|e-cigarettes
4713447|NCT03153202|Ibrutinib|ibrutinib
4713448|NCT03153202|Pembrolizumab|pembrolizumab
4713449|NCT03153202|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
4713450|NCT03153202|Mantle Cell Lymphoma|mantle cell lymphoma
4713451|NCT03153189|PA,menatal health,QOL|pa,menatal health,qol
4713452|NCT03153176|physical activity|physical activity
4713453|NCT03153176|physical fitness|physical fitness
4713454|NCT03153176|eating habits|eating habits
4713455|NCT03153176|sedentary behavior|sedentary behavior
4713456|NCT03153176|sleep quality|sleep quality
4713457|NCT03153176|satisfaction personal|satisfaction personal
4713458|NCT03153176|school health|school health
4713459|NCT03153176|adolescent|adolescent
4713460|NCT03153150|Oral anticoagulant|oral anticoagulant
4713461|NCT03153150|Factor Xa inhibitors|factor xa inhibitors
4713462|NCT03153150|Direct thrombin inhibitor|direct thrombin inhibitor
4713463|NCT03153150|Vitamin K antagonist|vitamin k antagonist
4713464|NCT03153150|Antiplatelet drug|antiplatelet drug
4713465|NCT03153124|Respiratory muscle strength|respiratory muscle strength
4713466|NCT03153124|Renal insufficiency|renal insufficiency
4713467|NCT03153124|Respiratory muscle training|respiratory muscle training
4713468|NCT03153098|physical activity|physical activity
4713469|NCT03153098|intervention|intervention
4713470|NCT03153098|behaviour change|behaviour change
4713471|NCT03153098|inactive adults|inactive adults
4713472|NCT03153098|behaviour change techniques|behaviour change techniques
4713473|NCT03153098|well-being|well-being
4713474|NCT03153085|Unresectable melanoma|unresectable melanoma
4713475|NCT03153085|Metastatic melanoma|metastatic melanoma
4713476|NCT03153085|Recurrent Melanoma|recurrent melanoma
4713477|NCT03153085|TBI-1401(HF10)|tbi-1401(hf10)
4713478|NCT03153085|HF10|hf10
4713479|NCT03153085|HSV-1|hsv-1
4713480|NCT03153085|Oncolytic virus|oncolytic virus
4713481|NCT03153085|Oncolytic viral immunotherapy|oncolytic viral immunotherapy
4713482|NCT03153085|Ipilimumab|ipilimumab
4713483|NCT03153085|Intratumoral administration|intratumoral administration
4713484|NCT03153085|canerpaturev|canerpaturev
4713485|NCT03153059|gut microbiota|gut microbiota
4713486|NCT03153059|stool frequency|stool frequency
4713487|NCT03153046|prebiotics|prebiotics
4713488|NCT03153046|cognitive impairment|cognitive impairment
4713489|NCT03153046|weight gain|weight gain
4713490|NCT03153033|Wheelchair propulsion|wheelchair propulsion
4713491|NCT03153033|Shoulder|shoulder
4713492|NCT03153033|Biomechanics|biomechanics
4713493|NCT03152994|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
4713494|NCT03152994|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
4713495|NCT03152994|neutrophil-lymphocyte ratio|neutrophil-lymphocyte ratio
4713496|NCT03152994|platelet-lymphocyte ratio|platelet-lymphocyte ratio
4713497|NCT03152994|lymphocyte-monocyte ratio|lymphocyte-monocyte ratio
4713498|NCT03152968|FMS|fms
4713499|NCT03152955|trigeminal neuralgia|trigeminal neuralgia
4713500|NCT03152955|nerve block|nerve block
4713501|NCT03152929|Surgery|surgery
4713502|NCT03152929|Breast|breast
4713503|NCT03152929|Pectoral Never Block|pectoral never block
4713504|NCT03152929|Paravertebral Block|paravertebral block
4713505|NCT03152929|Analgesia|analgesia
4713506|NCT03152929|Mastectomy|mastectomy
4713507|NCT03152916|subtalar joint|subtalar joint
4713508|NCT03152916|arthrodesis|arthrodesis
4713509|NCT03152916|3d printing|3d printing
4713510|NCT03152903|Recombinant BCG vaccine|recombinant bcg vaccine
4713511|NCT03152903|Category 1 pulmonary tuberculosis|category 1 pulmonary tuberculosis
4713512|NCT03152903|Recurrence|recurrence
4713513|NCT03152903|Efficacy|efficacy
4713514|NCT03152890|Insulin|insulin
4713515|NCT03152890|Liver transplantation|liver transplantation
4713516|NCT03152890|Hyperglycemia|hyperglycemia
4713517|NCT03152825|myocardial ischaemia|myocardial ischaemia
4713518|NCT03152825|myocardial viability|myocardial viability
4713519|NCT03152825|coronary chronic total occlusions|coronary chronic total occlusions
4713520|NCT03152825|cardiac magnetic resonance|cardiac magnetic resonance
4713521|NCT03152825|stress CMR|stress cmr
4713522|NCT03152799|remote ischaemic conditioning|remote ischaemic conditioning
4713523|NCT03152799|remote ischemic conditioning|remote ischemic conditioning
4713524|NCT03152799|cerebral infarction|cerebral infarction
4713525|NCT03152799|ischaemia reperfusion injury|ischaemia reperfusion injury
4713526|NCT03152799|ischemia reperfusion injury|ischemia reperfusion injury
4713527|NCT03152799|anterior circulation stroke|anterior circulation stroke
4713528|NCT03152799|mechanical thrombectomy|mechanical thrombectomy
4713529|NCT03152773|MRI Catheterization|mri catheterization
4713530|NCT03152773|Real-time MRI|real-time mri
4713531|NCT03152760|Alcoholism|alcoholism
4713532|NCT03152760|Healthy Volunteers|healthy volunteers
4713533|NCT03152760|Craving|craving
4713534|NCT03152760|Gut|gut
4713535|NCT03152734|Elderly patients, Mortality, morbidity, post-intervention|elderly patients, mortality, morbidity, post-intervention
4713536|NCT03152721|accelerometry|accelerometry
4713537|NCT03152721|home based|home based
4713538|NCT03152721|motor complications|motor complications
4713539|NCT03152721|Parkinson KinetiGraph|parkinson kinetigraph
4713540|NCT03152721|Registry|registry
4713541|NCT03152682|glucose|glucose
4713542|NCT03152682|glucose homeostasis|glucose homeostasis
4713543|NCT03152669|asthma|asthma
4713544|NCT03152669|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
4713545|NCT03152669|Salford Lung Study|salford lung study
4713546|NCT03152656|Familial hypercholesterolemia|familial hypercholesterolemia
4713547|NCT03152656|total cholesterol|total cholesterol
4713548|NCT03152656|low-density lipoprotein cholesterol|low-density lipoprotein cholesterol
4713549|NCT03152656|tendon xanthomas|tendon xanthomas
4713550|NCT03152656|premature atherosclerosis|premature atherosclerosis
4713551|NCT03152643|Cumulative live birth rates|cumulative live birth rates
4713552|NCT03152643|cleavage-stage embryo transfer|cleavage-stage embryo transfer
4713553|NCT03152643|blastocyst transfer|blastocyst transfer
4713554|NCT03152630|lncRNAs|lncrnas
4713555|NCT03152630|Alzheimer's disease|alzheimer's disease
4713556|NCT03152630|vascular dementia|vascular dementia
4713557|NCT03152617|bariatric surgery|bariatric surgery
4713558|NCT03152617|gastric bypass|gastric bypass
4713559|NCT03152617|malnutrition|malnutrition
4713560|NCT03152617|bone disease|bone disease
4713561|NCT03152617|oral health|oral health
4713562|NCT03152591|Polycystic ovary syndrome|polycystic ovary syndrome
4713563|NCT03152591|PCOS|pcos
4713564|NCT03152591|hyperandrogenism|hyperandrogenism
4713565|NCT03152591|insulin resistance|insulin resistance
4713566|NCT03152591|overweight|overweight
4713567|NCT03152591|obesity|obesity
4713568|NCT03152552|diabetes type 2|diabetes type 2
4713569|NCT03152552|heart failure|heart failure
4713570|NCT03152500|IOL|iol
4713571|NCT03152500|Stability|stability
4713572|NCT03152500|FEMTIS IOL|femtis iol
4713573|NCT03152500|Acrysof IOL|acrysof iol
4713574|NCT03152500|FLACS|flacs
4713575|NCT03152500|Capsulotomy|capsulotomy
4713576|NCT03152487|endoscopic ultrasound|endoscopic ultrasound
4713577|NCT03152487|celiac plexus neurolysis|celiac plexus neurolysis
4713578|NCT03152487|radiofrequency ablation|radiofrequency ablation
4713579|NCT03152487|pancreatic cancer|pancreatic cancer
4713580|NCT03152461|Viscoelastic testing|viscoelastic testing
4713581|NCT03152461|Coagulation|coagulation
4713582|NCT03152461|Quantra|quantra
4713583|NCT03152461|Hemostasis|hemostasis
4713584|NCT03152448|Prolaris|prolaris
4713585|NCT03152448|Prostate Cancer|prostate cancer
4713586|NCT03152409|Aspirin|aspirin
4713587|NCT03152409|Treatment|treatment
4713588|NCT03152409|Salicylic acid|salicylic acid
4713589|NCT03152409|anti-inflammatory|anti-inflammatory
4713590|NCT03152396|modifiable cardiovascular risk factors|modifiable cardiovascular risk factors
4713591|NCT03152396|cardiovascular risk factors|cardiovascular risk factors
4713592|NCT03152396|blood pressure|blood pressure
4713593|NCT03152396|LDL-cholesterol|ldl-cholesterol
4713594|NCT03152396|total-cholesterol|total-cholesterol
4713595|NCT03152396|HDL-cholesterol|hdl-cholesterol
4713596|NCT03152396|hemoglobin A1C|hemoglobin a1c
4713597|NCT03152396|tobacco cessation|tobacco cessation
4713598|NCT03152396|patient satisfaction|patient satisfaction
4713599|NCT03152383|Autism Spectrum Disorder|autism spectrum disorder
4713600|NCT03152383|Behavioral Research|behavioral research
4713601|NCT03152383|Psychology|psychology
4713602|NCT03152383|Cognitive Disorders|cognitive disorders
4713603|NCT03152370|E7046|e7046
4713604|NCT03152370|Radiotherapy/Chemoradiotherapy|radiotherapy/chemoradiotherapy
4713605|NCT03152370|Neoadjuvant therapy|neoadjuvant therapy
4713606|NCT03152370|Rectal cancer|rectal cancer
4713607|NCT03152357|osteoarthritis|osteoarthritis
4713608|NCT03152357|total knee arthroplasty|total knee arthroplasty
4713609|NCT03152357|TKA|tka
4713610|NCT03152357|TKR|tkr
4713611|NCT03152357|patient specific|patient specific
4713612|NCT03152357|Conformis|conformis
4713613|NCT03152344|Fall|fall
4713614|NCT03152344|Balance control|balance control
4713615|NCT03152344|Screening test|screening test
4713616|NCT03152344|Oxygen|oxygen
4713617|NCT03152344|Skeletal muscle mass|skeletal muscle mass
4713618|NCT03152331|Neurofeedback|neurofeedback
4713619|NCT03152318|Malignant Glioma|malignant glioma
4713620|NCT03152318|Brain Tumor|brain tumor
4713621|NCT03152318|Glioblastoma|glioblastoma
4713622|NCT03152305|Migraine|migraine
4713623|NCT03152305|Intracranial pressure|intracranial pressure
4713624|NCT03152305|Headache|headache
4713625|NCT03152253|Tobacco, Smoking, Text Message|tobacco, smoking, text message
4713626|NCT03152240|Acute Coronary Syndrome|acute coronary syndrome
4713627|NCT03152240|Primary Angioplasty|primary angioplasty
4713628|NCT03152240|Gender|gender
4713629|NCT03152214|Transition out of military|transition out of military
4713630|NCT03152188|Hepatic Encephalopathy|hepatic encephalopathy
4713631|NCT03152188|Cirrhosis|cirrhosis
4713632|NCT03152188|Liver|liver
4713633|NCT03152188|Openbiome|openbiome
4713634|NCT03152188|FMT Capsule|fmt capsule
4713635|NCT03152188|Placebo|placebo
4713636|NCT03152175|Memory Reconsolidation|memory reconsolidation
4713637|NCT03152175|Propranolol|propranolol
4713638|NCT03152175|Police officers|police officers
4713639|NCT03152175|911 operators|911 operators
4713640|NCT03152175|Efficacy|efficacy
4713641|NCT03152175|Cost-effectiveness|cost-effectiveness
4713642|NCT03152162|osteoarthritis|osteoarthritis
4713643|NCT03152162|patient-specific|patient-specific
4713644|NCT03152162|knee replacement|knee replacement
4713645|NCT03152162|TKA|tka
4713646|NCT03152162|knee arthroplasty|knee arthroplasty
4713647|NCT03152162|total knee replacement|total knee replacement
4713648|NCT03152162|posterior stabilized|posterior stabilized
4713649|NCT03152149|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
4713650|NCT03152110|High Intensity Interval Training|high intensity interval training
4713651|NCT03152110|HIIT|hiit
4713652|NCT03152110|Physical Activity|physical activity
4713653|NCT03152071|thoracoscopic surgery|thoracoscopic surgery
4713654|NCT03152071|RATS|rats
4713655|NCT03152071|VATS|vats
4713656|NCT03152071|Robot|robot
4713657|NCT03152045|communication between adolescent patients and their clinician|communication between adolescent patients and their clinician
4713658|NCT03152032|employment service|employment service
4713659|NCT03152032|vocational counseling|vocational counseling
4713660|NCT03152032|employment outcome|employment outcome
4713661|NCT03152032|schizophrenia|schizophrenia
4713662|NCT03152032|bipolar|bipolar
4713663|NCT03152032|occupational therapy in mental health|occupational therapy in mental health
4713664|NCT03152019|Hemorrhagic Hereditary Telangiectasia (HHT)|hemorrhagic hereditary telangiectasia (hht)
4713665|NCT03152019|Antiangiogenic therapy|antiangiogenic therapy
4713666|NCT03152019|Tacrolimus|tacrolimus
4713667|NCT03152006|Healthcare transition|healthcare transition
4713668|NCT03152006|Adolescents|adolescents
4713669|NCT03152006|Nigeria|nigeria
4713670|NCT03151993|Ischemic Stroke|ischemic stroke
4713671|NCT03151993|Fibrinolysis|fibrinolysis
4713672|NCT03151993|Fortelyzin|fortelyzin
4713673|NCT03151954|nasal epithelium stem cells|nasal epithelium stem cells
4713674|NCT03151954|Hippo-YAP pathway|hippo-yap pathway
4713675|NCT03151954|proliferation|proliferation
4713676|NCT03151954|differentiation|differentiation
4713677|NCT03151863|Dexmedetomidine|dexmedetomidine
4713678|NCT03151863|Opioids|opioids
4713679|NCT03151863|Palliative Care|palliative care
4713680|NCT03151863|Elderly people|elderly people
4713681|NCT03151863|Nursing care|nursing care
4713682|NCT03151863|Analgesia|analgesia
4713683|NCT03151863|Sedation|sedation
4713684|NCT03151863|Anxiolysis|anxiolysis
4713685|NCT03151863|Intranasal|intranasal
4713686|NCT03151850|fungal|fungal
4713687|NCT03151850|mucosa|mucosa
4713688|NCT03151850|diversity|diversity
4713689|NCT03151850|Basidiomycete|basidiomycete
4713690|NCT03151837|Diabetes|diabetes
4713691|NCT03151837|Bitter melon(Momordica charantia)|bitter melon(momordica charantia)
4713692|NCT03151837|Insulin sensitivity|insulin sensitivity
4713693|NCT03151811|Refractory Multiple Myeloma|refractory multiple myeloma
4713694|NCT03151811|Relapsed Multiple Myeloma|relapsed multiple myeloma
4713695|NCT03151811|Melflufen|melflufen
4713696|NCT03151811|Pomalidomide|pomalidomide
4713697|NCT03151811|Dexamethasone|dexamethasone
4713698|NCT03151798|Nonalcoholic fatty liver|nonalcoholic fatty liver
4713699|NCT03151798|Exercise|exercise
4713700|NCT03151798|Weight loss diet|weight loss diet
4713702|NCT03151785|Schools|schools
4713703|NCT03151785|Education|education
4713704|NCT03151785|Lifesaver|lifesaver
4713705|NCT03151733|SILS|sils
4713706|NCT03151733|colorectal cancer|colorectal cancer
4713707|NCT03151694|childhood obesity|childhood obesity
4713708|NCT03151694|body weight|body weight
4713709|NCT03151694|nutritional risk|nutritional risk
4713710|NCT03151681|Reconsolidation|reconsolidation
4713711|NCT03151681|Propranolol|propranolol
4713712|NCT03151681|Infidelity|infidelity
4713713|NCT03151681|Attachment injury|attachment injury
4713714|NCT03151681|Romantic relationships|romantic relationships
4713715|NCT03151603|Uva Ursi|uva ursi
4713716|NCT03151603|fosfomycin|fosfomycin
4713717|NCT03151603|uncomplicated urinary tract infection of women|uncomplicated urinary tract infection of women
4713718|NCT03151564|Diseases of liver|diseases of liver
4713719|NCT03151564|Colon carcinoma|colon carcinoma
4713720|NCT03151564|Colorectal carcinoma|colorectal carcinoma
4713721|NCT03151564|Liver metastases|liver metastases
4713722|NCT03151564|Computed tomography|computed tomography
4713723|NCT03151564|CT|ct
4713724|NCT03151564|Reduced radiation doses|reduced radiation doses
4713725|NCT03151538|Pedography|pedography
4713726|NCT03151538|Exercise|exercise
4713727|NCT03151538|Play Training|play training
4713728|NCT03151538|Pes Planus|pes planus
4713729|NCT03151538|Femoral Anteversion|femoral anteversion
4713730|NCT03151512|MRI|mri
4713731|NCT03151512|distortion correction|distortion correction
4713732|NCT03151512|Magnetic Resonance Imaging|magnetic resonance imaging
4713733|NCT03151512|prostheses|prostheses
4713734|NCT03151447|Breast Cancer|breast cancer
4713735|NCT03151447|Anti-PD1 Antibody|anti-pd1 antibody
4713736|NCT03151447|Stereotactic Body Radiation Therapy|stereotactic body radiation therapy
4713737|NCT03151434|VATS|vats
4713738|NCT03151434|pain|pain
4713739|NCT03151421|air quality feedback|air quality feedback
4713740|NCT03151421|second-hand smoke|second-hand smoke
4713741|NCT03151421|passive smoking|passive smoking
4713742|NCT03151421|exposure to second-hand smoke|exposure to second-hand smoke
4713743|NCT03151421|second-hand smoke exposure prevention|second-hand smoke exposure prevention
4713744|NCT03151408|AML|aml
4713745|NCT03151395|COPD|copd
4713746|NCT03151395|AECOPD|aecopd
4713747|NCT03151395|GOLD (Global Initiative for Chronic Obstructive Lung Disease)|gold (global initiative for chronic obstructive lung disease)
4713748|NCT03151395|Asia Pacific|asia pacific
4713749|NCT03151382|Alzheimer Disease|alzheimer disease
4713750|NCT03151382|Cognitive Function|cognitive function
4713751|NCT03151382|tandospirone|tandospirone
4713752|NCT03151304|MDS|mds
4713753|NCT03151291|cancer cachexia|cancer cachexia
4713754|NCT03151291|WB-EMS|wb-ems
4713755|NCT03151291|skeletal muscle mass|skeletal muscle mass
4713756|NCT03151291|exercise|exercise
4713757|NCT03151291|nutrition|nutrition
4713758|NCT03151291|dietary supplements|dietary supplements
4713759|NCT03151278|Fluoroscopy|fluoroscopy
4713760|NCT03151278|Ablation|ablation
4713761|NCT03151278|Three dimensional|three dimensional
4713762|NCT03151278|Atrial arrhythmia|atrial arrhythmia
4713763|NCT03151278|Radiation|radiation
4713764|NCT03151265|Functional Outcome Measures|functional outcome measures
4713765|NCT03151265|Wearable Sensors|wearable sensors
4713766|NCT03151265|ViMove|vimove
4713767|NCT03151265|Low Back Pain|low back pain
4713768|NCT03151265|Range of Movement|range of movement
4713769|NCT03151265|Muscle Activity|muscle activity
4713770|NCT03151265|ThermaCare|thermacare
4713771|NCT03151226|obstructive sleep apnea screen negative|obstructive sleep apnea screen negative
4713772|NCT03151226|respiratory depression|respiratory depression
4713773|NCT03151226|cesarean section|cesarean section
4713774|NCT03151200|Amblyopia treatment|amblyopia treatment
4713775|NCT03151161|chemotherapy|chemotherapy
4713776|NCT03151161|maintenance therapy|maintenance therapy
4713777|NCT03151161|icotinib|icotinib
4713778|NCT03151148|allogeneic targeted microbiome transplant (TMT)|allogeneic targeted microbiome transplant (tmt)
4713779|NCT03151148|dysbiosis in AD|dysbiosis in ad
4713780|NCT03151148|Staphylococcus aureus colonized skin|staphylococcus aureus colonized skin
4713781|NCT03151148|antimicrobial peptides (AMPs)|antimicrobial peptides (amps)
4713782|NCT03151148|randomized trial|randomized trial
4713783|NCT03151135|Energy metabolism|energy metabolism
4713784|NCT03151109|reverse total shoulder arthroplasty|reverse total shoulder arthroplasty
4713785|NCT03151109|glenoid bone loss|glenoid bone loss
4713786|NCT03151083|Health Technology|health technology
4713787|NCT03151083|Internet-Based Psychotherapy|internet-based psychotherapy
4713788|NCT03151083|self-care|self-care
4713789|NCT03151083|Primary Care|primary care
4713790|NCT03151083|Mental Health|mental health
4713791|NCT03151057|Idelalisib|idelalisib
4713792|NCT03151057|Zydelig|zydelig
4713793|NCT03151057|Gilead|gilead
4713794|NCT03151057|allo transplant|allo transplant
4713795|NCT03151057|Gladstone|gladstone
4713796|NCT03151057|PI3K inhibitor|pi3k inhibitor
4713797|NCT03151057|post transplant maintenance therapy|post transplant maintenance therapy
4713798|NCT03151044|epirubicin|epirubicin
4713799|NCT03151044|high-dose|high-dose
4713800|NCT03151044|Diffuse Large B-cell Lymphoma|diffuse large b-cell lymphoma
4713801|NCT03151044|medium/high-risk|medium/high-risk
4713802|NCT03151031|balance|balance
4713803|NCT03151031|college students|college students
4713804|NCT03151031|star excursion balance test|star excursion balance test
4713805|NCT03151018|coronary artery disease|coronary artery disease
4713806|NCT03151018|percutaneous coronary intervention|percutaneous coronary intervention
4713807|NCT03151018|zotarolimus-eluting stents|zotarolimus-eluting stents
4713808|NCT03151005|Polycystic Ovary Syndrome (PCOS)|polycystic ovary syndrome (pcos)
4713809|NCT03151005|Overweight|overweight
4713810|NCT03151005|Obesity|obesity
4713811|NCT03151005|GLP-1 Agonist|glp-1 agonist
4713812|NCT03151005|Oral contraceptives (OCs)|oral contraceptives (ocs)
4713813|NCT03151005|Metformin|metformin
4713814|NCT03151005|Reproductive Disorders|reproductive disorders
4713815|NCT03151005|Cardiovascular risk factor|cardiovascular risk factor
4713816|NCT03151005|Lipid Metabolism|lipid metabolism
4713817|NCT03150992|Feasibility|feasibility
4713818|NCT03150992|Elemental Diet|elemental diet
4713819|NCT03150992|Quality of life|quality of life
4713820|NCT03150992|Palliative|palliative
4713821|NCT03150992|Nutrition|nutrition
4713823|NCT03150992|Peritoneal|peritoneal
4713824|NCT03150992|Advanced|advanced
4713825|NCT03150992|Metastatic|metastatic
4713826|NCT03150992|Bowel obstruction|bowel obstruction
4713827|NCT03150992|Inoperable|inoperable
4713828|NCT03150979|Stroke|stroke
4713829|NCT03150979|Assistive devices|assistive devices
4713830|NCT03150979|Gait|gait
4713831|NCT03150979|Rehabilitation|rehabilitation
4713832|NCT03150979|Clinical trial|clinical trial
4713833|NCT03150966|Multiple sclerosis|multiple sclerosis
4713834|NCT03150966|Nanocurcumin|nanocurcumin
4713835|NCT03150966|MicroRNAs|micrornas
4713836|NCT03150966|Th17 cells|th17 cells
4713837|NCT03150953|anesthesia|anesthesia
4713838|NCT03150953|MRI|mri
4713839|NCT03150953|thermoregulation|thermoregulation
4713840|NCT03150862|Adult glioblastoma, adult gian cell glioblastoma, adult gliosarcoma, glioma neoplasms|adult glioblastoma, adult gian cell glioblastoma, adult gliosarcoma, glioma neoplasms
4713841|NCT03150862|recurrent adult brain tumor|recurrent adult brain tumor
4713842|NCT03150862|neoplasms, central nervous system neoplasms, neoplasms by histologic type, neoplasms by site|neoplasms, central nervous system neoplasms, neoplasms by histologic type, neoplasms by site
4713843|NCT03150862|astrocytoma|astrocytoma
4713844|NCT03150862|neuroepithelial|neuroepithelial
4713845|NCT03150862|neuroectodermal tumors|neuroectodermal tumors
4713846|NCT03150862|germ cell and embryonal|germ cell and embryonal
4713847|NCT03150862|antineoplastic agents|antineoplastic agents
4713848|NCT03150862|glandular and epithelial|glandular and epithelial
4713849|NCT03150862|nerve tissue, nervous system diseases|nerve tissue, nervous system diseases
4713850|NCT03150862|temozolomide|temozolomide
4713851|NCT03150862|BGB-290|bgb-290
4713852|NCT03150862|alkylating, alkylating agents|alkylating, alkylating agents
4713853|NCT03150862|molecular mechanisms of pharmacological action|molecular mechanisms of pharmacological action
4713854|NCT03150862|Poly(ADP-ribose) polymerase inhibitors|poly(adp-ribose) polymerase inhibitors
4713855|NCT03150862|enzyme inhibitors|enzyme inhibitors
4713856|NCT03150836|bladder cancer|bladder cancer
4713857|NCT03150836|urothelial|urothelial
4713858|NCT03150823|Direct current|direct current
4713859|NCT03150823|Galvanic current|galvanic current
4713860|NCT03150823|Handgrip Force|handgrip force
4713861|NCT03150823|Palmar Grip|palmar grip
4713862|NCT03150823|Dynamometry|dynamometry
4713863|NCT03150823|Miofeedback|miofeedback
4713864|NCT03150810|Ovarian cancer|ovarian cancer
4713865|NCT03150810|Triple negative breast cancer|triple negative breast cancer
4713866|NCT03150810|Small cell lung cancer|small cell lung cancer
4713867|NCT03150810|Prostate cancer,|prostate cancer,
4713868|NCT03150810|Gastric cancer|gastric cancer
4713869|NCT03150810|neoplasms|neoplasms
4713870|NCT03150810|temozolomide|temozolomide
4713871|NCT03150810|BGB-290|bgb-290
4713872|NCT03150810|antineoplastic agents|antineoplastic agents
4713873|NCT03150810|alkylating, alkylating agents,|alkylating, alkylating agents,
4713874|NCT03150810|Poly (ADP-ribose) polymerase inhibitors|poly (adp-ribose) polymerase inhibitors
4713875|NCT03150810|enzyme inhibitors|enzyme inhibitors
4713876|NCT03150797|UCSF|ucsf
4713877|NCT03150797|UCLA|ucla
4713878|NCT03150797|melatonin|melatonin
4713879|NCT03150797|migraine|migraine
4713880|NCT03150797|headache|headache
4713881|NCT03150784|Motor Learning|motor learning
4713882|NCT03150784|Coordination|coordination
4713883|NCT03150784|Children|children
4713884|NCT03150784|Motor Skills Disorders|motor skills disorders
4713885|NCT03150784|Movement|movement
4713886|NCT03150758|Erectile Disfunction|erectile disfunction
4713887|NCT03150758|Urinary Function|urinary function
4713888|NCT03150706|POLE mutation|pole mutation
4713889|NCT03150706|mismatch repair deficient|mismatch repair deficient
4713890|NCT03150706|Avelumab|avelumab
4713891|NCT03150680|SYNTAX score|syntax score
4713892|NCT03150680|SNPs|snps
4713893|NCT03150680|Genetics|genetics
4713894|NCT03150680|Pharmacogenetics|pharmacogenetics
4713895|NCT03150680|Genetic Risk Score|genetic risk score
4713896|NCT03150680|Precision Medicine|precision medicine
4713897|NCT03150654|macular pigment|macular pigment
4713898|NCT03150654|macular pigment optical density|macular pigment optical density
4713899|NCT03150654|diabetic retinopathy|diabetic retinopathy
4713900|NCT03150654|laser pan-retinal photocoagulation|laser pan-retinal photocoagulation
4713901|NCT03150641|Maternal blood loss|maternal blood loss
4713902|NCT03150641|Cesarean delivery|cesarean delivery
4713903|NCT03150641|Delayed cord clamping|delayed cord clamping
4713904|NCT03150641|Neonatal health|neonatal health
4713905|NCT03150576|Triple negative breast cancer|triple negative breast cancer
4713906|NCT03150576|germline BRCA|germline brca
4713907|NCT03150576|platinum and PARP inhibitor|platinum and parp inhibitor
4713908|NCT03150576|neoadjuvant chemotherapy|neoadjuvant chemotherapy
4713909|NCT03150576|olaparib|olaparib
4713910|NCT03150563|Stretching|stretching
4713911|NCT03150563|Stretching sensation|stretching sensation
4713912|NCT03150563|Isokinetic dynamometry|isokinetic dynamometry
4713913|NCT03150563|Stretching load.|stretching load.
4713914|NCT03150550|Mindfulness|mindfulness
4713915|NCT03150550|Alcohol|alcohol
4713916|NCT03150550|Alcohol Use Disorder|alcohol use disorder
4713917|NCT03150550|Relapse|relapse
4713918|NCT03150550|Relapse Prevention|relapse prevention
4713919|NCT03150550|Cognitive-behavioral therapy|cognitive-behavioral therapy
4713920|NCT03150537|jet injector|jet injector
4713921|NCT03150537|influenza vaccine|influenza vaccine
4713922|NCT03150537|immune response|immune response
4713923|NCT03150524|stroke|stroke
4713924|NCT03150524|RCVS|rcvs
4713925|NCT03150498|Food Effect|food effect
4713926|NCT03150498|Pharmacokinetics|pharmacokinetics
4713927|NCT03150472|Dental Instruments|dental instruments
4713928|NCT03150472|Dental Technology|dental technology
4713929|NCT03150446|laparoscopy|laparoscopy
4713930|NCT03150446|ureteral catheterization|ureteral catheterization
4713931|NCT03150420|calciphylaxis|calciphylaxis
4713932|NCT03150420|calcific uremic arteriolopathy, calcinosis|calcific uremic arteriolopathy, calcinosis
4713933|NCT03150420|calcium metabolism disorders|calcium metabolism disorders
4713934|NCT03150420|metabolic diseases|metabolic diseases
4713935|NCT03150420|sodium thiosulfate|sodium thiosulfate
4713936|NCT03150342|CZT scanner|czt scanner
4713937|NCT03150342|myocardial perfusion imaging|myocardial perfusion imaging
4713938|NCT03150342|Hypertrophic Cardiomyopathy|hypertrophic cardiomyopathy
4713939|NCT03150303|Periprocedural period|periprocedural period
4713940|NCT03150303|Anticoagulant treatment|anticoagulant treatment
4713941|NCT03150303|Thromboembolic events|thromboembolic events
4713942|NCT03150303|Bleeding events|bleeding events
4713943|NCT03150264|lung protective ventilation strategies|lung protective ventilation strategies
4713944|NCT03150264|obesity|obesity
4713945|NCT03150225|andropause|andropause
4713946|NCT03150225|depressive symptoms|depressive symptoms
4713947|NCT03150225|stress|stress
4713948|NCT03150225|abdominal Obesity|abdominal obesity
4713949|NCT03150225|testosterone|testosterone
4713950|NCT03150225|erectile dysfunction|erectile dysfunction
4713951|NCT03150186|second hand smoke|second hand smoke
4713952|NCT03150186|passive smoking|passive smoking
4713953|NCT03150186|airborne nicotine|airborne nicotine
4713954|NCT03150186|private settings|private settings
4713955|NCT03150186|outdoors|outdoors
4713956|NCT03150173|opioid use disorder, syringe exchange, HIV risk reduction|opioid use disorder, syringe exchange, hiv risk reduction
4713957|NCT03150160|travoprost|travoprost
4713958|NCT03150160|brinzolamide 1% / brimonidine 0.2%|brinzolamide 1% / brimonidine 0.2%
4713959|NCT03150160|normal tension glaucoma|normal tension glaucoma
4713960|NCT03150160|intraocular pressure|intraocular pressure
4713961|NCT03150160|efficacy|efficacy
4713962|NCT03150160|safety|safety
4713963|NCT03150147|Organ preservation|organ preservation
4713964|NCT03150147|Survival|survival
4713965|NCT03150147|Graft function|graft function
4713966|NCT03150147|Reperfusion injury|reperfusion injury
4713967|NCT03150147|Heart transplantation|heart transplantation
4713968|NCT03150134|Acute Myeloid Leukemia|acute myeloid leukemia
4713969|NCT03150134|transplantation|transplantation
4713970|NCT03150134|allogeneic transplantation|allogeneic transplantation
4713971|NCT03150134|immunosuppressive agents|immunosuppressive agents
4713972|NCT03150082|GR37547|gr37547
4713973|NCT03150082|Cross-over|cross-over
4713974|NCT03150082|Bioequivalence|bioequivalence
4713975|NCT03150082|Ciprofloxacin|ciprofloxacin
4713976|NCT03150069|Pregnancy|pregnancy
4713977|NCT03150056|abiraterone|abiraterone
4713978|NCT03150056|castrate-resistant prostate cancer|castrate-resistant prostate cancer
4713979|NCT03150056|androgen receptor targeted therapy|androgen receptor targeted therapy
4713980|NCT03150056|RP2D|rp2d
4713981|NCT03150056|enzalutamide|enzalutamide
4713982|NCT03150056|GSK525762|gsk525762
4713983|NCT03150043|Hemoglobin|hemoglobin
4713984|NCT03150043|Cesarean delivery|cesarean delivery
4713985|NCT03150004|Acute myeloid leukemia|acute myeloid leukemia
4713986|NCT03150004|AML|aml
4713987|NCT03150004|salvage chemotherapy|salvage chemotherapy
4713988|NCT03150004|CLAG-M|clag-m
4713989|NCT03150004|relapse acute myeloid leukemia|relapse acute myeloid leukemia
4713990|NCT03150004|secondary acute myeloid leukemia|secondary acute myeloid leukemia
4713991|NCT03150004|phase II|phase ii
4713992|NCT03150004|pharmacogenomics|pharmacogenomics
4713993|NCT03149991|treatment resistant|treatment resistant
4713994|NCT03149991|inadequate response|inadequate response
4713995|NCT03149978|Neoadjuvant Chemoradiation|neoadjuvant chemoradiation
4713996|NCT03149978|treatment effect prediction|treatment effect prediction
4713997|NCT03149978|metabonomics|metabonomics
4713998|NCT03149913|below the knee artery|below the knee artery
4713999|NCT03149913|endovascular|endovascular
4714000|NCT03149913|drug coated balloon|drug coated balloon
4714001|NCT03149913|critical limb ischemia|critical limb ischemia
4714002|NCT03149848|Tuberculosis|tuberculosis
4714003|NCT03149848|Human Immunodeficiency Virus|human immunodeficiency virus
4714004|NCT03149848|Rifabutin|rifabutin
4714005|NCT03149848|Drug-drug interaction|drug-drug interaction
4714006|NCT03149848|Cabotegravir|cabotegravir
4714007|NCT03149809|Urinary incontinence|urinary incontinence
4714008|NCT03149809|Parkinson disease|parkinson disease
4714009|NCT03149809|Overactive urinary bladder|overactive urinary bladder
4714010|NCT03149809|Nocturia|nocturia
4714011|NCT03149757|Treatment Adherence|treatment adherence
4714012|NCT03149757|Alcohol or Drugs|alcohol or drugs
4714013|NCT03149757|Behavioral|behavioral
4714014|NCT03149757|Internet|internet
4714015|NCT03149757|Adolescents|adolescents
4714016|NCT03149757|Young Adults|young adults
4714017|NCT03149757|Social Support|social support
4714018|NCT03149718|Pharmacy|pharmacy
4714019|NCT03149718|Intervention|intervention
4714020|NCT03149718|Medication Adherence|medication adherence
4714021|NCT03149705|Ischemic stroke, stroke, bio-collection, Imaging markers, biomarkers, clinical outcomes|ischemic stroke, stroke, bio-collection, imaging markers, biomarkers, clinical outcomes
4714022|NCT03149679|Cyclophosphamide|cyclophosphamide
4714023|NCT03149679|Colorectal Cancer Metastatic|colorectal cancer metastatic
4714024|NCT03149679|TP53 Gene Mutation|tp53 gene mutation
4714025|NCT03149653|lipid emulsion|lipid emulsion
4714026|NCT03149653|olive oil|olive oil
4714027|NCT03149653|fish oil|fish oil
4714028|NCT03149653|intestinal failure|intestinal failure
4714029|NCT03149653|home parenteral nutrition|home parenteral nutrition
4714030|NCT03149640|Prevention|prevention
4714031|NCT03149640|inhaled amikacin|inhaled amikacin
4714032|NCT03149640|placebo|placebo
4714033|NCT03149614|mobilization|mobilization
4714034|NCT03149614|resonant oscillation|resonant oscillation
4714035|NCT03149575|Glioma|glioma
4714036|NCT03149575|Glioblastoma|glioblastoma
4714037|NCT03149575|Glioblastoma multiforme|glioblastoma multiforme
4714038|NCT03149575|GBM|gbm
4714039|NCT03149575|brain tumor|brain tumor
4714040|NCT03149575|brain cancer|brain cancer
4714041|NCT03149575|recurrent brain tumor|recurrent brain tumor
4714042|NCT03149575|recurrent brain cancer|recurrent brain cancer
4714043|NCT03149575|refractory brain tumor|refractory brain tumor
4714044|NCT03149575|refractory brain cancer|refractory brain cancer
4714045|NCT03149575|recurrent GBM|recurrent gbm
4714046|NCT03149575|refractory GBM|refractory gbm
4714047|NCT03149575|recurrent glioma|recurrent glioma
4714048|NCT03149575|refractory glioma|refractory glioma
4714049|NCT03149575|recurrent glioblastoma|recurrent glioblastoma
4714050|NCT03149575|refractory glioblastoma|refractory glioblastoma
4714051|NCT03149575|recurrent glioblastoma multiforme|recurrent glioblastoma multiforme
4714052|NCT03149575|refractory glioblastoma multiforme|refractory glioblastoma multiforme
4714053|NCT03149575|failed temodar|failed temodar
4714054|NCT03149575|failed temozolomide|failed temozolomide
4714055|NCT03149575|temodar refractory|temodar refractory
4714056|NCT03149575|temozolomide refractory|temozolomide refractory
4714057|NCT03149575|failed avastin|failed avastin
4714058|NCT03149575|avastin refractory|avastin refractory
4714059|NCT03149575|failed bevacizumab|failed bevacizumab
4714060|NCT03149575|bevacizumab refractory|bevacizumab refractory
4714061|NCT03149575|avastin failure|avastin failure
4714062|NCT03149575|bevacizumab failure|bevacizumab failure
4714063|NCT03149575|STAR-3|star-3
4714064|NCT03149549|cancer|cancer
4714065|NCT03149549|solid tumor|solid tumor
4714066|NCT03149549|PROCLAIM|proclaim
4714067|NCT03149549|CX-2009|cx-2009
4714068|NCT03149549|PROBODY™ Therapeutic|probody™ therapeutic
4714069|NCT03149549|Drug Conjugate|drug conjugate
4714070|NCT03149549|Antibody drug conjugate|antibody drug conjugate
4714071|NCT03149549|CD166|cd166
4714072|NCT03149536|pharmacogenetic|pharmacogenetic
4714073|NCT03149536|pharmacogenomic|pharmacogenomic
4714074|NCT03149536|polymorphism|polymorphism
4714075|NCT03149536|individualized controlled ovarian stimulation|individualized controlled ovarian stimulation
4714076|NCT03149536|algorithm|algorithm
4714077|NCT03149536|assisted reproduction|assisted reproduction
4714078|NCT03149523|exhaustive genetic and immunological analyses|exhaustive genetic and immunological analyses
4714079|NCT03149523|targeted therapies|targeted therapies
4714080|NCT03149523|colon cancer|colon cancer
4714081|NCT03149523|kidney cancer|kidney cancer
4714082|NCT03149523|liver cancer|liver cancer
4714083|NCT03149523|immunological tumor microenvironment|immunological tumor microenvironment
4714084|NCT03149523|tumor microenvironment heterogeneity|tumor microenvironment heterogeneity
4714085|NCT03149510|mobile application|mobile application
4714086|NCT03149510|mHealth|mhealth
4714087|NCT03149458|stroke|stroke
4714088|NCT03149458|balance|balance
4714089|NCT03149458|dance|dance
4714090|NCT03149432|mirror therapy|mirror therapy
4714091|NCT03149432|amputation|amputation
4714092|NCT03149432|phantom pain|phantom pain
4714093|NCT03149419|postmenopause|postmenopause
4714094|NCT03149419|paroxetine|paroxetine
4714095|NCT03149419|endothelial dysfunction|endothelial dysfunction
4714096|NCT03149419|blood pressure|blood pressure
4714097|NCT03149419|heart rate variability|heart rate variability
4714098|NCT03149419|sleep quality|sleep quality
4714099|NCT03149419|perceived stress|perceived stress
4714100|NCT03149419|sleepiness|sleepiness
4714101|NCT03149393|Functional Dyspepsia|functional dyspepsia
4714102|NCT03149393|Qizhi Weitong Granules|qizhi weitong granules
4714103|NCT03149393|Traditional Chinese Medicine|traditional chinese medicine
4714104|NCT03149328|Home Dialysis|home dialysis
4714105|NCT03149328|Person-Centred Care|person-centred care
4714106|NCT03149328|Patient-Reported Outcome Measures|patient-reported outcome measures
4714107|NCT03149328|Process Evaluation|process evaluation
4714108|NCT03149328|Educational Support|educational support
4714109|NCT03149328|Electronic Patient-Reported Outcome Measures|electronic patient-reported outcome measures
4714110|NCT03149328|Patient-Reported Experience Measures|patient-reported experience measures
4714111|NCT03149302|Manual therapy|manual therapy
4714112|NCT03149302|Sensorimotor exercises|sensorimotor exercises
4714113|NCT03149302|Balance exercises|balance exercises
4714114|NCT03149302|Cervical mobilization|cervical mobilization
4714115|NCT03149302|Specific neck muscle exercises|specific neck muscle exercises
4714116|NCT03149263|botulinum toxin|botulinum toxin
4714117|NCT03149263|anxiety reduction|anxiety reduction
4714118|NCT03149263|pain reduction|pain reduction
4714119|NCT03149263|medical clowns|medical clowns
4714120|NCT03149263|distraction|distraction
4714121|NCT03149250|Aggregometry|aggregometry
4714122|NCT03149237|Mozambique|mozambique
4714123|NCT03149237|Couples-based services|couples-based services
4714124|NCT03149237|HIV/AIDS|hiv/aids
4714125|NCT03149237|Ante-natal Care|ante-natal care
4714126|NCT03149198|Fibromyalgia, pilates, exercises|fibromyalgia, pilates, exercises
4714127|NCT03149185|prostate cancer|prostate cancer
4714128|NCT03149185|advanced prostate cancer|advanced prostate cancer
4714129|NCT03149185|technology based|technology based
4714130|NCT03149146|Clinical Decision Making|clinical decision making
4714131|NCT03149146|Myanmar Physical therapists|myanmar physical therapists
4714132|NCT03149146|Educational workshop|educational workshop
4714133|NCT03149133|Biomechanics|biomechanics
4714134|NCT03149133|Strength training|strength training
4714135|NCT03149133|Elastography|elastography
4714136|NCT03149133|Ultrasound|ultrasound
4714137|NCT03149120|Metastatic|metastatic
4714138|NCT03149120|Unresectable|unresectable
4714139|NCT03149120|anthracycline|anthracycline
4714140|NCT03149120|chemotherapy|chemotherapy
4714141|NCT03149120|systemic therapy|systemic therapy
4714142|NCT03149107|Prodrome, CHR, Schizophrenia, prevention, N-acetylcysteine|prodrome, chr, schizophrenia, prevention, n-acetylcysteine
4714143|NCT03149094|Self-Management|self-management
4714144|NCT03149094|mHealth|mhealth
4714145|NCT03149042|FFR|ffr
4714146|NCT03149042|Fractional Flow Reserve|fractional flow reserve
4714147|NCT03149042|Atherosclerosis|atherosclerosis
4714148|NCT03149042|Coronary|coronary
4714149|NCT03149042|stenosis|stenosis
4714150|NCT03149029|Metastatic Melanoma|metastatic melanoma
4714151|NCT03149003|Glioblastoma|glioblastoma
4714152|NCT03149003|Wilms Tumor 1|wilms tumor 1
4714153|NCT03149003|Cancer Vaccines|cancer vaccines
4714154|NCT03149003|Neoplasms|neoplasms
4714155|NCT03148990|Double Viral Vaccine Measles and Rubella|double viral vaccine measles and rubella
4714156|NCT03148990|Safety Efficacy Imunogenicity|safety efficacy imunogenicity
4714157|NCT03148977|Matrix Metalloproteinases|matrix metalloproteinases
4714158|NCT03148951|MPV|mpv
4714159|NCT03148951|NLR|nlr
4714160|NCT03148951|Postoperative pain|postoperative pain
4714161|NCT03148938|DAM|dam
4714162|NCT03148938|multiple sclerosis|multiple sclerosis
4714163|NCT03148938|MSFC|msfc
4714164|NCT03148938|application|application
4714165|NCT03148938|mobile|mobile
4714166|NCT03148925|nicotine vaccine|nicotine vaccine
4714167|NCT03148925|smoking vaccine|smoking vaccine
4714168|NCT03148925|smoking cessation|smoking cessation
4714169|NCT03148925|SELA-070|sela-070
4714170|NCT03148899|Sleep Apnea|sleep apnea
4714171|NCT03148899|Oxytocin Nasal Spray|oxytocin nasal spray
4714172|NCT03148886|Physical activity|physical activity
4714173|NCT03148860|Psoriatic Arthritis|psoriatic arthritis
4714174|NCT03148860|Ustekinumab|ustekinumab
4714175|NCT03148860|Methotrexate|methotrexate
4714176|NCT03148860|DAS28|das28
4714177|NCT03148834|Acute Myocardial Infarction Reperfusion Injury|acute myocardial infarction reperfusion injury
4714178|NCT03148821|pressure ulcer|pressure ulcer
4714179|NCT03148821|pressure sore|pressure sore
4714180|NCT03148821|patient positioning|patient positioning
4714181|NCT03148769|Bloodstream infections, epidemiology|bloodstream infections, epidemiology
4714182|NCT03148678|Emotional reactivity|emotional reactivity
4714183|NCT03148678|Cognitive flexibility|cognitive flexibility
4714184|NCT03148665|Oral Cancer|oral cancer
4714185|NCT03148665|Head and Neck Cancer|head and neck cancer
4714186|NCT03148639|auditory hallucination|auditory hallucination
4714187|NCT03148639|schizophrenia|schizophrenia
4714188|NCT03148639|treatment-resistant|treatment-resistant
4714189|NCT03148639|psychotherapy|psychotherapy
4714190|NCT03148639|virtual reality|virtual reality
4714191|NCT03148639|avatar|avatar
4714192|NCT03148626|mindfulness curriculum|mindfulness curriculum
4714193|NCT03148600|Ileoanal pouch, pelvic floor exercise|ileoanal pouch, pelvic floor exercise
4714194|NCT03148587|abortion|abortion
4714195|NCT03148587|medical abortion|medical abortion
4714196|NCT03148587|mifepristone|mifepristone
4714197|NCT03148587|pregnancy test|pregnancy test
4714199|NCT03148548|thrombophilia screening|thrombophilia screening
4714200|NCT03148548|patients|patients
4714201|NCT03148548|risk factors|risk factors
4714202|NCT03148548|post-thrombotic syndrome|post-thrombotic syndrome
4714203|NCT03148496|abdominal surgery|abdominal surgery
4714204|NCT03148496|wound complication|wound complication
4714205|NCT03148483|Pregnancy outcome|pregnancy outcome
4714206|NCT03148483|Feasibility|feasibility
4714207|NCT03148483|Milk Fortification|milk fortification
4714208|NCT03148483|Periodontitis|periodontitis
4714209|NCT03148483|Pregnant women|pregnant women
4714210|NCT03148483|Periodontal Therapy|periodontal therapy
4714211|NCT03148470|theta burst stimulation|theta burst stimulation
4714212|NCT03148470|Language switching|language switching
4714213|NCT03148470|dorsolateral prefrontal cortex|dorsolateral prefrontal cortex
4714214|NCT03148457|Stroke|stroke
4714215|NCT03148457|Direct oral anticoagulation|direct oral anticoagulation
4714216|NCT03148457|Apixaban|apixaban
4714217|NCT03148457|Dabigatran|dabigatran
4714218|NCT03148457|Rivaroxaban|rivaroxaban
4714219|NCT03148457|Edoxaban|edoxaban
4714220|NCT03148457|Therapy initiation|therapy initiation
4714221|NCT03148457|Major bleeding|major bleeding
4714222|NCT03148457|Atrial fibrillation|atrial fibrillation
4714223|NCT03148379|Total Knee Replacement|total knee replacement
4714224|NCT03148366|Self Efficacy|self efficacy
4714225|NCT03148353|ultrasonography, corticosteroid, subacromial impingement syndrome, shoulder pain|ultrasonography, corticosteroid, subacromial impingement syndrome, shoulder pain
4714226|NCT03148249|Randomized control trial|randomized control trial
4714227|NCT03148249|Charles Bonnet syndrome|charles bonnet syndrome
4714228|NCT03148249|visual hallucinations|visual hallucinations
4714229|NCT03148249|age related macular degeneration|age related macular degeneration
4714230|NCT03148249|patient education|patient education
4714231|NCT03148223|Dysmenorrhea|dysmenorrhea
4714232|NCT03148223|acupuncture|acupuncture
4714233|NCT03148223|auriculotherapy|auriculotherapy
4714234|NCT03148197|Allogeneic hematopoietic stem cell transplantation|allogeneic hematopoietic stem cell transplantation
4714235|NCT03148197|Graft-versus-host-disease|graft-versus-host-disease
4714236|NCT03148197|Acute Myeloid Leukemia|acute myeloid leukemia
4714237|NCT03148184|reverse total shoulder arthroplasty|reverse total shoulder arthroplasty
4714238|NCT03148184|60 years old or younger|60 years old or younger
4714239|NCT03148184|outcomes|outcomes
4714240|NCT03148171|Pre-Exposure Prophylaxis (PrEP); Retention in PrEP Care|pre-exposure prophylaxis (prep); retention in prep care
4714241|NCT03148158|Bladder Cancer|bladder cancer
4714242|NCT03148158|Flexible cystoscopy|flexible cystoscopy
4714243|NCT03148158|Diagnosis|diagnosis
4714244|NCT03148132|Retinopathy of Prematurity|retinopathy of prematurity
4714245|NCT03148132|VEGF|vegf
4714246|NCT03148132|Bevacizumab|bevacizumab
4714247|NCT03148132|Ranibizumab|ranibizumab
4714248|NCT03148093|Metastatic Colorectal Cancer|metastatic colorectal cancer
4714249|NCT03148093|Registry|registry
4714250|NCT03148093|Patient Reported Outcomes|patient reported outcomes
4714251|NCT03148093|Treatment Patterns|treatment patterns
4714252|NCT03148093|Prescription Use|prescription use
4714253|NCT03148067|Risk Factors|risk factors
4714254|NCT03148067|Incidence|incidence
4714255|NCT03148067|Epidemiology|epidemiology
4714256|NCT03148054|Anastomosis|anastomosis
4714257|NCT03148054|Colon|colon
4714258|NCT03148054|CT|ct
4714259|NCT03148054|Endoscopy|endoscopy
4714260|NCT03148054|Enema|enema
4714261|NCT03148054|Detection leak|detection leak
4714262|NCT03148054|Anastomotic leak|anastomotic leak
4714263|NCT03147989|MultiHance|multihance
4714264|NCT03147989|MRI|mri
4714265|NCT03147989|CNS|cns
4714266|NCT03147989|Gadobenate Dimeglumine|gadobenate dimeglumine
4714267|NCT03147963|therapy|therapy
4714268|NCT03147963|breast cancer|breast cancer
4714269|NCT03147963|docetaxel|docetaxel
4714270|NCT03147963|metastasis|metastasis
4714271|NCT03147950|Prone-Flexed Position|prone-flexed position
4714272|NCT03147950|Percutaneous Nephrolithotomy (PCNL)|percutaneous nephrolithotomy (pcnl)
4714273|NCT03147950|Clavien-Dindo Classification Score|clavien-dindo classification score
4714274|NCT03147911|Stroke or systemic embolism|stroke or systemic embolism
4714275|NCT03147911|CHA2DS2-VASc score|cha2ds2-vasc score
4714276|NCT03147898|Whooping cough|whooping cough
4714277|NCT03147898|Pertussis|pertussis
4714278|NCT03147807|Carbapenems de-escalation, rapid diagnostic test,|carbapenems de-escalation, rapid diagnostic test,
4714279|NCT03147807|Carbapenem-antimicrobial de-escalation-rapid diagnostic test|carbapenem-antimicrobial de-escalation-rapid diagnostic test
4714280|NCT03147781|auriculotherapy, human milk, breastfeeding, lactogenesis|auriculotherapy, human milk, breastfeeding, lactogenesis
4714281|NCT03147768|Laser Tissue Welding|laser tissue welding
4714282|NCT03147768|Pancreatic Sealing|pancreatic sealing
4714283|NCT03147768|Hemostasis|hemostasis
4714284|NCT03147768|Pancreatic Tumors|pancreatic tumors
4714285|NCT03147768|Pancreatic Resection|pancreatic resection
4714286|NCT03147768|Pancreatic leakage|pancreatic leakage
4714287|NCT03147768|LTW|ltw
4714288|NCT03147755|stroke|stroke
4714289|NCT03147742|ruxolitinib|ruxolitinib
4714290|NCT03147742|acute or chronic steroid-refractory GVHD|acute or chronic steroid-refractory gvhd
4714291|NCT03147742|hematopoietic stem cell transplantation (allo-HSCT)|hematopoietic stem cell transplantation (allo-hsct)
4714292|NCT03147729|Radiofrequency|radiofrequency
4714293|NCT03147729|Anal incontinence|anal incontinence
4714294|NCT03147729|Fecal incontinence|fecal incontinence
4714295|NCT03147729|Women sexual function|women sexual function
4714296|NCT03147729|Sexuality|sexuality
4714297|NCT03147703|Microbiota|microbiota
4714298|NCT03147703|Food timing|food timing
4714299|NCT03147703|Obesity|obesity
4714300|NCT03147690|Solid Organ Injury|solid organ injury
4714301|NCT03147677|Type 2 diabetic nephropathy|type 2 diabetic nephropathy
4714302|NCT03147677|Alfacalcidol|alfacalcidol
4714303|NCT03147664|pompe disease|pompe disease
4714304|NCT03147664|exercise capacity|exercise capacity
4714305|NCT03147664|cardiopulmonary exercise testing|cardiopulmonary exercise testing
4714306|NCT03147651|Cystic fibrosis|cystic fibrosis
4714307|NCT03147651|exercise capacity|exercise capacity
4714308|NCT03147651|non-cystic fibrosis|non-cystic fibrosis
4714309|NCT03147651|bronchiectasis|bronchiectasis
4714310|NCT03147625|Aged|aged
4714311|NCT03147625|Independent living|independent living
4714312|NCT03147625|Health Promotion|health promotion
4714509|NCT03146312|gene array|gene array
4714313|NCT03147625|Residence Characteristics|residence characteristics
4714314|NCT03147625|Elderly-only household|elderly-only household
4714315|NCT03147599|Mebeverine|mebeverine
4714316|NCT03147599|Incontinence|incontinence
4714317|NCT03147599|Orthotopic Neobladder|orthotopic neobladder
4714318|NCT03147586|Immune Nutrition|immune nutrition
4714319|NCT03147586|Morbidity|morbidity
4714320|NCT03147573|Hypertension|hypertension
4714321|NCT03147573|Blood pressure monitoring|blood pressure monitoring
4714322|NCT03147560|Immunogenicity|immunogenicity
4714323|NCT03147560|Safety|safety
4714324|NCT03147560|Sabin IPV|sabin ipv
4714325|NCT03147560|bOPV|bopv
4714326|NCT03147508|Diagnostics, clinical criteria, clincal reasoning, neck pain|diagnostics, clinical criteria, clincal reasoning, neck pain
4714327|NCT03147456|bariatric|bariatric
4714328|NCT03147456|obesity|obesity
4714329|NCT03147456|protein supplements|protein supplements
4714330|NCT03147443|traditional Chinese medicine|traditional chinese medicine
4714331|NCT03147443|Drugs, Chinese Herbal|drugs, chinese herbal
4714332|NCT03147443|N-of-1 trials|n-of-1 trials
4714333|NCT03147443|sputum|sputum
4714334|NCT03147443|symptoms|symptoms
4714335|NCT03147443|individualized treatment|individualized treatment
4714336|NCT03147443|stable bronchiectasis|stable bronchiectasis
4714337|NCT03147391|Atrial Fibrillation|atrial fibrillation
4714338|NCT03147391|Left Atrial Appendage Closure|left atrial appendage closure
4714339|NCT03147391|LAmbre device|lambre device
4714340|NCT03147391|Stroke|stroke
4714341|NCT03147352|Fasciitis|fasciitis
4714342|NCT03147352|Gangrene|gangrene
4714343|NCT03147352|Fasciitis, Necrotizing|fasciitis, necrotizing
4714344|NCT03147352|Soft Tissue Infections|soft tissue infections
4714345|NCT03147352|Fournier's Gangrene|fournier's gangrene
4714346|NCT03147352|Streptococcal septic shock syndrome|streptococcal septic shock syndrome
4714347|NCT03147352|Flesh eating bacteria|flesh eating bacteria
4714348|NCT03147352|Meleneys ulcer|meleneys ulcer
4714349|NCT03147352|Wounds and Injuries|wounds and injuries
4714350|NCT03147352|Streptococcus pyogenes|streptococcus pyogenes
4714351|NCT03147352|Staphylococcus aureus|staphylococcus aureus
4714352|NCT03147352|Soft Tissue Infections/blood|soft tissue infections/blood
4714353|NCT03147352|Necrosis/blood|necrosis/blood
4714354|NCT03147352|Necrosis/diagnosis|necrosis/diagnosis
4714355|NCT03147352|Necrosis/mortality|necrosis/mortality
4714356|NCT03147352|Necrosis/surgery|necrosis/surgery
4714357|NCT03147352|Prognosis|prognosis
4714358|NCT03147352|Risk Factors|risk factors
4714359|NCT03147352|Bacterial Infections|bacterial infections
4714360|NCT03147352|Infection|infection
4714361|NCT03147352|Skin Diseases, Bacterial|skin diseases, bacterial
4714362|NCT03147352|Observational study|observational study
4714363|NCT03147352|Biological markers|biological markers
4714364|NCT03147352|Endothelium|endothelium
4714365|NCT03147352|suPAR|supar
4714366|NCT03147352|sTM|stm
4714367|NCT03147352|syndecan-1|syndecan-1
4714368|NCT03147352|sE-selectin|se-selectin
4714369|NCT03147352|VE-cadherin|ve-cadherin
4714370|NCT03147352|protein C|protein c
4714371|NCT03147352|Hyperbaric oxygen therapy|hyperbaric oxygen therapy
4714372|NCT03147352|HBOT|hbot
4714373|NCT03147339|AGEs( Advanced glycation end products)|ages( advanced glycation end products)
4714374|NCT03147313|extracorporeal shock wave|extracorporeal shock wave
4714375|NCT03147313|microsurgical nerve coaptation|microsurgical nerve coaptation
4714376|NCT03147313|nerve regeneration|nerve regeneration
4714377|NCT03147300|Low back pain|low back pain
4714378|NCT03147300|Model of care|model of care
4714379|NCT03147300|Primary health care|primary health care
4714380|NCT03147300|Implementation|implementation
4714381|NCT03147300|Patient-rated outcome|patient-rated outcome
4714382|NCT03147300|Clinician-rated outcome|clinician-rated outcome
4714383|NCT03147300|Cost-effectiveness|cost-effectiveness
4714384|NCT03147287|Breast Cancer|breast cancer
4714385|NCT03147274|Diabetes Mellitus, Type 1|diabetes mellitus, type 1
4714386|NCT03147274|Adolescence|adolescence
4714387|NCT03147222|hip fracture|hip fracture
4714388|NCT03147222|dementia|dementia
4714389|NCT03147222|intervention|intervention
4714390|NCT03147157|tacrolimus|tacrolimus
4714391|NCT03147157|histocompatibility antigens|histocompatibility antigens
4714392|NCT03147131|Total Hip Arthroplasty|total hip arthroplasty
4714393|NCT03147131|Short Stem|short stem
4714394|NCT03147131|DEXA|dexa
4714395|NCT03147118|trapeziometacarpal arthritis|trapeziometacarpal arthritis
4714396|NCT03147105|chronic progressive multiple sclerosis, mobility, arm ergometry, rehabilitation|chronic progressive multiple sclerosis, mobility, arm ergometry, rehabilitation
4714397|NCT03147079|obesity|obesity
4714398|NCT03147079|pregnancy|pregnancy
4714399|NCT03147079|lifestyle|lifestyle
4714400|NCT03147079|gestational weight gain|gestational weight gain
4714401|NCT03147079|weight of offspring|weight of offspring
4714402|NCT03147079|antenatal care|antenatal care
4714403|NCT03147079|health behavior|health behavior
4714404|NCT03147079|physical activity|physical activity
4714405|NCT03147079|diet|diet
4714406|NCT03147079|programme evaluation|programme evaluation
4714407|NCT03147079|costs and costs analysis|costs and costs analysis
4714408|NCT03147066|Dezocine|dezocine
4714409|NCT03147066|CRBD|crbd
4714410|NCT03147066|General anesthesia|general anesthesia
4714411|NCT03147066|Urinary catheter|urinary catheter
4714412|NCT03147040|Lobular|lobular
4714413|NCT03147040|Metastatic or incurable locally advanced cancer|metastatic or incurable locally advanced cancer
4714414|NCT03147040|Disease progression on endocrine therapy in advanced setting|disease progression on endocrine therapy in advanced setting
4714415|NCT03147027|ischemic cardiomyopathy|ischemic cardiomyopathy
4714416|NCT03147027|prophylactic ablation|prophylactic ablation
4714417|NCT03147014|Echocardiography|echocardiography
4714418|NCT03147014|Congenital Heart Disease|congenital heart disease
4714419|NCT03147014|Maternal hyperoxygenation|maternal hyperoxygenation
4714420|NCT03147001|Endurance exercise|endurance exercise
4714421|NCT03147001|Dietary protein|dietary protein
4714422|NCT03146975|Beta-defensins|beta-defensins
4714423|NCT03146975|Chronic periodontitis|chronic periodontitis
4714424|NCT03146975|Diabetes mellitus|diabetes mellitus
4714425|NCT03146975|Non-surgical periodontal therapy|non-surgical periodontal therapy
4714426|NCT03146897|Food Aid, Malnutrition, RUSF, FBF, Supplementary Food|food aid, malnutrition, rusf, fbf, supplementary food
4714427|NCT03146845|Diabetic Foot Ulcer|diabetic foot ulcer
4714428|NCT03146845|Pressure Ulcer|pressure ulcer
4714429|NCT03146845|Leg Ulcer|leg ulcer
4714430|NCT03146819|osteoarthritis|osteoarthritis
4714431|NCT03146819|osteoarthritis knee|osteoarthritis knee
4714432|NCT03146819|total knee replacement|total knee replacement
4714433|NCT03146819|patient specific|patient specific
4714434|NCT03146819|total knee arthroplasty|total knee arthroplasty
4714435|NCT03146819|orthopedics|orthopedics
4714436|NCT03146806|Cancer pain|cancer pain
4714437|NCT03146806|Anesthesiology|anesthesiology
4714438|NCT03146806|Opiates|opiates
4714439|NCT03146806|Intranasal ketamine|intranasal ketamine
4714440|NCT03146793|Calciphylaxis/complications|calciphylaxis/complications
4714441|NCT03146793|Kidney Failure, Chronic/complications|kidney failure, chronic/complications
4714442|NCT03146793|Renal Dialysis|renal dialysis
4714443|NCT03146793|Thiosulfates/therapeutic use|thiosulfates/therapeutic use
4714444|NCT03146793|Time Factors|time factors
4714445|NCT03146741|Heart Failure|heart failure
4714446|NCT03146702|Quality of Life|quality of life
4714447|NCT03146689|osteoarthritis|osteoarthritis
4714448|NCT03146689|n-of-1|n-of-1
4714449|NCT03146689|ibuprofen|ibuprofen
4714450|NCT03146689|capsaicin|capsaicin
4714451|NCT03146689|NSAID|nsaid
4714452|NCT03146689|topical|topical
4714453|NCT03146663|Platinum-resistant|platinum-resistant
4714454|NCT03146663|ovarian neoplasm|ovarian neoplasm
4714455|NCT03146663|antineoplastic agents|antineoplastic agents
4714456|NCT03146663|ovarian diseases|ovarian diseases
4714457|NCT03146663|cancer of the ovary|cancer of the ovary
4714458|NCT03146637|Activated CIK|activated cik
4714459|NCT03146637|MUC1/CEA/EpCAM/GPC3|muc1/cea/epcam/gpc3
4714460|NCT03146637|Bispecfic antibody|bispecfic antibody
4714461|NCT03146637|liver cancer|liver cancer
4714462|NCT03146598|Foot deformity|foot deformity
4714463|NCT03146598|Orthopaedic management|orthopaedic management
4714464|NCT03146598|prevention|prevention
4714465|NCT03146598|side pole static ankle foot orthosis|side pole static ankle foot orthosis
4714466|NCT03146585|Glycocalyx|glycocalyx
4714467|NCT03146559|Cross education|cross education
4714468|NCT03146559|EMG|emg
4714469|NCT03146520|Syndecan 2|syndecan 2
4714470|NCT03146520|Methylation biomarker|methylation biomarker
4714471|NCT03146520|Colorectal cancer|colorectal cancer
4714472|NCT03146520|EarlyTect Colon Cancer test|earlytect colon cancer test
4714473|NCT03146481|Anesthetic efficacy, Irriversible pulpitis, Aceclofenac|anesthetic efficacy, irriversible pulpitis, aceclofenac
4714474|NCT03146455|Thrombelastograghy|thrombelastograghy
4714475|NCT03146455|reference ranges|reference ranges
4714476|NCT03146455|racial|racial
4714477|NCT03146455|geographic|geographic
4714478|NCT03146455|Blood Transfusion|blood transfusion
4714479|NCT03146442|increased dietary protein|increased dietary protein
4714480|NCT03146442|breakfast|breakfast
4714481|NCT03146442|weight management|weight management
4714482|NCT03146442|satiety|satiety
4714483|NCT03146442|glucose control|glucose control
4714484|NCT03146442|fMRI|fmri
4714485|NCT03146442|cognitive performance|cognitive performance
4714486|NCT03146442|memory|memory
4714487|NCT03146442|attention|attention
4714488|NCT03146442|executive function|executive function
4714489|NCT03146442|structural MRI|structural mri
4714490|NCT03146442|sleep quality|sleep quality
4714491|NCT03146403|HSV|hsv
4714492|NCT03146403|Herpes|herpes
4714493|NCT03146403|Genital Herpes|genital herpes
4714494|NCT03146403|Vaccine|vaccine
4714495|NCT03146390|biofilms|biofilms
4714496|NCT03146390|essential oils|essential oils
4714497|NCT03146390|microscopy, confocal|microscopy, confocal
4714498|NCT03146390|mouthwashes|mouthwashes
4714499|NCT03146364|Virtual Reality|virtual reality
4714500|NCT03146351|preterm|preterm
4714501|NCT03146351|infant|infant
4714502|NCT03146351|physiotherapy|physiotherapy
4714503|NCT03146338|Anti-EGFR|anti-egfr
4714504|NCT03146338|Hypomagnesemia|hypomagnesemia
4714505|NCT03146338|Magnesium-rich mineral water|magnesium-rich mineral water
4714506|NCT03146338|Metastatic colorectal or head and neck cancers|metastatic colorectal or head and neck cancers
4714507|NCT03146325|H. pylori infection|h. pylori infection
4714508|NCT03146312|gene expression|gene expression
4714510|NCT03146312|epigenetics|epigenetics
4714511|NCT03146312|DNA methylation|dna methylation
4714512|NCT03146260|TESE|tese
4714513|NCT03146260|Sperm retreival|sperm retreival
4714514|NCT03146260|Azoospermia|azoospermia
4714515|NCT03146260|FSH|fsh
4714516|NCT03146260|LH|lh
4714517|NCT03146208|Growth differentiation factor-15|growth differentiation factor-15
4714518|NCT03146208|Dipeptidyl-peptidase inhibitors (DPP4 -I)|dipeptidyl-peptidase inhibitors (dpp4 -i)
4714519|NCT03146208|Coronroy artery diseases|coronroy artery diseases
4714520|NCT03146195|pelvic organ prolapse|pelvic organ prolapse
4714521|NCT03146195|dynamic magnetic resonance imaging|dynamic magnetic resonance imaging
4714522|NCT03146195|three-dimensional reconstruction|three-dimensional reconstruction
4714523|NCT03146195|space coordinates|space coordinates
4714524|NCT03146182|C-reactive protein|c-reactive protein
4714525|NCT03146182|Procalcitonin|procalcitonin
4714526|NCT03146182|Community-acquired pneumonia|community-acquired pneumonia
4714527|NCT03146182|Antibiotic stewardship|antibiotic stewardship
4714528|NCT03146156|obesity|obesity
4714529|NCT03146156|overweight|overweight
4714530|NCT03146156|lifestyle intervention|lifestyle intervention
4714531|NCT03146156|fetal growth/adiposity|fetal growth/adiposity
4714532|NCT03146156|Mediterranean diet|mediterranean diet
4714533|NCT03146117|PET CT|pet ct
4714534|NCT03146091|Antibiotics|antibiotics
4714535|NCT03146052|Colon cleansing|colon cleansing
4714536|NCT03146013|HTLV|htlv
4714537|NCT03146013|Confirmatory|confirmatory
4714538|NCT03146013|Supplemental|supplemental
4714539|NCT03146013|Blot|blot
4714540|NCT03146013|HTLV-I|htlv-i
4714541|NCT03146013|HTLV-II|htlv-ii
4714542|NCT03145987|Cognitive functioning|cognitive functioning
4714543|NCT03145987|Neuropsychological status|neuropsychological status
4714544|NCT03145987|Vitis vinifera|vitis vinifera
4714545|NCT03145974|respiratory failure|respiratory failure
4714546|NCT03145974|mechanical ventilation|mechanical ventilation
4714547|NCT03145961|Breast cancer early stage|breast cancer early stage
4714548|NCT03145961|circulating tumour DNA|circulating tumour dna
4714549|NCT03145961|pembrolizumab|pembrolizumab
4714550|NCT03145961|targeted therapy|targeted therapy
4714551|NCT03145961|randomised clinical trial|randomised clinical trial
4714552|NCT03145961|phase II|phase ii
4714553|NCT03145961|mutation screening|mutation screening
4714554|NCT03145961|intermediate endpoint|intermediate endpoint
4714555|NCT03145948|Tolerability|tolerability
4714556|NCT03145948|Psoriasis|psoriasis
4714557|NCT03145948|Pharmacokinetics|pharmacokinetics
4714558|NCT03145948|Safety|safety
4714559|NCT03145948|Healthy Volunteers|healthy volunteers
4714560|NCT03145909|Cancer|cancer
4714561|NCT03145909|Metastatic|metastatic
4714562|NCT03145909|Prolactin Receptor (PRLR)|prolactin receptor (prlr)
4714563|NCT03145909|Breast cancer|breast cancer
4714564|NCT03145909|Colorectal cancer|colorectal cancer
4714565|NCT03145909|Adrenocortical carcinoma,|adrenocortical carcinoma,
4714566|NCT03145909|Chromophobe renal cell carcinoma|chromophobe renal cell carcinoma
4714567|NCT03145909|Hepatocellular carcinoma|hepatocellular carcinoma
4714568|NCT03145896|vitamin D|vitamin d
4714569|NCT03145896|Anemia|anemia
4714570|NCT03145896|IBD|ibd
4714571|NCT03145857|Gallium-68|gallium-68
4714572|NCT03145857|Positron Emission Tomography|positron emission tomography
4714573|NCT03145844|DAA|daa
4714574|NCT03145844|Hepatitis|hepatitis
4714575|NCT03145831|Pediatrics|pediatrics
4714576|NCT03145818|dissemination|dissemination
4714577|NCT03145805|blood chemical analysis|blood chemical analysis
4714578|NCT03145805|bupivacaine|bupivacaine
4714579|NCT03145805|local anesthetic toxicity|local anesthetic toxicity
4714580|NCT03145805|Drug-Related Side Effects and Adverse Reactions|drug-related side effects and adverse reactions
4714581|NCT03145766|Rabies virus|rabies virus
4714582|NCT03145753|HIV testing program|hiv testing program
4714583|NCT03145753|HCV testing program|hcv testing program
4714584|NCT03145753|education|education
4714585|NCT03145727|Chemotherapy|chemotherapy
4714586|NCT03145727|nausea|nausea
4714587|NCT03145727|vomiting|vomiting
4714588|NCT03145727|transcutaneous electrical acupoint stimulation|transcutaneous electrical acupoint stimulation
4714589|NCT03145714|POCD|pocd
4714590|NCT03145714|Elderly|elderly
4714591|NCT03145688|Behavioural|behavioural
4714592|NCT03145688|Family physical activity habit|family physical activity habit
4714593|NCT03145675|Anticoagulation|anticoagulation
4714594|NCT03145675|Enoxaparin|enoxaparin
4714595|NCT03145675|Dose|dose
4714596|NCT03145649|Breast milk|breast milk
4714597|NCT03145649|Hormone|hormone
4714598|NCT03145649|Infant growth|infant growth
4714599|NCT03145649|Gestational diabetes mellitus|gestational diabetes mellitus
4714600|NCT03145636|Obesity|obesity
4714601|NCT03145636|Bariatric surgery|bariatric surgery
4714602|NCT03145636|Vagal blocking|vagal blocking
4714603|NCT03145636|vBloc therapy|vbloc therapy
4714604|NCT03145636|Vagus Nerve|vagus nerve
4714605|NCT03145636|Percent excess weight loss|percent excess weight loss
4714606|NCT03145636|Percent total body weight loss|percent total body weight loss
4714607|NCT03145597|facings|facings
4714608|NCT03145597|veneers|veneers
4714609|NCT03145597|laminates|laminates
4714610|NCT03145597|existing|existing
4714611|NCT03145597|restorations|restorations
4714612|NCT03145597|esthetics|esthetics
4714613|NCT03145597|dental|dental
4714614|NCT03145584|Total Knee Arthroplasty|total knee arthroplasty
4714615|NCT03145584|Physiotherapy|physiotherapy
4714616|NCT03145558|Tirapazamine, embolization, TACE, Hepatocellular carcinoma|tirapazamine, embolization, tace, hepatocellular carcinoma
4714617|NCT03145493|Drainage, Suction|drainage, suction
4714618|NCT03145493|tranexamic acid|tranexamic acid
4714619|NCT03145480|leukemia|leukemia
4714620|NCT03145480|richter|richter
4714621|NCT03145467|Migraine|migraine
4714622|NCT03145467|Paracetamol|paracetamol
4714623|NCT03145467|Zolmitriptan|zolmitriptan
4714624|NCT03145467|Emergency services|emergency services
4714625|NCT03145454|Pain|pain
4714626|NCT03145454|children|children
4714627|NCT03145454|emergency|emergency
4714628|NCT03145454|electroencephalography|electroencephalography
4714629|NCT03145454|heart rate|heart rate
4714630|NCT03145454|skin conductance|skin conductance
4714631|NCT03145454|pupillary diameter|pupillary diameter
4714632|NCT03145415|pudendal nerve block|pudendal nerve block
4714633|NCT03145415|hypospadias|hypospadias
4714634|NCT03145415|caudal block|caudal block
4714635|NCT03145376|TAVI|tavi
4714636|NCT03145376|MitraClip|mitraclip
4714637|NCT03145376|geriatric assessment|geriatric assessment
4714638|NCT03145376|heart rate variability|heart rate variability
4714639|NCT03145376|elderly|elderly
4714640|NCT03145350|NAFLD|nafld
4714641|NCT03145350|Fat intake|fat intake
4714642|NCT03145350|Sugar intake|sugar intake
4714643|NCT03145311|Repetitive transcranial magnetic stimulation, Drug Induced Tardive Syndrome|repetitive transcranial magnetic stimulation, drug induced tardive syndrome
4714644|NCT03145298|HPAH (heritable)|hpah (heritable)
4714645|NCT03145298|IPAH (idiopathic)|ipah (idiopathic)
4714646|NCT03145298|PAH-CTD (connective tissue diseases)|pah-ctd (connective tissue diseases)
4714647|NCT03145298|PAH-HIV (human immunodeficiency virus)|pah-hiv (human immunodeficiency virus)
4714648|NCT03145285|Abiraterone Acetate|abiraterone acetate
4714649|NCT03145285|Cushing Syndrome|cushing syndrome
4714650|NCT03145285|Adrenocortical Carcinoma|adrenocortical carcinoma
4714651|NCT03145272|Pharmacogenomics|pharmacogenomics
4714652|NCT03145272|Pharmacokinetics|pharmacokinetics
4714653|NCT03145272|Oxycodone|oxycodone
4714654|NCT03145246|intrabony defect|intrabony defect
4714655|NCT03145246|periodontal regeneration|periodontal regeneration
4714656|NCT03145233|physiotherapy|physiotherapy
4714657|NCT03145220|EA-230|ea-230
4714658|NCT03145220|Systemic Inflammatory Response Syndrome|systemic inflammatory response syndrome
4714659|NCT03145220|Acute Kidney Injury|acute kidney injury
4714660|NCT03145220|Interleukin-6|interleukin-6
4714661|NCT03145220|Safety|safety
4714662|NCT03145220|Tolerability|tolerability
4714663|NCT03145220|Phase II|phase ii
4714664|NCT03145220|Randomized clinical trial|randomized clinical trial
4714665|NCT03145155|continuum of care|continuum of care
4714666|NCT03145155|maternal|maternal
4714667|NCT03145155|newborn|newborn
4714668|NCT03145155|child health|child health
4714669|NCT03145155|noncommunicable diseases|noncommunicable diseases
4714670|NCT03145142|Near-Infrared Spectroscopy|near-infrared spectroscopy
4714671|NCT03145129|Intraocular pressure|intraocular pressure
4714672|NCT03145129|IOP|iop
4714673|NCT03145129|CPAP|cpap
4714674|NCT03145090|bone scintigraphy|bone scintigraphy
4714675|NCT03145090|knee arthroplasty|knee arthroplasty
4714676|NCT03145090|spect-ct|spect-ct
4714677|NCT03145090|quantification|quantification
4714678|NCT03145077|Head and Neck Cancer|head and neck cancer
4714679|NCT03145077|Osteoradionecrosis|osteoradionecrosis
4714680|NCT03145077|ORN|orn
4714681|NCT03145077|Dynamic contrast-enhanced magnetic resonance imaging|dynamic contrast-enhanced magnetic resonance imaging
4714682|NCT03145077|DCE-MRI|dce-mri
4714683|NCT03145077|Questionnaires|questionnaires
4714684|NCT03145077|Surveys|surveys
4714685|NCT03145064|relapsed/refractory non-GCB type|relapsed/refractory non-gcb type
4714686|NCT03145051|saline solution|saline solution
4714687|NCT03145051|minerals|minerals
4714688|NCT03145051|cystic fibrosis|cystic fibrosis
4714689|NCT03145051|chronic rhinosinusitis|chronic rhinosinusitis
4714690|NCT03145051|nasal irrigation|nasal irrigation
4714691|NCT03145012|Cancer|cancer
4714692|NCT03145012|Immunity|immunity
4714693|NCT03145012|Peripheral Blood Mononuclear Cells|peripheral blood mononuclear cells
4714694|NCT03145012|Ranitidine|ranitidine
4714695|NCT03144999|Dry AMD|dry amd
4714696|NCT03144999|Dry Age-related Macular Degeneration|dry age-related macular degeneration
4714697|NCT03144999|Gene Therapy|gene therapy
4714698|NCT03144999|Complement|complement
4714699|NCT03144999|Intravitreal Injection|intravitreal injection
4714700|NCT03144999|Geographic Atrophy|geographic atrophy
4714701|NCT03144999|Drusen|drusen
4714702|NCT03144999|Membrane Attack Complex|membrane attack complex
4714703|NCT03144999|CD59|cd59
4714704|NCT03144934|HPV|hpv
4714705|NCT03144921|Early-stage Dementia|early-stage dementia
4714706|NCT03144921|Early-stage Alzheimer's disease|early-stage alzheimer's disease
4714707|NCT03144921|Care partner|care partner
4714708|NCT03144921|Caregivers|caregivers
4714709|NCT03144921|Caregiving|caregiving
4714710|NCT03144869|type 1 diabetes mellitus|type 1 diabetes mellitus
4715117|NCT03142178|knee|knee
4714711|NCT03144869|physical activity|physical activity
4714712|NCT03144869|children|children
4714713|NCT03144869|constant glucose monitoring|constant glucose monitoring
4714714|NCT03144856|Biliary Tract Cancer|biliary tract cancer
4714715|NCT03144856|Second line thrapy|second line thrapy
4714716|NCT03144856|Apatinib|apatinib
4714717|NCT03144843|Gastric cancer|gastric cancer
4714718|NCT03144843|Peritoneal metastasis|peritoneal metastasis
4714719|NCT03144843|Paclitaxol|paclitaxol
4714720|NCT03144843|Apatinib|apatinib
4714721|NCT03144843|Second-line chemotherapy|second-line chemotherapy
4714722|NCT03144817|hemodialysis|hemodialysis
4714723|NCT03144817|fluid overload|fluid overload
4714724|NCT03144817|dialysis disequilibrium|dialysis disequilibrium
4714725|NCT03144817|intra-dialytic hypotension|intra-dialytic hypotension
4714726|NCT03144817|dialysate sodium lowering|dialysate sodium lowering
4714727|NCT03144804|Colorectal Cancer|colorectal cancer
4714728|NCT03144778|Malignant Neoplasms of Oropharynx|malignant neoplasms of oropharynx
4714729|NCT03144778|CD8+ tumor infiltrating lymphocytes|cd8+ tumor infiltrating lymphocytes
4714730|NCT03144778|Biomarkers|biomarkers
4714731|NCT03144778|Durvalumab|durvalumab
4714732|NCT03144778|MEDI4736|medi4736
4714733|NCT03144778|Tremelimumab|tremelimumab
4714734|NCT03144778|Ticilimumab|ticilimumab
4714735|NCT03144778|CP-675,206|cp-675,206
4714736|NCT03144765|taTME|tatme
4714737|NCT03144765|Transanal|transanal
4714738|NCT03144765|Rectal cancer|rectal cancer
4714739|NCT03144765|Colorectal|colorectal
4714740|NCT03144765|Total mesorectal excision|total mesorectal excision
4714741|NCT03144765|TME|tme
4714742|NCT03144687|Myelofibrosis|myelofibrosis
4714743|NCT03144687|Janus kinase (JAK) inhibitor|janus kinase (jak) inhibitor
4714744|NCT03144687|itacitinib|itacitinib
4714745|NCT03144687|ruxolitinib|ruxolitinib
4714746|NCT03144674|Marginal zone lymphoma|marginal zone lymphoma
4714747|NCT03144674|phosphatidylinositol 3-kinase (PI3K)δ inhibitor|phosphatidylinositol 3-kinase (pi3k)δ inhibitor
4714748|NCT03144674|indolent (slow-growing) non-Hodgkin lymphoma B-cell lymphoma|indolent (slow-growing) non-hodgkin lymphoma b-cell lymphoma
4714749|NCT03144661|hepatocellular carcinoma|hepatocellular carcinoma
4714750|NCT03144661|cholangiocarcinoma|cholangiocarcinoma
4714751|NCT03144661|esophageal|esophageal
4714752|NCT03144661|nasopharyngeal|nasopharyngeal
4714753|NCT03144661|serous ovarian|serous ovarian
4714754|NCT03144661|solid tumors|solid tumors
4714755|NCT03144661|fibroblast growth factor (FGF)|fibroblast growth factor (fgf)
4714756|NCT03144661|fibroblast growth factor receptor (FGFR)|fibroblast growth factor receptor (fgfr)
4714757|NCT03144635|Direct Acting Antivirals|direct acting antivirals
4714758|NCT03144635|Grazoprevir|grazoprevir
4714759|NCT03144635|Elbasvir|elbasvir
4714760|NCT03144622|(4S)-4-(3-[18F]fluoropropyl-)-L-glutamate|(4s)-4-(3-[18f]fluoropropyl-)-l-glutamate
4714761|NCT03144622|18F-FSPG|18f-fspg
4714762|NCT03144622|PET/CT|pet/ct
4714763|NCT03144622|system xC-transporter|system xc-transporter
4714764|NCT03144609|mechanical ventilation, obesity, oral-surgical procedures|mechanical ventilation, obesity, oral-surgical procedures
4714765|NCT03144583|CART19|cart19
4714766|NCT03144570|ICU, encephalitis, meningo-encephalitis, seizures|icu, encephalitis, meningo-encephalitis, seizures
4714767|NCT03144557|Education|education
4714768|NCT03144557|COPD|copd
4714769|NCT03144557|Inhalation Devices|inhalation devices
4714770|NCT03144544|Similarity|similarity
4714771|NCT03144544|Diversity|diversity
4714772|NCT03144531|School-age child|school-age child
4714773|NCT03144518|Positive Affect|positive affect
4714774|NCT03144518|Positive Mood|positive mood
4714775|NCT03144518|Influenza Vaccination|influenza vaccination
4714776|NCT03144518|Vaccination|vaccination
4714777|NCT03144518|Randomised Controlled Trial|randomised controlled trial
4714778|NCT03144505|Type 2 Diabetes|type 2 diabetes
4714779|NCT03144505|Exercise|exercise
4714780|NCT03144505|High Intensity Interval Training|high intensity interval training
4714781|NCT03144505|Glycemic Control|glycemic control
4714782|NCT03144492|Cell Culture|cell culture
4714783|NCT03144492|Microgravity co-culture|microgravity co-culture
4714784|NCT03144453|Curare|curare
4714785|NCT03144453|Robotic surgery|robotic surgery
4714786|NCT03144440|ZEPATIER|zepatier
4714787|NCT03144427|albumin|albumin
4714788|NCT03144427|resuscitation|resuscitation
4714789|NCT03144427|burns|burns
4714790|NCT03144427|shock|shock
4714791|NCT03144427|fluid creep|fluid creep
4714792|NCT03144401|cesarean section|cesarean section
4714793|NCT03144401|Misoprostol|misoprostol
4714794|NCT03144401|sublingual|sublingual
4714795|NCT03144401|uterotonics|uterotonics
4714796|NCT03144323|Intraoral elastics|intraoral elastics
4714797|NCT03144258|congenital heart defects|congenital heart defects
4714798|NCT03144258|systemic microcirculation|systemic microcirculation
4714799|NCT03144258|laser Doppler perfusion imaging|laser doppler perfusion imaging
4714800|NCT03144258|cardiac corrective surgery|cardiac corrective surgery
4714801|NCT03144245|AML|aml
4714802|NCT03144245|treatment|treatment
4714803|NCT03144245|relapsed|relapsed
4714804|NCT03144245|refractory|refractory
4714805|NCT03144245|phase 1|phase 1
4714806|NCT03144219|intracranial pressure|intracranial pressure
4714807|NCT03144219|transcranial Doppler|transcranial doppler
4714808|NCT03144219|jugular compression|jugular compression
4714809|NCT03144219|cerebral compliance|cerebral compliance
4714810|NCT03144193|topical treatment|topical treatment
4714811|NCT03144193|wrinkles|wrinkles
4714812|NCT03144193|extracellular matrix|extracellular matrix
4714813|NCT03144180|pregnant|pregnant
4714814|NCT03144180|third trimester|third trimester
4714815|NCT03144180|umbilical cord blood collection|umbilical cord blood collection
4714816|NCT03144154|Cancer|cancer
4714817|NCT03144154|Fatigue|fatigue
4714818|NCT03144154|Hypnosis|hypnosis
4714819|NCT03144154|Self-hypnosis|self-hypnosis
4714820|NCT03144154|Self-care|self-care
4714821|NCT03144154|Emotional distress|emotional distress
4714822|NCT03144154|Cancer survivors|cancer survivors
4714823|NCT03144128|vitamin D|vitamin d
4714824|NCT03144128|muscle|muscle
4714825|NCT03144128|metabolism|metabolism
4714826|NCT03144128|cancer cachexia|cancer cachexia
4714827|NCT03144115|oxytocin|oxytocin
4714828|NCT03144115|sex hormone|sex hormone
4714829|NCT03144115|verbal reward|verbal reward
4714830|NCT03144115|mate selection|mate selection
4714831|NCT03144115|metaphorical language|metaphorical language
4714832|NCT03144089|Morbid obesity|morbid obesity
4714833|NCT03144089|Obstructive sleep apnea|obstructive sleep apnea
4714834|NCT03144089|Mask ventilation|mask ventilation
4714835|NCT03144089|Upper airway obstruction|upper airway obstruction
4714836|NCT03144076|healthcare|healthcare
4714837|NCT03144076|India|india
4714838|NCT03144076|health insurance|health insurance
4714839|NCT03144076|RSBY|rsby
4714840|NCT03144076|free health insurance|free health insurance
4714841|NCT03144076|inpatient insurance|inpatient insurance
4714842|NCT03144076|wealth transfer|wealth transfer
4714843|NCT03144063|Disease Activity|disease activity
4714844|NCT03144063|SLEDAI-2K|sledai-2k
4714845|NCT03144024|Tricuspid Regurgitation|tricuspid regurgitation
4714846|NCT03144024|Insufficiency, Tricuspid Valve|insufficiency, tricuspid valve
4714847|NCT03144024|Valvular Annuloplasty|valvular annuloplasty
4714848|NCT03144024|Cardiac Valve Annulus Repair|cardiac valve annulus repair
4714849|NCT03144011|acute kidney injury, cardiosurgery|acute kidney injury, cardiosurgery
4714850|NCT03143985|TEW-7197|tew-7197
4714851|NCT03143985|Pomalidomide|pomalidomide
4714852|NCT03143972|Dexmedetomidine|dexmedetomidine
4714853|NCT03143972|Remifentanil|remifentanil
4714854|NCT03143972|Pharmacodynamics|pharmacodynamics
4714855|NCT03143972|Interaction|interaction
4714856|NCT03143946|neuroendocrine tumor|neuroendocrine tumor
4714857|NCT03143946|vitamin|vitamin
4714858|NCT03143946|diet|diet
4714859|NCT03143933|propofol, BIS, general anesthesia|propofol, bis, general anesthesia
4714860|NCT03143920|hyperbaric oxygen|hyperbaric oxygen
4714861|NCT03143920|inflammation|inflammation
4714862|NCT03143920|chronic disease|chronic disease
4714863|NCT03143920|urinary bladder|urinary bladder
4714864|NCT03143920|urinary tract infection|urinary tract infection
4714865|NCT03143920|recurrent urinary tract infection|recurrent urinary tract infection
4714866|NCT03143920|painful bladder syndrome|painful bladder syndrome
4714867|NCT03143920|chronic pain|chronic pain
4714868|NCT03143920|hypoxia|hypoxia
4714869|NCT03143920|bacterial infection|bacterial infection
4714870|NCT03143907|Mindfulness|mindfulness
4714871|NCT03143907|Group Therapy|group therapy
4714872|NCT03143894|Breast Cancer|breast cancer
4714873|NCT03143894|Cognition|cognition
4714874|NCT03143894|Fatigue|fatigue
4714875|NCT03143894|Cancer-related Cognitive Impairment|cancer-related cognitive impairment
4714876|NCT03143894|Transcranial Direct Current Stimulation|transcranial direct current stimulation
4714877|NCT03143868|acute exercise|acute exercise
4714878|NCT03143868|resistance exercise|resistance exercise
4714879|NCT03143868|aerobic exercise|aerobic exercise
4714880|NCT03143868|appetite|appetite
4714881|NCT03143868|energy intake|energy intake
4714882|NCT03143855|oxycodone|oxycodone
4714883|NCT03143855|lorcaserin|lorcaserin
4714884|NCT03143855|Belviq|belviq
4714886|NCT03143842|accelerate learning|accelerate learning
4714887|NCT03143842|memory|memory
4714888|NCT03143829|gerontology|gerontology
4714889|NCT03143829|symptom self-management|symptom self-management
4714890|NCT03143829|Chemotherapy-induced Nausea and Vomiting|chemotherapy-induced nausea and vomiting
4714891|NCT03143816|diabetes|diabetes
4714892|NCT03143816|time in range|time in range
4714893|NCT03143816|inhaled insulin|inhaled insulin
4714894|NCT03143816|continuous glucose monitoring|continuous glucose monitoring
4714895|NCT03143816|type 1 diabetes|type 1 diabetes
4714896|NCT03143816|hypoglycemia|hypoglycemia
4714897|NCT03143816|post prandial hypergylcemia|post prandial hypergylcemia
4714898|NCT03143790|Erectile Function|erectile function
4714899|NCT03143790|Prostatectomy|prostatectomy
4714900|NCT03143790|Extracorporeal Shock Wave Therapy|extracorporeal shock wave therapy
4714901|NCT03143790|IIEF-5|iief-5
4714902|NCT03143777|physiotherapy|physiotherapy
4714903|NCT03143777|rehabilitation|rehabilitation
4714904|NCT03143777|critical care|critical care
4714905|NCT03143777|seating|seating
4714906|NCT03143738|regional anesthesia|regional anesthesia
4714907|NCT03143738|knee replacement|knee replacement
4714908|NCT03143738|pain treatment|pain treatment
4714909|NCT03143738|rehabilitation|rehabilitation
4714910|NCT03143686|Severe symptomatic Aortic Stenosis|severe symptomatic aortic stenosis
4714911|NCT03143673|Severe Symptomatic Aortic Valve Stenosis|severe symptomatic aortic valve stenosis
4714912|NCT03143660|obesity|obesity
4714913|NCT03143608|GERD|gerd
4714914|NCT03143608|Hiatal hernia repair|hiatal hernia repair
4714915|NCT03143608|Transoral Incision less fundoplication|transoral incision less fundoplication
4714916|NCT03143595|Preexisting cognitive impairment|preexisting cognitive impairment
4714917|NCT03143595|Elderly|elderly
4714918|NCT03143595|Outcomes|outcomes
4714919|NCT03143556|renal transplant|renal transplant
4714920|NCT03143556|magnetic ureteral stent|magnetic ureteral stent
4714921|NCT03143556|Black-Star®|black-star®
4714922|NCT03143543|cocaine disorder|cocaine disorder
4714923|NCT03143543|opioid disorder|opioid disorder
4714924|NCT03143543|lorcaserin|lorcaserin
4714925|NCT03143543|MRI|mri
4714926|NCT03143543|fMRI|fmri
4714927|NCT03143530|Ropivacaine|ropivacaine
4714928|NCT03143517|Inflammatory Bowel Diseases|inflammatory bowel diseases
4714929|NCT03143517|Irritable Bowel Syndrome|irritable bowel syndrome
4714930|NCT03143517|Ulcerative Colitis|ulcerative colitis
4714931|NCT03143517|Crohn Disease|crohn disease
4714932|NCT03143517|Indeterminate Colitis|indeterminate colitis
4714933|NCT03143426|3D laparoscopic cholecystectomy|3d laparoscopic cholecystectomy
4714934|NCT03143426|Junior surgeons|junior surgeons
4714935|NCT03143426|Complication|complication
4714936|NCT03143426|Conversion|conversion
4714937|NCT03143413|Salivary glands ultrasonography|salivary glands ultrasonography
4714938|NCT03143413|Systemic sclerosis|systemic sclerosis
4714939|NCT03143413|Gougerot Sjogren syndrome|gougerot sjogren syndrome
4714940|NCT03143413|Sicca syndrome|sicca syndrome
4714941|NCT03143400|Probiotics|probiotics
4714942|NCT03143400|Galenic form|galenic form
4714943|NCT03143400|Digestive tract|digestive tract
4714944|NCT03143400|Intestinal microbiota|intestinal microbiota
4714945|NCT03143400|Lactobacillus salivarius|lactobacillus salivarius
4714946|NCT03143361|aortic valve stenosis|aortic valve stenosis
4714947|NCT03143361|heart valves|heart valves
4714948|NCT03143361|heart surgery|heart surgery
4714949|NCT03143335|Breast; Reconstruction; BAD; Implant; ADM|breast; reconstruction; bad; implant; adm
4714950|NCT03143322|Bone-only metastases|bone-only metastases
4714951|NCT03143322|solid tumors|solid tumors
4714952|NCT03143322|SBRT|sbrt
4714953|NCT03143283|suicide|suicide
4714954|NCT03143283|lethal means|lethal means
4714955|NCT03143283|counseling|counseling
4714956|NCT03143283|youth|youth
4714957|NCT03143283|parents|parents
4714958|NCT03143283|firearms|firearms
4714959|NCT03143283|medication|medication
4714960|NCT03143283|suicidal|suicidal
4714961|NCT03143283|emergency department|emergency department
4714962|NCT03143270|nivolumab|nivolumab
4714963|NCT03143270|deb-TACE|deb-tace
4714964|NCT03143270|17-087|17-087
4714965|NCT03143218|Malaria|malaria
4714966|NCT03143218|Seasonal vaccination|seasonal vaccination
4714967|NCT03143218|Seasonal chemoprevention|seasonal chemoprevention
4714968|NCT03143192|DME, Micropulse Laser, Anti-VEGF|dme, micropulse laser, anti-vegf
4714969|NCT03143140|Ablation Techniques|ablation techniques
4714970|NCT03143101|FluMist Quadrivalent|flumist quadrivalent
4714971|NCT03143101|Trivalent|trivalent
4714972|NCT03143101|Influenza|influenza
4714973|NCT03143101|Vaccine|vaccine
4714974|NCT03143101|Prevention|prevention
4714975|NCT03143088|Blood pressure|blood pressure
4714976|NCT03143088|Medical clown|medical clown
4714977|NCT03143088|Pediatric|pediatric
4714978|NCT03143062|National Early Warning Score|national early warning score
4714979|NCT03143062|Rapid response system|rapid response system
4714980|NCT03143049|Pomalidomide|pomalidomide
4714981|NCT03143036|daratumumab|daratumumab
4714982|NCT03142971|Shock waves|shock waves
4714983|NCT03142971|Greater trochanteric pain syndrome|greater trochanteric pain syndrome
4714984|NCT03142932|smoking|smoking
4714985|NCT03142919|Mood Disorder|mood disorder
4714986|NCT03142919|MDD|mdd
4714987|NCT03142919|Endotoxin|endotoxin
4714988|NCT03142919|MRI|mri
4714989|NCT03142919|CRP|crp
4714990|NCT03142906|preoperative, perioperative, point-of-care ultrasound|preoperative, perioperative, point-of-care ultrasound
4714991|NCT03142893|testosterone|testosterone
4714992|NCT03142893|cortisol|cortisol
4714993|NCT03142880|marginally hyperbaric|marginally hyperbaric
4714994|NCT03142880|ropivacaine|ropivacaine
4714995|NCT03142880|cesarean|cesarean
4714996|NCT03142867|Non-Alcoholic Fatty Liver Disease|non-alcoholic fatty liver disease
4714997|NCT03142867|Non Alcoholic Steatohepatitis|non alcoholic steatohepatitis
4714998|NCT03142867|Prevalence|prevalence
4714999|NCT03142867|Coronary Artery Disease|coronary artery disease
4715000|NCT03142867|PDFF|pdff
4715001|NCT03142854|bowel preparation|bowel preparation
4715002|NCT03142854|colonoscopy|colonoscopy
4715003|NCT03142854|predictive model|predictive model
4715004|NCT03142841|Depression|depression
4715005|NCT03142841|Burden|burden
4715006|NCT03142841|Problem Solving Ability|problem solving ability
4715007|NCT03142841|Caregivers|caregivers
4715008|NCT03142841|Stroke|stroke
4715009|NCT03142841|Veterans|veterans
4715010|NCT03142828|chlorhexidine, dental implant, in-situ drug delivery,|chlorhexidine, dental implant, in-situ drug delivery,
4715218|NCT03141437|Surveys|surveys
4715011|NCT03142815|Coronary Artery Bypass Graft (CABG), Arterial stiffness|coronary artery bypass graft (cabg), arterial stiffness
4715012|NCT03142802|Testicular cancer|testicular cancer
4715013|NCT03142802|low-dose CT|low-dose ct
4715014|NCT03142802|CT scan|ct scan
4715015|NCT03142789|Pain|pain
4715016|NCT03142789|Total knee arthroplasty|total knee arthroplasty
4715017|NCT03142789|Regional anesthesia|regional anesthesia
4715018|NCT03142776|clarithromycin|clarithromycin
4715019|NCT03142776|photodynamic therapy|photodynamic therapy
4715020|NCT03142776|Antimicrobial therapy|antimicrobial therapy
4715021|NCT03142776|Periodontal pocket|periodontal pocket
4715022|NCT03142724|HV|hv
4715023|NCT03142698|hepatic steatosis|hepatic steatosis
4715024|NCT03142698|MRImaging|mrimaging
4715025|NCT03142685|NEC|nec
4715026|NCT03142685|Bowel Ultrasound|bowel ultrasound
4715027|NCT03142685|CHD|chd
4715028|NCT03142672|Postoperative pain|postoperative pain
4715029|NCT03142672|child|child
4715030|NCT03142672|pulpotomy|pulpotomy
4715031|NCT03142672|general anesthesia|general anesthesia
4715032|NCT03142620|Drug resistant H.pylori infection|drug resistant h.pylori infection
4715033|NCT03142620|vitamin D|vitamin d
4715034|NCT03142620|gastritis|gastritis
4715035|NCT03142529|Non dialysis|non dialysis
4715036|NCT03142516|Clinical Trial, Phase II|clinical trial, phase ii
4715037|NCT03142516|Elderly|elderly
4715038|NCT03142516|Aged|aged
4715039|NCT03142516|Disease-Free Survival|disease-free survival
4715040|NCT03142516|Safety|safety
4715041|NCT03142516|Tolerability|tolerability
4715042|NCT03142516|Chemotherapy regimen|chemotherapy regimen
4715043|NCT03142516|Monoclonal antibody|monoclonal antibody
4715044|NCT03142516|FOLFIRI|folfiri
4715045|NCT03142516|Panitumumab|panitumumab
4715046|NCT03142516|RAS/BRAF Wild-type|ras/braf wild-type
4715047|NCT03142503|psoriatic arthritis|psoriatic arthritis
4715048|NCT03142503|psoriasis|psoriasis
4715049|NCT03142503|body composition|body composition
4715050|NCT03142503|DXA measurements|dxa measurements
4715051|NCT03142503|spondyloarthritis|spondyloarthritis
4715052|NCT03142503|diet therapy|diet therapy
4715053|NCT03142503|adipose tissue|adipose tissue
4715054|NCT03142490|Acupuncture|acupuncture
4715055|NCT03142490|Infertility|infertility
4715056|NCT03142490|In vitro fertilization|in vitro fertilization
4715057|NCT03142490|Quality of life|quality of life
4715058|NCT03142490|Stress|stress
4715059|NCT03142490|Anxiety|anxiety
4715060|NCT03142477|Therapeutic touch|therapeutic touch
4715061|NCT03142477|Reiki|reiki
4715062|NCT03142477|Laying-on-of-Hands|laying-on-of-hands
4715063|NCT03142477|Spiritual Therapies|spiritual therapies
4715064|NCT03142464|saline solution|saline solution
4715065|NCT03142464|laparoscopy|laparoscopy
4715066|NCT03142464|cholecystectomy|cholecystectomy
4715067|NCT03142464|outcomes|outcomes
4715068|NCT03142412|Lupus|lupus
4715070|NCT03142412|Systemic Lupus Erythematosus|systemic lupus erythematosus
4715071|NCT03142399|heart failure|heart failure
4715072|NCT03142399|cardiac reabilitation|cardiac reabilitation
4715073|NCT03142399|nutritional status|nutritional status
4715074|NCT03142399|quality of life|quality of life
4715075|NCT03142399|milk protein|milk protein
4715076|NCT03142386|geriatric oncology|geriatric oncology
4715077|NCT03142386|pain|pain
4715078|NCT03142386|osteopathic manipulative treatment|osteopathic manipulative treatment
4715079|NCT03142386|quality of life|quality of life
4715080|NCT03142373|heart rate variability|heart rate variability
4715081|NCT03142373|autonomic nervous system|autonomic nervous system
4715082|NCT03142373|osteopathic manipulative treatment|osteopathic manipulative treatment
4715083|NCT03142373|skin conductance|skin conductance
4715084|NCT03142347|remote endarterectomy|remote endarterectomy
4715085|NCT03142347|DCB balloon|dcb balloon
4715086|NCT03142334|PD1|pd1
4715087|NCT03142334|PD-1|pd-1
4715088|NCT03142334|PDL1|pdl1
4715089|NCT03142334|PD-L1|pd-l1
4715090|NCT03142334|Adjuvant|adjuvant
4715091|NCT03142308|Satisfaction|satisfaction
4715092|NCT03142308|Training program|training program
4715093|NCT03142308|Egypt|egypt
4715094|NCT03142308|Cross-sectional|cross-sectional
4715095|NCT03142308|Multi-center|multi-center
4715096|NCT03142295|Urine transfusion|urine transfusion
4715097|NCT03142295|Recurrent urinary tract infection|recurrent urinary tract infection
4715098|NCT03142295|Urinary microbiota|urinary microbiota
4715099|NCT03142282|maintenance treatment|maintenance treatment
4715100|NCT03142243|Tennis|tennis
4715101|NCT03142243|Asymmetry|asymmetry
4715102|NCT03142243|Morphological|morphological
4715103|NCT03142230|feeding tube|feeding tube
4715104|NCT03142230|gastric|gastric
4715105|NCT03142230|newborn infant|newborn infant
4715106|NCT03142230|nursing|nursing
4715107|NCT03142230|pain|pain
4715108|NCT03142191|Idiopathic Pulmonary Fibrosis (IPF)|idiopathic pulmonary fibrosis (ipf)
4715109|NCT03142191|Pulmonary Fibrosis|pulmonary fibrosis
4715110|NCT03142191|CC-90001|cc-90001
4715111|NCT03142191|Safety|safety
4715112|NCT03142191|Efficacy|efficacy
4715113|NCT03142191|IPF|ipf
4715114|NCT03142191|idiopathic pulmonary fibrosis|idiopathic pulmonary fibrosis
4715115|NCT03142178|osteoarthritis|osteoarthritis
4715116|NCT03142178|pain|pain
4715118|NCT03142152|Functional Mitral Regurgitation|functional mitral regurgitation
4715119|NCT03142152|Percutaneous Mitral Valve Repair|percutaneous mitral valve repair
4715120|NCT03142152|Percutaneous Mitral Valve Annuloplasty|percutaneous mitral valve annuloplasty
4715121|NCT03142152|Coronary Sinus Annuloplasty|coronary sinus annuloplasty
4715122|NCT03142152|Secondary Mitral Regurgitation|secondary mitral regurgitation
4715123|NCT03142152|Functional MR|functional mr
4715124|NCT03142152|FMR|fmr
4715125|NCT03142139|Observational study; DTaP-IPV-Hib; Atopic Dermatitis; AD; Heterologous immunity; Non-specific effects; Non-targeted effects; Immunization;|observational study; dtap-ipv-hib; atopic dermatitis; ad; heterologous immunity; non-specific effects; non-targeted effects; immunization;
4715126|NCT03142113|optimization|optimization
4715127|NCT03142113|adalimumab|adalimumab
4715128|NCT03142087|balance|balance
4715129|NCT03142087|brain tumor|brain tumor
4715130|NCT03142087|virtual reality|virtual reality
4715131|NCT03142074|Improve diagnosis|improve diagnosis
4715132|NCT03142009|Community-Based Participatory Research|community-based participatory research
4715133|NCT03141996|vibration|vibration
4715134|NCT03141996|stroke|stroke
4715135|NCT03141996|activities of daily living|activities of daily living
4715136|NCT03141983|ESRD|esrd
4715137|NCT03141983|End-Stage Kidney Disease|end-stage kidney disease
4715138|NCT03141970|Proteinuria Hypoproteinemia Edema Hypoalbuminemia Prednisone|proteinuria hypoproteinemia edema hypoalbuminemia prednisone
4715139|NCT03141957|Aging|aging
4715140|NCT03141957|Hypermetabolism|hypermetabolism
4715141|NCT03141944|non motor symptoms|non motor symptoms
4715142|NCT03141931|Nutraceutical supplement|nutraceutical supplement
4715143|NCT03141905|patient safety|patient safety
4715144|NCT03141905|self-management|self-management
4715145|NCT03141905|remote monitoring|remote monitoring
4715146|NCT03141879|Frailty|frailty
4715147|NCT03141879|Physical Activity|physical activity
4715148|NCT03141879|Resistance training|resistance training
4715149|NCT03141853|Randomized Controlled Trial|randomized controlled trial
4715150|NCT03141853|Intervention Study|intervention study
4715151|NCT03141827|Lipoprotein|lipoprotein
4715152|NCT03141827|Apolipoprotein|apolipoprotein
4715153|NCT03141827|Pancreatic clamp|pancreatic clamp
4715154|NCT03141827|Insulin|insulin
4715155|NCT03141827|Nasal|nasal
4715156|NCT03141801|ACL|acl
4715157|NCT03141801|Knee|knee
4715158|NCT03141801|Muscle|muscle
4715159|NCT03141788|Aligners|aligners
4715160|NCT03141775|Clostridium difficile associated diarrhea (CDAD)|clostridium difficile associated diarrhea (cdad)
4715161|NCT03141762|Falls|falls
4715162|NCT03141762|Intensive care|intensive care
4715163|NCT03141736|Infant|infant
4715164|NCT03141736|Newborn|newborn
4715165|NCT03141736|Preterm|preterm
4715166|NCT03141736|Hypothermia|hypothermia
4715167|NCT03141736|Kangaroo|kangaroo
4715168|NCT03141736|Plastic|plastic
4715169|NCT03141736|Bag|bag
4715170|NCT03141723|Infant|infant
4715171|NCT03141723|Newborn|newborn
4715172|NCT03141723|Preterm|preterm
4715173|NCT03141723|Hypothermia|hypothermia
4715174|NCT03141723|Kangaroo|kangaroo
4715175|NCT03141723|Plastic|plastic
4715176|NCT03141723|Bag|bag
4715177|NCT03141697|Carbon Dioxide|carbon dioxide
4715178|NCT03141697|Coloboscopy|coloboscopy
4715179|NCT03141671|Prostate Cancer|prostate cancer
4715180|NCT03141658|TS-134|ts-134
4715181|NCT03141658|ketamine|ketamine
4715182|NCT03141658|fMRI|fmri
4715183|NCT03141619|cerebral oximetry|cerebral oximetry
4715184|NCT03141619|near-infrared spectroscopy|near-infrared spectroscopy
4715185|NCT03141619|neurocognitive|neurocognitive
4715186|NCT03141619|post-ICU syndrome|post-icu syndrome
4715187|NCT03141593|adherence to medication|adherence to medication
4715188|NCT03141593|electronic monitoring|electronic monitoring
4715189|NCT03141567|Lymphangiogenesis|lymphangiogenesis
4715190|NCT03141567|Heart Failure|heart failure
4715191|NCT03141541|low back pain|low back pain
4715192|NCT03141541|cognitive behavioural therapy|cognitive behavioural therapy
4715193|NCT03141541|randomised controlled trial|randomised controlled trial
4715194|NCT03141528|Self-learning|self-learning
4715195|NCT03141528|Instructor-led learning|instructor-led learning
4715196|NCT03141528|Long-term retention|long-term retention
4715197|NCT03141515|lung ultrasound|lung ultrasound
4715198|NCT03141515|recruitment maneuver|recruitment maneuver
4715199|NCT03141515|atelectasis|atelectasis
4715200|NCT03141515|children|children
4715201|NCT03141502|tension wound|tension wound
4715202|NCT03141502|skin stretching device|skin stretching device
4715203|NCT03141502|skin grafting|skin grafting
4715204|NCT03141476|Surgery|surgery
4715205|NCT03141476|Obesity|obesity
4715206|NCT03141476|Drug|drug
4715207|NCT03141476|Antibiotics|antibiotics
4715208|NCT03141476|Cefuroxime|cefuroxime
4715209|NCT03141463|Therapeutic vaccination|therapeutic vaccination
4715210|NCT03141437|Malignant Neoplasm of Breast|malignant neoplasm of breast
4715211|NCT03141437|Malignant Neoplasm of Female Genital Organs|malignant neoplasm of female genital organs
4715212|NCT03141437|Lymphoma|lymphoma
4715213|NCT03141437|Myeloma|myeloma
4715214|NCT03141437|Decision Aid Website|decision aid website
4715215|NCT03141437|DA|da
4715216|NCT03141437|Fertility preservation support|fertility preservation support
4715217|NCT03141437|Questionnaires|questionnaires
4715219|NCT03141437|Educational materials|educational materials
4715220|NCT03141372|Total Laparoscopic Hysterectomy|total laparoscopic hysterectomy
4715221|NCT03141372|Urinary Retention|urinary retention
4715222|NCT03141372|Backfill Void Trial|backfill void trial
4715223|NCT03141372|Autofill Void Trial|autofill void trial
4715224|NCT03141307|Neonatal screening|neonatal screening
4715225|NCT03141307|Biobank|biobank
4715226|NCT03141307|Broad Consent|broad consent
4715227|NCT03141294|tracheostomy，fascia，force gauge|tracheostomy，fascia，force gauge
4715228|NCT03141281|aging|aging
4715229|NCT03141281|cognitive ability|cognitive ability
4715230|NCT03141281|IADL|iadl
4715231|NCT03141281|driving|driving
4715232|NCT03141281|financial fraud|financial fraud
4715233|NCT03141281|perception|perception
4715234|NCT03141281|attention|attention
4715235|NCT03141281|memory|memory
4715236|NCT03141255|Therapeutic Hypothermia (TH)|therapeutic hypothermia (th)
4715237|NCT03141242|Advance Care Planning|advance care planning
4715238|NCT03141242|Group Medial Visit|group medial visit
4715239|NCT03141242|Shared Medical Appointment|shared medical appointment
4715240|NCT03141229|MBSR|mbsr
4715241|NCT03141229|Children|children
4715242|NCT03141229|Teacher|teacher
4715243|NCT03141229|School|school
4715244|NCT03141229|Burnout|burnout
4715245|NCT03141229|Classroom behavior|classroom behavior
4715246|NCT03141125|Erythrocyte sedimentation rate|erythrocyte sedimentation rate
4715247|NCT03141125|Modified Rodnan Skin Score|modified rodnan skin score
4715248|NCT03141125|B-cell Activating Factor|b-cell activating factor
4715249|NCT03141125|soluble-CD40Ligand|soluble-cd40ligand
4715250|NCT03141125|Procollagen Type-1 N-terminal Propeptide|procollagen type-1 n-terminal propeptide
4715251|NCT03141125|Scleroderma|scleroderma
4715252|NCT03141099|OHCA|ohca
4715253|NCT03141099|Hemodynamic|hemodynamic
4715254|NCT03141099|TTM|ttm
4715255|NCT03141099|post-rescusitation care|post-rescusitation care
4715256|NCT03141099|Blood pressure targets|blood pressure targets
4715257|NCT03141099|Oxygenation targets|oxygenation targets
4715258|NCT03141086|shift work disorder|shift work disorder
4715259|NCT03141073|GKA|gka
4715260|NCT03141073|T2DM|t2dm
4715261|NCT03141073|HMS5552|hms5552
4715262|NCT03141073|Add on therapy|add on therapy
4715263|NCT03141073|Metformin|metformin
4715264|NCT03141047|Sexual trauma, Lifespan Integration|sexual trauma, lifespan integration
4715265|NCT03141008|Ketosis|ketosis
4715266|NCT03141008|NAFLD|nafld
4715267|NCT03141008|Obesity|obesity
4715268|NCT03140995|Exercise|exercise
4715269|NCT03140995|Sleep|sleep
4715270|NCT03140982|propofol|propofol
4715271|NCT03140982|pharmacology|pharmacology
4715272|NCT03140982|anesthesic induction|anesthesic induction
4715273|NCT03140982|drug titration|drug titration
4715274|NCT03140969|CEP290|cep290
4715275|NCT03140969|p.Cys998X|p.cys998x
4715276|NCT03140969|c.2991+1655A>G|c.2991+1655a>g
4715277|NCT03140969|RNA therapy|rna therapy
4715278|NCT03140969|Antisense oligonucleotide|antisense oligonucleotide
4715279|NCT03140969|Leber's congenital amaurosis|leber's congenital amaurosis
4715280|NCT03140943|carfilzomib|carfilzomib
4715281|NCT03140917|Liver function|liver function
4715282|NCT03140917|Future liver remnant|future liver remnant
4715283|NCT03140917|Chemotherapy|chemotherapy
4715284|NCT03140891|preterm infant|preterm infant
4715285|NCT03140891|respiratory distress syndrome|respiratory distress syndrome
4715286|NCT03140891|nasal high frequence oscillation ventilation|nasal high frequence oscillation ventilation
4715287|NCT03140865|Alzheimer's|alzheimer's
4715288|NCT03140865|observational|observational
4715289|NCT03140865|prediabetes|prediabetes
4715290|NCT03140865|mild cognitive impairment|mild cognitive impairment
4715291|NCT03140774|Ebola vaccine|ebola vaccine
4715292|NCT03140774|immunogenicity|immunogenicity
4715293|NCT03140774|persistence|persistence
4715294|NCT03140722|anemia|anemia
4715295|NCT03140722|kidney|kidney
4715296|NCT03140722|dialysis-dependent chronic kidney disease|dialysis-dependent chronic kidney disease
4715297|NCT03140722|CKD|ckd
4715298|NCT03140722|DD-CKD|dd-ckd
4715299|NCT03140722|renal|renal
4715300|NCT03140722|vadadustat|vadadustat
4715301|NCT03140722|AKB-6548|akb-6548
4715302|NCT03140722|hypoxia-inducible factor|hypoxia-inducible factor
4715303|NCT03140722|HIF|hif
4715304|NCT03140722|hypoxia-inducible factor prolyl-hydroxylase inhibitor|hypoxia-inducible factor prolyl-hydroxylase inhibitor
4715305|NCT03140722|HIF-PHI|hif-phi
4715306|NCT03140722|hyporesponder|hyporesponder
4715307|NCT03140722|hyporesponsive|hyporesponsive
4715308|NCT03140722|epoetin alfa|epoetin alfa
4715309|NCT03140722|hemoglobin|hemoglobin
4715310|NCT03140722|erythropoiesis stimulating agent|erythropoiesis stimulating agent
4715311|NCT03140722|ESA|esa
4715312|NCT03140709|Salivary|salivary
4715313|NCT03140709|Oxytocin|oxytocin
4715314|NCT03140709|Induction|induction
4715315|NCT03140709|Labor|labor
4715316|NCT03140657|Ankylosing spondylitis, Nanocurcumin, MicroRNA, Th17 cells|ankylosing spondylitis, nanocurcumin, microrna, th17 cells
4715317|NCT03140644|thoracic sarcoidosis|thoracic sarcoidosis
4715318|NCT03140644|ultra-low dose computed tomography|ultra-low dose computed tomography
4715319|NCT03140644|Magnetic resonance imaging using Ultrashort echo time|magnetic resonance imaging using ultrashort echo time
4715320|NCT03140631|atrial fibrillation|atrial fibrillation
4715321|NCT03140631|catheter ablation|catheter ablation
4715322|NCT03140631|protamine sulfate|protamine sulfate
4715323|NCT03140631|anticoagulation reversal|anticoagulation reversal
4715324|NCT03140618|single-system-design|single-system-design
4715325|NCT03140618|mixed methods|mixed methods
4715326|NCT03140618|psychiatric inpatient care|psychiatric inpatient care
4715327|NCT03140618|work environment|work environment
4715328|NCT03140618|rebuilding|rebuilding
4715329|NCT03140579|recruitment|recruitment
4715330|NCT03140579|lung homogeneity|lung homogeneity
4715331|NCT03140579|airway pressure release ventilation|airway pressure release ventilation
4715332|NCT03140566|heart failure|heart failure
4715333|NCT03140566|acute decompensated heart failure|acute decompensated heart failure
4715334|NCT03140566|congestion|congestion
4715335|NCT03140566|inferior vena cava|inferior vena cava
4715336|NCT03140553|Neoadjuvant Treatment|neoadjuvant treatment
4715337|NCT03140553|HER2-Positive Breast Cancer|her2-positive breast cancer
4715338|NCT03140540|Fluid management|fluid management
4715339|NCT03140540|goal-directed therapy|goal-directed therapy
4715340|NCT03140540|transesophageal echocardiography|transesophageal echocardiography
4715341|NCT03140514|Urine chemokine monitoring|urine chemokine monitoring
4715342|NCT03140488|Induction of labor|induction of labor
4715343|NCT03140488|Pitocin|pitocin
4715344|NCT03140488|BMI|bmi
4715345|NCT03140475|Metacognition|metacognition
4715346|NCT03140475|Mousetracking|mousetracking
4715347|NCT03140475|EEG|eeg
4715348|NCT03140475|Event related potentials|event related potentials
4715349|NCT03140475|Frequency analysis|frequency analysis
4715350|NCT03140475|Depression|depression
4715351|NCT03140462|Tacrolimus|tacrolimus
4715352|NCT03140462|Pharmacokinetics|pharmacokinetics
4715353|NCT03140462|Genetic polymorphisms|genetic polymorphisms
4715354|NCT03140449|Tuberous sclerosis complex|tuberous sclerosis complex
4715355|NCT03140449|facial angiofibroma|facial angiofibroma
4715356|NCT03140449|rapamycin|rapamycin
4715357|NCT03140449|calcitriol|calcitriol
4715358|NCT03140436|stain removal efficacy, air polishing powder|stain removal efficacy, air polishing powder
4715359|NCT03140423|MRSA|mrsa
4715360|NCT03140423|healthcare-associated infections|healthcare-associated infections
4715361|NCT03140423|mupirocin|mupirocin
4715362|NCT03140423|iodophor|iodophor
4715363|NCT03140423|resistance|resistance
4715364|NCT03140410|Staphylococci|staphylococci
4715365|NCT03140410|Blood-stream infections|blood-stream infections
4715366|NCT03140410|Linezolid|linezolid
4715367|NCT03140397|Bioavailability|bioavailability
4715368|NCT03140397|Pharmacokinetics|pharmacokinetics
4715369|NCT03140397|8-prenylnaringenin|8-prenylnaringenin
4715370|NCT03140397|6-prenylnaringenin|6-prenylnaringenin
4715371|NCT03140397|Prenylflavonoids|prenylflavonoids
4715372|NCT03140397|PBMC|pbmc
4715373|NCT03140371|Enteral feeding|enteral feeding
4715374|NCT03140371|Oral nutritional supplements|oral nutritional supplements
4715375|NCT03140371|Peptide-based feed|peptide-based feed
4715376|NCT03140371|Hydrolysed feed|hydrolysed feed
4715377|NCT03140371|Semi-elemental feed|semi-elemental feed
4715378|NCT03140345|Hemodialysis|hemodialysis
4715379|NCT03140345|Microcirculation|microcirculation
4715380|NCT03140345|Traditional Chinese Medicine|traditional chinese medicine
4715381|NCT03140345|Hemodialysis vascular access|hemodialysis vascular access
4715382|NCT03140319|Fibroblast|fibroblast
4715383|NCT03140319|Cell transplantation|cell transplantation
4715384|NCT03140306|Computed tomography|computed tomography
4715385|NCT03140306|Model based iterative reconstruction|model based iterative reconstruction
4715386|NCT03140306|Low dose CT|low dose ct
4715387|NCT03140293|Chorionic villus sampling|chorionic villus sampling
4715388|NCT03140293|Pain|pain
4715389|NCT03140293|Anxiety|anxiety
4715390|NCT03140280|Black raspberries|black raspberries
4715391|NCT03140280|MDS|mds
4715392|NCT03140280|Myelodysplastic Syndromes|myelodysplastic syndromes
4715393|NCT03140280|hypomethylating effects|hypomethylating effects
4715394|NCT03140280|chemopreventive agent|chemopreventive agent
4715395|NCT03140280|BRB|brb
4715396|NCT03140280|pharmokinetics|pharmokinetics
4715397|NCT03140267|Ventilated induced diaphragmatic dysfunction|ventilated induced diaphragmatic dysfunction
4715398|NCT03140267|Weaning|weaning
4715399|NCT03140267|Inspiratory muscle training|inspiratory muscle training
4715400|NCT03140215|Baska|baska
4715401|NCT03140215|seal pressure|seal pressure
4715402|NCT03140215|I-Gel|i-gel
4715403|NCT03140215|Supraglottic airway device|supraglottic airway device
4715404|NCT03140189|Esophageal cancer|esophageal cancer
4715405|NCT03140189|Robotic|robotic
4715406|NCT03140189|Ivor-Lewis esophagectomy|ivor-lewis esophagectomy
4715407|NCT03140176|Sunitinib|sunitinib
4715408|NCT03140176|Metastatic Renal Cell Carcinoma|metastatic renal cell carcinoma
4715409|NCT03140176|Africa Middle East|africa middle east
4715410|NCT03140098|Collagen membrane|collagen membrane
4715411|NCT03140098|Cardiac surgery|cardiac surgery
4715412|NCT03140098|Postoperative complication|postoperative complication
4715413|NCT03140072|Asthma, Single Ascending Dose (SAD), Multiple Ascending Dose (MAD), AZD9898|asthma, single ascending dose (sad), multiple ascending dose (mad), azd9898
4715414|NCT03140059|surgical procedure|surgical procedure
4715415|NCT03140059|residual pockets|residual pockets
4715416|NCT03140059|agressive periodontitis|agressive periodontitis
4715417|NCT03140059|antimicrobial photodynamic therapy|antimicrobial photodynamic therapy
4715418|NCT03140020|aneurysm|aneurysm
4715419|NCT03140020|cognition|cognition
4715420|NCT03140020|functional connectivity|functional connectivity
4715421|NCT03140020|frontal lobe function|frontal lobe function
4715422|NCT03140020|neuropsychological testing|neuropsychological testing
4715423|NCT03140020|coiling|coiling
4715424|NCT03140020|clipping|clipping
4715425|NCT03140007|ERCP|ercp
4715426|NCT03140007|cholangioscopy|cholangioscopy
4715427|NCT03139994|occlusion|occlusion
4715428|NCT03139994|pain|pain
4715429|NCT03139981|eczema|eczema
4715430|NCT03139955|Feasibility Study|feasibility study
4715431|NCT03139955|Pre/Post-Operative Patient Monitoring|pre/post-operative patient monitoring
4715432|NCT03139955|Continuous Patient Monitoring|continuous patient monitoring
4715433|NCT03139955|Patient Deterioration Identification|patient deterioration identification
4715434|NCT03139955|Bodytrak|bodytrak
4715435|NCT03139955|National Early Warning System|national early warning system
4715436|NCT03139955|Patient Safety|patient safety
4715437|NCT03139942|Endoscopy|endoscopy
4715438|NCT03139942|Colonoscopy|colonoscopy
4715439|NCT03139942|Hyperspectral imaging|hyperspectral imaging
4715440|NCT03139942|Tissue classification|tissue classification
4715441|NCT03139942|Tissue autofluorescence|tissue autofluorescence
4715442|NCT03139942|Advanced imaging techniques|advanced imaging techniques
4715443|NCT03139916|Glioblastoma|glioblastoma
4715444|NCT03139903|Seckel Syndrome|seckel syndrome
4715445|NCT03139903|Microcephalic Osteodysplastic Primordial Dwarfism Type II|microcephalic osteodysplastic primordial dwarfism type ii
4715446|NCT03139864|Type 1 diabetes|type 1 diabetes
4715447|NCT03139864|Control|control
4715448|NCT03139864|Physical activity|physical activity
4715449|NCT03139864|Substrate utilization|substrate utilization
4715450|NCT03139864|Hormonal regulation|hormonal regulation
4715451|NCT03139851|Solid tumor|solid tumor
4715452|NCT03139851|Breast cancer|breast cancer
4715453|NCT03139851|Metastatic cancer|metastatic cancer
4715454|NCT03139851|Pembrolizumab|pembrolizumab
4715455|NCT03139851|Metronomic cyclophosphamide|metronomic cyclophosphamide
4715456|NCT03139838|Palliative Care|palliative care
4715457|NCT03139838|Pragmatic Clinical Trial|pragmatic clinical trial
4715458|NCT03139838|Electronic Health Records|electronic health records
4715459|NCT03139838|Economics, Behavioral|economics, behavioral
4715460|NCT03139812|continuous contact lens wear|continuous contact lens wear
4715461|NCT03139812|silicone hydrogel contact lenses|silicone hydrogel contact lenses
4715462|NCT03139812|irrigation|irrigation
4715463|NCT03139812|corneal epithelial permeability|corneal epithelial permeability
4715464|NCT03139812|contact lens-related adverse events|contact lens-related adverse events
4715465|NCT03139734|Sacral Nerve Modulation|sacral nerve modulation
4715466|NCT03139708|Mydriasis|mydriasis
4715467|NCT03139708|Cycloplegics|cycloplegics
4715468|NCT03139630|HIV, Dyslipidemia|hiv, dyslipidemia
4715469|NCT03139630|Dyslipidemia|dyslipidemia
4715470|NCT03139630|Protease Inhibitor|protease inhibitor
4715471|NCT03139630|Ritonavir|ritonavir
4715472|NCT03139630|PCSK9|pcsk9
4715473|NCT03139630|Observational|observational
4715474|NCT03139617|Fascia Iliaca Block|fascia iliaca block
4715475|NCT03139617|Femoral 3-in-1 block|femoral 3-in-1 block
4715476|NCT03139617|Fracture femur|fracture femur
4715477|NCT03139617|Spinal anesthesia|spinal anesthesia
4715478|NCT03139604|Acute graft-versus-host disease|acute graft-versus-host disease
4715479|NCT03139604|Janus kinase (JAK) inhibitor|janus kinase (jak) inhibitor
4715480|NCT03139604|itacitinib|itacitinib
4715481|NCT03139604|corticosteroids|corticosteroids
4715482|NCT03139604|allogeneic hematopoietic stem cell transplant (allo-HSCT)|allogeneic hematopoietic stem cell transplant (allo-hsct)
4715483|NCT03139565|Influenza|influenza
4715484|NCT03139565|Solid Organ Transplant|solid organ transplant
4715485|NCT03139565|Infection|infection
4715486|NCT03139565|Vaccine|vaccine
4715487|NCT03139565|Immunogenicity|immunogenicity
4715488|NCT03139552|Taste Test|taste test
4715489|NCT03139552|Spices|spices
4715490|NCT03139552|Reduced sugar|reduced sugar
4715491|NCT03139552|Food liking|food liking
4715492|NCT03139526|Craniopharyngioma|craniopharyngioma
4715493|NCT03139526|Children|children
4715494|NCT03139526|Social participation|social participation
4715495|NCT03139526|Life-H questionnaire|life-h questionnaire
4715496|NCT03139487|Anticoagulant Adverse Reaction|anticoagulant adverse reaction
4715497|NCT03139487|Cancer-associated Thrombosis|cancer-associated thrombosis
4715498|NCT03139487|Low molecular weight heparin|low molecular weight heparin
4715499|NCT03139487|Direct oral anticoagulant|direct oral anticoagulant
4715500|NCT03139461|Physical Therapy|physical therapy
4715501|NCT03139461|Capacity Building|capacity building
4715502|NCT03139461|Clinical-Community Linkages|clinical-community linkages
4715503|NCT03139396|inlay bridge, tub shaped design|inlay bridge, tub shaped design
4715504|NCT03139383|postoperative nausea|postoperative nausea
4715505|NCT03139383|postoperative vomiting|postoperative vomiting
4715506|NCT03139383|gynecologic laparoscopic surgery|gynecologic laparoscopic surgery
4715507|NCT03139344|metabolism|metabolism
4715508|NCT03139344|exercise|exercise
4715509|NCT03139344|glucose|glucose
4715609|NCT03138564|Nursing|nursing
4715510|NCT03139344|secondary health conditions|secondary health conditions
4715511|NCT03139344|quality of life|quality of life
4715512|NCT03139305|glucagon|glucagon
4715513|NCT03139266|cystic fibrosis|cystic fibrosis
4715514|NCT03139266|mindfulness|mindfulness
4715515|NCT03139266|cognitive behavioral therapy|cognitive behavioral therapy
4715516|NCT03139266|UPLIFT|uplift
4715517|NCT03139266|anxiety|anxiety
4715518|NCT03139266|depression|depression
4715519|NCT03139266|web based intervention|web based intervention
4715520|NCT03139253|Helicobacter Pylori Infection|helicobacter pylori infection
4715521|NCT03139253|Antimicrobial susceptibility testing (AST)|antimicrobial susceptibility testing (ast)
4715522|NCT03139253|Triple Therapy|triple therapy
4715523|NCT03139201|silicone hydrogel soft contact lens|silicone hydrogel soft contact lens
4715524|NCT03139188|Cancer|cancer
4715525|NCT03139188|incurable pathologies|incurable pathologies
4715526|NCT03139188|palliative care|palliative care
4715527|NCT03139162|Home Care Services|home care services
4715528|NCT03139162|Aging|aging
4715529|NCT03139162|Frailty|frailty
4715530|NCT03139162|Complexity|complexity
4715531|NCT03139162|Nursing|nursing
4715532|NCT03139149|conservative treatment|conservative treatment
4715533|NCT03139149|laparoscopic adhesiolysis|laparoscopic adhesiolysis
4715534|NCT03139149|strangulation|strangulation
4715535|NCT03139071|coffee consumption|coffee consumption
4715536|NCT03139071|cardiovascular diseases|cardiovascular diseases
4715537|NCT03139071|coronary artery calcium|coronary artery calcium
4715538|NCT03139071|subclinical atherosclerosis|subclinical atherosclerosis
4715539|NCT03139019|Diabetes prevention|diabetes prevention
4715540|NCT03139019|Weight loss|weight loss
4715541|NCT03139019|Lifestyle change|lifestyle change
4715542|NCT03138967|Malignant neoplasms of urinary tract|malignant neoplasms of urinary tract
4715543|NCT03138967|Bladder cancer|bladder cancer
4715544|NCT03138967|Outpatient bladder procedures|outpatient bladder procedures
4715545|NCT03138967|Outpatient cystoscopy procedure|outpatient cystoscopy procedure
4715546|NCT03138967|Transurethral resection of the bladder|transurethral resection of the bladder
4715547|NCT03138967|TURB|turb
4715548|NCT03138967|Rocuronium|rocuronium
4715549|NCT03138967|Rocuronium Bromide|rocuronium bromide
4715550|NCT03138967|Zemuron|zemuron
4715551|NCT03138967|Sugammadex|sugammadex
4715552|NCT03138967|Neostigmine|neostigmine
4715553|NCT03138967|Glycopyrrolate|glycopyrrolate
4715554|NCT03138928|glaucoma|glaucoma
4715555|NCT03138928|trabeculectomy|trabeculectomy
4715556|NCT03138928|minimally invasive glaucoma surgery|minimally invasive glaucoma surgery
4715557|NCT03138928|XEN45 gel stent|xen45 gel stent
4715558|NCT03138915|clinically significant portal hypertension|clinically significant portal hypertension
4715559|NCT03138915|hepatic venous pressure gradient|hepatic venous pressure gradient
4715560|NCT03138915|radiomics|radiomics
4715561|NCT03138889|NKTR-214|nktr-214
4715562|NCT03138889|Atezolizumab|atezolizumab
4715563|NCT03138889|Tecentriq®|tecentriq®
4715564|NCT03138889|Metastatic Urothelial Bladder Cancer|metastatic urothelial bladder cancer
4715565|NCT03138889|Metastatic Non-Small Cell Lung Cancer|metastatic non-small cell lung cancer
4715566|NCT03138889|Pembrolizumab|pembrolizumab
4715567|NCT03138889|Keytruda®|keytruda®
4715568|NCT03138889|Melanoma|melanoma
4715570|NCT03138889|NSCLC|nsclc
4715571|NCT03138850|intravenous sedation|intravenous sedation
4715572|NCT03138850|esophagogastroduodenalscopy|esophagogastroduodenalscopy
4715573|NCT03138850|upper airway|upper airway
4715574|NCT03138850|mandibular advancement device|mandibular advancement device
4715575|NCT03138850|high flow nasal cannula|high flow nasal cannula
4715576|NCT03138837|Bladder cancer|bladder cancer
4715577|NCT03138837|Magnetic Resonance Imaging|magnetic resonance imaging
4715578|NCT03138837|Bladder Cancer Superficial|bladder cancer superficial
4715579|NCT03138824|Bladder Urothelial Carcinoma|bladder urothelial carcinoma
4715580|NCT03138824|TURBT|turbt
4715581|NCT03138824|Recurrence|recurrence
4715582|NCT03138824|Progression|progression
4715583|NCT03138811|asthma|asthma
4715584|NCT03138811|allergen bronchoprovocation|allergen bronchoprovocation
4715585|NCT03138811|pharmacodynamics|pharmacodynamics
4715586|NCT03138811|pharmacokinetics|pharmacokinetics
4715587|NCT03138811|safety|safety
4715588|NCT03138811|tolerability|tolerability
4715589|NCT03138798|Labor|labor
4715590|NCT03138798|Second stage|second stage
4715591|NCT03138798|Dental device|dental device
4715592|NCT03138746|hyperbaric oxygenation|hyperbaric oxygenation
4715593|NCT03138746|insulin sensitivity|insulin sensitivity
4715594|NCT03138746|human|human
4715595|NCT03138746|inflammation|inflammation
4715596|NCT03138655|Drug therapy|drug therapy
4715597|NCT03138642|mucosal melanoma|mucosal melanoma
4715598|NCT03138642|radiotherapy|radiotherapy
4715599|NCT03138616|Gestational diabetes mellitus|gestational diabetes mellitus
4715600|NCT03138616|vitamin D|vitamin d
4715601|NCT03138616|postpartum|postpartum
4715602|NCT03138603|surgery|surgery
4715603|NCT03138603|heart disease|heart disease
4715604|NCT03138603|metoprolol|metoprolol
4715605|NCT03138603|myocardial injury|myocardial injury
4715606|NCT03138590|transcranial Direct Current Stimulation (tDCS)|transcranial direct current stimulation (tdcs)
4715607|NCT03138590|accelerate learning|accelerate learning
4715608|NCT03138590|memory|memory
4715610|NCT03138564|Nephrology|nephrology
4715611|NCT03138564|Behavioral Research|behavioral research
4715612|NCT03138564|Social Research|social research
4715613|NCT03138551|Sensory Food Aversions|sensory food aversions
4715614|NCT03138538|Advanced Solid Tumors|advanced solid tumors
4715615|NCT03138538|M8891|m8891
4715616|NCT03138538|Methionine Aminopeptidase 2 Inhibitor|methionine aminopeptidase 2 inhibitor
4715617|NCT03138512|localized; resected; adjuvant|localized; resected; adjuvant
4715618|NCT03138473|SYNTAX Score|syntax score
4715619|NCT03138473|residual SYNTAX score|residual syntax score
4715620|NCT03138473|SYNTAX Revascularization Index|syntax revascularization index
4715621|NCT03138447|insulin|insulin
4715622|NCT03138447|basal|basal
4715623|NCT03138447|titration|titration
4715624|NCT03138447|digital health|digital health
4715625|NCT03138434|Abdominal Aortic Aneurysm|abdominal aortic aneurysm
4715626|NCT03138434|4D flow MRI|4d flow mri
4715627|NCT03138434|DCE-MRI|dce-mri
4715628|NCT03138434|T1 and T2 mapping|t1 and t2 mapping
4715629|NCT03138408|Ovarian cancer|ovarian cancer
4715630|NCT03138408|Endometrial cancer|endometrial cancer
4715631|NCT03138408|SC-004|sc-004
4715632|NCT03138408|Maximum tolerated dose (MTD)|maximum tolerated dose (mtd)
4715633|NCT03138408|ABBV-181|abbv-181
4715634|NCT03138395|acute myeloid leukemia|acute myeloid leukemia
4715635|NCT03138395|myelodysplastic syndrome|myelodysplastic syndrome
4715636|NCT03138395|relapse|relapse
4715637|NCT03138395|PCR|pcr
4715638|NCT03138395|droplet digital|droplet digital
4715639|NCT03138395|polymerase chain reaction|polymerase chain reaction
4715640|NCT03138382|obesity|obesity
4715641|NCT03138382|metabolic syndrome|metabolic syndrome
4715642|NCT03138369|Obesity|obesity
4715643|NCT03138369|Metabolic Syndrome|metabolic syndrome
4715644|NCT03138369|Prediabetes|prediabetes
4715645|NCT03138369|Glycemic control|glycemic control
4715646|NCT03138369|Hypercholesterolemia|hypercholesterolemia
4715647|NCT03138369|Abdominal obesity|abdominal obesity
4715648|NCT03138369|Weight Loss|weight loss
4715649|NCT03138356|Type 2 diabetes mellitus, saxagliptin, dapagliflozin, metformin XR, fixed-dose combination, healthy subjects, crossover, cohorts.|type 2 diabetes mellitus, saxagliptin, dapagliflozin, metformin xr, fixed-dose combination, healthy subjects, crossover, cohorts.
4715650|NCT03138304|decision making|decision making
4715651|NCT03138304|heuristics|heuristics
4715652|NCT03138226|uterus, transplantation, infertility, twin|uterus, transplantation, infertility, twin
4715653|NCT03138213|pancreaticoduodenectomy|pancreaticoduodenectomy
4715654|NCT03138213|surgical outcome|surgical outcome
4715655|NCT03138200|Transfusion|transfusion
4715656|NCT03138200|ScvO2|scvo2
4715657|NCT03138200|Hemoglobin|hemoglobin
4715658|NCT03138187|spontaneous physical activity|spontaneous physical activity
4715659|NCT03138187|caloric intake|caloric intake
4715660|NCT03138174|Blood Glucose Monitor System Accuracy|blood glucose monitor system accuracy
4715661|NCT03138161|cancer immunotherapy, combination chemo-/immunotherapy|cancer immunotherapy, combination chemo-/immunotherapy
4715662|NCT03138148|intensive care|intensive care
4715663|NCT03138135|PrEP|prep
4715664|NCT03138135|HIV prevention|hiv prevention
4715665|NCT03138135|Risk reduction|risk reduction
4715666|NCT03138135|STI prevention|sti prevention
4715667|NCT03138135|Home HIV testing|home hiv testing
4715668|NCT03138135|HIV testing|hiv testing
4715669|NCT03138135|STI testing|sti testing
4715670|NCT03138109|non-cardiac surgery|non-cardiac surgery
4715671|NCT03138109|major adverse cardiac event|major adverse cardiac event
4715672|NCT03138083|Mesenchymal-epithelial transition factor (MET) inhibitor|mesenchymal-epithelial transition factor (met) inhibitor
4715673|NCT03138044|Hepatocellular Carcinoma|hepatocellular carcinoma
4715674|NCT03138044|Ipsilateral Liver Lobe Devascularization|ipsilateral liver lobe devascularization
4715675|NCT03138044|Alcohol Treatment|alcohol treatment
4715676|NCT03138044|CILDAT|cildat
4715677|NCT03138031|Percutaneuos Ethanol alcohol injection|percutaneuos ethanol alcohol injection
4715678|NCT03138005|Emergency Care, Prehospital|emergency care, prehospital
4715679|NCT03138005|Resuscitation|resuscitation
4715680|NCT03138005|Oxygen|oxygen
4715681|NCT03138005|Cardiac Arrest|cardiac arrest
4715682|NCT03138005|Heart Arrest|heart arrest
4715683|NCT03137992|COPD|copd
4715684|NCT03137979|Periodontitis|periodontitis
4715685|NCT03137979|Gingiva mesenchymal stem cells|gingiva mesenchymal stem cells
4715686|NCT03137966|Diabetes mellitus, foot ulcer, deferoxamine|diabetes mellitus, foot ulcer, deferoxamine
4715687|NCT03137940|Unilateral Cerebral Palsy|unilateral cerebral palsy
4715688|NCT03137940|tDCS|tdcs
4715689|NCT03137940|Safety|safety
4715690|NCT03137940|Upper Limb functions|upper limb functions
4715691|NCT03137927|bordetella pertussis|bordetella pertussis
4715692|NCT03137927|vaccine|vaccine
4715693|NCT03137927|Immunologic Factors|immunologic factors
4715694|NCT03137927|whooping cough|whooping cough
4715695|NCT03137914|orthognathic surgery|orthognathic surgery
4715696|NCT03137914|TMJ|tmj
4715697|NCT03137914|osteoarthritis|osteoarthritis
4715698|NCT03137875|Tuberculosis|tuberculosis
4715699|NCT03137875|TB|tb
4715700|NCT03137875|MDR-TB|mdr-tb
4715701|NCT03137875|LIPA|lipa
4715702|NCT03137875|filter paper|filter paper
4715703|NCT03137875|slides|slides
4715704|NCT03137875|MTBDR Plus|mtbdr plus
4715705|NCT03137849|Yoga|yoga
4716414|NCT03133208|sepsis|sepsis
4715706|NCT03137849|Hypertension|hypertension
4715707|NCT03137849|Post-Menopausal Women|post-menopausal women
4715708|NCT03137849|Heart Rate Variability|heart rate variability
4715709|NCT03137823|diagnosis, tonsillitis, streptococcus, GABHS|diagnosis, tonsillitis, streptococcus, gabhs
4715710|NCT03137784|asthma,|asthma,
4715711|NCT03137784|NVA237,|nva237,
4715712|NCT03137784|glycopyrronium bromide|glycopyrronium bromide
4715713|NCT03137784|allergic asthma,|allergic asthma,
4715714|NCT03137784|allergy triggered asthma,|allergy triggered asthma,
4715715|NCT03137784|reactive asthma,|reactive asthma,
4715716|NCT03137784|asthma attack,|asthma attack,
4715717|NCT03137784|difficulty breathing|difficulty breathing
4715718|NCT03137745|Thromboelastography, chemotherapy,hyperthermic|thromboelastography, chemotherapy,hyperthermic
4715719|NCT03137693|histologically proven|histologically proven
4715720|NCT03137693|invasive adenocarcinoma of breast|invasive adenocarcinoma of breast
4715721|NCT03137693|node negative (N0)|node negative (n0)
4715722|NCT03137693|breast-conserving surgery|breast-conserving surgery
4715723|NCT03137693|negative for Her-2 amplification|negative for her-2 amplification
4715724|NCT03137693|estrogen receptor (ER) positive|estrogen receptor (er) positive
4715725|NCT03137693|progesterone receptor (PR) positive|progesterone receptor (pr) positive
4715726|NCT03137680|Arteriovenous Fistula|arteriovenous fistula
4715727|NCT03137680|Pre-operative Exercise|pre-operative exercise
4715728|NCT03137680|Fistula Maturation|fistula maturation
4715729|NCT03137667|Influenza Vaccination Rates|influenza vaccination rates
4715730|NCT03137654|Cognitive Training|cognitive training
4715731|NCT03137654|Emotion Processing|emotion processing
4715732|NCT03137641|occupational exposure|occupational exposure
4715733|NCT03137641|antineoplastic drugs|antineoplastic drugs
4715734|NCT03137641|biomonitoring|biomonitoring
4715735|NCT03137628|general anesthesia,mechanical ventilation,colectomy|general anesthesia,mechanical ventilation,colectomy
4715736|NCT03137589|Telemedicine|telemedicine
4715737|NCT03137576|Awake Thoracic Surgery, Erector Spinae Plane Block|awake thoracic surgery, erector spinae plane block
4715738|NCT03137563|Women|women
4715739|NCT03137563|25-65 years|25-65 years
4715740|NCT03137537|Lymphoma|lymphoma
4715741|NCT03137537|Abnormal resting heart rate|abnormal resting heart rate
4715742|NCT03137537|Autonomic imbalance|autonomic imbalance
4715743|NCT03137537|Cancer survivorship|cancer survivorship
4715744|NCT03137524|Fan or Air Therapy|fan or air therapy
4715745|NCT03137511|Public Health|public health
4715746|NCT03137511|General Medicine|general medicine
4715747|NCT03137511|Dermatology|dermatology
4715748|NCT03137498|renal colic|renal colic
4715749|NCT03137498|lidocaine|lidocaine
4715750|NCT03137498|ketorolac|ketorolac
4715751|NCT03137498|acute pain|acute pain
4715752|NCT03137472|TMS, CRPS, Sham|tms, crps, sham
4715753|NCT03137459|Transtheoretical Model (TTM)|transtheoretical model (ttm)
4715754|NCT03137446|Intravenous fluid resuscitation|intravenous fluid resuscitation
4715755|NCT03137446|Septic shock|septic shock
4715756|NCT03137446|Severe sepsis|severe sepsis
4715757|NCT03137446|Fluid restriction|fluid restriction
4715758|NCT03137433|Weight loss|weight loss
4715759|NCT03137433|Cardiometabolic|cardiometabolic
4715760|NCT03137433|Meal-replacement therapy|meal-replacement therapy
4715761|NCT03137407|heel pain|heel pain
4715762|NCT03137394|spinal cord injury|spinal cord injury
4715763|NCT03137394|shoulder pain|shoulder pain
4715764|NCT03137394|psychosocial|psychosocial
4715765|NCT03137368|ovarian function suppression/ablation|ovarian function suppression/ablation
4715766|NCT03137368|breast cancer|breast cancer
4715767|NCT03137368|Exemestane|exemestane
4715768|NCT03137368|Tamoxifen|tamoxifen
4715769|NCT03137368|CYP2D6*10 mutations|cyp2d6*10 mutations
4715770|NCT03137355|Leigh Syndrome|leigh syndrome
4715771|NCT03137355|Leigh Disease|leigh disease
4715772|NCT03137355|Leigh's Necrotizing Encephalopathy|leigh's necrotizing encephalopathy
4715773|NCT03137355|Subacute Necrotizing Encephalomyelopathy|subacute necrotizing encephalomyelopathy
4715774|NCT03137355|Subacute Necrotizing Encephalomyopathy|subacute necrotizing encephalomyopathy
4715775|NCT03137342|PrEP|prep
4715776|NCT03137342|Adherence|adherence
4715777|NCT03137342|Risk Reduction|risk reduction
4715778|NCT03137342|Stimulant Use|stimulant use
4715779|NCT03137290|Paediatric general anaesthesia|paediatric general anaesthesia
4715780|NCT03137290|Rocuronium|rocuronium
4715781|NCT03137290|Neostigmine|neostigmine
4715782|NCT03137290|Sugammadex|sugammadex
4715783|NCT03137277|Colonoscopy|colonoscopy
4715784|NCT03137277|ADR|adr
4715785|NCT03137277|Adenoma detection rate|adenoma detection rate
4715786|NCT03137277|colonoscopic imaging feature improvement|colonoscopic imaging feature improvement
4715787|NCT03137277|Olympus colonoscopes|olympus colonoscopes
4715788|NCT03137264|T790M mutation|t790m mutation
4715789|NCT03137264|EGFR epidermal growth factor receptor|egfr epidermal growth factor receptor
4715790|NCT03137264|non-invasive testing|non-invasive testing
4715791|NCT03137264|lung cancer|lung cancer
4715792|NCT03137251|Transcutaneous electrical nerve stimulation|transcutaneous electrical nerve stimulation
4715793|NCT03137251|TENS|tens
4715794|NCT03137251|Analgesia|analgesia
4715795|NCT03137251|Labour pain|labour pain
4715796|NCT03137251|Physical therapy modality|physical therapy modality
4715797|NCT03137238|Self-motion perception|self-motion perception
4715798|NCT03137238|Optic flow|optic flow
4715799|NCT03137238|Vestibular system|vestibular system
4715800|NCT03137238|Multisensory integration|multisensory integration
4715801|NCT03137238|Parkinson's disease|parkinson's disease
4715802|NCT03137212|Percutaneous Coronary Intervention|percutaneous coronary intervention
4715803|NCT03137212|STEMI|stemi
4715804|NCT03137212|Thrombosis|thrombosis
4715805|NCT03137199|stem cell|stem cell
4715806|NCT03137199|mesenchymal stem cell|mesenchymal stem cell
4715807|NCT03137199|lung|lung
4715808|NCT03137199|asthma|asthma
4715809|NCT03137186|Metformin, prostate cancer|metformin, prostate cancer
4715810|NCT03137147|pediatric|pediatric
4715811|NCT03137147|children|children
4715812|NCT03137147|adolescent|adolescent
4715814|NCT03137147|pain|pain
4715815|NCT03137147|cognitive-behavioral therapy|cognitive-behavioral therapy
4715816|NCT03137121|nausea|nausea
4715817|NCT03137121|vomiting|vomiting
4715818|NCT03137121|olanzapine|olanzapine
4715819|NCT03137082|Alcohol Use Disorder|alcohol use disorder
4715820|NCT03137082|Guanfacine|guanfacine
4715821|NCT03137082|Stress|stress
4715822|NCT03137082|Craving|craving
4715823|NCT03137082|Gender|gender
4715824|NCT03137082|Relapse|relapse
4715825|NCT03137056|Hemodialysis|hemodialysis
4715826|NCT03137056|Membrane|membrane
4715827|NCT03137056|Albumin|albumin
4715828|NCT03137056|Proteomics|proteomics
4715829|NCT03137043|GINA guidelines|gina guidelines
4715830|NCT03137043|Prevalence|prevalence
4715831|NCT03137043|Mepolizumab|mepolizumab
4715832|NCT03137043|severe asthma|severe asthma
4715833|NCT03137043|Spain|spain
4715834|NCT03137030|Abuse deterrent formulation|abuse deterrent formulation
4715835|NCT03137030|Hydrocodone|hydrocodone
4715836|NCT03137030|Analgesics, Opioid|analgesics, opioid
4715837|NCT03137030|Narcotics|narcotics
4715838|NCT03137017|Abuse deterrent formulation|abuse deterrent formulation
4715839|NCT03137017|Hydrocodone|hydrocodone
4715840|NCT03137017|Analgesics, Opioid|analgesics, opioid
4715841|NCT03137017|Narcotics|narcotics
4715842|NCT03136991|Oral myeloperoxidase inhibitor|oral myeloperoxidase inhibitor
4715843|NCT03136978|Macrophages|macrophages
4715844|NCT03136978|Macrophages, Peritoneal|macrophages, peritoneal
4715845|NCT03136978|Endometriosis|endometriosis
4715846|NCT03136952|NIRS|nirs
4715847|NCT03136952|Monitoring|monitoring
4715848|NCT03136952|Pediatric|pediatric
4715849|NCT03136874|donors|donors
4715850|NCT03136874|gametes|gametes
4715851|NCT03136874|motivation|motivation
4715852|NCT03136874|psychological|psychological
4715853|NCT03136861|axial spondyloarthritis|axial spondyloarthritis
4715854|NCT03136861|ankylosing spondylitis|ankylosing spondylitis
4715855|NCT03136861|non-radiographic axial spondyloarthritis|non-radiographic axial spondyloarthritis
4715856|NCT03136861|inflammatory back pain|inflammatory back pain
4715857|NCT03136861|spinal pain|spinal pain
4715858|NCT03136861|secukinumab|secukinumab
4715859|NCT03136861|AIN457|ain457
4715860|NCT03136848|perfusion|perfusion
4715861|NCT03136822|Diabetic Foot|diabetic foot
4715862|NCT03136744|Sedentary behaviour|sedentary behaviour
4715863|NCT03136744|Co-morbidity|co-morbidity
4715864|NCT03136744|Intervention|intervention
4715865|NCT03136731|Celiac disease, Gluten, Microbiome, Genetic|celiac disease, gluten, microbiome, genetic
4715866|NCT03136718|mHealth|mhealth
4715867|NCT03136718|Hearing aids|hearing aids
4715868|NCT03136718|Auditory rehabilitation|auditory rehabilitation
4715869|NCT03136718|Adult|adult
4715870|NCT03136718|Reusable Learning Object|reusable learning object
4715871|NCT03136718|Education|education
4715872|NCT03136718|Personalised|personalised
4715873|NCT03136718|Telehealth|telehealth
4715874|NCT03136718|Teleaudiology|teleaudiology
4715875|NCT03136705|Phosphorus Homeostasis|phosphorus homeostasis
4715876|NCT03136705|FGF23|fgf23
4715877|NCT03136705|Vitamin D|vitamin d
4715878|NCT03136692|app|app
4715879|NCT03136692|weight loss|weight loss
4715880|NCT03136692|diet|diet
4715881|NCT03136692|behavior|behavior
4715882|NCT03136653|DARPin|darpin
4715883|NCT03136653|MP0250|mp0250
4715884|NCT03136653|VEGF|vegf
4715885|NCT03136653|HGF|hgf
4715886|NCT03136653|RRMM|rrmm
4715887|NCT03136627|RCC, Tivozanib, Nivolumab, Metastatic Renal Cell Cancer|rcc, tivozanib, nivolumab, metastatic renal cell cancer
4715888|NCT03136588|Information and Communication Technology|information and communication technology
4715889|NCT03136588|Adherence|adherence
4715890|NCT03136588|Kidney transplantation|kidney transplantation
4715891|NCT03136523|NSCLC|nsclc
4715892|NCT03136523|SCLC|sclc
4715893|NCT03136523|MOLECULAR BIOMARKERS|molecular biomarkers
4715894|NCT03136523|EGFR|egfr
4715895|NCT03136523|PD-L1|pd-l1
4715896|NCT03136523|ALK|alk
4715897|NCT03136523|KRAS|kras
4715898|NCT03136458|contrast media|contrast media
4715899|NCT03136458|nephropathy|nephropathy
4715900|NCT03136458|ischemic preconditioning|ischemic preconditioning
4715901|NCT03136445|Tranexamic acid|tranexamic acid
4715902|NCT03136445|Platelet transfusion|platelet transfusion
4715903|NCT03136432|Cerebral Palsy|cerebral palsy
4715904|NCT03136432|Functional Exercise Capacity|functional exercise capacity
4715905|NCT03136432|Quality of Life|quality of life
4715906|NCT03136419|microbiota|microbiota
4715907|NCT03136419|innate immunity|innate immunity
4715908|NCT03136393|nutrition|nutrition
4715909|NCT03136393|pregnancy|pregnancy
4715910|NCT03136393|birth weight|birth weight
4715911|NCT03136380|healthy Japanese subjects|healthy japanese subjects
4715912|NCT03136380|CXCR2 inhibitor|cxcr2 inhibitor
4715913|NCT03136380|Danirixin|danirixin
4715914|NCT03136367|encounter decision aids|encounter decision aids
4715915|NCT03136367|shared decision making|shared decision making
4715916|NCT03136367|socioeconomic status|socioeconomic status
4715917|NCT03136367|disparities|disparities
4715918|NCT03136367|decision quality|decision quality
4715919|NCT03136341|Upper Limb|upper limb
4715920|NCT03136341|Tremor|tremor
4715921|NCT03136341|task-dependent|task-dependent
4715922|NCT03136315|Renal failure|renal failure
4715923|NCT03136315|athlete|athlete
4715924|NCT03136315|ultra endurance|ultra endurance
4715925|NCT03136263|Attention|attention
4715926|NCT03136263|Attention deficit/hyperactivity disorder|attention deficit/hyperactivity disorder
4715927|NCT03136263|Cognitive control|cognitive control
4715928|NCT03136263|Executive control|executive control
4715929|NCT03136263|Executive functions|executive functions
4715930|NCT03136263|Impulse control|impulse control
4715931|NCT03136263|Impulsivity|impulsivity
4715932|NCT03136263|Oxytocin|oxytocin
4715933|NCT03136250|Muscle Energy Techniques|muscle energy techniques
4715934|NCT03136250|Autogenic Inhibition|autogenic inhibition
4715935|NCT03136250|Reciprocal Inhibition|reciprocal inhibition
4715936|NCT03136250|Stretching|stretching
4715937|NCT03136250|Range of Motion|range of motion
4715938|NCT03136250|Muscle Strength|muscle strength
4715939|NCT03136250|VAS|vas
4715940|NCT03136250|Neck Disability Index|neck disability index
4715941|NCT03136250|NDI|ndi
4715942|NCT03136224|circumcision|circumcision
4715943|NCT03136224|Thermocautery|thermocautery
4715944|NCT03136224|Clamp|clamp
4715945|NCT03136224|Surgical Circumcision|surgical circumcision
4715946|NCT03136198|Heart Failure|heart failure
4715947|NCT03136198|Acute Heart Failure|acute heart failure
4715948|NCT03136198|Pulmonary Edema|pulmonary edema
4715949|NCT03136198|Lung ultrasound|lung ultrasound
4715950|NCT03136198|Extra vascular lung water|extra vascular lung water
4715951|NCT03136198|B-lines|b-lines
4715952|NCT03136185|LSD1|lsd1
4715953|NCT03136159|pregnancy|pregnancy
4715954|NCT03136159|delivery|delivery
4715955|NCT03136159|cesarean section|cesarean section
4715956|NCT03136159|wound healing|wound healing
4715957|NCT03136159|silver-containing dressing|silver-containing dressing
4715958|NCT03136146|Hematopoietic/Lymphoid Cancer|hematopoietic/lymphoid cancer
4715959|NCT03136146|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
4715960|NCT03136146|ALL|all
4715961|NCT03136146|Lymphoblastic Lymphoma|lymphoblastic lymphoma
4715962|NCT03136146|LL|ll
4715963|NCT03136146|Relapsed/Refractory|relapsed/refractory
4715964|NCT03136146|Clofarabine|clofarabine
4715965|NCT03136146|Clofarex|clofarex
4715966|NCT03136146|Clolar|clolar
4715967|NCT03136146|Etoposide|etoposide
4715968|NCT03136146|VePesid|vepesid
4715969|NCT03136146|Cyclophosphamide|cyclophosphamide
4715970|NCT03136146|Cytoxan|cytoxan
4715971|NCT03136146|Neosar|neosar
4715972|NCT03136146|Liposomal Vincristine|liposomal vincristine
4715973|NCT03136146|Vincristine Sulfate Liposomes Injection|vincristine sulfate liposomes injection
4715974|NCT03136146|VSLI|vsli
4715975|NCT03136146|Marqibo|marqibo
4715976|NCT03136146|Bortezomib|bortezomib
4715977|NCT03136146|Velcade|velcade
4715978|NCT03136146|LDP-341|ldp-341
4715979|NCT03136146|MLN341|mln341
4715980|NCT03136146|PS-341|ps-341
4715981|NCT03136146|Ofatumumab|ofatumumab
4715982|NCT03136146|Arzerra|arzerra
4715983|NCT03136146|Rituximab|rituximab
4715984|NCT03136146|Rituxan|rituxan
4715985|NCT03136146|Pegfilgrastim|pegfilgrastim
4715986|NCT03136146|Neulasta|neulasta
4715987|NCT03136146|PEG-G-CSF|peg-g-csf
4715988|NCT03136120|Ipratropium bromide|ipratropium bromide
4715989|NCT03136120|Cryobiopsy|cryobiopsy
4715990|NCT03136120|TBCB|tbcb
4715991|NCT03136120|IPF|ipf
4715992|NCT03136120|Transbronchial cryobiopsy|transbronchial cryobiopsy
4715993|NCT03136120|Interstitial lung disease|interstitial lung disease
4715994|NCT03136094|American Indian|american indian
4715995|NCT03136094|Alaska Native|alaska native
4715996|NCT03136094|Youth and Young Adult|youth and young adult
4715997|NCT03136094|SBIRT|sbirt
4715998|NCT03136081|Septic shock|septic shock
4715999|NCT03136081|Candidiasis|candidiasis
4716000|NCT03136081|Candidemia|candidemia
4716001|NCT03136081|Bacteremia|bacteremia
4716002|NCT03136081|Immunoparalysis|immunoparalysis
4716003|NCT03136055|NEC|nec
4716004|NCT03136029|HFrEF|hfref
4716005|NCT03136029|Exercise Intolerance|exercise intolerance
4716006|NCT03136029|Nitric Oxide|nitric oxide
4716007|NCT03135990|Virtual Reality|virtual reality
4716008|NCT03135990|Exposure Therapy|exposure therapy
4716009|NCT03135990|Cognitive Behavioral Therapy|cognitive behavioral therapy
4716010|NCT03135990|Extinction Learning|extinction learning
4716011|NCT03135964|NPWT|npwt
4716012|NCT03135964|foam|foam
4716013|NCT03135964|gauze|gauze
4716014|NCT03135951|Breast Cancer|breast cancer
4716015|NCT03135951|Pharmacokinetics|pharmacokinetics
4716016|NCT03135951|Long-acting Myeloid Growth Factor|long-acting myeloid growth factor
4716017|NCT03135951|Early Stage Breast Cancer|early stage breast cancer
4716018|NCT03135951|Docetaxel + Cyclophosphamide (TC) Chemotherapy|docetaxel + cyclophosphamide (tc) chemotherapy
4716019|NCT03135912|Tinea Pedis|tinea pedis
4716020|NCT03135912|Athlete's Foot|athlete's foot
4716021|NCT03135886|HIV|hiv
4716022|NCT03135886|HIV Testing|hiv testing
4716023|NCT03135886|Hepatitis C Virus Testing|hepatitis c virus testing
4716024|NCT03135886|Opioid Use Disorder Treatment|opioid use disorder treatment
4716025|NCT03135886|Substance Use Disorders Treatment|substance use disorders treatment
4716026|NCT03135886|Hepatitis C Virus|hepatitis c virus
4716027|NCT03135886|Practice Coaching|practice coaching
4716028|NCT03135860|Inhaled Nitric Oxide|inhaled nitric oxide
4716029|NCT03135860|COPD|copd
4716030|NCT03135860|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
4716031|NCT03135860|Idopathic Pulmonary Fibrosis|idopathic pulmonary fibrosis
4716032|NCT03135860|Long Term Oxygen Therapy (LTOT)|long term oxygen therapy (ltot)
4716033|NCT03135808|MRI|mri
4716034|NCT03135808|Imaging,|imaging,
4716035|NCT03135808|Anatomy|anatomy
4716036|NCT03135808|Tissue|tissue
4716037|NCT03135808|Colorectal|colorectal
4716038|NCT03135808|Sigmoid|sigmoid
4716039|NCT03135808|Colon|colon
4716040|NCT03135808|Pathology|pathology
4716041|NCT03135795|sufentanil|sufentanil
4716042|NCT03135795|DNA methylation|dna methylation
4716043|NCT03135769|avelumab|avelumab
4716044|NCT03135769|PDL1|pdl1
4716045|NCT03135769|Gestational Trophoblastic Neoplasias|gestational trophoblastic neoplasias
4716046|NCT03135769|GTN|gtn
4716047|NCT03135769|Hydatiform mole|hydatiform mole
4716048|NCT03135769|hCG|hcg
4716049|NCT03135717|Chronic kidney disease|chronic kidney disease
4716050|NCT03135717|Enteral nutrition|enteral nutrition
4716051|NCT03135717|Oral nutritional supplements|oral nutritional supplements
4716052|NCT03135717|Parenteral nutrition|parenteral nutrition
4716053|NCT03135717|Refeeding|refeeding
4716054|NCT03135717|Wasting|wasting
4716055|NCT03135652|Radiotherapy|radiotherapy
4716056|NCT03135652|Colorectal Cancer|colorectal cancer
4716057|NCT03135652|Liver Metastases|liver metastases
4716058|NCT03135639|tACS|tacs
4716059|NCT03135639|transcranial alternating current stimulation|transcranial alternating current stimulation
4716060|NCT03135639|stimulation|stimulation
4716061|NCT03135639|healthy control|healthy control
4716062|NCT03135639|alpha oscillations|alpha oscillations
4716063|NCT03135639|heart rate variability|heart rate variability
4716064|NCT03135626|Pulpotomy|pulpotomy
4716065|NCT03135626|Primary molars|primary molars
4716066|NCT03135613|Knee tumor|knee tumor
4716067|NCT03135613|Microwave|microwave
4716068|NCT03135613|Gait|gait
4716069|NCT03135600|Knee|knee
4716070|NCT03135600|ACL Injury|acl injury
4716071|NCT03135600|Kinematics|kinematics
4716072|NCT03135587|Knee|knee
4716073|NCT03135587|Loading|loading
4716074|NCT03135587|Kinematics|kinematics
4716075|NCT03135522|Chronic cough|chronic cough
4716076|NCT03135522|Refractory cough|refractory cough
4716077|NCT03135522|Chronic refractory cough|chronic refractory cough
4716078|NCT03135522|Zinc|zinc
4716079|NCT03135522|Zinc acetate|zinc acetate
4716080|NCT03135509|Healthy Subjects|healthy subjects
4716081|NCT03135509|CC-220 Capsules|cc-220 capsules
4716082|NCT03135509|Relative Bioavailability|relative bioavailability
4716083|NCT03135509|Phase 1|phase 1
4716084|NCT03135470|pain|pain
4716085|NCT03135470|ambulatory surgery|ambulatory surgery
4716086|NCT03135470|oxycodone|oxycodone
4716087|NCT03135470|adverse effect|adverse effect
4716088|NCT03135444|Screening|screening
4716089|NCT03135444|Shared Decision Making|shared decision making
4716090|NCT03135418|Virtual Reality|virtual reality
4716091|NCT03135392|Breast Cancer|breast cancer
4716092|NCT03135392|sensation recovery|sensation recovery
4716093|NCT03135392|Neurotization|neurotization
4716094|NCT03135366|Tuberculosis|tuberculosis
4716096|NCT03135366|Adherence|adherence
4716097|NCT03135366|Mobile Health|mobile health
4716098|NCT03135366|mHealth|mhealth
4716099|NCT03135366|Behavior change|behavior change
4716100|NCT03135366|Social and Behavior Change Communication (SBCC)|social and behavior change communication (sbcc)
4716101|NCT03135366|Drug-Resistance|drug-resistance
4716102|NCT03135366|Keheala|keheala
4716103|NCT03135275|ST-elevation Myocardial Infarction|st-elevation myocardial infarction
4716104|NCT03135275|Multivessel coronary disease|multivessel coronary disease
4716105|NCT03135275|Immediate complete coronary revascularization|immediate complete coronary revascularization
4716106|NCT03135275|Staged complete coronary revascularization|staged complete coronary revascularization
4716107|NCT03135275|Percutaneous coronary intervention|percutaneous coronary intervention
4716108|NCT03135275|Biodegradable-polymer everolimus-eluting stent|biodegradable-polymer everolimus-eluting stent
4716109|NCT03135236|Parent training|parent training
4716110|NCT03135236|Family education|family education
4716111|NCT03135236|Young adults|young adults
4716112|NCT03135236|Down syndrome|down syndrome
4716113|NCT03135236|sexuality|sexuality
4716114|NCT03135223|Physical activity|physical activity
4716514|NCT03132519|Desflurane|desflurane
4716115|NCT03135145|Single Event Multilevel Lower Extremity Orthopedic Surgery (SEMLS)|single event multilevel lower extremity orthopedic surgery (semls)
4716116|NCT03135145|Physical Therapy|physical therapy
4716117|NCT03135145|Gait Training|gait training
4716118|NCT03135145|Functional Walking|functional walking
4716119|NCT03135145|Selective Dorsal Rhizotomy (SDR)|selective dorsal rhizotomy (sdr)
4716120|NCT03135132|High visceral fat|high visceral fat
4716121|NCT03135132|Low calorie diet|low calorie diet
4716122|NCT03135132|Mild weight loss|mild weight loss
4716123|NCT03135132|Metabolomics|metabolomics
4716124|NCT03135132|Metabolites|metabolites
4716125|NCT03135132|Acylcarnitines|acylcarnitines
4716126|NCT03135093|synergies|synergies
4716127|NCT03135093|upper limb|upper limb
4716128|NCT03135093|vision|vision
4716129|NCT03135067|HIV self-testing|hiv self-testing
4716130|NCT03135067|female sex workers|female sex workers
4716131|NCT03135067|partner testing|partner testing
4716132|NCT03135067|couples testing|couples testing
4716133|NCT03135067|transactional sex|transactional sex
4716134|NCT03135054|FLT3-ITD (+) AML; Quizartinib, Omacetaxine mepesuccinate|flt3-itd (+) aml; quizartinib, omacetaxine mepesuccinate
4716135|NCT03135041|Prebiotics|prebiotics
4716136|NCT03135041|Microbiome|microbiome
4716137|NCT03135041|Glucose metabolism|glucose metabolism
4716138|NCT03134976|Salvage surgery|salvage surgery
4716139|NCT03134976|Head and neck cancer|head and neck cancer
4716140|NCT03134976|Wound healing|wound healing
4716141|NCT03134976|Hypothyroidism|hypothyroidism
4716142|NCT03134976|Levothyroxine|levothyroxine
4716143|NCT03134937|Gastric Ultrasound|gastric ultrasound
4716144|NCT03134937|Gastric Distension|gastric distension
4716145|NCT03134937|Gastric Volume|gastric volume
4716146|NCT03134937|Gastric Fluid Volume|gastric fluid volume
4716147|NCT03134937|High-flow oxygen therapy|high-flow oxygen therapy
4716148|NCT03134937|HFHHNO|hfhhno
4716149|NCT03134937|Healthy volunteer|healthy volunteer
4716150|NCT03134924|Bacterial Vaginosis|bacterial vaginosis
4716151|NCT03134885|suicide|suicide
4716152|NCT03134885|suicidal conducts|suicidal conducts
4716153|NCT03134885|post discharge monitoring system|post discharge monitoring system
4716154|NCT03134872|PD-1|pd-1
4716155|NCT03134872|PD-L1|pd-l1
4716156|NCT03134872|SHR-1210|shr-1210
4716157|NCT03134872|Carboplatin|carboplatin
4716158|NCT03134872|Pemetrexed|pemetrexed
4716159|NCT03134859|motor development|motor development
4716160|NCT03134846|Intraoperative fluorescence imaging|intraoperative fluorescence imaging
4716161|NCT03134846|Cetuximab-IRDye800CW|cetuximab-irdye800cw
4716162|NCT03134846|Molecular imaging|molecular imaging
4716163|NCT03134833|HIV|hiv
4716164|NCT03134833|STI|sti
4716165|NCT03134833|Mental Health|mental health
4716166|NCT03134833|Substance Use|substance use
4716167|NCT03134833|Peer Support|peer support
4716168|NCT03134820|Low molecular weight heparins|low molecular weight heparins
4716169|NCT03134820|Procoagulants|procoagulants
4716170|NCT03134820|Phospholipid-dependent Microparticles|phospholipid-dependent microparticles
4716171|NCT03134794|neuroeconomics|neuroeconomics
4716172|NCT03134794|multiple sclerosis|multiple sclerosis
4716173|NCT03134794|educational intervention|educational intervention
4716174|NCT03134794|traffic light system|traffic light system
4716175|NCT03134794|aversion to ambiguity|aversion to ambiguity
4716176|NCT03134794|risk|risk
4716177|NCT03134794|outcomes|outcomes
4716178|NCT03134794|knowledge|knowledge
4716179|NCT03134794|action|action
4716180|NCT03134794|gaps|gaps
4716181|NCT03134794|disease modifying agents|disease modifying agents
4716182|NCT03134755|Asthma|asthma
4716183|NCT03134755|Children|children
4716184|NCT03134755|Stress|stress
4716185|NCT03134755|Puerto Rican|puerto rican
4716186|NCT03134755|Health disparities|health disparities
4716187|NCT03134755|Treatment response|treatment response
4716188|NCT03134742|soft tissue sarcoma extremities|soft tissue sarcoma extremities
4716189|NCT03134729|Serratus Block, Pain Management, lung lobectomy|serratus block, pain management, lung lobectomy
4716190|NCT03134690|Poor ovarian response gonadotropins antagonist|poor ovarian response gonadotropins antagonist
4716191|NCT03134677|Spinal anesthesia|spinal anesthesia
4716192|NCT03134677|General anesthesia|general anesthesia
4716193|NCT03134677|P wave dispersion|p wave dispersion
4716194|NCT03134651|Anxiety|anxiety
4716195|NCT03134651|Oocyte retrieval|oocyte retrieval
4716196|NCT03134651|Monitoring of brain function|monitoring of brain function
4716197|NCT03134625|metabolomics|metabolomics
4716198|NCT03134625|biomarker|biomarker
4716199|NCT03134625|acute rejection|acute rejection
4716200|NCT03134612|lidocain|lidocain
4716201|NCT03134612|ondansetron|ondansetron
4716202|NCT03134612|pain|pain
4716203|NCT03134612|propofol|propofol
4716204|NCT03134586|Capsule endoscopy|capsule endoscopy
4716205|NCT03134586|Crohn's disease|crohn's disease
4716206|NCT03134586|Magnetic resonance enterography|magnetic resonance enterography
4716207|NCT03134586|Ileocolonoscopy|ileocolonoscopy
4716208|NCT03134586|Bowel Ultrasound|bowel ultrasound
4716209|NCT03134586|diagnostic imaging|diagnostic imaging
4716210|NCT03134573|Relapsing Remitting Multiple Sclerosis (RRMS),|relapsing remitting multiple sclerosis (rrms),
4716211|NCT03134573|Clinically isolated Syndrome (CIS),|clinically isolated syndrome (cis),
4716713|NCT03131375|children|children
4716212|NCT03134573|Secondary Progressive Multiple Sclerosis (SPMS)|secondary progressive multiple sclerosis (spms)
4716213|NCT03134560|vein display instrument|vein display instrument
4716214|NCT03134560|pediatric|pediatric
4716215|NCT03134560|vein access|vein access
4716216|NCT03134560|vein cannulation|vein cannulation
4716217|NCT03134547|emergence agitation|emergence agitation
4716218|NCT03134547|sevoflurane|sevoflurane
4716219|NCT03134547|children|children
4716220|NCT03134534|lobectomy|lobectomy
4716221|NCT03134534|robot-assisted thoracoscopic surgery|robot-assisted thoracoscopic surgery
4716222|NCT03134534|lung cancer|lung cancer
4716223|NCT03134521|bone and joint infection|bone and joint infection
4716224|NCT03134521|daptomycin|daptomycin
4716225|NCT03134521|population pharmacokinetics|population pharmacokinetics
4716226|NCT03134521|Glycoprotein-P (PgP)|glycoprotein-p (pgp)
4716227|NCT03134482|in vitro maturation (IVM)|in vitro maturation (ivm)
4716228|NCT03134482|polycystic ovarian syndrome (PCOS)|polycystic ovarian syndrome (pcos)
4716229|NCT03134482|ovarian hyperstimulation syndrome (OHSS)|ovarian hyperstimulation syndrome (ohss)
4716230|NCT03134482|assisted reproductive technology (ART)|assisted reproductive technology (art)
4716231|NCT03134430|Regional nerve block|regional nerve block
4716232|NCT03134430|cancer recurrence|cancer recurrence
4716233|NCT03134404|RAMP|ramp
4716234|NCT03134404|Rapid Access|rapid access
4716235|NCT03134404|Metastasis to Bone|metastasis to bone
4716236|NCT03134404|Cancer|cancer
4716237|NCT03134378|Helicobacter pylori|helicobacter pylori
4716238|NCT03134378|triple therapy|triple therapy
4716239|NCT03134378|eradication|eradication
4716240|NCT03134365|meal ingestion|meal ingestion
4716241|NCT03134365|palatability|palatability
4716242|NCT03134365|postprandial responses|postprandial responses
4716243|NCT03134365|hedonic response|hedonic response
4716244|NCT03134352|subacute|subacute
4716245|NCT03134339|nicotine, smoking|nicotine, smoking
4716246|NCT03134209|Monocryl|monocryl
4716247|NCT03134209|Dermabond|dermabond
4716248|NCT03134209|Polyester mesh|polyester mesh
4716249|NCT03134209|Joint Disease|joint disease
4716250|NCT03134209|Arthropathy|arthropathy
4716251|NCT03134209|Joint Replacement|joint replacement
4716252|NCT03134196|Herpes Zoster Ophthalmicus|herpes zoster ophthalmicus
4716253|NCT03134196|Zoster Eye Disease Study|zoster eye disease study
4716254|NCT03134196|Varicella Zoster Virus|varicella zoster virus
4716255|NCT03134196|Zoster|zoster
4716256|NCT03134196|Shingles|shingles
4716258|NCT03134183|dilation and evacuation|dilation and evacuation
4716259|NCT03134183|abortion|abortion
4716260|NCT03134183|second trimester|second trimester
4716261|NCT03134183|mifepristone|mifepristone
4716262|NCT03134183|misoprostol|misoprostol
4716263|NCT03134170|pharmacist|pharmacist
4716264|NCT03134170|diabetes|diabetes
4716265|NCT03134170|Preventative Care|preventative care
4716266|NCT03134170|Quality of Life|quality of life
4716267|NCT03134157|Leiomyoma simvastatin infertility|leiomyoma simvastatin infertility
4716268|NCT03134144|Exoskeleton|exoskeleton
4716269|NCT03134144|Manual materials handling|manual materials handling
4716270|NCT03134144|Musculoskeletal disorders|musculoskeletal disorders
4716271|NCT03134144|Posture|posture
4716272|NCT03134144|Standing work|standing work
4716273|NCT03134144|Muscle activity|muscle activity
4716274|NCT03134118|Thymoma|thymoma
4716275|NCT03134118|Phase II|phase ii
4716276|NCT03134118|nivolumab|nivolumab
4716277|NCT03134118|Thymic carcinoma|thymic carcinoma
4716278|NCT03134079|Taste Testing|taste testing
4716279|NCT03134079|Spices|spices
4716280|NCT03134079|Reduced sugar|reduced sugar
4716281|NCT03134079|Food liking|food liking
4716282|NCT03134053|hypertrophy scar|hypertrophy scar
4716283|NCT03134053|burn|burn
4716284|NCT03134040|Incentives|incentives
4716285|NCT03134040|Motivation|motivation
4716286|NCT03133975|high dose vitamin D|high dose vitamin d
4716287|NCT03133975|dyslipidemia|dyslipidemia
4716288|NCT03133975|premenopausal women|premenopausal women
4716289|NCT03133923|Attenuated Mumps Vaccine(F-genotype，Human Diploid Cell, KMB-17), safety, immunogenecity|attenuated mumps vaccine(f-genotype，human diploid cell, kmb-17), safety, immunogenecity
4716290|NCT03133910|Pharmacokinetics|pharmacokinetics
4716291|NCT03133910|Ceftazidime|ceftazidime
4716292|NCT03133897|dexamethasone|dexamethasone
4716293|NCT03133897|prednisone|prednisone
4716294|NCT03133897|inpatient|inpatient
4716295|NCT03133897|paediatrics|paediatrics
4716296|NCT03133884|chronic tension-type headache|chronic tension-type headache
4716297|NCT03133884|acupuncture|acupuncture
4716298|NCT03133884|Deqi|deqi
4716299|NCT03133845|delirium|delirium
4716300|NCT03133845|elderly|elderly
4716301|NCT03133845|lumbar|lumbar
4716302|NCT03133845|surgery|surgery
4716303|NCT03133832|Schistosomiasis haematobium|schistosomiasis haematobium
4716304|NCT03133832|Praziquantel|praziquantel
4716305|NCT03133832|A randomized controlled trial|a randomized controlled trial
4716306|NCT03133806|Percutaneous Occlusion|percutaneous occlusion
4716307|NCT03133793|heart failure with preserved ejection fraction|heart failure with preserved ejection fraction
4716308|NCT03133767|Normal saline|normal saline
4716309|NCT03133767|Lactated ringers|lactated ringers
4716310|NCT03133767|Emergency department|emergency department
4716311|NCT03133741|GIP|gip
4716312|NCT03133741|GIP receptor antagonist|gip receptor antagonist
4716313|NCT03133728|EID HIV|eid hiv
4716314|NCT03133728|Early Infant Diagnosis|early infant diagnosis
4716315|NCT03133728|Point of Care|point of care
4716316|NCT03133728|Infant|infant
4716317|NCT03133728|HIV|hiv
4716318|NCT03133715|robot-assisted|robot-assisted
4716319|NCT03133689|Alcohol|alcohol
4716320|NCT03133689|Coronary heart disease|coronary heart disease
4716321|NCT03133689|Ischemic heart disease|ischemic heart disease
4716322|NCT03133689|Cardiovascular health|cardiovascular health
4716323|NCT03133689|Individual participant data meta-analysis|individual participant data meta-analysis
4716324|NCT03133689|Longitudinal|longitudinal
4716325|NCT03133676|Osteoarthritis|osteoarthritis
4716326|NCT03133676|Arthritis|arthritis
4716327|NCT03133676|Joint Disease|joint disease
4716328|NCT03133676|Osteoarthritis, Knee|osteoarthritis, knee
4716329|NCT03133663|electrocardiogram|electrocardiogram
4716330|NCT03133663|premature|premature
4716331|NCT03133663|resuscitation|resuscitation
4716332|NCT03133650|Vascular-Targeted Photodynamic Therapy (VTP)|vascular-targeted photodynamic therapy (vtp)
4716333|NCT03133650|15-319|15-319
4716334|NCT03133624|unruptured intracranial aneurysms|unruptured intracranial aneurysms
4716335|NCT03133624|rupture risk|rupture risk
4716336|NCT03133624|computational fluid dynamic|computational fluid dynamic
4716337|NCT03133624|high resolution magnetic resonance images|high resolution magnetic resonance images
4716338|NCT03133624|gene|gene
4716339|NCT03133624|multi dimensional prediction model|multi dimensional prediction model
4716340|NCT03133624|clinical features|clinical features
4716341|NCT03133624|risk factors|risk factors
4716342|NCT03133624|registry study|registry study
4716343|NCT03133624|china|china
4716344|NCT03133624|biomarkers|biomarkers
4716345|NCT03133611|Speech disorder|speech disorder
4716346|NCT03133611|Acoustic analysis|acoustic analysis
4716347|NCT03133611|Dysarthria|dysarthria
4716348|NCT03133598|Un-ruptured intracranial aneurysm|un-ruptured intracranial aneurysm
4716349|NCT03133598|Interventional therapy and craniotomy|interventional therapy and craniotomy
4716350|NCT03133598|Prospective cohort study|prospective cohort study
4716351|NCT03133598|China|china
4716352|NCT03133546|NSCLC|nsclc
4716353|NCT03133546|EGFR|egfr
4716354|NCT03133546|TKI|tki
4716355|NCT03133546|EGFRm|egfrm
4716356|NCT03133546|T790M|t790m
4716357|NCT03133533|robot-assisted|robot-assisted
4716358|NCT03133520|Respiratory failure|respiratory failure
4716359|NCT03133520|immuncompromise patients|immuncompromise patients
4716360|NCT03133520|high flow oxygen|high flow oxygen
4716361|NCT03133507|cancer|cancer
4716362|NCT03133507|salivary alpha amylase|salivary alpha amylase
4716363|NCT03133507|pain|pain
4716364|NCT03133507|positive affect|positive affect
4716365|NCT03133507|emotion regulation strategies|emotion regulation strategies
4716366|NCT03133481|Adductor Canal Block|adductor canal block
4716367|NCT03133481|Femoral Canal Block|femoral canal block
4716368|NCT03133468|AJM347|ajm347
4716369|NCT03133468|pharmacokinetics|pharmacokinetics
4716370|NCT03133468|food effect study|food effect study
4716371|NCT03133468|pharmacodynamics|pharmacodynamics
4716372|NCT03133455|Rumination|rumination
4716373|NCT03133429|carotid artery|carotid artery
4716374|NCT03133429|stroke|stroke
4716375|NCT03133429|stent|stent
4716376|NCT03133416|rotator cuff tendinopathy|rotator cuff tendinopathy
4716377|NCT03133416|rotator cuff tear|rotator cuff tear
4716378|NCT03133416|platelet-rich plasma|platelet-rich plasma
4716379|NCT03133416|physiotherapy|physiotherapy
4716380|NCT03133416|exercise|exercise
4716381|NCT03133377|Early activity and mobilization, rehabilitation, intensive care|early activity and mobilization, rehabilitation, intensive care
4716382|NCT03133325|Hyaluronic Acid, Lidocaine|hyaluronic acid, lidocaine
4716383|NCT03133286|Anal Cancer|anal cancer
4716384|NCT03133286|Bladder|bladder
4716385|NCT03133286|Cervical|cervical
4716386|NCT03133286|Colorectal|colorectal
4716387|NCT03133286|Esophageal|esophageal
4716388|NCT03133286|Gallbladder|gallbladder
4716389|NCT03133286|Liver|liver
4716390|NCT03133286|Ovarian|ovarian
4716391|NCT03133286|Pancreas|pancreas
4716392|NCT03133286|Pancreatic|pancreatic
4716393|NCT03133286|Prostate|prostate
4716394|NCT03133286|Rectal|rectal
4716395|NCT03133286|Renal|renal
4716396|NCT03133286|Kidney|kidney
4716397|NCT03133286|Stomach|stomach
4716398|NCT03133286|Testicular|testicular
4716399|NCT03133286|Uterine|uterine
4716400|NCT03133286|Cancer|cancer
4716401|NCT03133286|Radiation Therapy|radiation therapy
4716402|NCT03133286|Radiation Treatment|radiation treatment
4716403|NCT03133273|Colorectal Cancer Metastatic|colorectal cancer metastatic
4716404|NCT03133273|Chemosensitivity|chemosensitivity
4716405|NCT03133221|NHL|nhl
4716406|NCT03133221|indolent NHL|indolent nhl
4716407|NCT03133221|Zydelig|zydelig
4716408|NCT03133221|Idelalisib|idelalisib
4716409|NCT03133221|B-cell NHL|b-cell nhl
4716410|NCT03133221|Non-Hodgkin Lymphoma|non-hodgkin lymphoma
4716411|NCT03133221|Maintenance|maintenance
4716412|NCT03133221|Transformed B-cell Non-Hodgkin's lymphoma|transformed b-cell non-hodgkin's lymphoma
4716413|NCT03133221|Autologous Stem Cell Transplantation|autologous stem cell transplantation
4716415|NCT03133208|sepsis associated encephalopathy|sepsis associated encephalopathy
4716416|NCT03133208|sepsis associated delirium|sepsis associated delirium
4716417|NCT03133208|altered mental status|altered mental status
4716418|NCT03133195|Terriparatide, bone fracture healing, PFNA|terriparatide, bone fracture healing, pfna
4716419|NCT03133169|Thalassemia|thalassemia
4716420|NCT03133169|Glutamine/glutamate ratio|glutamine/glutamate ratio
4716421|NCT03133169|Pulmonary hypertension|pulmonary hypertension
4716422|NCT03133156|Exercise|exercise
4716423|NCT03133156|Training|training
4716424|NCT03133156|Type 2 Diabetes|type 2 diabetes
4716425|NCT03133156|Mellitus|mellitus
4716426|NCT03133143|Cognitive Function|cognitive function
4716427|NCT03133143|Schizophrenia and Disorders with Psychotic Features|schizophrenia and disorders with psychotic features
4716428|NCT03133143|Computers, Digital|computers, digital
4716429|NCT03133130|Scar|scar
4716430|NCT03133130|Scar prevention|scar prevention
4716431|NCT03133130|siRNA|sirna
4716432|NCT03133091|PIEB|pieb
4716433|NCT03133091|PCEA|pcea
4716434|NCT03133091|LEVOBUPIVACAINE|levobupivacaine
4716435|NCT03133078|Side Hop|side hop
4716436|NCT03133078|Forward Hop|forward hop
4716437|NCT03133078|Step test|step test
4716438|NCT03133078|Vertical Jump|vertical jump
4716439|NCT03133052|cognitive control training|cognitive control training
4716440|NCT03133052|aMCI|amci
4716441|NCT03133052|MRI|mri
4716442|NCT03133052|RCT|rct
4716443|NCT03133026|obstructive Jaundice|obstructive jaundice
4716444|NCT03133026|Self Expandable Metal Stents (SEMS)|self expandable metal stents (sems)
4716445|NCT03133026|Cholangitis|cholangitis
4716446|NCT03133000|Recurrent abdominal wall hernia|recurrent abdominal wall hernia
4716447|NCT03133000|Incisional hernia|incisional hernia
4716448|NCT03132987|quadriceps strength|quadriceps strength
4716449|NCT03132987|quadriceps voluntary activation|quadriceps voluntary activation
4716450|NCT03132987|progressive strength program|progressive strength program
4716451|NCT03132961|Vestibular evoked myogenic potentials|vestibular evoked myogenic potentials
4716452|NCT03132961|Electrocochleography|electrocochleography
4716453|NCT03132961|Infrasound|infrasound
4716454|NCT03132948|ALL Cancer Patients|all cancer patients
4716455|NCT03132948|Quality of Life|quality of life
4716456|NCT03132948|Fitness|fitness
4716457|NCT03132935|Non-STEMI Acute Coronary Syndrome|non-stemi acute coronary syndrome
4716458|NCT03132935|ST-segment elevation myocardial infarction|st-segment elevation myocardial infarction
4716459|NCT03132935|Telemedicine|telemedicine
4716460|NCT03132922|Cell Therapy|cell therapy
4716461|NCT03132922|T Cell Therapy|t cell therapy
4716462|NCT03132922|SPEAR T Cell|spear t cell
4716463|NCT03132922|MAGE-A4|mage-a4
4716464|NCT03132922|Immuno-oncology|immuno-oncology
4716465|NCT03132922|Metastatic|metastatic
4716466|NCT03132922|Urothelial Cancer|urothelial cancer
4716467|NCT03132922|Previously Treated|previously treated
4716468|NCT03132922|T Cell Receptor|t cell receptor
4716469|NCT03132922|Squamous, adenosquamous, or large cell NSCLC|squamous, adenosquamous, or large cell nsclc
4716470|NCT03132922|Squamous or adenocarcinoma esophageal cancer|squamous or adenocarcinoma esophageal cancer
4716471|NCT03132922|Sarcoma|sarcoma
4716472|NCT03132922|Melanoma|melanoma
4716473|NCT03132922|Bladder|bladder
4716474|NCT03132922|Ovarian|ovarian
4716475|NCT03132818|Procreation with donation|procreation with donation
4716476|NCT03132792|Alpha-fetoprotein|alpha-fetoprotein
4716477|NCT03132792|Cell Therapy|cell therapy
4716478|NCT03132792|T Cell Therapy|t cell therapy
4716479|NCT03132792|SPEAR T Cell|spear t cell
4716480|NCT03132792|Immuno-oncology|immuno-oncology
4716481|NCT03132792|Metastatic|metastatic
4716482|NCT03132792|Previously treated|previously treated
4716483|NCT03132792|T Cell Receptor|t cell receptor
4716484|NCT03132779|Intralipid|intralipid
4716485|NCT03132779|NK cells|nk cells
4716486|NCT03132779|Recurrent miscarriage|recurrent miscarriage
4716487|NCT03132740|Hepatic Carcinoma,Three-dimensional Visualization|hepatic carcinoma,three-dimensional visualization
4716488|NCT03132714|Full-mouth ultrasonic debridement|full-mouth ultrasonic debridement
4716489|NCT03132714|Clarithromycin|clarithromycin
4716490|NCT03132714|Amoxicillin|amoxicillin
4716491|NCT03132714|Metronidazole|metronidazole
4716492|NCT03132714|Antimicrobial therapy|antimicrobial therapy
4716493|NCT03132714|Photodynamic therapy|photodynamic therapy
4716494|NCT03132714|Low-level laser therapy|low-level laser therapy
4716495|NCT03132675|Melanoma|melanoma
4716496|NCT03132675|pIL-12|pil-12
4716497|NCT03132675|pembrolizumab|pembrolizumab
4716498|NCT03132675|tavokinogene telseplasmid|tavokinogene telseplasmid
4716499|NCT03132649|Three dimensional visualization|three dimensional visualization
4716500|NCT03132649|Operation strategy|operation strategy
4716501|NCT03132597|stress|stress
4716502|NCT03132597|anxiety|anxiety
4716503|NCT03132597|depression|depression
4716504|NCT03132597|quality of life|quality of life
4716505|NCT03132597|Mindfulness|mindfulness
4716506|NCT03132584|Non Hodgkin Lymphoma|non hodgkin lymphoma
4716507|NCT03132571|Schizophrenia|schizophrenia
4716508|NCT03132571|Diabetes|diabetes
4716509|NCT03132571|Obesity|obesity
4716510|NCT03132519|Cough|cough
4716511|NCT03132519|Hypertension|hypertension
4716512|NCT03132519|Remifentanil|remifentanil
4716513|NCT03132519|Sevoflurane|sevoflurane
4716515|NCT03132467|Breast Cancer|breast cancer
4716516|NCT03132467|Hormone Receptor Positive, HER2 Negative Breast Cancer|hormone receptor positive, her2 negative breast cancer
4716517|NCT03132467|Tremelimumab|tremelimumab
4716518|NCT03132467|Ticilimumab|ticilimumab
4716519|NCT03132467|CP-675,206|cp-675,206
4716520|NCT03132467|Durvalumab|durvalumab
4716521|NCT03132467|MEDI4736|medi4736
4716522|NCT03132454|Hematopoietic/Lymphoid Cancer|hematopoietic/lymphoid cancer
4716523|NCT03132454|Acute myeloid leukemia|acute myeloid leukemia
4716524|NCT03132454|AML|aml
4716525|NCT03132454|Acute lymphoblastic leukemia|acute lymphoblastic leukemia
4716526|NCT03132454|ALL|all
4716527|NCT03132454|Relapsed or refractory|relapsed or refractory
4716528|NCT03132454|R/R|r/r
4716529|NCT03132454|Palbociclib|palbociclib
4716530|NCT03132454|PD-0332991|pd-0332991
4716531|NCT03132454|Ibrance|ibrance
4716532|NCT03132454|Sorafenib|sorafenib
4716533|NCT03132454|Nexavar|nexavar
4716534|NCT03132454|BAY 43-9006|bay 43-9006
4716535|NCT03132454|Decitabine|decitabine
4716536|NCT03132454|Dacogen|dacogen
4716537|NCT03132454|Dexamethasone|dexamethasone
4716538|NCT03132454|Decadron|decadron
4716539|NCT03132441|advanced heart failure|advanced heart failure
4716540|NCT03132441|NYHA Class III-IV|nyha class iii-iv
4716541|NCT03132441|frailty|frailty
4716542|NCT03132441|cardiac rehabilitation|cardiac rehabilitation
4716543|NCT03132415|Prevention & Control|prevention & control
4716544|NCT03132415|Internet|internet
4716545|NCT03132415|Adolescents|adolescents
4716546|NCT03132415|Young adults|young adults
4716547|NCT03132402|Elisa|elisa
4716548|NCT03132402|Plasmodium Falciparum|plasmodium falciparum
4716549|NCT03132389|Sexual assault|sexual assault
4716550|NCT03132389|Sexually transmitted diseases|sexually transmitted diseases
4716551|NCT03132389|Chlamydia trachomatis|chlamydia trachomatis
4716552|NCT03132389|Mycoplasma genitalium|mycoplasma genitalium
4716553|NCT03132389|Neisseria gonorrhoeae|neisseria gonorrhoeae
4716554|NCT03132389|Hepatitis B and C|hepatitis b and c
4716555|NCT03132389|HIV|hiv
4716556|NCT03132389|Syphilis|syphilis
4716557|NCT03132389|Follow up visits after sexual assault|follow up visits after sexual assault
4716558|NCT03132324|Sickle cell disease (SCD)|sickle cell disease (scd)
4716559|NCT03132324|sickle cell SS|sickle cell ss
4716560|NCT03132324|lysine demethylase 1 (LSD1) inhibition|lysine demethylase 1 (lsd1) inhibition
4716561|NCT03132311|yellow fever vaccine|yellow fever vaccine
4716562|NCT03132311|hiv|hiv
4716563|NCT03132272|ADAsorb apheresis|adasorb apheresis
4716564|NCT03132272|Globaffin adsorber|globaffin adsorber
4716565|NCT03132272|Agonistic Autoantibodies|agonistic autoantibodies
4716566|NCT03132272|Immunoadsorption|immunoadsorption
4716567|NCT03132272|Alzheimer Dementia|alzheimer dementia
4716568|NCT03132259|Dexmedethomidine|dexmedethomidine
4716569|NCT03132246|Methicillin-resistant Staphylococcus aureus (MRSA)|methicillin-resistant staphylococcus aureus (mrsa)
4716570|NCT03132246|Infection|infection
4716571|NCT03132246|Biofilm Assay|biofilm assay
4716572|NCT03132233|Migraine|migraine
4716573|NCT03132233|Prevention|prevention
4716574|NCT03132233|Prophylaxis|prophylaxis
4716575|NCT03132233|Ketone bodies|ketone bodies
4716576|NCT03132233|Beta-hydroxybutyrate|beta-hydroxybutyrate
4716577|NCT03132233|Double-blind|double-blind
4716578|NCT03132233|Randomised|randomised
4716579|NCT03132233|Placebo controlled|placebo controlled
4716580|NCT03132233|Mitochondrial functioning|mitochondrial functioning
4716581|NCT03132233|Energy metabolism|energy metabolism
4716582|NCT03132233|Intervention|intervention
4716583|NCT03132233|Dietary Supplement|dietary supplement
4716584|NCT03132220|critical care nurses|critical care nurses
4716585|NCT03132220|mindfulness-based cognitive therapy|mindfulness-based cognitive therapy
4716586|NCT03132220|Burn-out Syndrome|burn-out syndrome
4716587|NCT03132220|Post-traumatic Stress Disorder|post-traumatic stress disorder
4716588|NCT03132220|Cognitive Behavioral Therapy|cognitive behavioral therapy
4716589|NCT03132207|Oral Health|oral health
4716590|NCT03132207|Pregnancy|pregnancy
4716591|NCT03132207|Prevention|prevention
4716592|NCT03132207|adverse pregnancy outcomes|adverse pregnancy outcomes
4716593|NCT03132181|Empagliflozin|empagliflozin
4716594|NCT03132181|Diabetes|diabetes
4716595|NCT03132181|Systemic vascular resistance|systemic vascular resistance
4716596|NCT03132181|Cardiac output|cardiac output
4716597|NCT03132181|Blood pressure|blood pressure
4716598|NCT03132168|cystectomy|cystectomy
4716599|NCT03132168|urology|urology
4716600|NCT03132168|surgery|surgery
4716601|NCT03132129|Type 2 diabetes|type 2 diabetes
4716602|NCT03132129|Diabetic cardiomyopathy|diabetic cardiomyopathy
4716603|NCT03132129|Cardiovascular magnetic resonance|cardiovascular magnetic resonance
4716604|NCT03132116|Cat Scratch Disease's lymphadenitis|cat scratch disease's lymphadenitis
4716605|NCT03132116|Infectious Diseases|infectious diseases
4716606|NCT03132103|Vitamin D deficiency|vitamin d deficiency
4716607|NCT03132103|Simulated sunlight radiation|simulated sunlight radiation
4716608|NCT03132103|Oral vitamin D3|oral vitamin d3
4716609|NCT03132051|carpal tunnel syndrome|carpal tunnel syndrome
4716610|NCT03132025|Metastatic Colorectal Cancer|metastatic colorectal cancer
4716611|NCT03132025|Apatinib|apatinib
4716612|NCT03132025|Capecitabine|capecitabine
4716613|NCT03131999|VEGF-D|vegf-d
4716614|NCT03131999|Imatinib mesylate|imatinib mesylate
4716615|NCT03131999|Sirolimus|sirolimus
4716616|NCT03131921|Energy expenditure|energy expenditure
4716617|NCT03131921|Nutrition|nutrition
4716618|NCT03131921|Colorectal cancer|colorectal cancer
4716619|NCT03131921|Dietary needs|dietary needs
4716620|NCT03131921|Breast cancer|breast cancer
4716621|NCT03131908|Melanoma and other malignant neoplasms of skin|melanoma and other malignant neoplasms of skin
4716622|NCT03131908|Metastatic Melanoma|metastatic melanoma
4716623|NCT03131908|GSK2633771|gsk2633771
4716624|NCT03131908|Pembrolizumab|pembrolizumab
4716625|NCT03131908|Keytruda|keytruda
4716626|NCT03131908|MK-3475|mk-3475
4716627|NCT03131908|SCH-900475|sch-900475
4716628|NCT03131895|Drug therapy|drug therapy
4716629|NCT03131882|trigger finger|trigger finger
4716630|NCT03131882|trigger thumb|trigger thumb
4716631|NCT03131882|ultrasound guided|ultrasound guided
4716632|NCT03131882|hyaluronic acid|hyaluronic acid
4716633|NCT03131856|Geriatrics|geriatrics
4716634|NCT03131856|Nutritional risk|nutritional risk
4716635|NCT03131856|Multi-disciplinary intervention|multi-disciplinary intervention
4716636|NCT03131856|Randomized Controlled Trial|randomized controlled trial
4716637|NCT03131843|skin infection|skin infection
4716638|NCT03131843|vaccination|vaccination
4716639|NCT03131843|children|children
4716640|NCT03131843|alcohol swab|alcohol swab
4716641|NCT03131843|skin preparation|skin preparation
4716642|NCT03131804|Aerobic|aerobic
4716643|NCT03131804|Intradialytic|intradialytic
4716644|NCT03131804|Cardio-metabolic markers|cardio-metabolic markers
4716645|NCT03131804|Dialysis Adequacy|dialysis adequacy
4716646|NCT03131804|Quality of Life|quality of life
4716647|NCT03131804|Cost Effectiveness|cost effectiveness
4716648|NCT03131791|Extracorporeal Shock Wave|extracorporeal shock wave
4716649|NCT03131791|Spasticity in stokes|spasticity in stokes
4716650|NCT03131791|Botulinum toxin|botulinum toxin
4716651|NCT03131752|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
4716652|NCT03131752|muscle strength|muscle strength
4716653|NCT03131752|physical activity|physical activity
4716654|NCT03131739|Resilience|resilience
4716655|NCT03131739|Alaska Native|alaska native
4716656|NCT03131739|Community Based Participatory Research|community based participatory research
4716657|NCT03131739|Culture and Community Factors|culture and community factors
4716658|NCT03131739|Protective Factors|protective factors
4716659|NCT03131739|Risk Factors|risk factors
4716660|NCT03131726|simvastatin|simvastatin
4716661|NCT03131726|diclofenac|diclofenac
4716662|NCT03131713|Mohs micrographic surgery|mohs micrographic surgery
4716663|NCT03131713|pain|pain
4716664|NCT03131713|functional status|functional status
4716665|NCT03131700|RPH101|rph101
4716666|NCT03131700|RPH-101|rph-101
4716667|NCT03131700|Biosimilar|biosimilar
4716668|NCT03131700|Bevacizumab|bevacizumab
4716669|NCT03131700|Safety|safety
4716670|NCT03131674|Somatic tinnitus|somatic tinnitus
4716671|NCT03131635|Developmental|developmental
4716672|NCT03131596|intrauterine balloon|intrauterine balloon
4716673|NCT03131596|hysteroscopy|hysteroscopy
4716674|NCT03131583|SHR4640 Febuxostat Colchicine pharmacodynamics|shr4640 febuxostat colchicine pharmacodynamics
4716675|NCT03131570|Psoriasis|psoriasis
4716676|NCT03131570|Chronic Plaque Psoriasis|chronic plaque psoriasis
4716677|NCT03131570|Secukinumab|secukinumab
4716678|NCT03131544|BPH|bph
4716679|NCT03131544|Benign Prostatic Hypertrophy|benign prostatic hypertrophy
4716680|NCT03131544|MRI|mri
4716681|NCT03131544|Prostate|prostate
4716682|NCT03131544|Lower Urinary Tract Symptoms|lower urinary tract symptoms
4716683|NCT03131544|Nocturia|nocturia
4716684|NCT03131544|Incomplete bladder emptying|incomplete bladder emptying
4716685|NCT03131479|renal function|renal function
4716686|NCT03131479|sodium-glucose co-transporter|sodium-glucose co-transporter
4716687|NCT03131479|pharmacokinetics|pharmacokinetics
4716688|NCT03131479|decreased renal function|decreased renal function
4716689|NCT03131479|decreased kidney function|decreased kidney function
4716690|NCT03131479|kidney disease|kidney disease
4716691|NCT03131479|urinary glucose excretion|urinary glucose excretion
4716692|NCT03131479|UGE|uge
4716693|NCT03131466|Trigeminal Neuralgia|trigeminal neuralgia
4716694|NCT03131466|Pulsed Radiofrequency|pulsed radiofrequency
4716695|NCT03131466|Gasserian Ganglion|gasserian ganglion
4716696|NCT03131453|Placebo controlled,|placebo controlled,
4716697|NCT03131453|APOE4 carriers,|apoe4 carriers,
4716698|NCT03131453|Homozygotes,|homozygotes,
4716699|NCT03131453|Heterozygotes,|heterozygotes,
4716700|NCT03131453|Brain Amyloid,|brain amyloid,
4716701|NCT03131453|Preclinical Alzheimer's Disease (AD),|preclinical alzheimer's disease (ad),
4716702|NCT03131453|Aβ lowering,|aβ lowering,
4716703|NCT03131453|BACE-1 inhibitor|bace-1 inhibitor
4716704|NCT03131427|Wilson's Disease|wilson's disease
4716705|NCT03131427|Hereditary Hemochromatosis|hereditary hemochromatosis
4716706|NCT03131427|Hereditary Hyperbilirubinemias|hereditary hyperbilirubinemias
4716707|NCT03131427|Inherited Cholestatic Liver Disease|inherited cholestatic liver disease
4716708|NCT03131427|Genetic Testing|genetic testing
4716709|NCT03131375|dexmedetomidine|dexmedetomidine
4716710|NCT03131375|emergence delirium|emergence delirium
4716711|NCT03131375|anesthesia|anesthesia
4716712|NCT03131375|propofol|propofol
4716715|NCT03131323|delineate the prevalence of abnormal nasal finding in wheezy child|delineate the prevalence of abnormal nasal finding in wheezy child
4716716|NCT03131297|anal fistulas|anal fistulas
4716717|NCT03131297|evaluation of radiofrequency|evaluation of radiofrequency
4716718|NCT03131271|Percutaneous coronary intervention|percutaneous coronary intervention
4716719|NCT03131271|Femoral arterial catheter|femoral arterial catheter
4716720|NCT03131271|Pain|pain
4716721|NCT03131271|Cold application|cold application
4716722|NCT03131271|Nursing|nursing
4716723|NCT03131206|Non-small cell lung cancer|non-small cell lung cancer
4716724|NCT03131206|NSCLC|nsclc
4716725|NCT03131206|ALK|alk
4716726|NCT03131206|RET|ret
4716727|NCT03131206|alectinib|alectinib
4716728|NCT03131206|Thyroid cancer|thyroid cancer
4716729|NCT03131128|Mindfulness-based intervention|mindfulness-based intervention
4716730|NCT03131128|Weight loss|weight loss
4716731|NCT03131128|Workplace health promotion|workplace health promotion
4716732|NCT03131128|Obesity|obesity
4716733|NCT03131063|Extracorporeal Membrane Oxygenation|extracorporeal membrane oxygenation
4716734|NCT03131063|Sepsis|sepsis
4716735|NCT03131063|Antibiotics|antibiotics
4716736|NCT03131063|Pharmacokinetic|pharmacokinetic
4716737|NCT03131063|Intensive Care Unit|intensive care unit
4716738|NCT03131050|Scopolamine|scopolamine
4716739|NCT03131037|immunotherapy|immunotherapy
4716740|NCT03131037|immuno-oncology|immuno-oncology
4716741|NCT03131037|tumor vaccine|tumor vaccine
4716742|NCT03131024|anthracyclines|anthracyclines
4716743|NCT03130998|smoking cessation|smoking cessation
4716744|NCT03130998|depression|depression
4716745|NCT03130998|mental health|mental health
4716746|NCT03130998|mood management|mood management
4716747|NCT03130998|primary care|primary care
4716748|NCT03130998|screening|screening
4716749|NCT03130998|brief intervention|brief intervention
4716750|NCT03130998|referral to treatment|referral to treatment
4716751|NCT03130985|microRNA|microrna
4716752|NCT03130985|biomarker|biomarker
4716753|NCT03130946|breast neoplasms|breast neoplasms
4716754|NCT03130946|Ultrasonography, Interventional|ultrasonography, interventional
4716755|NCT03130946|Biopsy, Large-Core Needle|biopsy, large-core needle
4716756|NCT03130946|Biopsy, Fine-Needle|biopsy, fine-needle
4716757|NCT03130933|third molar|third molar
4716758|NCT03130933|oral surgical procedures|oral surgical procedures
4716759|NCT03130933|antibiotic prophylaxis|antibiotic prophylaxis
4716760|NCT03130933|placebo effect|placebo effect
4716761|NCT03130920|preconditioning, resection|preconditioning, resection
4716762|NCT03130894|trimethylamine-N-oxide|trimethylamine-n-oxide
4716763|NCT03130894|type2 Diabetes|type2 diabetes
4716764|NCT03130894|enzyme flavin monooxygenase 3 polymorphisms|enzyme flavin monooxygenase 3 polymorphisms
4716765|NCT03130855|pediatric patients|pediatric patients
4716766|NCT03130855|articaine local anesthesia|articaine local anesthesia
4716767|NCT03130829|NSCLC|nsclc
4716768|NCT03130829|QoL|qol
4716769|NCT03130829|Fucoidan|fucoidan
4716770|NCT03130816|Umbilical cord blood transplantation|umbilical cord blood transplantation
4716771|NCT03130816|Cytokine changes|cytokine changes
4716772|NCT03130764|Non-small Cell Lung Cancer|non-small cell lung cancer
4716773|NCT03130712|immunotherapy|immunotherapy
4716774|NCT03130712|GPC3-CART|gpc3-cart
4716775|NCT03130712|HCC|hcc
4716776|NCT03130699|Diabetes|diabetes
4716777|NCT03130699|mHealth|mhealth
4716778|NCT03130699|Medical Assistant|medical assistant
4716779|NCT03130699|Automated|automated
4716780|NCT03130699|Adaptive Feedback|adaptive feedback
4716781|NCT03130699|Self-Management Support|self-management support
4716782|NCT03130699|Hispanics|hispanics
4716783|NCT03130699|HbA1c|hba1c
4716784|NCT03130699|Cyberinfrastructure|cyberinfrastructure
4716785|NCT03130699|Federally-Qualified Health Centers|federally-qualified health centers
4716786|NCT03130699|Cost-Effectiveness|cost-effectiveness
4716787|NCT03130699|T2DM|t2dm
4716788|NCT03130699|Pay-for-Performance|pay-for-performance
4716789|NCT03130699|Medication Adherence|medication adherence
4716790|NCT03130699|LDL-C|ldl-c
4716791|NCT03130699|Systolic Blood Pressure|systolic blood pressure
4716792|NCT03130699|Text Messaging|text messaging
4716793|NCT03130673|hip fracture|hip fracture
4716794|NCT03130673|trochanteric fracure|trochanteric fracure
4716795|NCT03130673|subtrocantheric fracture|subtrocantheric fracture
4716796|NCT03130673|femoral head fracture|femoral head fracture
4716797|NCT03130673|epidemiology|epidemiology
4716798|NCT03130660|central line|central line
4716799|NCT03130660|Central Line Complication|central line complication
4716800|NCT03130634|CPT-11(irinotecan)|cpt-11(irinotecan)
4716801|NCT03130634|silymarin|silymarin
4716802|NCT03130634|GI toxicity|gi toxicity
4716803|NCT03130608|liver disease|liver disease
4716804|NCT03130608|transplant|transplant
4716805|NCT03130608|muscle wasting|muscle wasting
4716806|NCT03130608|breathing exercise|breathing exercise
4716807|NCT03130595|accelerometry|accelerometry
4716808|NCT03130595|Parkinson Kinetigraph|parkinson kinetigraph
4716809|NCT03130582|high-dose etoposide,autologous peripheral blood stem cell transplantation|high-dose etoposide,autologous peripheral blood stem cell transplantation
4716810|NCT03130569|Risk Assessment|risk assessment
4716811|NCT03130569|Personal Genomic Testing|personal genomic testing
4716812|NCT03130569|Skin Cancer|skin cancer
4716813|NCT03130569|Primary Care|primary care
4716814|NCT03130556|Glasdegib|glasdegib
4716815|NCT03130556|PF-04449913|pf-04449913
4716816|NCT03130556|Pharmacokinetics|pharmacokinetics
4716817|NCT03130556|Bioavailability|bioavailability
4716818|NCT03130543|Brief resolved unexplained event|brief resolved unexplained event
4716819|NCT03130530|robotic|robotic
4716820|NCT03130530|colorectal|colorectal
4716821|NCT03130530|surgery|surgery
4716822|NCT03130517|hemolysis,newborn|hemolysis,newborn
4716823|NCT03130478|long-acting injectable antipsychotic|long-acting injectable antipsychotic
4716824|NCT03130478|persistence|persistence
4716825|NCT03130465|adherence|adherence
4716826|NCT03130465|long-acting injectable antipsychotic|long-acting injectable antipsychotic
4716827|NCT03130465|all-cause treatment discontinuation|all-cause treatment discontinuation
4716828|NCT03130465|recent-onset schizophrenia|recent-onset schizophrenia
4716829|NCT03130465|daily oral atypical antipsychotic|daily oral atypical antipsychotic
4716830|NCT03130439|Breast Cancer|breast cancer
4716831|NCT03130426|Diabetes|diabetes
4716832|NCT03130426|iGlarLixi|iglarlixi
4716833|NCT03130426|Metformin|metformin
4716834|NCT03130426|Insulin|insulin
4716835|NCT03130426|Diet|diet
4716836|NCT03130426|Exercise|exercise
4716837|NCT03130426|Lifestyle|lifestyle
4716838|NCT03130413|Ambu Aura Gain|ambu aura gain
4716839|NCT03130413|Air-Q intubating laryngeal airway|air-q intubating laryngeal airway
4716840|NCT03130413|Paediatric surgery|paediatric surgery
4716841|NCT03130400|Knee|knee
4716842|NCT03130400|Gait|gait
4716843|NCT03130400|Injuries|injuries
4716844|NCT03130400|Arthritis|arthritis
4716845|NCT03130387|Hytsteroscopy|hytsteroscopy
4716846|NCT03130374|mesenchymal stem cells|mesenchymal stem cells
4716847|NCT03130374|Tracheal Stenosis|tracheal stenosis
4716848|NCT03130374|Laryngeal Stenosis|laryngeal stenosis
4716849|NCT03130374|cell therapy|cell therapy
4716850|NCT03130309|Knee|knee
4716851|NCT03130309|Replacement|replacement
4716852|NCT03130309|Mobile-bearing|mobile-bearing
4716853|NCT03130309|unicompartmental prosthesis|unicompartmental prosthesis
4716854|NCT03130296|HIV infection|hiv infection
4716855|NCT03130296|Fc receptor polymorphism (FcR)|fc receptor polymorphism (fcr)
4716856|NCT03130283|Acute patients|acute patients
4716857|NCT03130283|Exacerbated chronic patients|exacerbated chronic patients
4716858|NCT03130270|nasopharyngeal carcinoma|nasopharyngeal carcinoma
4716859|NCT03130270|disease-free survival|disease-free survival
4716860|NCT03130270|adverse reaction|adverse reaction
4716861|NCT03130257|blood pressure measurement|blood pressure measurement
4716862|NCT03130231|Delirium β2-microspheres|delirium β2-microspheres
4716863|NCT03130179|Bioequivalence|bioequivalence
4716864|NCT03130166|Postoperative pain|postoperative pain
4716865|NCT03130166|Postoperative recovery|postoperative recovery
4716866|NCT03130166|Intracorporeal anastomosis|intracorporeal anastomosis
4716867|NCT03130166|Robotic right colectomy|robotic right colectomy
4716868|NCT03130114|Mortality|mortality
4716869|NCT03130114|Infant|infant
4716870|NCT03130114|Antibiotics|antibiotics
4716871|NCT03130114|Linear Growth|linear growth
4716872|NCT03130101|Type 1 Diabetes|type 1 diabetes
4716873|NCT03130101|Exercise|exercise
4716874|NCT03130101|Basal insulin|basal insulin
4716875|NCT03130101|CSII|csii
4716876|NCT03130101|OmniPod|omnipod
4716877|NCT03130101|CGM|cgm
4716878|NCT03130088|Out-Of-Hospital Cardiac Arrest|out-of-hospital cardiac arrest
4716879|NCT03130088|Resuscitation Registry|resuscitation registry
4716880|NCT03130088|EuReCa TWO|eureca two
4716881|NCT03130062|Resistance Exercise|resistance exercise
4716882|NCT03130062|Functional Fitness|functional fitness
4716883|NCT03130062|Actigraphy|actigraphy
4716884|NCT03130062|Primary Sjögren Syndrome|primary sjögren syndrome
4716885|NCT03130049|Peripheral nerve block|peripheral nerve block
4716886|NCT03130049|Ultrasound|ultrasound
4716887|NCT03130036|Memory|memory
4716888|NCT03130036|Cognitive|cognitive
4716889|NCT03129984|mandibular movements|mandibular movements
4716890|NCT03129958|NECK PAIN, OFFICE WORKERS|neck pain, office workers
4716891|NCT03129945|Obstetric Labor, Premature|obstetric labor, premature
4716892|NCT03129945|Tocolytic Agents|tocolytic agents
4716893|NCT03129932|gluten|gluten
4716894|NCT03129932|adipokine|adipokine
4716895|NCT03129932|obesity|obesity
4716896|NCT03129932|diet|diet
4716897|NCT03129906|Fibromyalgia; non-celiac gluten sensitivity|fibromyalgia; non-celiac gluten sensitivity
4716898|NCT03129880|Voice disorder|voice disorder
4716899|NCT03129880|Hoarseness|hoarseness
4716900|NCT03129880|Phonation Disorders|phonation disorders
4716901|NCT03129880|Speech Disorders|speech disorders
4716902|NCT03129854|prostate cancer|prostate cancer
4716903|NCT03129854|metastatic|metastatic
4716904|NCT03129854|cryotherapy|cryotherapy
4716905|NCT03129854|ADT|adt
4716906|NCT03129841|weight loss|weight loss
4716907|NCT03129841|dietary pattern|dietary pattern
4716908|NCT03129841|late dinner|late dinner
4716909|NCT03129841|early dinner|early dinner
4716910|NCT03129828|Diffuse Large B Cell Lymphoma|diffuse large b cell lymphoma
4716911|NCT03129828|Ibrutinib|ibrutinib
4716912|NCT03129828|Bortezomib|bortezomib
4716913|NCT03129815|extubation|extubation
4716914|NCT03129815|pediatric resuscitation|pediatric resuscitation
4716915|NCT03129815|reintubation|reintubation
4716916|NCT03129815|failures of extubation.|failures of extubation.
4716917|NCT03129802|extubation|extubation
4716918|NCT03129802|pediatric resuscitation|pediatric resuscitation
4716919|NCT03129802|reintubation|reintubation
4716920|NCT03129802|failures of extubation.|failures of extubation.
4716921|NCT03129802|Respiratory Insufficiency|respiratory insufficiency
4716922|NCT03129763|SPY-ICG Angiography|spy-icg angiography
4716923|NCT03129763|Tissue Expander|tissue expander
4716924|NCT03129763|Capsule Pressure|capsule pressure
4716925|NCT03129763|Blood Supply|blood supply
4716926|NCT03129724|Kidney Neoplasms|kidney neoplasms
4716927|NCT03129724|Kidney|kidney
4716928|NCT03129724|Neoplasms|neoplasms
4716929|NCT03129724|TKI|tki
4716930|NCT03129724|Axitinib|axitinib
4716931|NCT03129724|VEGF|vegf
4716932|NCT03129724|mTORi|mtori
4716933|NCT03129685|Hepatocellular carcinoma|hepatocellular carcinoma
4716934|NCT03129685|Devascularization|devascularization
4716935|NCT03129672|allograft|allograft
4716936|NCT03129672|distal tibia sarcoma|distal tibia sarcoma
4716937|NCT03129659|Coronary CT Angiography|coronary ct angiography
4716938|NCT03129659|High-sensitivity Troponin|high-sensitivity troponin
4716939|NCT03129659|Diagnosis|diagnosis
4716940|NCT03129620|Ampicillin|ampicillin
4716941|NCT03129607|POPF|popf
4716942|NCT03129607|Classification system|classification system
4716943|NCT03129581|obesity, diet, sleep activity|obesity, diet, sleep activity
4716944|NCT03129555|Non-vitamin K antagonist oral anticoagulation|non-vitamin k antagonist oral anticoagulation
4716945|NCT03129555|Non-vitamin K Antagonist Oral Anticoagulants|non-vitamin k antagonist oral anticoagulants
4716946|NCT03129555|Direct-acting Oral Anticoagulants|direct-acting oral anticoagulants
4716947|NCT03129555|Novel oral anticoagulant drugs|novel oral anticoagulant drugs
4716948|NCT03129516|imaginary|imaginary
4716949|NCT03129516|Turkish version|turkish version
4716950|NCT03129516|motor imagery|motor imagery
4716951|NCT03129516|reliability|reliability
4716952|NCT03129503|Optical coherence tomography (OCT)|optical coherence tomography (oct)
4716953|NCT03129490|Atrial Fibrillation|atrial fibrillation
4716954|NCT03129490|Non-vitamin K antagonist oral anticoagulation|non-vitamin k antagonist oral anticoagulation
4716955|NCT03129490|Direct-acting oral anticoagulants|direct-acting oral anticoagulants
4716956|NCT03129490|Novel oral anticoagulant drugs|novel oral anticoagulant drugs
4716957|NCT03129490|Non-vitamin K antagonist oral anticoagulants|non-vitamin k antagonist oral anticoagulants
4716958|NCT03129477|Non invasive ventilation in COPD|non invasive ventilation in copd
4716959|NCT03129477|Noninvasive ventilation|noninvasive ventilation
4716960|NCT03129477|Tele-monitoring|tele-monitoring
4716961|NCT03129438|continuous EEG|continuous eeg
4716962|NCT03129438|routine EEG|routine eeg
4716963|NCT03129438|prognosis|prognosis
4716964|NCT03129425|Patient|patient
4716965|NCT03129425|Caregiver|caregiver
4716966|NCT03129425|Coping|coping
4716967|NCT03129425|Psychosocial adaptation|psychosocial adaptation
4716968|NCT03129399|anesthesia|anesthesia
4716969|NCT03129399|King Vision|king vision
4716970|NCT03129399|videolaryngoscope|videolaryngoscope
4716971|NCT03129399|nasotracheal|nasotracheal
4716972|NCT03129360|Early Psychosis|early psychosis
4716973|NCT03129360|Levetiracetam|levetiracetam
4716974|NCT03129308|HIV|hiv
4716975|NCT03129308|Cutaneous Autoantibodies|cutaneous autoantibodies
4716976|NCT03129308|Indirect Immunofluorescence|indirect immunofluorescence
4716977|NCT03129269|Cognitive decline|cognitive decline
4716978|NCT03129269|frailty|frailty
4716979|NCT03129269|mild cognitive impairment|mild cognitive impairment
4716980|NCT03129269|Positron Emission Tomography, PET|positron emission tomography, pet
4716981|NCT03129269|Alzheimer disease|alzheimer disease
4716982|NCT03129269|amyloid load|amyloid load
4716983|NCT03129269|Magnetic resonance imaging, MRI|magnetic resonance imaging, mri
4716984|NCT03129256|non-small cell lung cancer|non-small cell lung cancer
4716985|NCT03129256|Apatinib|apatinib
4716986|NCT03129256|S1|s1
4716987|NCT03129217|Diaphragm function|diaphragm function
4716988|NCT03129217|Acute respiratory failure|acute respiratory failure
4716989|NCT03129217|Weaning|weaning
4716990|NCT03129204|intensive care unit|intensive care unit
4716991|NCT03129204|critical care|critical care
4716992|NCT03129204|family|family
4716993|NCT03129204|caregiver|caregiver
4716994|NCT03129204|actigraphy|actigraphy
4716995|NCT03129178|Nitrate|nitrate
4716996|NCT03129178|Nitric oxide|nitric oxide
4716997|NCT03129178|Microvascular|microvascular
4716998|NCT03129165|Cardiovascular diseases|cardiovascular diseases
4716999|NCT03129165|Public Health|public health
4717000|NCT03129165|Hypertension|hypertension
4717001|NCT03129165|Smoking|smoking
4717002|NCT03129165|Hypercholesterolemia|hypercholesterolemia
4717003|NCT03129165|Food Habits|food habits
4717004|NCT03129165|Exercise|exercise
4717005|NCT03129165|Anxiety|anxiety
4717006|NCT03129165|Depression|depression
4717007|NCT03129165|Obesity|obesity
4717008|NCT03129165|Diabetes|diabetes
4717009|NCT03129139|Metastatic|metastatic
4717010|NCT03128996|Bone marrow transplant|bone marrow transplant
4717011|NCT03128996|Transplant|transplant
4717012|NCT03128996|Transplantation|transplantation
4717013|NCT03128996|Reduced Intensity|reduced intensity
4717014|NCT03128996|Familial HLA mismatched|familial hla mismatched
4717015|NCT03128905|Colchicine|colchicine
4717016|NCT03128905|Corticoids|corticoids
4717017|NCT03128905|Prednisone|prednisone
4717018|NCT03128905|CPPD|cppd
4717019|NCT03128905|Calcium Pyrophosphate Deposition Disease|calcium pyrophosphate deposition disease
4717020|NCT03128879|Primary lymphoid haematopoietic neoplasms|primary lymphoid haematopoietic neoplasms
4717021|NCT03128879|Chronic lymphocytic leukemia|chronic lymphocytic leukemia
4717022|NCT03128879|CLL|cll
4717023|NCT03128879|Small lymphocytic lymphoma|small lymphocytic lymphoma
4717024|NCT03128879|SLL|sll
4717025|NCT03128879|High risk|high risk
4717026|NCT03128879|Venetoclax|venetoclax
4717027|NCT03128879|ABT-199|abt-199
4717028|NCT03128879|GDC-0199|gdc-0199
4717029|NCT03128879|Ibrutinib|ibrutinib
4717030|NCT03128879|PCI-32765|pci-32765
4717031|NCT03128879|Imbruvica|imbruvica
4717032|NCT03128879|Allopurinol|allopurinol
4717033|NCT03128879|Lopurin|lopurin
4717034|NCT03128879|Zurinol|zurinol
4717035|NCT03128879|Zyloprim|zyloprim
4717036|NCT03128866|Malignant neoplasms of bone and articular cartilage|malignant neoplasms of bone and articular cartilage
4717037|NCT03128866|Pelvic Tumor|pelvic tumor
4717038|NCT03128866|Tranexamic acid|tranexamic acid
4717039|NCT03128814|Tennis|tennis
4717040|NCT03128814|Asymmetry|asymmetry
4717041|NCT03128814|Structural|structural
4717042|NCT03128814|Functional|functional
4717043|NCT03128801|Low Back Pain|low back pain
4717044|NCT03128801|Back Pain|back pain
4717045|NCT03128801|Muscle Stretching Exercises|muscle stretching exercises
4717046|NCT03128801|Stabilization Exercise|stabilization exercise
4717047|NCT03128801|Exercise Therapy|exercise therapy
4717048|NCT03128801|Exercise Movement|exercise movement
4717049|NCT03128801|Exercise Movement Tecniques|exercise movement tecniques
4717050|NCT03128801|Pain|pain
4717051|NCT03128801|Disability|disability
4717052|NCT03128788|epidurography epidural pressure patient posture|epidurography epidural pressure patient posture
4717053|NCT03128749|Obsessive-Compulsive Disorder|obsessive-compulsive disorder
4717054|NCT03128749|Mindfulness Based Intervention|mindfulness based intervention
4717055|NCT03128749|Cognitive-Behavioral Therapy|cognitive-behavioral therapy
4717056|NCT03128749|Functional Magnetic Resonance Imaging|functional magnetic resonance imaging
4717057|NCT03128749|Neuropsychology|neuropsychology
4717058|NCT03128749|Childhood Maltreatment|childhood maltreatment
4717059|NCT03128723|Acne|acne
4717060|NCT03128710|Survey|survey
4717061|NCT03128710|Focus Group|focus group
4717062|NCT03128710|Treatment Preferences|treatment preferences
4717063|NCT03128697|Obesity|obesity
4717064|NCT03128697|Satiety quotient|satiety quotient
4717065|NCT03128697|Appetite control|appetite control
4717066|NCT03128697|Weight loss|weight loss
4717067|NCT03128697|Satiety phenotype|satiety phenotype
4717068|NCT03128697|Functional food|functional food
4717069|NCT03128684|lentils|lentils
4717070|NCT03128684|satiety|satiety
4717071|NCT03128684|appetite|appetite
4717072|NCT03128684|food intake|food intake
4717073|NCT03128684|24-hour energy intake|24-hour energy intake
4717074|NCT03128671|intensive care unit|intensive care unit
4717075|NCT03128671|critical care|critical care
4717076|NCT03128671|mechanical ventilation|mechanical ventilation
4717077|NCT03128671|confusion|confusion
4717078|NCT03128671|polysomnography|polysomnography
4717079|NCT03128671|delirium|delirium
4717080|NCT03128671|adult|adult
4717081|NCT03128658|Trauma induced coagulopathy|trauma induced coagulopathy
4717082|NCT03128554|Not Ready to Quit|not ready to quit
4717083|NCT03128554|Primary Care|primary care
4717084|NCT03128554|Tobacco|tobacco
4717085|NCT03128554|Reduce to Quit|reduce to quit
4717086|NCT03128554|Smoking Reduction|smoking reduction
4717087|NCT03128528|SGLT-2 inhibitor, Chronic heart failure, tissue sodium,|sglt-2 inhibitor, chronic heart failure, tissue sodium,
4717088|NCT03128515|Hydroxyurea|hydroxyurea
4717089|NCT03128502|saliva|saliva
4717091|NCT03128502|pentraxin-3|pentraxin-3
4717092|NCT03128489|Safety|safety
4717093|NCT03128489|Infanrix™-IPV/Hib|infanrix™-ipv/hib
4717094|NCT03128489|Immunogenicity|immunogenicity
4717095|NCT03128489|Indian infants|indian infants
4717096|NCT03128489|Combined vaccine|combined vaccine
4717097|NCT03128463|Age-Related Macular Degeneration|age-related macular degeneration
4717098|NCT03128463|Polypoidal Choroidal Vasculopathy|polypoidal choroidal vasculopathy
4717099|NCT03128463|Pathological Myopia|pathological myopia
4717100|NCT03128463|Conbercept|conbercept
4717101|NCT03128450|Parkinson Disease|parkinson disease
4717102|NCT03128450|Neural stem cell|neural stem cell
4717103|NCT03128450|Nasal delivery|nasal delivery
4717104|NCT03128437|Anxiety|anxiety
4717105|NCT03128437|Young Adults|young adults
4717106|NCT03128437|Health Behaviors|health behaviors
4717107|NCT03128411|Leukemia, Chronic Myelogenous|leukemia, chronic myelogenous
4717108|NCT03128398|Gastroparesis|gastroparesis
4717109|NCT03128385|Upper limb neurorehabilitation|upper limb neurorehabilitation
4717110|NCT03128385|Neurological rehabilitation|neurological rehabilitation
4717111|NCT03128385|Upper extremity|upper extremity
4717112|NCT03128281|Malignant Neoplasms of Female Genital Organs|malignant neoplasms of female genital organs
4717113|NCT03128281|Laparoscopic gynecologic surgery|laparoscopic gynecologic surgery
4717213|NCT03127800|Hypoxaemia|hypoxaemia
4717114|NCT03128281|Robotic gynecologic surgery|robotic gynecologic surgery
4717115|NCT03128281|AirSeal® Insufflation System|airseal® insufflation system
4717116|NCT03128281|AIS|ais
4717117|NCT03128281|Conventional Insufflation System|conventional insufflation system
4717118|NCT03128281|CIS|cis
4717119|NCT03128281|Questionnaires|questionnaires
4717120|NCT03128281|Surveys|surveys
4717121|NCT03128255|Fusion|fusion
4717122|NCT03128255|Hybrid Imaging|hybrid imaging
4717123|NCT03128255|Mapping|mapping
4717124|NCT03128255|Iodine|iodine
4717125|NCT03128255|Ultrasound|ultrasound
4717126|NCT03128242|oxytocin|oxytocin
4717127|NCT03128242|attention bias|attention bias
4717128|NCT03128242|attention training|attention training
4717129|NCT03128242|eye-tracking|eye-tracking
4717130|NCT03128203|Oxytocin|oxytocin
4717131|NCT03128203|Resting-state|resting-state
4717132|NCT03128203|Functional connectivity|functional connectivity
4717133|NCT03128203|BOLD|bold
4717134|NCT03128190|high-risk surgery|high-risk surgery
4717135|NCT03128190|pulse-pressure variation|pulse-pressure variation
4717136|NCT03128190|monitoring|monitoring
4717137|NCT03128190|Postoperative Complications|postoperative complications
4717138|NCT03128177|nocturnal hypertension|nocturnal hypertension
4717139|NCT03128177|non-dipping blood pressure|non-dipping blood pressure
4717140|NCT03128177|obstructive sleep apnea|obstructive sleep apnea
4717141|NCT03128151|NMB (Neuromuscular Blockade)|nmb (neuromuscular blockade)
4717142|NCT03128151|Anesthesia|anesthesia
4717143|NCT03128151|Curarization|curarization
4717144|NCT03128151|TOFr (train of four)|tofr (train of four)
4717145|NCT03128151|PACU (postanesthesia care unit)|pacu (postanesthesia care unit)
4717146|NCT03128151|Monitorization|monitorization
4717147|NCT03128112|Parental perception, obesity, overweight|parental perception, obesity, overweight
4717148|NCT03128099|Social Skills|social skills
4717149|NCT03128099|Social attention|social attention
4717150|NCT03128099|Virtual reality|virtual reality
4717151|NCT03128099|Eye tracking|eye tracking
4717152|NCT03128073|Heart failure, Cardio-Renal Syndrome|heart failure, cardio-renal syndrome
4717153|NCT03128047|pediatric cancer|pediatric cancer
4717154|NCT03128047|brain tumor|brain tumor
4717155|NCT03128047|glioblastoma|glioblastoma
4717156|NCT03128047|high grade brain tumor|high grade brain tumor
4717157|NCT03128047|malignant brain tumor|malignant brain tumor
4717158|NCT03128021|Depression|depression
4717159|NCT03128021|fMRI|fmri
4717160|NCT03128021|Escitalopram|escitalopram
4717161|NCT03128021|Lexapro|lexapro
4717162|NCT03128021|Randomized Clinical Trial|randomized clinical trial
4717163|NCT03128021|Levomilnacipran|levomilnacipran
4717164|NCT03128021|Fetzima|fetzima
4717165|NCT03127995|Breast Cancer pT1-3, pN0-N3, M0|breast cancer pt1-3, pn0-n3, m0
4717166|NCT03127995|Lymph Node Irradiation|lymph node irradiation
4717167|NCT03127982|Anxiety Depression Emotion PTSD Randomized Clinical Trial|anxiety depression emotion ptsd randomized clinical trial
4717168|NCT03127969|Rheumatoid hand|rheumatoid hand
4717169|NCT03127969|Fluidotherapy|fluidotherapy
4717170|NCT03127969|Rehabilitation|rehabilitation
4717171|NCT03127943|lidocaine, mandible|lidocaine, mandible
4717172|NCT03127930|Cognitive Impairment|cognitive impairment
4717173|NCT03127930|Memory loss|memory loss
4717174|NCT03127930|Caregivers|caregivers
4717175|NCT03127930|Medication adherence|medication adherence
4717176|NCT03127930|Medication compliance|medication compliance
4717177|NCT03127930|Medication management|medication management
4717178|NCT03127930|Problem solving|problem solving
4717179|NCT03127930|Quality of Life|quality of life
4717180|NCT03127930|Health resource utilization|health resource utilization
4717181|NCT03127930|Community dwelling|community dwelling
4717182|NCT03127917|Gait Speed|gait speed
4717183|NCT03127917|Cognitive Function|cognitive function
4717184|NCT03127904|Varicose ulcer|varicose ulcer
4717185|NCT03127904|Compressive therapy|compressive therapy
4717186|NCT03127904|Venous ulcer|venous ulcer
4717187|NCT03127904|Chronic venous disease|chronic venous disease
4717188|NCT03127891|pranayama yoga|pranayama yoga
4717189|NCT03127878|Exercise|exercise
4717190|NCT03127878|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
4717191|NCT03127878|Activities of Daily Living|activities of daily living
4717192|NCT03127878|Upper Extremity|upper extremity
4717193|NCT03127878|Motor Activity|motor activity
4717194|NCT03127839|Exercise|exercise
4717195|NCT03127839|Pain Neuroscience Education|pain neuroscience education
4717196|NCT03127839|Physical Therapy|physical therapy
4717197|NCT03127839|Subacromial Pain|subacromial pain
4717198|NCT03127839|Rotator Cuff|rotator cuff
4717199|NCT03127826|Low Back Pain|low back pain
4717200|NCT03127826|Risk-Stratified Care|risk-stratified care
4717201|NCT03127813|glaucoma|glaucoma
4717202|NCT03127813|OSA|osa
4717203|NCT03127813|apnoea|apnoea
4717204|NCT03127813|intraocular|intraocular
4717205|NCT03127813|CPAP|cpap
4717206|NCT03127813|airway|airway
4717207|NCT03127813|pressure|pressure
4717208|NCT03127813|blindness|blindness
4717209|NCT03127800|Obstructive Sleep Apnoea|obstructive sleep apnoea
4717210|NCT03127800|Morphine sulphate|morphine sulphate
4717211|NCT03127800|Sleep Disordered Breathing|sleep disordered breathing
4717212|NCT03127800|Central Sleep Apnoea|central sleep apnoea
4717214|NCT03127800|Hypercapnia|hypercapnia
4717215|NCT03127800|Cheyne-Stokes Respiration|cheyne-stokes respiration
4717216|NCT03127800|Analgesia|analgesia
4717217|NCT03127800|Respiration|respiration
4717218|NCT03127800|Apnoea-Hypopnea Index|apnoea-hypopnea index
4717219|NCT03127800|Oxygen Desaturation Index|oxygen desaturation index
4717220|NCT03127800|Oximetry|oximetry
4717221|NCT03127800|Respiratory Polygraphy|respiratory polygraphy
4717222|NCT03127800|Polysomnography|polysomnography
4717223|NCT03127774|Cisplatin|cisplatin
4717224|NCT03127774|Heated Cisplatin|heated cisplatin
4717225|NCT03127761|Multiple Myeloma|multiple myeloma
4717226|NCT03127748|ventricular septal defect,transcatheter closure|ventricular septal defect,transcatheter closure
4717227|NCT03127735|Phase 1|phase 1
4717228|NCT03127735|mIDH1|midh1
4717229|NCT03127735|IDH1 mutation|idh1 mutation
4717230|NCT03127735|mIDH1 inhibitor|midh1 inhibitor
4717231|NCT03127709|17-199|17-199
4717232|NCT03127709|histiocytosis|histiocytosis
4717233|NCT03127696|Fecal Microbiota Transplant|fecal microbiota transplant
4717234|NCT03127631|Androgen Deprivation Therapy|androgen deprivation therapy
4717235|NCT03127553|salt intake|salt intake
4717236|NCT03127553|functional food|functional food
4717237|NCT03127553|low-salt bread|low-salt bread
4717238|NCT03127553|blood pressure|blood pressure
4717239|NCT03127514|Randomized|randomized
4717240|NCT03127514|Double-blind|double-blind
4717241|NCT03127514|Placebo-controlled|placebo-controlled
4717242|NCT03127514|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
4717243|NCT03127514|Sodium Phenylbutyrate|sodium phenylbutyrate
4717244|NCT03127514|Tauroursodeoxycholic Acid|tauroursodeoxycholic acid
4717245|NCT03127475|Parkinson's disease|parkinson's disease
4717246|NCT03127475|freezing of gait|freezing of gait
4717247|NCT03127475|electrophysiology|electrophysiology
4717248|NCT03127475|magnetic resonance image|magnetic resonance image
4717249|NCT03127475|direct current stimulation|direct current stimulation
4717250|NCT03127423|Hybrid ablation|hybrid ablation
4717251|NCT03127423|Thoracoscope|thoracoscope
4717252|NCT03127397|antiretroviral therapy|antiretroviral therapy
4717253|NCT03127397|HIV/AIDS|hiv/aids
4717254|NCT03127397|ART adherence|art adherence
4717255|NCT03127371|Nitrous Oxide|nitrous oxide
4717256|NCT03127371|Abscess|abscess
4717257|NCT03127371|Incision and drainage|incision and drainage
4717258|NCT03127358|Addiction|addiction
4717259|NCT03127358|Sustained Viral Response|sustained viral response
4717260|NCT03127358|Adherence|adherence
4717261|NCT03127358|Adverse Effects|adverse effects
4717262|NCT03127358|Direct Acting Antiviral Agent|direct acting antiviral agent
4717263|NCT03127358|Chronic Hepatitis C|chronic hepatitis c
4717264|NCT03127358|Resistance Development|resistance development
4717265|NCT03127358|Methadone Clinic|methadone clinic
4717266|NCT03127358|Primary Care|primary care
4717267|NCT03127358|Directly Observed Therapy|directly observed therapy
4717268|NCT03127358|Randomized Controlled Trial|randomized controlled trial
4717269|NCT03127358|Resistance|resistance
4717270|NCT03127358|Reinfection|reinfection
4717271|NCT03127358|Treatment Outcome|treatment outcome
4717272|NCT03127358|Patient Navigation|patient navigation
4717273|NCT03127358|Multi-Site|multi-site
4717274|NCT03127358|Liver Disease|liver disease
4717275|NCT03127358|Intervention|intervention
4717276|NCT03127332|Treatment care planning|treatment care planning
4717277|NCT03127306|Pain|pain
4717278|NCT03127306|Behavioural Pain Scale|behavioural pain scale
4717279|NCT03127306|BPS|bps
4717280|NCT03127306|NRS|nrs
4717281|NCT03127306|Delirium|delirium
4717282|NCT03127306|CAM-ICU|cam-icu
4717283|NCT03127280|urinary tract infections|urinary tract infections
4717284|NCT03127280|postoperative voiding dysfunction|postoperative voiding dysfunction
4717285|NCT03127280|foley removal|foley removal
4717286|NCT03127280|patient satisfaction|patient satisfaction
4717287|NCT03127254|Video Narrative|video narrative
4717288|NCT03127241|Assistive devices|assistive devices
4717289|NCT03127241|Randomized controlled trial (RCT)|randomized controlled trial (rct)
4717290|NCT03127241|Upper limbs|upper limbs
4717291|NCT03127241|Robotic devices|robotic devices
4717292|NCT03127228|Laser|laser
4717293|NCT03127202|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
4717294|NCT03127150|Chylous leakage|chylous leakage
4717295|NCT03127150|Diagnostic criteria|diagnostic criteria
4717296|NCT03127150|Pancreas surgery|pancreas surgery
4717297|NCT03127150|Therapy|therapy
4717298|NCT03127098|locally advanced or metastatic|locally advanced or metastatic
4717299|NCT03127098|carcinoembryonic antigen (CEA)-expressing|carcinoembryonic antigen (cea)-expressing
4717300|NCT03127098|CEA|cea
4717301|NCT03127098|carcinoembryonic antigen|carcinoembryonic antigen
4717302|NCT03127072|colorectal cancer|colorectal cancer
4717303|NCT03127072|liver metastasis|liver metastasis
4717304|NCT03127072|Radiofrequency Ablation|radiofrequency ablation
4717305|NCT03127072|chemotherapy|chemotherapy
4717306|NCT03127072|target therapy|target therapy
4717307|NCT03127059|Dysfunctional Breathing|dysfunctional breathing
4717308|NCT03127059|Uncontrolled Asthma|uncontrolled asthma
4717309|NCT03127059|Breathing Exercises|breathing exercises
4717310|NCT03127059|Adults|adults
4717311|NCT03127007|immunotherapy|immunotherapy
4717312|NCT03127007|anti-PD-L1|anti-pd-l1
4717313|NCT03126955|microvascular decompression, Xth nerve|microvascular decompression, xth nerve
4717314|NCT03126942|Aged patients|aged patients
4717315|NCT03126942|Cost Estimates|cost estimates
4717316|NCT03126942|Complete Denture|complete denture
4717317|NCT03126942|Dental Economics|dental economics
4717318|NCT03126942|Dental Implants|dental implants
4717319|NCT03126942|Dental Prosthesis, Implant-Supported|dental prosthesis, implant-supported
4717320|NCT03126942|Denture Retention|denture retention
4717321|NCT03126942|Minimally Invasive Surgical Procedures|minimally invasive surgical procedures
4717322|NCT03126942|Oral Health-Related Quality of Life|oral health-related quality of life
4717323|NCT03126942|Overdenture|overdenture
4717324|NCT03126942|Patient Acceptance of Health Care|patient acceptance of health care
4717325|NCT03126942|Quality of Healthcare|quality of healthcare
4717326|NCT03126942|Quality of Life|quality of life
4717327|NCT03126942|Patient Satisfaction|patient satisfaction
4717328|NCT03126942|Single implant overdenture|single implant overdenture
4717329|NCT03126929|disorders of consciousness|disorders of consciousness
4717330|NCT03126929|Vegetative state|vegetative state
4717331|NCT03126929|Minimally conscious state|minimally conscious state
4717332|NCT03126929|Emergence from MCS|emergence from mcs
4717333|NCT03126929|Coma Recovery Scale-Revised|coma recovery scale-revised
4717334|NCT03126890|Pharmacokinetics,adverse events|pharmacokinetics,adverse events
4717335|NCT03126890|Linezolid|linezolid
4717336|NCT03126890|Therapeutic drug monitoring|therapeutic drug monitoring
4717337|NCT03126890|Myelosuppression|myelosuppression
4717338|NCT03126890|Lactic acidosis|lactic acidosis
4717339|NCT03126890|Peripheral neuropathy|peripheral neuropathy
4717340|NCT03126864|Hematopoietic/Lymphoid Cancer|hematopoietic/lymphoid cancer
4717341|NCT03126864|Acute Myeloid Leukemia|acute myeloid leukemia
4717342|NCT03126864|AML|aml
4717343|NCT03126864|Relapsed or Refractory CD33-Positive|relapsed or refractory cd33-positive
4717344|NCT03126864|CD33-CAR-T cells|cd33-car-t cells
4717345|NCT03126864|Fludarabine|fludarabine
4717346|NCT03126864|Fludarabine phosphate|fludarabine phosphate
4717347|NCT03126864|Fludara|fludara
4717348|NCT03126864|Cyclophosphamide|cyclophosphamide
4717349|NCT03126864|Cytoxan|cytoxan
4717350|NCT03126864|Neosar|neosar
4717351|NCT03126838|diaphragm|diaphragm
4717352|NCT03126838|ultrasound|ultrasound
4717353|NCT03126838|dysfunction|dysfunction
4717354|NCT03126838|cardiac surgery|cardiac surgery
4717355|NCT03126838|weaning|weaning
4717356|NCT03126812|Primary stage 4|primary stage 4
4717357|NCT03126812|Neo adjuvant|neo adjuvant
4717358|NCT03126786|Diabetes Mellitus|diabetes mellitus
4717359|NCT03126786|Diabetic Retinopathy|diabetic retinopathy
4717360|NCT03126786|Microneedle|microneedle
4717361|NCT03126786|Mircoinjection|mircoinjection
4717362|NCT03126786|Triamcinolone|triamcinolone
4717363|NCT03126786|Choroid|choroid
4717364|NCT03126786|Choroid Injection|choroid injection
4717365|NCT03126786|Aflibercept|aflibercept
4717366|NCT03126786|Suprachoroidal|suprachoroidal
4717367|NCT03126773|non-interventional|non-interventional
4717368|NCT03126773|cohort|cohort
4717369|NCT03126773|Angeliq Micro|angeliq micro
4717370|NCT03126773|menopause|menopause
4717371|NCT03126773|Russia|russia
4717372|NCT03126734|Down Syndrome|down syndrome
4717373|NCT03126734|Acceptance|acceptance
4717374|NCT03126734|Commitment|commitment
4717375|NCT03126734|Concience of influence|concience of influence
4717376|NCT03126721|drug interaction|drug interaction
4717377|NCT03126721|PF-06751979|pf-06751979
4717378|NCT03126721|oral midazolam|oral midazolam
4717379|NCT03126695|Abnormal hemoglobin (called hemoglobin S or sickle hemoglobin) in the red blood cells|abnormal hemoglobin (called hemoglobin s or sickle hemoglobin) in the red blood cells
4717380|NCT03126695|Thrombotic cardiovascular events|thrombotic cardiovascular events
4717381|NCT03126695|Acute coronary syndrome|acute coronary syndrome
4717382|NCT03126695|P2Y12 platelet inhibitor|p2y12 platelet inhibitor
4717383|NCT03126695|Brilinta|brilinta
4717384|NCT03126682|Wellbutrin|wellbutrin
4717385|NCT03126682|Electroconvulsive therapy|electroconvulsive therapy
4717386|NCT03126682|Right Unilateral Ultra Brief|right unilateral ultra brief
4717387|NCT03126669|Hyperbaric oxygen|hyperbaric oxygen
4717388|NCT03126669|multitasking performance|multitasking performance
4717389|NCT03126669|cognitive funcitons|cognitive funcitons
4717390|NCT03126656|testosterone|testosterone
4717391|NCT03126656|chronic heart failure|chronic heart failure
4717392|NCT03126552|hookworm|hookworm
4717393|NCT03126552|controlled human infection model|controlled human infection model
4717394|NCT03126539|aging|aging
4717395|NCT03126539|ultraviolet exposure|ultraviolet exposure
4717396|NCT03126539|skin fragility|skin fragility
4717397|NCT03126539|sulforaphane|sulforaphane
4717398|NCT03126513|G-POEM|g-poem
4717399|NCT03126513|Safety|safety
4717400|NCT03126513|Efficacy|efficacy
4717401|NCT03126500|Malnutrition|malnutrition
4717402|NCT03126500|Disease-related malnutrition|disease-related malnutrition
4717403|NCT03126500|Frailty|frailty
4717404|NCT03126500|Sarcopenia|sarcopenia
4717405|NCT03126500|Hospital discharge|hospital discharge
4717406|NCT03126500|Geriatrics|geriatrics
4717407|NCT03126461|metastatic melanoma|metastatic melanoma
4717408|NCT03126448|Infection|infection
4717409|NCT03126448|Nonunion|nonunion
4717410|NCT03126448|Fracture healing|fracture healing
4717411|NCT03126435|FOLFIRINOX|folfirinox
4717412|NCT03126435|5-Fluorouracil|5-fluorouracil
4717413|NCT03126435|folinic acid|folinic acid
4717414|NCT03126435|irinotecan|irinotecan
4717415|NCT03126435|oxaliplatin|oxaliplatin
4717416|NCT03126435|Gemcitabine|gemcitabine
4717417|NCT03126409|coronary artery disease|coronary artery disease
4717418|NCT03126409|coronary artery bypass graft|coronary artery bypass graft
4717419|NCT03126344|King Vision|king vision
4717420|NCT03126331|Kidney Cancer|kidney cancer
4717421|NCT03126331|Metastatic|metastatic
4717422|NCT03126331|Nivolumab|nivolumab
4717423|NCT03126305|exposure|exposure
4717424|NCT03126305|response prevention|response prevention
4717425|NCT03126305|web-based application|web-based application
4717426|NCT03126292|Medical home|medical home
4717427|NCT03126292|Primary care|primary care
4717428|NCT03126292|Children|children
4717429|NCT03126292|Development|development
4717430|NCT03126279|Osteoarthritis|osteoarthritis
4717431|NCT03126279|Pain|pain
4717432|NCT03126279|Postoperative Pain|postoperative pain
4717433|NCT03126253|childhood anemia, socioeconomic status|childhood anemia, socioeconomic status
4717434|NCT03126227|AR101|ar101
4717435|NCT03126227|Characterized Peanut Allergen|characterized peanut allergen
4717436|NCT03126227|CPNA (Characterized Peanut Allergen)|cpna (characterized peanut allergen)
4717437|NCT03126227|OIT (oral immunotherapy)|oit (oral immunotherapy)
4717438|NCT03126227|Peanut Allergy|peanut allergy
4717439|NCT03126227|Peanut-Allergic Children|peanut-allergic children
4717440|NCT03126227|Desensitization|desensitization
4717441|NCT03126227|ARC007|arc007
4717442|NCT03126227|Characterized Oral Desensitization Immunotherapy (CODIT™)|characterized oral desensitization immunotherapy (codit™)
4717443|NCT03126214|atrial fibrillation|atrial fibrillation
4717444|NCT03126214|stroke|stroke
4717445|NCT03126214|oral anticoagulation therapy|oral anticoagulation therapy
4717446|NCT03126214|pharmacist case management|pharmacist case management
4717447|NCT03126201|focal segmental glomerulosclerosis|focal segmental glomerulosclerosis
4717448|NCT03126201|disease progression|disease progression
4717449|NCT03126175|conservative treatment, treatment outcome|conservative treatment, treatment outcome
4717450|NCT03126162|minimally invasive gynecologic surgery|minimally invasive gynecologic surgery
4717451|NCT03126162|same-day discharge|same-day discharge
4717452|NCT03126162|bladder testing|bladder testing
4717453|NCT03126136|Fetal heart rate abnormalities|fetal heart rate abnormalities
4717454|NCT03126136|Pregnancy|pregnancy
4717455|NCT03126136|Epidural analgesia|epidural analgesia
4717456|NCT03126136|Pulse pressure|pulse pressure
4717457|NCT03126123|Anal condylomatosis|anal condylomatosis
4717458|NCT03126123|surgery|surgery
4717459|NCT03126123|acetic acid|acetic acid
4717460|NCT03126123|dysplastic areas|dysplastic areas
4717461|NCT03126110|cervical cancer|cervical cancer
4717462|NCT03126110|endometrial cancer|endometrial cancer
4717463|NCT03126110|gastric cancer (stomach, esophageal, and gastroesophageal junction [GEJ])|gastric cancer (stomach, esophageal, and gastroesophageal junction [gej])
4717464|NCT03126110|hepatocellular carcinoma (HCC)|hepatocellular carcinoma (hcc)
4717465|NCT03126110|melanoma|melanoma
4717466|NCT03126110|Merkel cell carcinoma|merkel cell carcinoma
4717467|NCT03126110|mesothelioma|mesothelioma
4717468|NCT03126110|microsatellite instability-high (MSI-H) colorectal cancer (CRC)|microsatellite instability-high (msi-h) colorectal cancer (crc)
4717469|NCT03126110|non-small cell lung cancer (NSCLC)|non-small cell lung cancer (nsclc)
4717470|NCT03126110|ovarian cancer|ovarian cancer
4717471|NCT03126110|squamous cell carcinoma of the head and neck (SCCHN)|squamous cell carcinoma of the head and neck (scchn)
4717472|NCT03126110|small cell lung cancer (SCLC)|small cell lung cancer (sclc)
4717473|NCT03126110|renal cell carcinoma (RCC)|renal cell carcinoma (rcc)
4717474|NCT03126110|triple-negative breast cancer (TNBC)|triple-negative breast cancer (tnbc)
4717475|NCT03126110|urothelial carcinoma|urothelial carcinoma
4717476|NCT03126110|glucocorticoid-induced tumor necrosis factor receptor (GITR)|glucocorticoid-induced tumor necrosis factor receptor (gitr)
4717477|NCT03126058|enhanced recovery after surgery|enhanced recovery after surgery
4717478|NCT03126058|colorectal cancer|colorectal cancer
4717479|NCT03126045|Lumbar puncture|lumbar puncture
4717480|NCT03126045|Post lumbar puncture headache|post lumbar puncture headache
4717481|NCT03126045|Atraumatic needle|atraumatic needle
4717482|NCT03126045|Haematology|haematology
4717483|NCT03126032|Sepsis|sepsis
4717484|NCT03126032|SIRS|sirs
4717485|NCT03126032|Glycocalyx|glycocalyx
4717486|NCT03126032|Glycocheck™-System|glycocheck™-system
4717487|NCT03126032|Infection|infection
4717488|NCT03126019|Follicular lymphoma|follicular lymphoma
4717489|NCT03126019|non-Hodgkin lymphoma (NHL)|non-hodgkin lymphoma (nhl)
4717490|NCT03126019|phosphatidylinositol 3-kinase (PI3K) δ inhibitor|phosphatidylinositol 3-kinase (pi3k) δ inhibitor
4717491|NCT03125993|obesity; brisk walking|obesity; brisk walking
4717492|NCT03125928|Atezolizumab|atezolizumab
4717493|NCT03125928|PD-L1|pd-l1
4717494|NCT03125915|couples HIV testing; drug intervention; communication skills|couples hiv testing; drug intervention; communication skills
4717495|NCT03125889|Image-guided|image-guided
4717496|NCT03125889|BPH|bph
4717497|NCT03125889|Aquablation|aquablation
4717498|NCT03125889|AQUABEAM|aquabeam
4717499|NCT03125889|LUTS|luts
4717500|NCT03125889|Tissue resection|tissue resection
4717501|NCT03125889|Robotics|robotics
4717502|NCT03125863|Image-guided|image-guided
4717503|NCT03125863|BPH|bph
4717504|NCT03125863|Aquablation|aquablation
4717505|NCT03125863|AQUABEAM|aquabeam
4717506|NCT03125863|LUTS|luts
4717507|NCT03125863|Tissue resection|tissue resection
4717508|NCT03125863|Robotics|robotics
4717509|NCT03125850|day-ward|day-ward
4717510|NCT03125850|inpatient|inpatient
4717511|NCT03125811|Isopropyl alcohol|isopropyl alcohol
4717512|NCT03125811|Zofran|zofran
4717513|NCT03125811|antiemetics|antiemetics
4717514|NCT03125798|video-assisted thoracic surgery|video-assisted thoracic surgery
4717515|NCT03125798|LigaSure|ligasure
4717516|NCT03125798|mediastinal lymph node dissection|mediastinal lymph node dissection
4717517|NCT03125785|congenital cataract, contact lens|congenital cataract, contact lens
4717518|NCT03125772|coronary artery disease|coronary artery disease
4717519|NCT03125772|diabetes mellitus|diabetes mellitus
4717520|NCT03125772|everolimus|everolimus
4717521|NCT03125772|paclitaxel stents|paclitaxel stents
4717522|NCT03125759|Ischemic Stroke|ischemic stroke
4717523|NCT03125759|Omentin|omentin
4717524|NCT03125733|Endoscopy, Digestive system|endoscopy, digestive system
4717525|NCT03125733|Natural orifice transluminal endoscopic surgery|natural orifice transluminal endoscopic surgery
4717526|NCT03125733|Therapeutic|therapeutic
4717527|NCT03125733|Complications|complications
4717528|NCT03125720|cardiac resynchronization therapy|cardiac resynchronization therapy
4717529|NCT03125720|chronic heart failure|chronic heart failure
4717530|NCT03125720|image fusion-guided implantation|image fusion-guided implantation
4717531|NCT03125720|SPECT|spect
4717532|NCT03125720|venogram|venogram
4717533|NCT03125681|remote ischemic conditioning|remote ischemic conditioning
4717534|NCT03125681|off-pump coronary artery bypass surgery|off-pump coronary artery bypass surgery
4717535|NCT03125655|cytokines|cytokines
4717536|NCT03125642|Lymphoblastic Lymphoma|lymphoblastic lymphoma
4717537|NCT03125642|Mature B-cell Lymphomas|mature b-cell lymphomas
4717538|NCT03125642|Follicular Lymphoma|follicular lymphoma
4717539|NCT03125642|Diffuse Large B-Cell Lymphoma|diffuse large b-cell lymphoma
4717540|NCT03125642|Mantle Cell Lymphoma|mantle cell lymphoma
4717541|NCT03125642|Burkitt's/Burkitt's like|burkitt's/burkitt's like
4717542|NCT03125642|Mature T-Cell Lymphoma|mature t-cell lymphoma
4717543|NCT03125616|Prematurity|prematurity
4717544|NCT03125616|Vaccination|vaccination
4717545|NCT03125603|Immunotherapy|immunotherapy
4717546|NCT03125603|Anti-PD-(L)-1|anti-pd-(l)-1
4717547|NCT03125603|Anti-CTLA-4|anti-ctla-4
4717548|NCT03125590|Osteoporosis, osteopenia, test-retest, validity, PEQ, questionnaire, facilitators, barriers, exercise, physical activity|osteoporosis, osteopenia, test-retest, validity, peq, questionnaire, facilitators, barriers, exercise, physical activity
4717549|NCT03125577|4S CAR-T|4s car-t
4717550|NCT03125577|CD19|cd19
4717551|NCT03125577|CD20|cd20
4717552|NCT03125577|CD22|cd22
4717553|NCT03125577|CD38|cd38
4717554|NCT03125577|CD123|cd123
4717555|NCT03125577|B cell leukemia|b cell leukemia
4717556|NCT03125577|B-ALL|b-all
4717557|NCT03125577|CD70|cd70
4717558|NCT03125577|CD30|cd30
4717559|NCT03125551|Dietary supplements|dietary supplements
4717560|NCT03125551|Bleeding tendency|bleeding tendency
4717561|NCT03125538|Motor Imagery|motor imagery
4717562|NCT03125538|Amputation|amputation
4717563|NCT03125538|Functional rehabilitation|functional rehabilitation
4717564|NCT03125538|Locomotion|locomotion
4717565|NCT03125538|Phantom-limb pain|phantom-limb pain
4717566|NCT03125525|migraine|migraine
4717567|NCT03125525|transcutaneous|transcutaneous
4717568|NCT03125525|supraorbital|supraorbital
4717569|NCT03125525|nerve|nerve
4717570|NCT03125525|stimulation|stimulation
4717571|NCT03125512|Sleep Apnea Syndromes|sleep apnea syndromes
4717572|NCT03125512|Positional sleep apnea|positional sleep apnea
4717573|NCT03125512|CPAP|cpap
4717574|NCT03125512|Night Shift|night shift
4717575|NCT03125486|subcutaneous Belimumab|subcutaneous belimumab
4717576|NCT03125486|Individual Patient Compassionate Use|individual patient compassionate use
4717577|NCT03125486|SLE|sle
4717578|NCT03125486|GSK1550188|gsk1550188
4717579|NCT03125447|Prematurely born children|prematurely born children
4717580|NCT03125447|Attention function|attention function
4717581|NCT03125447|Posture|posture
4717582|NCT03125447|Mobility|mobility
4717583|NCT03125356|diet soda|diet soda
4717584|NCT03125356|low-calorie sweeteners|low-calorie sweeteners
4717585|NCT03125356|obesity|obesity
4717586|NCT03125343|radiotherapy|radiotherapy
4717587|NCT03125343|chemotherapy|chemotherapy
4717588|NCT03125343|complete response|complete response
4717589|NCT03125330|Coaching|coaching
4717590|NCT03125330|Professional coaching|professional coaching
4717591|NCT03125330|Emergency physicians|emergency physicians
4717592|NCT03125330|Emergency medicine|emergency medicine
4717593|NCT03125330|Goal attainment|goal attainment
4717594|NCT03125330|Leadership strengths|leadership strengths
4717595|NCT03125330|Well-being|well-being
4717596|NCT03125330|Burnout|burnout
4717597|NCT03125330|Adult level of development|adult level of development
4717598|NCT03125330|Group coaching|group coaching
4717599|NCT03125330|Instructor|instructor
4717600|NCT03125330|Assistant professor|assistant professor
4717601|NCT03125330|Academic faculty|academic faculty
4717602|NCT03125330|Subject-Object Interview|subject-object interview
4717603|NCT03125304|Endometriosis|endometriosis
4717604|NCT03125304|acupuncture|acupuncture
4717605|NCT03125304|pain|pain
4717606|NCT03125304|dysmenorrhea|dysmenorrhea
4717607|NCT03125291|Substance Use and Abuse|substance use and abuse
4717608|NCT03125291|Risky Sexual Behavior|risky sexual behavior
4717609|NCT03125291|Behavior Problems|behavior problems
4717610|NCT03125291|Academic Achievement|academic achievement
4717611|NCT03125265|nutrition|nutrition
4717612|NCT03125265|hemodialysis|hemodialysis
4717613|NCT03125265|mortality|mortality
4717614|NCT03125265|omega 3|omega 3
4717615|NCT03125252|Delirium|delirium
4717616|NCT03125252|Reanimation|reanimation
4717617|NCT03125252|Conversational hypnosis|conversational hypnosis
4717618|NCT03125239|Refractory Adult Acute Myeloid Leukemia|refractory adult acute myeloid leukemia
4717619|NCT03125239|Relapsed Adult Acute Myeloid Leukemia|relapsed adult acute myeloid leukemia
4717620|NCT03125187|Sodium Heparin|sodium heparin
4717621|NCT03125187|Intravenous administration|intravenous administration
4717622|NCT03125187|Pharmacokinetics|pharmacokinetics
4717623|NCT03125187|Coagulation factor|coagulation factor
4717624|NCT03125174|sputum|sputum
4717625|NCT03125174|bronchiectasis|bronchiectasis
4717626|NCT03125174|lung disease|lung disease
4717627|NCT03125161|colorectal cancer|colorectal cancer
4717628|NCT03125161|liver metastasis|liver metastasis
4717629|NCT03125161|hepatic arterial infusion|hepatic arterial infusion
4717630|NCT03125161|chemotherapy|chemotherapy
4717631|NCT03125161|target therapy|target therapy
4717632|NCT03125161|conversional resection rates|conversional resection rates
4717633|NCT03125083|Skin restricted lupus|skin restricted lupus
4717634|NCT03125083|Psychiatric disorders|psychiatric disorders
4717635|NCT03125083|Inflammation|inflammation
4717636|NCT03125083|Kynurenine pathway|kynurenine pathway
4717637|NCT03124667|adherence|adherence
4717638|NCT03124667|cognition|cognition
4717639|NCT03124667|exercise|exercise
4717640|NCT03124667|aging|aging
4717641|NCT03124667|brain training|brain training
4717642|NCT03124667|cognitive training|cognitive training
4717643|NCT03124667|executive function|executive function
4717644|NCT03124641|Hypothermic oxygenated machine perfusion|hypothermic oxygenated machine perfusion
4717645|NCT03124641|Orthotopic liver transplantation|orthotopic liver transplantation
4717646|NCT03124641|Extended criteria donation|extended criteria donation
4717647|NCT03124641|Donation after brain death|donation after brain death
4717648|NCT03124641|HOPE|hope
4717649|NCT03124563|Exercise|exercise
4717650|NCT03124563|Health Behavior|health behavior
4717651|NCT03124563|Aging|aging
4717652|NCT03124550|Caregivers|caregivers
4717653|NCT03124550|Exercise|exercise
4717654|NCT03124550|Behavior Change|behavior change
4717655|NCT03124537|Physical Exercise|physical exercise
4717656|NCT03124537|Behavior Change|behavior change
4717657|NCT03124524|estradiol valerate/dienogest|estradiol valerate/dienogest
4717658|NCT03124524|ethinylestradiol/ drospirenone|ethinylestradiol/ drospirenone
4717659|NCT03124524|pelvic pain|pelvic pain
4717660|NCT03124524|primary dysmenorrhea|primary dysmenorrhea
4717661|NCT03124524|uterine artery doppler indices|uterine artery doppler indices
4717662|NCT03124498|Hepatocellular Carcinoma, Autologous Cytokine-Induced Killer|hepatocellular carcinoma, autologous cytokine-induced killer
4717663|NCT03124459|CMT1 / CMTX|cmt1 / cmtx
4717664|NCT03124446|mindfulness|mindfulness
4717665|NCT03124433|prostate cancer|prostate cancer
4717666|NCT03124433|prostatectomy, retropubic|prostatectomy, retropubic
4717667|NCT03124433|Androgen Receptor Antagonists|androgen receptor antagonists
4717668|NCT03124420|Helicobacter Infection|helicobacter infection
4717669|NCT03124420|Eradication therapy|eradication therapy
4717670|NCT03124420|Antibiotics|antibiotics
4717671|NCT03124368|factor D|factor d
4717672|NCT03124368|fD|fd
4717673|NCT03124368|alternative pathway|alternative pathway
4717674|NCT03124368|complement mediated disease|complement mediated disease
4717675|NCT03124368|idiopathic MPGN|idiopathic mpgn
4717676|NCT03124368|MPGN Type I|mpgn type i
4717677|NCT03124368|MPGN Type II|mpgn type ii
4717678|NCT03124368|MPGN Type III|mpgn type iii
4717679|NCT03124368|Primary MPGN|primary mpgn
4717680|NCT03124368|MCGN|mcgn
4717681|NCT03124368|Mesangiocapillary Glomerulonephritis|mesangiocapillary glomerulonephritis
4717682|NCT03124355|vagal stimulation|vagal stimulation
4717683|NCT03124355|POTS|pots
4717684|NCT03124355|galantamine|galantamine
4717685|NCT03124355|pyridostigmine|pyridostigmine
4717686|NCT03124238|massage|massage
4717687|NCT03124212|mutation carrier|mutation carrier
4717688|NCT03124212|blood relative|blood relative
4717689|NCT03124212|genetic testing|genetic testing
4717690|NCT03124212|family-based cohort|family-based cohort
4717691|NCT03124199|Eradication|eradication
4717692|NCT03124199|Helicobacter pylori|helicobacter pylori
4717693|NCT03124199|rifaximin|rifaximin
4717694|NCT03124199|therapy|therapy
4717695|NCT03124199|standard triple therapy|standard triple therapy
4717696|NCT03124186|motor recovery|motor recovery
4717697|NCT03124186|neuroplasticity|neuroplasticity
4717698|NCT03124186|subacute|subacute
4717699|NCT03124186|human|human
4717700|NCT03124186|sensory|sensory
4717701|NCT03124186|nerve stimulation|nerve stimulation
4717702|NCT03124173|fMRI|fmri
4717703|NCT03124173|cingulate cortex|cingulate cortex
4717704|NCT03124173|adaptation|adaptation
4717705|NCT03124173|frontal cortex|frontal cortex
4717706|NCT03124160|Healthy Women|healthy women
4717707|NCT03124160|Female Contraception|female contraception
4717708|NCT03124160|IUD|iud
4717709|NCT03124147|motor recovery|motor recovery
4717710|NCT03124147|neuroplasticity|neuroplasticity
4717711|NCT03124147|chronic|chronic
4717712|NCT03124147|human|human
4717713|NCT03124147|noninvasive brain stimulation|noninvasive brain stimulation
4717714|NCT03124147|neuromodulation|neuromodulation
4717715|NCT03124108|Elafibranor|elafibranor
4717716|NCT03124108|Primary Biliary Cholangitis|primary biliary cholangitis
4717717|NCT03124108|Alkaline phosphatase|alkaline phosphatase
4717718|NCT03124095|physical exercise|physical exercise
4717719|NCT03124095|combined training|combined training
4717720|NCT03124095|physical activity|physical activity
4717721|NCT03124095|physical fitness|physical fitness
4717722|NCT03124056|Extracorporeal photopheresis|extracorporeal photopheresis
4717723|NCT03124056|Biomarker of response|biomarker of response
4717724|NCT03124056|Steroid resistant|steroid resistant
4717725|NCT03124030|direct oral anticoagulant|direct oral anticoagulant
4717726|NCT03124030|oral anticoagulant therapy|oral anticoagulant therapy
4717727|NCT03124030|dental extraction|dental extraction
4717728|NCT03124030|bleeding complication|bleeding complication
4717729|NCT03124030|atrial fibrillation|atrial fibrillation
4717730|NCT03124030|deep venous thrombosis|deep venous thrombosis
4717731|NCT03124004|direct oral anticoagulant|direct oral anticoagulant
4717732|NCT03124004|oral anticoagulant therapy|oral anticoagulant therapy
4717733|NCT03124004|periodontal disease|periodontal disease
4717734|NCT03124004|periodontal debridement|periodontal debridement
4717735|NCT03124004|ultrasonic periodontal debridement|ultrasonic periodontal debridement
4717736|NCT03124004|ultrasonic scaling|ultrasonic scaling
4717737|NCT03124004|periodontal scaling|periodontal scaling
4717738|NCT03124004|subgingival scaling|subgingival scaling
4717739|NCT03123978|castration resistant prostate cancer|castration resistant prostate cancer
4717740|NCT03123965|Special Access Scheme|special access scheme
4717741|NCT03123965|Expanded Access|expanded access
4717742|NCT03123965|Pre-approval Access|pre-approval access
4717743|NCT03123965|Compassionate Use|compassionate use
4717744|NCT03123965|Special Access Program|special access program
4717745|NCT03123965|Named Patient Basis|named patient basis
4717746|NCT03123952|Expanded Access|expanded access
4717747|NCT03123952|Pre-approval Access|pre-approval access
4717748|NCT03123952|Compassionate Use|compassionate use
4717749|NCT03123952|Special Access Program|special access program
4717750|NCT03123952|Named Patient Basis|named patient basis
4717751|NCT03123952|Special Access Scheme|special access scheme
4717752|NCT03123939|ALL|all
4717753|NCT03123926|spontaneous preterm birth|spontaneous preterm birth
4717754|NCT03123926|lipids|lipids
4717755|NCT03123926|biomarkers|biomarkers
4717756|NCT03123874|human milk|human milk
4717757|NCT03123874|breast milk|breast milk
4717758|NCT03123874|expressed human milk|expressed human milk
4717759|NCT03123874|bacterial communities|bacterial communities
4717760|NCT03123874|microbiome|microbiome
4717761|NCT03123874|breast pump|breast pump
4717762|NCT03123874|bacterial growth|bacterial growth
4717763|NCT03123861|Pelvic Organ Prolapse|pelvic organ prolapse
4717764|NCT03123861|postoperative gluteal pain|postoperative gluteal pain
4717765|NCT03123861|opioid use|opioid use
4717766|NCT03123835|Achalasia|achalasia
4717767|NCT03123835|Fistula|fistula
4717768|NCT03123835|Obesity|obesity
4717769|NCT03123835|POEM|poem
4717770|NCT03123835|GERD|gerd
4717771|NCT03123835|endoscopic|endoscopic
4717772|NCT03123835|treatments|treatments
4717773|NCT03123835|post bariatric surger weight gain|post bariatric surger weight gain
4717774|NCT03123835|endoluminal|endoluminal
4717775|NCT03123835|Bariatric Surgery|bariatric surgery
4717776|NCT03123835|Barretts|barretts
4717777|NCT03123809|Diabetes Mellitus|diabetes mellitus
4717778|NCT03123809|gastroparesis|gastroparesis
4717779|NCT03123809|gastric electrical stimulation|gastric electrical stimulation
4717780|NCT03123809|pyloroplasty|pyloroplasty
4717781|NCT03123809|Idiopathic -unknown etiology|idiopathic -unknown etiology
4717782|NCT03123796|chronic rejection|chronic rejection
4717783|NCT03123796|transplant outcome|transplant outcome
4717784|NCT03123783|CD40|cd40
4717785|NCT03123783|Immunotherapy|immunotherapy
4717786|NCT03123783|Nivolumab|nivolumab
4717787|NCT03123783|APX005M|apx005m
4717788|NCT03123783|PD-1|pd-1
4717789|NCT03123770|Breast cancer|breast cancer
4717790|NCT03123770|Neoadjuvant Chemotherapy|neoadjuvant chemotherapy
4717791|NCT03123770|Pegylated liposomal doxorubicin|pegylated liposomal doxorubicin
4717792|NCT03123770|PLD|pld
4717793|NCT03123744|Palbociclib|palbociclib
4717794|NCT03123744|Cyclin Pathway|cyclin pathway
4717795|NCT03123744|kinase inhibitor|kinase inhibitor
4717796|NCT03123731|physical activity|physical activity
4717797|NCT03123731|diet|diet
4717798|NCT03123731|mHealth|mhealth
4717799|NCT03123731|Fitbit|fitbit
4717800|NCT03123731|neurocognition|neurocognition
4717801|NCT03123731|text messaging|text messaging
4717802|NCT03123718|methotrexate|methotrexate
4717803|NCT03123640|Medication reconciliation|medication reconciliation
4717804|NCT03123640|Medication review|medication review
4717805|NCT03123640|Drug related admission|drug related admission
4717806|NCT03123627|Cytomegalovirus, Seropositive|cytomegalovirus, seropositive
4717807|NCT03123614|Photorefractive keratectomy|photorefractive keratectomy
4717808|NCT03123601|Nursing home|nursing home
4717809|NCT03123601|Falls|falls
4717810|NCT03123601|Dysphasia|dysphasia
4717811|NCT03123601|Choking|choking
4717812|NCT03123601|Dehydration|dehydration
4717813|NCT03123588|Essential thrombocythemia|essential thrombocythemia
4717814|NCT03123588|hydroxyurea-resistant|hydroxyurea-resistant
4717815|NCT03123588|hydroxyurea-intolerant|hydroxyurea-intolerant
4717816|NCT03123588|ruxolitinib|ruxolitinib
4717817|NCT03123588|anagrelide|anagrelide
4717818|NCT03123562|Cerebral palsy|cerebral palsy
4717819|NCT03123562|Stem cells|stem cells
4717820|NCT03123562|Neonatal icterus|neonatal icterus
4717821|NCT03123536|high risk|high risk
4717822|NCT03123536|complication|complication
4717823|NCT03123536|Ultrasonography|ultrasonography
4717824|NCT03123510|probiotics|probiotics
4717825|NCT03123510|prebiotics|prebiotics
4717826|NCT03123510|synbiotics|synbiotics
4717827|NCT03123510|obesity|obesity
4717828|NCT03123497|Idiopathic Thrombocytopenic Purpura|idiopathic thrombocytopenic purpura
4717829|NCT03123484|beta-elemene|beta-elemene
4717830|NCT03123471|Plaque Psoriasis|plaque psoriasis
4717831|NCT03123471|Scalp|scalp
4717832|NCT03123471|Double-Blind|double-blind
4717833|NCT03123471|Efficacy|efficacy
4717834|NCT03123471|Safety|safety
4717835|NCT03123471|CC-10004|cc-10004
4717836|NCT03123471|Apremilast|apremilast
4717837|NCT03123471|Otezla|otezla
4717838|NCT03123471|Itch|itch
4717839|NCT03123471|Head|head
4717840|NCT03123458|MSC|msc
4717841|NCT03123458|GVHDs|gvhds
4717842|NCT03123458|transplantation|transplantation
4717843|NCT03123445|endostar|endostar
4717844|NCT03123432|immunomodulating nutrients|immunomodulating nutrients
4717845|NCT03123406|cinacalcet|cinacalcet
4717846|NCT03123406|secondary hyperparathyroidism|secondary hyperparathyroidism
4717847|NCT03123406|calcimimetics|calcimimetics
4717848|NCT03123406|CKD-MBD|ckd-mbd
4717849|NCT03123393|Drug therapy|drug therapy
4717850|NCT03123315|hysterectomy|hysterectomy
4717851|NCT03123315|ureter|ureter
4717852|NCT03123302|MRI scan, sedation, epilepsia|mri scan, sedation, epilepsia
4717853|NCT03123289|PET/CT|pet/ct
4717854|NCT03123289|68Gallium Citrate|68gallium citrate
4717855|NCT03123289|Orthopedic Hardware infection|orthopedic hardware infection
4717856|NCT03123250|Lower Urinary Tract Symptoms (LUTS)|lower urinary tract symptoms (luts)
4717857|NCT03123250|AQUABEAM|aquabeam
4717858|NCT03123250|Aquablation|aquablation
4717859|NCT03123250|Benign Prostatic Hyperplasia (BPH)|benign prostatic hyperplasia (bph)
4717860|NCT03123224|Caregiver|caregiver
4717861|NCT03123224|Caregiving|caregiving
4717862|NCT03123224|TBI|tbi
4717863|NCT03123224|dementia|dementia
4717864|NCT03123224|Alzheimer's disease|alzheimer's disease
4717865|NCT03123224|physical exercise|physical exercise
4717866|NCT03123224|physical activity|physical activity
4717867|NCT03123224|psychosocial|psychosocial
4717868|NCT03123224|caregiver skills training|caregiver skills training
4717869|NCT03123211|Expanded Access|expanded access
4717870|NCT03123211|Pre-approval Access|pre-approval access
4717871|NCT03123211|Compassionate Use|compassionate use
4717872|NCT03123211|Special Access Program|special access program
4717873|NCT03123211|Named Patient Basis|named patient basis
4717874|NCT03123211|Special Access Scheme|special access scheme
4717875|NCT03123198|borderline personality disorder, dialectical behavior therapy, suicidal behaviors|borderline personality disorder, dialectical behavior therapy, suicidal behaviors
4717876|NCT03123172|co2 gap|co2 gap
4717877|NCT03123172|PPV|ppv
4717878|NCT03123172|resuscitation|resuscitation
4717879|NCT03123172|liver transplantation|liver transplantation
4717880|NCT03123146|Cognitive Behavioral Therapy|cognitive behavioral therapy
4717881|NCT03123107|Vitamin C|vitamin c
4717882|NCT03123107|Postoperative atrial fibrillation|postoperative atrial fibrillation
4717883|NCT03123107|coronary artery bypass graft|coronary artery bypass graft
4717884|NCT03123107|ascorbic acid|ascorbic acid
4717885|NCT03123055|Urothelial Cell Carcinoma|urothelial cell carcinoma
4717886|NCT03123055|UCC|ucc
4717887|NCT03123055|bladder cancer|bladder cancer
4717888|NCT03123055|B-701|b-701
4717889|NCT03123055|FGFR3|fgfr3
4717890|NCT03123055|invasive bladder cancer|invasive bladder cancer
4717891|NCT03123055|Transitional Cell Carcinoma|transitional cell carcinoma
4717892|NCT03123055|TCC|tcc
4717893|NCT03123055|second line therapy|second line therapy
4717894|NCT03123055|monoclonal antibody|monoclonal antibody
4717895|NCT03123055|combination therapy|combination therapy
4717896|NCT03123055|Phase 1b|phase 1b
4717897|NCT03123055|pembrolizumab|pembrolizumab
4717898|NCT03123055|checkpoint inhibitor|checkpoint inhibitor
4717899|NCT03123055|Phase 2|phase 2
4717900|NCT03123055|Urothelial Carcinoma|urothelial carcinoma
4717901|NCT03123042|Sentinel lymph node|sentinel lymph node
4717902|NCT03123042|Early gastric cancer|early gastric cancer
4718002|NCT03122314|paracetamol|paracetamol
4717903|NCT03123042|Non-curative endoscopic resection|non-curative endoscopic resection
4717904|NCT03123029|Expanded Access|expanded access
4717905|NCT03123029|Pre-approval Access|pre-approval access
4717906|NCT03123029|Compassionate Use|compassionate use
4717907|NCT03123029|Special Access Program|special access program
4717908|NCT03123029|Named Patient Basis|named patient basis
4717909|NCT03123029|Special Access Scheme|special access scheme
4717910|NCT03123016|Vitiligo|vitiligo
4717911|NCT03123003|Bone age,|bone age,
4717912|NCT03123003|Height prediction|height prediction
4717913|NCT03123003|Growth|growth
4717914|NCT03122938|lactoferrin|lactoferrin
4717915|NCT03122938|Iron Metabolism|iron metabolism
4717916|NCT03122938|iron-deficiency anemia|iron-deficiency anemia
4717917|NCT03122938|pregnant women|pregnant women
4717918|NCT03122938|fetal development|fetal development
4717919|NCT03122912|fish oil|fish oil
4717920|NCT03122899|SI-BONE|si-bone
4717921|NCT03122899|sacroiliac joint|sacroiliac joint
4717922|NCT03122899|degenerative sacroiliitis|degenerative sacroiliitis
4717923|NCT03122899|sacroiliac joint disruption|sacroiliac joint disruption
4717924|NCT03122899|iFuse|ifuse
4717925|NCT03122860|SM04690|sm04690
4717926|NCT03122860|Wnt pathway inhibitor|wnt pathway inhibitor
4717927|NCT03122860|osteoarthritis|osteoarthritis
4717928|NCT03122860|Samumed|samumed
4717929|NCT03122834|Heart Failure|heart failure
4717930|NCT03122834|Genetic Polymorphism|genetic polymorphism
4717931|NCT03122834|RAAS|raas
4717932|NCT03122834|Cardiac Fibrosis|cardiac fibrosis
4717933|NCT03122834|Remodeling|remodeling
4717934|NCT03122808|Tachysystole|tachysystole
4717935|NCT03122808|Excessive Uterine Activity|excessive uterine activity
4717936|NCT03122769|Metformin|metformin
4717937|NCT03122769|Heart Failure|heart failure
4717938|NCT03122769|Organic cation transporter|organic cation transporter
4717939|NCT03122769|Pharmacogenetics|pharmacogenetics
4717940|NCT03122769|Pharmacokinetics|pharmacokinetics
4717941|NCT03122769|Positron Emission Tomography|positron emission tomography
4717942|NCT03122756|Intravenous Dexamethasone|intravenous dexamethasone
4717943|NCT03122756|Spinal Anesthesia|spinal anesthesia
4717944|NCT03122756|Post-cesarean Section Pain|post-cesarean section pain
4717945|NCT03122730|Cardiac surgery|cardiac surgery
4717946|NCT03122730|Cardiopulmonary bypass|cardiopulmonary bypass
4717947|NCT03122730|Epoprostenol|epoprostenol
4717948|NCT03122717|Non-Small Cell Lung Cancer|non-small cell lung cancer
4717949|NCT03122665|Nefopam|nefopam
4717950|NCT03122665|Pharmacokinetics|pharmacokinetics
4717951|NCT03122665|Shivering,|shivering,
4717952|NCT03122665|Thermoregulation|thermoregulation
4717953|NCT03122665|Anesthesia|anesthesia
4717954|NCT03122626|stroke|stroke
4717955|NCT03122626|community-based exercise program|community-based exercise program
4717956|NCT03122626|task-oriented exercise|task-oriented exercise
4717957|NCT03122626|group exercise program|group exercise program
4717958|NCT03122626|healthcare-recreation partnership|healthcare-recreation partnership
4717959|NCT03122626|randomized controlled pilot trial|randomized controlled pilot trial
4717960|NCT03122626|mixed methods|mixed methods
4717961|NCT03122587|tACS|tacs
4717962|NCT03122587|Brain Stimulation|brain stimulation
4717963|NCT03122587|Transcranial Alternating Current Stimulation|transcranial alternating current stimulation
4717964|NCT03122587|Substance Use|substance use
4717965|NCT03122574|aromatherapy|aromatherapy
4717966|NCT03122574|pediatric|pediatric
4717967|NCT03122574|venipuncture|venipuncture
4717968|NCT03122574|lavender|lavender
4717969|NCT03122574|pain management|pain management
4717970|NCT03122548|stomach cancer|stomach cancer
4717971|NCT03122548|gastric cancer|gastric cancer
4717972|NCT03122548|esophageal cancer|esophageal cancer
4717973|NCT03122548|digestive system diseases|digestive system diseases
4717974|NCT03122548|gastrointestinal diseases|gastrointestinal diseases
4717975|NCT03122548|stomach diseases|stomach diseases
4717976|NCT03122535|Femtosecond LASIK (FS--LASIK)|femtosecond lasik (fs--lasik)
4717977|NCT03122535|Visual acuity|visual acuity
4717978|NCT03122535|Refractive errors|refractive errors
4717979|NCT03122535|Side-cut angles|side-cut angles
4717980|NCT03122522|unresectable|unresectable
4717981|NCT03122522|III or stage IV|iii or stage iv
4717982|NCT03122522|Ipilimumab|ipilimumab
4717983|NCT03122522|Nivolumab|nivolumab
4717984|NCT03122522|17-162|17-162
4717985|NCT03122509|Durvalumab|durvalumab
4717986|NCT03122509|Tremelimumab|tremelimumab
4717987|NCT03122509|Radiation Therapy|radiation therapy
4717988|NCT03122509|Ablation|ablation
4717989|NCT03122509|17-139|17-139
4717990|NCT03122496|Durvalumab (Medi4736)|durvalumab (medi4736)
4717991|NCT03122496|Tremelimumab|tremelimumab
4717992|NCT03122496|Image Guided Stereotactic Body Radiotherapy (SBRT)|image guided stereotactic body radiotherapy (sbrt)
4717993|NCT03122496|17-108|17-108
4717994|NCT03122470|TRUS biopsy|trus biopsy
4717995|NCT03122470|Pelvic MRI|pelvic mri
4717996|NCT03122457|Actinic Keratosis|actinic keratosis
4717997|NCT03122366|single nucleotide polymorphisms|single nucleotide polymorphisms
4717998|NCT03122366|Toll-like receptor-4|toll-like receptor-4
4717999|NCT03122340|Acute Coronary Syndrome|acute coronary syndrome
4718000|NCT03122340|Polyprenols|polyprenols
4718001|NCT03122340|Cholesterol|cholesterol
4718003|NCT03122314|dexketoprofen|dexketoprofen
4718004|NCT03122314|emergency department|emergency department
4718005|NCT03122314|musculoskeletal pain|musculoskeletal pain
4718006|NCT03122275|Adherence|adherence
4718007|NCT03122275|Directive Counseling|directive counseling
4718008|NCT03122262|Antiretroviral Agents, first-line antiretroviral therapy|antiretroviral agents, first-line antiretroviral therapy
4718009|NCT03122262|dolutegravir|dolutegravir
4718010|NCT03122262|Tenofovir alafenamide|tenofovir alafenamide
4718011|NCT03122249|Palliative care|palliative care
4718012|NCT03122249|Symptom management|symptom management
4718013|NCT03122249|Self-management|self-management
4718014|NCT03122249|Rural area|rural area
4718015|NCT03122249|eHealth|ehealth
4718016|NCT03122249|telehealth|telehealth
4718017|NCT03122223|HIV|hiv
4718018|NCT03122158|major depressive disorder|major depressive disorder
4718019|NCT03122158|anxiety disorders|anxiety disorders
4718020|NCT03122158|adolescent|adolescent
4718021|NCT03122158|child|child
4718022|NCT03122145|healthy|healthy
4718023|NCT03122145|volunteer|volunteer
4718024|NCT03122132|Hepatitis C Infection|hepatitis c infection
4718025|NCT03122132|Ombitasvir/Paritaprevir/Ritonavir+dasabuvir|ombitasvir/paritaprevir/ritonavir+dasabuvir
4718026|NCT03122119|Sacroiliac|sacroiliac
4718027|NCT03122119|Joint Injection|joint injection
4718028|NCT03122119|Platelet Rich Plasma|platelet rich plasma
4718029|NCT03122119|Ultrasound|ultrasound
4718030|NCT03122119|Low Back Pain|low back pain
4718031|NCT03122119|Corticosteroid|corticosteroid
4718032|NCT03122093|pediatric|pediatric
4718033|NCT03122093|dietary treatment|dietary treatment
4718034|NCT03122093|celiac disease|celiac disease
4718035|NCT03122093|T1D|t1d
4718036|NCT03122080|acupuncture|acupuncture
4718037|NCT03122080|insomnia|insomnia
4718038|NCT03122080|depression|depression
4718039|NCT03122080|antidepressants|antidepressants
4718040|NCT03122067|oxytocin|oxytocin
4718041|NCT03122067|social cognition|social cognition
4718042|NCT03122067|fMRI|fmri
4718043|NCT03122067|empathy|empathy
4718044|NCT03122054|Laparoscopic Cholecystectomy, Delayed Cholecystectomy|laparoscopic cholecystectomy, delayed cholecystectomy
4718045|NCT03122041|metformin intolerance|metformin intolerance
4718046|NCT03122041|PCOS|pcos
4718047|NCT03122041|Sitagliptin|sitagliptin
4718048|NCT03122041|beta cell function|beta cell function
4718049|NCT03122028|LAmbre|lambre
4718050|NCT03122002|Ischemic Stroke|ischemic stroke
4718051|NCT03122002|Cerebral Infarction|cerebral infarction
4718052|NCT03122002|Cerebrovascular Disorders|cerebrovascular disorders
4718053|NCT03121950|dementia|dementia
4718054|NCT03121924|oocyte denudation|oocyte denudation
4718055|NCT03121924|preincubation|preincubation
4718056|NCT03121924|icsi|icsi
4718057|NCT03121924|oocyte donation|oocyte donation
4718058|NCT03121911|Recent Myocardial Infarction|recent myocardial infarction
4718059|NCT03121911|Interval Physical Training|interval physical training
4718060|NCT03121911|Inspiratory Muscle Training|inspiratory muscle training
4718061|NCT03121911|Expiratory Flow Limitation|expiratory flow limitation
4718062|NCT03121911|Ventilatory Efficiency|ventilatory efficiency
4718063|NCT03121911|Inflammatory Markers|inflammatory markers
4718064|NCT03121911|Heart Rate Variability|heart rate variability
4718065|NCT03121859|TENS|tens
4718066|NCT03121859|interferential current therapy|interferential current therapy
4718067|NCT03121859|Chronic neck pain|chronic neck pain
4718068|NCT03121846|Apatinib|apatinib
4718069|NCT03121846|Soft Tissue Sarcoma|soft tissue sarcoma
4718070|NCT03121833|Endostar|endostar
4718071|NCT03121833|Soft Tissue Sarcoma|soft tissue sarcoma
4718072|NCT03121833|Chemotherapy|chemotherapy
4718073|NCT03121807|home parenteral nutrition|home parenteral nutrition
4718074|NCT03121794|ultrasonography|ultrasonography
4718075|NCT03121794|Intraosseous Vascular access|intraosseous vascular access
4718076|NCT03121794|humerus|humerus
4718077|NCT03121794|anatomic landmark|anatomic landmark
4718078|NCT03121768|Prognostic Model|prognostic model
4718079|NCT03121768|Bladder Cancer|bladder cancer
4718080|NCT03121768|Superficial Bladder Cancer|superficial bladder cancer
4718081|NCT03121768|Recurrence|recurrence
4718082|NCT03121768|Progression|progression
4718083|NCT03121768|BCG|bcg
4718084|NCT03121742|Suicide|suicide
4718085|NCT03121729|enhanced recovery after surgery|enhanced recovery after surgery
4718086|NCT03121729|gastric cancer|gastric cancer
4718087|NCT03121664|Drug drug interaction, CYP3A4, itraconazole|drug drug interaction, cyp3a4, itraconazole
4718088|NCT03121651|Mobile technology|mobile technology
4718089|NCT03121651|Reinforcement-learning|reinforcement-learning
4718090|NCT03121651|Medication management|medication management
4718091|NCT03121638|Varicella Vaccine|varicella vaccine
4718092|NCT03121638|Herpes Zoster Vaccine|herpes zoster vaccine
4718093|NCT03121612|RDS|rds
4718094|NCT03121573|near infrared spectroscopy, NIRS, duloxetine|near infrared spectroscopy, nirs, duloxetine
4718095|NCT03121560|Hysteroscopy|hysteroscopy
4718096|NCT03121560|Saline infusion hysterosonography|saline infusion hysterosonography
4718097|NCT03121534|Hematopoietic/Lymphoid Cancer|hematopoietic/lymphoid cancer
4718098|NCT03121534|Richter's transformation|richter's transformation
4718099|NCT03121534|RT|rt
4718100|NCT03121534|Blinatumomab|blinatumomab
4718101|NCT03121534|Dexamethasone|dexamethasone
4718102|NCT03121534|Decadron|decadron
4718103|NCT03121521|statins liver enzymes melatonin|statins liver enzymes melatonin
4718104|NCT03121430|peripheral arterial disease|peripheral arterial disease
4718105|NCT03121430|Drug eluting peripheral vascular stent system|drug eluting peripheral vascular stent system
4718106|NCT03121430|primary patency|primary patency
4718107|NCT03121378|Hip Joint Alloplasty|hip joint alloplasty
4718108|NCT03121378|Bone Cements|bone cements
4718109|NCT03121378|Impedance Aggregometry|impedance aggregometry
4718110|NCT03121378|Platelet Activation|platelet activation
4718111|NCT03121365|Digital literacy|digital literacy
4718112|NCT03121365|Reading|reading
4718113|NCT03121352|Carboplatin|carboplatin
4718114|NCT03121352|Nab-Paclitaxel|nab-paclitaxel
4718115|NCT03121352|Pembrolizumab|pembrolizumab
4718116|NCT03121326|Sarcopenia|sarcopenia
4718117|NCT03121326|Aging|aging
4718118|NCT03121326|Biomarkers|biomarkers
4718119|NCT03121326|Metabolomics|metabolomics
4718120|NCT03121313|Tegafur-uracil|tegafur-uracil
4718121|NCT03121313|distant metastasis|distant metastasis
4718122|NCT03121313|oral cavity cancer|oral cavity cancer
4718123|NCT03121261|levobupivacaine|levobupivacaine
4718124|NCT03121261|nerve fibers|nerve fibers
4718125|NCT03121261|clonidine|clonidine
4718126|NCT03121248|Accelerated radiotherapy|accelerated radiotherapy
4718127|NCT03121248|Older women|older women
4718128|NCT03121248|Hypo-fractonation|hypo-fractonation
4718129|NCT03121235|aspergillosis|aspergillosis
4718130|NCT03121235|mycosis|mycosis
4718131|NCT03121235|neutropenia|neutropenia
4718132|NCT03121235|hematologic diseases|hematologic diseases
4718133|NCT03121235|AsperGenius PCR|aspergenius pcr
4718134|NCT03121235|Ambisome|ambisome
4718135|NCT03121235|Voriconazole|voriconazole
4718136|NCT03121196|Social deprivation|social deprivation
4718137|NCT03121196|Adverse perinatal outcomes|adverse perinatal outcomes
4718138|NCT03121183|Cardiology|cardiology
4718139|NCT03121183|Device Removal|device removal
4718140|NCT03121183|Pacemaker|pacemaker
4718141|NCT03121183|Defibrillators|defibrillators
4718142|NCT03121183|Catheterization|catheterization
4718143|NCT03121183|Laser Therapy|laser therapy
4718144|NCT03121183|Cost-Benefit Analysis|cost-benefit analysis
4718145|NCT03121170|primary dysmenorrhea|primary dysmenorrhea
4718146|NCT03121170|extracorporeal shock wave therapy|extracorporeal shock wave therapy
4718147|NCT03121170|traditional Chinese medicine|traditional chinese medicine
4718148|NCT03121157|African Americans|african americans
4718149|NCT03121157|Emerging adults|emerging adults
4718150|NCT03121157|Medication adherence|medication adherence
4718151|NCT03121157|eHealth|ehealth
4718152|NCT03121118|Mild Cognitive Impairment|mild cognitive impairment
4718153|NCT03121118|Amyvid|amyvid
4718154|NCT03121118|Amyloid Imaging|amyloid imaging
4718155|NCT03121118|PET Brain Scan|pet brain scan
4718156|NCT03121118|Amyloid Plaque|amyloid plaque
4718157|NCT03121118|Ethics|ethics
4718158|NCT03121118|Results disclosure|results disclosure
4718159|NCT03121105|Idiopathic Inflammatory demyelinating disorders of the central nervous system|idiopathic inflammatory demyelinating disorders of the central nervous system
4718160|NCT03121105|Multiple Sclerosis|multiple sclerosis
4718161|NCT03121105|Neuromyelitis Optica|neuromyelitis optica
4718162|NCT03121105|MRI|mri
4718163|NCT03121105|pahtological|pahtological
4718164|NCT03121079|Interferon-alpha|interferon-alpha
4718165|NCT03121079|Relapse|relapse
4718166|NCT03121079|prevention|prevention
4718167|NCT03121079|hematopietic stem cell transplantation|hematopietic stem cell transplantation
4718168|NCT03121079|acute myeloid leukemia|acute myeloid leukemia
4718169|NCT03121066|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
4718170|NCT03121066|Non invasive brain stimulation|non invasive brain stimulation
4718171|NCT03121066|Theta Burst Protocol|theta burst protocol
4718172|NCT03121066|Brain connectivity|brain connectivity
4718173|NCT03121066|Dorsolateral prefrontal cortex|dorsolateral prefrontal cortex
4718174|NCT03121066|Parietal cortex|parietal cortex
4718175|NCT03121053|transcatheter aortic valve implantation|transcatheter aortic valve implantation
4718176|NCT03121053|transcatheter aortic valve replacement|transcatheter aortic valve replacement
4718177|NCT03121040|Vespa amino acid mixture (VAAM®)|vespa amino acid mixture (vaam®)
4718178|NCT03121040|Young athletes|young athletes
4718179|NCT03121040|Nutrition|nutrition
4718180|NCT03121040|lactic acid accumulation|lactic acid accumulation
4718181|NCT03121040|Anaerobic metabolism|anaerobic metabolism
4718182|NCT03121040|ATP|atp
4718183|NCT03121040|Sports damage|sports damage
4718184|NCT03121027|Anemia|anemia
4718185|NCT03121027|Ever married women|ever married women
4718186|NCT03121027|Economic inequality|economic inequality
4718187|NCT03121027|Diabetes|diabetes
4718188|NCT03121027|Maternity|maternity
4718189|NCT03121027|BMI|bmi
4718190|NCT03120988|Knee OA|knee oa
4718191|NCT03120988|lavage|lavage
4718192|NCT03120988|Platelet Poor Plasma (PPP)|platelet poor plasma (ppp)
4718193|NCT03120975|Anti-Infective Agents|anti-infective agents
4718194|NCT03120975|Decision Support Systems, Clinical|decision support systems, clinical
4718195|NCT03120975|Quality Improvement|quality improvement
4718196|NCT03120949|Rheumatoid Arthritis|rheumatoid arthritis
4718197|NCT03120949|moderate|moderate
4718198|NCT03120949|severe|severe
4718199|NCT03120949|subcutaneous|subcutaneous
4718200|NCT03120949|Olokizumab|olokizumab
4718201|NCT03120949|open-label|open-label
4718202|NCT03120936|Adherence|adherence
4718203|NCT03120936|Transgender|transgender
4718204|NCT03120936|PrEP|prep
4718205|NCT03120936|HIV Prevention|hiv prevention
4718206|NCT03120936|Truvada|truvada
4718207|NCT03120936|HIV Risk Reduction|hiv risk reduction
4718208|NCT03120923|subacromial injection|subacromial injection
4718209|NCT03120871|Beta cell failure|beta cell failure
4718210|NCT03120871|Puberty|puberty
4718211|NCT03120871|Microbiome|microbiome
4718212|NCT03120871|Insulin Sensitivity|insulin sensitivity
4718213|NCT03120858|motor imagery|motor imagery
4718214|NCT03120858|kinesthetic imagery|kinesthetic imagery
4718215|NCT03120858|reliability|reliability
4718216|NCT03120858|Turkish version|turkish version
4718217|NCT03120845|Pain,|pain,
4718218|NCT03120845|one-visit|one-visit
4718219|NCT03120845|two visits|two visits
4718220|NCT03120819|exercise|exercise
4718221|NCT03120819|fatigue|fatigue
4718222|NCT03120819|physical activity|physical activity
4718223|NCT03120754|ERAS|eras
4718224|NCT03120754|Peritoneal drainage|peritoneal drainage
4718225|NCT03120754|Primary Closure|primary closure
4718226|NCT03120741|Healthcare Quality|healthcare quality
4718227|NCT03120728|Emergency contraception|emergency contraception
4718228|NCT03120728|Contraceptive vaginal ring|contraceptive vaginal ring
4718229|NCT03120728|NuvaRing|nuvaring
4718230|NCT03120728|Contraception|contraception
4718231|NCT03120715|low molecular weight heparin (LMWH)|low molecular weight heparin (lmwh)
4718232|NCT03120715|frozen embryo transfer (FET)|frozen embryo transfer (fet)
4718233|NCT03120715|pregnancy|pregnancy
4718234|NCT03120689|VITOM|vitom
4718235|NCT03120689|Adult learners|adult learners
4718236|NCT03120689|Medical students|medical students
4718237|NCT03120689|Residents|residents
4718238|NCT03120689|Vaginal surgery|vaginal surgery
4718239|NCT03120689|Medical education|medical education
4718240|NCT03120676|Relapsed|relapsed
4718241|NCT03120676|Refractory|refractory
4718242|NCT03120676|Atezolizumab|atezolizumab
4718243|NCT03120676|17-191|17-191
4718244|NCT03120663|antimicrobials|antimicrobials
4718245|NCT03120663|pharmacokinetics|pharmacokinetics
4718246|NCT03120663|augmented renal clearance|augmented renal clearance
4718247|NCT03120663|non critically ill|non critically ill
4718248|NCT03120637|Methylene Blue|methylene blue
4718249|NCT03120637|Septic Shock|septic shock
4718250|NCT03120637|Vasoplegia|vasoplegia
4718251|NCT03120637|Cirrhosis|cirrhosis
4718252|NCT03120611|Exercise|exercise
4718253|NCT03120611|Hemodialysis|hemodialysis
4718254|NCT03120611|Virtual Reality|virtual reality
4718255|NCT03120598|preparation strategies|preparation strategies
4718256|NCT03120598|implementation strategies|implementation strategies
4718257|NCT03120598|sustainment strategies|sustainment strategies
4718258|NCT03120585|Respiratory Distress Syndrome, Newborn|respiratory distress syndrome, newborn
4718259|NCT03120585|fluid restriction|fluid restriction
4718260|NCT03120572|Respiratory muscle strength|respiratory muscle strength
4718261|NCT03120572|Diaphragmatic surface electromyography|diaphragmatic surface electromyography
4718262|NCT03120572|Functional capacity|functional capacity
4718263|NCT03120559|Gingivitis|gingivitis
4718264|NCT03120559|SMS|sms
4718265|NCT03120559|Dental floss|dental floss
4718266|NCT03120559|behavior change|behavior change
4718267|NCT03120559|HAPA|hapa
4718268|NCT03120546|cervical spine motion|cervical spine motion
4718269|NCT03120546|video laryngoscope|video laryngoscope
4718270|NCT03120546|rigid video stylet|rigid video stylet
4718271|NCT03120533|iontophoresis|iontophoresis
4718272|NCT03120533|treprostinil|treprostinil
4718273|NCT03120507|in-hospital cardiac arrest|in-hospital cardiac arrest
4718274|NCT03120507|IHCA|ihca
4718275|NCT03120507|quality of life|quality of life
4718276|NCT03120507|QoL|qol
4718277|NCT03120507|patient-reported outcomes|patient-reported outcomes
4718278|NCT03120494|HIV prevention, high risk MSM, sero-discordant couples, PrEP|hiv prevention, high risk msm, sero-discordant couples, prep
4718279|NCT03120468|alcohol, alcohol dependence, addiction, alcohol use disorder|alcohol, alcohol dependence, addiction, alcohol use disorder
4718280|NCT03120455|weight loss|weight loss
4718281|NCT03120455|Almond|almond
4718282|NCT03120455|Pistachio|pistachio
4718283|NCT03120455|hypoenergetic diet|hypoenergetic diet
4718284|NCT03120455|Nut|nut
4718285|NCT03120442|postoperative delirium|postoperative delirium
4718286|NCT03120442|total knee arthroplasty|total knee arthroplasty
4718287|NCT03120442|propofol|propofol
4718288|NCT03120442|dexmedetomidine|dexmedetomidine
4718289|NCT03120442|fentanyl|fentanyl
4718290|NCT03120442|inflammatory response|inflammatory response
4718291|NCT03120442|interleukins|interleukins
4718292|NCT03120442|CAM-ICU|cam-icu
4718293|NCT03120429|lean fish|lean fish
4718294|NCT03120429|weight loss|weight loss
4718295|NCT03120429|Diet|diet
4718296|NCT03120364|Herpes Zoster Vaccine|herpes zoster vaccine
4718297|NCT03120364|Prevention of Herpes Zoster|prevention of herpes zoster
4718298|NCT03120338|Child and Adolescent|child and adolescent
4718299|NCT03120338|Randomised Controlled Trial|randomised controlled trial
4718300|NCT03120338|Paediatrics|paediatrics
4718301|NCT03120338|DAWBA|dawba
4718698|NCT03117972|LDH|ldh
4718302|NCT03120338|eHealth Services|ehealth services
4718303|NCT03120312|outcome|outcome
4718304|NCT03120286|OBESITY|obesity
4718305|NCT03120286|In Vitro Fertilization (IVF)|in vitro fertilization (ivf)
4718306|NCT03120286|Polycystic ovary syndrome (PCOS)|polycystic ovary syndrome (pcos)
4718307|NCT03120260|Caloric Restriction|caloric restriction
4718308|NCT03120260|weight loss|weight loss
4718309|NCT03120260|sleep|sleep
4718310|NCT03120221|Pregnancy|pregnancy
4718311|NCT03120221|Iodine deficiency|iodine deficiency
4718312|NCT03120221|Thyroid|thyroid
4718313|NCT03120208|Postpartum psychological disorders|postpartum psychological disorders
4718314|NCT03120208|immediate postpartum hemorrhage.|immediate postpartum hemorrhage.
4718315|NCT03120182|aspirin|aspirin
4718316|NCT03120182|bleeding risk|bleeding risk
4718317|NCT03120182|intracranial bleeding|intracranial bleeding
4718318|NCT03120182|burr-hole drainage|burr-hole drainage
4718319|NCT03120182|chronic subdural hematoma|chronic subdural hematoma
4718320|NCT03120182|anticoagulation|anticoagulation
4718321|NCT03120169|COPD|copd
4718322|NCT03120169|exercise|exercise
4718323|NCT03120169|training|training
4718324|NCT03120169|cycling|cycling
4718325|NCT03120169|treadmill|treadmill
4718326|NCT03120169|walking|walking
4718327|NCT03120169|pulmonary rehabilitation|pulmonary rehabilitation
4718328|NCT03120156|sensomotoric insoles|sensomotoric insoles
4718329|NCT03120156|postural control|postural control
4718330|NCT03120156|proprioceptive insoles|proprioceptive insoles
4718331|NCT03120156|insoles|insoles
4718332|NCT03120143|Small-sided ball games|small-sided ball games
4718333|NCT03120143|Aging|aging
4718334|NCT03120143|Muscle mass|muscle mass
4718335|NCT03120143|Health|health
4718336|NCT03120143|Training|training
4718337|NCT03120143|Protein intake|protein intake
4718338|NCT03120143|Physical function|physical function
4718339|NCT03120143|Physiological adaptations|physiological adaptations
4718340|NCT03120130|Phase I,|phase i,
4718341|NCT03120117|Midurethral Slings|midurethral slings
4718342|NCT03120078|Ultrasound|ultrasound
4718343|NCT03120065|adherence|adherence
4718344|NCT03120013|Transcranial direct current stimulation|transcranial direct current stimulation
4718345|NCT03120013|Transcranial magnetic stimulation|transcranial magnetic stimulation
4718346|NCT03120013|Spinocerebellar ataxia|spinocerebellar ataxia
4718347|NCT03120013|Cerebellar ataxia|cerebellar ataxia
4718348|NCT03120000|DLBCL|dlbcl
4718349|NCT03119987|Red cell Distribution Width|red cell distribution width
4718350|NCT03119987|Risk|risk
4718351|NCT03119987|Mortality|mortality
4718352|NCT03119987|Hemorrhage|hemorrhage
4718354|NCT03119974|TPO-RAS|tpo-ras
4718355|NCT03119974|Thrombopoietin-receptor agonists|thrombopoietin-receptor agonists
4718356|NCT03119961|Amyloid Amyloid Plaque|amyloid amyloid plaque
4718357|NCT03119961|Tau Protein|tau protein
4718358|NCT03119961|Sonication|sonication
4718359|NCT03119948|Muscle spasticity|muscle spasticity
4718360|NCT03119948|Botulinum toxin|botulinum toxin
4718361|NCT03119935|ambu bag, ventilation, tidal volume|ambu bag, ventilation, tidal volume
4718362|NCT03119922|major sickle cell disease (SCD)|major sickle cell disease (scd)
4718363|NCT03119922|children|children
4718364|NCT03119922|pneumococcal preventive measures|pneumococcal preventive measures
4718365|NCT03119909|fMRI|fmri
4718366|NCT03119909|cingulate cortex|cingulate cortex
4718367|NCT03119909|adaptation|adaptation
4718368|NCT03119909|frontal cortex|frontal cortex
4718369|NCT03119896|chronic pain|chronic pain
4718370|NCT03119896|self-management|self-management
4718371|NCT03119896|pain management|pain management
4718372|NCT03119896|doctor patient communication|doctor patient communication
4718373|NCT03119896|primary care|primary care
4718374|NCT03119883|Myeloma|myeloma
4718375|NCT03119883|Metabolism|metabolism
4718376|NCT03119883|Glutamine|glutamine
4718377|NCT03119870|fMRI|fmri
4718378|NCT03119870|EEG|eeg
4718379|NCT03119870|behavior|behavior
4718380|NCT03119870|cingulate cortex|cingulate cortex
4718381|NCT03119857|Non-metastatic Prostate Cancer|non-metastatic prostate cancer
4718382|NCT03119831|chlorhexidine|chlorhexidine
4718383|NCT03119831|alcohol|alcohol
4718384|NCT03119831|C31G|c31g
4718385|NCT03119831|Mouthrinses|mouthrinses
4718386|NCT03119831|Early postsurgical wound healing|early postsurgical wound healing
4718387|NCT03119818|ESRD|esrd
4718388|NCT03119818|hemodialysis|hemodialysis
4718389|NCT03119818|phosphate|phosphate
4718390|NCT03119818|ATP|atp
4718391|NCT03119818|magnetic resonance spectroscopy|magnetic resonance spectroscopy
4718392|NCT03119805|composite scores|composite scores
4718393|NCT03119805|patient reported outcomes|patient reported outcomes
4718394|NCT03119805|patient perpective|patient perpective
4718395|NCT03119805|physician perspective|physician perspective
4718396|NCT03119805|cut-off values|cut-off values
4718397|NCT03119805|flare|flare
4718398|NCT03119805|remission|remission
4718399|NCT03119805|minimal disease activity|minimal disease activity
4718400|NCT03119805|low disease activity|low disease activity
4718401|NCT03119792|Behavioral Modification|behavioral modification
4718402|NCT03119792|Health Community|health community
4718403|NCT03119792|Community Intervention|community intervention
4718404|NCT03119792|Prevention|prevention
4718405|NCT03119792|Cardiovascular Health|cardiovascular health
4718406|NCT03119792|Education Intervention|education intervention
4718407|NCT03119792|Colombia|colombia
4718408|NCT03119779|pulpotomy|pulpotomy
4718409|NCT03119779|deep caries|deep caries
4718410|NCT03119779|permanent molars|permanent molars
4718411|NCT03119779|MTA|mta
4718412|NCT03119753|Rapid Prototyping technique|rapid prototyping technique
4718413|NCT03119753|complete denture|complete denture
4718414|NCT03119714|bronchoprovocation|bronchoprovocation
4718415|NCT03119714|early-late asthmatic reaction|early-late asthmatic reaction
4718416|NCT03119714|mast cell stabilizer|mast cell stabilizer
4718417|NCT03119714|mast cell mediators|mast cell mediators
4718418|NCT03119714|sputum eosinophils|sputum eosinophils
4718419|NCT03119701|Patients Surviving Open Surgery|patients surviving open surgery
4718420|NCT03119701|Ruptured Abdominal Aortic Aneurysm|ruptured abdominal aortic aneurysm
4718421|NCT03119675|Myopia|myopia
4718422|NCT03119675|Hyperopia|hyperopia
4718423|NCT03119675|Anisometropia|anisometropia
4718424|NCT03119675|Amblyopia Risk Factors|amblyopia risk factors
4718425|NCT03119675|Risk Factors|risk factors
4718426|NCT03119675|Smartphone Application (App)|smartphone application (app)
4718427|NCT03119675|Photoscreening|photoscreening
4718428|NCT03119675|Vision Screening|vision screening
4718429|NCT03119675|Mobile Vision Screening|mobile vision screening
4718430|NCT03119662|Acute kidney injury (AKI)|acute kidney injury (aki)
4718431|NCT03119662|Acute kidney injury network (AKIN)|acute kidney injury network (akin)
4718432|NCT03119662|Chronic kidney disease (CKD)|chronic kidney disease (ckd)
4718433|NCT03119662|Contrast-enhanced computed tomography (CECT)|contrast-enhanced computed tomography (cect)
4718434|NCT03119662|Endovascular Aneurysm Repair (EVAR)|endovascular aneurysm repair (evar)
4718435|NCT03119662|Iodixanol|iodixanol
4718436|NCT03119662|Non-enhanced computed tomography (NECT)|non-enhanced computed tomography (nect)
4718437|NCT03119662|Serum creatinine (SCr)|serum creatinine (scr)
4718438|NCT03119623|Heart Failure|heart failure
4718439|NCT03119623|Endothelial function|endothelial function
4718440|NCT03119623|Brachial Artery Reactivity Test|brachial artery reactivity test
4718441|NCT03119623|Sacubitril/Valsartan|sacubitril/valsartan
4718442|NCT03119623|Enalapril|enalapril
4718443|NCT03119623|HFREF|hfref
4718444|NCT03119597|low mood, depression|low mood, depression
4718445|NCT03119584|chronic constipation|chronic constipation
4718446|NCT03119584|diabetes|diabetes
4718447|NCT03119571|Cardiac arrest|cardiac arrest
4718448|NCT03119571|Ventricular fibrillation|ventricular fibrillation
4718449|NCT03119571|coronary artery disease|coronary artery disease
4718450|NCT03119545|intervention|intervention
4718451|NCT03119545|support program|support program
4718452|NCT03119545|family centered|family centered
4718453|NCT03119545|parental death|parental death
4718454|NCT03119519|NSCLC|nsclc
4718455|NCT03119519|Oligometastases|oligometastases
4718456|NCT03119519|radiotherapy|radiotherapy
4718457|NCT03119493|Metabolic syndrome X|metabolic syndrome x
4718458|NCT03119493|Autonomic nervous system|autonomic nervous system
4718459|NCT03119493|Aerobic exercise|aerobic exercise
4718460|NCT03119493|Exercise|exercise
4718461|NCT03119493|Heart rate|heart rate
4718462|NCT03119480|Acute Kidney Injury|acute kidney injury
4718463|NCT03119480|Electronic alerts|electronic alerts
4718464|NCT03119402|Reading|reading
4718465|NCT03119402|Developmental Dyslexia|developmental dyslexia
4718466|NCT03119402|Music|music
4718467|NCT03119402|Rhythm|rhythm
4718468|NCT03119402|transcranial electrical stimulation|transcranial electrical stimulation
4718469|NCT03119402|transcranial direct current stimulation|transcranial direct current stimulation
4718470|NCT03119389|Hand Hygiene|hand hygiene
4718471|NCT03119389|Non-sterile glove use|non-sterile glove use
4718472|NCT03119376|peer review|peer review
4718473|NCT03119376|online tool|online tool
4718474|NCT03119376|Randomized Controlled Trial|randomized controlled trial
4718475|NCT03119363|cancer-related fatigue|cancer-related fatigue
4718476|NCT03119363|circadian rhythms|circadian rhythms
4718477|NCT03119363|light therapy|light therapy
4718478|NCT03119363|systematic light exposure|systematic light exposure
4718479|NCT03119363|cancer survivors|cancer survivors
4718480|NCT03119363|oncology|oncology
4718481|NCT03119363|Multiple Myeloma|multiple myeloma
4718482|NCT03119363|Hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
4718483|NCT03119363|Autologous stem cell transplantation|autologous stem cell transplantation
4718484|NCT03119337|male circumcision, text-based follow-up, Zimbabwe,|male circumcision, text-based follow-up, zimbabwe,
4718485|NCT03119324|Biomodulation|biomodulation
4718486|NCT03119324|LLLT|lllt
4718487|NCT03119324|Temporomandibular Joint Disorders|temporomandibular joint disorders
4718488|NCT03119324|Pain management|pain management
4718489|NCT03119285|ovarian cancer|ovarian cancer
4718490|NCT03119285|BRCA1|brca1
4718491|NCT03119285|BRCA2|brca2
4718492|NCT03119285|BROCA|broca
4718493|NCT03119246|beta testing|beta testing
4718494|NCT03119246|assessment battery|assessment battery
4718495|NCT03119246|HD|hd
4718496|NCT03119207|ICU|icu
4718497|NCT03119168|screening|screening
4718498|NCT03119168|adenoma detection rate|adenoma detection rate
4718499|NCT03119168|simethicone|simethicone
4718500|NCT03119155|Congenital Heart Disease|congenital heart disease
4718501|NCT03119155|Echocardiography|echocardiography
4718502|NCT03119155|Diagnosis|diagnosis
4718503|NCT03119129|prevention|prevention
4718504|NCT03119129|health disparities|health disparities
4718505|NCT03119129|Native Hawaiians and other Pacific Islanders|native hawaiians and other pacific islanders
4718506|NCT03119116|Stroke Prevention in NVAF patients|stroke prevention in nvaf patients
4718507|NCT03119103|respiratory pattern|respiratory pattern
4718508|NCT03119103|sensor data|sensor data
4718509|NCT03119103|bed sheet|bed sheet
4718510|NCT03119103|pressure|pressure
4718511|NCT03119103|respiration rate|respiration rate
4718512|NCT03119090|biomarkers|biomarkers
4718513|NCT03119090|Fontan operation|fontan operation
4718514|NCT03119090|Single ventricle|single ventricle
4718515|NCT03119090|congenital heart disease|congenital heart disease
4718516|NCT03119077|PCOS|pcos
4718517|NCT03119051|mild cognitive impairment|mild cognitive impairment
4718518|NCT03119038|total hip|total hip
4718519|NCT03119038|degenerative joint disease|degenerative joint disease
4718520|NCT03119038|osteoarthritis|osteoarthritis
4718521|NCT03119025|Dendritic Cells|dendritic cells
4718522|NCT03119025|DC-based Vaccines|dc-based vaccines
4718523|NCT03119025|Chronic HCV Infection|chronic hcv infection
4718524|NCT03119025|Antigen-Specific T cell response|antigen-specific t cell response
4718525|NCT03119025|Recombinant HCV-Core antigen|recombinant hcv-core antigen
4718526|NCT03119025|Recombinant HCV-NS3 antigen|recombinant hcv-ns3 antigen
4718527|NCT03119012|Bioresorbable scaffold|bioresorbable scaffold
4718528|NCT03119012|Dual antiplatelet therapy|dual antiplatelet therapy
4718529|NCT03119012|P2Y12 receptor inhibitor|p2y12 receptor inhibitor
4718530|NCT03119012|Coronary artery disease|coronary artery disease
4718531|NCT03118986|olanzapine|olanzapine
4718532|NCT03118986|vomiting|vomiting
4718533|NCT03118986|children|children
4718534|NCT03118986|adolescents|adolescents
4718535|NCT03118986|bone marrow transplant|bone marrow transplant
4718536|NCT03118986|supportive care|supportive care
4718537|NCT03118934|contact lenses|contact lenses
4718538|NCT03118934|presbyopia|presbyopia
4718539|NCT03118934|multifocal|multifocal
4718540|NCT03118908|Succinate|succinate
4718541|NCT03118908|B complex vitamins|b complex vitamins
4718542|NCT03118908|menopause|menopause
4718543|NCT03118882|Breast cancer screening|breast cancer screening
4718544|NCT03118882|Colorectal Cancer screening|colorectal cancer screening
4718545|NCT03118882|Primary prevention|primary prevention
4718546|NCT03118882|Lifestyles|lifestyles
4718547|NCT03118882|Teachable moment|teachable moment
4718548|NCT03118869|Asthma|asthma
4718549|NCT03118869|B2 adrenergic receptors|b2 adrenergic receptors
4718550|NCT03118869|Polymorphism|polymorphism
4718551|NCT03118804|Weaning|weaning
4718552|NCT03118804|Mechanical ventilation|mechanical ventilation
4718553|NCT03118804|Electrical impedance tomography|electrical impedance tomography
4718554|NCT03118804|Tidal distribution|tidal distribution
4718555|NCT03118778|Stress Ulcer Prevention|stress ulcer prevention
4718556|NCT03118726|LARC|larc
4718557|NCT03118726|New Mexico|new mexico
4718558|NCT03118726|Contraception|contraception
4718559|NCT03118713|Glimepride|glimepride
4718560|NCT03118713|Metformin|metformin
4718561|NCT03118713|Ipragliflozin|ipragliflozin
4718562|NCT03118713|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
4718563|NCT03118713|ASP1941|asp1941
4718564|NCT03118687|Immune system|immune system
4718565|NCT03118674|Interventional, Open-label, PCT, Hepatitis C|interventional, open-label, pct, hepatitis c
4718566|NCT03118648|upper limb|upper limb
4718567|NCT03118648|functional recovery|functional recovery
4718568|NCT03118648|activities of daily living|activities of daily living
4718569|NCT03118635|Summer|summer
4718570|NCT03118635|Diet|diet
4718571|NCT03118635|Physical Activity|physical activity
4718572|NCT03118635|Sedentary behavior|sedentary behavior
4718573|NCT03118635|Low-income|low-income
4718574|NCT03118609|Caregivers|caregivers
4718575|NCT03118609|Chronic Pain|chronic pain
4718576|NCT03118596|intubation|intubation
4718577|NCT03118596|tracheal|tracheal
4718578|NCT03118596|airway device|airway device
4718579|NCT03118596|supra-glottic airway device|supra-glottic airway device
4718580|NCT03118596|fibreoptic scope|fibreoptic scope
4718581|NCT03118570|Osteogenesis Imperfecta|osteogenesis imperfecta
4718582|NCT03118570|Brittle Bone Disease|brittle bone disease
4718583|NCT03118557|pelvic floor|pelvic floor
4718584|NCT03118557|strengthening|strengthening
4718585|NCT03118557|Stress|stress
4718586|NCT03118557|urinary|urinary
4718587|NCT03118557|incontinence|incontinence
4718588|NCT03118544|Chronic Total Occlusion|chronic total occlusion
4718589|NCT03118544|Coronary Artery Disease|coronary artery disease
4718590|NCT03118544|Percutaneous Coronary Intervention|percutaneous coronary intervention
4718591|NCT03118544|CTO|cto
4718592|NCT03118544|PCI|pci
4718593|NCT03118531|Long Lesion|long lesion
4718594|NCT03118531|In-stent Late Lumen Loss (LLL)|in-stent late lumen loss (lll)
4718595|NCT03118531|Major Adverse Cardiac Events (MACE)|major adverse cardiac events (mace)
4718596|NCT03118531|MYOCARDIAL INFARCTION (MI)|myocardial infarction (mi)
4718597|NCT03118531|TARGET VESSEL REVASCULARIZATION (TVR)|target vessel revascularization (tvr)
4718598|NCT03118531|TARGET LESION REVASCULARIZATION (TLR)|target lesion revascularization (tlr)
4718599|NCT03118531|Target Vessel Failure (TVF)|target vessel failure (tvf)
4718600|NCT03118531|Target Lesion Failure (TLF)|target lesion failure (tlf)
4718601|NCT03118531|Stent Thrombosis (ST)|stent thrombosis (st)
4718602|NCT03118479|IHH|ihh
4718603|NCT03118479|KS|ks
4718604|NCT03118479|Idiopathic hypogonadotropic hypogonadism|idiopathic hypogonadotropic hypogonadism
4718605|NCT03118479|GnRH deficiency|gnrh deficiency
4718606|NCT03118466|AML|aml
4718607|NCT03118453|Musculoskeletal pain/*therapy|musculoskeletal pain/*therapy
4718608|NCT03118453|Behavioral medicine|behavioral medicine
4718609|NCT03118453|Physical therapy|physical therapy
4718610|NCT03118453|Cost-benefit analyses|cost-benefit analyses
4718611|NCT03118453|Treatment outcome|treatment outcome
4718612|NCT03118453|Adults|adults
4718613|NCT03118440|Fluoroscopy|fluoroscopy
4718614|NCT03118440|Pacemaker|pacemaker
4718615|NCT03118440|Three dimensional|three dimensional
4718616|NCT03118440|Radiation|radiation
4718617|NCT03118440|Imaging|imaging
4718618|NCT03118427|Fluoroscopy|fluoroscopy
4718619|NCT03118427|Pacemaker|pacemaker
4718620|NCT03118427|Three dimensional|three dimensional
4718621|NCT03118427|Radiation|radiation
4718622|NCT03118427|Imaging|imaging
4718623|NCT03118414|Balance|balance
4718624|NCT03118414|Cognition|cognition
4718625|NCT03118414|Exercise|exercise
4718626|NCT03118362|Burns|burns
4718627|NCT03118362|Critically ill|critically ill
4718628|NCT03118362|Acid-Base status|acid-base status
4718629|NCT03118349|CA19-9 Positive Malignancies|ca19-9 positive malignancies
4718630|NCT03118323|willingness topay|willingness topay
4718631|NCT03118323|WTP|wtp
4718632|NCT03118323|health economic|health economic
4718633|NCT03118323|preference-based measures|preference-based measures
4718634|NCT03118310|Reduction of liver fat|reduction of liver fat
4718635|NCT03118297|Etonogestrel Implant|etonogestrel implant
4718636|NCT03118284|Foley catheter|foley catheter
4718637|NCT03118271|lumbar disc herniation|lumbar disc herniation
4718638|NCT03118271|lumbar traction|lumbar traction
4718639|NCT03118271|spinal manipulation|spinal manipulation
4718640|NCT03118271|lumbar surgery|lumbar surgery
4718641|NCT03118258|Vaginal HPV self-sampling|vaginal hpv self-sampling
4718642|NCT03118258|Pap test smear|pap test smear
4718643|NCT03118258|cervical cancer screening|cervical cancer screening
4718644|NCT03118258|deprivation|deprivation
4718645|NCT03118258|sexual and reproductive health|sexual and reproductive health
4718646|NCT03118258|Precariousness|precariousness
4718647|NCT03118232|Nursing Homes|nursing homes
4718648|NCT03118232|Health Facilities|health facilities
4718649|NCT03118232|Infections|infections
4718650|NCT03118232|Readmissions|readmissions
4718651|NCT03118232|Multi-Drug resistance|multi-drug resistance
4718652|NCT03118232|Antibiotic Use|antibiotic use
4718653|NCT03118219|assisted reproductive technology|assisted reproductive technology
4718654|NCT03118219|embryo transfer|embryo transfer
4718655|NCT03118219|online intervention|online intervention
4718656|NCT03118219|rct|rct
4718657|NCT03118206|Lumbar spinal stenosis|lumbar spinal stenosis
4718658|NCT03118206|spinal manipulation|spinal manipulation
4718659|NCT03118206|physical therapy|physical therapy
4718660|NCT03118206|surgery|surgery
4718661|NCT03118193|depression|depression
4718662|NCT03118193|antidepressant|antidepressant
4718663|NCT03118193|resistance|resistance
4718664|NCT03118167|Acrylamide|acrylamide
4718665|NCT03118167|Tea polyphenols|tea polyphenols
4718666|NCT03118167|Water-soluble antioxidant of bamboo leaves|water-soluble antioxidant of bamboo leaves
4718667|NCT03118154|endometriosis|endometriosis
4718668|NCT03118154|pelvic pain|pelvic pain
4718669|NCT03118154|dysmenorrhea|dysmenorrhea
4718670|NCT03118141|preimplantation genetic screening|preimplantation genetic screening
4718671|NCT03118141|single embryo transfer|single embryo transfer
4718672|NCT03118141|frozen embryo transfer|frozen embryo transfer
4718673|NCT03118141|cumulative live birth rate|cumulative live birth rate
4718674|NCT03118128|Acute Lymphoblastic Leukemia (ALL), ABCB1, Metformin|acute lymphoblastic leukemia (all), abcb1, metformin
4718675|NCT03118115|bioimpedance|bioimpedance
4718676|NCT03118115|thrombosis|thrombosis
4718677|NCT03118115|free flap|free flap
4718678|NCT03118115|microsurgerie|microsurgerie
4718679|NCT03118115|breast reconstruction|breast reconstruction
4718680|NCT03118089|Oral nutritional supplements|oral nutritional supplements
4718681|NCT03118050|exercise|exercise
4718682|NCT03118050|bed rest|bed rest
4718683|NCT03118050|muscle|muscle
4718684|NCT03118050|nutrition|nutrition
4718685|NCT03118050|amino acids|amino acids
4718686|NCT03118037|Radiofrequency Ablation|radiofrequency ablation
4718687|NCT03118024|deep inferior epigastric perforator flap|deep inferior epigastric perforator flap
4718688|NCT03118024|fluid restriction|fluid restriction
4718689|NCT03118024|catecholamine restriction|catecholamine restriction
4718690|NCT03118011|Tobacco use, withdrawal symptoms|tobacco use, withdrawal symptoms
4718691|NCT03117985|HIV reservoirs|hiv reservoirs
4718692|NCT03117985|HIV persistence|hiv persistence
4718693|NCT03117985|Viral rebound|viral rebound
4718694|NCT03117972|Metastatic colorectal cancer|metastatic colorectal cancer
4718695|NCT03117972|Biomarker|biomarker
4718696|NCT03117972|Chemotherapy intensification|chemotherapy intensification
4718697|NCT03117972|Syndecan1|syndecan1
4718699|NCT03117972|CD138|cd138
4718700|NCT03117946|immunomonitoring|immunomonitoring
4718701|NCT03117946|immune checkpoint|immune checkpoint
4718702|NCT03117946|chemoradiation|chemoradiation
4718703|NCT03117946|T cells|t cells
4718704|NCT03117933|BRCA1/2 mutation|brca1/2 mutation
4718705|NCT03117933|Platinum resistance|platinum resistance
4718706|NCT03117920|Refractory pancreatic cancer|refractory pancreatic cancer
4718707|NCT03117920|Minnelide|minnelide
4718708|NCT03117920|Minnelide002|minnelide002
4718709|NCT03117920|2017-000126-36|2017-000126-36
4718710|NCT03117881|Multiple Sclerosis|multiple sclerosis
4718711|NCT03117881|Yoga|yoga
4718712|NCT03117881|Pilates|pilates
4718713|NCT03117881|Telerehabilitation|telerehabilitation
4718714|NCT03117881|Physical activity|physical activity
4718715|NCT03117842|Female entertainment workers|female entertainment workers
4718716|NCT03117842|mHealth|mhealth
4718717|NCT03117842|HIV testing|hiv testing
4718718|NCT03117842|Cambodia|cambodia
4718719|NCT03117816|deep molecular remission of MR4 or better|deep molecular remission of mr4 or better
4718720|NCT03117803|Aneurysm, Intracranial|aneurysm, intracranial
4718721|NCT03117803|Registries|registries
4718722|NCT03117803|Multicenter Studies|multicenter studies
4718723|NCT03117803|People's Republic of China|people's republic of china
4718724|NCT03117790|elderly|elderly
4718725|NCT03117790|surgery|surgery
4718726|NCT03117790|analgesia|analgesia
4718727|NCT03117790|dexmedetomidine|dexmedetomidine
4718728|NCT03117790|sleep quality|sleep quality
4718729|NCT03117751|Leukemia|leukemia
4718730|NCT03117751|Lymphoma|lymphoma
4718731|NCT03117751|Pediatric|pediatric
4718732|NCT03117751|B-Cell|b-cell
4718733|NCT03117751|T-Cell|t-cell
4718734|NCT03117725|oxidative stress|oxidative stress
4718735|NCT03117725|antioxidants|antioxidants
4718736|NCT03117725|diminished ovarian reserve|diminished ovarian reserve
4718737|NCT03117712|cerebral blood supply|cerebral blood supply
4718738|NCT03117712|cardiopulmonary bypass|cardiopulmonary bypass
4718739|NCT03117712|open-heart cardiac surgery|open-heart cardiac surgery
4718740|NCT03117699|Hemiplegia|hemiplegia
4718741|NCT03117699|transport device|transport device
4718742|NCT03117673|right ventricular systolic pressure (RVSP)|right ventricular systolic pressure (rvsp)
4718743|NCT03117673|Transesophageal echocardiography|transesophageal echocardiography
4718744|NCT03117634|anti vegf|anti vegf
4718745|NCT03117634|aflibercept|aflibercept
4718746|NCT03117634|treat and extend|treat and extend
4718747|NCT03117621|Blincyto|blincyto
4718748|NCT03117608|OA|oa
4718749|NCT03117608|aMAT|amat
4718750|NCT03117608|PRP|prp
4718751|NCT03117595|Single Shot Spinal|single shot spinal
4718752|NCT03117595|Intrathecal narcotics|intrathecal narcotics
4718753|NCT03117595|Morphine|morphine
4718754|NCT03117595|Fentanyl|fentanyl
4718755|NCT03117595|Labour Analgesia|labour analgesia
4718756|NCT03117582|C. diff|c. diff
4718757|NCT03117582|CDI|cdi
4718758|NCT03117582|Clostridium Difficile Infection|clostridium difficile infection
4718759|NCT03117582|Diarrhea|diarrhea
4718760|NCT03117582|Fecal microbiota transplantation|fecal microbiota transplantation
4718761|NCT03117582|FMT|fmt
4718762|NCT03117543|Screening|screening
4718763|NCT03117530|minocycline|minocycline
4718764|NCT03117530|brain inflammation|brain inflammation
4718765|NCT03117530|microglia|microglia
4718766|NCT03117530|cognition|cognition
4718767|NCT03117517|PCOS|pcos
4718768|NCT03117504|Stress urinary incontinence|stress urinary incontinence
4718769|NCT03117504|SUI|sui
4718770|NCT03117491|Gow-Gates nerve block|gow-gates nerve block
4718771|NCT03117491|Inferior alveolar nerve block|inferior alveolar nerve block
4718772|NCT03117491|local anesthesia|local anesthesia
4718773|NCT03117491|molar|molar
4718774|NCT03117491|pulpitis|pulpitis
4718775|NCT03117452|schizophrenia|schizophrenia
4718776|NCT03117452|visual processing|visual processing
4718777|NCT03117452|cognitive training|cognitive training
4718778|NCT03117452|visual training|visual training
4718779|NCT03117426|Symfony Extended Range of Vision IOL|symfony extended range of vision iol
4718780|NCT03117426|AT LISA tri 839MP IOL|at lisa tri 839mp iol
4718781|NCT03117426|Trifocal IOL|trifocal iol
4718782|NCT03117426|Extended depth of focus IOLs|extended depth of focus iols
4718783|NCT03117413|Cochlear implantation|cochlear implantation
4718784|NCT03117413|Deafness|deafness
4718785|NCT03117413|Auditory cortex|auditory cortex
4718786|NCT03117413|Auditory plasticity|auditory plasticity
4718787|NCT03117413|Tinnitus|tinnitus
4718788|NCT03117361|multiple myeloma|multiple myeloma
4718789|NCT03117361|plitidepsin|plitidepsin
4718790|NCT03117361|Aplidin|aplidin
4718791|NCT03117348|Enteral Nutrition|enteral nutrition
4718792|NCT03117348|Digestive System Neoplasms|digestive system neoplasms
4718793|NCT03117348|Randomized Controlled Trial|randomized controlled trial
4718794|NCT03117348|Clinical Outcomes|clinical outcomes
4718795|NCT03117335|Non-small Cell Lung Cancer|non-small cell lung cancer
4718796|NCT03117335|Sulijia|sulijia
4718797|NCT03117335|Recombinant endostatin|recombinant endostatin
4718798|NCT03117335|Vinorelbine|vinorelbine
4718799|NCT03117335|Cisplatin|cisplatin
4718800|NCT03117322|cerebral palsy|cerebral palsy
4718801|NCT03117322|children|children
4718802|NCT03117322|chronic constipation|chronic constipation
4718803|NCT03117322|synbiotic|synbiotic
4718804|NCT03117322|prebiotics|prebiotics
4718805|NCT03117322|probiotics|probiotics
4718806|NCT03117322|agave inulin|agave inulin
4718807|NCT03117322|microbiota|microbiota
4718808|NCT03117309|Nivolumab|nivolumab
4718809|NCT03117309|Ipilimumab|ipilimumab
4718810|NCT03117309|OPDIVO|opdivo
4718811|NCT03117309|IgG1 kappa immunoglobulin|igg1 kappa immunoglobulin
4718812|NCT03117296|physical therapy|physical therapy
4718813|NCT03117296|occupational therapy|occupational therapy
4718814|NCT03117296|tAVR|tavr
4718815|NCT03117283|Laparoscopic surgery|laparoscopic surgery
4718816|NCT03117283|Radical total gastrectomy|radical total gastrectomy
4718817|NCT03117283|Bursectomy|bursectomy
4718818|NCT03117283|Advanced posterior gastric wall cancer|advanced posterior gastric wall cancer
4718819|NCT03117257|Lobaplatin|lobaplatin
4718820|NCT03117257|head and neck cancer|head and neck cancer
4718821|NCT03117257|chronic-chemotherapy|chronic-chemotherapy
4718822|NCT03117231|osteoarthritis|osteoarthritis
4718823|NCT03117231|elderly|elderly
4718824|NCT03117231|musculoskeletal pain|musculoskeletal pain
4718825|NCT03117231|transcranial direct current stimulation|transcranial direct current stimulation
4718826|NCT03117192|zinc supplementation|zinc supplementation
4718827|NCT03117192|immunity|immunity
4718828|NCT03117192|thalassemia|thalassemia
4718829|NCT03117166|lidocaine implantation ICD|lidocaine implantation icd
4718830|NCT03117140|Brachial Plexus Block|brachial plexus block
4718831|NCT03117140|Clonidine|clonidine
4718832|NCT03117140|Dexamethasone|dexamethasone
4718833|NCT03117140|Buprenorphine|buprenorphine
4718834|NCT03117114|colonoscopy|colonoscopy
4718836|NCT03117114|resection|resection
4718837|NCT03117101|Tolerability Pharmacokinetics|tolerability pharmacokinetics
4718838|NCT03117088|Standardized handover|standardized handover
4718839|NCT03117088|Online-based|online-based
4718840|NCT03117088|SOFA-Score|sofa-score
4718841|NCT03117088|ICU|icu
4718842|NCT03117088|ISBAR3|isbar3
4718843|NCT03117075|cancer pain, wearable device|cancer pain, wearable device
4718844|NCT03117036|lymphoma|lymphoma
4718845|NCT03117036|cohort|cohort
4718846|NCT03117036|serum|serum
4718847|NCT03117036|cell-free DNA|cell-free dna
4718848|NCT03117023|dexmedetomidine|dexmedetomidine
4718849|NCT03117023|sleep deprivation|sleep deprivation
4718850|NCT03117023|gastric cancer|gastric cancer
4718851|NCT03117023|middle-aged and elderly patient|middle-aged and elderly patient
4718852|NCT03117010|Hemophagocytic lymphohistiocytosis|hemophagocytic lymphohistiocytosis
4718853|NCT03116997|neuromuscular blockade|neuromuscular blockade
4718854|NCT03116997|sugammadex|sugammadex
4718855|NCT03116997|SUG|sug
4718856|NCT03116997|neostigmine|neostigmine
4718857|NCT03116997|NEO/GLYCO|neo/glyco
4718858|NCT03116997|17-207|17-207
4718859|NCT03116984|Hepatocellular Carcinoma|hepatocellular carcinoma
4718860|NCT03116984|external- beam radiotherapy (EBRT)|external- beam radiotherapy (ebrt)
4718861|NCT03116984|transarterial chemoembolization (TACE)|transarterial chemoembolization (tace)
4718862|NCT03116971|M3814, Small Cell Lung Cancer (SCLC), Deoxyribonucleic acid-dependent protein kinase inhibitor, Chemotherapy|m3814, small cell lung cancer (sclc), deoxyribonucleic acid-dependent protein kinase inhibitor, chemotherapy
4718863|NCT03116958|CPAP compliance|cpap compliance
4718864|NCT03116958|Telemedicine integrated platform|telemedicine integrated platform
4718865|NCT03116958|Standard management|standard management
4718866|NCT03116958|Cost-effectiveness|cost-effectiveness
4718867|NCT03116945|PET/CT|pet/ct
4718868|NCT03116945|68Gallium Citrate|68gallium citrate
4718869|NCT03116945|Hepatocellular carcinoma|hepatocellular carcinoma
4718870|NCT03116932|HIV prevention, high risk MSM, PrEP|hiv prevention, high risk msm, prep
4718871|NCT03116919|nutrition|nutrition
4718872|NCT03116919|Potatoes|potatoes
4718873|NCT03116919|endothelial function|endothelial function
4718874|NCT03116919|feeding trial|feeding trial
4718875|NCT03116880|Aorta, Abdominal/surgery|aorta, abdominal/surgery
4718876|NCT03116880|Endovascular Procedures|endovascular procedures
4718877|NCT03116854|Acute Coronary Syndrome|acute coronary syndrome
4718878|NCT03116854|Beta Blockers|beta blockers
4718879|NCT03116854|Prognosis|prognosis
4718880|NCT03116828|epilepsy|epilepsy
4718881|NCT03116828|seizures|seizures
4718882|NCT03116828|partial on-set seizures|partial on-set seizures
4718883|NCT03116815|blood pressure|blood pressure
4718884|NCT03116815|monitoring|monitoring
4718885|NCT03116815|hypertension|hypertension
4718886|NCT03116815|patient reported outcomes|patient reported outcomes
4718887|NCT03116776|walnut shell glasses moxibustion|walnut shell glasses moxibustion
4718888|NCT03116776|dry eye|dry eye
4718889|NCT03116776|randomized controlled trial|randomized controlled trial
4718890|NCT03116750|mechanical thrombectomy|mechanical thrombectomy
4718891|NCT03116737|AOM|aom
4718892|NCT03116724|catheterization, central venous|catheterization, central venous
4718893|NCT03116724|jugular veins|jugular veins
4718894|NCT03116724|echocardiography, transesophageal|echocardiography, transesophageal
4718895|NCT03116672|pain|pain
4718896|NCT03116672|Diclofenac|diclofenac
4718897|NCT03116672|NSAID|nsaid
4718898|NCT03116672|Ketorolac|ketorolac
4718899|NCT03116646|mastication|mastication
4718900|NCT03116646|cerebral palsy|cerebral palsy
4718901|NCT03116646|family|family
4718902|NCT03116633|lung cancer|lung cancer
4718903|NCT03116633|biopsy|biopsy
4718904|NCT03116620|mastication|mastication
4718905|NCT03116620|children with neuromuscular disorders|children with neuromuscular disorders
4718906|NCT03116607|User satisfaction|user satisfaction
4718907|NCT03116607|Readmission|readmission
4718908|NCT03116607|Emergency department|emergency department
4718909|NCT03116607|Pharmaceutical intervention|pharmaceutical intervention
4718910|NCT03116594|Herpes Zoster Vaccine|herpes zoster vaccine
4718911|NCT03116594|Prevention of Herpes Zoster|prevention of herpes zoster
4718912|NCT03116581|Perceptual Decision|perceptual decision
4718913|NCT03116581|Social Cognition|social cognition
4718914|NCT03116581|Motivation|motivation
4718915|NCT03116568|IBD|ibd
4718916|NCT03116568|Meconium|meconium
4718917|NCT03116568|Pregnancy|pregnancy
4718918|NCT03116568|Microbiota|microbiota
4718919|NCT03116568|Newborn|newborn
4718920|NCT03116555|Apatinib|apatinib
4718921|NCT03116555|Irinotecan|irinotecan
4718922|NCT03116555|Second-line|second-line
4718923|NCT03116555|Metastatic Gastric Adenocarcinoma|metastatic gastric adenocarcinoma
4718924|NCT03116529|Neoadjuvant|neoadjuvant
4718925|NCT03116529|Soft Tissue Sarcoma|soft tissue sarcoma
4718926|NCT03116529|Immunotherapy|immunotherapy
4718927|NCT03116529|Checkpoint Inhibitor|checkpoint inhibitor
4718928|NCT03116529|PD-1 (Programmed Cell Death Protein 1)|pd-1 (programmed cell death protein 1)
4718929|NCT03116529|PD-L1 (Programmed Death Ligand 1)|pd-l1 (programmed death ligand 1)
4718930|NCT03116529|CTLA-4 (Cytotoxic T-Lymphocyte-Associated Protein 4)|ctla-4 (cytotoxic t-lymphocyte-associated protein 4)
4718931|NCT03116529|Radiotherapy|radiotherapy
4718932|NCT03116529|Durvalumab|durvalumab
4718933|NCT03116529|Tremelimumab|tremelimumab
4718934|NCT03116529|Surgery|surgery
4718935|NCT03116529|Radiation|radiation
4718936|NCT03116529|Combined|combined
4718937|NCT03116529|Preoperative|preoperative
4718938|NCT03116503|Suicide|suicide
4718939|NCT03116490|morbidity|morbidity
4718940|NCT03116490|mortality|mortality
4718941|NCT03116490|hip fracture|hip fracture
4718942|NCT03116490|anesthesia type|anesthesia type
4718943|NCT03116490|POSSUM|possum
4718944|NCT03116451|foot health|foot health
4718945|NCT03116451|nurses|nurses
4718946|NCT03116451|work well-being|work well-being
4718947|NCT03116438|Coronary Artery Disease|coronary artery disease
4718948|NCT03116438|Nuclear Stress Test|nuclear stress test
4718949|NCT03116438|CT Angiography|ct angiography
4718950|NCT03116438|Angiography|angiography
4718951|NCT03116425|Precision Medicine|precision medicine
4718952|NCT03116425|Functional Neuroimaging|functional neuroimaging
4718953|NCT03116425|Transcranial Magnetic Stimulation, Repetitive|transcranial magnetic stimulation, repetitive
4718954|NCT03116425|Transcranial Direct Current Stimulation|transcranial direct current stimulation
4718955|NCT03116425|Monocentric|monocentric
4718956|NCT03116425|Comparative balanced, randomized|comparative balanced, randomized
4718957|NCT03116425|double-blind cross-over 3 Arms Study|double-blind cross-over 3 arms study
4718958|NCT03116412|Malignant melanoma|malignant melanoma
4718959|NCT03116412|Follow up|follow up
4718960|NCT03116412|Radiology|radiology
4718961|NCT03116412|Survival|survival
4718962|NCT03116399|Older adults|older adults
4718963|NCT03116399|Social Support|social support
4718964|NCT03116399|Technology uptake|technology uptake
4718965|NCT03116373|Posture|posture
4718966|NCT03116373|Physiology|physiology
4718967|NCT03116373|Head|head
4718968|NCT03116373|Intubation|intubation
4718969|NCT03116373|Intratracheal methods|intratracheal methods
4718970|NCT03116334|Obesity|obesity
4718971|NCT03116334|BMI|bmi
4718972|NCT03116334|executive functioning|executive functioning
4718973|NCT03116334|general cognitive ability|general cognitive ability
4718974|NCT03116334|twin study|twin study
4718975|NCT03116334|heritability|heritability
4718976|NCT03116334|cognition|cognition
4718977|NCT03116334|GCTA|gcta
4718978|NCT03116243|migrant and seasonal head start|migrant and seasonal head start
4718979|NCT03116243|early childhood education|early childhood education
4718980|NCT03116243|head start|head start
4718981|NCT03116230|Knee pathology|knee pathology
4718982|NCT03116217|renal function|renal function
4718983|NCT03116217|post natal|post natal
4718984|NCT03116217|peptidome|peptidome
4718985|NCT03116204|Dependency|dependency
4718986|NCT03116204|FRC department|frc department
4718987|NCT03116204|scale validation|scale validation
4718988|NCT03116204|validity|validity
4718989|NCT03116204|reliability|reliability
4718990|NCT03116178|Fluid therapy|fluid therapy
4718991|NCT03116178|oximetry|oximetry
4718992|NCT03116178|thromboelastography|thromboelastography
4718993|NCT03116178|intraoperative/method|intraoperative/method
4718994|NCT03116178|monitoring|monitoring
4718995|NCT03116139|Computed tomography scan|computed tomography scan
4718996|NCT03116139|Ventilation-perfusion lung scan|ventilation-perfusion lung scan
4718997|NCT03116139|Acute kidney injury|acute kidney injury
4718998|NCT03116139|Pulmonary embolism|pulmonary embolism
4718999|NCT03116139|Contrast-induced nephropathy|contrast-induced nephropathy
4719000|NCT03116087|Postmenopausal women|postmenopausal women
4719001|NCT03116061|Multimorbidity|multimorbidity
4719002|NCT03116061|Family Medicine|family medicine
4719003|NCT03116061|decompensation|decompensation
4719004|NCT03116061|predictive value|predictive value
4719005|NCT03116022|menopause|menopause
4719006|NCT03116022|sexual dysfunction|sexual dysfunction
4719007|NCT03116022|coital pain|coital pain
4719008|NCT03116022|vagina|vagina
4719009|NCT03116009|Obesity|obesity
4719010|NCT03116009|Pregnancy|pregnancy
4719011|NCT03116009|Diabetes Mellitus|diabetes mellitus
4719012|NCT03116009|Perinatal Outcomes|perinatal outcomes
4719013|NCT03115957|Parenteral Nutrition|parenteral nutrition
4719014|NCT03115957|Digestive System Neoplasms|digestive system neoplasms
4719015|NCT03115957|Randomized Controlled Trials|randomized controlled trials
4719016|NCT03115957|Clinical Outcomes|clinical outcomes
4719017|NCT03115957|Postoperative Period|postoperative period
4719018|NCT03115905|Aneurysmal Subarachnoid Hemorrhage|aneurysmal subarachnoid hemorrhage
4719019|NCT03115905|Emergency Medical Services|emergency medical services
4719020|NCT03115905|Registry Study|registry study
4719021|NCT03115905|China|china
4719022|NCT03115866|Healthy Diet|healthy diet
4719023|NCT03115866|Fruits and Vegetables|fruits and vegetables
4719024|NCT03115866|Metabolome|metabolome
4719025|NCT03115866|Microbiome|microbiome
4719026|NCT03115866|Young Adults|young adults
4719027|NCT03115788|Thermal|thermal
4719028|NCT03115762|ASKB1202|askb1202
4719029|NCT03115749|Crohn's disease|crohn's disease
4719030|NCT03115749|ulcerative colitis|ulcerative colitis
4719031|NCT03115749|mesenchymal stem cells|mesenchymal stem cells
4719032|NCT03115749|intestinal inflammation|intestinal inflammation
4719033|NCT03115736|HIV|hiv
4719034|NCT03115736|Hepatitis B|hepatitis b
4719035|NCT03115736|Renal dysfunction|renal dysfunction
4719036|NCT03115736|tenofovir alafenamide|tenofovir alafenamide
4719037|NCT03115723|Hospitalization|hospitalization
4719038|NCT03115723|Health Care Economics and Organizations|health care economics and organizations
4719039|NCT03115710|Keratoconus|keratoconus
4719040|NCT03115710|Prevalence|prevalence
4719041|NCT03115671|Phosphatidylserine|phosphatidylserine
4719042|NCT03115671|Omega-3|omega-3
4719043|NCT03115606|videolaryngoscope|videolaryngoscope
4719044|NCT03115606|Fastrach LMA|fastrach lma
4719045|NCT03115606|cervical motion|cervical motion
4719046|NCT03115593|hysteroscopy|hysteroscopy
4719047|NCT03115593|pipette|pipette
4719048|NCT03115593|biopsy|biopsy
4719049|NCT03115593|endometrial cancer|endometrial cancer
4719050|NCT03115541|venous thromboembolism prophylaxis|venous thromboembolism prophylaxis
4719051|NCT03115541|deep vein thrombosis|deep vein thrombosis
4719052|NCT03115541|pulmonary embolus|pulmonary embolus
4719053|NCT03115541|esophageal resection|esophageal resection
4719054|NCT03115541|incidence|incidence
4719055|NCT03115528|Malignant neoplasms of independent (primary) multiple sites|malignant neoplasms of independent (primary) multiple sites
4719056|NCT03115528|Medical oncologists|medical oncologists
4719057|NCT03115528|Palliative care physicians|palliative care physicians
4719058|NCT03115528|Questionnaire|questionnaire
4719059|NCT03115528|Survey|survey
4719060|NCT03115515|Thyroid Stimulating Hormone|thyroid stimulating hormone
4719061|NCT03115489|seizure|seizure
4719062|NCT03115489|glutamate activation|glutamate activation
4719063|NCT03115489|N-Methyl D-Aspartate|n-methyl d-aspartate
4719064|NCT03115489|gamma-aminobutyric acid receptor|gamma-aminobutyric acid receptor
4719065|NCT03115489|Ketamine|ketamine
4719066|NCT03115463|Neonatal Resuscitation|neonatal resuscitation
4719067|NCT03115463|Prematurity|prematurity
4719068|NCT03115463|Oxygen|oxygen
4719069|NCT03115450|External ventricular drain (EVD)|external ventricular drain (evd)
4719070|NCT03115450|Placement of Bolt|placement of bolt
4719071|NCT03115437|Body mass|body mass
4719072|NCT03115437|Running-related injury|running-related injury
4719073|NCT03115437|Sports injury prevention|sports injury prevention
4719074|NCT03115437|Impact forces|impact forces
4719075|NCT03115437|Epidemiology|epidemiology
4719076|NCT03115437|Running biomechanics|running biomechanics
4719077|NCT03115437|Sports footwear|sports footwear
4719078|NCT03115437|Shoe cushioning|shoe cushioning
4719079|NCT03115424|Weight Loss|weight loss
4719080|NCT03115424|Bariatric Surgery|bariatric surgery
4719081|NCT03115398|Fitness Tracker|fitness tracker
4719082|NCT03115398|Activity Monitoring|activity monitoring
4719083|NCT03115398|Chemotherapy|chemotherapy
4719084|NCT03115398|Radiation Therapy|radiation therapy
4719085|NCT03115398|Chemoradiotherapy|chemoradiotherapy
4719086|NCT03115359|Chronic Low Back Pain|chronic low back pain
4719087|NCT03115359|Opioid Therapy|opioid therapy
4719088|NCT03115359|Chronic Pain|chronic pain
4719089|NCT03115359|Mindfulness Meditation|mindfulness meditation
4719090|NCT03115359|Cognitive Behavioral Therapy|cognitive behavioral therapy
4719091|NCT03115359|Opioid-treated Chronic Low Back Pain|opioid-treated chronic low back pain
4719092|NCT03115359|CLBP|clbp
4719093|NCT03115307|Insemination|insemination
4719094|NCT03115307|Luteal phase support|luteal phase support
4719095|NCT03115307|Gonadotropin-releasing hormone agonist|gonadotropin-releasing hormone agonist
4719096|NCT03115307|Triptoreline|triptoreline
4719097|NCT03115268|social support|social support
4719098|NCT03115255|retinopathy of prematurity|retinopathy of prematurity
4719099|NCT03115255|ranibizumab|ranibizumab
4719100|NCT03115255|vascular endothelial growth factor|vascular endothelial growth factor
4719101|NCT03115229|Obesity|obesity
4719102|NCT03115229|Overweight|overweight
4719103|NCT03115229|Physical Activity|physical activity
4719104|NCT03115229|Nutrition|nutrition
4719105|NCT03115229|Nursing|nursing
4719106|NCT03115203|muscle skin|muscle skin
4719107|NCT03115203|IRM 3 tesla|irm 3 tesla
4719108|NCT03115138|Biopsy|biopsy
4719109|NCT03115125|B lymphocyte|b lymphocyte
4719110|NCT03115086|Bile Acid Synthesis Disorder|bile acid synthesis disorder
4719111|NCT03115086|Zellweger Spectrum Disorder|zellweger spectrum disorder
4719112|NCT03115086|Peroxisomal Disorder|peroxisomal disorder
4719113|NCT03115086|Cholic Acid|cholic acid
4719114|NCT03115086|Cholbam|cholbam
4719115|NCT03115086|Kolbam|kolbam
4719116|NCT03115086|The Replace Registry|the replace registry
4719117|NCT03115073|Vulvovaginal candidiasis|vulvovaginal candidiasis
4719118|NCT03115073|Candiplus|candiplus
4719119|NCT03115073|Clotrimazole|clotrimazole
4719120|NCT03115073|Safety|safety
4719121|NCT03115073|Tolerability|tolerability
4719122|NCT03115073|Clinical efficacy|clinical efficacy
4719123|NCT03115034|carotid stenosis|carotid stenosis
4719124|NCT03115034|melatonin|melatonin
4719125|NCT03115034|vascular injury|vascular injury
4719126|NCT03115034|ischemia reperfusion|ischemia reperfusion
4719127|NCT03114995|Tirofiban|tirofiban
4719128|NCT03114995|Resistance to antiplatelet agents|resistance to antiplatelet agents
4719129|NCT03114982|Prevention of varicella|prevention of varicella
4719130|NCT03114982|Varicella-zoster vaccine|varicella-zoster vaccine
4719131|NCT03114969|Overall error|overall error
4719132|NCT03114969|Error rate|error rate
4719133|NCT03114969|Critical error|critical error
4719134|NCT03114969|COPD|copd
4719135|NCT03114969|ELLIPTA|ellipta
4719136|NCT03114969|Dry powder inhaler|dry powder inhaler
4719137|NCT03114943|prevention of varicella|prevention of varicella
4719138|NCT03114943|Varicella-zoster vaccine|varicella-zoster vaccine
4719139|NCT03114917|Suicide|suicide
4719140|NCT03114917|Self-harm|self-harm
4719141|NCT03114917|Psychosis|psychosis
4719142|NCT03114917|Community|community
4719143|NCT03114917|Suicide Prevention|suicide prevention
4719144|NCT03114917|CBT|cbt
4719145|NCT03114917|CARMS|carms
4719146|NCT03114917|Randomised controlled trial|randomised controlled trial
4719147|NCT03114891|post-traumatic stress|post-traumatic stress
4719148|NCT03114891|depression|depression
4719149|NCT03114865|bone marrow|bone marrow
4719150|NCT03114865|bone marrow transplant|bone marrow transplant
4719151|NCT03114865|allogeneic|allogeneic
4719152|NCT03114865|tacrolimus|tacrolimus
4719153|NCT03114865|cyclophosphamide|cyclophosphamide
4719154|NCT03114865|Blinatumomab|blinatumomab
4719155|NCT03114839|Lactobacillus casei strain Shirota|lactobacillus casei strain shirota
4719156|NCT03114839|Yakult|yakult
4719157|NCT03114839|IntelliCap|intellicap
4719158|NCT03114761|Roux-en-Y Gastric Bypass|roux-en-y gastric bypass
4719159|NCT03114761|Internal Herniation|internal herniation
4719160|NCT03114761|Computed Tomography|computed tomography
4719161|NCT03114748|deep brain stimulation|deep brain stimulation
4719162|NCT03114748|EEG|eeg
4719163|NCT03114709|Mindfulness|mindfulness
4719164|NCT03114709|Exercise|exercise
4719165|NCT03114709|Physical activity|physical activity
4719166|NCT03114709|Behavior change|behavior change
4719167|NCT03114709|Aging|aging
4719168|NCT03114709|Randomized controlled trial|randomized controlled trial
4719169|NCT03114709|Pilot|pilot
4719170|NCT03114670|Leukemia|leukemia
4719171|NCT03114670|Leukemia, Myeloid|leukemia, myeloid
4719172|NCT03114670|Recurrence|recurrence
4719173|NCT03114670|Neoplasms by Histologic Type|neoplasms by histologic type
4719174|NCT03114670|Disease Attributes|disease attributes
4719175|NCT03114670|Cyclophosphamide|cyclophosphamide
4719176|NCT03114670|Fludarabine|fludarabine
4719177|NCT03114670|CD123|cd123
4719178|NCT03114670|Chimeric Antigen Receptor modified T-cells|chimeric antigen receptor modified t-cells
4719179|NCT03114631|dendritic cells, pancreatic cancer, immunotherapy|dendritic cells, pancreatic cancer, immunotherapy
4719180|NCT03114566|transplant donor|transplant donor
4719181|NCT03114566|HLA typed|hla typed
4719182|NCT03114566|17-211|17-211
4719183|NCT03114553|family health history|family health history
4719184|NCT03114553|prevention|prevention
4719185|NCT03114553|genetic risk|genetic risk
4719186|NCT03114553|clinical decision support|clinical decision support
4719187|NCT03114527|Dedifferentiated liposarcoma|dedifferentiated liposarcoma
4719188|NCT03114527|DDL|ddl
4719189|NCT03114527|Leiomyosarcoma|leiomyosarcoma
4719190|NCT03114527|LMS|lms
4719191|NCT03114527|Ribociclib|ribociclib
4719192|NCT03114501|Malignant neoplasms of lip oral cavity and pharynx|malignant neoplasms of lip oral cavity and pharynx
4719193|NCT03114501|Head and Neck Cancer|head and neck cancer
4719194|NCT03114501|Yoga|yoga
4719195|NCT03114501|Questionnaires|questionnaires
4719196|NCT03114501|Surveys|surveys
4719197|NCT03114462|Malignant neoplasms of respiratory and intrathoracic organs|malignant neoplasms of respiratory and intrathoracic organs
4719198|NCT03114462|Squamous cell carcinoma of the larynx|squamous cell carcinoma of the larynx
4719199|NCT03114462|Stereotactic hypofractionated radioablation|stereotactic hypofractionated radioablation
4719200|NCT03114462|HYDRA|hydra
4719201|NCT03114462|Questionnaires|questionnaires
4719202|NCT03114462|Surveys|surveys
4719203|NCT03114423|EMDR|emdr
4719204|NCT03114423|Psychotherapy|psychotherapy
4719205|NCT03114423|Substance Use Disorders|substance use disorders
4719206|NCT03114423|Eye Movement Desensitization and Reprocessing|eye movement desensitization and reprocessing
4719207|NCT03114371|Prader-Willi syndrome|prader-willi syndrome
4719208|NCT03114371|Oxytocin|oxytocin
4719209|NCT03114371|Behavioural troubles|behavioural troubles
4719210|NCT03114358|De-escalation|de-escalation
4719211|NCT03114358|Carbapenems|carbapenems
4719212|NCT03114358|Antimicrobial stewardship|antimicrobial stewardship
4719213|NCT03114345|Pressure ulcer|pressure ulcer
4719214|NCT03114345|Interface pressure|interface pressure
4719215|NCT03114345|Pressure mapping device|pressure mapping device
4719216|NCT03114345|Monitoring|monitoring
4719217|NCT03114345|Microvascularization|microvascularization
4719218|NCT03114319|TNO155|tno155
4719219|NCT03114319|SHP2|shp2
4719220|NCT03114319|advanced solid tumor|advanced solid tumor
4719221|NCT03114319|NSCLC|nsclc
4719222|NCT03114319|HNSCC|hnscc
4719223|NCT03114319|Esophageal SCC|esophageal scc
4719224|NCT03114319|EGFR|egfr
4719225|NCT03114319|GIST|gist
4719226|NCT03114319|PTPN11|ptpn11
4719227|NCT03114319|cancers with a mass|cancers with a mass
4719228|NCT03114319|bulky tumor|bulky tumor
4719229|NCT03114319|nodule|nodule
4719230|NCT03114319|lump|lump
4719231|NCT03114319|advanced solid malignancies|advanced solid malignancies
4719232|NCT03114306|ERAS|eras
4719233|NCT03114306|pain|pain
4719234|NCT03114306|knee arthroplasty|knee arthroplasty
4719235|NCT03114306|joint pain|joint pain
4719236|NCT03114306|regional anaesthesia|regional anaesthesia
4719237|NCT03114293|Physical activity|physical activity
4719238|NCT03114293|Mobility|mobility
4719239|NCT03114254|Recurrent|recurrent
4719240|NCT03114254|Locally advanced|locally advanced
4719241|NCT03114254|Metastatic|metastatic
4719242|NCT03114241|COPD|copd
4719243|NCT03114241|Physical activity|physical activity
4719244|NCT03114241|Endothelial function|endothelial function
4719245|NCT03114228|myeloid|myeloid
4719246|NCT03114228|leukemia|leukemia
4719247|NCT03114228|FLT3-mutated|flt3-mutated
4719248|NCT03114228|PKC412|pkc412
4719249|NCT03114228|midostaurin|midostaurin
4719250|NCT03114228|adult|adult
4719252|NCT03114228|ETP|etp
4719253|NCT03114228|FMS-like tyrosine kinase receptor|fms-like tyrosine kinase receptor
4719254|NCT03114228|Acute myeloid leukemia|acute myeloid leukemia
4719255|NCT03114215|Biotin|biotin
4719256|NCT03114215|MD1003|md1003
4719257|NCT03114215|ALSFRS-R|alsfrs-r
4719258|NCT03114189|Sleep disturbance|sleep disturbance
4719259|NCT03114189|footbath|footbath
4719260|NCT03114189|Kneipp|kneipp
4719261|NCT03114189|care of sleep|care of sleep
4719262|NCT03114189|sleep|sleep
4719263|NCT03114150|physical activity|physical activity
4719264|NCT03114150|aging|aging
4719265|NCT03114150|learning and memory|learning and memory
4719266|NCT03114150|exercise|exercise
4719267|NCT03114150|brain|brain
4719268|NCT03114137|Sub-Saharan Africa|sub-saharan africa
4719269|NCT03114137|Sickle Cell Disease|sickle cell disease
4719270|NCT03114137|Vasculopathy|vasculopathy
4719271|NCT03114137|Nephropathy|nephropathy
4719272|NCT03114137|Pulmonary hypertension|pulmonary hypertension
4719273|NCT03114137|cardiac disease|cardiac disease
4719274|NCT03114137|hemolysis|hemolysis
4719275|NCT03114137|pulse wave velocity|pulse wave velocity
4719276|NCT03114137|blood viscosity|blood viscosity
4719277|NCT03114124|ablation|ablation
4719278|NCT03114124|atrioventricular node|atrioventricular node
4719279|NCT03114124|microfidelity|microfidelity
4719280|NCT03114098|Drug Resistance|drug resistance
4719281|NCT03114098|CYP2D6|cyp2d6
4719282|NCT03114098|cytochrom P450|cytochrom p450
4719283|NCT03114072|Pregnancy|pregnancy
4719284|NCT03114072|Blue-blockers|blue-blockers
4719285|NCT03114072|Sleep quality|sleep quality
4719286|NCT03114072|Melatonin|melatonin
4719287|NCT03114059|Late Effects of Surgery|late effects of surgery
4719288|NCT03114033|Cardiac Arrest|cardiac arrest
4719289|NCT03114033|Intensive Care Unit|intensive care unit
4719290|NCT03114033|Therapeutic Mild Hypercapnia|therapeutic mild hypercapnia
4719291|NCT03114033|Normocapnia|normocapnia
4719292|NCT03114033|Mortality|mortality
4719293|NCT03114033|Neurological function|neurological function
4719294|NCT03114020|Emphysema|emphysema
4719295|NCT03114020|COPD|copd
4719296|NCT03114020|Alpha-1 Antitrypsin Deficiency|alpha-1 antitrypsin deficiency
4719297|NCT03114007|Mental health problems|mental health problems
4719298|NCT03114007|Substance misuse|substance misuse
4719299|NCT03114007|Psychosocial difficulties|psychosocial difficulties
4719300|NCT03114007|Youth|youth
4719301|NCT03113994|Spinal Cord Injury|spinal cord injury
4719302|NCT03113994|Osteoporosis|osteoporosis
4719303|NCT03113994|Cardiometabolic Syndrome|cardiometabolic syndrome
4719304|NCT03113916|Culturally-tailored|culturally-tailored
4719305|NCT03113916|Weight Loss|weight loss
4719306|NCT03113916|Diabetes|diabetes
4719307|NCT03113916|Women|women
4719308|NCT03113916|Hispanic|hispanic
4719309|NCT03113916|Obesity|obesity
4719310|NCT03113903|Pain|pain
4719311|NCT03113903|psychophysics|psychophysics
4719312|NCT03113903|Nociception|nociception
4719313|NCT03113903|Sensitivity|sensitivity
4719314|NCT03113903|Senses|senses
4719315|NCT03113903|Phenotyping|phenotyping
4719316|NCT03113903|Questionnaire|questionnaire
4719317|NCT03113903|Anxiety|anxiety
4719318|NCT03113903|Depression|depression
4719319|NCT03113903|Catastrophizing|catastrophizing
4719320|NCT03113890|pharmacogenetic testing|pharmacogenetic testing
4719321|NCT03113890|genomic|genomic
4719322|NCT03113890|assay|assay
4719323|NCT03113890|PTSD|ptsd
4719324|NCT03113890|pharmacodynamic|pharmacodynamic
4719325|NCT03113890|pharmacokinetic|pharmacokinetic
4719326|NCT03113890|psychiatric disorders|psychiatric disorders
4719327|NCT03113864|Vision|vision
4719328|NCT03113864|Eye Health|eye health
4719329|NCT03113864|Lutein|lutein
4719330|NCT03113864|Carotenoids|carotenoids
4719331|NCT03113838|Drug-Induced Liver Injury|drug-induced liver injury
4719332|NCT03113825|breast carcinoma|breast carcinoma
4719333|NCT03113825|DCIS|dcis
4719334|NCT03113786|Discectomy|discectomy
4719335|NCT03113786|Lumbar discectomy|lumbar discectomy
4719336|NCT03113786|Protruding disc|protruding disc
4719337|NCT03113747|Allogeneic adipose-derived stem cells|allogeneic adipose-derived stem cells
4719338|NCT03113747|burn wounds|burn wounds
4719339|NCT03113747|wound healing|wound healing
4719340|NCT03113747|regeneration|regeneration
4719342|NCT03113747|skin tissue engineering|skin tissue engineering
4719343|NCT03113708|heparin|heparin
4719344|NCT03113708|heparin antagonists|heparin antagonists
4719345|NCT03113708|cardiac surgery|cardiac surgery
4719346|NCT03113708|active clotting time|active clotting time
4719347|NCT03113695|Richter's Syndrome|richter's syndrome
4719348|NCT03113695|CLL|cll
4719349|NCT03113695|Chronic Lumphocytic Leukemia|chronic lumphocytic leukemia
4719350|NCT03113695|obinutuzumab|obinutuzumab
4719351|NCT03113695|HDMP|hdmp
4719352|NCT03113695|lenalidomide|lenalidomide
4719353|NCT03113695|cancer|cancer
4719354|NCT03113695|methylprednisolone|methylprednisolone
4719355|NCT03113643|Acute Myeloid Leukemia|acute myeloid leukemia
4719356|NCT03113643|Myelodysplastic Syndrome|myelodysplastic syndrome
4719357|NCT03113630|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
4719358|NCT03113630|Virtual Reality Exposure Therapy|virtual reality exposure therapy
4719359|NCT03113630|User-Computer Interface|user-computer interface
4719360|NCT03113630|Rehabilitation|rehabilitation
4719361|NCT03113630|Motor Activity|motor activity
4719362|NCT03113591|total hip arthroplasty|total hip arthroplasty
4719363|NCT03113591|minimal invasive|minimal invasive
4719364|NCT03113578|Balloon enteroscopy|balloon enteroscopy
4719365|NCT03113578|colonoscopy|colonoscopy
4719366|NCT03113578|polyps|polyps
4719367|NCT03113461|cognitive impairment|cognitive impairment
4719368|NCT03113461|sleep apnea|sleep apnea
4719369|NCT03113461|positive airway pressure therapy|positive airway pressure therapy
4719370|NCT03113448|capsaicin|capsaicin
4719371|NCT03113448|neuropathic pain|neuropathic pain
4719372|NCT03113448|diabetic neuropathy|diabetic neuropathy
4719373|NCT03113448|topical lotion|topical lotion
4719374|NCT03113435|CO2 gap|co2 gap
4719375|NCT03113435|oxygen consumption|oxygen consumption
4719376|NCT03113435|Stroke volume optimization|stroke volume optimization
4719377|NCT03113422|High Tumor Burden Follicular Lymphoma|high tumor burden follicular lymphoma
4719378|NCT03113422|Venetoclax|venetoclax
4719379|NCT03113422|Obinutuzumab|obinutuzumab
4719380|NCT03113422|Bendamustine|bendamustine
4719381|NCT03113422|Bcl-2 Family Protein Inhibitor|bcl-2 family protein inhibitor
4719382|NCT03113422|Monoclonal Antibody|monoclonal antibody
4719383|NCT03113409|Outpatient detoxification|outpatient detoxification
4719384|NCT03113409|Opioid dependence|opioid dependence
4719385|NCT03113409|Naltrexone|naltrexone
4719386|NCT03113409|Vivitrol|vivitrol
4719387|NCT03113409|Buprenorphine|buprenorphine
4719388|NCT03113383|Thoracoabdominal Aortic Aneurysm|thoracoabdominal aortic aneurysm
4719389|NCT03113383|Endovascular Aneurysm Repair|endovascular aneurysm repair
4719390|NCT03113383|Stent-Graft|stent-graft
4719391|NCT03113370|n-3 polyunsaturated fatty acids|n-3 polyunsaturated fatty acids
4719392|NCT03113370|tobacco use|tobacco use
4719393|NCT03113370|postpartum|postpartum
4719394|NCT03113357|myofascial release|myofascial release
4719395|NCT03113357|cervicogenic headache|cervicogenic headache
4719396|NCT03113357|pain intensity|pain intensity
4719397|NCT03113357|exercise therapy|exercise therapy
4719398|NCT03113357|pressure pain threshold|pressure pain threshold
4719399|NCT03113331|Intrauterine growth restriction|intrauterine growth restriction
4719400|NCT03113331|Preterm birth|preterm birth
4719401|NCT03113331|Birth defect|birth defect
4719402|NCT03113331|Infant growth|infant growth
4719403|NCT03113331|Neurodevelopmental outcomes|neurodevelopmental outcomes
4719404|NCT03113318|Pulmonary neoplasm|pulmonary neoplasm
4719405|NCT03113318|Metastasis|metastasis
4719406|NCT03113318|colorectal neoplasm|colorectal neoplasm
4719407|NCT03113305|Gastric bypass|gastric bypass
4719408|NCT03113305|Morbid obesity|morbid obesity
4719409|NCT03113305|Food choice|food choice
4719410|NCT03113305|Ingestive behaviour|ingestive behaviour
4719411|NCT03113292|physical therapy|physical therapy
4719412|NCT03113292|therapeutic exercises|therapeutic exercises
4719413|NCT03113292|low back pain|low back pain
4719414|NCT03113266|anti-PD-1 monoclonal antibody|anti-pd-1 monoclonal antibody
4719415|NCT03113266|Metastatic|metastatic
4719416|NCT03113266|Advanced|advanced
4719417|NCT03113266|Bladder Urothelial Carcinoma|bladder urothelial carcinoma
4719418|NCT03113253|Tranexamic Acid|tranexamic acid
4719419|NCT03113253|Burn|burn
4719420|NCT03113253|Surgery|surgery
4719421|NCT03113253|Excision|excision
4719422|NCT03113240|Glutamin|glutamin
4719423|NCT03113240|Enteral Nutrition|enteral nutrition
4719424|NCT03113240|Intensive Care Unit|intensive care unit
4719425|NCT03113240|Intestinal Permeability|intestinal permeability
4719426|NCT03113227|induction of labor|induction of labor
4719427|NCT03113227|Bishop score|bishop score
4719428|NCT03113227|posterior cervical angle|posterior cervical angle
4719429|NCT03113227|cervical length|cervical length
4719430|NCT03113201|Depression|depression
4719431|NCT03113201|Collaborative care|collaborative care
4719432|NCT03113201|Care manager|care manager
4719433|NCT03113201|Anxiety|anxiety
4719434|NCT03113201|Psychiatry|psychiatry
4719435|NCT03113201|Consultation-liaison|consultation-liaison
4719436|NCT03113201|General practitioner|general practitioner
4719437|NCT03113175|Anxiety|anxiety
4719438|NCT03113175|Collaborative care|collaborative care
4719439|NCT03113175|Consultation-liaison|consultation-liaison
4719440|NCT03113175|General practitioner|general practitioner
4719441|NCT03113175|Psychiatry|psychiatry
4719442|NCT03113162|multiple sclerosis|multiple sclerosis
4719443|NCT03113162|HSCT|hsct
4719444|NCT03113149|Physical Therapy Modalities|physical therapy modalities
4719445|NCT03113149|Recovery of Function|recovery of function
4719446|NCT03113149|Predictive Value of Tests|predictive value of tests
4719447|NCT03113149|Cohort Studies|cohort studies
4719448|NCT03113123|Adherence|adherence
4719449|NCT03113123|Prevention|prevention
4719450|NCT03113123|Tenofovir|tenofovir
4719451|NCT03113123|Emtricitabine|emtricitabine
4719452|NCT03113123|Antiretroviral|antiretroviral
4719453|NCT03113123|Prophylaxis|prophylaxis
4719454|NCT03113123|Men who have sex with men|men who have sex with men
4719455|NCT03113110|Empagliflozin|empagliflozin
4719456|NCT03113110|SGLT-2 Inhibition|sglt-2 inhibition
4719457|NCT03113110|Glucose Metabolism|glucose metabolism
4719458|NCT03113084|Sodium Heparin|sodium heparin
4719459|NCT03113084|Pharmacokinetics|pharmacokinetics
4719460|NCT03113084|Coagulation factor|coagulation factor
4719461|NCT03113058|HBV infection,γδT cells,Adoptive treatment|hbv infection,γδt cells,adoptive treatment
4719462|NCT03113032|total knee replacement|total knee replacement
4719463|NCT03113032|sensorimotor training|sensorimotor training
4719464|NCT03113032|pre-surgery exercise|pre-surgery exercise
4719465|NCT03113032|sensorimotor function|sensorimotor function
4719466|NCT03113032|neuromuscular|neuromuscular
4719467|NCT03113019|dendritic cell, IL-12, IL-18, сytotoxicity|dendritic cell, il-12, il-18, сytotoxicity
4719468|NCT03112993|spine surgery|spine surgery
4719469|NCT03112993|neuromuscular blockade|neuromuscular blockade
4719470|NCT03112993|sugammadex|sugammadex
4719471|NCT03112993|elderly|elderly
4719472|NCT03112993|reversal|reversal
4719473|NCT03112993|neostigmine|neostigmine
4719474|NCT03112993|recovery|recovery
4719475|NCT03112980|Aortic Valve Stenosis|aortic valve stenosis
4719476|NCT03112980|Transcatheter Aortic Valve Replacement|transcatheter aortic valve replacement
4719477|NCT03112980|Surgical aortic valve replacement|surgical aortic valve replacement
4719478|NCT03112980|Intermediate operative risk|intermediate operative risk
4719479|NCT03112915|postoperative pain|postoperative pain
4719480|NCT03112915|Laparoscopic cholecystectomy|laparoscopic cholecystectomy
4719481|NCT03112915|Quadratus lumborum block|quadratus lumborum block
4719482|NCT03112915|transversus abdominis plan block|transversus abdominis plan block
4719483|NCT03112889|McArdle Disease|mcardle disease
4719484|NCT03112889|McArdle's Disease|mcardle's disease
4719485|NCT03112889|Glycogen Storage Disease Type V|glycogen storage disease type v
4719486|NCT03112889|GSDV|gsdv
4719487|NCT03112889|Sodium Valproate|sodium valproate
4719488|NCT03112889|Valproic Acid|valproic acid
4719489|NCT03112889|Myophosphorylase Deficiency|myophosphorylase deficiency
4719490|NCT03112889|Muscle Phosphorylase Deficiency|muscle phosphorylase deficiency
4719491|NCT03112889|Glycogenosis|glycogenosis
4719492|NCT03112889|Glycogen Storage Disorder|glycogen storage disorder
4719493|NCT03112876|younger age|younger age
4719494|NCT03112876|older age|older age
4719495|NCT03112876|atopic dermatitis|atopic dermatitis
4719496|NCT03112876|acne|acne
4719497|NCT03112876|smoker|smoker
4719498|NCT03112850|Crossover design|crossover design
4719499|NCT03112850|Randomized controlled trial|randomized controlled trial
4719500|NCT03112850|Aural rehabilitation intervention|aural rehabilitation intervention
4719501|NCT03112798|tracheal intubation|tracheal intubation
4719502|NCT03112798|Macintosh blade|macintosh blade
4719503|NCT03112798|Miller blade|miller blade
4719504|NCT03112785|Hip|hip
4719505|NCT03112785|Arthroplasty|arthroplasty
4719506|NCT03112785|Stem|stem
4719507|NCT03112785|Outcome|outcome
4719508|NCT03112746|child|child
4719509|NCT03112746|goal|goal
4719510|NCT03112746|intervention|intervention
4719511|NCT03112746|motor skills disorder|motor skills disorder
4719512|NCT03112746|occupational therapy|occupational therapy
4719513|NCT03112655|diagnosis|diagnosis
4719514|NCT03112655|sensitivity|sensitivity
4719515|NCT03112655|specificity|specificity
4719516|NCT03112655|therapeutic outcome|therapeutic outcome
4719517|NCT03112655|cerebrospinal fluid|cerebrospinal fluid
4719518|NCT03112629|Quality of Care|quality of care
4719519|NCT03112629|aortic stenosis|aortic stenosis
4719520|NCT03112629|transcatheter aortic valve implantation|transcatheter aortic valve implantation
4719521|NCT03112629|surgical aortic valve replacement|surgical aortic valve replacement
4719522|NCT03112629|facilitated data relay|facilitated data relay
4719523|NCT03112603|Graft-versus-host disease (GvHD)|graft-versus-host disease (gvhd)
4719524|NCT03112603|Chronic GvHD (cGvHD)|chronic gvhd (cgvhd)
4719525|NCT03112603|steroid-refractory|steroid-refractory
4719526|NCT03112603|ruxolitinib|ruxolitinib
4719527|NCT03112603|Janus kinase inhibitor|janus kinase inhibitor
4719528|NCT03112590|Histologically confirmed HER2 positive breast cancer|histologically confirmed her2 positive breast cancer
4719529|NCT03112590|Unresectable breast cancer|unresectable breast cancer
4719530|NCT03112590|Locally advanced breast cancer|locally advanced breast cancer
4719531|NCT03112590|Metastatic breast cancer|metastatic breast cancer
4719532|NCT03112590|Clinical stage 2-3 early stage breast cancer|clinical stage 2-3 early stage breast cancer
4719533|NCT03112564|Endotracheal intubation|endotracheal intubation
4719534|NCT03112564|muscle relaxants|muscle relaxants
4719535|NCT03112564|inhalational anesthesia|inhalational anesthesia
4719536|NCT03112538|insulin pump|insulin pump
4719537|NCT03112538|basal bolus insulin|basal bolus insulin
4719538|NCT03112525|rivaroxaban|rivaroxaban
4719539|NCT03112525|apixaban|apixaban
4719540|NCT03112525|cytochrome|cytochrome
4719541|NCT03112525|anticoagulant|anticoagulant
4719542|NCT03112525|transporter|transporter
4719543|NCT03112525|polymorphism|polymorphism
4719544|NCT03112525|genotyping|genotyping
4719545|NCT03112525|phenotyping|phenotyping
4719546|NCT03112512|optimal positive end-expiratory pressure determination|optimal positive end-expiratory pressure determination
4719547|NCT03112512|Electrical impedance tomography|electrical impedance tomography
4719548|NCT03112499|Acute Kidney Injury|acute kidney injury
4719549|NCT03112499|PCNL|pcnl
4719550|NCT03112499|mini-PCNL|mini-pcnl
4719551|NCT03112499|RIRS|rirs
4719552|NCT03112499|urine biomarkers|urine biomarkers
4719553|NCT03112486|out-of-hospital cardiac arrest|out-of-hospital cardiac arrest
4719554|NCT03112486|neurological outcome|neurological outcome
4719555|NCT03112486|prognostication|prognostication
4719556|NCT03112486|cerebral performance category|cerebral performance category
4719557|NCT03112486|hypoxic-ischemic brain injury|hypoxic-ischemic brain injury
4719558|NCT03112486|biomarkers|biomarkers
4719559|NCT03112460|Cardiopulmonary Resuscitation|cardiopulmonary resuscitation
4719560|NCT03112447|medial epicondyle humerus|medial epicondyle humerus
4719561|NCT03112447|absorbable cartilage nail|absorbable cartilage nail
4719562|NCT03112421|IVD|ivd
4719563|NCT03112408|cerebellar lesion|cerebellar lesion
4719564|NCT03112408|saccadic adaptation|saccadic adaptation
4719565|NCT03112408|spatial localization|spatial localization
4719566|NCT03112408|visuo spatial perception|visuo spatial perception
4719567|NCT03112408|eye movements|eye movements
4719568|NCT03112369|American Indian / Alaska Native|american indian / alaska native
4719569|NCT03112369|HIV Prevention|hiv prevention
4719570|NCT03112369|Sexual Risk Behavior|sexual risk behavior
4719571|NCT03112369|Trauma|trauma
4719572|NCT03112369|Substance Use|substance use
4719573|NCT03112356|infectious endocarditis|infectious endocarditis
4719574|NCT03112356|prosthetic valve infection|prosthetic valve infection
4719575|NCT03112356|implantable cardiac device infection|implantable cardiac device infection
4719576|NCT03112356|99mTc-Leukoscan® scintigraphy|99mtc-leukoscan® scintigraphy
4719577|NCT03112343|ICT based clinical trial|ict based clinical trial
4719578|NCT03112343|Contract research organization (CRO)|contract research organization (cro)
4719579|NCT03112343|eCRF|ecrf
4719580|NCT03112343|Joint Electronic-institutional review board (eIRB)|joint electronic-institutional review board (eirb)
4719581|NCT03112343|Centralized monitoring|centralized monitoring
4719582|NCT03112330|atrophic rhinitis|atrophic rhinitis
4719583|NCT03112317|Surgery|surgery
4719584|NCT03112317|Hypothermia|hypothermia
4719585|NCT03112317|Prevention|prevention
4719586|NCT03112317|Surgical Site Infection|surgical site infection
4719587|NCT03112317|Bleeding|bleeding
4719588|NCT03112304|children|children
4719589|NCT03112304|youth|youth
4719590|NCT03112304|adolescents|adolescents
4719591|NCT03112304|anxiety|anxiety
4719592|NCT03112304|depression|depression
4719593|NCT03112304|trauma|trauma
4719594|NCT03112304|behavior problems|behavior problems
4719595|NCT03112304|evidence-based treatments|evidence-based treatments
4719596|NCT03112304|manualized|manualized
4719597|NCT03112304|cognitive-behavioral therapy|cognitive-behavioral therapy
4719598|NCT03112304|mental health|mental health
4719599|NCT03112291|anti-microbial agents|anti-microbial agents
4719600|NCT03112291|apexification|apexification
4719601|NCT03112291|dental pulp|dental pulp
4719602|NCT03112291|endodontics|endodontics
4719603|NCT03112291|root canal therapy|root canal therapy
4719604|NCT03112291|dental trauma|dental trauma
4719605|NCT03112278|tooth erosion|tooth erosion
4719606|NCT03112278|Computer-Aided Design|computer-aided design
4719607|NCT03112278|occlusal veneers|occlusal veneers
4719608|NCT03112278|dental veneers|dental veneers
4719609|NCT03112265|anxiety|anxiety
4719610|NCT03112265|depression|depression
4719611|NCT03112265|trauma|trauma
4719612|NCT03112265|behavior problems|behavior problems
4719613|NCT03112265|evidence-based treatments|evidence-based treatments
4719614|NCT03112265|manualized treatments|manualized treatments
4719615|NCT03112265|cognitive-behavioral therapy|cognitive-behavioral therapy
4719616|NCT03112265|youth|youth
4719617|NCT03112265|mental health|mental health
4719618|NCT03112265|self-regulation|self-regulation
4719619|NCT03112265|neuroimaging|neuroimaging
4719620|NCT03112252|Immunotherapy|immunotherapy
4719621|NCT03112239|Asthma|asthma
4719622|NCT03112239|Photobiomodulation|photobiomodulation
4719623|NCT03112239|Resistance Training|resistance training
4719624|NCT03112226|cognitive impairment|cognitive impairment
4719625|NCT03112226|menopause|menopause
4719626|NCT03112226|estrogen|estrogen
4719627|NCT03112226|functional MRI|functional mri
4719628|NCT03112226|executive function|executive function
4719629|NCT03112226|endothelial function|endothelial function
4719630|NCT03112226|arterial stiffness|arterial stiffness
4719631|NCT03112200|Subchondroplasty|subchondroplasty
4719632|NCT03112200|Arthroscopy|arthroscopy
4719633|NCT03112200|Bone Substitute Material|bone substitute material
4719634|NCT03112200|Subchondral Bone Defect|subchondral bone defect
4719635|NCT03112200|AccuFill|accufill
4719636|NCT03112200|Bone Marrow Lesion|bone marrow lesion
4719637|NCT03112200|Knee Replacement|knee replacement
4719638|NCT03112200|Knee Replacement Alternative|knee replacement alternative
4719639|NCT03112187|IDA|ida
4719640|NCT03112187|iron deficiency anemia|iron deficiency anemia
4719641|NCT03112187|iron supplements|iron supplements
4719642|NCT03112187|Pakistan|pakistan
4719643|NCT03112187|Liposomal iron|liposomal iron
4719644|NCT03112174|PCYC|pcyc
4719645|NCT03112174|MCL|mcl
4719646|NCT03112174|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
4719647|NCT03112174|NHL|nhl
4719648|NCT03112174|ibrutinib|ibrutinib
4719649|NCT03112174|venetoclax|venetoclax
4719650|NCT03112174|Pharmacyclics|pharmacyclics
4719651|NCT03112122|Bone Marrow Edema|bone marrow edema
4719652|NCT03112122|Mesenchymal Stem Cells|mesenchymal stem cells
4719653|NCT03112096|Tau|tau
4719654|NCT03112096|neurodegeneration|neurodegeneration
4719655|NCT03112096|positron emission tomography|positron emission tomography
4719656|NCT03112083|krill powder|krill powder
4719657|NCT03112083|krill oil|krill oil
4719658|NCT03112083|safety|safety
4719659|NCT03112083|tolerability|tolerability
4719660|NCT03112083|adverse event|adverse event
4719661|NCT03112083|omega-3 fatty acids|omega-3 fatty acids
4719662|NCT03112083|eicosapentaenoic acid|eicosapentaenoic acid
4719663|NCT03112083|docosahexaenoic acid|docosahexaenoic acid
4719664|NCT03112044|Lung|lung
4719665|NCT03112044|Transplant|transplant
4719666|NCT03112044|Hepatitis C|hepatitis c
4719667|NCT03112044|DAAs|daas
4719668|NCT03112044|Epclusa|epclusa
4719669|NCT03112031|Tamoxifen|tamoxifen
4719670|NCT03112031|Cryptococcal meningitis|cryptococcal meningitis
4719671|NCT03112031|Cryptococcus neoformans|cryptococcus neoformans
4719672|NCT03112031|Human immunodeficiency virus|human immunodeficiency virus
4719673|NCT03112018|premature birth|premature birth
4719674|NCT03112018|neonatal mortality|neonatal mortality
4719675|NCT03112018|premature infant|premature infant
4719676|NCT03112005|Diabetic Eye Disease|diabetic eye disease
4719677|NCT03111992|Myeloma,|myeloma,
4719678|NCT03111992|Multiple Myeloma,|multiple myeloma,
4719679|NCT03111992|Hematologic Diseases,|hematologic diseases,
4719680|NCT03111992|Myeloma, Multiple,|myeloma, multiple,
4719681|NCT03111992|Myeloma-Multiple,|myeloma-multiple,
4719682|NCT03111992|Programmed Cell Death 1 Receptor|programmed cell death 1 receptor
4719683|NCT03111979|beta-alanine|beta-alanine
4719684|NCT03111979|Carnosine|carnosine
4719685|NCT03111979|Neuromuscular|neuromuscular
4719686|NCT03111979|Stimulation|stimulation
4719687|NCT03111979|Skeletal muscle|skeletal muscle
4719688|NCT03111966|Hepatitis C|hepatitis c
4719689|NCT03111953|Bariatric Surgery|bariatric surgery
4719690|NCT03111953|Roux-en-Y gastric bypass|roux-en-y gastric bypass
4719691|NCT03111953|Biliopancreatic Diversion|biliopancreatic diversion
4719692|NCT03111927|Nutrition, Brain Development, Cognition, Heathy Infants|nutrition, brain development, cognition, heathy infants
4719693|NCT03111901|pembrolizumab|pembrolizumab
4719694|NCT03111901|IL-2|il-2
4719695|NCT03111901|interleukin-2|interleukin-2
4719696|NCT03111901|MK-3475|mk-3475
4719697|NCT03111875|Hypothermia|hypothermia
4719698|NCT03111875|Intraoperative warming|intraoperative warming
4719699|NCT03111875|non-cardiac surgery|non-cardiac surgery
4719700|NCT03111875|myocardial injury|myocardial injury
4719701|NCT03111849|COPD|copd
4719702|NCT03111849|Sarcopenia|sarcopenia
4719703|NCT03111849|Prevalence|prevalence
4719704|NCT03111849|Mortality|mortality
4719705|NCT03111849|Malnutrition|malnutrition
4719706|NCT03111849|Nutritional assessment|nutritional assessment
4719707|NCT03111849|Body composition|body composition
4719708|NCT03111849|Pulmonary cachexia|pulmonary cachexia
4719709|NCT03111810|Corticosteroids|corticosteroids
4719710|NCT03111810|Prednisolone|prednisolone
4719711|NCT03111810|11 beta-Hydroxysteroid dehydrogenase1 inhibitor|11 beta-hydroxysteroid dehydrogenase1 inhibitor
4719712|NCT03111810|Iatrogenic Cushing's disease|iatrogenic cushing's disease
4719713|NCT03111810|AZD4017|azd4017
4719714|NCT03111784|Fish Consumption, Fatty acid composition, Lipid Profile, Tocopherol, Sociodemographics|fish consumption, fatty acid composition, lipid profile, tocopherol, sociodemographics
4719715|NCT03111771|Cancer|cancer
4719716|NCT03111771|Cachexia|cachexia
4719717|NCT03111771|Myosteatosis|myosteatosis
4719718|NCT03111771|Mitochondrial activity|mitochondrial activity
4719719|NCT03111771|Upper aerodigestive pathways|upper aerodigestive pathways
4719720|NCT03111771|Lipotoxicity|lipotoxicity
4719721|NCT03111745|Reactivation or Proliferation of Latent Viral Infections.|reactivation or proliferation of latent viral infections.
4719722|NCT03111745|VIRAL INFECTION|viral infection
4719723|NCT03111745|Lymphoproliferation|lymphoproliferation
4719724|NCT03111732|Immune-Based Strategies|immune-based strategies
4719725|NCT03111732|Anti-PD1 Therapy|anti-pd1 therapy
4719726|NCT03111732|Chronic Inflammation|chronic inflammation
4719727|NCT03111732|Combination Chemotherapy|combination chemotherapy
4719728|NCT03111693|Epicardial fat|epicardial fat
4719729|NCT03111693|Obesity|obesity
4719730|NCT03111693|Cardiovascular risks markers|cardiovascular risks markers
4719731|NCT03111693|Metabolic syndrome|metabolic syndrome
4719732|NCT03111693|Low dose computed tomography|low dose computed tomography
4719733|NCT03111667|Marijuana|marijuana
4719734|NCT03111667|Motivational Enhancement Therapy|motivational enhancement therapy
4719735|NCT03111667|Adolescents|adolescents
4719736|NCT03111615|Aromatase inhibitors|aromatase inhibitors
4719737|NCT03111615|Luminal Breast Cancer neoadjuvant hormone therapy|luminal breast cancer neoadjuvant hormone therapy
4719738|NCT03111602|polyphenols|polyphenols
4719739|NCT03111602|pregnant|pregnant
4719740|NCT03111602|fetal ductal constriction|fetal ductal constriction
4719741|NCT03111602|prostaglandin E2|prostaglandin e2
4719742|NCT03111589|Sickle Cell Disease|sickle cell disease
4719743|NCT03111589|Heme oxidase-1 (HO-1)|heme oxidase-1 (ho-1)
4719744|NCT03111537|cigarette|cigarette
4719745|NCT03111537|smoking|smoking
4719746|NCT03111537|e-cigarette|e-cigarette
4719747|NCT03111537|nicotine replacement therapy|nicotine replacement therapy
4719748|NCT03111537|nrt|nrt
4719749|NCT03111537|tobacco|tobacco
4719750|NCT03111524|stuttering|stuttering
4719751|NCT03111524|children who stutter|children who stutter
4719752|NCT03111524|peer attitudes|peer attitudes
4719753|NCT03111524|classroom-based intervention|classroom-based intervention
4719754|NCT03111524|teasing|teasing
4719755|NCT03111524|bullying|bullying
4719756|NCT03111498|Vacuum assisted delivery|vacuum assisted delivery
4719757|NCT03111498|technical skills|technical skills
4719758|NCT03111498|training|training
4719759|NCT03111459|endograft repair,|endograft repair,
4719760|NCT03111433|Type 1 Diabetes mellitus|type 1 diabetes mellitus
4719761|NCT03111433|Coenzyme Q10|coenzyme q10
4719762|NCT03111433|endothelial dysfunction|endothelial dysfunction
4719763|NCT03111433|pediatric patients|pediatric patients
4719764|NCT03111407|primary total knee arthroplasty|primary total knee arthroplasty
4719765|NCT03111394|MS|ms
4719766|NCT03111394|23andMe|23andme
4719767|NCT03111394|MRI|mri
4719768|NCT03111394|Genome-wide association studies|genome-wide association studies
4719769|NCT03111368|eus-fna|eus-fna
4719770|NCT03111368|pancreatic neoplasm|pancreatic neoplasm
4719771|NCT03111368|slow-pull|slow-pull
4719772|NCT03111368|negative pressure|negative pressure
4719773|NCT03111355|nuts|nuts
4719774|NCT03111355|micronutrients|micronutrients
4719775|NCT03111355|nutrigenomics|nutrigenomics
4719776|NCT03111355|nutrigenetics|nutrigenetics
4719777|NCT03111342|Intrauterine contraception|intrauterine contraception
4719778|NCT03111342|Pain|pain
4719779|NCT03111342|Anesthesia|anesthesia
4719780|NCT03111342|LNG-IUD|lng-iud
4719781|NCT03111342|nulligravida|nulligravida
4719782|NCT03111329|Gastric residuals assessment|gastric residuals assessment
4719783|NCT03111329|Prematurity|prematurity
4719784|NCT03111329|Necrotizing Enterocolitis of Newborn|necrotizing enterocolitis of newborn
4719785|NCT03111329|Sepsis Newborn|sepsis newborn
4719786|NCT03111329|Nutrition of newborn|nutrition of newborn
4719787|NCT03111329|feeding tolerance of newborn|feeding tolerance of newborn
4719788|NCT03111316|Cervical Ripening|cervical ripening
4719789|NCT03111316|Induction of Labor|induction of labor
4719790|NCT03111290|Facial recognition|facial recognition
4719791|NCT03111277|neuropathic pain|neuropathic pain
4719792|NCT03111264|Overweight|overweight
4719793|NCT03111264|Obesity|obesity
4719794|NCT03111264|Prevention|prevention
4719795|NCT03111264|Children|children
4719796|NCT03111264|Childcare|childcare
4719797|NCT03111264|Physical Activity|physical activity
4719798|NCT03111264|Nutrition|nutrition
4719799|NCT03111264|Wellness|wellness
4719800|NCT03111264|Environment|environment
4719801|NCT03111264|Intervention|intervention
4719802|NCT03111264|Feeding|feeding
4719803|NCT03111238|Autologous|autologous
4719804|NCT03111238|Bone Marrow-derived Mononuclear Cells (BM-MNCs)|bone marrow-derived mononuclear cells (bm-mncs)
4719901|NCT03110809|weight|weight
4719805|NCT03111238|Advanced Therapy Medicinal Product (ATMP)|advanced therapy medicinal product (atmp)
4719806|NCT03111238|Tissue-engineered Medicinal Product|tissue-engineered medicinal product
4719807|NCT03111238|Revascularization|revascularization
4719808|NCT03111238|Angiogenesis|angiogenesis
4719809|NCT03111238|Vasculogenesis|vasculogenesis
4719810|NCT03111238|Arteriogenesis|arteriogenesis
4719811|NCT03111212|Acute respiratory distress syndrome|acute respiratory distress syndrome
4719812|NCT03111199|Low back pain|low back pain
4719813|NCT03111199|Analgesia|analgesia
4719814|NCT03111199|Physical therapy|physical therapy
4719815|NCT03111186|oxycodone|oxycodone
4719816|NCT03111186|ibuprofen|ibuprofen
4719817|NCT03111186|acetaminophen|acetaminophen
4719818|NCT03111186|soft-tissue hand surgery|soft-tissue hand surgery
4719819|NCT03111186|carpal tunnel release|carpal tunnel release
4719820|NCT03111186|Dupuytren contracture release|dupuytren contracture release
4719821|NCT03111186|Trigger digit release|trigger digit release
4719822|NCT03111186|Ganglion cyst removal|ganglion cyst removal
4719823|NCT03111186|De Quervain's release|de quervain's release
4719824|NCT03111173|ECG|ecg
4719825|NCT03111173|Fetus|fetus
4719826|NCT03111173|R peak extraction|r peak extraction
4719827|NCT03111160|Small-incision lenticule extraction|small-incision lenticule extraction
4719828|NCT03111160|femtosecond laser|femtosecond laser
4719829|NCT03111160|lower laser energy level|lower laser energy level
4719830|NCT03111160|early visual recovery|early visual recovery
4719831|NCT03111134|abdominal wound closure techniques|abdominal wound closure techniques
4719832|NCT03111134|layered closure|layered closure
4719833|NCT03111134|component separation technique|component separation technique
4719834|NCT03111121|deeply anesthetized|deeply anesthetized
4719835|NCT03111121|ideal surgical exposure|ideal surgical exposure
4719836|NCT03111121|muscle relaxation|muscle relaxation
4719837|NCT03111121|Adults|adults
4719838|NCT03111069|Malignant neoplasms of mesothelial and soft tissue|malignant neoplasms of mesothelial and soft tissue
4719839|NCT03111069|Pelvic and Abdominal Rhabdomyosarcoma|pelvic and abdominal rhabdomyosarcoma
4719840|NCT03111069|Undifferentiated Sarcomas|undifferentiated sarcomas
4719841|NCT03111069|Unresectable or Refractory|unresectable or refractory
4719842|NCT03111069|Abdominal tumors|abdominal tumors
4719843|NCT03111069|Hyperthermic intra-peritoneal chemotherapy|hyperthermic intra-peritoneal chemotherapy
4719844|NCT03111069|HIPEC|hipec
4719845|NCT03111069|Abdominal surgery|abdominal surgery
4719846|NCT03111069|Doxorubicin|doxorubicin
4719847|NCT03111069|Doxorubicin Hydrochloride|doxorubicin hydrochloride
4719848|NCT03111069|Adriamycin PFS|adriamycin pfs
4719849|NCT03111069|Adriamycin RDF|adriamycin rdf
4719850|NCT03111069|Adriamycin|adriamycin
4719851|NCT03111069|Rubex|rubex
4719852|NCT03111069|Intra-operative radiation|intra-operative radiation
4719853|NCT03111069|IORT|iort
4719854|NCT03111069|Brachytherapy|brachytherapy
4719855|NCT03111043|computed tomography|computed tomography
4719856|NCT03111043|Sudden cardiac arrest|sudden cardiac arrest
4719857|NCT03111043|Cardiac computed tomography|cardiac computed tomography
4719858|NCT03111043|Diagnostic accuracy|diagnostic accuracy
4719859|NCT03111043|Clinical outcome|clinical outcome
4719860|NCT03111017|muscle sympathetic nerve activity|muscle sympathetic nerve activity
4719861|NCT03111017|exercise tolerance|exercise tolerance
4719862|NCT03111017|exercise training|exercise training
4719863|NCT03111017|peak oxygen uptake|peak oxygen uptake
4719864|NCT03111004|information technology|information technology
4719865|NCT03111004|telemedicine|telemedicine
4719866|NCT03111004|integrated care|integrated care
4719867|NCT03111004|MAST framework|mast framework
4719868|NCT03111004|organizational change|organizational change
4719869|NCT03111004|social care|social care
4719870|NCT03111004|elderly patients|elderly patients
4719871|NCT03110991|Depression|depression
4719872|NCT03110991|Depressive symptoms|depressive symptoms
4719873|NCT03110991|Prevention|prevention
4719874|NCT03110991|Non-professional caregivers|non-professional caregivers
4719875|NCT03110991|App|app
4719876|NCT03110978|Malignant neoplasms of respiratory and intrathoracic organs|malignant neoplasms of respiratory and intrathoracic organs
4719877|NCT03110978|Non-small Cell Lung Cancer|non-small cell lung cancer
4719878|NCT03110978|NSCLC|nsclc
4719879|NCT03110978|Squamous cell carcinoma|squamous cell carcinoma
4719880|NCT03110978|Adenocarcinoma|adenocarcinoma
4719881|NCT03110978|Large cell carcinoma|large cell carcinoma
4719882|NCT03110978|Bronchioloalveolar cell carcinoma|bronchioloalveolar cell carcinoma
4719883|NCT03110978|Stereotactic ablative radiotherapy|stereotactic ablative radiotherapy
4719884|NCT03110978|SABR|sabr
4719885|NCT03110978|Nivolumab|nivolumab
4719886|NCT03110978|BMS-936558|bms-936558
4719887|NCT03110978|Opdivo|opdivo
4719888|NCT03110978|Immunotherapy|immunotherapy
4719889|NCT03110913|Healthy|healthy
4719890|NCT03110913|Men|men
4719891|NCT03110913|Adults|adults
4719892|NCT03110913|Methionine|methionine
4719893|NCT03110887|Dynamic prediction model|dynamic prediction model
4719894|NCT03110822|Ruxolitinib|ruxolitinib
4719895|NCT03110822|Steroids|steroids
4719896|NCT03110822|Lenalidomide|lenalidomide
4719897|NCT03110822|Relapsed/Refractory Multiple Myeloma|relapsed/refractory multiple myeloma
4719898|NCT03110809|obesity|obesity
4719899|NCT03110809|brown|brown
4719900|NCT03110809|fat|fat
4719902|NCT03110809|loss|loss
4719903|NCT03110783|Bioseal as an Adjunct to Sutured Dural Repair|bioseal as an adjunct to sutured dural repair
4719904|NCT03110783|elective posterior fossa|elective posterior fossa
4719905|NCT03110783|supratentorial procedure|supratentorial procedure
4719906|NCT03110770|Flavivirus|flavivirus
4719907|NCT03110770|Zika|zika
4719908|NCT03110770|Vaccine|vaccine
4719909|NCT03110770|Physiological Effects of Drugs|physiological effects of drugs
4719910|NCT03110770|Immunologic Factors|immunologic factors
4719911|NCT03110770|Virus-like Particles|virus-like particles
4719912|NCT03110770|Zika vaccine|zika vaccine
4719913|NCT03110757|AP 10-701|ap 10-701
4719914|NCT03110757|healthy adults|healthy adults
4719915|NCT03110757|Immunogenicity|immunogenicity
4719916|NCT03110757|Phase Ib|phase ib
4719917|NCT03110757|Reactogenicity|reactogenicity
4719918|NCT03110757|Safety|safety
4719919|NCT03110757|Schistosomiasis|schistosomiasis
4719920|NCT03110757|Sm-TSP-2/Alhydrogel®|sm-tsp-2/alhydrogel®
4719921|NCT03110718|robotic rehabilitation|robotic rehabilitation
4719922|NCT03110718|muscle vibration|muscle vibration
4719923|NCT03110718|combined approach|combined approach
4719924|NCT03110679|osteoarthritis|osteoarthritis
4719925|NCT03110679|autologous bone marrow concentrate|autologous bone marrow concentrate
4719926|NCT03110666|knee osteoarthritis ,|knee osteoarthritis ,
4719927|NCT03110666|bone marrow aspirate|bone marrow aspirate
4719928|NCT03110666|injections|injections
4719929|NCT03110627|Single-chamber ICD (implantable cardioverter-defibrillator)|single-chamber icd (implantable cardioverter-defibrillator)
4719930|NCT03110627|Cardiac Arrhythmias|cardiac arrhythmias
4719931|NCT03110627|Atrial fibrillation|atrial fibrillation
4719932|NCT03110627|Atrial flutter|atrial flutter
4719933|NCT03110627|Stroke|stroke
4719934|NCT03110614|COPD|copd
4719935|NCT03110614|acute|acute
4719936|NCT03110614|exacerbation|exacerbation
4719937|NCT03110614|lung ultrasound|lung ultrasound
4719938|NCT03110588|metastatic prostate cancer|metastatic prostate cancer
4719939|NCT03110588|castration-resistant prostate cancer|castration-resistant prostate cancer
4719940|NCT03110588|PACE (Prednisone, Abiraterone, Cabazitaxel, and Enzalutamide)|pace (prednisone, abiraterone, cabazitaxel, and enzalutamide)
4719941|NCT03110575|TNX-102 SL|tnx-102 sl
4719942|NCT03110575|Bedtime|bedtime
4719943|NCT03110575|Sublingual|sublingual
4719944|NCT03110575|3-month|3-month
4719945|NCT03110575|Safety|safety
4719946|NCT03110575|Efficacy|efficacy
4719947|NCT03110575|PTSD|ptsd
4719948|NCT03110562|Relapsed or Refractory Multiple Myeloma|relapsed or refractory multiple myeloma
4719949|NCT03110562|RRMM|rrmm
4719950|NCT03110562|Bortezomib|bortezomib
4719951|NCT03110562|Dexamethasone|dexamethasone
4719952|NCT03110536|Burnout syndrome|burnout syndrome
4719953|NCT03110536|Triage|triage
4719954|NCT03110536|Nurse|nurse
4719955|NCT03110536|Emergency Department|emergency department
4719956|NCT03110536|Romania|romania
4719957|NCT03110497|Cervical cancer|cervical cancer
4719958|NCT03110497|Image guided Brachytherapy|image guided brachytherapy
4719959|NCT03110497|single application|single application
4719960|NCT03110471|Cognitive impairment|cognitive impairment
4719961|NCT03110471|antipsychotics|antipsychotics
4719962|NCT03110471|antidepressants|antidepressants
4719963|NCT03110458|Acute unilateral vestibulopathy, AUV|acute unilateral vestibulopathy, auv
4719964|NCT03110419|Elderly|elderly
4719965|NCT03110419|Frailty|frailty
4719966|NCT03110419|Multicomponent training|multicomponent training
4719967|NCT03110419|Physical exercise|physical exercise
4719968|NCT03110419|Functional capacity|functional capacity
4719969|NCT03110419|Complexity|complexity
4719970|NCT03110419|Physical Therapy|physical therapy
4719971|NCT03110406|renal transplant recipients|renal transplant recipients
4719972|NCT03110406|exercise|exercise
4719973|NCT03110406|heart rate variability|heart rate variability
4719974|NCT03110406|Cardiovascular mortality|cardiovascular mortality
4719975|NCT03110393|Obese|obese
4719976|NCT03110393|Laryngeal Mask Airway|laryngeal mask airway
4719977|NCT03110393|Anaesthesia|anaesthesia
4719978|NCT03110354|AML|aml
4719979|NCT03110354|ALL|all
4719980|NCT03110354|Enhancer of zeste homolog (EZH) inhibitor|enhancer of zeste homolog (ezh) inhibitor
4719981|NCT03110354|DS-3201b|ds-3201b
4719982|NCT03110315|Multiple Sclerosis|multiple sclerosis
4719983|NCT03110315|Fatigue|fatigue
4719984|NCT03110315|Insomnia|insomnia
4719985|NCT03110315|Suvorexant|suvorexant
4719986|NCT03110315|Belsomra|belsomra
4719987|NCT03110315|Sleep disorder|sleep disorder
4719988|NCT03110315|Sleep|sleep
4719989|NCT03110302|Posttraumatic Stress Disorder|posttraumatic stress disorder
4719990|NCT03110302|Telehealth|telehealth
4719991|NCT03110302|Video teleconferencing|video teleconferencing
4719992|NCT03110302|In home therapy|in home therapy
4719993|NCT03110302|Prolonged Exposure|prolonged exposure
4719994|NCT03110289|Fecal microbiota transplantation|fecal microbiota transplantation
4719995|NCT03110250|Familial Hypercholesterolemia|familial hypercholesterolemia
4719996|NCT03110250|registry|registry
4719997|NCT03110250|Turkey|turkey
4719998|NCT03110250|Lipid lowering therapy|lipid lowering therapy
4719999|NCT03110224|Subchondroplasty|subchondroplasty
4720000|NCT03110224|Bone Marrow Lesion|bone marrow lesion
4720001|NCT03110224|Arthroscopy|arthroscopy
4720002|NCT03110224|Bone Substitute Material|bone substitute material
4720003|NCT03110224|AccuFill|accufill
4720004|NCT03110224|Subchondral Bone Defect|subchondral bone defect
4720005|NCT03110198|Mesalazine|mesalazine
4720006|NCT03110198|Ulcerative Colitis(UC)|ulcerative colitis(uc)
4720007|NCT03110198|Enema|enema
4720008|NCT03110172|Osteoarthritis|osteoarthritis
4720009|NCT03110172|Depression|depression
4720010|NCT03110172|Pain|pain
4720011|NCT03110159|Photodynamic therapy|photodynamic therapy
4720012|NCT03110159|Prevention|prevention
4720013|NCT03110159|Actinic Keratosis|actinic keratosis
4720014|NCT03110159|Skin Cancer|skin cancer
4720015|NCT03110159|Non-melanoma Skin Cancer|non-melanoma skin cancer
4720016|NCT03110159|Sun Damaged Skin|sun damaged skin
4720017|NCT03110159|Solid Organ Transplant|solid organ transplant
4720018|NCT03110159|PDT|pdt
4720019|NCT03110133|Clostridium Difficile Infection|clostridium difficile infection
4720020|NCT03110133|CP101|cp101
4720021|NCT03110133|Crestovo|crestovo
4720022|NCT03110133|FMT|fmt
4720023|NCT03110133|CDI|cdi
4720024|NCT03110133|C. difficile|c. difficile
4720025|NCT03110133|C. diff|c. diff
4720026|NCT03110133|Recurrenct Clostridium Difficile Infection|recurrenct clostridium difficile infection
4720027|NCT03110133|Recurrent C. diff|recurrent c. diff
4720028|NCT03110133|Recurrent CDI|recurrent cdi
4720029|NCT03110133|Finch|finch
4720030|NCT03110068|microvascular invasion|microvascular invasion
4720031|NCT03110068|serum biomarker|serum biomarker
4720032|NCT03110068|radiological feature|radiological feature
4720033|NCT03110068|pathological differentiation|pathological differentiation
4720034|NCT03110003|Neuraxial epidural techniques|neuraxial epidural techniques
4720035|NCT03110003|Combined spinal epidural|combined spinal epidural
4720036|NCT03110003|Epidural volume extension|epidural volume extension
4720037|NCT03110003|Transient Neurologic Symptoms (TNS)|transient neurologic symptoms (tns)
4720038|NCT03109977|17-059|17-059
4720039|NCT03109977|Zr-DFO-pertuzumab|zr-dfo-pertuzumab
4720040|NCT03109951|Type 2 diabetes|type 2 diabetes
4720041|NCT03109951|colonoscopy|colonoscopy
4720042|NCT03109951|hypoglycemia|hypoglycemia
4720043|NCT03109951|hyperglycemia|hyperglycemia
4720044|NCT03109951|polyethylene glycol|polyethylene glycol
4720045|NCT03109925|PAE|pae
4720046|NCT03109925|embolization|embolization
4720047|NCT03109925|non-surgical|non-surgical
4720048|NCT03109925|prostate artery embolization|prostate artery embolization
4720049|NCT03109925|radio-opaque embolic|radio-opaque embolic
4720050|NCT03109899|mHealth|mhealth
4720051|NCT03109899|HIV Prevention|hiv prevention
4720052|NCT03109886|Unresectable Hepatocellular Carcinoma|unresectable hepatocellular carcinoma
4720053|NCT03109886|Metastatic Hepatocellular Carcinoma|metastatic hepatocellular carcinoma
4720054|NCT03109886|Child-Pugh Class A|child-pugh class a
4720055|NCT03109860|Chronic neuropathic pain|chronic neuropathic pain
4720056|NCT03109834|Weight Management Programs|weight management programs
4720057|NCT03109834|Weight loss stabilization|weight loss stabilization
4720058|NCT03109834|Cardiometabolic risk|cardiometabolic risk
4720059|NCT03109821|Exercise Therapy|exercise therapy
4720060|NCT03109821|Rehabilitation|rehabilitation
4720061|NCT03109782|Spinal Cord Injury|spinal cord injury
4720062|NCT03109782|Spine Surgery|spine surgery
4720063|NCT03109782|Patient Registry|patient registry
4720064|NCT03109782|Trauma|trauma
4720065|NCT03109743|HIV treatment|hiv treatment
4720066|NCT03109743|Adherence Group Treatment|adherence group treatment
4720067|NCT03109717|Treatment Resistant Depression|treatment resistant depression
4720068|NCT03109704|scapular kinematics|scapular kinematics
4720069|NCT03109704|thoracic spine|thoracic spine
4720070|NCT03109704|thrust manipulation|thrust manipulation
4720071|NCT03109652|total knee replacement arthroplasty|total knee replacement arthroplasty
4720072|NCT03109652|total knee arthroplasty|total knee arthroplasty
4720073|NCT03109652|tranexamic acid|tranexamic acid
4720074|NCT03109652|oral tranexamic acid|oral tranexamic acid
4720075|NCT03109652|transfusion|transfusion
4720076|NCT03109652|blood loss|blood loss
4720077|NCT03109639|EUS|eus
4720078|NCT03109639|FNA|fna
4720079|NCT03109639|FNB|fnb
4720080|NCT03109639|Core Histology|core histology
4720081|NCT03109626|DHA, replacement, treatment, brain PET-FDG, ataxia|dha, replacement, treatment, brain pet-fdg, ataxia
4720082|NCT03109613|Positive end-expiratory pressure|positive end-expiratory pressure
4720083|NCT03109613|PEEP|peep
4720084|NCT03109613|Bronchopulmonary Dysplasia|bronchopulmonary dysplasia
4720085|NCT03109613|Ventilator Induced Lung Injury|ventilator induced lung injury
4720086|NCT03109613|V/Q mismatch|v/q mismatch
4720087|NCT03109522|axillary reverse mapping (ARM)|axillary reverse mapping (arm)
4720088|NCT03109522|sentinel lymph node biopsy (SLNB)|sentinel lymph node biopsy (slnb)
4720089|NCT03109522|axillary lymph node dissection (ALND)|axillary lymph node dissection (alnd)
4720090|NCT03109522|lymphedema|lymphedema
4720091|NCT03109522|breast cancer|breast cancer
4720092|NCT03109522|surgery|surgery
4720093|NCT03109496|OME|ome
4720094|NCT03109496|Otitis Media with Effusion|otitis media with effusion
4720095|NCT03109496|Microbiota|microbiota
4720096|NCT03109496|Microbiome|microbiome
4720097|NCT03109496|URT|urt
4720098|NCT03109496|Upper Respiratory Tract|upper respiratory tract
4720099|NCT03109496|Healthy URT microbiota|healthy urt microbiota
4720100|NCT03109483|geriatric patients|geriatric patients
4720101|NCT03109483|elderly|elderly
4720102|NCT03109483|multicomponent physical therapy|multicomponent physical therapy
4720103|NCT03109470|Tocilizumab|tocilizumab
4720104|NCT03109470|Early Rheumatoid Arthritis|early rheumatoid arthritis
4720105|NCT03109470|Observational|observational
4720106|NCT03109470|Canadian|canadian
4720107|NCT03109457|Hepatitis C Virus|hepatitis c virus
4720108|NCT03109457|Oral squamous cell carcinoma|oral squamous cell carcinoma
4720109|NCT03109444|Hip Growth Chart|hip growth chart
4720110|NCT03109431|HIV Treatment Continuum|hiv treatment continuum
4720111|NCT03109431|HIV Disease Progression|hiv disease progression
4720112|NCT03109431|Mental Health|mental health
4720113|NCT03109431|Substance Use|substance use
4720114|NCT03109431|ARV Adherence|arv adherence
4720115|NCT03109431|Retention in Care|retention in care
4720116|NCT03109431|STI|sti
4720117|NCT03109418|Ketamine|ketamine
4720118|NCT03109418|Postoperative morbidity|postoperative morbidity
4720119|NCT03109353|Photopheresis|photopheresis
4720120|NCT03109353|5-aminolevulinic acid|5-aminolevulinic acid
4720121|NCT03109353|Extracorporeal Circulation|extracorporeal circulation
4720122|NCT03109340|abdominal obesity|abdominal obesity
4720123|NCT03109340|walking|walking
4720124|NCT03109340|aerobic exercise|aerobic exercise
4720125|NCT03109314|amblyopia|amblyopia
4720126|NCT03109314|donepezil|donepezil
4720127|NCT03109314|perceptual learning|perceptual learning
4720128|NCT03109314|crowding|crowding
4720129|NCT03109314|contrast sensitivity|contrast sensitivity
4720130|NCT03109314|visual acuity|visual acuity
4720131|NCT03109301|Mesenchymal Neoplasm|mesenchymal neoplasm
4720132|NCT03109301|Neurofibromatosis 1|neurofibromatosis 1
4720133|NCT03109301|Plexiform Neurofibromas|plexiform neurofibromas
4720134|NCT03109288|Targeted Therapy|targeted therapy
4720135|NCT03109288|Multiple Sclerosis|multiple sclerosis
4720136|NCT03109288|Biomarkers|biomarkers
4720137|NCT03109288|Combination Therapy|combination therapy
4720138|NCT03109184|Dating violence prevention|dating violence prevention
4720139|NCT03109184|Adolescent boys|adolescent boys
4720140|NCT03109184|Middle school|middle school
4720141|NCT03109184|Web-based prevention|web-based prevention
4720142|NCT03109171|Endoscopy|endoscopy
4720143|NCT03109171|Lasers|lasers
4720144|NCT03109171|Fiber Optic Technology|fiber optic technology
4720145|NCT03109171|Bronchoscopy|bronchoscopy
4720146|NCT03109171|Esthesiometer|esthesiometer
4720147|NCT03109171|Mechanoreceptors|mechanoreceptors
4720148|NCT03109171|Diagnosis|diagnosis
4720149|NCT03109171|Reflex|reflex
4720150|NCT03109171|Reproducibility of Results|reproducibility of results
4720151|NCT03109171|Reliability of Results|reliability of results
4720152|NCT03109171|Validity of Results|validity of results
4720153|NCT03109171|Sensory Thresholds|sensory thresholds
4720154|NCT03109158|squamous cell carcinoma|squamous cell carcinoma
4720155|NCT03109158|head|head
4720156|NCT03109158|neck|neck
4720157|NCT03109145|Shared decision making|shared decision making
4720158|NCT03109145|Knowledge|knowledge
4720159|NCT03109145|Patient portal|patient portal
4720160|NCT03109145|Secure messaging|secure messaging
4720161|NCT03109119|genomic instability|genomic instability
4720162|NCT03109119|Sevoflurane|sevoflurane
4720163|NCT03109119|General anaesthesia|general anaesthesia
4720164|NCT03109106|MICU|micu
4720165|NCT03109106|CICU|cicu
4720166|NCT03109106|PCT - Procalcitonin|pct - procalcitonin
4720167|NCT03109106|B·R·A·H·M·S PCT sensitive Kryptor®|b·r·a·h·m·s pct sensitive kryptor®
4720168|NCT03109106|Antibiotic initiation|antibiotic initiation
4720169|NCT03109106|Antibiotic de-escalation|antibiotic de-escalation
4720170|NCT03109093|ALL|all
4720171|NCT03109093|acute lymphoblastic leukemia|acute lymphoblastic leukemia
4720172|NCT03109093|MRD positive|mrd positive
4720173|NCT03109093|minimal residual disease|minimal residual disease
4720174|NCT03109093|blinatumomab|blinatumomab
4720175|NCT03109067|Cholesterol, HDL, Postprandial Period, Polymorphism, Genetic|cholesterol, hdl, postprandial period, polymorphism, genetic
4720176|NCT03109054|Melatonin|melatonin
4720177|NCT03109054|Anxiety|anxiety
4720178|NCT03109041|Whipple|whipple
4720179|NCT03109041|brachytherapy|brachytherapy
4720180|NCT03109041|CivaSheet|civasheet
4720181|NCT03109041|CivaTech Oncology|civatech oncology
4720182|NCT03109041|radiation|radiation
4720183|NCT03109041|intraoperative radiation|intraoperative radiation
4720184|NCT03109041|IORT|iort
4720185|NCT03109041|resectable pancreatic cancer|resectable pancreatic cancer
4720186|NCT03109041|Pd-103|pd-103
4720187|NCT03109015|metastatic renal cell carcinoma|metastatic renal cell carcinoma
4720188|NCT03109015|sunitinib|sunitinib
4720189|NCT03109015|Sutent|sutent
4720190|NCT03109015|cardiopulmonary function|cardiopulmonary function
4720191|NCT03108976|Autism|autism
4720192|NCT03108976|Sensori-motor learning|sensori-motor learning
4720193|NCT03108976|Development|development
4720194|NCT03108976|Neuroimaging|neuroimaging
4720195|NCT03108872|Anticoagulants|anticoagulants
4720196|NCT03108872|Atrial Appendage|atrial appendage
4720197|NCT03108872|Stroke|stroke
4720198|NCT03108846|Alzheimer's Disease|alzheimer's disease
4720199|NCT03108846|Agitation|agitation
4720200|NCT03108807|Emergency Department|emergency department
4720201|NCT03108807|Medical patients|medical patients
4720202|NCT03108807|D-dimer|d-dimer
4720203|NCT03108807|National Early Warning Score|national early warning score
4720204|NCT03108807|NEWS|news
4720205|NCT03108807|30-days mortality|30-days mortality
4720206|NCT03108807|Mortality|mortality
4720207|NCT03108794|hepatitis B，registry,cirrhosis, HCC|hepatitis b，registry,cirrhosis, hcc
4720208|NCT03108781|Dementia|dementia
4720209|NCT03108781|Behavioral Psychiatric symptoms|behavioral psychiatric symptoms
4720210|NCT03108781|Treatment|treatment
4720211|NCT03108755|ASP7713|asp7713
4720212|NCT03108729|epilepsy|epilepsy
4720213|NCT03108729|Partial-onset seizures|partial-onset seizures
4720214|NCT03108729|Focal epilepsy|focal epilepsy
4720215|NCT03108729|Focal seizures|focal seizures
4720216|NCT03108729|Partial onset seizures|partial onset seizures
4720217|NCT03108729|Pediatric|pediatric
4720218|NCT03108729|Partial seizures|partial seizures
4720219|NCT03108703|RCC|rcc
4720220|NCT03108703|Stereotactic Body Radiotherapy|stereotactic body radiotherapy
4720221|NCT03108703|SBRT|sbrt
4720222|NCT03108703|Stereotactic Ablative Radiotherapy|stereotactic ablative radiotherapy
4720223|NCT03108703|SABR|sabr
4720224|NCT03108690|Therapeutic drug monitoring|therapeutic drug monitoring
4720225|NCT03108690|Continuous infusion|continuous infusion
4720226|NCT03108690|Beta-lactam|beta-lactam
4720227|NCT03108690|Antibiotics|antibiotics
4720228|NCT03108690|Bacteraemia|bacteraemia
4720229|NCT03108677|RNA profiling|rna profiling
4720230|NCT03108677|Exosome|exosome
4720231|NCT03108677|Lung Metastases|lung metastases
4720232|NCT03108677|Osteosarcoma|osteosarcoma
4720233|NCT03108664|SYL1001|syl1001
4720234|NCT03108664|siRNA|sirna
4720235|NCT03108625|children|children
4720236|NCT03108625|adolescent|adolescent
4720237|NCT03108612|diagnostic accuracy|diagnostic accuracy
4720238|NCT03108612|upper limb|upper limb
4720239|NCT03108599|Health Promotion|health promotion
4720240|NCT03108599|Injury Prevention|injury prevention
4720241|NCT03108599|Safety|safety
4720242|NCT03108599|Wellbeing|wellbeing
4720243|NCT03108599|Physical Activity|physical activity
4720244|NCT03108599|Sleep|sleep
4720245|NCT03108599|Whole Body Vibration|whole body vibration
4720246|NCT03108599|Self-Monitoring|self-monitoring
4720247|NCT03108586|restorations|restorations
4720248|NCT03108586|diagnosis|diagnosis
4720249|NCT03108586|secondary caries|secondary caries
4720250|NCT03108586|treatment decision|treatment decision
4720251|NCT03108560|sublobar resection|sublobar resection
4720252|NCT03108560|lobectomy|lobectomy
4720253|NCT03108547|Sarcoidosis|sarcoidosis
4720254|NCT03108547|Scalp hair cortisol and testosterone|scalp hair cortisol and testosterone
4720255|NCT03108547|Fatigue|fatigue
4720256|NCT03108547|Biomarker|biomarker
4720257|NCT03108547|Psychological distress|psychological distress
4720258|NCT03108521|DPP - 4; GLP1R ; gene polymorphism research; diabetes|dpp - 4; glp1r ; gene polymorphism research; diabetes
4720259|NCT03108495|LN-145|ln-145
4720260|NCT03108495|Cell Therapy|cell therapy
4720261|NCT03108495|Autologous Adoptive Cell Transfer|autologous adoptive cell transfer
4720262|NCT03108495|Autologous Adoptive Cell Therapy|autologous adoptive cell therapy
4720263|NCT03108495|Cellular Immuno-therapy|cellular immuno-therapy
4720264|NCT03108495|Tumor Infiltrating Lymphocytes|tumor infiltrating lymphocytes
4720265|NCT03108495|TIL|til
4720266|NCT03108495|IL-2|il-2
4720267|NCT03108482|Acute Pain|acute pain
4720268|NCT03108482|Post-surgical Pain|post-surgical pain
4720269|NCT03108482|Bunionectomy|bunionectomy
4720270|NCT03108482|Co-crystal|co-crystal
4720271|NCT03108482|Tramadol|tramadol
4720272|NCT03108482|Celecoxib|celecoxib
4720273|NCT03108469|migraine|migraine
4720274|NCT03108456|atherectomy|atherectomy
4720275|NCT03108456|CAD|cad
4720276|NCT03108456|severe calcium|severe calcium
4720277|NCT03108456|orbital atherectomy|orbital atherectomy
4720278|NCT03108456|minimum stent area|minimum stent area
4720279|NCT03108404|predictive score|predictive score
4720280|NCT03108378|Gadolinium|gadolinium
4720281|NCT03108378|Bone|bone
4720282|NCT03108378|Skin|skin
4720283|NCT03108300|efficacy|efficacy
4720284|NCT03108300|propranolol hydrochloride|propranolol hydrochloride
4720285|NCT03108300|sts|sts
4720286|NCT03108274|Midazolam|midazolam
4720287|NCT03108274|Fexofenadine|fexofenadine
4720288|NCT03108274|Mycophenolate Mofetil|mycophenolate mofetil
4720289|NCT03108248|transarterial chemoembolization|transarterial chemoembolization
4720290|NCT03108248|stent|stent
4720291|NCT03108248|irradiation|irradiation
4720292|NCT03108248|survival|survival
4720293|NCT03108248|decompensation|decompensation
4720294|NCT03108248|tumor response|tumor response
4720295|NCT03108222|chronic kidney disease|chronic kidney disease
4720296|NCT03108222|CKD|ckd
4720297|NCT03108222|renal failure|renal failure
4720298|NCT03108222|phosphorus|phosphorus
4720299|NCT03108222|phosphate|phosphate
4720300|NCT03108222|intestinal absorption|intestinal absorption
4720301|NCT03108196|bladder cancer， neobladder, detaenial sigmoid, ileal|bladder cancer， neobladder, detaenial sigmoid, ileal
4720302|NCT03108157|IVF|ivf
4720303|NCT03108157|DONOR EGGS|donor eggs
4720304|NCT03108157|ENDOMETRIAL SCRATCH|endometrial scratch
4720305|NCT03108157|PIPELLE|pipelle
4720306|NCT03108157|ONGOING PREGNANCY|ongoing pregnancy
4720307|NCT03108144|smoking cessation|smoking cessation
4720308|NCT03108144|alcohol|alcohol
4720309|NCT03108144|primary care|primary care
4720310|NCT03108144|screening|screening
4720311|NCT03108144|brief intervention|brief intervention
4720312|NCT03108144|referral to treatment|referral to treatment
4720313|NCT03108144|cancer risk|cancer risk
4720314|NCT03108131|Malignant Neoplasms of Digestive Organs|malignant neoplasms of digestive organs
4720315|NCT03108131|Melanoma and Other Malignant Neoplasms of Skin|melanoma and other malignant neoplasms of skin
4720316|NCT03108131|Appendiceal Adenocarcinoma|appendiceal adenocarcinoma
4720317|NCT03108131|Cutaneous Squamous Cell Carcinoma|cutaneous squamous cell carcinoma
4720318|NCT03108131|Small Bowel Adenocarcinoma|small bowel adenocarcinoma
4720319|NCT03108131|Advanced rare tumors|advanced rare tumors
4720320|NCT03108131|Cobimetinib|cobimetinib
4720321|NCT03108131|Atezolizumab|atezolizumab
4720322|NCT03108131|MPDL3280A|mpdl3280a
4720323|NCT03108118|Diaphragm dysfunction|diaphragm dysfunction
4720324|NCT03108118|Acute respiratory failure|acute respiratory failure
4720325|NCT03108118|Weaning|weaning
4720326|NCT03108092|Drug Utilization Review|drug utilization review
4720327|NCT03108092|Older people|older people
4720328|NCT03108092|Health economics|health economics
4720329|NCT03108079|Urologic Injuries|urologic injuries
4720330|NCT03108079|Urologic Diseases|urologic diseases
4720331|NCT03108079|Bladder Infection|bladder infection
4720332|NCT03108079|Urinary Tract Infections|urinary tract infections
4720333|NCT03108079|Mucosal Inflammation|mucosal inflammation
4720334|NCT03108079|Mucosal Infection|mucosal infection
4720335|NCT03108079|Bladder Injury|bladder injury
4720336|NCT03108079|Catheter Related Infections|catheter related infections
4720337|NCT03108079|Catheter Complications|catheter complications
4720338|NCT03108079|Catheter Infection|catheter infection
4720339|NCT03108079|Indwelling Catheter|indwelling catheter
4720340|NCT03108079|Pelvic Floor Disorders|pelvic floor disorders
4720341|NCT03108079|Urinary Incontinence|urinary incontinence
4720342|NCT03108053|urinary stones|urinary stones
4720343|NCT03108053|semirigid ureteroscopy|semirigid ureteroscopy
4720344|NCT03108053|guidewire|guidewire
4720345|NCT03108027|QVM149,|qvm149,
4720346|NCT03108027|asthma,|asthma,
4720347|NCT03108027|allergic asthma,|allergic asthma,
4720348|NCT03108027|allergy triggered asthma,|allergy triggered asthma,
4720349|NCT03108027|reactive asthma,|reactive asthma,
4720350|NCT03108027|asthma attack,|asthma attack,
4720351|NCT03108027|difficulty breathing|difficulty breathing
4720352|NCT03107962|NK/T cell lymphoma|nk/t cell lymphoma
4720353|NCT03107962|immunotherapy|immunotherapy
4720354|NCT03107962|clinical trial|clinical trial
4720355|NCT03107962|RR|rr
4720356|NCT03107962|PFS|pfs
4720357|NCT03107962|OS|os
4720358|NCT03107949|Diaphragm atrophy|diaphragm atrophy
4720359|NCT03107949|VIDD|vidd
4720360|NCT03107949|weaning failure|weaning failure
4720361|NCT03107949|SBT|sbt
4720362|NCT03107923|Myocardial fibrosis|myocardial fibrosis
4720363|NCT03107923|Aortic Valve Stenosis|aortic valve stenosis
4720364|NCT03107923|TAVI|tavi
4720365|NCT03107923|Outcome|outcome
4720366|NCT03107897|TAVR|tavr
4720367|NCT03107897|elevated frailty score|elevated frailty score
4720368|NCT03107897|Transcatheter Valve Replacement|transcatheter valve replacement
4720369|NCT03107871|valganciclovir|valganciclovir
4720370|NCT03107845|CBT|cbt
4720371|NCT03107845|Psychometric Feedback|psychometric feedback
4720372|NCT03107845|Clinical Support Tools|clinical support tools
4720373|NCT03107845|Personalized Mental Health|personalized mental health
4720374|NCT03107819|Plasma metabolomics|plasma metabolomics
4720375|NCT03107819|Urinary metabolomics|urinary metabolomics
4720376|NCT03107819|Metabonomics|metabonomics
4720377|NCT03107819|Biomarker discovery|biomarker discovery
4720378|NCT03107806|acute coronary syndromes|acute coronary syndromes
4720379|NCT03107806|hyperglycemia|hyperglycemia
4720380|NCT03107806|hypoglycemia|hypoglycemia
4720381|NCT03107806|continuous glucose monitoring|continuous glucose monitoring
4720382|NCT03107741|Metabolic Syndrome|metabolic syndrome
4720383|NCT03107741|Waist circumference|waist circumference
4720384|NCT03107741|Blood pressure|blood pressure
4720385|NCT03107741|Triglyceride|triglyceride
4720386|NCT03107741|HDL cholesterol|hdl cholesterol
4720387|NCT03107728|orthotics|orthotics
4720388|NCT03107728|high-energy lower extremity trauma|high-energy lower extremity trauma
4720389|NCT03107728|physical therapy|physical therapy
4720390|NCT03107728|bracing|bracing
4720391|NCT03107728|functional performance|functional performance
4720392|NCT03107728|performance assessment|performance assessment
4720393|NCT03107715|exclusive breastfeeding|exclusive breastfeeding
4720394|NCT03107715|health disparity|health disparity
4720395|NCT03107715|prenatal intervention|prenatal intervention
4720396|NCT03107689|ILE|ile
4720397|NCT03107689|lipid|lipid
4720398|NCT03107689|overdose|overdose
4720399|NCT03107689|resuscitation|resuscitation
4720400|NCT03107676|trunk extensors; endurance, peak torque, power, work|trunk extensors; endurance, peak torque, power, work
4720401|NCT03107663|PET/CT|pet/ct
4720402|NCT03107663|Imaging|imaging
4720403|NCT03107663|⁸⁹Zr-Df-IAB22M2C|⁸⁹zr-df-iab22m2c
4720404|NCT03107663|CD8 + T Cells|cd8 + t cells
4720405|NCT03107663|Standard of Care|standard of care
4720406|NCT03107637|Embolic Stroke of Undetermined Source|embolic stroke of undetermined source
4720407|NCT03107637|transesophageal echocardiography|transesophageal echocardiography
4720408|NCT03107637|cardiac source of embolism|cardiac source of embolism
4720409|NCT03107637|ischemic stroke|ischemic stroke
4720410|NCT03107598|spinal anesthesia|spinal anesthesia
4720411|NCT03107598|neonatal outcome|neonatal outcome
4720412|NCT03107598|Caesarean Section|caesarean section
4720413|NCT03107585|cervical plexus block|cervical plexus block
4720414|NCT03107585|thyroidectomy|thyroidectomy
4720415|NCT03107585|opioid consumption|opioid consumption
4720416|NCT03107559|perfüsion index|perfüsion index
4720417|NCT03107559|epidural analgesia|epidural analgesia
4720418|NCT03107559|labor|labor
4720419|NCT03107546|Syndactyly|syndactyly
4720420|NCT03107546|Syndactyly release surgery|syndactyly release surgery
4720421|NCT03107546|Full thickness skin graft|full thickness skin graft
4720422|NCT03107546|Hyalomatrix|hyalomatrix
4720423|NCT03107546|Scar formation|scar formation
4720424|NCT03107520|contrast-enhanced ultrasound|contrast-enhanced ultrasound
4720425|NCT03107520|Lumason|lumason
4720426|NCT03107520|developmental dysplasia of the hip (DDH)|developmental dysplasia of the hip (ddh)
4720427|NCT03107520|avascular necrosis|avascular necrosis
4720428|NCT03107507|EEG with Periodic Abnormalities|eeg with periodic abnormalities
4720429|NCT03107507|Levetiracetam|levetiracetam
4720430|NCT03107507|Phenobarbitone|phenobarbitone
4720431|NCT03107507|neonatal seizures|neonatal seizures
4720432|NCT03107507|Neurodevelopmental Abnormality|neurodevelopmental abnormality
4720433|NCT03107481|Acetaminophen|acetaminophen
4720434|NCT03107481|Hydromorphone|hydromorphone
4720435|NCT03107481|Emergency Department|emergency department
4720436|NCT03107481|Narcotics|narcotics
4720437|NCT03107481|Analgesics, Opioid|analgesics, opioid
4720438|NCT03107481|Analgesics, Non-Narcotic|analgesics, non-narcotic
4720439|NCT03107468|Non-surgical treatment|non-surgical treatment
4720440|NCT03107468|Acupuncture|acupuncture
4720441|NCT03107468|Chuna|chuna
4720442|NCT03107468|Physiotherapy|physiotherapy
4720443|NCT03107468|Epidural steroid injection|epidural steroid injection
4720444|NCT03107455|MitraClip|mitraclip
4720445|NCT03107455|Acute mitral regurgitation|acute mitral regurgitation
4720446|NCT03107455|Acute myocardial infarction|acute myocardial infarction
4720447|NCT03107442|Arterial stiffness|arterial stiffness
4720448|NCT03107442|Markers of Inflammation|markers of inflammation
4720449|NCT03107442|Exercise|exercise
4720450|NCT03107442|Physical fitness|physical fitness
4720451|NCT03107442|Cardiovascular risk|cardiovascular risk
4720452|NCT03107442|Autoimmune diseases|autoimmune diseases
4720453|NCT03107429|Trendelenburg|trendelenburg
4720454|NCT03107429|Laparoscopic colorectal surgery|laparoscopic colorectal surgery
4720455|NCT03107429|POVL|povl
4720456|NCT03107416|Bumetanide|bumetanide
4720457|NCT03107416|Diuretic|diuretic
4720458|NCT03107416|Transarterial Embolization (TAE)|transarterial embolization (tae)
4720459|NCT03107416|17-141|17-141
4720460|NCT03107403|dreams bereavement|dreams bereavement
4720461|NCT03107403|emotional|emotional
4720462|NCT03107403|regulation|regulation
4720463|NCT03107403|bereavement|bereavement
4720464|NCT03107338|Pre-emptive analgesia; Dexketoprofen trometamol|pre-emptive analgesia; dexketoprofen trometamol
4720465|NCT03107208|DKA|dka
4720466|NCT03107208|type 1 diabetes|type 1 diabetes
4720467|NCT03107208|children|children
4720468|NCT03107208|continuous glucose monitoring|continuous glucose monitoring
4720469|NCT03107182|HPV- positive HNSCC|hpv- positive hnscc
4720470|NCT03107182|head and neck squamous cell carcinoma|head and neck squamous cell carcinoma
4720471|NCT03107156|Treatment care planning|treatment care planning
4720472|NCT03107143|Pressure ulcer prevention|pressure ulcer prevention
4720473|NCT03107143|Pressure injury|pressure injury
4720474|NCT03107091|Terlipressin|terlipressin
4720475|NCT03107091|Terlipressin acetate|terlipressin acetate
4720476|NCT03107065|Sweating|sweating
4720477|NCT03107026|Binge eating Disorder|binge eating disorder
4720478|NCT03107026|dasotraline|dasotraline
4720479|NCT03107013|Mass Balance|mass balance
4720480|NCT03107013|Phase 1|phase 1
4720481|NCT03106987|polymerisation inhibitor (PARPi)|polymerisation inhibitor (parpi)
4720482|NCT03106987|PARPi re-treatment|parpi re-treatment
4720483|NCT03106987|BRCA1/2 (+ve)|brca1/2 (+ve)
4720484|NCT03106987|BRCA1/2 (-ve)|brca1/2 (-ve)
4720485|NCT03106987|Olaparib|olaparib
4720486|NCT03106987|ovarian cancer|ovarian cancer
4720487|NCT03106987|progression free survival (PFS)|progression free survival (pfs)
4720488|NCT03106935|recurrent pregnancy loss|recurrent pregnancy loss
4720489|NCT03106935|Clinical hypothyroidism|clinical hypothyroidism
4720490|NCT03106935|Subclinical hypothyroidism|subclinical hypothyroidism
4720491|NCT03106935|thyroid stimulating hormone|thyroid stimulating hormone
4720492|NCT03106935|thyroid peroxidase antibody|thyroid peroxidase antibody
4720493|NCT03106935|Levothyroxine|levothyroxine
4720494|NCT03106922|Polyethylene glycol|polyethylene glycol
4720495|NCT03106922|Bowel cleansing|bowel cleansing
4720496|NCT03106922|Colonoscopy|colonoscopy
4720497|NCT03106909|stroke|stroke
4720498|NCT03106909|pneumonia|pneumonia
4720499|NCT03106909|biomarkers|biomarkers
4720500|NCT03106909|pulmonary CT|pulmonary ct
4720501|NCT03106883|Attention bias modification|attention bias modification
4720502|NCT03106883|Cognitive bias modification|cognitive bias modification
4720503|NCT03106883|Eye-tracking|eye-tracking
4720504|NCT03106883|Treatment|treatment
4720505|NCT03106844|FMT|fmt
4720506|NCT03106844|IBD|ibd
4720507|NCT03106805|intrauterine device|intrauterine device
4720508|NCT03106779|Phase 3|phase 3
4720509|NCT03106779|Chronic Myelogenous Leukemia|chronic myelogenous leukemia
4720510|NCT03106779|CML|cml
4720511|NCT03106779|bosutinib|bosutinib
4720512|NCT03106779|ABL001|abl001
4720513|NCT03106779|tyrosine kinase inhibitor|tyrosine kinase inhibitor
4720514|NCT03106779|Chronic myelogenous leukemia (CML)|chronic myelogenous leukemia (cml)
4720515|NCT03106779|chronic myeloid leukemia (CML)|chronic myeloid leukemia (cml)
4720516|NCT03106779|chronic myelocytic leukemia (CML)|chronic myelocytic leukemia (cml)
4720517|NCT03106779|chronic granulocytic leukemia (CGL)|chronic granulocytic leukemia (cgl)
4720518|NCT03106779|cancer of the white blood cells|cancer of the white blood cells
4720519|NCT03106779|clonal bone marrow stem cell disorder|clonal bone marrow stem cell disorder
4720520|NCT03106779|proliferation of mature granulocytes|proliferation of mature granulocytes
4720521|NCT03106753|External Cephalic Version|external cephalic version
4720522|NCT03106753|neuraxial analgesia|neuraxial analgesia
4720523|NCT03106740|Microglia|microglia
4720524|NCT03106740|Minocycline|minocycline
4720525|NCT03106740|Magnetic Resonance Imaging|magnetic resonance imaging
4720526|NCT03106740|Positron Emission Tomography|positron emission tomography
4720527|NCT03106740|Pain|pain
4720528|NCT03106740|Astrocytes|astrocytes
4720529|NCT03106740|Glia|glia
4720530|NCT03106740|Human|human
4720531|NCT03106740|Back Pain|back pain
4720532|NCT03106727|Community Health Workers|community health workers
4720533|NCT03106727|Maternal and Child Health|maternal and child health
4720534|NCT03106727|Integrated Care|integrated care
4720535|NCT03106727|Malawi|malawi
4720536|NCT03106727|NCD|ncd
4720537|NCT03106714|persistence|persistence
4720538|NCT03106714|body fluids|body fluids
4720539|NCT03106688|PET imaging|pet imaging
4720540|NCT03106688|Cannabinoid receptor|cannabinoid receptor
4720541|NCT03106688|Opioid receptor|opioid receptor
4720542|NCT03106688|Addiction|addiction
4720543|NCT03106688|fMRI imaging|fmri imaging
4720544|NCT03106675|HIFU|hifu
4720545|NCT03106675|MR-HIFU|mr-hifu
4720546|NCT03106675|MRgFUs|mrgfus
4720547|NCT03106675|MRI-intervention|mri-intervention
4720548|NCT03106675|Palliation|palliation
4720549|NCT03106662|Mesenchymal stem cell|mesenchymal stem cell
4720550|NCT03106662|haploidentical hematopoietic stem cell transplantation|haploidentical hematopoietic stem cell transplantation
4720551|NCT03106662|graft-versus-host disease|graft-versus-host disease
4720552|NCT03106662|engraftment|engraftment
4720553|NCT03106636|Preschool-aged|preschool-aged
4720554|NCT03106636|Foster children|foster children
4720555|NCT03106636|child welfare|child welfare
4720556|NCT03106636|Fostercare|fostercare
4720557|NCT03106636|Parent training|parent training
4720558|NCT03106636|early adversity|early adversity
4720559|NCT03106636|curriculum based|curriculum based
4720560|NCT03106636|early intervention|early intervention
4720561|NCT03106636|preschool|preschool
4720562|NCT03106636|foster placement disruptions|foster placement disruptions
4720563|NCT03106636|manualized intervention|manualized intervention
4720564|NCT03106636|group based intervention|group based intervention
4720565|NCT03106636|high-risk children|high-risk children
4720566|NCT03106610|Bladder cancer|bladder cancer
4720567|NCT03106610|Cancer of urothelium|cancer of urothelium
4720568|NCT03106610|Transitional cell carcinoma|transitional cell carcinoma
4720569|NCT03106610|Carcinoma in situ|carcinoma in situ
4720570|NCT03106610|Nivolumab|nivolumab
4720571|NCT03106610|BMS-936558|bms-936558
4720572|NCT03106610|Opdivo|opdivo
4720573|NCT03106610|Questionnaires|questionnaires
4720574|NCT03106610|Surveys|surveys
4720575|NCT03106597|Peripheral Edema|peripheral edema
4720576|NCT03106597|Bioimpedance Analysis|bioimpedance analysis
4720577|NCT03106584|Knee pain|knee pain
4720578|NCT03106584|Glucosamine|glucosamine
4720579|NCT03106584|WOMAC|womac
4720580|NCT03106584|Osteoarthritis|osteoarthritis
4720581|NCT03106571|Phase 1 clinical trial|phase 1 clinical trial
4720582|NCT03106506|Implants|implants
4720583|NCT03106506|Conjunctive tissue graft|conjunctive tissue graft
4720584|NCT03106506|Prospective study|prospective study
4720585|NCT03106480|Pre-diabetes|pre-diabetes
4720586|NCT03106480|Diabetes Mellitus|diabetes mellitus
4720587|NCT03106480|HIV|hiv
4720588|NCT03106480|ART|art
4720589|NCT03106480|Body composition|body composition
4720590|NCT03106480|Inflammation|inflammation
4720591|NCT03106480|Insulin resistance|insulin resistance
4720592|NCT03106480|Beta-cell function|beta-cell function
4720593|NCT03106480|Pre-Hypertension|pre-hypertension
4720594|NCT03106480|Hypertension|hypertension
4720595|NCT03106467|appendectomy|appendectomy
4720596|NCT03106467|laparoscopic|laparoscopic
4720597|NCT03106467|single port|single port
4720598|NCT03106467|randomized|randomized
4720599|NCT03106389|misoprostol|misoprostol
4720600|NCT03106389|transcervical balloon catheter|transcervical balloon catheter
4720601|NCT03106389|second trimester|second trimester
4720602|NCT03106389|induced abortion|induced abortion
4720603|NCT03106337|Thyroid|thyroid
4720604|NCT03106337|Follicular Neoplasms|follicular neoplasms
4720605|NCT03106337|Bethesda System|bethesda system
4720606|NCT03106337|Elastography|elastography
4720607|NCT03106337|Doppler ultrasound|doppler ultrasound
4720608|NCT03106337|Thyroidectomy|thyroidectomy
4720609|NCT03106324|Multiple Myeloma|multiple myeloma
4720610|NCT03106324|Non transplant eligible|non transplant eligible
4720611|NCT03106324|Revlimid|revlimid
4720612|NCT03106324|PASS|pass
4720613|NCT03106324|Non-interventional|non-interventional
4720614|NCT03106324|Lenalidomide|lenalidomide
4720615|NCT03106298|Iron Deficiency|iron deficiency
4720616|NCT03106298|Fibroblast Growth Factor 23|fibroblast growth factor 23
4720617|NCT03106298|Phosphate|phosphate
4720618|NCT03106259|FURESTEM-RA|furestem-ra
4720619|NCT03106246|Extracellular vesicles|extracellular vesicles
4720620|NCT03106246|Autoimmunity|autoimmunity
4720621|NCT03106246|Beta-cell injury|beta-cell injury
4720622|NCT03106233|Breast reconstruction|breast reconstruction
4720623|NCT03106233|Perforator flap|perforator flap
4720624|NCT03106233|Microsurgery|microsurgery
4720625|NCT03106168|Extraction|extraction
4720626|NCT03106168|Local Anesthetic|local anesthetic
4720627|NCT03106168|Mepivacaine|mepivacaine
4720628|NCT03106168|Mandibular Molar|mandibular molar
4720629|NCT03106142|intervention, improvement strategy|intervention, improvement strategy
4720630|NCT03106116|Coronary Heart Disease|coronary heart disease
4720631|NCT03106116|Ventricular Function|ventricular function
4720632|NCT03106116|Vascular Endothelium|vascular endothelium
4720633|NCT03106116|Counterpulsation, External|counterpulsation, external
4720634|NCT03106103|urodynamics|urodynamics
4720635|NCT03106103|cystitis|cystitis
4720636|NCT03106103|prophylactic antibiotics|prophylactic antibiotics
4720637|NCT03106103|bacteriuria|bacteriuria
4720638|NCT03106090|survivorship care plan|survivorship care plan
4720639|NCT03106090|head and neck cancer|head and neck cancer
4720640|NCT03106090|survivorship|survivorship
4720641|NCT03106077|Malignant neoplasm of breast|malignant neoplasm of breast
4720642|NCT03106077|Triple-Negative Breast Cancer|triple-negative breast cancer
4720643|NCT03106077|TNBC|tnbc
4720644|NCT03106077|Metastatic Triple-Negative Breast Cancer|metastatic triple-negative breast cancer
4720645|NCT03106077|Newly Diagnosed Triple-Negative Breast Cancer|newly diagnosed triple-negative breast cancer
4720646|NCT03106077|Mirvetuximab Soravtansine|mirvetuximab soravtansine
4720647|NCT03106077|IMGN853|imgn853
4720648|NCT03106051|Arthritis|arthritis
4720649|NCT03106051|Psoriatic|psoriatic
4720650|NCT03106051|Observational|observational
4720651|NCT03106051|Apremilast|apremilast
4720652|NCT03106038|contrast agent|contrast agent
4720653|NCT03106038|ureter imaging|ureter imaging
4720654|NCT03106038|intraoperative monitoring|intraoperative monitoring
4720655|NCT03106038|intraoperative procedures|intraoperative procedures
4720656|NCT03106038|near infrared fluorescence|near infrared fluorescence
4720657|NCT03106038|minimally invasive|minimally invasive
4720658|NCT03105973|jail|jail
4720659|NCT03105973|prison|prison
4720660|NCT03105973|technology|technology
4720661|NCT03105973|depression|depression
4720662|NCT03105973|CBT|cbt
4720663|NCT03105947|lipids|lipids
4720664|NCT03105947|dietary fats|dietary fats
4720665|NCT03105921|Locally advanced pancreatic carcinoma|locally advanced pancreatic carcinoma
4720666|NCT03105921|Irreversible electroporation|irreversible electroporation
4720667|NCT03105921|Interventional radiology|interventional radiology
4720668|NCT03105895|Incisional hernia|incisional hernia
4720669|NCT03105895|Mesh prevention|mesh prevention
4720670|NCT03105895|Mesh augmentation|mesh augmentation
4720671|NCT03105882|Spinal Cord Injury|spinal cord injury
4720672|NCT03105882|SCI|sci
4720673|NCT03105882|Complete (AIS A) Traumatic Acute Spinal Cord Injury|complete (ais a) traumatic acute spinal cord injury
4720674|NCT03105869|repeatability|repeatability
4720675|NCT03105869|positron emission tomography (PET)|positron emission tomography (pet)
4720676|NCT03105869|fluorocholine|fluorocholine
4720677|NCT03105856|Mass screening|mass screening
4720678|NCT03105856|Vaccination|vaccination
4720679|NCT03105856|Mexico|mexico
4720680|NCT03105843|Asthma|asthma
4720681|NCT03105843|Cough|cough
4720682|NCT03105843|Eucapneic Voluntary Hyperventilation|eucapneic voluntary hyperventilation
4720683|NCT03105843|Hypertonic Saline|hypertonic saline
4720684|NCT03105817|Asymmetric cellulose triacetate|asymmetric cellulose triacetate
4720685|NCT03105817|Biocompatibility|biocompatibility
4720686|NCT03105817|Hemodiafiltration on-line|hemodiafiltration on-line
4720687|NCT03105817|Convective volume|convective volume
4720688|NCT03105817|Adequacy|adequacy
4720689|NCT03105778|BNP|bnp
4720690|NCT03105778|IVD|ivd
4720691|NCT03105765|Neuropathic Pain|neuropathic pain
4720692|NCT03105765|Chronic Pain|chronic pain
4720693|NCT03105765|Posterolateral thoracotomy|posterolateral thoracotomy
4720694|NCT03105752|Outcome Assessments (Health Care)|outcome assessments (health care)
4720695|NCT03105752|Volunteers|volunteers
4720696|NCT03105752|Informed consent|informed consent
4720697|NCT03105752|Comprehension|comprehension
4720698|NCT03105752|Language tests|language tests
4720699|NCT03105726|End Stage Heart Failure|end stage heart failure
4720700|NCT03105726|New York Heart Association functional class III or IV|new york heart association functional class iii or iv
4720701|NCT03105726|Heart transplantation|heart transplantation
4720702|NCT03105726|Ventricular assisted devices|ventricular assisted devices
4720703|NCT03105726|Cardiogenic shock|cardiogenic shock
4720704|NCT03105713|Checklist|checklist
4720705|NCT03105713|Patient Checklist|patient checklist
4720706|NCT03105713|Surgery|surgery
4720707|NCT03105713|Safety|safety
4720708|NCT03105713|Patient Involvement|patient involvement
4720709|NCT03105700|epilepsy|epilepsy
4720710|NCT03105700|depression|depression
4720711|NCT03105700|refractory|refractory
4720712|NCT03105700|temporal lobe|temporal lobe
4720713|NCT03105700|TMS|tms
4720714|NCT03105700|biomarker|biomarker
4720715|NCT03105687|mHealth|mhealth
4720716|NCT03105687|SMS reminders|sms reminders
4720717|NCT03105687|adherence|adherence
4720718|NCT03105687|antihypertensive drugs|antihypertensive drugs
4720719|NCT03105687|pharmacists|pharmacists
4720720|NCT03105687|cost-effectiveness|cost-effectiveness
4720721|NCT03105674|analgesia|analgesia
4720722|NCT03105674|peri-anal procedure|peri-anal procedure
4720723|NCT03105674|peri-anal block|peri-anal block
4720724|NCT03105674|anal surgery|anal surgery
4720725|NCT03105635|Community Resources|community resources
4720726|NCT03105635|Health Navigator|health navigator
4720727|NCT03105622|Exercise|exercise
4720728|NCT03105622|Screen|screen
4720729|NCT03105622|Music|music
4720730|NCT03105622|Energy compensation|energy compensation
4720731|NCT03105622|Adolescents|adolescents
4720732|NCT03105622|Running+screen|running+screen
4720733|NCT03105622|Running+music|running+music
4720734|NCT03105622|Running without stimulus (control condition)|running without stimulus (control condition)
4720735|NCT03105609|hyperspectral imaging, Ranibizumab|hyperspectral imaging, ranibizumab
4720736|NCT03105583|Medication beliefs|medication beliefs
4720737|NCT03105583|Information desire|information desire
4720738|NCT03105583|Vitamin deficiencies|vitamin deficiencies
4720739|NCT03105570|breast neoplasms|breast neoplasms
4720740|NCT03105570|Mastectomy, Subcutaneous|mastectomy, subcutaneous
4720741|NCT03105570|Areola|areola
4720742|NCT03105557|Prematurely born newborns|prematurely born newborns
4720743|NCT03105557|Urine|urine
4720744|NCT03105557|Collecting device|collecting device
4720745|NCT03105544|simulation-based training|simulation-based training
4720746|NCT03105544|obstetric ultrasound|obstetric ultrasound
4720747|NCT03105544|intrauterine growth restriction|intrauterine growth restriction
4720748|NCT03105544|ultrasound simulation|ultrasound simulation
4720749|NCT03105531|primary aldosteronism|primary aldosteronism
4720750|NCT03105531|hypertension|hypertension
4720751|NCT03105531|screening|screening
4720752|NCT03105531|secondary hypertension|secondary hypertension
4720753|NCT03105518|assisted reproduction|assisted reproduction
4720754|NCT03105518|postoperative pain|postoperative pain
4720755|NCT03105518|opioid|opioid
4720756|NCT03105492|Prenatal Testing|prenatal testing
4720757|NCT03105492|Whole Genome Sequencing|whole genome sequencing
4720758|NCT03105479|vancomycin|vancomycin
4720759|NCT03105479|children|children
4720760|NCT03105479|cadazolid|cadazolid
4720761|NCT03105479|clostridium difficile associated diarrhea|clostridium difficile associated diarrhea
4720762|NCT03105466|Corneal Transplantation|corneal transplantation
4720763|NCT03105466|Xenotransplantation|xenotransplantation
4720764|NCT03105466|Bioegineered cornea|bioegineered cornea
4720765|NCT03105453|Assisted reproductive technologies|assisted reproductive technologies
4720766|NCT03105453|Microbiome|microbiome
4720767|NCT03105440|breast cancer|breast cancer
4720768|NCT03105440|lymphedema|lymphedema
4720769|NCT03105440|pain|pain
4720770|NCT03105440|range of motion|range of motion
4720771|NCT03105440|technologic innovation|technologic innovation
4720772|NCT03105440|rehabilitation|rehabilitation
4720773|NCT03105414|Mechanical ventilation|mechanical ventilation
4720774|NCT03105414|Pediatrics|pediatrics
4720775|NCT03105414|Cross infection|cross infection
4720776|NCT03105414|Intensive care|intensive care
4720777|NCT03105414|Diagnosis|diagnosis
4720778|NCT03105375|Potassium competitive acid blocker|potassium competitive acid blocker
4720779|NCT03105375|X842|x842
4720780|NCT03105375|Gastroesophageal reflux disease|gastroesophageal reflux disease
4720781|NCT03105375|Esophagitis|esophagitis
4720782|NCT03105375|Intragastric pH|intragastric ph
4720783|NCT03105375|Acid inhibition|acid inhibition
4720784|NCT03105362|Oral Rehydration Solutions|oral rehydration solutions
4720785|NCT03105310|Hepatitis D|hepatitis d
4720786|NCT03105310|Ezetimibe|ezetimibe
4720787|NCT03105310|Pegylated interferon|pegylated interferon
4720788|NCT03105297|Nasal dilator strip|nasal dilator strip
4720789|NCT03105297|Sleep disordered breathing|sleep disordered breathing
4720790|NCT03105284|stem cell|stem cell
4720791|NCT03105284|liposuction|liposuction
4720792|NCT03105284|regenerative medicine|regenerative medicine
4720793|NCT03105245|electroconvulsive therapy|electroconvulsive therapy
4720794|NCT03105245|anaesthesia|anaesthesia
4720795|NCT03105206|lowl pole renal calculus|lowl pole renal calculus
4720796|NCT03105206|anatomical parameters|anatomical parameters
4720797|NCT03105206|flexible ureteroscopy|flexible ureteroscopy
4720798|NCT03105193|Colon surgery|colon surgery
4720799|NCT03105193|Lignocaine|lignocaine
4720800|NCT03105193|Lidocaine|lidocaine
4720801|NCT03105193|Analgesia|analgesia
4720802|NCT03105193|Local anaesthetic|local anaesthetic
4720803|NCT03105167|CBT|cbt
4720804|NCT03105167|RCT|rct
4720805|NCT03105167|TLIF|tlif
4720806|NCT03105141|Intracranial atherosclerotic stenosis|intracranial atherosclerotic stenosis
4720807|NCT03105141|Remote ischemic conditioning|remote ischemic conditioning
4720808|NCT03105141|Stroke|stroke
4720809|NCT03105115|fentanyl|fentanyl
4720810|NCT03105115|dexmedetomidine|dexmedetomidine
4720811|NCT03105102|risankizumab|risankizumab
4720812|NCT03105102|ABBV-066|abbv-066
4720813|NCT03105102|BI 655066|bi 655066
4720814|NCT03105050|access|access
4720815|NCT03105050|policy|policy
4720816|NCT03105024|specific phobia|specific phobia
4720817|NCT03105024|height phobia|height phobia
4720818|NCT03105024|exposure|exposure
4720819|NCT03105024|virtual reality|virtual reality
4720820|NCT03105024|extinction|extinction
4720821|NCT03105024|self-efficacy|self-efficacy
4720822|NCT03105011|Type 2 diabetes|type 2 diabetes
4720823|NCT03104998|Idiopathic|idiopathic
4720824|NCT03104998|Infertility|infertility
4720825|NCT03104998|coenzyme q10|coenzyme q10
4720826|NCT03104998|Pakistan|pakistan
4720827|NCT03104985|Trophic ulcer; low level laser therapy; Chronic Venous Insufficiency|trophic ulcer; low level laser therapy; chronic venous insufficiency
4720828|NCT03104972|ADHD|adhd
4720829|NCT03104972|TRANS CRANIAL ELECTRIC STIMULATION|trans cranial electric stimulation
4720830|NCT03104959|hangovers|hangovers
4720831|NCT03104959|N-acetyl cysteine|n-acetyl cysteine
4720832|NCT03104959|alcohol|alcohol
4720833|NCT03104933|Proadrenomedullin|proadrenomedullin
4720834|NCT03104933|Copeptin|copeptin
4720835|NCT03104933|Vasopressors|vasopressors
4720836|NCT03104933|Septic Shock|septic shock
4720837|NCT03104920|ERAS|eras
4720838|NCT03104920|Time to ready for discharge|time to ready for discharge
4720839|NCT03104907|IPSS|ipss
4720840|NCT03104907|Quality of Life|quality of life
4720841|NCT03104907|DAN-PSS|dan-pss
4720842|NCT03104907|Complications|complications
4720843|NCT03104907|Prostate cancer|prostate cancer
4720844|NCT03104881|stroke|stroke
4720845|NCT03104855|cystic fibrosis|cystic fibrosis
4720846|NCT03104855|vitamin d catabolism|vitamin d catabolism
4720847|NCT03104816|Acetaminophen po|acetaminophen po
4720848|NCT03104816|Acetaminophen IV|acetaminophen iv
4720849|NCT03104816|Pain management|pain management
4720850|NCT03104816|minimally invasive lumbar fusions|minimally invasive lumbar fusions
4720851|NCT03104816|Ofirmev|ofirmev
4720852|NCT03104816|Analgesics|analgesics
4720853|NCT03104816|Opioid|opioid
4720854|NCT03104816|Pain|pain
4720855|NCT03104816|Postoperative|postoperative
4720856|NCT03104816|Spinal|spinal
4720857|NCT03104764|labial frenulum|labial frenulum
4720858|NCT03104764|surgery|surgery
4720859|NCT03104764|scalpel technique|scalpel technique
4720860|NCT03104764|Er:YAG laser|er:yag laser
4720861|NCT03104751|Complex Congenital Heart Defect|complex congenital heart defect
4720862|NCT03104751|Infants|infants
4720863|NCT03104725|5-S-Cysteinyldopamine|5-s-cysteinyldopamine
4720864|NCT03104725|Cerebrospinal Fluid|cerebrospinal fluid
4720865|NCT03104725|PARKINSONS DISEASE|parkinsons disease
4720866|NCT03104725|MONOAMINE OXIDASE INHIBITOR|monoamine oxidase inhibitor
4720867|NCT03104712|glycemic index|glycemic index
4720868|NCT03104699|Antibodies|antibodies
4720869|NCT03104699|Immunologic effects|immunologic effects
4720870|NCT03104699|Physiological Effects of Drugs|physiological effects of drugs
4720871|NCT03104673|Molecular signature|molecular signature
4720872|NCT03104673|Thailand-Myanmar border|thailand-myanmar border
4720873|NCT03104621|preservative-free, tafluprost|preservative-free, tafluprost
4720874|NCT03104595|EC-18, febrile neutropenia, breast cancer, chemotherapy|ec-18, febrile neutropenia, breast cancer, chemotherapy
4720875|NCT03104582|ERCP|ercp
4720876|NCT03104582|PTBD|ptbd
4720877|NCT03104582|EBD|ebd
4720878|NCT03104582|Cholangitis|cholangitis
4720879|NCT03104582|Complication|complication
4720880|NCT03104582|Klatskin tumor|klatskin tumor
4720881|NCT03104569|ERCP|ercp
4720882|NCT03104569|Contrast agent|contrast agent
4720883|NCT03104569|Hilar cholangiocarcinoma|hilar cholangiocarcinoma
4720884|NCT03104569|Cholangitis|cholangitis
4720885|NCT03104569|Nonionic|nonionic
4720886|NCT03104543|survivor|survivor
4720887|NCT03104543|undertreatment|undertreatment
4720888|NCT03104543|adherence|adherence
4720889|NCT03104543|self-efficacy|self-efficacy
4720890|NCT03104530|Crab|crab
4720891|NCT03104530|Brown meat|brown meat
4720892|NCT03104530|Cadmium body burden|cadmium body burden
4720893|NCT03104530|Ferritin|ferritin
4720894|NCT03104530|Zinc|zinc
4720895|NCT03104530|Selenium|selenium
4720896|NCT03104530|Creatinine|creatinine
4720897|NCT03104530|B2-Microglobulin|b2-microglobulin
4720898|NCT03104517|Urinary Incontinence|urinary incontinence
4720899|NCT03104517|Urinary Stress Incontinence|urinary stress incontinence
4720900|NCT03104517|Lower Urinary Tract Symptoms|lower urinary tract symptoms
4720901|NCT03104517|Urinary Bladder|urinary bladder
4720902|NCT03104517|Urinary Tract Diseases|urinary tract diseases
4720903|NCT03104517|Bladder|bladder
4720904|NCT03104517|Urinary Leak|urinary leak
4720905|NCT03104517|Urine Leak|urine leak
4720906|NCT03104517|Bladder Leak|bladder leak
4720907|NCT03104517|Urethra|urethra
4720908|NCT03104517|Urethral Sphincter|urethral sphincter
4720909|NCT03104504|Suicide Screening|suicide screening
4720910|NCT03104504|Safety Planning|safety planning
4720911|NCT03104491|allogeneic hematopoietic stem cell transplantation|allogeneic hematopoietic stem cell transplantation
4720912|NCT03104491|donor chimerism|donor chimerism
4720913|NCT03104478|DLBCL|dlbcl
4720914|NCT03104478|Real time molecular characterization|real time molecular characterization
4720915|NCT03104465|Chronic Pain|chronic pain
4720916|NCT03104465|Mindfulness|mindfulness
4720917|NCT03104465|Behavioral Health|behavioral health
4720918|NCT03104465|Quality of Life|quality of life
4720919|NCT03104439|Pancreatic Cancer|pancreatic cancer
4720920|NCT03104439|Microsatellite Stable Colorectal Cancer|microsatellite stable colorectal cancer
4720921|NCT03104426|Hemolytic disease of the fetus and newborn|hemolytic disease of the fetus and newborn
4720922|NCT03104426|HDFN|hdfn
4720923|NCT03104426|Red blood cell alloimmunization|red blood cell alloimmunization
4720924|NCT03104413|ABBV-066|abbv-066
4720925|NCT03104413|BI 655066|bi 655066
4720926|NCT03104400|Arthritis|arthritis
4720927|NCT03104400|Psoriasis|psoriasis
4720928|NCT03104400|Anti-inflammatory|anti-inflammatory
4720929|NCT03104400|Joint disease|joint disease
4720930|NCT03104400|Musculoskeletal disease|musculoskeletal disease
4720931|NCT03104400|Anti-Rheumatic|anti-rheumatic
4720932|NCT03104387|Air pollution|air pollution
4720933|NCT03104387|Diesel exhaust|diesel exhaust
4720934|NCT03104387|Ultrafine particles|ultrafine particles
4720935|NCT03104387|Vascular function|vascular function
4720936|NCT03104387|Endothelium function|endothelium function
4720937|NCT03104387|Heart rate variability|heart rate variability
4720938|NCT03104387|DNA damage|dna damage
4720939|NCT03104374|Arthritis|arthritis
4720940|NCT03104374|Psoriasis|psoriasis
4720941|NCT03104374|Anti-Rheumatic|anti-rheumatic
4720942|NCT03104374|Anti-inflammatory|anti-inflammatory
4720943|NCT03104374|Joint disease|joint disease
4720944|NCT03104374|Musculoskeletal disease|musculoskeletal disease
4720945|NCT03104361|intersitial cystitis|intersitial cystitis
4720946|NCT03104361|Bladder pain syndrome|bladder pain syndrome
4720947|NCT03104361|Intravesical treatment|intravesical treatment
4720948|NCT03104348|COPD|copd
4720949|NCT03104348|Primary care|primary care
4720950|NCT03104335|soft tissue sarcoma|soft tissue sarcoma
4720951|NCT03104335|advanced|advanced
4720952|NCT03104335|apatinib|apatinib
4720953|NCT03104335|tyrosine-kinase inhibitors|tyrosine-kinase inhibitors
4720954|NCT03104322|digital health|digital health
4720955|NCT03104322|home spirometry|home spirometry
4720956|NCT03104322|patient reported outcome measure|patient reported outcome measure
4720957|NCT03104322|e-health|e-health
4720958|NCT03104322|pirfenidone|pirfenidone
4720959|NCT03104322|nintedanib|nintedanib
4720960|NCT03104322|FVC|fvc
4720961|NCT03104322|antifibrotic|antifibrotic
4720962|NCT03104296|NIRS|nirs
4720963|NCT03104296|Griffiths Mental Development Scales|griffiths mental development scales
4720964|NCT03104296|prematurity|prematurity
4720965|NCT03104283|apatinib|apatinib
4720966|NCT03104283|gastric cancer|gastric cancer
4720967|NCT03104283|elderly patients|elderly patients
4720968|NCT03104270|Elotuzumab, Multiple Myeloma, Phase 2|elotuzumab, multiple myeloma, phase 2
4720969|NCT03104257|Healthy Control, Cannabis, Dependence|healthy control, cannabis, dependence
4720970|NCT03104244|concussion|concussion
4720971|NCT03104244|subconcussive impacts|subconcussive impacts
4720972|NCT03104244|brain function|brain function
4720973|NCT03104244|football|football
4720974|NCT03104231|atrial fibrillation|atrial fibrillation
4720975|NCT03104231|oral anticoagulantion|oral anticoagulantion
4720976|NCT03104231|stroke prevention|stroke prevention
4720977|NCT03104231|education|education
4720978|NCT03104231|e-medicine|e-medicine
4720979|NCT03104205|frail elderly|frail elderly
4720980|NCT03104205|telemedicine|telemedicine
4720981|NCT03104205|obesity|obesity
4720982|NCT03104205|rural health|rural health
4720983|NCT03104205|health promotion|health promotion
4720984|NCT03104205|weight loss|weight loss
4720985|NCT03104192|frail elderly|frail elderly
4720986|NCT03104192|telemedicine|telemedicine
4720987|NCT03104192|obesity|obesity
4720988|NCT03104192|rural health|rural health
4720989|NCT03104192|health promotion|health promotion
4720990|NCT03104192|weight loss|weight loss
4720991|NCT03104127|Lower-limb robotic device|lower-limb robotic device
4720992|NCT03104127|Gait|gait
4720993|NCT03104127|Balance|balance
4720994|NCT03104127|Pressure|pressure
4720995|NCT03104127|Chronic stroke|chronic stroke
4720996|NCT03104127|Blood pressure|blood pressure
4720997|NCT03104127|Blood velocity|blood velocity
4720998|NCT03104127|Aerobic fitness|aerobic fitness
4720999|NCT03104127|Strength|strength
4721000|NCT03104101|PTNS|ptns
4721001|NCT03104101|Neuromodulation|neuromodulation
4721002|NCT03104101|TPTNS|tptns
4721003|NCT03104101|Trospium chloride|trospium chloride
4721004|NCT03104075|Genomics|genomics
4721005|NCT03104075|Epigenomics|epigenomics
4721209|NCT03102372|exercise|exercise
4721006|NCT03104075|Pneumococcal vaccine|pneumococcal vaccine
4721007|NCT03104075|Elderly|elderly
4721008|NCT03104049|Parkinson's Disease|parkinson's disease
4721009|NCT03104049|Neuromuscular taping|neuromuscular taping
4721010|NCT03104049|Trunk|trunk
4721011|NCT03104049|Posture|posture
4721012|NCT03104049|Kinematic|kinematic
4721013|NCT03104049|rehabilitation|rehabilitation
4721014|NCT03104036|Feacal bacterial transplantation|feacal bacterial transplantation
4721015|NCT03104036|Left-sided ulcerative colitis|left-sided ulcerative colitis
4721016|NCT03103997|Liver|liver
4721017|NCT03103997|EUS|eus
4721018|NCT03103997|Biopsy|biopsy
4721019|NCT03103997|Heparin|heparin
4721020|NCT03103984|Obesity|obesity
4721021|NCT03103984|Liver transplantation|liver transplantation
4721022|NCT03103984|weight loss diet|weight loss diet
4721023|NCT03103984|immunosuppression|immunosuppression
4721024|NCT03103958|probiotic|probiotic
4721025|NCT03103958|metagenomic|metagenomic
4721026|NCT03103958|constipation|constipation
4721027|NCT03103945|Atrial Fibrillation|atrial fibrillation
4721028|NCT03103945|Atrial Arrhythmia|atrial arrhythmia
4721029|NCT03103945|Arrhythmias, Cardiac|arrhythmias, cardiac
4721030|NCT03103945|Cardiac Diseases|cardiac diseases
4721031|NCT03103945|Electrophysiologic Techniques, Cardiac|electrophysiologic techniques, cardiac
4721032|NCT03103945|Electrophysiology|electrophysiology
4721033|NCT03103945|Remote Magnetic Navigation|remote magnetic navigation
4721034|NCT03103945|Contact Detection System|contact detection system
4721035|NCT03103932|biomarkers|biomarkers
4721036|NCT03103932|heart failure|heart failure
4721037|NCT03103932|hospital admission|hospital admission
4721038|NCT03103919|Parkinson´s Disease|parkinson´s disease
4721039|NCT03103919|Kinesia-360™|kinesia-360™
4721040|NCT03103919|Kinesia-ONE™|kinesia-one™
4721041|NCT03103919|Biosensor|biosensor
4721042|NCT03103880|Patient Adherence|patient adherence
4721043|NCT03103880|Mobile Applications|mobile applications
4721044|NCT03103880|Mobile Health|mobile health
4721045|NCT03103854|Exercise|exercise
4721046|NCT03103854|Secondary Prevention|secondary prevention
4721047|NCT03103854|Diabetes|diabetes
4721048|NCT03103854|Rehabilitation|rehabilitation
4721049|NCT03103841|Children|children
4721050|NCT03103815|Amyotrophic lateral sclerosis, survival, adverse event|amyotrophic lateral sclerosis, survival, adverse event
4721051|NCT03103763|Elderly|elderly
4721052|NCT03103763|Anticoagulation|anticoagulation
4721053|NCT03103763|Risk Assessment|risk assessment
4721054|NCT03103750|Vitamin D|vitamin d
4721055|NCT03103737|Well-being|well-being
4721056|NCT03103737|Information and communication technologies|information and communication technologies
4721057|NCT03103737|Hospital|hospital
4721058|NCT03103711|Virtual reality|virtual reality
4721059|NCT03103711|Well-being|well-being
4721060|NCT03103711|Hospital|hospital
4721061|NCT03103698|analgesia per-operative|analgesia per-operative
4721062|NCT03103685|Dual antiplatelet therapy|dual antiplatelet therapy
4721063|NCT03103685|Dental procedure|dental procedure
4721064|NCT03103672|quality of anesthesia|quality of anesthesia
4721065|NCT03103672|reduce recovery time|reduce recovery time
4721066|NCT03103633|oxygen dynamics|oxygen dynamics
4721067|NCT03103633|Prognosis|prognosis
4721068|NCT03103555|Anti-interferon gamma autoantibody|anti-interferon gamma autoantibody
4721069|NCT03103542|ITI|iti
4721070|NCT03103542|rFVIIIFc|rfviiifc
4721071|NCT03103542|Immune Tolerance Induction|immune tolerance induction
4721072|NCT03103490|PET/MR|pet/mr
4721073|NCT03103425|New onset seizures|new onset seizures
4721074|NCT03103412|Active Mild Ulcerative Colitis, Active Moderate Ulcerative Colitis, Healthy Subjects|active mild ulcerative colitis, active moderate ulcerative colitis, healthy subjects
4721075|NCT03103386|fermented rye bran|fermented rye bran
4721076|NCT03103386|H. pylori infections|h. pylori infections
4721077|NCT03103386|non-communicable diseases|non-communicable diseases
4721078|NCT03103373|Echocardiography|echocardiography
4721079|NCT03103373|anesthesia|anesthesia
4721080|NCT03103373|general surgery|general surgery
4721081|NCT03103347|EEG|eeg
4721082|NCT03103347|Parkinson Disease|parkinson disease
4721083|NCT03103347|Beta Oscillations|beta oscillations
4721084|NCT03103308|Cancer|cancer
4721085|NCT03103308|Exercise|exercise
4721086|NCT03103308|Physical Function|physical function
4721087|NCT03103295|tissue engineering,|tissue engineering,
4721088|NCT03103295|regeneration,|regeneration,
4721089|NCT03103295|repair,|repair,
4721090|NCT03103295|traumatic bone defects,|traumatic bone defects,
4721091|NCT03103295|regenerative therapy|regenerative therapy
4721092|NCT03103269|Overweight|overweight
4721094|NCT03103269|Prevention|prevention
4721095|NCT03103269|Diet|diet
4721096|NCT03103269|Physical activity|physical activity
4721097|NCT03103269|Depression|depression
4721098|NCT03103269|Anxiety|anxiety
4721099|NCT03103269|Stages of change|stages of change
4721100|NCT03103269|Barriers|barriers
4721101|NCT03103269|Perceptions|perceptions
4721102|NCT03103269|Environment|environment
4721103|NCT03103269|Eating Disorder|eating disorder
4721104|NCT03103269|Self efficacy|self efficacy
4721105|NCT03103243|Lupus|lupus
4721106|NCT03103243|SLE|sle
4721107|NCT03103243|Erythematosus|erythematosus
4721210|NCT03102372|Protein|protein
4721108|NCT03103230|Motor evoked potentials|motor evoked potentials
4721109|NCT03103230|aphasia|aphasia
4721110|NCT03103230|prognosis|prognosis
4721111|NCT03103230|stroke|stroke
4721112|NCT03103204|Obesity|obesity
4721113|NCT03103204|Periodontitis|periodontitis
4721114|NCT03103204|Therapeutics|therapeutics
4721115|NCT03103204|Chlorhexidine|chlorhexidine
4721116|NCT03103152|Prostate Cancer|prostate cancer
4721117|NCT03103152|Active Surveillance|active surveillance
4721118|NCT03103152|Chemo-prevention|chemo-prevention
4721119|NCT03103126|pedometer-determined walking|pedometer-determined walking
4721120|NCT03103126|resistance exercise|resistance exercise
4721121|NCT03103100|Local anesthetic|local anesthetic
4721122|NCT03103100|Labor epidural|labor epidural
4721123|NCT03103074|botulinum toxin|botulinum toxin
4721124|NCT03103061|Computed Tomography|computed tomography
4721125|NCT03102996|Alkali|alkali
4721126|NCT03102996|Graft|graft
4721127|NCT03102996|Acid base|acid base
4721128|NCT03102996|Metabolic acidosis|metabolic acidosis
4721129|NCT03102996|Chronic kidney disease|chronic kidney disease
4721130|NCT03102983|MRI, Functional|mri, functional
4721131|NCT03102970|COPD, Pain, Exacerbation|copd, pain, exacerbation
4721132|NCT03102918|Cannabidiol|cannabidiol
4721133|NCT03102879|mesenchymal stem cells|mesenchymal stem cells
4721134|NCT03102879|regenerative procedures|regenerative procedures
4721135|NCT03102879|tissue engineering|tissue engineering
4721136|NCT03102879|regenerative endodontic|regenerative endodontic
4721137|NCT03102879|scaffold|scaffold
4721138|NCT03102879|cell encapsulation|cell encapsulation
4721139|NCT03102879|dental pulp|dental pulp
4721140|NCT03102879|pulp regeneration|pulp regeneration
4721141|NCT03102879|plasma-derived biomaterial|plasma-derived biomaterial
4721142|NCT03102879|allogenic stem cells|allogenic stem cells
4721143|NCT03102879|mesenchymal stromal cells|mesenchymal stromal cells
4721144|NCT03102879|adult stem cells|adult stem cells
4721145|NCT03102879|umbilical cord stem cells|umbilical cord stem cells
4721146|NCT03102840|Carriage|carriage
4721147|NCT03102840|Immunogenicity|immunogenicity
4721148|NCT03102840|Pneumococcal conjugate vaccine 13 (PCV 13)|pneumococcal conjugate vaccine 13 (pcv 13)
4721149|NCT03102840|Children|children
4721150|NCT03102840|Pneumococcus|pneumococcus
4721151|NCT03102775|poverty|poverty
4721152|NCT03102775|unemployment|unemployment
4721153|NCT03102775|cluster-randomized|cluster-randomized
4721154|NCT03102775|family-project|family-project
4721155|NCT03102762|Erectile dysfunction|erectile dysfunction
4721156|NCT03102762|Botulinum toxin A|botulinum toxin a
4721157|NCT03102762|Botox|botox
4721158|NCT03102749|Airways|airways
4721159|NCT03102749|asthma|asthma
4721160|NCT03102749|overweight|overweight
4721161|NCT03102736|depression|depression
4721162|NCT03102736|ketamine|ketamine
4721163|NCT03102736|nitroprusside|nitroprusside
4721164|NCT03102723|STEMI|stemi
4721165|NCT03102723|primary percutaneous coronary intervention (PPCI)|primary percutaneous coronary intervention (ppci)
4721166|NCT03102723|cangrelor|cangrelor
4721167|NCT03102723|reperfusion|reperfusion
4721168|NCT03102697|Intragastric balloon|intragastric balloon
4721169|NCT03102697|obesity|obesity
4721170|NCT03102697|metabolic syndrome|metabolic syndrome
4721171|NCT03102697|bariatric surgery|bariatric surgery
4721172|NCT03102684|e-cigarette|e-cigarette
4721173|NCT03102684|electronic cigarette|electronic cigarette
4721174|NCT03102684|passive exposure|passive exposure
4721175|NCT03102684|secondhand exposure|secondhand exposure
4721176|NCT03102684|smoking|smoking
4721177|NCT03102684|respiratory system|respiratory system
4721178|NCT03102619|Wireless monitoring|wireless monitoring
4721179|NCT03102619|Postoperative complications|postoperative complications
4721180|NCT03102619|Vital parameters|vital parameters
4721181|NCT03102619|Continuous monitoring|continuous monitoring
4721182|NCT03102606|Plinabulin|plinabulin
4721183|NCT03102606|Pegfilgrastim|pegfilgrastim
4721184|NCT03102606|Duration of Severe Neutropenia|duration of severe neutropenia
4721185|NCT03102606|Bone Pain|bone pain
4721186|NCT03102580|Shared Decision Making|shared decision making
4721187|NCT03102554|Exome Sequencing|exome sequencing
4721188|NCT03102502|Coronary Heart Disease|coronary heart disease
4721189|NCT03102502|Atherosclerosis|atherosclerosis
4721190|NCT03102502|Vascular Endothelium|vascular endothelium
4721191|NCT03102502|Counterpulsation, External|counterpulsation, external
4721192|NCT03102463|Insulin sensitivity|insulin sensitivity
4721193|NCT03102463|Obesity|obesity
4721194|NCT03102463|Insulin resistance|insulin resistance
4721195|NCT03102463|Milk derived hydrolysate|milk derived hydrolysate
4721196|NCT03102463|Hyperinsulinemic-euglycaemic clamp|hyperinsulinemic-euglycaemic clamp
4721197|NCT03102437|Cardiac Contractility Modulation|cardiac contractility modulation
4721198|NCT03102437|CCM|ccm
4721199|NCT03102437|FIX-HF-5CA|fix-hf-5ca
4721200|NCT03102437|Continued Access|continued access
4721201|NCT03102398|Erectile Dysfunction|erectile dysfunction
4721202|NCT03102398|PDE5 inhibitor|pde5 inhibitor
4721203|NCT03102398|Sexual Dysfunction|sexual dysfunction
4721204|NCT03102385|blood donation|blood donation
4721205|NCT03102385|motivation|motivation
4721206|NCT03102385|donor retention|donor retention
4721207|NCT03102372|FFM|ffm
4721208|NCT03102372|VLCD|vlcd
4721211|NCT03102372|Obesity|obesity
4721212|NCT03102346|cardiorespiratory fitness|cardiorespiratory fitness
4721213|NCT03102346|coronary artery disease|coronary artery disease
4721214|NCT03102346|cardiac rehabilitation|cardiac rehabilitation
4721215|NCT03102346|remote control|remote control
4721216|NCT03102346|major adverse cardiac and cerebrovascular events|major adverse cardiac and cerebrovascular events
4721217|NCT03102320|cholangiocarcinoma|cholangiocarcinoma
4721218|NCT03102320|pancreatic cancer|pancreatic cancer
4721219|NCT03102320|triple-negative breast cancer|triple-negative breast cancer
4721220|NCT03102320|non-small cell lung cancer|non-small cell lung cancer
4721221|NCT03102320|thymic carcinoma|thymic carcinoma
4721222|NCT03102320|gastric including gastroesophageal junction cancer|gastric including gastroesophageal junction cancer
4721223|NCT03102307|Targeted axillary dissection|targeted axillary dissection
4721224|NCT03102307|Sentinel node biopsy|sentinel node biopsy
4721225|NCT03102307|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
4721226|NCT03102255|Nasotracheal intubation|nasotracheal intubation
4721227|NCT03102229|Activity Monitoring|activity monitoring
4721228|NCT03102229|Chemotherapy|chemotherapy
4721229|NCT03102229|Radiotherapy|radiotherapy
4721230|NCT03102164|heart failure|heart failure
4721231|NCT03102164|decompensation|decompensation
4721232|NCT03102125|heart transplant, acute graft rejection, chronic graft rejection|heart transplant, acute graft rejection, chronic graft rejection
4721233|NCT03102112|Glioma APT MRI|glioma apt mri
4721234|NCT03102073|Reading speed|reading speed
4721235|NCT03102047|microsatellite stable|microsatellite stable
4721236|NCT03102047|MSS|mss
4721237|NCT03102047|durvalumab|durvalumab
4721238|NCT03102047|NSABP|nsabp
4721239|NCT03102008|Transdiagnostic Treatment|transdiagnostic treatment
4721240|NCT03102008|Emotional Disorders|emotional disorders
4721241|NCT03102008|Adolescence|adolescence
4721242|NCT03102008|Psychotherapy|psychotherapy
4721243|NCT03101995|Treatment|treatment
4721244|NCT03101995|Locally advanced cervical cancer|locally advanced cervical cancer
4721245|NCT03101995|Renal failure|renal failure
4721246|NCT03101995|Gemcitabine|gemcitabine
4721247|NCT03101969|language|language
4721248|NCT03101969|scheduled|scheduled
4721249|NCT03101969|appointment|appointment
4721250|NCT03101956|Spine Manipulation|spine manipulation
4721251|NCT03101943|Sugar|sugar
4721252|NCT03101943|Sweetened|sweetened
4721253|NCT03101943|Beverages|beverages
4721254|NCT03101891|Amnioinfusion|amnioinfusion
4721255|NCT03101891|Fetal therapy|fetal therapy
4721256|NCT03101878|Healthy Volunteers, IONIS AGT-Lrx|healthy volunteers, ionis agt-lrx
4721257|NCT03101865|Type 1 diabetes|type 1 diabetes
4721258|NCT03101865|Artificial Pancreas|artificial pancreas
4721259|NCT03101865|Closed-loop glucose control|closed-loop glucose control
4721260|NCT03101865|Very young children|very young children
4721261|NCT03101865|Continuous subcutaneous insulin infusion|continuous subcutaneous insulin infusion
4721262|NCT03101865|Continuous glucose monitoring|continuous glucose monitoring
4721263|NCT03101852|severe acute malnutrition|severe acute malnutrition
4721264|NCT03101852|moderate acute malnutrition|moderate acute malnutrition
4721265|NCT03101852|HIV-infection|hiv-infection
4721266|NCT03101852|adolescents|adolescents
4721267|NCT03101852|antiretroviral|antiretroviral
4721268|NCT03101852|Africa|africa
4721269|NCT03101852|ready-to-use food|ready-to-use food
4721270|NCT03101852|outpatient care|outpatient care
4721271|NCT03101839|AZD4785|azd4785
4721272|NCT03101839|KRAS|kras
4721273|NCT03101839|KRAS mutations|kras mutations
4721274|NCT03101839|Non-small cell lung cancer|non-small cell lung cancer
4721275|NCT03101839|Advanced solid tumours|advanced solid tumours
4721276|NCT03101826|Polyvagal Theory|polyvagal theory
4721277|NCT03101826|Respiratory Sinus Arrhythmia|respiratory sinus arrhythmia
4721278|NCT03101826|Heart rate|heart rate
4721279|NCT03101826|Social Behavior|social behavior
4721280|NCT03101826|Arginine Vasopressin|arginine vasopressin
4721281|NCT03101826|Dichotic Listening Tests|dichotic listening tests
4721282|NCT03101826|Oxytocin|oxytocin
4721283|NCT03101826|Hyperacusis|hyperacusis
4721284|NCT03101826|Affect|affect
4721285|NCT03101826|Auditory perception|auditory perception
4721286|NCT03101826|Sound spectrography|sound spectrography
4721287|NCT03101800|Azathioprine|azathioprine
4721288|NCT03101800|Allopurinol|allopurinol
4721289|NCT03101800|Antimetabolites|antimetabolites
4721290|NCT03101800|Ulcerative Colitis|ulcerative colitis
4721291|NCT03101787|ECPR|ecpr
4721292|NCT03101787|Extracorporeal CardioPulmonary Resuscitation|extracorporeal cardiopulmonary resuscitation
4721293|NCT03101787|OHCA|ohca
4721294|NCT03101787|Out-of-Hospital Cardiac Arrest|out-of-hospital cardiac arrest
4721295|NCT03101787|CPR|cpr
4721296|NCT03101787|CardioPulmonary Resuscitation|cardiopulmonary resuscitation
4721297|NCT03101787|ECMO|ecmo
4721298|NCT03101787|ExtraCorporeal Membrane Oxygenation|extracorporeal membrane oxygenation
4721299|NCT03101787|Refractory Cardiac Arrest|refractory cardiac arrest
4721300|NCT03101774|inspiratory muscle training|inspiratory muscle training
4721301|NCT03101748|Malignant neoplasm of breast|malignant neoplasm of breast
4721302|NCT03101748|Metastatic breast cancer|metastatic breast cancer
4721303|NCT03101748|Locally advanced breast cancer|locally advanced breast cancer
4721304|NCT03101748|HER2-positive|her2-positive
4721305|NCT03101748|HER2+|her2+
4721306|NCT03101748|HER2-negative/ER-positive|her2-negative/er-positive
4721307|NCT03101748|HER2-/ER+|her2-/er+
4721308|NCT03101748|Locally advanced inflammatory breast cancer|locally advanced inflammatory breast cancer
4721309|NCT03101748|IBC|ibc
4721310|NCT03101748|Neratinib|neratinib
4721311|NCT03101748|Paclitaxel|paclitaxel
4721312|NCT03101748|Taxol|taxol
4721313|NCT03101748|Doxorubicin|doxorubicin
4721314|NCT03101748|Doxorubicin Hydrochloride|doxorubicin hydrochloride
4721315|NCT03101748|Adriamycin PFS|adriamycin pfs
4721316|NCT03101748|Adriamycin RDF|adriamycin rdf
4721317|NCT03101748|Adriamycin|adriamycin
4721318|NCT03101748|Rubex|rubex
4721319|NCT03101748|Pertuzumab|pertuzumab
4721320|NCT03101748|Perjeta|perjeta
4721321|NCT03101748|Trastuzumab|trastuzumab
4721322|NCT03101748|Herceptin|herceptin
4721323|NCT03101748|Cyclophosphamide|cyclophosphamide
4721324|NCT03101748|Cytoxan|cytoxan
4721325|NCT03101748|Neosar|neosar
4721326|NCT03101722|presbycusis|presbycusis
4721327|NCT03101722|tinnitus|tinnitus
4721328|NCT03101722|cognitive impairment|cognitive impairment
4721329|NCT03101722|Huperzine A|huperzine a
4721330|NCT03101722|hearing aid|hearing aid
4721331|NCT03101722|age-related hearing impairment|age-related hearing impairment
4721332|NCT03101696|coronary angiography|coronary angiography
4721333|NCT03101696|coronary conductance|coronary conductance
4721334|NCT03101696|hyperemia|hyperemia
4721335|NCT03101696|regadenoson|regadenoson
4721336|NCT03101696|fractional flow reserve|fractional flow reserve
4721337|NCT03101696|coronary flow reserve|coronary flow reserve
4721338|NCT03101696|index of microcirculatory resistance|index of microcirculatory resistance
4721339|NCT03101631|Elderly population with cancer|elderly population with cancer
4721340|NCT03101631|Toxicity risk|toxicity risk
4721341|NCT03101631|Mortality risk|mortality risk
4721342|NCT03101631|Frailty conditions in elderly population|frailty conditions in elderly population
4721343|NCT03101631|Chemotherapy in elderly population|chemotherapy in elderly population
4721344|NCT03101618|allergen|allergen
4721345|NCT03101618|allergy|allergy
4721346|NCT03101618|pet|pet
4721347|NCT03101592|antiretroviral therapy|antiretroviral therapy
4721348|NCT03101592|retention|retention
4721349|NCT03101592|ART|art
4721350|NCT03101592|cost-effectiveness|cost-effectiveness
4721351|NCT03101592|virologic suppression|virologic suppression
4721352|NCT03101579|Leptomeningeal metastasis|leptomeningeal metastasis
4721353|NCT03101579|Recurrence|recurrence
4721354|NCT03101579|Intrathecal chemotherapy|intrathecal chemotherapy
4721355|NCT03101579|Pemetrexed|pemetrexed
4721356|NCT03101540|Major Depressive Disorder,|major depressive disorder,
4721357|NCT03101540|omega-3 polyunsaturated fatty acid|omega-3 polyunsaturated fatty acid
4721358|NCT03101540|PUFA|pufa
4721359|NCT03101540|Pregnancy|pregnancy
4721360|NCT03101540|eicosapentaenoic acid (EPA) supplementation|eicosapentaenoic acid (epa) supplementation
4721361|NCT03101540|cytokine|cytokine
4721362|NCT03101540|docosahexaenoic acid (DHA)|docosahexaenoic acid (dha)
4721363|NCT03101527|Major Depressive Disorder|major depressive disorder
4721364|NCT03101527|omega-3 polyunsaturated fatty acid|omega-3 polyunsaturated fatty acid
4721365|NCT03101527|PUFA|pufa
4721366|NCT03101527|Pregnancy|pregnancy
4721367|NCT03101527|eicosapentaenoic acid (EPA) supplementation|eicosapentaenoic acid (epa) supplementation
4721368|NCT03101514|head and neck|head and neck
4721369|NCT03101514|tumor|tumor
4721370|NCT03101514|radiotherapy|radiotherapy
4721371|NCT03101514|mucositis|mucositis
4721372|NCT03101514|toxicity|toxicity
4721373|NCT03101514|Kanglaite injection|kanglaite injection
4721374|NCT03101488|KN035|kn035
4721375|NCT03101488|phase 1|phase 1
4721376|NCT03101475|Colorectal Cancer|colorectal cancer
4721377|NCT03101475|Liver Metastases|liver metastases
4721378|NCT03101475|Durvalumab|durvalumab
4721379|NCT03101475|Tremelimumab|tremelimumab
4721380|NCT03101436|Insulin Resistance|insulin resistance
4721381|NCT03101436|Extra Virgin Olive Oil|extra virgin olive oil
4721382|NCT03101436|Red Wine|red wine
4721383|NCT03101436|Diet|diet
4721384|NCT03101436|Microbiota|microbiota
4721385|NCT03101423|thalassemia|thalassemia
4721386|NCT03101423|transplantation|transplantation
4721387|NCT03101423|chimerism|chimerism
4721388|NCT03101423|donor ymphocytes|donor ymphocytes
4721389|NCT03101410|Gluten|gluten
4721390|NCT03101410|sport performance|sport performance
4721391|NCT03101397|serum KL-6|serum kl-6
4721392|NCT03101397|pulmonary function test|pulmonary function test
4721393|NCT03101397|CT score|ct score
4721394|NCT03101397|evaluation|evaluation
4721395|NCT03101358|cutaneous metastases|cutaneous metastases
4721396|NCT03101358|cutaneous metastasis|cutaneous metastasis
4721397|NCT03101358|skin metastases|skin metastases
4721398|NCT03101358|skin metastasis|skin metastasis
4721399|NCT03101306|cervix, radiotherapy, magnetic resonance imaging|cervix, radiotherapy, magnetic resonance imaging
4721400|NCT03101293|Drug therapy|drug therapy
4721401|NCT03101267|Cedar pollinosis|cedar pollinosis
4721402|NCT03101267|ASP4070|asp4070
4721403|NCT03101267|DNA plasmid vaccine|dna plasmid vaccine
4721404|NCT03101254|Melanoma|melanoma
4721405|NCT03101241|Essential Tremor|essential tremor
4721406|NCT03101241|Movement Disorders|movement disorders
4721507|NCT03100734|Etanercept|etanercept
4721407|NCT03101241|thalamocortical dysrhythmias|thalamocortical dysrhythmias
4721408|NCT03101228|Physical Activity|physical activity
4721409|NCT03101228|Metabolic Syndrome|metabolic syndrome
4721410|NCT03101228|Insulin Sensitivity|insulin sensitivity
4721411|NCT03101228|Cardiovascular Risk Factor|cardiovascular risk factor
4721412|NCT03101228|Sedentary Lifestyle|sedentary lifestyle
4721413|NCT03101228|Accelerometry|accelerometry
4721414|NCT03101189|safety|safety
4721415|NCT03101189|Japanese|japanese
4721416|NCT03101189|pharmacokinetics|pharmacokinetics
4721417|NCT03101176|multiparametric ultrasound|multiparametric ultrasound
4721418|NCT03101176|prostate cancer|prostate cancer
4721419|NCT03101176|contrast ultrasound|contrast ultrasound
4721420|NCT03101176|CEUS|ceus
4721421|NCT03101176|radical prostatectomy|radical prostatectomy
4721422|NCT03101150|Maternal vitamin D|maternal vitamin d
4721423|NCT03101150|Deficiency|deficiency
4721424|NCT03101150|Insufficiency|insufficiency
4721425|NCT03101150|Pregnancy|pregnancy
4721426|NCT03101150|Pre-eclampsia|pre-eclampsia
4721427|NCT03101150|IUGR|iugr
4721428|NCT03101124|Hemostasis, Surgical|hemostasis, surgical
4721429|NCT03101124|Tranexamic Acid|tranexamic acid
4721430|NCT03101124|Antifibrinolytic Agents|antifibrinolytic agents
4721431|NCT03101124|Administration, Cutaneous|administration, cutaneous
4721432|NCT03101124|Administration, Intravenous|administration, intravenous
4721433|NCT03101124|Administration, Topical|administration, topical
4721434|NCT03101072|Gram-negative bacteremia|gram-negative bacteremia
4721435|NCT03101072|antibiotic durations|antibiotic durations
4721436|NCT03101072|point-of-care randomization|point-of-care randomization
4721437|NCT03101059|Tracheal|tracheal
4721438|NCT03101059|Bronchial|bronchial
4721439|NCT03101059|Tracheobronchiomegaly|tracheobronchiomegaly
4721440|NCT03101059|Collapse|collapse
4721441|NCT03101059|obstructive sleep apnea syndrome|obstructive sleep apnea syndrome
4721442|NCT03101059|Computer Tomography|computer tomography
4721443|NCT03101059|Impedance Tomography|impedance tomography
4721444|NCT03101046|Docetaxel|docetaxel
4721445|NCT03101046|Cabazitaxel|cabazitaxel
4721446|NCT03101033|Herniated lumbar disc|herniated lumbar disc
4721447|NCT03101033|Epidural neuroplasty|epidural neuroplasty
4721448|NCT03101033|Epidural injection|epidural injection
4721449|NCT03101020|Visceral Manipulation|visceral manipulation
4721450|NCT03101007|Comparative study|comparative study
4721451|NCT03101007|Knee Prosthesis|knee prosthesis
4721452|NCT03101007|Prosthesis Design|prosthesis design
4721453|NCT03101007|Treatment Outcome|treatment outcome
4721454|NCT03101007|Follow-up studies|follow-up studies
4721455|NCT03101007|Arthroplast, Replacement, Knee/methods|arthroplast, replacement, knee/methods
4721456|NCT03100981|Mindfulness-Based Cognitive Therapy|mindfulness-based cognitive therapy
4721457|NCT03100981|Internet-delivered|internet-delivered
4721458|NCT03100981|Breast cancer|breast cancer
4721459|NCT03100981|Prostate cancer|prostate cancer
4721460|NCT03100981|Survivors|survivors
4721461|NCT03100981|Depression|depression
4721462|NCT03100981|Anxiety|anxiety
4721463|NCT03100981|Stress|stress
4721464|NCT03100838|Proton Pump Inhibitor|proton pump inhibitor
4721465|NCT03100838|Bioequivalence|bioequivalence
4721466|NCT03100838|Drug-Drug Interaction|drug-drug interaction
4721467|NCT03100838|Modified Release|modified release
4721468|NCT03100838|Nifedipine|nifedipine
4721469|NCT03100825|QVM149,|qvm149,
4721470|NCT03100825|Asthma,|asthma,
4721471|NCT03100825|Japanese,|japanese,
4721472|NCT03100825|Allergic asthma,|allergic asthma,
4721473|NCT03100825|Allergy triggered asthma,|allergy triggered asthma,
4721474|NCT03100825|Reactive asthma,|reactive asthma,
4721475|NCT03100825|Asthma attack,|asthma attack,
4721476|NCT03100825|Difficulty breathing|difficulty breathing
4721477|NCT03100812|Hypertensive|hypertensive
4721478|NCT03100812|Hypertension|hypertension
4721479|NCT03100812|Filipino|filipino
4721480|NCT03100799|Osteoarthritis|osteoarthritis
4721481|NCT03100799|Senescence|senescence
4721482|NCT03100799|Magnetic resonance imaging|magnetic resonance imaging
4721483|NCT03100799|Arthroscopy|arthroscopy
4721484|NCT03100799|Arthrocentesis|arthrocentesis
4721485|NCT03100799|Biomarker|biomarker
4721486|NCT03100786|Tuberculosis|tuberculosis
4721487|NCT03100786|tuberculous meningitis|tuberculous meningitis
4721488|NCT03100786|drug induced liver injury|drug induced liver injury
4721489|NCT03100786|dexamethasone|dexamethasone
4721490|NCT03100786|LTA4H|lta4h
4721491|NCT03100786|host genotype|host genotype
4721492|NCT03100786|personalized medicine|personalized medicine
4721493|NCT03100773|alpha-amylases|alpha-amylases
4721494|NCT03100773|child|child
4721495|NCT03100773|cortisol|cortisol
4721496|NCT03100773|dental anxiety|dental anxiety
4721497|NCT03100773|dental atraumatic restorative treatment|dental atraumatic restorative treatment
4721498|NCT03100773|health education|health education
4721499|NCT03100773|microbiota|microbiota
4721500|NCT03100773|oral hygiene|oral hygiene
4721501|NCT03100773|quality of life|quality of life
4721502|NCT03100773|saliva|saliva
4721503|NCT03100734|Rheumatoid arthritis|rheumatoid arthritis
4721504|NCT03100734|Axial spondyloarthritis|axial spondyloarthritis
4721505|NCT03100734|Observational|observational
4721506|NCT03100734|Biosimilar|biosimilar
4721508|NCT03100734|Benepali|benepali
4721509|NCT03100734|Enbrel|enbrel
4721510|NCT03100721|Chronic pain|chronic pain
4721511|NCT03100721|Musculoskeletal diseases|musculoskeletal diseases
4721512|NCT03100721|Pain Neuroscience Education|pain neuroscience education
4721513|NCT03100721|Physiotherapy|physiotherapy
4721514|NCT03100656|psychopathology|psychopathology
4721515|NCT03100656|treatment|treatment
4721516|NCT03100656|epoxide hydrolases|epoxide hydrolases
4721517|NCT03100656|polyunsaturated fatty acids|polyunsaturated fatty acids
4721518|NCT03100656|eicosanoids|eicosanoids
4721519|NCT03100643|HIV/AIDS, mHealth, intervention development, African American men|hiv/aids, mhealth, intervention development, african american men
4721520|NCT03100617|Family caregiver|family caregiver
4721521|NCT03100604|middle ear pressure|middle ear pressure
4721522|NCT03100604|sevoflurane|sevoflurane
4721523|NCT03100604|desflurane|desflurane
4721524|NCT03100578|PANCREAS|pancreas
4721525|NCT03100578|ENDOSCOPIC INTERVENTION|endoscopic intervention
4721526|NCT03100578|PLASTIC STENT|plastic stent
4721527|NCT03100578|SELF EXPANDING METALLIC STENT|self expanding metallic stent
4721528|NCT03100578|ENDOSCOPIC TRANSMURAL DRAINAGE|endoscopic transmural drainage
4721529|NCT03100578|WALLED OFF PANCREATIC NECROSIS|walled off pancreatic necrosis
4721530|NCT03100565|colposcopy|colposcopy
4721531|NCT03100565|pain|pain
4721532|NCT03100565|coughing|coughing
4721533|NCT03100565|anesthetic spray|anesthetic spray
4721534|NCT03100552|Colonoscopy|colonoscopy
4721535|NCT03100552|Endoscopic resection|endoscopic resection
4721536|NCT03100552|Sessile serrated adenoma|sessile serrated adenoma
4721537|NCT03100539|Massage|massage
4721538|NCT03100539|Caregiver|caregiver
4721539|NCT03100539|Fascia|fascia
4721540|NCT03100526|High-Risk Patients|high-risk patients
4721541|NCT03100500|QVM149,|qvm149,
4721542|NCT03100500|Asthma,|asthma,
4721543|NCT03100500|Japanese,|japanese,
4721544|NCT03100500|Allergic asthma,|allergic asthma,
4721545|NCT03100500|Allergy triggered asthma,|allergy triggered asthma,
4721546|NCT03100500|Reactive asthma,|reactive asthma,
4721547|NCT03100500|Asthma attack,|asthma attack,
4721548|NCT03100500|Difficulty breathing|difficulty breathing
4721549|NCT03100474|tremor|tremor
4721550|NCT03100474|Parkinson's|parkinson's
4721551|NCT03100474|movement|movement
4721552|NCT03100474|neuropathic|neuropathic
4721553|NCT03100474|pain|pain
4721554|NCT03100461|Cancer Screening|cancer screening
4721555|NCT03100461|Colon Cancer|colon cancer
4721556|NCT03100461|Colon Cancer Screening|colon cancer screening
4721557|NCT03100409|Cervical cancer|cervical cancer
4721558|NCT03100383|gestational diabetes|gestational diabetes
4721559|NCT03100383|Type2 Diabetes|type2 diabetes
4721560|NCT03100331|neuropsychological outcomes|neuropsychological outcomes
4721561|NCT03100331|HIV/AIDS|hiv/aids
4721562|NCT03100331|international adoption|international adoption
4721563|NCT03100331|perinatal infection|perinatal infection
4721564|NCT03100292|primary bariatric surgery|primary bariatric surgery
4721565|NCT03100292|morbid obesity|morbid obesity
4721566|NCT03100292|South Korea|south korea
4721567|NCT03100292|sleeve gastrectomy|sleeve gastrectomy
4721568|NCT03100292|Roux-en Y gastric bypass|roux-en y gastric bypass
4721569|NCT03100279|cognitive behavioral therapy|cognitive behavioral therapy
4721570|NCT03100279|treatment mediators|treatment mediators
4721571|NCT03100279|trajectories of change|trajectories of change
4721572|NCT03100253|Rheumatoid Arthritis|rheumatoid arthritis
4721573|NCT03100253|Tocilizumab|tocilizumab
4721574|NCT03100253|anti-TNF treatment|anti-tnf treatment
4721575|NCT03100201|robotic-assisted rehabilitation|robotic-assisted rehabilitation
4721576|NCT03100201|humeral fracture|humeral fracture
4721577|NCT03100201|randomised controlled study|randomised controlled study
4721578|NCT03100188|peritoneal dialysis|peritoneal dialysis
4721579|NCT03100188|incremental peritoneal dialysis|incremental peritoneal dialysis
4721580|NCT03100188|quality of life|quality of life
4721581|NCT03100188|end stage renal disease|end stage renal disease
4721582|NCT03100188|adequacy|adequacy
4721583|NCT03100162|probiotics|probiotics
4721584|NCT03100162|metabolic syndrome|metabolic syndrome
4721585|NCT03100162|obesity|obesity
4721586|NCT03100162|microbiome|microbiome
4721587|NCT03100136|PET|pet
4721588|NCT03100136|[11C]PF-06809247|[11c]pf-06809247
4721589|NCT03100136|Reliability|reliability
4721590|NCT03100136|Scan, Safety|scan, safety
4721591|NCT03100110|Brain-Computer Interface|brain-computer interface
4721592|NCT03100110|Brain-Machine Interface|brain-machine interface
4721593|NCT03100110|Prefrontal Cortex|prefrontal cortex
4721594|NCT03100084|Preeclampsia|preeclampsia
4721595|NCT03100084|Diabetes in Pregnancy|diabetes in pregnancy
4721596|NCT03100084|Fetal Growth Restriction|fetal growth restriction
4721597|NCT03100084|Reduced Fetal Movements|reduced fetal movements
4721598|NCT03100058|Obesity|obesity
4721599|NCT03100058|Overweight|overweight
4721600|NCT03100045|HPV|hpv
4721601|NCT03100045|suppository|suppository
4721602|NCT03100045|Artesunate|artesunate
4721603|NCT03100045|artemisinin|artemisinin
4721604|NCT03100045|anal dysplasia|anal dysplasia
4721605|NCT03100045|treatment|treatment
4721606|NCT03100045|alternative treatment|alternative treatment
4721607|NCT03100045|anal precancer|anal precancer
4721608|NCT03100045|Johns Hopkins|johns hopkins
4721609|NCT03100045|Sandy Fang|sandy fang
4721610|NCT03100045|Frantz Viral Therapeutics|frantz viral therapeutics
4721611|NCT03100032|Spinal Fusion|spinal fusion
4721612|NCT03100032|Lumbar Interbody Fusion|lumbar interbody fusion
4721613|NCT03100032|Autologous Stem Cell Therapy|autologous stem cell therapy
4721614|NCT03100032|Bone Graft|bone graft
4721615|NCT03100032|Demineralized Bone Matrix|demineralized bone matrix
4721616|NCT03100032|Polyetheretherketone (PEEK) cage|polyetheretherketone (peek) cage
4721617|NCT03100019|Resveratrol|resveratrol
4721618|NCT03100019|Cerebral blood flow|cerebral blood flow
4721619|NCT03100019|Cognition|cognition
4721620|NCT03099993|Unilateral cerebral palsy|unilateral cerebral palsy
4721621|NCT03099993|kinematics|kinematics
4721622|NCT03099993|electromyography|electromyography
4721623|NCT03099993|constraint-induced therapy|constraint-induced therapy
4721624|NCT03099993|muscle activation|muscle activation
4721625|NCT03099993|upper limb|upper limb
4721626|NCT03099993|child|child
4721627|NCT03099941|Low Back Pain, Mechanical, Biofeedback, Pain, Chronic|low back pain, mechanical, biofeedback, pain, chronic
4721628|NCT03099902|Asthma|asthma
4721629|NCT03099902|Wheezing|wheezing
4721630|NCT03099902|GSTP1|gstp1
4721631|NCT03099902|TNFa|tnfa
4721632|NCT03099902|Secondhand smoking|secondhand smoking
4721633|NCT03099902|Passive smoking|passive smoking
4721634|NCT03099902|Intrauterine smoking|intrauterine smoking
4721635|NCT03099850|Chronic Pancreatitis|chronic pancreatitis
4721636|NCT03099850|Data management|data management
4721637|NCT03099850|Regulatory compliance|regulatory compliance
4721638|NCT03099850|Protocol monitoring|protocol monitoring
4721639|NCT03099824|Healthy Adult|healthy adult
4721640|NCT03099824|Oral Capsule|oral capsule
4721641|NCT03099824|Superoxide Dismutase|superoxide dismutase
4721642|NCT03099824|Free Radical Oxygen|free radical oxygen
4721643|NCT03099824|Single Ascending Dose|single ascending dose
4721644|NCT03099824|GC4702 Oral Form Capsule|gc4702 oral form capsule
4721645|NCT03099824|Food Effect Cohort|food effect cohort
4721646|NCT03099772|Cognitive-Behavioral Therapy|cognitive-behavioral therapy
4721647|NCT03099759|Vitamin D Dosing Regimens|vitamin d dosing regimens
4721648|NCT03099759|Blood Serum 25(OH)D3 Levels|blood serum 25(oh)d3 levels
4721649|NCT03099746|chronically critically ill|chronically critically ill
4721650|NCT03099746|surrogate decision maker|surrogate decision maker
4721651|NCT03099707|Treatment|treatment
4721652|NCT03099707|ART|art
4721653|NCT03099707|South Africa|south africa
4721654|NCT03099694|NRDS|nrds
4721655|NCT03099694|nHFOV|nhfov
4721656|NCT03099694|nCPAP|ncpap
4721657|NCT03099694|preterm infants|preterm infants
4721658|NCT03099655|Heart Failure|heart failure
4721659|NCT03099655|Cardiac Pacing|cardiac pacing
4721660|NCT03099655|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
4721661|NCT03099655|Left Ventricular Lead|left ventricular lead
4721662|NCT03099642|lumbar puncture|lumbar puncture
4721663|NCT03099642|Point of care ultrasound|point of care ultrasound
4721664|NCT03099642|children|children
4721665|NCT03099629|Inspiratory muscle training|inspiratory muscle training
4721666|NCT03099629|Diaphragmatic surface electromyography|diaphragmatic surface electromyography
4721667|NCT03099629|Respiratory muscle strength|respiratory muscle strength
4721668|NCT03099629|Functional capacity|functional capacity
4721669|NCT03099616|propofol|propofol
4721670|NCT03099616|CLADS|clads
4721671|NCT03099616|Desflurane|desflurane
4721672|NCT03099616|Obesity|obesity
4721673|NCT03099564|Pembrolizumab|pembrolizumab
4721674|NCT03099564|Y90 Radioembolization|y90 radioembolization
4721675|NCT03099564|KEYTRUDA®|keytruda®
4721676|NCT03099564|TheraSphere®|therasphere®
4721677|NCT03099564|PD-1|pd-1
4721678|NCT03099564|IgG4/kappa isotype|igg4/kappa isotype
4721679|NCT03099551|Plaque|plaque
4721680|NCT03099551|oral hygiene|oral hygiene
4721681|NCT03099551|gingivitis|gingivitis
4721682|NCT03099551|sonic toothbrush|sonic toothbrush
4721683|NCT03099551|manual toothbrush|manual toothbrush
4721684|NCT03099538|Ixekizumab|ixekizumab
4721685|NCT03099538|Bullous Pemphigoid|bullous pemphigoid
4721686|NCT03099538|Pemphigoid|pemphigoid
4721687|NCT03099538|IL17|il17
4721688|NCT03099538|IL-17|il-17
4721689|NCT03099538|Interleukin 17|interleukin 17
4721690|NCT03099512|Patellofemoral pain|patellofemoral pain
4721691|NCT03099512|foot deformity|foot deformity
4721692|NCT03099512|foot pronation|foot pronation
4721693|NCT03099512|short foot exercise|short foot exercise
4721694|NCT03099473|electroacupuncture|electroacupuncture
4721695|NCT03099473|trochlear nerve palsy|trochlear nerve palsy
4721696|NCT03099473|eyeball movement|eyeball movement
4721697|NCT03099473|diplopia|diplopia
4721698|NCT03099473|ocular motility disorder|ocular motility disorder
4721699|NCT03099460|electroacupuncture|electroacupuncture
4721700|NCT03099460|abducens nerve palsy|abducens nerve palsy
4721701|NCT03099460|eyeball movement|eyeball movement
4721702|NCT03099460|diplopia|diplopia
4721703|NCT03099460|ocular motility disorder|ocular motility disorder
4721704|NCT03099447|electroacupuncture|electroacupuncture
4721705|NCT03099447|oculomotor nerve palsy|oculomotor nerve palsy
4721706|NCT03099447|rehabilitation|rehabilitation
4721707|NCT03099447|diplopia|diplopia
4722011|NCT03097874|FBT|fbt
4721708|NCT03099447|ocular motility disorder|ocular motility disorder
4721709|NCT03099434|Live Donor Transplant, Social Media, Education, Advocacy, Live Donor|live donor transplant, social media, education, advocacy, live donor
4721710|NCT03099421|Benign prostatic obstruction|benign prostatic obstruction
4721711|NCT03099421|benign prostatic enlargement|benign prostatic enlargement
4721712|NCT03099421|benign prostatic hyperplasia|benign prostatic hyperplasia
4721713|NCT03099421|prostatic artery embolization|prostatic artery embolization
4721714|NCT03099421|Quality of Life|quality of life
4721715|NCT03099421|IPSS|ipss
4721716|NCT03099421|DAN-PSS|dan-pss
4721717|NCT03099421|Complications|complications
4721718|NCT03099408|Recurrence|recurrence
4721719|NCT03099408|Lactobacillus Vaginal Suppositories|lactobacillus vaginal suppositories
4721720|NCT03099395|myocardial infarction|myocardial infarction
4721721|NCT03099369|Peripheral Artery Disease|peripheral artery disease
4721722|NCT03099369|Peripheral Arterial Disease|peripheral arterial disease
4721723|NCT03099369|Exercise|exercise
4721724|NCT03099369|Step Count|step count
4721725|NCT03099369|Fitness Monitor|fitness monitor
4721726|NCT03099369|Mobile Health|mobile health
4721727|NCT03099369|Walking Ability|walking ability
4721728|NCT03099369|Quality of Life|quality of life
4721729|NCT03099343|sodium|sodium
4721730|NCT03099343|salt|salt
4721731|NCT03099343|diet|diet
4721732|NCT03099343|tailored messaging|tailored messaging
4721733|NCT03099343|mobile application|mobile application
4721734|NCT03099317|Knee Osteoarthritis|knee osteoarthritis
4721735|NCT03099317|Sinew Acupuncture|sinew acupuncture
4721736|NCT03099317|Pain|pain
4721737|NCT03099304|Vitiligo|vitiligo
4721738|NCT03099304|depigmenting disorder|depigmenting disorder
4721739|NCT03099304|topical JAK inhibitor|topical jak inhibitor
4721740|NCT03099278|hepatitis D|hepatitis d
4721741|NCT03099278|Ezetimibe|ezetimibe
4721742|NCT03099278|HDV RNA|hdv rna
4721743|NCT03099161|Advanced Solid Tumor|advanced solid tumor
4721744|NCT03099161|Programmed Cell Death Receptor 1 (PD-1)|programmed cell death receptor 1 (pd-1)
4721745|NCT03099161|Programmed Cell Death Receptor Ligand 1 (PD-L1)|programmed cell death receptor ligand 1 (pd-l1)
4721746|NCT03099161|PD1|pd1
4721747|NCT03099161|PD-1|pd-1
4721748|NCT03099161|PDL1|pdl1
4721749|NCT03099161|PD-L1|pd-l1
4721750|NCT03099109|TIM-3|tim-3
4721751|NCT03099109|PD-L1|pd-l1
4721752|NCT03099096|SB240563|sb240563
4721753|NCT03099096|Mepolizumab|mepolizumab
4721754|NCT03099096|self-administration|self-administration
4721755|NCT03099096|eosinophilic asthma|eosinophilic asthma
4721756|NCT03099096|autoinjector|autoinjector
4721757|NCT03099083|Psoriasis|psoriasis
4721758|NCT03099083|Adalimumab|adalimumab
4721759|NCT03099083|Humira|humira
4721760|NCT03099083|Korea|korea
4721761|NCT03099070|Stress|stress
4721762|NCT03099070|Fasting|fasting
4721763|NCT03099070|Migraine|migraine
4721764|NCT03099031|Ottawa score|ottawa score
4721765|NCT03099031|tinzaparin|tinzaparin
4721766|NCT03099031|low-molecular weight heparin|low-molecular weight heparin
4721767|NCT03099031|anticoagulants|anticoagulants
4721768|NCT03099031|venous thrombosis|venous thrombosis
4721769|NCT03099031|thromboembolism|thromboembolism
4721770|NCT03099031|hemostatic disorders|hemostatic disorders
4721771|NCT03099031|vascular disease|vascular disease
4721772|NCT03099031|neoplasms|neoplasms
4721773|NCT03099031|breast neoplasms|breast neoplasms
4721774|NCT03099031|lung neoplasms|lung neoplasms
4721775|NCT03099031|prostatic neoplasms|prostatic neoplasms
4721776|NCT03099031|colorectal neoplasms|colorectal neoplasms
4721777|NCT03099031|genital neoplasms|genital neoplasms
4721778|NCT03099031|urogenital neoplasms|urogenital neoplasms
4721779|NCT03099031|intestinal neoplasms|intestinal neoplasms
4721780|NCT03099031|digestive system neoplasms|digestive system neoplasms
4721781|NCT03099031|lymphoma|lymphoma
4721782|NCT03099031|leukemia|leukemia
4721783|NCT03099031|multiple myeloma|multiple myeloma
4721784|NCT03099031|lymphoproliferative disorders|lymphoproliferative disorders
4721785|NCT03099031|myeloproliferative disorders|myeloproliferative disorders
4721786|NCT03099031|lymphatic disease|lymphatic disease
4721787|NCT03099018|GAS|gas
4721788|NCT03099018|pharyngitis|pharyngitis
4721789|NCT03099018|children|children
4721790|NCT03099018|RADT|radt
4721791|NCT03099005|neuropathic pain|neuropathic pain
4721792|NCT03099005|human immunovirus|human immunovirus
4721793|NCT03099005|vaporized cannabis|vaporized cannabis
4721794|NCT03098979|Chronic Heart Failure|chronic heart failure
4721795|NCT03098979|Heart Failure with Preserved Ejection Fraction|heart failure with preserved ejection fraction
4721796|NCT03098953|Ocular Installation|ocular installation
4721797|NCT03098927|Motor Imagery|motor imagery
4721798|NCT03098927|Spinal Cord Injury|spinal cord injury
4721799|NCT03098927|Motor Function Improvement|motor function improvement
4721800|NCT03098914|Pathogen|pathogen
4721801|NCT03098914|Mortality|mortality
4721802|NCT03098914|Community-acquired Pneumonia|community-acquired pneumonia
4721803|NCT03098914|Risk factors|risk factors
4721804|NCT03098901|TTR Amyloidosis|ttr amyloidosis
4721805|NCT03098901|Heart Failure with Preserved Ejection Fraction|heart failure with preserved ejection fraction
4721806|NCT03098901|Ventricular arrhythmia|ventricular arrhythmia
4721807|NCT03098901|Cardiac Conduction Disturbances|cardiac conduction disturbances
4721808|NCT03098888|side effects|side effects
4721809|NCT03098888|decision making|decision making
4721810|NCT03098888|indications|indications
4721811|NCT03098888|risk factors|risk factors
4721812|NCT03098862|Ebola Virus|ebola virus
4721813|NCT03098862|Genome-Wide Association Study|genome-wide association study
4721814|NCT03098862|Liberia|liberia
4721815|NCT03098862|Ebola Survivors|ebola survivors
4721816|NCT03098862|Ebola Contacts|ebola contacts
4721817|NCT03098849|Buteyko-based breathing technique training|buteyko-based breathing technique training
4721818|NCT03098836|metastatic|metastatic
4721819|NCT03098836|castrate resistant|castrate resistant
4721820|NCT03098797|Barth Syndrome|barth syndrome
4721821|NCT03098797|elamipretide|elamipretide
4721822|NCT03098797|MTP-131|mtp-131
4721823|NCT03098797|Stealth|stealth
4721824|NCT03098797|Stealth BT|stealth bt
4721825|NCT03098797|BTHS|bths
4721826|NCT03098784|airport environment|airport environment
4721827|NCT03098784|Air France|air france
4721828|NCT03098784|flightline employees|flightline employees
4721829|NCT03098784|administrative employees|administrative employees
4721830|NCT03098758|Polymerase Chain Reaction|polymerase chain reaction
4721831|NCT03098758|gastric cancer|gastric cancer
4721832|NCT03098758|citology|citology
4721833|NCT03098758|peritoneal washing|peritoneal washing
4721834|NCT03098758|CK20|ck20
4721835|NCT03098758|CEA|cea
4721836|NCT03098758|BER-EP4|ber-ep4
4721837|NCT03098732|Stroke|stroke
4721838|NCT03098732|Ischemic|ischemic
4721839|NCT03098732|Tissue Plasminogen Activator|tissue plasminogen activator
4721840|NCT03098732|Thrombolysis|thrombolysis
4721841|NCT03098732|Vascular Diseases|vascular diseases
4721842|NCT03098732|Cerebrovascular Disorders|cerebrovascular disorders
4721843|NCT03098732|Fibrinolytic Agents|fibrinolytic agents
4721844|NCT03098732|Plasminogen|plasminogen
4721845|NCT03098693|Serodiscordant|serodiscordant
4721846|NCT03098693|Pre-exposure Prophylaxis|pre-exposure prophylaxis
4721847|NCT03098693|Self-testing|self-testing
4721848|NCT03098693|Tanzania|tanzania
4721849|NCT03098680|Adverse reactions|adverse reactions
4721850|NCT03098680|Cardiovascular|cardiovascular
4721851|NCT03098680|Translation|translation
4721852|NCT03098680|Modelling|modelling
4721853|NCT03098680|Pharmacokinetics|pharmacokinetics
4721854|NCT03098680|Pharmacodynamics|pharmacodynamics
4721855|NCT03098654|Human Immunodeficiency Virus|human immunodeficiency virus
4721856|NCT03098654|Community Health Services|community health services
4721857|NCT03098654|Chronic Disease|chronic disease
4721858|NCT03098654|Integrated Delivery of Health Care|integrated delivery of health care
4721859|NCT03098654|Tanzania|tanzania
4721860|NCT03098589|Adult T-cell Leukemia Lymphoma|adult t-cell leukemia lymphoma
4721861|NCT03098589|Teratogenicity|teratogenicity
4721862|NCT03098589|Myelosuppression|myelosuppression
4721863|NCT03098589|Haemorrhage|haemorrhage
4721864|NCT03098589|Infection|infection
4721865|NCT03098589|Thromboembolism|thromboembolism
4721866|NCT03098589|Hypersensitivity|hypersensitivity
4721867|NCT03098589|Tumor lysis syndrome|tumor lysis syndrome
4721868|NCT03098589|Peripheral neuropathy|peripheral neuropathy
4721869|NCT03098589|Ischaemic heart disease|ischaemic heart disease
4721870|NCT03098589|Cardiac failure|cardiac failure
4721871|NCT03098589|Arrhythmia|arrhythmia
4721872|NCT03098589|Renal failure|renal failure
4721873|NCT03098589|Interstitial lung disease|interstitial lung disease
4721874|NCT03098589|Hepatic disorder|hepatic disorder
4721875|NCT03098589|Hypothyroidism|hypothyroidism
4721876|NCT03098589|Gastrointestinal perforation|gastrointestinal perforation
4721877|NCT03098589|Orthostatic hypotension|orthostatic hypotension
4721878|NCT03098589|Convulsion|convulsion
4721879|NCT03098589|Somnolence|somnolence
4721880|NCT03098589|Confusion|confusion
4721881|NCT03098589|Fatigue|fatigue
4721882|NCT03098589|Dizziness|dizziness
4721883|NCT03098589|Blurred vision|blurred vision
4721884|NCT03098589|Second primary cancer|second primary cancer
4721885|NCT03098589|Cataract|cataract
4721886|NCT03098589|Revlimid capsules|revlimid capsules
4721887|NCT03098576|advanced|advanced
4721888|NCT03098576|metastatic solid tumors|metastatic solid tumors
4721889|NCT03098563|Clinical Trial|clinical trial
4721890|NCT03098563|Phase II|phase ii
4721891|NCT03098550|Non-small cell lung cancer (NSCLC)|non-small cell lung cancer (nsclc)
4721892|NCT03098550|Triple Negative Breast Cancer (TNBC)|triple negative breast cancer (tnbc)
4721893|NCT03098550|Pancreatic Cancer (PAC)|pancreatic cancer (pac)
4721894|NCT03098524|Cardiac surgery|cardiac surgery
4721895|NCT03098524|Mechanical ventilation|mechanical ventilation
4721896|NCT03098524|Cardiopulmonary bypass|cardiopulmonary bypass
4721897|NCT03098524|Pneumonia|pneumonia
4721898|NCT03098524|Atelectasis|atelectasis
4721899|NCT03098511|Neurological Determination of Death|neurological determination of death
4721900|NCT03098511|Determination of Death|determination of death
4721901|NCT03098511|CT-Perfusion scan|ct-perfusion scan
4721902|NCT03098511|Ancillary Test|ancillary test
4721903|NCT03098511|Organ Donation|organ donation
4721904|NCT03098498|periodontitis|periodontitis
4721905|NCT03098498|scaling|scaling
4721906|NCT03098498|attachment gain|attachment gain
4721907|NCT03098498|air polishing|air polishing
4721908|NCT03098498|periodontal lesion|periodontal lesion
4721909|NCT03098459|Delirium|delirium
4721910|NCT03098459|Cognitive Impairment|cognitive impairment
4721911|NCT03098459|Alzheimer's Disease|alzheimer's disease
4721912|NCT03098459|Encephalopathy|encephalopathy
4721913|NCT03098459|Trauma|trauma
4721914|NCT03098459|Polytrauma|polytrauma
4721915|NCT03098459|ICU|icu
4721916|NCT03098459|Critical Illness|critical illness
4721917|NCT03098459|Traumatic Brain Injury|traumatic brain injury
4721918|NCT03098459|INSIGHT-ICU|insight-icu
4721919|NCT03098459|INSIGHT|insight
4721920|NCT03098459|Intracerebral hemorrhage|intracerebral hemorrhage
4721921|NCT03098459|Subarachnoid hemorrhage|subarachnoid hemorrhage
4721922|NCT03098459|Neurotrauma|neurotrauma
4721923|NCT03098459|Neuropsychology|neuropsychology
4721924|NCT03098459|Dementia|dementia
4721925|NCT03098459|Critical Care|critical care
4721926|NCT03098459|Subdural hemorrhage|subdural hemorrhage
4721927|NCT03098459|Cognition|cognition
4721928|NCT03098459|Neuropsychological Outcomes|neuropsychological outcomes
4721929|NCT03098459|Neuropsychology Dysfunction|neuropsychology dysfunction
4721930|NCT03098459|Inflammation|inflammation
4721931|NCT03098459|Neuroinflammation|neuroinflammation
4721932|NCT03098459|Inflammatory Mechanisms|inflammatory mechanisms
4721933|NCT03098459|Burn|burn
4721934|NCT03098459|Critically Injured|critically injured
4721935|NCT03098459|Injury|injury
4721936|NCT03098459|Head Injury|head injury
4721937|NCT03098459|Long-term Cognitive Impairment|long-term cognitive impairment
4721938|NCT03098459|ICU-related Dementia|icu-related dementia
4721939|NCT03098459|Employment|employment
4721940|NCT03098459|Return to Work|return to work
4721941|NCT03098394|Rapid turnaround test|rapid turnaround test
4721942|NCT03098394|RTAT|rtat
4721943|NCT03098394|Gonorrhea|gonorrhea
4721944|NCT03098394|Chlamydia|chlamydia
4721945|NCT03098394|STI|sti
4721946|NCT03098368|Parkinson's disease|parkinson's disease
4721947|NCT03098368|Rotigotine transdermal patch|rotigotine transdermal patch
4721948|NCT03098368|Nocturnal hypokinesia|nocturnal hypokinesia
4721949|NCT03098355|CART|cart
4721950|NCT03098355|CD19|cd19
4721951|NCT03098355|CD22|cd22
4721952|NCT03098355|Interleukin-2|interleukin-2
4721953|NCT03098342|Onychomycosis|onychomycosis
4721954|NCT03098342|photodynamic therapy|photodynamic therapy
4721955|NCT03098342|methylene blue|methylene blue
4721956|NCT03098342|amorolfine, nail lacquer|amorolfine, nail lacquer
4721957|NCT03098342|Asians|asians
4721958|NCT03098329|Screening|screening
4721959|NCT03098329|men|men
4721960|NCT03098329|expedited treatment|expedited treatment
4721961|NCT03098316|Cross sectional studies|cross sectional studies
4721962|NCT03098316|Metabolomics|metabolomics
4721963|NCT03098316|Glaucoma|glaucoma
4721964|NCT03098316|Low tension glaucoma|low tension glaucoma
4721965|NCT03098316|Ophthalmologic surgical procedures|ophthalmologic surgical procedures
4721966|NCT03098290|GermanVasc|germanvasc
4721967|NCT03098290|Peripheral Arterial Disease|peripheral arterial disease
4721968|NCT03098290|IDOMENEO|idomeneo
4721969|NCT03098290|Routine Data|routine data
4721970|NCT03098290|Registry Data|registry data
4721971|NCT03098290|Data Validity|data validity
4721972|NCT03098199|Antimullerian Hormone|antimullerian hormone
4721973|NCT03098199|In vitro fertilization|in vitro fertilization
4721974|NCT03098199|Medications|medications
4721975|NCT03098199|Dosing|dosing
4721976|NCT03098186|Medication adherence|medication adherence
4721977|NCT03098186|mHealth|mhealth
4721978|NCT03098173|Early colonoscopy|early colonoscopy
4721979|NCT03098173|Stigmata of recent hemorrhage|stigmata of recent hemorrhage
4721980|NCT03098173|Rebleeding|rebleeding
4721981|NCT03098160|Immunotherapy|immunotherapy
4721982|NCT03098160|Hypoxia|hypoxia
4721983|NCT03098160|Evofosfamide|evofosfamide
4721984|NCT03098160|Ipilimumab|ipilimumab
4721985|NCT03098160|TH-302|th-302
4721986|NCT03098069|Kangaroo Mother Care|kangaroo mother care
4721987|NCT03098069|Low Birth Weight|low birth weight
4721988|NCT03098069|Implementation research|implementation research
4721989|NCT03098043|Hypothermic machine perfusion|hypothermic machine perfusion
4721990|NCT03098043|Donation after circulatory death|donation after circulatory death
4721991|NCT03098043|Extended criteria liver grafts|extended criteria liver grafts
4721992|NCT03098030|Dinutuximab|dinutuximab
4721993|NCT03098030|Irinotecan|irinotecan
4721994|NCT03098030|Topotecan|topotecan
4721995|NCT03097991|Coparenting Unmarried African-American Prenatal|coparenting unmarried african-american prenatal
4721996|NCT03097913|nasotracheal intubation|nasotracheal intubation
4721997|NCT03097913|video-stylet|video-stylet
4721998|NCT03097913|nasal cavity injury|nasal cavity injury
4721999|NCT03097900|Postoperative Ileus|postoperative ileus
4722000|NCT03097900|Caffeine Citrate|caffeine citrate
4722001|NCT03097887|Omega Loop Gastric Bypass|omega loop gastric bypass
4722002|NCT03097887|Reflux|reflux
4722003|NCT03097887|Mini Gastric Bypass|mini gastric bypass
4722004|NCT03097874|anorexia|anorexia
4722005|NCT03097874|anorexia nervosa|anorexia nervosa
4722006|NCT03097874|eating disorder|eating disorder
4722007|NCT03097874|weight|weight
4722008|NCT03097874|eating|eating
4722009|NCT03097874|weight loss|weight loss
4722010|NCT03097874|family based treatment|family based treatment
4722012|NCT03097874|family treatment|family treatment
4722013|NCT03097874|therapy|therapy
4722014|NCT03097874|Maudsley method|maudsley method
4722015|NCT03097783|hyaluronic acid, midface|hyaluronic acid, midface
4722016|NCT03097757|Ultrasound|ultrasound
4722017|NCT03097757|Forearm Fracture Reduction|forearm fracture reduction
4722018|NCT03097757|Pediatric Emergency Department|pediatric emergency department
4722019|NCT03097744|Lateral Meniscus Tear|lateral meniscus tear
4722020|NCT03097744|Medial Meniscus Tear|medial meniscus tear
4722021|NCT03097731|interleukin-10|interleukin-10
4722022|NCT03097731|inflammatory bowel disease|inflammatory bowel disease
4722023|NCT03097692|cardiac preconditioning|cardiac preconditioning
4722024|NCT03097692|open heart surgery|open heart surgery
4722025|NCT03097692|createnine|createnine
4722026|NCT03097692|inflammation|inflammation
4722027|NCT03097653|breast cancer screening|breast cancer screening
4722028|NCT03097653|mammography|mammography
4722029|NCT03097653|decision-aid|decision-aid
4722030|NCT03097653|informed choice|informed choice
4722031|NCT03097653|National Cancer Screening Program|national cancer screening program
4722032|NCT03097627|Indocyanine Green|indocyanine green
4722033|NCT03097627|Near-infrared imaging|near-infrared imaging
4722034|NCT03097575|Lung lesions|lung lesions
4722035|NCT03097575|Navigational bronchoscopy|navigational bronchoscopy
4722036|NCT03097575|Near infrared imaging|near infrared imaging
4722037|NCT03097575|Lymphadenectomy|lymphadenectomy
4722038|NCT03097562|Cataract|cataract
4722039|NCT03097562|Femtosecond laser|femtosecond laser
4722040|NCT03097562|Cornea|cornea
4722041|NCT03097562|Anatomy|anatomy
4722042|NCT03097562|FSL|fsl
4722043|NCT03097562|surgery|surgery
4722044|NCT03097549|urinary incontinence|urinary incontinence
4722045|NCT03097549|urgency urinary incontinence|urgency urinary incontinence
4722046|NCT03097549|mixed urinary incontinence|mixed urinary incontinence
4722047|NCT03097549|smartphone application|smartphone application
4722048|NCT03097549|ehealth|ehealth
4722049|NCT03097549|mhealth|mhealth
4722050|NCT03097549|randomized controlled trial|randomized controlled trial
4722051|NCT03097549|self management|self management
4722052|NCT03097549|treatment|treatment
4722053|NCT03097536|Blood Sugar|blood sugar
4722054|NCT03097523|NSBRI|nsbri
4722055|NCT03097510|Perceived stress|perceived stress
4722056|NCT03097510|Leadership|leadership
4722057|NCT03097510|Transcendental Meditation|transcendental meditation
4722058|NCT03097497|Chronic Non-specific Low-Back Pain|chronic non-specific low-back pain
4722059|NCT03097497|Chronic Low-Back Pain|chronic low-back pain
4722060|NCT03097497|Physiotherapy|physiotherapy
4722061|NCT03097497|Therapeutic Exercise|therapeutic exercise
4722062|NCT03097497|Primary Care|primary care
4722063|NCT03097497|Transverse Abdominal Muscle|transverse abdominal muscle
4722064|NCT03097458|Counselling for Families|counselling for families
4722065|NCT03097458|Parental cancer|parental cancer
4722066|NCT03097458|Psychological distress and adjustment|psychological distress and adjustment
4722067|NCT03097445|Smoking|smoking
4722068|NCT03097445|Nicotine|nicotine
4722069|NCT03097445|Nicotine Replacement Therapy|nicotine replacement therapy
4722070|NCT03097445|Nicotine Patch|nicotine patch
4722071|NCT03097445|Mass Distribution|mass distribution
4722072|NCT03097445|Tobacco Control|tobacco control
4722073|NCT03097445|Cancer Prevention|cancer prevention
4722074|NCT03097445|Randomized Controlled Trial|randomized controlled trial
4722075|NCT03097419|non-ST segment elevation myocardial infarction|non-st segment elevation myocardial infarction
4722076|NCT03097419|myocardial infarction|myocardial infarction
4722077|NCT03097419|remote ischemic conditioning|remote ischemic conditioning
4722078|NCT03097419|ischemic conditioning|ischemic conditioning
4722079|NCT03097419|sphygmomanometer|sphygmomanometer
4722080|NCT03097419|metabolomics|metabolomics
4722081|NCT03097380|Healthy volunteer study|healthy volunteer study
4722082|NCT03097367|laparoscopic radical prostatectomy|laparoscopic radical prostatectomy
4722083|NCT03097367|urinary incontinence|urinary incontinence
4722084|NCT03097367|prostate cancer|prostate cancer
4722085|NCT03097367|bladder neck level|bladder neck level
4722086|NCT03097367|urodynamics|urodynamics
4722087|NCT03097354|alcohol use|alcohol use
4722088|NCT03097354|consumption measure|consumption measure
4722089|NCT03097354|Composite International Diagnostic Interview (CIDI)|composite international diagnostic interview (cidi)
4722090|NCT03097354|internet survey|internet survey
4722091|NCT03097354|standardized assessment|standardized assessment
4722092|NCT03097328|Renal Cell Carcinoma|renal cell carcinoma
4722093|NCT03097315|Uveitis|uveitis
4722094|NCT03097315|UME|ume
4722095|NCT03097315|Posterior Uveitis|posterior uveitis
4722096|NCT03097315|Anterior Uveitis|anterior uveitis
4722097|NCT03097315|Intermediate Uveitis|intermediate uveitis
4722098|NCT03097315|Panuveitis|panuveitis
4722099|NCT03097315|Non-infectious Uveitis|non-infectious uveitis
4722100|NCT03097315|Triamcinolone|triamcinolone
4722102|NCT03097315|Choroidal Injection|choroidal injection
4722103|NCT03097315|Suprachoroidal|suprachoroidal
4722104|NCT03097315|Microneedle|microneedle
4722105|NCT03097315|Microinjection|microinjection
4722106|NCT03097302|laser-assisted keratotomy|laser-assisted keratotomy
4722107|NCT03097302|anterior astigmatism|anterior astigmatism
4722108|NCT03097302|posterior astigmatism|posterior astigmatism
4722109|NCT03097302|total corneal refractive power|total corneal refractive power
4722110|NCT03097302|nomogram|nomogram
4722111|NCT03097289|Healthy Adults|healthy adults
4722112|NCT03097250|PKU|pku
4722113|NCT03097250|Neuropsychology|neuropsychology
4722114|NCT03097250|MRI|mri
4722115|NCT03097198|Juvenile|juvenile
4722116|NCT03097198|Traditional Chinese Medicine|traditional chinese medicine
4722117|NCT03097198|Plum-blossom needle|plum-blossom needle
4722118|NCT03097185|pancreatitis|pancreatitis
4722119|NCT03097185|islet cell|islet cell
4722120|NCT03097172|Percutaneous Coronary Intervention (PCI)|percutaneous coronary intervention (pci)
4722121|NCT03097172|Chronic Total Occlusion (CTO)|chronic total occlusion (cto)
4722122|NCT03097172|Cardiac MRI|cardiac mri
4722123|NCT03097172|Fractional Flow Reserve (FFR)|fractional flow reserve (ffr)
4722124|NCT03097172|Doppler Flow Velocity|doppler flow velocity
4722125|NCT03097172|Cardiovascular Disease|cardiovascular disease
4722126|NCT03097172|Atherosclerosis|atherosclerosis
4722127|NCT03097172|Hydrostatic Pressure|hydrostatic pressure
4722128|NCT03097159|costoclavicular block|costoclavicular block
4722129|NCT03097146|Stroke|stroke
4722130|NCT03097146|Aftercare|aftercare
4722131|NCT03097146|Comprehensive Care|comprehensive care
4722132|NCT03097107|hypertriglyceridemia|hypertriglyceridemia
4722133|NCT03097107|dyslipidemia|dyslipidemia
4722134|NCT03097107|saroglitazar magnesium|saroglitazar magnesium
4722135|NCT03097107|lipid disorder|lipid disorder
4722136|NCT03097094|Dog allergy|dog allergy
4722137|NCT03097094|Can f 5|can f 5
4722138|NCT03097094|Male dog|male dog
4722139|NCT03097094|Female dog|female dog
4722140|NCT03097094|Allergen components|allergen components
4722141|NCT03097055|Stroke|stroke
4722142|NCT03097055|Acupuncture|acupuncture
4722143|NCT03097055|antiinflammatory|antiinflammatory
4722144|NCT03097055|NIHSS|nihss
4722145|NCT03097029|pancreatic enzymes|pancreatic enzymes
4722146|NCT03097016|Renal Impairment|renal impairment
4722147|NCT03097016|Pharmacokinetics|pharmacokinetics
4722148|NCT03097016|CC-122|cc-122
4722149|NCT03097016|Mild|mild
4722150|NCT03097016|Moderate|moderate
4722151|NCT03097016|Severe|severe
4722152|NCT03097003|Proriasis|proriasis
4722153|NCT03097003|Real-life management|real-life management
4722154|NCT03097003|Observational|observational
4722155|NCT03097003|Otezla|otezla
4722156|NCT03097003|CC-10004|cc-10004
4722157|NCT03097003|Apremilast|apremilast
4722158|NCT03097003|Belgium|belgium
4722159|NCT03097003|OTELO|otelo
4722160|NCT03096990|Psoriatic Arthritis|psoriatic arthritis
4722161|NCT03096990|Observational|observational
4722162|NCT03096990|Otezla|otezla
4722163|NCT03096990|Apremilast|apremilast
4722164|NCT03096990|Real-Life management|real-life management
4722165|NCT03096990|Belgium|belgium
4722166|NCT03096990|APOLO|apolo
4722167|NCT03096990|CC-10004|cc-10004
4722168|NCT03096977|Hand dexterity|hand dexterity
4722169|NCT03096977|Multiple sclerosis|multiple sclerosis
4722170|NCT03096977|Nine Holes Peg|nine holes peg
4722171|NCT03096964|Elderly training|elderly training
4722172|NCT03096964|Pole walking|pole walking
4722173|NCT03096964|Locomotor Rehabilitation Index|locomotor rehabilitation index
4722174|NCT03096964|Self-selected speed of walking|self-selected speed of walking
4722175|NCT03096964|Recovery|recovery
4722176|NCT03096938|cell-free DNA|cell-free dna
4722177|NCT03096938|methylation|methylation
4722178|NCT03096938|markers|markers
4722179|NCT03096938|cancer|cancer
4722180|NCT03096938|screening|screening
4722181|NCT03096925|non-cardiac chest pain|non-cardiac chest pain
4722182|NCT03096925|anxiety|anxiety
4722183|NCT03096912|CDK4 inhibitor|cdk4 inhibitor
4722184|NCT03096912|LEE011|lee011
4722185|NCT03096912|ribociclib|ribociclib
4722186|NCT03096912|liposarcoma dedifferentiated|liposarcoma dedifferentiated
4722187|NCT03096912|liposarcoma well differentiated|liposarcoma well differentiated
4722188|NCT03096886|Cognitive Behavioral Therapy|cognitive behavioral therapy
4722189|NCT03096886|Computer-Assisted Cognitive Behavioral Therapy|computer-assisted cognitive behavioral therapy
4722190|NCT03096886|Computer-Augmented Cognitive Behavioral Therapy|computer-augmented cognitive behavioral therapy
4722191|NCT03096886|CBT|cbt
4722192|NCT03096886|Computer-Assisted CBT|computer-assisted cbt
4722193|NCT03096886|Computer-Augmented CBT|computer-augmented cbt
4722194|NCT03096847|ribociclib|ribociclib
4722195|NCT03096847|LEE011|lee011
4722196|NCT03096847|RIBECCA|ribecca
4722197|NCT03096847|breast cancer|breast cancer
4722198|NCT03096847|breast carcinoma|breast carcinoma
4722199|NCT03096847|HR-positive|hr-positive
4722200|NCT03096847|HER2-negative|her2-negative
4722201|NCT03096847|advanced breast cancer|advanced breast cancer
4722202|NCT03096847|Letrozole|letrozole
4722203|NCT03096847|CDK4/6|cdk4/6
4722204|NCT03096834|Migraine|migraine
4722205|NCT03096834|attack|attack
4722206|NCT03096834|headache|headache
4722207|NCT03096834|episodic|episodic
4722208|NCT03096834|aura|aura
4722209|NCT03096834|AMG 334|amg 334
4722210|NCT03096834|CGRP receptor agonist|cgrp receptor agonist
4722211|NCT03096834|erenumab|erenumab
4722212|NCT03096808|adaptive radiotherapy|adaptive radiotherapy
4722213|NCT03096808|ART|art
4722319|NCT03096496|ATO|ato
4722214|NCT03096808|intensity modulated radiation therapy|intensity modulated radiation therapy
4722215|NCT03096808|IMRT|imrt
4722216|NCT03096795|MEDI3506|medi3506
4722217|NCT03096795|Safety|safety
4722218|NCT03096795|Tolerability|tolerability
4722219|NCT03096795|Pharmacokinetics|pharmacokinetics
4722220|NCT03096795|Immunogenicity|immunogenicity
4722221|NCT03096782|Acute Myelogenous Leukemia|acute myelogenous leukemia
4722222|NCT03096782|AML|aml
4722223|NCT03096782|Myelodysplastic Syndrome|myelodysplastic syndrome
4722224|NCT03096782|MDS|mds
4722225|NCT03096782|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
4722226|NCT03096782|ALL|all
4722227|NCT03096782|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
4722228|NCT03096782|NHL|nhl
4722229|NCT03096782|Small Lymphocytic Lymphoma|small lymphocytic lymphoma
4722230|NCT03096782|SLL|sll
4722231|NCT03096782|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
4722232|NCT03096782|CLL|cll
4722233|NCT03096782|Hodgkin's Disease|hodgkin's disease
4722234|NCT03096782|HD|hd
4722235|NCT03096782|Busulfan|busulfan
4722236|NCT03096782|Busulfex|busulfex
4722237|NCT03096782|Myleran|myleran
4722238|NCT03096782|Rituximab|rituximab
4722239|NCT03096782|Rituxan|rituxan
4722240|NCT03096782|ATG|atg
4722241|NCT03096782|ATG(rabbit)|atg(rabbit)
4722242|NCT03096782|Rabbit Antithymocyte Globulin|rabbit antithymocyte globulin
4722243|NCT03096782|Rabbit Antilymphocyte Globulin|rabbit antilymphocyte globulin
4722244|NCT03096782|Rabbit ATG|rabbit atg
4722245|NCT03096782|rATg|ratg
4722246|NCT03096782|Thymoglobulin|thymoglobulin
4722247|NCT03096782|Fludarabine|fludarabine
4722248|NCT03096782|Fludarabine Phosphate|fludarabine phosphate
4722249|NCT03096782|Fludara|fludara
4722250|NCT03096782|Clofarabine|clofarabine
4722251|NCT03096782|Clofarex|clofarex
4722252|NCT03096782|Clolar|clolar
4722253|NCT03096782|Total Body Irradiation|total body irradiation
4722254|NCT03096782|TBI|tbi
4722255|NCT03096782|XRT|xrt
4722256|NCT03096782|External Beam Radiotherapy|external beam radiotherapy
4722257|NCT03096782|Mycophenolate Mofetil|mycophenolate mofetil
4722258|NCT03096782|MMF|mmf
4722259|NCT03096782|CellCept|cellcept
4722260|NCT03096782|Tacrolimus|tacrolimus
4722261|NCT03096782|Prograf|prograf
4722262|NCT03096782|G-CSF|g-csf
4722263|NCT03096782|Filgrastim|filgrastim
4722264|NCT03096782|Neupogen|neupogen
4722265|NCT03096782|Melphalan|melphalan
4722266|NCT03096782|Alkeran|alkeran
4722267|NCT03096782|Cyclophosphamide|cyclophosphamide
4722268|NCT03096782|Cytoxan|cytoxan
4722269|NCT03096782|Neosar|neosar
4722270|NCT03096782|Mesna|mesna
4722271|NCT03096782|Mesnex|mesnex
4722272|NCT03096782|Cord Blood Transplantation|cord blood transplantation
4722273|NCT03096782|Stem Cell Transplant|stem cell transplant
4722274|NCT03096756|Oral Formulation|oral formulation
4722275|NCT03096756|Food Effect|food effect
4722276|NCT03096756|Superoxide Dismutase|superoxide dismutase
4722277|NCT03096756|Single Ascending Dose|single ascending dose
4722278|NCT03096756|GC4702|gc4702
4722279|NCT03096756|Bioavailability|bioavailability
4722280|NCT03096756|Pharmacokinetics|pharmacokinetics
4722281|NCT03096756|Active Comparator|active comparator
4722282|NCT03096730|Remifentanil|remifentanil
4722283|NCT03096730|Opioid-induced hyperalgesia|opioid-induced hyperalgesia
4722284|NCT03096730|Postoperative pain|postoperative pain
4722285|NCT03096730|pain intensity|pain intensity
4722286|NCT03096691|cervical pessary|cervical pessary
4722287|NCT03096691|preterm labor|preterm labor
4722288|NCT03096691|Cervical insufficiency|cervical insufficiency
4722289|NCT03096678|Left Bundle Branch Block|left bundle branch block
4722290|NCT03096678|Regional/Globle cardiac function|regional/globle cardiac function
4722291|NCT03096678|Mechanical asynchrony|mechanical asynchrony
4722292|NCT03096678|Cardiovascular Magnetic Resonance|cardiovascular magnetic resonance
4722293|NCT03096678|Outcome|outcome
4722294|NCT03096678|Cardiovascular events|cardiovascular events
4722295|NCT03096665|venous blood|venous blood
4722296|NCT03096665|arterial blood|arterial blood
4722297|NCT03096665|capillary blood|capillary blood
4722298|NCT03096652|gynecologic cancer - panniculectomy|gynecologic cancer - panniculectomy
4722299|NCT03096639|Diaphragm atrophy|diaphragm atrophy
4722300|NCT03096639|VIDD|vidd
4722301|NCT03096639|Weaning failure|weaning failure
4722302|NCT03096626|Depression|depression
4722303|NCT03096613|heart failure|heart failure
4722304|NCT03096613|Subclinical Hypothyroidism|subclinical hypothyroidism
4722305|NCT03096613|levothyroxine|levothyroxine
4722306|NCT03096613|6-minute walk test|6-minute walk test
4722307|NCT03096600|spine|spine
4722308|NCT03096587|XP Endo Finisher|xp endo finisher
4722309|NCT03096587|ultrasonic activated irrigation|ultrasonic activated irrigation
4722310|NCT03096587|postoperative pain|postoperative pain
4722311|NCT03096574|Respiratory Syncytial Virus (RSV)|respiratory syncytial virus (rsv)
4722312|NCT03096574|Maternal vaccination|maternal vaccination
4722313|NCT03096574|Attitudes|attitudes
4722314|NCT03096574|Pregnancy|pregnancy
4722315|NCT03096548|Skin Cancer|skin cancer
4722316|NCT03096548|Tattoo|tattoo
4722317|NCT03096496|Quality of life|quality of life
4722318|NCT03096496|acute promyelocytic leukemia|acute promyelocytic leukemia
4722320|NCT03096457|leishmaniasis|leishmaniasis
4722321|NCT03096457|L.braziliensis|l.braziliensis
4722322|NCT03096457|paromomycin cream|paromomycin cream
4722323|NCT03096457|intralesional pentamidine|intralesional pentamidine
4722324|NCT03096457|leishmaniasis local therapy|leishmaniasis local therapy
4722325|NCT03096431|whole-brain radiation therapy|whole-brain radiation therapy
4722326|NCT03096431|sterotactic radiosurgery|sterotactic radiosurgery
4722327|NCT03096431|cognitive rehabilitation|cognitive rehabilitation
4722328|NCT03096431|physical activity|physical activity
4722329|NCT03096379|TB|tb
4722330|NCT03096379|CD|cd
4722331|NCT03096379|MRE|mre
4722332|NCT03096379|ileocecal|ileocecal
4722333|NCT03096366|anterior cruciate ligament reconstruction|anterior cruciate ligament reconstruction
4722334|NCT03096353|NALOXONE|naloxone
4722335|NCT03096353|fMRI|fmri
4722336|NCT03096353|Functional Magnetic Resonance Imaging (fMRI)|functional magnetic resonance imaging (fmri)
4722337|NCT03096340|SN-38|sn-38
4722338|NCT03096340|irinotecan|irinotecan
4722339|NCT03096327|Quality of Life|quality of life
4722340|NCT03096327|Asthma control test|asthma control test
4722341|NCT03096327|Montelukast|montelukast
4722342|NCT03096327|Asthma|asthma
4722343|NCT03096314|ARDS|ards
4722344|NCT03096314|Vitamin D|vitamin d
4722345|NCT03096301|temporomandibular disorder|temporomandibular disorder
4722346|NCT03096301|photobiomodulation|photobiomodulation
4722347|NCT03096301|pain|pain
4722348|NCT03096275|Mycophenolate mofetil|mycophenolate mofetil
4722349|NCT03096275|Methotrexate|methotrexate
4722350|NCT03096275|cyclophosphamide|cyclophosphamide
4722351|NCT03096262|cognitive skills|cognitive skills
4722352|NCT03096262|technical|technical
4722353|NCT03096262|internet platform|internet platform
4722354|NCT03096262|Stroke|stroke
4722355|NCT03096262|Hemiparesis|hemiparesis
4722356|NCT03096249|oxytocin|oxytocin
4722357|NCT03096249|emotion recognition|emotion recognition
4722358|NCT03096249|emotion processing|emotion processing
4722359|NCT03096249|social salience|social salience
4722360|NCT03096249|face processing|face processing
4722361|NCT03096249|Electroencephalography (EEG)|electroencephalography (eeg)
4722362|NCT03096210|Maxillar sinus|maxillar sinus
4722363|NCT03096210|Titanium-Prepared Platelet Rich Fibrin|titanium-prepared platelet rich fibrin
4722364|NCT03096210|Allograft|allograft
4722365|NCT03096210|implant|implant
4722366|NCT03096197|Spinal Cord injury (SCI)|spinal cord injury (sci)
4722367|NCT03096197|Transcutaneous lumbosacral stimulation (TLS)|transcutaneous lumbosacral stimulation (tls)
4722368|NCT03096197|Exoskeleton-Assisted Walking (EAW)|exoskeleton-assisted walking (eaw)
4722369|NCT03096184|head and neck cancer|head and neck cancer
4722370|NCT03096184|Apatinib|apatinib
4722371|NCT03096184|Tegafur Gimeracil Oteracil|tegafur gimeracil oteracil
4722372|NCT03096171|Stress|stress
4722373|NCT03096171|Well-being|well-being
4722374|NCT03096171|Positive Psychology|positive psychology
4722375|NCT03096158|Coronary artery bypass grafting|coronary artery bypass grafting
4722376|NCT03096158|Cardiorespiratory rehabilitation|cardiorespiratory rehabilitation
4722377|NCT03096158|Functional electrical stimulation|functional electrical stimulation
4722378|NCT03096158|Inspiratory muscle training|inspiratory muscle training
4722379|NCT03096158|Aerobic training|aerobic training
4722380|NCT03096158|Isometric handgrip training|isometric handgrip training
4722381|NCT03096158|Functional capacity|functional capacity
4722382|NCT03096158|Endothelial function|endothelial function
4722383|NCT03096158|Cardiac function|cardiac function
4722384|NCT03096145|tobacco|tobacco
4722385|NCT03096145|quitlines|quitlines
4722386|NCT03096145|social support|social support
4722387|NCT03096145|mobile support|mobile support
4722388|NCT03096132|Obesity|obesity
4722389|NCT03096132|Overweight|overweight
4722390|NCT03096132|Overeating|overeating
4722391|NCT03096132|Body Mass Index|body mass index
4722392|NCT03096132|Treatment|treatment
4722393|NCT03096132|Intervention|intervention
4722394|NCT03096132|Family Based Therapy|family based therapy
4722395|NCT03096132|Weight|weight
4722396|NCT03096132|Children|children
4722397|NCT03096119|blood pressure monitoring, home|blood pressure monitoring, home
4722398|NCT03096119|Asia|asia
4722399|NCT03096093|Pancreatic|pancreatic
4722400|NCT03096093|Late stage cancer|late stage cancer
4722401|NCT03096093|Immunotherapy|immunotherapy
4722402|NCT03096093|Phase I|phase i
4722403|NCT03096093|Vaccination|vaccination
4722404|NCT03096080|ARPKD|arpkd
4722405|NCT03096080|Autosomal Recessive Polycystic Kidney Disease|autosomal recessive polycystic kidney disease
4722406|NCT03096080|Pediatric Polycystic Kidney|pediatric polycystic kidney
4722407|NCT03096080|Tesevatinib|tesevatinib
4722408|NCT03096080|Polycystic Kidney Disease|polycystic kidney disease
4722409|NCT03096041|auriculotherapy|auriculotherapy
4722410|NCT03096041|aromatase inhibitors|aromatase inhibitors
4722411|NCT03096041|adjuvant treatment|adjuvant treatment
4722412|NCT03096028|maternal nutrition|maternal nutrition
4722413|NCT03096028|neurocognitive development|neurocognitive development
4722414|NCT03096028|brain volume|brain volume
4722415|NCT03096002|PreDiabetes, Lifestyle intervention, Exercise Behavior, Adherence|prediabetes, lifestyle intervention, exercise behavior, adherence
4722416|NCT03095989|mindfulness|mindfulness
4722417|NCT03095976|Guided Tissue Regeneration,|guided tissue regeneration,
4722418|NCT03095976|Amnion-Chorion,|amnion-chorion,
4722419|NCT03095976|Intrabony defects,|intrabony defects,
4722420|NCT03095976|furcation|furcation
4722421|NCT03095950|Spin|spin
4722422|NCT03095950|Misleading reporting|misleading reporting
4722423|NCT03095950|Misleading interpretation|misleading interpretation
4722424|NCT03095950|Misleading extrapolation|misleading extrapolation
4722425|NCT03095950|Randomized controlled trials|randomized controlled trials
4722426|NCT03095950|Patients|patients
4722427|NCT03095924|Spin|spin
4722428|NCT03095924|Misleading reporting|misleading reporting
4722429|NCT03095924|Misleading interpretation|misleading interpretation
4722430|NCT03095924|Misleading extrapolation|misleading extrapolation
4722431|NCT03095924|Randomized controlled trials|randomized controlled trials
4722432|NCT03095924|Patients|patients
4722433|NCT03095911|Spin|spin
4722434|NCT03095911|Misleading reporting|misleading reporting
4722435|NCT03095911|Misleading interpretation|misleading interpretation
4722436|NCT03095911|Misleading extrapolation|misleading extrapolation
4722437|NCT03095911|Randomized controlled trials|randomized controlled trials
4722438|NCT03095911|Patients|patients
4722439|NCT03095898|Colonoscopy|colonoscopy
4722440|NCT03095898|Acupuncture|acupuncture
4722441|NCT03095885|Urine Oxalate|urine oxalate
4722442|NCT03095885|Nephrolithiasis|nephrolithiasis
4722443|NCT03095885|Kidney Stones|kidney stones
4722444|NCT03095885|Hyperoxaluria|hyperoxaluria
4722445|NCT03095885|Enteric Hyperoxaluria|enteric hyperoxaluria
4722446|NCT03095885|urological Diseases|urological diseases
4722447|NCT03095885|Kidney Diseases|kidney diseases
4722448|NCT03095885|Dietary Oxalate|dietary oxalate
4722449|NCT03095885|Idiopathic Hyperoxaluria|idiopathic hyperoxaluria
4722450|NCT03095885|Oxalate Absorption|oxalate absorption
4722451|NCT03095872|photodamaged skin|photodamaged skin
4722452|NCT03095872|wound healing|wound healing
4722453|NCT03095872|CO2 laser|co2 laser
4722454|NCT03095820|Community|community
4722455|NCT03095820|Depressive Symptoms|depressive symptoms
4722456|NCT03095820|Mental Health Program|mental health program
4722457|NCT03095820|Older adults|older adults
4722458|NCT03095768|Lifestyle|lifestyle
4722459|NCT03095768|Nutrition|nutrition
4722460|NCT03095768|Cooking|cooking
4722461|NCT03095742|Microdialysis|microdialysis
4722462|NCT03095742|Cerebral metabolism|cerebral metabolism
4722463|NCT03095742|Cardiac arrest|cardiac arrest
4722464|NCT03095742|Intravenous|intravenous
4722465|NCT03095742|Neurological prognosis|neurological prognosis
4722466|NCT03095716|Carbon dioxide pneumoperitoneum|carbon dioxide pneumoperitoneum
4722467|NCT03095716|Intraperitoneal pressure|intraperitoneal pressure
4722468|NCT03095716|Post-operative recovery|post-operative recovery
4722469|NCT03095716|Laparoscopic Humidification System|laparoscopic humidification system
4722470|NCT03095703|Sirolimus|sirolimus
4722471|NCT03095703|Intestinal adenomas|intestinal adenomas
4722472|NCT03095690|Osteoporosis|osteoporosis
4722473|NCT03095690|Parkinson|parkinson
4722474|NCT03095690|HR-pQCT|hr-pqct
4722475|NCT03095690|bone microstructure|bone microstructure
4722476|NCT03095690|fracture risk|fracture risk
4722477|NCT03095677|dynamic apnea|dynamic apnea
4722478|NCT03095677|muscle oxygenation|muscle oxygenation
4722479|NCT03095677|physical performance|physical performance
4722480|NCT03095664|lifestyle intervention|lifestyle intervention
4722481|NCT03095664|endometrial cancer|endometrial cancer
4722482|NCT03095664|survival|survival
4722483|NCT03095638|Dispersible tablets|dispersible tablets
4722484|NCT03095638|Bioavailability|bioavailability
4722485|NCT03095638|Dolutegravir|dolutegravir
4722486|NCT03095638|Healthy|healthy
4722487|NCT03095638|Conventional tablets|conventional tablets
4722488|NCT03095625|Sepsis|sepsis
4722489|NCT03095625|Bleeding disorder|bleeding disorder
4722490|NCT03095625|Viscoelastic tests|viscoelastic tests
4722491|NCT03095599|Influenza|influenza
4722492|NCT03095599|Vaccine|vaccine
4722493|NCT03095586|Spin|spin
4722494|NCT03095586|Misleading reporting|misleading reporting
4722495|NCT03095586|Misleading interpretation|misleading interpretation
4722496|NCT03095586|Misleading extrapolation|misleading extrapolation
4722497|NCT03095586|Randomized controlled trials|randomized controlled trials
4722498|NCT03095586|Patients|patients
4722499|NCT03095573|Celiac disease|celiac disease
4722500|NCT03095573|Enteropathy associated T cell lymphoma|enteropathy associated t cell lymphoma
4722501|NCT03095573|Refractory celiac disease|refractory celiac disease
4722502|NCT03095573|Small bowel adenocarcinoma|small bowel adenocarcinoma
4722503|NCT03095534|Occupational Therapy|occupational therapy
4722504|NCT03095534|Aging in place|aging in place
4722505|NCT03095534|Activities of daily living|activities of daily living
4722506|NCT03095534|Community program|community program
4722507|NCT03095521|Angal|angal
4722508|NCT03095521|ANTI-ANGIN® FORMULA|anti-angin® formula
4722509|NCT03095521|sore throat|sore throat
4722510|NCT03095521|no less therapeutic efficacy|no less therapeutic efficacy
4722511|NCT03095508|Angal S|angal s
4722512|NCT03095508|ANTI-ANGIN FORMULA|anti-angin formula
4722513|NCT03095508|Sore Throat|sore throat
4722514|NCT03095508|no less therapeutic efficacy|no less therapeutic efficacy
4722515|NCT03095495|Heated Humidified High Flow Nasal Cannula (HHHFNC)|heated humidified high flow nasal cannula (hhhfnc)
4722516|NCT03095495|Low Flow Nasal Cannula|low flow nasal cannula
4722517|NCT03095495|Bronchiolitis|bronchiolitis
4722518|NCT03095495|Respiratory Syncytial Virus (RSV)|respiratory syncytial virus (rsv)
4722519|NCT03095495|Respiratory Failure|respiratory failure
4722520|NCT03095495|High Flow Nasal Cannula (HFNC)|high flow nasal cannula (hfnc)
4722521|NCT03095495|Lung Diseases, Obstructive|lung diseases, obstructive
4722522|NCT03095482|Arachnophobia (fear of spiders)|arachnophobia (fear of spiders)
4722523|NCT03095482|Ophidophobia (fear of snakes)|ophidophobia (fear of snakes)
4722524|NCT03095482|Claustrophobia (fear of tightly enclosed spaces)|claustrophobia (fear of tightly enclosed spaces)
4722525|NCT03095482|Germaphobia (fear of germs, dirtiness, and contamination)|germaphobia (fear of germs, dirtiness, and contamination)
4722526|NCT03095456|Chronic Obstructive Pulmonary Disease, COPD, Low Peak Inspiratory Flow Rate|chronic obstructive pulmonary disease, copd, low peak inspiratory flow rate
4722527|NCT03095443|Delirium|delirium
4722528|NCT03095443|Critical Illness|critical illness
4722529|NCT03095443|Music Therapy|music therapy
4722530|NCT03095430|Trauma|trauma
4722531|NCT03095430|General Anesthesia|general anesthesia
4722532|NCT03095430|Surgical Pleth Index|surgical pleth index
4722533|NCT03095430|Entropy|entropy
4722534|NCT03095417|Delirium|delirium
4722535|NCT03095417|Alzheimer's Disease|alzheimer's disease
4722536|NCT03095417|Aging|aging
4722537|NCT03095417|Exercise Therapy|exercise therapy
4722538|NCT03095417|Cognitive Training|cognitive training
4722539|NCT03095378|gingival recession|gingival recession
4722540|NCT03095339|Burkina Faso|burkina faso
4722541|NCT03095339|Community-based randomized controlled trial|community-based randomized controlled trial
4722542|NCT03095339|Cysticercosis|cysticercosis
4722543|NCT03095339|Implementation Research|implementation research
4722544|NCT03095339|Effectiveness|effectiveness
4722545|NCT03095313|Transcatheter Aortic Valve Replacement (TAVR).|transcatheter aortic valve replacement (tavr).
4722546|NCT03095313|Surgical bioprosthetic aortic valve replacement|surgical bioprosthetic aortic valve replacement
4722547|NCT03095300|Prone Position|prone position
4722548|NCT03095300|High-flow oxygen therapy|high-flow oxygen therapy
4722549|NCT03095287|Factor VIII|factor viii
4722550|NCT03095287|von Willebrand Factor|von willebrand factor
4722551|NCT03095287|Plasma-derived|plasma-derived
4722552|NCT03095287|Inhibitors|inhibitors
4722553|NCT03095287|Immune tolerance induction|immune tolerance induction
4722554|NCT03095287|ITI|iti
4722555|NCT03095287|Antibodies|antibodies
4722556|NCT03095287|Hemophilia A|hemophilia a
4722557|NCT03095261|Cardiovascular Disease|cardiovascular disease
4722558|NCT03095261|Cardiac Rehabilitation|cardiac rehabilitation
4722559|NCT03095261|Financial Incentives|financial incentives
4722560|NCT03095261|Outpatient (Phase II) Cardiac Rehabilitation Exercise Adherence|outpatient (phase ii) cardiac rehabilitation exercise adherence
4722561|NCT03095235|keratoconus|keratoconus
4722562|NCT03095235|cornea ectasia|cornea ectasia
4722563|NCT03095183|Posterior oropharynx exam|posterior oropharynx exam
4722564|NCT03095183|Pediatric|pediatric
4722565|NCT03095183|Tongue Depressor|tongue depressor
4722566|NCT03095183|Flavored Tongue Depressor|flavored tongue depressor
4722567|NCT03095144|pyloromyotomy|pyloromyotomy
4722568|NCT03095144|spinal anaesthesia|spinal anaesthesia
4722569|NCT03095144|surgical outcomes|surgical outcomes
4722570|NCT03095144|general anaesthesia|general anaesthesia
4722571|NCT03095144|infants|infants
4722572|NCT03095131|Heart Spectrum Blood Pressure MonitorHeart Spectrum|heart spectrum blood pressure monitorheart spectrum
4722573|NCT03095079|endostar|endostar
4722574|NCT03095079|dacarbazine|dacarbazine
4722575|NCT03095079|cisplatin|cisplatin
4722576|NCT03095066|aggression|aggression
4722577|NCT03095066|agitation|agitation
4722578|NCT03095066|irritability|irritability
4722579|NCT03095066|non-penetrating brain injury|non-penetrating brain injury
4722580|NCT03095066|traumatic brain injury|traumatic brain injury
4722581|NCT03095066|TBI|tbi
4722582|NCT03095066|AVP-786|avp-786
4722583|NCT03095053|blastocyst|blastocyst
4722584|NCT03095053|comprehensive chromosome screening|comprehensive chromosome screening
4722585|NCT03095053|euploidy|euploidy
4722586|NCT03095053|frozen embryo transfer|frozen embryo transfer
4722587|NCT03095001|bevacizumab|bevacizumab
4722588|NCT03095001|Intraperitoneal administration|intraperitoneal administration
4722589|NCT03095001|Ovarian Cancer|ovarian cancer
4722590|NCT03095001|Peritoneal Adhesion|peritoneal adhesion
4722591|NCT03094962|Kinematics|kinematics
4722592|NCT03094962|MRI Scans|mri scans
4722593|NCT03094962|CT Scan, Single-Photon Emission|ct scan, single-photon emission
4722594|NCT03094962|finger interphalangeal joint|finger interphalangeal joint
4722595|NCT03094949|microwave ablation|microwave ablation
4722596|NCT03094949|partial nephrectomy|partial nephrectomy
4722597|NCT03094910|Raynaud Phenomenon|raynaud phenomenon
4722598|NCT03094910|Hand and Arm Vibration Syndrome|hand and arm vibration syndrome
4722599|NCT03094910|Autonomic Imbalance|autonomic imbalance
4722600|NCT03094910|Thermography|thermography
4722601|NCT03094897|Breast Neoplasms,Prostatic Neoplasms|breast neoplasms,prostatic neoplasms
4722602|NCT03094858|Smartphone, sedentary behavior, smartphone intervention|smartphone, sedentary behavior, smartphone intervention
4722603|NCT03094832|ARQ 092|arq 092
4722604|NCT03094832|ArQule|arqule
4722605|NCT03094832|AKT|akt
4722606|NCT03094832|PIK3CA|pik3ca
4722607|NCT03094832|Overgrowth|overgrowth
4722608|NCT03094832|Congenital malformations|congenital malformations
4722609|NCT03094793|abnormal EEGs (AIC)|abnormal eegs (aic)
4722610|NCT03094767|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
4722611|NCT03094767|Heart Rate Variability|heart rate variability
4722612|NCT03094767|Rehabilitation|rehabilitation
4722613|NCT03094767|Hemoglobin Glycated|hemoglobin glycated
4722614|NCT03094715|Mechanical thrombectomy|mechanical thrombectomy
4722615|NCT03094715|Endovascular thrombectomy|endovascular thrombectomy
4722616|NCT03094689|Physical activity|physical activity
4722617|NCT03094689|Muscle pain|muscle pain
4722618|NCT03094689|Cryotherapy|cryotherapy
4722619|NCT03094676|Massage|massage
4722620|NCT03094676|Autonomic nervous system|autonomic nervous system
4722621|NCT03094676|Recovery of Physiological Function|recovery of physiological function
4722622|NCT03094676|Heart Rate|heart rate
4722623|NCT03094663|IPACK|ipack
4722624|NCT03094663|PAI|pai
4722625|NCT03094650|stroke|stroke
4722626|NCT03094650|neurorehabilitation|neurorehabilitation
4722627|NCT03094650|virtual reality|virtual reality
4722628|NCT03094650|rehabilitation dose|rehabilitation dose
4722629|NCT03094650|motor rehabilitation|motor rehabilitation
4722630|NCT03094637|Hematopoietic/Lymphoid Cancer|hematopoietic/lymphoid cancer
4722631|NCT03094637|Myelodysplastic Syndrome|myelodysplastic syndrome
4722632|NCT03094637|MDS|mds
4722633|NCT03094637|Higher risk|higher risk
4722634|NCT03094637|Azacitidine|azacitidine
4722635|NCT03094637|5-azacytidine|5-azacytidine
4722636|NCT03094637|5-aza|5-aza
4722637|NCT03094637|Vidaza|vidaza
4722638|NCT03094637|5-AZC|5-azc
4722639|NCT03094637|AZA-CR|aza-cr
4722640|NCT03094637|Ladakamycin|ladakamycin
4722641|NCT03094637|NSC-102816|nsc-102816
4722642|NCT03094637|Azacytidine|azacytidine
4722643|NCT03094637|Pembrolizumab|pembrolizumab
4722644|NCT03094637|Keytruda|keytruda
4722645|NCT03094637|MK-3475|mk-3475
4722646|NCT03094637|SCH-900475|sch-900475
4722647|NCT03094624|Amusia|amusia
4722648|NCT03094624|Audition|audition
4722649|NCT03094624|Short-term memory|short-term memory
4722650|NCT03094624|Emotions|emotions
4722651|NCT03094624|EEG|eeg
4722652|NCT03094624|MEG|meg
4722653|NCT03094624|MRI|mri
4722654|NCT03094611|Acute lymphocytic leukemia|acute lymphocytic leukemia
4722655|NCT03094611|ALL|all
4722656|NCT03094611|CD22-positive|cd22-positive
4722657|NCT03094611|Inotuzumab Ozogamicin|inotuzumab ozogamicin
4722658|NCT03094611|CMC-544|cmc-544
4722659|NCT03094585|Healthy nurses|healthy nurses
4722660|NCT03094572|spinal cord circuitry|spinal cord circuitry
4722661|NCT03094572|hemiplegia|hemiplegia
4722662|NCT03094572|rhythmic task|rhythmic task
4722663|NCT03094559|peripheral arterial disease|peripheral arterial disease
4722664|NCT03094546|subjective cognitive decline|subjective cognitive decline
4722665|NCT03094546|Alzheimer's disease, dementia|alzheimer's disease, dementia
4722666|NCT03094546|dietary supplement|dietary supplement
4722667|NCT03094546|polyamine|polyamine
4722668|NCT03094546|prevention|prevention
4722669|NCT03094546|treatment|treatment
4722670|NCT03094546|lifestyle|lifestyle
4722671|NCT03094546|memory|memory
4722672|NCT03094546|autophagy|autophagy
4722673|NCT03094533|Anesthesia, intravenous|anesthesia, intravenous
4722674|NCT03094533|Anesthesia, inhalation|anesthesia, inhalation
4722675|NCT03094533|propofol|propofol
4722676|NCT03094533|sevoflurane|sevoflurane
4722677|NCT03094533|glucose|glucose
4722678|NCT03094468|terbinafine nail solution|terbinafine nail solution
4722679|NCT03094468|nail fungal infection|nail fungal infection
4722680|NCT03094468|topical antifungal drug|topical antifungal drug
4722681|NCT03094455|Tele-rehabilitation|tele-rehabilitation
4722682|NCT03094455|Action Observation|action observation
4722683|NCT03094455|Mirror neurons|mirror neurons
4722684|NCT03094455|ICT|ict
4722685|NCT03094442|Quality of Recovery|quality of recovery
4722686|NCT03094442|Minimally Invasive Sacrocolpopexy|minimally invasive sacrocolpopexy
4722687|NCT03094442|Dexamethasone|dexamethasone
4722688|NCT03094377|Multisensory stimulation; motor recovery|multisensory stimulation; motor recovery
4722689|NCT03094364|Constraint-induced movement therapy|constraint-induced movement therapy
4722690|NCT03094364|video game|video game
4722691|NCT03094364|virtual reality|virtual reality
4722692|NCT03094364|upper extremity|upper extremity
4722693|NCT03094364|CI therapy|ci therapy
4722694|NCT03094364|rehabilitation|rehabilitation
4722695|NCT03094364|hemiparesis|hemiparesis
4722696|NCT03094364|MS|ms
4722697|NCT03094364|multiple sclerosis|multiple sclerosis
4722698|NCT03094364|progressive multiple sclerosis|progressive multiple sclerosis
4722699|NCT03094364|primary progressive multiple sclerosis|primary progressive multiple sclerosis
4722700|NCT03094364|secondary progressive multiple sclerosis|secondary progressive multiple sclerosis
4722701|NCT03094364|motor|motor
4722702|NCT03094364|physical therapy|physical therapy
4722703|NCT03094364|physiotherapy|physiotherapy
4722704|NCT03094364|occupational therapy|occupational therapy
4722705|NCT03094364|arm|arm
4722706|NCT03094364|hand|hand
4722707|NCT03094351|robot assisted esophagectomy|robot assisted esophagectomy
4722708|NCT03094351|minimally invasive esophagectomy|minimally invasive esophagectomy
4722709|NCT03094351|esophageal cancer|esophageal cancer
4722807|NCT03093909|osteosarcoma|osteosarcoma
4722710|NCT03094338|Psychology, Educational [F02.784.629]|psychology, educational [f02.784.629]
4722711|NCT03094325|Septal Myectomy|septal myectomy
4722712|NCT03094312|SEEG|seeg
4722713|NCT03094312|ISD|isd
4722714|NCT03094312|cognitive disorder|cognitive disorder
4722715|NCT03094312|epilepsy surgery|epilepsy surgery
4722716|NCT03094286|HIV|hiv
4722717|NCT03094286|HIV with cancer patient|hiv with cancer patient
4722718|NCT03094286|D006678|d006678
4722719|NCT03094273|Melanocytic neoplasm|melanocytic neoplasm
4722720|NCT03094273|Biopsy|biopsy
4722721|NCT03094273|Saucerization biopsy|saucerization biopsy
4722722|NCT03094273|Skin lesion|skin lesion
4722723|NCT03094247|Malnutrition|malnutrition
4722724|NCT03094247|Micronutrients|micronutrients
4722725|NCT03094247|Polyunsaturated fatty acids|polyunsaturated fatty acids
4722726|NCT03094247|Ready-to-use therapeutic foods|ready-to-use therapeutic foods
4722727|NCT03094247|Omega-3 fatty acids|omega-3 fatty acids
4722728|NCT03094247|Peanuts|peanuts
4722729|NCT03094195|post-herpetic neuralgia|post-herpetic neuralgia
4722730|NCT03094195|neuropathic pain|neuropathic pain
4722731|NCT03094195|angiotensin II type 2 receptor antagonist|angiotensin ii type 2 receptor antagonist
4722732|NCT03094195|dose ranging|dose ranging
4722733|NCT03094130|Spin|spin
4722734|NCT03094130|Misleading reporting|misleading reporting
4722735|NCT03094130|Misleading interpretation|misleading interpretation
4722736|NCT03094130|Misleading extrapolation|misleading extrapolation
4722737|NCT03094130|phase I/II trials|phase i/ii trials
4722738|NCT03094130|non-randomized trials|non-randomized trials
4722739|NCT03094130|Patients|patients
4722740|NCT03094117|Spin|spin
4722741|NCT03094117|Misleading reporting|misleading reporting
4722742|NCT03094117|Misleading interpretation|misleading interpretation
4722743|NCT03094117|Misleading extrapolation|misleading extrapolation
4722744|NCT03094117|phase I/II trials|phase i/ii trials
4722745|NCT03094117|non-randomized trials|non-randomized trials
4722746|NCT03094117|Patients|patients
4722747|NCT03094104|Spin|spin
4722748|NCT03094104|Misleading reporting|misleading reporting
4722749|NCT03094104|Misleading interpretation|misleading interpretation
4722750|NCT03094104|Misleading extrapolation|misleading extrapolation
4722751|NCT03094104|phase I/II trials|phase i/ii trials
4722752|NCT03094104|non-randomized trials|non-randomized trials
4722753|NCT03094104|Patients|patients
4722754|NCT03094091|Spin|spin
4722755|NCT03094091|Misleading reporting|misleading reporting
4722756|NCT03094091|Misleading interpretation|misleading interpretation
4722757|NCT03094091|Misleading extrapolation|misleading extrapolation
4722758|NCT03094091|phase I/II trials|phase i/ii trials
4722759|NCT03094091|non-randomized trials|non-randomized trials
4722760|NCT03094091|Patients|patients
4722761|NCT03094078|Spin|spin
4722762|NCT03094078|Misleading reporting|misleading reporting
4722763|NCT03094078|Misleading interpretation|misleading interpretation
4722764|NCT03094078|Misleading extrapolation|misleading extrapolation
4722765|NCT03094078|Animal studies|animal studies
4722766|NCT03094078|Cell culture studies|cell culture studies
4722767|NCT03094078|Pre-clinical studies|pre-clinical studies
4722768|NCT03094065|Spin|spin
4722769|NCT03094065|Misleading reporting|misleading reporting
4722770|NCT03094065|Misleading interpretation|misleading interpretation
4722771|NCT03094065|Misleading extrapolation|misleading extrapolation
4722772|NCT03094065|Animal studies|animal studies
4722773|NCT03094065|Cell culture studies|cell culture studies
4722774|NCT03094065|Pre-clinical studies|pre-clinical studies
4722775|NCT03094052|neratinib|neratinib
4722776|NCT03094052|trastuzumab|trastuzumab
4722777|NCT03094052|crofelemer|crofelemer
4722778|NCT03094026|Hematologic cancers|hematologic cancers
4722779|NCT03094026|Hematopoietic cell transplantation|hematopoietic cell transplantation
4722780|NCT03094026|cognitive training|cognitive training
4722781|NCT03094026|genetic knowledge|genetic knowledge
4722782|NCT03094026|genetic attitude|genetic attitude
4722783|NCT03094026|adult cancer survivors|adult cancer survivors
4722784|NCT03094013|psycho-social factors, psychological symptoms|psycho-social factors, psychological symptoms
4722785|NCT03094000|Bulimia Nervosa|bulimia nervosa
4722786|NCT03094000|Binge-Eating|binge-eating
4722787|NCT03094000|Self monitoring|self monitoring
4722788|NCT03094000|Cognitive Behavioral Therapy (CBT)|cognitive behavioral therapy (cbt)
4722789|NCT03094000|Mindfulness|mindfulness
4722790|NCT03093987|Shock|shock
4722791|NCT03093987|Critical Care Ultrasound|critical care ultrasound
4722792|NCT03093987|Lactate|lactate
4722793|NCT03093987|Mortality|mortality
4722794|NCT03093987|Prognosis|prognosis
4722795|NCT03093935|Post-Stroke|post-stroke
4722796|NCT03093935|Neuromodulation|neuromodulation
4722797|NCT03093935|Axillary nerve|axillary nerve
4722798|NCT03093935|Peripheral Nerve Stimulation|peripheral nerve stimulation
4722799|NCT03093922|Gemcitabine|gemcitabine
4722800|NCT03093922|Atezolizumab|atezolizumab
4722801|NCT03093922|Cisplatin|cisplatin
4722802|NCT03093922|16-1621|16-1621
4722803|NCT03093909|Solid Tumors and Pulmonary Metastases|solid tumors and pulmonary metastases
4722804|NCT03093909|aerosol gemcitabine|aerosol gemcitabine
4722805|NCT03093909|aerosol GCB|aerosol gcb
4722806|NCT03093909|Lung metastases|lung metastases
4722808|NCT03093896|almonds|almonds
4722809|NCT03093896|cereal snack|cereal snack
4722810|NCT03093870|Neoplasms|neoplasms
4722811|NCT03093870|Biliary Tract Neoplasms|biliary tract neoplasms
4722812|NCT03093870|Bile Duct Neoplasms|bile duct neoplasms
4722813|NCT03093870|Gallbladder Neoplasms|gallbladder neoplasms
4722814|NCT03093844|Stem Cell Transplant|stem cell transplant
4722815|NCT03093844|Umbilical Cord Blood Transplant|umbilical cord blood transplant
4722816|NCT03093844|Haploidentical CD34+ Selected Cells|haploidentical cd34+ selected cells
4722817|NCT03093805|Hematopoietic Stem Cell Transplant|hematopoietic stem cell transplant
4722818|NCT03093805|Graft Versus Host Disease|graft versus host disease
4722819|NCT03093779|Hearing Loss|hearing loss
4722820|NCT03093779|Deaf|deaf
4722821|NCT03093779|Health Literacy|health literacy
4722822|NCT03093779|Health Information|health information
4722823|NCT03093779|Visual Learning|visual learning
4722824|NCT03093766|Aetiology|aetiology
4722825|NCT03093740|hemodialysis|hemodialysis
4722826|NCT03093740|renal failure|renal failure
4722827|NCT03093740|kidney transplant|kidney transplant
4722828|NCT03093714|Cystic Fibrosis|cystic fibrosis
4722829|NCT03093636|Type 1 Diabetes Mellitus (T1DM)|type 1 diabetes mellitus (t1dm)
4722830|NCT03093636|Continuous Glucose Monitor (CGM)|continuous glucose monitor (cgm)
4722831|NCT03093636|Multiple Daily Injections (MDI)|multiple daily injections (mdi)
4722832|NCT03093636|Insulin Pen|insulin pen
4722833|NCT03093636|inControl Advice|incontrol advice
4722834|NCT03093636|Decision Support System (DSS)|decision support system (dss)
4722835|NCT03093623|physical activity|physical activity
4722836|NCT03093623|abstain from smoking|abstain from smoking
4722837|NCT03093623|human papillomavirus (HPV)|human papillomavirus (hpv)
4722838|NCT03093623|cervical intraepithelial neoplasia (CIN)|cervical intraepithelial neoplasia (cin)
4722839|NCT03093558|adherence|adherence
4722840|NCT03093558|quality of life|quality of life
4722841|NCT03093558|health literacy|health literacy
4722842|NCT03093545|rabies|rabies
4722843|NCT03093545|obese|obese
4722844|NCT03093545|immunoglobulin|immunoglobulin
4722845|NCT03093545|rabies vaccine|rabies vaccine
4722846|NCT03093545|post-exposure|post-exposure
4722847|NCT03093545|immunogenicity|immunogenicity
4722848|NCT03093532|emergency department|emergency department
4722849|NCT03093532|stage 2 hypertension|stage 2 hypertension
4722850|NCT03093532|minorities|minorities
4722851|NCT03093506|Erythropoietin|erythropoietin
4722852|NCT03093506|Randomized controlled trial|randomized controlled trial
4722853|NCT03093506|Human volunteers|human volunteers
4722854|NCT03093506|Mitochondrial function|mitochondrial function
4722855|NCT03093506|Cognitive performance|cognitive performance
4722856|NCT03093467|Internet|internet
4722857|NCT03093467|Mental Health|mental health
4722858|NCT03093441|High-intensity interval training|high-intensity interval training
4722859|NCT03093441|cardiometabolic|cardiometabolic
4722860|NCT03093441|physical performance|physical performance
4722861|NCT03093441|psychosocial adaptation|psychosocial adaptation
4722862|NCT03093428|Prostate Cancer|prostate cancer
4722863|NCT03093415|Hepatitis C|hepatitis c
4722864|NCT03093415|HCV|hcv
4722865|NCT03093415|People Who Inject Drugs|people who inject drugs
4722866|NCT03093415|PWID|pwid
4722867|NCT03093415|Medication Assisted Therapy|medication assisted therapy
4722868|NCT03093415|MAT|mat
4722869|NCT03093415|Needle Exchange Program|needle exchange program
4722870|NCT03093402|JBT-101 (also known as lenabasum)|jbt-101 (also known as lenabasum)
4722871|NCT03093402|efficacy|efficacy
4722872|NCT03093402|musculoskeletal disease|musculoskeletal disease
4722873|NCT03093402|randomized trial|randomized trial
4722874|NCT03093376|Anxiety|anxiety
4722875|NCT03093376|Effortful Control|effortful control
4722876|NCT03093376|Preschool|preschool
4722877|NCT03093376|ERN|ern
4722878|NCT03093350|Breast Cancer|breast cancer
4722879|NCT03093350|Tumor Associated Antigen Specific T cells|tumor associated antigen specific t cells
4722880|NCT03093337|Neuromotor sequelae|neuromotor sequelae
4722881|NCT03093337|Cognitive disorders|cognitive disorders
4722882|NCT03093337|Cerebral development|cerebral development
4722883|NCT03093337|Psychomotoricity|psychomotoricity
4722884|NCT03093337|Postural management|postural management
4722885|NCT03093337|Motor coordination|motor coordination
4722886|NCT03093337|Parenthood|parenthood
4722887|NCT03093324|Relapsing Remitting Multiple Sclerosis|relapsing remitting multiple sclerosis
4722888|NCT03093324|RRMS|rrms
4722889|NCT03093324|Multiple Sclerosis|multiple sclerosis
4722890|NCT03093324|MS|ms
4722891|NCT03093324|Alkermes|alkermes
4722892|NCT03093324|ALKS 8700|alks 8700
4722893|NCT03093324|Dimethyl Fumarate|dimethyl fumarate
4722894|NCT03093324|DMF|dmf
4722895|NCT03093324|Tecfidera|tecfidera
4722896|NCT03093311|Near-Infrared Spectroscopy|near-infrared spectroscopy
4722897|NCT03093311|Neurosurgical Procedures|neurosurgical procedures
4722898|NCT03093311|Cognitive Dysfunction|cognitive dysfunction
4722899|NCT03093272|Prostate Cancer|prostate cancer
4722900|NCT03093259|ABX464|abx464
4722901|NCT03093259|Ulcerative Colitis|ulcerative colitis
4722902|NCT03093259|Refractory|refractory
4722903|NCT03093246|Full-mouth ultrasonic debridement|full-mouth ultrasonic debridement
4722904|NCT03093246|Aspirin|aspirin
4722905|NCT03093246|Omega-3 polyunsaturated fatty acids|omega-3 polyunsaturated fatty acids
4723104|NCT03091699|Exercise|exercise
4722906|NCT03093246|Non-surgical therapy|non-surgical therapy
4722907|NCT03093207|Aggressive periodontitis|aggressive periodontitis
4722908|NCT03093207|Aspirin|aspirin
4722909|NCT03093207|Omega-3 polyunsaturated fatty acids|omega-3 polyunsaturated fatty acids
4722910|NCT03093207|Surgical therapy|surgical therapy
4722911|NCT03093142|transcranial direct current stimulation (tDCs)|transcranial direct current stimulation (tdcs)
4722912|NCT03093142|neurofeedback|neurofeedback
4722913|NCT03093116|ALK Gene Rearrangement|alk gene rearrangement
4722914|NCT03093116|ROS1 Gene Rearrangement|ros1 gene rearrangement
4722915|NCT03093116|NTRK 1/2/3 Gene Rearrangement|ntrk 1/2/3 gene rearrangement
4722916|NCT03093103|empagliflozin|empagliflozin
4722917|NCT03093103|kidney|kidney
4722918|NCT03093103|BOLD-MRI|bold-mri
4722919|NCT03093090|furosemide|furosemide
4722920|NCT03093051|Termination|termination
4722921|NCT03093051|Unpinning|unpinning
4722922|NCT03093051|Therapy|therapy
4722923|NCT03093025|Major Depressive Disorder|major depressive disorder
4722924|NCT03093025|Adjunctive Treatment|adjunctive treatment
4722925|NCT03092999|Pharmacokinetics|pharmacokinetics
4722926|NCT03092960|Latino|latino
4722927|NCT03092960|Male|male
4722928|NCT03092908|calcium oxalate|calcium oxalate
4722929|NCT03092908|nephrolithiasis|nephrolithiasis
4722930|NCT03092908|Mature vinegar|mature vinegar
4722931|NCT03092908|prophylaxis|prophylaxis
4722932|NCT03092869|Feet|feet
4722933|NCT03092869|Ankle|ankle
4722934|NCT03092869|Balance|balance
4722935|NCT03092869|Manual Therapy|manual therapy
4722936|NCT03092869|Older Adult|older adult
4722937|NCT03092830|SCC|scc
4722938|NCT03092830|BCC|bcc
4722939|NCT03092830|DNA|dna
4722940|NCT03092830|RNA|rna
4722941|NCT03092830|HEDGE HOG|hedge hog
4722942|NCT03092830|epidermal growth factor receptor|epidermal growth factor receptor
4722943|NCT03092817|Tuberculosis|tuberculosis
4722944|NCT03092817|tuberculous meningitis|tuberculous meningitis
4722945|NCT03092817|drug induced liver injury|drug induced liver injury
4722946|NCT03092817|HIV|hiv
4722947|NCT03092817|IRIS|iris
4722948|NCT03092817|randomized controlled trial|randomized controlled trial
4722949|NCT03092817|dexamethasone|dexamethasone
4722950|NCT03092804|Shunting|shunting
4722951|NCT03092804|Brain constructure|brain constructure
4722952|NCT03092804|Neural network|neural network
4722953|NCT03092791|Drug Therapy|drug therapy
4722954|NCT03092778|Cryoablation|cryoablation
4722955|NCT03092778|Radiology|radiology
4722956|NCT03092765|E6011|e6011
4722957|NCT03092765|Ursodeoxycholic acid|ursodeoxycholic acid
4722958|NCT03092765|Japan|japan
4722959|NCT03092726|ASP8062|asp8062
4722960|NCT03092726|Fibromyalgia|fibromyalgia
4722961|NCT03092713|Cognitive Rehabilitation|cognitive rehabilitation
4722962|NCT03092713|Supported employment|supported employment
4722963|NCT03092713|Mild and moderate TBI|mild and moderate tbi
4722964|NCT03092713|Return to work|return to work
4722965|NCT03092713|Randomized Controlled Trial|randomized controlled trial
4722966|NCT03092687|Mental Illness|mental illness
4722967|NCT03092687|Aging|aging
4722968|NCT03092687|Normal Development|normal development
4722969|NCT03092661|Oxygen saturation|oxygen saturation
4722970|NCT03092661|Pulse oximetry|pulse oximetry
4722971|NCT03092661|Neonate|neonate
4722972|NCT03092661|Infant|infant
4722973|NCT03092622|Exercise Therapy|exercise therapy
4722974|NCT03092609|Attentional Bias to Threat|attentional bias to threat
4722975|NCT03092596|HIV infection|hiv infection
4722976|NCT03092596|drug abuse|drug abuse
4722977|NCT03092596|substance use|substance use
4722978|NCT03092596|alcohol abuse|alcohol abuse
4722979|NCT03092596|screening|screening
4722980|NCT03092596|treatment|treatment
4722981|NCT03092596|primary care|primary care
4722982|NCT03092596|motivational interviewing|motivational interviewing
4722983|NCT03092570|Motor learning|motor learning
4722984|NCT03092570|stroke|stroke
4722985|NCT03092570|tDCS|tdcs
4722986|NCT03092570|upper limb|upper limb
4722987|NCT03092531|HIV|hiv
4722988|NCT03092531|ART Adherence|art adherence
4722989|NCT03092531|Adolescents|adolescents
4722990|NCT03092518|Surgical Resection|surgical resection
4722991|NCT03092518|Progression Free Survival|progression free survival
4722992|NCT03092518|Gastroesophageal Junction (Siewert III) Adenocarcinoma|gastroesophageal junction (siewert iii) adenocarcinoma
4722993|NCT03092505|Herpes|herpes
4722994|NCT03092505|Uganda|uganda
4722995|NCT03092505|HSV|hsv
4722996|NCT03092505|Sample|sample
4722997|NCT03092492|Age Related Macular Degeneration|age related macular degeneration
4722998|NCT03092492|Age Related Macular Degeneration (AMD)|age related macular degeneration (amd)
4722999|NCT03092492|Reticular Pseudodrusen|reticular pseudodrusen
4723000|NCT03092466|femoral nerve block|femoral nerve block
4723001|NCT03092466|elderly patient|elderly patient
4723002|NCT03092466|cognitive impairment|cognitive impairment
4723003|NCT03092466|hip fracture|hip fracture
4723004|NCT03092466|regional anesthesia|regional anesthesia
4723005|NCT03092440|Medical Education|medical education
4723006|NCT03092440|simulation|simulation
4723007|NCT03092440|serious game|serious game
4723008|NCT03092440|validity|validity
4723009|NCT03092401|Liver transplantation|liver transplantation
4723010|NCT03092401|Hepatopulmonary Syndrome|hepatopulmonary syndrome
4723011|NCT03092401|Liver Cirrhosis|liver cirrhosis
4723012|NCT03092388|Sleep-Disordered Breathing|sleep-disordered breathing
4723013|NCT03092388|Heart Failure|heart failure
4723014|NCT03092388|Leg Fluid Shift|leg fluid shift
4723015|NCT03092375|HCV|hcv
4723016|NCT03092375|Previously treated|previously treated
4723017|NCT03092362|persistent atrial fibrillation|persistent atrial fibrillation
4723018|NCT03092362|Heart rate variability|heart rate variability
4723019|NCT03092362|quality of life|quality of life
4723020|NCT03092336|Peripheral Arterial Disease, training|peripheral arterial disease, training
4723021|NCT03092310|Artificial Pancreas|artificial pancreas
4723022|NCT03092271|suicide|suicide
4723023|NCT03092271|suicide attempt|suicide attempt
4723024|NCT03092271|self harm|self harm
4723025|NCT03092271|depression|depression
4723026|NCT03092193|Naproxen|naproxen
4723027|NCT03092193|Association of naproxen-esomeprazole|association of naproxen-esomeprazole
4723028|NCT03092193|High pressure liquid chromatography|high pressure liquid chromatography
4723029|NCT03092193|Cytochrome P450|cytochrome p450
4723030|NCT03092180|Dermatomyositis|dermatomyositis
4723031|NCT03092180|Immunomodulation|immunomodulation
4723032|NCT03092180|Immunosuppressive agents|immunosuppressive agents
4723033|NCT03092180|Myositis|myositis
4723034|NCT03092180|Polymyositis|polymyositis
4723035|NCT03092180|Necrotizing myopathies|necrotizing myopathies
4723036|NCT03092180|Antisynthetase syndrome|antisynthetase syndrome
4723037|NCT03092128|Gastrointestinal stromal tumor (GIST)|gastrointestinal stromal tumor (gist)
4723038|NCT03092128|Imatinib|imatinib
4723039|NCT03092128|Pharmacogenetics|pharmacogenetics
4723040|NCT03092128|Pharmacokinetics|pharmacokinetics
4723041|NCT03092128|Precision medicine|precision medicine
4723042|NCT03092128|Somatic and germ-line mutations|somatic and germ-line mutations
4723043|NCT03092115|Men who have sex with men (MSM)|men who have sex with men (msm)
4723044|NCT03092115|mHealth|mhealth
4723045|NCT03092115|antiretroviral therapy (ART)|antiretroviral therapy (art)
4723046|NCT03092115|native android app|native android app
4723047|NCT03092089|Sonothrombolysis, STEMI, PPCI, Microbubbles|sonothrombolysis, stemi, ppci, microbubbles
4723048|NCT03092076|pharmacokinetics|pharmacokinetics
4723049|NCT03092076|antiplatelet effects|antiplatelet effects
4723050|NCT03092076|single nucleotide polymorphism (SNP)|single nucleotide polymorphism (snp)
4723051|NCT03092024|Systemic Sclerosis|systemic sclerosis
4723052|NCT03092024|Scleroderma|scleroderma
4723053|NCT03092024|Hand|hand
4723054|NCT03092024|Intervention|intervention
4723055|NCT03092024|Exercise|exercise
4723056|NCT03091985|Breastshield|breastshield
4723057|NCT03091985|Breastpump|breastpump
4723058|NCT03091985|Breastfeeding|breastfeeding
4723059|NCT03091972|Persistent Atrial Fibrillation|persistent atrial fibrillation
4723060|NCT03091972|Linear ablation|linear ablation
4723061|NCT03091972|Catheter ablation|catheter ablation
4723062|NCT03091972|Contact force|contact force
4723063|NCT03091946|Oatmeal; Post-prandial glycemic response ; Post-prandial insulin response; Post-prandial hunger|oatmeal; post-prandial glycemic response ; post-prandial insulin response; post-prandial hunger
4723064|NCT03091933|allogeneic hematopoietic stem cell transplantation|allogeneic hematopoietic stem cell transplantation
4723065|NCT03091933|relapsed hematopoietic malignancy|relapsed hematopoietic malignancy
4723066|NCT03091933|HLA matched donor|hla matched donor
4723067|NCT03091933|minor histocompatibilty antigen (MiHA)|minor histocompatibilty antigen (miha)
4723068|NCT03091907|Necrotizing enterocolitis|necrotizing enterocolitis
4723069|NCT03091907|Followup|followup
4723070|NCT03091907|Neurodevelopmental impairments|neurodevelopmental impairments
4723071|NCT03091907|Growth impairments|growth impairments
4723072|NCT03091907|Gut function|gut function
4723073|NCT03091907|Behavioural impairments|behavioural impairments
4723074|NCT03091894|Dexmedetomidine|dexmedetomidine
4723075|NCT03091894|Sleep|sleep
4723076|NCT03091894|Endoscopy|endoscopy
4723077|NCT03091894|Propofol|propofol
4723078|NCT03091881|Granisetron|granisetron
4723079|NCT03091881|Spinal induced hypotension|spinal induced hypotension
4723080|NCT03091790|ventral hernia|ventral hernia
4723081|NCT03091790|mesh|mesh
4723082|NCT03091777|bacterial vaginosis|bacterial vaginosis
4723083|NCT03091777|vaginal infection|vaginal infection
4723084|NCT03091777|BV|bv
4723085|NCT03091764|NMIBC|nmibc
4723086|NCT03091764|non-muscle invasive bladder cancer|non-muscle invasive bladder cancer
4723087|NCT03091764|Patient reported outcome|patient reported outcome
4723088|NCT03091764|Symptom burden|symptom burden
4723089|NCT03091764|Questionnaire|questionnaire
4723090|NCT03091751|Factor IX (FIX)|factor ix (fix)
4723091|NCT03091738|sleep|sleep
4723092|NCT03091725|Obesity|obesity
4723093|NCT03091725|Roux-en-Y gastric bypass (RYGB)|roux-en-y gastric bypass (rygb)
4723094|NCT03091725|Very low calorie diet|very low calorie diet
4723095|NCT03091725|Fibroblast growth factor 21 (FGF21)|fibroblast growth factor 21 (fgf21)
4723096|NCT03091712|Degludec|degludec
4723097|NCT03091712|MIDS|mids
4723098|NCT03091712|Mobile Insulin Dosing System|mobile insulin dosing system
4723099|NCT03091712|Glooko|glooko
4723100|NCT03091712|Tresiba|tresiba
4723101|NCT03091712|Tresiba® U-200 FlexTouch®|tresiba® u-200 flextouch®
4723102|NCT03091699|Smoking|smoking
4723103|NCT03091699|Nicotine|nicotine
4723105|NCT03091699|Cognition|cognition
4723106|NCT03091686|Sedentary Behaviour|sedentary behaviour
4723107|NCT03091686|Health Behaviour Change|health behaviour change
4723108|NCT03091686|Health Action Process Approach|health action process approach
4723109|NCT03091686|Intervention|intervention
4723110|NCT03091686|Prolonged Sitting|prolonged sitting
4723111|NCT03091686|Light Intensity Physical Activity|light intensity physical activity
4723112|NCT03091686|Motivational Factors|motivational factors
4723113|NCT03091686|Intentions|intentions
4723114|NCT03091686|Diabetes|diabetes
4723115|NCT03091686|Self-Efficacy|self-efficacy
4723116|NCT03091686|Risk Perception|risk perception
4723117|NCT03091686|Outcome Expectancies|outcome expectancies
4723118|NCT03091647|Chinese women|chinese women
4723119|NCT03091647|Cancer-related fatigue|cancer-related fatigue
4723120|NCT03091647|Acupressure|acupressure
4723121|NCT03091634|Xue-Fu-Zhu-Yu Capsule|xue-fu-zhu-yu capsule
4723122|NCT03091634|Qi Stagnation and Blood Stasis syndrome|qi stagnation and blood stasis syndrome
4723123|NCT03091634|National Center for Complementary and Integrative Health|national center for complementary and integrative health
4723124|NCT03091621|Deep Vein Thrombosis|deep vein thrombosis
4723125|NCT03091621|pulmonary embolism|pulmonary embolism
4723126|NCT03091608|Drug-Induced Liver Injury|drug-induced liver injury
4723127|NCT03091582|Psychological Therapy|psychological therapy
4723128|NCT03091556|Drug-Induced Liver Injury|drug-induced liver injury
4723129|NCT03091530|Throwing|throwing
4723130|NCT03091530|Sleeper Stretch|sleeper stretch
4723131|NCT03091530|Balloon Blow|balloon blow
4723132|NCT03091530|GIRD (Glenohumeral internal rotation deficit)|gird (glenohumeral internal rotation deficit)
4723133|NCT03091517|Online lifestyle modification|online lifestyle modification
4723134|NCT03091517|Self-management|self-management
4723135|NCT03091517|HbA1c|hba1c
4723136|NCT03091439|Osteomyelitis|osteomyelitis
4723137|NCT03091439|dalbavancin|dalbavancin
4723138|NCT03091439|antibiotic|antibiotic
4723139|NCT03091400|Memory Disorders|memory disorders
4723140|NCT03091400|Multiple Sclerosis|multiple sclerosis
4723141|NCT03091400|Atomoxetine Hydrochloride|atomoxetine hydrochloride
4723142|NCT03091387|neonates, extubation|neonates, extubation
4723143|NCT03091361|Bacterial imaging|bacterial imaging
4723144|NCT03091361|PPV|ppv
4723145|NCT03091361|Chronic wounds|chronic wounds
4723146|NCT03091309|Inflammatory Bowel Diseases|inflammatory bowel diseases
4723147|NCT03091309|Medication Adherence|medication adherence
4723148|NCT03091309|Crohn Disease|crohn disease
4723149|NCT03091309|Ulcerative Colitis|ulcerative colitis
4723150|NCT03091309|Pregnancy|pregnancy
4723151|NCT03091309|Counselling|counselling
4723152|NCT03091309|Patient Education|patient education
4723153|NCT03091283|time management, anaesthesia training program|time management, anaesthesia training program
4723154|NCT03091270|gliomas|gliomas
4723155|NCT03091270|motor functional cortex|motor functional cortex
4723156|NCT03091270|ZOOMit-fMRI|zoomit-fmri
4723157|NCT03091270|BOLD-fMRI|bold-fmri
4723158|NCT03091257|Multiple Myeloma|multiple myeloma
4723159|NCT03091244|Drug-Induced Liver Injury|drug-induced liver injury
4723160|NCT03091218|Drug-Induced Liver Injury|drug-induced liver injury
4723161|NCT03091192|Papillary Renal Cell Cancer|papillary renal cell cancer
4723162|NCT03091192|AZD6094|azd6094
4723163|NCT03091192|Savolitinib|savolitinib
4723164|NCT03091179|airway management|airway management
4723165|NCT03091179|high flow nasal oxygen|high flow nasal oxygen
4723166|NCT03091179|high flow nasal cannula|high flow nasal cannula
4723167|NCT03091179|THRIVE|thrive
4723168|NCT03091140|Parathyroidectomy|parathyroidectomy
4723169|NCT03091140|Muscular Functional Characteristics|muscular functional characteristics
4723170|NCT03091140|Parathyroid Glands|parathyroid glands
4723171|NCT03091114|fractures, risk prediction|fractures, risk prediction
4723172|NCT03091101|keratoconus|keratoconus
4723173|NCT03091101|corneal innervation|corneal innervation
4723174|NCT03091101|scleral contact lenses|scleral contact lenses
4723175|NCT03091075|Rotator Cuff Tear|rotator cuff tear
4723176|NCT03091075|Rotator Cuff|rotator cuff
4723177|NCT03091075|Anabolic Steroid|anabolic steroid
4723178|NCT03091075|Testosterone|testosterone
4723179|NCT03091075|Oxandrolone|oxandrolone
4723180|NCT03091049|coronary|coronary
4723181|NCT03091049|catheterization|catheterization
4723182|NCT03091049|transradial|transradial
4723183|NCT03091049|anesthesia|anesthesia
4723184|NCT03091036|Chronic|chronic
4723185|NCT03091036|Complex|complex
4723186|NCT03091023|Endometrial receptivity|endometrial receptivity
4723187|NCT03091023|Transcriptomic|transcriptomic
4723188|NCT03091023|Single cell|single cell
4723189|NCT03091023|Endometrial fluid|endometrial fluid
4723190|NCT03090997|resveratrol, vitamin C, antioxidant therapy, antioxidant capacity|resveratrol, vitamin c, antioxidant therapy, antioxidant capacity
4723191|NCT03090984|Hemodialysis|hemodialysis
4723192|NCT03090984|Coagulation activation|coagulation activation
4723193|NCT03090958|technology|technology
4723194|NCT03090958|app|app
4723195|NCT03090958|YMSM|ymsm
4723196|NCT03090958|HIV|hiv
4723197|NCT03090945|Endoscopy|endoscopy
4723198|NCT03090945|GI Bleeding|gi bleeding
4723199|NCT03090945|Pediatrics|pediatrics
4723200|NCT03090945|Upper Gastrointestinal Bleeding|upper gastrointestinal bleeding
4723201|NCT03090945|Gastro Intestinal Bleeding|gastro intestinal bleeding
4723202|NCT03090906|volume gain|volume gain
4723203|NCT03090906|soft tissue augmentation|soft tissue augmentation
4723204|NCT03090906|dental implants|dental implants
4723205|NCT03090906|histology|histology
4723206|NCT03090880|Low-molecular-weight Heparin|low-molecular-weight heparin
4723207|NCT03090880|Tinzaparin|tinzaparin
4723208|NCT03090867|Clinical Practice Guideline|clinical practice guideline
4723209|NCT03090867|Critical care|critical care
4723210|NCT03090867|Family-centered care|family-centered care
4723211|NCT03090867|Professional-family relations|professional-family relations
4723212|NCT03090867|Family nursing|family nursing
4723213|NCT03090867|Anxiety|anxiety
4723214|NCT03090867|Depression|depression
4723215|NCT03090867|Participation in care|participation in care
4723216|NCT03090854|Alzheimer's Disease|alzheimer's disease
4723217|NCT03090854|Cognition|cognition
4723218|NCT03090854|Cholinergic target|cholinergic target
4723219|NCT03090841|Cytomegalovirus Congenital|cytomegalovirus congenital
4723220|NCT03090841|Non-invasive diagnosis|non-invasive diagnosis
4723221|NCT03090841|Omics|omics
4723222|NCT03090841|Biomarkers|biomarkers
4723223|NCT03090828|economic evaluation|economic evaluation
4723224|NCT03090828|e health|e health
4723225|NCT03090815|Circulating Tumor DNA|circulating tumor dna
4723226|NCT03090815|Prognostic|prognostic
4723227|NCT03090815|Molecular tests|molecular tests
4723228|NCT03090802|Human Immunodeficiency Virus|human immunodeficiency virus
4723229|NCT03090802|resilience|resilience
4723230|NCT03090802|adolescent mothers|adolescent mothers
4723231|NCT03090802|Sub-Saharan Africa|sub-saharan africa
4723232|NCT03090802|intimate partner violence|intimate partner violence
4723233|NCT03090802|postpartum period|postpartum period
4723234|NCT03090789|Friedreich Ataxia|friedreich ataxia
4723235|NCT03090789|Neuro-degenerative disease|neuro-degenerative disease
4723236|NCT03090698|osteoarthritis|osteoarthritis
4723237|NCT03090698|knee|knee
4723238|NCT03090698|treatment|treatment
4723239|NCT03090685|Chikungunya Fever|chikungunya fever
4723240|NCT03090685|Pain|pain
4723241|NCT03090685|Mobility Limitation|mobility limitation
4723242|NCT03090685|Auriculotherapy|auriculotherapy
4723243|NCT03090685|Complementary Therapies|complementary therapies
4723244|NCT03090685|Physical Therapy|physical therapy
4723245|NCT03090672|Arthritis|arthritis
4723246|NCT03090672|Degenerative|degenerative
4723247|NCT03090672|Tendinosis|tendinosis
4723248|NCT03090672|Jont disease|jont disease
4723249|NCT03090672|Low back pain|low back pain
4723250|NCT03090659|multiple myeloma|multiple myeloma
4723251|NCT03090659|BCMA|bcma
4723252|NCT03090659|CAR-T|car-t
4723253|NCT03090646|social behavioral|social behavioral
4723254|NCT03090646|living donor kidney transplant|living donor kidney transplant
4723255|NCT03090646|follow-up|follow-up
4723256|NCT03090646|health utilization|health utilization
4723257|NCT03090646|incentives|incentives
4723258|NCT03090633|Fetoscopy|fetoscopy
4723259|NCT03090633|Fetal surgery|fetal surgery
4723260|NCT03090633|Fetal spina bifida|fetal spina bifida
4723261|NCT03090594|Cryoprobe|cryoprobe
4723262|NCT03090594|Bronchoscopy|bronchoscopy
4723263|NCT03090594|Acute cellular rejection|acute cellular rejection
4723264|NCT03090581|Graft Rejection/diagnosis|graft rejection/diagnosis
4723265|NCT03090581|Lung Transplantation|lung transplantation
4723266|NCT03090581|Cryoprobe|cryoprobe
4723267|NCT03090555|adhesive capsulitis|adhesive capsulitis
4723268|NCT03090555|clinical trial|clinical trial
4723269|NCT03090555|manipulation|manipulation
4723270|NCT03090529|Exercise training|exercise training
4723271|NCT03090529|Ambulatory blood pressure|ambulatory blood pressure
4723272|NCT03090529|Resistant Hypertension|resistant hypertension
4723273|NCT03090529|Nitric Oxide|nitric oxide
4723274|NCT03090516|Ginkgo biloba dispersible tablets|ginkgo biloba dispersible tablets
4723275|NCT03090516|Alzheimer's|alzheimer's
4723276|NCT03090503|Antipsychotic agents|antipsychotic agents
4723277|NCT03090503|Treatment|treatment
4723278|NCT03090503|Effectiveness|effectiveness
4723279|NCT03090503|Aripiprazole|aripiprazole
4723280|NCT03090503|Risperidone|risperidone
4723281|NCT03090490|Treatment|treatment
4723282|NCT03090490|Maintenance|maintenance
4723283|NCT03090464|Type 2 diabetes mellitus|type 2 diabetes mellitus
4723284|NCT03090464|Digital disease management|digital disease management
4723285|NCT03090464|T2DM|t2dm
4723286|NCT03090464|Hyperglycemia|hyperglycemia
4723287|NCT03090464|Diabetes mellitus|diabetes mellitus
4723288|NCT03090451|Insulin|insulin
4723289|NCT03090451|Glucose Clamp|glucose clamp
4723290|NCT03090451|Glucose Tracer|glucose tracer
4723291|NCT03090451|Artificial Pancreas|artificial pancreas
4723292|NCT03090451|Exercise|exercise
4723293|NCT03090451|Aerobic|aerobic
4723294|NCT03090399|Goal Directed Fluid Therapy|goal directed fluid therapy
4723295|NCT03090373|Catheter|catheter
4723296|NCT03090373|UTI's|uti's
4723297|NCT03090360|Healthy babies|healthy babies
4723298|NCT03090360|Infant formula|infant formula
4723299|NCT03090360|Growth|growth
4723300|NCT03090334|beta-d-glucan|beta-d-glucan
4723301|NCT03090334|abdominal candidiasis|abdominal candidiasis
4723302|NCT03090321|fitness|fitness
4723303|NCT03090321|health|health
4723304|NCT03090321|activity|activity
4723305|NCT03090321|heart risk|heart risk
4723306|NCT03090321|wellness|wellness
4723307|NCT03090282|mechanical treatment|mechanical treatment
4723308|NCT03090282|implant|implant
4723309|NCT03090269|cocaine|cocaine
4723310|NCT03090269|methylphenidate|methylphenidate
4723311|NCT03090269|psychostimulant|psychostimulant
4723312|NCT03090269|ADHD|adhd
4723313|NCT03090269|effective dose|effective dose
4723314|NCT03090269|pharmacokinetics|pharmacokinetics
4723315|NCT03090269|crack|crack
4723316|NCT03090243|Glaucoma|glaucoma
4723317|NCT03090243|Intraocular pressure|intraocular pressure
4723318|NCT03090243|Colonoscopy|colonoscopy
4723319|NCT03090243|Virtual Colonoscopy|virtual colonoscopy
4723320|NCT03090243|Valsalva|valsalva
4723321|NCT03090230|Descending Thoracic Aorta|descending thoracic aorta
4723322|NCT03090230|DTA|dta
4723323|NCT03090230|Transection|transection
4723324|NCT03090230|Traumatic Injury of the Descending Thoracic Aorta|traumatic injury of the descending thoracic aorta
4723325|NCT03090217|Radiotherapy|radiotherapy
4723326|NCT03090217|Brachytherapy|brachytherapy
4723327|NCT03090217|Physiotherapy|physiotherapy
4723328|NCT03090217|Vaginal dilators|vaginal dilators
4723329|NCT03090217|Pelvic floor exercises|pelvic floor exercises
4723330|NCT03090217|Vaginal Stenosis|vaginal stenosis
4723331|NCT03090204|strain|strain
4723332|NCT03090204|myocarditic deformation imaging|myocarditic deformation imaging
4723333|NCT03090204|right ventricle (RV)|right ventricle (rv)
4723334|NCT03090204|systolic RV function|systolic rv function
4723335|NCT03090204|preload dependence|preload dependence
4723336|NCT03090204|contractility|contractility
4723337|NCT03090204|intermittent hemodialysis (HDI)|intermittent hemodialysis (hdi)
4723338|NCT03090165|Triple Negative Breast Neoplasms|triple negative breast neoplasms
4723339|NCT03090165|ribociclib|ribociclib
4723340|NCT03090165|LEE011|lee011
4723341|NCT03090165|CDK 4/6 inhibitor|cdk 4/6 inhibitor
4723342|NCT03090165|bicalutamide|bicalutamide
4723343|NCT03090152|Total Hip Replacement|total hip replacement
4723344|NCT03090152|Total Hip Arthroplasty|total hip arthroplasty
4723345|NCT03090139|Drug therapy|drug therapy
4723346|NCT03090113|Stroke|stroke
4723347|NCT03090113|Embolic Stroke|embolic stroke
4723348|NCT03090113|Shuxuetong|shuxuetong
4723349|NCT03090113|Recurrence|recurrence
4723350|NCT03090113|Symptomatic New Cerebral Infarction|symptomatic new cerebral infarction
4723351|NCT03090113|Asymptomatic New Cerebral Infarction|asymptomatic new cerebral infarction
4723352|NCT03090087|Diameter of retinal arteries|diameter of retinal arteries
4723353|NCT03090087|Adenosine|adenosine
4723354|NCT03090087|Hypoxia|hypoxia
4723355|NCT03090035|HCV genotype 2, HCV genotype 3, IL-28B, PEG-INF.|hcv genotype 2, hcv genotype 3, il-28b, peg-inf.
4723356|NCT03090009|Peri-implant Mucositis|peri-implant mucositis
4723357|NCT03090009|NSAID|nsaid
4723358|NCT03090009|Microbiome|microbiome
4723359|NCT03090009|16s Ribosomal Pyro-sequencing|16s ribosomal pyro-sequencing
4723360|NCT03089996|piezocision|piezocision
4723361|NCT03089996|corticotomy|corticotomy
4723362|NCT03089996|Gingival Crevicular Fluid|gingival crevicular fluid
4723363|NCT03089983|prison|prison
4723364|NCT03089957|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
4723365|NCT03089957|Critical Illness|critical illness
4723366|NCT03089957|Randomized Controlled Trial|randomized controlled trial
4723367|NCT03089957|Ulinastatin|ulinastatin
4723368|NCT03089944|Hepatitis C Virus (HCV)|hepatitis c virus (hcv)
4723369|NCT03089944|Glecaprevir|glecaprevir
4723370|NCT03089944|Pibrentasvir|pibrentasvir
4723371|NCT03089944|Treatment Naïve|treatment naïve
4723372|NCT03089944|Cirrhosis|cirrhosis
4723373|NCT03089944|Compensated Cirrhosis|compensated cirrhosis
4723374|NCT03089944|Genotype (GT) 1-6|genotype (gt) 1-6
4723375|NCT03089944|Pangenotypic|pangenotypic
4723376|NCT03089944|Chronic Hepatitis C Virus (HCV)|chronic hepatitis c virus (hcv)
4723377|NCT03089879|Immunogenicity, Vaccine|immunogenicity, vaccine
4723378|NCT03089879|Immunologic Memory|immunologic memory
4723379|NCT03089879|GMMA|gmma
4723380|NCT03089879|Shigella Vaccines|shigella vaccines
4723381|NCT03089879|Shigellosis|shigellosis
4723382|NCT03089879|Dysentery, Bacillary|dysentery, bacillary
4723383|NCT03089879|Healthy Volunteers|healthy volunteers
4723384|NCT03089879|Safety|safety
4723385|NCT03089879|Bacteria|bacteria
4723386|NCT03089879|Clinical Trials, Phase 1|clinical trials, phase 1
4723387|NCT03089879|Shigella sonnei|shigella sonnei
4723388|NCT03089866|Central nervous System|central nervous system
4723389|NCT03089866|Memory functions|memory functions
4723390|NCT03089866|Executive functions|executive functions
4723391|NCT03089866|Cognitive impairment|cognitive impairment
4723392|NCT03089853|COPD|copd
4723393|NCT03089853|pulmonary rehabilitation|pulmonary rehabilitation
4723394|NCT03089853|telehealth|telehealth
4723395|NCT03089853|smart|smart
4723396|NCT03089853|technology|technology
4723397|NCT03089853|NEMS|nems
4723398|NCT03089853|acute exacerbation|acute exacerbation
4723399|NCT03089840|normothermic perfusion|normothermic perfusion
4723400|NCT03089840|liver transplantation|liver transplantation
4723401|NCT03089827|Memory|memory
4723402|NCT03089814|tissue oxygen saturation, ischemic conditioning|tissue oxygen saturation, ischemic conditioning
4723403|NCT03089801|health care access|health care access
4723404|NCT03089801|eHealth|ehealth
4723405|NCT03089801|telehealth|telehealth
4723406|NCT03089775|Contact|contact
4723407|NCT03089775|Treatment|treatment
4723408|NCT03089775|Prevention|prevention
4723409|NCT03089775|BBI-2000|bbi-2000
4723410|NCT03089775|Dermatitis|dermatitis
4723411|NCT03089775|Allergic|allergic
4723412|NCT03089736|Pain|pain
4723413|NCT03089736|Head and neck cancer|head and neck cancer
4723414|NCT03089736|depression|depression
4723415|NCT03089736|anxiety|anxiety
4723416|NCT03089736|health|health
4723417|NCT03089736|catastrophizing|catastrophizing
4723418|NCT03089723|carpometacarpal joint ostearthritis|carpometacarpal joint ostearthritis
4723419|NCT03089723|hyaluronic acid|hyaluronic acid
4723420|NCT03089723|Rhizarthrosis|rhizarthrosis
4723421|NCT03089697|N-Rephasin SAL200|n-rephasin sal200
4723422|NCT03089697|Methicillin-Sensitive Staphylococcus aureus|methicillin-sensitive staphylococcus aureus
4723423|NCT03089697|Methicillin Resistant Staphylococcus Aureus|methicillin resistant staphylococcus aureus
4723424|NCT03089684|NHANES|nhanes
4723425|NCT03089684|Folate|folate
4723426|NCT03089684|Folic Acid|folic acid
4723427|NCT03089671|Vitamin B|vitamin b
4723428|NCT03089671|5% Dextrose in Water|5% dextrose in water
4723429|NCT03089671|Cystoscopy|cystoscopy
4723430|NCT03089671|Ureter|ureter
4723431|NCT03089658|Metastatic Merkel Cell Carcinoma|metastatic merkel cell carcinoma
4723432|NCT03089658|Expanded Access Program|expanded access program
4723433|NCT03089658|Temporary Authorisation for Use|temporary authorisation for use
4723434|NCT03089658|Avelumab|avelumab
4723435|NCT03089632|gluten-free diet|gluten-free diet
4723436|NCT03089632|gluten sensitivity|gluten sensitivity
4723437|NCT03089632|dyspepsia|dyspepsia
4723438|NCT03089632|diabetes mellitus, type 1|diabetes mellitus, type 1
4723439|NCT03089632|gastroparesis|gastroparesis
4723440|NCT03089632|motility|motility
4723441|NCT03089619|Alveolar bone|alveolar bone
4723442|NCT03089619|Bone resorption|bone resorption
4723443|NCT03089619|dental implants|dental implants
4723444|NCT03089593|Thermic Effect of Food|thermic effect of food
4723445|NCT03089593|Energy Expenditure|energy expenditure
4723446|NCT03089593|Ginger|ginger
4723447|NCT03089567|Silver diamine Fluoride|silver diamine fluoride
4723448|NCT03089567|Streptococcus mutans|streptococcus mutans
4723449|NCT03089567|Caries prevention|caries prevention
4723450|NCT03089567|Fluoride|fluoride
4723451|NCT03089528|Direct laryngoscopy|direct laryngoscopy
4723452|NCT03089528|Videolaryngoscopy|videolaryngoscopy
4723453|NCT03089528|Diabetes Mellitus|diabetes mellitus
4723454|NCT03089528|Intubation|intubation
4723455|NCT03089528|Anesthesia|anesthesia
4723456|NCT03089515|World Trade Center|world trade center
4723457|NCT03089515|World Trade Center Survivors|world trade center survivors
4723458|NCT03089502|Exercise|exercise
4723459|NCT03089502|Cardiac Rehabilitation|cardiac rehabilitation
4723460|NCT03089502|Breast Caner|breast caner
4723461|NCT03089502|Left Ventricular Dysfunction|left ventricular dysfunction
4723462|NCT03089502|Trastuzumab|trastuzumab
4723463|NCT03089502|Anthracyclines|anthracyclines
4723464|NCT03089489|Primary graft dysfunction|primary graft dysfunction
4723465|NCT03089489|Lung transplantation|lung transplantation
4723466|NCT03089489|Surfactant Protein|surfactant protein
4723467|NCT03089489|inflammation|inflammation
4723468|NCT03089476|Prevention|prevention
4723469|NCT03089476|Predictors|predictors
4723470|NCT03089463|Diabetes|diabetes
4723471|NCT03089463|Diabetic Foot|diabetic foot
4723472|NCT03089463|Biomechanics|biomechanics
4723473|NCT03089463|Stratification|stratification
4723474|NCT03089463|Diabetes Complications|diabetes complications
4723475|NCT03089463|Diabetes; Neuropathic (Manifestation)|diabetes; neuropathic (manifestation)
4723476|NCT03089463|Risk Factors|risk factors
4723477|NCT03089463|Prospective Studies|prospective studies
4723478|NCT03089424|low back pain, photobiomodulation therapy, LLLT|low back pain, photobiomodulation therapy, lllt
4723479|NCT03089411|myeloma multiple|myeloma multiple
4723480|NCT03089411|newly diagnosed|newly diagnosed
4723481|NCT03089398|Hybrid Coronary Revascularization|hybrid coronary revascularization
4723482|NCT03089398|Coronary Artery Bypass Grafting|coronary artery bypass grafting
4723483|NCT03089398|Percutaneous Coronary Intervention|percutaneous coronary intervention
4723484|NCT03089372|Erectile Dysfunction|erectile dysfunction
4723485|NCT03089372|Low intensity extracorporeal shock wave treatment|low intensity extracorporeal shock wave treatment
4723486|NCT03089359|Unspecific symptoms|unspecific symptoms
4723487|NCT03089359|Soluvent urokinase plasminogen activator receptor|soluvent urokinase plasminogen activator receptor
4723488|NCT03089359|Lactate|lactate
4723489|NCT03089359|Emergency Medical Services|emergency medical services
4723490|NCT03089346|Imaging|imaging
4723491|NCT03089346|Bronchial Remodeling|bronchial remodeling
4723492|NCT03089320|HIV, Heavy drinking, Alcohol Abuse, AIDS|hiv, heavy drinking, alcohol abuse, aids
4723493|NCT03089307|Erectile Dysfunction|erectile dysfunction
4723494|NCT03089307|Low intensity extracorporeal shock wave treatment|low intensity extracorporeal shock wave treatment
4723495|NCT03089294|Erectile Dysfunction|erectile dysfunction
4723496|NCT03089294|Low intensity extracorporeal shock wave treatment|low intensity extracorporeal shock wave treatment
4723497|NCT03089268|sessile serrated polyp|sessile serrated polyp
4723498|NCT03089268|prevalence|prevalence
4723499|NCT03089268|colorectal cancer|colorectal cancer
4723500|NCT03089268|molecular biology|molecular biology
4723501|NCT03089255|Thrombophylaxis|thrombophylaxis
4723502|NCT03089255|Deep Venous Thrombosis|deep venous thrombosis
4723503|NCT03089255|Pulmonary Embolism|pulmonary embolism
4723504|NCT03089255|Lower Leg Trauma|lower leg trauma
4723505|NCT03089229|Topical Cream|topical cream
4723506|NCT03089229|Novel|novel
4723507|NCT03089190|Appetite|appetite
4723508|NCT03089190|Satiety|satiety
4723509|NCT03089190|Energy intake|energy intake
4723510|NCT03089190|Hunger|hunger
4723511|NCT03089190|Peptide|peptide
4723512|NCT03089190|Encapsulation|encapsulation
4723513|NCT03089177|Randomized Controlled Trial|randomized controlled trial
4723514|NCT03089177|Community Gardening|community gardening
4723515|NCT03089177|Health Behavior Change|health behavior change
4723516|NCT03089177|Physical Activity|physical activity
4723517|NCT03089177|Diet|diet
4723518|NCT03089177|Obesity|obesity
4723519|NCT03089177|Cancer Prevention|cancer prevention
4723520|NCT03089177|Neighborhood|neighborhood
4723521|NCT03089151|Pilot Randomized Controlled Trial|pilot randomized controlled trial
4723522|NCT03089151|Community Garden|community garden
4723523|NCT03089151|Health Behavior Change|health behavior change
4723524|NCT03089151|Physical Activity|physical activity
4723525|NCT03089151|Diet|diet
4723526|NCT03089151|Obesity|obesity
4723527|NCT03089151|Neighborhood|neighborhood
4723528|NCT03089151|Microbiome|microbiome
4723529|NCT03089151|Inflammatory biomarkers|inflammatory biomarkers
4723530|NCT03089125|Lung Cancer|lung cancer
4723531|NCT03089099|Metastatic Castration-Resistant Prostate Cancer|metastatic castration-resistant prostate cancer
4723532|NCT03089099|circulating tumor cells|circulating tumor cells
4723533|NCT03089099|Prognosis|prognosis
4723534|NCT03089099|Liquid biopsy|liquid biopsy
4723535|NCT03089086|meningococcal B vaccine|meningococcal b vaccine
4723536|NCT03089086|herd immunity|herd immunity
4723537|NCT03089086|adolescents|adolescents
4723538|NCT03089086|young adults|young adults
4723539|NCT03089086|south australia|south australia
4723540|NCT03089060|Fingertip Amputation|fingertip amputation
4723541|NCT03089060|Fingertip Regeneration|fingertip regeneration
4723542|NCT03089060|Infection|infection
4723543|NCT03089060|Occlusive Dressings|occlusive dressings
4723544|NCT03089060|Pediatric Surgery|pediatric surgery
4723545|NCT03089060|Silicone Finger Cap|silicone finger cap
4723546|NCT03089021|neck pain,|neck pain,
4723547|NCT03088982|Family Medicine|family medicine
4723548|NCT03088982|multimorbidity|multimorbidity
4723549|NCT03088982|prevention|prevention
4723550|NCT03088969|Chronic Low Back Pain|chronic low back pain
4723551|NCT03088969|Function|function
4723552|NCT03088969|Self-efficacy|self-efficacy
4723553|NCT03088969|Return to work|return to work
4723554|NCT03088969|Questionnaire|questionnaire
4723555|NCT03088956|Longitudinal|longitudinal
4723556|NCT03088956|Caregiver|caregiver
4723557|NCT03088956|Cognitive assessments|cognitive assessments
4723558|NCT03088956|Behavioral assessments|behavioral assessments
4723559|NCT03088956|Functional assessments|functional assessments
4723560|NCT03088904|Inactivated influenza vaccine quadrivalent|inactivated influenza vaccine quadrivalent
4723561|NCT03088904|Live, attenuated influenza vaccine quadrivalent|live, attenuated influenza vaccine quadrivalent
4723562|NCT03088904|Monozygotic twins|monozygotic twins
4723563|NCT03088904|Dizygotic twins|dizygotic twins
4723564|NCT03088904|Adults|adults
4723565|NCT03088904|Adolescents|adolescents
4723566|NCT03088891|altitude training|altitude training
4723567|NCT03088891|antioxidants|antioxidants
4723568|NCT03088891|oxidative stress|oxidative stress
4723569|NCT03088891|elite athletes|elite athletes
4723570|NCT03088891|inflammation|inflammation
4723571|NCT03088891|diet|diet
4723572|NCT03088878|Chronic lymphocytic leukemia|chronic lymphocytic leukemia
4723573|NCT03088878|Small lymphocytic lymphoma|small lymphocytic lymphoma
4723574|NCT03088878|Mantle cell lymphoma|mantle cell lymphoma
4723575|NCT03088878|Receptor Tyrosine Kinase-like Orphan Receptor 1 (ROR1)|receptor tyrosine kinase-like orphan receptor 1 (ror1)
4723576|NCT03088878|Bruton Tyrosine Kinase (BTK)|bruton tyrosine kinase (btk)
4723577|NCT03088774|Low back pain|low back pain
4723578|NCT03088761|tracheal tube|tracheal tube
4723579|NCT03088761|cuff pressure|cuff pressure
4723580|NCT03088748|total knee arthroplasty|total knee arthroplasty
4723581|NCT03088722|Contraceptive implant|contraceptive implant
4723582|NCT03088722|Task sharing|task sharing
4723583|NCT03088722|Nigeria|nigeria
4723584|NCT03088709|NHL|nhl
4723585|NCT03088709|Non-Hodgkin Lymphoma|non-hodgkin lymphoma
4723586|NCT03088709|Haploidentical|haploidentical
4723587|NCT03088709|Bone Marrow Transplant|bone marrow transplant
4723588|NCT03088709|Stem Cell Transplant|stem cell transplant
4723589|NCT03088709|Acute Myeloid Leukemia|acute myeloid leukemia
4723590|NCT03088709|Acute Lymphocytic Leukemia|acute lymphocytic leukemia
4723591|NCT03088709|Myelodysplastic Syndrome|myelodysplastic syndrome
4723592|NCT03088709|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
4723593|NCT03088709|GVHD|gvhd
4723594|NCT03088696|laparoscopic|laparoscopic
4723595|NCT03088696|acupuncture|acupuncture
4723596|NCT03088683|sleeve gastrectomy|sleeve gastrectomy
4723597|NCT03088683|liver retractor|liver retractor
4723598|NCT03088683|nathanson|nathanson
4723599|NCT03088683|reveel|reveel
4723600|NCT03088683|liver trauma|liver trauma
4723601|NCT03088657|Cohort study|cohort study
4723602|NCT03088657|early-onset mood disorders|early-onset mood disorders
4723603|NCT03088618|Nasal obstruction|nasal obstruction
4723604|NCT03088618|Septal deformity|septal deformity
4723605|NCT03088618|Septoplasty|septoplasty
4723606|NCT03088618|TnR Mesh|tnr mesh
4723607|NCT03088618|polycaprolactone|polycaprolactone
4723608|NCT03088592|Deep Brain Stimulation|deep brain stimulation
4723609|NCT03088579|radiation shielding|radiation shielding
4723610|NCT03088553|Ganciclovir|ganciclovir
4723611|NCT03088553|trough concentrations|trough concentrations
4723612|NCT03088553|CMV viral load|cmv viral load
4723613|NCT03088553|safety|safety
4723614|NCT03088553|Solid organ transplantation (heart, kidney or liver)|solid organ transplantation (heart, kidney or liver)
4723615|NCT03088514|Hypertension|hypertension
4723616|NCT03088514|Left Ventricular Hypertrophy|left ventricular hypertrophy
4723617|NCT03088514|Endothelial Dysfunction|endothelial dysfunction
4723618|NCT03088514|Nitrate|nitrate
4723619|NCT03088501|Birth cohort, follow-up, IVRS|birth cohort, follow-up, ivrs
4723620|NCT03088488|25-OH vitamin D|25-oh vitamin d
4723621|NCT03088488|RANKL|rankl
4723622|NCT03088488|Osteoprotogerin|osteoprotogerin
4723623|NCT03088488|TNF-α|tnf-α
4723624|NCT03088462|Bipolar Disorder|bipolar disorder
4723625|NCT03088462|Smartphone|smartphone
4723626|NCT03088462|Behavior Therapy|behavior therapy
4723627|NCT03088449|Crohns disease|crohns disease
4723628|NCT03088449|primary non response|primary non response
4723629|NCT03088449|lose of response|lose of response
4723630|NCT03088449|personalising anti-TNF therapy|personalising anti-tnf therapy
4723631|NCT03088449|Anti-TNF|anti-tnf
4723632|NCT03088449|PANTS|pants
4723633|NCT03088449|Biosimilars|biosimilars
4723634|NCT03088436|MRI|mri
4723635|NCT03088436|Breast|breast
4723636|NCT03088423|MRI|mri
4723637|NCT03088423|Stereotactic body radiation therapy|stereotactic body radiation therapy
4723638|NCT03088384|Post Traumatic Stress Disorder|post traumatic stress disorder
4723639|NCT03088384|PTSD|ptsd
4723640|NCT03088384|Combat Trauma|combat trauma
4723641|NCT03088371|Total knee replacement|total knee replacement
4723642|NCT03088371|Psoas Sciatic block|psoas sciatic block
4723643|NCT03088371|Epidural anaesthesia|epidural anaesthesia
4723644|NCT03088345|Fontan Palliation Surgery|fontan palliation surgery
4723645|NCT03088345|Post-Operative Care|post-operative care
4723646|NCT03088319|postnatal depression stress mindfulness allostatic load|postnatal depression stress mindfulness allostatic load
4723647|NCT03088293|idiopathic refractory scleritis|idiopathic refractory scleritis
4723648|NCT03088293|infliximab|infliximab
4723649|NCT03088293|cyclophosphamide|cyclophosphamide
4723650|NCT03088241|randomized clinical trial|randomized clinical trial
4723651|NCT03088241|low level viremia|low level viremia
4723652|NCT03088241|lesotho|lesotho
4723653|NCT03088241|resource-limited setting|resource-limited setting
4723654|NCT03088241|ART first-line failure|art first-line failure
4723655|NCT03088215|Trigger Point Pain, Myofascial|trigger point pain, myofascial
4723656|NCT03088215|shock-waves|shock-waves
4723657|NCT03088215|extracorporeal shock-wave treatment (ESWT)|extracorporeal shock-wave treatment (eswt)
4723658|NCT03088215|pain|pain
4723659|NCT03088215|trigger point|trigger point
4723660|NCT03088215|referred pain|referred pain
4723661|NCT03088202|cancer|cancer
4723662|NCT03088202|palliative care|palliative care
4723663|NCT03088202|PROMs|proms
4723664|NCT03088202|survival|survival
4723665|NCT03088202|QoL|qol
4723666|NCT03088202|referral|referral
4723667|NCT03088189|maternal nutrition|maternal nutrition
4723668|NCT03088189|periconceptional|periconceptional
4723669|NCT03088189|neurocognitive development|neurocognitive development
4723670|NCT03088176|Melanoma|melanoma
4723671|NCT03088176|BRAF inhibitor|braf inhibitor
4723672|NCT03088176|Intratumoral injection|intratumoral injection
4723673|NCT03088176|Talimogene laherparepvec|talimogene laherparepvec
4723674|NCT03088176|MEK inhibitor|mek inhibitor
4723675|NCT03088176|dabrafenib|dabrafenib
4723676|NCT03088176|trametinib|trametinib
4723677|NCT03088150|Hepatic resection|hepatic resection
4723678|NCT03088150|Liver surgery|liver surgery
4723679|NCT03088150|Thermal ablation|thermal ablation
4723680|NCT03088150|Radiofrequency ablation|radiofrequency ablation
4723681|NCT03088150|Microwave ablation|microwave ablation
4723682|NCT03088150|RFA|rfa
4723683|NCT03088150|MWA|mwa
4723684|NCT03088137|in vitro fertilization|in vitro fertilization
4723685|NCT03088111|Anthim®|anthim®
4723686|NCT03088111|Obiltoxaximab|obiltoxaximab
4723687|NCT03088111|anthrax|anthrax
4723688|NCT03088111|anti-toxin|anti-toxin
4723689|NCT03088098|left atrial appendage occlusion|left atrial appendage occlusion
4723690|NCT03088098|transcatheter aortic valve implantation|transcatheter aortic valve implantation
4723691|NCT03088098|atrial fibrillation|atrial fibrillation
4723692|NCT03088072|Edoxaban|edoxaban
4723693|NCT03088072|WATCHMAN device|watchman device
4723694|NCT03088020|CCHS|cchs
4723695|NCT03088020|PHOX2B|phox2b
4723696|NCT03088020|Paired-like Homeobox gene PHOX2B|paired-like homeobox gene phox2b
4723697|NCT03088020|autonomic nervous system dysregulation|autonomic nervous system dysregulation
4723698|NCT03088020|control of breathing|control of breathing
4723699|NCT03088020|Hirschsprung disease|hirschsprung disease
4723700|NCT03088020|neural crest tumors|neural crest tumors
4723701|NCT03088020|neuroblastoma|neuroblastoma
4723702|NCT03088020|ganglioneuroma|ganglioneuroma
4723703|NCT03088020|ganglioneuroblastoma|ganglioneuroblastoma
4723704|NCT03088020|artificial ventilation|artificial ventilation
4723705|NCT03088020|diaphragm pacing|diaphragm pacing
4723706|NCT03088007|Intellectual Deficiency|intellectual deficiency
4723707|NCT03088007|cognitive, adaptive|cognitive, adaptive
4723708|NCT03088007|behavioral and academic profile|behavioral and academic profile
4723709|NCT03088007|regular and special schools|regular and special schools
4723710|NCT03087942|end stage renal disase ESRD|end stage renal disase esrd
4723711|NCT03087942|dialysis effect on pharmacokinetics PK|dialysis effect on pharmacokinetics pk
4723712|NCT03087942|renal impairment|renal impairment
4723713|NCT03087903|Prostate Specific Antigen (PSA)|prostate specific antigen (psa)
4723714|NCT03087903|Non-Metastatic Prostate Cancer|non-metastatic prostate cancer
4723715|NCT03087890|Microbial drug resistance|microbial drug resistance
4723716|NCT03087890|Beta-lactamase|beta-lactamase
4723717|NCT03087890|Cotrimoxazole|cotrimoxazole
4723718|NCT03087890|Trimethoprim-sulfamethoxazole|trimethoprim-sulfamethoxazole
4723719|NCT03087890|Tanzania|tanzania
4723720|NCT03087864|esophageal cancer|esophageal cancer
4723721|NCT03087864|PD-L1 inhibition|pd-l1 inhibition
4723722|NCT03087864|chemoradiation|chemoradiation
4723723|NCT03087851|Denosumab|denosumab
4723724|NCT03087851|Bone Turnover markers|bone turnover markers
4723725|NCT03087851|Drug Holiday|drug holiday
4723726|NCT03087812|Microbiological burden|microbiological burden
4723727|NCT03087812|kidney|kidney
4723728|NCT03087812|stone|stone
4723729|NCT03087812|durability of flexible endoscopes|durability of flexible endoscopes
4723730|NCT03087734|Prostheses and Implants|prostheses and implants
4723731|NCT03087721|Metabolic Syndrome|metabolic syndrome
4723732|NCT03087721|Exercise Training|exercise training
4723733|NCT03087721|Interval Training|interval training
4723734|NCT03087721|Skeletal Muscle|skeletal muscle
4723735|NCT03087721|Risk Factors|risk factors
4723736|NCT03087721|Insulin Resistance|insulin resistance
4723737|NCT03087695|Nasopharyngeal carcinoma|nasopharyngeal carcinoma
4723738|NCT03087695|EBV DNA|ebv dna
4723739|NCT03087695|Chemoradiotherapy|chemoradiotherapy
4723740|NCT03087669|Left Ventricular Assist Device|left ventricular assist device
4723741|NCT03087669|Hemodynamic monitoring|hemodynamic monitoring
4723742|NCT03087656|levofloxacin|levofloxacin
4723743|NCT03087656|Ceftriaxone|ceftriaxone
4723744|NCT03087656|Cholangitis|cholangitis
4723745|NCT03087656|ERCP|ercp
4723746|NCT03087643|Flow-mediated dilation|flow-mediated dilation
4723747|NCT03087643|Passive limb movement|passive limb movement
4723748|NCT03087604|epidural catheter placement|epidural catheter placement
4723749|NCT03087578|overactive bladder, acupuncture|overactive bladder, acupuncture
4723750|NCT03087526|Non Invasive Prenatal Diagnosis (NIPD)|non invasive prenatal diagnosis (nipd)
4723751|NCT03087526|Circulating Fetal Trophoblastic Cells (CFTC)|circulating fetal trophoblastic cells (cftc)
4723752|NCT03087526|Huntington's Disease|huntington's disease
4723753|NCT03087526|Myotonic Dystrophy Type 1|myotonic dystrophy type 1
4723754|NCT03087526|Fragile X syndrome|fragile x syndrome
4723755|NCT03087526|Spinocerebellar Ataxia type 1|spinocerebellar ataxia type 1
4723756|NCT03087526|Spinocerebellar Ataxia type 2|spinocerebellar ataxia type 2
4723757|NCT03087526|Spinocerebellar Ataxia type 3|spinocerebellar ataxia type 3
4723758|NCT03087500|Down Syndrome|down syndrome
4723759|NCT03087500|Typically Developing Participants|typically developing participants
4723760|NCT03087500|Children|children
4723761|NCT03087500|Adolescents|adolescents
4723762|NCT03087500|Adults|adults
4723763|NCT03087448|ALK rearranged|alk rearranged
4723764|NCT03087448|Stage IIIB NSCLC|stage iiib nsclc
4723765|NCT03087448|Stage IV NSCLC|stage iv nsclc
4723766|NCT03087448|ROS-1 rearranged NSCLC|ros-1 rearranged nsclc
4723767|NCT03087396|bone marrow defect|bone marrow defect
4723768|NCT03087396|bone marrow lesion|bone marrow lesion
4723769|NCT03087396|stress fracture|stress fracture
4723770|NCT03087396|calcium phosphate|calcium phosphate
4723771|NCT03087396|bone substitute material|bone substitute material
4723772|NCT03087370|CXCR4 Mutation|cxcr4 mutation
4723773|NCT03087370|Primary immunodeficiency disorder|primary immunodeficiency disorder
4723774|NCT03087370|Warts|warts
4723775|NCT03087370|Hypogammaglobulinemia|hypogammaglobulinemia
4723776|NCT03087370|Infections|infections
4723777|NCT03087370|Myelokathexis|myelokathexis
4723778|NCT03087370|Human papillomavirus (HPV)|human papillomavirus (hpv)
4723779|NCT03087370|Neutropenia|neutropenia
4723780|NCT03087370|Herpes|herpes
4723781|NCT03087344|Postprandial liver and spleen stiffness measurements|postprandial liver and spleen stiffness measurements
4723782|NCT03087344|Transient elastography|transient elastography
4723783|NCT03087344|Cirrhosis|cirrhosis
4723784|NCT03087344|Acoustic radiation force impulse|acoustic radiation force impulse
4723785|NCT03087318|Obstructive sleep apnea (OSA)|obstructive sleep apnea (osa)
4723786|NCT03087318|Overweight and moderate obesity|overweight and moderate obesity
4723787|NCT03087318|Sport prescription|sport prescription
4723788|NCT03087318|Physical activity|physical activity
4723789|NCT03087305|Interventional Pulmonary|interventional pulmonary
4723790|NCT03087305|EBUS-TBNA|ebus-tbna
4723791|NCT03087305|Lung cancer staging|lung cancer staging
4723792|NCT03087292|blood flow restriction|blood flow restriction
4723793|NCT03087292|resistance training|resistance training
4723794|NCT03087292|coronary heart disease|coronary heart disease
4723795|NCT03087240|Disease Activity Score 28 (DAS28)|disease activity score 28 (das28)
4723796|NCT03087240|Health Assessment Questionnaire (HAQ)|health assessment questionnaire (haq)
4723797|NCT03087240|Dental Scaling|dental scaling
4723798|NCT03087240|Dental Polishing|dental polishing
4723799|NCT03087240|Oral Health|oral health
4723800|NCT03087240|Gingival Crevicular Fluid|gingival crevicular fluid
4723801|NCT03087240|Inflammatory Cytokine Profile|inflammatory cytokine profile
4723802|NCT03087240|Biofilm|biofilm
4723803|NCT03087240|Oral Microbiome|oral microbiome
4723804|NCT03087240|Intestinal Microbiome|intestinal microbiome
4723805|NCT03087227|mHealth|mhealth
4723806|NCT03087227|febrile neutropenia|febrile neutropenia
4723807|NCT03087227|neutropenia/chemically induced/*complications|neutropenia/chemically induced/*complications
4723808|NCT03087227|antineoplastic agents/*adverse events|antineoplastic agents/*adverse events
4723809|NCT03087227|Patient readmission|patient readmission
4723810|NCT03087227|disease management|disease management
4723811|NCT03087201|Chronic tic disorders|chronic tic disorders
4723812|NCT03087201|Tourette syndrome|tourette syndrome
4723813|NCT03087149|vitamin D|vitamin d
4723814|NCT03087149|supplementation|supplementation
4723815|NCT03087149|hydroxyvitamin D|hydroxyvitamin d
4723816|NCT03087149|pretrem infants|pretrem infants
4723817|NCT03087149|osteopenia|osteopenia
4723818|NCT03087136|multiple sclerosis|multiple sclerosis
4723819|NCT03087136|pediatric|pediatric
4723820|NCT03087123|single-case design|single-case design
4723821|NCT03087123|children|children
4723822|NCT03087123|health equity|health equity
4723823|NCT03087123|mobile health|mobile health
4723824|NCT03087071|Colorectal cancer|colorectal cancer
4723825|NCT03087071|Colorectal adenocarcinoma|colorectal adenocarcinoma
4723826|NCT03087071|EGFR S492R or other ectodomain mutations in circulating free tumor DNA|egfr s492r or other ectodomain mutations in circulating free tumor dna
4723827|NCT03087071|Detectable KRAS or NRAS mutations in exons 2, 3, or 4; or BRAF codon 600 mutations in circulating free tumor DNA|detectable kras or nras mutations in exons 2, 3, or 4; or braf codon 600 mutations in circulating free tumor dna
4723828|NCT03087071|No detectable mutations in circulating free tumor DNA|no detectable mutations in circulating free tumor dna
4723829|NCT03087071|Panitumumab|panitumumab
4723830|NCT03087071|Vectibix|vectibix
4723831|NCT03087071|Trametinib|trametinib
4723832|NCT03087071|GSK1120212|gsk1120212
4723833|NCT03087058|Treatment of Hyperkalemia|treatment of hyperkalemia
4723834|NCT03087058|Hyperkalemia|hyperkalemia
4723835|NCT03087058|Potassium|potassium
4723836|NCT03087058|Chronic Kidney Disease|chronic kidney disease
4723837|NCT03087032|Liraglutide|liraglutide
4723838|NCT03087032|Insulin Glargine|insulin glargine
4723839|NCT03087032|Prandial Insulin|prandial insulin
4723840|NCT03087019|adenoid cystic carcinoma|adenoid cystic carcinoma
4723841|NCT03086980|health related quality of life|health related quality of life
4723842|NCT03086980|utility|utility
4723843|NCT03086980|regression|regression
4723844|NCT03086967|cervical ripening|cervical ripening
4723845|NCT03086967|double lumen catheter|double lumen catheter
4723846|NCT03086954|CD19 positive lymphoma|cd19 positive lymphoma
4723847|NCT03086915|neuromuscular blockade|neuromuscular blockade
4723848|NCT03086915|muscle relaxation|muscle relaxation
4723849|NCT03086915|muscle relaxant|muscle relaxant
4723850|NCT03086902|Ablation; Cryo Energy; Radofrequency Ablation|ablation; cryo energy; radofrequency ablation
4723851|NCT03086863|electroacupuncture|electroacupuncture
4723852|NCT03086863|randomized controlled trial|randomized controlled trial
4723853|NCT03086824|Bone Metastasis|bone metastasis
4723854|NCT03086811|feeding interaction, infant eating habits, hunger satiety cues, childhood obesity|feeding interaction, infant eating habits, hunger satiety cues, childhood obesity
4723855|NCT03086798|Magill forceps|magill forceps
4723856|NCT03086798|cuff inflation|cuff inflation
4723857|NCT03086798|Nasotracheal Intubation|nasotracheal intubation
4723858|NCT03086746|Remodeling|remodeling
4723859|NCT03086733|Lung Cancer|lung cancer
4723860|NCT03086733|Non small cell lung cancer|non small cell lung cancer
4723861|NCT03086733|Metformin|metformin
4723862|NCT03086733|Pre-operative treatment|pre-operative treatment
4723863|NCT03086733|Neoadjuvant treatments|neoadjuvant treatments
4723864|NCT03086733|Cancer|cancer
4723865|NCT03086733|Phase II|phase ii
4723866|NCT03086720|Adhesive system|adhesive system
4723867|NCT03086720|Controlled clinical trial|controlled clinical trial
4723868|NCT03086720|Dental restoration|dental restoration
4723869|NCT03086720|Noncarious cervical lesions|noncarious cervical lesions
4723870|NCT03086720|Dental restoration failure|dental restoration failure
4723871|NCT03086720|Sodium hypochlorite|sodium hypochlorite
4723872|NCT03086707|nasal mucociliary clearance|nasal mucociliary clearance
4723873|NCT03086707|saccharine transit time|saccharine transit time
4723874|NCT03086694|oromaxillofacial surgery|oromaxillofacial surgery
4723875|NCT03086694|nasotracheal intubation|nasotracheal intubation
4723876|NCT03086694|stroke volume variation|stroke volume variation
4723877|NCT03086681|Cervical carcinoma|cervical carcinoma
4723878|NCT03086681|endostar|endostar
4723879|NCT03086681|concurrent chemoradiotherapy|concurrent chemoradiotherapy
4723880|NCT03086668|Nasotracheal Intubation|nasotracheal intubation
4723881|NCT03086668|jaw thrust|jaw thrust
4723882|NCT03086668|hook-finger|hook-finger
4723883|NCT03086655|biological markers|biological markers
4723884|NCT03086655|monitoring device|monitoring device
4723885|NCT03086655|wireless technology|wireless technology
4723886|NCT03086642|locally advanced pancreatic cancer|locally advanced pancreatic cancer
4723887|NCT03086642|locally advanced pancreas cancer|locally advanced pancreas cancer
4723888|NCT03086642|metastatic pancreatic cancer|metastatic pancreatic cancer
4723889|NCT03086642|metastatic pancreas cancer|metastatic pancreas cancer
4723890|NCT03086642|refractory|refractory
4723891|NCT03086642|refractory pancreatic cancer|refractory pancreatic cancer
4723892|NCT03086642|refractory pancreas cancer|refractory pancreas cancer
4723893|NCT03086642|T-Vec|t-vec
4723894|NCT03086642|T Vec|t vec
4723895|NCT03086616|DIPG|dipg
4723896|NCT03086616|CED|ced
4723897|NCT03086616|glioma|glioma
4723898|NCT03086590|Body composition|body composition
4723899|NCT03086590|Ultrasound|ultrasound
4723900|NCT03086590|Chronic Pulmonary Obstructive Disease|chronic pulmonary obstructive disease
4723901|NCT03086590|Respiratory muscles|respiratory muscles
4723902|NCT03086564|HCC|hcc
4723903|NCT03086564|ADCC|adcc
4723904|NCT03086564|TACE|tace
4723905|NCT03086564|immuno therapy|immuno therapy
4723906|NCT03086551|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
4723907|NCT03086551|Motor Impairment|motor impairment
4723908|NCT03086551|Rehabilitation|rehabilitation
4723909|NCT03086551|Motor Learning|motor learning
4723910|NCT03086525|Chronic pain|chronic pain
4723911|NCT03086525|Psychological factors|psychological factors
4723912|NCT03086525|Musculoskeletal pain|musculoskeletal pain
4723913|NCT03086525|Prognosis|prognosis
4723914|NCT03086499|pectus excavatum|pectus excavatum
4723915|NCT03086486|Tuberculosis|tuberculosis
4723916|NCT03086486|Multi Drug-Resistant Tuberculosis|multi drug-resistant tuberculosis
4723917|NCT03086486|Extensively Drug-Resistant Tuberculosis|extensively drug-resistant tuberculosis
4723918|NCT03086486|Drug-Resistant Tuberculosis|drug-resistant tuberculosis
4723919|NCT03086486|Pretomanid|pretomanid
4723920|NCT03086486|PA-824|pa-824
4723921|NCT03086486|Bedaquiline|bedaquiline
4723922|NCT03086486|Linezolid|linezolid
4723923|NCT03086486|NC-007|nc-007
4723924|NCT03086486|TB Alliance|tb alliance
4723925|NCT03086486|pre-XDR-TB|pre-xdr-tb
4723926|NCT03086473|caffeine|caffeine
4723927|NCT03086473|intubation|intubation
4723928|NCT03086473|hemodynamics|hemodynamics
4723929|NCT03086473|mechanical ventilation|mechanical ventilation
4723930|NCT03086473|cardiac output|cardiac output
4723931|NCT03086473|near infrared spectroscopy|near infrared spectroscopy
4723932|NCT03086473|functional echocardiography|functional echocardiography
4723933|NCT03086434|Culturally tailored intervention|culturally tailored intervention
4723934|NCT03086434|American Indian early adolescents|american indian early adolescents
4723935|NCT03086434|Prevention of substance use|prevention of substance use
4723936|NCT03086421|Childhood cancer|childhood cancer
4723937|NCT03086421|Social functioning|social functioning
4723938|NCT03086421|Social development|social development
4723939|NCT03086408|airway management|airway management
4723940|NCT03086408|high flow nasal oxygen|high flow nasal oxygen
4723941|NCT03086408|high flow nasal cannula|high flow nasal cannula
4723942|NCT03086408|THRIVE|thrive
4723943|NCT03086395|relapsed|relapsed
4723944|NCT03086395|refractory|refractory
4723945|NCT03086382|Lacosamide|lacosamide
4723946|NCT03086382|Syrup|syrup
4723947|NCT03086382|Bioequivalence|bioequivalence
4723948|NCT03086382|Tablet|tablet
4723949|NCT03086343|Musculoskeletal Disease|musculoskeletal disease
4723950|NCT03086343|Arthritis|arthritis
4723951|NCT03086343|Joint Disease|joint disease
4723952|NCT03086343|Anti-inflammatory agents|anti-inflammatory agents
4723953|NCT03086343|Antirheumatic agents|antirheumatic agents
4723954|NCT03086317|Pulmonary Medicine|pulmonary medicine
4723955|NCT03086317|Therapy Evaluation|therapy evaluation
4723956|NCT03086304|postoperative intestinal obstruction;TEAS|postoperative intestinal obstruction;teas
4723957|NCT03086265|airway management|airway management
4723958|NCT03086265|high flow nasal oxygen high flow nasal cannula THRIVE|high flow nasal oxygen high flow nasal cannula thrive
4723959|NCT03086265|high flow nasal cannula THRIVE|high flow nasal cannula thrive
4723960|NCT03086265|THRIVE|thrive
4723961|NCT03086239|Advanced, Recurrent Small Cell Lung Cancer|advanced, recurrent small cell lung cancer
4723962|NCT03086239|Small Cell Lung Cancer|small cell lung cancer
4723963|NCT03086239|Rovalpituzumab tesirine|rovalpituzumab tesirine
4723964|NCT03086239|Cancer|cancer
4723965|NCT03086226|Mycetoma Fosravuconazole Itraconazole Surgery Sudan|mycetoma fosravuconazole itraconazole surgery sudan
4723966|NCT03086213|nonintubated uniport thoracoscopic surgery|nonintubated uniport thoracoscopic surgery
4723967|NCT03086213|paravertebral nerve block|paravertebral nerve block
4723968|NCT03086213|intercostal nerve block|intercostal nerve block
4723969|NCT03086213|peripheral solitary pulmonary nodule|peripheral solitary pulmonary nodule
4723970|NCT03086200|PrEP|prep
4723971|NCT03086200|Pre-exposure Prophylaxis|pre-exposure prophylaxis
4723972|NCT03086200|Text messaging|text messaging
4723973|NCT03086200|Truvada|truvada
4723974|NCT03086200|Motivational interviewing|motivational interviewing
4723975|NCT03086200|Transgender|transgender
4723976|NCT03086200|Gender Non-conforming|gender non-conforming
4723977|NCT03086187|weight bearing|weight bearing
4723978|NCT03086187|muscle unloading|muscle unloading
4723979|NCT03086187|bone loss|bone loss
4723980|NCT03086187|arterial adaptation|arterial adaptation
4723981|NCT03086187|muscular adaptation|muscular adaptation
4723982|NCT03086174|anti-PD-1 monoclonal antibody|anti-pd-1 monoclonal antibody
4723983|NCT03086174|advanced|advanced
4723984|NCT03086174|melanoma|melanoma
4723985|NCT03086174|kidney cancer|kidney cancer
4723986|NCT03086122|OSA|osa
4723987|NCT03086122|Erectile Dysfunction|erectile dysfunction
4723988|NCT03086122|CPAP treatment|cpap treatment
4723989|NCT03086122|Endothelial Dysfunction|endothelial dysfunction
4723990|NCT03086122|Cardiovascular risk|cardiovascular risk
4723991|NCT03086109|prevalence|prevalence
4723992|NCT03086109|Bone Degenerative Disease|bone degenerative disease
4723993|NCT03086083|Traumatic memories|traumatic memories
4723994|NCT03086083|comparative study|comparative study
4723995|NCT03086083|single session|single session
4723996|NCT03086083|EMDR|emdr
4723997|NCT03086083|Beck inventory|beck inventory
4723998|NCT03086070|omeprazole|omeprazole
4723999|NCT03086070|placebo|placebo
4724000|NCT03086070|treatment|treatment
4724001|NCT03086070|adults|adults
4724002|NCT03086057|PrEP|prep
4724003|NCT03086057|Prevention|prevention
4724004|NCT03086057|Male Sex Workers (MSW)|male sex workers (msw)
4724005|NCT03086031|Traumatic brain injury, Vocational rehabilitation, Caregiver intervention,|traumatic brain injury, vocational rehabilitation, caregiver intervention,
4724006|NCT03086005|Metformin|metformin
4724007|NCT03085992|rectal cancer|rectal cancer
4724008|NCT03085992|FOLFOXIRI|folfoxiri
4724009|NCT03085992|bevacizumab|bevacizumab
4724010|NCT03085992|trust|trust
4724011|NCT03085966|central memory T cell|central memory t cell
4724012|NCT03085966|metastatic castration-resistant prostate cancer|metastatic castration-resistant prostate cancer
4724013|NCT03085953|Psychological health|psychological health
4724014|NCT03085953|Well-being|well-being
4724015|NCT03085953|Employee|employee
4724016|NCT03085927|music therapy|music therapy
4724017|NCT03085927|neoplasms|neoplasms
4724018|NCT03085927|play|play
4724019|NCT03085927|children|children
4724020|NCT03085927|parents|parents
4724021|NCT03085914|solid tumors|solid tumors
4724022|NCT03085914|colorectal cancer|colorectal cancer
4724023|NCT03085914|pancreatic ductal adenocarcinoma|pancreatic ductal adenocarcinoma
4724024|NCT03085914|non-small cell lung cancer|non-small cell lung cancer
4724025|NCT03085914|PD-1|pd-1
4724026|NCT03085914|PD-L1|pd-l1
4724027|NCT03085914|epacadostat|epacadostat
4724028|NCT03085914|IDO inhibitor|ido inhibitor
4724029|NCT03085888|Cancer Screening|cancer screening
4724030|NCT03085888|Next Generation Sequencing|next generation sequencing
4724031|NCT03085888|Circulating cell-free nucleic acid|circulating cell-free nucleic acid
4724032|NCT03085888|Circulating cell-free tumor DNA|circulating cell-free tumor dna
4724033|NCT03085888|Deep sequencing|deep sequencing
4724034|NCT03085875|Weight Change|weight change
4724035|NCT03085875|Healthy Pregnancy|healthy pregnancy
4724036|NCT03085875|Physiologic Sensors|physiologic sensors
4724037|NCT03085862|Ultrasonography|ultrasonography
4724038|NCT03085862|Extravascular lung water|extravascular lung water
4724039|NCT03085862|PaO2/FiO2 ratio|pao2/fio2 ratio
4724040|NCT03085836|Drug Therapy|drug therapy
4724041|NCT03085797|SB240563|sb240563
4724042|NCT03085797|Nasal Polyps|nasal polyps
4724043|NCT03085797|Mepolizumab|mepolizumab
4724044|NCT03085797|Phase 3|phase 3
4724045|NCT03085797|Parallel group|parallel group
4724046|NCT03085797|Efficacy|efficacy
4724047|NCT03085758|Early Septic Shock|early septic shock
4724048|NCT03085745|Writer's cramp|writer's cramp
4724049|NCT03085745|Sensorimotor plasticity|sensorimotor plasticity
4724050|NCT03085745|TMS|tms
4724051|NCT03085745|Afferent inhibition|afferent inhibition
4724052|NCT03085745|Motor mapping|motor mapping
4724053|NCT03085745|Sensory mapping|sensory mapping
4724054|NCT03085745|adaptive sensorimotor synergies|adaptive sensorimotor synergies
4724055|NCT03085745|fine motor control|fine motor control
4724056|NCT03085732|saline irrigation|saline irrigation
4724057|NCT03085732|abdominal hysterectomy|abdominal hysterectomy
4724058|NCT03085732|postoperative infectious morbidities|postoperative infectious morbidities
4724059|NCT03085732|gastrointestinal disturbances|gastrointestinal disturbances
4724060|NCT03085719|Head and Neck Cancer|head and neck cancer
4724061|NCT03085680|Curcumin, physical function, cognitive function|curcumin, physical function, cognitive function
4724062|NCT03085667|Left atrial appendage occluder|left atrial appendage occluder
4724063|NCT03085667|Watchman device|watchman device
4724064|NCT03085667|Atrial fibrillation|atrial fibrillation
4724065|NCT03085667|atrial natriureitc peptide|atrial natriureitc peptide
4724066|NCT03085667|brain natriuretic peptide|brain natriuretic peptide
4724067|NCT03085654|multiple doses|multiple doses
4724068|NCT03085654|oxytocin|oxytocin
4724069|NCT03085654|trait anxiety|trait anxiety
4724070|NCT03085641|High flow oxygen therapy|high flow oxygen therapy
4724071|NCT03085628|social sharing|social sharing
4724072|NCT03085628|social reward|social reward
4724178|NCT03085004|Cyst Ablation|cyst ablation
4724073|NCT03085628|functional magnetic resonance imaging|functional magnetic resonance imaging
4724074|NCT03085628|reward circuit|reward circuit
4724075|NCT03085589|elderly|elderly
4724076|NCT03085589|telemedicine|telemedicine
4724077|NCT03085589|obesity|obesity
4724078|NCT03085589|rural health|rural health
4724079|NCT03085589|health promotion|health promotion
4724080|NCT03085576|Atrial Fibrillation|atrial fibrillation
4724081|NCT03085576|Anticoagulation|anticoagulation
4724082|NCT03085576|Stroke|stroke
4724083|NCT03085576|Vitamin K antagonist|vitamin k antagonist
4724084|NCT03085576|Cardioversion|cardioversion
4724085|NCT03085576|INR (International Normalized Ratio)|inr (international normalized ratio)
4724086|NCT03085550|diabetic foot ulcer|diabetic foot ulcer
4724087|NCT03085550|diabetes mellitus|diabetes mellitus
4724088|NCT03085550|fat grafting|fat grafting
4724089|NCT03085550|platelet rich plasma|platelet rich plasma
4724090|NCT03085550|wound healing|wound healing
4724091|NCT03085537|home monitoring|home monitoring
4724092|NCT03085537|Non-invasive mechanical ventilation|non-invasive mechanical ventilation
4724093|NCT03085511|Egg breakfast|egg breakfast
4724094|NCT03085511|Weight loss|weight loss
4724095|NCT03085511|Satiety|satiety
4724096|NCT03085511|Insulin|insulin
4724097|NCT03085511|Glucagon-Like Peptide 1|glucagon-like peptide 1
4724098|NCT03085511|PYY (3-36) peptide|pyy (3-36) peptide
4724099|NCT03085511|Ghrelin|ghrelin
4724100|NCT03085511|Glucose|glucose
4724101|NCT03085511|Protein quality|protein quality
4724102|NCT03085498|retinal vessels|retinal vessels
4724103|NCT03085498|physical activity|physical activity
4724104|NCT03085498|children|children
4724105|NCT03085498|psychosocial health|psychosocial health
4724106|NCT03085485|COPD|copd
4724107|NCT03085485|CFTR|cftr
4724108|NCT03085485|ivacaftor|ivacaftor
4724109|NCT03085485|topic trial|topic trial
4724110|NCT03085472|intracerebral hemrrohage|intracerebral hemrrohage
4724111|NCT03085472|stroke|stroke
4724112|NCT03085472|China|china
4724113|NCT03085472|hematoma|hematoma
4724114|NCT03085472|CT|ct
4724115|NCT03085472|predictor|predictor
4724116|NCT03085472|prognosis|prognosis
4724117|NCT03085472|outcome|outcome
4724118|NCT03085420|Burns|burns
4724119|NCT03085420|Pediatrics|pediatrics
4724120|NCT03085420|Cardiac Arrhythmia|cardiac arrhythmia
4724121|NCT03085394|Morbid Obesity|morbid obesity
4724122|NCT03085394|Sleeve gastrectomy|sleeve gastrectomy
4724123|NCT03085368|breast cancer|breast cancer
4724124|NCT03085368|her-2 positive|her-2 positive
4724125|NCT03085368|lapatinib|lapatinib
4724126|NCT03085368|herceptin|herceptin
4724127|NCT03085355|neck pain|neck pain
4724128|NCT03085342|liver|liver
4724129|NCT03085342|fibrosis|fibrosis
4724130|NCT03085342|MRI|mri
4724131|NCT03085329|bubble nasal continuous positive airway pressure|bubble nasal continuous positive airway pressure
4724132|NCT03085329|respiratory support|respiratory support
4724133|NCT03085290|dry eye syndrome|dry eye syndrome
4724134|NCT03085290|serum eye drops|serum eye drops
4724135|NCT03085277|Bovine colostrum|bovine colostrum
4724136|NCT03085277|Preterm formula|preterm formula
4724137|NCT03085277|Very preterm infants|very preterm infants
4724138|NCT03085277|Enteral feeding|enteral feeding
4724139|NCT03085225|Advanced tumor|advanced tumor
4724140|NCT03085225|Pretreated tumor|pretreated tumor
4724141|NCT03085225|Soft Tissue Sarcomas|soft tissue sarcomas
4724142|NCT03085225|Ovarian Carcinomas|ovarian carcinomas
4724143|NCT03085225|Phase Ib|phase ib
4724144|NCT03085225|Circulating DNA|circulating dna
4724145|NCT03085199|gastric cancer|gastric cancer
4724146|NCT03085199|laparoscopic gastrectomy|laparoscopic gastrectomy
4724147|NCT03085199|laparoscopic reinforcement suture (LARS)|laparoscopic reinforcement suture (lars)
4724148|NCT03085173|CAR T Cells Targeting CD19|car t cells targeting cd19
4724149|NCT03085173|EGFRt/19-28z/4-1BBL|egfrt/19-28z/4-1bbl
4724150|NCT03085173|16-1570|16-1570
4724151|NCT03085147|Tongue|tongue
4724152|NCT03085147|Mouth|mouth
4724153|NCT03085147|Fluorescent PARP1 Binding Imaging Agent|fluorescent parp1 binding imaging agent
4724154|NCT03085147|PARPi-FL|parpi-fl
4724155|NCT03085147|15-336|15-336
4724156|NCT03085121|extramedullary|extramedullary
4724157|NCT03085121|intramedullary|intramedullary
4724158|NCT03085121|total knee arthroplasty (TKA)|total knee arthroplasty (tka)
4724159|NCT03085069|PD-1|pd-1
4724160|NCT03085069|PD-L1|pd-l1
4724161|NCT03085069|shr-1210|shr-1210
4724162|NCT03085056|Trametinib|trametinib
4724163|NCT03085056|Paclitaxel|paclitaxel
4724164|NCT03085056|15-055|15-055
4724165|NCT03085043|Prostate Cancer|prostate cancer
4724166|NCT03085043|Whole body MRI|whole body mri
4724167|NCT03085043|MRI of the pelvis|mri of the pelvis
4724168|NCT03085043|Magnetic resonance imaging|magnetic resonance imaging
4724169|NCT03085043|Bone scan|bone scan
4724170|NCT03085043|Computed tomography scan of abdomen and pelvis|computed tomography scan of abdomen and pelvis
4724171|NCT03085043|CT|ct
4724172|NCT03085030|infertility|infertility
4724173|NCT03085030|IVF|ivf
4724174|NCT03085030|ICSI|icsi
4724175|NCT03085030|poor responders in IVF/ICSI cycles|poor responders in ivf/icsi cycles
4724176|NCT03085030|antioxidant|antioxidant
4724177|NCT03085004|Pancreatic cyst|pancreatic cyst
4724179|NCT03085004|Eus-FNA (fine-needle aspiration )|eus-fna (fine-needle aspiration )
4724180|NCT03085004|Chemotherapy|chemotherapy
4724181|NCT03084952|safety|safety
4724182|NCT03084952|pharmacokynetics|pharmacokynetics
4724183|NCT03084952|leishmaniasis treatment|leishmaniasis treatment
4724184|NCT03084913|dietary treatment|dietary treatment
4724185|NCT03084887|Tissue Expansion Devices|tissue expansion devices
4724186|NCT03084887|Tissue Expansion|tissue expansion
4724187|NCT03084887|common complications|common complications
4724188|NCT03084887|intervention study|intervention study
4724189|NCT03084874|COPD|copd
4724190|NCT03084874|Physical Activity|physical activity
4724191|NCT03084874|Sedentary behaviour|sedentary behaviour
4724192|NCT03084874|Hospitalization|hospitalization
4724193|NCT03084848|brain/cognitive measures|brain/cognitive measures
4724194|NCT03084848|condition|condition
4724195|NCT03084848|inhibitor control|inhibitor control
4724196|NCT03084848|training at adolescence|training at adolescence
4724197|NCT03084835|tobacco|tobacco
4724198|NCT03084835|smoking|smoking
4724199|NCT03084835|low dose computed tomography|low dose computed tomography
4724200|NCT03084835|lung screening|lung screening
4724201|NCT03084835|text messaging|text messaging
4724202|NCT03084783|dexamethasone|dexamethasone
4724203|NCT03084783|HSV encephalitis|hsv encephalitis
4724204|NCT03084770|NF-PNEN|nf-pnen
4724205|NCT03084731|Microbiota|microbiota
4724206|NCT03084731|Complementary Food|complementary food
4724207|NCT03084692|caregiver|caregiver
4724208|NCT03084692|lung cancer|lung cancer
4724209|NCT03084692|yoga|yoga
4724210|NCT03084692|resistance exercise|resistance exercise
4724211|NCT03084679|Heart Failure|heart failure
4724212|NCT03084679|Hypertrophy|hypertrophy
4724213|NCT03084679|Fibrosis|fibrosis
4724214|NCT03084679|Magnetic Resonance|magnetic resonance
4724215|NCT03084653|Trocar entery|trocar entery
4724216|NCT03084653|Surgery, Laparoscopic|surgery, laparoscopic
4724217|NCT03084627|tailored dietary advice|tailored dietary advice
4724218|NCT03084627|nutrient adequacy|nutrient adequacy
4724219|NCT03084627|dietary modifications|dietary modifications
4724220|NCT03084614|Infectious Diseases|infectious diseases
4724221|NCT03084614|Dendritic Cells|dendritic cells
4724222|NCT03084614|Pathogens|pathogens
4724223|NCT03084614|Passive Cellular Immunity|passive cellular immunity
4724224|NCT03084614|Immune-Modulating|immune-modulating
4724225|NCT03084575|neuroaxial rhizolysis -selective rhizolysis-thermal radiofrequency|neuroaxial rhizolysis -selective rhizolysis-thermal radiofrequency
4724226|NCT03084510|High risk for surgical valve replacement|high risk for surgical valve replacement
4724227|NCT03084510|transcatheter aortic valve replacement|transcatheter aortic valve replacement
4724228|NCT03084497|Massage|massage
4724229|NCT03084497|Development|development
4724230|NCT03084471|Programmed death ligand 1 (PD-L1)|programmed death ligand 1 (pd-l1)
4724231|NCT03084471|Cytotoxic T-lymphocyte antigen-4 (CTLA-4)|cytotoxic t-lymphocyte antigen-4 (ctla-4)
4724232|NCT03084471|Durvalumab in combination with tremelimumab|durvalumab in combination with tremelimumab
4724233|NCT03084458|Increasing daily physical activity|increasing daily physical activity
4724234|NCT03084445|Brominated Flame Retardants (BFRs)|brominated flame retardants (bfrs)
4724235|NCT03084445|Phthalates|phthalates
4724236|NCT03084445|pregnant women|pregnant women
4724237|NCT03084445|newborn|newborn
4724238|NCT03084445|Heavy Metals|heavy metals
4724239|NCT03084445|Volatile Organic Compounds|volatile organic compounds
4724240|NCT03084432|caffeine|caffeine
4724241|NCT03084432|bone mineral content|bone mineral content
4724242|NCT03084419|Rheumatoid Arthritis|rheumatoid arthritis
4724243|NCT03084419|Interstitial Lung Disease|interstitial lung disease
4724244|NCT03084419|RA-ILD|ra-ild
4724245|NCT03084419|Abatacept|abatacept
4724246|NCT03084406|Substance Abuse|substance abuse
4724247|NCT03084406|Implementation Science|implementation science
4724248|NCT03084406|Evidence-based Practices|evidence-based practices
4724249|NCT03084393|non-cardiac surgery|non-cardiac surgery
4724250|NCT03084393|Postoperative Cognitive Dysfunction|postoperative cognitive dysfunction
4724251|NCT03084354|pelvic floor|pelvic floor
4724252|NCT03084354|women's experiences|women's experiences
4724253|NCT03084354|bladder care|bladder care
4724254|NCT03084354|pregnancy|pregnancy
4724255|NCT03084354|labour|labour
4724256|NCT03084354|postpartum|postpartum
4724257|NCT03084341|Elasticity|elasticity
4724258|NCT03084341|Electric Stimulation|electric stimulation
4724259|NCT03084341|Muscle Stretching Exercises|muscle stretching exercises
4724260|NCT03084315|smoking|smoking
4724261|NCT03084315|electronic cigarettes|electronic cigarettes
4724262|NCT03084315|nicotine|nicotine
4724263|NCT03084302|sedentary behavior|sedentary behavior
4724264|NCT03084302|physical activity|physical activity
4724265|NCT03084276|meal ingestion|meal ingestion
4724266|NCT03084276|meal composition|meal composition
4724267|NCT03084276|postprandial responses|postprandial responses
4724268|NCT03084276|hedonic sensations|hedonic sensations
4724269|NCT03084276|homeostatic sensations|homeostatic sensations
4724270|NCT03084276|new composition|new composition
4724271|NCT03084211|emergency department|emergency department
4724272|NCT03084211|concussion|concussion
4724273|NCT03084211|head injury|head injury
4724274|NCT03084198|Bioartificial Liver|bioartificial liver
4724474|NCT03082807|Obesity|obesity
4724275|NCT03084198|Acute Liver Failure|acute liver failure
4724276|NCT03084185|decompensation|decompensation
4724277|NCT03084185|deficit|deficit
4724278|NCT03084185|metabolomics|metabolomics
4724279|NCT03084185|portal hypertension|portal hypertension
4724280|NCT03084133|Therapeutic education strategy|therapeutic education strategy
4724281|NCT03084107|Elder care|elder care
4724282|NCT03084107|Active aging|active aging
4724283|NCT03084107|Intelligent Care Facilities for Elders|intelligent care facilities for elders
4724284|NCT03084094|Fibromyalgia|fibromyalgia
4724285|NCT03084094|tDCS|tdcs
4724286|NCT03084081|Human Papilloma Virus (HPV)|human papilloma virus (hpv)
4724287|NCT03084081|Cryotherapy|cryotherapy
4724288|NCT03084081|Thermoablation|thermoablation
4724289|NCT03084081|Thermocoagulation|thermocoagulation
4724290|NCT03084081|Low and Middle Income Countries (LMICs)|low and middle income countries (lmics)
4724291|NCT03084042|emotional impairments|emotional impairments
4724292|NCT03084042|cognitive impairments|cognitive impairments
4724293|NCT03084029|oxytocin|oxytocin
4724294|NCT03084029|fMRI|fmri
4724295|NCT03084029|empathy|empathy
4724296|NCT03083964|Middle aged women|middle aged women
4724297|NCT03083964|35-64yrs|35-64yrs
4724298|NCT03083964|BMI= >30|bmi= >30
4724299|NCT03083951|Complete mesocolon excision|complete mesocolon excision
4724300|NCT03083951|Sigmoid cancer|sigmoid cancer
4724301|NCT03083951|Colorectal cancer|colorectal cancer
4724302|NCT03083938|Pancreatoduodenectomy|pancreatoduodenectomy
4724303|NCT03083938|Omentum|omentum
4724304|NCT03083938|Wrapping|wrapping
4724305|NCT03083938|Roll-up|roll-up
4724306|NCT03083938|Whipple|whipple
4724307|NCT03083912|Malnutrition|malnutrition
4724308|NCT03083912|Disability|disability
4724309|NCT03083912|Oral Nutritional Supplementation|oral nutritional supplementation
4724310|NCT03083899|Diabetes|diabetes
4724311|NCT03083899|Organization|organization
4724312|NCT03083899|Out-patient control|out-patient control
4724313|NCT03083873|LN-145|ln-145
4724314|NCT03083873|Cell Therapy|cell therapy
4724315|NCT03083873|Autologous Adoptive Cell Transfer|autologous adoptive cell transfer
4724316|NCT03083873|Autologous Adoptive Cell Therapy|autologous adoptive cell therapy
4724317|NCT03083873|Cellular Immuno-therapy|cellular immuno-therapy
4724318|NCT03083873|Tumor Infiltrating Lymphocytes|tumor infiltrating lymphocytes
4724319|NCT03083873|TIL|til
4724320|NCT03083873|IL-2|il-2
4724321|NCT03083847|Malaria|malaria
4724322|NCT03083847|Parasitemia|parasitemia
4724323|NCT03083847|Immune|immune
4724324|NCT03083847|Responses|responses
4724325|NCT03083847|Sporozoites|sporozoites
4724326|NCT03083834|cosyntropin|cosyntropin
4724327|NCT03083834|salivary free cortisol|salivary free cortisol
4724328|NCT03083834|mitotane|mitotane
4724329|NCT03083808|PD-1|pd-1
4724330|NCT03083808|PD-L1 Inhibitor|pd-l1 inhibitor
4724331|NCT03083808|Pembrolizumab|pembrolizumab
4724332|NCT03083808|Docetaxel|docetaxel
4724333|NCT03083808|Pemetrexed|pemetrexed
4724334|NCT03083808|Gemcitabine|gemcitabine
4724335|NCT03083795|Social relationships|social relationships
4724336|NCT03083795|Vulnerable connections|vulnerable connections
4724337|NCT03083795|Diabetes Distress|diabetes distress
4724338|NCT03083795|Support group|support group
4724339|NCT03083782|Apixaban|apixaban
4724340|NCT03083782|Cyclosporine|cyclosporine
4724341|NCT03083782|Tacrolimus|tacrolimus
4724342|NCT03083782|Cytochrome P450 CYP3A4|cytochrome p450 cyp3a4
4724343|NCT03083782|Permeability Glycoprotein P-gp|permeability glycoprotein p-gp
4724344|NCT03083782|Breast cancer resistance protein BCRP|breast cancer resistance protein bcrp
4724345|NCT03083782|Factor Xa Inhibitors|factor xa inhibitors
4724346|NCT03083782|Anticoagulants|anticoagulants
4724347|NCT03083782|Enzyme Inhibitors|enzyme inhibitors
4724348|NCT03083769|tacrolimus|tacrolimus
4724349|NCT03083769|genetic variants|genetic variants
4724350|NCT03083769|side effects|side effects
4724351|NCT03083743|Carcinoma, Non-Small-Cell Lung|carcinoma, non-small-cell lung
4724352|NCT03083743|Carcinoma, Bronchogenic|carcinoma, bronchogenic
4724353|NCT03083743|Bronchial Neoplasms|bronchial neoplasms
4724354|NCT03083743|Lung Neoplasms|lung neoplasms
4724355|NCT03083743|Thoracic Neoplasms|thoracic neoplasms
4724356|NCT03083743|Neoplasms|neoplasms
4724357|NCT03083743|Lung Diseases|lung diseases
4724358|NCT03083743|Antineoplastic Agents, Cytokines|antineoplastic agents, cytokines
4724359|NCT03083743|Antineoplastic Agents|antineoplastic agents
4724360|NCT03083743|Biological activity factor|biological activity factor
4724361|NCT03083743|Genetic Engineering|genetic engineering
4724362|NCT03083743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
4724363|NCT03083743|Physiological Effects of Drugs|physiological effects of drugs
4724364|NCT03083730|Atopic Dermatitis|atopic dermatitis
4724365|NCT03083730|Eczema|eczema
4724366|NCT03083730|Systemic Inflammation|systemic inflammation
4724367|NCT03083730|UVB Phototherapy|uvb phototherapy
4724368|NCT03083691|Nivolumab|nivolumab
4724369|NCT03083691|Ipilimumab|ipilimumab
4724370|NCT03083678|EGFR|egfr
4724371|NCT03083678|Afatinib|afatinib
4724372|NCT03083665|Epilepsy|epilepsy
4724373|NCT03083665|Partial seizures with or without secondary generalization|partial seizures with or without secondary generalization
4724374|NCT03083665|Brivaracetam|brivaracetam
4724375|NCT03083665|Asian subjects|asian subjects
4724376|NCT03083652|physiotherapy|physiotherapy
4724377|NCT03083652|neuromuscular electrical stimulation|neuromuscular electrical stimulation
4724378|NCT03083652|exercise capacity|exercise capacity
4724379|NCT03083639|Drug Therapy|drug therapy
4724380|NCT03083626|Chronic pain|chronic pain
4724381|NCT03083626|Narcotic abuse|narcotic abuse
4724382|NCT03083626|Opioid related disorders|opioid related disorders
4724383|NCT03083626|Opiate substitution treatment|opiate substitution treatment
4724384|NCT03083626|Buprenorphine|buprenorphine
4724385|NCT03083626|Pregabalin|pregabalin
4724386|NCT03083626|Methadone|methadone
4724387|NCT03083613|Raltitrexed|raltitrexed
4724388|NCT03083613|Paclitaxel|paclitaxel
4724389|NCT03083613|chemotherapy|chemotherapy
4724390|NCT03083613|Gastric cancer|gastric cancer
4724391|NCT03083613|Gastroesophageal Junction Adenocarcinoma|gastroesophageal junction adenocarcinoma
4724392|NCT03083600|protein hydrolysates|protein hydrolysates
4724393|NCT03083600|HbA1c|hba1c
4724394|NCT03083600|prediabetes|prediabetes
4724395|NCT03083574|Hematology|hematology
4724396|NCT03083574|Chronic graft versus host disease (cGVHD)|chronic graft versus host disease (cgvhd)
4724397|NCT03083574|Extracorporeal photopheresis|extracorporeal photopheresis
4724398|NCT03083574|Hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
4724399|NCT03083574|Donor lymphocyte infusion|donor lymphocyte infusion
4724400|NCT03083522|Cold Hypersensitivity|cold hypersensitivity
4724401|NCT03083522|Korean medicine|korean medicine
4724402|NCT03083522|Ojeok-san|ojeok-san
4724403|NCT03083522|Cold intolerance|cold intolerance
4724404|NCT03083418|AECOPD|aecopd
4724405|NCT03083418|EDP|edp
4724406|NCT03083418|Neural Respiratory Drive|neural respiratory drive
4724407|NCT03083418|Surface EMGdi|surface emgdi
4724408|NCT03083392|DIVA|diva
4724409|NCT03083392|sinusitis|sinusitis
4724410|NCT03083392|maxillary|maxillary
4724411|NCT03083379|Incentive spirometry|incentive spirometry
4724412|NCT03083379|EzPAP|ezpap
4724413|NCT03083379|Electrical impedance tomography|electrical impedance tomography
4724414|NCT03083366|spinal cord injury|spinal cord injury
4724415|NCT03083366|Neurogenic|neurogenic
4724416|NCT03083366|bladder|bladder
4724417|NCT03083366|electrical stimulation|electrical stimulation
4724418|NCT03083366|neuromodulation|neuromodulation
4724419|NCT03083301|Cardiac resynchronisation|cardiac resynchronisation
4724420|NCT03083223|patient positioning|patient positioning
4724421|NCT03083223|lung diseases|lung diseases
4724422|NCT03083223|oxygenation|oxygenation
4724423|NCT03083223|hemodynamic parameters|hemodynamic parameters
4724424|NCT03083223|vital signs|vital signs
4724425|NCT03083197|Scrub Typhus|scrub typhus
4724426|NCT03083197|Antibiotic Resistance|antibiotic resistance
4724427|NCT03083184|Hemodialysis|hemodialysis
4724428|NCT03083184|hemodiafiltration|hemodiafiltration
4724429|NCT03083184|tunnelled dialysis catheter|tunnelled dialysis catheter
4724430|NCT03083184|interdialytic lock solution|interdialytic lock solution
4724431|NCT03083184|preventing tunnelled catheter infection|preventing tunnelled catheter infection
4724432|NCT03083171|Adrecizumab|adrecizumab
4724433|NCT03083171|Adrenomedullin|adrenomedullin
4724434|NCT03083171|Healthy volunteers|healthy volunteers
4724435|NCT03083171|LPS|lps
4724436|NCT03083171|Monoclonal recombinant antibody|monoclonal recombinant antibody
4724437|NCT03083132|freezing of gait|freezing of gait
4724438|NCT03083067|AECOPD|aecopd
4724439|NCT03083067|air pollution|air pollution
4724440|NCT03083067|COPD|copd
4724441|NCT03083067|salvational Intervention|salvational intervention
4724442|NCT03083041|SHR-1210|shr-1210
4724443|NCT03083041|Apatinib|apatinib
4724444|NCT03083041|NSCLC|nsclc
4724445|NCT03083028|Ankle Fracture|ankle fracture
4724446|NCT03083015|regeneration, MTA apexification and TAP|regeneration, mta apexification and tap
4724447|NCT03083015|revascularization|revascularization
4724448|NCT03082963|atrial fibrillation|atrial fibrillation
4724449|NCT03082963|ablation|ablation
4724450|NCT03082950|hpv prevalence|hpv prevalence
4724451|NCT03082950|recurrence rate|recurrence rate
4724452|NCT03082950|survival|survival
4724453|NCT03082924|surface EMGdi|surface emgdi
4724454|NCT03082924|pulmonary rehabilitation|pulmonary rehabilitation
4724455|NCT03082924|inspiratory muscle training|inspiratory muscle training
4724456|NCT03082924|exercise training|exercise training
4724457|NCT03082911|screening|screening
4724458|NCT03082911|early detection|early detection
4724459|NCT03082911|participation|participation
4724460|NCT03082872|Reduction, Fracture|reduction, fracture
4724461|NCT03082859|Exercise|exercise
4724462|NCT03082859|Interval Training|interval training
4724463|NCT03082859|Glycaemic Control|glycaemic control
4724464|NCT03082859|Type 2 Diabetes|type 2 diabetes
4724465|NCT03082846|malignant glioma|malignant glioma
4724466|NCT03082846|intensity modulated radiation therapy|intensity modulated radiation therapy
4724467|NCT03082846|simultaneous integrated boost|simultaneous integrated boost
4724468|NCT03082846|hypofractionation|hypofractionation
4724469|NCT03082846|temozolomide|temozolomide
4724470|NCT03082846|maximum tolerated dose|maximum tolerated dose
4724471|NCT03082807|Caloric Restriction|caloric restriction
4724472|NCT03082807|Diet|diet
4724473|NCT03082807|Exercise|exercise
4724475|NCT03082807|Overweight|overweight
4724476|NCT03082807|Sedentary lifestyle|sedentary lifestyle
4724477|NCT03082807|weight loss|weight loss
4724478|NCT03082807|Men|men
4724479|NCT03082794|Dietary Formulations|dietary formulations
4724480|NCT03082794|Lifestyle|lifestyle
4724481|NCT03082794|Obesity|obesity
4724482|NCT03082794|Overweight|overweight
4724483|NCT03082794|weight loss|weight loss
4724484|NCT03082781|Diet|diet
4724485|NCT03082781|Exercise|exercise
4724486|NCT03082781|Obesity|obesity
4724487|NCT03082781|Overweight|overweight
4724488|NCT03082781|Weight loss|weight loss
4724489|NCT03082768|HV|hv
4724490|NCT03082742|diuretics|diuretics
4724491|NCT03082742|furosemide|furosemide
4724492|NCT03082742|hydrochlorothiazide|hydrochlorothiazide
4724493|NCT03082742|CKD-MBD|ckd-mbd
4724494|NCT03082742|HRpQCT|hrpqct
4724495|NCT03082742|parathyroid hormone|parathyroid hormone
4724496|NCT03082716|cardioplegia|cardioplegia
4724497|NCT03082716|myocardial protection|myocardial protection
4724498|NCT03082716|custodiol|custodiol
4724499|NCT03082716|htk|htk
4724500|NCT03082677|Ixazomib|ixazomib
4724501|NCT03082677|Graft-versus-Host Disease|graft-versus-host disease
4724502|NCT03082677|Allogeneic Hematopoietic Stem Cell Transplantation|allogeneic hematopoietic stem cell transplantation
4724503|NCT03082677|16-076|16-076
4724504|NCT03082651|Running injuries, footwear, alternating load|running injuries, footwear, alternating load
4724505|NCT03082612|Behavioral research|behavioral research
4724506|NCT03082612|Social research|social research
4724507|NCT03082612|Spirituality|spirituality
4724508|NCT03082612|Late stage cancer|late stage cancer
4724509|NCT03082547|Headache|headache
4724510|NCT03082547|Neuropsychological tests|neuropsychological tests
4724511|NCT03082547|Myofascial trigger points|myofascial trigger points
4724512|NCT03082547|electrophysiology|electrophysiology
4724513|NCT03082534|Head and Neck Cancer|head and neck cancer
4724514|NCT03082534|Pembrolizumab|pembrolizumab
4724515|NCT03082534|Keytruda®|keytruda®
4724516|NCT03082534|Cetuximab|cetuximab
4724517|NCT03082534|Erbitux®|erbitux®
4724518|NCT03082534|Recurrent|recurrent
4724519|NCT03082534|Metastatic|metastatic
4724520|NCT03082534|PD-1|pd-1
4724521|NCT03082534|PD-L1|pd-l1
4724522|NCT03082534|non-EBV related Nasopharynx|non-ebv related nasopharynx
4724523|NCT03082521|After hours care; Primary care; Antibiotics; Action Research|after hours care; primary care; antibiotics; action research
4724524|NCT03082508|Algisyl|algisyl
4724525|NCT03082508|Heart Failure|heart failure
4724526|NCT03082508|Dilated Cardiomyopathy|dilated cardiomyopathy
4724527|NCT03082508|Alginate Hydrogel|alginate hydrogel
4724528|NCT03082508|Heart Failure with Reduced Ejection Fraction|heart failure with reduced ejection fraction
4724529|NCT03082508|Congestive Heart Failure|congestive heart failure
4724530|NCT03082495|Exercise|exercise
4724531|NCT03082495|Cancer|cancer
4724532|NCT03082495|Symptom management|symptom management
4724533|NCT03082495|Quality of life|quality of life
4724534|NCT03082495|presurgical|presurgical
4724535|NCT03082495|chemoradiotherapy|chemoradiotherapy
4724536|NCT03082495|Physical Fitness|physical fitness
4724537|NCT03082482|Smoking Cessation|smoking cessation
4724538|NCT03082482|HIV|hiv
4724539|NCT03082482|AIDS|aids
4724540|NCT03082469|Severe acute pancreatitis|severe acute pancreatitis
4724541|NCT03082469|Haemodynamic monitoring|haemodynamic monitoring
4724542|NCT03082469|Cytokine removal|cytokine removal
4724543|NCT03082469|Vasopressor dependency index|vasopressor dependency index
4724544|NCT03082456|molecuiar breast imaging|molecuiar breast imaging
4724545|NCT03082456|MBI|mbi
4724546|NCT03082456|breast cancer|breast cancer
4724547|NCT03082456|mammography|mammography
4724548|NCT03082456|sonography|sonography
4724549|NCT03082456|recall rate|recall rate
4724550|NCT03082456|diagnostic accuracy|diagnostic accuracy
4724551|NCT03082456|breast echo|breast echo
4724552|NCT03082456|female population|female population
4724553|NCT03082443|Cardiac rehabilitation|cardiac rehabilitation
4724554|NCT03082443|psychology|psychology
4724555|NCT03082443|nutrition|nutrition
4724556|NCT03082443|stress|stress
4724557|NCT03082443|quality of life|quality of life
4724558|NCT03082417|Bone Fracture|bone fracture
4724559|NCT03082417|75 years old|75 years old
4724560|NCT03082417|Elderly|elderly
4724561|NCT03082417|Older adults|older adults
4724562|NCT03082417|Pain scale|pain scale
4724563|NCT03082417|Pain documentation|pain documentation
4724564|NCT03082417|Analgesics|analgesics
4724565|NCT03082417|Acetaminophen|acetaminophen
4724566|NCT03082417|Opioid|opioid
4724567|NCT03082417|Nonsteroidal anti-inflammatory drugs|nonsteroidal anti-inflammatory drugs
4724568|NCT03082417|Emergency Department|emergency department
4724569|NCT03082404|Chronic kidney disease|chronic kidney disease
4724570|NCT03082404|Inspiratory muscle training|inspiratory muscle training
4724571|NCT03082391|Ventral Hernia Repair|ventral hernia repair
4724572|NCT03082391|Heavyweight Mesh|heavyweight mesh
4724573|NCT03082391|Mediumweight Mesh|mediumweight mesh
4724574|NCT03082365|oral findings or oral manifestations|oral findings or oral manifestations
4724575|NCT03082365|pre-dialysis or end stage renal disease|pre-dialysis or end stage renal disease
4724576|NCT03082326|shock|shock
4724577|NCT03082326|critical care ultrasound|critical care ultrasound
4724578|NCT03082326|hemodynamics|hemodynamics
4724579|NCT03082326|lung pathology|lung pathology
4724580|NCT03082326|epidemic|epidemic
4724581|NCT03082326|prognosis|prognosis
4724582|NCT03082313|infant|infant
4724583|NCT03082313|leg movement|leg movement
4724584|NCT03082313|wearable sensors|wearable sensors
4724585|NCT03082313|early intervention|early intervention
4724586|NCT03082300|ASP8273|asp8273
4724587|NCT03082300|Epidermal growth factor receptor (EGFR) mutations|epidermal growth factor receptor (egfr) mutations
4724588|NCT03082300|naquotinib|naquotinib
4724589|NCT03082300|Non-small cell lung cancer (NSCLC)|non-small cell lung cancer (nsclc)
4724590|NCT03082300|Bioequivalence|bioequivalence
4724591|NCT03082261|Failed Back Surgery Syndrome|failed back surgery syndrome
4724592|NCT03082261|Radiculopathy|radiculopathy
4724593|NCT03082261|Post Laminectomy Syndrome|post laminectomy syndrome
4724594|NCT03082248|Low Back Pain|low back pain
4724595|NCT03082248|Surgery|surgery
4724596|NCT03082248|Lumbar Spine|lumbar spine
4724597|NCT03082248|Physical Therapy Modalities|physical therapy modalities
4724598|NCT03082248|Rehabilitation|rehabilitation
4724599|NCT03082235|Healthy participants|healthy participants
4724600|NCT03082235|E6742|e6742
4724601|NCT03082235|pharmacokinetics|pharmacokinetics
4724602|NCT03082222|partial onset seizures with or without secondary generalization|partial onset seizures with or without secondary generalization
4724603|NCT03082209|Solid Tumors|solid tumors
4724604|NCT03082209|Hematologic Malignancies|hematologic malignancies
4724605|NCT03082209|Cancer|cancer
4724606|NCT03082209|non-Hodgkin lymphoma|non-hodgkin lymphoma
4724607|NCT03082209|acute myeloid leukemia (AML)|acute myeloid leukemia (aml)
4724608|NCT03082209|colorectal cancer (CRC)|colorectal cancer (crc)
4724609|NCT03082209|Diffuse Large B-Cell Lymphoma (DLBCL)|diffuse large b-cell lymphoma (dlbcl)
4724610|NCT03082196|sodium fluoride|sodium fluoride
4724611|NCT03082196|povidone iodine|povidone iodine
4724612|NCT03082196|varnish|varnish
4724613|NCT03082170|sleep apnea|sleep apnea
4724614|NCT03082170|robotic surgery for base of tongue|robotic surgery for base of tongue
4724615|NCT03082170|soft palate surgery|soft palate surgery
4724616|NCT03082170|post operative swallowing evaluation|post operative swallowing evaluation
4724617|NCT03082170|dysphagia|dysphagia
4724618|NCT03082131|Gut Microbiota|gut microbiota
4724619|NCT03082131|Glycemic Response|glycemic response
4724620|NCT03082131|Resistant Starch|resistant starch
4724621|NCT03082131|Fiber|fiber
4724622|NCT03082092|Knee|knee
4724623|NCT03082092|Pain|pain
4724624|NCT03082092|Recovery|recovery
4724625|NCT03082092|Steroid|steroid
4724626|NCT03082092|Replacement|replacement
4724627|NCT03082092|Arthroplasty|arthroplasty
4724628|NCT03082079|GIST|gist
4724629|NCT03082079|ESD|esd
4724630|NCT03082066|bone access|bone access
4724631|NCT03082066|intraosseus needle|intraosseus needle
4724632|NCT03082066|resuscitation|resuscitation
4724633|NCT03082066|infusion|infusion
4724634|NCT03082066|volume therapy|volume therapy
4724635|NCT03082066|emergency|emergency
4724636|NCT03082027|ultrasonography|ultrasonography
4724637|NCT03082027|carpal tunnel syndrome|carpal tunnel syndrome
4724638|NCT03082014|Hypertension|hypertension
4724639|NCT03082014|Cerebrovascular Reactivity|cerebrovascular reactivity
4724640|NCT03082014|Blood Pressure Variability|blood pressure variability
4724641|NCT03082001|Neonate|neonate
4724642|NCT03082001|Pain|pain
4724643|NCT03082001|ELBW|elbw
4724644|NCT03081988|Esophageal Cancer|esophageal cancer
4724645|NCT03081988|chemoradiotherapy response|chemoradiotherapy response
4724646|NCT03081988|molecular factors|molecular factors
4724647|NCT03081975|adenoma detection rate|adenoma detection rate
4724648|NCT03081975|narrow band imaging|narrow band imaging
4724649|NCT03081949|peripartum cardiomyopathy|peripartum cardiomyopathy
4724650|NCT03081949|Ventricular remodelling|ventricular remodelling
4724651|NCT03081949|Survival|survival
4724652|NCT03081949|Selenium|selenium
4724653|NCT03081949|Oxidative stress|oxidative stress
4724654|NCT03081949|Nigeria|nigeria
4724655|NCT03081923|Immunotherapy|immunotherapy
4724656|NCT03081923|Durvalumab|durvalumab
4724657|NCT03081923|Tremelimumab|tremelimumab
4724658|NCT03081923|Combination therapy|combination therapy
4724659|NCT03081923|Testicular cancer|testicular cancer
4724660|NCT03081910|Autologous CAR T cells|autologous car t cells
4724661|NCT03081910|T-cell acute lymphoblastic lymphoma|t-cell acute lymphoblastic lymphoma
4724662|NCT03081910|T-non-Hodgkin Lymphoma|t-non-hodgkin lymphoma
4724663|NCT03081910|T-cell Acute Lymphoblastic Leukemia|t-cell acute lymphoblastic leukemia
4724664|NCT03081884|Prostate cancer|prostate cancer
4724665|NCT03081884|Metastatic cancer|metastatic cancer
4724666|NCT03081884|Urogenital disorders|urogenital disorders
4724667|NCT03081884|Oncology|oncology
4724668|NCT03081884|Radiology|radiology
4724669|NCT03081858|NMIBC|nmibc
4724670|NCT03081858|Paclitaxel|paclitaxel
4724671|NCT03081858|Antineoplastic Agents|antineoplastic agents
4724672|NCT03081832|Prader-Willi|prader-willi
4724673|NCT03081832|Oxytocin|oxytocin
4724674|NCT03081832|Communication skills|communication skills
4724675|NCT03081832|Oral skills|oral skills
4724676|NCT03081832|Brain activity|brain activity
4724677|NCT03081832|Hormonal disease|hormonal disease
4724678|NCT03081806|Phase 3|phase 3
4724679|NCT03081806|Efficacy|efficacy
4724680|NCT03081806|Safety|safety
4724681|NCT03081806|Osteoarthritis, Knee|osteoarthritis, knee
4724682|NCT03081793|postoperative monitoring|postoperative monitoring
4724683|NCT03081793|plethysmography|plethysmography
4724684|NCT03081793|monitoring|monitoring
4724685|NCT03081780|AML|aml
4724686|NCT03081767|PET/CT|pet/ct
4724687|NCT03081767|digital PET/CT|digital pet/ct
4724688|NCT03081715|esophageal cancer|esophageal cancer
4724689|NCT03081715|immune checkpoint|immune checkpoint
4724690|NCT03081715|PD-1|pd-1
4724691|NCT03081715|CRISPER|crisper
4724692|NCT03081715|autologous cell infusion|autologous cell infusion
4724693|NCT03081676|Maturity-Onset Diabetes of the Young, Type 3|maturity-onset diabetes of the young, type 3
4724694|NCT03081676|Glucose-dependent insulinotropic peptide|glucose-dependent insulinotropic peptide
4724695|NCT03081676|Glucagon-like-peptide 1|glucagon-like-peptide 1
4724696|NCT03081676|Dipeptidyl peptidase 4|dipeptidyl peptidase 4
4724697|NCT03081676|Glimepiride|glimepiride
4724698|NCT03081676|Sulphonylurea|sulphonylurea
4724699|NCT03081676|Glucose clamp|glucose clamp
4724700|NCT03081676|Hepatocyte nuclear factor 1 alpha|hepatocyte nuclear factor 1 alpha
4724701|NCT03081663|total knee arthroplasty|total knee arthroplasty
4724702|NCT03081663|quadriceps sparing mid-vastus|quadriceps sparing mid-vastus
4724703|NCT03081663|medial para-patellar|medial para-patellar
4724704|NCT03081624|preterm|preterm
4724705|NCT03081624|neurological status|neurological status
4724706|NCT03081624|School Readiness|school readiness
4724707|NCT03081585|fmri|fmri
4724708|NCT03081585|neuronal reward processing|neuronal reward processing
4724709|NCT03081585|hormonal satiety signalling|hormonal satiety signalling
4724710|NCT03081585|fasting|fasting
4724711|NCT03081559|transgender|transgender
4724712|NCT03081559|women|women
4724713|NCT03081533|Circular dance|circular dance
4724714|NCT03081533|Older caregiver|older caregiver
4724715|NCT03081533|Dance Therapy|dance therapy
4724716|NCT03081507|Muslim Americans|muslim americans
4724717|NCT03081507|Patient Navigation|patient navigation
4724718|NCT03081507|Breast Cancer|breast cancer
4724719|NCT03081507|Cervical Cancer|cervical cancer
4724720|NCT03081494|PDR001|pdr001
4724721|NCT03081494|immunotherapy|immunotherapy
4724722|NCT03081494|regorafenib|regorafenib
4724723|NCT03081494|CRC|crc
4724724|NCT03081494|MMS|mms
4724725|NCT03081494|CMS4|cms4
4724726|NCT03081494|ElevatION:CRC-102|elevation:crc-102
4724727|NCT03081481|Intraprostatic|intraprostatic
4724728|NCT03081481|MRI lesion|mri lesion
4724729|NCT03081481|Prostate biopsies|prostate biopsies
4724730|NCT03081468|Optical coherence tomography|optical coherence tomography
4724731|NCT03081468|Pupillometry|pupillometry
4724732|NCT03081468|Automated|automated
4724733|NCT03081468|Binocular|binocular
4724734|NCT03081455|Screening|screening
4724735|NCT03081455|Hereditary Cancer|hereditary cancer
4724736|NCT03081403|Sensitive skin|sensitive skin
4724737|NCT03081403|Quantitative Sensory Testing|quantitative sensory testing
4724738|NCT03081364|Cardiac Implanted Device|cardiac implanted device
4724739|NCT03081351|Extended retroperitoneal lymphadenectomy, Nerve plexus clearance, Survival benefit|extended retroperitoneal lymphadenectomy, nerve plexus clearance, survival benefit
4724740|NCT03081338|ALS, MND, Care, Patient journey|als, mnd, care, patient journey
4724741|NCT03081325|uRM|urm
4724742|NCT03081325|RIF|rif
4724743|NCT03081325|Th1|th1
4724744|NCT03081325|Th2|th2
4724745|NCT03081325|Treg|treg
4724746|NCT03081325|lymphocyte immunotherapy|lymphocyte immunotherapy
4724747|NCT03081312|Family Cancer Caregivers,|family cancer caregivers,
4724748|NCT03081312|Needs|needs
4724749|NCT03081312|Burden of Care|burden of care
4724750|NCT03081312|Quality of Life|quality of life
4724751|NCT03081273|Antimicrobial susceptibility|antimicrobial susceptibility
4724752|NCT03081273|Biofilm formation|biofilm formation
4724753|NCT03081273|Bone and joint infection|bone and joint infection
4724754|NCT03081273|Corynebacterium spp|corynebacterium spp
4724755|NCT03081273|Osteoblast|osteoblast
4724756|NCT03081273|Outcome|outcome
4724757|NCT03081273|Prosthetic joint infection|prosthetic joint infection
4724758|NCT03081260|Total Knee Arthroplasty|total knee arthroplasty
4724759|NCT03081260|Patella|patella
4724760|NCT03081260|Resurfacing|resurfacing
4724761|NCT03081260|IKS score|iks score
4724762|NCT03081234|Hormone receptor-positive|hormone receptor-positive
4724763|NCT03081234|Estrogen and/or progesterone receptor-positive|estrogen and/or progesterone receptor-positive
4724764|NCT03081234|HER2-negative|her2-negative
4724765|NCT03081234|Intermediate risk early breast cancer|intermediate risk early breast cancer
4724766|NCT03081234|Adjuvant|adjuvant
4724767|NCT03081234|Ribociclib|ribociclib
4724768|NCT03081234|LEE011|lee011
4724769|NCT03081234|CDK4/6 inhibitor|cdk4/6 inhibitor
4724770|NCT03081234|Endocrine therapy|endocrine therapy
4724771|NCT03081234|Phase III|phase iii
4724772|NCT03081234|breast carcinoma|breast carcinoma
4724773|NCT03081234|breast cancer|breast cancer
4724774|NCT03081208|IVF|ivf
4724775|NCT03081208|ICSI|icsi
4724776|NCT03081195|child behavior|child behavior
4724777|NCT03081195|intervention|intervention
4724778|NCT03081195|multiple family group|multiple family group
4724779|NCT03081195|Sub Saharan Africa|sub saharan africa
4724780|NCT03081195|caregivers|caregivers
4724781|NCT03081182|Pediatric Chronic Pancreatitis|pediatric chronic pancreatitis
4724782|NCT03081182|Data management|data management
4724783|NCT03081182|Regulatory compliance|regulatory compliance
4724784|NCT03081182|Protocol monitoring|protocol monitoring
4724785|NCT03081156|chronic obstructive pulmonary disease (COPD)|chronic obstructive pulmonary disease (copd)
4724786|NCT03081156|exercise intolerance|exercise intolerance
4724787|NCT03081156|dynamic hyperinflation|dynamic hyperinflation
4724788|NCT03081117|HIV-Associated Neurocognitive Disorder (HAND)|hiv-associated neurocognitive disorder (hand)
4724789|NCT03081117|Intranasal|intranasal
4724790|NCT03081052|Heart and Lung transplantation surgery|heart and lung transplantation surgery
4724791|NCT03081052|Pulmonary vasodilation therapy|pulmonary vasodilation therapy
4724792|NCT03081039|cholangiocarcinoma|cholangiocarcinoma
4724793|NCT03081039|gemcitabine|gemcitabine
4724794|NCT03081039|carboplatin|carboplatin
4724795|NCT03081039|cisplatin|cisplatin
4724796|NCT03081026|surgery|surgery
4724797|NCT03081026|ages 6-16|ages 6-16
4724798|NCT03081013|adolescents|adolescents
4724799|NCT03081013|social norms|social norms
4724800|NCT03080974|irreversible electroporation|irreversible electroporation
4724801|NCT03080974|Nivolumab|nivolumab
4724802|NCT03080961|Barrier cream|barrier cream
4724803|NCT03080922|Acute Myeloid Leukemia|acute myeloid leukemia
4724804|NCT03080922|Relapsed|relapsed
4724805|NCT03080922|Refractory|refractory
4724806|NCT03080922|hematopoietic stem cell|hematopoietic stem cell
4724807|NCT03080909|Satiety|satiety
4724808|NCT03080909|Nutrient|nutrient
4724809|NCT03080909|Appetite|appetite
4724810|NCT03080909|Encapsulation|encapsulation
4724811|NCT03080909|Lipid|lipid
4724812|NCT03080909|Amino acid|amino acid
4724813|NCT03080909|Probiotic bacteria|probiotic bacteria
4724814|NCT03080870|Art intervention|art intervention
4724815|NCT03080870|Quality of Life|quality of life
4724816|NCT03080870|Well-being|well-being
4724817|NCT03080870|Physical performance|physical performance
4724818|NCT03080870|Family caregivers|family caregivers
4724819|NCT03080870|Older adults|older adults
4724820|NCT03080831|Maintenance Fluid Therapy|maintenance fluid therapy
4724821|NCT03080818|Probiotic, Cognitive Function, Mood|probiotic, cognitive function, mood
4724822|NCT03080792|stem cell transplantation|stem cell transplantation
4724823|NCT03080792|exercise|exercise
4724824|NCT03080792|high intensity interval training|high intensity interval training
4724825|NCT03080792|resistance training|resistance training
4724826|NCT03080792|physical fitness|physical fitness
4724827|NCT03080792|cancer|cancer
4724828|NCT03080753|Sphinkeeper|sphinkeeper
4724829|NCT03080753|Intersphincteric implants|intersphincteric implants
4724830|NCT03080753|Gatekeeper|gatekeeper
4724831|NCT03080714|no known ocular pathology|no known ocular pathology
4724832|NCT03080714|Glaucoma|glaucoma
4724833|NCT03080714|Retinal Disease|retinal disease
4724834|NCT03080701|Behavioral: Automated Mailing|behavioral: automated mailing
4724835|NCT03080675|Aging population|aging population
4724836|NCT03080649|dental caries, Er:YAG laser, rotary bur|dental caries, er:yag laser, rotary bur
4724837|NCT03080636|Post-exercise hypotension|post-exercise hypotension
4724838|NCT03080636|Aerobic Exercise|aerobic exercise
4724839|NCT03080636|Resistance Exercise|resistance exercise
4724840|NCT03080636|Autonomic Stress|autonomic stress
4724841|NCT03080636|Heart Rate Variability|heart rate variability
4724842|NCT03080636|Sex difference|sex difference
4724843|NCT03080610|Post-Dural Puncture Headache [C10.228.140.546.699.124]|post-dural puncture headache [c10.228.140.546.699.124]
4724844|NCT03080610|Blood Patch, Epidural [E02.319.267.530.580.300.145]|blood patch, epidural [e02.319.267.530.580.300.145]
4724845|NCT03080584|acupuncture|acupuncture
4724846|NCT03080584|IVF|ivf
4724847|NCT03080584|AMH|amh
4724848|NCT03080584|ovarian reserve|ovarian reserve
4724849|NCT03080558|Indocyanine green fluorescence|indocyanine green fluorescence
4724850|NCT03080558|Rectal vascularisation|rectal vascularisation
4724851|NCT03080558|Vaginal vascularisation|vaginal vascularisation
4724852|NCT03080558|Laparoscopic surgery|laparoscopic surgery
4724853|NCT03080558|Rectal shaving|rectal shaving
4724854|NCT03080558|Recto vaginal node|recto vaginal node
4724855|NCT03080558|Deep Endometriosis|deep endometriosis
4724856|NCT03080532|Microbiome|microbiome
4724857|NCT03080532|Mediterranean diet|mediterranean diet
4724858|NCT03080519|renal artery stenosis|renal artery stenosis
4724859|NCT03080519|balloon angioplasty|balloon angioplasty
4724860|NCT03080519|stents|stents
4724861|NCT03080493|Abortion|abortion
4724862|NCT03080493|Osmotic dilators|osmotic dilators
4724863|NCT03080493|Gabapentin|gabapentin
4724864|NCT03080493|Text message|text message
4724865|NCT03080480|Chronic Granulomatous Disease|chronic granulomatous disease
4724866|NCT03080480|Severe Infection|severe infection
4724867|NCT03080480|PPARγ|pparγ
4724868|NCT03080480|Pioglitazone|pioglitazone
4724869|NCT03080480|phagocytes|phagocytes
4724870|NCT03080467|Trauma|trauma
4724871|NCT03080467|Laceration|laceration
4724872|NCT03080467|Suture|suture
4724873|NCT03080467|Cosmesis|cosmesis
4724874|NCT03080467|Ethyl-2-Cyanoacrylate|ethyl-2-cyanoacrylate
4724875|NCT03080467|Tissue adhesive|tissue adhesive
4724876|NCT03080467|Lip lacerations|lip lacerations
4724877|NCT03080467|Skalp lacerations|skalp lacerations
4724878|NCT03080467|Facial injuries|facial injuries
4724879|NCT03080454|stroke|stroke
4724880|NCT03080454|CVA|cva
4724881|NCT03080454|Spasticity|spasticity
4724882|NCT03080454|hemiparesis|hemiparesis
4724883|NCT03080454|rehabilitation|rehabilitation
4724884|NCT03080454|tsDCS|tsdcs
4724885|NCT03080454|non-invasive stimulation|non-invasive stimulation
4724886|NCT03080428|Breast cancer|breast cancer
4724887|NCT03080428|ER-positive|er-positive
4724888|NCT03080428|Her-2 negative|her-2 negative
4724889|NCT03080428|genomic test|genomic test
4724890|NCT03080402|Anterior Cruciate Ligament|anterior cruciate ligament
4724891|NCT03080402|ACL injury|acl injury
4724892|NCT03080402|Injury prevention|injury prevention
4724893|NCT03080402|Perturbation training|perturbation training
4724894|NCT03080402|Risk factors|risk factors
4724895|NCT03080389|overactive bladder|overactive bladder
4724896|NCT03080389|overactive detrusor|overactive detrusor
4724897|NCT03080389|urgency-frequency|urgency-frequency
4724898|NCT03080389|urinary tract infection|urinary tract infection
4724899|NCT03080376|Exercise|exercise
4724900|NCT03080376|Web-based intervention|web-based intervention
4724901|NCT03080363|Extracorporeal Shockwave Lithotripsy|extracorporeal shockwave lithotripsy
4724902|NCT03080363|Quadratus Lumborum Block|quadratus lumborum block
4724903|NCT03080363|bupivacaine|bupivacaine
4724904|NCT03080363|lidocaine|lidocaine
4724905|NCT03080350|Fentanyl|fentanyl
4724906|NCT03080350|Transmucosal administration|transmucosal administration
4724907|NCT03080350|Endovenous administration|endovenous administration
4724908|NCT03080350|Pain therapy|pain therapy
4724909|NCT03080350|Mountain emergency medicine|mountain emergency medicine
4724910|NCT03080324|Fentanyl|fentanyl
4724911|NCT03080324|Transmucosal administration|transmucosal administration
4724912|NCT03080324|Endovenous administration|endovenous administration
4724913|NCT03080324|Pain therapy|pain therapy
4724914|NCT03080311|Bcl-2/Bcl-xL dual inhibitor|bcl-2/bcl-xl dual inhibitor
4724915|NCT03080272|individual patient|individual patient
4724916|NCT03080259|ADHD|adhd
4724917|NCT03080259|Stimulant Misuse|stimulant misuse
4724918|NCT03080259|Stimulant Diversion|stimulant diversion
4724919|NCT03080233|stroke|stroke
4724920|NCT03080233|Validation|validation
4724921|NCT03080233|Clinical decision support tool|clinical decision support tool
4724922|NCT03080207|Lower Extremity Lymphedema|lower extremity lymphedema
4724923|NCT03080207|Physiotherapy|physiotherapy
4724924|NCT03080207|Complex Decongestive Physiotherapy|complex decongestive physiotherapy
4724925|NCT03080207|Low Level Laser|low level laser
4724926|NCT03080207|Platelet rich plasma|platelet rich plasma
4724927|NCT03080194|schizophrenia|schizophrenia
4724928|NCT03080194|violence risk|violence risk
4724929|NCT03080194|long-acting antipsychotics|long-acting antipsychotics
4724930|NCT03080194|community-based|community-based
4724931|NCT03080168|suicidal ideation|suicidal ideation
4724932|NCT03080168|suicidal behavior|suicidal behavior
4724933|NCT03080168|Veterans|veterans
4724934|NCT03080168|inpatients|inpatients
4724935|NCT03080168|Actigraphy|actigraphy
4724936|NCT03080168|implicit associations|implicit associations
4724937|NCT03080168|risk factors|risk factors
4724938|NCT03080129|Liver cirrhosis|liver cirrhosis
4724939|NCT03080129|Sarcopenia|sarcopenia
4724940|NCT03080129|Microbiome|microbiome
4724941|NCT03080116|Randomized|randomized
4724942|NCT03080116|Placebo-controlled|placebo-controlled
4724943|NCT03080116|Neoadjuvant|neoadjuvant
4724944|NCT03080116|Androgen deprivation|androgen deprivation
4724945|NCT03080116|Antiandrogen|antiandrogen
4724946|NCT03080116|Radical Prostatectomy|radical prostatectomy
4724947|NCT03080103|Acute Appendicitis|acute appendicitis
4724948|NCT03080103|Uncomplicated Acute Appendicitis|uncomplicated acute appendicitis
4724949|NCT03080103|Appendectomy|appendectomy
4724950|NCT03080103|Conservative Treatment|conservative treatment
4724951|NCT03080103|Antibiotic-first Treatment|antibiotic-first treatment
4724952|NCT03080103|Recurrent Appendicitis|recurrent appendicitis
4724953|NCT03080103|Prospective Study|prospective study
4724954|NCT03080051|PSP|psp
4724955|NCT03080051|AD|ad
4724956|NCT03080051|HV|hv
4724957|NCT03080038|Sepsis|sepsis
4724958|NCT03080038|Shock|shock
4724959|NCT03080038|Septic Shock|septic shock
4724960|NCT03080038|Fluid Therapy|fluid therapy
4724961|NCT03080038|Resuscitation|resuscitation
4724962|NCT03080038|Pediatrics|pediatrics
4724963|NCT03080038|Emergency Medicine|emergency medicine
4724964|NCT03080038|Critical Care|critical care
4724965|NCT03080025|CBCT® (Cognitively Based Compassion-Training)|cbct® (cognitively based compassion-training)
4724966|NCT03080025|Psychobiological Evaluation|psychobiological evaluation
4724967|NCT03080025|Real Time Social Interaction|real time social interaction
4724968|NCT03080025|Eye-Tracking|eye-tracking
4724969|NCT03080025|Heart Rate Variability|heart rate variability
4724970|NCT03080025|IL-6|il-6
4724971|NCT03080025|IL-1b|il-1b
4724972|NCT03080025|Cortisol|cortisol
4724973|NCT03080025|Alpha-Amylase|alpha-amylase
4724974|NCT03080025|Randomised Controlled Trial|randomised controlled trial
4724975|NCT03080025|Compassion|compassion
4724976|NCT03080025|Empathy|empathy
4724977|NCT03080025|Relationship Quality|relationship quality
4724978|NCT03080025|Interpersonal Relations|interpersonal relations
4724979|NCT03080025|Stress|stress
4724980|NCT03079986|Pancreatic surgery|pancreatic surgery
4724981|NCT03079986|Chylous ascites|chylous ascites
4724982|NCT03079973|Calcipotriene|calcipotriene
4724983|NCT03079960|Parkinson|parkinson
4724984|NCT03079960|DBS|dbs
4724985|NCT03079960|Deep Brain Stimulation|deep brain stimulation
4724986|NCT03079960|LFP|lfp
4724987|NCT03079960|Local Field Potentials|local field potentials
4724988|NCT03079960|EEG|eeg
4724989|NCT03079960|Electroencephalogram|electroencephalogram
4724990|NCT03079947|Circulating DNA|circulating dna
4724991|NCT03079947|Diffuse Large B Cell Lymphoma|diffuse large b cell lymphoma
4724992|NCT03079947|Peripheral T-Cell Lymphoma|peripheral t-cell lymphoma
4724993|NCT03079947|prognosis|prognosis
4724994|NCT03079934|Bioresorbable vascular scaffold|bioresorbable vascular scaffold
4724995|NCT03079934|Optical coherence tomography|optical coherence tomography
4724996|NCT03079934|strut coverage|strut coverage
4724997|NCT03079934|acute coronary syndrome|acute coronary syndrome
4724998|NCT03079921|Islet Graft Function|islet graft function
4724999|NCT03079921|Islet Cell transplantation|islet cell transplantation
4725000|NCT03079921|Auto-islet transplantation|auto-islet transplantation
4725001|NCT03079921|Intra-hepatic islets|intra-hepatic islets
4725002|NCT03079921|Extra-hepatic islets|extra-hepatic islets
4725003|NCT03079908|Laparoscopy|laparoscopy
4725004|NCT03079908|Surgery|surgery
4725005|NCT03079908|Training|training
4725006|NCT03079908|Virtual reality|virtual reality
4725007|NCT03079908|Simulation|simulation
4725008|NCT03079908|Robotic Surgery|robotic surgery
4725009|NCT03079908|Da Vinci|da vinci
4725010|NCT03079895|Depression|depression
4725011|NCT03079895|internet|internet
4725012|NCT03079895|Cognitive Behavioral Therapy|cognitive behavioral therapy
4725013|NCT03079895|CBT|cbt
4725014|NCT03079895|computer|computer
4725015|NCT03079895|Primary Care|primary care
4725016|NCT03079895|Psychiatry|psychiatry
4725017|NCT03079895|treatment|treatment
4725018|NCT03079895|self-help|self-help
4725019|NCT03079895|managed care|managed care
4725020|NCT03079882|Ultrasound|ultrasound
4725021|NCT03079882|Viscoelasticity|viscoelasticity
4725022|NCT03079882|Viscoelastic Response (VisR) Ultrasound|viscoelastic response (visr) ultrasound
4725023|NCT03079856|Emerging adults|emerging adults
4725024|NCT03079856|Drugs|drugs
4725025|NCT03079856|HIV|hiv
4725026|NCT03079856|Risky Sex Behaviors|risky sex behaviors
4725027|NCT03079830|aortic valve surgery|aortic valve surgery
4725028|NCT03079830|postoperative pain|postoperative pain
4725029|NCT03079791|OCT|oct
4725030|NCT03079791|cardiac allograft vasculopathy|cardiac allograft vasculopathy
4725031|NCT03079791|CAV|cav
4725032|NCT03079791|intravascular imaging|intravascular imaging
4725033|NCT03079765|Telehealth|telehealth
4725034|NCT03079765|Functional behavior assessment|functional behavior assessment
4725035|NCT03079713|pain|pain
4725036|NCT03079713|anesthesia|anesthesia
4725037|NCT03079713|vibrator|vibrator
4725038|NCT03079713|intravitreal|intravitreal
4725039|NCT03079713|injection|injection
4725040|NCT03079687|Ovarian cancer|ovarian cancer
4725041|NCT03079687|gynaecological cancer|gynaecological cancer
4725042|NCT03079687|platinum-sensitive disease|platinum-sensitive disease
4725043|NCT03079687|platinum-sensitive relapsed|platinum-sensitive relapsed
4725044|NCT03079687|Olaparib|olaparib
4725045|NCT03079687|Ovarian Neoplasms|ovarian neoplasms
4725046|NCT03079687|Neoplasms|neoplasms
4725047|NCT03079687|Ovarian Disease|ovarian disease
4725048|NCT03079687|fallopean tube cancer|fallopean tube cancer
4725049|NCT03079687|primary peritoneal cancer|primary peritoneal cancer
4725050|NCT03079687|epithelial ovarian cancer|epithelial ovarian cancer
4725051|NCT03079687|PARP inhibitors|parp inhibitors
4725052|NCT03079687|Poly (ADP-ribose) polymerase inhibitors.|poly (adp-ribose) polymerase inhibitors.
4725053|NCT03079674|transient Ischemic Attack|transient ischemic attack
4725054|NCT03079674|minor Stroke|minor stroke
4725055|NCT03079674|non-disabling ischemic cerebrovascular events|non-disabling ischemic cerebrovascular events
4725056|NCT03079674|biomarker|biomarker
4725057|NCT03079674|epidemiology|epidemiology
4725058|NCT03079674|prognosis|prognosis
4725059|NCT03079661|pollution|pollution
4725060|NCT03079661|ozone|ozone
4725061|NCT03079661|Copd|copd
4725062|NCT03079661|particles|particles
4725063|NCT03079648|Angelica gigas N. extract|angelica gigas n. extract
4725064|NCT03079648|Hyperlipidemia|hyperlipidemia
4725065|NCT03079648|Clinical Trial|clinical trial
4725066|NCT03079596|gastric cancer|gastric cancer
4725067|NCT03079596|ERAS (early recovery after surgery)|eras (early recovery after surgery)
4725068|NCT03079596|laparoscopic total gastrectomy|laparoscopic total gastrectomy
4725069|NCT03079557|Adolescent|adolescent
4725070|NCT03079557|Injections, intraperitoneal|injections, intraperitoneal
4725071|NCT03079557|Endoscopy|endoscopy
4725072|NCT03079557|Botulinum Toxins, Type A|botulinum toxins, type a
4725073|NCT03079557|OnabotulinumtoxinA|onabotulinumtoxina
4725074|NCT03079518|iron deficiency|iron deficiency
4725075|NCT03079518|HFREF|hfref
4725076|NCT03079518|FGF23|fgf23
4725077|NCT03079518|ferric carboxymaltose|ferric carboxymaltose
4725078|NCT03079479|Arthoplasty|arthoplasty
4725079|NCT03079479|Gait|gait
4725080|NCT03079479|muscle strenght|muscle strenght
4725081|NCT03079479|Quality of life|quality of life
4725082|NCT03079466|Sleep apnea|sleep apnea
4725083|NCT03079466|Elderly|elderly
4725084|NCT03079466|CPAP|cpap
4725085|NCT03079453|Dexamethasone|dexamethasone
4725086|NCT03079453|Tonsillectomy|tonsillectomy
4725087|NCT03079453|Uvula|uvula
4725088|NCT03079453|Edema|edema
4725089|NCT03079453|Uvula edema|uvula edema
4725090|NCT03079453|Post-tonsillectomy|post-tonsillectomy
4725091|NCT03079440|Neuroendocrine tumors|neuroendocrine tumors
4725092|NCT03079440|Neuroendocrine Carcinoma|neuroendocrine carcinoma
4725093|NCT03079440|Capecitabine|capecitabine
4725094|NCT03079440|Temozolomide|temozolomide
4725095|NCT03079427|Cholangiocarcinoma|cholangiocarcinoma
4725096|NCT03079427|Adjuvant chemotherapy|adjuvant chemotherapy
4725097|NCT03079414|Sudden Cardiac Death|sudden cardiac death
4725098|NCT03079414|Cardiac Arrhythmia|cardiac arrhythmia
4725099|NCT03079414|Electrophysiology Study|electrophysiology study
4725100|NCT03079414|Genetics|genetics
4725101|NCT03079401|biventricular conversion|biventricular conversion
4725102|NCT03079375|cross sectional|cross sectional
4725103|NCT03079375|medication review|medication review
4725104|NCT03079375|readmissions|readmissions
4725105|NCT03079375|follow-up|follow-up
4725106|NCT03079336|Randomized controlled design development|randomized controlled design development
4725107|NCT03079336|Translational Research|translational research
4725108|NCT03079336|Psychological Interventions|psychological interventions
4725109|NCT03079336|Contextual Model of Psychotherapy|contextual model of psychotherapy
4725110|NCT03079323|External beam radiotherapy|external beam radiotherapy
4725111|NCT03079323|Prostate cancer|prostate cancer
4725112|NCT03079323|Elective para-aortic radiation therapy|elective para-aortic radiation therapy
4725113|NCT03079323|PART|part
4725114|NCT03079310|spinal cord stimulation|spinal cord stimulation
4725115|NCT03079310|gait analysis|gait analysis
4725116|NCT03079310|whole-body kinematics|whole-body kinematics
4725117|NCT03079310|Parkinson's disease|parkinson's disease
4725118|NCT03079310|Neuromodulation|neuromodulation
4725119|NCT03079310|Feature extraction|feature extraction
4725120|NCT03079297|Antidepressant|antidepressant
4725121|NCT03079297|Inflammation|inflammation
4725122|NCT03079297|Biomarker|biomarker
4725123|NCT03079297|Depression|depression
4725124|NCT03079297|Treatment Resistant Depression|treatment resistant depression
4725125|NCT03079297|Leucine|leucine
4725126|NCT03079258|vascular structure|vascular structure
4725127|NCT03079258|vascular function|vascular function
4725128|NCT03079258|cerebrovascular reactivity|cerebrovascular reactivity
4725129|NCT03079258|physical activity|physical activity
4725130|NCT03079258|sedentary behaviour|sedentary behaviour
4725131|NCT03079258|offspring health|offspring health
4725132|NCT03079258|maternal health|maternal health
4725133|NCT03079245|Neonatal ICU|neonatal icu
4725134|NCT03079245|antimicrobial stewardship|antimicrobial stewardship
4725135|NCT03079232|Optical biopsy|optical biopsy
4725136|NCT03079232|Skin cancer|skin cancer
4725137|NCT03079232|Diagnostic performance|diagnostic performance
4725138|NCT03079206|hazelnut|hazelnut
4725139|NCT03079206|allergens|allergens
4725140|NCT03079206|basophile-activation-test|basophile-activation-test
4725141|NCT03079206|food|food
4725142|NCT03079206|allergy|allergy
4725143|NCT03079193|post thyroidectomy|post thyroidectomy
4725144|NCT03079193|laryngeoscopic examination|laryngeoscopic examination
4725145|NCT03079180|Tendon|tendon
4725146|NCT03079180|Ageing|ageing
4725147|NCT03079180|Training|training
4725148|NCT03079180|Achilles tendon|achilles tendon
4725149|NCT03079180|Patella tendon|patella tendon
4725150|NCT03079180|Skeletal muscle|skeletal muscle
4725151|NCT03079180|Adaptation|adaptation
4725152|NCT03079180|Triceps Surae|triceps surae
4725153|NCT03079180|Quadriceps|quadriceps
4725154|NCT03079115|Atorvastatin|atorvastatin
4725155|NCT03079089|Allogenic cell stem transplant|allogenic cell stem transplant
4725156|NCT03079089|Sequential chemotherapy|sequential chemotherapy
4725157|NCT03079089|Haploidentical transplant|haploidentical transplant
4725158|NCT03079076|Postoperative Analgesia|postoperative analgesia
4725159|NCT03079076|Ultrasound guided thoracolumbar interfascial plane block|ultrasound guided thoracolumbar interfascial plane block
4725160|NCT03079011|ESR1 mutation detection, ctDNA|esr1 mutation detection, ctdna
4725161|NCT03078998|Juvenile Idiopathic Arthritis|juvenile idiopathic arthritis
4725162|NCT03078998|Cerebral Palsy|cerebral palsy
4725163|NCT03078998|Obstetric Brachial Plexus Palsy|obstetric brachial plexus palsy
4725164|NCT03078998|Human Computer Interaction|human computer interaction
4725165|NCT03078998|Leap Motion|leap motion
4725166|NCT03078998|Video Game Based Rehabilitation|video game based rehabilitation
4725167|NCT03078985|real-time MRI|real-time mri
4725168|NCT03078985|electrophysiology study|electrophysiology study
4725169|NCT03078985|atrial flutter ablation|atrial flutter ablation
4725170|NCT03078985|active tracking|active tracking
4725171|NCT03078946|Cardiac surgery|cardiac surgery
4725172|NCT03078946|delirium|delirium
4725173|NCT03078946|dexmedetomidine|dexmedetomidine
4725174|NCT03078946|morphine|morphine
4725175|NCT03078946|midazolam|midazolam
4725176|NCT03078933|DFU|dfu
4725177|NCT03078907|daily life|daily life
4725178|NCT03078907|physical activity|physical activity
4725179|NCT03078907|actigraphy|actigraphy
4725180|NCT03078907|PAH-SYMPACT|pah-sympact
4725181|NCT03078894|Zika|zika
4725182|NCT03078894|Dengue|dengue
4725183|NCT03078894|Chikagunya|chikagunya
4725184|NCT03078894|Peru|peru
4725185|NCT03078829|gender identity|gender identity
4725186|NCT03078829|trans female|trans female
4725187|NCT03078829|GnRH agonists|gnrh agonists
4725188|NCT03078829|QTc interval|qtc interval
4725189|NCT03078803|fecal transplant|fecal transplant
4725190|NCT03078803|inflammatory bowel disease|inflammatory bowel disease
4725191|NCT03078777|Pharmacokinetics|pharmacokinetics
4725192|NCT03078764|Mobile health (mHealth)|mobile health (mhealth)
4725193|NCT03078751|Hormone receptor-positive|hormone receptor-positive
4725194|NCT03078751|Estrogen and/or progesterone receptor-positive|estrogen and/or progesterone receptor-positive
4725195|NCT03078751|HER2-negative|her2-negative
4725196|NCT03078751|High risk early breast cancer|high risk early breast cancer
4725197|NCT03078751|Adjuvant|adjuvant
4725198|NCT03078751|Ribociclib|ribociclib
4725199|NCT03078751|LEE011|lee011
4725200|NCT03078751|CDK4/6 inhibitor|cdk4/6 inhibitor
4725201|NCT03078751|Endocrine therapy|endocrine therapy
4725202|NCT03078751|Phase II|phase ii
4725203|NCT03078751|Breast carcinoma|breast carcinoma
4725204|NCT03078751|Breast cancer|breast cancer
4725205|NCT03078738|OMT-28|omt-28
4725206|NCT03078738|Atrial Fibrillation|atrial fibrillation
4725207|NCT03078738|SAD|sad
4725208|NCT03078738|MAD|mad
4725209|NCT03078738|First-in-Man|first-in-man
4725210|NCT03078738|Cardiovascular|cardiovascular
4725211|NCT03078725|gestational diabetes|gestational diabetes
4725212|NCT03078725|glyburide|glyburide
4725213|NCT03078725|metformin|metformin
4725214|NCT03078725|failure rate|failure rate
4725215|NCT03078712|Septic Shock|septic shock
4725216|NCT03078712|Lactate|lactate
4725217|NCT03078712|Capillary Refill Time|capillary refill time
4725218|NCT03078712|Fluid Responsiveness|fluid responsiveness
4725219|NCT03078712|Mortality|mortality
4725220|NCT03078699|Thymoma|thymoma
4725221|NCT03078699|Thymic tumor|thymic tumor
4725222|NCT03078699|Stereotactic body radiotherapy|stereotactic body radiotherapy
4725223|NCT03078686|Stem Cells,PRP, tSVF,cSVF,Alopecia Areata,Scarring Alopecia|stem cells,prp, tsvf,csvf,alopecia areata,scarring alopecia
4725224|NCT03078673|Cross country poling, motor skill, strength training|cross country poling, motor skill, strength training
4725225|NCT03078634|Irritable bowel syndrome|irritable bowel syndrome
4725226|NCT03078634|Constipation|constipation
4725227|NCT03078634|Functional dyspepsia|functional dyspepsia
4725228|NCT03078634|Multi-disciplinary treatment|multi-disciplinary treatment
4725229|NCT03078621|stem cells|stem cells
4725230|NCT03078608|anxiety|anxiety
4725231|NCT03078608|quality of life|quality of life
4725232|NCT03078608|mindfulness|mindfulness
4725233|NCT03078608|meditation|meditation
4725234|NCT03078608|depression|depression
4725235|NCT03078595|periodontal disease|periodontal disease
4725236|NCT03078595|plaque-induced gingivitis|plaque-induced gingivitis
4725237|NCT03078595|bleeding on probing|bleeding on probing
4725238|NCT03078595|von willebrand disease|von willebrand disease
4725239|NCT03078595|gingival bleeding|gingival bleeding
4725240|NCT03078582|PNH|pnh
4725241|NCT03078569|Poor responders|poor responders
4725242|NCT03078556|FDC|fdc
4725243|NCT03078556|Lamivudine|lamivudine
4725244|NCT03078556|Bio-equivalence|bio-equivalence
4725245|NCT03078556|Dolutegravir|dolutegravir
4725246|NCT03078556|HIV|hiv
4725247|NCT03078530|GWI|gwi
4725248|NCT03078530|IBS|ibs
4725249|NCT03078530|Irritable Bowel Syndrome|irritable bowel syndrome
4725250|NCT03078530|Gulf War Illness|gulf war illness
4725251|NCT03078530|Probiotics|probiotics
4725252|NCT03078517|I-gel|i-gel
4725253|NCT03078517|Laryngeal mask airway protector|laryngeal mask airway protector
4725254|NCT03078491|type 1 diabetes|type 1 diabetes
4725255|NCT03078491|geriatrics|geriatrics
4725256|NCT03078491|older adults|older adults
4725257|NCT03078491|technology|technology
4725258|NCT03078491|CGM|cgm
4725259|NCT03078491|clinical decision support|clinical decision support
4725260|NCT03078491|hypoglycemia|hypoglycemia
4725261|NCT03078439|very preterm birth|very preterm birth
4725262|NCT03078439|developmental disorders|developmental disorders
4725263|NCT03078439|health problems|health problems
4725264|NCT03078439|prospective population-based cohort|prospective population-based cohort
4725265|NCT03078426|Lung|lung
4725266|NCT03078426|MRI|mri
4725267|NCT03078426|CT|ct
4725268|NCT03078426|Usual interstitial pneumonia|usual interstitial pneumonia
4725269|NCT03078426|Ultra-short echo time|ultra-short echo time
4725270|NCT03078413|Mustard Procedure|mustard procedure
4725271|NCT03078374|Reduced anti-coagulation, mechanical circulatory support.|reduced anti-coagulation, mechanical circulatory support.
4725272|NCT03078361|cancer screening|cancer screening
4725273|NCT03078361|colon|colon
4725274|NCT03078348|cancer screening|cancer screening
4725275|NCT03078335|Late onset sepsis|late onset sepsis
4725276|NCT03078335|glove based care|glove based care
4725277|NCT03078335|NICU|nicu
4725278|NCT03078335|Non sterile gloves|non sterile gloves
4725279|NCT03078335|infection control|infection control
4725280|NCT03078309|retinitis pigmentosa|retinitis pigmentosa
4725281|NCT03078309|retinal degeneration|retinal degeneration
4725282|NCT03078309|cannabis|cannabis
4725283|NCT03078309|THC|thc
4725284|NCT03078309|CBD|cbd
4725285|NCT03078309|electrophysiology|electrophysiology
4725286|NCT03078309|visual functions|visual functions
4725287|NCT03078309|eye|eye
4725288|NCT03078309|retina|retina
4725289|NCT03078270|social anxiety|social anxiety
4725290|NCT03078270|botulinum toxin|botulinum toxin
4725291|NCT03078270|botox|botox
4725292|NCT03078257|Platelet Activities|platelet activities
4725293|NCT03078257|light aggregometry|light aggregometry
4725294|NCT03078257|VerifyNow P2Y12-assay|verifynow p2y12-assay
4725295|NCT03078257|peripheral vein|peripheral vein
4725296|NCT03078257|peripheral artery|peripheral artery
4725297|NCT03078257|intracoronary artery|intracoronary artery
4725298|NCT03078257|tirofiban|tirofiban
4725299|NCT03078257|antiplatelet thrombolysin|antiplatelet thrombolysin
4725300|NCT03078218|Pulse oximetry|pulse oximetry
4725301|NCT03078218|Asymptomatic newborns|asymptomatic newborns
4725302|NCT03078205|TCM multi-channel therapy|tcm multi-channel therapy
4725303|NCT03078205|ART failure|art failure
4725304|NCT03078179|Probiotic|probiotic
4725305|NCT03078179|Child|child
4725306|NCT03078179|Care, dental|care, dental
4725307|NCT03078166|Cardiac Failure|cardiac failure
4725308|NCT03078166|Congestive Heart Failure|congestive heart failure
4725309|NCT03078166|Heart Decompensation|heart decompensation
4725310|NCT03078166|Heart Failure, Congestive|heart failure, congestive
4725311|NCT03078166|Heart Failure, Left-Sided|heart failure, left-sided
4725312|NCT03078166|Heart Failure, Right-Sided|heart failure, right-sided
4725313|NCT03078166|Left-Sided Heart Failure|left-sided heart failure
4725314|NCT03078166|Myocardial Failure|myocardial failure
4725315|NCT03078166|Right-Sided Heart Failure|right-sided heart failure
4725316|NCT03078166|Outcomes|outcomes
4725317|NCT03078166|Co-morbidities|co-morbidities
4725318|NCT03078166|Biomarkers|biomarkers
4725319|NCT03078101|Empagliflozin|empagliflozin
4725320|NCT03078101|SGLT-2 Inhibiton and RAS in CKD|sglt-2 inhibiton and ras in ckd
4725321|NCT03078075|Methamphetamine|methamphetamine
4725322|NCT03078075|Methamphetamine Use Disorder|methamphetamine use disorder
4725323|NCT03078075|Naltrexone|naltrexone
4725324|NCT03078075|Bupropion|bupropion
4725325|NCT03078075|Vivitrol®|vivitrol®
4725326|NCT03078062|Spinal anesthesia|spinal anesthesia
4725327|NCT03078062|Motor block|motor block
4725328|NCT03078062|Sensory block|sensory block
4725329|NCT03078062|Dexamethasone|dexamethasone
4725330|NCT03078036|HER2-ve metastatic breast cancer|her2-ve metastatic breast cancer
4725331|NCT03078036|gBRCA, sBRCA and HRR gene mutations|gbrca, sbrca and hrr gene mutations
4725332|NCT03078023|EoE|eoe
4725333|NCT03078010|Antibiotic|antibiotic
4725334|NCT03078010|piperacillin-tazobactam|piperacillin-tazobactam
4725335|NCT03078010|cefepime|cefepime
4725336|NCT03078010|aztreonam|aztreonam
4725337|NCT03078010|17-097|17-097
4725338|NCT03077997|Diabetes|diabetes
4725339|NCT03077997|Diabetes distress|diabetes distress
4725340|NCT03077971|Carers of People with Multiple Sclerosis|carers of people with multiple sclerosis
4725341|NCT03077971|Carer Strain|carer strain
4725342|NCT03077971|Acceptance and Commitment Therapy|acceptance and commitment therapy
4725343|NCT03077945|biofeedback|biofeedback
4725344|NCT03077945|heart rate variability|heart rate variability
4725345|NCT03077945|HRV|hrv
4725346|NCT03077945|psychophysiology|psychophysiology
4725347|NCT03077945|reappraisal|reappraisal
4725348|NCT03077945|cognitive reappraisal|cognitive reappraisal
4725349|NCT03077945|arousal reappraisal|arousal reappraisal
4725350|NCT03077945|woman|woman
4725351|NCT03077945|women|women
4725352|NCT03077945|female|female
4725353|NCT03077945|smoker|smoker
4725354|NCT03077945|relapse|relapse
4725355|NCT03077945|cigarette|cigarette
4725356|NCT03077945|craving|craving
4725357|NCT03077945|self regulation|self regulation
4725358|NCT03077945|emotion regulation|emotion regulation
4725359|NCT03077945|stress response|stress response
4725360|NCT03077945|cognitive behavioral intervention|cognitive behavioral intervention
4725361|NCT03077945|respiratory sinus arrhythmia|respiratory sinus arrhythmia
4725362|NCT03077945|smoking cessation intervention|smoking cessation intervention
4725363|NCT03077919|Posttraumatic Stress Disorder|posttraumatic stress disorder
4725364|NCT03077919|Generalized Anxiety Disorder|generalized anxiety disorder
4725365|NCT03077919|Depression|depression
4725366|NCT03077919|Distress|distress
4725367|NCT03077919|Alcohol Use|alcohol use
4725368|NCT03077919|Pain|pain
4725369|NCT03077906|Gastroœsophageal Reflux|gastroœsophageal reflux
4725370|NCT03077906|Sleeve Gastrectomy|sleeve gastrectomy
4725371|NCT03077880|implant insertion|implant insertion
4725372|NCT03077880|bone resorption|bone resorption
4725373|NCT03077880|soft tissue|soft tissue
4725374|NCT03077867|sinus lift|sinus lift
4725375|NCT03077867|synthetic hydroxyapatite|synthetic hydroxyapatite
4725376|NCT03077867|bone graft|bone graft
4725377|NCT03077854|Lung Cancer|lung cancer
4725378|NCT03077854|Radiotherapy|radiotherapy
4725379|NCT03077854|Biomarkers|biomarkers
4725380|NCT03077854|Radiation Lung Injury|radiation lung injury
4725381|NCT03077854|Quality of Life|quality of life
4725382|NCT03077841|Malignant neoplasm of breast|malignant neoplasm of breast
4725383|NCT03077841|Breast cancer|breast cancer
4725384|NCT03077841|Radiation therapy|radiation therapy
4725386|NCT03077841|External beam radiation therapy|external beam radiation therapy
4725387|NCT03077841|Shorter course|shorter course
4725388|NCT03077841|Questionnaires|questionnaires
4725389|NCT03077841|Surveys|surveys
4725390|NCT03077802|Seldinger technique|seldinger technique
4725391|NCT03077802|Modified Seldinger technique|modified seldinger technique
4725392|NCT03077802|Complication|complication
4725393|NCT03077802|Success rate|success rate
4725394|NCT03077789|visual acuity|visual acuity
4725395|NCT03077789|prognosis epidemiology|prognosis epidemiology
4725396|NCT03077763|nitrite|nitrite
4725397|NCT03077763|haemoglobin|haemoglobin
4725398|NCT03077763|normoxia|normoxia
4725399|NCT03077763|hypoxia|hypoxia
4725400|NCT03077763|vasodilatation|vasodilatation
4725401|NCT03077763|blood|blood
4725402|NCT03077750|viral skin disease|viral skin disease
4725403|NCT03077737|Treatment access|treatment access
4725404|NCT03077737|Treatment utilization|treatment utilization
4725405|NCT03077737|Smoking cessation|smoking cessation
4725406|NCT03077737|Low income|low income
4725407|NCT03077737|Electronic health record system|electronic health record system
4725408|NCT03077737|Electronic referral|electronic referral
4725409|NCT03077724|n-3 polyunsaturated fatty acids|n-3 polyunsaturated fatty acids
4725410|NCT03077724|tobacco use|tobacco use
4725411|NCT03077724|pregnancy|pregnancy
4725412|NCT03077698|Endometrial cancer|endometrial cancer
4725413|NCT03077698|Recurrent or persistent endometrial carcinoma|recurrent or persistent endometrial carcinoma
4725414|NCT03077698|Progesterone Receptor Negative|progesterone receptor negative
4725415|NCT03077698|Sodium Cridanimod|sodium cridanimod
4725416|NCT03077685|pancreatic neoplasms|pancreatic neoplasms
4725417|NCT03077685|digestive system neoplasms|digestive system neoplasms
4725418|NCT03077685|pancreatic diseases|pancreatic diseases
4725419|NCT03077685|digestive system diseases|digestive system diseases
4725420|NCT03077685|pancreatic adenocarcinoma|pancreatic adenocarcinoma
4725421|NCT03077685|pancreatic cancer|pancreatic cancer
4725422|NCT03077672|Mitochondrial DNA|mitochondrial dna
4725423|NCT03077672|Lactate|lactate
4725424|NCT03077672|Mortality|mortality
4725425|NCT03077672|Emergency Department|emergency department
4725426|NCT03077672|Intensive Care Unit|intensive care unit
4725427|NCT03077672|Triage|triage
4725428|NCT03077672|Organ Dysfunction|organ dysfunction
4725429|NCT03077672|Biomarker|biomarker
4725430|NCT03077672|Prognosis|prognosis
4725431|NCT03077659|prostate cancer|prostate cancer
4725432|NCT03077659|prostatic neoplasms|prostatic neoplasms
4725433|NCT03077659|genital neoplasms, male|genital neoplasms, male
4725434|NCT03077659|urogenital neoplasms|urogenital neoplasms
4725435|NCT03077659|prostatic diseases|prostatic diseases
4725436|NCT03077646|firearm|firearm
4725437|NCT03077646|gun|gun
4725438|NCT03077646|safety|safety
4725439|NCT03077646|pediatric|pediatric
4725440|NCT03077646|inpatient|inpatient
4725441|NCT03077633|Cerclage|cerclage
4725442|NCT03077633|Cervical shortening|cervical shortening
4725443|NCT03077633|Twins|twins
4725444|NCT03077633|Progesterone|progesterone
4725445|NCT03077568|internet|internet
4725446|NCT03077568|web-based|web-based
4725447|NCT03077568|behavior change|behavior change
4725448|NCT03077568|stress-management|stress-management
4725449|NCT03077555|quick starting contraception|quick starting contraception
4725450|NCT03077542|Peripheral Blood Stem Cells|peripheral blood stem cells
4725451|NCT03077542|Host-Donor Chimerism|host-donor chimerism
4725452|NCT03077542|Graft Versus Host Disease|graft versus host disease
4725453|NCT03077542|Haploidentical|haploidentical
4725454|NCT03077542|Donor Apheresis|donor apheresis
4725455|NCT03077503|Hemodynamic response|hemodynamic response
4725456|NCT03077503|Skull pins application|skull pins application
4725457|NCT03077503|Dexmedetomidine|dexmedetomidine
4725458|NCT03077503|Fentanyl|fentanyl
4725459|NCT03077490|Pelvic organ prolapse|pelvic organ prolapse
4725460|NCT03077490|transvaginal mesh|transvaginal mesh
4725461|NCT03077490|complications|complications
4725462|NCT03077464|nutrition education|nutrition education
4725463|NCT03077464|Vegetables|vegetables
4725464|NCT03077464|Fruit|fruit
4725465|NCT03077438|Meningitis|meningitis
4725466|NCT03077438|Meningococcal Meningitis|meningococcal meningitis
4725467|NCT03077438|MenACYW conjugate vaccine|menacyw conjugate vaccine
4725468|NCT03077438|MENVEO®|menveo®
4725469|NCT03077399|lateropulsion|lateropulsion
4725470|NCT03077399|stroke|stroke
4725471|NCT03077399|Pusher syndrome|pusher syndrome
4725472|NCT03077386|patient navigator|patient navigator
4725473|NCT03077386|community health worker|community health worker
4725474|NCT03077386|multi-morbidity|multi-morbidity
4725475|NCT03077386|primary care|primary care
4725476|NCT03077386|social determinants of health|social determinants of health
4725477|NCT03077373|systolic blood pressure|systolic blood pressure
4725478|NCT03077373|physical activity|physical activity
4725479|NCT03077373|sedentary time|sedentary time
4725480|NCT03077373|smoking|smoking
4725481|NCT03077347|Schizophrenia|schizophrenia
4725482|NCT03077347|Transcranial Direct Current Stimulation|transcranial direct current stimulation
4725483|NCT03077347|tDCS|tdcs
4725484|NCT03077347|Cognitive Control|cognitive control
4725485|NCT03077347|fMRI|fmri
4725486|NCT03077347|Dorsolateral Prefrontal Cortex|dorsolateral prefrontal cortex
4725487|NCT03077308|Auditory ERP, Visual ERP, EEG|auditory erp, visual erp, eeg
4725488|NCT03077282|Prasaprohyai extract, Healthy volunteers|prasaprohyai extract, healthy volunteers
4725489|NCT03077269|burn|burn
4725490|NCT03077269|coagulation|coagulation
4725491|NCT03077269|inflammation|inflammation
4725492|NCT03077256|Ankle Arthrodesis|ankle arthrodesis
4725493|NCT03077256|Cellular Allograft|cellular allograft
4725494|NCT03077243|Human Papillomavirus|human papillomavirus
4725495|NCT03077243|Oropharynx|oropharynx
4725496|NCT03077243|Oropharyngeal Squamous Cell Carcinoma|oropharyngeal squamous cell carcinoma
4725497|NCT03077243|Squamous Cell Carcinoma|squamous cell carcinoma
4725498|NCT03077243|Radiation Therapy|radiation therapy
4725499|NCT03077243|Chemotherapy|chemotherapy
4725500|NCT03077243|p16|p16
4725501|NCT03077217|covert hepatic encephalopathy|covert hepatic encephalopathy
4725502|NCT03077217|low-dose rifaximin|low-dose rifaximin
4725503|NCT03077204|Total cervical vertebrectomy|total cervical vertebrectomy
4725504|NCT03077204|Partial cervical vertebrectomy|partial cervical vertebrectomy
4725505|NCT03077204|Failed previous fusion|failed previous fusion
4725506|NCT03077204|Spinal stenosis|spinal stenosis
4725507|NCT03077204|Tumor|tumor
4725508|NCT03077204|Decompression of the spinal cord|decompression of the spinal cord
4725509|NCT03077204|Pseudoarthrosis|pseudoarthrosis
4725510|NCT03077204|Curvatures|curvatures
4725511|NCT03077204|Deformities|deformities
4725512|NCT03077191|hypofractionated whole breast radiotherapy|hypofractionated whole breast radiotherapy
4725513|NCT03077191|breast cancer|breast cancer
4725514|NCT03077191|conservative treatment|conservative treatment
4725515|NCT03077191|quality of life|quality of life
4725516|NCT03077178|Soft Tissue Sarcoma|soft tissue sarcoma
4725517|NCT03077178|Surgery|surgery
4725518|NCT03077178|Functional Impact|functional impact
4725519|NCT03077178|Elderly Patient|elderly patient
4725520|NCT03077178|Geriatrics|geriatrics
4725521|NCT03077152|copd, aecopd, antibiotic use|copd, aecopd, antibiotic use
4725522|NCT03077126|elastography|elastography
4725523|NCT03077126|ultrasound|ultrasound
4725524|NCT03077126|prostate|prostate
4725525|NCT03077126|cancer screening|cancer screening
4725526|NCT03077113|lung cancer|lung cancer
4725527|NCT03077113|radiation therapy|radiation therapy
4725528|NCT03077048|CKD|ckd
4725529|NCT03077048|Ketosteril|ketosteril
4725530|NCT03077048|keto-acids|keto-acids
4725531|NCT03077048|ketoanalogues|ketoanalogues
4725532|NCT03077048|Chronic kidney disease|chronic kidney disease
4725533|NCT03077035|ICDAS|icdas
4725534|NCT03077035|DIAGNOdent|diagnodent
4725535|NCT03077035|glass ionomer sealant|glass ionomer sealant
4725536|NCT03077035|resin-based sealant|resin-based sealant
4725537|NCT03077035|pit and fissure sealants|pit and fissure sealants
4725538|NCT03077035|effectiveness of preventing caries|effectiveness of preventing caries
4725539|NCT03076983|Ventilation Monitoring|ventilation monitoring
4725540|NCT03076983|Electrical Impedance Tomography|electrical impedance tomography
4725541|NCT03076931|Voice|voice
4725542|NCT03076931|Biomarker|biomarker
4725543|NCT03076931|Airway Reconstruction|airway reconstruction
4725544|NCT03076918|PDT, Methyl Aminolevulinate, Light Emitting Textile|pdt, methyl aminolevulinate, light emitting textile
4725545|NCT03076892|PDT|pdt
4725546|NCT03076892|Methyl Aminolevulinate|methyl aminolevulinate
4725547|NCT03076892|light emitting textile|light emitting textile
4725548|NCT03076879|Cervical Cancer|cervical cancer
4725549|NCT03076879|Pap smear|pap smear
4725550|NCT03076879|Screening|screening
4725551|NCT03076879|Beliefs|beliefs
4725552|NCT03076879|Attitude|attitude
4725553|NCT03076879|Nursing|nursing
4725554|NCT03076840|hamstring tightness|hamstring tightness
4725555|NCT03076801|Choral Singing|choral singing
4725556|NCT03076801|Music|music
4725557|NCT03076801|Quality of Life|quality of life
4725558|NCT03076801|Psychosocial Stress|psychosocial stress
4725559|NCT03076801|Cardiac Rehabilitation|cardiac rehabilitation
4725560|NCT03076788|echocardiography|echocardiography
4725561|NCT03076788|intraventricular pressure gradients|intraventricular pressure gradients
4725562|NCT03076788|cardiac remodeling|cardiac remodeling
4725563|NCT03076788|athletes|athletes
4725564|NCT03076775|Betamethasone|betamethasone
4725565|NCT03076775|Late preterm|late preterm
4725566|NCT03076775|Steroids|steroids
4725567|NCT03076762|interstitial cystitis|interstitial cystitis
4725568|NCT03076762|pain|pain
4725569|NCT03076762|intravesical injection|intravesical injection
4725570|NCT03076762|therapy|therapy
4725571|NCT03076762|bladder|bladder
4725572|NCT03076749|Betalactam|betalactam
4725573|NCT03076749|Decision tree|decision tree
4725574|NCT03076749|Drug hypersensitivity|drug hypersensitivity
4725575|NCT03076749|Logistic regression|logistic regression
4725576|NCT03076749|Predictive modelling|predictive modelling
4725577|NCT03076710|spine surgery|spine surgery
4725578|NCT03076710|post-operative pain|post-operative pain
4725579|NCT03076710|patient controlled analgesia|patient controlled analgesia
4725580|NCT03076710|Exparel®|exparel®
4725581|NCT03076710|bupivacaine|bupivacaine
4725582|NCT03076697|fundus photography|fundus photography
4725583|NCT03076697|smartphone-based photography|smartphone-based photography
4725584|NCT03076671|Palliative Care|palliative care
4725585|NCT03076671|Supportive Care|supportive care
4725586|NCT03076671|Movement Disorders|movement disorders
4725587|NCT03076671|Brain Disease|brain disease
4725588|NCT03076671|Neurodegeneration|neurodegeneration
4725589|NCT03076671|Parkinson's Disease|parkinson's disease
4725590|NCT03076632|transcranial magnetic stimulation|transcranial magnetic stimulation
4725591|NCT03076632|neurostimulation|neurostimulation
4725592|NCT03076632|non-invasive stimulation|non-invasive stimulation
4725593|NCT03076632|closed-loop stimulation|closed-loop stimulation
4725594|NCT03076619|pregnancy induced hypertension|pregnancy induced hypertension
4725595|NCT03076619|ophthalmoscopy|ophthalmoscopy
4725596|NCT03076593|geriatric|geriatric
4725597|NCT03076567|Epidemiology|epidemiology
4725598|NCT03076567|Cancer|cancer
4725599|NCT03076567|Methylation|methylation
4725600|NCT03076567|Genetics|genetics
4725601|NCT03076567|Screening|screening
4725602|NCT03076554|Programmed Death 1 (PD-1)|programmed death 1 (pd-1)
4725603|NCT03076554|Immune Checkpoint Blockade|immune checkpoint blockade
4725604|NCT03076541|Restless legs syndrome|restless legs syndrome
4725605|NCT03076541|Periodic leg movements|periodic leg movements
4725606|NCT03076541|Heart rate|heart rate
4725607|NCT03076541|Heart rate variability|heart rate variability
4725608|NCT03076541|Microarousals|microarousals
4725609|NCT03076541|Autonomic nervous system activity|autonomic nervous system activity
4725610|NCT03076528|exercise|exercise
4725611|NCT03076528|exergame|exergame
4725612|NCT03076528|hemodialysis|hemodialysis
4725613|NCT03076528|balance|balance
4725614|NCT03076502|ctDNA|ctdna
4725615|NCT03076502|Gastrointestinal Cancer|gastrointestinal cancer
4725616|NCT03076502|ROS|ros
4725617|NCT03076502|Hepatobiliary Pancreatic Cancer|hepatobiliary pancreatic cancer
4725618|NCT03076476|Coronary Stent|coronary stent
4725619|NCT03076476|PCI|pci
4725620|NCT03076476|BVS|bvs
4725621|NCT03076476|Index of microcirculatory resistance|index of microcirculatory resistance
4725622|NCT03076463|Polyphenols|polyphenols
4725623|NCT03076463|Metabolic syndrome|metabolic syndrome
4725624|NCT03076463|Cardiometabolic risk|cardiometabolic risk
4725625|NCT03076463|Grape pomace|grape pomace
4725626|NCT03076463|Postprandial glucose|postprandial glucose
4725627|NCT03076463|Insulin resistance|insulin resistance
4725628|NCT03076463|Obesity|obesity
4725629|NCT03076450|Acute respiratory distress syndrome, ARDS|acute respiratory distress syndrome, ards
4725630|NCT03076450|Point-of-care lung ultrasound,POC-LUS|point-of-care lung ultrasound,poc-lus
4725631|NCT03076450|Pressure-volume curve, PVC|pressure-volume curve, pvc
4725632|NCT03076450|Positive end-expiratory pressure, PEEP|positive end-expiratory pressure, peep
4725633|NCT03076450|Ultrasound re-aeration score, US-RAS|ultrasound re-aeration score, us-ras
4725634|NCT03076411|Dyspepsia|dyspepsia
4725635|NCT03076411|Observational trial|observational trial
4725636|NCT03076411|Enzyme therapy|enzyme therapy
4725637|NCT03076411|Pepsin|pepsin
4725638|NCT03076385|VAL-506440|val-506440
4725639|NCT03076385|H10N8 antigen mRNA|h10n8 antigen mrna
4725640|NCT03076385|Influenza vaccine|influenza vaccine
4725641|NCT03076372|Cancer|cancer
4725642|NCT03076372|Oncology|oncology
4725643|NCT03076372|Phase I|phase i
4725644|NCT03076372|Gemcitabine|gemcitabine
4725645|NCT03076372|Carboplatin|carboplatin
4725646|NCT03076372|MM-310|mm-310
4725647|NCT03076372|EphA2|epha2
4725648|NCT03076372|Ephrin A2|ephrin a2
4725649|NCT03076372|Solid tumors|solid tumors
4725650|NCT03076372|urothelial carcinoma|urothelial carcinoma
4725651|NCT03076372|gastric carcinoma|gastric carcinoma
4725652|NCT03076372|squamous cell carcinoma of the head and neck|squamous cell carcinoma of the head and neck
4725653|NCT03076372|ovarian cancer|ovarian cancer
4725654|NCT03076372|pancreatic ductal adenocarcinoma|pancreatic ductal adenocarcinoma
4725655|NCT03076372|prostate adenocarcinoma|prostate adenocarcinoma
4725656|NCT03076372|non-small cell lung cancer|non-small cell lung cancer
4725657|NCT03076372|small cell lung cancer|small cell lung cancer
4725658|NCT03076372|triple negative breast cancer|triple negative breast cancer
4725659|NCT03076372|endometrial carcinoma|endometrial carcinoma
4725660|NCT03076372|soft tissue sarcoma|soft tissue sarcoma
4725661|NCT03076372|Merrimack|merrimack
4725662|NCT03076320|Modified diallyl disulfide oxide (M-DDO)|modified diallyl disulfide oxide (m-ddo)
4725663|NCT03076320|Pirfenidone (PFD)|pirfenidone (pfd)
4725664|NCT03076320|Adapalene + Benzoyl peroxide (A-BPO)|adapalene + benzoyl peroxide (a-bpo)
4725665|NCT03076294|knee ostearthritis|knee ostearthritis
4725666|NCT03076294|transcranial magnetic stimulation|transcranial magnetic stimulation
4725667|NCT03076294|repetitive transcranial magnetic stimulation|repetitive transcranial magnetic stimulation
4725668|NCT03076294|chronic pain|chronic pain
4725669|NCT03076294|musculoskeletal manipulations|musculoskeletal manipulations
4725670|NCT03076216|Pancreatic Cancer|pancreatic cancer
4725671|NCT03076216|Pancreas|pancreas
4725672|NCT03076216|metastases|metastases
4725673|NCT03076216|pancreatic tumour|pancreatic tumour
4725674|NCT03076216|unresectable|unresectable
4725675|NCT03076216|locally advanced|locally advanced
4725676|NCT03076216|implantable|implantable
4725677|NCT03076216|radiographic|radiographic
4725678|NCT03076216|device|device
4725679|NCT03076216|Phosphorous-32 (P32)|phosphorous-32 (p32)
4725680|NCT03076216|OncoSil™|oncosil™
4725681|NCT03076216|brachytherapy|brachytherapy
4725682|NCT03076216|gemcitabine|gemcitabine
4725683|NCT03076216|nab-paclitaxel|nab-paclitaxel
4725684|NCT03076216|Abraxane|abraxane
4725685|NCT03076190|psychology|psychology
4725686|NCT03076190|pain|pain
4725687|NCT03076190|surgery|surgery
4725688|NCT03076190|treatment|treatment
4725689|NCT03076190|catastrophizing|catastrophizing
4725690|NCT03076190|cancer|cancer
4725691|NCT03076177|knee osteoarthritis, kinesio taping, knee function, pain|knee osteoarthritis, kinesio taping, knee function, pain
4725692|NCT03076164|erlotinib|erlotinib
4725693|NCT03076164|trametinib|trametinib
4725694|NCT03076164|15-098|15-098
4725695|NCT03076151|Transplantation|transplantation
4725696|NCT03076151|Kidney|kidney
4725697|NCT03076151|pharmacokinetic|pharmacokinetic
4725698|NCT03076151|bayesian estimators|bayesian estimators
4725699|NCT03076138|Gene-activated matrix|gene-activated matrix
4725700|NCT03076138|Bone substitute|bone substitute
4725701|NCT03076138|Bone grafting|bone grafting
4725702|NCT03076138|Dental implantation|dental implantation
4725703|NCT03076138|gene therapy|gene therapy
4725704|NCT03076138|plasmid DNA|plasmid dna
4725705|NCT03076138|VEGF gene|vegf gene
4725706|NCT03076138|octacalcium phosphate|octacalcium phosphate
4725707|NCT03076125|Primary Stroke Prevention, Risk Factors for Stroke|primary stroke prevention, risk factors for stroke
4725708|NCT03076112|Ipragliflozin|ipragliflozin
4725709|NCT03076112|Sitagliptin|sitagliptin
4725710|NCT03076099|Dexmedetomidine|dexmedetomidine
4725711|NCT03076099|brain arteriovenous malformation|brain arteriovenous malformation
4725712|NCT03076099|embolization|embolization
4725713|NCT03076099|post-operative hypertension|post-operative hypertension
4725714|NCT03076073|Ultrasound|ultrasound
4725715|NCT03076073|Achilles tendon|achilles tendon
4725716|NCT03076073|Patellar tendon|patellar tendon
4725717|NCT03076073|obesity|obesity
4725718|NCT03076060|Ketogenic Diet|ketogenic diet
4725719|NCT03076060|Very low calories diet|very low calories diet
4725720|NCT03076060|ketone bodies|ketone bodies
4725721|NCT03075995|lapatinib|lapatinib
4725722|NCT03075995|steady state plasma concentration|steady state plasma concentration
4725723|NCT03075995|high-fat breakfast|high-fat breakfast
4725724|NCT03075969|Chronic myeloid leukemia; quality of life|chronic myeloid leukemia; quality of life
4725725|NCT03075930|Atrial fibrillation|atrial fibrillation
4725726|NCT03075930|ECG|ecg
4725727|NCT03075930|Body surface potential map|body surface potential map
4725728|NCT03075930|Recurrence of AF|recurrence of af
4725729|NCT03075917|Allergic rhinitis|allergic rhinitis
4725730|NCT03075865|intermaxillary fixation|intermaxillary fixation
4725731|NCT03075865|maxillo-mandibular fixation|maxillo-mandibular fixation
4725732|NCT03075852|Heads-up display, NGENUITY, Vitreoretinal surgery|heads-up display, ngenuity, vitreoretinal surgery
4725733|NCT03075800|Assertive Community Treatment (ACT) Only|assertive community treatment (act) only
4725734|NCT03075800|Assertive Community Treatment (ACT) + Illness Management and Recovery (IMR)|assertive community treatment (act) + illness management and recovery (imr)
4725735|NCT03075787|Obstructive sleep apnea|obstructive sleep apnea
4725736|NCT03075787|Heart rate|heart rate
4725737|NCT03075787|Heart rate variability|heart rate variability
4725738|NCT03075787|Microarousals|microarousals
4725739|NCT03075787|Autonomic nervous system activity|autonomic nervous system activity
4725740|NCT03075761|Venous thromboembolism|venous thromboembolism
4725741|NCT03075761|Deep Vein Thrombosis|deep vein thrombosis
4725742|NCT03075761|Lower Extremity|lower extremity
4725743|NCT03075761|Blood clot|blood clot
4725744|NCT03075761|Anticoagulation|anticoagulation
4725745|NCT03075761|Physical Activity|physical activity
4725746|NCT03075761|Fitbit|fitbit
4725747|NCT03075761|Post-thrombotic syndrome|post-thrombotic syndrome
4725748|NCT03075761|Post-phlebitic syndrome|post-phlebitic syndrome
4725749|NCT03075761|Thrombosis|thrombosis
4725750|NCT03075748|Vascular|vascular
4725751|NCT03075748|Stent|stent
4725752|NCT03075748|Graft|graft
4725753|NCT03075735|Castration-Resistant Prostate Cancer|castration-resistant prostate cancer
4725754|NCT03075735|DNA-repair|dna-repair
4725755|NCT03075735|BRCA1|brca1
4725756|NCT03075735|BRCA2|brca2
4725757|NCT03075735|ATM|atm
4725758|NCT03075735|PALB2|palb2
4725759|NCT03075709|Clinical Pathway|clinical pathway
4725760|NCT03075709|CPW|cpw
4725761|NCT03075709|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
4725762|NCT03075709|COPD|copd
4725763|NCT03075709|Protocol|protocol
4725764|NCT03075709|Adherence|adherence
4725765|NCT03075709|Readmission|readmission
4725766|NCT03075709|Length of Stay|length of stay
4725767|NCT03075709|Cost|cost
4725768|NCT03075683|Cognitive behavioural therapy|cognitive behavioural therapy
4725769|NCT03075683|Non-pharmacological treatment|non-pharmacological treatment
4725770|NCT03075683|Internet mediated|internet mediated
4725771|NCT03075579|ADHD, cortisol, α-amylase, actometer|adhd, cortisol, α-amylase, actometer
4725772|NCT03075566|coronary artery disease|coronary artery disease
4725773|NCT03075566|risk factors|risk factors
4725774|NCT03075566|inflammation|inflammation
4725775|NCT03075566|biomarkers|biomarkers
4725776|NCT03075566|atherosclerosis|atherosclerosis
4725777|NCT03075540|Latinas|latinas
4725778|NCT03075527|Mesothelioma|mesothelioma
4725779|NCT03075514|ketogenic|ketogenic
4725780|NCT03075501|drug cues|drug cues
4725781|NCT03075475|Child|child
4725782|NCT03075475|Adolescent|adolescent
4725783|NCT03075475|Mental Health|mental health
4725784|NCT03075475|Randomized Controlled Trial|randomized controlled trial
4725785|NCT03075462|PARP inhibitor|parp inhibitor
4725786|NCT03075462|VEGFR inhibitor|vegfr inhibitor
4725787|NCT03075462|Combination therapy|combination therapy
4725788|NCT03075462|Ovarian Cancer|ovarian cancer
4725789|NCT03075462|Triple Negative Breast Cancer|triple negative breast cancer
4725790|NCT03075436|Sanitation|sanitation
4725791|NCT03075436|Hygiene|hygiene
4725792|NCT03075436|Public Health|public health
4725793|NCT03075436|Behavior change|behavior change
4725794|NCT03075436|Neglected tropical diseases|neglected tropical diseases
4725795|NCT03075436|Demand-side sanitation and hygiene|demand-side sanitation and hygiene
4725796|NCT03075436|Mental well-being|mental well-being
4725797|NCT03075436|Water insecurity|water insecurity
4725798|NCT03075436|Sanitation insecurity|sanitation insecurity
4725799|NCT03075436|Collective efficacy|collective efficacy
4725800|NCT03075410|ascending dose|ascending dose
4725801|NCT03075410|Pharmacokinetics|pharmacokinetics
4725802|NCT03075410|GSK3036656|gsk3036656
4725803|NCT03075410|FTIH|ftih
4725804|NCT03075410|Safety|safety
4725805|NCT03075397|HIV-1|hiv-1
4725806|NCT03075397|Colo-rectal transmission|colo-rectal transmission
4725807|NCT03075397|seminal plasma|seminal plasma
4725808|NCT03075384|computer-assisted navigation system|computer-assisted navigation system
4725809|NCT03075332|Detraining|detraining
4725810|NCT03075332|Physical aptitude|physical aptitude
4725811|NCT03075332|HIV|hiv
4725812|NCT03075280|ERCP|ercp
4725813|NCT03075280|ERAS|eras
4725814|NCT03075280|complication|complication
4725815|NCT03075280|fatigue|fatigue
4725816|NCT03075280|high carbohydrate diet|high carbohydrate diet
4725817|NCT03075254|Pain|pain
4725818|NCT03075254|Fatigue|fatigue
4725819|NCT03075241|Sleep Disturbances|sleep disturbances
4725820|NCT03075241|Alzheimer Disease|alzheimer disease
4725821|NCT03075241|Insomnia|insomnia
4725822|NCT03075241|Z-Drugs|z-drugs
4725823|NCT03075241|Treatment|treatment
4725824|NCT03075228|microbiota|microbiota
4725825|NCT03075228|small intestine|small intestine
4725826|NCT03075228|metabolic disease|metabolic disease
4725827|NCT03075202|Schizophrenia|schizophrenia
4725828|NCT03075202|Smoking|smoking
4725829|NCT03075202|E-cigarette|e-cigarette
4725830|NCT03075189|Frailty|frailty
4725831|NCT03075189|geriatric|geriatric
4725832|NCT03075189|hospitalized|hospitalized
4725833|NCT03075189|enrichment|enrichment
4725834|NCT03075189|whey protein|whey protein
4725835|NCT03075189|protein intake|protein intake
4725836|NCT03075189|sarcopenia|sarcopenia
4725837|NCT03075189|dietary counseling|dietary counseling
4725838|NCT03075176|Photorefractive keratectomy|photorefractive keratectomy
4725839|NCT03075176|Laser-assisted in situ keratomileusis|laser-assisted in situ keratomileusis
4725840|NCT03075163|PONV|ponv
4725841|NCT03075163|Nausea|nausea
4725842|NCT03075163|Vomiting|vomiting
4725843|NCT03075163|Acupressure|acupressure
4725844|NCT03075150|PVI|pvi
4725845|NCT03075150|Dynamic Cardiac Monitors|dynamic cardiac monitors
4725846|NCT03075150|SVV|svv
4725847|NCT03075150|PPV|ppv
4725848|NCT03075137|ischemic stroke|ischemic stroke
4725849|NCT03075137|external counter pulsation|external counter pulsation
4725850|NCT03075137|mRS|mrs
4725851|NCT03075124|Coronary Artery Disease|coronary artery disease
4725852|NCT03075124|external counter pulsation|external counter pulsation
4725853|NCT03075124|major adverse cardiovascular events|major adverse cardiovascular events
4725854|NCT03075098|Colposcopy|colposcopy
4725855|NCT03075098|oral epithelial dysplasia|oral epithelial dysplasia
4725856|NCT03075098|diagnostic accuracy|diagnostic accuracy
4725857|NCT03075072|Brain metastases|brain metastases
4725858|NCT03075072|Brain metastasis|brain metastasis
4725859|NCT03075072|Lung cancer|lung cancer
4725860|NCT03075072|Melanoma|melanoma
4725861|NCT03075072|Breast cancer|breast cancer
4725862|NCT03075072|Kidney cancer|kidney cancer
4725863|NCT03075072|Renal cell carcinoma|renal cell carcinoma
4725864|NCT03075072|Stereotactic radiation|stereotactic radiation
4725865|NCT03075072|Stereotactic radiosurgery|stereotactic radiosurgery
4725866|NCT03075072|SRS|srs
4725867|NCT03075072|Stereotactic|stereotactic
4725868|NCT03075072|Whole brain radiation|whole brain radiation
4725869|NCT03075072|WBRT|wbrt
4725870|NCT03075072|Hippocampal avoidance|hippocampal avoidance
4725871|NCT03075072|Hippocampal sparing|hippocampal sparing
4725872|NCT03075072|Hippocampal|hippocampal
4725873|NCT03075072|Hippocampus|hippocampus
4725874|NCT03075072|Radiation|radiation
4725875|NCT03075072|Quality of Life|quality of life
4725876|NCT03075072|Neurocognitive|neurocognitive
4725877|NCT03075072|Neurocognition|neurocognition
4725878|NCT03075072|Survival|survival
4725879|NCT03075072|Salvage|salvage
4725880|NCT03075072|MDASI|mdasi
4725881|NCT03075072|Chemotherapy|chemotherapy
4725882|NCT03075072|Recurrence|recurrence
4725883|NCT03075046|Blue Light Emitting Diode|blue light emitting diode
4725884|NCT03075046|Women|women
4725885|NCT03075033|Shikani optical stylet, rigid optical stylets, awake, fiber-optic intubation, and cervical spine injury.|shikani optical stylet, rigid optical stylets, awake, fiber-optic intubation, and cervical spine injury.
4725886|NCT03075007|Alzheimer Disease|alzheimer disease
4725887|NCT03075007|Aging|aging
4725888|NCT03075007|Dementia|dementia
4725889|NCT03075007|PET|pet
4725890|NCT03074994|Tranexamic acid|tranexamic acid
4725891|NCT03074994|Peri-articular injection|peri-articular injection
4725892|NCT03074994|Intraarticular injection|intraarticular injection
4725893|NCT03074994|Total knee arthroplasty|total knee arthroplasty
4725894|NCT03074994|Blood loss|blood loss
4725895|NCT03074955|Hypotension|hypotension
4725896|NCT03074955|Propofol|propofol
4725897|NCT03074955|Trendelenburg|trendelenburg
4725898|NCT03074955|leg wrapping|leg wrapping
4725899|NCT03074929|risk communication|risk communication
4725900|NCT03074903|intrauterine device|intrauterine device
4725901|NCT03074903|bleeding|bleeding
4725902|NCT03074877|Substance Use|substance use
4725903|NCT03074864|Activating mutations,lung cancer,radiotherapy|activating mutations,lung cancer,radiotherapy
4725904|NCT03074851|low sodium salt|low sodium salt
4725905|NCT03074851|blood pressure|blood pressure
4725906|NCT03074851|reporter|reporter
4725907|NCT03074838|Cardiac surgery|cardiac surgery
4725908|NCT03074838|TAVI|tavi
4725909|NCT03074825|Non-Hodgkin's lymphoma|non-hodgkin's lymphoma
4725910|NCT03074825|Relapsed/Refractory|relapsed/refractory
4725911|NCT03074825|Aurora kinase B|aurora kinase b
4725912|NCT03074734|secondhand smoke|secondhand smoke
4725913|NCT03074734|passive smoking|passive smoking
4725914|NCT03074734|respiratory diseases|respiratory diseases
4725915|NCT03074734|COPD|copd
4725916|NCT03074734|asthma|asthma
4725917|NCT03074734|SHS health effect|shs health effect
4725918|NCT03074708|Three-Dimensional Image|three-dimensional image
4725919|NCT03074708|Three Dimensional Printing|three dimensional printing
4725920|NCT03074682|Resuscitation|resuscitation
4725921|NCT03074669|Anxiety symptoms/disorders (OCD, PTSD, GAD, SAD, Panic)|anxiety symptoms/disorders (ocd, ptsd, gad, sad, panic)
4725922|NCT03074656|infliximab|infliximab
4725923|NCT03074656|therapeutic drug monitoring|therapeutic drug monitoring
4725924|NCT03074656|anti drug antibodies|anti drug antibodies
4725925|NCT03074604|Brain Injuries|brain injuries
4725926|NCT03074604|Neurological Injury|neurological injury
4725927|NCT03074604|Stroke|stroke
4725928|NCT03074604|Postoperative Cognitive Dysfunction|postoperative cognitive dysfunction
4725929|NCT03074604|Postoperative Delirium|postoperative delirium
4725930|NCT03074604|Coronary Artery Disease|coronary artery disease
4725931|NCT03074604|Coronary Artery Bypass Grafting|coronary artery bypass grafting
4725932|NCT03074604|Coronary Artery Bypass Surgery|coronary artery bypass surgery
4725933|NCT03074604|Bypass surgery|bypass surgery
4725934|NCT03074604|Beating Heart Coronary Artery Bypass|beating heart coronary artery bypass
4725935|NCT03074604|Off-Pump Coronary Artery Bypass|off-pump coronary artery bypass
4725936|NCT03074591|Iron deficiency|iron deficiency
4725937|NCT03074591|Heart failure|heart failure
4725938|NCT03074578|sleep|sleep
4725939|NCT03074578|verbal abuse|verbal abuse
4725940|NCT03074578|polysomnography|polysomnography
4725941|NCT03074578|perception|perception
4725942|NCT03074578|neuropsychological tests|neuropsychological tests
4725943|NCT03074565|Sanative Therapy|sanative therapy
4725944|NCT03074565|Ultrasonic Therapy|ultrasonic therapy
4725945|NCT03074565|Deep Scaling|deep scaling
4725946|NCT03074565|Hand Scaling|hand scaling
4725947|NCT03074552|probiotics|probiotics
4725948|NCT03074552|VAP|vap
4725949|NCT03074552|microbiome|microbiome
4725950|NCT03074552|trauma|trauma
4725951|NCT03074552|infections|infections
4725952|NCT03074513|Malignant neoplasms of digestive organs|malignant neoplasms of digestive organs
4725953|NCT03074513|Malignant neoplasms of lip oral cavity and pharynx|malignant neoplasms of lip oral cavity and pharynx
4725954|NCT03074513|Malignant neoplasms of mesothelial and soft tissue|malignant neoplasms of mesothelial and soft tissue
4725955|NCT03074513|Malignant neoplasms of respiratory and intrathoracic organs|malignant neoplasms of respiratory and intrathoracic organs
4725956|NCT03074513|Rare Solid Tumors|rare solid tumors
4725957|NCT03074513|Atezolizumab|atezolizumab
4725958|NCT03074513|MPDL3280A|mpdl3280a
4725959|NCT03074513|Bevacizumab|bevacizumab
4725960|NCT03074513|Avastin|avastin
4725961|NCT03074513|Anti-VEGF monoclonal antibody|anti-vegf monoclonal antibody
4725962|NCT03074513|rhuMAb-VEGF|rhumab-vegf
4725963|NCT03074513|Phone call|phone call
4725964|NCT03074500|Kinesio taping|kinesio taping
4725965|NCT03074500|lateral epicondylitis|lateral epicondylitis
4725966|NCT03074500|tennis elbow|tennis elbow
4725967|NCT03074500|treatment|treatment
4725968|NCT03074487|Spinal cord ischemia|spinal cord ischemia
4725969|NCT03074487|Postoperative|postoperative
4725970|NCT03074487|Thoracoabdominal Aneurysm|thoracoabdominal aneurysm
4725971|NCT03074487|Monitoring|monitoring
4725972|NCT03074474|use of mesh|use of mesh
4725973|NCT03074461|Rectal Cancer|rectal cancer
4725974|NCT03074461|Low Anterior Resection|low anterior resection
4725975|NCT03074461|Coloplasty Pouch|coloplasty pouch
4725976|NCT03074461|Side-to-end Anastomosis|side-to-end anastomosis
4725977|NCT03074461|Continence|continence
4725978|NCT03074461|Quality of Life|quality of life
4725979|NCT03074448|Colonoscopy|colonoscopy
4725980|NCT03074448|Intestinal Cleaning|intestinal cleaning
4725981|NCT03074448|Picoprep|picoprep
4725982|NCT03074448|Aquanet|aquanet
4725983|NCT03074422|Functional neurosurgery|functional neurosurgery
4725984|NCT03074422|Pain management|pain management
4725985|NCT03074422|Hypnosis|hypnosis
4725986|NCT03074422|Stereotaxy|stereotaxy
4725987|NCT03074422|Parkinson disease|parkinson disease
4725988|NCT03074422|Essential tremor|essential tremor
4725989|NCT03074422|Dystonia|dystonia
4725990|NCT03074422|Invasive monitoring of epilepsy|invasive monitoring of epilepsy
4725991|NCT03074409|Oxytocin|oxytocin
4725992|NCT03074344|Dry Eye Syndrome|dry eye syndrome
4725993|NCT03074344|artificial tear|artificial tear
4725994|NCT03074344|CoQ10|coq10
4725995|NCT03074344|Hyaluronic acid|hyaluronic acid
4725996|NCT03074305|In-bioresorbable vascular scaffold restenosis|in-bioresorbable vascular scaffold restenosis
4725997|NCT03074305|drug-eluting stent|drug-eluting stent
4725998|NCT03074305|drug-eluting balloon|drug-eluting balloon
4725999|NCT03074305|bioresorbable scaffold|bioresorbable scaffold
4726000|NCT03074279|Epilepsy|epilepsy
4726001|NCT03074279|SUDEP|sudep
4726002|NCT03074279|case-control study|case-control study
4726003|NCT03074279|risks factors|risks factors
4726004|NCT03074240|Truncal block|truncal block
4726005|NCT03074240|Surgical anesthesia|surgical anesthesia
4726006|NCT03074240|Postoperative pain control|postoperative pain control
4726007|NCT03074214|copeptin|copeptin
4726008|NCT03074214|myocardial infarct size|myocardial infarct size
4726009|NCT03074214|prognosis|prognosis
4726010|NCT03074214|ST-elevation myocardial infarction|st-elevation myocardial infarction
4726011|NCT03074214|percutaneous coronary intervention|percutaneous coronary intervention
4726012|NCT03074201|ERCP, choledocholithiasis, cholangioscopy|ercp, choledocholithiasis, cholangioscopy
4726013|NCT03074188|oral findings or oral manifestation|oral findings or oral manifestation
4726014|NCT03074188|pre-dialysis stage or end stage renal disease|pre-dialysis stage or end stage renal disease
4726015|NCT03074136|photodynamic therapy|photodynamic therapy
4726016|NCT03074136|diode laser|diode laser
4726017|NCT03074136|immature permanent teeth|immature permanent teeth
4726018|NCT03074136|endodontic therapy|endodontic therapy
4726019|NCT03074123|cosyntropin stimulation test|cosyntropin stimulation test
4726020|NCT03074123|low-dose|low-dose
4726021|NCT03074110|Inhalation Anaesthetics, Sevoflurane|inhalation anaesthetics, sevoflurane
4726022|NCT03074110|Carbon Dioxide|carbon dioxide
4726023|NCT03074110|Hyperventilation|hyperventilation
4726024|NCT03074110|Anaesthesia Recovery Period|anaesthesia recovery period
4726025|NCT03074110|Ventilators|ventilators
4726026|NCT03074097|Rectus sheath block, Postoperative pain,TNF alpha and IL-6|rectus sheath block, postoperative pain,tnf alpha and il-6
4726027|NCT03074084|abdominal pain|abdominal pain
4726028|NCT03074084|adult|adult
4726029|NCT03074084|emergency department|emergency department
4726030|NCT03074084|electronic nose|electronic nose
4726031|NCT03074084|celiac disease|celiac disease
4726032|NCT03074071|Disambiguation, Depression, Burnout|disambiguation, depression, burnout
4726033|NCT03074045|Intrauterine|intrauterine
4726034|NCT03074045|Birth control|birth control
4726035|NCT03073993|nasogastric|nasogastric
4726036|NCT03073993|orogastric|orogastric
4726037|NCT03073993|nutrition|nutrition
4726038|NCT03073993|preterm|preterm
4726039|NCT03073993|feeding tube|feeding tube
4726040|NCT03073993|insertion|insertion
4726041|NCT03073993|episodes|episodes
4726042|NCT03073993|bradycardia|bradycardia
4726043|NCT03073993|desaturation|desaturation
4726044|NCT03073980|in vitro fertilization|in vitro fertilization
4726045|NCT03073980|oocyte retrieval|oocyte retrieval
4726046|NCT03073980|acetaminophen|acetaminophen
4726047|NCT03073980|postoperative pain control|postoperative pain control
4726048|NCT03073954|Health Behavior|health behavior
4726049|NCT03073954|Executive function|executive function
4726050|NCT03073954|Working-memory training|working-memory training
4726051|NCT03073954|Feasibility|feasibility
4726052|NCT03073954|Impulsivity|impulsivity
4726053|NCT03073941|Knee arthroplasty|knee arthroplasty
4726054|NCT03073941|Knee function|knee function
4726055|NCT03073941|Total knee replacement|total knee replacement
4726056|NCT03073941|Persona total knee system|persona total knee system
4726057|NCT03073941|NexGen total knee system|nexgen total knee system
4726058|NCT03073928|Nerve block|nerve block
4726059|NCT03073928|Diaphragm function|diaphragm function
4726060|NCT03073889|Aneurysm Clipping|aneurysm clipping
4726061|NCT03073889|Scalp nerve block|scalp nerve block
4726062|NCT03073889|Scalp infiltration|scalp infiltration
4726063|NCT03073889|Ropivacaine|ropivacaine
4726064|NCT03073876|Alzheimer Disease|alzheimer disease
4726065|NCT03073876|Attention|attention
4726066|NCT03073876|Donepezil hydrochloride|donepezil hydrochloride
4726067|NCT03073863|LDL Cholesterol|ldl cholesterol
4726068|NCT03073863|Statin intensity|statin intensity
4726069|NCT03073863|post hoc analysis|post hoc analysis
4726070|NCT03073863|Achieved LDL Cholesterol level|achieved ldl cholesterol level
4726071|NCT03073811|protein supplementation|protein supplementation
4726072|NCT03073811|older adults|older adults
4726073|NCT03073811|nutrition perihabilitation|nutrition perihabilitation
4726074|NCT03073811|perioperative optimization|perioperative optimization
4726075|NCT03073811|Veterans|veterans
4726076|NCT03073798|Lung Disease|lung disease
4726077|NCT03073798|Breathing Difficulty|breathing difficulty
4726078|NCT03073798|Smoking|smoking
4726079|NCT03073798|Mucociliary|mucociliary
4726080|NCT03073746|Google|google
4726081|NCT03073746|Knowledge Panels|knowledge panels
4726082|NCT03073746|Health Search|health search
4726083|NCT03073746|Online|online
4726084|NCT03073746|Internet|internet
4726085|NCT03073746|Smartphone|smartphone
4726086|NCT03073746|Tablet|tablet
4726087|NCT03073746|Digital|digital
4726088|NCT03073746|Mobile|mobile
4726089|NCT03073746|Symptoms|symptoms
4726090|NCT03073746|Differential diagnosis|differential diagnosis
4726091|NCT03073746|Diagnosis|diagnosis
4726092|NCT03073746|Anxiety|anxiety
4726093|NCT03073707|Non-Typhoid Salmonella|non-typhoid salmonella
4726094|NCT03073707|Invasive blood stream infections|invasive blood stream infections
4726095|NCT03073707|Reservoir|reservoir
4726096|NCT03073707|Household environment|household environment
4726097|NCT03073707|Children|children
4726098|NCT03073694|Peritoneal Surface Disease|peritoneal surface disease
4726099|NCT03073694|mitomycin-c|mitomycin-c
4726100|NCT03073694|melphalan|melphalan
4726101|NCT03073694|Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (CRS-HIPEC)|cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (crs-hipec)
4726102|NCT03073694|Peritoneal Carcinomatosis|peritoneal carcinomatosis
4726103|NCT03073681|cataract|cataract
4726104|NCT03073655|shoulder pain|shoulder pain
4726105|NCT03073655|shoulder function|shoulder function
4726106|NCT03073642|Hydrotherapy|hydrotherapy
4726107|NCT03073642|Pain education|pain education
4726108|NCT03073577|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
4726109|NCT03073577|Islet Transplantation|islet transplantation
4726110|NCT03073577|Diabetes|diabetes
4726111|NCT03073577|Diabetes Treatment|diabetes treatment
4726112|NCT03073564|Dyspnea|dyspnea
4726113|NCT03073564|Cardiopulmonary Exercise Test|cardiopulmonary exercise test
4726114|NCT03073564|Positive-Pressure Respiration|positive-pressure respiration
4726115|NCT03073525|Stage IIIb|stage iiib
4726116|NCT03073525|Stage IV|stage iv
4726117|NCT03073525|Ovarian Cancer|ovarian cancer
4726118|NCT03073525|Cervical Cancer|cervical cancer
4726119|NCT03073525|Uterine Cancer|uterine cancer
4726120|NCT03073525|Immunotherapy|immunotherapy
4726121|NCT03073447|Myocardial infarction|myocardial infarction
4726122|NCT03073447|Women|women
4726123|NCT03073447|Young|young
4726124|NCT03073447|Primary PCI|primary pci
4726125|NCT03073447|Hormone|hormone
4726126|NCT03073408|Propofol|propofol
4726127|NCT03073408|Bispectral index (BIS)|bispectral index (bis)
4726128|NCT03073408|Closed loop|closed loop
4726129|NCT03073356|Myocardial metabolism|myocardial metabolism
4726130|NCT03073356|Positron emission tomography|positron emission tomography
4726131|NCT03073356|Echocardiography|echocardiography
4726132|NCT03073356|Right sided heart catheterization|right sided heart catheterization
4726133|NCT03073317|Preterm Infants|preterm infants
4726134|NCT03073317|Premature Birth|premature birth
4726135|NCT03073317|Placenta growth factor|placenta growth factor
4726136|NCT03073317|Prenatal Care|prenatal care
4726137|NCT03073317|PERINATAL MORTALITY|perinatal mortality
4726138|NCT03073317|Pre-Eclampsia|pre-eclampsia
4726139|NCT03073304|isolated limb perfusion|isolated limb perfusion
4726140|NCT03073291|cannabis|cannabis
4726141|NCT03073291|commerce|commerce
4726142|NCT03073265|DOAC|doac
4726143|NCT03073265|apixaban|apixaban
4726144|NCT03073265|IVD|ivd
4726145|NCT03073239|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
4726146|NCT03073239|Bulbar disfunction|bulbar disfunction
4726147|NCT03073239|Rik factors ALS|rik factors als
4726148|NCT03073200|children|children
4726149|NCT03073200|psoriasis treatment|psoriasis treatment
4726150|NCT03073200|adolescents|adolescents
4726151|NCT03073187|Asthma|asthma
4726152|NCT03073187|Sleep|sleep
4726153|NCT03073187|Adolescents|adolescents
4726154|NCT03073187|Urban|urban
4726155|NCT03073187|Intervention|intervention
4726156|NCT03073187|High school|high school
4726157|NCT03073174|dietary intake|dietary intake
4726158|NCT03073174|nutritional supplements|nutritional supplements
4726159|NCT03073174|sanative therapy|sanative therapy
4726160|NCT03073174|healing|healing
4726161|NCT03073174|flavonoids|flavonoids
4726162|NCT03073174|tea|tea
4726163|NCT03073161|flavonoids|flavonoids
4726164|NCT03073161|tea|tea
4726165|NCT03073161|dietary intake|dietary intake
4726166|NCT03073161|nutritional supplements|nutritional supplements
4726167|NCT03073161|periodontal disease|periodontal disease
4726168|NCT03073161|healing|healing
4726169|NCT03073161|sanative therapy|sanative therapy
4726170|NCT03073096|axillary nodal dissection|axillary nodal dissection
4726171|NCT03073096|groin nodal dissection|groin nodal dissection
4726172|NCT03073083|autograft|autograft
4726173|NCT03073070|diabetic children|diabetic children
4726174|NCT03073070|RBC lifespan|rbc lifespan
4726175|NCT03073044|Quality of life|quality of life
4726176|NCT03073044|psychosocial and psychological problems|psychosocial and psychological problems
4726177|NCT03073005|ventricular assist device (VAD)|ventricular assist device (vad)
4726178|NCT03073005|heart failure|heart failure
4726179|NCT03073005|simulation|simulation
4726180|NCT03072966|Distress|distress
4726181|NCT03072966|Exercise|exercise
4726182|NCT03072966|Wearable device|wearable device
4726183|NCT03072966|Smartphone|smartphone
4726184|NCT03072927|Lumbar Spinal Stenosis|lumbar spinal stenosis
4726185|NCT03072927|Interspinous process decompression|interspinous process decompression
4726186|NCT03072927|MILD|mild
4726187|NCT03072927|Medicare|medicare
4726188|NCT03072888|acute pain|acute pain
4726189|NCT03072888|Transcutaneous Electric Nerve Stimulation|transcutaneous electric nerve stimulation
4726190|NCT03072888|Anesthesia Recovery Period|anesthesia recovery period
4726191|NCT03072875|Suicidality|suicidality
4726192|NCT03072875|Collaborative Assessment and Management of Suicidality|collaborative assessment and management of suicidality
4726193|NCT03072875|Technology|technology
4726194|NCT03072875|Suicide Prevention|suicide prevention
4726195|NCT03072875|Suicide Intervention|suicide intervention
4726196|NCT03072862|Cochlear implant treatment, aging adults|cochlear implant treatment, aging adults
4726197|NCT03072849|Pediatrics|pediatrics
4726198|NCT03072849|Airflow obstruction|airflow obstruction
4726199|NCT03072849|Chronic graft-vs-host disease|chronic graft-vs-host disease
4726200|NCT03072849|Bronchiolitis obliterans syndrome|bronchiolitis obliterans syndrome
4726201|NCT03072823|CVDs|cvds
4726202|NCT03072823|cardiovascular diseases|cardiovascular diseases
4726203|NCT03072823|n-3 polyunsaturated fatty acids|n-3 polyunsaturated fatty acids
4726204|NCT03072823|depression|depression
4726205|NCT03072810|Positive psychology|positive psychology
4726206|NCT03072810|Wellbeing|wellbeing
4726207|NCT03072810|Chronic pain|chronic pain
4726208|NCT03072810|Mindfulness|mindfulness
4726209|NCT03072797|Atherosclerosis|atherosclerosis
4726210|NCT03072797|Longitudinal|longitudinal
4726211|NCT03072797|Biomarker|biomarker
4726212|NCT03072797|Coronary angiography|coronary angiography
4726213|NCT03072797|Follow-up|follow-up
4726214|NCT03072797|Metabolomics|metabolomics
4726215|NCT03072797|Risk factor|risk factor
4726216|NCT03072758|Male partner involvement|male partner involvement
4726217|NCT03072745|Cognitive Impairment|cognitive impairment
4726218|NCT03072732|Heart Failure|heart failure
4726219|NCT03072732|Hemodialysis|hemodialysis
4726220|NCT03072706|hip replacement|hip replacement
4726221|NCT03072706|acetabulum|acetabulum
4726222|NCT03072706|anteversion|anteversion
4726223|NCT03072706|position|position
4726224|NCT03072706|guide|guide
4726225|NCT03072667|prematurity|prematurity
4726226|NCT03072667|bowel atresia|bowel atresia
4726227|NCT03072667|necrotizing entercolitis|necrotizing entercolitis
4726228|NCT03072667|parenteral nutrition associated liver disease (PNALD)|parenteral nutrition associated liver disease (pnald)
4726229|NCT03072667|intestinal failure|intestinal failure
4726230|NCT03072667|parenteral nutrition associated cholestasis|parenteral nutrition associated cholestasis
4726231|NCT03072667|fish oil|fish oil
4726232|NCT03072641|Probiotics|probiotics
4726233|NCT03072641|Epigenetics|epigenetics
4726234|NCT03072641|Microbiota|microbiota
4726235|NCT03072628|nicotine|nicotine
4726236|NCT03072628|sympathetic nerve activity|sympathetic nerve activity
4726237|NCT03072628|oxidative stress|oxidative stress
4726238|NCT03072602|Racial differences|racial differences
4726239|NCT03072576|Diagnosis|diagnosis
4726240|NCT03072576|Xpert MTB/RIF|xpert mtb/rif
4726241|NCT03072576|Ultra Xpert MTB/RIF|ultra xpert mtb/rif
4726242|NCT03072550|fungal nail|fungal nail
4726243|NCT03072550|toenail fungus|toenail fungus
4726244|NCT03072537|growth|growth
4726245|NCT03072537|BMI|bmi
4726246|NCT03072537|obesity|obesity
4726247|NCT03072537|childhood|childhood
4726248|NCT03072537|adolescence|adolescence
4726249|NCT03072537|development|development
4726250|NCT03072524|pre-hospital stroke scale test|pre-hospital stroke scale test
4726251|NCT03072524|severe hemiparesis|severe hemiparesis
4726252|NCT03072524|large vessel occlusion|large vessel occlusion
4726253|NCT03072524|mechanical thrombectomy|mechanical thrombectomy
4726254|NCT03072485|aging|aging
4726255|NCT03072472|Colorectal Cancer|colorectal cancer
4726256|NCT03072472|Endoscopy|endoscopy
4726257|NCT03072472|Screening|screening
4726258|NCT03072472|Colonic Adenoma|colonic adenoma
4726259|NCT03072472|Adenoma Detection Rate|adenoma detection rate
4726260|NCT03072472|Endocuff|endocuff
4726261|NCT03072472|Endocuff Vision|endocuff vision
4726262|NCT03072446|Uterine Fibroid|uterine fibroid
4726263|NCT03072446|Embolization|embolization
4726264|NCT03072446|symptoms|symptoms
4726265|NCT03072446|Gel-Beads|gel-beads
4726266|NCT03072433|child malnutrition|child malnutrition
4726267|NCT03072433|child development|child development
4726268|NCT03072433|counseling|counseling
4726269|NCT03072420|MRI, fingers compression|mri, fingers compression
4726270|NCT03072381|CLE|cle
4726271|NCT03072381|epicondylosis|epicondylosis
4726272|NCT03072381|platelet rich plasma|platelet rich plasma
4726273|NCT03072381|PRP|prp
4726274|NCT03072381|ultrasound|ultrasound
4726275|NCT03072381|shear wave ultrasound|shear wave ultrasound
4726276|NCT03072381|tendinopathy|tendinopathy
4726277|NCT03072381|elbow|elbow
4726278|NCT03072381|tenis elbow|tenis elbow
4726279|NCT03072381|plasma|plasma
4726280|NCT03072381|plasma injection|plasma injection
4726281|NCT03072381|tendinosis|tendinosis
4726282|NCT03072381|tendinitis|tendinitis
4726283|NCT03072355|fatigue|fatigue
4726284|NCT03072355|resistance test|resistance test
4726285|NCT03072316|breast cancer|breast cancer
4726286|NCT03072316|mastectomy|mastectomy
4726287|NCT03072316|deep inferior perforator flap reconstruction|deep inferior perforator flap reconstruction
4726288|NCT03072316|post mastectomy radiotherapy|post mastectomy radiotherapy
4726289|NCT03072303|Brittle Bone|brittle bone
4726290|NCT03072303|Osteogenesis Imperfecta|osteogenesis imperfecta
4726291|NCT03072303|BBD|bbd
4726292|NCT03072303|OI|oi
4726293|NCT03072303|Congenital Abnormalities|congenital abnormalities
4726294|NCT03072303|Congenital Bone Disorder|congenital bone disorder
4726295|NCT03072303|Lobstein Syndrome|lobstein syndrome
4726296|NCT03072277|DHA|dha
4726297|NCT03072277|Docosa Hexaenoic Acid|docosa hexaenoic acid
4726298|NCT03072277|Omega 3 fatty acid|omega 3 fatty acid
4726299|NCT03072277|Newborn Outcome|newborn outcome
4726300|NCT03072277|Birth Size|birth size
4726301|NCT03072277|Gestational Age|gestational age
4726302|NCT03072277|DASII|dasii
4726303|NCT03072277|Prenatal Supplementation|prenatal supplementation
4726304|NCT03072277|Randomized Controlled Trial|randomized controlled trial
4726305|NCT03072277|Neurodevelopment|neurodevelopment
4726306|NCT03072264|Generalized Anxiety Disorder, GAD, mindfulness, anxiety|generalized anxiety disorder, gad, mindfulness, anxiety
4726307|NCT03072238|Metastatic Castrate-Resistant Prostate Cancer|metastatic castrate-resistant prostate cancer
4726308|NCT03072225|herbal medicine|herbal medicine
4726309|NCT03072225|stroke|stroke
4726310|NCT03072225|vulnerable plaques of carotid artery|vulnerable plaques of carotid artery
4726311|NCT03072212|HIV|hiv
4726312|NCT03072212|Stroke|stroke
4726313|NCT03072212|Cerebral vascular accident|cerebral vascular accident
4726314|NCT03072212|Uganda|uganda
4726315|NCT03072199|Rituximab|rituximab
4726316|NCT03072199|B cells|b cells
4726317|NCT03072160|Anti-PD1/PDL1|anti-pd1/pdl1
4726318|NCT03072160|Vaccine Therapy|vaccine therapy
4726319|NCT03072160|TKI-Naive|tki-naive
4726320|NCT03072134|Glioma|glioma
4726321|NCT03072134|Glioblastoma|glioblastoma
4726322|NCT03072134|Astrocytoma|astrocytoma
4726323|NCT03072134|Brain Cancer|brain cancer
4726324|NCT03072134|New Diagnosed Glioma|new diagnosed glioma
4726325|NCT03072134|Temozolomide|temozolomide
4726326|NCT03072134|Radiation|radiation
4726327|NCT03072134|Neural Stem Cells|neural stem cells
4726328|NCT03072134|Virotherapy|virotherapy
4726329|NCT03072134|Adenovirus|adenovirus
4726330|NCT03072134|Oncolytic virotherapy|oncolytic virotherapy
4726331|NCT03072121|coronary artery disease|coronary artery disease
4726332|NCT03072121|revascularization|revascularization
4726333|NCT03072121|Shexiang Baoxin Pill|shexiang baoxin pill
4726334|NCT03072095|Colorectal Neoplasms|colorectal neoplasms
4726335|NCT03072095|Colonic Neoplasms|colonic neoplasms
4726336|NCT03072095|Gastrointestinal Neoplasms|gastrointestinal neoplasms
4726337|NCT03072095|Digestive System Neoplasms|digestive system neoplasms
4726338|NCT03072095|Neoplasms|neoplasms
4726339|NCT03072095|Digestive System Diseases|digestive system diseases
4726340|NCT03072095|Gastrointestinal Diseases|gastrointestinal diseases
4726341|NCT03072095|Colonic Diseases|colonic diseases
4726342|NCT03072095|Rectal Diseases|rectal diseases
4726343|NCT03072082|coronary artery disease|coronary artery disease
4726344|NCT03072082|revascularization|revascularization
4726345|NCT03072082|Danlou Tablet|danlou tablet
4726346|NCT03072043|myelodysplastic syndrome (MDS)|myelodysplastic syndrome (mds)
4726347|NCT03072043|TP53 mutant myelodysplastic syndrome|tp53 mutant myelodysplastic syndrome
4726348|NCT03072043|MDS/myeloproliferative neoplasm (MPN)|mds/myeloproliferative neoplasm (mpn)
4726349|NCT03072043|chronic myelomonocytic leukemia (CMML)|chronic myelomonocytic leukemia (cmml)
4726350|NCT03072043|acute myeloid leukemia (AML)|acute myeloid leukemia (aml)
4726351|NCT03072030|Ebola Virus Disease|ebola virus disease
4726352|NCT03072030|Hemorrhagic Fever, Ebola|hemorrhagic fever, ebola
4726353|NCT03072030|Vaccines|vaccines
4726354|NCT03072030|GP protein, Ebola virus|gp protein, ebola virus
4726355|NCT03072030|Ebola Virus Vaccines|ebola virus vaccines
4726356|NCT03072004|Leprosy|leprosy
4726357|NCT03072004|Neuropathy|neuropathy
4726358|NCT03072004|LLLT|lllt
4726359|NCT03071991|preinsicional bupivacain|preinsicional bupivacain
4726360|NCT03071991|laparoscopic bariatric surgery|laparoscopic bariatric surgery
4726361|NCT03071991|postoperative pain|postoperative pain
4726362|NCT03071978|Heart Failure|heart failure
4726363|NCT03071978|LV-fusion pacing|lv-fusion pacing
4726364|NCT03071978|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
4726365|NCT03071952|Heart Failure|heart failure
4726366|NCT03071952|Chronotropic Incompetence|chronotropic incompetence
4726367|NCT03071952|Rate Response|rate response
4726368|NCT03071952|Exercise Test|exercise test
4726369|NCT03071874|Meningioma|meningioma
4726370|NCT03071861|darbepoetin|darbepoetin
4726371|NCT03071861|Brain Diseases|brain diseases
4726372|NCT03071835|Stem Cells|stem cells
4726373|NCT03071835|Cardiovascular|cardiovascular
4726374|NCT03071835|Quality of Life|quality of life
4726375|NCT03071835|Cardiomyopathy|cardiomyopathy
4726376|NCT03071822|PTCLs|ptcls
4726377|NCT03071809|Solid tumor|solid tumor
4726378|NCT03071809|carcinoma|carcinoma
4726379|NCT03071809|sarcoma|sarcoma
4726380|NCT03071809|stage I|stage i
4726381|NCT03071809|stage II|stage ii
4726382|NCT03071809|stage III|stage iii
4726383|NCT03071770|Healthy Volunteers|healthy volunteers
4726384|NCT03071770|Japanese|japanese
4726385|NCT03071770|Caucasian|caucasian
4726386|NCT03071757|Solid Tumors|solid tumors
4726387|NCT03071757|Cancer|cancer
4726388|NCT03071757|Metastatic Solid Tumors|metastatic solid tumors
4726389|NCT03071757|Advanced Solid Tumors|advanced solid tumors
4726390|NCT03071757|Triple negative breast cancer (TNBC)|triple negative breast cancer (tnbc)
4726391|NCT03071757|Ovarian cancer|ovarian cancer
4726392|NCT03071757|Hepatocellular carcinoma (HCC)|hepatocellular carcinoma (hcc)
4726393|NCT03071757|Gastric cancer|gastric cancer
4726394|NCT03071757|Mesothelioma|mesothelioma
4726395|NCT03071757|Small cell lung cancer (SCLC)|small cell lung cancer (sclc)
4726396|NCT03071757|Cholangiocarcinoma|cholangiocarcinoma
4726397|NCT03071757|Merkel cell carcinoma|merkel cell carcinoma
4726398|NCT03071757|Melanoma|melanoma
4726399|NCT03071757|Non-small cell lung cancer (NSCLC)|non-small cell lung cancer (nsclc)
4726400|NCT03071731|Glittre|glittre
4726401|NCT03071731|COPD|copd
4726402|NCT03071731|sit-to-stand|sit-to-stand
4726403|NCT03071731|responsiveness|responsiveness
4726404|NCT03071731|bronchodilation|bronchodilation
4726405|NCT03071718|cardiovascular diseases|cardiovascular diseases
4726406|NCT03071718|gut microbiota|gut microbiota
4726407|NCT03071718|Mediterranean diet|mediterranean diet
4726408|NCT03071705|NSCLC|nsclc
4726409|NCT03071705|metformin|metformin
4726410|NCT03071705|metformin plus TKI|metformin plus tki
4726411|NCT03071705|EGFR positive status|egfr positive status
4726412|NCT03071666|Nepal|nepal
4726413|NCT03071666|South Asia|south asia
4726414|NCT03071666|Nutrition|nutrition
4726415|NCT03071666|Pregnancy|pregnancy
4726416|NCT03071666|Neurodevelopment|neurodevelopment
4726417|NCT03071666|Growth|growth
4726418|NCT03071653|Cardiomyopathy|cardiomyopathy
4726419|NCT03071653|Left Cardiac Sympathetic Denervation|left cardiac sympathetic denervation
4726420|NCT03071640|old|old
4726421|NCT03071640|elderly|elderly
4726422|NCT03071640|radiotherapy|radiotherapy
4726423|NCT03071640|geriatric assessment|geriatric assessment
4726424|NCT03071627|Spin|spin
4726425|NCT03071627|Misleading reporting|misleading reporting
4726426|NCT03071627|Misleading interpretation|misleading interpretation
4726427|NCT03071627|Misleading extrapolation|misleading extrapolation
4726428|NCT03071627|Animal studies|animal studies
4726429|NCT03071627|Cell culture studies|cell culture studies
4726430|NCT03071627|Pre-clinical studies|pre-clinical studies
4726431|NCT03071614|Spin, misleading reporting, misleading interpretation, misleading extrapolation, animal studies, cell culture studies, pre-clinical studies|spin, misleading reporting, misleading interpretation, misleading extrapolation, animal studies, cell culture studies, pre-clinical studies
4726432|NCT03071614|Misleading reporting|misleading reporting
4726433|NCT03071614|Misleading interpretation|misleading interpretation
4726434|NCT03071614|Misleading extrapolation|misleading extrapolation
4726435|NCT03071614|Animal studies|animal studies
4726436|NCT03071614|Cell culture studies|cell culture studies
4726437|NCT03071614|Pre-clinical studies|pre-clinical studies
4726438|NCT03071601|Laceration|laceration
4726439|NCT03071601|Suture|suture
4726440|NCT03071601|Topical anesthesia|topical anesthesia
4726441|NCT03071601|Lidocaine|lidocaine
4726442|NCT03071575|measles|measles
4726443|NCT03071575|rubella|rubella
4726444|NCT03071575|immunogenicity|immunogenicity
4726445|NCT03071575|congenital rubella syndrome|congenital rubella syndrome
4726446|NCT03071575|measles-rubella vaccine|measles-rubella vaccine
4726447|NCT03071562|HIV|hiv
4726448|NCT03071562|Cognitive impairment|cognitive impairment
4726449|NCT03071562|Aging|aging
4726450|NCT03071562|Physical Activity|physical activity
4726451|NCT03071562|Exercise|exercise
4726452|NCT03071562|Yoga|yoga
4726453|NCT03071562|Neuroplasticity|neuroplasticity
4726454|NCT03071549|Acne vulgaris|acne vulgaris
4726455|NCT03071549|Chemical peeling|chemical peeling
4726456|NCT03071549|Dermoscopy|dermoscopy
4726457|NCT03071536|furosemide stress test|furosemide stress test
4726458|NCT03071536|kidney transplantation|kidney transplantation
4726459|NCT03071536|urine output|urine output
4726460|NCT03071536|perioperation|perioperation
4726461|NCT03071536|delayed graft function|delayed graft function
4726462|NCT03071497|Iron-deficiency|iron-deficiency
4726463|NCT03071497|Anemia|anemia
4726464|NCT03071497|Iron-deficiency Anemia|iron-deficiency anemia
4726465|NCT03071497|Zinc protoporphyrin|zinc protoporphyrin
4726466|NCT03071484|Early Stages of Psychosis|early stages of psychosis
4726467|NCT03071484|Schizophrenia|schizophrenia
4726468|NCT03071484|Transcranial Direct Current Stimulation|transcranial direct current stimulation
4726469|NCT03071484|Cognitive Symptomatology|cognitive symptomatology
4726470|NCT03071484|Double-blind Randomized Controlled Trial|double-blind randomized controlled trial
4726471|NCT03071419|fathers|fathers
4726472|NCT03071406|Merkel cell carcinoma (MCC)|merkel cell carcinoma (mcc)
4726473|NCT03071406|Metastatic|metastatic
4726474|NCT03071406|Metastasis|metastasis
4726475|NCT03071406|Stereotactic body radiation therapy (SBRT)|stereotactic body radiation therapy (sbrt)
4726476|NCT03071406|Immunology|immunology
4726477|NCT03071406|Antibody|antibody
4726478|NCT03071406|Nivolumab|nivolumab
4726479|NCT03071406|Ipilimumab|ipilimumab
4726480|NCT03071406|Metastatic skin cancer|metastatic skin cancer
4726481|NCT03071406|Cutaneous|cutaneous
4726482|NCT03071393|acute intermittent hypoxia|acute intermittent hypoxia
4726483|NCT03071393|walking|walking
4726484|NCT03071393|breathing|breathing
4726485|NCT03071393|standing|standing
4726486|NCT03071393|sitting|sitting
4726487|NCT03071393|spinal cord injury|spinal cord injury
4726488|NCT03071367|Airway Management|airway management
4726489|NCT03071367|Medical students|medical students
4726490|NCT03071367|Intratracheal intubation|intratracheal intubation
4726491|NCT03071367|Educational Technology|educational technology
4726492|NCT03071354|ICU-acquired weakness|icu-acquired weakness
4726493|NCT03071341|MPS I; Hurler Syndrome|mps i; hurler syndrome
4726494|NCT03071315|Economic evaluation|economic evaluation
4726495|NCT03071315|Heroin dependence|heroin dependence
4726496|NCT03071315|Compulsory treatment|compulsory treatment
4726497|NCT03071315|Methadone treatment|methadone treatment
4726498|NCT03071315|Vietnam|vietnam
4726499|NCT03071315|East and Southeast Asia|east and southeast asia
4726500|NCT03071315|Cost-effectiveness|cost-effectiveness
4726501|NCT03071302|Keratoconus,Corneal Dystrophies, corneal Tomography, topography|keratoconus,corneal dystrophies, corneal tomography, topography
4726502|NCT03071263|Treatment of Hyperkalemia|treatment of hyperkalemia
4726503|NCT03071263|Hyperkalemia|hyperkalemia
4726504|NCT03071263|Potassium|potassium
4726505|NCT03071263|Chronic Kidney Disease|chronic kidney disease
4726506|NCT03071263|Hypertension|hypertension
4726507|NCT03071263|Resistant Hypertension|resistant hypertension
4726508|NCT03071263|Spironolactone|spironolactone
4726509|NCT03071237|infrapyloric artery|infrapyloric artery
4726510|NCT03071237|gastric cancer|gastric cancer
4726511|NCT03071224|AD|ad
4726512|NCT03071224|HV|hv
4726513|NCT03071211|pelvic organ prolapse|pelvic organ prolapse
4726514|NCT03071211|urinary catheters|urinary catheters
4726515|NCT03071198|Neoadjuvant Chemotherapy|neoadjuvant chemotherapy
4726516|NCT03071185|free flap|free flap
4726517|NCT03071185|nerve block|nerve block
4726518|NCT03071185|elective reconstructive surgery|elective reconstructive surgery
4726519|NCT03071185|free fibular|free fibular
4726520|NCT03071185|anterolateral thigh flaps|anterolateral thigh flaps
4726521|NCT03071159|Flash Glucose Monitoring|flash glucose monitoring
4726522|NCT03071159|Usability|usability
4726523|NCT03071159|Metabolic control|metabolic control
4726524|NCT03071055|Macular Degeneration|macular degeneration
4726525|NCT03071055|AMD|amd
4726526|NCT03071055|Wet AMD|wet amd
4726527|NCT03071055|Lucentis|lucentis
4726528|NCT03071029|family planning|family planning
4726529|NCT03071029|reproductive health|reproductive health
4726530|NCT03071029|abortion|abortion
4726531|NCT03071029|health providers|health providers
4726532|NCT03071016|T2D,|t2d,
4726533|NCT03071016|Type 2 Diabetes,|type 2 diabetes,
4726534|NCT03071016|T2DM|t2dm
4726535|NCT03071003|Pharmacokinetics|pharmacokinetics
4726536|NCT03071003|Healthy Volunteer Study|healthy volunteer study
4726537|NCT03070990|Enfortumab vedotin|enfortumab vedotin
4726538|NCT03070990|ASG-22CE|asg-22ce
4726539|NCT03070990|ASG-22ME|asg-22me
4726540|NCT03070990|Metastatic Urothelial Cancer|metastatic urothelial cancer
4726541|NCT03070977|Interprofessional education|interprofessional education
4726542|NCT03070977|study unit|study unit
4726543|NCT03070977|Psychiatry|psychiatry
4726544|NCT03070951|Uterine Fibroid|uterine fibroid
4726545|NCT03070951|Leiomyomata|leiomyomata
4726546|NCT03070951|Heavy Menstrual Bleeding|heavy menstrual bleeding
4726547|NCT03070951|HMB|hmb
4726548|NCT03070951|Heavy Uterine Bleeding|heavy uterine bleeding
4726549|NCT03070951|Menorrhagia|menorrhagia
4726550|NCT03070951|OBE2109 + Add-back|obe2109 + add-back
4726551|NCT03070938|Chronic wounds|chronic wounds
4726552|NCT03070938|Acute Wounds|acute wounds
4726553|NCT03070938|PHMB|phmb
4726554|NCT03070938|Wound Management|wound management
4726555|NCT03070938|Bioburden|bioburden
4726556|NCT03070938|Collagen|collagen
4726557|NCT03070925|Antimicrobial|antimicrobial
4726558|NCT03070925|Collagen|collagen
4726559|NCT03070925|Bioburden|bioburden
4726560|NCT03070925|Biofilm|biofilm
4726561|NCT03070925|PHMB|phmb
4726562|NCT03070925|Chronic wounds|chronic wounds
4726563|NCT03070925|Acute wounds|acute wounds
4726564|NCT03070912|mechanical circulatory support|mechanical circulatory support
4726565|NCT03070912|bleeding, acquired von willebrand disease|bleeding, acquired von willebrand disease
4726566|NCT03070912|acquired von willebrand disease|acquired von willebrand disease
4726567|NCT03070899|Uterine Fibroid|uterine fibroid
4726568|NCT03070899|Leiomyomata|leiomyomata
4726569|NCT03070899|Heavy Menstrual Bleeding|heavy menstrual bleeding
4726570|NCT03070899|HMB|hmb
4726571|NCT03070899|Heavy Uterine Bleeding|heavy uterine bleeding
4726572|NCT03070899|Menorrhagia|menorrhagia
4726573|NCT03070899|OBE2109 + Add-back|obe2109 + add-back
4726574|NCT03070873|Quality of life|quality of life
4726575|NCT03070873|Vaginal mesh|vaginal mesh
4726576|NCT03070873|Mesh complications|mesh complications
4726577|NCT03070860|Low Grade Chronic vascular and skin Inflammation|low grade chronic vascular and skin inflammation
4726578|NCT03070860|Molecular vascular and skin Calcification|molecular vascular and skin calcification
4726579|NCT03070860|Calcium Score|calcium score
4726580|NCT03070847|tranexamic acid|tranexamic acid
4726581|NCT03070847|rhinoplasty|rhinoplasty
4726582|NCT03070847|bleeding reduction|bleeding reduction
4726583|NCT03070821|neurofeedback|neurofeedback
4726584|NCT03070821|real-time functional MRI|real-time functional mri
4726585|NCT03070821|parahippocampus|parahippocampus
4726586|NCT03070808|obesity|obesity
4726587|NCT03070808|voice|voice
4726588|NCT03070795|post-operative ileus|post-operative ileus
4726589|NCT03070795|early feeding|early feeding
4726590|NCT03070795|delayed feeding|delayed feeding
4726591|NCT03070782|IONIS-APO(a)-LRx|ionis-apo(a)-lrx
4726592|NCT03070782|AKCEA-APO(a)-LRx|akcea-apo(a)-lrx
4726593|NCT03070782|Dyslipidemia|dyslipidemia
4726594|NCT03070782|Dyslipoproteinemia|dyslipoproteinemia
4726595|NCT03070782|Hyperlipidemia|hyperlipidemia
4726596|NCT03070782|Hyperlipoproteinemia|hyperlipoproteinemia
4726597|NCT03070782|Hyperlipoproteinemia(a)|hyperlipoproteinemia(a)
4726598|NCT03070782|Hyperlipoproteinemia a|hyperlipoproteinemia a
4726599|NCT03070782|Lipoprotein|lipoprotein
4726600|NCT03070782|Lipoprotein(a)|lipoprotein(a)
4726601|NCT03070782|Lipoprotein a|lipoprotein a
4726602|NCT03070782|Lp(a)|lp(a)
4726603|NCT03070782|Lp a|lp a
4726604|NCT03070756|auto-CPAP|auto-cpap
4726605|NCT03070756|forced oscillation technique|forced oscillation technique
4726606|NCT03070756|obstructive sleep apnea|obstructive sleep apnea
4726607|NCT03070743|basilar invagination|basilar invagination
4726608|NCT03070743|atlantoaxial dislocation|atlantoaxial dislocation
4726609|NCT03070743|surgery|surgery
4726610|NCT03070743|restoration technique|restoration technique
4726611|NCT03070730|Tachycardia|tachycardia
4726612|NCT03070730|orthostatic symptoms|orthostatic symptoms
4726613|NCT03070730|autonomic reflex|autonomic reflex
4726614|NCT03070717|High myopia, shortsightedness, retinal changes|high myopia, shortsightedness, retinal changes
4726615|NCT03070691|Basal cell carcinoma|basal cell carcinoma
4726616|NCT03070691|Nevoid Basal Cell Carcinoma Syndrome|nevoid basal cell carcinoma syndrome
4726617|NCT03070691|NBCCS, Gorlin syndrome|nbccs, gorlin syndrome
4726618|NCT03070691|Gorlin-Goltz Syndrome|gorlin-goltz syndrome
4726619|NCT03070691|Basal Cell Nevus Syndrome|basal cell nevus syndrome
4726620|NCT03070691|BCNS, Hedgehog pathway inhibitor|bcns, hedgehog pathway inhibitor
4726621|NCT03070691|topical|topical
4726622|NCT03070691|Smoothened|smoothened
4726623|NCT03070665|endoscopic submucosal dissection|endoscopic submucosal dissection
4726624|NCT03070665|postoperation bleeding|postoperation bleeding
4726625|NCT03070652|attachment|attachment
4726626|NCT03070652|bonding psychological|bonding psychological
4726627|NCT03070626|General Surgery|general surgery
4726628|NCT03070626|Carbohydrates|carbohydrates
4726629|NCT03070626|Perioperative|perioperative
4726630|NCT03070613|Colonoscopy|colonoscopy
4726631|NCT03070613|Fluorescence guided surgery|fluorescence guided surgery
4726632|NCT03070600|PrEP|prep
4726633|NCT03070574|Lynch Syndrome|lynch syndrome
4726634|NCT03070574|Chemoprevention|chemoprevention
4726635|NCT03070574|Mesalazine|mesalazine
4726636|NCT03070535|APOE E4; cognition; metabolic markers; beta-amyloid|apoe e4; cognition; metabolic markers; beta-amyloid
4726637|NCT03070496|Myocardial infarction|myocardial infarction
4726638|NCT03070496|bio-collection|bio-collection
4726639|NCT03070496|Imaging markers|imaging markers
4726640|NCT03070496|biomarkers|biomarkers
4726641|NCT03070496|STEMI|stemi
4726642|NCT03070496|clinical outcomes|clinical outcomes
4726643|NCT03070457|bariatric surgery|bariatric surgery
4726644|NCT03070457|sleeve gastrectomy|sleeve gastrectomy
4726645|NCT03070457|eras|eras
4726646|NCT03070444|Essix retainer|essix retainer
4726647|NCT03070444|Cuspid-to-cuspid retainer|cuspid-to-cuspid retainer
4726648|NCT03070431|spinal cord compression, radiotherapy|spinal cord compression, radiotherapy
4726649|NCT03070418|DHS|dhs
4726650|NCT03070418|DCS|dcs
4726651|NCT03070418|Boyd and Griffin Classification|boyd and griffin classification
4726652|NCT03070405|Tenofovir Disoproxil Fumarate|tenofovir disoproxil fumarate
4726653|NCT03070405|4-Aminosalicylic Acid|4-aminosalicylic acid
4726654|NCT03070405|Tuberculosis|tuberculosis
4726655|NCT03070405|HIV|hiv
4726656|NCT03070392|Melanoma|melanoma
4726657|NCT03070392|Uveal Cancer|uveal cancer
4726658|NCT03070392|IMCgp100|imcgp100
4726659|NCT03070392|Immunotherapy|immunotherapy
4726660|NCT03070366|Oligometastasis|oligometastasis
4726661|NCT03070366|stereotactic irradiation|stereotactic irradiation
4726662|NCT03070353|Cirrhosis|cirrhosis
4726663|NCT03070353|AKI|aki
4726664|NCT03070353|Albumin|albumin
4726665|NCT03070353|Dextran|dextran
4726666|NCT03070340|mastectomy|mastectomy
4726667|NCT03070340|breast MRI|breast mri
4726668|NCT03070340|contrast enhanced mammography|contrast enhanced mammography
4726669|NCT03070340|CEDM|cedm
4726670|NCT03070340|17-045|17-045
4726671|NCT03070327|B-cell Maturation Antigen (BCMA)|b-cell maturation antigen (bcma)
4726672|NCT03070327|Targeted EGFRt/BCMA-41BBz|targeted egfrt/bcma-41bbz
4726673|NCT03070327|Chimeric antigen receptor (CAR)|chimeric antigen receptor (car)
4726674|NCT03070327|Lenalidomide|lenalidomide
4726675|NCT03070327|17-025|17-025
4726676|NCT03070314|Echinacea|echinacea
4726677|NCT03070314|bioavailability|bioavailability
4726678|NCT03070314|children|children
4726679|NCT03070301|LEE011|lee011
4726680|NCT03070301|Everolimus|everolimus
4726681|NCT03070301|16-1535|16-1535
4726682|NCT03070288|RGB|rgb
4726683|NCT03070288|red-green-blue|red-green-blue
4726684|NCT03070288|rhinitis|rhinitis
4726685|NCT03070288|allergic rhinitis|allergic rhinitis
4726686|NCT03070288|nasal mucosa|nasal mucosa
4726687|NCT03070275|surgical implant placement|surgical implant placement
4726688|NCT03070275|crestal bone|crestal bone
4726689|NCT03070275|mucosa thickness|mucosa thickness
4726690|NCT03070275|stem cells|stem cells
4726691|NCT03070275|fibrin glue|fibrin glue
4726692|NCT03070275|collagen fleece|collagen fleece
4726693|NCT03070262|esophageal cancer|esophageal cancer
4726694|NCT03070262|caffeic acid|caffeic acid
4726695|NCT03070249|Emergency Department|emergency department
4726696|NCT03070236|Breast Cancer|breast cancer
4726697|NCT03070184|Racial differences|racial differences
4726698|NCT03070158|Premature Infant|premature infant
4726699|NCT03070158|Mother-Infant Interaction|mother-infant interaction
4726700|NCT03070158|Acoustic stimulation/methods|acoustic stimulation/methods
4726701|NCT03070158|Touch|touch
4726702|NCT03070158|Visual Stimulation|visual stimulation
4726703|NCT03070158|Vestibule, Labyrinth/physiology|vestibule, labyrinth/physiology
4726704|NCT03070145|Prostate Cancer|prostate cancer
4726705|NCT03070093|Acute myeloid leukemia (AML)|acute myeloid leukemia (aml)
4726706|NCT03070093|FMS-like Tyrosine kinase-3 (FLT3) mutations|fms-like tyrosine kinase-3 (flt3) mutations
4726707|NCT03070093|gilteritinib|gilteritinib
4726708|NCT03070093|Expanded access|expanded access
4726709|NCT03070093|ASP2215|asp2215
4726710|NCT03070015|Weight Loss|weight loss
4726711|NCT03070015|Obesity|obesity
4726712|NCT03070015|Overweight|overweight
4726713|NCT03069989|Tolerability|tolerability
4726714|NCT03069989|IPF|ipf
4726715|NCT03069989|PET imaging|pet imaging
4726716|NCT03069989|Idiopathic Pulmonary Fibrosis|idiopathic pulmonary fibrosis
4726717|NCT03069989|Safety|safety
4726718|NCT03069989|Pharmacokinetics|pharmacokinetics
4726719|NCT03069989|Double-blind|double-blind
4726720|NCT03069950|Hepatic Arterial Infusion|hepatic arterial infusion
4726721|NCT03069950|Floxuridine (FUDR)|floxuridine (fudr)
4726722|NCT03069950|Irinotecan (CPT-11)|irinotecan (cpt-11)
4726723|NCT03069950|FLUOROURACIL|fluorouracil
4726724|NCT03069950|PANITUMUMAB|panitumumab
4726725|NCT03069950|16-1341|16-1341
4726726|NCT03069911|Parkinson Disease|parkinson disease
4726727|NCT03069911|Parkinsonism|parkinsonism
4726728|NCT03069911|Depression|depression
4726729|NCT03069911|OnabotulinumtoxinA|onabotulinumtoxina
4726730|NCT03069911|BOTOX|botox
4726731|NCT03069898|Marital relationship|marital relationship
4726732|NCT03069872|Transvaginal ultrasound|transvaginal ultrasound
4726733|NCT03069872|General practice|general practice
4726734|NCT03069872|Early diagnosis|early diagnosis
4726735|NCT03069872|Symptoms|symptoms
4726736|NCT03069859|Post partum hemorrhage|post partum hemorrhage
4726737|NCT03069859|Tranexamic acid|tranexamic acid
4726738|NCT03069859|Spontaneous vaginal delivery|spontaneous vaginal delivery
4726739|NCT03069859|C-section|c-section
4726740|NCT03069846|skin cancer|skin cancer
4726741|NCT03069846|laser spectroscopy|laser spectroscopy
4726742|NCT03069846|non-invasive diagnostics|non-invasive diagnostics
4726743|NCT03069781|estrogen|estrogen
4726744|NCT03069768|Nicotine addiction|nicotine addiction
4726745|NCT03069768|Cigarette smoking|cigarette smoking
4726746|NCT03069768|Smoking cessation|smoking cessation
4726747|NCT03069768|Quit smoking|quit smoking
4726748|NCT03069755|India|india
4726749|NCT03069755|Perioperative mortality|perioperative mortality
4726750|NCT03069755|Trauma|trauma
4726751|NCT03069755|Surgery|surgery
4726752|NCT03069742|Breast Cancer Prevention|breast cancer prevention
4726753|NCT03069742|Risk Assessment|risk assessment
4726754|NCT03069742|Chemoprevention|chemoprevention
4726755|NCT03069742|Decision Making|decision making
4726756|NCT03069729|screen|screen
4726757|NCT03069716|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
4726758|NCT03069703|Vaccine|vaccine
4726759|NCT03069703|ANCA- associated vasculitides|anca- associated vasculitides
4726760|NCT03069703|pneumovax|pneumovax
4726761|NCT03069703|prevenar|prevenar
4726762|NCT03069703|pneumovas|pneumovas
4726763|NCT03069677|midazolam|midazolam
4726764|NCT03069664|Pancreatic Cancer|pancreatic cancer
4726765|NCT03069664|Pancreatic Duct Stricture|pancreatic duct stricture
4726766|NCT03069664|Endoscopic treatment|endoscopic treatment
4726767|NCT03069638|sedation|sedation
4726768|NCT03069638|pediatrics|pediatrics
4726769|NCT03069638|intranasal sedation|intranasal sedation
4726770|NCT03069638|dexmedetomidine|dexmedetomidine
4726771|NCT03069638|dinitrous oxide|dinitrous oxide
4726772|NCT03069638|intra-articular joint injection|intra-articular joint injection
4726773|NCT03069625|Cystic Fibrosis|cystic fibrosis
4726774|NCT03069625|Exercise Testing|exercise testing
4726775|NCT03069625|Muscular strength|muscular strength
4726776|NCT03069625|Pediatrics|pediatrics
4726777|NCT03069625|Quality of life|quality of life
4726778|NCT03069612|repetitive transcranial magnetic stimulation|repetitive transcranial magnetic stimulation
4726779|NCT03069612|working memory|working memory
4726780|NCT03069612|gamma oscillations|gamma oscillations
4726781|NCT03069612|dorsolateral prefrontal cortex|dorsolateral prefrontal cortex
4726782|NCT03069573|Eosinophilic Esophagitis|eosinophilic esophagitis
4726783|NCT03069573|Gastroesophageal Reflux|gastroesophageal reflux
4726784|NCT03069573|Diagnose|diagnose
4726785|NCT03069573|Biomarker|biomarker
4726786|NCT03069560|suicide attempt|suicide attempt
4726787|NCT03069560|SMS monitoring|sms monitoring
4726788|NCT03069560|Phone|phone
4726789|NCT03069560|Prevention control|prevention control
4726790|NCT03069560|tertiary healthcare|tertiary healthcare
4726791|NCT03069534|MDR-TB|mdr-tb
4726792|NCT03069534|rhIL-2|rhil-2
4726793|NCT03069534|immunotherapy|immunotherapy
4726794|NCT03069495|Allergy|allergy
4726795|NCT03069495|Asthma|asthma
4726796|NCT03069495|Urticaria|urticaria
4726797|NCT03069482|Smoking|smoking
4726798|NCT03069482|mHealth|mhealth
4726799|NCT03069482|Serious Mental Illness|serious mental illness
4726800|NCT03069482|Acceptance and Commitment Therapy|acceptance and commitment therapy
4726801|NCT03069482|US DHHS Clinical Practice Guidelines|us dhhs clinical practice guidelines
4726802|NCT03069469|CSF1R|csf1r
4726803|NCT03069469|ALL|all
4726804|NCT03069469|CML|cml
4726805|NCT03069469|AML|aml
4726806|NCT03069469|MDS|mds
4726807|NCT03069456|sevoflurane|sevoflurane
4726808|NCT03069456|Bistpectral index|bistpectral index
4726809|NCT03069456|Anesthetic Depth Monitoring System|anesthetic depth monitoring system
4726810|NCT03069456|population pharmacodynamics|population pharmacodynamics
4726811|NCT03069443|Isometric handgrip training|isometric handgrip training
4726812|NCT03069443|home training|home training
4726813|NCT03069443|older adults|older adults
4726814|NCT03069443|Hypertension|hypertension
4726815|NCT03069417|HIV|hiv
4726816|NCT03069417|Medication adherence|medication adherence
4726817|NCT03069417|PMTCT|pmtct
4726818|NCT03069417|Depression|depression
4726819|NCT03069391|exercise|exercise
4726820|NCT03069391|exergame|exergame
4726821|NCT03069378|Metastatic|metastatic
4726822|NCT03069378|Locally Advanced|locally advanced
4726823|NCT03069378|Talimogene Laherparepvec (T-VEC)|talimogene laherparepvec (t-vec)
4726824|NCT03069378|Pembrolizumab|pembrolizumab
4726825|NCT03069378|16-1534|16-1534
4726826|NCT03069365|Chronic Hepatitis C Virus|chronic hepatitis c virus
4726827|NCT03069365|Chronic Kidney Disease|chronic kidney disease
4726828|NCT03069365|Glecaprevir|glecaprevir
4726829|NCT03069365|Pibrentasvir|pibrentasvir
4726830|NCT03069365|Hepatitis C Virus Genotype|hepatitis c virus genotype
4726831|NCT03069365|compensated cirrhosis|compensated cirrhosis
4726832|NCT03069365|non-cirrhotic|non-cirrhotic
4726833|NCT03069365|interferon (IFN)|interferon (ifn)
4726834|NCT03069365|treatment naïve|treatment naïve
4726835|NCT03069365|sofosbuvir (SOF)|sofosbuvir (sof)
4726836|NCT03069365|pegylated interferon (pegIFN)|pegylated interferon (pegifn)
4726837|NCT03069365|ribavirin (RBV)|ribavirin (rbv)
4726838|NCT03069352|Acute Myeloid Leukemia|acute myeloid leukemia
4726839|NCT03069352|Leukemia|leukemia
4726840|NCT03069352|Treatment naïve|treatment naïve
4726841|NCT03069352|Venetoclax|venetoclax
4726842|NCT03069352|Cytarabine|cytarabine
4726843|NCT03069326|Ruxolitinib|ruxolitinib
4726844|NCT03069326|Thalidomide|thalidomide
4726845|NCT03069326|16-1498|16-1498
4726846|NCT03069313|Aromatase Inhibitor|aromatase inhibitor
4726847|NCT03069313|Breast Cancer|breast cancer
4726848|NCT03069313|Arthralgia|arthralgia
4726849|NCT03069313|Musculoskeletal symptoms|musculoskeletal symptoms
4726850|NCT03069313|Joint pain|joint pain
4726851|NCT03069261|Breast reconstruction|breast reconstruction
4726852|NCT03069261|Autologous tissue flaps|autologous tissue flaps
4726853|NCT03069261|Indocyanine green angiography|indocyanine green angiography
4726854|NCT03069261|Breast cancer|breast cancer
4726855|NCT03069235|HIV|hiv
4726856|NCT03069235|Breast Feeding|breast feeding
4726857|NCT03069222|diffusion tensor imaging|diffusion tensor imaging
4726858|NCT03069196|Prevalence|prevalence
4726859|NCT03069196|Incidence|incidence
4726860|NCT03069196|Type 1 diabetes and its Micro-vascular complications|type 1 diabetes and its micro-vascular complications
4726861|NCT03069196|Type 1 diabetes and its Macro-vascular complications|type 1 diabetes and its macro-vascular complications
4726862|NCT03069196|Type 1 Diabetes and its complications in India|type 1 diabetes and its complications in india
4726863|NCT03069183|Fascia Iliaca Block|fascia iliaca block
4726864|NCT03069183|Total Hip Arthroplasty|total hip arthroplasty
4726865|NCT03069183|Total Hip Replacement|total hip replacement
4726866|NCT03069183|Ultrasound|ultrasound
4726867|NCT03069144|Psoriasis|psoriasis
4726868|NCT03069144|Topical|topical
4726869|NCT03069131|primary prophylaxis|primary prophylaxis
4726870|NCT03069131|rifaximin|rifaximin
4726871|NCT03069118|Telemedicine|telemedicine
4726872|NCT03069118|Online Treatment|online treatment
4726873|NCT03069118|Digital Intervention|digital intervention
4726874|NCT03069079|primary immunodeficiency|primary immunodeficiency
4726875|NCT03069079|dental health|dental health
4726876|NCT03069079|neutrophil defect|neutrophil defect
4726877|NCT03069079|periodontitis|periodontitis
4726878|NCT03069066|In-stent restenosis|in-stent restenosis
4726879|NCT03069066|Bioresorbable vascular scaffold|bioresorbable vascular scaffold
4726880|NCT03069066|Stent|stent
4726881|NCT03069066|Drug-eluting stent|drug-eluting stent
4726882|NCT03069066|Coronary angiography|coronary angiography
4726883|NCT03069066|Scoring balloon|scoring balloon
4726884|NCT03069040|cervical cancer|cervical cancer
4726885|NCT03069040|NSRH|nsrh
4726886|NCT03069040|RH|rh
4726887|NCT03069040|urine flow mechanics|urine flow mechanics
4726888|NCT03069040|anorectal dynamics|anorectal dynamics
4726889|NCT03069027|Nasal surgery|nasal surgery
4726890|NCT03069027|external nasal nerve block|external nasal nerve block
4726891|NCT03069027|postoperative agitation|postoperative agitation
4726892|NCT03069001|HCV treatment|hcv treatment
4726893|NCT03068988|bone marrow stem cells|bone marrow stem cells
4726894|NCT03068988|rotator cuff lesion|rotator cuff lesion
4726895|NCT03068936|Nasopharyngeal Carcinoma|nasopharyngeal carcinoma
4726896|NCT03068936|Intensity modulated radiotherapy|intensity modulated radiotherapy
4726897|NCT03068936|Cisplatin|cisplatin
4726898|NCT03068923|Blood clot|blood clot
4726899|NCT03068923|Deep Vein Thrombosis|deep vein thrombosis
4726900|NCT03068923|Pulmonary Embolism|pulmonary embolism
4726901|NCT03068923|Lower Extremity|lower extremity
4726902|NCT03068923|Upper Extremity|upper extremity
4726903|NCT03068923|Cerebral sinus|cerebral sinus
4726904|NCT03068923|Renal vein|renal vein
4726905|NCT03068923|Portal vein|portal vein
4726906|NCT03068923|thrombin|thrombin
4726907|NCT03068923|fibrinolysis|fibrinolysis
4726908|NCT03068923|coagulation|coagulation
4726909|NCT03068923|anticoagulation|anticoagulation
4726910|NCT03068923|Post trombotic syndrome|post trombotic syndrome
4726911|NCT03068923|Post pulmonary embolism syndrome|post pulmonary embolism syndrome
4726912|NCT03068923|Chronic thromboembolic pulmonary hypertension|chronic thromboembolic pulmonary hypertension
4726913|NCT03068910|Hyperandrogenism|hyperandrogenism
4726914|NCT03068910|Polycystic ovary syndrome|polycystic ovary syndrome
4726915|NCT03068910|Puberty|puberty
4726916|NCT03068845|non-maturing arteriovenous fistula|non-maturing arteriovenous fistula
4726917|NCT03068845|stenosis of arteriovenous fistula|stenosis of arteriovenous fistula
4726918|NCT03068845|drug-eluting balloon|drug-eluting balloon
4726919|NCT03068767|HBV DNA, qHBsAg|hbv dna, qhbsag
4726920|NCT03068754|ALS|als
4726921|NCT03068728|bilateral chronic rhino sinusitis|bilateral chronic rhino sinusitis
4726922|NCT03068715|transcranial magnetic stimulation|transcranial magnetic stimulation
4726923|NCT03068715|theta burst|theta burst
4726924|NCT03068689|Partial nephrectomy, RIPC, Reperfusion Injury|partial nephrectomy, ripc, reperfusion injury
4726925|NCT03068676|Depression|depression
4726926|NCT03068676|Anxiety|anxiety
4726927|NCT03068676|Internet-delivered|internet-delivered
4726928|NCT03068676|CBT|cbt
4726929|NCT03068676|Primary Care|primary care
4726930|NCT03068663|lung cancer|lung cancer
4726931|NCT03068663|intestinal microbiota|intestinal microbiota
4726932|NCT03068663|lung microbiota|lung microbiota
4726933|NCT03068663|surgery|surgery
4726934|NCT03068663|chemotherapy|chemotherapy
4726935|NCT03068624|Melanoma and Other Malignant Neoplasms of Skin|melanoma and other malignant neoplasms of skin
4726936|NCT03068624|Metastatic uveal melanoma|metastatic uveal melanoma
4726937|NCT03068624|Autologous CD8+ T cells|autologous cd8+ t cells
4726938|NCT03068624|Cyclophosphamide|cyclophosphamide
4726939|NCT03068624|Cytoxan|cytoxan
4726940|NCT03068624|Neosar|neosar
4726941|NCT03068624|Interleukin-2|interleukin-2
4726942|NCT03068624|IL-2|il-2
4726943|NCT03068624|Aldesleukin|aldesleukin
4726944|NCT03068624|Proleukin|proleukin
4726945|NCT03068624|Ipilimumab|ipilimumab
4726946|NCT03068624|Yervoy|yervoy
4726947|NCT03068624|BMS-734016|bms-734016
4726948|NCT03068624|MDX010|mdx010
4726949|NCT03068585|PAD|pad
4726950|NCT03068585|CLI|cli
4726951|NCT03068585|stage 2a-3 of Pokrovsky-Fonteine|stage 2a-3 of pokrovsky-fonteine
4726952|NCT03068572|minimal change esophageal reflux disease diagnosis|minimal change esophageal reflux disease diagnosis
4726953|NCT03068572|Linked Color imaging|linked color imaging
4726954|NCT03068572|non-erosive reflux disease|non-erosive reflux disease
4726955|NCT03068546|Oral Microbiota|oral microbiota
4726956|NCT03068533|DH, dentin hypersensitivity, chronic periodontitis|dh, dentin hypersensitivity, chronic periodontitis
4726957|NCT03068520|PET|pet
4726958|NCT03068520|MRI|mri
4726959|NCT03068520|BRAIN METASTASIS|brain metastasis
4726960|NCT03068520|BRAIN PRIMARY TUMOR|brain primary tumor
4726961|NCT03068520|RESPONSE TO TREATMENT|response to treatment
4726962|NCT03068507|Perioperative|perioperative
4726963|NCT03068507|functional capability|functional capability
4726964|NCT03068507|Prehabilitation|prehabilitation
4726965|NCT03068507|thoracoscopic lobectomy|thoracoscopic lobectomy
4726966|NCT03068507|Lung Cancer|lung cancer
4726967|NCT03068494|Coronary Bifurcation Lesion|coronary bifurcation lesion
4726968|NCT03068494|2nd generation drug-eluting stent|2nd generation drug-eluting stent
4726969|NCT03068442|Carotid artery|carotid artery
4726970|NCT03068442|MRI|mri
4726971|NCT03068442|PET|pet
4726972|NCT03068442|Intraplaque hemorrhage|intraplaque hemorrhage
4726973|NCT03068429|obsessive-compulsive disorder|obsessive-compulsive disorder
4726974|NCT03068429|fear conditioning|fear conditioning
4726975|NCT03068429|functional neuroimaging|functional neuroimaging
4726976|NCT03068429|sertraline|sertraline
4726977|NCT03068403|CEUS Perfusion|ceus perfusion
4726978|NCT03068403|Rectal Cancer|rectal cancer
4726979|NCT03068403|Tumor Perfusion|tumor perfusion
4726980|NCT03068403|Radiochemotherapy|radiochemotherapy
4726981|NCT03068377|lycopene|lycopene
4726982|NCT03068377|eye|eye
4726983|NCT03068377|vessel function|vessel function
4726984|NCT03068364|Mortality|mortality
4726985|NCT03068364|Hypertension|hypertension
4726986|NCT03068364|Left ventricular hypertrophy|left ventricular hypertrophy
4726987|NCT03068364|NT-proBNP|nt-probnp
4726988|NCT03068364|ECG|ecg
4726989|NCT03068364|Transthoracic echocardiography|transthoracic echocardiography
4726990|NCT03068299|Prevention|prevention
4726991|NCT03068299|Cognition|cognition
4726992|NCT03068299|Aged care|aged care
4726993|NCT03068299|Caregivers|caregivers
4726994|NCT03068299|Frail elderly|frail elderly
4726995|NCT03068299|Dancing therapy|dancing therapy
4726996|NCT03068299|Rural population|rural population
4726997|NCT03068273|Hospitalization|hospitalization
4726998|NCT03068260|caesarean section|caesarean section
4726999|NCT03068260|postoperative pain|postoperative pain
4727000|NCT03068260|transmuscular quadratus lumborum block|transmuscular quadratus lumborum block
4727001|NCT03068260|reduction of opioid consumption|reduction of opioid consumption
4727002|NCT03068208|Methylene blue|methylene blue
4727003|NCT03068208|photodynamic therapy|photodynamic therapy
4727004|NCT03068208|primary cutaneous localized amyloidosis|primary cutaneous localized amyloidosis
4727005|NCT03068208|lichen amyloidosis|lichen amyloidosis
4727006|NCT03068195|laparoscopy|laparoscopy
4727007|NCT03068195|microwave|microwave
4727008|NCT03068195|ablation technique|ablation technique
4727009|NCT03068182|Exercise ,Autonomic cardiac function ,Adult subjects|exercise ,autonomic cardiac function ,adult subjects
4727010|NCT03068169|remote ECG|remote ecg
4727011|NCT03068169|atrial fibrillation|atrial fibrillation
4727012|NCT03068169|cardiac rehabilitation|cardiac rehabilitation
4727013|NCT03068169|cardiac resynchronization therapy|cardiac resynchronization therapy
4727014|NCT03068169|supraventricular tachycardia|supraventricular tachycardia
4727015|NCT03068156|308-nm excimer laser|308-nm excimer laser
4727016|NCT03068156|primary localized cutaneous amyloidosis|primary localized cutaneous amyloidosis
4727017|NCT03068156|lichen amyloidosis|lichen amyloidosis
4727018|NCT03068156|Asians|asians
4727019|NCT03068130|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
4727020|NCT03068130|Pulmonary Hypertension|pulmonary hypertension
4727021|NCT03068130|PH|ph
4727022|NCT03068130|PAH|pah
4727023|NCT03068130|Bardoxolone methyl|bardoxolone methyl
4727024|NCT03068130|6-minute walk distance|6-minute walk distance
4727025|NCT03068130|CDDO-ME|cddo-me
4727026|NCT03068130|RTA 402|rta 402
4727027|NCT03068130|LARIAT|lariat
4727028|NCT03068130|CATALYST|catalyst
4727029|NCT03068130|RANGER|ranger
4727030|NCT03068117|Specialist Palliative Care|specialist palliative care
4727031|NCT03068117|Symptom Control|symptom control
4727032|NCT03068117|Early Referral|early referral
4727033|NCT03068117|Quality of Life|quality of life
4727034|NCT03068117|Malignant Pleural Mesothelioma|malignant pleural mesothelioma
4727035|NCT03068117|Mesothelioma|mesothelioma
4727036|NCT03068104|Trauma|trauma
4727037|NCT03068104|Haemorrhage|haemorrhage
4727038|NCT03068104|Massive transfusion|massive transfusion
4727039|NCT03068104|India|india
4727040|NCT03068091|Interstitial Lung Disease|interstitial lung disease
4727041|NCT03068091|Idiopathic Pulmonary Fibrosis|idiopathic pulmonary fibrosis
4727042|NCT03068065|Liraglutide|liraglutide
4727043|NCT03068065|Metformin|metformin
4727044|NCT03068065|Gliclazide|gliclazide
4727045|NCT03068039|MRI|mri
4727046|NCT03068039|blood glucose|blood glucose
4727047|NCT03068039|porridge|porridge
4727048|NCT03068039|breakfast|breakfast
4727049|NCT03068039|satiety|satiety
4727050|NCT03068039|plasma peptides|plasma peptides
4727051|NCT03068026|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
4727052|NCT03068026|Non-invasive ventilation|non-invasive ventilation
4727053|NCT03068013|CALM|calm
4727054|NCT03068013|Depression|depression
4727055|NCT03068013|Demoralization|demoralization
4727056|NCT03068013|Cancer|cancer
4727057|NCT03068013|Spirituality|spirituality
4727058|NCT03068013|Psychotherapy|psychotherapy
4727059|NCT03068013|Quality of Life|quality of life
4727060|NCT03068013|Anxiety|anxiety
4727061|NCT03068013|Post-Traumatic Growth|post-traumatic growth
4727062|NCT03068000|Martial arts|martial arts
4727063|NCT03068000|Judo|judo
4727064|NCT03068000|Motor skills|motor skills
4727065|NCT03068000|Physical fitness|physical fitness
4727066|NCT03068000|Cardiovascular parameters|cardiovascular parameters
4727067|NCT03068000|Quality of life|quality of life
4727068|NCT03068000|Physical Activity|physical activity
4727069|NCT03067974|ketamine|ketamine
4727070|NCT03067974|pediatric|pediatric
4727071|NCT03067974|procedural sedation|procedural sedation
4727072|NCT03067961|Enteric fever|enteric fever
4727073|NCT03067961|Typhoid|typhoid
4727074|NCT03067961|Salmonella Typhi|salmonella typhi
4727075|NCT03067961|Challenge study|challenge study
4727076|NCT03067961|Human model of infection|human model of infection
4727077|NCT03067961|Typhoid toxin|typhoid toxin
4727078|NCT03067922|Mastectomy|mastectomy
4727079|NCT03067922|Pain|pain
4727080|NCT03067922|Severity|severity
4727081|NCT03067922|Life quality|life quality
4727082|NCT03067896|spinal block|spinal block
4727083|NCT03067896|stress response|stress response
4727084|NCT03067896|dexmedetomidine|dexmedetomidine
4727085|NCT03067896|intrathecally|intrathecally
4727086|NCT03067870|Stem cells|stem cells
4727087|NCT03067870|Rheumatoid arthritis|rheumatoid arthritis
4727088|NCT03067831|stem cells|stem cells
4727089|NCT03067818|arm|arm
4727090|NCT03067818|rehabilitation|rehabilitation
4727091|NCT03067818|non-invasive brain stimulation|non-invasive brain stimulation
4727092|NCT03067818|transcranial magnetic stimulation|transcranial magnetic stimulation
4727093|NCT03067818|upper extremity|upper extremity
4727094|NCT03067805|Oxytocin effect|oxytocin effect
4727095|NCT03067805|romantic jealousy|romantic jealousy
4727096|NCT03067805|Arousal Rating|arousal rating
4727097|NCT03067805|Jealousy Rating|jealousy rating
4727098|NCT03067792|inoperable gastric cancer|inoperable gastric cancer
4727099|NCT03067792|palliative chemotherapy|palliative chemotherapy
4727100|NCT03067740|appendicectomy|appendicectomy
4727101|NCT03067740|children|children
4727102|NCT03067740|local anesthetics|local anesthetics
4727103|NCT03067740|laparoscopy|laparoscopy
4727104|NCT03067740|peritoneum|peritoneum
4727105|NCT03067675|no known ocular pathology|no known ocular pathology
4727106|NCT03067623|Thin endometrium|thin endometrium
4727107|NCT03067623|Endometrial thickness|endometrial thickness
4727108|NCT03067584|Familial cancer|familial cancer
4727109|NCT03067584|Genetic predisposition|genetic predisposition
4727110|NCT03067584|Heritable disease|heritable disease
4727111|NCT03067584|Cancer risk|cancer risk
4727112|NCT03067584|Genome analysis|genome analysis
4727113|NCT03067584|Genetic modifiers|genetic modifiers
4727241|NCT03066882|Obesity|obesity
4727114|NCT03067584|Next generation sequencing (NGS)|next generation sequencing (ngs)
4727115|NCT03067584|Genetic counseling|genetic counseling
4727116|NCT03067584|DNA|dna
4727117|NCT03067571|Hematopoietic/Lymphoid Cancer|hematopoietic/lymphoid cancer
4727118|NCT03067571|Acute Myelogenous Leukemia|acute myelogenous leukemia
4727119|NCT03067571|AML|aml
4727120|NCT03067571|High-Risk Myelodysplastic Syndrome|high-risk myelodysplastic syndrome
4727121|NCT03067571|MDA|mda
4727122|NCT03067571|Daratumumab|daratumumab
4727123|NCT03067558|Pneumonia|pneumonia
4727124|NCT03067558|Diagnostics|diagnostics
4727125|NCT03067558|Childhood|childhood
4727126|NCT03067558|Respiratory rate|respiratory rate
4727127|NCT03067558|Ethiopia|ethiopia
4727128|NCT03067506|Drug Therapy|drug therapy
4727129|NCT03067454|early mobilisation|early mobilisation
4727130|NCT03067454|metacarpal fracture|metacarpal fracture
4727131|NCT03067454|operation|operation
4727132|NCT03067441|hyperlipidemia|hyperlipidemia
4727133|NCT03067441|cholesterol|cholesterol
4727134|NCT03067441|heterozygous familial hypercholesterolemia|heterozygous familial hypercholesterolemia
4727135|NCT03067441|atherosclerotic cardiovascular disease|atherosclerotic cardiovascular disease
4727136|NCT03067441|ASCVD|ascvd
4727137|NCT03067441|HeFH|hefh
4727138|NCT03067441|LDL|ldl
4727139|NCT03067428|Fructose|fructose
4727140|NCT03067428|Diet|diet
4727141|NCT03067415|Glaucoma, Primary Open Angle|glaucoma, primary open angle
4727142|NCT03067415|Ocular hypertension|ocular hypertension
4727143|NCT03067415|CKD-351|ckd-351
4727144|NCT03067402|Myocardial Infarction|myocardial infarction
4727145|NCT03067402|Physiological Stress Test|physiological stress test
4727146|NCT03067402|Nuclear Image Perfusion|nuclear image perfusion
4727147|NCT03067402|Angioplasty|angioplasty
4727148|NCT03067402|Coronary Artery Bypass Graft|coronary artery bypass graft
4727149|NCT03067402|Percutaneous Coronary Intervention|percutaneous coronary intervention
4727150|NCT03067402|Angina|angina
4727151|NCT03067402|Ischemia|ischemia
4727152|NCT03067376|ADME|adme
4727153|NCT03067376|Metabolism|metabolism
4727154|NCT03067376|Metabolite Profiling|metabolite profiling
4727155|NCT03067376|Excretion|excretion
4727156|NCT03067350|voriconazole|voriconazole
4727157|NCT03067350|pharmacogenetics|pharmacogenetics
4727158|NCT03067350|pharmacokinetics|pharmacokinetics
4727159|NCT03067350|therapeutic drug monitoring|therapeutic drug monitoring
4727160|NCT03067337|Stainless Steel Crowns|stainless steel crowns
4727161|NCT03067337|Zirconia Crowns|zirconia crowns
4727162|NCT03067337|Aesthetic restorations|aesthetic restorations
4727163|NCT03067324|Islet Transplantation|islet transplantation
4727164|NCT03067298|pregnancy|pregnancy
4727165|NCT03067298|screening|screening
4727166|NCT03067298|doppler|doppler
4727167|NCT03067298|markers|markers
4727168|NCT03067298|PlGF|plgf
4727169|NCT03067298|sFlt-1|sflt-1
4727170|NCT03067298|placenta|placenta
4727171|NCT03067272|Permanent contraception|permanent contraception
4727172|NCT03067272|Birth control|birth control
4727173|NCT03067259|eldery patients|eldery patients
4727174|NCT03067259|cognitive impairment|cognitive impairment
4727175|NCT03067246|Supraglottic device|supraglottic device
4727176|NCT03067246|Fibre optic scope|fibre optic scope
4727177|NCT03067246|Endotracheal intubation|endotracheal intubation
4727178|NCT03067220|outpatients|outpatients
4727179|NCT03067220|general surgery|general surgery
4727180|NCT03067220|virtual clinic|virtual clinic
4727181|NCT03067220|patient satisfaction|patient satisfaction
4727182|NCT03067207|mindfulness meditation|mindfulness meditation
4727183|NCT03067207|Adolescent|adolescent
4727184|NCT03067207|eHealth|ehealth
4727185|NCT03067207|randomized trial|randomized trial
4727186|NCT03067194|Osteoarthritis Hand|osteoarthritis hand
4727187|NCT03067155|allogeneic stem cell transplantation|allogeneic stem cell transplantation
4727188|NCT03067155|CMV reactivation|cmv reactivation
4727189|NCT03067129|Chronic Hepatitis C Virus|chronic hepatitis c virus
4727190|NCT03067129|Glecaprevir|glecaprevir
4727191|NCT03067129|Pibrentasvir|pibrentasvir
4727192|NCT03067129|Pharmacokinetic|pharmacokinetic
4727193|NCT03067129|Treatment naïve|treatment naïve
4727194|NCT03067129|Treatment experienced|treatment experienced
4727195|NCT03067129|Interferon (IFN)|interferon (ifn)
4727196|NCT03067129|pegylated interferon (pegIFN)|pegylated interferon (pegifn)
4727197|NCT03067129|Ribavirin (RBV)|ribavirin (rbv)
4727198|NCT03067129|sofosbuvir|sofosbuvir
4727199|NCT03067129|Non-cirrhotic cirrhosis|non-cirrhotic cirrhosis
4727200|NCT03067129|Compensated (Child-Pugh A) cirrhosis|compensated (child-pugh a) cirrhosis
4727201|NCT03067116|balance, postural|balance, postural
4727202|NCT03067116|fall risk|fall risk
4727203|NCT03067116|anthropometrics|anthropometrics
4727204|NCT03067116|blood pressure|blood pressure
4727205|NCT03067116|SpO2|spo2
4727206|NCT03067116|heart rate|heart rate
4727207|NCT03067116|heart rate variability|heart rate variability
4727208|NCT03067116|stance width|stance width
4727209|NCT03067103|Adenotonsillectomy|adenotonsillectomy
4727210|NCT03067103|pain|pain
4727211|NCT03067103|topic analgesia|topic analgesia
4727212|NCT03067103|child|child
4727213|NCT03067077|SMILE|smile
4727214|NCT03067077|LASIK|lasik
4727215|NCT03067077|Myopia|myopia
4727216|NCT03067077|Wavefront-guided|wavefront-guided
4727217|NCT03067012|Oncometabolic surgery|oncometabolic surgery
4727218|NCT03067012|Long limb uncut Roux-en-Y gastrojejunostomy|long limb uncut roux-en-y gastrojejunostomy
4727219|NCT03067012|Obesity|obesity
4727220|NCT03067012|Diabetes|diabetes
4727221|NCT03067012|Early gastric cancer|early gastric cancer
4727222|NCT03066986|Venom anaphylaxis|venom anaphylaxis
4727223|NCT03066986|Myrmecia piluosa|myrmecia piluosa
4727224|NCT03066986|Immunological adjuvant|immunological adjuvant
4727225|NCT03066986|Immunotherapy|immunotherapy
4727226|NCT03066986|Jack jumper ant|jack jumper ant
4727227|NCT03066973|breath exercises|breath exercises
4727228|NCT03066973|labor pain|labor pain
4727229|NCT03066973|labor duration|labor duration
4727230|NCT03066973|VAS|vas
4727231|NCT03066934|Noninvasive Positive Pressure Ventilation|noninvasive positive pressure ventilation
4727232|NCT03066934|Nasal high flow|nasal high flow
4727233|NCT03066934|Respiratory Failure|respiratory failure
4727234|NCT03066934|Childhood|childhood
4727235|NCT03066921|Lactic acid bacteria|lactic acid bacteria
4727236|NCT03066921|dyslipidemia uremic toxins|dyslipidemia uremic toxins
4727237|NCT03066921|Hemodialysis|hemodialysis
4727238|NCT03066908|Chronic Rhinosinusitis|chronic rhinosinusitis
4727239|NCT03066882|Caloric Restriction|caloric restriction
4727240|NCT03066882|Diet|diet
4727242|NCT03066882|Overweight|overweight
4727243|NCT03066882|Sedentary Lifestyle|sedentary lifestyle
4727244|NCT03066882|Weight loss|weight loss
4727245|NCT03066882|Women|women
4727246|NCT03066856|BRCA genes|brca genes
4727247|NCT03066856|Mutation carriers|mutation carriers
4727248|NCT03066856|IGF-I|igf-i
4727249|NCT03066856|Diet|diet
4727250|NCT03066817|Vitamin D|vitamin d
4727251|NCT03066817|Deficiency|deficiency
4727252|NCT03066817|Insufficiency|insufficiency
4727253|NCT03066817|Bone turnover|bone turnover
4727254|NCT03066817|Bone healing|bone healing
4727255|NCT03066817|Polytrauma|polytrauma
4727256|NCT03066804|Cardiovascular Diseases|cardiovascular diseases
4727257|NCT03066804|Heart Failure|heart failure
4727258|NCT03066804|Heart failure with Preserved Ejection Fraction|heart failure with preserved ejection fraction
4727259|NCT03066804|NT-proBNP|nt-probnp
4727260|NCT03066804|KCCQ|kccq
4727261|NCT03066804|6 MWT|6 mwt
4727262|NCT03066804|SF-36|sf-36
4727263|NCT03066804|NYHA Class|nyha class
4727264|NCT03066804|LCZ696|lcz696
4727265|NCT03066804|Enalapril|enalapril
4727266|NCT03066804|Valsartan|valsartan
4727267|NCT03066804|Angiotensin-Converting Enzyme Inhibitors (ACEi)|angiotensin-converting enzyme inhibitors (acei)
4727268|NCT03066804|Angiotensin II Type 1 Receptor Blockers (ARB)|angiotensin ii type 1 receptor blockers (arb)
4727269|NCT03066804|Renin Angiotensin System Inhibitors (RASi)|renin angiotensin system inhibitors (rasi)
4727270|NCT03066778|Extensive stage small cell lung cancer (ES-SCLC)|extensive stage small cell lung cancer (es-sclc)
4727271|NCT03066778|Programmed cell death protein-1 (PD-1)|programmed cell death protein-1 (pd-1)
4727272|NCT03066778|Programmed cell death-ligand 1 (PD-L1)|programmed cell death-ligand 1 (pd-l1)
4727273|NCT03066778|PD1|pd1
4727274|NCT03066778|PDL1|pdl1
4727275|NCT03066726|Biophysical profile|biophysical profile
4727276|NCT03066726|Cesarean section|cesarean section
4727277|NCT03066726|Estimated fetal weight|estimated fetal weight
4727278|NCT03066726|Middle cerebral artery|middle cerebral artery
4727279|NCT03066726|Umbilical artery|umbilical artery
4727280|NCT03066726|Fetal growth restriction|fetal growth restriction
4727281|NCT03066726|Pulsatility index|pulsatility index
4727282|NCT03066726|Estimated gestational age|estimated gestational age
4727283|NCT03066726|Doppler|doppler
4727284|NCT03066648|Acute Myeloid Leukemia|acute myeloid leukemia
4727285|NCT03066648|Myelodysplastic syndromes|myelodysplastic syndromes
4727286|NCT03066635|Nerve block|nerve block
4727287|NCT03066635|Ganglia, Parasympathetic|ganglia, parasympathetic
4727288|NCT03066635|Botulinum Toxins, Type A|botulinum toxins, type a
4727289|NCT03066635|Injection|injection
4727290|NCT03066609|Plaque psoriasis, Secukinumab, Skin condition, skin disease, itching, psoriasis vulgaris, immune-mediated systemic disease, skin lesions, scaly patches, papules|plaque psoriasis, secukinumab, skin condition, skin disease, itching, psoriasis vulgaris, immune-mediated systemic disease, skin lesions, scaly patches, papules
4727291|NCT03066583|meniscus repair|meniscus repair
4727292|NCT03066583|platelet rich plasma|platelet rich plasma
4727293|NCT03066570|Graded Exposure|graded exposure
4727294|NCT03066570|Quality of Life|quality of life
4727295|NCT03066570|Physical Activity|physical activity
4727296|NCT03066570|Anxiety|anxiety
4727297|NCT03066557|Hepatocellular Carcinoma|hepatocellular carcinoma
4727298|NCT03066557|Apatinib|apatinib
4727299|NCT03066544|migraine|migraine
4727300|NCT03066544|responder|responder
4727301|NCT03066544|non-responder|non-responder
4727302|NCT03066544|treatment|treatment
4727303|NCT03066531|ACT|act
4727304|NCT03066531|CBT obesity|cbt obesity
4727305|NCT03066531|Eating disorders|eating disorders
4727306|NCT03066531|Health psychology|health psychology
4727307|NCT03066518|melatonin|melatonin
4727308|NCT03066518|sleep|sleep
4727309|NCT03066518|dementia|dementia
4727310|NCT03066518|cognition|cognition
4727311|NCT03066492|Tertiary Care Center|tertiary care center
4727312|NCT03066492|Patient Readmission|patient readmission
4727313|NCT03066492|Health Services Research|health services research
4727314|NCT03066492|Hospital Readmissions|hospital readmissions
4727315|NCT03066466|Acute Myeloid Leukemia|acute myeloid leukemia
4727316|NCT03066466|Acute Lymphocytic Leukemia|acute lymphocytic leukemia
4727317|NCT03066466|Myelodysplastic Syndrome|myelodysplastic syndrome
4727318|NCT03066466|BMT|bmt
4727319|NCT03066466|Matched unrelated donor transplant|matched unrelated donor transplant
4727320|NCT03066466|Graft versus Host Disease|graft versus host disease
4727321|NCT03066466|GVHD|gvhd
4727322|NCT03066453|cystic fibrosis, tobramycin, antibiotic courses, FEV1|cystic fibrosis, tobramycin, antibiotic courses, fev1
4727323|NCT03066440|diabetic ketoacidosis|diabetic ketoacidosis
4727324|NCT03066440|fluid management|fluid management
4727325|NCT03066440|hyperchloremia|hyperchloremia
4727326|NCT03066427|Clear Cell Renal Carcinoma|clear cell renal carcinoma
4727327|NCT03066427|Sunitinib|sunitinib
4727328|NCT03066414|hemochromatosis|hemochromatosis
4727329|NCT03066414|blood withdrawal|blood withdrawal
4727330|NCT03066414|respiratory variations|respiratory variations
4727331|NCT03066414|inferior vena cava|inferior vena cava
4727332|NCT03066414|internal jugular vein|internal jugular vein
4727333|NCT03066414|ultrasound|ultrasound
4727334|NCT03066414|ultrasonography|ultrasonography
4727335|NCT03066414|echography|echography
4727336|NCT03066401|hyperferritinemia|hyperferritinemia
4727337|NCT03066401|dysmetabolic hyperferritinemia|dysmetabolic hyperferritinemia
4727338|NCT03066401|obese|obese
4727339|NCT03066401|blood withdrawal|blood withdrawal
4727340|NCT03066401|respiratory variations|respiratory variations
4727341|NCT03066401|inferior vena cava|inferior vena cava
4727342|NCT03066401|internal jugular vein|internal jugular vein
4727343|NCT03066401|ultrasound|ultrasound
4727344|NCT03066401|ultrasonography|ultrasonography
4727345|NCT03066401|echography|echography
4727346|NCT03066388|fluid|fluid
4727347|NCT03066388|fluid responsiveness|fluid responsiveness
4727348|NCT03066388|pulse pressure|pulse pressure
4727349|NCT03066388|noninvasive monitoring|noninvasive monitoring
4727350|NCT03066388|pulse pressure variations|pulse pressure variations
4727351|NCT03066388|volume expansion|volume expansion
4727352|NCT03066388|SIRS|sirs
4727353|NCT03066388|systemic inflammatory response syndrome|systemic inflammatory response syndrome
4727354|NCT03066375|vena cava|vena cava
4727355|NCT03066375|fluid|fluid
4727356|NCT03066375|sepsis|sepsis
4727357|NCT03066375|echocardiography|echocardiography
4727358|NCT03066375|ultrasound|ultrasound
4727359|NCT03066375|ultrasonography|ultrasonography
4727360|NCT03066375|collapsibility index|collapsibility index
4727361|NCT03066375|circulatory failure|circulatory failure
4727362|NCT03066375|irregular cardiac rhythm|irregular cardiac rhythm
4727363|NCT03066375|fluid responsiveness|fluid responsiveness
4727364|NCT03066375|Spontaneous breathing|spontaneous breathing
4727365|NCT03066362|Spontaneous ventilation|spontaneous ventilation
4727366|NCT03066323|Blood glucose|blood glucose
4727367|NCT03066310|Bladder cancer|bladder cancer
4727368|NCT03066310|Urine|urine
4727369|NCT03066310|DNA biomarker|dna biomarker
4727370|NCT03066310|Diagnosis|diagnosis
4727371|NCT03066297|Clinical stage IA non-small cell lung cancer|clinical stage ia non-small cell lung cancer
4727372|NCT03066297|Lobectomy|lobectomy
4727373|NCT03066297|Segmentectomy|segmentectomy
4727374|NCT03066297|Wedge resection|wedge resection
4727886|NCT03063372|Burnout|burnout
4727375|NCT03066297|Sublobar resection|sublobar resection
4727376|NCT03066297|Limited resection|limited resection
4727377|NCT03066284|Children|children
4727378|NCT03066284|Adolescents|adolescents
4727379|NCT03066284|Parents|parents
4727380|NCT03066284|Insulin Pump Therapy|insulin pump therapy
4727381|NCT03066271|Aerobic exercise|aerobic exercise
4727382|NCT03066271|Lung Cancer|lung cancer
4727383|NCT03066258|nAMD|namd
4727384|NCT03066258|wet AMD|wet amd
4727385|NCT03066258|gene therapy|gene therapy
4727386|NCT03066245|Aneurysmal bone cysts|aneurysmal bone cysts
4727387|NCT03066245|PLGA|plga
4727388|NCT03066245|Platelet Lysate|platelet lysate
4727389|NCT03066245|Bone marrow|bone marrow
4727390|NCT03066245|Mesenchymal stem cells|mesenchymal stem cells
4727391|NCT03066232|Delirium|delirium
4727392|NCT03066232|Dementia|dementia
4727393|NCT03066232|Physical function|physical function
4727394|NCT03066206|Malignant Neoplasm of Respiratory and Intrathoracic Organ|malignant neoplasm of respiratory and intrathoracic organ
4727395|NCT03066206|Non-Small Cell Lung Cancer|non-small cell lung cancer
4727396|NCT03066206|NSCLC|nsclc
4727397|NCT03066206|Advanced|advanced
4727398|NCT03066206|EGFR exon 20 mutation|egfr exon 20 mutation
4727399|NCT03066206|EGFR-positive|egfr-positive
4727400|NCT03066206|Poziotinib|poziotinib
4727401|NCT03066193|Motor tics|motor tics
4727402|NCT03066193|Vocal tics|vocal tics
4727403|NCT03066193|Cannabinoids|cannabinoids
4727404|NCT03066193|Dronabinol|dronabinol
4727405|NCT03066193|PEA|pea
4727406|NCT03066193|Palmitoylethanolamide|palmitoylethanolamide
4727407|NCT03066193|Tourettes|tourettes
4727408|NCT03066193|TS|ts
4727409|NCT03066167|Cancer of the gastro-esophageal junction|cancer of the gastro-esophageal junction
4727410|NCT03066167|Watson score|watson score
4727411|NCT03066167|Ogilvie score|ogilvie score
4727412|NCT03066167|Goldschmid score|goldschmid score
4727413|NCT03066167|Validation|validation
4727414|NCT03066167|Quality of Life|quality of life
4727415|NCT03066154|High risk prostate cancer|high risk prostate cancer
4727416|NCT03066154|>T2cN+M0|>t2cn+m0
4727417|NCT03066128|Task shifting|task shifting
4727418|NCT03066128|HIV care|hiv care
4727419|NCT03066115|Cerebral blood flow|cerebral blood flow
4727420|NCT03066115|Cyclooxygenase|cyclooxygenase
4727421|NCT03066115|Nitric oxide synthase|nitric oxide synthase
4727422|NCT03066115|Reactive Oxygen Species|reactive oxygen species
4727423|NCT03066102|sensorimotor system|sensorimotor system
4727424|NCT03066102|scapular joint position sense|scapular joint position sense
4727425|NCT03066102|fatigue|fatigue
4727426|NCT03066089|FBS,HbA1C, PPBS|fbs,hba1c, ppbs
4727427|NCT03066050|Ischemic Mitral Regurgitation|ischemic mitral regurgitation
4727428|NCT03066050|Mitral Valve Disease|mitral valve disease
4727429|NCT03066050|Moderate Mitral Regurgitation|moderate mitral regurgitation
4727430|NCT03066050|Severe Mitral Regurgitation|severe mitral regurgitation
4727431|NCT03066037|regional-anaesthesiological infiltration|regional-anaesthesiological infiltration
4727432|NCT03066037|block series|block series
4727433|NCT03066037|invasive pain treatment|invasive pain treatment
4727434|NCT03066011|mold-active triazoles|mold-active triazoles
4727435|NCT03065972|kidney disease|kidney disease
4727436|NCT03065972|vascular access|vascular access
4727437|NCT03065972|graft|graft
4727438|NCT03065972|fistula|fistula
4727439|NCT03065972|hemodialysis|hemodialysis
4727440|NCT03065972|dialysis|dialysis
4727441|NCT03065959|CK-2127107|ck-2127107
4727442|NCT03065959|Mobility Limitation|mobility limitation
4727443|NCT03065959|Phase 1b|phase 1b
4727444|NCT03065959|skeletal muscle fatigue|skeletal muscle fatigue
4727445|NCT03065946|Therapeutic hypothermia|therapeutic hypothermia
4727446|NCT03065946|Electroencephalogram|electroencephalogram
4727447|NCT03065946|Neuron-Specific Enolase|neuron-specific enolase
4727448|NCT03065946|Return of Spontaneous Circulation|return of spontaneous circulation
4727449|NCT03065946|S-100B|s-100b
4727450|NCT03065933|mania|mania
4727451|NCT03065933|clonidine|clonidine
4727452|NCT03065933|bipolar disorder|bipolar disorder
4727453|NCT03065894|stratified care|stratified care
4727454|NCT03065894|psychologically informed practice|psychologically informed practice
4727455|NCT03065894|matched care|matched care
4727456|NCT03065868|gastric polyp|gastric polyp
4727457|NCT03065868|Helicobacter pylori eradication|helicobacter pylori eradication
4727458|NCT03065855|laparoscopic mesorectal excision|laparoscopic mesorectal excision
4727459|NCT03065855|rectal cancer|rectal cancer
4727460|NCT03065855|urinary distention|urinary distention
4727461|NCT03065842|Stigma|stigma
4727462|NCT03065842|Pregnancy|pregnancy
4727463|NCT03065842|Abortion|abortion
4727464|NCT03065842|Contraception|contraception
4727465|NCT03065842|Adolescence|adolescence
4727466|NCT03065829|caregiver|caregiver
4727467|NCT03065829|chronically critically ill|chronically critically ill
4727468|NCT03065777|single file.|single file.
4727469|NCT03065777|ONE ENDO.|one endo.
4727470|NCT03065777|F6 SkyTaper.|f6 skytaper.
4727471|NCT03065777|ProTaper Universal.|protaper universal.
4727472|NCT03065777|irreversible pulpitis.|irreversible pulpitis.
4727473|NCT03065777|postoperative pain.|postoperative pain.
4727474|NCT03065764|Pembrolizumab|pembrolizumab
4727475|NCT03065764|89Zirconium|89zirconium
4727476|NCT03065738|reduction osteotomy|reduction osteotomy
4727477|NCT03065738|knee arthroplasty|knee arthroplasty
4727478|NCT03065712|Breast Cancer|breast cancer
4727479|NCT03065712|PET/CT|pet/ct
4727480|NCT03065712|FES|fes
4727481|NCT03065712|18F Fluoroestradiol|18f fluoroestradiol
4727482|NCT03065712|Breast|breast
4727483|NCT03065699|Medical device|medical device
4727484|NCT03065699|Liver dialysis|liver dialysis
4727485|NCT03065699|Haemofilter|haemofilter
4727486|NCT03065699|ACLF|aclf
4727487|NCT03065686|Cleft Lip and Palate|cleft lip and palate
4727488|NCT03065686|CL/P|cl/p
4727489|NCT03065686|WES|wes
4727490|NCT03065673|Tooth bleaching|tooth bleaching
4727491|NCT03065673|Tooth sensitivity|tooth sensitivity
4727492|NCT03065660|Missed miscarriage|missed miscarriage
4727493|NCT03065660|Mifepristone|mifepristone
4727494|NCT03065660|Misoprostol|misoprostol
4727495|NCT03065660|Medical management|medical management
4727496|NCT03065647|Out-of-hospital cardiac arrest|out-of-hospital cardiac arrest
4727497|NCT03065647|Cardiac Arrest|cardiac arrest
4727498|NCT03065647|Heart Arrest|heart arrest
4727499|NCT03065647|Sudden Cardiac Arrest|sudden cardiac arrest
4727500|NCT03065647|Cardiopulmonary Resuscitation|cardiopulmonary resuscitation
4727501|NCT03065647|Extracorporeal Cardiopulmonary Resuscitation|extracorporeal cardiopulmonary resuscitation
4727502|NCT03065647|Extracorporeal Membrane Oxygenation|extracorporeal membrane oxygenation
4727503|NCT03065647|CPR|cpr
4727504|NCT03065647|ECPR|ecpr
4727505|NCT03065647|ECMO|ecmo
4727506|NCT03065647|Emergency Medical Services|emergency medical services
4727507|NCT03065647|EMS|ems
4727508|NCT03065647|OHCA|ohca
4727509|NCT03065621|Breast|breast
4727510|NCT03065595|Ophiocephalus striatus|ophiocephalus striatus
4727511|NCT03065595|IGF-1|igf-1
4727512|NCT03065595|hypoalbuminemia|hypoalbuminemia
4727513|NCT03065595|MNA score|mna score
4727514|NCT03065595|elderly|elderly
4727515|NCT03065543|Hyperlipidemias|hyperlipidemias
4727516|NCT03065543|Secondary prevention|secondary prevention
4727517|NCT03065543|high risk patients|high risk patients
4727518|NCT03065543|very high risk patients|very high risk patients
4727519|NCT03065530|Dexmedetomidine|dexmedetomidine
4727520|NCT03065530|Butorphanol tartrate|butorphanol tartrate
4727521|NCT03065530|Analgesia|analgesia
4727522|NCT03065530|Breastfeeding|breastfeeding
4727523|NCT03065530|Relative infant dose|relative infant dose
4727524|NCT03065517|Criminal Justice|criminal justice
4727525|NCT03065517|Juvenile Delinquency|juvenile delinquency
4727526|NCT03065491|Red yeast rice|red yeast rice
4727527|NCT03065491|Phytosterols|phytosterols
4727528|NCT03065491|L-Tyrosol|l-tyrosol
4727529|NCT03065491|Lipids|lipids
4727530|NCT03065491|LDL-cholesterol|ldl-cholesterol
4727531|NCT03065491|Endothelial function|endothelial function
4727532|NCT03065478|Peripheral Neuropathy|peripheral neuropathy
4727533|NCT03065478|Chemotherapy induced|chemotherapy induced
4727534|NCT03065478|CIPN|cipn
4727535|NCT03065465|Upper GI hemorrhage|upper gi hemorrhage
4727536|NCT03065465|Stigmata of recent hemorrhage|stigmata of recent hemorrhage
4727537|NCT03065465|Diverticular Hemorrhage|diverticular hemorrhage
4727538|NCT03065465|Ulcers|ulcers
4727539|NCT03065400|Myelofibrosis|myelofibrosis
4727540|NCT03065400|Acute Leukemia|acute leukemia
4727541|NCT03065387|Metastatic solid tumors|metastatic solid tumors
4727542|NCT03065387|Genetic mutation|genetic mutation
4727543|NCT03065387|Biomarkers|biomarkers
4727544|NCT03065387|Neratinib|neratinib
4727545|NCT03065387|Everolimus|everolimus
4727546|NCT03065387|Afinitor|afinitor
4727547|NCT03065387|Zortress|zortress
4727548|NCT03065387|RAD001|rad001
4727549|NCT03065387|Palbociclib|palbociclib
4727550|NCT03065387|PD-0332991|pd-0332991
4727551|NCT03065387|Ibrance|ibrance
4727552|NCT03065387|Trametinib|trametinib
4727553|NCT03065361|Chronic Kidney Disease|chronic kidney disease
4727554|NCT03065361|Handgrip Strength|handgrip strength
4727555|NCT03065361|Fine Motor Skills|fine motor skills
4727556|NCT03065361|Sensitivity|sensitivity
4727557|NCT03065348|prehabilitation|prehabilitation
4727558|NCT03065348|nutrition|nutrition
4727559|NCT03065348|hydration|hydration
4727560|NCT03065348|cystectomy and urinary diversion|cystectomy and urinary diversion
4727561|NCT03065348|regional anesthesia|regional anesthesia
4727562|NCT03065348|cognition|cognition
4727563|NCT03065335|Magnetic Resonance Imaging|magnetic resonance imaging
4727564|NCT03065335|Magnetoencephalography|magnetoencephalography
4727565|NCT03065335|Major Depressive Disorder|major depressive disorder
4727566|NCT03065335|Ketamine|ketamine
4727567|NCT03065335|NEUROPHARMACOLOGY|neuropharmacology
4727568|NCT03065322|PCOS|pcos
4727569|NCT03065322|OSA|osa
4727570|NCT03065296|Behavior|behavior
4727571|NCT03065296|education|education
4727572|NCT03065296|medical residents|medical residents
4727573|NCT03065296|knowledge|knowledge
4727574|NCT03065296|confidence|confidence
4727575|NCT03065296|skills assessment|skills assessment
4727576|NCT03065257|EMR|emr
4727577|NCT03065257|ESD|esd
4727578|NCT03065257|Resection|resection
4727579|NCT03065257|STER|ster
4727580|NCT03065257|EFTR|eftr
4727581|NCT03065257|Submucosal dissection|submucosal dissection
4727582|NCT03065257|Endoscopic resection|endoscopic resection
4727583|NCT03065244|Kawasaki disease|kawasaki disease
4727584|NCT03065218|Thyroid|thyroid
4727585|NCT03065218|sestamibi|sestamibi
4727586|NCT03065192|Gene Therapy|gene therapy
4727587|NCT03065192|PD|pd
4727588|NCT03065192|Parkinson's Disease|parkinson's disease
4727589|NCT03065192|Aromatic L- Amino Acid Decarboxylase|aromatic l- amino acid decarboxylase
4727590|NCT03065192|AADC|aadc
4727591|NCT03065192|AAV2-AADC|aav2-aadc
4727592|NCT03065192|AAV2|aav2
4727593|NCT03065192|Viral Vector|viral vector
4727594|NCT03065192|Gene Transfer|gene transfer
4727595|NCT03065192|MRI|mri
4727596|NCT03065192|PET|pet
4727597|NCT03065192|VY-AADC01|vy-aadc01
4727598|NCT03065153|Torso|torso
4727599|NCT03065153|Trunk|trunk
4727600|NCT03065088|Exercise|exercise
4727601|NCT03065088|Feasibility Studies|feasibility studies
4727602|NCT03065088|Healthy Lifestyle|healthy lifestyle
4727603|NCT03065088|Health Promotion|health promotion
4727604|NCT03065088|Health Behavior|health behavior
4727605|NCT03065088|Aging|aging
4727606|NCT03065088|Activities of Daily Living|activities of daily living
4727607|NCT03065088|Mobile Applications|mobile applications
4727608|NCT03065062|Lung Cancer Squamous Cell|lung cancer squamous cell
4727609|NCT03065062|Head & Neck Cancer|head & neck cancer
4727610|NCT03065062|Neoplasms|neoplasms
4727611|NCT03065062|Endometrial Cancer|endometrial cancer
4727612|NCT03065049|Physical Activity|physical activity
4727613|NCT03065049|Peer-facilitation|peer-facilitation
4727614|NCT03065049|Methadone Maintenance Therapy|methadone maintenance therapy
4727615|NCT03065036|Primary Open Angle Glaucoma|primary open angle glaucoma
4727616|NCT03065036|POAG|poag
4727617|NCT03065023|advanced tumor|advanced tumor
4727618|NCT03065023|intratumoral injection|intratumoral injection
4727619|NCT03065023|intralesional injection|intralesional injection
4727620|NCT03064997|prebiotic|prebiotic
4727621|NCT03064997|pediatric patients|pediatric patients
4727622|NCT03064997|health status|health status
4727623|NCT03064997|intestine permeability|intestine permeability
4727624|NCT03064971|Quitline|quitline
4727625|NCT03064971|culturally specific|culturally specific
4727626|NCT03064958|glucose regulation|glucose regulation
4727627|NCT03064958|lipids|lipids
4727628|NCT03064958|Immune markers|immune markers
4727629|NCT03064958|Endothelium, Vascular|endothelium, vascular
4727630|NCT03064945|Livia TENS|livia tens
4727631|NCT03064945|safety and efficacy|safety and efficacy
4727632|NCT03064945|menstruating women|menstruating women
4727633|NCT03064919|hunger and fullness|hunger and fullness
4727634|NCT03064919|regulation of energy intake|regulation of energy intake
4727635|NCT03064919|energy compensation|energy compensation
4727636|NCT03064919|nutrition knowledge|nutrition knowledge
4727637|NCT03064906|T1D, Omnipod|t1d, omnipod
4727638|NCT03064880|Thoracic surgery|thoracic surgery
4727639|NCT03064880|Fluid responsiveness|fluid responsiveness
4727640|NCT03064880|Hemodynamics|hemodynamics
4727641|NCT03064880|Oxidative stress|oxidative stress
4727642|NCT03064880|Goal-directed fluid therapy|goal-directed fluid therapy
4727643|NCT03064867|venetoclax|venetoclax
4727644|NCT03064867|rituximab|rituximab
4727645|NCT03064867|ifosfamide|ifosfamide
4727646|NCT03064867|carboplatin|carboplatin
4727647|NCT03064867|etoposide|etoposide
4727648|NCT03064854|PDR001|pdr001
4727649|NCT03064854|immunotherapy|immunotherapy
4727650|NCT03064854|Non-small cell lung cancer|non-small cell lung cancer
4727651|NCT03064854|lung|lung
4727652|NCT03064854|NSCLC|nsclc
4727653|NCT03064802|BioBurst|bioburst
4727654|NCT03064802|Spinal Fusion|spinal fusion
4727655|NCT03064802|Cellular Allograft|cellular allograft
4727656|NCT03064789|Candidiases|candidiases
4727657|NCT03064789|Vaginal Infections|vaginal infections
4727658|NCT03064776|telemedicine|telemedicine
4727659|NCT03064763|Unresectable Stage IIIB-IV Malignant Melanoma|unresectable stage iiib-iv malignant melanoma
4727660|NCT03064750|Exercise Therapy|exercise therapy
4727661|NCT03064750|Pelvic Floor|pelvic floor
4727662|NCT03064750|Preoperative Care|preoperative care
4727663|NCT03064724|smoking|smoking
4727664|NCT03064724|tobacco use|tobacco use
4727665|NCT03064724|Asian|asian
4727666|NCT03064724|patients|patients
4727667|NCT03064724|provider advice|provider advice
4727668|NCT03064724|digital health intervention|digital health intervention
4727669|NCT03064685|Pyogenic Liver abscess|pyogenic liver abscess
4727670|NCT03064685|Liver transplantation|liver transplantation
4727671|NCT03064685|Biliary disease|biliary disease
4727672|NCT03064659|Postoperative pulmonary complications|postoperative pulmonary complications
4727673|NCT03064659|Driving Pressure|driving pressure
4727674|NCT03064659|Limitation of Expiratory Flow|limitation of expiratory flow
4727675|NCT03064659|Cardiac Surgery|cardiac surgery
4727676|NCT03064659|Cardio-pulmonary bypass|cardio-pulmonary bypass
4727677|NCT03064646|ORGAN PRESERVATION|organ preservation
4727678|NCT03064646|WATCH AND WAIT|watch and wait
4727679|NCT03064646|TRANSANAL ENDOSCOPIC MICROSURGERY|transanal endoscopic microsurgery
4727680|NCT03064633|Dexamethasone|dexamethasone
4727681|NCT03064633|Dexmedetomidine|dexmedetomidine
4727682|NCT03064633|Transversus abdominis plane block|transversus abdominis plane block
4728382|NCT03059719|safety|safety
4727683|NCT03064633|Local anesthetic adjuvants|local anesthetic adjuvants
4727684|NCT03064633|postoperative pain|postoperative pain
4727685|NCT03064620|PCV effects|pcv effects
4727686|NCT03064620|S. pneumoniae carriage|s. pneumoniae carriage
4727687|NCT03064620|S. aureus carriage|s. aureus carriage
4727688|NCT03064620|Indirect vaccination effects|indirect vaccination effects
4727689|NCT03064620|Palestinian-Israeli Collaborative Research (PICR)|palestinian-israeli collaborative research (picr)
4727690|NCT03064607|Neonates|neonates
4727691|NCT03064607|biomarkers|biomarkers
4727692|NCT03064607|EXIT procedure|exit procedure
4727693|NCT03064607|Cesarean Section|cesarean section
4727694|NCT03064581|Cervical Cancer|cervical cancer
4727695|NCT03064581|Screening|screening
4727696|NCT03064581|Pap Test|pap test
4727697|NCT03064581|Pacific Islander Americans|pacific islander americans
4727698|NCT03064568|Myomectomy, Misoprostol, Vasopressin, Blood loss|myomectomy, misoprostol, vasopressin, blood loss
4727699|NCT03064555|Renal|renal
4727700|NCT03064555|Acute|acute
4727701|NCT03064555|Exercise|exercise
4727702|NCT03064555|Dialysis|dialysis
4727703|NCT03064555|Hemodialysis|hemodialysis
4727704|NCT03064555|End stage renal disease|end stage renal disease
4727705|NCT03064555|Aerobic|aerobic
4727706|NCT03064503|myocardial fibrosis|myocardial fibrosis
4727707|NCT03064503|cardiac function|cardiac function
4727708|NCT03064503|ageing|ageing
4727709|NCT03064477|Unified Protocol|unified protocol
4727710|NCT03064477|Transdiagnostic approach|transdiagnostic approach
4727711|NCT03064477|Public health|public health
4727712|NCT03064464|methicillin-resistant Staphylococcus aureus|methicillin-resistant staphylococcus aureus
4727713|NCT03064451|persistent atrial fibrillation - ablation procedure|persistent atrial fibrillation - ablation procedure
4727714|NCT03064373|S. aureus|s. aureus
4727715|NCT03064373|carriage|carriage
4727716|NCT03064373|mother-neonatal transmission|mother-neonatal transmission
4727717|NCT03064373|microbiome|microbiome
4727718|NCT03064347|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
4727719|NCT03064347|Obesity|obesity
4727720|NCT03064347|Nutrient|nutrient
4727721|NCT03064321|cognitive behavioral treatment|cognitive behavioral treatment
4727722|NCT03064308|Frailty|frailty
4727723|NCT03064308|Surgery|surgery
4727724|NCT03064308|Physical function|physical function
4727725|NCT03064308|Cognitive function|cognitive function
4727726|NCT03064308|Quality of life|quality of life
4727727|NCT03064308|Exercise|exercise
4727728|NCT03064308|Rehabilitation|rehabilitation
4727729|NCT03064308|Delirium|delirium
4727730|NCT03064308|Morbidity|morbidity
4727731|NCT03064308|Mortality|mortality
4727732|NCT03064308|Length of stay|length of stay
4727733|NCT03064308|Well-being|well-being
4727734|NCT03064308|Elderly|elderly
4727735|NCT03064308|Older surgical patient|older surgical patient
4727736|NCT03064308|Radical prostatectomy|radical prostatectomy
4727737|NCT03064308|Radical cystectomy|radical cystectomy
4727738|NCT03064308|Radical cystoprostatectomy|radical cystoprostatectomy
4727739|NCT03064308|Aortic Aneurysm Repair|aortic aneurysm repair
4727740|NCT03064308|Major Cavity Surgery|major cavity surgery
4727741|NCT03064308|Abdominal Surgery|abdominal surgery
4727742|NCT03064308|Recovery|recovery
4727743|NCT03064308|Nephrectomy|nephrectomy
4727744|NCT03064269|CNS B cell acute lymphocytic leukemia|cns b cell acute lymphocytic leukemia
4727745|NCT03064256|Exercisy therapy|exercisy therapy
4727746|NCT03064256|Hypertension|hypertension
4727747|NCT03064256|Physiopathology|physiopathology
4727748|NCT03064256|Heart rate|heart rate
4727749|NCT03064256|Nonlinear dynamics|nonlinear dynamics
4727750|NCT03064217|Clinical crown lengthening|clinical crown lengthening
4727751|NCT03064217|intraoral imaging|intraoral imaging
4727752|NCT03064217|Emax crown|emax crown
4727753|NCT03064191|intra-canal medications|intra-canal medications
4727754|NCT03064178|periodontal therapy|periodontal therapy
4727755|NCT03064178|anticipated pain|anticipated pain
4727756|NCT03064178|experienced pain|experienced pain
4727757|NCT03064178|pain medication use|pain medication use
4727758|NCT03064139|physical activity|physical activity
4727759|NCT03064139|gait|gait
4727760|NCT03064139|biomechanics|biomechanics
4727761|NCT03064126|Artery|artery
4727762|NCT03064126|Atherosclerosis|atherosclerosis
4727763|NCT03064126|Arterial|arterial
4727764|NCT03064126|Peripheral|peripheral
4727765|NCT03064126|Plaque|plaque
4727766|NCT03064126|Angioplasty|angioplasty
4727768|NCT03064113|Chronic Obstructive Pulmonary Disease, COPD|chronic obstructive pulmonary disease, copd
4727769|NCT03064087|Self-Sampling|self-sampling
4727770|NCT03064087|HPV Testing|hpv testing
4727771|NCT03064087|Diagnostic Test Accuracy|diagnostic test accuracy
4727772|NCT03064087|Cervical Intraepithelial Neoplasia|cervical intraepithelial neoplasia
4727773|NCT03064087|Urine|urine
4727774|NCT03064087|Cervical Cancer Screening|cervical cancer screening
4727775|NCT03064048|Argininosuccinate Lyase Deficiency|argininosuccinate lyase deficiency
4727776|NCT03064048|Urea Cycle Disorder|urea cycle disorder
4727777|NCT03064022|weight gain|weight gain
4727778|NCT03064022|head circumference|head circumference
4727779|NCT03064022|length|length
4727780|NCT03064022|neurodevelopment|neurodevelopment
4727781|NCT03063983|osteosarcoma|osteosarcoma
4727782|NCT03063983|metastatic|metastatic
4727783|NCT03063983|metronomic therapy|metronomic therapy
4727784|NCT03063970|Upper extremity|upper extremity
4727785|NCT03063970|Rehabilitation|rehabilitation
4727786|NCT03063931|Breast cancer|breast cancer
4727787|NCT03063931|Mastectomy|mastectomy
4727788|NCT03063931|Pain|pain
4727789|NCT03063931|Anxiety and Depression|anxiety and depression
4727790|NCT03063931|Cognition|cognition
4727791|NCT03063931|Quality of life|quality of life
4727792|NCT03063905|Opioid related disorders|opioid related disorders
4727793|NCT03063905|Narcotic abuse|narcotic abuse
4727794|NCT03063879|hepatitis C|hepatitis c
4727795|NCT03063879|renal failure|renal failure
4727796|NCT03063879|sofosbuvir|sofosbuvir
4727797|NCT03063879|daclatasvir|daclatasvir
4727798|NCT03063840|hepatocellular carcinoma|hepatocellular carcinoma
4727799|NCT03063840|microwave ablation|microwave ablation
4727800|NCT03063840|liver cancer|liver cancer
4727801|NCT03063801|Congenital Heart Disease|congenital heart disease
4727802|NCT03063801|Blood products transfusion|blood products transfusion
4727803|NCT03063762|Renal Cell Carcinoma|renal cell carcinoma
4727804|NCT03063762|RO6874281|ro6874281
4727805|NCT03063762|Atezolizumab|atezolizumab
4727806|NCT03063762|Bevacizumab|bevacizumab
4727807|NCT03063723|Chronic Hepatitis C|chronic hepatitis c
4727808|NCT03063723|Monocytes|monocytes
4727809|NCT03063723|Nk cells|nk cells
4727810|NCT03063723|direct-acting antiviral agents|direct-acting antiviral agents
4727811|NCT03063697|Carvedilol SR Cap|carvedilol sr cap
4727812|NCT03063697|Essential hypertension|essential hypertension
4727813|NCT03063697|Chronic stable angina|chronic stable angina
4727814|NCT03063697|Congestive heart failure|congestive heart failure
4727815|NCT03063671|postmastectomy pain|postmastectomy pain
4727816|NCT03063658|Ibuprofen|ibuprofen
4727817|NCT03063658|Paracetamol|paracetamol
4727818|NCT03063658|Laparoscopic cholecystectomy|laparoscopic cholecystectomy
4727819|NCT03063658|Morphine|morphine
4727820|NCT03063658|Visual analog scale|visual analog scale
4727821|NCT03063645|Healthy volunteer|healthy volunteer
4727822|NCT03063645|AC-1202|ac-1202
4727823|NCT03063645|AC-SD-01|ac-sd-01
4727824|NCT03063645|Pharacokinetic|pharacokinetic
4727825|NCT03063645|ketone body|ketone body
4727826|NCT03063554|Endoscopy|endoscopy
4727827|NCT03063554|Pancreatic Cancer|pancreatic cancer
4727828|NCT03063554|Bile duct|bile duct
4727829|NCT03063554|Periampullary|periampullary
4727830|NCT03063554|ERCP|ercp
4727831|NCT03063554|Biliary drainage|biliary drainage
4727832|NCT03063554|Biliary obstruction|biliary obstruction
4727833|NCT03063554|EUSBD|eusbd
4727834|NCT03063554|TEUS|teus
4727835|NCT03063554|EUS|eus
4727836|NCT03063554|Endoscopic Ultrasound|endoscopic ultrasound
4727837|NCT03063528|Pregnancy|pregnancy
4727838|NCT03063528|Weight|weight
4727839|NCT03063528|Gestational weight gain|gestational weight gain
4727840|NCT03063528|Stress reduction|stress reduction
4727841|NCT03063528|Exercise|exercise
4727842|NCT03063515|Insulin secretion|insulin secretion
4727843|NCT03063450|anti PD-L1|anti pd-l1
4727844|NCT03063450|nivolumab|nivolumab
4727845|NCT03063450|immunotherapy|immunotherapy
4727846|NCT03063450|RECIST|recist
4727847|NCT03063450|quality of life|quality of life
4727848|NCT03063450|survival|survival
4727849|NCT03063450|immune checkpoint inhibition|immune checkpoint inhibition
4727850|NCT03063437|vancomycin resistant enterococcus|vancomycin resistant enterococcus
4727851|NCT03063437|VRE|vre
4727852|NCT03063437|decolonization|decolonization
4727853|NCT03063437|VRE colonization|vre colonization
4727854|NCT03063437|fecal microbiota transplantation|fecal microbiota transplantation
4727855|NCT03063437|FMT|fmt
4727856|NCT03063437|FMT capsule|fmt capsule
4727857|NCT03063437|capsule|capsule
4727858|NCT03063437|antimicrobial resistance|antimicrobial resistance
4727859|NCT03063437|antibiotic resistance|antibiotic resistance
4727860|NCT03063437|MDRO|mdro
4727861|NCT03063437|multidrug-resistant organism|multidrug-resistant organism
4727862|NCT03063437|OpenBiome|openbiome
4727863|NCT03063424|isocapnic voluntary hyperventilation|isocapnic voluntary hyperventilation
4727864|NCT03063424|eucapnic voluntary hyperventilation|eucapnic voluntary hyperventilation
4727865|NCT03063424|exercise induced bronchoconstriction|exercise induced bronchoconstriction
4727866|NCT03063424|exercise challenge cycle ergometer|exercise challenge cycle ergometer
4727867|NCT03063411|Maths reasoning|maths reasoning
4727868|NCT03063411|Working memory|working memory
4727869|NCT03063411|Executive Functions|executive functions
4727870|NCT03063411|Cognitive Control|cognitive control
4727871|NCT03063411|Academic Skills|academic skills
4727872|NCT03063411|Randomised Control Trial|randomised control trial
4727873|NCT03063385|Adolescents|adolescents
4727874|NCT03063385|Parents|parents
4727875|NCT03063385|Web-based|web-based
4727876|NCT03063385|Puerto Rico|puerto rico
4727877|NCT03063385|Latino|latino
4727878|NCT03063385|Sexual communication|sexual communication
4727879|NCT03063385|Stigma|stigma
4727880|NCT03063385|Randomized controlled trial|randomized controlled trial
4727881|NCT03063385|STD|std
4727882|NCT03063385|Intercourse|intercourse
4727883|NCT03063385|Sexual behavior|sexual behavior
4727884|NCT03063385|HIV/AIDS|hiv/aids
4727885|NCT03063372|Pomegranate|pomegranate
4727887|NCT03063372|Psychological Distress|psychological distress
4727888|NCT03063372|Antioxidant|antioxidant
4727889|NCT03063359|traumatic pain|traumatic pain
4727890|NCT03063359|children|children
4727891|NCT03063359|fentanyl|fentanyl
4727892|NCT03063359|intranasal use|intranasal use
4727893|NCT03063333|spinal cord injury|spinal cord injury
4727894|NCT03063333|hypnosis|hypnosis
4727895|NCT03063333|pain|pain
4727896|NCT03063333|pain catastrophizing|pain catastrophizing
4727897|NCT03063333|coping|coping
4727898|NCT03063307|Tooth, Deciduous|tooth, deciduous
4727899|NCT03063307|Dental Caries|dental caries
4727900|NCT03063307|Glass Ionomer Cements|glass ionomer cements
4727901|NCT03063307|Dental Atraumatic Restorative Treatment|dental atraumatic restorative treatment
4727902|NCT03063307|Cariostatic Agents|cariostatic agents
4727903|NCT03063307|Fluorides|fluorides
4727904|NCT03063294|Coordination, Administrative|coordination, administrative
4727905|NCT03063294|Coaching|coaching
4727906|NCT03063294|Primary Care|primary care
4727907|NCT03063294|Quality Improvement|quality improvement
4727908|NCT03063281|ficolin-2|ficolin-2
4727909|NCT03063281|anti-ficolin-2 antibodies|anti-ficolin-2 antibodies
4727910|NCT03063281|lupus nephritis|lupus nephritis
4727911|NCT03063281|Lupus Erythematosus, Systemic|lupus erythematosus, systemic
4727912|NCT03063281|biomarker|biomarker
4727913|NCT03063281|ficolin-3|ficolin-3
4727914|NCT03063281|anti-ficolin-3 antibodies|anti-ficolin-3 antibodies
4727915|NCT03063268|Electronic Consent|electronic consent
4727916|NCT03063268|Human Behavior|human behavior
4727917|NCT03063268|Bioethics|bioethics
4727918|NCT03063268|Research Ethics|research ethics
4727919|NCT03063268|Electronic Medical Records (EMR)|electronic medical records (emr)
4727920|NCT03063268|Electronic Health Records (EHR)|electronic health records (ehr)
4727921|NCT03063268|Informed Consent Form|informed consent form
4727922|NCT03063268|Interactive Consent|interactive consent
4727923|NCT03063268|Health Record Data|health record data
4727924|NCT03063242|Sargramostim|sargramostim
4727925|NCT03063229|Insulin Pump Therapy|insulin pump therapy
4727926|NCT03063229|Islet Cell Transplant|islet cell transplant
4727927|NCT03063229|Energy Expenditure|energy expenditure
4727928|NCT03063177|chronic thoracic pain|chronic thoracic pain
4727929|NCT03063177|spine stiffness|spine stiffness
4727930|NCT03063177|spinal manipulation|spinal manipulation
4727931|NCT03063177|spinal manipulative therapy|spinal manipulative therapy
4727932|NCT03063164|Femtosecond laser|femtosecond laser
4727933|NCT03063164|Visumax|visumax
4727934|NCT03063164|Intralase IFS150|intralase ifs150
4727935|NCT03063164|LASIK|lasik
4727936|NCT03063138|Diabetic foot ulcer|diabetic foot ulcer
4727937|NCT03063138|Measurement|measurement
4727938|NCT03063138|Wound healing|wound healing
4727939|NCT03063138|Measurement device|measurement device
4727940|NCT03063138|Three-dimensional measurements|three-dimensional measurements
4727941|NCT03063125|radical cystectomy|radical cystectomy
4727942|NCT03063125|hypogonadism|hypogonadism
4727943|NCT03063008|Lumbar spine; Fusion; Titanium; PEEK|lumbar spine; fusion; titanium; peek
4727944|NCT03062930|stroke|stroke
4727945|NCT03062930|hemiparesis|hemiparesis
4727946|NCT03062930|lesion hemisphere|lesion hemisphere
4727947|NCT03062930|ipsilesional deficits|ipsilesional deficits
4727948|NCT03062930|contralesional deficits|contralesional deficits
4727949|NCT03062930|rehabilitation|rehabilitation
4727950|NCT03062930|remediation|remediation
4727951|NCT03062930|paretic arm|paretic arm
4727952|NCT03062904|healthy|healthy
4727953|NCT03062904|respiratory system|respiratory system
4727954|NCT03062904|ventilation|ventilation
4727955|NCT03062904|paradoxical effect|paradoxical effect
4727956|NCT03062904|methacholine|methacholine
4727957|NCT03062904|bronchodilator|bronchodilator
4727958|NCT03062904|NEP|nep
4727959|NCT03062904|EFL|efl
4727960|NCT03062865|Rheumatoid arthritis (RA)|rheumatoid arthritis (ra)
4727961|NCT03062865|TNF-alpha inhibitors|tnf-alpha inhibitors
4727962|NCT03062852|Medication Errors/prevention & control|medication errors/prevention & control
4727963|NCT03062852|Nursing Staff, Hospital/organization & administration|nursing staff, hospital/organization & administration
4727964|NCT03062852|Drug Therapy/nursing|drug therapy/nursing
4727965|NCT03062852|Safety Management|safety management
4727966|NCT03062852|Medication Systems, Hospital/organization & administration|medication systems, hospital/organization & administration
4727967|NCT03062826|OCT|oct
4727968|NCT03062826|STEMI|stemi
4727969|NCT03062813|Hepatitis B virus, tacrolimus,membranous nephropathy|hepatitis b virus, tacrolimus,membranous nephropathy
4727970|NCT03062800|thalidomide|thalidomide
4727971|NCT03062800|pemetrexed|pemetrexed
4727972|NCT03062800|nsclc|nsclc
4727973|NCT03062800|maintenance treatment|maintenance treatment
4727974|NCT03062722|microsurgical treatment|microsurgical treatment
4727975|NCT03062722|pain|pain
4727976|NCT03062722|dexterity|dexterity
4727977|NCT03062722|Phalen sign|phalen sign
4727978|NCT03062722|functional status|functional status
4727979|NCT03062709|tobacco cessation|tobacco cessation
4727980|NCT03062709|bronchiolitis|bronchiolitis
4727981|NCT03062709|pneumonia|pneumonia
4727982|NCT03062709|pediatric|pediatric
4727983|NCT03062709|environmental tobacco smoke|environmental tobacco smoke
4727984|NCT03062709|secondhand tobacco smoke|secondhand tobacco smoke
4727985|NCT03062709|thirdhand tobacco smoke|thirdhand tobacco smoke
4727986|NCT03062709|tobacco smoke|tobacco smoke
4727987|NCT03062709|asthma|asthma
4727988|NCT03062709|reactive airway disease|reactive airway disease
4727989|NCT03062709|bronchopulmonary dysplasia|bronchopulmonary dysplasia
4727990|NCT03062683|lactate|lactate
4727991|NCT03062683|syncope|syncope
4727992|NCT03062644|Open Total or Subtotal Abdominal Hysterectomy|open total or subtotal abdominal hysterectomy
4727993|NCT03062631|Congenital Myasthenic Syndrome|congenital myasthenic syndrome
4727994|NCT03062631|Lambert-Eaton Myasthenic Syndrome|lambert-eaton myasthenic syndrome
4727995|NCT03062631|3,4 DAP|3,4 dap
4727996|NCT03062631|3,4 Diaminopyridine|3,4 diaminopyridine
4727997|NCT03062592|incretin|incretin
4727998|NCT03062592|insulin|insulin
4727999|NCT03062592|glucose|glucose
4728000|NCT03062566|biomarkers|biomarkers
4728001|NCT03062566|point-of-care analysis|point-of-care analysis
4728002|NCT03062540|PTSD|ptsd
4728003|NCT03062540|Military-related PTSD|military-related ptsd
4728004|NCT03062527|Nutrition|nutrition
4728005|NCT03062527|Training support|training support
4728006|NCT03062527|Low Glycemic Index|low glycemic index
4728007|NCT03062527|Moderate Glycemic Index|moderate glycemic index
4728008|NCT03062527|Endurance|endurance
4728009|NCT03062527|Running|running
4728010|NCT03062449|L-Serine, Alzheimer's Disease, AD, Memory,|l-serine, alzheimer's disease, ad, memory,
4728011|NCT03062436|CML, treatment free remission|cml, treatment free remission
4728012|NCT03062410|Health Related Quality of Life|health related quality of life
4728013|NCT03062410|Routine clinical practice|routine clinical practice
4728014|NCT03062410|Electronic Patient Reported Outcome|electronic patient reported outcome
4728015|NCT03062410|EORTC QLQ-C30|eortc qlq-c30
4728016|NCT03062410|Pazopanib|pazopanib
4728017|NCT03062410|Sunitinib|sunitinib
4728018|NCT03062410|Tyrosine Kinase Inhibitor anti-VEGF|tyrosine kinase inhibitor anti-vegf
4728019|NCT03062410|Patient Reported Outcome|patient reported outcome
4728020|NCT03062410|Supportive Care|supportive care
4728021|NCT03062410|Quality of Life|quality of life
4728022|NCT03062384|brain|brain
4728023|NCT03062384|health|health
4728024|NCT03062358|Programmed Cell Death Receptor 1 (PD-1)|programmed cell death receptor 1 (pd-1)
4728025|NCT03062358|Programmed Cell Death Receptor Ligand 1 (PD-L1)|programmed cell death receptor ligand 1 (pd-l1)
4728026|NCT03062358|Programmed Cell Death Receptor Ligand 2 (PD-L2)|programmed cell death receptor ligand 2 (pd-l2)
4728027|NCT03062358|PD1|pd1
4728028|NCT03062358|PD-1|pd-1
4728029|NCT03062358|PDL1|pdl1
4728030|NCT03062358|PD-L1|pd-l1
4728031|NCT03062358|PDL2|pdl2
4728032|NCT03062345|Stroke|stroke
4728033|NCT03062345|Virtual Reality Therapy|virtual reality therapy
4728034|NCT03062345|Rehabilitation|rehabilitation
4728035|NCT03062345|Upper Extremity|upper extremity
4728036|NCT03062345|Arm|arm
4728037|NCT03062345|Telerehabilitation|telerehabilitation
4728038|NCT03062319|anticoagulant|anticoagulant
4728039|NCT03062319|antiplatelet|antiplatelet
4728040|NCT03062306|Cerebral Oxygenation|cerebral oxygenation
4728041|NCT03062306|Cardiopulmonary Resuscitation|cardiopulmonary resuscitation
4728042|NCT03062306|Chest Compression|chest compression
4728043|NCT03062293|Lumbo-pelvic muscles|lumbo-pelvic muscles
4728044|NCT03062293|Rehabilitation|rehabilitation
4728045|NCT03062293|Exercise|exercise
4728046|NCT03062293|Low back pain|low back pain
4728047|NCT03062293|Functional Re-adaptive Exercise Device|functional re-adaptive exercise device
4728048|NCT03062280|Extension study|extension study
4728049|NCT03062267|mhealth|mhealth
4728050|NCT03062267|texting intervention|texting intervention
4728051|NCT03062267|mobile health|mobile health
4728052|NCT03062267|mobile mental health|mobile mental health
4728053|NCT03062254|PSMA|psma
4728054|NCT03062241|cryoablation|cryoablation
4728055|NCT03062241|conventional treatment of heart failure|conventional treatment of heart failure
4728056|NCT03062228|stillbirth|stillbirth
4728057|NCT03062228|sleep|sleep
4728058|NCT03062228|low birth weight|low birth weight
4728059|NCT03062228|pregnancy|pregnancy
4728060|NCT03062228|supine|supine
4728061|NCT03062228|small for gestational age|small for gestational age
4728062|NCT03062215|Culturally adapted psychotherapy|culturally adapted psychotherapy
4728063|NCT03062215|Internet-delivered treatment|internet-delivered treatment
4728064|NCT03062215|Depression|depression
4728065|NCT03062215|Latin America|latin america
4728066|NCT03062202|Depression|depression
4728067|NCT03062202|Anxiety|anxiety
4728068|NCT03062202|Online interventions|online interventions
4728069|NCT03062202|CBT|cbt
4728070|NCT03062202|IAPT|iapt
4728071|NCT03062176|Heart failure|heart failure
4728072|NCT03062176|End-stage renal disease|end-stage renal disease
4728073|NCT03062176|Interleukin-1|interleukin-1
4728074|NCT03062176|Interleukin-1 receptor antagonist|interleukin-1 receptor antagonist
4728075|NCT03062176|Metabolomics|metabolomics
4728076|NCT03062176|Lipidomics|lipidomics
4728077|NCT03062176|Chronic kidney disease|chronic kidney disease
4728078|NCT03062137|bronchoscopy|bronchoscopy
4728079|NCT03062137|saturation|saturation
4728080|NCT03062124|SpyGlass|spyglass
4728081|NCT03062124|Pancreatoscopy|pancreatoscopy
4728082|NCT03062072|normoglycemia|normoglycemia
4728083|NCT03062072|cancer|cancer
4728084|NCT03062072|chemotherapy|chemotherapy
4728085|NCT03062072|Hyperglycemia Drug Induced|hyperglycemia drug induced
4728086|NCT03062046|Atrial Fibrillation|atrial fibrillation
4728087|NCT03062020|Preterm Birth|preterm birth
4728088|NCT03062020|Asymptomatic high-risk women|asymptomatic high-risk women
4728089|NCT03062020|QUIPP|quipp
4728090|NCT03062020|Quantitative fetal fibronectin|quantitative fetal fibronectin
4728091|NCT03062020|Cervical length|cervical length
4728092|NCT03061968|acupressure|acupressure
4728093|NCT03061968|very-low- birth-weight premature|very-low- birth-weight premature
4728094|NCT03061968|body weight|body weight
4728095|NCT03061968|behavioral state|behavioral state
4728096|NCT03061968|developmental status|developmental status
4728097|NCT03061903|total hip arthroplasty|total hip arthroplasty
4728098|NCT03061903|direct anterior approach|direct anterior approach
4728099|NCT03061903|wound complication|wound complication
4728100|NCT03061890|children's environmental health|children's environmental health
4728101|NCT03061890|prematurity|prematurity
4728102|NCT03061890|preterm birth|preterm birth
4728103|NCT03061890|phthalates|phthalates
4728104|NCT03061890|NICU|nicu
4728105|NCT03061890|stress|stress
4728106|NCT03061890|lung health|lung health
4728107|NCT03061890|neurodevelopment|neurodevelopment
4728108|NCT03061890|growth|growth
4728109|NCT03061877|Rheumatoid arthritis|rheumatoid arthritis
4728110|NCT03061877|Anxiety|anxiety
4728111|NCT03061877|Depression|depression
4728112|NCT03061825|Aneurysm|aneurysm
4728113|NCT03061825|Aortic Aneurysm|aortic aneurysm
4728114|NCT03061825|Aortic Aneurysm, Abdominal|aortic aneurysm, abdominal
4728115|NCT03061825|Iliac Aneurysm|iliac aneurysm
4728116|NCT03061825|Vascular Diseases|vascular diseases
4728117|NCT03061825|Cardiovascular Diseases|cardiovascular diseases
4728118|NCT03061825|Aortic Diseases|aortic diseases
4728119|NCT03061812|Small cell lung cancer (SCLC)|small cell lung cancer (sclc)
4728120|NCT03061812|Delta-like protein 3 (DLL3)|delta-like protein 3 (dll3)
4728121|NCT03061812|rovalpituzumab tesirine|rovalpituzumab tesirine
4728122|NCT03061812|topotecan|topotecan
4728123|NCT03061812|metastatic|metastatic
4728124|NCT03061760|Prostate cancer|prostate cancer
4728125|NCT03061760|Incontinence|incontinence
4728126|NCT03061760|Radical prostatectomy|radical prostatectomy
4728127|NCT03061760|Urge urinary incontinence|urge urinary incontinence
4728128|NCT03061734|Migraine Disorders|migraine disorders
4728129|NCT03061734|Headache Disorders|headache disorders
4728130|NCT03061734|Migraine with Aura|migraine with aura
4728131|NCT03061734|Migraine without Aura|migraine without aura
4728132|NCT03061721|NASH|nash
4728133|NCT03061721|NAFLD|nafld
4728134|NCT03061721|Saroglitazar|saroglitazar
4728135|NCT03061669|heart failure|heart failure
4728136|NCT03061669|pulmonary hypertension|pulmonary hypertension
4728137|NCT03061669|right heart catheterization|right heart catheterization
4728138|NCT03061591|Turmeric|turmeric
4728139|NCT03061591|Curcumin|curcumin
4728140|NCT03061591|colorectal polyps|colorectal polyps
4728141|NCT03061591|colorectal neoplasia|colorectal neoplasia
4728142|NCT03061591|mutyh mutation|mutyh mutation
4728143|NCT03061591|apc mutation|apc mutation
4728144|NCT03061578|Tear Film|tear film
4728145|NCT03061578|Hyperspectral imaging|hyperspectral imaging
4728146|NCT03061578|Low Humidity Environmental Exposure Chamber|low humidity environmental exposure chamber
4728147|NCT03061565|erythropoietin|erythropoietin
4728148|NCT03061565|traumatic brain injury|traumatic brain injury
4728149|NCT03061539|Immunogenic signature|immunogenic signature
4728150|NCT03061513|Parkinson Disease|parkinson disease
4728151|NCT03061513|ubiquinol|ubiquinol
4728152|NCT03061513|CoQ10|coq10
4728153|NCT03061513|magnetic resonance spectroscopy|magnetic resonance spectroscopy
4728154|NCT03061513|lactate|lactate
4728155|NCT03061513|glutathione|glutathione
4728156|NCT03061500|Proadrenomedullin|proadrenomedullin
4728157|NCT03061500|Sepsis|sepsis
4728158|NCT03061500|Intraabdominal Infections|intraabdominal infections
4728159|NCT03061500|prognosis|prognosis
4728160|NCT03061474|Mild Cognitive Impairment|mild cognitive impairment
4728161|NCT03061474|Alzheimer's Disease|alzheimer's disease
4728162|NCT03061474|Nicotinamide|nicotinamide
4728163|NCT03061474|Niacinamide|niacinamide
4728164|NCT03061474|Niacin|niacin
4728165|NCT03061474|Nicotinic Acids|nicotinic acids
4728166|NCT03061474|Vitamin|vitamin
4728167|NCT03061474|Neurodegenerative Diseases|neurodegenerative diseases
4728168|NCT03061474|Tauopathies|tauopathies
4728169|NCT03061474|Dementia|dementia
4728170|NCT03061461|Extracorporeal shock wave therapy|extracorporeal shock wave therapy
4728171|NCT03061461|ESWT|eswt
4728172|NCT03061461|Radial extracorporeal shock wave therapy|radial extracorporeal shock wave therapy
4728173|NCT03061461|rESWT|reswt
4728174|NCT03061461|Diabetes|diabetes
4728175|NCT03061435|Vulvar Cancer|vulvar cancer
4728176|NCT03061435|Cervical Cancer|cervical cancer
4728177|NCT03061435|Vulvar Dysplasia|vulvar dysplasia
4728178|NCT03061435|Cervical Dysplasia|cervical dysplasia
4728179|NCT03061435|Anal Cancer|anal cancer
4728180|NCT03061435|Anal Dysplasia|anal dysplasia
4728181|NCT03061435|HPV|hpv
4728182|NCT03061357|activity tracker|activity tracker
4728183|NCT03061357|behavior change|behavior change
4728184|NCT03061318|Fine Needle Aspiration, Genetic Classifier|fine needle aspiration, genetic classifier
4728185|NCT03061279|Medial Malleolus fractures|medial malleolus fractures
4728186|NCT03061279|headless screws|headless screws
4728187|NCT03061279|headed screws|headed screws
4728188|NCT03061266|type 2 diabetes mellitus, application, e-health education|type 2 diabetes mellitus, application, e-health education
4728189|NCT03061253|Electronic Cigarettes|electronic cigarettes
4728190|NCT03061253|Laser Doppler Flowmetry|laser doppler flowmetry
4728191|NCT03061253|Ultrasound|ultrasound
4728192|NCT03061253|Nicotine Replacement Therapy|nicotine replacement therapy
4728193|NCT03061240|Internet of Things|internet of things
4728194|NCT03061136|Cognition|cognition
4728195|NCT03061136|Gamma oscillations|gamma oscillations
4728196|NCT03061136|EEG|eeg
4728197|NCT03061136|Executive function|executive function
4728198|NCT03061136|Benzodiazepine|benzodiazepine
4728199|NCT03061136|GABA|gaba
4728200|NCT03061097|Autologous Fecal Microbiota Transplantation|autologous fecal microbiota transplantation
4728201|NCT03061084|Spina Bifida,Neurogenic bladder, Myelomeningocele, Meningocele|spina bifida,neurogenic bladder, myelomeningocele, meningocele
4728202|NCT03061071|Positional Sleep Apnea|positional sleep apnea
4728203|NCT03061071|Positional Obstructive Sleep Apnea|positional obstructive sleep apnea
4728204|NCT03061071|POSA|posa
4728205|NCT03061071|OSA|osa
4728206|NCT03061071|Obstructive Sleep Apnea|obstructive sleep apnea
4728207|NCT03061071|Sleep Apnea|sleep apnea
4728208|NCT03061019|child|child
4728209|NCT03061019|myofunctional therapy|myofunctional therapy
4728210|NCT03061019|adenotonsillectomy|adenotonsillectomy
4728211|NCT03061019|randomized controlled trial|randomized controlled trial
4728212|NCT03060993|Cannabis|cannabis
4728213|NCT03060993|Marijuana|marijuana
4728214|NCT03060967|motivation, instrumental tasks, food-related stimuli, size/time discrimination, major depression|motivation, instrumental tasks, food-related stimuli, size/time discrimination, major depression
4728215|NCT03060954|Visual Disorder|visual disorder
4728216|NCT03060928|Rotator Cuff Tear|rotator cuff tear
4728217|NCT03060928|Artelon®|artelon®
4728218|NCT03060915|Actigraphy|actigraphy
4728219|NCT03060915|Polysomnography|polysomnography
4728220|NCT03060915|Obstructive Sleep Apnea|obstructive sleep apnea
4728221|NCT03060889|Cesarean section|cesarean section
4728222|NCT03060889|placenta previa|placenta previa
4728223|NCT03060889|Tranexamic acid|tranexamic acid
4728224|NCT03060876|shoulder fractures|shoulder fractures
4728225|NCT03060876|humeral fractures|humeral fractures
4728226|NCT03060876|operative therapy|operative therapy
4728227|NCT03060876|conservative therapy|conservative therapy
4728228|NCT03060876|range of motion, articular|range of motion, articular
4728229|NCT03060876|quality of life|quality of life
4728230|NCT03060876|proximal|proximal
4728231|NCT03060863|children|children
4728232|NCT03060837|RIRS|rirs
4728233|NCT03060837|Kidney Stone|kidney stone
4728234|NCT03060837|Single lung ventilation|single lung ventilation
4728235|NCT03060837|Simultaneous normal ventilation|simultaneous normal ventilation
4728236|NCT03060824|Osmolality|osmolality
4728237|NCT03060824|Sodium|sodium
4728238|NCT03060824|CABG|cabg
4728239|NCT03060824|Cardiovascular Diseases|cardiovascular diseases
4728240|NCT03060824|Cardiopulmonary bypass|cardiopulmonary bypass
4728241|NCT03060772|Pulmonary Medicine|pulmonary medicine
4728242|NCT03060772|Oxidative Stress|oxidative stress
4728243|NCT03060772|Pioglitazone|pioglitazone
4728244|NCT03060772|Immunology|immunology
4728245|NCT03060772|Addictive/Compulsive Behavior|addictive/compulsive behavior
4728246|NCT03060759|Multiple Sclerosis|multiple sclerosis
4728372|NCT03059862|microbiota|microbiota
4728247|NCT03060759|Relapsing-Remitting Multiple Sclerosis|relapsing-remitting multiple sclerosis
4728248|NCT03060759|Fatigue|fatigue
4728249|NCT03060759|Light Therapy|light therapy
4728250|NCT03060720|Pancreatic Cancer|pancreatic cancer
4728251|NCT03060694|Non-alcoholic Fatty Liver Disease|non-alcoholic fatty liver disease
4728252|NCT03060694|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
4728253|NCT03060668|Critical Illness|critical illness
4728254|NCT03060668|Indirect Calorimetry|indirect calorimetry
4728255|NCT03060668|Dietary Proteins|dietary proteins
4728256|NCT03060655|PLGA-Mg|plga-mg
4728257|NCT03060655|fracture|fracture
4728258|NCT03060655|fixation|fixation
4728259|NCT03060655|union|union
4728260|NCT03060642|Microenvironment|microenvironment
4728261|NCT03060642|Microbiome|microbiome
4728262|NCT03060642|Screening|screening
4728263|NCT03060642|Barrett Esophagus|barrett esophagus
4728264|NCT03060642|Esophageal Adenocarcinoma|esophageal adenocarcinoma
4728265|NCT03060603|Erythropoietin|erythropoietin
4728266|NCT03060603|Endometrium|endometrium
4728267|NCT03060603|Doppler Ultrasonography|doppler ultrasonography
4728268|NCT03060590|sarcopenia, uremic toxins|sarcopenia, uremic toxins
4728269|NCT03060564|shoulder|shoulder
4728270|NCT03060564|orthopaedics|orthopaedics
4728271|NCT03060525|Deaf|deaf
4728272|NCT03060525|American Sign Language|american sign language
4728273|NCT03060525|Overweight|overweight
4728274|NCT03060525|Obese|obese
4728275|NCT03060512|Opioid Induced constipation,|opioid induced constipation,
4728276|NCT03060512|constipation,|constipation,
4728277|NCT03060512|laxative,|laxative,
4728278|NCT03060512|bowel movement,|bowel movement,
4728279|NCT03060512|Movantik,|movantik,
4728280|NCT03060512|Naloxegol|naloxegol
4728281|NCT03060499|Thyroidectomy|thyroidectomy
4728282|NCT03060499|Myocardial Function|myocardial function
4728283|NCT03060499|Thyroid gland|thyroid gland
4728284|NCT03060499|Heart|heart
4728285|NCT03060473|PPROM|pprom
4728286|NCT03060473|Azithromycin|azithromycin
4728287|NCT03060473|Erythromycin|erythromycin
4728288|NCT03060434|pentoxifylline|pentoxifylline
4728289|NCT03060434|Disc hernia|disc hernia
4728290|NCT03060434|sciatica|sciatica
4728291|NCT03060434|lumbar radiculopathy|lumbar radiculopathy
4728292|NCT03060408|Fluid Therapy|fluid therapy
4728293|NCT03060408|Laparoscopy|laparoscopy
4728294|NCT03060369|Tissue Perfusion|tissue perfusion
4728295|NCT03060369|Noninvasive Monitoring|noninvasive monitoring
4728296|NCT03060369|Near-infrared spectroscopy|near-infrared spectroscopy
4728297|NCT03060369|CareGuide|careguide
4728298|NCT03060317|Disorders of consciousness|disorders of consciousness
4728299|NCT03060317|validation studies|validation studies
4728300|NCT03060317|coma|coma
4728301|NCT03060317|vegetative state|vegetative state
4728302|NCT03060304|tamoxifen|tamoxifen
4728303|NCT03060304|thin endometrium|thin endometrium
4728304|NCT03060304|frozen embryo transfer|frozen embryo transfer
4728305|NCT03060304|pregnancy rate|pregnancy rate
4728306|NCT03060291|Family Check-up|family check-up
4728307|NCT03060278|smoking cessation, food pantry|smoking cessation, food pantry
4728308|NCT03060265|multimodal analgesia|multimodal analgesia
4728309|NCT03060265|paracetamol|paracetamol
4728310|NCT03060265|cesarean section|cesarean section
4728311|NCT03060252|Drug-Induced Liver Injury|drug-induced liver injury
4728312|NCT03060239|Parkinson Disease|parkinson disease
4728313|NCT03060239|Near infrared Spectroscopy|near infrared spectroscopy
4728314|NCT03060239|REM sleep behaviour disorder|rem sleep behaviour disorder
4728315|NCT03060239|Supplementary motor area|supplementary motor area
4728316|NCT03060213|Well-Being|well-being
4728317|NCT03060213|e-Health|e-health
4728318|NCT03060213|Randomized Controlled Trial|randomized controlled trial
4728319|NCT03060213|Self-Efficacy|self-efficacy
4728320|NCT03060213|Interpersonal well-being|interpersonal well-being
4728321|NCT03060213|Community well-being|community well-being
4728322|NCT03060213|Occupational well-being|occupational well-being
4728323|NCT03060213|Physical well-being|physical well-being
4728324|NCT03060213|Psychological well-being|psychological well-being
4728325|NCT03060213|Economic well-being|economic well-being
4728326|NCT03060200|depression|depression
4728327|NCT03060200|treatment|treatment
4728328|NCT03060200|CBT|cbt
4728329|NCT03060200|online|online
4728330|NCT03060200|app|app
4728331|NCT03060161|Health promotion|health promotion
4728332|NCT03060161|Healthy Diet|healthy diet
4728333|NCT03060161|Exercise|exercise
4728334|NCT03060148|Heart failure|heart failure
4728335|NCT03060148|Spinal cord stimulation|spinal cord stimulation
4728336|NCT03060109|Traumatic brain injury|traumatic brain injury
4728337|NCT03060109|Head injury|head injury
4728338|NCT03060031|Oxytocin|oxytocin
4728339|NCT03060005|Sjögren's syndrome|sjögren's syndrome
4728340|NCT03060005|meibomian gland dysfunction|meibomian gland dysfunction
4728341|NCT03060005|dry eye disease|dry eye disease
4728342|NCT03059940|Smoking Cessation|smoking cessation
4728343|NCT03059940|Low Dose computed tomography|low dose computed tomography
4728344|NCT03059940|LDCT|ldct
4728345|NCT03059940|Quitline|quitline
4728346|NCT03059940|Questionnaires|questionnaires
4728347|NCT03059940|Surveys|surveys
4728348|NCT03059940|Counseling|counseling
4728349|NCT03059940|Smoking cessation drugs|smoking cessation drugs
4728350|NCT03059940|Anti-Smoking Drug|anti-smoking drug
4728351|NCT03059940|Nicotine replacement therapy|nicotine replacement therapy
4728352|NCT03059940|NRT|nrt
4728353|NCT03059940|Nicotine Patch|nicotine patch
4728354|NCT03059927|Cruciate retaining|cruciate retaining
4728355|NCT03059927|Anterior stabilized|anterior stabilized
4728356|NCT03059927|Posterior stabilized|posterior stabilized
4728357|NCT03059927|Posterior cruciate ligament|posterior cruciate ligament
4728358|NCT03059927|Degenerative knee joint disease|degenerative knee joint disease
4728359|NCT03059927|Knee injury and Osteoarthritis Outcome Score|knee injury and osteoarthritis outcome score
4728360|NCT03059927|Kinematic radiostereometry|kinematic radiostereometry
4728361|NCT03059901|Physical Activity|physical activity
4728362|NCT03059901|Latina Women|latina women
4728363|NCT03059901|Minority Health|minority health
4728364|NCT03059901|Mobile Technology|mobile technology
4728365|NCT03059901|Social Support|social support
4728366|NCT03059875|Breastcancer|breastcancer
4728367|NCT03059875|Standardized Geriatric Evaluation|standardized geriatric evaluation
4728368|NCT03059875|Onco-Geriatric Filter|onco-geriatric filter
4728369|NCT03059862|immunity|immunity
4728370|NCT03059862|Aryl-hydrocarbon receptor|aryl-hydrocarbon receptor
4728371|NCT03059862|immune homeostasis|immune homeostasis
4728373|NCT03059862|tryptophan|tryptophan
4728374|NCT03059836|n3 PUFA|n3 pufa
4728375|NCT03059823|Solid tumors|solid tumors
4728376|NCT03059823|Metastatic cancer|metastatic cancer
4728377|NCT03059745|Cholecystitis|cholecystitis
4728378|NCT03059745|Cholelithiasis|cholelithiasis
4728379|NCT03059732|Gastric cancer|gastric cancer
4728380|NCT03059732|Thailand|thailand
4728381|NCT03059732|Japan|japan
4728383|NCT03059719|pharmacokinetics|pharmacokinetics
4728384|NCT03059719|pharmacodynamics|pharmacodynamics
4728385|NCT03059693|Eczema|eczema
4728386|NCT03059693|Topical|topical
4728387|NCT03059680|Potassium|potassium
4728388|NCT03059680|Nutrition|nutrition
4728389|NCT03059667|Small Cell Lun cancer|small cell lun cancer
4728390|NCT03059667|IFCT|ifct
4728391|NCT03059667|immune therapy|immune therapy
4728392|NCT03059654|Percutaneous tracheostomy|percutaneous tracheostomy
4728393|NCT03059654|surgical tracheostomy|surgical tracheostomy
4728394|NCT03059654|airway ultrasound|airway ultrasound
4728395|NCT03059654|intensive care|intensive care
4728396|NCT03059641|Next Generation Sequencing (NGS)|next generation sequencing (ngs)
4728397|NCT03059641|Tyrosine Kinase Inhibitor (TKI)|tyrosine kinase inhibitor (tki)
4728398|NCT03059641|liquid biopsy|liquid biopsy
4728399|NCT03059641|EGFR Gene mutation|egfr gene mutation
4728400|NCT03059589|food anaphylaxis|food anaphylaxis
4728401|NCT03059589|peanut anaphylaxis|peanut anaphylaxis
4728402|NCT03059589|food oral immunotherapy|food oral immunotherapy
4728403|NCT03059589|food allergy|food allergy
4728404|NCT03059589|food allergy treatment|food allergy treatment
4728405|NCT03059576|Chronobiology|chronobiology
4728406|NCT03059576|Circadian rhythms|circadian rhythms
4728407|NCT03059576|Heritability|heritability
4728408|NCT03059576|Twins|twins
4728409|NCT03059563|Varenicline|varenicline
4728410|NCT03059563|Positron Emission Tomography|positron emission tomography
4728411|NCT03059563|Functional Magnetic Resonance Imaging|functional magnetic resonance imaging
4728412|NCT03059563|Methamphetamine Abuse|methamphetamine abuse
4728413|NCT03059550|cardiac rehabilitation|cardiac rehabilitation
4728414|NCT03059550|prediabetes|prediabetes
4728415|NCT03059524|microRNA|microrna
4728416|NCT03059498|PECS I and II|pecs i and ii
4728417|NCT03059498|PECS blocks|pecs blocks
4728418|NCT03059485|Leukemia|leukemia
4728419|NCT03059472|physical activity|physical activity
4728420|NCT03059472|nutrition|nutrition
4728421|NCT03059472|social network|social network
4728422|NCT03059472|civic engagement|civic engagement
4728423|NCT03059459|Lung Diseases, Obstructive|lung diseases, obstructive
4728424|NCT03059459|Air Pollution|air pollution
4728425|NCT03059459|Particulate Matter|particulate matter
4728426|NCT03059433|Substance use|substance use
4728427|NCT03059433|adolescent|adolescent
4728428|NCT03059433|health|health
4728429|NCT03059433|social network|social network
4728430|NCT03059420|CFEOM (Congenital Fibrosis of Extraocular Muscles)|cfeom (congenital fibrosis of extraocular muscles)
4728431|NCT03059420|CCDD (Congenital Cranial Dysinnervation Disorders)|ccdd (congenital cranial dysinnervation disorders)
4728432|NCT03059420|DRS (Duane Retraction Syndrome)|drs (duane retraction syndrome)
4728433|NCT03059420|DRRS (Duane Radial Ray Syndrome)|drrs (duane radial ray syndrome)
4728434|NCT03059420|Strabismus|strabismus
4728435|NCT03059420|MGJWS (Marcus Gunn Jaw Winking Syndrome)|mgjws (marcus gunn jaw winking syndrome)
4728436|NCT03059420|HGP (Horizontal Gaze Palsy)|hgp (horizontal gaze palsy)
4728437|NCT03059420|HGPPS (Horizontal Gaze Palsy with Progressive Scoliosis)|hgpps (horizontal gaze palsy with progressive scoliosis)
4728438|NCT03059420|Moebius|moebius
4728439|NCT03059394|reliability|reliability
4728440|NCT03059394|validity|validity
4728441|NCT03059394|measurement error|measurement error
4728442|NCT03059381|adolescent epilepsy participants|adolescent epilepsy participants
4728443|NCT03059381|partial seizures|partial seizures
4728444|NCT03059381|primary generalized Tonic-clonic seizures|primary generalized tonic-clonic seizures
4728445|NCT03059342|spastic diplegic CP|spastic diplegic cp
4728446|NCT03059342|self-care|self-care
4728447|NCT03059342|functional mobility|functional mobility
4728448|NCT03059342|multilevel surgery|multilevel surgery
4728449|NCT03059329|adult epilepsy participants|adult epilepsy participants
4728450|NCT03059329|partial seizures|partial seizures
4728451|NCT03059329|primary generalized Tonic-clonic seizures|primary generalized tonic-clonic seizures
4728452|NCT03059316|controlled hypotension, perfusion|controlled hypotension, perfusion
4728453|NCT03059290|post operative pain|post operative pain
4728454|NCT03059290|Post operative flare ups|post operative flare ups
4728455|NCT03059290|Post endodontic pain|post endodontic pain
4728456|NCT03059290|Post endodontic flare ups|post endodontic flare ups
4728457|NCT03059290|Necrotic teeth|necrotic teeth
4728458|NCT03059290|Non vital teeth|non vital teeth
4728459|NCT03059290|Neolix file|neolix file
4728460|NCT03059290|Single rotating file|single rotating file
4728461|NCT03059290|Protaper next file|protaper next file
4728462|NCT03059290|Multiple rotating file|multiple rotating file
4728463|NCT03059290|Single visit|single visit
4728464|NCT03059277|Diabetic Macular Edema|diabetic macular edema
4728465|NCT03059277|Diabetes|diabetes
4728466|NCT03059277|reduced treatment frequency|reduced treatment frequency
4728467|NCT03059251|CLL, obinutuzumab, treatment|cll, obinutuzumab, treatment
4728468|NCT03059238|Pain control|pain control
4728469|NCT03059238|TACE|tace
4728470|NCT03059238|Opioids|opioids
4728471|NCT03059238|NSAIDs|nsaids
4728472|NCT03059225|Stroke|stroke
4728473|NCT03059225|Aphasia|aphasia
4728474|NCT03059225|rTMS|rtms
4728475|NCT03059225|Functional MRI|functional mri
4728476|NCT03059225|Speech training|speech training
4728477|NCT03059212|working memory|working memory
4728478|NCT03059212|parkinson's disease|parkinson's disease
4728479|NCT03059199|Prospective/Retrospective|prospective/retrospective
4728480|NCT03059173|Polycystic ovary syndrome|polycystic ovary syndrome
4728481|NCT03059173|Reproductive medicine|reproductive medicine
4728482|NCT03059160|Rett syndrome, Triheptanoic acid, Walking, EEG|rett syndrome, triheptanoic acid, walking, eeg
4728483|NCT03059134|Overactive bladder|overactive bladder
4728484|NCT03059134|Pharmacotherapy|pharmacotherapy
4728485|NCT03059134|Adverse event|adverse event
4728486|NCT03059121|HIV|hiv
4728487|NCT03059121|Lipodystrophy|lipodystrophy
4728488|NCT03059043|Phakic Intraocular Lenses|phakic intraocular lenses
4728489|NCT03059043|viscoelastic|viscoelastic
4728490|NCT03059030|Thrombocytopenia|thrombocytopenia
4728491|NCT03059030|cirrhosis|cirrhosis
4728492|NCT03059030|Therasphere®|therasphere®
4728493|NCT03059030|Y90|y90
4728494|NCT03059030|Radioembolization|radioembolization
4728495|NCT03059004|physical therapy|physical therapy
4728496|NCT03058965|AD|ad
4728497|NCT03058965|HV|hv
4728498|NCT03058965|PSP|psp
4728499|NCT03058952|pain management|pain management
4728500|NCT03058952|fatigue|fatigue
4728501|NCT03058952|mindfulness|mindfulness
4728502|NCT03058952|Gulf War|gulf war
4728503|NCT03058939|Breast Cancer|breast cancer
4728504|NCT03058939|Breast Cancer Stage II|breast cancer stage ii
4728505|NCT03058939|Breast Cancer Stage III|breast cancer stage iii
4728506|NCT03058939|Paclitaxel|paclitaxel
4728507|NCT03058939|Taxol|taxol
4728508|NCT03058926|Chronic Pancreatitis|chronic pancreatitis
4728509|NCT03058926|Diabetes|diabetes
4728510|NCT03058926|Pancreatic Cancer|pancreatic cancer
4728511|NCT03058926|Data Management|data management
4728512|NCT03058926|Protocol compliance|protocol compliance
4728513|NCT03058926|Regulatory compliance|regulatory compliance
4728514|NCT03058926|Consortium studies|consortium studies
4728515|NCT03058900|Fecal Microbiota Transplantation|fecal microbiota transplantation
4728516|NCT03058900|FMT|fmt
4728517|NCT03058900|Randomized Controlled Trial|randomized controlled trial
4728518|NCT03058900|Intestinal microbiome|intestinal microbiome
4728519|NCT03058900|RCT|rct
4728520|NCT03058887|High Intensity Interval Training|high intensity interval training
4728521|NCT03058887|Exercise|exercise
4728522|NCT03058887|Microcirculation|microcirculation
4728523|NCT03058874|Chronic Kidney Disease|chronic kidney disease
4728524|NCT03058874|Hemodialysis|hemodialysis
4728525|NCT03058874|Hypertension|hypertension
4728526|NCT03058874|Arterial Stifness|arterial stifness
4728527|NCT03058874|Ambulatory Blood Pressure Monitoring|ambulatory blood pressure monitoring
4728528|NCT03058848|Phenylketonuria|phenylketonuria
4728529|NCT03058848|PKU|pku
4728530|NCT03058848|Metabolism|metabolism
4728531|NCT03058848|Metabolic|metabolic
4728532|NCT03058848|Control|control
4728533|NCT03058848|Acceptability|acceptability
4728534|NCT03058835|HIV|hiv
4728535|NCT03058835|Truvada|truvada
4728536|NCT03058796|stroke|stroke
4728537|NCT03058796|rehabilitation|rehabilitation
4728538|NCT03058796|Hemipelegia|hemipelegia
4728539|NCT03058770|chronic stroke, sensorimotor retraining|chronic stroke, sensorimotor retraining
4728540|NCT03058692|Immunogenicity|immunogenicity
4728541|NCT03058692|Influenza Vaccine|influenza vaccine
4728542|NCT03058692|M-001 vaccine|m-001 vaccine
4728543|NCT03058692|Reactogenicity|reactogenicity
4728544|NCT03058692|Safety|safety
4728545|NCT03058679|diet|diet
4728546|NCT03058679|specific carbohydrate diet|specific carbohydrate diet
4728547|NCT03058679|Mediterranean style diet|mediterranean style diet
4728548|NCT03058679|randomized controlled trial|randomized controlled trial
4728549|NCT03058666|Aerosol|aerosol
4728550|NCT03058666|surfactant|surfactant
4728551|NCT03058666|calfactant|calfactant
4728552|NCT03058666|Infasurf|infasurf
4728553|NCT03058666|Respiratory Distress Syndrome|respiratory distress syndrome
4728554|NCT03058666|RDS|rds
4728555|NCT03058666|Premature|premature
4728556|NCT03058666|Neonates|neonates
4728557|NCT03058614|Contrast-enhanced ultrasound|contrast-enhanced ultrasound
4728558|NCT03058614|Percutaneous nephrolithotomy|percutaneous nephrolithotomy
4728559|NCT03058575|Microbiome|microbiome
4728560|NCT03058575|Gut|gut
4728561|NCT03058575|Skin|skin
4728562|NCT03058575|Fiber|fiber
4728563|NCT03058575|Starch|starch
4728564|NCT03058549|Expectant parents|expectant parents
4728565|NCT03058549|Relationship education|relationship education
4728566|NCT03058536|twin short cervix pessary progesterone preterm birth|twin short cervix pessary progesterone preterm birth
4728567|NCT03058523|Flavour|flavour
4728568|NCT03058523|Infants|infants
4728569|NCT03058523|Taste|taste
4728570|NCT03058523|Pregnancy|pregnancy
4728571|NCT03058523|Programming|programming
4728572|NCT03058523|Fruit|fruit
4728573|NCT03058523|Vegetables|vegetables
4728574|NCT03058523|Bitter profile|bitter profile
4728575|NCT03058523|Food preferences|food preferences
4728576|NCT03058510|bifurcation lesion|bifurcation lesion
4728577|NCT03058510|atherectomy|atherectomy
4728578|NCT03058510|calcification|calcification
4728579|NCT03058510|stent|stent
4728580|NCT03058445|Central venous catheter|central venous catheter
4728581|NCT03058445|MMode echocardiography|mmode echocardiography
4729075|NCT03055104|guideline|guideline
4728582|NCT03058406|Sarcoma, Soft Tissue|sarcoma, soft tissue
4728583|NCT03058406|Halaven Injection|halaven injection
4728584|NCT03058406|E7389|e7389
4728585|NCT03058341|postoperative pain|postoperative pain
4728586|NCT03058341|propofol|propofol
4728587|NCT03058341|TIVA|tiva
4728588|NCT03058328|Inflammation/physiopathology, Immune System/immunology,|inflammation/physiopathology, immune system/immunology,
4728589|NCT03058328|Neuroimmunomodulation/physiology, General Surgery|neuroimmunomodulation/physiology, general surgery
4728590|NCT03058328|Heart Rate/physiology*Vagus Nerve/physiology*|heart rate/physiology*vagus nerve/physiology*
4728591|NCT03058315|Physical activity|physical activity
4728592|NCT03058315|Disease perception|disease perception
4728593|NCT03058315|Pain beliefs|pain beliefs
4728594|NCT03058315|Disability|disability
4728595|NCT03058315|Advice|advice
4728596|NCT03058289|Neoplasm|neoplasm
4728597|NCT03058289|Malignancy|malignancy
4728598|NCT03058289|Intratumoral|intratumoral
4728599|NCT03058289|Intralesional|intralesional
4728600|NCT03058289|anti-PD-1 antibodies|anti-pd-1 antibodies
4728601|NCT03058289|Immuno therapy|immuno therapy
4728602|NCT03058289|Dose escalation|dose escalation
4728603|NCT03058289|Platinum|platinum
4728604|NCT03058289|Intensity Therapeutics|intensity therapeutics
4728605|NCT03058289|INT230-6|int230-6
4728606|NCT03058289|cisplatin|cisplatin
4728607|NCT03058289|vinblastine|vinblastine
4728608|NCT03058289|PD-1|pd-1
4728609|NCT03058276|rTMS|rtms
4728610|NCT03058276|AAT|aat
4728611|NCT03058276|Alcohol-Dependence|alcohol-dependence
4728612|NCT03058276|Relapses|relapses
4728613|NCT03058224|Pain, Symptom Severity|pain, symptom severity
4728614|NCT03058224|Immunoglobulin IgY|immunoglobulin igy
4728615|NCT03058224|Fibromyalgia|fibromyalgia
4728616|NCT03058224|Widespread Pain Index|widespread pain index
4728617|NCT03058224|Eggyolk|eggyolk
4728618|NCT03058224|FIQ-R|fiq-r
4728619|NCT03058224|SF-36v2TM|sf-36v2tm
4728620|NCT03058224|MOS-SS|mos-ss
4728621|NCT03058224|FSS|fss
4728622|NCT03058224|PGIC|pgic
4728623|NCT03058224|Quality of life|quality of life
4728624|NCT03058211|Pneumococcal pneumonia|pneumococcal pneumonia
4728625|NCT03058211|Acute cardiovascular events|acute cardiovascular events
4728626|NCT03058198|Glioma|glioma
4728627|NCT03058198|PET|pet
4728628|NCT03058198|EGFR vIII|egfr viii
4728629|NCT03058198|Multimodal neuronavigation|multimodal neuronavigation
4728630|NCT03058198|Molecular pathology|molecular pathology
4728631|NCT03058198|PET-CT|pet-ct
4728632|NCT03058198|Neuronavigation|neuronavigation
4728633|NCT03058185|Lamin A/C|lamin a/c
4728634|NCT03058185|Emerin|emerin
4728635|NCT03058146|Exercise|exercise
4728636|NCT03058146|Fitness|fitness
4728637|NCT03058146|Physical Activity|physical activity
4728638|NCT03058146|Cognitive Aging|cognitive aging
4728639|NCT03058146|Cerebral Blood Flow|cerebral blood flow
4728640|NCT03058146|Brain Imaging|brain imaging
4728641|NCT03058146|Unsupervised Intervention|unsupervised intervention
4728642|NCT03058146|Mobile Health|mobile health
4728643|NCT03058146|Free-living exercise intervention|free-living exercise intervention
4728644|NCT03058133|fMRI, perception, face-voice processing|fmri, perception, face-voice processing
4728645|NCT03058107|Nutrition Therapy|nutrition therapy
4728646|NCT03058081|COPD|copd
4728647|NCT03058081|Exercise|exercise
4728648|NCT03058081|High Flow Nasal|high flow nasal
4728649|NCT03058081|Muscle Oxygenation|muscle oxygenation
4728650|NCT03058081|Pulmonary Rehabilitation|pulmonary rehabilitation
4728651|NCT03058042|Urinary Incontinence, Stress|urinary incontinence, stress
4728652|NCT03058042|Pelvic Floor; Exercise|pelvic floor; exercise
4728653|NCT03058042|Physical Therapy Modalities|physical therapy modalities
4728654|NCT03058003|balance, postural|balance, postural
4728655|NCT03058003|postural equilibrium|postural equilibrium
4728656|NCT03058003|chronic pain|chronic pain
4728657|NCT03058003|Chronic nonspecific low back pain|chronic nonspecific low back pain
4728658|NCT03058003|Fibromyalgia|fibromyalgia
4728659|NCT03058003|Cervicogenic headache|cervicogenic headache
4728660|NCT03058003|Chronic tension type headache|chronic tension type headache
4728661|NCT03058003|Irritable bowel syndrome|irritable bowel syndrome
4728662|NCT03058003|Whiplash associated disorder|whiplash associated disorder
4728663|NCT03058003|Temporomandibular disorder|temporomandibular disorder
4728664|NCT03057990|Pyrimethamine|pyrimethamine
4728665|NCT03057990|Myelodysplastic Syndromes (MDS)|myelodysplastic syndromes (mds)
4728666|NCT03057990|Refractory|refractory
4728667|NCT03057990|Relapsed|relapsed
4728668|NCT03057938|Alzheimer|alzheimer
4728669|NCT03057938|Subjective Cognitive Decline|subjective cognitive decline
4728670|NCT03057938|Florbetaben|florbetaben
4728671|NCT03057925|thyroid nodule|thyroid nodule
4728672|NCT03057925|microwave ablation|microwave ablation
4728673|NCT03057912|Cervical intraepithelial neoplasiaⅠ|cervical intraepithelial neoplasiaⅰ
4728674|NCT03057912|TALEN|talen
4728675|NCT03057912|CRISPR/Cas9|crispr/cas9
4728676|NCT03057899|Herbal medicine|herbal medicine
4728677|NCT03057899|phytotherapy|phytotherapy
4728678|NCT03057899|testosterone|testosterone
4728679|NCT03057873|protein|protein
4728680|NCT03057873|fiber|fiber
4728681|NCT03057873|weight loss|weight loss
4728682|NCT03057873|fat loss|fat loss
4728683|NCT03057821|hydrogen peroxide|hydrogen peroxide
4728684|NCT03057821|Propionibacterium Acnes|propionibacterium acnes
4728685|NCT03057821|shoulder arthroplasty|shoulder arthroplasty
4728686|NCT03057808|Pregnancy|pregnancy
4728687|NCT03057808|Postpartum|postpartum
4728688|NCT03057782|Pain|pain
4728689|NCT03057782|Sedation|sedation
4728690|NCT03057782|Surgery|surgery
4728691|NCT03057769|ERCP, post-ERCP pancreatitis, indomethacin, epinephrine|ercp, post-ercp pancreatitis, indomethacin, epinephrine
4728692|NCT03057756|Multi-drug Resistant Tuberculosis|multi-drug resistant tuberculosis
4728693|NCT03057756|short course regimen protocol|short course regimen protocol
4728694|NCT03057730|acellular dermal matrix|acellular dermal matrix
4728695|NCT03057704|Propofol|propofol
4728696|NCT03057704|lidocaine|lidocaine
4728697|NCT03057704|pain|pain
4728698|NCT03057691|Acute Coronary Syndrome|acute coronary syndrome
4728699|NCT03057691|Major Depressive Disorder|major depressive disorder
4728700|NCT03057691|Generalized Anxiety Disorder|generalized anxiety disorder
4728701|NCT03057691|Percutaneous Coronary Intervention|percutaneous coronary intervention
4728702|NCT03057691|Major Adverse Cardiovascular Events|major adverse cardiovascular events
4728703|NCT03057613|radiation|radiation
4728704|NCT03057613|resected|resected
4728705|NCT03057600|African ancestry|african ancestry
4728706|NCT03057600|African American|african american
4728707|NCT03057600|CB-839|cb-839
4728708|NCT03057600|Glutaminase Inhibitor|glutaminase inhibitor
4728709|NCT03057600|Glutaminase|glutaminase
4728710|NCT03057600|TNBC|tnbc
4728711|NCT03057600|Tumor Metabolism|tumor metabolism
4728712|NCT03057600|Glutamine|glutamine
4728713|NCT03057561|CAD|cad
4728714|NCT03057548|Atrial Fibrillation|atrial fibrillation
4728715|NCT03057548|Long-Standing Atrial Fibrillation|long-standing atrial fibrillation
4728716|NCT03057548|Posterior Left Atrial Wall Ablation|posterior left atrial wall ablation
4728717|NCT03057535|Exercise|exercise
4728718|NCT03057535|Sodium Bicarbonate|sodium bicarbonate
4728719|NCT03057535|Ventilatory equivalent for carbon dioxide|ventilatory equivalent for carbon dioxide
4728720|NCT03057522|Run|run
4728721|NCT03057522|Cadence|cadence
4728722|NCT03057522|Home exercise|home exercise
4728723|NCT03057509|Carcinoid Tumors|carcinoid tumors
4728724|NCT03057470|Diabetes|diabetes
4728725|NCT03057470|Exercise|exercise
4728726|NCT03057470|Insulin|insulin
4728727|NCT03057444|resistant starch type III|resistant starch type iii
4728728|NCT03057444|butyrate-producing gut bacteria|butyrate-producing gut bacteria
4728729|NCT03057444|diabetes mellitus type 2|diabetes mellitus type 2
4728730|NCT03057444|prediabetes|prediabetes
4728731|NCT03057431|kidney stones|kidney stones
4728732|NCT03057431|hydrochlorothiazide|hydrochlorothiazide
4728733|NCT03057405|intra-operative navigation|intra-operative navigation
4728734|NCT03057405|3D virtual planning|3d virtual planning
4728735|NCT03057405|intra-operative cone beam computed tomography (CBCT)|intra-operative cone beam computed tomography (cbct)
4728736|NCT03057392|immersion|immersion
4728737|NCT03057392|ultrafiltration|ultrafiltration
4728738|NCT03057392|dialysis|dialysis
4728739|NCT03057379|HPV vaccine|hpv vaccine
4728740|NCT03057379|Immunization registry|immunization registry
4728741|NCT03057379|Reminder recall|reminder recall
4728742|NCT03057366|Drug therapy|drug therapy
4728743|NCT03057340|Advanced non-small cell lung cancer|advanced non-small cell lung cancer
4728744|NCT03057340|Dribbles|dribbles
4728745|NCT03057275|Threatened Premature Labor|threatened premature labor
4728746|NCT03057275|Abdominal Fetal ECG|abdominal fetal ecg
4728747|NCT03057262|temporomandibular joint disorders|temporomandibular joint disorders
4728748|NCT03057262|disc displacement with reduction|disc displacement with reduction
4728749|NCT03057262|anterior repositioning splint|anterior repositioning splint
4728750|NCT03057249|Surgery|surgery
4728751|NCT03057249|Thermography|thermography
4728752|NCT03057249|Perfusion|perfusion
4728753|NCT03057249|Imaging|imaging
4728754|NCT03057236|psychological, behavioral, psychosocial, antiviral, liver|psychological, behavioral, psychosocial, antiviral, liver
4728755|NCT03057223|3D printing|3d printing
4728756|NCT03057223|patient-specific titanium plate|patient-specific titanium plate
4728757|NCT03057223|mandibular malignancy|mandibular malignancy
4728758|NCT03057223|dento-maxillofacial deformity|dento-maxillofacial deformity
4728759|NCT03057223|orthognathic surgery|orthognathic surgery
4728760|NCT03057223|mandibular reconstruction|mandibular reconstruction
4728761|NCT03057210|Exercise|exercise
4728762|NCT03057210|Massage|massage
4728763|NCT03057210|Post-exercise recovery|post-exercise recovery
4728764|NCT03057210|Athletic performance|athletic performance
4728765|NCT03057184|Adult Day Care Center|adult day care center
4728766|NCT03057184|behavioral problems|behavioral problems
4728767|NCT03057184|caregivers|caregivers
4728768|NCT03057171|Helicobacter pylori|helicobacter pylori
4728769|NCT03057171|long non-coding RNA|long non-coding rna
4728770|NCT03057171|THRIL|thril
4728771|NCT03057171|PACER|pacer
4728772|NCT03057171|cagA|caga
4728773|NCT03057158|OAB|oab
4728774|NCT03057158|Insulin resistance|insulin resistance
4728775|NCT03057158|diabetes|diabetes
4728776|NCT03057158|pre-diabetes|pre-diabetes
4728777|NCT03057145|Solid Tumor|solid tumor
4728778|NCT03057093|NSTEMI, ECG|nstemi, ecg
4729274|NCT03053791|PPN|ppn
4728779|NCT03057067|Embolization, Therapeutic|embolization, therapeutic
4728780|NCT03057067|Pelvis|pelvis
4728781|NCT03056976|Overdenture|overdenture
4728782|NCT03056976|Dental implant|dental implant
4728783|NCT03056976|Complete denture|complete denture
4728784|NCT03056976|Cost analysis|cost analysis
4728785|NCT03056963|Guided Imagery|guided imagery
4728786|NCT03056950|Blood Flow Restriciton|blood flow restriciton
4728787|NCT03056950|Occlusion training|occlusion training
4728788|NCT03056950|Distal radius fracture|distal radius fracture
4728789|NCT03056911|ozone therapy|ozone therapy
4728790|NCT03056911|percutaneous treatment|percutaneous treatment
4728791|NCT03056911|Oswestry Disability Index (ODI)|oswestry disability index (odi)
4728792|NCT03056911|Visual analog Scale (VAS)|visual analog scale (vas)
4728793|NCT03056911|Neuropathic Pain Questionnaire (DN-4)|neuropathic pain questionnaire (dn-4)
4728794|NCT03056911|cervical|cervical
4728795|NCT03056898|eicosapentaenoic acid|eicosapentaenoic acid
4728796|NCT03056898|EPA|epa
4728797|NCT03056898|docosahexaenoic acid|docosahexaenoic acid
4728798|NCT03056898|DHA|dha
4728799|NCT03056898|omega-3 index|omega-3 index
4728800|NCT03056885|one-lung ventilation|one-lung ventilation
4728801|NCT03056885|broncho-alveolar lavage|broncho-alveolar lavage
4728802|NCT03056885|protective ventilation|protective ventilation
4728803|NCT03056885|cytokines|cytokines
4728804|NCT03056885|thoracic surgery|thoracic surgery
4728805|NCT03056859|Operator satisfaction with device|operator satisfaction with device
4728806|NCT03056846|probiotic|probiotic
4728807|NCT03056846|gastrointestinal|gastrointestinal
4728808|NCT03056846|stress|stress
4728809|NCT03056846|student|student
4728810|NCT03056820|tracheal intubation|tracheal intubation
4728811|NCT03056807|tolerable apneic time|tolerable apneic time
4728812|NCT03056807|bariatric surgery|bariatric surgery
4728813|NCT03056807|gastric band surgery|gastric band surgery
4728814|NCT03056807|intubation|intubation
4728815|NCT03056794|pyruvate|pyruvate
4728816|NCT03056794|pyruvate dehydrogenase|pyruvate dehydrogenase
4728817|NCT03056794|PDC|pdc
4728818|NCT03056794|PDCD|pdcd
4728819|NCT03056755|advanced breast cancer|advanced breast cancer
4728820|NCT03056755|PIK3CA|pik3ca
4728821|NCT03056755|CDK 4/6 inhibitor|cdk 4/6 inhibitor
4728822|NCT03056755|fulvestrant|fulvestrant
4728823|NCT03056755|letrozole|letrozole
4728824|NCT03056755|HR+|hr+
4728825|NCT03056755|HER-negative|her-negative
4728826|NCT03056755|post menopausal|post menopausal
4728827|NCT03056755|pre-menopausal|pre-menopausal
4728828|NCT03056716|thoracic surgery|thoracic surgery
4728829|NCT03056716|silastic drains|silastic drains
4728830|NCT03056716|conventional drains|conventional drains
4728831|NCT03056690|ASP0819|asp0819
4728832|NCT03056690|Fibromyalgia|fibromyalgia
4728833|NCT03056677|Whey protein|whey protein
4728834|NCT03056677|Dietary supplementation|dietary supplementation
4728835|NCT03056677|Glucose|glucose
4728836|NCT03056677|GLP-1|glp-1
4728837|NCT03056677|Satiety|satiety
4728838|NCT03056651|heart failure|heart failure
4728839|NCT03056651|day care|day care
4728840|NCT03056651|prognosis|prognosis
4728841|NCT03056638|Androgen Deprivation Therapy|androgen deprivation therapy
4728842|NCT03056638|Ultra-Hypofractionated SBRT|ultra-hypofractionated sbrt
4728843|NCT03056638|16-1686|16-1686
4728844|NCT03056625|fortified rice|fortified rice
4728845|NCT03056625|lactating women|lactating women
4728846|NCT03056625|13C2-retinol isotope dilution|13c2-retinol isotope dilution
4728847|NCT03056625|vitamin A liver store|vitamin a liver store
4728848|NCT03056599|in vivo drug sensitivity|in vivo drug sensitivity
4728849|NCT03056599|personalized medicine|personalized medicine
4728850|NCT03056599|precision oncology|precision oncology
4728851|NCT03056599|in vivo oncology|in vivo oncology
4728852|NCT03056599|soft tissue sarcoma|soft tissue sarcoma
4728853|NCT03056599|chemotherapy|chemotherapy
4728854|NCT03056599|microinjection|microinjection
4728855|NCT03056599|microdosing|microdosing
4728856|NCT03056573|TAVI|tavi
4728857|NCT03056573|Valvular heart disease|valvular heart disease
4728858|NCT03056573|Transcatheter aortic valve implantation|transcatheter aortic valve implantation
4728859|NCT03056534|Primary Total Hip Arthroplasty|primary total hip arthroplasty
4728860|NCT03056534|Non-Inflammatory Arthritis|non-inflammatory arthritis
4728861|NCT03056534|Degenerative Joint Disease|degenerative joint disease
4728862|NCT03056534|R3 Delta Ceramic Acetabular Insert|r3 delta ceramic acetabular insert
4728863|NCT03056508|diet|diet
4728864|NCT03056508|nutrition|nutrition
4728865|NCT03056508|aerobic exercise|aerobic exercise
4728866|NCT03056508|cognition|cognition
4728867|NCT03056508|grey matter|grey matter
4728868|NCT03056508|cerebral blood flow|cerebral blood flow
4728869|NCT03056508|neural activity|neural activity
4728870|NCT03056508|resting state connectivity|resting state connectivity
4728871|NCT03056482|cannabis|cannabis
4728872|NCT03056482|haloperidol|haloperidol
4728873|NCT03056482|ondansetron|ondansetron
4728874|NCT03056482|hyperemesis|hyperemesis
4728875|NCT03056482|cyclic vomiting syndrome|cyclic vomiting syndrome
4728876|NCT03056469|patient-reported outcomes|patient-reported outcomes
4728877|NCT03056469|supportive care|supportive care
4728878|NCT03056469|clinical practice|clinical practice
4728879|NCT03056469|hematological cancer|hematological cancer
4728880|NCT03056430|MRI, Neuroplasticity, Balance, Spatial orientation, Hippocampus, Slacklining|mri, neuroplasticity, balance, spatial orientation, hippocampus, slacklining
4728881|NCT03056417|chronic pain|chronic pain
4728882|NCT03056417|telomere|telomere
4728883|NCT03056417|telomerase|telomerase
4728884|NCT03056417|life style|life style
4728885|NCT03056391|knowlesi malaria|knowlesi malaria
4728886|NCT03056391|paracetamol|paracetamol
4728887|NCT03056391|renal function|renal function
4728888|NCT03056391|haemolysis|haemolysis
4728889|NCT03056391|oxidative stress|oxidative stress
4728890|NCT03056365|Detoxification|detoxification
4728891|NCT03056365|Outpatient|outpatient
4728892|NCT03056365|Advanced Nursing|advanced nursing
4728893|NCT03056365|Health Services|health services
4728894|NCT03056339|B-Lymphoid Malignancies|b-lymphoid malignancies
4728895|NCT03056339|Relapsed/Refractory|relapsed/refractory
4728896|NCT03056339|Acute lymphocytic leukemia|acute lymphocytic leukemia
4728897|NCT03056339|ALL|all
4728898|NCT03056339|Chronic lymphocytic leukemia|chronic lymphocytic leukemia
4728899|NCT03056339|CLL|cll
4728900|NCT03056339|Non-Hodgkin lymphoma|non-hodgkin lymphoma
4728901|NCT03056339|NHL|nhl
4728902|NCT03056339|(CAR).CD19-CD28-zeta-2A-iCasp9-IL15-transduced cord blood natural killer cells|(car).cd19-cd28-zeta-2a-icasp9-il15-transduced cord blood natural killer cells
4728903|NCT03056339|CB-NK cells|cb-nk cells
4728904|NCT03056339|Fludarabine|fludarabine
4728905|NCT03056339|Fludarabine phosphate|fludarabine phosphate
4728906|NCT03056339|Fludara|fludara
4728907|NCT03056339|Cyclophosphamide|cyclophosphamide
4728908|NCT03056339|Cytoxan|cytoxan
4728909|NCT03056339|Neosar|neosar
4728910|NCT03056339|AP1903|ap1903
4728911|NCT03056339|Mesna|mesna
4728912|NCT03056339|Mesnex|mesnex
4728913|NCT03056313|Delivery, Obstetric|delivery, obstetric
4728914|NCT03056313|Uterine Contraction|uterine contraction
4728915|NCT03056313|Cervix Uteri|cervix uteri
4728916|NCT03056274|Metformin|metformin
4728917|NCT03056274|Ursodeoxycholic acid|ursodeoxycholic acid
4728918|NCT03056274|Outcomes|outcomes
4728919|NCT03056261|Combined general-epidural anesthesia intestinal recovery|combined general-epidural anesthesia intestinal recovery
4728920|NCT03056235|Atrophic acne scar|atrophic acne scar
4728921|NCT03056209|Mitochondrial DNA tRNALeu(UUR) m.3243A<G Mutation|mitochondrial dna trnaleu(uur) m.3243a<g mutation
4728922|NCT03056157|Moral Injury|moral injury
4728923|NCT03056157|Post-traumatic Stress Disorder|post-traumatic stress disorder
4728924|NCT03056157|Traumatic Loss|traumatic loss
4728925|NCT03056157|Adaptive Disclosure|adaptive disclosure
4728926|NCT03056157|Veterans|veterans
4728927|NCT03056144|spinal muscular atrophy|spinal muscular atrophy
4728928|NCT03056144|total body vibration|total body vibration
4728929|NCT03056144|children|children
4728930|NCT03056118|OPTIMA-C|optima-c
4728931|NCT03056105|Well-being, affiliation, inflammation|well-being, affiliation, inflammation
4728932|NCT03056092|ranibizumab|ranibizumab
4728933|NCT03056092|aqueous cytokine|aqueous cytokine
4728934|NCT03056092|age related macular degeneration|age related macular degeneration
4728935|NCT03056092|diabetic macular edema|diabetic macular edema
4728936|NCT03056092|retinal vein occlusion|retinal vein occlusion
4728937|NCT03056079|neovascular age related macular degeneration|neovascular age related macular degeneration
4728938|NCT03056079|diabetic macular edema|diabetic macular edema
4728939|NCT03056079|retinal vein occlusion|retinal vein occlusion
4728940|NCT03056079|aflibercept|aflibercept
4728941|NCT03056079|aqueous humor cytokine|aqueous humor cytokine
4728942|NCT03056053|insomnia|insomnia
4728943|NCT03055975|Bacteria|bacteria
4728944|NCT03055975|Root canal treatment|root canal treatment
4728945|NCT03055975|Endodontics|endodontics
4728946|NCT03055962|Healthy Participants|healthy participants
4728947|NCT03055962|E2609|e2609
4728948|NCT03055962|Pharmacokinetics|pharmacokinetics
4728949|NCT03055962|Japan|japan
4728950|NCT03055949|early rehabilitation|early rehabilitation
4728951|NCT03055949|early mobilization|early mobilization
4728952|NCT03055949|surgical intensive care unit|surgical intensive care unit
4728953|NCT03055884|transcranial Direct Current Stimulation (tDCS)|transcranial direct current stimulation (tdcs)
4728954|NCT03055884|accelerated learning|accelerated learning
4728955|NCT03055884|memory|memory
4728956|NCT03055871|Behavioural: Family physical activity habit|behavioural: family physical activity habit
4728957|NCT03055858|PDA, ADO II AS|pda, ado ii as
4728958|NCT03055819|Brow Lift|brow lift
4728959|NCT03055819|Brow Ptosis|brow ptosis
4728960|NCT03055806|Sex|sex
4728961|NCT03055806|Sexual Dysfunction|sexual dysfunction
4728962|NCT03055806|IX-01|ix-01
4728963|NCT03055741|Alzheimer's disease|alzheimer's disease
4728964|NCT03055728|streptococcal infections|streptococcal infections
4728965|NCT03055728|rapid strep testing|rapid strep testing
4728966|NCT03055728|rapid antigen detection test|rapid antigen detection test
4728967|NCT03055715|NSCLC|nsclc
4728968|NCT03055715|Radiotherapy|radiotherapy
4728969|NCT03055715|young DEGRO|young degro
4728970|NCT03055715|tumor volume|tumor volume
4728971|NCT03055715|lung cancer|lung cancer
4728972|NCT03055715|radiochemotherapy|radiochemotherapy
4728973|NCT03055715|prognostic factors|prognostic factors
4728974|NCT03055702|Short Message Service|short message service
4728975|NCT03055702|appointment reminder|appointment reminder
4728976|NCT03055702|Attendance rate|attendance rate
4728977|NCT03055689|Colonoscopy|colonoscopy
4728978|NCT03055689|Educational intervention|educational intervention
4728979|NCT03055676|Pancreaticoduodenectomy|pancreaticoduodenectomy
4728980|NCT03055676|Time of drain removal|time of drain removal
4728981|NCT03055624|prostate artery embolization (PAE)|prostate artery embolization (pae)
4728982|NCT03055624|benign prostatic hyperplasia (BPH)|benign prostatic hyperplasia (bph)
4728983|NCT03055624|lower urinary tract symptoms (LUTS)|lower urinary tract symptoms (luts)
4728984|NCT03055611|Blood Coagulation Disorder|blood coagulation disorder
4728985|NCT03055611|Hematologic Diseases|hematologic diseases
4728986|NCT03055611|Coagulation Protein Disorder|coagulation protein disorder
4728987|NCT03055611|Hemorrhagic Disorder|hemorrhagic disorder
4728988|NCT03055611|Genetic Diseases, Inborn|genetic diseases, inborn
4728989|NCT03055585|Wolbachia; Ae. aegypti; Indonesia; Dengue; Cluster-randomised trial|wolbachia; ae. aegypti; indonesia; dengue; cluster-randomised trial
4728990|NCT03055572|Rhinitis|rhinitis
4728991|NCT03055572|Chronic Rhinosinusitis|chronic rhinosinusitis
4728992|NCT03055572|Olfactory Training|olfactory training
4728993|NCT03055559|Iron, Hemoglobin, Feritin, erytrocyty. transferin|iron, hemoglobin, feritin, erytrocyty. transferin
4728994|NCT03055546|oxytocin|oxytocin
4728995|NCT03055546|emotion regulation|emotion regulation
4728996|NCT03055533|Behavioral|behavioral
4728997|NCT03055533|Social|social
4728998|NCT03055533|Headsprout reading program|headsprout reading program
4728999|NCT03055520|schizophrenia|schizophrenia
4729000|NCT03055520|cognition|cognition
4729001|NCT03055520|arithmetic training|arithmetic training
4729002|NCT03055520|Kumon method|kumon method
4729003|NCT03055481|neonatal jaundice|neonatal jaundice
4729004|NCT03055481|phototherapy|phototherapy
4729005|NCT03055481|neonate|neonate
4729006|NCT03055429|Prisoners|prisoners
4729007|NCT03055429|End-of-life care|end-of-life care
4729008|NCT03055429|Geriatric care|geriatric care
4729009|NCT03055429|Palliative care|palliative care
4729010|NCT03055429|Hospice care|hospice care
4729011|NCT03055416|Overweight|overweight
4729012|NCT03055416|Obesity|obesity
4729013|NCT03055416|Physical Activity|physical activity
4729014|NCT03055416|African-American Men|african-american men
4729015|NCT03055416|mHealth|mhealth
4729016|NCT03055416|Mobile Health|mobile health
4729017|NCT03055390|hyoscine butylbromide|hyoscine butylbromide
4729018|NCT03055390|progress of labor|progress of labor
4729019|NCT03055390|duration of labor|duration of labor
4729020|NCT03055377|cannabis|cannabis
4729021|NCT03055377|marijuana|marijuana
4729022|NCT03055377|youth|youth
4729023|NCT03055377|adolescent|adolescent
4729024|NCT03055377|pharmacotherapy|pharmacotherapy
4729025|NCT03055377|medication|medication
4729026|NCT03055377|n-acetylcysteine|n-acetylcysteine
4729027|NCT03055377|trial|trial
4729028|NCT03055351|Exercise motivation|exercise motivation
4729029|NCT03055351|Psychological well-being|psychological well-being
4729030|NCT03055351|Healthy living|healthy living
4729031|NCT03055351|Physical activity|physical activity
4729032|NCT03055351|Autonomy support|autonomy support
4729033|NCT03055351|Self-determination theory|self-determination theory
4729034|NCT03055338|Schizophrenia, acute episode|schizophrenia, acute episode
4729035|NCT03055338|Schizophrenia Spectrum and Other Psychotic Disorders|schizophrenia spectrum and other psychotic disorders
4729036|NCT03055338|Mental Disorders|mental disorders
4729037|NCT03055247|Chronic granulomatous disease X-linked|chronic granulomatous disease x-linked
4729038|NCT03055247|Ibuprofen|ibuprofen
4729039|NCT03055247|Mobilization regimen|mobilization regimen
4729040|NCT03055247|Gene Therapy|gene therapy
4729041|NCT03055234|Oral treprostinil|oral treprostinil
4729042|NCT03055234|6-Minute Walk Distance|6-minute walk distance
4729043|NCT03055234|PH|ph
4729044|NCT03055234|sickle cell|sickle cell
4729045|NCT03055221|Remodulin|remodulin
4729046|NCT03055221|6-Minute Walk Test|6-minute walk test
4729047|NCT03055208|Glioblastoma|glioblastoma
4729048|NCT03055208|Radiosurgery|radiosurgery
4729049|NCT03055208|Gamma Knife|gamma knife
4729050|NCT03055195|subcutaneous|subcutaneous
4729051|NCT03055195|safety|safety
4729052|NCT03055195|mepolizumab|mepolizumab
4729053|NCT03055195|efficacy|efficacy
4729054|NCT03055195|atopic dermatitis|atopic dermatitis
4729055|NCT03055182|Isokinetic|isokinetic
4729056|NCT03055182|oxygenation|oxygenation
4729057|NCT03055182|deoxygenation|deoxygenation
4729058|NCT03055182|aerobic metabolism|aerobic metabolism
4729059|NCT03055169|hyperglycemia|hyperglycemia
4729060|NCT03055169|Multiple Organ Failure|multiple organ failure
4729061|NCT03055169|biobank|biobank
4729062|NCT03055169|diabetes|diabetes
4729063|NCT03055156|Sleep Apnea|sleep apnea
4729064|NCT03055156|Insomnia|insomnia
4729065|NCT03055156|sleep disorders|sleep disorders
4729066|NCT03055156|sleep environment|sleep environment
4729067|NCT03055156|core body temperature|core body temperature
4729068|NCT03055117|Shoulder pain|shoulder pain
4729069|NCT03055117|Physiotherapy|physiotherapy
4729070|NCT03055117|Rehabilitation|rehabilitation
4729071|NCT03055117|Exercise|exercise
4729072|NCT03055104|severe malnutrition|severe malnutrition
4729073|NCT03055104|Critically Ill|critically ill
4729074|NCT03055104|refeeding syndrome|refeeding syndrome
4729076|NCT03055065|Adenoviral conjunctivitis diagnosed with AdenoPlus™ Test|adenoviral conjunctivitis diagnosed with adenoplus™ test
4729077|NCT03055000|Mosquito-Borne Diseases|mosquito-borne diseases
4729078|NCT03055000|Universal Mosquito Vaccine|universal mosquito vaccine
4729079|NCT03055000|Mosquito Transmission|mosquito transmission
4729080|NCT03055000|Vector Borne Viruses|vector borne viruses
4729081|NCT03055000|Vaccine|vaccine
4729082|NCT03054974|Stroke|stroke
4729083|NCT03054974|Traditional Chinese Medicine|traditional chinese medicine
4729084|NCT03054974|Rehabilitation|rehabilitation
4729085|NCT03054961|epilepsy|epilepsy
4729086|NCT03054961|cytochrome oxidase redox state|cytochrome oxidase redox state
4729087|NCT03054961|childhood epilepsy|childhood epilepsy
4729088|NCT03054961|partial epilepsy|partial epilepsy
4729089|NCT03054961|NIRS|nirs
4729090|NCT03054961|near-infrared spectroscopy|near-infrared spectroscopy
4729091|NCT03054961|regional cerebral oxygen saturation|regional cerebral oxygen saturation
4729092|NCT03054935|Energy Expenditure|energy expenditure
4729093|NCT03054935|Body Composition|body composition
4729094|NCT03054935|Food Intake|food intake
4729095|NCT03054896|Richter Syndrome|richter syndrome
4729096|NCT03054883|Mantle Cell Lymphoma|mantle cell lymphoma
4729097|NCT03054883|minimal residual disease|minimal residual disease
4729098|NCT03054883|cytosine arabinoside|cytosine arabinoside
4729099|NCT03054870|pulmonary ventilation|pulmonary ventilation
4729100|NCT03054870|ventilation scintigraphy|ventilation scintigraphy
4729101|NCT03054844|Intranasal|intranasal
4729102|NCT03054844|Pain|pain
4729103|NCT03054844|Lidocaine|lidocaine
4729104|NCT03054844|Midazolam|midazolam
4729105|NCT03054844|Emergency department|emergency department
4729106|NCT03054766|Laser Photocoagulation|laser photocoagulation
4729107|NCT03054766|Ranibizumab|ranibizumab
4729108|NCT03054766|Branch Retinal Vein Occlusion|branch retinal vein occlusion
4729109|NCT03054766|Vascular Endothecial Growth Factor|vascular endothecial growth factor
4729110|NCT03054753|Abduction brace|abduction brace
4729111|NCT03054753|Compliance|compliance
4729112|NCT03054753|Rotator cuff tear|rotator cuff tear
4729113|NCT03054753|Rotator cuff repair|rotator cuff repair
4729114|NCT03054740|Vapocoolant applied prior to IV access|vapocoolant applied prior to iv access
4729115|NCT03054727|Post Thrombotic Syndrome|post thrombotic syndrome
4729116|NCT03054727|Venous Thromboembolism|venous thromboembolism
4729117|NCT03054727|Incidence|incidence
4729118|NCT03054727|Risk factors|risk factors
4729119|NCT03054727|Venous ulcer|venous ulcer
4729120|NCT03054701|Patellofemoral pain|patellofemoral pain
4729121|NCT03054701|PFP|pfp
4729122|NCT03054701|PFPS|pfps
4729123|NCT03054675|lung resection|lung resection
4729124|NCT03054675|lung function|lung function
4729125|NCT03054675|VATS|vats
4729126|NCT03054675|Thoracotomy|thoracotomy
4729127|NCT03054662|Haemophilia|haemophilia
4729128|NCT03054610|plantar fascitis|plantar fascitis
4729129|NCT03054610|Botulinum toxin A|botulinum toxin a
4729130|NCT03054610|Betamethason Sodium Phosphate|betamethason sodium phosphate
4729131|NCT03054610|infiltration|infiltration
4729132|NCT03054610|plantar fascia|plantar fascia
4729133|NCT03054558|Junctional zone|junctional zone
4729134|NCT03054558|recurrent pregnancy loss|recurrent pregnancy loss
4729135|NCT03054558|3D power Doppler|3d power doppler
4729136|NCT03054480|Fractional Micro-Needle Radiofrequency|fractional micro-needle radiofrequency
4729137|NCT03054480|Intradermal Botulinum Toxin A|intradermal botulinum toxin a
4729138|NCT03054441|Upper limb|upper limb
4729139|NCT03054441|Inertial sensors|inertial sensors
4729140|NCT03054415|neuronal-glial-epithelial unit, anorectal function|neuronal-glial-epithelial unit, anorectal function
4729141|NCT03054376|Immobilization|immobilization
4729142|NCT03054376|Angiogenesis|angiogenesis
4729143|NCT03054376|Skeletal muscle|skeletal muscle
4729144|NCT03054376|Exercise training|exercise training
4729145|NCT03054376|Vascular function|vascular function
4729146|NCT03054363|Metastatic Breast Cancer|metastatic breast cancer
4729147|NCT03054363|Tucatinib|tucatinib
4729148|NCT03054363|Palbociclib|palbociclib
4729149|NCT03054363|Letrozole|letrozole
4729150|NCT03054363|HR-positive|hr-positive
4729151|NCT03054363|HER2-positive|her2-positive
4729152|NCT03054363|ER-positive|er-positive
4729153|NCT03054363|PR-positive|pr-positive
4729154|NCT03054363|HER2-targeted therapy|her2-targeted therapy
4729155|NCT03054363|CDK4/6 inhibitor|cdk4/6 inhibitor
4729156|NCT03054363|ONT-380|ont-380
4729157|NCT03054363|Ibrance|ibrance
4729158|NCT03054350|Anemia|anemia
4729159|NCT03054350|kidney|kidney
4729160|NCT03054350|dialysis-dependent chronic kidney disease|dialysis-dependent chronic kidney disease
4729161|NCT03054350|CKD|ckd
4729162|NCT03054350|DD-CKD|dd-ckd
4729163|NCT03054350|renal|renal
4729164|NCT03054350|vadadustat|vadadustat
4729165|NCT03054350|AKB-6548|akb-6548
4729166|NCT03054350|hypoxia-inducible factor|hypoxia-inducible factor
4729167|NCT03054350|HIF|hif
4729168|NCT03054350|hypoxia-inducible factor prolyl-hydroxylase inhibitor|hypoxia-inducible factor prolyl-hydroxylase inhibitor
4729169|NCT03054350|HIF-PHI|hif-phi
4729170|NCT03054350|Japan|japan
4729171|NCT03054350|Japanese|japanese
4729172|NCT03054337|Anemia|anemia
4729173|NCT03054337|kidney|kidney
4729275|NCT03053778|Readmission|readmission
4729174|NCT03054337|non-dialysis dependent chronic kidney disease|non-dialysis dependent chronic kidney disease
4729175|NCT03054337|CKD|ckd
4729176|NCT03054337|NDD-CKD|ndd-ckd
4729177|NCT03054337|renal|renal
4729178|NCT03054337|vadadustat|vadadustat
4729179|NCT03054337|AKB-6548|akb-6548
4729180|NCT03054337|hypoxia-inducible factor|hypoxia-inducible factor
4729181|NCT03054337|HIF|hif
4729182|NCT03054337|hypoxia-inducible factor prolyl-hydroxylase inhibitor|hypoxia-inducible factor prolyl-hydroxylase inhibitor
4729183|NCT03054337|HIF-PHI|hif-phi
4729184|NCT03054337|Japan|japan
4729185|NCT03054337|Japanese|japanese
4729186|NCT03054324|Cardiovascular Diseases|cardiovascular diseases
4729187|NCT03054324|Fractional Flow Reserve|fractional flow reserve
4729188|NCT03054324|Ischemic Heart Disease|ischemic heart disease
4729189|NCT03054324|CT Angiogram|ct angiogram
4729190|NCT03054285|Seizures|seizures
4729191|NCT03054285|Traumatic Brain Injury|traumatic brain injury
4729192|NCT03054285|Prophylaxis|prophylaxis
4729193|NCT03054285|Levetiracetam|levetiracetam
4729194|NCT03054272|High-fidelity simulation|high-fidelity simulation
4729195|NCT03054272|Eye-tracking|eye-tracking
4729196|NCT03054272|Difficult intubation|difficult intubation
4729197|NCT03054233|spinal anesthesia|spinal anesthesia
4729198|NCT03054233|spinal-bone contact|spinal-bone contact
4729199|NCT03054233|caesarian section|caesarian section
4729200|NCT03054233|crossed leg sitting position|crossed leg sitting position
4729201|NCT03054194|Healthy participants|healthy participants
4729202|NCT03054194|E2730|e2730
4729203|NCT03054194|Pharmacokinetics|pharmacokinetics
4729204|NCT03054181|Observational|observational
4729205|NCT03054181|Infection|infection
4729206|NCT03054181|Utilisation|utilisation
4729207|NCT03054181|Safety|safety
4729208|NCT03054181|Tolerability|tolerability
4729209|NCT03054181|Infusion|infusion
4729210|NCT03054181|chronic|chronic
4729211|NCT03054168|Protein Synthesis|protein synthesis
4729212|NCT03054168|Hypertrophy|hypertrophy
4729213|NCT03054168|Testosterone|testosterone
4729214|NCT03054155|hidradenitis suppurativa|hidradenitis suppurativa
4729215|NCT03054155|hidradenitis|hidradenitis
4729216|NCT03054155|laser|laser
4729217|NCT03054103|ketamine|ketamine
4729218|NCT03054103|midazolam|midazolam
4729219|NCT03054103|sedation|sedation
4729220|NCT03054090|Cardiovascular Diseases|cardiovascular diseases
4729221|NCT03054090|Primary Care|primary care
4729222|NCT03054077|pre-procedural anxiety|pre-procedural anxiety
4729223|NCT03054077|children|children
4729224|NCT03054077|pediatric sedation|pediatric sedation
4729225|NCT03054051|HIV prevention|hiv prevention
4729226|NCT03054051|Preadolescence|preadolescence
4729227|NCT03054051|Mobile phone game|mobile phone game
4729228|NCT03054051|Feasibility|feasibility
4729229|NCT03054012|CAD-CAM software|cad-cam software
4729230|NCT03054012|accuracy|accuracy
4729231|NCT03054012|head and neck region|head and neck region
4729232|NCT03054012|mandibular reconstruction|mandibular reconstruction
4729233|NCT03053999|Multiple Endocrine Neoplasia|multiple endocrine neoplasia
4729234|NCT03053999|Pancreatic Neuroendocrine Tumors|pancreatic neuroendocrine tumors
4729235|NCT03053999|Hyperparathyroidism|hyperparathyroidism
4729236|NCT03053999|HPTH|hpth
4729237|NCT03053999|PNET|pnet
4729238|NCT03053999|Biomarkers|biomarkers
4729239|NCT03053999|Parathyroidectomy|parathyroidectomy
4729240|NCT03053999|Genome sequencing|genome sequencing
4729241|NCT03053999|Data review|data review
4729242|NCT03053973|COPD|copd
4729243|NCT03053973|airway inflammation|airway inflammation
4729244|NCT03053973|airway remodeling|airway remodeling
4729245|NCT03053973|health-related auality of life|health-related auality of life
4729246|NCT03053973|forced expiratory volume 1 second|forced expiratory volume 1 second
4729247|NCT03053947|Intranasal Ketamine|intranasal ketamine
4729248|NCT03053947|Pain Management|pain management
4729249|NCT03053934|Online counselling|online counselling
4729250|NCT03053921|gingival recession|gingival recession
4729251|NCT03053921|Zuchellis technique,|zuchellis technique,
4729252|NCT03053921|placental membrane|placental membrane
4729253|NCT03053908|Orexin|orexin
4729254|NCT03053908|Core Body Temperature|core body temperature
4729255|NCT03053882|mouth wash , green tea , peppermint , bad breath|mouth wash , green tea , peppermint , bad breath
4729256|NCT03053856|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
4729257|NCT03053856|Adjuvant pembrolizumab|adjuvant pembrolizumab
4729258|NCT03053843|Atrial fibrillation|atrial fibrillation
4729259|NCT03053843|Mediterranean Diet|mediterranean diet
4729260|NCT03053843|Extra Virgin Olive Oil|extra virgin olive oil
4729261|NCT03053843|Ablation|ablation
4729262|NCT03053830|Ketamine|ketamine
4729263|NCT03053830|Major Depressive Disorder|major depressive disorder
4729264|NCT03053804|MR/PET|mr/pet
4729265|NCT03053804|Non-small cell lung cancer (NSCLC)|non-small cell lung cancer (nsclc)
4729266|NCT03053791|Deep brain stimulation|deep brain stimulation
4729267|NCT03053791|DBS|dbs
4729268|NCT03053791|Spinal cord injury|spinal cord injury
4729269|NCT03053791|SCI|sci
4729270|NCT03053791|Paraplegia|paraplegia
4729271|NCT03053791|Mesencephalic locomotor region|mesencephalic locomotor region
4729272|NCT03053791|MLR|mlr
4729273|NCT03053791|Pedunculopontine nucleus|pedunculopontine nucleus
4729276|NCT03053778|Early follow-up|early follow-up
4729277|NCT03053778|Heart valves|heart valves
4729278|NCT03053778|Heart valve surgery|heart valve surgery
4729279|NCT03053739|Systemic sclerosis, Associated Pulmonary Arterial Hypertension|systemic sclerosis, associated pulmonary arterial hypertension
4729280|NCT03053726|Variable Frequency Stimulation|variable frequency stimulation
4729281|NCT03053713|Mediterranean diet pattern|mediterranean diet pattern
4729282|NCT03053713|nutrition|nutrition
4729283|NCT03053713|diet intervention|diet intervention
4729284|NCT03053713|disease activity|disease activity
4729285|NCT03053713|intestinal microbiome|intestinal microbiome
4729286|NCT03053713|inflammatory bowel disease|inflammatory bowel disease
4729287|NCT03053700|Rosacea, Bromonidine, intensed pulse light|rosacea, bromonidine, intensed pulse light
4729288|NCT03053661|Head and Neck Squamous Cell Carcinoma|head and neck squamous cell carcinoma
4729289|NCT03053661|cancer-specific immunity|cancer-specific immunity
4729290|NCT03053661|cancer immunology|cancer immunology
4729291|NCT03053661|cancer-testis antigens|cancer-testis antigens
4729292|NCT03053661|human papilloma virus|human papilloma virus
4729293|NCT03053661|immune modulatory cells|immune modulatory cells
4729294|NCT03053648|Insomnia|insomnia
4729295|NCT03053648|Randomized controlled trial|randomized controlled trial
4729296|NCT03053648|Acupressure|acupressure
4729297|NCT03053648|Self-help|self-help
4729298|NCT03053635|Photodynamic Therapy|photodynamic therapy
4729299|NCT03053635|Non-muscle invasive bladder cancer (NMIBC)|non-muscle invasive bladder cancer (nmibc)
4729300|NCT03053635|Urothelial carcinoma|urothelial carcinoma
4729301|NCT03053635|Ta bladder cancer|ta bladder cancer
4729302|NCT03053635|T1 bladder cancer|t1 bladder cancer
4729303|NCT03053635|Refractory to BCG|refractory to bcg
4729304|NCT03053609|gastroesophageal reflux|gastroesophageal reflux
4729305|NCT03053609|apnea|apnea
4729306|NCT03053609|bradycardia|bradycardia
4729307|NCT03053609|desaturation|desaturation
4729308|NCT03053609|impedance|impedance
4729309|NCT03053596|HCC|hcc
4729310|NCT03053596|LifePearl|lifepearl
4729311|NCT03053583|larynx, laryngoscopy|larynx, laryngoscopy
4729312|NCT03053583|vocal cords, laryngoscopy|vocal cords, laryngoscopy
4729313|NCT03053583|airway|airway
4729314|NCT03053583|pediatric|pediatric
4729315|NCT03053570|Cryoballoon|cryoballoon
4729316|NCT03053570|Contact Force|contact force
4729317|NCT03053570|Persistent Atrial Fibrillation|persistent atrial fibrillation
4729318|NCT03053557|mental health consumers|mental health consumers
4729319|NCT03053544|rectal cancer|rectal cancer
4729320|NCT03053544|adenocarcinoma of the rectum|adenocarcinoma of the rectum
4729321|NCT03053544|node positive rectal tumors|node positive rectal tumors
4729322|NCT03053544|metformin|metformin
4729323|NCT03053544|neoadjuvant chemoradiation|neoadjuvant chemoradiation
4729324|NCT03053518|Type 2 Diabetes|type 2 diabetes
4729325|NCT03053518|Hyperglycemia|hyperglycemia
4729326|NCT03053518|Personal Nutrition Project|personal nutrition project
4729327|NCT03053505|fecal microbiota transplantation (FMT)|fecal microbiota transplantation (fmt)
4729328|NCT03053505|Clostridium difficile infection|clostridium difficile infection
4729329|NCT03053505|gut flora|gut flora
4729330|NCT03053505|human microbiome|human microbiome
4729331|NCT03053505|colitis|colitis
4729332|NCT03053492|Video Games|video games
4729333|NCT03053479|surgery|surgery
4729334|NCT03053479|native tissue prolapse repair|native tissue prolapse repair
4729335|NCT03053479|laparoscopic sacrocolpopexy|laparoscopic sacrocolpopexy
4729336|NCT03053479|vaginal mesh|vaginal mesh
4729337|NCT03053466|Advanced Solid Tumor|advanced solid tumor
4729338|NCT03053466|Relapsed Solid Tumor|relapsed solid tumor
4729339|NCT03053466|Recurrent Solid Tumor|recurrent solid tumor
4729340|NCT03053453|Total Knee Replacement Arthroplasty|total knee replacement arthroplasty
4729341|NCT03053427|Restless Legs Syndrome|restless legs syndrome
4729342|NCT03053427|Gabapentin enacarbil|gabapentin enacarbil
4729343|NCT03053401|Quadriceps muscle strength|quadriceps muscle strength
4729344|NCT03053401|Anterior cruciate ligament repair|anterior cruciate ligament repair
4729345|NCT03053401|Femoral nerve block|femoral nerve block
4729346|NCT03053401|Adductor Canal block|adductor canal block
4729347|NCT03053401|Saphenous nerve block in the Adductor Canal|saphenous nerve block in the adductor canal
4729348|NCT03053401|Pediatrics|pediatrics
4729349|NCT03053401|Postoperative analgesia|postoperative analgesia
4729350|NCT03053401|Ultrasound guided nerve block|ultrasound guided nerve block
4729351|NCT03053323|Preconception|preconception
4729352|NCT03053323|Pregnancy|pregnancy
4729353|NCT03053323|Lifestyle|lifestyle
4729354|NCT03053310|surgery|surgery
4729355|NCT03053310|curative intent|curative intent
4729356|NCT03053310|geriatric assessment|geriatric assessment
4729357|NCT03053310|30-day postoperative morbidity|30-day postoperative morbidity
4729358|NCT03053297|EGFR|egfr
4729359|NCT03053297|EGFR mutation|egfr mutation
4729360|NCT03053297|EGFRm|egfrm
4729361|NCT03053297|EGFR-TKI|egfr-tki
4729362|NCT03053297|Health care resource utilization|health care resource utilization
4729363|NCT03053297|Health-Related Quality of Life|health-related quality of life
4729364|NCT03053297|Locally advanced or metastatic lung cancer|locally advanced or metastatic lung cancer
4729365|NCT03053297|NSCLC|nsclc
4729366|NCT03053297|Non-Small Cell Lung Cancer|non-small cell lung cancer
4729367|NCT03053297|Observational study|observational study
4729368|NCT03053297|Osimertinib|osimertinib
4729369|NCT03053297|Personalized medicine|personalized medicine
4729370|NCT03053297|PRO|pro
4729371|NCT03053297|Patient Reported Outcome|patient reported outcome
4729372|NCT03053297|Resistance|resistance
4729373|NCT03053297|T790M|t790m
4729374|NCT03053297|Carcinoma, Non-Small-Cell Lung|carcinoma, non-small-cell lung
4729375|NCT03053297|Carcinoma, Bronchogenic|carcinoma, bronchogenic
4729376|NCT03053297|Bronchial Neoplasms|bronchial neoplasms
4729377|NCT03053297|Lung Neoplasms|lung neoplasms
4729378|NCT03053297|Respiratory Tract Neoplasms|respiratory tract neoplasms
4729379|NCT03053297|Thoracic neoplasms, Neoplasms by site|thoracic neoplasms, neoplasms by site
4729380|NCT03053297|Lung diseases|lung diseases
4729381|NCT03053297|Respiratory Tract diseases|respiratory tract diseases
4729382|NCT03053297|Cancer Chemotherapy|cancer chemotherapy
4729383|NCT03053297|Combination Chemotherapy|combination chemotherapy
4729384|NCT03053297|Immunotherapy|immunotherapy
4729385|NCT03053297|Radiation|radiation
4729386|NCT03053271|Endogenous Cushing's Syndrome|endogenous cushing's syndrome
4729387|NCT03053271|ATR-101|atr-101
4729388|NCT03053271|CS|cs
4729389|NCT03053245|Collaborative Care Model|collaborative care model
4729390|NCT03053245|Intensive Care Unit|intensive care unit
4729391|NCT03053193|breast cancer|breast cancer
4729392|NCT03053193|stage I|stage i
4729393|NCT03053193|stage II|stage ii
4729394|NCT03053193|stage III|stage iii
4729395|NCT03053180|Paritaprevir|paritaprevir
4729396|NCT03053180|Dasabuvir|dasabuvir
4729397|NCT03053180|Ombitasvir|ombitasvir
4729398|NCT03053180|Ritonavir|ritonavir
4729399|NCT03053180|Ribavirin free|ribavirin free
4729400|NCT03053180|Chronic Hepatitis C genotype 1b (GT1b)|chronic hepatitis c genotype 1b (gt1b)
4729401|NCT03053180|Cirrhosis|cirrhosis
4729402|NCT03053180|Compensated liver cirrhosis|compensated liver cirrhosis
4729403|NCT03053180|Hepatitis|hepatitis
4729404|NCT03053167|Raltitrexed|raltitrexed
4729405|NCT03053167|Irinotecan|irinotecan
4729406|NCT03053167|Second-line Treatment|second-line treatment
4729407|NCT03053167|Advanced Colorectal Cancer(ACC)|advanced colorectal cancer(acc)
4729408|NCT03053154|Pelvic Inclination|pelvic inclination
4729409|NCT03053154|Sit to Stand|sit to stand
4729410|NCT03053154|Stroke|stroke
4729411|NCT03053154|Anterior pelvic tilt|anterior pelvic tilt
4729412|NCT03053154|Posterior pelvic tilt|posterior pelvic tilt
4729413|NCT03053128|cardiac ischemia|cardiac ischemia
4729414|NCT03053102|PNH|pnh
4729415|NCT03053102|Paroxysmal|paroxysmal
4729416|NCT03053102|Hemoglobinuria|hemoglobinuria
4729417|NCT03053089|MPS I; Hurler Syndrome|mps i; hurler syndrome
4729418|NCT03053076|cord blood mononuclear cells|cord blood mononuclear cells
4729419|NCT03053076|safety|safety
4729420|NCT03053076|effect|effect
4729421|NCT03053076|neonates|neonates
4729422|NCT03053037|apical size|apical size
4729423|NCT03053037|root canal treatment success|root canal treatment success
4729424|NCT03053037|micro biome analysis|micro biome analysis
4729425|NCT03053037|pulp necrosis|pulp necrosis
4729426|NCT03052985|medical devices (meshes)|medical devices (meshes)
4729427|NCT03052985|surgery|surgery
4729428|NCT03052946|fecal incontinence, anorectal manometry, bulking agents|fecal incontinence, anorectal manometry, bulking agents
4729429|NCT03052933|copanlisib|copanlisib
4729430|NCT03052933|gemcitabine|gemcitabine
4729431|NCT03052933|peripheral T-cell lymphoma|peripheral t-cell lymphoma
4729432|NCT03052933|extranodal NK/T-cell lymphoma|extranodal nk/t-cell lymphoma
4729433|NCT03052920|cochlear implant|cochlear implant
4729434|NCT03052920|asymmetric hearing loss|asymmetric hearing loss
4729435|NCT03052894|anesthesiology|anesthesiology
4729436|NCT03052894|neuromuscular blockade|neuromuscular blockade
4729437|NCT03052894|monitoring device|monitoring device
4729438|NCT03052855|Psychiatry|psychiatry
4729439|NCT03052855|Suicidal behaviour|suicidal behaviour
4729440|NCT03052855|Cerebral metabolites|cerebral metabolites
4729441|NCT03052855|MRI|mri
4729442|NCT03052855|Inflammatory markers|inflammatory markers
4729443|NCT03052803|coronary stenosis|coronary stenosis
4729444|NCT03052803|fractional flow reserve|fractional flow reserve
4729445|NCT03052751|UCB7665|ucb7665
4729446|NCT03052751|Myasthenia Gravis|myasthenia gravis
4729447|NCT03052738|central nervous system (brain or spinal) tumor|central nervous system (brain or spinal) tumor
4729448|NCT03052712|Disorders of socio-emotional|disorders of socio-emotional
4729449|NCT03052712|Alzheimer|alzheimer
4729450|NCT03052712|frontal temporal dementia|frontal temporal dementia
4729451|NCT03052712|Parkinson|parkinson
4729452|NCT03052712|Huntington|huntington
4729453|NCT03052712|traumatic brain injury|traumatic brain injury
4729454|NCT03052712|stroke|stroke
4729455|NCT03052712|focal lesions|focal lesions
4729456|NCT03052699|Complications; Cesarean Section|complications; cesarean section
4729457|NCT03052686|Uterine rupture|uterine rupture
4729458|NCT03052673|ketamine|ketamine
4729459|NCT03052673|fentanyl|fentanyl
4729460|NCT03052673|postoperative pain|postoperative pain
4729461|NCT03052660|Midazolam|midazolam
4729462|NCT03052660|Anxiety|anxiety
4729463|NCT03052660|Clinical trial|clinical trial
4729464|NCT03052660|Patient Satisfaction|patient satisfaction
4729465|NCT03052647|dermaclip|dermaclip
4729466|NCT03052647|subcuticular|subcuticular
4729764|NCT03050554|Avelumab|avelumab
4729467|NCT03052647|cesarean section|cesarean section
4729468|NCT03052647|staples|staples
4729469|NCT03052647|adhesive latch|adhesive latch
4729470|NCT03052647|rousseau|rousseau
4729471|NCT03052608|ALK; anaplastic lymphoma kinase; Non-Small-Cell Lung cancer; NSCLC|alk; anaplastic lymphoma kinase; non-small-cell lung cancer; nsclc
4729472|NCT03052556|cystic Fibrosis|cystic fibrosis
4729473|NCT03052556|cervical cancer|cervical cancer
4729474|NCT03052556|screening|screening
4729475|NCT03052556|human papilloma virus (HPV)|human papilloma virus (hpv)
4729476|NCT03052556|pap smear test|pap smear test
4729477|NCT03052517|Asthma, QAW039|asthma, qaw039
4729478|NCT03052465|Motility|motility
4729479|NCT03052413|thinning hair|thinning hair
4729480|NCT03052413|female pattern hair loss|female pattern hair loss
4729481|NCT03052400|type 2 diabetes mellitus|type 2 diabetes mellitus
4729482|NCT03052400|insulin resistance|insulin resistance
4729483|NCT03052400|mifepristone|mifepristone
4729484|NCT03052400|glucocorticoids|glucocorticoids
4729485|NCT03052374|Video-Feedback Interaction Guidance|video-feedback interaction guidance
4729486|NCT03052374|Depressed Mothers and their Infants|depressed mothers and their infants
4729487|NCT03052361|Children|children
4729488|NCT03052361|emergency department|emergency department
4729489|NCT03052361|ondansetron|ondansetron
4729490|NCT03052348|Topical Antibiotics|topical antibiotics
4729491|NCT03052348|Fusidic Acid|fusidic acid
4729492|NCT03052348|Atopic Dermatitis|atopic dermatitis
4729493|NCT03052348|Eczema|eczema
4729494|NCT03052335|colorectal cancer|colorectal cancer
4729495|NCT03052335|screening|screening
4729496|NCT03052335|colon capsule|colon capsule
4729497|NCT03052335|colonoscopy|colonoscopy
4729498|NCT03052283|Cystic fibrosis|cystic fibrosis
4729499|NCT03052283|Abdomen|abdomen
4729500|NCT03052283|Pancreas|pancreas
4729501|NCT03052283|Liver|liver
4729502|NCT03052283|Gut|gut
4729503|NCT03052283|Symptom Score|symptom score
4729504|NCT03052283|Patient reported outcome measure (PROM)|patient reported outcome measure (prom)
4729505|NCT03052257|Glaucoma|glaucoma
4729506|NCT03052257|Disease management|disease management
4729507|NCT03052257|Smart bottle|smart bottle
4729508|NCT03052244|tDCS (trans cranial direct current stimulation)|tdcs (trans cranial direct current stimulation)
4729509|NCT03052244|Visual illusion|visual illusion
4729510|NCT03052244|Neuropathic pain|neuropathic pain
4729511|NCT03052244|Spinal cord Injury|spinal cord injury
4729512|NCT03052231|adherence|adherence
4729513|NCT03052231|cystic fibrosis|cystic fibrosis
4729514|NCT03052218|children|children
4729515|NCT03052218|pain|pain
4729516|NCT03052218|Cytochrome P450 CYP2D6 genotype|cytochrome p450 cyp2d6 genotype
4729517|NCT03052218|Cytochrome P450 CYP2D6 phenotype|cytochrome p450 cyp2d6 phenotype
4729518|NCT03052218|Pupillometry|pupillometry
4729519|NCT03052205|ILLUMINATE-101|illuminate-101
4729520|NCT03052205|melanoma|melanoma
4729521|NCT03052127|Uveal melanoma|uveal melanoma
4729522|NCT03052127|Eye cancer|eye cancer
4729523|NCT03052127|Ocular melanoma|ocular melanoma
4729524|NCT03052127|Choroidal melanoma|choroidal melanoma
4729525|NCT03052114|Electrical Impedance Tomography|electrical impedance tomography
4729526|NCT03052114|EIT|eit
4729527|NCT03052114|Stroke|stroke
4729528|NCT03052114|Craniocerebral Injury|craniocerebral injury
4729529|NCT03052114|Head Injury|head injury
4729530|NCT03052101|PLCH|plch
4729531|NCT03052101|Air travel|air travel
4729532|NCT03052101|pneumothorax|pneumothorax
4729533|NCT03052101|pleurodesis|pleurodesis
4729534|NCT03052075|Primary Hyperparathyroidism|primary hyperparathyroidism
4729535|NCT03052075|Parathyroidectomy|parathyroidectomy
4729536|NCT03052075|Bone mineral density|bone mineral density
4729537|NCT03052075|BMD|bmd
4729538|NCT03052075|Data Review|data review
4729539|NCT03052049|Prostate Artery Embolization|prostate artery embolization
4729540|NCT03052036|Acute Coronary Syndrome|acute coronary syndrome
4729541|NCT03052023|dual approach|dual approach
4729542|NCT03052023|laparoscopic hernioplasty|laparoscopic hernioplasty
4729543|NCT03052010|HIV-1 serodiscordant couples|hiv-1 serodiscordant couples
4729544|NCT03052010|PrEP as Bridge to ART|prep as bridge to art
4729545|NCT03051919|Laparoscopic sleeve gastrectomy|laparoscopic sleeve gastrectomy
4729546|NCT03051919|reinforcement|reinforcement
4729547|NCT03051919|leak|leak
4729548|NCT03051906|Carcinoma, squamous cell|carcinoma, squamous cell
4729549|NCT03051906|Head and Neck Neoplasms|head and neck neoplasms
4729550|NCT03051906|Radiotherapy|radiotherapy
4729551|NCT03051906|Immunotherapy|immunotherapy
4729552|NCT03051880|Epidermal Growth Factor|epidermal growth factor
4729553|NCT03051854|Violence|violence
4729554|NCT03051854|Children|children
4729555|NCT03051854|Prevalence|prevalence
4729556|NCT03051854|Abuse|abuse
4729557|NCT03051854|Prevention|prevention
4729558|NCT03051828|fencing, cancer|fencing, cancer
4729559|NCT03051815|obstructive sleep apnea|obstructive sleep apnea
4729560|NCT03051802|Endoscopy|endoscopy
4729561|NCT03051802|HDR Brachytherapy|hdr brachytherapy
4729562|NCT03051802|navigation|navigation
4729563|NCT03051789|Menstrual hygiene management|menstrual hygiene management
4729564|NCT03051789|Sexual and Reproductive Health|sexual and reproductive health
4729565|NCT03051789|Adolescent schoolgirls|adolescent schoolgirls
4729566|NCT03051789|School dropoout|school dropoout
4729567|NCT03051789|sub-Saharan Africa|sub-saharan africa
4729568|NCT03051789|Kenya|kenya
4729569|NCT03051776|Compression garments|compression garments
4729570|NCT03051776|Kinesio Taping|kinesio taping
4729571|NCT03051776|Breast Cancer-Related Lymphedema|breast cancer-related lymphedema
4729572|NCT03051763|pulmonary hypertension|pulmonary hypertension
4729573|NCT03051763|commercial air travel|commercial air travel
4729574|NCT03051750|Breast Cancer-Related Lymphedema|breast cancer-related lymphedema
4729575|NCT03051750|Complex Physical Therapy|complex physical therapy
4729576|NCT03051750|Pressotherapy|pressotherapy
4729577|NCT03051750|Kinesio Taping|kinesio taping
4729578|NCT03051750|Physiotherapy|physiotherapy
4729579|NCT03051750|Manual Lymph Drainage|manual lymph drainage
4729580|NCT03051750|Multilayer Bandage|multilayer bandage
4729581|NCT03051750|TTDL questionnaire|ttdl questionnaire
4729582|NCT03051737|Multi-scale|multi-scale
4729583|NCT03051737|Prediction|prediction
4729584|NCT03051737|Patient Flow|patient flow
4729585|NCT03051737|Emergency Department|emergency department
4729586|NCT03051737|Hospitalization|hospitalization
4729587|NCT03051737|Ile-de-France|ile-de-france
4729588|NCT03051724|OSA|osa
4729589|NCT03051724|CPAP management|cpap management
4729590|NCT03051724|Telemedicine|telemedicine
4729591|NCT03051698|C1-inhibitor|c1-inhibitor
4729592|NCT03051698|house dust mite|house dust mite
4729593|NCT03051698|complement system|complement system
4729594|NCT03051672|Breast Cancer|breast cancer
4729595|NCT03051659|Breast Cancer|breast cancer
4729596|NCT03051646|Exercise|exercise
4729597|NCT03051646|Time to Exhaustion|time to exhaustion
4729598|NCT03051620|Bone turnover markers|bone turnover markers
4729599|NCT03051620|Alendronate|alendronate
4729600|NCT03051620|Drug Holiday|drug holiday
4729601|NCT03051607|Motor Fluctuations|motor fluctuations
4729602|NCT03051607|Off time|off time
4729603|NCT03051607|On time|on time
4729604|NCT03051607|Dyskinesia|dyskinesia
4729605|NCT03051581|Lymphoma, T-Cell, Peripheral|lymphoma, t-cell, peripheral
4729606|NCT03051581|Positron-Emission Tomography|positron-emission tomography
4729607|NCT03051581|Prognosis|prognosis
4729608|NCT03051568|Lymphoma, T-Cell, Peripheral|lymphoma, t-cell, peripheral
4729609|NCT03051568|Positron-Emission Tomography|positron-emission tomography
4729610|NCT03051568|Prognosis|prognosis
4729611|NCT03051555|Lymphoma, Extranodal NK-T-Cell|lymphoma, extranodal nk-t-cell
4729612|NCT03051555|Positron-Emission Tomography|positron-emission tomography
4729613|NCT03051555|Prognosis|prognosis
4729614|NCT03051542|Lymphoma, Extranodal NK-T-Cell|lymphoma, extranodal nk-t-cell
4729615|NCT03051542|Positron-Emission Tomography|positron-emission tomography
4729616|NCT03051542|Prognosis|prognosis
4729617|NCT03051451|Hydrochloride of Metformin / Fluoxetine|hydrochloride of metformin / fluoxetine
4729618|NCT03051451|Placebo|placebo
4729619|NCT03051451|Obesity|obesity
4729620|NCT03051425|Probiotics|probiotics
4729621|NCT03051425|Immune function|immune function
4729622|NCT03051425|Natural killer cell activity|natural killer cell activity
4729623|NCT03051425|Interleukin-12|interleukin-12
4729624|NCT03051425|Interferon-gamma|interferon-gamma
4729625|NCT03051425|Immunoglobulin|immunoglobulin
4729626|NCT03051399|Constipation|constipation
4729627|NCT03051399|Gastrointestinal symptoms of discomfort|gastrointestinal symptoms of discomfort
4729628|NCT03051399|Quality of life|quality of life
4729629|NCT03051399|Saccharomyces cerevisiae|saccharomyces cerevisiae
4729630|NCT03051399|Gut microbiome|gut microbiome
4729631|NCT03051360|aortic valve stenosis|aortic valve stenosis
4729632|NCT03051360|PCSK9 inhibitor|pcsk9 inhibitor
4729633|NCT03051308|Parathyroid cell viability|parathyroid cell viability
4729634|NCT03051308|Ischemia|ischemia
4729635|NCT03051308|Parathyroid allotransplantation|parathyroid allotransplantation
4729636|NCT03051308|Vitamin D Receptor|vitamin d receptor
4729637|NCT03051308|Calcium Sensing Receptor|calcium sensing receptor
4729638|NCT03051295|Communication Barriers|communication barriers
4729639|NCT03051295|Persuasive Communication|persuasive communication
4729640|NCT03051295|Risk|risk
4729641|NCT03051269|Electroporation|electroporation
4729642|NCT03051269|Calcium|calcium
4729643|NCT03051269|Head and Neck cancer|head and neck cancer
4729644|NCT03051256|REL-1017|rel-1017
4729645|NCT03051256|d-Methadone|d-methadone
4729646|NCT03051256|Methadone|methadone
4729647|NCT03051256|Depression|depression
4729648|NCT03051256|Refractory Depression|refractory depression
4729649|NCT03051256|Antidepressant|antidepressant
4729650|NCT03051256|Adjunctive Treatment|adjunctive treatment
4729651|NCT03051256|NMDA Receptor Antagonist|nmda receptor antagonist
4729652|NCT03051256|Excitatory Amino Acid Antagonist|excitatory amino acid antagonist
4729653|NCT03051256|Glutamate Antagonist|glutamate antagonist
4729654|NCT03051230|Blood Coagulation Disorders|blood coagulation disorders
4729655|NCT03051230|Cell-Derived Microparticles|cell-derived microparticles
4729656|NCT03051230|Superovulation|superovulation
4729657|NCT03051230|Fertilization in Vitro|fertilization in vitro
4729658|NCT03051230|Biomarkers|biomarkers
4729659|NCT03051217|Psoriasis|psoriasis
4729660|NCT03051217|PSO|pso
4729661|NCT03051217|Chronic plaque psoriasis|chronic plaque psoriasis
4729662|NCT03051217|Certolizumb Pegol|certolizumb pegol
4729663|NCT03051217|Cimzia|cimzia
4729866|NCT03050138|Recurrence|recurrence
4729664|NCT03051217|Generalized pustular psoriasis and erythrodermic psoriasis|generalized pustular psoriasis and erythrodermic psoriasis
4729665|NCT03051191|atherosclerotic cardiovascular diseases|atherosclerotic cardiovascular diseases
4729666|NCT03051191|nonischemic heart failure|nonischemic heart failure
4729667|NCT03051191|cancer|cancer
4729668|NCT03051165|Cardiovascular Disease|cardiovascular disease
4729669|NCT03051165|Pulmonary Medicine|pulmonary medicine
4729670|NCT03051165|Hypoglossal Nerve Stimulation|hypoglossal nerve stimulation
4729671|NCT03051139|Implementation Science|implementation science
4729672|NCT03051139|Low Tidal Volume Ventilation (LTVV)|low tidal volume ventilation (ltvv)
4729673|NCT03051126|Parathyroid disease|parathyroid disease
4729674|NCT03051126|Parathyroid Tissue Bank|parathyroid tissue bank
4729675|NCT03051126|Database|database
4729676|NCT03051126|Blood samples|blood samples
4729677|NCT03051100|hyperlididemia|hyperlididemia
4729678|NCT03051100|LDL|ldl
4729679|NCT03051100|cholesterol|cholesterol
4729680|NCT03051074|Anxiety|anxiety
4729681|NCT03051074|Floating|floating
4729682|NCT03051061|Atrial Fibrillation|atrial fibrillation
4729683|NCT03051061|Coronary Heart Disease|coronary heart disease
4729684|NCT03051061|antithrombotic treatment|antithrombotic treatment
4729685|NCT03051061|clinical prognosis|clinical prognosis
4729686|NCT03051048|Acute Myocardial Infarction|acute myocardial infarction
4729687|NCT03051035|non-hematological malignancies|non-hematological malignancies
4729688|NCT03051035|non-squamous|non-squamous
4729689|NCT03051035|squamous|squamous
4729690|NCT03051035|BRAF|braf
4729691|NCT03051035|KRAS|kras
4729692|NCT03051035|NRAS|nras
4729693|NCT03051022|Bupivacaine|bupivacaine
4729694|NCT03051022|adjuvant|adjuvant
4729695|NCT03051022|regional anesthesia|regional anesthesia
4729696|NCT03051022|dexamethasone|dexamethasone
4729697|NCT03051022|morphine|morphine
4729698|NCT03050983|Respiratory Compromise|respiratory compromise
4729699|NCT03050970|minor head trauma|minor head trauma
4729700|NCT03050970|child|child
4729701|NCT03050970|age less than 2 years|age less than 2 years
4729702|NCT03050970|Clinically-important traumatic brain injury (ciTBI)|clinically-important traumatic brain injury (citbi)
4729703|NCT03050970|Computed tomography scan|computed tomography scan
4729704|NCT03050970|Radiation exposure from CT scans|radiation exposure from ct scans
4729705|NCT03050944|Fertility|fertility
4729706|NCT03050944|Infertility|infertility
4729707|NCT03050944|Dietary Patterns|dietary patterns
4729708|NCT03050944|Mediterranean diet|mediterranean diet
4729709|NCT03050944|Adiponectin|adiponectin
4729710|NCT03050944|Follistatin|follistatin
4729711|NCT03050944|Assisted Reproduction|assisted reproduction
4729712|NCT03050944|In Vitro Fertilization|in vitro fertilization
4729713|NCT03050944|Semen quality|semen quality
4729714|NCT03050944|Diet|diet
4729715|NCT03050944|IVF|ivf
4729716|NCT03050931|Electrical Impedance Tomography|electrical impedance tomography
4729717|NCT03050931|EIT|eit
4729718|NCT03050931|Epilepsy|epilepsy
4729719|NCT03050879|Stomach Neoplasms|stomach neoplasms
4729720|NCT03050879|Indocyanine Green Tracer|indocyanine green tracer
4729721|NCT03050879|Laparoscopic Gastrectomy|laparoscopic gastrectomy
4729722|NCT03050879|Lymph Node Dissection|lymph node dissection
4729723|NCT03050866|Androgen Receptor|androgen receptor
4729724|NCT03050866|AR-V7|ar-v7
4729725|NCT03050866|Predictive Factor|predictive factor
4729726|NCT03050814|Anti-PDL1 Antibody|anti-pdl1 antibody
4729727|NCT03050814|Therapeutic Cancer Vaccine|therapeutic cancer vaccine
4729728|NCT03050814|Mismatch Repair Deficiency|mismatch repair deficiency
4729729|NCT03050814|Progression Free Survival|progression free survival
4729730|NCT03050814|Adenovirus Based, CEA-Targeting Vaccine|adenovirus based, cea-targeting vaccine
4729731|NCT03050801|Explicit Memory|explicit memory
4729732|NCT03050801|Implicit Memory|implicit memory
4729733|NCT03050801|Memory Disorder|memory disorder
4729734|NCT03050788|Smartphone confocal microscopy|smartphone confocal microscopy
4729735|NCT03050788|Kaposi Sarcoma|kaposi sarcoma
4729736|NCT03050788|Point of care diagnosis|point of care diagnosis
4729737|NCT03050762|Endocrine Disease|endocrine disease
4729738|NCT03050762|Thyroid disease|thyroid disease
4729739|NCT03050762|Parathyroid disease|parathyroid disease
4729740|NCT03050762|Adrenal disease|adrenal disease
4729741|NCT03050762|Data Review|data review
4729742|NCT03050762|Database|database
4729743|NCT03050736|Glioma|glioma
4729744|NCT03050736|Glioblastoma|glioblastoma
4729745|NCT03050736|Glioblastoma multiforme|glioblastoma multiforme
4729747|NCT03050736|brain tumor|brain tumor
4729748|NCT03050736|brain cancer|brain cancer
4729749|NCT03050632|working memory|working memory
4729750|NCT03050632|adherence|adherence
4729751|NCT03050606|Exercise Therapy|exercise therapy
4729752|NCT03050606|Exercise Movement Techniques|exercise movement techniques
4729753|NCT03050606|Pilates-Based Exercises|pilates-based exercises
4729754|NCT03050606|Cost-effectiveness|cost-effectiveness
4729755|NCT03050593|HFpEF|hfpef
4729756|NCT03050593|HFrEF|hfref
4729757|NCT03050580|Abused women|abused women
4729758|NCT03050580|treatment group|treatment group
4729759|NCT03050580|family violence|family violence
4729760|NCT03050567|Microemboli|microemboli
4729761|NCT03050554|cancer|cancer
4729762|NCT03050554|Non-Small Cell Lung Cancer|non-small cell lung cancer
4729763|NCT03050554|SBRT|sbrt
4729765|NCT03050554|Stereotactic Body Radiation Therapy|stereotactic body radiation therapy
4729766|NCT03050554|radiation|radiation
4729767|NCT03050554|NSCLC|nsclc
4729768|NCT03050554|PD-1|pd-1
4729769|NCT03050554|PD-L1|pd-l1
4729770|NCT03050554|Immunotherapy|immunotherapy
4729771|NCT03050554|Lung|lung
4729772|NCT03050541|MDMA|mdma
4729773|NCT03050541|adult|adult
4729774|NCT03050528|Acceptance and Commitment Therapy|acceptance and commitment therapy
4729775|NCT03050528|Exercise|exercise
4729776|NCT03050528|Psychology|psychology
4729777|NCT03050528|Psychological therapy|psychological therapy
4729778|NCT03050528|Physiotherapy|physiotherapy
4729779|NCT03050528|Physical therapy|physical therapy
4729780|NCT03050502|Hemothorax|hemothorax
4729781|NCT03050502|Management|management
4729782|NCT03050489|CABG|cabg
4729783|NCT03050489|Off-Pump CABG|off-pump cabg
4729784|NCT03050489|On-Pump CABG|on-pump cabg
4729785|NCT03050489|ischemic-reperfusion injury during CABG|ischemic-reperfusion injury during cabg
4729786|NCT03050489|comparison of On- and Off- Pump CABG|comparison of on- and off- pump cabg
4729787|NCT03050489|Ischemic Heart Disease|ischemic heart disease
4729788|NCT03050489|Myocardial ischemia-reperfusion and myeloperoxidase|myocardial ischemia-reperfusion and myeloperoxidase
4729789|NCT03050489|Myocardial ischemia-reperfusion biomarkers|myocardial ischemia-reperfusion biomarkers
4729790|NCT03050476|side-effects|side-effects
4729791|NCT03050476|heart-lung machine|heart-lung machine
4729792|NCT03050476|alkaline phosphatase|alkaline phosphatase
4729793|NCT03050437|Failed in First Line EGFR-TKI|failed in first line egfr-tki
4729794|NCT03050437|EGFR Activating Mutation|egfr activating mutation
4729795|NCT03050437|Pemetrexed|pemetrexed
4729796|NCT03050424|COPD|copd
4729797|NCT03050424|Iron|iron
4729798|NCT03050424|Exercise Capacity|exercise capacity
4729799|NCT03050424|Non-anaemic iron deficiency|non-anaemic iron deficiency
4729800|NCT03050411|Non Small Cell Lung Cancer|non small cell lung cancer
4729801|NCT03050411|EGFR-TKI resistance|egfr-tki resistance
4729802|NCT03050411|Apatinib|apatinib
4729803|NCT03050411|anti-angiogenesis drugs|anti-angiogenesis drugs
4729804|NCT03050398|HR-positive|hr-positive
4729805|NCT03050398|HER2-negative|her2-negative
4729806|NCT03050398|Advanced breast cancer|advanced breast cancer
4729807|NCT03050398|LEE011|lee011
4729808|NCT03050398|ribociclib|ribociclib
4729809|NCT03050398|letrozole|letrozole
4729810|NCT03050398|femara|femara
4729811|NCT03050398|CDK|cdk
4729812|NCT03050398|CDK4|cdk4
4729813|NCT03050398|CDK6|cdk6
4729814|NCT03050398|CDK4/6|cdk4/6
4729815|NCT03050398|CDK4/6 inhibitor|cdk4/6 inhibitor
4729816|NCT03050398|Phase III|phase iii
4729817|NCT03050398|Phase IIIb|phase iiib
4729818|NCT03050398|ER-positive|er-positive
4729819|NCT03050398|PR-positive|pr-positive
4729820|NCT03050398|Postmenopausal|postmenopausal
4729821|NCT03050398|Premenopausal|premenopausal
4729822|NCT03050398|Men|men
4729823|NCT03050385|cognitive rehabilitation|cognitive rehabilitation
4729824|NCT03050359|Drug therapy|drug therapy
4729825|NCT03050359|Gastrointestinal Diseases|gastrointestinal diseases
4729826|NCT03050359|Digestive System Diseases|digestive system diseases
4729827|NCT03050359|Lansoprazole|lansoprazole
4729828|NCT03050359|Anti-Ulcer Agents|anti-ulcer agents
4729829|NCT03050359|Gastrointestinal Agents|gastrointestinal agents
4729830|NCT03050359|Proton Pump Inhibitors|proton pump inhibitors
4729831|NCT03050359|Enzyme Inhibitors|enzyme inhibitors
4729832|NCT03050359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
4729833|NCT03050346|Magnetic Resonance Imaging|magnetic resonance imaging
4729834|NCT03050346|Coronary Artery Disease|coronary artery disease
4729835|NCT03050346|Apnea|apnea
4729836|NCT03050346|Hyperventilation|hyperventilation
4729837|NCT03050346|BOLD|bold
4729838|NCT03050346|Breathing Maneuvers|breathing maneuvers
4729839|NCT03050346|Myocardial Oxygenation|myocardial oxygenation
4729840|NCT03050320|Resilience|resilience
4729841|NCT03050320|Exercise in the workplace|exercise in the workplace
4729842|NCT03050307|Drug therapy|drug therapy
4729843|NCT03050268|Familial cancer|familial cancer
4729844|NCT03050268|Genetic predisposition|genetic predisposition
4729845|NCT03050268|Heritable disease|heritable disease
4729846|NCT03050268|Cancer risk|cancer risk
4729847|NCT03050268|Genome analysis|genome analysis
4729848|NCT03050268|Genetic modifiers|genetic modifiers
4729849|NCT03050268|Next generation sequencing (NGS)|next generation sequencing (ngs)
4729850|NCT03050268|Genetic counseling|genetic counseling
4729851|NCT03050268|DNA|dna
4729852|NCT03050255|supplemental oxygen|supplemental oxygen
4729853|NCT03050255|walking capacity|walking capacity
4729854|NCT03050255|exercise capacity|exercise capacity
4729855|NCT03050255|endurance shuttle walk test|endurance shuttle walk test
4729856|NCT03050190|CART therapy|cart therapy
4729857|NCT03050190|4SCAR19|4scar19
4729858|NCT03050190|CD19|cd19
4729859|NCT03050190|B cell leukemia|b cell leukemia
4729860|NCT03050190|B-ALL|b-all
4729861|NCT03050177|Bioequivalence Study|bioequivalence study
4729862|NCT03050138|Postthrombotic Syndrome|postthrombotic syndrome
4729863|NCT03050138|Venous Thrombosis|venous thrombosis
4729864|NCT03050138|Quality of Life|quality of life
4729865|NCT03050138|Hemorrhage|hemorrhage
4729867|NCT03050112|MacNew questionnaire|macnew questionnaire
4729868|NCT03050112|Quality of life|quality of life
4729869|NCT03050034|Wireless monitoring system|wireless monitoring system
4729870|NCT03050034|Acute Medicine|acute medicine
4729871|NCT03050034|Poly-pathological patients|poly-pathological patients
4729872|NCT03050034|Internal Medicine core competencies|internal medicine core competencies
4729873|NCT03050034|Acute Complex Care Model|acute complex care model
4729874|NCT03050021|Delirium|delirium
4729875|NCT03050021|Intensive care unit|intensive care unit
4729876|NCT03050008|Cataract Surgery|cataract surgery
4729877|NCT03049995|effectiveness; imaging; prognosis; stress echocardiography|effectiveness; imaging; prognosis; stress echocardiography
4729878|NCT03049982|Oral appliance therapy|oral appliance therapy
4729879|NCT03049969|Working Memory|working memory
4729880|NCT03049969|Cognitive Training|cognitive training
4729881|NCT03049969|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
4729882|NCT03049956|Ocular Vestibular Evoked Myogenic Potentials|ocular vestibular evoked myogenic potentials
4729883|NCT03049943|low level laser therapy|low level laser therapy
4729884|NCT03049943|hyposalivation|hyposalivation
4729885|NCT03049930|Burns|burns
4729886|NCT03049930|Ketamine|ketamine
4729887|NCT03049930|Anesthesia|anesthesia
4729888|NCT03049917|financial incentive|financial incentive
4729889|NCT03049917|pediatric HIV testing|pediatric hiv testing
4729890|NCT03049904|Indian, North America|indian, north america
4729891|NCT03049904|Male, Two-Spirit|male, two-spirit
4729892|NCT03049904|HIV Prevention|hiv prevention
4729893|NCT03049904|MSM|msm
4729894|NCT03049891|Antiretroviral Therapy|antiretroviral therapy
4729895|NCT03049891|Retention|retention
4729896|NCT03049891|Loss to Follow Up|loss to follow up
4729897|NCT03049878|postoperative pain|postoperative pain
4729898|NCT03049878|paracetamol|paracetamol
4729899|NCT03049878|codeine|codeine
4729900|NCT03049878|tooth extractions|tooth extractions
4729901|NCT03049878|analgesia|analgesia
4729902|NCT03049878|premedication|premedication
4729903|NCT03049826|nutrient|nutrient
4729904|NCT03049800|Recent onset psychotic illness|recent onset psychotic illness
4729905|NCT03049800|Healthy controls|healthy controls
4729906|NCT03049800|Cognitive training|cognitive training
4729907|NCT03049800|7T Magnetic Resonance Imaging|7t magnetic resonance imaging
4729908|NCT03049787|physical therapy|physical therapy
4729909|NCT03049787|home exercise|home exercise
4729910|NCT03049787|adhesive capsulitis|adhesive capsulitis
4729911|NCT03049748|Heart-Assist Devices, Self-care, Quality of Life|heart-assist devices, self-care, quality of life
4729912|NCT03049709|central blood pressure|central blood pressure
4729913|NCT03049709|measurement|measurement
4729914|NCT03049709|oscillometric radial pulse wave analysis|oscillometric radial pulse wave analysis
4729915|NCT03049696|Roux-En-Y Gastric Bypass|roux-en-y gastric bypass
4729916|NCT03049696|Bariatric Surgery|bariatric surgery
4729917|NCT03049696|Pre-Operative Physical Activity and Education Program|pre-operative physical activity and education program
4729918|NCT03049696|Obesity|obesity
4729919|NCT03049696|Exercise|exercise
4729920|NCT03049696|Behaviour Modification|behaviour modification
4729921|NCT03049696|Surgical Outcomes|surgical outcomes
4729922|NCT03049696|Quality of Life|quality of life
4729923|NCT03049683|Vestibular evoked myogenic potentials|vestibular evoked myogenic potentials
4729924|NCT03049670|Safety Issue|safety issue
4729925|NCT03049644|chronic lower back pain|chronic lower back pain
4729926|NCT03049644|Manual Therapy|manual therapy
4729927|NCT03049644|Mechanical Diagnosis and Treatment|mechanical diagnosis and treatment
4729928|NCT03049631|Pre-diabetes|pre-diabetes
4729929|NCT03049631|red raspberry|red raspberry
4729930|NCT03049631|fructooligosaccharide|fructooligosaccharide
4729931|NCT03049631|metagenomics|metagenomics
4729932|NCT03049631|polyphenol bioavailability|polyphenol bioavailability
4729933|NCT03049631|glycemic response|glycemic response
4729934|NCT03049631|insulin response|insulin response
4729935|NCT03049605|Neuropathies laser and magnetic therapy|neuropathies laser and magnetic therapy
4729936|NCT03049592|Diabetes|diabetes
4729937|NCT03049592|Contraception|contraception
4729938|NCT03049592|Prenatal Counseling|prenatal counseling
4729939|NCT03049566|Bleeding|bleeding
4729940|NCT03049566|Adverse Cardiac Events|adverse cardiac events
4729941|NCT03049566|Adherence, Medication|adherence, medication
4729942|NCT03049566|Aspirin|aspirin
4729943|NCT03049566|Acetylsalicylic acid|acetylsalicylic acid
4729944|NCT03049553|Cervical screening|cervical screening
4729945|NCT03049553|Human papillomavirus (HPV)|human papillomavirus (hpv)
4729946|NCT03049553|Cytology|cytology
4729947|NCT03049553|HPV-test|hpv-test
4729948|NCT03049553|Cervical intraepithelial neoplasia (CIN)|cervical intraepithelial neoplasia (cin)
4729949|NCT03049527|Chronic Kidney Disease|chronic kidney disease
4729950|NCT03049527|Unknown Origin|unknown origin
4729951|NCT03049514|Thrombolysis|thrombolysis
4729952|NCT03049514|Recanalization|recanalization
4729953|NCT03049514|Dynamic retinal angiography|dynamic retinal angiography
4729954|NCT03049501|Alzheimer's caregivers|alzheimer's caregivers
4729955|NCT03049501|Technology-based intervention|technology-based intervention
4729956|NCT03049501|Culturally-tailored intervention|culturally-tailored intervention
4729957|NCT03049488|Immune Response|immune response
4729958|NCT03049488|Respiratory Syncytial Virus|respiratory syncytial virus
4729959|NCT03049488|Vaccine-Mediated Protection|vaccine-mediated protection
4729960|NCT03049488|Neutralizing Antibody|neutralizing antibody
4729961|NCT03049488|Antibody Response|antibody response
4729962|NCT03049475|Pain|pain
4729963|NCT03049475|Cell Free DNA|cell free dna
4729964|NCT03049475|Inflammatory Markers|inflammatory markers
4729965|NCT03049475|Microparticles|microparticles
4729966|NCT03049475|NETosis|netosis
4729967|NCT03049462|Brown Adipose Tissue|brown adipose tissue
4729968|NCT03049462|Energy Expenditure|energy expenditure
4729969|NCT03049462|Energy Metabolism|energy metabolism
4729970|NCT03049462|Obesity|obesity
4729971|NCT03049449|Gene Therapy|gene therapy
4729972|NCT03049449|Adoptive T Cell Therapy|adoptive t cell therapy
4729973|NCT03049449|T-cell infusion|t-cell infusion
4729974|NCT03049449|Allogeneic Stem Cell Transplantation|allogeneic stem cell transplantation
4729975|NCT03049449|Immunohistochemistry|immunohistochemistry
4729976|NCT03049436|Physical activity|physical activity
4729977|NCT03049436|cancer|cancer
4729978|NCT03049436|chemotherapy|chemotherapy
4729979|NCT03049436|daily care unit|daily care unit
4729980|NCT03049410|Cystectomy|cystectomy
4729981|NCT03049332|Quality of Life|quality of life
4729982|NCT03049306|Obstructive sleep apnea|obstructive sleep apnea
4729983|NCT03049306|CPAP|cpap
4729984|NCT03049306|Propranolol|propranolol
4729985|NCT03049306|Metabolism|metabolism
4729986|NCT03049293|COPD,IVF|copd,ivf
4729987|NCT03049267|acne inversa|acne inversa
4729988|NCT03049241|Children|children
4729989|NCT03049241|Neuromuscular fatigue|neuromuscular fatigue
4729990|NCT03049241|Muscle group|muscle group
4729991|NCT03049241|Magnetic Nerve stimulation|magnetic nerve stimulation
4729992|NCT03049241|Muscle length|muscle length
4729993|NCT03049241|Stiffness|stiffness
4729994|NCT03049241|prepubertal children|prepubertal children
4729995|NCT03049241|adults|adults
4729996|NCT03049228|Spectrum Analysis|spectrum analysis
4729997|NCT03049228|Mitochondria|mitochondria
4729998|NCT03049228|Peroxisome Proliferator-Activated Receptors|peroxisome proliferator-activated receptors
4729999|NCT03049228|Respirometry|respirometry
4730000|NCT03049228|Human|human
4730001|NCT03049228|Heart|heart
4730002|NCT03049189|non-functional and functional P-NET|non-functional and functional p-net
4730003|NCT03049189|non-functional GE-NET|non-functional ge-net
4730004|NCT03049176|HIV-discordant couple|hiv-discordant couple
4730005|NCT03049176|ART|art
4730006|NCT03049176|PrEP|prep
4730007|NCT03049176|semen washing|semen washing
4730008|NCT03049176|artificial vaginal insemination|artificial vaginal insemination
4730009|NCT03049176|safer conception|safer conception
4730010|NCT03049176|pregnancy|pregnancy
4730011|NCT03049150|Urine|urine
4730012|NCT03049150|Mass Spectometry|mass spectometry
4730013|NCT03049150|Observational|observational
4730014|NCT03049124|Exercise|exercise
4730015|NCT03049124|Feasibility trial|feasibility trial
4730016|NCT03049124|Cancer|cancer
4730017|NCT03049124|Chemoradiation|chemoradiation
4730018|NCT03049111|Der F (House Dust Mite)|der f (house dust mite)
4730019|NCT03049098|Eye-tracking|eye-tracking
4730020|NCT03049098|High Fidelity Simulation Training|high fidelity simulation training
4730021|NCT03049098|Visual Perception|visual perception
4730022|NCT03049085|OPCAB|opcab
4730023|NCT03049085|ASA|asa
4730024|NCT03049085|Aspirin|aspirin
4730025|NCT03049020|pelvic organ prolapse|pelvic organ prolapse
4730026|NCT03049020|sacrocolpopexy|sacrocolpopexy
4730027|NCT03049020|pelvic floor ultrasound|pelvic floor ultrasound
4730028|NCT03049007|bereavement|bereavement
4730029|NCT03049007|natural grief|natural grief
4730030|NCT03049007|prolonged grief|prolonged grief
4730031|NCT03049007|complicated grief|complicated grief
4730032|NCT03048994|Glutamine|glutamine
4730033|NCT03048994|Severe sepsis|severe sepsis
4730034|NCT03048981|Thrombocyte aggregation|thrombocyte aggregation
4730035|NCT03048981|Fish oil|fish oil
4730036|NCT03048981|Alternative medicine|alternative medicine
4730037|NCT03048981|Point of care testing|point of care testing
4730038|NCT03048981|Coagulation monitoring|coagulation monitoring
4730039|NCT03048968|Exoskeleton Device|exoskeleton device
4730040|NCT03048968|elderly|elderly
4730041|NCT03048968|stroke|stroke
4730042|NCT03048942|Breast cancer|breast cancer
4730043|NCT03048942|HER2 negative|her2 negative
4730044|NCT03048942|Cabazitaxel|cabazitaxel
4730045|NCT03048942|Paclitaxel|paclitaxel
4730046|NCT03048942|Chemotherapy|chemotherapy
4730047|NCT03048916|dysphagia|dysphagia
4730048|NCT03048916|stroke|stroke
4730049|NCT03048916|magnetic resonance imaging|magnetic resonance imaging
4730050|NCT03048916|videofluoroscopy|videofluoroscopy
4730051|NCT03048903|Gastrointestinal dysfunction|gastrointestinal dysfunction
4730052|NCT03048903|sepsis|sepsis
4730053|NCT03048903|trauma|trauma
4730054|NCT03048890|PAD|pad
4730055|NCT03048877|Radioactive iodine-refractory|radioactive iodine-refractory
4730056|NCT03048877|differentiated thyroid cancer|differentiated thyroid cancer
4730057|NCT03048877|Apatinib|apatinib
4730058|NCT03048877|anti-angiogenesis drugs|anti-angiogenesis drugs
4730059|NCT03048864|Metabolic Screening|metabolic screening
4730060|NCT03048864|24 hour urine|24 hour urine
4730061|NCT03048851|Cerebral palsy|cerebral palsy
4730062|NCT03048851|sensory electrical stimulation|sensory electrical stimulation
4730063|NCT03048851|virtual reality constraint-induced therapy|virtual reality constraint-induced therapy
4730064|NCT03048812|Dental implant|dental implant
4730065|NCT03048812|Mandibular overdenture|mandibular overdenture
4730066|NCT03048812|Cross-over study|cross-over study
4730067|NCT03048786|Peer mentoring|peer mentoring
4730068|NCT03048786|social support|social support
4730069|NCT03048786|text messaging|text messaging
4730070|NCT03048786|smoking cessation|smoking cessation
4730071|NCT03048773|shockwave therapy|shockwave therapy
4730072|NCT03048773|knee osteoarthritis|knee osteoarthritis
4730073|NCT03048760|MRI scan|mri scan
4730074|NCT03048760|Organs at Risk|organs at risk
4730075|NCT03048708|Bariatric surgery|bariatric surgery
4730076|NCT03048708|Leptin|leptin
4730077|NCT03048708|Thyroid function tests|thyroid function tests
4730078|NCT03048617|Primary Mitochondrial Disease|primary mitochondrial disease
4730079|NCT03048617|Stealth|stealth
4730080|NCT03048617|Myopathy|myopathy
4730081|NCT03048617|exercise intolerance|exercise intolerance
4730082|NCT03048617|muscle pain|muscle pain
4730083|NCT03048617|Mitochondrial Myopathy|mitochondrial myopathy
4730084|NCT03048617|Primary Mitochondrial Myopathy|primary mitochondrial myopathy
4730085|NCT03048578|Roux-en-Y gastric bypass (RYGB)|roux-en-y gastric bypass (rygb)
4730086|NCT03048565|mindfulness|mindfulness
4730087|NCT03048565|caregivers|caregivers
4730088|NCT03048552|drug use|drug use
4730089|NCT03048552|drug addiction|drug addiction
4730090|NCT03048552|drug habituation|drug habituation
4730091|NCT03048552|drug use disorders|drug use disorders
4730092|NCT03048552|organic mental disorders|organic mental disorders
4730093|NCT03048552|substance-induced|substance-induced
4730094|NCT03048552|substance abuse|substance abuse
4730095|NCT03048552|substance addiction|substance addiction
4730096|NCT03048552|substance dependence|substance dependence
4730097|NCT03048552|substance use disorders|substance use disorders
4730098|NCT03048539|Endoscopic surgery|endoscopic surgery
4730099|NCT03048539|Thyroidectomy|thyroidectomy
4730100|NCT03048539|Quality of life|quality of life
4730101|NCT03048513|Melioidosis|melioidosis
4730102|NCT03048513|Head and Neck|head and neck
4730103|NCT03048513|Clinical|clinical
4730104|NCT03048474|progressive disease after at least 1 course of chemotherapy|progressive disease after at least 1 course of chemotherapy
4730105|NCT03048448|Hepatic impairment,|hepatic impairment,
4730106|NCT03048448|Fevipiprant,|fevipiprant,
4730107|NCT03048448|adults,|adults,
4730108|NCT03048448|pharmacokinetics|pharmacokinetics
4730109|NCT03048435|Cervical Cancer|cervical cancer
4730110|NCT03048435|Patient Reported Outcomes|patient reported outcomes
4730111|NCT03048435|Radiation Therapy|radiation therapy
4730112|NCT03048435|EORTC QLQ-CX24|eortc qlq-cx24
4730113|NCT03048435|Quality of Life|quality of life
4730114|NCT03048383|Facial paralysis|facial paralysis
4730115|NCT03048383|Facial synkinesis|facial synkinesis
4730116|NCT03048383|Botulinum toxin|botulinum toxin
4730117|NCT03048344|acute promyelocytic leukemia|acute promyelocytic leukemia
4730118|NCT03048344|APL|apl
4730119|NCT03048344|arsenic trioxide|arsenic trioxide
4730496|NCT03045848|Coronary Artery Disease|coronary artery disease
4730120|NCT03048331|Functional Electrical Stimulation|functional electrical stimulation
4730121|NCT03048331|Tetraplegia|tetraplegia
4730122|NCT03048331|Reconstructive Hand Surgery|reconstructive hand surgery
4730123|NCT03048292|Embolectomy|embolectomy
4730124|NCT03048292|Embolus|embolus
4730125|NCT03048292|Thrombectomy|thrombectomy
4730126|NCT03048292|Thrombolysis|thrombolysis
4730127|NCT03048292|Thrombus|thrombus
4730128|NCT03048292|Mobile|mobile
4730129|NCT03048292|Interventional|interventional
4730130|NCT03048292|Neurointervention|neurointervention
4730131|NCT03048292|Stroke|stroke
4730132|NCT03048292|Ischemic|ischemic
4730133|NCT03048292|Acute|acute
4730134|NCT03048292|Endovascular|endovascular
4730135|NCT03048292|Cerebrovascular|cerebrovascular
4730136|NCT03048292|Clot|clot
4730137|NCT03048292|Stent Retriever|stent retriever
4730138|NCT03048292|Tissue Plasminogen Activator|tissue plasminogen activator
4730139|NCT03048292|Drip and Ship|drip and ship
4730140|NCT03048292|Mothership|mothership
4730141|NCT03048292|Trip and Treat|trip and treat
4730142|NCT03048279|Multiple Endocrine Neoplasia Syndromes|multiple endocrine neoplasia syndromes
4730143|NCT03048279|MEN1|men1
4730144|NCT03048279|MEN2|men2
4730145|NCT03048279|Relatives|relatives
4730146|NCT03048279|Database|database
4730147|NCT03048279|Questionnaires|questionnaires
4730148|NCT03048279|Surveys|surveys
4730149|NCT03048266|Multiple endocrine neoplasia|multiple endocrine neoplasia
4730150|NCT03048266|MEN1|men1
4730151|NCT03048266|Aggressive pancreatic neuroendocrine tumors|aggressive pancreatic neuroendocrine tumors
4730152|NCT03048266|PNET|pnet
4730153|NCT03048266|Non-aggressive pancreatic neuroendocrine tumors|non-aggressive pancreatic neuroendocrine tumors
4730154|NCT03048266|Metabolomics|metabolomics
4730155|NCT03048266|Genetics|genetics
4730156|NCT03048266|Biomarkers|biomarkers
4730157|NCT03048240|Glioblastoma|glioblastoma
4730158|NCT03048227|TIDM|tidm
4730159|NCT03048227|Type1diabetes|type1diabetes
4730160|NCT03048227|Implantable Pump|implantable pump
4730161|NCT03048227|CGM|cgm
4730162|NCT03048214|Nerve block; Infraclavicular; Acute pain|nerve block; infraclavicular; acute pain
4730163|NCT03048201|Physica KR|physica kr
4730164|NCT03048201|Physica CR|physica cr
4730165|NCT03048201|Physica PS|physica ps
4730166|NCT03048201|Kinematic Retaining|kinematic retaining
4730167|NCT03048201|Cruciate Retaining|cruciate retaining
4730168|NCT03048201|Posterior Stabilized|posterior stabilized
4730169|NCT03048201|Physica System|physica system
4730170|NCT03048175|C-reactive protein|c-reactive protein
4730171|NCT03048175|Systemic inflammation|systemic inflammation
4730172|NCT03048175|Third molar|third molar
4730173|NCT03048175|Wisdom tooth|wisdom tooth
4730174|NCT03048149|hazelnut allergy|hazelnut allergy
4730175|NCT03048123|Hepatic arterial infusion chemotherapy|hepatic arterial infusion chemotherapy
4730176|NCT03048123|Transarterial Chemoembolization|transarterial chemoembolization
4730177|NCT03048123|Large and unresectable HCC|large and unresectable hcc
4730178|NCT03048071|Contegra|contegra
4730179|NCT03048071|Homograft|homograft
4730180|NCT03048045|chronic periodontitis|chronic periodontitis
4730181|NCT03048045|aggressive periodontitis|aggressive periodontitis
4730182|NCT03048045|supportive periodontal treatment|supportive periodontal treatment
4730183|NCT03048032|acute heart failure|acute heart failure
4730184|NCT03048032|right ventricular failure|right ventricular failure
4730185|NCT03048032|cardiac biomarkers|cardiac biomarkers
4730186|NCT03048032|echocardiography|echocardiography
4730187|NCT03048032|diagnosis|diagnosis
4730188|NCT03048032|prognosis|prognosis
4730189|NCT03047993|Myelodysplastic syndrome|myelodysplastic syndrome
4730190|NCT03047993|MDS|mds
4730191|NCT03047993|Other diseases of blood and blood-forming organs|other diseases of blood and blood-forming organs
4730192|NCT03047993|CB-839|cb-839
4730193|NCT03047993|Azacitidine|azacitidine
4730194|NCT03047993|5-azacytidine|5-azacytidine
4730195|NCT03047993|5-aza|5-aza
4730196|NCT03047993|Vidaza|vidaza
4730197|NCT03047993|5-AZC|5-azc
4730198|NCT03047993|AZA-CR|aza-cr
4730199|NCT03047993|Ladakamycin|ladakamycin
4730200|NCT03047993|NSC-102816|nsc-102816
4730201|NCT03047993|Azacytidine|azacytidine
4730202|NCT03047993|Pharmacokinetic testing|pharmacokinetic testing
4730203|NCT03047993|Pharmacodynamic testing|pharmacodynamic testing
4730204|NCT03047980|SWS|sws
4730205|NCT03047980|Cognitive impairment|cognitive impairment
4730206|NCT03047980|sirolimus|sirolimus
4730207|NCT03047915|Anxiety|anxiety
4730208|NCT03047915|Music intervention|music intervention
4730209|NCT03047915|Emergency department (ED)|emergency department (ed)
4730210|NCT03047902|Adolescent Smoking Cessation Asthma Carbon Monoxide.|adolescent smoking cessation asthma carbon monoxide.
4730211|NCT03047876|cardiac|cardiac
4730212|NCT03047876|aortic arch surgery|aortic arch surgery
4730213|NCT03047876|Brain vascular reactivity|brain vascular reactivity
4730214|NCT03047876|neonates|neonates
4730215|NCT03047876|infants|infants
4730216|NCT03047863|Epidermal Growth Factor|epidermal growth factor
4730217|NCT03047850|Sternotomy|sternotomy
4730218|NCT03047837|Colorectal cancer|colorectal cancer
4730219|NCT03047837|aspirin|aspirin
4730220|NCT03047837|metformin|metformin
4730221|NCT03047837|chemoprevention|chemoprevention
4730222|NCT03047798|centella asiatica|centella asiatica
4730223|NCT03047798|bamboo salt|bamboo salt
4730224|NCT03047798|magnolia bark|magnolia bark
4730225|NCT03047798|gingivitis|gingivitis
4730226|NCT03047798|dental plaque|dental plaque
4730227|NCT03047798|mouthrinse|mouthrinse
4730228|NCT03047785|Myocardial Infarction|myocardial infarction
4730229|NCT03047785|Highly sensitive troponin|highly sensitive troponin
4730230|NCT03047785|Hospital population|hospital population
4730231|NCT03047785|99th percentile|99th percentile
4730232|NCT03047785|Upper limit of normal|upper limit of normal
4730233|NCT03047733|Vitiligo|vitiligo
4730234|NCT03047733|308 nm excimer laser|308 nm excimer laser
4730235|NCT03047720|bedwetting|bedwetting
4730236|NCT03047707|ultrasound elastography|ultrasound elastography
4730237|NCT03047707|S-Shearwave|s-shearwave
4730238|NCT03047707|liver|liver
4730239|NCT03047707|fibrosis|fibrosis
4730240|NCT03047694|Lexico-semantic stimulation|lexico-semantic stimulation
4730241|NCT03047694|tactile tablet|tactile tablet
4730242|NCT03047681|TAVR|tavr
4730243|NCT03047681|tryptse|tryptse
4730244|NCT03047681|mast|mast
4730245|NCT03047642|biomarker|biomarker
4730246|NCT03047642|low and middle income countries|low and middle income countries
4730247|NCT03047642|fever|fever
4730248|NCT03047642|antimicrobial resistance|antimicrobial resistance
4730249|NCT03047642|diagnostic|diagnostic
4730250|NCT03047629|non-motor symptoms|non-motor symptoms
4730251|NCT03047603|Hepatocellular carcinoma|hepatocellular carcinoma
4730252|NCT03047603|Protein induced by vitamin K absence or antagonist-II|protein induced by vitamin k absence or antagonist-ii
4730253|NCT03047603|Differential diagnosis|differential diagnosis
4730254|NCT03047603|Des-γ-carboxy prothrombin|des-γ-carboxy prothrombin
4730255|NCT03047603|Alpha-fetoprotein|alpha-fetoprotein
4730256|NCT03047603|Lens culinaris agglutinin-reactive fraction of alpha-fetoprotein-fetoprotein|lens culinaris agglutinin-reactive fraction of alpha-fetoprotein-fetoprotein
4730257|NCT03047590|exercise behavior|exercise behavior
4730258|NCT03047590|exercise prescription|exercise prescription
4730259|NCT03047590|affect-based exercise|affect-based exercise
4730260|NCT03047590|affect-guided exercise|affect-guided exercise
4730261|NCT03047590|self-paced exercise|self-paced exercise
4730262|NCT03047590|self-selected exercise|self-selected exercise
4730263|NCT03047577|Brief intervention|brief intervention
4730264|NCT03047577|Alcohol|alcohol
4730265|NCT03047577|Alcohol use disorder|alcohol use disorder
4730266|NCT03047577|Intensive care unit|intensive care unit
4730267|NCT03047577|Critically ill|critically ill
4730268|NCT03047577|Audit|audit
4730269|NCT03047564|Total Knee Arthroplasty|total knee arthroplasty
4730270|NCT03047564|Total Knee Replacement|total knee replacement
4730271|NCT03047564|Outcome|outcome
4730272|NCT03047564|Metal ion concentration|metal ion concentration
4730273|NCT03047564|Results|results
4730274|NCT03047551|Abortion, induced|abortion, induced
4730275|NCT03047551|Ultrasonography|ultrasonography
4730276|NCT03047551|Health Services accessibility|health services accessibility
4730277|NCT03047551|Pragmatic Clinical Trial|pragmatic clinical trial
4730278|NCT03047551|Randomized controlled trial as topic|randomized controlled trial as topic
4730279|NCT03047538|Arterial hypertension|arterial hypertension
4730280|NCT03047538|Dyslipidemia|dyslipidemia
4730281|NCT03047538|Blood pressure control|blood pressure control
4730282|NCT03047538|Fixed combination|fixed combination
4730283|NCT03047525|cytokine-induced killer cell|cytokine-induced killer cell
4730284|NCT03047525|dendritic and cytokine-induced killer cells|dendritic and cytokine-induced killer cells
4730285|NCT03047512|Depression in adolescents|depression in adolescents
4730286|NCT03047512|Mental Health|mental health
4730287|NCT03047512|E-mental health|e-mental health
4730288|NCT03047512|Prevention and Early intervention|prevention and early intervention
4730289|NCT03047486|insulin pump|insulin pump
4730290|NCT03047486|continuous glucose monitoring sensor|continuous glucose monitoring sensor
4730291|NCT03047486|predictive low glucose suspend|predictive low glucose suspend
4730292|NCT03047473|newly diagnosed|newly diagnosed
4730293|NCT03047460|motor evoked potential|motor evoked potential
4730294|NCT03047460|somatosensory evoked potentials|somatosensory evoked potentials
4730295|NCT03047460|biomarker|biomarker
4730296|NCT03047408|REM Sleep Behavior Disorder|rem sleep behavior disorder
4730297|NCT03047408|Parkinson's Disease|parkinson's disease
4730298|NCT03047408|REM sleep without Atonia|rem sleep without atonia
4730299|NCT03047395|ABBV-066|abbv-066
4730300|NCT03047395|BI 655066|bi 655066
4730301|NCT03047369|leukodystrophy|leukodystrophy
4730302|NCT03047369|white matter disease|white matter disease
4730303|NCT03047369|leukoencephalopathy|leukoencephalopathy
4730304|NCT03047369|myelin|myelin
4730305|NCT03047369|demyelinating|demyelinating
4730306|NCT03047369|mdbp|mdbp
4730307|NCT03047343|pulmonary artery strapping|pulmonary artery strapping
4730308|NCT03047330|menopause|menopause
4730309|NCT03047330|sleep fragmentation|sleep fragmentation
4730310|NCT03047330|leuprolide|leuprolide
4730311|NCT03047330|adipokine|adipokine
4730312|NCT03047330|weight gain|weight gain
4730313|NCT03047330|leptin|leptin
4730314|NCT03047317|pharmacokinetics|pharmacokinetics
4730315|NCT03047291|mucositis, periimplantitis, probiotic|mucositis, periimplantitis, probiotic
4730316|NCT03047226|Lynch Syndrome|lynch syndrome
4730317|NCT03047226|mismatch repair|mismatch repair
4730318|NCT03047226|microsatellite instability|microsatellite instability
4730319|NCT03047226|next-generation sequencing|next-generation sequencing
4730320|NCT03047226|immunohistochemistry|immunohistochemistry
4730321|NCT03047200|Diabetes Mellitus|diabetes mellitus
4730322|NCT03047200|Hypoglycemia|hypoglycemia
4730323|NCT03047200|Hyperglycemia|hyperglycemia
4730324|NCT03047200|Type 1 Diabetes|type 1 diabetes
4730325|NCT03047200|Islet Cell Transplantation|islet cell transplantation
4730326|NCT03047174|Head and Neck Neoplasms, Radio(chemo)therapy|head and neck neoplasms, radio(chemo)therapy
4730327|NCT03047161|magnetocardiography|magnetocardiography
4730328|NCT03047135|high-risk biochemically-recurrent|high-risk biochemically-recurrent
4730329|NCT03047122|Breast|breast
4730330|NCT03047122|ultrasonography|ultrasonography
4730331|NCT03047109|Ephedrine|ephedrine
4730332|NCT03047109|Phenylephrine|phenylephrine
4730333|NCT03047109|Spinal Hypotension|spinal hypotension
4730334|NCT03047109|Cesarean Section|cesarean section
4730335|NCT03047109|Maternal Cardiodynamics|maternal cardiodynamics
4730336|NCT03047083|Retrospective|retrospective
4730337|NCT03047083|Non-interventional Study|non-interventional study
4730338|NCT03047083|FMS-like tyrosine kinase-3 (FLT3) mutations|fms-like tyrosine kinase-3 (flt3) mutations
4730339|NCT03047044|lumbar fusion surgery|lumbar fusion surgery
4730340|NCT03047044|Patient Controlled Analgesia|patient controlled analgesia
4730341|NCT03047044|Optimizing Basal Infusion Mode|optimizing basal infusion mode
4730342|NCT03047018|Nutrition|nutrition
4730343|NCT03046992|EGFR|egfr
4730344|NCT03046992|Non-Small Cell Lung Cancer|non-small cell lung cancer
4730345|NCT03046992|T790M|t790m
4730346|NCT03046992|Brain Metastasis|brain metastasis
4730347|NCT03046979|apatinib|apatinib
4730348|NCT03046979|advanced hepatocellular carcinoma|advanced hepatocellular carcinoma
4730349|NCT03046953|Lymphoma|lymphoma
4730350|NCT03046927|Type 1 diabetes|type 1 diabetes
4730351|NCT03046927|vitamin D|vitamin d
4730352|NCT03046927|honeymoon phase|honeymoon phase
4730353|NCT03046901|Vancomycin|vancomycin
4730354|NCT03046901|Primary Sclerosing cholangitis|primary sclerosing cholangitis
4730355|NCT03046901|Post-liver transplantation|post-liver transplantation
4730356|NCT03046849|Lynch Syndrome|lynch syndrome
4730357|NCT03046849|next-generation sequencing|next-generation sequencing
4730358|NCT03046849|germline mutation|germline mutation
4730359|NCT03046836|Couples|couples
4730360|NCT03046836|Oxytocin|oxytocin
4730361|NCT03046836|Aggression|aggression
4730362|NCT03046836|Alcohol|alcohol
4730363|NCT03046771|falls|falls
4730364|NCT03046771|readmissions|readmissions
4730365|NCT03046771|emergency department visits|emergency department visits
4730366|NCT03046771|transitions of care|transitions of care
4730367|NCT03046745|Gastric cancer, endoscopy, pepsinogen, TFF3, biomarker|gastric cancer, endoscopy, pepsinogen, tff3, biomarker
4730368|NCT03046732|Kidney Transplant Education|kidney transplant education
4730369|NCT03046732|Transplant Readiness|transplant readiness
4730370|NCT03046732|Living Donor Kidney Transplant|living donor kidney transplant
4730371|NCT03046732|Chronic Kidney Disease|chronic kidney disease
4730372|NCT03046732|End Stage Kidney Disease|end stage kidney disease
4730373|NCT03046732|Renal Replacement Therapy|renal replacement therapy
4730374|NCT03046719|bupivacaine|bupivacaine
4730375|NCT03046719|intravitreal|intravitreal
4730376|NCT03046719|analgesia|analgesia
4730377|NCT03046719|silicone oil removal|silicone oil removal
4730378|NCT03046719|retinal detachment|retinal detachment
4730379|NCT03046719|subconjunctival|subconjunctival
4730380|NCT03046706|voice rest|voice rest
4730381|NCT03046706|laryngeal surgery|laryngeal surgery
4730382|NCT03046706|glottic polyp|glottic polyp
4730383|NCT03046706|glottic cyst|glottic cyst
4730384|NCT03046693|Non-arteritic anterior ischemic optic neuropathy|non-arteritic anterior ischemic optic neuropathy
4730385|NCT03046693|pattern electroretinography|pattern electroretinography
4730386|NCT03046693|citicoline|citicoline
4730387|NCT03046693|retinal ganglion cell|retinal ganglion cell
4730388|NCT03046693|visual field|visual field
4730389|NCT03046667|Beta glucans|beta glucans
4730390|NCT03046667|Barley|barley
4730391|NCT03046667|SCFA|scfa
4730392|NCT03046667|Calprotectin|calprotectin
4730393|NCT03046667|Microbiota|microbiota
4730394|NCT03046667|Hydrogene|hydrogene
4730395|NCT03046667|Methane|methane
4730396|NCT03046667|Metabolomics|metabolomics
4730397|NCT03046667|Stool volume|stool volume
4730398|NCT03046667|Stool frequency|stool frequency
4730399|NCT03046641|Caloric Restriction|caloric restriction
4730400|NCT03046641|Dietary Formulations|dietary formulations
4730401|NCT03046641|Exercise|exercise
4730403|NCT03046615|EEG electrodes|eeg electrodes
4730404|NCT03046563|acupressure|acupressure
4730405|NCT03046563|abdominal massage|abdominal massage
4730406|NCT03046563|constipation|constipation
4730407|NCT03046563|stroke patients|stroke patients
4730408|NCT03046563|Traditional Chinese medicine|traditional chinese medicine
4730409|NCT03046524|Parathyroid Carcinoma|parathyroid carcinoma
4730410|NCT03046524|Parathyroid Neoplasm|parathyroid neoplasm
4730411|NCT03046524|Chart Review|chart review
4730412|NCT03046485|AMD|amd
4730413|NCT03046485|vision loss|vision loss
4730414|NCT03046485|self-management strategies|self-management strategies
4730415|NCT03046485|low-vision rehabilitation|low-vision rehabilitation
4730416|NCT03046485|IVI|ivi
4730417|NCT03046472|thorax curve angle|thorax curve angle
4730418|NCT03046459|cytokines|cytokines
4730419|NCT03046459|interleukin-2|interleukin-2
4730420|NCT03046459|Safety Issues|safety issues
4730421|NCT03046446|Osteoarthritis|osteoarthritis
4730422|NCT03046446|Knee|knee
4730423|NCT03046446|Pain|pain
4730424|NCT03046446|Steroid|steroid
4730425|NCT03046446|Intra-articular|intra-articular
4730426|NCT03046446|Injection|injection
4730427|NCT03046433|children|children
4730428|NCT03046433|asthma|asthma
4730429|NCT03046433|China|china
4730430|NCT03046394|prosthetic feet|prosthetic feet
4730431|NCT03046394|gait pattern|gait pattern
4730432|NCT03046394|one leg standing|one leg standing
4730433|NCT03046394|walking speed|walking speed
4730434|NCT03046342|Gastroenteritis, Polymerase chain reaction|gastroenteritis, polymerase chain reaction
4730435|NCT03046329|patient care planning|patient care planning
4730436|NCT03046316|Therapeutics|therapeutics
4730437|NCT03046303|ERAS,gastric cancer|eras,gastric cancer
4730438|NCT03046264|central blood pressure|central blood pressure
4730439|NCT03046264|measurement|measurement
4730440|NCT03046264|oscillometric radial pulse wave analysis|oscillometric radial pulse wave analysis
4730441|NCT03046186|Gastric sleeve|gastric sleeve
4730442|NCT03046186|Gastric bypass|gastric bypass
4730443|NCT03046160|PPT|ppt
4730444|NCT03046160|Scapula|scapula
4730445|NCT03046160|Intervention|intervention
4730446|NCT03046160|Manual therapy|manual therapy
4730447|NCT03046160|mobilization|mobilization
4730448|NCT03046121|dementia|dementia
4730449|NCT03046121|acute care|acute care
4730450|NCT03046121|post-acute recovery|post-acute recovery
4730451|NCT03046121|family caregivers|family caregivers
4730452|NCT03046095|Muscle Hypertrophy|muscle hypertrophy
4730453|NCT03046095|Muscle Atrophy|muscle atrophy
4730454|NCT03046095|Resistance Training|resistance training
4730455|NCT03046095|Immobilization|immobilization
4730554|NCT03045393|FRa|fra
4730456|NCT03046069|Triple therapy|triple therapy
4730457|NCT03046069|COPD|copd
4730458|NCT03046069|DCE|dce
4730459|NCT03046069|Qualitative|qualitative
4730460|NCT03046004|breast cancer|breast cancer
4730461|NCT03046004|screening|screening
4730462|NCT03046004|decision aid|decision aid
4730463|NCT03046004|informed choice|informed choice
4730464|NCT03046004|decisional conflict|decisional conflict
4730465|NCT03045965|Salpingectomy|salpingectomy
4730466|NCT03045965|Hysterectomy|hysterectomy
4730467|NCT03045965|Ovarian cancer|ovarian cancer
4730468|NCT03045952|Multicenter study|multicenter study
4730469|NCT03045952|microwave|microwave
4730470|NCT03045939|cervical ripening|cervical ripening
4730471|NCT03045939|labor induction|labor induction
4730472|NCT03045939|double balloon device|double balloon device
4730473|NCT03045939|cervical ripening device|cervical ripening device
4730474|NCT03045939|unfavorable cervix|unfavorable cervix
4730475|NCT03045913|Observational registry|observational registry
4730476|NCT03045913|All-comers open label registry|all-comers open label registry
4730477|NCT03045913|Genoss DES|genoss des
4730478|NCT03045913|Multicenter|multicenter
4730479|NCT03045913|Stenting|stenting
4730480|NCT03045913|Coronary Artery Disease|coronary artery disease
4730481|NCT03045913|Coronary revascularization|coronary revascularization
4730482|NCT03045913|Percutaneous Coronary Intervention|percutaneous coronary intervention
4730483|NCT03045887|repeat dose|repeat dose
4730484|NCT03045887|GSK2292767|gsk2292767
4730485|NCT03045887|smoke|smoke
4730486|NCT03045887|tolerability|tolerability
4730487|NCT03045887|safety|safety
4730488|NCT03045887|dry powder inhalation|dry powder inhalation
4730489|NCT03045887|pharmacokinetics|pharmacokinetics
4730490|NCT03045887|single dose|single dose
4730491|NCT03045848|Observational registry|observational registry
4730492|NCT03045848|All-comers open label registry|all-comers open label registry
4730493|NCT03045848|Drug coated stent|drug coated stent
4730494|NCT03045848|Multicenter|multicenter
4730495|NCT03045848|Stenting|stenting
4730497|NCT03045848|Coronary revascularization|coronary revascularization
4730498|NCT03045848|Percutaneous Coronary Intervention|percutaneous coronary intervention
4730499|NCT03045835|laparoscopic cholecystectomy BASKA mask Endotracheal tube|laparoscopic cholecystectomy baska mask endotracheal tube
4730500|NCT03045822|Bioimpedance analysis|bioimpedance analysis
4730501|NCT03045822|implantable cardioverter-defibrillators|implantable cardioverter-defibrillators
4730502|NCT03045822|pacemakers|pacemakers
4730503|NCT03045809|Syndromic management|syndromic management
4730504|NCT03045809|Point of care testing|point of care testing
4730505|NCT03045783|gastric varices|gastric varices
4730506|NCT03045783|endoscopic injection of tissue adhesive|endoscopic injection of tissue adhesive
4730507|NCT03045731|kidney transplantation|kidney transplantation
4730508|NCT03045731|ultrasound|ultrasound
4730509|NCT03045731|mathematical model|mathematical model
4730510|NCT03045718|Horticultural Therapy|horticultural therapy
4730511|NCT03045718|Dementia|dementia
4730512|NCT03045718|Randomized Controlled Trial|randomized controlled trial
4730513|NCT03045718|Elderly|elderly
4730514|NCT03045718|Prevention|prevention
4730515|NCT03045692|drug dosing, eGFR, CCr|drug dosing, egfr, ccr
4730516|NCT03045679|Roux-en Y gastric bypass|roux-en y gastric bypass
4730517|NCT03045679|One-anastomosis gastric bypass|one-anastomosis gastric bypass
4730518|NCT03045679|Mini-gastric bypass|mini-gastric bypass
4730519|NCT03045679|metabolic surgery|metabolic surgery
4730520|NCT03045653|Breast Cancer|breast cancer
4730521|NCT03045653|high dose Tamoxifen|high dose tamoxifen
4730522|NCT03045653|endocrine therapy|endocrine therapy
4730523|NCT03045653|Hormone Receptor Positive Malignant Neoplasm of Breast|hormone receptor positive malignant neoplasm of breast
4730524|NCT03045653|Tamoxifen|tamoxifen
4730525|NCT03045653|Breast Cancer Metastatic|breast cancer metastatic
4730526|NCT03045640|ECD|ecd
4730527|NCT03045640|parenting program|parenting program
4730528|NCT03045640|home visiting|home visiting
4730529|NCT03045627|Acute Myeloid Leukemia|acute myeloid leukemia
4730530|NCT03045627|PEG-G-CSF|peg-g-csf
4730531|NCT03045601|Diagnostic Techniques, Cardiovascular|diagnostic techniques, cardiovascular
4730532|NCT03045601|Coronary Angiography|coronary angiography
4730533|NCT03045601|Fractional Flow Reserve, Myocardial|fractional flow reserve, myocardial
4730534|NCT03045601|Echocardiography, Stress|echocardiography, stress
4730535|NCT03045510|Decitabine Myelodysplastic syndrome|decitabine myelodysplastic syndrome
4730536|NCT03045484|nasopharyngeal carcinoma|nasopharyngeal carcinoma
4730537|NCT03045484|Oral Mucositis Pain|oral mucositis pain
4730538|NCT03045484|Oxycodone|oxycodone
4730539|NCT03045458|one stage dental implant|one stage dental implant
4730540|NCT03045458|two stage dental implant|two stage dental implant
4730541|NCT03045458|Interleukin-1β|interleukin-1β
4730542|NCT03045445|CT|ct
4730543|NCT03045445|dual energy|dual energy
4730544|NCT03045445|low dose|low dose
4730545|NCT03045432|Stroke|stroke
4730546|NCT03045432|Hemiplegia|hemiplegia
4730547|NCT03045432|Rotator Cuff Injury|rotator cuff injury
4730548|NCT03045419|MRI|mri
4730549|NCT03045419|gadoxetic acid|gadoxetic acid
4730550|NCT03045419|CT|ct
4730551|NCT03045393|Neoadjuvant|neoadjuvant
4730552|NCT03045393|Breast Cancer|breast cancer
4730553|NCT03045393|Folate Receptor Alpha|folate receptor alpha
4730555|NCT03045393|TNBC|tnbc
4730556|NCT03045393|Triple Negative Breast Cancer|triple negative breast cancer
4730557|NCT03045393|Preoperative|preoperative
4730558|NCT03045393|Presurgery|presurgery
4730559|NCT03045393|Mirvetuximab Soravtansine|mirvetuximab soravtansine
4730560|NCT03045393|IMGN853|imgn853
4730561|NCT03045367|Metamorphopsia|metamorphopsia
4730562|NCT03045367|Epiretinal membrane|epiretinal membrane
4730563|NCT03045367|Vitrectomy|vitrectomy
4730564|NCT03045354|children|children
4730565|NCT03045354|dietary carbohydrates|dietary carbohydrates
4730566|NCT03045354|satiety|satiety
4730567|NCT03045354|appetite|appetite
4730568|NCT03045354|blood glucose|blood glucose
4730569|NCT03045354|solanum tuberosum|solanum tuberosum
4730570|NCT03045354|obesity|obesity
4730571|NCT03045354|breakfast|breakfast
4730572|NCT03045276|Spina Bifida|spina bifida
4730573|NCT03045276|Kidney Transplant|kidney transplant
4730574|NCT03045263|ASD|asd
4730575|NCT03045237|Pregnancy|pregnancy
4730576|NCT03045237|Physical activity|physical activity
4730577|NCT03045237|Newborn|newborn
4730578|NCT03045237|Depressive Symptoms|depressive symptoms
4730579|NCT03045237|Dietary habits|dietary habits
4730580|NCT03045237|Healthy lifestyles|healthy lifestyles
4730581|NCT03045224|PAD, PTA, mortality, morbidity, amputation rate, quality of life|pad, pta, mortality, morbidity, amputation rate, quality of life
4730582|NCT03045224|Percutaneous transluminal angioplasty (PTA), Stenting, balloon angioplasty|percutaneous transluminal angioplasty (pta), stenting, balloon angioplasty
4730583|NCT03045198|cystic fibrosis|cystic fibrosis
4730584|NCT03045185|Non Vital teeth|non vital teeth
4730585|NCT03045185|Traumatised teeth|traumatised teeth
4730586|NCT03045185|Immature teeth|immature teeth
4730587|NCT03045185|Regenerative Endodontics|regenerative endodontics
4730588|NCT03045172|Lichen Sclerosus|lichen sclerosus
4730589|NCT03045172|Platelet Rich Plasma|platelet rich plasma
4730590|NCT03045172|Vulvar|vulvar
4730591|NCT03045172|Vulva|vulva
4730592|NCT03045159|deployment cycle|deployment cycle
4730593|NCT03045159|military family|military family
4730594|NCT03045159|prevention|prevention
4730595|NCT03045159|stress|stress
4730596|NCT03045159|military child|military child
4730597|NCT03045159|parenting|parenting
4730598|NCT03045159|coparenting|coparenting
4730599|NCT03045146|Acute Ischemic Stroke, Thrombectomy|acute ischemic stroke, thrombectomy
4730600|NCT03045133|Postoperative pain|postoperative pain
4730601|NCT03045133|Postoperative nausea and vomiting|postoperative nausea and vomiting
4730602|NCT03045133|Quality of recovery|quality of recovery
4730603|NCT03045133|QoR-40|qor-40
4730604|NCT03045133|Total intravenous anesthesia|total intravenous anesthesia
4730605|NCT03045107|right colon|right colon
4730606|NCT03045107|laparoscopic right colectomy|laparoscopic right colectomy
4730607|NCT03045107|intracorporeal anastomosis|intracorporeal anastomosis
4730608|NCT03045107|extracorporeal anastomosis|extracorporeal anastomosis
4730609|NCT03045107|hospital stay|hospital stay
4730610|NCT03045107|quality of life|quality of life
4730611|NCT03045107|costs|costs
4730612|NCT03045094|pediatric|pediatric
4730613|NCT03045094|intubation|intubation
4730614|NCT03045094|neck movement|neck movement
4730615|NCT03045055|Acute ischemic stroke|acute ischemic stroke
4730616|NCT03045055|Endovascular treatment|endovascular treatment
4730617|NCT03045055|Remote ischemic conditioning|remote ischemic conditioning
4730618|NCT03045042|Pompe|pompe
4730619|NCT03045042|microRNA|microrna
4730620|NCT03045042|biomarker|biomarker
4730621|NCT03045042|muscle MRI|muscle mri
4730622|NCT03045042|glycogenosis|glycogenosis
4730623|NCT03045029|PAH|pah
4730624|NCT03045029|Oral Treprostiinil|oral treprostiinil
4730625|NCT03045029|Orenitram|orenitram
4730626|NCT03045016|Acute stress Disorder|acute stress disorder
4730627|NCT03045016|Post Traumatic Stress Disorder|post traumatic stress disorder
4730628|NCT03045016|Prevention|prevention
4730629|NCT03045016|trauma|trauma
4730630|NCT03045016|prazosin|prazosin
4730631|NCT03045003|Resilience, Supportive Care, Psychosocial Care, Nursing|resilience, supportive care, psychosocial care, nursing
4730632|NCT03044990|Acute coronary syndrome|acute coronary syndrome
4730633|NCT03044990|renal insufficiency|renal insufficiency
4730634|NCT03044990|mortality|mortality
4730635|NCT03044977|3-Iodobenzylguanidine|3-iodobenzylguanidine
4730636|NCT03044977|dose-response relationship, radiation|dose-response relationship, radiation
4730637|NCT03044977|theranostic|theranostic
4730638|NCT03044977|radionuclide|radionuclide
4730639|NCT03044977|MIBG|mibg
4730640|NCT03044977|DOTA|dota
4730641|NCT03044964|Angina, Chest Pain|angina, chest pain
4730642|NCT03044951|atrial fibrillation|atrial fibrillation
4730643|NCT03044951|cryoablation|cryoablation
4730644|NCT03044951|irrigated radiofrequency ablation|irrigated radiofrequency ablation
4730645|NCT03044951|pulmonary vein isolation|pulmonary vein isolation
4730646|NCT03044938|Asthma|asthma
4730647|NCT03044938|Salbutamol|salbutamol
4730648|NCT03044938|Exercise|exercise
4730649|NCT03044938|Heart Rate|heart rate
4730650|NCT03044938|Blood pressure|blood pressure
4730651|NCT03044925|persistent atrial fibrillation|persistent atrial fibrillation
4730652|NCT03044925|remote magnetic navigation|remote magnetic navigation
4730653|NCT03044925|cryoablation|cryoablation
4730654|NCT03044899|Surgery|surgery
4730655|NCT03044899|Complications|complications
4730656|NCT03044899|Mortality|mortality
4730657|NCT03044886|Vitamin D|vitamin d
4730658|NCT03044821|Neural Tube Defect|neural tube defect
4730659|NCT03044795|homologous recombination deficiency|homologous recombination deficiency
4730660|NCT03044795|veliparib|veliparib
4730661|NCT03044795|PARP inhibitor|parp inhibitor
4730662|NCT03044795|biomarker|biomarker
4730663|NCT03044769|Congenital Lung Anomalies|congenital lung anomalies
4730664|NCT03044756|GnRH antagonist|gnrh antagonist
4730665|NCT03044756|Pituitary downregulation|pituitary downregulation
4730666|NCT03044756|IVF|ivf
4730667|NCT03044756|ICSI|icsi
4730668|NCT03044743|PD-1|pd-1
4730669|NCT03044743|CRISPR Cas9|crispr cas9
4730670|NCT03044743|EBV|ebv
4730671|NCT03044743|advanced stage malignancies|advanced stage malignancies
4730672|NCT03044717|Nutrition Education|nutrition education
4730673|NCT03044717|Cardiology Fellows|cardiology fellows
4730674|NCT03044652|Vulvovaginal Dryness|vulvovaginal dryness
4730675|NCT03044626|Nivolumab|nivolumab
4730676|NCT03044626|Radiotherapy|radiotherapy
4730677|NCT03044600|Parathyroid disease|parathyroid disease
4730678|NCT03044600|Hyperparathyroidism|hyperparathyroidism
4730679|NCT03044600|Chart review|chart review
4730680|NCT03044600|MEN1-negative|men1-negative
4730681|NCT03044600|HRPT2 mutations|hrpt2 mutations
4730682|NCT03044587|Biliary Tract Cancer|biliary tract cancer
4730683|NCT03044587|NaI-IRI|nai-iri
4730684|NCT03044574|venous thromboembolism|venous thromboembolism
4730685|NCT03044574|deep vein thrombosis|deep vein thrombosis
4730686|NCT03044574|pulmonary embolism|pulmonary embolism
4730687|NCT03044574|prevention|prevention
4730688|NCT03044574|intermittent pneumatic compression|intermittent pneumatic compression
4730689|NCT03044574|sequential pneumatic compression|sequential pneumatic compression
4730690|NCT03044574|surgery|surgery
4730691|NCT03044574|elastic compression|elastic compression
4730692|NCT03044574|low-molecular weight heparin|low-molecular weight heparin
4730693|NCT03044574|prophylaxis|prophylaxis
4730694|NCT03044535|quality of life|quality of life
4730695|NCT03044535|mechanical circulatory support|mechanical circulatory support
4730696|NCT03044509|Immunodiagnostics tests|immunodiagnostics tests
4730697|NCT03044509|TB exposure|tb exposure
4730698|NCT03044509|Latent TB|latent tb
4730699|NCT03044509|TB disease|tb disease
4730700|NCT03044509|Biomarkers|biomarkers
4730701|NCT03044496|NIR Spectroscopy|nir spectroscopy
4730702|NCT03044496|Nerve Blockade|nerve blockade
4730703|NCT03044496|Surgical Arteriovenous Shunt|surgical arteriovenous shunt
4730704|NCT03044483|Sepsis|sepsis
4730705|NCT03044483|Microcirculatory function|microcirculatory function
4730706|NCT03044444|performance|performance
4730707|NCT03044444|polyphenols|polyphenols
4730708|NCT03044444|nutrition|nutrition
4730709|NCT03044444|sports|sports
4730710|NCT03044431|Shortness of breath|shortness of breath
4730711|NCT03044431|Breathlessness|breathlessness
4730712|NCT03044431|Stem cells|stem cells
4730713|NCT03044431|Platelet rich plasma|platelet rich plasma
4730714|NCT03044431|Quality of life|quality of life
4730715|NCT03044431|Pulmonary Function|pulmonary function
4730716|NCT03044418|laser|laser
4730717|NCT03044418|endotracheal tube|endotracheal tube
4730718|NCT03044418|total intravenous anesthesia|total intravenous anesthesia
4730719|NCT03044418|side effect|side effect
4730720|NCT03044418|endolaryngeal surgery|endolaryngeal surgery
4730721|NCT03044405|fluid responsiveness|fluid responsiveness
4730722|NCT03044405|focused echocardiography|focused echocardiography
4730723|NCT03044405|major surgery|major surgery
4730724|NCT03044392|Programmed Intermittent Epidural Bolus|programmed intermittent epidural bolus
4730725|NCT03044392|Labour Analgesia|labour analgesia
4730726|NCT03044392|Pain|pain
4730727|NCT03044353|echocardiography (ECHO)|echocardiography (echo)
4730728|NCT03044353|skin biopsy|skin biopsy
4730729|NCT03044353|monoclonal anti-serum amyloid p component antibody (anti-SAP mAb)|monoclonal anti-serum amyloid p component antibody (anti-sap mab)
4730730|NCT03044353|Amyloidosis|amyloidosis
4730731|NCT03044353|cardiac magnetic resonance imaging (CMR)|cardiac magnetic resonance imaging (cmr)
4730732|NCT03044353|biomarkers|biomarkers
4730733|NCT03044353|cardiac functional measures|cardiac functional measures
4730734|NCT03044353|left ventricular mass|left ventricular mass
4730735|NCT03044314|pulmonary hypertension|pulmonary hypertension
4730736|NCT03044314|vasodilator challenge|vasodilator challenge
4730737|NCT03044314|echocardiography|echocardiography
4730738|NCT03044314|outcomes|outcomes
4730739|NCT03044314|iloprost|iloprost
4730740|NCT03044314|inhaled nitric oxide|inhaled nitric oxide
4730741|NCT03044249|Psychotic Disorders|psychotic disorders
4730742|NCT03044223|pseudomonas aeruginosa|pseudomonas aeruginosa
4730743|NCT03044223|critically ill patient|critically ill patient
4730744|NCT03044223|sepsis|sepsis
4730745|NCT03044223|monocyte|monocyte
4730746|NCT03044223|macrophage|macrophage
4730747|NCT03044223|cytokine|cytokine
4730748|NCT03044223|severity of disease|severity of disease
4730749|NCT03044210|Rest energetic cost measured by indirect calorimetry|rest energetic cost measured by indirect calorimetry
4730750|NCT03044210|Hormonal axis|hormonal axis
4730751|NCT03044210|Mitochondrial oxidative phosphorylation|mitochondrial oxidative phosphorylation
4730752|NCT03044210|Basal metabolism|basal metabolism
4730753|NCT03044197|prostate cancer|prostate cancer
4730754|NCT03044197|magnetic resonance imaging|magnetic resonance imaging
4730755|NCT03044197|transperineal biopsy|transperineal biopsy
4730756|NCT03044197|target lesion|target lesion
4730757|NCT03044197|fusion biopsy|fusion biopsy
4730758|NCT03044184|Tranexamic Acid|tranexamic acid
4730759|NCT03044184|Antifibrinolytic|antifibrinolytic
4730760|NCT03044158|tuberculosis|tuberculosis
4730761|NCT03044158|implementation science|implementation science
4730762|NCT03044158|point-of-care|point-of-care
4730763|NCT03044158|diagnostics|diagnostics
4730764|NCT03044158|GeneXpert|genexpert
4730765|NCT03044158|Uganda|uganda
4730766|NCT03044145|Cultural Competence|cultural competence
4730767|NCT03044145|Patient-Clinician communication|patient-clinician communication
4730768|NCT03044132|Diabetic Foot Ulcer|diabetic foot ulcer
4730769|NCT03044132|DFU|dfu
4730770|NCT03044132|Lower Extremity Wound|lower extremity wound
4730771|NCT03044132|Skin Substitute|skin substitute
4730772|NCT03044106|hamstrings|hamstrings
4730773|NCT03044106|flexibility|flexibility
4730774|NCT03044106|strength|strength
4730775|NCT03044106|pain pressure threshold|pain pressure threshold
4730776|NCT03044106|lllt|lllt
4730777|NCT03044106|photobiomodulation|photobiomodulation
4730778|NCT03044106|cranial reflex|cranial reflex
4730779|NCT03044106|cranial laser reflex technique|cranial laser reflex technique
4730780|NCT03044106|CLRT|clrt
4730781|NCT03044080|Walking Disorder|walking disorder
4730782|NCT03044080|Stroke|stroke
4730783|NCT03044080|Botulinum Toxin|botulinum toxin
4730784|NCT03044080|Spasticity|spasticity
4730785|NCT03044067|Chronic pain|chronic pain
4730786|NCT03044067|Fibromyalgia|fibromyalgia
4730787|NCT03044067|Pain neuroscience education|pain neuroscience education
4730788|NCT03044067|Exercise|exercise
4730789|NCT03044054|HIFU|hifu
4730790|NCT03044041|Blood loss|blood loss
4730791|NCT03044041|Tranexamic acid|tranexamic acid
4730792|NCT03044041|Total knee arthroplasty|total knee arthroplasty
4730793|NCT03044041|Topical administration|topical administration
4730794|NCT03043989|docetaxel|docetaxel
4730795|NCT03043989|cabazitaxel|cabazitaxel
4730796|NCT03043989|phase 1b|phase 1b
4730797|NCT03043989|castration-resistant|castration-resistant
4730798|NCT03043989|bone metastasis|bone metastasis
4730799|NCT03043976|Physical activity|physical activity
4730800|NCT03043976|Steps count|steps count
4730801|NCT03043950|mCRC|mcrc
4730802|NCT03043950|First line|first line
4730803|NCT03043950|Panitumumab|panitumumab
4730804|NCT03043950|mCCS Prognostic Score|mccs prognostic score
4730805|NCT03043950|Prognosis|prognosis
4730806|NCT03043950|Ras wild type|ras wild type
4730807|NCT03043924|hypothalamus|hypothalamus
4730808|NCT03043924|Diffusion Magnetic Resonance Imaging|diffusion magnetic resonance imaging
4730809|NCT03043924|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
4730810|NCT03043911|early detection|early detection
4730811|NCT03043911|respiratory events|respiratory events
4730812|NCT03043911|sepsis|sepsis
4730813|NCT03043872|Carcinoma, Small Cell Lung|carcinoma, small cell lung
4730814|NCT03043872|Oat Cell Carcinoma of Lung|oat cell carcinoma of lung
4730815|NCT03043872|Oat Cell Lung Cancer|oat cell lung cancer
4730816|NCT03043872|Small Cell Cancer Of The Lung|small cell cancer of the lung
4730817|NCT03043872|Small Cell Lung Cancer|small cell lung cancer
4730818|NCT03043846|Treat to Target approach|treat to target approach
4730819|NCT03043820|raloxifene|raloxifene
4730820|NCT03043820|selective estrogen receptor modulator (SERM)|selective estrogen receptor modulator (serm)
4730821|NCT03043820|schizophrenia|schizophrenia
4730822|NCT03043820|psychosis|psychosis
4730823|NCT03043820|cognition|cognition
4730824|NCT03043820|negative symptoms|negative symptoms
4730825|NCT03043807|prostatectomy|prostatectomy
4730826|NCT03043807|androgen deprivation|androgen deprivation
4730827|NCT03043807|chemotherapy|chemotherapy
4730828|NCT03043807|radiation|radiation
4730829|NCT03043794|early stage|early stage
4730830|NCT03043794|low risk|low risk
4730831|NCT03043768|Parkinson's disease|parkinson's disease
4730832|NCT03043768|Autonomic|autonomic
4730833|NCT03043768|Diagnosis|diagnosis
4730834|NCT03043768|Pilomotor|pilomotor
4730835|NCT03043768|Alpha-synuclein|alpha-synuclein
4730836|NCT03043768|Axon-reflex|axon-reflex
4730837|NCT03043768|Peripheral nerve fibers|peripheral nerve fibers
4730838|NCT03043729|neoadjuvant|neoadjuvant
4730839|NCT03043729|MRI-defined T3|mri-defined t3
4730840|NCT03043729|mFOLFOX6|mfolfox6
4730841|NCT03043729|Aflibercept|aflibercept
4730842|NCT03043690|menopause|menopause
4730843|NCT03043690|ammonium succinate|ammonium succinate
4730844|NCT03043664|GEP-NET|gep-net
4730845|NCT03043664|Pembrolizumab|pembrolizumab
4730846|NCT03043664|Lanreotide depot|lanreotide depot
4730847|NCT03043664|PD-1|pd-1
4730848|NCT03043651|Pulmonary Hypertension|pulmonary hypertension
4730849|NCT03043651|HFpEF|hfpef
4730850|NCT03043651|6-Minute Walk Test|6-minute walk test
4730851|NCT03043651|Oral Treprostinil|oral treprostinil
4730852|NCT03043638|multiple adjacent gingival recessions|multiple adjacent gingival recessions
4730853|NCT03043638|platelet rich plasma|platelet rich plasma
4730854|NCT03043638|acellular dermal matrix|acellular dermal matrix
4731250|NCT03041636|INCB018424|incb018424
4730855|NCT03043638|coronally advanced flap|coronally advanced flap
4730856|NCT03043638|gingival recession|gingival recession
4730857|NCT03043638|root coverage|root coverage
4730858|NCT03043638|clinical attachment level|clinical attachment level
4730859|NCT03043625|Neck pain|neck pain
4730860|NCT03043625|visceral manipulation|visceral manipulation
4730861|NCT03043625|functional dyspepsia|functional dyspepsia
4730862|NCT03043625|electromyography|electromyography
4730863|NCT03043625|pain|pain
4730864|NCT03043612|Ureteroscopy for urolithiasis|ureteroscopy for urolithiasis
4730865|NCT03043599|Thoracic|thoracic
4730866|NCT03043599|Radiotherapy|radiotherapy
4730867|NCT03043599|Platinum Based Chemotherapy|platinum based chemotherapy
4730868|NCT03043599|Immunotherapy|immunotherapy
4730869|NCT03043599|Ipilimumab|ipilimumab
4730870|NCT03043599|Nivolumab|nivolumab
4730997|NCT03042975|imaging|imaging
4730871|NCT03043599|Extensive-Stage Disease Small Cell Lung Cancer (ED-SCLC)|extensive-stage disease small cell lung cancer (ed-sclc)
4730872|NCT03043586|Acromegaly|acromegaly
4730873|NCT03043560|depression|depression
4730874|NCT03043560|anhedonia|anhedonia
4730875|NCT03043560|reward|reward
4730876|NCT03043547|nal-IRI|nal-iri
4730877|NCT03043547|5-Fluorouracil|5-fluorouracil
4730878|NCT03043508|Genetic mutation|genetic mutation
4730879|NCT03043508|MEN1|men1
4730880|NCT03043508|Pancreatic neuroendocrine tumor|pancreatic neuroendocrine tumor
4730881|NCT03043508|PNET|pnet
4730882|NCT03043508|Chart review|chart review
4730883|NCT03043508|Questionnaire|questionnaire
4730884|NCT03043508|Survey|survey
4730885|NCT03043495|dexamethasone|dexamethasone
4730886|NCT03043495|supraclavicular brachial plexus block|supraclavicular brachial plexus block
4730887|NCT03043495|ultrasound|ultrasound
4730888|NCT03043482|VS-105|vs-105
4730889|NCT03043482|Renal Insufficiency, Chronic|renal insufficiency, chronic
4730890|NCT03043482|Secondary hyperparathyroidism|secondary hyperparathyroidism
4730891|NCT03043469|dysfunctional breathing|dysfunctional breathing
4730892|NCT03043443|sleep|sleep
4730893|NCT03043443|Alcohol dependence|alcohol dependence
4730894|NCT03043443|Melatonin|melatonin
4730895|NCT03043417|Stigma|stigma
4730896|NCT03043417|Primary Health Care|primary health care
4730897|NCT03043417|Recovery|recovery
4730898|NCT03043391|Pediatric Malignant Glioma|pediatric malignant glioma
4730899|NCT03043391|PVSRIPO|pvsripo
4730900|NCT03043391|Pro00071228|pro00071228
4730901|NCT03043391|Eric Thompson|eric thompson
4730902|NCT03043391|Darell Bigner|darell bigner
4730903|NCT03043391|Oncolytic Poliovirus|oncolytic poliovirus
4730904|NCT03043391|David Ashley|david ashley
4730905|NCT03043378|Malignant Neoplasms of Independent (Primary) Multiple Sites|malignant neoplasms of independent (primary) multiple sites
4730906|NCT03043378|Non-malignant pain|non-malignant pain
4730907|NCT03043378|Supportive care|supportive care
4730908|NCT03043378|Questionnaires|questionnaires
4730909|NCT03043378|Surveys|surveys
4730910|NCT03043378|Chronic non-malignant pain|chronic non-malignant pain
4730911|NCT03043365|Fish Oils|fish oils
4730912|NCT03043365|Long Chain Monounsaturated Fatty Acids|long chain monounsaturated fatty acids
4730913|NCT03043365|Lipoproteins|lipoproteins
4730914|NCT03043365|Cardiovascular Disease|cardiovascular disease
4730915|NCT03043352|SAM|sam
4730916|NCT03043352|Malnutrition|malnutrition
4730917|NCT03043352|LHW|lhw
4730918|NCT03043352|CMAM|cmam
4730919|NCT03043339|Microbiota composition|microbiota composition
4730920|NCT03043339|Kidney transplant recipient|kidney transplant recipient
4730921|NCT03043339|Kidney transplant donor|kidney transplant donor
4730922|NCT03043339|Antibiotics|antibiotics
4730923|NCT03043339|Drug resistance|drug resistance
4730924|NCT03043339|Transplantation surgery|transplantation surgery
4730925|NCT03043326|Pre-exposure Prophylaxis|pre-exposure prophylaxis
4730926|NCT03043326|MSM and transgender women|msm and transgender women
4730927|NCT03043313|Tucatinib|tucatinib
4730928|NCT03043313|Trastuzumab|trastuzumab
4730929|NCT03043313|HER2|her2
4730930|NCT03043313|ERBB2|erbb2
4730931|NCT03043313|Colorectal cancer|colorectal cancer
4730932|NCT03043300|Travelers' diarrhea|travelers' diarrhea
4730933|NCT03043300|Intestinal microbiota|intestinal microbiota
4730934|NCT03043300|Antibiotic resistance|antibiotic resistance
4730935|NCT03043300|Antibiotics|antibiotics
4730936|NCT03043300|Gastrointestinal disorders|gastrointestinal disorders
4730937|NCT03043300|Infectious diseases|infectious diseases
4730938|NCT03043300|International Travel|international travel
4730939|NCT03043300|Travel Medicine|travel medicine
4730940|NCT03043300|Resistome|resistome
4730941|NCT03043300|Microbiome|microbiome
4730942|NCT03043261|CHF|chf
4730943|NCT03043248|TRK-700|trk-700
4730944|NCT03043248|PK|pk
4730945|NCT03043248|Digoxin|digoxin
4730946|NCT03043248|Midazolam|midazolam
4730947|NCT03043248|Drug-Drug interaction|drug-drug interaction
4730948|NCT03043248|P-glycoprotein|p-glycoprotein
4730949|NCT03043248|CYP3A4|cyp3a4
4730950|NCT03043248|MDR1|mdr1
4730951|NCT03043248|pharmacokinetics|pharmacokinetics
4730952|NCT03043248|multidrug resistance 1|multidrug resistance 1
4730953|NCT03043222|prostate artery embolization|prostate artery embolization
4730954|NCT03043222|Prostatic Urethral Lift, Urolift|prostatic urethral lift, urolift
4731548|NCT03039504|Succinates|succinates
4730955|NCT03043222|Minimally invasive|minimally invasive
4730956|NCT03043222|non-surgical|non-surgical
4730957|NCT03043222|maintenance of sexual function|maintenance of sexual function
4730958|NCT03043222|complications of TURP , surgery|complications of turp , surgery
4730959|NCT03043183|gastric cancer|gastric cancer
4730960|NCT03043183|Enhanced recovery after surgery|enhanced recovery after surgery
4730961|NCT03043170|Adults|adults
4730962|NCT03043170|Emergency Department|emergency department
4730963|NCT03043170|Haemodynamics|haemodynamics
4730964|NCT03043170|Resuscitation|resuscitation
4730965|NCT03043170|Shock|shock
4730966|NCT03043170|Uscom|uscom
4730967|NCT03043131|Cardiopulmonary bypass prime|cardiopulmonary bypass prime
4730968|NCT03043131|Plasma Lyte - A|plasma lyte - a
4730969|NCT03043131|Ringer;s lactate|ringer;s lactate
4730970|NCT03043131|Acidosis|acidosis
4730971|NCT03043118|Eating Behaviors|eating behaviors
4730972|NCT03043118|Preschool|preschool
4730973|NCT03043118|Vegetable Intake|vegetable intake
4730974|NCT03043105|Multicentric Castleman's Disease|multicentric castleman's disease
4730975|NCT03043105|Thalidomide, cyclophosphamide and prednisone (TCP regimen)|thalidomide, cyclophosphamide and prednisone (tcp regimen)
4730976|NCT03043105|Efficacy|efficacy
4730977|NCT03043105|Safety|safety
4730978|NCT03043092|ultrasound, transcranial Doppler, arterial diseases|ultrasound, transcranial doppler, arterial diseases
4730979|NCT03043066|Chronic Periodontitis|chronic periodontitis
4730980|NCT03043066|TRAP-5b|trap-5b
4730981|NCT03043066|Non-surgical periodontal therapy|non-surgical periodontal therapy
4730982|NCT03043066|Systemic antibiotics|systemic antibiotics
4730983|NCT03043053|weight loss|weight loss
4730984|NCT03043053|body mass index|body mass index
4730985|NCT03043053|oxytocin|oxytocin
4730986|NCT03043053|magnetic resonance imaging|magnetic resonance imaging
4730987|NCT03043040|suicide, attempted|suicide, attempted
4730988|NCT03043040|prevention|prevention
4730989|NCT03043040|telemedicine|telemedicine
4730990|NCT03042988|supine hypertension|supine hypertension
4730991|NCT03042988|autonomic failure|autonomic failure
4730992|NCT03042988|heat stress|heat stress
4730993|NCT03042988|orthostatic hypotension|orthostatic hypotension
4730994|NCT03042975|spasmodic dysphonia|spasmodic dysphonia
4730995|NCT03042975|dystonia|dystonia
4730996|NCT03042975|laryngeal dystonia|laryngeal dystonia
4730998|NCT03042975|genetics|genetics
4730999|NCT03042962|dystonia|dystonia
4731000|NCT03042962|imaging|imaging
4731001|NCT03042962|genetics|genetics
4731002|NCT03042962|neuropathology|neuropathology
4731003|NCT03042936|Children|children
4731004|NCT03042936|Teens|teens
4731005|NCT03042936|Adolescents|adolescents
4731006|NCT03042936|Type 2 diabetes|type 2 diabetes
4731007|NCT03042936|Impaired glucose tolerance|impaired glucose tolerance
4731008|NCT03042936|Exercise|exercise
4731009|NCT03042936|Nutrition|nutrition
4731010|NCT03042936|Education|education
4731011|NCT03042923|Intestinal permeability|intestinal permeability
4731012|NCT03042884|Benign Neoplasms|benign neoplasms
4731013|NCT03042884|In Situ Neoplasms|in situ neoplasms
4731014|NCT03042884|Malignant Neoplasms of Independent (Primary) Multiple Sites|malignant neoplasms of independent (primary) multiple sites
4731015|NCT03042884|Wearable exercise trackers|wearable exercise trackers
4731016|NCT03042884|Questionnaires|questionnaires
4731017|NCT03042884|Surveys|surveys
4731018|NCT03042871|PM-CNV ,Ranibizumab, Dosing Strategy|pm-cnv ,ranibizumab, dosing strategy
4731019|NCT03042858|PPV|ppv
4731020|NCT03042858|patent processus vaginalis|patent processus vaginalis
4731021|NCT03042858|inguinal hernia|inguinal hernia
4731022|NCT03042832|Leadership|leadership
4731023|NCT03042832|Organizational Climate|organizational climate
4731024|NCT03042832|Implementation|implementation
4731025|NCT03042832|Implementation Climate|implementation climate
4731026|NCT03042832|Motivational Interviewing|motivational interviewing
4731027|NCT03042832|Fidelity|fidelity
4731028|NCT03042806|Physical Activity|physical activity
4731029|NCT03042806|Questionnaire|questionnaire
4731030|NCT03042793|myeloma|myeloma
4731031|NCT03042793|vaccination|vaccination
4731032|NCT03042793|PD-L1|pd-l1
4731033|NCT03042793|peptide vaccine|peptide vaccine
4731034|NCT03042793|cancer vaccine|cancer vaccine
4731035|NCT03042793|immunotherapy|immunotherapy
4731036|NCT03042780|Gastroenteropancreatic neuroendocrine carcinomas (GEP-NECs)|gastroenteropancreatic neuroendocrine carcinomas (gep-necs)
4731037|NCT03042780|Metastatic|metastatic
4731038|NCT03042780|High grade|high grade
4731039|NCT03042780|Pancreas|pancreas
4731040|NCT03042780|Neuroendocrine carcinoma of gastrointestinal tract|neuroendocrine carcinoma of gastrointestinal tract
4731041|NCT03042754|LAM|lam
4731042|NCT03042754|XpertMTB/RIF|xpertmtb/rif
4731043|NCT03042754|treatment outcome|treatment outcome
4731044|NCT03042754|Microbacterial tuberculosis|microbacterial tuberculosis
4731045|NCT03042715|Supportive Care|supportive care
4731046|NCT03042689|AML|aml
4731047|NCT03042676|anti-T lymphocytic globulin (ATG)|anti-t lymphocytic globulin (atg)
4731048|NCT03042676|allogeneic stem cell transplant|allogeneic stem cell transplant
4731049|NCT03042676|prophylaxis of GVHD|prophylaxis of gvhd
4731050|NCT03042663|stellate ganglion block|stellate ganglion block
4731051|NCT03042663|arterial cannula|arterial cannula
4731052|NCT03042663|ischemia|ischemia
4731053|NCT03042663|septic shock|septic shock
4731054|NCT03042611|Gastric Cancer|gastric cancer
4731055|NCT03042611|Gastric Adenocarcinoma|gastric adenocarcinoma
4731056|NCT03042611|Gastro-esophageal Cancer|gastro-esophageal cancer
4731057|NCT03042611|Gastro-esophageal junction Cancer|gastro-esophageal junction cancer
4731058|NCT03042611|Stomach Cancer|stomach cancer
4731059|NCT03042611|Tumor|tumor
4731060|NCT03042611|Oncology|oncology
4731061|NCT03042611|Antiangiogenesis|antiangiogenesis
4731062|NCT03042611|Metastatic|metastatic
4731063|NCT03042598|Safe Apneic Period|safe apneic period
4731064|NCT03042598|Emergency Intubation|emergency intubation
4731065|NCT03042598|Biphasic Cuirass Ventilation (BCV)|biphasic cuirass ventilation (bcv)
4731066|NCT03042598|Non-invasive ventilation|non-invasive ventilation
4731067|NCT03042598|Peri-intubation Hemodynamic instability|peri-intubation hemodynamic instability
4731068|NCT03042598|desaturation|desaturation
4731069|NCT03042598|waveform capnography|waveform capnography
4731070|NCT03042598|Patient safety|patient safety
4731071|NCT03042585|BMT|bmt
4731072|NCT03042585|NHL|nhl
4731073|NCT03042585|Non-Hodgkin Lymphoma|non-hodgkin lymphoma
4731074|NCT03042585|Relapsed Non-Hodgkin Lymphoma|relapsed non-hodgkin lymphoma
4731075|NCT03042585|Refractory Non-Hodgkin Lymphoma|refractory non-hodgkin lymphoma
4731076|NCT03042585|autologous stem cell transplantation|autologous stem cell transplantation
4731077|NCT03042572|Critical Limb Ischemia (CLI)|critical limb ischemia (cli)
4731078|NCT03042572|Severe Limb Ischemia (SLI)|severe limb ischemia (sli)
4731079|NCT03042572|Peripheral Artery Disease (PAD)|peripheral artery disease (pad)
4731080|NCT03042572|Peripheral Artery Occlusive Disease (PAOD)|peripheral artery occlusive disease (paod)
4731081|NCT03042572|Cardiovascular disease|cardiovascular disease
4731082|NCT03042572|Mesenchymal stromal cell (MSC)|mesenchymal stromal cell (msc)
4731083|NCT03042572|Mesenchymal stem cell (MSC)|mesenchymal stem cell (msc)
4731084|NCT03042494|Prebiotic|prebiotic
4731085|NCT03042494|Gut microbiota|gut microbiota
4731086|NCT03042494|Dietary fiber|dietary fiber
4731087|NCT03042494|Gastrointestinal tolerance|gastrointestinal tolerance
4731088|NCT03042481|chronic hepatitis B|chronic hepatitis b
4731089|NCT03042481|entecavir|entecavir
4731090|NCT03042481|tenofovir|tenofovir
4731091|NCT03042481|off-therapy|off-therapy
4731092|NCT03042481|relapse|relapse
4731093|NCT03042442|pancreatic cancer|pancreatic cancer
4731094|NCT03042442|cachexia|cachexia
4731095|NCT03042442|perineural invasion|perineural invasion
4731096|NCT03042442|pain|pain
4731097|NCT03042442|diabetes|diabetes
4731098|NCT03042429|neuroblastoma|neuroblastoma
4731099|NCT03042429|chemotherapy|chemotherapy
4731100|NCT03042429|autologous stem cell transplantation|autologous stem cell transplantation
4731101|NCT03042429|radiotherapy|radiotherapy
4731102|NCT03042429|mIBG|mibg
4731103|NCT03042429|tumor resection|tumor resection
4731104|NCT03042416|18F-DOPA PET/CT|18f-dopa pet/ct
4731105|NCT03042403|hemodynamics|hemodynamics
4731106|NCT03042403|physiotherapy|physiotherapy
4731107|NCT03042403|breath stacking|breath stacking
4731108|NCT03042377|Endodontics|endodontics
4731109|NCT03042377|Retreatment|retreatment
4731110|NCT03042377|Postoperative Pain|postoperative pain
4731111|NCT03042377|Visual Analogue Pain Scale|visual analogue pain scale
4731112|NCT03042364|Endometrium, Cytokines, Endometrial secretion, Implantation, Endometrial scratching|endometrium, cytokines, endometrial secretion, implantation, endometrial scratching
4731113|NCT03042351|Urinary Incontinence|urinary incontinence
4731114|NCT03042351|Pelvic Floor|pelvic floor
4731115|NCT03042325|Drug therapy|drug therapy
4731116|NCT03042286|statin|statin
4731117|NCT03042286|myalgia|myalgia
4731118|NCT03042286|myopathy|myopathy
4731119|NCT03042286|adverse drug reactions (ADRs)|adverse drug reactions (adrs)
4731120|NCT03042286|pharmacokinetics and pharmacogenetics|pharmacokinetics and pharmacogenetics
4731121|NCT03042273|recurrent|recurrent
4731122|NCT03042260|trimethoprim, sulfamethoxazole drug combination|trimethoprim, sulfamethoxazole drug combination
4731123|NCT03042260|Infection|infection
4731124|NCT03042260|Prophylaxis|prophylaxis
4731125|NCT03042234|Obesity|obesity
4731126|NCT03042234|Exercise|exercise
4731127|NCT03042234|Fat oxidation|fat oxidation
4731128|NCT03042234|Adolescent|adolescent
4731129|NCT03042234|Insulin resistance|insulin resistance
4731130|NCT03042195|Supplementary Parenteral Nutrition|supplementary parenteral nutrition
4731131|NCT03042195|Postoperative Nutrition|postoperative nutrition
4731132|NCT03042195|Postoperative complications|postoperative complications
4731133|NCT03042169|Stage IV gastric cancer|stage iv gastric cancer
4731134|NCT03042169|palliative surgery|palliative surgery
4731135|NCT03042169|chemotherapy|chemotherapy
4731136|NCT03042169|survival|survival
4731137|NCT03042169|quality of life|quality of life
4731138|NCT03042143|Acute respiratory distress syndrome|acute respiratory distress syndrome
4731139|NCT03042143|Human umbilical cord-derived mesenchymal stem cells|human umbilical cord-derived mesenchymal stem cells
4731140|NCT03042104|Stenosis|stenosis
4731141|NCT03042104|Heart Disease|heart disease
4731142|NCT03042104|Valve|valve
4731143|NCT03042104|Tricuspid|tricuspid
4731144|NCT03042104|Aortic Valve|aortic valve
4731145|NCT03042104|Asymptomatic|asymptomatic
4731146|NCT03042078|Fluoroscopy|fluoroscopy
4731147|NCT03042078|Ablation|ablation
4731148|NCT03042078|Three dimensional|three dimensional
4731149|NCT03042078|Paroxysmal supraventricular tachycardia|paroxysmal supraventricular tachycardia
4731150|NCT03042078|Radiation|radiation
4731151|NCT03042065|pediatrics|pediatrics
4731152|NCT03042065|asthma|asthma
4731153|NCT03042065|nebulization|nebulization
4731154|NCT03042065|vibrating mesh|vibrating mesh
4731155|NCT03042065|salbutamol|salbutamol
4731156|NCT03042065|Efficiency|efficiency
4731157|NCT03042013|ASP8273|asp8273
4731158|NCT03042013|Non-Small-Cell Lung Cancer|non-small-cell lung cancer
4731159|NCT03042013|EGFR mutations|egfr mutations
4731160|NCT03042013|Oncology|oncology
4731161|NCT03042000|rectal cancer|rectal cancer
4731162|NCT03042000|neoadjuvant chemoradiation|neoadjuvant chemoradiation
4731163|NCT03042000|circulating tumor DNA|circulating tumor dna
4731164|NCT03042000|local recurrence|local recurrence
4731165|NCT03042000|long-term survival|long-term survival
4731166|NCT03041987|Cohort studies|cohort studies
4731167|NCT03041987|Prognosis|prognosis
4731168|NCT03041974|Red Blood Cell Transfusion|red blood cell transfusion
4731169|NCT03041974|Cell-Derived Microparticles|cell-derived microparticles
4731170|NCT03041961|Vascular function|vascular function
4731171|NCT03041961|Endothelial function|endothelial function
4731172|NCT03041961|(Poly)phenols|(poly)phenols
4731173|NCT03041948|Inguinal hernia|inguinal hernia
4731174|NCT03041948|Caudal nerve block|caudal nerve block
4731175|NCT03041948|Ilioinguinal nerve block|ilioinguinal nerve block
4731176|NCT03041948|Pain|pain
4731177|NCT03041935|Testicle|testicle
4731178|NCT03041935|Pain|pain
4731179|NCT03041935|Orchiopexy|orchiopexy
4731180|NCT03041935|Caudal nerve block|caudal nerve block
4731181|NCT03041935|Ilioinguinal nerve block|ilioinguinal nerve block
4731182|NCT03041922|Elastography|elastography
4731183|NCT03041922|Buttocks|buttocks
4731184|NCT03041922|Ultrasound|ultrasound
4731185|NCT03041922|Soft tissue|soft tissue
4731186|NCT03041870|PET-fMRI|pet-fmri
4731187|NCT03041870|dominance|dominance
4731188|NCT03041870|5HT transporter|5ht transporter
4731189|NCT03041857|Videofluoroscopy|videofluoroscopy
4731190|NCT03041857|GMK Sphere|gmk sphere
4731191|NCT03041857|GMK PS Fixed Bearing|gmk ps fixed bearing
4731192|NCT03041857|GMK UC Mobile Bearing|gmk uc mobile bearing
4731193|NCT03041844|therapeutic ultrasound|therapeutic ultrasound
4731194|NCT03041844|quality of life|quality of life
4731195|NCT03041831|frail elderly|frail elderly
4731196|NCT03041831|telemedicine|telemedicine
4731197|NCT03041831|obesity|obesity
4731198|NCT03041831|rural health|rural health
4731199|NCT03041831|health promotion|health promotion
4731200|NCT03041818|cerebral palsy|cerebral palsy
4731201|NCT03041818|horseback riding|horseback riding
4731202|NCT03041805|venous thromboembolism|venous thromboembolism
4731203|NCT03041805|deep vein thrombosis|deep vein thrombosis
4731204|NCT03041805|pulmonary embolism|pulmonary embolism
4731205|NCT03041805|varicose veins|varicose veins
4731206|NCT03041805|surgery|surgery
4731207|NCT03041805|endovenous laser treatment|endovenous laser treatment
4731208|NCT03041805|radiofrequency ablation|radiofrequency ablation
4731209|NCT03041805|ultrasound-guided foam sclerotherapy|ultrasound-guided foam sclerotherapy
4731210|NCT03041805|register|register
4731211|NCT03041805|anticoagulation|anticoagulation
4731212|NCT03041766|Schistosomiasis|schistosomiasis
4731213|NCT03041766|Recombinant vaccine|recombinant vaccine
4731214|NCT03041766|rSm14|rsm14
4731215|NCT03041766|GLA-SE|gla-se
4731216|NCT03041766|Fatty acid-binding protein (FABP)|fatty acid-binding protein (fabp)
4731217|NCT03041766|Phase II Clinical Trial|phase ii clinical trial
4731218|NCT03041766|Senegal|senegal
4731219|NCT03041753|stroke|stroke
4731220|NCT03041753|thrombolysis|thrombolysis
4731221|NCT03041753|metalloproteinases|metalloproteinases
4731222|NCT03041753|blood brain barrier|blood brain barrier
4731223|NCT03041740|Bronchopulmonary Dysplasia|bronchopulmonary dysplasia
4731224|NCT03041740|Neonates|neonates
4731225|NCT03041714|Essential Tremor|essential tremor
4731226|NCT03041714|Cervical Dystonia|cervical dystonia
4731227|NCT03041714|Hand Dystonia|hand dystonia
4731228|NCT03041714|Neurophysiology|neurophysiology
4731229|NCT03041714|Dystonic Tremor|dystonic tremor
4731230|NCT03041701|ERMS|erms
4731231|NCT03041701|ARMS|arms
4731232|NCT03041701|Monoclonal Antibody|monoclonal antibody
4731233|NCT03041701|YES|yes
4731234|NCT03041701|RMS|rms
4731235|NCT03041675|Lacer Acupuncture|lacer acupuncture
4731236|NCT03041675|Paralytic ileus|paralytic ileus
4731237|NCT03041649|Gastroesophageal Reflux|gastroesophageal reflux
4731238|NCT03041649|Feeding Disorder|feeding disorder
4731239|NCT03041649|Gastrostomy tube|gastrostomy tube
4731240|NCT03041649|Family Satisfaction|family satisfaction
4731241|NCT03041649|GT button|gt button
4731242|NCT03041649|Enteral nutrition|enteral nutrition
4731243|NCT03041649|Gastrostomy button|gastrostomy button
4731244|NCT03041636|Malignant Neoplasms Stated as Primary Lymphoid Haematopoietic|malignant neoplasms stated as primary lymphoid haematopoietic
4731245|NCT03041636|Other Diseases of Blood and Blood-Forming Organs|other diseases of blood and blood-forming organs
4731246|NCT03041636|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
4731247|NCT03041636|CLL|cll
4731248|NCT03041636|Ruxolitinib|ruxolitinib
4731249|NCT03041636|Jakafi|jakafi
4731251|NCT03041636|Small Lymphocytic Lymphoma|small lymphocytic lymphoma
4731252|NCT03041636|SLL|sll
4731253|NCT03041623|IIPs|iips
4731254|NCT03041558|healthy relationships|healthy relationships
4731255|NCT03041558|interpersonal relations|interpersonal relations
4731256|NCT03041558|domestic violence|domestic violence
4731257|NCT03041532|retroflexion proximal|retroflexion proximal
4731258|NCT03041532|colorectal cancer screening programme|colorectal cancer screening programme
4731259|NCT03041532|adenoma detection rate|adenoma detection rate
4731260|NCT03041532|right colon|right colon
4731261|NCT03041519|Fluoroscopy|fluoroscopy
4731262|NCT03041519|Ablation|ablation
4731263|NCT03041519|Three dimensional|three dimensional
4731264|NCT03041519|Ventricular arrhythmias|ventricular arrhythmias
4731265|NCT03041519|Radiation|radiation
4731266|NCT03041506|Shoulder dislocation reduction|shoulder dislocation reduction
4731267|NCT03041506|Ultrasound guided interscalene block (ISCB)|ultrasound guided interscalene block (iscb)
4731268|NCT03041506|Sedation|sedation
4731269|NCT03041493|Electronic Cigarettes|electronic cigarettes
4731270|NCT03041493|17-071|17-071
4731271|NCT03041480|chronic periodontitis|chronic periodontitis
4731272|NCT03041480|lipids|lipids
4731273|NCT03041480|Lp-PLA2|lp-pla2
4731274|NCT03041402|non-invasive ventilation|non-invasive ventilation
4731275|NCT03041402|Pressure Support Ventilation|pressure support ventilation
4731276|NCT03041402|Neurally Adjusted Ventilatory Assist|neurally adjusted ventilatory assist
4731277|NCT03041402|patient-ventilator interaction|patient-ventilator interaction
4731278|NCT03041402|ventilator performance|ventilator performance
4731279|NCT03041402|asynchrony|asynchrony
4731280|NCT03041389|Computerized Cognitive Behavioral Therapy|computerized cognitive behavioral therapy
4731281|NCT03041350|Emergency Medical Services|emergency medical services
4731282|NCT03041350|Smartphone|smartphone
4731283|NCT03041350|Survival|survival
4731284|NCT03041324|MPS ll|mps ll
4731285|NCT03041324|Mucopolysaccharidosis|mucopolysaccharidosis
4731286|NCT03041324|Hunter syndrome|hunter syndrome
4731287|NCT03041324|gene editing|gene editing
4731288|NCT03041324|gene therapy|gene therapy
4731289|NCT03041324|zinc finger|zinc finger
4731290|NCT03041324|ZFN|zfn
4731291|NCT03041324|SB-913|sb-913
4731292|NCT03041324|rare|rare
4731293|NCT03041324|genetic|genetic
4731294|NCT03041324|DNA|dna
4731295|NCT03041324|Sangamo|sangamo
4731296|NCT03041324|Genomic editing|genomic editing
4731297|NCT03041324|Champions|champions
4731298|NCT03041324|Hunter|hunter
4731299|NCT03041311|Small Cell Lung Cancer|small cell lung cancer
4731300|NCT03041311|CDK 4/6 Inhibitor|cdk 4/6 inhibitor
4731301|NCT03041311|Immune Checkpoint Inhibitor|immune checkpoint inhibitor
4731302|NCT03041246|pelvic floor|pelvic floor
4731303|NCT03041207|ventilator associated infection|ventilator associated infection
4731304|NCT03041207|ventilator associated pneumonia|ventilator associated pneumonia
4731305|NCT03041207|ventilator associated tracheitis|ventilator associated tracheitis
4731306|NCT03041207|Lower respiratory infection|lower respiratory infection
4731307|NCT03041181|Nivolumab|nivolumab
4731308|NCT03041181|BMS-936558-01|bms-936558-01
4731309|NCT03041181|Anti-PD-1 Antibody|anti-pd-1 antibody
4731310|NCT03041181|Docetaxel|docetaxel
4731311|NCT03041181|Pemetrexed|pemetrexed
4731312|NCT03041181|Gemcitabine|gemcitabine
4731313|NCT03041142|Obesity|obesity
4731314|NCT03041142|Cardiovascular risk factors|cardiovascular risk factors
4731315|NCT03041142|Interdisciplinary intervention|interdisciplinary intervention
4731316|NCT03041129|hepatic de novo lipogenesis|hepatic de novo lipogenesis
4731317|NCT03041116|PKAN|pkan
4731318|NCT03041090|infiltration|infiltration
4731319|NCT03041090|extravasation|extravasation
4731320|NCT03041090|PET/CT|pet/ct
4731321|NCT03041090|PET|pet
4731322|NCT03041090|PET-CT|pet-ct
4731323|NCT03041025|Systemic Sclerosis|systemic sclerosis
4731324|NCT03041025|Repeat-dose|repeat-dose
4731325|NCT03041025|Phase IIA|phase iia
4731326|NCT03041025|GSK2330811|gsk2330811
4731327|NCT03041025|Pharmacodynamics|pharmacodynamics
4731328|NCT03041025|Pharmacokinetics|pharmacokinetics
4731329|NCT03041025|Proof of mechanism study|proof of mechanism study
4731330|NCT03041012|HIV-1|hiv-1
4731331|NCT03041012|Latency Reversal Agent|latency reversal agent
4731332|NCT03041012|Immunotherapy|immunotherapy
4731333|NCT03040999|Head and Neck Squamous Cell Carcinoma|head and neck squamous cell carcinoma
4731334|NCT03040999|Programmed Cell Death Receptor 1 (PD-1)|programmed cell death receptor 1 (pd-1)
4731335|NCT03040999|Programmed Cell Death Receptor Ligand 1 (PD-L1)|programmed cell death receptor ligand 1 (pd-l1)
4731336|NCT03040999|Programmed Cell Death Receptor Ligand 2 (PD-L2)|programmed cell death receptor ligand 2 (pd-l2)
4731337|NCT03040999|PD1|pd1
4731338|NCT03040999|PD-1|pd-1
4731339|NCT03040999|PDL1|pdl1
4731340|NCT03040999|PD-L1|pd-l1
4731341|NCT03040999|PDL2|pdl2
4731342|NCT03040973|capmatinib|capmatinib
4731343|NCT03040973|cMET|cmet
4731344|NCT03040973|advanced solid tumor|advanced solid tumor
4731345|NCT03040973|cancer|cancer
4731346|NCT03040960|infection|infection
4731347|NCT03040960|wound infection|wound infection
4731348|NCT03040960|surgical wound infection|surgical wound infection
4731349|NCT03040960|Staphylococcal infections|staphylococcal infections
4731350|NCT03040960|wound and injuries|wound and injuries
4731351|NCT03040960|postoperative complications|postoperative complications
4731352|NCT03040960|Gram-positive bacterial infections|gram-positive bacterial infections
4731353|NCT03040960|bacterial infections|bacterial infections
4731354|NCT03040895|Parenting practices|parenting practices
4731355|NCT03040856|Omega 3|omega 3
4731356|NCT03040856|Supplements|supplements
4731357|NCT03040856|Alpha Linolenic Acid|alpha linolenic acid
4731358|NCT03040843|documentation|documentation
4731359|NCT03040843|altered mental status|altered mental status
4731360|NCT03040843|definition|definition
4731361|NCT03040843|clinically|clinically
4731362|NCT03040804|hidradenitis suppurativa|hidradenitis suppurativa
4731363|NCT03040804|HS|hs
4731364|NCT03040804|radiotherapy|radiotherapy
4731365|NCT03040791|prostate cancer|prostate cancer
4731366|NCT03040778|MRONJ|mronj
4731367|NCT03040778|BRONJ|bronj
4731368|NCT03040765|Osteoporosis|osteoporosis
4731369|NCT03040765|Beta-Thalassemia Major|beta-thalassemia major
4731370|NCT03040765|Denosumab|denosumab
4731371|NCT03040765|Zoledronic Acid|zoledronic acid
4731372|NCT03040739|O'ARM|o'arm
4731373|NCT03040726|In situ neoplasm|in situ neoplasm
4731374|NCT03040726|Malignant neoplasms of independent (primary) multiple sites|malignant neoplasms of independent (primary) multiple sites
4731375|NCT03040726|Symptoms and signs involving the digestive system and abdomen|symptoms and signs involving the digestive system and abdomen
4731376|NCT03040726|Chronic nausea and vomiting|chronic nausea and vomiting
4731377|NCT03040726|Netupitant/Palonosetron|netupitant/palonosetron
4731378|NCT03040726|NEPA|nepa
4731379|NCT03040726|Placebo|placebo
4731380|NCT03040726|Sugar pill|sugar pill
4731381|NCT03040726|Symptom questionnaires|symptom questionnaires
4731382|NCT03040726|Surveys|surveys
4731383|NCT03040726|Pill diary|pill diary
4731384|NCT03040726|Akynzeo|akynzeo
4731385|NCT03040700|coronary artery disease|coronary artery disease
4731386|NCT03040700|surgery|surgery
4731387|NCT03040700|angina|angina
4731388|NCT03040700|myocardial ischemia|myocardial ischemia
4731389|NCT03040700|non-invasive testing|non-invasive testing
4731390|NCT03040687|ETEC|etec
4731391|NCT03040687|Escherichia coli|escherichia coli
4731392|NCT03040687|enteritis|enteritis
4731393|NCT03040687|challenge|challenge
4731394|NCT03040687|CS6|cs6
4731395|NCT03040687|B7A|b7a
4731396|NCT03040674|Shortness of breath|shortness of breath
4731397|NCT03040674|Breathlessness|breathlessness
4731398|NCT03040674|Stem cells|stem cells
4731399|NCT03040674|Platelet rich plasma|platelet rich plasma
4731400|NCT03040674|Quality of life|quality of life
4731401|NCT03040674|Pulmonary function|pulmonary function
4731402|NCT03040622|WATCHMAN|watchman
4731403|NCT03040622|Left Atrial Appendage Closure|left atrial appendage closure
4731404|NCT03040622|Thrombosis|thrombosis
4731405|NCT03040622|Platelet Function|platelet function
4731406|NCT03040609|Profound Multiple Intellectual Disabilities|profound multiple intellectual disabilities
4731407|NCT03040609|Visual-Behavioral Scale|visual-behavioral scale
4731408|NCT03040596|vocal fold nodules|vocal fold nodules
4731409|NCT03040596|inhaled steroid|inhaled steroid
4731410|NCT03040596|steroid|steroid
4731411|NCT03040596|children|children
4731412|NCT03040596|nodules|nodules
4731413|NCT03040583|Primary Sjögren's syndrome (PSS)|primary sjögren's syndrome (pss)
4731414|NCT03040583|auto-immune diseases|auto-immune diseases
4731415|NCT03040557|plantar fasciitis|plantar fasciitis
4731416|NCT03040557|shoes|shoes
4731417|NCT03040557|insoles|insoles
4731418|NCT03040557|pain|pain
4731419|NCT03040557|foot|foot
4731420|NCT03040544|minimally invasive surgery|minimally invasive surgery
4731421|NCT03040544|video-based trainer|video-based trainer
4731422|NCT03040544|laparoscopic|laparoscopic
4731423|NCT03040544|simulation training|simulation training
4731424|NCT03040544|surgical education|surgical education
4731425|NCT03040531|glucocorticoid|glucocorticoid
4731426|NCT03040531|genistein|genistein
4731427|NCT03040531|alendronate|alendronate
4731428|NCT03040518|Behaviour change|behaviour change
4731429|NCT03040518|Male obesity|male obesity
4731430|NCT03040518|SMS|sms
4731431|NCT03040518|Financial Incentive|financial incentive
4731432|NCT03040518|Endowment incentive|endowment incentive
4731433|NCT03040466|ureteroscopy|ureteroscopy
4731434|NCT03040466|flexible ureteroscope|flexible ureteroscope
4731435|NCT03040466|randomized controlled trial|randomized controlled trial
4731436|NCT03040453|Irreversible electroporation|irreversible electroporation
4731437|NCT03040453|Microwave ablation|microwave ablation
4731438|NCT03040427|F-18 florbetapir|f-18 florbetapir
4731439|NCT03040427|Amyvid|amyvid
4731440|NCT03040427|PET scan|pet scan
4731441|NCT03040427|Early detection|early detection
4731442|NCT03040414|Hybrid closed loop|hybrid closed loop
4731443|NCT03040414|Closed loop|closed loop
4731444|NCT03040414|Artificial pancreas|artificial pancreas
4731445|NCT03040401|CMML|cmml
4731446|NCT03040401|Ceplene|ceplene
4731447|NCT03040401|Interleukin-2|interleukin-2
4731448|NCT03040388|Electroconvulsive therapy|electroconvulsive therapy
4731449|NCT03040388|Depressive Disorder|depressive disorder
4731450|NCT03040388|Magnetic Resonance Imaging|magnetic resonance imaging
4731451|NCT03040388|Hippocampus|hippocampus
4731452|NCT03040388|Brain-Derived Neurotrophic Factor|brain-derived neurotrophic factor
4731453|NCT03040388|Vascular Endothelial Growth Factor|vascular endothelial growth factor
4731454|NCT03040388|Blood-Brain Barrier|blood-brain barrier
4731455|NCT03040349|primary care|primary care
4731456|NCT03040349|greece|greece
4731457|NCT03040349|cyprus|cyprus
4731458|NCT03040349|tobacco use treatment|tobacco use treatment
4731459|NCT03040349|evidence-based guidelines|evidence-based guidelines
4731460|NCT03040336|surgery|surgery
4731461|NCT03040336|prehabilitation|prehabilitation
4731462|NCT03040336|exercise therapy|exercise therapy
4731463|NCT03040336|nutrition support|nutrition support
4731464|NCT03040297|Weaning from mechanical ventilation|weaning from mechanical ventilation
4731465|NCT03040297|tracheostomized patients|tracheostomized patients
4731466|NCT03040297|Tracheal gas insufflation|tracheal gas insufflation
4731467|NCT03040284|noninvasive monitoring|noninvasive monitoring
4731468|NCT03040284|intracranial pressure|intracranial pressure
4731469|NCT03040284|cochlear electrophysiology|cochlear electrophysiology
4731470|NCT03040284|aneurysmal subarachnoid haemorrhage|aneurysmal subarachnoid haemorrhage
4731471|NCT03040284|cerebrovascular disorders|cerebrovascular disorders
4731472|NCT03040284|brain diseases|brain diseases
4731473|NCT03040271|School-based intervention|school-based intervention
4731474|NCT03040258|School-based intervention|school-based intervention
4731475|NCT03040245|Emergency physician|emergency physician
4731476|NCT03040245|Whiplash Book|whiplash book
4731477|NCT03040245|Whiplash trauma|whiplash trauma
4731478|NCT03040245|Fears|fears
4731479|NCT03040245|Beliefs|beliefs
4731480|NCT03040193|Lignocaine|lignocaine
4731481|NCT03040180|Neoplasms|neoplasms
4731482|NCT03040180|Neoplasms, primary|neoplasms, primary
4731483|NCT03040180|Cancer|cancer
4731484|NCT03040180|Colorectal cancer|colorectal cancer
4731485|NCT03040180|rectal cancer|rectal cancer
4731486|NCT03040180|rectal cancer, locally advanced|rectal cancer, locally advanced
4731487|NCT03040180|Electrochemotherapy|electrochemotherapy
4731488|NCT03040180|Electroporation|electroporation
4731489|NCT03040180|Neoadjuvant therapy|neoadjuvant therapy
4731490|NCT03040180|Antineoplastic, antibodies|antineoplastic, antibodies
4731491|NCT03040180|Bleomycin|bleomycin
4731492|NCT03040180|Pathologic processes|pathologic processes
4731493|NCT03040180|Neoplastic processes|neoplastic processes
4731494|NCT03040154|Filipino|filipino
4731495|NCT03040102|Advanced Cancer|advanced cancer
4731496|NCT03040063|aneurysm, poplietl artery, acute limb ischemia|aneurysm, poplietl artery, acute limb ischemia
4731497|NCT03040024|Anesthesiology|anesthesiology
4731498|NCT03040011|Vaginal Surgery|vaginal surgery
4731499|NCT03040011|Pelvic Organ Prolapse|pelvic organ prolapse
4731500|NCT03040011|Postoperative Pain|postoperative pain
4731501|NCT03039959|Chronic Kidney Disease|chronic kidney disease
4731502|NCT03039946|Fluid therapy|fluid therapy
4731503|NCT03039946|Hemodynamic flow monitoring|hemodynamic flow monitoring
4731504|NCT03039946|Closed-loop system|closed-loop system
4731505|NCT03039946|Goal-directed fluid therapy|goal-directed fluid therapy
4731506|NCT03039946|Anesthesiology|anesthesiology
4731508|NCT03039907|Replacement|replacement
4731509|NCT03039894|school-based, evaluation, interrupted time series|school-based, evaluation, interrupted time series
4731510|NCT03039881|Minute ventilation, ExSpiron monitor|minute ventilation, exspiron monitor
4731511|NCT03039855|Mitral|mitral
4731512|NCT03039855|Regurgitation|regurgitation
4731513|NCT03039855|Heart valve|heart valve
4731514|NCT03039855|Transcatheter|transcatheter
4731515|NCT03039855|Transapical|transapical
4731516|NCT03039855|Functional|functional
4731517|NCT03039855|Degenerative|degenerative
4731518|NCT03039855|TMVR|tmvr
4731519|NCT03039842|dextromethorphan; memantine; treatment response|dextromethorphan; memantine; treatment response
4731520|NCT03039790|Immunogenicity, Norovirus vaccination|immunogenicity, norovirus vaccination
4731521|NCT03039686|muscular dystrophy|muscular dystrophy
4731522|NCT03039686|Duchenne's Muscular Dystrophy|duchenne's muscular dystrophy
4731523|NCT03039686|DMD|dmd
4731524|NCT03039673|interleukin-2|interleukin-2
4731525|NCT03039673|low-dose interleukin-2|low-dose interleukin-2
4731526|NCT03039608|esophageal stricture|esophageal stricture
4731527|NCT03039608|endoscopic submucosal dissection|endoscopic submucosal dissection
4731528|NCT03039608|prevention|prevention
4731529|NCT03039595|Early rectal cancer|early rectal cancer
4731530|NCT03039595|Ploidy|ploidy
4731531|NCT03039595|Tumour:stroma ratio|tumour:stroma ratio
4731532|NCT03039582|perineal tear|perineal tear
4731533|NCT03039582|bidigital palpation|bidigital palpation
4731534|NCT03039582|perineal ultrasound|perineal ultrasound
4731535|NCT03039582|post partum diagnostics|post partum diagnostics
4731536|NCT03039569|Type 2 diabetes patients|type 2 diabetes patients
4731537|NCT03039569|Diabetes self-management|diabetes self-management
4731538|NCT03039569|Cardiovascular diseases awareness|cardiovascular diseases awareness
4731539|NCT03039569|Home food environment|home food environment
4731540|NCT03039569|Text message|text message
4731541|NCT03039530|Postpartum Depression|postpartum depression
4731542|NCT03039530|Cognitive Behavioral Therapy|cognitive behavioral therapy
4731543|NCT03039530|Public Health|public health
4731544|NCT03039530|Mother|mother
4731545|NCT03039530|Infant|infant
4731546|NCT03039530|Emotion|emotion
4731547|NCT03039517|Adaptive Compression Therapy Delivery System|adaptive compression therapy delivery system
4731549|NCT03039504|Dietary supplement|dietary supplement
4731550|NCT03039491|pneumococcal vaccination|pneumococcal vaccination
4731551|NCT03039465|Indwelling Trachea-oesophageal Prosthesis|indwelling trachea-oesophageal prosthesis
4731552|NCT03039465|Voice Rehabilitation|voice rehabilitation
4731553|NCT03039465|Total Laryngectomy|total laryngectomy
4731554|NCT03039439|Immunohistochemical profiling of tumors|immunohistochemical profiling of tumors
4731555|NCT03039439|Biomarkers|biomarkers
4731556|NCT03039374|OASI|oasi
4731557|NCT03039374|Faecal incontinence|faecal incontinence
4731558|NCT03039374|Obstetric anal sphincter injury|obstetric anal sphincter injury
4731559|NCT03039374|MRI|mri
4731560|NCT03039348|Breast Cancer Female|breast cancer female
4731561|NCT03039348|Mastectomy|mastectomy
4731562|NCT03039348|Breast Reconstruction|breast reconstruction
4731563|NCT03039348|questionnaire|questionnaire
4731564|NCT03039309|Endoscopic Submucosal Dissection|endoscopic submucosal dissection
4731565|NCT03039296|Low back pain|low back pain
4731566|NCT03039296|Facet joints|facet joints
4731567|NCT03039296|Endoscopic rhizotomy|endoscopic rhizotomy
4731568|NCT03039283|Moderate to profound sensorineural hearing loss|moderate to profound sensorineural hearing loss
4731569|NCT03039270|Tooth Sensitivity|tooth sensitivity
4731570|NCT03039270|Tooth Bleaching|tooth bleaching
4731571|NCT03039270|Desensitizing agent|desensitizing agent
4731572|NCT03039270|Sonic vibration|sonic vibration
4731573|NCT03039257|hematopoietic stem cell transplant|hematopoietic stem cell transplant
4731574|NCT03039257|vitamin a|vitamin a
4731575|NCT03039244|Photochemotherapy|photochemotherapy
4731576|NCT03039244|Photosensitizing agents|photosensitizing agents
4731577|NCT03039244|Smokers|smokers
4731578|NCT03039231|PTSD|ptsd
4731579|NCT03039218|erectile dysfunction|erectile dysfunction
4731580|NCT03039218|shockwave|shockwave
4731581|NCT03039218|Dornier|dornier
4731582|NCT03039205|Platelet aggregation|platelet aggregation
4731583|NCT03039205|Adenosine|adenosine
4731584|NCT03039205|Coronary artery disease|coronary artery disease
4731585|NCT03039205|Kidney dysfunction|kidney dysfunction
4731586|NCT03039205|Ticagrelor|ticagrelor
4731587|NCT03039205|Clopidogrel|clopidogrel
4731588|NCT03039127|Hyperthermia|hyperthermia
4731589|NCT03039127|Laser Coagulation|laser coagulation
4731590|NCT03039127|Laser Therapy|laser therapy
4731591|NCT03039127|Induced|induced
4731592|NCT03039114|Follicular lymphoma|follicular lymphoma
4731593|NCT03039114|relapsed|relapsed
4731594|NCT03039114|refractory|refractory
4731595|NCT03039114|non-Hodgkin lymphoma|non-hodgkin lymphoma
4731596|NCT03039114|phosphatidylinositol 3-kinase (PI3K)|phosphatidylinositol 3-kinase (pi3k)
4731597|NCT03039101|allergen|allergen
4731598|NCT03039101|neutrophils|neutrophils
4731599|NCT03039101|allergy|allergy
4731600|NCT03039062|Serum miR-122|serum mir-122
4731601|NCT03039062|drug-induced liver injury by chemotherapy|drug-induced liver injury by chemotherapy
4731602|NCT03039062|malignant tumor patients|malignant tumor patients
4731603|NCT03039049|GnRH agonist trigger|gnrh agonist trigger
4731604|NCT03039049|IVF|ivf
4731605|NCT03039049|Luteal phase support|luteal phase support
4731606|NCT03039049|Mid-luteal GnRH agonist|mid-luteal gnrh agonist
4731607|NCT03039036|Labor Induction|labor induction
4731608|NCT03039036|Early Amniotomy|early amniotomy
4731609|NCT03039036|Foley catheter|foley catheter
4731610|NCT03039023|TMAO|tmao
4731611|NCT03039023|choline|choline
4731612|NCT03039023|eggs|eggs
4731613|NCT03039023|gastrointestinal microbiome|gastrointestinal microbiome
4731614|NCT03039023|healthy volunteers|healthy volunteers
4731615|NCT03038984|IBD|ibd
4731616|NCT03038984|Telemedicine|telemedicine
4731617|NCT03038984|At-home monitoring|at-home monitoring
4731618|NCT03038984|Disease activity|disease activity
4731619|NCT03038984|fecal calprotectin|fecal calprotectin
4731620|NCT03038984|Total inflammation burden|total inflammation burden
4731621|NCT03038984|11 years follow up|11 years follow up
4731622|NCT03038958|Local Anaesthetic|local anaesthetic
4731623|NCT03038958|spinal anesthesia|spinal anesthesia
4731624|NCT03038958|Knee arthroscopy|knee arthroscopy
4731625|NCT03038945|Laparoscopy|laparoscopy
4731626|NCT03038945|Hysterectomy|hysterectomy
4731627|NCT03038945|Suture Techniques|suture techniques
4731628|NCT03038932|whole genome sequencing (WGS)|whole genome sequencing (wgs)
4731629|NCT03038919|prolonged mechanical ventilation|prolonged mechanical ventilation
4731630|NCT03038919|critically ill patients|critically ill patients
4731631|NCT03038919|anabolic steroid|anabolic steroid
4731632|NCT03038893|Ultrasonography|ultrasonography
4731633|NCT03038893|Point-of-care systems|point-of-care systems
4731634|NCT03038893|Deep venous thrombosis|deep venous thrombosis
4731635|NCT03038893|Hospitalization|hospitalization
4731637|NCT03038750|Healthy Volunteers|healthy volunteers
4731638|NCT03038750|Genetic Risk Markers for Cardiovascular Disease|genetic risk markers for cardiovascular disease
4731639|NCT03038750|Non-Alcoholic Fatty Liver Disease|non-alcoholic fatty liver disease
4731640|NCT03038750|Coronary Disease|coronary disease
4731641|NCT03038750|Hypertension|hypertension
4731642|NCT03038750|Venous Thromboses|venous thromboses
4731643|NCT03038750|Venous Thromboembolism|venous thromboembolism
4731644|NCT03038750|Coronary Heart Disease|coronary heart disease
4731645|NCT03038750|Coronary Artery Disease|coronary artery disease
4731646|NCT03038737|nylon|nylon
4731647|NCT03038737|polyamide|polyamide
4731648|NCT03038737|PEEK|peek
4731649|NCT03038737|partial denture|partial denture
4731650|NCT03038724|HIV testing|hiv testing
4731651|NCT03038698|spirometry|spirometry
4731652|NCT03038698|normative values|normative values
4731653|NCT03038698|health|health
4731654|NCT03038698|south africa|south africa
4731655|NCT03038698|children|children
4731656|NCT03038685|Secondary prevention|secondary prevention
4731657|NCT03038685|Web-based intervention|web-based intervention
4731658|NCT03038685|Strokecoach|strokecoach
4731659|NCT03038646|Pharmacokinetics|pharmacokinetics
4731660|NCT03038646|Food Effect|food effect
4731661|NCT03038620|Obesity|obesity
4731662|NCT03038620|Visceral|visceral
4731663|NCT03038620|Cardiovascular Disease|cardiovascular disease
4731664|NCT03038620|Fat|fat
4731665|NCT03038594|Burns|burns
4731666|NCT03038594|Growth Hormone|growth hormone
4731667|NCT03038594|Lean Body Mass|lean body mass
4731668|NCT03038594|Strength|strength
4731669|NCT03038594|Exercise Endurance|exercise endurance
4731670|NCT03038581|Deep wrist injury|deep wrist injury
4731671|NCT03038581|Self inflicted|self inflicted
4731672|NCT03038581|Traumatic wrist injury|traumatic wrist injury
4731673|NCT03038568|colorectal liver metastases|colorectal liver metastases
4731674|NCT03038568|CT scan|ct scan
4731675|NCT03038568|17-010|17-010
4731676|NCT03038555|Medical staff|medical staff
4731677|NCT03038555|preeclampsia|preeclampsia
4731678|NCT03038555|cohort study|cohort study
4731679|NCT03038555|further effect|further effect
4731680|NCT03038529|low back pain , Ozone|low back pain , ozone
4731681|NCT03038503|refractory septic shock|refractory septic shock
4731682|NCT03038503|catecholamine resistance septic shock|catecholamine resistance septic shock
4731683|NCT03038503|terlipressin|terlipressin
4731684|NCT03038503|methylene blue|methylene blue
4731685|NCT03038477|Borderline Resectable Pancreatic Ductal Adenocarcinoma|borderline resectable pancreatic ductal adenocarcinoma
4731686|NCT03038477|Durvalumab|durvalumab
4731687|NCT03038399|Duchenne muscular dystrophy|duchenne muscular dystrophy
4731688|NCT03038399|vamorolone|vamorolone
4731689|NCT03038347|cross-cultural competencies|cross-cultural competencies
4731690|NCT03038347|internet-based training|internet-based training
4731691|NCT03038347|cognitive-behavioural therapy (CBT)|cognitive-behavioural therapy (cbt)
4731692|NCT03038347|psychotherapy training|psychotherapy training
4731693|NCT03038347|competence training|competence training
4731694|NCT03038321|BCG Cystitis|bcg cystitis
4731695|NCT03038321|Bladder Cancer|bladder cancer
4731696|NCT03038321|Levofloxacin|levofloxacin
4731697|NCT03038321|Solifenacin|solifenacin
4731698|NCT03038321|Lornoxicam|lornoxicam
4731699|NCT03038308|ropinirole|ropinirole
4731700|NCT03038308|hyperprolactinemia|hyperprolactinemia
4731701|NCT03038308|prolactin|prolactin
4731702|NCT03038295|Retinopathy of Prematurity|retinopathy of prematurity
4731703|NCT03038295|propranolol|propranolol
4731704|NCT03038295|ROP|rop
4731705|NCT03038269|Robotics|robotics
4731706|NCT03038269|Upper Extremity|upper extremity
4731707|NCT03038256|High Risk Rectal Cancer|high risk rectal cancer
4731708|NCT03038256|Total neoadjuvant chemoradiotherapy|total neoadjuvant chemoradiotherapy
4731709|NCT03038256|Lengthening interval between radiotherapy and surgery|lengthening interval between radiotherapy and surgery
4731710|NCT03038243|Shigella|shigella
4731711|NCT03038243|vaccine|vaccine
4731712|NCT03038243|shigellosis|shigellosis
4731713|NCT03038243|dysentery|dysentery
4731714|NCT03038243|whole cell|whole cell
4731715|NCT03038230|human bispecific full length IgG antibody, CLEC12A, CD3|human bispecific full length igg antibody, clec12a, cd3
4731716|NCT03038230|MCLA-117|mcla-117
4731717|NCT03038230|First in Human|first in human
4731718|NCT03038230|Antibodies, Bispecific|antibodies, bispecific
4731719|NCT03038230|Immunologic Factors|immunologic factors
4731720|NCT03038230|relapsed, refractory patient|relapsed, refractory patient
4731721|NCT03038230|AML, minimal residual disease (MRD)|aml, minimal residual disease (mrd)
4731722|NCT03038230|Acute Myelogenous Leukemia|acute myelogenous leukemia
4731723|NCT03038230|Acute Myeloid Leukemia|acute myeloid leukemia
4731724|NCT03038230|CD34+CD38|cd34+cd38
4731725|NCT03038230|T-cell recruiting|t-cell recruiting
4731726|NCT03038217|rectal cancer|rectal cancer
4731727|NCT03038217|neoajuvant chemoradiation|neoajuvant chemoradiation
4731728|NCT03038217|circulating tumor DNA|circulating tumor dna
4731729|NCT03038204|Papillary muscles approximation|papillary muscles approximation
4731730|NCT03038178|Mycobacterium Infections, Nontuberculous|mycobacterium infections, nontuberculous
4731731|NCT03038178|Mycobacteria, Atypical|mycobacteria, atypical
4731732|NCT03038178|Amikacin|amikacin
4731733|NCT03038178|Inhalation|inhalation
4731734|NCT03038165|Hemodialysis|hemodialysis
4731735|NCT03038165|Intradialytic hypertension|intradialytic hypertension
4731736|NCT03038165|Hemodynamics changes|hemodynamics changes
4731737|NCT03038152|Disorder of breast|disorder of breast
4731738|NCT03038152|Breast Cancer|breast cancer
4731739|NCT03038152|Lymph node metastasis|lymph node metastasis
4731740|NCT03038152|Magseed marker|magseed marker
4731741|NCT03038152|Lymph node removal|lymph node removal
4731742|NCT03038139|forward head posture|forward head posture
4731743|NCT03038139|postural correction|postural correction
4731744|NCT03038139|spinal muscles|spinal muscles
4731745|NCT03038126|chronic kidney disease|chronic kidney disease
4731746|NCT03038126|patient safety|patient safety
4731747|NCT03038126|home telehealth|home telehealth
4731748|NCT03038061|Diaphragm|diaphragm
4731749|NCT03038061|EIT|eit
4731750|NCT03038061|Laparoscopy|laparoscopy
4731751|NCT03038009|Coronary Artery Bypass Graft|coronary artery bypass graft
4731752|NCT03038009|Dual Antiplatelet Therapy|dual antiplatelet therapy
4731753|NCT03038009|Gastrointestinal|gastrointestinal
4731754|NCT03038009|Mucosal Injury|mucosal injury
4731755|NCT03038009|Proton Pump Inhibitor|proton pump inhibitor
4731756|NCT03037996|anesthesia|anesthesia
4731757|NCT03037996|satisfaction|satisfaction
4731758|NCT03037983|Schizophrenia|schizophrenia
4731759|NCT03037983|Transcranial magnetic stimulation|transcranial magnetic stimulation
4731760|NCT03037983|Electroencephalography|electroencephalography
4731761|NCT03037944|Adenomyosis|adenomyosis
4731762|NCT03037944|Contraceptive pills|contraceptive pills
4731763|NCT03037944|Levonorgestrel-releasing Intrauterine System|levonorgestrel-releasing intrauterine system
4731764|NCT03037918|Gut Microbiota|gut microbiota
4731765|NCT03037918|High Fat Diets|high fat diets
4731766|NCT03037918|Probiotics|probiotics
4731767|NCT03037918|Glycaemic Control|glycaemic control
4731768|NCT03037853|Atlas|atlas
4731769|NCT03037853|Full human Body|full human body
4731770|NCT03037853|MRI|mri
4731771|NCT03037840|RF EMF|rf emf
4731772|NCT03037840|In Vivo|in vivo
4731773|NCT03037840|tumor specific frequencies|tumor specific frequencies
4731774|NCT03037827|endovenous laser ablation|endovenous laser ablation
4731775|NCT03037827|radial fiber|radial fiber
4731776|NCT03037827|linear endovenous energy density|linear endovenous energy density
4731777|NCT03037827|1470 nm|1470 nm
4731778|NCT03037827|occlusion rate|occlusion rate
4731779|NCT03037814|restorative materials|restorative materials
4731780|NCT03037814|primary teeth|primary teeth
4731781|NCT03037814|children|children
4731782|NCT03037788|Excessive sweating|excessive sweating
4731783|NCT03037775|tobacco|tobacco
4731784|NCT03037775|cardiovascular system|cardiovascular system
4731785|NCT03037775|sympathetic nervous system|sympathetic nervous system
4731786|NCT03037684|neuropathic pain|neuropathic pain
4731787|NCT03037684|chronic postoperative pain|chronic postoperative pain
4731788|NCT03037671|Malglycemia|malglycemia
4731789|NCT03037658|physical activity|physical activity
4731790|NCT03037658|walking|walking
4731791|NCT03037658|incentive|incentive
4731792|NCT03037658|step count|step count
4731793|NCT03037645|CLL|cll
4731794|NCT03037645|hematological diseases|hematological diseases
4731795|NCT03037645|relapsed|relapsed
4731796|NCT03037645|cancer|cancer
4731797|NCT03037645|malignancy|malignancy
4731798|NCT03037645|SNS-062|sns-062
4731799|NCT03037645|B-lymphoid|b-lymphoid
4731800|NCT03037645|chronic lymphocytic leukemia|chronic lymphocytic leukemia
4731801|NCT03037645|small lymphocytic lymphoma|small lymphocytic lymphoma
4731802|NCT03037645|lymphoplasmacytoid lymphoma|lymphoplasmacytoid lymphoma
4731803|NCT03037645|Waldenström's macrogloulinemia|waldenström's macrogloulinemia
4731804|NCT03037645|mantle cell lymphoma|mantle cell lymphoma
4731805|NCT03037645|SLL|sll
4731806|NCT03037645|LPL|lpl
4731807|NCT03037645|WM|wm
4731808|NCT03037645|MCL|mcl
4731809|NCT03037645|refractory|refractory
4731810|NCT03037645|DLBCL-ABC|dlbcl-abc
4731811|NCT03037645|DLBCL|dlbcl
4731812|NCT03037645|follicular lymphoma|follicular lymphoma
4731813|NCT03037645|diffuse large B-cell lymphoma|diffuse large b-cell lymphoma
4731814|NCT03037645|CLL/SLL|cll/sll
4731815|NCT03037593|Pregnancy|pregnancy
4731816|NCT03037593|Gestational Diabetes|gestational diabetes
4731817|NCT03037580|Pulmonary Hypertension|pulmonary hypertension
4731818|NCT03037580|6-Minute Walk Test|6-minute walk test
4731819|NCT03037580|HFpEF|hfpef
4731820|NCT03037580|Oral Treprostinil|oral treprostinil
4731821|NCT03037554|Skin Temperature|skin temperature
4731822|NCT03037554|Hot Flashes|hot flashes
4731823|NCT03037554|Sleep Disturbance|sleep disturbance
4731824|NCT03037541|Wake Forest|wake forest
4731825|NCT03037541|Actinic Keratosis|actinic keratosis
4731826|NCT03037541|Cryosurgery|cryosurgery
4731827|NCT03037541|Cream|cream
4731828|NCT03037502|Men's Health|men's health
4731829|NCT03037502|weight loss|weight loss
4731830|NCT03037502|African American men|african american men
4731831|NCT03037502|Latino men|latino men
4731832|NCT03037437|Hepatocellular Cancer|hepatocellular cancer
4731833|NCT03037437|Sorafenib|sorafenib
4731834|NCT03037437|Hydroxychloroquine|hydroxychloroquine
4731835|NCT03037424|Cyroprecipitate|cyroprecipitate
4731836|NCT03037424|Fibrinogen|fibrinogen
4731837|NCT03037424|Cardiac Surgery|cardiac surgery
4731838|NCT03037411|Atherosclerosis|atherosclerosis
4731839|NCT03037411|Superficial Femoral Artery (SFA)|superficial femoral artery (sfa)
4731840|NCT03037411|Proximal Popliteal Artery (PPA)|proximal popliteal artery (ppa)
4731841|NCT03037411|Stenting|stenting
4731842|NCT03037411|Paclitaxel|paclitaxel
4731843|NCT03037411|Health Economics|health economics
4731844|NCT03037385|RET Lung|ret lung
4731845|NCT03037385|RET Thyroid|ret thyroid
4731846|NCT03037385|RET fusion|ret fusion
4731847|NCT03037385|RET alteration|ret alteration
4731848|NCT03037385|RET mutation|ret mutation
4731849|NCT03037385|RET positive|ret positive
4731850|NCT03037385|RET inhibitor|ret inhibitor
4731851|NCT03037385|RET altered|ret altered
4731852|NCT03037385|RET rearrangement|ret rearrangement
4731853|NCT03037385|RET NSCLC|ret nsclc
4731854|NCT03037385|RET medullary thyroid cancer|ret medullary thyroid cancer
4731855|NCT03037385|RET-rearranged NSCLC|ret-rearranged nsclc
4731856|NCT03037385|RET-rearranged thyroid|ret-rearranged thyroid
4731857|NCT03037385|M918T|m918t
4731858|NCT03037385|TRIM33-RET|trim33-ret
4731859|NCT03037385|RET fusion lung cancer|ret fusion lung cancer
4731860|NCT03037385|RET fusion thyroid cancer|ret fusion thyroid cancer
4731861|NCT03037385|lung cancer mutation|lung cancer mutation
4731862|NCT03037385|BLUE 667|blue 667
4731863|NCT03037385|RET tyrosine kinase|ret tyrosine kinase
4731864|NCT03037385|RET gene mutation|ret gene mutation
4731865|NCT03037385|RET kinase|ret kinase
4731866|NCT03037385|RET MTC|ret mtc
4731867|NCT03037385|advanced lung cancer|advanced lung cancer
4731868|NCT03037385|advanced non small cell lung cancer|advanced non small cell lung cancer
4731869|NCT03037385|metastatic lung cancer|metastatic lung cancer
4731870|NCT03037385|KIF5B-RET|kif5b-ret
4731871|NCT03037385|CCDC6-RET|ccdc6-ret
4731872|NCT03037385|NCOA4-RET|ncoa4-ret
4731873|NCT03037385|advance solid tumor|advance solid tumor
4731874|NCT03037385|V804L|v804l
4731875|NCT03037385|V804M|v804m
4731876|NCT03037385|thyroid cancer RET inhibitor|thyroid cancer ret inhibitor
4731877|NCT03037385|lung cancer RET inhibitor|lung cancer ret inhibitor
4731878|NCT03037385|RET PTC|ret ptc
4731879|NCT03037385|rearranged during transfection|rearranged during transfection
4731880|NCT03037372|adults|adults
4731881|NCT03037372|antiretroviral therapy|antiretroviral therapy
4731882|NCT03037359|PID|pid
4731883|NCT03037346|Malignant neoplasms of female genital organs|malignant neoplasms of female genital organs
4731884|NCT03037346|Invasive gynecologic malignancy|invasive gynecologic malignancy
4731885|NCT03037346|Medical Power of Attorney Documents|medical power of attorney documents
4731886|NCT03037346|MPOAD|mpoad
4731887|NCT03037346|Questionnaires|questionnaires
4731888|NCT03037346|Surveys|surveys
4731889|NCT03037333|echocardiogram|echocardiogram
4731890|NCT03037333|Electrocardiogram: Electrical Alternans|electrocardiogram: electrical alternans
4731891|NCT03037333|fluoroscopy|fluoroscopy
4731892|NCT03037229|Myocardial Infarction|myocardial infarction
4731893|NCT03037229|Ischemia|ischemia
4731894|NCT03037229|Myocardial Ischemia|myocardial ischemia
4731895|NCT03037229|Heart Diseases|heart diseases
4731896|NCT03037229|Cardiovascular Diseases|cardiovascular diseases
4731897|NCT03037229|Vascular Diseases|vascular diseases
4731898|NCT03037216|Exercise|exercise
4731899|NCT03037164|INTERCEPT|intercept
4731900|NCT03037164|Red Blood Cells|red blood cells
4731901|NCT03037164|RBC|rbc
4731902|NCT03037164|Pathogen Inactivation|pathogen inactivation
4731903|NCT03037164|Zika|zika
4731904|NCT03037164|Cerus|cerus
4731905|NCT03037164|Pathogen Reduction|pathogen reduction
4731906|NCT03037151|Safety|safety
4731907|NCT03037151|Efficacy|efficacy
4731908|NCT03037151|grazoprevir|grazoprevir
4731909|NCT03037151|elbasvir|elbasvir
4731910|NCT03037151|compensated cirrhosis|compensated cirrhosis
4731911|NCT03037151|genotype 1 (GT1)|genotype 1 (gt1)
4731912|NCT03037151|genotype 6 (GT6)|genotype 6 (gt6)
4731913|NCT03037151|hepatitis virus C (HCV)|hepatitis virus c (hcv)
4731914|NCT03037151|human immunodeficiency virus (HIV)|human immunodeficiency virus (hiv)
4731915|NCT03037138|postdialysis washed-out|postdialysis washed-out
4731916|NCT03037099|Glycemic index|glycemic index
4731917|NCT03037099|dietary intakes|dietary intakes
4731918|NCT03037086|NSCLC|nsclc
4731919|NCT03037073|Duloxetine|duloxetine
4731920|NCT03037073|Succinylcholine|succinylcholine
4731921|NCT03037073|Postoperative Myalgia|postoperative myalgia
4731922|NCT03037073|Microlaryngoscopy|microlaryngoscopy
4731923|NCT03037060|Alcohol use, problem|alcohol use, problem
4731924|NCT03037021|Sickle Cell Disease|sickle cell disease
4731925|NCT03037021|Needs Assessment|needs assessment
4731926|NCT03037021|Barriers to care|barriers to care
4731927|NCT03037021|Access to care|access to care
4731928|NCT03037021|Primary care|primary care
4731929|NCT03037008|perineal sonography|perineal sonography
4731930|NCT03037008|male sling|male sling
4731931|NCT03037008|post prostatectomy incontinence|post prostatectomy incontinence
4731932|NCT03037008|ultrasonography|ultrasonography
4731933|NCT03036956|subclinical hypothyroidism in pregnancy|subclinical hypothyroidism in pregnancy
4731934|NCT03036904|venetoclax|venetoclax
4731935|NCT03036904|dose-adjusted EPOCH-R|dose-adjusted epoch-r
4731936|NCT03036904|aggressive B-Cell lymphoma|aggressive b-cell lymphoma
4731937|NCT03036904|Lymphoma|lymphoma
4731938|NCT03036904|Non-Hodgkin lymphoma|non-hodgkin lymphoma
4731939|NCT03036904|Diffuse large B-cell lymphoma|diffuse large b-cell lymphoma
4731940|NCT03036904|Double hit lymphoma|double hit lymphoma
4731941|NCT03036891|Gastroparesis|gastroparesis
4731942|NCT03036891|Opioid-Induced|opioid-induced
4731943|NCT03036891|Delayed Gastric Emptying|delayed gastric emptying
4731944|NCT03036878|Osteochondral|osteochondral
4731945|NCT03036878|Marrow Stimulation|marrow stimulation
4731946|NCT03036878|ReNu|renu
4731947|NCT03036865|Healthy participants|healthy participants
4731948|NCT03036865|BOS161721|bos161721
4731949|NCT03036865|Pharmacokinetics|pharmacokinetics
4731950|NCT03036865|Pharmacodynamics|pharmacodynamics
4731951|NCT03036826|renal replacement therapy|renal replacement therapy
4731952|NCT03036787|Premature Baby|premature baby
4731953|NCT03036787|motor development|motor development
4731954|NCT03036787|cognitive development|cognitive development
4731955|NCT03036774|Gastric contents|gastric contents
4731956|NCT03036774|Ultrasound|ultrasound
4731957|NCT03036774|Diabetes|diabetes
4731958|NCT03036761|Auriculotherapy|auriculotherapy
4731959|NCT03036696|Retention|retention
4731960|NCT03036696|Lactation|lactation
4731961|NCT03036696|Human milk|human milk
4731962|NCT03036696|Pregnancy|pregnancy
4731963|NCT03036696|Clinical Research Studies|clinical research studies
4731964|NCT03036696|BEACH|beach
4731965|NCT03036657|Acupuncture|acupuncture
4731966|NCT03036657|Electroacupuncture|electroacupuncture
4731967|NCT03036657|Nerve Conduction Studies|nerve conduction studies
4731968|NCT03036657|Quantitative Sensory Testing|quantitative sensory testing
4731969|NCT03036644|electronic cigarette|electronic cigarette
4731970|NCT03036644|e-cigarette|e-cigarette
4731971|NCT03036644|oxidative stress|oxidative stress
4731972|NCT03036644|tobacco smoking|tobacco smoking
4731973|NCT03036618|BMI|bmi
4731974|NCT03036618|Blood Cholesterol|blood cholesterol
4731975|NCT03036618|Glucose|glucose
4731976|NCT03036618|Insulin|insulin
4731977|NCT03036618|Gut health|gut health
4731978|NCT03036605|dexamethasone|dexamethasone
4731979|NCT03036605|bupivacaine|bupivacaine
4731980|NCT03036605|nasal surgery|nasal surgery
4731981|NCT03036605|nasal packing|nasal packing
4731982|NCT03036592|Glucose tolerance test, MTNR1B, nutrigenomics, food timing|glucose tolerance test, mtnr1b, nutrigenomics, food timing
4731983|NCT03036579|CAD/CAM|cad/cam
4731984|NCT03036579|Ceramic|ceramic
4731985|NCT03036579|Crown|crown
4731986|NCT03036553|Chronic pain|chronic pain
4731987|NCT03036553|Psychological factors|psychological factors
4731988|NCT03036553|Musculoskeletal pain|musculoskeletal pain
4731989|NCT03036553|Prognosis|prognosis
4731990|NCT03036540|upper limb thrombosis, midline catheter|upper limb thrombosis, midline catheter
4731991|NCT03036527|Bladder|bladder
4731992|NCT03036527|Sexual Function|sexual function
4731993|NCT03036514|numeric rating scale|numeric rating scale
4731994|NCT03036514|opioid side effects|opioid side effects
4731995|NCT03036488|PD1|pd1
4731996|NCT03036488|PD-1|pd-1
4731997|NCT03036488|PDL1|pdl1
4731998|NCT03036488|PD-L1|pd-l1
4731999|NCT03036462|intravenous iron|intravenous iron
4732000|NCT03036462|systolic heart failure|systolic heart failure
4732001|NCT03036462|iron deficiency|iron deficiency
4732002|NCT03036462|morbidity|morbidity
4732003|NCT03036462|mortality|mortality
4732004|NCT03036449|Medication errors|medication errors
4732005|NCT03036449|Patient safety|patient safety
4732006|NCT03036436|Cancer|cancer
4732007|NCT03036436|EHealth|ehealth
4732008|NCT03036436|Cancer Survivor|cancer survivor
4732009|NCT03036436|Rehabilitation|rehabilitation
4732010|NCT03036410|Hearing Aid Usage (monaural, binaural)|hearing aid usage (monaural, binaural)
4732011|NCT03036410|Cochlear Implant Usage (monaural, binaural)|cochlear implant usage (monaural, binaural)
4732012|NCT03036410|Hearing Aid and Cochlear Implant Usage (monaural)|hearing aid and cochlear implant usage (monaural)
4732013|NCT03036397|Anxiety|anxiety
4732014|NCT03036397|Vasopressin|vasopressin
4732015|NCT03036397|Fear-Potentiated Startle|fear-potentiated startle
4732016|NCT03036397|Shock Threat|shock threat
4732017|NCT03036397|Emotion Recognition|emotion recognition
4732018|NCT03036384|scheduled cesarean delivery|scheduled cesarean delivery
4732019|NCT03036384|spinal anesthesia|spinal anesthesia
4732020|NCT03036384|local anesthesia|local anesthesia
4732021|NCT03036371|Neurogenesis|neurogenesis
4732022|NCT03036371|Memory|memory
4732023|NCT03036371|Spatial Processing|spatial processing
4732024|NCT03036371|Hippocampus|hippocampus
4732025|NCT03036371|Cognition|cognition
4732026|NCT03036371|Aerobic Exercise|aerobic exercise
4732027|NCT03036332|aerobic interval training|aerobic interval training
4732028|NCT03036332|biomarkers|biomarkers
4732029|NCT03036306|scar|scar
4732030|NCT03036306|nefopam|nefopam
4732031|NCT03036306|cicatrix|cicatrix
4732032|NCT03036280|E2609|e2609
4732033|NCT03036280|elenbecestat|elenbecestat
4732034|NCT03036280|Alzheimer's Disease|alzheimer's disease
4732035|NCT03036280|Early Alzheimer's Disease|early alzheimer's disease
4732036|NCT03036280|Prodromal Alzheimer's Disease|prodromal alzheimer's disease
4732037|NCT03036280|Dementia|dementia
4732038|NCT03036280|Dementia, Alzheimer's type|dementia, alzheimer's type
4732039|NCT03036280|mild cognitive impairment|mild cognitive impairment
4732040|NCT03036280|MissionAD2|missionad2
4732041|NCT03036267|health disparity|health disparity
4732042|NCT03036267|motivational interviewing|motivational interviewing
4732043|NCT03036267|African American adults|african american adults
4732044|NCT03036267|Federally Qualified Health Centers|federally qualified health centers
4732045|NCT03036267|adherence|adherence
4732046|NCT03036267|health beliefs|health beliefs
4732047|NCT03036267|self-management|self-management
4732048|NCT03036267|asthma control|asthma control
4732049|NCT03036254|Diabetes Mellitus|diabetes mellitus
4732050|NCT03036254|Cognition|cognition
4732051|NCT03036241|drug-eluting balloon,|drug-eluting balloon,
4732052|NCT03036241|target lesion revascularization (TLR)|target lesion revascularization (tlr)
4732053|NCT03036241|restenosis|restenosis
4732054|NCT03036228|Solid tumours|solid tumours
4732055|NCT03036202|epinephrine|epinephrine
4732056|NCT03036163|Tuberculosis|tuberculosis
4732057|NCT03036150|Chronic Kidney Disease (CKD)|chronic kidney disease (ckd)
4732058|NCT03036150|Cardiovascular Events (CV)|cardiovascular events (cv)
4732059|NCT03036150|Phase III outcome trial|phase iii outcome trial
4732060|NCT03036137|Tinnitus|tinnitus
4732061|NCT03036137|Electroencephalogram|electroencephalogram
4732062|NCT03036137|Transcranial Direct Current Stimulation|transcranial direct current stimulation
4732063|NCT03036124|HFrEF|hfref
4732064|NCT03036124|Heart Failure (HF)|heart failure (hf)
4732065|NCT03036124|Cardiovascular Events (CV)|cardiovascular events (cv)
4732066|NCT03036124|Phase III outcome trial|phase iii outcome trial
4732067|NCT03036085|postoperative pain|postoperative pain
4732068|NCT03036085|video-assisted thoracoscopic surgery (VATS)|video-assisted thoracoscopic surgery (vats)
4732069|NCT03036085|opioids|opioids
4732070|NCT03036085|bupivacaine|bupivacaine
4732071|NCT03036085|liposomal bupivacaine|liposomal bupivacaine
4732072|NCT03036085|analgesia|analgesia
4732073|NCT03036085|local anesthetics|local anesthetics
4732074|NCT03036072|Therapeutic Hypothermia|therapeutic hypothermia
4732075|NCT03036059|Twice a year treatment|twice a year treatment
4732076|NCT03036059|Biannual treatment|biannual treatment
4732077|NCT03036059|Wuchereria bancrofti|wuchereria bancrofti
4732078|NCT03036007|Spine, Disc, Neck pain, Rehabilitation, Exercise Therapy, Internet|spine, disc, neck pain, rehabilitation, exercise therapy, internet
4732079|NCT03035968|Vojta therapy|vojta therapy
4732080|NCT03035968|reflex locomotion|reflex locomotion
4732081|NCT03035968|stroke rehabilitation|stroke rehabilitation
4732082|NCT03035968|stroke|stroke
4732083|NCT03035968|physiotherapy|physiotherapy
4732084|NCT03035955|Rosacea|rosacea
4732085|NCT03035955|Wake Forest|wake forest
4732086|NCT03035955|Demodex|demodex
4732087|NCT03035955|Finacea Gel|finacea gel
4732088|NCT03035942|Intrathecal morphine|intrathecal morphine
4732089|NCT03035942|Nausea and vomiting|nausea and vomiting
4732090|NCT03035942|Quality of recovery|quality of recovery
4732091|NCT03035942|Patient satisfaction|patient satisfaction
4732092|NCT03035942|Pruritus|pruritus
4732093|NCT03035942|Postoperative pain|postoperative pain
4732094|NCT03035916|transversus abdominal plane block|transversus abdominal plane block
4732095|NCT03035916|epidural anesthesia|epidural anesthesia
4732096|NCT03035916|stress response|stress response
4732097|NCT03035916|anesthetic recovery|anesthetic recovery
4732098|NCT03035890|NSCLC|nsclc
4732099|NCT03035890|Lung Cancer|lung cancer
4732100|NCT03035890|Non Small Cell Lung Cancer|non small cell lung cancer
4732101|NCT03035877|Antisocial Behavior|antisocial behavior
4732102|NCT03035877|Alcohol Abuse|alcohol abuse
4732103|NCT03035877|Drug Abuse|drug abuse
4732104|NCT03035877|Young Adults|young adults
4732105|NCT03035864|Ocular discomfort after cataract and refractive surgery|ocular discomfort after cataract and refractive surgery
4732106|NCT03035864|cataract surgery|cataract surgery
4732107|NCT03035864|refractive surgery|refractive surgery
4732108|NCT03035851|Alzheimer Disease|alzheimer disease
4732109|NCT03035851|Dementia|dementia
4732110|NCT03035851|Exercise|exercise
4732111|NCT03035851|Physical Activity|physical activity
4732112|NCT03035851|Brain blood flow|brain blood flow
4732113|NCT03035851|Cognition|cognition
4732114|NCT03035851|Fitness|fitness
4732115|NCT03035812|Bicarbonate|bicarbonate
4732116|NCT03035773|Cancer|cancer
4732117|NCT03035773|Oncology|oncology
4732118|NCT03035773|Survivorship|survivorship
4732119|NCT03035760|Helminths|helminths
4732120|NCT03035760|Oxfendazole|oxfendazole
4732121|NCT03035760|Pharmacokinetics|pharmacokinetics
4732122|NCT03035760|Safety|safety
4732123|NCT03035747|registry|registry
4732124|NCT03035747|varicose veins|varicose veins
4732125|NCT03035747|conventional surgery|conventional surgery
4732126|NCT03035747|thermal ablation|thermal ablation
4732127|NCT03035747|radiofrequency|radiofrequency
4732128|NCT03035747|laser|laser
4732129|NCT03035747|sclerotherapy|sclerotherapy
4732130|NCT03035721|Full term healthy infants|full term healthy infants
4732131|NCT03035721|Low protein content formula|low protein content formula
4732132|NCT03035721|Safety|safety
4732133|NCT03035721|Growth|growth
4732134|NCT03035721|Body composition|body composition
4732135|NCT03035695|Trauma|trauma
4732136|NCT03035695|Scalp injuries|scalp injuries
4732137|NCT03035695|Profused Bleeding|profused bleeding
4732138|NCT03035695|Accident|accident
4732139|NCT03035656|Pain|pain
4732140|NCT03035656|analgesic|analgesic
4732141|NCT03035656|spinal fusion|spinal fusion
4732142|NCT03035630|Avelumab|avelumab
4732143|NCT03035630|Sunitinib|sunitinib
4732144|NCT03035630|MSB0010718C|msb0010718c
4732145|NCT03035630|Sutent|sutent
4732146|NCT03035630|IgG1 antibody|igg1 antibody
4732147|NCT03035630|Anti-PD-L1|anti-pd-l1
4732148|NCT03035630|Tyrosine kinase inhibitor|tyrosine kinase inhibitor
4732149|NCT03035617|Bupivacaine|bupivacaine
4732150|NCT03035604|Malnutrition|malnutrition
4732151|NCT03035604|Nutritional status|nutritional status
4732152|NCT03035604|Mini Nutritional Assessment|mini nutritional assessment
4732153|NCT03035604|MNA|mna
4732154|NCT03035604|Weight loss|weight loss
4732155|NCT03035604|Body Mass Index|body mass index
4732156|NCT03035604|BMI|bmi
4732157|NCT03035604|Lean muscle mas|lean muscle mas
4732158|NCT03035604|American Society for Parenteral and Enteral Nutrition|american society for parenteral and enteral nutrition
4732159|NCT03035578|Pharmacokinetics|pharmacokinetics
4732160|NCT03035578|Pharmacodynamics|pharmacodynamics
4732161|NCT03035578|Morphine|morphine
4732162|NCT03035578|Neonatal|neonatal
4732163|NCT03035565|Heart Failure|heart failure
4732164|NCT03035565|Cognition in Heart Failure|cognition in heart failure
4732165|NCT03035552|Congenital heart disease (CCHD)|congenital heart disease (cchd)
4732166|NCT03035552|Non-Nutritive Suck|non-nutritive suck
4732167|NCT03035539|Rehabilitation|rehabilitation
4732168|NCT03035513|Continuous spikes|continuous spikes
4732169|NCT03035513|Epilepsy|epilepsy
4732170|NCT03035513|Nervous system disease|nervous system disease
4732171|NCT03035513|Neuronal plasticity|neuronal plasticity
4732172|NCT03035513|Diffusion MRI|diffusion mri
4732173|NCT03035513|Functional MRI|functional mri
4732174|NCT03035513|waves during slow sleep (CSWS)|waves during slow sleep (csws)
4732175|NCT03035474|Heart Failure|heart failure
4732176|NCT03035474|Quality Improvement|quality improvement
4732177|NCT03035461|diagnosis annoucement|diagnosis annoucement
4732178|NCT03035461|patient's feelings|patient's feelings
4732179|NCT03035448|Malignant neoplasms of independent (primary) multiple sites|malignant neoplasms of independent (primary) multiple sites
4732180|NCT03035448|Advanced cancer|advanced cancer
4732181|NCT03035448|Recurrent cancer|recurrent cancer
4732182|NCT03035448|Metastatic disease|metastatic disease
4732183|NCT03035448|Palliative care|palliative care
4732184|NCT03035448|Videos|videos
4732185|NCT03035448|Questionnaires|questionnaires
4732186|NCT03035448|Surveys|surveys
4732187|NCT03035435|fast-track rehabilitation|fast-track rehabilitation
4732188|NCT03035435|fast-track surgery|fast-track surgery
4732189|NCT03035422|Allogenic cell stem transplant, Sequential chemotherapy Haploidentical transplant|allogenic cell stem transplant, sequential chemotherapy haploidentical transplant
4732190|NCT03035409|Malignant neoplasms of independent (primary) multiple sites|malignant neoplasms of independent (primary) multiple sites
4732191|NCT03035409|Advanced Cancer|advanced cancer
4732192|NCT03035409|Metastatic or recurrent incurable solid tumors|metastatic or recurrent incurable solid tumors
4732193|NCT03035409|Anamorelin|anamorelin
4732194|NCT03035409|Physical activity|physical activity
4732195|NCT03035409|Questionnaires|questionnaires
4732196|NCT03035409|Surveys|surveys
4732197|NCT03035409|Dietary Counseling|dietary counseling
4732198|NCT03035409|Exercise Counseling|exercise counseling
4732199|NCT03035383|Large thyroid|large thyroid
4732200|NCT03035383|purse string suture|purse string suture
4732201|NCT03035383|thyroidectomy|thyroidectomy
4732202|NCT03035370|Pertussis|pertussis
4732203|NCT03035370|Epicutaneous ImmunoTherapy (EPIT)|epicutaneous immunotherapy (epit)
4732204|NCT03035370|Vaccine|vaccine
4732205|NCT03035370|Viaskin PT|viaskin pt
4732206|NCT03035357|Malignant neoplasms of male genital organs|malignant neoplasms of male genital organs
4732207|NCT03035357|Prostate cancer|prostate cancer
4732208|NCT03035357|Adenocarcinoma of the prostate|adenocarcinoma of the prostate
4732209|NCT03035357|Daratumumab|daratumumab
4732210|NCT03035357|Biomarker response|biomarker response
4732211|NCT03035305|Seasonal malaria chemoprevention|seasonal malaria chemoprevention
4732212|NCT03035305|Lipid-based nutrient supplement|lipid-based nutrient supplement
4732213|NCT03035305|Children|children
4732214|NCT03035305|Mali|mali
4732215|NCT03035279|Advanced colorectal cancer|advanced colorectal cancer
4732216|NCT03035279|Cancer|cancer
4732217|NCT03035279|Metastatic colorectal cancer|metastatic colorectal cancer
4732218|NCT03035279|Unresectable colorectal cancer|unresectable colorectal cancer
4732219|NCT03035279|Maximum tolerated dose|maximum tolerated dose
4732220|NCT03035279|Pharmacokinetics|pharmacokinetics
4732221|NCT03035266|blood flow restriction|blood flow restriction
4732222|NCT03035266|strength|strength
4732223|NCT03035266|muscle atrophy|muscle atrophy
4732224|NCT03035266|post-operative therapy|post-operative therapy
4732225|NCT03035266|knee|knee
4732226|NCT03035201|Memory|memory
4732227|NCT03035201|Mild Cognitive Impairment|mild cognitive impairment
4732228|NCT03035201|Alzheimer's Disease|alzheimer's disease
4732229|NCT03035201|Cognition|cognition
4732230|NCT03035188|resectable|resectable
4732231|NCT03035175|Residences|residences
4732232|NCT03035175|Video Laryngoscopy|video laryngoscopy
4732233|NCT03035175|Intubations|intubations
4732234|NCT03035175|Neonatal|neonatal
4732235|NCT03035175|NICU|nicu
4732236|NCT03035175|neonates|neonates
4732237|NCT03035175|Medical Education|medical education
4732238|NCT03035162|dual tDCS|dual tdcs
4732239|NCT03035162|physical rehabilitation|physical rehabilitation
4732240|NCT03035162|lower limb functions|lower limb functions
4732241|NCT03035149|Obesity|obesity
4732242|NCT03035149|Metabolic Syndrome|metabolic syndrome
4732243|NCT03035149|Dyspnea|dyspnea
4732244|NCT03035149|Pulmonary Function|pulmonary function
4732245|NCT03035149|Exercise Capacity|exercise capacity
4732246|NCT03035136|polyps|polyps
4732247|NCT03035123|Heart Failure|heart failure
4732248|NCT03035123|Therapeutic education|therapeutic education
4732249|NCT03035123|Quality of life|quality of life
4732250|NCT03035071|Minimal-invasive esophagectomy|minimal-invasive esophagectomy
4732251|NCT03035071|Esophageal resection|esophageal resection
4732252|NCT03035071|Hybrid esophagectomy|hybrid esophagectomy
4732253|NCT03035058|Drug therapy|drug therapy
4732254|NCT03035032|Leuprolide acetate|leuprolide acetate
4732255|NCT03035032|Prostate cancer|prostate cancer
4732256|NCT03035019|anxiety|anxiety
4732257|NCT03035019|behavioral app|behavioral app
4732258|NCT03035006|Hepatocellular carcinoma|hepatocellular carcinoma
4732259|NCT03035006|Portal vein tumor thrombosis|portal vein tumor thrombosis
4732260|NCT03035006|TLC388|tlc388
4732261|NCT03035006|Chemoradiotherapy|chemoradiotherapy
4732262|NCT03035006|Lipotecan|lipotecan
4732263|NCT03034993|Healthcare for homeless|healthcare for homeless
4732264|NCT03034993|Text messages|text messages
4732265|NCT03034993|Primary care visits|primary care visits
4732266|NCT03034993|Medication adherence|medication adherence
4732267|NCT03034993|Inpatient admissions|inpatient admissions
4732268|NCT03034967|HCRU exacerbations|hcru exacerbations
4732269|NCT03034967|SGRQ|sgrq
4732270|NCT03034967|CXCR2 antagonist|cxcr2 antagonist
4732271|NCT03034967|GSK1325756|gsk1325756
4732272|NCT03034967|Danirixin|danirixin
4732273|NCT03034967|COPD|copd
4732274|NCT03034941|Obesity|obesity
4732275|NCT03034941|PCOS|pcos
4732276|NCT03034941|Infertility|infertility
4732277|NCT03034941|Liraglutide|liraglutide
4732278|NCT03034941|Metformin|metformin
4732279|NCT03034941|IVF|ivf
4732280|NCT03034915|Vilanterol|vilanterol
4732281|NCT03034915|COPD|copd
4732282|NCT03034915|HRQoL|hrqol
4732283|NCT03034915|Salmeterol|salmeterol
4732284|NCT03034915|Umeclidinium|umeclidinium
4732285|NCT03034889|Anesthesia|anesthesia
4732286|NCT03034889|Children|children
4732287|NCT03034889|General Anesthesia|general anesthesia
4732288|NCT03034889|Neurocognitive Outcome|neurocognitive outcome
4732289|NCT03034876|"Acute Kidney Injury, diagnosis, children, shock"|"acute kidney injury, diagnosis, children, shock"
4732290|NCT03034863|Family Caregivers|family caregivers
4732291|NCT03034863|Spouse Caregivers|spouse caregivers
4732292|NCT03034863|Veterans|veterans
4732293|NCT03034863|Suicide|suicide
4732294|NCT03034863|Clinical Trial|clinical trial
4732295|NCT03034863|Military Families|military families
4732296|NCT03034863|Military Psychology|military psychology
4732297|NCT03034850|cytoreductive surgery|cytoreductive surgery
4732298|NCT03034850|hyperthermic intraperitoneal peroperative chemotherapy|hyperthermic intraperitoneal peroperative chemotherapy
4732299|NCT03034850|platelet function|platelet function
4732300|NCT03034850|thrombin generation|thrombin generation
4732301|NCT03034850|thromboelastometry|thromboelastometry
4732302|NCT03034824|diode laser|diode laser
4732303|NCT03034824|Er,Cr:YSGG laser|er,cr:ysgg laser
4732304|NCT03034824|Aggressive Periodontitis|aggressive periodontitis
4732305|NCT03034824|Clinical periodontal parameters|clinical periodontal parameters
4732306|NCT03034824|Gingival crevicular fluid cytokines levels|gingival crevicular fluid cytokines levels
4732307|NCT03034811|Noninflammatory degenerative joint disease|noninflammatory degenerative joint disease
4732308|NCT03034811|Osteoarthritis|osteoarthritis
4732309|NCT03034811|Avascular necrosis|avascular necrosis
4732310|NCT03034811|Traumatic arthritis|traumatic arthritis
4732311|NCT03034811|Partial knee arthroplasty|partial knee arthroplasty
4732312|NCT03034811|Unicompartmental knee arthroplasty|unicompartmental knee arthroplasty
4732313|NCT03034772|neovascular|neovascular
4732314|NCT03034772|wet|wet
4732315|NCT03034772|age-related|age-related
4732316|NCT03034772|macular degeneration|macular degeneration
4732317|NCT03034772|dorzolamide|dorzolamide
4732318|NCT03034772|timolol|timolol
4732319|NCT03034759|continuous glucose monitoring|continuous glucose monitoring
4732320|NCT03034746|alzheimer's disease, physical activity, cognitive training|alzheimer's disease, physical activity, cognitive training
4732321|NCT03034733|Arthroplasty|arthroplasty
4732322|NCT03034733|Knee Replacement|knee replacement
4732323|NCT03034733|Pain, Postoperative|pain, postoperative
4732324|NCT03034733|Glucocorticoids|glucocorticoids
4732325|NCT03034733|Dexamethasone|dexamethasone
4732326|NCT03034720|Concussion|concussion
4732327|NCT03034720|persistent post-concussive symptoms|persistent post-concussive symptoms
4732328|NCT03034720|CBT|cbt
4732329|NCT03034720|collaborative care|collaborative care
4732330|NCT03034720|Depression|depression
4732331|NCT03034720|Anxiety|anxiety
4732332|NCT03034707|biotin pharmacokinetic|biotin pharmacokinetic
4732333|NCT03034707|biotinylated assay|biotinylated assay
4732334|NCT03034707|hormone measurement|hormone measurement
4732335|NCT03034707|thyroid|thyroid
4732336|NCT03034707|parathyroid|parathyroid
4732337|NCT03034707|prolactin|prolactin
4732338|NCT03034668|Botanical Supplement|botanical supplement
4732339|NCT03034668|Performance-Enhancing Supplement|performance-enhancing supplement
4732340|NCT03034655|Vestibular rehabilitation|vestibular rehabilitation
4732341|NCT03034655|Falls in elderly|falls in elderly
4732342|NCT03034655|Computerized dynamic posturography|computerized dynamic posturography
4732343|NCT03034655|Mobile posturography|mobile posturography
4732344|NCT03034642|Apoptosis|apoptosis
4732345|NCT03034642|Bronchoscopy|bronchoscopy
4732346|NCT03034642|Human|human
4732347|NCT03034642|Mice, inbred strains|mice, inbred strains
4732348|NCT03034642|Macrophages, Alveolar|macrophages, alveolar
4732349|NCT03034642|MicroRNAs|micrornas
4732350|NCT03034642|Streptococcus pneumoniae|streptococcus pneumoniae
4732351|NCT03034642|Fluticasone|fluticasone
4732352|NCT03034616|Primary ovarian insufficiency|primary ovarian insufficiency
4732353|NCT03034616|In-vivo activation|in-vivo activation
4732354|NCT03034551|Adherence|adherence
4732355|NCT03034551|Financial Incentives|financial incentives
4732356|NCT03034551|Remote Monitoring|remote monitoring
4732357|NCT03034551|Self-Weighing|self-weighing
4732358|NCT03034551|Behavioral Economics|behavioral economics
4732359|NCT03034551|Telehealth|telehealth
4732360|NCT03034551|mobile health (mHealth)|mobile health (mhealth)
4732361|NCT03034551|Smartphone App|smartphone app
4732362|NCT03034551|Wellth App|wellth app
4732363|NCT03034486|Glaucoma|glaucoma
4732364|NCT03034473|locally advanced rectal cancer|locally advanced rectal cancer
4732365|NCT03034473|translational research|translational research
4732366|NCT03034473|Biomarker|biomarker
4732367|NCT03034447|Asthma|asthma
4732368|NCT03034447|Obstructive Sleep Apnea|obstructive sleep apnea
4732369|NCT03034447|Children|children
4732370|NCT03034447|Teenagers|teenagers
4732371|NCT03034408|Impulsivity|impulsivity
4732372|NCT03034408|Nalmefene|nalmefene
4732373|NCT03034408|Baclofen|baclofen
4732374|NCT03034395|Melanoma|melanoma
4732375|NCT03034395|cT2N0M0|ct2n0m0
4732376|NCT03034382|morphine|morphine
4732377|NCT03034382|nalbuphine|nalbuphine
4732378|NCT03034382|arthroscopic rotator cuff repair|arthroscopic rotator cuff repair
4732379|NCT03034382|ultrasound guided interscalene block|ultrasound guided interscalene block
4732380|NCT03034369|Integration|integration
4732381|NCT03034369|Primary Care|primary care
4732382|NCT03034369|Behavioral Health|behavioral health
4732383|NCT03034369|Health Care Reform|health care reform
4732384|NCT03034369|Medical Home|medical home
4732385|NCT03034369|Accountable Care Organization|accountable care organization
4732386|NCT03034356|Schizophrenia|schizophrenia
4732387|NCT03034343|Mindfulness|mindfulness
4732388|NCT03034343|Internet program|internet program
4732389|NCT03034343|Depression|depression
4732390|NCT03034343|Cost-effectiveness|cost-effectiveness
4732391|NCT03034330|informal care|informal care
4732392|NCT03034330|empowerment|empowerment
4732393|NCT03034330|family-focused intervention|family-focused intervention
4732394|NCT03034330|stroke rehabilitation|stroke rehabilitation
4732395|NCT03034317|Diaphragm Pacing|diaphragm pacing
4732396|NCT03034304|MASCT-I，DC，T cell|masct-i，dc，t cell
4732397|NCT03034304|Advanced solid tumors|advanced solid tumors
4732398|NCT03034304|Bladder Cancer|bladder cancer
4732399|NCT03034304|Soft Tissue Sarcoma|soft tissue sarcoma
4732400|NCT03034291|Cocoa|cocoa
4732401|NCT03034291|obesity|obesity
4732402|NCT03034291|HOMA-IR|homa-ir
4732403|NCT03034291|BMI|bmi
4732404|NCT03034291|Quality of life|quality of life
4732405|NCT03034278|opioid use|opioid use
4732406|NCT03034265|hypertension; exosome; angiotensin; sodium channel; kidney; aldosterone; renin; urine|hypertension; exosome; angiotensin; sodium channel; kidney; aldosterone; renin; urine
4732407|NCT03034226|Hypoglycemia-Associated Autonomic Failure (HAAF)|hypoglycemia-associated autonomic failure (haaf)
4732408|NCT03034213|mesh|mesh
4732409|NCT03034200|Pheochromocytoma-paraganglioma|pheochromocytoma-paraganglioma
4732410|NCT03034200|ONC201|onc201
4732411|NCT03034187|Acute toxicity|acute toxicity
4732412|NCT03034187|Late toxicity|late toxicity
4732413|NCT03034187|Quality of Life since 2011(set-up SFP-prostate)|quality of life since 2011(set-up sfp-prostate)
4732414|NCT03034174|tigecycline|tigecycline
4732415|NCT03034174|pharmacokinetics|pharmacokinetics
4732416|NCT03034148|Coronary artery disease|coronary artery disease
4732417|NCT03034148|Atherothrombosis|atherothrombosis
4732418|NCT03034148|Thrombin generation|thrombin generation
4732419|NCT03034148|Platelet Acetyl Coenzyme A carboxylase phosphorylation|platelet acetyl coenzyme a carboxylase phosphorylation
4732420|NCT03034109|Transcranial Direct Current Stimulation|transcranial direct current stimulation
4732421|NCT03034109|Stroke|stroke
4732422|NCT03034109|Electric Stimulation Therapy|electric stimulation therapy
4732423|NCT03034109|Prefrontal Cortex|prefrontal cortex
4732424|NCT03034109|Electroencephalography|electroencephalography
4732425|NCT03034109|Cognition|cognition
4732426|NCT03034109|Neurological Rehabilitation|neurological rehabilitation
4732427|NCT03034109|Memory|memory
4732428|NCT03034109|Working Memory|working memory
4732429|NCT03034109|Attention|attention
4732430|NCT03034109|Concentration|concentration
4732431|NCT03034109|Short-Term Memory|short-term memory
4732432|NCT03034109|Planning|planning
4732433|NCT03034109|Executive Function|executive function
4732434|NCT03034109|Cerebrovascular disease|cerebrovascular disease
4732435|NCT03034083|healthy marriage|healthy marriage
4732436|NCT03034083|healthy relationships|healthy relationships
4732437|NCT03034083|parenting|parenting
4732438|NCT03034083|healthy marriage and relationship education|healthy marriage and relationship education
4732439|NCT03034070|MRI|mri
4732440|NCT03034070|MRI sequences|mri sequences
4732441|NCT03034070|prostate cancer|prostate cancer
4732442|NCT03034070|cancer|cancer
4732443|NCT03034070|staging|staging
4732444|NCT03034070|bone metastasis|bone metastasis
4732445|NCT03034070|node metastasis|node metastasis
4732446|NCT03034031|Traumatic Brain Injury|traumatic brain injury
4732447|NCT03034031|Children|children
4732448|NCT03034031|Pediatric|pediatric
4732449|NCT03034031|MRI|mri
4732450|NCT03034031|fMRI|fmri
4732451|NCT03034031|Cognition|cognition
4732452|NCT03034031|DTI|dti
4732453|NCT03034031|Longitudinal|longitudinal
4732454|NCT03034031|Connectivity|connectivity
4732455|NCT03034031|DAI|dai
4732456|NCT03034031|Neuropsychology|neuropsychology
4732457|NCT03034031|Rehabilitation|rehabilitation
4732458|NCT03034018|insomnia|insomnia
4732459|NCT03034018|hot flashes|hot flashes
4732460|NCT03034018|menopause|menopause
4732461|NCT03034018|suvorexant|suvorexant
4732462|NCT03034018|belsomra|belsomra
4732463|NCT03034005|Inhaled corticosteroids|inhaled corticosteroids
4732464|NCT03034005|Airway hyper-responsiveness|airway hyper-responsiveness
4732465|NCT03034005|Airway smooth muscle|airway smooth muscle
4732466|NCT03034005|sodium-potassium pump|sodium-potassium pump
4732467|NCT03033966|Cerebral Oximetry|cerebral oximetry
4732468|NCT03033966|Cerebral Venous Thrombosis|cerebral venous thrombosis
4732469|NCT03033966|Decompressive Craniectomy|decompressive craniectomy
4732470|NCT03033927|Stage IV Pancreatic Cancer|stage iv pancreatic cancer
4732471|NCT03033927|FOLFIRINOX|folfirinox
4732472|NCT03033927|gem/nab-P chemotherapy|gem/nab-p chemotherapy
4732473|NCT03033927|17-042|17-042
4732474|NCT03033914|Nivolumab|nivolumab
4732475|NCT03033914|adriamycin|adriamycin
4732476|NCT03033914|bleomycin|bleomycin
4732477|NCT03033914|vinblastine|vinblastine
4732478|NCT03033914|dacarbazine|dacarbazine
4732479|NCT03033914|16-1536|16-1536
4732480|NCT03033901|Veterans|veterans
4732481|NCT03033901|Comparative Effectiveness Research|comparative effectiveness research
4732482|NCT03033901|Diagnosis|diagnosis
4732483|NCT03033836|transgender women|transgender women
4732484|NCT03033823|Alcoholism|alcoholism
4732485|NCT03033823|Delirium|delirium
4732486|NCT03033823|Magnesium Deficiency|magnesium deficiency
4732487|NCT03033797|assitive technology|assitive technology
4732488|NCT03033797|virtual reality games|virtual reality games
4732489|NCT03033797|intellectual disability|intellectual disability
4732490|NCT03033797|augmentative and alternative communication|augmentative and alternative communication
4732491|NCT03033784|Neuroscience|neuroscience
4732492|NCT03033758|comorbidities|comorbidities
4732493|NCT03033732|opioid agonist treatment|opioid agonist treatment
4732494|NCT03033732|pragmatic|pragmatic
4732495|NCT03033732|prescription opioid use|prescription opioid use
4732496|NCT03033732|patient engagement|patient engagement
4732497|NCT03033719|Colorectal Surgery|colorectal surgery
4732498|NCT03033719|Geriatrics|geriatrics
4732499|NCT03033719|Digestive Oncology|digestive oncology
4732500|NCT03033719|Colon cancer|colon cancer
4732501|NCT03033719|Elderly patients|elderly patients
4732502|NCT03033719|Laparoscopy|laparoscopy
4732503|NCT03033719|Laparotomy|laparotomy
4732504|NCT03033719|Morbidity|morbidity
4732505|NCT03033667|perioperative fasting|perioperative fasting
4732506|NCT03033667|free fatty acids|free fatty acids
4732507|NCT03033667|coronary bypass grfting|coronary bypass grfting
4732508|NCT03033589|Pain control|pain control
4732509|NCT03033589|Anterior Cruciate Ligament (ACL_ Reconstruction)|anterior cruciate ligament (acl_ reconstruction)
4732510|NCT03033589|Regional Anesthesia|regional anesthesia
4732511|NCT03033550|HPV vaccination|hpv vaccination
4732512|NCT03033550|Cervical cancer screening|cervical cancer screening
4732513|NCT03033550|Primary care setting|primary care setting
4732514|NCT03033550|Primary prevention of cervical cancer|primary prevention of cervical cancer
4732515|NCT03033550|Secondary prevention of cervical cancer|secondary prevention of cervical cancer
4732516|NCT03033550|Mobile health information|mobile health information
4732517|NCT03033511|Extensive-Stage Small Cell Lung Cancer (ED SCLC)|extensive-stage small cell lung cancer (ed sclc)
4732518|NCT03033511|Cancer|cancer
4732519|NCT03033511|Platinum-Based Chemotherapy|platinum-based chemotherapy
4732520|NCT03033511|Rovalpituzumab tesirine|rovalpituzumab tesirine
4732521|NCT03033511|first-line chemotherapy|first-line chemotherapy
4732522|NCT03033511|(SCLC)|(sclc)
4732523|NCT03033485|Picolinamide|picolinamide
4732524|NCT03033485|PET/CT|pet/ct
4732525|NCT03033485|Diagnosis|diagnosis
4732526|NCT03033485|Melanoma|melanoma
4732527|NCT03033459|breast feeding|breast feeding
4732528|NCT03033459|motivational interviewing|motivational interviewing
4732529|NCT03033420|Unipolar disorder|unipolar disorder
4732530|NCT03033420|Bipolar disorder|bipolar disorder
4732531|NCT03033420|Randomized controlled trial|randomized controlled trial
4732532|NCT03033420|Smartphone|smartphone
4732533|NCT03033420|Re-admission|re-admission
4732534|NCT03033420|CBT|cbt
4732535|NCT03033381|Children|children
4732536|NCT03033381|Inguinal hernia|inguinal hernia
4732537|NCT03033381|Testis|testis
4732538|NCT03033381|Doppler ultrasonography|doppler ultrasonography
4732539|NCT03033368|immunological outcome|immunological outcome
4732540|NCT03033368|virologic outcomes|virologic outcomes
4732541|NCT03033368|HIV-1 infected adolescents|hiv-1 infected adolescents
4732542|NCT03033368|EFV switch to RPV|efv switch to rpv
4732543|NCT03033368|Rilpivirine pharmacokinetic|rilpivirine pharmacokinetic
4732544|NCT03033368|neuropsychiatric adverse events|neuropsychiatric adverse events
4732545|NCT03033355|Neurogenic Bladder, Detrusor Overactivity, Botox, fMRI, neurogenic detrusor overactivity|neurogenic bladder, detrusor overactivity, botox, fmri, neurogenic detrusor overactivity
4732546|NCT03033342|Phase 1|phase 1
4732547|NCT03033316|Multiple Myeloma|multiple myeloma
4732548|NCT03033316|Liposomal Dexamethasone|liposomal dexamethasone
4732549|NCT03033316|Targeted Drug Delivery|targeted drug delivery
4732550|NCT03033303|Hu3F8|hu3f8
4732551|NCT03033303|GM-CSF|gm-csf
4732552|NCT03033303|Isotretinoin|isotretinoin
4732553|NCT03033303|16-1643|16-1643
4732554|NCT03033290|Qi-tonifying regimen|qi-tonifying regimen
4732555|NCT03033290|immune-modulation|immune-modulation
4732556|NCT03033290|gut microbiota|gut microbiota
4732557|NCT03033251|COPD exacerbation|copd exacerbation
4732558|NCT03033251|Work of breathing|work of breathing
4732559|NCT03033251|Non invasive ventilation|non invasive ventilation
4732560|NCT03033251|High Flow Oxygen Cannula|high flow oxygen cannula
4732561|NCT03033225|Pancrease|pancrease
4732562|NCT03033225|Cancer|cancer
4732563|NCT03033225|Photodynamic Therapy|photodynamic therapy
4732564|NCT03033225|Pancreatic|pancreatic
4732565|NCT03033225|Tumor|tumor
4732566|NCT03033225|unresectable|unresectable
4732567|NCT03033199|Gut microbiota|gut microbiota
4732568|NCT03033199|Immune thrombocytopenia|immune thrombocytopenia
4732569|NCT03033186|Everolimus|everolimus
4732570|NCT03033186|Long term site effects|long term site effects
4732571|NCT03033186|Dried Blood Spot|dried blood spot
4732572|NCT03033186|Therapeutic Drug Monitoring|therapeutic drug monitoring
4732573|NCT03033160|Estrogen|estrogen
4732574|NCT03033160|Hematuria|hematuria
4732575|NCT03033121|growth hormone|growth hormone
4732576|NCT03033121|children|children
4732577|NCT03033121|metabolism|metabolism
4732578|NCT03033095|TNF inhibitor|tnf inhibitor
4732579|NCT03033095|Etanercept|etanercept
4732580|NCT03033095|Spondyloarthritis|spondyloarthritis
4732581|NCT03033095|Biomarkers analysis|biomarkers analysis
4732582|NCT03033095|Personnalized medicine|personnalized medicine
4732583|NCT03033056|fear-conditioning|fear-conditioning
4732584|NCT03033056|behavioral avoidance|behavioral avoidance
4732585|NCT03033056|anxiety disorders|anxiety disorders
4732586|NCT03033056|fMRI|fmri
4732587|NCT03033043|aortic|aortic
4732588|NCT03033043|dissection|dissection
4732589|NCT03033043|type B|type b
4732590|NCT03033043|thoracic|thoracic
4732591|NCT03033030|Ultrasound|ultrasound
4732592|NCT03033030|Digital Breast Tomosynthesis|digital breast tomosynthesis
4732593|NCT03033030|Cancer Detection rate|cancer detection rate
4732594|NCT03033030|Sensitivity|sensitivity
4732595|NCT03033030|Specificity|specificity
4732596|NCT03033030|Breast density|breast density
4732597|NCT03033017|HIV|hiv
4732598|NCT03032991|Gestational diabetes|gestational diabetes
4732599|NCT03032991|Neurodevelopment|neurodevelopment
4732600|NCT03032991|Placenta|placenta
4732601|NCT03032991|Gut microbiota|gut microbiota
4732602|NCT03032991|Protectins|protectins
4732603|NCT03032991|MFSD2a|mfsd2a
4732604|NCT03032991|AdipoRon|adiporon
4732605|NCT03032965|atrial fibrillation|atrial fibrillation
4732606|NCT03032965|ablation|ablation
4732607|NCT03032965|adenosine|adenosine
4732608|NCT03032952|RCT|rct
4732609|NCT03032952|Computerised interventions|computerised interventions
4732610|NCT03032952|Mobile applications|mobile applications
4732611|NCT03032952|Stress, Psychological|stress, psychological
4732612|NCT03032952|Depressive symptoms|depressive symptoms
4732613|NCT03032952|Anxious symptoms|anxious symptoms
4732614|NCT03032952|Students|students
4732615|NCT03032952|Mental health|mental health
4732616|NCT03032926|Anxiety|anxiety
4732617|NCT03032913|Pancreas|pancreas
4732618|NCT03032913|Pancreatic|pancreatic
4732619|NCT03032913|Cancer|cancer
4732620|NCT03032913|Circulating tumor cell (CTC)|circulating tumor cell (ctc)
4732621|NCT03032913|Adenocarcinoma|adenocarcinoma
4732622|NCT03032913|Ductal|ductal
4732623|NCT03032913|Exosome|exosome
4732624|NCT03032900|Major lung resection|major lung resection
4732625|NCT03032900|Right Ventricular Dysfunction|right ventricular dysfunction
4732626|NCT03032900|2D Strain|2d strain
4732627|NCT03032887|hygiene|hygiene
4732628|NCT03032887|prenatal care|prenatal care
4732629|NCT03032887|postnatal care|postnatal care
4732630|NCT03032874|Colorectal cancer|colorectal cancer
4732631|NCT03032874|Polyps|polyps
4732632|NCT03032874|Colonoscopy|colonoscopy
4732633|NCT03032874|Rectal bleeding|rectal bleeding
4732634|NCT03032874|Nigeria|nigeria
4732635|NCT03032861|Orange juice|orange juice
4732636|NCT03032861|Microbiota|microbiota
4732637|NCT03032861|Prebiotic|prebiotic
4732638|NCT03032861|Flavanones|flavanones
4732639|NCT03032861|Bioavailability|bioavailability
4732640|NCT03032835|Calciphylaxis|calciphylaxis
4732641|NCT03032835|Warfarin|warfarin
4732642|NCT03032835|Dialysis|dialysis
4732643|NCT03032822|Opioid consumption|opioid consumption
4732644|NCT03032822|postdischarge|postdischarge
4732645|NCT03032822|cystectomy|cystectomy
4732646|NCT03032744|Pediatric|pediatric
4732647|NCT03032744|School Based Health Center|school based health center
4732648|NCT03032731|Physical activity|physical activity
4732649|NCT03032731|Diet|diet
4732650|NCT03032731|Health Behavior|health behavior
4732651|NCT03032705|Restorations|restorations
4732652|NCT03032705|Composite|composite
4732653|NCT03032679|pain, acute, chronic, knee arthroplasty|pain, acute, chronic, knee arthroplasty
4732654|NCT03032666|Thalassemia|thalassemia
4732655|NCT03032666|HCV|hcv
4732656|NCT03032666|Sofosbuvir|sofosbuvir
4732657|NCT03032666|Ledipasvir|ledipasvir
4732658|NCT03032653|ankle, fracture, rehabilitation, weightbearing, early, late|ankle, fracture, rehabilitation, weightbearing, early, late
4732659|NCT03032640|Glucose|glucose
4732660|NCT03032640|Sweet taste receptors|sweet taste receptors
4732661|NCT03032640|Artificial sweeteners|artificial sweeteners
4732662|NCT03032601|MS (Multiple Sclerosis)|ms (multiple sclerosis)
4732663|NCT03032601|Acute Fulminating|acute fulminating
4732664|NCT03032601|Sclerosis|sclerosis
4732665|NCT03032601|FDG|fdg
4732666|NCT03032601|18F Fluorodeoxyglucose|18f fluorodeoxyglucose
4732667|NCT03032601|18F-FDG|18f-fdg
4732668|NCT03032601|18FDG|18fdg
4732669|NCT03032601|2-Fluoro-2-deoxy-D-glucose|2-fluoro-2-deoxy-d-glucose
4732670|NCT03032601|2-Fluoro-2-deoxyglucose|2-fluoro-2-deoxyglucose
4732671|NCT03032601|Fludeoxyglucose F 18|fludeoxyglucose f 18
4732672|NCT03032601|Fluorine-18-fluorodeoxyglucose|fluorine-18-fluorodeoxyglucose
4732673|NCT03032601|Fluorodeoxyglucose F 18|fluorodeoxyglucose f 18
4732674|NCT03032601|PET Scan|pet scan
4732675|NCT03032601|Tomography, Positron-Emission|tomography, positron-emission
4732676|NCT03032601|Magnetic Resonance Imaging, Functional|magnetic resonance imaging, functional
4732677|NCT03032601|fMRI|fmri
4732678|NCT03032601|PET-MRI|pet-mri
4732679|NCT03032601|Acetylcysteine|acetylcysteine
4732680|NCT03032601|N-acetyl cysteine|n-acetyl cysteine
4732681|NCT03032601|NAC|nac
4732682|NCT03032601|Oral supplements|oral supplements
4732683|NCT03032575|HIV|hiv
4732684|NCT03032562|respiratory muscle strength|respiratory muscle strength
4732685|NCT03032562|sleep-disordered breathing|sleep-disordered breathing
4732686|NCT03032562|neuromuscular disease|neuromuscular disease
4732687|NCT03032562|chronic-obstructive pulmonary disease|chronic-obstructive pulmonary disease
4732688|NCT03032497|Brain Computer Interface|brain computer interface
4732689|NCT03032497|Electroencephalogram (EEG)|electroencephalogram (eeg)
4732690|NCT03032497|Chronic Pain|chronic pain
4732691|NCT03032471|Subarachnoid Hemorrhage|subarachnoid hemorrhage
4732692|NCT03032471|Delayed cerebral ischemia|delayed cerebral ischemia
4732693|NCT03032471|Cognitive Impairment|cognitive impairment
4732694|NCT03032471|Montreal Cognitive Assessment|montreal cognitive assessment
4732695|NCT03032471|MoCA|moca
4732696|NCT03032471|Cognitive Deterioration|cognitive deterioration
4732697|NCT03032458|Shock Wave Lithotripsy|shock wave lithotripsy
4732698|NCT03032458|Ketorolac|ketorolac
4732699|NCT03032458|Xylocaine Gel|xylocaine gel
4732700|NCT03032458|Pethidine|pethidine
4732701|NCT03032445|Body Water/physiology|body water/physiology
4732702|NCT03032445|Hyponatremia/etiology|hyponatremia/etiology
4732703|NCT03032445|Physical Exertion/physiology|physical exertion/physiology
4732704|NCT03032445|Running/physiology|running/physiology
4732705|NCT03032445|Sodium/blood|sodium/blood
4732706|NCT03032445|Ethanol|ethanol
4732707|NCT03032380|Hospital-acquired pneumonia (HAP)|hospital-acquired pneumonia (hap)
4732708|NCT03032380|S-649266|s-649266
4732709|NCT03032380|linezolid|linezolid
4732710|NCT03032380|meropenem|meropenem
4732711|NCT03032380|Healthcare-associated pneumonia (HCAP)|healthcare-associated pneumonia (hcap)
4732712|NCT03032380|nosocomial pneumonia|nosocomial pneumonia
4732713|NCT03032380|Ventilator-associated pneumonia (VAP)|ventilator-associated pneumonia (vap)
4732714|NCT03032380|Gram-negative pathogens|gram-negative pathogens
4732715|NCT03032380|pneumonia|pneumonia
4732716|NCT03032380|cefiderocol|cefiderocol
4732717|NCT03032354|probiotics|probiotics
4732718|NCT03032354|children|children
4732719|NCT03032354|remission|remission
4732720|NCT03032341|mobility assessment tool|mobility assessment tool
4732721|NCT03032302|TBI|tbi
4732722|NCT03032289|active transport|active transport
4732723|NCT03032289|cycling|cycling
4732724|NCT03032289|walking|walking
4732725|NCT03032276|Safe motherhood|safe motherhood
4732726|NCT03032276|Newborn survival|newborn survival
4732727|NCT03032276|Community|community
4732728|NCT03032276|Cluster Randomized Trial|cluster randomized trial
4732729|NCT03032237|Protein intake|protein intake
4732730|NCT03032237|Older adults|older adults
4732731|NCT03032237|Protein-rich|protein-rich
4732732|NCT03032237|Acceptance|acceptance
4732733|NCT03032237|Liking|liking
4732734|NCT03032237|Readymade meals|readymade meals
4732735|NCT03032224|Body composition|body composition
4732736|NCT03032224|sarcopenia|sarcopenia
4732737|NCT03032224|Dysphagia|dysphagia
4732738|NCT03032224|Surgery|surgery
4732739|NCT03032224|Quality of Life|quality of life
4732740|NCT03032224|Morbidity|morbidity
4732741|NCT03032185|menopause|menopause
4732742|NCT03032185|post-menopause|post-menopause
4732743|NCT03032185|transcutaneous electrical nerve stimulation|transcutaneous electrical nerve stimulation
4732744|NCT03032185|electrical stimulation therapy|electrical stimulation therapy
4732745|NCT03032185|women's health|women's health
4732746|NCT03032133|Total Knee Arthroplasty|total knee arthroplasty
4732747|NCT03032133|Total Knee Replacement|total knee replacement
4732748|NCT03032133|Outcome|outcome
4732749|NCT03032133|Results|results
4732750|NCT03032133|Pain|pain
4732751|NCT03032107|Breast Cancer|breast cancer
4732752|NCT03032094|Gingival Recession|gingival recession
4732753|NCT03032055|sickle cell desease|sickle cell desease
4732754|NCT03032055|vaso occlusive crisis|vaso occlusive crisis
4732755|NCT03032055|acute chest syndrome|acute chest syndrome
4732756|NCT03032055|Validation of predictif score of acute chest syndrome|validation of predictif score of acute chest syndrome
4732757|NCT03032042|intestinal microbiome|intestinal microbiome
4732758|NCT03032042|soil-transmitted helminths|soil-transmitted helminths
4732759|NCT03032042|mass drug administration|mass drug administration
4732760|NCT03032016|VOD|vod
4732761|NCT03032016|Defibrotide|defibrotide
4732762|NCT03032016|Defitelio|defitelio
4732763|NCT03032016|Registry|registry
4732764|NCT03032016|SOS|sos
4732765|NCT03031990|Yoga|yoga
4732766|NCT03031990|Oocyte cryopreservation|oocyte cryopreservation
4732767|NCT03031990|In-vitro fertilization|in-vitro fertilization
4732768|NCT03031951|Former athletes|former athletes
4732769|NCT03031951|Body composition|body composition
4732770|NCT03031951|Adaptive thermogenesis|adaptive thermogenesis
4732771|NCT03031951|Physical activity|physical activity
4732772|NCT03031951|Energy expenditure|energy expenditure
4732773|NCT03031951|Sedentary behavior|sedentary behavior
4732774|NCT03031951|Fat mass|fat mass
4732775|NCT03031951|Abdominal fat mass|abdominal fat mass
4732776|NCT03031951|Nutrition|nutrition
4732777|NCT03031951|Behavior modification|behavior modification
4732778|NCT03031938|Exposure in utero in tanezumab program|exposure in utero in tanezumab program
4732779|NCT03031925|Annexin A2|annexin a2
4732780|NCT03031925|biomarker|biomarker
4732781|NCT03031821|Prostate Cancer|prostate cancer
4732782|NCT03031821|ADT|adt
4732783|NCT03031821|iADT|iadt
4732784|NCT03031821|Metabolic Syndrome|metabolic syndrome
4732785|NCT03031821|Androgen Deprivation Therapy|androgen deprivation therapy
4732786|NCT03031821|Phase III|phase iii
4732787|NCT03031821|Phase 3|phase 3
4732788|NCT03031821|Randomized|randomized
4732789|NCT03031821|Intermittent Androgen Deprivation Therapy|intermittent androgen deprivation therapy
4732790|NCT03031795|intrauterine device|intrauterine device
4732791|NCT03031782|JIA, JPsA, ERA, Secukinumab, ILAR|jia, jpsa, era, secukinumab, ilar
4732792|NCT03031756|Air polishing|air polishing
4732793|NCT03031743|rotavirus vaccine|rotavirus vaccine
4732794|NCT03031743|human microbiome|human microbiome
4732795|NCT03031743|fecal microbiome|fecal microbiome
4732796|NCT03031743|vaccine immunogenicity|vaccine immunogenicity
4732797|NCT03031743|Rotarix|rotarix
4732798|NCT03031743|immune response, mucosal|immune response, mucosal
4732799|NCT03031665|GABA|gaba
4732800|NCT03031665|Depression|depression
4732801|NCT03031665|Stress|stress
4732802|NCT03031665|Androgens|androgens
4732803|NCT03031652|pain|pain
4732804|NCT03031652|axial length|axial length
4732805|NCT03031652|anterior chamber depth|anterior chamber depth
4732806|NCT03031652|intraocular pressure|intraocular pressure
4732807|NCT03031639|endoscopic|endoscopic
4732808|NCT03031639|thyroidectomy|thyroidectomy
4732809|NCT03031613|intraocular pressure|intraocular pressure
4732810|NCT03031613|intracerebral pressure|intracerebral pressure
4732811|NCT03031587|Thermometric MRI|thermometric mri
4732812|NCT03031587|Myocardium|myocardium
4732813|NCT03031574|Serotonin 4 (5-HT4) receptor|serotonin 4 (5-ht4) receptor
4732814|NCT03031574|Phase 1|phase 1
4732815|NCT03031509|Nonunion Fracture of limb|nonunion fracture of limb
4732816|NCT03031496|Cross-over|cross-over
4732817|NCT03031496|Hydrochlorothiazide|hydrochlorothiazide
4732818|NCT03031496|Amiloride hydrochloride|amiloride hydrochloride
4732819|NCT03031496|Phase I|phase i
4732820|NCT03031496|GSK3542503|gsk3542503
4732821|NCT03031496|Bioequivalence|bioequivalence
4732822|NCT03031496|FTIH|ftih
4732823|NCT03031470|Liver Transplant|liver transplant
4732824|NCT03031470|Ischemia-reperfusion injury|ischemia-reperfusion injury
4732825|NCT03031470|Early allograft dysfunction|early allograft dysfunction
4732826|NCT03031444|colorectal liver metastasis|colorectal liver metastasis
4732827|NCT03031444|preoperative|preoperative
4732828|NCT03031444|chemotherapy|chemotherapy
4732829|NCT03031444|targeted therapy|targeted therapy
4732830|NCT03031431|Hypothermia|hypothermia
4732831|NCT03031431|Infant Warmer|infant warmer
4732832|NCT03031340|Spinal fusion|spinal fusion
4732833|NCT03031340|pregabalin|pregabalin
4732834|NCT03031340|Spinal fusion surgeries|spinal fusion surgeries
4732835|NCT03031340|two or more vertebrae|two or more vertebrae
4732836|NCT03031327|Ocular Discomfort Following Refractive Surgery|ocular discomfort following refractive surgery
4732837|NCT03031327|Refractive Surgery|refractive surgery
4732838|NCT03031314|Joint Replacement|joint replacement
4732839|NCT03031314|Knee Replacement|knee replacement
4732840|NCT03031314|Wound Healing|wound healing
4732841|NCT03031314|Hip Replacement|hip replacement
4732842|NCT03031288|gastroesophageal reflux|gastroesophageal reflux
4732843|NCT03031288|swallow|swallow
4732844|NCT03031288|feeding bottle|feeding bottle
4732845|NCT03031288|cardiorespiratory|cardiorespiratory
4732846|NCT03031288|apnoea|apnoea
4732847|NCT03031288|preterm|preterm
4732848|NCT03031288|impedance-pH-metry|impedance-ph-metry
4732849|NCT03031275|extracorporeal circulation|extracorporeal circulation
4732850|NCT03031275|critical care outcomes|critical care outcomes
4732851|NCT03031236|Early Childhood Development (ECD)|early childhood development (ecd)
4732852|NCT03031236|Psychosocial stimulation|psychosocial stimulation
4732853|NCT03031236|Cognition|cognition
4732854|NCT03031236|Parenting|parenting
4732855|NCT03031236|Malnutrition|malnutrition
4732856|NCT03031236|Bangladesh|bangladesh
4732857|NCT03031236|Childhood Maltreatment|childhood maltreatment
4732858|NCT03031223|Spinal cord injuries|spinal cord injuries
4732859|NCT03031223|low-level laser therapy|low-level laser therapy
4732860|NCT03031210|Non-severe community-acquired pneumonia|non-severe community-acquired pneumonia
4732861|NCT03031210|Amoxicillin treatment|amoxicillin treatment
4732862|NCT03031210|Twice daily antibiotic regimen|twice daily antibiotic regimen
4732863|NCT03031197|adherence|adherence
4732864|NCT03031197|adolescent|adolescent
4732865|NCT03031197|HIV/AIDS|hiv/aids
4732866|NCT03031197|Vietnam|vietnam
4732867|NCT03031184|Agitation|agitation
4732868|NCT03031184|Agitated behaviours|agitated behaviours
4732869|NCT03031184|Alzheimer's Disease|alzheimer's disease
4732870|NCT03031171|community engagement, navigation, cancer screening|community engagement, navigation, cancer screening
4732871|NCT03031132|Protein-rich breakfast|protein-rich breakfast
4732872|NCT03031132|Breakfast Skipping|breakfast skipping
4732873|NCT03031132|Young Adults|young adults
4732874|NCT03031132|Breakfast|breakfast
4732875|NCT03031132|Food form|food form
4732876|NCT03031132|fMRI|fmri
4732877|NCT03031132|Ghrelin|ghrelin
4732878|NCT03031132|PYY|pyy
4732879|NCT03031132|Sleep|sleep
4732880|NCT03031119|nonalcoholic steatohepatitis|nonalcoholic steatohepatitis
4732881|NCT03031106|Patient-reported outcomes, Health-related QoL, Internet-based tool|patient-reported outcomes, health-related qol, internet-based tool
4732882|NCT03031093|aerosol therapy|aerosol therapy
4732883|NCT03031093|pulmonary scintigraphy|pulmonary scintigraphy
4732884|NCT03031093|upper airways anatomy|upper airways anatomy
4732885|NCT03031093|High Flow Nasal Cannula|high flow nasal cannula
4732886|NCT03031080|Collagenase, Night-splinting, Dupuytrens, Contracture|collagenase, night-splinting, dupuytrens, contracture
4732887|NCT03031067|Donors and donation|donors and donation
4732888|NCT03031067|Extended criteria donor|extended criteria donor
4732889|NCT03031067|Organ perfusion and preservation|organ perfusion and preservation
4732890|NCT03031067|Liver transplantation|liver transplantation
4732891|NCT03031067|Kidney transplantation|kidney transplantation
4732892|NCT03031067|Preservation injury|preservation injury
4732893|NCT03031067|Ischemia reperfusion injury|ischemia reperfusion injury
4732894|NCT03031054|Hydrodissection|hydrodissection
4732895|NCT03031054|hyaluronic acid|hyaluronic acid
4732896|NCT03031041|Hydrodissection|hydrodissection
4732897|NCT03031041|short-axis|short-axis
4732898|NCT03031041|long-axis|long-axis
4732899|NCT03031028|refractory epilepsy,|refractory epilepsy,
4732900|NCT03031028|ketogenic diet|ketogenic diet
4732901|NCT03031028|classic ketogenic diet|classic ketogenic diet
4732902|NCT03031028|seizure rate|seizure rate
4732903|NCT03031028|efficacy|efficacy
4732904|NCT03031028|epilepsy|epilepsy
4732905|NCT03031015|Reduction, Fracture|reduction, fracture
4732906|NCT03031002|exposure|exposure
4732907|NCT03031002|spider phobia|spider phobia
4732908|NCT03031002|generalization|generalization
4732909|NCT03031002|extinction|extinction
4732910|NCT03030976|CD19|cd19
4732911|NCT03030976|CAR-T|car-t
4732912|NCT03030976|SLE|sle
4732913|NCT03030963|Equal ratio ventilation(ERV)|equal ratio ventilation(erv)
4732914|NCT03030963|Peak inspiratory pressure(PIP)|peak inspiratory pressure(pip)
4732915|NCT03030963|Blood loss|blood loss
4732916|NCT03030963|Posterior lumbar interbody fusion(PLIF)|posterior lumbar interbody fusion(plif)
4732917|NCT03030963|Prone position|prone position
4732918|NCT03030924|suicide|suicide
4732919|NCT03030885|Radiopharmaceutical (131I-MIP-1095)|radiopharmaceutical (131i-mip-1095)
4732920|NCT03030885|16-1110|16-1110
4732921|NCT03030846|pregnancy|pregnancy
4732922|NCT03030846|pelvic floor muscles|pelvic floor muscles
4732923|NCT03030846|Lumbo-pelvic pain|lumbo-pelvic pain
4732924|NCT03030846|Stabilization exercises|stabilization exercises
4732925|NCT03030846|abdominal muscles thickness|abdominal muscles thickness
4732926|NCT03030846|Multifidus muscles thickness|multifidus muscles thickness
4732927|NCT03030846|Multifidus muscles cross section area|multifidus muscles cross section area
4732928|NCT03030820|cirrhosis|cirrhosis
4732929|NCT03030820|Periodontitis|periodontitis
4732930|NCT03030820|oral health|oral health
4732931|NCT03030820|gingivitis|gingivitis
4732932|NCT03030820|inflammation|inflammation
4732933|NCT03030794|Gulf War Illness|gulf war illness
4732934|NCT03030794|Headache|headache
4732935|NCT03030794|Muscle Pain|muscle pain
4732936|NCT03030794|Joint Pain|joint pain
4732937|NCT03030794|TMS|tms
4732938|NCT03030768|Pre-Exposure Prophylaxis|pre-exposure prophylaxis
4732939|NCT03030768|Fertility|fertility
4732940|NCT03030768|mHealth|mhealth
4732941|NCT03030768|Pregnancy|pregnancy
4732942|NCT03030716|antinutrients|antinutrients
4732943|NCT03030716|tannins|tannins
4732944|NCT03030716|proanthocyanidins|proanthocyanidins
4732945|NCT03030716|salivary proline-rich proteins|salivary proline-rich proteins
4732946|NCT03030703|Phytic acid|phytic acid
4732947|NCT03030703|Cystatin|cystatin
4732948|NCT03030703|Salivary proline-rich protein|salivary proline-rich protein
4732949|NCT03030703|antinutrient|antinutrient
4732950|NCT03030690|Proximal Dental Caries|proximal dental caries
4732951|NCT03030690|Glass Carbomer|glass carbomer
4732952|NCT03030690|Hydroxyapatite Enhanced Glass Ionomer|hydroxyapatite enhanced glass ionomer
4732953|NCT03030690|Primary Teeth|primary teeth
4732954|NCT03030677|pecs block|pecs block
4732955|NCT03030677|breast surgery|breast surgery
4732956|NCT03030677|ultrasound guidence|ultrasound guidence
4732957|NCT03030664|constipation|constipation
4732958|NCT03030664|Lactobacillus reuteri|lactobacillus reuteri
4732959|NCT03030664|probiotics|probiotics
4732960|NCT03030651|Breastfeeding|breastfeeding
4732961|NCT03030651|Education and support|education and support
4732962|NCT03030651|Ethiopia|ethiopia
4732963|NCT03030651|Timely initiation of breastfeeding|timely initiation of breastfeeding
4732964|NCT03030625|Prostate Cancer|prostate cancer
4732965|NCT03030625|VMAT|vmat
4732966|NCT03030625|Dominant Intraprostatic Lesion|dominant intraprostatic lesion
4732967|NCT03030625|Intensity modulated radiotherapy|intensity modulated radiotherapy
4732968|NCT03030586|Blood cell biomarkers, peripheral circulating biomarkers|blood cell biomarkers, peripheral circulating biomarkers
4732969|NCT03030573|Bile duct injury|bile duct injury
4732970|NCT03030573|Bile duct defect|bile duct defect
4732971|NCT03030573|Round ligament|round ligament
4732972|NCT03030573|Reconstruction|reconstruction
4732973|NCT03030508|biomarks|biomarks
4732974|NCT03030508|colorectal cancer|colorectal cancer
4732975|NCT03030508|capecitabine|capecitabine
4732976|NCT03030508|gene polymorphism|gene polymorphism
4732977|NCT03030495|Ischemic Heart Disease|ischemic heart disease
4732978|NCT03030495|Stable angina|stable angina
4732979|NCT03030495|Fractional flow reserve|fractional flow reserve
4732980|NCT03030495|Index of Microcirculatory Resistance|index of microcirculatory resistance
4732981|NCT03030495|Coronary Flow Reserve|coronary flow reserve
4732982|NCT03030495|Intravascular Imaging|intravascular imaging
4732983|NCT03030482|Anxiety|anxiety
4732984|NCT03030482|intensive care|intensive care
4732985|NCT03030482|mechanical ventilation|mechanical ventilation
4732986|NCT03030482|touch massage|touch massage
4732987|NCT03030456|whole body vibration|whole body vibration
4732988|NCT03030456|Oxidative Stress|oxidative stress
4732989|NCT03030456|Aged|aged
4732990|NCT03030456|Biochemical profile|biochemical profile
4732991|NCT03030456|muscle strength|muscle strength
4732992|NCT03030456|flexibility|flexibility
4732993|NCT03030443|Pain management|pain management
4732994|NCT03030443|Nitrous|nitrous
4732995|NCT03030417|Topoisomerase 1 Inhibitor|topoisomerase 1 inhibitor
4732996|NCT03030417|Epithelial-Mesenchymal Transition|epithelial-mesenchymal transition
4732997|NCT03030417|Pharmacodynamics|pharmacodynamics
4732998|NCT03030417|DNA Damage|dna damage
4732999|NCT03030417|Pharmacokinetics|pharmacokinetics
4733000|NCT03030404|Genetics|genetics
4733001|NCT03030404|Familial Background|familial background
4733002|NCT03030404|Inherited Cancer Syndrome|inherited cancer syndrome
4733003|NCT03030404|Germline Mutation in the CDH1 Gene|germline mutation in the cdh1 gene
4733004|NCT03030404|Genetic Testing|genetic testing
4733005|NCT03030391|Camp|camp
4733006|NCT03030391|Radiation Absorbed Dose|radiation absorbed dose
4733007|NCT03030391|Compartmental Analysis|compartmental analysis
4733008|NCT03030365|Orientation, Disorientation.|orientation, disorientation.
4733009|NCT03030352|Child Mental Health|child mental health
4733010|NCT03030352|Parenting|parenting
4733011|NCT03030352|Autonomy Support|autonomy support
4733012|NCT03030352|How-to Parenting Program|how-to parenting program
4733013|NCT03030352|Randomized Controlled Trial|randomized controlled trial
4733014|NCT03030352|Primary Prevention|primary prevention
4733015|NCT03030352|Parental Mental Health|parental mental health
4733016|NCT03030352|Child Well-Being|child well-being
4733017|NCT03030339|Vitamin A status|vitamin a status
4733018|NCT03030339|infant|infant
4733019|NCT03030339|dietary assessment|dietary assessment
4733020|NCT03030339|retinol isotope dilution|retinol isotope dilution
4733021|NCT03030339|breast milk intake|breast milk intake
4733022|NCT03030300|type 2 diabetes|type 2 diabetes
4733023|NCT03030300|remission|remission
4733024|NCT03030300|short-term intensive insulin therapy|short-term intensive insulin therapy
4733025|NCT03030235|diabetes|diabetes
4733026|NCT03030235|heart failure|heart failure
4733027|NCT03030235|dapagliflozin|dapagliflozin
4733028|NCT03030235|SGLT-2 inhibitors|sglt-2 inhibitors
4733029|NCT03030222|diabetes|diabetes
4733030|NCT03030222|heart failure|heart failure
4733031|NCT03030222|empagliflozin|empagliflozin
4733032|NCT03030222|SGLT-2 inhibitors|sglt-2 inhibitors
4733033|NCT03030209|pancreatectomy|pancreatectomy
4733034|NCT03030209|diabetes mellitus|diabetes mellitus
4733035|NCT03030183|PNH|pnh
4733036|NCT03030157|urothelial cancer|urothelial cancer
4733037|NCT03030157|bladder cancer|bladder cancer
4733038|NCT03030157|nephroureterectomy|nephroureterectomy
4733039|NCT03030131|IFCT|ifct
4733040|NCT03030131|neodjuvant|neodjuvant
4733041|NCT03030131|immune therapy|immune therapy
4733042|NCT03030131|Non small cell lung cancer|non small cell lung cancer
4733043|NCT03030118|hydroxychloroquine|hydroxychloroquine
4733044|NCT03030105|Cognition|cognition
4733045|NCT03030105|Dementia|dementia
4733046|NCT03030105|Phosphodiesterase Type 4D|phosphodiesterase type 4d
4733047|NCT03030105|PDE4D|pde4d
4733048|NCT03030105|Scopolamine|scopolamine
4733049|NCT03030105|Donepezil|donepezil
4733050|NCT03030066|DS-1001b|ds-1001b
4733051|NCT03030066|IDH1 mutation|idh1 mutation
4733052|NCT03030066|Developmental Phase I|developmental phase i
4733053|NCT03030066|Glioma|glioma
4733054|NCT03030053|Flavanols|flavanols
4733055|NCT03030053|Flavonoids|flavonoids
4733056|NCT03030053|Polyphenols|polyphenols
4733057|NCT03030053|Cognition|cognition
4733058|NCT03030053|Aging|aging
4733059|NCT03030040|mindfulness-based cognitive therapy|mindfulness-based cognitive therapy
4733060|NCT03030040|self-help|self-help
4733061|NCT03030040|healthcare staff|healthcare staff
4733062|NCT03030027|Intergeneration|intergeneration
4733063|NCT03030027|Reappraisal|reappraisal
4733064|NCT03030027|Caregiving|caregiving
4733065|NCT03030001|mesothelin|mesothelin
4733066|NCT03030001|PD-1|pd-1
4733067|NCT03030001|CAR T|car t
4733068|NCT03030001|solid tumor|solid tumor
4733069|NCT03029988|adenocarcinoma, Colorectal Carcinoma, liver metastases|adenocarcinoma, colorectal carcinoma, liver metastases
4733070|NCT03029975|beef|beef
4733071|NCT03029975|protein|protein
4733072|NCT03029975|resistance training|resistance training
4733073|NCT03029975|strength|strength
4733074|NCT03029975|performance|performance
4733075|NCT03029962|Teenage Pregnancy Prevention|teenage pregnancy prevention
4733076|NCT03029962|LGB Girls|lgb girls
4733077|NCT03029962|Text-Messaging|text-messaging
4733078|NCT03029962|Information-Motivation-Behavioral Skills(IMB)Model|information-motivation-behavioral skills(imb)model
4733079|NCT03029949|chronic dizziness|chronic dizziness
4733080|NCT03029949|persistent postural-perceptual dizziness|persistent postural-perceptual dizziness
4733081|NCT03029949|acceptance and commitment therapy|acceptance and commitment therapy
4733082|NCT03029949|behavior therapy|behavior therapy
4733083|NCT03029949|vestibular rehabilitation|vestibular rehabilitation
4733084|NCT03029936|obesity|obesity
4733085|NCT03029936|asthma|asthma
4733086|NCT03029936|diaphragm excursion|diaphragm excursion
4733087|NCT03029936|pulmonary function test|pulmonary function test
4733088|NCT03029923|smoking|smoking
4733089|NCT03029923|depression|depression
4733090|NCT03029923|Behavioral Activation|behavioral activation
4733091|NCT03029910|Eccentric exercise|eccentric exercise
4733092|NCT03029910|Whole body vibration|whole body vibration
4733093|NCT03029910|Cryotherapy|cryotherapy
4733094|NCT03029884|thalamic pain|thalamic pain
4733095|NCT03029884|chronic pain|chronic pain
4733096|NCT03029884|spinal cord injury|spinal cord injury
4733097|NCT03029884|phantom limb|phantom limb
4733098|NCT03029871|lung cancer|lung cancer
4733099|NCT03029871|adenovirus|adenovirus
4733100|NCT03029871|gene therapy|gene therapy
4733101|NCT03029871|SBRT|sbrt
4733102|NCT03029793|Esophageal Cancer|esophageal cancer
4733103|NCT03029793|Prediction|prediction
4733104|NCT03029793|Biomarker|biomarker
4733105|NCT03029793|MRI-DWI|mri-dwi
4733106|NCT03029793|PET-CT|pet-ct
4733107|NCT03029767|Hypertension|hypertension
4733108|NCT03029767|Anthropometry|anthropometry
4733109|NCT03029767|Aerobic exercise|aerobic exercise
4733110|NCT03029767|Resistance exercise|resistance exercise
4733111|NCT03029728|Hereditary and acquired C1-inhibitor deficiency|hereditary and acquired c1-inhibitor deficiency
4733112|NCT03029728|C1 esterase inhibitor, hereditary angioedema,|c1 esterase inhibitor, hereditary angioedema,
4733113|NCT03029715|Sleeve gastrectomy|sleeve gastrectomy
4733114|NCT03029715|TIVA|tiva
4733115|NCT03029702|Gestational diabetes|gestational diabetes
4733116|NCT03029702|Diabetes in pregnancy|diabetes in pregnancy
4733117|NCT03029702|Insulin resistance|insulin resistance
4733118|NCT03029702|Insulin secretion deficiency|insulin secretion deficiency
4733119|NCT03029689|HIV infection|hiv infection
4733120|NCT03029689|Gut microbiome|gut microbiome
4733121|NCT03029689|Raltegravir|raltegravir
4733122|NCT03029689|Raltegravir intensification|raltegravir intensification
4733123|NCT03029689|Bacterial richness|bacterial richness
4733124|NCT03029676|spinal anesthesia, TURBT, POCD, premedication|spinal anesthesia, turbt, pocd, premedication
4733125|NCT03029663|bladder cancer|bladder cancer
4733126|NCT03029663|postoperative complications|postoperative complications
4733127|NCT03029650|Peer Review|peer review
4733128|NCT03029650|Research|research
4733129|NCT03029637|Resin bonded bridges|resin bonded bridges
4733130|NCT03029637|Randomized controlled trial|randomized controlled trial
4733131|NCT03029585|ovarian carcinoma|ovarian carcinoma
4733132|NCT03029585|ovarian cancer|ovarian cancer
4733133|NCT03029585|ovarian neoplasms|ovarian neoplasms
4733134|NCT03029585|ovarian diseases|ovarian diseases
4733135|NCT03029559|Inspiratory threshold loading|inspiratory threshold loading
4733136|NCT03029520|Endodontic Postoperative Pain|endodontic postoperative pain
4733137|NCT03029520|iRoot SP Sealer|iroot sp sealer
4733138|NCT03029520|Randomized Clinical Trial|randomized clinical trial
4733139|NCT03029520|Herofill carrier-based obturation|herofill carrier-based obturation
4733141|NCT03029507|Military|military
4733142|NCT03029507|Acceptance and Commitment Therapy|acceptance and commitment therapy
4733143|NCT03029507|Overweight|overweight
4733144|NCT03029507|Weight-management|weight-management
4733145|NCT03029507|Navy Personnel|navy personnel
4733146|NCT03029507|Fitness|fitness
4733147|NCT03029494|oxidative stress|oxidative stress
4733148|NCT03029494|saliva|saliva
4733149|NCT03029468|Cognitive behavioral therapy|cognitive behavioral therapy
4733150|NCT03029468|Chronic pain|chronic pain
4733151|NCT03029468|Sickle cell disease|sickle cell disease
4733152|NCT03029468|Mobile phone app|mobile phone app
4733153|NCT03029468|Mental health|mental health
4733154|NCT03029468|Behavioral intervention|behavioral intervention
4733155|NCT03029468|Behavioral health|behavioral health
4733156|NCT03029442|Spinal Cord Injury|spinal cord injury
4733157|NCT03029442|Denosumab|denosumab
4733158|NCT03029442|Osteoporosis|osteoporosis
4733159|NCT03029442|Dual Energy X-ray Absorptiometry|dual energy x-ray absorptiometry
4733160|NCT03029429|pseudohypoparathyroidism|pseudohypoparathyroidism
4733161|NCT03029429|AHO|aho
4733162|NCT03029429|Albright Hereditary Osteodystrophy|albright hereditary osteodystrophy
4733163|NCT03029390|Prediabetes|prediabetes
4733164|NCT03029390|hyperglycemia|hyperglycemia
4733165|NCT03029390|Impaired Fasting Glucose|impaired fasting glucose
4733166|NCT03029390|Metformin|metformin
4733167|NCT03029390|Berberine|berberine
4733168|NCT03029390|glucose intolerance|glucose intolerance
4733169|NCT03029377|CFS|cfs
4733170|NCT03029377|Stress|stress
4733171|NCT03029377|Norepinephrine Transporter (NET)|norepinephrine transporter (net)
4733172|NCT03029377|Norepinephrine (NE)|norepinephrine (ne)
4733173|NCT03029377|Healthy Controls|healthy controls
4733174|NCT03029377|Fatigue|fatigue
4733175|NCT03029364|Maximal Fat Oxidation|maximal fat oxidation
4733176|NCT03029364|Exercise|exercise
4733177|NCT03029364|Intra-individual variability|intra-individual variability
4733178|NCT03029364|Determinants|determinants
4733179|NCT03029364|Whole-body fat oxidation|whole-body fat oxidation
4733180|NCT03029364|Body composition|body composition
4733181|NCT03029351|albuminuria|albuminuria
4733182|NCT03029351|GLP-1 Receptor Agonist|glp-1 receptor agonist
4733183|NCT03029351|Type 2 Diabetes|type 2 diabetes
4733184|NCT03029338|lymphoma|lymphoma
4733185|NCT03029338|non-hodgkin|non-hodgkin
4733186|NCT03029338|B-cell|b-cell
4733187|NCT03029338|CD19 CAR T cells|cd19 car t cells
4733188|NCT03029338|refractory|refractory
4733189|NCT03029338|relapse|relapse
4733190|NCT03029312|whole body vibration|whole body vibration
4733191|NCT03029312|Muscle function|muscle function
4733192|NCT03029312|Physical activity|physical activity
4733193|NCT03029312|bone density|bone density
4733194|NCT03029286|Breast Cancer|breast cancer
4733195|NCT03029286|Breast Density|breast density
4733196|NCT03029247|Anemia|anemia
4733197|NCT03029247|Daprodustat|daprodustat
4733198|NCT03029247|Blood pressure|blood pressure
4733199|NCT03029247|ESA|esa
4733200|NCT03029247|CKD|ckd
4733201|NCT03029208|Daprodustat, recombinant human erythropoietin, darbepoetin, anemia, chronic kidney disease, dialysis, ESRD|daprodustat, recombinant human erythropoietin, darbepoetin, anemia, chronic kidney disease, dialysis, esrd
4733202|NCT03029195|cleft lip and palate|cleft lip and palate
4733203|NCT03029195|nasoalveolar molding|nasoalveolar molding
4733204|NCT03029195|Egyptian infants|egyptian infants
4733205|NCT03029195|quantitative analysis|quantitative analysis
4733206|NCT03029182|Exercise|exercise
4733207|NCT03029182|Cancer|cancer
4733208|NCT03029182|Obesity|obesity
4733209|NCT03029169|Supraventricular Arrhythmia|supraventricular arrhythmia
4733210|NCT03029169|Septic shock|septic shock
4733211|NCT03029169|Propafenone|propafenone
4733212|NCT03029169|Amiodarone|amiodarone
4733213|NCT03029169|Intensive Care|intensive care
4733214|NCT03029156|Asthma|asthma
4733215|NCT03029156|Aeroneb|aeroneb
4733216|NCT03029156|Aerogen|aerogen
4733217|NCT03029156|Bronchodilator|bronchodilator
4733218|NCT03029143|Drug Therapy|drug therapy
4733219|NCT03029130|vesicovaginal fistula|vesicovaginal fistula
4733220|NCT03029130|urinary catheter|urinary catheter
4733221|NCT03029130|catheter extension|catheter extension
4733222|NCT03029117|rheumatic pregnancy|rheumatic pregnancy
4733223|NCT03029104|Keratoconus|keratoconus
4733224|NCT03029104|Forme fruste keratoconus|forme fruste keratoconus
4733225|NCT03029104|Post-LASIK ectasia|post-lasik ectasia
4733226|NCT03029104|Pellucid marginal degeneration|pellucid marginal degeneration
4733227|NCT03029104|Forme fruste pellucid marginal degeneration|forme fruste pellucid marginal degeneration
4733228|NCT03029104|Diurnal fluctuation post-radial keratotomy|diurnal fluctuation post-radial keratotomy
4733229|NCT03029104|Terrien's marginal degeneration|terrien's marginal degeneration
4733230|NCT03029078|XDR|xdr
4733231|NCT03029078|fecal microbiota transplant|fecal microbiota transplant
4733232|NCT03029078|eradicate|eradicate
4733233|NCT03029078|colonization|colonization
4733234|NCT03029078|CRE|cre
4733235|NCT03029078|GRE|gre
4733236|NCT03029078|bacteria|bacteria
4733237|NCT03029065|lung Adenocarcinoma with brain (meningeal) metastasis|lung adenocarcinoma with brain (meningeal) metastasis
4733238|NCT03029039|Platelet|platelet
4733239|NCT03029039|severe sepsis|severe sepsis
4733240|NCT03029039|inflammation|inflammation
4733241|NCT03029039|S. aureus|s. aureus
4733242|NCT03029039|biomarkers|biomarkers
4733243|NCT03029026|Cardiac amyloidosis|cardiac amyloidosis
4733244|NCT03029026|Aortic stenosis|aortic stenosis
4733245|NCT03029026|DPD scintigraphy|dpd scintigraphy
4733246|NCT03028987|Quadrivalent, inactivated influenza vaccine|quadrivalent, inactivated influenza vaccine
4733247|NCT03028987|Quadrivalent, live, attenuated influenza vaccine|quadrivalent, live, attenuated influenza vaccine
4733248|NCT03028987|Identical twin adults|identical twin adults
4733249|NCT03028974|Inactivated influenza vaccine|inactivated influenza vaccine
4733250|NCT03028974|Live, attenuated influenza vaccine|live, attenuated influenza vaccine
4733251|NCT03028974|Young children|young children
4733252|NCT03028974|Adults|adults
4733253|NCT03028922|creos xenogain|creos xenogain
4733254|NCT03028909|Influenza A|influenza a
4733255|NCT03028909|MEDI8852|medi8852
4733256|NCT03028896|LMA Flexible|lma flexible
4733257|NCT03028870|Osteoarthritis|osteoarthritis
4733258|NCT03028870|Pain|pain
4733259|NCT03028870|Osteoarthritis Knee|osteoarthritis knee
4733260|NCT03028844|Neonate|neonate
4733261|NCT03028844|preterm|preterm
4733262|NCT03028844|pain|pain
4733263|NCT03028844|music|music
4733264|NCT03028844|EEG|eeg
4733265|NCT03028844|venepuncture|venepuncture
4733266|NCT03028805|Informatics|informatics
4733267|NCT03028805|COPD|copd
4733268|NCT03028805|quality improvement|quality improvement
4733269|NCT03028792|attention training, youth, latino|attention training, youth, latino
4733270|NCT03028779|Outpatient,fast-track, arthroplasty, Total knee arthroplasty (TKA), Total hip Arthroplasty (THA)|outpatient,fast-track, arthroplasty, total knee arthroplasty (tka), total hip arthroplasty (tha)
4733271|NCT03028714|University|university
4733272|NCT03028714|College|college
4733273|NCT03028714|University students|university students
4733274|NCT03028714|Health education|health education
4733275|NCT03028714|Educational techonology|educational techonology
4733276|NCT03028714|Internet|internet
4733277|NCT03028714|Nutrition knowledge|nutrition knowledge
4733278|NCT03028714|Eating behaviour|eating behaviour
4733279|NCT03028714|Diet|diet
4733280|NCT03028714|Physical Activity|physical activity
4733281|NCT03028714|Weight gain prevention|weight gain prevention
4733282|NCT03028701|Formoterol|formoterol
4733283|NCT03028701|Budesonide|budesonide
4733284|NCT03028701|Dry powder inhalation|dry powder inhalation
4733285|NCT03028701|Discair|discair
4733286|NCT03028701|COPD|copd
4733287|NCT03028662|Alcohol Dependence|alcohol dependence
4733288|NCT03028662|Brain Connectivity|brain connectivity
4733289|NCT03028662|Inhibition|inhibition
4733290|NCT03028649|β-hydroxy-β-methylbutyric acid|β-hydroxy-β-methylbutyric acid
4733291|NCT03028649|Sport supplements|sport supplements
4733292|NCT03028649|Training support|training support
4733293|NCT03028649|Adaptation|adaptation
4733294|NCT03028636|fecal incontinence|fecal incontinence
4733295|NCT03028636|bowel control|bowel control
4733296|NCT03028636|accidental bowel leakage|accidental bowel leakage
4733297|NCT03028636|medical device|medical device
4733298|NCT03028636|women's health|women's health
4733299|NCT03028636|vaginal insert|vaginal insert
4733300|NCT03028636|pessary|pessary
4733301|NCT03028636|incontinence|incontinence
4733302|NCT03028636|bowel continence|bowel continence
4733303|NCT03028636|pump|pump
4733304|NCT03028597|Hypertension|hypertension
4733305|NCT03028597|Medication Adherence|medication adherence
4733306|NCT03028597|Values Affirmation|values affirmation
4733307|NCT03028597|African Americans|african americans
4733308|NCT03028584|BrCa|brca
4733309|NCT03028584|PrCa|prca
4733310|NCT03028584|CRCa|crca
4733311|NCT03028558|Electronic Cigarettes|electronic cigarettes
4733312|NCT03028558|Healthy Volunteers|healthy volunteers
4733313|NCT03028558|E-Cigarettes Smokers|e-cigarettes smokers
4733314|NCT03028558|E-Cigarettes|e-cigarettes
4733315|NCT03028545|schizophrenia|schizophrenia
4733316|NCT03028545|anorexia|anorexia
4733317|NCT03028545|bipolar disorders|bipolar disorders
4733318|NCT03028545|personality disorders|personality disorders
4733319|NCT03028532|Healthy Volunteers|healthy volunteers
4733320|NCT03028532|Sports Medicine|sports medicine
4733321|NCT03028532|Anti-doping|anti-doping
4733322|NCT03028532|Athletes|athletes
4733323|NCT03028532|Men's Health|men's health
4733324|NCT03028480|Exacerbation|exacerbation
4733325|NCT03028480|Mepolizumab|mepolizumab
4733326|NCT03028480|NUCALA|nucala
4733327|NCT03028467|GSK3196165|gsk3196165
4733328|NCT03028467|Active Rheumatoid Arthritis|active rheumatoid arthritis
4733329|NCT03028467|Methotrexate|methotrexate
4733330|NCT03028467|Monoclonal Antibody|monoclonal antibody
4733331|NCT03028467|Efficacy|efficacy
4733332|NCT03028467|Electrocardiogram|electrocardiogram
4733333|NCT03028467|Tolerability|tolerability
4733334|NCT03028467|Pharmacokinetics|pharmacokinetics
4733335|NCT03028467|Japanese Subjects|japanese subjects
4733336|NCT03028441|Chikungunya|chikungunya
4733337|NCT03028441|Immunogenicity|immunogenicity
4733338|NCT03028441|Measles|measles
4733339|NCT03028441|Vaccine|vaccine
4733340|NCT03028428|Osteoarthritis|osteoarthritis
4733341|NCT03028428|Stem Cell|stem cell
4733342|NCT03028428|Knee|knee
4733343|NCT03028428|Mesenchymal Stem Cell|mesenchymal stem cell
4733344|NCT03028389|elderly patients|elderly patients
4733345|NCT03028389|non-cardiac surgery|non-cardiac surgery
4733346|NCT03028389|ischemic preconditioning|ischemic preconditioning
4733347|NCT03028389|delirium|delirium
4733348|NCT03028376|biomarker|biomarker
4733349|NCT03028376|point-of-care analysis|point-of-care analysis
4733350|NCT03028337|Malignant neoplasms of eye brain and other parts of central nervous system|malignant neoplasms of eye brain and other parts of central nervous system
4733351|NCT03028337|Solid tumor malignancy|solid tumor malignancy
4733352|NCT03028337|Radiographic evidence of spine metastasis|radiographic evidence of spine metastasis
4733353|NCT03028337|Spine radiosurgery|spine radiosurgery
4733354|NCT03028337|Radiation therapy|radiation therapy
4733355|NCT03028337|Radiotherapy|radiotherapy
4733356|NCT03028337|Questionnaires|questionnaires
4733357|NCT03028337|Surveys|surveys
4733358|NCT03028337|XRT|xrt
4733359|NCT03028311|Malignant neoplasms of digestive organs|malignant neoplasms of digestive organs
4733360|NCT03028311|Metastatic liver tumors|metastatic liver tumors
4733361|NCT03028311|SIR-Spheres treatment|sir-spheres treatment
4733362|NCT03028311|90Y-radioembolization|90y-radioembolization
4733363|NCT03028285|succinate|succinate
4733364|NCT03028285|arginine|arginine
4733365|NCT03028285|vasodilation|vasodilation
4733366|NCT03028285|peripheral vascular disease|peripheral vascular disease
4733367|NCT03028272|tympanic membrane perforation|tympanic membrane perforation
4733368|NCT03028233|physical activity|physical activity
4733369|NCT03028233|healthy eating|healthy eating
4733370|NCT03028233|weight|weight
4733371|NCT03028233|families|families
4733372|NCT03028233|Community Health Worker|community health worker
4733373|NCT03028233|childhood obesity|childhood obesity
4733374|NCT03028233|built environment|built environment
4733375|NCT03028207|EPI-Scan-II Study|epi-scan-ii study
4733376|NCT03028207|COPD|copd
4733377|NCT03028207|Epidemiology|epidemiology
4733378|NCT03028207|Spain|spain
4733379|NCT03028207|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
4733380|NCT03028207|Prevalence|prevalence
4733381|NCT03028207|Cross-sectional|cross-sectional
4733382|NCT03028194|Pre-eclampsia|pre-eclampsia
4733383|NCT03028194|Eclampsia|eclampsia
4733384|NCT03028194|Postpartum uterine curettage|postpartum uterine curettage
4733385|NCT03028181|smoke|smoke
4733386|NCT03028181|acute pancreatitis|acute pancreatitis
4733387|NCT03028181|pro/antioxidant status|pro/antioxidant status
4733388|NCT03028181|pro-inflammatory factors|pro-inflammatory factors
4733389|NCT03028181|lipid profile|lipid profile
4733390|NCT03028181|exocrine functions of pancreas|exocrine functions of pancreas
4733391|NCT03028168|Yôga|yôga
4733392|NCT03028168|Breathing Techniques|breathing techniques
4733393|NCT03028168|Heart Failure and Preserved Ejection Fraction|heart failure and preserved ejection fraction
4733394|NCT03028129|Tuberculosis|tuberculosis
4733395|NCT03028129|Primary prevention|primary prevention
4733396|NCT03028129|Prisoners|prisoners
4733397|NCT03028129|Controlled Clinical Trial|controlled clinical trial
4733398|NCT03028129|Isoniazid|isoniazid
4733399|NCT03028116|vaccine|vaccine
4733400|NCT03028116|1 phase|1 phase
4733401|NCT03028116|safety|safety
4733402|NCT03028077|ultrafiltered red ginseng|ultrafiltered red ginseng
4733403|NCT03028077|hydrolyzed ginseng|hydrolyzed ginseng
4733404|NCT03028077|acute respiratory illness|acute respiratory illness
4733405|NCT03028077|clinical trial|clinical trial
4733406|NCT03028038|Platelet-rich plasma|platelet-rich plasma
4733407|NCT03028038|Rapid maxillary expansion|rapid maxillary expansion
4733408|NCT03028038|Buccal bone thickness|buccal bone thickness
4733409|NCT03028038|Alveolar bone loss|alveolar bone loss
4733410|NCT03028038|Alveolar bone resorption|alveolar bone resorption
4733411|NCT03028025|radial artery occlusion|radial artery occlusion
4733412|NCT03028025|time to hemostasis|time to hemostasis
4733413|NCT03028025|radial artery|radial artery
4733414|NCT03028025|transradial catheterization|transradial catheterization
4733415|NCT03028025|TR band|tr band
4733416|NCT03028025|Statseal|statseal
4733417|NCT03028025|hemostasis band|hemostasis band
4733418|NCT03028025|potassium ferrate|potassium ferrate
4733419|NCT03028025|percutaneous coronary intervention|percutaneous coronary intervention
4733420|NCT03028012|Trigger Point Injections|trigger point injections
4733421|NCT03028012|steroid|steroid
4733422|NCT03028012|nsaid|nsaid
4733423|NCT03027999|Rituximab|rituximab
4733424|NCT03027999|tight monitoring|tight monitoring
4733425|NCT03027960|cardio-renal|cardio-renal
4733426|NCT03027947|Phantom Limb Pain|phantom limb pain
4733427|NCT03027947|Lower-Limb Amputation|lower-limb amputation
4733428|NCT03027947|Electrodes|electrodes
4733429|NCT03027947|Stimulation|stimulation
4733430|NCT03027947|Pain|pain
4733431|NCT03027947|Sensation|sensation
4733432|NCT03027882|Reliability|reliability
4733433|NCT03027882|Validity|validity
4733434|NCT03027882|Functional Testing|functional testing
4733435|NCT03027856|Percutaneous intervention (PCI)|percutaneous intervention (pci)
4733436|NCT03027856|Optical coherence tomography (OCT)|optical coherence tomography (oct)
4733437|NCT03027856|Bifurcation lesion|bifurcation lesion
4733438|NCT03027856|Bioresorbable stents (BRS)|bioresorbable stents (brs)
4733439|NCT03027843|low ovarian reserve|low ovarian reserve
4733440|NCT03027843|growth hormone|growth hormone
4733441|NCT03027843|embryo quality|embryo quality
4733442|NCT03027843|live birth|live birth
4733443|NCT03027843|clinical pregnancy|clinical pregnancy
4733444|NCT03027830|Provisional side-branch intervention strategy|provisional side-branch intervention strategy
4733445|NCT03027830|iFR|ifr
4733446|NCT03027830|Pilot study|pilot study
4733447|NCT03027817|Prone positioning|prone positioning
4733448|NCT03027817|Non-invasive Cardiac Output Monitoring|non-invasive cardiac output monitoring
4733449|NCT03027791|Biosensors|biosensors
4733450|NCT03027791|Virtual Reality|virtual reality
4733451|NCT03027791|Dietary Sodium|dietary sodium
4733452|NCT03027778|arterial stiffness|arterial stiffness
4733453|NCT03027778|hemodialysis|hemodialysis
4733454|NCT03027778|intradialytic pedalling exercise|intradialytic pedalling exercise
4733455|NCT03027778|carotid-femoral pulse wave velocity|carotid-femoral pulse wave velocity
4733456|NCT03027778|chronic kidney disease|chronic kidney disease
4733457|NCT03027778|hemodynamics|hemodynamics
4733458|NCT03027778|augmentation index|augmentation index
4733459|NCT03027752|carotid endaretectomy|carotid endaretectomy
4733460|NCT03027713|NAVA: neurally adjusted ventilatory assist|nava: neurally adjusted ventilatory assist
4733461|NCT03027713|Diaphragm electromyographic activity|diaphragm electromyographic activity
4733462|NCT03027713|Weaning|weaning
4733463|NCT03027687|Smoking|smoking
4733464|NCT03027687|EMA|ema
4733465|NCT03027687|ERPs|erps
4733466|NCT03027687|tDCS|tdcs
4733467|NCT03027687|Cigarette consumption|cigarette consumption
4733468|NCT03027687|Inhibitory control|inhibitory control
4733469|NCT03027687|Reward processing|reward processing
4733470|NCT03027674|Raynaud Phenomena|raynaud phenomena
4733471|NCT03027674|System; Sclerosis|system; sclerosis
4733472|NCT03027674|Lupus Erythematosus, Systemic|lupus erythematosus, systemic
4733473|NCT03027674|Ultrasound|ultrasound
4733474|NCT03027674|sildenafil|sildenafil
4733475|NCT03027674|Nifedipine|nifedipine
4733476|NCT03027661|para-cervical block|para-cervical block
4733477|NCT03027661|laparoscopic hysterectomy|laparoscopic hysterectomy
4733478|NCT03027648|levonorgestrel-releasing intrauterine system|levonorgestrel-releasing intrauterine system
4733479|NCT03027648|adenomyosis|adenomyosis
4733480|NCT03027635|diuretic resistant ascites|diuretic resistant ascites
4733481|NCT03027635|Paracentesis|paracentesis
4733482|NCT03027635|PleurX|pleurx
4733483|NCT03027635|Peritoneal tunnelated catheter|peritoneal tunnelated catheter
4733484|NCT03027622|quality of life|quality of life
4733485|NCT03027622|pericoronitis|pericoronitis
4733486|NCT03027622|third molar|third molar
4733487|NCT03027609|Pseudomonas aeruginosa|pseudomonas aeruginosa
4733488|NCT03027609|pneumonia|pneumonia
4733489|NCT03027570|Exergame|exergame
4733490|NCT03027570|Cellular apps|cellular apps
4733491|NCT03027570|Smartphone|smartphone
4733492|NCT03027570|Overweight|overweight
4733493|NCT03027570|Obesity|obesity
4733494|NCT03027570|Children|children
4733495|NCT03027570|Physical activity|physical activity
4733496|NCT03027570|Fitness|fitness
4733497|NCT03027570|Motivation|motivation
4733498|NCT03027570|BMI|bmi
4733499|NCT03027557|Primary Hyperparathyroidism|primary hyperparathyroidism
4733500|NCT03027557|Parathyroid Adenoma|parathyroid adenoma
4733501|NCT03027557|Parathyroid Hyperplasia|parathyroid hyperplasia
4733502|NCT03027557|Cinacalcet|cinacalcet
4733503|NCT03027557|Denosumab|denosumab
4733504|NCT03027557|Drug Therapy|drug therapy
4733505|NCT03027557|Bone Mineral Density|bone mineral density
4733506|NCT03027557|Calcium|calcium
4733507|NCT03027544|multiple brain metastases|multiple brain metastases
4733508|NCT03027544|large brain metastases|large brain metastases
4733509|NCT03027544|meningeal metastases|meningeal metastases
4733510|NCT03027544|tomotherapy|tomotherapy
4733511|NCT03027531|reproductive health, condoms, sexually transmitted diseases, contraception|reproductive health, condoms, sexually transmitted diseases, contraception
4733512|NCT03027505|MUAC|muac
4733513|NCT03027505|Acute malnutrition|acute malnutrition
4733514|NCT03027505|RUTF|rutf
4733515|NCT03027505|Children|children
4733516|NCT03027505|Burkina Faso|burkina faso
4733517|NCT03027492|Non-celiac Wheat Sensitivity|non-celiac wheat sensitivity
4733518|NCT03027492|gynaecological disorders|gynaecological disorders
4733519|NCT03027492|gluten-free diet|gluten-free diet
4733520|NCT03027479|weight loss|weight loss
4733521|NCT03027479|ovarian cancer|ovarian cancer
4733522|NCT03027479|endometrial cancer|endometrial cancer
4733523|NCT03027479|energy metabolism|energy metabolism
4733524|NCT03027479|Body mass index|body mass index
4733525|NCT03027479|obesity|obesity
4733526|NCT03027479|muscle energy|muscle energy
4733527|NCT03027466|Quitting Smoking|quitting smoking
4733528|NCT03027466|Phone Application|phone application
4733529|NCT03027440|Stress Response|stress response
4733530|NCT03027440|Neurodevelopment|neurodevelopment
4733531|NCT03027440|Biomarkers|biomarkers
4733532|NCT03027440|Cohort Study|cohort study
4733533|NCT03027427|Screening|screening
4733534|NCT03027427|Heritable Gastric Malignancy|heritable gastric malignancy
4733535|NCT03027427|Molecular Profiling|molecular profiling
4733536|NCT03027427|Molecular Alterations|molecular alterations
4733537|NCT03027414|Anxiety|anxiety
4733538|NCT03027414|Startle|startle
4733539|NCT03027414|Dorsolateral Prefrontal Cortex|dorsolateral prefrontal cortex
4733540|NCT03027414|Transcranial Magnetic Stimulation (TMS)|transcranial magnetic stimulation (tms)
4733541|NCT03027414|Working Memory|working memory
4733542|NCT03027401|Genetic Testing|genetic testing
4733543|NCT03027401|Tumor Profiling|tumor profiling
4733544|NCT03027401|Biorepository|biorepository
4733545|NCT03027388|Brain Tumor|brain tumor
4733546|NCT03027388|Blood Brain Barrier|blood brain barrier
4733547|NCT03027388|Pharmacokinetics|pharmacokinetics
4733548|NCT03027388|Pharmacodynamics|pharmacodynamics
4733549|NCT03027375|chronic heart failure|chronic heart failure
4733550|NCT03027375|traditional Chinese medicine|traditional chinese medicine
4733551|NCT03027375|Qishen granules|qishen granules
4733552|NCT03027336|dyslipidemia|dyslipidemia
4733553|NCT03027336|dietary supplement|dietary supplement
4733554|NCT03027323|undifferentiated hypotension|undifferentiated hypotension
4733555|NCT03027323|central venous cannulation|central venous cannulation
4733556|NCT03027310|Dystonic Tremor|dystonic tremor
4733557|NCT03027310|Essential Tremor|essential tremor
4733558|NCT03027310|Tremor|tremor
4733559|NCT03027310|Voice Tremor|voice tremor
4733560|NCT03027310|Parkinson's Disease|parkinson's disease
4733561|NCT03027284|Neoplasm|neoplasm
4733562|NCT03027258|Mobile health technology|mobile health technology
4733563|NCT03027245|locally advanced or metastatic breast cancer|locally advanced or metastatic breast cancer
4733564|NCT03027245|peripheral neuropathy|peripheral neuropathy
4733565|NCT03027245|chemotherapy-induced peripheral neuropathy|chemotherapy-induced peripheral neuropathy
4733566|NCT03027245|eribulin|eribulin
4733567|NCT03027232|infection|infection
4733568|NCT03027193|Vaccine|vaccine
4733570|NCT03027154|diagnostic test|diagnostic test
4733571|NCT03027154|children|children
4733572|NCT03027154|diagnosis of tuberculosis|diagnosis of tuberculosis
4733573|NCT03027141|Face Transplant|face transplant
4733574|NCT03027128|Phase 1|phase 1
4733575|NCT03027128|Metastatic|metastatic
4733576|NCT03027128|Locally Advanced|locally advanced
4733577|NCT03027128|Cancer|cancer
4733578|NCT03027128|Cell Therapy|cell therapy
4733579|NCT03027102|allogenic double negative T cells|allogenic double negative t cells
4733580|NCT03027102|DNT cells|dnt cells
4733581|NCT03027089|Aspergillus-specific IgG|aspergillus-specific igg
4733582|NCT03027076|prostatitis|prostatitis
4733583|NCT03027076|chronic prostatitis|chronic prostatitis
4733584|NCT03027076|chronic pelvic pain syndrome|chronic pelvic pain syndrome
4733585|NCT03027076|interstitial cystitis|interstitial cystitis
4733586|NCT03027076|painful bladder syndrome|painful bladder syndrome
4733587|NCT03027076|bladder pain syndrome|bladder pain syndrome
4733588|NCT03027076|biomarkers|biomarkers
4733589|NCT03027076|biological markers|biological markers
4733590|NCT03027076|bacteria|bacteria
4733591|NCT03027076|microbiome|microbiome
4733592|NCT03027076|inflammation|inflammation
4733593|NCT03027063|Speckle tracking echocardiography|speckle tracking echocardiography
4733594|NCT03027050|periodontitis|periodontitis
4733595|NCT03027050|Growth factors|growth factors
4733596|NCT03027050|Periodontal healing|periodontal healing
4733597|NCT03027024|Intraocular Lens|intraocular lens
4733598|NCT03027024|trifocal|trifocal
4733599|NCT03027024|cataract|cataract
4733600|NCT03027024|PhysIOL|physiol
4733601|NCT03026998|hereditary retinoblastoma,|hereditary retinoblastoma,
4733602|NCT03026998|External beam radiation therapy (EBRT)|external beam radiation therapy (ebrt)
4733603|NCT03026985|Extracorporeal Membrane Oxygenation|extracorporeal membrane oxygenation
4733604|NCT03026985|Ultrasonography|ultrasonography
4733605|NCT03026985|Intensive Care Units|intensive care units
4733606|NCT03026972|Safety|safety
4733607|NCT03026972|Tolerance|tolerance
4733608|NCT03026946|Alitretinoin|alitretinoin
4733609|NCT03026946|Cyclosporine A|cyclosporine a
4733610|NCT03026946|Hand eczema|hand eczema
4733611|NCT03026920|Fracture|fracture
4733612|NCT03026920|outcome|outcome
4733613|NCT03026920|pelvic|pelvic
4733614|NCT03026920|acetabular|acetabular
4733615|NCT03026907|Alitretinoin|alitretinoin
4733616|NCT03026907|Azathioprine|azathioprine
4733617|NCT03026907|Hand eczema|hand eczema
4733618|NCT03026881|PARP inhibitor|parp inhibitor
4733619|NCT03026881|VEGFR inhibitor|vegfr inhibitor
4733620|NCT03026881|Combination therapy|combination therapy
4733621|NCT03026881|Gastric cancer|gastric cancer
4733622|NCT03026868|acetabular|acetabular
4733623|NCT03026868|quadrilateral surface plate|quadrilateral surface plate
4733624|NCT03026855|Autologous PRP|autologous prp
4733625|NCT03026855|Non-healing ulcer|non-healing ulcer
4733626|NCT03026855|Point-of-care|point-of-care
4733627|NCT03026829|Sound therapy|sound therapy
4733628|NCT03026829|Tinnitus relief|tinnitus relief
4733629|NCT03026816|epidural stimulation|epidural stimulation
4733630|NCT03026816|spinal cord stimulation|spinal cord stimulation
4733631|NCT03026816|autonomic dysfunction|autonomic dysfunction
4733632|NCT03026790|Opioid analgesics|opioid analgesics
4733633|NCT03026790|Opioid partial agonists|opioid partial agonists
4733634|NCT03026790|Health care delivery|health care delivery
4733635|NCT03026790|Back pain|back pain
4733636|NCT03026790|Osteoarthritis|osteoarthritis
4733637|NCT03026790|Veterans health|veterans health
4733638|NCT03026764|cost|cost
4733639|NCT03026764|total hip replacement|total hip replacement
4733640|NCT03026764|outpatient Surgery|outpatient surgery
4733641|NCT03026764|satisfaction|satisfaction
4733642|NCT03026764|arthroplasty|arthroplasty
4733643|NCT03026725|tooth sensitivity|tooth sensitivity
4733644|NCT03026725|tri calcium phosphate|tri calcium phosphate
4733645|NCT03026725|at-home whitening|at-home whitening
4733646|NCT03026712|Robotic therapy|robotic therapy
4733647|NCT03026712|tDCS|tdcs
4733648|NCT03026712|non invasive electrical stimulation|non invasive electrical stimulation
4733649|NCT03026712|ArmeoPower|armeopower
4733650|NCT03026712|interhemispheric balance|interhemispheric balance
4733651|NCT03026699|Brain|brain
4733652|NCT03026699|Nervous system|nervous system
4733653|NCT03026699|Neuro-oncology|neuro-oncology
4733654|NCT03026699|Caregivers|caregivers
4733655|NCT03026699|Cancer patient|cancer patient
4733656|NCT03026699|Family caregivers|family caregivers
4733657|NCT03026699|Brain tumors|brain tumors
4733658|NCT03026699|Quality of life|quality of life
4733659|NCT03026699|Stress|stress
4733660|NCT03026699|Social support|social support
4733661|NCT03026699|Feasibility|feasibility
4733662|NCT03026699|Electronic Social Network Assessment Program (eSNAP)|electronic social network assessment program (esnap)
4733663|NCT03026660|Moringa Oleifera|moringa oleifera
4733664|NCT03026634|Sleep-Disordered Breathing|sleep-disordered breathing
4733665|NCT03026634|Heart Failure|heart failure
4733666|NCT03026634|Heart Transplantation|heart transplantation
4733667|NCT03026569|orange juice|orange juice
4733668|NCT03026569|chronic hepatitis C|chronic hepatitis c
4733669|NCT03026569|biochemical markers|biochemical markers
4733670|NCT03026569|oxidative stress|oxidative stress
4733671|NCT03026569|nutritional status|nutritional status
4733672|NCT03026569|antioxidants|antioxidants
4733673|NCT03026517|Phenformin|phenformin
4733674|NCT03026517|Dabrafenib|dabrafenib
4733675|NCT03026517|Trametinib|trametinib
4733676|NCT03026517|BRAF|braf
4733677|NCT03026517|15-318|15-318
4733678|NCT03026478|oral lichen planus|oral lichen planus
4733679|NCT03026478|betamethasone|betamethasone
4733680|NCT03026478|clobetasol|clobetasol
4733681|NCT03026478|orabase|orabase
4733682|NCT03026439|mild COPD|mild copd
4733683|NCT03026439|early COPD|early copd
4733684|NCT03026439|six-min walk test|six-min walk test
4733685|NCT03026439|computed tomography|computed tomography
4733686|NCT03026439|emphysema|emphysema
4733687|NCT03026439|airway disease|airway disease
4733688|NCT03026439|peripheral muscle mass|peripheral muscle mass
4733689|NCT03026439|Saint George's Respiratory Questionnaire|saint george's respiratory questionnaire
4733690|NCT03026426|Depression|depression
4733691|NCT03026426|Chronic diseases|chronic diseases
4733692|NCT03026426|Mobile technology|mobile technology
4733693|NCT03026426|Clinical trial|clinical trial
4733694|NCT03026413|atrial fibrillation|atrial fibrillation
4733695|NCT03026413|pulmonary vein isolation|pulmonary vein isolation
4733696|NCT03026413|Contact Force|contact force
4733697|NCT03026413|antrum|antrum
4733698|NCT03026387|Suicidal behavior|suicidal behavior
4733699|NCT03026387|Suicide attempt|suicide attempt
4733700|NCT03026387|Emergency department|emergency department
4733701|NCT03026387|Psychometrics|psychometrics
4733702|NCT03026387|Neuropsychological tests|neuropsychological tests
4733703|NCT03026387|Suicidal ideation|suicidal ideation
4733704|NCT03026374|psychosocial support|psychosocial support
4733705|NCT03026374|resilience|resilience
4733706|NCT03026374|metastatic breast cancer|metastatic breast cancer
4733707|NCT03026374|survival|survival
4733708|NCT03026374|Quality of Life|quality of life
4733709|NCT03026348|RSV|rsv
4733710|NCT03026335|Positive Youth Development|positive youth development
4733711|NCT03026296|Physical Fitness|physical fitness
4733712|NCT03026296|Health Status|health status
4733713|NCT03026296|Exercise|exercise
4733714|NCT03026296|Tobacco Use Cessation|tobacco use cessation
4733715|NCT03026296|Quality of Life|quality of life
4733716|NCT03026296|Healthy Diet|healthy diet
4733717|NCT03026296|Health Promotion|health promotion
4733718|NCT03026296|Patient Education as Topic|patient education as topic
4733719|NCT03026296|Counseling|counseling
4733720|NCT03026270|Physiotherapy|physiotherapy
4733721|NCT03026270|Paraffin|paraffin
4733722|NCT03026270|Burn|burn
4733723|NCT03026270|Contracture|contracture
4733724|NCT03026244|Immunity|immunity
4733725|NCT03026244|Elderly|elderly
4733726|NCT03026244|Inflammation|inflammation
4733727|NCT03026244|Milk protein|milk protein
4733728|NCT03026244|Prebiotics|prebiotics
4733729|NCT03026231|Fecal microbiota transplantation|fecal microbiota transplantation
4733730|NCT03026166|Cancer|cancer
4733731|NCT03026166|Extensive-Stage Small Cell Lung Cancer|extensive-stage small cell lung cancer
4733732|NCT03026166|Nivolumab|nivolumab
4733733|NCT03026166|Ipilimumab|ipilimumab
4733734|NCT03026166|Rovalpituzumab tesirine|rovalpituzumab tesirine
4733735|NCT03026140|MSI tumors|msi tumors
4733736|NCT03026140|MSS tumors|mss tumors
4733737|NCT03026140|short-term immunotherapy|short-term immunotherapy
4733738|NCT03026140|surgical resection|surgical resection
4733739|NCT03026140|nivolumab|nivolumab
4733740|NCT03026140|ipilimumab|ipilimumab
4733741|NCT03026127|Suicide|suicide
4733742|NCT03026127|Middle-aged and Older Adults|middle-aged and older adults
4733743|NCT03026127|Cognitive Reappraisal|cognitive reappraisal
4733744|NCT03026127|Emotion Regulation|emotion regulation
4733745|NCT03026088|Chronic Heart Failure|chronic heart failure
4733746|NCT03026088|Bisoprolol|bisoprolol
4733747|NCT03026088|Heart rate control|heart rate control
4733748|NCT03026062|Recurrent Platinum-Resistant Epithelial Ovarian Cancer|recurrent platinum-resistant epithelial ovarian cancer
4733749|NCT03026062|Ovarian Cancer|ovarian cancer
4733750|NCT03026062|epithelial ovarian cancer|epithelial ovarian cancer
4733751|NCT03026036|Depression|depression
4733752|NCT03026036|MRI|mri
4733753|NCT03026036|PET|pet
4733754|NCT03026036|Reward|reward
4733755|NCT03026023|Heart Transplant|heart transplant
4733756|NCT03026023|Cardiac Transplant|cardiac transplant
4733757|NCT03026023|Hepatitis C|hepatitis c
4733758|NCT03026023|Zepatier|zepatier
4733759|NCT03025971|Severe Aortic Stenosis and/or severe aortic regurgitation|severe aortic stenosis and/or severe aortic regurgitation
4733760|NCT03025919|Advanced glycation end-product|advanced glycation end-product
4733761|NCT03025919|Glycosuria|glycosuria
4733762|NCT03025893|Sunitinib|sunitinib
4733763|NCT03025893|Lomustine|lomustine
4733764|NCT03025893|High-dose|high-dose
4733765|NCT03025893|Intermittent|intermittent
4733766|NCT03025880|Advanced Breast Cancer|advanced breast cancer
4733767|NCT03025880|Pembrolizumab|pembrolizumab
4733768|NCT03025880|HER2-negative|her2-negative
4733769|NCT03025828|Membranous nephropathy|membranous nephropathy
4733770|NCT03025828|adrenocorticotropic hormone|adrenocorticotropic hormone
4733771|NCT03025828|ACTH|acth
4733772|NCT03025828|proteinuria|proteinuria
4733773|NCT03025828|glomerulonephritis|glomerulonephritis
4733774|NCT03025815|Infant, Premature|infant, premature
4733775|NCT03025802|Molecular diagnosis|molecular diagnosis
4733776|NCT03025802|Pathogen identification|pathogen identification
4733777|NCT03025802|Sepsis|sepsis
4733778|NCT03025802|Bacteremia|bacteremia
4733779|NCT03025802|Rapid diagnostics|rapid diagnostics
4733780|NCT03025789|T.b gambiense|t.b gambiense
4733781|NCT03025789|HAT|hat
4733782|NCT03025789|outpatients|outpatients
4733783|NCT03025763|Craniosynostosis|craniosynostosis
4733784|NCT03025763|Bone|bone
4733785|NCT03025763|Birth Defect|birth defect
4733786|NCT03025763|Congenital Anomaly|congenital anomaly
4733787|NCT03025763|Malformation|malformation
4733788|NCT03025763|Genetics|genetics
4733789|NCT03025763|Genomics|genomics
4733790|NCT03025763|Skull|skull
4733791|NCT03025763|Human|human
4733792|NCT03025763|Mouse|mouse
4733793|NCT03025763|Imaging|imaging
4733794|NCT03025763|Cell Biology|cell biology
4733795|NCT03025763|Induced Pluripotent Stem Cells|induced pluripotent stem cells
4733796|NCT03025763|System Biology|system biology
4733797|NCT03025737|Hypertrophy, Left Ventricular|hypertrophy, left ventricular
4733798|NCT03025737|Ventricular Remodeling|ventricular remodeling
4733799|NCT03025711|Advanced HER2+ breast cancer|advanced her2+ breast cancer
4733800|NCT03025711|Pertuzumab|pertuzumab
4733801|NCT03025711|Trastuzumab emtansine|trastuzumab emtansine
4733802|NCT03025711|Compassionate use|compassionate use
4733803|NCT03025711|Early access program|early access program
4733804|NCT03025711|Effectiveness|effectiveness
4733805|NCT03025711|Safety|safety
4733806|NCT03025698|Eltrombopag|eltrombopag
4733807|NCT03025698|hATG|hatg
4733808|NCT03025698|CsA|csa
4733809|NCT03025698|previously untreated or relapsed severe aplastic anemia|previously untreated or relapsed severe aplastic anemia
4733810|NCT03025698|recurrent aplastic anemia|recurrent aplastic anemia
4733811|NCT03025698|Severe aplastic anemia|severe aplastic anemia
4733812|NCT03025698|Pharmacokinetics|pharmacokinetics
4733813|NCT03025698|Immunosuppressive therapy|immunosuppressive therapy
4733814|NCT03025698|ETB115|etb115
4733815|NCT03025685|Percutaneous Coronary Intervention|percutaneous coronary intervention
4733816|NCT03025685|Coronary Artery Disease|coronary artery disease
4733817|NCT03025685|Wire|wire
4733818|NCT03025685|Coronary stenting|coronary stenting
4733819|NCT03025659|pediatric|pediatric
4733820|NCT03025659|congenital heart disease|congenital heart disease
4733821|NCT03025646|Maternal depression|maternal depression
4733822|NCT03025646|ASD|asd
4733823|NCT03025646|Home based training program|home based training program
4733824|NCT03025633|PEARL|pearl
4733825|NCT03025620|Alphalinolenic acid|alphalinolenic acid
4733826|NCT03025620|Lipid cardiovascular risk factors|lipid cardiovascular risk factors
4733827|NCT03025620|Inflammation|inflammation
4733828|NCT03025607|Prevention|prevention
4733829|NCT03025607|Mobile health|mobile health
4733830|NCT03025607|Autonomous motivation|autonomous motivation
4733831|NCT03025594|Paralytic sellfish toxins|paralytic sellfish toxins
4733832|NCT03025594|Gonyautoxin|gonyautoxin
4733833|NCT03025594|Post surgery pain management|post surgery pain management
4733834|NCT03025594|total knee arthroplasty|total knee arthroplasty
4733835|NCT03025568|nylon|nylon
4733836|NCT03025568|polyamide|polyamide
4733837|NCT03025568|denture base|denture base
4733838|NCT03025555|nylon|nylon
4733839|NCT03025555|polyamide|polyamide
4733840|NCT03025555|PEEK|peek
4733841|NCT03025555|partial denture|partial denture
4733842|NCT03025542|Psoriasis|psoriasis
4733843|NCT03025542|Chronic Plaque Psoriasis|chronic plaque psoriasis
4733844|NCT03025542|Bimekizumab|bimekizumab
4733845|NCT03025490|Capnography|capnography
4733846|NCT03025490|Electrophysiology|electrophysiology
4733847|NCT03025477|Intraperitoneal|intraperitoneal
4733848|NCT03025477|Intravenous|intravenous
4733849|NCT03025477|Completeness of cytoreduction score|completeness of cytoreduction score
4733850|NCT03025477|Carboplatin|carboplatin
4733851|NCT03025477|Epirubicin|epirubicin
4733852|NCT03025477|Paclitaxel|paclitaxel
4733853|NCT03025477|Cisplatin|cisplatin
4733854|NCT03025451|nutrition|nutrition
4733855|NCT03025451|exercise|exercise
4733856|NCT03025451|stress|stress
4733857|NCT03025451|gender|gender
4733858|NCT03025451|age|age
4733859|NCT03025451|community support|community support
4733860|NCT03025451|cardiovascular disease|cardiovascular disease
4733861|NCT03025451|diabetes|diabetes
4733862|NCT03025451|hypertension|hypertension
4733863|NCT03025451|dyslipidemia|dyslipidemia
4733864|NCT03025451|cholesterol|cholesterol
4733865|NCT03025451|overweight|overweight
4733866|NCT03025451|obesity|obesity
4733867|NCT03025451|lifestyle|lifestyle
4733868|NCT03025438|angiosarcoma|angiosarcoma
4733869|NCT03025438|Cytology|cytology
4733870|NCT03025438|liver|liver
4733871|NCT03025438|cancer|cancer
4733872|NCT03025412|Achilles Tendon|achilles tendon
4733873|NCT03025412|Endoscopy|endoscopy
4733874|NCT03025412|Minimally Invasive Surgical Procedures|minimally invasive surgical procedures
4733875|NCT03025412|Exercise therapy|exercise therapy
4733876|NCT03025399|tang wang prescription|tang wang prescription
4733877|NCT03025321|Cocaine|cocaine
4733878|NCT03025321|tDCS|tdcs
4733879|NCT03025321|EMA|ema
4733880|NCT03025321|Inhibitory control|inhibitory control
4733881|NCT03025321|Reward processing|reward processing
4733882|NCT03025321|Addiction|addiction
4733883|NCT03025321|dlPFC|dlpfc
4733884|NCT03025321|craving|craving
4733885|NCT03025321|cognitive control|cognitive control
4733886|NCT03025256|Melanoma and other malignant neoplasms of skin|melanoma and other malignant neoplasms of skin
4733887|NCT03025256|Leptomeningeal disease|leptomeningeal disease
4733889|NCT03025256|Nivolumab|nivolumab
4733890|NCT03025256|BMS-936558|bms-936558
4733891|NCT03025256|Opdivo|opdivo
4733892|NCT03025243|computer aided design , dental implants , accuracy|computer aided design , dental implants , accuracy
4733893|NCT03025204|Regeneration Procedures|regeneration procedures
4733894|NCT03025204|Intrabony Defects|intrabony defects
4733895|NCT03025204|Cronic Periodontitis|cronic periodontitis
4733896|NCT03025191|incarceration|incarceration
4733897|NCT03025191|HIV|hiv
4733898|NCT03025152|Hou Gu Mi Xi|hou gu mi xi
4733899|NCT03025152|Shen Ling Bai Zhu San|shen ling bai zhu san
4733900|NCT03025152|radical gastrectomy|radical gastrectomy
4733901|NCT03025152|gastric cancer|gastric cancer
4733902|NCT03025152|traditional Chinese medicine|traditional chinese medicine
4733903|NCT03025152|randomized controlled trial|randomized controlled trial
4733904|NCT03025139|breast cancer|breast cancer
4733905|NCT03025139|younger women|younger women
4733906|NCT03025139|education|education
4733907|NCT03025139|mindfulness meditation|mindfulness meditation
4733908|NCT03025139|depression|depression
4733909|NCT03025139|cancer survivor|cancer survivor
4733910|NCT03025074|Liver Disease|liver disease
4733911|NCT03025074|Obesity|obesity
4733912|NCT03025074|Hepatitis|hepatitis
4733913|NCT03025074|HIV|hiv
4733914|NCT03025074|Hepatology|hepatology
4733915|NCT03025061|Breath pattern|breath pattern
4733916|NCT03025061|Children|children
4733917|NCT03025061|Repeatability|repeatability
4733918|NCT03025035|BRCA-mutation|brca-mutation
4733919|NCT03025035|Immune checkpoint inhibition|immune checkpoint inhibition
4733920|NCT03025035|Immunotherapy|immunotherapy
4733921|NCT03025035|Advanced BRCA-mutated breast cancer|advanced brca-mutated breast cancer
4733922|NCT03024957|morphine|morphine
4733923|NCT03024957|dexmedetomidine|dexmedetomidine
4733924|NCT03024957|immune system|immune system
4733925|NCT03024944|Diabetes Mellitus|diabetes mellitus
4733926|NCT03024944|Alzheimer's Disease|alzheimer's disease
4733927|NCT03024944|Dementia|dementia
4733928|NCT03024944|THK|thk
4733929|NCT03024918|monochorionic|monochorionic
4733930|NCT03024918|placental sharing|placental sharing
4733931|NCT03024892|Fluorenscent image guided surgery|fluorenscent image guided surgery
4733932|NCT03024892|indocyanide green|indocyanide green
4733933|NCT03024892|laparoscopic cholecystectomy|laparoscopic cholecystectomy
4733934|NCT03024892|common bile duct injury|common bile duct injury
4733935|NCT03024879|Motilin|motilin
4733936|NCT03024879|Erythromycin|erythromycin
4733937|NCT03024879|Food intake|food intake
4733938|NCT03024853|Best Possible Self|best possible self
4733939|NCT03024853|Positive Intervention|positive intervention
4733940|NCT03024853|Optimism|optimism
4733941|NCT03024840|Propofol|propofol
4733942|NCT03024840|Neurocognitive Disorders|neurocognitive disorders
4733943|NCT03024840|Liver transplantation|liver transplantation
4733944|NCT03024840|Pediatrics|pediatrics
4733945|NCT03024840|Brain Injuries|brain injuries
4733946|NCT03024827|Infantile Spasms|infantile spasms
4733947|NCT03024827|Lennox Gastaut Syndrome|lennox gastaut syndrome
4733948|NCT03024827|Doose Syndrome|doose syndrome
4733949|NCT03024827|Continuous Spike Wave in Sleep|continuous spike wave in sleep
4733950|NCT03024827|Landau-Kleffner Syndrome|landau-kleffner syndrome
4733951|NCT03024827|Dravet Syndrome|dravet syndrome
4733952|NCT03024827|Malignant Migrating Partial Seizures of Infancy (MMPSI)|malignant migrating partial seizures of infancy (mmpsi)
4733953|NCT03024788|Glycosylated haemoglobin|glycosylated haemoglobin
4733954|NCT03024788|advanced glycation end products|advanced glycation end products
4733955|NCT03024775|Non-celiac Wheat Sensitivity|non-celiac wheat sensitivity
4733956|NCT03024775|ancient wheats|ancient wheats
4733957|NCT03024775|modern wheats|modern wheats
4733958|NCT03024775|ATIs|atis
4733959|NCT03024749|Spinal Arteriovenous Malformation|spinal arteriovenous malformation
4733960|NCT03024749|Spinal Arteriovenous Fistula|spinal arteriovenous fistula
4733961|NCT03024723|Obese patient|obese patient
4733962|NCT03024723|nasal CPAP|nasal cpap
4733963|NCT03024710|Stunting|stunting
4733964|NCT03024710|complementary feeding Index|complementary feeding index
4733965|NCT03024710|Bangladesh|bangladesh
4733966|NCT03024697|Breast surgery|breast surgery
4733967|NCT03024697|Pectoral plane block|pectoral plane block
4733968|NCT03024697|PECs|pecs
4733969|NCT03024697|Local anaesthesia infusion|local anaesthesia infusion
4733970|NCT03024697|Analgesia|analgesia
4733971|NCT03024684|Hepatocellular carcinoma|hepatocellular carcinoma
4733972|NCT03024684|statin|statin
4733973|NCT03024684|curative ablation|curative ablation
4733974|NCT03024658|Pulmonary artery systolic pressure|pulmonary artery systolic pressure
4733975|NCT03024658|Positive end expiratory pressure|positive end expiratory pressure
4733976|NCT03024658|morbidly obese|morbidly obese
4733977|NCT03024658|laparoscopic bariatric surgery|laparoscopic bariatric surgery
4733978|NCT03024645|Postpartum Depression|postpartum depression
4733979|NCT03024645|Cognitive-Behavioral Therapy|cognitive-behavioral therapy
4733980|NCT03024645|Prevention|prevention
4733981|NCT03024645|Web-Based Psychological Intervention|web-based psychological intervention
4733982|NCT03024593|Cyberchondria|cyberchondria
4733983|NCT03024593|health-related internet use|health-related internet use
4733984|NCT03024593|pathological health anxiety|pathological health anxiety
4733985|NCT03024580|Megestrol Acetate|megestrol acetate
4733986|NCT03024580|Steroid, Receptors|steroid, receptors
4733987|NCT03024567|Calorimetry|calorimetry
4733988|NCT03024567|Blood pressure|blood pressure
4733989|NCT03024567|Immunophenotyping|immunophenotyping
4733990|NCT03024567|Gut microbial composition|gut microbial composition
4733991|NCT03024554|aortic aneurysm involving iliac arteries|aortic aneurysm involving iliac arteries
4733992|NCT03024554|abdominal aortic aneurysm|abdominal aortic aneurysm
4733993|NCT03024554|MFM|mfm
4733994|NCT03024554|Multilayer Flow Modulator|multilayer flow modulator
4733995|NCT03024554|Multilayer Stent|multilayer stent
4733996|NCT03024528|Pain|pain
4733997|NCT03024528|CPOT|cpot
4733998|NCT03024528|ICU Delirium|icu delirium
4733999|NCT03024528|Critical Care Pain Observation Tool|critical care pain observation tool
4734000|NCT03024528|NRS|nrs
4734001|NCT03024528|Behaviour|behaviour
4734002|NCT03024528|Critical care|critical care
4734003|NCT03024528|Intensive Care|intensive care
4734004|NCT03024502|vulvovaginal candidiasis|vulvovaginal candidiasis
4734005|NCT03024502|EPPAF mucoadhesive gel|eppaf mucoadhesive gel
4734006|NCT03024502|clotrimazol|clotrimazol
4734007|NCT03024489|Phase I/II|phase i/ii
4734008|NCT03024476|behavioral intervention|behavioral intervention
4734009|NCT03024476|prespecified medication algorithm|prespecified medication algorithm
4734010|NCT03024476|bluetooth-equipped sphygmomanometer|bluetooth-equipped sphygmomanometer
4734011|NCT03024463|Breast Neoplasm; Internal Lymph Node; Sentinel Lymph Node Biospy|breast neoplasm; internal lymph node; sentinel lymph node biospy
4734012|NCT03024450|Gastric cancer|gastric cancer
4734013|NCT03024450|HER2|her2
4734014|NCT03024450|trastuzumab|trastuzumab
4734015|NCT03024450|prognosis|prognosis
4734016|NCT03024437|PD-L1 inhibitor|pd-l1 inhibitor
4734017|NCT03024359|Obesity|obesity
4734018|NCT03024359|Brown adipose tissue|brown adipose tissue
4734019|NCT03024359|Monounsaturated fatty acids|monounsaturated fatty acids
4734020|NCT03024359|Hypothalamic inflammation|hypothalamic inflammation
4734021|NCT03024333|Dysphagia|dysphagia
4734022|NCT03024333|Swallowing Sound|swallowing sound
4734023|NCT03024333|Acoustic Analysis|acoustic analysis
4734024|NCT03024307|Pharmaceutical Care|pharmaceutical care
4734025|NCT03024307|Medication Adherence|medication adherence
4734026|NCT03024307|Direct Costs|direct costs
4734027|NCT03024281|Aspergillus|aspergillus
4734028|NCT03024281|Antifungal susceptibility|antifungal susceptibility
4734029|NCT03024281|Azole resistance|azole resistance
4734030|NCT03024255|sweat gland disease|sweat gland disease
4734031|NCT03024255|sweating|sweating
4734032|NCT03024255|underarm|underarm
4734033|NCT03024229|Transplantation;perfusion machine|transplantation;perfusion machine
4734034|NCT03024190|stroke|stroke
4734035|NCT03024190|spasticity|spasticity
4734036|NCT03024190|Kinesiotaping|kinesiotaping
4734037|NCT03024190|sonography|sonography
4734038|NCT03024190|exercise|exercise
4734039|NCT03024177|Human rhinovirus|human rhinovirus
4734040|NCT03024177|HRV|hrv
4734041|NCT03024177|Hematopoietic Stem Cell Transplant|hematopoietic stem cell transplant
4734042|NCT03024177|HSCT|hsct
4734043|NCT03024177|Antiviral|antiviral
4734044|NCT03024177|vapendavir|vapendavir
4734045|NCT03024177|Allogeneic|allogeneic
4734046|NCT03024177|Autologous|autologous
4734047|NCT03024164|youth; etiology; prognosis; recurrence; biomarkers|youth; etiology; prognosis; recurrence; biomarkers
4734048|NCT03024125|lean mass|lean mass
4734049|NCT03024125|postmenopausal|postmenopausal
4734050|NCT03024125|protein|protein
4734051|NCT03024099|hippotherapy Gross Motor Function Functional performance.|hippotherapy gross motor function functional performance.
4734052|NCT03024060|Actinic Keratosis|actinic keratosis
4734053|NCT03024021|therapeutic hypothermia|therapeutic hypothermia
4734054|NCT03024021|targeted temperature management|targeted temperature management
4734055|NCT03024021|neurological outcome|neurological outcome
4734056|NCT03024021|post-cardiac arrest syndrome|post-cardiac arrest syndrome
4734057|NCT03024008|Critical Gap|critical gap
4734058|NCT03024008|Comminuted Fracture|comminuted fracture
4734059|NCT03024008|Extra-Articular|extra-articular
4734060|NCT03023930|Opioid Use Disorder|opioid use disorder
4734061|NCT03023917|jaundice,complication|jaundice,complication
4734062|NCT03023891|glucocorticoids|glucocorticoids
4734063|NCT03023891|efficacy|efficacy
4734064|NCT03023891|metabolic toxicity|metabolic toxicity
4734065|NCT03023865|Long gap esophageal atresia|long gap esophageal atresia
4734066|NCT03023839|Delirium|delirium
4734067|NCT03023839|Trauma|trauma
4734068|NCT03023839|Injury|injury
4734069|NCT03023839|restraints|restraints
4734070|NCT03023761|Endodontic retreatments|endodontic retreatments
4734071|NCT03023761|Low level laser|low level laser
4734072|NCT03023761|Pain|pain
4734073|NCT03023748|activated vitamin D treatment|activated vitamin d treatment
4734074|NCT03023709|Quadrivalent inactivated influenza vaccine|quadrivalent inactivated influenza vaccine
4734075|NCT03023709|Quadrivalent live, attenuated influenza vaccine|quadrivalent live, attenuated influenza vaccine
4734076|NCT03023709|Adults with obstructive sleep apnea|adults with obstructive sleep apnea
4734077|NCT03023696|C5 Palsy|c5 palsy
4734078|NCT03023683|Live, attenuated influenza vaccine|live, attenuated influenza vaccine
4734079|NCT03023683|Children and young adults|children and young adults
4734080|NCT03023670|Lung|lung
4734081|NCT03023670|Cardiopulmonary Bypass|cardiopulmonary bypass
4734082|NCT03023670|Pediatric|pediatric
4734083|NCT03023670|Cardiac surgery|cardiac surgery
4734084|NCT03023657|arousal|arousal
4734085|NCT03023657|Consciousness Disorders|consciousness disorders
4734086|NCT03023657|vegetative state|vegetative state
4734087|NCT03023657|minimally conscious state|minimally conscious state
4734088|NCT03023644|Congenital Heart Disease|congenital heart disease
4734089|NCT03023644|Neurodevelopmental Disorders|neurodevelopmental disorders
4734090|NCT03023644|Children|children
4734091|NCT03023644|Executive Function|executive function
4734092|NCT03023644|Working Memory|working memory
4734093|NCT03023644|Cognitive interventions|cognitive interventions
4734094|NCT03023644|Infant Open Heart Surgery|infant open heart surgery
4734095|NCT03023631|GARDASIL 9|gardasil 9
4734096|NCT03023631|Post allogeneic stem cell transplantation|post allogeneic stem cell transplantation
4734097|NCT03023631|HPV infection prevention|hpv infection prevention
4734098|NCT03023618|[G09.330.380]|[g09.330.380]
4734099|NCT03023605|Pulmonary embolism|pulmonary embolism
4734100|NCT03023605|Adherence to practice guidelines|adherence to practice guidelines
4734101|NCT03023605|Age-adjusted D-dimer|age-adjusted d-dimer
4734102|NCT03023605|Clinical prediction rules|clinical prediction rules
4734103|NCT03023605|Elderly patients|elderly patients
4734104|NCT03023592|Sjogren's Syndrome|sjogren's syndrome
4734105|NCT03023592|Iguratimod|iguratimod
4734106|NCT03023566|Dotarem|dotarem
4734107|NCT03023566|MRI|mri
4734108|NCT03023566|pediatric|pediatric
4734109|NCT03023566|safety|safety
4734110|NCT03023566|efficacy|efficacy
4734111|NCT03023553|Trivalent, inactivated influenza vaccine|trivalent, inactivated influenza vaccine
4734112|NCT03023553|Live, attenuated influenza vaccine|live, attenuated influenza vaccine
4734113|NCT03023553|Nasopharyngeal swabs|nasopharyngeal swabs
4734114|NCT03023553|Young adults|young adults
4734115|NCT03023540|Charcot Marie Tooth Type 1A|charcot marie tooth type 1a
4734116|NCT03023540|Peripheral neuropathy|peripheral neuropathy
4734117|NCT03023540|PXT3003|pxt3003
4734118|NCT03023527|Refractory|refractory
4734119|NCT03023527|Relapsed|relapsed
4734120|NCT03023527|Nivolumab|nivolumab
4734121|NCT03023514|Oocyte donation|oocyte donation
4734122|NCT03023514|IVF|ivf
4734123|NCT03023514|Lipoic acid|lipoic acid
4734124|NCT03023514|Implantation rate|implantation rate
4734125|NCT03023514|Endometrial receptivity|endometrial receptivity
4734126|NCT03023488|flexible ureteroscopy|flexible ureteroscopy
4734127|NCT03023488|blood flow|blood flow
4734128|NCT03023436|Stomach Neoplasms|stomach neoplasms
4734129|NCT03023436|Cytoreduction Surgical Procedures|cytoreduction surgical procedures
4734130|NCT03023410|Revision TKA|revision tka
4734131|NCT03023410|Instability|instability
4734132|NCT03023410|Stiffness|stiffness
4734133|NCT03023410|Aseptic Loosening|aseptic loosening
4734134|NCT03023410|Polyethylene Wear|polyethylene wear
4734135|NCT03023410|Malrotation|malrotation
4734136|NCT03023410|Soft Tissue Imbalance|soft tissue imbalance
4734137|NCT03023397|E-cig smokers|e-cig smokers
4734138|NCT03023384|Acute Myeloid Leukemia|acute myeloid leukemia
4734139|NCT03023384|Chemotherapy|chemotherapy
4734140|NCT03023384|Autologous Stem Cell Transplantation|autologous stem cell transplantation
4734438|NCT03021655|Youth|youth
4734141|NCT03023384|Developing country|developing country
4734142|NCT03023384|Clinical network|clinical network
4734143|NCT03023371|Registry; cohort study; IgG4-related disease|registry; cohort study; igg4-related disease
4734144|NCT03023358|peripheral T cell lymphoma|peripheral t cell lymphoma
4734145|NCT03023345|cancer|cancer
4734146|NCT03023345|prostate|prostate
4734147|NCT03023345|PSA|psa
4734148|NCT03023345|biopsies|biopsies
4734149|NCT03023345|microwave trans rectal focal treatment|microwave trans rectal focal treatment
4734150|NCT03023332|Caregiver|caregiver
4734151|NCT03023332|Biofeedback|biofeedback
4734152|NCT03023332|Resourcefulness|resourcefulness
4734153|NCT03023332|Self-Management|self-management
4734154|NCT03023293|n-3 polyunsaturated fatty acids|n-3 polyunsaturated fatty acids
4734155|NCT03023293|irisin|irisin
4734156|NCT03023241|BPS/IC|bps/ic
4734157|NCT03023241|OAB|oab
4734158|NCT03023228|Diabetes mellitus|diabetes mellitus
4734159|NCT03023228|Hyperglycemia|hyperglycemia
4734160|NCT03023228|Inpatient|inpatient
4734161|NCT03023228|self-management education|self-management education
4734162|NCT03023215|Meditation|meditation
4734163|NCT03023215|Breast Biopsy|breast biopsy
4734164|NCT03023215|Stereotactic Breast Biopsy|stereotactic breast biopsy
4734165|NCT03023215|SBB|sbb
4734166|NCT03023215|Guided meditation|guided meditation
4734167|NCT03023215|Focused breathing|focused breathing
4734168|NCT03023215|Electroencephalogram|electroencephalogram
4734169|NCT03023215|EEG|eeg
4734170|NCT03023215|Heart rate|heart rate
4734171|NCT03023215|HR|hr
4734172|NCT03023215|Questionnaires|questionnaires
4734173|NCT03023215|Surveys|surveys
4734174|NCT03023189|Upper digestive bleeding|upper digestive bleeding
4734175|NCT03023189|Haemorrhage|haemorrhage
4734176|NCT03023189|Cirrhosis|cirrhosis
4734177|NCT03023189|Antifibrinolytic|antifibrinolytic
4734178|NCT03023189|Tranexamic acid|tranexamic acid
4734179|NCT03023189|Emergency|emergency
4734180|NCT03023176|Trivalent, inactivated influenza vaccine|trivalent, inactivated influenza vaccine
4734181|NCT03023176|Child identical twins|child identical twins
4734182|NCT03023176|Child fraternal twins|child fraternal twins
4734183|NCT03023163|autonomic dysreflexia|autonomic dysreflexia
4734184|NCT03023163|baroreceptor integrity|baroreceptor integrity
4734185|NCT03023163|sympathetic integrity|sympathetic integrity
4734186|NCT03023163|vagal integrity|vagal integrity
4734187|NCT03023163|autonomic integrity|autonomic integrity
4734188|NCT03023163|arterial stiffness|arterial stiffness
4734189|NCT03023163|cognitive function|cognitive function
4734190|NCT03023163|traumatic brain injury|traumatic brain injury
4734191|NCT03023163|cerebral blood flow|cerebral blood flow
4734192|NCT03023163|white matter hyperintensities|white matter hyperintensities
4734193|NCT03023163|cerebral vascular resistance index|cerebral vascular resistance index
4734194|NCT03023137|prevention|prevention
4734195|NCT03023137|carbohydrate|carbohydrate
4734196|NCT03023137|exercise|exercise
4734197|NCT03023137|neonatal hypoglycemia|neonatal hypoglycemia
4734198|NCT03023111|Cutaneous leishmaniasis|cutaneous leishmaniasis
4734199|NCT03023111|miltefosine|miltefosine
4734200|NCT03023111|cytokines|cytokines
4734201|NCT03023111|treatment|treatment
4734202|NCT03023098|Restenosis|restenosis
4734203|NCT03023098|Drug-eluting balloon|drug-eluting balloon
4734204|NCT03023098|Vein graft|vein graft
4734205|NCT03023059|L-DOPA|l-dopa
4734206|NCT03023059|GPR143|gpr143
4734207|NCT03023059|PEDF|pedf
4734208|NCT03023059|VEGF|vegf
4734209|NCT03023033|PMTCT|pmtct
4734210|NCT03023033|MNCH|mnch
4734211|NCT03023020|Dual Antiplatelet Therapy|dual antiplatelet therapy
4734212|NCT03022994|Non-celiac wheat sensitivity|non-celiac wheat sensitivity
4734213|NCT03022994|eosinophils|eosinophils
4734214|NCT03022994|lymphocytes|lymphocytes
4734215|NCT03022994|duodenal biopsies|duodenal biopsies
4734216|NCT03022994|rectal biopsies|rectal biopsies
4734217|NCT03022825|BCG|bcg
4734218|NCT03022825|bladder cancer|bladder cancer
4734219|NCT03022825|immunotherapy|immunotherapy
4734220|NCT03022825|interleukin-15|interleukin-15
4734221|NCT03022825|intravesical|intravesical
4734222|NCT03022825|non-muscle invasive|non-muscle invasive
4734223|NCT03022825|NMIBC|nmibc
4734224|NCT03022812|Neck pain|neck pain
4734225|NCT03022812|Rehabilitation|rehabilitation
4734226|NCT03022812|Exercise Therapy|exercise therapy
4734227|NCT03022812|Internet|internet
4734228|NCT03022799|FAF1|faf1
4734229|NCT03022799|Fas (TNFRSF6)-associated factor 1|fas (tnfrsf6)-associated factor 1
4734230|NCT03022799|FAF1 inhibitor|faf1 inhibitor
4734231|NCT03022799|KM-819|km-819
4734232|NCT03022786|Dermatitis|dermatitis
4734233|NCT03022760|Exhaustion Disorder|exhaustion disorder
4734234|NCT03022682|ethnicity|ethnicity
4734235|NCT03022682|inflammation|inflammation
4734236|NCT03022669|mobile health|mobile health
4734237|NCT03022669|veterans|veterans
4734238|NCT03022669|cardiovascular disease|cardiovascular disease
4734239|NCT03022669|medication adherence|medication adherence
4734240|NCT03022656|Orthotic treatment, Ultrasound Imaging|orthotic treatment, ultrasound imaging
4734241|NCT03022630|palliative care|palliative care
4734242|NCT03022630|cirrhosis|cirrhosis
4734243|NCT03022630|liver disease|liver disease
4734244|NCT03022630|hepatology|hepatology
4734245|NCT03022630|end of life care|end of life care
4734246|NCT03022630|supportive care|supportive care
4734247|NCT03022578|Malignant Neoplasms of Eye Brain and Other Parts of Central Nervous System|malignant neoplasms of eye brain and other parts of central nervous system
4734248|NCT03022578|Glioblastoma|glioblastoma
4734249|NCT03022578|Anaplastic Astrocytoma|anaplastic astrocytoma
4734250|NCT03022578|AA|aa
4734251|NCT03022578|Laser interstitial thermal therapy|laser interstitial thermal therapy
4734252|NCT03022578|LITT|litt
4734253|NCT03022578|Lomustine|lomustine
4734254|NCT03022578|CeeNU|ceenu
4734255|NCT03022578|CCNU|ccnu
4734256|NCT03022565|Uveal Melanoma|uveal melanoma
4734257|NCT03022552|Myocardial Infarction|myocardial infarction
4734258|NCT03022552|Women|women
4734259|NCT03022552|Platelets|platelets
4734260|NCT03022552|Blood Collection|blood collection
4734261|NCT03022552|Genomics|genomics
4734262|NCT03022526|Pregnant|pregnant
4734263|NCT03022526|Analgesia|analgesia
4734264|NCT03022526|Labor analgesia|labor analgesia
4734265|NCT03022526|Epidural|epidural
4734266|NCT03022526|Combined spinal epidural|combined spinal epidural
4734267|NCT03022513|Non-celiac Wheat Sensitivity|non-celiac wheat sensitivity
4734268|NCT03022513|fibromyalgia|fibromyalgia
4734269|NCT03022513|synovitis|synovitis
4734270|NCT03022487|Sudden Cardiac Death (SCD)|sudden cardiac death (scd)
4734271|NCT03022487|implantable cardioverter defibrillator|implantable cardioverter defibrillator
4734272|NCT03022487|electrophysiological|electrophysiological
4734273|NCT03022487|EP|ep
4734274|NCT03022487|Ischaemic cardiomyopathy|ischaemic cardiomyopathy
4734275|NCT03022487|Ventricular Arrhythmia|ventricular arrhythmia
4734276|NCT03022487|ICD|icd
4734277|NCT03022474|Childhood obesity|childhood obesity
4734278|NCT03022461|Heart Failure|heart failure
4734279|NCT03022461|Ventricular Dysfunction|ventricular dysfunction
4734280|NCT03022461|Cardiomyopathies|cardiomyopathies
4734281|NCT03022461|Heart Disease|heart disease
4734282|NCT03022461|Cardiovascular Disease|cardiovascular disease
4734283|NCT03022461|Heart-assist Devices|heart-assist devices
4734284|NCT03022461|Thoratec Corporation|thoratec corporation
4734285|NCT03022448|soft tissue sarcomas (STS)|soft tissue sarcomas (sts)
4734286|NCT03022448|trabectedin|trabectedin
4734287|NCT03022448|metastatic STS patients|metastatic sts patients
4734288|NCT03022448|overall survival|overall survival
4734289|NCT03022435|Inactivated influenza vaccine|inactivated influenza vaccine
4734290|NCT03022435|Live, attenuated influenza vaccine|live, attenuated influenza vaccine
4734291|NCT03022435|Adult and elderly identical twins|adult and elderly identical twins
4734292|NCT03022435|Adult fraternal twins|adult fraternal twins
4734293|NCT03022422|Trivalent, inactivated influenza vaccine|trivalent, inactivated influenza vaccine
4734294|NCT03022422|High-Dose trivalent, inactivated influenza vaccine|high-dose trivalent, inactivated influenza vaccine
4734295|NCT03022422|Adult and elderly identical twins|adult and elderly identical twins
4734296|NCT03022422|Adult fraternal twins|adult fraternal twins
4734297|NCT03022409|Treatment naïve|treatment naïve
4734298|NCT03022409|Head and Neck Squamous Cell Carcinoma (HNSCC)|head and neck squamous cell carcinoma (hnscc)
4734299|NCT03022409|DNA Damage Repair (DDR)|dna damage repair (ddr)
4734300|NCT03022396|Inactivated influenza vaccine|inactivated influenza vaccine
4734301|NCT03022396|Identical twins|identical twins
4734302|NCT03022396|Fraternal twins|fraternal twins
4734303|NCT03022396|High-Dose influenza vaccine|high-dose influenza vaccine
4734304|NCT03022396|Elderly twins|elderly twins
4734305|NCT03022396|Child twins|child twins
4734306|NCT03022396|Inactivated influenza vaccine, high-dose|inactivated influenza vaccine, high-dose
4734307|NCT03022383|no known ocular pathology|no known ocular pathology
4734308|NCT03022370|informal settlements|informal settlements
4734309|NCT03022370|poverty|poverty
4734310|NCT03022344|DD2 plaque study|dd2 plaque study
4734311|NCT03022344|Coronary plaque|coronary plaque
4734312|NCT03022344|Type-2 diabetes mellitus|type-2 diabetes mellitus
4734313|NCT03022331|Idiopathic aortitis|idiopathic aortitis
4734314|NCT03022331|Isolated aortitis|isolated aortitis
4734315|NCT03022331|Vasculitis|vasculitis
4734316|NCT03022318|GPR143|gpr143
4734317|NCT03022318|PEDF|pedf
4734318|NCT03022318|VEGF|vegf
4734319|NCT03022318|LDOPA|ldopa
4734320|NCT03022305|Hip alignment|hip alignment
4734321|NCT03022305|Hip misalignment|hip misalignment
4734322|NCT03022305|Shoulder function|shoulder function
4734323|NCT03022305|Shoulder rotation|shoulder rotation
4734324|NCT03022305|Athletic shoulder injuries|athletic shoulder injuries
4734325|NCT03022305|Athletic hip alignment|athletic hip alignment
4734326|NCT03022305|Hip and shoulder alignment|hip and shoulder alignment
4734327|NCT03022305|Hip joint|hip joint
4734328|NCT03022305|Hip joint alignment|hip joint alignment
4734329|NCT03022305|Hip joint misalignment|hip joint misalignment
4734330|NCT03022279|Pediatric|pediatric
4734331|NCT03022279|post-operative pain prevention|post-operative pain prevention
4734332|NCT03022279|Anesthesia, Infiltration|anesthesia, infiltration
4734333|NCT03022279|Nerve Blockade|nerve blockade
4734334|NCT03022266|Adherence|adherence
4734335|NCT03022266|CleverCap® Lite BLE C035|clevercap® lite ble c035
4734336|NCT03022266|Smartphone App|smartphone app
4734337|NCT03022266|Telehealth|telehealth
4734338|NCT03022266|Digital Health|digital health
4734339|NCT03022266|Mobile Phone App|mobile phone app
4734340|NCT03022266|Behavioral Economics|behavioral economics
4734341|NCT03022266|Aspirin|aspirin
4734342|NCT03022266|Wellth App|wellth app
4734343|NCT03022253|PDA|pda
4734344|NCT03022253|Platelets|platelets
4734345|NCT03022227|cochlear implant ;|cochlear implant ;
4734346|NCT03022214|Dietary supplementation|dietary supplementation
4734347|NCT03022214|Exercise|exercise
4734348|NCT03022214|Increase Resilience|increase resilience
4734349|NCT03022214|Oxidative Stress|oxidative stress
4734350|NCT03022214|Efficacy|efficacy
4734351|NCT03022201|Motilitone|motilitone
4734352|NCT03022188|pancreatic incidentaloma|pancreatic incidentaloma
4734353|NCT03022188|pancreatic neuroendocrine tumor|pancreatic neuroendocrine tumor
4734354|NCT03022188|EUS-guided fine-needle aspiration|eus-guided fine-needle aspiration
4734355|NCT03022188|contrast-enhanced endoscopic ultrasound|contrast-enhanced endoscopic ultrasound
4734356|NCT03022175|Safety|safety
4734357|NCT03022175|Tolerability|tolerability
4734358|NCT03022175|Pharmacokinetics|pharmacokinetics
4734359|NCT03022162|Neuropathic Pain, Paclitaxel, CIPN|neuropathic pain, paclitaxel, cipn
4734360|NCT03022136|epidural block|epidural block
4734361|NCT03022136|dermatome|dermatome
4734362|NCT03022136|human|human
4734363|NCT03022136|spinal nerve|spinal nerve
4734364|NCT03022136|thoracic|thoracic
4734365|NCT03022071|Cognitive behavior therapy|cognitive behavior therapy
4734366|NCT03022071|Psychodynamic therapy|psychodynamic therapy
4734367|NCT03022071|Mediators|mediators
4734368|NCT03022071|Moderators|moderators
4734369|NCT03022045|Generalized Pustular Psoriasis|generalized pustular psoriasis
4734370|NCT03022045|Erythrodermic Psoriasis|erythrodermic psoriasis
4734371|NCT03022045|risankizumab|risankizumab
4734372|NCT03022045|Japanese|japanese
4734373|NCT03022032|Gynecologic cancer|gynecologic cancer
4734374|NCT03022019|autologous cell suspension grafting|autologous cell suspension grafting
4734375|NCT03022019|vitiligo|vitiligo
4734376|NCT03022019|non-segmental|non-segmental
4734377|NCT03022019|ReNovaCell|renovacell
4734378|NCT03021967|incurable pathologies|incurable pathologies
4734379|NCT03021967|palliative care|palliative care
4734380|NCT03021954|platelet rich plasma|platelet rich plasma
4734381|NCT03021954|pelvic floor disorders|pelvic floor disorders
4734382|NCT03021954|primipara|primipara
4734383|NCT03021941|Gaucher Disease|gaucher disease
4734384|NCT03021941|Enzyme Replacement Therapy|enzyme replacement therapy
4734385|NCT03021928|Stroke|stroke
4734386|NCT03021928|Atrial Fibrillation|atrial fibrillation
4734387|NCT03021928|Anticoagulation|anticoagulation
4734388|NCT03021928|NOAC|noac
4734389|NCT03021889|HIV / AIDS|hiv / aids
4734390|NCT03021889|Dyslipidemia|dyslipidemia
4734391|NCT03021889|Adolescents|adolescents
4734392|NCT03021889|Nutritional Therapy|nutritional therapy
4734393|NCT03021863|Dissemination|dissemination
4734394|NCT03021863|Tone|tone
4734395|NCT03021863|Survey reminders|survey reminders
4734396|NCT03021863|Questionnaires|questionnaires
4734397|NCT03021850|Pliability|pliability
4734398|NCT03021850|Cryotherapy|cryotherapy
4734399|NCT03021850|Hot temperature|hot temperature
4734400|NCT03021850|Hyperthermia, induced|hyperthermia, induced
4734401|NCT03021850|Randomized Controlled Trial|randomized controlled trial
4734402|NCT03021850|Hamstring muscles|hamstring muscles
4734403|NCT03021850|Muscle stretching exercises|muscle stretching exercises
4734404|NCT03021824|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
4734405|NCT03021824|ARDS|ards
4734406|NCT03021824|Acute Lung Injury|acute lung injury
4734407|NCT03021824|ALI|ali
4734408|NCT03021824|Mechanical Ventilation|mechanical ventilation
4734409|NCT03021824|Extracorporeal Membrane Oxygenation|extracorporeal membrane oxygenation
4734410|NCT03021824|Neuromuscular Blockade|neuromuscular blockade
4734411|NCT03021824|Vasodilator Agents|vasodilator agents
4734412|NCT03021824|Prone Position|prone position
4734413|NCT03021824|ECMO|ecmo
4734414|NCT03021824|Acute Respiratory Failure|acute respiratory failure
4734415|NCT03021798|Sarcopenia|sarcopenia
4734416|NCT03021798|Sarcopenic Obesity|sarcopenic obesity
4734417|NCT03021798|observational study|observational study
4734418|NCT03021798|6-minute walking distance|6-minute walking distance
4734419|NCT03021798|400 meters walking test|400 meters walking test
4734420|NCT03021798|Patient Reported Outcomes|patient reported outcomes
4734421|NCT03021785|Neovascular Age-Related Macular Degeneration|neovascular age-related macular degeneration
4734422|NCT03021785|Anti-VEGF|anti-vegf
4734423|NCT03021785|CNV|cnv
4734424|NCT03021785|TK001|tk001
4734425|NCT03021772|Neostigmine|neostigmine
4734426|NCT03021772|Dexamethasone|dexamethasone
4734427|NCT03021772|Intravenous Local Anesthesia|intravenous local anesthesia
4734428|NCT03021746|African-American|african-american
4734429|NCT03021720|Uterine fibroid embolization|uterine fibroid embolization
4734430|NCT03021720|Uterine artery embolization|uterine artery embolization
4734431|NCT03021720|Arterial access|arterial access
4734432|NCT03021720|Radial access|radial access
4734433|NCT03021720|Interventional radiology|interventional radiology
4734434|NCT03021720|Quality of life|quality of life
4734435|NCT03021720|Patient Satisfaction|patient satisfaction
4734436|NCT03021720|Patient centered care|patient centered care
4734437|NCT03021720|Uterine fibroid|uterine fibroid
4734439|NCT03021655|Randomized controlled trial|randomized controlled trial
4734440|NCT03021655|Adventure-based training|adventure-based training
4734441|NCT03021655|WhatsApp|whatsapp
4734442|NCT03021642|healthy volunteer|healthy volunteer
4734443|NCT03021642|Tepotinib|tepotinib
4734444|NCT03021642|Mesenchymal-epithelial transition factor|mesenchymal-epithelial transition factor
4734445|NCT03021642|Translocated promoter region|translocated promoter region
4734446|NCT03021616|energy drink|energy drink
4734447|NCT03021616|qtc interval|qtc interval
4734448|NCT03021616|clotting time|clotting time
4734449|NCT03021616|thorough qt study|thorough qt study
4734450|NCT03021603|Hope|hope
4734451|NCT03021603|psychotherapy|psychotherapy
4734452|NCT03021603|palliative|palliative
4734453|NCT03021603|low-intensity intervention|low-intensity intervention
4734454|NCT03021590|Helicobacter pylori|helicobacter pylori
4734455|NCT03021590|Helicobacter Infections|helicobacter infections
4734456|NCT03021590|Proton Pump Inhibitors|proton pump inhibitors
4734457|NCT03021590|sequential therapy|sequential therapy
4734458|NCT03021590|Clarithromycin|clarithromycin
4734459|NCT03021590|Tinidazole|tinidazole
4734460|NCT03021577|orbital atherectomy system|orbital atherectomy system
4734461|NCT03021577|rotational atherectomy|rotational atherectomy
4734462|NCT03021577|Fractional flow reserve|fractional flow reserve
4734463|NCT03021577|coronary flow reserve|coronary flow reserve
4734464|NCT03021577|index of microcirculatory resistance (IMR)|index of microcirculatory resistance (imr)
4734465|NCT03021551|oxygen|oxygen
4734466|NCT03021551|desaturation|desaturation
4734467|NCT03021551|obesity|obesity
4734468|NCT03021538|Cardiopulmonary Bypass|cardiopulmonary bypass
4734469|NCT03021538|Extracorporeal Membrane Oxygenation|extracorporeal membrane oxygenation
4734470|NCT03021538|Primary Graft Dysfunction|primary graft dysfunction
4734471|NCT03021538|Hemorrhage|hemorrhage
4734472|NCT03021538|Mechanical Ventilator|mechanical ventilator
4734473|NCT03021525|Goal-directed therapy|goal-directed therapy
4734474|NCT03021525|postoperative morbidity|postoperative morbidity
4734475|NCT03021525|haemodynamic optimisation|haemodynamic optimisation
4734476|NCT03021525|individualised medicine|individualised medicine
4734477|NCT03021525|Pulse pressure variation|pulse pressure variation
4734478|NCT03021525|Cardiac output|cardiac output
4734479|NCT03021499|lupus nephritis|lupus nephritis
4734480|NCT03021499|calcineurin inhibitors|calcineurin inhibitors
4734481|NCT03021499|voclosporin|voclosporin
4734482|NCT03021486|Malignant neoplasms of independent (primary) multiple sites|malignant neoplasms of independent (primary) multiple sites
4734483|NCT03021486|Haloperidol|haloperidol
4734484|NCT03021486|Chlorpromazine|chlorpromazine
4734485|NCT03021486|Chlorpromazine hydrochloride|chlorpromazine hydrochloride
4734486|NCT03021486|Thorazine|thorazine
4734487|NCT03021486|Symptom questionnaire|symptom questionnaire
4734488|NCT03021486|Survey|survey
4734489|NCT03021486|Delirium|delirium
4734490|NCT03021486|Acute palliative care unit|acute palliative care unit
4734491|NCT03021486|APCU|apcu
4734492|NCT03021473|oxygen reserve index|oxygen reserve index
4734493|NCT03021473|desaturation|desaturation
4734494|NCT03021473|safety|safety
4734495|NCT03021434|Water Supply/standards|water supply/standards
4734496|NCT03021434|Water microbiology|water microbiology
4734497|NCT03021434|India|india
4734498|NCT03021434|Hand disinfection|hand disinfection
4735000|NCT03018041|Kidney transplantation|kidney transplantation
4734499|NCT03021434|Escherichia coli Infections/prevention & control|escherichia coli infections/prevention & control
4734500|NCT03021434|Hygiene|hygiene
4734501|NCT03021434|Health behavior|health behavior
4734502|NCT03021434|Drinking water|drinking water
4734503|NCT03021434|Informational intervention|informational intervention
4734504|NCT03021421|Total knee arthroplasty|total knee arthroplasty
4734505|NCT03021421|unilateral spinal anaesthesia|unilateral spinal anaesthesia
4734506|NCT03021421|psoas compartment block|psoas compartment block
4734507|NCT03021421|sciatic nerve block|sciatic nerve block
4734508|NCT03021421|haemodynamic effects|haemodynamic effects
4734509|NCT03021343|Atrial fibrillation|atrial fibrillation
4734510|NCT03021343|Colchicine|colchicine
4734511|NCT03021343|Cardiac surgery|cardiac surgery
4734512|NCT03021304|SB240563|sb240563
4734513|NCT03021304|self-administration|self-administration
4734514|NCT03021304|Mepolizumab|mepolizumab
4734515|NCT03021304|safety syringe|safety syringe
4734516|NCT03021304|Eosinophilic asthma|eosinophilic asthma
4734517|NCT03021278|Tactile acuity|tactile acuity
4734518|NCT03021278|Chronic pain|chronic pain
4734519|NCT03021278|Two-point discrimination|two-point discrimination
4734520|NCT03021278|Point-to-point test|point-to-point test
4734521|NCT03021278|Two-point estimation|two-point estimation
4734522|NCT03021278|Body image|body image
4734523|NCT03021239|Ramp Test|ramp test
4734524|NCT03021239|Continuous Flow -Left Ventricular Assist Device (CF-LVAD)|continuous flow -left ventricular assist device (cf-lvad)
4734525|NCT03021239|LVAD Hemodynamics|lvad hemodynamics
4734526|NCT03021226|Health Behavior|health behavior
4734527|NCT03021174|CIPN|cipn
4734528|NCT03021174|Chemotherapy-induced peripheral neuropathy|chemotherapy-induced peripheral neuropathy
4734529|NCT03021161|probiotic|probiotic
4734530|NCT03021148|Non-celiac wheat sensitivity|non-celiac wheat sensitivity
4734531|NCT03021148|self-reported|self-reported
4734532|NCT03021122|Medication errors|medication errors
4734533|NCT03021122|Resuscitation|resuscitation
4734534|NCT03021122|Drugs|drugs
4734535|NCT03021122|Pediatrics|pediatrics
4734536|NCT03021122|Biomedical technology|biomedical technology
4734537|NCT03021109|ultrasound|ultrasound
4734538|NCT03021109|pediatrics|pediatrics
4734539|NCT03021109|gastroenteritis|gastroenteritis
4734540|NCT03021083|Lumbar multi-level fusions|lumbar multi-level fusions
4734541|NCT03021083|Patient Controlled Analgesia|patient controlled analgesia
4734542|NCT03021083|Fentanyl|fentanyl
4734543|NCT03021083|Opioid Analgesia|opioid analgesia
4734544|NCT03021070|Ante natal visit|ante natal visit
4734545|NCT03021070|Facility delivery|facility delivery
4734546|NCT03021070|Post natal visit|post natal visit
4734547|NCT03021070|Continuum of care|continuum of care
4734548|NCT03021070|Conditional cash transfer|conditional cash transfer
4734549|NCT03021070|Maternal and child health|maternal and child health
4734550|NCT03021070|Cluster randomized trial|cluster randomized trial
4734551|NCT03021031|Parkinson's Disease|parkinson's disease
4734552|NCT03021018|Epilepsy|epilepsy
4734553|NCT03021018|Brivaracetam|brivaracetam
4734554|NCT03021018|Epilepsy Monitoring Unit|epilepsy monitoring unit
4734555|NCT03021018|Increased seizure activity|increased seizure activity
4734556|NCT03020992|Axial Spondyloarthritis|axial spondyloarthritis
4734557|NCT03020992|axSpA|axspa
4734558|NCT03020992|Anterior Uveitis|anterior uveitis
4734559|NCT03020992|Certolizumab Pegol|certolizumab pegol
4734560|NCT03020992|Cimzia|cimzia
4734561|NCT03020875|Acetaminophen|acetaminophen
4734562|NCT03020875|Pain management|pain management
4734563|NCT03020862|Dietary nitrate|dietary nitrate
4734564|NCT03020862|Physical performance|physical performance
4734565|NCT03020862|Blood pressure|blood pressure
4734566|NCT03020862|Nitrite|nitrite
4734567|NCT03020862|Exercise|exercise
4734568|NCT03020849|hypofibrinogenemia|hypofibrinogenemia
4734569|NCT03020849|prediction score|prediction score
4734570|NCT03020849|severe trauma|severe trauma
4734571|NCT03020823|SCB01A|scb01a
4734572|NCT03020823|squamous cell carcinoma of head and neck|squamous cell carcinoma of head and neck
4734573|NCT03020784|acute neuroinflammatory|acute neuroinflammatory
4734574|NCT03020771|Crimean-congo hemorrhagic fever|crimean-congo hemorrhagic fever
4734575|NCT03020771|vaccine|vaccine
4734576|NCT03020771|human|human
4734577|NCT03020771|phase I|phase i
4734578|NCT03020745|Pharmacokinetics|pharmacokinetics
4734579|NCT03020745|Safety|safety
4734580|NCT03020745|Pharmacodynamics|pharmacodynamics
4734581|NCT03020745|Efficacy|efficacy
4734582|NCT03020745|Chronic Hepatitis B|chronic hepatitis b
4734583|NCT03020745|GSK3389404|gsk3389404
4734584|NCT03020732|growth factor|growth factor
4734585|NCT03020732|mucogingival surgery|mucogingival surgery
4734586|NCT03020732|gingival recession|gingival recession
4734587|NCT03020719|Growth Parameters|growth parameters
4734588|NCT03020719|Cystic Fibrosis|cystic fibrosis
4734589|NCT03020706|magnesium sulphate|magnesium sulphate
4734590|NCT03020706|neostigmine|neostigmine
4734591|NCT03020693|electrostimulation|electrostimulation
4734592|NCT03020693|exercise program|exercise program
4734593|NCT03020667|Cigarette|cigarette
4734594|NCT03020667|IQOS|iqos
4734595|NCT03020667|Nicotine-containing product|nicotine-containing product
4734596|NCT03020667|Tobacco|tobacco
4734597|NCT03020641|low pressure pneumoperitoneum|low pressure pneumoperitoneum
4734598|NCT03020641|standard pressure pneumoperitoneum|standard pressure pneumoperitoneum
4734599|NCT03020641|laparoscopy cholecystectomy|laparoscopy cholecystectomy
4734600|NCT03020628|Influenza Vaccines|influenza vaccines
4734601|NCT03020628|Vaccines, Inactivated|vaccines, inactivated
4734602|NCT03020628|Cell Culture-Derived|cell culture-derived
4734603|NCT03020615|Sickle cell|sickle cell
4734604|NCT03020615|Hydroxyurea|hydroxyurea
4734605|NCT03020615|Infants|infants
4734606|NCT03020589|Renal Transplant|renal transplant
4734607|NCT03020589|Tacrolimus|tacrolimus
4734608|NCT03020589|UNC|unc
4734609|NCT03020589|Phase IV|phase iv
4734610|NCT03020550|GERD|gerd
4734611|NCT03020550|Galvanic Skin Response|galvanic skin response
4734612|NCT03020550|Heart Rate Variability|heart rate variability
4734613|NCT03020537|Trivalent inactivated influenza vaccine|trivalent inactivated influenza vaccine
4734614|NCT03020537|Young children|young children
4734615|NCT03020537|Young adults|young adults
4734616|NCT03020511|Modern grains|modern grains
4734617|NCT03020511|ancient grains|ancient grains
4734618|NCT03020511|immunologic response|immunologic response
4734619|NCT03020511|microbiota|microbiota
4734620|NCT03020498|Inactivated influenza vaccine|inactivated influenza vaccine
4734621|NCT03020498|Live, attenuated influenza vaccine|live, attenuated influenza vaccine
4734622|NCT03020498|Child identical twins and non-twins|child identical twins and non-twins
4734623|NCT03020498|Young and elderly non-twin adults|young and elderly non-twin adults
4734624|NCT03020472|Live, attenuated influenza vaccine|live, attenuated influenza vaccine
4734625|NCT03020472|Children|children
4734626|NCT03020459|macular holes|macular holes
4734627|NCT03020433|Stroke|stroke
4734628|NCT03020433|rehab|rehab
4734629|NCT03020433|rehabilitation|rehabilitation
4734630|NCT03020433|paresis|paresis
4734631|NCT03020433|paralysis|paralysis
4734632|NCT03020433|stroke therapy|stroke therapy
4734634|NCT03020433|cerebrovascular accident|cerebrovascular accident
4734635|NCT03020433|brain diseases|brain diseases
4734636|NCT03020433|TMS|tms
4734637|NCT03020433|transcranial magnetic stimulation|transcranial magnetic stimulation
4734638|NCT03020433|CIMT|cimt
4734639|NCT03020433|constraint induced movement therapy|constraint induced movement therapy
4734640|NCT03020433|MRI|mri
4734641|NCT03020407|Septic Shock|septic shock
4734642|NCT03020407|Inferior vene cava diameter|inferior vene cava diameter
4734643|NCT03020407|Resuscitation|resuscitation
4734644|NCT03020407|Mortality|mortality
4734645|NCT03020394|COPD Exacerbation|copd exacerbation
4734646|NCT03020394|Noninvasive Positive Ventilation|noninvasive positive ventilation
4734647|NCT03020394|Invasive Positive Ventilation|invasive positive ventilation
4734648|NCT03020394|severe|severe
4734649|NCT03020342|HCC|hcc
4734650|NCT03020342|chimera DNA|chimera dna
4734651|NCT03020342|circulating DNA|circulating dna
4734652|NCT03020342|biomarker|biomarker
4734653|NCT03020329|Induction Chemotherapy|induction chemotherapy
4734654|NCT03020329|Nasopharyngeal carcinoma|nasopharyngeal carcinoma
4734655|NCT03020329|Chemoradiotherapy|chemoradiotherapy
4734656|NCT03020290|femoropopliteal artery|femoropopliteal artery
4734657|NCT03020290|interwoven nitinol stent|interwoven nitinol stent
4734658|NCT03020290|self-expanding-endovascular|self-expanding-endovascular
4734659|NCT03020290|TASC C and TASC D|tasc c and tasc d
4734660|NCT03020290|Peripheral Arterial Disease|peripheral arterial disease
4734661|NCT03020264|Type 2 Diabetes|type 2 diabetes
4734662|NCT03020264|Hypoglycemia|hypoglycemia
4734663|NCT03020264|Elderly|elderly
4734664|NCT03020264|Insulinotherapy|insulinotherapy
4734665|NCT03020251|preoperative rehabilitation program|preoperative rehabilitation program
4734666|NCT03020251|chest physiotherapy|chest physiotherapy
4734667|NCT03020251|lung cancer resection|lung cancer resection
4734668|NCT03020212|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
4734669|NCT03020212|High altitude|high altitude
4734670|NCT03020212|Oxygen|oxygen
4734671|NCT03020212|long-term oxygen therapy|long-term oxygen therapy
4734672|NCT03020212|pulmonary hypertension|pulmonary hypertension
4734673|NCT03020212|chronic hypoxemia|chronic hypoxemia
4734674|NCT03020199|Psoriasis|psoriasis
4734675|NCT03020134|pharmacokinetics|pharmacokinetics
4734676|NCT03020134|Danoprevir/r|danoprevir/r
4734677|NCT03020134|Ravidasvir|ravidasvir
4734678|NCT03020095|Ravidasvir|ravidasvir
4734679|NCT03020095|HCV GT1|hcv gt1
4734680|NCT03020095|SVR12|svr12
4734681|NCT03020095|Danoprevir/r|danoprevir/r
4734682|NCT03020082|Danoprevir|danoprevir
4734683|NCT03020082|non-cirrhotic|non-cirrhotic
4734684|NCT03020082|Chinese HCV G1|chinese hcv g1
4734685|NCT03020082|SVR12|svr12
4734686|NCT03020069|Type 1 Diabetes|type 1 diabetes
4734687|NCT03020069|Adolescents|adolescents
4734688|NCT03020069|Glucose Monitoring|glucose monitoring
4734689|NCT03020056|cataract surgery|cataract surgery
4734690|NCT03020056|socioeconomic status|socioeconomic status
4734691|NCT03020056|quality of life|quality of life
4734692|NCT03020056|rural area|rural area
4734693|NCT03020056|China|china
4734694|NCT03020056|randomized controlled trial|randomized controlled trial
4734695|NCT03020030|acute lymphoblastic leukemia|acute lymphoblastic leukemia
4734696|NCT03020004|Danoprevir|danoprevir
4734697|NCT03020004|SVR12|svr12
4734698|NCT03020004|Chinese HCV G1|chinese hcv g1
4734699|NCT03020004|non-cirrhotic|non-cirrhotic
4734700|NCT03019991|pharmacokinetics,Danoprevir|pharmacokinetics,danoprevir
4734701|NCT03019939|Acute Myeloid Leukemia|acute myeloid leukemia
4734702|NCT03019939|AML|aml
4734703|NCT03019939|Myelodysplastic Syndrome|myelodysplastic syndrome
4734704|NCT03019939|MDS|mds
4734705|NCT03019939|Neutropenia|neutropenia
4734706|NCT03019939|Invasive fungal infection|invasive fungal infection
4734707|NCT03019939|IFI|ifi
4734708|NCT03019939|Isavuconazole|isavuconazole
4734709|NCT03019939|BAL8557|bal8557
4734710|NCT03019926|systemic lupus erythematosus|systemic lupus erythematosus
4734711|NCT03019926|observance|observance
4734712|NCT03019926|hydroxychloroquine dosage|hydroxychloroquine dosage
4734713|NCT03019926|risk factors of non-observance|risk factors of non-observance
4734714|NCT03019926|SLICC score|slicc score
4734715|NCT03019926|SLEDAI score|sledai score
4734716|NCT03019913|Skeletal muscle|skeletal muscle
4734717|NCT03019861|Ayurveda|ayurveda
4734718|NCT03019861|IBS|ibs
4734719|NCT03019861|Complementary medicine|complementary medicine
4734720|NCT03019861|nutritional counseling|nutritional counseling
4734721|NCT03019848|Redox and pro-inflammatory status|redox and pro-inflammatory status
4734722|NCT03019835|mivacurium|mivacurium
4734723|NCT03019835|neostigmine|neostigmine
4734724|NCT03019835|antagonism|antagonism
4734725|NCT03019783|Endothelial function|endothelial function
4734726|NCT03019770|Pre-Exposure Prophylaxis|pre-exposure prophylaxis
4734727|NCT03019770|HIV|hiv
4734728|NCT03019770|Decision Aid|decision aid
4734729|NCT03019770|Shared Decision Making|shared decision making
4734730|NCT03019744|Functional Electrical Stimulation|functional electrical stimulation
4734731|NCT03019744|Cerebrovascular accident|cerebrovascular accident
4734732|NCT03019744|Stroke|stroke
4734733|NCT03019744|Electromyography|electromyography
4734734|NCT03019731|Tics|tics
4734735|NCT03019731|Behavioral therapy|behavioral therapy
4734736|NCT03019731|Neurologic Examination|neurologic examination
4734737|NCT03019718|Inpatient rehabilitation|inpatient rehabilitation
4734738|NCT03019718|Internet-based intervention|internet-based intervention
4734739|NCT03019718|Aftercare|aftercare
4734740|NCT03019718|Return to work|return to work
4734741|NCT03019718|Psychodynamic|psychodynamic
4734742|NCT03019705|Cyberchondria|cyberchondria
4734743|NCT03019705|health-related internet use|health-related internet use
4734744|NCT03019705|pathological health anxiety|pathological health anxiety
4734745|NCT03019705|ambulatory assessment|ambulatory assessment
4734746|NCT03019666|MM|mm
4734747|NCT03019666|NHL|nhl
4734748|NCT03019640|B-Cell Non-Hodgkin Lymphoma|b-cell non-hodgkin lymphoma
4734749|NCT03019640|Relapsed follicular lymphoma|relapsed follicular lymphoma
4734750|NCT03019640|Indolent B-cell histology|indolent b-cell histology
4734751|NCT03019640|Natural killer cells|natural killer cells
4734752|NCT03019640|NK|nk
4734753|NCT03019640|Stem cell transplant|stem cell transplant
4734754|NCT03019640|Rituximab|rituximab
4734755|NCT03019640|Rituxan|rituxan
4734756|NCT03019640|Carmustine|carmustine
4734757|NCT03019640|BCNU|bcnu
4734758|NCT03019640|BiCNU|bicnu
4734759|NCT03019640|Etoposide|etoposide
4734760|NCT03019640|VePesid|vepesid
4734761|NCT03019640|Cytarabine|cytarabine
4734762|NCT03019640|Ara-C|ara-c
4734763|NCT03019640|Cytosar|cytosar
4734764|NCT03019640|DepoCyt|depocyt
4734765|NCT03019640|Cytosine arabinosine hydrochloride|cytosine arabinosine hydrochloride
4734766|NCT03019640|Melphalan|melphalan
4734767|NCT03019640|Alkeran|alkeran
4734768|NCT03019640|Lenalidomide|lenalidomide
4734769|NCT03019640|CC-5013|cc-5013
4734770|NCT03019640|Revlimid|revlimid
4734771|NCT03019640|G-CSF|g-csf
4734772|NCT03019640|Filgrastim|filgrastim
4734773|NCT03019640|Neupogen|neupogen
4734774|NCT03019601|HIV|hiv
4734775|NCT03019601|PMTCT|pmtct
4734776|NCT03019588|PD1|pd1
4734777|NCT03019588|PD-1|pd-1
4734778|NCT03019588|PDL1|pdl1
4734779|NCT03019588|PD-L1|pd-l1
4734780|NCT03019562|postoperative pain|postoperative pain
4734781|NCT03019523|caffeine|caffeine
4734782|NCT03019523|mental performance|mental performance
4734783|NCT03019523|reaction time|reaction time
4734784|NCT03019523|focus|focus
4734785|NCT03019497|PTSD|ptsd
4734786|NCT03019497|Related Problems|related problems
4734787|NCT03019497|Therapy|therapy
4734788|NCT03019497|Traumatic Event|traumatic event
4734789|NCT03019497|Quality of Life|quality of life
4734790|NCT03019497|Cognitive Behavioral Therapy (CBT)|cognitive behavioral therapy (cbt)
4734791|NCT03019497|Major depression|major depression
4734792|NCT03019497|Sleep disorders|sleep disorders
4734793|NCT03019497|Pain|pain
4734794|NCT03019497|Stressors|stressors
4734795|NCT03019497|Social support|social support
4734796|NCT03019497|Substance use disorder|substance use disorder
4734797|NCT03019497|Anxiety disorder|anxiety disorder
4734798|NCT03019484|Self-efficacy|self-efficacy
4734799|NCT03019484|Self Efficacy|self efficacy
4734800|NCT03019484|Nurses's Role|nurses's role
4734801|NCT03019484|Professional Role|professional role
4734802|NCT03019484|Clinical Trial|clinical trial
4734803|NCT03019484|Breast Feeding|breast feeding
4734804|NCT03019458|prospective randomized trial|prospective randomized trial
4734805|NCT03019419|sporadic ALS|sporadic als
4734806|NCT03019419|perampanel|perampanel
4734807|NCT03019393|non-transferrin bound iron (NTBI)|non-transferrin bound iron (ntbi)
4734808|NCT03019393|Red meat|red meat
4734809|NCT03019393|Non-transferrin bound iron (NTBI) in serum|non-transferrin bound iron (ntbi) in serum
4734810|NCT03019367|Premature infants|premature infants
4734811|NCT03019367|Umbilical cord milking|umbilical cord milking
4734812|NCT03019367|Delayed cord clamping|delayed cord clamping
4734813|NCT03019367|Intraventricular Hemorrhage|intraventricular hemorrhage
4734814|NCT03019367|Death|death
4734815|NCT03019354|high flow oxygen|high flow oxygen
4734816|NCT03019354|pulmonary atelectasis|pulmonary atelectasis
4734817|NCT03019354|intravenous general anesthesia|intravenous general anesthesia
4734818|NCT03019341|Nausea|nausea
4734819|NCT03019341|Vomiting|vomiting
4734820|NCT03019341|Non-ionic contrast media|non-ionic contrast media
4734821|NCT03019341|Side effect|side effect
4734822|NCT03019328|peanut allergy|peanut allergy
4734823|NCT03019328|food allergens|food allergens
4734824|NCT03019328|atopic dermatitis|atopic dermatitis
4734825|NCT03019328|eczema|eczema
4734826|NCT03019328|infant food allergy testing|infant food allergy testing
4734827|NCT03019328|skin prick testing|skin prick testing
4734828|NCT03019328|peanut IgE|peanut ige
4734829|NCT03019328|early peanut introduction|early peanut introduction
4734830|NCT03019328|food allergy prevention|food allergy prevention
4734831|NCT03019315|Ovarian Cancer|ovarian cancer
4734832|NCT03019315|Chemotherapy|chemotherapy
4734833|NCT03019315|Response Rate|response rate
4734834|NCT03019315|Survival|survival
4734835|NCT03019250|Colostrum|colostrum
4734836|NCT03019250|Critical Care Outcomes|critical care outcomes
4734837|NCT03019250|Intensive Care Unit|intensive care unit
4734838|NCT03019250|Inflammation|inflammation
4734839|NCT03019250|Infection|infection
4734840|NCT03019250|mortality|mortality
4734841|NCT03019224|Tooth whitening|tooth whitening
4734842|NCT03019224|Dentifrice|dentifrice
4734843|NCT03019224|Sensitivity|sensitivity
4734844|NCT03019211|Physical Therapy Modalities|physical therapy modalities
4734845|NCT03019211|Accidental Fall|accidental fall
4734846|NCT03019211|Elderly|elderly
4734847|NCT03019211|Hydrotherapy|hydrotherapy
4734848|NCT03019211|Nursing Home|nursing home
4734849|NCT03019198|Tranexamic Acid|tranexamic acid
4734850|NCT03019198|Blood loss|blood loss
4734851|NCT03019198|Tranfusion|tranfusion
4734852|NCT03019185|Alport Syndrome|alport syndrome
4734853|NCT03019185|Bardoxolone methyl|bardoxolone methyl
4734854|NCT03019185|CDDO-ME|cddo-me
4734855|NCT03019185|RTA 402|rta 402
4734856|NCT03019146|Prehabilitation|prehabilitation
4734857|NCT03019133|Heart rate|heart rate
4734858|NCT03019133|Blood pressure variability|blood pressure variability
4734859|NCT03019094|overactive bladder|overactive bladder
4734860|NCT03019094|urge urinary incontinence|urge urinary incontinence
4734861|NCT03019094|urgency frequency|urgency frequency
4734862|NCT03019068|recruitment potential|recruitment potential
4734863|NCT03019068|prediction|prediction
4734864|NCT03019068|databases|databases
4734865|NCT03019068|Clinical Trial Recruitment Support Systems (CTRSS)|clinical trial recruitment support systems (ctrss)
4734866|NCT03019042|Hou Gu Mi Xi|hou gu mi xi
4734867|NCT03019042|Shen Ling Bai Zhu San|shen ling bai zhu san
4734868|NCT03019042|mild gastrointestinal disorders|mild gastrointestinal disorders
4734869|NCT03019042|traditional Chinese medicine|traditional chinese medicine
4734870|NCT03019042|randomized controlled trial|randomized controlled trial
4734871|NCT03019029|Peripheral Nerve Amyloidosis|peripheral nerve amyloidosis
4734872|NCT03019003|Head and Neck Cancer|head and neck cancer
4734873|NCT03018964|Single incision|single incision
4734874|NCT03018964|Solo surgery|solo surgery
4734875|NCT03018951|frailty, assessement|frailty, assessement
4734876|NCT03018938|mid mixture insulin analog|mid mixture insulin analog
4734877|NCT03018938|basal insulin analog|basal insulin analog
4734878|NCT03018912|Subjective Sleep Vital Sign (VS)|subjective sleep vital sign (vs)
4734879|NCT03018912|Primary Care|primary care
4734880|NCT03018912|Sleep Medicine|sleep medicine
4734881|NCT03018912|Cognitive Behavioral Therapy (CBT)|cognitive behavioral therapy (cbt)
4734882|NCT03018912|Obstructive Sleep Apnea (OSA)|obstructive sleep apnea (osa)
4734883|NCT03018912|Insomnia|insomnia
4734884|NCT03018912|Complex Sleep Disorders|complex sleep disorders
4734885|NCT03018912|Predictive Analytics|predictive analytics
4734886|NCT03018912|Screening|screening
4734887|NCT03018912|Therapy Outcomes|therapy outcomes
4734888|NCT03018899|paravertebral block|paravertebral block
4734889|NCT03018899|ultrasound|ultrasound
4734890|NCT03018899|percutaneous nephrolithotomy|percutaneous nephrolithotomy
4734891|NCT03018899|postoperative pain|postoperative pain
4734892|NCT03018873|remote ischemic preconditioning|remote ischemic preconditioning
4734893|NCT03018873|acute myocardial infarction|acute myocardial infarction
4734894|NCT03018860|Active second stage|active second stage
4734895|NCT03018860|Neonatal morbidity|neonatal morbidity
4734896|NCT03018860|Operative delivery|operative delivery
4734897|NCT03018860|Labor|labor
4734898|NCT03018834|Acute Myocarditis|acute myocarditis
4734899|NCT03018834|ANAKINRA|anakinra
4734900|NCT03018808|Eosinophilia|eosinophilia
4734901|NCT03018808|COPD prevalence|copd prevalence
4734902|NCT03018808|Primary care subjects|primary care subjects
4734903|NCT03018795|peri-implantitis|peri-implantitis
4734904|NCT03018795|Surgical regenerative treatment|surgical regenerative treatment
4734905|NCT03018795|ozone therapy|ozone therapy
4734906|NCT03018730|Fabry disease|fabry disease
4734907|NCT03018730|Enzyme-Replacement Therapy|enzyme-replacement therapy
4734908|NCT03018730|pegunigalsidase alfa|pegunigalsidase alfa
4734909|NCT03018730|PRX-102|prx-102
4734910|NCT03018730|alpha galactosidase-A|alpha galactosidase-a
4734911|NCT03018704|alcoholism|alcoholism
4734912|NCT03018704|treatment|treatment
4734913|NCT03018652|COPD|copd
4734914|NCT03018652|Ig|ig
4734915|NCT03018652|IPRAC|iprac
4734916|NCT03018652|outpatient|outpatient
4734917|NCT03018626|Non-germinal b-cell-like|non-germinal b-cell-like
4734918|NCT03018626|R-ACVBP|r-acvbp
4734919|NCT03018626|DA-EPOCH-R|da-epoch-r
4734920|NCT03018613|Chronic Functional Constipation|chronic functional constipation
4734921|NCT03018613|Intestinal Bacteria Flora Disturbance|intestinal bacteria flora disturbance
4734922|NCT03018613|Fecal Microbiota Transplantation|fecal microbiota transplantation
4734923|NCT03018600|prednisone, autoimmune disease|prednisone, autoimmune disease
4734924|NCT03018509|JTE-451|jte-451
4734925|NCT03018509|psoriasis|psoriasis
4734926|NCT03018470|COPD|copd
4734927|NCT03018470|Non invasive ventilation|non invasive ventilation
4734928|NCT03018470|NIV|niv
4734929|NCT03018470|Acute exacerbation COPD|acute exacerbation copd
4734930|NCT03018470|AECOPD|aecopd
4734931|NCT03018470|Telemonitoring|telemonitoring
4734932|NCT03018457|Trabecular microarchitecture|trabecular microarchitecture
4734933|NCT03018457|alveolar bone|alveolar bone
4734934|NCT03018457|osseointegration|osseointegration
4734935|NCT03018457|dental implant|dental implant
4734936|NCT03018431|Lung ultrasonography|lung ultrasonography
4734937|NCT03018431|Chest CT scan|chest ct scan
4734938|NCT03018431|ventilator-associated pneumonia|ventilator-associated pneumonia
4734939|NCT03018431|ventilator-associated tracheobronchitis|ventilator-associated tracheobronchitis
4734940|NCT03018431|antibiotic stewardship|antibiotic stewardship
4734941|NCT03018418|Anal Cancer|anal cancer
4734942|NCT03018379|Obesity|obesity
4734943|NCT03018379|Body composition|body composition
4734944|NCT03018379|energy expenditure|energy expenditure
4734945|NCT03018379|sedentarity|sedentarity
4734946|NCT03018379|dietary behaviors|dietary behaviors
4734947|NCT03018366|estrogen|estrogen
4734948|NCT03018366|premenopause|premenopause
4734949|NCT03018366|menopause|menopause
4734950|NCT03018366|amenorrhea|amenorrhea
4734951|NCT03018353|Hepatitis C, Chronic|hepatitis c, chronic
4734952|NCT03018353|Jail|jail
4734953|NCT03018353|Patient Navigation|patient navigation
4734954|NCT03018353|Incarcerated Population|incarcerated population
4734955|NCT03018353|HCV|hcv
4734956|NCT03018353|Sofosbuvir/Velpatasvir|sofosbuvir/velpatasvir
4734957|NCT03018353|Hepatitis C|hepatitis c
4734958|NCT03018288|Malignant Gliomas|malignant gliomas
4734959|NCT03018288|Immunotherapy|immunotherapy
4734960|NCT03018275|Lyophilized Biotherapeutic, Microbiome, Probiotic|lyophilized biotherapeutic, microbiome, probiotic
4734961|NCT03018275|Commensal Gram-negative Bacteria|commensal gram-negative bacteria
4734962|NCT03018275|Staphylococcus Aureus|staphylococcus aureus
4734963|NCT03018275|Transepidermal Water Loss|transepidermal water loss
4734964|NCT03018275|Allergic Diseases|allergic diseases
4734965|NCT03018262|Surround Inhibition|surround inhibition
4734966|NCT03018262|Motor Control|motor control
4734967|NCT03018262|Transcranial Magnetic Stimulation (TMS)|transcranial magnetic stimulation (tms)
4734968|NCT03018262|TMS-Evoked Potential|tms-evoked potential
4734969|NCT03018236|cocaine|cocaine
4734970|NCT03018236|alcohol|alcohol
4734971|NCT03018236|substance use disorders|substance use disorders
4734972|NCT03018236|addiction|addiction
4734973|NCT03018236|N-acetylcysteine|n-acetylcysteine
4734974|NCT03018236|randomized controlled trial|randomized controlled trial
4734975|NCT03018223|Acute leukemia in CR|acute leukemia in cr
4734976|NCT03018223|Chronic myeloid leukemia|chronic myeloid leukemia
4734977|NCT03018223|Non-Hodgkin lymphoma in high risk|non-hodgkin lymphoma in high risk
4734978|NCT03018223|Graft vs. Host Disease|graft vs. host disease
4734979|NCT03018223|GVHD|gvhd
4734980|NCT03018223|Hematopoietic cell transplant (HCT)|hematopoietic cell transplant (hct)
4734981|NCT03018197|Personal Health Record|personal health record
4734982|NCT03018197|Medication Knowledge|medication knowledge
4734983|NCT03018197|Anticoagulants|anticoagulants
4734984|NCT03018197|Patient Engagement|patient engagement
4734985|NCT03018184|MRI|mri
4734986|NCT03018184|CCSA|ccsa
4734987|NCT03018184|Contractile Cross Sectional Area|contractile cross sectional area
4734988|NCT03018184|Strength|strength
4734989|NCT03018171|clonidine, spinal injections|clonidine, spinal injections
4734990|NCT03018132|perinatal mental health|perinatal mental health
4734991|NCT03018106|Female sexual disorder|female sexual disorder
4734992|NCT03018106|Aging|aging
4734993|NCT03018106|Menopause|menopause
4734994|NCT03018106|Obstetrics/Gynecology|obstetrics/gynecology
4734995|NCT03018106|Female urogenital disorder|female urogenital disorder
4734996|NCT03018093|Relapsed or refractory acute lymphoblastic leukemia|relapsed or refractory acute lymphoblastic leukemia
4734997|NCT03018093|Anti-CD19 chimeric antigen receptor T-cell|anti-cd19 chimeric antigen receptor t-cell
4734998|NCT03018054|moderate active ulcerative colitis|moderate active ulcerative colitis
4734999|NCT03018054|Japanese|japanese
4735001|NCT03018041|Renal transplantation|renal transplantation
4735002|NCT03018041|Omega-3 fatty acids|omega-3 fatty acids
4735003|NCT03018041|Marine n-3 fatty acids|marine n-3 fatty acids
4735004|NCT03018041|Fatty acids|fatty acids
4735005|NCT03018041|Inflammation|inflammation
4735006|NCT03018041|Interstitial fibrosis|interstitial fibrosis
4735007|NCT03018041|Glomerular filtration rate|glomerular filtration rate
4735008|NCT03018041|Renal function|renal function
4735009|NCT03018041|Allograft function|allograft function
4735010|NCT03018041|Proteinuria|proteinuria
4735011|NCT03018041|Blood pressure|blood pressure
4735012|NCT03018041|Heart rate variability|heart rate variability
4735013|NCT03018041|Lipids|lipids
4735014|NCT03018041|Blood glucose|blood glucose
4735015|NCT03018041|Body mass index|body mass index
4735016|NCT03018041|Fatty acid composition|fatty acid composition
4735017|NCT03018041|Gas chromatography|gas chromatography
4735018|NCT03018041|Interventional study|interventional study
4735019|NCT03018041|Allograft biopsy|allograft biopsy
4735020|NCT03018041|Kidney biopsy|kidney biopsy
4735021|NCT03018015|Bioequivalence|bioequivalence
4735022|NCT03018015|Healthy|healthy
4735023|NCT03018015|Bioavailability|bioavailability
4735024|NCT03018015|Ibuprofen|ibuprofen
4735025|NCT03018002|HIV, PMTCT|hiv, pmtct
4735026|NCT03017989|Near Infrared Fluorescence Imaging|near infrared fluorescence imaging
4735027|NCT03017989|Indocyanine green (ICG)|indocyanine green (icg)
4735028|NCT03017963|acute coronary syndrome|acute coronary syndrome
4735029|NCT03017963|sodium thiosulfate|sodium thiosulfate
4735030|NCT03017963|maximum tolerable dose|maximum tolerable dose
4735031|NCT03017963|dose-limiting toxicity|dose-limiting toxicity
4735032|NCT03017911|PICC Line|picc line
4735033|NCT03017911|Complications|complications
4735034|NCT03017911|Thrombosis|thrombosis
4735035|NCT03017911|Infection|infection
4735036|NCT03017898|FiLaC|filac
4735037|NCT03017898|Fistula Laser Closure|fistula laser closure
4735038|NCT03017898|Laser Coagulation|laser coagulation
4735039|NCT03017872|HIV, second-line|hiv, second-line
4735040|NCT03017833|Solid Tumors|solid tumors
4735041|NCT03017833|Advanced Cancer|advanced cancer
4735042|NCT03017833|Metformin|metformin
4735043|NCT03017833|Metformin ER|metformin er
4735044|NCT03017833|TAK-228|tak-228
4735045|NCT03017833|MLN0128|mln0128
4735046|NCT03017833|TAK228|tak228
4735047|NCT03017794|Radiotherapy|radiotherapy
4735048|NCT03017794|Chromogranin A|chromogranin a
4735049|NCT03017794|Neuroendocrine differentiation|neuroendocrine differentiation
4735050|NCT03017781|Bipolar|bipolar
4735051|NCT03017781|High-Risk Off-Spring|high-risk off-spring
4735052|NCT03017781|Psychosocial Functioning|psychosocial functioning
4735053|NCT03017768|Acute tryptophan depletion, esophageal sensitivity,|acute tryptophan depletion, esophageal sensitivity,
4735054|NCT03017716|Inflammatory back pain|inflammatory back pain
4735055|NCT03017716|gluten-free diet|gluten-free diet
4735056|NCT03017716|celiac disease|celiac disease
4735057|NCT03017716|non-celiac wheat sensitivity|non-celiac wheat sensitivity
4735058|NCT03017703|Endothelial dysfunction|endothelial dysfunction
4735059|NCT03017703|Insulin resistance|insulin resistance
4735060|NCT03017703|Type 2 diabetes|type 2 diabetes
4735061|NCT03017703|Mineralocorticoid blocker|mineralocorticoid blocker
4735062|NCT03017625|COPD|copd
4735063|NCT03017625|Cardiovascular Disease|cardiovascular disease
4735064|NCT03017625|Platelets|platelets
4735065|NCT03017625|Inflammation|inflammation
4735066|NCT03017612|Presbyopia|presbyopia
4735067|NCT03017573|Immunological biomarkers|immunological biomarkers
4735068|NCT03017573|molecular profil|molecular profil
4735069|NCT03017573|Circulating tumor DNA (ctDNA)|circulating tumor dna (ctdna)
4735070|NCT03017560|Breast Cancer|breast cancer
4735071|NCT03017560|Chemotherapy|chemotherapy
4735072|NCT03017560|Verbal Memory|verbal memory
4735073|NCT03017560|Processing Speed|processing speed
4735074|NCT03017534|Patient-Therapist Interaction|patient-therapist interaction
4735075|NCT03017534|Non-Specific Effects|non-specific effects
4735076|NCT03017534|Manual Therapy|manual therapy
4735077|NCT03017534|Neurodynamics|neurodynamics
4735078|NCT03017534|Sham|sham
4735079|NCT03017521|Refractory solid tumors|refractory solid tumors
4735080|NCT03017521|AKT inhibitor|akt inhibitor
4735081|NCT03017508|Cross-over study|cross-over study
4735082|NCT03017508|Riluzole|riluzole
4735083|NCT03017508|Double-blind study|double-blind study
4735084|NCT03017508|Speech task|speech task
4735085|NCT03017508|Social Anxiety Disorder|social anxiety disorder
4735086|NCT03017495|food-drug interaction|food-drug interaction
4735087|NCT03017495|drug-drug interaction|drug-drug interaction
4735088|NCT03017495|pharmacokinetics|pharmacokinetics
4735089|NCT03017469|Resilience|resilience
4735090|NCT03017469|Workplace Stress|workplace stress
4735091|NCT03017469|Occupational Fatigue|occupational fatigue
4735092|NCT03017469|Compassion Fatigue|compassion fatigue
4735093|NCT03017469|Peer Support|peer support
4735094|NCT03017469|Self-Care|self-care
4735095|NCT03017469|Employee Assistance|employee assistance
4735096|NCT03017456|Survivorship|survivorship
4735097|NCT03017456|Prostate Cancer|prostate cancer
4735098|NCT03017456|Survivorship Care Plan|survivorship care plan
4735099|NCT03017443|Weight Loss|weight loss
4735100|NCT03017443|Obesity|obesity
4735101|NCT03017443|Overweight|overweight
4735102|NCT03017391|palliative care|palliative care
4735103|NCT03017391|palliative medicine|palliative medicine
4735104|NCT03017391|palliative|palliative
4735105|NCT03017378|influenza vector|influenza vector
4735106|NCT03017378|tuberculosis|tuberculosis
4735107|NCT03017378|vaccine|vaccine
4735108|NCT03017365|Motor Control|motor control
4735109|NCT03017365|Balance|balance
4735110|NCT03017352|Diabetes Mellitus, Type 1|diabetes mellitus, type 1
4735111|NCT03017352|Exenatide|exenatide
4735112|NCT03017352|Incretins|incretins
4735113|NCT03017352|GLP-1|glp-1
4735114|NCT03017352|Insulin|insulin
4735115|NCT03017339|Low Lever Laser Therapy|low lever laser therapy
4735116|NCT03017339|Exercise Therapy|exercise therapy
4735117|NCT03017339|Chronic Pain|chronic pain
4735118|NCT03017287|Glucose blood measurements, glucometer, BGM, Diabetes App|glucose blood measurements, glucometer, bgm, diabetes app
4735119|NCT03017274|Non-celiac wheat sensitivity|non-celiac wheat sensitivity
4735120|NCT03017274|celiac disease|celiac disease
4735121|NCT03017274|abdominal ultrasonography;|abdominal ultrasonography;
4735122|NCT03017261|Osteoarthritis|osteoarthritis
4735123|NCT03017261|Arthroplasty|arthroplasty
4735124|NCT03017261|Robotic Surgery|robotic surgery
4735125|NCT03017261|Knee|knee
4735126|NCT03017248|pain|pain
4735127|NCT03017248|ketamine|ketamine
4735128|NCT03017248|morphine|morphine
4735129|NCT03017248|analgesia|analgesia
4735130|NCT03017248|emergency|emergency
4735131|NCT03017144|non-technical skills (NTS)|non-technical skills (nts)
4735132|NCT03017144|human factors|human factors
4735133|NCT03017144|team work|team work
4735331|NCT03015870|voice|voice
4735134|NCT03017144|Crew Resource Management / Crisis Resource Management (CRM)|crew resource management / crisis resource management (crm)
4735135|NCT03017144|technical skills (TS)|technical skills (ts)
4735136|NCT03017144|Cardiopulmonary resuscitation|cardiopulmonary resuscitation
4735137|NCT03017144|Advanced cardiac life support|advanced cardiac life support
4735138|NCT03017079|Semi-solidification|semi-solidification
4735139|NCT03017079|caloric debt|caloric debt
4735140|NCT03017079|enteral nutrition|enteral nutrition
4735141|NCT03017079|critical illness|critical illness
4735142|NCT03017066|Ultrasonography|ultrasonography
4735143|NCT03017066|Child|child
4735144|NCT03017066|Preoperative period|preoperative period
4735145|NCT03017053|Neck dissection|neck dissection
4735146|NCT03017053|Survival|survival
4735147|NCT03017053|Early oral cancer|early oral cancer
4735148|NCT03017053|Early oral cavity squamous cancer with node negative neck|early oral cavity squamous cancer with node negative neck
4735149|NCT03017027|human-animal interaction|human-animal interaction
4735150|NCT03017014|Crohn's Disease|crohn's disease
4735151|NCT03017014|Adalimumab|adalimumab
4735152|NCT03017014|Humira®|humira®
4735153|NCT03016988|Mantle cell lymphoma|mantle cell lymphoma
4735154|NCT03016988|Bortezomib|bortezomib
4735155|NCT03016988|Fludarabine|fludarabine
4735156|NCT03016988|Cytarabine|cytarabine
4735157|NCT03016975|Edwards Cardioband|edwards cardioband
4735158|NCT03016975|Mitral Valve|mitral valve
4735159|NCT03016975|Transcatheter|transcatheter
4735160|NCT03016975|Mitral repair|mitral repair
4735161|NCT03016975|Functional mitral regurgitation|functional mitral regurgitation
4735162|NCT03016975|Secondary mitral regurgitation|secondary mitral regurgitation
4735163|NCT03016975|Annuloplasty|annuloplasty
4735164|NCT03016936|Metabolic equivalents (METs)|metabolic equivalents (mets)
4735165|NCT03016936|European Society of Anaesthesiology (ESA)|european society of anaesthesiology (esa)
4735166|NCT03016936|Noncardiac surgery|noncardiac surgery
4735167|NCT03016936|Cardiovascular Mortality|cardiovascular mortality
4735168|NCT03016923|cerebral palsy|cerebral palsy
4735169|NCT03016923|hemiplegia|hemiplegia
4735170|NCT03016923|fes|fes
4735171|NCT03016923|grasping|grasping
4735172|NCT03016897|ALS|als
4735173|NCT03016897|neurodegenerative|neurodegenerative
4735174|NCT03016884|Herpes Zoster|herpes zoster
4735175|NCT03016884|anti TNF alpha|anti tnf alpha
4735176|NCT03016884|tofacitinib|tofacitinib
4735177|NCT03016884|Rheumatoid Arthritis|rheumatoid arthritis
4735178|NCT03016845|ciprofloxacin|ciprofloxacin
4735179|NCT03016845|pharmacokinetics|pharmacokinetics
4735180|NCT03016845|Intensive Care Unit|intensive care unit
4735181|NCT03016845|Cystatin C|cystatin c
4735182|NCT03016845|CKD-EPI|ckd-epi
4735183|NCT03016845|renal function|renal function
4735184|NCT03016780|Ulcerative Colitis|ulcerative colitis
4735185|NCT03016780|Intestinal Bacteria Flora Disturbance|intestinal bacteria flora disturbance
4735186|NCT03016780|Fecal Microbiota Transplantation|fecal microbiota transplantation
4735187|NCT03016780|Intestinal Mucosal Immunity|intestinal mucosal immunity
4735188|NCT03016767|oral feeding|oral feeding
4735189|NCT03016767|oral stimulation|oral stimulation
4735190|NCT03016767|physiotherapy intervention|physiotherapy intervention
4735191|NCT03016754|sudden cardiac death|sudden cardiac death
4735192|NCT03016754|SCD|scd
4735193|NCT03016754|sudden cardiac arrest|sudden cardiac arrest
4735194|NCT03016754|SCA|sca
4735195|NCT03016754|heart failure|heart failure
4735196|NCT03016754|HF|hf
4735197|NCT03016741|cognitive function|cognitive function
4735198|NCT03016741|hormonal therapy|hormonal therapy
4735199|NCT03016741|cancer survivorship|cancer survivorship
4735200|NCT03016741|dementia|dementia
4735201|NCT03016741|cognitive dysfunction|cognitive dysfunction
4735202|NCT03016741|mild cognitive impairment|mild cognitive impairment
4735203|NCT03016728|exercise|exercise
4735204|NCT03016728|physical activity|physical activity
4735205|NCT03016728|pilot study|pilot study
4735206|NCT03016728|randomized controlled trial|randomized controlled trial
4735207|NCT03016728|cancer|cancer
4735208|NCT03016728|adolescent and young adult|adolescent and young adult
4735209|NCT03016728|AYA|aya
4735210|NCT03016715|Epidermolysis bullosa simplex|epidermolysis bullosa simplex
4735211|NCT03016676|Spinal Manipulation|spinal manipulation
4735212|NCT03016676|Postural Instability|postural instability
4735213|NCT03016676|Quality of Life|quality of life
4735214|NCT03016650|Acetaminophen|acetaminophen
4735215|NCT03016650|Ibuprofen|ibuprofen
4735216|NCT03016637|endoscopic ultrasonography|endoscopic ultrasonography
4735217|NCT03016637|EUS-FNA|eus-fna
4735218|NCT03016598|oxytocin|oxytocin
4735219|NCT03016598|substance-related disorders|substance-related disorders
4735220|NCT03016598|Opioid Replacement Therapy|opioid replacement therapy
4735221|NCT03016598|Psychophysiology|psychophysiology
4735222|NCT03016598|Stress Biomarkers|stress biomarkers
4735223|NCT03016572|Suicide|suicide
4735224|NCT03016572|Adolescent|adolescent
4735225|NCT03016572|Intervention|intervention
4735226|NCT03016572|Crisis|crisis
4735227|NCT03016572|Follow-Up|follow-up
4735228|NCT03016559|releasing muscle|releasing muscle
4735229|NCT03016559|quadratus lumborum|quadratus lumborum
4735230|NCT03016559|hip angle|hip angle
4735231|NCT03016546|Pregnancy|pregnancy
4735232|NCT03016533|Dolutegravir|dolutegravir
4735233|NCT03016533|Continued access study|continued access study
4735234|NCT03016533|HIV-1|hiv-1
4735235|NCT03016533|GSK1349572|gsk1349572
4735236|NCT03016533|Pediatric|pediatric
4735237|NCT03016507|intraocular pressure|intraocular pressure
4735238|NCT03016507|phacoemulsification|phacoemulsification
4735239|NCT03016507|cataract|cataract
4735240|NCT03016468|Oral Treprostinil|oral treprostinil
4735241|NCT03016468|Remodulin|remodulin
4735242|NCT03016468|Selexipag|selexipag
4735243|NCT03016468|6 Minute Walk Test|6 minute walk test
4735244|NCT03016455|Kidney Transplant|kidney transplant
4735245|NCT03016455|Immunology|immunology
4735246|NCT03016442|Double balloon catheter|double balloon catheter
4735247|NCT03016442|Dinoprostone|dinoprostone
4735248|NCT03016442|Labor induction|labor induction
4735249|NCT03016429|pacemaker|pacemaker
4735250|NCT03016429|defibrillator|defibrillator
4735251|NCT03016429|magnetic resonance imaging|magnetic resonance imaging
4735252|NCT03016429|cardiac implantable electronic device|cardiac implantable electronic device
4735253|NCT03016390|Cardiac Implantable Electronic Device|cardiac implantable electronic device
4735254|NCT03016390|Pacemaker|pacemaker
4735255|NCT03016390|Automatic Implantable Cardioverter-Defibrillator (AICD)|automatic implantable cardioverter-defibrillator (aicd)
4735256|NCT03016390|Electromagnetic interference (EMI)|electromagnetic interference (emi)
4735257|NCT03016390|Keyless access system|keyless access system
4735258|NCT03016390|Keyless entry system|keyless entry system
4735259|NCT03016377|CAR T cells|car t cells
4735260|NCT03016377|CD19|cd19
4735261|NCT03016377|Leukemia|leukemia
4735262|NCT03016377|T Lymphocytes|t lymphocytes
4735263|NCT03016377|AP1903|ap1903
4735264|NCT03016377|Cytokine Release Syndrome|cytokine release syndrome
4735265|NCT03016351|Hypertension|hypertension
4735266|NCT03016351|Exercise|exercise
4735267|NCT03016351|African Americans|african americans
4735268|NCT03016351|Arterial Function|arterial function
4735269|NCT03016351|Arterial Stiffness|arterial stiffness
4735270|NCT03016286|Whole body vibration|whole body vibration
4735271|NCT03016286|Bone myoregulation reflex|bone myoregulation reflex
4735272|NCT03016286|H-reflex|h-reflex
4735273|NCT03016260|Rheumatoid Arthritis|rheumatoid arthritis
4735274|NCT03016260|Anti TNF|anti tnf
4735275|NCT03016260|Infliximab|infliximab
4735276|NCT03016260|Adalimumab|adalimumab
4735277|NCT03016260|Etanercept|etanercept
4735278|NCT03016260|Golimumab|golimumab
4735279|NCT03016260|Certolizumab Pegol|certolizumab pegol
4735280|NCT03016260|Infliximab biosimilar|infliximab biosimilar
4735281|NCT03016260|Etanercept biosimilar|etanercept biosimilar
4735282|NCT03016260|Methotrexate|methotrexate
4735283|NCT03016247|magnetic resonance imaging, trust, reward|magnetic resonance imaging, trust, reward
4735284|NCT03016234|intraocular pressure|intraocular pressure
4735285|NCT03016234|trendelenburg position|trendelenburg position
4735286|NCT03016234|pneumoperitoneum|pneumoperitoneum
4735287|NCT03016221|local skin responses|local skin responses
4735288|NCT03016221|hyperemia|hyperemia
4735289|NCT03016221|thermal sensation|thermal sensation
4735290|NCT03016221|topical warming ointments|topical warming ointments
4735291|NCT03016221|topical cooling ointments|topical cooling ointments
4735292|NCT03016221|skin perfusion|skin perfusion
4735293|NCT03016221|subjective thermal sensation|subjective thermal sensation
4735294|NCT03016221|muscle tissue oxygenation|muscle tissue oxygenation
4735295|NCT03016221|skin temperature|skin temperature
4735296|NCT03016221|skin redness|skin redness
4735297|NCT03016221|erythema|erythema
4735298|NCT03016143|phase II|phase ii
4735299|NCT03016143|split|split
4735300|NCT03016143|vaccine|vaccine
4735301|NCT03016130|leukemia|leukemia
4735302|NCT03016130|myelodysplastic|myelodysplastic
4735303|NCT03016130|myeloid|myeloid
4735304|NCT03016130|lymphoblastic|lymphoblastic
4735305|NCT03016130|diet|diet
4735306|NCT03016130|infection|infection
4735307|NCT03016130|hematopoietic|hematopoietic
4735308|NCT03016130|stem cell|stem cell
4735309|NCT03016130|transplant|transplant
4735310|NCT03016104|magnetic seizure therapy|magnetic seizure therapy
4735311|NCT03016104|electroconvulsive therapy|electroconvulsive therapy
4735312|NCT03016104|bipolar mania|bipolar mania
4735313|NCT03016104|cognition|cognition
4735314|NCT03016104|controlled trial|controlled trial
4735315|NCT03016052|ABMT|abmt
4735316|NCT03016052|social anxiety|social anxiety
4735317|NCT03016052|generalized anxiety|generalized anxiety
4735318|NCT03016026|ERAS,Laparoscopy,Distal Gastrectomy,Safety,Effectiveness|eras,laparoscopy,distal gastrectomy,safety,effectiveness
4735319|NCT03016000|diffuse large B-cell lymphoma|diffuse large b-cell lymphoma
4735320|NCT03016000|Thalidomide|thalidomide
4735321|NCT03016000|Maintenance|maintenance
4735322|NCT03015987|Diode laser|diode laser
4735323|NCT03015987|asymptomatic pulp|asymptomatic pulp
4735324|NCT03015987|Laser activated irrigation|laser activated irrigation
4735325|NCT03015987|continuous ultrasonic activation|continuous ultrasonic activation
4735326|NCT03015987|post obturation pain|post obturation pain
4735327|NCT03015935|Obesity, Morbid|obesity, morbid
4735328|NCT03015883|Squamous Cell Carcinoma|squamous cell carcinoma
4735329|NCT03015883|Alpha emitting radiation|alpha emitting radiation
4735330|NCT03015870|vocal dysfunction|vocal dysfunction
4735332|NCT03015870|vocal folds|vocal folds
4735333|NCT03015870|vocal aging|vocal aging
4735334|NCT03015844|MIBG|mibg
4735335|NCT03015844|131I-MIBG|131i-mibg
4735336|NCT03015844|relapsed|relapsed
4735337|NCT03015844|neuroblastoma|neuroblastoma
4735338|NCT03015844|pheochromocytoma|pheochromocytoma
4735339|NCT03015831|Atrial fibrillation|atrial fibrillation
4735340|NCT03015831|Cardiac surgery|cardiac surgery
4735341|NCT03015831|Colchicine|colchicine
4735342|NCT03015766|insomnia|insomnia
4735343|NCT03015766|hemodialysis|hemodialysis
4735344|NCT03015766|auricular acupressure|auricular acupressure
4735345|NCT03015766|randomized controlled trial|randomized controlled trial
4735346|NCT03015753|Migraine|migraine
4735347|NCT03015753|Tai Chi|tai chi
4735348|NCT03015753|Prophylaxis|prophylaxis
4735349|NCT03015753|Randomized controlled trial|randomized controlled trial
4735350|NCT03015740|Malignant neoplasms of urinary tract|malignant neoplasms of urinary tract
4735351|NCT03015740|Other disorders of kidney and ureter|other disorders of kidney and ureter
4735352|NCT03015740|Renal cell carcinoma|renal cell carcinoma
4735353|NCT03015740|RCC|rcc
4735354|NCT03015740|Metastatic|metastatic
4735355|NCT03015740|MGCD516|mgcd516
4735356|NCT03015740|Nivolumab|nivolumab
4735357|NCT03015740|BMS-936558|bms-936558
4735358|NCT03015740|Opdivo|opdivo
4735359|NCT03015727|nasopharyngeal carcinoma|nasopharyngeal carcinoma
4735360|NCT03015727|Induction chemotherapy|induction chemotherapy
4735361|NCT03015727|radiotherapy|radiotherapy
4735362|NCT03015727|chemoradiotherapy|chemoradiotherapy
4735363|NCT03015701|Unresectable|unresectable
4735364|NCT03015688|Biomarkers|biomarkers
4735365|NCT03015662|Quality of Life|quality of life
4735366|NCT03015662|Fatigue|fatigue
4735367|NCT03015662|Anxiety|anxiety
4735368|NCT03015662|Physical Therapy Modalities|physical therapy modalities
4735369|NCT03015662|Pain|pain
4735370|NCT03015649|breast cancer, surgical guidance system|breast cancer, surgical guidance system
4735371|NCT03015636|Cognitive Behaviour Therapy|cognitive behaviour therapy
4735372|NCT03015636|Psychological Intervention|psychological intervention
4735373|NCT03015623|Mesenchymal stromal cells|mesenchymal stromal cells
4735374|NCT03015623|MSC|msc
4735375|NCT03015623|Stem cells|stem cells
4735376|NCT03015623|Mesenchymal stem cells|mesenchymal stem cells
4735377|NCT03015610|Personalized Medicine|personalized medicine
4735378|NCT03015610|CYP2C19|cyp2c19
4735379|NCT03015610|Lansoprazole|lansoprazole
4735380|NCT03015610|Pharmacokinetics|pharmacokinetics
4735381|NCT03015597|Smoking|smoking
4735382|NCT03015597|Tobacco Smoking|tobacco smoking
4735383|NCT03015597|Smoking, Tobacco|smoking, tobacco
4735384|NCT03015597|Smoking Cessation|smoking cessation
4735385|NCT03015597|Opiate Addiction|opiate addiction
4735386|NCT03015597|Opiate Dependence|opiate dependence
4735387|NCT03015597|Contingency Management|contingency management
4735388|NCT03015571|heterotopic gastric mucosa|heterotopic gastric mucosa
4735389|NCT03015571|cervical inlet patch|cervical inlet patch
4735390|NCT03015571|narrow band imaging|narrow band imaging
4735391|NCT03015571|endoscopy|endoscopy
4735392|NCT03015558|Drug Resistance|drug resistance
4735393|NCT03015558|Neuropathic Pain|neuropathic pain
4735394|NCT03015558|opercular-insular cortex|opercular-insular cortex
4735395|NCT03015558|Transcranial Direct Current Stimulation|transcranial direct current stimulation
4735396|NCT03015545|Muscle Stiffness|muscle stiffness
4735397|NCT03015545|Ultrasound elastography|ultrasound elastography
4735398|NCT03015545|H-reflex|h-reflex
4735399|NCT03015545|Whole body vibration|whole body vibration
4735400|NCT03015532|knee|knee
4735401|NCT03015532|knee replacement|knee replacement
4735402|NCT03015532|arthroplasty|arthroplasty
4735403|NCT03015532|joint replacement|joint replacement
4735404|NCT03015532|knee pain|knee pain
4735405|NCT03015519|GSK716155|gsk716155
4735406|NCT03015519|Type 2 diabetes mellitus|type 2 diabetes mellitus
4735407|NCT03015519|albiglutide|albiglutide
4735408|NCT03015519|safety|safety
4735409|NCT03015519|pediatric|pediatric
4735410|NCT03015519|efficacy|efficacy
4735411|NCT03015493|Neck pain|neck pain
4735412|NCT03015493|Neurodynamics|neurodynamics
4735413|NCT03015493|Spinal manipulative therapy|spinal manipulative therapy
4735414|NCT03015480|Mobile Application|mobile application
4735415|NCT03015480|Chronic Kidney Disease|chronic kidney disease
4735416|NCT03015480|Diabetes Mellitus|diabetes mellitus
4735417|NCT03015480|Albuminuria|albuminuria
4735418|NCT03015480|Diet|diet
4735419|NCT03015467|acute pancreatitis|acute pancreatitis
4735420|NCT03015467|intestinal mucosal barrier|intestinal mucosal barrier
4735421|NCT03015467|Fecal Microbiota Transplantation|fecal microbiota transplantation
4735422|NCT03015454|InSight|insight
4735423|NCT03015454|Dascena|dascena
4735424|NCT03015441|Healthy subjects|healthy subjects
4735425|NCT03015441|Probiotics|probiotics
4735426|NCT03015441|Breath test|breath test
4735427|NCT03015441|Dihydrogen|dihydrogen
4735428|NCT03015441|Methane|methane
4735429|NCT03015441|Intestinal gas production|intestinal gas production
4735430|NCT03015441|Gut microbiota|gut microbiota
4735431|NCT03015428|Family caregivers|family caregivers
4735432|NCT03015428|training programme|training programme
4735433|NCT03015428|dementia|dementia
4735434|NCT03015415|elbow|elbow
4735435|NCT03015415|posttraumatic stiffness|posttraumatic stiffness
4735436|NCT03015415|elbow contractures|elbow contractures
4735437|NCT03015415|stiff elbow|stiff elbow
4735438|NCT03015415|dynamic orthoses|dynamic orthoses
4735439|NCT03015415|Dynamic splint|dynamic splint
4735440|NCT03015415|Rehabilitation|rehabilitation
4735441|NCT03015415|Splint|splint
4735442|NCT03015415|Effectiveness of bracing|effectiveness of bracing
4735443|NCT03015376|epithelial ovarian cancer|epithelial ovarian cancer
4735444|NCT03015376|Hereditary Breast and Ovarian Cancer Syndrome|hereditary breast and ovarian cancer syndrome
4735445|NCT03015376|next-generation sequencing|next-generation sequencing
4735446|NCT03015376|High-Throughput Nucleotide Sequencing|high-throughput nucleotide sequencing
4735447|NCT03015363|Hypertension|hypertension
4735448|NCT03015363|Telemonitoring|telemonitoring
4735449|NCT03015363|Vital signs|vital signs
4735450|NCT03015350|blood sevoflurane concentration|blood sevoflurane concentration
4735451|NCT03015350|blood desflurane concentration|blood desflurane concentration
4735452|NCT03015350|one lung ventilation|one lung ventilation
4735453|NCT03015311|Blood pressure control|blood pressure control
4735454|NCT03015298|gastric cancer|gastric cancer
4735455|NCT03015298|Simultaneous PET/MRI|simultaneous pet/mri
4735456|NCT03015298|PET/CT|pet/ct
4735457|NCT03015272|minimally-verbal|minimally-verbal
4735458|NCT03015272|children|children
4735459|NCT03015272|intervention|intervention
4735460|NCT03015272|singing|singing
4735461|NCT03015272|music|music
4735462|NCT03015233|Lactate|lactate
4735463|NCT03015233|Acute Abdominal Pain|acute abdominal pain
4735464|NCT03015233|Acute Abdomen|acute abdomen
4735465|NCT03015233|Strong Ion Gap|strong ion gap
4735466|NCT03015233|Renal Colic|renal colic
4735467|NCT03015233|Emergency Department|emergency department
4735468|NCT03015233|Emergency|emergency
4735469|NCT03015233|Surgery|surgery
4735470|NCT03015233|Stewart|stewart
4735471|NCT03015194|LVOT (left ventricular outflow tract, obstruction)|lvot (left ventricular outflow tract, obstruction)
4735472|NCT03015194|Transcatheter Mitral Valve Implantation|transcatheter mitral valve implantation
4735473|NCT03015194|Transcatheter Heart Valve|transcatheter heart valve
4735474|NCT03015194|Mitral Valve Regurgitation|mitral valve regurgitation
4735475|NCT03015194|Mitral Valve Stenosis|mitral valve stenosis
4735476|NCT03015181|Broadly Neutralizing|broadly neutralizing
4735477|NCT03015181|HIV Prevention|hiv prevention
4735478|NCT03015181|Anti-Drug Antibody|anti-drug antibody
4735479|NCT03015181|HIV-1|hiv-1
4735480|NCT03015181|Immune Response|immune response
4735481|NCT03015129|Durvalumab|durvalumab
4735482|NCT03015129|MEDI4736|medi4736
4735483|NCT03015129|Tremelimumab|tremelimumab
4735484|NCT03015129|anti-PD-L1 Antibody|anti-pd-l1 antibody
4735485|NCT03015129|anti-CTLA-4 antibody|anti-ctla-4 antibody
4735486|NCT03015129|16-1491|16-1491
4735487|NCT03015116|photobiomodulation|photobiomodulation
4735488|NCT03015116|plantar fasciitis|plantar fasciitis
4735489|NCT03015090|COPD|copd
4735490|NCT03015090|CYP1A2|cyp1a2
4735491|NCT03015090|Theophylline|theophylline
4735492|NCT03015077|Glutamine|glutamine
4735493|NCT03015051|Bronchiolitis|bronchiolitis
4735494|NCT03015051|High flow nasal cannula|high flow nasal cannula
4735495|NCT03015051|Oxygen therapy|oxygen therapy
4735496|NCT03015025|Acenocoumarol|acenocoumarol
4735497|NCT03015025|Cytochrome P450|cytochrome p450
4735498|NCT03015025|Pharmacogenetics|pharmacogenetics
4735499|NCT03015025|Algorithm|algorithm
4735500|NCT03015025|CYP2C9|cyp2c9
4735501|NCT03015025|VKORC1|vkorc1
4735502|NCT03015025|CYP4F2|cyp4f2
4735503|NCT03015025|P450 oxidoreductase (POR)|p450 oxidoreductase (por)
4735504|NCT03015012|Nutrigenomics|nutrigenomics
4735505|NCT03015012|Genetics|genetics
4735506|NCT03015012|Overweight|overweight
4735507|NCT03015012|Obesity|obesity
4735508|NCT03015012|Transplantation|transplantation
4735509|NCT03015012|Nutrition|nutrition
4735510|NCT03015012|Dietetics|dietetics
4735511|NCT03015012|BMI|bmi
4735512|NCT03015012|Body Composition|body composition
4735513|NCT03014999|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
4735514|NCT03014999|Spinal Cord Injury|spinal cord injury
4735515|NCT03014999|Humans|humans
4735516|NCT03014986|HCV|hcv
4735517|NCT03014947|MSB11022|msb11022
4735518|NCT03014947|Humira®|humira®
4735519|NCT03014934|Aspergillosis|aspergillosis
4735520|NCT03014934|IA|ia
4735521|NCT03014908|Type 1 diabetes|type 1 diabetes
4735522|NCT03014908|1H-NMR spectroscopy|1h-nmr spectroscopy
4735523|NCT03014908|Metabolomics|metabolomics
4735524|NCT03014908|Pediatrics|pediatrics
4735525|NCT03014895|E3112|e3112
4735526|NCT03014895|Pharmacokinetics|pharmacokinetics
4735527|NCT03014895|Japanese|japanese
4735528|NCT03014869|COPD Exacerbation|copd exacerbation
4735529|NCT03014869|High Flow Oxygen|high flow oxygen
4735530|NCT03014869|Noninvasive Positive Ventilation|noninvasive positive ventilation
4735531|NCT03014869|moderate|moderate
4735532|NCT03014856|Metabolic syndrome|metabolic syndrome
4735533|NCT03014856|Metabolomics|metabolomics
4735534|NCT03014856|NMR spectroscopy|nmr spectroscopy
4735535|NCT03014843|Esophagal sensitivity, GERD, endogenous opiods|esophagal sensitivity, gerd, endogenous opiods
4735536|NCT03014791|Epidemiology|epidemiology
4735537|NCT03014791|Ethnicity|ethnicity
4735538|NCT03014791|Age|age
4735539|NCT03014791|Weight|weight
4735540|NCT03014791|Hypertensive|hypertensive
4735541|NCT03014791|Cardiac Output|cardiac output
4735542|NCT03014791|Peripheral Vascular Resistance|peripheral vascular resistance
4735543|NCT03014791|Arterial Stiffness|arterial stiffness
4735544|NCT03014791|Healthy Volunteers|healthy volunteers
4735545|NCT03014791|Endothelial function|endothelial function
4735546|NCT03014791|Arterial Structure|arterial structure
4735547|NCT03014791|Left ventricular mass/function|left ventricular mass/function
4735548|NCT03014765|endothelial dysfunction|endothelial dysfunction
4735549|NCT03014765|perioperative stress|perioperative stress
4735550|NCT03014765|cardiovascular complications|cardiovascular complications
4735551|NCT03014765|inflammatory markers|inflammatory markers
4735552|NCT03014739|Elastography|elastography
4735553|NCT03014739|Musculoskeletal System|musculoskeletal system
4735554|NCT03014726|reduced urine flow rate|reduced urine flow rate
4735555|NCT03014726|low peak flow rate|low peak flow rate
4735556|NCT03014726|urinary tract infections|urinary tract infections
4735557|NCT03014713|Dexmedetomidine|dexmedetomidine
4735558|NCT03014713|Dezocine|dezocine
4735559|NCT03014713|Flubiprofen|flubiprofen
4735560|NCT03014713|Analgesia|analgesia
4735561|NCT03014713|Colorectal Surgery|colorectal surgery
4735562|NCT03014687|transsphenoidal surgery|transsphenoidal surgery
4735563|NCT03014674|SB-240563|sb-240563
4735564|NCT03014674|subcutaneous|subcutaneous
4735565|NCT03014674|lyophilized drug product|lyophilized drug product
4735566|NCT03014674|Mepolizumab|mepolizumab
4735567|NCT03014674|liquid drug product|liquid drug product
4735568|NCT03014674|safety syringe|safety syringe
4735569|NCT03014674|auto injector|auto injector
4735570|NCT03014661|pollinosis, quality of life, specific immunotherapy|pollinosis, quality of life, specific immunotherapy
4735571|NCT03014635|glabellar lines, frown lines|glabellar lines, frown lines
4735572|NCT03014622|glabellar lines, frown lines|glabellar lines, frown lines
4735573|NCT03014609|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
4735574|NCT03014609|cardiovascular risk|cardiovascular risk
4735575|NCT03014609|inflammation|inflammation
4735576|NCT03014609|oxidative stress|oxidative stress
4735577|NCT03014609|peripheral muscle function|peripheral muscle function
4735578|NCT03014570|behavior,|behavior,
4735579|NCT03014570|apathy|apathy
4735580|NCT03014570|mood|mood
4735581|NCT03014570|function|function
4735582|NCT03014570|cognition|cognition
4735583|NCT03014557|atrial fibrillation|atrial fibrillation
4735584|NCT03014557|left atrial appendage closure|left atrial appendage closure
4735585|NCT03014557|WATCHMAN|watchman
4735586|NCT03014518|Adolescent|adolescent
4735587|NCT03014518|Biological Markers|biological markers
4735588|NCT03014518|Biomarkers|biomarkers
4735589|NCT03014518|Biomarkers for suicidality|biomarkers for suicidality
4735590|NCT03014518|Blood brain barrier|blood brain barrier
4735591|NCT03014518|Clinical predictors|clinical predictors
4735592|NCT03014518|Cytokine|cytokine
4735593|NCT03014518|Feeling suicidal|feeling suicidal
4735594|NCT03014518|Inflammation|inflammation
4735595|NCT03014518|Inflammatory marker|inflammatory marker
4735596|NCT03014518|Inpatient discharge|inpatient discharge
4735597|NCT03014518|Interleukin-1 beta|interleukin-1 beta
4735598|NCT03014518|IL-1ß|il-1ß
4735599|NCT03014518|Interleukin-6|interleukin-6
4735600|NCT03014518|IL-6|il-6
4735601|NCT03014518|Kynurenic acid|kynurenic acid
4735602|NCT03014518|Kynurenine pathway|kynurenine pathway
4735603|NCT03014518|Neuroinflammation|neuroinflammation
4735604|NCT03014518|Novel marker|novel marker
4735605|NCT03014518|Peripheral blood biomarkers|peripheral blood biomarkers
4735606|NCT03014518|Picolinic acid|picolinic acid
4735607|NCT03014518|Plasma biomarker|plasma biomarker
4735608|NCT03014518|Psychiatric inpatient|psychiatric inpatient
4735609|NCT03014518|S100B|s100b
4735610|NCT03014518|Serum biomarker|serum biomarker
4735611|NCT03014518|Stress|stress
4735612|NCT03014518|Suicide|suicide
4735613|NCT03014518|Suicidal behavior|suicidal behavior
4735614|NCT03014518|Suicidal risk|suicidal risk
4735615|NCT03014518|Tumor necrosis factor alpha|tumor necrosis factor alpha
4735616|NCT03014518|TNF-α|tnf-α
4735617|NCT03014505|Cirrhosis|cirrhosis
4735618|NCT03014505|Fecal Microbiota Transplantation|fecal microbiota transplantation
4735619|NCT03014505|Intestinal flora|intestinal flora
4735620|NCT03014505|Intestinal mucosal barrier|intestinal mucosal barrier
4735621|NCT03014505|Intestinal Bacteria Flora Disturbance|intestinal bacteria flora disturbance
4735622|NCT03014401|stem cell|stem cell
4735623|NCT03014401|knee pain|knee pain
4735624|NCT03014401|osteoarthritis|osteoarthritis
4735625|NCT03014401|arthritis|arthritis
4735626|NCT03014401|ADSC|adsc
4735627|NCT03014401|fat stem cell|fat stem cell
4735628|NCT03014349|Glaucoma|glaucoma
4735629|NCT03014349|Ocular hypertension|ocular hypertension
4735630|NCT03014336|co2 removal, anesthesia|co2 removal, anesthesia
4735631|NCT03014323|insulin sensitivity|insulin sensitivity
4735632|NCT03014323|African American|african american
4735633|NCT03014323|obese|obese
4735634|NCT03014310|A/H5N8|a/h5n8
4735635|NCT03014310|Adjuvants|adjuvants
4735636|NCT03014310|AS03|as03
4735637|NCT03014310|Inactivated|inactivated
4735638|NCT03014310|Influenza|influenza
4735639|NCT03014310|MF59|mf59
4735640|NCT03014310|Monovalent|monovalent
4735641|NCT03014284|Tissue collection|tissue collection
4735642|NCT03014284|colonoscopic surgical procedures|colonoscopic surgical procedures
4735643|NCT03014258|Biology|biology
4735644|NCT03014258|falciparum|falciparum
4735645|NCT03014258|Immunity|immunity
4735646|NCT03014258|Infections|infections
4735647|NCT03014258|Malaria|malaria
4735648|NCT03014258|Pf|pf
4735649|NCT03014258|Plasmodium|plasmodium
4735650|NCT03014258|Systems|systems
4735651|NCT03014232|sustained low-efficiency diafiltration (SLED-f)|sustained low-efficiency diafiltration (sled-f)
4735652|NCT03014232|high cut-off dialyzer|high cut-off dialyzer
4735653|NCT03014232|cytokines|cytokines
4735654|NCT03014180|Heart failure, CRT|heart failure, crt
4735655|NCT03014167|transmission interruption|transmission interruption
4735656|NCT03014167|intestinal nematodes|intestinal nematodes
4735657|NCT03014167|soil-transmitted helminths|soil-transmitted helminths
4735658|NCT03014167|mass drug administration|mass drug administration
4735659|NCT03014167|Benin|benin
4735660|NCT03014167|India|india
4735661|NCT03014167|Malawi|malawi
4735662|NCT03014154|video games|video games
4735663|NCT03014154|asthma|asthma
4735664|NCT03014154|physical exercise|physical exercise
4735665|NCT03014128|musculoskeletal disorders|musculoskeletal disorders
4735666|NCT03014128|upper extremity|upper extremity
4735667|NCT03014128|work|work
4735668|NCT03014128|surgical instruments|surgical instruments
4735669|NCT03014115|arachidonic|arachidonic
4735670|NCT03014115|docosahexaenoic acid|docosahexaenoic acid
4735671|NCT03014115|infant formula|infant formula
4735672|NCT03014089|mRNA-1325|mrna-1325
4735673|NCT03014089|Zika vaccine|zika vaccine
4735674|NCT03014063|sepsis|sepsis
4735675|NCT03014063|septic shock|septic shock
4735676|NCT03014063|vasopressin|vasopressin
4735677|NCT03014063|AVP|avp
4735678|NCT03014050|physical activity|physical activity
4735679|NCT03014050|fitness|fitness
4735680|NCT03014050|cognition|cognition
4735681|NCT03014050|mood|mood
4735682|NCT03014050|depression|depression
4735683|NCT03014050|anxiety|anxiety
4735684|NCT03014050|sleep quality|sleep quality
4735685|NCT03014050|tremor|tremor
4735686|NCT03014050|gait|gait
4735687|NCT03014037|Orthopedics|orthopedics
4735688|NCT03014024|Distal Radius Fracture|distal radius fracture
4735689|NCT03014024|Low Level Laser Therapy|low level laser therapy
4735690|NCT03013985|Blood glucose|blood glucose
4735691|NCT03013972|ColoRectal Cancer|colorectal cancer
4735692|NCT03013972|Adjuvant Chemotherapy|adjuvant chemotherapy
4735693|NCT03013972|Cancer-related Fatigue|cancer-related fatigue
4735694|NCT03013972|Brief fatigue inventory (BFI)|brief fatigue inventory (bfi)
4735695|NCT03013972|Functional Assessment of Cancer Therapy-General 7 (FACT-G7)|functional assessment of cancer therapy-general 7 (fact-g7)
4735696|NCT03013920|upper urinary tract cancer|upper urinary tract cancer
4735697|NCT03013920|confocal laser endomicroscopy|confocal laser endomicroscopy
4735698|NCT03013920|urothelial carcinoma|urothelial carcinoma
4735699|NCT03013907|Hypertension|hypertension
4735700|NCT03013907|Coping|coping
4735701|NCT03013907|Relaxing|relaxing
4735702|NCT03013894|bladder neoplasm|bladder neoplasm
4735703|NCT03013894|urothelium carcinoma|urothelium carcinoma
4735704|NCT03013894|confocal laser endomicroscopy|confocal laser endomicroscopy
4735705|NCT03013881|UB-921|ub-921
4735706|NCT03013881|anti-HER2 monoclonal antibody|anti-her2 monoclonal antibody
4735707|NCT03013881|breast neoplasm|breast neoplasm
4735708|NCT03013881|breast cancer|breast cancer
4735709|NCT03013881|Herceptin|herceptin
4735710|NCT03013881|Trastuzumab|trastuzumab
4735711|NCT03013881|HER2|her2
4735712|NCT03013855|Digital rectal exam|digital rectal exam
4735713|NCT03013855|Colon cancer screening|colon cancer screening
4735714|NCT03013842|pregnancy|pregnancy
4735715|NCT03013842|fetal monitoring|fetal monitoring
4735716|NCT03013842|fetal oximetry|fetal oximetry
4735717|NCT03013842|fetal heart rate|fetal heart rate
4735718|NCT03013842|pulse oximetry|pulse oximetry
4735719|NCT03013842|near infrared spectroscopy|near infrared spectroscopy
4735720|NCT03013829|Kidney Paired Donation|kidney paired donation
4735721|NCT03013777|Familial dysautonomia|familial dysautonomia
4735722|NCT03013699|diet|diet
4735723|NCT03013699|nutrition|nutrition
4735724|NCT03013699|survival|survival
4735725|NCT03013699|recurrence|recurrence
4735726|NCT03013699|cruciferous|cruciferous
4735727|NCT03013699|dark leafy greens|dark leafy greens
4735728|NCT03013673|leishmaniasis, visceral, neglected, HIV, co-infection, asymptomatic, Ethiopia|leishmaniasis, visceral, neglected, hiv, co-infection, asymptomatic, ethiopia
4735729|NCT03013647|actinic keratosis|actinic keratosis
4735730|NCT03013647|field cancerization|field cancerization
4735731|NCT03013647|photodynamic therapy|photodynamic therapy
4735732|NCT03013647|daylight photodynamic therapy|daylight photodynamic therapy
4735733|NCT03013634|dexmedetomidine|dexmedetomidine
4735734|NCT03013621|Renal Failure|renal failure
4735735|NCT03013621|Renal Insufficiency|renal insufficiency
4735736|NCT03013621|Acute Renal Failure|acute renal failure
4735737|NCT03013621|Acute Renal Injury|acute renal injury
4735738|NCT03013621|Kidney Failure|kidney failure
4735739|NCT03013621|Kidney Insufficiency|kidney insufficiency
4735740|NCT03013621|Acute Kidney Failure|acute kidney failure
4735741|NCT03013621|Acute Kidney Injury|acute kidney injury
4735742|NCT03013621|Ventricular dysfunction|ventricular dysfunction
4735743|NCT03013621|Venous congestion|venous congestion
4735744|NCT03013621|Renal function|renal function
4735745|NCT03013621|Kidney function|kidney function
4735746|NCT03013621|Venous heart failure|venous heart failure
4735747|NCT03013608|Nail bed injury|nail bed injury
4735748|NCT03013608|Nail bed injuries|nail bed injuries
4735749|NCT03013608|Nail|nail
4735750|NCT03013608|Children|children
4735751|NCT03013608|Fingertip injury|fingertip injury
4735752|NCT03013595|Mental health|mental health
4735753|NCT03013595|Youth mental health|youth mental health
4735754|NCT03013595|Adolescent|adolescent
4735755|NCT03013595|Health services|health services
4735756|NCT03013595|Transition|transition
4735757|NCT03013595|Longitudinal cohort study|longitudinal cohort study
4736135|NCT03011138|gait velocity|gait velocity
4735758|NCT03013595|Cluster randomised controlled trial|cluster randomised controlled trial
4735759|NCT03013595|Young adult|young adult
4735760|NCT03013556|HBeAg positive|hbeag positive
4735761|NCT03013543|POMC deficiency obesity|pomc deficiency obesity
4735762|NCT03013543|LepR deficiency obesity|lepr deficiency obesity
4735763|NCT03013543|Bardet-Biedl syndrome|bardet-biedl syndrome
4735764|NCT03013543|Alström Syndrome|alström syndrome
4735765|NCT03013530|Intensive care unit|intensive care unit
4735766|NCT03013530|Triage and Therapy.|triage and therapy.
4735767|NCT03013530|Advance Directives (AD).|advance directives (ad).
4735768|NCT03013530|Simulation model of real situations. (hypothetical scenario)|simulation model of real situations. (hypothetical scenario)
4735769|NCT03013530|Intensivist physician.|intensivist physician.
4735770|NCT03013517|Allergy|allergy
4735771|NCT03013517|food allergy|food allergy
4735772|NCT03013517|viaskin|viaskin
4735773|NCT03013517|peanut|peanut
4735774|NCT03013517|epicutaneous|epicutaneous
4735775|NCT03013504|randomized|randomized
4735776|NCT03013504|double-blind|double-blind
4735777|NCT03013504|parallel group|parallel group
4735778|NCT03013504|equivalence|equivalence
4735779|NCT03013504|multicentre|multicentre
4735780|NCT03013504|phase III|phase iii
4735781|NCT03013504|efficacy|efficacy
4735782|NCT03013504|safety|safety
4735783|NCT03013504|pharmacokinetics|pharmacokinetics
4735784|NCT03013504|HD201|hd201
4735785|NCT03013504|docetaxel|docetaxel
4735786|NCT03013504|Herceptin|herceptin
4735787|NCT03013504|HER2 positive|her2 positive
4735788|NCT03013504|breast cancer|breast cancer
4735789|NCT03013504|early breast cancer|early breast cancer
4735790|NCT03013491|cancer|cancer
4735791|NCT03013491|checkpoint inhibitor|checkpoint inhibitor
4735792|NCT03013491|monotherapy|monotherapy
4735793|NCT03013491|combination|combination
4735794|NCT03013491|PD-L1|pd-l1
4735795|NCT03013491|CTLA-4|ctla-4
4735796|NCT03013491|solid tumor|solid tumor
4735797|NCT03013491|lymphoma|lymphoma
4735798|NCT03013491|BRAF|braf
4735799|NCT03013491|PROCLAIM|proclaim
4735800|NCT03013491|CX-072|cx-072
4735801|NCT03013491|PROCLAIM-CX-072|proclaim-cx-072
4735802|NCT03013374|protein accretion|protein accretion
4735803|NCT03013374|body composition|body composition
4735804|NCT03013361|ropivacaine, bupivacaine|ropivacaine, bupivacaine
4735805|NCT03013335|Clear-cell|clear-cell
4735806|NCT03013335|Nivolumab|nivolumab
4735807|NCT03013335|Renal cell carcinoma|renal cell carcinoma
4735808|NCT03013335|Immunotherapy|immunotherapy
4735809|NCT03013309|Hybrid|hybrid
4735810|NCT03013309|Implementation|implementation
4735811|NCT03013309|Effectiveness|effectiveness
4735812|NCT03013309|Parent training|parent training
4735813|NCT03013309|Fidelity|fidelity
4735814|NCT03013309|Cost-Effectiveness|cost-effectiveness
4735815|NCT03013309|Primary Care|primary care
4735816|NCT03013296|GIP|gip
4735817|NCT03013296|GIP receptor antagonist|gip receptor antagonist
4735818|NCT03013270|Rehabilitation|rehabilitation
4735819|NCT03013270|Exercise|exercise
4735820|NCT03013270|Training|training
4735821|NCT03013257|Relapsed Graves' disease|relapsed graves' disease
4735822|NCT03013257|High Intensity Focused Ultrasound|high intensity focused ultrasound
4735823|NCT03013257|RAI|rai
4735824|NCT03013244|prevention|prevention
4735825|NCT03013244|eating disorder|eating disorder
4735826|NCT03013244|men|men
4735827|NCT03013244|intervention|intervention
4735828|NCT03013244|muscle dysmorphia|muscle dysmorphia
4735829|NCT03013244|peer-led|peer-led
4735830|NCT03013231|ACL Reconstruction|acl reconstruction
4735831|NCT03013231|Return to Sport|return to sport
4735832|NCT03013231|Resilience|resilience
4735833|NCT03013218|Neoplasms|neoplasms
4735834|NCT03013218|CD47|cd47
4735835|NCT03013218|SIRPα|sirpα
4735836|NCT03013218|ALX148|alx148
4735837|NCT03013205|adhesive capsulitis|adhesive capsulitis
4735838|NCT03013153|Rectal Cancer|rectal cancer
4735839|NCT03013153|Inferior Mesenteric Artery|inferior mesenteric artery
4735840|NCT03013153|Ligation|ligation
4735841|NCT03013153|Apical Lymph Nodes|apical lymph nodes
4735842|NCT03013153|Laparoscopy|laparoscopy
4735843|NCT03013153|IMA Types|ima types
4735844|NCT03013140|Anesthesia, Obstetric|anesthesia, obstetric
4735845|NCT03013140|fluid therapy|fluid therapy
4735846|NCT03013140|cesarean section|cesarean section
4735847|NCT03013140|spinal anesthesia|spinal anesthesia
4735848|NCT03013127|Osteogenic Sarcoma|osteogenic sarcoma
4735849|NCT03013127|Osteosarcoma|osteosarcoma
4735850|NCT03013127|Sarcoma, Osteogenic|sarcoma, osteogenic
4735851|NCT03013127|Pembrolizumab|pembrolizumab
4735852|NCT03013127|Immunotherapy|immunotherapy
4735853|NCT03013114|Bortezomib Immune thrombocytopenia|bortezomib immune thrombocytopenia
4735854|NCT03013101|anti-PD-1 monoclonal antibody|anti-pd-1 monoclonal antibody
4735855|NCT03013101|advanced|advanced
4735856|NCT03013101|metastatic|metastatic
4735857|NCT03013101|melanoma|melanoma
4735858|NCT03013088|Chronic|chronic
4735859|NCT03013088|Occlusion|occlusion
4735860|NCT03013088|CTO|cto
4735861|NCT03013023|Behavioral and Transaction Interventions|behavioral and transaction interventions
4735862|NCT03013023|Parents' Biopsychosocial Well-being|parents' biopsychosocial well-being
4735863|NCT03013023|Preterm Infants|preterm infants
4735864|NCT03013023|Sleep|sleep
4735865|NCT03013023|Salivary cortisol|salivary cortisol
4735866|NCT03013010|Randomized|randomized
4735867|NCT03013010|Open Label|open label
4735868|NCT03013010|Multicenter|multicenter
4735869|NCT03012984|elderly|elderly
4735870|NCT03012984|surgery|surgery
4735871|NCT03012984|analgesia|analgesia
4735872|NCT03012984|dexmedetomidine|dexmedetomidine
4735873|NCT03012984|delirium|delirium
4735874|NCT03012971|Elderly|elderly
4735875|NCT03012971|Surgery|surgery
4735876|NCT03012971|Analgesia|analgesia
4735877|NCT03012971|Dexmedetomidine|dexmedetomidine
4735878|NCT03012971|Long-term outcome|long-term outcome
4735879|NCT03012945|Elderly|elderly
4735880|NCT03012945|Cancer surgery|cancer surgery
4735881|NCT03012945|Epidural anesthesia and analgesia|epidural anesthesia and analgesia
4735882|NCT03012945|Long-term survival|long-term survival
4735883|NCT03012945|Quality of life|quality of life
4735884|NCT03012919|active decision support system|active decision support system
4735885|NCT03012919|goal directed therapy|goal directed therapy
4735886|NCT03012919|Lidco|lidco
4735887|NCT03012919|vascular surgery|vascular surgery
4735888|NCT03012919|hemodynamic optimization|hemodynamic optimization
4735889|NCT03012893|ultrasonography to identify C7 spinous process|ultrasonography to identify c7 spinous process
4735890|NCT03012867|criticall illness|criticall illness
4735891|NCT03012867|enteral nutrition|enteral nutrition
4735892|NCT03012854|Esophageal achalasia|esophageal achalasia
4735893|NCT03012854|Peroral endoscopic myotomy|peroral endoscopic myotomy
4735894|NCT03012854|POEM|poem
4735895|NCT03012815|gabapentin|gabapentin
4735896|NCT03012815|Alcohol Withdrawal Syndrome|alcohol withdrawal syndrome
4735897|NCT03012815|benzodiazepine|benzodiazepine
4735898|NCT03012815|symptom-triggered|symptom-triggered
4735900|NCT03012724|Deep Transcranial Magnetic Stimulation|deep transcranial magnetic stimulation
4735901|NCT03012724|MDD|mdd
4735902|NCT03012724|Major Depressive Disorder|major depressive disorder
4735903|NCT03012659|contraceptive counseling|contraceptive counseling
4735904|NCT03012659|cluster randomized trial|cluster randomized trial
4735905|NCT03012659|provider counseling training|provider counseling training
4735906|NCT03012646|Treprostinil|treprostinil
4735907|NCT03012646|PH|ph
4735908|NCT03012646|COPD|copd
4735909|NCT03012646|6 Minute Walk Test|6 minute walk test
4735910|NCT03012633|hyperfibrinolysis, Lysis Timer|hyperfibrinolysis, lysis timer
4735911|NCT03012607|PrEP|prep
4735912|NCT03012594|Small bowel motility disorder|small bowel motility disorder
4735913|NCT03012594|Slow intestinal motility|slow intestinal motility
4735914|NCT03012594|Small bowel bacterial overgrowth|small bowel bacterial overgrowth
4735915|NCT03012555|Sickle Cell Disease|sickle cell disease
4735916|NCT03012555|Vitamin D|vitamin d
4735917|NCT03012529|Rifampin|rifampin
4735918|NCT03012529|Double-blind|double-blind
4735919|NCT03012529|Clinical Trial|clinical trial
4735920|NCT03012529|Veterans|veterans
4735921|NCT03012529|Diabetes|diabetes
4735922|NCT03012516|Physical Therapy Specialty|physical therapy specialty
4735923|NCT03012516|Exercise Test|exercise test
4735924|NCT03012516|Prescriptions|prescriptions
4735925|NCT03012516|Counseling|counseling
4735926|NCT03012516|Primary Health Care|primary health care
4735927|NCT03012516|Exercise|exercise
4735928|NCT03012490|Remote monitoring|remote monitoring
4735929|NCT03012477|Triple-negative metastatic breast cancer|triple-negative metastatic breast cancer
4735930|NCT03012451|Stress|stress
4735931|NCT03012451|Insecurity|insecurity
4735932|NCT03012451|Mental Health|mental health
4735933|NCT03012438|Near infrared fluorescence|near infrared fluorescence
4735934|NCT03012438|ICG|icg
4735935|NCT03012438|Parathyroid gland|parathyroid gland
4735936|NCT03012425|Cognitive Behavioral Therapy|cognitive behavioral therapy
4735937|NCT03012425|Acupuncture|acupuncture
4735938|NCT03012425|17-001|17-001
4735939|NCT03012399|Malignant Neoplasm of Breast|malignant neoplasm of breast
4735940|NCT03012399|Breast Cancer|breast cancer
4735941|NCT03012399|Hypnosedation|hypnosedation
4735942|NCT03012399|Hypnotherapist|hypnotherapist
4735943|NCT03012399|Questionnaires|questionnaires
4735944|NCT03012399|Surveys|surveys
4735945|NCT03012386|CD36|cd36
4735946|NCT03012386|Endothelial dysfunction|endothelial dysfunction
4735947|NCT03012386|African Americans|african americans
4735948|NCT03012373|methadone|methadone
4735949|NCT03012373|heroin|heroin
4735950|NCT03012373|acupuncture|acupuncture
4735951|NCT03012360|Infectiology|infectiology
4735952|NCT03012360|Biology of infectious agents|biology of infectious agents
4735953|NCT03012360|Hygiene|hygiene
4735954|NCT03012360|Pneumology|pneumology
4735955|NCT03012360|Critical Care|critical care
4735956|NCT03012308|Myocardial Dysfunction|myocardial dysfunction
4735957|NCT03012308|left ventricular|left ventricular
4735958|NCT03012308|mitral valve doppler|mitral valve doppler
4735959|NCT03012308|mitral ring doppler|mitral ring doppler
4735960|NCT03012308|ultrasound signs|ultrasound signs
4735961|NCT03012308|lung edema|lung edema
4735962|NCT03012295|Genetic Testing|genetic testing
4735963|NCT03012295|Chinese Population|chinese population
4735964|NCT03012256|Cardio-Respiratory Disease Management|cardio-respiratory disease management
4735965|NCT03012256|Chronic Disease Management|chronic disease management
4735966|NCT03012256|Cluster-randomized Trial|cluster-randomized trial
4735967|NCT03012256|Multi-component Intervention|multi-component intervention
4735968|NCT03012256|DIVERT Scale|divert scale
4735969|NCT03012256|Frail Elderly|frail elderly
4735970|NCT03012256|Interprofessional Care|interprofessional care
4735971|NCT03012256|Pragmatic Trial|pragmatic trial
4735972|NCT03012256|Targeted Intervention|targeted intervention
4735973|NCT03012256|Home Care|home care
4735974|NCT03012204|Cerebrovascular Disease|cerebrovascular disease
4735975|NCT03012204|Repetitive Transcranial Magnetic Stimulation|repetitive transcranial magnetic stimulation
4735976|NCT03012178|Mitral Regurgitation|mitral regurgitation
4735977|NCT03012178|Mitral valve Surgery|mitral valve surgery
4735978|NCT03012178|MRI|mri
4735979|NCT03012165|ADX-102|adx-102
4735980|NCT03012165|Allergic Conjunctivitis|allergic conjunctivitis
4735981|NCT03012152|Oncoplastic surgery|oncoplastic surgery
4735982|NCT03012152|Standard conservative surgery|standard conservative surgery
4735983|NCT03012152|Patient satisfaction|patient satisfaction
4735984|NCT03012152|Margin Status|margin status
4735985|NCT03012113|Adipose tissue|adipose tissue
4735986|NCT03012113|Type 2 Diabetes|type 2 diabetes
4735987|NCT03012061|Respiratory|respiratory
4735988|NCT03012061|Efficacy|efficacy
4735989|NCT03012061|Umeclidinium bromide|umeclidinium bromide
4735990|NCT03012061|Parallel|parallel
4735991|NCT03012061|Asthma|asthma
4735992|NCT03012061|Dry powder inhaler|dry powder inhaler
4735993|NCT03012048|water treatment|water treatment
4735994|NCT03012035|psychotherapy|psychotherapy
4735995|NCT03012035|exposition|exposition
4735996|NCT03012035|spider fear|spider fear
4735997|NCT03012035|expectation|expectation
4735998|NCT03012022|Healthy Volunteers|healthy volunteers
4735999|NCT03012022|Congestive Heart Failure|congestive heart failure
4736000|NCT03012022|Cardiomyopathies|cardiomyopathies
4736001|NCT03012022|Heart Failure|heart failure
4736002|NCT03012022|Risk Factors|risk factors
4736003|NCT03012009|Bowen's Disease|bowen's disease
4736004|NCT03012009|Superficial Basal Cel Carcinoma|superficial basal cel carcinoma
4736005|NCT03012009|Non melanoma skin cancer|non melanoma skin cancer
4736006|NCT03012009|Photodynamic therapy|photodynamic therapy
4736007|NCT03012009|PDT|pdt
4736008|NCT03012009|CO2 laser|co2 laser
4736009|NCT03012009|Laser assisted drug delivery|laser assisted drug delivery
4736010|NCT03012009|Carbon dioxide laser|carbon dioxide laser
4736011|NCT03012009|Laser assisted photodynamic therapy|laser assisted photodynamic therapy
4736012|NCT03011983|Magnetoencephalography (MEG)|magnetoencephalography (meg)
4736013|NCT03011983|Magnetic resonance imaging (MRI)|magnetic resonance imaging (mri)
4736014|NCT03011892|Atopic dermatitis|atopic dermatitis
4736015|NCT03011892|eczema|eczema
4736016|NCT03011892|pruritus|pruritus
4736017|NCT03011892|Janus kinase (JAK) inhibitors|janus kinase (jak) inhibitors
4736018|NCT03011840|Patient education handout|patient education handout
4736019|NCT03011840|Patient satisfaction|patient satisfaction
4736020|NCT03011775|Pioglitazone, Insulin Resistance|pioglitazone, insulin resistance
4736021|NCT03011775|Atherosclerosis, Coronary Heart Disease|atherosclerosis, coronary heart disease
4736022|NCT03011749|Radium-223 therapy|radium-223 therapy
4736023|NCT03011710|e-cigarette|e-cigarette
4736024|NCT03011710|blood flow|blood flow
4736025|NCT03011710|oral effects|oral effects
4736026|NCT03011710|oral pH|oral ph
4736027|NCT03011684|Fertility Preservation|fertility preservation
4736028|NCT03011684|Breast Cancer|breast cancer
4736029|NCT03011671|Malignant Glioma of Brain|malignant glioma of brain
4736030|NCT03011671|Acetazolamide|acetazolamide
4736031|NCT03011671|Temozolomide|temozolomide
4736032|NCT03011619|Depression|depression
4736033|NCT03011619|Cognitive Behavioral Therapy (CBT)|cognitive behavioral therapy (cbt)
4736034|NCT03011606|prostate|prostate
4736035|NCT03011606|ablation|ablation
4736036|NCT03011606|focal|focal
4736037|NCT03011606|cancer|cancer
4736038|NCT03011580|Vitamin D|vitamin d
4736039|NCT03011567|Postpartum|postpartum
4736040|NCT03011541|Stem Cells|stem cells
4736041|NCT03011541|Bone Marrow Derived Stem Cells|bone marrow derived stem cells
4736042|NCT03011541|BMSC|bmsc
4736043|NCT03011541|Mesenchymal Stem Cells|mesenchymal stem cells
4736044|NCT03011541|MSC|msc
4736045|NCT03011541|Eye Disease|eye disease
4736046|NCT03011541|Ophthalmology|ophthalmology
4736047|NCT03011541|Ophthalmic Disease|ophthalmic disease
4736048|NCT03011541|Retina|retina
4736049|NCT03011541|Retinal Disease|retinal disease
4736050|NCT03011541|Macular Degeneration|macular degeneration
4736051|NCT03011541|Age Related Macular Degeneration|age related macular degeneration
4736052|NCT03011541|Myopic Macular Degeneration|myopic macular degeneration
4736053|NCT03011541|Geographic Atrophy|geographic atrophy
4736054|NCT03011541|Dry Macular Degeneration|dry macular degeneration
4736055|NCT03011541|Wet Macular Degeneration|wet macular degeneration
4736056|NCT03011541|Retinal Atrophy|retinal atrophy
4736057|NCT03011541|Retinal Dystrophy|retinal dystrophy
4736058|NCT03011541|Hereditary Retinal Dystrophy|hereditary retinal dystrophy
4736059|NCT03011541|Malattia Leventinese|malattia leventinese
4736060|NCT03011541|Retinitis Pigmentosa|retinitis pigmentosa
4736061|NCT03011541|Stargardt Disease|stargardt disease
4736062|NCT03011541|Cone Dystrophy|cone dystrophy
4736063|NCT03011541|Rod-Cone Dystrophy|rod-cone dystrophy
4736064|NCT03011541|Cone-Rod Dystrophy|cone-rod dystrophy
4736065|NCT03011541|Maculopathy|maculopathy
4736066|NCT03011541|Optic Nerve Disease|optic nerve disease
4736067|NCT03011541|Optic Atrophy|optic atrophy
4736068|NCT03011541|Optic Neuropathy|optic neuropathy
4736069|NCT03011541|Ischemic Optic Neuropathy|ischemic optic neuropathy
4736070|NCT03011541|Optic Nerve Damage|optic nerve damage
4736071|NCT03011541|Optic Nerve Compression|optic nerve compression
4736072|NCT03011541|Compressive Optic Neuropathy|compressive optic neuropathy
4736073|NCT03011541|Devics Syndrome|devics syndrome
4736074|NCT03011541|Ushers Syndrome|ushers syndrome
4736075|NCT03011541|Neuromyelitis Optica|neuromyelitis optica
4736076|NCT03011541|Dominant Optic Atrophy|dominant optic atrophy
4736077|NCT03011541|Kjers Optic Atrophy|kjers optic atrophy
4736078|NCT03011541|Leber Hereditary Optic Neuropathy|leber hereditary optic neuropathy
4736079|NCT03011541|Blindness|blindness
4736080|NCT03011541|Vision Loss|vision loss
4736081|NCT03011541|Retina Atrophy|retina atrophy
4736082|NCT03011437|linked color imaging|linked color imaging
4736083|NCT03011437|Helicobacter Pylori|helicobacter pylori
4736084|NCT03011424|Liver resection|liver resection
4736085|NCT03011424|post hepatectomy liver failure|post hepatectomy liver failure
4736086|NCT03011424|liver dialysis|liver dialysis
4736087|NCT03011424|encephalopathy|encephalopathy
4736088|NCT03011424|mortality|mortality
4736089|NCT03011411|methods, qualitative research|methods, qualitative research
4736090|NCT03011372|Myeloid neoplasm|myeloid neoplasm
4736091|NCT03011372|fibroblast growth factor receptor inhibitor|fibroblast growth factor receptor inhibitor
4736092|NCT03011372|FGFR1 rearrangement|fgfr1 rearrangement
4736093|NCT03011372|8p11|8p11
4736094|NCT03011372|eosinophilia|eosinophilia
4736095|NCT03011372|eosinophilic syndrome|eosinophilic syndrome
4736096|NCT03011372|Lymphoid neoplasm|lymphoid neoplasm
4736097|NCT03011359|Colon resection|colon resection
4736098|NCT03011359|Patient Controlled Analgesia|patient controlled analgesia
4736099|NCT03011359|Optimizing Basal Infusion Mode|optimizing basal infusion mode
4736100|NCT03011346|Aortic valve stenosis|aortic valve stenosis
4736101|NCT03011346|Transcatheter aortic valve implantation|transcatheter aortic valve implantation
4736102|NCT03011346|Transcatheter aortic valve replacement|transcatheter aortic valve replacement
4736103|NCT03011346|Randomized controlled trial|randomized controlled trial
4736104|NCT03011320|ovarian cancer|ovarian cancer
4736105|NCT03011320|specimen collection|specimen collection
4736106|NCT03011268|Tumor Necrosis Factor-alpha/antagonists & inhibitors|tumor necrosis factor-alpha/antagonists & inhibitors
4736107|NCT03011268|Infliximab|infliximab
4736108|NCT03011268|Adalimumab|adalimumab
4736109|NCT03011268|Golimumab|golimumab
4736110|NCT03011268|Recurrence|recurrence
4736111|NCT03011255|Esophageal cancer|esophageal cancer
4736112|NCT03011255|Peptide specific CTL|peptide specific ctl
4736113|NCT03011255|Radiation|radiation
4736114|NCT03011242|Psoriatic Arthritis|psoriatic arthritis
4736115|NCT03011242|PDUS|pdus
4736116|NCT03011203|glycogen storage disease type IIIa|glycogen storage disease type iiia
4736117|NCT03011203|exercise|exercise
4736118|NCT03011203|ketone esters|ketone esters
4736119|NCT03011203|magnetic resonance spectroscopy|magnetic resonance spectroscopy
4736120|NCT03011190|Terapia Iconica|terapia iconica
4736121|NCT03011190|BPD|bpd
4736122|NCT03011190|adolescence|adolescence
4736123|NCT03011190|suicide|suicide
4736124|NCT03011164|Running|running
4736125|NCT03011164|Gait velocity|gait velocity
4736126|NCT03011164|Kinematics|kinematics
4736127|NCT03011151|pediatric|pediatric
4736128|NCT03011151|critical illness|critical illness
4736129|NCT03011151|surgery|surgery
4736130|NCT03011151|gastrointestinal dysfunction|gastrointestinal dysfunction
4736131|NCT03011151|gastric emptying|gastric emptying
4736132|NCT03011151|epithelial barrier|epithelial barrier
4736133|NCT03011151|nutrition|nutrition
4736134|NCT03011138|knee|knee
4736136|NCT03011138|kinematic parameters|kinematic parameters
4736137|NCT03011112|Osteoarthritis, Knee|osteoarthritis, knee
4736138|NCT03011112|WOMAC|womac
4736139|NCT03011112|gait|gait
4736140|NCT03011112|kinematics|kinematics
4736141|NCT03011086|Autoantibodies, Oral Submucous Fibrosis|autoantibodies, oral submucous fibrosis
4736142|NCT03011060|neo-adjuvant chemotherapy|neo-adjuvant chemotherapy
4736143|NCT03011060|pathological complete response|pathological complete response
4736144|NCT03011060|Neoadjuvant Therapy|neoadjuvant therapy
4736145|NCT03011060|Capecitabine|capecitabine
4736146|NCT03011060|Chemotherapy, Adjuvant|chemotherapy, adjuvant
4736147|NCT03011047|endoscopic, trans-antral, subciliary|endoscopic, trans-antral, subciliary
4736148|NCT03011021|Autoimmune Diabetes|autoimmune diabetes
4736149|NCT03011021|Umbilical Cord Blood Regulatory T Lymphocyte|umbilical cord blood regulatory t lymphocyte
4736150|NCT03011021|Liraglutide|liraglutide
4736151|NCT03010995|electronic cigarette|electronic cigarette
4736152|NCT03010995|endothelial function|endothelial function
4736153|NCT03010969|Endothelial dysfunction|endothelial dysfunction
4736154|NCT03010969|Surgery|surgery
4736155|NCT03010969|Pulmonary function|pulmonary function
4736156|NCT03010969|Blood glucose level|blood glucose level
4736157|NCT03010969|Patient-related outcomes|patient-related outcomes
4736158|NCT03010956|Arterial stiffness|arterial stiffness
4736159|NCT03010956|Endothelial glycocalyx|endothelial glycocalyx
4736160|NCT03010956|Coronary flow reserve|coronary flow reserve
4736161|NCT03010943|virtual reality|virtual reality
4736162|NCT03010943|glioma surgery|glioma surgery
4736163|NCT03010943|awake craniotomy|awake craniotomy
4736164|NCT03010943|brain tumor|brain tumor
4736165|NCT03010943|glioma|glioma
4736166|NCT03010943|neurosurgery|neurosurgery
4736167|NCT03010917|Alcohol Dependence|alcohol dependence
4736168|NCT03010917|Fish Oil|fish oil
4736169|NCT03010891|Preterm infant|preterm infant
4736170|NCT03010891|Stress|stress
4736171|NCT03010891|Salivary DHEA|salivary dhea
4736172|NCT03010891|Salivary cortisol|salivary cortisol
4736173|NCT03010891|Actigraphy|actigraphy
4736174|NCT03010878|yoga|yoga
4736175|NCT03010878|chronic pain|chronic pain
4736176|NCT03010878|occupational therapy|occupational therapy
4736177|NCT03010878|self-management|self-management
4736178|NCT03010865|HDAC inhibitors|hdac inhibitors
4736179|NCT03010865|Inflammation|inflammation
4736180|NCT03010852|Bariatric Surgery|bariatric surgery
4736181|NCT03010852|Spirometry Monitoring|spirometry monitoring
4736182|NCT03010761|addiction|addiction
4736183|NCT03010761|betel-quid|betel-quid
4736184|NCT03010761|drug therapy|drug therapy
4736185|NCT03010761|clinical trial|clinical trial
4736186|NCT03010748|corneal morphology|corneal morphology
4736187|NCT03010748|Chinese population|chinese population
4736188|NCT03010748|corneal curvature|corneal curvature
4736189|NCT03010748|corneal thickness|corneal thickness
4736190|NCT03010748|higher order aberrations|higher order aberrations
4736191|NCT03010735|Kidney Failure, Chronic|kidney failure, chronic
4736192|NCT03010735|Probiotics|probiotics
4736193|NCT03010735|Uremic toxins|uremic toxins
4736194|NCT03010735|Gastrointestinal Microbiome|gastrointestinal microbiome
4736195|NCT03010709|Aneurysmal Subarachnoid Haemorrhage|aneurysmal subarachnoid haemorrhage
4736196|NCT03010709|Delayed Ischaemic Neurological Deficit|delayed ischaemic neurological deficit
4736197|NCT03010709|Induced Hypertension|induced hypertension
4736198|NCT03010709|Partial Brain Tissue Oxygen Tension|partial brain tissue oxygen tension
4736199|NCT03010709|Cerebral Microdialysis|cerebral microdialysis
4736200|NCT03010696|Kidney Failure, Chronic|kidney failure, chronic
4736201|NCT03010696|Uremic toxins|uremic toxins
4736202|NCT03010696|Gastrointestinal Microbiome|gastrointestinal microbiome
4736203|NCT03010696|Metabolomics|metabolomics
4736204|NCT03010683|Arterial stiffness|arterial stiffness
4736205|NCT03010683|Endothelial glycocalyx|endothelial glycocalyx
4736206|NCT03010683|Coronary flow reserve|coronary flow reserve
4736207|NCT03010670|Oxytocin|oxytocin
4736208|NCT03010670|Gaze processing|gaze processing
4736209|NCT03010670|Interpersonal motor resonance|interpersonal motor resonance
4736210|NCT03010618|hall technique|hall technique
4736211|NCT03010618|stainless steel crowns|stainless steel crowns
4736212|NCT03010618|temporomandibular joint|temporomandibular joint
4736213|NCT03010618|dental caries|dental caries
4736214|NCT03010618|occlusion|occlusion
4736215|NCT03010605|physical therapy post total knee replacement|physical therapy post total knee replacement
4736216|NCT03010605|range of motion|range of motion
4736217|NCT03010605|goniometry|goniometry
4736218|NCT03010592|Lung volume reduction treatment|lung volume reduction treatment
4736219|NCT03010592|Endobronchial cryotherapy|endobronchial cryotherapy
4736220|NCT03010592|Microvesicles|microvesicles
4736221|NCT03010579|Anemia|anemia
4736222|NCT03010579|Lymphoma|lymphoma
4736223|NCT03010579|Hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
4736224|NCT03010579|Erythropoietin|erythropoietin
4736225|NCT03010566|Lung volume reduction coil|lung volume reduction coil
4736226|NCT03010566|Lung Microbiome|lung microbiome
4736227|NCT03010527|Chronic plaque psoriasis|chronic plaque psoriasis
4736228|NCT03010527|Psoriasis|psoriasis
4736229|NCT03010527|Bimekizumab|bimekizumab
4736230|NCT03010488|Chronotherapy|chronotherapy
4736231|NCT03010488|Light Therapy|light therapy
4736232|NCT03010462|Stroke|stroke
4736233|NCT03010462|rTMS|rtms
4736234|NCT03010462|Motor rehabilitation|motor rehabilitation
4736331|NCT03009825|Psychological distress|psychological distress
4736235|NCT03010449|Lung volume reduction treatment|lung volume reduction treatment
4736236|NCT03010449|Autologous blood instillation|autologous blood instillation
4736237|NCT03010449|Intra-bronchial valve (IBV)|intra-bronchial valve (ibv)
4736238|NCT03010449|Endobronchial valve|endobronchial valve
4736239|NCT03010423|Non-obstructive coronary artery disease|non-obstructive coronary artery disease
4736240|NCT03010423|Nicorandil|nicorandil
4736241|NCT03010371|positive psychotherapy, online, breast cancer, survivors|positive psychotherapy, online, breast cancer, survivors
4736242|NCT03010332|Cytomegalovirus|cytomegalovirus
4736243|NCT03010332|Cytomegalovirus Viremia|cytomegalovirus viremia
4736244|NCT03010332|Cytomegalovirus Infection|cytomegalovirus infection
4736245|NCT03010332|CMV Infection|cmv infection
4736246|NCT03010332|Hematopoietic Cell Transplant|hematopoietic cell transplant
4736247|NCT03010332|Solid Organ Transplant|solid organ transplant
4736248|NCT03010332|Human Immunodeficiency Virus|human immunodeficiency virus
4736249|NCT03010332|Cytomegalovirus Disease|cytomegalovirus disease
4736250|NCT03010332|Hematopoietic Stem Cell Transplant|hematopoietic stem cell transplant
4736251|NCT03010332|CMV|cmv
4736252|NCT03010332|CMV syndrome|cmv syndrome
4736253|NCT03010332|Cytomegalovirus syndrome|cytomegalovirus syndrome
4736254|NCT03010332|CMV disease|cmv disease
4736255|NCT03010332|CMV viremia|cmv viremia
4736256|NCT03010332|allogeneic|allogeneic
4736257|NCT03010332|third-party|third-party
4736258|NCT03010293|Antimicrobial therapy|antimicrobial therapy
4736259|NCT03010293|Debridement|debridement
4736260|NCT03010293|Osteomyelitis|osteomyelitis
4736261|NCT03010293|Muscular flap|muscular flap
4736262|NCT03010293|Pressure ulcer|pressure ulcer
4736263|NCT03010293|Treatment failure|treatment failure
4736264|NCT03010293|Vacuum-assisted closure therapy|vacuum-assisted closure therapy
4736265|NCT03010267|DP-R213|dp-r213
4736266|NCT03010241|Diabetes Distal Symmetric Polyneuropathy|diabetes distal symmetric polyneuropathy
4736267|NCT03010241|Chinese medicine|chinese medicine
4736268|NCT03010228|VLA15|vla15
4736269|NCT03010228|Lyme Borreliosis|lyme borreliosis
4736270|NCT03010228|Multivalent Recombinant OspA Vaccine|multivalent recombinant ospa vaccine
4736271|NCT03010215|Minimally Invasive Surgery|minimally invasive surgery
4736272|NCT03010215|Percutaneous distal osteotomy|percutaneous distal osteotomy
4736273|NCT03010215|Distal Metatarsal Minimally-invasive Osteotomy (DMMO)|distal metatarsal minimally-invasive osteotomy (dmmo)
4736274|NCT03010215|Percutaneous Tenotomy|percutaneous tenotomy
4736275|NCT03010215|Forefoot|forefoot
4736276|NCT03010215|Metatarsal bones|metatarsal bones
4736277|NCT03010202|immune thrombocytopenia|immune thrombocytopenia
4736278|NCT03010202|rituximab|rituximab
4736279|NCT03010202|thrombocytopenia|thrombocytopenia
4736280|NCT03010189|Cluster headache|cluster headache
4736281|NCT03010189|Actigraphy|actigraphy
4736282|NCT03010189|Pupillometry|pupillometry
4736283|NCT03010163|pedometer|pedometer
4736284|NCT03010163|walking|walking
4736285|NCT03010163|taxi driver|taxi driver
4736286|NCT03010163|16-1659|16-1659
4736287|NCT03010150|Malignant neoplasms of lip oral cavity and pharynx|malignant neoplasms of lip oral cavity and pharynx
4736288|NCT03010150|Head and Neck Cancer|head and neck cancer
4736289|NCT03010150|Nasopharyngeal cancer|nasopharyngeal cancer
4736290|NCT03010150|Oropharyngeal cancer|oropharyngeal cancer
4736291|NCT03010150|Hypopharyngeal cancer|hypopharyngeal cancer
4736292|NCT03010150|Laryngeal cancer|laryngeal cancer
4736293|NCT03010150|Unknown primary cancer with cervical metastases|unknown primary cancer with cervical metastases
4736294|NCT03010150|Questionnaire|questionnaire
4736295|NCT03010150|Survey|survey
4736296|NCT03010150|Blood draw|blood draw
4736297|NCT03010150|Cytokines|cytokines
4736298|NCT03010111|Latent Tuberculosis|latent tuberculosis
4736299|NCT03010111|Interferons|interferons
4736300|NCT03010111|Tuberculosis|tuberculosis
4736301|NCT03010111|Healthcare|healthcare
4736302|NCT03010098|POCD|pocd
4736303|NCT03010098|narcotrend|narcotrend
4736304|NCT03010098|closed-loop of target controlled infusion|closed-loop of target controlled infusion
4736305|NCT03010033|pulmonary rehabilitation|pulmonary rehabilitation
4736306|NCT03010033|lobectomy|lobectomy
4736307|NCT03010033|smoker|smoker
4736308|NCT03010020|HIV Prevention|hiv prevention
4736309|NCT03010020|MSM|msm
4736310|NCT03010020|Rectal Gonorrhea|rectal gonorrhea
4736311|NCT03010020|Rectal Chlamydia|rectal chlamydia
4736312|NCT03010020|Personalized Cognitive Counseling|personalized cognitive counseling
4736313|NCT03010007|Influenza|influenza
4736314|NCT03010007|High-Throughput Nucleotide Sequencing|high-throughput nucleotide sequencing
4736315|NCT03010007|Viral Transmission|viral transmission
4736316|NCT03009981|PSA|psa
4736317|NCT03009981|Degarelix|degarelix
4736318|NCT03009981|Apalutamide|apalutamide
4736319|NCT03009981|Abiraterone Acetate|abiraterone acetate
4736320|NCT03009981|Radical Prostatectomy|radical prostatectomy
4736321|NCT03009942|nitric oxide|nitric oxide
4736322|NCT03009942|arginase|arginase
4736323|NCT03009942|loading|loading
4736324|NCT03009890|elderly|elderly
4736325|NCT03009890|intra articular|intra articular
4736326|NCT03009890|RCT|rct
4736327|NCT03009864|Diabetic Kidney Disease|diabetic kidney disease
4736328|NCT03009864|TCM|tcm
4736329|NCT03009864|RCT|rct
4736330|NCT03009825|Trauma exposure|trauma exposure
4736526|NCT03008694|PET/CT|pet/ct
4736332|NCT03009825|Emotion regulation|emotion regulation
4736333|NCT03009825|Mindfulness|mindfulness
4736334|NCT03009825|Eating pathology|eating pathology
4736335|NCT03009799|adenoviral conjunctivis|adenoviral conjunctivis
4736336|NCT03009799|iota-carrageenan|iota-carrageenan
4736337|NCT03009773|subacute stroke|subacute stroke
4736338|NCT03009773|multitasking rehabilitation|multitasking rehabilitation
4736339|NCT03009773|walking|walking
4736340|NCT03009747|rectal cancer|rectal cancer
4736341|NCT03009747|anterior resection syndrome|anterior resection syndrome
4736342|NCT03009747|sphincter-preserving surgery|sphincter-preserving surgery
4736343|NCT03009708|Allograft|allograft
4736344|NCT03009708|Cytomegalovirus|cytomegalovirus
4736345|NCT03009708|Platelets|platelets
4736346|NCT03009708|Hematopoietic stem cells|hematopoietic stem cells
4736347|NCT03009708|Graft Versus Host Disease (GVH)|graft versus host disease (gvh)
4736348|NCT03009708|Hemostasis|hemostasis
4736349|NCT03009708|Adaptive immunity|adaptive immunity
4736350|NCT03009708|Innate immunity|innate immunity
4736351|NCT03009708|Post graft follow up|post graft follow up
4736352|NCT03009695|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
4736353|NCT03009695|Obesity|obesity
4736354|NCT03009695|Food Craving|food craving
4736355|NCT03009695|Appetite/Satiety Hormones|appetite/satiety hormones
4736356|NCT03009695|fMRI|fmri
4736357|NCT03009695|Intestinal microbiota|intestinal microbiota
4736358|NCT03009695|Physical activity|physical activity
4736359|NCT03009669|pleth variability index|pleth variability index
4736360|NCT03009669|stroke volume variation|stroke volume variation
4736361|NCT03009669|perfusion Index|perfusion index
4736362|NCT03009669|intraoperative|intraoperative
4736363|NCT03009669|intestinal tumor|intestinal tumor
4736364|NCT03009656|Stroke|stroke
4736365|NCT03009656|Emergency|emergency
4736366|NCT03009656|Focal Neurological Deficits|focal neurological deficits
4736367|NCT03009656|Diagnostic|diagnostic
4736368|NCT03009643|Nitric Oxide|nitric oxide
4736369|NCT03009643|hypoxemia|hypoxemia
4736370|NCT03009643|aortic surgery|aortic surgery
4736371|NCT03009630|Electromagnetic navigation bronchoscopy(ENB)|electromagnetic navigation bronchoscopy(enb)
4736372|NCT03009630|Radiofrequency ablation(RFA)|radiofrequency ablation(rfa)
4736373|NCT03009630|Peripheral lung cancer|peripheral lung cancer
4736374|NCT03009617|adolescents|adolescents
4736375|NCT03009617|web-based health education|web-based health education
4736376|NCT03009617|eHealth literacy|ehealth literacy
4736377|NCT03009591|Hemophilia|hemophilia
4736378|NCT03009591|Elbow|elbow
4736379|NCT03009591|Arthropathy|arthropathy
4736380|NCT03009591|Joint pain|joint pain
4736381|NCT03009591|Range of motion|range of motion
4736382|NCT03009591|Myofascial techniques|myofascial techniques
4736383|NCT03009591|Safety patients|safety patients
4736384|NCT03009591|Quality of life|quality of life
4736385|NCT03009591|Functionality|functionality
4736386|NCT03009565|coronary artery disease|coronary artery disease
4736387|NCT03009565|human gut microbiota|human gut microbiota
4736388|NCT03009565|microbiome|microbiome
4736389|NCT03009552|speckle tracking echocardiography|speckle tracking echocardiography
4736390|NCT03009552|strain|strain
4736391|NCT03009552|strain rate|strain rate
4736392|NCT03009552|torsion|torsion
4736393|NCT03009539|Prevention with Hispanic youth|prevention with hispanic youth
4736394|NCT03009539|eHealth preventive intervention in primary care|ehealth preventive intervention in primary care
4736395|NCT03009539|Hispanic adolescent|hispanic adolescent
4736396|NCT03009539|Familias Unidas|familias unidas
4736397|NCT03009539|eHealth Familias Unidas|ehealth familias unidas
4736398|NCT03009539|effectiveness trial|effectiveness trial
4736399|NCT03009539|sexually transmitted disease|sexually transmitted disease
4736400|NCT03009539|parent-centered|parent-centered
4736401|NCT03009539|Hispanic|hispanic
4736402|NCT03009539|sexual risk behavior|sexual risk behavior
4736403|NCT03009526|Malaria|malaria
4736404|NCT03009526|Pregnancy|pregnancy
4736405|NCT03009526|Malawi|malawi
4736406|NCT03009526|Intermittent preventive treatment|intermittent preventive treatment
4736407|NCT03009526|dihydroartemisinin-piperaquine|dihydroartemisinin-piperaquine
4736408|NCT03009526|sulfadoxine-pyrimethamine|sulfadoxine-pyrimethamine
4736409|NCT03009461|Hepatocellular carcinoma|hepatocellular carcinoma
4736410|NCT03009461|Portal vein tumor thrombosis|portal vein tumor thrombosis
4736411|NCT03009461|Hepatic arterial infusion chemotherapy|hepatic arterial infusion chemotherapy
4736412|NCT03009461|Sorafenib|sorafenib
4736413|NCT03009396|Crohn's Disease,|crohn's disease,
4736414|NCT03009396|moderate to severe|moderate to severe
4736415|NCT03009396|remission|remission
4736416|NCT03009396|Mycobacterium avium paratuberculosis|mycobacterium avium paratuberculosis
4736417|NCT03009396|antibiotic|antibiotic
4736418|NCT03009370|Ovarian reserve, pregnancy loss|ovarian reserve, pregnancy loss
4736419|NCT03009357|wearable activity tracker|wearable activity tracker
4736420|NCT03009357|thyrotoxicosis|thyrotoxicosis
4736421|NCT03009344|relapsed or refractory B-cell non-Hodgkin's lymphoma|relapsed or refractory b-cell non-hodgkin's lymphoma
4736422|NCT03009344|tazemetostat|tazemetostat
4736423|NCT03009344|Japan|japan
4736424|NCT03009331|Postoperative pulmonary dysfunction|postoperative pulmonary dysfunction
4736425|NCT03009331|Postoperative pulmonary complication|postoperative pulmonary complication
4737216|NCT03003949|estrogen|estrogen
4736426|NCT03009331|Recruitment manouver|recruitment manouver
4736427|NCT03009331|Prone position|prone position
4736428|NCT03009318|Glioma|glioma
4736429|NCT03009318|Magnetic resonance spectroscopy|magnetic resonance spectroscopy
4736430|NCT03009318|Methionine|methionine
4736431|NCT03009318|PET/CT|pet/ct
4736432|NCT03009292|solid tumor|solid tumor
4736433|NCT03009292|Lenvatinib|lenvatinib
4736434|NCT03009292|pharmacokinetics|pharmacokinetics
4736435|NCT03009279|blood pressure|blood pressure
4736436|NCT03009279|fasting plasma glucose|fasting plasma glucose
4736437|NCT03009279|thyroid stimulating hormone|thyroid stimulating hormone
4736438|NCT03009253|Neoadjuvant therapy|neoadjuvant therapy
4736439|NCT03009253|Pancreatic Cancer|pancreatic cancer
4736440|NCT03009227|colon cancer|colon cancer
4736441|NCT03009227|lymph node dissection|lymph node dissection
4736442|NCT03009227|D3 lymph node dissection|d3 lymph node dissection
4736443|NCT03009214|solid epithelial cancer|solid epithelial cancer
4736444|NCT03009214|CD44v6|cd44v6
4736445|NCT03009214|c-Met|c-met
4736446|NCT03009214|VEGFR-2|vegfr-2
4736447|NCT03009214|RON|ron
4736448|NCT03009214|receptor tyrosine kinase|receptor tyrosine kinase
4736449|NCT03009188|Axenfeld-Rieger syndrom, genetic findings|axenfeld-rieger syndrom, genetic findings
4736450|NCT03009136|Perennial Allergic Rhinitis|perennial allergic rhinitis
4736451|NCT03009136|Herbal Medicine|herbal medicine
4736452|NCT03009136|Korean Medicine|korean medicine
4736453|NCT03009136|So-Cheong-Ryong-Tang|so-cheong-ryong-tang
4736454|NCT03009123|cohort study|cohort study
4736455|NCT03009123|prostate cancer|prostate cancer
4736456|NCT03009123|population-based study|population-based study
4736457|NCT03009123|benign prostatic hypertrophy|benign prostatic hypertrophy
4736458|NCT03009097|Chronic periodontitis|chronic periodontitis
4736459|NCT03009097|atorvastatin|atorvastatin
4736460|NCT03009097|intrabony defect|intrabony defect
4736461|NCT03009071|Neck Pain|neck pain
4736462|NCT03009071|Disability Evaluation|disability evaluation
4736463|NCT03009071|Costs and Cost Analysis|costs and cost analysis
4736464|NCT03009071|Doin Exercise Therapy|doin exercise therapy
4736465|NCT03009071|Acupuncture|acupuncture
4736466|NCT03009058|Unresectable cancer|unresectable cancer
4736467|NCT03009058|pancreatic|pancreatic
4736468|NCT03009058|melanoma|melanoma
4736469|NCT03009058|breast|breast
4736470|NCT03009058|lung|lung
4736471|NCT03009058|colorectal|colorectal
4736472|NCT03009058|cholangio|cholangio
4736473|NCT03009058|sarcoma|sarcoma
4736474|NCT03009045|bone and joint infection|bone and joint infection
4736475|NCT03009045|osteomyelitis|osteomyelitis
4736476|NCT03009045|tedizolid|tedizolid
4736477|NCT03009032|HIV|hiv
4736478|NCT03009032|immunologic recovery|immunologic recovery
4736479|NCT03009032|microbiota|microbiota
4736480|NCT03009032|prebiotics|prebiotics
4736481|NCT03009032|probiotics|probiotics
4736482|NCT03009032|synbiotics|synbiotics
4736483|NCT03009006|Calcium hydroxide intracanal medication|calcium hydroxide intracanal medication
4736484|NCT03009006|Ca(OH)2 intracanal medication|ca(oh)2 intracanal medication
4736485|NCT03009006|Chlorhexidene gel|chlorhexidene gel
4736486|NCT03009006|CHX gel|chx gel
4736487|NCT03009006|Root canal treatment|root canal treatment
4736488|NCT03008967|Total Knee Arthroplasty|total knee arthroplasty
4736489|NCT03008967|Total Hip Arthroplasty|total hip arthroplasty
4736490|NCT03008967|Rehabilitation|rehabilitation
4736491|NCT03008954|weight loss|weight loss
4736492|NCT03008954|body composition|body composition
4736493|NCT03008954|glycemic control|glycemic control
4736494|NCT03008954|satiety|satiety
4736495|NCT03008941|HIV|hiv
4736496|NCT03008941|microbiota|microbiota
4736497|NCT03008941|inflammation|inflammation
4736498|NCT03008941|fecal microbiota restoration|fecal microbiota restoration
4736499|NCT03008915|alpha-1 antitrypsin deficiency|alpha-1 antitrypsin deficiency
4736500|NCT03008915|Emphysema|emphysema
4736501|NCT03008915|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
4736502|NCT03008889|Repetitive Self-Injurious Behavior|repetitive self-injurious behavior
4736503|NCT03008889|N-acetylcysteine (NAC)|n-acetylcysteine (nac)
4736504|NCT03008876|neonate|neonate
4736505|NCT03008876|acetaminophen|acetaminophen
4736506|NCT03008850|Shivering|shivering
4736507|NCT03008850|Intrathecal|intrathecal
4736508|NCT03008850|Magnesium Sulfate|magnesium sulfate
4736509|NCT03008811|Atrial Fibrillation|atrial fibrillation
4736510|NCT03008811|Catheter Ablation|catheter ablation
4736511|NCT03008798|Intracranial Artery|intracranial artery
4736512|NCT03008798|in-stent restenosis|in-stent restenosis
4736513|NCT03008798|Herbal Medicine|herbal medicine
4736514|NCT03008785|isoflavone|isoflavone
4736515|NCT03008785|blood pressure|blood pressure
4736516|NCT03008785|climateric symptoms|climateric symptoms
4736517|NCT03008785|exercise|exercise
4736518|NCT03008759|Fluoride|fluoride
4736519|NCT03008759|Dental caries|dental caries
4736520|NCT03008759|Dentifrice|dentifrice
4736521|NCT03008720|functional electrical simulation|functional electrical simulation
4736522|NCT03008707|Laparoscopic peritoneal lavage|laparoscopic peritoneal lavage
4736523|NCT03008707|laparoscopic sigmoidectomy|laparoscopic sigmoidectomy
4736524|NCT03008707|complicated acute diverticulitis|complicated acute diverticulitis
4736525|NCT03008707|D004238|d004238
4736527|NCT03008642|Polycythemia|polycythemia
4736528|NCT03008642|CO-Rebreathing|co-rebreathing
4736529|NCT03008642|red cell mass determination|red cell mass determination
4736530|NCT03008642|myeloproliferative neoplasms|myeloproliferative neoplasms
4736531|NCT03008603|CT-guided minimally invasive procedures|ct-guided minimally invasive procedures
4736532|NCT03008603|Robot|robot
4736533|NCT03008590|Pain management|pain management
4736534|NCT03008590|Naltrexone|naltrexone
4736535|NCT03008590|Controlled clinical trials, randomized|controlled clinical trials, randomized
4736536|NCT03008512|Liver Neoplasms|liver neoplasms
4736537|NCT03008512|Antineoplastic Agents|antineoplastic agents
4736538|NCT03008512|Carcinoma, Hepatocellular|carcinoma, hepatocellular
4736539|NCT03008512|Genexol-PM|genexol-pm
4736540|NCT03008512|Neoplasms by Site|neoplasms by site
4736541|NCT03008512|Sorafenib|sorafenib
4736542|NCT03008512|Liver Diseases|liver diseases
4736543|NCT03008512|Digestive System Neoplasms|digestive system neoplasms
4736544|NCT03008499|Metastatic colorectal cancer|metastatic colorectal cancer
4736545|NCT03008499|High-activity natural killer|high-activity natural killer
4736546|NCT03008447|E2006|e2006
4736547|NCT03008447|postural stability|postural stability
4736548|NCT03008447|auditory awakening threshold|auditory awakening threshold
4736549|NCT03008447|cognitive performance|cognitive performance
4736550|NCT03008447|healthy participants|healthy participants
4736551|NCT03008434|yoga|yoga
4736552|NCT03008434|Traumatic Brain Injury|traumatic brain injury
4736553|NCT03008408|Malignant neoplasms of female genital organs|malignant neoplasms of female genital organs
4736554|NCT03008408|Endometrial carcinoma|endometrial carcinoma
4736555|NCT03008408|Advanced or Recurrent|advanced or recurrent
4736556|NCT03008408|Endometrioid and mixed endometrioid tumors|endometrioid and mixed endometrioid tumors
4736557|NCT03008408|Ribociclib|ribociclib
4736558|NCT03008408|LEE011|lee011
4736559|NCT03008408|Everolimus|everolimus
4736560|NCT03008408|Afinitor|afinitor
4736561|NCT03008408|Zortress|zortress
4736562|NCT03008408|RAD001|rad001
4736563|NCT03008408|Letrozole|letrozole
4736564|NCT03008408|Femara|femara
4736565|NCT03008382|Interstitial Cystitis|interstitial cystitis
4736566|NCT03008382|Pelvic Pain|pelvic pain
4736567|NCT03008343|Irreversible Electroporation|irreversible electroporation
4736568|NCT03008343|NK Immunotherapy|nk immunotherapy
4736569|NCT03008343|Recurrent Liver Carcinoma|recurrent liver carcinoma
4736570|NCT03008330|Metastatic tongue cancer|metastatic tongue cancer
4736571|NCT03008330|High-activity natural killer|high-activity natural killer
4736572|NCT03008304|Metastatic pancreatic cancer|metastatic pancreatic cancer
4736573|NCT03008304|High-activity natural killer Immunotherapy|high-activity natural killer immunotherapy
4736574|NCT03008265|Fascial dehiscence|fascial dehiscence
4736575|NCT03008265|Mortality|mortality
4736576|NCT03008252|Non-celiac wheat sensitivity|non-celiac wheat sensitivity
4736577|NCT03008252|lactose intolerance|lactose intolerance
4736578|NCT03008252|cow's milk protein allergy|cow's milk protein allergy
4736579|NCT03008187|AML|aml
4736580|NCT03008174|tracheostomy|tracheostomy
4736581|NCT03008174|quality of life|quality of life
4736582|NCT03008174|speaking valve|speaking valve
4736583|NCT03008174|speech|speech
4736584|NCT03008174|mechanically ventilated patients|mechanically ventilated patients
4736585|NCT03008161|GAIM|gaim
4736586|NCT03008161|amyloid|amyloid
4736587|NCT03008161|anti-aBeta|anti-abeta
4736588|NCT03008161|anti-tau|anti-tau
4736589|NCT03008122|Flavivirus|flavivirus
4736590|NCT03008122|Inactivated|inactivated
4736591|NCT03008122|Phase I|phase i
4736592|NCT03008122|Vaccine|vaccine
4736593|NCT03008122|ZIKA|zika
4736594|NCT03008122|ZPIV|zpiv
4736595|NCT03008109|EGFR-TKI|egfr-tki
4736596|NCT03008109|Recombinant human endostatin|recombinant human endostatin
4736597|NCT03008070|Non-Alcoholic Steatohepatitis|non-alcoholic steatohepatitis
4736598|NCT03008070|NASH|nash
4736599|NCT03008070|peroxisome proliferator-activated receptor (PPAR)|peroxisome proliferator-activated receptor (ppar)
4736600|NCT03008070|Liver Diseases|liver diseases
4736601|NCT03008070|Fibrosis|fibrosis
4736602|NCT03008070|Fatty Liver|fatty liver
4736603|NCT03008070|Non-alcoholic Fatty Liver Disease|non-alcoholic fatty liver disease
4736604|NCT03008070|Digestive System Diseases|digestive system diseases
4736605|NCT03008070|IVA337|iva337
4736606|NCT03008057|vitamin D|vitamin d
4736607|NCT03008057|YKL40|ykl40
4736608|NCT03008057|PAI-1|pai-1
4736609|NCT03008057|RAGE|rage
4736610|NCT03008057|AGEs|ages
4736611|NCT03008057|glyoxalase enzyme|glyoxalase enzyme
4736612|NCT03008057|TNF-alpha|tnf-alpha
4736613|NCT03008057|IL-6|il-6
4736614|NCT03008057|Diabetes|diabetes
4736615|NCT03007992|Breast cancer|breast cancer
4736616|NCT03007992|Vinorelbine|vinorelbine
4736617|NCT03007992|Metronomic chemotherapy|metronomic chemotherapy
4736618|NCT03007953|Palliative Care|palliative care
4736619|NCT03007953|Supportive Care|supportive care
4736620|NCT03007940|Implementation Strategies|implementation strategies
4736621|NCT03007940|Sustainability|sustainability
4736622|NCT03007940|Integrated Services|integrated services
4736623|NCT03007927|pain|pain
4736624|NCT03007927|hernia repair|hernia repair
4736625|NCT03007927|Dexamethasone|dexamethasone
4736626|NCT03007914|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
4736627|NCT03007914|Medicine, Chinese Traditional|medicine, chinese traditional
4736628|NCT03007914|Humans|humans
4736629|NCT03007914|Treatment Outcome|treatment outcome
4736630|NCT03007888|IPX203 (carbidopa-levodopa) Extended-Release capsules|ipx203 (carbidopa-levodopa) extended-release capsules
4736631|NCT03007875|Metastatic lung cancer|metastatic lung cancer
4736632|NCT03007875|High-activity natural killer|high-activity natural killer
4736633|NCT03007836|Metastatic Nasopharyngeal Cancer|metastatic nasopharyngeal cancer
4736634|NCT03007836|High-activity natural killer|high-activity natural killer
4736635|NCT03007823|Metastatic Melanoma|metastatic melanoma
4736636|NCT03007823|High-activity natural killer|high-activity natural killer
4736637|NCT03007784|Consciousness|consciousness
4736638|NCT03007784|Disorder of consciousness|disorder of consciousness
4736639|NCT03007784|Minimally conscious state|minimally conscious state
4736640|NCT03007784|Vegetative state|vegetative state
4736641|NCT03007784|Exit-MCS|exit-mcs
4736642|NCT03007784|Transcranial direct current stimulation (tDCS)|transcranial direct current stimulation (tdcs)
4736643|NCT03007784|CRS-R|crs-r
4736644|NCT03007784|EEG|eeg
4736645|NCT03007784|Cognitive ERPs|cognitive erps
4736646|NCT03007758|Hernia repair|hernia repair
4736647|NCT03007758|Robotic hernia repair|robotic hernia repair
4736648|NCT03007758|Open hernia repair|open hernia repair
4736649|NCT03007758|Incisional hernia|incisional hernia
4736650|NCT03007745|Continuous positive airway pressure|continuous positive airway pressure
4736651|NCT03007628|magnetic seizure therapy|magnetic seizure therapy
4736652|NCT03007628|electroconvulsive therapy|electroconvulsive therapy
4736653|NCT03007628|controlled trial|controlled trial
4736654|NCT03007602|Hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
4736655|NCT03007602|Aerobic exercise|aerobic exercise
4736656|NCT03007602|Quality of Life|quality of life
4736657|NCT03007602|Muscle Strength|muscle strength
4736658|NCT03007602|Depression|depression
4736659|NCT03007602|exercise capacity|exercise capacity
4736660|NCT03007602|dyspnea|dyspnea
4736661|NCT03007602|anxiety|anxiety
4736662|NCT03007602|fatigue|fatigue
4736663|NCT03007602|pulmonary functions|pulmonary functions
4736664|NCT03007589|erythema|erythema
4736665|NCT03007589|persistent pigment darkening|persistent pigment darkening
4736666|NCT03007589|sunburn|sunburn
4736667|NCT03007589|suntan|suntan
4736668|NCT03007563|Diagnosis|diagnosis
4736669|NCT03007563|Cell Phones|cell phones
4736670|NCT03007563|Infant, Newborn|infant, newborn
4736671|NCT03007550|Gastric cancer|gastric cancer
4736672|NCT03007550|Laparoscopic total gastrectomy|laparoscopic total gastrectomy
4736673|NCT03007550|Open total gastrectomy|open total gastrectomy
4736674|NCT03007537|Erythropoietin|erythropoietin
4736675|NCT03007537|Cardiac Surgery Associated-acute Kidney Injury|cardiac surgery associated-acute kidney injury
4736676|NCT03007524|rosuvastatin|rosuvastatin
4736677|NCT03007524|optical coherence tomography|optical coherence tomography
4736678|NCT03007524|acute coronary syndrome|acute coronary syndrome
4736679|NCT03007511|Percutaneous Endoscopic Gastrostomy|percutaneous endoscopic gastrostomy
4736680|NCT03007511|Feeding tube|feeding tube
4736681|NCT03007511|Enteral nutrition|enteral nutrition
4736682|NCT03007511|Endoscopy|endoscopy
4736683|NCT03007511|Gastrointestinal|gastrointestinal
4736684|NCT03007472|cochlear implant, sound processor|cochlear implant, sound processor
4736685|NCT03007459|Body composition|body composition
4736686|NCT03007459|Bone mineral density|bone mineral density
4736687|NCT03007459|Binge Eating|binge eating
4736688|NCT03007459|Eating Disorder|eating disorder
4736689|NCT03007459|Exercise Dependency|exercise dependency
4736690|NCT03007459|Depression|depression
4736691|NCT03007459|Perfectionism|perfectionism
4736692|NCT03007459|Body building|body building
4736693|NCT03007459|Drive for Muscularity|drive for muscularity
4736694|NCT03007459|Drive for leanness|drive for leanness
4736695|NCT03007446|Apatinib|apatinib
4736696|NCT03007446|SOX|sox
4736697|NCT03007446|Conversion Surgery|conversion surgery
4736698|NCT03007446|unresectable gastric cancer|unresectable gastric cancer
4736699|NCT03007433|gastric emptying|gastric emptying
4736700|NCT03007433|functional dyspepsia|functional dyspepsia
4736701|NCT03007433|non invasive imaging|non invasive imaging
4736702|NCT03007433|MRI|mri
4736703|NCT03007433|gamma scintigraphy|gamma scintigraphy
4736704|NCT03007433|gastroparesis|gastroparesis
4736705|NCT03007407|microsatellite stable|microsatellite stable
4736706|NCT03007407|MSS|mss
4736707|NCT03007407|durvalumab|durvalumab
4736708|NCT03007407|tremelimumab|tremelimumab
4736709|NCT03007407|mCRC|mcrc
4736710|NCT03007407|NSABP|nsabp
4736711|NCT03007394|Cocaine Use Disorder|cocaine use disorder
4736712|NCT03007342|Amoxicillin|amoxicillin
4736713|NCT03007342|clavulanic acid|clavulanic acid
4736714|NCT03007342|Periapical periodontitis|periapical periodontitis
4736715|NCT03007342|Post-operative pain|post-operative pain
4736716|NCT03007329|SGLT2 inhibitor|sglt2 inhibitor
4736717|NCT03007329|GLP1 agonist|glp1 agonist
4736718|NCT03007329|type 2 Diabetes|type 2 diabetes
4736719|NCT03007329|steatosis of the liver|steatosis of the liver
4736720|NCT03007329|ectopic lipids|ectopic lipids
4736721|NCT03007329|combined therapy|combined therapy
4736722|NCT03007264|cold atmospheric plasma|cold atmospheric plasma
4736723|NCT03007264|pain|pain
4736724|NCT03007264|bacteria|bacteria
4736725|NCT03007264|skin parameters|skin parameters
4736726|NCT03007186|Blood glucose monitoring|blood glucose monitoring
4736727|NCT03007186|Glucose tolerance|glucose tolerance
4736728|NCT03007186|HbA1C|hba1c
4736729|NCT03007186|Insulin|insulin
4736730|NCT03007186|Betamethasone|betamethasone
4736731|NCT03007173|umbilical pilonidal sinus|umbilical pilonidal sinus
4736732|NCT03007082|endovascular treatment|endovascular treatment
4736733|NCT03007082|mechanical thrombectomy|mechanical thrombectomy
4736734|NCT03007082|stent retriever|stent retriever
4736735|NCT03007082|human|human
4736736|NCT03007056|high flow nasal cannula|high flow nasal cannula
4736737|NCT03007056|nasal continuous positive airway pressure|nasal continuous positive airway pressure
4736738|NCT03007056|noninvasive ventilatory support|noninvasive ventilatory support
4736739|NCT03007056|newborn developmental care|newborn developmental care
4736740|NCT03007056|bronchopulmonary dysplasia|bronchopulmonary dysplasia
4736741|NCT03007056|weaning|weaning
4736742|NCT03007056|pain|pain
4736743|NCT03007056|length of stay|length of stay
4736744|NCT03007030|Lung Diseases Due to External Agents|lung diseases due to external agents
4736745|NCT03007030|Mesothelioma|mesothelioma
4736746|NCT03007030|Unresectable malignant pleural mesothelioma|unresectable malignant pleural mesothelioma
4736747|NCT03007030|MPM|mpm
4736748|NCT03007030|CD30+|cd30+
4736749|NCT03007030|Brentuximab vedotin|brentuximab vedotin
4736750|NCT03007030|SGN-35|sgn-35
4736751|NCT03007030|Adcetris|adcetris
4736752|NCT03007004|Systemic aclerosis|systemic aclerosis
4736753|NCT03007004|digital ulcer|digital ulcer
4736754|NCT03007004|botulinum toxin|botulinum toxin
4736755|NCT03006991|methotrexate, Juvenile Idiopathic Arthritis|methotrexate, juvenile idiopathic arthritis
4736756|NCT03006965|hemophilia|hemophilia
4736757|NCT03006965|Hemophilia A|hemophilia a
4736758|NCT03006965|Factor VIII|factor viii
4736759|NCT03006965|Advate|advate
4736760|NCT03006965|Antithrombotic factor|antithrombotic factor
4736761|NCT03006965|Pharmacokinetic dosing|pharmacokinetic dosing
4736762|NCT03006965|hemarthrosis|hemarthrosis
4736763|NCT03006965|myPKFiT|mypkfit
4736764|NCT03006926|hepatocellular carcinoma|hepatocellular carcinoma
4736765|NCT03006926|E7080|e7080
4736766|NCT03006926|lenvatinib|lenvatinib
4736767|NCT03006926|pembrolizumab|pembrolizumab
4736768|NCT03006926|Japan|japan
4736769|NCT03006913|Genetic counseling modes|genetic counseling modes
4736770|NCT03006887|solid tumors|solid tumors
4736771|NCT03006887|non-small cell lung cancer|non-small cell lung cancer
4736772|NCT03006887|predominantly clear cell renal cell carcinoma|predominantly clear cell renal cell carcinoma
4736773|NCT03006887|endometrial carcinoma|endometrial carcinoma
4736774|NCT03006887|urothelial carcinoma|urothelial carcinoma
4736775|NCT03006887|squamous cell carcinoma of the head and neck|squamous cell carcinoma of the head and neck
4736776|NCT03006887|non-uveal melanoma|non-uveal melanoma
4736777|NCT03006887|E7080|e7080
4736778|NCT03006887|lenvatinib|lenvatinib
4736779|NCT03006887|pembrolizumab|pembrolizumab
4736780|NCT03006887|Japan|japan
4736781|NCT03006848|Osteosarcoma|osteosarcoma
4736782|NCT03006848|PD-L1|pd-l1
4736783|NCT03006848|Immunotherapy|immunotherapy
4736784|NCT03006835|Clopidogrel; Platelet Inhibition Ratio|clopidogrel; platelet inhibition ratio
4736785|NCT03006822|Myofascial Trigger Points|myofascial trigger points
4736786|NCT03006822|Liberation for Pression|liberation for pression
4736787|NCT03006822|Therapy Soft Tissue|therapy soft tissue
4736788|NCT03006809|Ulcerative colitis|ulcerative colitis
4736789|NCT03006809|FMT|fmt
4736790|NCT03006809|fecal transplant|fecal transplant
4736791|NCT03006796|Obesity|obesity
4736792|NCT03006705|ONO-4538,BMS-936558,Nivolumab,gastric,adjuvant,S-1,CapeOX|ono-4538,bms-936558,nivolumab,gastric,adjuvant,s-1,capeox
4736793|NCT03006614|Breast Cancer Model|breast cancer model
4736794|NCT03006614|Effects of Chemotherapy|effects of chemotherapy
4736795|NCT03006614|breast cancer|breast cancer
4736796|NCT03006588|FNA,EUS,retropharyngeal lymph node (RPLN),NPC|fna,eus,retropharyngeal lymph node (rpln),npc
4736797|NCT03006575|Non-small cell lung cancer|non-small cell lung cancer
4736798|NCT03006575|Split-course Chemoradiotherapy|split-course chemoradiotherapy
4736799|NCT03006575|Locoregional recurrence|locoregional recurrence
4736800|NCT03006575|Postoperative recurrence|postoperative recurrence
4736801|NCT03006575|Consolidation chemotherapy|consolidation chemotherapy
4736802|NCT03006549|Emergency Manual|emergency manual
4736803|NCT03006549|Crisis Checklist|crisis checklist
4736804|NCT03006523|donor intrauterine insemination|donor intrauterine insemination
4736805|NCT03006523|insemination volume|insemination volume
4736806|NCT03006523|Live Birth Rates|live birth rates
4736807|NCT03006523|donor sperm|donor sperm
4736808|NCT03006510|inpatient diabetes|inpatient diabetes
4736809|NCT03006510|hypoglycemia|hypoglycemia
4736810|NCT03006497|neck|neck
4736811|NCT03006497|motor control|motor control
4736812|NCT03006497|motor learning|motor learning
4736813|NCT03006484|Cardiac arrest|cardiac arrest
4736814|NCT03006484|Inhospital Cardiac Arrest|inhospital cardiac arrest
4736815|NCT03006484|Cardiopulmonary Resuscitation|cardiopulmonary resuscitation
4736816|NCT03006471|Prediabetes|prediabetes
4736817|NCT03006471|Prehypertension|prehypertension
4736818|NCT03006471|Variability of blood pressure|variability of blood pressure
4736819|NCT03006471|ABPM|abpm
4736820|NCT03006471|Dapagliflozin|dapagliflozin
4736821|NCT03006471|SGLT2|sglt2
4736822|NCT03006432|OESOPHAGO-GASTRIC CARCINOMA|oesophago-gastric carcinoma
4736823|NCT03006419|kidney transplantation|kidney transplantation
4736824|NCT03006419|induction|induction
4736825|NCT03006419|thymoglobulin|thymoglobulin
4736826|NCT03006419|basiliximab|basiliximab
4736827|NCT03006419|acute rejection|acute rejection
4736828|NCT03006419|graft loss|graft loss
4736829|NCT03006406|endometriosis|endometriosis
4736830|NCT03006406|long term GnRH-a|long term gnrh-a
4736831|NCT03006393|Neuroscience|neuroscience
4736832|NCT03006393|Behavioral|behavioral
4736833|NCT03006393|Social|social
4736834|NCT03006354|high frequency oscillatory ventilation|high frequency oscillatory ventilation
4736835|NCT03006354|newborn|newborn
4736836|NCT03006354|noninvasive ventilation|noninvasive ventilation
4736837|NCT03006354|transient tachypnea of the newborn|transient tachypnea of the newborn
4736838|NCT03006328|weight gain|weight gain
4736839|NCT03006328|weight loss|weight loss
4736840|NCT03006315|multiple myeloma|multiple myeloma
4736841|NCT03006315|garmin vivofit|garmin vivofit
4736842|NCT03006302|pancreatic cancer|pancreatic cancer
4736843|NCT03006302|vaccine|vaccine
4736844|NCT03006302|immunotherapy|immunotherapy
4736845|NCT03006302|MK-3475|mk-3475
4736846|NCT03006302|PD-1|pd-1
4736847|NCT03006302|IDO|ido
4736848|NCT03006289|Metabolic Syndrome|metabolic syndrome
4736849|NCT03006289|fasting plasma glucose|fasting plasma glucose
4736850|NCT03006263|Stomach Neoplasms|stomach neoplasms
4736851|NCT03006263|Totally Laparoscopic Total Gastrectomy|totally laparoscopic total gastrectomy
4736852|NCT03006263|Laparoscopy Assisted Total Gastrectomy|laparoscopy assisted total gastrectomy
4736853|NCT03006250|Desflurane|desflurane
4736854|NCT03006250|Sevoflurane|sevoflurane
4736855|NCT03006250|Respiratory Complications|respiratory complications
4736856|NCT03006224|secondary smoking|secondary smoking
4736857|NCT03006224|one lung ventilation|one lung ventilation
4736858|NCT03006224|arterial oxygen tension|arterial oxygen tension
4736859|NCT03006224|lobectomy|lobectomy
4736860|NCT03006211|nitrogen protoxide|nitrogen protoxide
4736861|NCT03006211|oxygen|oxygen
4736862|NCT03006211|corneal endothelial|corneal endothelial
4736863|NCT03006211|pediatric|pediatric
4736864|NCT03006107|Irreversible pulpitis|irreversible pulpitis
4736865|NCT03006107|Post endodontic pain|post endodontic pain
4736866|NCT03006107|Symptomatic pulpitis pain|symptomatic pulpitis pain
4736867|NCT03006107|Single visit RCT pain|single visit rct pain
4736868|NCT03006107|Root canal treatment flare up|root canal treatment flare up
4736869|NCT03006107|Single dose piroxicam|single dose piroxicam
4736870|NCT03006107|Intraligamentary piroxicam|intraligamentary piroxicam
4736871|NCT03006107|Intraligamentary mepecaine|intraligamentary mepecaine
4736872|NCT03006094|questionnaire|questionnaire
4736873|NCT03006094|hip|hip
4736874|NCT03006094|pain|pain
4736875|NCT03006081|Retinal nonperfusion|retinal nonperfusion
4736876|NCT03006081|Aflibercept|aflibercept
4736877|NCT03006068|Ulcerative Colitis (UC)|ulcerative colitis (uc)
4736878|NCT03006068|Upadacitinib (ABT-494)|upadacitinib (abt-494)
4736879|NCT03006068|Open-Label Extension (OLE)|open-label extension (ole)
4736880|NCT03006068|Safety|safety
4736881|NCT03006068|Efficacy|efficacy
4736882|NCT03006042|bupivacaine|bupivacaine
4736883|NCT03006042|local anaesthetics|local anaesthetics
4736884|NCT03006042|cesarean section|cesarean section
4736885|NCT03006042|transversus abdominis plane block|transversus abdominis plane block
4736886|NCT03006042|toxicity|toxicity
4736887|NCT03006042|ultrasound guidance|ultrasound guidance
4736888|NCT03006042|QTc interval|qtc interval
4736889|NCT03006003|Osteoporosis|osteoporosis
4736890|NCT03006003|Raloxifene|raloxifene
4736891|NCT03006003|Central nervous disorders|central nervous disorders
4736892|NCT03005990|Sleep disturbance|sleep disturbance
4736893|NCT03005990|Body composition|body composition
4736894|NCT03005990|Energy metabolism|energy metabolism
4736895|NCT03005990|Exercise training|exercise training
4736896|NCT03005990|Community-dwelling elderly|community-dwelling elderly
4736897|NCT03005977|Urodynamics|urodynamics
4736898|NCT03005977|Pyridium pad test|pyridium pad test
4736899|NCT03005977|Cough stress test|cough stress test
4736900|NCT03005977|Pelvic organ prolapse|pelvic organ prolapse
4736901|NCT03005938|Cerebral Palsy|cerebral palsy
4736902|NCT03005938|Spinal Manipulation|spinal manipulation
4736903|NCT03005938|Muscle Spasticity|muscle spasticity
4736904|NCT03005938|Manual Dexterity|manual dexterity
4736905|NCT03005912|Speech Comprehension|speech comprehension
4736906|NCT03005912|Telephony|telephony
4736907|NCT03005912|VoIP|voip
4736908|NCT03005886|Periodontitis|periodontitis
4736909|NCT03005886|Periodontal-systemic disease|periodontal-systemic disease
4736910|NCT03005886|Cardiovascular diseases|cardiovascular diseases
4736911|NCT03005886|Gingival crevicular fluid|gingival crevicular fluid
4736912|NCT03005886|Acute myocardial infarction|acute myocardial infarction
4736913|NCT03005886|Neopterin|neopterin
4736914|NCT03005886|Vascular cell adhesion molecule-1|vascular cell adhesion molecule-1
4736915|NCT03005873|osteoarthritis of the knee|osteoarthritis of the knee
4736916|NCT03005873|TLC599|tlc599
4736917|NCT03005873|Dexamethasone|dexamethasone
4736918|NCT03005873|DSP|dsp
4736919|NCT03005834|Atherosclerotic cardiovascular diseases, cancers|atherosclerotic cardiovascular diseases, cancers
4736920|NCT03005821|pediatric massage|pediatric massage
4736921|NCT03005821|Tuina therapy|tuina therapy
4736922|NCT03005821|acute diarrhea|acute diarrhea
4736923|NCT03005808|appendectomy, pediatrics, nerve block, abdominal wall|appendectomy, pediatrics, nerve block, abdominal wall
4736924|NCT03005795|cervical dysplasia|cervical dysplasia
4736925|NCT03005795|colposcopy|colposcopy
4736926|NCT03005795|anxiety|anxiety
4736927|NCT03005795|music|music
4736928|NCT03005795|mozart|mozart
4736929|NCT03005795|randomized controlled trial|randomized controlled trial
4736930|NCT03005769|persistence|persistence
4736931|NCT03005769|long-acting injectable antipsychotic|long-acting injectable antipsychotic
4736932|NCT03005769|adherence|adherence
4736933|NCT03005743|Cervical cancer|cervical cancer
4736934|NCT03005743|Brachytherapy|brachytherapy
4736935|NCT03005743|Conventional planning|conventional planning
4736936|NCT03005743|MR based Brachytherapy|mr based brachytherapy
4736937|NCT03005717|submental|submental
4736938|NCT03005717|Salmeterol Xinafoate|salmeterol xinafoate
4736939|NCT03005717|LIPO-202|lipo-202
4736940|NCT03005717|bulge|bulge
4736941|NCT03005704|Ticagrelor|ticagrelor
4736942|NCT03005704|Acetylsalicylic acid|acetylsalicylic acid
4736943|NCT03005704|Platelet transfusion|platelet transfusion
4736944|NCT03005704|Reversal|reversal
4736945|NCT03005691|metabolite|metabolite
4736946|NCT03005691|central sensitization|central sensitization
4736947|NCT03005691|whiplash|whiplash
4736948|NCT03005678|glucocorticoids, steroids, osteoporosis|glucocorticoids, steroids, osteoporosis
4736949|NCT03005665|optic nerve sheath diameter|optic nerve sheath diameter
4736950|NCT03005665|acetazolamide|acetazolamide
4736951|NCT03005652|Subjective Cognitive Decline|subjective cognitive decline
4736952|NCT03005652|Mental Health|mental health
4736953|NCT03005652|Meditation|meditation
4736954|NCT03005652|Health Education|health education
4736955|NCT03005613|Pelvic organ prolapse|pelvic organ prolapse
4736956|NCT03005613|Sacrospinous ligament fixation|sacrospinous ligament fixation
4736957|NCT03005613|Ischial spine fascia fixation|ischial spine fascia fixation
4736958|NCT03005613|Clinical outcome|clinical outcome
4736959|NCT03005600|Screening, diagnosis, risk stratification, ethnic|screening, diagnosis, risk stratification, ethnic
4736960|NCT03005574|Severe Mental Illness|severe mental illness
4736961|NCT03005574|Cognitive Remediation|cognitive remediation
4736962|NCT03005574|Employment|employment
4736963|NCT03005548|Transcranial Direct Current Stimulation|transcranial direct current stimulation
4736964|NCT03005548|Pain Postoperative|pain postoperative
4736965|NCT03005548|Thoracotomy|thoracotomy
4736966|NCT03005509|Quality improvement|quality improvement
4736967|NCT03005509|Injury|injury
4736968|NCT03005509|Injuries|injuries
4736969|NCT03005483|GABAPENTIN POSTOPERATIVE PAIN CHILD|gabapentin postoperative pain child
4736970|NCT03005470|Prehypertension|prehypertension
4736971|NCT03005470|Hypertension|hypertension
4736972|NCT03005470|Blood pressure|blood pressure
4736973|NCT03005470|Intervention|intervention
4736974|NCT03005470|Lifestyle|lifestyle
4736975|NCT03005470|Blood pressure monitoring|blood pressure monitoring
4736976|NCT03005470|Ambulatory Blood Pressure Monitoring|ambulatory blood pressure monitoring
4736977|NCT03005470|Text Messages|text messages
4736978|NCT03005470|High blood pressure|high blood pressure
4736979|NCT03005444|liver cirrhosis|liver cirrhosis
4736980|NCT03005444|Transjugular Intrahepatic Portosystemic Stent Shunt|transjugular intrahepatic portosystemic stent shunt
4736981|NCT03005444|Anticoagulation|anticoagulation
4736982|NCT03005444|Survival|survival
4736983|NCT03005444|Additional decompensation|additional decompensation
4736984|NCT03005431|Parenting|parenting
4736985|NCT03005431|Training|training
4736986|NCT03005431|Support|support
4736987|NCT03005431|On-line|on-line
4736988|NCT03005431|Stress|stress
4736989|NCT03005405|Dental Caries|dental caries
4736990|NCT03005405|Primary tooth|primary tooth
4736991|NCT03005405|Ionomer Sealants|ionomer sealants
4736992|NCT03005405|Glass Ionomer Restoration|glass ionomer restoration
4736993|NCT03005392|Cancer|cancer
4736994|NCT03005392|Physical therapy|physical therapy
4736995|NCT03005392|Cardiorespiratory fitness|cardiorespiratory fitness
4736996|NCT03005379|FMT|fmt
4736997|NCT03005379|recurrent c. difficile|recurrent c. difficile
4736998|NCT03005379|infectious disease|infectious disease
4736999|NCT03005379|intestine|intestine
4737000|NCT03005379|clinical trial|clinical trial
4737001|NCT03005379|gastrointestinal|gastrointestinal
4737002|NCT03005379|prevention|prevention
4737003|NCT03005379|randomized|randomized
4737004|NCT03005379|diarrhea|diarrhea
4737005|NCT03005379|fecal microbiota therapy|fecal microbiota therapy
4737006|NCT03005366|Atrial fibrillation|atrial fibrillation
4737007|NCT03005366|vernakalant|vernakalant
4737008|NCT03005366|flecainide|flecainide
4737009|NCT03005366|cardioversion|cardioversion
4737010|NCT03005301|electroacupuncture instrument|electroacupuncture instrument
4737011|NCT03005288|type 2 diabetes|type 2 diabetes
4737012|NCT03005288|obesity|obesity
4737013|NCT03005288|DXA|dxa
4737014|NCT03005288|MRI|mri
4737217|NCT03003949|stress|stress
4737015|NCT03005236|Kidney transplant|kidney transplant
4737016|NCT03005236|Tacrolimus|tacrolimus
4737017|NCT03005236|Envarsus|envarsus
4737018|NCT03005236|Older adult|older adult
4737019|NCT03005236|Elderly|elderly
4737020|NCT03005158|High-sensitivity cardiac troponin I|high-sensitivity cardiac troponin i
4737021|NCT03005158|Myocardial infarction|myocardial infarction
4737022|NCT03005158|Acute coronary syndrome|acute coronary syndrome
4737023|NCT03005158|Cluster-randomized trial|cluster-randomized trial
4737024|NCT03005132|GBM; Integrative Analysis; WES|gbm; integrative analysis; wes
4737025|NCT03004989|Qualitative study|qualitative study
4737026|NCT03004989|Musculoskeletal Disorders|musculoskeletal disorders
4737027|NCT03004989|Return to Work Programme|return to work programme
4737028|NCT03004976|hematopoietic stem cells|hematopoietic stem cells
4737029|NCT03004976|umbilical cord blood|umbilical cord blood
4737030|NCT03004976|stroke|stroke
4737031|NCT03004976|ischemic stroke|ischemic stroke
4737032|NCT03004963|Peritoneal Dialysis|peritoneal dialysis
4737033|NCT03004963|Volume Status|volume status
4737034|NCT03004963|Body Composition Monitor|body composition monitor
4737035|NCT03004911|fibromyalgia|fibromyalgia
4737036|NCT03004911|mobile application|mobile application
4737037|NCT03004911|self-care|self-care
4737038|NCT03004911|quality of life|quality of life
4737039|NCT03004872|birth experience|birth experience
4737040|NCT03004872|postpartum depression|postpartum depression
4737041|NCT03004872|PTSD|ptsd
4737042|NCT03004872|pain during labor|pain during labor
4737043|NCT03004872|pain during cesarean delivery|pain during cesarean delivery
4737044|NCT03004872|non-elective induction of labor|non-elective induction of labor
4737045|NCT03004872|unplanned surgery for urgent/emergent cesarean delivery|unplanned surgery for urgent/emergent cesarean delivery
4737046|NCT03004872|postpartum hemorrhage|postpartum hemorrhage
4737047|NCT03004859|atrial fibrillation|atrial fibrillation
4737048|NCT03004859|screening|screening
4737049|NCT03004859|electrocardiogram|electrocardiogram
4737050|NCT03004859|community pharmacy|community pharmacy
4737051|NCT03004859|Germany|germany
4737052|NCT03004846|Vehicle- controlled|vehicle- controlled
4737053|NCT03004846|GSK2981278|gsk2981278
4737054|NCT03004846|Plaque psoriasis|plaque psoriasis
4737055|NCT03004820|Minor Ischemic Stroke|minor ischemic stroke
4737056|NCT03004820|Transient Ischemic Attack|transient ischemic attack
4737057|NCT03004820|Remote Ischemic Conditioning|remote ischemic conditioning
4737058|NCT03004807|Nutrition|nutrition
4737059|NCT03004807|Aging|aging
4737060|NCT03004807|Multivitamin|multivitamin
4737061|NCT03004781|parenting intervention|parenting intervention
4737062|NCT03004781|externalizing behavior|externalizing behavior
4737063|NCT03004781|emotion coaching practices|emotion coaching practices
4737064|NCT03004781|self-efficacy beliefs|self-efficacy beliefs
4737065|NCT03004742|polyphenols|polyphenols
4737066|NCT03004742|metabolomics|metabolomics
4737067|NCT03004742|oxidative stress|oxidative stress
4737068|NCT03004729|Allergy|allergy
4737069|NCT03004729|Atopic Dermatitis|atopic dermatitis
4737070|NCT03004729|Immunoglobulin E (IgE)|immunoglobulin e (ige)
4737071|NCT03004729|CMPA|cmpa
4737072|NCT03004703|Interleukin 6|interleukin 6
4737073|NCT03004703|Tocilizumab|tocilizumab
4737074|NCT03004703|Acute coronary syndrome|acute coronary syndrome
4737075|NCT03004703|STEMI|stemi
4737076|NCT03004703|Inflammation|inflammation
4737077|NCT03004690|biosafety|biosafety
4737078|NCT03004690|outbreaks|outbreaks
4737079|NCT03004690|clinic|clinic
4737080|NCT03004690|personal protective equipment|personal protective equipment
4737081|NCT03004690|ergonomics|ergonomics
4737082|NCT03004690|error rates|error rates
4737083|NCT03004664|Latinos|latinos
4737084|NCT03004664|Low Income|low income
4737085|NCT03004664|Self Management|self management
4737086|NCT03004664|Education|education
4737087|NCT03004664|Cultural Competence|cultural competence
4737088|NCT03004638|Atherosclerosis|atherosclerosis
4737089|NCT03004638|Cardiovascular Disease|cardiovascular disease
4737090|NCT03004638|CAD|cad
4737091|NCT03004638|Atherosclerotic Cardiovascular Disease|atherosclerotic cardiovascular disease
4737092|NCT03004612|prediabetes|prediabetes
4737093|NCT03004599|Valvular Heart Disease|valvular heart disease
4737094|NCT03004599|Critical Aortic Stenosis|critical aortic stenosis
4737095|NCT03004599|Severe Aortic Stenosis|severe aortic stenosis
4737096|NCT03004599|High Risk|high risk
4737097|NCT03004599|Aortic Valve Replacement|aortic valve replacement
4737098|NCT03004599|Cardiovascular Disease|cardiovascular disease
4737099|NCT03004599|Aortic Stenosis|aortic stenosis
4737100|NCT03004599|Heart Valve Therapy|heart valve therapy
4737101|NCT03004599|Transcatheter|transcatheter
4737102|NCT03004599|Transfemoral|transfemoral
4737103|NCT03004599|TAVI|tavi
4737104|NCT03004599|TAVR|tavr
4737105|NCT03004599|ACURATE neo™ Aortic Bioprosthesis|acurate neo™ aortic bioprosthesis
4737106|NCT03004599|ACURATE TF™ Transfemoral Delivery System|acurate tf™ transfemoral delivery system
4737107|NCT03004586|Malignant Neoplasm of Respiratory and Intrathoracic Organ Carcinoma|malignant neoplasm of respiratory and intrathoracic organ carcinoma
4737108|NCT03004586|Lung cancer|lung cancer
4737109|NCT03004586|Ultrasound-guided transbronchial needle aspiration|ultrasound-guided transbronchial needle aspiration
4737110|NCT03004586|EBUS-TBNA|ebus-tbna
4737111|NCT03004586|25-gauge needle|25-gauge needle
4737112|NCT03004586|22-gauge needle|22-gauge needle
4737113|NCT03004573|Parkinson Disease|parkinson disease
4737114|NCT03004573|emotional recognition|emotional recognition
4737115|NCT03004573|Deep Brain Stimulation|deep brain stimulation
4737116|NCT03004560|Bariatric|bariatric
4737117|NCT03004560|standard laparoscopic surgery|standard laparoscopic surgery
4737118|NCT03004560|minimally invasive|minimally invasive
4737119|NCT03004560|scars|scars
4737120|NCT03004560|psychology|psychology
4737121|NCT03004534|Breast Cancer|breast cancer
4737122|NCT03004534|Breast Carcinoma|breast carcinoma
4737123|NCT03004534|Breast Tumours|breast tumours
4737124|NCT03004534|Early Breast Cancer|early breast cancer
4737125|NCT03004521|Lithium|lithium
4737126|NCT03004521|Quetiapine|quetiapine
4737127|NCT03004521|Augmentation|augmentation
4737128|NCT03004508|Ginkgo Biloba Extract|ginkgo biloba extract
4737129|NCT03004508|Safety|safety
4737130|NCT03004508|Genomic Stability|genomic stability
4737131|NCT03004508|DNA cell maintenance|dna cell maintenance
4737132|NCT03004482|NICU|nicu
4737133|NCT03004482|Recorded video images|recorded video images
4737134|NCT03004482|physiological disorders|physiological disorders
4737135|NCT03004456|Phlebotomy|phlebotomy
4737136|NCT03004456|Pain|pain
4737137|NCT03004456|Distress|distress
4737138|NCT03004443|Psychiatry|psychiatry
4737139|NCT03004430|Mantra|mantra
4737140|NCT03004430|Meditation|meditation
4737141|NCT03004391|Shared decision making|shared decision making
4737142|NCT03004391|Follow-up|follow-up
4737143|NCT03004378|obesity|obesity
4737144|NCT03004378|adolescent|adolescent
4737145|NCT03004378|tracking device|tracking device
4737146|NCT03004378|fitbit|fitbit
4737147|NCT03004326|DIV|div
4737148|NCT03004326|CSS|css
4737149|NCT03004326|EGPA|egpa
4737150|NCT03004326|HSP|hsp
4737151|NCT03004326|GPA|gpa
4737152|NCT03004326|MPA|mpa
4737153|NCT03004326|PAN|pan
4737154|NCT03004326|Wegeners|wegeners
4737155|NCT03004313|migraine|migraine
4737156|NCT03004300|maxillary expansion|maxillary expansion
4737157|NCT03004300|adenotonsillar hypertrophy|adenotonsillar hypertrophy
4737158|NCT03004300|airway volume|airway volume
4737159|NCT03004261|cytomegalovirus infection|cytomegalovirus infection
4737160|NCT03004261|cytotoxic T lymphocyte|cytotoxic t lymphocyte
4737161|NCT03004261|hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
4737162|NCT03004248|glabellar lines, frown lines|glabellar lines, frown lines
4737163|NCT03004209|Erythropoietin|erythropoietin
4737164|NCT03004209|Autoimmune encephalitis|autoimmune encephalitis
4737165|NCT03004196|White Spot Lesion|white spot lesion
4737166|NCT03004196|Probiotics|probiotics
4737167|NCT03004196|Chlorhexidine|chlorhexidine
4737168|NCT03004196|Streptococcus Mutans|streptococcus mutans
4737169|NCT03004196|Fixed Orthodontic Treatment|fixed orthodontic treatment
4737170|NCT03004170|HIV|hiv
4737171|NCT03004170|Motivational Interviewing|motivational interviewing
4737172|NCT03004170|Telephone|telephone
4737173|NCT03004170|Telehealth|telehealth
4737174|NCT03004170|Risky Sex|risky sex
4737175|NCT03004170|Unprotected Sex|unprotected sex
4737176|NCT03004170|Condoms|condoms
4737177|NCT03004170|Older Adults|older adults
4737178|NCT03004157|infant|infant
4737179|NCT03004157|cardiopulmonary resuscitation|cardiopulmonary resuscitation
4737180|NCT03004157|hemodynamics|hemodynamics
4737181|NCT03004157|chest compressions|chest compressions
4737182|NCT03004105|Malignant Neoplasm of Respiratory and Intrathoracic Organ Carcinoma|malignant neoplasm of respiratory and intrathoracic organ carcinoma
4737183|NCT03004105|Advanced Lung Cancer|advanced lung cancer
4737184|NCT03004105|Recurrent Nonsmall Cell Lung Cancer|recurrent nonsmall cell lung cancer
4737185|NCT03004105|Selumetinib|selumetinib
4737186|NCT03004105|AZD6244|azd6244
4737187|NCT03004105|Durvalumab|durvalumab
4737188|NCT03004105|MEDI4736|medi4736
4737189|NCT03004092|bis(methylthio)gliotoxin|bis(methylthio)gliotoxin
4737190|NCT03004092|lateral flow device|lateral flow device
4737191|NCT03004092|JF5|jf5
4737192|NCT03004092|Galactomannan|galactomannan
4737193|NCT03004092|Invasive aspergillosis|invasive aspergillosis
4737194|NCT03004053|Reflectance Confocal Microscopy|reflectance confocal microscopy
4737195|NCT03004053|Normal Oral Tissue|normal oral tissue
4737196|NCT03004053|16-1652|16-1652
4737197|NCT03004027|health behaviour change|health behaviour change
4737198|NCT03004027|implementation intention|implementation intention
4737199|NCT03004027|if then plan|if then plan
4737200|NCT03004027|skin condition|skin condition
4737201|NCT03004027|visible difference|visible difference
4737202|NCT03004027|self help|self help
4737203|NCT03004014|sleep endoscopy|sleep endoscopy
4737204|NCT03004014|sedation|sedation
4737205|NCT03004001|Severe proteinuria|severe proteinuria
4737206|NCT03004001|Dyslipidemia|dyslipidemia
4737207|NCT03003975|Ablation|ablation
4737208|NCT03003975|Cryoballoon|cryoballoon
4737209|NCT03003975|Achieve|achieve
4737210|NCT03003962|NSCLC|nsclc
4737211|NCT03003962|PD-L1|pd-l1
4737212|NCT03003962|Durvalumab (MEDI4736)|durvalumab (medi4736)
4737213|NCT03003962|OS|os
4737214|NCT03003949|perimenopause|perimenopause
4737215|NCT03003949|menopause transition|menopause transition
4737218|NCT03003949|mood|mood
4737219|NCT03003936|Glucose tolerance|glucose tolerance
4737220|NCT03003936|MTNR1B|mtnr1b
4737221|NCT03003936|nutrigenomics|nutrigenomics
4737222|NCT03003936|Food timing|food timing
4737223|NCT03003923|Vegetable intake|vegetable intake
4737224|NCT03003923|Taste exposures|taste exposures
4737225|NCT03003923|Educational intervention|educational intervention
4737226|NCT03003923|Preschool children|preschool children
4737227|NCT03003923|Healthy eating intervention|healthy eating intervention
4737228|NCT03003910|Best Possible Self|best possible self
4737229|NCT03003897|Dietary Fiber|dietary fiber
4737230|NCT03003897|Soluble Fiber|soluble fiber
4737231|NCT03003897|Body Mass Index|body mass index
4737232|NCT03003897|Body Weight|body weight
4737233|NCT03003897|Blood Glucose|blood glucose
4737234|NCT03003897|Insulin|insulin
4737235|NCT03003871|stroke|stroke
4737236|NCT03003871|randomized controled clinical trial|randomized controled clinical trial
4737237|NCT03003871|oral health promotion|oral health promotion
4737238|NCT03003858|gingivitis|gingivitis
4737239|NCT03003858|hyaluronic acid|hyaluronic acid
4737240|NCT03003858|pediatrics|pediatrics
4737241|NCT03003858|medical devices|medical devices
4737242|NCT03003806|Insulin pump treatment|insulin pump treatment
4737243|NCT03003806|Type 1 diabetes|type 1 diabetes
4737244|NCT03003806|Pump setting advisor|pump setting advisor
4737245|NCT03003689|Scaling and Root Planing|scaling and root planing
4737246|NCT03003689|Er:YAG|er:yag
4737247|NCT03003663|Fall Prevention|fall prevention
4737248|NCT03003663|Interrupted Time-Series Study|interrupted time-series study
4737249|NCT03003663|Patient Safety|patient safety
4737250|NCT03003663|Patient-Centered Care|patient-centered care
4737251|NCT03003663|Patient Monitoring|patient monitoring
4737252|NCT03003663|Health Care Technology|health care technology
4737253|NCT03003663|Mobile Applications|mobile applications
4737254|NCT03003663|Bedside Monitor|bedside monitor
4737255|NCT03003663|Mechanical Fall|mechanical fall
4737256|NCT03003650|Severe Symptomatic Aortic Valve Stenosis|severe symptomatic aortic valve stenosis
4737257|NCT03003624|Incisions|incisions
4737258|NCT03003624|microdissection needle|microdissection needle
4737259|NCT03003598|Intraocular pressure|intraocular pressure
4737260|NCT03003598|videolaryngoscope|videolaryngoscope
4737261|NCT03003598|direct laryngoscope|direct laryngoscope
4737262|NCT03003585|intraocular pressure|intraocular pressure
4737263|NCT03003585|direct laryngoscopy|direct laryngoscopy
4737264|NCT03003585|fiberoptic bronchoscopy|fiberoptic bronchoscopy
4737265|NCT03003572|Sjögren's syndrome|sjögren's syndrome
4737266|NCT03003572|Immunoglobulin E|immunoglobulin e
4737267|NCT03003572|Anti-Ro/SSA|anti-ro/ssa
4737268|NCT03003572|Autoimmune disease|autoimmune disease
4737269|NCT03003572|Biomarker|biomarker
4737270|NCT03003559|COPD Exacerbation|copd exacerbation
4737271|NCT03003559|High Flow Oxygen|high flow oxygen
4737272|NCT03003559|Nasal Cannula|nasal cannula
4737273|NCT03003559|mild|mild
4737274|NCT03003533|Adeno-Associated Virus (AAV)|adeno-associated virus (aav)
4737275|NCT03003533|Blood Coagulation Disorders|blood coagulation disorders
4737276|NCT03003533|Blood Coagulation Disorders, Inherited|blood coagulation disorders, inherited
4737277|NCT03003533|Coagulation Protein Disorders|coagulation protein disorders
4737278|NCT03003533|Factor VIII (FVIII)|factor viii (fviii)
4737279|NCT03003533|Factor VIII (FVIII) Deficiency|factor viii (fviii) deficiency
4737280|NCT03003533|Factor VIII (FVIII) Gene|factor viii (fviii) gene
4737281|NCT03003533|Factor VIII (FVIII) Protein|factor viii (fviii) protein
4737282|NCT03003533|Genetic Diseases, Inborn|genetic diseases, inborn
4737283|NCT03003533|Genetic Diseases, X-Linked|genetic diseases, x-linked
4737284|NCT03003533|Gene Therapy|gene therapy
4737285|NCT03003533|Gene Transfer|gene transfer
4737286|NCT03003533|Hematologic Diseases|hematologic diseases
4737287|NCT03003533|Hemorrhagic Disorders|hemorrhagic disorders
4737288|NCT03003533|Recombinant|recombinant
4737289|NCT03003533|Vector|vector
4737290|NCT03003520|Lymphoma|lymphoma
4737291|NCT03003520|Diffuse-large B-Cell Lymphoma|diffuse-large b-cell lymphoma
4737292|NCT03003520|Durvalumab|durvalumab
4737293|NCT03003520|Anti-PD-L1 Antibody|anti-pd-l1 antibody
4737294|NCT03003520|MEDI4736|medi4736
4737295|NCT03003520|Immune Checkpoint|immune checkpoint
4737296|NCT03003520|Rituximab|rituximab
4737297|NCT03003520|Cyclophosphamide|cyclophosphamide
4737298|NCT03003520|Doxorubicin|doxorubicin
4737299|NCT03003520|Vincristine|vincristine
4737300|NCT03003520|Prednisone/Prednisolone|prednisone/prednisolone
4737301|NCT03003520|Lenalidomide|lenalidomide
4737302|NCT03003507|Hyperglycemia|hyperglycemia
4737303|NCT03003507|Fructose|fructose
4737304|NCT03003507|Diabetes mellitus|diabetes mellitus
4737305|NCT03003507|Enteral Nutrition|enteral nutrition
4737306|NCT03003507|Glycemic Variability|glycemic variability
4737307|NCT03003468|Anti-PD-1|anti-pd-1
4737308|NCT03003468|Pembrolizumab|pembrolizumab
4737309|NCT03003468|Imprime PGG|imprime pgg
4737310|NCT03003468|MK-3475|mk-3475
4737311|NCT03003455|Nasotracheal Intubation|nasotracheal intubation
4737312|NCT03003442|Multivitamin/mineral|multivitamin/mineral
4737313|NCT03003442|Exercise|exercise
4737314|NCT03003442|Fatigue|fatigue
4737315|NCT03003442|Stress|stress
4737316|NCT03003442|Arousal|arousal
4737624|NCT03001752|open flap|open flap
4737317|NCT03003442|Energy expenditure|energy expenditure
4737318|NCT03003442|Recovery biomarkers|recovery biomarkers
4737319|NCT03003442|Cognition|cognition
4737320|NCT03003429|Heart rate variability|heart rate variability
4737321|NCT03003429|anxiety|anxiety
4737322|NCT03003429|Autonomic dysfunction|autonomic dysfunction
4737323|NCT03003403|mHealth|mhealth
4737324|NCT03003403|Digital Health|digital health
4737325|NCT03003403|Primary Care|primary care
4737326|NCT03003403|Pragmatic Clinical Trial|pragmatic clinical trial
4737327|NCT03003403|Behavior Change|behavior change
4737328|NCT03003403|Weight Management|weight management
4737329|NCT03003390|child|child
4737330|NCT03003390|critical illness|critical illness
4737331|NCT03003390|venous thromboembolism|venous thromboembolism
4737332|NCT03003390|enoxaparin|enoxaparin
4737333|NCT03003390|thrombin generation|thrombin generation
4737334|NCT03003377|Sevoflurane|sevoflurane
4737335|NCT03003377|Remifentanil|remifentanil
4737336|NCT03003377|Laryngeal mask supreme|laryngeal mask supreme
4737337|NCT03003377|laryngeal mask proseal|laryngeal mask proseal
4737338|NCT03003351|Fistula|fistula
4737339|NCT03003351|Cohort Study|cohort study
4737340|NCT03003338|chronic HCV Genotype 1b infection|chronic hcv genotype 1b infection
4737341|NCT03003338|HCV RNA|hcv rna
4737342|NCT03003338|OBV/PTV/r in combination with DSV|obv/ptv/r in combination with dsv
4737343|NCT03003338|neuropsychiatric manifestations|neuropsychiatric manifestations
4737344|NCT03003325|low risk of thrombosis|low risk of thrombosis
4737345|NCT03003325|Interferon|interferon
4737346|NCT03003312|Urolithiasis|urolithiasis
4737347|NCT03003312|Uyghur|uyghur
4737348|NCT03003312|Prevalence|prevalence
4737349|NCT03003312|Associated factors|associated factors
4737350|NCT03003312|Children|children
4737351|NCT03003299|Sapien 3|sapien 3
4737352|NCT03003299|Partner 3|partner 3
4737353|NCT03003299|cardiovascular disease|cardiovascular disease
4737354|NCT03003299|heart disease|heart disease
4737355|NCT03003299|aortic stenosis|aortic stenosis
4737356|NCT03003299|SAVR|savr
4737357|NCT03003299|TAVR|tavr
4737358|NCT03003299|failing surgical valve|failing surgical valve
4737359|NCT03003299|failing bioprosthetic valve|failing bioprosthetic valve
4737360|NCT03003299|failing valve|failing valve
4737361|NCT03003286|Contingency Behavior Management|contingency behavior management
4737362|NCT03003286|Flexible|flexible
4737363|NCT03003286|Unstuck|unstuck
4737364|NCT03003286|Low Income|low income
4737365|NCT03003286|Behavior|behavior
4737366|NCT03003286|Coping|coping
4737367|NCT03003286|Disparity|disparity
4737368|NCT03003286|Problem Solving|problem solving
4737369|NCT03003286|Self-Control|self-control
4737370|NCT03003286|impulsive|impulsive
4737371|NCT03003286|intervention|intervention
4737372|NCT03003221|Parent training|parent training
4737373|NCT03003221|Dental care|dental care
4737374|NCT03003169|surgery|surgery
4737375|NCT03003169|breast cancer|breast cancer
4737376|NCT03003169|quality of life|quality of life
4737377|NCT03003156|magnetic seizure therapy|magnetic seizure therapy
4737378|NCT03003156|schizophrenia|schizophrenia
4737379|NCT03003156|controlled trial|controlled trial
4737380|NCT03003156|cognition|cognition
4737381|NCT03003130|Hyaluronic acid|hyaluronic acid
4737382|NCT03003130|Comparative study|comparative study
4737383|NCT03003130|NLF|nlf
4737384|NCT03003117|Infant|infant
4737385|NCT03003117|Diet|diet
4737386|NCT03003117|Growth|growth
4737387|NCT03003117|Breastfeeding|breastfeeding
4737388|NCT03003117|Complementary feeding|complementary feeding
4737389|NCT03003117|Pregnancy|pregnancy
4737390|NCT03003117|Body mass index|body mass index
4737391|NCT03003117|Social disadvantage|social disadvantage
4737392|NCT03003117|Randomized controlled trial|randomized controlled trial
4737393|NCT03003117|Education|education
4737394|NCT03003117|Food vouchers|food vouchers
4737395|NCT03003104|Skin diseases|skin diseases
4737396|NCT03003104|rosacea|rosacea
4737397|NCT03003078|Pancreatic cancer|pancreatic cancer
4737398|NCT03003078|Pancreas|pancreas
4737399|NCT03003078|metastases|metastases
4737400|NCT03003078|pancreatic tumour|pancreatic tumour
4737401|NCT03003078|unresectable|unresectable
4737402|NCT03003078|locally advanced|locally advanced
4737403|NCT03003078|implantable|implantable
4737404|NCT03003078|radiographic|radiographic
4737405|NCT03003078|device|device
4737406|NCT03003078|Phosphorous-32|phosphorous-32
4737407|NCT03003078|OncoSil™|oncosil™
4737408|NCT03003078|brachytherapy|brachytherapy
4737409|NCT03003078|FOLFIRINOX|folfirinox
4737410|NCT03003078|gemcitabine|gemcitabine
4737411|NCT03003078|nab-paclitaxel|nab-paclitaxel
4737412|NCT03003078|Abraxane|abraxane
4737413|NCT03003065|Inoperable cholangiocarcinoma|inoperable cholangiocarcinoma
4737414|NCT03003065|Photodynamic therapy|photodynamic therapy
4737415|NCT03003065|Endoscopic retrograde cholangiopancreatography|endoscopic retrograde cholangiopancreatography
4737416|NCT03003052|dental implants|dental implants
4737417|NCT03003052|edentulous|edentulous
4737418|NCT03003052|dental hygiene|dental hygiene
4737419|NCT03003052|evidence-based dentistry|evidence-based dentistry
4737420|NCT03003039|GB241|gb241
4737421|NCT03003039|Rituximab|rituximab
4737422|NCT03003039|B-cell Lymphoma|b-cell lymphoma
4737423|NCT03003026|motor learning|motor learning
4737424|NCT03003026|participation|participation
4737425|NCT03003013|Odontogenic cysts|odontogenic cysts
4737426|NCT03003013|Bone substitutes materials|bone substitutes materials
4737427|NCT03003013|SYMBIOS®|symbios®
4737428|NCT03003013|Platelets rich fibrin (PRF)|platelets rich fibrin (prf)
4737429|NCT03003013|Bone regeneration|bone regeneration
4737430|NCT03002974|Gout|gout
4737431|NCT03002974|Interleukin 1 receptor antagonist|interleukin 1 receptor antagonist
4737432|NCT03002974|IL-1 receptor antagonist|il-1 receptor antagonist
4737433|NCT03002896|Cancer|cancer
4737434|NCT03002896|Caregivers|caregivers
4737435|NCT03002896|Pep-pal|pep-pal
4737436|NCT03002896|Pep-Pal + Treatment as Usual|pep-pal + treatment as usual
4737437|NCT03002896|Treatment as Usual|treatment as usual
4737438|NCT03002857|Laryngeal Mask Airway|laryngeal mask airway
4737439|NCT03002857|Urologic Surgical Procedure|urologic surgical procedure
4737440|NCT03002831|CIK|cik
4737441|NCT03002831|Chemotherapy|chemotherapy
4737442|NCT03002831|Pancreatic Cancer|pancreatic cancer
4737443|NCT03002818|Chronic Hepatitis C (HCV)|chronic hepatitis c (hcv)
4737444|NCT03002818|Genotype 1|genotype 1
4737445|NCT03002818|Paritaprevir|paritaprevir
4737446|NCT03002818|Ritonavir|ritonavir
4737447|NCT03002818|ombitasvir|ombitasvir
4737448|NCT03002818|Dasabuvir|dasabuvir
4737449|NCT03002818|Sustained Virological Response|sustained virological response
4737450|NCT03002805|Phase I|phase i
4737451|NCT03002805|CBT-1®|cbt-1®
4737452|NCT03002805|Doxorubicin|doxorubicin
4737453|NCT03002805|Sarcoma|sarcoma
4737454|NCT03002792|anesthesia|anesthesia
4737455|NCT03002792|neurodevelopment|neurodevelopment
4737456|NCT03002792|dental caries|dental caries
4737457|NCT03002753|OCD|ocd
4737458|NCT03002753|obsessive-compulsive disorder|obsessive-compulsive disorder
4737459|NCT03002753|cognitive therapy|cognitive therapy
4737460|NCT03002753|metacognitive therapy|metacognitive therapy
4737461|NCT03002753|cognitive restructuring|cognitive restructuring
4737462|NCT03002753|detached mindfulness|detached mindfulness
4737463|NCT03002753|comparison|comparison
4737464|NCT03002753|Germany|germany
4737465|NCT03002753|Muenster|muenster
4737466|NCT03002753|Christoph-Dornier-Stiftung|christoph-dornier-stiftung
4737467|NCT03002753|metacognition|metacognition
4737468|NCT03002727|Colorectal cancer|colorectal cancer
4737469|NCT03002727|Microsatellite|microsatellite
4737470|NCT03002727|Colorectal cancer stem cells|colorectal cancer stem cells
4737471|NCT03002714|Resistance Training|resistance training
4737472|NCT03002714|Psychological Stress|psychological stress
4737473|NCT03002714|Aging|aging
4737474|NCT03002714|Hypertension|hypertension
4737475|NCT03002714|Autonomic Nervous System|autonomic nervous system
4737476|NCT03002701|Prevention|prevention
4737477|NCT03002701|Critical care|critical care
4737478|NCT03002701|Delirium|delirium
4737479|NCT03002701|Nurse|nurse
4737480|NCT03002701|RCT|rct
4737481|NCT03002675|Adipose tissue|adipose tissue
4737482|NCT03002675|Type 2 diabetes|type 2 diabetes
4737483|NCT03002649|Dermatomyositis|dermatomyositis
4737484|NCT03002649|Tofacitinib|tofacitinib
4737485|NCT03002649|Refractory dermatomyositis|refractory dermatomyositis
4737486|NCT03002636|Obesity|obesity
4737487|NCT03002636|Anesthesia Complications|anesthesia complications
4737488|NCT03002636|Body Mass Index (BMI)|body mass index (bmi)
4737489|NCT03002623|Dual Inhibitor of HDAC and P13K Signaling|dual inhibitor of hdac and p13k signaling
4737490|NCT03002623|HDAC2|hdac2
4737491|NCT03002623|EGFR/RAS/RAF/MEK/ERK Signaling Pathway Inhibition|egfr/ras/raf/mek/erk signaling pathway inhibition
4737492|NCT03002584|IBS, population|ibs, population
4737493|NCT03002558|Hypertension|hypertension
4737494|NCT03002558|Continuous Positive Airway Pressure|continuous positive airway pressure
4737495|NCT03002558|Obstructive Sleep Apnea|obstructive sleep apnea
4737496|NCT03002558|Cardiovascular Diseases|cardiovascular diseases
4737497|NCT03002545|Magnesium|magnesium
4737498|NCT03002545|Type II diabetes|type ii diabetes
4737499|NCT03002545|magnesium-sensitive genes|magnesium-sensitive genes
4737500|NCT03002532|Breast cancer|breast cancer
4737501|NCT03002532|Brain metastasis|brain metastasis
4737502|NCT03002532|Whole brain radiotherapy|whole brain radiotherapy
4737503|NCT03002532|Hippocampal avoidance|hippocampal avoidance
4737504|NCT03002532|Neurocognitive function|neurocognitive function
4737505|NCT03002532|intracranial failure|intracranial failure
4737506|NCT03002506|ceftolozane|ceftolozane
4737507|NCT03002506|tazobactam|tazobactam
4737508|NCT03002493|Rifampicin|rifampicin
4737509|NCT03002493|Pharmacokinetics|pharmacokinetics
4737510|NCT03002493|Eribulin Mesylate|eribulin mesylate
4737511|NCT03002493|E7389|e7389
4737512|NCT03002493|Advanced Solid Tumors|advanced solid tumors
4737513|NCT03002493|Tumors|tumors
4737514|NCT03002454|99mTc Pertechnetate|99mtc pertechnetate
4737515|NCT03002454|Sodium Pertechnetate|sodium pertechnetate
4737516|NCT03002454|Technetium|technetium
4737517|NCT03002454|Molybdenum|molybdenum
4737518|NCT03002454|MDP|mdp
4737519|NCT03002454|neutron activation|neutron activation
4737520|NCT03002402|asthma|asthma
4737521|NCT03002402|insomnia|insomnia
4737522|NCT03002402|cognitive-behavioral treatment|cognitive-behavioral treatment
4737625|NCT03001752|flapless|flapless
4737523|NCT03002389|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
4737524|NCT03002389|COPD|copd
4737525|NCT03002389|emphysema|emphysema
4737526|NCT03002389|MRI|mri
4737527|NCT03002389|hyper polarized gas MRI|hyper polarized gas mri
4737528|NCT03002363|autism|autism
4737529|NCT03002363|audiology|audiology
4737530|NCT03002363|video modeling|video modeling
4737531|NCT03002363|testing compliance|testing compliance
4737532|NCT03002350|Circulating tumor cells (CTCs)|circulating tumor cells (ctcs)
4737533|NCT03002350|Optically induced dielectrophoresis (ODEP)|optically induced dielectrophoresis (odep)
4737534|NCT03002350|Cell sorting|cell sorting
4737535|NCT03002350|Next-generation sequencing (NGS)|next-generation sequencing (ngs)
4737536|NCT03002350|disruptive mutation|disruptive mutation
4737537|NCT03002337|aromatherapy massage, yoga|aromatherapy massage, yoga
4737538|NCT03002324|Vaccines|vaccines
4737539|NCT03002324|Childhood Vaccination|childhood vaccination
4737540|NCT03002324|Decision Making|decision making
4737541|NCT03002324|Health Belief Model|health belief model
4737542|NCT03002311|Bioinformatics|bioinformatics
4737543|NCT03002311|Electronic pharmacology|electronic pharmacology
4737544|NCT03002311|Mobile health|mobile health
4737545|NCT03002311|Electronic health|electronic health
4737546|NCT03002311|Adherence|adherence
4737547|NCT03002311|Digital health|digital health
4737548|NCT03002311|Health information technology|health information technology
4737549|NCT03002311|mHealth|mhealth
4737550|NCT03002311|eHealth|ehealth
4737551|NCT03002259|cardiac surgery|cardiac surgery
4737552|NCT03002233|TRK-820|trk-820
4737553|NCT03002233|Hemodialysis|hemodialysis
4737554|NCT03002233|Uremic Pruritus|uremic pruritus
4737555|NCT03002194|rhytides|rhytides
4737556|NCT03002194|wrinkle|wrinkle
4737557|NCT03002142|Alzheimer|alzheimer
4737558|NCT03002142|Hearing loss|hearing loss
4737559|NCT03002142|Cognition|cognition
4737560|NCT03002142|Quality of life|quality of life
4737561|NCT03002142|Hearing aids|hearing aids
4737562|NCT03002090|iron deficiency|iron deficiency
4737563|NCT03002090|anemia|anemia
4737564|NCT03002090|exercise training|exercise training
4737565|NCT03002090|aerobic|aerobic
4737566|NCT03002090|performance|performance
4737567|NCT03002090|Chinese medicine|chinese medicine
4737568|NCT03002090|BaZhen KeLi|bazhen keli
4737569|NCT03002064|Esophagus squamous carcinoma|esophagus squamous carcinoma
4737570|NCT03002064|First-line chemotherapy|first-line chemotherapy
4737571|NCT03002064|Docetaxel|docetaxel
4737572|NCT03002064|Cisplatin|cisplatin
4737573|NCT03002064|5-fluorouracil|5-fluorouracil
4737574|NCT03002038|neuromyelitis optica spectrum disorder|neuromyelitis optica spectrum disorder
4737575|NCT03002038|azathioprine|azathioprine
4737576|NCT03002038|rituximab|rituximab
4737577|NCT03002038|clinical trial|clinical trial
4737578|NCT03002038|annual relapse rate|annual relapse rate
4737579|NCT03002038|expanded disability status scale|expanded disability status scale
4737580|NCT03002012|cryptococcal antigen|cryptococcal antigen
4737581|NCT03002012|preemptive treatment|preemptive treatment
4737582|NCT03002012|CRAG+|crag+
4737583|NCT03002012|sertraline|sertraline
4737584|NCT03002012|fluconazole|fluconazole
4737585|NCT03002012|randomized clinical trial|randomized clinical trial
4737586|NCT03002012|HIV|hiv
4737587|NCT03001999|Diabetes|diabetes
4737588|NCT03001999|Positive Psychology|positive psychology
4737589|NCT03001999|Physical Activity|physical activity
4737590|NCT03001986|safety|safety
4737591|NCT03001986|efficacy|efficacy
4737592|NCT03001986|hand, foot and mouth disease (HFMD)|hand, foot and mouth disease (hfmd)
4737593|NCT03001973|Lupus nephritis|lupus nephritis
4737594|NCT03001973|Patient survival|patient survival
4737595|NCT03001973|Renal survival|renal survival
4737596|NCT03001947|IgA nephropathy|iga nephropathy
4737597|NCT03001947|All-cause mortality|all-cause mortality
4737598|NCT03001947|Cardiovascular mortality|cardiovascular mortality
4737599|NCT03001947|A composite renal outcome|a composite renal outcome
4737600|NCT03001934|Nephrotic syndrome|nephrotic syndrome
4737601|NCT03001934|Treatment response|treatment response
4737602|NCT03001934|Renal function|renal function
4737603|NCT03001921|Hemodialysis|hemodialysis
4737604|NCT03001921|Patient survival|patient survival
4737605|NCT03001921|Quality of life|quality of life
4737606|NCT03001921|Hemodialysis access|hemodialysis access
4737607|NCT03001908|shoulder|shoulder
4737608|NCT03001908|mobilization|mobilization
4737609|NCT03001908|electromyography|electromyography
4737610|NCT03001908|imaging ultrasound|imaging ultrasound
4737611|NCT03001804|Multiple Myeloma|multiple myeloma
4737612|NCT03001804|Revlimid|revlimid
4737613|NCT03001804|Lenalidomide|lenalidomide
4737614|NCT03001804|Non-transplantable|non-transplantable
4737615|NCT03001791|CO2 laser|co2 laser
4737616|NCT03001791|thermal damage zone|thermal damage zone
4737617|NCT03001791|Er:YAG laser|er:yag laser
4737618|NCT03001778|Physical Activity|physical activity
4737619|NCT03001778|Older Adults|older adults
4737620|NCT03001778|Independent Living Facilities|independent living facilities
4737621|NCT03001778|Multimedia technology|multimedia technology
4737622|NCT03001752|post-extraction dental implant|post-extraction dental implant
4737623|NCT03001752|immediate dental implant|immediate dental implant
4737626|NCT03001752|bone grafting|bone grafting
4737627|NCT03001752|CT Cone Beam|ct cone beam
4737628|NCT03001687|hepcidin|hepcidin
4737629|NCT03001687|sepsis|sepsis
4737630|NCT03001687|surgery|surgery
4737631|NCT03001687|vitamin D|vitamin d
4737632|NCT03001661|Propess|propess
4737633|NCT03001661|Dilapan-S|dilapan-s
4737634|NCT03001661|Dinoprostone|dinoprostone
4737635|NCT03001661|Labour|labour
4737636|NCT03001661|Induction|induction
4737637|NCT03001661|Child birth|child birth
4737638|NCT03001596|Neoadjuvant Chemoradiotherapy|neoadjuvant chemoradiotherapy
4737639|NCT03001596|Neoadjuvant Chemotherapy|neoadjuvant chemotherapy
4737640|NCT03001596|Minimally Invasive Esophagectomy|minimally invasive esophagectomy
4737641|NCT03001596|Esophageal Squamous Cell Carcinoma（cT3-4aN0-1M0）|esophageal squamous cell carcinoma（ct3-4an0-1m0）
4737642|NCT03001583|Mediterranean diet|mediterranean diet
4737643|NCT03001583|weight loss|weight loss
4737644|NCT03001583|type 2 diabetes|type 2 diabetes
4737645|NCT03001583|education program|education program
4737646|NCT03001583|cooking|cooking
4737647|NCT03001557|Mild to Moderate Alzheimer's Disease Dementia|mild to moderate alzheimer's disease dementia
4737648|NCT03001557|sleep|sleep
4737649|NCT03001557|circadian rhythms|circadian rhythms
4737650|NCT03001531|Complete paraplegia|complete paraplegia
4737651|NCT03001466|Cataract|cataract
4737652|NCT03001466|Urea-loaded NPs|urea-loaded nps
4737653|NCT03001466|TEM examination|tem examination
4737654|NCT03001453|Exparel|exparel
4737655|NCT03001453|total hip replacement|total hip replacement
4737656|NCT03001453|bupivacaine|bupivacaine
4737657|NCT03001440|REMS|rems
4737658|NCT03001440|Smoking cessation|smoking cessation
4737659|NCT03001440|WELLBUTRIN|wellbutrin
4737660|NCT03001440|ZYBAN|zyban
4737661|NCT03001440|Neuropsychiatric adverse events|neuropsychiatric adverse events
4737662|NCT03001388|Cystic Fibrosis Liver Disease|cystic fibrosis liver disease
4737663|NCT03001388|Pancreatic insufficiency|pancreatic insufficiency
4737664|NCT03001388|Cystic Fibrosis|cystic fibrosis
4737665|NCT03001388|Transient Elastography|transient elastography
4737666|NCT03001375|Laparoscopic colectomy.|laparoscopic colectomy.
4737667|NCT03001375|Splenic flexure mobilization.|splenic flexure mobilization.
4737668|NCT03001375|Anastomotic leakage.|anastomotic leakage.
4737669|NCT03001349|Malignant neoplasms of digestive organs|malignant neoplasms of digestive organs
4737670|NCT03001349|Neuroendocrine Tumors|neuroendocrine tumors
4737671|NCT03001349|NET|net
4737672|NCT03001349|Malignant neoplasms of eye brain and other parts of central nervous system|malignant neoplasms of eye brain and other parts of central nervous system
4737673|NCT03001349|PET/CT scan|pet/ct scan
4737674|NCT03001349|68Ga-DOTATOC|68ga-dotatoc
4737675|NCT03001336|Thyroid|thyroid
4737676|NCT03001336|Diabetes Mellitus|diabetes mellitus
4737677|NCT03001297|atherosclerosis; acute coronary syndrome; MEDI5884|atherosclerosis; acute coronary syndrome; medi5884
4737678|NCT03001271|Angiotensin-(1-7)|angiotensin-(1-7)
4737679|NCT03001271|Renin-angiotensin System|renin-angiotensin system
4737680|NCT03001271|Autonomic Nervous System|autonomic nervous system
4737681|NCT03001245|adolescents|adolescents
4737682|NCT03001245|depression|depression
4737683|NCT03001245|psychotherapy|psychotherapy
4737684|NCT03001245|interpersonal therapy|interpersonal therapy
4737685|NCT03001232|Movement-oriented Dementia Care|movement-oriented dementia care
4737686|NCT03001232|QoL|qol
4737687|NCT03001232|ADL|adl
4737688|NCT03001232|Nursing Home|nursing home
4737689|NCT03001193|Primary slow progress|primary slow progress
4737690|NCT03001193|Prolonged latent phase|prolonged latent phase
4737691|NCT03001193|Labor arrest|labor arrest
4737692|NCT03001180|Generalized Lymphatic Anomaly|generalized lymphatic anomaly
4737693|NCT03001180|Vascular Anomaly|vascular anomaly
4737694|NCT03001180|Kaposiform Hemangioendothelioma|kaposiform hemangioendothelioma
4737695|NCT03001180|Kaposiform Lymphangiomatosis|kaposiform lymphangiomatosis
4737696|NCT03001180|Vascular Endothelial Growth Factor|vascular endothelial growth factor
4737697|NCT03001180|Biomarkers|biomarkers
4737698|NCT03001180|GLA|gla
4737699|NCT03001180|KLA|kla
4737700|NCT03001180|KHE|khe
4737701|NCT03001180|GSD|gsd
4737702|NCT03001167|Microbiome|microbiome
4737703|NCT03001167|Antibiotics|antibiotics
4737704|NCT03001167|Growth|growth
4737705|NCT03001141|MultiPoint Pacing|multipoint pacing
4737706|NCT03001141|Heart Failure|heart failure
4737707|NCT03001141|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
4737708|NCT03001141|Quadripolar pacing|quadripolar pacing
4737709|NCT03001115|Adalimumab|adalimumab
4737710|NCT03001115|Safety|safety
4737711|NCT03001115|Hidradenitis Suppurativa|hidradenitis suppurativa
4737712|NCT03001115|Korean participants|korean participants
4737713|NCT03001102|Preoperative Care|preoperative care
4737714|NCT03001102|Baths|baths
4737715|NCT03001102|Chlorhexidine|chlorhexidine
4737716|NCT03001102|Soaps|soaps
4737717|NCT03001102|Povidone-Iodine|povidone-iodine
4737718|NCT03001102|Arthroplasty, Replacement, Hip|arthroplasty, replacement, hip
4737719|NCT03001102|Surgical Wound Infection|surgical wound infection
4737720|NCT03001089|Neonatology|neonatology
4737721|NCT03001089|Endocrinology|endocrinology
4737722|NCT03001076|hyperlididemia|hyperlididemia
4737723|NCT03001076|LDL|ldl
4737724|NCT03001076|cholesterol|cholesterol
4737725|NCT03001076|statin intolerance|statin intolerance
4737726|NCT03001037|Functional Outcome Measures|functional outcome measures
4737727|NCT03001037|Wearable Sensors|wearable sensors
4737728|NCT03001037|ViMove|vimove
4737729|NCT03001037|Low Back Pain|low back pain
4737730|NCT03001037|Range of Movement|range of movement
4737731|NCT03001037|Muscle Activity|muscle activity
4737732|NCT03000998|HPV|hpv
4737733|NCT03000998|Cancer|cancer
4737734|NCT03000985|schizophrenia|schizophrenia
4737735|NCT03000985|psychoeducation program|psychoeducation program
4737736|NCT03000985|family caregiver|family caregiver
4737737|NCT03000985|relapse|relapse
4737738|NCT03000985|medication adherence|medication adherence
4737739|NCT03000985|burden|burden
4737740|NCT03000972|Augmentation|augmentation
4737741|NCT03000972|PET-CT|pet-ct
4737742|NCT03000972|Positron Emission Tomography|positron emission tomography
4737743|NCT03000972|Fluorine-18|fluorine-18
4737744|NCT03000946|Pancreatectomy|pancreatectomy
4737745|NCT03000946|Somatostatin analogue|somatostatin analogue
4737746|NCT03000946|Octreotide|octreotide
4737747|NCT03000946|Pancreatic fistula|pancreatic fistula
4737748|NCT03000920|short message service (SMS)|short message service (sms)
4737749|NCT03000920|screening|screening
4737750|NCT03000920|cost-effectiveness|cost-effectiveness
4737751|NCT03000907|prevention|prevention
4737752|NCT03000907|frailty|frailty
4737753|NCT03000907|obese|obese
4737754|NCT03000907|elderly|elderly
4737755|NCT03000907|physical exercise|physical exercise
4737756|NCT03000894|cognitive-behavioral therapy for insomnia|cognitive-behavioral therapy for insomnia
4737757|NCT03000894|insomnia|insomnia
4737758|NCT03000894|mood disorder|mood disorder
4737759|NCT03000868|Colonic Polyps|colonic polyps
4737760|NCT03000868|Endoscopic Mucosal Resection|endoscopic mucosal resection
4737761|NCT03000868|Colonoscopy|colonoscopy
4737762|NCT03000855|Malignant biliary obstruction|malignant biliary obstruction
4737763|NCT03000855|EUS - guided choledocho-duodenostomy|eus - guided choledocho-duodenostomy
4737764|NCT03000855|ERCP with covered metallic stents|ercp with covered metallic stents
4737765|NCT03000842|autonomic control|autonomic control
4737766|NCT03000842|transcutaneous vagal nerve stimulation|transcutaneous vagal nerve stimulation
4737767|NCT03000842|transauricular vagal nerve stimulation|transauricular vagal nerve stimulation
4737768|NCT03000829|Code blue|code blue
4737769|NCT03000829|Code team|code team
4737770|NCT03000829|Crisis team leadership|crisis team leadership
4737771|NCT03000829|Cardiopulmonary resuscitation|cardiopulmonary resuscitation
4737772|NCT03000829|Telemedicine|telemedicine
4737773|NCT03000829|Simulation|simulation
4737774|NCT03000829|Mock code|mock code
4737775|NCT03000829|In-hospital cardiac arrest|in-hospital cardiac arrest
4737776|NCT03000790|Anterior disc displacement|anterior disc displacement
4737777|NCT03000790|TMD therapy|tmd therapy
4737778|NCT03000790|internal derangement|internal derangement
4737779|NCT03000790|Lingual Ring|lingual ring
4737780|NCT03000777|melatonin|melatonin
4737781|NCT03000777|zinc|zinc
4737782|NCT03000777|Myalgic Encephalomyelitis|myalgic encephalomyelitis
4737783|NCT03000777|Chronic Fatigue Syndrome|chronic fatigue syndrome
4737784|NCT03000777|sleep|sleep
4737785|NCT03000777|pain|pain
4737786|NCT03000764|Skin biopsy|skin biopsy
4737787|NCT03000764|Radiotherapy|radiotherapy
4737788|NCT03000764|RNA biomarker|rna biomarker
4737789|NCT03000764|HSP biomarker|hsp biomarker
4737790|NCT03000764|Exon junction array|exon junction array
4737791|NCT03000764|Gene expression|gene expression
4737792|NCT03000764|Radiosensitivity prediction|radiosensitivity prediction
4737793|NCT03000751|CT scan|ct scan
4737794|NCT03000751|CT exam|ct exam
4737795|NCT03000751|ionizing radiation|ionizing radiation
4737796|NCT03000751|medical imaging|medical imaging
4737797|NCT03000751|cat scan|cat scan
4737798|NCT03000751|radiation|radiation
4737799|NCT03000738|CD16- monocyte/CD16+ monocyte ratio|cd16- monocyte/cd16+ monocyte ratio
4737800|NCT03000738|CytoDiff flow cytometric system|cytodiff flow cytometric system
4737801|NCT03000738|Diffuse Large B Cell Lymphoma|diffuse large b cell lymphoma
4737802|NCT03000738|Peripheral T-Cell Lymphoma|peripheral t-cell lymphoma
4737803|NCT03000738|prognosis|prognosis
4737804|NCT03000712|adipose tissue derived mesenchymal stem cell|adipose tissue derived mesenchymal stem cell
4737805|NCT03000712|osteoarthritis|osteoarthritis
4737806|NCT03000712|degenerative arthritis|degenerative arthritis
4737807|NCT03000712|kyung hee university hospital|kyung hee university hospital
4737808|NCT03000712|biostar|biostar
4737809|NCT03000712|Rbio|rbio
4737810|NCT03000712|Osteoarthritis, Knee|osteoarthritis, knee
4737811|NCT03000712|High tibial osteotomy|high tibial osteotomy
4737812|NCT03000712|Joint Diseases|joint diseases
4737813|NCT03000699|cognitive bias modification|cognitive bias modification
4737814|NCT03000699|interpretation bias|interpretation bias
4737815|NCT03000699|suicidal ideation|suicidal ideation
4737816|NCT03000699|depression|depression
4737817|NCT03000686|GSK2586881, Acute hypoxia, Exercise|gsk2586881, acute hypoxia, exercise
4737818|NCT03000660|Amyloidosis|amyloidosis
4737819|NCT03000660|AL Amyloidosis|al amyloidosis
4737820|NCT03000660|Amyloid Light Chain Amylodosis|amyloid light chain amylodosis
4737821|NCT03000660|ABT-199|abt-199
4737822|NCT03000660|Venetoclax|venetoclax
4738025|NCT02999503|nutrition|nutrition
4737823|NCT03000647|Pelvic floor muscle exercise|pelvic floor muscle exercise
4737824|NCT03000647|Supervision|supervision
4737825|NCT03000647|Physiotherapy|physiotherapy
4737826|NCT03000621|MicroRNA|microrna
4737827|NCT03000621|miR-122|mir-122
4737828|NCT03000621|Diagnosis|diagnosis
4737829|NCT03000621|Prognosis|prognosis
4737830|NCT03000595|eczema|eczema
4737831|NCT03000569|Parkinson|parkinson
4737832|NCT03000543|vitamin A|vitamin a
4737833|NCT03000543|vitamin A isotope|vitamin a isotope
4737834|NCT03000543|Inflammation|inflammation
4737835|NCT03000530|Depression|depression
4737836|NCT03000517|levofloxacin|levofloxacin
4737837|NCT03000517|multi-drug resistant TB|multi-drug resistant tb
4737838|NCT03000517|pharmacokinetics|pharmacokinetics
4737839|NCT03000465|pneumoperitoneum pressure|pneumoperitoneum pressure
4737840|NCT03000465|laparoscopic pressure|laparoscopic pressure
4737841|NCT03000465|intra-abdominal insufflation|intra-abdominal insufflation
4737842|NCT03000465|intra-abdominal pressures|intra-abdominal pressures
4737843|NCT03000465|abdominal compliance|abdominal compliance
4737844|NCT03000452|Multiple Myeloma|multiple myeloma
4737845|NCT03000452|Daratumumab|daratumumab
4737846|NCT03000452|Durvalumab|durvalumab
4737847|NCT03000452|Relapsed and Refractory Multiple Myeloma|relapsed and refractory multiple myeloma
4737848|NCT03000439|systemic Juvenile Idiopathic Arthritis|systemic juvenile idiopathic arthritis
4737849|NCT03000439|Xeljanz|xeljanz
4737850|NCT03000439|Tofacitinib|tofacitinib
4737851|NCT03000439|sJIA|sjia
4737852|NCT03000439|CP-690 550|cp-690 550
4737853|NCT03000426|Low level laser therapy|low level laser therapy
4737854|NCT03000387|Nicotine Replacement Therapy|nicotine replacement therapy
4737855|NCT03000387|Smoking Cessation|smoking cessation
4737856|NCT03000387|Randomized Clinical Trial|randomized clinical trial
4737857|NCT03000387|Nicotine Patch|nicotine patch
4737858|NCT03000387|Abstinence|abstinence
4737859|NCT03000387|Placebo|placebo
4737860|NCT03000387|Double blind|double blind
4737861|NCT03000361|Colonoscopy|colonoscopy
4737862|NCT03000361|motorized spiral endoscopy|motorized spiral endoscopy
4737863|NCT03000361|adenoma detection rate|adenoma detection rate
4737864|NCT03000348|Exacerbation|exacerbation
4737865|NCT03000348|CF|cf
4737866|NCT03000348|Lung disease|lung disease
4737867|NCT03000348|Lung infection|lung infection
4737868|NCT03000348|Gram negative|gram negative
4737869|NCT03000348|Bacterial Infection|bacterial infection
4737870|NCT03000348|pneumonia|pneumonia
4737871|NCT03000348|bronchitis|bronchitis
4737872|NCT03000335|microRNA|microrna
4737873|NCT03000335|relapse|relapse
4737874|NCT03000335|blood|blood
4737875|NCT03000335|in vitro diagnostics|in vitro diagnostics
4737876|NCT03000335|prediction|prediction
4737877|NCT03000335|lab test|lab test
4737878|NCT03000296|autologous|autologous
4737879|NCT03000296|lymphoablation|lymphoablation
4737880|NCT03000296|hematopoetic stem cell transplant|hematopoetic stem cell transplant
4737881|NCT03000296|immune system|immune system
4737882|NCT03000296|Bone marrow transplant|bone marrow transplant
4737883|NCT03000283|Conivaptan|conivaptan
4737884|NCT03000270|Infarct Size|infarct size
4737885|NCT03000270|Impella|impella
4737886|NCT03000270|Unloading|unloading
4737887|NCT03000270|Left Ventricle|left ventricle
4737888|NCT03000270|PPCI|ppci
4737889|NCT03000270|STEMI|stemi
4737890|NCT03000257|Cancer|cancer
4737891|NCT03000257|Advanced Solid Tumors|advanced solid tumors
4737892|NCT03000257|Non-small cell lung cancer (NSCLC)|non-small cell lung cancer (nsclc)
4737893|NCT03000257|Triple negative breast cancer|triple negative breast cancer
4737894|NCT03000257|Ovarian cancer|ovarian cancer
4737895|NCT03000257|Hepatocellular carcinoma|hepatocellular carcinoma
4737896|NCT03000257|Gastric cancer|gastric cancer
4737897|NCT03000257|Small cell lung cancer|small cell lung cancer
4737898|NCT03000257|Mesothelioma|mesothelioma
4737899|NCT03000257|Cholangiocarcinoma|cholangiocarcinoma
4737900|NCT03000257|Merkel cell carcinoma|merkel cell carcinoma
4737901|NCT03000257|Head and neck cancer|head and neck cancer
4737902|NCT03000244|Natural History|natural history
4737903|NCT03000244|HCT|hct
4737904|NCT03000205|Dextrose prolotherapy|dextrose prolotherapy
4737905|NCT03000205|patients|patients
4737906|NCT03000192|Survivorship|survivorship
4737907|NCT03000192|Cancer|cancer
4737908|NCT03000192|Recovery|recovery
4737909|NCT03000192|Self-management|self-management
4737910|NCT03000192|Cohort|cohort
4737911|NCT03000179|small bowel cancer, small bowel carcinoma|small bowel cancer, small bowel carcinoma
4737912|NCT03000127|testosterone|testosterone
4737913|NCT03000127|multiple sclerosis|multiple sclerosis
4737914|NCT03000127|fatigue|fatigue
4737915|NCT03000114|Collagenase injection|collagenase injection
4737916|NCT03000114|percutaneous needle aponeurotomy|percutaneous needle aponeurotomy
4737917|NCT03000101|Biomarkers|biomarkers
4737918|NCT03000101|Colitis|colitis
4737919|NCT03000101|Colitis, Ulcerative|colitis, ulcerative
4737920|NCT03000101|Colonic Diseases|colonic diseases
4737921|NCT03000101|Crohn Disease|crohn disease
4737922|NCT03000101|Digestive System Diseases|digestive system diseases
4737923|NCT03000101|Fruit|fruit
4737924|NCT03000101|Fruit and Vegetable Juices|fruit and vegetable juices
4737925|NCT03000101|Gastroenteritis|gastroenteritis
4737926|NCT03000101|Gastrointestinal Diseases|gastrointestinal diseases
4737927|NCT03000101|Humans|humans
4737928|NCT03000101|Hydrolysable Tannins|hydrolysable tannins
4737929|NCT03000101|Inflammation|inflammation
4737930|NCT03000101|Inflammatory Bowel Diseases|inflammatory bowel diseases
4737931|NCT03000101|Intestinal Diseases|intestinal diseases
4737932|NCT03000101|Punicaceae|punicaceae
4737933|NCT03000075|BI 655066|bi 655066
4737934|NCT03000075|ABBV-066|abbv-066
4737935|NCT03000075|risankizumab|risankizumab
4737936|NCT03000062|overweight, general practice|overweight, general practice
4737937|NCT03000049|sepsis|sepsis
4737938|NCT03000049|septic shock|septic shock
4737939|NCT03000049|blood cultures|blood cultures
4737940|NCT03000049|anti-infective therapy|anti-infective therapy
4737941|NCT03000036|Breast cancer|breast cancer
4737942|NCT03000036|Doxorubicin|doxorubicin
4737943|NCT03000036|Cardiovascular Magnetic Resonance|cardiovascular magnetic resonance
4737944|NCT03000036|T1 mapping|t1 mapping
4737945|NCT03000023|Hepatitis C|hepatitis c
4737946|NCT03000023|Patient-Reported Outcomes|patient-reported outcomes
4737947|NCT03000023|DAA Treatment|daa treatment
4737948|NCT03000023|Qualitative|qualitative
4737949|NCT03000023|Mixed methods|mixed methods
4737950|NCT03000010|Wound Vac|wound vac
4737951|NCT03000010|Neuromuscular Scoliosis|neuromuscular scoliosis
4737952|NCT03000010|Posterior Spinal Fusion|posterior spinal fusion
4737953|NCT02999997|Physical therapy modalities|physical therapy modalities
4737954|NCT02999997|Dual-task performance|dual-task performance
4737955|NCT02999997|Parkinson's disease|parkinson's disease
4737956|NCT02999997|Active music therapy|active music therapy
4737957|NCT02999997|Physical activity|physical activity
4737958|NCT02999971|circuit class therapy|circuit class therapy
4737959|NCT02999971|ICF model|icf model
4737960|NCT02999971|aquatic therapy|aquatic therapy
4737961|NCT02999971|neuro-rehabilitation|neuro-rehabilitation
4737962|NCT02999945|preterm infants|preterm infants
4737963|NCT02999945|SGA infants|sga infants
4737964|NCT02999945|IUGR infants|iugr infants
4737965|NCT02999945|growth|growth
4737966|NCT02999945|body composition|body composition
4737967|NCT02999945|metabolomics|metabolomics
4737968|NCT02999945|microbiome|microbiome
4737969|NCT02999945|adiposity markers|adiposity markers
4737970|NCT02999945|metabolic programming|metabolic programming
4737971|NCT02999945|neurodevelopmental outcome|neurodevelopmental outcome
4737972|NCT02999906|PAH|pah
4737973|NCT02999906|Oral Treprostinil|oral treprostinil
4737974|NCT02999906|dual therapy|dual therapy
4737975|NCT02999906|6 Minute Walk Test|6 minute walk test
4737976|NCT02999854|Haploidentical stem cell transplantation|haploidentical stem cell transplantation
4737977|NCT02999854|Graft-versus-host disease|graft-versus-host disease
4737978|NCT02999854|Immune reconstitution|immune reconstitution
4737979|NCT02999854|Alloreactive T-cells|alloreactive t-cells
4737980|NCT02999854|Photodynamic treatment|photodynamic treatment
4737981|NCT02999854|Hematologic malignancy|hematologic malignancy
4737982|NCT02999854|Transplant-related mortality|transplant-related mortality
4737983|NCT02999854|Overall survival|overall survival
4737984|NCT02999854|GRFS|grfs
4737985|NCT02999854|GVHD|gvhd
4737986|NCT02999841|Visceral fat|visceral fat
4737987|NCT02999828|safety|safety
4737988|NCT02999828|immune persistence|immune persistence
4737989|NCT02999815|Tetanus|tetanus
4737990|NCT02999802|Nutrient Sensing|nutrient sensing
4737991|NCT02999802|Exercise|exercise
4737992|NCT02999802|Elderly|elderly
4737993|NCT02999789|Asthma/drug therapy|asthma/drug therapy
4737994|NCT02999789|Medication Adherence/statistics & numerical data|medication adherence/statistics & numerical data
4737995|NCT02999789|Reminder Systems|reminder systems
4737996|NCT02999789|Communication Barriers|communication barriers
4737997|NCT02999776|Plaques Psoriasis|plaques psoriasis
4737998|NCT02999776|Topical|topical
4737999|NCT02999776|Laser microporation|laser microporation
4738000|NCT02999763|lipolysis|lipolysis
4738001|NCT02999763|fat reduction|fat reduction
4738002|NCT02999763|circumference reduction|circumference reduction
4738003|NCT02999737|Platelet Rich Plasma|platelet rich plasma
4738004|NCT02999737|PRP|prp
4738005|NCT02999737|Hair loss|hair loss
4738006|NCT02999737|Alopecia|alopecia
4738007|NCT02999737|Hypotrichosis|hypotrichosis
4738008|NCT02999737|Hair diseases|hair diseases
4738009|NCT02999698|Psoriasis|psoriasis
4738010|NCT02999698|Hidradenitis|hidradenitis
4738011|NCT02999698|Psychological impact|psychological impact
4738012|NCT02999698|Quality of life|quality of life
4738013|NCT02999659|pupillometry|pupillometry
4738014|NCT02999659|autonomous nerve system|autonomous nerve system
4738015|NCT02999646|head and neck squamous cell carcinoma|head and neck squamous cell carcinoma
4738016|NCT02999646|cancer|cancer
4738017|NCT02999646|HNSCC|hnscc
4738018|NCT02999646|immunotherapy|immunotherapy
4738019|NCT02999646|MVX-ONCO-1|mvx-onco-1
4738020|NCT02999607|Transcranial direct current stimulation|transcranial direct current stimulation
4738021|NCT02999607|Positron emission tomography|positron emission tomography
4738022|NCT02999529|Chemotherapy|chemotherapy
4738023|NCT02999529|Oncology|oncology
4738024|NCT02999503|adhd treatment|adhd treatment
4738026|NCT02999477|Breast Cancer|breast cancer
4738027|NCT02999464|stroke|stroke
4738028|NCT02999464|qigong|qigong
4738029|NCT02999464|randomized controlled trial|randomized controlled trial
4738030|NCT02999464|body-mind exercise|body-mind exercise
4738031|NCT02999464|balance|balance
4738032|NCT02999464|quality of life|quality of life
4738033|NCT02999464|wellbeing|wellbeing
4738034|NCT02999412|Integrated Healthcare System|integrated healthcare system
4738035|NCT02999412|Inappropriate Prescribing|inappropriate prescribing
4738036|NCT02999412|Pragmatic Clinical Trial|pragmatic clinical trial
4738037|NCT02999412|Crossover Design|crossover design
4738038|NCT02999412|Randomised Controlled Trial|randomised controlled trial
4738039|NCT02999399|Smoker|smoker
4738040|NCT02999399|Former smoker|former smoker
4738041|NCT02999386|stress, hyperglycemia, inflammatory markers, trauma, HbA1c|stress, hyperglycemia, inflammatory markers, trauma, hba1c
4738042|NCT02999386|interleukin-6|interleukin-6
4738043|NCT02999373|prevention, infection, preterm, cord blood mononuclear cells|prevention, infection, preterm, cord blood mononuclear cells
4738044|NCT02999360|Aphasia|aphasia
4738045|NCT02999360|Speech Therapy|speech therapy
4738046|NCT02999360|Aerobic Exercise (AE)|aerobic exercise (ae)
4738047|NCT02999347|Treatment Outcome|treatment outcome
4738048|NCT02999347|Mid-urethral slings|mid-urethral slings
4738049|NCT02999347|Gynecologic Surgery Procedures|gynecologic surgery procedures
4738050|NCT02999334|Group healthcare models|group healthcare models
4738051|NCT02999334|Antenatal care|antenatal care
4738052|NCT02999334|Prenatal care|prenatal care
4738053|NCT02999334|Perinatal health|perinatal health
4738054|NCT02999334|CenteringPregnancy|centeringpregnancy
4738055|NCT02999334|sub-Saharan Africa|sub-saharan africa
4738056|NCT02999334|Malawi|malawi
4738057|NCT02999334|Tanzania|tanzania
4738058|NCT02999334|Pregnancy|pregnancy
4738059|NCT02999308|haemophilia|haemophilia
4738060|NCT02999308|prophylaxis|prophylaxis
4738061|NCT02999308|children|children
4738062|NCT02999282|TMS|tms
4738063|NCT02999282|tDCS|tdcs
4738064|NCT02999282|Rehabilitation|rehabilitation
4738065|NCT02999269|electroconvulsive therapy|electroconvulsive therapy
4738066|NCT02999269|MRI|mri
4738067|NCT02999269|major depressive disorder|major depressive disorder
4738068|NCT02999256|Tart Cherry Juice|tart cherry juice
4738069|NCT02999256|Fat Oxidation|fat oxidation
4738070|NCT02999256|Lipid Profile|lipid profile
4738071|NCT02999256|Anthocyanins|anthocyanins
4738072|NCT02999256|Exercise|exercise
4738073|NCT02999256|Calorie Restrictive Mimetic|calorie restrictive mimetic
4738074|NCT02999230|Cavities|cavities
4738075|NCT02999217|iron isomaltoside|iron isomaltoside
4738076|NCT02999217|plasma ferritin|plasma ferritin
4738077|NCT02999217|haemoglobin|haemoglobin
4738078|NCT02999217|colorectal cancer|colorectal cancer
4738079|NCT02999165|Breastfeeding|breastfeeding
4738080|NCT02999165|CPAP|cpap
4738081|NCT02999165|Humidified High Flow Nasal Cannula Oxygen|humidified high flow nasal cannula oxygen
4738082|NCT02999165|preterm neonate|preterm neonate
4738083|NCT02999152|Bio-markers|bio-markers
4738084|NCT02999152|Radiation|radiation
4738085|NCT02999152|Appropriate therapeutic strategy|appropriate therapeutic strategy
4738086|NCT02999152|Total Body Irradiation|total body irradiation
4738087|NCT02999152|Partial Body Irradiation|partial body irradiation
4738088|NCT02999139|Injury|injury
4738089|NCT02999139|Prevention|prevention
4738090|NCT02999126|Total Intravenous Anesthesia|total intravenous anesthesia
4738091|NCT02999126|Titration|titration
4738092|NCT02999126|Target Controlled Infusion|target controlled infusion
4738093|NCT02999126|Propofol|propofol
4738094|NCT02999126|Bispectral index|bispectral index
4738095|NCT02999113|non-technical skills|non-technical skills
4738096|NCT02999113|patient safety|patient safety
4738097|NCT02999113|medical education|medical education
4738098|NCT02999100|oxytocin|oxytocin
4738099|NCT02999100|non-pregnant|non-pregnant
4738100|NCT02999100|pregnant|pregnant
4738101|NCT02999100|Postpartum Hemorrhage|postpartum hemorrhage
4738102|NCT02999087|Head and Neck cancer|head and neck cancer
4738103|NCT02999087|Immunotherapy|immunotherapy
4738104|NCT02999074|exercise|exercise
4738105|NCT02999074|resistance training|resistance training
4738106|NCT02999074|aerobic training|aerobic training
4738107|NCT02999074|breast cancer|breast cancer
4738108|NCT02999074|neoadjuvant chemotherapy|neoadjuvant chemotherapy
4738109|NCT02999074|fatigue|fatigue
4738110|NCT02999074|quality of life|quality of life
4738111|NCT02999074|tumor response|tumor response
4738112|NCT02999061|pre-term children|pre-term children
4738113|NCT02999048|panax notoginseng saponins|panax notoginseng saponins
4738114|NCT02999048|hypertensive intracerebral hemorrhage|hypertensive intracerebral hemorrhage
4738115|NCT02999048|hematoma|hematoma
4738116|NCT02999048|neurological function|neurological function
4738117|NCT02999035|ocular surface sensitivity|ocular surface sensitivity
4738118|NCT02999022|bone fractures|bone fractures
4738119|NCT02999022|bony callus|bony callus
4738120|NCT02999022|fractures, bone|fractures, bone
4738121|NCT02999022|lithium|lithium
4738122|NCT02999022|lithium carbonate|lithium carbonate
4738123|NCT02999022|osteogenesis|osteogenesis
4738124|NCT02999022|bone development|bone development
4738125|NCT02999022|fracture healing|fracture healing
4738126|NCT02999022|fracture repair|fracture repair
4738127|NCT02998970|Cardiovascular Disease|cardiovascular disease
4738128|NCT02998970|Type 2 Diabetes|type 2 diabetes
4738129|NCT02998970|Cardiac Magnetic Resonance Imaging|cardiac magnetic resonance imaging
4738130|NCT02998957|Acupuncture|acupuncture
4738131|NCT02998957|TENS|tens
4738132|NCT02998957|Physiotherapy|physiotherapy
4738133|NCT02998931|Glutamin|glutamin
4738134|NCT02998931|Enteral Nutrition|enteral nutrition
4738135|NCT02998931|Intensive Care Unit|intensive care unit
4738136|NCT02998931|Critical Care Outcomes|critical care outcomes
4738137|NCT02998931|inflammatory|inflammatory
4738138|NCT02998931|Immune System|immune system
4738139|NCT02998918|Inflammation|inflammation
4738140|NCT02998918|HDL|hdl
4738141|NCT02998918|Anti-inflammatory|anti-inflammatory
4738142|NCT02998918|Supplementation|supplementation
4738143|NCT02998918|Curcumin|curcumin
4738144|NCT02998918|polyphenol|polyphenol
4738145|NCT02998918|V-cam|v-cam
4738146|NCT02998918|I-cam|i-cam
4738147|NCT02998918|atherosclerosis|atherosclerosis
4738148|NCT02998918|cardiovascular disease|cardiovascular disease
4738149|NCT02998918|atherogenesis|atherogenesis
4738150|NCT02998918|antioxidant|antioxidant
4738151|NCT02998918|resveratrol|resveratrol
4738152|NCT02998918|quercetin|quercetin
4738153|NCT02998892|Sedentary Behavior|sedentary behavior
4738154|NCT02998866|Cryoballoon Pulmonary Vein Isolation|cryoballoon pulmonary vein isolation
4738155|NCT02998866|Esophageal Effects|esophageal effects
4738156|NCT02998853|Non culprit|non culprit
4738157|NCT02998853|STEMI PCI|stemi pci
4738158|NCT02998853|angio QFR|angio qfr
4738159|NCT02998853|FFR|ffr
4738160|NCT02998853|Staged procedure|staged procedure
4738161|NCT02998840|elevated blood pressure|elevated blood pressure
4738162|NCT02998814|fissure sealant|fissure sealant
4738163|NCT02998814|etch and rinse|etch and rinse
4738164|NCT02998814|self etch|self etch
4738165|NCT02998788|heart failure|heart failure
4738166|NCT02998788|risk factor|risk factor
4738167|NCT02998788|cardiovascular disease|cardiovascular disease
4738168|NCT02998788|lifestyle behavior|lifestyle behavior
4738169|NCT02998775|in vitro protein binding|in vitro protein binding
4738170|NCT02998775|hepatic impairment|hepatic impairment
4738171|NCT02998775|renal impairment|renal impairment
4738172|NCT02998762|major depression|major depression
4738173|NCT02998762|major depressive disorder|major depressive disorder
4738174|NCT02998762|biomarkers|biomarkers
4738175|NCT02998762|MDD|mdd
4738176|NCT02998762|long term follow up|long term follow up
4738177|NCT02998736|Colon|colon
4738178|NCT02998723|Basic Life Support|basic life support
4738179|NCT02998723|Education, Medical|education, medical
4738180|NCT02998723|Cardiopulmonary Resuscitation|cardiopulmonary resuscitation
4738181|NCT02998723|Learning|learning
4738182|NCT02998697|Systolic Heart Failure|systolic heart failure
4738183|NCT02998697|Anemia|anemia
4738184|NCT02998697|Iron Deficiency|iron deficiency
4738185|NCT02998684|Autism|autism
4738186|NCT02998684|Adolescent|adolescent
4738187|NCT02998684|Social skills|social skills
4738188|NCT02998671|Acne, inflammatory acne, efficacy, safety, PK|acne, inflammatory acne, efficacy, safety, pk
4738189|NCT02998658|Laparoscopy|laparoscopy
4738190|NCT02998658|Barbed sutures|barbed sutures
4738191|NCT02998658|Hysterectomy|hysterectomy
4738192|NCT02998645|severe acquired aplastic anemia|severe acquired aplastic anemia
4738193|NCT02998645|SAA|saa
4738194|NCT02998645|first line|first line
4738195|NCT02998645|eltrombopag|eltrombopag
4738196|NCT02998645|cyclosporine|cyclosporine
4738197|NCT02998645|h-ATG|h-atg
4738198|NCT02998645|severe aplastic anemia|severe aplastic anemia
4738199|NCT02998645|aplastic anemia|aplastic anemia
4738200|NCT02998593|Semen parameters Male infertility oligospermia Traditional Medicine|semen parameters male infertility oligospermia traditional medicine
4738201|NCT02998580|late-life depression|late-life depression
4738202|NCT02998580|treatment resistance|treatment resistance
4738203|NCT02998515|supplemental oxygen|supplemental oxygen
4738204|NCT02998515|concentrator|concentrator
4738205|NCT02998515|endurance shuttle walk test|endurance shuttle walk test
4738206|NCT02998502|Obsessive Compulsive Disorder (OCD)|obsessive compulsive disorder (ocd)
4738207|NCT02998502|Anxiety|anxiety
4738208|NCT02998502|Pediatrics|pediatrics
4738209|NCT02998489|enteral nutrition|enteral nutrition
4738210|NCT02998489|infant,premature|infant,premature
4738211|NCT02998489|feeding method|feeding method
4738212|NCT02998476|Diffuse large B-cell lymphoma|diffuse large b-cell lymphoma
4738213|NCT02998476|relapsed|relapsed
4738214|NCT02998476|refractory|refractory
4738215|NCT02998476|non-Hodgkin lymphoma|non-hodgkin lymphoma
4738216|NCT02998476|phosphatidylinositol 3-kinase δ (PI3Kδ) inhibitor|phosphatidylinositol 3-kinase δ (pi3kδ) inhibitor
4738217|NCT02998476|Bruton's tyrosine kinase (BTK)|bruton's tyrosine kinase (btk)
4738218|NCT02998463|Skin-to-skin|skin-to-skin
4738219|NCT02998463|Kangaroo Care|kangaroo care
4738220|NCT02998463|Kangaroo Mother Care|kangaroo mother care
4738221|NCT02998450|Sickle Cell Disease|sickle cell disease
4738222|NCT02998450|Sickle Beta 0 Thalassemia|sickle beta 0 thalassemia
4738223|NCT02998424|propofol|propofol
4738224|NCT02998424|pupillary diameter|pupillary diameter
4738225|NCT02998411|anti-infectives|anti-infectives
4738226|NCT02998411|adults|adults
4738227|NCT02998411|pharmacokinetic|pharmacokinetic
4738228|NCT02998411|pharmacodynamic end-points|pharmacodynamic end-points
4738229|NCT02998411|clinical cure|clinical cure
4738230|NCT02998398|Biosimilar|biosimilar
4738231|NCT02998385|salivary glands|salivary glands
4738232|NCT02998385|sinus carcinoma|sinus carcinoma
4738233|NCT02998385|radiochemotherapy concomitant|radiochemotherapy concomitant
4738234|NCT02998385|cisplatin|cisplatin
4738235|NCT02998385|protontherapy|protontherapy
4738236|NCT02998346|Nutrition|nutrition
4738237|NCT02998346|CRRT|crrt
4738238|NCT02998346|CVVH|cvvh
4738239|NCT02998346|citrate|citrate
4738240|NCT02998346|anticoagulation|anticoagulation
4738241|NCT02998346|caloric uptake|caloric uptake
4738242|NCT02998333|Instability|instability
4738243|NCT02998333|Ankle|ankle
4738244|NCT02998333|Surgical stabilization|surgical stabilization
4738245|NCT02998281|cerebral palsy|cerebral palsy
4738246|NCT02998281|inspiratory muscle training|inspiratory muscle training
4738247|NCT02998255|PEG|peg
4738248|NCT02998255|Bowel preparation|bowel preparation
4738249|NCT02998255|Colonoscopy|colonoscopy
4738250|NCT02998203|organic diet|organic diet
4738251|NCT02998203|health|health
4738252|NCT02998203|pesticides|pesticides
4738253|NCT02998203|inflammation biomarkers|inflammation biomarkers
4738254|NCT02998203|oxidative stress biomarkers|oxidative stress biomarkers
4738255|NCT02998177|Postoperative pain|postoperative pain
4738256|NCT02998177|Rebound pain|rebound pain
4738257|NCT02998177|Gut microbiome|gut microbiome
4738258|NCT02998177|Gut microbiota|gut microbiota
4738259|NCT02998177|Peripheral nerve block|peripheral nerve block
4738260|NCT02998177|Axillary brachial plexus block|axillary brachial plexus block
4738261|NCT02998138|Chronic Pain|chronic pain
4738262|NCT02998138|Pain, Postoperative|pain, postoperative
4738263|NCT02998112|fecal microbiota transplantation|fecal microbiota transplantation
4738264|NCT02998112|Ulcerative colitis|ulcerative colitis
4738265|NCT02998099|Healthy Volunteers|healthy volunteers
4738266|NCT02998099|Rivipansel|rivipansel
4738267|NCT02998060|Robot|robot
4738268|NCT02998060|Spinal Fusion|spinal fusion
4738269|NCT02998060|Spine|spine
4738270|NCT02998060|Navigation|navigation
4738271|NCT02998060|Freehand|freehand
4738272|NCT02998008|Exercise Therapy|exercise therapy
4738273|NCT02998008|Heart Function Tests|heart function tests
4738274|NCT02998008|Heart/physiology|heart/physiology
4738275|NCT02998008|Echocardiography|echocardiography
4738276|NCT02997995|T2-T4 Breast cancer|t2-t4 breast cancer
4738277|NCT02997995|Estrogen Receptor Positive Tumor|estrogen receptor positive tumor
4738278|NCT02997995|PD-1|pd-1
4738279|NCT02997995|Neoadjuvant|neoadjuvant
4738280|NCT02997995|Immune-attractants|immune-attractants
4738281|NCT02997995|lymphocytes activation|lymphocytes activation
4738282|NCT02997982|Alzheimer's Disease|alzheimer's disease
4738283|NCT02997982|Herpes Simplex Virus|herpes simplex virus
4738284|NCT02997982|HSV|hsv
4738285|NCT02997982|Antiviral Drugs|antiviral drugs
4738286|NCT02997969|HIV|hiv
4738287|NCT02997943|Obesity|obesity
4738288|NCT02997943|Weight Loss|weight loss
4738289|NCT02997943|Diet|diet
4738290|NCT02997943|Physical Activity|physical activity
4738291|NCT02997943|Mobile Health|mobile health
4738292|NCT02997904|lice comb|lice comb
4738293|NCT02997904|human head lice infestations|human head lice infestations
4738294|NCT02997904|combing solution|combing solution
4738295|NCT02997891|cognition|cognition
4738296|NCT02997891|hip replacement|hip replacement
4738297|NCT02997891|physical activity|physical activity
4738298|NCT02997891|quality of life|quality of life
4738299|NCT02997891|psychological distress|psychological distress
4738300|NCT02997878|autoimmune|autoimmune
4738301|NCT02997878|AiH|aih
4738302|NCT02997878|PSC|psc
4738303|NCT02997878|liver disease|liver disease
4738304|NCT02997878|cholangitis|cholangitis
4738305|NCT02997865|heart failure|heart failure
4738306|NCT02997865|depressive disorder, major|depressive disorder, major
4738307|NCT02997865|cognitive therapy|cognitive therapy
4738308|NCT02997865|antidepressive agents|antidepressive agents
4738309|NCT02997865|self-care|self-care
4738310|NCT02997852|human-animal interaction|human-animal interaction
4738311|NCT02997787|adenomyosis|adenomyosis
4738312|NCT02997787|leiomyoma|leiomyoma
4738313|NCT02997787|neutrophil to lymphocyte ratio|neutrophil to lymphocyte ratio
4738314|NCT02997787|platelet to lymphocyte ratio|platelet to lymphocyte ratio
4738315|NCT02997748|acute kidney injury|acute kidney injury
4738316|NCT02997748|cardiac surgery|cardiac surgery
4738317|NCT02997748|Remote ischemic preconditioning|remote ischemic preconditioning
4738318|NCT02997748|[TIMP-2]*[IGFBP7]|[timp-2]*[igfbp7]
4738319|NCT02997735|Secondhand Smoke|secondhand smoke
4738320|NCT02997735|Nicotine Replacement Therapy|nicotine replacement therapy
4738321|NCT02997735|Clinical Decision Support|clinical decision support
4738322|NCT02997735|Tobacco quitline|tobacco quitline
4738323|NCT02997722|ketamine|ketamine
4738324|NCT02997722|suicide|suicide
4738325|NCT02997709|Prostate Cancer|prostate cancer
4738326|NCT02997709|Circulating Tumor Cells|circulating tumor cells
4738327|NCT02997709|CTCs|ctcs
4740297|NCT02984761|Neoplasms|neoplasms
4738328|NCT02997709|Androgen Deprivation Therapy|androgen deprivation therapy
4738329|NCT02997709|ADT|adt
4738330|NCT02997670|Cardiac resynchronization pacing therapy|cardiac resynchronization pacing therapy
4738331|NCT02997644|patient education|patient education
4738332|NCT02997644|orthopaedic surgery|orthopaedic surgery
4738333|NCT02997644|post-surgical pain|post-surgical pain
4738334|NCT02997644|chronic opioid use|chronic opioid use
4738335|NCT02997631|Pain Management|pain management
4738336|NCT02997631|Distraction Therapy|distraction therapy
4738337|NCT02997631|Robot Based Distraction|robot based distraction
4738338|NCT02997631|MEDi|medi
4738339|NCT02997605|low disease activity|low disease activity
4738340|NCT02997605|remission|remission
4738341|NCT02997566|Autonomic Nervous System|autonomic nervous system
4738342|NCT02997566|Sympathetic Nervous System|sympathetic nervous system
4738343|NCT02997566|Heart Rate|heart rate
4738344|NCT02997553|Indocyanine green (ICG)|indocyanine green (icg)
4738345|NCT02997553|Sentinel lymph node biopsy|sentinel lymph node biopsy
4738346|NCT02997553|Technetium99|technetium99
4738347|NCT02997553|Tumors|tumors
4738348|NCT02997553|Optonuclear probe|optonuclear probe
4738349|NCT02997553|Surgery|surgery
4738350|NCT02997540|female breast lesion|female breast lesion
4738351|NCT02997540|ultrasound examination|ultrasound examination
4738352|NCT02997514|Solution focused coaching|solution focused coaching
4738353|NCT02997514|Self determination|self determination
4738354|NCT02997488|videolaryngoscope|videolaryngoscope
4738355|NCT02997475|Bulimia Nervosa|bulimia nervosa
4738356|NCT02997475|Bulimia|bulimia
4738357|NCT02997475|fMRI|fmri
4738358|NCT02997475|Emotion Regulation|emotion regulation
4738359|NCT02997475|Response Inhibition|response inhibition
4738360|NCT02997462|Monocyte|monocyte
4738361|NCT02997462|Oxidative Stress|oxidative stress
4738362|NCT02997462|Endothelial Function|endothelial function
4738363|NCT02997462|Congestive Heart Failure|congestive heart failure
4738364|NCT02997449|Non-Small Cell Lung Cancer (NSCLC)|non-small cell lung cancer (nsclc)
4738365|NCT02997449|Stereotactic ablative radiotherapy (SABR)|stereotactic ablative radiotherapy (sabr)
4738366|NCT02997449|Intrathoracic nodal staging|intrathoracic nodal staging
4738367|NCT02997423|Glioblastoma Multiforme|glioblastoma multiforme
4738368|NCT02997423|Biomarker|biomarker
4738369|NCT02997423|Cytochrome C Oxidase|cytochrome c oxidase
4738370|NCT02997423|Newly diagnosed|newly diagnosed
4738371|NCT02997410|Ozone|ozone
4738372|NCT02997371|Traumatic brain injury|traumatic brain injury
4738373|NCT02997371|Microdialysis|microdialysis
4738374|NCT02997371|Interleukin-1 receptor antagonist|interleukin-1 receptor antagonist
4738375|NCT02997371|Magnetic Resonance Imaging|magnetic resonance imaging
4738376|NCT02997371|Positron Emission Tomography|positron emission tomography
4738377|NCT02997345|PPROM|pprom
4738378|NCT02997319|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
4738379|NCT02997319|Insulin Resistance|insulin resistance
4738380|NCT02997319|Shift Work|shift work
4738381|NCT02997319|Circadian Rhythms|circadian rhythms
4738382|NCT02997319|MTNR1B|mtnr1b
4738383|NCT02997306|Moh's Surgery|moh's surgery
4738384|NCT02997306|Erythema|erythema
4738385|NCT02997306|Face|face
4738386|NCT02997306|Simple Interrupted Sutures|simple interrupted sutures
4738387|NCT02997306|Running Sutures|running sutures
4738388|NCT02997306|Image Processing|image processing
4738389|NCT02997280|acute graft-versus-host disease|acute graft-versus-host disease
4738390|NCT02997280|chronic graft-versus-host disease|chronic graft-versus-host disease
4738391|NCT02997280|Steroid-refractory GVHD|steroid-refractory gvhd
4738392|NCT02997280|ruxolitinib|ruxolitinib
4738393|NCT02997280|JAK inhibitors|jak inhibitors
4738394|NCT02997254|atrial fibrillation|atrial fibrillation
4738395|NCT02997254|ablation|ablation
4738396|NCT02997254|abnormal heart rhythm|abnormal heart rhythm
4738397|NCT02997241|Colonic Neoplasms|colonic neoplasms
4738398|NCT02997241|recurrence|recurrence
4738399|NCT02997215|intravenous lidocaine|intravenous lidocaine
4738400|NCT02997215|postoperative pain management|postoperative pain management
4738401|NCT02997202|Gilteritinib|gilteritinib
4738402|NCT02997202|ASP2215|asp2215
4738403|NCT02997202|Safety and Efficacy|safety and efficacy
4738404|NCT02997202|Acute Myeloid Leukemia|acute myeloid leukemia
4738405|NCT02997150|Idiopathic nephrotic syndrome-child-steroid dependant-IL2|idiopathic nephrotic syndrome-child-steroid dependant-il2
4738406|NCT02997150|Safety|safety
4738407|NCT02997150|Efficacy|efficacy
4738408|NCT02997137|Chronic psychological distress|chronic psychological distress
4738409|NCT02997137|Chronic exhaustion conditions|chronic exhaustion conditions
4738410|NCT02997137|Perceived Stress Questionnaire 30 (PSQ30)|perceived stress questionnaire 30 (psq30)
4738411|NCT02997137|Stress management|stress management
4738412|NCT02997137|Dietary supplement|dietary supplement
4738413|NCT02997124|Alveolar bone grafting|alveolar bone grafting
4738414|NCT02997124|delirium|delirium
4738415|NCT02997124|early ambulation|early ambulation
4738416|NCT02997098|Hepatectomy|hepatectomy
4738417|NCT02997085|Pain|pain
4738418|NCT02997085|Virtual Reality|virtual reality
4738419|NCT02997085|Opioid|opioid
4738420|NCT02997085|Prescription pain reliever|prescription pain reliever
4738421|NCT02997085|Treatment|treatment
4738422|NCT02997072|electrical impedance tomography|electrical impedance tomography
4738423|NCT02997072|high frequency jet ventilation|high frequency jet ventilation
4738424|NCT02997072|drive pressure|drive pressure
4738425|NCT02997059|Crohn disease|crohn disease
4738426|NCT02997059|Candida|candida
4738427|NCT02997059|ASCA|asca
4738428|NCT02997046|Ferumoxytol|ferumoxytol
4738430|NCT02997046|fistula|fistula
4738431|NCT02997046|graft|graft
4738432|NCT02997046|kidney transplant|kidney transplant
4738433|NCT02997046|angiography|angiography
4738434|NCT02997046|arteriovenous|arteriovenous
4738435|NCT02997033|Bone|bone
4738436|NCT02997033|Sex steroids|sex steroids
4738437|NCT02997033|Body composition|body composition
4738438|NCT02997033|Men|men
4738439|NCT02997007|tDCS|tdcs
4738440|NCT02997007|Mild Cognitive Impairment|mild cognitive impairment
4738441|NCT02997007|fMRI|fmri
4738442|NCT02997007|Healthy ageing|healthy ageing
4738443|NCT02996955|Low Back Pain|low back pain
4738444|NCT02996955|Social Support|social support
4738445|NCT02996955|Illness Perceptions|illness perceptions
4738446|NCT02996955|Activity Advice|activity advice
4738447|NCT02996942|haemophilia, joint disease, quality of life|haemophilia, joint disease, quality of life
4738448|NCT02996903|Cardiac Computed Tomography (CT) Angiography (CCTA)|cardiac computed tomography (ct) angiography (ccta)
4738449|NCT02996903|coronary artery disease|coronary artery disease
4738450|NCT02996903|malignancy induction|malignancy induction
4738451|NCT02996903|radiation dose|radiation dose
4738452|NCT02996903|dose saving techniques|dose saving techniques
4738453|NCT02996903|effective dose|effective dose
4738454|NCT02996864|college students|college students
4738455|NCT02996864|physical activity|physical activity
4738456|NCT02996864|sleep behaviors|sleep behaviors
4738457|NCT02996864|diet|diet
4738458|NCT02996851|Fibrinolytic Agents|fibrinolytic agents
4738459|NCT02996851|Adverse effects|adverse effects
4738460|NCT02996851|Norway|norway
4738461|NCT02996851|Registries|registries
4738462|NCT02996812|Post-bariatric hypoglycemia|post-bariatric hypoglycemia
4738463|NCT02996812|Non-insulinoma pancreatogenous hypoglycemia syndrome|non-insulinoma pancreatogenous hypoglycemia syndrome
4738464|NCT02996812|Late dumping syndrome|late dumping syndrome
4738465|NCT02996773|high-risk malignancies|high-risk malignancies
4738466|NCT02996773|Lymphoma|lymphoma
4738467|NCT02996773|Haploidentical|haploidentical
4738468|NCT02996773|Bone Marrow Transplant (BMT)|bone marrow transplant (bmt)
4738469|NCT02996773|Post-transplant|post-transplant
4738470|NCT02996773|myeloablative (MAC)|myeloablative (mac)
4738471|NCT02996773|reduced intensity conditioning (RIC)|reduced intensity conditioning (ric)
4738472|NCT02996773|haploidentical hematopoietic cell transplantation (HHCT)|haploidentical hematopoietic cell transplantation (hhct)
4738473|NCT02996773|Leukemia|leukemia
4738474|NCT02996747|bone tumors|bone tumors
4738475|NCT02996747|chondroma|chondroma
4738476|NCT02996747|chondrosarcoma|chondrosarcoma
4738477|NCT02996734|bone tumors|bone tumors
4738478|NCT02996734|giant cell tumor|giant cell tumor
4738479|NCT02996734|treatment|treatment
4738480|NCT02996708|Telemedicine|telemedicine
4738481|NCT02996708|Health economics|health economics
4738482|NCT02996695|Chemoprophylaxis|chemoprophylaxis
4738483|NCT02996695|Chloroquine|chloroquine
4738484|NCT02996695|Cryopreserved|cryopreserved
4738485|NCT02996695|Malaria|malaria
4738486|NCT02996695|Plasmodium|plasmodium
4738487|NCT02996695|Sporozoites|sporozoites
4738488|NCT02996682|Communicable Diseases|communicable diseases
4738489|NCT02996682|Hepatitis|hepatitis
4738490|NCT02996682|Hepatitis C|hepatitis c
4738491|NCT02996682|Virus Diseases|virus diseases
4738492|NCT02996682|Liver Diseases|liver diseases
4738493|NCT02996682|Digestive System Diseases|digestive system diseases
4738494|NCT02996682|Hepatitis, Viral, Human|hepatitis, viral, human
4738495|NCT02996682|Velpatasvir|velpatasvir
4738496|NCT02996682|Flaviviridae Infections|flaviviridae infections
4738497|NCT02996682|RNA Virus Infections|rna virus infections
4738498|NCT02996682|Ribavirin|ribavirin
4738499|NCT02996682|Sofosbuvir|sofosbuvir
4738500|NCT02996682|Antiviral Agents|antiviral agents
4738501|NCT02996682|Antimetabolites|antimetabolites
4738502|NCT02996682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
4738503|NCT02996682|Anti-Infective Agents|anti-infective agents
4738504|NCT02996682|Decompensated Cirrhosis|decompensated cirrhosis
4738505|NCT02996643|Adolescent Idiopathic Scoliosis|adolescent idiopathic scoliosis
4738506|NCT02996643|Brace Treatment|brace treatment
4738507|NCT02996643|Ultrasound Imaging|ultrasound imaging
4738508|NCT02996630|LVOTO|lvoto
4738509|NCT02996630|Fallot|fallot
4738510|NCT02996630|Great Arteries Transposition|great arteries transposition
4738511|NCT02996617|Lymphomas Non-Hodgkin's B-Cell|lymphomas non-hodgkin's b-cell
4738512|NCT02996617|Lymphomas Non-Hodgkin's T-Cell|lymphomas non-hodgkin's t-cell
4738513|NCT02996617|PEG-rhG-CSF|peg-rhg-csf
4738514|NCT02996617|Neutropenia|neutropenia
4738515|NCT02996604|acupuncture|acupuncture
4738516|NCT02996604|functional dyspepsia|functional dyspepsia
4738517|NCT02996604|functional magnetic resonance imaging (fMRI)|functional magnetic resonance imaging (fmri)
4738518|NCT02996591|Nerve Block|nerve block
4738519|NCT02996591|General Anesthesia|general anesthesia
4738520|NCT02996591|Spinal Anesthesia|spinal anesthesia
4738521|NCT02996591|Pain|pain
4740992|NCT02980497|gingivitis|gingivitis
4738522|NCT02996591|Postoperative Nausea and Vomiting|postoperative nausea and vomiting
4738523|NCT02996578|Cognition|cognition
4738524|NCT02996578|Cacao|cacao
4738525|NCT02996578|Flavan-3-ols|flavan-3-ols
4738526|NCT02996578|Blood Pressure|blood pressure
4738527|NCT02996578|hemoglobin A1c protein, human|hemoglobin a1c protein, human
4738528|NCT02996578|Memory|memory
4738529|NCT02996565|Clinic care|clinic care
4738530|NCT02996565|Team-based care|team-based care
4738531|NCT02996565|Medication Therapy Management (MTM)|medication therapy management (mtm)
4738532|NCT02996565|Telehealth|telehealth
4738533|NCT02996565|Cluster-randomized|cluster-randomized
4738534|NCT02996565|Home blood pressure monitoring|home blood pressure monitoring
4738535|NCT02996565|Pharmacist|pharmacist
4738536|NCT02996552|Tricuspid annulus dilation|tricuspid annulus dilation
4738537|NCT02996552|mitral valve regurgitation|mitral valve regurgitation
4738538|NCT02996526|vocal cord palsy dysfunction thoracic surgery complication|vocal cord palsy dysfunction thoracic surgery complication
4738539|NCT02996513|Vitamin A status|vitamin a status
4738540|NCT02996513|Retinol Isotope Dilution|retinol isotope dilution
4738541|NCT02996513|Nigeria|nigeria
4738542|NCT02996513|Preschool children|preschool children
4738543|NCT02996513|Malaria|malaria
4738544|NCT02996513|Inflammation|inflammation
4738545|NCT02996474|Pembrolizumab|pembrolizumab
4738546|NCT02996474|Decitabine|decitabine
4738547|NCT02996474|AML (Acute Myelogenous Leukemia)|aml (acute myelogenous leukemia)
4738548|NCT02996461|Zika Infection|zika infection
4738549|NCT02996461|Immune Response|immune response
4738550|NCT02996461|Flavivirus|flavivirus
4738551|NCT02996461|Arthropod-Borne Virus|arthropod-borne virus
4738552|NCT02996448|AD-HIES|ad-hies
4738553|NCT02996448|Anti-rAls3 Antibody|anti-rals3 antibody
4738554|NCT02996448|Staphylococcus Aureus|staphylococcus aureus
4738555|NCT02996448|Candida Albicans|candida albicans
4738556|NCT02996448|RNA Transcriptome|rna transcriptome
4738557|NCT02996396|AAA, Aortoiliac Aneurysm|aaa, aortoiliac aneurysm
4738558|NCT02996383|arthroplasty|arthroplasty
4738559|NCT02996370|esthetic|esthetic
4738560|NCT02996370|inter-implant papilla|inter-implant papilla
4738561|NCT02996370|soft tissue tickness|soft tissue tickness
4738562|NCT02996370|crestal bone loss|crestal bone loss
4738563|NCT02996370|second stage surgery|second stage surgery
4738564|NCT02996357|Incontinence-associated dermatitis|incontinence-associated dermatitis
4738565|NCT02996357|Risk factor|risk factor
4738566|NCT02996357|Intensive care unit|intensive care unit
4738567|NCT02996357|Prevention|prevention
4738568|NCT02996331|Ulcer|ulcer
4738569|NCT02996331|Pressure Ulcer|pressure ulcer
4738570|NCT02996331|Pathologic Processes|pathologic processes
4738571|NCT02996331|Skin Ulcer|skin ulcer
4738572|NCT02996331|Skin Diseases|skin diseases
4738573|NCT02996292|Crowding|crowding
4738574|NCT02996292|Self ligating|self ligating
4738575|NCT02996292|CBCT|cbct
4738576|NCT02996292|RCT|rct
4738577|NCT02996279|Neonate|neonate
4738578|NCT02996279|Chorioamnionitis|chorioamnionitis
4738579|NCT02996279|S100A12|s100a12
4738580|NCT02996266|Targeted Temperature Management|targeted temperature management
4738581|NCT02996175|Behavior|behavior
4738582|NCT02996175|Sleep|sleep
4738583|NCT02996175|Problems|problems
4738584|NCT02996175|Intervention|intervention
4738585|NCT02996162|Bronchopulmonary Dysplasia|bronchopulmonary dysplasia
4738586|NCT02996162|Chronic Lung Disease|chronic lung disease
4738587|NCT02996162|Prematurity|prematurity
4738588|NCT02996084|Imaging research|imaging research
4738589|NCT02995980|breast cancer screening|breast cancer screening
4738590|NCT02995980|dense breasts|dense breasts
4738591|NCT02995980|dual-energy contrast-enhanced digital mammography|dual-energy contrast-enhanced digital mammography
4738592|NCT02995954|Combination therapy|combination therapy
4738593|NCT02995954|ACE inhibitor Calcium Antagonist|ace inhibitor calcium antagonist
4738594|NCT02995941|reliability|reliability
4738595|NCT02995941|validity|validity
4738596|NCT02995941|classification|classification
4738597|NCT02995941|irritability|irritability
4738598|NCT02995941|symptom|symptom
4738599|NCT02995941|intensity|intensity
4738600|NCT02995941|intervention|intervention
4738601|NCT02995928|Subarachnoid Hemorrhage|subarachnoid hemorrhage
4738602|NCT02995928|Decompressive Craniectomy|decompressive craniectomy
4738603|NCT02995928|Cerebral Aneurysm|cerebral aneurysm
4738604|NCT02995837|Obstructive Sleep Apnea Syndrome|obstructive sleep apnea syndrome
4738605|NCT02995837|Cerebral Blood Flow|cerebral blood flow
4738606|NCT02995837|Neurocognition|neurocognition
4738607|NCT02995824|Liver transplantation|liver transplantation
4738608|NCT02995824|HIV infection|hiv infection
4738609|NCT02995824|Antiretroviral therapy|antiretroviral therapy
4738610|NCT02995824|Raltegravir|raltegravir
4738611|NCT02995785|Simulation|simulation
4738612|NCT02995733|asthma|asthma
4738613|NCT02995733|African Americans|african americans
4738614|NCT02995733|Hispanics|hispanics
4738615|NCT02995707|Thalidomide NTDT|thalidomide ntdt
4738616|NCT02995681|COPD|copd
4738617|NCT02995681|Falls|falls
4738618|NCT02995681|Balance training|balance training
4738619|NCT02995642|Aortic Aneurysm, Abdominal|aortic aneurysm, abdominal
4738620|NCT02995642|Carotid Stenosis|carotid stenosis
4738621|NCT02995642|Atherosclerosis|atherosclerosis
4738622|NCT02995642|Angiogenesis|angiogenesis
4738623|NCT02995642|Inflammation|inflammation
4738624|NCT02995642|Macrophages|macrophages
4738625|NCT02995642|Positron-Emission Tomography|positron-emission tomography
4738626|NCT02995642|Computerized tomography|computerized tomography
4738627|NCT02995642|Magnetic Resonance Imaging|magnetic resonance imaging
4738628|NCT02995642|(18F)FPP(RGD)2|(18f)fpp(rgd)2
4738629|NCT02995616|Robot-Assisted Gait Training|robot-assisted gait training
4738630|NCT02995616|Guidance force|guidance force
4738631|NCT02995616|Stroke|stroke
4738632|NCT02995616|Energy Consumption|energy consumption
4738633|NCT02995616|Cardiorespiratory Load|cardiorespiratory load
4738634|NCT02995564|Social Skills|social skills
4738635|NCT02995564|Asperger's|asperger's
4738636|NCT02995564|High-functioning autism|high-functioning autism
4738637|NCT02995564|Young adults|young adults
4738638|NCT02995551|Menisci, Tibial|menisci, tibial
4738639|NCT02995551|Knee Injuries|knee injuries
4738640|NCT02995551|Arthroscopy|arthroscopy
4738641|NCT02995551|Exercise|exercise
4738642|NCT02995551|Young adults|young adults
4738643|NCT02995551|Treatment Outcome|treatment outcome
4738644|NCT02995551|Humans|humans
4738645|NCT02995512|myocardial infarction|myocardial infarction
4738646|NCT02995512|colchicine|colchicine
4738647|NCT02995512|anti-inflammatory|anti-inflammatory
4738648|NCT02995499|ASA-PS classification|asa-ps classification
4738649|NCT02995499|inter-rater reliability|inter-rater reliability
4738650|NCT02995499|general surgery|general surgery
4738651|NCT02995473|Psoriasis|psoriasis
4738652|NCT02995460|Exercise Therapy|exercise therapy
4738653|NCT02995447|propofol|propofol
4738654|NCT02995447|electroencephalogram|electroencephalogram
4738655|NCT02995434|Virtual Reality|virtual reality
4738656|NCT02995434|Cancer Survivorship|cancer survivorship
4738657|NCT02995434|Pain Management|pain management
4738658|NCT02995434|Cancer Pain Management|cancer pain management
4738659|NCT02995434|Chronic Pain Management|chronic pain management
4738660|NCT02995434|Adjunctive Pain Management|adjunctive pain management
4738661|NCT02995408|resiliency training|resiliency training
4738662|NCT02995408|parenting|parenting
4738663|NCT02995408|Autism Spectrum Disorders|autism spectrum disorders
4738664|NCT02995369|Sealants|sealants
4738665|NCT02995369|Dryshield|dryshield
4738666|NCT02995369|Cotton roll|cotton roll
4738667|NCT02995369|Isolation|isolation
4738668|NCT02995369|Efficiency|efficiency
4738669|NCT02995369|Preference|preference
4738670|NCT02995356|Ectopic pregnancy|ectopic pregnancy
4738671|NCT02995356|Axonemal Dynein Heavy Chain 5|axonemal dynein heavy chain 5
4738672|NCT02995356|Creatine Kinase|creatine kinase
4738673|NCT02995356|Cervical fluid|cervical fluid
4738674|NCT02995330|Metastatic Castration-Resistant Prostate Cancer|metastatic castration-resistant prostate cancer
4738675|NCT02995330|Bone Marrow Transplantation|bone marrow transplantation
4738676|NCT02995317|Aged|aged
4738677|NCT02995317|Gait|gait
4738678|NCT02995317|Postural Balance|postural balance
4738679|NCT02995317|Accelerometry|accelerometry
4738680|NCT02995317|Physical Activity|physical activity
4738681|NCT02995265|Exoskeleton|exoskeleton
4738682|NCT02995265|Stroke|stroke
4738683|NCT02995265|Walking|walking
4738684|NCT02995265|Rehabilitation|rehabilitation
4738685|NCT02995187|Apatinib|apatinib
4738686|NCT02995187|Third-line and Later Therapy|third-line and later therapy
4738687|NCT02995187|Small Cell Lung Cancer|small cell lung cancer
4738688|NCT02995174|amblyopia|amblyopia
4738689|NCT02995174|fixation stability|fixation stability
4738690|NCT02995174|perceptual learning|perceptual learning
4738691|NCT02995083|osteoarthritis|osteoarthritis
4738692|NCT02995057|Microneedles|microneedles
4738693|NCT02995057|Biocompatibility|biocompatibility
4738694|NCT02995057|Allergy|allergy
4738695|NCT02995057|Metal|metal
4738696|NCT02995057|Nickel|nickel
4738697|NCT02995057|Contact dermatitis|contact dermatitis
4738698|NCT02995005|mother to child transmission|mother to child transmission
4738699|NCT02995005|hepatitis B|hepatitis b
4738700|NCT02995005|tenofovir|tenofovir
4738701|NCT02994953|Avelumab|avelumab
4738702|NCT02994953|M9241|m9241
4738703|NCT02994953|NHS-IL12|nhs-il12
4738704|NCT02994953|Advanced Solid Tumors|advanced solid tumors
4738705|NCT02994927|ANCA-associated vasculitis|anca-associated vasculitis
4738706|NCT02994927|complement|complement
4738707|NCT02994927|vasculitis|vasculitis
4738708|NCT02994927|C5aR|c5ar
4738709|NCT02994927|avacopan|avacopan
4738710|NCT02994927|CCX168|ccx168
4738711|NCT02994927|MPA|mpa
4738712|NCT02994927|GPA|gpa
4738713|NCT02994914|Breast Cancer|breast cancer
4738714|NCT02994914|Onco Geriatric Evaluation|onco geriatric evaluation
4738715|NCT02994914|Radiotherapy|radiotherapy
4738716|NCT02994914|Hypo fractionated radiotherapy|hypo fractionated radiotherapy
4738717|NCT02994914|Normo fractionated radiotherapy|normo fractionated radiotherapy
4738718|NCT02994914|Large hypo fractionated radiotherapy|large hypo fractionated radiotherapy
4738719|NCT02994901|Sarcopenia|sarcopenia
4738720|NCT02994901|Geriatrics|geriatrics
4738721|NCT02994901|Biomarker|biomarker
4738722|NCT02994836|Crohn's Disease|crohn's disease
4738723|NCT02994836|Inflammatory bowel disease|inflammatory bowel disease
4741090|NCT02979990|infertility|infertility
4738724|NCT02994836|Anti-TNF discontinuation|anti-tnf discontinuation
4738725|NCT02994836|Ulcerative colitis|ulcerative colitis
4738726|NCT02994810|Breastfeeding|breastfeeding
4738727|NCT02994810|Orientation|orientation
4738728|NCT02994797|salivary glands|salivary glands
4738729|NCT02994797|ultrasonography|ultrasonography
4738730|NCT02994797|elastometry|elastometry
4738731|NCT02994797|elastography|elastography
4738732|NCT02994771|Lymphedema, Breast cancer|lymphedema, breast cancer
4738733|NCT02994758|Prostate|prostate
4738734|NCT02994758|bladder|bladder
4738735|NCT02994758|renal|renal
4738736|NCT02994758|NGS|ngs
4738737|NCT02994758|DSRT|dsrt
4738738|NCT02994758|drug screening|drug screening
4738739|NCT02994758|sequencing|sequencing
4738740|NCT02994758|personalised medicine|personalised medicine
4738741|NCT02994680|Air Pollution|air pollution
4738742|NCT02994680|Liquefied Petroleum Gas|liquefied petroleum gas
4738743|NCT02994680|Cookstove|cookstove
4738744|NCT02994680|Behavioral Intervention|behavioral intervention
4738745|NCT02994680|Propane Stove|propane stove
4738746|NCT02994667|Electrophysiology|electrophysiology
4738747|NCT02994641|critical care|critical care
4738748|NCT02994641|patient discharge|patient discharge
4738749|NCT02994641|costs and cost analysis|costs and cost analysis
4738750|NCT02994641|length of stay|length of stay
4738751|NCT02994641|hospital mortality|hospital mortality
4738752|NCT02994628|oxidative stress|oxidative stress
4738753|NCT02994628|immune function|immune function
4738754|NCT02994628|muscle damage|muscle damage
4738755|NCT02994628|carbohydrate|carbohydrate
4738756|NCT02994628|polyphenols|polyphenols
4738757|NCT02994628|cycling|cycling
4738758|NCT02994615|Index of Microvascular Resistance|index of microvascular resistance
4738759|NCT02994615|Microvascular dysfunction|microvascular dysfunction
4738760|NCT02994602|Healthy Men|healthy men
4738761|NCT02994602|Male Contraception|male contraception
4738762|NCT02994602|Healthy Women|healthy women
4738763|NCT02994602|Transfer|transfer
4738764|NCT02994602|Transference|transference
4738765|NCT02994602|Gel|gel
4738766|NCT02994602|Nestorone|nestorone
4738767|NCT02994602|Testosterone|testosterone
4738768|NCT02994550|FSH|fsh
4738769|NCT02994550|LH|lh
4738770|NCT02994550|IVF|ivf
4738771|NCT02994511|Circulating tumour DNA|circulating tumour dna
4738772|NCT02994511|ctDNA|ctdna
4738773|NCT02994420|Obesity|obesity
4738774|NCT02994420|Menstrual Cycle|menstrual cycle
4738775|NCT02994420|Gonadal Steroid Hormones|gonadal steroid hormones
4738776|NCT02994420|Satiety Response|satiety response
4738777|NCT02994420|Glucagon-Like Peptide 1|glucagon-like peptide 1
4738778|NCT02994420|Cholecystokinin|cholecystokinin
4738779|NCT02994420|Magnetic Resonance Imaging|magnetic resonance imaging
4738780|NCT02994381|Healthy Male Adults|healthy male adults
4738781|NCT02994381|14C|14c
4738782|NCT02994381|RPC1063|rpc1063
4738783|NCT02994368|retinal degeneration|retinal degeneration
4738784|NCT02994368|eye|eye
4738785|NCT02994368|REP-1 gene|rep-1 gene
4738786|NCT02994355|Family planning clinics|family planning clinics
4738787|NCT02994355|Implementation Science|implementation science
4738788|NCT02994355|Systems Analysis and Improvement Approach (SAIA)|systems analysis and improvement approach (saia)
4738789|NCT02994342|vaginal dryness|vaginal dryness
4738790|NCT02994342|vaginal gel|vaginal gel
4738791|NCT02994342|colostrum|colostrum
4738792|NCT02994342|vaginal atrophy|vaginal atrophy
4738793|NCT02994329|HIV testing|hiv testing
4738794|NCT02994329|Linkage to care|linkage to care
4738795|NCT02994303|Fabry disease|fabry disease
4738796|NCT02994303|Fabry nephropathy|fabry nephropathy
4738797|NCT02994303|end-stage renal disease|end-stage renal disease
4738798|NCT02994303|Anderson-Fabry disease|anderson-fabry disease
4738799|NCT02994303|Fabry's disease|fabry's disease
4738800|NCT02994277|"Artificial Pancreas"|"artificial pancreas"
4738801|NCT02994277|"control System"|"control system"
4738802|NCT02994277|"Closed loop"|"closed loop"
4738803|NCT02994277|diabetes|diabetes
4738804|NCT02994277|"T1DM"|"t1dm"
4738805|NCT02994277|"pump"|"pump"
4738806|NCT02994277|algorithm|algorithm
4738807|NCT02994277|CGM|cgm
4738808|NCT02994199|Active video gaming|active video gaming
4738809|NCT02994199|Energy expenditure|energy expenditure
4738810|NCT02994186|cognitive function|cognitive function
4738811|NCT02994186|obesity|obesity
4738812|NCT02994186|bariatric surgery|bariatric surgery
4738813|NCT02994186|metabolic surgery|metabolic surgery
4738814|NCT02994160|peripheral nerve|peripheral nerve
4738815|NCT02994160|intraneural electrode|intraneural electrode
4738816|NCT02994160|hand amputation|hand amputation
4738817|NCT02994108|Human Papillomavirus|human papillomavirus
4738818|NCT02994108|Men Who Have Sex with Men|men who have sex with men
4738819|NCT02994082|Rural health|rural health
4738820|NCT02994082|Veterans|veterans
4738821|NCT02994082|Smokeless tobacco cessation|smokeless tobacco cessation
4738822|NCT02994069|Cisplatin|cisplatin
4738823|NCT02994069|Squamous Cell|squamous cell
4738824|NCT02994069|Carcinoma|carcinoma
4738825|NCT02994030|neuromuscular disorder|neuromuscular disorder
4738826|NCT02994017|cystic fibrosis|cystic fibrosis
4738827|NCT02994017|Cardiopulmonary exercise testing|cardiopulmonary exercise testing
4738828|NCT02994017|prognostic|prognostic
4738829|NCT02994004|Hospital, medical decision-making, role conflict, f-MRI|hospital, medical decision-making, role conflict, f-mri
4738830|NCT02993978|Pediatric radiotherapy|pediatric radiotherapy
4738831|NCT02993926|Drug Therapy|drug therapy
4738832|NCT02993887|Caregiver|caregiver
4738833|NCT02993887|Technology Dependent Children|technology dependent children
4738834|NCT02993887|Resourcefulness|resourcefulness
4738835|NCT02993887|Mindfulness|mindfulness
4738836|NCT02993874|Ergonemic resources|ergonemic resources
4738837|NCT02993874|Walking capacity|walking capacity
4738838|NCT02993874|Peripheral artery disease|peripheral artery disease
4738839|NCT02993861|Epilepsy|epilepsy
4738840|NCT02993861|Obese|obese
4738841|NCT02993848|Scapula|scapula
4738842|NCT02993848|Fracture|fracture
4738843|NCT02993796|Krabbe disease|krabbe disease
4738844|NCT02993796|globoid cell leukodystrophy|globoid cell leukodystrophy
4738845|NCT02993796|galactosylceramide lipidosis|galactosylceramide lipidosis
4738846|NCT02993796|sphingolipidosis|sphingolipidosis
4738847|NCT02993783|Drug Therapy|drug therapy
4738848|NCT02993757|Dengue Fever|dengue fever
4738849|NCT02993757|Dengue Hemorrhagic Fever|dengue hemorrhagic fever
4738850|NCT02993757|Human Papillomavirus Disease|human papillomavirus disease
4738851|NCT02993757|CYD Dengue Vaccine|cyd dengue vaccine
4738852|NCT02993757|Dengvaxia®|dengvaxia®
4738853|NCT02993757|Gardasil®|gardasil®
4738854|NCT02993744|preterm birth|preterm birth
4738855|NCT02993744|corticosteroids|corticosteroids
4738856|NCT02993744|inflammatory parameters|inflammatory parameters
4738857|NCT02993744|betamethasone|betamethasone
4738858|NCT02993744|leukocytes|leukocytes
4738859|NCT02993731|Neoplasms|neoplasms
4738860|NCT02993731|Neoplasms by Site|neoplasms by site
4738861|NCT02993731|Digestive System Neoplasms|digestive system neoplasms
4738862|NCT02993731|Endocrine Gland Neoplasms|endocrine gland neoplasms
4738863|NCT02993731|Pancreatic Neoplasms|pancreatic neoplasms
4738864|NCT02993731|Adenocarcinoma|adenocarcinoma
4738865|NCT02993731|Neoplasms, Glandular and Epithelial|neoplasms, glandular and epithelial
4738866|NCT02993731|Neoplasms by Histologic Type|neoplasms by histologic type
4738867|NCT02993731|Digestive System Diseases|digestive system diseases
4738868|NCT02993731|Pancreatic Diseases|pancreatic diseases
4738869|NCT02993731|Endocrine System Diseases|endocrine system diseases
4738870|NCT02993731|Albumin-Bound Paclitaxel|albumin-bound paclitaxel
4738871|NCT02993731|Gemcitabine|gemcitabine
4738872|NCT02993692|direct laryngoscopy|direct laryngoscopy
4738873|NCT02993692|fiberopitc bronchoscopy|fiberopitc bronchoscopy
4738874|NCT02993692|nasotracheal intubation|nasotracheal intubation
4738875|NCT02993640|vasopressin|vasopressin
4738876|NCT02993640|nitroglycerine|nitroglycerine
4738877|NCT02993640|portal pressure|portal pressure
4738878|NCT02993640|portal flow|portal flow
4738879|NCT02993627|obesity|obesity
4738880|NCT02993627|BMI|bmi
4738881|NCT02993627|body weight|body weight
4738882|NCT02993601|Heart Failure|heart failure
4738883|NCT02993601|Edema|edema
4738884|NCT02993601|Oedema|oedema
4738885|NCT02993601|Decompensated Heartfailure|decompensated heartfailure
4738886|NCT02993588|Melatonin|melatonin
4738887|NCT02993588|IVF/ICSI|ivf/icsi
4738888|NCT02993588|Poor ovarian response|poor ovarian response
4738889|NCT02993575|Pharmacokinetics|pharmacokinetics
4738890|NCT02993575|Flucloxacillin|flucloxacillin
4738891|NCT02993575|Continuous infusion|continuous infusion
4738892|NCT02993575|Intensive Care Unit|intensive care unit
4738893|NCT02993562|Food intake|food intake
4738894|NCT02993562|Resting Energy Expenditure|resting energy expenditure
4738895|NCT02993562|Gall Bladder emptying|gall bladder emptying
4738896|NCT02993562|Insulin response|insulin response
4738897|NCT02993562|Body Composition|body composition
4738898|NCT02993523|Acute Myeloid Leukemia|acute myeloid leukemia
4738899|NCT02993523|Venetoclax|venetoclax
4738900|NCT02993523|Treatment Naïve|treatment naïve
4738901|NCT02993523|Azacitidine|azacitidine
4738902|NCT02993510|microfracture|microfracture
4738903|NCT02993510|enhanced marrow stimulation|enhanced marrow stimulation
4738904|NCT02993510|articular cartilage|articular cartilage
4738905|NCT02993510|Autologous Matrix-Induced Chondrogenesis|autologous matrix-induced chondrogenesis
4738906|NCT02993510|Chondro-Gide®|chondro-gide®
4738907|NCT02993510|knee surgery|knee surgery
4738908|NCT02993510|AMIC|amic
4738909|NCT02993458|dietary patterns|dietary patterns
4738910|NCT02993458|blood pressure|blood pressure
4738911|NCT02993458|adolescents|adolescents
4738912|NCT02993458|dietary sodium|dietary sodium
4738913|NCT02993393|Simulation Training [I02.903.847]|simulation training [i02.903.847]
4738914|NCT02993393|Problem-Based Learning [F02.463.425.720]|problem-based learning [f02.463.425.720]
4738915|NCT02993380|Olive oil|olive oil
4738916|NCT02993380|Erythrocyte membrane fatty acid contents|erythrocyte membrane fatty acid contents
4738917|NCT02993380|Oleic acid|oleic acid
4738918|NCT02993367|Butylphthalide Soft Capsules|butylphthalide soft capsules
4738919|NCT02993367|VCIND|vcind
4738920|NCT02993367|fMRI|fmri
4738921|NCT02993302|vitamin D|vitamin d
4738922|NCT02993302|graves' disease|graves' disease
4738923|NCT02993302|dendritic cells|dendritic cells
4738924|NCT02993224|thalassemia|thalassemia
4738925|NCT02993224|TDT|tdt
4738926|NCT02993224|transfusion-dependent|transfusion-dependent
4738927|NCT02993224|non-transfusion-dependent|non-transfusion-dependent
4738928|NCT02993224|NTDT|ntdt
4738929|NCT02993211|Bladder cancer|bladder cancer
4738930|NCT02993211|Transurethral resection|transurethral resection
4738931|NCT02993211|En bloc resection|en bloc resection
4738932|NCT02993211|TURBT|turbt
4738933|NCT02993185|pregnancy|pregnancy
4738934|NCT02993185|adolescents|adolescents
4738935|NCT02993185|sexually transmitted diseases|sexually transmitted diseases
4738936|NCT02993185|decision making|decision making
4738937|NCT02993185|prevention education|prevention education
4738938|NCT02993107|AR101|ar101
4738939|NCT02993107|Characterized Peanut Allergen|characterized peanut allergen
4738940|NCT02993107|CPNA (Characterized Peanut Allergen)|cpna (characterized peanut allergen)
4738941|NCT02993107|OIT (oral immunotherapy)|oit (oral immunotherapy)
4738942|NCT02993107|Peanut Allergy|peanut allergy
4738943|NCT02993107|Allergy|allergy
4738944|NCT02993107|Peanut-Allergic Children|peanut-allergic children
4738945|NCT02993107|Peanut-Allergic Adults|peanut-allergic adults
4738946|NCT02993107|Desensitization|desensitization
4738947|NCT02993107|PALISADE|palisade
4738948|NCT02993094|breast cancer|breast cancer
4738949|NCT02993094|advanced triple negative|advanced triple negative
4738950|NCT02993094|ixazomib|ixazomib
4738951|NCT02993094|carboplatin|carboplatin
4738952|NCT02993094|CARIXA|carixa
4738953|NCT02993094|Study Group of Medical Tumor Therapy (AGMT)|study group of medical tumor therapy (agmt)
4738954|NCT02993081|YAG laser|yag laser
4738955|NCT02993068|Genetic testing|genetic testing
4738956|NCT02993068|Genetic educational video|genetic educational video
4738957|NCT02993068|Genetic counseling|genetic counseling
4738958|NCT02993068|Online genetic test results|online genetic test results
4738959|NCT02993068|Telephone genetic counseling|telephone genetic counseling
4738960|NCT02993068|Saliva test|saliva test
4738961|NCT02993068|Questionnaires|questionnaires
4738962|NCT02993068|Surveys|surveys
4738963|NCT02993042|Rehabilitation|rehabilitation
4738964|NCT02993042|Robot-assisted gait training|robot-assisted gait training
4738965|NCT02993029|99Tc-MDP|99tc-mdp
4738966|NCT02993029|osteoarthritis|osteoarthritis
4738967|NCT02993029|celecoxib|celecoxib
4738968|NCT02992977|Vaccine, neoantigen|vaccine, neoantigen
4738969|NCT02992951|Infection|infection
4738970|NCT02992951|Surgical Site Infection|surgical site infection
4738971|NCT02992951|Dialkylcarbamoylchloride|dialkylcarbamoylchloride
4738972|NCT02992938|Opioid hyperalgesia|opioid hyperalgesia
4738973|NCT02992938|Acetazolamide|acetazolamide
4738974|NCT02992938|Remifentanil|remifentanil
4738975|NCT02992925|Haemophilus influenza type b|haemophilus influenza type b
4738976|NCT02992925|Adsorbed Diphteria-purified Pertussis-Tetanus-Inactivate poliovirus combined vaccine|adsorbed diphteria-purified pertussis-tetanus-inactivate poliovirus combined vaccine
4738977|NCT02992925|Hib|hib
4738978|NCT02992925|DPT-IPV|dpt-ipv
4738979|NCT02992899|stress disorders, post-traumatic|stress disorders, post-traumatic
4738980|NCT02992899|posttraumatic stress disorder|posttraumatic stress disorder
4738981|NCT02992899|PTSD|ptsd
4738982|NCT02992899|vagal nerve|vagal nerve
4738983|NCT02992886|elderly patients|elderly patients
4738984|NCT02992886|rectal cancer|rectal cancer
4738985|NCT02992886|preoperative chemoradiotherapy|preoperative chemoradiotherapy
4738986|NCT02992886|comprehensive geriatric assessment|comprehensive geriatric assessment
4738987|NCT02992860|Myelodysplastic Syndrome (MDS)|myelodysplastic syndrome (mds)
4738988|NCT02992860|Acute Myeloid Leukemia (AML)|acute myeloid leukemia (aml)
4738989|NCT02992860|hypomethylating agent (HMA) treatment|hypomethylating agent (hma) treatment
4738990|NCT02992860|leukemic stem cell|leukemic stem cell
4738991|NCT02992860|CD123|cd123
4738992|NCT02992860|immunotherapy|immunotherapy
4738993|NCT02992847|Multiple sclerosis|multiple sclerosis
4738994|NCT02992847|Gadolinium based contrast agent|gadolinium based contrast agent
4738995|NCT02992847|MRI|mri
4738996|NCT02992847|Dentate nucleus|dentate nucleus
4738997|NCT02992821|Hand-held|hand-held
4738998|NCT02992821|Ultrasound|ultrasound
4738999|NCT02992821|Diagnosis|diagnosis
4739000|NCT02992821|Carotid artery stenosis|carotid artery stenosis
4739001|NCT02992808|IVF|ivf
4739002|NCT02992808|Ovarian stimulation|ovarian stimulation
4739003|NCT02992808|Androgenic profile|androgenic profile
4739004|NCT02992808|Follicular fluid|follicular fluid
4739005|NCT02992808|Recombinant gonadotropins|recombinant gonadotropins
4739006|NCT02992808|human menopausal gonadotropin|human menopausal gonadotropin
4739007|NCT02992769|Breast Cancer|breast cancer
4739008|NCT02992769|Nomogram|nomogram
4739009|NCT02992769|Ultrasound|ultrasound
4739010|NCT02992769|Axillary Metastases|axillary metastases
4739011|NCT02992743|Sarcoma|sarcoma
4739012|NCT02992743|Cell Therapy|cell therapy
4739013|NCT02992743|T Cell Therapy|t cell therapy
4739014|NCT02992743|NY-ESO-1|ny-eso-1
4739015|NCT02992743|Immuno-oncology|immuno-oncology
4739016|NCT02992743|Metastatic|metastatic
4739017|NCT02992743|Previously treated|previously treated
4739018|NCT02992743|T Cell Receptor|t cell receptor
4739019|NCT02992730|Medication Adherence|medication adherence
4739020|NCT02992665|Calcium ionophore|calcium ionophore
4739021|NCT02992665|Fertilization|fertilization
4739022|NCT02992665|Sperm|sperm
4739023|NCT02992665|Oocyte|oocyte
4739024|NCT02992665|ICSI|icsi
4739025|NCT02992639|High visceral fat|high visceral fat
4739026|NCT02992639|Liver enzymes|liver enzymes
4739027|NCT02992639|Aminotransferase|aminotransferase
4739028|NCT02992639|Mild calorie restriction|mild calorie restriction
4739029|NCT02992600|non-cardiac surgery|non-cardiac surgery
4739030|NCT02992600|Postoperative Cognitive Dysfunction|postoperative cognitive dysfunction
4739031|NCT02992574|Post-Mastectomy Radiation|post-mastectomy radiation
4739032|NCT02992574|Node Negative|node negative
4739033|NCT02992574|Early breast Cancer|early breast cancer
4739034|NCT02992561|Aggression|aggression
4739035|NCT02992561|Violence|violence
4739036|NCT02992561|Post-conflict reconstruction|post-conflict reconstruction
4739037|NCT02992561|Demobilization|demobilization
4739038|NCT02992561|Traumatized offenders|traumatized offenders
4739039|NCT02992548|chronic kidney disease|chronic kidney disease
4739040|NCT02992548|pravastatin|pravastatin
4739041|NCT02992548|erythrocyte membrane fatty acid|erythrocyte membrane fatty acid
4739042|NCT02992483|multiple myeloma|multiple myeloma
4739043|NCT02992483|lymphoma|lymphoma
4739044|NCT02992483|dlbcl|dlbcl
4739045|NCT02992431|patient care planning|patient care planning
4739046|NCT02992431|primary health care|primary health care
4739047|NCT02992431|comorbidity|comorbidity
4739048|NCT02992418|Dengue Fever|dengue fever
4739049|NCT02992418|Dengue Hemorrhagic Fever|dengue hemorrhagic fever
4739050|NCT02992418|CYD Dengue Vaccine|cyd dengue vaccine
4739051|NCT02992418|Degavaxia®|degavaxia®
4739052|NCT02992392|Tear film|tear film
4739053|NCT02992392|Lipid layer|lipid layer
4739054|NCT02992392|Liposic|liposic
4739055|NCT02992392|Tears Naturale Forte|tears naturale forte
4739056|NCT02992379|Anterior disc displacement|anterior disc displacement
4739057|NCT02992379|Stabilizing splint|stabilizing splint
4739058|NCT02992366|socket shield|socket shield
4739059|NCT02992366|volumetric tissue alteration|volumetric tissue alteration
4739060|NCT02992366|immediate implant|immediate implant
4739061|NCT02992353|VATS|vats
4739062|NCT02992353|NSCLC|nsclc
4739063|NCT02992353|recurrence rate|recurrence rate
4739064|NCT02992288|Chronic Heart Failure|chronic heart failure
4739065|NCT02992288|Heart Failure with Reduced Ejection Fraction|heart failure with reduced ejection fraction
4739066|NCT02992275|Hip|hip
4739067|NCT02992275|Muscle|muscle
4739068|NCT02992275|Skeletal/physiopathology|skeletal/physiopathology
4739069|NCT02992223|Aggressive B-cell non-Hodgkin Lymphoma|aggressive b-cell non-hodgkin lymphoma
4739070|NCT02992223|Relapsed|relapsed
4739071|NCT02992223|Refractory|refractory
4739072|NCT02992223|Zevalin|zevalin
4739073|NCT02992223|Y90 Ibritumomab Tiuxetan|y90 ibritumomab tiuxetan
4739074|NCT02992223|Autologous stem cell transplant|autologous stem cell transplant
4739075|NCT02992223|BEAM|beam
4739076|NCT02992223|Recurrent|recurrent
4739077|NCT02992210|CAR|car
4739078|NCT02992210|chimeric antigen receptor|chimeric antigen receptor
4739079|NCT02992210|adoptive T cell transfer|adoptive t cell transfer
4739080|NCT02992197|Rotavirus|rotavirus
4739081|NCT02992197|Oral vaccines|oral vaccines
4739082|NCT02992197|Vaccine underperformance|vaccine underperformance
4739083|NCT02992197|Vaccine shedding|vaccine shedding
4739084|NCT02992184|HCV|hcv
4739085|NCT02992184|Genedrive|genedrive
4739086|NCT02992184|Point of Care|point of care
4739087|NCT02992119|safety|safety
4739088|NCT02992119|immunogenicity|immunogenicity
4739089|NCT02992106|Maternal Obesity|maternal obesity
4739090|NCT02992106|Endothelial Dysfunction|endothelial dysfunction
4739091|NCT02992106|Childhood Obesity|childhood obesity
4739092|NCT02992093|Polycystic ovary syndrome|polycystic ovary syndrome
4739093|NCT02992093|Metabonomics|metabonomics
4739094|NCT02992093|Traditional Chinese medicine syndromes|traditional chinese medicine syndromes
4739095|NCT02992080|Patient with Cystic Fibrosis|patient with cystic fibrosis
4739096|NCT02992080|Patient without Cystic fibrosis|patient without cystic fibrosis
4739097|NCT02992067|lymph node metastasis|lymph node metastasis
4739098|NCT02992067|breast cancer|breast cancer
4739099|NCT02992067|CK19|ck19
4739100|NCT02992067|contrast-enhanced ultrasonography|contrast-enhanced ultrasonography
4739101|NCT02992028|Rotator cuff repair|rotator cuff repair
4739102|NCT02992028|Vitamin C|vitamin c
4739103|NCT02992028|postoperative pain|postoperative pain
4739104|NCT02991989|Home-based exercise|home-based exercise
4739105|NCT02991989|Exercise snacking|exercise snacking
4739106|NCT02991989|Protein|protein
4739107|NCT02991989|Yogurt|yogurt
4739108|NCT02991976|Normobaric hyperoxia|normobaric hyperoxia
4739109|NCT02991976|Cerebral oxygenation|cerebral oxygenation
4739110|NCT02991976|Near-infrared spectroscopy|near-infrared spectroscopy
4739111|NCT02991976|Carotid endarterectomy|carotid endarterectomy
4739112|NCT02991976|TIVA|tiva
4739113|NCT02991924|endobronchial ultrasound|endobronchial ultrasound
4739114|NCT02991924|EBUS-TBNA|ebus-tbna
4739115|NCT02991924|lung cancer|lung cancer
4739116|NCT02991924|staging|staging
4739117|NCT02991911|metastatic, prostate cancer|metastatic, prostate cancer
4739118|NCT02991898|CML|cml
4739119|NCT02991898|MDS|mds
4739120|NCT02991898|CLL|cll
4739121|NCT02991898|ALL|all
4739122|NCT02991898|AML|aml
4739123|NCT02991872|Persistence|persistence
4739124|NCT02991872|Purified chicken-embryo cell rabies vaccine|purified chicken-embryo cell rabies vaccine
4739125|NCT02991872|Rabies Virus Neutralizing Antibody (RVNA)|rabies virus neutralizing antibody (rvna)
4739126|NCT02991872|Immunogenicity|immunogenicity
4739127|NCT02991872|Post-Exposure Prophylaxis (PEP)|post-exposure prophylaxis (pep)
4739128|NCT02991872|Rabipur|rabipur
4739129|NCT02991859|Dose-response|dose-response
4739130|NCT02991859|AMP challenge|amp challenge
4739131|NCT02991859|cortisol suppression|cortisol suppression
4739132|NCT02991859|dose escalation|dose escalation
4739133|NCT02991859|therapeutic index|therapeutic index
4739134|NCT02991846|chronic graft-versus-host disease cGVHD|chronic graft-versus-host disease cgvhd
4739135|NCT02991846|Hematopoietic stem cell transplantation HSCT|hematopoietic stem cell transplantation hsct
4739136|NCT02991846|NIH consensus criteria|nih consensus criteria
4739137|NCT02991846|GITMO|gitmo
4739138|NCT02991833|fecal incontinence|fecal incontinence
4739139|NCT02991833|care product|care product
4739140|NCT02991833|bowel incontinence|bowel incontinence
4739141|NCT02991807|PTEN|pten
4739142|NCT02991807|PTEN Gene Mutation|pten gene mutation
4739143|NCT02991807|PTEN Hamartoma Tumor Syndrome|pten hamartoma tumor syndrome
4739144|NCT02991807|Autism|autism
4739145|NCT02991807|Intellectual Disability|intellectual disability
4739146|NCT02991807|Neurocognition|neurocognition
4739147|NCT02991807|Afinitor|afinitor
4739148|NCT02991807|Everolimus|everolimus
4739149|NCT02991807|RAD001|rad001
4739150|NCT02991794|prostatectomy|prostatectomy
4739151|NCT02991794|laparoscopy|laparoscopy
4739152|NCT02991794|3D visualization|3d visualization
4739153|NCT02991794|learning curve|learning curve
4739154|NCT02991794|anastomosis|anastomosis
4739155|NCT02991742|nephropathy|nephropathy
4739156|NCT02991742|catheterization|catheterization
4739157|NCT02991742|contrast media|contrast media
4739158|NCT02991742|ioxaglate|ioxaglate
4739159|NCT02991742|iodixanol|iodixanol
4739160|NCT02991742|high risk|high risk
4739161|NCT02991742|prevention|prevention
4739162|NCT02991729|Decision aid|decision aid
4739163|NCT02991703|Arterial stiffness|arterial stiffness
4739164|NCT02991703|pulse wave velocity|pulse wave velocity
4739165|NCT02991703|Sphygmocor|sphygmocor
4739166|NCT02991703|applanation tonometry|applanation tonometry
4739167|NCT02991703|pOpmètre|popmètre
4739168|NCT02991703|children|children
4739169|NCT02991703|EPIPAGE cohort|epipage cohort
4739170|NCT02991690|Hypothermia|hypothermia
4739171|NCT02991690|Cervical Spinal Cord Injury|cervical spinal cord injury
4739172|NCT02991690|Trauma|trauma
4739173|NCT02991677|exercise|exercise
4739174|NCT02991677|neuropathy|neuropathy
4739175|NCT02991664|glass ionomer cement|glass ionomer cement
4739176|NCT02991664|composite resin|composite resin
4739177|NCT02991651|RXR agonist IRX4204 erlotinib|rxr agonist irx4204 erlotinib
4739178|NCT02991599|Hepatitis B, Vaccine|hepatitis b, vaccine
4739179|NCT02991599|Immunogenicity|immunogenicity
4739180|NCT02991599|methadone maintenance treatment|methadone maintenance treatment
4739181|NCT02991599|Randomized Controlled Trial|randomized controlled trial
4739182|NCT02991586|Emotional Instability|emotional instability
4739183|NCT02991586|Family Therapy|family therapy
4739184|NCT02991586|BPD|bpd
4739185|NCT02991586|DBT|dbt
4739186|NCT02991560|physiotherapy|physiotherapy
4739187|NCT02991560|taping|taping
4739188|NCT02991560|conservative treatment|conservative treatment
4739189|NCT02991534|Patient Participation [N05.300.150.600.620]|patient participation [n05.300.150.600.620]
4739190|NCT02991534|Health Behavior [F01.145.488]|health behavior [f01.145.488]
4739191|NCT02991534|Women [M01.975]|women [m01.975]
4739192|NCT02991534|Patient Satisfaction [N05.715.360.600]|patient satisfaction [n05.715.360.600]
4739193|NCT02991534|Physicians, Primary Care [M01.526.485.810.800]|physicians, primary care [m01.526.485.810.800]
4739194|NCT02991534|Physicians, Women [M01.526.485.810.820]|physicians, women [m01.526.485.810.820]
4739195|NCT02991534|Health Educators [M01.526.485.410]|health educators [m01.526.485.410]
4739196|NCT02991534|Cardiovascular Diseases [C14]|cardiovascular diseases [c14]
4739197|NCT02991534|Hypertension [C14.907.489]|hypertension [c14.907.489]
4739198|NCT02991534|Hyperlipidemias [C18.452.584.500.500]|hyperlipidemias [c18.452.584.500.500]
4739199|NCT02991534|Dyslipidemias [C18.452.584.500]|dyslipidemias [c18.452.584.500]
4739200|NCT02991534|Obesity [C18.654.726.500]|obesity [c18.654.726.500]
4739201|NCT02991534|Diabetes Mellitus [C18.452.394.750]|diabetes mellitus [c18.452.394.750]
4739202|NCT02991534|Tobacco Use Disorder [C25.775.912]|tobacco use disorder [c25.775.912]
4739203|NCT02991534|Overweight [C23.888.144.699]|overweight [c23.888.144.699]
4739204|NCT02991508|Adrecizumab|adrecizumab
4739205|NCT02991508|Phase 1 clinical trial|phase 1 clinical trial
4739206|NCT02991508|Adrenomedullin|adrenomedullin
4739207|NCT02991508|Healthy volunteers|healthy volunteers
4739208|NCT02991508|Monoclonal recombinant antibody|monoclonal recombinant antibody
4739209|NCT02991495|epidemic response|epidemic response
4739210|NCT02991482|MPM|mpm
4739211|NCT02991456|malignant glioma|malignant glioma
4739212|NCT02991456|temozolomide|temozolomide
4739213|NCT02991456|temodar|temodar
4739214|NCT02991456|radiation|radiation
4739215|NCT02991456|emesis|emesis
4739216|NCT02991456|nausea|nausea
4739217|NCT02991456|vomiting|vomiting
4739218|NCT02991456|chemotherapy|chemotherapy
4739219|NCT02991456|Affronti|affronti
4739220|NCT02991456|Peters|peters
4739221|NCT02991456|00076418|00076418
4739222|NCT02991430|migraine headache, episodic|migraine headache, episodic
4739223|NCT02991378|preschool children|preschool children
4739224|NCT02991378|emotional disorders/problems|emotional disorders/problems
4739225|NCT02991378|stress related disorders/problems|stress related disorders/problems
4739226|NCT02991378|early intervention|early intervention
4739227|NCT02991352|Vascular Malformations|vascular malformations
4739228|NCT02991352|Image Guidance|image guidance
4739229|NCT02991339|Dexamethasone|dexamethasone
4739230|NCT02991339|Liver Dysfunction|liver dysfunction
4739231|NCT02991339|Hepatectomy|hepatectomy
4739232|NCT02991339|Bilirubinaemia|bilirubinaemia
4739233|NCT02991339|Jaundice|jaundice
4739234|NCT02991326|Osteopathic Manipulative Treatment|osteopathic manipulative treatment
4739235|NCT02991326|Temporomandibular Disorder|temporomandibular disorder
4739236|NCT02991300|focal defect|focal defect
4739237|NCT02991300|focal lesion|focal lesion
4739238|NCT02991300|chondral lesion|chondral lesion
4739239|NCT02991300|osteochondral lesion|osteochondral lesion
4739240|NCT02991274|T790M|t790m
4739241|NCT02991274|EGFR (Epidermal Growth Factor Receptor) mutation|egfr (epidermal growth factor receptor) mutation
4739242|NCT02991274|NSCLC|nsclc
4739243|NCT02991196|Advanced colorectal cancer|advanced colorectal cancer
4739244|NCT02991196|DNA mismatch repair (MMR)|dna mismatch repair (mmr)
4739245|NCT02991196|MMR-proficient Subjects|mmr-proficient subjects
4739246|NCT02991196|TRAIL-R2 (DR5) Antibody|trail-r2 (dr5) antibody
4739247|NCT02991183|Caregivers|caregivers
4739248|NCT02991183|Acceptance and Commitment Therapy|acceptance and commitment therapy
4739249|NCT02991170|myocardial infarction|myocardial infarction
4739250|NCT02991170|ventricular arrhythmia|ventricular arrhythmia
4739251|NCT02991170|radiofrequency ablation|radiofrequency ablation
4739252|NCT02991170|Coronary Artery Bypass Grafts|coronary artery bypass grafts
4739253|NCT02991157|cerebral vasospasm|cerebral vasospasm
4739254|NCT02991157|nimodipine|nimodipine
4739255|NCT02991144|Gene Transfer|gene transfer
4739256|NCT02991144|OTC Deficiency|otc deficiency
4739257|NCT02991144|Urea Cycle Disorder|urea cycle disorder
4739258|NCT02991131|Acute bacterial skin infection|acute bacterial skin infection
4739259|NCT02991131|Acute Bacterial Skin and Skin Structure Infection (ABSSSI)|acute bacterial skin and skin structure infection (absssi)
4739260|NCT02991131|Abscess|abscess
4739261|NCT02991131|Cellulitis|cellulitis
4739262|NCT02991131|Erysipelas|erysipelas
4739263|NCT02991131|Wound infection|wound infection
4739264|NCT02991131|Methicillin resistant Staphylococcus aureus (MRSA)|methicillin resistant staphylococcus aureus (mrsa)
4739265|NCT02991118|hyperlipidemia|hyperlipidemia
4739266|NCT02991118|cholesterol|cholesterol
4739267|NCT02991118|familial hypercholesterolemia|familial hypercholesterolemia
4739268|NCT02991118|atherosclerotic cardiovascular disease|atherosclerotic cardiovascular disease
4739269|NCT02991118|ASCVD|ascvd
4739270|NCT02991118|HeFH|hefh
4739271|NCT02991118|LDL|ldl
4739272|NCT02991105|Malignancy|malignancy
4739273|NCT02991105|Cancer|cancer
4739274|NCT02991105|Organ Transplantation|organ transplantation
4739275|NCT02991092|colon carcinoma|colon carcinoma
4739276|NCT02991092|liquid treatment|liquid treatment
4739277|NCT02991092|fast-track surgery|fast-track surgery
4739278|NCT02991079|Food Habits|food habits
4739279|NCT02991079|Health education|health education
4739280|NCT02991079|Physical activity|physical activity
4739281|NCT02991079|Information and Communication Technologies|information and communication technologies
4739282|NCT02991066|Acute promyelocytic leukemia|acute promyelocytic leukemia
4739283|NCT02991066|Coagulopathy|coagulopathy
4739284|NCT02991066|Microparticles|microparticles
4739285|NCT02991066|Mechanism|mechanism
4739286|NCT02991053|Intra-operative anesthesia|intra-operative anesthesia
4739287|NCT02991053|Pediatric patient|pediatric patient
4739288|NCT02991053|Transversus Abdominis Plane Block|transversus abdominis plane block
4739289|NCT02991053|ilioinguinal / iliohypogastric nerve block|ilioinguinal / iliohypogastric nerve block
4739290|NCT02991027|no known ocular pathology|no known ocular pathology
4739291|NCT02991014|music intervention|music intervention
4739292|NCT02991014|heart rate variability|heart rate variability
4739293|NCT02991014|frequency modulation|frequency modulation
4739294|NCT02991014|pain perception|pain perception
4739295|NCT02991014|cold pressor test (CPT)|cold pressor test (cpt)
4739296|NCT02991001|Hydrodissection|hydrodissection
4739297|NCT02990988|Blood donation|blood donation
4739298|NCT02990988|Iron repletion|iron repletion
4739299|NCT02990988|Transfusion|transfusion
4739300|NCT02990975|Intra-operative anesthesia|intra-operative anesthesia
4739301|NCT02990975|Pediatric patient|pediatric patient
4739302|NCT02990975|Transversus Abdominis Plane Block|transversus abdominis plane block
4739303|NCT02990962|perineural injection|perineural injection
4739304|NCT02990962|ultrasound-guided|ultrasound-guided
4739305|NCT02990962|dextrose|dextrose
4739306|NCT02990962|steroid|steroid
4739307|NCT02990936|Oropharynx squamous cell carcinoma|oropharynx squamous cell carcinoma
4739308|NCT02990936|tumor growth|tumor growth
4739309|NCT02990936|predictive markers|predictive markers
4739310|NCT02990936|tumoral kinetics|tumoral kinetics
4739311|NCT02990910|respiratory adverse events|respiratory adverse events
4739312|NCT02990910|adenotonsillectomy|adenotonsillectomy
4739313|NCT02990910|opioid analgesia|opioid analgesia
4739314|NCT02990910|children|children
4739315|NCT02990897|Medical informatics|medical informatics
4739316|NCT02990897|Quality of care|quality of care
4739317|NCT02990897|Referral|referral
4739318|NCT02990884|Intra-operative anesthesia and analgesia|intra-operative anesthesia and analgesia
4739319|NCT02990884|ilioinguinal / iliohyogogastric nerve block|ilioinguinal / iliohyogogastric nerve block
4739320|NCT02990884|Pediatric patient|pediatric patient
4739321|NCT02990819|Immunodeficiencies|immunodeficiencies
4739322|NCT02990819|Immune dysregulation syndromes|immune dysregulation syndromes
4739323|NCT02990793|PTSD|ptsd
4739324|NCT02990793|Concussion|concussion
4739325|NCT02990793|TBI|tbi
4739326|NCT02990793|TMS|tms
4739327|NCT02990741|atrial fibrillation|atrial fibrillation
4739328|NCT02990741|automated ECG system|automated ecg system
4739329|NCT02990728|Endometrial Cancer.Mirena®|endometrial cancer.mirena®
4739330|NCT02990715|average risk CRC screening|average risk crc screening
4739331|NCT02990715|Non compliant patients for CRC screening|non compliant patients for crc screening
4739332|NCT02990715|Counterindicated patients for colonoscopy|counterindicated patients for colonoscopy
4739333|NCT02990702|Infraclavicular block|infraclavicular block
4739334|NCT02990702|Retroclavicular block|retroclavicular block
4739335|NCT02990702|Ultrasound|ultrasound
4739336|NCT02990676|Cognition|cognition
4739337|NCT02990676|Computerised cognitive training|computerised cognitive training
4739338|NCT02990676|Feasibility study|feasibility study
4739339|NCT02990676|Huntington's disease|huntington's disease
4739340|NCT02990676|Translational|translational
4739341|NCT02990663|Pragmatic|pragmatic
4739342|NCT02990663|Primary Care|primary care
4739343|NCT02990663|Chronotherapy|chronotherapy
4739344|NCT02990663|Administrative Data|administrative data
4739345|NCT02990663|Stroke|stroke
4739346|NCT02990663|Myocardial Infarction|myocardial infarction
4739347|NCT02990663|Congestive Heart Failure|congestive heart failure
4739348|NCT02990663|Glaucoma|glaucoma
4739349|NCT02990663|Dementia|dementia
4739350|NCT02990663|Hip Fracture|hip fracture
4739351|NCT02990637|Olive leaf extract|olive leaf extract
4739352|NCT02990637|Cardiovascular health|cardiovascular health
4739353|NCT02990637|Cholesterol|cholesterol
4739354|NCT02990624|psoriasis|psoriasis
4739355|NCT02990624|photochemotherapy|photochemotherapy
4739356|NCT02990624|atherosclerosis|atherosclerosis
4739357|NCT02990624|metabolic syndrome|metabolic syndrome
4739358|NCT02990624|cardiovascular risk|cardiovascular risk
4739359|NCT02990598|Hydroxyurea|hydroxyurea
4739360|NCT02990572|Amish|amish
4739361|NCT02990572|Mennonite|mennonite
4739362|NCT02990559|Iron repletion|iron repletion
4739363|NCT02990559|Blood donation|blood donation
4739364|NCT02990559|Transfusion|transfusion
4739365|NCT02990507|mobility impairment|mobility impairment
4739366|NCT02990507|virtual environment|virtual environment
4739367|NCT02990507|exercise|exercise
4739368|NCT02990507|physical activity|physical activity
4739369|NCT02990468|Mucositis|mucositis
4739370|NCT02990468|Xerostomia|xerostomia
4739371|NCT02990455|alcohol|alcohol
4739372|NCT02990455|drinking|drinking
4739373|NCT02990455|smoking|smoking
4739374|NCT02990455|cigarette|cigarette
4739375|NCT02990455|nicotine|nicotine
4739376|NCT02990442|rTMS|rtms
4739377|NCT02990442|Repetitive Transcranial Magnetic Stimulation|repetitive transcranial magnetic stimulation
4739378|NCT02990442|Brain Stimulation|brain stimulation
4739379|NCT02990429|hypothermia|hypothermia
4739380|NCT02990429|Shivering|shivering
4739381|NCT02990429|Gynecologic laparoscopic surgery|gynecologic laparoscopic surgery
4739382|NCT02990429|Warming|warming
4739383|NCT02990429|General anesthesia|general anesthesia
4739384|NCT02990377|Opioid Analgesics|opioid analgesics
4739385|NCT02990377|Opioid Safety|opioid safety
4739386|NCT02990377|Emergency Department|emergency department
4739387|NCT02990377|Motivational Enhancement|motivational enhancement
4739388|NCT02990377|Interactive Voice Response|interactive voice response
4739389|NCT02990377|Reinforcement Learning|reinforcement learning
4739390|NCT02990377|mHealth|mhealth
4739391|NCT02990364|Circumcision|circumcision
4739392|NCT02990364|Analgesia|analgesia
4739393|NCT02990364|Controlled Clinical Trial|controlled clinical trial
4739394|NCT02990325|ABX464, HIV infection|abx464, hiv infection
4739395|NCT02990299|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
4739396|NCT02990299|Medication Adherence|medication adherence
4739397|NCT02990299|Telemedicine|telemedicine
4739398|NCT02990299|Community Health Workers|community health workers
4739399|NCT02990299|Pharmacists|pharmacists
4739400|NCT02990299|Mobile Health|mobile health
4739401|NCT02990286|Non specific intertitial pneumonia|non specific intertitial pneumonia
4739402|NCT02990286|interstitial pneumonia with autoimmune feature|interstitial pneumonia with autoimmune feature
4739403|NCT02990286|connective tissue disease|connective tissue disease
4739404|NCT02990286|rituximab|rituximab
4739405|NCT02990286|Mycophenolate Mofetil|mycophenolate mofetil
4739406|NCT02990286|pulmonary fibrosis|pulmonary fibrosis
4739407|NCT02990247|Asthma|asthma
4739408|NCT02990247|Exacerbations|exacerbations
4739409|NCT02990247|Telemonitoring|telemonitoring
4739410|NCT02990247|Biomarkers|biomarkers
4739411|NCT02990234|Capsular Repair|capsular repair
4739412|NCT02990234|FAI|fai
4739413|NCT02990234|Hip|hip
4739414|NCT02990221|Field Cancerization|field cancerization
4739415|NCT02990208|Diaphragmatic Breathing|diaphragmatic breathing
4739416|NCT02990208|Virtual Reality Exposure Therapy|virtual reality exposure therapy
4739417|NCT02990182|Yellow Fever Vaccine|yellow fever vaccine
4739418|NCT02990182|Immunity, Humoral|immunity, humoral
4739419|NCT02990182|Immunity, Cellular|immunity, cellular
4739420|NCT02990182|children|children
4739421|NCT02990156|Coils|coils
4739422|NCT02990091|TBI|tbi
4739423|NCT02990091|DHA|dha
4739424|NCT02990091|omega-3 highly unsaturated fatty acids|omega-3 highly unsaturated fatty acids
4739425|NCT02990091|synaptamide|synaptamide
4739426|NCT02990078|TBI|tbi
4739427|NCT02990078|CVR|cvr
4739428|NCT02990078|Hypercapnia|hypercapnia
4739429|NCT02990078|fNIRS|fnirs
4739430|NCT02990065|PROTEIN SUPPLEMENTATION|protein supplementation
4739431|NCT02990065|NUTRITIONAL STATUS|nutritional status
4739432|NCT02990039|physical activity|physical activity
4739433|NCT02990039|sedentary time|sedentary time
4739434|NCT02990039|feasibility study|feasibility study
4739435|NCT02990039|accelerometer|accelerometer
4739436|NCT02989987|PTSD|ptsd
4739437|NCT02989987|Shame|shame
4739438|NCT02989987|Narrative Exposure Therapy|narrative exposure therapy
4739439|NCT02989987|Sexual and gender based violence (SGBV)|sexual and gender based violence (sgbv)
4739440|NCT02989987|DR Congo|dr congo
4739441|NCT02989974|Survivorship Care|survivorship care
4739442|NCT02989974|Caregiving|caregiving
4739443|NCT02989948|Endovascular|endovascular
4739444|NCT02989935|respiratory muscle|respiratory muscle
4739445|NCT02989935|bronchodilator|bronchodilator
4739446|NCT02989896|Perfusion index|perfusion index
4739447|NCT02989896|Peripheral nerve block success|peripheral nerve block success
4739448|NCT02989896|older age|older age
4739449|NCT02989883|achalasia|achalasia
4739450|NCT02989883|POEM|poem
4739451|NCT02989883|outcome|outcome
4739452|NCT02989870|Liver Disease|liver disease
4739453|NCT02989870|Child-Pugh Class A|child-pugh class a
4739454|NCT02989870|Child-Pugh Class B7|child-pugh class b7
4739455|NCT02989857|IDH1|idh1
4739456|NCT02989831|diabetic neuropathy|diabetic neuropathy
4739457|NCT02989831|foot ulcers|foot ulcers
4739458|NCT02989831|random vibration|random vibration
4739459|NCT02989831|vibration perception threshold|vibration perception threshold
4739460|NCT02989831|mechanical noise|mechanical noise
4739461|NCT02989805|Emergency Medicine|emergency medicine
4739462|NCT02989805|Psychiatry|psychiatry
4739463|NCT02989805|Health Promotion|health promotion
4739464|NCT02989805|Public Health|public health
4739465|NCT02989792|pain|pain
4739466|NCT02989753|Prevention|prevention
4739467|NCT02989740|Diabetes Mellitus|diabetes mellitus
4739468|NCT02989740|Thincap fibroatheroma|thincap fibroatheroma
4739469|NCT02989740|Optical Coherence Tomography|optical coherence tomography
4739470|NCT02989740|Fractional Flow Reserve|fractional flow reserve
4739471|NCT02989701|Plerixafor|plerixafor
4739472|NCT02989675|pediatric|pediatric
4739473|NCT02989675|critical illness|critical illness
4739474|NCT02989675|Malawi|malawi
4739475|NCT02989649|Drug Therapy|drug therapy
4739476|NCT02989584|bladder cancer|bladder cancer
4739477|NCT02989584|metastatic bladder cancer|metastatic bladder cancer
4739478|NCT02989584|atezolizumab|atezolizumab
4739479|NCT02989584|urothelial carcinoma|urothelial carcinoma
4739480|NCT02989519|preterm labor|preterm labor
4739481|NCT02989519|progesterone efficacy|progesterone efficacy
4739482|NCT02989519|threatened preterm labor|threatened preterm labor
4739483|NCT02989493|Alcoholism|alcoholism
4739484|NCT02989493|Stress|stress
4739485|NCT02989493|Norepinephrine|norepinephrine
4739486|NCT02989493|Doxazosin|doxazosin
4739487|NCT02989493|Anxiety|anxiety
4739488|NCT02989493|Startle Potentiation|startle potentiation
4739489|NCT02989493|Relapse|relapse
4739490|NCT02989493|Adrenergic Antagonists|adrenergic antagonists
4739491|NCT02989493|Surrogate Endpoint|surrogate endpoint
4739492|NCT02989480|Cardiomyopathy|cardiomyopathy
4739493|NCT02989441|Perfusion Index|perfusion index
4739494|NCT02989441|Hemodynamics|hemodynamics
4739495|NCT02989441|Anesthesia|anesthesia
4739496|NCT02989441|Stroke Volume|stroke volume
4739497|NCT02989415|Anesthesia|anesthesia
4739498|NCT02989415|Mechanical Ventilation|mechanical ventilation
4739499|NCT02989415|Robotic Surgery|robotic surgery
4739500|NCT02989415|Postoperative Pulmonary Complications|postoperative pulmonary complications
4739501|NCT02989402|Alzheimer, Rivastigmine|alzheimer, rivastigmine
4739502|NCT02989363|deep brain surgery and complex back surgery|deep brain surgery and complex back surgery
4739503|NCT02989337|Hyperemesis Gravidarum|hyperemesis gravidarum
4739504|NCT02989337|Inflammatory adhesion molecules|inflammatory adhesion molecules
4739505|NCT02989337|Dehydration|dehydration
4739506|NCT02989311|Iron absorption|iron absorption
4739507|NCT02989311|Iron deficiency|iron deficiency
4739508|NCT02989311|Hepcidin|hepcidin
4739509|NCT02989311|Stable isotopes|stable isotopes
4739510|NCT02989311|Anemia|anemia
4739511|NCT02989311|Infants|infants
4739512|NCT02989298|Peritoneal Dialysis (PD)|peritoneal dialysis (pd)
4739513|NCT02989298|Residual renal function|residual renal function
4739514|NCT02989298|Peritoneum function|peritoneum function
4739515|NCT02989298|Peritonitis rate|peritonitis rate
4739516|NCT02989298|Technical survival|technical survival
4739517|NCT02989298|Patient survival|patient survival
4739518|NCT02989285|HIV|hiv
4739519|NCT02989285|HIV-associated neurocognitive disorder (HAND)|hiv-associated neurocognitive disorder (hand)
4739520|NCT02989285|Neurology|neurology
4739521|NCT02989285|Latent HIV|latent hiv
4739522|NCT02989285|HIV Reservoirs|hiv reservoirs
4739523|NCT02989259|apatinib|apatinib
4739524|NCT02989259|advanced head and neck cancer|advanced head and neck cancer
4739525|NCT02989259|non-squamous|non-squamous
4739526|NCT02989246|pediatrics|pediatrics
4739527|NCT02989246|ventilator weaning|ventilator weaning
4739528|NCT02989220|Miscarriage|miscarriage
4739529|NCT02989207|Glaucoma|glaucoma
4739530|NCT02989207|Trabeculectomy|trabeculectomy
4739531|NCT02989207|Glaucoma drainage implant|glaucoma drainage implant
4739532|NCT02989207|Africa and Africa-Caribbean|africa and africa-caribbean
4739533|NCT02989168|Idiopathic pulmonary fibrosis|idiopathic pulmonary fibrosis
4739534|NCT02989168|hypoxemia|hypoxemia
4739535|NCT02989168|oxygen|oxygen
4739536|NCT02989142|interpregnancy|interpregnancy
4739537|NCT02989142|pregnancy-induced hypertension|pregnancy-induced hypertension
4739538|NCT02989142|gestational diabetes mellitus|gestational diabetes mellitus
4739539|NCT02989142|caesarean section|caesarean section
4739540|NCT02989142|large-for-gestational-age|large-for-gestational-age
4739541|NCT02989129|Polyneuropathies and Other Disorders of the Peripheral Nervous System|polyneuropathies and other disorders of the peripheral nervous system
4739542|NCT02989129|Chemotherapy Induced Neuropathic Pain|chemotherapy induced neuropathic pain
4739543|NCT02989129|CINP|cinp
4739544|NCT02989129|Quercetin|quercetin
4739545|NCT02989129|Questionnaires|questionnaires
4739546|NCT02989129|Surveys|surveys
4739547|NCT02989116|Learning|learning
4739548|NCT02989116|Executive functions|executive functions
4739549|NCT02989116|Cognitive control|cognitive control
4739550|NCT02989116|Prefrontal Cortex|prefrontal cortex
4739551|NCT02989116|Typically developing children|typically developing children
4739552|NCT02989116|Genotype|genotype
4739553|NCT02989116|Functional Magnetic Resonance Imaging|functional magnetic resonance imaging
4739554|NCT02989116|Structural Magnetic Resonance Imaging|structural magnetic resonance imaging
4739555|NCT02989116|Inhibition|inhibition
4739556|NCT02989116|Working Memory|working memory
4739557|NCT02989116|Metacognition|metacognition
4739558|NCT02989116|Mindfulness|mindfulness
4739559|NCT02989116|Preterm children|preterm children
4739560|NCT02989116|Developmental Psychology|developmental psychology
4739561|NCT02989116|Developmental cognitive neuroscience|developmental cognitive neuroscience
4739562|NCT02989116|Touch screen tablet|touch screen tablet
4739563|NCT02989116|Adaptive training|adaptive training
4739564|NCT02989103|Hyperthyroidism|hyperthyroidism
4739565|NCT02989103|Radiation|radiation
4739566|NCT02989103|Mortality|mortality
4739567|NCT02989090|Patient Engagement|patient engagement
4739568|NCT02989090|Defibrillators|defibrillators
4739569|NCT02989090|Health Records, Personal|health records, personal
4739570|NCT02989090|Patient Portal|patient portal
4739571|NCT02989077|combined coronary and cerebral ischemia|combined coronary and cerebral ischemia
4739572|NCT02989064|Cell Therapy|cell therapy
4739573|NCT02989064|T Cell Therapy|t cell therapy
4739574|NCT02989064|SPEAR T Cell|spear t cell
4739575|NCT02989064|MAGE-A10|mage-a10
4739576|NCT02989064|Immuno-oncology|immuno-oncology
4739577|NCT02989064|Metastatic|metastatic
4739578|NCT02989064|Urothelial Cancer|urothelial cancer
4739579|NCT02989064|Previously Treated|previously treated
4739580|NCT02989064|T Cell Receptor|t cell receptor
4739581|NCT02989038|smoker|smoker
4739582|NCT02989038|young adult|young adult
4739583|NCT02988999|D-allulose or erythritol|d-allulose or erythritol
4739584|NCT02988986|mTOR|mtor
4739585|NCT02988986|Tamoxifen|tamoxifen
4739586|NCT02988986|Breast Cancer|breast cancer
4739587|NCT02988973|Roxadustat|roxadustat
4739588|NCT02988973|Anemia|anemia
4739589|NCT02988973|Non-dialysis chronic kidney disease|non-dialysis chronic kidney disease
4739590|NCT02988973|ASP1517|asp1517
4739591|NCT02988960|Non-small cell lung cancer (NSCLC)|non-small cell lung cancer (nsclc)
4739592|NCT02988960|Squamous cell carcinoma of the head and neck (SCCHN)|squamous cell carcinoma of the head and neck (scchn)
4739593|NCT02988960|Advanced solid tumor|advanced solid tumor
4739594|NCT02988960|Cancer|cancer
4739595|NCT02988960|Pancreatic adenocarcinoma|pancreatic adenocarcinoma
4739596|NCT02988960|Cutaneous melanoma|cutaneous melanoma
4739597|NCT02988947|Knee Arthroplasty|knee arthroplasty
4739598|NCT02988947|Hypnosis|hypnosis
4739599|NCT02988947|Pain Neuroscience Education|pain neuroscience education
4739600|NCT02988947|Pain|pain
4739601|NCT02988947|Catastrophizing|catastrophizing
4739602|NCT02988947|Optimism|optimism
4739603|NCT02988947|Distress|distress
4739604|NCT02988947|Hope|hope
4739605|NCT02988947|Self-Efficacy|self-efficacy
4739606|NCT02988895|Brachytherapy|brachytherapy
4739607|NCT02988895|Wet AMD|wet amd
4739608|NCT02988869|COPD|copd
4739609|NCT02988869|Tiotropium|tiotropium
4739610|NCT02988869|Formoterol|formoterol
4739612|NCT02988830|Subcutaneous stimulation|subcutaneous stimulation
4739613|NCT02988804|endoscopic endonasal transsphenoidal surgery|endoscopic endonasal transsphenoidal surgery
4739614|NCT02988804|laryngeal mask|laryngeal mask
4739615|NCT02988765|vulvar cancer|vulvar cancer
4739616|NCT02988765|inguinal lymph node|inguinal lymph node
4739617|NCT02988765|lymph node status|lymph node status
4739618|NCT02988765|cytology|cytology
4739619|NCT02988765|core biopsy|core biopsy
4739620|NCT02988726|Neurofibroma|neurofibroma
4739621|NCT02988726|Schwannoma|schwannoma
4739622|NCT02988713|stimulation|stimulation
4739623|NCT02988713|chronic pain|chronic pain
4739624|NCT02988713|back pain|back pain
4739625|NCT02988713|leg pain|leg pain
4739626|NCT02988687|fatigue|fatigue
4739627|NCT02988687|quality of life|quality of life
4739628|NCT02988687|depression|depression
4739629|NCT02988687|cognitive function|cognitive function
4739630|NCT02988687|growth hormone|growth hormone
4739631|NCT02988687|traumatic brain injury|traumatic brain injury
4739632|NCT02988674|Adalimumab|adalimumab
4739633|NCT02988674|Ankylosing spondylitis|ankylosing spondylitis
4739634|NCT02988674|Psoriatic arthritis|psoriatic arthritis
4739635|NCT02988674|Spondylarthritis|spondylarthritis
4739636|NCT02988674|Humira®|humira®
4739637|NCT02988661|Autoimmunity|autoimmunity
4739638|NCT02988661|Immune System Disorders|immune system disorders
4739639|NCT02988648|Metastatic Breast Cancer|metastatic breast cancer
4739640|NCT02988635|Early Palliative Care|early palliative care
4739641|NCT02988635|Simultaneous Care|simultaneous care
4739642|NCT02988635|Chemotherapy|chemotherapy
4739643|NCT02988635|Quality of Life|quality of life
4739644|NCT02988596|Concussion|concussion
4739645|NCT02988596|Rehabilitation|rehabilitation
4739646|NCT02988583|silicone oil|silicone oil
4739647|NCT02988583|emulsification|emulsification
4739648|NCT02988583|retinal detachment surgery|retinal detachment surgery
4739649|NCT02988557|cerebral palsy|cerebral palsy
4739650|NCT02988557|gait|gait
4739651|NCT02988557|slope|slope
4739652|NCT02988557|electromyography|electromyography
4739653|NCT02988531|PET|pet
4739654|NCT02988531|MRI|mri
4739655|NCT02988531|Attenuation|attenuation
4739656|NCT02988531|Correction|correction
4739657|NCT02988531|Cardiovascular|cardiovascular
4739658|NCT02988531|coronary|coronary
4739659|NCT02988531|disease|disease
4739660|NCT02988518|Psychiatry|psychiatry
4739661|NCT02988518|Bipolar disorder|bipolar disorder
4739662|NCT02988518|Memory complaints|memory complaints
4739663|NCT02988518|Global functioning|global functioning
4739664|NCT02988518|Cognitive remediation|cognitive remediation
4739665|NCT02988518|Working memory|working memory
4739666|NCT02988466|Acute Leukemias|acute leukemias
4739667|NCT02988466|Acute myeloid leukemia (AML)|acute myeloid leukemia (aml)
4739668|NCT02988466|Acute lymphoblastic leukemia (ALL)/lymphoma|acute lymphoblastic leukemia (all)/lymphoma
4739669|NCT02988466|Biphenotypic/Undifferentiated/Prolymphocytic Leukemias|biphenotypic/undifferentiated/prolymphocytic leukemias
4739670|NCT02988466|Myelodysplastic syndrome|myelodysplastic syndrome
4739671|NCT02988466|Chronic myelogenous leukemia|chronic myelogenous leukemia
4739672|NCT02988466|Minimal Residual Disease (MRD) positive leukemia|minimal residual disease (mrd) positive leukemia
4739673|NCT02988466|Leukemia or Myelodysplastic Syndromes (MDS) in aplasia|leukemia or myelodysplastic syndromes (mds) in aplasia
4739674|NCT02988466|Myeloproliferative neoplasms/myelofibrosis|myeloproliferative neoplasms/myelofibrosis
4739675|NCT02988466|Relapsed large-cell lymphoma, mantle-cell lymphoma and Hodgkin lymphoma|relapsed large-cell lymphoma, mantle-cell lymphoma and hodgkin lymphoma
4739676|NCT02988466|Burkitt's lymphoma|burkitt's lymphoma
4739677|NCT02988466|Relapsed T-cell lymphoma|relapsed t-cell lymphoma
4739678|NCT02988466|Natural Killer cell malignancies|natural killer cell malignancies
4739679|NCT02988466|Relapsed chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL), marginal zone B-cell lymphoma, follicular lymphoma|relapsed chronic lymphocytic leukemia/small lymphocytic lymphoma (cll/sll), marginal zone b-cell lymphoma, follicular lymphoma
4739680|NCT02988466|Lymphoplasmacytic lymphoma|lymphoplasmacytic lymphoma
4739681|NCT02988466|Relapsed multiple myeloma|relapsed multiple myeloma
4739682|NCT02988466|Bone marrow failure syndromes|bone marrow failure syndromes
4739683|NCT02988453|mentalization-based treatment|mentalization-based treatment
4739684|NCT02988453|conduct disorder|conduct disorder
4739685|NCT02988453|adolescents|adolescents
4739686|NCT02988440|HCC|hcc
4739687|NCT02988440|Hepatocellular carcinoma|hepatocellular carcinoma
4739688|NCT02988440|Hepatocellular carcinoma (HCC)|hepatocellular carcinoma (hcc)
4739689|NCT02988440|PDR001|pdr001
4739690|NCT02988440|liver cancer|liver cancer
4739691|NCT02988440|immunotherapy liver|immunotherapy liver
4739692|NCT02988440|malignant hepatoma|malignant hepatoma
4739693|NCT02988440|Hepatocellular cancer|hepatocellular cancer
4739694|NCT02988440|advanced hepatocellular carcinoma (HCC)|advanced hepatocellular carcinoma (hcc)
4739695|NCT02988440|advanced liver cancer|advanced liver cancer
4739696|NCT02988440|liver cancer progression|liver cancer progression
4739697|NCT02988440|sorafenib|sorafenib
4739698|NCT02988440|anti-PD1|anti-pd1
4739699|NCT02988440|first line|first line
4739700|NCT02988414|Sepsis|sepsis
4739701|NCT02988414|Infection|infection
4739702|NCT02988414|Culture|culture
4739703|NCT02988414|Sequencing|sequencing
4739704|NCT02988414|Non-invasive|non-invasive
4739705|NCT02988414|NGS|ngs
4739706|NCT02988375|insomnia|insomnia
4739707|NCT02988375|depression|depression
4739708|NCT02988375|digital CBTI|digital cbti
4739709|NCT02988375|online CBTI|online cbti
4739710|NCT02988336|difficult intubation|difficult intubation
4739711|NCT02988336|thyromental height|thyromental height
4739712|NCT02988323|sport concussion|sport concussion
4739713|NCT02988323|cervical spine|cervical spine
4739714|NCT02988323|vestibular rehabilitation|vestibular rehabilitation
4739715|NCT02988323|exercise|exercise
4739716|NCT02988323|rehabilitation|rehabilitation
4739717|NCT02988323|children|children
4739718|NCT02988323|youth|youth
4739719|NCT02988310|Limb Loss|limb loss
4739720|NCT02988310|Gait Characteristics|gait characteristics
4739721|NCT02988284|Gait variability|gait variability
4739722|NCT02988271|Meditation|meditation
4739723|NCT02988271|Anxiety|anxiety
4739724|NCT02988271|Psychosocial distress|psychosocial distress
4739725|NCT02988271|Depression|depression
4739726|NCT02988271|Questionnaires|questionnaires
4739727|NCT02988271|Surveys|surveys
4739728|NCT02988271|Meditation Video|meditation video
4739729|NCT02988271|Meditation app|meditation app
4739730|NCT02988258|Ex vivo gene therapy|ex vivo gene therapy
4739731|NCT02988258|T cell receptor transduction|t cell receptor transduction
4739732|NCT02988258|Immunotherapy|immunotherapy
4739733|NCT02988258|Allogeneic Haematopoietic Stem Cell Transplantation|allogeneic haematopoietic stem cell transplantation
4739734|NCT02988258|CMV|cmv
4739735|NCT02988232|Work Related Chronic Low Back Pain|work related chronic low back pain
4739736|NCT02988232|Korean Medicine|korean medicine
4739737|NCT02988232|Sogyeonghwalhyeol-tang|sogyeonghwalhyeol-tang
4739738|NCT02988219|cardiac arrhythmia|cardiac arrhythmia
4739739|NCT02988219|epidural anesthesia|epidural anesthesia
4739740|NCT02988219|combined anesthesia|combined anesthesia
4739741|NCT02988219|general anesthesia|general anesthesia
4739742|NCT02988219|NSS|nss
4739743|NCT02988219|radical nephrectomy|radical nephrectomy
4739744|NCT02988219|extraperitoneal|extraperitoneal
4739745|NCT02988193|clinical reasoning artificial intelligence|clinical reasoning artificial intelligence
4739746|NCT02988193|poorly controlled hypertension|poorly controlled hypertension
4739747|NCT02988167|Spontaneous Breathing Trial (SBT)|spontaneous breathing trial (sbt)
4739748|NCT02988167|Extubation Decision Support Tool|extubation decision support tool
4739749|NCT02988167|Extubation|extubation
4739750|NCT02988167|Extubation Readiness|extubation readiness
4739751|NCT02988154|Medical education|medical education
4739752|NCT02988154|simulation|simulation
4739753|NCT02988154|neurosurgical education|neurosurgical education
4739754|NCT02988154|Simulation laboratory|simulation laboratory
4739755|NCT02988154|Ventricular drain|ventricular drain
4739756|NCT02988128|Embolization Device|embolization device
4739757|NCT02988128|Flow Diverter|flow diverter
4739758|NCT02988128|Intra saccular device|intra saccular device
4739759|NCT02988128|Vascular Reconstruction Device|vascular reconstruction device
4739760|NCT02988128|Ruptured Intracranial Aneurysm|ruptured intracranial aneurysm
4739761|NCT02988128|Unruptured Intracranial Aneurysm|unruptured intracranial aneurysm
4739762|NCT02988115|hyperlipidemia|hyperlipidemia
4739763|NCT02988115|cholesterol|cholesterol
4739764|NCT02988115|familial hypercholesterolemia|familial hypercholesterolemia
4739765|NCT02988115|atherosclerotic cardiovascular disease|atherosclerotic cardiovascular disease
4739766|NCT02988115|ASCVD|ascvd
4739767|NCT02988115|HeFH|hefh
4739768|NCT02988115|LDL|ldl
4739769|NCT02988115|statin intolerence|statin intolerence
4739770|NCT02988102|S100B, NSE|s100b, nse
4739771|NCT02988102|moderate brain trauma|moderate brain trauma
4739772|NCT02988102|mild brain trauma|mild brain trauma
4739773|NCT02988089|Helicobacter Pylori Infection|helicobacter pylori infection
4739774|NCT02988089|Antimicrobial susceptibility testing (AST)|antimicrobial susceptibility testing (ast)
4739775|NCT02988076|database|database
4739776|NCT02988076|probability|probability
4739777|NCT02988076|response|response
4739778|NCT02988076|depression|depression
4739779|NCT02988076|medication|medication
4739780|NCT02988076|quantitative|quantitative
4739781|NCT02988076|electroencephalogram|electroencephalogram
4739782|NCT02988063|Varithena|varithena
4739783|NCT02988063|Polidocanol Endovenous Microfoam|polidocanol endovenous microfoam
4739784|NCT02988050|Epilepsy Surgery|epilepsy surgery
4739785|NCT02988050|Conscious sedation|conscious sedation
4739786|NCT02988011|type 2 diabetes|type 2 diabetes
4739787|NCT02988011|gastric by-pass surgery|gastric by-pass surgery
4739788|NCT02988011|low calorie diet|low calorie diet
4739789|NCT02988011|glucose metabolism|glucose metabolism
4739790|NCT02987998|Pembrolizumab|pembrolizumab
4739791|NCT02987998|Chemoradiation|chemoradiation
4739792|NCT02987985|Opioid-sparing|opioid-sparing
4739793|NCT02987985|Opioid-free|opioid-free
4739794|NCT02987959|TAK-228|tak-228
4739795|NCT02987959|MLN0128|mln0128
4739796|NCT02987959|mTOR|mtor
4739797|NCT02987933|Chronic Pain|chronic pain
4739798|NCT02987933|fMRI|fmri
4739799|NCT02987933|DTI|dti
4739800|NCT02987894|TAVI|tavi
4739801|NCT02987894|Transcatheter Aortic Valve Replacement|transcatheter aortic valve replacement
4739802|NCT02987894|Transcatheter Aortic Valve Implant|transcatheter aortic valve implant
4739803|NCT02987894|Transfemoral access|transfemoral access
4739804|NCT02987894|Aortic valve regurgitation|aortic valve regurgitation
4739805|NCT02987868|Somatostatin|somatostatin
4739806|NCT02987868|Thyroid Hormone|thyroid hormone
4739807|NCT02987868|Growth Hormone|growth hormone
4739808|NCT02987842|Mild cognitive impairment|mild cognitive impairment
4739809|NCT02987842|Alzhiemer's disease|alzhiemer's disease
4739810|NCT02987842|Neurofeedback|neurofeedback
4739811|NCT02987842|EEG|eeg
4739812|NCT02987803|Patient Engagement|patient engagement
4739813|NCT02987803|Public Reporting|public reporting
4739814|NCT02987803|Quality Measurement|quality measurement
4739815|NCT02987790|Intensive care|intensive care
4739816|NCT02987790|Sepsis|sepsis
4739817|NCT02987790|Biomarkers|biomarkers
4739818|NCT02987790|C-reactive Protein|c-reactive protein
4739819|NCT02987790|Antimicrobial|antimicrobial
4739820|NCT02987790|Systemic infection|systemic infection
4739821|NCT02987764|Premature|premature
4739822|NCT02987764|Birth weight|birth weight
4739823|NCT02987725|Adolescence|adolescence
4739824|NCT02987725|Autonomic Nervous System|autonomic nervous system
4739825|NCT02987725|Hypnosis|hypnosis
4739826|NCT02987725|Pain|pain
4739827|NCT02987725|Sickle Cell Disease|sickle cell disease
4739828|NCT02987712|Thromboelastography|thromboelastography
4739829|NCT02987699|Hepatocellular Carcinoma|hepatocellular carcinoma
4739830|NCT02987699|Hepatic arterial infusion chemotherapy|hepatic arterial infusion chemotherapy
4739831|NCT02987699|optimal dose|optimal dose
4739832|NCT02987686|Topical Infliximab|topical infliximab
4739833|NCT02987686|Cornea|cornea
4739834|NCT02987686|Keratolysis|keratolysis
4739835|NCT02987673|Mini/One anastomosis gastric bypass|mini/one anastomosis gastric bypass
4739836|NCT02987673|Sleeve Gastrectomy|sleeve gastrectomy
4739837|NCT02987673|Gastro-esophageal sphincter function|gastro-esophageal sphincter function
4739838|NCT02987634|gingivitis|gingivitis
4739839|NCT02987634|dental implant|dental implant
4739840|NCT02987634|mouthwash|mouthwash
4739841|NCT02987595|intervention|intervention
4739842|NCT02987595|lignans|lignans
4739843|NCT02987595|whole-grain|whole-grain
4739844|NCT02987582|mental health|mental health
4739845|NCT02987582|mindfulness|mindfulness
4739846|NCT02987582|shame|shame
4739847|NCT02987569|Home Parenteral Nutrition|home parenteral nutrition
4739848|NCT02987569|HPN|hpn
4739849|NCT02987569|Total Parenteral Nutrition|total parenteral nutrition
4739850|NCT02987569|TPN|tpn
4739851|NCT02987569|mConnect|mconnect
4739852|NCT02987569|SBS|sbs
4739853|NCT02987569|short bowel disorder|short bowel disorder
4739854|NCT02987569|telehealth|telehealth
4739855|NCT02987569|telemedicine|telemedicine
4739856|NCT02987543|metastatic castration-resistant prostate cancer (mCRPC)|metastatic castration-resistant prostate cancer (mcrpc)
4739857|NCT02987543|homologous recombination repair (HRR)|homologous recombination repair (hrr)
4739858|NCT02987530|primary infection|primary infection
4739859|NCT02987517|running|running
4739860|NCT02987517|vertical load rates|vertical load rates
4739861|NCT02987517|cadence|cadence
4739862|NCT02987517|footstrike|footstrike
4739863|NCT02987504|Cancer|cancer
4739864|NCT02987504|Solid tumor|solid tumor
4739865|NCT02987504|Phase 1|phase 1
4739866|NCT02987491|exercise|exercise
4739867|NCT02987478|Vitamin D following intra cytoplasmic sperm injection|vitamin d following intra cytoplasmic sperm injection
4739868|NCT02987452|exercise|exercise
4739869|NCT02987452|resistant hypertension|resistant hypertension
4739870|NCT02987452|blood pressure|blood pressure
4739871|NCT02987439|COPD|copd
4739872|NCT02987439|Exacerbation|exacerbation
4739873|NCT02987439|Rehabilitation|rehabilitation
4739874|NCT02987413|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
4739875|NCT02987400|DLBCL|dlbcl
4739876|NCT02987400|GA-101|ga-101
4739877|NCT02987400|ABT-199|abt-199
4739878|NCT02987400|relapsed DLBCL|relapsed dlbcl
4739879|NCT02987400|refractory DLBCL|refractory dlbcl
4739880|NCT02987400|AGMT|agmt
4739881|NCT02987400|Diffuse large B-cell lymphoma|diffuse large b-cell lymphoma
4739882|NCT02987400|window of opportunity|window of opportunity
4739883|NCT02987387|Tetralogy of Fallot|tetralogy of fallot
4739884|NCT02987387|Aortic Valve Defect/Disease Resulting in Ross Procedure|aortic valve defect/disease resulting in ross procedure
4739885|NCT02987387|Transcatheter pulmonary valve implantation|transcatheter pulmonary valve implantation
4739886|NCT02987387|Transcatheter pulmonary valve replacement|transcatheter pulmonary valve replacement
4739887|NCT02987387|Pulmonary Atresia|pulmonary atresia
4739888|NCT02987387|Pulmonary Stenosis|pulmonary stenosis
4739889|NCT02987374|Influenza Vaccine|influenza vaccine
4739890|NCT02987348|type 2 diabetes|type 2 diabetes
4739891|NCT02987309|indirect calorimetry|indirect calorimetry
4739892|NCT02987309|method comparison|method comparison
4739893|NCT02987296|Colorectal Cancer|colorectal cancer
4739894|NCT02987296|Surgery|surgery
4739895|NCT02987296|Arginine depletion|arginine depletion
4739896|NCT02987296|Immune system dysfunction|immune system dysfunction
4739897|NCT02987296|Arginine Supplementation|arginine supplementation
4739898|NCT02987270|mass screen and treat|mass screen and treat
4739899|NCT02987270|malaria|malaria
4739900|NCT02987270|asymptomatic infections|asymptomatic infections
4739901|NCT02987270|transmission reduction|transmission reduction
4739902|NCT02987270|infectious reservoir|infectious reservoir
4739903|NCT02987270|kenya|kenya
4739904|NCT02987257|Therapeutics|therapeutics
4739905|NCT02987257|Management|management
4739906|NCT02987257|Cyclosporine|cyclosporine
4739907|NCT02987257|Etanercept|etanercept
4739908|NCT02987257|Supportive Care|supportive care
4739909|NCT02987257|Immunopathogenesis|immunopathogenesis
4739910|NCT02987257|Genetics|genetics
4739911|NCT02987257|Adverse Drug Reaction|adverse drug reaction
4739912|NCT02987244|Chidamide, T Cell Non-Hodgkin's Lymphoma|chidamide, t cell non-hodgkin's lymphoma
4739913|NCT02987218|POCD|pocd
4739914|NCT02987218|subarachnoid hemorrhage|subarachnoid hemorrhage
4739915|NCT02987218|Propofol|propofol
4739916|NCT02987218|Desflurane|desflurane
4739917|NCT02987192|spinal anesthesia|spinal anesthesia
4739918|NCT02987192|anticoagulation|anticoagulation
4739919|NCT02987192|minimally invasive|minimally invasive
4739920|NCT02987192|Cesarean Section|cesarean section
4739921|NCT02987192|Maternal|maternal
4739922|NCT02987166|immunotherapy|immunotherapy
4739923|NCT02987166|pembrolizumab|pembrolizumab
4739924|NCT02987166|MK-3475|mk-3475
4739925|NCT02987166|High-dose conformal radiation therapy|high-dose conformal radiation therapy
4739926|NCT02987166|HDCRT|hdcrt
4739927|NCT02987166|advanced solid tumor|advanced solid tumor
4739928|NCT02987153|Kyphoplasty|kyphoplasty
4739929|NCT02987153|Spinal metastases|spinal metastases
4739930|NCT02987153|IORT|iort
4739931|NCT02987153|Intraoperative radiation therapy|intraoperative radiation therapy
4739932|NCT02987153|Pain management|pain management
4739933|NCT02987140|Parkinson's disease|parkinson's disease
4739934|NCT02987140|freezing of gait|freezing of gait
4739935|NCT02987140|context-dependency|context-dependency
4739936|NCT02987140|transcranial magnetic stimulation|transcranial magnetic stimulation
4739937|NCT02987140|visual cues|visual cues
4739938|NCT02987062|Atrial Fibrillation|atrial fibrillation
4739939|NCT02987062|Non-vitamin K Oral Anticoagulants|non-vitamin k oral anticoagulants
4739940|NCT02987062|Vitamin K Antagonists|vitamin k antagonists
4739941|NCT02987062|ROCKET-AF|rocket-af
4739942|NCT02987062|RE-LY|re-ly
4739943|NCT02987062|ARISTOTLE|aristotle
4739944|NCT02987049|heart disease, cardiac rehabilitation|heart disease, cardiac rehabilitation
4739945|NCT02987036|nebulizer technologies, lung mechanics, beta-agonistic drug|nebulizer technologies, lung mechanics, beta-agonistic drug
4739946|NCT02987023|infertility, uterus, transplantation|infertility, uterus, transplantation
4739947|NCT02986997|epidural anesthesia|epidural anesthesia
4739948|NCT02986997|prone position|prone position
4739949|NCT02986997|percutaneous nephrolithotomy|percutaneous nephrolithotomy
4739950|NCT02986984|Diabetes|diabetes
4739951|NCT02986984|Chronic kidney disease|chronic kidney disease
4739952|NCT02986984|Progression|progression
4739953|NCT02986984|Genomics|genomics
4739954|NCT02986984|Transcriptomics|transcriptomics
4739955|NCT02986971|Contraceptive implant|contraceptive implant
4739956|NCT02986945|Depressive symptoms|depressive symptoms
4739957|NCT02986945|resiliency|resiliency
4739958|NCT02986945|Health Promotion|health promotion
4739959|NCT02986945|minority health|minority health
4739960|NCT02986945|text-messaging app|text-messaging app
4739961|NCT02986945|participatory technology development|participatory technology development
4739962|NCT02986932|Blood-Brain Barrier|blood-brain barrier
4739963|NCT02986919|Malignant peripheral Nerve Sheath Tumors (MPNST); Neurofibromatosis sarcoma|malignant peripheral nerve sheath tumors (mpnst); neurofibromatosis sarcoma
4739964|NCT02986906|ulnar neuropathy at elbow|ulnar neuropathy at elbow
4739965|NCT02986906|Dextrose|dextrose
4739966|NCT02986906|perineural injection|perineural injection
4739967|NCT02986893|Multiple Sclerosis|multiple sclerosis
4739968|NCT02986893|Diet|diet
4739969|NCT02986893|Clinical Trial|clinical trial
4739970|NCT02986854|Meningococcal disease|meningococcal disease
4739971|NCT02986854|Booster vaccination|booster vaccination
4739972|NCT02986854|Meningitis|meningitis
4739973|NCT02986854|Antibody persistence|antibody persistence
4739974|NCT02986828|platelet rich plasma|platelet rich plasma
4739975|NCT02986828|Hydrodissection|hydrodissection
4739976|NCT02986737|TAVI|tavi
4739977|NCT02986737|Aortic Stenosis|aortic stenosis
4739978|NCT02986737|Transcatether Aortic Valve Implantation|transcatether aortic valve implantation
4739979|NCT02986724|Drug therapy|drug therapy
4739980|NCT02986698|intrauterine transfusion|intrauterine transfusion
4739981|NCT02986698|in utero human stem cell transplantation|in utero human stem cell transplantation
4739982|NCT02986685|Refractory reflux esophagitis|refractory reflux esophagitis
4739983|NCT02986685|Rabeprazole|rabeprazole
4739984|NCT02986685|trimebutine maleate|trimebutine maleate
4739985|NCT02986672|ADHD|adhd
4739986|NCT02986672|omega 3|omega 3
4739987|NCT02986672|children|children
4739988|NCT02986672|nutrition|nutrition
4739989|NCT02986672|MUFA|mufa
4739990|NCT02986672|ADD|add
4739991|NCT02986672|PUFA|pufa
4739992|NCT02986672|Calanus|calanus
4739993|NCT02986672|learning difficulties|learning difficulties
4739994|NCT02986633|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
4739995|NCT02986633|Echocardiography|echocardiography
4739996|NCT02986633|Biventricular Pacing|biventricular pacing
4739997|NCT02986568|Ontogenetic surgery|ontogenetic surgery
4739998|NCT02986568|TMMR|tmmr
4739999|NCT02986568|PMMR|pmmr
4740000|NCT02986568|LEER|leer
4740001|NCT02986555|Stress|stress
4740002|NCT02986555|Virtual Reality|virtual reality
4740003|NCT02986555|Motion sickness|motion sickness
4740004|NCT02986555|Visual Fatigue|visual fatigue
4740005|NCT02986555|Biofeedback|biofeedback
4740006|NCT02986542|newborns,femoral artery, catheterization|newborns,femoral artery, catheterization
4740007|NCT02986490|Mental disorders|mental disorders
4740008|NCT02986490|Antipsychotic agents|antipsychotic agents
4740009|NCT02986490|Magnesium|magnesium
4740010|NCT02986490|Cardiovascular risk factor|cardiovascular risk factor
4740011|NCT02986490|Metabolic syndrome|metabolic syndrome
4740012|NCT02986464|Virtual reality|virtual reality
4740013|NCT02986464|Immersive distraction|immersive distraction
4740014|NCT02986464|Virtual world|virtual world
4740015|NCT02986464|Virtual environment|virtual environment
4740016|NCT02986464|Procedural pain|procedural pain
4740017|NCT02986464|Acute pain|acute pain
4740018|NCT02986464|Pain Management|pain management
4740019|NCT02986464|Children, Child|children, child
4740020|NCT02986464|Kid, Kids|kid, kids
4740021|NCT02986464|Pediatric, Pediatrics|pediatric, pediatrics
4740022|NCT02986464|Young children|young children
4740023|NCT02986464|Burns|burns
4740024|NCT02986464|Burn injuries|burn injuries
4740025|NCT02986464|Burn unit|burn unit
4740026|NCT02986464|Hydrotherapy|hydrotherapy
4740027|NCT02986464|Burn dressing|burn dressing
4740028|NCT02986464|Non-pharmacological|non-pharmacological
4740029|NCT02986464|Clinical Research|clinical research
4740030|NCT02986464|Nursing Practice|nursing practice
4740031|NCT02986438|Cocaine|cocaine
4740032|NCT02986438|Addiction|addiction
4740033|NCT02986438|rTMS|rtms
4740034|NCT02986438|fMRI|fmri
4740035|NCT02986425|Drug Utilization Review|drug utilization review
4740036|NCT02986425|Older people|older people
4740037|NCT02986399|fast track|fast track
4740038|NCT02986386|Dental Occlusion|dental occlusion
4740039|NCT02986386|Oral Health|oral health
4740040|NCT02986386|Mastication|mastication
4740041|NCT02986386|Dementia|dementia
4740042|NCT02986386|Psychological health|psychological health
4740043|NCT02986373|risankizumab|risankizumab
4740044|NCT02986373|ABBV-066|abbv-066
4740045|NCT02986373|BI655066|bi655066
4740046|NCT02986334|chronic|chronic
4740047|NCT02986334|low back|low back
4740048|NCT02986334|back|back
4740049|NCT02986334|pain|pain
4740050|NCT02986334|brain|brain
4740051|NCT02986334|MRI|mri
4740052|NCT02986321|anti-inflammatory respiratory drug|anti-inflammatory respiratory drug
4740053|NCT02986321|PDE4 inhibitor|pde4 inhibitor
4740054|NCT02986308|Metabolomics|metabolomics
4740055|NCT02986308|Intestinal Polyps|intestinal polyps
4740056|NCT02986308|TCM Syndromes|tcm syndromes
4740057|NCT02986308|TCM Constitution Types|tcm constitution types
4740058|NCT02986295|BioMime, Ultimaster, Ischemic heart disease, DES|biomime, ultimaster, ischemic heart disease, des
4740059|NCT02986282|ankle - brachial index|ankle - brachial index
4740060|NCT02986269|Respiratory Function|respiratory function
4740061|NCT02986269|Patient Positioning|patient positioning
4740062|NCT02986269|anesthesia|anesthesia
4740063|NCT02986256|telemedicine|telemedicine
4740064|NCT02986230|Cancer prevention|cancer prevention
4740065|NCT02986230|Clinical Decision Support|clinical decision support
4740066|NCT02986230|Rural Health|rural health
4740067|NCT02986230|Shared Decision Making|shared decision making
4740068|NCT02986204|implant removal|implant removal
4740069|NCT02986204|Nexplanon|nexplanon
4740070|NCT02986204|Implanon|implanon
4740071|NCT02986204|contraception|contraception
4740072|NCT02986204|ENG|eng
4740073|NCT02986191|gingival graft|gingival graft
4740074|NCT02986191|free gingival graft|free gingival graft
4740075|NCT02986191|coronally advanced flap|coronally advanced flap
4740076|NCT02986191|reduced keratinized gingiva|reduced keratinized gingiva
4740077|NCT02986178|Glioblastoma|glioblastoma
4740078|NCT02986178|Glioma|glioma
4740079|NCT02986178|PVSRIPO|pvsripo
4740080|NCT02986178|Duke|duke
4740081|NCT02986178|Pro00077024|pro00077024
4740082|NCT02986178|Ashley|ashley
4740083|NCT02986178|Brain tumor|brain tumor
4740084|NCT02986178|Bigner|bigner
4740085|NCT02986165|Platelet Aggregation|platelet aggregation
4740086|NCT02986152|PTSD|ptsd
4740087|NCT02986152|anxiety|anxiety
4740088|NCT02986152|depression|depression
4740089|NCT02986152|distress|distress
4740090|NCT02986152|fear|fear
4740091|NCT02986152|coping|coping
4740092|NCT02986152|support|support
4740093|NCT02986152|caregiver|caregiver
4740094|NCT02986152|oncology|oncology
4740095|NCT02986152|app|app
4740096|NCT02986152|mobile app|mobile app
4740097|NCT02986126|Depression|depression
4740098|NCT02986126|Resilience|resilience
4740099|NCT02986126|Minority health|minority health
4740100|NCT02986126|Community-based participatory research|community-based participatory research
4740101|NCT02986126|Lesbian, gay, bisexual, transgender, and intersex (LGBTI) health|lesbian, gay, bisexual, transgender, and intersex (lgbti) health
4740102|NCT02986126|Racial / ethnic health disparities|racial / ethnic health disparities
4740103|NCT02986126|Patient-centered outcomes research|patient-centered outcomes research
4740104|NCT02986126|Comparative-effectiveness research|comparative-effectiveness research
4740105|NCT02986100|rucaparib|rucaparib
4740106|NCT02986100|CO-338|co-338
4740107|NCT02986100|Clovis|clovis
4740108|NCT02986100|Clovis Oncology|clovis oncology
4740109|NCT02986100|PARP inhibitor|parp inhibitor
4740110|NCT02986100|Absorption|absorption
4740111|NCT02986100|Metabolism|metabolism
4740112|NCT02986100|Excretion|excretion
4740113|NCT02986048|proton beam|proton beam
4740114|NCT02986048|registry|registry
4740115|NCT02986048|radiation|radiation
4740116|NCT02986048|cancer|cancer
4740117|NCT02986022|Self-efficacy|self-efficacy
4740118|NCT02986022|optimism|optimism
4740119|NCT02986022|altruism|altruism
4740120|NCT02986022|goal setting|goal setting
4740121|NCT02986009|emotion management|emotion management
4740122|NCT02986009|positive and negative affect|positive and negative affect
4740123|NCT02986009|satisfaction with parent-child relationship|satisfaction with parent-child relationship
4740124|NCT02986009|subjective happiness|subjective happiness
4740125|NCT02986009|family harmony|family harmony
4740126|NCT02985996|Preventative Medicine|preventative medicine
4740127|NCT02985996|Infectious Diseases|infectious diseases
4740128|NCT02985996|Sexually Transmitted Diseases|sexually transmitted diseases
4740129|NCT02985983|Brodalumab|brodalumab
4740130|NCT02985983|KHK4827|khk4827
4740131|NCT02985983|Axial Spondyloarthritis|axial spondyloarthritis
4740132|NCT02985970|crush induction, RSI|crush induction, rsi
4740133|NCT02985944|colorectal cancer|colorectal cancer
4740134|NCT02985944|Colon polyp|colon polyp
4740135|NCT02985944|Colonoscopy|colonoscopy
4740136|NCT02985944|Adenoma detection rate|adenoma detection rate
4740137|NCT02985905|Zinc supplementation|zinc supplementation
4740138|NCT02985905|Thiol|thiol
4740139|NCT02985905|Glutathione peroxidase|glutathione peroxidase
4740140|NCT02985905|Sulfhydryl oxidase|sulfhydryl oxidase
4740141|NCT02985892|Physical therapy|physical therapy
4740142|NCT02985892|Muscle Stretching Exercises|muscle stretching exercises
4740143|NCT02985892|Low Back pain|low back pain
4740144|NCT02985879|PSP|psp
4740145|NCT02985879|Steele-Richardson-Olszewski syndrome|steele-richardson-olszewski syndrome
4740146|NCT02985879|tauopathy|tauopathy
4740147|NCT02985866|Artificial Pancreas|artificial pancreas
4740148|NCT02985866|Closed Loop Control|closed loop control
4740149|NCT02985866|Continuous Glucose Monitor (CGM)|continuous glucose monitor (cgm)
4740150|NCT02985866|inControl Diabetes Management Platform|incontrol diabetes management platform
4740151|NCT02985840|ondansetron|ondansetron
4740152|NCT02985840|dexamethasone|dexamethasone
4740153|NCT02985814|COPD Asthma Overlap|copd asthma overlap
4740154|NCT02985775|CMV-specific T cell|cmv-specific t cell
4740155|NCT02985775|haploidentical stem cell transplantation|haploidentical stem cell transplantation
4740156|NCT02985775|immunologic response|immunologic response
4740157|NCT02985775|acute GVHD|acute gvhd
4740158|NCT02985762|bupivacaine|bupivacaine
4740159|NCT02985762|exparel|exparel
4740160|NCT02985762|analgesic|analgesic
4740161|NCT02985762|lumbar spine|lumbar spine
4740162|NCT02985749|Autism Spectrum Disorders|autism spectrum disorders
4740163|NCT02985749|Pervasive Developmental Disorder|pervasive developmental disorder
4740164|NCT02985749|ASD|asd
4740165|NCT02985749|PDD|pdd
4740166|NCT02985749|Oxytocin|oxytocin
4740167|NCT02985749|Syntocinon|syntocinon
4740168|NCT02985749|Social Impairment|social impairment
4740169|NCT02985749|Treatment|treatment
4740170|NCT02985671|Postural Low Back Pain|postural low back pain
4740171|NCT02985671|Mechanical Low Back Pain|mechanical low back pain
4740172|NCT02985671|Low Back Pain|low back pain
4740173|NCT02985671|acetaminophen|acetaminophen
4740174|NCT02985671|caffeine|caffeine
4740175|NCT02985671|orphenadrine|orphenadrine
4740176|NCT02985671|diclofenac sodium|diclofenac sodium
4740177|NCT02985645|CGF|cgf
4740178|NCT02985645|sinus augmentation|sinus augmentation
4740179|NCT02985645|DIVA|diva
4740180|NCT02985645|Platelet-Rich Plasma|platelet-rich plasma
4740181|NCT02985554|hematologic malignancies|hematologic malignancies
4740182|NCT02985554|allogeneic stem cell transplantation (allo-SCT)|allogeneic stem cell transplantation (allo-sct)
4740183|NCT02985541|Birth Control|birth control
4740184|NCT02985541|Heavy menstrual bleeding|heavy menstrual bleeding
4740185|NCT02985515|Anosmia|anosmia
4740186|NCT02985515|Hyposmia|hyposmia
4740187|NCT02985515|Intranasal Steroid Irrigation|intranasal steroid irrigation
4740188|NCT02985515|Olfactory Neuroplasticity|olfactory neuroplasticity
4740189|NCT02985515|Olfactory training|olfactory training
4740190|NCT02985502|Quality of Life|quality of life
4740191|NCT02985502|Diabetes Mellitus|diabetes mellitus
4740192|NCT02985502|Pancreatectomy|pancreatectomy
4740193|NCT02985476|Electronic health records|electronic health records
4740194|NCT02985476|Health records personal|health records personal
4740195|NCT02985437|wound healing|wound healing
4740196|NCT02985437|Bovine Lung Surfactant|bovine lung surfactant
4740197|NCT02985437|SATOSU|satosu
4740198|NCT02985385|Congenital Lethal Malformations|congenital lethal malformations
4740199|NCT02985359|Program impact evaluation|program impact evaluation
4740200|NCT02985359|Malawi|malawi
4740201|NCT02985359|Lipid-based nutrient supplements|lipid-based nutrient supplements
4740202|NCT02985359|Social behavior change communication|social behavior change communication
4740203|NCT02985359|Childhood stunting|childhood stunting
4740204|NCT02985346|Idiopathic pulmonary hemosiderosis|idiopathic pulmonary hemosiderosis
4741091|NCT02979990|education|education
4740205|NCT02985346|Bone marrow mesenchymal stem cells|bone marrow mesenchymal stem cells
4740206|NCT02985333|paclitaxe,cyclophosphamide,dexamethasone, Multiple Myeloma|paclitaxe,cyclophosphamide,dexamethasone, multiple myeloma
4740207|NCT02985320|Sabin strain|sabin strain
4740208|NCT02985320|Inactivated poliovirus vaccine|inactivated poliovirus vaccine
4740209|NCT02985320|poliomyelitis|poliomyelitis
4740210|NCT02985320|safety|safety
4740211|NCT02985320|immunogenicity|immunogenicity
4740212|NCT02985320|infant|infant
4740213|NCT02985294|Neuropathic pain|neuropathic pain
4740214|NCT02985294|Quantitative Sensory Testing|quantitative sensory testing
4740215|NCT02985294|Multiple Excitability Measures|multiple excitability measures
4740216|NCT02985294|Threshold Tracking|threshold tracking
4740217|NCT02985281|direct acting antiviral drugs, chronic hepatitis C virus infection|direct acting antiviral drugs, chronic hepatitis c virus infection
4740218|NCT02985268|MitraClip|mitraclip
4740219|NCT02985268|Cardiovascular resynchronization therapy|cardiovascular resynchronization therapy
4740220|NCT02985268|Six minute walk test|six minute walk test
4740221|NCT02985268|Mitral regurgitation|mitral regurgitation
4740222|NCT02985268|CRT-D|crt-d
4740223|NCT02985255|Neoadjuvant Chemotherapy|neoadjuvant chemotherapy
4740224|NCT02985255|Tongue Malignancy|tongue malignancy
4740225|NCT02985255|Squamous Cell Carcinoma|squamous cell carcinoma
4740226|NCT02985203|lung cancer|lung cancer
4740227|NCT02985203|vinorelbine|vinorelbine
4740228|NCT02985203|metronomic chemotherapy|metronomic chemotherapy
4740229|NCT02985190|Azacitidine|azacitidine
4740230|NCT02985190|MDS|mds
4740231|NCT02985190|Systemic auto-immune and inflammatory disorders|systemic auto-immune and inflammatory disorders
4740232|NCT02985177|Children|children
4740233|NCT02985177|Musculoskeletal injury|musculoskeletal injury
4740234|NCT02985177|Emergency department|emergency department
4740235|NCT02985177|Analgesia|analgesia
4740236|NCT02985177|Opioids|opioids
4740237|NCT02985164|Anesthesiology( H02.403.066 )|anesthesiology( h02.403.066 )
4740238|NCT02985164|Radiation Protection( N06.850.810.425)|radiation protection( n06.850.810.425)
4740239|NCT02985164|Cholangiopancreatography, Endoscopic Retrograde(D002760 )|cholangiopancreatography, endoscopic retrograde(d002760 )
4740240|NCT02985151|Scar|scar
4740241|NCT02985151|Carbon Dioxide Laser|carbon dioxide laser
4740242|NCT02985151|Laser Ablation|laser ablation
4740243|NCT02985125|Pancreas|pancreas
4740244|NCT02985125|5-FU|5-fu
4740245|NCT02985125|Gemcitabine|gemcitabine
4740246|NCT02985125|LEE011|lee011
4740247|NCT02985125|Everolimus|everolimus
4740248|NCT02985125|Refractory|refractory
4740249|NCT02985125|Chemotherapy|chemotherapy
4740250|NCT02985086|term premature rupture of membranes, antibiotic prophylaxis, chorioamnionitis, endometritis, neonatal infection|term premature rupture of membranes, antibiotic prophylaxis, chorioamnionitis, endometritis, neonatal infection
4740251|NCT02985060|Therapeutic hypothermia|therapeutic hypothermia
4740252|NCT02985047|Brief admission|brief admission
4740253|NCT02985047|admission|admission
4740254|NCT02985047|deliberate self-harm|deliberate self-harm
4740255|NCT02985047|self-harm|self-harm
4740256|NCT02985034|HCC|hcc
4740257|NCT02985034|RFA|rfa
4740258|NCT02985034|Liver tumor|liver tumor
4740259|NCT02985008|Shock, IVBP, ECMO, In hospital death|shock, ivbp, ecmo, in hospital death
4740260|NCT02984995|FLT3-ITD|flt3-itd
4740261|NCT02984995|Positive refractory or relapsed acute myeloid leukemia|positive refractory or relapsed acute myeloid leukemia
4740262|NCT02984995|Hematology malignancy|hematology malignancy
4740263|NCT02984995|Developmental Phase II|developmental phase ii
4740264|NCT02984956|Hypotension|hypotension
4740265|NCT02984956|Pleth variability index|pleth variability index
4740266|NCT02984956|Hip Fracture|hip fracture
4740267|NCT02984956|Spinal anesthesia|spinal anesthesia
4740268|NCT02984943|Rheumatoid Arthritis|rheumatoid arthritis
4740269|NCT02984943|Hyperbaric Oxygen|hyperbaric oxygen
4740270|NCT02984917|anterior transversalis fascia repair; preperitoneal repair|anterior transversalis fascia repair; preperitoneal repair
4740271|NCT02984904|Fusarium Infection|fusarium infection
4740272|NCT02984904|Corneal ulcer|corneal ulcer
4740273|NCT02984904|Spain|spain
4740274|NCT02984904|Epidemiology|epidemiology
4740275|NCT02984891|Intravascular ultrasound|intravascular ultrasound
4740276|NCT02984891|Optical coherence tomography|optical coherence tomography
4740277|NCT02984865|transversus plane block|transversus plane block
4740278|NCT02984865|opioid|opioid
4740279|NCT02984865|nalbuphine|nalbuphine
4740280|NCT02984865|gastrointestinal surgery|gastrointestinal surgery
4740281|NCT02984865|elderly patient|elderly patient
4740282|NCT02984865|rectus sheath block|rectus sheath block
4740283|NCT02984865|Peritoneal dialysis|peritoneal dialysis
4740284|NCT02984839|intra-abdominal surgery|intra-abdominal surgery
4740285|NCT02984839|neuromuscular blocking agent|neuromuscular blocking agent
4740286|NCT02984839|post-anesthesia care unit|post-anesthesia care unit
4740287|NCT02984787|Gastric Cancer|gastric cancer
4740289|NCT02984787|2D|2d
4740290|NCT02984774|Endometriosis|endometriosis
4740291|NCT02984774|Infertility|infertility
4740292|NCT02984774|Telomerase activity|telomerase activity
4740293|NCT02984761|Carcinoma, Non-Small Cell Lung|carcinoma, non-small cell lung
4740294|NCT02984761|Respiratory Tract Neoplasms|respiratory tract neoplasms
4740295|NCT02984761|Thoracic Neoplasms|thoracic neoplasms
4740296|NCT02984761|Neoplasms by Site|neoplasms by site
4740298|NCT02984761|Lung Diseases|lung diseases
4740299|NCT02984761|Respiratory Tract Diseases|respiratory tract diseases
4740300|NCT02984761|Carcinoma, Bronchogenic|carcinoma, bronchogenic
4740301|NCT02984761|Bronchial Neoplasms|bronchial neoplasms
4740302|NCT02984761|Radiosurgery|radiosurgery
4740303|NCT02984761|Radiotherapy|radiotherapy
4740304|NCT02984761|Radiotherapy, Image-Guided|radiotherapy, image-guided
4740305|NCT02984761|Lung Neoplasms|lung neoplasms
4740306|NCT02984748|cochlear implants|cochlear implants
4740307|NCT02984748|hearing loss|hearing loss
4740308|NCT02984735|chewing|chewing
4740309|NCT02984735|cerebral palsy|cerebral palsy
4740310|NCT02984735|chewing disorders|chewing disorders
4740311|NCT02984735|gross motor function|gross motor function
4740312|NCT02984722|PCOS|pcos
4740313|NCT02984722|metformin|metformin
4740314|NCT02984670|Cognitive therapy|cognitive therapy
4740315|NCT02984670|Behavior therapy|behavior therapy
4740316|NCT02984670|Moderation|moderation
4740317|NCT02984670|Mediation|mediation
4740318|NCT02984657|Hypoxemia|hypoxemia
4740319|NCT02984657|Reverse Trendelenburg|reverse trendelenburg
4740320|NCT02984592|premature ejaculation|premature ejaculation
4740321|NCT02984592|intravaginal ejaculatory latency time|intravaginal ejaculatory latency time
4740322|NCT02984592|premature ejaculation diagnostic tools|premature ejaculation diagnostic tools
4740323|NCT02984566|Primary liver cancer|primary liver cancer
4740324|NCT02984566|Secondary liver cancer|secondary liver cancer
4740325|NCT02984566|Kilovoltage Intrafraction Monitoring|kilovoltage intrafraction monitoring
4740326|NCT02984566|Stereotactic Ablative Body Radiation|stereotactic ablative body radiation
4740327|NCT02984553|accelerometry|accelerometry
4740328|NCT02984553|aerobic fitness|aerobic fitness
4740329|NCT02984553|metabolic thresholds|metabolic thresholds
4740330|NCT02984553|moderate to vigorous physical activity|moderate to vigorous physical activity
4740331|NCT02984501|radiochemotherapy|radiochemotherapy
4740332|NCT02984501|neoadjuvant therapy|neoadjuvant therapy
4740333|NCT02984488|necrotic teeth|necrotic teeth
4740334|NCT02984488|single visit|single visit
4740335|NCT02984488|multiple visits|multiple visits
4740336|NCT02984488|protaper next|protaper next
4740337|NCT02984475|Beta Thalassemia|beta thalassemia
4740338|NCT02984475|Metformin|metformin
4740339|NCT02984475|Oxidative stress|oxidative stress
4740340|NCT02984475|Iron overload|iron overload
4740341|NCT02984475|Liver function|liver function
4740342|NCT02984462|percutaneous|percutaneous
4740343|NCT02984462|non-fixed|non-fixed
4740344|NCT02984462|Akin ;|akin ;
4740345|NCT02984462|osteotomy|osteotomy
4740346|NCT02984449|cardiac rehabilitation|cardiac rehabilitation
4740347|NCT02984449|surgical complications|surgical complications
4740348|NCT02984449|quality of life|quality of life
4740349|NCT02984449|preoperative|preoperative
4740350|NCT02984449|cardiac surgery|cardiac surgery
4740351|NCT02984423|Ovarian Cancer|ovarian cancer
4740352|NCT02984423|BRCA mutations|brca mutations
4740353|NCT02984410|T1-T2, N0 oropharyngeal carcinoma|t1-t2, n0 oropharyngeal carcinoma
4740354|NCT02984397|pain|pain
4740355|NCT02984397|ketotifen|ketotifen
4740356|NCT02984397|pediatric|pediatric
4740357|NCT02984397|mast cell|mast cell
4740358|NCT02984384|Trauma|trauma
4740359|NCT02984384|Blood clot|blood clot
4740360|NCT02984384|Venous Thromboembolism|venous thromboembolism
4740361|NCT02984384|Pulmonary Embolism|pulmonary embolism
4740362|NCT02984384|Deep Vein Thrombosis|deep vein thrombosis
4740363|NCT02984384|Thromboprophylaxis|thromboprophylaxis
4740364|NCT02984384|Blood clot prevention|blood clot prevention
4740365|NCT02984384|trauma patients|trauma patients
4740366|NCT02984371|atrial fibrillation|atrial fibrillation
4740367|NCT02984371|ganglionated plexi|ganglionated plexi
4740368|NCT02984371|ischemic heart disease|ischemic heart disease
4740369|NCT02984293|Atorvastatin|atorvastatin
4740370|NCT02984293|LILRB5|lilrb5
4740371|NCT02984293|Statin intolerance|statin intolerance
4740372|NCT02984254|knee|knee
4740373|NCT02984254|knee osteoarthritis|knee osteoarthritis
4740374|NCT02984254|Bracing|bracing
4740375|NCT02984254|patellofemoral osteoarthritis|patellofemoral osteoarthritis
4740376|NCT02984189|Physical Exercise|physical exercise
4740377|NCT02984189|Physical Therapy|physical therapy
4740378|NCT02984189|Physical Performance|physical performance
4740379|NCT02984189|Critical Power|critical power
4740380|NCT02984189|Respiratory Muscle|respiratory muscle
4740381|NCT02984176|Simethicone|simethicone
4740382|NCT02984176|Laparoscopies|laparoscopies
4740383|NCT02984176|Pain|pain
4740384|NCT02984163|cancer|cancer
4740385|NCT02984163|exercise|exercise
4740386|NCT02984137|Lewy body disease|lewy body disease
4740387|NCT02984137|REM Sleep Behavior Disorder|rem sleep behavior disorder
4740388|NCT02984137|Parkinson disease|parkinson disease
4740389|NCT02984137|Imaging|imaging
4740390|NCT02984137|Bio-markers|bio-markers
4740391|NCT02984137|Prospective cohort|prospective cohort
4740392|NCT02984111|Coronary artery bypass|coronary artery bypass
4740393|NCT02984111|Erythropoietin|erythropoietin
4740394|NCT02984111|Inflammation|inflammation
4740395|NCT02984111|IL-6|il-6
4740396|NCT02984111|Reperfusion injury|reperfusion injury
4740397|NCT02984111|YKL- 40|ykl- 40
4741491|NCT02977845|fatigue|fatigue
4740398|NCT02984098|procedural pain, 40% Dextrose, heel lance|procedural pain, 40% dextrose, heel lance
4740399|NCT02984085|RDEB|rdeb
4740400|NCT02984085|Stem cells|stem cells
4740401|NCT02984085|Gene therapy|gene therapy
4740402|NCT02984046|Acute bronchiolitis|acute bronchiolitis
4740403|NCT02984046|RSV|rsv
4740404|NCT02984046|CC16|cc16
4740405|NCT02984046|SP-D|sp-d
4740406|NCT02984046|sRAGE|srage
4740407|NCT02984046|Severity|severity
4740408|NCT02984046|Biomarkers|biomarkers
4740409|NCT02983994|asthma, devices|asthma, devices
4740410|NCT02983968|Oncology|oncology
4740411|NCT02983968|Hepatology|hepatology
4740412|NCT02983968|Public Health|public health
4740413|NCT02983968|Liver|liver
4740414|NCT02983942|ketogenic diet|ketogenic diet
4740415|NCT02983942|Primary Central Nervous System Lymphoma|primary central nervous system lymphoma
4740416|NCT02983942|chemotherapy|chemotherapy
4740417|NCT02983916|Adhesions|adhesions
4740418|NCT02983916|Adhesiolysis|adhesiolysis
4740419|NCT02983916|chronic pain|chronic pain
4740420|NCT02983916|post-operative complications|post-operative complications
4740421|NCT02983916|anti-adhesion barrier|anti-adhesion barrier
4740422|NCT02983916|cine-MRI|cine-mri
4740423|NCT02983916|shared decision making|shared decision making
4740424|NCT02983851|Noninvasive mechanical ventilation|noninvasive mechanical ventilation
4740425|NCT02983851|Invasive mechanical ventilation|invasive mechanical ventilation
4740426|NCT02983838|Amyloid|amyloid
4740427|NCT02983838|BDNF|bdnf
4740428|NCT02983838|major depressive disorder|major depressive disorder
4740429|NCT02983838|cognitive decline|cognitive decline
4740430|NCT02983825|CPAP|cpap
4740431|NCT02983825|Bronchopulmonary Dysplasia|bronchopulmonary dysplasia
4740432|NCT02983825|Ventilator Induced Lung Injury|ventilator induced lung injury
4740433|NCT02983825|V/Q mismatch|v/q mismatch
4740434|NCT02983799|BRCA, ovarian, platinum, chemotherapy|brca, ovarian, platinum, chemotherapy
4740435|NCT02983760|Pulmonary embolism|pulmonary embolism
4740436|NCT02983747|Platelet Rich Plasma|platelet rich plasma
4740437|NCT02983747|Intervertebral Disk Injection Therapy|intervertebral disk injection therapy
4740438|NCT02983747|Low Back Pain|low back pain
4740439|NCT02983747|Ultrasound Guided|ultrasound guided
4740440|NCT02983747|Degenerative Spinal Disease|degenerative spinal disease
4740441|NCT02983734|Gulf War|gulf war
4740442|NCT02983734|D-cycloserine|d-cycloserine
4740443|NCT02983734|Neuroinflammation|neuroinflammation
4740444|NCT02983734|Cognition|cognition
4740445|NCT02983734|Memory|memory
4740446|NCT02983708|Neuroregeneration|neuroregeneration
4740447|NCT02983708|G-CSF|g-csf
4740448|NCT02983708|Peripheral blood mononuclear cells|peripheral blood mononuclear cells
4740449|NCT02983708|Cerebral palsy|cerebral palsy
4740450|NCT02983682|Anesthetics, Local|anesthetics, local
4740451|NCT02983682|Lidocaine|lidocaine
4740452|NCT02983682|Pediatrics|pediatrics
4740453|NCT02983682|Children|children
4740454|NCT02983682|Adolescents|adolescents
4740455|NCT02983669|Thymus Plant|thymus plant
4740456|NCT02983669|Multiflotriol [Supplementary Concept]|multiflotriol [supplementary concept]
4740457|NCT02983669|Zataria multiflora|zataria multiflora
4740458|NCT02983669|Complementary Therapies|complementary therapies
4740459|NCT02983669|Herbal Medicine|herbal medicine
4740460|NCT02983669|Medicine, traditional|medicine, traditional
4740461|NCT02983656|Vaccine Safety|vaccine safety
4740462|NCT02983643|Skeletal Muscle Index|skeletal muscle index
4740463|NCT02983643|Visceral Adipose Tissue|visceral adipose tissue
4740464|NCT02983643|Metabolic Syndrome|metabolic syndrome
4740465|NCT02983604|Exemestane|exemestane
4740466|NCT02983604|Aromasin|aromasin
4740467|NCT02983604|Fulvestrant|fulvestrant
4740468|NCT02983604|Faslodex|faslodex
4740469|NCT02983604|Breast Cancer,|breast cancer,
4740470|NCT02983604|HER 2-|her 2-
4740471|NCT02983604|Estrogen receptor positive|estrogen receptor positive
4740472|NCT02983578|Pancreatic cancer|pancreatic cancer
4740473|NCT02983578|Mismatch deficient colorectal cancer|mismatch deficient colorectal cancer
4740474|NCT02983578|Non-small cell lung cancer|non-small cell lung cancer
4740475|NCT02983578|NSCLC|nsclc
4740476|NCT02983578|AZD9150|azd9150
4740477|NCT02983578|MEDI4736|medi4736
4740478|NCT02983578|Durvalumab|durvalumab
4740479|NCT02983565|Long-term oxygen therapy|long-term oxygen therapy
4740480|NCT02983565|Intelligent oxygen therapy system|intelligent oxygen therapy system
4740481|NCT02983565|Auto-titrating oxygen system|auto-titrating oxygen system
4740482|NCT02983552|Amblyopia|amblyopia
4740483|NCT02983539|sarcomas|sarcomas
4740484|NCT02983539|immunocytochemistry|immunocytochemistry
4740485|NCT02983539|circulating tumor cells|circulating tumor cells
4740486|NCT02983526|short stem|short stem
4740487|NCT02983513|Early intervention|early intervention
4740488|NCT02983513|Brain Development|brain development
4740489|NCT02983513|Neurodevelopment|neurodevelopment
4740490|NCT02983500|Patient Reported Outcome (PRO)|patient reported outcome (pro)
4740491|NCT02983487|Bordetella Pertussis|bordetella pertussis
4740492|NCT02983487|Whooping Cough|whooping cough
4740493|NCT02983487|vaccine|vaccine
4740494|NCT02983461|urinary incontinence|urinary incontinence
4740495|NCT02983461|pelvic floor dysfunction|pelvic floor dysfunction
4740496|NCT02983435|Osteopathic Treatment|osteopathic treatment
4740497|NCT02983435|Postural control|postural control
4740498|NCT02983435|Neuromuscular activation|neuromuscular activation
4740499|NCT02983435|Physiotherapy|physiotherapy
4740500|NCT02983409|computerized tomography|computerized tomography
4740501|NCT02983409|Urinary Calculi|urinary calculi
4740502|NCT02983409|Patient admission|patient admission
4740503|NCT02983409|Pain|pain
4740504|NCT02983396|RELF method|relf method
4740505|NCT02983396|Medical device|medical device
4740506|NCT02983396|Admission delay|admission delay
4740507|NCT02983383|Varicocele|varicocele
4740508|NCT02983383|TAP block|tap block
4740509|NCT02983383|spinal anesthesia|spinal anesthesia
4740510|NCT02983357|Shoulder Arthroplasty|shoulder arthroplasty
4740511|NCT02983357|glenohumeral arthritis|glenohumeral arthritis
4740512|NCT02983344|fascia iliaca compartment block|fascia iliaca compartment block
4740513|NCT02983344|fentanyl|fentanyl
4740514|NCT02983266|Hyperadrenergia|hyperadrenergia
4740515|NCT02983266|Inflammatory stress|inflammatory stress
4740516|NCT02983214|Cilostazol|cilostazol
4740517|NCT02983214|Clopidogrel|clopidogrel
4740518|NCT02983214|Peripheral Artery Disease|peripheral artery disease
4740519|NCT02983201|Orthopedic Pain Syndromes|orthopedic pain syndromes
4740520|NCT02983201|Thumbtack Intra-dermal Needle|thumbtack intra-dermal needle
4740521|NCT02983201|Filiform needle|filiform needle
4740522|NCT02983201|Acupuncture|acupuncture
4740523|NCT02983188|Schizophrenia|schizophrenia
4740524|NCT02983188|Berberine|berberine
4740525|NCT02983188|Metabolic Syndrome|metabolic syndrome
4740526|NCT02983188|Chinese medicine|chinese medicine
4740527|NCT02983188|Herbal medicine|herbal medicine
4740528|NCT02983175|ultrasonogaphy|ultrasonogaphy
4740529|NCT02983175|full stomach|full stomach
4740530|NCT02983175|pulmonary aspiration|pulmonary aspiration
4740531|NCT02983175|anaesthesia|anaesthesia
4740532|NCT02983136|Hand Hygiene|hand hygiene
4740533|NCT02983136|Implementation|implementation
4740534|NCT02983136|Partnership|partnership
4740535|NCT02983136|Surgery|surgery
4740536|NCT02983123|Acute MI|acute mi
4740537|NCT02983123|Acute myocardial infarction cardiac troponin|acute myocardial infarction cardiac troponin
4740538|NCT02983123|High-sensitivity cardiac troponin T|high-sensitivity cardiac troponin t
4740539|NCT02983123|0/1-hour algorithm|0/1-hour algorithm
4740540|NCT02983123|Outpatient clinic|outpatient clinic
4740541|NCT02983123|Cardiac troponin|cardiac troponin
4740542|NCT02983123|Chest pain|chest pain
4740543|NCT02983110|Hormones, Transgender|hormones, transgender
4740544|NCT02983097|lymphoma|lymphoma
4740545|NCT02983097|relapse|relapse
4740546|NCT02983097|recurrence|recurrence
4740547|NCT02983097|progress|progress
4740548|NCT02983097|progressive|progressive
4740549|NCT02983097|b-cell lymphoma|b-cell lymphoma
4740550|NCT02983097|chemotherapy|chemotherapy
4740551|NCT02983097|immunotherapy|immunotherapy
4740552|NCT02983097|IMiD|imid
4740553|NCT02983097|Salvage chemotherapy|salvage chemotherapy
4740554|NCT02983097|peripheral stem cell mobilization|peripheral stem cell mobilization
4740555|NCT02983097|lenalidomide|lenalidomide
4740556|NCT02983097|Rituximab|rituximab
4740557|NCT02983097|CD20|cd20
4740558|NCT02983097|Cytarabine|cytarabine
4740559|NCT02983097|Ara-C|ara-c
4740560|NCT02983097|platinum-based chemotherapy|platinum-based chemotherapy
4740561|NCT02983097|Cisplatin|cisplatin
4740562|NCT02983097|Carboplatin|carboplatin
4740563|NCT02983097|Cisplatinum|cisplatinum
4740564|NCT02983097|Carboplatinum|carboplatinum
4740565|NCT02983097|Dexamethasone|dexamethasone
4740566|NCT02983084|Orthodontic wires|orthodontic wires
4740567|NCT02983084|Root resorption|root resorption
4740568|NCT02983071|Breast Cancer|breast cancer
4740569|NCT02983071|CDK 4/6 Inhibitor|cdk 4/6 inhibitor
4740570|NCT02983071|HER2-Negative|her2-negative
4740571|NCT02983071|HR-Positive|hr-positive
4740572|NCT02983071|HR+|hr+
4740573|NCT02983071|HER2-|her2-
4740574|NCT02983071|HER2 -ve|her2 -ve
4740575|NCT02983071|HER2 +ve|her2 +ve
4740576|NCT02983032|Caregivers|caregivers
4740577|NCT02983032|Insomnia|insomnia
4740578|NCT02983019|influenza|influenza
4740579|NCT02983019|flu|flu
4740580|NCT02983019|acute respiratory viral infection|acute respiratory viral infection
4740581|NCT02983019|ARVI|arvi
4740582|NCT02983019|acute upper respiratory infection|acute upper respiratory infection
4740583|NCT02983019|AURI|auri
4740584|NCT02983006|TRAIL-DR5|trail-dr5
4740585|NCT02983006|DS-8273a|ds-8273a
4740586|NCT02983006|Immunoglobulin gamma-1 (IgG1)|immunoglobulin gamma-1 (igg1)
4740587|NCT02983006|Cell mediated cytotoxicity (ADCC)|cell mediated cytotoxicity (adcc)
4740588|NCT02983006|Complement dependent cytotoxicity (CDC)|complement dependent cytotoxicity (cdc)
4740589|NCT02983006|DR5|dr5
4740590|NCT02983006|Immunoglobulin G4 (IgG4)|immunoglobulin g4 (igg4)
4740591|NCT02983006|Monoclonal antibody|monoclonal antibody
4740592|NCT02983006|Programmed Cell Death 1 (PD-1)|programmed cell death 1 (pd-1)
4740593|NCT02982993|hepatitis C virus|hepatitis c virus
4740594|NCT02982993|linkage-to-care|linkage-to-care
4740595|NCT02982993|World Trade Center Health Program cohort|world trade center health program cohort
4740596|NCT02982993|Baby Boomer|baby boomer
4740597|NCT02982993|risk factors for hepatitis C virus infection|risk factors for hepatitis c virus infection
4740598|NCT02982967|child|child
4740599|NCT02982967|physical activity|physical activity
4740600|NCT02982967|irisin|irisin
4740601|NCT02982967|EPCs|epcs
4740602|NCT02982941|Neuroblastoma|neuroblastoma
4740603|NCT02982941|Rhabdomyosarcoma|rhabdomyosarcoma
4740604|NCT02982941|Osteosarcoma|osteosarcoma
4740605|NCT02982941|Ewing Sarcoma|ewing sarcoma
4740606|NCT02982941|Wilms Tumor|wilms tumor
4740607|NCT02982941|Desmoplastic Small Round Cell Tumor|desmoplastic small round cell tumor
4740608|NCT02982941|pediatric|pediatric
4740609|NCT02982928|Obesity|obesity
4740610|NCT02982928|Bariatrics|bariatrics
4740611|NCT02982928|Acetaminophen|acetaminophen
4740612|NCT02982928|robot-assisted or laparoscopic bariatric surgery|robot-assisted or laparoscopic bariatric surgery
4740613|NCT02982928|Pharmacokinetics|pharmacokinetics
4740614|NCT02982902|Immunotherapy|immunotherapy
4740615|NCT02982902|T-Cell Therapy|t-cell therapy
4740616|NCT02982902|Lymphoproliferative Disorder|lymphoproliferative disorder
4740617|NCT02982889|Analytical, Diagnostic,Therapeutic Technique and Equipment|analytical, diagnostic,therapeutic technique and equipment
4740618|NCT02982889|Anesthesia and Analgesia|anesthesia and analgesia
4740619|NCT02982876|Silicone Airway stent|silicone airway stent
4740620|NCT02982876|Metallic Airway stent|metallic airway stent
4740621|NCT02982850|Atrial Fibrillation|atrial fibrillation
4740622|NCT02982850|Valvular Insufficiency|valvular insufficiency
4740623|NCT02982850|Valvular Stenosis|valvular stenosis
4740624|NCT02982824|Children|children
4740625|NCT02982824|IQ|iq
4740626|NCT02982824|Idiopathic epilepsy|idiopathic epilepsy
4740627|NCT02982824|Magnesium supplementation|magnesium supplementation
4740628|NCT02982824|Seizure control|seizure control
4740629|NCT02982824|Chalfont score|chalfont score
4740630|NCT02982811|Activity-based|activity-based
4740631|NCT02982811|Client-centred|client-centred
4740632|NCT02982811|Rehabilitation|rehabilitation
4740633|NCT02982811|Quality of life|quality of life
4740634|NCT02982772|Nicotine Replacement|nicotine replacement
4740635|NCT02982772|Smoking|smoking
4740636|NCT02982772|HIV|hiv
4740637|NCT02982746|Head and neck cancer|head and neck cancer
4740638|NCT02982746|Person Centred Care|person centred care
4740639|NCT02982746|Health related quality of life|health related quality of life
4740640|NCT02982746|EORTC QLQ-C30|eortc qlq-c30
4740641|NCT02982746|EORTC QLQ-C35|eortc qlq-c35
4740642|NCT02982720|cholangiocarcinoma|cholangiocarcinoma
4740643|NCT02982720|Pembrolizumab|pembrolizumab
4740644|NCT02982720|MK-3475|mk-3475
4740645|NCT02982720|Sylatron|sylatron
4740646|NCT02982720|peginterferon alfa-2b|peginterferon alfa-2b
4740647|NCT02982694|MSI|msi
4740648|NCT02982694|colorectal|colorectal
4740649|NCT02982694|chemotherapy|chemotherapy
4740650|NCT02982694|Bevacizumab|bevacizumab
4740651|NCT02982694|Atezolizumab|atezolizumab
4740652|NCT02982681|Periodontal disease|periodontal disease
4740653|NCT02982681|Platelet rich fibrin|platelet rich fibrin
4740654|NCT02982668|severe stroke|severe stroke
4740655|NCT02982668|Acute Stroke|acute stroke
4740656|NCT02982668|Enteral Feeding|enteral feeding
4740657|NCT02982668|Mortality|mortality
4740658|NCT02982668|Disability|disability
4740659|NCT02982668|Clinical trial|clinical trial
4740660|NCT02982655|Severe Stroke|severe stroke
4740661|NCT02982655|Acute Stroke|acute stroke
4740662|NCT02982655|Antihypertension|antihypertension
4740663|NCT02982655|mortality|mortality
4740664|NCT02982655|disability|disability
4740665|NCT02982655|clinical trial|clinical trial
4740666|NCT02982629|Glaucoma|glaucoma
4740667|NCT02982629|Eye Care|eye care
4740668|NCT02982629|Community Outreach|community outreach
4740669|NCT02982577|Xerostomia|xerostomia
4740670|NCT02982577|Pilocarpine|pilocarpine
4740671|NCT02982577|Quality of life|quality of life
4740672|NCT02982564|Exercise|exercise
4740673|NCT02982564|Physical Functioning|physical functioning
4740674|NCT02982564|Hispanic|hispanic
4740675|NCT02982538|posttraumatic stress symptoms|posttraumatic stress symptoms
4740676|NCT02982538|implementation|implementation
4740677|NCT02982538|dissemination|dissemination
4740678|NCT02982538|PTSD|ptsd
4740679|NCT02982525|Mussels|mussels
4740680|NCT02982525|Dietary Intervention|dietary intervention
4740681|NCT02982525|Long-term intervention|long-term intervention
4740682|NCT02982525|Vitamin D status|vitamin d status
4740683|NCT02982525|Selenium|selenium
4740684|NCT02982525|Iodine|iodine
4740685|NCT02982525|Vitamin B12|vitamin b12
4740686|NCT02982525|Omega-3 index|omega-3 index
4740687|NCT02982512|Potential local fields|potential local fields
4740688|NCT02982512|Subthalamic neuronal activity|subthalamic neuronal activity
4740689|NCT02982499|glaucoma|glaucoma
4740690|NCT02982499|Leber optic neuropathy|leber optic neuropathy
4740691|NCT02982499|anterior ischemic optic neuropathy|anterior ischemic optic neuropathy
4740692|NCT02982486|nivolumab|nivolumab
4740693|NCT02982486|ipilimumab|ipilimumab
4740694|NCT02982486|immunotherapy|immunotherapy
4740695|NCT02982486|PD-1 inhibitor|pd-1 inhibitor
4740696|NCT02982486|sarcoma|sarcoma
4740697|NCT02982460|Rotator cuff tendinopathy|rotator cuff tendinopathy
4740698|NCT02982460|Eccentric exercise|eccentric exercise
4740699|NCT02982460|Isoinertial training|isoinertial training
4740798|NCT02981732|Osteoporosis|osteoporosis
4740700|NCT02982447|blue laser imaging,detection,randomized trial|blue laser imaging,detection,randomized trial
4740701|NCT02982434|atrial fibrillation|atrial fibrillation
4740702|NCT02982434|botulinum toxin|botulinum toxin
4740703|NCT02982434|ischemic heart disease|ischemic heart disease
4740704|NCT02982395|Nanoxel M|nanoxel m
4740705|NCT02982395|Docetaxel PM|docetaxel pm
4740706|NCT02982395|Docetaxel|docetaxel
4740707|NCT02982395|Mitomycin C|mitomycin c
4740708|NCT02982395|BCG|bcg
4740709|NCT02982395|BCG refractory|bcg refractory
4740710|NCT02982395|Non muscle invasive bladder cancer|non muscle invasive bladder cancer
4740711|NCT02982395|intravesical|intravesical
4740712|NCT02982395|superficial bladder cancer|superficial bladder cancer
4740713|NCT02982395|Urothelial carcinoma|urothelial carcinoma
4740714|NCT02982395|Transitional cell carcinoma|transitional cell carcinoma
4740715|NCT02982382|Low Back Pain|low back pain
4740716|NCT02982382|Musculoskeletal Manipulations|musculoskeletal manipulations
4740717|NCT02982382|Neurophysiology|neurophysiology
4740718|NCT02982382|Education|education
4740719|NCT02982317|Neuraxial anesthesia|neuraxial anesthesia
4740720|NCT02982317|Obstetrics|obstetrics
4740721|NCT02982317|Ultrasound|ultrasound
4740722|NCT02982252|Power mobility|power mobility
4740723|NCT02982252|Wheelchair skills training|wheelchair skills training
4740724|NCT02982252|Older adults|older adults
4740725|NCT02982226|Plantar Fasciitis|plantar fasciitis
4740726|NCT02982226|Jogger's Heel|jogger's heel
4740727|NCT02982226|ReNu|renu
4740728|NCT02982213|Newest Vital Sign|newest vital sign
4740729|NCT02982213|Anxiety|anxiety
4740730|NCT02982213|Health literacy|health literacy
4740731|NCT02982213|Neuraxial Analgesia|neuraxial analgesia
4740732|NCT02982213|Epidural catheter placement|epidural catheter placement
4740733|NCT02982213|Pregnancy|pregnancy
4740734|NCT02982213|Parturients|parturients
4740735|NCT02982213|Pain Catastrophizing Scale|pain catastrophizing scale
4740736|NCT02982213|STAI questionnaire|stai questionnaire
4740737|NCT02982213|Companion|companion
4740738|NCT02982200|Embolization Device|embolization device
4740739|NCT02982200|Medina|medina
4740740|NCT02982200|Rupture Intracranial Aneurysm|rupture intracranial aneurysm
4740741|NCT02982200|Unrupture Intracranial Aneurysm|unrupture intracranial aneurysm
4740742|NCT02982187|HANDIHALER|handihaler
4740743|NCT02982187|ELLIPTA|ellipta
4740744|NCT02982187|TURBUHALER|turbuhaler
4740745|NCT02982187|DISKUS|diskus
4740746|NCT02982187|COPD|copd
4740747|NCT02982187|critical error|critical error
4740748|NCT02982187|inhaler preference|inhaler preference
4740749|NCT02982174|no known ocular pathology|no known ocular pathology
4740750|NCT02982161|Third Molar Tooth Extraction|third molar tooth extraction
4740751|NCT02982148|sentinel lymph node biopsy|sentinel lymph node biopsy
4740752|NCT02982148|methylene blue|methylene blue
4740753|NCT02982148|intradermal injection|intradermal injection
4740754|NCT02982148|subcutaneous injection|subcutaneous injection
4740755|NCT02982135|hemorrhagic moyamoya disease|hemorrhagic moyamoya disease
4740756|NCT02982135|bypass|bypass
4740757|NCT02982135|indirect bypass|indirect bypass
4740758|NCT02982083|Rheumatoid arthritis|rheumatoid arthritis
4740759|NCT02982083|Raloxifene|raloxifene
4740760|NCT02982083|Disease activity|disease activity
4740761|NCT02982070|psychological well-being, academic success|psychological well-being, academic success
4740762|NCT02982044|blood flow|blood flow
4740763|NCT02982044|endothelial function|endothelial function
4740764|NCT02982044|shear stress|shear stress
4740765|NCT02982031|Ultrasound-guided lumbar plexus blockade|ultrasound-guided lumbar plexus blockade
4740766|NCT02982031|Shamrock technique|shamrock technique
4740767|NCT02982031|Paramedian transverse scan|paramedian transverse scan
4740768|NCT02982031|USG LPB|usg lpb
4740769|NCT02982031|USGRA|usgra
4740770|NCT02982005|KHK4827 (brodalumab)|khk4827 (brodalumab)
4740771|NCT02981979|Takayasu Arteritis|takayasu arteritis
4740772|NCT02981979|Leflunomide|leflunomide
4740773|NCT02981953|Valtech Cardio|valtech cardio
4740774|NCT02981953|Cardioband|cardioband
4740775|NCT02981953|Tricuspid|tricuspid
4740776|NCT02981940|Brain Tumor|brain tumor
4740777|NCT02981914|Classical Hodgkin Lymphoma|classical hodgkin lymphoma
4740778|NCT02981914|B-cell Non-Hodgkin Lymphoma|b-cell non-hodgkin lymphoma
4740779|NCT02981914|Acute Myeloid Leukemia|acute myeloid leukemia
4740780|NCT02981914|Myelodysplastic Syndromes|myelodysplastic syndromes
4740781|NCT02981914|pembrolizumab|pembrolizumab
4740782|NCT02981875|reading eye movement|reading eye movement
4740783|NCT02981862|HPV infection|hpv infection
4740784|NCT02981862|Blood sample|blood sample
4740785|NCT02981862|Biopsy|biopsy
4740786|NCT02981836|live attenuated varicella vaccine|live attenuated varicella vaccine
4740787|NCT02981836|protective effect|protective effect
4740788|NCT02981836|safety|safety
4740789|NCT02981836|immunogenicity|immunogenicity
4740790|NCT02981836|child|child
4740791|NCT02981810|TONSILLAR COBLATION|tonsillar coblation
4740792|NCT02981797|symptomatic bone metastasis|symptomatic bone metastasis
4740793|NCT02981797|metastatic|metastatic
4740794|NCT02981797|castration resistant|castration resistant
4740795|NCT02981784|chronic myeloid leukemia (CML)|chronic myeloid leukemia (cml)
4740796|NCT02981784|Philadelphia-positive (Ph+)|philadelphia-positive (ph+)
4740797|NCT02981784|Acute Lymphoblastic Leukemia (ALL)|acute lymphoblastic leukemia (all)
4740799|NCT02981732|kidney yin deficiency syndrome|kidney yin deficiency syndrome
4740800|NCT02981732|liuwei dihuang pill|liuwei dihuang pill
4740801|NCT02981706|Arteriovenous Fistula (AVF)|arteriovenous fistula (avf)
4740802|NCT02981706|Arteriovenous Graft (AVG)|arteriovenous graft (avg)
4740803|NCT02981680|remote ischemic preconditioning; transient limb ischemia; acute kidney injury; coronary artery bypass graft surgery|remote ischemic preconditioning; transient limb ischemia; acute kidney injury; coronary artery bypass graft surgery
4740804|NCT02981641|Pancreatic cancer|pancreatic cancer
4740805|NCT02981641|Intraoperative radiotherapy (IORT)|intraoperative radiotherapy (iort)
4740806|NCT02981641|Concurrent Chemoradiotherapy (CCRT)|concurrent chemoradiotherapy (ccrt)
4740807|NCT02981602|Hepatitis|hepatitis
4740808|NCT02981602|Chronic|chronic
4740809|NCT02981602|HBV|hbv
4740810|NCT02981576|Spinal Cord Injury|spinal cord injury
4740811|NCT02981576|Mesenchymal Stem Cells|mesenchymal stem cells
4740812|NCT02981563|engagement|engagement
4740813|NCT02981563|psychiatric in-patient care|psychiatric in-patient care
4740814|NCT02981563|mental health nursing|mental health nursing
4740815|NCT02981563|quality interactions|quality interactions
4740816|NCT02981550|Infection|infection
4740817|NCT02981524|Colorectal Neoplasms|colorectal neoplasms
4740818|NCT02981524|Gastrointestinal Neoplasms|gastrointestinal neoplasms
4740819|NCT02981524|Digestive System Neoplasms|digestive system neoplasms
4740820|NCT02981524|Neoplasms by Site|neoplasms by site
4740821|NCT02981524|Neoplasms|neoplasms
4740822|NCT02981524|Digestive System Diseases|digestive system diseases
4740823|NCT02981524|Gastrointestinal Diseases|gastrointestinal diseases
4740824|NCT02981524|Intestinal Diseases|intestinal diseases
4740825|NCT02981524|Rectal Diseases|rectal diseases
4740826|NCT02981524|Colonic Diseases|colonic diseases
4740827|NCT02981498|Hepatic arterial infusion chemotherapy|hepatic arterial infusion chemotherapy
4740828|NCT02981498|Sorafenib|sorafenib
4740829|NCT02981485|Fat Grafting, Breast Cancer Lymphedema|fat grafting, breast cancer lymphedema
4740830|NCT02981459|bladder pain|bladder pain
4740831|NCT02981459|urinary frequency|urinary frequency
4740832|NCT02981459|urinary urgency|urinary urgency
4740833|NCT02981459|mirabegron|mirabegron
4740834|NCT02981407|Red Blood Cell Transfusion|red blood cell transfusion
4740835|NCT02981407|Anemia|anemia
4740836|NCT02981407|Heart Disease|heart disease
4740837|NCT02981407|Cardiovascular Disease|cardiovascular disease
4740838|NCT02981381|sTMS|stms
4740839|NCT02981381|NeoSync|neosync
4740840|NCT02981381|NEST|nest
4740841|NCT02981381|synchronous|synchronous
4740842|NCT02981381|non-invasive neuromodulation|non-invasive neuromodulation
4740843|NCT02981381|TMS|tms
4740844|NCT02981381|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
4740845|NCT02981381|PTSD|ptsd
4740846|NCT02981381|EEG|eeg
4740847|NCT02981381|Depression|depression
4740848|NCT02981368|Diagnostic|diagnostic
4740849|NCT02981368|Imaging|imaging
4740850|NCT02981368|2301|2301
4740851|NCT02981368|PET/CT|pet/ct
4740852|NCT02981368|PyL|pyl
4740853|NCT02981368|PSMA|psma
4740854|NCT02981368|radical prostatectomy|radical prostatectomy
4740855|NCT02981368|metastatic prostate cancer|metastatic prostate cancer
4740856|NCT02981368|recurrent prostate cancer|recurrent prostate cancer
4740857|NCT02981355|BST-CarGel|bst-cargel
4740858|NCT02981355|Microfracture|microfracture
4740859|NCT02981355|Cartilage Lesion, Chondral Lesion|cartilage lesion, chondral lesion
4740860|NCT02981355|Femoral condyle|femoral condyle
4740861|NCT02981355|Bone Marrow Stimulation|bone marrow stimulation
4740862|NCT02981355|Cartilage Repair|cartilage repair
4740863|NCT02981355|Tear of Articular Cartilage of Knee, Current|tear of articular cartilage of knee, current
4740864|NCT02981342|pancreatic cancer|pancreatic cancer
4740865|NCT02981329|Metformin|metformin
4740866|NCT02981329|Sickle Cell Anemia|sickle cell anemia
4740867|NCT02981329|Sickle Cell Disease|sickle cell disease
4740868|NCT02981329|Hemoglobinopathies|hemoglobinopathies
4740869|NCT02981329|Hemoglobin Disorder|hemoglobin disorder
4740870|NCT02981329|Blood Disease|blood disease
4740871|NCT02981329|Hemoglobin Disease; Sickle-Cell, Thalassemia|hemoglobin disease; sickle-cell, thalassemia
4740872|NCT02981329|Hemoglobin Disease|hemoglobin disease
4740873|NCT02981277|Bronchoscopy|bronchoscopy
4740874|NCT02981277|Lignocaine|lignocaine
4740875|NCT02981264|Bronchoscopy|bronchoscopy
4740876|NCT02981264|Lignocaine|lignocaine
4740877|NCT02981264|Endobronchial Ultrasound|endobronchial ultrasound
4740878|NCT02981251|Hypertension|hypertension
4740879|NCT02981251|Uncontrolled blood pressure|uncontrolled blood pressure
4740880|NCT02981251|Health education|health education
4740881|NCT02981251|Community based|community based
4740882|NCT02981199|microtransplantation|microtransplantation
4740883|NCT02981199|multiple myeloma|multiple myeloma
4740884|NCT02981186|Intraocular Lens|intraocular lens
4740885|NCT02981186|trifocal|trifocal
4740886|NCT02981186|cataract|cataract
4740887|NCT02981186|PhysIOL|physiol
4740888|NCT02981147|cough|cough
4740889|NCT02981147|thyme|thyme
4740890|NCT02981147|Cisti|cisti
4740891|NCT02981147|Ivy Leaves|ivy leaves
4740892|NCT02981134|bioabsorbable scaffold|bioabsorbable scaffold
4740893|NCT02981134|computed tomography|computed tomography
4740894|NCT02981121|Diabetes Prevention|diabetes prevention
4740991|NCT02980497|plaque|plaque
4740895|NCT02981082|Systemic Sclerosis, Scleroderma, PAH, Pulmonary Hypertension|systemic sclerosis, scleroderma, pah, pulmonary hypertension
4740896|NCT02981056|Skincare regimens|skincare regimens
4740897|NCT02981056|Skin moisturization|skin moisturization
4740898|NCT02981056|Skin barrier|skin barrier
4740899|NCT02981056|Skin development|skin development
4740900|NCT02981017|Chronic sinusitis|chronic sinusitis
4740901|NCT02981017|Frontal sinusitis|frontal sinusitis
4740902|NCT02981017|Skull base neoplasm|skull base neoplasm
4740903|NCT02981004|Aortic valve disease, patient prosthesis mismatch|aortic valve disease, patient prosthesis mismatch
4740904|NCT02980965|breast cancer|breast cancer
4740905|NCT02980965|neoadjuvant chemotherapy|neoadjuvant chemotherapy
4740906|NCT02980965|endocrine therapy|endocrine therapy
4740907|NCT02980965|concurrent|concurrent
4740908|NCT02980887|Pulmonary arterial hypertension|pulmonary arterial hypertension
4740909|NCT02980874|RVO|rvo
4740910|NCT02980874|ME|me
4740911|NCT02980874|Central Subfield Thickness|central subfield thickness
4740912|NCT02980874|OCT|oct
4740913|NCT02980874|Optical Coherence Tomography|optical coherence tomography
4740914|NCT02980874|Cystoid Macular Edema|cystoid macular edema
4740915|NCT02980874|Subretinal Fluid|subretinal fluid
4740916|NCT02980874|Eylea|eylea
4740917|NCT02980874|Aflibercept|aflibercept
4740918|NCT02980874|Anti-VEGF|anti-vegf
4740919|NCT02980874|Suprachoroidal|suprachoroidal
4740920|NCT02980861|Gastric Cancer|gastric cancer
4740921|NCT02980861|Splenic Hilum Lymph Nodes Dissection|splenic hilum lymph nodes dissection
4740922|NCT02980861|Gastrectomy|gastrectomy
4740923|NCT02980848|digital mammography|digital mammography
4740924|NCT02980848|digital breast tomosynthesis|digital breast tomosynthesis
4740925|NCT02980848|breast magnetic resonance imaging|breast magnetic resonance imaging
4740926|NCT02980848|screening|screening
4740927|NCT02980848|breast density|breast density
4740928|NCT02980848|breast imaging|breast imaging
4740929|NCT02980848|pre-operative magnetic resonance imaging|pre-operative magnetic resonance imaging
4740930|NCT02980796|Brain|brain
4740931|NCT02980796|MRI|mri
4740932|NCT02980796|Exercise|exercise
4740933|NCT02980796|Rehabilitation|rehabilitation
4740934|NCT02980796|TMS|tms
4740935|NCT02980770|Obstructive Sleep Apnea|obstructive sleep apnea
4740936|NCT02980770|Obesity Hypoventilation Syndrome|obesity hypoventilation syndrome
4740937|NCT02980770|Hypercapnia|hypercapnia
4740938|NCT02980770|Post-Op Complication|post-op complication
4740939|NCT02980770|Acid-Base Imbalance|acid-base imbalance
4740940|NCT02980744|Stroke|stroke
4740941|NCT02980744|Sedentary behaviour|sedentary behaviour
4740942|NCT02980744|Intervention|intervention
4740943|NCT02980731|Relapsed CLL|relapsed cll
4740944|NCT02980731|Refractory CLL|refractory cll
4740945|NCT02980731|17p deletion|17p deletion
4740946|NCT02980731|TP53 gene|tp53 gene
4740947|NCT02980731|B-Cell receptor inhibitor (BCRi)|b-cell receptor inhibitor (bcri)
4740948|NCT02980731|European Organization of Research and Treatment of Cancer Quality of Life Core Questionnaire (EORTC QLQ-C30)|european organization of research and treatment of cancer quality of life core questionnaire (eortc qlq-c30)
4740949|NCT02980731|Overall response rate (ORR)|overall response rate (orr)
4740950|NCT02980731|Duration of overall response (Dor)|duration of overall response (dor)
4740951|NCT02980731|Complete remission rate (CR + CRi)|complete remission rate (cr + cri)
4740952|NCT02980731|Progression-free survival (PFS)|progression-free survival (pfs)
4740953|NCT02980731|Overall survival (OS)|overall survival (os)
4740954|NCT02980718|Olfaction training|olfaction training
4740955|NCT02980718|Smell|smell
4740956|NCT02980653|Phase II study|phase ii study
4740957|NCT02980653|Critical body weight loss|critical body weight loss
4740958|NCT02980653|Concurrent chemoradiotherapy|concurrent chemoradiotherapy
4740959|NCT02980653|Megestrol acetate|megestrol acetate
4740960|NCT02980653|Head and neck cancer|head and neck cancer
4740961|NCT02980640|Multiple Sclerosis|multiple sclerosis
4740962|NCT02980640|Treatment|treatment
4740963|NCT02980640|Quality of Life|quality of life
4740964|NCT02980640|Symptoms|symptoms
4740965|NCT02980627|Eating Disorders|eating disorders
4740966|NCT02980627|Diabulimia|diabulimia
4740967|NCT02980627|ED-T1DM|ed-t1dm
4740968|NCT02980627|Type 1 Diabetes|type 1 diabetes
4740969|NCT02980627|Mobile Technology|mobile technology
4740970|NCT02980627|Acceptance and Commitment Therapy|acceptance and commitment therapy
4740971|NCT02980614|phase-contrast MRI|phase-contrast mri
4740972|NCT02980614|blood flow|blood flow
4740973|NCT02980614|velocity mapping|velocity mapping
4740974|NCT02980614|Quantitative MRI|quantitative mri
4740975|NCT02980614|Cardiac imaging|cardiac imaging
4740976|NCT02980614|Tetralogy of Fallot|tetralogy of fallot
4740977|NCT02980601|Traumatic Defect|traumatic defect
4740978|NCT02980601|Chronic Wounds|chronic wounds
4740979|NCT02980575|COPD|copd
4740980|NCT02980575|Music|music
4740981|NCT02980575|Exercise|exercise
4740982|NCT02980562|Bowel preparation|bowel preparation
4740983|NCT02980562|Ascorbic acid|ascorbic acid
4740984|NCT02980562|Bisacodyl|bisacodyl
4740985|NCT02980562|Polyethylene glycol|polyethylene glycol
4740986|NCT02980536|NSCLC|nsclc
4740987|NCT02980536|TKI|tki
4740988|NCT02980536|Mutation|mutation
4740989|NCT02980536|Liquid Biopsy|liquid biopsy
4740990|NCT02980497|mouthrinse|mouthrinse
4740993|NCT02980497|gum bleeding|gum bleeding
4740994|NCT02980484|rTMS|rtms
4740995|NCT02980458|Healthy|healthy
4740996|NCT02980458|Bioequivalence|bioequivalence
4740997|NCT02980458|Deferiprone|deferiprone
4740998|NCT02980445|Myopia|myopia
4740999|NCT02980445|Outdoor time|outdoor time
4741000|NCT02980445|Children|children
4741001|NCT02980445|Intervention|intervention
4741002|NCT02980445|Prevention|prevention
4741003|NCT02980432|vestibular|vestibular
4741004|NCT02980432|spatial orientation|spatial orientation
4741005|NCT02980432|vision|vision
4741006|NCT02980432|optokinetic|optokinetic
4741007|NCT02980406|FODMAP|fodmap
4741008|NCT02980406|Irritable bowel syndrome|irritable bowel syndrome
4741009|NCT02980406|Gastric accommodation|gastric accommodation
4741010|NCT02980406|Gastric motility|gastric motility
4741011|NCT02980406|brain-gut axis|brain-gut axis
4741012|NCT02980393|congenital heart disease|congenital heart disease
4741013|NCT02980393|smart mobile technology|smart mobile technology
4741014|NCT02980393|children|children
4741015|NCT02980393|adolescents|adolescents
4741016|NCT02980393|lifestyle counselling|lifestyle counselling
4741017|NCT02980393|nutrition|nutrition
4741018|NCT02980393|physical activity|physical activity
4741019|NCT02980380|non-invasive brain computer interface|non-invasive brain computer interface
4741020|NCT02980380|communication|communication
4741021|NCT02980380|amyotrophic lateral sclerosis|amyotrophic lateral sclerosis
4741022|NCT02980380|complete locked-in state|complete locked-in state
4741023|NCT02980367|Anterior Cruciate Ligament|anterior cruciate ligament
4741024|NCT02980367|ACL|acl
4741025|NCT02980367|Anterior Cruciate Ligament deficiency|anterior cruciate ligament deficiency
4741026|NCT02980367|ACL deficiency|acl deficiency
4741027|NCT02980367|ACLD|acld
4741028|NCT02980367|Anterior Cruciate Ligament reconstruction|anterior cruciate ligament reconstruction
4741029|NCT02980367|ACL reconstruction|acl reconstruction
4741030|NCT02980367|Anterior Cruciate Ligament physiotherapy|anterior cruciate ligament physiotherapy
4741031|NCT02980367|Anterior Cruciate Ligament rehabilitation|anterior cruciate ligament rehabilitation
4741032|NCT02980367|ACL physiotherapy|acl physiotherapy
4741033|NCT02980367|ACL rehabilitation|acl rehabilitation
4741034|NCT02980367|Anterior Cruciate Ligament management|anterior cruciate ligament management
4741035|NCT02980367|ACL management|acl management
4741036|NCT02980354|endothelial progenitor cells, ischaemic stroke, aging|endothelial progenitor cells, ischaemic stroke, aging
4741037|NCT02980341|Oncology|oncology
4741038|NCT02980341|HER3|her3
4741039|NCT02980341|Antibody drug conjugate|antibody drug conjugate
4741040|NCT02980341|Developmental Phase I/II|developmental phase i/ii
4741041|NCT02980328|Overactive bladder|overactive bladder
4741042|NCT02980328|Urinary incontinence|urinary incontinence
4741043|NCT02980328|Low-level light therapy|low-level light therapy
4741044|NCT02980315|nasopharyngeal carcinoma|nasopharyngeal carcinoma
4741045|NCT02980315|EBV related cancers|ebv related cancers
4741046|NCT02980302|Mental retardation MR|mental retardation mr
4741047|NCT02980302|IQ|iq
4741048|NCT02980302|Mutation|mutation
4741049|NCT02980302|Gene MYT1L|gene myt1l
4741050|NCT02980276|Gestational Diabetes|gestational diabetes
4741051|NCT02980276|Diabetes|diabetes
4741052|NCT02980276|Pregnancy|pregnancy
4741053|NCT02980263|Kawasaki disease|kawasaki disease
4741054|NCT02980263|Coronary artery aneurysm|coronary artery aneurysm
4741055|NCT02980263|mucocutaneous lymph node syndrome|mucocutaneous lymph node syndrome
4741056|NCT02980263|lymph node syndrome|lymph node syndrome
4741057|NCT02980263|canakinumab|canakinumab
4741058|NCT02980263|intravenous immunoglobulin naïve (IVIG-naïve)|intravenous immunoglobulin naïve (ivig-naïve)
4741059|NCT02980263|intravenous immunoglobulin refractory (IVIG-refractory)|intravenous immunoglobulin refractory (ivig-refractory)
4741060|NCT02980263|pediatric|pediatric
4741061|NCT02980250|feeding intolerance|feeding intolerance
4741062|NCT02980250|premature infant|premature infant
4741063|NCT02980250|domperidone|domperidone
4741064|NCT02980237|Office workers|office workers
4741065|NCT02980237|Quality of life|quality of life
4741066|NCT02980237|e-Learning|e-learning
4741067|NCT02980237|Occupational health|occupational health
4741068|NCT02980211|Alveolar Bone|alveolar bone
4741069|NCT02980211|Alveolar Ridge|alveolar ridge
4741070|NCT02980211|Bone Resorption|bone resorption
4741071|NCT02980211|Bone Grafting|bone grafting
4741072|NCT02980211|Barrier Membrane|barrier membrane
4741073|NCT02980172|triage|triage
4741074|NCT02980120|Eating Disorders|eating disorders
4741075|NCT02980120|Anorexia Nervosa|anorexia nervosa
4741076|NCT02980120|Bulimia Nervosa|bulimia nervosa
4741077|NCT02980094|aging|aging
4741078|NCT02980094|nutrients|nutrients
4741079|NCT02980094|milk|milk
4741080|NCT02980094|dietary supplementation|dietary supplementation
4741081|NCT02980055|connective tissue graft|connective tissue graft
4741082|NCT02980055|transplantation|transplantation
4741083|NCT02980055|collagen|collagen
4741084|NCT02980055|autologous|autologous
4741085|NCT02980055|gingiva|gingiva
4741086|NCT02980029|Resectable Tumors|resectable tumors
4741087|NCT02980003|contrast media|contrast media
4741088|NCT02980003|contrast-induced acute kidney injury (AKI)|contrast-induced acute kidney injury (aki)
4741089|NCT02980003|contrast-induced nephropathy (CIN)|contrast-induced nephropathy (cin)
4741092|NCT02979951|Observational Study|observational study
4741093|NCT02979951|Non-Interventional Study|non-interventional study
4741094|NCT02979951|Registries|registries
4741095|NCT02979951|Prospective|prospective
4741096|NCT02979951|Monitored|monitored
4741097|NCT02979951|Multicentric|multicentric
4741098|NCT02979951|International|international
4741099|NCT02979951|Fosfomycin|fosfomycin
4741100|NCT02979951|Infectofos|infectofos
4741101|NCT02979951|Fomicyt|fomicyt
4741102|NCT02979951|Bacterial Infections|bacterial infections
4741103|NCT02979951|Gram-Negative Bacterial Infections|gram-negative bacterial infections
4741104|NCT02979951|Gram-Positive Bacterial Infections|gram-positive bacterial infections
4741105|NCT02979951|Bone Diseases, Infectious|bone diseases, infectious
4741106|NCT02979951|Osteomyelitis|osteomyelitis
4741107|NCT02979951|Central Nervous System Bacterial Infections|central nervous system bacterial infections
4741108|NCT02979951|Meningitis, Bacterial|meningitis, bacterial
4741109|NCT02979951|Encephalitis|encephalitis
4741110|NCT02979951|Brain Abscess|brain abscess
4741111|NCT02979951|Urinary Tract Infections|urinary tract infections
4741112|NCT02979951|Respiratory Tract Infections|respiratory tract infections
4741113|NCT02979951|Pneumonia, Bacterial|pneumonia, bacterial
4741114|NCT02979951|Skin Diseases, Bacterial|skin diseases, bacterial
4741115|NCT02979951|Soft Tissue Infections|soft tissue infections
4741116|NCT02979951|Intraabdominal Infections|intraabdominal infections
4741117|NCT02979951|Sepsis|sepsis
4741118|NCT02979951|Bacteremia|bacteremia
4741119|NCT02979951|Endocarditis, Bacterial|endocarditis, bacterial
4741120|NCT02979951|Treatment Outcome|treatment outcome
4741121|NCT02979951|Clinical Efficacy|clinical efficacy
4741122|NCT02979951|Microbiological Efficacy|microbiological efficacy
4741123|NCT02979951|Safety|safety
4741124|NCT02979925|neuropathic pain|neuropathic pain
4741125|NCT02979925|TMS|tms
4741126|NCT02979925|nerve injury|nerve injury
4741127|NCT02979925|transcutaneous magnetic stimulation|transcutaneous magnetic stimulation
4741128|NCT02979912|Persistent corneal epithelial defect|persistent corneal epithelial defect
4741129|NCT02979912|Platelet Lysate|platelet lysate
4741130|NCT02979899|angiosarcoma|angiosarcoma
4741131|NCT02979886|single nucleotide polymorphism,GnRH receptor, IVF|single nucleotide polymorphism,gnrh receptor, ivf
4741132|NCT02979873|Rapamycin|rapamycin
4741133|NCT02979873|Relapse Prevention|relapse prevention
4741134|NCT02979873|Immune Tolerance|immune tolerance
4741135|NCT02979847|persistent atrial fibrillation|persistent atrial fibrillation
4741136|NCT02979847|catheter ablation|catheter ablation
4741137|NCT02979847|hybrid|hybrid
4741138|NCT02979834|fetal movement|fetal movement
4741139|NCT02979834|placenta site|placenta site
4741140|NCT02979834|body mass index|body mass index
4741141|NCT02979834|maternal education|maternal education
4741142|NCT02979821|pan-HER inhibitor|pan-her inhibitor
4741143|NCT02979782|cardiac surgery|cardiac surgery
4741144|NCT02979782|neurological outcome|neurological outcome
4741145|NCT02979782|minimal invasive coronary artery bypass graft (Endo-CABG)|minimal invasive coronary artery bypass graft (endo-cabg)
4741146|NCT02979769|Open-label extension study|open-label extension study
4741147|NCT02979769|Clinical trial Phase 2|clinical trial phase 2
4741148|NCT02979769|Efficacy and safety|efficacy and safety
4741149|NCT02979769|Heterotopic ossification|heterotopic ossification
4741150|NCT02979769|Flare-up|flare-up
4741151|NCT02979769|Palovarotene|palovarotene
4741152|NCT02979769|Retinoic acide receptor agonist|retinoic acide receptor agonist
4741153|NCT02979769|Retinoic acide receptor gamma agonist|retinoic acide receptor gamma agonist
4741154|NCT02979769|Clementia|clementia
4741155|NCT02979769|Myositis Ossificans|myositis ossificans
4741156|NCT02979769|Munchmeyer's Disease|munchmeyer's disease
4741157|NCT02979769|FOP|fop
4741158|NCT02979717|satiety|satiety
4741159|NCT02979717|protein|protein
4741160|NCT02979717|fiber|fiber
4741161|NCT02979678|Breast cancer, quality of life|breast cancer, quality of life
4741162|NCT02979639|Herpes Zoster|herpes zoster
4741163|NCT02979639|Reactogenicity|reactogenicity
4741164|NCT02979639|Quality of life|quality of life
4741165|NCT02979639|Shingles|shingles
4741166|NCT02979626|hospitalization|hospitalization
4741167|NCT02979626|intensive care unit|intensive care unit
4741168|NCT02979626|school absenteeism|school absenteeism
4741169|NCT02979626|work absenteeism|work absenteeism
4741170|NCT02979600|Oral immunotherapy|oral immunotherapy
4741171|NCT02979600|Oral tolerance induction|oral tolerance induction
4741172|NCT02979574|acupuncture|acupuncture
4741173|NCT02979574|pain|pain
4741174|NCT02979574|chronic pain|chronic pain
4741175|NCT02979574|pain management|pain management
4741176|NCT02979574|16-1579|16-1579
4741177|NCT02979561|Dabigatran etexilate|dabigatran etexilate
4741178|NCT02979561|Recurrence of DVT|recurrence of dvt
4741179|NCT02979561|Pulmonary Embolism|pulmonary embolism
4741180|NCT02979561|Warfarin|warfarin
4741181|NCT02979548|Aprepitant|aprepitant
4741182|NCT02979535|Dengue Fever|dengue fever
4741183|NCT02979535|Dengue Hemorrhagic Fever|dengue hemorrhagic fever
4741184|NCT02979535|Human Papillomavirus Disease|human papillomavirus disease
4741185|NCT02979535|CYD Dengue Vaccine|cyd dengue vaccine
4741186|NCT02979535|Dengvaxia®|dengvaxia®
4741187|NCT02979535|Cervarix®|cervarix®
4741188|NCT02979522|Drug therapy, pediatric Hodgkin disease, frontline Hodgkin disease, advanced stage Hodgkin disease, pediatric lymphoma|drug therapy, pediatric hodgkin disease, frontline hodgkin disease, advanced stage hodgkin disease, pediatric lymphoma
4741189|NCT02979496|immune|immune
4741190|NCT02979496|citrus|citrus
4741191|NCT02979470|advanced colon cancer|advanced colon cancer
4741192|NCT02979470|advanced rectum cancer|advanced rectum cancer
4741193|NCT02979470|circulating tumor cells|circulating tumor cells
4741194|NCT02979470|immune response|immune response
4741195|NCT02979470|mutations|mutations
4741196|NCT02979457|telephone consultation, patient involvement|telephone consultation, patient involvement
4741197|NCT02979418|Water insecurity|water insecurity
4741198|NCT02979340|Cystic Fibrosis Liver Disease|cystic fibrosis liver disease
4741199|NCT02979340|Pancreatic Insufficiency|pancreatic insufficiency
4741200|NCT02979275|acute kidney injury|acute kidney injury
4741201|NCT02979275|cardiopulmonary bypass|cardiopulmonary bypass
4741202|NCT02979275|neutrophil gelatinase-associated lipocalin|neutrophil gelatinase-associated lipocalin
4741203|NCT02979275|tissue hypoxia|tissue hypoxia
4741204|NCT02979249|Interventional|interventional
4741205|NCT02979249|open-label|open-label
4741206|NCT02979249|EPP|epp
4741207|NCT02979249|XLP|xlp
4741208|NCT02979249|porphyria|porphyria
4741209|NCT02979197|High blood pressure|high blood pressure
4741210|NCT02979197|Systolic blood pressure|systolic blood pressure
4741211|NCT02979197|Diastolic blood pressure|diastolic blood pressure
4741212|NCT02979197|Antihypertensive|antihypertensive
4741213|NCT02979184|Lymphedema, Obstructive Sleep Apnea , Intensive Decongestive Physiotherapy|lymphedema, obstructive sleep apnea , intensive decongestive physiotherapy
4741214|NCT02979119|Hemophilia|hemophilia
4741215|NCT02979119|Children, ,|children, ,
4741216|NCT02979119|Inhibitors,|inhibitors,
4741217|NCT02979119|Prophylaxis|prophylaxis
4741218|NCT02979119|Long-term outcome|long-term outcome
4741219|NCT02979119|Congenital|congenital
4741220|NCT02979093|maternal drug addiction|maternal drug addiction
4741221|NCT02979093|mother-infant attachment|mother-infant attachment
4741222|NCT02979093|intranasal oxytocin|intranasal oxytocin
4741223|NCT02979093|unresolved trauma|unresolved trauma
4741224|NCT02979093|maternal brain responses|maternal brain responses
4741225|NCT02979093|mother-infant synchrony|mother-infant synchrony
4741226|NCT02979067|Apnoea time, preoxygenation, difficult airway, emergency|apnoea time, preoxygenation, difficult airway, emergency
4741227|NCT02979041|neck pain|neck pain
4741228|NCT02979041|Virtual reality|virtual reality
4741229|NCT02979041|Range of motion|range of motion
4741230|NCT02979041|physiotherapy|physiotherapy
4741231|NCT02979041|Air force|air force
4741232|NCT02979041|kinematics|kinematics
4741233|NCT02979028|TEAS|teas
4741234|NCT02979028|complication|complication
4741235|NCT02978989|Laparoscopic cholecystectomy|laparoscopic cholecystectomy
4741236|NCT02978989|Solo surgery|solo surgery
4741237|NCT02978989|Camera holder|camera holder
4741238|NCT02978989|Cholecystitis|cholecystitis
4741239|NCT02978976|RDS|rds
4741240|NCT02978976|Doppler on fetal pulmonary artery|doppler on fetal pulmonary artery
4741241|NCT02978963|Excessive worry|excessive worry
4741242|NCT02978963|Worry|worry
4741243|NCT02978963|Adolescents|adolescents
4741244|NCT02978963|Intolerance of uncertainty|intolerance of uncertainty
4741245|NCT02978950|duplex ultrasound|duplex ultrasound
4741246|NCT02978950|trauma|trauma
4741247|NCT02978950|venous thromboembolism|venous thromboembolism
4741248|NCT02978950|prevention|prevention
4741249|NCT02978924|spinal cord|spinal cord
4741250|NCT02978924|tsDCS|tsdcs
4741251|NCT02978924|3D motion capture|3d motion capture
4741252|NCT02978924|EMG|emg
4741253|NCT02978911|RMI|rmi
4741254|NCT02978898|Follicular Lymphoma|follicular lymphoma
4741255|NCT02978898|flow cytometry|flow cytometry
4741256|NCT02978898|CD180|cd180
4741257|NCT02978898|Toll-like receptor|toll-like receptor
4741258|NCT02978898|lymphoproliferative disease|lymphoproliferative disease
4741259|NCT02978885|Acute lung injury|acute lung injury
4741260|NCT02978885|Chronic obstructive pulmonary disease (COPD)|chronic obstructive pulmonary disease (copd)
4741261|NCT02978885|Whipple procedures|whipple procedures
4741262|NCT02978885|pancreatico-duodenectomies|pancreatico-duodenectomies
4741263|NCT02978872|Cardiac surgery|cardiac surgery
4741264|NCT02978872|Quantra|quantra
4741265|NCT02978872|Viscoelastic testing|viscoelastic testing
4741266|NCT02978872|Coagulation|coagulation
4741267|NCT02978859|MGCD516|mgcd516
4741268|NCT02978859|Sarcoma|sarcoma
4741269|NCT02978859|liposarcoma|liposarcoma
4741270|NCT02978859|Unresectable Liposarcoma|unresectable liposarcoma
4741271|NCT02978859|Metastatic Liposarcoma|metastatic liposarcoma
4741272|NCT02978833|Gluteus Medius Tendinosis|gluteus medius tendinosis
4741273|NCT02978820|scientific exercise approach to scoliosis|scientific exercise approach to scoliosis
4741274|NCT02978820|core stabilization training|core stabilization training
4741275|NCT02978820|bracing|bracing
4741276|NCT02978820|adolescent idiopathic scoliosis|adolescent idiopathic scoliosis
4741277|NCT02978794|stroke, clinical pathway, medical care|stroke, clinical pathway, medical care
4741278|NCT02978781|Tremor|tremor
4741279|NCT02978768|dementia|dementia
4741280|NCT02978768|Tai Chi|tai chi
4741281|NCT02978768|mental training|mental training
4741282|NCT02978768|cognitive rehabilitation|cognitive rehabilitation
4741283|NCT02978742|Eating Disorders|eating disorders
4741284|NCT02978742|Bulimia Nervosa|bulimia nervosa
4741285|NCT02978742|Binge Eating Disorder|binge eating disorder
4741286|NCT02978742|App|app
4741287|NCT02978742|Smartphone|smartphone
4741288|NCT02978742|Self-Help|self-help
4741289|NCT02978742|Coaching|coaching
4741290|NCT02978742|Recovery Record|recovery record
4741291|NCT02978742|Mobile Phone|mobile phone
4741292|NCT02978742|Cognitive Behavioral Therapy|cognitive behavioral therapy
4741293|NCT02978729|Telemedicine|telemedicine
4741294|NCT02978729|Counseling, Genetic|counseling, genetic
4741295|NCT02978716|Breast Cancer|breast cancer
4741296|NCT02978716|CDK 4/6 Inhibitor|cdk 4/6 inhibitor
4741297|NCT02978716|Triple Negative Breast Cancer|triple negative breast cancer
4741298|NCT02978716|Metastatic|metastatic
4741299|NCT02978677|brain tumors|brain tumors
4741300|NCT02978677|proton radiotherapy|proton radiotherapy
4741301|NCT02978677|photon radiotherapy|photon radiotherapy
4741302|NCT02978664|colonoscopy|colonoscopy
4741303|NCT02978664|water exchange|water exchange
4741304|NCT02978664|adenoma detection rate|adenoma detection rate
4741305|NCT02978664|distraction|distraction
4741306|NCT02978651|EDS|eds
4741307|NCT02978651|OSA|osa
4741308|NCT02978638|Spinal cord injury|spinal cord injury
4741309|NCT02978638|Bladder capacity|bladder capacity
4741310|NCT02978638|Electrical stimulation|electrical stimulation
4741311|NCT02978638|Continence|continence
4741312|NCT02978638|Urodynamics|urodynamics
4741313|NCT02978612|Colorectal Neoplasms|colorectal neoplasms
4741314|NCT02978586|PSMA|psma
4741315|NCT02978586|PET/MRI|pet/mri
4741316|NCT02978573|First MTP Joint|first mtp joint
4741317|NCT02978573|Hallux Rigidus|hallux rigidus
4741318|NCT02978573|Hallux Limitus|hallux limitus
4741319|NCT02978573|Cartilage Replacement|cartilage replacement
4741320|NCT02978573|Osteoarthritis|osteoarthritis
4741321|NCT02978573|First MTP Joint Osteoarthritis|first mtp joint osteoarthritis
4741322|NCT02978573|Big Toe Pain|big toe pain
4741323|NCT02978547|Resectable pancreatic ductal adenocarcinoma|resectable pancreatic ductal adenocarcinoma
4741324|NCT02978547|PDAC|pdac
4741325|NCT02978547|Metformin|metformin
4741326|NCT02978534|pregnant|pregnant
4741327|NCT02978534|quetiapine|quetiapine
4741328|NCT02978534|bipolar|bipolar
4741329|NCT02978534|women|women
4741330|NCT02978534|female|female
4741331|NCT02978534|postpartum|postpartum
4741332|NCT02978534|seroquel|seroquel
4741333|NCT02978534|perinatal|perinatal
4741334|NCT02978534|manic-depressive|manic-depressive
4741335|NCT02978469|Habitual Physical Activity (HPA); Sedentary Behavior;|habitual physical activity (hpa); sedentary behavior;
4741336|NCT02978456|IVUS guided PCI|ivus guided pci
4741337|NCT02978456|QCA guided PCI|qca guided pci
4741338|NCT02978443|Melanoma|melanoma
4741339|NCT02978443|Mucosal|mucosal
4741340|NCT02978443|Acral Lentiginous|acral lentiginous
4741341|NCT02978443|Ipilimumab|ipilimumab
4741342|NCT02978443|Nivolumab|nivolumab
4741343|NCT02978443|Anti-tumor|anti-tumor
4741344|NCT02978443|Potential Predictors|potential predictors
4741345|NCT02978443|Opdivo|opdivo
4741346|NCT02978443|Yervoy|yervoy
4741347|NCT02978430|Fluid therapy|fluid therapy
4741348|NCT02978430|Anesthesiology|anesthesiology
4741349|NCT02978430|Major surgery|major surgery
4741350|NCT02978430|Goal-directed fluid therapy|goal-directed fluid therapy
4741351|NCT02978430|Fluid responsiveness|fluid responsiveness
4741352|NCT02978430|Closed-loop system|closed-loop system
4741353|NCT02978417|Medication-assisted treatment|medication-assisted treatment
4741354|NCT02978417|Drug Court|drug court
4741355|NCT02978417|Pilot study|pilot study
4741356|NCT02978417|Opioid dependence|opioid dependence
4741357|NCT02978417|Criminal justice|criminal justice
4741358|NCT02978404|radiosurgery|radiosurgery
4741359|NCT02978404|PD-1|pd-1
4741360|NCT02978404|Nivolumab|nivolumab
4741361|NCT02978326|Postpartum Care|postpartum care
4741362|NCT02978287|Calcium sensing receptor|calcium sensing receptor
4741363|NCT02978287|Parathyroid cell viability|parathyroid cell viability
4741364|NCT02978287|Parathyroid allotransplantation|parathyroid allotransplantation
4741365|NCT02978287|Transporting solution|transporting solution
4741366|NCT02978235|Multiple Myeloma|multiple myeloma
4741367|NCT02978235|Relapsed/Refractory|relapsed/refractory
4741368|NCT02978235|Lymphoma|lymphoma
4741369|NCT02978235|Non-Hodgkin Lymphoma|non-hodgkin lymphoma
4741370|NCT02978235|Diffuse Large B-Cell Lymphoma|diffuse large b-cell lymphoma
4741371|NCT02978235|DLBCL|dlbcl
4741372|NCT02978235|Mantle Cell Lymphoma|mantle cell lymphoma
4741373|NCT02978235|MCL|mcl
4741374|NCT02978235|Peripheral T-Cell Lymphoma|peripheral t-cell lymphoma
4741375|NCT02978235|PTCL|ptcl
4741376|NCT02978235|TAS4464|tas4464
4741377|NCT02978235|NEDD8|nedd8
4741378|NCT02978235|NAE inhibitor|nae inhibitor
4741379|NCT02978235|Neoplasms|neoplasms
4741380|NCT02978235|Hematologic Diseases|hematologic diseases
4741381|NCT02978235|Myeloma|myeloma
4741382|NCT02978170|Bronchoscopy|bronchoscopy
4741383|NCT02978170|Lung lesions|lung lesions
4741384|NCT02978170|Cone Beam Computed Tomography|cone beam computed tomography
4741385|NCT02978170|CBCT|cbct
4741386|NCT02978170|Cone Beam CT|cone beam ct
4741387|NCT02978157|Helicobacter pylori|helicobacter pylori
4741388|NCT02978157|Eradication rate|eradication rate
4741389|NCT02978157|Rescue treatment|rescue treatment
4741390|NCT02978144|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
4741391|NCT02978131|TUBERCULOSIS|tuberculosis
4741392|NCT02978131|Sensitivity and Specificity|sensitivity and specificity
4741393|NCT02978131|Polymerase Chain Reaction|polymerase chain reaction
4741394|NCT02978131|Immunohistochemistry|immunohistochemistry
4741395|NCT02978131|Histochemistry|histochemistry
4741396|NCT02978131|Paraformaldehyde and paraffin embedded tissues|paraformaldehyde and paraffin embedded tissues
4741397|NCT02978053|Bright light|bright light
4741398|NCT02978053|Sleepiness|sleepiness
4741399|NCT02978053|Sleep|sleep
4741400|NCT02978053|Psychomotor vigilance|psychomotor vigilance
4741401|NCT02978040|Antiplatelet therapy|antiplatelet therapy
4741402|NCT02978040|Cangrelor|cangrelor
4741403|NCT02978040|Tirofiban|tirofiban
4741404|NCT02978040|Prasugrel|prasugrel
4741405|NCT02978040|Acute Myocardial Infarction|acute myocardial infarction
4741406|NCT02978040|Primary Percutaneous Coronary Intervention|primary percutaneous coronary intervention
4741407|NCT02978040|Pharmacokinetic/Pharmacodynamic|pharmacokinetic/pharmacodynamic
4741408|NCT02978027|motivational interviewing|motivational interviewing
4741409|NCT02978027|brief alcohol intervention in primary care|brief alcohol intervention in primary care
4741410|NCT02978014|Prostate|prostate
4741411|NCT02978014|Radiotherapy|radiotherapy
4741412|NCT02978014|Obturator|obturator
4741413|NCT02978014|Toxicity|toxicity
4741414|NCT02978014|Bowel|bowel
4741415|NCT02978014|Urinary|urinary
4741416|NCT02978014|Sexual|sexual
4741417|NCT02978014|PROM|prom
4741418|NCT02978014|EPIC|epic
4741419|NCT02977988|Mindfulness|mindfulness
4741420|NCT02977988|Women|women
4741421|NCT02977988|Relapse prevention|relapse prevention
4741422|NCT02977988|Clinical trial|clinical trial
4741423|NCT02977988|Substance use disorder|substance use disorder
4741424|NCT02977988|Ethnically diverse|ethnically diverse
4741425|NCT02977988|Underserved|underserved
4741426|NCT02977988|Health disparities|health disparities
4741427|NCT02977988|Stress|stress
4741428|NCT02977988|Addiction|addiction
4741429|NCT02977988|Latina/Hispanic|latina/hispanic
4741430|NCT02977988|African American|african american
4741431|NCT02977988|Treatment retention|treatment retention
4741432|NCT02977988|Residential treatment|residential treatment
4741433|NCT02977988|Brain Imaging|brain imaging
4741434|NCT02977975|Irritable bowel syndrome|irritable bowel syndrome
4741435|NCT02977975|The human microbiome|the human microbiome
4741436|NCT02977975|Microbiota|microbiota
4741437|NCT02977975|Gut microbiota|gut microbiota
4741438|NCT02977975|Probiotics|probiotics
4741439|NCT02977975|Sauerkraut|sauerkraut
4741440|NCT02977949|SERM|serm
4741441|NCT02977949|Season|season
4741442|NCT02977949|Variation|variation
4741443|NCT02977949|Vitamin D|vitamin d
4741444|NCT02977923|Virtual reality|virtual reality
4741445|NCT02977923|Immersive distraction|immersive distraction
4741446|NCT02977923|Oculus rift|oculus rift
4741447|NCT02977923|Virtual world|virtual world
4741448|NCT02977923|Virtual environment|virtual environment
4741449|NCT02977923|Procedural pain|procedural pain
4741450|NCT02977923|Procedural anxiety|procedural anxiety
4741451|NCT02977923|Acute pain|acute pain
4741452|NCT02977923|Pain management|pain management
4741453|NCT02977923|Anxiety|anxiety
4741454|NCT02977923|Children, Child|children, child
4741455|NCT02977923|Kid, Kids|kid, kids
4741456|NCT02977923|Pediatric, Pediatrics|pediatric, pediatrics
4741457|NCT02977923|Young children|young children
4741458|NCT02977923|Burns|burns
4741459|NCT02977923|Burn injuries|burn injuries
4741460|NCT02977923|Burn unit|burn unit
4741461|NCT02977923|Physiotherapy|physiotherapy
4741462|NCT02977923|Physical therapy|physical therapy
4741463|NCT02977923|Burn dressing|burn dressing
4741464|NCT02977923|Dressing change|dressing change
4741465|NCT02977923|Non-pharmacological, nonpharmacological|non-pharmacological, nonpharmacological
4741466|NCT02977923|Clinical Research|clinical research
4741467|NCT02977923|Nursing Practice|nursing practice
4741468|NCT02977923|Trauma|trauma
4741469|NCT02977897|Diarrhea|diarrhea
4741470|NCT02977897|Immunosuppression|immunosuppression
4741471|NCT02977897|Post-transplantation|post-transplantation
4741472|NCT02977897|Octreotide|octreotide
4741473|NCT02977897|Mycophenolate Mofetil|mycophenolate mofetil
4741474|NCT02977897|Fecal Calprotectin|fecal calprotectin
4741475|NCT02977884|nutrition|nutrition
4741476|NCT02977884|exercise|exercise
4741477|NCT02977884|stress|stress
4741478|NCT02977884|cardiovascular disease|cardiovascular disease
4741479|NCT02977884|diabetes|diabetes
4741480|NCT02977884|hypertension|hypertension
4741481|NCT02977884|dyslipidemia|dyslipidemia
4741482|NCT02977884|cholesterol|cholesterol
4741483|NCT02977884|overweight|overweight
4741484|NCT02977884|obesity|obesity
4741485|NCT02977884|lifestyle|lifestyle
4741486|NCT02977871|Cesarean section|cesarean section
4741487|NCT02977871|operating time|operating time
4741488|NCT02977871|bladder|bladder
4741489|NCT02977871|urinary retention|urinary retention
4741490|NCT02977845|dypsnea|dypsnea
4741492|NCT02977845|anxiety|anxiety
4741493|NCT02977845|Qigong|qigong
4741494|NCT02977845|Lung cancer|lung cancer
4741495|NCT02977832|LUTS|luts
4741496|NCT02977832|Iresine celosia|iresine celosia
4741497|NCT02977832|Odyliresin|odyliresin
4741498|NCT02977832|medical therapy|medical therapy
4741499|NCT02977780|Glioblastoma|glioblastoma
4741500|NCT02977728|MTBI|mtbi
4741501|NCT02977728|olfaction|olfaction
4741502|NCT02977728|acute|acute
4741503|NCT02977715|Democratic Republic of the Congo|democratic republic of the congo
4741504|NCT02977715|IMVAMUNE|imvamune
4741505|NCT02977715|Modified Vaccinia Ankara (MVA)|modified vaccinia ankara (mva)
4741506|NCT02977715|Monkeypox|monkeypox
4741507|NCT02977715|Orthopoxvirus|orthopoxvirus
4741508|NCT02977715|Vaccine|vaccine
4741509|NCT02977715|Vaccinia virus|vaccinia virus
4741510|NCT02977689|Isocitrate dehydrogenase (IDH)|isocitrate dehydrogenase (idh)
4741511|NCT02977689|R-2-Hydroxyglutarate (2-HG)|r-2-hydroxyglutarate (2-hg)
4741512|NCT02977689|Gene encoding UDP-glucuronosyltransferase (UGT1A1)|gene encoding udp-glucuronosyltransferase (ugt1a1)
4741513|NCT02977689|Glioblastoma (GBM)|glioblastoma (gbm)
4741514|NCT02977689|IDH305|idh305
4741515|NCT02977689|IDHR132 mutations|idhr132 mutations
4741516|NCT02977689|Astrocytoma|astrocytoma
4741517|NCT02977689|Oligodendroglioma|oligodendroglioma
4741518|NCT02977689|Oligoastrocytoma|oligoastrocytoma
4741519|NCT02977689|IDH1 R132H|idh1 r132h
4741520|NCT02977689|IDH1|idh1
4741522|NCT02977637|hereditary|hereditary
4741523|NCT02977637|hemorrhagic|hemorrhagic
4741524|NCT02977637|telangiectasia|telangiectasia
4741525|NCT02977637|feraheme|feraheme
4741526|NCT02977585|continous positive airway pressure|continous positive airway pressure
4741527|NCT02977585|helmet|helmet
4741528|NCT02977585|non invasive|non invasive
4741529|NCT02977585|positive end expiratory pressure|positive end expiratory pressure
4741530|NCT02977585|severe bronchiolitis|severe bronchiolitis
4741531|NCT02977585|pediatric intensive care unit|pediatric intensive care unit
4741532|NCT02977572|Non-invasive ventilation,|non-invasive ventilation,
4741533|NCT02977572|continuous positive airway pressure|continuous positive airway pressure
4741534|NCT02977572|cardiogenic pulmonary oedema,|cardiogenic pulmonary oedema,
4741535|NCT02977572|acute respiratory failure|acute respiratory failure
4741536|NCT02977559|Laryngeal Tube Suction Ambu AuraGain Leak Pressure|laryngeal tube suction ambu auragain leak pressure
4741537|NCT02977546|Hemodynamics|hemodynamics
4741538|NCT02977546|Noninvasive|noninvasive
4741539|NCT02977546|Pulse contour analysis|pulse contour analysis
4741540|NCT02977546|Heart failure|heart failure
4741541|NCT02977546|Swan Ganz Catheterization|swan ganz catheterization
4741542|NCT02977546|Pulmonary artery Catheter|pulmonary artery catheter
4741543|NCT02977468|triple negative breast cancer|triple negative breast cancer
4741544|NCT02977468|Pembrolizumab|pembrolizumab
4741545|NCT02977468|IORT|iort
4741546|NCT02977468|tumor microenvironment|tumor microenvironment
4741547|NCT02977442|Mitochondrial Dynamics|mitochondrial dynamics
4741548|NCT02977442|Insulin Resistance|insulin resistance
4741549|NCT02977442|Exercise and Diabetes|exercise and diabetes
4741550|NCT02977429|Tumor|tumor
4741551|NCT02977429|Abdominal infection|abdominal infection
4741552|NCT02977429|Hemodynamics|hemodynamics
4741553|NCT02977429|Pcv-aCO2|pcv-aco2
4741554|NCT02977429|Early Goal-directed Therapy (EGDT)|early goal-directed therapy (egdt)
4741555|NCT02977416|Juvenile idiopathic arthritis|juvenile idiopathic arthritis
4741556|NCT02977416|fat oxidation|fat oxidation
4741557|NCT02977416|exercise|exercise
4741558|NCT02977403|Binge Eating|binge eating
4741559|NCT02977403|Eating Behavior|eating behavior
4741560|NCT02977403|Children|children
4741561|NCT02977403|Magnetoencephalography|magnetoencephalography
4741562|NCT02977403|Loss of Control|loss of control
4741563|NCT02977351|Periodontopathogenic microorganisms|periodontopathogenic microorganisms
4741564|NCT02977351|Non-surgical periodontal treatment|non-surgical periodontal treatment
4741565|NCT02977325|Physical activity level|physical activity level
4741566|NCT02977325|Personal efficacy|personal efficacy
4741567|NCT02977325|Knee osteoarthritis|knee osteoarthritis
4741568|NCT02977325|Self-management|self-management
4741569|NCT02977325|Self-care|self-care
4741570|NCT02977325|Education and exercise in knee osteoarthritis|education and exercise in knee osteoarthritis
4741571|NCT02977273|Meal size|meal size
4741572|NCT02977260|Meal size|meal size
4741573|NCT02977247|SoftVue|softvue
4741574|NCT02977247|Dense Breast Tissue|dense breast tissue
4741575|NCT02977247|Breast Screening|breast screening
4741576|NCT02977247|Abnormal Breast|abnormal breast
4741577|NCT02977247|Normal Breast|normal breast
4741578|NCT02977247|Breast Imaging|breast imaging
4741579|NCT02977247|Breast Biopsy|breast biopsy
4741580|NCT02977247|Mammography|mammography
4741581|NCT02977247|Tomosynthesis|tomosynthesis
4741582|NCT02977247|Automated Breast Ultrasound|automated breast ultrasound
4741583|NCT02977247|Breast Cancer|breast cancer
4741584|NCT02977247|Breast Carcinoma|breast carcinoma
4741585|NCT02977247|Breast Tumors|breast tumors
4741586|NCT02977247|Mammary Carcinoma|mammary carcinoma
4741587|NCT02977247|Malignant Breast Tumor|malignant breast tumor
4741588|NCT02977247|Mammary Neoplasm|mammary neoplasm
4741589|NCT02977247|Mammary Cancer|mammary cancer
4741590|NCT02977247|ABUS|abus
4741591|NCT02977247|AWBUS|awbus
4741592|NCT02977247|Breast Tomography|breast tomography
4741593|NCT02977247|ATUS|atus
4741594|NCT02977247|ABTUS|abtus
4741595|NCT02977247|Mammogram|mammogram
4741596|NCT02977247|3D Mammogram|3d mammogram
4741597|NCT02977247|3D ABUS|3d abus
4741598|NCT02977247|3D Breast Ultrasound|3d breast ultrasound
4741599|NCT02977247|DBT|dbt
4741600|NCT02977247|FFDM|ffdm
4741601|NCT02977247|Digital Mammography|digital mammography
4741602|NCT02977247|Breast Ultrasound|breast ultrasound
4741603|NCT02977247|Dense Breasts|dense breasts
4741604|NCT02977247|Breast Density|breast density
4741605|NCT02977247|Dense Parenchyma|dense parenchyma
4741606|NCT02977247|Asymptomatic|asymptomatic
4741607|NCT02977247|Delphinus|delphinus
4741608|NCT02977247|Delphinus Medical Technologies|delphinus medical technologies
4741609|NCT02977247|Diagnostic Breast Imaging|diagnostic breast imaging
4741610|NCT02977221|corticotomy|corticotomy
4741611|NCT02977221|piezocision|piezocision
4741612|NCT02977221|piezosurgery|piezosurgery
4741613|NCT02977221|acceleration of tooth movement|acceleration of tooth movement
4741614|NCT02977221|crowded anterior teeth|crowded anterior teeth
4741615|NCT02977208|Gabapentin|gabapentin
4741616|NCT02977208|OCT2|oct2
4741617|NCT02977208|OCTN1|octn1
4741618|NCT02977208|Pharmacogenetics|pharmacogenetics
4741619|NCT02977208|Pharmacokinetics|pharmacokinetics
4741620|NCT02977208|Polymorphisms|polymorphisms
4741621|NCT02977195|First in Human|first in human
4741622|NCT02977195|monoclonal antibody|monoclonal antibody
4741623|NCT02977195|Netrin-1|netrin-1
4741624|NCT02977156|Injectable lesion|injectable lesion
4741625|NCT02977156|Intra-tumoral injection|intra-tumoral injection
4741626|NCT02977143|fluid responsiveness|fluid responsiveness
4741627|NCT02977143|central venous pressure|central venous pressure
4741628|NCT02977143|positive end-expiratory pressure|positive end-expiratory pressure
4741629|NCT02977143|robot surgery|robot surgery
4741630|NCT02977117|magnesium|magnesium
4741631|NCT02977117|ectopic calcification|ectopic calcification
4741632|NCT02977117|chronic kidney disease - mineral and bone disorder|chronic kidney disease - mineral and bone disorder
4741633|NCT02977117|serum calcification propensity|serum calcification propensity
4741634|NCT02977091|short stature|short stature
4741635|NCT02977091|fitness|fitness
4741636|NCT02977091|children|children
4741637|NCT02977078|Inhaler|inhaler
4741638|NCT02977065|Dyslipidemia|dyslipidemia
4741639|NCT02977065|CETP Inhibitors|cetp inhibitors
4741640|NCT02977065|Hyperlipidemia|hyperlipidemia
4741641|NCT02977052|Melanoma|melanoma
4741642|NCT02977052|Ipilimumab|ipilimumab
4741643|NCT02977052|Nivolumab|nivolumab
4741644|NCT02977052|Neo-adjuvant|neo-adjuvant
4741645|NCT02976987|Colvir|colvir
4741646|NCT02976987|high grade squamous intraepithelial lesions|high grade squamous intraepithelial lesions
4741647|NCT02976987|cervix|cervix
4741648|NCT02976974|chronic pain|chronic pain
4741649|NCT02976974|central sensitization|central sensitization
4741650|NCT02976974|function|function
4741651|NCT02976974|force|force
4741652|NCT02976974|ultrasonography|ultrasonography
4741653|NCT02976961|Information|information
4741654|NCT02976961|Empowerment|empowerment
4741655|NCT02976922|RAS|ras
4741656|NCT02976922|microbiome|microbiome
4741657|NCT02976922|probiotics|probiotics
4741658|NCT02976883|Hypoxia|hypoxia
4741659|NCT02976883|HX4|hx4
4741660|NCT02976883|PET CT|pet ct
4741661|NCT02976883|Radiotherapy|radiotherapy
4741662|NCT02976870|Hydronephrosis|hydronephrosis
4741663|NCT02976870|Anterior Lumbar Interbody Fusion|anterior lumbar interbody fusion
4741664|NCT02976857|refractory diffuse large B-cell lymphoma|refractory diffuse large b-cell lymphoma
4741665|NCT02976857|anti-CD19 chimeric antigen receptor T-cell|anti-cd19 chimeric antigen receptor t-cell
4741666|NCT02976844|optimal balloon volume|optimal balloon volume
4741667|NCT02976844|positive end-expiratory pressure|positive end-expiratory pressure
4741668|NCT02976831|Plaque psoriasis vulgaris|plaque psoriasis vulgaris
4741669|NCT02976792|Transcatheter aortic valve implantation|transcatheter aortic valve implantation
4741670|NCT02976792|Acute Kidney Injury|acute kidney injury
4741671|NCT02976792|early acute kidney injury detection|early acute kidney injury detection
4741672|NCT02976792|Nephrocheck™|nephrocheck™
4741673|NCT02976792|Renal Resistive Index|renal resistive index
4741674|NCT02976766|Neuroprotection|neuroprotection
4741675|NCT02976766|Clinical trial|clinical trial
4741676|NCT02976766|Traditional Chinese medicine|traditional chinese medicine
4741677|NCT02976766|Axonal loss|axonal loss
4741678|NCT02976766|Jiaogulan|jiaogulan
4741679|NCT02976766|Gynostemma pentaphyllum|gynostemma pentaphyllum
4741680|NCT02976766|Optical coherence tomography|optical coherence tomography
4741681|NCT02976753|Blood Coagulation Disorders|blood coagulation disorders
4741682|NCT02976753|Hematologic Diseases|hematologic diseases
4741683|NCT02976753|Coagulation Protein Disorders|coagulation protein disorders
4741684|NCT02976753|Hemorrhagic Disorders|hemorrhagic disorders
4741685|NCT02976753|Genetic Diseases, Inborn|genetic diseases, inborn
4741686|NCT02976740|lung cancer|lung cancer
4741687|NCT02976740|SBRT|sbrt
4741688|NCT02976740|rhGM-CSF|rhgm-csf
4741689|NCT02976740|Thymosin Alpha 1|thymosin alpha 1
4741690|NCT02976727|Vitamin D|vitamin d
4741691|NCT02976727|Calcipotriol|calcipotriol
4741692|NCT02976727|Ablative fractional laser|ablative fractional laser
4741693|NCT02976727|Actinic keratosis|actinic keratosis
4741694|NCT02976727|Photodynamic therapy|photodynamic therapy
4741695|NCT02976714|Cystic Fibrosis|cystic fibrosis
4741696|NCT02976714|Lung disease|lung disease
4741697|NCT02976714|DNA methylation|dna methylation
4741698|NCT02976714|Predictive biomarkers|predictive biomarkers
4741699|NCT02976701|STEMI|stemi
4741700|NCT02976701|acute coronary syndrome|acute coronary syndrome
4741701|NCT02976701|DLBS1033|dlbs1033
4741702|NCT02976701|microvascular resistance index|microvascular resistance index
4741703|NCT02976701|Left ventricular function|left ventricular function
4741704|NCT02976688|Endstage renal Disease|endstage renal disease
4741705|NCT02976688|Hemodialysis|hemodialysis
4741706|NCT02976649|Morbid obesity|morbid obesity
4741707|NCT02976649|Bariatric surgery|bariatric surgery
4741708|NCT02976649|Multi-dimensional score|multi-dimensional score
4741709|NCT02976636|Obesity treatment|obesity treatment
4741710|NCT02976636|Parenting training|parenting training
4741711|NCT02976636|Parenting style|parenting style
4741712|NCT02976636|Family-based behavioral therapy|family-based behavioral therapy
4741713|NCT02976623|metrics|metrics
4741714|NCT02976623|feedback|feedback
4741715|NCT02976623|ultrasound-guided|ultrasound-guided
4741716|NCT02976623|procedural skills|procedural skills
4741717|NCT02976610|hemolysis|hemolysis
4741718|NCT02976597|Abdominal surgery, pain, local, transversus abdominus block.|abdominal surgery, pain, local, transversus abdominus block.
4741719|NCT02976584|EEG|eeg
4741720|NCT02976584|Cardiac Surgery|cardiac surgery
4741721|NCT02976584|Seizure|seizure
4741722|NCT02976584|Tranexamic acid|tranexamic acid
4741723|NCT02976558|CAM|cam
4741724|NCT02976558|allogenic Stem Cell Transplantation|allogenic stem cell transplantation
4741725|NCT02976558|Graft-Versus-Host Disease|graft-versus-host disease
4741726|NCT02976558|Depression|depression
4741727|NCT02976558|Quality of Life|quality of life
4741728|NCT02976558|Acupuncture|acupuncture
4741729|NCT02976558|Traditional chinese Medicine|traditional chinese medicine
4741730|NCT02976558|Integrative medicine|integrative medicine
4741731|NCT02976558|Complementary and Alternative Medicine|complementary and alternative medicine
4741732|NCT02976558|Music therapy TaKeTiNa|music therapy taketina
4741733|NCT02976558|Clown theatrical performance|clown theatrical performance
4741734|NCT02976558|Humour|humour
4741735|NCT02976558|Chemotherapy side effects|chemotherapy side effects
4741736|NCT02976558|Psycho neuro immune system|psycho neuro immune system
4741737|NCT02976558|GvHD|gvhd
4741738|NCT02976558|PNEIS|pneis
4741739|NCT02976558|CMV|cmv
4741740|NCT02976558|EBV|ebv
4741741|NCT02976558|holistic medicine|holistic medicine
4741742|NCT02976532|Electromagnetic tracking|electromagnetic tracking
4741743|NCT02976532|Internal rotation gait|internal rotation gait
4741744|NCT02976532|Femoral derotation osteotomy|femoral derotation osteotomy
4741745|NCT02976480|Irrigation|irrigation
4741746|NCT02976454|Obesity treatment|obesity treatment
4741747|NCT02976454|Primary care|primary care
4741748|NCT02976454|Guided Self-Help|guided self-help
4741749|NCT02976428|knee soft tissue balancing|knee soft tissue balancing
4741750|NCT02976428|sensor-guided|sensor-guided
4741751|NCT02976428|range of motion|range of motion
4741752|NCT02976415|Cardiac Surgery|cardiac surgery
4741753|NCT02976415|Physiotherapy|physiotherapy
4741754|NCT02976415|In-Bed Cycling|in-bed cycling
4741755|NCT02976415|Mechanical Ventilation|mechanical ventilation
4741756|NCT02976415|Cycle Ergometry|cycle ergometry
4741757|NCT02976415|Early Mobilization|early mobilization
4741758|NCT02976415|Rehabilitation|rehabilitation
4741759|NCT02976415|Critical Care|critical care
4741760|NCT02976415|Intensive Care Unit|intensive care unit
4741761|NCT02976389|Supplemental Nutrition Assistance Program|supplemental nutrition assistance program
4741762|NCT02976389|Food insecurity|food insecurity
4741763|NCT02976389|fruit and vegetable|fruit and vegetable
4741764|NCT02976389|healthy diet|healthy diet
4741765|NCT02976376|Myocardial infarction|myocardial infarction
4741766|NCT02976376|e-Health|e-health
4741767|NCT02976376|mHealth|mhealth
4741768|NCT02976376|mobile phones|mobile phones
4741769|NCT02976376|smartphone|smartphone
4741770|NCT02976376|follow-up|follow-up
4741771|NCT02976363|Radiotherapy|radiotherapy
4741772|NCT02976363|Respiratory muscles|respiratory muscles
4741773|NCT02976363|Neoplasms|neoplasms
4741774|NCT02976363|Breast|breast
4741775|NCT02976350|Heart failure|heart failure
4741776|NCT02976350|Heart failure with preserved ejection fraction|heart failure with preserved ejection fraction
4741777|NCT02976350|GH deficiency|gh deficiency
4741778|NCT02976350|Testosterone deficiency|testosterone deficiency
4741779|NCT02976350|Low- T3 syndrome|low- t3 syndrome
4741780|NCT02976350|Multiple Hormone Deficiencies|multiple hormone deficiencies
4741781|NCT02976337|Central sensitization|central sensitization
4741782|NCT02976337|Endogenous opioids|endogenous opioids
4741783|NCT02976337|Humans|humans
4741784|NCT02976337|Latent sensitization|latent sensitization
4741785|NCT02976337|Mandibular third molar extraction|mandibular third molar extraction
4741786|NCT02976337|Naloxone|naloxone
4741787|NCT02976337|Pain|pain
4741788|NCT02976337|Pressure algometry|pressure algometry
4741789|NCT02976337|Randomized controlled trial|randomized controlled trial
4741790|NCT02976337|Secondary hyperalgesia|secondary hyperalgesia
4741791|NCT02976337|Target controlled infusion|target controlled infusion
4741792|NCT02976311|inflammatory reaction|inflammatory reaction
4741793|NCT02976311|IL-6|il-6
4741794|NCT02976311|TNF|tnf
4741795|NCT02976311|Misgav Ladach technique|misgav ladach technique
4741796|NCT02976311|Pfannenstiel-Kerr technique|pfannenstiel-kerr technique
4741797|NCT02976311|cesarean delivery|cesarean delivery
4741798|NCT02976311|cesarean technique|cesarean technique
4741799|NCT02976298|cerebellum|cerebellum
4741800|NCT02976298|supplementary motor area|supplementary motor area
4741801|NCT02976285|arthroscopic rotator cuff repair|arthroscopic rotator cuff repair
4741802|NCT02976285|patch augmentation|patch augmentation
4741803|NCT02976272|Bortezomib regimen|bortezomib regimen
4741804|NCT02976272|patients with multiple myeloma|patients with multiple myeloma
4741805|NCT02976233|Acute Respiratory Failure|acute respiratory failure
4741806|NCT02976233|Non Invasive Ventilation|non invasive ventilation
4741807|NCT02976233|Ultrasound|ultrasound
4741808|NCT02976233|Diaphragm Thickening|diaphragm thickening
4741809|NCT02976168|Cognitive functioning|cognitive functioning
4741810|NCT02976168|Brain tissue oxygenation|brain tissue oxygenation
4741811|NCT02976168|cerebral perfusion|cerebral perfusion
4741812|NCT02976168|head down tilt|head down tilt
4741813|NCT02976155|critically ill, intensive care, enteral nutrition|critically ill, intensive care, enteral nutrition
4741814|NCT02976142|gastric cancer, metastatic|gastric cancer, metastatic
4741815|NCT02976142|positive wash cytology|positive wash cytology
4741816|NCT02976142|neoadjuvant intraperitoneal immunotherapy|neoadjuvant intraperitoneal immunotherapy
4741817|NCT02976116|Fruquintinib|fruquintinib
4741818|NCT02976116|NSCLC|nsclc
4741819|NCT02976116|1st line|1st line
4741820|NCT02976103|recovery|recovery
4741821|NCT02976103|pain|pain
4741822|NCT02976103|surgical drains|surgical drains
4741823|NCT02976077|social cognition|social cognition
4741824|NCT02976077|cognitive remediation|cognitive remediation
4741825|NCT02976077|emotions|emotions
4741826|NCT02976077|theory of mind|theory of mind
4741827|NCT02976077|attributions|attributions
4741828|NCT02976077|social perception|social perception
4741829|NCT02976064|physical activity|physical activity
4741830|NCT02976064|lifestyle|lifestyle
4741831|NCT02976064|adaptive case management|adaptive case management
4741832|NCT02976064|telemedicine|telemedicine
4741833|NCT02976064|integrated care|integrated care
4741834|NCT02976064|collaborative self-management|collaborative self-management
4741835|NCT02976038|Primary Mitochondrial Disease|primary mitochondrial disease
4741836|NCT02976038|Stealth|stealth
4741837|NCT02976038|elamipretide|elamipretide
4741838|NCT02976012|Proliferative Diabetic Retinopathy|proliferative diabetic retinopathy
4741839|NCT02976012|Aflibercept|aflibercept
4741840|NCT02976012|Vitreous Hemorrhage|vitreous hemorrhage
4741841|NCT02975986|Nephrolithiasis, Uric Acid|nephrolithiasis, uric acid
4741842|NCT02975986|Fatty Acid|fatty acid
4741843|NCT02975973|tDCS|tdcs
4741844|NCT02975973|cognitive control|cognitive control
4741845|NCT02975973|EEG|eeg
4741846|NCT02975973|gamma oscillations|gamma oscillations
4741847|NCT02975960|systemic sclerosis|systemic sclerosis
4741848|NCT02975960|adipose derived stem cell|adipose derived stem cell
4741849|NCT02975960|stromal vascular fraction|stromal vascular fraction
4741850|NCT02975960|digital ulcer|digital ulcer
4741851|NCT02975960|gangrene|gangrene
4741852|NCT02975934|CRPC|crpc
4741853|NCT02975934|PARP inhibitor|parp inhibitor
4741854|NCT02975934|PARPi|parpi
4741855|NCT02975934|BRCA|brca
4741856|NCT02975934|ATM|atm
4741857|NCT02975934|HRD|hrd
4741858|NCT02975934|TRITON|triton
4741859|NCT02975934|homologous recombination|homologous recombination
4741860|NCT02975934|DNA repair|dna repair
4741861|NCT02975934|DNA defect|dna defect
4741862|NCT02975934|DNA anomaly|dna anomaly
4741863|NCT02975934|germline|germline
4741864|NCT02975934|somatic|somatic
4741865|NCT02975921|Pleural Effusion|pleural effusion
4741866|NCT02975921|Thoracentesis|thoracentesis
4741867|NCT02975921|Pleural Cavity|pleural cavity
4741868|NCT02975921|Pleurodesis|pleurodesis
4741869|NCT02975921|Tunneled Pleural Catheter|tunneled pleural catheter
4741870|NCT02975908|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
4741871|NCT02975908|epidemiology|epidemiology
4741872|NCT02975908|clinical features|clinical features
4741873|NCT02975908|management|management
4741874|NCT02975908|prognosis|prognosis
4741875|NCT02975869|Leukemia|leukemia
4741876|NCT02975869|Acute Myeloid Leukemia|acute myeloid leukemia
4741877|NCT02975856|Anthocyanins|anthocyanins
4741878|NCT02975856|Bioavailability|bioavailability
4741879|NCT02975856|Flavonoids|flavonoids
4741880|NCT02975856|Port wine|port wine
4741881|NCT02975856|Red wine|red wine
4741882|NCT02975817|pediatric, intraoperative, neurosurgery, inadvertent|pediatric, intraoperative, neurosurgery, inadvertent
4741883|NCT02975804|cerebral palsy|cerebral palsy
4741884|NCT02975804|video games|video games
4741885|NCT02975804|postural control|postural control
4741886|NCT02975804|balance|balance
4741887|NCT02975804|children|children
4741888|NCT02975791|Airway Obstruction|airway obstruction
4741889|NCT02975778|80 years old|80 years old
4741890|NCT02975765|corticotomy|corticotomy
4741891|NCT02975765|minimally invasive|minimally invasive
4741892|NCT02975765|piezosurgery|piezosurgery
4741893|NCT02975765|piezocision|piezocision
4741895|NCT02975765|discomfort|discomfort
4741896|NCT02975739|Intratumoral|intratumoral
4741897|NCT02975739|Tongue|tongue
4741898|NCT02975739|Microspheres|microspheres
4741899|NCT02975726|Liver Cirrhosis|liver cirrhosis
4741900|NCT02975726|Refractory ascites|refractory ascites
4741901|NCT02975726|PD catheter|pd catheter
4741902|NCT02975713|P4,ART,IVF,FSH,LH,AMH|p4,art,ivf,fsh,lh,amh
4741903|NCT02975700|PLX3397|plx3397
4741904|NCT02975700|Kit-mutant Melanoma|kit-mutant melanoma
4741905|NCT02975700|Unresectable or Metastatic KIT-mutated Melanoma|unresectable or metastatic kit-mutated melanoma
4741906|NCT02975700|Developmental Phase I/II|developmental phase i/ii
4741907|NCT02975687|Acute|acute
4741908|NCT02975687|Leukemia|leukemia
4741909|NCT02975687|Lymphoid|lymphoid
4741910|NCT02975687|CD19|cd19
4741911|NCT02975687|Refractory|refractory
4741912|NCT02975635|Patients' Preferences|patients' preferences
4741913|NCT02975596|educational intervention|educational intervention
4741914|NCT02975583|Atherosclerosis|atherosclerosis
4741915|NCT02975557|Brimonidine|brimonidine
4741916|NCT02975557|Dry Eye|dry eye
4741917|NCT02975557|oGVHD|ogvhd
4741918|NCT02975557|MGD|mgd
4741919|NCT02975544|social and emotional competence|social and emotional competence
4741920|NCT02975544|healthy lifestyles|healthy lifestyles
4741921|NCT02975544|children|children
4741922|NCT02975544|educational programme|educational programme
4741923|NCT02975531|Pompage|pompage
4741924|NCT02975479|Hay fever|hay fever
4741925|NCT02975479|Pollen allergy|pollen allergy
4741926|NCT02975479|Allergic rhinitis|allergic rhinitis
4741927|NCT02975440|Vilaprisan|vilaprisan
4741928|NCT02975440|PK|pk
4741929|NCT02975440|rifampicin|rifampicin
4741930|NCT02975440|midazolam,|midazolam,
4741931|NCT02975440|CYP3A4 induction|cyp3a4 induction
4741932|NCT02975440|drug-drug interaction|drug-drug interaction
4741933|NCT02975427|Diet|diet
4741934|NCT02975427|Abdominal bioelectrical impedance analysis|abdominal bioelectrical impedance analysis
4741935|NCT02975427|Anthropometry|anthropometry
4741936|NCT02975427|Insulin resistance|insulin resistance
4741937|NCT02975362|Acupuncture Treatment; Motor Dysfunction; Stroke Patients|acupuncture treatment; motor dysfunction; stroke patients
4741938|NCT02975349|M2951|m2951
4741939|NCT02975349|Relapsing Multiple Sclerosis|relapsing multiple sclerosis
4741940|NCT02975349|Bruton's Tyrosine Kinase inhibitor|bruton's tyrosine kinase inhibitor
4741941|NCT02975336|Systemic Lupus Erythematosus|systemic lupus erythematosus
4741942|NCT02975336|M2951|m2951
4741943|NCT02975336|Placebo|placebo
4741944|NCT02975336|Dose response|dose response
4741945|NCT02975336|Oral Corticosteroids|oral corticosteroids
4741946|NCT02975336|Safety|safety
4741947|NCT02975336|Efficacy|efficacy
4741948|NCT02975336|Autoimmune And Inflammatory Disorders|autoimmune and inflammatory disorders
4741949|NCT02975323|hepatic venous pressure gradient|hepatic venous pressure gradient
4741950|NCT02975323|liver disease|liver disease
4741951|NCT02975323|US Doppler waveform|us doppler waveform
4741952|NCT02975323|Cirrhosis|cirrhosis
4741953|NCT02975297|smoking|smoking
4741954|NCT02975297|pre-diabetes|pre-diabetes
4741955|NCT02975297|overweight|overweight
4741956|NCT02975297|exenatide|exenatide
4741957|NCT02975297|GLP-1 agonists|glp-1 agonists
4741958|NCT02975284|bronchial thermoplasty|bronchial thermoplasty
4741959|NCT02975284|long term|long term
4741960|NCT02975284|interventional bronchoscopy|interventional bronchoscopy
4741961|NCT02975258|HIV|hiv
4741962|NCT02975258|Asthma|asthma
4741963|NCT02975258|Adiposity|adiposity
4741964|NCT02975258|Lung disease|lung disease
4741965|NCT02975258|Weight|weight
4741966|NCT02975258|Fat|fat
4741967|NCT02975258|Obese|obese
4741968|NCT02975245|Male infertility|male infertility
4741969|NCT02975245|Germ cells|germ cells
4741970|NCT02975245|Chemotherapy|chemotherapy
4741971|NCT02975245|Sperm|sperm
4741972|NCT02975232|nutrition disparities|nutrition disparities
4741973|NCT02975232|SNAP population|snap population
4741974|NCT02975232|behavioral economics|behavioral economics
4741975|NCT02975232|retail setting|retail setting
4741976|NCT02975232|point of purchase education|point of purchase education
4741977|NCT02975232|pediatric obesity|pediatric obesity
4741978|NCT02975232|rural population|rural population
4741979|NCT02975232|fruit and vegetable purchases|fruit and vegetable purchases
4741980|NCT02975232|fruit and vegetable consumption|fruit and vegetable consumption
4741981|NCT02975193|Parkinsons Disease|parkinsons disease
4741982|NCT02975193|Cognition|cognition
4741983|NCT02975167|Induction of labor|induction of labor
4741984|NCT02975167|mechanical cervical ripening|mechanical cervical ripening
4741985|NCT02975167|patient satisfaction|patient satisfaction
4741986|NCT02975167|outpatient|outpatient
4741987|NCT02975167|cost savings|cost savings
4741988|NCT02975154|osteoarthritis|osteoarthritis
4741989|NCT02975154|microcurrent|microcurrent
4741990|NCT02975154|knee|knee
4741991|NCT02975154|electrotherapy|electrotherapy
4741992|NCT02975141|Palliative Chemotherapy|palliative chemotherapy
4741993|NCT02975141|Afatinib|afatinib
4741994|NCT02975141|Gemcitabine|gemcitabine
4741995|NCT02975141|nab-paclitaxel|nab-paclitaxel
4741996|NCT02975141|pancreatic cancer|pancreatic cancer
4741997|NCT02975128|Minimal invasive|minimal invasive
4741998|NCT02975128|Biopsy|biopsy
4741999|NCT02975089|Frailty|frailty
4742000|NCT02975089|nutrition education|nutrition education
4742001|NCT02975089|designed dishware|designed dishware
4742002|NCT02975089|balanced diet|balanced diet
4742003|NCT02975089|multiple dietary components|multiple dietary components
4742004|NCT02975076|Sanchitongshu|sanchitongshu
4742005|NCT02975076|Acute Minor Stroke|acute minor stroke
4742006|NCT02975076|Transient Ischemic Attack|transient ischemic attack
4742007|NCT02975063|Exclusive breastfeeding|exclusive breastfeeding
4742008|NCT02975024|mandibular vestibuloplasty|mandibular vestibuloplasty
4742009|NCT02975024|wound healing|wound healing
4742010|NCT02975024|microcirculation|microcirculation
4742011|NCT02975024|Laser Speckle Contrast Imager|laser speckle contrast imager
4742012|NCT02975024|Mucograft|mucograft
4742013|NCT02975024|strip gingival graft|strip gingival graft
4742014|NCT02975011|Magnetic Resonance Imaging|magnetic resonance imaging
4742015|NCT02975011|Patient Satisfaction|patient satisfaction
4742016|NCT02975011|Numeric Rating Scale|numeric rating scale
4742017|NCT02974998|Human Immunodeficiency Virus (HIV)|human immunodeficiency virus (hiv)
4742018|NCT02974998|HIV Testing and Counseling (HTC)|hiv testing and counseling (htc)
4742019|NCT02974998|Sexually Transmitted Infections (STIs)|sexually transmitted infections (stis)
4742020|NCT02974998|Substance Abuse|substance abuse
4742021|NCT02974998|Gender Based Violence|gender based violence
4742022|NCT02974998|Gang Violence|gang violence
4742023|NCT02974998|Victimization|victimization
4742024|NCT02974998|Linkage to Care|linkage to care
4742025|NCT02974998|Sexual Risk|sexual risk
4742026|NCT02974998|Out-of-school Adolescents|out-of-school adolescents
4742027|NCT02974998|Young Women|young women
4742028|NCT02974985|Facelift|facelift
4742029|NCT02974985|HA Filler|ha filler
4742030|NCT02974985|Hyaluronic acid|hyaluronic acid
4742031|NCT02974985|Facial Rejuvenation|facial rejuvenation
4742032|NCT02974985|Aging Face|aging face
4742033|NCT02974985|WIZDOM|wizdom
4742034|NCT02974985|Midface lift|midface lift
4742035|NCT02974985|Midface augmentation|midface augmentation
4742036|NCT02974933|apatinib|apatinib
4742037|NCT02974933|pemetrexed|pemetrexed
4742038|NCT02974933|NSCLC|nsclc
4742039|NCT02974907|Dry Eye Syndrome|dry eye syndrome
4742040|NCT02974907|Dry Eye|dry eye
4742041|NCT02974907|DES|des
4742042|NCT02974868|Phase 2|phase 2
4742043|NCT02974868|randomized|randomized
4742044|NCT02974868|double-blind|double-blind
4742045|NCT02974868|placebo|placebo
4742046|NCT02974868|alopecia areata|alopecia areata
4742047|NCT02974868|safety|safety
4742048|NCT02974868|efficacy|efficacy
4742049|NCT02974868|JAK|jak
4742050|NCT02974868|janus kinase|janus kinase
4742051|NCT02974868|moderate|moderate
4742052|NCT02974868|severe|severe
4742053|NCT02974855|hemophilia|hemophilia
4742054|NCT02974829|Chronic Hepatitis B|chronic hepatitis b
4742055|NCT02974816|Glooko|glooko
4742056|NCT02974816|Mobile health application|mobile health application
4742057|NCT02974816|Insulin treated|insulin treated
4742058|NCT02974816|Type 2 Diabetes|type 2 diabetes
4742059|NCT02974816|Remote patient monitoring|remote patient monitoring
4742060|NCT02974816|Certified diabetes educator|certified diabetes educator
4742061|NCT02974816|mHealth Advantage|mhealth advantage
4742062|NCT02974816|Population health|population health
4742063|NCT02974790|echocardiography|echocardiography
4742064|NCT02974790|training|training
4742065|NCT02974790|emergency department|emergency department
4742066|NCT02974790|circulatory failure|circulatory failure
4742067|NCT02974751|Aquablation|aquablation
4742068|NCT02974751|AQUABEAM|aquabeam
4742069|NCT02974751|BPH|bph
4742070|NCT02974751|LUTS|luts
4742071|NCT02974725|NSCLC|nsclc
4742072|NCT02974725|KRAS|kras
4742073|NCT02974725|BRAF|braf
4742074|NCT02974725|LXH254|lxh254
4742075|NCT02974725|LTT462|ltt462
4742076|NCT02974725|Trametinib|trametinib
4742077|NCT02974725|Non-small cell lung carcinoma (NSCLC)|non-small cell lung carcinoma (nsclc)
4742078|NCT02974725|treatment of lung cancer after first metastasis|treatment of lung cancer after first metastasis
4742079|NCT02974725|lung cancer|lung cancer
4742080|NCT02974725|lung adenocarcinoma|lung adenocarcinoma
4742081|NCT02974725|Large-cell lung carcinoma|large-cell lung carcinoma
4742082|NCT02974725|Non small cell lung carcinoma|non small cell lung carcinoma
4742083|NCT02974725|Non small cell lung cancer|non small cell lung cancer
4742084|NCT02974725|Large cell lung carcinoma|large cell lung carcinoma
4742085|NCT02974725|Large cell lung cancer|large cell lung cancer
4742086|NCT02974725|squamous cell lung carcinoma|squamous cell lung carcinoma
4742087|NCT02974712|Arterial blood gases|arterial blood gases
4742088|NCT02974712|MAP|map
4742089|NCT02974712|HR|hr
4742090|NCT02974673|Spinal Cord Injury|spinal cord injury
4742091|NCT02974673|Genito sexuals disorders|genito sexuals disorders
4742092|NCT02974673|Ejaculatory test|ejaculatory test
4742093|NCT02974647|Ruxolitinib|ruxolitinib
4742094|NCT02974647|T or NK Cell|t or nk cell
4742095|NCT02974647|Relapsed|relapsed
4742096|NCT02974647|Refractory|refractory
4742097|NCT02974634|Ileostomy|ileostomy
4742098|NCT02974608|Placental|placental
4742099|NCT02974608|Fetal Loss|fetal loss
4742100|NCT02974608|Observational|observational
4742101|NCT02974608|Antenatal|antenatal
4742102|NCT02974608|Infection|infection
4742103|NCT02974608|Malaria|malaria
4742104|NCT02974595|Autoinflammation|autoinflammation
4742105|NCT02974595|Pediatric Syndromes|pediatric syndromes
4742106|NCT02974595|Immune Dysregulation|immune dysregulation
4742107|NCT02974595|IL-1 Mediated Diseases|il-1 mediated diseases
4742108|NCT02974595|Interferonopathies|interferonopathies
4742109|NCT02974582|Marketing|marketing
4742110|NCT02974582|Smoking|smoking
4742111|NCT02974582|Cigarette|cigarette
4742112|NCT02974582|Young Adult|young adult
4742113|NCT02974582|Socioeconomic Status|socioeconomic status
4742114|NCT02974569|adolescents|adolescents
4742115|NCT02974569|young adults|young adults
4742116|NCT02974543|tinnitus|tinnitus
4742117|NCT02974517|time-lapes|time-lapes
4742118|NCT02974517|IVF/ICSI|ivf/icsi
4742119|NCT02974517|pregnancy outcome|pregnancy outcome
4742120|NCT02974491|hemodialysis|hemodialysis
4742121|NCT02974491|diabetes mellitus|diabetes mellitus
4742122|NCT02974491|apple juice|apple juice
4742123|NCT02974491|potassium|potassium
4742124|NCT02974478|orange juice consumption|orange juice consumption
4742125|NCT02974478|glucose homeostasis|glucose homeostasis
4742126|NCT02974478|antioxidative status|antioxidative status
4742127|NCT02974465|Brain injuries|brain injuries
4742128|NCT02974465|upper extremity|upper extremity
4742129|NCT02974465|biofeedback|biofeedback
4742130|NCT02974465|electromyography|electromyography
4742131|NCT02974465|recovery of function|recovery of function
4742132|NCT02974400|internet-based intervention|internet-based intervention
4742133|NCT02974400|e-mental health|e-mental health
4742134|NCT02974400|cognitive behavioural intervention|cognitive behavioural intervention
4742135|NCT02974322|Crohn's Disease|crohn's disease
4742136|NCT02974322|GED-0301|ged-0301
4742137|NCT02974322|Mongersen|mongersen
4742138|NCT02974322|Adolescent|adolescent
4742139|NCT02974322|Pediatric|pediatric
4742140|NCT02974322|Children|children
4742141|NCT02974309|Youth|youth
4742142|NCT02974309|Diabetes Management|diabetes management
4742143|NCT02974309|Sleep|sleep
4742144|NCT02974283|Normobaric hyperoxia|normobaric hyperoxia
4742145|NCT02974283|r-tPA thrombolytic therapy|r-tpa thrombolytic therapy
4742146|NCT02974257|cardiac arrest|cardiac arrest
4742147|NCT02974257|thiamine|thiamine
4742148|NCT02974257|oxygen consumption|oxygen consumption
4742149|NCT02974257|lactate|lactate
4742150|NCT02974257|shock|shock
4742151|NCT02974244|Type 2 diabetes|type 2 diabetes
4742152|NCT02974192|Ischemic stroke|ischemic stroke
4742153|NCT02974192|Soluble CD40 Ligand|soluble cd40 ligand
4742154|NCT02974192|Neopetrin|neopetrin
4742155|NCT02974192|stroke risk factors|stroke risk factors
4742156|NCT02974192|functional outcome|functional outcome
4742157|NCT02974166|Temporomandibular Disorder|temporomandibular disorder
4742158|NCT02974166|Osteopathic Manipulative Treatment|osteopathic manipulative treatment
4742159|NCT02974166|Rigid Splint|rigid splint
4742160|NCT02974166|Speech Therapy|speech therapy
4742161|NCT02974127|intracranial benign meningioma|intracranial benign meningioma
4742162|NCT02974127|radiosurgery|radiosurgery
4742163|NCT02974127|large meningioma|large meningioma
4742164|NCT02974127|critical site|critical site
4742165|NCT02974127|multisession radiosurgery|multisession radiosurgery
4742166|NCT02974101|Spinal cord stimulation|spinal cord stimulation
4742167|NCT02974101|AdaptiveStim|adaptivestim
4742168|NCT02974062|Position sense|position sense
4742169|NCT02974062|Lumbar stabilization exercise|lumbar stabilization exercise
4742170|NCT02974049|Ivermectin|ivermectin
4742171|NCT02974049|Albendazole|albendazole
4742172|NCT02974049|Diethylcarbamazine|diethylcarbamazine
4742173|NCT02974036|Patient education|patient education
4742174|NCT02974036|Osteoarthritis|osteoarthritis
4742175|NCT02974036|Primary health care|primary health care
4742176|NCT02974010|d-cycloserine|d-cycloserine
4742177|NCT02974010|lurasidone|lurasidone
4742178|NCT02974010|ketamine|ketamine
4742179|NCT02974010|randomized controlled trial|randomized controlled trial
4742180|NCT02973984|Anticoagulant Treatments|anticoagulant treatments
4742181|NCT02973984|Multidimensional Prognostic Index (MPI)|multidimensional prognostic index (mpi)
4742182|NCT02973984|Comprehensive Geriatric Assessment (CGA)|comprehensive geriatric assessment (cga)
4742183|NCT02973984|Frailty|frailty
4742184|NCT02973984|Elderly|elderly
4742185|NCT02973984|Atrial Fibrillation|atrial fibrillation
4742186|NCT02973971|Blood cell biomarkers, peripheral circulating biomarkers|blood cell biomarkers, peripheral circulating biomarkers
4742187|NCT02973958|Penis|penis
4742188|NCT02973958|Pain|pain
4742189|NCT02973958|Ketorolac|ketorolac
4742190|NCT02973958|Circumcision|circumcision
4742191|NCT02973945|Pulmonary Rehabilitation|pulmonary rehabilitation
4742192|NCT02973945|High Flow Nasal Cannula|high flow nasal cannula
4742193|NCT02973945|The Venturi Mask|the venturi mask
4742194|NCT02973945|Exercise capacity|exercise capacity
4742195|NCT02973945|Aerobic capacity|aerobic capacity
4742196|NCT02973945|HFNC|hfnc
4742197|NCT02973932|cognitive-behavioral psychotherapy|cognitive-behavioral psychotherapy
4742198|NCT02973932|obsessive-compulsive disorder|obsessive-compulsive disorder
4742199|NCT02973932|internet-based|internet-based
4742200|NCT02973893|Chronic Venous Leg Ulcer|chronic venous leg ulcer
4742201|NCT02973880|Steroid/antibiotic associated treatment|steroid/antibiotic associated treatment
4742202|NCT02973880|Phaco-emulsification|phaco-emulsification
4742203|NCT02973880|Cataract extraction|cataract extraction
4742204|NCT02973867|Bone mineral density|bone mineral density
4742205|NCT02973867|Myokines|myokines
4742206|NCT02973867|Adipokines|adipokines
4742207|NCT02973815|family meals|family meals
4742208|NCT02973815|home food availability|home food availability
4742209|NCT02973802|Graves Disease|graves disease
4742210|NCT02973802|Phase 1|phase 1
4742211|NCT02973789|Non-Small Cell Lung Cancer|non-small cell lung cancer
4742212|NCT02973789|NSCLC|nsclc
4742213|NCT02973789|Treatment|treatment
4742214|NCT02973789|Minimal Toxicity|minimal toxicity
4742215|NCT02973789|TTFields|ttfields
4742216|NCT02973789|TTF|ttf
4742217|NCT02973789|Tumor Treating Fields|tumor treating fields
4742218|NCT02973789|Novocure|novocure
4742219|NCT02973789|Docetaxel|docetaxel
4742220|NCT02973789|PD-1 inhibitor|pd-1 inhibitor
4742221|NCT02973789|PD-L1 inhibitor|pd-l1 inhibitor
4742222|NCT02973789|Immune checkpoint inhibitor|immune checkpoint inhibitor
4742223|NCT02973750|high-grade serous cancer|high-grade serous cancer
4742224|NCT02973750|stage III cancer|stage iii cancer
4742225|NCT02973750|stage IV cancer|stage iv cancer
4742226|NCT02973724|Extubation|extubation
4742227|NCT02973724|Remifentanil|remifentanil
4742228|NCT02973724|Laryngomicrosurgery|laryngomicrosurgery
4742229|NCT02973685|Hepatic arterial infusion chemotherapy|hepatic arterial infusion chemotherapy
4742230|NCT02973685|Transarterial Chemoembolization|transarterial chemoembolization
4742231|NCT02973685|BCLC A/B|bclc a/b
4742232|NCT02973672|Fluorescence|fluorescence
4742233|NCT02973672|Surgery|surgery
4742234|NCT02973672|Cancer|cancer
4742235|NCT02973672|SGM-101|sgm-101
4742236|NCT02973672|Near Infrared|near infrared
4742237|NCT02973672|Immunophotodetection|immunophotodetection
4742238|NCT02973646|chronic hepatitis b|chronic hepatitis b
4742239|NCT02973646|peginterferon alfa-2b|peginterferon alfa-2b
4742240|NCT02973646|interferon gene mutation|interferon gene mutation
4742241|NCT02973646|interferon receptor|interferon receptor
4742242|NCT02973633|Heart Failure|heart failure
4742243|NCT02973633|Remodeling|remodeling
4742244|NCT02973633|Myocardial Infarction|myocardial infarction
4742245|NCT02973633|Left Ventricular Hypertrophy|left ventricular hypertrophy
4742246|NCT02973633|Diffusion Tensor MRI|diffusion tensor mri
4742247|NCT02973594|left ventricular reverse remodeling|left ventricular reverse remodeling
4742248|NCT02973594|beta-1 adrenergic receptor signaling|beta-1 adrenergic receptor signaling
4742249|NCT02973594|idiopathic dilated cardiomyopathy|idiopathic dilated cardiomyopathy
4742250|NCT02973594|HCN4 inhibition|hcn4 inhibition
4742251|NCT02973594|beta-1 adrenergic receptor blocker|beta-1 adrenergic receptor blocker
4742252|NCT02973594|gene expression|gene expression
4742253|NCT02973581|Surgical Pleth Index (SPI)|surgical pleth index (spi)
4742254|NCT02973581|General Anaesthesia (GA),|general anaesthesia (ga),
4742255|NCT02973581|Numerical Rating Scale (NRS)|numerical rating scale (nrs)
4742256|NCT02973581|Adequacy of Anaesthesia (AoA)|adequacy of anaesthesia (aoa)
4742257|NCT02973581|Peribulbar Block (PBB)|peribulbar block (pbb)
4742258|NCT02973581|Topical Analgesia (TA)|topical analgesia (ta)
4742259|NCT02973581|Oculocardiac reflex (OCR)|oculocardiac reflex (ocr)
4742260|NCT02973581|Postoperative nausea nad vomiting (PONV)|postoperative nausea nad vomiting (ponv)
4742261|NCT02973581|paracetamol|paracetamol
4742262|NCT02973581|metamizol|metamizol
4742263|NCT02973542|IBS|ibs
4742264|NCT02973542|Ethosuximide|ethosuximide
4742265|NCT02973542|Pain|pain
4742266|NCT02973529|Percutaneous intervention (PCI)|percutaneous intervention (pci)
4742267|NCT02973529|Optical coherence tomography (OCT)|optical coherence tomography (oct)
4742268|NCT02973529|Bifurcation lesion|bifurcation lesion
4742269|NCT02973529|Bioresorbable stents (BRS)|bioresorbable stents (brs)
4742270|NCT02973503|Hepatitis C|hepatitis c
4742271|NCT02973503|Genotype 1B|genotype 1b
4742272|NCT02973503|Non Severe Fibrosis|non severe fibrosis
4742273|NCT02973503|Treatment Naïve|treatment naïve
4742274|NCT02973503|8 Weeks of Treatment|8 weeks of treatment
4742275|NCT02973503|Elbasvir/Grazoprevir Combination|elbasvir/grazoprevir combination
4742276|NCT02973490|ESD;Transanal Tube Drainage;Colorectal Tumor|esd;transanal tube drainage;colorectal tumor
4742277|NCT02973438|Spinal Cord Injuries|spinal cord injuries
4742278|NCT02973438|Obesity|obesity
4742279|NCT02973438|Insulin Resistance|insulin resistance
4742280|NCT02973438|Intermittent hypoxia|intermittent hypoxia
4742281|NCT02973425|mHealth, Smoking cessation,|mhealth, smoking cessation,
4742282|NCT02973399|CLL|cll
4742283|NCT02973399|Leukemia, Chronic Lymphocytic|leukemia, chronic lymphocytic
4742284|NCT02973399|Hsp90|hsp90
4742285|NCT02973399|Ibrutinib|ibrutinib
4742286|NCT02973386|Local advanced|local advanced
4742287|NCT02973386|High Risk|high risk
4742288|NCT02973386|Nasopharyngeal Carcinoma|nasopharyngeal carcinoma
4742289|NCT02973373|MRI|mri
4742290|NCT02973373|Chest|chest
4742291|NCT02973373|Apnea|apnea
4742292|NCT02973347|Enteral Feeding|enteral feeding
4742293|NCT02973347|Ventilator-Associated Pneumonia|ventilator-associated pneumonia
4742294|NCT02973347|Mechanical Ventilation|mechanical ventilation
4742295|NCT02973347|Pediatric Intensive Care Unit|pediatric intensive care unit
4742296|NCT02973347|Critical Illness|critical illness
4742297|NCT02973334|sweeteners|sweeteners
4742298|NCT02973334|sugar|sugar
4742299|NCT02973334|stress response|stress response
4742300|NCT02973295|NAFLD;|nafld;
4742301|NCT02973295|Fibroscan|fibroscan
4742302|NCT02973295|Silymarin|silymarin
4742303|NCT02973256|Meningioma grade II|meningioma grade ii
4742304|NCT02973256|Meningioma grade III|meningioma grade iii
4742305|NCT02973243|early warning scoring|early warning scoring
4742306|NCT02973243|respiration rate|respiration rate
4742307|NCT02973243|acute care teams|acute care teams
4742308|NCT02973243|NEWS|news
4742309|NCT02973243|CREWS|crews
4742310|NCT02973230|Pregnancy, Ectopic|pregnancy, ectopic
4742311|NCT02973230|Vascular Endothelial Growth Factor A|vascular endothelial growth factor a
4742312|NCT02973230|Pregnancy, Tubal|pregnancy, tubal
4742313|NCT02973217|Hyperthermia, Induced|hyperthermia, induced
4742314|NCT02973217|Laser Coagulation|laser coagulation
4742315|NCT02973217|Laser Therapy|laser therapy
4742316|NCT02973204|tumor DNA|tumor dna
4742317|NCT02973204|circulating tumor cells|circulating tumor cells
4742318|NCT02973204|biopsy|biopsy
4742319|NCT02973191|Leukemia|leukemia
4742320|NCT02973191|B-Cell Acute Lymphoblastic Leukemia|b-cell acute lymphoblastic leukemia
4742321|NCT02973191|JCAR015|jcar015
4742322|NCT02973152|Type I Thyroplasty|type i thyroplasty
4742323|NCT02973152|Reinnervation|reinnervation
4742324|NCT02973113|Nivolumab|nivolumab
4742325|NCT02973113|Hodgkin Lymphoma|hodgkin lymphoma
4742326|NCT02973113|Non-Hodgkin Lymphoma|non-hodgkin lymphoma
4742327|NCT02973113|Lymphoproliferative Disorders|lymphoproliferative disorders
4742328|NCT02973113|EBV-specific T Cells|ebv-specific t cells
4742329|NCT02973074|iron deficiency|iron deficiency
4742330|NCT02973074|patient blood management|patient blood management
4742331|NCT02973074|anemia|anemia
4742332|NCT02973048|Cesarean delivery|cesarean delivery
4742333|NCT02973048|Spinal anesthesia|spinal anesthesia
4742334|NCT02973048|Local anesthetics|local anesthetics
4742335|NCT02973009|The Sleeve Gastrectomy (SG)|the sleeve gastrectomy (sg)
4742336|NCT02973009|bariatric surgery|bariatric surgery
4742337|NCT02973009|laparoscopy|laparoscopy
4742338|NCT02973009|systematic closure of the epigastric|systematic closure of the epigastric
4742339|NCT02972983|Staphylococcus aureus|staphylococcus aureus
4742340|NCT02972983|Bacteremia|bacteremia
4742341|NCT02972983|Daptomycin|daptomycin
4742342|NCT02972957|intranasal|intranasal
4742343|NCT02972957|flu vaccine|flu vaccine
4742344|NCT02972957|Gambian children|gambian children
4742345|NCT02972931|HIV infection|hiv infection
4742346|NCT02972931|low HIV reservoir|low hiv reservoir
4742347|NCT02972931|functional cure|functional cure
4742348|NCT02972905|pharmacokinetics|pharmacokinetics
4742349|NCT02972905|GSK2269557|gsk2269557
4742350|NCT02972905|Dry powder Inhaler (DPI)|dry powder inhaler (dpi)
4742351|NCT02972905|tolerability|tolerability
4742352|NCT02972905|safety|safety
4742353|NCT02972905|ELLIPTA|ellipta
4742354|NCT02972879|trigger finger|trigger finger
4742355|NCT02972879|Therapeutic Modalities|therapeutic modalities
4742356|NCT02972879|Corticosteroid Injection|corticosteroid injection
4742357|NCT02972879|non-surgical treatment|non-surgical treatment
4742358|NCT02972879|physical therapy|physical therapy
4742359|NCT02972840|Bruton tyrosine kinase inhibitor|bruton tyrosine kinase inhibitor
4742360|NCT02972840|Btk|btk
4742361|NCT02972840|ACP-196|acp-196
4742362|NCT02972840|Mantle Cell Lymphoma|mantle cell lymphoma
4742363|NCT02972840|acalabrutinib|acalabrutinib
4742364|NCT02972840|ACE-LY-308|ace-ly-308
4742365|NCT02972840|Treatment naive|treatment naive
4742366|NCT02972840|Lymphoma|lymphoma
4742367|NCT02972840|non-Hodgkins|non-hodgkins
4742368|NCT02972814|Troponin|troponin
4742369|NCT02972814|Point of care test|point of care test
4742370|NCT02972814|myocardial infarction|myocardial infarction
4742371|NCT02972801|Spermatogonial stem cells|spermatogonial stem cells
4742372|NCT02972801|Testis|testis
4742373|NCT02972801|Fertility|fertility
4742374|NCT02972801|Infertility|infertility
4742375|NCT02972801|Oncofertility|oncofertility
4742376|NCT02972762|depth of anesthesia\postoperation delirium|depth of anesthesia\postoperation delirium
4742377|NCT02972736|Radiation dose|radiation dose
4742378|NCT02972736|percutaneous coronary intervention|percutaneous coronary intervention
4742379|NCT02972736|Coronary|coronary
4742380|NCT02972736|Interventional radiology|interventional radiology
4742381|NCT02972736|Electrophysiology|electrophysiology
4742382|NCT02972723|Metformin Therapy in HCV|metformin therapy in hcv
4742383|NCT02972684|Cardiopulmonary Bypass|cardiopulmonary bypass
4742384|NCT02972684|Hemorrhage|hemorrhage
4742385|NCT02972684|blood transfusion|blood transfusion
4742386|NCT02972684|Point-of-care test|point-of-care test
4742387|NCT02972684|health economics|health economics
4742388|NCT02972671|MiStent|mistent
4742389|NCT02972658|Alzheimer's Disease|alzheimer's disease
4742390|NCT02972658|Dementia|dementia
4742391|NCT02972658|Brain Diseases|brain diseases
4742392|NCT02972658|Neurodegenerative Diseases|neurodegenerative diseases
4742393|NCT02972658|Central Nervous System Diseases|central nervous system diseases
4742394|NCT02972658|Nervous System Diseases|nervous system diseases
4742395|NCT02972658|Mental Disorders|mental disorders
4742396|NCT02972658|Delirium, Dementia, Amnestic, Cognitive Disorders|delirium, dementia, amnestic, cognitive disorders
4742397|NCT02972658|Tauopathies|tauopathies
4742399|NCT02972658|Amyloid|amyloid
4742400|NCT02972632|Drug Therapy|drug therapy
4742401|NCT02972619|Blood Pressure|blood pressure
4742402|NCT02972619|Lipids|lipids
4742403|NCT02972619|Cardiovascular|cardiovascular
4742404|NCT02972619|Health Services|health services
4742405|NCT02972619|Hypertension|hypertension
4742406|NCT02972606|HIV|hiv
4742407|NCT02972606|Peripheral Neuropathy|peripheral neuropathy
4742408|NCT02972606|Chronic Pain|chronic pain
4742409|NCT02972606|Qualitative Research|qualitative research
4742410|NCT02972567|probiotics|probiotics
4742411|NCT02972567|metabolic syndrome|metabolic syndrome
4742412|NCT02972567|non-alcoholic fatty liver disease|non-alcoholic fatty liver disease
4742413|NCT02972528|DFU|dfu
4742414|NCT02972528|Diabetic Foot Ulcer|diabetic foot ulcer
4742415|NCT02972528|Diabetes|diabetes
4742416|NCT02972528|Platelet Rich Plasma|platelet rich plasma
4742417|NCT02972515|Smoking|smoking
4742418|NCT02972515|Smoking cessation|smoking cessation
4742419|NCT02972515|Multiple behaviors|multiple behaviors
4742420|NCT02972515|mHealth|mhealth
4742421|NCT02972515|Mobile Application|mobile application
4742422|NCT02972502|Metoclopramide (Reglan)|metoclopramide (reglan)
4742423|NCT02972502|Haloperidol (Haldol)|haloperidol (haldol)
4742424|NCT02972476|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
4742425|NCT02972463|Gastrointestinal|gastrointestinal
4742426|NCT02972463|Microbiome|microbiome
4742427|NCT02972463|Inflammation|inflammation
4742428|NCT02972437|GAS in oral cavity|gas in oral cavity
4742429|NCT02972424|pelvic fracture|pelvic fracture
4742430|NCT02972424|healing|healing
4742431|NCT02972424|teriparatide|teriparatide
4742432|NCT02972398|treatment resistant depression|treatment resistant depression
4742433|NCT02972398|N-Acetyl Cysteine|n-acetyl cysteine
4742434|NCT02972398|inflammation mediators|inflammation mediators
4742435|NCT02972398|oxidative stress|oxidative stress
4742436|NCT02972398|brain imaging|brain imaging
4742437|NCT02972385|warfarin|warfarin
4742438|NCT02972385|blood clotting|blood clotting
4742439|NCT02972372|esophageal cancer|esophageal cancer
4742440|NCT02972372|chemoradiation|chemoradiation
4742441|NCT02972372|esophagectomy|esophagectomy
4742442|NCT02972359|Neridronic Acid|neridronic acid
4742443|NCT02972359|Neridronate|neridronate
4742444|NCT02972359|CRPS|crps
4742445|NCT02972359|RSD (reflex sympathetic dystrophy)|rsd (reflex sympathetic dystrophy)
4742446|NCT02972294|iron isomaltoside|iron isomaltoside
4742447|NCT02972294|tranexamic acid|tranexamic acid
4742448|NCT02972203|Mindfulness|mindfulness
4742449|NCT02972203|primary care|primary care
4742450|NCT02972203|self-control|self-control
4742451|NCT02972203|self-regulation|self-regulation
4742452|NCT02972203|adherence|adherence
4742453|NCT02972177|Lung cancer|lung cancer
4742454|NCT02972177|Transbronchial ablation|transbronchial ablation
4742455|NCT02972177|Radiofrequency ablation|radiofrequency ablation
4742456|NCT02972177|Microwave ablation|microwave ablation
4742457|NCT02972164|Childhood obesity|childhood obesity
4742458|NCT02972164|Lifestyle|lifestyle
4742459|NCT02972164|Prevention|prevention
4742460|NCT02972164|Intervention|intervention
4742461|NCT02972164|Behavioural psychology|behavioural psychology
4742462|NCT02972138|Sickle-cells Disease|sickle-cells disease
4742463|NCT02972138|bisphosphonates|bisphosphonates
4742464|NCT02972138|Vitamine D|vitamine d
4742465|NCT02972125|Lacosamide|lacosamide
4742466|NCT02972125|Bioequivalence|bioequivalence
4742467|NCT02972125|Dry Syrup|dry syrup
4742468|NCT02972073|Low back pain|low back pain
4742469|NCT02972073|Neuromuscular control|neuromuscular control
4742470|NCT02972060|Hormone Naive Prostate Cancer|hormone naive prostate cancer
4742471|NCT02972047|Reflux|reflux
4742472|NCT02972021|respiratory insufficiency|respiratory insufficiency
4742473|NCT02972021|High-flow nasal cannula|high-flow nasal cannula
4742474|NCT02972008|Aortic stenosis|aortic stenosis
4742475|NCT02972008|Transaortic valve replacement|transaortic valve replacement
4742476|NCT02972008|stroke|stroke
4742477|NCT02972008|Epigenetic|epigenetic
4742478|NCT02971969|gene therapy|gene therapy
4742479|NCT02971969|Hemophilia B|hemophilia b
4742480|NCT02971956|Esophageal Cancer|esophageal cancer
4742481|NCT02971917|Chest radiography|chest radiography
4742482|NCT02971917|Image improvements|image improvements
4742483|NCT02971917|Image Reconstruction|image reconstruction
4742484|NCT02971917|Preprocessing|preprocessing
4742485|NCT02971917|MTF|mtf
4742486|NCT02971904|newborn|newborn
4742487|NCT02971904|prematurity|prematurity
4742488|NCT02971904|preterm|preterm
4742489|NCT02971904|human milk|human milk
4742490|NCT02971904|human milk analyzer|human milk analyzer
4742491|NCT02971904|neonatology|neonatology
4742492|NCT02971904|neonatal intensive care unit|neonatal intensive care unit
4742493|NCT02971904|low birth weight|low birth weight
4743577|NCT02964897|Homeless|homeless
4742494|NCT02971865|Cognitive Behavior Therapy|cognitive behavior therapy
4742495|NCT02971865|Chiropractic|chiropractic
4742496|NCT02971865|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
4742497|NCT02971865|Primary care shared visit|primary care shared visit
4742498|NCT02971852|Hypnosis|hypnosis
4742499|NCT02971852|Anesthesia|anesthesia
4742500|NCT02971852|Suggestion|suggestion
4742501|NCT02971852|Thermography|thermography
4742502|NCT02971826|Stroke|stroke
4742503|NCT02971826|thrombectomy|thrombectomy
4742504|NCT02971826|REVIVETM SE|revivetm se
4742505|NCT02971826|MRI|mri
4742506|NCT02971826|Computed Tomography|computed tomography
4742507|NCT02971813|cardiac rehabilitation|cardiac rehabilitation
4742508|NCT02971813|social media|social media
4742509|NCT02971813|adherence|adherence
4742510|NCT02971813|motivation|motivation
4742511|NCT02971800|sodium fluorescein|sodium fluorescein
4742512|NCT02971800|ureteral efflux|ureteral efflux
4742513|NCT02971800|laparoscopic hysterectomy|laparoscopic hysterectomy
4742514|NCT02971774|stroke|stroke
4742515|NCT02971774|botulinum toxin injection|botulinum toxin injection
4742516|NCT02971774|daily life|daily life
4742517|NCT02971748|hormone receptor-positive localized inflammatory breast cancer|hormone receptor-positive localized inflammatory breast cancer
4742518|NCT02971748|Hormonal therapy|hormonal therapy
4742519|NCT02971748|IBC|ibc
4742520|NCT02971748|standard adjuvant hormonal therapy|standard adjuvant hormonal therapy
4742521|NCT02971748|maintenance therapy|maintenance therapy
4742522|NCT02971748|immune related biomarkers|immune related biomarkers
4742523|NCT02971748|PD-L1 expression|pd-l1 expression
4742524|NCT02971748|HR positive|hr positive
4742525|NCT02971748|HR-positive localized IBC|hr-positive localized ibc
4742526|NCT02971735|cognitive style|cognitive style
4742527|NCT02971735|e-learning|e-learning
4742528|NCT02971735|mobile technology|mobile technology
4742529|NCT02971735|randomized controlled trial|randomized controlled trial
4742530|NCT02971735|otolaryngology-head and neck surgery|otolaryngology-head and neck surgery
4742531|NCT02971722|GLP-1 receptor agonist|glp-1 receptor agonist
4742532|NCT02971657|Staphylococcus aureus phenotypic characterization|staphylococcus aureus phenotypic characterization
4742533|NCT02971657|Antibiotic resistance|antibiotic resistance
4742534|NCT02971657|Orthopedic device related infections|orthopedic device related infections
4742535|NCT02971657|Phenotypic characterization|phenotypic characterization
4742536|NCT02971631|Dumping syndrome|dumping syndrome
4742537|NCT02971631|Gastrectomy|gastrectomy
4742538|NCT02971631|GLP-1|glp-1
4742539|NCT02971631|Insulin|insulin
4742540|NCT02971618|dapagliflozin,|dapagliflozin,
4742541|NCT02971618|Russia,|russia,
4742542|NCT02971618|retrospective study,|retrospective study,
4742543|NCT02971618|diabetes mellitus type 2|diabetes mellitus type 2
4742544|NCT02971579|ERCP|ercp
4742545|NCT02971579|biliary diseases|biliary diseases
4742546|NCT02971579|Pancreatic diseases|pancreatic diseases
4742547|NCT02971579|outcome|outcome
4742548|NCT02971579|Quality|quality
4742549|NCT02971579|Training|training
4742550|NCT02971566|feeding intolerance|feeding intolerance
4742551|NCT02971566|preterm infants|preterm infants
4742552|NCT02971566|near infrared spectroscopy|near infrared spectroscopy
4742553|NCT02971566|abnormal antenatal Doppler|abnormal antenatal doppler
4742554|NCT02971540|Surgical Pleth Index (SPI)|surgical pleth index (spi)
4742555|NCT02971540|General Anaesthesia (GA),|general anaesthesia (ga),
4742556|NCT02971540|Numerical Rating Scale (NRS)|numerical rating scale (nrs)
4742557|NCT02971540|Adequacy of Anaesthesia (AoA|adequacy of anaesthesia (aoa
4742558|NCT02971540|Spectral Entropy (SE)|spectral entropy (se)
4742559|NCT02971540|Local Anesthetic (LA)|local anesthetic (la)
4742560|NCT02971488|Hepatitis C|hepatitis c
4742561|NCT02971488|PWID|pwid
4742562|NCT02971488|Linkage-to-care|linkage-to-care
4742563|NCT02971475|Extracorporeal Shock Wave lithotripsy(ESWL)|extracorporeal shock wave lithotripsy(eswl)
4742564|NCT02971475|Endoscopic Retrograde Cholangiopancreatography(ERCP)|endoscopic retrograde cholangiopancreatography(ercp)
4742565|NCT02971475|chronic pancreatitis|chronic pancreatitis
4742566|NCT02971475|pain relief|pain relief
4742567|NCT02971462|stroke|stroke
4742568|NCT02971462|Vertebrobasilar atherosclerosis|vertebrobasilar atherosclerosis
4742569|NCT02971462|remote ischemic conditioning|remote ischemic conditioning
4742570|NCT02971449|Village Healthcare Team|village healthcare team
4742571|NCT02971449|mHealth|mhealth
4742572|NCT02971449|Telemedicine|telemedicine
4742573|NCT02971423|infection|infection
4742574|NCT02971423|gram-negative bacterium|gram-negative bacterium
4742575|NCT02971345|Hepatocellular carcinoma|hepatocellular carcinoma
4742576|NCT02971345|main portal vein tumor thrombus|main portal vein tumor thrombus
4742577|NCT02971345|endovascular brachytherapy|endovascular brachytherapy
4742578|NCT02971345|stent|stent
4742579|NCT02971345|chemoembolization|chemoembolization
4742580|NCT02971306|alcoholic hepatitis|alcoholic hepatitis
4742581|NCT02971306|alcoholic liver disease|alcoholic liver disease
4742582|NCT02971306|jaundice|jaundice
4742583|NCT02971306|ascites|ascites
4742584|NCT02971306|regeneration|regeneration
4742585|NCT02971293|AZD8871|azd8871
4742586|NCT02971293|long-acting muscarinic antagonist (LAMA)|long-acting muscarinic antagonist (lama)
4742587|NCT02971293|long-acting β2-agonist (LABA)|long-acting β2-agonist (laba)
4744086|NCT02961803|2MWT|2mwt
4742588|NCT02971293|inhaled long-acting bronchodilator|inhaled long-acting bronchodilator
4742589|NCT02971293|pharmacokinetics|pharmacokinetics
4742590|NCT02971293|safety|safety
4742591|NCT02971293|tolerability|tolerability
4742592|NCT02971293|efficacy|efficacy
4742593|NCT02971293|Phase IIa|phase iia
4742594|NCT02971293|Muscarinic receptor antagonist β2 adrenoceptor agonist (MABA)|muscarinic receptor antagonist β2 adrenoceptor agonist (maba)
4742595|NCT02971267|heart failure|heart failure
4742596|NCT02971267|cardiomyopathy|cardiomyopathy
4742597|NCT02971267|myocarditis|myocarditis
4742598|NCT02971254|cognitive functions|cognitive functions
4742599|NCT02971254|anaesthesia recovery|anaesthesia recovery
4742600|NCT02971254|sevoflurane|sevoflurane
4742601|NCT02971254|desflurane|desflurane
4742602|NCT02971241|Integeneration|integeneration
4742603|NCT02971241|Mobile technology|mobile technology
4742604|NCT02971241|Chronic disease management|chronic disease management
4742605|NCT02971241|Diabetes self-management|diabetes self-management
4742606|NCT02971228|glucagon|glucagon
4742607|NCT02971228|T1DM|t1dm
4742608|NCT02971228|Bionic Pancreas|bionic pancreas
4742609|NCT02971228|diabetes|diabetes
4742610|NCT02971228|iLet|ilet
4742611|NCT02971228|iPhone|iphone
4742612|NCT02971228|Beta Bionics|beta bionics
4742613|NCT02971228|Anti-hypoglycemia|anti-hypoglycemia
4742614|NCT02971228|Glucagon Analog|glucagon analog
4742615|NCT02971202|o-glcnacylation|o-glcnacylation
4742616|NCT02971202|hexosamine|hexosamine
4742617|NCT02971163|Syncope|syncope
4742618|NCT02971163|Shared Decision-Making|shared decision-making
4742619|NCT02971163|Emergency Medicine|emergency medicine
4742620|NCT02971163|Decision Aid|decision aid
4742621|NCT02971137|Smoking|smoking
4742622|NCT02971137|Cigarette Smoking|cigarette smoking
4742623|NCT02971137|Veterans|veterans
4742624|NCT02971137|Tobacco Use|tobacco use
4742625|NCT02971137|Pain|pain
4742626|NCT02971124|Cognitive Performance|cognitive performance
4742627|NCT02971124|Meaningful Play|meaningful play
4742628|NCT02971124|Screening test|screening test
4742629|NCT02971124|Dementia|dementia
4742630|NCT02971085|low-risk prostate cancer|low-risk prostate cancer
4742631|NCT02971085|active surveillance|active surveillance
4742632|NCT02971085|pathologic reclassification|pathologic reclassification
4742633|NCT02971072|address|address
4742634|NCT02971072|atrophic|atrophic
4742635|NCT02971072|base|base
4742636|NCT02971072|clinical|clinical
4742637|NCT02971072|cost|cost
4742638|NCT02971072|data|data
4742639|NCT02971072|disability|disability
4742640|NCT02971072|effectiveness|effectiveness
4742641|NCT02971072|attention|attention
4742642|NCT02971072|biofeedback|biofeedback
4742643|NCT02971072|electrical stimulation|electrical stimulation
4742644|NCT02971072|electromyography|electromyography
4742645|NCT02971072|exercise|exercise
4742646|NCT02971072|exertion|exertion
4742647|NCT02971072|health care service utilization|health care service utilization
4742648|NCT02971072|improved|improved
4742649|NCT02971072|injection of therapeutic agent|injection of therapeutic agent
4742650|NCT02971072|innovation|innovation
4742651|NCT02971072|intervention|intervention
4742652|NCT02971072|knowledge|knowledge
4742653|NCT02971072|local anesthetics|local anesthetics
4742654|NCT02971072|measures|measures
4742655|NCT02971072|modeling|modeling
4742657|NCT02971072|motor control|motor control
4742658|NCT02971072|muscle|muscle
4742659|NCT02971072|neuroadaptation|neuroadaptation
4742660|NCT02971072|neurophysiology|neurophysiology
4742661|NCT02971072|novel|novel
4742662|NCT02971072|outcome|outcome
4742663|NCT02971072|outcome measure|outcome measure
4742664|NCT02971072|pain inhibition|pain inhibition
4742665|NCT02971072|patients|patients
4742666|NCT02971072|pattern|pattern
4742667|NCT02971072|programs|programs
4742668|NCT02971072|public health relevance|public health relevance
4742669|NCT02971072|rehabilitation strategy|rehabilitation strategy
4742670|NCT02971072|relating to nervous system|relating to nervous system
4742671|NCT02971072|reporting|reporting
4742672|NCT02971072|research|research
4742673|NCT02971072|rotator cuff|rotator cuff
4742674|NCT02971072|shoulder|shoulder
4742675|NCT02971072|staging|staging
4742676|NCT02971072|strength training|strength training
4742677|NCT02971072|success|success
4742678|NCT02971072|systematic review|systematic review
4742679|NCT02971072|techniques|techniques
4742680|NCT02971072|testing|testing
4742681|NCT02971072|time|time
4742682|NCT02971072|training|training
4742683|NCT02971072|treatment strategy|treatment strategy
4742684|NCT02971072|United States|united states
4742685|NCT02971072|work|work
4742686|NCT02971059|Elderly|elderly
4742687|NCT02971059|Phenylalanine|phenylalanine
4742688|NCT02971059|Healthy|healthy
4742689|NCT02971046|healthy children|healthy children
4742690|NCT02971046|protein|protein
4742691|NCT02971046|glutathione|glutathione
4742692|NCT02971046|protein requirement|protein requirement
4742693|NCT02971033|hepatitis C virus|hepatitis c virus
4742694|NCT02971033|antiviral treatment|antiviral treatment
4742695|NCT02971033|viral entry inhibitor|viral entry inhibitor
4742696|NCT02971033|mathematical modeling|mathematical modeling
4742697|NCT02970994|Linear growth and neurodevelopment outcome|linear growth and neurodevelopment outcome
4742698|NCT02970994|< 34 weeks|< 34 weeks
4742699|NCT02970981|Monoclonal antibody|monoclonal antibody
4742700|NCT02970981|Programmed Death-1 (PD-1)|programmed death-1 (pd-1)
4742701|NCT02970981|Programmed Death-Ligand 1 (PD-L1)|programmed death-ligand 1 (pd-l1)
4742702|NCT02970981|Cytotoxic T lymphocyte-associated antigen 4 (CTLA-4)|cytotoxic t lymphocyte-associated antigen 4 (ctla-4)
4742703|NCT02970981|Antigen|antigen
4742704|NCT02970929|Schizophrenia|schizophrenia
4742705|NCT02970916|metastatic colorectal cancer|metastatic colorectal cancer
4742706|NCT02970916|FOLFIRI|folfiri
4742707|NCT02970916|aflibercept|aflibercept
4742708|NCT02970916|oxaliplatin|oxaliplatin
4742709|NCT02970916|ACE polymorphisms|ace polymorphisms
4742710|NCT02970890|Total Hip Arthroplasty (THA)|total hip arthroplasty (tha)
4742711|NCT02970890|Phototherapy|phototherapy
4742712|NCT02970890|Low-level laser therapy|low-level laser therapy
4742713|NCT02970890|Light-emitting diodes|light-emitting diodes
4742714|NCT02970877|Fecal microbiota transplant|fecal microbiota transplant
4742715|NCT02970877|Intestinal microbiome|intestinal microbiome
4742716|NCT02970877|Oral microbiome|oral microbiome
4742717|NCT02970877|Mucosa associated microbiome|mucosa associated microbiome
4742718|NCT02970877|Appetite|appetite
4742719|NCT02970877|Metabolome|metabolome
4742720|NCT02970877|Depression|depression
4742721|NCT02970877|Anxiety|anxiety
4742722|NCT02970864|Nerve regeneration|nerve regeneration
4742723|NCT02970864|Peripheral nerve injury|peripheral nerve injury
4742724|NCT02970864|Nerve conduits|nerve conduits
4742725|NCT02970864|Sensory nerve transection|sensory nerve transection
4742726|NCT02970851|Endothelin receptor antagonist (ERA)|endothelin receptor antagonist (era)
4742727|NCT02970851|pulmonary artery hypertension (PAH),|pulmonary artery hypertension (pah),
4742728|NCT02970851|18F-2-fluoro-2-deoxy-D-glucose (18F-FDG) Positron Emission Tomography/Computed Tomography (PET/CT)|18f-2-fluoro-2-deoxy-d-glucose (18f-fdg) positron emission tomography/computed tomography (pet/ct)
4742729|NCT02970851|Rubidium-82 (82Rb) PET/CT|rubidium-82 (82rb) pet/ct
4742730|NCT02970838|Formula diet|formula diet
4742731|NCT02970825|exercise medicine|exercise medicine
4742732|NCT02970825|youth|youth
4742733|NCT02970825|adolescents|adolescents
4742734|NCT02970825|students|students
4742735|NCT02970721|bipolar disorder|bipolar disorder
4742736|NCT02970721|adverse outcomes|adverse outcomes
4742737|NCT02970721|readmission|readmission
4742738|NCT02970721|polytherapy|polytherapy
4742739|NCT02970695|insomnia|insomnia
4742740|NCT02970695|older people|older people
4742741|NCT02970695|auriculotherapy|auriculotherapy
4742742|NCT02970669|Heart failure with reduced left ventricular ejection fraction (LVEF)|heart failure with reduced left ventricular ejection fraction (lvef)
4742743|NCT02970669|Cardiac dysfunction|cardiac dysfunction
4742744|NCT02970669|Heart muscle dysfunction|heart muscle dysfunction
4742745|NCT02970669|Left ventricular (LV) dilation|left ventricular (lv) dilation
4742746|NCT02970669|Left ventricular hypertrophy|left ventricular hypertrophy
4742747|NCT02970669|HF|hf
4742748|NCT02970669|AHF|ahf
4742749|NCT02970669|CHF|chf
4742750|NCT02970669|acute heart failure|acute heart failure
4742751|NCT02970669|chronic heart failure|chronic heart failure
4742752|NCT02970669|congestive heart failure|congestive heart failure
4742753|NCT02970669|congestive cardiac failure|congestive cardiac failure
4742754|NCT02970669|Heart failure|heart failure
4742755|NCT02970669|HReEF|hreef
4742756|NCT02970669|Physical Activity|physical activity
4742757|NCT02970669|Actigraphy|actigraphy
4742758|NCT02970669|Home sleep test|home sleep test
4742759|NCT02970669|wake|wake
4742760|NCT02970643|Olanzapine|olanzapine
4742761|NCT02970643|Chemotherapy-Induced Nausea and Vomiting|chemotherapy-induced nausea and vomiting
4742762|NCT02970643|Moderate risk|moderate risk
4742763|NCT02970630|prophylaxis|prophylaxis
4742764|NCT02970591|FODMAPS|fodmaps
4742765|NCT02970591|carbohydrates|carbohydrates
4742766|NCT02970591|metabolomics|metabolomics
4742767|NCT02970591|microbiota|microbiota
4742768|NCT02970565|Family Nurture Intervention|family nurture intervention
4742769|NCT02970565|Martha G. Welch MD|martha g. welch md
4742770|NCT02970565|Randomized Control Trial|randomized control trial
4742771|NCT02970565|Pre-school Intervention|pre-school intervention
4742772|NCT02970565|Preschool Intervention|preschool intervention
4742773|NCT02970565|Multiple Family Group Intervention|multiple family group intervention
4742774|NCT02970565|Emotional Connection|emotional connection
4742775|NCT02970565|Co-regulation|co-regulation
4742776|NCT02970552|PreTerm Birth|preterm birth
4742777|NCT02970552|HIV|hiv
4742778|NCT02970552|Vaginal Progesterone|vaginal progesterone
4742779|NCT02970552|ART|art
4742780|NCT02970552|Adherence|adherence
4742781|NCT02970552|Feasibility|feasibility
4742782|NCT02970526|Colorectal cancer survivors|colorectal cancer survivors
4742783|NCT02970513|Escherichia coli|escherichia coli
4742784|NCT02970513|Microbiota|microbiota
4742785|NCT02970513|Colorectal cancer|colorectal cancer
4742786|NCT02970513|Psychiatric disorders|psychiatric disorders
4742787|NCT02970513|Personality traits|personality traits
4742788|NCT02970500|Cognitive impairment|cognitive impairment
4742789|NCT02970500|Methylphenidate|methylphenidate
4742790|NCT02970500|Cancer-related cognitive impairment|cancer-related cognitive impairment
4742791|NCT02970500|Mixed method|mixed method
4742792|NCT02970500|Phase II study|phase ii study
4742793|NCT02970500|Breast cancer|breast cancer
4742794|NCT02970487|cataract|cataract
4742795|NCT02970461|personal health record|personal health record
4742796|NCT02970461|gamification|gamification
4742797|NCT02970461|chronic patient care|chronic patient care
4742798|NCT02970448|LITT|litt
4742799|NCT02970448|Brain Tumor|brain tumor
4742800|NCT02970448|Temozolomide|temozolomide
4742801|NCT02970435|surgery|surgery
4742802|NCT02970435|video discharge instructions|video discharge instructions
4742803|NCT02970422|Survey|survey
4742804|NCT02970422|Priorities|priorities
4742805|NCT02970422|Activities|activities
4742806|NCT02970422|Participation|participation
4742807|NCT02970357|Evaluation|evaluation
4742808|NCT02970357|Therapeutic education|therapeutic education
4742809|NCT02970357|Type 1 Diabetes|type 1 diabetes
4742810|NCT02970357|Children|children
4742811|NCT02970344|Coping Skills Training|coping skills training
4742812|NCT02970344|Diabetes Education|diabetes education
4742813|NCT02970318|CLL|cll
4742814|NCT02970318|BTK|btk
4742815|NCT02970318|Bruton Tyrosine Kinase|bruton tyrosine kinase
4742816|NCT02970318|acalabrutinib|acalabrutinib
4742817|NCT02970318|ACP-196|acp-196
4742818|NCT02970279|Behavioural activation|behavioural activation
4742819|NCT02970279|Psychotherapy, group|psychotherapy, group
4742820|NCT02970279|Depression|depression
4742821|NCT02970279|Depressive disorder|depressive disorder
4742822|NCT02970266|Leber Congenital Amaurosis|leber congenital amaurosis
4742823|NCT02970266|Genetic Decryption|genetic decryption
4742824|NCT02970266|The genotype-phenotype correlations|the genotype-phenotype correlations
4742825|NCT02970266|Ethnicity families|ethnicity families
4742826|NCT02970240|cardiopulmonary exercise testing|cardiopulmonary exercise testing
4742827|NCT02970240|inflammation|inflammation
4742828|NCT02970240|oxidative status|oxidative status
4742829|NCT02970227|heart failure|heart failure
4742830|NCT02970227|cardiomyopathies|cardiomyopathies
4742831|NCT02970227|myocarditis|myocarditis
4742832|NCT02970214|heart failure|heart failure
4742833|NCT02970214|heart disease|heart disease
4742834|NCT02970214|cardiovascular disease|cardiovascular disease
4742835|NCT02970214|metabolic risk|metabolic risk
4742836|NCT02970214|comorbidities|comorbidities
4742837|NCT02970201|eHealth|ehealth
4742838|NCT02970201|mHealth|mhealth
4742839|NCT02970201|Hemodialysis|hemodialysis
4742840|NCT02970201|Adherence|adherence
4742841|NCT02970201|Electronic intervention|electronic intervention
4742842|NCT02970201|ESRD|esrd
4742843|NCT02970201|Nephrology|nephrology
4742844|NCT02970188|time restricted feeding|time restricted feeding
4742845|NCT02970188|endothelial function|endothelial function
4742846|NCT02970188|arterial stiffness|arterial stiffness
4742847|NCT02970188|intermittent fasting|intermittent fasting
4742848|NCT02970175|Terlipressin|terlipressin
4742849|NCT02970162|LEMS|lems
4742850|NCT02970136|Increased Screening Uptake|increased screening uptake
4742851|NCT02970136|Community Health Worker|community health worker
4742852|NCT02970136|Medically Underserved|medically underserved
4742853|NCT02970097|infraclavicular brachial plexus block|infraclavicular brachial plexus block
4742854|NCT02970097|wrist arthroscopy|wrist arthroscopy
4742855|NCT02970097|quality of recovery score|quality of recovery score
4742856|NCT02970097|pain score|pain score
4742857|NCT02970097|modified sleep quality assessment|modified sleep quality assessment
4742858|NCT02970071|Spatio-Temporal Image Correlation|spatio-temporal image correlation
4742859|NCT02970071|Complicated congenital heart disease|complicated congenital heart disease
4742860|NCT02970071|Echocardiography|echocardiography
4742861|NCT02970006|spinal cord stimulation|spinal cord stimulation
4742862|NCT02970006|virtual reality|virtual reality
4742863|NCT02970006|full body illusion|full body illusion
4742864|NCT02969980|MDS|mds
4742865|NCT02969980|AML progressed from MDS|aml progressed from mds
4742866|NCT02969980|CMML|cmml
4742867|NCT02969967|rehabilitation|rehabilitation
4742868|NCT02969967|upper extremity|upper extremity
4742869|NCT02969967|orthosis|orthosis
4742870|NCT02969967|SaeboFlex|saeboflex
4742871|NCT02969941|Parkinson Disease|parkinson disease
4742872|NCT02969941|Functional Magnetic Resonance Imaging|functional magnetic resonance imaging
4742873|NCT02969941|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
4742874|NCT02969928|Full-mouth ultrasonic debridement|full-mouth ultrasonic debridement
4742875|NCT02969928|Clarithromycin|clarithromycin
4742876|NCT02969928|Amoxicillin|amoxicillin
4742877|NCT02969928|Metronidazole|metronidazole
4742878|NCT02969915|people who inject drugs|people who inject drugs
4742879|NCT02969915|men who have sex with men|men who have sex with men
4742880|NCT02969915|HIV|hiv
4742881|NCT02969915|India|india
4742882|NCT02969902|Procedural pain|procedural pain
4742883|NCT02969902|Phlebotomy|phlebotomy
4742884|NCT02969902|Distraction|distraction
4742885|NCT02969902|Hand-held computer|hand-held computer
4742886|NCT02969902|Children|children
4742887|NCT02969889|Airtraq|airtraq
4742888|NCT02969889|Intubating laryngeal mask airway|intubating laryngeal mask airway
4742889|NCT02969889|BMI>35|bmi>35
4742890|NCT02969863|bionic pancreas|bionic pancreas
4744477|NCT02959710|AC-1202|ac-1202
4742891|NCT02969850|vitamin D supplementation|vitamin d supplementation
4742892|NCT02969850|calcium supplementation|calcium supplementation
4742893|NCT02969837|Multiple Myeloma|multiple myeloma
4742894|NCT02969837|Elotuzumab|elotuzumab
4742895|NCT02969837|Carfilzomib (Kyprolis)|carfilzomib (kyprolis)
4742896|NCT02969837|Lenalidomide (Revlimid)|lenalidomide (revlimid)
4742897|NCT02969837|Dexamethasone (E-KRd)|dexamethasone (e-krd)
4742898|NCT02969824|Sport Injury|sport injury
4742899|NCT02969824|Concussion|concussion
4742900|NCT02969824|Active Recovery|active recovery
4742901|NCT02969785|Postural control|postural control
4742902|NCT02969785|Physiotherapy|physiotherapy
4742903|NCT02969785|Sports injuries|sports injuries
4742904|NCT02969785|Low back pain|low back pain
4742905|NCT02969785|training|training
4742906|NCT02969759|Bioenergetics|bioenergetics
4742907|NCT02969759|Protein Metabolism|protein metabolism
4742908|NCT02969759|Sporadic Amyotrophic Lateral Sclerosis|sporadic amyotrophic lateral sclerosis
4742909|NCT02969746|activated charcoal, direct oral anticoagulant|activated charcoal, direct oral anticoagulant
4742910|NCT02969733|postoperative analgesia|postoperative analgesia
4742911|NCT02969733|PainMatcher|painmatcher
4742912|NCT02969707|repetitive Transcranial Magnetic Stimulation|repetitive transcranial magnetic stimulation
4742913|NCT02969707|functional MRI|functional mri
4742914|NCT02969707|Fibromyalgia|fibromyalgia
4742915|NCT02969707|Hypnosis|hypnosis
4742916|NCT02969707|Pain Assessment|pain assessment
4742917|NCT02969694|addiction|addiction
4742918|NCT02969694|hypersexuality|hypersexuality
4742919|NCT02969694|psychostimulants|psychostimulants
4742920|NCT02969668|opioid substitution treatment|opioid substitution treatment
4742921|NCT02969668|interferon-free direct acting antivirals|interferon-free direct acting antivirals
4742922|NCT02969668|hepatitis c therapy|hepatitis c therapy
4742923|NCT02969655|Safety|safety
4742924|NCT02969655|Efficacy|efficacy
4742925|NCT02969655|Daprodustat|daprodustat
4742926|NCT02969655|Chronic kidney disease|chronic kidney disease
4742927|NCT02969616|lumbar, fusion, DDD, Trinity Elite|lumbar, fusion, ddd, trinity elite
4742928|NCT02969603|PET/MRI|pet/mri
4742929|NCT02969603|muscular activity|muscular activity
4742930|NCT02969603|11C-acetate|11c-acetate
4742931|NCT02969590|Contraception|contraception
4742932|NCT02969590|Mucus|mucus
4742933|NCT02969590|Cervix|cervix
4742934|NCT02969590|progestin|progestin
4742935|NCT02969590|hormones|hormones
4742936|NCT02969577|Androgen deprivation therapy|androgen deprivation therapy
4742937|NCT02969577|ADT|adt
4742938|NCT02969564|prostate cancer|prostate cancer
4742939|NCT02969564|bone metastases|bone metastases
4742940|NCT02969564|PET/MRI|pet/mri
4742941|NCT02969525|Psoriatic Arthritis|psoriatic arthritis
4742942|NCT02969525|PsA|psa
4742943|NCT02969525|Bimekizumab|bimekizumab
4742944|NCT02969512|Patient education|patient education
4742945|NCT02969512|Advanced hip osteoarthritis|advanced hip osteoarthritis
4742946|NCT02969512|Online education|online education
4742947|NCT02969512|Computer-assisted instruction|computer-assisted instruction
4742948|NCT02969512|e-learning|e-learning
4742949|NCT02969512|Older adult|older adult
4742950|NCT02969499|Electroconvulsive Therapy|electroconvulsive therapy
4742951|NCT02969499|Dementia|dementia
4742952|NCT02969473|esophageal squamous cell carcinoma|esophageal squamous cell carcinoma
4742953|NCT02969473|concurrent chemoradiotherapy|concurrent chemoradiotherapy
4742954|NCT02969473|docetaxel|docetaxel
4742955|NCT02969473|cisplatin|cisplatin
4742956|NCT02969473|5-fluorouracil|5-fluorouracil
4742957|NCT02969447|Retained Placenta|retained placenta
4742958|NCT02969447|Second trimester medical termination|second trimester medical termination
4742959|NCT02969447|Third stage labor|third stage labor
4742960|NCT02969447|Oxytocin|oxytocin
4742961|NCT02969395|3T|3t
4742962|NCT02969395|Magnetic Resonance Imaging (MRI)|magnetic resonance imaging (mri)
4742963|NCT02969395|Implantable Cardioverter Defibrillator (ICD)|implantable cardioverter defibrillator (icd)
4742964|NCT02969395|Implantable Pulse Generator (IPG)|implantable pulse generator (ipg)
4742965|NCT02969395|Cardiac Resynchronization Therapy (CRT)|cardiac resynchronization therapy (crt)
4742966|NCT02969395|Cardiac Implantable Electronic Device (CIED)|cardiac implantable electronic device (cied)
4742967|NCT02969382|Schizophrenia|schizophrenia
4742968|NCT02969369|Parkinson's Disease Psychosis|parkinson's disease psychosis
4742969|NCT02969304|Tecfidera|tecfidera
4742970|NCT02969304|Off-label|off-label
4742971|NCT02969304|Utilization|utilization
4742972|NCT02969278|vulvar cancer|vulvar cancer
4742973|NCT02969278|sentinel node biopsy|sentinel node biopsy
4742974|NCT02969278|inguino-femoral lymphadenectomy|inguino-femoral lymphadenectomy
4742975|NCT02969278|18F FDG- PET/TC|18f fdg- pet/tc
4742976|NCT02969278|guidelines|guidelines
4742977|NCT02969278|preoperative imaging|preoperative imaging
4742978|NCT02969265|Drug therapy|drug therapy
4742979|NCT02969226|mechanical ventilation|mechanical ventilation
4742980|NCT02969226|weaning|weaning
4742981|NCT02969226|critically ill|critically ill
4742982|NCT02969226|spontaneous breathing trial|spontaneous breathing trial
4742983|NCT02969226|screening|screening
4742984|NCT02969226|invasive ventilation|invasive ventilation
4742985|NCT02969226|SBT technique|sbt technique
4742986|NCT02969213|Electronic management of epilepsy|electronic management of epilepsy
4742987|NCT02969213|biological etiology|biological etiology
4742988|NCT02969213|Chinese children|chinese children
4742989|NCT02969200|Fabry Disease|fabry disease
4742990|NCT02969200|Nephropathy|nephropathy
4742991|NCT02969200|Measured GFR|measured gfr
4742992|NCT02969200|Enzyme replacement therapy|enzyme replacement therapy
4742993|NCT02969161|PMTCT (Prevention of Mother-to-Child Transmission)|pmtct (prevention of mother-to-child transmission)
4742994|NCT02969161|HIV (Human Immunodeficiency Virus)|hiv (human immunodeficiency virus)
4742995|NCT02969161|Loss to follow-up (LTF)|loss to follow-up (ltf)
4742996|NCT02969161|Option B+ (B+)|option b+ (b+)
4742997|NCT02969161|ART (antiretroviral therapy)|art (antiretroviral therapy)
4742998|NCT02969148|Laparoscopic|laparoscopic
4742999|NCT02969148|Bursectomy|bursectomy
4743000|NCT02969148|D2 lymphadenectomy|d2 lymphadenectomy
4743001|NCT02969148|Gastric Cancer|gastric cancer
4743002|NCT02969122|gastric cancer|gastric cancer
4743003|NCT02969122|peritoneal cytology|peritoneal cytology
4743004|NCT02969083|UTUC|utuc
4743005|NCT02969083|Upper Tract Urothelial Carcinoma|upper tract urothelial carcinoma
4743006|NCT02969083|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
4743007|NCT02969083|Adjuvant chemotherapy|adjuvant chemotherapy
4743008|NCT02969083|Radical nephroureterectomy|radical nephroureterectomy
4743009|NCT02969057|Lipidemic Response|lipidemic response
4743010|NCT02969031|communication|communication
4743011|NCT02969018|plaque psoriasis|plaque psoriasis
4743012|NCT02969005|radiopaque localizer grid|radiopaque localizer grid
4743013|NCT02969005|methylene blue|methylene blue
4743014|NCT02969005|reduce radiation exposure|reduce radiation exposure
4743015|NCT02968979|cachexia|cachexia
4743016|NCT02968979|Non-Small Cell Lung cancer|non-small cell lung cancer
4743017|NCT02968979|anorexia|anorexia
4743018|NCT02968979|malnutrition|malnutrition
4743019|NCT02968940|Programmed cell death protein 1 (PD-1)|programmed cell death protein 1 (pd-1)
4743020|NCT02968940|Programmed death-ligand 1 (PD-L1)|programmed death-ligand 1 (pd-l1)
4743021|NCT02968940|Immunotherapy|immunotherapy
4743022|NCT02968940|Hypofractionated Radiotherapy (HFRT)|hypofractionated radiotherapy (hfrt)
4743023|NCT02968940|Isocitrate dehydrogenase (IDH)|isocitrate dehydrogenase (idh)
4743024|NCT02968940|Glioma|glioma
4743025|NCT02968914|Asthma|asthma
4743026|NCT02968914|Chronic Obstructive pulmonary Disease|chronic obstructive pulmonary disease
4743027|NCT02968914|Pharmacokinetics|pharmacokinetics
4743028|NCT02968914|Healthy volunteers|healthy volunteers
4743029|NCT02968875|endurance training|endurance training
4743030|NCT02968875|BDNF analysis|bdnf analysis
4743031|NCT02968875|cognitive function|cognitive function
4743032|NCT02968875|physiological abilities|physiological abilities
4743033|NCT02968849|HIV|hiv
4743034|NCT02968823|Postoperative Pain|postoperative pain
4743035|NCT02968823|Anesthesia|anesthesia
4743036|NCT02968823|Oral Surgery|oral surgery
4743037|NCT02968784|Prostate Cancer|prostate cancer
4743038|NCT02968784|MRgFUS|mrgfus
4743039|NCT02968784|ExAblate|exablate
4743040|NCT02968784|Focused Ultrasound|focused ultrasound
4743041|NCT02968771|Coronary artery disease|coronary artery disease
4743042|NCT02968771|Cardiac perfusion SPECT|cardiac perfusion spect
4743043|NCT02968771|Metabolomics|metabolomics
4743044|NCT02968745|Rheumatoid arthritis|rheumatoid arthritis
4743045|NCT02968745|human activity|human activity
4743046|NCT02968745|Canadian Occupational Performance Measure|canadian occupational performance measure
4743047|NCT02968706|High Flow Nasal Cannula|high flow nasal cannula
4743048|NCT02968706|Colonoscopy|colonoscopy
4743049|NCT02968706|Obesity|obesity
4743050|NCT02968654|Blood Transfusion|blood transfusion
4743051|NCT02968654|Brain Injury|brain injury
4743052|NCT02968654|Outcome|outcome
4743053|NCT02968654|Hemoglobin|hemoglobin
4743054|NCT02968615|fiber|fiber
4743055|NCT02968615|lean protein|lean protein
4743056|NCT02968615|loss weight|loss weight
4743057|NCT02968589|Tele-rehabilitation|tele-rehabilitation
4743058|NCT02968589|Function|function
4743059|NCT02968589|Quality of life|quality of life
4743060|NCT02968589|Exercise|exercise
4743061|NCT02968589|Occupational Therapy|occupational therapy
4743062|NCT02968589|Physiotherapy|physiotherapy
4743063|NCT02968589|Caregiver burden|caregiver burden
4743064|NCT02968576|healthy volunteers|healthy volunteers
4743065|NCT02968576|pharmacokinetics|pharmacokinetics
4743066|NCT02968537|Alcohol use disorders|alcohol use disorders
4743067|NCT02968537|inhibition|inhibition
4743068|NCT02968537|EEG|eeg
4743069|NCT02968537|cortisol|cortisol
4743070|NCT02968537|Training|training
4743071|NCT02968537|clinical outcome measures|clinical outcome measures
4743072|NCT02968498|Blood glucose level|blood glucose level
4743073|NCT02968498|Oral intake|oral intake
4743074|NCT02968498|Lactulose|lactulose
4743075|NCT02968498|Healthy volunteers|healthy volunteers
4743076|NCT02968485|advanced solid tumor|advanced solid tumor
4743077|NCT02968485|Protein Kinase MEK inhibitor (MEKi)|protein kinase mek inhibitor (meki)
4743078|NCT02968485|Safety|safety
4743079|NCT02968485|Pharmacokinetics|pharmacokinetics
4743080|NCT02968472|4s CAR-T19|4s car-t19
4743081|NCT02968472|B cell leukemia|b cell leukemia
4743082|NCT02968472|B-ALL|b-all
4743083|NCT02968459|Mesenchymal Stem Cells|mesenchymal stem cells
4743084|NCT02968459|Cesarean Section|cesarean section
4743085|NCT02968459|Uterine Scar|uterine scar
4743086|NCT02968446|Valchlor|valchlor
4743087|NCT02968446|Vitamin D|vitamin d
4743088|NCT02968446|Healthy Volunteer|healthy volunteer
4743089|NCT02968433|Young Male Plasma|young male plasma
4743090|NCT02968381|tobacco|tobacco
4743091|NCT02968381|smoking|smoking
4743092|NCT02968381|imagery|imagery
4743093|NCT02968342|Hypoactive sexual desire disorder|hypoactive sexual desire disorder
4743094|NCT02968212|Mycobacterium avium Complex|mycobacterium avium complex
4743095|NCT02968212|Clofazimine|clofazimine
4743096|NCT02968186|Mass Screening|mass screening
4743097|NCT02968186|Counseling|counseling
4743098|NCT02968186|Primary Health Care|primary health care
4743099|NCT02968173|Bronchopulmonary dysplasia (BPD)|bronchopulmonary dysplasia (bpd)
4743100|NCT02968173|RSV hospitalization|rsv hospitalization
4743101|NCT02968173|Palivizumab|palivizumab
4743102|NCT02968173|Immunoprophylaxis|immunoprophylaxis
4743103|NCT02968173|Chronic lung disease (CLD) of prematurity|chronic lung disease (cld) of prematurity
4743104|NCT02968147|atrial fibrillation|atrial fibrillation
4743105|NCT02968147|catheter ablation|catheter ablation
4743106|NCT02968147|general anaesthesia|general anaesthesia
4743107|NCT02968082|MVD|mvd
4743108|NCT02968082|Scopolamine|scopolamine
4743109|NCT02968082|Microvascular Decompression|microvascular decompression
4743110|NCT02968056|atrial fibrillation|atrial fibrillation
4743111|NCT02968056|radiofrequency ablation|radiofrequency ablation
4743112|NCT02968043|physiotherapeutic scoliosis specific exercise|physiotherapeutic scoliosis specific exercise
4743113|NCT02968030|Aged|aged
4743114|NCT02968030|Postural balance|postural balance
4743115|NCT02968030|Muscle strength|muscle strength
4743116|NCT02967991|EUS|eus
4743117|NCT02967991|Biopsy|biopsy
4743118|NCT02967991|Liver|liver
4743119|NCT02967991|FNA|fna
4743120|NCT02967991|FNB|fnb
4743121|NCT02967978|risk factors|risk factors
4743122|NCT02967978|Calcium isotopes|calcium isotopes
4743123|NCT02967978|calcium turnover|calcium turnover
4743124|NCT02967978|DXA|dxa
4743125|NCT02967965|clinical confounders|clinical confounders
4743126|NCT02967965|myocardial infarction size|myocardial infarction size
4743127|NCT02967965|determinants of myocardial infarct injury|determinants of myocardial infarct injury
4743128|NCT02967952|out-of-hospital cardiac arrest (OHCA)|out-of-hospital cardiac arrest (ohca)
4743129|NCT02967952|supraglottic airway (SGA)|supraglottic airway (sga)
4743130|NCT02967952|endotracheal intubation (ETI)|endotracheal intubation (eti)
4743131|NCT02967952|emergency medical system (EMS)|emergency medical system (ems)
4743132|NCT02967952|Supraglottic Airway Versus Endotracheal tube (SAVE)|supraglottic airway versus endotracheal tube (save)
4743133|NCT02967926|common bile duct stone|common bile duct stone
4743134|NCT02967926|cholangioscopy|cholangioscopy
4743135|NCT02967926|SpyGlass|spyglass
4743136|NCT02967926|non-fluoroscopic|non-fluoroscopic
4743137|NCT02967913|Cesarean delivery|cesarean delivery
4743138|NCT02967913|Obstetrical delivery|obstetrical delivery
4743139|NCT02967913|PFDI-20|pfdi-20
4743140|NCT02967913|UDI-6|udi-6
4743141|NCT02967913|Bladder flap|bladder flap
4743142|NCT02967874|Adipose -Derived Stromal Vascular Fraction Cells|adipose -derived stromal vascular fraction cells
4743143|NCT02967874|Knee Osteoarthritis|knee osteoarthritis
4743144|NCT02967874|Intra-articular Administration|intra-articular administration
4743145|NCT02967874|Liposuction|liposuction
4743146|NCT02967861|chronic periodontitis|chronic periodontitis
4743147|NCT02967861|Nuclear factor-kappa B|nuclear factor-kappa b
4743148|NCT02967861|Pranayama|pranayama
4743149|NCT02967861|Peroxisome proliferator - activated receptor gamma|peroxisome proliferator - activated receptor gamma
4743150|NCT02967861|Red complex microorganisms|red complex microorganisms
4743151|NCT02967848|Radiotherapy|radiotherapy
4743152|NCT02967848|Mebrofenin|mebrofenin
4743153|NCT02967848|Liver|liver
4743154|NCT02967848|Cancer|cancer
4743155|NCT02967848|SPECT|spect
4743156|NCT02967770|Metastatic|metastatic
4743157|NCT02967770|Pancreas|pancreas
4743158|NCT02967770|Cancer|cancer
4743159|NCT02967692|PDR001|pdr001
4743160|NCT02967692|dabrafenib|dabrafenib
4743161|NCT02967692|trametinib|trametinib
4743162|NCT02967692|melanoma|melanoma
4743163|NCT02967692|immunotherapy|immunotherapy
4743164|NCT02967692|PD 1 inhibitor|pd 1 inhibitor
4743165|NCT02967692|anti PD1|anti pd1
4743166|NCT02967692|PD-1|pd-1
4743167|NCT02967692|anti-PD-1|anti-pd-1
4743168|NCT02967692|combination treatment|combination treatment
4743169|NCT02967692|malignant skin cancer|malignant skin cancer
4743170|NCT02967692|skin cancer|skin cancer
4743171|NCT02967692|BRAF V600|braf v600
4743172|NCT02967692|unresectable BRAF V600 mutated melanoma|unresectable braf v600 mutated melanoma
4743173|NCT02967692|metastatic BRAF V600 mutated melanoma|metastatic braf v600 mutated melanoma
4743174|NCT02967679|Neuropathy|neuropathy
4743175|NCT02967679|Demyelinating polyradiculoneuropathy|demyelinating polyradiculoneuropathy
4743176|NCT02967640|Ketamine|ketamine
4743177|NCT02967640|Analgesics|analgesics
4743178|NCT02967640|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists
4743179|NCT02967640|Receptors, Glutamate|receptors, glutamate
4743180|NCT02967640|Shoulder|shoulder
4743181|NCT02967601|shivering, cesarean section, anxiety, STAI|shivering, cesarean section, anxiety, stai
4744478|NCT02959710|AC-1204|ac-1204
4743182|NCT02967588|Medication adherence|medication adherence
4743183|NCT02967588|Behavioural intervention|behavioural intervention
4743184|NCT02967588|Acute coronary syndrome|acute coronary syndrome
4743185|NCT02967588|Medication beliefs|medication beliefs
4743186|NCT02967588|Implementation intentions|implementation intentions
4743187|NCT02967575|cervical total disc replacement (cTDR)|cervical total disc replacement (ctdr)
4743188|NCT02967536|cognitive function|cognitive function
4743189|NCT02967536|microglia|microglia
4743190|NCT02967536|neuroinflammation|neuroinflammation
4743191|NCT02967523|Hepatocellular carcinoma|hepatocellular carcinoma
4743192|NCT02967523|DEB-TACE|deb-tace
4743193|NCT02967497|Chemotherapy|chemotherapy
4743194|NCT02967497|Herbal medicine|herbal medicine
4743195|NCT02967497|Lung cancer|lung cancer
4743196|NCT02967484|Acupuncture|acupuncture
4743197|NCT02967484|Hypertension|hypertension
4743198|NCT02967484|Second prevention of Stroke|second prevention of stroke
4743199|NCT02967484|Efficacy|efficacy
4743200|NCT02967484|RCT|rct
4743201|NCT02967484|Study protocol|study protocol
4743202|NCT02967471|ARDS|ards
4743203|NCT02967458|prostate cancer|prostate cancer
4743204|NCT02967458|prostate ultrasound|prostate ultrasound
4743205|NCT02967458|subharmonic imaging|subharmonic imaging
4743206|NCT02967458|prostate biopsy|prostate biopsy
4743207|NCT02967432|Staphylococcus aureus|staphylococcus aureus
4743208|NCT02967432|Staphylococcal colonization|staphylococcal colonization
4743209|NCT02967432|Staphylococcal infection|staphylococcal infection
4743210|NCT02967432|Mupirocin|mupirocin
4743211|NCT02967432|Mupirocin-resistance|mupirocin-resistance
4743212|NCT02967419|Repeated Implantation Failure; TWEAK;Fn14;JAK/STAT3;Indoleamine 2,3-dioxygenase|repeated implantation failure; tweak;fn14;jak/stat3;indoleamine 2,3-dioxygenase
4743213|NCT02967406|Lifestyle modification|lifestyle modification
4743214|NCT02967406|Primary prevention|primary prevention
4743215|NCT02967406|Community-based intervention|community-based intervention
4743216|NCT02967406|Randomized control trial|randomized control trial
4743217|NCT02967328|Reticulated Platelets|reticulated platelets
4743218|NCT02967328|Immune Thrombocytopenia|immune thrombocytopenia
4743219|NCT02967302|knee arthritis, morphine, local injection, pain|knee arthritis, morphine, local injection, pain
4743220|NCT02967289|colon|colon
4743221|NCT02967289|cancer|cancer
4743222|NCT02967289|stage 3|stage 3
4743223|NCT02967289|high-risk|high-risk
4743224|NCT02967289|mFolfirinox|mfolfirinox
4743225|NCT02967289|mFolfox6|mfolfox6
4743226|NCT02967289|adjuvant|adjuvant
4743227|NCT02967276|Metformin|metformin
4743228|NCT02967276|Dexamethasone|dexamethasone
4743229|NCT02967276|Multiple Myeloma|multiple myeloma
4743230|NCT02967263|Acute Kidney Injury|acute kidney injury
4743231|NCT02967263|Proteinosis|proteinosis
4743232|NCT02967263|Epidemiology|epidemiology
4743233|NCT02967263|Risk factors|risk factors
4743234|NCT02967198|Fusion|fusion
4743235|NCT02967198|Ablation|ablation
4743236|NCT02967198|Percutaneous biopsy|percutaneous biopsy
4743237|NCT02967198|Shear wave elastography|shear wave elastography
4743238|NCT02967159|chronic obstructive pulmonary disease (COPD)|chronic obstructive pulmonary disease (copd)
4743239|NCT02967159|asthma|asthma
4743240|NCT02967107|adenoma|adenoma
4743241|NCT02967107|colorectal cancer|colorectal cancer
4743242|NCT02967107|polypectomy|polypectomy
4743243|NCT02967107|colonoscopy|colonoscopy
4743244|NCT02967081|Pulpitis|pulpitis
4743245|NCT02967081|Biomarker|biomarker
4743246|NCT02967081|Diagnostic|diagnostic
4743247|NCT02967081|Dentinal fluid|dentinal fluid
4743248|NCT02967068|CSS|css
4743249|NCT02967068|EGPA|egpa
4743250|NCT02967068|GCA|gca
4743251|NCT02967068|GPA|gpa
4743252|NCT02967068|MPA|mpa
4743253|NCT02967068|PAN|pan
4743254|NCT02967068|TAK|tak
4743255|NCT02967068|HSP|hsp
4743256|NCT02966951|osteoarthrosis|osteoarthrosis
4743257|NCT02966951|knee|knee
4743258|NCT02966951|adipose tissue|adipose tissue
4743259|NCT02966951|stem cells|stem cells
4743260|NCT02966951|cell therapy|cell therapy
4743261|NCT02966925|Vulvovaginal dryness|vulvovaginal dryness
4743262|NCT02966886|Surgical Management|surgical management
4743263|NCT02966873|Post Traumatic Stress Disorder (PTSD)|post traumatic stress disorder (ptsd)
4743264|NCT02966873|Addiction|addiction
4743265|NCT02966873|Alcohol Use Disorder|alcohol use disorder
4743266|NCT02966873|Cognitive Behavioral Therapy|cognitive behavioral therapy
4743267|NCT02966873|N-acetylcysteine (NAC)|n-acetylcysteine (nac)
4743268|NCT02966847|Video assisted thoracoscopy|video assisted thoracoscopy
4743269|NCT02966847|Cone beam computed tomography|cone beam computed tomography
4743270|NCT02966834|PBC|pbc
4743271|NCT02966834|itch|itch
4743272|NCT02966834|GSK2330672|gsk2330672
4743273|NCT02966834|GLIMMER|glimmer
4743274|NCT02966834|primary biliary cholangitis|primary biliary cholangitis
4743275|NCT02966834|pruritus|pruritus
4743276|NCT02966821|Sulfatinib|sulfatinib
4743277|NCT02966821|Biliary Tract Cancer|biliary tract cancer
4743278|NCT02966821|Second-line|second-line
4743279|NCT02966795|glecaprevir|glecaprevir
4743280|NCT02966795|pibrentasvir|pibrentasvir
4743281|NCT02966795|compensated cirrhosis|compensated cirrhosis
4743282|NCT02966795|non-cirrhotic|non-cirrhotic
4743283|NCT02966795|interferon (IFN)|interferon (ifn)
4743284|NCT02966795|pegylated interferon (pegIFN)|pegylated interferon (pegifn)
4743285|NCT02966795|ribavirin (RBV)|ribavirin (rbv)
4743286|NCT02966795|sofosbuvir (SOF)|sofosbuvir (sof)
4743287|NCT02966795|Sustained Virologic Response 12 weeks post dosing (SVR12)|sustained virologic response 12 weeks post dosing (svr12)
4743288|NCT02966782|Relapsed/refractory|relapsed/refractory
4743289|NCT02966782|Venetoclax|venetoclax
4743290|NCT02966782|Azacitidine|azacitidine
4743291|NCT02966756|Relapsed chronic lymphocytic leukemia (CLL)|relapsed chronic lymphocytic leukemia (cll)
4743292|NCT02966756|Refractory chronic lymphocytic leukemia (CLL)|refractory chronic lymphocytic leukemia (cll)
4743293|NCT02966756|17p deletion|17p deletion
4743294|NCT02966756|venetoclax|venetoclax
4743295|NCT02966756|Leukemia|leukemia
4743296|NCT02966756|Lymphoproliferative Disorders|lymphoproliferative disorders
4743297|NCT02966730|follicular lymphoma|follicular lymphoma
4743298|NCT02966730|Ibrutinib|ibrutinib
4743299|NCT02966730|FLIPP|flipp
4743300|NCT02966730|16-396|16-396
4743301|NCT02966717|Rituximab|rituximab
4743302|NCT02966717|Mesenchymal stem cells|mesenchymal stem cells
4743303|NCT02966717|primary nephrotic syndrome|primary nephrotic syndrome
4743304|NCT02966717|chronic kidney disease|chronic kidney disease
4743305|NCT02966678|Glaucoma, Dychromatopsia|glaucoma, dychromatopsia
4743306|NCT02966652|Male|male
4743307|NCT02966652|Hypogonadism|hypogonadism
4743308|NCT02966652|Primary|primary
4743309|NCT02966652|Secondary|secondary
4743310|NCT02966652|Androgen deficiency|androgen deficiency
4743311|NCT02966626|Pragmatic, Sodium-Glucose Transporter 2 inhibitor, Malaysia|pragmatic, sodium-glucose transporter 2 inhibitor, malaysia
4743312|NCT02966574|Whole body MRI|whole body mri
4743313|NCT02966574|Breastcancer|breastcancer
4743314|NCT02966561|Pulmonary Rehabilitation|pulmonary rehabilitation
4743315|NCT02966561|Physical Activity|physical activity
4743316|NCT02966561|Behaviour Change|behaviour change
4743317|NCT02966561|Pedometer|pedometer
4743318|NCT02966522|Thalidoide|thalidoide
4743319|NCT02966483|Rectal cancer|rectal cancer
4743320|NCT02966483|Laparoscopic surgery|laparoscopic surgery
4743321|NCT02966483|Total mesorectal excision|total mesorectal excision
4743322|NCT02966483|Transanal|transanal
4743323|NCT02966483|Multicentre randomised clinical trial|multicentre randomised clinical trial
4743324|NCT02966470|surgical outcomes|surgical outcomes
4743325|NCT02966457|hematological infection, decolonization|hematological infection, decolonization
4743326|NCT02966418|Hypoxic preconditioning|hypoxic preconditioning
4743327|NCT02966418|Carotid artery stenosis|carotid artery stenosis
4743328|NCT02966418|Ischemic cerebrovascular disease|ischemic cerebrovascular disease
4743329|NCT02966392|Cuff pressure|cuff pressure
4743330|NCT02966392|Ventilator associated pneumonia|ventilator associated pneumonia
4743331|NCT02966392|Respiratory tract infections|respiratory tract infections
4743332|NCT02966379|Electroacoustic stimulation|electroacoustic stimulation
4743333|NCT02966353|Ruxolitinib|ruxolitinib
4743334|NCT02966353|anemia|anemia
4743335|NCT02966353|Primary Myelofibrosis|primary myelofibrosis
4743336|NCT02966353|PMF|pmf
4743337|NCT02966353|Post-Polycythemia Vera-Myelofibrosis|post-polycythemia vera-myelofibrosis
4743338|NCT02966353|PPV-MF|ppv-mf
4743339|NCT02966353|Post-Essential Thrombocythemia Myelofibrosis|post-essential thrombocythemia myelofibrosis
4743340|NCT02966353|PET-MF|pet-mf
4743341|NCT02966340|Alcoholism|alcoholism
4743342|NCT02966340|Prazosin|prazosin
4743343|NCT02966340|Startle Potentiation|startle potentiation
4743344|NCT02966340|Norepinephrine|norepinephrine
4743345|NCT02966340|Anxiety|anxiety
4743346|NCT02966340|Fear|fear
4743347|NCT02966340|Stress|stress
4743348|NCT02966314|Angioedema|angioedema
4743349|NCT02966314|Idiopathic Angioedema|idiopathic angioedema
4743350|NCT02966314|IAE|iae
4743351|NCT02966301|c GvHD|c gvhd
4743352|NCT02966301|Arsenic Trioxyde|arsenic trioxyde
4743353|NCT02966301|Hematology|hematology
4743354|NCT02966275|glucagon|glucagon
4743355|NCT02966275|continuous glucose monitorering (CGM)|continuous glucose monitorering (cgm)
4743356|NCT02966275|artificial pancreas|artificial pancreas
4743357|NCT02966275|hypoglycemia|hypoglycemia
4743358|NCT02966275|post-bariatric hypoglycemia|post-bariatric hypoglycemia
4743359|NCT02966275|bionic pancreas|bionic pancreas
4743360|NCT02966275|bariatric surgery|bariatric surgery
4743361|NCT02966249|dexmetomidine, intrathecally, intavenously,anesthesia|dexmetomidine, intrathecally, intavenously,anesthesia
4743362|NCT02966236|percutaneous nephrolithotomy|percutaneous nephrolithotomy
4743363|NCT02966171|Advanced Solid Malignancies|advanced solid malignancies
4743364|NCT02966158|Aerobic Interval Training|aerobic interval training
4743365|NCT02966158|Fitness|fitness
4743366|NCT02966158|Endothelial Function|endothelial function
4743367|NCT02966158|Cognition|cognition
4743368|NCT02966145|CBD|cbd
4743369|NCT02966145|CBS|cbs
4743370|NCT02966145|CBGD|cbgd
4743371|NCT02966145|PSP|psp
4743372|NCT02966145|nfvPPA|nfvppa
4743373|NCT02966145|oPSP|opsp
4743374|NCT02966145|vPSP|vpsp
4743375|NCT02966145|o/vPSP|o/vpsp
4743376|NCT02966145|Corticobasal Degeneration|corticobasal degeneration
4743377|NCT02966145|Corticobasal Syndrome|corticobasal syndrome
4743378|NCT02966145|Cortocal-basal Ganglionic Degeneration|cortocal-basal ganglionic degeneration
4743379|NCT02966145|Progressive Supranuclear Palsy|progressive supranuclear palsy
4743380|NCT02966145|Nonfluent Variant Primary Progressive Aphasia|nonfluent variant primary progressive aphasia
4743381|NCT02966145|Oligosymptomatic Progressive Supranuclear Palsy|oligosymptomatic progressive supranuclear palsy
4743382|NCT02966145|Variant Progressive Supranuclear Palsy|variant progressive supranuclear palsy
4743383|NCT02966145|Biomarker|biomarker
4743384|NCT02966145|Neuroimaging|neuroimaging
4743385|NCT02966145|MRI|mri
4743386|NCT02966145|PET|pet
4743387|NCT02966145|Tau|tau
4743388|NCT02966145|Oculomotor|oculomotor
4743389|NCT02966145|Retinal Imaging|retinal imaging
4743390|NCT02966132|Asian American|asian american
4743391|NCT02966132|Immigrant Health|immigrant health
4743392|NCT02966132|Digital Health Intervention|digital health intervention
4743393|NCT02966132|Federally Qualified Health Centers|federally qualified health centers
4743394|NCT02966119|stroke|stroke
4743395|NCT02966119|intracranial hemorrhage|intracranial hemorrhage
4743396|NCT02966119|intracerebral hemorrhage|intracerebral hemorrhage
4743397|NCT02966119|antithrombotic drugs|antithrombotic drugs
4743398|NCT02966119|brain microbleeds|brain microbleeds
4743399|NCT02966093|Differentiated thyroid cancer|differentiated thyroid cancer
4743400|NCT02966093|Chinese participants|chinese participants
4743401|NCT02966093|Phase 3|phase 3
4743402|NCT02966093|Lenvatinib|lenvatinib
4743403|NCT02966093|E7080|e7080
4743404|NCT02966080|extracorporeal membrane oxygenation|extracorporeal membrane oxygenation
4743405|NCT02966080|intravenous heparin|intravenous heparin
4743406|NCT02966067|Microneedles|microneedles
4743407|NCT02966067|Dental Anaesthesia|dental anaesthesia
4743408|NCT02966041|Postoperative Nausea and Vomiting|postoperative nausea and vomiting
4743409|NCT02966041|PONV|ponv
4743410|NCT02966041|CSICU|csicu
4743411|NCT02966041|post-cardiac surgery|post-cardiac surgery
4743412|NCT02966041|cardiac intensive care unit|cardiac intensive care unit
4743413|NCT02966028|CAC|cac
4743414|NCT02966028|calcium|calcium
4743415|NCT02966028|ESRD|esrd
4743416|NCT02966028|calcification|calcification
4743417|NCT02966028|cardiovascular|cardiovascular
4743418|NCT02966028|heart|heart
4743419|NCT02966028|kidney|kidney
4743420|NCT02966028|hemodialysis|hemodialysis
4743421|NCT02966028|Agatston|agatston
4743422|NCT02965989|nursery care|nursery care
4743423|NCT02965989|nursery infection|nursery infection
4743424|NCT02965989|online learning|online learning
4743425|NCT02965950|breast cancer|breast cancer
4743426|NCT02965950|TP53|tp53
4743427|NCT02965950|cyclophosphamide|cyclophosphamide
4743428|NCT02965937|Attentively embracing story|attentively embracing story
4743429|NCT02965937|story-centred care|story-centred care
4743430|NCT02965937|heart rate variability|heart rate variability
4743431|NCT02965937|cognitive function|cognitive function
4743432|NCT02965911|UDCA, Fenofibrate|udca, fenofibrate
4743433|NCT02965898|chronic pancreatitis|chronic pancreatitis
4743434|NCT02965898|vitamin d|vitamin d
4743435|NCT02965898|pancreatitis|pancreatitis
4743436|NCT02965898|Pancreatic stellate cell|pancreatic stellate cell
4743437|NCT02965898|rct|rct
4743438|NCT02965885|Phase I|phase i
4743439|NCT02965885|Solid Tumors|solid tumors
4743440|NCT02965885|Pharmacokinetics|pharmacokinetics
4743441|NCT02965885|Pharmacodynamics|pharmacodynamics
4743442|NCT02965885|MTD|mtd
4743443|NCT02965885|TAS116|tas116
4743444|NCT02965885|HSP90 Inhibitor|hsp90 inhibitor
4743445|NCT02965885|Neoplasms|neoplasms
4743446|NCT02965885|HER2 positive MBC|her2 positive mbc
4743447|NCT02965885|NSCLC EGFR|nsclc egfr
4743448|NCT02965885|NSCLC ALK positive|nsclc alk positive
4743449|NCT02965872|Postural Balance|postural balance
4743450|NCT02965859|Chronic Hepatitis B|chronic hepatitis b
4743451|NCT02965846|EDE|ede
4743452|NCT02965846|evaporative dry eye|evaporative dry eye
4743453|NCT02965833|Contact lens induced dryness|contact lens induced dryness
4743454|NCT02965820|Contact lens induced dryness|contact lens induced dryness
4743455|NCT02965807|Bronchial Thermoplasty|bronchial thermoplasty
4743456|NCT02965807|moderate asthma|moderate asthma
4743457|NCT02965807|China|china
4743458|NCT02965794|surgery|surgery
4743459|NCT02965794|bowel|bowel
4743460|NCT02965794|rectum|rectum
4743461|NCT02965794|cancer|cancer
4743462|NCT02965794|nutrition|nutrition
4743463|NCT02965755|Metastatic Breast Cancer|metastatic breast cancer
4743464|NCT02965755|Breast Cancer|breast cancer
4743465|NCT02965755|Molecular profiling|molecular profiling
4743466|NCT02965755|Personalized medicine|personalized medicine
4743467|NCT02965742|DXA|dxa
4743468|NCT02965742|DMS|dms
4743469|NCT02965742|STRATOS|stratos
4743470|NCT02965729|behavior goals|behavior goals
4743471|NCT02965729|self-monitoring|self-monitoring
4743472|NCT02965729|pedometer|pedometer
4743473|NCT02965729|physical activity|physical activity
4743474|NCT02965690|Total Knee Arthroplasty (TKA)|total knee arthroplasty (tka)
4743475|NCT02965690|TKR|tkr
4743476|NCT02965690|Knee kinematics|knee kinematics
4743477|NCT02965690|Dynamic RSA|dynamic rsa
4743478|NCT02965690|Fluoroscopy|fluoroscopy
4743479|NCT02965690|Roentgen Fluoroscopic Stereophotogrammetric Analysis|roentgen fluoroscopic stereophotogrammetric analysis
4743480|NCT02965677|drug eluting balloon|drug eluting balloon
4743481|NCT02965677|Femoral Popliteal Artery|femoral popliteal artery
4744582|NCT02958943|stroke|stroke
4743482|NCT02965651|embodied conversational agent|embodied conversational agent
4743483|NCT02965651|virtual patient agent|virtual patient agent
4743484|NCT02965651|meditation|meditation
4743485|NCT02965651|mindfulness based stress reduction|mindfulness based stress reduction
4743486|NCT02965651|nutrition|nutrition
4743487|NCT02965638|LHH|lhh
4743488|NCT02965612|Grass Allergy|grass allergy
4743489|NCT02965612|Allergic Rhinitis|allergic rhinitis
4743490|NCT02965612|Allergic Asthma|allergic asthma
4743491|NCT02965612|Paediatric|paediatric
4743492|NCT02965599|pharmacodynamics|pharmacodynamics
4743493|NCT02965599|tolerability|tolerability
4743494|NCT02965599|GSK3117391|gsk3117391
4743495|NCT02965599|safety|safety
4743496|NCT02965599|efficacy|efficacy
4743497|NCT02965599|rheumatoid arthritis|rheumatoid arthritis
4743498|NCT02965599|pharmacokinetics|pharmacokinetics
4743499|NCT02965547|Ischemic Preconditioning|ischemic preconditioning
4743500|NCT02965547|dynamic cerebral autoregulation|dynamic cerebral autoregulation
4743501|NCT02965534|night vision|night vision
4743502|NCT02965534|mesopic visual acuity|mesopic visual acuity
4743503|NCT02965534|aberrometry|aberrometry
4743504|NCT02965534|mesopic spectacle correction|mesopic spectacle correction
4743505|NCT02965534|night myopia|night myopia
4743506|NCT02965508|Home-bound|home-bound
4743507|NCT02965508|home-based primary care|home-based primary care
4743508|NCT02965495|Osteoarthritis|osteoarthritis
4743509|NCT02965482|methacholine, airway hyperresponsiveness|methacholine, airway hyperresponsiveness
4743510|NCT02965417|Resistance to anti-EGFR monoclonal antibodies|resistance to anti-egfr monoclonal antibodies
4743511|NCT02965417|Mutation of ECD-EGFR|mutation of ecd-egfr
4743512|NCT02965404|live attenuated varicella vaccine|live attenuated varicella vaccine
4743513|NCT02965404|safety|safety
4743514|NCT02965404|adult|adult
4743515|NCT02965404|adolescent|adolescent
4743516|NCT02965404|child|child
4743517|NCT02965391|Circulating Tumor DNA|circulating tumor dna
4743518|NCT02965391|Half time|half time
4743519|NCT02965391|Lung cancer|lung cancer
4743520|NCT02965391|Surgery|surgery
4743521|NCT02965391|Surveillance|surveillance
4743522|NCT02965339|Vasoplegia|vasoplegia
4743523|NCT02965339|endothelial dysfunction|endothelial dysfunction
4743524|NCT02965339|extracorporeal circulation|extracorporeal circulation
4743525|NCT02965339|cardiac surgery|cardiac surgery
4743526|NCT02965300|Pulmonary lesion|pulmonary lesion
4743527|NCT02965300|Volatile Organic Compositions(VOCs)|volatile organic compositions(vocs)
4743528|NCT02965248|Locally advanced colorectal cancer|locally advanced colorectal cancer
4743529|NCT02965248|Hyperthermic intraperitoneal chemotherapy|hyperthermic intraperitoneal chemotherapy
4743530|NCT02965222|blastocyst|blastocyst
4743531|NCT02965222|pregnancy rate|pregnancy rate
4743532|NCT02965209|endoscopy|endoscopy
4743533|NCT02965209|small bowel endoscopy|small bowel endoscopy
4743534|NCT02965209|motorized spiral endoscopy|motorized spiral endoscopy
4743535|NCT02965209|spiral endoscopy|spiral endoscopy
4743536|NCT02965144|long-term survivors, high-grade glioma|long-term survivors, high-grade glioma
4743537|NCT02965079|extracorporeal CO2 removal|extracorporeal co2 removal
4743538|NCT02965079|registry|registry
4743539|NCT02965079|COPD and ARDS|copd and ards
4743540|NCT02965079|CEDIT on behalf of APHP|cedit on behalf of aphp
4743541|NCT02965040|ASP1517|asp1517
4743542|NCT02965040|Normal renal function|normal renal function
4743543|NCT02965040|Dialysis|dialysis
4743544|NCT02965040|Roxadustat|roxadustat
4743545|NCT02965040|Metabolites|metabolites
4743546|NCT02965040|Pharmacokinetics|pharmacokinetics
4743547|NCT02965040|Impaired renal function|impaired renal function
4743548|NCT02965027|Chronic Headache|chronic headache
4743549|NCT02965027|Post-Traumatic Stress Disorder|post-traumatic stress disorder
4743550|NCT02965027|Iraq/Afghanistan Veteran|iraq/afghanistan veteran
4743551|NCT02965014|Human Immunodeficiency Virus (HIV)|human immunodeficiency virus (hiv)
4743552|NCT02965014|Sexually transmitted infections (STI)|sexually transmitted infections (sti)
4743553|NCT02965014|mHealth|mhealth
4743554|NCT02965014|Substance abuse|substance abuse
4743555|NCT02965014|Violence|violence
4743556|NCT02965014|Victimization|victimization
4743557|NCT02965014|Sexual Risk|sexual risk
4743558|NCT02965001|Molecular Imaging|molecular imaging
4743559|NCT02965001|uPAR-PET/CT|upar-pet/ct
4743560|NCT02965001|Head and neck cancer|head and neck cancer
4743561|NCT02965001|curative intended radiotherapy|curative intended radiotherapy
4743562|NCT02964949|Nonvalvular Atrial Fibrillation|nonvalvular atrial fibrillation
4743563|NCT02964949|High Creatinine Clearance|high creatinine clearance
4743564|NCT02964949|Developmental Phase III|developmental phase iii
4743565|NCT02964949|Anticoagulant Naïve|anticoagulant naïve
4743566|NCT02964936|Anemia|anemia
4743567|NCT02964936|Non-dialysis chronic kidney disease|non-dialysis chronic kidney disease
4743568|NCT02964936|Roxadustat|roxadustat
4743569|NCT02964936|ASP1517|asp1517
4743570|NCT02964923|Genetic polymorphism|genetic polymorphism
4743571|NCT02964923|Metabolic side effects of drugs|metabolic side effects of drugs
4743572|NCT02964923|schizophrenia|schizophrenia
4743573|NCT02964923|Second-Generation Antipsychotic|second-generation antipsychotic
4743574|NCT02964923|Cannabinoid Receptor Type 1|cannabinoid receptor type 1
4743575|NCT02964910|Hepatitis E|hepatitis e
4743576|NCT02964897|justice involvement|justice involvement
4743578|NCT02964897|Vulnerable Populations|vulnerable populations
4743579|NCT02964897|Linkage to care|linkage to care
4743580|NCT02964897|Veterans|veterans
4743581|NCT02964884|Neurofibromatosis Type 1|neurofibromatosis type 1
4743582|NCT02964884|Learning Disability|learning disability
4743583|NCT02964884|Reading Disability|reading disability
4743584|NCT02964884|NF1|nf1
4743585|NCT02964871|Long-term care facility|long-term care facility
4743586|NCT02964871|Elderly|elderly
4743587|NCT02964858|Radiation Dose|radiation dose
4743588|NCT02964858|Optimization|optimization
4743589|NCT02964858|NHL|nhl
4743590|NCT02964858|DLBCL|dlbcl
4743591|NCT02964858|R-CHOP|r-chop
4743592|NCT02964832|Basic Cardiac Life Support, Education, Feedback|basic cardiac life support, education, feedback
4743593|NCT02964793|Fetal Growth Restriction|fetal growth restriction
4743594|NCT02964793|Customised Fetal Weight Reference|customised fetal weight reference
4743595|NCT02964793|Estimated fetal Weight|estimated fetal weight
4743596|NCT02964793|Symphysis Fundal Height|symphysis fundal height
4743597|NCT02964767|HIV|hiv
4743598|NCT02964767|HIV-Tb co infection|hiv-tb co infection
4743599|NCT02964767|CD4 Cell|cd4 cell
4743600|NCT02964741|Episodic Migraine|episodic migraine
4743601|NCT02964741|Headache|headache
4743602|NCT02964741|Opioid|opioid
4743603|NCT02964689|Advanced non-small cell lung cancer|advanced non-small cell lung cancer
4743604|NCT02964689|KRAS mutations|kras mutations
4743605|NCT02964689|Binimetinib|binimetinib
4743606|NCT02964689|Pemetrexed|pemetrexed
4743607|NCT02964689|Cisplatin|cisplatin
4743608|NCT02964689|Phase IB trial|phase ib trial
4743609|NCT02964624|Osteoarthritis|osteoarthritis
4743610|NCT02964624|biomarkers|biomarkers
4743611|NCT02964624|HMGB1|hmgb1
4743612|NCT02964624|knee|knee
4743613|NCT02964598|Adolescent|adolescent
4743614|NCT02964598|Population-based|population-based
4743615|NCT02964598|Social jetlag|social jetlag
4743616|NCT02964598|Intervention|intervention
4743617|NCT02964598|Bright light|bright light
4743618|NCT02964598|Motivation|motivation
4743619|NCT02964598|Circadian regulation|circadian regulation
4743620|NCT02964598|Behavioral change|behavioral change
4743621|NCT02964585|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
4743622|NCT02964585|Endothelial Cells|endothelial cells
4743623|NCT02964585|Cellular Biomarker|cellular biomarker
4743624|NCT02964585|Endothelial Dysfunction|endothelial dysfunction
4743625|NCT02964585|CD34+|cd34+
4743626|NCT02964585|Impaired renal function|impaired renal function
4743627|NCT02964546|direct oral anticoagulants|direct oral anticoagulants
4743628|NCT02964546|atrial fibrillation|atrial fibrillation
4743629|NCT02964546|renal function|renal function
4743630|NCT02964546|ckd-epi|ckd-epi
4743631|NCT02964546|plasmatic concentration|plasmatic concentration
4743632|NCT02964520|trait anxiety|trait anxiety
4743633|NCT02964520|A/T neurofeedback|a/t neurofeedback
4743634|NCT02964520|EEG biofeedback|eeg biofeedback
4743635|NCT02964520|randomized|randomized
4743636|NCT02964507|GSK525762|gsk525762
4743637|NCT02964507|ER+ breast cancer|er+ breast cancer
4743638|NCT02964507|mTPI|mtpi
4743639|NCT02964481|malignant|malignant
4743640|NCT02964481|genetics|genetics
4743641|NCT02964481|RYR1|ryr1
4743642|NCT02964481|CAC-NA1S|cac-na1s
4743643|NCT02964481|hyperthermia|hyperthermia
4743644|NCT02964468|Rectal Cancer|rectal cancer
4743645|NCT02964468|IMRT|imrt
4743646|NCT02964468|Radiation Dose Escalation|radiation dose escalation
4743647|NCT02964455|Esophageal squamous cell carcinoma|esophageal squamous cell carcinoma
4743648|NCT02964455|Chemoradiotherapy|chemoradiotherapy
4743649|NCT02964455|Docetaxel|docetaxel
4743650|NCT02964455|Nedaplatin|nedaplatin
4743651|NCT02964455|Twice weekly|twice weekly
4743652|NCT02964416|supratentorial craniotomy|supratentorial craniotomy
4743653|NCT02964416|extubation response|extubation response
4743654|NCT02964416|emergence|emergence
4743655|NCT02964416|tramadol|tramadol
4743656|NCT02964403|COX-2|cox-2
4743657|NCT02964403|ERCP|ercp
4743658|NCT02964403|Pancreatitis|pancreatitis
4743659|NCT02964390|CTEPH|cteph
4743660|NCT02964390|balloon pulmonary angioplasty|balloon pulmonary angioplasty
4743661|NCT02964377|Pediatric|pediatric
4743662|NCT02964377|muscle disease|muscle disease
4743663|NCT02964377|Duchenne muscular dystrophy|duchenne muscular dystrophy
4743664|NCT02964377|cardiomyopathy|cardiomyopathy
4743665|NCT02964364|TAKAYASU ARTERITIS|takayasu arteritis
4743666|NCT02964351|MicroRNA|microrna
4743667|NCT02964351|Prostate Carcinoma|prostate carcinoma
4743668|NCT02964351|PET-MR|pet-mr
4743669|NCT02964325|hypoproliferative thrombocytopenia|hypoproliferative thrombocytopenia
4743670|NCT02964325|hematologic malignancies|hematologic malignancies
4743671|NCT02964325|thrombocytopenia|thrombocytopenia
4743672|NCT02964325|platelet therapy|platelet therapy
4743673|NCT02964325|apheresis|apheresis
4743674|NCT02964325|pathogen reduction therapy|pathogen reduction therapy
4743675|NCT02964299|Gastrointestinal endoscopy|gastrointestinal endoscopy
4743676|NCT02964299|Moderate sedation|moderate sedation
4743677|NCT02964299|Airway management|airway management
4743678|NCT02964286|Cancer|cancer
4743679|NCT02964286|Acupressure|acupressure
4743680|NCT02964286|Hematopoietic Cell Growth Factors|hematopoietic cell growth factors
4743681|NCT02964273|Autosomal Dominant Polycystic Kidney Disease|autosomal dominant polycystic kidney disease
4743682|NCT02964273|ADPKD|adpkd
4743683|NCT02964273|Tolvaptan|tolvaptan
4743684|NCT02964273|Renal cysts|renal cysts
4743685|NCT02964273|Chronic Kidney Disease|chronic kidney disease
4743686|NCT02964273|Genetic Kidney Disease|genetic kidney disease
4743687|NCT02964260|Hepatocellular Carcinoma; Embolization; Ablation; simultaneously; sequentially|hepatocellular carcinoma; embolization; ablation; simultaneously; sequentially
4743688|NCT02964234|Mammography Screening|mammography screening
4743689|NCT02964234|Latinas|latinas
4743690|NCT02964234|Breast cancer disparities|breast cancer disparities
4743691|NCT02964208|Atrial Fibrillation|atrial fibrillation
4743692|NCT02964208|Thromboembolism|thromboembolism
4743693|NCT02964208|Stroke|stroke
4743694|NCT02964208|ACP|acp
4743695|NCT02964208|Left Atrial Appendage|left atrial appendage
4743696|NCT02964208|Cardiac Plug|cardiac plug
4743697|NCT02964208|Amulet|amulet
4743698|NCT02964208|Amplatzer|amplatzer
4743699|NCT02964182|Mental and Behavioral Disorders Due to Use of Tobacco|mental and behavioral disorders due to use of tobacco
4743700|NCT02964182|Carbon monoxide Testing|carbon monoxide testing
4743701|NCT02964182|CO|co
4743702|NCT02964182|Questionnaires|questionnaires
4743703|NCT02964182|Surveys|surveys
4743704|NCT02964182|Smartphone assessments|smartphone assessments
4743705|NCT02964182|Electronic assessments|electronic assessments
4743706|NCT02964182|Usual brand cigarettes|usual brand cigarettes
4743707|NCT02964182|UB|ub
4743708|NCT02964182|Very Low Nicotine Content Cigarettes|very low nicotine content cigarettes
4743709|NCT02964182|VLNCC|vlncc
4743710|NCT02964182|E-cigarettes|e-cigarettes
4743711|NCT02964182|ECIG|ecig
4743712|NCT02964156|RA|ra
4743713|NCT02964156|Insole|insole
4743714|NCT02964156|Forefoot|forefoot
4743715|NCT02964156|Walking Ability|walking ability
4743716|NCT02964156|Pain|pain
4743717|NCT02964117|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
4743718|NCT02964091|Hepatitis C Virus|hepatitis c virus
4743719|NCT02964091|sofosbuvir/ledipasvir|sofosbuvir/ledipasvir
4743720|NCT02964091|Efficacy|efficacy
4743721|NCT02964078|Kidney Disease|kidney disease
4743722|NCT02964078|Metastatic|metastatic
4743723|NCT02964078|Antibody|antibody
4743724|NCT02964065|Influenza Vaccines|influenza vaccines
4743725|NCT02964065|LAIV|laiv
4743726|NCT02964039|stroke|stroke
4743727|NCT02964039|rehabilitation|rehabilitation
4743728|NCT02964039|gait|gait
4743729|NCT02964026|pulmonary artery catheter|pulmonary artery catheter
4743730|NCT02964026|Swan-Ganz catheter|swan-ganz catheter
4743731|NCT02964013|Programmed Cell Death Receptor 1 (PD-1)|programmed cell death receptor 1 (pd-1)
4743732|NCT02964013|Programmed Cell Death Receptor Ligand 1 (PD-L1)|programmed cell death receptor ligand 1 (pd-l1)
4743733|NCT02964013|Programmed Cell Death Receptor Ligand 2 (PD-L2)|programmed cell death receptor ligand 2 (pd-l2)
4743734|NCT02964013|PD-1|pd-1
4743735|NCT02964013|PDL1|pdl1
4743736|NCT02964013|PD-L1|pd-l1
4743737|NCT02964013|PD-L2|pd-l2
4743738|NCT02964000|Pain|pain
4743739|NCT02964000|Low level laser therapy|low level laser therapy
4743740|NCT02964000|Sham|sham
4743741|NCT02964000|Chronic Pain|chronic pain
4743742|NCT02964000|Opioid|opioid
4743743|NCT02964000|Physical activity|physical activity
4743744|NCT02964000|Quality of sleep|quality of sleep
4743745|NCT02963974|cochlear implant|cochlear implant
4743746|NCT02963961|Delirium|delirium
4743747|NCT02963961|Cognition|cognition
4743748|NCT02963961|Prehabilitation|prehabilitation
4743749|NCT02963961|Neuroplasticity|neuroplasticity
4743750|NCT02963909|Adjuvant|adjuvant
4743751|NCT02963909|Alum|alum
4743752|NCT02963909|Inactivated|inactivated
4743753|NCT02963909|Purified|purified
4743754|NCT02963909|Vaccine|vaccine
4743755|NCT02963909|Virus|virus
4743756|NCT02963909|Zika|zika
4743757|NCT02963896|vestibular rehabilitation|vestibular rehabilitation
4743758|NCT02963883|ScVO2|scvo2
4743759|NCT02963883|Post operative red cell transfusion|post operative red cell transfusion
4743760|NCT02963870|Cognitive behavioral|cognitive behavioral
4743761|NCT02963870|security plan|security plan
4743762|NCT02963870|suicidal Recidivism in adolescents|suicidal recidivism in adolescents
4743763|NCT02963857|breast surgery|breast surgery
4743764|NCT02963857|acute pain|acute pain
4743765|NCT02963857|regional anesthesia|regional anesthesia
4743766|NCT02963831|Oncos-102|oncos-102
4743767|NCT02963831|Durvalumab|durvalumab
4743768|NCT02963831|Peritoneal|peritoneal
4743769|NCT02963831|Cyclophosphamide|cyclophosphamide
4743770|NCT02963818|Brief intervention|brief intervention
4743771|NCT02963818|Harm reduction|harm reduction
4743772|NCT02963818|Young adult|young adult
4743773|NCT02963818|College Student|college student
4743774|NCT02963805|Children|children
4743775|NCT02963805|Physical activity|physical activity
4743776|NCT02963805|Physical competence|physical competence
4743777|NCT02963805|Obesity|obesity
4743778|NCT02963805|School|school
4743779|NCT02963805|Health|health
4743780|NCT02963805|Fundamental movement skills|fundamental movement skills
4743781|NCT02963792|Professionalism|professionalism
4743782|NCT02963792|Burnout prevention|burnout prevention
4743783|NCT02963792|Resiliency|resiliency
4743784|NCT02963792|Student education|student education
4743785|NCT02963766|Pediatrics|pediatrics
4743786|NCT02963753|Hyperemesis gravidarum|hyperemesis gravidarum
4743787|NCT02963753|gestational diabetes mellitus|gestational diabetes mellitus
4743788|NCT02963753|oral glucose tolerance test|oral glucose tolerance test
4743789|NCT02963740|breast cancer survivor|breast cancer survivor
4743790|NCT02963740|weight loss program|weight loss program
4743791|NCT02963727|osteoarthrosis|osteoarthrosis
4743792|NCT02963727|Knee|knee
4743793|NCT02963727|Wharton Jelly|wharton jelly
4743794|NCT02963714|Hepatitis B, Vaccine|hepatitis b, vaccine
4743795|NCT02963714|Randomized Controlled Trial|randomized controlled trial
4743796|NCT02963714|Hemodialysis|hemodialysis
4743797|NCT02963714|Immunogenicity|immunogenicity
4743798|NCT02963662|obesity|obesity
4743799|NCT02963662|bariatric surgery|bariatric surgery
4743800|NCT02963662|gut hormones|gut hormones
4743801|NCT02963662|inflammatory adipokine|inflammatory adipokine
4743802|NCT02963649|Drug-eluting angioplasty balloon, Drug coated angioplasty balloon, Experimental, percutaneous transluminal angioplasty (PTA)|drug-eluting angioplasty balloon, drug coated angioplasty balloon, experimental, percutaneous transluminal angioplasty (pta)
4743803|NCT02963636|family medicine group|family medicine group
4743804|NCT02963636|pharmacists|pharmacists
4743805|NCT02963636|primary health care|primary health care
4743806|NCT02963636|pharmaceutical services|pharmaceutical services
4743807|NCT02963636|interprofessional relations|interprofessional relations
4743808|NCT02963623|fibtem|fibtem
4743809|NCT02963623|total knee replacement|total knee replacement
4743810|NCT02963584|chronic total occlusion|chronic total occlusion
4743811|NCT02963584|decision aid|decision aid
4743812|NCT02963506|AS|as
4743813|NCT02963506|Ankylosing Spondylitis|ankylosing spondylitis
4743814|NCT02963506|Bimekizumab|bimekizumab
4743815|NCT02963493|relapsed refractory multiple myeloma|relapsed refractory multiple myeloma
4743816|NCT02963467|multiple inert gas elimination technique|multiple inert gas elimination technique
4743817|NCT02963467|smoking|smoking
4743818|NCT02963467|pulmonary disorder|pulmonary disorder
4743819|NCT02963441|Diabetic Retinopathy|diabetic retinopathy
4743820|NCT02963441|Macular Edema|macular edema
4743821|NCT02963415|Subjective memory complaint|subjective memory complaint
4743822|NCT02963363|Breast cancer|breast cancer
4743823|NCT02963363|HER2+|her2+
4743824|NCT02963363|Adapted physical activity|adapted physical activity
4743825|NCT02963363|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
4743826|NCT02963337|remifentanil|remifentanil
4743827|NCT02963337|combined spinal-epidural analgesia|combined spinal-epidural analgesia
4743828|NCT02963337|multiparous|multiparous
4743829|NCT02963272|Heart failure|heart failure
4743830|NCT02963272|ST2|st2
4743831|NCT02963272|fibrosis|fibrosis
4743832|NCT02963246|mindfulness|mindfulness
4743833|NCT02963246|quality of life|quality of life
4743834|NCT02963246|Bowel Disease|bowel disease
4743835|NCT02963207|colorectal polyp|colorectal polyp
4743836|NCT02963207|colorectal lesion|colorectal lesion
4743837|NCT02963207|Modified Sano's Classification|modified sano's classification
4743838|NCT02963207|NICE classification|nice classification
4743839|NCT02963207|NBI|nbi
4743840|NCT02963207|PIVI guidelines|pivi guidelines
4743841|NCT02963207|SSA/P|ssa/p
4743842|NCT02963207|sessile serrated adenoma|sessile serrated adenoma
4743843|NCT02963207|sessile serrated polyp|sessile serrated polyp
4743844|NCT02963194|self-processing|self-processing
4743845|NCT02963194|endowment effect|endowment effect
4743846|NCT02963194|neuroimage|neuroimage
4743847|NCT02963181|Melatonin|melatonin
4743848|NCT02963181|Yohimbine|yohimbine
4743849|NCT02963181|Anti-hypertensive agents|anti-hypertensive agents
4743850|NCT02963155|prostate, metastatic|prostate, metastatic
4743851|NCT02963142|Intensive care|intensive care
4743852|NCT02963142|Extra-corporeal membrane oxygenation (ECMO)|extra-corporeal membrane oxygenation (ecmo)
4743853|NCT02963142|Severe Respiratory Infections|severe respiratory infections
4743854|NCT02963142|Sequencing|sequencing
4743855|NCT02963142|Metagenome|metagenome
4743856|NCT02963142|Diagnosis|diagnosis
4743857|NCT02963129|Hereditary Hemorrhagic Telangiectasia|hereditary hemorrhagic telangiectasia
4743858|NCT02963129|Epistaxis|epistaxis
4743859|NCT02963116|Pharmacokinetics (PK)|pharmacokinetics (pk)
4743860|NCT02963116|Bioavailability (BA)|bioavailability (ba)
4743861|NCT02963116|Safety|safety
4743862|NCT02963116|Tolerability|tolerability
4743863|NCT02963116|Healthy Volunteers|healthy volunteers
4743864|NCT02963103|Tacrolimus|tacrolimus
4743865|NCT02963103|Kidney transplantation|kidney transplantation
4743866|NCT02963090|SCLC|sclc
4743867|NCT02963090|small cell lung cancer|small cell lung cancer
4743868|NCT02963090|lung cancer|lung cancer
4743869|NCT02963090|topotecan|topotecan
4743870|NCT02963090|pembrolizumab|pembrolizumab
4743871|NCT02963064|Immunodeficiency|immunodeficiency
4743872|NCT02963064|Pediatric|pediatric
4743873|NCT02963064|SCID|scid
4743874|NCT02963064|Bone Marrow Transplantation|bone marrow transplantation
4743875|NCT02963064|GVHD|gvhd
4743876|NCT02963064|Stem Cells|stem cells
4743877|NCT02963064|Chimerism|chimerism
4743878|NCT02963064|Transplant|transplant
4743879|NCT02963064|BMT|bmt
4743880|NCT02963051|metastatic castrate-resistant prostate cancer (mCRPC)|metastatic castrate-resistant prostate cancer (mcrpc)
4743881|NCT02963051|neuroendocrine prostate cancer (NEPC)|neuroendocrine prostate cancer (nepc)
4743882|NCT02963051|adenocarcinoma castrate-resistant prostate cancer (CRPC)|adenocarcinoma castrate-resistant prostate cancer (crpc)
4743883|NCT02963051|Copper|copper
4743884|NCT02963051|Disulfiram|disulfiram
4743885|NCT02962999|Ketamine|ketamine
4743886|NCT02962999|One lung ventilation|one lung ventilation
4743887|NCT02962999|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
4743888|NCT02962986|vasopressor|vasopressor
4743889|NCT02962986|blood pressure|blood pressure
4743890|NCT02962986|cesarean section|cesarean section
4743891|NCT02962986|spinal anesthesia|spinal anesthesia
4743892|NCT02962973|Advanced heart failure|advanced heart failure
4743893|NCT02962973|Total artificial heart|total artificial heart
4743894|NCT02962947|Melanoma|melanoma
4743895|NCT02962947|Propanolol|propanolol
4743896|NCT02962947|Betablockers|betablockers
4743897|NCT02962908|broad|broad
4743898|NCT02962908|universal|universal
4743899|NCT02962908|vaccine|vaccine
4743900|NCT02962908|influenza|influenza
4743901|NCT02962908|peptide|peptide
4743902|NCT02962908|Tcell|tcell
4743903|NCT02962908|UNISEC|unisec
4743904|NCT02962895|Sjogren, VAY736, ianalumab|sjogren, vay736, ianalumab
4743905|NCT02962843|Behavior Problem|behavior problem
4743906|NCT02962843|Social Competence|social competence
4743907|NCT02962843|Student|student
4743908|NCT02962843|Children|children
4743909|NCT02962830|fetal pain|fetal pain
4743910|NCT02962830|fetal analgesia|fetal analgesia
4743911|NCT02962804|kidney|kidney
4743912|NCT02962804|renal cell|renal cell
4743913|NCT02962804|cancer|cancer
4743914|NCT02962804|metastatic|metastatic
4743915|NCT02962804|recurrent|recurrent
4743916|NCT02962791|symptomatic heart failure|symptomatic heart failure
4743917|NCT02962778|treatment-resistant|treatment-resistant
4743918|NCT02962739|healthy volunteers|healthy volunteers
4743919|NCT02962726|Anorexia|anorexia
4743920|NCT02962726|Depression|depression
4743921|NCT02962726|Microbiome|microbiome
4743922|NCT02962713|Atraumatic Restorative Treatment|atraumatic restorative treatment
4743923|NCT02962713|glass ionomer cement|glass ionomer cement
4743924|NCT02962713|primary teeth|primary teeth
4743925|NCT02962713|dental caries.|dental caries.
4743926|NCT02962700|continuous haemofiltration|continuous haemofiltration
4743927|NCT02962700|intermittent haemodialysis|intermittent haemodialysis
4743928|NCT02962687|Veterans|veterans
4743929|NCT02962687|Cognitive impairments|cognitive impairments
4743930|NCT02962687|Nursing care management|nursing care management
4743931|NCT02962687|Videoconferencing|videoconferencing
4743932|NCT02962674|BPH|bph
4743933|NCT02962661|Other forms of heart disease|other forms of heart disease
4743934|NCT02962661|Left ventricular dysfunction|left ventricular dysfunction
4743935|NCT02962661|LV|lv
4743936|NCT02962661|Heart failure secondary to chemotherapy with anthracyclines|heart failure secondary to chemotherapy with anthracyclines
4743937|NCT02962661|Human mesenchymal stem cells|human mesenchymal stem cells
4743938|NCT02962661|hMSCs|hmscs
4743939|NCT02962661|Mesenchymal Stromal Cells|mesenchymal stromal cells
4743940|NCT02962661|MSCs|mscs
4743941|NCT02962661|Intravenous infusion|intravenous infusion
4743942|NCT02962661|Transendocardial injection|transendocardial injection
4743943|NCT02962661|Standard of care drugs for heart failure|standard of care drugs for heart failure
4743944|NCT02962648|IDA|ida
4743945|NCT02962622|Neurocognition|neurocognition
4743946|NCT02962622|Exercise|exercise
4743947|NCT02962622|Metabolism|metabolism
4743948|NCT02962622|Hispanic women|hispanic women
4743949|NCT02962609|Feeding|feeding
4743950|NCT02962609|preterm infant|preterm infant
4743951|NCT02962609|physiological characteristics|physiological characteristics
4743952|NCT02962609|position|position
4743953|NCT02962609|ESL|esl
4743954|NCT02962609|ESU|esu
4743955|NCT02962557|ventilatory depression|ventilatory depression
4743956|NCT02962544|Femtosecond|femtosecond
4743957|NCT02962544|Small incision lenticule extraction|small incision lenticule extraction
4743958|NCT02962544|Lenticule extraction|lenticule extraction
4743959|NCT02962544|LASIK|lasik
4743960|NCT02962544|Myopia|myopia
4743961|NCT02962518|Pressure Device|pressure device
4743962|NCT02962518|Clip|clip
4743963|NCT02962518|Triamcinolone|triamcinolone
4743964|NCT02962518|Fillet Technique|fillet technique
4743965|NCT02962492|Dapagliflozin|dapagliflozin
4743966|NCT02962492|Ketogenesis|ketogenesis
4743967|NCT02962492|Type 1 Diabetes|type 1 diabetes
4743968|NCT02962492|DKA|dka
4743969|NCT02962492|ketones|ketones
4743970|NCT02962492|exenatide/Bydureon|exenatide/bydureon
4743971|NCT02962414|Everolimus|everolimus
4743972|NCT02962414|Tuberous sclerosis complex|tuberous sclerosis complex
4743973|NCT02962414|TSC|tsc
4743974|NCT02962414|Refractory seizure|refractory seizure
4743975|NCT02962414|Roll over study|roll over study
4743976|NCT02962414|Long term safety|long term safety
4743977|NCT02962414|PASS|pass
4743978|NCT02962388|efficacy|efficacy
4743979|NCT02962388|safety|safety
4743980|NCT02962375|orange pomace fiber|orange pomace fiber
4743981|NCT02962375|glycemic response|glycemic response
4743982|NCT02962297|Vitamin E, Non Diabetic|vitamin e, non diabetic
4744785|NCT02957630|Hemostasis|hemostasis
4743983|NCT02962271|Musculoskeletal Ultrasound|musculoskeletal ultrasound
4743984|NCT02962271|Psoriatic Arthritis|psoriatic arthritis
4743985|NCT02962271|Enthesopathy|enthesopathy
4743986|NCT02962245|Ulcerative Colitis|ulcerative colitis
4743987|NCT02962245|Berberine|berberine
4743988|NCT02962232|drug eluting balloon|drug eluting balloon
4743989|NCT02962232|arterial vasculature below the knee|arterial vasculature below the knee
4743990|NCT02962219|oesophagectomy|oesophagectomy
4743991|NCT02962193|ADL|adl
4743992|NCT02962193|Bariatric surgery|bariatric surgery
4743993|NCT02962193|Daily participation|daily participation
4743994|NCT02962180|derma-rolling system, vitiligo|derma-rolling system, vitiligo
4743995|NCT02962167|measles virus|measles virus
4743996|NCT02962167|recurrent medulloblastoma|recurrent medulloblastoma
4743997|NCT02962167|recurrent ATRT|recurrent atrt
4743998|NCT02962154|Invasive Coronary Angiography|invasive coronary angiography
4743999|NCT02962154|Myocardial Infarction|myocardial infarction
4744000|NCT02962154|Major Depressive Disorder|major depressive disorder
4744001|NCT02962154|Bipolar I Disorder|bipolar i disorder
4744002|NCT02962154|Bipolar II Disorder|bipolar ii disorder
4744003|NCT02962154|Mental Stress|mental stress
4744004|NCT02962141|drug eluting balloon, Arteriovenous Fistulae|drug eluting balloon, arteriovenous fistulae
4744005|NCT02962089|Protein-energy wasting|protein-energy wasting
4744006|NCT02962089|Hemodialysis patients|hemodialysis patients
4744007|NCT02962089|Microbiota|microbiota
4744008|NCT02962089|Branched chain amino acids|branched chain amino acids
4744009|NCT02962089|Undernutrition|undernutrition
4744010|NCT02962089|Malnutrition|malnutrition
4744011|NCT02962089|Renal failure|renal failure
4744012|NCT02962089|Dialysis|dialysis
4744013|NCT02962089|Protein|protein
4744014|NCT02962089|Appetite|appetite
4744015|NCT02962089|Body composition|body composition
4744016|NCT02962089|Energy expenditure|energy expenditure
4744017|NCT02962063|Durvalumab|durvalumab
4744018|NCT02962063|Anti-PD-L1 Antibody|anti-pd-l1 antibody
4744019|NCT02962063|16-1405|16-1405
4744020|NCT02962011|Cesarean, incision, suture,|cesarean, incision, suture,
4744021|NCT02961998|hepatocellular carcinoma|hepatocellular carcinoma
4744022|NCT02961998|sorafenib|sorafenib
4744023|NCT02961998|celecoxib|celecoxib
4744024|NCT02961972|vegetarianism|vegetarianism
4744025|NCT02961972|Hyperhomocysteinemia|hyperhomocysteinemia
4744026|NCT02961972|vegan vegetarian|vegan vegetarian
4744027|NCT02961933|hypoxemia|hypoxemia
4744028|NCT02961933|intubation|intubation
4744029|NCT02961933|apneic oxygenation|apneic oxygenation
4744030|NCT02961907|periconceptional habits|periconceptional habits
4744031|NCT02961907|Pregnancy|pregnancy
4744032|NCT02961907|Infertility|infertility
4744033|NCT02961894|Atherectomy|atherectomy
4744034|NCT02961894|Atherosclerosis|atherosclerosis
4744035|NCT02961868|Renal Artery Obstruction|renal artery obstruction
4744036|NCT02961868|Carotid Artery Diseases|carotid artery diseases
4744037|NCT02961868|Genetic Association Studies|genetic association studies
4744038|NCT02961829|Dendritic Cell vaccination using|dendritic cell vaccination using
4744039|NCT02961829|antiretroviral intensification|antiretroviral intensification
4744040|NCT02961829|Auranofin|auranofin
4744041|NCT02961829|Histone Deacetylase Inhibitor|histone deacetylase inhibitor
4744042|NCT02961829|residual viral replication|residual viral replication
4744043|NCT02961829|HIV sanctuaries|hiv sanctuaries
4744044|NCT02961829|HIV latency|hiv latency
4744045|NCT02961816|Lymphoma|lymphoma
4744046|NCT02961816|Refractory/Relapsed Lymphoma|refractory/relapsed lymphoma
4744047|NCT02961816|Diffuse large B-cell lymphoma|diffuse large b-cell lymphoma
4744048|NCT02961816|Hodgkin's lymphoma|hodgkin's lymphoma
4744049|NCT02961816|T-cell Lymphoma|t-cell lymphoma
4744050|NCT02961816|Palifermin|palifermin
4744051|NCT02961816|Kepivance|kepivance
4744052|NCT02961816|Panobinostat|panobinostat
4744053|NCT02961816|LBH589B|lbh589b
4744054|NCT02961816|Gemcitabine|gemcitabine
4744055|NCT02961816|Gemcitabine Hydrochloride|gemcitabine hydrochloride
4744056|NCT02961816|Gemzar|gemzar
4744057|NCT02961816|Busulfan|busulfan
4744058|NCT02961816|Busulfex|busulfex
4744059|NCT02961816|Myleran|myleran
4744060|NCT02961816|Melphalan|melphalan
4744061|NCT02961816|Alkeran|alkeran
4744062|NCT02961816|Rituximab|rituximab
4744063|NCT02961816|Rituxan|rituxan
4744064|NCT02961816|Dexamethasone|dexamethasone
4744065|NCT02961816|Decadron|decadron
4744066|NCT02961816|Caphosol|caphosol
4744067|NCT02961816|Glutamine|glutamine
4744068|NCT02961816|Enterex|enterex
4744069|NCT02961816|Glutapak-10|glutapak-10
4744070|NCT02961816|NutreStore|nutrestore
4744071|NCT02961816|Resource|resource
4744072|NCT02961816|GlutaSolve|glutasolve
4744073|NCT02961816|Sympt-X G.I.|sympt-x g.i.
4744074|NCT02961816|Sympt-X|sympt-x
4744075|NCT02961816|Pyridoxine|pyridoxine
4744076|NCT02961816|G-CSF|g-csf
4744077|NCT02961816|Filgrastim|filgrastim
4744078|NCT02961816|Neupogen|neupogen
4744079|NCT02961816|Stem cell transplant|stem cell transplant
4744080|NCT02961803|AMN|amn
4744081|NCT02961803|MD1003|md1003
4744082|NCT02961803|Adrenomyeloneuropathy|adrenomyeloneuropathy
4744083|NCT02961803|ALD|ald
4744084|NCT02961803|Adrenoleukodystrophy|adrenoleukodystrophy
4744085|NCT02961803|Biotin|biotin
4744087|NCT02961803|Two-minute walk test|two-minute walk test
4744088|NCT02961803|TW25|tw25
4744089|NCT02961803|Timed 25-Foot Walk|timed 25-foot walk
4744090|NCT02961764|Critical Pathways|critical pathways
4744091|NCT02961764|Health Facilities|health facilities
4744092|NCT02961764|Clinical Protocols|clinical protocols
4744093|NCT02961764|Patient Satisfaction|patient satisfaction
4744094|NCT02961764|Absenteeism|absenteeism
4744095|NCT02961764|Anti-Bacterial Agents|anti-bacterial agents
4744096|NCT02961764|Quality of Life|quality of life
4744097|NCT02961764|Economics, Medical|economics, medical
4744098|NCT02961764|Health Resources|health resources
4744099|NCT02961764|Health resource utilization|health resource utilization
4744100|NCT02961764|Acute bacterial skin and skin structure infection (ABSSSI)|acute bacterial skin and skin structure infection (absssi)
4744101|NCT02961751|Ciprofloxacin-susceptibility|ciprofloxacin-susceptibility
4744102|NCT02961751|Efficacy|efficacy
4744103|NCT02961751|Gyrase A Assay|gyrase a assay
4744104|NCT02961751|Neisseria gonorrhoeae|neisseria gonorrhoeae
4744105|NCT02961647|Hemodynamic stress test|hemodynamic stress test
4744106|NCT02961647|Surgical intervention|surgical intervention
4744107|NCT02961634|onychomycosis|onychomycosis
4744108|NCT02961634|nail|nail
4744109|NCT02961595|Oral polio vaccine|oral polio vaccine
4744110|NCT02961595|Inactivated polio vaccine|inactivated polio vaccine
4744111|NCT02961595|Enterovirus|enterovirus
4744112|NCT02961595|Type 1 diabetes|type 1 diabetes
4744113|NCT02961595|Autoantibody|autoantibody
4744114|NCT02961582|Sacral neuromodulation|sacral neuromodulation
4744115|NCT02961582|Constipation|constipation
4744116|NCT02961582|Slow-transit constipation|slow-transit constipation
4744117|NCT02961582|Surgery|surgery
4744118|NCT02961582|Colorectal surgery|colorectal surgery
4744119|NCT02961582|Cost-effectiveness|cost-effectiveness
4744120|NCT02961582|Quality of life|quality of life
4744121|NCT02961556|AJG555|ajg555
4744122|NCT02961556|Constipation|constipation
4744123|NCT02961556|Phase 3|phase 3
4744124|NCT02961556|Pediatric participants|pediatric participants
4744125|NCT02961491|MIBG|mibg
4744126|NCT02961491|Azedra|azedra
4744127|NCT02961491|Rare neuroendocrine tumors|rare neuroendocrine tumors
4744128|NCT02961491|Iobenguane I 131|iobenguane i 131
4744129|NCT02961491|Progenics|progenics
4744130|NCT02961465|Sacral neuromodulation|sacral neuromodulation
4744131|NCT02961465|Constipation|constipation
4744132|NCT02961465|Slow-transit constipation|slow-transit constipation
4744133|NCT02961465|Surgery|surgery
4744134|NCT02961465|Colorectal surgery|colorectal surgery
4744135|NCT02961465|Cost-effectiveness|cost-effectiveness
4744136|NCT02961465|Quality of life|quality of life
4744137|NCT02961387|Tracheal stenosis, Hydrogen generator, Hydrogen-oxygen, Dyspnea.|tracheal stenosis, hydrogen generator, hydrogen-oxygen, dyspnea.
4744138|NCT02961361|dexmedetomidine|dexmedetomidine
4744139|NCT02961361|coracoid|coracoid
4744140|NCT02961361|brachial plexus block|brachial plexus block
4744141|NCT02961348|Oral anticoagulants (NOAC)|oral anticoagulants (noac)
4744142|NCT02961309|THC|thc
4744143|NCT02961309|marijuana|marijuana
4744144|NCT02961309|tobacco cigarette|tobacco cigarette
4744145|NCT02961309|smoking|smoking
4744146|NCT02961296|Helicobacter Pylori|helicobacter pylori
4744147|NCT02961283|BRAF Kinases|braf kinases
4744148|NCT02961283|PIK3CA protein, human|pik3ca protein, human
4744149|NCT02961244|Surgical Site Infection|surgical site infection
4744150|NCT02961244|normothermia|normothermia
4744151|NCT02961244|hypothermia|hypothermia
4744152|NCT02961244|prewarming|prewarming
4744153|NCT02961231|Pneumococcal conjugate vaccine|pneumococcal conjugate vaccine
4744154|NCT02961231|Herd immunity|herd immunity
4744155|NCT02961231|Reduced dosing schedule|reduced dosing schedule
4744156|NCT02961218|Sickle cell disease|sickle cell disease
4744157|NCT02961218|hemoglobinopathy|hemoglobinopathy
4744158|NCT02961218|pediatric|pediatric
4744159|NCT02961166|IVIG|ivig
4744160|NCT02961166|ARDS|ards
4744161|NCT02961166|ECMO|ecmo
4744162|NCT02961140|Outcome|outcome
4744163|NCT02961127|tissue factor pathway inhibitor|tissue factor pathway inhibitor
4744164|NCT02961114|Prostatitis, Chronic|prostatitis, chronic
4744165|NCT02961114|Nocturia|nocturia
4744166|NCT02961114|BPH With Urinary Obstruction|bph with urinary obstruction
4744167|NCT02961101|relapsed or refractory|relapsed or refractory
4744168|NCT02961101|malignancies|malignancies
4744169|NCT02961101|decitabine|decitabine
4744170|NCT02961101|anti-PD-1 antibody|anti-pd-1 antibody
4744171|NCT02961088|Systematic review and meta-analysis|systematic review and meta-analysis
4744172|NCT02961088|Evidence-based medicine (EBM)|evidence-based medicine (ebm)
4744173|NCT02961088|Evidence-based nutrition (EBN)|evidence-based nutrition (ebn)
4744174|NCT02961088|Clinical practice guidelines|clinical practice guidelines
4744175|NCT02961088|Glycemic index|glycemic index
4744176|NCT02961088|Pasta|pasta
4744177|NCT02961088|Glycemic load|glycemic load
4744178|NCT02961088|Body weight|body weight
4744179|NCT02961088|Cardiovascular risk factors|cardiovascular risk factors
4744180|NCT02961088|Cardiovascular disease|cardiovascular disease
4744181|NCT02961062|ocular pain|ocular pain
4744182|NCT02961062|photorefractive keratectomy (PRK)|photorefractive keratectomy (prk)
4744183|NCT02961062|SAF312|saf312
4744184|NCT02961062|corneal epithelial defect|corneal epithelial defect
4744185|NCT02961036|Surveys and Questionnaires|surveys and questionnaires
4744186|NCT02961010|school based prevention, child sexual and domestic abuse|school based prevention, child sexual and domestic abuse
4744187|NCT02960997|epidermolysis bullosa simplex|epidermolysis bullosa simplex
4744188|NCT02960958|Rheumatoid arthritis|rheumatoid arthritis
4744189|NCT02960958|Metabolomics|metabolomics
4744190|NCT02960958|urine|urine
4744191|NCT02960932|Hemiplegic|hemiplegic
4744192|NCT02960932|Child|child
4744193|NCT02960932|Elastography|elastography
4744194|NCT02960932|paralysis|paralysis
4744195|NCT02960893|Ataxia|ataxia
4744196|NCT02960893|SCA|sca
4744197|NCT02960893|Spinocerebellar Ataxia|spinocerebellar ataxia
4744198|NCT02960880|Rivaroxaban, Phenprocoumon, retrospective cohort study, Non-Valvular Atrial fibrillation, NVAF|rivaroxaban, phenprocoumon, retrospective cohort study, non-valvular atrial fibrillation, nvaf
4744199|NCT02960867|paediatric|paediatric
4744200|NCT02960867|kidney|kidney
4744201|NCT02960815|influenza vaccine|influenza vaccine
4744202|NCT02960815|Transplantation|transplantation
4744203|NCT02960815|imiquimod|imiquimod
4744204|NCT02960815|HIV infection|hiv infection
4744205|NCT02960815|immunogenicity|immunogenicity
4744206|NCT02960802|kidney transplant|kidney transplant
4744207|NCT02960802|renal blood flow|renal blood flow
4744208|NCT02960789|Dehydration|dehydration
4744209|NCT02960789|Children|children
4744210|NCT02960789|Measurement|measurement
4744211|NCT02960776|Body Weight|body weight
4744212|NCT02960776|Habitual sleep|habitual sleep
4744213|NCT02960763|Comparative Effectiveness Research|comparative effectiveness research
4744214|NCT02960763|Pragmatic Clinical Trials|pragmatic clinical trials
4744215|NCT02960763|Patient-Centered Outcomes Research|patient-centered outcomes research
4744216|NCT02960750|workplace|workplace
4744217|NCT02960750|sedentary behavior|sedentary behavior
4744218|NCT02960750|physical activity|physical activity
4744219|NCT02960750|physical risk factors|physical risk factors
4744220|NCT02960750|mental well-being|mental well-being
4744221|NCT02960750|presenteeism|presenteeism
4744222|NCT02960750|work productivity|work productivity
4744223|NCT02960750|activity-related energy expenditures|activity-related energy expenditures
4744224|NCT02960737|Dysphagia|dysphagia
4744225|NCT02960737|Stroke|stroke
4744226|NCT02960737|Intervention|intervention
4744227|NCT02960737|Oral screen|oral screen
4744228|NCT02960737|Incidence|incidence
4744229|NCT02960724|Uroplasminogen Plasminogen Activator Receptor|uroplasminogen plasminogen activator receptor
4744230|NCT02960724|Oropharyngeal cancer|oropharyngeal cancer
4744231|NCT02960724|oral cancer|oral cancer
4744232|NCT02960724|Positron Emission Tomography|positron emission tomography
4744233|NCT02960698|cognitive impulsivity|cognitive impulsivity
4744234|NCT02960698|IRM|irm
4744235|NCT02960698|Tourette Syndrome|tourette syndrome
4744236|NCT02960672|KL-6|kl-6
4744237|NCT02960672|disease progression|disease progression
4744238|NCT02960672|predict|predict
4744239|NCT02960672|biomarkers|biomarkers
4744240|NCT02960672|MMP-7|mmp-7
4744241|NCT02960659|Metformin|metformin
4744242|NCT02960659|Glucose|glucose
4744243|NCT02960646|Leukemia|leukemia
4744244|NCT02960646|Blood And Marrow Transplantation|blood and marrow transplantation
4744245|NCT02960646|Acute lymphocytic leukemia|acute lymphocytic leukemia
4744246|NCT02960646|ALL|all
4744247|NCT02960646|Acute myeloid leukemia|acute myeloid leukemia
4744248|NCT02960646|AML|aml
4744249|NCT02960646|Chronic lymphocytic leukemia|chronic lymphocytic leukemia
4744250|NCT02960646|CLL|cll
4744251|NCT02960646|Chronic myeloid leukemia|chronic myeloid leukemia
4744252|NCT02960646|CML|cml
4744253|NCT02960646|Hodgkin's disease|hodgkin's disease
4744254|NCT02960646|Non-Hodgkin's lymphoma|non-hodgkin's lymphoma
4744255|NCT02960646|NHL|nhl
4744256|NCT02960646|Small lymphocytic lymphoma|small lymphocytic lymphoma
4744257|NCT02960646|SLL|sll
4744258|NCT02960646|Myelodysplastic syndrome (MDS|myelodysplastic syndrome (mds
4744259|NCT02960646|MDS|mds
4744260|NCT02960646|Aplastic anemia|aplastic anemia
4744261|NCT02960646|Modified (CD45RA depleted) peripheral blood (PB) stem cell infusion|modified (cd45ra depleted) peripheral blood (pb) stem cell infusion
4744262|NCT02960646|T cells|t cells
4744263|NCT02960646|Haploidentical transplantation|haploidentical transplantation
4744264|NCT02960646|Rituximab|rituximab
4744265|NCT02960646|Rituxan|rituxan
4744266|NCT02960646|Melphalan|melphalan
4744267|NCT02960646|Alkeran|alkeran
4744268|NCT02960646|Fludarabine|fludarabine
4744269|NCT02960646|Fludarabine Phosphate|fludarabine phosphate
4744270|NCT02960646|Fludara|fludara
4744271|NCT02960646|Cyclophosphamide|cyclophosphamide
4744272|NCT02960646|Cytoxan|cytoxan
4744273|NCT02960646|Neosar|neosar
4744274|NCT02960646|G-CSF|g-csf
4744275|NCT02960646|Filgrastim|filgrastim
4744276|NCT02960646|Neupogen|neupogen
4744277|NCT02960620|Humanitarian Device Exemption|humanitarian device exemption
4744278|NCT02960620|Liver Disease|liver disease
4744279|NCT02960620|HDE #980006|hde #980006
4744280|NCT02960594|Immunotherapy|immunotherapy
4744281|NCT02960594|Human Telomerase Reverse Transcriptase (hTERT)|human telomerase reverse transcriptase (htert)
4744282|NCT02960594|Breast Neoplasms|breast neoplasms
4744283|NCT02960594|Lung Neoplasms|lung neoplasms
4744284|NCT02960594|Pancreatic Neoplasms|pancreatic neoplasms
4744285|NCT02960594|High Risk of Relapse|high risk of relapse
4744286|NCT02960594|Post Definitive Surgery|post definitive surgery
4744287|NCT02960594|Post Adjuvant Therapy|post adjuvant therapy
4744288|NCT02960594|No Evidence of Disease|no evidence of disease
4744289|NCT02960568|primaquine|primaquine
4744290|NCT02960568|metabolism|metabolism
4744291|NCT02960568|malaria|malaria
4744292|NCT02960568|hypnozoite|hypnozoite
4744293|NCT02960568|vivax|vivax
4744294|NCT02960568|CYP2D6|cyp2d6
4744295|NCT02960568|active duty personnel|active duty personnel
4744296|NCT02960555|Myeloma|myeloma
4744297|NCT02960555|Smoldering Multiple Myeloma|smoldering multiple myeloma
4744298|NCT02960555|SMM|smm
4744299|NCT02960555|Intermediate or high risk|intermediate or high risk
4744300|NCT02960555|SAR650984|sar650984
4744301|NCT02960555|Diphenhydramine|diphenhydramine
4744302|NCT02960555|Benadryl|benadryl
4744303|NCT02960555|Ranitidine|ranitidine
4744304|NCT02960555|Ranitidine Hydrochloride|ranitidine hydrochloride
4744305|NCT02960555|Zantac|zantac
4744306|NCT02960555|Methylprednisolone|methylprednisolone
4744307|NCT02960555|Depo-Medrol|depo-medrol
4744308|NCT02960555|Medrol|medrol
4744309|NCT02960555|Solu-Medrol|solu-medrol
4744310|NCT02960542|lifestyle intervention|lifestyle intervention
4744311|NCT02960542|weight-loss|weight-loss
4744312|NCT02960503|sickle cell disease|sickle cell disease
4744313|NCT02960503|pulmonary complications|pulmonary complications
4744314|NCT02960503|reduced FEV1|reduced fev1
4744315|NCT02960503|azithromycin|azithromycin
4744316|NCT02960503|lung function|lung function
4744317|NCT02960490|E6011|e6011
4744318|NCT02960490|rheumatoid arthritis|rheumatoid arthritis
4744319|NCT02960477|Shoulder pain|shoulder pain
4744320|NCT02960477|Shoulder surgery|shoulder surgery
4744321|NCT02960477|Pain neuroscience education|pain neuroscience education
4744322|NCT02960477|Chronic pain|chronic pain
4744323|NCT02960464|Parkinson Disease|parkinson disease
4744324|NCT02960464|Depression|depression
4744325|NCT02960464|Transcranial Direct Current Stimulation|transcranial direct current stimulation
4744326|NCT02960464|Neuromodulation|neuromodulation
4744327|NCT02960451|prodrome|prodrome
4744328|NCT02960451|cognitive behavioral therapy|cognitive behavioral therapy
4744329|NCT02960451|family focused therapy|family focused therapy
4744330|NCT02960438|E6011|e6011
4744331|NCT02960438|rheumatoid arthritis|rheumatoid arthritis
4744332|NCT02960373|Dried fruit|dried fruit
4744333|NCT02960373|Glycemic Index|glycemic index
4744334|NCT02960373|Catalytic dose|catalytic dose
4744335|NCT02960373|Glycemic response|glycemic response
4744336|NCT02960373|Fructose|fructose
4744337|NCT02960373|Postprandial|postprandial
4744338|NCT02960373|Randomized clinical trial|randomized clinical trial
4744339|NCT02960373|Carbohydrate metabolism|carbohydrate metabolism
4744340|NCT02960334|Screening|screening
4744341|NCT02960334|Silent Atrial Fibrillation|silent atrial fibrillation
4744342|NCT02960334|Undertreated Atrial Fibrillation|undertreated atrial fibrillation
4744343|NCT02960334|Actionable Atrial Fibrillation|actionable atrial fibrillation
4744344|NCT02960334|MyDiagnostick|mydiagnostick
4744345|NCT02960334|Opportunistic Screening|opportunistic screening
4744346|NCT02960334|Preoperative Consultation|preoperative consultation
4744347|NCT02960334|OAC|oac
4744348|NCT02960334|VKA|vka
4744349|NCT02960334|NOAC|noac
4744350|NCT02960321|myocardial injury|myocardial injury
4744351|NCT02960321|high-sensitivity troponin I|high-sensitivity troponin i
4744352|NCT02960321|periprocedural myocardial infarction|periprocedural myocardial infarction
4744353|NCT02960269|rural health|rural health
4744354|NCT02960269|telehealth|telehealth
4744355|NCT02960269|physiotherapy|physiotherapy
4744356|NCT02960269|interprofessional|interprofessional
4744357|NCT02960243|Deep Brain Stimulation|deep brain stimulation
4744358|NCT02960243|Laryngeal Motor Cortex|laryngeal motor cortex
4744359|NCT02960243|Essential Voice Tremor|essential voice tremor
4744360|NCT02960243|Essential Tremor|essential tremor
4744361|NCT02960230|peptide vaccine|peptide vaccine
4744362|NCT02960230|immunotherapy|immunotherapy
4744363|NCT02960230|DIPG|dipg
4744364|NCT02960230|vaccine|vaccine
4744365|NCT02960204|cirrhosis|cirrhosis
4744366|NCT02960204|Portal Hypertension|portal hypertension
4744367|NCT02960204|Non-alcoholic Steatohepatitis|non-alcoholic steatohepatitis
4744368|NCT02960204|Liver cirrhosis|liver cirrhosis
4744369|NCT02960152|periodontitis|periodontitis
4744370|NCT02960113|cesarean section|cesarean section
4744371|NCT02960113|acupressure point p6|acupressure point p6
4744372|NCT02960113|scopolamine patch|scopolamine patch
4744373|NCT02960100|Cancer prevention|cancer prevention
4744374|NCT02960100|HPV|hpv
4744375|NCT02960100|Human papillomavirus vaccine|human papillomavirus vaccine
4744376|NCT02960074|Allergy, Peanut|allergy, peanut
4744377|NCT02960074|Hypersensitivity Peanut|hypersensitivity peanut
4744378|NCT02960074|Peanut Allergy|peanut allergy
4744379|NCT02960074|Donor Feces Infusion|donor feces infusion
4744380|NCT02960074|Fecal Transplant|fecal transplant
4744381|NCT02960074|Fecal Transplantation|fecal transplantation
4744382|NCT02960074|Intestinal Microbiota Transfer|intestinal microbiota transfer
4744383|NCT02960074|Fecal Microbiota Transplantation|fecal microbiota transplantation
4744384|NCT02960074|Food allergy|food allergy
4744385|NCT02960061|Intraperitoneal chemotherapy|intraperitoneal chemotherapy
4744386|NCT02960061|gastric cancer|gastric cancer
4744387|NCT02960061|Neo-adjuvant chemotherapy|neo-adjuvant chemotherapy
4744388|NCT02960048|Anterior disc displacement|anterior disc displacement
4744389|NCT02960048|TMD therapy|tmd therapy
4744390|NCT02960048|internal derangement|internal derangement
4744391|NCT02960048|occlusal splint|occlusal splint
4744392|NCT02960048|anterior repositioning splint|anterior repositioning splint
4744393|NCT02960035|Mardird sonographic enthesis index|mardird sonographic enthesis index
4744394|NCT02960035|Spondyloarthropathy|spondyloarthropathy
4744395|NCT02960035|Ultrasonics|ultrasonics
4744396|NCT02960035|Etanercept|etanercept
4744397|NCT02960022|prostate cancer|prostate cancer
4744398|NCT02960022|prednisone|prednisone
4744399|NCT02960022|MDV3100|mdv3100
4744400|NCT02960022|enzalutamide|enzalutamide
4744401|NCT02960022|Xtandi|xtandi
4744402|NCT02960022|abiraterone acetate|abiraterone acetate
4744403|NCT02959944|chronic graft versus host disease|chronic graft versus host disease
4744404|NCT02959944|PCYC1140|pcyc1140
4744405|NCT02959944|PCYC1140IM|pcyc1140im
4744406|NCT02959944|1140|1140
4744407|NCT02959944|Ibrutinib|ibrutinib
4744408|NCT02959944|GVHD|gvhd
4744409|NCT02959944|Steroid dependent|steroid dependent
4744410|NCT02959944|refractory|refractory
4744411|NCT02959944|chronic|chronic
4744412|NCT02959944|PCI32765|pci32765
4744413|NCT02959944|IMBRUVICA|imbruvica
4744414|NCT02959944|Pharmacyclics|pharmacyclics
4744415|NCT02959944|PCYC|pcyc
4744416|NCT02959944|graft versus host disease|graft versus host disease
4744417|NCT02959944|immunology|immunology
4744418|NCT02959944|new onset graft versus host disease|new onset graft versus host disease
4744419|NCT02959944|INTEGRATE|integrate
4744420|NCT02959944|Corticosteroids|corticosteroids
4744421|NCT02959944|prednisone|prednisone
4744422|NCT02959931|Dietary Potassium|dietary potassium
4744423|NCT02959892|Drug therapy|drug therapy
4744424|NCT02959879|FOLFOX|folfox
4744425|NCT02959879|FOLFIRINOX|folfirinox
4744426|NCT02959853|Hypogonadism|hypogonadism
4744427|NCT02959853|Severe obesity|severe obesity
4744428|NCT02959827|Hypothyroidism,|hypothyroidism,
4744429|NCT02959827|children,|children,
4744430|NCT02959827|iodinated contrast agents,|iodinated contrast agents,
4744431|NCT02959827|retrospective cohort,|retrospective cohort,
4744432|NCT02959827|database|database
4744433|NCT02959814|Fractional Flow Reserve|fractional flow reserve
4744434|NCT02959814|Quantitative Coronary Analysis|quantitative coronary analysis
4744435|NCT02959814|Stable coronary artery disease|stable coronary artery disease
4744436|NCT02959814|Angina pectoris|angina pectoris
4744437|NCT02959801|Deep Venous Thrombosis|deep venous thrombosis
4744438|NCT02959801|Percutaneous Mechanical Thrombectomy|percutaneous mechanical thrombectomy
4744439|NCT02959788|Heart rate variability|heart rate variability
4744440|NCT02959775|Hepatitis B vaccination|hepatitis b vaccination
4744441|NCT02959775|Immunogenicity|immunogenicity
4744442|NCT02959775|Randomized controlled trial|randomized controlled trial
4744443|NCT02959775|Drug abuse|drug abuse
4744444|NCT02959762|G01 [Biological Sciences]|g01 [biological sciences]
4744445|NCT02959762|G02.513 [Nutrition]|g02.513 [nutrition]
4744446|NCT02959762|G06.696.259 [Child Nutrition]|g06.696.259 [child nutrition]
4744447|NCT02959762|G07.553.481.398.571 [Obesity]|g07.553.481.398.571 [obesity]
4744448|NCT02959762|G06 [Biochemical Phenomena, Metabolism, and Nutrition]|g06 [biochemical phenomena, metabolism, and nutrition]
4744449|NCT02959762|G12.392.617 [Insulin Resistance]|g12.392.617 [insulin resistance]
4744450|NCT02959762|G06.696.259.500 [Adolescent Nutrition]|g06.696.259.500 [adolescent nutrition]
4744451|NCT02959762|A06 [Endocrine System]|a06 [endocrine system]
4744452|NCT02959762|A07 [Cardiovascular System]|a07 [cardiovascular system]
4744453|NCT02959762|C18.452.297.681 [Obesity in Diabetes]|c18.452.297.681 [obesity in diabetes]
4744454|NCT02959762|C18.452.555 [Insulin Resistance]|c18.452.555 [insulin resistance]
4744455|NCT02959762|C18 [Nutritional and Metabolic Diseases]|c18 [nutritional and metabolic diseases]
4744456|NCT02959762|C18.452.494 [Hyperlipidemia]|c18.452.494 [hyperlipidemia]
4744457|NCT02959762|C18.452.460 [Hyperglycemia]|c18.452.460 [hyperglycemia]
4744458|NCT02959762|C14 [Cardiovascular Diseases]|c14 [cardiovascular diseases]
4744459|NCT02959762|D11.786.875.844 [Vitamin K 2]|d11.786.875.844 [vitamin k 2]
4744460|NCT02959762|D02.806.550.750 [Vitamin K 2]|d02.806.550.750 [vitamin k 2]
4744461|NCT02959762|E02.293 [Diet Therapy]|e02.293 [diet therapy]
4744462|NCT02959762|E02 [Therapeutics]|e02 [therapeutics]
4744463|NCT02959762|F04.096.544.215.508.428 [Primary Prevention]|f04.096.544.215.508.428 [primary prevention]
4744464|NCT02959762|N01.224.425.525 [Nutritional Status]|n01.224.425.525 [nutritional status]
4744465|NCT02959749|Osimertinib|osimertinib
4744466|NCT02959749|EGFR T790M Resistant Mutation|egfr t790m resistant mutation
4744467|NCT02959749|Docetaxel|docetaxel
4744468|NCT02959749|Bevacizumab|bevacizumab
4744469|NCT02959749|Non Small Cell Lung|non small cell lung
4744470|NCT02959736|Vegetative State (VS)|vegetative state (vs)
4744471|NCT02959736|Minimally Conscious State (MCS)|minimally conscious state (mcs)
4744472|NCT02959736|Brain Injuries|brain injuries
4744473|NCT02959723|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
4744474|NCT02959723|BMPR2|bmpr2
4744475|NCT02959723|Inflammation|inflammation
4744476|NCT02959710|Healthy volunteers|healthy volunteers
4744479|NCT02959710|Pharmacokinetic|pharmacokinetic
4744480|NCT02959710|ketone body|ketone body
4744481|NCT02959697|Blepharoptosis|blepharoptosis
4744482|NCT02959697|Ptosis|ptosis
4744483|NCT02959697|Surgery|surgery
4744484|NCT02959697|Pain Reduction|pain reduction
4744485|NCT02959697|Anesthetic|anesthetic
4744486|NCT02959697|Local Anesthetic|local anesthetic
4744487|NCT02959697|Subconjunctival|subconjunctival
4744488|NCT02959593|Primary open-angle glaucoma|primary open-angle glaucoma
4744489|NCT02959593|retinal capillary blood flow|retinal capillary blood flow
4744490|NCT02959593|visual stimulation|visual stimulation
4744491|NCT02959580|Granulomatous|granulomatous
4744492|NCT02959580|Mastitis|mastitis
4744493|NCT02959580|topical steroids|topical steroids
4744494|NCT02959567|cervix|cervix
4744495|NCT02959567|cervical dilation|cervical dilation
4744496|NCT02959567|balloon catheter|balloon catheter
4744497|NCT02959554|Advanced|advanced
4744498|NCT02959554|Metastatic|metastatic
4744499|NCT02959554|RCC|rcc
4744500|NCT02959541|Leukovorin|leukovorin
4744501|NCT02959476|Postoperative pain|postoperative pain
4744502|NCT02959476|Postsurgical pain|postsurgical pain
4744503|NCT02959463|Malignant pleural mesothelioma|malignant pleural mesothelioma
4744504|NCT02959463|MPM|mpm
4744505|NCT02959463|Non-metastatic|non-metastatic
4744506|NCT02959463|Pembrolizumab|pembrolizumab
4744507|NCT02959463|Keytruda|keytruda
4744508|NCT02959463|MK-3475|mk-3475
4744509|NCT02959463|SCH-900475|sch-900475
4744510|NCT02959463|Radiation therapy|radiation therapy
4744511|NCT02959463|Radiation treatment|radiation treatment
4744512|NCT02959463|XRT|xrt
4744513|NCT02959463|Intensity modulated radiation therapy|intensity modulated radiation therapy
4744514|NCT02959463|IMRT|imrt
4744515|NCT02959463|Proton beam therapy|proton beam therapy
4744516|NCT02959463|PBT|pbt
4744517|NCT02959463|3D conformal therapy|3d conformal therapy
4744518|NCT02959450|Nutritional Intervention in Oropharyngeal Dysphagia|nutritional intervention in oropharyngeal dysphagia
4744519|NCT02959437|Solid tumors|solid tumors
4744520|NCT02959437|NSCLC|nsclc
4744521|NCT02959437|CRC|crc
4744522|NCT02959359|Chronic hepatitis C|chronic hepatitis c
4744523|NCT02959359|Hepatocellular Carcinoma|hepatocellular carcinoma
4744524|NCT02959359|Direct-acting antiviral (DAA)|direct-acting antiviral (daa)
4744525|NCT02959359|Recurrence|recurrence
4744526|NCT02959346|Minimal invasive thoracoscopic surgery|minimal invasive thoracoscopic surgery
4744527|NCT02959346|Pain control|pain control
4744528|NCT02959346|Acupuncture|acupuncture
4744529|NCT02959346|Randomized controlled trial|randomized controlled trial
4744530|NCT02959307|Depression|depression
4744531|NCT02959307|Major Depressive Disorder|major depressive disorder
4744532|NCT02959307|Major Depressive Episode|major depressive episode
4744533|NCT02959294|TBI|tbi
4744534|NCT02959294|mTBI|mtbi
4744535|NCT02959294|Concussion, Brain|concussion, brain
4744536|NCT02959294|Loss Consciousness, Traumatic|loss consciousness, traumatic
4744537|NCT02959294|Headaches|headaches
4744538|NCT02959242|glaucoma, follow-up intervals, treatment efficiency|glaucoma, follow-up intervals, treatment efficiency
4744539|NCT02959229|Late onset sepsis|late onset sepsis
4744540|NCT02959229|Bovine Lactoferrin|bovine lactoferrin
4744541|NCT02959216|Aerobic Exercise|aerobic exercise
4744542|NCT02959203|Central Venous Catheter|central venous catheter
4744543|NCT02959203|Ultrasound|ultrasound
4744544|NCT02959203|Chest X-ray|chest x-ray
4744545|NCT02959203|Pneumothorax|pneumothorax
4744546|NCT02959190|prevention|prevention
4744547|NCT02959190|prophylaxis|prophylaxis
4744548|NCT02959190|headache|headache
4744549|NCT02959177|prevention|prevention
4744550|NCT02959177|prophylaxis|prophylaxis
4744551|NCT02959177|headache|headache
4744552|NCT02959112|pancreatitis after ERCP|pancreatitis after ercp
4744553|NCT02959112|epinephrine|epinephrine
4744554|NCT02959112|papilla|papilla
4744555|NCT02959112|rectal indomethacin|rectal indomethacin
4744556|NCT02959099|Acute coronary syndrome (ACS)|acute coronary syndrome (acs)
4744557|NCT02959099|Atherosclerotic plaque morphology|atherosclerotic plaque morphology
4744558|NCT02959099|Coronary Computed Tomographic Angiography (CCTA)|coronary computed tomographic angiography (ccta)
4744559|NCT02959099|Gender disparities|gender disparities
4744560|NCT02959086|Epidemiology|epidemiology
4744561|NCT02959086|Shanghai|shanghai
4744562|NCT02959086|Cancer|cancer
4744563|NCT02959086|Adolescents|adolescents
4744564|NCT02959086|Children|children
4744565|NCT02959073|Symptom recording|symptom recording
4744566|NCT02959047|MRI|mri
4744567|NCT02959047|PCSK9 inhibition|pcsk9 inhibition
4744568|NCT02959047|LDL cholesterol|ldl cholesterol
4744569|NCT02959021|weight loss|weight loss
4744570|NCT02959021|behavioral|behavioral
4744571|NCT02959021|primary care|primary care
4744572|NCT02959021|lifestyle|lifestyle
4744573|NCT02958995|Drug Therapy|drug therapy
4744574|NCT02958982|RP3128|rp3128
4744575|NCT02958982|Phase 1|phase 1
4744576|NCT02958982|Healthy volunteers|healthy volunteers
4744577|NCT02958969|venous thromboembolism|venous thromboembolism
4744578|NCT02958969|multiple myeloma|multiple myeloma
4744579|NCT02958969|anticoagulation|anticoagulation
4744580|NCT02958956|Drug Therapy|drug therapy
4744581|NCT02958943|atrial fibrillation|atrial fibrillation
4744583|NCT02958943|computerized decision support|computerized decision support
4744584|NCT02958904|Sexuality|sexuality
4744585|NCT02958904|Spinal cord injuries|spinal cord injuries
4744586|NCT02958904|Erectile dysfunction|erectile dysfunction
4744587|NCT02958904|depression|depression
4744588|NCT02958865|Mayo score|mayo score
4744589|NCT02958852|Breast Cancer|breast cancer
4744590|NCT02958852|Endocrine Treatment|endocrine treatment
4744591|NCT02958852|Atorvastatin|atorvastatin
4744592|NCT02958852|Mechanisms of Resistance|mechanisms of resistance
4744593|NCT02958852|Statins|statins
4744594|NCT02958852|Fulvestrant|fulvestrant
4744595|NCT02958852|Circulating Tumor Cells|circulating tumor cells
4744596|NCT02958852|Statins and Endocrine Treatment|statins and endocrine treatment
4744597|NCT02958852|Tumor Marker Expression|tumor marker expression
4744598|NCT02958852|ER+ Metastatic Breast Cancer|er+ metastatic breast cancer
4744599|NCT02958852|Circulating Tumor DNA|circulating tumor dna
4744600|NCT02958852|Cholesterol|cholesterol
4744601|NCT02958839|Atrial fibrillation|atrial fibrillation
4744602|NCT02958839|Fibroblast Growth factor 23|fibroblast growth factor 23
4744603|NCT02958800|Deprescribing|deprescribing
4744604|NCT02958800|Single patient open label trial|single patient open label trial
4744605|NCT02958800|Long-term care|long-term care
4744606|NCT02958761|knee arthrosis|knee arthrosis
4744607|NCT02958761|platelet-derived growth factors|platelet-derived growth factors
4744608|NCT02958735|exercise|exercise
4744609|NCT02958735|cognition|cognition
4744610|NCT02958735|brain-derived neurotrophic factor|brain-derived neurotrophic factor
4744611|NCT02958735|insulin-like growth factor 1|insulin-like growth factor 1
4744612|NCT02958735|cortisol|cortisol
4744613|NCT02958683|Optoelectronic plethysmography|optoelectronic plethysmography
4744614|NCT02958683|Structure light plethysmography|structure light plethysmography
4744615|NCT02958683|Respiratory Function Tests|respiratory function tests
4744616|NCT02958657|Platelet function|platelet function
4744617|NCT02958657|Autonomic Nervous System|autonomic nervous system
4744618|NCT02958657|Multiplate® (Multiple Electrode Aggregometry - MEA)|multiplate® (multiple electrode aggregometry - mea)
4744619|NCT02958657|VerifyNow®|verifynow®
4744620|NCT02958644|synbiotic|synbiotic
4744621|NCT02958644|obesity|obesity
4744622|NCT02958644|body mass index|body mass index
4744623|NCT02958644|microbiota|microbiota
4744624|NCT02958605|Children|children
4744625|NCT02958605|resuscitation|resuscitation
4744626|NCT02958605|smartphone|smartphone
4744627|NCT02958592|shear-wave elastography|shear-wave elastography
4744628|NCT02958592|hepatic fibrosis|hepatic fibrosis
4744629|NCT02958592|liver tumor|liver tumor
4744630|NCT02958566|Pain control|pain control
4744631|NCT02958566|Post-operative pain|post-operative pain
4744632|NCT02958566|Narcotic|narcotic
4744633|NCT02958566|Non-narcotic|non-narcotic
4744634|NCT02958566|Side effect|side effect
4744635|NCT02958566|Toxicity|toxicity
4744636|NCT02958553|Lower Extremity Limb Loss|lower extremity limb loss
4744637|NCT02958553|Prosthesis Use|prosthesis use
4744638|NCT02958540|Prophylaxis|prophylaxis
4744639|NCT02958527|Effexor|effexor
4744640|NCT02958527|Depression|depression
4744641|NCT02958527|Depressed state|depressed state
4744642|NCT02958514|IPL|ipl
4744643|NCT02958514|MGD|mgd
4744644|NCT02958501|Vitamin D|vitamin d
4744645|NCT02958501|Inflammatory Bowel Diseases|inflammatory bowel diseases
4744646|NCT02958488|34 to 36 Weeks Preterm Neonates|34 to 36 weeks preterm neonates
4744647|NCT02958488|Respiratory Distress Syndrom|respiratory distress syndrom
4744648|NCT02958488|High Flow Nasal Cannula|high flow nasal cannula
4744649|NCT02958436|Safety|safety
4744650|NCT02958436|Tolerability|tolerability
4744651|NCT02958436|Pharmacokinetics|pharmacokinetics
4744652|NCT02958436|REGN3500|regn3500
4744653|NCT02958410|CD30|cd30
4744654|NCT02958410|CAR-T|car-t
4744655|NCT02958397|Myeloid Malignancies|myeloid malignancies
4744656|NCT02958397|CAR-T|car-t
4744657|NCT02958397|CD33|cd33
4744658|NCT02958384|Myeloid Malignancies|myeloid malignancies
4744659|NCT02958384|CAR-T|car-t
4744660|NCT02958384|LeY|ley
4744661|NCT02958371|Functional magnetic resonance imaging|functional magnetic resonance imaging
4744662|NCT02958371|Taste|taste
4744663|NCT02958371|Feeding behavior|feeding behavior
4744664|NCT02958371|Choice behavior|choice behavior
4744665|NCT02958358|pulmonary hypertension|pulmonary hypertension
4744666|NCT02958358|ambrisentan|ambrisentan
4744667|NCT02958358|PET imaging|pet imaging
4744668|NCT02958358|CT/PET|ct/pet
4744669|NCT02958332|video games|video games
4744670|NCT02958306|cleft lip repair|cleft lip repair
4744671|NCT02958306|cheiloplasty|cheiloplasty
4744672|NCT02958306|PRP|prp
4744673|NCT02958306|platelet rich plasma|platelet rich plasma
4744674|NCT02958280|Exercise|exercise
4744675|NCT02958280|Smartphone|smartphone
4744676|NCT02958267|knee osteoarthritis|knee osteoarthritis
4744677|NCT02958267|regenerative medicine|regenerative medicine
4744678|NCT02958267|orthobiologics|orthobiologics
4744679|NCT02958267|cellular therapy|cellular therapy
4744680|NCT02958254|hamstring|hamstring
4744681|NCT02958254|ultrasonography|ultrasonography
4744682|NCT02958254|validation|validation
4744683|NCT02958254|magnetic resonance imaging|magnetic resonance imaging
4744684|NCT02958254|muscle thickness|muscle thickness
4744685|NCT02958241|spondylolisthesis|spondylolisthesis
4744686|NCT02958241|Lumbar spine|lumbar spine
4744687|NCT02958241|MRI|mri
4744688|NCT02958228|Positive Affect|positive affect
4744689|NCT02958228|Mental Imagery|mental imagery
4744690|NCT02958228|Cognitive Bias Modification|cognitive bias modification
4744691|NCT02958228|Cognitive Control Training|cognitive control training
4744692|NCT02958215|Orthostatic|orthostatic
4744693|NCT02958215|Cesarean section|cesarean section
4744694|NCT02958215|Pregnant|pregnant
4744695|NCT02958215|Phenyephrine|phenyephrine
4744696|NCT02958215|Hypotension|hypotension
4744697|NCT02958202|Duchenne Muscular Dystrophy|duchenne muscular dystrophy
4744698|NCT02958202|DMD|dmd
4744699|NCT02958202|Dystrophin|dystrophin
4744700|NCT02958202|BMN 044|bmn 044
4744701|NCT02958202|PRO044|pro044
4744702|NCT02958202|BioMarin|biomarin
4744703|NCT02958189|Twitter|twitter
4744704|NCT02958189|social support|social support
4744705|NCT02958189|internet intervention|internet intervention
4744706|NCT02958189|sedentary lifestyle|sedentary lifestyle
4744707|NCT02958189|walking|walking
4744708|NCT02958189|behavior change|behavior change
4744709|NCT02958163|Hepatocellular cancer|hepatocellular cancer
4744710|NCT02958163|Stereotactic Body Radiotherapy|stereotactic body radiotherapy
4744711|NCT02958163|Chemoembolization, Therapeutic|chemoembolization, therapeutic
4744712|NCT02958111|Nasopharyngeal Carcinoma|nasopharyngeal carcinoma
4744713|NCT02958111|Adjuvant chemotherapy|adjuvant chemotherapy
4744714|NCT02958111|Capecitabine|capecitabine
4744715|NCT02958098|myocardial infarction|myocardial infarction
4744716|NCT02958098|stroke|stroke
4744717|NCT02958098|dilated cardiomyopathy|dilated cardiomyopathy
4744718|NCT02958098|systolic heart failure|systolic heart failure
4744719|NCT02958098|atrial fibrillation|atrial fibrillation
4744720|NCT02958098|aortic dissection|aortic dissection
4744721|NCT02958098|wearable devices|wearable devices
4744722|NCT02958098|genomic sequencing|genomic sequencing
4744723|NCT02958072|Malleoli ulcers|malleoli ulcers
4744724|NCT02958072|Diabetes|diabetes
4744725|NCT02958072|Healing|healing
4744726|NCT02958072|Dressing|dressing
4744727|NCT02958072|LeucoPatch|leucopatch
4744728|NCT02958059|ERCP|ercp
4744729|NCT02958059|prophylaxis|prophylaxis
4744730|NCT02958059|antibiotics|antibiotics
4744731|NCT02958059|infection|infection
4744732|NCT02958059|cholangitis|cholangitis
4744733|NCT02958020|cohort, osteoporosis, bone mineral density, Chinese|cohort, osteoporosis, bone mineral density, chinese
4744734|NCT02957981|BRCA1|brca1
4744735|NCT02957981|BRCA2|brca2
4744736|NCT02957981|Men|men
4744737|NCT02957981|Hereditary Cancer|hereditary cancer
4744738|NCT02957981|Prostate Cancer|prostate cancer
4744739|NCT02957981|Male Breast Cancer|male breast cancer
4744740|NCT02957968|Breast Cancer|breast cancer
4744741|NCT02957955|Heart failure|heart failure
4744742|NCT02957942|Repetitive transcranial magnetic stimulation (rTMS)|repetitive transcranial magnetic stimulation (rtms)
4744743|NCT02957942|Spasmodic dysphonia|spasmodic dysphonia
4744744|NCT02957942|Dystonia|dystonia
4744745|NCT02957877|Anticoagulation|anticoagulation
4744746|NCT02957877|Anti-Xa activity|anti-xa activity
4744747|NCT02957877|Low-molecular weight heparin|low-molecular weight heparin
4744748|NCT02957877|Unfractionated heparin|unfractionated heparin
4744749|NCT02957838|Transferrin Receptor|transferrin receptor
4744750|NCT02957838|Type 2 Diabetes|type 2 diabetes
4744751|NCT02957838|Stearic Acid (C18:0)|stearic acid (c18:0)
4744752|NCT02957838|Mitochondrial Morphology|mitochondrial morphology
4744753|NCT02957838|Crossover Study|crossover study
4744754|NCT02957812|Gait|gait
4744755|NCT02957812|Balance Control|balance control
4744756|NCT02957812|Orthotics|orthotics
4744757|NCT02957799|Pregnancy|pregnancy
4744758|NCT02957799|Home Healthcare Visits|home healthcare visits
4744759|NCT02957799|Community Health Workers|community health workers
4744760|NCT02957799|Infants|infants
4744761|NCT02957786|cytisine|cytisine
4744762|NCT02957786|varenicline|varenicline
4744763|NCT02957786|smoking cessation|smoking cessation
4744764|NCT02957786|indigenous|indigenous
4744765|NCT02957747|Women Veterans|women veterans
4744766|NCT02957747|Sexual Trauma|sexual trauma
4744767|NCT02957734|Vertical dimension of occlusion|vertical dimension of occlusion
4744768|NCT02957734|Direct composite restorations|direct composite restorations
4744769|NCT02957734|Indirect composite restorations|indirect composite restorations
4744770|NCT02957734|Tooth wear|tooth wear
4744771|NCT02957734|Failure|failure
4744772|NCT02957734|Quality of Life|quality of life
4744773|NCT02957695|frontal brain lesions|frontal brain lesions
4744774|NCT02957695|neurofeedback|neurofeedback
4744775|NCT02957695|cognitive functions|cognitive functions
4744776|NCT02957682|Hyperlipidemias|hyperlipidemias
4744777|NCT02957682|Dyslipidemias|dyslipidemias
4744778|NCT02957682|Lipid Metabolism Disorders|lipid metabolism disorders
4744779|NCT02957630|Estetrol (E4)|estetrol (e4)
4744780|NCT02957630|Drospirenone (DRSP)|drospirenone (drsp)
4744781|NCT02957630|Ethinylestradiol (EE)|ethinylestradiol (ee)
4744782|NCT02957630|Levonorgestrel (LNG)|levonorgestrel (lng)
4744783|NCT02957630|Oral contraceptive|oral contraceptive
4744784|NCT02957630|Prevention of pregnancy|prevention of pregnancy
4744786|NCT02957630|Metabolism|metabolism
4744787|NCT02957617|Neuropathic Pain From Lumbosacral Radiculopathy|neuropathic pain from lumbosacral radiculopathy
4744788|NCT02957604|Pregnancy; Cardiovascular Diseases; High serum cholesterol|pregnancy; cardiovascular diseases; high serum cholesterol
4744789|NCT02957591|Depression|depression
4744790|NCT02957591|probiotic supplementation|probiotic supplementation
4744791|NCT02957591|Adjuvant Therapy|adjuvant therapy
4744792|NCT02957591|Gut microbiome|gut microbiome
4744793|NCT02957591|Psychological functioning|psychological functioning
4744794|NCT02957591|Brain imaging|brain imaging
4744795|NCT02957591|Brain-Gut interactions|brain-gut interactions
4744796|NCT02957591|Sleep|sleep
4744797|NCT02957578|Tympanostomy Tube|tympanostomy tube
4744798|NCT02957578|Ventilation Tube|ventilation tube
4744799|NCT02957578|Grommet|grommet
4744800|NCT02957578|Otitis Media|otitis media
4744801|NCT02957578|Middle Ear Effusion|middle ear effusion
4744802|NCT02957565|Malignant neoplasms of independent (primary) multiple sites|malignant neoplasms of independent (primary) multiple sites
4744803|NCT02957565|Questionnaires|questionnaires
4744804|NCT02957565|Surveys|surveys
4744805|NCT02957565|Videos|videos
4744806|NCT02957565|Advanced Cancer|advanced cancer
4744807|NCT02957539|motivation|motivation
4744808|NCT02957539|patient incentives|patient incentives
4744809|NCT02957513|Diabetes|diabetes
4744810|NCT02957513|Uncontrolled|uncontrolled
4744811|NCT02957513|Chronic Disease|chronic disease
4744812|NCT02957513|Chronic Conditions|chronic conditions
4744813|NCT02957513|Medically Underserved Areas|medically underserved areas
4744814|NCT02957513|African Americans|african americans
4744815|NCT02957513|Health Coaching|health coaching
4744816|NCT02957513|Health Education|health education
4744817|NCT02957513|Text Messaging|text messaging
4744818|NCT02957513|Text Messages|text messages
4744819|NCT02957513|Mobile Health|mobile health
4744820|NCT02957474|Healthy Volunteers|healthy volunteers
4744821|NCT02957474|Pharmacokinetics|pharmacokinetics
4744822|NCT02957474|Food Effect|food effect
4744823|NCT02957474|Proton Pump|proton pump
4744824|NCT02957474|GED-0301|ged-0301
4744825|NCT02957474|Mongersen|mongersen
4744826|NCT02957422|milk|milk
4744827|NCT02957422|brain aging|brain aging
4744828|NCT02957422|antioxidant|antioxidant
4744829|NCT02957422|glutathione|glutathione
4744830|NCT02957422|dietary intervention|dietary intervention
4744831|NCT02957422|brain imaging|brain imaging
4744832|NCT02957409|Heart failure|heart failure
4744833|NCT02957409|Heart Failure with Reduced Ejection Fraction|heart failure with reduced ejection fraction
4744834|NCT02957409|HFrEF|hfref
4744835|NCT02957383|Sleep, Melatonin|sleep, melatonin
4744836|NCT02957383|Circadian Rhythm|circadian rhythm
4744837|NCT02957383|Temperature|temperature
4744838|NCT02957383|screen illumination|screen illumination
4744839|NCT02957344|health communication|health communication
4744840|NCT02957344|Zika virus|zika virus
4744841|NCT02957344|legislation|legislation
4744842|NCT02957344|vaccination|vaccination
4744843|NCT02957344|Child Care|child care
4744844|NCT02957305|misoprostol|misoprostol
4744845|NCT02957305|miscarriage|miscarriage
4744846|NCT02957279|sepsis|sepsis
4744847|NCT02957279|exosomes|exosomes
4744848|NCT02957279|dendritic cell|dendritic cell
4744849|NCT02957266|cervical cancer|cervical cancer
4744850|NCT02957266|interstitial brachytherapy|interstitial brachytherapy
4744851|NCT02957266|gemcitabine|gemcitabine
4744852|NCT02957266|volumetric arc therapy|volumetric arc therapy
4744853|NCT02957253|Quality of care|quality of care
4744854|NCT02957253|Health related quality of life|health related quality of life
4744855|NCT02957253|Nurse-led clinic|nurse-led clinic
4744856|NCT02957253|Health economics|health economics
4744857|NCT02957240|Forearm [A01.378.800.585]|forearm [a01.378.800.585]
4744858|NCT02957240|Radius [A02.835.232.087.090.700]|radius [a02.835.232.087.090.700]
4744859|NCT02957240|Motor Skills [F02.808.260]|motor skills [f02.808.260]
4744860|NCT02957240|Task Performance and Analysis [F02.808.600]|task performance and analysis [f02.808.600]
4744861|NCT02957240|Casts, Surgical [E07.858.442.660.430.500]|casts, surgical [e07.858.442.660.430.500]
4744862|NCT02957240|Splints [E07.858.690.725.430.750]|splints [e07.858.690.725.430.750]
4744863|NCT02957240|motor representation techniques|motor representation techniques
4744864|NCT02957240|mirror therapy|mirror therapy
4744865|NCT02957240|Women [M01.975]|women [m01.975]
4744866|NCT02957227|Alzheimer's disease|alzheimer's disease
4744867|NCT02957227|Frontotemporal Dementia|frontotemporal dementia
4744868|NCT02957227|Lewy Body Dementia|lewy body dementia
4744869|NCT02957227|Diagnosis|diagnosis
4744870|NCT02957188|Eicosapentaenoic acid|eicosapentaenoic acid
4744871|NCT02957188|Arachidonic acid|arachidonic acid
4744872|NCT02957188|Metabolism|metabolism
4744873|NCT02957188|Healthy aging|healthy aging
4744874|NCT02957175|Immunophenotyping|immunophenotyping
4744875|NCT02957175|Perioperative Care|perioperative care
4744876|NCT02957175|Innate Immunity|innate immunity
4744877|NCT02957175|Cardiac Surgical Procedures|cardiac surgical procedures
4744878|NCT02957136|Respiratory Tract Infections|respiratory tract infections
4744879|NCT02957136|Influenza, Human|influenza, human
4744880|NCT02957136|Common Cold|common cold
4744881|NCT02957136|Viral Infection|viral infection
4744882|NCT02957136|Pathology, Molecular|pathology, molecular
4744883|NCT02957136|Molecular Diagnostics|molecular diagnostics
4744884|NCT02957136|Diagnostic Testing|diagnostic testing
4744885|NCT02957136|Clinical Microbiology|clinical microbiology
4744886|NCT02957136|Polymerase Chain Reaction|polymerase chain reaction
4744887|NCT02957136|Antibiotic Stewardship|antibiotic stewardship
4744888|NCT02957136|Antimicrobial Use|antimicrobial use
4744889|NCT02957136|Emergency Department|emergency department
4744890|NCT02957136|Emergency Room|emergency room
4744891|NCT02957123|macrophages M2 type|macrophages m2 type
4744892|NCT02957123|cytokines|cytokines
4744893|NCT02957123|intranasal administration|intranasal administration
4744894|NCT02957123|neuroprotection|neuroprotection
4744895|NCT02957123|neuroregeneration|neuroregeneration
4744896|NCT02957123|organic brain syndrome|organic brain syndrome
4744897|NCT02957123|neurocognitive disorders|neurocognitive disorders
4744898|NCT02957097|Gabapentin|gabapentin
4744899|NCT02957097|acute pain|acute pain
4744900|NCT02957084|difficult laryngoscopy|difficult laryngoscopy
4744901|NCT02957084|neck circumference|neck circumference
4744902|NCT02957084|sternomental distance|sternomental distance
4744903|NCT02957084|thyromental distance|thyromental distance
4744904|NCT02957084|hyomental distance|hyomental distance
4744905|NCT02957084|thyrosternal distance|thyrosternal distance
4744906|NCT02957058|Colonoscopy|colonoscopy
4744907|NCT02957058|Endoscopic Mucosal Resection|endoscopic mucosal resection
4744908|NCT02957058|Adenoma Recurrence|adenoma recurrence
4744909|NCT02957058|EMR defect thermal ablation|emr defect thermal ablation
4744910|NCT02956993|peripheral artery disease|peripheral artery disease
4744912|NCT02956993|vonapanitase|vonapanitase
4744913|NCT02956993|critical limb ischemia|critical limb ischemia
4744914|NCT02956993|CLI|cli
4744915|NCT02956993|tibial artery|tibial artery
4744916|NCT02956993|stenosis|stenosis
4744917|NCT02956993|distal popliteal artery|distal popliteal artery
4744918|NCT02956993|peroneal artery|peroneal artery
4744919|NCT02956993|below the knee|below the knee
4744920|NCT02956993|BTK|btk
4744921|NCT02956993|elastase|elastase
4744922|NCT02956993|chymotrypsin-like elastase 1|chymotrypsin-like elastase 1
4744923|NCT02956993|CELA1|cela1
4744924|NCT02956993|PRT-201|prt-201
4744925|NCT02956980|type 1 interferons|type 1 interferons
4744926|NCT02956980|children|children
4744927|NCT02956980|gender|gender
4744928|NCT02956980|pubertal status|pubertal status
4744929|NCT02956980|sex difference|sex difference
4744930|NCT02956967|Non-Interventional Study|non-interventional study
4744931|NCT02956954|Enzyme replacement therapy|enzyme replacement therapy
4744932|NCT02956941|Academic performance|academic performance
4744933|NCT02956941|Behaviour change communication|behaviour change communication
4744934|NCT02956941|Nutritional status|nutritional status
4744935|NCT02956941|School children|school children
4744936|NCT02956941|Ethiopia|ethiopia
4744937|NCT02956915|Transcatheter aortic valve implantation|transcatheter aortic valve implantation
4744938|NCT02956915|SAPIEN-3 prostheses|sapien-3 prostheses
4744939|NCT02956915|Length of stay|length of stay
4744940|NCT02956915|Aortic stenosis|aortic stenosis
4744941|NCT02956889|Carcinoma, Basal Cell|carcinoma, basal cell
4744942|NCT02956889|Vismodegib|vismodegib
4744943|NCT02956889|Radiotherapy|radiotherapy
4744944|NCT02956837|Vaccines|vaccines
4744945|NCT02956837|Respiratory Syncytial Viruses|respiratory syncytial viruses
4744946|NCT02956837|Safety|safety
4744947|NCT02956837|Reactogenicity|reactogenicity
4744948|NCT02956837|Ranking of Formulations|ranking of formulations
4744949|NCT02956837|Immunogenicity|immunogenicity
4744950|NCT02956824|Magnetic Resonance Imaging (MRI)|magnetic resonance imaging (mri)
4744951|NCT02956824|Sacro-iliac joints|sacro-iliac joints
4744952|NCT02956824|Pelvis|pelvis
4744953|NCT02956824|Erosion|erosion
4744954|NCT02956824|Fat deposit|fat deposit
4744955|NCT02956824|Subchondral sclerosis|subchondral sclerosis
4744956|NCT02956824|Bone marrow edema|bone marrow edema
4744957|NCT02956824|Axial spondyloarthritis|axial spondyloarthritis
4744958|NCT02956811|Type 2 Diabetes|type 2 diabetes
4744959|NCT02956811|Left Ventricular Hypertrophy|left ventricular hypertrophy
4744960|NCT02956811|Dapagliflozin|dapagliflozin
4744961|NCT02956798|Renal Cell, Stereotactic ablative body radiotherapy (SAbR), Pazopanib, Oligo-mets|renal cell, stereotactic ablative body radiotherapy (sabr), pazopanib, oligo-mets
4744962|NCT02956785|Propess|propess
4744963|NCT02956759|diabetic retinopathy|diabetic retinopathy
4744964|NCT02956759|Pan-retinal photocoagulation|pan-retinal photocoagulation
4744965|NCT02956759|proliferative|proliferative
4744966|NCT02956759|non-proliferative|non-proliferative
4744967|NCT02956733|inexpensive, fasciotomy|inexpensive, fasciotomy
4744968|NCT02956707|neonates|neonates
4744969|NCT02956707|cardiopulmonary bypass|cardiopulmonary bypass
4744970|NCT02956707|adrenal insufficiency|adrenal insufficiency
4744971|NCT02956707|congenital heart disease|congenital heart disease
4744972|NCT02956694|Aged|aged
4744973|NCT02956694|Cognitive impairment|cognitive impairment
4744974|NCT02956694|Neurocognitive Disorders|neurocognitive disorders
4744975|NCT02956694|Shared decision making|shared decision making
4744976|NCT02956694|Distance learning|distance learning
4744977|NCT02956694|Primary care|primary care
4744978|NCT02956694|Decision support tool|decision support tool
4744979|NCT02956694|Patient decision aid|patient decision aid
4744980|NCT02956668|tDCS|tdcs
4744981|NCT02956668|Visual field|visual field
4744982|NCT02956668|Stroke|stroke
4744983|NCT02956616|Enhanced Recovery|enhanced recovery
4744984|NCT02956590|dyslipidemia|dyslipidemia
4744985|NCT02956590|obesity|obesity
4744986|NCT02956590|pitavastatin|pitavastatin
4744987|NCT02956590|lipids|lipids
4744988|NCT02956577|Global Longitudinal Strain (GLS)|global longitudinal strain (gls)
4744989|NCT02956577|Coronary Flow Velocity Reserve (CFVR)|coronary flow velocity reserve (cfvr)
4744990|NCT02956577|Cardiac dysfunction|cardiac dysfunction
4744991|NCT02956577|Microcirculation|microcirculation
4744992|NCT02956577|Coronary Computed Tomography Angiography (CCTA)|coronary computed tomography angiography (ccta)
4744993|NCT02956577|Type 1 Diabetes|type 1 diabetes
4744994|NCT02956577|Type 2 Diabetes|type 2 diabetes
4744995|NCT02956551|advanced non-small cell lung cancer|advanced non-small cell lung cancer
4744996|NCT02956551|cell based therapy|cell based therapy
4744997|NCT02956551|safety|safety
4744998|NCT02956551|clinical efficacy|clinical efficacy
4744999|NCT02956486|elenbecestat|elenbecestat
4745000|NCT02956486|E2609|e2609
4745001|NCT02956486|Alzheimer's Disease|alzheimer's disease
4745002|NCT02956486|Early Alzheimer's Disease|early alzheimer's disease
4745003|NCT02956486|Prodromal Alzheimer's Disease|prodromal alzheimer's disease
4745004|NCT02956486|Dementia|dementia
4745005|NCT02956486|Dementia, Alzheimer's type|dementia, alzheimer's type
4745006|NCT02956486|mild cognitive impairment|mild cognitive impairment
4745007|NCT02956486|MissionAD1|missionad1
4745008|NCT02956473|Breast Cancer|breast cancer
4745009|NCT02956447|Kisspeptin|kisspeptin
4745010|NCT02956447|Hyperprolactinemia|hyperprolactinemia
4745011|NCT02956408|Obesity|obesity
4745012|NCT02956408|Pediatrics|pediatrics
4745013|NCT02956408|Vitamin D deficiency|vitamin d deficiency
4745014|NCT02956395|adaptive case management approach|adaptive case management approach
4745015|NCT02956395|Transitional Care|transitional care
4745016|NCT02956395|multimorbidity|multimorbidity
4745017|NCT02956382|Ibrutinib|ibrutinib
4745018|NCT02956382|Venetoclax|venetoclax
4745019|NCT02956382|Follicular|follicular
4745020|NCT02956382|Refractory|refractory
4745021|NCT02956382|Relapsed|relapsed
4745022|NCT02956382|Lymphoma|lymphoma
4745023|NCT02956343|Atrial fibrillation|atrial fibrillation
4745024|NCT02956343|cardiovascular App|cardiovascular app
4745025|NCT02956343|Rhythm monitoring|rhythm monitoring
4745026|NCT02956343|Stroke prevention|stroke prevention
4745027|NCT02956330|RVO|rvo
4745028|NCT02956330|ME|me
4745029|NCT02956330|Central Subfield Thickness|central subfield thickness
4745030|NCT02956330|OCT|oct
4745031|NCT02956330|Optical Coherence Tomography|optical coherence tomography
4745032|NCT02956330|Cystoid Macular Edema|cystoid macular edema
4745033|NCT02956330|Subretinal Fluid|subretinal fluid
4745034|NCT02956330|Eylea|eylea
4745035|NCT02956330|Aflibercept|aflibercept
4745036|NCT02956330|Anti-VEGF|anti-vegf
4745037|NCT02956291|glioma|glioma
4745038|NCT02956291|brain tumor|brain tumor
4745039|NCT02956291|brain metastasis|brain metastasis
4745040|NCT02956278|allopurinol|allopurinol
4745041|NCT02956252|cholecystectomy, laparoscopic|cholecystectomy, laparoscopic
4745042|NCT02956252|spinal anesthesia|spinal anesthesia
4745043|NCT02956252|general anesthesia|general anesthesia
4745044|NCT02956252|cholecystectomy|cholecystectomy
4745045|NCT02956239|cervical precancer|cervical precancer
4745046|NCT02956239|screening|screening
4745047|NCT02956239|treatment|treatment
4745048|NCT02956239|thermo-coagulation|thermo-coagulation
4745049|NCT02956239|thermal ablation|thermal ablation
4745050|NCT02956239|Reducing overtreatment|reducing overtreatment
4745051|NCT02956213|COPD|copd
4745052|NCT02956213|air filter|air filter
4745053|NCT02956213|indoor air quality|indoor air quality
4745054|NCT02956213|respiratory symptoms|respiratory symptoms
4745055|NCT02956213|emphysema|emphysema
4745056|NCT02956213|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
4745057|NCT02956213|tobacco use|tobacco use
4745058|NCT02956200|Fingolimod Hydrochloride|fingolimod hydrochloride
4745059|NCT02956200|Intravenous thrombolysis|intravenous thrombolysis
4745060|NCT02956200|Mechanical thrombectomy|mechanical thrombectomy
4745061|NCT02956200|Acute ischemic stroke|acute ischemic stroke
4745062|NCT02956161|Sleep|sleep
4745063|NCT02956161|Auditory stimulations|auditory stimulations
4745064|NCT02956161|Slow oscillations|slow oscillations
4745065|NCT02956096|tDCS|tdcs
4745066|NCT02956096|Stroke|stroke
4745067|NCT02956096|Autonomic Modulation|autonomic modulation
4745068|NCT02956070|dental bleaching|dental bleaching
4745069|NCT02956070|antiinflammatory|antiinflammatory
4745070|NCT02956070|tooth sensitivity|tooth sensitivity
4745071|NCT02956031|cancer prevention|cancer prevention
4745072|NCT02956031|cervical screening|cervical screening
4745073|NCT02956031|cervical cancer|cervical cancer
4745074|NCT02956031|cervical disease|cervical disease
4745075|NCT02956031|cervical neoplasm|cervical neoplasm
4745076|NCT02956031|HPV testing|hpv testing
4745077|NCT02956031|immunocytochemistry|immunocytochemistry
4745078|NCT02956031|triage techniques|triage techniques
4745079|NCT02956018|children|children
4745080|NCT02955979|acute renal insufficiency|acute renal insufficiency
4745081|NCT02955979|Iodinated Contrast Agents|iodinated contrast agents
4745082|NCT02955979|pediatric|pediatric
4745083|NCT02955966|Aspergillosis|aspergillosis
4745084|NCT02955966|Haematological malignancy|haematological malignancy
4745085|NCT02955966|18F-FDG PET/CT|18f-fdg pet/ct
4745086|NCT02955966|Biomarkers|biomarkers
4745087|NCT02955940|Solid tumors|solid tumors
4745088|NCT02955940|ruxolitinib|ruxolitinib
4745089|NCT02955940|regorafenib|regorafenib
4745090|NCT02955940|capecitabine|capecitabine
4745091|NCT02955927|Myopia control,ortho-k, atropine eye drops, children|myopia control,ortho-k, atropine eye drops, children
4745092|NCT02955914|Optimism|optimism
4745093|NCT02955914|Pessimism|pessimism
4745094|NCT02955914|Recovery|recovery
4745095|NCT02955914|Elective Cardiac surgery|elective cardiac surgery
4745096|NCT02955901|Randomized controlled trial|randomized controlled trial
4745097|NCT02955901|Colonoscopy|colonoscopy
4745098|NCT02955901|Colon Disease|colon disease
4745099|NCT02955901|Low residue diet|low residue diet
4745100|NCT02955901|Colon preparation|colon preparation
4745101|NCT02955875|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
4745102|NCT02955875|Pharmaceutical Services|pharmaceutical services
4745103|NCT02955862|Cryptococcal antigenemia|cryptococcal antigenemia
4745104|NCT02955862|Cryptococcal meningitis|cryptococcal meningitis
4745105|NCT02955862|HIV/AIDS|hiv/aids
4745106|NCT02955849|glaucoma|glaucoma
4745107|NCT02955849|rural|rural
4745108|NCT02955849|China|china
4745109|NCT02955849|SLT|slt
4745110|NCT02955836|Patient Safety|patient safety
4745111|NCT02955836|Quality indicator|quality indicator
4745112|NCT02955836|Information system|information system
4745113|NCT02955836|Nursing|nursing
4745114|NCT02955836|Healthcare Quality|healthcare quality
4745115|NCT02955836|Quality measurement|quality measurement
4745116|NCT02955823|B cell Lymphoma|b cell lymphoma
4745117|NCT02955823|non-Hodgkin Lymphoma|non-hodgkin lymphoma
4745118|NCT02955823|Elderly patients|elderly patients
4745119|NCT02955810|Newly Diagnosed|newly diagnosed
4745120|NCT02955810|Treatment Naiive|treatment naiive
4745121|NCT02955797|Meningitis|meningitis
4745122|NCT02955797|Meningococcal Meningitis|meningococcal meningitis
4745123|NCT02955797|MenACYW conjugate vaccine|menacyw conjugate vaccine
4745124|NCT02955797|Nimenrix®|nimenrix®
4745125|NCT02955797|Menjugate®|menjugate®
4745126|NCT02955771|photodynamic therapy(PDT)|photodynamic therapy(pdt)
4745127|NCT02955771|stenting|stenting
4745128|NCT02955771|Hilar Cholangiocarcinoma|hilar cholangiocarcinoma
4745129|NCT02955771|Deuteporfin|deuteporfin
4745130|NCT02955719|Collaborative Care|collaborative care
4745131|NCT02955719|Depression|depression
4745132|NCT02955719|Anxiety|anxiety
4745133|NCT02955719|Mild Cognitive Impairment|mild cognitive impairment
4745134|NCT02955719|Integrated Care Pathway|integrated care pathway
4745135|NCT02955693|Pharmacokinetics|pharmacokinetics
4745136|NCT02955693|Healthy volunteers|healthy volunteers
4745137|NCT02955693|Monomethylfumarate|monomethylfumarate
4745138|NCT02955693|Dimethyl fumarate|dimethyl fumarate
4745139|NCT02955693|Fumaderm®|fumaderm®
4745140|NCT02955693|Ethyl fumarate|ethyl fumarate
4745141|NCT02955680|emergence delirium|emergence delirium
4745142|NCT02955680|emergence time|emergence time
4745143|NCT02955680|bispectral index|bispectral index
4745144|NCT02955667|invivo microscopy|invivo microscopy
4745145|NCT02955667|colposcopy|colposcopy
4745146|NCT02955667|cervical precancer and cancer|cervical precancer and cancer
4745147|NCT02955641|Laser peripheral iridotomy|laser peripheral iridotomy
4745148|NCT02955641|topical anti-inflammatory drops|topical anti-inflammatory drops
4745149|NCT02955602|PBC|pbc
4745150|NCT02955602|Primary Biliary Cholangitis (PBC)|primary biliary cholangitis (pbc)
4745151|NCT02955576|Psoriasis|psoriasis
4745152|NCT02955563|decision making for incapacitated patients|decision making for incapacitated patients
4745153|NCT02955563|intensive care|intensive care
4745154|NCT02955563|surrogate decision making|surrogate decision making
4745155|NCT02955563|patient centered care|patient centered care
4745156|NCT02955563|Palliative Care|palliative care
4745157|NCT02955563|End of Life|end of life
4745158|NCT02955563|Quality of Communication|quality of communication
4745159|NCT02955563|Anxiety|anxiety
4745160|NCT02955563|Depression|depression
4745161|NCT02955550|Multiple Myeloma|multiple myeloma
4745162|NCT02955550|Plasma Cell Myeloma|plasma cell myeloma
4745163|NCT02955550|Plasma Cell Neoplasm|plasma cell neoplasm
4745164|NCT02955550|Relapsed/refractory Myeloma|relapsed/refractory myeloma
4745165|NCT02955550|PNK-007|pnk-007
4745166|NCT02955550|Recombinant Human IL-2 (RHIL-2)|recombinant human il-2 (rhil-2)
4745167|NCT02955550|Human IL-2|human il-2
4745168|NCT02955550|Bone Marrow Transplant|bone marrow transplant
4745169|NCT02955537|Hypertension|hypertension
4745170|NCT02955537|mHealth|mhealth
4745171|NCT02955485|Ankle|ankle
4745172|NCT02955485|Instability|instability
4745173|NCT02955485|Prediction|prediction
4745174|NCT02955472|Neuralgia, Postherpetic|neuralgia, postherpetic
4745175|NCT02955472|Postherpetic Neuralgia|postherpetic neuralgia
4745176|NCT02955472|Diabetic Neuropathies|diabetic neuropathies
4745177|NCT02955472|Diabetic Neuralgia|diabetic neuralgia
4745178|NCT02955472|Diabetic Polyneuropathy|diabetic polyneuropathy
4745179|NCT02955472|Diabetic Neuropathy, Painful|diabetic neuropathy, painful
4745180|NCT02955472|Neuralgia|neuralgia
4745181|NCT02955472|Neuropathic Pain|neuropathic pain
4745182|NCT02955472|Pregabalin|pregabalin
4745183|NCT02955472|Pharmacokinetics|pharmacokinetics
4745184|NCT02955472|Bioequivalent|bioequivalent
4745185|NCT02955459|Healthy volunteers|healthy volunteers
4745186|NCT02955459|Pharmacokinetics|pharmacokinetics
4745187|NCT02955446|Refractory Tumors|refractory tumors
4745188|NCT02955446|Advanced Solid Tumors|advanced solid tumors
4745189|NCT02955433|Rideshare|rideshare
4745190|NCT02955433|Digital transportation network|digital transportation network
4745191|NCT02955433|Missed appointment|missed appointment
4745192|NCT02955420|Autoantibodies|autoantibodies
4745193|NCT02955420|Heart Failure|heart failure
4745194|NCT02955420|Fatigue Syndrome, Chronic|fatigue syndrome, chronic
4745195|NCT02955420|Idiopathic Pulmonary Hypertension|idiopathic pulmonary hypertension
4745196|NCT02955420|Cardiomyopathies|cardiomyopathies
4745197|NCT02955394|ER+/Her2 - breast cancer|er+/her2 - breast cancer
4745198|NCT02955394|Preoperative Fulvestrant|preoperative fulvestrant
4745199|NCT02955394|Enzalutamide|enzalutamide
4745200|NCT02955368|DP-R212|dp-r212
4745201|NCT02955303|Cognitive training|cognitive training
4745202|NCT02955303|Tablet computers|tablet computers
4745203|NCT02955277|Cognitive training|cognitive training
4745204|NCT02955277|Tablet computers|tablet computers
4745205|NCT02955264|Glycosylation|glycosylation
4745206|NCT02955264|Glucose Metabolic Disorder|glucose metabolic disorder
4745207|NCT02955264|Galactose|galactose
4745208|NCT02955251|Cancer|cancer
4745209|NCT02955251|Neoplasm|neoplasm
4745210|NCT02955251|Advanced solid tumor|advanced solid tumor
4745211|NCT02955251|Nivolumab|nivolumab
4745212|NCT02955251|Non-small cell lung cancer (NSCLC)|non-small cell lung cancer (nsclc)
4745213|NCT02955251|Non-squamous NSCLC|non-squamous nsclc
4745214|NCT02955251|Ovarian cancer|ovarian cancer
4745215|NCT02955238|Intervention|intervention
4745216|NCT02955238|Cardiovascular Disease|cardiovascular disease
4745217|NCT02955238|CVD|cvd
4745218|NCT02955238|Diabetes|diabetes
4745219|NCT02955238|Latinos|latinos
4745220|NCT02955238|CIMT|cimt
4745221|NCT02955238|Medication Adherence|medication adherence
4745222|NCT02955238|Risk Factors|risk factors
4745223|NCT02955238|T2D|t2d
4745224|NCT02955225|Knee loads|knee loads
4745225|NCT02955225|Knee adduction moment|knee adduction moment
4745226|NCT02955225|Biomechanical intervention|biomechanical intervention
4745227|NCT02955225|Insole|insole
4745228|NCT02955225|Shoe|shoe
4745229|NCT02955212|Rheumatoid Arthritis|rheumatoid arthritis
4745230|NCT02955212|Conventional Synthetic Disease-Modifying Anti-Rheumatic Drugs (csDMARDs)|conventional synthetic disease-modifying anti-rheumatic drugs (csdmards)
4745231|NCT02955212|ABT-494|abt-494
4745232|NCT02955134|central blinded histological assessment|central blinded histological assessment
4745233|NCT02955134|traditional Chinese medicine intervention|traditional chinese medicine intervention
4745234|NCT02955134|long-term follow-up study|long-term follow-up study
4745235|NCT02955134|biological specimen banks|biological specimen banks
4745236|NCT02955121|Cytochrome P-450 CYP2C19|cytochrome p-450 cyp2c19
4745237|NCT02955121|Pharmacogenetics|pharmacogenetics
4745238|NCT02955121|Platelet Aggregation Inhibitors|platelet aggregation inhibitors
4745239|NCT02955121|Percutaneous Coronary Intervention|percutaneous coronary intervention
4745240|NCT02955069|Advanced or metastatic|advanced or metastatic
4745241|NCT02955069|NET|net
4745242|NCT02955069|pNET|pnet
4745243|NCT02955069|GI NET|gi net
4745244|NCT02955069|thoracic NET|thoracic net
4745245|NCT02955069|GEP-NEC|gep-nec
4745246|NCT02955056|Weber B|weber b
4745247|NCT02955043|Hematopoietic Stem Cell Transplantation (HSCT)|hematopoietic stem cell transplantation (hsct)
4745248|NCT02955043|Fatigue|fatigue
4745249|NCT02955043|Insomnia|insomnia
4745250|NCT02955043|Depression|depression
4745251|NCT02955043|Behavioral Intervention|behavioral intervention
4745252|NCT02955017|obesity|obesity
4745253|NCT02955017|children|children
4745254|NCT02955017|adolescents|adolescents
4745255|NCT02955017|new technology|new technology
4745256|NCT02955017|mobile health|mobile health
4745257|NCT02955017|chronic disease|chronic disease
4745258|NCT02955004|silent brain embolism|silent brain embolism
4745259|NCT02955004|atrial fibrillation|atrial fibrillation
4745260|NCT02955004|cardioversion|cardioversion
4745261|NCT02954965|graduate student|graduate student
4745262|NCT02954965|burnout|burnout
4745263|NCT02954965|stress|stress
4745264|NCT02954965|mood|mood
4745265|NCT02954939|lupus nephritis|lupus nephritis
4745266|NCT02954939|lymphocyte subsets|lymphocyte subsets
4745267|NCT02954939|cytokines|cytokines
4745268|NCT02954939|mycophenolate mofetil|mycophenolate mofetil
4745269|NCT02954939|cyclophosphamide|cyclophosphamide
4745270|NCT02954900|Breast Cancer Prevention|breast cancer prevention
4745271|NCT02954900|Risk Assessment|risk assessment
4745272|NCT02954900|Chemoprevention|chemoprevention
4745273|NCT02954900|Decision Making|decision making
4745274|NCT02954887|GWP42003-P|gwp42003-p
4745275|NCT02954887|Cannabidiol|cannabidiol
4745276|NCT02954809|fatigue|fatigue
4745277|NCT02954809|sleep disturbances|sleep disturbances
4745278|NCT02954809|circadian activity rhythms|circadian activity rhythms
4745279|NCT02954783|Prostate cancer|prostate cancer
4745280|NCT02954783|Localized|localized
4745281|NCT02954783|Exercise|exercise
4745282|NCT02954783|Physical activity|physical activity
4745283|NCT02954783|Natural killer cells|natural killer cells
4745284|NCT02954783|Immune cells|immune cells
4745285|NCT02954757|uterine adenomyosis|uterine adenomyosis
4745286|NCT02954744|uterine fibroid|uterine fibroid
4745287|NCT02954731|Cognitive Behavior Therapy|cognitive behavior therapy
4745288|NCT02954731|Negative Affect|negative affect
4745289|NCT02954731|Unified Protocol|unified protocol
4745290|NCT02954731|Session Tracking|session tracking
4745291|NCT02954731|Mechanisms of Change in Psychotherapy|mechanisms of change in psychotherapy
4745292|NCT02954718|activity performance|activity performance
4745293|NCT02954718|juvenile idiopathic arthritis|juvenile idiopathic arthritis
4745294|NCT02954718|virtual reality|virtual reality
4745295|NCT02954679|Psychoactive Substances Consumption|psychoactive substances consumption
4745296|NCT02954679|Substance-related Disorder|substance-related disorder
4745297|NCT02954679|Off label-use|off label-use
4745298|NCT02954679|Cognitive Enhancement|cognitive enhancement
4745299|NCT02954679|Students|students
4745300|NCT02954679|Doping|doping
4745301|NCT02954679|Stimulants|stimulants
4745302|NCT02954679|Drug abuse|drug abuse
4745303|NCT02954679|Methylphenidate|methylphenidate
4745304|NCT02954679|Addictovigilance|addictovigilance
4745305|NCT02954679|CEIP|ceip
4745306|NCT02954666|cardio-neuromodulation|cardio-neuromodulation
4745307|NCT02954666|cardio-neuroablation|cardio-neuroablation
4745308|NCT02954666|ablation|ablation
4745309|NCT02954666|ganglionated plexi|ganglionated plexi
4745310|NCT02954666|anterior right ganglionated plexus|anterior right ganglionated plexus
4745311|NCT02954666|syncope|syncope
4745312|NCT02954653|relapsed|relapsed
4745313|NCT02954653|refractory|refractory
4745314|NCT02954653|acute myeloid leukemia|acute myeloid leukemia
4745316|NCT02954627|Osteoarthritis|osteoarthritis
4745317|NCT02954627|Obesity|obesity
4745318|NCT02954627|Liraglutide 3 mg|liraglutide 3 mg
4745319|NCT02954627|Liraglutide|liraglutide
4745320|NCT02954627|Ultrasound|ultrasound
4745321|NCT02954601|Oral Insulin|oral insulin
4745322|NCT02954601|DM T2 (Diabetes Mellitus Type 2)|dm t2 (diabetes mellitus type 2)
4745323|NCT02954562|anxiety|anxiety
4745324|NCT02954562|fMRI|fmri
4745325|NCT02954562|emotion regulation|emotion regulation
4745326|NCT02954549|vitamin D deficiency, genomics, vitamin D supplementation|vitamin d deficiency, genomics, vitamin d supplementation
4745327|NCT02954536|pembrolizumab|pembrolizumab
4745328|NCT02954536|trastuzumab|trastuzumab
4745329|NCT02954536|capecitabine|capecitabine
4745330|NCT02954536|cisplatin|cisplatin
4745331|NCT02954536|Stage IV|stage iv
4745332|NCT02954536|HER2-positive|her2-positive
4745333|NCT02954536|esophagogastric cancer|esophagogastric cancer
4745334|NCT02954536|16-937|16-937
4745335|NCT02954536|Oxaliplatin|oxaliplatin
4745336|NCT02954536|5-Fluorouracil (5-FU)|5-fluorouracil (5-fu)
4745337|NCT02954523|NSCLC|nsclc
4745338|NCT02954523|Non-small cell|non-small cell
4745339|NCT02954523|Lung Cancer|lung cancer
4745340|NCT02954523|Dasatinib|dasatinib
4745341|NCT02954523|Osimertinib|osimertinib
4745342|NCT02954523|AZD9291|azd9291
4745343|NCT02954523|EGFR Mutations|egfr mutations
4745344|NCT02954523|Epidermal growth factor receptor (EGFR)|epidermal growth factor receptor (egfr)
4745345|NCT02954445|BCMA|bcma
4745346|NCT02954445|CAR-T|car-t
4745347|NCT02954432|transcranial Direct Current Stimulation|transcranial direct current stimulation
4745348|NCT02954432|Transcranial Ultrasound|transcranial ultrasound
4745349|NCT02954432|non-invasive brain stimulation|non-invasive brain stimulation
4745350|NCT02954419|IgA Nephropathy|iga nephropathy
4745351|NCT02954419|Biomarker|biomarker
4745352|NCT02954406|Drug Therapy|drug therapy
4745353|NCT02954393|Periodontal disease|periodontal disease
4745354|NCT02954393|Metronidazole|metronidazole
4745355|NCT02954393|Amoxicillin|amoxicillin
4745356|NCT02954393|Scaling and root planing|scaling and root planing
4745357|NCT02954393|Healing phase|healing phase
4745358|NCT02954354|Flu|flu
4745359|NCT02954354|Baloxavir Marboxil|baloxavir marboxil
4745360|NCT02954354|Oseltamivir|oseltamivir
4745361|NCT02954354|Tamiflu®|tamiflu®
4745362|NCT02954302|Delayed gastric emptying|delayed gastric emptying
4745363|NCT02954302|pancreaticoduodenectomy|pancreaticoduodenectomy
4745364|NCT02954289|modifiable risk factors|modifiable risk factors
4745365|NCT02954289|lifestyle|lifestyle
4745366|NCT02954289|nutrition|nutrition
4745367|NCT02954289|weight control|weight control
4745368|NCT02954289|dietary intervention|dietary intervention
4745369|NCT02954289|health promotion|health promotion
4745370|NCT02954289|patient-partner outcomes|patient-partner outcomes
4745371|NCT02954289|survivorship|survivorship
4745372|NCT02954289|prostate cancer outcomes|prostate cancer outcomes
4745373|NCT02954276|safety|safety
4745374|NCT02954263|Multiple ascending dose (MAD)|multiple ascending dose (mad)
4745375|NCT02954237|Non-valvular atrial fibrillation (NVAF)|non-valvular atrial fibrillation (nvaf)
4745376|NCT02954237|Anticoagulant|anticoagulant
4745377|NCT02954237|Warfarin|warfarin
4745378|NCT02954237|Stroke|stroke
4745379|NCT02954224|sleep apnea, delirium|sleep apnea, delirium
4745380|NCT02954211|rTMS|rtms
4745583|NCT02953301|HDAC|hdac
4745381|NCT02954211|noninvasive brain stimulation|noninvasive brain stimulation
4745382|NCT02954211|physical therapy|physical therapy
4745383|NCT02954185|Shoulder Pain|shoulder pain
4745384|NCT02954146|Veterans|veterans
4745385|NCT02954146|Posttraumatic Stress Disorder|posttraumatic stress disorder
4745386|NCT02954146|Anger|anger
4745387|NCT02954146|Behavioral Health|behavioral health
4745388|NCT02954146|Mobile Health Technology|mobile health technology
4745389|NCT02954133|Alignment phase|alignment phase
4745390|NCT02954133|Photobiomodulation|photobiomodulation
4745391|NCT02954133|Orthodontic treatment|orthodontic treatment
4745392|NCT02954133|Malocclusion|malocclusion
4745393|NCT02954133|OrthoPulse™|orthopulse™
4745394|NCT02954133|Invisalign|invisalign
4745395|NCT02954120|8- hydroxy -2´- deoxyguanosine|8- hydroxy -2´- deoxyguanosine
4745396|NCT02954120|Malondialdehyde|malondialdehyde
4745397|NCT02954120|Total antioxidant status|total antioxidant status
4745398|NCT02954120|Oxidative stres|oxidative stres
4745399|NCT02954068|Oxytocin|oxytocin
4745400|NCT02954055|locally advanced|locally advanced
4745401|NCT02954055|metastatic|metastatic
4745402|NCT02954055|breast cancer|breast cancer
4745403|NCT02954055|ER-positive|er-positive
4745404|NCT02954055|HER2-negative|her2-negative
4745405|NCT02954055|Stage IV|stage iv
4745406|NCT02954042|Incontinence|incontinence
4745407|NCT02954016|Obesity|obesity
4745408|NCT02954016|Weight Loss|weight loss
4745409|NCT02954016|Hypertension|hypertension
4745410|NCT02954016|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
4745411|NCT02954016|Hyperlipidemia|hyperlipidemia
4745412|NCT02954003|Obesity|obesity
4745413|NCT02954003|Weight Loss|weight loss
4745414|NCT02953990|Pregnancy|pregnancy
4745415|NCT02953990|Self-Management|self-management
4745416|NCT02953990|Yoga|yoga
4745417|NCT02953951|blood transfusion|blood transfusion
4745418|NCT02953951|free hemoglobin|free hemoglobin
4745419|NCT02953951|nitric oxide|nitric oxide
4745420|NCT02953951|endothelium-dependent vasodilatation|endothelium-dependent vasodilatation
4745421|NCT02953951|peripheral artery tonometry|peripheral artery tonometry
4745422|NCT02953951|cardiac surgery.|cardiac surgery.
4745423|NCT02953938|Ranibizumab|ranibizumab
4745424|NCT02953938|Grid&Direct short pulse laser photocoagulation|grid&direct short pulse laser photocoagulation
4745425|NCT02953938|Macular edema,|macular edema,
4745426|NCT02953938|Branch retinal vein occlusion (BRVO)|branch retinal vein occlusion (brvo)
4745427|NCT02953938|BCVA|bcva
4745428|NCT02953938|CSFT|csft
4745429|NCT02953938|pro re nata|pro re nata
4745430|NCT02953925|primary health care|primary health care
4745431|NCT02953925|village doctor|village doctor
4745432|NCT02953925|township hospital|township hospital
4745433|NCT02953925|community health center|community health center
4745434|NCT02953912|Rotation|rotation
4745435|NCT02953912|Reciprocation|reciprocation
4745436|NCT02953912|single file|single file
4745437|NCT02953912|postoperative pain|postoperative pain
4745438|NCT02953912|Reciproc|reciproc
4745439|NCT02953912|One Shape|one shape
4745440|NCT02953912|Symptomatic irreversible pulpitis|symptomatic irreversible pulpitis
4745441|NCT02953899|Internet|internet
4745442|NCT02953899|Contingency Management|contingency management
4745443|NCT02953899|Gambling Disorder|gambling disorder
4745444|NCT02953899|Rural|rural
4745445|NCT02953886|Caries|caries
4745446|NCT02953886|Cavity|cavity
4745447|NCT02953886|Silver Diamine Fluoride (SDF)|silver diamine fluoride (sdf)
4745448|NCT02953886|HOMINGS|homings
4745449|NCT02953860|Advanced Breast Cancer|advanced breast cancer
4745450|NCT02953860|ER+/Her2 Advanced Breast Cancer|er+/her2 advanced breast cancer
4745451|NCT02953834|insulin regulation in pregnancy|insulin regulation in pregnancy
4745452|NCT02953834|kisspeptin|kisspeptin
4745453|NCT02953808|GSK2315698|gsk2315698
4745454|NCT02953808|Dose-ascending|dose-ascending
4745455|NCT02953808|Systemic amyloidosis|systemic amyloidosis
4745456|NCT02953782|Colorectal Neoplasms, Hu5F9-G4, CD47, cetuximab|colorectal neoplasms, hu5f9-g4, cd47, cetuximab
4745457|NCT02953756|Brain metastases|brain metastases
4745458|NCT02953756|Cognition|cognition
4745459|NCT02953756|Radiosurgery|radiosurgery
4745460|NCT02953756|Stereotactic radiosurgery|stereotactic radiosurgery
4745461|NCT02953756|Gamma Knife Radiosurgery|gamma knife radiosurgery
4745462|NCT02953756|Quality of Life|quality of life
4745463|NCT02953756|Fatigue|fatigue
4745464|NCT02953756|Anxiety|anxiety
4745465|NCT02953756|Depression|depression
4745466|NCT02953743|E7080|e7080
4745467|NCT02953743|Lenvatinib|lenvatinib
4745468|NCT02953743|Pharmacokinetic study|pharmacokinetic study
4745469|NCT02953743|Chinese participants|chinese participants
4745470|NCT02953743|Unresectable Hepatocellular Carcinoma|unresectable hepatocellular carcinoma
4745471|NCT02953717|Brain metastases|brain metastases
4745472|NCT02953717|Cognition|cognition
4745473|NCT02953717|Radiosurgery|radiosurgery
4745474|NCT02953717|Gamma Knife Radiosurgery|gamma knife radiosurgery
4745475|NCT02953717|Stereotactic radiosurgery|stereotactic radiosurgery
4745476|NCT02953717|Whole Brain Radiation Therapy|whole brain radiation therapy
4745477|NCT02953717|Quality of Life|quality of life
4745478|NCT02953717|Fatigue|fatigue
4745479|NCT02953717|Anxiety|anxiety
4745480|NCT02953717|Depression|depression
4745481|NCT02953704|Myelofibrosis|myelofibrosis
4745482|NCT02953704|essential thrombocythemia|essential thrombocythemia
4745483|NCT02953704|clinical characteristics|clinical characteristics
4745484|NCT02953704|disease burden|disease burden
4745485|NCT02953704|patient-reported outcomes|patient-reported outcomes
4745486|NCT02953691|perioperative|perioperative
4745487|NCT02953691|surgery|surgery
4745488|NCT02953691|pain|pain
4745489|NCT02953691|anxiety|anxiety
4745490|NCT02953691|post operative cognitive dysfunction|post operative cognitive dysfunction
4745491|NCT02953691|cognition|cognition
4745492|NCT02953678|Graft-versus-host disease (GVHD)|graft-versus-host disease (gvhd)
4745493|NCT02953678|acute GVHD|acute gvhd
4745494|NCT02953678|steroid-refractory|steroid-refractory
4745495|NCT02953678|ruxolitinib|ruxolitinib
4745496|NCT02953678|Janus kinase inhibitor|janus kinase inhibitor
4745497|NCT02953665|Parkinson's Disease, Liraglutide|parkinson's disease, liraglutide
4745498|NCT02953665|Antidiabetic agents|antidiabetic agents
4745499|NCT02953665|GLP-1 agonists|glp-1 agonists
4745500|NCT02953665|Insulin resistance|insulin resistance
4745501|NCT02953626|pilot RCT|pilot rct
4745502|NCT02953626|waitlist-controlled RCT|waitlist-controlled rct
4745503|NCT02953626|postpartum depression|postpartum depression
4745504|NCT02953613|Cardiac Catheterization|cardiac catheterization
4745505|NCT02953613|Cardiac intervention|cardiac intervention
4745506|NCT02953613|coronary angiogram|coronary angiogram
4745507|NCT02953613|coronary artery disease|coronary artery disease
4745508|NCT02953613|atherosclerosis|atherosclerosis
4745509|NCT02953587|Obesity|obesity
4745510|NCT02953587|Bariatric Surgery|bariatric surgery
4745511|NCT02953574|geriatric nursing|geriatric nursing
4745512|NCT02953561|Relapsed Acute Myeloid Leukemia|relapsed acute myeloid leukemia
4745513|NCT02953561|Refractory Acute Myeloid Leukemia|refractory acute myeloid leukemia
4745514|NCT02953561|Acute Myeloid Leukemia|acute myeloid leukemia
4745515|NCT02953561|AML|aml
4745516|NCT02953561|Avelumab|avelumab
4745517|NCT02953561|antiPDL1|antipdl1
4745518|NCT02953561|5-azacytidine|5-azacytidine
4745519|NCT02953561|Azacitidine|azacitidine
4745520|NCT02953561|5-aza|5-aza
4745521|NCT02953561|Vidaza|vidaza
4745522|NCT02953561|5-AZC|5-azc
4745523|NCT02953561|AZA-CR|aza-cr
4745524|NCT02953561|Ladakamycin|ladakamycin
4745525|NCT02953561|NSC-102816|nsc-102816
4745526|NCT02953561|Azacytidine|azacytidine
4745527|NCT02953548|GWP42003-P|gwp42003-p
4745528|NCT02953548|Cannabidiol|cannabidiol
4745529|NCT02953522|Polymorphism|polymorphism
4745531|NCT02953522|Oxidative stress|oxidative stress
4745532|NCT02953522|Overweight and Obesity|overweight and obesity
4745533|NCT02953509|non-Hodgkin's lymphoma|non-hodgkin's lymphoma
4745534|NCT02953509|diffuse large B-cell lymphoma|diffuse large b-cell lymphoma
4745535|NCT02953509|indolent lymphoma|indolent lymphoma
4745536|NCT02953509|Hu5F9-G4|hu5f9-g4
4745537|NCT02953509|CD47|cd47
4745538|NCT02953496|peripheral artery disease|peripheral artery disease
4745539|NCT02953496|PAD|pad
4745540|NCT02953496|vonapanitase|vonapanitase
4745541|NCT02953496|claudication|claudication
4745542|NCT02953496|superficial femoral artery|superficial femoral artery
4745543|NCT02953496|SFA|sfa
4745544|NCT02953496|popliteal artery|popliteal artery
4745545|NCT02953496|stenosis|stenosis
4745546|NCT02953496|elastase|elastase
4745547|NCT02953496|chymotrypsin-like elastase 1|chymotrypsin-like elastase 1
4745548|NCT02953496|CELA1|cela1
4745549|NCT02953496|PRT-201|prt-201
4745550|NCT02953483|Ex Vivo lung perfusion|ex vivo lung perfusion
4745551|NCT02953470|chronic pain|chronic pain
4745552|NCT02953470|community-dwelling|community-dwelling
4745553|NCT02953470|older adults|older adults
4745554|NCT02953470|physical activity|physical activity
4745555|NCT02953470|physiotherapy|physiotherapy
4745556|NCT02953470|behavioural medicine|behavioural medicine
4745557|NCT02953470|biopsychosocial|biopsychosocial
4745558|NCT02953470|exercise|exercise
4745559|NCT02953470|independency|independency
4745560|NCT02953470|everyday activities|everyday activities
4745561|NCT02953470|self-efficacy|self-efficacy
4745562|NCT02953470|quality of life|quality of life
4745563|NCT02953470|pain-related beliefs|pain-related beliefs
4745564|NCT02953470|pain-related disability|pain-related disability
4745565|NCT02953431|Asthma|asthma
4745566|NCT02953431|Obesity|obesity
4745567|NCT02953353|Obesity|obesity
4745568|NCT02953353|Feeding behavior|feeding behavior
4745569|NCT02953353|Transcranial direct current stimulation|transcranial direct current stimulation
4745570|NCT02953353|Weight loss|weight loss
4745571|NCT02953340|Neutropenia|neutropenia
4745572|NCT02953340|Breast Cancer|breast cancer
4745573|NCT02953340|Long-acting Myeloid Growth Factor|long-acting myeloid growth factor
4745574|NCT02953340|Early Stage Breast Cancer|early stage breast cancer
4745575|NCT02953340|Docetaxel + Cyclophosphamide (TC) chemotherapy|docetaxel + cyclophosphamide (tc) chemotherapy
4745576|NCT02953327|Non-Specific Effect of Vaccine|non-specific effect of vaccine
4745577|NCT02953327|Middle aged|middle aged
4745578|NCT02953327|Immunity, heterologous|immunity, heterologous
4745579|NCT02953301|Cutaneous T-Cell Lymphoma (CTLC)|cutaneous t-cell lymphoma (ctlc)
4745580|NCT02953301|Maintenance|maintenance
4745581|NCT02953301|resminostat|resminostat
4745582|NCT02953301|4SC|4sc
4745584|NCT02953301|Mycosis Fungoides|mycosis fungoides
4745585|NCT02953301|Sézary Syndrome|sézary syndrome
4745586|NCT02953262|Diabetes Mellitus|diabetes mellitus
4745587|NCT02953262|Personal Health Records|personal health records
4745588|NCT02953262|Patient Outcome Assessment|patient outcome assessment
4745589|NCT02953262|Mental Health|mental health
4745590|NCT02953184|neoadjuvant chemotherapy|neoadjuvant chemotherapy
4745591|NCT02953184|Pegylated liposomal doxorubicin|pegylated liposomal doxorubicin
4745592|NCT02953184|breast cancer|breast cancer
4745593|NCT02953171|Irritable Bowel Syndrome|irritable bowel syndrome
4745594|NCT02953171|The human microbiome|the human microbiome
4745595|NCT02953171|Microbiota|microbiota
4745596|NCT02953171|Gut microbiota|gut microbiota
4745597|NCT02953171|Probiotics|probiotics
4745598|NCT02953171|Sauerkraut|sauerkraut
4745599|NCT02953106|Asthma|asthma
4745600|NCT02953106|Rhinitis|rhinitis
4745601|NCT02953106|Dymista|dymista
4745602|NCT02953106|allergy|allergy
4745603|NCT02953093|acarbose|acarbose
4745604|NCT02953093|aging|aging
4745605|NCT02953054|Pain|pain
4745606|NCT02953054|Bunionectomy|bunionectomy
4745607|NCT02953054|Dexmedetomidine|dexmedetomidine
4745608|NCT02953054|Transdermal|transdermal
4745609|NCT02953054|Patch|patch
4745610|NCT02953054|Postoperative|postoperative
4745611|NCT02953054|DMTS|dmts
4745612|NCT02953028|Continuous Positive Airway Pressure|continuous positive airway pressure
4745613|NCT02953028|Mandibular Advancing Splint|mandibular advancing splint
4745614|NCT02953028|Efficacy|efficacy
4745615|NCT02953028|Compliance|compliance
4745616|NCT02953028|Health related quality of life|health related quality of life
4745617|NCT02953028|Randomized Controlled Trial|randomized controlled trial
4745618|NCT02953028|Snoring|snoring
4745619|NCT02953028|Mandibular Advancing Appliance|mandibular advancing appliance
4745620|NCT02953028|Mandibular Advancing Device|mandibular advancing device
4745621|NCT02953028|Humans|humans
4745622|NCT02953028|Quality of Life|quality of life
4745623|NCT02953028|Sleep Apnea, Obstructive|sleep apnea, obstructive
4745624|NCT02953015|Chronic Migraine|chronic migraine
4745625|NCT02953015|Manipulative treatments|manipulative treatments
4745626|NCT02953015|Transcutaneous Electrical Nerve Stimulation|transcutaneous electrical nerve stimulation
4745627|NCT02952989|MSI-high|msi-high
4745628|NCT02952989|dMMR|dmmr
4745629|NCT02952989|PD-L1|pd-l1
4745630|NCT02952976|open abdomen|open abdomen
4745631|NCT02952976|Damage control|damage control
4745632|NCT02952976|Abdominal Compartment Syndrome|abdominal compartment syndrome
4745633|NCT02952950|Intra Oral Vacuum|intra oral vacuum
4745634|NCT02952950|protein content breastmilk|protein content breastmilk
4745635|NCT02952937|Neuralgia, Postherpetic|neuralgia, postherpetic
4745636|NCT02952937|Postherpetic Neuralgia|postherpetic neuralgia
4745637|NCT02952937|Diabetic Neuropathies|diabetic neuropathies
4745638|NCT02952937|Diabetic Neuralgia|diabetic neuralgia
4745639|NCT02952937|Diabetic Polyneuropathy|diabetic polyneuropathy
4745640|NCT02952937|Diabetic Neuropathy, Painful|diabetic neuropathy, painful
4745641|NCT02952937|Neuralgia|neuralgia
4745642|NCT02952937|Neuropathic Pain|neuropathic pain
4745643|NCT02952937|Pregabalin|pregabalin
4745644|NCT02952937|Pharmacokinetics|pharmacokinetics
4745645|NCT02952937|Bioequivalent|bioequivalent
4745646|NCT02952898|solar keratoses|solar keratoses
4745647|NCT02952872|Computerized Brief Intervention|computerized brief intervention
4745648|NCT02952833|Inactivated|inactivated
4745649|NCT02952833|Phase I|phase i
4745650|NCT02952833|placebo-controlled|placebo-controlled
4745651|NCT02952833|Vaccine|vaccine
4745652|NCT02952833|ZIKA|zika
4745653|NCT02952820|insomnia|insomnia
4745654|NCT02952794|endoscopic submucosal dissection (ESD)|endoscopic submucosal dissection (esd)
4745655|NCT02952794|endoscopic mucosal band ligation (EMBL)|endoscopic mucosal band ligation (embl)
4745656|NCT02952781|ECG Monitoring|ecg monitoring
4745657|NCT02952781|Palpitations|palpitations
4745658|NCT02952716|carbon monoxide poisoning|carbon monoxide poisoning
4745659|NCT02952716|delayed encephalopathy|delayed encephalopathy
4745660|NCT02952638|Lipids|lipids
4745661|NCT02952638|lysophosphatidic acid|lysophosphatidic acid
4745662|NCT02952638|Lysophospholipids|lysophospholipids
4745663|NCT02952638|phosphatidylcholine|phosphatidylcholine
4745664|NCT02952638|lysophosphatidylcholine|lysophosphatidylcholine
4745665|NCT02952638|autotaxin|autotaxin
4745666|NCT02952638|dietary|dietary
4745667|NCT02952625|PET/MRI|pet/mri
4745668|NCT02952599|Non-interventional Study|non-interventional study
4745669|NCT02952599|Real World Evidence|real world evidence
4745670|NCT02952599|Patients with Acute VTE treated with Edoxaban|patients with acute vte treated with edoxaban
4745671|NCT02952599|Efficacy/Safety|efficacy/safety
4745672|NCT02952560|Ultrasound|ultrasound
4745673|NCT02952560|Computed Tomography|computed tomography
4745674|NCT02952560|Oral cavity size|oral cavity size
4745675|NCT02952560|The Mallampati classification|the mallampati classification
4745676|NCT02952534|CRPC|crpc
4745677|NCT02952534|PARP inhibitor|parp inhibitor
4745678|NCT02952534|PARPi|parpi
4745679|NCT02952534|BRCA|brca
4745680|NCT02952534|ATM|atm
4745681|NCT02952534|HRD|hrd
4745682|NCT02952534|TRITON|triton
4745683|NCT02952534|homologous recombination|homologous recombination
4745684|NCT02952534|DNA repair|dna repair
4745685|NCT02952534|DNA defect|dna defect
4745686|NCT02952534|DNA anomaly|dna anomaly
4745687|NCT02952534|BARD1|bard1
4745688|NCT02952534|BRIP1|brip1
4745689|NCT02952534|CDK12|cdk12
4745690|NCT02952534|CHEK2|chek2
4745691|NCT02952534|FANCA|fanca
4745692|NCT02952534|NBN|nbn
4745693|NCT02952534|PALB2|palb2
4745694|NCT02952534|RAD51|rad51
4745695|NCT02952534|RAD51B|rad51b
4745696|NCT02952534|RAD51C|rad51c
4745697|NCT02952534|RAD51D|rad51d
4745698|NCT02952534|RAD54L|rad54l
4745699|NCT02952534|germline|germline
4745700|NCT02952534|somatic|somatic
4745701|NCT02952495|Alcohol Consumption|alcohol consumption
4745702|NCT02952495|Older Adults|older adults
4745703|NCT02952482|adrenoleukodystrophy|adrenoleukodystrophy
4745704|NCT02952482|C26:0-lyso-PC|c26:0-lyso-pc
4745705|NCT02952469|Positron-Emission Tomography|positron-emission tomography
4745706|NCT02952469|(68Ga)Glu-urea-Lys(Ahx)-HBED-CC|(68ga)glu-urea-lys(ahx)-hbed-cc
4745707|NCT02952469|(68Ga)PSMA-HBED-CC|(68ga)psma-hbed-cc
4745708|NCT02952469|Glu-NH-CO-NH-Lys-(Ahx)-((68)Ga(HBED-CC))|glu-nh-co-nh-lys-(ahx)-((68)ga(hbed-cc))
4745709|NCT02952469|(68)Ga-PSMA|(68)ga-psma
4745710|NCT02952469|68Ga-PSMA-11|68ga-psma-11
4745711|NCT02952456|SUDEP|sudep
4745712|NCT02952456|Epilepsy|epilepsy
4745713|NCT02952456|Qualitative research|qualitative research
4745714|NCT02952456|Risks associated with epilepsy|risks associated with epilepsy
4745715|NCT02952456|Epilepsy-related deaths|epilepsy-related deaths
4745716|NCT02952391|cognition|cognition
4745717|NCT02952391|cholinergic system|cholinergic system
4745718|NCT02952365|LASIK, Ingrowth, Tissue sealant|lasik, ingrowth, tissue sealant
4745719|NCT02952300|irreversible pulpitis|irreversible pulpitis
4745720|NCT02952300|reciprocation|reciprocation
4745721|NCT02952300|rotation|rotation
4745722|NCT02952300|single file|single file
4745723|NCT02952300|wave one|wave one
4745724|NCT02952300|neolix|neolix
4745725|NCT02952209|Alveolar Ridge Preservation|alveolar ridge preservation
4745726|NCT02952209|Xenograft bone graft|xenograft bone graft
4745727|NCT02952209|Collagen membrane|collagen membrane
4745728|NCT02952196|Amphetamine|amphetamine
4745729|NCT02952196|Cannabinoids|cannabinoids
4745730|NCT02952183|Autonomic nerve monitoring|autonomic nerve monitoring
4745731|NCT02952183|Nerve-sparing surgery|nerve-sparing surgery
4745732|NCT02952131|IBD,Crohn's,Ulcerative Bowel; Diverticulitis;IBS;UC|ibd,crohn's,ulcerative bowel; diverticulitis;ibs;uc
4745733|NCT02952105|cardiac arrest|cardiac arrest
4745734|NCT02952105|identify of electrocardiac rhythm|identify of electrocardiac rhythm
4745735|NCT02952105|ventricuar fibrillation|ventricuar fibrillation
4745736|NCT02952105|defibrillation|defibrillation
4745737|NCT02952092|ASP1517|asp1517
4745738|NCT02952092|Renal anemia|renal anemia
4745739|NCT02952092|Hemodialysis|hemodialysis
4745740|NCT02952092|Roxadustat|roxadustat
4745741|NCT02952053|Myofascial Trigger Points|myofascial trigger points
4745742|NCT02952053|Dry needling|dry needling
4745743|NCT02952053|Myotonometry|myotonometry
4745744|NCT02952040|ASP1517|asp1517
4745745|NCT02952040|Pharmacokinetics|pharmacokinetics
4745746|NCT02952040|Drug-drug interaction|drug-drug interaction
4745747|NCT02952001|Uveitis|uveitis
4745748|NCT02952001|UME|ume
4745749|NCT02952001|Posterior Uveitis|posterior uveitis
4745750|NCT02952001|Anterior Uveitis|anterior uveitis
4745751|NCT02952001|Intermediate Uveitis|intermediate uveitis
4745752|NCT02952001|Panuveitis|panuveitis
4745753|NCT02952001|Non-infectious Uveitis|non-infectious uveitis
4745754|NCT02952001|Triamcinolone|triamcinolone
4745755|NCT02952001|Choroid|choroid
4745756|NCT02952001|Choroidal Injection|choroidal injection
4745757|NCT02952001|Suprachoroidal|suprachoroidal
4745758|NCT02952001|Microneedle|microneedle
4745759|NCT02952001|Microinjection|microinjection
4745760|NCT02951949|atherosclerosis, endogenous estrogens, age|atherosclerosis, endogenous estrogens, age
4745761|NCT02951897|circulating tumor cells|circulating tumor cells
4745762|NCT02951897|lung adenocarcinoma|lung adenocarcinoma
4745763|NCT02951897|treatment|treatment
4745764|NCT02951897|early diagnosis|early diagnosis
4745765|NCT02951884|Aspiration|aspiration
4745766|NCT02951884|Bupivacaine|bupivacaine
4745767|NCT02951884|Epinephrine|epinephrine
4745768|NCT02951884|Marcaine|marcaine
4745769|NCT02951884|Pain|pain
4745770|NCT02951884|Shin Bone|shin bone
4745771|NCT02951871|Follicular lymphoma; death, rituximab, treatment related toxicity|follicular lymphoma; death, rituximab, treatment related toxicity
4745772|NCT02951858|Alcohol,Smoking,and Substance Use Involvement Screening Test|alcohol,smoking,and substance use involvement screening test
4745773|NCT02951858|Brief Intervention|brief intervention
4745774|NCT02951858|Substance Use|substance use
4745775|NCT02951858|Primary Medical and Health Care Institution|primary medical and health care institution
4745776|NCT02951793|intensive care unit|intensive care unit
4745777|NCT02951793|delirium|delirium
4745778|NCT02951793|substance withdrawal|substance withdrawal
4745779|NCT02951767|anti-PD-L1|anti-pd-l1
4745780|NCT02951767|PD-L1|pd-l1
4745781|NCT02951767|MPDL3280A|mpdl3280a
4745782|NCT02951767|PD-1|pd-1
4745783|NCT02951767|bladder cancer|bladder cancer
4745784|NCT02951767|atezolizumab|atezolizumab
4745785|NCT02951767|Tecentriq|tecentriq
4745786|NCT02951754|ADHD|adhd
4745787|NCT02951754|Adults|adults
4745788|NCT02951754|treatment|treatment
4745789|NCT02951754|Methylphenidate|methylphenidate
4745790|NCT02951650|vagus nerve stimulation|vagus nerve stimulation
4745791|NCT02951637|Adenocarcinoma, EGFR, Gefitinib, Pemetrexed, Carboplatin|adenocarcinoma, egfr, gefitinib, pemetrexed, carboplatin
4745792|NCT02951624|Exercise|exercise
4745793|NCT02951624|Breaking prolonged sitting|breaking prolonged sitting
4745794|NCT02951624|physical activity|physical activity
4745795|NCT02951572|Noninvasive Ventilation|noninvasive ventilation
4745796|NCT02951572|Physical activity|physical activity
4745797|NCT02951520|Patients|patients
4745798|NCT02951481|Clostridium difficile.|clostridium difficile.
4745799|NCT02951481|Antimicrobial Stewardship.|antimicrobial stewardship.
4745800|NCT02951481|Enterocolitis, Pseudomembranous|enterocolitis, pseudomembranous
4745801|NCT02951442|Arterial stiffness|arterial stiffness
4745802|NCT02951442|Klotho-FGF23|klotho-fgf23
4745803|NCT02951403|elbow arthroscopy|elbow arthroscopy
4745804|NCT02951403|DASH|dash
4745805|NCT02951403|elbow locking|elbow locking
4745806|NCT02951403|elbow osteoarthritis|elbow osteoarthritis
4745807|NCT02951390|Surveillance|surveillance
4745808|NCT02951390|Colorectal cancer|colorectal cancer
4745809|NCT02951390|Colonoscopy|colonoscopy
4745810|NCT02951390|Adenoma|adenoma
4745811|NCT02951390|Chromoendoscopy|chromoendoscopy
4745812|NCT02951377|mechanical diagnosis therapy (MDT)|mechanical diagnosis therapy (mdt)
4745813|NCT02951377|physical therapy|physical therapy
4745814|NCT02951377|steroid injection|steroid injection
4745815|NCT02951377|exercise|exercise
4745816|NCT02951364|observational|observational
4745817|NCT02951338|Physical activity|physical activity
4745818|NCT02951338|Exercise|exercise
4745819|NCT02951338|Behaviour change|behaviour change
4745820|NCT02951338|Rehabilitation|rehabilitation
4745821|NCT02951338|Self-management|self-management
4745822|NCT02951338|Education|education
4745823|NCT02951325|adjuvant RT|adjuvant rt
4745824|NCT02951312|Emphysema|emphysema
4745825|NCT02951312|Chronic bronchitis|chronic bronchitis
4745826|NCT02951312|COPD|copd
4745827|NCT02951312|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
4745828|NCT02951286|Skeletal openbite|skeletal openbite
4745829|NCT02951286|Molar intrusion|molar intrusion
4745830|NCT02951286|high pull headgear|high pull headgear
4745831|NCT02951273|abdominal surgery|abdominal surgery
4745832|NCT02951273|blood pressure|blood pressure
4745833|NCT02951273|cardiac output|cardiac output
4745834|NCT02951273|cerebral blood flow|cerebral blood flow
4745835|NCT02951273|cerebral oxygenation|cerebral oxygenation
4745836|NCT02951273|CO2 reactivity|co2 reactivity
4745837|NCT02951273|duplex ultrasound|duplex ultrasound
4745838|NCT02951273|general anaesthesia|general anaesthesia
4745839|NCT02951273|mesenteric traction syndrome|mesenteric traction syndrome
4745840|NCT02951273|near-infrared spectroscopy|near-infrared spectroscopy
4745841|NCT02951273|upper gastrointestinal cancer surgery|upper gastrointestinal cancer surgery
4745842|NCT02951234|coronary artery lesions|coronary artery lesions
4745843|NCT02951234|intravenous immunoglobulin|intravenous immunoglobulin
4745844|NCT02951234|Kawasaki disease|kawasaki disease
4745845|NCT02951234|randomized clinical trial|randomized clinical trial
4745846|NCT02951234|aspirin|aspirin
4745847|NCT02951130|CDH|cdh
4745848|NCT02951130|PPHN|pphn
4745849|NCT02951130|HRF|hrf
4745850|NCT02951117|lymphoid malignancies|lymphoid malignancies
4745851|NCT02951117|Next generation sequencing|next generation sequencing
4745852|NCT02951117|Refractory Multiple Myeloma|refractory multiple myeloma
4745853|NCT02951117|Relapsed Multiple Myeloma|relapsed multiple myeloma
4745854|NCT02951052|Long-acting cabotegravir|long-acting cabotegravir
4745855|NCT02951052|Virologic failure|virologic failure
4745856|NCT02951052|long-acting rilpivirine|long-acting rilpivirine
4745857|NCT02951052|Antiretroviral|antiretroviral
4745858|NCT02951039|Non valvular Atrial Fibrillation|non valvular atrial fibrillation
4745859|NCT02951039|Non-interventional Study|non-interventional study
4745860|NCT02951039|Efficacy/Safety|efficacy/safety
4745861|NCT02951039|Real World Evidence|real world evidence
4745862|NCT02951026|knee|knee
4745863|NCT02951026|osteoarthritis|osteoarthritis
4745864|NCT02951026|intra-articular injection|intra-articular injection
4745865|NCT02951026|SM04690|sm04690
4745866|NCT02951000|thyroidectomy|thyroidectomy
4745867|NCT02951000|postoperative pain|postoperative pain
4745868|NCT02951000|wound healing|wound healing
4745869|NCT02950987|Li-Fraumeni Syndrome (LFS)|li-fraumeni syndrome (lfs)
4745870|NCT02950987|Cancer Predisposition Syndromes|cancer predisposition syndromes
4745871|NCT02950987|LFS|lfs
4745872|NCT02950974|sterofundin|sterofundin
4745873|NCT02950974|resuscitation|resuscitation
4745874|NCT02950974|normal saline|normal saline
4745875|NCT02950974|chloride|chloride
4745876|NCT02950974|fluid|fluid
4745877|NCT02950974|SID|sid
4745878|NCT02950974|pH|ph
4745879|NCT02950974|osmolality|osmolality
4745880|NCT02950974|urine|urine
4745881|NCT02950961|Anxiety [F01.470.132]|anxiety [f01.470.132]
4745882|NCT02950961|Depression [F01.145.126.350]|depression [f01.145.126.350]
4745883|NCT02950961|Stress Disorders, Post-Traumatic [F03.950.750.500]|stress disorders, post-traumatic [f03.950.750.500]
4745884|NCT02950961|Primary Health Care [N04.590.233.727]|primary health care [n04.590.233.727]
4745885|NCT02950961|Mental Health [F02.418]|mental health [f02.418]
4745886|NCT02950961|Patient Participation [N05.300.150.600.620]|patient participation [n05.300.150.600.620]
4745887|NCT02950961|Patient Satisfaction [N05.300.150.600.630]|patient satisfaction [n05.300.150.600.630]
4745888|NCT02950961|Patient Preference [N05.300.150.600.630.500]|patient preference [n05.300.150.600.630.500]
4745889|NCT02950961|Physicians, Primary Care [M01.526.485.810.800]|physicians, primary care [m01.526.485.810.800]
4745890|NCT02950961|Physicians, Women [M01.526.485.810.820]|physicians, women [m01.526.485.810.820]
4745891|NCT02950961|Health Behavior [F01.145.488]|health behavior [f01.145.488]
4745892|NCT02950909|Therapeutic exercise|therapeutic exercise
4745893|NCT02950909|Chronic pain|chronic pain
4745894|NCT02950909|Neck extensors|neck extensors
4745895|NCT02950883|Cystic Fibrosis|cystic fibrosis
4745896|NCT02950883|Hypertonic Saline|hypertonic saline
4745897|NCT02950883|Inhaled Saline|inhaled saline
4745898|NCT02950883|Digestive System Diseases|digestive system diseases
4745899|NCT02950883|Genetic Diseases, Inborn|genetic diseases, inborn
4745900|NCT02950883|Lung Diseases|lung diseases
4745901|NCT02950883|Pancreatic Diseases|pancreatic diseases
4745902|NCT02950883|Pathologic Processes|pathologic processes
4745903|NCT02950883|Respiratory Tract Diseases|respiratory tract diseases
4745904|NCT02950883|Computed Tomography (CT)|computed tomography (ct)
4745905|NCT02950844|Atrial fibrillation|atrial fibrillation
4745906|NCT02950844|Electrogram|electrogram
4745907|NCT02950844|Ablation|ablation
4745908|NCT02950844|Drivers|drivers
4745909|NCT02950831|Chronic Pain|chronic pain
4745910|NCT02950831|BurstDR|burstdr
4745911|NCT02950831|spinal cord stimulation|spinal cord stimulation
4745912|NCT02950831|Accelerometry|accelerometry
4745913|NCT02950818|self-care|self-care
4745914|NCT02950818|health education|health education
4745915|NCT02950818|chronic disease|chronic disease
4745916|NCT02950818|heart diseases|heart diseases
4745917|NCT02950818|risk factors for heart disease|risk factors for heart disease
4745918|NCT02950805|AZD5634|azd5634
4745919|NCT02950805|Mucociliary Clearance|mucociliary clearance
4745920|NCT02950805|Safety|safety
4745921|NCT02950805|Tolerability|tolerability
4745922|NCT02950805|Pharmacokinetic|pharmacokinetic
4745923|NCT02950805|Cystic Fibrosis|cystic fibrosis
4745924|NCT02950805|Cross-Over Study|cross-over study
4745925|NCT02950792|Non-Small Cell Lung Cancer|non-small cell lung cancer
4745926|NCT02950792|NSCLC|nsclc
4745927|NCT02950766|Kidney Cancer|kidney cancer
4745928|NCT02950753|Elevated Serum Lactate|elevated serum lactate
4745929|NCT02950753|Serum lactate|serum lactate
4745930|NCT02950753|Ringer's Lactate|ringer's lactate
4745931|NCT02950753|Lactated Ringer's|lactated ringer's
4745932|NCT02950753|Hyperlactatemia|hyperlactatemia
4745933|NCT02950740|malnutrition|malnutrition
4745934|NCT02950727|orthognathic surgery|orthognathic surgery
4745935|NCT02950727|bicortical screws|bicortical screws
4745936|NCT02950727|monocortical plates|monocortical plates
4745937|NCT02950675|Burn patient|burn patient
4745938|NCT02950675|Developmental Disabilities|developmental disabilities
4745939|NCT02950675|Body function|body function
4745940|NCT02950675|Participation|participation
4745941|NCT02950675|Quality of Life|quality of life
4745942|NCT02950675|longitudinal study|longitudinal study
4745943|NCT02950636|Epilepsy|epilepsy
4745944|NCT02950610|Electronic nose|electronic nose
4745945|NCT02950610|Non invasive diagnosis of NAFLD|non invasive diagnosis of nafld
4745946|NCT02950610|NAFLD|nafld
4745947|NCT02950610|exhaled breath analysis|exhaled breath analysis
4745948|NCT02950610|Volatile organic compounds|volatile organic compounds
4745949|NCT02950545|astigmatism, contact lens, driving|astigmatism, contact lens, driving
4745950|NCT02950532|Posterior ligamentous complex|posterior ligamentous complex
4745951|NCT02950532|Thoracolumbar fractures|thoracolumbar fractures
4745952|NCT02950532|Interspinous distance|interspinous distance
4745953|NCT02950532|Local kyphosis|local kyphosis
4745954|NCT02950506|Interictal|interictal
4745955|NCT02950506|Cognitive|cognitive
4745956|NCT02950506|Dysfunction|dysfunction
4745957|NCT02950506|tDCS|tdcs
4745958|NCT02950506|transcranial direct current stimulation|transcranial direct current stimulation
4745959|NCT02950480|Mastectomy|mastectomy
4745960|NCT02950467|HIV/AIDS|hiv/aids
4745961|NCT02950467|Demoralization|demoralization
4745962|NCT02950467|Psilocybin|psilocybin
4745963|NCT02950467|Group therapy|group therapy
4745964|NCT02950454|Progressive Multiple Sclerosis|progressive multiple sclerosis
4745965|NCT02950454|Rehabilitation|rehabilitation
4745966|NCT02950454|Exercise|exercise
4745967|NCT02950441|Nicotinamide Riboside|nicotinamide riboside
4745968|NCT02950441|Nicotinamide Adenine Dinucleotide|nicotinamide adenine dinucleotide
4745969|NCT02950441|Skeletal muscle|skeletal muscle
4745970|NCT02950441|Metabolism|metabolism
4745971|NCT02950428|TAVI|tavi
4745972|NCT02950428|Aortic Stenosis|aortic stenosis
4745973|NCT02950428|transcatether Aortic Valve Implantation|transcatether aortic valve implantation
4745974|NCT02950389|PMMA|pmma
4745975|NCT02950389|on-line HFR|on-line hfr
4745976|NCT02950389|free light chains|free light chains
4745977|NCT02950389|toxins|toxins
4745978|NCT02950389|removal|removal
4745979|NCT02950389|hemodialysis|hemodialysis
4745980|NCT02950376|synthetic drugs|synthetic drugs
4745981|NCT02950376|virtual reality|virtual reality
4745982|NCT02950376|addiction evaluation|addiction evaluation
4745983|NCT02950376|physiological data|physiological data
4745984|NCT02950376|eye movement index|eye movement index
4745985|NCT02950363|Depression|depression
4745986|NCT02950363|Suicide|suicide
4745987|NCT02950363|Anxiety disorder|anxiety disorder
4745988|NCT02950363|Burn out|burn out
4745989|NCT02950363|Sleep quality|sleep quality
4745990|NCT02950363|Stress|stress
4745991|NCT02950350|Cervical cancer|cervical cancer
4745992|NCT02950350|Precision medicine|precision medicine
4745993|NCT02950350|Individualized treatment|individualized treatment
4745994|NCT02950350|Surgical staging|surgical staging
4745995|NCT02950337|Unbiopsied Early Stage Non Small Cell Lung Cancer|unbiopsied early stage non small cell lung cancer
4745996|NCT02950324|Prehabilitation|prehabilitation
4745997|NCT02950324|Oesophago-gastric|oesophago-gastric
4745998|NCT02950324|Cancer|cancer
4745999|NCT02950324|Neo-adjuvant|neo-adjuvant
4746000|NCT02950324|Exercise|exercise
4746001|NCT02950324|Cardiopulmonary exercise test|cardiopulmonary exercise test
4746002|NCT02950324|Insulin resistance|insulin resistance
4746003|NCT02950298|Pompe|pompe
4746004|NCT02950298|Glycogen Storage Disease II|glycogen storage disease ii
4746005|NCT02950298|Telemedicine|telemedicine
4746006|NCT02950298|Duke University Medical Center|duke university medical center
4746007|NCT02950259|Breast Cancer|breast cancer
4746008|NCT02950259|Early Stage Breast Cancer|early stage breast cancer
4746009|NCT02950259|Male breast cancer|male breast cancer
4746010|NCT02950259|IRX-2|irx-2
4746011|NCT02950259|Immunotherapy|immunotherapy
4746012|NCT02950259|Triple Negative Breast Cancer|triple negative breast cancer
4746013|NCT02950233|postoperative pain|postoperative pain
4746014|NCT02950233|VATS|vats
4746015|NCT02950233|activities of daily living|activities of daily living
4746016|NCT02950233|quality of life|quality of life
4746017|NCT02950194|mesh|mesh
4746018|NCT02950194|rectus diastasis|rectus diastasis
4746019|NCT02950194|panniculectomy|panniculectomy
4746020|NCT02950194|abdominoplasty|abdominoplasty
4746021|NCT02950168|Diagnostic procedures|diagnostic procedures
4746022|NCT02950168|Interventional procedures|interventional procedures
4746023|NCT02950168|Planned or unplanned|planned or unplanned
4746024|NCT02950168|Edoxaban-treated population|edoxaban-treated population
4746025|NCT02950142|order sets|order sets
4746026|NCT02950142|decision support|decision support
4746027|NCT02950142|laboratory test|laboratory test
4746028|NCT02950142|primary care|primary care
4746029|NCT02950129|pelvic girdle dysfunction|pelvic girdle dysfunction
4746030|NCT02950103|solid tumor|solid tumor
4746031|NCT02950103|phase II|phase ii
4746032|NCT02950103|phosphoethanolamine|phosphoethanolamine
4746033|NCT02950090|Knee symptoms|knee symptoms
4746034|NCT02950090|physical activity|physical activity
4746035|NCT02950090|Fitbit|fitbit
4746036|NCT02950090|Accelerometer|accelerometer
4746037|NCT02950090|remote coaching|remote coaching
4746038|NCT02950064|BRCA|brca
4746039|NCT02950064|BRCA1|brca1
4746040|NCT02950064|BRCA2|brca2
4746041|NCT02950064|Pancreatic cancer|pancreatic cancer
4746042|NCT02950064|Ovarian cancer|ovarian cancer
4746043|NCT02950064|Castrate resistant prostate cancer|castrate resistant prostate cancer
4746044|NCT02950064|Triple negative breast cancer|triple negative breast cancer
4746045|NCT02950064|Breast cancer|breast cancer
4746046|NCT02950064|DNA repair mutation-positive solid tumors|dna repair mutation-positive solid tumors
4746048|NCT02950038|Lung Cancer, Nonsmall Cell|lung cancer, nonsmall cell
4746049|NCT02950038|Advanced non-small cell lung cancer|advanced non-small cell lung cancer
4746050|NCT02950038|NSCLC|nsclc
4746051|NCT02950038|Stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
4746052|NCT02950038|Recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
4746053|NCT02950038|Ibrutinib|ibrutinib
4746054|NCT02950038|PCI-32765|pci-32765
4746055|NCT02950038|Imbruvica|imbruvica
4746056|NCT02950038|Nivolumab|nivolumab
4746057|NCT02950038|BMS-936558|bms-936558
4746058|NCT02950038|Opdivo|opdivo
4746059|NCT02950012|Healthy|healthy
4746060|NCT02950012|Bloating|bloating
4746061|NCT02950012|Abdominal Discomfort|abdominal discomfort
4746062|NCT02950012|Gas|gas
4746063|NCT02950012|Probiotic|probiotic
4746064|NCT02950012|Bacillus Subtillis|bacillus subtillis
4746065|NCT02949999|Calcineurin inhibitor|calcineurin inhibitor
4746066|NCT02949999|Voclosporin|voclosporin
4746067|NCT02949973|lupus nephritis|lupus nephritis
4746068|NCT02949973|calcineurin inhibitors|calcineurin inhibitors
4746069|NCT02949973|voclosporin|voclosporin
4746070|NCT02949960|Eczema|eczema
4746071|NCT02949960|Dermatitis|dermatitis
4746072|NCT02949960|Skin Diseases|skin diseases
4746073|NCT02949960|Skin Diseases, Genetic|skin diseases, genetic
4746074|NCT02949960|Dermatitis, Atopic|dermatitis, atopic
4746075|NCT02949960|Skin Diseases, Eczematous|skin diseases, eczematous
4746076|NCT02949960|Hypersensitivity|hypersensitivity
4746077|NCT02949960|Immune System Diseases|immune system diseases
4746078|NCT02949947|Malignant Neoplasms of Mesothelial and Soft Tissue|malignant neoplasms of mesothelial and soft tissue
4746079|NCT02949947|Gastrointestinal Stromal Tumor|gastrointestinal stromal tumor
4746080|NCT02949947|GIST|gist
4746081|NCT02949947|Iron-deficiency anemia|iron-deficiency anemia
4746082|NCT02949947|Ferric Carboxymaltose|ferric carboxymaltose
4746083|NCT02949947|Injectafer|injectafer
4746084|NCT02949947|Iron supplement|iron supplement
4746085|NCT02949947|Health Questionnaire|health questionnaire
4746086|NCT02949947|Survey|survey
4746087|NCT02949908|Relapsing Remitting Multiple Sclerosis|relapsing remitting multiple sclerosis
4746088|NCT02949908|Rebif|rebif
4746089|NCT02949908|Treatment Satisfaction Questionnaire for Medication Version II|treatment satisfaction questionnaire for medication version ii
4746090|NCT02949908|Multiple Sclerosis International Quality of Life Questionnaire|multiple sclerosis international quality of life questionnaire
4746091|NCT02949882|Diarrhea|diarrhea
4746092|NCT02949882|Constipation|constipation
4746093|NCT02949882|Elderly|elderly
4746094|NCT02949882|Nursing Homes|nursing homes
4746095|NCT02949882|Probiotics|probiotics
4746096|NCT02949882|Bowel Habits|bowel habits
4746097|NCT02949830|RNAi therapeutic|rnai therapeutic
4746098|NCT02949830|Porphyria|porphyria
4746099|NCT02949830|AIP|aip
4746100|NCT02949830|Heme/Haem Arginate|heme/haem arginate
4746101|NCT02949817|upper limb function|upper limb function
4746102|NCT02949817|multi-IMU (inertial measurement unit) sensors|multi-imu (inertial measurement unit) sensors
4746103|NCT02949817|Melbourne Assessment of Unilateral Upper Limb Function (MUUL-2)|melbourne assessment of unilateral upper limb function (muul-2)
4746104|NCT02949791|cisplatin|cisplatin
4746105|NCT02949791|HIPEC|hipec
4746106|NCT02949791|Intra abdominal pressure|intra abdominal pressure
4746107|NCT02949791|tissue drug concentration|tissue drug concentration
4746108|NCT02949713|HIV|hiv
4746109|NCT02949713|infant feeding|infant feeding
4746110|NCT02949713|mHealth|mhealth
4746111|NCT02949713|behavioural intervention|behavioural intervention
4746112|NCT02949700|metformin|metformin
4746113|NCT02949700|head and neck cancer|head and neck cancer
4746114|NCT02949687|ileal interposition|ileal interposition
4746115|NCT02949687|metabolic surgery|metabolic surgery
4746116|NCT02949687|diabetes|diabetes
4746117|NCT02949687|intra abdominal selective denervation|intra abdominal selective denervation
4746118|NCT02949648|Electronic cigarette|electronic cigarette
4746119|NCT02949635|Aged|aged
4746120|NCT02949635|Patient readmission|patient readmission
4746121|NCT02949635|Geriatric Assessment|geriatric assessment
4746122|NCT02949635|Mortality|mortality
4746123|NCT02949622|Metabolic syndrome|metabolic syndrome
4746124|NCT02949622|Mediterranean diet|mediterranean diet
4746125|NCT02949622|Stress|stress
4746126|NCT02949622|quality of life|quality of life
4746127|NCT02949622|psychological factors|psychological factors
4746128|NCT02949609|stroke|stroke
4746129|NCT02949609|mirror therapy|mirror therapy
4746130|NCT02949609|neurorehabilitation|neurorehabilitation
4746131|NCT02949596|quality of sexual life|quality of sexual life
4746132|NCT02949596|intensity-modulated radiotherapy|intensity-modulated radiotherapy
4746133|NCT02949596|concurrent chemoradiotherapy|concurrent chemoradiotherapy
4746134|NCT02949583|DENTAL PLAQUE|dental plaque
4746135|NCT02949583|MEDICINAL PLANTS|medicinal plants
4746136|NCT02949583|GINGIVITIS|gingivitis
4746137|NCT02949505|Prehabilitation|prehabilitation
4746138|NCT02949505|liver transplant|liver transplant
4746139|NCT02949505|functional capacity|functional capacity
4746140|NCT02949505|exercise|exercise
4746141|NCT02949492|Liver|liver
4746142|NCT02949492|Transplant|transplant
4746143|NCT02949492|Immunosuppression|immunosuppression
4746144|NCT02949479|sex offenses|sex offenses
4746145|NCT02949466|knee osteoarthritis|knee osteoarthritis
4746146|NCT02949466|triamcinolone|triamcinolone
4746147|NCT02949466|therapeutic effects|therapeutic effects
4746148|NCT02949453|suicide|suicide
4746149|NCT02949453|prevention|prevention
4746150|NCT02949440|Laparoscopic right Hemicolectomy|laparoscopic right hemicolectomy
4746151|NCT02949440|Caudal-to-cranial Approach|caudal-to-cranial approach
4746152|NCT02949427|Microbiome|microbiome
4746153|NCT02949427|Mycobiome|mycobiome
4746154|NCT02949427|Virome|virome
4746155|NCT02949427|Pediatric leukemia|pediatric leukemia
4746156|NCT02949427|Pediatric bone marrow transplantation|pediatric bone marrow transplantation
4746157|NCT02949414|Malacia|malacia
4746158|NCT02949414|Stenosis|stenosis
4746159|NCT02949414|Trachea|trachea
4746160|NCT02949414|Transplant|transplant
4746161|NCT02949349|Systemic Lupus Erythematosus|systemic lupus erythematosus
4746162|NCT02949349|Lupus Nephritis|lupus nephritis
4746163|NCT02949349|Mycophenolate Mofetil|mycophenolate mofetil
4746164|NCT02949349|Azathioprine|azathioprine
4746165|NCT02949349|Maintenance Therapy|maintenance therapy
4746166|NCT02949349|Prednisolone|prednisolone
4746167|NCT02949349|Serum albumin|serum albumin
4746168|NCT02949349|Serum creatinine|serum creatinine
4746169|NCT02949349|Spot urine protein/creatinine ratio|spot urine protein/creatinine ratio
4746170|NCT02949323|children|children
4746171|NCT02949323|renal stone|renal stone
4746172|NCT02949323|metabolic evaluation|metabolic evaluation
4746173|NCT02949323|Mutational analysis|mutational analysis
4746174|NCT02949297|abdominal|abdominal
4746175|NCT02949297|aortic|aortic
4746176|NCT02949297|aneurysm|aneurysm
4746177|NCT02949271|epidural analgesia|epidural analgesia
4746477|NCT02947399|Thyroid|thyroid
4746178|NCT02949258|gastric cancer|gastric cancer
4746179|NCT02949258|Borrmann type 4|borrmann type 4
4746180|NCT02949258|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
4746181|NCT02949258|Intra-arterial administration|intra-arterial administration
4746182|NCT02949245|Spine|spine
4746183|NCT02949245|Surgery|surgery
4746184|NCT02949245|Prospective Studies|prospective studies
4746185|NCT02949245|Deformity|deformity
4746186|NCT02949245|Neurologic deficit|neurologic deficit
4746187|NCT02949180|Atrial fibrillation|atrial fibrillation
4746188|NCT02949180|Rhythm monitoring|rhythm monitoring
4746189|NCT02949180|Cardiovascular App|cardiovascular app
4746190|NCT02949180|m-health|m-health
4746191|NCT02949167|Nurse-led follow-up after breast cancer|nurse-led follow-up after breast cancer
4746192|NCT02949115|Red beetroot|red beetroot
4746193|NCT02949115|Dietary Nitrate|dietary nitrate
4746194|NCT02949115|Polyphenols|polyphenols
4746195|NCT02949115|Endothelial Function|endothelial function
4746196|NCT02949115|High-Fat Meal|high-fat meal
4746197|NCT02949115|Overweight|overweight
4746198|NCT02949115|Obesity|obesity
4746199|NCT02949115|Aging|aging
4746200|NCT02949115|Cardiometabolic|cardiometabolic
4746201|NCT02949089|safety|safety
4746202|NCT02949089|tolerability|tolerability
4746203|NCT02949089|rising multiple doses|rising multiple doses
4746204|NCT02949089|ACH04|ach04
4746205|NCT02949089|adult|adult
4746206|NCT02949089|male|male
4746207|NCT02949063|school lunch|school lunch
4746208|NCT02949063|occupational therapy|occupational therapy
4746209|NCT02949024|Diabetes mellitus|diabetes mellitus
4746210|NCT02949024|Diabetic retinopathy|diabetic retinopathy
4746211|NCT02949024|Microneedle|microneedle
4746212|NCT02949024|Microinjection|microinjection
4746213|NCT02949024|Triamcinolone|triamcinolone
4746214|NCT02949024|Choroid|choroid
4746215|NCT02949024|Choroid Injection|choroid injection
4746216|NCT02949024|Aflibercept|aflibercept
4746217|NCT02949024|Suprachoroidal|suprachoroidal
4746218|NCT02949011|Tamiflu®|tamiflu®
4746219|NCT02949011|Influenza|influenza
4746220|NCT02949011|Oseltamivir|oseltamivir
4746222|NCT02949011|S-033188|s-033188
4746223|NCT02948985|Metastatic colorectal cancer|metastatic colorectal cancer
4746224|NCT02948985|Cetuximab|cetuximab
4746225|NCT02948985|CTCs|ctcs
4746226|NCT02948985|ct DNA|ct dna
4746227|NCT02948972|deep infiltrating endometriosis|deep infiltrating endometriosis
4746228|NCT02948972|endometriosis surgery|endometriosis surgery
4746229|NCT02948972|In vitro fertilization|in vitro fertilization
4746230|NCT02948946|lung cancer|lung cancer
4746231|NCT02948946|pancreatic cancer|pancreatic cancer
4746232|NCT02948933|Dengue Fever|dengue fever
4746233|NCT02948933|Dengue Hemorrhagic Fever|dengue hemorrhagic fever
4746234|NCT02948933|Dengvaxia®|dengvaxia®
4746235|NCT02948920|ephedrine|ephedrine
4746236|NCT02948920|core temperature|core temperature
4746237|NCT02948920|tympanic temperature|tympanic temperature
4746238|NCT02948920|heat loss|heat loss
4746239|NCT02948920|spinal anesthesia|spinal anesthesia
4746240|NCT02948920|neuraxial|neuraxial
4746241|NCT02948920|hypothermia|hypothermia
4746242|NCT02948920|shivering|shivering
4746243|NCT02948881|Osteoporosis|osteoporosis
4746244|NCT02948881|bisphosphonates|bisphosphonates
4746245|NCT02948881|bone|bone
4746246|NCT02948868|Methamphetamine|methamphetamine
4746247|NCT02948868|MRI|mri
4746248|NCT02948868|South Africa|south africa
4746249|NCT02948868|Contingency Management|contingency management
4746250|NCT02948855|Long non-coding RNA（LncRNA）|long non-coding rna（lncrna）
4746251|NCT02948855|Thymoma|thymoma
4746252|NCT02948855|Autoimmune disease|autoimmune disease
4746253|NCT02948855|Notch2 Signaling pathway|notch2 signaling pathway
4746254|NCT02948855|Regulatory B cell（Breg）|regulatory b cell（breg）
4746255|NCT02948829|Drug therapy|drug therapy
4746256|NCT02948803|intervention|intervention
4746257|NCT02948803|mHealth|mhealth
4746258|NCT02948803|physical activity|physical activity
4746259|NCT02948803|active transport|active transport
4746260|NCT02948803|smartphone|smartphone
4746261|NCT02948803|application|application
4746262|NCT02948764|breast cancer|breast cancer
4746263|NCT02948764|vacuum-assisted biopsy|vacuum-assisted biopsy
4746264|NCT02948764|pathological complete response|pathological complete response
4746265|NCT02948712|distress|distress
4746266|NCT02948712|survivorship|survivorship
4746267|NCT02948712|transition period|transition period
4746268|NCT02948699|nasopharyngeal carcinoma|nasopharyngeal carcinoma
4746269|NCT02948699|intensity-modulated radiotherapy|intensity-modulated radiotherapy
4746270|NCT02948699|nutrition support|nutrition support
4746271|NCT02948699|nutrition assessment|nutrition assessment
4746272|NCT02948686|dentin bonding agents|dentin bonding agents
4746273|NCT02948686|tooth sensitivity|tooth sensitivity
4746274|NCT02948686|composite resin restoration|composite resin restoration
4746275|NCT02948673|type 2 diabetes|type 2 diabetes
4746276|NCT02948673|mitochondrial reactive oxygen species production|mitochondrial reactive oxygen species production
4746277|NCT02948673|oxidative stress|oxidative stress
4746278|NCT02948673|antioxidant treatment|antioxidant treatment
4746279|NCT02948673|glutathione supplementation|glutathione supplementation
4746478|NCT02947399|I-124|i-124
4746280|NCT02948621|Endoscopic sleeve gastroplasty|endoscopic sleeve gastroplasty
4746281|NCT02948621|Excess weight loss|excess weight loss
4746282|NCT02948621|Quality of life|quality of life
4746283|NCT02948608|spondyloarthropathy|spondyloarthropathy
4746284|NCT02948608|ankylosing spondylitis|ankylosing spondylitis
4746285|NCT02948608|spinal diseases|spinal diseases
4746286|NCT02948608|spondylitis|spondylitis
4746287|NCT02948608|spondylarthritis|spondylarthritis
4746288|NCT02948608|psoriasis|psoriasis
4746289|NCT02948608|uveitis|uveitis
4746290|NCT02948608|joint diseases|joint diseases
4746291|NCT02948582|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
4746292|NCT02948582|COPD|copd
4746293|NCT02948582|Emphysema|emphysema
4746294|NCT02948582|Chronic bronchitis|chronic bronchitis
4746295|NCT02948569|Obesity|obesity
4746296|NCT02948569|Hyperlipidemia|hyperlipidemia
4746297|NCT02948569|Impaired fasting glucose|impaired fasting glucose
4746298|NCT02948569|Insulin resistance|insulin resistance
4746299|NCT02948569|Hypertension|hypertension
4746300|NCT02948504|Unruptured Intracranial Aneurysm|unruptured intracranial aneurysm
4746301|NCT02948504|Small aneurysms|small aneurysms
4746302|NCT02948504|Risk of rupture|risk of rupture
4746303|NCT02948504|Natural history|natural history
4746304|NCT02948504|Endovascular Coiling|endovascular coiling
4746305|NCT02948504|Surgical clipping|surgical clipping
4746306|NCT02948491|Complementary Therapies|complementary therapies
4746307|NCT02948491|Neonate Intensive Care Units (NICU)|neonate intensive care units (nicu)
4746308|NCT02948491|Child Development|child development
4746309|NCT02948491|Infants Premature|infants premature
4746310|NCT02948478|precariousness|precariousness
4746311|NCT02948478|care pathways|care pathways
4746312|NCT02948465|Neutrophil Extracellular Traps|neutrophil extracellular traps
4746313|NCT02948452|anorexia nervosa|anorexia nervosa
4746314|NCT02948452|anxiety|anxiety
4746315|NCT02948452|reward|reward
4746316|NCT02948452|recurrence|recurrence
4746317|NCT02948452|magnetic resonance imaging|magnetic resonance imaging
4746318|NCT02948439|pregnancy|pregnancy
4746319|NCT02948439|cardiovascular|cardiovascular
4746320|NCT02948439|nervous system|nervous system
4746321|NCT02948439|exercise|exercise
4746322|NCT02948426|Immunotherapy|immunotherapy
4746323|NCT02948426|Adoptive Cell Therapy|adoptive cell therapy
4746324|NCT02948426|Carcinomatosis|carcinomatosis
4746325|NCT02948426|CA125|ca125
4746326|NCT02948413|Traumatic Stress|traumatic stress
4746327|NCT02948413|Oncology|oncology
4746328|NCT02948413|Lymphoma|lymphoma
4746329|NCT02948413|Leukemia|leukemia
4746330|NCT02948335|Microbial communities|microbial communities
4746331|NCT02948335|Hospital environment|hospital environment
4746332|NCT02948335|Disinfection|disinfection
4746333|NCT02948335|Adenosine triphosphate measures|adenosine triphosphate measures
4746334|NCT02948335|Bioburden|bioburden
4746335|NCT02948322|Acromegaly,|acromegaly,
4746336|NCT02948322|water retention|water retention
4746337|NCT02948322|myocardial fibrosis|myocardial fibrosis
4746338|NCT02948322|left ventricular hypertrophy|left ventricular hypertrophy
4746339|NCT02948322|left ventricular dysfunction|left ventricular dysfunction
4746340|NCT02948309|Primary diagnosis|primary diagnosis
4746341|NCT02948309|Relapse|relapse
4746342|NCT02948257|Vessel closure|vessel closure
4746343|NCT02948257|Antegrade access|antegrade access
4746344|NCT02948257|Femoral arteriotomy|femoral arteriotomy
4746345|NCT02948257|Peripheral endovascular interventions|peripheral endovascular interventions
4746346|NCT02948244|fshd|fshd
4746347|NCT02948244|creatine monohydrate|creatine monohydrate
4746348|NCT02948244|children|children
4746349|NCT02948244|pediatrics|pediatrics
4746350|NCT02948244|Facio-Scapulo-Humeral Dystrophy|facio-scapulo-humeral dystrophy
4746351|NCT02948205|Infertility, TU-LESS, 3D laparoscopy|infertility, tu-less, 3d laparoscopy
4746352|NCT02948192|Preterm Delivery|preterm delivery
4746353|NCT02948192|Preterm Birth|preterm birth
4746354|NCT02948192|Vaginal Microbiome|vaginal microbiome
4746355|NCT02948192|Microbiome|microbiome
4746356|NCT02948192|Gut Microbiome|gut microbiome
4746357|NCT02948192|African American|african american
4746358|NCT02948192|Metabolomics|metabolomics
4746359|NCT02948192|Pregnancy|pregnancy
4746360|NCT02948166|remote endarterectomy|remote endarterectomy
4746361|NCT02948166|Angioplasty with stenting of the superficial femoral artery|angioplasty with stenting of the superficial femoral artery
4746362|NCT02948140|Subdiaphragmatic infarction|subdiaphragmatic infarction
4746363|NCT02948101|Malignant Neoplasm of Female Genital Organs|malignant neoplasm of female genital organs
4746364|NCT02948101|Epithelial ovarian cancer|epithelial ovarian cancer
4746365|NCT02948101|Fallopian tube cancer|fallopian tube cancer
4746366|NCT02948101|Primary peritoneal cancer|primary peritoneal cancer
4746367|NCT02948101|PD 0360324|pd 0360324
4746368|NCT02948101|Cyclophosphamide|cyclophosphamide
4746369|NCT02948101|Cytoxan|cytoxan
4746370|NCT02948101|Neosar|neosar
4746371|NCT02948101|Pharmacokinetic testing|pharmacokinetic testing
4746372|NCT02948101|PK|pk
4746373|NCT02948101|Pharmacodynamic testing|pharmacodynamic testing
4746374|NCT02948101|PD|pd
4746375|NCT02948088|Tenosynovial Giant Cell Tumors|tenosynovial giant cell tumors
4746376|NCT02948088|Disease registry|disease registry
4746785|NCT02945332|behavior|behavior
4746377|NCT02948088|Routine clinical practice|routine clinical practice
4746378|NCT02948088|Real World Evidence|real world evidence
4746379|NCT02948062|ALD|ald
4746380|NCT02948062|Newborn Screening|newborn screening
4746381|NCT02948049|Accelerometer|accelerometer
4746382|NCT02948049|Spinal Cord Stimulator|spinal cord stimulator
4746383|NCT02948049|Peripheral Nerve Stimulator|peripheral nerve stimulator
4746384|NCT02948049|Physical Function|physical function
4746385|NCT02947997|Healthy Volunteers|healthy volunteers
4746386|NCT02947984|sphenoid region|sphenoid region
4746387|NCT02947984|parasellar area|parasellar area
4746388|NCT02947984|photon radiation therapy|photon radiation therapy
4746389|NCT02947984|proton radiation therapy|proton radiation therapy
4746390|NCT02947958|teleconsultation|teleconsultation
4746391|NCT02947958|urology|urology
4746392|NCT02947958|primary care|primary care
4746393|NCT02947958|tertiary care|tertiary care
4746394|NCT02947932|acute pancreatitis|acute pancreatitis
4746395|NCT02947932|post-ERCP|post-ercp
4746396|NCT02947932|endoscopy|endoscopy
4746397|NCT02947919|Perioperative Period|perioperative period
4746398|NCT02947919|Music|music
4746399|NCT02947906|Gait|gait
4746400|NCT02947906|Loading|loading
4746401|NCT02947906|Multiple Sclerosis|multiple sclerosis
4746402|NCT02947906|Plantar Pressure|plantar pressure
4746403|NCT02947893|Nilotinib in Alzheimer's disease|nilotinib in alzheimer's disease
4746404|NCT02947880|autism, Bumetanide|autism, bumetanide
4746405|NCT02947854|Vaccine|vaccine
4746406|NCT02947854|Photochemical Internalisation|photochemical internalisation
4746407|NCT02947854|Immune Response|immune response
4746408|NCT02947854|Peptide vaccine|peptide vaccine
4746409|NCT02947854|Anti cancer vaccine|anti cancer vaccine
4746410|NCT02947828|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
4746411|NCT02947828|Polyneuropathies, Diabetic|polyneuropathies, diabetic
4746412|NCT02947750|Hypertension|hypertension
4746413|NCT02947750|Kidney Disorder|kidney disorder
4746414|NCT02947750|Nephrology|nephrology
4746415|NCT02947750|Physiology|physiology
4746416|NCT02947737|Skin graft|skin graft
4746417|NCT02947724|chocolate cyst|chocolate cyst
4746418|NCT02947724|laparoscopy|laparoscopy
4746419|NCT02947724|surgicel|surgicel
4746420|NCT02947711|E2027|e2027
4746421|NCT02947711|Healthy participants|healthy participants
4746422|NCT02947711|Pharmacokinetics|pharmacokinetics
4746423|NCT02947698|acute kidney injury|acute kidney injury
4746424|NCT02947698|weekend admission|weekend admission
4746425|NCT02947698|mortality|mortality
4746426|NCT02947685|breast cancer|breast cancer
4746427|NCT02947685|malignant tumor of the breast|malignant tumor of the breast
4746428|NCT02947685|HER2+|her2+
4746430|NCT02947685|metastatic breast cancer|metastatic breast cancer
4746431|NCT02947659|Body mass index|body mass index
4746432|NCT02947659|Academic stress|academic stress
4746433|NCT02947659|Musculoskeletal disorders|musculoskeletal disorders
4746434|NCT02947607|Human gut microbiome|human gut microbiome
4746435|NCT02947607|Colorectal cancer|colorectal cancer
4746436|NCT02947607|Colorectal adenoma|colorectal adenoma
4746437|NCT02947607|Gut bacteria|gut bacteria
4746438|NCT02947607|Metagenomics|metagenomics
4746439|NCT02947607|Metatranscriptomics|metatranscriptomics
4746440|NCT02947581|subarachnoid neurocysticercosis|subarachnoid neurocysticercosis
4746441|NCT02947581|albendazole|albendazole
4746442|NCT02947581|praziquantel|praziquantel
4746443|NCT02947568|Non-alcoholic Fatty Liver Disease|non-alcoholic fatty liver disease
4746444|NCT02947568|Chronic Kidney Disease|chronic kidney disease
4746445|NCT02947568|Diabetes Mellitus|diabetes mellitus
4746446|NCT02947568|Cross-sectional|cross-sectional
4746447|NCT02947555|diabetes mellitus|diabetes mellitus
4746448|NCT02947555|atherosclerosis|atherosclerosis
4746449|NCT02947555|AGE|age
4746450|NCT02947555|lens autofluorescence|lens autofluorescence
4746451|NCT02947529|Hemiarthroplasty|hemiarthroplasty
4746452|NCT02947529|Intramedullary nail|intramedullary nail
4746453|NCT02947529|Tranexamic acid|tranexamic acid
4746454|NCT02947529|Transfusion|transfusion
4746455|NCT02947516|Endoscopic Ultrasound-Guided Fine Needle Aspiration|endoscopic ultrasound-guided fine needle aspiration
4746456|NCT02947516|liver|liver
4746457|NCT02947516|biopsy|biopsy
4746458|NCT02947516|pain|pain
4746459|NCT02947503|Gestational Diabetes|gestational diabetes
4746460|NCT02947503|Insulin Resistance|insulin resistance
4746461|NCT02947503|Metformin|metformin
4746462|NCT02947503|Hyperinsulinaemia|hyperinsulinaemia
4746463|NCT02947503|Prevention of Complications|prevention of complications
4746464|NCT02947503|Long Term Study|long term study
4746465|NCT02947503|Mother and Child|mother and child
4746466|NCT02947503|Health Benefits|health benefits
4746467|NCT02947490|Blood pressure monitoring|blood pressure monitoring
4746468|NCT02947490|self BP monitoring|self bp monitoring
4746469|NCT02947490|self BP management|self bp management
4746470|NCT02947438|Renal anemia|renal anemia
4746471|NCT02947438|Haemodialysis|haemodialysis
4746472|NCT02947438|Maintenance phase|maintenance phase
4746473|NCT02947412|sleeve gastrectomy|sleeve gastrectomy
4746474|NCT02947412|long-term follow-up|long-term follow-up
4746475|NCT02947412|gastroesophageal reflux disease after sleeve|gastroesophageal reflux disease after sleeve
4746476|NCT02947412|revisional surgery|revisional surgery
4746479|NCT02947399|Thyroid hormone Withdrawal|thyroid hormone withdrawal
4746480|NCT02947373|brain tumor|brain tumor
4746481|NCT02947373|children|children
4746482|NCT02947321|Radiofrequency ablation|radiofrequency ablation
4746483|NCT02947308|Anxiety|anxiety
4746484|NCT02947308|Depression|depression
4746485|NCT02947243|Virtual reality|virtual reality
4746486|NCT02947243|Immersive distraction|immersive distraction
4746487|NCT02947243|Oculus rift|oculus rift
4746488|NCT02947243|Virtual world|virtual world
4746489|NCT02947243|Virtual environment|virtual environment
4746490|NCT02947243|Procedural pain|procedural pain
4746491|NCT02947243|Procedural anxiety|procedural anxiety
4746492|NCT02947243|Acute pain|acute pain
4746493|NCT02947243|Pain management|pain management
4746494|NCT02947243|Anxiety|anxiety
4746495|NCT02947243|Children, Child|children, child
4746496|NCT02947243|Kid, Kids|kid, kids
4746497|NCT02947243|Pediatric, Pediatrics|pediatric, pediatrics
4746498|NCT02947243|Young children|young children
4746499|NCT02947243|Burns|burns
4746500|NCT02947243|Burn injuries|burn injuries
4746501|NCT02947243|Burn unit|burn unit
4746502|NCT02947243|Physiotherapy|physiotherapy
4746503|NCT02947243|Physical therapy|physical therapy
4746504|NCT02947243|Burn dressing|burn dressing
4746505|NCT02947243|Dressing change|dressing change
4746506|NCT02947243|Non-pharmacological, nonpharmacological|non-pharmacological, nonpharmacological
4746507|NCT02947243|Clinical Research|clinical research
4746508|NCT02947243|Nursing Practice|nursing practice
4746509|NCT02947230|Mobility|mobility
4746510|NCT02947230|Aging|aging
4746511|NCT02947230|Knowledge Translation|knowledge translation
4746512|NCT02947230|Physical Activity|physical activity
4746513|NCT02947217|Immunology|immunology
4746514|NCT02947217|Pregnancy|pregnancy
4746515|NCT02947217|Implantation Rate|implantation rate
4746516|NCT02947217|Fertilization in Vitro|fertilization in vitro
4746517|NCT02947204|Bronchiolitis|bronchiolitis
4746518|NCT02947204|Length of Hospital Stay|length of hospital stay
4746519|NCT02947204|Clinical Trial|clinical trial
4746520|NCT02947204|Oxygen Saturation Monitoring|oxygen saturation monitoring
4746521|NCT02947152|HKT288|hkt288
4746522|NCT02947152|CDH6|cdh6
4746523|NCT02947152|ADC|adc
4746524|NCT02947152|maytansine|maytansine
4746525|NCT02947152|epithelial ovarian cancer|epithelial ovarian cancer
4746526|NCT02947152|renal cell carcinoma|renal cell carcinoma
4746527|NCT02947152|RCC|rcc
4746528|NCT02947126|cystic fibrosis|cystic fibrosis
4746529|NCT02947126|mucociliary clearance|mucociliary clearance
4746530|NCT02947126|CFTR|cftr
4746531|NCT02947113|cancer|cancer
4746532|NCT02947100|Sickle Cell Disease|sickle cell disease
4746533|NCT02947100|omega-3 fatty acids|omega-3 fatty acids
4746534|NCT02947100|Docosahexaenoic Acid (DHA)|docosahexaenoic acid (dha)
4746535|NCT02947100|Eicosapentaenoic Acid (EPA)|eicosapentaenoic acid (epa)
4746536|NCT02947087|Islet autotransplantation|islet autotransplantation
4746537|NCT02947087|Alpha1 anti trypsin|alpha1 anti trypsin
4746538|NCT02947074|Yoga|yoga
4746539|NCT02947074|Meditation|meditation
4746540|NCT02947074|Glutathione|glutathione
4746541|NCT02947074|Catecholamine|catecholamine
4746542|NCT02947074|polysomnography|polysomnography
4746543|NCT02947061|Advanced Breast Cancer,first treatment, S1, Capecitabine|advanced breast cancer,first treatment, s1, capecitabine
4746544|NCT02947035|thyroid cancer|thyroid cancer
4746545|NCT02947035|thyroid nodule|thyroid nodule
4746546|NCT02947035|thyroidectomy|thyroidectomy
4746547|NCT02947035|personalized medicine|personalized medicine
4746548|NCT02947022|gadolinium|gadolinium
4746549|NCT02947022|deposition|deposition
4746550|NCT02947022|GBCA|gbca
4746551|NCT02947022|Extremity Pain|extremity pain
4746552|NCT02947022|Skin Pain|skin pain
4746553|NCT02947022|Chest Wall Pain|chest wall pain
4746554|NCT02946944|Pulmonary Embolism|pulmonary embolism
4746555|NCT02946944|sildenafil|sildenafil
4746556|NCT02946944|oral anticoagulation therapy|oral anticoagulation therapy
4746557|NCT02946918|levothyroxine|levothyroxine
4746558|NCT02946853|Atrial Fibrillation|atrial fibrillation
4746559|NCT02946853|CRT|crt
4746560|NCT02946853|AV Junction Ablation|av junction ablation
4746561|NCT02946853|LVESV|lvesv
4746562|NCT02946827|FODMAPs diet|fodmaps diet
4746563|NCT02946827|micro-macro nutrients intake|micro-macro nutrients intake
4746564|NCT02946827|IBS (Irritable Bowel Syndrome)|ibs (irritable bowel syndrome)
4746565|NCT02946814|essential oils|essential oils
4746566|NCT02946814|microscope, colfocal|microscope, colfocal
4746567|NCT02946814|dental plaque|dental plaque
4746568|NCT02946801|Biofilms|biofilms
4746569|NCT02946801|essential oils|essential oils
4746570|NCT02946801|alcohol|alcohol
4746571|NCT02946801|microscopy, confocal|microscopy, confocal
4746572|NCT02946801|mouthwashes|mouthwashes
4746573|NCT02946775|septicemia|septicemia
4746574|NCT02946775|bacteremia|bacteremia
4746575|NCT02946775|pneumonia|pneumonia
4746576|NCT02946775|meningitis|meningitis
4746577|NCT02946762|HIV|hiv
4746578|NCT02946762|TB|tb
4746579|NCT02946762|Antiretroviral Treatment|antiretroviral treatment
4746580|NCT02946762|Anti-tuberculosis Treatment|anti-tuberculosis treatment
4746581|NCT02946762|HIV Counselling and Testing|hiv counselling and testing
4746582|NCT02946762|Treatment as Prevention|treatment as prevention
4746583|NCT02946749|Scar pregnancy|scar pregnancy
4746584|NCT02946749|Placenta planting abnormal disease|placenta planting abnormal disease
4746585|NCT02946749|Early diagnosis|early diagnosis
4746586|NCT02946749|Individualized treatment|individualized treatment
4746587|NCT02946736|Sleep|sleep
4746588|NCT02946736|Physical Health|physical health
4746589|NCT02946736|Psychological Health|psychological health
4746590|NCT02946736|Well-Being|well-being
4746591|NCT02946736|Employee|employee
4746592|NCT02946736|Actigraphy|actigraphy
4746593|NCT02946710|Alzheimer disease|alzheimer disease
4746594|NCT02946710|Alzheimer's disease, biomarkers|alzheimer's disease, biomarkers
4746595|NCT02946710|p75NTR-ECD|p75ntr-ecd
4746596|NCT02946697|Chinese|chinese
4746597|NCT02946697|cancer survivors|cancer survivors
4746598|NCT02946697|Quality of Life|quality of life
4746599|NCT02946697|Social Support|social support
4746600|NCT02946658|COPD, Emphysema|copd, emphysema
4746601|NCT02946619|Chinese breast cancer survivors|chinese breast cancer survivors
4746602|NCT02946619|expressive writing|expressive writing
4746603|NCT02946554|Acute-On-Chronic Liver Failure|acute-on-chronic liver failure
4746604|NCT02946554|ACLF|aclf
4746605|NCT02946541|DA-1229|da-1229
4746606|NCT02946541|evogliptin|evogliptin
4746607|NCT02946541|DPP-IV inhibitor|dpp-iv inhibitor
4746608|NCT02946541|Suganon|suganon
4746609|NCT02946541|DPP-4 inhibitor|dpp-4 inhibitor
4746610|NCT02946515|Pediatrics|pediatrics
4746611|NCT02946489|cannabis|cannabis
4746612|NCT02946489|mindfulness based relapse prevention|mindfulness based relapse prevention
4746613|NCT02946489|motivational enhancement therapy|motivational enhancement therapy
4746614|NCT02946437|severe SAH|severe sah
4746615|NCT02946437|prevention of vasospasm and/ or brain oedema|prevention of vasospasm and/ or brain oedema
4746616|NCT02946437|Sevoflurane|sevoflurane
4746617|NCT02946437|Postconditioning|postconditioning
4746618|NCT02946411|Hyperglycemia|hyperglycemia
4746619|NCT02946385|meningococcal disease|meningococcal disease
4746620|NCT02946385|meningitis|meningitis
4746621|NCT02946385|booster|booster
4746622|NCT02946385|antibody persistence|antibody persistence
4746623|NCT02946372|retina surgery|retina surgery
4746624|NCT02946372|macula|macula
4746625|NCT02946372|macular hole|macular hole
4746626|NCT02946372|internal limiting membrane (ILM)|internal limiting membrane (ilm)
4746627|NCT02946372|vitrectomy|vitrectomy
4746628|NCT02946372|autologous transplantation|autologous transplantation
4746629|NCT02946346|Human papillomaviruses|human papillomaviruses
4746630|NCT02946346|Clearance|clearance
4746631|NCT02946346|Kinetics|kinetics
4746632|NCT02946346|Ecology|ecology
4746633|NCT02946346|Bacterial vaginosis|bacterial vaginosis
4746634|NCT02946346|Immune response|immune response
4746635|NCT02946346|Microbiota|microbiota
4746636|NCT02946333|Multiple Myeloma|multiple myeloma
4746637|NCT02946333|autologous stem cell transplant (ASCT)|autologous stem cell transplant (asct)
4746638|NCT02946333|QoLMMBuS|qolmmbus
4746639|NCT02946333|healthcare costs|healthcare costs
4746640|NCT02946320|PCI, bioabsorbable scaffold|pci, bioabsorbable scaffold
4746641|NCT02946281|self-management|self-management
4746642|NCT02946281|health behavior|health behavior
4746643|NCT02946281|cardiac disease|cardiac disease
4746644|NCT02946281|habits|habits
4746645|NCT02946281|lifestyle|lifestyle
4746646|NCT02946255|Psychosis|psychosis
4746647|NCT02946255|Psychosis NOS|psychosis nos
4746648|NCT02946255|Schizophrenia|schizophrenia
4746649|NCT02946255|Hospital discharge|hospital discharge
4746650|NCT02946255|Inpatient psychiatry|inpatient psychiatry
4746651|NCT02946190|Acellular pertussis vaccines Genetically-detoxified pertussis toxin Adolescents|acellular pertussis vaccines genetically-detoxified pertussis toxin adolescents
4746652|NCT02946177|Immunology|immunology
4746653|NCT02946177|Pregnancy|pregnancy
4746654|NCT02946177|Implantation Rate|implantation rate
4746655|NCT02946177|Fertilization in Vitro|fertilization in vitro
4746656|NCT02946177|Oocyte donor egg recipient|oocyte donor egg recipient
4746657|NCT02946151|Epilepsy|epilepsy
4746658|NCT02946151|Seizure monitoring|seizure monitoring
4746659|NCT02946151|Electroencephalography|electroencephalography
4746660|NCT02946138|Hepatocellular Carcinoma|hepatocellular carcinoma
4746661|NCT02946138|carbon-ion radiotherapy|carbon-ion radiotherapy
4746662|NCT02946138|GM-CSF|gm-csf
4746663|NCT02946138|immunotherapy|immunotherapy
4746664|NCT02946086|motor skill learning, visuo-spatial attention|motor skill learning, visuo-spatial attention
4746665|NCT02946047|HIV|hiv
4746666|NCT02946047|ART|art
4746667|NCT02946047|Antiretroviral|antiretroviral
4746668|NCT02946047|Therapy|therapy
4746669|NCT02946047|Reservoir|reservoir
4746670|NCT02946047|Cure|cure
4746671|NCT02946034|CKD|ckd
4746672|NCT02946034|HCV|hcv
4746673|NCT02946021|Lymphedema|lymphedema
4746674|NCT02946021|Cancer|cancer
4746675|NCT02946021|Head Cancer|head cancer
4746676|NCT02946021|Neck Cancer|neck cancer
4746677|NCT02945982|Portal Hypertension|portal hypertension
4746678|NCT02945982|Fuzheng Huayu|fuzheng huayu
4746679|NCT02945982|Hepatitis B|hepatitis b
4746680|NCT02945969|dietary sodium|dietary sodium
4746681|NCT02945969|albuminuria|albuminuria
4746682|NCT02945969|chronic kidney disease|chronic kidney disease
4746683|NCT02945956|Portal Hypertension|portal hypertension
4747191|NCT02942875|subacute|subacute
4746684|NCT02945956|Fuzheng Huayu|fuzheng huayu
4746685|NCT02945956|Hepatitis B|hepatitis b
4746686|NCT02945930|Enbucrilate|enbucrilate
4746687|NCT02945930|Esophageal and Gastric Varices|esophageal and gastric varices
4746688|NCT02945930|Endoscopy|endoscopy
4746689|NCT02945930|Safety|safety
4746690|NCT02945930|Efficacy|efficacy
4746691|NCT02945891|mass screening|mass screening
4746692|NCT02945891|coverage|coverage
4746693|NCT02945891|self-sampling|self-sampling
4746694|NCT02945891|clinical validity|clinical validity
4746695|NCT02945878|radiotherapy, oral mucositis,oral mucosa protection|radiotherapy, oral mucositis,oral mucosa protection
4746696|NCT02945839|Migraine|migraine
4746697|NCT02945839|emergency department|emergency department
4746698|NCT02945826|urokinase plasminogen activator receptor|urokinase plasminogen activator receptor
4746699|NCT02945826|positron emission tomography|positron emission tomography
4746700|NCT02945826|glioblastoma multiforme|glioblastoma multiforme
4746701|NCT02945813|Prostate Cancer|prostate cancer
4746702|NCT02945813|Prostate Cancer after Prostatectomy|prostate cancer after prostatectomy
4746703|NCT02945813|Phase II Trial|phase ii trial
4746704|NCT02945813|Salvage Radiotherapy|salvage radiotherapy
4746705|NCT02945813|Metformin|metformin
4746706|NCT02945800|relapsed|relapsed
4746707|NCT02945800|refractory|refractory
4746708|NCT02945800|soft tissue|soft tissue
4746709|NCT02945800|bones and joints|bones and joints
4746710|NCT02945800|non-rhabdomyosarcoma soft tissue sarcoma|non-rhabdomyosarcoma soft tissue sarcoma
4746711|NCT02945800|pediatric|pediatric
4746712|NCT02945787|Spanish speaking|spanish speaking
4746713|NCT02945787|self-help|self-help
4746714|NCT02945787|tobacco abstinence|tobacco abstinence
4746715|NCT02945787|public health|public health
4746716|NCT02945787|Forever Free|forever free
4746717|NCT02945787|Stop Smoking for Good|stop smoking for good
4746718|NCT02945774|PET|pet
4746719|NCT02945774|MRI|mri
4746720|NCT02945774|Inflammation|inflammation
4746721|NCT02945774|Microglia|microglia
4746722|NCT02945774|FEPPA|feppa
4746723|NCT02945748|pediatric|pediatric
4746724|NCT02945748|cardiac output|cardiac output
4746725|NCT02945748|fluid responsiveness|fluid responsiveness
4746726|NCT02945748|critically ill|critically ill
4746727|NCT02945748|hemodynamic monitoring|hemodynamic monitoring
4746728|NCT02945735|depression|depression
4746729|NCT02945735|cognitive bias modification|cognitive bias modification
4746730|NCT02945735|MDD|mdd
4746731|NCT02945735|major depressive disorder|major depressive disorder
4746732|NCT02945735|attention bias modification treatment|attention bias modification treatment
4746733|NCT02945722|Hemodialysis|hemodialysis
4746734|NCT02945722|S. Aureus|s. aureus
4746735|NCT02945722|Decolonization|decolonization
4746736|NCT02945722|Persistent carriage|persistent carriage
4746737|NCT02945709|PTSD|ptsd
4746738|NCT02945709|attention training|attention training
4746739|NCT02945709|cognitive bias modification|cognitive bias modification
4746740|NCT02945696|nerve block|nerve block
4746741|NCT02945696|laparoscopy|laparoscopy
4746742|NCT02945696|anesthesia|anesthesia
4746743|NCT02945683|atopic dermatitis, probiotics, vitamin D3, L. reuteri|atopic dermatitis, probiotics, vitamin d3, l. reuteri
4746744|NCT02945644|obstructive sleep apnea|obstructive sleep apnea
4746745|NCT02945644|trazodone|trazodone
4746746|NCT02945644|positive airway pressure|positive airway pressure
4746747|NCT02945644|adherence|adherence
4746748|NCT02945631|HPV|hpv
4746749|NCT02945631|Induction Chemotherapy|induction chemotherapy
4746750|NCT02945631|De-Intensified Chemoradiotherapy|de-intensified chemoradiotherapy
4746751|NCT02945631|Oropharynx Cancer|oropharynx cancer
4746752|NCT02945618|cryotherapy|cryotherapy
4746753|NCT02945618|physical therapy|physical therapy
4746754|NCT02945592|Hemispatial Neglect|hemispatial neglect
4746755|NCT02945592|cueing|cueing
4746756|NCT02945592|egocentric-allocentric|egocentric-allocentric
4746757|NCT02945592|early rehabilitation|early rehabilitation
4746758|NCT02945592|parietal tDCS|parietal tdcs
4746759|NCT02945579|Breast Cancer|breast cancer
4746760|NCT02945579|Surveillance|surveillance
4746761|NCT02945579|Breast biopsy|breast biopsy
4746762|NCT02945579|Questionnaires|questionnaires
4746763|NCT02945579|Surveys|surveys
4746764|NCT02945540|Gestational diabetes|gestational diabetes
4746765|NCT02945540|Patient education|patient education
4746766|NCT02945540|Patient Satisfaction|patient satisfaction
4746767|NCT02945514|Healthy|healthy
4746768|NCT02945514|Diet|diet
4746769|NCT02945514|Microbiome|microbiome
4746770|NCT02945514|Personalized|personalized
4746771|NCT02945514|Custom|custom
4746772|NCT02945475|functional magnetic resonance imaging|functional magnetic resonance imaging
4746773|NCT02945475|eating behavior|eating behavior
4746774|NCT02945475|sugar|sugar
4746775|NCT02945475|fructose|fructose
4746776|NCT02945449|Wharton jelly mesenchymal stem cells|wharton jelly mesenchymal stem cells
4746777|NCT02945449|Erectile Dysfunction|erectile dysfunction
4746778|NCT02945449|Diabetes|diabetes
4746779|NCT02945397|Return to work|return to work
4746780|NCT02945397|Work rehabilitation|work rehabilitation
4746781|NCT02945397|Sick-leave|sick-leave
4746782|NCT02945384|family well-being|family well-being
4746783|NCT02945332|exercise|exercise
4746784|NCT02945332|activity|activity
4746786|NCT02945306|Sleep Disordered Breathing|sleep disordered breathing
4746787|NCT02945306|Adenotonsillectomy|adenotonsillectomy
4746788|NCT02945306|Child|child
4746789|NCT02945293|Pain|pain
4746790|NCT02945293|Elderly|elderly
4746791|NCT02945293|Aged|aged
4746792|NCT02945293|Opioid|opioid
4746793|NCT02945293|Cognition|cognition
4746794|NCT02945293|Side-effects|side-effects
4746795|NCT02945293|Alcohol|alcohol
4746796|NCT02945293|Alcohol Use Disorder (AUD)|alcohol use disorder (aud)
4746797|NCT02945293|Older|older
4746798|NCT02945280|apixaban|apixaban
4746799|NCT02945280|factor Xa inhibitors|factor xa inhibitors
4746800|NCT02945280|antithrombotic agent|antithrombotic agent
4746801|NCT02945280|deep vein thrombosis|deep vein thrombosis
4746802|NCT02945280|upper extremity|upper extremity
4746803|NCT02945267|Pancreatic Cancer|pancreatic cancer
4746804|NCT02945267|Unresectable|unresectable
4746805|NCT02945267|Maintenance Treatment|maintenance treatment
4746806|NCT02945254|sleep onset latency|sleep onset latency
4746807|NCT02945254|sleep quality|sleep quality
4746808|NCT02945254|insomnia|insomnia
4746809|NCT02945228|Genotype 2|genotype 2
4746810|NCT02945228|Paritaprevir|paritaprevir
4746811|NCT02945228|Hepatitis C Virus (HCV)|hepatitis c virus (hcv)
4746812|NCT02945228|Ritonavir|ritonavir
4746813|NCT02945228|ombitasvir|ombitasvir
4746814|NCT02945189|Pregnancy|pregnancy
4746815|NCT02945176|Boston Keratoprosthesis|boston keratoprosthesis
4746816|NCT02945150|hemodialysis|hemodialysis
4746817|NCT02945150|peritoneal dialysis|peritoneal dialysis
4746818|NCT02945150|renal failure|renal failure
4746819|NCT02945150|kidney transplant|kidney transplant
4746820|NCT02945085|older adults|older adults
4746821|NCT02945085|family caregivers|family caregivers
4746822|NCT02945085|Medicare Advantage beneficiaries|medicare advantage beneficiaries
4746823|NCT02945072|Child Behavior|child behavior
4746824|NCT02945072|Problem Behavior|problem behavior
4746825|NCT02945072|postoperative behaviour problems|postoperative behaviour problems
4746826|NCT02945059|Liver regeneration|liver regeneration
4746827|NCT02945059|portal vein embolization|portal vein embolization
4746828|NCT02945059|gelatin powder|gelatin powder
4746829|NCT02945059|liver surgery|liver surgery
4746830|NCT02945059|hepatectomy|hepatectomy
4746831|NCT02945033|Pi3k mutation|pi3k mutation
4746832|NCT02945033|Aspirin|aspirin
4746833|NCT02944968|Interventional|interventional
4746834|NCT02944968|Radiofrequency Ablation|radiofrequency ablation
4746835|NCT02944968|Paroxysmal Atrial Fibrillation|paroxysmal atrial fibrillation
4746836|NCT02944929|Spastic hemiparesis|spastic hemiparesis
4746837|NCT02944929|Stroke|stroke
4746838|NCT02944929|Self-rehabilitation|self-rehabilitation
4746839|NCT02944929|Botulinum Toxin Injections|botulinum toxin injections
4746840|NCT02944903|audit|audit
4746841|NCT02944903|Lung cancer|lung cancer
4746842|NCT02944903|screening practice|screening practice
4746843|NCT02944903|Egypt|egypt
4746844|NCT02944851|Blood donors|blood donors
4746845|NCT02944851|blood donation|blood donation
4746846|NCT02944851|traumatic blood loss|traumatic blood loss
4746847|NCT02944851|Trauma|trauma
4746848|NCT02944838|older adults|older adults
4746849|NCT02944838|physical activity|physical activity
4746850|NCT02944838|built environment|built environment
4746851|NCT02944825|Urolithiasis|urolithiasis
4746852|NCT02944825|UTI|uti
4746853|NCT02944786|Chronic pain|chronic pain
4746854|NCT02944786|Adolescents|adolescents
4746855|NCT02944786|School nurse|school nurse
4746856|NCT02944773|newborn|newborn
4746857|NCT02944773|facilitated tucking|facilitated tucking
4746858|NCT02944773|position|position
4746859|NCT02944773|weight|weight
4746860|NCT02944773|stress|stress
4746861|NCT02944747|Gestational age, Preterm birth, LMP, Bangladesh|gestational age, preterm birth, lmp, bangladesh
4746862|NCT02944734|Candesartan|candesartan
4746863|NCT02944734|Amlodipine|amlodipine
4746864|NCT02944734|Hypertension|hypertension
4746865|NCT02944734|Vascular Diseases|vascular diseases
4746866|NCT02944734|Cardiovascular Diseases|cardiovascular diseases
4746867|NCT02944734|Antihypertensive Agents|antihypertensive agents
4746868|NCT02944734|Vasodilator Agents|vasodilator agents
4746869|NCT02944734|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers
4746870|NCT02944734|Angiotensin Receptor Antagonists|angiotensin receptor antagonists
4746871|NCT02944734|Calcium Channel Blockers|calcium channel blockers
4746872|NCT02944721|Neuropathic Pain|neuropathic pain
4746873|NCT02944708|maintenance chemotherapy|maintenance chemotherapy
4746874|NCT02944695|audit|audit
4746875|NCT02944695|infection control|infection control
4746876|NCT02944695|bronchoscopy unit|bronchoscopy unit
4746877|NCT02944695|Egypt|egypt
4746878|NCT02944682|Obstetrics|obstetrics
4746879|NCT02944682|Pregnancy Outcomes|pregnancy outcomes
4746880|NCT02944682|Pediatrics|pediatrics
4746881|NCT02944682|Atherosclerosis|atherosclerosis
4746882|NCT02944682|Cancer|cancer
4746883|NCT02944682|Cardiovascular Disease|cardiovascular disease
4746884|NCT02944682|Public Health|public health
4746885|NCT02944682|Environmental Air Pollutants|environmental air pollutants
4746886|NCT02944656|Perioperative pain|perioperative pain
4746887|NCT02944656|Outpatient surgery|outpatient surgery
4746888|NCT02944656|Obstetrics/gynecology|obstetrics/gynecology
4746889|NCT02944656|Pain management|pain management
4746890|NCT02944630|quality of life|quality of life
4746891|NCT02944630|psychotherapy|psychotherapy
4746892|NCT02944630|psoriasis|psoriasis
4746893|NCT02944630|treatments|treatments
4746894|NCT02944578|Cancer|cancer
4746895|NCT02944578|HIV|hiv
4746896|NCT02944578|Oncology|oncology
4746897|NCT02944578|Infectious Diseases|infectious diseases
4746898|NCT02944578|HPV|hpv
4746899|NCT02944578|Preventive Medicine|preventive medicine
4746900|NCT02944539|Mitochondrial DNA copy number|mitochondrial dna copy number
4746901|NCT02944539|Gastric cancer|gastric cancer
4746902|NCT02944526|suprascapular nerve|suprascapular nerve
4746903|NCT02944500|Brain|brain
4746904|NCT02944500|Liraglutide|liraglutide
4746905|NCT02944500|MRI|mri
4746906|NCT02944487|safety|safety
4746907|NCT02944487|pharmacokinetics|pharmacokinetics
4746908|NCT02944474|Pharmacokinetics|pharmacokinetics
4746909|NCT02944474|Safety|safety
4746910|NCT02944448|Osteoarthritis|osteoarthritis
4746911|NCT02944448|Hip|hip
4746912|NCT02944448|Knee|knee
4746913|NCT02944448|CR485|cr485
4746914|NCT02944448|Analgesic|analgesic
4746915|NCT02944448|Kappa opioid|kappa opioid
4746916|NCT02944435|Glutaminase Inhibitor|glutaminase inhibitor
4746917|NCT02944435|Glutaminase|glutaminase
4746918|NCT02944435|CB-839|cb-839
4746919|NCT02944396|metastatic|metastatic
4746920|NCT02944396|non-small cell lung cancer|non-small cell lung cancer
4746921|NCT02944396|Eastern Cooperative Oncology Group (ECOG)|eastern cooperative oncology group (ecog)
4746922|NCT02944396|veliparib|veliparib
4746923|NCT02944396|nivolumab|nivolumab
4746924|NCT02944396|Platinum Doublet Chemotherapy|platinum doublet chemotherapy
4746925|NCT02944396|carboplatin|carboplatin
4746926|NCT02944396|paclitaxel|paclitaxel
4746927|NCT02944396|pemetrexed|pemetrexed
4746928|NCT02944396|Response Evaluation Criteria In Solid Tumors (RECIST)|response evaluation criteria in solid tumors (recist)
4746929|NCT02944396|Common Terminology Criteria for Adverse Events (CTCAE)|common terminology criteria for adverse events (ctcae)
4746930|NCT02944396|Poly (ADP) ribose polymerase (PARP)|poly (adp) ribose polymerase (parp)
4746931|NCT02944396|Immuno Oncology|immuno oncology
4746932|NCT02944396|Metastatic or Advanced Non-Small Cell Lung Cancer (NSCLC)|metastatic or advanced non-small cell lung cancer (nsclc)
4746933|NCT02944383|Hypertriglycerides|hypertriglycerides
4746934|NCT02944344|breast cancer|breast cancer
4746935|NCT02944344|stage 4|stage 4
4746936|NCT02944344|metastatic|metastatic
4746937|NCT02944344|hospice|hospice
4746938|NCT02944344|palliative care|palliative care
4746939|NCT02944344|end of life|end of life
4746940|NCT02944344|advance directive|advance directive
4746941|NCT02944344|oncology|oncology
4746942|NCT02944344|caregiver|caregiver
4746943|NCT02944344|provider|provider
4746944|NCT02944344|coping|coping
4746945|NCT02944344|support|support
4746946|NCT02944344|online|online
4746947|NCT02944331|Steam ablation|steam ablation
4746948|NCT02944331|Endothermal ablation|endothermal ablation
4746949|NCT02944331|Varicose vein treatment|varicose vein treatment
4746950|NCT02944331|Venous insufficiency|venous insufficiency
4746951|NCT02944331|Saphenous vein reflux|saphenous vein reflux
4746952|NCT02944331|Recurrent varicosity|recurrent varicosity
4746953|NCT02944318|Physical Activity|physical activity
4746954|NCT02944318|Healthy Lifestyle|healthy lifestyle
4746955|NCT02944318|Academic performance|academic performance
4746956|NCT02944292|Intra-abdominal pressure|intra-abdominal pressure
4746957|NCT02944292|Intra-abdominal hypertension|intra-abdominal hypertension
4746958|NCT02944266|post general anaesthesia induced|post general anaesthesia induced
4746959|NCT02944253|Diet, Reducing|diet, reducing
4746960|NCT02944253|Hunger|hunger
4746961|NCT02944253|Appetite Regulation|appetite regulation
4746962|NCT02944253|Ketogenic Diet|ketogenic diet
4746963|NCT02944253|Caloric Restriction|caloric restriction
4746964|NCT02944253|Weight Loss|weight loss
4746965|NCT02944253|Ketosis|ketosis
4746966|NCT02944214|Hyperuricemia|hyperuricemia
4746967|NCT02944214|Renal Function|renal function
4746968|NCT02944214|Chronic kidney disease|chronic kidney disease
4746969|NCT02944214|Febuxostat|febuxostat
4746970|NCT02944214|Benzbromarone|benzbromarone
4746971|NCT02944201|carvedilol|carvedilol
4746972|NCT02944201|biomarkers|biomarkers
4746973|NCT02944201|autonomic nerves|autonomic nerves
4746974|NCT02944188|enhanced recovery after surgery|enhanced recovery after surgery
4746975|NCT02944188|right hemicolectomy|right hemicolectomy
4746976|NCT02944162|AML|aml
4746977|NCT02944162|CD33|cd33
4746978|NCT02944162|CAR-NK|car-nk
4746979|NCT02944136|cancer|cancer
4746980|NCT02944136|stepped collaborative care intervention|stepped collaborative care intervention
4746981|NCT02944136|depression|depression
4746982|NCT02944136|quality of life|quality of life
4746983|NCT02944136|stress|stress
4746984|NCT02944136|dyadic function|dyadic function
4746985|NCT02944136|spousal or intimate caregiver|spousal or intimate caregiver
4746986|NCT02944123|Half dose|half dose
4746987|NCT02944123|Newer oral P2Y12 receptor inhibitors|newer oral p2y12 receptor inhibitors
4746988|NCT02944123|Acute coronary syndrome|acute coronary syndrome
4746989|NCT02944097|Bioavailability|bioavailability
4746990|NCT02944097|Pharmacokinetics|pharmacokinetics
4746991|NCT02944097|trans-resveratrol|trans-resveratrol
4746992|NCT02944097|trans-epsilon-viniferin|trans-epsilon-viniferin
4746993|NCT02944097|Vineatrol 30|vineatrol 30
4746994|NCT02944084|Bioavailability|bioavailability
4746995|NCT02944084|Pharmacokinetics|pharmacokinetics
4746996|NCT02944084|Rice bran extract|rice bran extract
4746997|NCT02944084|Vitamin E|vitamin e
4746998|NCT02944084|Gamma-oryzanol|gamma-oryzanol
4746999|NCT02944084|Ferulic acid|ferulic acid
4747000|NCT02944071|femoropopliteal artery lesions|femoropopliteal artery lesions
4747001|NCT02944071|Percutaneous Transluminal Angioplasty|percutaneous transluminal angioplasty
4747002|NCT02944071|Peripheral Artery Disease|peripheral artery disease
4747003|NCT02944071|Drug-coated Balloon|drug-coated balloon
4747004|NCT02944058|Multiloc|multiloc
4747005|NCT02944058|Philos|philos
4747006|NCT02944058|Locking plate|locking plate
4747007|NCT02944058|Straight nail|straight nail
4747008|NCT02944058|Randomized controlled trial|randomized controlled trial
4747009|NCT02944058|3 and 4 part fractures|3 and 4 part fractures
4747010|NCT02944019|Nonvalvular Atrial Fibrillation|nonvalvular atrial fibrillation
4747011|NCT02944019|Post Authorisation Safety Study|post authorisation safety study
4747012|NCT02944019|Safety|safety
4747013|NCT02944019|Real World Evidence|real world evidence
4747014|NCT02944006|MRI|mri
4747015|NCT02943993|Post-Authorisation Safety Study|post-authorisation safety study
4747016|NCT02943993|Real World Evidence|real world evidence
4747017|NCT02943993|Edoxaban|edoxaban
4747018|NCT02943993|Efficacy/Safety|efficacy/safety
4747019|NCT02943980|Intraoperative nerve monitoring, airway management|intraoperative nerve monitoring, airway management
4747020|NCT02943967|Refractive Surgical Procedures|refractive surgical procedures
4747021|NCT02943967|Photorefractive Keratectomy|photorefractive keratectomy
4747022|NCT02943967|Aberrometry|aberrometry
4747023|NCT02943954|Fractional Flow Reserve|fractional flow reserve
4747024|NCT02943915|Spinal Cord|spinal cord
4747025|NCT02943915|Injury|injury
4747026|NCT02943915|Exoskeleton|exoskeleton
4747027|NCT02943915|Ekso|ekso
4747028|NCT02943915|Rehabilitation|rehabilitation
4747029|NCT02943902|immunogenicity|immunogenicity
4747030|NCT02943889|Mesenchymal stem cells|mesenchymal stem cells
4747031|NCT02943889|Liver cirrhosis|liver cirrhosis
4747032|NCT02943889|Stem cell therapy|stem cell therapy
4747033|NCT02943876|risk prediction|risk prediction
4747034|NCT02943876|risk score|risk score
4747035|NCT02943876|accuracy of risk perception|accuracy of risk perception
4747036|NCT02943876|self-help|self-help
4747037|NCT02943876|psychological distress|psychological distress
4747038|NCT02943850|stem cells|stem cells
4747039|NCT02943850|growth factor|growth factor
4747040|NCT02943850|ALS|als
4747041|NCT02943824|brachytherapy|brachytherapy
4747042|NCT02943824|machine learning|machine learning
4747043|NCT02943824|treatment planning|treatment planning
4747044|NCT02943824|Low-Dose-Rate brachytherapy|low-dose-rate brachytherapy
4747045|NCT02943811|endometrial cancer|endometrial cancer
4747046|NCT02943811|survival|survival
4747047|NCT02943811|uterine manipulator|uterine manipulator
4747048|NCT02943798|Pulmonary Large Cell Neuroendocrine Carcinoma,chemotherapy|pulmonary large cell neuroendocrine carcinoma,chemotherapy
4747049|NCT02943785|Transcatheter Aortic Valve Implantation -- TAVI|transcatheter aortic valve implantation -- tavi
4747050|NCT02943785|Anticoagulation|anticoagulation
4747051|NCT02943785|Atrial Fibrillation|atrial fibrillation
4747052|NCT02943785|ENVISAGE-TAVI-AF|envisage-tavi-af
4747053|NCT02943746|Standard Protein Diet|standard protein diet
4747054|NCT02943746|High Protein Diet|high protein diet
4747055|NCT02943746|Growth|growth
4747056|NCT02943746|Body Composition|body composition
4747057|NCT02943746|Extremely Low Birth Weight|extremely low birth weight
4747058|NCT02943746|Human Milk Derived Fortifier|human milk derived fortifier
4747059|NCT02943746|Protein|protein
4747060|NCT02943746|Targeted Fortification|targeted fortification
4747061|NCT02943746|Human Milk Diet|human milk diet
4747062|NCT02943746|Prematurity|prematurity
4747063|NCT02943733|Pancreatic neuroendocrine tumors (pNETs)|pancreatic neuroendocrine tumors (pnets)
4747064|NCT02943733|Pancreatic neuroendocrine tumors|pancreatic neuroendocrine tumors
4747065|NCT02943733|pNETs|pnets
4747066|NCT02943733|NETs|nets
4747067|NCT02943707|liver diseases|liver diseases
4747068|NCT02943707|Bone Marrow Cell Transplantation|bone marrow cell transplantation
4747069|NCT02943694|TaTME|tatme
4747070|NCT02943694|Complications|complications
4747071|NCT02943694|Instrument|instrument
4747072|NCT02943642|MF|mf
4747073|NCT02943642|CTCL|ctcl
4747074|NCT02943642|Cutaneous T Cell Lymphoma|cutaneous t cell lymphoma
4747075|NCT02943616|Absorb GT1 BVS|absorb gt1 bvs
4747076|NCT02943616|BVS|bvs
4747077|NCT02943616|Bioabsorbable|bioabsorbable
4747078|NCT02943616|Myocardial ischemia|myocardial ischemia
4747079|NCT02943616|Stent thrombosis|stent thrombosis
4747080|NCT02943616|Stents|stents
4747081|NCT02943603|mFOLFOX6|mfolfox6
4747082|NCT02943603|pembrolizumab|pembrolizumab
4747083|NCT02943590|Cancer Treatment Related to Heart Failure|cancer treatment related to heart failure
4747084|NCT02943551|Pediatrics|pediatrics
4747085|NCT02943551|Respiratory disease|respiratory disease
4747086|NCT02943551|antibiotic use|antibiotic use
4747087|NCT02943538|Crohn's Disease|crohn's disease
4747088|NCT02943538|Colitis, Ulcerative|colitis, ulcerative
4747089|NCT02943538|Telemedicine|telemedicine
4747090|NCT02943525|vaginal packing|vaginal packing
4747091|NCT02943525|pelvic organ prolapse|pelvic organ prolapse
4747092|NCT02943525|pain and satisfaction|pain and satisfaction
4747093|NCT02943486|Mesenchymal stromal cells|mesenchymal stromal cells
4747094|NCT02943486|Fitostimoline|fitostimoline
4747095|NCT02943486|MSC derivatives|msc derivatives
4747096|NCT02943486|Diabetes|diabetes
4747097|NCT02943473|Smoldering multiple myeloma|smoldering multiple myeloma
4747098|NCT02943473|myeloma|myeloma
4747099|NCT02943473|smoldering|smoldering
4747100|NCT02943473|ibrutinib|ibrutinib
4747101|NCT02943408|Veterans|veterans
4747102|NCT02943408|mental health|mental health
4747103|NCT02943408|Patient-Centered Care|patient-centered care
4747104|NCT02943382|MGD|mgd
4747105|NCT02943382|Autologous Serum|autologous serum
4747106|NCT02943382|Meibomian gland dysfunction|meibomian gland dysfunction
4747107|NCT02943382|Dry eye disease|dry eye disease
4747108|NCT02943382|FAB|fab
4747109|NCT02943382|Fingerprick autologous blood|fingerprick autologous blood
4747110|NCT02943369|cangrelor|cangrelor
4747111|NCT02943369|ticagrelor|ticagrelor
4747112|NCT02943369|P2Y12 receptor antagonist|p2y12 receptor antagonist
4747113|NCT02943369|acute myocardial infarction|acute myocardial infarction
4747114|NCT02943330|Depression|depression
4747115|NCT02943330|Cytokines|cytokines
4747116|NCT02943330|Hemodialysis|hemodialysis
4747117|NCT02943330|Interferon treatment|interferon treatment
4747118|NCT02943330|Hepatitis C|hepatitis c
4747119|NCT02943304|Pregnancy|pregnancy
4747120|NCT02943304|Fetal Development|fetal development
4747121|NCT02943304|Child Development|child development
4747122|NCT02943304|Developmental Disabilities|developmental disabilities
4747123|NCT02943304|Zika Virus Infection|zika virus infection
4747124|NCT02943291|Exercise therapy|exercise therapy
4747125|NCT02943291|Adipose tissue|adipose tissue
4747126|NCT02943291|Mitochondria|mitochondria
4747127|NCT02943291|Oxidative Phosphorylation|oxidative phosphorylation
4747128|NCT02943265|Care Coordination|care coordination
4747129|NCT02943252|apatinib|apatinib
4747130|NCT02943252|S1|s1
4747131|NCT02943252|advanced head and neck cancer|advanced head and neck cancer
4747132|NCT02943252|non-squamous|non-squamous
4747133|NCT02943213|Chlorpromazine|chlorpromazine
4747134|NCT02943213|Hydrochloride|hydrochloride
4747135|NCT02943213|Chlorpromazine Hydrochloride|chlorpromazine hydrochloride
4747136|NCT02943213|Bioavailability|bioavailability
4747137|NCT02943213|Variability|variability
4747138|NCT02943213|Variable|variable
4747139|NCT02943213|Absorption|absorption
4747140|NCT02943213|USL Pharma|usl pharma
4747141|NCT02943213|USL|usl
4747142|NCT02943213|Healthy|healthy
4747143|NCT02943213|South Africa|south africa
4747144|NCT02943213|Cycle|cycle
4747145|NCT02943213|Anti-Psychotic|anti-psychotic
4747146|NCT02943161|Obesity|obesity
4747147|NCT02943161|L-citrulline|l-citrulline
4747148|NCT02943109|patient portal|patient portal
4747149|NCT02943109|Health Information Technology|health information technology
4747150|NCT02943109|Electronic Health Records|electronic health records
4747151|NCT02943109|Inpatient Care|inpatient care
4747152|NCT02943109|Outpatient Care|outpatient care
4747153|NCT02943109|Patient Engagement|patient engagement
4747154|NCT02943070|Rezum|rezum
4747155|NCT02943070|Water Vapor Ablation|water vapor ablation
4747156|NCT02943031|bile duct tumor|bile duct tumor
4747157|NCT02943031|individualized precise treatment programs|individualized precise treatment programs
4747158|NCT02943018|ultrasound anovaginal distance, observer variation|ultrasound anovaginal distance, observer variation
4747159|NCT02942979|Facilitation|facilitation
4747160|NCT02942979|Implementation|implementation
4747161|NCT02942979|Homelessness|homelessness
4747162|NCT02942979|Substance Use Disorder|substance use disorder
4747163|NCT02942979|Mental Illness|mental illness
4747164|NCT02942979|Co-Occurring Disorders|co-occurring disorders
4747165|NCT02942979|Veterans|veterans
4747166|NCT02942979|Primary Care|primary care
4747167|NCT02942966|Angioplasty|angioplasty
4747168|NCT02942966|Below the Knee|below the knee
4747169|NCT02942966|PAD|pad
4747170|NCT02942966|Critical Limb Ischemia|critical limb ischemia
4747171|NCT02942966|Lesion|lesion
4747172|NCT02942966|Claudication|claudication
4747173|NCT02942953|Pacemaker, Artificial|pacemaker, artificial
4747174|NCT02942953|Diaphragmatic pacing|diaphragmatic pacing
4747175|NCT02942927|Polypharmacy|polypharmacy
4747176|NCT02942927|Multimorbidity|multimorbidity
4747177|NCT02942927|Randomized Control Trial|randomized control trial
4747178|NCT02942927|Drug Discontinuation|drug discontinuation
4747179|NCT02942927|Patient Preference|patient preference
4747180|NCT02942927|eHealth|ehealth
4747181|NCT02942901|PET-CT|pet-ct
4747182|NCT02942901|pulmonary metstasectomy|pulmonary metstasectomy
4747183|NCT02942888|Mild Cognitive Impairment|mild cognitive impairment
4747184|NCT02942888|MCI|mci
4747185|NCT02942888|NAD|nad
4747186|NCT02942888|nicotinamide riboside|nicotinamide riboside
4747187|NCT02942888|aging|aging
4747188|NCT02942875|upper limb|upper limb
4747189|NCT02942875|mirror therapy|mirror therapy
4747190|NCT02942875|rehabilitation|rehabilitation
4747192|NCT02942849|Bemfola|bemfola
4747193|NCT02942849|r-hFSH|r-hfsh
4747194|NCT02942849|Oocytes|oocytes
4747195|NCT02942849|Pregnancy|pregnancy
4747196|NCT02942849|OHSS|ohss
4747197|NCT02942836|Respiration Rate Detection|respiration rate detection
4747198|NCT02942823|obesity|obesity
4747199|NCT02942823|child|child
4747200|NCT02942823|primary prevention|primary prevention
4747201|NCT02942823|serious game|serious game
4747202|NCT02942823|nutrition|nutrition
4747203|NCT02942823|physical activity|physical activity
4747204|NCT02942823|psychosocial|psychosocial
4747205|NCT02942823|stress|stress
4747206|NCT02942823|knowledge|knowledge
4747207|NCT02942823|diet|diet
4747208|NCT02942823|energy density|energy density
4747209|NCT02942823|beverages|beverages
4747210|NCT02942823|food pyramide|food pyramide
4747211|NCT02942732|Vitamin D|vitamin d
4747212|NCT02942732|Glucose|glucose
4747213|NCT02942732|HbA1C|hba1c
4747214|NCT02942732|Insulin resistance|insulin resistance
4747215|NCT02942732|Blood lipids|blood lipids
4747216|NCT02942693|Apatinib|apatinib
4747217|NCT02942693|Particle therapy|particle therapy
4747218|NCT02942680|coronary artery bypass grafting|coronary artery bypass grafting
4747219|NCT02942641|Urethral catheter|urethral catheter
4747220|NCT02942641|clean intermittent catheterization|clean intermittent catheterization
4747221|NCT02942641|UTI|uti
4747222|NCT02942641|pain|pain
4747223|NCT02942641|quality of life|quality of life
4747224|NCT02942641|hematuria|hematuria
4747225|NCT02942641|cloudy urine|cloudy urine
4747226|NCT02942589|Portion Size|portion size
4747227|NCT02942563|Local Advanced Rectal Cancer|local advanced rectal cancer
4747228|NCT02942563|Total Neoadjuvant Therapy|total neoadjuvant therapy
4747229|NCT02942563|FOLFOXIRI|folfoxiri
4747230|NCT02942498|behavior, cognitive|behavior, cognitive
4747231|NCT02942472|clinical pregnancy rate after embryo transfer|clinical pregnancy rate after embryo transfer
4747232|NCT02942459|music therapy|music therapy
4747233|NCT02942459|double-blinded|double-blinded
4747234|NCT02942459|Randomized Controlled study (RCT)|randomized controlled study (rct)
4747235|NCT02942459|Schizophrenia, negative symptoms|schizophrenia, negative symptoms
4747236|NCT02942407|Renal dialysis|renal dialysis
4747237|NCT02942329|humanized anti-PD-1 monoclonal antibody|humanized anti-pd-1 monoclonal antibody
4747238|NCT02942329|apatinib|apatinib
4747239|NCT02942329|Gastric Neoplasms|gastric neoplasms
4747240|NCT02942329|Gastric Cancer|gastric cancer
4747241|NCT02942329|Cancer of Stomach|cancer of stomach
4747242|NCT02942329|Hepatocellular Carcinoma|hepatocellular carcinoma
4747243|NCT02942329|Liver Cancer, Adult|liver cancer, adult
4747244|NCT02942329|Liver Cell Carcinoma|liver cell carcinoma
4747245|NCT02942316|Heart Rate|heart rate
4747246|NCT02942316|Reflex, Pupillary|reflex, pupillary
4747247|NCT02942316|Monitoring, Intraoperative|monitoring, intraoperative
4747248|NCT02942303|Botulinum Toxin, Rejuvenation, Brow lift, Eyebrow.|botulinum toxin, rejuvenation, brow lift, eyebrow.
4747249|NCT02942290|Higher-Risk (HR) Myelodysplastic Syndromes (MDS)|higher-risk (hr) myelodysplastic syndromes (mds)
4747250|NCT02942290|Pharmacokinetic|pharmacokinetic
4747251|NCT02942290|Venetoclax|venetoclax
4747252|NCT02942290|Azacitidine|azacitidine
4747253|NCT02942290|Acute Myelogenous Leukemia|acute myelogenous leukemia
4747254|NCT02942290|Myelodysplastic Syndromes (MDS)|myelodysplastic syndromes (mds)
4747255|NCT02942290|Treatment-Naïve Higher-Risk|treatment-naïve higher-risk
4747256|NCT02942277|Malaria|malaria
4747257|NCT02942277|Reactogenicity|reactogenicity
4747258|NCT02942277|Antibody|antibody
4747259|NCT02942277|Direct Skin Feed|direct skin feed
4747260|NCT02942277|Mosquito|mosquito
4747261|NCT02942264|Brain Tumor|brain tumor
4747262|NCT02942264|Glioblastoma|glioblastoma
4747263|NCT02942264|Relapse|relapse
4747264|NCT02942264|Randomized|randomized
4747265|NCT02942264|temodar|temodar
4747266|NCT02942251|MDD|mdd
4747267|NCT02942251|big data analytics|big data analytics
4747268|NCT02942238|CME|cme
4747269|NCT02942238|Right hemi Colon cancer|right hemi colon cancer
4747270|NCT02942238|D3|d3
4747271|NCT02942238|laparoscopy|laparoscopy
4747272|NCT02942225|Attention-deficit/hyperactivity disorder|attention-deficit/hyperactivity disorder
4747273|NCT02942225|metabolomics|metabolomics
4747274|NCT02942225|neuropsychological deficits|neuropsychological deficits
4747275|NCT02942225|pathway analysis|pathway analysis
4747276|NCT02942212|Smoking Cessation|smoking cessation
4747277|NCT02942212|Nicotine patch|nicotine patch
4747278|NCT02942212|Nicoderm Committed Quitters|nicoderm committed quitters
4747279|NCT02942212|CQ|cq
4747280|NCT02942212|Nicoderm CQ|nicoderm cq
4747281|NCT02942212|Questionnaires|questionnaires
4747282|NCT02942212|Surveys|surveys
4747283|NCT02942212|Interviews|interviews
4747284|NCT02942212|Breath tests|breath tests
4747285|NCT02942173|CD45RA-depletion|cd45ra-depletion
4747286|NCT02942173|TCR-alpha/beta depletion|tcr-alpha/beta depletion
4747287|NCT02942173|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
4747288|NCT02942121|surgery education|surgery education
4747289|NCT02942121|radical cystectomy|radical cystectomy
4747290|NCT02942121|cystectomy|cystectomy
4747291|NCT02942121|muscle-invasive bladder cancer|muscle-invasive bladder cancer
4747691|NCT02939664|weight loss|weight loss
4747292|NCT02942108|piezolectric surgery|piezolectric surgery
4747293|NCT02942108|conventional surgery|conventional surgery
4747294|NCT02942108|lower third molars|lower third molars
4747295|NCT02942095|Advanced Solid Tumors|advanced solid tumors
4747296|NCT02942095|Metastatic cancer|metastatic cancer
4747297|NCT02942095|Ixazomib|ixazomib
4747298|NCT02942095|MLN9708|mln9708
4747299|NCT02942095|Erlotinib|erlotinib
4747300|NCT02942095|Erlotinib hydrochloride|erlotinib hydrochloride
4747301|NCT02942095|OSI-774|osi-774
4747302|NCT02942095|CP358774|cp358774
4747303|NCT02942095|Tarceva|tarceva
4747304|NCT02942043|Malignant pleural effusion|malignant pleural effusion
4747305|NCT02942043|Bevacizumab|bevacizumab
4747306|NCT02941991|Stargardt's Macular Dystrophy|stargardt's macular dystrophy
4747307|NCT02941991|Retinal Diseases|retinal diseases
4747308|NCT02941991|Macular Degeneration|macular degeneration
4747309|NCT02941991|fundus flavimaculatus|fundus flavimaculatus
4747310|NCT02941991|hESC-RPE|hesc-rpe
4747311|NCT02941991|ASP7316|asp7316
4747312|NCT02941991|juvenile macular dystrophy|juvenile macular dystrophy
4747313|NCT02941991|SMD|smd
4747314|NCT02941939|high intensity interval training|high intensity interval training
4747315|NCT02941939|hyperbaric oxygen|hyperbaric oxygen
4747316|NCT02941926|HR-positive HER2-negative|hr-positive her2-negative
4747317|NCT02941926|advanced breast cancer|advanced breast cancer
4747318|NCT02941926|LEE011|lee011
4747319|NCT02941926|ribociclib|ribociclib
4747320|NCT02941926|letrozole|letrozole
4747321|NCT02941926|goserelin|goserelin
4747322|NCT02941926|CDK|cdk
4747323|NCT02941926|CDK4|cdk4
4747324|NCT02941926|CDK6|cdk6
4747325|NCT02941926|CDK4/6|cdk4/6
4747326|NCT02941926|Phase IIIb|phase iiib
4747327|NCT02941926|ER-positive|er-positive
4747328|NCT02941926|PR-positive|pr-positive
4747329|NCT02941926|premenopausal|premenopausal
4747330|NCT02941926|postmenopausal|postmenopausal
4747331|NCT02941926|men with advanced breast cancer|men with advanced breast cancer
4747332|NCT02941900|Genetic Testing|genetic testing
4747333|NCT02941900|16-1243|16-1243
4747334|NCT02941887|Social behavior|social behavior
4747335|NCT02941887|Gingivitis|gingivitis
4747336|NCT02941887|Periodontitis|periodontitis
4747337|NCT02941887|Down's Syndrome|down's syndrome
4747338|NCT02941874|IRAP|irap
4747339|NCT02941874|Insulin Regulated Amino Peptidase|insulin regulated amino peptidase
4747340|NCT02941874|Diagnostic biomarker|diagnostic biomarker
4747341|NCT02941874|Type 2 diabetes|type 2 diabetes
4747342|NCT02941861|Hepatocellular carcinoma|hepatocellular carcinoma
4747343|NCT02941861|Cholangiocarcinoma|cholangiocarcinoma
4747344|NCT02941861|Recurrence|recurrence
4747345|NCT02941835|pre-operative radiotherapy|pre-operative radiotherapy
4747346|NCT02941783|Kovaltry|kovaltry
4747347|NCT02941783|hemophilia A|hemophilia a
4747348|NCT02941783|Japan|japan
4747349|NCT02941783|Post-marketing surveillance|post-marketing surveillance
4747350|NCT02941770|Adolescents|adolescents
4747351|NCT02941770|Overweight|overweight
4747352|NCT02941770|Obesity|obesity
4747353|NCT02941770|Weight Loss|weight loss
4747354|NCT02941770|Physical activity consultation|physical activity consultation
4747355|NCT02941770|Cardiorespiratory fitness|cardiorespiratory fitness
4747356|NCT02941770|Endothelial structure|endothelial structure
4747357|NCT02941770|Endothelial function|endothelial function
4747358|NCT02941757|Mediterranean Diet|mediterranean diet
4747359|NCT02941757|Firefighters|firefighters
4747360|NCT02941757|workplace|workplace
4747361|NCT02941757|Intervention|intervention
4747362|NCT02941757|obesity|obesity
4747363|NCT02941757|Randomized Control Trial|randomized control trial
4747364|NCT02941744|nivolumab|nivolumab
4747365|NCT02941744|ipilimumab|ipilimumab
4747366|NCT02941744|low fixed dose|low fixed dose
4747367|NCT02941744|adjuvant therapy|adjuvant therapy
4747368|NCT02941744|Melanoma|melanoma
4747369|NCT02941718|Smoking|smoking
4747370|NCT02941718|Smoking cessation|smoking cessation
4747371|NCT02941718|Nicotine|nicotine
4747372|NCT02941705|stem cell research|stem cell research
4747373|NCT02941640|Laparoscopic appendectomy|laparoscopic appendectomy
4747374|NCT02941640|Endoloop|endoloop
4747375|NCT02941640|Stapler|stapler
4747376|NCT02941640|Hem-o-lok clip|hem-o-lok clip
4747377|NCT02941640|DS clip|ds clip
4747378|NCT02941601|Thoracic Neoplasms|thoracic neoplasms
4747379|NCT02941601|Lung Diseases|lung diseases
4747380|NCT02941601|Lung Cancer|lung cancer
4747381|NCT02941601|Respiratory Tract Diseases|respiratory tract diseases
4747382|NCT02941601|Respiratory Tract Neoplasms|respiratory tract neoplasms
4747383|NCT02941601|Antineoplastic Agents|antineoplastic agents
4747384|NCT02941601|Monoclonal Antibodies|monoclonal antibodies
4747385|NCT02941562|rectal cancer, radiotherapy|rectal cancer, radiotherapy
4747386|NCT02941536|Circulating Tumor Cells|circulating tumor cells
4747387|NCT02941536|Stereotactic Radiosurgery|stereotactic radiosurgery
4747388|NCT02941497|Stress, Psychological|stress, psychological
4747389|NCT02941497|Obesity|obesity
4747390|NCT02941497|Physical Activity|physical activity
4747391|NCT02941497|Fruit|fruit
4747392|NCT02941497|Vegetables|vegetables
4747393|NCT02941497|Social Marketing|social marketing
4747394|NCT02941497|Peer Influence|peer influence
4747692|NCT02939651|Metastatic|metastatic
4747395|NCT02941497|Community-Based Participatory Research|community-based participatory research
4747396|NCT02941471|Constipation|constipation
4747397|NCT02941471|Neuromodulation|neuromodulation
4747398|NCT02941471|Interferential|interferential
4747399|NCT02941471|Transabdominal|transabdominal
4747400|NCT02941445|DPP4-inhibitors|dpp4-inhibitors
4747401|NCT02941419|Platelet lysate|platelet lysate
4747402|NCT02941419|Critical limb ischemia|critical limb ischemia
4747403|NCT02941419|Peripheral arterial disease|peripheral arterial disease
4747404|NCT02941406|Retina|retina
4747405|NCT02941406|Perimetry|perimetry
4747406|NCT02941393|internal tocodynamometry, external tocodynamometry, cesarean section, labor, newborn, vacuum extraction, dystocia|internal tocodynamometry, external tocodynamometry, cesarean section, labor, newborn, vacuum extraction, dystocia
4747407|NCT02941380|coronary artery bypass grafting|coronary artery bypass grafting
4747408|NCT02941380|cardiopulmonary bypass|cardiopulmonary bypass
4747409|NCT02941380|Cerebral oxidative stress|cerebral oxidative stress
4747410|NCT02941380|Cerebral inflammatory stress|cerebral inflammatory stress
4747411|NCT02941380|Cerebral hemodynamics|cerebral hemodynamics
4747412|NCT02941380|Postoperative cognitive dysfunction|postoperative cognitive dysfunction
4747413|NCT02941341|Bemfola|bemfola
4747414|NCT02941341|r-hFSH|r-hfsh
4747415|NCT02941341|ART|art
4747416|NCT02941341|Oocytes|oocytes
4747417|NCT02941341|OHSS|ohss
4747418|NCT02941341|Pregnancy|pregnancy
4747419|NCT02941328|SMA, SMN1, Kugelberg-Welander|sma, smn1, kugelberg-welander
4747420|NCT02941315|Cardiomyopathy|cardiomyopathy
4747421|NCT02941315|Heart Failure|heart failure
4747422|NCT02941315|Cardiac Magnetic Resonance|cardiac magnetic resonance
4747423|NCT02941302|gliomas|gliomas
4747424|NCT02941302|biological boundary|biological boundary
4747425|NCT02941302|imaging border|imaging border
4747426|NCT02941302|operation|operation
4747427|NCT02941263|AMD|amd
4747428|NCT02941263|Georgraphic Atrophy|georgraphic atrophy
4747429|NCT02941263|Macular Degeneration|macular degeneration
4747430|NCT02941237|Pulse oximetry|pulse oximetry
4747431|NCT02941237|Children|children
4747432|NCT02941211|cervix|cervix
4747433|NCT02941211|cervical dilation|cervical dilation
4747434|NCT02941211|balloon catheter|balloon catheter
4747435|NCT02941172|Brown adipose tissue|brown adipose tissue
4747436|NCT02941172|Cannabinoid receptor|cannabinoid receptor
4747437|NCT02941172|PET imaging|pet imaging
4747438|NCT02941172|Metabolism|metabolism
4747439|NCT02941120|Cartilage defect|cartilage defect
4747440|NCT02941120|Knee|knee
4747441|NCT02941120|ACT (Autologous chondrocyte implantation)|act (autologous chondrocyte implantation)
4747442|NCT02941120|NOVOCART® Inject|novocart® inject
4747443|NCT02941107|Aboriginal|aboriginal
4747444|NCT02941107|Rotavirus|rotavirus
4747445|NCT02941107|Vaccine|vaccine
4747446|NCT02941107|Diarrhoea|diarrhoea
4747447|NCT02941081|iron supplement|iron supplement
4747448|NCT02941068|severe sepsis|severe sepsis
4747449|NCT02941068|intra-abdominal perforation|intra-abdominal perforation
4747450|NCT02941068|surgical intensive care unit|surgical intensive care unit
4747451|NCT02941068|fungal infection|fungal infection
4747452|NCT02941068|prophylactic anti-fungal treatment|prophylactic anti-fungal treatment
4747453|NCT02941055|Diet|diet
4747454|NCT02941055|Inflammation|inflammation
4747455|NCT02941055|Metabolomics|metabolomics
4747456|NCT02941029|Radiation|radiation
4747457|NCT02941029|Chemotherapy|chemotherapy
4747458|NCT02941003|Early stage lung adenocarcinoma|early stage lung adenocarcinoma
4747459|NCT02941003|Intraoperative frozen section|intraoperative frozen section
4747460|NCT02941003|Diagnostic criteria|diagnostic criteria
4747461|NCT02940977|Circulating tumor cell|circulating tumor cell
4747462|NCT02940977|Epithelial to mesenchymal transition|epithelial to mesenchymal transition
4747463|NCT02940977|Prostate specific antigen (PSA)|prostate specific antigen (psa)
4747464|NCT02940977|Partin table|partin table
4747465|NCT02940925|Nasopharyngeal carcinoma|nasopharyngeal carcinoma
4747466|NCT02940925|induction chemotherapy|induction chemotherapy
4747467|NCT02940912|Parkinson disease|parkinson disease
4747468|NCT02940912|Insomnia|insomnia
4747469|NCT02940912|Sleep disorders|sleep disorders
4747470|NCT02940912|Polysomnography|polysomnography
4747471|NCT02940912|Apomorphine|apomorphine
4747472|NCT02940912|Multiple sleep latency test|multiple sleep latency test
4747473|NCT02940912|Parkinson Disease Sleep Scale 2 (PDSS-2)|parkinson disease sleep scale 2 (pdss-2)
4747474|NCT02940873|severe hypoglycemia|severe hypoglycemia
4747475|NCT02940873|impaired awareness of hypoglycemia|impaired awareness of hypoglycemia
4747476|NCT02940873|type 1 diabetes mellitus|type 1 diabetes mellitus
4747477|NCT02940873|cognitive behavioral therapy|cognitive behavioral therapy
4747478|NCT02940873|structured education|structured education
4747479|NCT02940847|ultrasound-guided technique|ultrasound-guided technique
4747480|NCT02940847|blind technique|blind technique
4747481|NCT02940847|medial brachial cutaneous nerve block|medial brachial cutaneous nerve block
4747482|NCT02940847|intercostobrachial nerve block|intercostobrachial nerve block
4747483|NCT02940821|Tooth Whitening|tooth whitening
4747484|NCT02940808|Caffeine|caffeine
4747485|NCT02940808|EEG|eeg
4747486|NCT02940808|Theta/beta ratio|theta/beta ratio
4747487|NCT02940808|Eye-blink rates|eye-blink rates
4747488|NCT02940808|Cognitive control|cognitive control
4747489|NCT02940808|Emotional Stroop|emotional stroop
4747490|NCT02940808|Global/local congruency|global/local congruency
4747491|NCT02940808|N-Back|n-back
4747492|NCT02940808|Prefrontal Cortex|prefrontal cortex
4747493|NCT02940795|breast feeding|breast feeding
4747494|NCT02940795|fructose|fructose
4747495|NCT02940769|depression|depression
4747496|NCT02940769|insomnia|insomnia
4747497|NCT02940769|light|light
4747498|NCT02940769|cortisol|cortisol
4747499|NCT02940769|melatonin|melatonin
4747500|NCT02940756|Malaria, efficacy, safety, ACT, DR Congo|malaria, efficacy, safety, act, dr congo
4747501|NCT02940743|Hemodialysis|hemodialysis
4747502|NCT02940704|Reciproc|reciproc
4747503|NCT02940704|One Shape|one shape
4747504|NCT02940704|reciprocation|reciprocation
4747505|NCT02940704|continuous rotation|continuous rotation
4747506|NCT02940704|irreversible pulpitis|irreversible pulpitis
4747507|NCT02940704|postoperative pain|postoperative pain
4747508|NCT02940678|Trauma|trauma
4747509|NCT02940678|Clinical prediction models|clinical prediction models
4747510|NCT02940678|Transferability studies|transferability studies
4747511|NCT02940678|Sweden|sweden
4747512|NCT02940652|Laryngeal mask,MRI|laryngeal mask,mri
4747513|NCT02940626|Pneumonia|pneumonia
4747514|NCT02940626|S. aureus|s. aureus
4747515|NCT02940626|Mechanically ventilated|mechanically ventilated
4747516|NCT02940613|Rapid response|rapid response
4747517|NCT02940613|Eating Disorders|eating disorders
4747518|NCT02940613|Cognitive Behavior Therapy|cognitive behavior therapy
4747519|NCT02940613|Bulimia Nervosa|bulimia nervosa
4747520|NCT02940613|Binge Eating Disorder|binge eating disorder
4747521|NCT02940613|Purging Disorder|purging disorder
4747522|NCT02940600|normothermic perfusion|normothermic perfusion
4747523|NCT02940600|old donors|old donors
4747524|NCT02940600|extended criteria grafts|extended criteria grafts
4747525|NCT02940600|reconditioning|reconditioning
4747526|NCT02940587|Non Healing Wound|non healing wound
4747527|NCT02940574|Oxytocin|oxytocin
4747528|NCT02940574|Autism Spectrum Disorders|autism spectrum disorders
4747529|NCT02940548|non-dipper hypertension|non-dipper hypertension
4747530|NCT02940548|young|young
4747531|NCT02940548|middle-aged|middle-aged
4747532|NCT02940548|ambulatory blood pressure monitoring|ambulatory blood pressure monitoring
4747533|NCT02940548|arterial stiffness|arterial stiffness
4747534|NCT02940548|nifedipine gastrointestinal therapeutic system (GITS)|nifedipine gastrointestinal therapeutic system (gits)
4747535|NCT02940496|Malignant neoplasms of digestive organs|malignant neoplasms of digestive organs
4747536|NCT02940496|Advanced liver cancer|advanced liver cancer
4747537|NCT02940496|Advanced hepatocellular carcinoma|advanced hepatocellular carcinoma
4747538|NCT02940496|Pembrolizumab|pembrolizumab
4747539|NCT02940496|Keytruda|keytruda
4747540|NCT02940496|MK-3475|mk-3475
4747541|NCT02940496|SCH-900475|sch-900475
4747542|NCT02940496|Biomarkers|biomarkers
4747543|NCT02940483|Ependymoma|ependymoma
4747544|NCT02940457|tDCS|tdcs
4747545|NCT02940457|MCI|mci
4747546|NCT02940457|Working Memory|working memory
4747547|NCT02940457|fNIRS|fnirs
4747548|NCT02940418|Diabetes Mellitus|diabetes mellitus
4747549|NCT02940418|Type 1|type 1
4747550|NCT02940418|Adipose derived mesenchymal stem cells|adipose derived mesenchymal stem cells
4747551|NCT02940405|Ketorolac Premedication|ketorolac premedication
4747552|NCT02940405|Anesthetic Efficiency|anesthetic efficiency
4747553|NCT02940405|Post-Endodontic Pain|post-endodontic pain
4747554|NCT02940405|Post-operative pain|post-operative pain
4747555|NCT02940405|Irreversible Pulpitis|irreversible pulpitis
4747556|NCT02940405|Oral premedication|oral premedication
4747557|NCT02940392|Rezum|rezum
4747558|NCT02940340|infective endocarditis|infective endocarditis
4747559|NCT02940340|systemic microcirculation|systemic microcirculation
4747560|NCT02940327|ECMO|ecmo
4747561|NCT02940327|PPHN|pphn
4747562|NCT02940327|Pulmonary Hypertension of the Newborn|pulmonary hypertension of the newborn
4747563|NCT02940327|Markers of inflammation|markers of inflammation
4747564|NCT02940327|Mi-Ecmo|mi-ecmo
4747565|NCT02940249|Polyphenol|polyphenol
4747566|NCT02940249|Apple|apple
4747567|NCT02940249|Fruit|fruit
4747568|NCT02940249|Hyperglycaemia|hyperglycaemia
4747569|NCT02940249|Metabolic|metabolic
4747570|NCT02940223|Malignant neoplasms of independent (primary) multiple sites|malignant neoplasms of independent (primary) multiple sites
4747571|NCT02940223|Cancer-related fatigue|cancer-related fatigue
4747572|NCT02940223|Fish oil|fish oil
4747573|NCT02940223|Icosapent ethyl|icosapent ethyl
4747574|NCT02940223|Quality of life questionnaire|quality of life questionnaire
4747575|NCT02940223|Symptom questionnaire|symptom questionnaire
4747576|NCT02940223|Walk test|walk test
4747577|NCT02940223|Chair/stand test|chair/stand test
4747578|NCT02940223|Placebo|placebo
4747579|NCT02940223|Resistance exercises|resistance exercises
4747580|NCT02940223|Walking program|walking program
4747581|NCT02940223|Resistance training|resistance training
4747582|NCT02940223|Stretching exercises|stretching exercises
4747583|NCT02940223|Advanced cancer|advanced cancer
4747584|NCT02940197|overweight|overweight
4747585|NCT02940197|Caloric Restriction|caloric restriction
4747586|NCT02940184|Physiology|physiology
4747587|NCT02940171|burns|burns
4747588|NCT02940171|critically ill|critically ill
4747589|NCT02940171|surgery outcome|surgery outcome
4747590|NCT02940171|mortality|mortality
4747591|NCT02940158|lentils|lentils
4747592|NCT02940158|diabetes|diabetes
4747593|NCT02940158|glycemia|glycemia
4747594|NCT02940158|insulin|insulin
4747595|NCT02940158|glucose|glucose
4747596|NCT02940145|inflammatory biomarkers|inflammatory biomarkers
4747597|NCT02940145|Interleukines|interleukines
4747598|NCT02940145|resistance training|resistance training
4747599|NCT02940145|phase angle|phase angle
4747600|NCT02940145|oxidative stress|oxidative stress
4747601|NCT02940106|oocyte cryopreservation|oocyte cryopreservation
4747602|NCT02940106|closed vitrification|closed vitrification
4747603|NCT02940106|open vitrification|open vitrification
4747604|NCT02940067|prehabilitation|prehabilitation
4747605|NCT02940067|pancreatectomy|pancreatectomy
4747606|NCT02940067|nutrition|nutrition
4747607|NCT02940067|exercise|exercise
4747608|NCT02940054|Early diagnosis|early diagnosis
4747609|NCT02940041|Diagnosis|diagnosis
4747610|NCT02940041|Sonography|sonography
4747611|NCT02940041|Magnetic Ressonance|magnetic ressonance
4747612|NCT02940015|Quality Control|quality control
4747613|NCT02940015|Urine|urine
4747614|NCT02940015|Tissue|tissue
4747615|NCT02940015|Normal|normal
4747616|NCT02940002|Plaque form psoriasis vulgaris|plaque form psoriasis vulgaris
4747617|NCT02939989|Chronic Hepatitis C (HCV)|chronic hepatitis c (hcv)
4747618|NCT02939989|HCV Genotype 1 (HCV GT1)|hcv genotype 1 (hcv gt1)
4747619|NCT02939989|HCV Genotype 2 (HCV GT2)|hcv genotype 2 (hcv gt2)
4747620|NCT02939989|HCV Genotype 3 (HCV GT3)|hcv genotype 3 (hcv gt3)
4747621|NCT02939989|HCV Genotype 4 (HCV GT4)|hcv genotype 4 (hcv gt4)
4747622|NCT02939989|HCV Genotype 5 (HCV GT5)|hcv genotype 5 (hcv gt5)
4747623|NCT02939989|HCV Genotype 6 (HCV GT6)|hcv genotype 6 (hcv gt6)
4747624|NCT02939989|Compensated Cirrhosis|compensated cirrhosis
4747625|NCT02939989|Non-cirrhotics|non-cirrhotics
4747626|NCT02939989|Virologic failure|virologic failure
4747627|NCT02939989|Hepatitis C Virus Infection|hepatitis c virus infection
4747628|NCT02939976|ST-Elevation Myocardial Infarction|st-elevation myocardial infarction
4747629|NCT02939963|weaning|weaning
4747630|NCT02939963|mechanical ventilation|mechanical ventilation
4747631|NCT02939963|work of breathing|work of breathing
4747632|NCT02939963|automatic tube compensation|automatic tube compensation
4747633|NCT02939963|pressure support ventilation|pressure support ventilation
4747634|NCT02939911|Residual neuromuscular blockade|residual neuromuscular blockade
4747635|NCT02939872|DAPT|dapt
4747636|NCT02939872|BVS|bvs
4747637|NCT02939872|Bioresorbable Vascular Scaffold|bioresorbable vascular scaffold
4747638|NCT02939872|Dual Antiplatelet Therapy|dual antiplatelet therapy
4747639|NCT02939859|Multiple Sclerosis|multiple sclerosis
4747640|NCT02939859|Demyelinating Diseases|demyelinating diseases
4747641|NCT02939859|Nervous System Diseases|nervous system diseases
4747642|NCT02939859|Autoimmune Disorders|autoimmune disorders
4747643|NCT02939846|Safety|safety
4747644|NCT02939846|Solid tumor|solid tumor
4747645|NCT02939846|Trametinib|trametinib
4747646|NCT02939846|Pharmacokinetics|pharmacokinetics
4747647|NCT02939820|RNAi therapeutic|rnai therapeutic
4747648|NCT02939820|FAP|fap
4747649|NCT02939820|Familial Amyloid Polyneuropathies|familial amyloid polyneuropathies
4747650|NCT02939820|TTR|ttr
4747651|NCT02939820|Transthyretin|transthyretin
4747652|NCT02939820|Amyloidosis|amyloidosis
4747653|NCT02939807|Yeliva™|yeliva™
4747654|NCT02939807|hepatocellular carcinoma|hepatocellular carcinoma
4747655|NCT02939807|ABC294640|abc294640
4747656|NCT02939807|hepatic neoplasms|hepatic neoplasms
4747657|NCT02939807|liver neoplasms|liver neoplasms
4747658|NCT02939807|hepatic cancer|hepatic cancer
4747659|NCT02939794|cardiac surgery|cardiac surgery
4747660|NCT02939794|hemoglobin|hemoglobin
4747661|NCT02939794|iron|iron
4747662|NCT02939755|Collaborative care intervention|collaborative care intervention
4747663|NCT02939755|Cancer|cancer
4747664|NCT02939755|Depression|depression
4747665|NCT02939755|Palliative care|palliative care
4747666|NCT02939755|Quality of life|quality of life
4747667|NCT02939755|Fatigue|fatigue
4747668|NCT02939755|Pain|pain
4747669|NCT02939742|preterm premature rupture of membranes|preterm premature rupture of membranes
4747670|NCT02939742|complications of prematurity|complications of prematurity
4747671|NCT02939742|neonatal morbidity|neonatal morbidity
4747672|NCT02939742|respiratory distress syndrome|respiratory distress syndrome
4747673|NCT02939742|antenatal corticosteroids|antenatal corticosteroids
4747674|NCT02939742|betamethasone|betamethasone
4747675|NCT02939729|prehabilitation|prehabilitation
4747676|NCT02939729|physiotherapy|physiotherapy
4747677|NCT02939729|cardiac|cardiac
4747678|NCT02939729|thoracic|thoracic
4747679|NCT02939729|preoperative|preoperative
4747680|NCT02939716|small bowel|small bowel
4747681|NCT02939716|bloating|bloating
4747682|NCT02939716|flow|flow
4747683|NCT02939703|Adipose tissue|adipose tissue
4747684|NCT02939703|calorimetry|calorimetry
4747685|NCT02939703|energy expenditure|energy expenditure
4747686|NCT02939703|microbiome|microbiome
4747687|NCT02939690|Catheter|catheter
4747688|NCT02939690|Umbilical vein|umbilical vein
4747689|NCT02939690|Neonate|neonate
4747690|NCT02939664|banded gastric bypass|banded gastric bypass
4747693|NCT02939651|High grade|high grade
4747694|NCT02939638|Plant-based diet|plant-based diet
4747695|NCT02939638|Obesity|obesity
4747696|NCT02939638|Insulin sensitivity|insulin sensitivity
4747697|NCT02939638|Intracellular lipid|intracellular lipid
4747698|NCT02939638|Postprandial metabolism|postprandial metabolism
4747699|NCT02939638|Vegan diet|vegan diet
4747700|NCT02939638|Beta-cell function|beta-cell function
4747701|NCT02939612|Stress management|stress management
4747702|NCT02939612|App|app
4747703|NCT02939599|Pulmonary hypertension (PH),|pulmonary hypertension (ph),
4747704|NCT02939599|Increase blood pressure in the pulmonary artery|increase blood pressure in the pulmonary artery
4747705|NCT02939599|Increased blood pressure in the pulmonary vein|increased blood pressure in the pulmonary vein
4747706|NCT02939599|Increased blood pressure in the lung vasculature|increased blood pressure in the lung vasculature
4747707|NCT02939599|Shortness of breath|shortness of breath
4747708|NCT02939599|Dizziness|dizziness
4747709|NCT02939599|Fainting|fainting
4747710|NCT02939599|Leg swelling|leg swelling
4747711|NCT02939599|Cough|cough
4747712|NCT02939599|Angina pector|angina pector
4747713|NCT02939586|Sleep, Sleep apnoea, Haemodialysis, Haemodiafiltration, end stage kidney disease|sleep, sleep apnoea, haemodialysis, haemodiafiltration, end stage kidney disease
4747714|NCT02939560|Autism Spectrum Disorder|autism spectrum disorder
4747715|NCT02939560|Autism|autism
4747716|NCT02939560|Depressive|depressive
4747717|NCT02939560|Depression|depression
4747718|NCT02939547|intravenous|intravenous
4747719|NCT02939547|cyclodextrin|cyclodextrin
4747720|NCT02939547|compassionate|compassionate
4747721|NCT02939547|Trappsol|trappsol
4747722|NCT02939534|Parkinson's disease|parkinson's disease
4747723|NCT02939534|autoimmunity|autoimmunity
4747724|NCT02939521|Pincer Nail|pincer nail
4747725|NCT02939521|Surgery|surgery
4747726|NCT02939508|Acute lower gastrointestinal dysfunction|acute lower gastrointestinal dysfunction
4747727|NCT02939508|Colon-originated lesions|colon-originated lesions
4747728|NCT02939508|Critical patient|critical patient
4747729|NCT02939508|Colonoscopic decompression|colonoscopic decompression
4747730|NCT02939508|Anticholinergic drugs|anticholinergic drugs
4747731|NCT02939495|Premature Ejaculation|premature ejaculation
4747732|NCT02939495|Erectile Dysfunction|erectile dysfunction
4747733|NCT02939495|DAP-SPEED|dap-speed
4747734|NCT02939495|Dapoxetine|dapoxetine
4747735|NCT02939495|Sildenafil|sildenafil
4747736|NCT02939469|Sympathetic Nerve Activity|sympathetic nerve activity
4747737|NCT02939469|Skin Sympathetic Nerve Activity|skin sympathetic nerve activity
4747738|NCT02939456|prostate|prostate
4747739|NCT02939456|cancer|cancer
4747740|NCT02939456|MRI|mri
4747741|NCT02939417|Laminate veneers|laminate veneers
4747742|NCT02939417|Grape seed extract|grape seed extract
4747743|NCT02939417|Emax|emax
4747744|NCT02939417|collagen cross-linking agent|collagen cross-linking agent
4747745|NCT02939404|Energy Intake|energy intake
4747746|NCT02939404|Energy Expenditure|energy expenditure
4747747|NCT02939404|Eating Behavior|eating behavior
4747748|NCT02939404|Cold Exposure|cold exposure
4747749|NCT02939378|ketogenic diet|ketogenic diet
4747750|NCT02939378|recurrent glioblastoma|recurrent glioblastoma
4747751|NCT02939378|chemotherapy|chemotherapy
4747752|NCT02939352|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
4747753|NCT02939352|Magnetic Resonance Imaging|magnetic resonance imaging
4747754|NCT02939352|MRI, Functional|mri, functional
4747755|NCT02939339|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
4747756|NCT02939313|alcohol|alcohol
4747757|NCT02939313|addiction|addiction
4747758|NCT02939313|cTBS|ctbs
4747759|NCT02939300|Melanoma|melanoma
4747760|NCT02939300|Leptomeningeal Metastases|leptomeningeal metastases
4747761|NCT02939287|autologous|autologous
4747762|NCT02939287|myeloma|myeloma
4747763|NCT02939287|transplant|transplant
4747764|NCT02939209|Rotator cuff repair|rotator cuff repair
4747765|NCT02939209|Interscalene block|interscalene block
4747766|NCT02939209|Hydromorphone|hydromorphone
4747767|NCT02939209|Pain|pain
4747768|NCT02939209|Rebound pain|rebound pain
4747769|NCT02939209|Acromioplasty|acromioplasty
4747770|NCT02939183|Multiple Myeloma|multiple myeloma
4747771|NCT02939157|Diagnostic Ultrasound|diagnostic ultrasound
4747772|NCT02939157|Primary Care|primary care
4747773|NCT02939131|Cognitive Behavioral Therapy|cognitive behavioral therapy
4747774|NCT02939131|Medication Management|medication management
4747775|NCT02939092|Gingival Bleeding on probing|gingival bleeding on probing
4747776|NCT02939079|Multiple Sclerosis|multiple sclerosis
4747777|NCT02939079|Fingolimod|fingolimod
4747778|NCT02939079|Fish Oil|fish oil
4747779|NCT02939053|Bioimpedance spectroscopy|bioimpedance spectroscopy
4747780|NCT02939040|positive activities intervention|positive activities intervention
4747781|NCT02939040|peri-operative|peri-operative
4747782|NCT02939014|Drug therapy|drug therapy
4747783|NCT02938988|Periodontal Diseases|periodontal diseases
4747784|NCT02938988|Down Syndrome|down syndrome
4747785|NCT02938975|malaria|malaria
4747786|NCT02938975|personal protection|personal protection
4747787|NCT02938975|permethrin treated clothing|permethrin treated clothing
4747788|NCT02938975|insect repellents|insect repellents
4747789|NCT02938975|army personnel|army personnel
4747790|NCT02938975|cluster randomised trial|cluster randomised trial
4747791|NCT02938949|Myocardial Infarction|myocardial infarction
4747792|NCT02938949|Low Density Lipoprotein Cholesterol|low density lipoprotein cholesterol
4747793|NCT02938949|proprotein convertase subtilisin kexin 9, human|proprotein convertase subtilisin kexin 9, human
4747794|NCT02938949|alirocumab|alirocumab
4747795|NCT02938910|Primary hyperaldosteronism|primary hyperaldosteronism
4747796|NCT02938910|Secondary hyperaldosteronism|secondary hyperaldosteronism
4747797|NCT02938910|Cardiac fibrosis|cardiac fibrosis
4747798|NCT02938910|magnetic resonance imaging|magnetic resonance imaging
4747799|NCT02938897|Telehealth|telehealth
4747800|NCT02938897|Weight loss|weight loss
4747801|NCT02938897|Diet quality|diet quality
4747802|NCT02938897|Behavioral counseling|behavioral counseling
4747803|NCT02938871|synbiotic|synbiotic
4747804|NCT02938871|infections|infections
4747805|NCT02938871|probiotics|probiotics
4747806|NCT02938871|liver transplantation|liver transplantation
4747807|NCT02938832|cardiovascular disease, diet, diabetes|cardiovascular disease, diet, diabetes
4747808|NCT02938819|upper limbs|upper limbs
4747809|NCT02938819|physiotherapy|physiotherapy
4747810|NCT02938793|cancer, malignancy|cancer, malignancy
4747811|NCT02938780|Behavioral economics|behavioral economics
4747812|NCT02938780|Breast cancer survivors|breast cancer survivors
4747813|NCT02938780|nutrition|nutrition
4747814|NCT02938780|physical activity|physical activity
4747815|NCT02938767|peritoneal dialysis|peritoneal dialysis
4747816|NCT02938767|carotid intima-media thickness|carotid intima-media thickness
4747817|NCT02938767|coronary flow reserve|coronary flow reserve
4747818|NCT02938767|cardiovascular mortality|cardiovascular mortality
4747819|NCT02938754|Hemiparesis|hemiparesis
4747820|NCT02938754|Functional independence|functional independence
4747821|NCT02938754|Virtual Rehabilitation|virtual rehabilitation
4747822|NCT02938741|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
4747823|NCT02938741|lymphoblastic lymphoma|lymphoblastic lymphoma
4747824|NCT02938741|stem-cell transplant|stem-cell transplant
4747825|NCT02938741|T-cell lymphoma|t-cell lymphoma
4747826|NCT02938741|ATG|atg
4747827|NCT02938728|AntiPD1|antipd1
4747828|NCT02938702|Active surveillance|active surveillance
4747829|NCT02938650|nitrolipid|nitrolipid
4747830|NCT02938650|microbiome|microbiome
4747831|NCT02938650|inflammation|inflammation
4747832|NCT02938650|cytokine|cytokine
4747833|NCT02938598|maternal depression|maternal depression
4747834|NCT02938598|pediatric-based maternal depression screening|pediatric-based maternal depression screening
4747835|NCT02938598|maternal health services|maternal health services
4747836|NCT02938546|Non-small-cell lung cancer|non-small-cell lung cancer
4747837|NCT02938546|18F-FDG PET/CT|18f-fdg pet/ct
4747838|NCT02938546|treatment response assessment|treatment response assessment
4747839|NCT02938520|Antiretroviral agent|antiretroviral agent
4747840|NCT02938520|Maintenance|maintenance
4747841|NCT02938520|rilpivirine|rilpivirine
4747842|NCT02938520|dolutegravir|dolutegravir
4747843|NCT02938520|TMC278|tmc278
4747844|NCT02938520|Triumeq|triumeq
4747845|NCT02938520|non-nucleoside reverse transcriptase inhibitor|non-nucleoside reverse transcriptase inhibitor
4747846|NCT02938520|once monthly, every 4 weeks, once daily|once monthly, every 4 weeks, once daily
4747847|NCT02938520|GSK1265744|gsk1265744
4747848|NCT02938520|CAB|cab
4747849|NCT02938520|Tivicay|tivicay
4747850|NCT02938520|Long-Acting Intramuscular rilpivirine|long-acting intramuscular rilpivirine
4747851|NCT02938520|lamivudine|lamivudine
4747852|NCT02938520|integrase inhibitor|integrase inhibitor
4747853|NCT02938520|Long-Acting Intramuscular Cabotegravir|long-acting intramuscular cabotegravir
4747854|NCT02938520|ART naïve|art naïve
4747855|NCT02938520|cabotegravir|cabotegravir
4747856|NCT02938520|abacavir|abacavir
4747857|NCT02938507|Overactive bladder, Incontinence|overactive bladder, incontinence
4747858|NCT02938481|colon cancer, lymph node, extent of bowel resection|colon cancer, lymph node, extent of bowel resection
4747859|NCT02938455|Hyperalgesia|hyperalgesia
4747860|NCT02938455|Opioids|opioids
4747861|NCT02938455|Postoperative pain|postoperative pain
4747862|NCT02938455|DNA methylation|dna methylation
4747863|NCT02938429|congenital|congenital
4747864|NCT02938390|Nipple Sparing Mastectomy|nipple sparing mastectomy
4747865|NCT02938390|Ultrasound|ultrasound
4747866|NCT02938351|Collaborative care intervention|collaborative care intervention
4747867|NCT02938351|kidney transplant|kidney transplant
4747868|NCT02938325|Electroencephalogram|electroencephalogram
4747869|NCT02938325|awareness|awareness
4747870|NCT02938286|Fractional laser|fractional laser
4747871|NCT02938286|Topical anesthesia|topical anesthesia
4747872|NCT02938286|Drug delivery|drug delivery
4747873|NCT02938286|CO2 laser|co2 laser
4747874|NCT02938286|Er:YAG laser|er:yag laser
4747875|NCT02938247|Malnutrition|malnutrition
4747876|NCT02938247|Geriatric subjects|geriatric subjects
4747877|NCT02938247|Nursing home|nursing home
4747878|NCT02938234|Malnutrition|malnutrition
4747879|NCT02938234|Geriatric subjects|geriatric subjects
4747880|NCT02938234|Nursing home|nursing home
4747881|NCT02938221|TeleStroke|telestroke
4747882|NCT02938221|HINTS|hints
4747883|NCT02938221|Diagnosis|diagnosis
4747884|NCT02938221|Telemedicine|telemedicine
4747885|NCT02938221|Acute Vestibular Syndrome|acute vestibular syndrome
4747886|NCT02938169|low back pain|low back pain
4747887|NCT02938169|surface EMG|surface emg
4747888|NCT02938169|exercise|exercise
4747889|NCT02938156|Hemophilia|hemophilia
4747890|NCT02938143|Jumpers knee|jumpers knee
4747891|NCT02938143|Patellar Tendinopathy|patellar tendinopathy
4747892|NCT02938143|Jumping Athletes|jumping athletes
4747893|NCT02938143|UTE MRI|ute mri
4747894|NCT02938143|Exercise Therapy|exercise therapy
4747895|NCT02938143|NBA|nba
4747896|NCT02938117|obesity|obesity
4747897|NCT02938117|eccentric exercise|eccentric exercise
4747898|NCT02938117|body composition|body composition
4747899|NCT02938117|training program|training program
4747900|NCT02938091|Hispanics|hispanics
4747901|NCT02938091|Single nucleotide polymorphism|single nucleotide polymorphism
4747902|NCT02938091|Hepatic lipase|hepatic lipase
4747903|NCT02938052|Heart Failure|heart failure
4747904|NCT02938052|Positive Psychology|positive psychology
4747905|NCT02938052|Adherence to Health Behaviors|adherence to health behaviors
4747906|NCT02938039|laryngeal airways|laryngeal airways
4747907|NCT02938039|infants|infants
4747908|NCT02938039|neonates|neonates
4747909|NCT02938039|children|children
4747910|NCT02938039|anesthetized|anesthetized
4747911|NCT02938000|aerobic training|aerobic training
4747912|NCT02938000|stroke|stroke
4747913|NCT02938000|exercise|exercise
4747914|NCT02938000|stroke recovery|stroke recovery
4747915|NCT02937974|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
4747916|NCT02937974|Xuebijing|xuebijing
4747917|NCT02937948|Locally advanced|locally advanced
4747918|NCT02937922|Exercise|exercise
4747919|NCT02937922|Endothelium|endothelium
4747920|NCT02937922|Hypertension|hypertension
4747921|NCT02937922|Endothelial progenitor cell|endothelial progenitor cell
4747922|NCT02937922|Endothelial microparticle|endothelial microparticle
4747923|NCT02937909|woundcare community nursing competence|woundcare community nursing competence
4747924|NCT02937883|Daily Activities|daily activities
4747925|NCT02937818|Platinum Refractory Extensive-Stage Carcinoma, Small Cell Lung|platinum refractory extensive-stage carcinoma, small cell lung
4747926|NCT02937818|Platinum Refractory Extensive-Stage Oat Cell Carcinoma of Lung|platinum refractory extensive-stage oat cell carcinoma of lung
4747927|NCT02937818|Platinum Refractory Extensive-Stage Oat Cell Lung Cancer|platinum refractory extensive-stage oat cell lung cancer
4747928|NCT02937818|Platinum Refractory Extensive-Stage Small Cell Cancer Of The Lung|platinum refractory extensive-stage small cell cancer of the lung
4747929|NCT02937818|Platinum Refractory Extensive-Stage Small Cell Lung Cancer|platinum refractory extensive-stage small cell lung cancer
4747930|NCT02937740|Hypogonadism|hypogonadism
4747931|NCT02937714|Teachers|teachers
4747932|NCT02937714|mental health literacy|mental health literacy
4747933|NCT02937714|school mental health promotion|school mental health promotion
4747934|NCT02937688|Parkinson's disease|parkinson's disease
4747935|NCT02937688|Deep Brain Stimulation|deep brain stimulation
4747936|NCT02937675|small molecule inhibitor of protein translation|small molecule inhibitor of protein translation
4747937|NCT02937675|immunomodulator|immunomodulator
4747938|NCT02937675|phase 1 dose escalation|phase 1 dose escalation
4747939|NCT02937649|Obesity|obesity
4747940|NCT02937649|Bariatric surgery|bariatric surgery
4747941|NCT02937649|Sleeve gastrectomy|sleeve gastrectomy
4747942|NCT02937649|Staple-line Leak|staple-line leak
4747943|NCT02937649|Bougie|bougie
4747944|NCT02937649|Calibration|calibration
4747945|NCT02937597|proficiency based progression|proficiency based progression
4747946|NCT02937597|feedback|feedback
4747947|NCT02937597|computer based assessment|computer based assessment
4747948|NCT02937597|non technical skills|non technical skills
4747949|NCT02937597|deteriorating patient|deteriorating patient
4747950|NCT02937597|ISBAR|isbar
4747951|NCT02937571|Carfilzomib|carfilzomib
4747952|NCT02937571|Lenalidomide|lenalidomide
4747953|NCT02937571|Dexamethasone|dexamethasone
4747954|NCT02937571|15-326|15-326
4747955|NCT02937558|hypoglycemia|hypoglycemia
4747956|NCT02937532|Fear of falling|fear of falling
4747957|NCT02937532|Fear avoidance behavior|fear avoidance behavior
4747958|NCT02937532|cognitive behavioral therapy|cognitive behavioral therapy
4747959|NCT02937532|Rehabilitation|rehabilitation
4747960|NCT02937519|Chronomodulated Chemotherapy|chronomodulated chemotherapy
4747961|NCT02937519|Intensity Modulated Radiation Therapy|intensity modulated radiation therapy
4747962|NCT02937519|Advanced Nasopharyngeal Cancer|advanced nasopharyngeal cancer
4747963|NCT02937506|propofol|propofol
4747964|NCT02937506|colonoscopy|colonoscopy
4747965|NCT02937506|patient satisfaction|patient satisfaction
4747966|NCT02937480|stroke|stroke
4747967|NCT02937480|physical activity|physical activity
4747968|NCT02937480|task performance|task performance
4747969|NCT02937480|clinical protocol|clinical protocol
4747970|NCT02937467|SWE|swe
4747971|NCT02937467|diagnosis|diagnosis
4747972|NCT02937454|Acute Heart Failure|acute heart failure
4747973|NCT02937454|Iron Deficiency|iron deficiency
4747974|NCT02937441|C10.228.140.187|c10.228.140.187
4747975|NCT02937428|vaccination|vaccination
4747976|NCT02937428|pain|pain
4747977|NCT02937428|fear|fear
4747978|NCT02937428|psychological intervention|psychological intervention
4747979|NCT02937415|carbon monoxide|carbon monoxide
4747980|NCT02937415|oxidative stress|oxidative stress
4747981|NCT02937415|waterpipe smoking|waterpipe smoking
4747982|NCT02937415|cigarette smoking|cigarette smoking
4747983|NCT02937415|pulmonary function test|pulmonary function test
4747984|NCT02937350|chronic kidney disease|chronic kidney disease
4747985|NCT02937350|vitamin d catabolism|vitamin d catabolism
4747986|NCT02937311|Taping, stroke|taping, stroke
4747987|NCT02937311|rehabilitation|rehabilitation
4747988|NCT02937311|shoulder pain|shoulder pain
4747989|NCT02937311|electrical stimulation|electrical stimulation
4747990|NCT02937298|Diet Induced Thermogenesis|diet induced thermogenesis
4747991|NCT02937298|Obesity|obesity
4747992|NCT02937298|Energy balance|energy balance
4747993|NCT02937298|Energy expenditure|energy expenditure
4747994|NCT02937298|berries|berries
4747995|NCT02937298|Sea Buckthorn|sea buckthorn
4747996|NCT02937298|Wild garlic|wild garlic
4747997|NCT02937272|TGF Beta|tgf beta
4747998|NCT02937233|Zika|zika
4747999|NCT02937233|Vaccine|vaccine
4748000|NCT02937233|ZPIV|zpiv
4748001|NCT02937207|Bronchial Asthma|bronchial asthma
4748002|NCT02937207|Traditional Chinese Medicine|traditional chinese medicine
4748003|NCT02937194|Early childhood caries (ECC)|early childhood caries (ecc)
4748004|NCT02937194|Oral health promotion|oral health promotion
4748005|NCT02937194|Randomized controlled trial|randomized controlled trial
4748006|NCT02937142|Behavior Therapy|behavior therapy
4748007|NCT02937142|Cognitive Therapy|cognitive therapy
4748008|NCT02937142|Adolescents|adolescents
4748009|NCT02937142|Psychotherapy, Group|psychotherapy, group
4748010|NCT02937129|Infrared tympanic thermometer|infrared tympanic thermometer
4748011|NCT02937129|Axillary thermometer|axillary thermometer
4748012|NCT02937129|Mercury glass thermometer|mercury glass thermometer
4748013|NCT02937129|Adult emergency department|adult emergency department
4748014|NCT02937103|Leukemia|leukemia
4748015|NCT02937103|Myeloid|myeloid
4748016|NCT02937103|CD123|cd123
4748017|NCT02937103|CAR-T|car-t
4748018|NCT02937090|Polycystic Ovary Syndrome|polycystic ovary syndrome
4748019|NCT02937090|Intestinal Microbiota|intestinal microbiota
4748020|NCT02937077|etiology|etiology
4748021|NCT02937038|Urine Biomarkers|urine biomarkers
4748022|NCT02937038|Child Nutrition|child nutrition
4748023|NCT02937038|Hydration|hydration
4748024|NCT02937038|Parent Nutrition Habits|parent nutrition habits
4748025|NCT02937025|Nonvalvular atrial fibrillation|nonvalvular atrial fibrillation
4748026|NCT02937025|Stroke|stroke
4748027|NCT02937025|Left Atrial Appendage Closure|left atrial appendage closure
4748028|NCT02937025|Intervention|intervention
4748029|NCT02937012|Primary Biliary Cirrhosis|primary biliary cirrhosis
4748030|NCT02937012|Primary Biliary Cholangitis|primary biliary cholangitis
4748031|NCT02937012|Bezafibrate|bezafibrate
4748032|NCT02937012|Ursodeoxycholic acid|ursodeoxycholic acid
4748033|NCT02936973|simple obesity|simple obesity
4748034|NCT02936973|catgut implantation|catgut implantation
4748035|NCT02936934|Adverse Drug Reaction|adverse drug reaction
4748036|NCT02936934|Morphine|morphine
4748037|NCT02936934|Oxycodone|oxycodone
4748038|NCT02936934|Abdominal hysterectomy|abdominal hysterectomy
4748039|NCT02936921|Toxoplasma gondii|toxoplasma gondii
4748040|NCT02936921|Toxoplasmosis|toxoplasmosis
4748041|NCT02936921|congenital|congenital
4748042|NCT02936921|prenatal|prenatal
4748043|NCT02936921|screening|screening
4748044|NCT02936921|treatment|treatment
4748045|NCT02936921|diagnosis|diagnosis
4748046|NCT02936908|Neuromuscular Diseases|neuromuscular diseases
4748047|NCT02936908|Muscular dystrophy|muscular dystrophy
4748048|NCT02936908|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
4748049|NCT02936908|Acute respiratory failure|acute respiratory failure
4748050|NCT02936908|respiratory care|respiratory care
4748051|NCT02936908|mechanical ventilation|mechanical ventilation
4748052|NCT02936908|weaning|weaning
4748053|NCT02936908|Intensive Care Unit|intensive care unit
4748054|NCT02936908|Critical Care|critical care
4748055|NCT02936908|Survival|survival
4748056|NCT02936882|ultrasonography|ultrasonography
4748057|NCT02936882|aspiration|aspiration
4748058|NCT02936882|emergency|emergency
4748059|NCT02936882|children|children
4748060|NCT02936882|antrum|antrum
4748061|NCT02936843|Pain|pain
4748062|NCT02936843|Inflammation|inflammation
4748063|NCT02936843|Diabetes Mellitus|diabetes mellitus
4748064|NCT02936843|Adult|adult
4748065|NCT02936843|Neuropathy|neuropathy
4748066|NCT02936817|HRCT|hrct
4748067|NCT02936817|High Resolution Computed Tomography scans|high resolution computed tomography scans
4748068|NCT02936817|Functional Respiratory Imaging|functional respiratory imaging
4748069|NCT02936817|CT scan|ct scan
4748070|NCT02936817|Computed Tomography|computed tomography
4748071|NCT02936817|COPD|copd
4748072|NCT02936817|sputum producing COPD patients|sputum producing copd patients
4748073|NCT02936817|Aerobika® device|aerobika® device
4748074|NCT02936804|early stage lung cancer|early stage lung cancer
4748075|NCT02936804|LDCT screening|ldct screening
4748076|NCT02936804|lung resection|lung resection
4748077|NCT02936804|electromagnetic navigation bronchoscopy|electromagnetic navigation bronchoscopy
4748078|NCT02936804|peripheral biomarker|peripheral biomarker
4748079|NCT02936791|autosomal dominant polycystic kidney disease|autosomal dominant polycystic kidney disease
4748080|NCT02936791|ADPKD|adpkd
4748081|NCT02936791|PKD biomarkers|pkd biomarkers
4748082|NCT02936791|Kidney Institute|kidney institute
4748083|NCT02936791|University of Kansas Medical Center|university of kansas medical center
4748084|NCT02936778|Short-term medical and psychosocial functioning|short-term medical and psychosocial functioning
4748085|NCT02936713|flatulence|flatulence
4748086|NCT02936713|gas|gas
4748087|NCT02936713|probiotics|probiotics
4748088|NCT02936713|fermented milk|fermented milk
4748089|NCT02936713|diet|diet
4748090|NCT02936713|functional gastrointestinal disorders|functional gastrointestinal disorders
4748091|NCT02936700|Psychiatry|psychiatry
4748092|NCT02936700|Suicide|suicide
4748093|NCT02936700|Randomized controlled trial|randomized controlled trial
4748094|NCT02936700|ACT|act
4748095|NCT02936700|fMRI|fmri
4748096|NCT02936687|blood flow|blood flow
4748097|NCT02936687|magnetic resonance imaging|magnetic resonance imaging
4748098|NCT02936687|insulin|insulin
4748099|NCT02936687|vasodilation|vasodilation
4748100|NCT02936661|postpartum hemorrhage， cesarean section， tranexamic acid|postpartum hemorrhage， cesarean section， tranexamic acid
4748101|NCT02936648|Hepatitis C|hepatitis c
4748102|NCT02936635|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
4748103|NCT02936635|ALS|als
4748104|NCT02936635|tirasemtiv|tirasemtiv
4748105|NCT02936609|healthcare access|healthcare access
4748106|NCT02936609|healthcare utilization|healthcare utilization
4748107|NCT02936609|preventive services|preventive services
4748108|NCT02936609|cancer survivors|cancer survivors
4748109|NCT02936531|evoked response potential|evoked response potential
4748110|NCT02936531|ERP|erp
4748111|NCT02936531|Brain Network Activation|brain network activation
4748112|NCT02936531|BNA|bna
4748113|NCT02936531|Biomarker|biomarker
4748114|NCT02936518|ankyloglossia|ankyloglossia
4748115|NCT02936518|breastfeeding|breastfeeding
4748116|NCT02936518|lip tie|lip tie
4748117|NCT02936505|chronic lung allograft dysfunction|chronic lung allograft dysfunction
4748118|NCT02936505|cyclosporin|cyclosporin
4748119|NCT02936505|tacrolimus|tacrolimus
4748120|NCT02936505|Bronchiolitis Obliterans Syndrome|bronchiolitis obliterans syndrome
4748121|NCT02936505|Restrictive Allograft Syndrome|restrictive allograft syndrome
4748122|NCT02936505|CLAD|clad
4748123|NCT02936492|Phase I|phase i
4748124|NCT02936492|Healthy volunteers|healthy volunteers
4748125|NCT02936466|Psychiatry|psychiatry
4748126|NCT02936466|Randomized controlled trial|randomized controlled trial
4748127|NCT02936466|Bipolar disorder|bipolar disorder
4748128|NCT02936466|Serious game|serious game
4748129|NCT02936466|Compliance|compliance
4748130|NCT02936466|Psychoeducation|psychoeducation
4748131|NCT02936453|Spinal Cord Injury|spinal cord injury
4748132|NCT02936453|Epidural Electrical Stimulation|epidural electrical stimulation
4748133|NCT02936453|Robot-assisted|robot-assisted
4748134|NCT02936440|acute kidney injury|acute kidney injury
4748135|NCT02936440|intensive care unit|intensive care unit
4748136|NCT02936440|bioelectrical impedance analysis|bioelectrical impedance analysis
4748137|NCT02936414|Berberine|berberine
4748138|NCT02936414|Cytokine|cytokine
4748139|NCT02936414|CRP|crp
4748140|NCT02936414|Metabolism|metabolism
4748141|NCT02936414|Schizophrenia|schizophrenia
4748142|NCT02936388|uveal melanoma|uveal melanoma
4748143|NCT02936388|liver metastasis|liver metastasis
4748144|NCT02936388|chemoembolisation|chemoembolisation
4748145|NCT02936388|radioembolisation|radioembolisation
4748146|NCT02936375|lupus|lupus
4748147|NCT02936375|nephritis|nephritis
4748148|NCT02936375|iguratimod|iguratimod
4748149|NCT02936362|Bread|bread
4748150|NCT02936362|Microbiome|microbiome
4748151|NCT02936362|Blood tests|blood tests
4748152|NCT02936362|Sourdough bread|sourdough bread
4748153|NCT02936362|Dietary intervention|dietary intervention
4748154|NCT02936349|Hereditary Hemorrhagic Telangiectasia (HHT)|hereditary hemorrhagic telangiectasia (hht)
4748155|NCT02936349|Pulmonary Arteriovenous Malformation (PAVM)|pulmonary arteriovenous malformation (pavm)
4748156|NCT02936349|Transthoracic Contrast Echocardiogram (TTCE)|transthoracic contrast echocardiogram (ttce)
4748157|NCT02936323|SCLC small cell lung cancer|sclc small cell lung cancer
4748158|NCT02936323|pancreatic neuroendocrine NET|pancreatic neuroendocrine net
4748159|NCT02936323|GI neuroendocrine NET|gi neuroendocrine net
4748160|NCT02936310|stress|stress
4748161|NCT02936310|mindfulness|mindfulness
4748162|NCT02936310|Mindful Living With Stress Intervention|mindful living with stress intervention
4748163|NCT02936310|nurse|nurse
4748164|NCT02936310|HIV/AIDS|hiv/aids
4748165|NCT02936271|Radiofrequency Ablation|radiofrequency ablation
4748166|NCT02936271|Sclerotherapy|sclerotherapy
4748167|NCT02936271|Vasculera|vasculera
4748168|NCT02936219|complementary feeding|complementary feeding
4748169|NCT02936219|breast milk|breast milk
4748170|NCT02936219|formula feeding|formula feeding
4748171|NCT02936219|combined feeding|combined feeding
4748172|NCT02936219|preterm infants|preterm infants
4748173|NCT02936219|body composition|body composition
4748174|NCT02936206|proliferation Index|proliferation index
4748175|NCT02936206|Tamoxifen|tamoxifen
4748176|NCT02936206|Fulvestrant|fulvestrant
4748177|NCT02936206|cyclinD1|cyclind1
4748178|NCT02936206|Breast cancer|breast cancer
4748179|NCT02936180|Rheumatoid arthritis|rheumatoid arthritis
4748180|NCT02936180|Flu vaccine|flu vaccine
4748181|NCT02936180|Influenza|influenza
4748182|NCT02936167|Ringer Lactate|ringer lactate
4748183|NCT02936167|Plasmalyte|plasmalyte
4748184|NCT02936167|Perioperative Period|perioperative period
4748185|NCT02936141|homeless, mental disorders, attendance|homeless, mental disorders, attendance
4748186|NCT02936102|Phase I|phase i
4748187|NCT02936102|FAZ053|faz053
4748188|NCT02936102|PDR001|pdr001
4748189|NCT02936102|Checkpoint inhibitor|checkpoint inhibitor
4748190|NCT02936102|PD-L1|pd-l1
4748191|NCT02936102|PD-1|pd-1
4748192|NCT02936063|Head and neck surgery|head and neck surgery
4748193|NCT02936063|Scar cosmesis|scar cosmesis
4748194|NCT02936063|Surgical staples|surgical staples
4748195|NCT02936063|Sutures|sutures
4748196|NCT02936063|Patient satisfaction|patient satisfaction
4748197|NCT02936050|Echocardiography|echocardiography
4748198|NCT02936050|Telemedicine|telemedicine
4748199|NCT02936050|Nurses|nurses
4748200|NCT02936050|Decision support|decision support
4748201|NCT02936050|eHealth|ehealth
4748202|NCT02936037|progressive multiple sclerosis|progressive multiple sclerosis
4748203|NCT02936037|MS|ms
4748204|NCT02936037|EDSS|edss
4748205|NCT02936037|TW25|tw25
4748206|NCT02936037|multiple sclerosis|multiple sclerosis
4748207|NCT02935998|schizophrenia|schizophrenia
4748208|NCT02935998|agitation|agitation
4748209|NCT02935998|ziprasidone|ziprasidone
4748210|NCT02935985|spontaneous intracerebral hemorrhage|spontaneous intracerebral hemorrhage
4748211|NCT02935985|point-of-care bio-markers|point-of-care bio-markers
4748212|NCT02935985|multicenter|multicenter
4748213|NCT02935985|Emergency Department|emergency department
4748214|NCT02935985|Romania|romania
4748215|NCT02935972|prostate biopsy, analgesia, anesthesia, pain, prostate cancer|prostate biopsy, analgesia, anesthesia, pain, prostate cancer
4748216|NCT02935946|pharyngeal swallow, NICU, intervention, thickening|pharyngeal swallow, nicu, intervention, thickening
4748217|NCT02935920|PRO, follow up|pro, follow up
4748218|NCT02935894|oxygenated lipids|oxygenated lipids
4748219|NCT02935894|metabolic profiling|metabolic profiling
4748220|NCT02935894|sphingoid bases|sphingoid bases
4748221|NCT02935894|ceramides|ceramides
4748222|NCT02935894|endocannabinoids|endocannabinoids
4748223|NCT02935894|non-invasive sampling|non-invasive sampling
4748224|NCT02935868|Saliva|saliva
4748225|NCT02935855|Diabetic patients|diabetic patients
4748226|NCT02935855|nondiabetic patients|nondiabetic patients
4748227|NCT02935842|Parkinson's Disease|parkinson's disease
4748228|NCT02935842|Word Retrieval|word retrieval
4748229|NCT02935842|Apraxia Symptoms|apraxia symptoms
4748230|NCT02935842|Dysarthria|dysarthria
4748231|NCT02935829|energy intake|energy intake
4748232|NCT02935829|blood glucose|blood glucose
4748233|NCT02935829|carob flour|carob flour
4748234|NCT02935790|unresectable|unresectable
4748235|NCT02935790|melanoma|melanoma
4748236|NCT02935777|Pomegranate extract|pomegranate extract
4748237|NCT02935777|cognitive function|cognitive function
4748238|NCT02935777|cognition|cognition
4748239|NCT02935777|polyphenols|polyphenols
4748240|NCT02935777|memory|memory
4748241|NCT02935738|prednisolone|prednisolone
4748242|NCT02935738|anti-sperm antibodies|anti-sperm antibodies
4748243|NCT02935738|sperm penetration assay|sperm penetration assay
4748244|NCT02935712|Safety|safety
4748245|NCT02935712|Tolerability|tolerability
4748246|NCT02935712|AZD8601|azd8601
4748247|NCT02935712|Type II Diabetes|type ii diabetes
4748248|NCT02935582|Topical|topical
4748249|NCT02935582|Real-world|real-world
4748250|NCT02935582|Local standard of care|local standard of care
4748251|NCT02935582|Non-interventional|non-interventional
4748252|NCT02935582|Calcipotriol|calcipotriol
4748253|NCT02935569|Alopecia|alopecia
4748254|NCT02935569|Radiotherapy|radiotherapy
4748255|NCT02935556|Post Partum Pre-eclampsia|post partum pre-eclampsia
4748256|NCT02935517|Color vision deficiency|color vision deficiency
4748257|NCT02935517|Color vision defects|color vision defects
4748258|NCT02935517|Vision disorders|vision disorders
4748259|NCT02935517|Sensation disorders|sensation disorders
4748260|NCT02935517|Neurologic manifestations|neurologic manifestations
4748261|NCT02935517|Nervous system diseases|nervous system diseases
4748262|NCT02935517|Eye diseases|eye diseases
4748263|NCT02935517|Signs and symptoms|signs and symptoms
4748264|NCT02935504|Depression|depression
4748265|NCT02935504|Pregnancy|pregnancy
4748266|NCT02935504|Postpartum|postpartum
4748267|NCT02935491|TAVI|tavi
4748268|NCT02935491|Aortic stenosis|aortic stenosis
4748269|NCT02935491|aortic stiffness|aortic stiffness
4748270|NCT02935491|calcifications|calcifications
4748271|NCT02935491|CT-scan|ct-scan
4748272|NCT02935491|Vascular impedance|vascular impedance
4748273|NCT02935478|bariatric surgery|bariatric surgery
4748274|NCT02935478|minimally invasive|minimally invasive
4748275|NCT02935478|Embolization|embolization
4748276|NCT02935478|ghrelin|ghrelin
4748277|NCT02935478|gastric artery embolization|gastric artery embolization
4748278|NCT02935452|Self-management|self-management
4748279|NCT02935452|Supportive self-management|supportive self-management
4748280|NCT02935452|Normalisation process theory|normalisation process theory
4748281|NCT02935452|Social networks|social networks
4748282|NCT02935439|Mobile Phone|mobile phone
4748283|NCT02935439|Self-efficacy|self-efficacy
4748284|NCT02935439|Quality of Life|quality of life
4748285|NCT02935439|Knowledge|knowledge
4748286|NCT02935439|Feasibility|feasibility
4748287|NCT02935426|cyanoacrylate|cyanoacrylate
4748288|NCT02935426|sutures|sutures
4748289|NCT02935400|porphyria|porphyria
4748290|NCT02935400|biomarkers|biomarkers
4748291|NCT02935387|Very early rheumatoid arthritis|very early rheumatoid arthritis
4748292|NCT02935374|children|children
4748293|NCT02935374|intestinal microbiome|intestinal microbiome
4748294|NCT02935374|microbiota|microbiota
4748295|NCT02935374|antimicrobial course|antimicrobial course
4748296|NCT02935374|amoxicillin|amoxicillin
4748297|NCT02935374|amoxicillin-clavulanate|amoxicillin-clavulanate
4748298|NCT02935374|macrolide|macrolide
4748299|NCT02935322|Prevention|prevention
4748300|NCT02935309|rectum|rectum
4748301|NCT02935309|transrectal|transrectal
4748302|NCT02935309|carcinoma|carcinoma
4748303|NCT02935270|Stroke|stroke
4748304|NCT02935270|Neglect|neglect
4748305|NCT02935270|Rehabilitation|rehabilitation
4748306|NCT02935244|Epidemiology|epidemiology
4748307|NCT02935231|minimal cessation advice|minimal cessation advice
4748308|NCT02935231|proactive|proactive
4748309|NCT02935231|nicotine replacement therapy|nicotine replacement therapy
4748310|NCT02935231|smoking hotspots|smoking hotspots
4748311|NCT02935192|seasonal influenza|seasonal influenza
4748312|NCT02935192|vaccine|vaccine
4748313|NCT02935153|CD22|cd22
4748314|NCT02935153|CAR-T|car-t
4748315|NCT02935153|Leukemia|leukemia
4748316|NCT02935153|Lymphoma|lymphoma
4748317|NCT02935127|absorbable sutures|absorbable sutures
4748318|NCT02935114|Tooth Bleaching|tooth bleaching
4748319|NCT02935114|Tooth Bleaching Agents|tooth bleaching agents
4748320|NCT02935114|Tooth Whitening|tooth whitening
4748321|NCT02935114|Hydrogen Peroxide|hydrogen peroxide
4748322|NCT02935114|Carbamide Peroxide|carbamide peroxide
4748323|NCT02935101|glucocorticoids|glucocorticoids
4748324|NCT02935101|craving|craving
4748325|NCT02935101|Heroin|heroin
4748326|NCT02935101|Cocaine|cocaine
4748327|NCT02935101|dependency|dependency
4748328|NCT02935088|FFR|ffr
4748329|NCT02935088|Percutaneous coronary intervention|percutaneous coronary intervention
4748330|NCT02935062|Speech|speech
4748331|NCT02935062|Speech Therapy|speech therapy
4748332|NCT02935062|Speech Sound Disorders|speech sound disorders
4748333|NCT02935062|Phonological Disorders|phonological disorders
4748334|NCT02935062|Auditory Perception|auditory perception
4748335|NCT02935010|Helicobacter pylori|helicobacter pylori
4748336|NCT02935010|Bismuth quadruple therapy|bismuth quadruple therapy
4748337|NCT02935010|Tailored therapy|tailored therapy
4748338|NCT02935010|Empiric therapy|empiric therapy
4748339|NCT02935010|clarithromycin susceptibility|clarithromycin susceptibility
4748340|NCT02934997|sepsis|sepsis
4748341|NCT02934997|septic shock|septic shock
4748342|NCT02934997|cholesterol|cholesterol
4748343|NCT02934997|high density lipoprotein|high density lipoprotein
4748344|NCT02934984|Pancreatic Cancer|pancreatic cancer
4748345|NCT02934984|recurrence|recurrence
4748346|NCT02934984|DNA|dna
4748347|NCT02934958|Colon Cancer Screening|colon cancer screening
4748348|NCT02934945|Budesonide/formoterol|budesonide/formoterol
4748349|NCT02934945|Typical asthma|typical asthma
4748350|NCT02934945|Cough variant asthma|cough variant asthma
4748351|NCT02934919|Nalmefene|nalmefene
4748352|NCT02934919|Impulse control disorders|impulse control disorders
4748353|NCT02934919|Parkinson's disease|parkinson's disease
4748354|NCT02934919|Tolerance|tolerance
4748355|NCT02934919|Efficacy|efficacy
4748356|NCT02934906|Neonatal Alloimmune Thrombocytopenia|neonatal alloimmune thrombocytopenia
4748357|NCT02934906|pregnancy|pregnancy
4748358|NCT02934906|human platelet allogantigen|human platelet allogantigen
4748359|NCT02934906|asian|asian
4748360|NCT02934906|Chinese|chinese
4748361|NCT02934880|adapted physical activity, cognitive functions|adapted physical activity, cognitive functions
4748362|NCT02934854|Creatine Transporter Deficiency (CTD)|creatine transporter deficiency (ctd)
4748363|NCT02934854|Guanidinoacetate Methyltransferase Deficiency (GAMT)|guanidinoacetate methyltransferase deficiency (gamt)
4748364|NCT02934854|Arginine: Glycine Amidinotransferase Deficiency (AGAT)|arginine: glycine amidinotransferase deficiency (agat)
4748365|NCT02934854|Biomarker|biomarker
4748366|NCT02934815|psychological intervention|psychological intervention
4748367|NCT02934815|breast cancer|breast cancer
4748368|NCT02934815|supportive-expressive group therapy|supportive-expressive group therapy
4748369|NCT02934815|emotion regulation|emotion regulation
4748370|NCT02934815|social support|social support
4748371|NCT02934815|attachment|attachment
4748372|NCT02934815|quality of life|quality of life
4748373|NCT02934789|submucosal fibroids|submucosal fibroids
4748374|NCT02934789|heavy menstrual bleeding|heavy menstrual bleeding
4748375|NCT02934789|quality of life|quality of life
4748376|NCT02934776|DTI|dti
4748377|NCT02934776|prostate cancer|prostate cancer
4748378|NCT02934776|MRI|mri
4748379|NCT02934750|pursed lip breathing|pursed lip breathing
4748380|NCT02934750|interstitial lund disease|interstitial lund disease
4748381|NCT02934750|exercise physiology|exercise physiology
4748382|NCT02934737|Obesity|obesity
4748383|NCT02934737|Diabetes Mellitus|diabetes mellitus
4748384|NCT02934724|HPV vaccines|hpv vaccines
4748385|NCT02934724|HPV-6|hpv-6
4748386|NCT02934724|HPV-11|hpv-11
4748387|NCT02934724|HPV-16|hpv-16
4748388|NCT02934724|HPV-18|hpv-18
4748389|NCT02934724|Gardasil|gardasil
4748390|NCT02934711|Multimorbidity|multimorbidity
4748391|NCT02934711|Exercise coordinated groups (GECO)|exercise coordinated groups (geco)
4748392|NCT02934711|Caregivers|caregivers
4748393|NCT02934685|Prostatic Neoplasms|prostatic neoplasms
4748394|NCT02934685|radiotherapy|radiotherapy
4748395|NCT02934646|Robotics|robotics
4748396|NCT02934646|Upper Extremity|upper extremity
4748397|NCT02934633|injury|injury
4748398|NCT02934633|child|child
4748399|NCT02934633|cars|cars
4748400|NCT02934633|pedestrians|pedestrians
4748401|NCT02934633|child safety|child safety
4748402|NCT02934633|interactive|interactive
4748403|NCT02934633|computer|computer
4748404|NCT02934633|prevention|prevention
4748405|NCT02934633|internet|internet
4748406|NCT02934633|CD-ROM|cd-rom
4748407|NCT02934620|pregnancy|pregnancy
4748408|NCT02934620|condom|condom
4748409|NCT02934620|HIV|hiv
4748410|NCT02934620|sexually transmitted infections|sexually transmitted infections
4748411|NCT02934607|Asthma|asthma
4748412|NCT02934607|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
4748413|NCT02934607|Spacer device|spacer device
4748414|NCT02934607|Symbicort|symbicort
4748415|NCT02934607|Pressurized metered-dose inhaler|pressurized metered-dose inhaler
4748416|NCT02934607|Relative bioavailability|relative bioavailability
4748417|NCT02934607|Crossover|crossover
4748418|NCT02934607|AstraZeneca|astrazeneca
4748419|NCT02934607|Safety|safety
4748420|NCT02934607|Activated charcoal|activated charcoal
4748421|NCT02934607|AeroChamber Plus Flow-Vu spacer device|aerochamber plus flow-vu spacer device
4748422|NCT02934568|Ribociclib|ribociclib
4748423|NCT02934568|LEE011|lee011
4748424|NCT02934542|Laparoscope holder|laparoscope holder
4748425|NCT02934542|Colon resection|colon resection
4748426|NCT02934542|Right hemicolectomy|right hemicolectomy
4748427|NCT02934542|Left hemicolectomy|left hemicolectomy
4748428|NCT02934542|Sigmoid resection|sigmoid resection
4748429|NCT02934542|Anti-reflux|anti-reflux
4748430|NCT02934542|Hiatal hernia|hiatal hernia
4748431|NCT02934516|Obstructed labor|obstructed labor
4748432|NCT02934516|C section. push method|c section. push method
4748433|NCT02934516|reverse breech|reverse breech
4748434|NCT02934503|Chemotherapy|chemotherapy
4748435|NCT02934503|PD-L1|pd-l1
4748436|NCT02934503|Thoracic radiotherapy|thoracic radiotherapy
4748437|NCT02934503|PD-1|pd-1
4748438|NCT02934503|MK-3475|mk-3475
4748439|NCT02934477|Myelofibrosis|myelofibrosis
4748440|NCT02934477|Hematopoietic Stem Cell Transplant|hematopoietic stem cell transplant
4748441|NCT02934477|Medicare|medicare
4748442|NCT02934438|nitric oxide|nitric oxide
4748443|NCT02934438|Neo40 supplement,|neo40 supplement,
4748444|NCT02934438|exercise tolerance|exercise tolerance
4748445|NCT02934425|Pork|pork
4748446|NCT02934425|Refined carbohydrates|refined carbohydrates
4748447|NCT02934425|Satiety|satiety
4748448|NCT02934425|Glucose|glucose
4748449|NCT02934425|Insulin|insulin
4748450|NCT02934425|Breakfast|breakfast
4748451|NCT02934425|Lipoprotein lipids|lipoprotein lipids
4748452|NCT02934399|dynamic hormone diagnostics|dynamic hormone diagnostics
4748453|NCT02934399|adrenal insufficiency|adrenal insufficiency
4748454|NCT02934399|congenital adrenal hyperplasia|congenital adrenal hyperplasia
4748455|NCT02934399|primary hyperaldosteronism|primary hyperaldosteronism
4748456|NCT02934399|cushing syndrome|cushing syndrome
4748457|NCT02934399|growth hormone deficiency|growth hormone deficiency
4748458|NCT02934399|acromegaly|acromegaly
4748459|NCT02934360|Lung Cancer|lung cancer
4748460|NCT02934360|Breast Cancer|breast cancer
4748461|NCT02934360|cell free DNA|cell free dna
4748462|NCT02934360|biomarker|biomarker
4748463|NCT02934347|Intubation, Back-up position; Glottis, View|intubation, back-up position; glottis, view
4748464|NCT02934334|major depression|major depression
4748465|NCT02934334|major depressive episode|major depressive episode
4748466|NCT02934334|biomarkers|biomarkers
4748467|NCT02934334|relapse|relapse
4748468|NCT02934334|near term relapse|near term relapse
4748469|NCT02934334|m-health|m-health
4748470|NCT02934321|Erythritol|erythritol
4748471|NCT02934321|Satiety Response|satiety response
4748472|NCT02934321|Ghrelin|ghrelin
4748473|NCT02934295|Rubeola|rubeola
4748474|NCT02934269|Healthy subjects|healthy subjects
4748475|NCT02934269|Safety|safety
4748476|NCT02934269|CC-90006|cc-90006
4748477|NCT02934269|Phase 1|phase 1
4748478|NCT02934269|Tolerability|tolerability
4748479|NCT02934256|Neurofibromatosis Type 2|neurofibromatosis type 2
4748480|NCT02934256|Vestibular Schwannoma|vestibular schwannoma
4748481|NCT02934256|Other NF2-related tumors|other nf2-related tumors
4748482|NCT02934243|Laryngeal Masks|laryngeal masks
4748483|NCT02934243|Ventilation|ventilation
4748484|NCT02934243|Risk factors|risk factors
4748485|NCT02934204|PCNSL|pcnsl
4748486|NCT02934204|DLBCL|dlbcl
4748487|NCT02934204|methotrexate|methotrexate
4748488|NCT02934204|temozolomide|temozolomide
4748489|NCT02934191|Tonsillectomy|tonsillectomy
4748490|NCT02934191|Post-operative complications|post-operative complications
4748491|NCT02934191|Post-operative pain|post-operative pain
4748492|NCT02934178|shigellosis|shigellosis
4748493|NCT02934178|Enterobacteriaceae Infections|enterobacteriaceae infections
4748494|NCT02934178|Gram-Negative Bacterial Infections|gram-negative bacterial infections
4748495|NCT02934178|Bacterial Infections|bacterial infections
4748496|NCT02934178|Gastroenteritis|gastroenteritis
4748497|NCT02934178|Gastrointestinal Diseases|gastrointestinal diseases
4748498|NCT02934178|Digestive System Diseases|digestive system diseases
4748499|NCT02934178|Intestinal Diseases|intestinal diseases
4748500|NCT02934165|child safety|child safety
4748501|NCT02934165|injury|injury
4748502|NCT02934165|computer|computer
4748503|NCT02934165|prevention|prevention
4748504|NCT02934165|internet|internet
4748505|NCT02934152|Gastroesophageal reflux disease|gastroesophageal reflux disease
4748506|NCT02934152|Helicobacter pylori|helicobacter pylori
4748507|NCT02934139|N91115|n91115
4748508|NCT02934139|Cavosonstat|cavosonstat
4748509|NCT02934139|Healthy Volunteer|healthy volunteer
4748510|NCT02934113|weight loss|weight loss
4748511|NCT02934113|text messaging|text messaging
4748512|NCT02934113|workplace|workplace
4748513|NCT02934113|participatory approach|participatory approach
4748514|NCT02934113|health care workers|health care workers
4748515|NCT02934100|Calcaneal spur|calcaneal spur
4748516|NCT02934100|Heel spur|heel spur
4748517|NCT02934100|ESWT|eswt
4748518|NCT02934100|Extracorporeal shock wave therapy|extracorporeal shock wave therapy
4748519|NCT02934100|ultrasound therapy|ultrasound therapy
4748520|NCT02934100|electric field diathermy|electric field diathermy
4748521|NCT02934100|skanlab 25 bodywave|skanlab 25 bodywave
4748522|NCT02934100|sham laser therapy|sham laser therapy
4748523|NCT02934087|snare technique|snare technique
4748524|NCT02934087|cannulation of contralateral gate|cannulation of contralateral gate
4748525|NCT02934087|endovascular|endovascular
4748526|NCT02934087|aneurysm|aneurysm
4748527|NCT02934087|AAA|aaa
4748528|NCT02934087|Abdominal Aortic Aneurysm|abdominal aortic aneurysm
4748529|NCT02934074|Limb Loss|limb loss
4748530|NCT02934074|Gait Variability|gait variability
4748531|NCT02934074|Phantom Sensation|phantom sensation
4748532|NCT02934074|Phantom Pain|phantom pain
4748533|NCT02934074|Peripheral Sensation|peripheral sensation
4748534|NCT02934061|Acute low back pain|acute low back pain
4748535|NCT02934022|Maraviroc|maraviroc
4748536|NCT02934022|HAART regimen|haart regimen
4748537|NCT02934022|Immunologic response|immunologic response
4748538|NCT02933996|immunosuppression|immunosuppression
4748539|NCT02933996|cardiac sugery|cardiac sugery
4748540|NCT02933996|Transcutaneous electrical acupoint stimulation|transcutaneous electrical acupoint stimulation
4748541|NCT02933996|postoperative|postoperative
4748542|NCT02933957|Vascular Evaluation|vascular evaluation
4748543|NCT02933957|influencing factor|influencing factor
4748544|NCT02933957|She Minority population|she minority population
4748545|NCT02933944|locally recurrent|locally recurrent
4748546|NCT02933918|Probiotics|probiotics
4748547|NCT02933918|Nasal Irrigation|nasal irrigation
4748548|NCT02933918|Healthy Volunteers|healthy volunteers
4748549|NCT02933801|metastatic castration resistant prostate cancer (mCRPC)|metastatic castration resistant prostate cancer (mcrpc)
4748550|NCT02933801|Prostate Cancer|prostate cancer
4748551|NCT02933801|phase II trial|phase ii trial
4748552|NCT02933801|ODM-201|odm-201
4748553|NCT02933801|maintenance therapy|maintenance therapy
4748554|NCT02933788|cardiovascular disease|cardiovascular disease
4748555|NCT02933788|atherosclerosis|atherosclerosis
4748556|NCT02933723|influenza vaccine|influenza vaccine
4748557|NCT02933723|nursing home|nursing home
4748558|NCT02933723|influenza|influenza
4748559|NCT02933723|vaccination|vaccination
4748560|NCT02933723|immunity|immunity
4748561|NCT02933723|cell-mediated immunity|cell-mediated immunity
4748562|NCT02933723|humoral immunity|humoral immunity
4748563|NCT02933710|Japanese encephalitis|japanese encephalitis
4748564|NCT02933710|IMOJEV®|imojev®
4748565|NCT02933710|Japanese encephalitis chimeric virus vaccine|japanese encephalitis chimeric virus vaccine
4748566|NCT02933697|Atrial Fibrillation|atrial fibrillation
4748567|NCT02933697|Kidney disease|kidney disease
4748568|NCT02933697|Anticoagulation|anticoagulation
4748569|NCT02933671|suprainguinal fascia iliaca (SIFI)|suprainguinal fascia iliaca (sifi)
4748570|NCT02933671|nerve block|nerve block
4748571|NCT02933645|Insulin|insulin
4748572|NCT02933645|Intranasal|intranasal
4748573|NCT02933645|Glucose/metabolism|glucose/metabolism
4748574|NCT02933645|Glucose homeostasis|glucose homeostasis
4748575|NCT02933632|Osteoarthritis|osteoarthritis
4748576|NCT02933632|Physiotherapy|physiotherapy
4748577|NCT02933632|Rehabilitation|rehabilitation
4748578|NCT02933632|Clinical Trials|clinical trials
4748579|NCT02933632|Accelerated rehabilitation|accelerated rehabilitation
4748580|NCT02933632|Hip Replacement Arthroplasty|hip replacement arthroplasty
4748581|NCT02933554|bariatric surgery|bariatric surgery
4748582|NCT02933554|minimally invasive|minimally invasive
4748583|NCT02933554|Embolization|embolization
4748584|NCT02933554|NASH|nash
4748585|NCT02933554|ghrelin|ghrelin
4748586|NCT02933554|gastric artery embolization|gastric artery embolization
4748587|NCT02933515|yoga|yoga
4748588|NCT02933515|occupational therapy|occupational therapy
4748589|NCT02933515|stroke|stroke
4748590|NCT02933463|children with high caries risk|children with high caries risk
4748591|NCT02933437|Brugada syndrome|brugada syndrome
4748592|NCT02933437|SCN5A|scn5a
4748593|NCT02933437|SCN10A|scn10a
4748594|NCT02933437|Ajmaline|ajmaline
4748595|NCT02933411|Bleeding Disorders|bleeding disorders
4748596|NCT02933411|Heavy Menstrual Bleeding|heavy menstrual bleeding
4748597|NCT02933359|cranial vault|cranial vault
4748598|NCT02933359|calvarial trauma|calvarial trauma
4748599|NCT02933359|calvarial reconstruction|calvarial reconstruction
4748600|NCT02933320|Indolent B-cell Lymphoma|indolent b-cell lymphoma
4748601|NCT02933320|Chronic Lymphocytic Leukaemia|chronic lymphocytic leukaemia
4748602|NCT02933320|Waldenström Macroglobulinaemia|waldenström macroglobulinaemia
4748603|NCT02933320|BI-1206|bi-1206
4748604|NCT02933320|CD32b|cd32b
4748605|NCT02933294|uniportal|uniportal
4748606|NCT02933294|lung cancer|lung cancer
4748607|NCT02933294|VATS|vats
4748608|NCT02933268|Autosomal Dominant Polycystic Kidney Disease|autosomal dominant polycystic kidney disease
4748609|NCT02933268|Polycystic Kidney Disease|polycystic kidney disease
4748610|NCT02933268|ADPKD|adpkd
4748611|NCT02933268|Water|water
4748612|NCT02933268|Vasopressin|vasopressin
4748613|NCT02933268|Dietary|dietary
4748614|NCT02933255|Safety|safety
4748615|NCT02933255|Neoadjuvant|neoadjuvant
4748616|NCT02933255|Prostatectomy|prostatectomy
4748617|NCT02933255|Immunotherapy|immunotherapy
4748618|NCT02933255|Vaccine|vaccine
4748619|NCT02933242|Cancer|cancer
4748620|NCT02933216|Cesarean Scar Diverticula|cesarean scar diverticula
4748621|NCT02933177|Dementia|dementia
4748622|NCT02933177|Alzheimer disease|alzheimer disease
4748623|NCT02933177|Behavioral and Psychological Symptoms of Dementia|behavioral and psychological symptoms of dementia
4748624|NCT02933177|non-drug intervention|non-drug intervention
4748625|NCT02933138|Lipoprotein Lipase|lipoprotein lipase
4748626|NCT02933138|Hypertriglyceridemia|hypertriglyceridemia
4748627|NCT02933138|Triglycerides|triglycerides
4748628|NCT02933138|Lipolysis|lipolysis
4748629|NCT02933138|Multifactorial Chylomicronemia|multifactorial chylomicronemia
4748630|NCT02933125|substance abuse|substance abuse
4748631|NCT02933125|group psychotherapy|group psychotherapy
4748632|NCT02933125|family therapy|family therapy
4748633|NCT02933125|longitudinal study|longitudinal study
4748634|NCT02933125|child and adolescent|child and adolescent
4748635|NCT02933112|Oral appliance therapy|oral appliance therapy
4748636|NCT02933086|Pregnant|pregnant
4748637|NCT02933086|Low Back Pain|low back pain
4748638|NCT02933086|Postural Control|postural control
4748639|NCT02933060|intravenous fluid|intravenous fluid
4748640|NCT02933060|headache|headache
4748641|NCT02933047|Hysterectomy|hysterectomy
4748642|NCT02933047|Patient satisfaction|patient satisfaction
4748643|NCT02933047|Rehabilitation|rehabilitation
4748644|NCT02933047|Laparoscopy|laparoscopy
4748645|NCT02933047|Return to work|return to work
4748646|NCT02933047|Exercise|exercise
4748647|NCT02933034|ISCHEMIC OR CORONARY HEART DISEASE|ischemic or coronary heart disease
4748648|NCT02933034|MYOCARDIAL INFARCTION|myocardial infarction
4748649|NCT02933034|MAGNETIC RESONANCE IMAGING|magnetic resonance imaging
4748650|NCT02933034|DELAYED GADOLINIUM ENHANCEMENT MRI|delayed gadolinium enhancement mri
4748651|NCT02933034|MANGANESE-ENHANCED MRI|manganese-enhanced mri
4748652|NCT02933034|INFARCT VOLUME/SIZE|infarct volume/size
4748653|NCT02933034|ALL CAUSE MORTALITY|all cause mortality
4748654|NCT02933034|VENTRICULAR ARRHYTHMIAS|ventricular arrhythmias
4748655|NCT02933021|MGUS|mgus
4748656|NCT02933008|ACL|acl
4748657|NCT02933008|biofeedback|biofeedback
4748658|NCT02933008|injury prevention|injury prevention
4748659|NCT02933008|virtual reality|virtual reality
4748660|NCT02932995|Optical Coherence Tomography|optical coherence tomography
4748661|NCT02932995|Drug-Eluting Stent|drug-eluting stent
4748662|NCT02932982|primary care|primary care
4748663|NCT02932982|chest pain|chest pain
4748664|NCT02932982|dyspnea|dyspnea
4748665|NCT02932956|GPC3-Positive Solid Tumors|gpc3-positive solid tumors
4748666|NCT02932956|GPC3-CAR T cells|gpc3-car t cells
4748667|NCT02932956|GPC3|gpc3
4748668|NCT02932956|Glypican|glypican
4748669|NCT02932930|QLB|qlb
4748670|NCT02932930|Abdominoplasty|abdominoplasty
4748671|NCT02932930|Quadratus lumborum block|quadratus lumborum block
4748672|NCT02932904|Drug therapy|drug therapy
4748673|NCT02932865|azoospermia|azoospermia
4748674|NCT02932865|male fertility|male fertility
4748675|NCT02932865|MD-TESE|md-tese
4748676|NCT02932865|miRNA|mirna
4748677|NCT02932865|piRNA|pirna
4748678|NCT02932865|male infertility|male infertility
4748679|NCT02932852|stem cell|stem cell
4748680|NCT02932852|mesenchymal|mesenchymal
4748681|NCT02932852|ADASc|adasc
4748682|NCT02932852|transplantation|transplantation
4748683|NCT02932852|cornea|cornea
4748684|NCT02932852|corneal defects|corneal defects
4748685|NCT02932852|keratoconus|keratoconus
4748686|NCT02932852|scaffold|scaffold
4748687|NCT02932852|lamina|lamina
4748688|NCT02932839|Epilepsy surgery|epilepsy surgery
4748689|NCT02932839|Micro-electrode arrays|micro-electrode arrays
4748792|NCT02932267|Dark skin|dark skin
4748690|NCT02932839|Single-neuron recordings|single-neuron recordings
4748691|NCT02932839|Electrocorticography|electrocorticography
4748692|NCT02932826|Autoimmune Diabetes|autoimmune diabetes
4748693|NCT02932826|Umbilical Cord Blood Cell|umbilical cord blood cell
4748694|NCT02932826|Regulatory T Lymphocyte|regulatory t lymphocyte
4748695|NCT02932826|Cell Therapy|cell therapy
4748696|NCT02932800|Catheters|catheters
4748697|NCT02932800|Vascular Access Devices|vascular access devices
4748698|NCT02932800|Suture Techniques|suture techniques
4748699|NCT02932800|microbiota|microbiota
4748700|NCT02932800|Blood Circulation|blood circulation
4748701|NCT02932774|SAR|sar
4748702|NCT02932774|seasonal allergic rhinitis|seasonal allergic rhinitis
4748703|NCT02932774|hay fever|hay fever
4748704|NCT02932774|seasonal allergic rhinoconjunctivitis|seasonal allergic rhinoconjunctivitis
4748705|NCT02932761|cesarean scar diverticula|cesarean scar diverticula
4748706|NCT02932761|vaginal repair|vaginal repair
4748707|NCT02932761|GnRHa|gnrha
4748708|NCT02932722|Propofol|propofol
4748709|NCT02932722|Sevoflurane|sevoflurane
4748710|NCT02932722|Preconditioning|preconditioning
4748711|NCT02932709|Emergency|emergency
4748712|NCT02932709|follow-up|follow-up
4748713|NCT02932709|nurse|nurse
4748714|NCT02932709|phone|phone
4748715|NCT02932709|suicide attempts|suicide attempts
4748716|NCT02932683|Resuscitation|resuscitation
4748717|NCT02932683|Neonatal|neonatal
4748718|NCT02932683|Education|education
4748719|NCT02932644|Rheumatoid Arthritis|rheumatoid arthritis
4748720|NCT02932644|Cardiovascular event|cardiovascular event
4748721|NCT02932644|Cardiovascular mortality|cardiovascular mortality
4748722|NCT02932644|Vitamin D|vitamin d
4748723|NCT02932631|hemiparesis|hemiparesis
4748724|NCT02932631|STROKE|stroke
4748725|NCT02932631|neural plasticity|neural plasticity
4748726|NCT02932631|PHYSICAL THERAPY|physical therapy
4748727|NCT02932605|Schizophrenia|schizophrenia
4748728|NCT02932605|Cannabidiol|cannabidiol
4748729|NCT02932605|Magnetic Resonance Spectroscopy (1H-MRS)|magnetic resonance spectroscopy (1h-mrs)
4748730|NCT02932605|Microglia|microglia
4748731|NCT02932566|Heart failure|heart failure
4748732|NCT02932566|Heart failure with preserved ejection fraction (HFpEF)|heart failure with preserved ejection fraction (hfpef)
4748733|NCT02932566|Myocardial fibrosis|myocardial fibrosis
4748734|NCT02932566|Extracellular volume fraction (ECV)|extracellular volume fraction (ecv)
4748735|NCT02932566|Interstitial fibrosis|interstitial fibrosis
4748736|NCT02932553|bioresorbable vascular scaffold|bioresorbable vascular scaffold
4748737|NCT02932553|variant angina|variant angina
4748738|NCT02932553|moderate coronary artery disease|moderate coronary artery disease
4748739|NCT02932553|vasospastic angina|vasospastic angina
4748740|NCT02932527|cannabis|cannabis
4748741|NCT02932501|Bisphosphonate|bisphosphonate
4748742|NCT02932501|Jaw|jaw
4748743|NCT02932501|Osteonecrosis|osteonecrosis
4748744|NCT02932501|Antiresorptive drugs|antiresorptive drugs
4748745|NCT02932501|Denosumab|denosumab
4748746|NCT02932488|PET-MR|pet-mr
4748747|NCT02932488|5-HT1B receptor|5-ht1b receptor
4748748|NCT02932488|Sumatriptan|sumatriptan
4748749|NCT02932488|phMRI|phmri
4748750|NCT02932488|[11C]AZ10419369|[11c]az10419369
4748751|NCT02932436|empagliflozin|empagliflozin
4748752|NCT02932436|diastolic function|diastolic function
4748753|NCT02932436|poorly controlled type 2 diabetes mellitus|poorly controlled type 2 diabetes mellitus
4748754|NCT02932423|Sugar-sweetened beverage|sugar-sweetened beverage
4748755|NCT02932423|Overweight|overweight
4748756|NCT02932423|Obese|obese
4748757|NCT02932423|Sugar|sugar
4748758|NCT02932423|Water|water
4748759|NCT02932397|Ambulatory surgery|ambulatory surgery
4748760|NCT02932397|Perioperative outcomes|perioperative outcomes
4748761|NCT02932397|General anesthesia under desflurane|general anesthesia under desflurane
4748762|NCT02932397|Prevention of coughing|prevention of coughing
4748763|NCT02932397|Propofol|propofol
4748764|NCT02932384|HIV|hiv
4748765|NCT02932384|Black/African American|black/african american
4748766|NCT02932384|Men|men
4748767|NCT02932384|Gay/bisexual|gay/bisexual
4748768|NCT02932384|Los Angeles|los angeles
4748769|NCT02932371|Cardiac output|cardiac output
4748770|NCT02932358|Intensive care units|intensive care units
4748771|NCT02932358|Delirium|delirium
4748772|NCT02932358|Cross infection|cross infection
4748773|NCT02932358|Mortality|mortality
4748774|NCT02932358|Length of stay|length of stay
4748775|NCT02932358|Burnout, Professional|burnout, professional
4748776|NCT02932358|Depression|depression
4748777|NCT02932358|Anxiety|anxiety
4748778|NCT02932345|EGFR mutation; non-small-cell lung cancer;|egfr mutation; non-small-cell lung cancer;
4748779|NCT02932332|shortness of breath|shortness of breath
4748780|NCT02932332|oxygen|oxygen
4748781|NCT02932332|breathing therapies|breathing therapies
4748782|NCT02932319|induction of labour|induction of labour
4748783|NCT02932319|nulliparous|nulliparous
4748784|NCT02932319|prolonged pregnancy|prolonged pregnancy
4748785|NCT02932319|foley catheter|foley catheter
4748786|NCT02932319|vaginal birth|vaginal birth
4748787|NCT02932280|Recurrent|recurrent
4748788|NCT02932280|Refractory Disease|refractory disease
4748789|NCT02932280|Neratinib|neratinib
4748790|NCT02932280|16-878|16-878
4748791|NCT02932267|Acne|acne
4748793|NCT02932254|Physiological Effects of Drugs|physiological effects of drugs
4748794|NCT02932254|Rocuronium|rocuronium
4748795|NCT02932254|Sugammadex sodium|sugammadex sodium
4748796|NCT02932254|Magnesium|magnesium
4748797|NCT02932254|Neuromuscular block, antagonism|neuromuscular block, antagonism
4748798|NCT02932215|mobile health device|mobile health device
4748799|NCT02932215|substance abuse treatment|substance abuse treatment
4748800|NCT02932215|quality of life|quality of life
4748801|NCT02932215|lorcaserin|lorcaserin
4748802|NCT02932202|Obesity|obesity
4748803|NCT02932202|Pregnancy|pregnancy
4748804|NCT02932202|Weight Gain|weight gain
4748805|NCT02932189|Mechanical Ventilator Weaning|mechanical ventilator weaning
4748806|NCT02932189|Respiratory Muscle Training|respiratory muscle training
4748807|NCT02932189|Mortality Rate|mortality rate
4748808|NCT02932176|Arteries|arteries
4748809|NCT02932163|Chronic low back pain|chronic low back pain
4748810|NCT02932163|disability|disability
4748811|NCT02932163|endurance|endurance
4748812|NCT02932150|CHB|chb
4748813|NCT02932150|HBV|hbv
4748814|NCT02932137|SLE,IL-2|sle,il-2
4748815|NCT02932124|German Resuscitation Registry|german resuscitation registry
4748816|NCT02932124|out-of-hospital cardiac arrest|out-of-hospital cardiac arrest
4748817|NCT02932124|cardiopulmonary resuscitation|cardiopulmonary resuscitation
4748818|NCT02932124|mechanical chest compression devices|mechanical chest compression devices
4748819|NCT02932111|IBS|ibs
4748820|NCT02932111|Osteopathic manipulative treatment|osteopathic manipulative treatment
4748821|NCT02932111|pain|pain
4748822|NCT02932085|Transcranial magnetic stimulation|transcranial magnetic stimulation
4748823|NCT02932085|Magnetic resonance imaging|magnetic resonance imaging
4748824|NCT02932085|Magnetic resonance spectroscopy|magnetic resonance spectroscopy
4748825|NCT02932059|Metamemory|metamemory
4748826|NCT02932059|Schizophrenia|schizophrenia
4748827|NCT02932059|Aging|aging
4748828|NCT02932059|Learning|learning
4748829|NCT02932059|Judgement of learning|judgement of learning
4748830|NCT02932059|Sentence construction strategy|sentence construction strategy
4748831|NCT02932046|eating disorders|eating disorders
4748832|NCT02932046|anorexia nervosa|anorexia nervosa
4748833|NCT02932046|appetite|appetite
4748834|NCT02932020|disc herniation|disc herniation
4748835|NCT02932020|spinal stenosis|spinal stenosis
4748836|NCT02932007|persistent|persistent
4748837|NCT02932007|longstanding persistent|longstanding persistent
4748838|NCT02931994|dental floss|dental floss
4748839|NCT02931994|gingival embrasure|gingival embrasure
4748840|NCT02931994|oral hygiene|oral hygiene
4748841|NCT02931981|DKK4|dkk4
4748842|NCT02931981|Gastrointestinal Stromal Tumor|gastrointestinal stromal tumor
4748843|NCT02931981|Biomarker|biomarker
4748844|NCT02931968|Monolithic Zirconia|monolithic zirconia
4748845|NCT02931968|Implant supported prosthesis|implant supported prosthesis
4748846|NCT02931968|Fixed partial denture|fixed partial denture
4748847|NCT02931955|allergy|allergy
4748848|NCT02931955|insect venom|insect venom
4748849|NCT02931955|pollen|pollen
4748850|NCT02931955|systems biology|systems biology
4748851|NCT02931942|AA|aa
4748852|NCT02931916|smart-phone|smart-phone
4748853|NCT02931916|assessment|assessment
4748854|NCT02931916|chronic ankle instability|chronic ankle instability
4748855|NCT02931903|implant supported restorations|implant supported restorations
4748856|NCT02931903|IPS Emax (lithium disilicate glass-ceramic)|ips emax (lithium disilicate glass-ceramic)
4748857|NCT02931903|Vita Enamic (hybrid dental ceramic)|vita enamic (hybrid dental ceramic)
4748858|NCT02931903|implant survival|implant survival
4748859|NCT02931903|peri-implant tissue response|peri-implant tissue response
4748860|NCT02931890|gastric cancer|gastric cancer
4748861|NCT02931890|radiotherapy|radiotherapy
4748862|NCT02931890|chemoradiotherapy|chemoradiotherapy
4748863|NCT02931877|Sevoflurane|sevoflurane
4748864|NCT02931877|Propofol|propofol
4748865|NCT02931877|Cardiac valvular surgery|cardiac valvular surgery
4748866|NCT02931877|Cardiopulmonary bypass|cardiopulmonary bypass
4748867|NCT02931877|Postoperative cognitive dysfunction|postoperative cognitive dysfunction
4748868|NCT02931825|high risk|high risk
4748869|NCT02931825|surveillance|surveillance
4748870|NCT02931825|screening|screening
4748871|NCT02931825|colonoscopy|colonoscopy
4748872|NCT02931812|cirrhosis|cirrhosis
4748873|NCT02931812|reward system|reward system
4748874|NCT02931812|taste sensitivity|taste sensitivity
4748875|NCT02931812|chronic renal failure|chronic renal failure
4748876|NCT02931799|Colitis, Ulcerative|colitis, ulcerative
4748877|NCT02931799|Crohn Disease|crohn disease
4748878|NCT02931799|Inflammatory Bowel Diseases|inflammatory bowel diseases
4748879|NCT02931799|Gastroenterology|gastroenterology
4748880|NCT02931799|Quality Improvement|quality improvement
4748881|NCT02931799|Post-Discharge|post-discharge
4748882|NCT02931786|core body temperature|core body temperature
4748883|NCT02931786|magnetic resonance imaging|magnetic resonance imaging
4748884|NCT02931786|propofol|propofol
4748885|NCT02931786|ketofol|ketofol
4748886|NCT02931773|Diabetes Autonomic Cardiovascular|diabetes autonomic cardiovascular
4748887|NCT02931747|Bacopa Monnieri|bacopa monnieri
4748888|NCT02931747|Working memory|working memory
4748889|NCT02931747|Cognitive processing|cognitive processing
4748890|NCT02931747|Student|student
4748891|NCT02931721|Azospermia|azospermia
4748892|NCT02931721|Micro Dissection Testicular Sperm Extraction|micro dissection testicular sperm extraction
4748893|NCT02931721|Male infertility|male infertility
4748894|NCT02931721|Testis|testis
4748895|NCT02931721|MRI|mri
4748896|NCT02931708|Heart Failure|heart failure
4748897|NCT02931708|Diaphragm|diaphragm
4748898|NCT02931708|Electrical Stimulation|electrical stimulation
4748899|NCT02931695|post partum|post partum
4748900|NCT02931682|Creatine transporter|creatine transporter
4748901|NCT02931682|developmental delay|developmental delay
4748902|NCT02931682|intellectual disability|intellectual disability
4748903|NCT02931682|X-linked|x-linked
4748904|NCT02931682|language|language
4748905|NCT02931682|seizure|seizure
4748906|NCT02931682|observational|observational
4748907|NCT02931682|brain spectroscopy|brain spectroscopy
4748908|NCT02931656|Gestational Diabetes|gestational diabetes
4748909|NCT02931643|Spices|spices
4748910|NCT02931643|Functional food|functional food
4748911|NCT02931643|Cardiometabolic risk|cardiometabolic risk
4748912|NCT02931643|Metabolic syndrome|metabolic syndrome
4748913|NCT02931643|Inflammation|inflammation
4748914|NCT02931643|Peripheral blood mononuclear cell|peripheral blood mononuclear cell
4748915|NCT02931643|Acute|acute
4748916|NCT02931643|miRNA|mirna
4748917|NCT02931630|Whey protein|whey protein
4748918|NCT02931630|Dietary fibers|dietary fibers
4748919|NCT02931630|Wheat bran|wheat bran
4748920|NCT02931630|Arabinoxylan|arabinoxylan
4748921|NCT02931630|Postprandial lipaemia|postprandial lipaemia
4748922|NCT02931630|Body composition|body composition
4748923|NCT02931630|Blood pressure|blood pressure
4748924|NCT02931630|Metabolic rate|metabolic rate
4748925|NCT02931630|Insulin sensitivity|insulin sensitivity
4748926|NCT02931630|Metabolic syndrome|metabolic syndrome
4748927|NCT02931604|sinus wash|sinus wash
4748928|NCT02931604|sinus lavage|sinus lavage
4748929|NCT02931604|Sinusitis|sinusitis
4748930|NCT02931591|Small for gestational age|small for gestational age
4748931|NCT02931591|insulin sensitivity|insulin sensitivity
4748932|NCT02931591|IGF-1 response|igf-1 response
4748933|NCT02931591|growth hormone treatment|growth hormone treatment
4748934|NCT02931578|glycemic index|glycemic index
4748935|NCT02931552|Breast cancer|breast cancer
4748936|NCT02931552|Latinas|latinas
4748937|NCT02931552|Peer support counselor|peer support counselor
4748938|NCT02931552|Spanish speaking|spanish speaking
4748939|NCT02931552|Community based|community based
4748940|NCT02931552|Rural|rural
4748941|NCT02931526|Tigecycline|tigecycline
4748942|NCT02931526|Continuous Renal Replacement Therapy|continuous renal replacement therapy
4748943|NCT02931526|Pharmacokinetics|pharmacokinetics
4748944|NCT02931500|machine learning|machine learning
4748945|NCT02931500|cohort study|cohort study
4748946|NCT02931474|Growth Hormone|growth hormone
4748947|NCT02931474|Traumatic Brain Injury|traumatic brain injury
4748948|NCT02931474|Insomnia|insomnia
4748949|NCT02931474|Polysomnography|polysomnography
4748950|NCT02931474|NREM Sleep|nrem sleep
4748951|NCT02931461|endobronchial transbronchial needle aspiration lung cancer procore|endobronchial transbronchial needle aspiration lung cancer procore
4748952|NCT02931448|Device assessment|device assessment
4748953|NCT02931435|Genicular Radiofrequency Ablation|genicular radiofrequency ablation
4748954|NCT02931435|Knee Arthroplasty, Total|knee arthroplasty, total
4748955|NCT02931422|HIV|hiv
4748956|NCT02931422|financial incentive|financial incentive
4748957|NCT02931422|pediatric HIV testing|pediatric hiv testing
4748958|NCT02931409|Positive end-expiratory pressure|positive end-expiratory pressure
4748959|NCT02931409|Static pulmonary compliance|static pulmonary compliance
4748960|NCT02931409|Lung Protective Ventilation|lung protective ventilation
4748961|NCT02931409|Radical cystectomy and urinary diversion|radical cystectomy and urinary diversion
4748962|NCT02931409|Postoperative pulmonary complications|postoperative pulmonary complications
4748963|NCT02931409|Procalcitonin|procalcitonin
4748964|NCT02931383|Liraglutide|liraglutide
4748965|NCT02931383|Liraglutide 3 mg|liraglutide 3 mg
4748966|NCT02931383|Osteoarthritis|osteoarthritis
4748967|NCT02931383|Obesity|obesity
4748968|NCT02931383|Ultrasound|ultrasound
4748969|NCT02931370|Osteoarthritis|osteoarthritis
4748970|NCT02931370|Obesity|obesity
4748971|NCT02931370|Ultrasound|ultrasound
4748972|NCT02931370|Liraglutide|liraglutide
4748973|NCT02931370|Liraglutide 3mg|liraglutide 3mg
4748974|NCT02931357|Treatment of teething in infants|treatment of teething in infants
4748975|NCT02931344|Osteoarthrtis|osteoarthrtis
4748976|NCT02931344|Obesity|obesity
4748977|NCT02931344|Liraglutide 3 mg|liraglutide 3 mg
4748978|NCT02931344|Liraglutide|liraglutide
4748979|NCT02931344|Biomarkers|biomarkers
4748980|NCT02931318|Organ donation|organ donation
4748981|NCT02931318|brain death|brain death
4748982|NCT02931318|public opinion|public opinion
4748983|NCT02931305|Epimedium prenylflavonoids|epimedium prenylflavonoids
4748984|NCT02931305|Osteoporosis|osteoporosis
4748985|NCT02931305|Cardiovascular diseases|cardiovascular diseases
4748986|NCT02931305|Phase 1|phase 1
4748987|NCT02931305|safety|safety
4748988|NCT02931305|tolerability|tolerability
4748989|NCT02931292|sleeve gastrectomy|sleeve gastrectomy
4748990|NCT02931292|laparoscopy|laparoscopy
4748991|NCT02931292|bariatric surgery|bariatric surgery
4748992|NCT02931292|obesity surgery|obesity surgery
4748993|NCT02931292|metabolic surgery|metabolic surgery
4748994|NCT02931214|Healthy Subjects|healthy subjects
4748995|NCT02931214|Pharmacokinetics|pharmacokinetics
4748996|NCT02931214|Pharmacodynamics|pharmacodynamics
4748997|NCT02931201|Positron-Emission Tomography|positron-emission tomography
4748998|NCT02931201|Prognosis|prognosis
4748999|NCT02931188|Vascular Diseases|vascular diseases
4749000|NCT02931188|Lipids|lipids
4749001|NCT02931188|Cholesteryl Ester Transfer Protein (CETP) Inhibition|cholesteryl ester transfer protein (cetp) inhibition
4749002|NCT02931188|Anacetrapib|anacetrapib
4749003|NCT02931188|Cardiovascular Disease|cardiovascular disease
4749004|NCT02931188|Cholesterol|cholesterol
4749005|NCT02931175|ACTH gel|acth gel
4749006|NCT02931175|Non-Infectious Uveitis|non-infectious uveitis
4749007|NCT02931175|ACTHAR|acthar
4749008|NCT02931175|Posterior Uveitis|posterior uveitis
4749009|NCT02931175|Intermediate Uveitis|intermediate uveitis
4749010|NCT02931175|Pan Uveitis|pan uveitis
4749011|NCT02931175|Uveitis|uveitis
4749012|NCT02931149|platelet-rich plasma|platelet-rich plasma
4749013|NCT02931149|endoscopic mucosal resection|endoscopic mucosal resection
4749014|NCT02931149|endoscopic submucosal dissection|endoscopic submucosal dissection
4749015|NCT02931110|Diffuse large B-cell lymphoma (DLBCL)|diffuse large b-cell lymphoma (dlbcl)
4749016|NCT02931110|follicular lymphoma (FL)|follicular lymphoma (fl)
4749017|NCT02931110|mantle cell lymphoma (MCL)|mantle cell lymphoma (mcl)
4749018|NCT02931110|Hodgkin lymphoma (HL)|hodgkin lymphoma (hl)
4749019|NCT02931110|Chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL)|chronic lymphocytic leukemia/small lymphocytic lymphoma (cll/sll)
4749020|NCT02931110|Multiple myeloma (MM)|multiple myeloma (mm)
4749021|NCT02931097|Parkinson's disease|parkinson's disease
4749022|NCT02931097|Deep brain stimulation|deep brain stimulation
4749023|NCT02931097|Mesencephalic locomotor region|mesencephalic locomotor region
4749024|NCT02931058|Knee-extension exercise|knee-extension exercise
4749025|NCT02931058|Quadriceps exercise|quadriceps exercise
4749026|NCT02931058|Knee osteoarthritis|knee osteoarthritis
4749027|NCT02931058|Exercise adherence|exercise adherence
4749028|NCT02931058|Dose-response relationship|dose-response relationship
4749029|NCT02931058|Prehabilitation|prehabilitation
4749030|NCT02931045|extracellular vesicles|extracellular vesicles
4749031|NCT02931045|inflammation|inflammation
4749032|NCT02931045|thrombosis|thrombosis
4749033|NCT02931045|antiplatelet drugs|antiplatelet drugs
4749034|NCT02931032|nano receptor|nano receptor
4749035|NCT02931032|oral microbiology|oral microbiology
4749036|NCT02931032|dental caries|dental caries
4749037|NCT02931032|periodontal disease|periodontal disease
4749038|NCT02931019|fiberoptic|fiberoptic
4749039|NCT02931019|intubation|intubation
4749040|NCT02931019|posture|posture
4749041|NCT02930954|NSCLC, EGFR, Bim, mutation abundance|nsclc, egfr, bim, mutation abundance
4749042|NCT02930941|tranexamic acid|tranexamic acid
4749043|NCT02930941|epistaxis|epistaxis
4749044|NCT02930941|emergency medicine|emergency medicine
4749045|NCT02930941|intranasal|intranasal
4749046|NCT02930941|TXA|txa
4749047|NCT02930928|Anaesthesia|anaesthesia
4749048|NCT02930928|Anthropometry|anthropometry
4749049|NCT02930928|Body weight and measures|body weight and measures
4749050|NCT02930928|Development|development
4749051|NCT02930928|Emergency treatment|emergency treatment
4749052|NCT02930928|Patient safety|patient safety
4749053|NCT02930915|Head and Neck Cancer|head and neck cancer
4749054|NCT02930915|Radiotherapy|radiotherapy
4749055|NCT02930902|Pancreatic Cancer|pancreatic cancer
4749056|NCT02930902|Pembrolizumab|pembrolizumab
4749057|NCT02930902|MK3475|mk3475
4749058|NCT02930902|Paricalcitol|paricalcitol
4749059|NCT02930902|Zemplar|zemplar
4749060|NCT02930902|Gemcitabine|gemcitabine
4749061|NCT02930902|Hydrochloride Gemzar|hydrochloride gemzar
4749062|NCT02930902|Nab-paclitaxel|nab-paclitaxel
4749063|NCT02930902|Paclitaxel|paclitaxel
4749064|NCT02930902|Abraxane|abraxane
4749065|NCT02930902|ABI-007|abi-007
4749066|NCT02930902|Resectable Pancreatic Cancer|resectable pancreatic cancer
4749067|NCT02930889|Therapeutic Embolization|therapeutic embolization
4749068|NCT02930889|Prostatic Artery Embolization|prostatic artery embolization
4749069|NCT02930876|sarcopenia|sarcopenia
4749070|NCT02930876|cancer|cancer
4749071|NCT02930876|chemotherapy|chemotherapy
4749072|NCT02930876|palliative care|palliative care
4749073|NCT02930876|resistance training|resistance training
4749074|NCT02930733|Postoperative Analgesia|postoperative analgesia
4749075|NCT02930733|Ultrasound guided serratus plane block|ultrasound guided serratus plane block
4749076|NCT02930720|TAUS|taus
4749077|NCT02930720|breathing protocols and cough|breathing protocols and cough
4749078|NCT02930720|pelvic floor displacement|pelvic floor displacement
4749079|NCT02930720|women|women
4749080|NCT02930720|SUI|sui
4749081|NCT02930707|magnesium sulfate|magnesium sulfate
4749082|NCT02930707|postoperative pain|postoperative pain
4749083|NCT02930707|TAP block|tap block
4749084|NCT02930707|total abdominal hysterectomy|total abdominal hysterectomy
4749085|NCT02930655|Fabry disease|fabry disease
4749086|NCT02930655|lucerastat|lucerastat
4749087|NCT02930642|Mindfulness|mindfulness
4749088|NCT02930642|Obesity|obesity
4749089|NCT02930642|Food insecurity|food insecurity
4749090|NCT02930642|Delay discounting|delay discounting
4749091|NCT02930629|Recovery Period, Anesthesia|recovery period, anesthesia
4749092|NCT02930629|Neuromuscular Monitoring|neuromuscular monitoring
4749093|NCT02930603|Developmental Disabilities|developmental disabilities
4749094|NCT02930603|Body function and body structure|body function and body structure
4749095|NCT02930603|Participation|participation
4749096|NCT02930603|Life activities|life activities
4749097|NCT02930603|Quality of Life|quality of life
4749098|NCT02930577|treatment adherence|treatment adherence
4749099|NCT02930577|outpatient treatment|outpatient treatment
4749100|NCT02930577|drug dependence|drug dependence
4749101|NCT02930525|apnea|apnea
4749102|NCT02930525|children|children
4749103|NCT02930525|hypercarbia|hypercarbia
4749104|NCT02930525|procedural sedation|procedural sedation
4749105|NCT02930525|HFNC|hfnc
4749106|NCT02930512|Bone mineral density|bone mineral density
4749107|NCT02930512|Osteoporosis|osteoporosis
4749108|NCT02930512|Parkinson's disease|parkinson's disease
4749109|NCT02930512|Bone turnover markers|bone turnover markers
4749110|NCT02930486|Syndesmosis|syndesmosis
4749111|NCT02930486|Injury|injury
4749112|NCT02930486|Ankle|ankle
4749113|NCT02930486|Fracture|fracture
4749114|NCT02930486|Weber C|weber c
4749115|NCT02930473|Psychotherapy|psychotherapy
4749116|NCT02930473|Nursing|nursing
4749117|NCT02930473|Nursing Care|nursing care
4749118|NCT02930473|Nursing Model|nursing model
4749119|NCT02930473|Randomised Controlled Trial|randomised controlled trial
4749120|NCT02930434|Vitamin D|vitamin d
4749121|NCT02930434|cholecalciferol|cholecalciferol
4749122|NCT02930434|Antarctica|antarctica
4749123|NCT02930434|Chile|chile
4749124|NCT02930434|cathelicidin|cathelicidin
4749125|NCT02930434|bone metabolism|bone metabolism
4749126|NCT02930434|cardiovascular risk|cardiovascular risk
4749127|NCT02930421|mild COPD|mild copd
4749128|NCT02930421|Exercise training|exercise training
4749129|NCT02930421|Six minute walking distance|six minute walking distance
4749130|NCT02930421|Quality of life|quality of life
4749131|NCT02930421|Saint George Respiratory Questionnaire (SGRQ)|saint george respiratory questionnaire (sgrq)
4749132|NCT02930395|Concussion|concussion
4749133|NCT02930395|Professional rugby players|professional rugby players
4749134|NCT02930395|S100B|s100b
4749135|NCT02930330|Exercise|exercise
4749136|NCT02930330|Interval training|interval training
4749137|NCT02930330|Blood platelets|blood platelets
4749138|NCT02930330|Platelet function tests|platelet function tests
4749139|NCT02930330|Physical fitness|physical fitness
4749140|NCT02930330|Rehabilitation|rehabilitation
4749141|NCT02930304|tennis elbow|tennis elbow
4749142|NCT02930304|pain|pain
4749143|NCT02930304|shock wave|shock wave
4749144|NCT02930304|kinesio taping|kinesio taping
4749145|NCT02930252|Self-expandable metal stent|self-expandable metal stent
4749146|NCT02930252|strictures|strictures
4749147|NCT02930252|biliary|biliary
4749148|NCT02930239|ACL-reconstruction|acl-reconstruction
4749149|NCT02930239|Gait rehabilitation|gait rehabilitation
4749150|NCT02930239|Anti Gravity treadmill|anti gravity treadmill
4749151|NCT02930239|ACL-rehabilitation|acl-rehabilitation
4749152|NCT02930213|unresponsive wakefulness syndrome|unresponsive wakefulness syndrome
4749153|NCT02930213|minimally conscious state|minimally conscious state
4749154|NCT02930213|circadian rhythms|circadian rhythms
4749155|NCT02930213|free-running period|free-running period
4749156|NCT02930200|Smoking Cessation|smoking cessation
4749157|NCT02930200|Smartphone Based Smoking Cessation|smartphone based smoking cessation
4749158|NCT02930187|Rheumatoid arthritis, remission, ultrasound|rheumatoid arthritis, remission, ultrasound
4749159|NCT02930161|Nonalcoholic Fatty Liver Disease|nonalcoholic fatty liver disease
4749160|NCT02930161|Nonalcoholic Steatohepatitis|nonalcoholic steatohepatitis
4749161|NCT02930161|Methionine|methionine
4749162|NCT02930161|Succinic acid|succinic acid
4749163|NCT02930148|mHealth|mhealth
4749164|NCT02930148|adolescents|adolescents
4749165|NCT02930148|quasi-experimental study|quasi-experimental study
4749166|NCT02930148|apps|apps
4749167|NCT02930148|lifestyles|lifestyles
4749168|NCT02930148|lifestyles knowledge|lifestyles knowledge
4749169|NCT02930148|dietary behaviour|dietary behaviour
4749170|NCT02930148|physical activity|physical activity
4749171|NCT02930148|sleeping behaviour|sleeping behaviour
4749172|NCT02930135|Indirect Pulp Capping, Young Permanent Molars|indirect pulp capping, young permanent molars
4749173|NCT02930070|sepsis|sepsis
4749174|NCT02930070|qSOFA|qsofa
4749175|NCT02930070|SOFA|sofa
4749176|NCT02930070|diagnostic accuracy|diagnostic accuracy
4749177|NCT02930057|lumbar dorsal root ganglion|lumbar dorsal root ganglion
4749178|NCT02930057|transforaminal epidural steroid injection|transforaminal epidural steroid injection
4749179|NCT02930057|chronic lumbosacral radicular pain|chronic lumbosacral radicular pain
4749180|NCT02930057|pulsed radiofrequency treatment|pulsed radiofrequency treatment
4749181|NCT02930057|betamethasone|betamethasone
4749182|NCT02930057|dorsal root ganglion|dorsal root ganglion
4749183|NCT02930044|Emergency department|emergency department
4749184|NCT02930044|Insulin|insulin
4749185|NCT02930044|Adult|adult
4749186|NCT02930031|muscle injury|muscle injury
4749187|NCT02930031|exercise|exercise
4749188|NCT02930031|redox status|redox status
4749189|NCT02930031|immune cells|immune cells
4749190|NCT02930018|Acute Ischemic Stroke|acute ischemic stroke
4749191|NCT02930018|Endovascular Thrombectomy|endovascular thrombectomy
4749192|NCT02930018|Neuroprotection|neuroprotection
4749193|NCT02930018|Tat-NR2B9c|tat-nr2b9c
4749194|NCT02930018|NA-1|na-1
4749195|NCT02930005|Psychotic|psychotic
4749196|NCT02930005|Schizophrenia|schizophrenia
4749197|NCT02930005|Schizoaffective|schizoaffective
4749198|NCT02930005|Bipolar|bipolar
4749199|NCT02929979|PTSD|ptsd
4749200|NCT02929979|Alcohol Use Disorder|alcohol use disorder
4749201|NCT02929979|Cognitive Training|cognitive training
4749202|NCT02929979|Veterans|veterans
4749203|NCT02929953|premature birth|premature birth
4749204|NCT02929953|risk factor|risk factor
4749205|NCT02929953|type 1 diabetes mellitus|type 1 diabetes mellitus
4749206|NCT02929953|seasonality|seasonality
4749207|NCT02929953|prevalence|prevalence
4749208|NCT02929953|enteral feeding|enteral feeding
4749209|NCT02929953|immunomodulating medications|immunomodulating medications
4749210|NCT02929953|early onset|early onset
4749211|NCT02929927|PDT|pdt
4749212|NCT02929914|Carious dentin|carious dentin
4749213|NCT02929914|Photodynamic Therapy|photodynamic therapy
4749214|NCT02929888|ST-segment elevacion myocardial infarction, platelets|st-segment elevacion myocardial infarction, platelets
4749215|NCT02929836|Ablation Linear Lesions|ablation linear lesions
4749216|NCT02929797|pancreatic cancer|pancreatic cancer
4749217|NCT02929784|Hemiplegic Shoulder Pain|hemiplegic shoulder pain
4749218|NCT02929784|transcranial Direct Current Stimulation|transcranial direct current stimulation
4749219|NCT02929784|Stroke|stroke
4749220|NCT02929771|Virtual Reality|virtual reality
4749221|NCT02929771|Subcutaneous Port Sampling|subcutaneous port sampling
4749222|NCT02929771|Pain|pain
4749223|NCT02929771|Children|children
4749224|NCT02929745|immunology, genetics|immunology, genetics
4749225|NCT02929667|Fluoxetine|fluoxetine
4749226|NCT02929641|Optical Enhancement technology|optical enhancement technology
4749227|NCT02929641|coloractal polyp prediction|coloractal polyp prediction
4749228|NCT02929602|prescribing|prescribing
4749229|NCT02929602|effectiveness|effectiveness
4749230|NCT02929602|dental|dental
4749231|NCT02929602|opioid|opioid
4749232|NCT02929602|analgesic|analgesic
4749233|NCT02929576|metastatic|metastatic
4749234|NCT02929576|triple negative|triple negative
4749235|NCT02929550|Cardiovascular disease|cardiovascular disease
4749236|NCT02929550|Costs|costs
4749237|NCT02929550|Guidelines|guidelines
4749238|NCT02929550|Lipids|lipids
4749239|NCT02929550|Myocardial infarction|myocardial infarction
4749240|NCT02929537|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
4749241|NCT02929537|registration research|registration research
4749242|NCT02929537|Medicine, Chinese Traditional|medicine, chinese traditional
4749243|NCT02929524|Ketamine|ketamine
4749244|NCT02929524|Intranasal administration|intranasal administration
4749245|NCT02929524|Pediatric nursing|pediatric nursing
4749246|NCT02929498|GSK2879552|gsk2879552
4749247|NCT02929498|Revised International Prognostic Scoring System (IPSS-R)|revised international prognostic scoring system (ipss-r)
4749248|NCT02929498|azacitidine|azacitidine
4749249|NCT02929498|hypomethylating agents|hypomethylating agents
4749250|NCT02929498|myelodysplastic syndrome|myelodysplastic syndrome
4749251|NCT02929472|Physical Activity|physical activity
4749252|NCT02929472|Physical Fitness|physical fitness
4749253|NCT02929472|Intervention|intervention
4749254|NCT02929472|Children and Adolescents|children and adolescents
4749255|NCT02929459|Gut Microbiota|gut microbiota
4749256|NCT02929459|Riboflavin|riboflavin
4749257|NCT02929459|Vitamin B2|vitamin b2
4749258|NCT02929459|oGTT|ogtt
4749259|NCT02929459|Faecalibacterium prausnitzii|faecalibacterium prausnitzii
4749260|NCT02929446|mobilisation|mobilisation
4749261|NCT02929446|physiotherapy|physiotherapy
4749262|NCT02929433|disability|disability
4749263|NCT02929433|pain|pain
4749264|NCT02929433|Rotator Cuff Tear|rotator cuff tear
4749265|NCT02929433|rehabilitation|rehabilitation
4749266|NCT02929433|range of motion (ROM)|range of motion (rom)
4749267|NCT02929420|Multicenter|multicenter
4749268|NCT02929420|randomized|randomized
4749269|NCT02929420|open|open
4749270|NCT02929420|parallel controlled|parallel controlled
4749271|NCT02929394|Histologically proven locally advanced or metastatic high grade STS (excluding histologies insensitive to chemotherapy such as ASPS, PECOMA subtypes)|histologically proven locally advanced or metastatic high grade sts (excluding histologies insensitive to chemotherapy such as asps, pecoma subtypes)
4749272|NCT02929381|Narrow Band Imaging|narrow band imaging
4749273|NCT02929381|Colorectal Cancer Screening|colorectal cancer screening
4749274|NCT02929381|Colonoscopy|colonoscopy
4749275|NCT02929381|Responsive Insertion Technology|responsive insertion technology
4749276|NCT02929381|Near Focus|near focus
4749277|NCT02929368|PICC-Line|picc-line
4749278|NCT02929355|Carotid atherosclerosis|carotid atherosclerosis
4749279|NCT02929355|duplex ultrasonography|duplex ultrasonography
4749280|NCT02929355|diabetes|diabetes
4749281|NCT02929355|vascular events|vascular events
4749282|NCT02929277|farm children|farm children
4749283|NCT02929277|non-farm children|non-farm children
4749284|NCT02929264|Healthy volunteer|healthy volunteer
4749285|NCT02929264|Experimental hyperalgesia|experimental hyperalgesia
4749286|NCT02929264|fMRI|fmri
4749287|NCT02929225|bacterial translocation;micro-inflammation;hemodialysis|bacterial translocation;micro-inflammation;hemodialysis
4749288|NCT02929212|Gastric Bypass|gastric bypass
4749289|NCT02929212|Meal Texture|meal texture
4749290|NCT02929212|Meal Number|meal number
4749291|NCT02929212|GLP-1|glp-1
4749292|NCT02929212|Glucose|glucose
4749293|NCT02929134|Lymphedema|lymphedema
4749294|NCT02929134|Lymphatic Filariasis|lymphatic filariasis
4749295|NCT02929134|Filariasis|filariasis
4749296|NCT02929134|Doxycycline|doxycycline
4749297|NCT02929121|Lymphedema|lymphedema
4749298|NCT02929121|Lymphatic Filariasis|lymphatic filariasis
4749299|NCT02929121|Filariasis|filariasis
4749300|NCT02929121|Doxycycline|doxycycline
4749301|NCT02929108|hospice|hospice
4749302|NCT02929108|caregiver|caregiver
4749303|NCT02929082|magnetic resonance force|magnetic resonance force
4749304|NCT02929069|Minority Stress|minority stress
4749305|NCT02929017|Idiopathic Pulmonary Fibrosis|idiopathic pulmonary fibrosis
4749306|NCT02929017|Fibrosis|fibrosis
4749308|NCT02929017|Caregivers|caregivers
4749309|NCT02929017|Pulmonary|pulmonary
4749310|NCT02929017|Palliative|palliative
4749311|NCT02929017|end of life|end of life
4749312|NCT02929017|Idiopathic|idiopathic
4749313|NCT02929004|Anterior Cruciate Ligament Reconstruction|anterior cruciate ligament reconstruction
4749314|NCT02929004|Local vibration training|local vibration training
4749315|NCT02929004|Ligamentoplasty|ligamentoplasty
4749316|NCT02929004|Anterior cruciate ligament|anterior cruciate ligament
4749317|NCT02929004|Corticospinal excitability|corticospinal excitability
4749318|NCT02929004|Elastography|elastography
4749319|NCT02929004|Knee extensor muscles|knee extensor muscles
4749320|NCT02929004|Readaptation|readaptation
4749321|NCT02928991|Acquired aplastic anemia|acquired aplastic anemia
4749322|NCT02928991|Inherited bone marrow failure|inherited bone marrow failure
4749323|NCT02928978|Premalignant Breast Disease|premalignant breast disease
4749324|NCT02928978|ALH|alh
4749325|NCT02928978|ADH|adh
4749326|NCT02928978|DCIS|dcis
4749327|NCT02928978|LCIS|lcis
4749328|NCT02928978|Breast Cancer Prevention|breast cancer prevention
4749329|NCT02928978|Ruxolitinib|ruxolitinib
4749330|NCT02928965|psychosis|psychosis
4749331|NCT02928965|schizophrenia|schizophrenia
4749332|NCT02928965|negative symptoms|negative symptoms
4749333|NCT02928965|minocycline|minocycline
4749334|NCT02928952|Mindfulness|mindfulness
4749335|NCT02928939|multimorbidity|multimorbidity
4749336|NCT02928939|multiple chronic conditions|multiple chronic conditions
4749337|NCT02928939|drug-drug interactions|drug-drug interactions
4749338|NCT02928939|drug-disease interactions|drug-disease interactions
4749339|NCT02928939|polypharmacy|polypharmacy
4749340|NCT02928939|Oral anticoagulants|oral anticoagulants
4749341|NCT02928939|Steroids|steroids
4749342|NCT02928913|sedentary|sedentary
4749343|NCT02928913|non-sedentary|non-sedentary
4749344|NCT02928913|populations|populations
4749345|NCT02928900|Adolescents|adolescents
4749346|NCT02928900|Clinical training|clinical training
4749347|NCT02928900|HIV care and treatment|hiv care and treatment
4749348|NCT02928900|Africa|africa
4749349|NCT02928861|Positron-Emission Tomography|positron-emission tomography
4749350|NCT02928861|Prognosis|prognosis
4749351|NCT02928835|Total knee arthroplasty|total knee arthroplasty
4749352|NCT02928835|Knee flexion|knee flexion
4749353|NCT02928835|Dynamic orthosis|dynamic orthosis
4749354|NCT02928822|stroke|stroke
4749355|NCT02928822|broca's aphasia|broca's aphasia
4749356|NCT02928822|priming|priming
4749357|NCT02928822|Intensive language-action therapy|intensive language-action therapy
4749358|NCT02928822|Rehabilitation gaming system|rehabilitation gaming system
4749359|NCT02928809|temporomandibular joint|temporomandibular joint
4749360|NCT02928809|temporomandibular disorder|temporomandibular disorder
4749361|NCT02928809|muscle fatigue|muscle fatigue
4749362|NCT02928809|low-level laser therapy|low-level laser therapy
4749363|NCT02928796|Attentional capacity|attentional capacity
4749364|NCT02928796|Working memory|working memory
4749365|NCT02928796|Simulation-based training|simulation-based training
4749366|NCT02928796|Eye-tracking|eye-tracking
4749367|NCT02928796|Visual attention|visual attention
4749368|NCT02928796|Psychophysiological measurement|psychophysiological measurement
4749369|NCT02928796|Surgical simulation|surgical simulation
4749370|NCT02928796|Computer-based simulation|computer-based simulation
4749371|NCT02928783|Home-based cardiac rehabilitation|home-based cardiac rehabilitation
4749372|NCT02928783|Quality of Medical Care|quality of medical care
4749373|NCT02928783|Heart Failure|heart failure
4749374|NCT02928757|Care coordination|care coordination
4749375|NCT02928757|Complex care kids Ontario|complex care kids ontario
4749376|NCT02928757|Technology-dependent|technology-dependent
4749377|NCT02928757|Quality of life|quality of life
4749378|NCT02928744|Resistance|resistance
4749379|NCT02928744|Forced oscillations|forced oscillations
4749380|NCT02928744|Dyspnea|dyspnea
4749381|NCT02928731|Cancer|cancer
4749382|NCT02928731|Quality of life|quality of life
4749383|NCT02928731|Child|child
4749384|NCT02928718|Post-ERCP pancreatitis|post-ercp pancreatitis
4749385|NCT02928718|Genetic variation|genetic variation
4749386|NCT02928705|analgesia|analgesia
4749387|NCT02928705|prehospital|prehospital
4749388|NCT02928705|telemedicine|telemedicine
4749389|NCT02928705|ambulance|ambulance
4749390|NCT02928705|opioids|opioids
4749391|NCT02928705|teleconsultation|teleconsultation
4749392|NCT02928705|tele-emergency medical services|tele-emergency medical services
4749393|NCT02928705|adverse events|adverse events
4749394|NCT02928705|prehospital emergency medical service physician|prehospital emergency medical service physician
4749395|NCT02928692|Minocycline|minocycline
4749396|NCT02928692|Postoperative cognitive dysfunction|postoperative cognitive dysfunction
4749397|NCT02928692|Postoperative delirium|postoperative delirium
4749398|NCT02928679|Magnetic resonance imaging|magnetic resonance imaging
4749399|NCT02928679|Dynamic contrast enhanced MRI|dynamic contrast enhanced mri
4749400|NCT02928679|Liraglutide 3 mg|liraglutide 3 mg
4749401|NCT02928679|Liraglutide|liraglutide
4749402|NCT02928679|Obesity|obesity
4749403|NCT02928679|Osteoarthritis|osteoarthritis
4749404|NCT02928666|decision-support|decision-support
4749405|NCT02928666|ontology|ontology
4749406|NCT02928666|computer-interpretable guidelines|computer-interpretable guidelines
4749407|NCT02928666|comorbidities|comorbidities
4749408|NCT02928653|energy intake|energy intake
4749409|NCT02928653|energy expenditure|energy expenditure
4749410|NCT02928653|appetite|appetite
4749411|NCT02928614|Osteoarthritis|osteoarthritis
4749412|NCT02928614|Obesity|obesity
4749413|NCT02928614|Liraglutide 3 mg|liraglutide 3 mg
4749414|NCT02928614|Liraglutide|liraglutide
4749415|NCT02928614|Biomarkers|biomarkers
4749416|NCT02928575|Glioblastoma|glioblastoma
4749417|NCT02928575|Sunitinib|sunitinib
4749418|NCT02928575|Temozolomide|temozolomide
4749419|NCT02928575|Radiation Therapy,|radiation therapy,
4749420|NCT02928575|MGMT|mgmt
4749421|NCT02928575|Biomarkers|biomarkers
4749422|NCT02928549|interviews|interviews
4749423|NCT02928549|16-1378|16-1378
4749424|NCT02928523|Autologous Fecal Microbiota Transplantation|autologous fecal microbiota transplantation
4749425|NCT02928497|Non-valvular atrial fibrillation|non-valvular atrial fibrillation
4749426|NCT02928497|Left atrial appendage|left atrial appendage
4749427|NCT02928484|Functional dyspepsia|functional dyspepsia
4749428|NCT02928484|Abdominal pain|abdominal pain
4749429|NCT02928484|Flatulence|flatulence
4749430|NCT02928484|Probiotics|probiotics
4749431|NCT02928484|Bifidobacterium|bifidobacterium
4749432|NCT02928484|Lactobacillus|lactobacillus
4749433|NCT02928471|Liraglutide|liraglutide
4749434|NCT02928471|Liraglutide 3 mg|liraglutide 3 mg
4749435|NCT02928471|Osteoarthritis|osteoarthritis
4749436|NCT02928471|Obesity|obesity
4749437|NCT02928471|Magnetic resonance imaging|magnetic resonance imaging
4749438|NCT02928471|Computed tomography|computed tomography
4749439|NCT02928471|Dynamic contrast enhanced MRI|dynamic contrast enhanced mri
4749440|NCT02928445|Dementia with Lewy bodies|dementia with lewy bodies
4749441|NCT02928445|dementia|dementia
4749442|NCT02928445|RVT-101|rvt-101
4749443|NCT02928445|intepirdine|intepirdine
4749444|NCT02928445|Lewy bodies|lewy bodies
4749445|NCT02928432|Castration-Resistant Prostate Cancer|castration-resistant prostate cancer
4749446|NCT02928432|Abiraterone acetate|abiraterone acetate
4749447|NCT02928432|Steroids Switch|steroids switch
4749448|NCT02928393|Stroke|stroke
4749449|NCT02928393|Motor impairment|motor impairment
4749450|NCT02928393|Stroke recovery|stroke recovery
4749451|NCT02928393|Middle cerebral artery stroke|middle cerebral artery stroke
4749452|NCT02928393|Fugl Meyer|fugl meyer
4749453|NCT02928393|Fugl-Meyer Motor Scale (FMMS)|fugl-meyer motor scale (fmms)
4749454|NCT02928354|Asthma|asthma
4749455|NCT02928354|Chronic obstructive pulmonary disease (COPD)|chronic obstructive pulmonary disease (copd)
4749456|NCT02928354|Healthy volunteers|healthy volunteers
4749457|NCT02928354|Pharmacokinetics (PK)|pharmacokinetics (pk)
4749458|NCT02928354|Bioavailability|bioavailability
4749459|NCT02928354|AZD7594|azd7594
4749460|NCT02928354|Safety|safety
4749461|NCT02928354|Tolerability|tolerability
4749462|NCT02928328|craniofacial pain|craniofacial pain
4749463|NCT02928328|masticatory muscle|masticatory muscle
4749464|NCT02928328|burning mouth syndrome|burning mouth syndrome
4749465|NCT02928328|temporomandibular disorders|temporomandibular disorders
4749466|NCT02928276|Rheumakit|rheumakit
4749467|NCT02928276|Rheumatoid Arthritis|rheumatoid arthritis
4749468|NCT02928276|anti-TNF|anti-tnf
4749469|NCT02928237|tDCS|tdcs
4749470|NCT02928237|cancer liver|cancer liver
4749471|NCT02928237|chronic abdominal pain|chronic abdominal pain
4749472|NCT02928237|VAS|vas
4749473|NCT02928237|VDS|vds
4749474|NCT02928237|HAM-D|ham-d
4749475|NCT02928237|BPI|bpi
4749476|NCT02928237|analgesia|analgesia
4749477|NCT02928224|Colorectal cancer|colorectal cancer
4749478|NCT02928224|BRAF|braf
4749479|NCT02928224|BRAFV600E|brafv600e
4749480|NCT02928198|Tomography, Optical Coherence|tomography, optical coherence
4749481|NCT02928198|Percutaneous Coronary Intervention|percutaneous coronary intervention
4749482|NCT02928198|Cardiac Catheterization|cardiac catheterization
4749483|NCT02928198|Coronary Biovascular Scaffold|coronary biovascular scaffold
4749484|NCT02928185|training manuals|training manuals
4749485|NCT02928185|patients and caregivers|patients and caregivers
4749486|NCT02928185|16-1334|16-1334
4749487|NCT02928172|q-CON|q-con
4749488|NCT02928172|q-NOX|q-nox
4749489|NCT02928172|BIS|bis
4749490|NCT02928172|Electroencephalograms (EEG)|electroencephalograms (eeg)
4749491|NCT02928172|Laryngeal Mask Airway (LMA)|laryngeal mask airway (lma)
4749492|NCT02928172|Sedation|sedation
4749493|NCT02928172|General Anesthesia|general anesthesia
4749494|NCT02928159|Low Pulse Amplitude Seizure Therapy|low pulse amplitude seizure therapy
4749495|NCT02928159|Electroconvulsive Therapy|electroconvulsive therapy
4749496|NCT02928159|Low Pulse Amplitude Electroconvulsive Therapy|low pulse amplitude electroconvulsive therapy
4749497|NCT02928159|Low Pulse Amplitude ECT|low pulse amplitude ect
4749498|NCT02928159|LAP|lap
4749499|NCT02928159|LAP-ST|lap-st
4749500|NCT02928159|ECT|ect
4749501|NCT02928159|Mood disorders|mood disorders
4749502|NCT02928159|Psychotic disorders|psychotic disorders
4749503|NCT02928146|TAPP|tapp
4749504|NCT02928146|TEP|tep
4749505|NCT02928146|Lichtenstein|lichtenstein
4749506|NCT02928146|syntethic mesh|syntethic mesh
4749507|NCT02928146|hernioplasty|hernioplasty
4749508|NCT02928133|Non-vitamin K antagonist oral anticoagulant (NOAC)|non-vitamin k antagonist oral anticoagulant (noac)
4749509|NCT02928133|Congenital heart disease|congenital heart disease
4749510|NCT02928133|Atrial fibrillation|atrial fibrillation
4749511|NCT02928133|Atrial tachyarrhythmia|atrial tachyarrhythmia
4749512|NCT02928133|Thromboembolism|thromboembolism
4749513|NCT02928094|refractory angina|refractory angina
4749514|NCT02928094|myocardial ischemia|myocardial ischemia
4749515|NCT02928094|angiogenesis|angiogenesis
4749516|NCT02928068|telehealth|telehealth
4749517|NCT02928055|Stroke|stroke
4749518|NCT02928055|Shoulder Pain|shoulder pain
4749519|NCT02928055|Electrical stimulation|electrical stimulation
4749520|NCT02928055|Neuromuscular stimulation|neuromuscular stimulation
4749521|NCT02928055|Intramuscular stimulation|intramuscular stimulation
4749522|NCT02928029|Radium-223 dichloride|radium-223 dichloride
4749523|NCT02928029|Bortezomib|bortezomib
4749524|NCT02928029|Dexamethasone|dexamethasone
4749525|NCT02928029|Relapsed multiple myeloma|relapsed multiple myeloma
4749526|NCT02928029|Combination therapy multiple myeloma|combination therapy multiple myeloma
4749527|NCT02928016|carbohydrate counting method|carbohydrate counting method
4749528|NCT02928016|protein|protein
4749529|NCT02928016|fat|fat
4749530|NCT02928016|glucose|glucose
4749531|NCT02928016|type 1 diabetes|type 1 diabetes
4749532|NCT02928003|Lung surgery|lung surgery
4749533|NCT02927977|dry needling|dry needling
4749534|NCT02927977|exercise|exercise
4749535|NCT02927977|manual therapy|manual therapy
4749536|NCT02927951|Diabetes Mellitus|diabetes mellitus
4749537|NCT02927951|Peripheral Neuropathy|peripheral neuropathy
4749538|NCT02927951|Diabetic Pain|diabetic pain
4749539|NCT02927899|Tomato-Soy-Arugula|tomato-soy-arugula
4749540|NCT02927873|Safety|safety
4749541|NCT02927873|Respiratory syncytial virus (RSV)|respiratory syncytial virus (rsv)
4749542|NCT02927873|Immunogenicity|immunogenicity
4749543|NCT02927873|Reactogenicity|reactogenicity
4749544|NCT02927873|Infants|infants
4749545|NCT02927873|Vaccine|vaccine
4749546|NCT02927860|sleep|sleep
4749547|NCT02927860|exercise|exercise
4749548|NCT02927860|activity|activity
4749549|NCT02927821|Adult Day Care Centers|adult day care centers
4749550|NCT02927821|Caregivers|caregivers
4749551|NCT02927808|Motivational Interviewing|motivational interviewing
4749552|NCT02927808|LDL-C|ldl-c
4749553|NCT02927808|LDL target|ldl target
4749554|NCT02927808|Medication adherence|medication adherence
4749555|NCT02927782|Cerebrospinal Fluid Leak|cerebrospinal fluid leak
4749556|NCT02927782|Lumbar|lumbar
4749557|NCT02927756|Non-Hodgkin Lymphoma Transformed Recurrent|non-hodgkin lymphoma transformed recurrent
4749558|NCT02927756|Discordant Lymphomas|discordant lymphomas
4749559|NCT02927756|Composite Lymphomas|composite lymphomas
4749560|NCT02927756|Follicular Lymphoma|follicular lymphoma
4749561|NCT02927756|Aggressive Lymphoma|aggressive lymphoma
4749562|NCT02927730|Retained placenta, surgical hysteroscopy, residua|retained placenta, surgical hysteroscopy, residua
4749563|NCT02927717|Grade 3b Follicular Lymphoma|grade 3b follicular lymphoma
4749564|NCT02927717|2016 WHO Criteria|2016 who criteria
4749565|NCT02927717|Front-line treatment|front-line treatment
4749566|NCT02927717|Rituximab|rituximab
4749567|NCT02927704|Aggressive Periodontitis|aggressive periodontitis
4749568|NCT02927704|monocyte chemoattractant protein-1|monocyte chemoattractant protein-1
4749569|NCT02927704|gingival crevicular fluid|gingival crevicular fluid
4749570|NCT02927704|enzyme-linked immunosorbent assay|enzyme-linked immunosorbent assay
4749571|NCT02927691|Rehabilitation|rehabilitation
4749572|NCT02927691|Parkinson's disease|parkinson's disease
4749573|NCT02927691|Swallowing|swallowing
4749574|NCT02927691|Cough|cough
4749575|NCT02927691|Dysphagia|dysphagia
4749576|NCT02927691|Dystussia|dystussia
4749577|NCT02927678|Diabetic foot|diabetic foot
4749578|NCT02927678|Osteomyelitis|osteomyelitis
4749579|NCT02927678|Antibiotic treatment|antibiotic treatment
4749580|NCT02927678|White Blood Cell SPECT/CT|white blood cell spect/ct
4749581|NCT02927665|Weight Loss|weight loss
4749582|NCT02927613|Home mechanical ventilation|home mechanical ventilation
4749583|NCT02927613|Mortality|mortality
4749584|NCT02927613|Complications|complications
4749987|NCT02925013|Lipids|lipids
4749585|NCT02927613|Developing country|developing country
4749586|NCT02927600|Glycemic response|glycemic response
4749587|NCT02927600|Glycemic index|glycemic index
4749588|NCT02927600|Meal intervention|meal intervention
4749589|NCT02927600|Chinese population|chinese population
4749591|NCT02927587|fiberoptic bronchoscopy|fiberoptic bronchoscopy
4749592|NCT02927587|sedation|sedation
4749593|NCT02927574|drug-coated balloon angioplasty|drug-coated balloon angioplasty
4749594|NCT02927574|angioplasty|angioplasty
4749595|NCT02927574|plain old balloon angioplasty|plain old balloon angioplasty
4749596|NCT02927574|peripheral arterial disease|peripheral arterial disease
4749597|NCT02927574|intermittent claudication|intermittent claudication
4749598|NCT02927574|systematic review|systematic review
4749599|NCT02927574|meta-analysis|meta-analysis
4749600|NCT02927574|Paclitaxel|paclitaxel
4749601|NCT02927522|Postoperative Cognitive Dysfunction|postoperative cognitive dysfunction
4749602|NCT02927522|Donepezil|donepezil
4749603|NCT02927522|Hip replacement|hip replacement
4749604|NCT02927522|Knee replacement|knee replacement
4749605|NCT02927496|Lymphedema|lymphedema
4749606|NCT02927496|Lymphatic Filariasis|lymphatic filariasis
4749607|NCT02927496|Filariasis|filariasis
4749608|NCT02927496|Doxycycline|doxycycline
4749609|NCT02927483|Venous Insufficiency|venous insufficiency
4749610|NCT02927470|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
4749611|NCT02927457|Cutaneous Lupus Erythematosus-CLE|cutaneous lupus erythematosus-cle
4749612|NCT02927457|Spleen Tyrosine Kinase-SYK|spleen tyrosine kinase-syk
4749613|NCT02927457|Photoprovocation-PV|photoprovocation-pv
4749614|NCT02927457|GSK2646264|gsk2646264
4749615|NCT02927431|Anti-inflammatory|anti-inflammatory
4749616|NCT02927431|Danirixin|danirixin
4749617|NCT02927431|Influenza|influenza
4749618|NCT02927431|Hospitalized patients|hospitalized patients
4749619|NCT02927405|gabapentin|gabapentin
4749620|NCT02927405|TAP block|tap block
4749621|NCT02927366|Pulmonary hypertension (PH),|pulmonary hypertension (ph),
4749622|NCT02927366|Increase blood pressure in the pulmonary artery|increase blood pressure in the pulmonary artery
4749623|NCT02927366|Increased blood pressure in the pulmonary vein|increased blood pressure in the pulmonary vein
4749624|NCT02927366|Increased blood pressure in the lung vasculature|increased blood pressure in the lung vasculature
4749625|NCT02927366|Shortness of breath|shortness of breath
4749626|NCT02927366|Dizziness|dizziness
4749627|NCT02927366|Fainting|fainting
4749628|NCT02927366|Leg swelling|leg swelling
4749629|NCT02927366|Cough|cough
4749630|NCT02927366|Angina pector|angina pector
4749631|NCT02927353|Bioequivalence, Biosimilarity, Pharmacokinetics, adalimumab|bioequivalence, biosimilarity, pharmacokinetics, adalimumab
4749632|NCT02927340|Lung Cancer|lung cancer
4749633|NCT02927288|PTSD, mTBI|ptsd, mtbi
4749634|NCT02927262|Acute myeloid leukemia|acute myeloid leukemia
4749635|NCT02927262|First Complete Remission|first complete remission
4749636|NCT02927262|gilteritinib|gilteritinib
4749637|NCT02927262|FLT3/ITD|flt3/itd
4749638|NCT02927262|AML|aml
4749639|NCT02927262|ASP2215|asp2215
4749640|NCT02927236|Non-Invasive Brain Stimulation|non-invasive brain stimulation
4749641|NCT02927236|Functional Magnetic Resonance Imaging (fMRI)|functional magnetic resonance imaging (fmri)
4749642|NCT02927210|Healthy Men|healthy men
4749643|NCT02927210|Male Contraception|male contraception
4749644|NCT02927210|Androgen|androgen
4749645|NCT02927210|Dimethandrolone|dimethandrolone
4749646|NCT02927171|Skilled Nursing Facility|skilled nursing facility
4749647|NCT02927171|Post-Acute Care|post-acute care
4749648|NCT02927171|Older Adults|older adults
4749649|NCT02927171|Physical Function|physical function
4749650|NCT02927171|Rehabilitation|rehabilitation
4749651|NCT02927132|Drinking, Alcohol|drinking, alcohol
4749652|NCT02927119|thyroglobulin|thyroglobulin
4749653|NCT02927119|iodine|iodine
4749654|NCT02927119|pregnancy|pregnancy
4749655|NCT02927106|leukemia|leukemia
4749656|NCT02927106|myeloid|myeloid
4749657|NCT02927106|genomics|genomics
4749658|NCT02927080|FSHD|fshd
4749659|NCT02927041|hemodynamic transesophageal echocardiography|hemodynamic transesophageal echocardiography
4749660|NCT02927028|energy availability|energy availability
4749661|NCT02927028|walnuts|walnuts
4749662|NCT02926989|Isotonic|isotonic
4749663|NCT02926989|Hypotonic|hypotonic
4749664|NCT02926989|Intravenous fluids|intravenous fluids
4749665|NCT02926976|Schizophrenia|schizophrenia
4749666|NCT02926963|Chronic Granulomatous Disease, Nox2, p22phox, iPS cells|chronic granulomatous disease, nox2, p22phox, ips cells
4749667|NCT02926911|Ductal Carcinoma|ductal carcinoma
4749668|NCT02926898|seizure|seizure
4749669|NCT02926898|tonic clonic|tonic clonic
4749670|NCT02926898|epilepsy|epilepsy
4749671|NCT02926898|myoclonic|myoclonic
4749672|NCT02926898|encephalopathy|encephalopathy
4749673|NCT02926885|liver|liver
4749674|NCT02926885|laparoscopy|laparoscopy
4749675|NCT02926885|Bariatric Surgery|bariatric surgery
4749676|NCT02926885|Esophagogastric Junction|esophagogastric junction
4749677|NCT02926885|obesity|obesity
4749678|NCT02926872|Screening|screening
4749679|NCT02926872|Hepatic Injury|hepatic injury
4749680|NCT02926872|Pediatric Patients|pediatric patients
4749681|NCT02926846|Peritoneal dialysis|peritoneal dialysis
4749682|NCT02926846|Lavage|lavage
4749683|NCT02926820|Huntington disease|huntington disease
4749684|NCT02926820|cognitive rehabilitation|cognitive rehabilitation
4749685|NCT02926820|cognitive dysfunction|cognitive dysfunction
4749686|NCT02926807|Atopic Dermatitis|atopic dermatitis
4749687|NCT02926807|Vascular Inflammation|vascular inflammation
4749688|NCT02926807|Coronary Atherosclerosis|coronary atherosclerosis
4749689|NCT02926807|Ascending aorta|ascending aorta
4749690|NCT02926807|Pet scan|pet scan
4749691|NCT02926768|Cancer|cancer
4749692|NCT02926768|Non Small Cell Lung Cancer|non small cell lung cancer
4749693|NCT02926768|EGFR sensitivity mutation|egfr sensitivity mutation
4749694|NCT02926768|T790M|t790m
4749695|NCT02926768|NSCLC|nsclc
4749696|NCT02926768|epidermal growth factor receptor|epidermal growth factor receptor
4749697|NCT02926768|EGFR|egfr
4749698|NCT02926768|EGFR inhibitor|egfr inhibitor
4749699|NCT02926768|Solid Tumors|solid tumors
4749700|NCT02926755|Intra Venous Ultrasound (IVUS)|intra venous ultrasound (ivus)
4749701|NCT02926755|Fractional Flow Reserve (FFR)|fractional flow reserve (ffr)
4749702|NCT02926755|Optical Coherence Tomography (OCT)|optical coherence tomography (oct)
4749703|NCT02926755|Acute Myocardial Infarction|acute myocardial infarction
4749704|NCT02926755|Coronary Artery Disease (CAD)|coronary artery disease (cad)
4749705|NCT02926755|Angiography|angiography
4749706|NCT02926742|Thrombolysis|thrombolysis
4749707|NCT02926742|Ultrasound Thrombolysis|ultrasound thrombolysis
4749708|NCT02926742|Pulmonary Embolism|pulmonary embolism
4749709|NCT02926742|Saddle PE|saddle pe
4749710|NCT02926742|Submassive PE|submassive pe
4749711|NCT02926742|Massive PE|massive pe
4749712|NCT02926742|Bilateral PE|bilateral pe
4749713|NCT02926729|Breast Cancer|breast cancer
4749714|NCT02926716|Stomach neoplasm|stomach neoplasm
4749715|NCT02926716|Endoscopy|endoscopy
4749716|NCT02926716|Narrow band imaging|narrow band imaging
4749717|NCT02926703|seizure|seizure
4749718|NCT02926703|lactate|lactate
4749719|NCT02926703|creatine kinase|creatine kinase
4749720|NCT02926677|PTSD|ptsd
4749721|NCT02926677|Child Trauma|child trauma
4749722|NCT02926677|Cue-Centered Treatment|cue-centered treatment
4749723|NCT02926677|Trauma-Focused Cognitive-Behavioral Therapy|trauma-focused cognitive-behavioral therapy
4749724|NCT02926677|fNIRs|fnirs
4749725|NCT02926677|CCT|cct
4749726|NCT02926677|TF-CBT|tf-cbt
4749727|NCT02926677|Posttraumatic stress|posttraumatic stress
4749728|NCT02926677|NIRX|nirx
4749729|NCT02926625|Unspecific fever|unspecific fever
4749730|NCT02926625|Ethiopia|ethiopia
4749731|NCT02926625|iCCM|iccm
4749732|NCT02926625|CHW|chw
4749733|NCT02926625|HEW|hew
4749734|NCT02926599|High Fidelity Simulation|high fidelity simulation
4749735|NCT02926586|RUNX1-RUNX1T1|runx1-runx1t1
4749736|NCT02926586|CBFβ-MYH11|cbfβ-myh11
4749737|NCT02926586|fludarabine|fludarabine
4749738|NCT02926586|cytarabine|cytarabine
4749739|NCT02926573|oral cavity|oral cavity
4749740|NCT02926573|oropharynx|oropharynx
4749741|NCT02926573|hypopharynx and larynx|hypopharynx and larynx
4749742|NCT02926560|Chronic inflammatory rheumatism|chronic inflammatory rheumatism
4749743|NCT02926547|proteomics|proteomics
4749744|NCT02926534|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
4749745|NCT02926534|smoking|smoking
4749746|NCT02926534|prevalence|prevalence
4749747|NCT02926534|cross-sectional study|cross-sectional study
4749748|NCT02926534|Kazakhstan|kazakhstan
4749749|NCT02926521|nerve block catheter|nerve block catheter
4749750|NCT02926521|catheter fixation|catheter fixation
4749751|NCT02926521|catheter dressing|catheter dressing
4749752|NCT02926508|Reading|reading
4749753|NCT02926508|Learning|learning
4749754|NCT02926508|Cognition|cognition
4749755|NCT02926482|Evidence-based practice implementation|evidence-based practice implementation
4749756|NCT02926482|Buprenorphine|buprenorphine
4749757|NCT02926482|Addiction treatment|addiction treatment
4749758|NCT02926482|Extended-release naltrexone|extended-release naltrexone
4749759|NCT02926482|Opioid use disorder|opioid use disorder
4749760|NCT02926469|Virtual Reality|virtual reality
4749761|NCT02926469|Analgesia|analgesia
4749762|NCT02926469|Immersive Virtual Reality|immersive virtual reality
4749763|NCT02926469|VR|vr
4749764|NCT02926469|Labor|labor
4749765|NCT02926469|Pain|pain
4749766|NCT02926443|Shoulder|shoulder
4749767|NCT02926443|Motor control|motor control
4749768|NCT02926443|Usual physiotherapy care|usual physiotherapy care
4749769|NCT02926443|Supervised exercise program|supervised exercise program
4749770|NCT02926404|Sagittal alignment|sagittal alignment
4749771|NCT02926404|Surgical planning|surgical planning
4749772|NCT02926404|Patient-specific|patient-specific
4749773|NCT02926404|Adult Spinal Deformity|adult spinal deformity
4749774|NCT02926352|LLLT|lllt
4749775|NCT02926352|LLLS|llls
4749776|NCT02926352|Low-Level Laser Stimulation|low-level laser stimulation
4749777|NCT02926352|Low-Level Laser Therapy|low-level laser therapy
4749778|NCT02926352|Low-Level Light Therapy|low-level light therapy
4749779|NCT02926352|Transcranial infrared light stimulation|transcranial infrared light stimulation
4749780|NCT02926352|Near-infrared light|near-infrared light
4749781|NCT02926352|Photobiomodulation|photobiomodulation
4749782|NCT02926352|Fear Extinction|fear extinction
4749783|NCT02926352|Exposure Therapy|exposure therapy
4749784|NCT02926352|Claustrophobia|claustrophobia
4749785|NCT02926352|Fear of enclosed spaces|fear of enclosed spaces
4749786|NCT02926352|Fear of contamination|fear of contamination
4749787|NCT02926352|Fear of public speaking|fear of public speaking
4749788|NCT02926352|Anxiety sensitivity|anxiety sensitivity
4749789|NCT02926352|Cytochrome oxidase|cytochrome oxidase
4749790|NCT02926352|Memory consolidation|memory consolidation
4749791|NCT02926352|Cognitive enhancer|cognitive enhancer
4749792|NCT02926326|Healthy Male volunteers|healthy male volunteers
4749793|NCT02926313|RCT|rct
4749794|NCT02926313|Specialized seating|specialized seating
4749795|NCT02926313|Pressure ulcers|pressure ulcers
4749796|NCT02926300|crohn's disease|crohn's disease
4749797|NCT02926300|stem cell therapy|stem cell therapy
4749798|NCT02926300|inflammatory bowel disease|inflammatory bowel disease
4749799|NCT02926300|hUCB-MSC|hucb-msc
4749800|NCT02926300|UCB-MSC|ucb-msc
4749801|NCT02926300|Umbilical cord Blood|umbilical cord blood
4749802|NCT02926300|Rheumatoid Arthritis|rheumatoid arthritis
4749803|NCT02926300|RA|ra
4749804|NCT02926300|Stem cell|stem cell
4749805|NCT02926300|Cell therapy|cell therapy
4749806|NCT02926300|Furestem|furestem
4749807|NCT02926300|Mesenchymal stem cell|mesenchymal stem cell
4749808|NCT02926300|MSC|msc
4749809|NCT02926287|prolapse surgery|prolapse surgery
4749810|NCT02926287|ambulatory surgery|ambulatory surgery
4749811|NCT02926274|whole blood|whole blood
4749812|NCT02926274|trauma|trauma
4749813|NCT02926274|transfusion|transfusion
4749814|NCT02926274|coagulopathy|coagulopathy
4749815|NCT02926248|Arthrofibrosis|arthrofibrosis
4749816|NCT02926235|Total Knee Arthroplasty|total knee arthroplasty
4749817|NCT02926209|colonoscopy|colonoscopy
4749818|NCT02926209|adenoma|adenoma
4749819|NCT02926209|polyp|polyp
4749820|NCT02926209|crc screening|crc screening
4749821|NCT02926196|ER-Negative|er-negative
4749822|NCT02926196|PR-Negative|pr-negative
4749823|NCT02926196|HER2-Negative|her2-negative
4749824|NCT02926144|Intratracheal intubation|intratracheal intubation
4749825|NCT02926144|videolaryngoscope|videolaryngoscope
4749826|NCT02926144|McGrath MAC|mcgrath mac
4749827|NCT02926131|stick test|stick test
4749828|NCT02926118|Glucose|glucose
4749829|NCT02926118|Continuous glucose monitor|continuous glucose monitor
4749830|NCT02926118|Glycemic load|glycemic load
4749831|NCT02926118|Dietary intervention|dietary intervention
4749832|NCT02926066|Aromatic L-amino acid decarboxylase (AADC)|aromatic l-amino acid decarboxylase (aadc)
4749833|NCT02926014|Dysphagia|dysphagia
4749834|NCT02926014|Lingual Tonsil Hypertrophy|lingual tonsil hypertrophy
4749835|NCT02926014|Lingual Tonsil Enlargement|lingual tonsil enlargement
4749836|NCT02926001|Taxes|taxes
4749837|NCT02926001|Beverages/economics|beverages/economics
4749838|NCT02926001|Carbonated Beverages/economics|carbonated beverages/economics
4749839|NCT02926001|Diet, Food and Nutrition/economics|diet, food and nutrition/economics
4749840|NCT02926001|Economics|economics
4749841|NCT02926001|Energy Intake|energy intake
4749842|NCT02926001|Risk Factors|risk factors
4749843|NCT02925988|Critically ill|critically ill
4749844|NCT02925988|High risk neonates|high risk neonates
4749845|NCT02925949|Treatment|treatment
4749846|NCT02925949|Adherence|adherence
4749847|NCT02925949|Intervention|intervention
4749848|NCT02925949|MSM Couples|msm couples
4749849|NCT02925936|Radiography|radiography
4749850|NCT02925936|Radiation|radiation
4749851|NCT02925936|Diagnostic imaging|diagnostic imaging
4749852|NCT02925871|stroke|stroke
4749853|NCT02925871|rehabilitation|rehabilitation
4749854|NCT02925871|interdisciplinary health team|interdisciplinary health team
4749855|NCT02925871|patient-centered care|patient-centered care
4749856|NCT02925871|care transition|care transition
4749857|NCT02925858|Ketamine|ketamine
4749858|NCT02925858|Cardiac surgery|cardiac surgery
4749859|NCT02925858|Pain|pain
4749860|NCT02925832|Deep topical fornix nerve block Anesthesia|deep topical fornix nerve block anesthesia
4749861|NCT02925832|Ropivacaine|ropivacaine
4749862|NCT02925832|Bupivacaine|bupivacaine
4749863|NCT02925832|Anaesthesia|anaesthesia
4749864|NCT02925832|Eye surgery blocks|eye surgery blocks
4749865|NCT02925832|Phacoemulsification|phacoemulsification
4749866|NCT02925819|Mitral regurgitation|mitral regurgitation
4749867|NCT02925819|Mitral stenosis|mitral stenosis
4749868|NCT02925819|Mitral valve repair deterioration|mitral valve repair deterioration
4749869|NCT02925819|Bioprosthesis degeneration|bioprosthesis degeneration
4749870|NCT02925780|Enamel defects|enamel defects
4749871|NCT02925780|Fluorosis|fluorosis
4749872|NCT02925741|bed linens|bed linens
4749873|NCT02925728|Finger-Food|finger-food
4749874|NCT02925702|Castration Resistant Prostate Cancer|castration resistant prostate cancer
4749875|NCT02925702|Radium-223|radium-223
4749876|NCT02925702|Biomarkers|biomarkers
4749877|NCT02925663|executive functioning|executive functioning
4749878|NCT02925650|Alzheimer's Disease|alzheimer's disease
4749879|NCT02925650|SILK™|silk™
4749880|NCT02925650|Pharmacodynamics|pharmacodynamics
4749881|NCT02925650|Safety|safety
4749882|NCT02925650|Pharmacokinetics|pharmacokinetics
4749883|NCT02925624|ablation index|ablation index
4749884|NCT02925624|pulmonary vein isolation|pulmonary vein isolation
4749885|NCT02925624|implantable loop recorder|implantable loop recorder
4749886|NCT02925611|Postoperative delirium|postoperative delirium
4749887|NCT02925611|spine surgery|spine surgery
4749888|NCT02925611|isoflurane|isoflurane
4749889|NCT02925611|desflurane|desflurane
4749890|NCT02925598|Laringeal masks|laringeal masks
4749891|NCT02925598|Cholecystectomy, Laparascopic|cholecystectomy, laparascopic
4749892|NCT02925598|Intubation, intratracheal|intubation, intratracheal
4749893|NCT02925572|pediatric obesity|pediatric obesity
4749894|NCT02925572|eccentric exercise|eccentric exercise
4749895|NCT02925572|body composition|body composition
4749896|NCT02925572|training program|training program
4749897|NCT02925559|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
4749898|NCT02925559|Glycemic Variability|glycemic variability
4749899|NCT02925559|Dapagliflozin|dapagliflozin
4749900|NCT02925559|Gliclazide MR|gliclazide mr
4749901|NCT02925559|Continuous Glucose Monitoring|continuous glucose monitoring
4749902|NCT02925559|Mean Amplitude of Glycemic Excursions|mean amplitude of glycemic excursions
4749903|NCT02925559|MAGE|mage
4749904|NCT02925546|Healthy|healthy
4749905|NCT02925546|Pharmacokinetics|pharmacokinetics
4749906|NCT02925546|Phase I|phase i
4749907|NCT02925546|GSK2798745|gsk2798745
4749908|NCT02925546|Tablet|tablet
4749909|NCT02925533|Bladder Cancer|bladder cancer
4749910|NCT02925533|Urothelial Cancer|urothelial cancer
4749911|NCT02925520|Cholestasis|cholestasis
4749912|NCT02925494|Uterine Fibroids|uterine fibroids
4749913|NCT02925494|Elagolix|elagolix
4749914|NCT02925494|Heavy Menstrual Bleeding|heavy menstrual bleeding
4749915|NCT02925494|Elagolix Sodium|elagolix sodium
4749916|NCT02925494|Elagolix plus Norethindrone Acetate|elagolix plus norethindrone acetate
4749917|NCT02925481|Yoga|yoga
4749918|NCT02925481|PTSD|ptsd
4749919|NCT02925481|mental health|mental health
4749920|NCT02925481|stillbirth|stillbirth
4749921|NCT02925468|orthodontics|orthodontics
4749922|NCT02925455|Hemiplegia|hemiplegia
4749923|NCT02925455|Functional Electrical Stimulation|functional electrical stimulation
4749924|NCT02925455|Video Games|video games
4749925|NCT02925455|Occupational Therapy|occupational therapy
4749926|NCT02925442|Unilateral Knee Arthroplasty|unilateral knee arthroplasty
4749927|NCT02925442|Radiofrequency Ablation|radiofrequency ablation
4749928|NCT02925442|Genicular|genicular
4749929|NCT02925442|RFA|rfa
4749930|NCT02925442|C-RFA|c-rfa
4749931|NCT02925442|t-RFA|t-rfa
4749932|NCT02925442|total knee replacement|total knee replacement
4749933|NCT02925364|magnetic resonance imaging|magnetic resonance imaging
4749934|NCT02925364|central pain processing|central pain processing
4749935|NCT02925364|anatomical MRI|anatomical mri
4749936|NCT02925364|fMRI|fmri
4749937|NCT02925325|Major depressive disorder|major depressive disorder
4749938|NCT02925325|Music therapy|music therapy
4749939|NCT02925325|Residual symptoms|residual symptoms
4749940|NCT02925286|gambling prevention|gambling prevention
4749941|NCT02925286|workplace policy|workplace policy
4749942|NCT02925273|dementia|dementia
4749943|NCT02925234|Molecular tumor profile|molecular tumor profile
4749944|NCT02925234|Multidisciplinary tumor board|multidisciplinary tumor board
4749945|NCT02925234|Antitumor drugs|antitumor drugs
4749946|NCT02925234|Molecular Targeted Therapy|molecular targeted therapy
4749947|NCT02925234|Drug Repositioning|drug repositioning
4749948|NCT02925234|Off-Label Use|off-label use
4749949|NCT02925234|Sequence Analysis, DNA|sequence analysis, dna
4749950|NCT02925221|Kidney Disease|kidney disease
4749951|NCT02925221|ADPKD-Related Outcome|adpkd-related outcome
4749952|NCT02925221|Quality of Life|quality of life
4749953|NCT02925195|Vitamin D|vitamin d
4749954|NCT02925195|cardiovascular disease|cardiovascular disease
4749955|NCT02925195|MESA|mesa
4749956|NCT02925195|genetics|genetics
4749957|NCT02925195|pharmacogenetics|pharmacogenetics
4749958|NCT02925195|blood pressure|blood pressure
4749959|NCT02925195|biomarkers|biomarkers
4749960|NCT02925169|Subglottis, cricoid, airway shape, CT imaging|subglottis, cricoid, airway shape, ct imaging
4749961|NCT02925156|Activity Energy Expenditure|activity energy expenditure
4749962|NCT02925156|Doubly Labeled Water|doubly labeled water
4749963|NCT02925156|Physical Activity|physical activity
4749964|NCT02925156|Obesity|obesity
4749965|NCT02925156|Diabetes|diabetes
4749966|NCT02925156|Cardiovascular Disease|cardiovascular disease
4749967|NCT02925156|Adiponectin|adiponectin
4749968|NCT02925156|Leptin|leptin
4749969|NCT02925156|Ghrelin|ghrelin
4749970|NCT02925143|Residual nerve blockade|residual nerve blockade
4749971|NCT02925143|Neuromuscular monitoring|neuromuscular monitoring
4749972|NCT02925143|Residual curarization|residual curarization
4749973|NCT02925143|Neuromuscular blocking agents|neuromuscular blocking agents
4749974|NCT02925143|E-learning|e-learning
4749975|NCT02925143|Web based learning|web based learning
4749976|NCT02925117|ABT-494|abt-494
4749977|NCT02925117|Atopic Dermatitis|atopic dermatitis
4749978|NCT02925104|cMET, INC280, food,|cmet, inc280, food,
4749979|NCT02925065|Parkinson's|parkinson's
4749980|NCT02925065|Non-traditional guitar instruction|non-traditional guitar instruction
4749981|NCT02925065|Guitar therapy|guitar therapy
4749982|NCT02925065|Upper extremity motor function|upper extremity motor function
4749983|NCT02925065|Hand dexterity|hand dexterity
4749984|NCT02925039|Rehabilitation|rehabilitation
4749985|NCT02925039|Geriatric|geriatric
4749986|NCT02925013|Omega 3|omega 3
4749988|NCT02925013|Pregnancy|pregnancy
4749989|NCT02925000|Advanced Malignancy|advanced malignancy
4749990|NCT02925000|lymphoma|lymphoma
4749991|NCT02925000|TLC178|tlc178
4749992|NCT02924948|Endoscopic ultrasonography|endoscopic ultrasonography
4749993|NCT02924922|renal cell carcinoma|renal cell carcinoma
4749994|NCT02924922|laparoscopic partial nephrectomy|laparoscopic partial nephrectomy
4749995|NCT02924922|robot-assisted partial nephrectomy|robot-assisted partial nephrectomy
4749996|NCT02924922|nephron sparing surgery|nephron sparing surgery
4749997|NCT02924922|warm ischemia time|warm ischemia time
4749998|NCT02924922|renal function loss|renal function loss
4749999|NCT02924870|health education|health education
4750000|NCT02924792|Intraosseous access|intraosseous access
4750001|NCT02924740|stress urinary incontinence|stress urinary incontinence
4750002|NCT02924740|quality of life|quality of life
4750003|NCT02924740|pelvic floor muscle training|pelvic floor muscle training
4750004|NCT02924740|pelvic floor muscle exercises|pelvic floor muscle exercises
4750005|NCT02924740|vaginal tampon training|vaginal tampon training
4750006|NCT02924727|Spontaneous AMI|spontaneous ami
4750007|NCT02924727|HF hospitalization|hf hospitalization
4750008|NCT02924727|outpatient HF|outpatient hf
4750009|NCT02924727|LV systolic dysfunction|lv systolic dysfunction
4750010|NCT02924727|pulmonary congestion|pulmonary congestion
4750011|NCT02924727|STEMI|stemi
4750012|NCT02924727|NSTEMI|nstemi
4750013|NCT02924727|randomized clinical trial|randomized clinical trial
4750014|NCT02924727|LCZ696|lcz696
4750015|NCT02924727|ramipril|ramipril
4750016|NCT02924714|GIST|gist
4750017|NCT02924701|prognosis|prognosis
4750018|NCT02924688|umeclidinium bromide|umeclidinium bromide
4750019|NCT02924688|fluticasone furoate|fluticasone furoate
4750020|NCT02924688|vilanterol|vilanterol
4750021|NCT02924688|fixed dose combination|fixed dose combination
4750022|NCT02924688|lung function|lung function
4750023|NCT02924688|albuterol/salbutamol|albuterol/salbutamol
4750024|NCT02924688|asthma|asthma
4750025|NCT02924688|closed triple therapy|closed triple therapy
4750026|NCT02924675|neuropathic pain, ent cancer, pregabalin|neuropathic pain, ent cancer, pregabalin
4750027|NCT02924649|Brain injury|brain injury
4750028|NCT02924649|Early mobilisation|early mobilisation
4750029|NCT02924649|Consciousness|consciousness
4750030|NCT02924649|Cerebral blood flow|cerebral blood flow
4750031|NCT02924649|Blood pressure|blood pressure
4750032|NCT02924636|C-section|c-section
4750033|NCT02924636|Instrumental delivery|instrumental delivery
4750034|NCT02924636|Pregnancy complications|pregnancy complications
4750035|NCT02924636|Macrosomia|macrosomia
4750036|NCT02924636|Neonatal complications|neonatal complications
4750037|NCT02924584|hormonal receptor positive, human epidermal growth factor receptor 2 negative, breast cancer, aromatse inhibitor, overall survival, prevalence|hormonal receptor positive, human epidermal growth factor receptor 2 negative, breast cancer, aromatse inhibitor, overall survival, prevalence
4750038|NCT02924558|Egg|egg
4750039|NCT02924558|Protein|protein
4750040|NCT02924558|Unsaturated fatty acids|unsaturated fatty acids
4750041|NCT02924558|Triglycerides|triglycerides
4750042|NCT02924558|Insulin sensitivity|insulin sensitivity
4750043|NCT02924558|Lipid triad|lipid triad
4750044|NCT02924506|cervical arthroplasty|cervical arthroplasty
4750045|NCT02924493|Endometriosis|endometriosis
4750046|NCT02924493|IBS|ibs
4750047|NCT02924493|Irritable bowel syndrome|irritable bowel syndrome
4750048|NCT02924493|low FODMAP diet|low fodmap diet
4750049|NCT02924493|FODMAPs|fodmaps
4750050|NCT02924493|visceral syndrome|visceral syndrome
4750051|NCT02924493|fermentable carbohydrates|fermentable carbohydrates
4750052|NCT02924493|visceral hypersensitivity|visceral hypersensitivity
4750053|NCT02924493|cross organ effect|cross organ effect
4750054|NCT02924480|invasive bladder cancer|invasive bladder cancer
4750055|NCT02924480|cystectomy|cystectomy
4750056|NCT02924480|high grade bladder cancer|high grade bladder cancer
4750057|NCT02924467|reminder systems|reminder systems
4750058|NCT02924467|Influenza vaccines|influenza vaccines
4750059|NCT02924454|metoprolol|metoprolol
4750060|NCT02924454|lipid emulsion|lipid emulsion
4750061|NCT02924454|pharmacodynamics|pharmacodynamics
4750062|NCT02924454|pharmacokinetics|pharmacokinetics
4750063|NCT02924441|Mammogram|mammogram
4750064|NCT02924441|Pain Management|pain management
4750065|NCT02924441|Lidocaine|lidocaine
4750066|NCT02924428|Acne|acne
4750067|NCT02924402|NHL|nhl
4750068|NCT02924402|B-cell Prolymphocytic Leukemia|b-cell prolymphocytic leukemia
4750069|NCT02924402|Transformed Lymphoma|transformed lymphoma
4750070|NCT02924402|Burkitt's Lymphoma|burkitt's lymphoma
4750071|NCT02924402|Mantle Cell Lymphoma|mantle cell lymphoma
4750072|NCT02924402|Hairy Cell Leukemia|hairy cell leukemia
4750073|NCT02924402|Splenic Marginal Zone Lymphoma|splenic marginal zone lymphoma
4750074|NCT02924402|Waldenstrom's Macroglobulinemia|waldenstrom's macroglobulinemia
4750075|NCT02924402|Variant Hairy Cell Leukemia|variant hairy cell leukemia
4750076|NCT02924402|Splenic B-cell Lymphoma/Leukemia|splenic b-cell lymphoma/leukemia
4750077|NCT02924402|Lymphoplasmacytic Lymphoma|lymphoplasmacytic lymphoma
4750078|NCT02924402|Extranodal Marginal Zone Lymphoma (MALT)|extranodal marginal zone lymphoma (malt)
4750079|NCT02924402|MALT Lymphoma|malt lymphoma
4750080|NCT02924402|Nodal Marginal Zone Lymphoma|nodal marginal zone lymphoma
4750081|NCT02924402|Follicular Lymphoma|follicular lymphoma
4750082|NCT02924402|In Situ Follicular Neoplasia|in situ follicular neoplasia
4750083|NCT02924402|Duodenal-type Follicular Lymphoma|duodenal-type follicular lymphoma
4750084|NCT02924402|Large B-cell Lymphoma with IRF4 rearrangement|large b-cell lymphoma with irf4 rearrangement
4750085|NCT02924402|Primary Cutaneous Follicle Center Lymphoma|primary cutaneous follicle center lymphoma
4750086|NCT02924402|Diffuse Large B-cell Lymphoma|diffuse large b-cell lymphoma
4750087|NCT02924402|DLBCL|dlbcl
4750088|NCT02924402|T-cell/Histiocyte-Rich Large B-cell Lymphoma|t-cell/histiocyte-rich large b-cell lymphoma
4750089|NCT02924402|Primary Cutaneous DLBCL, leg type|primary cutaneous dlbcl, leg type
4750090|NCT02924402|EBV-positive DLBCL, NOS|ebv-positive dlbcl, nos
4750091|NCT02924402|EBV-positive Mucocutaneous Ulcer|ebv-positive mucocutaneous ulcer
4750092|NCT02924402|DLBCL Associated with Chronic Inflammation|dlbcl associated with chronic inflammation
4750093|NCT02924402|Lymphomatoid Granulomatosis|lymphomatoid granulomatosis
4750094|NCT02924402|Primary Mediastinal (Thymic) Large B-cell Lymphoma|primary mediastinal (thymic) large b-cell lymphoma
4750095|NCT02924402|Intravascular Large B-cell Lymphoma|intravascular large b-cell lymphoma
4750096|NCT02924402|ALK+ Large B-cell Lymphoma|alk+ large b-cell lymphoma
4750097|NCT02924402|Plasmablastic Lymphoma|plasmablastic lymphoma
4750098|NCT02924402|Primary Effusion Lymphoma|primary effusion lymphoma
4750099|NCT02924402|HHV8+ DLBCL|hhv8+ dlbcl
4750100|NCT02924402|Burkitt-like Lymphoma with 11q Aberration|burkitt-like lymphoma with 11q aberration
4750101|NCT02924402|High-grade B-cell Lymphoma|high-grade b-cell lymphoma
4750102|NCT02924402|B-cell Lymphoma, unclassifiable|b-cell lymphoma, unclassifiable
4750103|NCT02924402|Post-transplant Lymphoproliferative Disorder|post-transplant lymphoproliferative disorder
4750104|NCT02924402|PTLD|ptld
4750105|NCT02924402|CLL|cll
4750106|NCT02924402|SLL|sll
4750107|NCT02924402|High-grade Lymphoma|high-grade lymphoma
4750108|NCT02924402|Richter's Transformation|richter's transformation
4750109|NCT02924376|Cholangiocarcinoma|cholangiocarcinoma
4750110|NCT02924376|fibroblast growth factor (FGF)|fibroblast growth factor (fgf)
4750111|NCT02924376|fibroblast growth factor receptor (FGFR)|fibroblast growth factor receptor (fgfr)
4750112|NCT02924376|FGF/FGFR alterations|fgf/fgfr alterations
4750113|NCT02924363|Cardiac Magnetic Resonance|cardiac magnetic resonance
4750114|NCT02924363|Mitra Clip|mitra clip
4750115|NCT02924363|Mitral Valve|mitral valve
4750116|NCT02924337|QT/QTC interval|qt/qtc interval
4750117|NCT02924337|Hypoglycemic Agents|hypoglycemic agents
4750118|NCT02924337|Imeglimin|imeglimin
4750119|NCT02924337|Healthy Volunteers|healthy volunteers
4750120|NCT02924324|local Injection|local injection
4750121|NCT02924324|pain Medication|pain medication
4750122|NCT02924324|propofol|propofol
4750123|NCT02924324|ropivacaine|ropivacaine
4750124|NCT02924324|16-1417|16-1417
4750125|NCT02924311|Diabetic Macular Edema|diabetic macular edema
4750126|NCT02924272|Drug Therapy|drug therapy
4750127|NCT02924259|muscle soreness|muscle soreness
4750128|NCT02924259|pain|pain
4750129|NCT02924259|myofascial release|myofascial release
4750130|NCT02924246|immunity|immunity
4750131|NCT02924246|vaccination|vaccination
4750132|NCT02924246|milk|milk
4750133|NCT02924233|Squamous|squamous
4750134|NCT02924233|Non-Small Cell Lung Cancer|non-small cell lung cancer
4750135|NCT02924233|NSCLC|nsclc
4750136|NCT02924207|diabetes mellitus|diabetes mellitus
4750137|NCT02924181|pulmonary vein isolation|pulmonary vein isolation
4750138|NCT02924181|contact force sensing catheter|contact force sensing catheter
4750139|NCT02924142|Kennedy classification for edentulous ridge|kennedy classification for edentulous ridge
4750140|NCT02924129|Chronic Pain|chronic pain
4750141|NCT02924129|Back Pain|back pain
4750142|NCT02924129|Leg Pain|leg pain
4750143|NCT02924129|Pain|pain
4750144|NCT02924129|Neurologic Manifestations|neurologic manifestations
4750145|NCT02924129|Nervous System Diseases|nervous system diseases
4750146|NCT02924129|Signs and Symptoms|signs and symptoms
4750147|NCT02924129|SCS|scs
4750148|NCT02924129|Closed Loop|closed loop
4750149|NCT02924116|insomnia|insomnia
4750150|NCT02924116|sleep|sleep
4750151|NCT02924116|Bioboosti|bioboosti
4750152|NCT02924116|Biomobie|biomobie
4750153|NCT02924116|device|device
4750154|NCT02924103|acute rhinosinusitis|acute rhinosinusitis
4750155|NCT02924103|staphylococcus aureus|staphylococcus aureus
4750156|NCT02924103|nasal vestibule|nasal vestibule
4750157|NCT02924103|contamination|contamination
4750158|NCT02924090|Major depressive disorder|major depressive disorder
4750159|NCT02924090|Etomidate|etomidate
4750160|NCT02924090|Ketamine|ketamine
4750161|NCT02924090|Hyperventilation|hyperventilation
4750162|NCT02924090|Electroconvulsive therapy|electroconvulsive therapy
4750163|NCT02924090|Depression|depression
4750164|NCT02924090|Anesthesia|anesthesia
4750165|NCT02924090|Nervous System Diseases|nervous system diseases
4750166|NCT02924090|Mental Disorders|mental disorders
4750167|NCT02924090|Electroencephalography|electroencephalography
4750168|NCT02924090|Cerebral Metabolism|cerebral metabolism
4750169|NCT02924038|low-grade glioma|low-grade glioma
4750170|NCT02924038|glioma|glioma
4750171|NCT02924038|immunotherapy|immunotherapy
4750172|NCT02924038|vaccine|vaccine
4750173|NCT02924038|WHO grade II|who grade ii
4750174|NCT02924012|post exercise hypotension|post exercise hypotension
4750175|NCT02924012|exercise|exercise
4750176|NCT02924012|video games|video games
4750177|NCT02923999|HIV|hiv
4750178|NCT02923999|MAB|mab
4750179|NCT02923999|PLANT|plant
4750180|NCT02923986|Liposomal Grb-2 treatment of Ph+ CML|liposomal grb-2 treatment of ph+ cml
4750181|NCT02923986|Liposomal Grb-2 with Das for Ph+ CML|liposomal grb-2 with das for ph+ cml
4750182|NCT02923947|Pharmacokinetics,|pharmacokinetics,
4750183|NCT02923947|Renal impairment,|renal impairment,
4750184|NCT02923947|Safety assessments,|safety assessments,
4750185|NCT02923947|Solid tumours,|solid tumours,
4750186|NCT02923947|EGFRm+|egfrm+
4750187|NCT02923947|EGFRm+/T790M+ inhibitor|egfrm+/t790m+ inhibitor
4750188|NCT02923908|Palatability|palatability
4750189|NCT02923908|Pediatrics|pediatrics
4750190|NCT02923908|Facial Recognition|facial recognition
4750191|NCT02923908|Taste|taste
4750192|NCT02923908|Facial Expressions|facial expressions
4750193|NCT02923882|Low-birth-weight|low-birth-weight
4750194|NCT02923882|Model kitchen|model kitchen
4750195|NCT02923882|Improved cookstove|improved cookstove
4750196|NCT02923869|Levobupivacaine|levobupivacaine
4750197|NCT02923869|Bupivacaine|bupivacaine
4750198|NCT02923869|Nerve Block|nerve block
4750199|NCT02923869|Cleft Palate|cleft palate
4750200|NCT02923856|Helicobacter pylori|helicobacter pylori
4750201|NCT02923856|Antibiotic resistance|antibiotic resistance
4750202|NCT02923856|Sequencing|sequencing
4750203|NCT02923843|frailty|frailty
4750204|NCT02923843|comprehensive geriatric assessment|comprehensive geriatric assessment
4750205|NCT02923817|spinal cord injury|spinal cord injury
4750206|NCT02923817|autologous transplants|autologous transplants
4750207|NCT02923817|bone marrow derived mononuclear cells|bone marrow derived mononuclear cells
4750208|NCT02923804|steatosis|steatosis
4750209|NCT02923804|NAFL|nafl
4750210|NCT02923804|NAFLD|nafld
4750211|NCT02923804|Polyunsaturated fatty acids|polyunsaturated fatty acids
4750212|NCT02923804|omega-3|omega-3
4750213|NCT02923804|EPA|epa
4750214|NCT02923804|DHA|dha
4750215|NCT02923804|fish oil|fish oil
4750216|NCT02923739|Malignant neoplasms of female genital organs|malignant neoplasms of female genital organs
4750217|NCT02923739|Ovarian Cancer|ovarian cancer
4750218|NCT02923739|Fallopian Tube Cancer|fallopian tube cancer
4750219|NCT02923739|Primary Peritoneal Cancer|primary peritoneal cancer
4750220|NCT02923739|relapsed/refractory|relapsed/refractory
4750221|NCT02923739|Platinum-resistant disease|platinum-resistant disease
4750222|NCT02923739|Paclitaxel|paclitaxel
4750223|NCT02923739|Taxol|taxol
4750224|NCT02923739|Bevacizumab|bevacizumab
4750225|NCT02923739|Avastin|avastin
4750226|NCT02923739|rhuMAb-VEGF|rhumab-vegf
4750227|NCT02923739|Anti-VEGF monoclonal antibody|anti-vegf monoclonal antibody
4750228|NCT02923739|Emactuzumab|emactuzumab
4750229|NCT02923739|RO5509554|ro5509554
4750230|NCT02923726|Antitachycardia Pacing Therapy|antitachycardia pacing therapy
4750231|NCT02923726|Shock Therapy|shock therapy
4750232|NCT02923726|Primary Prevention|primary prevention
4750233|NCT02923700|platelet rich plasma|platelet rich plasma
4750234|NCT02923700|intra-articular injection|intra-articular injection
4750235|NCT02923700|leukocytes|leukocytes
4750236|NCT02923687|Ketorolac|ketorolac
4750237|NCT02923687|Root canal treatment|root canal treatment
4750238|NCT02923687|Pain|pain
4750239|NCT02923687|Premedication|premedication
4750240|NCT02923661|single implant|single implant
4750241|NCT02923635|Oncoplastic breast surgery|oncoplastic breast surgery
4750242|NCT02923635|Standard Wide Local Excision|standard wide local excision
4750243|NCT02923596|Keloid|keloid
4750244|NCT02923570|proton-beam radiation therapy (PBRT)|proton-beam radiation therapy (pbrt)
4750245|NCT02923570|intensity-modulated radiation therapy (IMRT)|intensity-modulated radiation therapy (imrt)
4750246|NCT02923570|16-1416|16-1416
4750247|NCT02923544|Uterine Manipulator|uterine manipulator
4750248|NCT02923544|Yukio's Uterine Manipulating Instrument (YUMI)|yukio's uterine manipulating instrument (yumi)
4750249|NCT02923544|16-1397|16-1397
4750250|NCT02923518|Heart Screening|heart screening
4750251|NCT02923518|Master Athletes|master athletes
4750252|NCT02923518|Cardiovascular Disease|cardiovascular disease
4750253|NCT02923479|Rehabilitation|rehabilitation
4750254|NCT02923479|Robotics|robotics
4750255|NCT02923466|refractory solid tumor|refractory solid tumor
4750256|NCT02923427|laryngeal mask Supreme|laryngeal mask supreme
4750257|NCT02923427|i-gel|i-gel
4750258|NCT02923427|laparoscopic gynecological surgery|laparoscopic gynecological surgery
4750259|NCT02923414|Cardioversion|cardioversion
4750260|NCT02923401|Exercise|exercise
4750261|NCT02923401|Biomarkers|biomarkers
4750262|NCT02923401|Breast cancer high risk|breast cancer high risk
4750263|NCT02923401|Treadmill|treadmill
4750264|NCT02923401|Stationary bicycle|stationary bicycle
4750265|NCT02923401|Questionnaires|questionnaires
4750266|NCT02923401|Surveys|surveys
4750267|NCT02923401|Motivational sessions|motivational sessions
4750268|NCT02923401|Phone calls|phone calls
4750269|NCT02923401|Printed materials|printed materials
4750270|NCT02923362|GERD|gerd
4750271|NCT02923362|Reflux|reflux
4750272|NCT02923362|Acid Reflux|acid reflux
4750273|NCT02923362|Heartburn|heartburn
4750274|NCT02923362|Regurgitation|regurgitation
4750275|NCT02923362|Laryngopharyngeal Reflux|laryngopharyngeal reflux
4750276|NCT02923362|Hiatal Hernia|hiatal hernia
4750277|NCT02923362|LPR|lpr
4750278|NCT02923362|LINX|linx
4750279|NCT02923362|Magnetic Sphincter Augmentation|magnetic sphincter augmentation
4750280|NCT02923362|Antireflux Surgery|antireflux surgery
4750281|NCT02923362|Nissen|nissen
4750282|NCT02923349|Solid tumor|solid tumor
4750283|NCT02923349|adenocarcinoma of the endometrium|adenocarcinoma of the endometrium
4750284|NCT02923349|ovarian cancer|ovarian cancer
4750285|NCT02923349|renal cell carcinoma|renal cell carcinoma
4750286|NCT02923349|melanoma|melanoma
4750287|NCT02923349|non-small cell lung cancer|non-small cell lung cancer
4750288|NCT02923349|OX40|ox40
4750289|NCT02923349|immunoglobulin G monoclonal antibody|immunoglobulin g monoclonal antibody
4750290|NCT02923336|liver cirrhosis|liver cirrhosis
4750291|NCT02923336|variceal bleeding|variceal bleeding
4750292|NCT02923336|non selective beta blockers|non selective beta blockers
4750293|NCT02923323|Neurocognitive Function|neurocognitive function
4750294|NCT02923323|MRI|mri
4750295|NCT02923323|Diffusion Tensor Imaging (DTI)|diffusion tensor imaging (dti)
4750296|NCT02923323|Sleep|sleep
4750297|NCT02923297|parkinson|parkinson
4750298|NCT02923297|alpha-synuclein|alpha-synuclein
4750299|NCT02923297|GALIG|galig
4750300|NCT02923297|quantitative PCR (polymerase chain reaction)|quantitative pcr (polymerase chain reaction)
4750301|NCT02923271|Driving|driving
4750302|NCT02923271|Teens|teens
4750303|NCT02923271|Texting|texting
4750304|NCT02923271|Cellphone|cellphone
4750305|NCT02923271|DriveID|driveid
4750306|NCT02923271|Motor vehicle accident|motor vehicle accident
4750307|NCT02923258|head and neck squamous cell carcinoma|head and neck squamous cell carcinoma
4750308|NCT02923258|concurrent chemotherapy|concurrent chemotherapy
4750309|NCT02923258|High-Risk|high-risk
4750310|NCT02923232|Contact lens; Accommodation; Visual performance|contact lens; accommodation; visual performance
4750311|NCT02923219|Facial Rejuvenation|facial rejuvenation
4750312|NCT02923219|Adipose-Derived Stem Cells|adipose-derived stem cells
4750313|NCT02923206|apheresis|apheresis
4750314|NCT02923206|pregnancy|pregnancy
4750315|NCT02923206|pre-eclampsia|pre-eclampsia
4750316|NCT02923206|PE|pe
4750317|NCT02923206|sFlt-1|sflt-1
4750318|NCT02923206|Pre-term|pre-term
4750319|NCT02923167|CP|cp
4750320|NCT02923167|Cerebral Palsy|cerebral palsy
4750321|NCT02923167|Robotic|robotic
4750322|NCT02923167|Hand|hand
4750323|NCT02923167|Rehabilitation|rehabilitation
4750324|NCT02923154|NASH|nash
4750325|NCT02923141|substance use|substance use
4750326|NCT02923141|trauma|trauma
4750327|NCT02923141|HIV|hiv
4750328|NCT02923141|viral load|viral load
4750329|NCT02923141|women|women
4750330|NCT02923115|Venous thromboembolism|venous thromboembolism
4750331|NCT02923115|VTE|vte
4750332|NCT02923115|Pulmonary embolism|pulmonary embolism
4750333|NCT02923115|PE|pe
4750334|NCT02923115|Acute Submassive Pulmonary Embolism|acute submassive pulmonary embolism
4750335|NCT02923102|Recovery|recovery
4750336|NCT02923102|Muscle soreness|muscle soreness
4750337|NCT02923102|Lemon Verbena|lemon verbena
4750338|NCT02923089|Diabetes|diabetes
4750339|NCT02923089|Lentils|lentils
4750340|NCT02923089|Pulses|pulses
4750341|NCT02923089|Postprandial glycemia|postprandial glycemia
4750342|NCT02923076|Allogeneic Hematopoietic Cell Transplantation|allogeneic hematopoietic cell transplantation
4750343|NCT02923063|Chronic Kidney Disease|chronic kidney disease
4750344|NCT02923063|Mitochondrial Metabolism|mitochondrial metabolism
4750345|NCT02923063|Physical Performance|physical performance
4750346|NCT02923063|Exercise Intolerance|exercise intolerance
4750347|NCT02923063|Muscle Fatigue|muscle fatigue
4750348|NCT02922998|CD64 antigens|cd64 antigens
4750349|NCT02922998|Biomarkers|biomarkers
4750350|NCT02922998|Granulocyte Colony-Stimulating Factor|granulocyte colony-stimulating factor
4750351|NCT02922998|Interleukin-4|interleukin-4
4750352|NCT02922998|Interferon-gamma|interferon-gamma
4750353|NCT02922998|C-reactive protein|c-reactive protein
4750354|NCT02922998|lipopolysaccharide-binding protein|lipopolysaccharide-binding protein
4750355|NCT02922998|procalcitonin|procalcitonin
4750356|NCT02922998|Cytokines|cytokines
4750357|NCT02922998|Patients|patients
4750358|NCT02922998|Human|human
4750359|NCT02922998|Systemic Inflammatory Response Syndrome|systemic inflammatory response syndrome
4750360|NCT02922998|Sepsis|sepsis
4750361|NCT02922998|Infection|infection
4750362|NCT02922998|Antibiotics|antibiotics
4750363|NCT02922998|Intensive Care Units|intensive care units
4750364|NCT02922998|Point-of-Care Systems|point-of-care systems
4750365|NCT02922998|Bedside Testing|bedside testing
4750366|NCT02922985|Cesarean delivery|cesarean delivery
4750367|NCT02922985|Multimodal pain management|multimodal pain management
4750368|NCT02922972|Keloid scar|keloid scar
4750369|NCT02922972|Wound healing|wound healing
4750370|NCT02922972|Platelet-Rich Plasma|platelet-rich plasma
4750371|NCT02922972|RegenLab|regenlab
4750372|NCT02922959|Opioid Substitution Treatment|opioid substitution treatment
4750373|NCT02922959|Telephone intervention|telephone intervention
4750374|NCT02922959|secondary prevention|secondary prevention
4750375|NCT02922959|naloxone|naloxone
4750376|NCT02922946|entinostat|entinostat
4750377|NCT02922946|Histone Deacetylase Inhibitor|histone deacetylase inhibitor
4750378|NCT02922946|HDAC|hdac
4750379|NCT02922933|entinostat|entinostat
4750380|NCT02922933|Histone Deacetylase Inhibitor|histone deacetylase inhibitor
4750381|NCT02922933|HDAC|hdac
4750382|NCT02922868|Cystoscopy|cystoscopy
4750383|NCT02922868|EndoSheath|endosheath
4750384|NCT02922868|Infection Control|infection control
4750385|NCT02922868|Bacteriuria|bacteriuria
4750386|NCT02922842|transcutaneous electrical nerve stimulation|transcutaneous electrical nerve stimulation
4750387|NCT02922829|Food Insecurity|food insecurity
4750388|NCT02922829|Nutrition|nutrition
4750389|NCT02922816|Carbapenem-resistant Enterobacteriaceae (CRE)|carbapenem-resistant enterobacteriaceae (cre)
4750390|NCT02922816|Vancomycin-resistant Enterococcus (VRE)|vancomycin-resistant enterococcus (vre)
4750391|NCT02922816|Multidrug Resistant Organism (MDRO)|multidrug resistant organism (mdro)
4750392|NCT02922816|Fecal Microbiota Transplant (FMT)|fecal microbiota transplant (fmt)
4750393|NCT02922816|Renal Transplant|renal transplant
4750394|NCT02922816|Colonization|colonization
4750395|NCT02922816|Infection|infection
4750396|NCT02922816|Antibiotic Resistance|antibiotic resistance
4750397|NCT02922816|Resistome|resistome
4750398|NCT02922816|Multidrug Resistant (MDR) Pseudomonas|multidrug resistant (mdr) pseudomonas
4750399|NCT02922790|smoker|smoker
4750400|NCT02922790|smoking|smoking
4750401|NCT02922790|cigarette|cigarette
4750402|NCT02922790|cessation|cessation
4750403|NCT02922790|DNA|dna
4750404|NCT02922790|DNA damage|dna damage
4750405|NCT02922790|blood draw|blood draw
4750406|NCT02922790|feedback|feedback
4750407|NCT02922790|cellular|cellular
4750408|NCT02922790|tobacco|tobacco
4750409|NCT02922790|tobacco smoke|tobacco smoke
4750410|NCT02922764|Solid malignancy|solid malignancy
4750411|NCT02922764|Lymphoma|lymphoma
4750412|NCT02922764|Solid tumor|solid tumor
4750413|NCT02922764|Melanoma|melanoma
4750414|NCT02922764|Non-small cell lung cancer|non-small cell lung cancer
4750415|NCT02922764|Epithelial ovarian carcinoma|epithelial ovarian carcinoma
4750416|NCT02922764|Triple Breast cancer|triple breast cancer
4750417|NCT02922764|NSCLC|nsclc
4750418|NCT02922764|EOC|eoc
4750419|NCT02922764|TNBC|tnbc
4750420|NCT02922764|LXR|lxr
4750421|NCT02922764|ApoE|apoe
4750422|NCT02922764|mBC|mbc
4750423|NCT02922764|Small cell lung cancer|small cell lung cancer
4750424|NCT02922764|Renal cell cancer|renal cell cancer
4750425|NCT02922764|Bladder cancer|bladder cancer
4750426|NCT02922764|SCLC|sclc
4750427|NCT02922764|RCC|rcc
4750428|NCT02922764|BLC|blc
4750429|NCT02922751|transient elastography|transient elastography
4750430|NCT02922751|pediatric liver disease|pediatric liver disease
4750431|NCT02922751|biliary atresia|biliary atresia
4750432|NCT02922751|Alagille Syndrome|alagille syndrome
4750433|NCT02922751|Alpha1 Anti-Trypsin Deficiency|alpha1 anti-trypsin deficiency
4750434|NCT02922751|liver fibrosis|liver fibrosis
4750435|NCT02922751|cholestasis|cholestasis
4750436|NCT02922738|Clinical Knowledge Systems, Decision support, Dermatology|clinical knowledge systems, decision support, dermatology
4750437|NCT02922738|Technology Assessment|technology assessment
4750438|NCT02922673|human endotoxemia|human endotoxemia
4750440|NCT02922673|acetylsalicylic acid|acetylsalicylic acid
4750441|NCT02922673|placebo|placebo
4750442|NCT02922673|endotoxin tolerance|endotoxin tolerance
4750443|NCT02922660|Ambulatory surgery|ambulatory surgery
4750444|NCT02922660|Ophthalmic|ophthalmic
4750445|NCT02922660|Inhalation anesthesia|inhalation anesthesia
4750446|NCT02922660|Desflurane|desflurane
4750447|NCT02922660|Total intravenous anesthesia|total intravenous anesthesia
4750448|NCT02922634|postoperative health outcomes|postoperative health outcomes
4750449|NCT02922634|older surgical patients|older surgical patients
4750450|NCT02922608|Education, Medical|education, medical
4750451|NCT02922543|Multiple Myeloma|multiple myeloma
4750452|NCT02922543|Teratogenicity|teratogenicity
4750453|NCT02922543|Thrombocytopenia and haemorrhage|thrombocytopenia and haemorrhage
4750454|NCT02922543|Neutropenia and infection|neutropenia and infection
4750455|NCT02922543|Venous thromboembolism|venous thromboembolism
4750456|NCT02922543|Allergic reactions|allergic reactions
4750457|NCT02922543|Diarrhoea or constipation|diarrhoea or constipation
4750458|NCT02922543|Peripheral neuropathy|peripheral neuropathy
4750459|NCT02922543|Cardiac failure|cardiac failure
4750460|NCT02922543|Arrhythmia|arrhythmia
4750461|NCT02922543|Renal failure|renal failure
4750462|NCT02922543|Myocardial infarction|myocardial infarction
4750463|NCT02922543|Interstitial lung disease|interstitial lung disease
4750464|NCT02922543|Tumour lysis syndrome|tumour lysis syndrome
4750465|NCT02922517|biomarkers|biomarkers
4750466|NCT02922517|echocardiography|echocardiography
4750467|NCT02922517|MRI imaging|mri imaging
4750468|NCT02922517|nuclear medicine|nuclear medicine
4750469|NCT02922504|First trimester abortion|first trimester abortion
4750470|NCT02922504|Surgical abortion|surgical abortion
4750471|NCT02922504|Music intervention|music intervention
4750472|NCT02922504|Local anesthesia|local anesthesia
4750473|NCT02922504|Pain|pain
4750474|NCT02922439|chronic disease|chronic disease
4750475|NCT02922439|multimorbidity|multimorbidity
4750476|NCT02922439|chronic disease self-management|chronic disease self-management
4750477|NCT02922439|tailored information|tailored information
4750478|NCT02922439|mobile applications|mobile applications
4750479|NCT02922426|ALKS 3831|alks 3831
4750480|NCT02922426|Samidorphan|samidorphan
4750481|NCT02922426|Olanzapine|olanzapine
4750482|NCT02922413|Porphyria|porphyria
4750483|NCT02922413|Heme|heme
4750484|NCT02922400|Autism|autism
4750485|NCT02922400|Traumatic Brain Injury|traumatic brain injury
4750486|NCT02922400|Schizophrenia|schizophrenia
4750487|NCT02922400|Virtual-Reality Social Cognition Training|virtual-reality social cognition training
4750488|NCT02922387|varenicline|varenicline
4750489|NCT02922387|COPD|copd
4750490|NCT02922387|asthma|asthma
4750491|NCT02922387|pneumonia|pneumonia
4750492|NCT02922387|smoking cessation|smoking cessation
4750493|NCT02922374|acute severe colitis|acute severe colitis
4750494|NCT02922374|corticosteroids|corticosteroids
4750495|NCT02922374|UCEIS|uceis
4750496|NCT02922374|fecal calprotectin|fecal calprotectin
4750497|NCT02922348|premature ovarian failure|premature ovarian failure
4750498|NCT02922348|hormone replacement|hormone replacement
4750499|NCT02922335|Antisocial Behavior|antisocial behavior
4750500|NCT02922335|Mental Illness|mental illness
4750501|NCT02922335|Emerging Adulthood|emerging adulthood
4750502|NCT02922335|Criminal Behavior|criminal behavior
4750503|NCT02922335|Serious Mental Illness|serious mental illness
4750504|NCT02922322|Mat Pilates|mat pilates
4750505|NCT02922322|Chronic Nonspecific low back pain|chronic nonspecific low back pain
4750506|NCT02922322|Quality of life|quality of life
4750507|NCT02922322|Disability|disability
4750508|NCT02922322|transverse abdominal muscle|transverse abdominal muscle
4750509|NCT02922283|T cell response|t cell response
4750510|NCT02922283|Interleukin 2|interleukin 2
4750511|NCT02922283|PET scan|pet scan
4750512|NCT02922283|Ipilimumab|ipilimumab
4750513|NCT02922283|Pembrolizumab|pembrolizumab
4750514|NCT02922283|Nivolumab|nivolumab
4750515|NCT02922270|peritoneal dialysis: outcome|peritoneal dialysis: outcome
4750516|NCT02922270|peritoneal dialysis: complications|peritoneal dialysis: complications
4750517|NCT02922270|peritoneal dialysis: technique|peritoneal dialysis: technique
4750518|NCT02922270|peritoneal dialysis: peritonitis|peritoneal dialysis: peritonitis
4750519|NCT02922244|herbal products|herbal products
4750520|NCT02922244|reduction of radiation-induced dermatitis|reduction of radiation-induced dermatitis
4750521|NCT02922244|breast cancer|breast cancer
4750522|NCT02922244|radiotherapy|radiotherapy
4750523|NCT02922218|Castration Resistant Prostate Cancer|castration resistant prostate cancer
4750524|NCT02922218|Enzalutamide|enzalutamide
4750525|NCT02922218|Biomarkers|biomarkers
4750526|NCT02922192|Anti-inflammatory|anti-inflammatory
4750527|NCT02922192|Biologics|biologics
4750528|NCT02922192|Biologic and Biosimilars Collective Intelligence Consortium|biologic and biosimilars collective intelligence consortium
4750529|NCT02922192|BBCIC|bbcic
4750530|NCT02922179|Insulin|insulin
4750531|NCT02922179|Diabetes|diabetes
4750532|NCT02922179|Biologic and Biosimilars Collective Intelligence Consortium|biologic and biosimilars collective intelligence consortium
4750533|NCT02922179|BBCIC|bbcic
4750534|NCT02922179|Descriptive analysis|descriptive analysis
4750535|NCT02922153|CryoAnalgesia|cryoanalgesia
4750536|NCT02922153|Thoracotomy|thoracotomy
4750537|NCT02922153|FEV1|fev1
4750538|NCT02922153|VAS|vas
4750539|NCT02922140|pharmaceutical care service, clinical pharmacist|pharmaceutical care service, clinical pharmacist
4750540|NCT02922140|Cardiac rehabilitation unit|cardiac rehabilitation unit
4750541|NCT02922140|Acute coronary syndrome|acute coronary syndrome
4750542|NCT02922140|patient education and counselling|patient education and counselling
4750543|NCT02922127|Ulipristal Acetate (UPA)|ulipristal acetate (upa)
4750544|NCT02922127|Breast Cancer|breast cancer
4750545|NCT02922127|Combined Oral Contraceptive (COC)|combined oral contraceptive (coc)
4750546|NCT02922114|Ultrasonography|ultrasonography
4750547|NCT02922114|Clinical assesment|clinical assesment
4750548|NCT02922114|joint abnormalities|joint abnormalities
4750549|NCT02922088|Vein Graft Failure|vein graft failure
4750550|NCT02922088|Coronary Artery Bypass Graft Surgery|coronary artery bypass graft surgery
4750551|NCT02922088|Vascular Grafts|vascular grafts
4750552|NCT02922088|Saphenous Vein Grafts|saphenous vein grafts
4750553|NCT02922088|Vein Graft Disease|vein graft disease
4750554|NCT02922088|Vein Graft Treatment|vein graft treatment
4750555|NCT02922088|Vein Graft Handling|vein graft handling
4750556|NCT02922075|gingival recession|gingival recession
4750557|NCT02922075|immediate implant and provisional placement|immediate implant and provisional placement
4750558|NCT02922075|bone graft|bone graft
4750559|NCT02922075|connective tissue graft|connective tissue graft
4750560|NCT02922075|collagen matrix|collagen matrix
4750561|NCT02922062|lipids|lipids
4750562|NCT02922062|saturated fat|saturated fat
4750563|NCT02922062|palm oil|palm oil
4750564|NCT02922049|Probe Based Confocal Laser Endomicroscopy (pCLE)|probe based confocal laser endomicroscopy (pcle)
4750565|NCT02922049|Barrett's esophagus|barrett's esophagus
4750566|NCT02922049|BORN|born
4750567|NCT02922049|Intestinal metaplasia|intestinal metaplasia
4750568|NCT02921997|A/H5N1|a/h5n1
4750569|NCT02921997|A/H7N9|a/h7n9
4750570|NCT02921997|ASO3 Adjuvant|aso3 adjuvant
4750571|NCT02921997|influenza|influenza
4750572|NCT02921997|monovalent|monovalent
4750573|NCT02921997|pH1N1|ph1n1
4750574|NCT02921997|vaccines|vaccines
4750969|NCT02919514|surfaces|surfaces
4750575|NCT02921984|Salivary Gland Tumors|salivary gland tumors
4750576|NCT02921984|Head and Neck Cancer|head and neck cancer
4750577|NCT02921984|concurrent chemotherapy|concurrent chemotherapy
4750578|NCT02921984|genetic testing|genetic testing
4750579|NCT02921958|Parents of children with disabilities|parents of children with disabilities
4750580|NCT02921932|Physiotherapy|physiotherapy
4750581|NCT02921932|Inspiratory Muscle Training|inspiratory muscle training
4750582|NCT02921932|Perioperative Medicine|perioperative medicine
4750583|NCT02921932|Postoperative outcomes|postoperative outcomes
4750584|NCT02921932|Preoperative nutrition|preoperative nutrition
4750585|NCT02921932|Elderly, frail|elderly, frail
4750586|NCT02921906|Insulin|insulin
4750587|NCT02921906|Glucose|glucose
4750588|NCT02921906|Incretin|incretin
4750589|NCT02921906|GLP-1|glp-1
4750590|NCT02921906|Food|food
4750591|NCT02921867|ultrasound|ultrasound
4750592|NCT02921867|radiology|radiology
4750593|NCT02921867|simulation|simulation
4750594|NCT02921867|abdominal ultrasound|abdominal ultrasound
4750595|NCT02921867|medical education|medical education
4750596|NCT02921841|Adolescents|adolescents
4750597|NCT02921841|HIV prevention|hiv prevention
4750598|NCT02921841|computerized intervention|computerized intervention
4750599|NCT02921841|mental health treatment|mental health treatment
4750600|NCT02921828|Pomalyst|pomalyst
4750601|NCT02921828|Teratogenicity|teratogenicity
4750602|NCT02921828|bone marrow suppression|bone marrow suppression
4750603|NCT02921828|thromboembolism|thromboembolism
4750604|NCT02921828|peripheral neuropathy|peripheral neuropathy
4750605|NCT02921828|infection|infection
4750606|NCT02921828|tumour lysis syndrome|tumour lysis syndrome
4750607|NCT02921828|somnolence|somnolence
4750608|NCT02921828|depressed level of consciousness|depressed level of consciousness
4750609|NCT02921828|confusion|confusion
4750610|NCT02921828|fatigue|fatigue
4750611|NCT02921828|dizziness|dizziness
4750612|NCT02921828|acute renal failure|acute renal failure
4750613|NCT02921828|heart failure|heart failure
4750614|NCT02921828|arrhythmia|arrhythmia
4750615|NCT02921828|interstitial pneumonia|interstitial pneumonia
4750616|NCT02921828|hypersensitivity|hypersensitivity
4750617|NCT02921828|hepatic function disorder|hepatic function disorder
4750618|NCT02921828|jaundice|jaundice
4750619|NCT02921815|Leukemia|leukemia
4750620|NCT02921815|Acute Myeloid Leukemia|acute myeloid leukemia
4750621|NCT02921815|Revlimid|revlimid
4750622|NCT02921802|Teratogenicity|teratogenicity
4750623|NCT02921802|Thrombocytopenia and haemorrhage|thrombocytopenia and haemorrhage
4750624|NCT02921802|Neutropenia and infection|neutropenia and infection
4750625|NCT02921802|Venous thromboembolism|venous thromboembolism
4750626|NCT02921802|Allergic reactions|allergic reactions
4750627|NCT02921802|Diarrhoea or constipation|diarrhoea or constipation
4750628|NCT02921802|Peripheral neuropathy|peripheral neuropathy
4750629|NCT02921802|Cardiac failure|cardiac failure
4750630|NCT02921802|Arrhythmia|arrhythmia
4750631|NCT02921802|Renal failure|renal failure
4750632|NCT02921802|Myocardial infarction|myocardial infarction
4750633|NCT02921802|Interstitial lung disease|interstitial lung disease
4750634|NCT02921802|Tumour lysis syndrome|tumour lysis syndrome
4750635|NCT02921802|Transformation from myelodysplastic syndrome to acute myeloid leukemia|transformation from myelodysplastic syndrome to acute myeloid leukemia
4750636|NCT02921789|Bleselumab|bleselumab
4750637|NCT02921789|ASKP1240|askp1240
4750638|NCT02921789|Efficacy and Safety|efficacy and safety
4750639|NCT02921776|Vidatalk|vidatalk
4750640|NCT02921776|App|app
4750641|NCT02921776|Augmentative and Alternative Communication|augmentative and alternative communication
4750642|NCT02921776|iPad|ipad
4750643|NCT02921776|Android|android
4750644|NCT02921776|Mechanical ventilation|mechanical ventilation
4750645|NCT02921776|Patient Communication|patient communication
4750646|NCT02921776|Critical Illness|critical illness
4750647|NCT02921750|wound reduction wound healing, venous ulcers|wound reduction wound healing, venous ulcers
4750648|NCT02921737|metastatic|metastatic
4750649|NCT02921737|pancreatic|pancreatic
4750650|NCT02921737|adenocarcinoma|adenocarcinoma
4750651|NCT02921724|cancer|cancer
4750652|NCT02921724|oral drug|oral drug
4750653|NCT02921724|sunitinib|sunitinib
4750654|NCT02921724|capecitabine|capecitabine
4750655|NCT02921724|mobile app|mobile app
4750656|NCT02921659|nicotinamide riboside|nicotinamide riboside
4750657|NCT02921659|aging|aging
4750658|NCT02921659|arterial stiffness|arterial stiffness
4750659|NCT02921659|endothelial dysfunction|endothelial dysfunction
4750660|NCT02921646|energetic expenditure|energetic expenditure
4750661|NCT02921633|Immunization|immunization
4750662|NCT02921633|Behavioural insights|behavioural insights
4750663|NCT02921633|Children|children
4750664|NCT02921620|Gastrointestinal symptoms|gastrointestinal symptoms
4750665|NCT02921620|Diarrhea|diarrhea
4750666|NCT02921620|Abdominal pain|abdominal pain
4750667|NCT02921581|Dose painting|dose painting
4750668|NCT02921581|18F-FDG|18f-fdg
4750669|NCT02921581|Positron emission tomography|positron emission tomography
4750670|NCT02921581|Radiotherapy|radiotherapy
4750671|NCT02921555|RCT (randomized controlled trial)|rct (randomized controlled trial)
4750672|NCT02921529|Postoperative recovery|postoperative recovery
4750673|NCT02921529|colon surgery|colon surgery
4750674|NCT02921516|Adolescence|adolescence
4750675|NCT02921516|Adherence|adherence
4750676|NCT02921438|Cardiovascular Diseases|cardiovascular diseases
4750677|NCT02921438|Heart Diseases|heart diseases
4750678|NCT02921438|Myocardial Ischemia|myocardial ischemia
4750679|NCT02921438|NSTE ACS|nste acs
4750680|NCT02921438|NSTEMI|nstemi
4750681|NCT02921438|Unstable Angina Pectoris|unstable angina pectoris
4750682|NCT02921438|Coronary Artery Disease|coronary artery disease
4750683|NCT02921425|lifestyle|lifestyle
4750684|NCT02921425|patient health record|patient health record
4750685|NCT02921425|Veterans|veterans
4750686|NCT02921425|prediabetes|prediabetes
4750687|NCT02921373|perfluorocarbon imaging|perfluorocarbon imaging
4750688|NCT02921373|peripheral blood mononuclear cells|peripheral blood mononuclear cells
4750689|NCT02921373|cancer immunotherapy|cancer immunotherapy
4750690|NCT02921373|prostate cancer|prostate cancer
4750691|NCT02921373|MRI|mri
4750692|NCT02921360|thrombolytic therapy|thrombolytic therapy
4750693|NCT02921360|tissue plasminogen activator|tissue plasminogen activator
4750694|NCT02921360|aspirin|aspirin
4750695|NCT02921321|MRI|mri
4750696|NCT02921321|Muscular Dystrophy|muscular dystrophy
4750697|NCT02921321|Cardiac|cardiac
4750698|NCT02921321|Late gadolinium enhancement|late gadolinium enhancement
4750699|NCT02921308|Prematurity|prematurity
4750700|NCT02921308|Bronchopulmonary dysplasia|bronchopulmonary dysplasia
4750701|NCT02921308|MRI|mri
4750702|NCT02921308|PFT|pft
4750703|NCT02921308|Emphysema|emphysema
4750704|NCT02921282|genes|genes
4750705|NCT02921282|cues|cues
4750706|NCT02921282|reward|reward
4750707|NCT02921282|smoking|smoking
4750708|NCT02921230|atherosclerosis|atherosclerosis
4750709|NCT02921230|Superficial Femoral Artery (SFA)|superficial femoral artery (sfa)
4750710|NCT02921230|Proximal Popliteal Artery (PPA)|proximal popliteal artery (ppa)
4750711|NCT02921230|stenting|stenting
4750712|NCT02921230|paclitaxel|paclitaxel
4750713|NCT02921217|Cardiovascular diseases|cardiovascular diseases
4750714|NCT02921217|abdominal visceral fat|abdominal visceral fat
4750715|NCT02921217|subcutaneous body fat|subcutaneous body fat
4750716|NCT02921217|body weight|body weight
4750717|NCT02921217|waist circumference|waist circumference
4750718|NCT02921217|lipid profile|lipid profile
4750719|NCT02921217|insulin resistance|insulin resistance
4750720|NCT02921217|glucose metabolism|glucose metabolism
4750721|NCT02921217|blood pressure|blood pressure
4750722|NCT02921217|inflammation|inflammation
4750723|NCT02921217|adiponectin|adiponectin
4750724|NCT02921217|leptin|leptin
4750725|NCT02921217|metabolomics|metabolomics
4750726|NCT02921217|cardiovascular risk factor|cardiovascular risk factor
4750727|NCT02921204|Vitamin D|vitamin d
4750728|NCT02921204|Calcium|calcium
4750729|NCT02921204|Phytic Acid|phytic acid
4750730|NCT02921204|body weight|body weight
4750731|NCT02921191|recombinant human granulocyte colony-stimulating factors|recombinant human granulocyte colony-stimulating factors
4750732|NCT02921191|G-CSFs|g-csfs
4750733|NCT02921191|biosimilar|biosimilar
4750734|NCT02921191|biologics|biologics
4750735|NCT02921191|High Neutropenia Risk Chemotherapy|high neutropenia risk chemotherapy
4750736|NCT02921191|Biologic and Biosimilars Collective Intelligence Consortium|biologic and biosimilars collective intelligence consortium
4750737|NCT02921191|bbcic|bbcic
4750738|NCT02921165|tooth extraction|tooth extraction
4750739|NCT02921165|tooth socket healing|tooth socket healing
4750740|NCT02921165|hypertension|hypertension
4750741|NCT02921165|rinses|rinses
4750742|NCT02921139|Hepatocellular Carcinoma|hepatocellular carcinoma
4750743|NCT02921139|Transcatheter Arterial Chemoembolization (TACE)|transcatheter arterial chemoembolization (tace)
4750744|NCT02921139|Stereotactic ablative radiotherapy (SABR)|stereotactic ablative radiotherapy (sabr)
4750745|NCT02921113|suPAR|supar
4750746|NCT02921113|Acute Kidney Injury|acute kidney injury
4750747|NCT02921113|On-Pump Cardiac Surgery|on-pump cardiac surgery
4750748|NCT02921113|Biomarker|biomarker
4750749|NCT02921048|Eicosapentaenoic Acid|eicosapentaenoic acid
4750750|NCT02921048|Docosahexaenoic Acid|docosahexaenoic acid
4750751|NCT02921048|Ambient Air Pollution|ambient air pollution
4750752|NCT02921035|Relapsing Multiple Sclerosis|relapsing multiple sclerosis
4750753|NCT02921035|Interferon beta-1a|interferon beta-1a
4750754|NCT02921035|Rebif®|rebif®
4750755|NCT02921035|Morisky Medication Adherence Scale|morisky medication adherence scale
4750756|NCT02921022|Gemcitabine|gemcitabine
4750757|NCT02921022|Nab-paclitaxel|nab-paclitaxel
4750758|NCT02921022|PEGPH20|pegph20
4750759|NCT02921022|Rivaroxaban|rivaroxaban
4750760|NCT02921022|thromboembolic event (TE)|thromboembolic event (te)
4750761|NCT02921022|16-1066|16-1066
4750762|NCT02920996|NSCLC|nsclc
4750763|NCT02920996|MET|met
4750764|NCT02920996|Non-small cell lung cancer|non-small cell lung cancer
4750765|NCT02920996|MET mutation|met mutation
4750766|NCT02920996|NTRK rearrangement|ntrk rearrangement
4750767|NCT02920996|NTRK|ntrk
4750768|NCT02920996|targeted therapy|targeted therapy
4750769|NCT02920996|MET exon 14|met exon 14
4750770|NCT02920996|NTRK1|ntrk1
4750771|NCT02920996|NTRK2|ntrk2
4750772|NCT02920996|NTRK3|ntrk3
4750773|NCT02920996|merestinib|merestinib
4750774|NCT02920996|LY2801653|ly2801653
4750775|NCT02920918|Systolic Heart Failure|systolic heart failure
4750776|NCT02920918|Canagliflozin|canagliflozin
4750777|NCT02920918|Sitagliptin Phosphate|sitagliptin phosphate
4750778|NCT02920918|Type 2 Diabetes|type 2 diabetes
4750779|NCT02920918|SGLT2 inhibitor|sglt2 inhibitor
4750780|NCT02920918|DPPIV inhibitor|dppiv inhibitor
4750781|NCT02920866|Functional strength integration|functional strength integration
4750782|NCT02920866|Rehabilitation|rehabilitation
4750783|NCT02920866|Hip arthroplasty|hip arthroplasty
4750784|NCT02920866|Physical function|physical function
4750785|NCT02920866|Muscle performance|muscle performance
4750786|NCT02920866|Movement compensations|movement compensations
4750787|NCT02920853|chronic pain|chronic pain
4750788|NCT02920827|HIV Infections|hiv infections
4750789|NCT02920827|HIV seronegativity|hiv seronegativity
4750790|NCT02920801|saxagliptin|saxagliptin
4750791|NCT02920801|endothelial progenitor cell|endothelial progenitor cell
4750792|NCT02920801|flow-mediated dilation|flow-mediated dilation
4750793|NCT02920788|Rehabilitation|rehabilitation
4750794|NCT02920788|Functional Magnetic Resonance Imaging|functional magnetic resonance imaging
4750795|NCT02920749|anaesthesia|anaesthesia
4750796|NCT02920749|costs|costs
4750797|NCT02920749|recovery profiles|recovery profiles
4750798|NCT02920723|Sleep Apnea Syndromes|sleep apnea syndromes
4750799|NCT02920723|Sleep Apnea, Obstructives|sleep apnea, obstructives
4750800|NCT02920723|Training|training
4750801|NCT02920684|Early rehabilitation|early rehabilitation
4750802|NCT02920684|Mechanical ventilation|mechanical ventilation
4750803|NCT02920684|Physiotherapy|physiotherapy
4750804|NCT02920658|NAVS Naphthalan|navs naphthalan
4750805|NCT02920658|Betamethasone dipropionate|betamethasone dipropionate
4750806|NCT02920658|Topical treatment|topical treatment
4750807|NCT02920645|ICH|ich
4750808|NCT02920645|AVM|avm
4750809|NCT02920645|intracerebral hemorrhage|intracerebral hemorrhage
4750810|NCT02920645|arterio-venous malformation|arterio-venous malformation
4750811|NCT02920645|AVICH|avich
4750812|NCT02920632|Parkinson|parkinson
4750813|NCT02920632|Cognitive training|cognitive training
4750814|NCT02920632|Cognitive rehabilitation|cognitive rehabilitation
4750815|NCT02920632|Brain networks|brain networks
4750816|NCT02920619|ultrasound|ultrasound
4750817|NCT02920619|muscle|muscle
4750818|NCT02920606|pulpotomy|pulpotomy
4750819|NCT02920606|pulpitis|pulpitis
4750820|NCT02920606|mature tooth|mature tooth
4750821|NCT02920606|tricalcium silicate|tricalcium silicate
4750822|NCT02920593|Vitamin D; hypertensive disorders of pregnancy|vitamin d; hypertensive disorders of pregnancy
4750823|NCT02920580|Subarachnoid hemorrhage|subarachnoid hemorrhage
4750824|NCT02920580|Spontaneous intracerebral hemorrhage|spontaneous intracerebral hemorrhage
4750825|NCT02920580|Global cerebral anoxia/cardiac arrest|global cerebral anoxia/cardiac arrest
4750826|NCT02920580|Meningitis/Encephalitis/Cerebral abscess|meningitis/encephalitis/cerebral abscess
4750827|NCT02920580|Seizure|seizure
4750828|NCT02920580|Traumatic Brain Injury (TBI)|traumatic brain injury (tbi)
4750829|NCT02920580|Ischemic Stroke|ischemic stroke
4750830|NCT02920580|Brain tumor|brain tumor
4750831|NCT02920554|gallbladder cancer|gallbladder cancer
4750832|NCT02920554|bisegmentectomy|bisegmentectomy
4750833|NCT02920515|epidemiology|epidemiology
4750834|NCT02920515|treatment|treatment
4750835|NCT02920515|molecular pathological mechanism|molecular pathological mechanism
4750836|NCT02920515|environmental disrupting chemicals|environmental disrupting chemicals
4750837|NCT02920489|severity of labor pain|severity of labor pain
4750838|NCT02920489|individualized administration|individualized administration
4750839|NCT02920489|neuraxial labor analgesia|neuraxial labor analgesia
4750840|NCT02920476|lung|lung
4750841|NCT02920476|metastatic|metastatic
4750842|NCT02920476|carcinoma|carcinoma
4750843|NCT02920463|Anti-Infective agents|anti-infective agents
4750844|NCT02920463|Antimicrobial stewardship|antimicrobial stewardship
4750845|NCT02920463|Empirical antibiotic therapy|empirical antibiotic therapy
4750846|NCT02920463|De-escalation|de-escalation
4750847|NCT02920463|Critical care|critical care
4750848|NCT02920450|lung|lung
4750849|NCT02920450|carcinoma|carcinoma
4750850|NCT02920437|dietary salt|dietary salt
4750851|NCT02920437|24 hour urinary sodium excretion|24 hour urinary sodium excretion
4750852|NCT02920437|blood pressure|blood pressure
4750853|NCT02920437|hypertension|hypertension
4750854|NCT02920346|Neonatal Systemic lupus erythematosus|neonatal systemic lupus erythematosus
4750855|NCT02920346|Sjogren's syndrome|sjogren's syndrome
4750856|NCT02920346|Fetal Atrioventricular Block|fetal atrioventricular block
4750857|NCT02920346|Fetal Heart Block|fetal heart block
4750858|NCT02920333|stroke|stroke
4750859|NCT02920333|transcraniel direct current stimulation|transcraniel direct current stimulation
4750860|NCT02920333|repetitive transcraniel magnetic stimulation|repetitive transcraniel magnetic stimulation
4750861|NCT02920333|rehabilitation|rehabilitation
4750862|NCT02920333|lower extremities|lower extremities
4750863|NCT02920307|laparoscopic inguinal hernia repair|laparoscopic inguinal hernia repair
4750864|NCT02920307|total extraperitoneoscopic hernia repair|total extraperitoneoscopic hernia repair
4750865|NCT02920307|transabdominal preperitoneal hernia repair|transabdominal preperitoneal hernia repair
4750866|NCT02920307|inguinal hernia|inguinal hernia
4750867|NCT02920307|laparoscopy|laparoscopy
4750868|NCT02920307|hernia repair|hernia repair
4750869|NCT02920307|herniorraphy|herniorraphy
4750870|NCT02920307|laparoscopic surgery|laparoscopic surgery
4750871|NCT02920294|probiotics, microbiota, ileostoma|probiotics, microbiota, ileostoma
4750872|NCT02920268|dance-intervention|dance-intervention
4750873|NCT02920268|yoga|yoga
4750874|NCT02920268|adolescents|adolescents
4750875|NCT02920268|recurrent abdominal pain|recurrent abdominal pain
4750876|NCT02920242|Travelers|travelers
4750877|NCT02920242|diarrhea|diarrhea
4750878|NCT02920242|rifaximin|rifaximin
4750879|NCT02920242|equivalence|equivalence
4750880|NCT02920229|68Ga-PSMA|68ga-psma
4750881|NCT02920229|HBED-PET/CT|hbed-pet/ct
4750882|NCT02920229|biochemical relapse|biochemical relapse
4750883|NCT02920229|prostate cancer|prostate cancer
4750884|NCT02920229|radically treated|radically treated
4750885|NCT02920216|Head and Neck Neoplasms|head and neck neoplasms
4750886|NCT02920216|Recurrence|recurrence
4750887|NCT02920216|Indocyanine Green|indocyanine green
4750888|NCT02920216|Salvage surgery|salvage surgery
4750889|NCT02920203|Sudden unexpected death|sudden unexpected death
4750890|NCT02920203|young subjects|young subjects
4750891|NCT02920203|molecular genetic autopsy|molecular genetic autopsy
4750892|NCT02920203|sequencing|sequencing
4750893|NCT02920138|Obesity|obesity
4750894|NCT02920138|intraabdominal pressure|intraabdominal pressure
4750895|NCT02920138|cerebral oxymeter|cerebral oxymeter
4750896|NCT02920138|sleeve gastrectomy|sleeve gastrectomy
4750897|NCT02920138|laparoscopy|laparoscopy
4750898|NCT02920125|Vascular disease|vascular disease
4750899|NCT02920112|Obesity|obesity
4750900|NCT02920112|Bariatric Surgery|bariatric surgery
4750901|NCT02920112|Bariatrics|bariatrics
4750902|NCT02920112|Cognitive Therapy|cognitive therapy
4750903|NCT02920112|Binge eating|binge eating
4750904|NCT02920099|Nutrition literacy|nutrition literacy
4750905|NCT02920073|Microbiota|microbiota
4750906|NCT02920073|anorexia nervosa|anorexia nervosa
4750907|NCT02920073|under nutrition|under nutrition
4750908|NCT02920073|inpatients|inpatients
4750909|NCT02920073|enteral nutrition|enteral nutrition
4750910|NCT02920060|RSE|rse
4750911|NCT02920047|Fimasartan|fimasartan
4750912|NCT02920008|AML, acute myeloid leukemia, guadecitabine, SGI-110, Phase 3|aml, acute myeloid leukemia, guadecitabine, sgi-110, phase 3
4750913|NCT02919982|Anticoagulant|anticoagulant
4750914|NCT02919982|Nonvalvular atrial fibrillation|nonvalvular atrial fibrillation
4750915|NCT02919982|Registries|registries
4750916|NCT02919969|Anal Cancer|anal cancer
4750917|NCT02919956|Single Ventricle|single ventricle
4750918|NCT02919956|Fontan|fontan
4750919|NCT02919904|prostate cancer|prostate cancer
4750920|NCT02919904|sleep|sleep
4750921|NCT02919904|androgen deprivation therapy|androgen deprivation therapy
4750922|NCT02919891|intra-epidermal nerve fibre density|intra-epidermal nerve fibre density
4750923|NCT02919891|IENFD|ienfd
4750924|NCT02919891|Chronic Pain|chronic pain
4750925|NCT02919891|Post-mastectomy|post-mastectomy
4750926|NCT02919891|Post-mastectomy pain syndrome|post-mastectomy pain syndrome
4750927|NCT02919891|PMPS|pmps
4750928|NCT02919891|Chronic Post-Surgical Pain|chronic post-surgical pain
4750929|NCT02919891|CPSP|cpsp
4750930|NCT02919891|Mastectomy|mastectomy
4750931|NCT02919813|mindfulness group therapy|mindfulness group therapy
4750932|NCT02919813|vulvodynia|vulvodynia
4750933|NCT02919813|vulvar pain|vulvar pain
4750934|NCT02919787|Neoadjuvant treatment|neoadjuvant treatment
4750935|NCT02919761|persistant disease activity|persistant disease activity
4750936|NCT02919748|dementia|dementia
4750937|NCT02919748|cognitive decline|cognitive decline
4750938|NCT02919748|choral singing|choral singing
4750939|NCT02919748|health education program|health education program
4750940|NCT02919748|randomized controlled trial|randomized controlled trial
4750941|NCT02919735|Alopecia|alopecia
4750942|NCT02919735|Hair|hair
4750943|NCT02919735|Chemotherapy|chemotherapy
4750944|NCT02919735|Cancer|cancer
4750945|NCT02919722|Music therapy|music therapy
4750946|NCT02919722|sensorimotor cortex|sensorimotor cortex
4750947|NCT02919722|brain injury|brain injury
4750948|NCT02919696|CDK4/6 Inhibitor|cdk4/6 inhibitor
4750949|NCT02919683|Head and Neck Cancer|head and neck cancer
4750950|NCT02919670|Stem Cell Transplant|stem cell transplant
4750951|NCT02919644|vaccination|vaccination
4750952|NCT02919644|autologous dendritic cells|autologous dendritic cells
4750953|NCT02919644|autologous tumour homogenate|autologous tumour homogenate
4750954|NCT02919644|curative resection|curative resection
4750955|NCT02919644|stage IV colorectal cancer|stage iv colorectal cancer
4750956|NCT02919618|Ventricular Tachycardia|ventricular tachycardia
4750957|NCT02919618|Ablation|ablation
4750958|NCT02919618|Noninvasive|noninvasive
4750959|NCT02919605|Cutaneous Leishmaniasis|cutaneous leishmaniasis
4750960|NCT02919605|pentamidine isothionate|pentamidine isothionate
4750961|NCT02919605|treatment|treatment
4750962|NCT02919553|endoscopic ultrasound|endoscopic ultrasound
4750963|NCT02919553|wet-suction technique|wet-suction technique
4750964|NCT02919553|capillary technique|capillary technique
4750965|NCT02919553|fine needle aspiration|fine needle aspiration
4750966|NCT02919553|fine needle biopsy|fine needle biopsy
4750967|NCT02919514|fall prevention|fall prevention
4750968|NCT02919514|Aging|aging
4750970|NCT02919475|JTE-051|jte-051
4750971|NCT02919475|Active Rheumatoid Arthritis|active rheumatoid arthritis
4750972|NCT02919475|Efficacy|efficacy
4750973|NCT02919475|Safety|safety
4750974|NCT02919475|Tolerability|tolerability
4750975|NCT02919475|Rheumatoid Arthritis|rheumatoid arthritis
4750976|NCT02919462|Carcinoma, Non-Small-Cell Lung|carcinoma, non-small-cell lung
4750977|NCT02919462|advanced stage IIIB|advanced stage iiib
4750978|NCT02919462|high Thymidylate Synthase expression|high thymidylate synthase expression
4750979|NCT02919462|Treatment|treatment
4750980|NCT02919462|Chemotherapy Naïve Patients|chemotherapy naïve patients
4750981|NCT02919462|stage IIIB-IV Non-Squamous Non-Small Cell Lung Cancer|stage iiib-iv non-squamous non-small cell lung cancer
4750982|NCT02919462|Cisplatin and Pemetrexed|cisplatin and pemetrexed
4750983|NCT02919462|Cisplatin and Oral Vinorelbine|cisplatin and oral vinorelbine
4750984|NCT02919449|Lung Cancer Measles Nivolumab Opdivo|lung cancer measles nivolumab opdivo
4750985|NCT02919384|Embryonic development|embryonic development
4750986|NCT02919384|blastocyst stage|blastocyst stage
4750987|NCT02919345|Dapagliflozin|dapagliflozin
4750988|NCT02919345|Glibenclamide|glibenclamide
4750989|NCT02919345|Endothelial Function|endothelial function
4750990|NCT02919345|Vascular Endothelial Cells|vascular endothelial cells
4750991|NCT02919345|Flow Mediated Dilation|flow mediated dilation
4750992|NCT02919267|One lung ventilation|one lung ventilation
4750993|NCT02919267|Lung collapse|lung collapse
4750994|NCT02919267|Bronchial blocker|bronchial blocker
4750995|NCT02919267|Double lumen tube|double lumen tube
4750996|NCT02919267|video assisted thoracoscopic surgery|video assisted thoracoscopic surgery
4750997|NCT02919267|VATS|vats
4750998|NCT02919267|DLT|dlt
4750999|NCT02919267|Thoracic surgery|thoracic surgery
4751000|NCT02919267|Video-assisted|video-assisted
4751001|NCT02919241|dental anxiety|dental anxiety
4751002|NCT02919241|cognitive therapy|cognitive therapy
4751003|NCT02919228|cerebral oxygen metabolism|cerebral oxygen metabolism
4751004|NCT02919228|functional near-infrared spectroscopy|functional near-infrared spectroscopy
4751005|NCT02919228|partial pressure of carbon dioxide|partial pressure of carbon dioxide
4751006|NCT02919228|heart rate variability|heart rate variability
4751007|NCT02919228|blood pressure|blood pressure
4751008|NCT02919228|affect|affect
4751009|NCT02919228|mood|mood
4751010|NCT02919228|respiration|respiration
4751011|NCT02919228|systematic randomized cross-over study|systematic randomized cross-over study
4751012|NCT02919228|systemic physiology|systemic physiology
4751013|NCT02919228|electro-dermal activity|electro-dermal activity
4751014|NCT02919228|pulse-respiratory quotient|pulse-respiratory quotient
4751015|NCT02919189|cerebral oxygen metabolism|cerebral oxygen metabolism
4751016|NCT02919189|functional near-infrared spectroscopy|functional near-infrared spectroscopy
4751017|NCT02919189|partial pressure of carbon dioxide|partial pressure of carbon dioxide
4751018|NCT02919189|heart rate variability|heart rate variability
4751019|NCT02919189|blood pressure|blood pressure
4751020|NCT02919189|affect|affect
4751021|NCT02919189|mood|mood
4751022|NCT02919189|respiration|respiration
4751023|NCT02919189|systematic randomized cross-over study|systematic randomized cross-over study
4751024|NCT02919189|systemic physiology|systemic physiology
4751025|NCT02919189|electro-dermal activity|electro-dermal activity
4751026|NCT02919189|pulse-respiratory quotient|pulse-respiratory quotient
4751027|NCT02919163|cerebral oxygen metabolism|cerebral oxygen metabolism
4751028|NCT02919163|functional near-infrared spectroscopy|functional near-infrared spectroscopy
4751029|NCT02919163|partial pressure of carbon dioxide|partial pressure of carbon dioxide
4751030|NCT02919163|heart rate variability|heart rate variability
4751031|NCT02919163|blood pressure|blood pressure
4751032|NCT02919163|affect|affect
4751033|NCT02919163|mood|mood
4751034|NCT02919163|respiration|respiration
4751035|NCT02919163|systematic randomized cross-over study|systematic randomized cross-over study
4751036|NCT02919163|systemic physiology|systemic physiology
4751037|NCT02919163|electro-dermal activity|electro-dermal activity
4751038|NCT02919163|pulse-respiratory quotient|pulse-respiratory quotient
4751039|NCT02919150|Myofascial Trigger Points|myofascial trigger points
4751040|NCT02919150|Myotonometry|myotonometry
4751041|NCT02919150|Isokinetic Dynamometry|isokinetic dynamometry
4751042|NCT02919150|Assessment|assessment
4751043|NCT02919150|Reliability|reliability
4751044|NCT02919137|cerebral oxygen metabolism|cerebral oxygen metabolism
4751045|NCT02919137|functional near-infrared spectroscopy|functional near-infrared spectroscopy
4751046|NCT02919137|partial pressure of carbon dioxide|partial pressure of carbon dioxide
4751047|NCT02919137|heart rate variability|heart rate variability
4751048|NCT02919137|blood pressure|blood pressure
4751049|NCT02919137|affect|affect
4751050|NCT02919137|mood|mood
4751051|NCT02919137|respiration|respiration
4751052|NCT02919137|systematic randomized cross-over study|systematic randomized cross-over study
4751053|NCT02919137|systemic physiology|systemic physiology
4751054|NCT02919137|electro-dermal activity|electro-dermal activity
4751055|NCT02919137|pulse-respiratory quotient|pulse-respiratory quotient
4751056|NCT02919124|Coronary artery bypass grafting|coronary artery bypass grafting
4751057|NCT02919124|Anastomosis|anastomosis
4751058|NCT02919124|Ultrasonography|ultrasonography
4751059|NCT02919059|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
4751060|NCT02919059|DM|dm
4751061|NCT02919046|neuroblastoma|neuroblastoma
4751062|NCT02919046|CAR-T|car-t
4751063|NCT02919033|randomized controlled trial|randomized controlled trial
4751064|NCT02919033|telemedicine|telemedicine
4751065|NCT02919033|hypertension|hypertension
4751066|NCT02919033|primary care|primary care
4751067|NCT02919033|medication adherence|medication adherence
4751068|NCT02919020|Proprioceptive Neuromuscular Facilitation (PNF )|proprioceptive neuromuscular facilitation (pnf )
4751069|NCT02919020|resistance exercise|resistance exercise
4751070|NCT02918968|enzalutamide|enzalutamide
4751071|NCT02918968|Xtandi|xtandi
4751072|NCT02918968|Prostate Cancer|prostate cancer
4751073|NCT02918955|head and neck cancer|head and neck cancer
4751074|NCT02918955|radiotherapy|radiotherapy
4751075|NCT02918955|chemotherapy|chemotherapy
4751076|NCT02918955|neck dissection|neck dissection
4751077|NCT02918955|surgery|surgery
4751078|NCT02918955|quality of life|quality of life
4751079|NCT02918955|toxicity|toxicity
4751080|NCT02918955|oropharyngeal cancer|oropharyngeal cancer
4751081|NCT02918955|laryngeal cancer|laryngeal cancer
4751082|NCT02918955|hypopharyngeal cancer|hypopharyngeal cancer
4751083|NCT02918929|First-in-human|first-in-human
4751084|NCT02918929|Single Ascending Dose|single ascending dose
4751085|NCT02918929|Multiple Ascending Dose|multiple ascending dose
4751086|NCT02918890|Pediatric|pediatric
4751087|NCT02918890|HABIT|habit
4751088|NCT02918890|CIMT|cimt
4751089|NCT02918890|Cerebral Palsy|cerebral palsy
4751090|NCT02918890|Hemiplegia|hemiplegia
4751091|NCT02918890|Children|children
4751092|NCT02918890|Therapy|therapy
4751093|NCT02918877|Volatile Anesthetics|volatile anesthetics
4751094|NCT02918877|Intravenous Anesthetics|intravenous anesthetics
4751095|NCT02918877|Inflammatory Lung Injury|inflammatory lung injury
4751096|NCT02918877|Postoperative Pulmonary Complications|postoperative pulmonary complications
4751097|NCT02918877|Cardiac Surgery|cardiac surgery
4751098|NCT02918877|Cardiopulmonary Bypass|cardiopulmonary bypass
4751099|NCT02918864|Autism Spectrum Disorder|autism spectrum disorder
4751100|NCT02918864|Oxytocin|oxytocin
4751101|NCT02918864|Social Skills|social skills
4751102|NCT02918864|Social cognitive skills|social cognitive skills
4751103|NCT02918864|Cognitive Behavioral Intervention|cognitive behavioral intervention
4751104|NCT02918864|Combination treatment|combination treatment
4751105|NCT02918864|Syntocinon|syntocinon
4751106|NCT02918864|NETT (Nonverbal communication, Emotion recognition, Theory of mind Training)|nett (nonverbal communication, emotion recognition, theory of mind training)
4751107|NCT02918864|emotion recognition|emotion recognition
4751108|NCT02918864|theory of mind|theory of mind
4751109|NCT02918838|HIV|hiv
4751110|NCT02918838|Antiretroviral (ARV)|antiretroviral (arv)
4751111|NCT02918838|co-trimoxazole|co-trimoxazole
4751112|NCT02918838|SMS|sms
4751113|NCT02918838|Lottery incentive|lottery incentive
4751114|NCT02918838|mobile health|mobile health
4751115|NCT02918838|Uganda|uganda
4751116|NCT02918838|Youth|youth
4751117|NCT02918825|schizophrenia|schizophrenia
4751118|NCT02918825|clinical trial|clinical trial
4751119|NCT02918825|olanzapine|olanzapine
4751120|NCT02918825|paliperidone|paliperidone
4751121|NCT02918812|Hysterosalpingography|hysterosalpingography
4751122|NCT02918812|Pain relief|pain relief
4751123|NCT02918812|Infertility|infertility
4751124|NCT02918812|Intracervical block|intracervical block
4751125|NCT02918812|Diclofenac|diclofenac
4751126|NCT02918786|oxygen therapy|oxygen therapy
4751127|NCT02918786|continuous positive airway pressure|continuous positive airway pressure
4751128|NCT02918786|extubation|extubation
4751129|NCT02918773|Pediatrics|pediatrics
4751130|NCT02918773|Emergency Medicine|emergency medicine
4751131|NCT02918773|Ear infection|ear infection
4751132|NCT02918760|Gabapentin, chronic pelvic pain.|gabapentin, chronic pelvic pain.
4751133|NCT02918734|Anterior Cruciate Ligament|anterior cruciate ligament
4751134|NCT02918734|Bone-Patellar Tendon-Bone Grafting|bone-patellar tendon-bone grafting
4751135|NCT02918721|Hyaluronic Acid, Nasolabial Fold, Lidocaine|hyaluronic acid, nasolabial fold, lidocaine
4751136|NCT02918708|vaccination|vaccination
4751137|NCT02918708|immunisation|immunisation
4751138|NCT02918708|pneumococcal|pneumococcal
4751139|NCT02918708|conjugate|conjugate
4751140|NCT02918695|Geriatric assessment|geriatric assessment
4751141|NCT02918695|Fit and frail elderly|fit and frail elderly
4751142|NCT02918695|Geriatric oncology|geriatric oncology
4751143|NCT02918656|Cochrane|cochrane
4751144|NCT02918656|Abstract|abstract
4751145|NCT02918656|Infographics|infographics
4751146|NCT02918656|Understanding|understanding
4751147|NCT02918643|Elderly|elderly
4751148|NCT02918643|Potentially Inappropriate Medications|potentially inappropriate medications
4751149|NCT02918630|E-cigarettes|e-cigarettes
4751150|NCT02918630|Schizophrenia|schizophrenia
4751151|NCT02918617|dentin hypersensitivity|dentin hypersensitivity
4751152|NCT02918617|nanohydroxyapatite|nanohydroxyapatite
4751153|NCT02918617|calcium sodium phosphosilicate|calcium sodium phosphosilicate
4751154|NCT02918617|toothpaste|toothpaste
4751155|NCT02918617|tooth cream|tooth cream
4751156|NCT02918604|peripheral vein access|peripheral vein access
4751157|NCT02918604|infrared|infrared
4751158|NCT02918604|pediatric|pediatric
4751159|NCT02918578|Physical Inactivity|physical inactivity
4751160|NCT02918578|Behavior Change|behavior change
4751161|NCT02918526|Laryngeal masks|laryngeal masks
4751162|NCT02918513|Wellness|wellness
4751163|NCT02918513|Mental Wellness|mental wellness
4751164|NCT02918513|Well-Being|well-being
4751165|NCT02918500|Coronary Artery Bypass Surgery (CABG)|coronary artery bypass surgery (cabg)
4751166|NCT02918500|Nicotine Replacement Therapy (NRT)|nicotine replacement therapy (nrt)
4751167|NCT02918474|Contralateral prophylactic breast cancer|contralateral prophylactic breast cancer
4751168|NCT02918474|CPM|cpm
4751169|NCT02918474|Breast cancer surgery|breast cancer surgery
4751170|NCT02918474|Breast Cancer|breast cancer
4751171|NCT02918474|Questionnaire|questionnaire
4751172|NCT02918474|Survey|survey
4751173|NCT02918474|Decision tool|decision tool
4751174|NCT02918474|Contralateral Prophylactic Mastectomy|contralateral prophylactic mastectomy
4751175|NCT02918435|WE CARE|we care
4751176|NCT02918435|Pediatric practices|pediatric practices
4751177|NCT02918422|Diet Intervention|diet intervention
4751178|NCT02918422|Metabolic Syndrome|metabolic syndrome
4751179|NCT02918422|Feeding Study|feeding study
4751180|NCT02918422|Prediabetes|prediabetes
4751181|NCT02918396|Atrial Fibrillation|atrial fibrillation
4751182|NCT02918396|Atrial Fibrosis|atrial fibrosis
4751183|NCT02918396|Late Gadolinium Enhancement Magnetic Resonance Imaging|late gadolinium enhancement magnetic resonance imaging
4751184|NCT02918396|Computational Modeling|computational modeling
4751185|NCT02918396|Rotor Anchor Sites|rotor anchor sites
4751186|NCT02918370|Alcohol Use Disorder|alcohol use disorder
4751187|NCT02918370|Bipolar Disorder|bipolar disorder
4751188|NCT02918370|Mood|mood
4751189|NCT02918370|Alcohol Craving|alcohol craving
4751190|NCT02918370|Aripiprazole|aripiprazole
4751191|NCT02918344|calcium phosphate paste|calcium phosphate paste
4751192|NCT02918305|denervation|denervation
4751193|NCT02918305|resistant hypertension|resistant hypertension
4751194|NCT02918292|Haploidentical Bone Marrow|haploidentical bone marrow
4751195|NCT02918292|Hematopoietic Stem Cell Transplant (HSCT)|hematopoietic stem cell transplant (hsct)
4751196|NCT02918292|Severe Aplastic Anemia (SAA)|severe aplastic anemia (saa)
4751197|NCT02918292|Antithymocyte Globulin (ATG)|antithymocyte globulin (atg)
4751198|NCT02918266|Drug Therapy|drug therapy
4751199|NCT02918253|High dose-rate brachytherapy|high dose-rate brachytherapy
4751200|NCT02918227|Ejaculation|ejaculation
4751201|NCT02918227|Benign Prostatic Hyperplasia|benign prostatic hyperplasia
4751202|NCT02918227|Prostate|prostate
4751203|NCT02918214|Septic Shock|septic shock
4751204|NCT02918214|echocardiography|echocardiography
4751205|NCT02918214|diastolic dysfunction|diastolic dysfunction
4751206|NCT02918214|Transthoracic|transthoracic
4751207|NCT02918214|Transesophageal|transesophageal
4751208|NCT02918214|hyperkinesia|hyperkinesia
4751209|NCT02918214|prognosis|prognosis
4751210|NCT02918201|Administration, topical|administration, topical
4751211|NCT02918201|Tranexamic Acid|tranexamic acid
4751212|NCT02918201|Postoperative Care|postoperative care
4751213|NCT02918201|Bandages|bandages
4751214|NCT02918201|Occlusive Dressings|occlusive dressings
4751215|NCT02918175|mHealth|mhealth
4751216|NCT02918162|pembrolizumab|pembrolizumab
4751217|NCT02918162|adenocarcinoma|adenocarcinoma
4751218|NCT02918162|gastric cancer|gastric cancer
4751219|NCT02918162|Locoregional gastric adenocarcinoma|locoregional gastric adenocarcinoma
4751220|NCT02918162|Locoregional GE junction adenocarcinoma|locoregional ge junction adenocarcinoma
4751221|NCT02918149|Ultrasonography|ultrasonography
4751222|NCT02918149|Infant|infant
4751223|NCT02918149|Newborn|newborn
4751224|NCT02918149|Lumbar puncture|lumbar puncture
4751225|NCT02918149|Spinal puncture|spinal puncture
4751226|NCT02918149|Cerebrospinal fluid|cerebrospinal fluid
4751227|NCT02918123|Psoriasis|psoriasis
4751228|NCT02918123|Plaque psoriasis|plaque psoriasis
4751229|NCT02918123|Stem cell|stem cell
4751230|NCT02918123|Cell therapy|cell therapy
4751231|NCT02918123|Furestem|furestem
4751232|NCT02918123|Mesenchymal stem cell|mesenchymal stem cell
4751233|NCT02918123|MSC|msc
4751234|NCT02918123|Umbilical cord blood|umbilical cord blood
4751235|NCT02918123|hUCB-MSC|hucb-msc
4751236|NCT02918123|UCB-MSC|ucb-msc
4751237|NCT02918097|Cost effectiveness|cost effectiveness
4751238|NCT02918097|Bipolar disorder|bipolar disorder
4751239|NCT02918097|Depressive episodes|depressive episodes
4751240|NCT02918097|Quality of Life|quality of life
4751241|NCT02918084|sequential administration chemiotherapy|sequential administration chemiotherapy
4751242|NCT02918084|early breast cancer|early breast cancer
4751243|NCT02918084|breast cancer|breast cancer
4751244|NCT02918084|aromatase inhibitor|aromatase inhibitor
4751245|NCT02918084|adjuvant|adjuvant
4751246|NCT02918084|post menopausal|post menopausal
4751247|NCT02918071|Asthma,|asthma,
4751248|NCT02918071|Bronchial Diseases,|bronchial diseases,
4751249|NCT02918071|Respiratory Tract Diseases,|respiratory tract diseases,
4751250|NCT02918071|Lung Diseases,|lung diseases,
4751251|NCT02918071|Obstructive Lung Diseases,|obstructive lung diseases,
4751252|NCT02918071|Benralizumab|benralizumab
4751253|NCT02918058|Frailty|frailty
4751254|NCT02918058|Deprescription|deprescription
4751255|NCT02918045|Tooth Extraction|tooth extraction
4751256|NCT02918045|Surgical Hemostasis|surgical hemostasis
4751257|NCT02918045|Platelet Aggregation Inhibitors|platelet aggregation inhibitors
4751258|NCT02918045|Chitosan|chitosan
4751259|NCT02918032|Jordans anomaly|jordans anomaly
4751260|NCT02918032|neutral lipid storage disease|neutral lipid storage disease
4751261|NCT02918032|triglyceride deposit cardiovasculopathy|triglyceride deposit cardiovasculopathy
4751262|NCT02918032|ATGL gene|atgl gene
4751263|NCT02918032|CGI-58 gene|cgi-58 gene
4751264|NCT02918032|primary triglyceride deposit cardiomyovasculopathy (TGCV)|primary triglyceride deposit cardiomyovasculopathy (tgcv)
4751265|NCT02918032|neutral lipid storage disease with myopathy (NLSD-M)|neutral lipid storage disease with myopathy (nlsd-m)
4751266|NCT02917993|non-small cell lung cancer|non-small cell lung cancer
4751267|NCT02917993|locally advanced|locally advanced
4751268|NCT02917993|metastatic|metastatic
4751269|NCT02917993|epidermal growth factor receptor (EGFR) inhibition|epidermal growth factor receptor (egfr) inhibition
4751270|NCT02917993|Janus kinase inhibition|janus kinase inhibition
4751271|NCT02917980|structural Heart Diseases|structural heart diseases
4751272|NCT02917980|surgical treatment|surgical treatment
4751273|NCT02917980|interventional treatment|interventional treatment
4751274|NCT02917980|hybrid treatment|hybrid treatment
4751275|NCT02917954|eHealth/mHealth solutions|ehealth/mhealth solutions
4751276|NCT02917954|complex care needs|complex care needs
4751277|NCT02917954|seniors|seniors
4751278|NCT02917954|patient-centred care|patient-centred care
4751279|NCT02917954|goal-oriented care|goal-oriented care
4751280|NCT02917954|primary health care|primary health care
4751281|NCT02917954|implementation|implementation
4751282|NCT02917954|pragmatic trial|pragmatic trial
4751283|NCT02917954|health outcomes|health outcomes
4751284|NCT02917954|cost-effectiveness analysis|cost-effectiveness analysis
4751285|NCT02917928|carnosine, type 2 diabetes, cardiovascular factors|carnosine, type 2 diabetes, cardiovascular factors
4751286|NCT02917915|COPD|copd
4751287|NCT02917915|Emphysema|emphysema
4751288|NCT02917915|Chronic Bronchitis|chronic bronchitis
4751289|NCT02917915|Pulmonary rehabilitation|pulmonary rehabilitation
4751290|NCT02917915|Lung Diseases, Obstructive|lung diseases, obstructive
4751291|NCT02917902|student-run free clinic|student-run free clinic
4751292|NCT02917902|food supply|food supply
4751293|NCT02917902|food insecure|food insecure
4751294|NCT02917902|medically uninsured|medically uninsured
4751295|NCT02917902|medically underserved|medically underserved
4751296|NCT02917889|Caffeine|caffeine
4751297|NCT02917889|Autonomic Nervous System|autonomic nervous system
4751298|NCT02917889|Recovery|recovery
4751299|NCT02917889|Aerobic exercise|aerobic exercise
4751300|NCT02917876|Obstructive Sleep Apnea|obstructive sleep apnea
4751301|NCT02917876|Pregnancy|pregnancy
4751302|NCT02917876|Obesity|obesity
4751303|NCT02917876|Fluid shifts|fluid shifts
4751304|NCT02917876|Body composition|body composition
4751305|NCT02917876|Sleep|sleep
4751306|NCT02917863|Hypothyroidism|hypothyroidism
4751307|NCT02917863|Microbiota|microbiota
4751308|NCT02917863|Thyroid hormone|thyroid hormone
4751309|NCT02917863|L-Thyroxine|l-thyroxine
4751310|NCT02917863|Celiac disease|celiac disease
4751311|NCT02917850|stroke|stroke
4751312|NCT02917850|gait|gait
4751313|NCT02917850|hip flexors|hip flexors
4751314|NCT02917850|paresis|paresis
4751315|NCT02917850|hemiplegia|hemiplegia
4751316|NCT02917798|Genetic Testing|genetic testing
4751317|NCT02917798|16-919|16-919
4751318|NCT02917772|tailored immuno therapy|tailored immuno therapy
4751319|NCT02917772|Nivolumab|nivolumab
4751320|NCT02917772|Ipilimumab|ipilimumab
4751321|NCT02917772|boost|boost
4751322|NCT02917759|liver cancer|liver cancer
4751323|NCT02917759|biliary tract cancer|biliary tract cancer
4751324|NCT02917759|cholangiocarcinoma|cholangiocarcinoma
4751325|NCT02917759|hepatocellular carcinoma|hepatocellular carcinoma
4751326|NCT02917759|liver tumor|liver tumor
4751327|NCT02917759|biliary tumor|biliary tumor
4751328|NCT02917759|hepatoma|hepatoma
4751329|NCT02917759|liver mass|liver mass
4751330|NCT02917746|Cervical intraepithelial neoplasia|cervical intraepithelial neoplasia
4751331|NCT02917746|Imiquimod|imiquimod
4751332|NCT02917746|Treatment|treatment
4751333|NCT02917746|Predictive biomarkers|predictive biomarkers
4751334|NCT02917720|TKI discontinuation|tki discontinuation
4751336|NCT02917707|liver metastasis|liver metastasis
4751337|NCT02917681|ALS|als
4751338|NCT02917681|mesenchymal stem cells|mesenchymal stem cells
4751339|NCT02917681|intrathecal|intrathecal
4751340|NCT02917668|Obesity|obesity
4751341|NCT02917668|Hyperoxia|hyperoxia
4751342|NCT02917668|Hypercapnia|hypercapnia
4751343|NCT02917668|Postoperative complications|postoperative complications
4751344|NCT02917668|Cardiac surgical procedures|cardiac surgical procedures
4751345|NCT02917655|Education|education
4751346|NCT02917655|Quality of Life|quality of life
4751347|NCT02917655|Osteoarthritis|osteoarthritis
4751348|NCT02917655|Metabolic Syndrome|metabolic syndrome
4751349|NCT02917642|bacterial infection|bacterial infection
4751350|NCT02917642|endotoxin|endotoxin
4751351|NCT02917642|passive ultrasonic irrigation|passive ultrasonic irrigation
4751352|NCT02917642|root canal treatment|root canal treatment
4751353|NCT02917590|Spinal cord injury|spinal cord injury
4751354|NCT02917590|dual-task obstacle crossing|dual-task obstacle crossing
4751355|NCT02917564|Choroidal effusions|choroidal effusions
4751356|NCT02917564|Trabeculectomy|trabeculectomy
4751357|NCT02917551|Bacteremia, duration, non-critically ill, non-ICU|bacteremia, duration, non-critically ill, non-icu
4751358|NCT02917525|Calcium metabolism|calcium metabolism
4751359|NCT02917525|Matrix Gla Protein|matrix gla protein
4751360|NCT02917525|Vitamin K2|vitamin k2
4751361|NCT02917486|ExtraCorporeal Membrane Oxygenation|extracorporeal membrane oxygenation
4751362|NCT02917486|patient in intensive care|patient in intensive care
4751363|NCT02917486|pharmacokinetic modeling|pharmacokinetic modeling
4751364|NCT02917473|Medical skin examination|medical skin examination
4751365|NCT02917473|Skin Self Examination|skin self examination
4751366|NCT02917473|Sun protection|sun protection
4751367|NCT02917460|Rady|rady
4751368|NCT02917460|Pediatric|pediatric
4751369|NCT02917460|Genomic|genomic
4751370|NCT02917460|Precision medicine|precision medicine
4751371|NCT02917460|Biorepository|biorepository
4751372|NCT02917447|PTSD|ptsd
4751373|NCT02917447|Women Veterans|women veterans
4751374|NCT02917447|Online intervention|online intervention
4751375|NCT02917434|Obesity|obesity
4751376|NCT02917434|Psoriatic arthritis|psoriatic arthritis
4751377|NCT02917434|Psoriasis|psoriasis
4751378|NCT02917434|Metabolic syndrome|metabolic syndrome
4751379|NCT02917434|Cardiovascular disease|cardiovascular disease
4751380|NCT02917395|hypertrophic cardiomyopathy, disopyramide,|hypertrophic cardiomyopathy, disopyramide,
4751381|NCT02917369|LCLC; Integrative Analysis; Metastasis|lclc; integrative analysis; metastasis
4751382|NCT02917356|Healing touch|healing touch
4751383|NCT02917356|Faith Healing|faith healing
4751384|NCT02917356|Pain|pain
4751385|NCT02917356|Joint stiffness|joint stiffness
4751386|NCT02917356|Functional status|functional status
4751387|NCT02917356|Mental health|mental health
4751388|NCT02917356|Osteoarthritis|osteoarthritis
4751389|NCT02917304|Quadrivalent Influenza Vaccines|quadrivalent influenza vaccines
4751390|NCT02917291|Trauma Spinal Cord|trauma spinal cord
4751391|NCT02917291|Thoracic Acute Spinal Cord Injury|thoracic acute spinal cord injury
4751392|NCT02917291|Neurosurgery|neurosurgery
4751393|NCT02917291|Cell Therapy|cell therapy
4751394|NCT02917291|ATMP|atmp
4751395|NCT02917291|HC016 adipose mesenchymal stem cell|hc016 adipose mesenchymal stem cell
4751396|NCT02917291|SPINE|spine
4751397|NCT02917213|acute myocardial infarction|acute myocardial infarction
4751398|NCT02917213|cardiac embolism|cardiac embolism
4751399|NCT02917213|intracardiac fluid dynamics|intracardiac fluid dynamics
4751400|NCT02917213|silent brain infarct|silent brain infarct
4751401|NCT02917213|intracardiac blood stasis|intracardiac blood stasis
4751402|NCT02917174|asthma|asthma
4751403|NCT02917174|m-health|m-health
4751404|NCT02917174|asthma control|asthma control
4751405|NCT02917174|self-management|self-management
4751406|NCT02917161|Prostate|prostate
4751407|NCT02917161|Prostatic Neoplams|prostatic neoplams
4751408|NCT02917161|Therapeutic Embolization|therapeutic embolization
4751409|NCT02917161|Prostatectomy|prostatectomy
4751410|NCT02917122|Parkinson disease|parkinson disease
4751411|NCT02917122|transcranial direct current stimulation|transcranial direct current stimulation
4751412|NCT02917122|depression|depression
4751413|NCT02917122|dopamine transporter|dopamine transporter
4751414|NCT02917122|single photon emission computerized tomography|single photon emission computerized tomography
4751415|NCT02917083|chimeric antigen receptors|chimeric antigen receptors
4751416|NCT02917083|immunotherapy|immunotherapy
4751417|NCT02917083|CAR T-cells|car t-cells
4751418|NCT02917083|lymphoma|lymphoma
4751419|NCT02917083|Cyclophosphamide|cyclophosphamide
4751420|NCT02917083|fludarabine|fludarabine
4751421|NCT02917070|Consanguinity-associated kidney diseases|consanguinity-associated kidney diseases
4751422|NCT02917070|Turkey population|turkey population
4751423|NCT02917031|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
4751424|NCT02917031|Heart Failure|heart failure
4751425|NCT02917031|Saxagliptin|saxagliptin
4751426|NCT02917031|Sitagliptin|sitagliptin
4751427|NCT02917018|Dexmedetomidine|dexmedetomidine
4751428|NCT02917018|Stress response|stress response
4751429|NCT02917018|Emergence agitation|emergence agitation
4751430|NCT02917005|breast cancer|breast cancer
4751431|NCT02917005|hormone receptor positive, HER2 negative|hormone receptor positive, her2 negative
4751432|NCT02917005|palbociclib|palbociclib
4751433|NCT02917005|premenopausal|premenopausal
4751434|NCT02916992|spontaneous pneumothorax|spontaneous pneumothorax
4751435|NCT02916992|familial pneumothorax|familial pneumothorax
4751436|NCT02916992|Birt-Hogg-Dube syndrome|birt-hogg-dube syndrome
4751437|NCT02916992|prevalence|prevalence
4751438|NCT02916992|FLCN mutation|flcn mutation
4751439|NCT02916992|Lung cysts|lung cysts
4751441|NCT02916992|inherited disease|inherited disease
4751442|NCT02916992|genetic disease|genetic disease
4751443|NCT02916992|primary pneumothorax|primary pneumothorax
4751444|NCT02916992|CAT scan|cat scan
4751445|NCT02916992|CT scan|ct scan
4751446|NCT02916940|sprains of the proximal interphalangeal joints of the long fingers|sprains of the proximal interphalangeal joints of the long fingers
4751447|NCT02916940|Diprophos|diprophos
4751448|NCT02916927|ketamine|ketamine
4751449|NCT02916927|emergency department|emergency department
4751450|NCT02916914|preterm|preterm
4751451|NCT02916914|feeding|feeding
4751452|NCT02916914|oral transition|oral transition
4751453|NCT02916901|Dyslipidemia|dyslipidemia
4751454|NCT02916901|CKD-519|ckd-519
4751455|NCT02916901|CETP inhibitor|cetp inhibitor
4751456|NCT02916901|ABPM|abpm
4751457|NCT02916888|Atopic dermatitis|atopic dermatitis
4751458|NCT02916888|Topical corticosteroid|topical corticosteroid
4751459|NCT02916888|Pediatric|pediatric
4751460|NCT02916888|Eczema|eczema
4751461|NCT02916888|Quality of life|quality of life
4751462|NCT02916875|Shared decision Making|shared decision making
4751463|NCT02916875|Follow-up|follow-up
4751464|NCT02916862|fiber|fiber
4751465|NCT02916862|calcium absorption|calcium absorption
4751466|NCT02916862|bone mass|bone mass
4751467|NCT02916862|adolescents|adolescents
4751468|NCT02916849|Accidental Falls|accidental falls
4751469|NCT02916849|Prevention & Control|prevention & control
4751470|NCT02916849|Exercise|exercise
4751471|NCT02916849|Exercise therapy/methods*|exercise therapy/methods*
4751472|NCT02916849|Aged|aged
4751473|NCT02916849|Aged 80 and over|aged 80 and over
4751474|NCT02916849|Smartphone|smartphone
4751475|NCT02916849|Computers|computers
4751476|NCT02916849|Computers handheld|computers handheld
4751477|NCT02916849|Motivation|motivation
4751478|NCT02916849|Postural balance|postural balance
4751479|NCT02916849|Health behaviour|health behaviour
4751480|NCT02916849|mHealth|mhealth
4751481|NCT02916849|eHealth|ehealth
4751482|NCT02916810|transcranial magnetic stimulation|transcranial magnetic stimulation
4751483|NCT02916810|schizophrenia|schizophrenia
4751484|NCT02916810|MRI|mri
4751485|NCT02916797|Feedback|feedback
4751486|NCT02916797|Physical Therapy|physical therapy
4751487|NCT02916784|Sit-to-stand|sit-to-stand
4751488|NCT02916784|Walking devices|walking devices
4751489|NCT02916771|Smoldering Multiple Myeloma|smoldering multiple myeloma
4751490|NCT02916758|older adults|older adults
4751491|NCT02916758|community mobility|community mobility
4751492|NCT02916758|wellness|wellness
4751493|NCT02916758|isolation|isolation
4751494|NCT02916745|Non-small cell lung cancer|non-small cell lung cancer
4751495|NCT02916745|NSCLC|nsclc
4751496|NCT02916745|lung cancer|lung cancer
4751497|NCT02916745|lung carcinoma|lung carcinoma
4751498|NCT02916745|lung metastasis|lung metastasis
4751499|NCT02916732|asymptomatics|asymptomatics
4751500|NCT02916732|microcephaly|microcephaly
4751501|NCT02916732|abnormalities|abnormalities
4751502|NCT02916719|neo-adjuvant radiotherapy|neo-adjuvant radiotherapy
4751503|NCT02916719|breast cancer|breast cancer
4751504|NCT02916719|MRI|mri
4751505|NCT02916693|Mirabegron|mirabegron
4751506|NCT02916693|Overactive Bladder|overactive bladder
4751507|NCT02916693|Erectile Dysfunction|erectile dysfunction
4751508|NCT02916693|Beta 3 agonist|beta 3 agonist
4751509|NCT02916680|Pancreatic islet transplantation|pancreatic islet transplantation
4751510|NCT02916641|Fuzhenghuayu|fuzhenghuayu
4751511|NCT02916628|smoking cessation|smoking cessation
4751512|NCT02916628|group counseling|group counseling
4751513|NCT02916628|acupressure|acupressure
4751514|NCT02916628|serotonin|serotonin
4751515|NCT02916628|depressive symptoms|depressive symptoms
4751516|NCT02916628|resilience|resilience
4751517|NCT02916537|prostate cancer|prostate cancer
4751518|NCT02916537|prostate specific membrane antigen|prostate specific membrane antigen
4751519|NCT02916537|prostate neoplasms|prostate neoplasms
4751520|NCT02916537|metastatic prostate cancer|metastatic prostate cancer
4751521|NCT02916537|prostatic hyperplasia|prostatic hyperplasia
4751522|NCT02916524|Aphasia|aphasia
4751523|NCT02916524|Bilingualism|bilingualism
4751524|NCT02916524|Language therapy|language therapy
4751525|NCT02916524|Rehabilitation of speech and language disorders|rehabilitation of speech and language disorders
4751526|NCT02916524|Speech-language pathology|speech-language pathology
4751527|NCT02916498|chronic neuropathic pain in the low back and legs|chronic neuropathic pain in the low back and legs
4751528|NCT02916498|subperception spinal cord stimulation|subperception spinal cord stimulation
4751529|NCT02916485|bioresorbable scaffold|bioresorbable scaffold
4751530|NCT02916485|vascular restoration therapy|vascular restoration therapy
4751531|NCT02916472|AYA|aya
4751532|NCT02916472|exercise|exercise
4751533|NCT02916472|cancer|cancer
4751534|NCT02916472|cybercycling|cybercycling
4751535|NCT02916407|Anesthesia|anesthesia
4751536|NCT02916407|Agitation|agitation
4751537|NCT02916407|Extubation|extubation
4751538|NCT02916316|Lymphoma|lymphoma
4751539|NCT02916316|Large B-Cell|large b-cell
4751540|NCT02916316|Cardiotoxicity|cardiotoxicity
4751541|NCT02916303|Schizophrenia|schizophrenia
4751542|NCT02916303|Psychosis|psychosis
4751543|NCT02916303|Effectiveness|effectiveness
4751544|NCT02916290|Fuzhenghuayu|fuzhenghuayu
4751545|NCT02916264|scalp block, surgical peth index|scalp block, surgical peth index
4751546|NCT02916160|Chronic Heart failure|chronic heart failure
4751547|NCT02916160|Sleep Apnea Syndrome|sleep apnea syndrome
4751548|NCT02916160|Continuous Positive Airways Pressure|continuous positive airways pressure
4751549|NCT02916160|SACUBITRIL - VALSARTAN|sacubitril - valsartan
4751550|NCT02916108|Concussion|concussion
4751551|NCT02916108|Mild traumatic brain injury|mild traumatic brain injury
4751552|NCT02916108|EEG|eeg
4751553|NCT02916082|Cervical length|cervical length
4751554|NCT02916082|Prolonged pregnancy|prolonged pregnancy
4751653|NCT02915523|Entinostat|entinostat
4751555|NCT02916082|Vaginal birth|vaginal birth
4751556|NCT02916069|Spectroscopy|spectroscopy
4751557|NCT02916069|Transcranial Doppler|transcranial doppler
4751558|NCT02916069|Bispectral index|bispectral index
4751559|NCT02916069|Cardiac surgery|cardiac surgery
4751560|NCT02916056|Alzheimer's disease|alzheimer's disease
4751561|NCT02916056|RAGE|rage
4751562|NCT02916056|ADAS-cog|adas-cog
4751563|NCT02916056|CDR-sb|cdr-sb
4751564|NCT02916043|acute kidney injury|acute kidney injury
4751565|NCT02916043|cardiovascular surgery|cardiovascular surgery
4751566|NCT02916043|mortality|mortality
4751567|NCT02916030|Vitamin D|vitamin d
4751568|NCT02916030|Stroke|stroke
4751569|NCT02916030|Parathormone|parathormone
4751570|NCT02916017|Humira|humira
4751571|NCT02916017|Adalimumab|adalimumab
4751572|NCT02916017|Non-infectious Intermediate-, Posterior-, or Pan-uveitis|non-infectious intermediate-, posterior-, or pan-uveitis
4751573|NCT02916004|Analgesia|analgesia
4751574|NCT02916004|Pain measurement|pain measurement
4751575|NCT02916004|Nociception|nociception
4751576|NCT02916004|Electromyography|electromyography
4751577|NCT02916004|Electrical stimulation|electrical stimulation
4751578|NCT02916004|Pupillometry|pupillometry
4751579|NCT02916004|Critical care|critical care
4751580|NCT02916004|Sedation|sedation
4751581|NCT02915991|Coronary catheterization|coronary catheterization
4751582|NCT02915991|Instantaneous wave free ratio (iFR)|instantaneous wave free ratio (ifr)
4751583|NCT02915991|Fractional Flow Reserve (FFR)|fractional flow reserve (ffr)
4751584|NCT02915991|automated co-registration|automated co-registration
4751585|NCT02915939|Family caregiving|family caregiving
4751586|NCT02915939|Institutionalization|institutionalization
4751587|NCT02915939|Residential long-term care|residential long-term care
4751588|NCT02915939|Placement|placement
4751589|NCT02915939|Psychosocial support|psychosocial support
4751590|NCT02915939|Dementia|dementia
4751591|NCT02915939|Caregivers|caregivers
4751592|NCT02915939|Nursing homes|nursing homes
4751593|NCT02915939|Assisted Living Facilities|assisted living facilities
4751594|NCT02915939|Long-Term Care|long-term care
4751595|NCT02915939|Intervention Study|intervention study
4751596|NCT02915939|Psychosocial Support Systems|psychosocial support systems
4751597|NCT02915939|Social Support|social support
4751598|NCT02915939|Coping|coping
4751599|NCT02915900|In vitro fertilization|in vitro fertilization
4751600|NCT02915887|neck pain|neck pain
4751601|NCT02915887|chronic|chronic
4751602|NCT02915887|taping|taping
4751603|NCT02915887|kinematics|kinematics
4751604|NCT02915887|motion analysis|motion analysis
4751605|NCT02915887|physiotherapy|physiotherapy
4751606|NCT02915861|immune responses|immune responses
4751607|NCT02915861|vaccines|vaccines
4751608|NCT02915848|deep brain stimulation|deep brain stimulation
4751609|NCT02915848|local field potential|local field potential
4751610|NCT02915848|kinematic analysis|kinematic analysis
4751611|NCT02915835|Scleroderma|scleroderma
4751612|NCT02915835|Digital Ulcer|digital ulcer
4751613|NCT02915809|Influenza Vaccines|influenza vaccines
4751614|NCT02915796|Endothelial progenitor cell|endothelial progenitor cell
4751615|NCT02915796|Percutaneous transluminal angioplasty|percutaneous transluminal angioplasty
4751616|NCT02915783|unresectable advanced|unresectable advanced
4751617|NCT02915783|metastatic|metastatic
4751618|NCT02915770|Moderate dilatation of common bile duct|moderate dilatation of common bile duct
4751619|NCT02915757|Depression|depression
4751620|NCT02915757|EDOR test|edor test
4751621|NCT02915757|Electrodermal hyporeactivity|electrodermal hyporeactivity
4751622|NCT02915744|Breast Cancer Brain Metastases (BCBM)|breast cancer brain metastases (bcbm)
4751623|NCT02915744|Carcinoma|carcinoma
4751624|NCT02915731|Vitamin A stores|vitamin a stores
4751625|NCT02915731|Stable isotope dilution|stable isotope dilution
4751626|NCT02915731|Multiple vitamin A interventions|multiple vitamin a interventions
4751627|NCT02915718|dilated cardiomyopathy|dilated cardiomyopathy
4751628|NCT02915718|immunoadsorption|immunoadsorption
4751629|NCT02915692|Foley|foley
4751630|NCT02915692|CAUTI|cauti
4751631|NCT02915692|ERASE CAUTI|erase cauti
4751632|NCT02915679|Suicidal behavior|suicidal behavior
4751633|NCT02915679|psychological and social pain|psychological and social pain
4751634|NCT02915679|physical pain|physical pain
4751635|NCT02915679|pain perception|pain perception
4751636|NCT02915666|Melanoma, skin|melanoma, skin
4751637|NCT02915627|Antishock Garment|antishock garment
4751638|NCT02915614|alpha-1 antitrypsin deficiency|alpha-1 antitrypsin deficiency
4751639|NCT02915614|pulmonary rehabilitation|pulmonary rehabilitation
4751640|NCT02915614|exercise training|exercise training
4751641|NCT02915614|skeletal muscle biopsy|skeletal muscle biopsy
4751642|NCT02915562|rehabilitation|rehabilitation
4751643|NCT02915562|exercise|exercise
4751644|NCT02915562|outcome measurement|outcome measurement
4751645|NCT02915549|premature infant|premature infant
4751646|NCT02915549|early progressive feeding|early progressive feeding
4751647|NCT02915536|iodine excess|iodine excess
4751648|NCT02915536|thyroid disease|thyroid disease
4751649|NCT02915536|children|children
4751650|NCT02915536|tolerable upper intake level|tolerable upper intake level
4751651|NCT02915523|Ovarian Cancer|ovarian cancer
4751652|NCT02915523|Histone Deacetylase Inhibitors|histone deacetylase inhibitors
4751654|NCT02915523|Solid tumor|solid tumor
4751655|NCT02915523|Avelumab|avelumab
4751656|NCT02915523|SNDX-275|sndx-275
4751657|NCT02915523|Ovarian Neoplasms|ovarian neoplasms
4751658|NCT02915523|Ovarian Diseases|ovarian diseases
4751659|NCT02915523|Fallopian Tube Cancer|fallopian tube cancer
4751660|NCT02915523|Peritoneal Cancer|peritoneal cancer
4751661|NCT02915497|Prolonged Exposure Therapy|prolonged exposure therapy
4751662|NCT02915484|Transcranial Direct Current Stimulation|transcranial direct current stimulation
4751663|NCT02915484|Apathy|apathy
4751664|NCT02915484|Stroke|stroke
4751665|NCT02915484|Empathy|empathy
4751666|NCT02915484|Electric Stimulation Therapy|electric stimulation therapy
4751667|NCT02915484|Depression|depression
4751668|NCT02915484|Anhedonia|anhedonia
4751669|NCT02915484|Prefrontal Cortex|prefrontal cortex
4751670|NCT02915484|Electroencephalography|electroencephalography
4751671|NCT02915484|Cognition|cognition
4751672|NCT02915484|Emotions|emotions
4751791|NCT02915042|dexmedetomidine|dexmedetomidine
4751673|NCT02915484|Neurological Rehabilitation|neurological rehabilitation
4751674|NCT02915484|Brain Diseases|brain diseases
4751675|NCT02915484|Cerebrovascular Disorders|cerebrovascular disorders
4751676|NCT02915471|Adolescent|adolescent
4751677|NCT02915471|Online Peer Support|online peer support
4751678|NCT02915471|Managing Cancer|managing cancer
4751679|NCT02915471|Mentor|mentor
4751680|NCT02915458|Weaning|weaning
4751681|NCT02915458|Mechanical ventilation|mechanical ventilation
4751682|NCT02915458|synchrosqueezing transform|synchrosqueezing transform
4751683|NCT02915445|EpCAM CAR-T, solid tumors, cancer immunotherapy|epcam car-t, solid tumors, cancer immunotherapy
4751684|NCT02915432|Anti PD-1|anti pd-1
4751685|NCT02915432|JS001|js001
4751686|NCT02915432|Gastric Adenocarcinoma|gastric adenocarcinoma
4751687|NCT02915432|Esophageal Squamous Cell Carcinoma|esophageal squamous cell carcinoma
4751688|NCT02915432|Nasopharyngeal Carcinoma|nasopharyngeal carcinoma
4751689|NCT02915432|Head and Neck Squamous Cell Carcinoma|head and neck squamous cell carcinoma
4751690|NCT02915432|Simon's Two Stage|simon's two stage
4751691|NCT02915432|ORR|orr
4751692|NCT02915393|Chronic Gastritis|chronic gastritis
4751693|NCT02915393|Qi Deficiency Constitution|qi deficiency constitution
4751694|NCT02915393|Next Generation Sequencing|next generation sequencing
4751695|NCT02915393|Proteomics|proteomics
4751696|NCT02915393|Metabonomics|metabonomics
4751697|NCT02915367|HIV/AIDS|hiv/aids
4751698|NCT02915367|adherence|adherence
4751699|NCT02915367|women|women
4751700|NCT02915367|real time monitoring|real time monitoring
4751701|NCT02915367|risk|risk
4751702|NCT02915367|SMS|sms
4751703|NCT02915367|mHealth|mhealth
4751704|NCT02915315|blood pressure|blood pressure
4751705|NCT02915315|Hypertrophy|hypertrophy
4751706|NCT02915315|Left Ventricular|left ventricular
4751707|NCT02915315|arterial Stiffness|arterial stiffness
4751708|NCT02915315|Proteinuria|proteinuria
4751709|NCT02915315|baPWV|bapwv
4751710|NCT02915315|ambulatory Blood Pressure|ambulatory blood pressure
4751711|NCT02915302|Influenza|influenza
4751712|NCT02915302|Influenza virus vaccine|influenza virus vaccine
4751713|NCT02915302|Fluzone® Quadrivalent Influenza Vaccine (No Preservative)|fluzone® quadrivalent influenza vaccine (no preservative)
4751714|NCT02915289|Caesarean section|caesarean section
4751715|NCT02915289|Chlorhexidine gluconate|chlorhexidine gluconate
4751716|NCT02915276|Blastocyst|blastocyst
4751717|NCT02915276|Human|human
4751718|NCT02915276|DNA|dna
4751719|NCT02915276|Blastocentesis|blastocentesis
4751720|NCT02915263|Diabetes Complications|diabetes complications
4751721|NCT02915263|Diabetes Mellitus|diabetes mellitus
4751722|NCT02915263|Diabetic Neuropathies|diabetic neuropathies
4751723|NCT02915263|IGIV-C|igiv-c
4751724|NCT02915263|Immune Globulin Injection (Human), 10% Caprylate/Chromatography|immune globulin injection (human), 10% caprylate/chromatography
4751725|NCT02915263|Gamunex-C|gamunex-c
4751726|NCT02915237|Veterans|veterans
4751727|NCT02915237|Gulf War Illness|gulf war illness
4751728|NCT02915237|Gulf War Veterans's Illness|gulf war veterans's illness
4751729|NCT02915237|Gulf War Veterans' Medically Unexplained Illnesses|gulf war veterans' medically unexplained illnesses
4751730|NCT02915211|Epilepsy|epilepsy
4751731|NCT02915211|Glut|glut
4751732|NCT02915211|Ketogenic|ketogenic
4751733|NCT02915211|Glucose|glucose
4751734|NCT02915198|Metformin|metformin
4751735|NCT02915198|Atherosclerosis|atherosclerosis
4751736|NCT02915198|Prediabetic State|prediabetic state
4751737|NCT02915198|Hemoglobin A, Glycosylated|hemoglobin a, glycosylated
4751738|NCT02915198|Coronary Artery Disease|coronary artery disease
4751739|NCT02915198|Peripheral Arterial Disease|peripheral arterial disease
4751740|NCT02915198|Cerebrovascular Disorders|cerebrovascular disorders
4751741|NCT02915185|exercise|exercise
4751742|NCT02915185|rehabilitation|rehabilitation
4751743|NCT02915185|recovery of function|recovery of function
4751744|NCT02915185|transcranial magnetic stimulation|transcranial magnetic stimulation
4751745|NCT02915185|transcranial direct-current stimulation|transcranial direct-current stimulation
4751746|NCT02915172|Advanced Cancer|advanced cancer
4751747|NCT02915172|Malignant neoplasm of breast|malignant neoplasm of breast
4751748|NCT02915172|Malignant neoplasms of bone and articular cartilage|malignant neoplasms of bone and articular cartilage
4751846|NCT02914730|insulin|insulin
4751749|NCT02915172|Malignant neoplasms of digestive organs|malignant neoplasms of digestive organs
4751750|NCT02915172|Malignant neoplasms of eye brain and other parts of central nervous system|malignant neoplasms of eye brain and other parts of central nervous system
4751751|NCT02915172|Malignant neoplasms of female genital organs|malignant neoplasms of female genital organs
4751752|NCT02915172|Malignant neoplasms of ill-defined secondary and unspecified sites|malignant neoplasms of ill-defined secondary and unspecified sites
4751753|NCT02915172|Malignant neoplasms of independent (primary) multiple sites|malignant neoplasms of independent (primary) multiple sites
4751754|NCT02915172|Malignant neoplasms of lip oral cavity and pharynx|malignant neoplasms of lip oral cavity and pharynx
4751755|NCT02915172|Malignant neoplasms of male genital organs|malignant neoplasms of male genital organs
4751756|NCT02915172|Malignant neoplasms of mesothelial and soft tissue|malignant neoplasms of mesothelial and soft tissue
4751757|NCT02915172|Malignant neoplasms of respiratory and intrathoracic organs|malignant neoplasms of respiratory and intrathoracic organs
4751758|NCT02915172|Malignant neoplasms of thyroid and other endocrine glands|malignant neoplasms of thyroid and other endocrine glands
4751759|NCT02915172|Malignant neoplasms of urinary tract|malignant neoplasms of urinary tract
4751760|NCT02915172|Lenvatinib|lenvatinib
4751761|NCT02915172|E7080|e7080
4751762|NCT02915172|Lenvima|lenvima
4751763|NCT02915172|Capecitabine|capecitabine
4751764|NCT02915172|Xeloda|xeloda
4751765|NCT02915146|eczema|eczema
4751766|NCT02915146|phototherapy|phototherapy
4751767|NCT02915146|uva1|uva1
4751768|NCT02915146|uvb|uvb
4751769|NCT02915146|adults|adults
4751770|NCT02915146|children|children
4751771|NCT02915133|high myopia|high myopia
4751772|NCT02915133|myopia foveoschisis|myopia foveoschisis
4751773|NCT02915133|macular buckling|macular buckling
4751774|NCT02915120|Knee pain|knee pain
4751775|NCT02915120|osteoarthritis|osteoarthritis
4751776|NCT02915120|genicular nerve|genicular nerve
4751777|NCT02915120|ultrasonography|ultrasonography
4751778|NCT02915120|pulsed radiofrequency|pulsed radiofrequency
4751779|NCT02915107|drug eluting stents|drug eluting stents
4751780|NCT02915107|coronary vascular healing|coronary vascular healing
4751781|NCT02915068|patient-provider communication|patient-provider communication
4751782|NCT02915068|Electronic Health Records|electronic health records
4751783|NCT02915068|Provider education|provider education
4751784|NCT02915055|Analgesic efficacy|analgesic efficacy
4751785|NCT02915055|knee arthroplasty|knee arthroplasty
4751786|NCT02915055|Opioid consumption|opioid consumption
4751787|NCT02915055|Pain Medicine|pain medicine
4751788|NCT02915055|Narcotics|narcotics
4751789|NCT02915055|Multimodal Analgesia|multimodal analgesia
4751790|NCT02915042|Pain|pain
4751792|NCT02915042|postoperative|postoperative
4751793|NCT02915029|Native American|native american
4751794|NCT02915029|Community Health Representative|community health representative
4751795|NCT02915029|Home base|home base
4751796|NCT02915029|Diabetes|diabetes
4751797|NCT02915029|Point of care testing|point of care testing
4751798|NCT02915029|Patient Activation Measure|patient activation measure
4751799|NCT02915029|Patient preferences|patient preferences
4751800|NCT02915003|health care navigation|health care navigation
4751801|NCT02915003|health literacy|health literacy
4751802|NCT02915003|Affordable Care Act|affordable care act
4751803|NCT02914977|Relapsed|relapsed
4751804|NCT02914977|Refractory|refractory
4751805|NCT02914964|Fatigue|fatigue
4751806|NCT02914964|Quality of Life|quality of life
4751807|NCT02914964|Diet|diet
4751808|NCT02914951|Autism|autism
4751809|NCT02914951|Irritability|irritability
4751810|NCT02914951|Disruptive Behavior|disruptive behavior
4751811|NCT02914951|Aggression|aggression
4751812|NCT02914951|Behavior Therapy|behavior therapy
4751813|NCT02914951|Cognitive Behavioral Therapy|cognitive behavioral therapy
4751814|NCT02914951|Intellectual Disability|intellectual disability
4751815|NCT02914951|Cognitive Impairment|cognitive impairment
4751816|NCT02914925|CIT|cit
4751817|NCT02914925|ArmeoSpring|armeospring
4751818|NCT02914925|TMS|tms
4751819|NCT02914899|Chinese Taxi Drivers|chinese taxi drivers
4751820|NCT02914899|16-949|16-949
4751821|NCT02914886|Diabetes|diabetes
4751822|NCT02914886|Lipoatrophy|lipoatrophy
4751823|NCT02914886|children|children
4751824|NCT02914886|adolescents|adolescents
4751825|NCT02914886|adults|adults
4751826|NCT02914886|insulin therapy|insulin therapy
4751827|NCT02914873|prostate cancer|prostate cancer
4751828|NCT02914873|active surveillance|active surveillance
4751829|NCT02914873|standardised treatment triggers|standardised treatment triggers
4751830|NCT02914873|MRI|mri
4751831|NCT02914873|randomized|randomized
4751832|NCT02914821|consumption|consumption
4751833|NCT02914821|decision making|decision making
4751834|NCT02914821|policy|policy
4751835|NCT02914821|sweetened beverages|sweetened beverages
4751836|NCT02914821|taxes|taxes
4751837|NCT02914821|Diet, Food, and Nutrition|diet, food, and nutrition
4751838|NCT02914769|Depression|depression
4751839|NCT02914769|Ayahuasca|ayahuasca
4751840|NCT02914769|Psychedelics|psychedelics
4751841|NCT02914743|Oral health|oral health
4751842|NCT02914743|Diabetes|diabetes
4751843|NCT02914743|Interprofessionalism|interprofessionalism
4751844|NCT02914743|Periodontal disease|periodontal disease
4751845|NCT02914730|diabetes|diabetes
4751847|NCT02914730|medication adherence|medication adherence
4751848|NCT02914717|golimumab|golimumab
4751849|NCT02914691|Type 2 diabetes|type 2 diabetes
4751850|NCT02914691|Diabetic Nephropathy|diabetic nephropathy
4751851|NCT02914691|Proteomics|proteomics
4751852|NCT02914691|Albuminuria|albuminuria
4751853|NCT02914691|SGLT2 inhibitor|sglt2 inhibitor
4751854|NCT02914678|Emergency Medical Services|emergency medical services
4751855|NCT02914678|Analgesics|analgesics
4751856|NCT02914665|Heart failure|heart failure
4751857|NCT02914665|diuresis|diuresis
4751858|NCT02914665|dropsy|dropsy
4751859|NCT02914665|congestion|congestion
4751860|NCT02914665|elamipretide|elamipretide
4751861|NCT02914665|MTP-131|mtp-131
4751862|NCT02914665|Bendavia™|bendavia™
4751863|NCT02914652|Congenital Heart Disease|congenital heart disease
4751864|NCT02914652|Ventricular Septal Defect|ventricular septal defect
4751865|NCT02914652|Beta-2-agonists|beta-2-agonists
4751866|NCT02914652|Surgery|surgery
4751867|NCT02914652|Follow-up|follow-up
4751868|NCT02914626|Glaucoma, Neovascular|glaucoma, neovascular
4751869|NCT02914626|Ranibizumab|ranibizumab
4751870|NCT02914626|Intraocular pressure|intraocular pressure
4751871|NCT02914626|anti-VEGF|anti-vegf
4751872|NCT02914626|intravitreal injection|intravitreal injection
4751873|NCT02914483|Myocardial Infarction|myocardial infarction
4751874|NCT02914483|Women|women
4751875|NCT02914483|Stress Management|stress management
4751876|NCT02914470|advanced|advanced
4751877|NCT02914431|Personalized Titanium Plate|personalized titanium plate
4751878|NCT02914431|Orthognathic Surgery|orthognathic surgery
4751879|NCT02914431|Maxilla Repositioning|maxilla repositioning
4751880|NCT02914431|Accuracy|accuracy
4751881|NCT02914431|Computer-aided Design and Manufacturing|computer-aided design and manufacturing
4751882|NCT02914418|transcranial magnetic stimulation|transcranial magnetic stimulation
4751883|NCT02914418|Spinal Cord Injuries|spinal cord injuries
4751884|NCT02914418|Muscle Spasticity|muscle spasticity
4751885|NCT02914418|Pain|pain
4751886|NCT02914418|Spinal Cord|spinal cord
4751887|NCT02914418|Spinal Cord Diseases|spinal cord diseases
4751888|NCT02914405|131-I-mIBG therapy|131-i-mibg therapy
4751889|NCT02914405|ch14.18/CHO|ch14.18/cho
4751890|NCT02914405|Nivolumab|nivolumab
4751891|NCT02914392|case control study|case control study
4751892|NCT02914392|Environmental Factors|environmental factors
4751893|NCT02914392|Fetal Congenital Heart Disease|fetal congenital heart disease
4751894|NCT02914366|Ambroxol|ambroxol
4751895|NCT02914366|Dementia|dementia
4751896|NCT02914366|Parkinson's disease|parkinson's disease
4751897|NCT02914366|Disease modifying treatment|disease modifying treatment
4751898|NCT02914366|Pharmacological Chaperone|pharmacological chaperone
4751899|NCT02914366|GBA1|gba1
4751900|NCT02914353|Factor X!a|factor x!a
4751901|NCT02914353|anticoagulant|anticoagulant
4751902|NCT02914353|thromboembolism|thromboembolism
4751903|NCT02914353|venous thromboembolism|venous thromboembolism
4751904|NCT02914353|embolism and thrombosis|embolism and thrombosis
4751905|NCT02914353|enzyme inhibitors|enzyme inhibitors
4751906|NCT02914353|hematologic agent|hematologic agent
4751907|NCT02914327|CLL|cll
4751908|NCT02914327|Leukemia, Chronic Lymphocytic|leukemia, chronic lymphocytic
4751909|NCT02914327|Hsp90|hsp90
4751910|NCT02914327|BTK|btk
4751911|NCT02914327|Ibrutinib|ibrutinib
4751912|NCT02914314|epilepsy|epilepsy
4751913|NCT02914314|refractory partial seizures|refractory partial seizures
4751914|NCT02914249|Orange juice|orange juice
4751915|NCT02914249|Low-calorie diet|low-calorie diet
4751916|NCT02914249|Body composition|body composition
4751917|NCT02914249|Weight-loss|weight-loss
4751918|NCT02914249|Metabolic biomarkers|metabolic biomarkers
4751919|NCT02914249|Obese|obese
4751920|NCT02914236|Nasal valve|nasal valve
4751921|NCT02914236|Nasal airway obstruction|nasal airway obstruction
4751922|NCT02914210|TKR|tkr
4751923|NCT02914210|TKA|tka
4751924|NCT02914210|Knee|knee
4751925|NCT02914210|Surgery|surgery
4751926|NCT02914210|Replacement|replacement
4751927|NCT02914210|Rehabilitation|rehabilitation
4751928|NCT02914210|Virtual|virtual
4751929|NCT02914210|Physical Therapy|physical therapy
4751930|NCT02914210|Telerehabilitation|telerehabilitation
4751931|NCT02914197|Decision|decision
4751932|NCT02914197|Mammography|mammography
4751933|NCT02914197|Informed Choice|informed choice
4751934|NCT02914197|Full Information|full information
4751935|NCT02914197|Decision Aid|decision aid
4751936|NCT02914197|Self-efficacy|self-efficacy
4751937|NCT02914197|Shared decision making|shared decision making
4751938|NCT02914197|Over-detection|over-detection
4751939|NCT02914197|Over-diagnosis|over-diagnosis
4751940|NCT02914184|Safety|safety
4751941|NCT02914184|Healthy infants|healthy infants
4751942|NCT02914184|Immunogenicity|immunogenicity
4751943|NCT02914184|Human Rotavirus (HRV)|human rotavirus (hrv)
4751944|NCT02914171|Myopathic right ventricle|myopathic right ventricle
4751945|NCT02914158|breast cancer|breast cancer
4751946|NCT02914158|ovarian function suppression (OFS)|ovarian function suppression (ofs)
4751947|NCT02914158|aromatase inhibitors（AIs）|aromatase inhibitors（ais）
4751948|NCT02914158|tamoxifen（TAM）|tamoxifen（tam）
4751949|NCT02914119|Residual nerve blockade|residual nerve blockade
4751950|NCT02914119|Neuromuscular monitoring|neuromuscular monitoring
4751951|NCT02914119|Residual curarization|residual curarization
4751952|NCT02914119|Neuromuscular blocking agents|neuromuscular blocking agents
4751953|NCT02914106|Neuroactive steroids|neuroactive steroids
4751954|NCT02914106|Acute Ischemic Stroke|acute ischemic stroke
4751955|NCT02914106|Patients|patients
4751956|NCT02914093|Hypercapnia|hypercapnia
4751957|NCT02914093|Physiotherapy|physiotherapy
4751958|NCT02914093|Inspiratory Muscle Training|inspiratory muscle training
4751959|NCT02914067|Pediatric brain tumors|pediatric brain tumors
4751960|NCT02914067|Cognitive deficits|cognitive deficits
4751961|NCT02914067|Resting state functional connectivity|resting state functional connectivity
4751962|NCT02914067|NIH toolbox|nih toolbox
4751963|NCT02914054|ITP|itp
4751964|NCT02914041|Kyphosis|kyphosis
4751965|NCT02914041|Kyphosis wall distance|kyphosis wall distance
4751966|NCT02914041|elderly|elderly
4751967|NCT02914028|TAP block|tap block
4751968|NCT02914028|subacute pain|subacute pain
4751969|NCT02914028|inguinal herniography|inguinal herniography
4751970|NCT02913937|ultrasonic irrigation|ultrasonic irrigation
4751971|NCT02913937|pain|pain
4751972|NCT02913937|healing|healing
4751973|NCT02913937|apical periodontitis|apical periodontitis
4751974|NCT02913924|Marijuana|marijuana
4751975|NCT02913924|Treatment|treatment
4751976|NCT02913911|feedback|feedback
4751977|NCT02913898|learning|learning
4751978|NCT02913872|Spirometry|spirometry
4751979|NCT02913872|Exhaled Nitric Oxide|exhaled nitric oxide
4751980|NCT02913872|Primary Care|primary care
4751981|NCT02913859|prostate cancer|prostate cancer
4751982|NCT02913859|hormone-sensitive|hormone-sensitive
4751983|NCT02913859|metastasis|metastasis
4751984|NCT02913846|denutrition|denutrition
4751985|NCT02913846|hospital length of stay|hospital length of stay
4751986|NCT02913846|patient's autonomy|patient's autonomy
4751987|NCT02913833|Pain|pain
4751988|NCT02913833|Hospital length of stay|hospital length of stay
4751989|NCT02913833|Revalidation unit|revalidation unit
4751990|NCT02913781|Polar body removal|polar body removal
4751991|NCT02913781|ICSI|icsi
4751992|NCT02913781|Fertilization failure|fertilization failure
4751993|NCT02913742|Intraoperative Neurophysiological Monitoring|intraoperative neurophysiological monitoring
4751994|NCT02913729|breast cancer|breast cancer
4751995|NCT02913703|Ghrelin|ghrelin
4751996|NCT02913690|Hemodialysis|hemodialysis
4751997|NCT02913690|Tocotrienol|tocotrienol
4751998|NCT02913690|Vitamin E|vitamin e
4751999|NCT02913677|feeding intolerance|feeding intolerance
4752000|NCT02913677|minimal enteral nutrition|minimal enteral nutrition
4752001|NCT02913677|very low birth weight|very low birth weight
4752002|NCT02913677|preterm infant|preterm infant
4752003|NCT02913664|Dementia|dementia
4752004|NCT02913664|Alzheimer's Disease|alzheimer's disease
4752005|NCT02913664|Cognitive Function|cognitive function
4752006|NCT02913664|Blood Pressure|blood pressure
4752007|NCT02913664|Cholesterol|cholesterol
4752008|NCT02913664|Physical Activity|physical activity
4752009|NCT02913664|Exercise|exercise
4752010|NCT02913664|Magnetic Resonance Imaging|magnetic resonance imaging
4752011|NCT02913651|Idiopathic hypersomnia|idiopathic hypersomnia
4752012|NCT02913651|heart rate variability|heart rate variability
4752013|NCT02913651|parasympathetic activity|parasympathetic activity
4752014|NCT02913651|autonomic arousal response|autonomic arousal response
4752015|NCT02913625|Brachial plexus|brachial plexus
4752016|NCT02913625|Regional anesthesia|regional anesthesia
4752017|NCT02913625|Infraclavicular|infraclavicular
4752018|NCT02913625|Retroclavicular|retroclavicular
4752019|NCT02913625|Parasagittal|parasagittal
4752020|NCT02913625|Upper limb surgery|upper limb surgery
4752021|NCT02913625|Ultrasound guided block|ultrasound guided block
4752022|NCT02913625|Coracoid|coracoid
4752023|NCT02913612|Hemangioma|hemangioma
4752024|NCT02913612|Infantile Hemangioma|infantile hemangioma
4752025|NCT02913612|Pharmacokinetics|pharmacokinetics
4752026|NCT02913508|Drug therapy|drug therapy
4752027|NCT02913495|Progesterone|progesterone
4752028|NCT02913495|Prevention of preterm birth|prevention of preterm birth
4752029|NCT02913469|Morphine，Ticagrelor，STEMI，PCI|morphine，ticagrelor，stemi，pci
4752030|NCT02913417|uveal melanoma|uveal melanoma
4752031|NCT02913417|liver metastases|liver metastases
4752032|NCT02913391|noninvasive ventilation|noninvasive ventilation
4752033|NCT02913391|myocardial revascularization|myocardial revascularization
4752034|NCT02913391|pulmonary atelectasis|pulmonary atelectasis
4752035|NCT02913391|hypoxia|hypoxia
4752036|NCT02913391|positive end-expiratory pressure|positive end-expiratory pressure
4752037|NCT02913391|coronary artery bypass grafting|coronary artery bypass grafting
4752038|NCT02913391|extracorporeal circulation|extracorporeal circulation
4752039|NCT02913365|Haemoptysis|haemoptysis
4752040|NCT02913365|Hemoptysis|hemoptysis
4752041|NCT02913365|Airway bleeding|airway bleeding
4752042|NCT02913365|Pulmonary hemorrhage|pulmonary hemorrhage
4752043|NCT02913339|screening|screening
4752044|NCT02913339|telemedicine|telemedicine
4752045|NCT02913339|risk assessment|risk assessment
4752046|NCT02913339|prevention|prevention
4752047|NCT02913300|Lignocaine|lignocaine
4752048|NCT02913261|GvHD (Graft versus Host Disease)|gvhd (graft versus host disease)
4752049|NCT02913261|INC424|inc424
4752050|NCT02913261|ruxolitinib|ruxolitinib
4752051|NCT02913261|best available therapy (BAT)|best available therapy (bat)
4752052|NCT02913261|corticosteroid-refractory acute graft vs. host disease|corticosteroid-refractory acute graft vs. host disease
4752053|NCT02913261|allogeneic stem cell transplantation|allogeneic stem cell transplantation
4752054|NCT02913261|steroid refractory acute graft vs. host disease|steroid refractory acute graft vs. host disease
4752055|NCT02913261|Janus Kinase (JAK) inhibitor|janus kinase (jak) inhibitor
4752056|NCT02913248|periodontitis|periodontitis
4752057|NCT02913248|saliva|saliva
4752058|NCT02913248|bacteria|bacteria
4752059|NCT02913235|biofilm|biofilm
4752060|NCT02913235|saliva|saliva
4752061|NCT02913235|bacteria|bacteria
4752062|NCT02913235|oral hygiene|oral hygiene
4752063|NCT02913222|femoroacetabular impingement|femoroacetabular impingement
4752064|NCT02913222|labral tear|labral tear
4752065|NCT02913222|rehabilitation|rehabilitation
4752066|NCT02913183|acute stroke|acute stroke
4752067|NCT02913183|young health plasma|young health plasma
4752068|NCT02913183|efficacy|efficacy
4752069|NCT02913183|safety|safety
4752070|NCT02913105|Non-alcoholic Steatohepatitis|non-alcoholic steatohepatitis
4752071|NCT02913105|NASH|nash
4752072|NCT02913105|Fatty liver disease|fatty liver disease
4752073|NCT02913014|Antiarrhythmic Agents|antiarrhythmic agents
4752074|NCT02913014|Catheter Ablation, electric|catheter ablation, electric
4752075|NCT02913014|Cardiac Arrhythmias|cardiac arrhythmias
4752076|NCT02913014|Anti-Arrhythmia Drugs|anti-arrhythmia drugs
4752077|NCT02913001|Diet|diet
4752078|NCT02913001|glycemic index|glycemic index
4752079|NCT02913001|glycemic load|glycemic load
4752080|NCT02913001|Acne Vulgaris|acne vulgaris
4752081|NCT02912988|Subfertility|subfertility
4752082|NCT02912988|In-vitro fertilization|in-vitro fertilization
4752083|NCT02912988|Letrozole|letrozole
4752084|NCT02912949|Bispecific Antibody IgG1, HER2, HER3|bispecific antibody igg1, her2, her3
4752085|NCT02912949|First-in-human|first-in-human
4752086|NCT02912949|MCLA-128|mcla-128
4752087|NCT02912949|Antibodies, Bispecific|antibodies, bispecific
4752088|NCT02912949|Immunologic Factors|immunologic factors
4752089|NCT02912949|Cytokines|cytokines
4752090|NCT02912936|medium chain triglyceride|medium chain triglyceride
4752091|NCT02912936|MCT|mct
4752092|NCT02912936|coconut oil|coconut oil
4752093|NCT02912936|MRI|mri
4752094|NCT02912936|PET|pet
4752095|NCT02912936|ketones|ketones
4752096|NCT02912923|Stroke|stroke
4752097|NCT02912923|Rehabilitation Robotics|rehabilitation robotics
4752098|NCT02912923|Bimanual|bimanual
4752099|NCT02912923|Compensatory Movements|compensatory movements
4752100|NCT02912923|Hemiplegia|hemiplegia
4752101|NCT02912923|Kinematics|kinematics
4752102|NCT02912923|Reaching|reaching
4752103|NCT02912923|Trunk|trunk
4752104|NCT02912897|EBV-CTL|ebv-ctl
4752105|NCT02912897|Multiple sclerosis|multiple sclerosis
4752106|NCT02912897|cellular therapy|cellular therapy
4752107|NCT02912897|clinically isolated syndrome|clinically isolated syndrome
4752108|NCT02912871|subthalamotomy|subthalamotomy
4752109|NCT02912871|motor features|motor features
4752110|NCT02912871|deep brain stimulation|deep brain stimulation
4752111|NCT02912832|Diagnosis|diagnosis
4752112|NCT02912806|Knee Arthroplasty|knee arthroplasty
4752113|NCT02912806|Total knee replacement|total knee replacement
4752114|NCT02912806|Knee osteoarthritis|knee osteoarthritis
4752115|NCT02912806|Patient-Outcomes Measurement Program|patient-outcomes measurement program
4752116|NCT02912806|Surgical Registries|surgical registries
4752117|NCT02912806|Shared Decision Making|shared decision making
4752118|NCT02912806|Patient Reported Outcomes|patient reported outcomes
4752119|NCT02912806|Patient Experience|patient experience
4752120|NCT02912806|Cohort Studies|cohort studies
4752121|NCT02912767|lower-extremity lymphedema|lower-extremity lymphedema
4752122|NCT02912767|16-1001|16-1001
4752123|NCT02912702|Pegaspargase|pegaspargase
4752124|NCT02912702|hemophagocytic lymphohistiocytosis|hemophagocytic lymphohistiocytosis
4752125|NCT02912702|Epstein Barr virus|epstein barr virus
4752126|NCT02912702|initial treatment|initial treatment
4752127|NCT02912689|COPD|copd
4752128|NCT02912689|Non-invasive ventilation|non-invasive ventilation
4752129|NCT02912689|NAVA|nava
4752130|NCT02912676|Cancer|cancer
4752131|NCT02912676|Thioguanine|thioguanine
4752132|NCT02912676|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
4752133|NCT02912676|6 Mercaptopurine|6 mercaptopurine
4752134|NCT02912676|Maintenance Therapy of Leukemia|maintenance therapy of leukemia
4752135|NCT02912676|Denmark|denmark
4752136|NCT02912676|Lymphoblastic Lymphoma|lymphoblastic lymphoma
4752137|NCT02912650|ibuprofen|ibuprofen
4752138|NCT02912650|acetaminophen|acetaminophen
4752139|NCT02912650|pain|pain
4752140|NCT02912650|molar extraction|molar extraction
4752141|NCT02912624|Physical Examination|physical examination
4752142|NCT02912624|Diagnostic Imaging|diagnostic imaging
4752143|NCT02912624|Ultrasonography|ultrasonography
4752144|NCT02912624|Hemodynamics|hemodynamics
4752145|NCT02912624|Patient Outcome Assessment|patient outcome assessment
4752146|NCT02912624|Mortality|mortality
4752147|NCT02912585|colostrum|colostrum
4752148|NCT02912572|Endometrial Cancer|endometrial cancer
4752149|NCT02912546|Stroke, Acute|stroke, acute
4752150|NCT02912455|Post-Bariatric Surgery|post-bariatric surgery
4752151|NCT02912455|hemoglobin A1c protein, human|hemoglobin a1c protein, human
4752152|NCT02912442|thyroid|thyroid
4752153|NCT02912442|infertility|infertility
4752154|NCT02912442|autoimmunity|autoimmunity
4752155|NCT02912442|pregnancy loss|pregnancy loss
4752156|NCT02912442|autoantibodies|autoantibodies
4752157|NCT02912364|Eslicarbazepine|eslicarbazepine
4752158|NCT02912364|Carbamazepine|carbamazepine
4752159|NCT02912364|cognition|cognition
4752160|NCT02912351|Total Knee Arthroplasty|total knee arthroplasty
4752161|NCT02912351|Total Knee Replacement|total knee replacement
4752162|NCT02912351|Revision Knee Arthroplasty|revision knee arthroplasty
4752163|NCT02912338|Sarcopenic obesity|sarcopenic obesity
4752164|NCT02912338|Body composition|body composition
4752165|NCT02912338|Physical function|physical function
4752166|NCT02912338|quality of life|quality of life
4752167|NCT02912338|long term care|long term care
4752168|NCT02912312|Malignant neoplasm of breast|malignant neoplasm of breast
4752169|NCT02912312|Lymphedema|lymphedema
4752170|NCT02912312|Standard regional nodal irradiation|standard regional nodal irradiation
4752171|NCT02912312|RNI|rni
4752172|NCT02912312|Shortened regional nodal irradiation|shortened regional nodal irradiation
4752173|NCT02912312|Radiation therapy|radiation therapy
4752174|NCT02912312|XRT|xrt
4752175|NCT02912312|Arm swelling|arm swelling
4752176|NCT02912312|Questionnaires|questionnaires
4752177|NCT02912312|Surveys|surveys
4752178|NCT02912273|Geriatric assessment|geriatric assessment
4752179|NCT02912247|tumor necrosis factor-a blocker|tumor necrosis factor-a blocker
4752180|NCT02912247|pharmacokinetics|pharmacokinetics
4752181|NCT02912247|safety|safety
4752182|NCT02912169|Alzheimer's Disease|alzheimer's disease
4752183|NCT02912169|Alzheimer's|alzheimer's
4752184|NCT02912169|Stem cell|stem cell
4752185|NCT02912169|Adipose-derived stem cells|adipose-derived stem cells
4752186|NCT02912169|ASC|asc
4752187|NCT02912169|ADSC|adsc
4752188|NCT02912156|Pharmacokinetic|pharmacokinetic
4752189|NCT02912130|Exercise|exercise
4752190|NCT02912130|Nutrition|nutrition
4752191|NCT02912130|Sarcopenia|sarcopenia
4752192|NCT02912130|Healthy Ageing|healthy ageing
4752193|NCT02912130|Elderly|elderly
4752194|NCT02912130|Muscular Hypertrophy|muscular hypertrophy
4752195|NCT02912104|primary ovarian insufficiency|primary ovarian insufficiency
4752196|NCT02912104|premature ovarian failure|premature ovarian failure
4752197|NCT02912104|Infertility|infertility
4752198|NCT02912104|human amniotic epithelial cells transplantation|human amniotic epithelial cells transplantation
4752199|NCT02912052|Perioperative Chemotherapy|perioperative chemotherapy
4752200|NCT02912052|Postoperative Chemotherapy|postoperative chemotherapy
4752201|NCT02912052|Colon Cancer|colon cancer
4752202|NCT02912052|Resectable Liver Metastasis|resectable liver metastasis
4752203|NCT02912000|Dental Health Services|dental health services
4752204|NCT02912000|Sugar-Sweetened Beverages|sugar-sweetened beverages
4752205|NCT02912000|Tobacco control|tobacco control
4752206|NCT02912000|Pediatrics|pediatrics
4752207|NCT02912000|Parents|parents
4752208|NCT02911974|fine needle biopsy|fine needle biopsy
4752209|NCT02911974|EUS|eus
4752210|NCT02911974|solid pancreatic mass|solid pancreatic mass
4752211|NCT02911896|physical function|physical function
4752212|NCT02911896|critical care|critical care
4752213|NCT02911857|Canakinumab,|canakinumab,
4752214|NCT02911857|interleukin-1|interleukin-1
4752215|NCT02911857|Periodic Fevers Syndrome|periodic fevers syndrome
4752216|NCT02911857|TRAPS|traps
4752217|NCT02911857|HIDS|hids
4752218|NCT02911857|crFMF|crfmf
4752219|NCT02911857|auto-inflammatory diseases|auto-inflammatory diseases
4752220|NCT02911857|extension study|extension study
4752221|NCT02911805|Exercise|exercise
4752222|NCT02911805|Retinal Degeneration|retinal degeneration
4752223|NCT02911805|Neuropharmacology|neuropharmacology
4752224|NCT02911805|Brain-Derived Neurotrophic Factor|brain-derived neurotrophic factor
4752225|NCT02911805|Biometry|biometry
4752226|NCT02911805|Immunochemistry|immunochemistry
4752227|NCT02911805|Molecular Biology|molecular biology
4752228|NCT02911805|Neurosciences|neurosciences
4752229|NCT02911805|Ophthalmology|ophthalmology
4752230|NCT02911792|hyperfiltering|hyperfiltering
4752231|NCT02911792|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
4752232|NCT02911766|Periodontal Index|periodontal index
4752233|NCT02911727|Cesarean section|cesarean section
4752234|NCT02911727|Postnatal Care|postnatal care
4752235|NCT02911714|Kidney Transplantation|kidney transplantation
4752236|NCT02911714|Delayed Graft Function|delayed graft function
4752237|NCT02911714|Acute Allograft Rejection|acute allograft rejection
4752238|NCT02911714|Acute Kidney Injury|acute kidney injury
4752239|NCT02911597|Ketamine|ketamine
4752240|NCT02911597|Naltrexone|naltrexone
4752241|NCT02911597|Treatment-Resistant|treatment-resistant
4752242|NCT02911597|TRD|trd
4752243|NCT02911545|Atrial fibrillation|atrial fibrillation
4752244|NCT02911545|Anticoagulation|anticoagulation
4752245|NCT02911545|Cardioversion|cardioversion
4752246|NCT02911532|pterygium|pterygium
4752247|NCT02911532|tissue engineering|tissue engineering
4752248|NCT02911532|atretoblepharia|atretoblepharia
4752249|NCT02911519|Schizophrenia|schizophrenia
4752250|NCT02911519|Patient Education|patient education
4752251|NCT02911493|sedentary time|sedentary time
4752252|NCT02911493|number of steps/day|number of steps/day
4752253|NCT02911493|mobility|mobility
4752254|NCT02911493|disability|disability
4752255|NCT02911428|Ebola|ebola
4752256|NCT02911428|Ebola Virus Vaccines|ebola virus vaccines
4752257|NCT02911428|Haemorrhagic Fever|haemorrhagic fever
4752258|NCT02911428|Ebola Infection|ebola infection
4752259|NCT02911428|GP protein, Ebola virus|gp protein, ebola virus
4752260|NCT02911415|Ebola|ebola
4752261|NCT02911415|Ebola Virus Vaccines|ebola virus vaccines
4752262|NCT02911415|Haemorrhagic Fever|haemorrhagic fever
4752263|NCT02911415|Ebola Infection|ebola infection
4752264|NCT02911415|GP protein, Ebola virus|gp protein, ebola virus
4752265|NCT02911311|conbercept|conbercept
4752266|NCT02911311|anti-VEGF agent|anti-vegf agent
4752267|NCT02911311|panretinal photocoagulation|panretinal photocoagulation
4752268|NCT02911285|Alcohol|alcohol
4752269|NCT02911285|PTSD|ptsd
4752270|NCT02911285|Trauma|trauma
4752271|NCT02911285|Veteran|veteran
4752272|NCT02911285|Substance|substance
4752273|NCT02911285|Drug|drug
4752274|NCT02911285|Post Traumatic Stress Disorder|post traumatic stress disorder
4752275|NCT02911285|Military|military
4752276|NCT02911272|Partograph|partograph
4752277|NCT02911272|Best action line|best action line
4752278|NCT02911272|Prolonged labour prevention|prolonged labour prevention
4752279|NCT02911207|chronic ill patients|chronic ill patients
4752280|NCT02911207|Emotion management skill|emotion management skill
4752281|NCT02911207|Quality of Life|quality of life
4752282|NCT02911181|BIVA measurement|biva measurement
4752283|NCT02911181|SNAQ score|snaq score
4752284|NCT02911168|NERVE BLOCK|nerve block
4752285|NCT02911168|ANESTHESIA RECOVERY PERIOD|anesthesia recovery period
4752286|NCT02911168|PAIN MANAGEMENT|pain management
4752287|NCT02911155|Cohort Study|cohort study
4752288|NCT02911155|Radiation|radiation
4752289|NCT02911155|Occupation|occupation
4752290|NCT02911142|Treatment Naive|treatment naive
4752291|NCT02911142|Immune Modulatory|immune modulatory
4752292|NCT02911142|Chemotherapy|chemotherapy
4752293|NCT02911142|AIDS-Related Lymphoma|aids-related lymphoma
4752294|NCT02911142|PEL|pel
4752295|NCT02911129|Chronic Stroke|chronic stroke
4752296|NCT02911129|Neglect|neglect
4752297|NCT02911129|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
4752298|NCT02911129|Visual and Motor Integration|visual and motor integration
4752299|NCT02911129|Visual Fields|visual fields
4752300|NCT02911116|Panuveitis|panuveitis
4752301|NCT02911116|Intermediate Uveitis|intermediate uveitis
4752302|NCT02911116|Uveitis|uveitis
4752303|NCT02911103|Electrophysiology|electrophysiology
4752304|NCT02911103|Neurosurgery|neurosurgery
4752305|NCT02911103|Dystonia|dystonia
4752306|NCT02911103|Deep Brain Stimulation|deep brain stimulation
4752307|NCT02911090|Endometriosis|endometriosis
4752308|NCT02911090|Chronic pelvic pain|chronic pelvic pain
4752309|NCT02911090|Dyspareunia|dyspareunia
4752310|NCT02911077|Bacteria|bacteria
4752311|NCT02911064|Questionnaires|questionnaires
4752312|NCT02911064|Surveys|surveys
4752313|NCT02911064|Benign neoplasms|benign neoplasms
4752314|NCT02911064|Malignant neoplasms of independent (primary) multiple sites|malignant neoplasms of independent (primary) multiple sites
4752315|NCT02911064|Inpatient rehabilitation therapy|inpatient rehabilitation therapy
4752316|NCT02911038|Complete denture|complete denture
4752317|NCT02911038|PMMA|pmma
4752318|NCT02911038|Stereolithography|stereolithography
4752319|NCT02911025|epilepsy|epilepsy
4752320|NCT02911025|sleep|sleep
4752321|NCT02911025|antiepileptic drugs|antiepileptic drugs
4752322|NCT02910986|Mammography|mammography
4752323|NCT02910986|Breast Density|breast density
4752324|NCT02910986|Hispanic|hispanic
4752325|NCT02910973|Inflammation, Vagus Nerve Stimulation|inflammation, vagus nerve stimulation
4752326|NCT02910960|fine needle biopsy|fine needle biopsy
4752327|NCT02910960|EUS|eus
4752328|NCT02910960|solid pancreatic mass|solid pancreatic mass
4752329|NCT02910934|Indoor Residual Spray|indoor residual spray
4752330|NCT02910934|IRS|irs
4752331|NCT02910934|Insecticide Treated Net|insecticide treated net
4752332|NCT02910934|LLIN|llin
4752333|NCT02910934|ITN|itn
4752334|NCT02910921|Migraine|migraine
4752335|NCT02910921|Prediction|prediction
4752336|NCT02910921|Forecast|forecast
4752337|NCT02910921|App|app
4752338|NCT02910921|Fitbit|fitbit
4752339|NCT02910921|Individual|individual
4752340|NCT02910921|Algorithm|algorithm
4752341|NCT02910921|Machine Learning|machine learning
4752342|NCT02910921|Mayo Clinic|mayo clinic
4752343|NCT02910921|Allergan|allergan
4752344|NCT02910921|Second Opinion|second opinion
4752345|NCT02910908|Elderly|elderly
4752346|NCT02910908|ESRD prognosis|esrd prognosis
4752347|NCT02910908|help decision making dialysis therapeutic project|help decision making dialysis therapeutic project
4752348|NCT02910882|Pancreas Cancer|pancreas cancer
4752349|NCT02910882|Unresectable|unresectable
4752350|NCT02910882|Chemoradiation|chemoradiation
4752351|NCT02910882|PEGPH20|pegph20
4752352|NCT02910843|rectal cancer|rectal cancer
4752353|NCT02910843|Neoadjuvant treatment|neoadjuvant treatment
4752354|NCT02910843|Regorafenib|regorafenib
4752355|NCT02910843|Capecitabine|capecitabine
4752356|NCT02910843|locally advanced rectal cancer|locally advanced rectal cancer
4752357|NCT02910843|Phase Ib trial|phase ib trial
4752358|NCT02910804|GBM|gbm
4752359|NCT02910804|GRPR|grpr
4752360|NCT02910804|IRDye800|irdye800
4752361|NCT02910804|NIRF|nirf
4752362|NCT02910804|surgery|surgery
4752363|NCT02910726|indocyanine green fluorescent dye|indocyanine green fluorescent dye
4752364|NCT02910726|Technetium lymphoscintigraphy|technetium lymphoscintigraphy
4752365|NCT02910726|sentinel lymph node biopsy|sentinel lymph node biopsy
4752366|NCT02910726|16-1003|16-1003
4752367|NCT02910700|Melanoma|melanoma
4752368|NCT02910700|Metastatic Melanoma|metastatic melanoma
4752369|NCT02910700|BRAF- mutated metastatic melanoma|braf- mutated metastatic melanoma
4752370|NCT02910700|BRAF-wild type metastatic melanoma|braf-wild type metastatic melanoma
4752371|NCT02910700|Nivolumab|nivolumab
4752372|NCT02910700|BMS-936558|bms-936558
4752373|NCT02910700|Opdivo|opdivo
4752374|NCT02910700|Dabrafenib|dabrafenib
4752375|NCT02910700|Tafinlar|tafinlar
4752376|NCT02910700|GSK2118436|gsk2118436
4752377|NCT02910700|Trametinib|trametinib
4752378|NCT02910700|GSK1120212|gsk1120212
4752379|NCT02910687|Non ST Elevation Myocardial Infarction (NSTEMI)|non st elevation myocardial infarction (nstemi)
4752380|NCT02910687|Elderly|elderly
4752381|NCT02910687|Frailty|frailty
4752382|NCT02910687|Prognostic value|prognostic value
4752383|NCT02910661|Kidney Transplantation|kidney transplantation
4752384|NCT02910648|healthy|healthy
4752385|NCT02910648|BMI|bmi
4752386|NCT02910648|weight loss|weight loss
4752387|NCT02910648|sleep|sleep
4752388|NCT02910648|healthy sleeper|healthy sleeper
4752389|NCT02910648|overweight|overweight
4752390|NCT02910648|obese|obese
4752391|NCT02910635|Thorough QTc, Therapeutic dose, supra therapeutic dose|thorough qtc, therapeutic dose, supra therapeutic dose
4752392|NCT02910622|breast|breast
4752393|NCT02910622|ovarian|ovarian
4752394|NCT02910622|cancer|cancer
4752395|NCT02910609|preterm|preterm
4752396|NCT02910609|patent ductus arterioles|patent ductus arterioles
4752397|NCT02910609|treatment|treatment
4752398|NCT02910557|CTCAE - Common Terminology Criteria for Adverse Events|ctcae - common terminology criteria for adverse events
4752399|NCT02910557|eCRF - electronic case report form|ecrf - electronic case report form
4752400|NCT02910557|ECOG - Eastern Cooperative Oncology Group|ecog - eastern cooperative oncology group
4752401|NCT02910557|EDC - electronic data capture|edc - electronic data capture
4752402|NCT02910557|GM-CSF - human granulocyte macrophage colony-stimulating factor|gm-csf - human granulocyte macrophage colony-stimulating factor
4752403|NCT02910557|HCP - health care provider|hcp - health care provider
4752404|NCT02910557|HSV-1 - herpes simplex virus type 1|hsv-1 - herpes simplex virus type 1
4752405|NCT02910557|ICF - informed consent form|icf - informed consent form
4752406|NCT02910557|ICP - infected cell protein|icp - infected cell protein
4752407|NCT02910557|IEC - Independent Ethics Committee|iec - independent ethics committee
4752408|NCT02910557|IRB - Institutional Review Board|irb - institutional review board
4752409|NCT02910557|MedDRA - Medical Dictionary for Regulatory Activities|meddra - medical dictionary for regulatory activities
4752410|NCT02910557|PFU - plaque-forming unit|pfu - plaque-forming unit
4752411|NCT02910557|qPCR - quantitative polymerase chain reaction|qpcr - quantitative polymerase chain reaction
4752412|NCT02910557|SmPC - Summary of Product Characteristics|smpc - summary of product characteristics
4752413|NCT02910557|USPI - United States Prescribing Information|uspi - united states prescribing information
4752414|NCT02910531|Cystinuria|cystinuria
4752415|NCT02910531|Kidney stone|kidney stone
4752416|NCT02910531|Alpha lipoic acid|alpha lipoic acid
4752417|NCT02910479|Body Temperature|body temperature
4752418|NCT02910479|Thermometers|thermometers
4752419|NCT02910453|Pulmonary lobectomy|pulmonary lobectomy
4752420|NCT02910453|Video-Assisted Thoracic Surgery|video-assisted thoracic surgery
4752421|NCT02910453|Opto-electronic plethysmography|opto-electronic plethysmography
4752422|NCT02910453|Posterolateral thoracotomy|posterolateral thoracotomy
4752423|NCT02910427|stroke|stroke
4752424|NCT02910427|potassium and magnesium-enriched salt|potassium and magnesium-enriched salt
4752425|NCT02910427|neurological performance|neurological performance
4752426|NCT02910414|Renal Denervation|renal denervation
4752427|NCT02910414|Alcohol|alcohol
4752428|NCT02910388|conization|conization
4752429|NCT02910388|LLETZ|lletz
4752430|NCT02910388|loop excision|loop excision
4752431|NCT02910388|randomized controlled trial|randomized controlled trial
4752432|NCT02910388|colposcopy|colposcopy
4752433|NCT02910388|direct colposcopic vision|direct colposcopic vision
4752434|NCT02910388|intraoperative colposcopy|intraoperative colposcopy
4752435|NCT02910375|golimumab|golimumab
4752436|NCT02910375|drug monitoring|drug monitoring
4752437|NCT02910375|home based care|home based care
4752438|NCT02910349|valvular hear disease|valvular hear disease
4752439|NCT02910349|echocardiography|echocardiography
4752440|NCT02910349|magnetic resonance|magnetic resonance
4752441|NCT02910349|global longitudinal strain|global longitudinal strain
4752442|NCT02910349|T1 relaxation time|t1 relaxation time
4752443|NCT02910310|Uterine Balloon Tamponade|uterine balloon tamponade
4752444|NCT02910297|cannabidiol|cannabidiol
4752445|NCT02910297|Dravet Syndrome|dravet syndrome
4752446|NCT02910297|Lennox Gastaut Syndrome|lennox gastaut syndrome
4752447|NCT02910284|HSV|hsv
4752448|NCT02910284|Herpes|herpes
4752449|NCT02910284|Genital Herpes|genital herpes
4752450|NCT02910258|myelofibrosis|myelofibrosis
4752451|NCT02910258|pegylated interferon|pegylated interferon
4752452|NCT02910245|Therapeutic Drug Monitoring|therapeutic drug monitoring
4752453|NCT02910245|Mercaptopurine (6-MP)|mercaptopurine (6-mp)
4752454|NCT02910245|Thiopurine|thiopurine
4752455|NCT02910245|Efficacy|efficacy
4752456|NCT02910232|Rice starch|rice starch
4752457|NCT02910232|Porous composite|porous composite
4752458|NCT02910232|Biomaterial|biomaterial
4752459|NCT02910232|Bone regeneration|bone regeneration
4752460|NCT02910232|Clinical trial|clinical trial
4752461|NCT02910232|Hydroxyapatite|hydroxyapatite
4752462|NCT02910219|HER2|her2
4752463|NCT02910219|pertuzumab|pertuzumab
4752464|NCT02910219|trastuzumab|trastuzumab
4752465|NCT02910219|docetaxel|docetaxel
4752466|NCT02910219|paclitaxel|paclitaxel
4752467|NCT02910219|carboplatin|carboplatin
4752468|NCT02910219|crofelemer|crofelemer
4752469|NCT02910219|chemotherapy induced diarrhea|chemotherapy induced diarrhea
4752470|NCT02910206|etomidate|etomidate
4752471|NCT02910206|propofol|propofol
4752472|NCT02910193|alcoholism|alcoholism
4752473|NCT02910193|genetics|genetics
4752474|NCT02910193|functional MRI|functional mri
4752475|NCT02910193|structural MRI|structural mri
4752476|NCT02910193|first-degree relatives|first-degree relatives
4752477|NCT02910180|Tissue Repository|tissue repository
4752478|NCT02910180|Cerebrovascular Diseases|cerebrovascular diseases
4752479|NCT02910180|Stroke|stroke
4752480|NCT02910180|Aneurysm|aneurysm
4752481|NCT02910180|Arteriovenous malformation|arteriovenous malformation
4752482|NCT02910180|Fistula|fistula
4752483|NCT02910180|Intracranial Stenosis|intracranial stenosis
4752484|NCT02910180|Treatment|treatment
4752485|NCT02910180|Registry|registry
4752486|NCT02910180|Outcomes|outcomes
4752487|NCT02910141|Type 2 diabetes|type 2 diabetes
4752488|NCT02910141|Continuous subcutaneous insulin infusion|continuous subcutaneous insulin infusion
4752489|NCT02910141|Meta-analysis|meta-analysis
4752490|NCT02910141|Insulin pump therapy|insulin pump therapy
4752491|NCT02910141|Multiple daily insulin injections|multiple daily insulin injections
4752492|NCT02910102|RVT-101|rvt-101
4752493|NCT02910102|intepirdine|intepirdine
4752494|NCT02910102|Alzheimer's disease|alzheimer's disease
4752495|NCT02910102|Dementia with Lewy bodies|dementia with lewy bodies
4752496|NCT02910102|Lewy body dementia|lewy body dementia
4752497|NCT02910102|Parkinson's Disease Dementia|parkinson's disease dementia
4752498|NCT02910089|Diabetes Mellitus Type 2|diabetes mellitus type 2
4752499|NCT02910063|Relapsed/Refractory Aggressive B-Cell Non Hodgkin Lymphoma|relapsed/refractory aggressive b-cell non hodgkin lymphoma
4752500|NCT02910063|Blinatumomab|blinatumomab
4752501|NCT02910063|Leukemia|leukemia
4752502|NCT02910063|Standard of Care|standard of care
4752503|NCT02910063|SOC|soc
4752504|NCT02910063|Cancer|cancer
4752505|NCT02910063|Chemotherapy|chemotherapy
4752506|NCT02910050|androgen receptor|androgen receptor
4752507|NCT02910050|bicalutamide|bicalutamide
4752508|NCT02910050|aromatase inhibitors|aromatase inhibitors
4752509|NCT02910050|advanced breast cancer|advanced breast cancer
4752510|NCT02910050|letrozole|letrozole
4752511|NCT02910050|anastrozole|anastrozole
4752512|NCT02910050|exemestane|exemestane
4752513|NCT02910037|metagenomic next-generation sequencing|metagenomic next-generation sequencing
4752514|NCT02910037|microbiological diagnosis|microbiological diagnosis
4752515|NCT02910037|bacterial infections|bacterial infections
4752516|NCT02910037|viral infections|viral infections
4752517|NCT02910037|fungal infections|fungal infections
4752518|NCT02910037|parasitic infections|parasitic infections
4752519|NCT02909998|Biomarkers|biomarkers
4752520|NCT02909998|Genetic|genetic
4752521|NCT02909998|Chronic arthritis|chronic arthritis
4752522|NCT02909998|Treatment|treatment
4752523|NCT02909985|Infrared|infrared
4752524|NCT02909985|Dark Adaptation|dark adaptation
4752525|NCT02909985|Vision|vision
4752526|NCT02909985|Scotopic Threshold Response|scotopic threshold response
4752527|NCT02909985|Transient Receptor Potential (TRP) Channels|transient receptor potential (trp) channels
4752528|NCT02909985|Human|human
4752529|NCT02909959|sulforaphane|sulforaphane
4752530|NCT02909959|glucoraphanin|glucoraphanin
4752531|NCT02909959|physiologic effects of drugs|physiologic effects of drugs
4752532|NCT02909946|multidrug-resistant organisms|multidrug-resistant organisms
4752533|NCT02909946|nursing home|nursing home
4752534|NCT02909946|post-acute care|post-acute care
4752535|NCT02909946|long-term care|long-term care
4752536|NCT02909946|infection control|infection control
4752537|NCT02909920|Telerehabilitation|telerehabilitation
4752538|NCT02909920|Physiotherapy|physiotherapy
4752539|NCT02909920|Surgery|surgery
4752540|NCT02909920|Telemedicine|telemedicine
4752541|NCT02909894|Sedentary behaviour|sedentary behaviour
4752542|NCT02909894|Postprandial glycaemic response|postprandial glycaemic response
4752543|NCT02909881|polysaccharide|polysaccharide
4752544|NCT02909881|oxidation|oxidation
4752545|NCT02909881|endurance exercise|endurance exercise
4752546|NCT02909855|children|children
4752547|NCT02909855|psychological predictors|psychological predictors
4752548|NCT02909855|side-effects|side-effects
4752549|NCT02909855|vaccination|vaccination
4752550|NCT02909842|influenza|influenza
4752551|NCT02909842|vaccine|vaccine
4752552|NCT02909842|probiotic|probiotic
4752553|NCT02909842|immune response|immune response
4752554|NCT02909829|Diabetes Mellitus, Type 1|diabetes mellitus, type 1
4752555|NCT02909829|Artificial Pancreas|artificial pancreas
4752556|NCT02909829|Closed-Loop Delivery|closed-loop delivery
4752557|NCT02909829|Insulin|insulin
4752558|NCT02909829|Adolescent|adolescent
4752559|NCT02909829|Missed Bolus|missed bolus
4752560|NCT02909803|glucose|glucose
4752561|NCT02909803|glycemic index|glycemic index
4752562|NCT02909803|lentil|lentil
4752563|NCT02909803|polyphenols|polyphenols
4752564|NCT02909803|metabolites|metabolites
4752565|NCT02909803|bioavailability|bioavailability
4752566|NCT02909777|Lymphoma|lymphoma
4752567|NCT02909777|Neuroblastoma|neuroblastoma
4752568|NCT02909777|Brain Tumor|brain tumor
4752569|NCT02909777|Solid Tumor|solid tumor
4752570|NCT02909764|Salty taste|salty taste
4752571|NCT02909764|Psychophysics|psychophysics
4752572|NCT02909764|Genetics|genetics
4752573|NCT02909764|Diet|diet
4752574|NCT02909764|Age|age
4752575|NCT02909725|Physical activity|physical activity
4752576|NCT02909725|Sedentary time|sedentary time
4752577|NCT02909725|Pregnancy|pregnancy
4752578|NCT02909725|Pregnant women|pregnant women
4752579|NCT02909725|Weight gain|weight gain
4752580|NCT02909712|sub-Saharan|sub-saharan
4752581|NCT02909712|dihydroartemisinin|dihydroartemisinin
4752582|NCT02909712|piperaquine|piperaquine
4752583|NCT02909712|sulphadoxine-pyrimethamine|sulphadoxine-pyrimethamine
4752584|NCT02909712|antimalarials|antimalarials
4752585|NCT02909686|Gulf War Syndrome|gulf war syndrome
4752586|NCT02909686|Chronic Multisymptom Illnesses|chronic multisymptom illnesses
4752587|NCT02909686|Medically Unexplained Illnesses|medically unexplained illnesses
4752588|NCT02909673|adolescent behavior|adolescent behavior
4752589|NCT02909673|intimate partner violence|intimate partner violence
4752590|NCT02909673|youth risk behavior|youth risk behavior
4752591|NCT02909673|violence prevention|violence prevention
4752592|NCT02909673|teen dating violence|teen dating violence
4752593|NCT02909621|OsteoArthritis; FLEXOFYTOL®; Curcuma; biomarkers|osteoarthritis; flexofytol®; curcuma; biomarkers
4752594|NCT02909556|Transcatheter Aortic Valve Replacement|transcatheter aortic valve replacement
4752595|NCT02909556|TAVI|tavi
4752596|NCT02909556|Transcatheter Aortic Valve Implant|transcatheter aortic valve implant
4752597|NCT02909556|Transfemoral access|transfemoral access
4752598|NCT02909530|Endoscopic ultrasound-guided fine needle biopsy|endoscopic ultrasound-guided fine needle biopsy
4752599|NCT02909530|Olympus EZ Shot 3Plus|olympus ez shot 3plus
4752600|NCT02909530|Olympus EZ Shot 2|olympus ez shot 2
4752601|NCT02909452|entinostat|entinostat
4752602|NCT02909452|pembrolizumab|pembrolizumab
4752603|NCT02909452|solid tumor|solid tumor
4752604|NCT02909452|Histone Deacetylase Inhibitor|histone deacetylase inhibitor
4752605|NCT02909426|Screening|screening
4752606|NCT02909426|Digital mammography|digital mammography
4752607|NCT02909426|Ultrasonography|ultrasonography
4752608|NCT02909426|Sensitivity|sensitivity
4752609|NCT02909426|Specificity|specificity
4752610|NCT02909413|desflurane|desflurane
4752611|NCT02909413|sevoflurane|sevoflurane
4752612|NCT02909400|mitochondrial|mitochondrial
4752613|NCT02909400|oxidative phosphorylation (oxphos)|oxidative phosphorylation (oxphos)
4752614|NCT02909400|MELAS|melas
4752615|NCT02909400|MIDD|midd
4752616|NCT02909400|KH176|kh176
4752617|NCT02909400|Proof of Concept|proof of concept
4752618|NCT02909387|Epilepsy|epilepsy
4752619|NCT02909387|Seizure Disorder|seizure disorder
4752620|NCT02909374|Implementation|implementation
4752621|NCT02909374|fall prevention|fall prevention
4752622|NCT02909374|balance training|balance training
4752623|NCT02909348|Neoplasms|neoplasms
4752624|NCT02909348|Melanoma|melanoma
4752625|NCT02909348|Immunotherapy|immunotherapy
4752626|NCT02909348|Biomarkers|biomarkers
4752627|NCT02909309|Propofol|propofol
4752628|NCT02909309|Deep Sedation|deep sedation
4752629|NCT02909309|Anoxia|anoxia
4752630|NCT02909309|Hypercapnia|hypercapnia
4752631|NCT02909231|Patient Outcome Assessment|patient outcome assessment
4752632|NCT02909218|HIV/AIDS, Swaziland|hiv/aids, swaziland
4752633|NCT02909205|child|child
4752634|NCT02909205|gastrostomy|gastrostomy
4752635|NCT02909205|supportive care|supportive care
4752636|NCT02909205|educational program|educational program
4752637|NCT02909192|Parkinson's Disease|parkinson's disease
4752638|NCT02909192|Excessive Daytime Sleepiness|excessive daytime sleepiness
4752639|NCT02909192|Circadian Rhythms|circadian rhythms
4752640|NCT02909192|Light Therapy|light therapy
4752641|NCT02909179|Community Health Workers, mHealth, mobile phones, ANC, PNC, essential newborn care|community health workers, mhealth, mobile phones, anc, pnc, essential newborn care
4752642|NCT02909153|Triferic|triferic
4752643|NCT02909153|ferric pyrophosphate citrate|ferric pyrophosphate citrate
4752644|NCT02909153|peritoneal dialysis|peritoneal dialysis
4752645|NCT02909153|anemia|anemia
4752646|NCT02909153|chronic kidney disease|chronic kidney disease
4752647|NCT02909153|FPC|fpc
4752648|NCT02909127|deglutition|deglutition
4752649|NCT02909127|deglutition disorders|deglutition disorders
4752650|NCT02909127|pediatric dysphagia|pediatric dysphagia
4752651|NCT02909127|swallowing|swallowing
4752652|NCT02909114|stereotactic boday radiotherapy, oligometastases|stereotactic boday radiotherapy, oligometastases
4752653|NCT02909101|Working memory|working memory
4752654|NCT02909101|cognitive training|cognitive training
4752655|NCT02909101|HIV|hiv
4752656|NCT02909101|substance abuse|substance abuse
4752657|NCT02909088|stuttering|stuttering
4752658|NCT02909088|childhood onset fluency disorder|childhood onset fluency disorder
4752659|NCT02909088|ecopipam|ecopipam
4752660|NCT02909075|PET/CT|pet/ct
4752661|NCT02909075|MRI|mri
4752662|NCT02909075|Assess Thymic Function|assess thymic function
4752663|NCT02909075|16-1244|16-1244
4752664|NCT02909062|Electronic Activity Monitoring (EAM)|electronic activity monitoring (eam)
4752665|NCT02909062|16-493|16-493
4752666|NCT02909049|Prostate Biopsy|prostate biopsy
4752667|NCT02909049|Local Anesthesia|local anesthesia
4752668|NCT02909049|Pain|pain
4752669|NCT02909049|Biopsy of prostate|biopsy of prostate
4752670|NCT02909036|Melphalan|melphalan
4752671|NCT02909036|Autologous Hematopoietic Progenitor Cell Transplant|autologous hematopoietic progenitor cell transplant
4752672|NCT02909036|High Dose Therapy|high dose therapy
4752673|NCT02909036|16-875|16-875
4752674|NCT02909023|Hepatitis B Virus|hepatitis b virus
4752675|NCT02909023|Elispot test|elispot test
4752676|NCT02909023|T cellular immune response|t cellular immune response
4752677|NCT02908984|unilateral headache|unilateral headache
4752678|NCT02908984|cervical pain|cervical pain
4752679|NCT02908984|neck pain|neck pain
4752680|NCT02908984|voxel based morphometry|voxel based morphometry
4752681|NCT02908984|diffusion tensor imaging|diffusion tensor imaging
4752682|NCT02908984|structural brain changes|structural brain changes
4752683|NCT02908984|rehabilitation|rehabilitation
4752684|NCT02908971|soy based formula|soy based formula
4752685|NCT02908971|overweight|overweight
4752686|NCT02908971|adrenarche,|adrenarche,
4752687|NCT02908971|gonadarache|gonadarache
4752688|NCT02908945|Ketamine|ketamine
4752689|NCT02908945|Anesthesia|anesthesia
4752690|NCT02908945|EEG|eeg
4752691|NCT02908945|NeuroSENSE|neurosense
4752692|NCT02908945|Pain|pain
4752693|NCT02908919|Colonoscopy|colonoscopy
4752694|NCT02908919|Picosulfate sodium|picosulfate sodium
4752695|NCT02908919|Polyethylene glycol|polyethylene glycol
4752696|NCT02908919|Magnesium citrate|magnesium citrate
4752697|NCT02908919|Ascorbic acid|ascorbic acid
4752698|NCT02908919|SPMC (solution picosulfate + magnesium citrate)|spmc (solution picosulfate + magnesium citrate)
4752699|NCT02908919|PEGA (Polyethylene glycol + ascorbic acid)|pega (polyethylene glycol + ascorbic acid)
4752700|NCT02908880|MANTA, arterial closure device, large bore closure device|manta, arterial closure device, large bore closure device
4752701|NCT02908867|Sexuality|sexuality
4752702|NCT02908867|Spinal cord injuries|spinal cord injuries
4752703|NCT02908867|Complementary Therapies|complementary therapies
4752704|NCT02908867|Medicinal plants|medicinal plants
4752705|NCT02908854|Spices|spices
4752706|NCT02908854|Herbs|herbs
4752707|NCT02908854|Vegetables|vegetables
4752708|NCT02908854|National School Lunch Program|national school lunch program
4752709|NCT02908854|High school|high school
4752710|NCT02908828|Biological Products/therapeutic use|biological products/therapeutic use
4752711|NCT02908828|Copepoda|copepoda
4752712|NCT02908828|Dietary Supplements|dietary supplements
4752713|NCT02908828|Fish Oils|fish oils
4752714|NCT02908828|Fatty Acids, Omega-3|fatty acids, omega-3
4752715|NCT02908828|Oxygen Consumption|oxygen consumption
4752716|NCT02908828|Calanus|calanus
4752717|NCT02908828|Maximal oxygen uptake|maximal oxygen uptake
4752718|NCT02908828|Zooplankton|zooplankton
4752719|NCT02908789|Photochemotherapy|photochemotherapy
4752720|NCT02908763|Chronic Hepatitis B|chronic hepatitis b
4752721|NCT02908763|Peginterferon Alpha|peginterferon alpha
4752722|NCT02908750|oncology|oncology
4752723|NCT02908750|cancer|cancer
4752724|NCT02908750|non small cell lung cancer|non small cell lung cancer
4752725|NCT02908750|anticancer drug|anticancer drug
4752726|NCT02908750|lung neoplasms|lung neoplasms
4752727|NCT02908750|pharmacokinetics|pharmacokinetics
4752728|NCT02908750|AZD9291|azd9291
4752729|NCT02908750|osimertinib|osimertinib
4752730|NCT02908750|fexofenadine|fexofenadine
4752731|NCT02908750|TAGRISSO™|tagrisso™
4752732|NCT02908750|EGFR genes|egfr genes
4752733|NCT02908724|Familial cardiomyopathies|familial cardiomyopathies
4752734|NCT02908724|Hypertrophic cardiomyopathy|hypertrophic cardiomyopathy
4752735|NCT02908724|Left ventricular hypertrophy|left ventricular hypertrophy
4752736|NCT02908659|intensive care unit|intensive care unit
4752737|NCT02908659|patient's monitoring|patient's monitoring
4752738|NCT02908659|respiratory rate|respiratory rate
4752739|NCT02908633|open angle glaucoma|open angle glaucoma
4752740|NCT02908633|canaloplasty|canaloplasty
4752741|NCT02908633|migs|migs
4752742|NCT02908633|abic|abic
4752743|NCT02908594|Nursing|nursing
4752744|NCT02908594|ESRD|esrd
4752745|NCT02908594|hemodialysis|hemodialysis
4752746|NCT02908594|intradialytic exercise|intradialytic exercise
4752747|NCT02908594|depression|depression
4752748|NCT02908594|fatigue|fatigue
4752749|NCT02908594|Quality Of Life|quality of life
4752750|NCT02908594|self-efficacy|self-efficacy
4752751|NCT02908594|resilience|resilience
4752752|NCT02908568|mandibular stretching, trigeminocardiac reflex|mandibular stretching, trigeminocardiac reflex
4752753|NCT02908555|type 1 diabetes|type 1 diabetes
4752754|NCT02908555|adolescents|adolescents
4752755|NCT02908555|sleep|sleep
4752756|NCT02908490|Arthritis, Rheumatoid|arthritis, rheumatoid
4752757|NCT02908490|Atherosclerosis|atherosclerosis
4752758|NCT02908464|Cardiac Surgery|cardiac surgery
4752759|NCT02908464|Delirium|delirium
4752760|NCT02908464|Postoperative Cognitive Dysfunction|postoperative cognitive dysfunction
4752761|NCT02908451|Cancer|cancer
4752762|NCT02908451|Antibody Drug Conjugate|antibody drug conjugate
4752763|NCT02908451|AbGn-107|abgn-107
4752764|NCT02908451|Adenocarcinoma|adenocarcinoma
4752765|NCT02908451|Gastric|gastric
4752766|NCT02908451|Colorectal|colorectal
4752767|NCT02908451|Pancreatic|pancreatic
4752768|NCT02908412|Nerve Block|nerve block
4752769|NCT02908412|Spectrophotometry|spectrophotometry
4752770|NCT02908412|Bupivacaine|bupivacaine
4752771|NCT02908412|Spinal Surgery|spinal surgery
4752772|NCT02908412|Blood Loss, Surgical|blood loss, surgical
4752773|NCT02908386|Head and neck tumors|head and neck tumors
4752774|NCT02908386|Proton|proton
4752775|NCT02908386|Photon|photon
4752776|NCT02908386|replanning timing|replanning timing
4752777|NCT02908373|risk management|risk management
4752778|NCT02908373|nursing home|nursing home
4752779|NCT02908373|elderly|elderly
4752780|NCT02908373|care|care
4752781|NCT02908360|Double positive lymphocyte T F prausnitzii|double positive lymphocyte t f prausnitzii
4752782|NCT02908347|Plaque psoriasis|plaque psoriasis
4752783|NCT02908347|chronic|chronic
4752784|NCT02908347|moderate|moderate
4752785|NCT02908347|severe|severe
4752786|NCT02908347|Plaque|plaque
4752787|NCT02908308|Induced hypothermia|induced hypothermia
4752788|NCT02908308|Mild induced hypothermia|mild induced hypothermia
4752789|NCT02908308|Therapeutic hypothermia|therapeutic hypothermia
4752790|NCT02908308|Cardiac arrest|cardiac arrest
4752791|NCT02908308|Out-of-hospital cardiac arrest|out-of-hospital cardiac arrest
4752792|NCT02908308|Mortality|mortality
4752793|NCT02908308|Neurological function|neurological function
4752794|NCT02908308|Randomised clinical trial|randomised clinical trial
4752795|NCT02908282|tear film|tear film
4752796|NCT02908282|omega-3 fatty acids|omega-3 fatty acids
4752797|NCT02908282|eye drops|eye drops
4752798|NCT02908269|Influenza|influenza
4752799|NCT02908269|Fluzone® Quadrivalent, Influenza Vaccine (2016-2017 formulation)|fluzone® quadrivalent, influenza vaccine (2016-2017 formulation)
4752800|NCT02908269|Fluzone® High-Dose, Influenza Vaccine (2016-2017 formulation)|fluzone® high-dose, influenza vaccine (2016-2017 formulation)
4752801|NCT02908256|PVI|pvi
4752802|NCT02908256|delta PP|delta pp
4752803|NCT02908256|vascular filling|vascular filling
4752804|NCT02908243|Hemophilia|hemophilia
4752805|NCT02908243|Primary prophylaxis|primary prophylaxis
4752806|NCT02908243|Pettersson Score|pettersson score
4752807|NCT02908243|Joint function study|joint function study
4752808|NCT02908243|Comorbidity|comorbidity
4752809|NCT02908217|Polymyalgia Rheumatica|polymyalgia rheumatica
4752810|NCT02908217|Tocilizumab|tocilizumab
4752811|NCT02908217|Glucocorticoid|glucocorticoid
4752812|NCT02908204|superficial esophageal squamous cell carcinoma|superficial esophageal squamous cell carcinoma
4752813|NCT02908204|efficacy|efficacy
4752814|NCT02908204|survival|survival
4752815|NCT02908178|ductal carcinoma in situ (DCIS)|ductal carcinoma in situ (dcis)
4752816|NCT02908178|sentinel lymph node biopsy (SLNB)|sentinel lymph node biopsy (slnb)
4752817|NCT02908087|Diabetes Type 1|diabetes type 1
4752818|NCT02908087|Diabetes, Insulin-Dependent|diabetes, insulin-dependent
4752819|NCT02908087|Liraglutide|liraglutide
4752820|NCT02908087|GLP-1 Analogue|glp-1 analogue
4752821|NCT02908087|Early diagnosis|early diagnosis
4752822|NCT02908074|Hypogonadotropic|hypogonadotropic
4752823|NCT02908074|hypogonadism|hypogonadism
4752824|NCT02908074|testosterone|testosterone
4752825|NCT02908061|Mesh Placement|mesh placement
4752826|NCT02908061|Radical Cystectomy|radical cystectomy
4752827|NCT02908061|16-1285|16-1285
4752828|NCT02908048|liver cancer|liver cancer
4752829|NCT02908048|cholangiocarcinoma (CCA)|cholangiocarcinoma (cca)
4752830|NCT02908048|cirrhosis|cirrhosis
4752831|NCT02908048|hepatitis|hepatitis
4752832|NCT02908048|bile duct cancer|bile duct cancer
4752833|NCT02908048|hepatocellular carcinoma (HCC)|hepatocellular carcinoma (hcc)
4752834|NCT02908048|hepatobiliary carcinoma|hepatobiliary carcinoma
4752835|NCT02908048|hepatoma|hepatoma
4752836|NCT02908048|liver mass|liver mass
4752837|NCT02907983|Menopause|menopause
4752838|NCT02907983|Post-menopausal|post-menopausal
4752839|NCT02907970|Cervical cancer|cervical cancer
4752840|NCT02907970|Screening|screening
4752841|NCT02907970|Barriers|barriers
4752842|NCT02907931|hemodynamics|hemodynamics
4752843|NCT02907931|ultrasonography|ultrasonography
4752844|NCT02907879|Subarachnoid Hemorrhage|subarachnoid hemorrhage
4752845|NCT02907879|Ultrasound perfusion imaging|ultrasound perfusion imaging
4752846|NCT02907879|cerebral hypoperfusion|cerebral hypoperfusion
4752847|NCT02907879|vasospasm|vasospasm
4752848|NCT02907879|DIND|dind
4752849|NCT02907879|infarction|infarction
4752850|NCT02907827|complete remission|complete remission
4752851|NCT02907827|cfDNA|cfdna
4752852|NCT02907827|DW-MRI|dw-mri
4752853|NCT02907827|surveillance|surveillance
4752854|NCT02907814|Uveitis|uveitis
4752855|NCT02907814|Optical Coherence Tomography|optical coherence tomography
4752856|NCT02907801|congenital muscular torticollis|congenital muscular torticollis
4752857|NCT02907801|infants|infants
4752858|NCT02907801|perception-action approach|perception-action approach
4752859|NCT02907788|Cystic fibrosis|cystic fibrosis
4752860|NCT02907788|Neutrophils|neutrophils
4752862|NCT02907788|Inflammation|inflammation
4752863|NCT02907788|Lung disease|lung disease
4752864|NCT02907788|PRAGMA|pragma
4752865|NCT02907762|Endovascular|endovascular
4752866|NCT02907762|EVAR|evar
4752867|NCT02907762|Neck Angulation|neck angulation
4752868|NCT02907710|Nasopharyngeal carcinoma|nasopharyngeal carcinoma
4752869|NCT02907710|endostar|endostar
4752870|NCT02907710|chemoradiotherapy|chemoradiotherapy
4752871|NCT02907697|HIV/AIDS|hiv/aids
4752872|NCT02907697|adherence|adherence
4752873|NCT02907697|substance use|substance use
4752874|NCT02907697|HIV care continuum|hiv care continuum
4752875|NCT02907684|Cardiovascular disease|cardiovascular disease
4752876|NCT02907684|Non alcoholic fatty liver|non alcoholic fatty liver
4752877|NCT02907684|Diabetes|diabetes
4752878|NCT02907684|Almonds|almonds
4752879|NCT02907684|Endothelium-dependent vasodilation|endothelium-dependent vasodilation
4752880|NCT02907684|Fecal short chain fatty acids (SCFAs)|fecal short chain fatty acids (scfas)
4752881|NCT02907684|Snacking|snacking
4752882|NCT02907671|carpal tunnel injection|carpal tunnel injection
4752883|NCT02907671|corticosteroid|corticosteroid
4752884|NCT02907671|ultrasound-guided|ultrasound-guided
4752885|NCT02907671|musculoskeletal ultrasound|musculoskeletal ultrasound
4752886|NCT02907658|Internet Use Disorder|internet use disorder
4752887|NCT02907658|Internet Gaming Disorder|internet gaming disorder
4752888|NCT02907658|Cognitive-Behavioral Intervention|cognitive-behavioral intervention
4752889|NCT02907658|Indicated Prevention|indicated prevention
4752890|NCT02907658|Adolescents|adolescents
4752891|NCT02907658|Internet Addiction|internet addiction
4752892|NCT02907632|Metoclopramide|metoclopramide
4752893|NCT02907632|Pro kinetic|pro kinetic
4752894|NCT02907632|Gastroesophageal Reflux|gastroesophageal reflux
4752895|NCT02907632|Premature Infant|premature infant
4752896|NCT02907632|Low Birth Weight|low birth weight
4752897|NCT02907632|Kangaroo Mother Care Method|kangaroo mother care method
4752898|NCT02907619|Duchenne muscular dystrophy, myostatin, open-label|duchenne muscular dystrophy, myostatin, open-label
4752899|NCT02907606|Non-small-cell Lung Cancer|non-small-cell lung cancer
4752900|NCT02907606|circulating tumor DNA|circulating tumor dna
4752901|NCT02907606|urine|urine
4752902|NCT02907593|Bronchopulmonary dysplasia|bronchopulmonary dysplasia
4752903|NCT02907593|Pulmonary|pulmonary
4752904|NCT02907593|Surfactant|surfactant
4752905|NCT02907593|Steroids|steroids
4752906|NCT02907593|Extremely low gestational age|extremely low gestational age
4752907|NCT02907580|influenza|influenza
4752908|NCT02907580|vaccination|vaccination
4752909|NCT02907554|Preconditioning|preconditioning
4752910|NCT02907554|Tissue and organ procurement|tissue and organ procurement
4752911|NCT02907554|Cyclosporine A|cyclosporine a
4752912|NCT02907554|Kidney transplantation|kidney transplantation
4752913|NCT02907554|Delayed graft function|delayed graft function
4752914|NCT02907541|eLearning|elearning
4752915|NCT02907541|Quality Improvement Methods|quality improvement methods
4752916|NCT02907541|Knowledge Transfer|knowledge transfer
4752917|NCT02907541|Impact of learning|impact of learning
4752918|NCT02907515|single implant retained mandibular overdenture|single implant retained mandibular overdenture
4752919|NCT02907489|post operative pain|post operative pain
4752920|NCT02907489|triple antibiotic paste|triple antibiotic paste
4752921|NCT02907489|intracanal medication|intracanal medication
4752922|NCT02907476|Vagal-gamma amino-butyric acid (GABA)|vagal-gamma amino-butyric acid (gaba)
4752923|NCT02907476|Yoga|yoga
4752924|NCT02907476|Walking|walking
4752925|NCT02907463|Aortic Valve Replacement|aortic valve replacement
4752926|NCT02907463|Aortic Stenosis|aortic stenosis
4752927|NCT02907463|EDWARDS INTUITY Elite|edwards intuity elite
4752928|NCT02907463|Rapid deployment valves|rapid deployment valves
4752929|NCT02907437|Minocycline|minocycline
4752930|NCT02907437|Negative symptoms|negative symptoms
4752931|NCT02907437|Cognitive symptoms|cognitive symptoms
4752932|NCT02907437|Inflammation|inflammation
4752933|NCT02907411|Quadrivas|quadrivas
4752934|NCT02907411|Veins|veins
4752935|NCT02907411|Lipedema|lipedema
4752936|NCT02907411|Lymphedema|lymphedema
4752937|NCT02907398|Neurostimulation|neurostimulation
4752938|NCT02907398|Hypoglossal nerve|hypoglossal nerve
4752939|NCT02907398|Tongue|tongue
4752940|NCT02907398|Upper airway stimulation|upper airway stimulation
4752941|NCT02907398|Surgery|surgery
4752942|NCT02907385|Rectal Cancer|rectal cancer
4752943|NCT02907385|Low Anterior Resection|low anterior resection
4752944|NCT02907385|LifeSeal|lifeseal
4752945|NCT02907385|Surgical Sealant|surgical sealant
4752946|NCT02907372|cognitive dysfunctions|cognitive dysfunctions
4752947|NCT02907372|cognitive complaints|cognitive complaints
4752948|NCT02907372|metastatic prostate cancer|metastatic prostate cancer
4752949|NCT02907372|new generations of hormone-therapy|new generations of hormone-therapy
4752950|NCT02907333|Condom use|condom use
4752951|NCT02907333|Human Papillomavirus|human papillomavirus
4752952|NCT02907333|Conization|conization
4752953|NCT02907307|LactiSal|lactisal
4752954|NCT02907307|Vaginal therapy|vaginal therapy
4752955|NCT02907294|PDE10 inhibitor|pde10 inhibitor
4752956|NCT02907294|phosphodiesterase 10 inhibitor|phosphodiesterase 10 inhibitor
4752957|NCT02907294|Huntington's disease|huntington's disease
4752958|NCT02907294|psychiatric disorders|psychiatric disorders
4752959|NCT02907281|Multiple sclerosis,|multiple sclerosis,
4752960|NCT02907281|MS,|ms,
4752961|NCT02907281|Optical coherence tomography|optical coherence tomography
4752962|NCT02907281|OCT,|oct,
4752963|NCT02907281|RRMS|rrms
4752964|NCT02907268|botulinum toxin type A, intradermal|botulinum toxin type a, intradermal
4752965|NCT02907255|Pulse oximetry|pulse oximetry
4752966|NCT02907255|vital signs monitoring|vital signs monitoring
4752967|NCT02907255|wireless notification of clinicians|wireless notification of clinicians
4752968|NCT02907255|respiratory monitoring system|respiratory monitoring system
4752969|NCT02907242|stillbirth|stillbirth
4752970|NCT02907242|cerebroplacental ratio|cerebroplacental ratio
4752971|NCT02907242|fetal growth restriction|fetal growth restriction
4752972|NCT02907216|Healthy Japanese infants|healthy japanese infants
4752973|NCT02907216|Safety|safety
4752974|NCT02907216|Diphtheria, Tetanus, Pertussis and Inactivated Poliovirus (DPT-IPV) vaccine|diphtheria, tetanus, pertussis and inactivated poliovirus (dpt-ipv) vaccine
4752975|NCT02907216|Vaccination|vaccination
4752976|NCT02907216|Oral HRV liquid vaccine|oral hrv liquid vaccine
4752977|NCT02907216|Immunogenicity|immunogenicity
4752978|NCT02907190|pulses|pulses
4752979|NCT02907190|beans|beans
4752980|NCT02907190|blood glucose|blood glucose
4752981|NCT02907190|insulin|insulin
4752982|NCT02907112|meat intake|meat intake
4752983|NCT02907112|meat analogues|meat analogues
4752984|NCT02907112|LDL Cholesterol|ldl cholesterol
4752985|NCT02907112|HDL Cholesterol|hdl cholesterol
4752986|NCT02907099|Malignant neoplasms of digestive organs|malignant neoplasms of digestive organs
4752987|NCT02907099|Metastatic Pancreatic Cancer|metastatic pancreatic cancer
4752988|NCT02907099|Pancreatic adenocarcinoma|pancreatic adenocarcinoma
4752989|NCT02907099|BL-8040|bl-8040
4752990|NCT02907099|Pembrolizumab|pembrolizumab
4752991|NCT02907099|Keytruda|keytruda
4752992|NCT02907099|MK-3475|mk-3475
4752993|NCT02907099|SCH-900475|sch-900475
4752994|NCT02907099|Phone call|phone call
4752995|NCT02907060|prolonged pregnancy|prolonged pregnancy
4752996|NCT02907060|mechanical cervical ripening|mechanical cervical ripening
4752997|NCT02906995|pharmacokinetics|pharmacokinetics
4752998|NCT02906995|nicotine absorption|nicotine absorption
4752999|NCT02906982|Periodontal diseases|periodontal diseases
4753000|NCT02906982|Periodontitis|periodontitis
4753001|NCT02906982|Gingivitis|gingivitis
4753002|NCT02906982|Teeth Whitening|teeth whitening
4753003|NCT02906982|Dental Plaque Index|dental plaque index
4753004|NCT02906982|Periodontal Index|periodontal index
4753005|NCT02906982|Teeth Whitening Agents|teeth whitening agents
4753006|NCT02906982|Tooth Discoloration|tooth discoloration
4753007|NCT02906982|Mean Probing Depth|mean probing depth
4753008|NCT02906982|Pocket Depth|pocket depth
4753009|NCT02906943|Molecular Profiling|molecular profiling
4753010|NCT02906943|Advanced Cancer|advanced cancer
4753011|NCT02906943|Advanced Solid Tumors|advanced solid tumors
4753012|NCT02906943|Phase I Clinical Trial Candidates|phase i clinical trial candidates
4753013|NCT02906943|Next Generation Sequencing|next generation sequencing
4753014|NCT02906878|Intensive Care|intensive care
4753015|NCT02906878|Haematology|haematology
4753016|NCT02906878|Platelets prophylactic transfusion|platelets prophylactic transfusion
4753017|NCT02906839|cardiovascular risk|cardiovascular risk
4753018|NCT02906839|risk of atrial fibrillation recurrence|risk of atrial fibrillation recurrence
4753019|NCT02906839|sleep apnea syndrome|sleep apnea syndrome
4753020|NCT02906839|atrial fibrillation|atrial fibrillation
4753021|NCT02906826|Airway clearance technique|airway clearance technique
4753022|NCT02906826|Positive expiratory pressure technique|positive expiratory pressure technique
4753023|NCT02906826|Adherence|adherence
4753024|NCT02906813|Drug Therapy|drug therapy
4753025|NCT02906800|cisplatin|cisplatin
4753026|NCT02906800|head and neck cancer|head and neck cancer
4753027|NCT02906800|digoxin|digoxin
4753028|NCT02906787|Smoking Cessation|smoking cessation
4753029|NCT02906787|Weight Loss|weight loss
4753030|NCT02906761|asthma, aspirin|asthma, aspirin
4753031|NCT02906748|parathyroid autografting|parathyroid autografting
4753032|NCT02906748|thyroidectomy|thyroidectomy
4753033|NCT02906748|survival rate|survival rate
4753034|NCT02906748|hypoparathyroidism|hypoparathyroidism
4753035|NCT02906722|Nebulized colistin|nebulized colistin
4753036|NCT02906722|Intravenous colistin|intravenous colistin
4753037|NCT02906722|ventilator-associated pneumonia|ventilator-associated pneumonia
4753038|NCT02906722|multidrug resistance|multidrug resistance
4753039|NCT02906722|Gram-negative bacteria|gram-negative bacteria
4753040|NCT02906696|Chronic myelogenous leukemia|chronic myelogenous leukemia
4753041|NCT02906696|CML|cml
4753042|NCT02906696|Chronic phase post frontline TKI failure|chronic phase post frontline tki failure
4753043|NCT02906696|Tyrosine kinase inhibitor|tyrosine kinase inhibitor
4753044|NCT02906696|TKI|tki
4753045|NCT02906696|Bosutinib|bosutinib
4753046|NCT02906696|SKI-606|ski-606
4753047|NCT02906696|Phone calls|phone calls
4753048|NCT02906696|Questionnaires|questionnaires
4753049|NCT02906696|Surveys|surveys
4753050|NCT02906683|Urinary Incontinence|urinary incontinence
4753051|NCT02906683|Urinary Incontinence, Stress|urinary incontinence, stress
4753052|NCT02906683|Lower Urinary Tract Symptoms|lower urinary tract symptoms
4753053|NCT02906670|Epithelial malignancies|epithelial malignancies
4753054|NCT02906657|Medication Reconciliation|medication reconciliation
4753055|NCT02906657|Adverse Drug Event|adverse drug event
4753056|NCT02906657|Elderly|elderly
4753057|NCT02906657|patient pharmaceutical record|patient pharmaceutical record
4753058|NCT02906644|Nicotine addiction|nicotine addiction
4753059|NCT02906644|Cigarette smoking|cigarette smoking
4753060|NCT02906644|Smoking cessation|smoking cessation
4753061|NCT02906644|lorcaserin|lorcaserin
4753062|NCT02906644|Belviq|belviq
4753063|NCT02906644|Nicotine patches|nicotine patches
4753064|NCT02906631|encephalitis,|encephalitis,
4753065|NCT02906631|neurologic outcomes of all-cause encephalitis in intensive care unit|neurologic outcomes of all-cause encephalitis in intensive care unit
4753066|NCT02906631|outcome, intensive care unit|outcome, intensive care unit
4753067|NCT02906553|Nitric Oxide|nitric oxide
4753068|NCT02906553|Cognition|cognition
4753069|NCT02906527|Cardiology|cardiology
4753070|NCT02906527|Oral anticoagulants|oral anticoagulants
4753071|NCT02906527|Risk and Benefit analysis|risk and benefit analysis
4753072|NCT02906527|Health insurance databases|health insurance databases
4753073|NCT02906527|Safety|safety
4753074|NCT02906527|Elderly|elderly
4753075|NCT02906514|Hydroxyethyl Starch|hydroxyethyl starch
4753076|NCT02906514|Cardiac surgery|cardiac surgery
4753077|NCT02906514|Priming of cardiopulmonary bypass|priming of cardiopulmonary bypass
4753078|NCT02906501|Risperidone|risperidone
4753079|NCT02906501|ADHD|adhd
4753080|NCT02906501|DBD|dbd
4753081|NCT02906501|IGT|igt
4753082|NCT02906501|CNP|cnp
4753083|NCT02906501|Executive functions|executive functions
4753084|NCT02906488|Quality of life|quality of life
4753085|NCT02906475|Dermatitis, atopic|dermatitis, atopic
4753086|NCT02906475|prevention and control|prevention and control
4753087|NCT02906475|Infant|infant
4753088|NCT02906475|Skin care|skin care
4753089|NCT02906475|randomized controlled trial|randomized controlled trial
4753090|NCT02906462|Leonetti French law|leonetti french law
4753091|NCT02906462|Palliative care|palliative care
4753092|NCT02906449|concussion, mild head injury, mindfulness|concussion, mild head injury, mindfulness
4753093|NCT02906436|Lung transplantation|lung transplantation
4753094|NCT02906436|ExVivo reconditionning|exvivo reconditionning
4753095|NCT02906423|Quality of Life|quality of life
4753096|NCT02906423|Patient-Centered Care|patient-centered care
4753097|NCT02906423|Patient Outcome Assessment|patient outcome assessment
4753098|NCT02906384|hippocampus avoidance|hippocampus avoidance
4753099|NCT02906384|volumetric modulated arc therapy|volumetric modulated arc therapy
4753100|NCT02906384|functional MRI|functional mri
4753101|NCT02906384|hopkins Verbal Learning Test|hopkins verbal learning test
4753102|NCT02906384|prophylactic cranial irradiation|prophylactic cranial irradiation
4753103|NCT02906345|Septic shock|septic shock
4753104|NCT02906345|Fresh frozen plasma|fresh frozen plasma
4753105|NCT02906306|Older adults|older adults
4753106|NCT02906306|Occupational Therapy|occupational therapy
4753107|NCT02906306|Self-Efficacy|self-efficacy
4753108|NCT02906306|Psychological Well-being|psychological well-being
4753109|NCT02906280|EBUS-TBNA|ebus-tbna
4753110|NCT02906241|African Americans|african americans
4753111|NCT02906241|prostate cancer|prostate cancer
4753112|NCT02906241|Minority|minority
4753113|NCT02906241|Racial /Ethnic disparity|racial /ethnic disparity
4753114|NCT02906241|Cancer care|cancer care
4753115|NCT02906241|patient-physician communication|patient-physician communication
4753116|NCT02906241|cancer clinical trial accrual|cancer clinical trial accrual
4753117|NCT02906228|non-ionizing radiation|non-ionizing radiation
4753118|NCT02906215|mHealth|mhealth
4753119|NCT02906215|implementation|implementation
4753120|NCT02906215|PrEP|prep
4753121|NCT02906215|digital health|digital health
4753122|NCT02906163|EGFR mutation positive|egfr mutation positive
4753123|NCT02906163|Thymosin Alpha 1|thymosin alpha 1
4753124|NCT02906163|Tyrosine Kinase inhibitor|tyrosine kinase inhibitor
4753125|NCT02906163|Thymalfasin|thymalfasin
4753126|NCT02906163|Non Small Cell Lung Cancer|non small cell lung cancer
4753127|NCT02906150|EGFR Wild Type|egfr wild type
4753128|NCT02906150|Thymosin Alpha 1|thymosin alpha 1
4753129|NCT02906150|Non-Small Cell Lung Cancer|non-small cell lung cancer
4753130|NCT02906150|Thymalfasin|thymalfasin
4753131|NCT02906124|hypercholesterolaemia|hypercholesterolaemia
4753132|NCT02906124|Lipid lowering therapies|lipid lowering therapies
4753133|NCT02906124|Pregnancy|pregnancy
4753134|NCT02906111|Estriol|estriol
4753135|NCT02906111|Prolapse|prolapse
4753136|NCT02906111|Quality of life|quality of life
4753137|NCT02906111|Vaginal health|vaginal health
4753138|NCT02906111|Vaginal surgery|vaginal surgery
4753139|NCT02906098|Gingivitis|gingivitis
4753140|NCT02906098|Adolescents|adolescents
4753141|NCT02906098|Oral hygiene|oral hygiene
4753142|NCT02906098|Oral health behavior|oral health behavior
4753143|NCT02906098|Periodontal infection control|periodontal infection control
4753144|NCT02906085|[C10.228.140.546.399.750.250]|[c10.228.140.546.399.750.250]
4753145|NCT02906072|Obesity|obesity
4753146|NCT02906072|Body fat|body fat
4753147|NCT02906072|Plant-based diet|plant-based diet
4753148|NCT02906072|Plant-based meal replacement|plant-based meal replacement
4753149|NCT02906059|RAS|ras
4753150|NCT02906059|KRAS|kras
4753151|NCT02906059|NRAS|nras
4753152|NCT02906059|BRAF|braf
4753153|NCT02906059|Mutated|mutated
4753154|NCT02906059|Wee1 inhibitor|wee1 inhibitor
4753155|NCT02906046|SCA 3|sca 3
4753156|NCT02906046|Ataxic Gait|ataxic gait
4753157|NCT02906033|Surgical Procedures, Operative|surgical procedures, operative
4753158|NCT02906033|Operating Rooms|operating rooms
4753159|NCT02906033|Quality of Life|quality of life
4753160|NCT02906033|Surgery-related anxiety|surgery-related anxiety
4753161|NCT02905994|Leukemia|leukemia
4753162|NCT02905981|IRIDA|irida
4753163|NCT02905981|Triferic|triferic
4753164|NCT02905981|soluble ferric pyrophosphate|soluble ferric pyrophosphate
4753165|NCT02905981|Shohl's solution|shohl's solution
4753166|NCT02905968|Anastomotic leak|anastomotic leak
4753167|NCT02905968|Low rectal cancer|low rectal cancer
4753168|NCT02905929|sedentary behavior|sedentary behavior
4753169|NCT02905929|standing|standing
4753170|NCT02905929|sitting|sitting
4753171|NCT02905929|inclinometer|inclinometer
4753172|NCT02905864|Liraglutide|liraglutide
4753173|NCT02905864|Liraglutide 3 mg|liraglutide 3 mg
4753174|NCT02905864|Osteoarthritis|osteoarthritis
4753175|NCT02905864|Obesity|obesity
4753176|NCT02905799|Osteoarthritis|osteoarthritis
4753177|NCT02905799|Knee|knee
4753178|NCT02905799|Resveratrol|resveratrol
4753179|NCT02905799|Oral Treatment|oral treatment
4753180|NCT02905799|Pain|pain
4753181|NCT02905799|Trial|trial
4753182|NCT02905786|General Practice|general practice
4753183|NCT02905786|Nurse practitioner|nurse practitioner
4753184|NCT02905786|Natriuretic peptides|natriuretic peptides
4753185|NCT02905786|Clinical audit|clinical audit
4753186|NCT02905773|Intensity|intensity
4753187|NCT02905760|Acute Myocardial Infarction|acute myocardial infarction
4753188|NCT02905760|Right ventricular infarction|right ventricular infarction
4753189|NCT02905760|Diuretic|diuretic
4753190|NCT02905760|Fluid Expansion|fluid expansion
4753191|NCT02905747|Exercise Therapy|exercise therapy
4753192|NCT02905747|Musculoskeletal Pain|musculoskeletal pain
4753193|NCT02905747|Knee osteoarthritis|knee osteoarthritis
4753194|NCT02905747|Physical Therapy Modalities|physical therapy modalities
4753195|NCT02905734|Nicotine replacement therapy|nicotine replacement therapy
4753196|NCT02905734|Tobacco|tobacco
4753197|NCT02905708|normothermia|normothermia
4753198|NCT02905708|hypothermia|hypothermia
4753199|NCT02905695|Post-partum Perineal pain|post-partum perineal pain
4753200|NCT02905695|Episiotomy|episiotomy
4753201|NCT02905695|First-degree tear|first-degree tear
4753202|NCT02905669|distensibility|distensibility
4753203|NCT02905669|impedance planimetry|impedance planimetry
4753204|NCT02905669|esophagus|esophagus
4753205|NCT02905669|esophago-gastric junction|esophago-gastric junction
4753206|NCT02905669|pylorus|pylorus
4753207|NCT02905656|quitline|quitline
4753208|NCT02905656|nicotine replacement therapy|nicotine replacement therapy
4753209|NCT02905656|tobacco intervention|tobacco intervention
4753210|NCT02905656|smokers not ready to quit|smokers not ready to quit
4753211|NCT02905643|Pseudoprogression|pseudoprogression
4753212|NCT02905643|Brain Cancer|brain cancer
4753213|NCT02905630|coronary flow reserve|coronary flow reserve
4753214|NCT02905630|angina|angina
4753215|NCT02905630|exercise training|exercise training
4753216|NCT02905617|Breast Augmentation|breast augmentation
4753217|NCT02905617|Breast Revision-Augmentation|breast revision-augmentation
4753218|NCT02905604|rTMS|rtms
4753219|NCT02905604|negative symptoms|negative symptoms
4753220|NCT02905604|intermittent theta burst|intermittent theta burst
4753221|NCT02905604|iTBS|itbs
4753222|NCT02905604|repetitive transcranial magnetic stimulation|repetitive transcranial magnetic stimulation
4753223|NCT02905604|dorsomedial prefrontal cortex|dorsomedial prefrontal cortex
4753224|NCT02905604|dmPFC|dmpfc
4753225|NCT02905604|NIRS|nirs
4753226|NCT02905591|pharmacological ascorbate|pharmacological ascorbate
4753227|NCT02905591|ascorbic acid|ascorbic acid
4753228|NCT02905591|radiation|radiation
4753229|NCT02905591|chemotherapy|chemotherapy
4753230|NCT02905591|carboplatin|carboplatin
4753231|NCT02905591|paclitaxel|paclitaxel
4753232|NCT02905578|Ascorbate|ascorbate
4753233|NCT02905578|Vitamin C|vitamin c
4753234|NCT02905578|Pharmacological ascorbate|pharmacological ascorbate
4753235|NCT02905578|Pharmacologic ascorbate|pharmacologic ascorbate
4753236|NCT02905578|Ascorbic Acid|ascorbic acid
4753237|NCT02905578|gemcitabine|gemcitabine
4753238|NCT02905578|nab-paclitaxel|nab-paclitaxel
4753239|NCT02905578|Gemzar|gemzar
4753240|NCT02905578|Abraxane|abraxane
4753241|NCT02905565|Multicenter|multicenter
4753242|NCT02905565|Randomized|randomized
4753243|NCT02905565|Double-Blind|double-blind
4753244|NCT02905565|Placebo-Controlled|placebo-controlled
4753245|NCT02905565|Add-On to Standard-of-Care|add-on to standard-of-care
4753246|NCT02905565|Safety|safety
4753247|NCT02905565|Efficacy|efficacy
4753248|NCT02905552|Myelodysplastic syndrome (myelodysplasia)|myelodysplastic syndrome (myelodysplasia)
4753249|NCT02905552|Infection|infection
4753250|NCT02905552|Risk Factors|risk factors
4753251|NCT02905539|Iron|iron
4753252|NCT02905539|anemia|anemia
4753253|NCT02905539|phosphorus|phosphorus
4753254|NCT02905539|FGF-23|fgf-23
4753255|NCT02905526|Reproductive health|reproductive health
4753256|NCT02905513|Reproductive health|reproductive health
4753257|NCT02905500|Disability-Adjusted Life Years|disability-adjusted life years
4753258|NCT02905500|Epidemiology|epidemiology
4753259|NCT02905500|Public Health|public health
4753260|NCT02905487|Gestational Diabetes Mellitus|gestational diabetes mellitus
4753261|NCT02905487|Obesity|obesity
4753262|NCT02905487|Adipocytokin|adipocytokin
4753263|NCT02905474|chronic kidney disease, mobile applications, mHealth, medication reconciliation, self-management|chronic kidney disease, mobile applications, mhealth, medication reconciliation, self-management
4753264|NCT02905461|Reproductive health|reproductive health
4753265|NCT02905448|Obesity|obesity
4753266|NCT02905448|Body composition|body composition
4753267|NCT02905448|Atherosclerosis|atherosclerosis
4753268|NCT02905448|Insulin resistance|insulin resistance
4753269|NCT02905448|Hyperuricemia|hyperuricemia
4753270|NCT02905435|burns|burns
4753271|NCT02905435|autografts|autografts
4753272|NCT02905435|humans|humans
4753273|NCT02905435|biodegradable polyurethane|biodegradable polyurethane
4753274|NCT02905435|dermal matrix|dermal matrix
4753275|NCT02905435|synthetic|synthetic
4753276|NCT02905422|physical activity|physical activity
4753277|NCT02905422|sleep|sleep
4753278|NCT02905422|nutrition|nutrition
4753279|NCT02905422|Soldier|soldier
4753280|NCT02905422|prevention|prevention
4753281|NCT02905422|remote monitoring|remote monitoring
4753282|NCT02905422|mobile technology|mobile technology
4753283|NCT02905396|small fiber neuropathy|small fiber neuropathy
4753284|NCT02905396|spinal cord stimulation|spinal cord stimulation
4753285|NCT02905396|treatment|treatment
4753286|NCT02905396|pain|pain
4753287|NCT02905370|Home Health|home health
4753288|NCT02905370|Rehabilitation|rehabilitation
4753289|NCT02905370|High Intensity|high intensity
4753290|NCT02905370|Hospital Associated Deconditioning|hospital associated deconditioning
4753291|NCT02905370|Functional Mobility|functional mobility
4753292|NCT02905370|Physical Function|physical function
4753293|NCT02905357|Myocardial Infarction|myocardial infarction
4753294|NCT02905357|Women|women
4753295|NCT02905357|Imaging|imaging
4753296|NCT02905305|cochlear implants|cochlear implants
4753297|NCT02905305|Dexamethasone|dexamethasone
4753298|NCT02905305|combined device|combined device
4753299|NCT02905279|spider phobia|spider phobia
4753300|NCT02905279|animal phobia|animal phobia
4753301|NCT02905279|exposure therapy|exposure therapy
4753302|NCT02905279|biofeedback|biofeedback
4753303|NCT02905279|relaxation training|relaxation training
4753304|NCT02905240|Autologous Protein Solution|autologous protein solution
4753305|NCT02905240|APS|aps
4753306|NCT02905240|intra-articular injection|intra-articular injection
4753307|NCT02905240|osteoarthritis|osteoarthritis
4753308|NCT02905227|Adult smokers|adult smokers
4753309|NCT02905227|Asthma|asthma
4753310|NCT02905227|Healthy volunteers|healthy volunteers
4753311|NCT02905188|hepatocellular carcinoma|hepatocellular carcinoma
4753312|NCT02905188|GPC3-CAR T cells|gpc3-car t cells
4753313|NCT02905188|GPC3-positive hepatocellular carcinoma|gpc3-positive hepatocellular carcinoma
4753314|NCT02905175|rheumatoid arthritis|rheumatoid arthritis
4753315|NCT02905175|Porphyromonas gingivalis|porphyromonas gingivalis
4753316|NCT02905149|Oncological|oncological
4753317|NCT02905149|Surgery|surgery
4753318|NCT02905149|Breast|breast
4753319|NCT02905149|Reconstruction|reconstruction
4753320|NCT02905136|autoantibodies|autoantibodies
4753321|NCT02905136|neuronal synaptic receptors|neuronal synaptic receptors
4753322|NCT02905136|autoimmune encephalitis|autoimmune encephalitis
4753323|NCT02905110|Malignant Neoplasms, Brain|malignant neoplasms, brain
4753324|NCT02905097|Knee arthroplasty, Total|knee arthroplasty, total
4753325|NCT02905097|Knee replacement, Total|knee replacement, total
4753326|NCT02905097|Survival rate|survival rate
4753327|NCT02905097|Osseointegration|osseointegration
4753328|NCT02905097|Gait|gait
4753329|NCT02905071|mental health|mental health
4753330|NCT02905071|well-being at work|well-being at work
4753331|NCT02905071|screening|screening
4753332|NCT02905071|psychosocial risk|psychosocial risk
4753333|NCT02905071|psychometrics|psychometrics
4753334|NCT02905071|questionnaire|questionnaire
4753335|NCT02905071|job stress|job stress
4753336|NCT02905032|Afib|afib
4753337|NCT02905032|Atrial fib|atrial fib
4753338|NCT02905032|Shared|shared
4753339|NCT02905032|Decision|decision
4753340|NCT02905032|Making|making
4753341|NCT02905032|Aid|aid
4753342|NCT02905032|AF|af
4753343|NCT02905006|Psoriasis|psoriasis
4753344|NCT02905006|Chronic Plaque Psoriasis|chronic plaque psoriasis
4753345|NCT02905006|Bimekizumab|bimekizumab
4753346|NCT02904980|Quiet eye training|quiet eye training
4753347|NCT02904980|Visual Attention|visual attention
4753348|NCT02904954|Lung neoplasms|lung neoplasms
4753349|NCT02904954|Bronchial Neoplasms|bronchial neoplasms
4753350|NCT02904954|Carcinoma, bronchogenic|carcinoma, bronchogenic
4753351|NCT02904954|Neoplasms|neoplasms
4753352|NCT02904954|Neoplasms by site|neoplasms by site
4753353|NCT02904954|Respiratory Tract Diseases|respiratory tract diseases
4753354|NCT02904954|Respiratory Tract Neoplasms|respiratory tract neoplasms
4753355|NCT02904954|Thoracic Neoplasms|thoracic neoplasms
4753356|NCT02904941|Children|children
4753357|NCT02904941|Skin Transplantation|skin transplantation
4753358|NCT02904941|Amniotic Membrane|amniotic membrane
4753359|NCT02904902|efficacy|efficacy
4753360|NCT02904902|safety|safety
4753361|NCT02904902|adalimumab|adalimumab
4753362|NCT02904902|japanese participants|japanese participants
4753363|NCT02904850|Non-small cell lung cancer|non-small cell lung cancer
4753364|NCT02904850|locally advanced or metastatic|locally advanced or metastatic
4753365|NCT02904850|erlotinib monotherapy|erlotinib monotherapy
4753366|NCT02904837|Randomized clinical trial|randomized clinical trial
4753367|NCT02904837|Parkinson's disease|parkinson's disease
4753368|NCT02904837|Mental practice|mental practice
4753369|NCT02904837|Gait|gait
4753370|NCT02904824|adipose tissue|adipose tissue
4753371|NCT02904824|adult stem cells|adult stem cells
4753372|NCT02904824|vocal cord paralysis|vocal cord paralysis
4753373|NCT02904811|Chlamydia trachomatis|chlamydia trachomatis
4753374|NCT02904811|Pelvic inflammatory disease|pelvic inflammatory disease
4753375|NCT02904798|sunscreen|sunscreen
4753376|NCT02904798|photoprotection|photoprotection
4753377|NCT02904798|visible light|visible light
4753378|NCT02904746|follow-up|follow-up
4753379|NCT02904746|mental health appointment|mental health appointment
4753380|NCT02904720|Vitamin D; Pregnancy|vitamin d; pregnancy
4753381|NCT02904707|Skin Graft|skin graft
4753382|NCT02904668|chronic pain|chronic pain
4753383|NCT02904642|SMS reminder|sms reminder
4753384|NCT02904642|incentive|incentive
4753385|NCT02904642|mobile phone|mobile phone
4753386|NCT02904642|Immunization|immunization
4753387|NCT02904590|IBD|ibd
4753388|NCT02904590|Infection|infection
4753389|NCT02904577|Indolent B-Cell Lymphomas|indolent b-cell lymphomas
4753390|NCT02904577|prospective collection|prospective collection
4753391|NCT02904564|drug delivery|drug delivery
4753392|NCT02904564|Idiopathic Guttate Hypomelanosis|idiopathic guttate hypomelanosis
4753393|NCT02904551|prospective study|prospective study
4753394|NCT02904551|free gingival graft|free gingival graft
4753395|NCT02904551|keratinized gingiva|keratinized gingiva
4753396|NCT02904551|dental implant|dental implant
4753397|NCT02904538|Dexamethasone|dexamethasone
4753398|NCT02904538|Regional anesthesia|regional anesthesia
4753399|NCT02904538|Front foot surgery|front foot surgery
4753400|NCT02904538|Metacarpal osteotomy|metacarpal osteotomy
4753401|NCT02904525|newly diagnosed|newly diagnosed
4753402|NCT02904525|MRI|mri
4753403|NCT02904499|Atrial Fibrillation|atrial fibrillation
4753404|NCT02904499|Anticoagulants|anticoagulants
4753405|NCT02904499|Pharmacoepidemiology|pharmacoepidemiology
4753406|NCT02904447|hemicap|hemicap
4753407|NCT02904447|hallux rigidus|hallux rigidus
4753408|NCT02904434|voriconazole|voriconazole
4753409|NCT02904434|absorption|absorption
4753410|NCT02904434|pharmacokinetic|pharmacokinetic
4753411|NCT02904434|grapefruit juice|grapefruit juice
4753412|NCT02904434|bioavailability|bioavailability
4753413|NCT02904434|intestinal first-pass metabolism|intestinal first-pass metabolism
4753414|NCT02904434|pharmacokinetics|pharmacokinetics
4753415|NCT02904434|intestinal|intestinal
4753416|NCT02904421|scoliosis|scoliosis
4753417|NCT02904421|spinal deformity|spinal deformity
4753418|NCT02904421|vitamin D|vitamin d
4753419|NCT02904421|bone health|bone health
4753420|NCT02904408|quality of life|quality of life
4753421|NCT02904408|psychotherapy|psychotherapy
4753422|NCT02904408|hidradenitis|hidradenitis
4753423|NCT02904408|treatments|treatments
4753424|NCT02904356|OCD|ocd
4753425|NCT02904356|TMS|tms
4753426|NCT02904356|Neuromodulation|neuromodulation
4753427|NCT02904356|Obsessive-Compulsive Disorder|obsessive-compulsive disorder
4753428|NCT02904356|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
4753429|NCT02904356|Imaging|imaging
4753430|NCT02904343|hemodialysis machine|hemodialysis machine
4753431|NCT02904343|quality|quality
4753432|NCT02904343|safety|safety
4753433|NCT02904343|domestic|domestic
4753434|NCT02904304|Flu|flu
4753435|NCT02904304|Treatment|treatment
4753436|NCT02904291|Bariatric surgery|bariatric surgery
4753437|NCT02904291|Gastrointestinal tract|gastrointestinal tract
4753438|NCT02904291|Biological availability|biological availability
4753439|NCT02904291|Pharmacokinetics|pharmacokinetics
4753440|NCT02904291|Amlodipine|amlodipine
4753441|NCT02904278|Mobile Application Intervention|mobile application intervention
4753442|NCT02904278|Teen Pocket PATH® [TPP]|teen pocket path® [tpp]
4753443|NCT02904278|Adherence|adherence
4753444|NCT02904278|Medical Management|medical management
4753445|NCT02904265|continuous spike wave in sleep|continuous spike wave in sleep
4753446|NCT02904265|Landau-Kleffner syndrome|landau-kleffner syndrome
4753447|NCT02904265|acetazolamide|acetazolamide
4753448|NCT02904265|diazepam|diazepam
4753449|NCT02904252|Transient elastography|transient elastography
4753450|NCT02904252|Fibrotest|fibrotest
4753451|NCT02904239|Multidetector Computed Tomography|multidetector computed tomography
4753452|NCT02904239|Incidental cardiac findings|incidental cardiac findings
4753453|NCT02904239|Thoracic high-pitch Computed Tomography|thoracic high-pitch computed tomography
4753454|NCT02904239|Management guidelines|management guidelines
4753455|NCT02904226|ICOS|icos
4753456|NCT02904226|ICOS agonist monoclonal antibody|icos agonist monoclonal antibody
4753457|NCT02904226|JTX-2011|jtx-2011
4753458|NCT02904226|Anti-PD-1|anti-pd-1
4753459|NCT02904226|Nivolumab|nivolumab
4753460|NCT02904226|ICONIC|iconic
4753461|NCT02904226|Immunotherapy|immunotherapy
4753462|NCT02904226|Immuno-oncology|immuno-oncology
4753463|NCT02904226|Cancer|cancer
4753464|NCT02904226|Solid Tumor|solid tumor
4753465|NCT02904226|Dose Escalation|dose escalation
4753466|NCT02904226|Dose Expansion|dose expansion
4753467|NCT02904226|Anti-CTLA-4|anti-ctla-4
4753468|NCT02904226|Ipilimumab|ipilimumab
4753469|NCT02904226|Pembrolizumab|pembrolizumab
4753470|NCT02904213|vaccine|vaccine
4753471|NCT02904213|ComBe Five|combe five
4753472|NCT02904213|Vietnam|vietnam
4753473|NCT02904213|pentavalent|pentavalent
4753474|NCT02904135|Circulating Tumor Cells|circulating tumor cells
4753475|NCT02904070|Threat of|threat of
4753476|NCT02904044|School|school
4753477|NCT02904044|Sport|sport
4753478|NCT02904044|Injuries|injuries
4753479|NCT02904005|Suicide|suicide
4753480|NCT02904005|Prediction|prediction
4753481|NCT02904005|Prospective study|prospective study
4753482|NCT02904005|Suicide attempt|suicide attempt
4753483|NCT02904005|Risk management|risk management
4753484|NCT02903992|Frail Elderly|frail elderly
4753485|NCT02903992|sarcopenia|sarcopenia
4753486|NCT02903966|Tolerability|tolerability
4753487|NCT02903966|GSK2982772|gsk2982772
4753488|NCT02903966|Safety|safety
4753489|NCT02903966|Pharmacokinetics|pharmacokinetics
4753490|NCT02903966|RIP1 kinase inhibitor|rip1 kinase inhibitor
4753491|NCT02903966|Ulcerative colitis|ulcerative colitis
4753492|NCT02903966|Pharmacodynamics|pharmacodynamics
4753493|NCT02903914|Immuno-Oncology|immuno-oncology
4753494|NCT02903914|Checkpoint Inhibitors|checkpoint inhibitors
4753495|NCT02903914|Tumor Metabolism|tumor metabolism
4753496|NCT02903914|Programmed cell death protein-1 (PD-1) inhibitor|programmed cell death protein-1 (pd-1) inhibitor
4753497|NCT02903914|Programmed death ligand 1 (PD-L1) inhibitor|programmed death ligand 1 (pd-l1) inhibitor
4753498|NCT02903914|Solid Tumors|solid tumors
4753499|NCT02903914|RCC|rcc
4753500|NCT02903914|MEL|mel
4753501|NCT02903914|NSCLC|nsclc
4753502|NCT02903914|Arginase|arginase
4753503|NCT02903914|Arginase Inhibitor|arginase inhibitor
4753504|NCT02903914|INCB001158 (CB-1158)|incb001158 (cb-1158)
4753505|NCT02903914|SCCHN|scchn
4753506|NCT02903914|GEJ|gej
4753507|NCT02903914|Immune Therapy|immune therapy
4753508|NCT02903901|Delirium|delirium
4753509|NCT02903862|Caregivers|caregivers
4753510|NCT02903862|Case Management|case management
4753511|NCT02903862|Alzheimer's Disease|alzheimer's disease
4753512|NCT02903862|Cognition|cognition
4753513|NCT02903862|Caregiver Burden|caregiver burden
4753514|NCT02903862|Depression|depression
4753515|NCT02903823|spinal cord injury|spinal cord injury
4753516|NCT02903823|cerebral palsy|cerebral palsy
4753517|NCT02903823|stroke|stroke
4753518|NCT02903797|Endometrial hyperplasia|endometrial hyperplasia
4753519|NCT02903797|Irisin|irisin
4753520|NCT02903797|fibronectin type III domain containing 5|fibronectin type iii domain containing 5
4753521|NCT02903797|FNDC5 (fibronectin type III domain containing )|fndc5 (fibronectin type iii domain containing )
4753522|NCT02903771|Cantrixil|cantrixil
4753523|NCT02903771|Intraperitoneal|intraperitoneal
4753524|NCT02903719|Phrenic|phrenic
4753525|NCT02903719|Nerve block|nerve block
4753526|NCT02903719|Postoperative shoulder pain|postoperative shoulder pain
4753527|NCT02903719|Liver resection|liver resection
4753528|NCT02903706|gold miners|gold miners
4753529|NCT02903706|plasmodium carriers|plasmodium carriers
4753530|NCT02903706|artemisinine resistance|artemisinine resistance
4753531|NCT02903680|Relapse Prevention|relapse prevention
4753532|NCT02903680|Children|children
4753533|NCT02903667|bone grafting|bone grafting
4753534|NCT02903667|implantology|implantology
4753535|NCT02903667|oral surgery|oral surgery
4753536|NCT02903628|myopia|myopia
4753537|NCT02903615|glucose|glucose
4753538|NCT02903615|inflammation|inflammation
4753539|NCT02903602|sharing histories|sharing histories
4753540|NCT02903602|autobiographical memory|autobiographical memory
4753541|NCT02903602|health behavior|health behavior
4753542|NCT02903602|narrative communication|narrative communication
4753543|NCT02903602|community health workers|community health workers
4753544|NCT02903602|global health|global health
4753545|NCT02903602|maternal and child health|maternal and child health
4753546|NCT02903602|stunting|stunting
4753547|NCT02903537|Multiple Sclerosis|multiple sclerosis
4753548|NCT02903537|Dendritic Cells|dendritic cells
4753549|NCT02903537|Immune Tolerance|immune tolerance
4753550|NCT02903537|Myelin Proteins|myelin proteins
4753551|NCT02903537|Tolerogenic dendritic cells|tolerogenic dendritic cells
4753552|NCT02903511|Metformin|metformin
4753553|NCT02903511|total kidney volume|total kidney volume
4753554|NCT02903511|glomerular filtration rate|glomerular filtration rate
4753555|NCT02903498|disease control survival|disease control survival
4753556|NCT02903472|SCI|sci
4753557|NCT02903472|microbiome|microbiome
4753558|NCT02903472|metabolome|metabolome
4753559|NCT02903472|GI|gi
4753560|NCT02903472|UTI|uti
4753561|NCT02903472|DNA|dna
4753562|NCT02903472|genomics|genomics
4753563|NCT02903472|infections|infections
4753564|NCT02903472|tetraplegic|tetraplegic
4753565|NCT02903472|paraplegic|paraplegic
4753566|NCT02903459|Central Fat|central fat
4753567|NCT02903459|Subcutaneous Fat|subcutaneous fat
4753568|NCT02903459|Lumbar Lordosis Degree|lumbar lordosis degree
4753569|NCT02903459|Cellulite|cellulite
4753570|NCT02903433|Avocado|avocado
4753571|NCT02903433|Cardiovascular disease|cardiovascular disease
4753572|NCT02903407|Ventilators, Mechanical|ventilators, mechanical
4753573|NCT02903407|Intensive Care Units|intensive care units
4753574|NCT02903407|Deep Sedation|deep sedation
4753575|NCT02903381|Smoldering Multiple Myeloma|smoldering multiple myeloma
4753576|NCT02903368|Prostate Cancer|prostate cancer
4753577|NCT02903342|Fever|fever
4753578|NCT02903342|Febrile illness|febrile illness
4753579|NCT02903342|Children|children
4753580|NCT02903316|Fluid responsiveness|fluid responsiveness
4753581|NCT02903316|Perioperative|perioperative
4753582|NCT02903316|Extra systoles|extra systoles
4753583|NCT02903316|Coronary artery bypass|coronary artery bypass
4753584|NCT02903316|Systolic arterial pressure|systolic arterial pressure
4753585|NCT02903264|Gestational Diabetes Mellitus|gestational diabetes mellitus
4753586|NCT02903264|Obesity|obesity
4753587|NCT02903264|Periodontal Disease|periodontal disease
4753588|NCT02903251|Oxytocin|oxytocin
4753589|NCT02903251|Administration, Intranasal|administration, intranasal
4753590|NCT02903251|Ethanol|ethanol
4753591|NCT02903238|placebo|placebo
4753592|NCT02903238|pain|pain
4753593|NCT02903238|osteoarthritis|osteoarthritis
4753594|NCT02903225|Heart rate variability|heart rate variability
4753595|NCT02903225|Systolic heart failure|systolic heart failure
4753596|NCT02903225|Physical exercise|physical exercise
4753597|NCT02903225|Parasympathetic indexes|parasympathetic indexes
4753598|NCT02903212|Apoptotic cells|apoptotic cells
4753599|NCT02903199|Whey Protein|whey protein
4753600|NCT02903199|Postprandial Glycaemia|postprandial glycaemia
4753601|NCT02903199|Appetite Response|appetite response
4753602|NCT02903186|infants|infants
4753603|NCT02903186|minorities|minorities
4753604|NCT02903186|overfeeding|overfeeding
4753605|NCT02903186|WIC program|wic program
4753606|NCT02903186|feeding practices|feeding practices
4753607|NCT02903186|breastfeeding|breastfeeding
4753608|NCT02903173|respiratory depression|respiratory depression
4753609|NCT02903173|postpartum|postpartum
4753610|NCT02903173|neuraxial morphine|neuraxial morphine
4753611|NCT02903173|cesarean delivery|cesarean delivery
4753612|NCT02903160|Castration resistant|castration resistant
4753613|NCT02903160|Prostate cancer|prostate cancer
4753614|NCT02903160|Metastatic|metastatic
4753615|NCT02903160|First-line|first-line
4753616|NCT02903160|Treatment naive|treatment naive
4753617|NCT02903160|Rapidly cycling|rapidly cycling
4753618|NCT02903160|Non-cross resistant|non-cross resistant
4753619|NCT02903147|IVDR; driving behavior patterns; Meta-Cognitive Intervention|ivdr; driving behavior patterns; meta-cognitive intervention
4753620|NCT02903121|Unscheduled bleeding|unscheduled bleeding
4753621|NCT02903121|Long acting contraception|long acting contraception
4753622|NCT02903095|Single ascending dose|single ascending dose
4753623|NCT02903082|Myeloid-Derivated suppressive cell|myeloid-derivated suppressive cell
4753624|NCT02903082|Sepsis|sepsis
4753625|NCT02903082|Inflammatory Response Syndrome, Systemic|inflammatory response syndrome, systemic
4753626|NCT02903069|newly diagnosed|newly diagnosed
4753627|NCT02903069|malignant glioma|malignant glioma
4753628|NCT02903069|WHO Grade 4|who grade 4
4753629|NCT02903069|WHO Grade IV|who grade iv
4753630|NCT02903069|marizomib|marizomib
4753631|NCT02903069|MRZ|mrz
4753632|NCT02903069|TMZ|tmz
4753633|NCT02903069|RT|rt
4753634|NCT02903069|brain cancer|brain cancer
4753635|NCT02903069|proteasome inhibitor|proteasome inhibitor
4753636|NCT02903069|radiation|radiation
4753637|NCT02903069|temozolomide|temozolomide
4753638|NCT02903069|temodar|temodar
4753639|NCT02903069|chemotherapy|chemotherapy
4753640|NCT02903069|concurrent|concurrent
4753641|NCT02903069|adjuvant|adjuvant
4753642|NCT02903069|Optune|optune
4753643|NCT02903069|Novocure|novocure
4753644|NCT02903069|NovoTTF|novottf
4753645|NCT02903056|functional Magnetic Resonance Imaging|functional magnetic resonance imaging
4753646|NCT02903056|Diffusion Spectrum Imaging|diffusion spectrum imaging
4753647|NCT02903056|Susceptibility weighted imaging|susceptibility weighted imaging
4753648|NCT02903056|Magnetic Resonance Imaging|magnetic resonance imaging
4753649|NCT02903043|MicroRNAs|micrornas
4753650|NCT02903043|Angiogenesis|angiogenesis
4753651|NCT02903043|Skeletal muscle|skeletal muscle
4753652|NCT02903043|COPD|copd
4753653|NCT02903030|Gastrointestinal Microbiome|gastrointestinal microbiome
4753654|NCT02902991|liquid biopsy, breast cancer,circulating tumor biomarker|liquid biopsy, breast cancer,circulating tumor biomarker
4753655|NCT02902978|E6130|e6130
4753656|NCT02902978|Japanese healthy adult male participants|japanese healthy adult male participants
4753657|NCT02902978|Phase 1|phase 1
4753658|NCT02902978|Pharmacokinetics|pharmacokinetics
4753659|NCT02902965|Bruton's Tyrosine Kinase|bruton's tyrosine kinase
4753660|NCT02902965|Bortezomib|bortezomib
4753661|NCT02902965|Dexamethasone|dexamethasone
4753662|NCT02902965|Ibrutinib|ibrutinib
4753663|NCT02902939|Immune Suppression, Inflammatory Response, Cardiac Surgery|immune suppression, inflammatory response, cardiac surgery
4753664|NCT02902913|platelet reactivity|platelet reactivity
4753665|NCT02902913|phenolic|phenolic
4753666|NCT02902913|extra virgin olive oil|extra virgin olive oil
4753667|NCT02902913|cyclooxygenase|cyclooxygenase
4753668|NCT02902913|oleocanthal|oleocanthal
4753669|NCT02902913|oxylipin|oxylipin
4753670|NCT02902900|Multiple Myeloma|multiple myeloma
4753671|NCT02902900|Pomalidomide|pomalidomide
4753672|NCT02902900|Efficacy|efficacy
4753673|NCT02902835|Buprenorphine treatment|buprenorphine treatment
4753674|NCT02902835|Incarceration|incarceration
4753675|NCT02902835|Linkage Intervention|linkage intervention
4753676|NCT02902835|Opioid use disorder|opioid use disorder
4753677|NCT02902822|melanoma|melanoma
4753678|NCT02902822|non-melanoma skin cancer|non-melanoma skin cancer
4753679|NCT02902822|mole|mole
4753680|NCT02902822|app|app
4753681|NCT02902822|cliccailneo|cliccailneo
4753682|NCT02902809|open-label study|open-label study
4753683|NCT02902809|tralokinumab|tralokinumab
4753684|NCT02902809|subcutaneous|subcutaneous
4753685|NCT02902809|inadequately controlled asthma|inadequately controlled asthma
4753686|NCT02902809|asthma|asthma
4753687|NCT02902809|medium to high-dose of inhaled corticosteroid|medium to high-dose of inhaled corticosteroid
4753688|NCT02902809|long-acting β2-agonist|long-acting β2-agonist
4753689|NCT02902770|Pain|pain
4753690|NCT02902770|Lidocaine|lidocaine
4753691|NCT02902770|Ketorolac|ketorolac
4753692|NCT02902757|FDG|fdg
4753693|NCT02902757|PET/CT very early response (48 hrs)|pet/ct very early response (48 hrs)
4753694|NCT02902705|White adipose tissue|white adipose tissue
4753695|NCT02902705|chronic kidney disease|chronic kidney disease
4753696|NCT02902705|uremia|uremia
4753697|NCT02902705|adipocytes|adipocytes
4753698|NCT02902692|brief|brief
4753699|NCT02902692|mindfulness|mindfulness
4753700|NCT02902666|Bioequivalence|bioequivalence
4753701|NCT02902666|Paracetamol 1000 mg/codeine 30 mg|paracetamol 1000 mg/codeine 30 mg
4753702|NCT02902666|Co-efferalgan 500 mg/30 mg|co-efferalgan 500 mg/30 mg
4753703|NCT02902653|misoprostol|misoprostol
4753704|NCT02902653|dinoprostonal|dinoprostonal
4753705|NCT02902653|induction|induction
4753706|NCT02902614|embryo biopsy|embryo biopsy
4753707|NCT02902614|preimplantation genetic testing|preimplantation genetic testing
4753708|NCT02902614|animal pole|animal pole
4753709|NCT02902614|vegetal pole|vegetal pole
4753710|NCT02902614|day 3 embryo biopsy|day 3 embryo biopsy
4753711|NCT02902614|embryo implantation|embryo implantation
4753712|NCT02902614|Blastomeres|blastomeres
4753713|NCT02902588|Blood-Brain Barrier|blood-brain barrier
4753714|NCT02902588|Magnetic Resonance Imaging|magnetic resonance imaging
4753715|NCT02902588|Spectroscopy, Near-Infrared|spectroscopy, near-infrared
4753716|NCT02902588|Indocyanine green|indocyanine green
4753717|NCT02902575|Stomach Neoplasms|stomach neoplasms
4753718|NCT02902575|Laparoscopy|laparoscopy
4753719|NCT02902575|Advanced Gastric Cancer|advanced gastric cancer
4753720|NCT02902575|Neoadjuvant Chemotherapy|neoadjuvant chemotherapy
4753721|NCT02902549|Optical Coherence Tomography|optical coherence tomography
4753722|NCT02902549|Fluorescence Imaging|fluorescence imaging
4753723|NCT02902549|Sidestream Darkfield Microscopy|sidestream darkfield microscopy
4753724|NCT02902549|Laser Speckle Contrast Imaging|laser speckle contrast imaging
4753725|NCT02902536|Myasthenia Gravis|myasthenia gravis
4753726|NCT02902510|yoga|yoga
4753727|NCT02902510|function|function
4753728|NCT02902510|Parkinson's disease|parkinson's disease
4753729|NCT02902510|gait|gait
4753730|NCT02902510|balance|balance
4753731|NCT02902458|implantable cardioverter defibrillator|implantable cardioverter defibrillator
4753732|NCT02902458|primary prevention|primary prevention
4753733|NCT02902458|psychological follow-up|psychological follow-up
4753734|NCT02902458|anxiety|anxiety
4753735|NCT02902458|depression|depression
4753736|NCT02902458|quality of life|quality of life
4753737|NCT02902445|Vaccine|vaccine
4753738|NCT02902445|Polymorphism|polymorphism
4753739|NCT02902432|endostar|endostar
4753740|NCT02902432|cisplatin|cisplatin
4753741|NCT02902393|Fibrinolysis|fibrinolysis
4753742|NCT02902393|tPA|tpa
4753743|NCT02902367|mobility|mobility
4753744|NCT02902367|exercise|exercise
4753745|NCT02902367|walking capacity|walking capacity
4753746|NCT02902367|fat mass|fat mass
4753747|NCT02902367|muscles|muscles
4753748|NCT02902341|Nutrition Therapy|nutrition therapy
4753749|NCT02902315|Muscle soreness|muscle soreness
4753750|NCT02902315|Free radicals|free radicals
4753751|NCT02902315|Ascorbic acid|ascorbic acid
4753752|NCT02902315|Alpha-Tocopherol|alpha-tocopherol
4753753|NCT02902315|Cryotherapy|cryotherapy
4753754|NCT02902315|Exercise tolerance|exercise tolerance
4753755|NCT02902315|Resistance training|resistance training
4753756|NCT02902302|Bioequivalence|bioequivalence
4753757|NCT02902302|Ibuprofen 400 mg/5 ml|ibuprofen 400 mg/5 ml
4754556|NCT02896257|QuERI|queri
4753758|NCT02902302|Moment 400 mg coated tablet|moment 400 mg coated tablet
4753759|NCT02902302|Oral Suspension|oral suspension
4753760|NCT02902289|Bioequivalence|bioequivalence
4753761|NCT02902289|Ibuprofen 200 mg/5 ml|ibuprofen 200 mg/5 ml
4753762|NCT02902289|Moment 200 mg coated tablet|moment 200 mg coated tablet
4753763|NCT02902289|Oral Suspension|oral suspension
4753764|NCT02902276|plasma citrulline|plasma citrulline
4753765|NCT02902276|lipopolysaccharide|lipopolysaccharide
4753766|NCT02902276|critically ill|critically ill
4753767|NCT02902276|Hospitalization in an Intensive Care Unit|hospitalization in an intensive care unit
4753768|NCT02902263|Telemedecine|telemedecine
4753769|NCT02902263|Thrombolysis|thrombolysis
4753770|NCT02902250|Vertebroplasty|vertebroplasty
4753771|NCT02902250|Core decompression|core decompression
4753772|NCT02902250|Osteoporosis|osteoporosis
4753773|NCT02902211|ankle foot orthosis|ankle foot orthosis
4753774|NCT02902211|biomechanics|biomechanics
4753775|NCT02902211|mobility|mobility
4753776|NCT02902185|Chidamide|chidamide
4753777|NCT02902185|Histone Deacetylase Inhibitor|histone deacetylase inhibitor
4753778|NCT02902185|HIV-1 Reservoir|hiv-1 reservoir
4753779|NCT02902185|Chronic HIV infections|chronic hiv infections
4753780|NCT02902185|HIV Eradication|hiv eradication
4753781|NCT02902185|Antiretroviral Therapy|antiretroviral therapy
4753782|NCT02902159|Stress|stress
4753783|NCT02902159|Low Mood|low mood
4753784|NCT02902159|Mental Health|mental health
4753785|NCT02902159|Peer Support|peer support
4753786|NCT02902159|Online|online
4753787|NCT02902133|cerebrospinal fluid leak|cerebrospinal fluid leak
4753788|NCT02902107|Low Dose Rate Brachytherapy|low dose rate brachytherapy
4753789|NCT02902107|CivaSheet|civasheet
4753790|NCT02902107|16-605|16-605
4753791|NCT02902042|Unresectable or metastatic BRAF V600 mutant melanoma|unresectable or metastatic braf v600 mutant melanoma
4753792|NCT02902042|Encorafenib, binimetinib, pembrolizumab|encorafenib, binimetinib, pembrolizumab
4753793|NCT02902029|unresectable stage IIIB, IIIC, IV melanoma|unresectable stage iiib, iiic, iv melanoma
4753794|NCT02902016|PPARgamma|ppargamma
4753795|NCT02902016|Lactose intolerance|lactose intolerance
4753796|NCT02902016|Lactase|lactase
4753797|NCT02901990|mumps|mumps
4753798|NCT02901990|immunity|immunity
4753799|NCT02901990|cohort study|cohort study
4753800|NCT02901990|children|children
4753801|NCT02901990|vaccine|vaccine
4753802|NCT02901977|Hypertension|hypertension
4753803|NCT02901977|Blood pressure|blood pressure
4753804|NCT02901977|Hemostasis|hemostasis
4753805|NCT02901977|Endothelial function|endothelial function
4753806|NCT02901951|Hepatitis B surface antigen antibody|hepatitis b surface antigen antibody
4753807|NCT02901951|adult subjects|adult subjects
4753808|NCT02901951|Hepatitis B|hepatitis b
4753809|NCT02901951|HBV|hbv
4753810|NCT02901925|ABY-029|aby-029
4753811|NCT02901925|Affibody|affibody
4753812|NCT02901925|Molecular Fluorescence-Guided Surgery|molecular fluorescence-guided surgery
4753813|NCT02901925|Epidermal Growth Factor Receptor (EGFR)|epidermal growth factor receptor (egfr)
4753814|NCT02901912|physical activity|physical activity
4753815|NCT02901912|sedentarism|sedentarism
4753816|NCT02901912|fecal enzymatic activity|fecal enzymatic activity
4753817|NCT02901886|Rheumatoid Arthritis|rheumatoid arthritis
4753818|NCT02901886|Smoking Cessation|smoking cessation
4753819|NCT02901886|Disease Activity|disease activity
4753820|NCT02901886|Clinical Prevention|clinical prevention
4753821|NCT02901808|NOMI|nomi
4753822|NCT02901808|Angiography|angiography
4753823|NCT02901808|Digital Subtraction Angiography (DSA)|digital subtraction angiography (dsa)
4753824|NCT02901782|Knee|knee
4753825|NCT02901782|Titanium Plate|titanium plate
4753826|NCT02901730|laser peripheral iridoplasty|laser peripheral iridoplasty
4753827|NCT02901730|treatment|treatment
4753828|NCT02901678|skelatal open bite, posterior intrusion|skelatal open bite, posterior intrusion
4753829|NCT02901626|Short cervix|short cervix
4753830|NCT02901626|Preterm delivery|preterm delivery
4753831|NCT02901626|Singletons|singletons
4753832|NCT02901626|Pregnancy|pregnancy
4753833|NCT02901626|Pessary|pessary
4753834|NCT02901600|DMBT1 expression|dmbt1 expression
4753835|NCT02901600|Colorectal cancer|colorectal cancer
4753836|NCT02901548|BCG refractory CIS|bcg refractory cis
4753837|NCT02901548|Urothelial CIS of bladder|urothelial cis of bladder
4753838|NCT02901548|Carcinoma in situ (CIS)|carcinoma in situ (cis)
4753839|NCT02901548|Bacillus Calmette-Guérin (BCG)|bacillus calmette-guérin (bcg)
4753840|NCT02901548|Medi4736|medi4736
4753841|NCT02901548|Durvalumab|durvalumab
4753842|NCT02901548|CIS of the bladder|cis of the bladder
4753843|NCT02901548|Bladder cancer|bladder cancer
4753844|NCT02901548|BCG Vaccine|bcg vaccine
4753845|NCT02901548|Bladder diseases|bladder diseases
4753846|NCT02901548|Urothelial diseases|urothelial diseases
4753847|NCT02901535|telemedicine|telemedicine
4753848|NCT02901535|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
4753849|NCT02901535|Primary Health care|primary health care
4753850|NCT02901535|spirometry|spirometry
4753851|NCT02901522|telemedicine|telemedicine
4753852|NCT02901522|asthma control test|asthma control test
4753853|NCT02901522|Primary Health care|primary health care
4753854|NCT02901522|spirometry|spirometry
4753855|NCT02901509|Chikungunya|chikungunya
4753856|NCT02901509|Quality of Life|quality of life
4753857|NCT02901483|Head and Neck|head and neck
4753858|NCT02901457|Body Image|body image
4753859|NCT02901418|chronic hepatitis B|chronic hepatitis b
4753860|NCT02901418|mother to child transmission|mother to child transmission
4753861|NCT02901418|interruption|interruption
4753862|NCT02901418|hepatitis B immunoglobulin|hepatitis b immunoglobulin
4753863|NCT02901418|pregnancy|pregnancy
4753864|NCT02901418|HBsAg|hbsag
4753865|NCT02901418|newborns|newborns
4753866|NCT02901405|sarcoma|sarcoma
4753867|NCT02901405|infection|infection
4753868|NCT02901405|negative pressure|negative pressure
4753869|NCT02901392|Male Urethral Slings|male urethral slings
4753870|NCT02901392|Artificial Urinary Sphincter|artificial urinary sphincter
4753871|NCT02901392|Prostatectomy|prostatectomy
4753872|NCT02901392|Radiotherapy|radiotherapy
4753873|NCT02901379|atorvastatin|atorvastatin
4753874|NCT02901379|myocardial edema|myocardial edema
4753875|NCT02901379|Follistatin-like 1|follistatin-like 1
4753876|NCT02901379|FSTL1|fstl1
4753877|NCT02901379|atorvastatin 80mg|atorvastatin 80mg
4753878|NCT02901379|coronary artery bypass surgery|coronary artery bypass surgery
4753879|NCT02901366|Mass balance|mass balance
4753880|NCT02901340|Borderline idiopathic isolated oligohydramnios|borderline idiopathic isolated oligohydramnios
4753881|NCT02901340|Fetal renal artery doppler indices|fetal renal artery doppler indices
4753882|NCT02901340|neonatal outcomes|neonatal outcomes
4753883|NCT02901340|Maternal hydration|maternal hydration
4753884|NCT02901327|Lumbar Stabilisation Exercise|lumbar stabilisation exercise
4753885|NCT02901327|Treadmill Walk|treadmill walk
4753886|NCT02901327|Multifidus Muscle Activation|multifidus muscle activation
4753887|NCT02901327|Pain Intensity|pain intensity
4753888|NCT02901327|Functional Disability|functional disability
4753889|NCT02901288|pulmonary tuberculosis|pulmonary tuberculosis
4753890|NCT02901288|shortened regimen|shortened regimen
4753891|NCT02901288|clinical trial|clinical trial
4753892|NCT02901275|Clinical Trial, Phase II|clinical trial, phase ii
4753893|NCT02901275|Analgesia|analgesia
4753894|NCT02901262|continuous EEG|continuous eeg
4753895|NCT02901249|Cost effectiveness|cost effectiveness
4753896|NCT02901249|Unipolar Depression|unipolar depression
4753897|NCT02901249|Major Depression Disorder|major depression disorder
4753898|NCT02901249|Quality of life disorder|quality of life disorder
4753899|NCT02901236|trabeculectomy|trabeculectomy
4753900|NCT02901236|glaucoma|glaucoma
4753901|NCT02901236|filtration surgery|filtration surgery
4753902|NCT02901236|wound healing|wound healing
4753903|NCT02901236|angiogenesis|angiogenesis
4753904|NCT02901236|mitomycin|mitomycin
4753905|NCT02901236|vascular endothelial growth factor inhibition|vascular endothelial growth factor inhibition
4753906|NCT02901223|Oncoplastic breast surgery|oncoplastic breast surgery
4753907|NCT02901223|oncological safety|oncological safety
4753908|NCT02901223|patient satisfaction|patient satisfaction
4753909|NCT02901210|Recta prolapse|recta prolapse
4753910|NCT02901210|Intraoperative bleeding|intraoperative bleeding
4753911|NCT02901210|mucosal cauterization|mucosal cauterization
4753912|NCT02901197|capnography|capnography
4753913|NCT02901171|Smoking cessation|smoking cessation
4753914|NCT02901171|Acceptance and Commitment Therapy|acceptance and commitment therapy
4753915|NCT02901171|Smartphone|smartphone
4753916|NCT02901158|esophageal pressure|esophageal pressure
4753917|NCT02901158|chest wall elastance|chest wall elastance
4753918|NCT02901158|lung elastance|lung elastance
4753919|NCT02901158|transpulmonary pressure|transpulmonary pressure
4753920|NCT02901145|immunotherapy,solid tumor,pediatric|immunotherapy,solid tumor,pediatric
4753921|NCT02901106|Multiple Sclerosis, Relapsing-Remitting|multiple sclerosis, relapsing-remitting
4753922|NCT02901106|Dimethyl fumarate|dimethyl fumarate
4753923|NCT02901093|Stapes surgery|stapes surgery
4753924|NCT02901093|Sensorineural complications|sensorineural complications
4753925|NCT02901093|Inner ear|inner ear
4753926|NCT02901093|Imaging|imaging
4753927|NCT02901093|Cone Beam CT|cone beam ct
4753928|NCT02901067|Fibrinolysis|fibrinolysis
4753929|NCT02901015|schizophrenia|schizophrenia
4753930|NCT02901002|Complex Regional Pain Syndromes|complex regional pain syndromes
4753931|NCT02901002|Pain|pain
4753932|NCT02901002|Spontaneous sensations|spontaneous sensations
4753933|NCT02901002|interoception|interoception
4753934|NCT02900989|Psychiatry|psychiatry
4753935|NCT02900989|Pediatrics|pediatrics
4753936|NCT02900989|Suicide|suicide
4753937|NCT02900963|Nutrition|nutrition
4753938|NCT02900963|Head and Neck Cancer|head and neck cancer
4753939|NCT02900950|cancer|cancer
4753940|NCT02900950|resection margin|resection margin
4753941|NCT02900950|pathology|pathology
4753942|NCT02900950|pancreas|pancreas
4753943|NCT02900937|Stents|stents
4753944|NCT02900937|Angioplasty|angioplasty
4753945|NCT02900937|Coronary Vessels|coronary vessels
4753946|NCT02900937|Coronary Artery Disease|coronary artery disease
4753947|NCT02900937|Angina Pectoris|angina pectoris
4753948|NCT02900937|Myocardial Ischemia|myocardial ischemia
4753949|NCT02900937|Myocardial Infarction|myocardial infarction
4753950|NCT02900937|Myocardial Revascularization|myocardial revascularization
4753951|NCT02900924|PAD|pad
4753952|NCT02900924|PVD|pvd
4753953|NCT02900924|SFA stent|sfa stent
4753954|NCT02900911|head and neck cancer|head and neck cancer
4753955|NCT02900911|dysphagia|dysphagia
4753956|NCT02900911|rehabilitation|rehabilitation
4753957|NCT02900911|radiation therapy|radiation therapy
4753958|NCT02900820|Anti-Bacterial Agents|anti-bacterial agents
4753959|NCT02900820|Primary Health Care|primary health care
4753960|NCT02900820|Drug Resistance, Microbial|drug resistance, microbial
4753961|NCT02900820|Respiratory Tract Infections|respiratory tract infections
4753962|NCT02900781|Arthroplasty|arthroplasty
4753963|NCT02900781|Physical Therapy|physical therapy
4753964|NCT02900768|Bone Marrow Transplantation|bone marrow transplantation
4753965|NCT02900768|Exercise|exercise
4753966|NCT02900768|Rehabilitation|rehabilitation
4753967|NCT02900768|Cancer|cancer
4753968|NCT02900755|Electroencephalography|electroencephalography
4753969|NCT02900755|Perampanel|perampanel
4753970|NCT02900742|lung cancer|lung cancer
4753971|NCT02900742|traditional Chinese medicine|traditional chinese medicine
4753972|NCT02900742|maintenance therapy|maintenance therapy
4753973|NCT02900742|chemotherapy|chemotherapy
4753974|NCT02900677|Pancreatic Cancer|pancreatic cancer
4753975|NCT02900677|Fatigue|fatigue
4753976|NCT02900677|Nutrition|nutrition
4753977|NCT02900677|Quality of Life|quality of life
4753978|NCT02900664|CRC|crc
4753979|NCT02900664|TNBC|tnbc
4753980|NCT02900664|NSCLC (adenocarcinoma)|nsclc (adenocarcinoma)
4753981|NCT02900664|Immunomodulation|immunomodulation
4753982|NCT02900664|Biomarkers|biomarkers
4753983|NCT02900664|Bayesian logistic regression model|bayesian logistic regression model
4753984|NCT02900664|PDR001|pdr001
4753985|NCT02900664|Immunotherapy|immunotherapy
4753986|NCT02900651|MAK683, DLBCL, EED - Embryonic ectoderm development, EZH2 - Enhancer of zeste homolog 2|mak683, dlbcl, eed - embryonic ectoderm development, ezh2 - enhancer of zeste homolog 2
4753987|NCT02900638|mentoring|mentoring
4753988|NCT02900638|children|children
4753989|NCT02900638|cardiovascular health|cardiovascular health
4753990|NCT02900612|dyslipidemias,|dyslipidemias,
4753991|NCT02900612|aging|aging
4753992|NCT02900612|water aerobics training|water aerobics training
4753993|NCT02900612|resistance aquatic training|resistance aquatic training
4753994|NCT02900612|lipid profile|lipid profile
4753995|NCT02900599|HIV|hiv
4753996|NCT02900599|Behavior|behavior
4753997|NCT02900547|Systolic Heart Failure|systolic heart failure
4753998|NCT02900547|medical algorithm decision support system|medical algorithm decision support system
4753999|NCT02900534|grief|grief
4754000|NCT02900534|depression|depression
4754001|NCT02900534|bereavement|bereavement
4754002|NCT02900534|divorce|divorce
4754003|NCT02900534|online self-help|online self-help
4754004|NCT02900495|Nocturnal Enuresis|nocturnal enuresis
4754005|NCT02900495|Bedwetting|bedwetting
4754006|NCT02900495|TENS|tens
4754007|NCT02900469|RANK|rank
4754008|NCT02900469|RANKL|rankl
4754009|NCT02900456|Intra-aortic Balloon Pumps|intra-aortic balloon pumps
4754010|NCT02900456|Registry|registry
4754011|NCT02900417|type 2 diabetes|type 2 diabetes
4754012|NCT02900417|gut microbiota|gut microbiota
4754013|NCT02900417|sitagliptin|sitagliptin
4754014|NCT02900378|physical activity|physical activity
4754015|NCT02900378|actigraphy|actigraphy
4754016|NCT02900378|sleep|sleep
4754017|NCT02900378|sacubitril/valsartan|sacubitril/valsartan
4754018|NCT02900378|enalapril|enalapril
4754019|NCT02900378|heart failure|heart failure
4754020|NCT02900378|reduced ejection fraction|reduced ejection fraction
4754021|NCT02900378|randomized controlled trial|randomized controlled trial
4754022|NCT02900378|accelerometry|accelerometry
4754023|NCT02900365|trauma|trauma
4754024|NCT02900365|cataract|cataract
4754025|NCT02900365|lensectomy|lensectomy
4754026|NCT02900365|time|time
4754027|NCT02900365|early|early
4754028|NCT02900365|late|late
4754029|NCT02900352|Alcohol Use Disorder|alcohol use disorder
4754030|NCT02900352|Alcoholism|alcoholism
4754031|NCT02900352|Alcohol Dependence|alcohol dependence
4754032|NCT02900352|Zonisamide|zonisamide
4754033|NCT02900352|Alcohol Intoxication|alcohol intoxication
4754034|NCT02900352|Drinking Behaviors|drinking behaviors
4754035|NCT02900352|Anticonvulsants|anticonvulsants
4754036|NCT02900339|MRI|mri
4754037|NCT02900339|Sequence optimization|sequence optimization
4754038|NCT02900339|Healthy volunteers|healthy volunteers
4754039|NCT02900326|Exercise capacity|exercise capacity
4754040|NCT02900326|Mindfulness|mindfulness
4754041|NCT02900326|Quality of life|quality of life
4754042|NCT02900313|acute kidney injury|acute kidney injury
4754043|NCT02900313|cardiac surgery|cardiac surgery
4754044|NCT02900313|cardiac surgery associated acute kidney injury|cardiac surgery associated acute kidney injury
4754045|NCT02900313|renal replacement therapy|renal replacement therapy
4754046|NCT02900313|renal recovery|renal recovery
4754047|NCT02900313|serum hyperphosphatemia|serum hyperphosphatemia
4754048|NCT02900287|Survival|survival
4754049|NCT02900287|Cancer|cancer
4754050|NCT02900248|Biomarkers|biomarkers
4754051|NCT02900248|High-Throughput Nucleotide Sequencing|high-throughput nucleotide sequencing
4754052|NCT02900248|Neoplasms|neoplasms
4754053|NCT02900248|Myelodysplastic Syndromes|myelodysplastic syndromes
4754054|NCT02900235|Healthy|healthy
4754055|NCT02900209|Influenza|influenza
4754056|NCT02900209|Exacerbations|exacerbations
4754057|NCT02900196|Probiotics|probiotics
4754058|NCT02900196|Antibiotic Associated Diarrhea|antibiotic associated diarrhea
4754059|NCT02900196|Gastro-Intestinal disorders|gastro-intestinal disorders
4754060|NCT02900196|Helicobacter pylori|helicobacter pylori
4754061|NCT02900170|Rivaroxaban, Acute Kidney Injury|rivaroxaban, acute kidney injury
4754062|NCT02900157|Advanced Solid Tumor|advanced solid tumor
4754063|NCT02900157|Immunotherapy|immunotherapy
4754064|NCT02900157|MEDI9090|medi9090
4754065|NCT02900157|MEDI4736|medi4736
4754066|NCT02900157|Durvalumab|durvalumab
4754067|NCT02900118|Bone metastasis|bone metastasis
4754068|NCT02900118|PET-CT|pet-ct
4754069|NCT02900118|whole-body MRI|whole-body mri
4754070|NCT02900092|postmenopausal|postmenopausal
4754071|NCT02900092|women|women
4754072|NCT02900092|depression|depression
4754073|NCT02900079|malaria|malaria
4754074|NCT02900079|rapid diagnostic test|rapid diagnostic test
4754075|NCT02900079|travel|travel
4754076|NCT02900079|fever|fever
4754077|NCT02900079|self care|self care
4754078|NCT02900066|fever|fever
4754079|NCT02900066|traveler|traveler
4754080|NCT02900066|arbovirus|arbovirus
4754081|NCT02900066|rickettsia|rickettsia
4754082|NCT02900066|malaria|malaria
4754083|NCT02900066|filter paper|filter paper
4754084|NCT02900066|diagnosis|diagnosis
4754085|NCT02900001|myocardial infarction|myocardial infarction
4754086|NCT02900001|invasive strategy|invasive strategy
4754087|NCT02900001|elderly|elderly
4754088|NCT02900001|deferred|deferred
4754089|NCT02899988|IL-23|il-23
4754090|NCT02899988|dermatology|dermatology
4754091|NCT02899975|Validation|validation
4754092|NCT02899975|Information and Fitness Software|information and fitness software
4754093|NCT02899975|Elderly|elderly
4754094|NCT02899975|WeTakeCare|wetakecare
4754095|NCT02899949|dapagliflozin|dapagliflozin
4754096|NCT02899949|type 2 diabetes|type 2 diabetes
4754097|NCT02899949|real-world data|real-world data
4754098|NCT02899936|Mass drug administration|mass drug administration
4754099|NCT02899936|Safety Data|safety data
4754100|NCT02899897|echocardiography|echocardiography
4754101|NCT02899884|Drug Therapy|drug therapy
4754102|NCT02899871|joint pain|joint pain
4754103|NCT02899858|Thoracic spinal cord injury|thoracic spinal cord injury
4754104|NCT02899858|Paralysis|paralysis
4754105|NCT02899858|ASIA A|asia a
4754106|NCT02899858|Device|device
4754107|NCT02899832|children|children
4754108|NCT02899832|spasms|spasms
4754109|NCT02899819|pesticides|pesticides
4754110|NCT02899819|exposure|exposure
4754111|NCT02899819|in utero|in utero
4754112|NCT02899806|Video Information|video information
4754113|NCT02899806|Satisfaction|satisfaction
4754114|NCT02899806|Anxiety|anxiety
4754115|NCT02899806|Epidural Analgesia|epidural analgesia
4754116|NCT02899806|Comprehension|comprehension
4754117|NCT02899806|delivery|delivery
4754118|NCT02899767|transfusion dependency|transfusion dependency
4754119|NCT02899767|transfusion intensity|transfusion intensity
4754120|NCT02899767|prognosis|prognosis
4754121|NCT02899767|chemotherapy|chemotherapy
4754122|NCT02899754|lung cancer|lung cancer
4754123|NCT02899754|decision support|decision support
4754124|NCT02899754|implementation|implementation
4754125|NCT02899741|Medically intractable epilepsy, Omega-3|medically intractable epilepsy, omega-3
4754126|NCT02899689|Labor|labor
4754127|NCT02899689|Foley|foley
4754128|NCT02899689|Dilapan|dilapan
4754129|NCT02899689|Cervical Dilators|cervical dilators
4754130|NCT02899689|Induction|induction
4754131|NCT02899650|Delayed Onset Muscle Soreness|delayed onset muscle soreness
4754132|NCT02899650|Eccentric exercise|eccentric exercise
4754133|NCT02899650|Masters athlete|masters athlete
4754134|NCT02899637|Incomplete Spinal Cord Injury|incomplete spinal cord injury
4754135|NCT02899637|Rehabilitation|rehabilitation
4754136|NCT02899637|Non-invasive brain stimulation|non-invasive brain stimulation
4754137|NCT02899637|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
4754138|NCT02899611|Epilepsy|epilepsy
4754139|NCT02899585|Palliative care|palliative care
4754140|NCT02899546|Peripherally Inserted Central Catheter|peripherally inserted central catheter
4754141|NCT02899546|Infections|infections
4754142|NCT02899546|Radiology|radiology
4754143|NCT02899533|PAH|pah
4754144|NCT02899533|Pulmonary hypertension|pulmonary hypertension
4754145|NCT02899507|Out-of-hospital cardiac arrest|out-of-hospital cardiac arrest
4754146|NCT02899507|Prophylactic antibiotics|prophylactic antibiotics
4754147|NCT02899468|TBI|tbi
4754148|NCT02899468|Virtual Reality|virtual reality
4754149|NCT02899455|Hypertension|hypertension
4754150|NCT02899455|Hyperlipidemia|hyperlipidemia
4754151|NCT02899442|cardiovascular risk|cardiovascular risk
4754152|NCT02899442|Occupational Health|occupational health
4754153|NCT02899442|night work|night work
4754154|NCT02899442|Public Health|public health
4754155|NCT02899442|Preventive Health Services|preventive health services
4754156|NCT02899416|cardiovascular risk|cardiovascular risk
4754157|NCT02899416|young adulthood|young adulthood
4754158|NCT02899403|Cognitive Tasks|cognitive tasks
4754159|NCT02899403|Mild Cognitive Impairment|mild cognitive impairment
4754160|NCT02899403|Neurophysiological Correlates|neurophysiological correlates
4754161|NCT02899403|Healthy Volunteers|healthy volunteers
4754162|NCT02899377|PET/CT|pet/ct
4754163|NCT02899377|Primary Sjögren's Syndrome|primary sjögren's syndrome
4754164|NCT02899377|Magnetic resonance imaging|magnetic resonance imaging
4754165|NCT02899377|11^C-MET|11^c-met
4754166|NCT02899377|18^F-FDG|18^f-fdg
4754167|NCT02899364|Sodium thiosulfate|sodium thiosulfate
4754168|NCT02899364|STEMI|stemi
4754169|NCT02899364|Infarct size|infarct size
4754170|NCT02899364|Cardiac magnetic resonance imaging|cardiac magnetic resonance imaging
4754171|NCT02899364|Hydrogen sulfide|hydrogen sulfide
4754172|NCT02899286|Acute myeloid leukemia|acute myeloid leukemia
4754173|NCT02899286|AML|aml
4754174|NCT02899286|pegylated recombinant human arginase|pegylated recombinant human arginase
4754175|NCT02899286|PEG-BCT-100|peg-bct-100
4754176|NCT02899273|Early Childhood Caries|early childhood caries
4754177|NCT02899273|eye-tracking|eye-tracking
4754178|NCT02899273|children|children
4754179|NCT02899273|dentistry|dentistry
4754180|NCT02899273|face perception|face perception
4754181|NCT02899247|composite resin|composite resin
4754182|NCT02899247|surface sealant|surface sealant
4754183|NCT02899234|Nicotine|nicotine
4754184|NCT02899234|Electronic Cigarette|electronic cigarette
4754185|NCT02899195|Unresectable Mesothelioma|unresectable mesothelioma
4754186|NCT02899195|Durvalumab|durvalumab
4754187|NCT02899195|Anti-Programmed Death-Ligand 1 Antibody|anti-programmed death-ligand 1 antibody
4754188|NCT02899169|Acute promyelocytic leukemia|acute promyelocytic leukemia
4754562|NCT02896257|De-implementation|de-implementation
4754189|NCT02899169|Realgar-Indigo Naturalis Formula|realgar-indigo naturalis formula
4754190|NCT02899169|All-trans Retinoic Acid|all-trans retinoic acid
4754191|NCT02899091|Alzheimer's disease|alzheimer's disease
4754192|NCT02899091|Mesenchymal Stem cells|mesenchymal stem cells
4754193|NCT02899052|Multiple Myeloma|multiple myeloma
4754194|NCT02899052|Refractory myeloma|refractory myeloma
4754195|NCT02899052|Relapsed myeloma|relapsed myeloma
4754196|NCT02899026|Glucocorticosteroids|glucocorticosteroids
4754197|NCT02899026|Sirukumab|sirukumab
4754198|NCT02899026|Prednisone|prednisone
4754199|NCT02899026|Polymyalgia Rheumatica|polymyalgia rheumatica
4754200|NCT02899013|Perianal Lesions|perianal lesions
4754202|NCT02898987|Hepatitis C|hepatitis c
4754203|NCT02898987|Comorbidities|comorbidities
4754204|NCT02898987|AIDS|aids
4754205|NCT02898948|procalcitonin|procalcitonin
4754206|NCT02898948|bacterial infection|bacterial infection
4754207|NCT02898909|femtosecond laser-assisted cataract surgery|femtosecond laser-assisted cataract surgery
4754208|NCT02898909|nuclear lens fragmentation|nuclear lens fragmentation
4754209|NCT02898844|dieting|dieting
4754210|NCT02898844|dyads|dyads
4754211|NCT02898844|psychological well-being|psychological well-being
4754212|NCT02898844|weight loss|weight loss
4754213|NCT02898844|cortisol|cortisol
4754214|NCT02898792|sensitivity, opioid|sensitivity, opioid
4754215|NCT02898753|GSD-II|gsd-ii
4754216|NCT02898753|Pompe Disease|pompe disease
4754217|NCT02898753|Glycogen Storage Diseases|glycogen storage diseases
4754218|NCT02898753|GAA|gaa
4754219|NCT02898740|Parkinson's disease|parkinson's disease
4754220|NCT02898740|exercise therapy|exercise therapy
4754221|NCT02898740|quality of life|quality of life
4754222|NCT02898701|Motor Learning|motor learning
4754223|NCT02898701|Dose of Motor Practice|dose of motor practice
4754224|NCT02898701|Postural Control|postural control
4754225|NCT02898701|Serial Reaction Time Task|serial reaction time task
4754226|NCT02898701|Retention|retention
4754227|NCT02898701|Transfer|transfer
4754228|NCT02898701|Overpractice|overpractice
4754229|NCT02898701|Overtraining|overtraining
4754230|NCT02898701|Overlearning|overlearning
4754231|NCT02898688|Influenza vaccine|influenza vaccine
4754232|NCT02898688|Pertussis vaccine|pertussis vaccine
4754233|NCT02898688|Perinatal vaccination|perinatal vaccination
4754234|NCT02898688|Infant vaccination|infant vaccination
4754235|NCT02898662|inhaled|inhaled
4754236|NCT02898662|TLR9 agonist|tlr9 agonist
4754237|NCT02898662|withdrawal design|withdrawal design
4754238|NCT02898662|loss of control|loss of control
4754239|NCT02898532|Children, ADHD, target shooting sport|children, adhd, target shooting sport
4754240|NCT02898506|Diabetes Type 1|diabetes type 1
4754241|NCT02898506|Diabetes, Insulin-Dependent|diabetes, insulin-dependent
4754242|NCT02898506|Liraglutide|liraglutide
4754243|NCT02898506|Preclinical Type 1 Diabetes|preclinical type 1 diabetes
4754244|NCT02898506|GLP-1 Analogue|glp-1 analogue
4754245|NCT02898506|Dysglycemia|dysglycemia
4754246|NCT02898506|Prevention|prevention
4754247|NCT02898493|Validation of questionnaire|validation of questionnaire
4754248|NCT02898493|Quality of life|quality of life
4754249|NCT02898441|lung cancer screening|lung cancer screening
4754250|NCT02898441|low-dose CT|low-dose ct
4754251|NCT02898441|high-risk population|high-risk population
4754252|NCT02898415|HCC|hcc
4754253|NCT02898415|Liver Transplantation|liver transplantation
4754254|NCT02898415|AFP|afp
4754255|NCT02898415|Mortality|mortality
4754256|NCT02898415|Competing risk|competing risk
4754257|NCT02898415|Selection criteria|selection criteria
4754258|NCT02898415|Recurrence|recurrence
4754259|NCT02898376|spa care|spa care
4754260|NCT02898376|randomised controlled trial|randomised controlled trial
4754261|NCT02898376|pentoxifylline/tocopherol combination|pentoxifylline/tocopherol combination
4754262|NCT02898376|late sequelae|late sequelae
4754263|NCT02898376|radiotherapy|radiotherapy
4754264|NCT02898363|Care of disabled population|care of disabled population
4754265|NCT02898363|Mental retardation|mental retardation
4754266|NCT02898363|Cancer screening|cancer screening
4754267|NCT02898363|Cancer prevention|cancer prevention
4754268|NCT02898324|Bullying|bullying
4754269|NCT02898324|KiVa program|kiva program
4754270|NCT02898324|Primary school students|primary school students
4754271|NCT02898311|CAD-CAM|cad-cam
4754272|NCT02898311|composite dental resin|composite dental resin
4754273|NCT02898311|Immediate dental implant loading|immediate dental implant loading
4754274|NCT02898259|Lenalidomide|lenalidomide
4754275|NCT02898259|Ixazomib|ixazomib
4754276|NCT02898259|Rituximab|rituximab
4754277|NCT02898246|heart failure|heart failure
4754278|NCT02898246|fear of physical activity|fear of physical activity
4754279|NCT02898246|motor activity|motor activity
4754280|NCT02898233|depression|depression
4754281|NCT02898233|internet-based|internet-based
4754282|NCT02898233|treatment|treatment
4754283|NCT02898233|low-level light therapy|low-level light therapy
4754284|NCT02898233|LLLT|lllt
4754285|NCT02898233|deprexis|deprexis
4754286|NCT02898194|Surrogate Decision-making|surrogate decision-making
4754287|NCT02898194|Health Care|health care
4754288|NCT02898194|Medical Decisions|medical decisions
4754289|NCT02898194|End of Life Care|end of life care
4754290|NCT02898168|stroke|stroke
4754291|NCT02898168|Rehabilitation|rehabilitation
4754292|NCT02898168|WalkAide (WA)|walkaide (wa)
4754293|NCT02898168|Functional Electrical Stimulation (FES)|functional electrical stimulation (fes)
4754294|NCT02898155|Avoidable hospitalizations|avoidable hospitalizations
4754295|NCT02898155|primary care|primary care
4754296|NCT02898155|geographicvariation|geographicvariation
4754297|NCT02898142|Postprandial test|postprandial test
4754298|NCT02898142|Metabolic syndrime|metabolic syndrime
4754299|NCT02898142|HTG|htg
4754300|NCT02898129|chronic respiratory diseases|chronic respiratory diseases
4754301|NCT02898129|housing|housing
4754302|NCT02898129|lung function test|lung function test
4754303|NCT02898116|ALK-rearranged|alk-rearranged
4754304|NCT02898116|ALK-positive|alk-positive
4754305|NCT02898116|ALK Inhibitor|alk inhibitor
4754306|NCT02898116|Ensartinib|ensartinib
4754307|NCT02898116|X-396|x-396
4754308|NCT02898116|anti-PD-L1|anti-pd-l1
4754309|NCT02898116|Durvalumab|durvalumab
4754310|NCT02898116|MEDI4736|medi4736
4754311|NCT02898116|ALK|alk
4754312|NCT02898090|Quality indicators|quality indicators
4754313|NCT02898090|Appropriateness|appropriateness
4754314|NCT02898090|Oral anticoagulant prescriptions|oral anticoagulant prescriptions
4754315|NCT02898090|Development and validation|development and validation
4754316|NCT02898090|Hospital information system|hospital information system
4754317|NCT02898090|Information Storage and Retrieval|information storage and retrieval
4754318|NCT02898090|Natural Language Processing|natural language processing
4754319|NCT02898077|Second line|second line
4754320|NCT02898077|Angiogenesis|angiogenesis
4754321|NCT02898077|Vascular endothelial growth factor receptor 2|vascular endothelial growth factor receptor 2
4754322|NCT02898051|heparin low-molecular-weight;pharmacokinetics|heparin low-molecular-weight;pharmacokinetics
4754323|NCT02898012|Glioblastoma Multiforme|glioblastoma multiforme
4754324|NCT02898012|temozolomide|temozolomide
4754325|NCT02898012|bevacizumab|bevacizumab
4754326|NCT02897973|Spinal loads|spinal loads
4754327|NCT02897973|Trunk muscle force|trunk muscle force
4754328|NCT02897973|Computational modeling|computational modeling
4754329|NCT02897973|Unilateral lower limb amputation|unilateral lower limb amputation
4754330|NCT02897960|wheezing|wheezing
4754331|NCT02897960|bronchiolitis|bronchiolitis
4754332|NCT02897960|respiratory sound algorithm|respiratory sound algorithm
4754333|NCT02897947|Lumbosacral Region|lumbosacral region
4754334|NCT02897947|Surgery|surgery
4754335|NCT02897947|Registries|registries
4754336|NCT02897895|Lung transplantation in end-stage lung diseases|lung transplantation in end-stage lung diseases
4754337|NCT02897843|Electroconvulsive Therapy|electroconvulsive therapy
4754338|NCT02897843|Transcranial Direct Current Stimulation|transcranial direct current stimulation
4754339|NCT02897843|cognition|cognition
4754340|NCT02897817|Methotrexate|methotrexate
4754341|NCT02897817|Treatment adherence|treatment adherence
4754342|NCT02897804|multiphase optimization strategy|multiphase optimization strategy
4754343|NCT02897804|college students|college students
4754344|NCT02897778|entinostat|entinostat
4754345|NCT02897778|solid tumor|solid tumor
4754346|NCT02897778|Histone Deacetylase Inhibitors|histone deacetylase inhibitors
4754347|NCT02897765|Checkpoint Inhibitor|checkpoint inhibitor
4754348|NCT02897765|Immunotherapy|immunotherapy
4754349|NCT02897765|Personal Vaccine|personal vaccine
4754350|NCT02897765|Neoantigen|neoantigen
4754351|NCT02897765|Poly-ICLC|poly-iclc
4754352|NCT02897765|Peptide|peptide
4754353|NCT02897752|stroke|stroke
4754354|NCT02897752|Rehabilitation|rehabilitation
4754355|NCT02897752|WalkAide (WA)|walkaide (wa)
4754356|NCT02897752|Functional Electrical Stimulation (FES)|functional electrical stimulation (fes)
4754357|NCT02897713|mechanical ventilation|mechanical ventilation
4754358|NCT02897713|enteral nutrition|enteral nutrition
4754359|NCT02897713|feeding intolerance|feeding intolerance
4754360|NCT02897700|Chemotherapy|chemotherapy
4754361|NCT02897700|Safety|safety
4754362|NCT02897700|Tolerability|tolerability
4754363|NCT02897700|Efficacy|efficacy
4754364|NCT02897687|Autism Spectrum Disorder|autism spectrum disorder
4754365|NCT02897687|Social Skills|social skills
4754366|NCT02897687|Social Media|social media
4754367|NCT02897661|fecal microbiota transplantation|fecal microbiota transplantation
4754368|NCT02897661|enteral nutrition|enteral nutrition
4754369|NCT02897622|Eating disorders|eating disorders
4754370|NCT02897622|severe and enduring|severe and enduring
4754371|NCT02897622|quality of life|quality of life
4754372|NCT02897622|case management|case management
4754373|NCT02897609|Beta-lactamine|beta-lactamine
4754374|NCT02897609|β-lactamine|β-lactamine
4754375|NCT02897570|ghrelin|ghrelin
4754376|NCT02897570|breakfast meal|breakfast meal
4754377|NCT02897570|P-300|p-300
4754378|NCT02897531|Ileocolic, stapled, laparoscopy, right hemicolectomy|ileocolic, stapled, laparoscopy, right hemicolectomy
4754379|NCT02897518|Videolaryngoscopes|videolaryngoscopes
4754380|NCT02897518|Intubation|intubation
4754381|NCT02897505|post traumatic stress disorder (PTSD)|post traumatic stress disorder (ptsd)
4754382|NCT02897466|ventilator-associated pneumonia|ventilator-associated pneumonia
4754383|NCT02897466|Multidrug-resistant bacteria|multidrug-resistant bacteria
4754384|NCT02897440|Femoral Neck Fracture|femoral neck fracture
4754385|NCT02897440|Hip Arthroplasty|hip arthroplasty
4754386|NCT02897440|Repairing of soft tissue|repairing of soft tissue
4754387|NCT02897427|Oropharyngeal cancer|oropharyngeal cancer
4754388|NCT02897427|Anal cancer|anal cancer
4754389|NCT02897427|Penile cancer|penile cancer
4754390|NCT02897427|Human papillomavirus|human papillomavirus
4754391|NCT02897427|HPV|hpv
4754392|NCT02897427|HPV 16 E antigens|hpv 16 e antigens
4754393|NCT02897427|Oropharyngeal cancer screening|oropharyngeal cancer screening
4754394|NCT02897427|Dysplasia|dysplasia
4754395|NCT02897427|Ultrasound scans of throat and the lymph nodes in neck|ultrasound scans of throat and the lymph nodes in neck
4754396|NCT02897427|Anal cancer screening|anal cancer screening
4754397|NCT02897427|Anal pap test|anal pap test
4754398|NCT02897427|High-resolution anoscopy|high-resolution anoscopy
4754399|NCT02897427|HRA|hra
4754400|NCT02897427|Penile cancer screening|penile cancer screening
4754401|NCT02897401|urinary N'Nitrosonornicotine|urinary n'nitrosonornicotine
4754402|NCT02897401|nicotine|nicotine
4754403|NCT02897401|electronic cigarette|electronic cigarette
4754404|NCT02897401|nicotine remplacement treatment|nicotine remplacement treatment
4754405|NCT02897362|ADHD|adhd
4754406|NCT02897362|Sleep|sleep
4754407|NCT02897362|Adolescents|adolescents
4754408|NCT02897362|Neurocognition|neurocognition
4754409|NCT02897362|Polysomnography|polysomnography
4754410|NCT02897310|critically ill patients|critically ill patients
4754411|NCT02897310|acute kidney injury|acute kidney injury
4754412|NCT02897310|renal replacement therapy|renal replacement therapy
4754413|NCT02897310|long term outcome|long term outcome
4754414|NCT02897284|Mindfulness-based|mindfulness-based
4754415|NCT02897284|Self-care|self-care
4754416|NCT02897284|Health workers|health workers
4754417|NCT02897284|Epigenetics|epigenetics
4754418|NCT02897271|Eosinophilic Gastrointestinal Disorders|eosinophilic gastrointestinal disorders
4754419|NCT02897258|Dialysis|dialysis
4754420|NCT02897258|Thrombosis|thrombosis
4754421|NCT02897258|Haemorrhage|haemorrhage
4754422|NCT02897245|Myelogenous|myelogenous
4754423|NCT02897245|Chronic|chronic
4754424|NCT02897245|BCR-ABL Positive|bcr-abl positive
4754425|NCT02897232|Human Papillomavirus Vaccine|human papillomavirus vaccine
4754426|NCT02897232|HPV|hpv
4754427|NCT02897232|Patient Acceptance|patient acceptance
4754428|NCT02897232|Physician Comfort|physician comfort
4754429|NCT02897232|Male Vaccination|male vaccination
4754430|NCT02897232|HPV Associated Cancers|hpv associated cancers
4754431|NCT02897219|SGLT2 inhibitor|sglt2 inhibitor
4754432|NCT02897219|ASP1941|asp1941
4754433|NCT02897219|type 1 diabetes mellitus|type 1 diabetes mellitus
4754434|NCT02897206|Acute pancreatitis|acute pancreatitis
4754435|NCT02897206|Antibiotic prophylaxis|antibiotic prophylaxis
4754436|NCT02897206|Imipenem-cilastatin|imipenem-cilastatin
4754437|NCT02897206|Infected pancreatic necrosis|infected pancreatic necrosis
4754438|NCT02897206|Infection|infection
4754439|NCT02897206|Organ failure|organ failure
4754440|NCT02897180|tuberculosis|tuberculosis
4754441|NCT02897180|latent tuberculosis infection|latent tuberculosis infection
4754442|NCT02897180|Food supplement|food supplement
4754443|NCT02897180|Mycobacterium manresensis|mycobacterium manresensis
4754444|NCT02897180|Nyaditum resae|nyaditum resae
4754445|NCT02897180|Efficacy trial|efficacy trial
4754446|NCT02897167|Psychosis|psychosis
4754447|NCT02897167|Antipsychotic Agents|antipsychotic agents
4754448|NCT02897167|Immunology|immunology
4754449|NCT02897167|Schizophrenia Spectrum and Other Psychotic Disorders|schizophrenia spectrum and other psychotic disorders
4754451|NCT02897141|Health Management App|health management app
4754452|NCT02897141|HIV symptoms|hiv symptoms
4754453|NCT02897128|Sarcoma|sarcoma
4754454|NCT02897128|Radiation|radiation
4754455|NCT02897128|Wound healing|wound healing
4754456|NCT02897115|Axial Spondyloarthritis|axial spondyloarthritis
4754457|NCT02897115|Humira|humira
4754458|NCT02897089|universal adhesive|universal adhesive
4754459|NCT02897089|fissure sealants|fissure sealants
4754460|NCT02897089|retention|retention
4754461|NCT02897063|midodrine|midodrine
4754462|NCT02897063|droxidopa|droxidopa
4754463|NCT02897063|splanchnic circulation|splanchnic circulation
4754464|NCT02897037|Bivalirudin|bivalirudin
4754465|NCT02897037|Acute myocardial infarction|acute myocardial infarction
4754466|NCT02897037|percutaneous transluminal coronary angioplasty|percutaneous transluminal coronary angioplasty
4754467|NCT02897024|Cerebral Palsy|cerebral palsy
4754468|NCT02897024|Motor Impairments|motor impairments
4754469|NCT02896985|Patient Reported Outcome 2 (PRO 2)|patient reported outcome 2 (pro 2)
4754470|NCT02896985|C-Reactive Protein (CRP)|c-reactive protein (crp)
4754471|NCT02896985|Adalimumab|adalimumab
4754472|NCT02896985|Harvey Bradshaw Index (HBI)|harvey bradshaw index (hbi)
4754473|NCT02896985|Therapeutic Drug Monitoring (TDM)|therapeutic drug monitoring (tdm)
4754474|NCT02896985|Anti-Adalimumab Antibody (AAA)|anti-adalimumab antibody (aaa)
4754475|NCT02896972|vitrectomy|vitrectomy
4754476|NCT02896972|macular hole retinal detachment|macular hole retinal detachment
4754477|NCT02896972|high myopia|high myopia
4754478|NCT02896920|Hidradenitis Suppurativa (HS)|hidradenitis suppurativa (hs)
4754479|NCT02896920|Humira®|humira®
4754480|NCT02896920|Canada|canada
4754481|NCT02896816|Parkinson's|parkinson's
4754482|NCT02896803|Pancreatic Cancer|pancreatic cancer
4754483|NCT02896803|Chemotherapy|chemotherapy
4754484|NCT02896790|Cancer|cancer
4754485|NCT02896790|Oral Therapy|oral therapy
4754486|NCT02896790|Compliance|compliance
4754487|NCT02896790|Anthropology|anthropology
4754488|NCT02896790|Psychology|psychology
4754489|NCT02896777|pH|ph
4754490|NCT02896777|IVF|ivf
4754491|NCT02896777|live birth rate|live birth rate
4754492|NCT02896751|CPAP|cpap
4754493|NCT02896751|Noninvasive Ventilation Mask|noninvasive ventilation mask
4754494|NCT02896725|Venous leg ulcer|venous leg ulcer
4754495|NCT02896725|Acellular skin substitutes|acellular skin substitutes
4754496|NCT02896725|Keratin dressings|keratin dressings
4754497|NCT02896699|Pre-exposure prophylaxis (PrEP)|pre-exposure prophylaxis (prep)
4754498|NCT02896699|diffusion of innovation|diffusion of innovation
4754499|NCT02896699|men who have sex with men|men who have sex with men
4754500|NCT02896699|LGBT|lgbt
4754501|NCT02896699|African American|african american
4754502|NCT02896699|Black|black
4754503|NCT02896699|HIV|hiv
4754504|NCT02896699|network analysis|network analysis
4754505|NCT02896699|network intervention|network intervention
4754506|NCT02896686|Ileostomy closure|ileostomy closure
4754507|NCT02896686|Polypropylene Mesh|polypropylene mesh
4754508|NCT02896686|Incisional hernia|incisional hernia
4754509|NCT02896673|positive expiratory pressure (PEP)|positive expiratory pressure (pep)
4754510|NCT02896673|Acute Respiratory Distress Syndrome (ARDS)|acute respiratory distress syndrome (ards)
4754511|NCT02896673|electrical impedance tomography (EIT)|electrical impedance tomography (eit)
4754512|NCT02896673|tidal volume (TV)|tidal volume (tv)
4754513|NCT02896673|transpulmonary pressure (TPP)|transpulmonary pressure (tpp)
4754514|NCT02896621|Sleep Apnea|sleep apnea
4754515|NCT02896621|Hypertension|hypertension
4754516|NCT02896621|Chlortalidone|chlortalidone
4754517|NCT02896621|Diastolic function|diastolic function
4754518|NCT02896569|resurfacing|resurfacing
4754519|NCT02896569|ablation|ablation
4754520|NCT02896556|image analysis|image analysis
4754521|NCT02896543|dendritic cells|dendritic cells
4754522|NCT02896543|P-selectin|p-selectin
4754523|NCT02896504|Chemobrain|chemobrain
4754524|NCT02896504|Chemotherapy|chemotherapy
4754525|NCT02896504|Hormonal Therapy|hormonal therapy
4754526|NCT02896504|Neuroimaging|neuroimaging
4754527|NCT02896465|Children|children
4754528|NCT02896465|Diarrhea|diarrhea
4754529|NCT02896465|Human milk oligosaccharides|human milk oligosaccharides
4754530|NCT02896439|Traumatic|traumatic
4754531|NCT02896439|Acetabular|acetabular
4754532|NCT02896426|Parent training|parent training
4754533|NCT02896426|Preschoolers|preschoolers
4754534|NCT02896426|Behavior problems|behavior problems
4754535|NCT02896426|Oppositional Defiant Disorder|oppositional defiant disorder
4754536|NCT02896426|ODD|odd
4754537|NCT02896426|Conduct Disorder|conduct disorder
4754538|NCT02896426|CD|cd
4754539|NCT02896426|Children|children
4754540|NCT02896426|Parenting|parenting
4754541|NCT02896426|Collaborative Problem Solving|collaborative problem solving
4754542|NCT02896426|CPS|cps
4754543|NCT02896426|Disruptive behavior|disruptive behavior
4754544|NCT02896348|Hemiparesis|hemiparesis
4754545|NCT02896348|Stroke|stroke
4754546|NCT02896348|Rehabilitation|rehabilitation
4754547|NCT02896348|Home-based|home-based
4754548|NCT02896335|Recurrent Brain metastases|recurrent brain metastases
4754549|NCT02896283|wound healing|wound healing
4754550|NCT02896283|low-level laser therapy|low-level laser therapy
4754551|NCT02896283|gingival recession|gingival recession
4754552|NCT02896270|idiopathic podocytopathies|idiopathic podocytopathies
4754553|NCT02896270|Neprology|neprology
4754554|NCT02896257|Quality Improvement|quality improvement
4754555|NCT02896257|Quality Enhancement Research Initiatives|quality enhancement research initiatives
4754557|NCT02896257|Interventional|interventional
4754558|NCT02896257|Multicenter|multicenter
4754559|NCT02896257|Inhaled corticosteroids|inhaled corticosteroids
4754560|NCT02896257|Pneumonia|pneumonia
4754561|NCT02896257|Safety|safety
4754563|NCT02896257|Respiratory Tract Diseases|respiratory tract diseases
4754564|NCT02896257|Lung Diseases|lung diseases
4754565|NCT02896257|Lung Diseases, Obstructive|lung diseases, obstructive
4754566|NCT02896257|Pulmonary Diseases, Chronic Obstructive COPD|pulmonary diseases, chronic obstructive copd
4754567|NCT02896244|Clostridium difficile|clostridium difficile
4754568|NCT02896244|Clostridium difficile infection|clostridium difficile infection
4754569|NCT02896244|antibiotics|antibiotics
4754570|NCT02896244|antibiotics associated diarrhea|antibiotics associated diarrhea
4754571|NCT02896244|microbiome|microbiome
4754572|NCT02896244|microbiota|microbiota
4754573|NCT02896218|Vancomycin|vancomycin
4754574|NCT02896218|Critically Ill|critically ill
4754575|NCT02896218|Pharmacist|pharmacist
4754576|NCT02896218|Population Pharmacokinetic|population pharmacokinetic
4754577|NCT02896218|Bayesian Methods|bayesian methods
4754578|NCT02896192|POMC deficiency obesity|pomc deficiency obesity
4754579|NCT02896192|PCSK1 deficiency obesity|pcsk1 deficiency obesity
4754580|NCT02896179|Multiple sclerosis|multiple sclerosis
4754581|NCT02896179|Gait rehabilitation|gait rehabilitation
4754582|NCT02896179|Quality of life|quality of life
4754583|NCT02896179|Virtual reality|virtual reality
4754584|NCT02896179|Cognitive deficit|cognitive deficit
4754585|NCT02896179|Robot assisted gait training|robot assisted gait training
4754586|NCT02896166|nsclc and stage I and microwave ablation|nsclc and stage i and microwave ablation
4754587|NCT02896140|Type 2 diabetes|type 2 diabetes
4754588|NCT02896140|Obesity|obesity
4754589|NCT02896140|Nutrition|nutrition
4754590|NCT02896140|Dairy|dairy
4754591|NCT02896127|Ankylosing Spondyloarthritis|ankylosing spondyloarthritis
4754592|NCT02896127|Axial spondyloarthritis|axial spondyloarthritis
4754593|NCT02896101|Mild to moderate|mild to moderate
4754594|NCT02896075|delayed onset muscle soreness|delayed onset muscle soreness
4754595|NCT02896075|laughter|laughter
4754596|NCT02896049|neoplasms|neoplasms
4754597|NCT02896049|hyperthermia|hyperthermia
4754598|NCT02896036|Laparoscopic Entry|laparoscopic entry
4754599|NCT02896036|Veress Needle|veress needle
4754600|NCT02896036|Intraperitoneal insufflation|intraperitoneal insufflation
4754601|NCT02896036|Time|time
4754602|NCT02896036|Complications|complications
4754603|NCT02896023|predictors|predictors
4754604|NCT02896023|ovarian reserve|ovarian reserve
4754605|NCT02896023|infertile women|infertile women
4754606|NCT02896010|Mobile Health|mobile health
4754607|NCT02895997|mental fatigue|mental fatigue
4754608|NCT02895997|critical care|critical care
4754609|NCT02895984|Social network analysis|social network analysis
4754610|NCT02895984|Brief Motivational Interviewing|brief motivational interviewing
4754611|NCT02895984|College Students|college students
4754612|NCT02895971|Venous Thromboembolism|venous thromboembolism
4754613|NCT02895971|professional Practices|professional practices
4754614|NCT02895906|22q11.2 DS|22q11.2 ds
4754615|NCT02895880|Communication Tool|communication tool
4754616|NCT02895880|Cancer Survivors|cancer survivors
4754617|NCT02895880|Increase Statin|increase statin
4754618|NCT02895880|16-1128|16-1128
4754619|NCT02895854|Low risk prostate cancer|low risk prostate cancer
4754620|NCT02895854|Intermediate risk prostate cancer|intermediate risk prostate cancer
4754621|NCT02895854|Low dose-rate brachytherapy|low dose-rate brachytherapy
4754622|NCT02895854|Hypofractionated|hypofractionated
4754623|NCT02895854|Robotic external beam radiation|robotic external beam radiation
4754624|NCT02895854|Quality of life|quality of life
4754625|NCT02895841|oncology|oncology
4754626|NCT02895841|bone marrow transplant|bone marrow transplant
4754627|NCT02895841|sickle cell disease|sickle cell disease
4754628|NCT02895802|down syndrome|down syndrome
4754629|NCT02895789|spinal muscular atrophy|spinal muscular atrophy
4754630|NCT02895789|oxidative capacity|oxidative capacity
4754631|NCT02895789|exercise tolerance|exercise tolerance
4754632|NCT02895789|mitochondrial myopathy|mitochondrial myopathy
4754633|NCT02895789|SMA|sma
4754634|NCT02895789|six minute walk test|six minute walk test
4754635|NCT02895789|neuromuscular disease|neuromuscular disease
4754636|NCT02895789|ambulation|ambulation
4754637|NCT02895789|exercise|exercise
4754638|NCT02895789|mitochondria|mitochondria
4754639|NCT02895789|cycle ergometry|cycle ergometry
4754640|NCT02895789|near infrared spectroscopy|near infrared spectroscopy
4754641|NCT02895763|QUALITY OF LIFE|quality of life
4754642|NCT02895763|NEUROMUSCULAR DISEASES|neuromuscular diseases
4754643|NCT02895750|diabetes type 2|diabetes type 2
4754644|NCT02895750|Metformin|metformin
4754645|NCT02895750|chronic kidney disease|chronic kidney disease
4754646|NCT02895750|CKD|ckd
4754647|NCT02895737|aortic stenosis, transcatheter aortic valve replacement, stroke, ischemic infarction, cerebral embolic protection device|aortic stenosis, transcatheter aortic valve replacement, stroke, ischemic infarction, cerebral embolic protection device
4754648|NCT02895724|Hyperbaric oxygen therapy|hyperbaric oxygen therapy
4754649|NCT02895724|secondary lymphedema|secondary lymphedema
4754650|NCT02895698|Cupping|cupping
4754651|NCT02895698|Dry cupping|dry cupping
4754652|NCT02895698|Myofascial trigger points|myofascial trigger points
4754653|NCT02895685|Simulation|simulation
4754654|NCT02895685|Self-regulated training|self-regulated training
4754655|NCT02895685|Education|education
4754656|NCT02895685|Open surgery|open surgery
4754657|NCT02895685|Dyad training|dyad training
4754658|NCT02895659|fluid management|fluid management
4754659|NCT02895659|critical illness|critical illness
4754660|NCT02895659|hemodynamics|hemodynamics
4754661|NCT02895659|buffered infusates|buffered infusates
4754662|NCT02895633|MR imaging|mr imaging
4754663|NCT02895633|Diffusion weighted imaging|diffusion weighted imaging
4754664|NCT02895633|MR proton spectroscopy|mr proton spectroscopy
4754665|NCT02895633|CT perfusion|ct perfusion
4754666|NCT02895633|Contrast enhanced ultrasound|contrast enhanced ultrasound
4754667|NCT02895568|Antimalarial drug|antimalarial drug
4754668|NCT02895568|Resistance|resistance
4754669|NCT02895568|Republic of Chard|republic of chard
4754670|NCT02895555|ODI|odi
4754671|NCT02895503|Stage IA Non-Small Cell Lung Carcinoma|stage ia non-small cell lung carcinoma
4754672|NCT02895503|Stage IB Non-Small Cell Lung Carcinoma|stage ib non-small cell lung carcinoma
4754673|NCT02895503|Stage IIA Non-Small Cell Lung Carcinoma|stage iia non-small cell lung carcinoma
4754674|NCT02895503|Stage IIB Non-Small Cell Lung Carcinoma|stage iib non-small cell lung carcinoma
4754675|NCT02895503|Stage IIIA Non-Small Cell Lung Cancer|stage iiia non-small cell lung cancer
4754676|NCT02895503|Stage IIIB Non-Small Cell Lung Cancer|stage iiib non-small cell lung cancer
4754677|NCT02895503|Stage IV Non-Small Cell Lung Cancer|stage iv non-small cell lung cancer
4754678|NCT02895451|Exercise-based cardiac rehabilitation|exercise-based cardiac rehabilitation
4754679|NCT02895451|Physical capacity|physical capacity
4754680|NCT02895451|Adherence|adherence
4754681|NCT02895451|Behavioral medicine|behavioral medicine
4754682|NCT02895438|Gluten-Sensitive|gluten-sensitive
4754683|NCT02895438|Diet, Gluten-Free|diet, gluten-free
4754684|NCT02895438|Irritable Bowel Syndrome|irritable bowel syndrome
4754685|NCT02895438|non Coeliac Gluten sensitivity|non coeliac gluten sensitivity
4754686|NCT02895438|children|children
4754687|NCT02895425|Renal Transplant|renal transplant
4754688|NCT02895386|Hypertension|hypertension
4754689|NCT02895386|High Blood Pressure|high blood pressure
4754690|NCT02895386|Systolic Blood Pressure|systolic blood pressure
4754691|NCT02895386|Uncontrolled Hypertension|uncontrolled hypertension
4754692|NCT02895386|Essential Hypertension|essential hypertension
4754693|NCT02895386|Resistant Hypertension|resistant hypertension
4754694|NCT02895386|Vascular Disease|vascular disease
4754695|NCT02895373|platelet inhibition|platelet inhibition
4754696|NCT02895373|alprostadil|alprostadil
4754697|NCT02895373|extracorporeal membrane oxygenation|extracorporeal membrane oxygenation
4754698|NCT02895373|bleeding|bleeding
4754699|NCT02895373|thromboembolic|thromboembolic
4754700|NCT02895334|CHD|chd
4754701|NCT02895334|Congenital Heart Disease|congenital heart disease
4754702|NCT02895321|nano-hydroxyapatite|nano-hydroxyapatite
4754703|NCT02895321|potassium nitrate|potassium nitrate
4754704|NCT02895308|compliance|compliance
4754705|NCT02895295|Medicare Part D|medicare part d
4754706|NCT02895295|decision support|decision support
4754707|NCT02895295|prescription drugs|prescription drugs
4754708|NCT02895295|expert recommendation|expert recommendation
4754709|NCT02895295|health insurance choice|health insurance choice
4754710|NCT02895282|Obesity|obesity
4754711|NCT02895282|Chronobiology|chronobiology
4754712|NCT02895282|Circadian|circadian
4754713|NCT02895269|Complementary Alternative Providers|complementary alternative providers
4754714|NCT02895269|Collaborative Shared Care|collaborative shared care
4754715|NCT02895269|Primary Health Care Providers|primary health care providers
4754716|NCT02895269|Psychosis|psychosis
4754717|NCT02895230|Androgen-deprivation therapy|androgen-deprivation therapy
4754718|NCT02895230|Prostate cancer|prostate cancer
4754719|NCT02895230|Nationwide population-based cohort|nationwide population-based cohort
4754720|NCT02895230|Myocardial infarction|myocardial infarction
4754721|NCT02895230|Ischemic stroke|ischemic stroke
4754722|NCT02895217|Energy expenditure|energy expenditure
4754723|NCT02895217|Food intake|food intake
4754724|NCT02895217|Women|women
4754725|NCT02895217|aquacycling|aquacycling
4754726|NCT02895204|Fermented Maillard reacted whey protein|fermented maillard reacted whey protein
4754727|NCT02895204|Natural killer cell activity|natural killer cell activity
4754728|NCT02895204|Immune function|immune function
4754729|NCT02895204|Pre-albumin|pre-albumin
4754730|NCT02895204|Interleukin-12|interleukin-12
4754731|NCT02895178|Breast cancer|breast cancer
4754732|NCT02895178|Survivors|survivors
4754733|NCT02895178|Exercise|exercise
4754734|NCT02895165|breast neoplasms|breast neoplasms
4754735|NCT02895165|fertility preservation|fertility preservation
4754736|NCT02895165|pregnancy|pregnancy
4754737|NCT02895152|COPD|copd
4754738|NCT02895152|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
4754739|NCT02895152|Pulmonary Rehabilitation|pulmonary rehabilitation
4754740|NCT02895152|Activity Monitors|activity monitors
4754741|NCT02895152|Fitbit|fitbit
4754742|NCT02895152|Fitness Tracker|fitness tracker
4754743|NCT02895139|Additive Manufacture|additive manufacture
4754744|NCT02895139|Orthotic Insole|orthotic insole
4754745|NCT02895126|vulnerable family|vulnerable family
4754746|NCT02895113|Aspirin|aspirin
4754747|NCT02895113|Diabetes|diabetes
4754748|NCT02895113|Renal function|renal function
4754749|NCT02895113|Thromboxane|thromboxane
4754750|NCT02895100|ulcerative colitis|ulcerative colitis
4754751|NCT02895100|inflammatory bowel disease|inflammatory bowel disease
4754752|NCT02895100|PROPEL|propel
4754753|NCT02895100|Propel Study|propel study
4754754|NCT02895087|diurnal variation|diurnal variation
4754755|NCT02895087|stress|stress
4754756|NCT02895074|femtosecond laser-assisted cataract surgery (FLACS)|femtosecond laser-assisted cataract surgery (flacs)
4754757|NCT02895074|subfoveal choroidal thickness (SFCT)|subfoveal choroidal thickness (sfct)
4754758|NCT02895074|conventional phacoemulsification surgery (CPS)|conventional phacoemulsification surgery (cps)
4754759|NCT02895009|Coronary Disease|coronary disease
4754760|NCT02895009|Radial artery occlusion|radial artery occlusion
4754761|NCT02895009|transradial coronary intervention|transradial coronary intervention
4754762|NCT02894996|pediatric|pediatric
4754763|NCT02894996|anesthesia|anesthesia
4754764|NCT02894996|fluid responsiveness|fluid responsiveness
4754765|NCT02894996|hemodynamic|hemodynamic
4754766|NCT02894983|wrist fracture|wrist fracture
4754767|NCT02894983|colles fracture|colles fracture
4754768|NCT02894983|non-operative|non-operative
4754769|NCT02894983|rehabilitation|rehabilitation
4754770|NCT02894944|Pancreatic cancer|pancreatic cancer
4754771|NCT02894944|Adenovirus|adenovirus
4754772|NCT02894944|Gene therapy|gene therapy
4754773|NCT02894931|macrophage atherogenicity|macrophage atherogenicity
4754774|NCT02894931|dietary interventions|dietary interventions
4754775|NCT02894931|sugars|sugars
4754776|NCT02894931|amino acids|amino acids
4754777|NCT02894931|artificial sweeteners|artificial sweeteners
4754778|NCT02894931|atherosclerosis|atherosclerosis
4754779|NCT02894892|Electron Microscopy|electron microscopy
4754780|NCT02894892|Helicobacter pylori|helicobacter pylori
4754781|NCT02894892|Bismuth|bismuth
4754782|NCT02894879|Postoperative pulmonary complications|postoperative pulmonary complications
4754783|NCT02894866|hypoxic-ischemic encephalopathy|hypoxic-ischemic encephalopathy
4754784|NCT02894866|hyperbaric oxygen therapy|hyperbaric oxygen therapy
4754785|NCT02894840|GPO Tri Fluvac Vaccine|gpo tri fluvac vaccine
4754786|NCT02894840|Tri Fluvac Vaccine|tri fluvac vaccine
4754787|NCT02894814|Self administration|self administration
4754788|NCT02894814|Medication|medication
4754789|NCT02894814|Inpatient|inpatient
4754790|NCT02894814|Self-care|self-care
4754791|NCT02894814|Self-management|self-management
4754792|NCT02894814|Medical patients|medical patients
4754793|NCT02894749|hybrid rooms|hybrid rooms
4754794|NCT02894749|cone-beam computed tomography|cone-beam computed tomography
4754795|NCT02894723|Hypertension,|hypertension,
4754796|NCT02894723|Nitric Oxide|nitric oxide
4754797|NCT02894723|L-Arginine|l-arginine
4754798|NCT02894723|Arterial Stiffness|arterial stiffness
4754799|NCT02894723|Ambulatory blood pressure measurement|ambulatory blood pressure measurement
4754800|NCT02894710|postoperative pain|postoperative pain
4754801|NCT02894710|intravenous lidocaine|intravenous lidocaine
4754802|NCT02894710|chronic post-surgical pain|chronic post-surgical pain
4754803|NCT02894710|remifentanil|remifentanil
4754804|NCT02894710|patient controlled analgesia|patient controlled analgesia
4754805|NCT02894710|morphine consumption|morphine consumption
4754806|NCT02894710|ENT surgery|ent surgery
4754807|NCT02894632|MRI|mri
4754808|NCT02894632|Motion|motion
4754809|NCT02894632|Respiratory movement|respiratory movement
4754810|NCT02894632|Artifacts correction|artifacts correction
4754811|NCT02894619|urinary incontinence|urinary incontinence
4754812|NCT02894619|anal incontinence|anal incontinence
4754813|NCT02894619|sexuality|sexuality
4754814|NCT02894619|quality of life|quality of life
4754815|NCT02894606|Kidney Transplant|kidney transplant
4754816|NCT02894606|Immunology|immunology
4754817|NCT02894593|Antiplaque agents|antiplaque agents
4754818|NCT02894593|chemical plaque control|chemical plaque control
4754819|NCT02894593|oral hygiene|oral hygiene
4754820|NCT02894593|essential oils|essential oils
4754821|NCT02894593|alcohol|alcohol
4754822|NCT02894593|mouthwash|mouthwash
4754823|NCT02894541|Dyslipidemia|dyslipidemia
4754824|NCT02894541|CKD-519|ckd-519
4754825|NCT02894541|CETP inhibitor|cetp inhibitor
4754826|NCT02894541|Food Drug Interaction|food drug interaction
4754827|NCT02894528|Alveolar ridge|alveolar ridge
4754828|NCT02894528|guided bone regeneration|guided bone regeneration
4754829|NCT02894528|bone grafts|bone grafts
4754830|NCT02894502|Self-care|self-care
4754831|NCT02894502|Motivational interviewing|motivational interviewing
4754832|NCT02894502|Heart failure|heart failure
4754833|NCT02894502|Caregivers|caregivers
4754834|NCT02894476|satisfaction with care|satisfaction with care
4754835|NCT02894476|outpatient care|outpatient care
4754836|NCT02894476|self-reported health status|self-reported health status
4754837|NCT02894476|alcohol dependence|alcohol dependence
4754838|NCT02894476|opioid dependence|opioid dependence
4754839|NCT02894463|dental care|dental care
4754840|NCT02894463|emeno|emeno
4754841|NCT02894463|abuse|abuse
4754842|NCT02894450|Atrial fibrillation|atrial fibrillation
4754843|NCT02894450|oral anticoagulant|oral anticoagulant
4754844|NCT02894450|bioassay|bioassay
4754845|NCT02894450|elderly subject|elderly subject
4754846|NCT02894437|prevention|prevention
4754847|NCT02894437|organization|organization
4754848|NCT02894437|pressure ulcers|pressure ulcers
4754849|NCT02894424|Inner limiting membrane|inner limiting membrane
4754850|NCT02894424|Microperimetry|microperimetry
4754851|NCT02894424|surgical's dye|surgical's dye
4754852|NCT02894411|MRI|mri
4754853|NCT02894411|Excyclotorsion|excyclotorsion
4754854|NCT02894398|HR+|hr+
4754855|NCT02894398|HER2-|her2-
4754856|NCT02894398|Locally advanced (inoperable or metastatic) Breast Cancer|locally advanced (inoperable or metastatic) breast cancer
4754857|NCT02894398|Palbociclib|palbociclib
4754858|NCT02894398|Aromatase inhibitor or fulvestrant|aromatase inhibitor or fulvestrant
4754859|NCT02894398|Pre-/perimenopausal receiving LHRH agonist / ovarian ablation|pre-/perimenopausal receiving lhrh agonist / ovarian ablation
4754860|NCT02894398|Postmenopausal|postmenopausal
4754861|NCT02894372|Oral spray|oral spray
4754862|NCT02894372|Topical sprays|topical sprays
4754863|NCT02894372|Faringomoss|faringomoss
4754864|NCT02894372|Local phytotherapy|local phytotherapy
4754865|NCT02894359|Cervical spine|cervical spine
4754866|NCT02894359|Musculoskeletal imagery|musculoskeletal imagery
4754867|NCT02894359|computer modelling of cervical spine|computer modelling of cervical spine
4754868|NCT02894359|ConeBeam.|conebeam.
4754869|NCT02894346|Motivation|motivation
4754870|NCT02894346|Teachers|teachers
4754871|NCT02894346|Physical activity|physical activity
4754872|NCT02894346|School|school
4754873|NCT02894333|Parkinson's disease|parkinson's disease
4754874|NCT02894333|Action-effect prediction|action-effect prediction
4754875|NCT02894333|Sensory attenuation|sensory attenuation
4754876|NCT02894333|Voluntary action|voluntary action
4754877|NCT02894320|Parkinson's disease|parkinson's disease
4754878|NCT02894320|Voluntary action|voluntary action
4754879|NCT02894320|Action-effect preactivation|action-effect preactivation
4754880|NCT02894320|Action-effect prediction|action-effect prediction
4754881|NCT02894307|Mechanical prosthesis|mechanical prosthesis
4754882|NCT02894307|Rivaroxaban|rivaroxaban
4754883|NCT02894294|malaria|malaria
4754884|NCT02894294|chemoprevention|chemoprevention
4754885|NCT02894294|season|season
4754886|NCT02894294|anemia|anemia
4754887|NCT02894294|impact|impact
4754888|NCT02894294|coverage|coverage
4754889|NCT02894294|children|children
4754890|NCT02894281|Pupillary light reflex|pupillary light reflex
4754891|NCT02894281|Multiple sclerosis|multiple sclerosis
4754892|NCT02894190|Non Invasive Ventilation (NIV)|non invasive ventilation (niv)
4754893|NCT02894190|Adherence|adherence
4754894|NCT02894190|Beliefs|beliefs
4754895|NCT02894190|Development|development
4754896|NCT02894190|Validation|validation
4754897|NCT02894177|E02.880.820.950|e02.880.820.950
4754898|NCT02894164|Cystatin C|cystatin c
4754899|NCT02894164|Creatinine|creatinine
4754900|NCT02894164|Glomerular Filtration Rate|glomerular filtration rate
4754901|NCT02894125|Chronic Low Back Pain|chronic low back pain
4754902|NCT02894125|Old subject|old subject
4754903|NCT02894125|SPA Therapy|spa therapy
4754904|NCT02894125|Pain|pain
4754905|NCT02894125|Function|function
4754906|NCT02894125|Expectations|expectations
4754907|NCT02894125|Fears|fears
4754908|NCT02894112|endothelial dependent vasodilation|endothelial dependent vasodilation
4754909|NCT02894112|blood flow|blood flow
4754910|NCT02894112|blood glucose|blood glucose
4754911|NCT02894112|triglycerides|triglycerides
4754912|NCT02894112|non-fat milk|non-fat milk
4754913|NCT02894112|dairy|dairy
4754914|NCT02894099|Aged|aged
4754915|NCT02894099|Sedentary Behaviour|sedentary behaviour
4754916|NCT02894099|Blood Glucose|blood glucose
4754917|NCT02894099|Insulin|insulin
4754918|NCT02894099|Inflammatory markers|inflammatory markers
4754919|NCT02894086|acute appendicitis|acute appendicitis
4754920|NCT02894086|ambulatory appendicectomy|ambulatory appendicectomy
4754921|NCT02894073|obese patients|obese patients
4754922|NCT02894073|peripheral venous catheter|peripheral venous catheter
4754923|NCT02894060|Cardiovascular events|cardiovascular events
4754924|NCT02894047|calcium-sensitive receptor|calcium-sensitive receptor
4754925|NCT02894034|optic nerve sheath|optic nerve sheath
4754926|NCT02894034|meningeal hemorrhage|meningeal hemorrhage
4754927|NCT02894034|early phase|early phase
4754928|NCT02894034|prognostic|prognostic
4754929|NCT02894021|padding|padding
4754930|NCT02894021|lymphoceles|lymphoceles
4754931|NCT02894021|prevention|prevention
4754932|NCT02893995|PAH|pah
4754933|NCT02893995|Subcutaneous Treprostinil|subcutaneous treprostinil
4754934|NCT02893995|Remodulin|remodulin
4754935|NCT02893995|6 Minute Walk Test|6 minute walk test
4754936|NCT02893969|Physical Activity|physical activity
4754937|NCT02893969|Rest|rest
4754938|NCT02893956|Echocardiography|echocardiography
4754939|NCT02893956|postural support|postural support
4754940|NCT02893956|preterm neonate|preterm neonate
4754941|NCT02893904|Propofol|propofol
4754942|NCT02893904|Sevoflurane|sevoflurane
4754943|NCT02893904|Bispectral Index|bispectral index
4754944|NCT02893904|Children|children
4754945|NCT02893904|Electroencephalographic signs|electroencephalographic signs
4754946|NCT02893891|Obesity|obesity
4754947|NCT02893891|Bariatric medicine|bariatric medicine
4754948|NCT02893891|Sleeve gastric resection|sleeve gastric resection
4754949|NCT02893891|Gastric plication|gastric plication
4754950|NCT02893891|Intragastric ballon|intragastric ballon
4754951|NCT02893891|Body composition|body composition
4754952|NCT02893891|Adipokines|adipokines
4754953|NCT02893891|Ghrelin|ghrelin
4754954|NCT02893891|Bone mineral density|bone mineral density
4754955|NCT02893891|Quality of life|quality of life
4754956|NCT02893878|Seasonal influenza vaccines|seasonal influenza vaccines
4754957|NCT02893878|Passive Enhanced Safety surveillance|passive enhanced safety surveillance
4754958|NCT02893878|England|england
4754959|NCT02893878|Pilot study|pilot study
4754960|NCT02893865|Apnea syndrome|apnea syndrome
4754961|NCT02893865|Coronary artery disease|coronary artery disease
4754962|NCT02893865|Oxidative stress|oxidative stress
4754963|NCT02893865|Continuous positive airway pressure|continuous positive airway pressure
4754964|NCT02893865|Endothelial dysfunction|endothelial dysfunction
4754965|NCT02893839|Allergy|allergy
4754966|NCT02893839|cross-reactivity|cross-reactivity
4754967|NCT02893839|oral allergy syndrome|oral allergy syndrome
4754968|NCT02893839|potato|potato
4754969|NCT02893839|sensitization|sensitization
4754970|NCT02893826|Aneurysm|aneurysm
4754971|NCT02893826|Ruptured|ruptured
4754972|NCT02893826|nimodipine|nimodipine
4754973|NCT02893826|subarachnoid hemorrhage|subarachnoid hemorrhage
4754974|NCT02893800|assistive technology|assistive technology
4754975|NCT02893800|dementia care|dementia care
4754976|NCT02893800|tracking technology|tracking technology
4754977|NCT02893800|locating systems|locating systems
4754978|NCT02893800|user experience|user experience
4754979|NCT02893787|Speckle Tracking|speckle tracking
4754980|NCT02893787|Anthracyclines|anthracyclines
4754981|NCT02893787|Chilhood cancers|chilhood cancers
4754982|NCT02893787|Myocardial function|myocardial function
4754983|NCT02893787|Echocardiography|echocardiography
4754984|NCT02893761|breast cancer|breast cancer
4754985|NCT02893761|survival|survival
4754986|NCT02893761|prognosis factors|prognosis factors
4754987|NCT02893748|colon|colon
4754988|NCT02893748|polyps|polyps
4754989|NCT02893748|cancer|cancer
4754990|NCT02893748|screening|screening
4754991|NCT02893735|Clinical Trial|clinical trial
4754992|NCT02893735|Composite resin|composite resin
4754993|NCT02893722|ivf ,atosiban,repeated implantation failure,RCT|ivf ,atosiban,repeated implantation failure,rct
4754994|NCT02893683|Paris Visual Learning Test|paris visual learning test
4754995|NCT02893683|visual memory|visual memory
4754996|NCT02893683|criterion validity|criterion validity
4754997|NCT02893657|MELD score|meld score
4754998|NCT02893657|hemodynamics|hemodynamics
4754999|NCT02893657|liver abnormalities|liver abnormalities
4755000|NCT02893566|overweight|overweight
4755001|NCT02893566|body mass index|body mass index
4755002|NCT02893566|university students|university students
4755003|NCT02893566|physical activity|physical activity
4755004|NCT02893566|sedentary behavior|sedentary behavior
4755005|NCT02893566|body composition|body composition
4755006|NCT02893566|Mi Band|mi band
4755007|NCT02893514|Drug Use|drug use
4755008|NCT02893488|dolutegravir|dolutegravir
4755009|NCT02893488|abacavir|abacavir
4755010|NCT02893488|relative bioavailability|relative bioavailability
4755011|NCT02893488|palatability|palatability
4755012|NCT02893488|GSK2619619|gsk2619619
4755013|NCT02893488|palatability questionnaire|palatability questionnaire
4755014|NCT02893488|lamivudine|lamivudine
4755015|NCT02893488|pediatric|pediatric
4755016|NCT02893488|calcium|calcium
4755017|NCT02893488|dispersible tablet|dispersible tablet
4755018|NCT02893462|data warehousing|data warehousing
4755019|NCT02893462|data aggregation|data aggregation
4755020|NCT02893462|data mining|data mining
4755021|NCT02893449|Parkinson|parkinson
4755022|NCT02893449|SAS-SR|sas-sr
4755023|NCT02893449|Social adaptation|social adaptation
4755024|NCT02893449|Patients suffering from Parkinson's disease|patients suffering from parkinson's disease
4755025|NCT02893423|Ropivacaine|ropivacaine
4755026|NCT02893423|C-Section Analgesia|c-section analgesia
4755027|NCT02893423|Tap Block|tap block
4755028|NCT02893358|Allisartan Isoproxil|allisartan isoproxil
4755029|NCT02893358|left ventricular hypertrophy|left ventricular hypertrophy
4755030|NCT02893358|large arterial stiffness|large arterial stiffness
4755031|NCT02893358|microalbuminuria|microalbuminuria
4755032|NCT02893345|Self Care (Rehabilitation)|self care (rehabilitation)
4755033|NCT02893345|Community Participation|community participation
4755034|NCT02893345|Patient-Centered Outcomes Research|patient-centered outcomes research
4755035|NCT02893345|Informatics, Clinical|informatics, clinical
4755036|NCT02893319|Infant Feeding|infant feeding
4755037|NCT02893319|Infant Growth|infant growth
4755038|NCT02893306|Type1 Diabetes Mellitus|type1 diabetes mellitus
4755039|NCT02893306|Multipotent stromal cell|multipotent stromal cell
4755040|NCT02893306|Mesenchymal stem cell|mesenchymal stem cell
4755041|NCT02893306|Insulin|insulin
4755042|NCT02893306|Pancreatic reserve|pancreatic reserve
4755043|NCT02893306|Disease progression|disease progression
4755044|NCT02893267|Stroke|stroke
4755045|NCT02893267|Shoulder Pain|shoulder pain
4755046|NCT02893267|Electrical stimulation|electrical stimulation
4755047|NCT02893267|Neuromuscular stimulation|neuromuscular stimulation
4755048|NCT02893267|Intramuscular stimulation|intramuscular stimulation
4755049|NCT02893267|Physical Therapy|physical therapy
4755050|NCT02893254|ankylosing spondylitis, tumor necrosis factor-α inhibitors|ankylosing spondylitis, tumor necrosis factor-α inhibitors
4755051|NCT02893228|forced expiratory volume in 1 second|forced expiratory volume in 1 second
4755052|NCT02893228|forced vital capacity|forced vital capacity
4755053|NCT02893228|peak expiratory flow rate|peak expiratory flow rate
4755054|NCT02893228|interscalene block|interscalene block
4755055|NCT02893228|diaphragmatic paresis|diaphragmatic paresis
4755056|NCT02893202|PTSD|ptsd
4755057|NCT02893202|Equine assisted activities|equine assisted activities
4755058|NCT02893202|quality of life|quality of life
4755059|NCT02893189|CD19+|cd19+
4755060|NCT02893189|allogeneic transplant|allogeneic transplant
4755061|NCT02893189|relapse|relapse
4755062|NCT02893176|Lung Transplant|lung transplant
4755063|NCT02893176|Macitentan|macitentan
4755064|NCT02893176|CLAD|clad
4755066|NCT02893176|bronchiolitis obliterans|bronchiolitis obliterans
4755067|NCT02893176|chronic lung allograft dysfunction|chronic lung allograft dysfunction
4755068|NCT02893176|Organ Rejection|organ rejection
4755069|NCT02893163|Metabolic Syndrome|metabolic syndrome
4755070|NCT02893163|Cancer Risk|cancer risk
4755071|NCT02893163|Lifestyle Interventions|lifestyle interventions
4755072|NCT02893163|Primary Care|primary care
4755073|NCT02893163|Behavioural Change|behavioural change
4755074|NCT02893150|Mindful Eating|mindful eating
4755075|NCT02893150|Overweight|overweight
4755076|NCT02893150|Primary Care|primary care
4755077|NCT02893150|Randomized Clinical Trial|randomized clinical trial
4755078|NCT02893137|Tumour treating fields|tumour treating fields
4755079|NCT02893137|Optune|optune
4755080|NCT02893137|Craniectomy|craniectomy
4755081|NCT02893137|TTFields|ttfields
4755082|NCT02893124|chronic hepatitis B|chronic hepatitis b
4755083|NCT02893111|neuromyelitis optica spectrum disorders|neuromyelitis optica spectrum disorders
4755084|NCT02893111|Bortezomib|bortezomib
4755085|NCT02893111|Velcade|velcade
4755086|NCT02893111|Proteasome inhibitor|proteasome inhibitor
4755087|NCT02893072|Diabetes, Gestational|diabetes, gestational
4755088|NCT02893072|Nutrition Therapy|nutrition therapy
4755089|NCT02893046|care pathway|care pathway
4755090|NCT02893046|hospital- private network|hospital- private network
4755091|NCT02893046|early consultation|early consultation
4755092|NCT02893033|Dysphagia|dysphagia
4755093|NCT02893033|Repetitive Transcranial Magnetic Stimulation|repetitive transcranial magnetic stimulation
4755094|NCT02893033|Stroke|stroke
4755095|NCT02893020|Emotional experience and burnout in physicians|emotional experience and burnout in physicians
4755096|NCT02892994|therapeutic ultrasound|therapeutic ultrasound
4755097|NCT02892968|Regional Anesthesia Ultrasound guided|regional anesthesia ultrasound guided
4755098|NCT02892968|Emergency Department|emergency department
4755099|NCT02892968|Knowledge to Practice Intervention|knowledge to practice intervention
4755100|NCT02892955|Heart Failure|heart failure
4755101|NCT02892955|LVAS|lvas
4755102|NCT02892955|Ventricular Dysfunction|ventricular dysfunction
4755103|NCT02892955|Cardiomyopathy|cardiomyopathy
4755104|NCT02892955|Heart Disease|heart disease
4755105|NCT02892955|Cardiovascular Disease|cardiovascular disease
4755106|NCT02892955|Heart-assist devices|heart-assist devices
4755107|NCT02892955|Thoratec Corporation|thoratec corporation
4755108|NCT02892942|Controlled ovarian hyperstimulation|controlled ovarian hyperstimulation
4755109|NCT02892942|Estradiol|estradiol
4755110|NCT02892942|Embryo implantation|embryo implantation
4755111|NCT02892942|Endometrial receptivity|endometrial receptivity
4755112|NCT02892942|Fertility preservation|fertility preservation
4755113|NCT02892929|Motivational Interviewing|motivational interviewing
4755114|NCT02892929|Hypertension|hypertension
4755115|NCT02892929|Nursing|nursing
4755116|NCT02892929|Randomized Controlled Trial|randomized controlled trial
4755117|NCT02892929|Life Style|life style
4755118|NCT02892916|Delirium|delirium
4755119|NCT02892916|Ketamine|ketamine
4755120|NCT02892916|Elective orthopaedic surgery|elective orthopaedic surgery
4755121|NCT02892903|Fractional flow reserve (FFR)|fractional flow reserve (ffr)
4755122|NCT02892903|Pressure wire (PW)|pressure wire (pw)
4755123|NCT02892903|Coronary angiography|coronary angiography
4755124|NCT02892877|Complete Hydatidiform mole|complete hydatidiform mole
4755125|NCT02892877|Partial Hydatidiform mole|partial hydatidiform mole
4755126|NCT02892877|Invasive mole|invasive mole
4755127|NCT02892877|Choriocarcinoma|choriocarcinoma
4755128|NCT02892877|Post-molar neoplasia|post-molar neoplasia
4755129|NCT02892877|Placental Site Trophoblastic Tumor (PSTT)|placental site trophoblastic tumor (pstt)
4755130|NCT02892877|Epithelioid Trophoblastic Tumor (ETT)|epithelioid trophoblastic tumor (ett)
4755131|NCT02892877|hCG follow-up|hcg follow-up
4755132|NCT02892864|Bell's Palsy|bell's palsy
4755133|NCT02892864|Peripheral facial palsy|peripheral facial palsy
4755134|NCT02892851|STN-DBS|stn-dbs
4755135|NCT02892851|Craving|craving
4755136|NCT02892851|Cocaine addiction|cocaine addiction
4755137|NCT02892838|mobile bearing knee prosthesis|mobile bearing knee prosthesis
4755138|NCT02892825|Music|music
4755139|NCT02892825|cataract surgery|cataract surgery
4755140|NCT02892825|topical anaesthesia|topical anaesthesia
4755141|NCT02892825|anxiety|anxiety
4755142|NCT02892825|hypertension|hypertension
4755143|NCT02892786|circulating tumor cell|circulating tumor cell
4755144|NCT02892786|CellSearch™ method|cellsearch™ method
4755145|NCT02892786|RT-PCR|rt-pcr
4755146|NCT02892773|electrical impedance tomography|electrical impedance tomography
4755147|NCT02892773|incentive spirometry|incentive spirometry
4755148|NCT02892773|EzPAP|ezpap
4755149|NCT02892773|lung volume|lung volume
4755150|NCT02892773|atelectasis|atelectasis
4755151|NCT02892773|positive airway pressure|positive airway pressure
4755152|NCT02892773|pulmonary complication|pulmonary complication
4755153|NCT02892773|abdominal surgery|abdominal surgery
4755154|NCT02892773|end-expiratory lung volume|end-expiratory lung volume
4755155|NCT02892747|Chronic Heart Failure (CHF)|chronic heart failure (chf)
4755156|NCT02892747|Dietetics education|dietetics education
4755157|NCT02892747|Malnutrition|malnutrition
4755158|NCT02892721|CT Colonography|ct colonography
4755159|NCT02892721|Virtual colonoscopy|virtual colonoscopy
4755160|NCT02892721|Colorectal cancer|colorectal cancer
4755161|NCT02892721|Colon cancer|colon cancer
4755162|NCT02892721|Training|training
4755163|NCT02892708|supratentorial gliomas|supratentorial gliomas
4755164|NCT02892708|surgery|surgery
4755165|NCT02892708|magnetic resonance spectroscopy|magnetic resonance spectroscopy
4755166|NCT02892708|elderly|elderly
4755167|NCT02892630|Immune Thrombocytopenia|immune thrombocytopenia
4755168|NCT02892630|Pregnancy|pregnancy
4755169|NCT02892617|Modic 1|modic 1
4755170|NCT02892617|low back pain|low back pain
4755171|NCT02892604|Type 1 diabetes|type 1 diabetes
4755172|NCT02892604|artificial pancreas|artificial pancreas
4755173|NCT02892604|closed-loop insulin infusion|closed-loop insulin infusion
4755174|NCT02892565|systemic lupus erythematosus|systemic lupus erythematosus
4755175|NCT02892565|antiphospholipid syndrome|antiphospholipid syndrome
4755176|NCT02892565|antiphospholipid antibodies|antiphospholipid antibodies
4755177|NCT02892513|Colorectal Surgery|colorectal surgery
4755178|NCT02892513|transcutaneous electric nerve stimulation|transcutaneous electric nerve stimulation
4755179|NCT02892487|Quality of life|quality of life
4755180|NCT02892487|Radiotherapy|radiotherapy
4755181|NCT02892487|Dysphagia|dysphagia
4755182|NCT02892487|Oral cavity|oral cavity
4755183|NCT02892487|Oropharynx|oropharynx
4755184|NCT02892487|Hypopharynx|hypopharynx
4755185|NCT02892487|Larynx|larynx
4755186|NCT02892487|Swallowing rehabilitation|swallowing rehabilitation
4755187|NCT02892487|Toxicity|toxicity
4755188|NCT02892474|Coronary Arteriosclerosis|coronary arteriosclerosis
4755189|NCT02892474|Hybrid Coronary Revascularization|hybrid coronary revascularization
4755190|NCT02892474|Coronary Artery Bypass Grafting|coronary artery bypass grafting
4755191|NCT02892461|Anemia, Iron-Deficiency|anemia, iron-deficiency
4755192|NCT02892461|Cesarean Section|cesarean section
4755193|NCT02892461|Umbilical Cord Milking|umbilical cord milking
4755194|NCT02892461|Randomized Controlled Trial|randomized controlled trial
4755195|NCT02892409|Drug Therapy|drug therapy
4755196|NCT02892344|Phase III, blinded, QMF149, Mometasone furoate (MF), mild asthma, Adolescent, adult|phase iii, blinded, qmf149, mometasone furoate (mf), mild asthma, adolescent, adult
4755197|NCT02892331|exercise|exercise
4755198|NCT02892331|insulin resistance|insulin resistance
4755199|NCT02892331|mitochondrial function|mitochondrial function
4755200|NCT02892331|arterial stiffness|arterial stiffness
4755201|NCT02892331|exercise intensity|exercise intensity
4755202|NCT02892331|fitness|fitness
4755203|NCT02892305|Pancreaticoduodenectomy|pancreaticoduodenectomy
4755204|NCT02892305|Hepatectomy|hepatectomy
4755205|NCT02892305|Liver ablation|liver ablation
4755206|NCT02892305|Whipple|whipple
4755207|NCT02892279|Microneurography|microneurography
4755208|NCT02892279|Air pollution|air pollution
4755209|NCT02892266|Transplant recipients|transplant recipients
4755210|NCT02892266|Adolescents|adolescents
4755211|NCT02892266|Post-Traumatic Stress Symptoms (PTSS)|post-traumatic stress symptoms (ptss)
4755212|NCT02892266|Transplant Recipient and Family Impact(s)|transplant recipient and family impact(s)
4755213|NCT02892253|postoperative hypocalcemia|postoperative hypocalcemia
4755214|NCT02892253|near infrared imaging|near infrared imaging
4755215|NCT02892253|parathyroid autofluorescence|parathyroid autofluorescence
4755216|NCT02892227|bedside echography|bedside echography
4755217|NCT02892162|atrial fibrillation|atrial fibrillation
4755218|NCT02892162|catheter ablation|catheter ablation
4755219|NCT02892149|AKB-6548|akb-6548
4755220|NCT02892149|Chronic kidney disease|chronic kidney disease
4755221|NCT02892149|anemia|anemia
4755222|NCT02892149|CKD|ckd
4755223|NCT02892149|chronic renal insufficiency|chronic renal insufficiency
4755224|NCT02892149|renal impairment|renal impairment
4755225|NCT02892149|erythropoietin|erythropoietin
4755226|NCT02892149|kidney|kidney
4755227|NCT02892149|renal|renal
4755228|NCT02892149|oral anemia treatment|oral anemia treatment
4755229|NCT02892149|hemoglobin|hemoglobin
4755230|NCT02892149|hypoxia-inducible factor|hypoxia-inducible factor
4755231|NCT02892149|HIF|hif
4755232|NCT02892149|hypoxia-inducible factor prolyl-hydroxylase inhibitor|hypoxia-inducible factor prolyl-hydroxylase inhibitor
4755233|NCT02892149|HIF-PHI|hif-phi
4755234|NCT02892149|efficacy|efficacy
4755235|NCT02892149|safety|safety
4755236|NCT02892149|Phase 3|phase 3
4755237|NCT02892149|cardiovascular|cardiovascular
4755238|NCT02892149|DD-CKD|dd-ckd
4755239|NCT02892123|HER2|her2
4755240|NCT02892123|bispecific antibody|bispecific antibody
4755241|NCT02892123|biparatopic antibody|biparatopic antibody
4755242|NCT02892123|breast cancer|breast cancer
4755243|NCT02892123|gastric cancer|gastric cancer
4755244|NCT02892123|gastroesophageal cancer|gastroesophageal cancer
4755245|NCT02892123|ovarian cancer|ovarian cancer
4755246|NCT02892123|non-small cell lung cancer|non-small cell lung cancer
4755247|NCT02892110|Marijuana use|marijuana use
4755248|NCT02892110|Varenicline/Chantix|varenicline/chantix
4755249|NCT02892110|Motivational enhancement therapy|motivational enhancement therapy
4755250|NCT02892097|tDCS|tdcs
4755251|NCT02892097|neglect|neglect
4755252|NCT02892097|paresis|paresis
4755253|NCT02892097|transcranial direct current stimulation|transcranial direct current stimulation
4755254|NCT02892097|rehabilitation|rehabilitation
4755255|NCT02892084|Chronic Stroke ( > 6 months)|chronic stroke ( > 6 months)
4755256|NCT02892084|non-invasive brain stimulation|non-invasive brain stimulation
4755257|NCT02892084|rehabilitation|rehabilitation
4755258|NCT02892084|walking|walking
4755259|NCT02892084|kinetics|kinetics
4755260|NCT02892045|neuromuscular block|neuromuscular block
4755261|NCT02892045|monitoring|monitoring
4755262|NCT02892019|indacaterol acetate, asthma, GINA 2015, pediatrics|indacaterol acetate, asthma, gina 2015, pediatrics
4755263|NCT02891993|Cancer Care|cancer care
4755264|NCT02891980|Ad26|ad26
4755265|NCT02891980|Ebola|ebola
4755266|NCT02891980|immunogenicity response|immunogenicity response
4755267|NCT02891980|MVA-Multi Filo|mva-multi filo
4755268|NCT02891980|Omics|omics
4755269|NCT02891980|Zaire|zaire
4755270|NCT02891954|Glucosuria|glucosuria
4755271|NCT02891954|SGLT2 inhibitors|sglt2 inhibitors
4755272|NCT02891954|Canagliflozin|canagliflozin
4755273|NCT02891954|FGF23|fgf23
4755274|NCT02891954|Parathyroid hormone|parathyroid hormone
4755275|NCT02891954|1,25-Dihydroxyvitamin D|1,25-dihydroxyvitamin d
4755276|NCT02891954|Glucagon|glucagon
4755277|NCT02891954|Ketone bodies|ketone bodies
4755278|NCT02891954|Uric acid|uric acid
4755279|NCT02891954|Pharmacogenomics|pharmacogenomics
4755280|NCT02891928|Type 2 diabetes|type 2 diabetes
4755281|NCT02891928|Diabetic neuropathy|diabetic neuropathy
4755282|NCT02891928|Disorders of equilibrium|disorders of equilibrium
4755283|NCT02891928|"Rocker sole shoes"|"rocker sole shoes"
4755284|NCT02891928|Walking|walking
4755285|NCT02891915|Antimicrobial|antimicrobial
4755286|NCT02891915|Beta-Lactam|beta-lactam
4755287|NCT02891915|Pneumonia|pneumonia
4755288|NCT02891915|Short Course|short course
4755289|NCT02891915|Standard Course|standard course
4755290|NCT02891915|Therapy|therapy
4755291|NCT02891876|direct pulp capping, biodentine|direct pulp capping, biodentine
4755292|NCT02891863|Implantable Cardioverter-Defibrillator|implantable cardioverter-defibrillator
4755293|NCT02891837|L-citrulline|l-citrulline
4755294|NCT02891837|pediatric|pediatric
4755295|NCT02891837|Lung Injury|lung injury
4755296|NCT02891837|Bypass|bypass
4755297|NCT02891837|Heart Defects|heart defects
4755298|NCT02891837|Clinical Sequelae|clinical sequelae
4755299|NCT02891824|PD-L1|pd-l1
4755300|NCT02891824|Atezolizumab|atezolizumab
4755301|NCT02891824|Randomized, double blinded|randomized, double blinded
4755302|NCT02891824|first or second late relapse|first or second late relapse
4755303|NCT02891824|progressive non-mucinous epithelial ovarian cancer, primary peritoneal adenocarcinoma and / or fallopian-tube adenocarcinoma|progressive non-mucinous epithelial ovarian cancer, primary peritoneal adenocarcinoma and / or fallopian-tube adenocarcinoma
4755304|NCT02891824|progression-free survival|progression-free survival
4755305|NCT02891811|newly diagnosed multiple myeloma|newly diagnosed multiple myeloma
4755306|NCT02891811|carfilzomib|carfilzomib
4755307|NCT02891811|thalidomide|thalidomide
4755308|NCT02891811|lenalidomide|lenalidomide
4755309|NCT02891811|dexamethasone|dexamethasone
4755310|NCT02891811|transplant ineligible|transplant ineligible
4755311|NCT02891811|induction therapy|induction therapy
4755312|NCT02891811|maintenance|maintenance
4755313|NCT02891811|Study Group of Medical Tumour Therapy (AGMT)|study group of medical tumour therapy (agmt)
4755314|NCT02891798|analgesia,|analgesia,
4755315|NCT02891798|buprenorphine|buprenorphine
4755316|NCT02891798|clonidine|clonidine
4755317|NCT02891798|dexamethasone|dexamethasone
4755318|NCT02891798|bupivacaine|bupivacaine
4755319|NCT02891798|nerve block|nerve block
4755320|NCT02891733|Expression of the Neurotensin|expression of the neurotensin
4755321|NCT02891733|Neurotensin|neurotensin
4755322|NCT02891668|Basal Metabolic rate|basal metabolic rate
4755323|NCT02891668|Quality of life|quality of life
4755324|NCT02891668|Resting energy expenditure|resting energy expenditure
4755325|NCT02891668|Insulin resistance|insulin resistance
4755326|NCT02891668|Cognitive Function|cognitive function
4755327|NCT02891668|Body Composition|body composition
4755328|NCT02891642|malignancy|malignancy
4755329|NCT02891642|Pleural Effusion|pleural effusion
4755330|NCT02891642|Pleural Neoplasms|pleural neoplasms
4755331|NCT02891642|Ascites|ascites
4755332|NCT02891616|Melanoma|melanoma
4755333|NCT02891616|18F-FLT|18f-flt
4755334|NCT02891616|18F-FDG|18f-fdg
4755335|NCT02891616|PET/CT|pet/ct
4755336|NCT02891616|PET/MR|pet/mr
4755337|NCT02891577|intra abdominal hypertension|intra abdominal hypertension
4755338|NCT02891577|shock|shock
4755339|NCT02891577|critically ill|critically ill
4755340|NCT02891564|therapeutic video games, mobile interventions|therapeutic video games, mobile interventions
4755341|NCT02891551|Leukemia|leukemia
4755342|NCT02891551|Chronic|chronic
4755343|NCT02891551|Acute|acute
4755344|NCT02891551|Observational|observational
4755345|NCT02891551|Non-interventional|non-interventional
4755346|NCT02891551|OCEAN|ocean
4755347|NCT02891551|Netherlands|netherlands
4755348|NCT02891551|azacitidine|azacitidine
4755349|NCT02891538|EGCG|egcg
4755350|NCT02891538|Green Tea|green tea
4755351|NCT02891538|Colon Cancer|colon cancer
4755352|NCT02891512|Magnetic Fields|magnetic fields
4755353|NCT02891512|Pain|pain
4755354|NCT02891512|Paresthesia|paresthesia
4755355|NCT02891512|Visual Analogue Scale|visual analogue scale
4755356|NCT02891499|Miniscrews|miniscrews
4755357|NCT02891499|Mini-implants|mini-implants
4755358|NCT02891499|Temporal anchorage devices|temporal anchorage devices
4755359|NCT02891499|Bone screws|bone screws
4755360|NCT02891499|Stability|stability
4755361|NCT02891499|Displacement|displacement
4755362|NCT02891499|Low-level laser therapy|low-level laser therapy
4755363|NCT02891499|Cone-beam computed tomography|cone-beam computed tomography
4755364|NCT02891499|Resonance frequency analysis|resonance frequency analysis
4755365|NCT02891499|Orthodontic|orthodontic
4755366|NCT02891499|Orthodontic miniscrew implant|orthodontic miniscrew implant
4755367|NCT02891486|spinal surgery, surgical site infection|spinal surgery, surgical site infection
4755368|NCT02891473|Posture|posture
4755369|NCT02891473|Pain|pain
4755370|NCT02891473|Muscle stretching|muscle stretching
4755371|NCT02891473|Mézières method|mézières method
4755372|NCT02891473|Camptocormia|camptocormia
4755373|NCT02891473|Trunk control|trunk control
4755374|NCT02891460|Mitomycin C|mitomycin c
4755375|NCT02891460|MMC|mmc
4755376|NCT02891460|NMIBC|nmibc
4755377|NCT02891460|Non Muscle Invasive Bladder Cancer|non muscle invasive bladder cancer
4755378|NCT02891460|Hydrogel Reverse thermal gelation|hydrogel reverse thermal gelation
4755379|NCT02891460|Drug retention|drug retention
4755380|NCT02891460|Urinary Bladder Neoplasms|urinary bladder neoplasms
4755381|NCT02891460|Urologic Neoplasms|urologic neoplasms
4755382|NCT02891460|Urinary Bladder Diseases|urinary bladder diseases
4755383|NCT02891460|Urologic Diseases|urologic diseases
4755384|NCT02891434|Duchenne muscular dystrophy|duchenne muscular dystrophy
4755385|NCT02891434|motor learning|motor learning
4755386|NCT02891434|motor abilities|motor abilities
4755387|NCT02891395|allogeneic stem cell transplantation|allogeneic stem cell transplantation
4755388|NCT02891395|imatinib Mesylate|imatinib mesylate
4755389|NCT02891395|Nilotinib|nilotinib
4755390|NCT02891382|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
4755391|NCT02891382|Weight Loss|weight loss
4755392|NCT02891382|Financial Incentives|financial incentives
4755393|NCT02891382|Hemoglobin A, Glycosylated|hemoglobin a, glycosylated
4755394|NCT02891356|Adiponectin|adiponectin
4755395|NCT02891356|Bone remodelling markers|bone remodelling markers
4755396|NCT02891343|Cognitive Function|cognitive function
4755397|NCT02891343|Hypoxia|hypoxia
4755398|NCT02891343|Neurophysiological Function|neurophysiological function
4755399|NCT02891343|Effect of Alzheimer Disease symptomatic drugs|effect of alzheimer disease symptomatic drugs
4755400|NCT02891343|Healthy Subjects|healthy subjects
4755401|NCT02891330|Roux-en-Y Gastric ByPass|roux-en-y gastric bypass
4755402|NCT02891304|esophagogastroduodenoscopy|esophagogastroduodenoscopy
4755403|NCT02891291|optical coherence tomography|optical coherence tomography
4755404|NCT02891278|Leukemia|leukemia
4755405|NCT02891278|Sertraline|sertraline
4755406|NCT02891278|Cytosine Arabinoside|cytosine arabinoside
4755407|NCT02891278|Relapsed AML|relapsed aml
4755408|NCT02891278|Refractory AML|refractory aml
4755409|NCT02891239|laser treatment|laser treatment
4755410|NCT02891226|inflammatory bowel disease|inflammatory bowel disease
4755411|NCT02891226|IL-23|il-23
4755412|NCT02891226|biologic|biologic
4755413|NCT02891187|Postoperative Care|postoperative care
4755414|NCT02891187|Telephone follow-up|telephone follow-up
4755415|NCT02891187|Healthcare Value|healthcare value
4755416|NCT02891174|ibuprofen|ibuprofen
4755417|NCT02891174|acetaminophen|acetaminophen
4755418|NCT02891174|blood pressure|blood pressure
4755419|NCT02891174|post-partum|post-partum
4755420|NCT02891174|pain control|pain control
4755421|NCT02891174|pre-eclampsia|pre-eclampsia
4755422|NCT02891174|gestational hypertension|gestational hypertension
4755423|NCT02891161|durvalumab|durvalumab
4755424|NCT02891161|MEDI4736|medi4736
4755425|NCT02891161|anti-PD-L1|anti-pd-l1
4755426|NCT02891135|"WHO 'Treat all Antiretroviral Guidelines"|"who 'treat all antiretroviral guidelines"
4755427|NCT02891135|Simplified Algorithm for Treatment Eligibility (SLATE)|simplified algorithm for treatment eligibility (slate)
4755428|NCT02891096|respiratory complications|respiratory complications
4755555|NCT02890290|protein intake|protein intake
4755429|NCT02891096|respiratory muscle strength|respiratory muscle strength
4755430|NCT02891096|discriminator|discriminator
4755431|NCT02891083|adjuvant chemotherapy|adjuvant chemotherapy
4755432|NCT02891083|adjuvant radiotherapy|adjuvant radiotherapy
4755433|NCT02891083|lymph node metastasis|lymph node metastasis
4755434|NCT02891083|surgery|surgery
4755435|NCT02891083|squamous cell carcinoma|squamous cell carcinoma
4755436|NCT02891070|Cranial Surgery|cranial surgery
4755437|NCT02891070|Cerebrospinal Fluid Leak|cerebrospinal fluid leak
4755438|NCT02891070|Tisseel|tisseel
4755439|NCT02891031|Rhus|rhus
4755440|NCT02891031|Medicine, Traditional|medicine, traditional
4755441|NCT02891031|Herbal medicine|herbal medicine
4755442|NCT02891031|Uric acid|uric acid
4755443|NCT02890966|SHR4640 pharmacokinetics pharmacodynamics|shr4640 pharmacokinetics pharmacodynamics
4755444|NCT02890927|Geriatric Nursing|geriatric nursing
4755445|NCT02890927|Geriatric co-management|geriatric co-management
4755446|NCT02890927|Geriatric team|geriatric team
4755447|NCT02890901|Escherichia coli|escherichia coli
4755448|NCT02890901|Bloodstream infections|bloodstream infections
4755449|NCT02890901|Severity|severity
4755450|NCT02890901|Score|score
4755451|NCT02890901|Host factors|host factors
4755452|NCT02890901|Microbiology|microbiology
4755453|NCT02890888|small vessel disease of the brain|small vessel disease of the brain
4755454|NCT02890888|hyperbaric oxygen|hyperbaric oxygen
4755455|NCT02890888|functional connectivity MRI|functional connectivity mri
4755456|NCT02890875|ethanol lock|ethanol lock
4755457|NCT02890875|parenteral nutrition|parenteral nutrition
4755458|NCT02890862|Kinematics|kinematics
4755459|NCT02890862|Activity of Daily living|activity of daily living
4755460|NCT02890862|3D motion analysis|3d motion analysis
4755461|NCT02890836|Blood pressure|blood pressure
4755462|NCT02890836|Hypertension|hypertension
4755463|NCT02890836|White coat hypertension|white coat hypertension
4755464|NCT02890836|Preeclampsia|preeclampsia
4755465|NCT02890836|Anti-hypertensiva|anti-hypertensiva
4755466|NCT02890823|Antiepileptic Drugs|antiepileptic drugs
4755467|NCT02890823|Vitamin D Deficiency|vitamin d deficiency
4755468|NCT02890823|Asian|asian
4755469|NCT02890810|Acupuncture|acupuncture
4755470|NCT02890810|Back Pain|back pain
4755471|NCT02890810|Chronic Pain|chronic pain
4755472|NCT02890797|bronchiolitis|bronchiolitis
4755473|NCT02890797|parenchymal condensation|parenchymal condensation
4755474|NCT02890797|chest X-ray|chest x-ray
4755475|NCT02890797|chest ultrasound|chest ultrasound
4755476|NCT02890771|Turmeric|turmeric
4755477|NCT02890771|Chronic periodontitis|chronic periodontitis
4755478|NCT02890758|Natural Killer Cell|natural killer cell
4755479|NCT02890758|ALT-803|alt-803
4755480|NCT02890745|Empagliflozin|empagliflozin
4755481|NCT02890745|Oxidative stress|oxidative stress
4755482|NCT02890745|Oxidative nucleic acid modifications|oxidative nucleic acid modifications
4755483|NCT02890745|8-oxo-7,8-dihydro-2'-deoxyguanosine|8-oxo-7,8-dihydro-2'-deoxyguanosine
4755484|NCT02890745|8-oxo-7,8-dihydroguanosine|8-oxo-7,8-dihydroguanosine
4755485|NCT02890706|Pulmonary embolism (PE)|pulmonary embolism (pe)
4755486|NCT02890706|Dual-Energy CT (DECT)|dual-energy ct (dect)
4755487|NCT02890706|Subtraction imaging|subtraction imaging
4755488|NCT02890693|gestational diabetes mellitus|gestational diabetes mellitus
4755489|NCT02890693|randomized controlled trial|randomized controlled trial
4755490|NCT02890693|lifestyle intervention|lifestyle intervention
4755491|NCT02890693|cardiovascular|cardiovascular
4755492|NCT02890693|metabolic|metabolic
4755493|NCT02890693|mental health|mental health
4755494|NCT02890693|depression|depression
4755495|NCT02890693|physical activity|physical activity
4755496|NCT02890693|dietary intervention|dietary intervention
4755497|NCT02890680|platelet-rich fibrin|platelet-rich fibrin
4755498|NCT02890680|third molar|third molar
4755499|NCT02890680|bone regeneration|bone regeneration
4755500|NCT02890667|Cancer|cancer
4755501|NCT02890667|incidence|incidence
4755502|NCT02890667|health insurance data|health insurance data
4755503|NCT02890667|algorithms|algorithms
4755504|NCT02890654|Teenagers|teenagers
4755505|NCT02890654|Multidisciplinary approach|multidisciplinary approach
4755506|NCT02890654|Pain|pain
4755507|NCT02890654|Surgery|surgery
4755508|NCT02890628|Thai-Myanmar border|thai-myanmar border
4755509|NCT02890615|Survivors|survivors
4755510|NCT02890615|Self Care|self care
4755511|NCT02890589|Acute coronary syndrome|acute coronary syndrome
4755512|NCT02890589|ST (Software Test) -elevation|st (software test) -elevation
4755513|NCT02890576|cochlear implant|cochlear implant
4755514|NCT02890576|telemedicine|telemedicine
4755515|NCT02890576|new organization of patient monitoring|new organization of patient monitoring
4755516|NCT02890563|Varicose veins|varicose veins
4755517|NCT02890563|Compression stockings|compression stockings
4755518|NCT02890563|Sclerotherapy|sclerotherapy
4755519|NCT02890563|Radiofrequency ablation|radiofrequency ablation
4755520|NCT02890550|Ciliopathy|ciliopathy
4755521|NCT02890550|Retinitis pigmentosa|retinitis pigmentosa
4755522|NCT02890550|ALMS1 gene|alms1 gene
4755523|NCT02890537|Osteonecrosis|osteonecrosis
4755524|NCT02890537|Femoral Head|femoral head
4755525|NCT02890537|Hip|hip
4755526|NCT02890537|Orthopedics|orthopedics
4755527|NCT02890537|Bone|bone
4755528|NCT02890537|Musculoskeletal Disorders|musculoskeletal disorders
4755529|NCT02890524|aphthous stomatitis|aphthous stomatitis
4755530|NCT02890524|night guard|night guard
4755531|NCT02890524|inflammatory cytokine|inflammatory cytokine
4755532|NCT02890459|HIV|hiv
4755533|NCT02890459|incentives|incentives
4755534|NCT02890459|behavioral economics|behavioral economics
4755535|NCT02890446|attentional focus|attentional focus
4755536|NCT02890446|upper extremity|upper extremity
4755537|NCT02890446|hemiparesis|hemiparesis
4755538|NCT02890446|stroke|stroke
4755539|NCT02890394|Neck Pain|neck pain
4755540|NCT02890394|Suboccipital inhibition|suboccipital inhibition
4755541|NCT02890394|Physical Therapy|physical therapy
4755542|NCT02890368|CD47|cd47
4755543|NCT02890368|SIRPa|sirpa
4755544|NCT02890368|Immunotherapy|immunotherapy
4755545|NCT02890368|Checkpoint inhibitor|checkpoint inhibitor
4755546|NCT02890342|Propionic Acidemia|propionic acidemia
4755547|NCT02890342|Inborn Error of Metabolism|inborn error of metabolism
4755548|NCT02890342|Genetics|genetics
4755549|NCT02890342|Pccb|pccb
4755550|NCT02890342|Pcca|pcca
4755551|NCT02890290|Frail Elderly|frail elderly
4755552|NCT02890290|Diet, Food, and Nutrition|diet, food, and nutrition
4755553|NCT02890290|physical function|physical function
4755554|NCT02890290|marine protein hydrolysates|marine protein hydrolysates
4755556|NCT02890290|seafood intake|seafood intake
4755557|NCT02890290|ageing|ageing
4755558|NCT02890290|old|old
4755559|NCT02890290|nutrition|nutrition
4755560|NCT02890290|frail|frail
4755561|NCT02890264|End stage renal disease|end stage renal disease
4755562|NCT02890264|Dialysis|dialysis
4755563|NCT02890251|Infant|infant
4755564|NCT02890251|Premature|premature
4755565|NCT02890251|Diseases|diseases
4755566|NCT02890238|Sildenafil Citrate|sildenafil citrate
4755567|NCT02890238|Induction of Ovulation|induction of ovulation
4755568|NCT02890238|Pregnancy Rate|pregnancy rate
4755569|NCT02890225|stones|stones
4755570|NCT02890225|external physical vibration lithecbole|external physical vibration lithecbole
4755571|NCT02890212|Major depression, selenium, placebo, sertraline|major depression, selenium, placebo, sertraline
4755572|NCT02890186|narcotrend|narcotrend
4755573|NCT02890186|propofol|propofol
4755574|NCT02890186|remifentanil|remifentanil
4755575|NCT02890186|closed-loop of target controlled infusion|closed-loop of target controlled infusion
4755576|NCT02890173|Essential hypertension|essential hypertension
4755577|NCT02890173|Mineralocorticoid receptor antagonist|mineralocorticoid receptor antagonist
4755578|NCT02890173|Esaxerenone|esaxerenone
4755579|NCT02890173|Ambulatory blood pressure monitoring|ambulatory blood pressure monitoring
4755580|NCT02890160|Bioresorbable Vascular Scaffold|bioresorbable vascular scaffold
4755581|NCT02890147|SADs|sads
4755582|NCT02890147|Healthy Volunteers|healthy volunteers
4755583|NCT02890147|Molecular profiles|molecular profiles
4755584|NCT02890147|Omics Techniques|omics techniques
4755585|NCT02890134|SADs|sads
4755586|NCT02890134|Molecular Reclassification|molecular reclassification
4755587|NCT02890121|SADs|sads
4755588|NCT02890121|Molecular Reclassification|molecular reclassification
4755589|NCT02890108|High-Intensity Sweeteners|high-intensity sweeteners
4755590|NCT02890108|Non-Nutritive Sweeteners|non-nutritive sweeteners
4755591|NCT02890108|Artificial sweeteners|artificial sweeteners
4755592|NCT02890108|Glucose intolerance|glucose intolerance
4755593|NCT02890082|Breast cancer|breast cancer
4755594|NCT02890082|fertility|fertility
4755595|NCT02890082|chemotherapy|chemotherapy
4755596|NCT02890069|PDR001|pdr001
4755597|NCT02890069|CRC|crc
4755598|NCT02890069|TNBC|tnbc
4755599|NCT02890069|NSCLC|nsclc
4755600|NCT02890069|RCC|rcc
4755601|NCT02890069|Immunomodulation|immunomodulation
4755602|NCT02890069|Biomarkers|biomarkers
4755603|NCT02890069|Bayesian logistic regression model|bayesian logistic regression model
4755604|NCT02890056|sugar-sweetened beverage consumption|sugar-sweetened beverage consumption
4755605|NCT02890056|water consumption|water consumption
4755606|NCT02890056|dietary behaviors|dietary behaviors
4755607|NCT02890056|youth|youth
4755608|NCT02890043|spine|spine
4755609|NCT02890043|robot-assisted surgery|robot-assisted surgery
4755610|NCT02890043|pedicle screw|pedicle screw
4755611|NCT02890030|Cisplatin-based therapy|cisplatin-based therapy
4755612|NCT02890030|Ototoxicity|ototoxicity
4755613|NCT02890030|Neurotoxicity|neurotoxicity
4755614|NCT02890017|outpatient surgery|outpatient surgery
4755615|NCT02890017|urology medico-economic|urology medico-economic
4755616|NCT02890017|hotel|hotel
4755617|NCT02890004|Subarachnoid Hemorrhage|subarachnoid hemorrhage
4755618|NCT02890004|Neurointensive care|neurointensive care
4755619|NCT02890004|Observational registry|observational registry
4755620|NCT02889991|Myofascial pain.|myofascial pain.
4755621|NCT02889991|Myofascial trigger point.|myofascial trigger point.
4755622|NCT02889991|Infraspinatus muscle.|infraspinatus muscle.
4755623|NCT02889991|Deep dry needling.|deep dry needling.
4755624|NCT02889991|Local twitch response.|local twitch response.
4755625|NCT02889991|Fascial mechanotransduction.|fascial mechanotransduction.
4755626|NCT02889991|Needle grasp.|needle grasp.
4755627|NCT02889991|Myofascial fibrosis.|myofascial fibrosis.
4755628|NCT02889991|Elastography.|elastography.
4755629|NCT02889978|Cancer Screening|cancer screening
4755630|NCT02889978|High-Throughput Nucleotide Sequencing|high-throughput nucleotide sequencing
4755631|NCT02889978|Deep Sequencing|deep sequencing
4755632|NCT02889978|Circulating cell-free tumor DNA|circulating cell-free tumor dna
4755633|NCT02889965|Multiple sclerosis|multiple sclerosis
4755634|NCT02889965|Pharmacoepidemiology|pharmacoepidemiology
4755635|NCT02889965|Disease modifying drugs|disease modifying drugs
4755636|NCT02889965|Neuro-myelitis optica|neuro-myelitis optica
4755637|NCT02889952|postoperative hypocalcemia|postoperative hypocalcemia
4755638|NCT02889952|near infrared imaging|near infrared imaging
4755639|NCT02889952|parathyroid autofluorescence|parathyroid autofluorescence
4755640|NCT02889939|rehabilitation|rehabilitation
4755641|NCT02889939|recovery of function|recovery of function
4755642|NCT02889939|environment|environment
4755643|NCT02889900|ovarian cancer|ovarian cancer
4755644|NCT02889887|Preterm|preterm
4755645|NCT02889887|Sensory Processing|sensory processing
4755646|NCT02889887|Motor Development|motor development
4755647|NCT02889874|Radiation therapy|radiation therapy
4755648|NCT02889874|omission|omission
4755649|NCT02889874|non-inferiority|non-inferiority
4755650|NCT02889874|breast cancer|breast cancer
4755651|NCT02889861|Uveal melanoma|uveal melanoma
4755652|NCT02889861|Cutaneous melanoma|cutaneous melanoma
4755653|NCT02889835|Class II|class ii
4755654|NCT02889835|molar and premolar|molar and premolar
4755655|NCT02889835|resin composite|resin composite
4755656|NCT02889835|adult|adult
4755657|NCT02889835|restoration|restoration
4755658|NCT02889809|Growth Velocity|growth velocity
4755659|NCT02889809|Prepubertal|prepubertal
4755660|NCT02889809|Asthma|asthma
4755661|NCT02889809|Paediatric|paediatric
4755662|NCT02889783|urodynamics|urodynamics
4755663|NCT02889783|urethral sensation|urethral sensation
4755664|NCT02889783|urethral pain|urethral pain
4755665|NCT02889757|tuberculosis|tuberculosis
4755666|NCT02889757|acetylcysteine|acetylcysteine
4755667|NCT02889757|hepatotoxicity|hepatotoxicity
4755668|NCT02889744|Temperature|temperature
4755669|NCT02889744|Hypothermia|hypothermia
4755670|NCT02889744|Brain|brain
4755671|NCT02889744|Oxygen|oxygen
4755672|NCT02889744|Prognosis|prognosis
4755673|NCT02889731|Suicide|suicide
4755674|NCT02889731|Heights|heights
4755675|NCT02889731|Suicide hot spots|suicide hot spots
4755676|NCT02889731|Bridges|bridges
4755677|NCT02889705|Ultrasonography|ultrasonography
4755678|NCT02889705|echotexture|echotexture
4755679|NCT02889705|K value|k value
4755680|NCT02889705|SCM muscles|scm muscles
4755681|NCT02889705|CMT infants|cmt infants
4755682|NCT02889692|lung cancer|lung cancer
4755683|NCT02889692|traditional Chinese medicine|traditional chinese medicine
4755684|NCT02889692|maintenance therapy|maintenance therapy
4755685|NCT02889692|targeted therapy|targeted therapy
4755686|NCT02889679|Colonoscopy|colonoscopy
4755687|NCT02889679|Polypectomy|polypectomy
4755688|NCT02889666|relapsed|relapsed
4755689|NCT02889666|non-small cell lung cancer|non-small cell lung cancer
4755690|NCT02889666|cisplatin|cisplatin
4755691|NCT02889666|carboplatin|carboplatin
4755692|NCT02889666|oxaliplatin|oxaliplatin
4755693|NCT02889666|docetaxel|docetaxel
4755694|NCT02889666|gemcitabine|gemcitabine
4755695|NCT02889640|Educational Achievement|educational achievement
4755696|NCT02889640|Individualized Tutoring|individualized tutoring
4755697|NCT02889640|Mathematics|mathematics
4755698|NCT02889640|Academic Mismatch|academic mismatch
4755699|NCT02889640|Achievement Gap|achievement gap
4755700|NCT02889627|Fecal Microbiota Transplantation|fecal microbiota transplantation
4755701|NCT02889627|Gut microbiota|gut microbiota
4755702|NCT02889627|Brain-gut axis|brain-gut axis
4755703|NCT02889627|Epilepsy|epilepsy
4755704|NCT02889588|Refractive Surgery|refractive surgery
4755705|NCT02889588|higher order aberrations|higher order aberrations
4755706|NCT02889562|apixaban|apixaban
4755707|NCT02889562|anticoagulant|anticoagulant
4755708|NCT02889562|CABG|cabg
4755709|NCT02889562|thrombosis|thrombosis
4755710|NCT02889562|fibrillation|fibrillation
4755711|NCT02889536|parastomal hernia|parastomal hernia
4755712|NCT02889536|ostomy|ostomy
4755713|NCT02889536|qualitative|qualitative
4755714|NCT02889536|phenomenological-hermeneutic research|phenomenological-hermeneutic research
4755715|NCT02889536|symptoms|symptoms
4755716|NCT02889536|parastomal bulging|parastomal bulging
4755717|NCT02889523|Front line therapy|front line therapy
4755718|NCT02889523|Age-adjusted International Prognostic Index (aa-IPI) >1|age-adjusted international prognostic index (aa-ipi) >1
4755719|NCT02889523|60 to 80 years|60 to 80 years
4755720|NCT02889510|diabetes|diabetes
4755721|NCT02889510|liraglutide|liraglutide
4755722|NCT02889510|lung function|lung function
4755723|NCT02889497|vaccine|vaccine
4755724|NCT02889497|safety|safety
4755725|NCT02889497|immunogenicity|immunogenicity
4755726|NCT02889458|Chinese|chinese
4755727|NCT02889458|Breast Cancer|breast cancer
4755728|NCT02889458|Women|women
4755729|NCT02889419|Multiple Sclerosis|multiple sclerosis
4755730|NCT02889419|Disability|disability
4755731|NCT02889419|Underwear|underwear
4755732|NCT02889419|Urinary catheter|urinary catheter
4755733|NCT02889419|Self-catheterisation|self-catheterisation
4755734|NCT02889380|Infertility|infertility
4755735|NCT02889380|Cetrotide|cetrotide
4755736|NCT02889380|Assisted reproductive technology (ART)|assisted reproductive technology (art)
4755737|NCT02889341|Docosahexanoic Acid,|docosahexanoic acid,
4755738|NCT02889341|DNA fragmentation|dna fragmentation
4755739|NCT02889341|male fertility|male fertility
4755740|NCT02889341|Sperm parameters improvements|sperm parameters improvements
4755741|NCT02889315|PAH|pah
4755742|NCT02889315|treprostinil|treprostinil
4755743|NCT02889315|LenusPro|lenuspro
4755744|NCT02889315|implantable device|implantable device
4755745|NCT02889315|quality of life|quality of life
4755746|NCT02889289|traumatic brain injury|traumatic brain injury
4755747|NCT02889289|virtual reality|virtual reality
4755748|NCT02889289|Xbox kinect|xbox kinect
4755749|NCT02889289|balance|balance
4755750|NCT02889250|geriatric|geriatric
4755751|NCT02889250|depression|depression
4755752|NCT02889250|deep brain stimulation|deep brain stimulation
4755753|NCT02889250|subcallosal cingulate|subcallosal cingulate
4755754|NCT02889237|Fracture healing|fracture healing
4755755|NCT02889237|Calcium supplementation|calcium supplementation
4755756|NCT02889237|Vitamin D supplementation|vitamin d supplementation
4755757|NCT02889237|HR-pQCT|hr-pqct
4755758|NCT02889224|Obesity|obesity
4755759|NCT02889224|Cortisol|cortisol
4755760|NCT02889224|Hydrocortisone|hydrocortisone
4755761|NCT02889224|Endocannabinoïds|endocannabinoïds
4755762|NCT02889198|web-based tool|web-based tool
4755763|NCT02889198|child, preschool|child, preschool
4755764|NCT02889198|nutrition|nutrition
4755765|NCT02889198|implementation|implementation
4755766|NCT02889198|child care|child care
4755767|NCT02889185|Optical Coherence Tomography|optical coherence tomography
4755768|NCT02889185|Retinal camera|retinal camera
4755769|NCT02889159|photoaging|photoaging
4755770|NCT02889146|Intensive Care Units|intensive care units
4755771|NCT02889146|Physical Therapy Specialty|physical therapy specialty
4755772|NCT02889146|Critical illness|critical illness
4755773|NCT02889146|Muscle weakness|muscle weakness
4755774|NCT02889146|Bed rest|bed rest
4755775|NCT02889133|Iron deficiency|iron deficiency
4755776|NCT02889133|Transfusion|transfusion
4755777|NCT02889133|Blood donation|blood donation
4755778|NCT02889120|Drug advice by phone|drug advice by phone
4755779|NCT02889120|Teleprescription|teleprescription
4755780|NCT02889120|Medical call centre|medical call centre
4755781|NCT02889120|Out of hours call|out of hours call
4755782|NCT02889081|birth cohort|birth cohort
4755783|NCT02889081|prenatal|prenatal
4755784|NCT02889081|skin barrier|skin barrier
4755785|NCT02889081|atopic dermatitis|atopic dermatitis
4755786|NCT02889081|key nutritional factors|key nutritional factors
4755787|NCT02889016|PANS|pans
4755788|NCT02889016|PANDAS|pandas
4755789|NCT02888951|Diabetes|diabetes
4755790|NCT02888951|Diabetes Mellitus|diabetes mellitus
4755791|NCT02888951|Gastric Ultrasound|gastric ultrasound
4755792|NCT02888951|Preoperative fasting|preoperative fasting
4755793|NCT02888951|Empty Stomach|empty stomach
4755794|NCT02888951|Gastric Diabetes|gastric diabetes
4755795|NCT02888912|glass ionomer cement|glass ionomer cement
4755796|NCT02888912|composite resin|composite resin
4755797|NCT02888886|systemic inflammation|systemic inflammation
4755798|NCT02888873|composite resin|composite resin
4755799|NCT02888873|Clinical trial|clinical trial
4755800|NCT02888873|FDI (World Dental Federation) criteria|fdi (world dental federation) criteria
4755801|NCT02888860|genetic susceptibility|genetic susceptibility
4755802|NCT02888860|candida infection|candida infection
4755803|NCT02888860|colonization|colonization
4755804|NCT02888847|post bleaching teeth sensitivity|post bleaching teeth sensitivity
4755805|NCT02888834|elderly|elderly
4755806|NCT02888834|adverse drug reactions|adverse drug reactions
4755807|NCT02888834|hospitalized subjects|hospitalized subjects
4755808|NCT02888834|community-dwelling|community-dwelling
4755809|NCT02888808|gastroesophageal reflux disease|gastroesophageal reflux disease
4755810|NCT02888808|women|women
4755811|NCT02888808|Nigeria|nigeria
4755812|NCT02888808|obesity|obesity
4755813|NCT02888795|hypertonic dextrose prolotherapy|hypertonic dextrose prolotherapy
4755814|NCT02888795|osteoarthritis|osteoarthritis
4755815|NCT02888769|Coronary artery disease|coronary artery disease
4755816|NCT02888769|Text messages|text messages
4755817|NCT02888769|Blood pressure|blood pressure
4755818|NCT02888769|Lifestyle|lifestyle
4755819|NCT02888769|Risk factors|risk factors
4755820|NCT02888756|Immunotherapy|immunotherapy
4755821|NCT02888756|mRNA|mrna
4755822|NCT02888756|Lentivirus infection|lentivirus infection
4755823|NCT02888756|Virus disease|virus disease
4755824|NCT02888756|Sexually transmitted disease|sexually transmitted disease
4755825|NCT02888756|Immunodeficiency syndrome|immunodeficiency syndrome
4755826|NCT02888730|cystic fibrosis|cystic fibrosis
4755827|NCT02888730|chronic rhinosinusitis|chronic rhinosinusitis
4755828|NCT02888730|Lung Diseases|lung diseases
4755829|NCT02888730|tobramycin|tobramycin
4755830|NCT02888730|nebulized sonic aerosol therapy|nebulized sonic aerosol therapy
4755831|NCT02888704|Atopic dermatitis|atopic dermatitis
4755832|NCT02888704|Mesenchymal stem cells|mesenchymal stem cells
4755833|NCT02888678|ASPIRES|aspires
4755834|NCT02888652|Coronary Heart Disease|coronary heart disease
4755835|NCT02888652|PCI|pci
4755836|NCT02888652|Anti-Platelet Agents|anti-platelet agents
4755837|NCT02888613|mini-lumbotomy|mini-lumbotomy
4755838|NCT02888613|mini-laparotomy|mini-laparotomy
4755839|NCT02888613|retroperitoneal approach|retroperitoneal approach
4755840|NCT02888613|transperitoneal approach|transperitoneal approach
4755841|NCT02888613|abdominal aortic surgery|abdominal aortic surgery
4755842|NCT02888535|primary immunodeficiency|primary immunodeficiency
4755843|NCT02888535|secondary immunodeficiency|secondary immunodeficiency
4755844|NCT02888535|intensive care unit|intensive care unit
4755845|NCT02888535|infection|infection
4755846|NCT02888535|adult|adult
4755847|NCT02888509|depression|depression
4755848|NCT02888509|anxiety disorder|anxiety disorder
4755849|NCT02888509|bipolar disorder|bipolar disorder
4755850|NCT02888509|Magnetic Resonance Imaging|magnetic resonance imaging
4755851|NCT02888483|physical activity|physical activity
4755852|NCT02888483|energy expenditure|energy expenditure
4755853|NCT02888457|nasopharyngeal carriage|nasopharyngeal carriage
4755854|NCT02888457|Streptococcus pneumoniae|streptococcus pneumoniae
4755855|NCT02888457|acute otitis media|acute otitis media
4755856|NCT02888457|day-care centers|day-care centers
4755857|NCT02888431|pH|ph
4755858|NCT02888431|base deficit|base deficit
4755859|NCT02888431|lactate values|lactate values
4755860|NCT02888431|venous blood samples|venous blood samples
4755861|NCT02888431|arterial blood samples|arterial blood samples
4755862|NCT02888418|vaccine|vaccine
4755863|NCT02888418|safety|safety
4755864|NCT02888418|immunogenicity|immunogenicity
4755865|NCT02888405|Body Composition|body composition
4755866|NCT02888366|breast cancer|breast cancer
4755867|NCT02888366|breath test|breath test
4755868|NCT02888366|Menssana|menssana
4755869|NCT02888366|Ancillary|ancillary
4755870|NCT02888366|Mammography|mammography
4755871|NCT02888366|Rapid Point-of-care|rapid point-of-care
4755872|NCT02888366|Inflatable Bag|inflatable bag
4755873|NCT02888353|Magnetic Resonance Imaging and Pacemakers ICD|magnetic resonance imaging and pacemakers icd
4755874|NCT02888340|Acupuncture|acupuncture
4755875|NCT02888340|Emergency Department|emergency department
4755876|NCT02888340|Pain|pain
4755877|NCT02888314|mHealth|mhealth
4755878|NCT02888314|Pokemon Go|pokemon go
4755879|NCT02888288|adolescent|adolescent
4755880|NCT02888288|adolescence|adolescence
4755881|NCT02888288|HIV/AIDS|hiv/aids
4755882|NCT02888288|mental health|mental health
4755883|NCT02888288|cognitive behavioral therapy|cognitive behavioral therapy
4755884|NCT02888262|Bipolar disorder|bipolar disorder
4755885|NCT02888262|Blood|blood
4755886|NCT02888262|Smartphone|smartphone
4755887|NCT02888262|Brain imaging|brain imaging
4755888|NCT02888262|Cognition|cognition
4755889|NCT02888262|Neuropsychology|neuropsychology
4755890|NCT02888249|Tobacco withdrawal|tobacco withdrawal
4755891|NCT02888249|Autonomic Agents|autonomic agents
4755892|NCT02888236|Psoriasis|psoriasis
4755893|NCT02888080|pulmonary sarcoidosis|pulmonary sarcoidosis
4755894|NCT02888080|sarcoidosis|sarcoidosis
4755895|NCT02888080|canakinumab|canakinumab
4755896|NCT02888080|autoimmune diseases|autoimmune diseases
4755897|NCT02888080|granulomas|granulomas
4755898|NCT02888080|inflammation|inflammation
4755899|NCT02888080|lung function testing|lung function testing
4755900|NCT02888080|immunosuppressive agents|immunosuppressive agents
4755901|NCT02888080|interleukin|interleukin
4755902|NCT02888080|interleukin-1Beta|interleukin-1beta
4755903|NCT02888080|[F-18]FDG-PET/CT|[f-18]fdg-pet/ct
4755904|NCT02888080|respiratory|respiratory
4755905|NCT02888080|pulmonary|pulmonary
4755906|NCT02888080|steroids|steroids
4755907|NCT02888080|corticosteroids|corticosteroids
4755908|NCT02888080|lung diseases|lung diseases
4755909|NCT02888067|Neuromuscular Blockade|neuromuscular blockade
4755910|NCT02888041|Cervical ripening|cervical ripening
4755911|NCT02888041|Pregnancy|pregnancy
4755912|NCT02888041|Vaginal Administration|vaginal administration
4755913|NCT02888028|Remote ICD follow-up|remote icd follow-up
4755914|NCT02888028|HRQoL|hrqol
4755915|NCT02888028|Health related Quality of Life|health related quality of life
4755916|NCT02888028|Depression|depression
4755917|NCT02888028|anxiety|anxiety
4755918|NCT02888028|device acceptance|device acceptance
4755919|NCT02888028|telemedicine|telemedicine
4755920|NCT02888028|telemonitoring|telemonitoring
4755921|NCT02887989|Virtual Reality|virtual reality
4755922|NCT02887989|Non-Opioid Pain Management|non-opioid pain management
4755923|NCT02887976|Prostate Cancer|prostate cancer
4755924|NCT02887976|Castrate Resistant Prostate Cancer (CRPC)|castrate resistant prostate cancer (crpc)
4755925|NCT02887976|metastatic|metastatic
4755926|NCT02887976|castrate resistant|castrate resistant
4755927|NCT02887963|Iron Deficiency|iron deficiency
4755928|NCT02887963|Iron Deficiency Anemia|iron deficiency anemia
4755929|NCT02887963|Pregnant Women|pregnant women
4755930|NCT02887963|Gestation|gestation
4755931|NCT02887963|China|china
4755932|NCT02887963|Epidemiology|epidemiology
4755933|NCT02887872|stroke|stroke
4755934|NCT02887872|upper extremity function|upper extremity function
4755935|NCT02887872|rehabilitation|rehabilitation
4755936|NCT02887820|ECMO|ecmo
4755937|NCT02887820|TEG|teg
4755938|NCT02887807|Cardiac arrest|cardiac arrest
4755939|NCT02887807|Shockable|shockable
4755940|NCT02887807|Cyclosporine|cyclosporine
4755941|NCT02887794|pitch discrimination|pitch discrimination
4755942|NCT02887794|auditory processing disorders|auditory processing disorders
4755943|NCT02887794|auditory perception|auditory perception
4755944|NCT02887794|auditory-verbal hallucinations|auditory-verbal hallucinations
4755945|NCT02887794|theory of mind|theory of mind
4755946|NCT02887729|Polycystic disease|polycystic disease
4755947|NCT02887703|ataxia|ataxia
4755948|NCT02887703|balance training|balance training
4755949|NCT02887703|vibrotactile biofeedback|vibrotactile biofeedback
4755950|NCT02887703|sensory augmentation|sensory augmentation
4755951|NCT02887703|cerebellar ataxia|cerebellar ataxia
4755952|NCT02887690|MPL|mpl
4755953|NCT02887690|prosthetic limb|prosthetic limb
4755954|NCT02887690|upper extremity|upper extremity
4755955|NCT02887690|prosthesis|prosthesis
4755956|NCT02887677|Dapagliflozin|dapagliflozin
4755957|NCT02887677|Arterial Stiffness|arterial stiffness
4755958|NCT02887677|Aortic Pressure|aortic pressure
4755959|NCT02887651|cerebrale metastases|cerebrale metastases
4755960|NCT02887651|radiotherapy|radiotherapy
4755961|NCT02887651|surgery|surgery
4755962|NCT02887651|complete surgical resection|complete surgical resection
4755963|NCT02887651|resection|resection
4755964|NCT02887651|cavity boost radiation therapy|cavity boost radiation therapy
4755965|NCT02887651|observation|observation
4755966|NCT02887586|Auricular Needling|auricular needling
4755967|NCT02887586|Mechanism Study|mechanism study
4755968|NCT02887586|Anorexia|anorexia
4755969|NCT02887586|Cancer|cancer
4755970|NCT02887573|Bowel preparation|bowel preparation
4755971|NCT02887573|Colorectal polyps|colorectal polyps
4755972|NCT02887573|Colon capsule endoscopy|colon capsule endoscopy
4755973|NCT02887560|Right ventricle|right ventricle
4755974|NCT02887560|Pulmonary transplantation|pulmonary transplantation
4755975|NCT02887560|Strain|strain
4755976|NCT02887560|isovolumic acceleration (IVA)|isovolumic acceleration (iva)
4755977|NCT02887495|scleroderma|scleroderma
4755978|NCT02887495|biorepository|biorepository
4755979|NCT02887482|DNA|dna
4755980|NCT02887482|Vaccine|vaccine
4755981|NCT02887469|Hyponatremia|hyponatremia
4755982|NCT02887469|Hypertonic saline|hypertonic saline
4755983|NCT02887469|Treatment|treatment
4755984|NCT02887469|Osmotic demyelination syndrome|osmotic demyelination syndrome
4755985|NCT02887430|foot reflexology|foot reflexology
4755986|NCT02887430|pain intensity|pain intensity
4755987|NCT02887430|health-related quality of life|health-related quality of life
4755988|NCT02887417|platelet activation|platelet activation
4755989|NCT02887391|hemodialysis|hemodialysis
4755990|NCT02887391|nutritional status|nutritional status
4755991|NCT02887378|bronchial biopsy|bronchial biopsy
4755992|NCT02887365|colon cancer|colon cancer
4755993|NCT02887365|MSI-L|msi-l
4755994|NCT02887365|MSS|mss
4755995|NCT02887365|Tegafur-Uracil|tegafur-uracil
4755996|NCT02887365|Low-Level Microsatellite-Instability|low-level microsatellite-instability
4755997|NCT02887339|Informed Consent|informed consent
4755998|NCT02887339|Research donation request|research donation request
4755999|NCT02887339|Effective Communication|effective communication
4756000|NCT02887313|Rectal cancer|rectal cancer
4756001|NCT02887313|Neoadjuvant chemoradiation therapy|neoadjuvant chemoradiation therapy
4756002|NCT02887300|Quality of Health Care|quality of health care
4756003|NCT02887300|Psychological Stress|psychological stress
4756004|NCT02887300|Burnout|burnout
4756005|NCT02887300|Health Care Professional|health care professional
4756006|NCT02887300|Mantra Meditation|mantra meditation
4756007|NCT02887300|Health Care Economics|health care economics
4756008|NCT02887274|Systemic Inflammatory Response Syndrome (SIRS)|systemic inflammatory response syndrome (sirs)
4756009|NCT02887274|Sepsis|sepsis
4756010|NCT02887274|Severe Sepsis|severe sepsis
4756011|NCT02887274|Septic shock|septic shock
4756012|NCT02887274|Multiple organ failure|multiple organ failure
4756013|NCT02887261|Power Port|power port
4756014|NCT02887248|nab-paclitaxel|nab-paclitaxel
4756015|NCT02887248|gemcitabine|gemcitabine
4756016|NCT02887222|Epidural|epidural
4756017|NCT02887222|Labor analgesia|labor analgesia
4756018|NCT02887222|Programmed intermittent epidural bolus|programmed intermittent epidural bolus
4756019|NCT02887196|Breast Cancer|breast cancer
4756020|NCT02887183|Heart failure|heart failure
4756021|NCT02887183|Reduced left ventricular ejection fraction|reduced left ventricular ejection fraction
4756022|NCT02887183|HFrEF|hfref
4756023|NCT02887183|NT-proBNP|nt-probnp
4756024|NCT02887183|Cardiac remodeling|cardiac remodeling
4756025|NCT02887170|Adolescent|adolescent
4756026|NCT02887170|Lost to contact|lost to contact
4756027|NCT02887170|Recurrence|recurrence
4756028|NCT02887170|Long-term outcome|long-term outcome
4756029|NCT02887131|Subtalar arthritis|subtalar arthritis
4756030|NCT02887131|Subtalar instability|subtalar instability
4756031|NCT02887118|Erythrocytes|erythrocytes
4756032|NCT02887118|Sickle Cell Disease|sickle cell disease
4756033|NCT02887092|health determinants|health determinants
4756034|NCT02887092|epidemiology|epidemiology
4756035|NCT02887092|maintaining autonomy|maintaining autonomy
4756036|NCT02887092|psychology|psychology
4756037|NCT02887092|osteoarthritis|osteoarthritis
4756038|NCT02887092|perceived health|perceived health
4756039|NCT02887053|MRI|mri
4756040|NCT02887053|Healthy subjects|healthy subjects
4756041|NCT02887040|Diffuse, intrinsic brain stem glioma|diffuse, intrinsic brain stem glioma
4756042|NCT02887040|Antineoplaston therapy|antineoplaston therapy
4756043|NCT02887040|Radiation|radiation
4756044|NCT02887014|bowel preparation|bowel preparation
4756045|NCT02887014|colonoscopy|colonoscopy
4756046|NCT02887014|inpatients|inpatients
4756047|NCT02887014|cathartics|cathartics
4756048|NCT02887001|cost study|cost study
4756049|NCT02887001|clinical pharmacist|clinical pharmacist
4756050|NCT02886988|Botulinum toxin type A, scar|botulinum toxin type a, scar
4756051|NCT02886975|Renal Insufficiency, Chronic|renal insufficiency, chronic
4756052|NCT02886975|Diet, Protein-Restricted|diet, protein-restricted
4756053|NCT02886936|transtibial amputees|transtibial amputees
4756054|NCT02886910|Chorioamnionitis|chorioamnionitis
4756055|NCT02886910|Early onset neonatal sepsis|early onset neonatal sepsis
4756056|NCT02886910|Antibiotics|antibiotics
4756057|NCT02886910|Clinical observation|clinical observation
4756058|NCT02886897|Refractory solid tumors|refractory solid tumors
4756059|NCT02886897|Dendritic and Cytokine-induced killer cell|dendritic and cytokine-induced killer cell
4756060|NCT02886897|Anti-PD-1 antibody|anti-pd-1 antibody
4756061|NCT02886897|Combination immunotherapy|combination immunotherapy
4756062|NCT02886884|Diabetes|diabetes
4756063|NCT02886884|Endothelial dysfunction|endothelial dysfunction
4756064|NCT02886884|Stem cells|stem cells
4756065|NCT02886858|Depression|depression
4756066|NCT02886858|Moods disorders|moods disorders
4756067|NCT02886858|electroconvulsive therapy|electroconvulsive therapy
4756068|NCT02886845|SNP,Breast Neoplasms|snp,breast neoplasms
4756069|NCT02886832|Prostate Health|prostate health
4756070|NCT02886819|Whole body vibration|whole body vibration
4756071|NCT02886819|Tonic vibration reflex|tonic vibration reflex
4756072|NCT02886819|Bone myoregulation reflex|bone myoregulation reflex
4756073|NCT02886806|closed loop|closed loop
4756074|NCT02886806|remifentanil|remifentanil
4756075|NCT02886806|propofol|propofol
4756076|NCT02886767|skin to skin contact|skin to skin contact
4756077|NCT02886754|Clinical Communication|clinical communication
4756078|NCT02886754|ISBAR|isbar
4756079|NCT02886754|Simulation|simulation
4756080|NCT02886754|Performance|performance
4756081|NCT02886754|Non technical skills|non technical skills
4756082|NCT02886754|Proficiency|proficiency
4756083|NCT02886741|campaign|campaign
4756084|NCT02886741|surgical site infection|surgical site infection
4756085|NCT02886741|orthopedic surgery|orthopedic surgery
4756086|NCT02886741|quality improvement|quality improvement
4756087|NCT02886741|infection control|infection control
4756088|NCT02886650|Paediatrics|paediatrics
4756089|NCT02886650|epilepsy surgery|epilepsy surgery
4756090|NCT02886650|genetic mutation|genetic mutation
4756091|NCT02886650|focal seizures|focal seizures
4756092|NCT02886637|A baumannii infection|a baumannii infection
4756093|NCT02886637|Immunosuppression|immunosuppression
4756094|NCT02886637|prognosis|prognosis
4756095|NCT02886637|immune function|immune function
4756096|NCT02886585|Brain Metastases|brain metastases
4756097|NCT02886559|demethylating agent|demethylating agent
4756098|NCT02886559|chidamide|chidamide
4756099|NCT02886533|Major haemorrhage|major haemorrhage
4756100|NCT02886533|Oral anticoagulation|oral anticoagulation
4756101|NCT02886533|Antiplatelet drugs|antiplatelet drugs
4756102|NCT02886533|Gastrointestinal bleeding|gastrointestinal bleeding
4756103|NCT02886533|Intracranial haemorrhage|intracranial haemorrhage
4756104|NCT02886520|Urinary incontinence|urinary incontinence
4756105|NCT02886520|Materials|materials
4756106|NCT02886520|Surgery|surgery
4756107|NCT02886520|Transobturator tape|transobturator tape
4756108|NCT02886520|Polyvinylidene fluoride|polyvinylidene fluoride
4756109|NCT02886520|Polypropylene|polypropylene
4756110|NCT02886481|thyroidectomy|thyroidectomy
4756111|NCT02886481|Electrophysiologic|electrophysiologic
4756112|NCT02886481|vocal cord movement|vocal cord movement
4756113|NCT02886429|dexmedetomidine|dexmedetomidine
4756114|NCT02886429|bupivacaine|bupivacaine
4756115|NCT02886429|Ultrasound guided paravertebral block|ultrasound guided paravertebral block
4756116|NCT02886429|pain|pain
4756117|NCT02886429|post-thoracotomy|post-thoracotomy
4756118|NCT02886416|HIV infection|hiv infection
4756119|NCT02886390|remote ischemic conditioning|remote ischemic conditioning
4756120|NCT02886390|r-tPA thrombolytic therapy|r-tpa thrombolytic therapy
4756121|NCT02886351|Moderate Sedation|moderate sedation
4756122|NCT02886351|Pediatric Dentistry|pediatric dentistry
4756123|NCT02886351|Anxiety|anxiety
4756124|NCT02886325|Receipt of Preventive Cancer Screening|receipt of preventive cancer screening
4756125|NCT02886299|Fibrates|fibrates
4756126|NCT02886299|Statins|statins
4756127|NCT02886299|Hemodialysis|hemodialysis
4756128|NCT02886299|Dyslipidemia|dyslipidemia
4756129|NCT02886299|Improved Oxidative Stress|improved oxidative stress
4756130|NCT02886299|Egypt|egypt
4756131|NCT02886273|Sudden Cardiac Arrest|sudden cardiac arrest
4756132|NCT02886273|Out-of-hospital|out-of-hospital
4756133|NCT02886273|Ventricular fibrillation|ventricular fibrillation
4756134|NCT02886273|Classification|classification
4756135|NCT02886273|Mechanisms|mechanisms
4756136|NCT02886273|Biomarkers|biomarkers
4756137|NCT02886234|HIV|hiv
4756138|NCT02886234|Mindfulness|mindfulness
4756139|NCT02886234|Adherence behaviors|adherence behaviors
4756140|NCT02886234|Stress|stress
4756141|NCT02886234|Depression|depression
4756142|NCT02886221|Hallux Valgus|hallux valgus
4756143|NCT02886221|Reverdin-Isham Osteotomy|reverdin-isham osteotomy
4756144|NCT02886221|Minimally Invasive Surgery|minimally invasive surgery
4756145|NCT02886221|Percutaneous Distal Osteotomy|percutaneous distal osteotomy
4756146|NCT02886221|First Ray|first ray
4756147|NCT02886221|Forefoot|forefoot
4756148|NCT02886182|chronic hepatitis B|chronic hepatitis b
4756149|NCT02886182|pregnancy|pregnancy
4756150|NCT02886182|Cellular immune response|cellular immune response
4756151|NCT02886182|Clinical implications|clinical implications
4756152|NCT02886169|Sacha Inchi|sacha inchi
4756153|NCT02886169|High-fat meal|high-fat meal
4756154|NCT02886169|Postprandial inflammatory responses|postprandial inflammatory responses
4756155|NCT02886156|OSA|osa
4756156|NCT02886156|CPAP|cpap
4756157|NCT02886156|cognitive function|cognitive function
4756158|NCT02886156|gut microbiota|gut microbiota
4756159|NCT02886156|metabolomics|metabolomics
4756160|NCT02886130|Alpha-GPC|alpha-gpc
4756161|NCT02886130|Volleyball|volleyball
4756162|NCT02886130|Athletes|athletes
4756163|NCT02886130|Executive functions|executive functions
4756164|NCT02886130|Vertical jump|vertical jump
4756165|NCT02886130|Peak power|peak power
4756166|NCT02886104|synchronous|synchronous
4756167|NCT02886104|metachronous|metachronous
4756168|NCT02886104|colorectal liver metastasis|colorectal liver metastasis
4756169|NCT02886104|resection|resection
4756170|NCT02886104|ablation|ablation
4756171|NCT02886091|Keloids|keloids
4756172|NCT02886091|Shaving|shaving
4756173|NCT02886091|Ears|ears
4756174|NCT02886091|Cryosurgery|cryosurgery
4756175|NCT02886091|Hypertrophic scars|hypertrophic scars
4756176|NCT02886065|Myeloma|myeloma
4756177|NCT02886052|Cognitive behavior therapy|cognitive behavior therapy
4756178|NCT02886052|Internet treatment|internet treatment
4756179|NCT02886052|Self-help treatment|self-help treatment
4756180|NCT02886052|Insomnia|insomnia
4756181|NCT02886052|ICBT|icbt
4756182|NCT02886052|CBT-i|cbt-i
4756183|NCT02886052|Bereavement|bereavement
4756184|NCT02886039|Cardiorespiratory arrest|cardiorespiratory arrest
4756185|NCT02886039|Neurologic outcome|neurologic outcome
4756186|NCT02886039|Electroencephalogram|electroencephalogram
4756187|NCT02886039|Somatosensory evoked potential|somatosensory evoked potential
4756188|NCT02886039|Synek classification|synek classification
4756189|NCT02886039|Cerebral performance category|cerebral performance category
4756190|NCT02886039|Hypothermia|hypothermia
4756191|NCT02886026|Laser|laser
4756192|NCT02886026|Bladder cancer|bladder cancer
4756193|NCT02886026|Treatment|treatment
4756194|NCT02886026|Outpatient|outpatient
4756195|NCT02886026|TUR-BT|tur-bt
4756196|NCT02886013|prevalence|prevalence
4756197|NCT02885974|Celecoxib|celecoxib
4756198|NCT02885974|Bladder Cancer|bladder cancer
4756199|NCT02885909|type 2 diabetes|type 2 diabetes
4756200|NCT02885909|inpatient|inpatient
4756201|NCT02885909|glucose control|glucose control
4756202|NCT02885909|continue glucose monitor|continue glucose monitor
4756203|NCT02885896|Call center|call center
4756204|NCT02885896|nurses|nurses
4756205|NCT02885896|pediatrics|pediatrics
4756206|NCT02885896|standardized messages|standardized messages
4756207|NCT02885896|family counseling|family counseling
4756208|NCT02885870|biomarker|biomarker
4756209|NCT02885870|spinal cord disease|spinal cord disease
4756210|NCT02885870|resonance imaging|resonance imaging
4756211|NCT02885870|electrophysiology|electrophysiology
4756212|NCT02885831|Abduction splint|abduction splint
4756213|NCT02885831|Pubo-femoral distance|pubo-femoral distance
4756214|NCT02885792|Schizophrenia|schizophrenia
4756215|NCT02885792|Cardiovascular disease|cardiovascular disease
4756216|NCT02885792|Premature mortality|premature mortality
4756217|NCT02885792|Arteriosclerosis|arteriosclerosis
4756218|NCT02885792|Risk factor|risk factor
4756219|NCT02885792|Intervention|intervention
4756220|NCT02885792|Treatment|treatment
4756221|NCT02885792|Somatic morbidity|somatic morbidity
4756222|NCT02885766|CML|cml
4756223|NCT02885766|Myeloid leukaemia chronic|myeloid leukaemia chronic
4756224|NCT02885766|CML progression|cml progression
4756225|NCT02885766|Chronic phase chronic myeloid leukemia|chronic phase chronic myeloid leukemia
4756226|NCT02885766|PF-114|pf-114
4756227|NCT02885766|Cytogenetic response CCyR|cytogenetic response ccyr
4756228|NCT02885766|Major molecular response MMR|major molecular response mmr
4756229|NCT02885766|Complete molecular response CMR|complete molecular response cmr
4756230|NCT02885766|Leukemia, Myelogenous, Chronic, BCR-ABL Positive|leukemia, myelogenous, chronic, bcr-abl positive
4756231|NCT02885766|2-nd generation Bcr-Abl inhibitors resistant|2-nd generation bcr-abl inhibitors resistant
4756232|NCT02885753|colorectal|colorectal
4756233|NCT02885753|cancer|cancer
4756234|NCT02885753|metastasis|metastasis
4756235|NCT02885753|hepatic|hepatic
4756236|NCT02885701|postoperative dressing|postoperative dressing
4756237|NCT02885701|postoperative splint|postoperative splint
4756238|NCT02885701|mini-open carpal tunnel release|mini-open carpal tunnel release
4756239|NCT02885688|Septic Shock|septic shock
4756240|NCT02885688|Sepsis|sepsis
4756241|NCT02885688|Standard of care|standard of care
4756242|NCT02885688|Liquid nutrition|liquid nutrition
4756243|NCT02885688|Metabolic support|metabolic support
4756244|NCT02885688|Enteral nutrition|enteral nutrition
4756245|NCT02885688|Insulin Drip|insulin drip
4756246|NCT02885688|Glucose Drip|glucose drip
4756247|NCT02885662|Primary aldosteronism|primary aldosteronism
4756248|NCT02885662|Hypertension|hypertension
4756249|NCT02885662|mineralocorticoid receptor antagonist|mineralocorticoid receptor antagonist
4756250|NCT02885662|Developmental Phase III|developmental phase iii
4756251|NCT02885636|Heart Failure with Preserved Ejection Fraction|heart failure with preserved ejection fraction
4756252|NCT02885636|Pulmonary Hypertension|pulmonary hypertension
4756253|NCT02885597|Juanbi Pill|juanbi pill
4756254|NCT02885597|Methotrexate|methotrexate
4756255|NCT02885597|Active|active
4756256|NCT02885597|Rheumatoid Arthritis|rheumatoid arthritis
4756257|NCT02885584|Mechanical ventilation|mechanical ventilation
4756258|NCT02885558|Receptors, Calcium Channel Blocker|receptors, calcium channel blocker
4756259|NCT02885532|alcohol|alcohol
4756260|NCT02885519|Vocational Rehabilitation|vocational rehabilitation
4756261|NCT02885519|Common Mental Disorders|common mental disorders
4756262|NCT02885519|Return to Work|return to work
4756263|NCT02885519|Mental Health Services|mental health services
4756264|NCT02885519|Psychological Stress|psychological stress
4756265|NCT02885519|Adjustment Disorder|adjustment disorder
4756266|NCT02885519|Burnout|burnout
4756267|NCT02885519|Integration|integration
4756268|NCT02885519|Cognitive Behavior Therapy|cognitive behavior therapy
4756269|NCT02885493|Parkinson march|parkinson march
4756270|NCT02885467|Total Knee Arthroplasty|total knee arthroplasty
4756271|NCT02885441|Inflammation|inflammation
4756272|NCT02885389|Infantile spasms|infantile spasms
4756273|NCT02885389|West syndrome|west syndrome
4756274|NCT02885389|variant|variant
4756275|NCT02885389|mutation|mutation
4756276|NCT02885389|CNV|cnv
4756277|NCT02885389|sequencing|sequencing
4756278|NCT02885376|Mucositis|mucositis
4756279|NCT02885337|Frail Elderly|frail elderly
4756280|NCT02885337|Arthroplasty|arthroplasty
4756281|NCT02885337|Frailty|frailty
4756282|NCT02885324|High Grade Glioma|high grade glioma
4756283|NCT02885324|Cabozantinib|cabozantinib
4756284|NCT02885324|GBM|gbm
4756285|NCT02885324|Children|children
4756286|NCT02885324|AA|aa
4756287|NCT02885311|Drinking|drinking
4756288|NCT02885311|Excessive drinking|excessive drinking
4756289|NCT02885311|Alcohol use disorders|alcohol use disorders
4756290|NCT02885311|Primary Care|primary care
4756291|NCT02885285|Parkinson's disease|parkinson's disease
4756292|NCT02885285|fatigue|fatigue
4756293|NCT02885285|anxiety|anxiety
4756294|NCT02885285|depression|depression
4756295|NCT02885285|exercise|exercise
4756296|NCT02885272|Malignant neoplasms of eye brain and other parts of central nervous system|malignant neoplasms of eye brain and other parts of central nervous system
4756297|NCT02885272|Glioblastoma|glioblastoma
4756298|NCT02885272|FDG PET|fdg pet
4756299|NCT02885272|CT|ct
4756300|NCT02885272|MRI|mri
4756301|NCT02885246|Panama|panama
4756302|NCT02885246|Influenza B|influenza b
4756303|NCT02885246|Influenza A|influenza a
4756304|NCT02885246|Strain circulation|strain circulation
4756305|NCT02885246|Database|database
4756306|NCT02885233|Fall Prevention|fall prevention
4756307|NCT02885233|Multiple Sclerosis|multiple sclerosis
4756308|NCT02885233|Web-based education|web-based education
4756309|NCT02885233|Self-efficacy|self-efficacy
4756310|NCT02885207|Limbic encephalitis|limbic encephalitis
4756311|NCT02885207|anti-neuronal antibodies|anti-neuronal antibodies
4756312|NCT02885194|Parkinson Disease|parkinson disease
4756313|NCT02885194|Pain|pain
4756314|NCT02885194|Deep Brain Stimulation|deep brain stimulation
4756315|NCT02885194|Laser-Evoked Potentials|laser-evoked potentials
4756316|NCT02885168|vasoreactivity|vasoreactivity
4756317|NCT02885168|recombinant activated protein C|recombinant activated protein c
4756318|NCT02885116|NHF|nhf
4756319|NCT02885116|pulmonary hypertension|pulmonary hypertension
4756320|NCT02885103|NHF|nhf
4756321|NCT02885103|nasal highflow|nasal highflow
4756322|NCT02885038|Platelet Transfusion|platelet transfusion
4756323|NCT02885025|hypersensitivity|hypersensitivity
4756324|NCT02885025|antioxidants|antioxidants
4756325|NCT02884999|trauma|trauma
4756326|NCT02884999|bleeding|bleeding
4756327|NCT02884999|coagulopathy|coagulopathy
4756328|NCT02884999|guidelines compliance|guidelines compliance
4756329|NCT02884999|recommendation|recommendation
4756330|NCT02884999|transfusion|transfusion
4756331|NCT02884986|Etoricoxib|etoricoxib
4756332|NCT02884986|Spinal anaesthesia|spinal anaesthesia
4756333|NCT02884986|Postoperative pain|postoperative pain
4756334|NCT02884973|congenital heart|congenital heart
4756335|NCT02884973|NIRS|nirs
4756336|NCT02884960|Uterine Fibroids|uterine fibroids
4756337|NCT02884960|Embolization|embolization
4756338|NCT02884947|Brain Neoplasms|brain neoplasms
4756339|NCT02884947|Magnetic Resonance Imaging|magnetic resonance imaging
4756340|NCT02884947|Neurosurgery|neurosurgery
4756341|NCT02884934|venous thromboembolism|venous thromboembolism
4756342|NCT02884934|recurrent venous thromboembolism|recurrent venous thromboembolism
4756343|NCT02884934|anticoagulant-related bleeding|anticoagulant-related bleeding
4756344|NCT02884921|Postoperative pain|postoperative pain
4756345|NCT02884921|Dental treatment|dental treatment
4756346|NCT02884921|Paracetamol|paracetamol
4756347|NCT02884895|Intubating Laryngeal Tube Suction|intubating laryngeal tube suction
4756348|NCT02884895|Blind intubation|blind intubation
4756349|NCT02884882|Stroke Basal Ganglia|stroke basal ganglia
4756350|NCT02884882|Emotional change|emotional change
4756351|NCT02884869|Blind intubation,|blind intubation,
4756352|NCT02884869|Laryngeal Mask Airway|laryngeal mask airway
4756353|NCT02884856|color|color
4756354|NCT02884856|dentistry|dentistry
4756355|NCT02884856|gender|gender
4756356|NCT02884843|Laryngeal Tube|laryngeal tube
4756357|NCT02884843|blind intubation|blind intubation
4756358|NCT02884843|fiberoptic|fiberoptic
4756359|NCT02884804|Postpartum Hemorrhage|postpartum hemorrhage
4756360|NCT02884804|Immature platelet|immature platelet
4756361|NCT02884791|FGF21|fgf21
4756362|NCT02884791|Fibroblast growth factor|fibroblast growth factor
4756363|NCT02884791|fructose|fructose
4756364|NCT02884778|pain|pain
4756365|NCT02884778|monitoring|monitoring
4756366|NCT02884778|anesthesia|anesthesia
4756367|NCT02884765|mandibular condyle|mandibular condyle
4756368|NCT02884765|subcondylar|subcondylar
4756369|NCT02884765|mandible|mandible
4756370|NCT02884765|fracture|fracture
4756371|NCT02884700|Legionella|legionella
4756372|NCT02884700|Legionnaires' disease|legionnaires' disease
4756373|NCT02884700|Diagnosis|diagnosis
4756374|NCT02884700|Prognosis|prognosis
4756375|NCT02884674|Obsessive-Compulsive Disorder|obsessive-compulsive disorder
4756376|NCT02884674|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
4756377|NCT02884648|Malignant neoplasms of female genital organs|malignant neoplasms of female genital organs
4756378|NCT02884648|Ovarian Cancer|ovarian cancer
4756379|NCT02884648|Fallopian tube cancer|fallopian tube cancer
4756380|NCT02884648|Primary peritoneal cancer|primary peritoneal cancer
4756381|NCT02884648|Bevacizumab|bevacizumab
4756382|NCT02884648|Avastin|avastin
4756383|NCT02884648|Anti-VEGF monoclonal antibody|anti-vegf monoclonal antibody
4756384|NCT02884648|rhuMab-VEGF|rhumab-vegf
4756385|NCT02884635|Methotrexate|methotrexate
4756386|NCT02884635|ASP1707|asp1707
4756387|NCT02884635|Rheumatoid arthritis|rheumatoid arthritis
4756388|NCT02884622|Lung disease|lung disease
4756389|NCT02884622|Epigenetics|epigenetics
4756390|NCT02884622|DNA methylation|dna methylation
4756391|NCT02884622|Modifier genes|modifier genes
4756392|NCT02884596|Inferior alveolar nerve block|inferior alveolar nerve block
4756393|NCT02884596|irreversible pulpitis|irreversible pulpitis
4756394|NCT02884596|selective serotonin reuptake inhibitor antidepressants|selective serotonin reuptake inhibitor antidepressants
4756395|NCT02884583|Food allergy|food allergy
4756396|NCT02884583|asthma|asthma
4756397|NCT02884583|Predictive factor|predictive factor
4756398|NCT02884583|Exacerbation|exacerbation
4756399|NCT02884583|Prevalence|prevalence
4756400|NCT02884570|Tracheotomy|tracheotomy
4756401|NCT02884570|Anxiety|anxiety
4756402|NCT02884570|Depression|depression
4756403|NCT02884570|Back Home|back home
4756404|NCT02884518|dopamine receptor occupancy|dopamine receptor occupancy
4756405|NCT02884518|antipsychotics|antipsychotics
4756406|NCT02884518|positron emission tomography|positron emission tomography
4756407|NCT02884492|inflammation|inflammation
4756408|NCT02884492|aging|aging
4756409|NCT02884492|mild cognitive impairment|mild cognitive impairment
4756410|NCT02884453|gastrooesophageal carcinoma|gastrooesophageal carcinoma
4756411|NCT02884427|Direct current|direct current
4756412|NCT02884427|Dynamometry|dynamometry
4756413|NCT02884427|Hand strength|hand strength
4756414|NCT02884427|Electrotherapy|electrotherapy
4756415|NCT02884427|Transcutaneous Electric Nerve Stimulation|transcutaneous electric nerve stimulation
4756416|NCT02884414|Knee Pathology|knee pathology
4756417|NCT02884375|Elderly|elderly
4756418|NCT02884375|Cancer|cancer
4756419|NCT02884375|Geriatric assessment|geriatric assessment
4756420|NCT02884375|Treatment|treatment
4756421|NCT02884375|Epidemiology|epidemiology
4756422|NCT02884362|melanoma clinical biological database|melanoma clinical biological database
4756423|NCT02884349|Computer aided orthopaedic surgery|computer aided orthopaedic surgery
4756424|NCT02884349|Implant orientation|implant orientation
4756425|NCT02884349|Range of motion|range of motion
4756426|NCT02884310|Remifentanil|remifentanil
4756427|NCT02884310|Heart Rate Variability|heart rate variability
4756428|NCT02884310|Pupil dilation|pupil dilation
4756429|NCT02884310|SPI|spi
4756430|NCT02884284|breast cancer|breast cancer
4756431|NCT02884284|database|database
4756432|NCT02884271|CPR|cpr
4756433|NCT02884271|cardiac arrest|cardiac arrest
4756434|NCT02884271|operating room|operating room
4756435|NCT02884258|Assisted Reproductive Technology|assisted reproductive technology
4756436|NCT02884258|Obesity|obesity
4756437|NCT02884258|Bariatric Surgery|bariatric surgery
4756438|NCT02884258|Infertility|infertility
4756439|NCT02884258|Fertility Preservation|fertility preservation
4756440|NCT02884245|Fertility|fertility
4756441|NCT02884245|Reproductive processes|reproductive processes
4756442|NCT02884245|In vitro fertilization|in vitro fertilization
4756443|NCT02884245|Intracytoplasmic sperm injection|intracytoplasmic sperm injection
4756444|NCT02884245|Estrogens|estrogens
4756445|NCT02884245|Follicule Stimulating Hormon|follicule stimulating hormon
4756446|NCT02884219|Early treatment|early treatment
4756447|NCT02884219|Expectative treatment|expectative treatment
4756448|NCT02884219|Patent ductus arteriosus|patent ductus arteriosus
4756449|NCT02884219|Preterm|preterm
4756450|NCT02884206|heart failure|heart failure
4756451|NCT02884206|cognition|cognition
4756452|NCT02884206|positron emission tomography|positron emission tomography
4756453|NCT02884206|magnetic resonance imaging|magnetic resonance imaging
4756454|NCT02884206|LCZ696|lcz696
4756455|NCT02884206|valsartan|valsartan
4756456|NCT02884206|Chronic heart failure|chronic heart failure
4756457|NCT02884206|CHF|chf
4756458|NCT02884193|Cooling|cooling
4756459|NCT02884193|Cryotherapy|cryotherapy
4756460|NCT02884193|isometric Force|isometric force
4756461|NCT02884193|Palmar Grip|palmar grip
4756462|NCT02884193|Dynamometry|dynamometry
4756463|NCT02884180|Dexamethasone|dexamethasone
4756464|NCT02884180|Arthroplasty, Replacement, Knee|arthroplasty, replacement, knee
4756465|NCT02884180|Revision|revision
4756466|NCT02884154|Endoscopic ultrasonography|endoscopic ultrasonography
4756467|NCT02884154|Biopsy|biopsy
4756468|NCT02884154|Gastrointestinal tract|gastrointestinal tract
4756469|NCT02884154|Subepithelial tumor|subepithelial tumor
4756470|NCT02884141|Renal Artery Obstruction|renal artery obstruction
4756471|NCT02884141|Carotid Artery Diseases|carotid artery diseases
4756472|NCT02884141|Genetic Association Studies|genetic association studies
4756473|NCT02884102|genetic sequencing|genetic sequencing
4756474|NCT02884102|relapsed|relapsed
4756475|NCT02884076|Hemorrhoids|hemorrhoids
4756476|NCT02884076|Sodergren score|sodergren score
4756477|NCT02884076|Validation|validation
4756478|NCT02884063|PGS|pgs
4756479|NCT02884063|PGD|pgd
4756480|NCT02884063|free embryo DNA|free embryo dna
4756481|NCT02884063|NGS|ngs
4756482|NCT02884037|NAFLD|nafld
4756483|NCT02884037|Rifaximin|rifaximin
4756484|NCT02884037|Endotoxin and Homeostatic Model Assessment|endotoxin and homeostatic model assessment
4756485|NCT02884024|obesity|obesity
4756486|NCT02884024|inflammation|inflammation
4756487|NCT02884024|cancer risk|cancer risk
4756488|NCT02884011|Chronic antihypertensives|chronic antihypertensives
4756489|NCT02884011|Septic shock|septic shock
4756490|NCT02884011|Vasopressor|vasopressor
4756491|NCT02884011|Vasopressor dosing|vasopressor dosing
4756492|NCT02883998|home-based physical therapy|home-based physical therapy
4756493|NCT02883998|outpatient physical therapy|outpatient physical therapy
4756494|NCT02883998|unicompartmental knee arthroplasty|unicompartmental knee arthroplasty
4756495|NCT02883998|PT (Physical Therapy)|pt (physical therapy)
4756496|NCT02883998|osteoarthritis|osteoarthritis
4756497|NCT02883972|Immunization|immunization
4756498|NCT02883972|Behavioural insights|behavioural insights
4756499|NCT02883972|Children|children
4756500|NCT02883959|critically ill|critically ill
4756501|NCT02883959|mechanical ventilation|mechanical ventilation
4756502|NCT02883959|pain|pain
4756503|NCT02883959|nursing|nursing
4756504|NCT02883959|music|music
4756505|NCT02883842|Coronary artery disease|coronary artery disease
4756506|NCT02883842|Diabetes|diabetes
4756507|NCT02883842|Text messages|text messages
4756508|NCT02883777|Kidney Transplantation|kidney transplantation
4756509|NCT02883777|Low Glycemic Index|low glycemic index
4756510|NCT02883777|High Protein|high protein
4756511|NCT02883764|eicosapentaenoic acid|eicosapentaenoic acid
4756512|NCT02883764|EPA|epa
4756513|NCT02883764|docosahexaenoic acid|docosahexaenoic acid
4756514|NCT02883764|DHA|dha
4756515|NCT02883764|omega-3 index|omega-3 index
4756516|NCT02883751|diabetes mellitus|diabetes mellitus
4756517|NCT02883751|amputation stumps|amputation stumps
4756518|NCT02883751|diabetic foot|diabetic foot
4756519|NCT02883751|phototherapy|phototherapy
4756520|NCT02883751|clinical trial|clinical trial
4756521|NCT02883725|Esophageal atresia|esophageal atresia
4756522|NCT02883712|epilepsy|epilepsy
4756523|NCT02883712|pharmacoresistant|pharmacoresistant
4756524|NCT02883712|antiepileptic drug|antiepileptic drug
4756525|NCT02883712|pharmacokinetic|pharmacokinetic
4756526|NCT02883712|pharmacodynamic|pharmacodynamic
4756527|NCT02883712|pharmacogenetic|pharmacogenetic
4756528|NCT02883699|Breast cancer|breast cancer
4756529|NCT02883699|Prostate cancer|prostate cancer
4756530|NCT02883699|Exercise prescription|exercise prescription
4756531|NCT02883699|High intensity interval training|high intensity interval training
4756532|NCT02883699|Daily undulating periodization training|daily undulating periodization training
4756533|NCT02883699|Aerobic training|aerobic training
4756534|NCT02883699|Resistance training|resistance training
4756535|NCT02883699|Physical fitness|physical fitness
4756536|NCT02883699|Exercise|exercise
4756537|NCT02883686|depression|depression
4756538|NCT02883686|pregnancy|pregnancy
4756539|NCT02883686|behavioral activation|behavioral activation
4756540|NCT02883686|peer delivery|peer delivery
4756541|NCT02883686|effectiveness|effectiveness
4756542|NCT02883673|Postpartum Hemorrhage|postpartum hemorrhage
4756543|NCT02883660|genetics|genetics
4756544|NCT02883660|Antidepressants|antidepressants
4756545|NCT02883647|chronic hepatitis b, nucleos(t)ide analog|chronic hepatitis b, nucleos(t)ide analog
4756546|NCT02883634|Back pain|back pain
4756547|NCT02883634|spinal manipulation|spinal manipulation
4756548|NCT02883621|upper endoscopy|upper endoscopy
4756549|NCT02883621|cap assisted endoscopy|cap assisted endoscopy
4756550|NCT02883621|esophagus|esophagus
4756551|NCT02883608|Papilla|papilla
4756552|NCT02883608|major duodenal papilla|major duodenal papilla
4756553|NCT02883608|ampulla of vater|ampulla of vater
4756554|NCT02883595|thymosin alpha 1; sepsis; monocyte; pharmacokinetics|thymosin alpha 1; sepsis; monocyte; pharmacokinetics
4756555|NCT02883582|asthma ,hydrogen|asthma ,hydrogen
4756556|NCT02883569|Low back pain|low back pain
4756557|NCT02883569|Intervertebral Disc Degeneration|intervertebral disc degeneration
4756558|NCT02883569|Spinal stenosis|spinal stenosis
4756559|NCT02883569|Comparative Effectiveness Research|comparative effectiveness research
4756560|NCT02883569|Cost-Benefit Analysis|cost-benefit analysis
4756561|NCT02883556|Carcinoma|carcinoma
4756562|NCT02883556|Squamous Cell|squamous cell
4756563|NCT02883556|Skin|skin
4756564|NCT02883556|pembrolizumab|pembrolizumab
4756565|NCT02883556|Programmed Cell Death 1 Ligand 1|programmed cell death 1 ligand 1
4756566|NCT02883517|cell-free circulating DNA;|cell-free circulating dna;
4756567|NCT02883517|digital PCR|digital pcr
4756568|NCT02883517|liquid biopsy|liquid biopsy
4756569|NCT02883504|E/e' ratio|e/e' ratio
4756570|NCT02883504|Doppler echocardiography, filling pressure|doppler echocardiography, filling pressure
4756571|NCT02883504|Left Ventricular end-Diastolic Pressure|left ventricular end-diastolic pressure
4756572|NCT02883465|diaphragmatic dysfunction|diaphragmatic dysfunction
4756573|NCT02883465|mechanical ventilation weaning|mechanical ventilation weaning
4756574|NCT02883465|failure extubation rate|failure extubation rate
4756576|NCT02883426|H3N2v Influenza Viruses|h3n2v influenza viruses
4756577|NCT02883413|Adolescents|adolescents
4756578|NCT02883413|Cognitive Flexibility|cognitive flexibility
4756579|NCT02883413|Behavioral Flexibility|behavioral flexibility
4756580|NCT02883387|DIEP flap|diep flap
4756581|NCT02883387|Deep inferior epigastric artery perforator flap|deep inferior epigastric artery perforator flap
4756582|NCT02883374|cephalic and cervical adenocystic Carcinoma|cephalic and cervical adenocystic carcinoma
4756583|NCT02883374|Chidamide|chidamide
4756584|NCT02883309|Hemodialysis|hemodialysis
4756585|NCT02883309|Skeletal muscle|skeletal muscle
4756586|NCT02883309|Exercise|exercise
4756587|NCT02883309|Rehabilitation|rehabilitation
4756588|NCT02883309|Disability Evaluation|disability evaluation
4756589|NCT02883257|Major Depression|major depression
4756590|NCT02883257|Major Depressive Disorder|major depressive disorder
4756591|NCT02883257|Persistent Depressive Disorder|persistent depressive disorder
4756592|NCT02883257|Cognitive Behavioral Therapy|cognitive behavioral therapy
4756593|NCT02883257|Biomarkers|biomarkers
4756594|NCT02883218|immunosuppression|immunosuppression
4756595|NCT02883218|community-acquired sepsis|community-acquired sepsis
4756596|NCT02883218|mortality|mortality
4756597|NCT02883192|Cesarean section|cesarean section
4756598|NCT02883192|spinal anesthesia|spinal anesthesia
4756599|NCT02883192|hypotension|hypotension
4756600|NCT02883192|ondansetron|ondansetron
4756601|NCT02883153|Zirconium-89|zirconium-89
4756602|NCT02883153|PET/CT|pet/ct
4756603|NCT02883153|imaging|imaging
4756604|NCT02883153|girentuximab|girentuximab
4756605|NCT02883140|Sialography|sialography
4756606|NCT02883140|Cone-beam CT|cone-beam ct
4756607|NCT02883140|MRI sialography|mri sialography
4756608|NCT02883140|non tumor salivary symptoms|non tumor salivary symptoms
4756609|NCT02883127|Motivational Interviewing|motivational interviewing
4756610|NCT02883127|Diet|diet
4756611|NCT02883127|Carbohydrates|carbohydrates
4756612|NCT02883127|Psychosocial factors|psychosocial factors
4756613|NCT02883114|PF-06648671|pf-06648671
4756614|NCT02883114|GSM|gsm
4756615|NCT02883114|CYP3A|cyp3a
4756616|NCT02883114|drug interaction|drug interaction
4756617|NCT02883088|Optical coherence tomograhpy|optical coherence tomograhpy
4756618|NCT02883088|registry|registry
4756619|NCT02883088|Coronary artery disease|coronary artery disease
4756620|NCT02883036|tigecycline|tigecycline
4756621|NCT02883036|treatment|treatment
4756622|NCT02883036|mitochondrial biogenesis|mitochondrial biogenesis
4756623|NCT02883036|metabolic characteristics|metabolic characteristics
4756624|NCT02883023|Bleomycin|bleomycin
4756625|NCT02883023|Electroporation|electroporation
4756626|NCT02883010|Surgical incision|surgical incision
4756627|NCT02883010|surgical complication|surgical complication
4756628|NCT02883010|NPWT|npwt
4756629|NCT02883010|negative pressure|negative pressure
4756630|NCT02883010|colorectal surgery|colorectal surgery
4756631|NCT02883010|dehisced|dehisced
4756632|NCT02882971|chronic pain|chronic pain
4756633|NCT02882971|rating scale|rating scale
4756634|NCT02882958|Radiology|radiology
4756635|NCT02882932|peritonitis|peritonitis
4756636|NCT02882932|solutions|solutions
4756637|NCT02882932|normal saline|normal saline
4756638|NCT02882932|infection|infection
4756639|NCT02882932|peritoneal lavage|peritoneal lavage
4756640|NCT02882906|Stroke|stroke
4756641|NCT02882906|Pain|pain
4756642|NCT02882906|Shoulder|shoulder
4756643|NCT02882867|Prospective|prospective
4756644|NCT02882867|Epidemiology|epidemiology
4756645|NCT02882867|Track and Field|track and field
4756646|NCT02882841|AIEC (Adherent and Invasive Escherichia Coli)|aiec (adherent and invasive escherichia coli)
4756647|NCT02882841|Mucosal Healing|mucosal healing
4756648|NCT02882841|Non-invasive biomarkers|non-invasive biomarkers
4756649|NCT02882815|IrisFIT PFO|irisfit pfo
4756650|NCT02882802|anger|anger
4756651|NCT02882802|aggression|aggression
4756652|NCT02882763|Early intervention|early intervention
4756653|NCT02882763|ECCE|ecce
4756654|NCT02882763|Intervention study|intervention study
4756655|NCT02882763|Child development|child development
4756656|NCT02882763|At-risk families|at-risk families
4756657|NCT02882763|Psychosocial stress|psychosocial stress
4756658|NCT02882763|Prevention|prevention
4756659|NCT02882763|Educational opportunities|educational opportunities
4756660|NCT02882763|Randomized controlled trial|randomized controlled trial
4756661|NCT02882763|Evaluation|evaluation
4756662|NCT02882763|Parenting|parenting
4756663|NCT02882763|Parent-child interaction|parent-child interaction
4756664|NCT02882750|Lung Cancer|lung cancer
4756665|NCT02882750|Quality of Life|quality of life
4756666|NCT02882750|VATS|vats
4756667|NCT02882750|SABR|sabr
4756668|NCT02882698|Down syndrome|down syndrome
4756669|NCT02882698|motor skills|motor skills
4756670|NCT02882698|physiotherapy|physiotherapy
4756671|NCT02882698|mobile telephone|mobile telephone
4756672|NCT02882698|exposure to virtual reality therapy|exposure to virtual reality therapy
4756673|NCT02882685|Roux-en-Y gastric bypass|roux-en-y gastric bypass
4756674|NCT02882685|Mini-gastric bypass|mini-gastric bypass
4756675|NCT02882685|Single anastomosis gastric bypass|single anastomosis gastric bypass
4756676|NCT02882659|Clinical Trial, Phase I|clinical trial, phase i
4756677|NCT02882646|stroke|stroke
4756678|NCT02882646|cerebral palsy|cerebral palsy
4756679|NCT02882646|rehabilitation|rehabilitation
4756680|NCT02882646|robotics|robotics
4756681|NCT02882646|therapy|therapy
4756682|NCT02882646|bilateral|bilateral
4756683|NCT02882633|lumbar plexus block|lumbar plexus block
4756684|NCT02882633|fascia iliac block|fascia iliac block
4756685|NCT02882633|quality of recovery score|quality of recovery score
4756686|NCT02882633|pain score|pain score
4756687|NCT02882620|Colorectal neoplasm|colorectal neoplasm
4756688|NCT02882620|Screening|screening
4756689|NCT02882620|Patient navigation|patient navigation
4756690|NCT02882620|Randomized controlled trial|randomized controlled trial
4756691|NCT02882620|Cost-benefit analysis|cost-benefit analysis
4756692|NCT02882620|Health behavior|health behavior
4756693|NCT02882620|Health equity|health equity
4756694|NCT02882620|American Indians|american indians
4756695|NCT02882620|Community-based participatory research|community-based participatory research
4756696|NCT02882620|Fecal occult blood test|fecal occult blood test
4756697|NCT02882607|HIV|hiv
4756698|NCT02882607|Prevention|prevention
4756699|NCT02882607|unintended pregnancy|unintended pregnancy
4756700|NCT02882607|Malawi|malawi
4756701|NCT02882607|adolescent women|adolescent women
4756702|NCT02882607|community|community
4756703|NCT02882607|rural|rural
4756704|NCT02882581|Metformin|metformin
4756705|NCT02882581|Pharmacokinetics|pharmacokinetics
4756706|NCT02882581|Organic cation transporter|organic cation transporter
4756707|NCT02882581|Multidrug and toxin extrusion|multidrug and toxin extrusion
4756708|NCT02882581|Pharmacogenetics|pharmacogenetics
4756709|NCT02882581|positron emission tomography|positron emission tomography
4756710|NCT02882542|cerebral oxygen metabolism|cerebral oxygen metabolism
4756711|NCT02882542|functional near-infrared spectroscopy|functional near-infrared spectroscopy
4756712|NCT02882542|partial pressure of carbon dioxide|partial pressure of carbon dioxide
4756713|NCT02882542|heart rate variability|heart rate variability
4756714|NCT02882542|blood pressure|blood pressure
4756715|NCT02882542|affect|affect
4756716|NCT02882542|mood|mood
4756717|NCT02882542|respiration|respiration
4756718|NCT02882542|systematic randomized cross-over study|systematic randomized cross-over study
4756719|NCT02882542|systemic physiology|systemic physiology
4756720|NCT02882542|electro-dermal activity|electro-dermal activity
4756721|NCT02882542|pulse-respiratory quotient|pulse-respiratory quotient
4756722|NCT02882529|cerebral oxygen metabolism|cerebral oxygen metabolism
4756723|NCT02882529|functional near-infrared spectroscopy|functional near-infrared spectroscopy
4756724|NCT02882529|partial pressure of carbon dioxide|partial pressure of carbon dioxide
4756725|NCT02882529|heart rate variability|heart rate variability
4756726|NCT02882529|blood pressure|blood pressure
4756727|NCT02882529|affect|affect
4756728|NCT02882529|mood|mood
4756729|NCT02882529|respiration|respiration
4756730|NCT02882529|systematic randomized cross-over study|systematic randomized cross-over study
4756731|NCT02882529|systemic physiology|systemic physiology
4756732|NCT02882529|electro-dermal activity|electro-dermal activity
4756733|NCT02882529|pulse-respiratory quotient|pulse-respiratory quotient
4756734|NCT02882516|cerebral oxygen metabolism|cerebral oxygen metabolism
4756735|NCT02882516|functional near-infrared spectroscopy|functional near-infrared spectroscopy
4756736|NCT02882516|partial pressure of carbon dioxide|partial pressure of carbon dioxide
4756737|NCT02882516|heart rate variability|heart rate variability
4756738|NCT02882516|blood pressure|blood pressure
4756739|NCT02882516|affect|affect
4756740|NCT02882516|mood|mood
4756741|NCT02882516|respiration|respiration
4756742|NCT02882516|systematic randomized cross-over study|systematic randomized cross-over study
4756743|NCT02882516|systemic physiology|systemic physiology
4756744|NCT02882516|electro-dermal activity|electro-dermal activity
4756745|NCT02882516|pulse-respiratory quotient|pulse-respiratory quotient
4756746|NCT02882503|Endoscopic ultrasound|endoscopic ultrasound
4756747|NCT02882503|Radiofrequency ablation|radiofrequency ablation
4756748|NCT02882503|Pancreas|pancreas
4756749|NCT02882490|Tourette syndrome|tourette syndrome
4756750|NCT02882464|gingival recession|gingival recession
4756751|NCT02882464|mucogingival surgery|mucogingival surgery
4756752|NCT02882451|bile duct|bile duct
4756753|NCT02882451|endoscopic retrograde cholangiopancreatography|endoscopic retrograde cholangiopancreatography
4756754|NCT02882451|pinaverium bromide|pinaverium bromide
4756755|NCT02882425|selexipag|selexipag
4756756|NCT02882425|bioavailability|bioavailability
4756757|NCT02882412|effectiveness|effectiveness
4756758|NCT02882412|buprenorphine/naloxone|buprenorphine/naloxone
4756759|NCT02882412|iatrogenic opioid dependence|iatrogenic opioid dependence
4756760|NCT02882399|athletes|athletes
4756761|NCT02882373|Hypertensive diseases|hypertensive diseases
4756762|NCT02882373|Renal failure|renal failure
4756763|NCT02882373|High blood pressure|high blood pressure
4756764|NCT02882373|Proteinuria|proteinuria
4756765|NCT02882373|L-Arginine|l-arginine
4756766|NCT02882373|Placebo|placebo
4756767|NCT02882373|Phone call|phone call
4756768|NCT02882334|Focal Dystonia|focal dystonia
4756769|NCT02882334|Writer's cramp|writer's cramp
4756770|NCT02882321|Malignant Tumor of Lymphoid Hemopoietic and Related Tissue|malignant tumor of lymphoid hemopoietic and related tissue
4756771|NCT02882321|Acute myeloid leukemia|acute myeloid leukemia
4756772|NCT02882321|AML|aml
4756773|NCT02882321|Relapsed/Refractory|relapsed/refractory
4756774|NCT02882321|IACS-010759|iacs-010759
4756775|NCT02882321|Phone Call follow up|phone call follow up
4756776|NCT02882282|Diseases of oral cavity salivary glands and jaws|diseases of oral cavity salivary glands and jaws
4756777|NCT02882282|High risk oral intra-epithelial neoplasias|high risk oral intra-epithelial neoplasias
4756778|NCT02882282|IEN|ien
4756779|NCT02882282|Oral pre-malignant lesion(s)|oral pre-malignant lesion(s)
4756780|NCT02882282|History of invasive oral cancer|history of invasive oral cancer
4756781|NCT02882282|Pembrolizumab|pembrolizumab
4756782|NCT02882282|Keytruda|keytruda
4756783|NCT02882282|MK-3475|mk-3475
4756784|NCT02882282|SCH-900475|sch-900475
4756785|NCT02882282|Observation only|observation only
4756786|NCT02882269|locally advanced colon cancer|locally advanced colon cancer
4756787|NCT02882269|neoadjuvant chemotherapy|neoadjuvant chemotherapy
4756788|NCT02882256|laceration|laceration
4756789|NCT02882256|urinary tract infection|urinary tract infection
4756790|NCT02882256|minor head injury|minor head injury
4756791|NCT02882256|concussion|concussion
4756792|NCT02882217|Double-blind|double-blind
4756793|NCT02882217|Randomized|randomized
4756794|NCT02882217|Dose-escalating|dose-escalating
4756795|NCT02882217|Placebo-controlled|placebo-controlled
4756796|NCT02882217|Phase I|phase i
4756797|NCT02882217|Healthy volunteers|healthy volunteers
4756798|NCT02882217|Bronchial asthma|bronchial asthma
4756799|NCT02882217|Histamine glutarimide|histamine glutarimide
4756800|NCT02882217|EURRUS|eurrus
4756801|NCT02882191|contraception|contraception
4756802|NCT02882178|Prostate cancer|prostate cancer
4756803|NCT02882178|cabazitaxel|cabazitaxel
4756804|NCT02882178|consensus|consensus
4756805|NCT02882178|conformity|conformity
4756806|NCT02882178|prescription|prescription
4756807|NCT02882178|conditions of use|conditions of use
4756808|NCT02882165|COPD|copd
4756809|NCT02882165|Early Intervention|early intervention
4756810|NCT02882165|Risk|risk
4756811|NCT02882165|Stratification|stratification
4756812|NCT02882152|Analgesia|analgesia
4756813|NCT02882152|Nerve Block|nerve block
4756814|NCT02882152|Pain, Postoperative|pain, postoperative
4756815|NCT02882139|Electrical storm|electrical storm
4756816|NCT02882126|PAH|pah
4756817|NCT02882126|Subcutaneous Treprostinil|subcutaneous treprostinil
4756818|NCT02882126|Remodulin|remodulin
4756819|NCT02882126|6 Minute Walk Test|6 minute walk test
4756820|NCT02882100|influenza|influenza
4756821|NCT02882100|vaccine|vaccine
4756822|NCT02882100|vaccination|vaccination
4756823|NCT02882100|nursing home|nursing home
4756824|NCT02882100|cluster randomized trial|cluster randomized trial
4756825|NCT02882100|respiratory-related hospitalization|respiratory-related hospitalization
4756826|NCT02882061|neck pain|neck pain
4756827|NCT02882061|physical examination|physical examination
4756828|NCT02882061|thoracic manipulation|thoracic manipulation
4756829|NCT02882048|Opioid addiction|opioid addiction
4756830|NCT02882048|Opioid weaning|opioid weaning
4756831|NCT02882035|pain|pain
4756832|NCT02882035|patient comfort|patient comfort
4756833|NCT02882022|Eustachian tube dysfunction|eustachian tube dysfunction
4756834|NCT02882022|Audiometry|audiometry
4756835|NCT02881996|appendicitis|appendicitis
4756836|NCT02881996|pain|pain
4756837|NCT02881996|perforation|perforation
4756838|NCT02881983|alcohol use disorder|alcohol use disorder
4756839|NCT02881983|emotion processing|emotion processing
4756840|NCT02881983|abstinence|abstinence
4756841|NCT02881983|sympathetic system|sympathetic system
4756842|NCT02881983|parasympathetic system|parasympathetic system
4756843|NCT02881957|critical illness|critical illness
4756844|NCT02881957|craniocerebral trauma|craniocerebral trauma
4756845|NCT02881957|intracranial aneurysm|intracranial aneurysm
4756846|NCT02881957|spinal cord injuries|spinal cord injuries
4756847|NCT02881957|seizures|seizures
4756848|NCT02881957|meningitis|meningitis
4756849|NCT02881957|stroke|stroke
4756850|NCT02881957|vitamin d deficiency|vitamin d deficiency
4756851|NCT02881957|cholecalciferol|cholecalciferol
4756852|NCT02881957|intracranial hemorrhages|intracranial hemorrhages
4756853|NCT02881944|Gulf War Illness|gulf war illness
4756854|NCT02881944|Diet|diet
4756855|NCT02881944|IBS|ibs
4756856|NCT02881944|FODMAP|fodmap
4756857|NCT02881931|Huntington's disease|huntington's disease
4756858|NCT02881931|functional rating scale|functional rating scale
4756859|NCT02881931|cognitive pre-testing|cognitive pre-testing
4756860|NCT02881931|patient reported outcome (PRO)|patient reported outcome (pro)
4756861|NCT02881931|HDGEC participant at Pre-Manifest stage|hdgec participant at pre-manifest stage
4756862|NCT02881931|HDGEC participant at Early-Manifest stage|hdgec participant at early-manifest stage
4756863|NCT02881931|Corresponding HDGEC participant companion|corresponding hdgec participant companion
4756864|NCT02881892|CAPD|capd
4756865|NCT02881892|Peritoneal solute transport rate|peritoneal solute transport rate
4756866|NCT02881892|Dialysis adequacy|dialysis adequacy
4756867|NCT02881866|Air hunger|air hunger
4756868|NCT02881866|Work/effort|work/effort
4756869|NCT02881866|Aerosolized|aerosolized
4756870|NCT02881866|Hypercapnia|hypercapnia
4756871|NCT02881866|Resistive load|resistive load
4756872|NCT02881866|Nebulised|nebulised
4756873|NCT02881853|healthy|healthy
4756874|NCT02881853|atopic|atopic
4756875|NCT02881827|Saliva|saliva
4756876|NCT02881827|Low-level laser therapy|low-level laser therapy
4756877|NCT02881827|Masseter muscle|masseter muscle
4756878|NCT02881827|Salivary glands|salivary glands
4756879|NCT02881814|Lung ultrasound|lung ultrasound
4756880|NCT02881814|Chest physiotherapy|chest physiotherapy
4756881|NCT02881814|Decision-making process|decision-making process
4756882|NCT02881814|Diagnostic|diagnostic
4756883|NCT02881801|accelerometry|accelerometry
4756884|NCT02881775|TMS|tms
4756885|NCT02881775|rTMS|rtms
4756886|NCT02881775|corticospinal|corticospinal
4756887|NCT02881775|quadriceps|quadriceps
4756888|NCT02881762|hepatitis C virus (HCV)|hepatitis c virus (hcv)
4756889|NCT02881762|Maraviroc|maraviroc
4756890|NCT02881762|Human immunodeficiency virus (HCV)|human immunodeficiency virus (hcv)
4756891|NCT02881671|genetic|genetic
4756892|NCT02881671|congenital atrioventricular block|congenital atrioventricular block
4756893|NCT02881671|progressive Cardiac Conduction Disease|progressive cardiac conduction disease
4756894|NCT02881658|Plant sterols|plant sterols
4756895|NCT02881658|Low-Density Lipoprotein Cholesterol|low-density lipoprotein cholesterol
4756896|NCT02881658|Phytosterols|phytosterols
4756897|NCT02881658|Soya Beverage|soya beverage
4756898|NCT02881645|Intensive care units|intensive care units
4756899|NCT02881645|Nursing Care|nursing care
4756900|NCT02881645|Critical incidents|critical incidents
4756901|NCT02881645|Best practices|best practices
4756902|NCT02881619|Tooth bleaching|tooth bleaching
4756903|NCT02881593|Operating in Minimally Invasive|operating in minimally invasive
4756904|NCT02881567|Multiple Sclerosis|multiple sclerosis
4756905|NCT02881567|Daclizumab|daclizumab
4756906|NCT02881567|Tysabri-Switch|tysabri-switch
4756907|NCT02881528|Type 1 Diabetes|type 1 diabetes
4756908|NCT02881528|Juvenile Diabetes|juvenile diabetes
4756909|NCT02881502|granulocyte activation|granulocyte activation
4756910|NCT02881502|HDAC2|hdac2
4756911|NCT02881502|severe asthma|severe asthma
4756912|NCT02881437|Primary Immunodeficiency|primary immunodeficiency
4756913|NCT02881437|SubCutaneous Immunoglobulins|subcutaneous immunoglobulins
4756914|NCT02881424|Familiarity|familiarity
4756915|NCT02881424|Recollection|recollection
4756916|NCT02881424|Face Recognition|face recognition
4756917|NCT02881424|Alcohol dependence|alcohol dependence
4756918|NCT02881424|Social cognition|social cognition
4756919|NCT02881411|self-soft tissue therapy|self-soft tissue therapy
4756920|NCT02881411|trigger points|trigger points
4756921|NCT02881411|feasibility study|feasibility study
4756922|NCT02881398|Mobile Health|mobile health
4756923|NCT02881398|Telemedicine|telemedicine
4756924|NCT02881398|Pocket-Echocardiography|pocket-echocardiography
4756925|NCT02881385|Synchrony|synchrony
4756926|NCT02881385|Pressure Support Ventilation|pressure support ventilation
4756927|NCT02881372|oral food desensitization|oral food desensitization
4756928|NCT02881372|food elimination|food elimination
4756929|NCT02881372|food reintroduction|food reintroduction
4756930|NCT02881346|Psoriasis vulgaris|psoriasis vulgaris
4756931|NCT02881346|Plaque|plaque
4756932|NCT02881346|Topical|topical
4756933|NCT02881346|Calcipotriol|calcipotriol
4756934|NCT02881346|Foam|foam
4756935|NCT02881346|Spray|spray
4756936|NCT02881307|Rheumatoid Arthritis (RA)|rheumatoid arthritis (ra)
4756937|NCT02881307|Musculoskeletal Ultrasound (MSUS)|musculoskeletal ultrasound (msus)
4756938|NCT02881255|implantable cardioverter defibrillator|implantable cardioverter defibrillator
4756939|NCT02881255|subcutaneous ICD|subcutaneous icd
4756940|NCT02881255|transvenous ICD|transvenous icd
4756941|NCT02881255|inherited arrhythmia syndrome|inherited arrhythmia syndrome
4756942|NCT02881203|breast cancer|breast cancer
4756943|NCT02881203|radiation|radiation
4756944|NCT02881203|DIBH|dibh
4756945|NCT02881203|cardiac toxicity|cardiac toxicity
4756946|NCT02881177|oxytocin|oxytocin
4756947|NCT02881177|tolerability|tolerability
4756948|NCT02881177|HIV|hiv
4756949|NCT02881177|men who have sex with men (MSM)|men who have sex with men (msm)
4756950|NCT02881177|addiction|addiction
4756951|NCT02881164|Glycemia|glycemia
4756952|NCT02881164|Satiety|satiety
4756953|NCT02881164|Insulin|insulin
4756954|NCT02881164|Breakfast|breakfast
4756955|NCT02881164|Low glycemic index|low glycemic index
4756956|NCT02881164|High glycemic index|high glycemic index
4756957|NCT02881151|Deep brain stimulation|deep brain stimulation
4756958|NCT02881151|DBS|dbs
4756959|NCT02881151|Central thalamus|central thalamus
4756960|NCT02881151|TBI|tbi
4756961|NCT02881151|Traumatic brain injury|traumatic brain injury
4756962|NCT02881086|Acute lymphoblastic leukemia|acute lymphoblastic leukemia
4756963|NCT02881086|Lymphoblastic lymphoma|lymphoblastic lymphoma
4756964|NCT02881086|Nelarabine|nelarabine
4756965|NCT02881086|BCR-ABL|bcr-abl
4756966|NCT02881086|MRD|mrd
4756967|NCT02881086|PEG-Asparaginase|peg-asparaginase
4756968|NCT02881086|Rituximab|rituximab
4756969|NCT02881073|Placental Growth Factor|placental growth factor
4756970|NCT02881073|Maternal Morbidity|maternal morbidity
4756971|NCT02881073|Neonatal Morbidity|neonatal morbidity
4756972|NCT02881073|Pre-eclampsia|pre-eclampsia
4756973|NCT02881073|Heath Economics|heath economics
4756974|NCT02881060|Glucagon|glucagon
4756975|NCT02881060|Ethanol|ethanol
4756976|NCT02881034|Anemia|anemia
4756977|NCT02881034|Antiviral Agents|antiviral agents
4756978|NCT02881034|Glomerular Filtration Rate|glomerular filtration rate
4756979|NCT02881034|Hepatitis C|hepatitis c
4756980|NCT02881034|Ribavirin|ribavirin
4756981|NCT02881034|Telaprevir|telaprevir
4756982|NCT02881021|elastic tape|elastic tape
4756983|NCT02881021|kinesiology taping|kinesiology taping
4756984|NCT02881021|physiotherapy|physiotherapy
4756985|NCT02881021|rotator cuff|rotator cuff
4756986|NCT02881021|shoulder pain|shoulder pain
4756987|NCT02881021|tendon injuries|tendon injuries
4756988|NCT02880995|dopamine receptor occupancy|dopamine receptor occupancy
4756989|NCT02880995|antipsychotics|antipsychotics
4756990|NCT02880995|positron emission tomography|positron emission tomography
4756991|NCT02880956|Early Alzheimer's Disease (AD)|early alzheimer's disease (ad)
4756992|NCT02880956|Mild Cognitive Impairment (MCI)|mild cognitive impairment (mci)
4756993|NCT02880956|Mild Alzheimer's Disease (AD)|mild alzheimer's disease (ad)
4756994|NCT02880956|Tau|tau
4756995|NCT02880956|Early dementia|early dementia
4756996|NCT02880956|Tauopathies|tauopathies
4756997|NCT02880956|AD|ad
4756998|NCT02880956|Neurodegenerative diseases|neurodegenerative diseases
4756999|NCT02880956|Memory loss|memory loss
4757000|NCT02880956|Nervous system diseases|nervous system diseases
4757001|NCT02880930|vitamin D|vitamin d
4757002|NCT02880917|Attention|attention
4757003|NCT02880917|Memory (short and long-term)|memory (short and long-term)
4757004|NCT02880917|Conflict monitoring tasks|conflict monitoring tasks
4757005|NCT02880917|Verbal fluency|verbal fluency
4757006|NCT02880878|Subcortical Intracerebral Hemorrhage|subcortical intracerebral hemorrhage
4757007|NCT02880878|Intracerebral Hemorrhage|intracerebral hemorrhage
4757008|NCT02880878|Intracranial Hemorrhages|intracranial hemorrhages
4757009|NCT02880878|ICH|ich
4757010|NCT02880878|Hemorrhage|hemorrhage
4757011|NCT02880878|Cerebrovascular Disorders|cerebrovascular disorders
4757012|NCT02880878|Brain Diseases|brain diseases
4757013|NCT02880878|Central Nervous System Diseases|central nervous system diseases
4757014|NCT02880878|Nervous System Diseases|nervous system diseases
4757015|NCT02880878|Vascular Diseases|vascular diseases
4757016|NCT02880878|Cardiovascular Diseases|cardiovascular diseases
4757017|NCT02880878|Pathologic Processes|pathologic processes
4757018|NCT02880878|MIPS|mips
4757019|NCT02880878|Minimally Invasive Parafascicular Surgery|minimally invasive parafascicular surgery
4757020|NCT02880878|Neurosurgery|neurosurgery
4757021|NCT02880878|Medical Economic|medical economic
4757022|NCT02880878|Hospital Economics|hospital economics
4757023|NCT02880865|vaccine|vaccine
4757024|NCT02880852|Systemic Lupus Erythematosus|systemic lupus erythematosus
4757025|NCT02880852|Belimumab|belimumab
4757026|NCT02880852|Pharmacodynamics|pharmacodynamics
4757027|NCT02880852|safety tolerability|safety tolerability
4757028|NCT02880852|Pharmacokinetics|pharmacokinetics
4757029|NCT02880852|Chinese subjects|chinese subjects
4757030|NCT02880800|Analgesia, Patient-Controlled|analgesia, patient-controlled
4757031|NCT02880800|Analgesics, Opioid|analgesics, opioid
4757032|NCT02880800|Drug-Related Side Effects and Adverse Reactions|drug-related side effects and adverse reactions
4757033|NCT02880774|Temporomandibular Joint Disorders|temporomandibular joint disorders
4757034|NCT02880774|Mandibular Movement|mandibular movement
4757035|NCT02880774|Músculoesqueléticas Manipulations|músculoesqueléticas manipulations
4757036|NCT02880774|Modalities of Physiotherapy.|modalities of physiotherapy.
4757037|NCT02880761|hemodialysis|hemodialysis
4757038|NCT02880761|chronic renal failure|chronic renal failure
4757039|NCT02880761|arteriovenous fistulae|arteriovenous fistulae
4757040|NCT02880748|Water exchange colonoscopy|water exchange colonoscopy
4757041|NCT02880748|Adenoma miss rate|adenoma miss rate
4757042|NCT02880748|Polyps|polyps
4757043|NCT02880735|Myotonic Dystrophy|myotonic dystrophy
4757044|NCT02880735|Noninvasive Ventilation|noninvasive ventilation
4757045|NCT02880735|Respiratory Failure|respiratory failure
4757046|NCT02880722|Irritable Bowel Syndrome (IBS)|irritable bowel syndrome (ibs)
4757047|NCT02880722|Experience Sampling Method (ESM)|experience sampling method (esm)
4757048|NCT02880722|Ecological Momentary Assessment (EMA)|ecological momentary assessment (ema)
4757049|NCT02880722|Abdominal pain|abdominal pain
4757050|NCT02880696|Time Perception|time perception
4757051|NCT02880696|Tactile Perception|tactile perception
4757052|NCT02880696|Spectroscopy, Near-Infrared|spectroscopy, near-infrared
4757053|NCT02880683|Electrical Stimulation Therapy|electrical stimulation therapy
4757054|NCT02880683|Parasympathetic Nervous System|parasympathetic nervous system
4757055|NCT02880683|Sympathetic Fibers|sympathetic fibers
4757056|NCT02880683|Post Ganglionic|post ganglionic
4757057|NCT02880683|Congestive Heart Failure|congestive heart failure
4757058|NCT02880683|Heart Failure|heart failure
4757059|NCT02880670|Rheumatoid|rheumatoid
4757060|NCT02880657|superoxide dismutase|superoxide dismutase
4757061|NCT02880657|melon concentrate|melon concentrate
4757062|NCT02880657|oxidative stress|oxidative stress
4757063|NCT02880657|physical training|physical training
4757064|NCT02880644|Central retinal vein occlusion|central retinal vein occlusion
4757065|NCT02880644|OCT-A|oct-a
4757066|NCT02880644|CRVO|crvo
4757067|NCT02880618|Heart Failure|heart failure
4757068|NCT02880618|Reduced ejection fraction|reduced ejection fraction
4757069|NCT02880540|Adolescent|adolescent
4757070|NCT02880540|Bariatric|bariatric
4757071|NCT02880540|Obesity|obesity
4757072|NCT02880540|Pain|pain
4757073|NCT02880540|Opiate-sparing|opiate-sparing
4757074|NCT02880475|Moderate to severe chronic non-malignant pain|moderate to severe chronic non-malignant pain
4757075|NCT02880462|schizophrenia|schizophrenia
4757076|NCT02880462|sulforaphane|sulforaphane
4757077|NCT02880423|salpingectomy|salpingectomy
4757078|NCT02880423|cesarean section|cesarean section
4757079|NCT02880423|tubal ligation|tubal ligation
4757080|NCT02880423|morbidity|morbidity
4757081|NCT02880410|Glioblastoma|glioblastoma
4757082|NCT02880410|NeuroBlate|neuroblate
4757083|NCT02880410|LITT|litt
4757084|NCT02880410|Quality of Life|quality of life
4757085|NCT02880397|Anti-inflammatory agents, antimicrobials, Periodontitis|anti-inflammatory agents, antimicrobials, periodontitis
4757086|NCT02880371|Advanced Solid Tumors|advanced solid tumors
4757087|NCT02880371|Pembrolizumab|pembrolizumab
4757088|NCT02880371|ARRY-382|arry-382
4757089|NCT02880371|CSF-1R|csf-1r
4757090|NCT02880371|CSF1R|csf1r
4757091|NCT02880371|cfms|cfms
4757092|NCT02880332|Chronic pain|chronic pain
4757093|NCT02880332|Endogenous Pain Processing|endogenous pain processing
4757094|NCT02880332|Central sensitization|central sensitization
4757095|NCT02880332|Pain neuroscience education|pain neuroscience education
4757096|NCT02880319|Bone Cancer|bone cancer
4757097|NCT02880293|transplant conditioning|transplant conditioning
4757098|NCT02880293|KIR/HLA based haploidentical donor selection|kir/hla based haploidentical donor selection
4757099|NCT02880293|allogeneic hematopoietic cell transplantation|allogeneic hematopoietic cell transplantation
4757100|NCT02880254|body mass index change|body mass index change
4757101|NCT02880254|weight loss|weight loss
4757102|NCT02880254|patient compliance|patient compliance
4757103|NCT02880202|Massage Therapy|massage therapy
4757104|NCT02880202|Hospice|hospice
4757105|NCT02880202|Integrative Medicine|integrative medicine
4757106|NCT02880202|Palliative Care|palliative care
4757107|NCT02880202|Caregivers|caregivers
4757108|NCT02880189|Obesity NOS|obesity nos
4757109|NCT02880189|NASH|nash
4757110|NCT02880189|NASH with Fibrosis|nash with fibrosis
4757111|NCT02880189|Intragastric Balloon|intragastric balloon
4757112|NCT02880189|ORBERA|orbera
4757113|NCT02880189|ORBERA Intragastric Balloon|orbera intragastric balloon
4757114|NCT02880176|Behavioral Economics|behavioral economics
4757115|NCT02880176|Financial Incentives|financial incentives
4757116|NCT02880176|Bladder Cancer|bladder cancer
4757117|NCT02880176|Ambulation|ambulation
4757118|NCT02880176|Surgical Co-Morbidity|surgical co-morbidity
4757119|NCT02880176|Fitbit|fitbit
4757120|NCT02880176|Mobile Health|mobile health
4757121|NCT02880176|Radical Cystectomy|radical cystectomy
4757122|NCT02880150|elite climbers|elite climbers
4757123|NCT02880150|near infrared spectroscopy|near infrared spectroscopy
4757124|NCT02880124|Isotope Labeling, Stable|isotope labeling, stable
4757125|NCT02880124|Exercise, Physical|exercise, physical
4757126|NCT02880124|Calorimetry, Indirect|calorimetry, indirect
4757127|NCT02880124|Athletic Performance|athletic performance
4757128|NCT02880124|Sugar Maple|sugar maple
4757129|NCT02880111|Malignant Brain Tumor|malignant brain tumor
4757130|NCT02880111|patient sputum|patient sputum
4757131|NCT02880098|Neonatology|neonatology
4757132|NCT02880098|Troponin T|troponin t
4757133|NCT02880098|Standards|standards
4757134|NCT02880059|Sleep Apnea, Aneurysm, Subarachnoid Hemorrhage, Blood Pressure.|sleep apnea, aneurysm, subarachnoid hemorrhage, blood pressure.
4757135|NCT02880046|immune response|immune response
4757136|NCT02880046|T lymphocyte|t lymphocyte
4757137|NCT02880046|PD-1/PDL-1 pathway|pd-1/pdl-1 pathway
4757138|NCT02880033|Parkinson's disease|parkinson's disease
4757139|NCT02880033|Amyotrophic lateral sclerosis|amyotrophic lateral sclerosis
4757140|NCT02880033|Peripheral blood mononuclear cells|peripheral blood mononuclear cells
4757141|NCT02880033|ex vivo model for oxidative stress|ex vivo model for oxidative stress
4757142|NCT02880033|iron metabolism and chelation|iron metabolism and chelation
4757143|NCT02880007|Pulsed dose-rate brachytherapy|pulsed dose-rate brachytherapy
4757144|NCT02880007|3D dosimetry|3d dosimetry
4757145|NCT02880007|Prospective Studies|prospective studies
4757146|NCT02880007|Radiotherapy Dosage|radiotherapy dosage
4757147|NCT02880007|Uterine Cervical Neoplasms/radiotherapy|uterine cervical neoplasms/radiotherapy
4757148|NCT02880007|Brachytherapy/methods|brachytherapy/methods
4757149|NCT02879968|serum squamous cell carcinoma antigen|serum squamous cell carcinoma antigen
4757150|NCT02879968|tumor volume|tumor volume
4757151|NCT02879968|Head and Neck Cancer|head and neck cancer
4757152|NCT02879955|Glucagon-Like Peptide 1|glucagon-like peptide 1
4757153|NCT02879955|Carbohydrates|carbohydrates
4757154|NCT02879955|Gastric bypass|gastric bypass
4757155|NCT02879955|Bariatric Surgery|bariatric surgery
4757156|NCT02879955|Overweight|overweight
4757157|NCT02879942|Placental volume|placental volume
4757158|NCT02879942|First-trimester screening|first-trimester screening
4757159|NCT02879942|Ultrasound|ultrasound
4757160|NCT02879942|Preeclampsia|preeclampsia
4757161|NCT02879942|Intrauterine growth restriction|intrauterine growth restriction
4757162|NCT02879942|Biochemical markers|biochemical markers
4757163|NCT02879942|Uterine artery doppler|uterine artery doppler
4757164|NCT02879929|chronic nasal dysfunction|chronic nasal dysfunction
4757165|NCT02879929|Quality of life|quality of life
4757166|NCT02879929|measurement|measurement
4757167|NCT02879929|self-reporting questionnaire|self-reporting questionnaire
4757168|NCT02879929|development|development
4757169|NCT02879929|validation|validation
4757170|NCT02879903|Porphyromonas gingivalis|porphyromonas gingivalis
4757171|NCT02879903|Periodontal treatment|periodontal treatment
4757172|NCT02879903|Smokers|smokers
4757173|NCT02879877|First in human|first in human
4757174|NCT02879877|subjects|subjects
4757175|NCT02879864|fatigue|fatigue
4757176|NCT02879864|tiredness|tiredness
4757177|NCT02879864|luxo therapy|luxo therapy
4757178|NCT02879864|therapy by light|therapy by light
4757179|NCT02879851|ultrasound|ultrasound
4757180|NCT02879851|Koelis system|koelis system
4757181|NCT02879851|MRI|mri
4757182|NCT02879851|gold grain|gold grain
4757183|NCT02879825|Ventricular Premature Complexes|ventricular premature complexes
4757184|NCT02879812|Transplantation Surgery|transplantation surgery
4757185|NCT02879812|Nephrology|nephrology
4757186|NCT02879812|Organ and Tissue Transplantation|organ and tissue transplantation
4757187|NCT02879799|Family-centered care|family-centered care
4757188|NCT02879799|Family-integrated care|family-integrated care
4757189|NCT02879799|Neonatal intensive care unit|neonatal intensive care unit
4757190|NCT02879799|Premature|premature
4757191|NCT02879799|Infant|infant
4757192|NCT02879773|Respiratory Function Tests|respiratory function tests
4757193|NCT02879773|Computed tomography|computed tomography
4757194|NCT02879773|Thoracic surgical procedures|thoracic surgical procedures
4757195|NCT02879773|Diagnosis|diagnosis
4757196|NCT02879760|Lung|lung
4757197|NCT02879760|Cancer|cancer
4757198|NCT02879760|Chemotherapy|chemotherapy
4757199|NCT02879760|Oncolytic virus|oncolytic virus
4757200|NCT02879760|Immunotherapy|immunotherapy
4757201|NCT02879760|Pembrolizumab|pembrolizumab
4757202|NCT02879760|Keytruda|keytruda
4757203|NCT02879747|treatment|treatment
4757204|NCT02879747|growth hormone|growth hormone
4757205|NCT02879747|childhood|childhood
4757206|NCT02879747|short stature|short stature
4757207|NCT02879734|peritoneal dialysis|peritoneal dialysis
4757208|NCT02879734|laparoscopy|laparoscopy
4757209|NCT02879734|omentum|omentum
4757210|NCT02879721|Gastrointestinal|gastrointestinal
4757211|NCT02879708|Social Accountability|social accountability
4757212|NCT02879708|Healthcare Quality|healthcare quality
4757213|NCT02879708|Health System Strengthening|health system strengthening
4757214|NCT02879708|Child Health|child health
4757215|NCT02879708|Childhood pneumonia|childhood pneumonia
4757216|NCT02879708|Childhood diarrhea|childhood diarrhea
4757217|NCT02879682|glioma|glioma
4757218|NCT02879682|brain metastases|brain metastases
4757219|NCT02879682|nTMS|ntms
4757220|NCT02879630|pharmacokinetics|pharmacokinetics
4757221|NCT02879630|acyclovir|acyclovir
4757222|NCT02879604|cognitive remediation, cost-effectiveness analysis|cognitive remediation, cost-effectiveness analysis
4757223|NCT02879552|Upper blepharoplasty|upper blepharoplasty
4757224|NCT02879552|brassiere sutures|brassiere sutures
4757225|NCT02879552|tarsal platform show|tarsal platform show
4757226|NCT02879552|eyeshadow space|eyeshadow space
4757227|NCT02879552|brow fat span|brow fat span
4757228|NCT02879539|cochlear implants, power consumption,|cochlear implants, power consumption,
4757229|NCT02879526|Relapse/Refratory Peripheral T Cell Lymphoma|relapse/refratory peripheral t cell lymphoma
4757230|NCT02879526|Chidamide|chidamide
4757231|NCT02879526|Cyclophosphamide、Prednisone、Thalidomide(CPT)|cyclophosphamide、prednisone、thalidomide(cpt)
4757232|NCT02879500|Systematic review and meta-analysis|systematic review and meta-analysis
4757233|NCT02879500|Evidence-based medicine (EBM)|evidence-based medicine (ebm)
4757234|NCT02879500|Evidence-based nutrition (EBN)|evidence-based nutrition (ebn)
4757235|NCT02879500|Clinical practice guidelines|clinical practice guidelines
4757236|NCT02879500|Randomized controlled trials|randomized controlled trials
4757237|NCT02879500|Prospective cohort studies|prospective cohort studies
4757238|NCT02879500|Body weight|body weight
4757239|NCT02879500|Body mass index|body mass index
4757240|NCT02879500|Adiposity|adiposity
4757241|NCT02879500|Overweight|overweight
4757242|NCT02879500|Obesity|obesity
4757243|NCT02879461|SURGERY|surgery
4757244|NCT02879461|REHABILITATION|rehabilitation
4757245|NCT02879448|Non-valvular atrial fibrillation|non-valvular atrial fibrillation
4757246|NCT02879448|Left Atrial Appendage|left atrial appendage
4757247|NCT02879409|HbA1c variability|hba1c variability
4757248|NCT02879409|Diabetes Mellitus Type 2|diabetes mellitus type 2
4757249|NCT02879409|Diabetes microvascular complications|diabetes microvascular complications
4757250|NCT02879409|Diabetes macrovascular complications|diabetes macrovascular complications
4757251|NCT02879396|Older adults|older adults
4757252|NCT02879396|Avoidable admissions|avoidable admissions
4757253|NCT02879396|Assisted living home|assisted living home
4757254|NCT02879396|Emergency service calls|emergency service calls
4757255|NCT02879396|Heading Assisted Living Facilities|heading assisted living facilities
4757256|NCT02879383|Type 2 Diabetes|type 2 diabetes
4757257|NCT02879370|Anastomotic Leak|anastomotic leak
4757258|NCT02879370|Rectal cancer|rectal cancer
4757259|NCT02879370|Double stapling technique|double stapling technique
4757260|NCT02879357|Care management|care management
4757261|NCT02879357|end of life|end of life
4757262|NCT02879357|advanced care planning|advanced care planning
4757263|NCT02879357|palliative care|palliative care
4757264|NCT02879331|pulmonary emphysema|pulmonary emphysema
4757265|NCT02879331|coils|coils
4757266|NCT02879331|cycloergometry|cycloergometry
4757267|NCT02879331|lung volume reduction|lung volume reduction
4757268|NCT02879305|erythropoiesis stimulating agents|erythropoiesis stimulating agents
4757269|NCT02879305|GSK1278863|gsk1278863
4757270|NCT02879305|daprodustat|daprodustat
4757271|NCT02879305|anemia|anemia
4757272|NCT02879305|chronic kidney disease|chronic kidney disease
4757273|NCT02879305|hemoglobin|hemoglobin
4757274|NCT02879305|recombinant human erythropoietin|recombinant human erythropoietin
4757275|NCT02879292|Pyloric stenosis spinal anesthesia postoperative pain|pyloric stenosis spinal anesthesia postoperative pain
4757276|NCT02879279|Stroke|stroke
4757277|NCT02879279|Upper limb|upper limb
4757278|NCT02879279|Robotic rehabilitation|robotic rehabilitation
4757279|NCT02879266|Dengue Vaccine|dengue vaccine
4757280|NCT02879188|degenerative joint disease|degenerative joint disease
4757281|NCT02879188|total knee arthroplasty|total knee arthroplasty
4757282|NCT02879188|physical therapy|physical therapy
4757283|NCT02879188|arthroplasty, replacement, knee|arthroplasty, replacement, knee
4757284|NCT02879149|Ankle Fusions|ankle fusions
4757285|NCT02879149|AUGMENT® Bone Graft|augment® bone graft
4757286|NCT02879149|Autologous Bone Graft|autologous bone graft
4757287|NCT02879149|arthritis|arthritis
4757288|NCT02879149|ankle pain|ankle pain
4757289|NCT02879149|foot pain|foot pain
4757290|NCT02879149|hindfoot fracture|hindfoot fracture
4757291|NCT02879149|ankle fracture|ankle fracture
4757292|NCT02879136|Gait|gait
4757293|NCT02879136|Balance|balance
4757294|NCT02879136|PD|pd
4757295|NCT02879110|Sulforaphane|sulforaphane
4757296|NCT02879110|clinic trial|clinic trial
4757297|NCT02879110|Autism Spectrum Disorder|autism spectrum disorder
4757298|NCT02879110|Efficacy|efficacy
4757299|NCT02879110|Safety|safety
4757300|NCT02879110|Mechanism|mechanism
4757301|NCT02879032|Treadmill Scores|treadmill scores
4757302|NCT02879032|Coronary Angiogram|coronary angiogram
4757303|NCT02879032|Coronary Artery Disease|coronary artery disease
4757304|NCT02879006|Chinese herbal therapy|chinese herbal therapy
4757305|NCT02879006|Oral immunotherapy|oral immunotherapy
4757306|NCT02879006|Food allergy|food allergy
4757307|NCT02879006|Omalizumab|omalizumab
4757308|NCT02878928|Pharmacogenetic testing|pharmacogenetic testing
4757309|NCT02878928|PGx|pgx
4757310|NCT02878928|Depression|depression
4757311|NCT02878928|Neuropsychiatric diseases|neuropsychiatric diseases
4757312|NCT02878928|IDgenetix|idgenetix
4757313|NCT02878928|AltheaDx|altheadx
4757314|NCT02878902|emergency|emergency
4757315|NCT02878902|coordination|coordination
4757316|NCT02878902|dialysis|dialysis
4757317|NCT02878824|Neurophysiology|neurophysiology
4757318|NCT02878824|Autonomic|autonomic
4757319|NCT02878824|Sensory|sensory
4757320|NCT02878824|Child|child
4757321|NCT02878824|Ethnicity|ethnicity
4757322|NCT02878824|Environment|environment
4757323|NCT02878811|heart failure|heart failure
4757324|NCT02878811|prospective|prospective
4757325|NCT02878811|cohort|cohort
4757326|NCT02878785|AML|aml
4757327|NCT02878746|Mirror therapy|mirror therapy
4757328|NCT02878746|Proprioception|proprioception
4757329|NCT02878746|Rehabilitation|rehabilitation
4757330|NCT02878746|Stroke|stroke
4757331|NCT02878746|Hemiplegia|hemiplegia
4757332|NCT02878720|ischemic stroke|ischemic stroke
4757333|NCT02878720|hemorrhagic chronic|hemorrhagic chronic
4757334|NCT02878720|non-invasive vagus nerve stimulation|non-invasive vagus nerve stimulation
4757335|NCT02878720|robot-assisted rehabilitation|robot-assisted rehabilitation
4757336|NCT02878681|Diabetic Macular Edema.|diabetic macular edema.
4757337|NCT02878668|procalcitonin|procalcitonin
4757338|NCT02878668|post-operative|post-operative
4757339|NCT02878668|complication|complication
4757340|NCT02878668|CRP|crp
4757341|NCT02878655|N0 clinical and radiological|n0 clinical and radiological
4757342|NCT02878655|dissection IIb sector|dissection iib sector
4757343|NCT02878564|Schistosomiasis mansoni|schistosomiasis mansoni
4757344|NCT02878564|HIV susceptibility|hiv susceptibility
4757345|NCT02878564|Genital immunology|genital immunology
4757346|NCT02878564|Mucosal immunology|mucosal immunology
4757347|NCT02878564|HIV entry assay|hiv entry assay
4757348|NCT02878564|Adult women|adult women
4757349|NCT02878512|Segmental Epidural|segmental epidural
4757350|NCT02878512|Regional Anesthesia for PCNL|regional anesthesia for pcnl
4757351|NCT02878499|autism|autism
4757352|NCT02878499|autism spectrum disorder|autism spectrum disorder
4757353|NCT02878499|ASD|asd
4757354|NCT02878499|sleep|sleep
4757355|NCT02878499|Circadian|circadian
4757356|NCT02878499|Biological rhythms|biological rhythms
4757357|NCT02878499|melatonin|melatonin
4757358|NCT02878499|Cognition|cognition
4757359|NCT02878499|Behavior|behavior
4757360|NCT02878499|Longitudinal|longitudinal
4757361|NCT02878499|Longitudinal accelerated design|longitudinal accelerated design
4757362|NCT02878486|Physical activity|physical activity
4757363|NCT02878486|Alzheimer's disease|alzheimer's disease
4757364|NCT02878486|cognitive impairment|cognitive impairment
4757365|NCT02878486|sedentary behavior|sedentary behavior
4757366|NCT02878486|insulin sensitivity|insulin sensitivity
4757367|NCT02878460|HYPEROXIA|hyperoxia
4757368|NCT02878460|MECHANICAL VENTILATION|mechanical ventilation
4757369|NCT02878460|OXYGEN RESERVE INDEX|oxygen reserve index
4757370|NCT02878447|Haemoptysis|haemoptysis
4757371|NCT02878447|Radiotherapy|radiotherapy
4757372|NCT02878447|Tuberculosis|tuberculosis
4757373|NCT02878447|Aspergilloma|aspergilloma
4757374|NCT02878447|Bronchiectasis|bronchiectasis
4757375|NCT02878434|Cancer|cancer
4757376|NCT02878434|Fertility|fertility
4757377|NCT02878434|Pregnancy|pregnancy
4757378|NCT02878434|Chemotherapy|chemotherapy
4757379|NCT02878434|Radiotherapy|radiotherapy
4757380|NCT02878434|Long term|long term
4757381|NCT02878434|Follow up|follow up
4757382|NCT02878395|genomics|genomics
4757383|NCT02878395|epigenomics|epigenomics
4757384|NCT02878395|recurrence|recurrence
4757385|NCT02878382|PDT|pdt
4757386|NCT02878382|skin cancer|skin cancer
4757387|NCT02878382|calcipotriol|calcipotriol
4757388|NCT02878369|fluid replacement|fluid replacement
4757389|NCT02878356|Motivational Interviewing, Clinical supervision, Education|motivational interviewing, clinical supervision, education
4757390|NCT02878330|Respiratory Syncytial Virus, RSV|respiratory syncytial virus, rsv
4757391|NCT02878330|Preterm Infants|preterm infants
4757392|NCT02878330|Lower Respiratory Tract Infection|lower respiratory tract infection
4757393|NCT02878317|Glycosylation End Products, Advanced|glycosylation end products, advanced
4757394|NCT02878317|Skin autofluorescence|skin autofluorescence
4757395|NCT02878317|Renal Dialysis|renal dialysis
4757396|NCT02878304|Prognosis|prognosis
4757397|NCT02878304|Hand function|hand function
4757398|NCT02878304|Rehabilitation|rehabilitation
4757399|NCT02878304|Spasticity|spasticity
4757400|NCT02878304|MRI|mri
4757401|NCT02878278|Chidamide|chidamide
4757402|NCT02878278|Administration method|administration method
4757403|NCT02878265|malaria|malaria
4757404|NCT02878265|vitamin A|vitamin a
4757405|NCT02878265|Zinc|zinc
4757406|NCT02878265|Multivitamin|multivitamin
4757407|NCT02878252|COPD, Asthma, ACOS|copd, asthma, acos
4757408|NCT02878239|knee osteoarthritis|knee osteoarthritis
4757409|NCT02878239|gait|gait
4757410|NCT02878239|Kellgren-Lawrence Scores|kellgren-lawrence scores
4757411|NCT02878161|rheumatoid arthritis|rheumatoid arthritis
4757412|NCT02878161|tumor necrosis factor α inhibitor|tumor necrosis factor α inhibitor
4757413|NCT02878161|predictive|predictive
4757414|NCT02878161|iTRAQ|itraq
4757415|NCT02878161|signal pathway|signal pathway
4757416|NCT02878148|Nephrolithiasis|nephrolithiasis
4757417|NCT02878148|Ureteral stone|ureteral stone
4757418|NCT02878148|Acute renal colic|acute renal colic
4757419|NCT02878148|Ultrasonography|ultrasonography
4757420|NCT02878148|Computed tomography|computed tomography
4757421|NCT02878148|Diagnosis|diagnosis
4757422|NCT02878122|ovarian cancer|ovarian cancer
4757423|NCT02878122|chemo resistance|chemo resistance
4757424|NCT02878122|predictive factors|predictive factors
4757425|NCT02878122|cohort study|cohort study
4757426|NCT02878122|bio bank|bio bank
4757427|NCT02878109|Magnetic resonance imaging (MRI)|magnetic resonance imaging (mri)
4757428|NCT02878109|Transarterial chemoembolization (TACE)|transarterial chemoembolization (tace)
4757429|NCT02878096|nocturnal polyuria|nocturnal polyuria
4757430|NCT02878083|vedolizumab,|vedolizumab,
4757431|NCT02878083|confocal endomicroscopy|confocal endomicroscopy
4757432|NCT02878083|biomarker|biomarker
4757433|NCT02878083|ULCERATIVE COLITIS|ulcerative colitis
4757537|NCT02877342|Triage|triage
4757434|NCT02878070|Spinal Cord Injuries|spinal cord injuries
4757435|NCT02878070|Telemedicine|telemedicine
4757436|NCT02878070|Health Behaviors|health behaviors
4757437|NCT02878057|Apatinib|apatinib
4757438|NCT02878057|HER-2 Negative|her-2 negative
4757439|NCT02878057|Chest wall Metastasis|chest wall metastasis
4757440|NCT02878057|Multicenter Phase II Study|multicenter phase ii study
4757441|NCT02878057|Breast cancer|breast cancer
4757442|NCT02878044|Shared Decision Making, Decision Aid|shared decision making, decision aid
4757443|NCT02878031|Integrated Community Case Management|integrated community case management
4757444|NCT02878031|Community Health Worker|community health worker
4757445|NCT02878031|Nigeria|nigeria
4757446|NCT02878018|Cohort Study|cohort study
4757447|NCT02878018|Children|children
4757448|NCT02878018|Henoch-Schonlein Purpura Nephritis|henoch-schonlein purpura nephritis
4757449|NCT02878018|Traditional Chinese Medicine|traditional chinese medicine
4757450|NCT02878005|Intubating Laryngeal Tube|intubating laryngeal tube
4757451|NCT02878005|blind intubation|blind intubation
4757452|NCT02878005|fiberoptic|fiberoptic
4757453|NCT02877992|Infertility|infertility
4757454|NCT02877992|Tachykinin|tachykinin
4757455|NCT02877992|Kisspeptin|kisspeptin
4757456|NCT02877940|ProSeal LMA|proseal lma
4757457|NCT02877940|LTS-D|lts-d
4757458|NCT02877940|i-gel|i-gel
4757459|NCT02877914|heart failure, retrospective|heart failure, retrospective
4757460|NCT02877888|cost effectiveness|cost effectiveness
4757461|NCT02877888|fluoride varnish|fluoride varnish
4757462|NCT02877888|dental caries|dental caries
4757463|NCT02877875|anxiety|anxiety
4757464|NCT02877875|depression|depression
4757465|NCT02877875|trauma|trauma
4757466|NCT02877875|behavior problems|behavior problems
4757467|NCT02877875|evidence-based treatments|evidence-based treatments
4757468|NCT02877875|manualized treatments|manualized treatments
4757469|NCT02877875|cognitive-behavioral therapy|cognitive-behavioral therapy
4757470|NCT02877875|youth|youth
4757471|NCT02877875|mental health|mental health
4757472|NCT02877849|fMRI|fmri
4757473|NCT02877849|brain networks|brain networks
4757474|NCT02877849|biomarker|biomarker
4757475|NCT02877849|relapse|relapse
4757476|NCT02877849|alcohol|alcohol
4757477|NCT02877836|Dystonia|dystonia
4757478|NCT02877836|fMRI|fmri
4757479|NCT02877836|DTI|dti
4757480|NCT02877836|DBS|dbs
4757481|NCT02877823|Pediatric Antipsychotic Treatment|pediatric antipsychotic treatment
4757482|NCT02877823|Pediatric healthy lifestyle intervention|pediatric healthy lifestyle intervention
4757483|NCT02877823|Parent peer support|parent peer support
4757484|NCT02877784|screening|screening
4757485|NCT02877784|OPMD|opmd
4757486|NCT02877784|dysphagia|dysphagia
4757487|NCT02877784|dysarthria|dysarthria
4757488|NCT02877758|cutaneous aging|cutaneous aging
4757489|NCT02877758|skin rejuvenation|skin rejuvenation
4757490|NCT02877758|wrinkles|wrinkles
4757491|NCT02877732|Concussion|concussion
4757492|NCT02877732|Athletes|athletes
4757493|NCT02877732|Eye-tracking|eye-tracking
4757494|NCT02877732|Vision|vision
4757495|NCT02877706|Registry|registry
4757496|NCT02877693|ICD|icd
4757497|NCT02877693|Thoracic MRI Scan|thoracic mri scan
4757498|NCT02877693|tachycardia|tachycardia
4757499|NCT02877680|Strengths-based|strengths-based
4757500|NCT02877680|Mobile Health (mHealth)|mobile health (mhealth)
4757501|NCT02877680|Adolescence|adolescence
4757502|NCT02877680|Resilience|resilience
4757503|NCT02877680|Family|family
4757504|NCT02877667|tattoo|tattoo
4757505|NCT02877667|laser|laser
4757506|NCT02877654|Plasmatic zonulin|plasmatic zonulin
4757507|NCT02877654|Irritable Bowel Syndrome|irritable bowel syndrome
4757508|NCT02877654|Intestinal permeability|intestinal permeability
4757509|NCT02877641|Current Smoker|current smoker
4757510|NCT02877641|Former Smoker|former smoker
4757511|NCT02877628|pharmacokinetic|pharmacokinetic
4757512|NCT02877628|pharmacodynamic|pharmacodynamic
4757513|NCT02877628|tacrolimus|tacrolimus
4757514|NCT02877628|CYP3A5|cyp3a5
4757515|NCT02877628|liver transplantation|liver transplantation
4757516|NCT02877563|peripheral artery disease|peripheral artery disease
4757517|NCT02877563|contrast enhanced ultrasound|contrast enhanced ultrasound
4757518|NCT02877550|untreated Follicular lymphoma|untreated follicular lymphoma
4757519|NCT02877550|non-Hodgkin lymphoma|non-hodgkin lymphoma
4757520|NCT02877550|Obinutuzumab|obinutuzumab
4757521|NCT02877550|Gazyva|gazyva
4757522|NCT02877550|Gazyvaro|gazyvaro
4757523|NCT02877550|Venetoclax|venetoclax
4757524|NCT02877550|Venclexta|venclexta
4757525|NCT02877446|Left ventricular assist device (LVAD)|left ventricular assist device (lvad)
4757526|NCT02877446|Terminal heart failure|terminal heart failure
4757527|NCT02877446|Ventricular assist device (VAD)|ventricular assist device (vad)
4757528|NCT02877433|Small diameter implant|small diameter implant
4757529|NCT02877433|Cross-arch prostheses|cross-arch prostheses
4757530|NCT02877420|Endoscopy|endoscopy
4757531|NCT02877420|Simulation Training|simulation training
4757532|NCT02877420|Non-technical Skills|non-technical skills
4757533|NCT02877381|Tranexamic Acid|tranexamic acid
4757534|NCT02877381|Blood Transfusion|blood transfusion
4757535|NCT02877342|Injury|injury
4757536|NCT02877342|Injuries|injuries
4757538|NCT02877329|psychological effects|psychological effects
4757539|NCT02877303|Leukemia|leukemia
4757540|NCT02877303|Acute lymphoblastic leukemia|acute lymphoblastic leukemia
4757541|NCT02877303|ALL|all
4757542|NCT02877303|Newly diagnosed B-Cell Lineage Acute lymphoblastic leukemia|newly diagnosed b-cell lineage acute lymphoblastic leukemia
4757543|NCT02877303|Blinatumomab|blinatumomab
4757544|NCT02877303|Blincyto|blincyto
4757545|NCT02877303|G-CSF|g-csf
4757546|NCT02877303|Filgrastim|filgrastim
4757547|NCT02877303|Neupogen|neupogen
4757548|NCT02877303|Pegfilgrastim|pegfilgrastim
4757549|NCT02877303|Neulasta|neulasta
4757550|NCT02877303|PEG-G-CSF|peg-g-csf
4757551|NCT02877303|Cyclophosphamide|cyclophosphamide
4757552|NCT02877303|Cytoxan|cytoxan
4757553|NCT02877303|Neosar|neosar
4757554|NCT02877303|Revimmune|revimmune
4757555|NCT02877303|Clafen|clafen
4757556|NCT02877303|Mesna|mesna
4757557|NCT02877303|Mesnex|mesnex
4757558|NCT02877303|Dexamethasone|dexamethasone
4757559|NCT02877303|Decadron|decadron
4757560|NCT02877303|Ofatumumab|ofatumumab
4757561|NCT02877303|Arzerra|arzerra
4757562|NCT02877303|Methotrexate|methotrexate
4757563|NCT02877303|MTX|mtx
4757564|NCT02877303|Doxorubicin|doxorubicin
4757565|NCT02877303|Doxorubicin Hydrochloride|doxorubicin hydrochloride
4757566|NCT02877303|Adriamycin PFS|adriamycin pfs
4757567|NCT02877303|Adriamycin RDF|adriamycin rdf
4757568|NCT02877303|Adriamycin|adriamycin
4757569|NCT02877303|Rubex|rubex
4757570|NCT02877303|Vincristine|vincristine
4757571|NCT02877303|Oncovin|oncovin
4757572|NCT02877303|Vincasar PFS|vincasar pfs
4757573|NCT02877303|Vincristine Sulfate|vincristine sulfate
4757574|NCT02877303|LCR|lcr
4757575|NCT02877303|VCR|vcr
4757576|NCT02877303|Cytarabine|cytarabine
4757577|NCT02877303|ARA-C|ara-c
4757578|NCT02877303|Cytosar|cytosar
4757579|NCT02877303|DepoCyt|depocyt
4757580|NCT02877303|Cytosine Arabinosine Hydrochloride|cytosine arabinosine hydrochloride
4757581|NCT02877303|Arabino Sylcytosine|arabino sylcytosine
4757582|NCT02877303|Cytosine Arabinoside|cytosine arabinoside
4757583|NCT02877303|Rituximab|rituximab
4757584|NCT02877303|Rituxan|rituxan
4757585|NCT02877303|Leucovorin|leucovorin
4757586|NCT02877303|Citrovorum|citrovorum
4757587|NCT02877303|Wellcovorin|wellcovorin
4757588|NCT02877303|6-Mercaptopurine|6-mercaptopurine
4757589|NCT02877303|Mercaptopurine|mercaptopurine
4757590|NCT02877303|Purinethol|purinethol
4757591|NCT02877303|6-MP|6-mp
4757592|NCT02877303|Prednisone|prednisone
4757593|NCT02877303|Deltasone|deltasone
4757594|NCT02877303|Orasone|orasone
4757595|NCT02877303|Prednicen-M|prednicen-m
4757596|NCT02877290|COPD|copd
4757597|NCT02877290|NIRS|nirs
4757598|NCT02877290|NIV|niv
4757599|NCT02877290|Exercise|exercise
4757600|NCT02877264|Vapendavir|vapendavir
4757601|NCT02877264|Bioavailability|bioavailability
4757602|NCT02877264|Biological Availability|biological availability
4757603|NCT02877264|Volunteers|volunteers
4757604|NCT02877251|Venous Thromboembolism|venous thromboembolism
4757605|NCT02877251|Venous Thrombosis|venous thrombosis
4757606|NCT02877251|Pulmonary Thromboembolism|pulmonary thromboembolism
4757607|NCT02877251|National Registry|national registry
4757608|NCT02877251|Mexico|mexico
4757609|NCT02877251|Major Adverse Cardiovascular Events|major adverse cardiovascular events
4757610|NCT02877238|remote ischemic preconditioning|remote ischemic preconditioning
4757611|NCT02877238|sevoflurane|sevoflurane
4757612|NCT02877238|total intravenous anesthetic|total intravenous anesthetic
4757613|NCT02877212|ITP|itp
4757614|NCT02877212|Eltrombopag|eltrombopag
4757615|NCT02877212|Steroid refractory|steroid refractory
4757616|NCT02877212|Fc Receptor|fc receptor
4757617|NCT02877199|Hepatitis C|hepatitis c
4757618|NCT02877199|anti-E1E2 antibodies|anti-e1e2 antibodies
4757619|NCT02877199|cirrhosis|cirrhosis
4757620|NCT02877199|triple therapy|triple therapy
4757621|NCT02877173|Arteriosclerosis Obliterans|arteriosclerosis obliterans
4757622|NCT02877173|Atherosclerotic Occlusive Disease of the Lower Extremities|atherosclerotic occlusive disease of the lower extremities
4757623|NCT02877173|Intermittent Claudication|intermittent claudication
4757624|NCT02877121|interstitial lung disease|interstitial lung disease
4757625|NCT02877121|Respiratory Muscle Function|respiratory muscle function
4757626|NCT02877121|Neural Respiratory Drive|neural respiratory drive
4757627|NCT02877056|Colorectal adenocarcinoma|colorectal adenocarcinoma
4757628|NCT02877056|Neoadjuvant therapy|neoadjuvant therapy
4757629|NCT02877056|Endoscopy|endoscopy
4757630|NCT02877056|Endoscopic biopsy|endoscopic biopsy
4757631|NCT02877056|Biomarkers|biomarkers
4757632|NCT02877056|Genes|genes
4757633|NCT02876991|choline positron emission tomography|choline positron emission tomography
4757634|NCT02876991|occult recurrence|occult recurrence
4757635|NCT02876991|prostatic adenocarcinoma|prostatic adenocarcinoma
4757636|NCT02876991|sodium fluoride positron emission tomography|sodium fluoride positron emission tomography
4757637|NCT02876952|Cardio-respiratory fitness|cardio-respiratory fitness
4757638|NCT02876952|high intensity exercise training|high intensity exercise training
4757639|NCT02876939|Hereditary Sensory Neuropathy|hereditary sensory neuropathy
4757640|NCT02876939|Autonomic Neuropathy|autonomic neuropathy
4758231|NCT02872948|Digital PCR|digital pcr
4757641|NCT02876939|Familial Dysautonomia|familial dysautonomia
4757642|NCT02876939|proprioception|proprioception
4757643|NCT02876939|motor control|motor control
4757644|NCT02876939|sensory nervous system.|sensory nervous system.
4757645|NCT02876939|HSAN III|hsan iii
4757646|NCT02876939|IKBKAP gene mutation|ikbkap gene mutation
4757647|NCT02876926|HIV testing|hiv testing
4757648|NCT02876926|Self-testing|self-testing
4757649|NCT02876926|Counseling|counseling
4757650|NCT02876926|Referral|referral
4757651|NCT02876874|Rheumatoid Arthritis|rheumatoid arthritis
4757652|NCT02876874|lymph nodes morphology|lymph nodes morphology
4757653|NCT02876874|drainage of lymphatic vessels|drainage of lymphatic vessels
4757654|NCT02876861|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
4757655|NCT02876861|upper tract urothelial carcinoma|upper tract urothelial carcinoma
4757656|NCT02876848|Administrative Claims, Healthcare|administrative claims, healthcare
4757657|NCT02876848|Aromatase Inhibitors|aromatase inhibitors
4757658|NCT02876848|Breast Neoplasms|breast neoplasms
4757659|NCT02876848|Health Services for the Aged|health services for the aged
4757660|NCT02876848|Medical Informatics Applications|medical informatics applications
4757661|NCT02876848|Medication Adherence|medication adherence
4757662|NCT02876848|Outcome and Process Assessment (Health Care)|outcome and process assessment (health care)
4757663|NCT02876848|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators
4757664|NCT02876848|Telemedicine|telemedicine
4757665|NCT02876835|hemoglobin|hemoglobin
4757666|NCT02876835|anemia|anemia
4757667|NCT02876835|non-dialysis|non-dialysis
4757668|NCT02876835|GSK1278863|gsk1278863
4757669|NCT02876835|erythropoiesis stimulating agents|erythropoiesis stimulating agents
4757670|NCT02876835|daprodustat|daprodustat
4757671|NCT02876835|chronic kidney disease|chronic kidney disease
4757672|NCT02876809|centenarians|centenarians
4757673|NCT02876809|geriatric|geriatric
4757674|NCT02876809|telomere length|telomere length
4757675|NCT02876809|progerin|progerin
4757676|NCT02876809|metagenome|metagenome
4757677|NCT02876809|metabolome|metabolome
4757678|NCT02876796|fractional de novo lipogenesis|fractional de novo lipogenesis
4757679|NCT02876796|DNL|dnl
4757680|NCT02876796|pharmacodynamic|pharmacodynamic
4757681|NCT02876796|pharmacokinetic|pharmacokinetic
4757682|NCT02876705|Patterns|patterns
4757683|NCT02876705|Pain|pain
4757684|NCT02876705|Cycling|cycling
4757685|NCT02876705|Running|running
4757686|NCT02876705|Exhaustion|exhaustion
4757687|NCT02876679|Hematopoietic Stem Cell|hematopoietic stem cell
4757688|NCT02876679|Transplantation|transplantation
4757689|NCT02876679|Graft vs Host Disease|graft vs host disease
4757690|NCT02876679|Cyclophosphamide|cyclophosphamide
4757691|NCT02876679|Anti-Thymocyte Globulin|anti-thymocyte globulin
4757692|NCT02876679|GVHD prophylaxis|gvhd prophylaxis
4757693|NCT02876666|Spinal Cord Injuries|spinal cord injuries
4757694|NCT02876666|Health Behavior|health behavior
4757695|NCT02876653|Obstructive sleep apnea|obstructive sleep apnea
4757696|NCT02876653|Aging|aging
4757697|NCT02876653|Telomere length|telomere length
4757823|NCT02875860|Balloon|balloon
4757698|NCT02876614|radionuclide cisternography|radionuclide cisternography
4757699|NCT02876614|CSF leak|csf leak
4757700|NCT02876614|imaging|imaging
4757701|NCT02876601|Coagulation|coagulation
4757702|NCT02876601|Inflammation|inflammation
4757703|NCT02876601|Defibrotide|defibrotide
4757704|NCT02876601|Fibrinolysis|fibrinolysis
4757705|NCT02876588|Wrong-Patient Errors|wrong-patient errors
4757706|NCT02876588|Retract-and-Reorder Tool|retract-and-reorder tool
4757707|NCT02876562|Gingival Recession Coverage|gingival recession coverage
4757708|NCT02876549|G6PD|g6pd
4757709|NCT02876549|Primaquine|primaquine
4757710|NCT02876510|Ovarian Cancer|ovarian cancer
4757711|NCT02876510|Esophageal Cancer|esophageal cancer
4757712|NCT02876510|Head and neck squamous cell carcinoma|head and neck squamous cell carcinoma
4757713|NCT02876510|non-small cell lung cancer|non-small cell lung cancer
4757714|NCT02876510|Gastric Cancer|gastric cancer
4757715|NCT02876510|T-cell Therapy|t-cell therapy
4757716|NCT02876510|immunotherapy|immunotherapy
4757717|NCT02876510|adoptive cellular therapy|adoptive cellular therapy
4757718|NCT02876510|T-cell receptor|t-cell receptor
4757719|NCT02876510|cell therapy|cell therapy
4757720|NCT02876510|cytotherapy|cytotherapy
4757721|NCT02876510|IMA101|ima101
4757722|NCT02876458|Coronary angiogram|coronary angiogram
4757723|NCT02876458|Survival rate|survival rate
4757724|NCT02876458|Neurological sequel|neurological sequel
4757725|NCT02876445|Huntington's disease|huntington's disease
4757726|NCT02876445|Caregiver|caregiver
4757727|NCT02876445|ZARIT burden scale|zarit burden scale
4757728|NCT02876419|nucleic acid polymer REP 2139 HBsAg hepatitis B hepatitis D|nucleic acid polymer rep 2139 hbsag hepatitis b hepatitis d
4757729|NCT02876367|Epidemiology|epidemiology
4757730|NCT02876354|Hemodialysis|hemodialysis
4757731|NCT02876354|Vitamin k2|vitamin k2
4757732|NCT02876354|Vascular calcifications|vascular calcifications
4757733|NCT02876341|Chronic antihypertensives|chronic antihypertensives
4757734|NCT02876341|New onset atrial fibrillation|new onset atrial fibrillation
4757735|NCT02876341|Septic shock|septic shock
4757736|NCT02876328|Ebola Vaccine|ebola vaccine
4757737|NCT02876315|innate immunity|innate immunity
4757738|NCT02876315|elderly adults|elderly adults
4757739|NCT02876315|multivitamin supplement|multivitamin supplement
4757740|NCT02876315|vitamin D|vitamin d
4757741|NCT02876315|vitamin C|vitamin c
4757742|NCT02876315|zinc|zinc
4757743|NCT02876302|Inflammatory Breast Cancer|inflammatory breast cancer
4757744|NCT02876302|Breast Cancer|breast cancer
4757745|NCT02876302|Triple Negative Breast Cancer|triple negative breast cancer
4757746|NCT02876263|aortic diseases|aortic diseases
4757747|NCT02876263|aortic aneurysm|aortic aneurysm
4757748|NCT02876263|electroencephalography|electroencephalography
4757749|NCT02876263|Near-Infrared spectroscopy|near-infrared spectroscopy
4757750|NCT02876263|Transcranial Doppler ultrasonography|transcranial doppler ultrasonography
4757751|NCT02876263|Cardiopulmonary arrest|cardiopulmonary arrest
4757752|NCT02876263|Hypothermia, Induced|hypothermia, induced
4757753|NCT02876250|Lung transplantation|lung transplantation
4757754|NCT02876250|Cyclosporine|cyclosporine
4757755|NCT02876250|Postconditioning|postconditioning
4757756|NCT02876211|Renal disease|renal disease
4757757|NCT02876211|Erythropoiesis|erythropoiesis
4757758|NCT02876211|Erythropoietin stimulating agent|erythropoietin stimulating agent
4757759|NCT02876211|Iron|iron
4757760|NCT02876211|Klotho|klotho
4757761|NCT02876211|Selective vitamin D receptor activation|selective vitamin d receptor activation
4757762|NCT02876198|Retinal neovascularization|retinal neovascularization
4757763|NCT02876198|Anti-VEGF|anti-vegf
4757764|NCT02876198|Retinal Nerve Fiber Layer (RNFL)|retinal nerve fiber layer (rnfl)
4757765|NCT02876185|Glaucoma surveillance|glaucoma surveillance
4757766|NCT02876185|Orthoptist|orthoptist
4757767|NCT02876172|PTSD|ptsd
4757768|NCT02876172|psychotherapy|psychotherapy
4757769|NCT02876172|MDMA|mdma
4757770|NCT02876172|dyad|dyad
4757771|NCT02876172|cognitive behavioral therapy|cognitive behavioral therapy
4757772|NCT02876159|Vaccination|vaccination
4757773|NCT02876146|Albendazole|albendazole
4757774|NCT02876146|Benzimidazole|benzimidazole
4757775|NCT02876146|Echinococcus multilocularis|echinococcus multilocularis
4757776|NCT02876146|Alveolar echinococcosis|alveolar echinococcosis
4757777|NCT02876146|Liver Diseases|liver diseases
4757778|NCT02876107|Malignant neoplasm of breast|malignant neoplasm of breast
4757779|NCT02876107|Breast cancer|breast cancer
4757780|NCT02876107|Newly diagnosed primary triple-negative inflammatory breast cancer|newly diagnosed primary triple-negative inflammatory breast cancer
4757781|NCT02876107|Inflammatory breast cancer|inflammatory breast cancer
4757782|NCT02876107|IBC|ibc
4757783|NCT02876107|TN-IBC|tn-ibc
4757784|NCT02876107|Breast biopsy|breast biopsy
4757785|NCT02876107|Mammogram|mammogram
4757786|NCT02876107|Ultrasound|ultrasound
4757787|NCT02876107|Paclitaxel|paclitaxel
4757788|NCT02876107|Taxol|taxol
4757789|NCT02876107|Carboplatin|carboplatin
4757790|NCT02876107|Paraplatin|paraplatin
4757791|NCT02876107|Panitumumab|panitumumab
4757792|NCT02876107|Vectibix|vectibix
4757793|NCT02876107|Doxorubicin|doxorubicin
4757794|NCT02876107|Doxorubicin Hydrochloride|doxorubicin hydrochloride
4757795|NCT02876107|Adriamycin PFS|adriamycin pfs
4757796|NCT02876107|Adriamycin RDF|adriamycin rdf
4757797|NCT02876107|Adriamycin|adriamycin
4757798|NCT02876107|Rubex|rubex
4757799|NCT02876107|Cyclophosphamide|cyclophosphamide
4757800|NCT02876107|Cytoxan|cytoxan
4757801|NCT02876107|Neosar|neosar
4757802|NCT02876055|Nerve Block/methods|nerve block/methods
4757803|NCT02876055|Pain, Postoperative/prevention & control|pain, postoperative/prevention & control
4757804|NCT02876055|Anesthetics, Local/administration & dosage|anesthetics, local/administration & dosage
4757805|NCT02876055|Brachial Plexus/ultrasonography|brachial plexus/ultrasonography
4757806|NCT02876055|Shoulder Pain/prevention & control|shoulder pain/prevention & control
4757807|NCT02876042|Heart Failure|heart failure
4757808|NCT02876042|Preserved Ejection Fraction|preserved ejection fraction
4757809|NCT02875938|left middle cerebral artery|left middle cerebral artery
4757810|NCT02875938|cerebrovascular accident (CVA)|cerebrovascular accident (cva)
4757811|NCT02875938|stroke|stroke
4757812|NCT02875925|blood coagulation|blood coagulation
4757813|NCT02875912|Family|family
4757814|NCT02875912|Care Rituals|care rituals
4757815|NCT02875912|End of Life|end of life
4757816|NCT02875912|Discordance of care|discordance of care
4757817|NCT02875860|CDH|cdh
4757818|NCT02875860|Congenital Diaphragmatic Hernia|congenital diaphragmatic hernia
4757819|NCT02875860|Fetal Tracheal Occlusion|fetal tracheal occlusion
4757820|NCT02875860|FETO|feto
4757821|NCT02875860|plug-unplug|plug-unplug
4757822|NCT02875860|GoldBal2|goldbal2
4757824|NCT02875860|Goldvalve Balloon|goldvalve balloon
4757825|NCT02875860|TOTAL|total
4757826|NCT02875795|linguistic|linguistic
4757827|NCT02875795|quality of life|quality of life
4757828|NCT02875782|Smoking Cessation|smoking cessation
4757829|NCT02875769|cetylpyridinium chloride|cetylpyridinium chloride
4757830|NCT02875769|chlorhexidine|chlorhexidine
4757831|NCT02875769|oral aerosol|oral aerosol
4757832|NCT02875769|oral splatter|oral splatter
4757833|NCT02875769|mouthwash|mouthwash
4757834|NCT02875769|microbiology|microbiology
4757835|NCT02875704|DR|dr
4757836|NCT02875704|AMD|amd
4757837|NCT02875691|disease activity|disease activity
4757838|NCT02875652|circulation tumor DNA|circulation tumor dna
4757839|NCT02875652|choroidal melanoma|choroidal melanoma
4757840|NCT02875639|Ischemic Heart Failure|ischemic heart failure
4757841|NCT02875639|coronary artery disease|coronary artery disease
4757842|NCT02875639|qi deficiency and blood stasis|qi deficiency and blood stasis
4757843|NCT02875613|Nasopharyngeal|nasopharyngeal
4757844|NCT02875613|PD-L1|pd-l1
4757845|NCT02875613|monoclonal antibody|monoclonal antibody
4757846|NCT02875613|Epstein-barr virus|epstein-barr virus
4757847|NCT02875600|chronic gastro-intestinal ischemia|chronic gastro-intestinal ischemia
4757848|NCT02875600|oxygen deficiency of the gastro-intestinal tract|oxygen deficiency of the gastro-intestinal tract
4757849|NCT02875587|OHSS|ohss
4757850|NCT02875587|Infertility|infertility
4757851|NCT02875587|Cabergoline|cabergoline
4757852|NCT02875587|Calcium gluconate|calcium gluconate
4757853|NCT02875587|IVF-ET|ivf-et
4757854|NCT02875574|Isoniazid|isoniazid
4757855|NCT02875574|Drug Resistance|drug resistance
4757856|NCT02875535|Evidence-based|evidence-based
4757857|NCT02875535|lesbian, gay, bisexual, transgender, intersex, and queer|lesbian, gay, bisexual, transgender, intersex, and queer
4757858|NCT02875535|adolescent|adolescent
4757859|NCT02875535|Suicide prevention|suicide prevention
4757860|NCT02875535|Implementation study|implementation study
4757861|NCT02875522|COPD|copd
4757862|NCT02875522|Exercise Training|exercise training
4757863|NCT02875522|Flow-Mediated Dilation|flow-mediated dilation
4757864|NCT02875522|Arterial Stiffness|arterial stiffness
4757865|NCT02875522|Echocardiography|echocardiography
4757866|NCT02875522|Cerebrovascular Physiology|cerebrovascular physiology
4757867|NCT02875470|non-surgical periodontal debridement|non-surgical periodontal debridement
4757868|NCT02875470|root planing/instrumentation|root planing/instrumentation
4757869|NCT02875470|cytokine(s)|cytokine(s)
4757870|NCT02875470|dental plaque|dental plaque
4757871|NCT02875470|microscopy, electron, scanning|microscopy, electron, scanning
4757872|NCT02875457|small cell lung cancer; apatinib; etoposide; cisplatin|small cell lung cancer; apatinib; etoposide; cisplatin
4757873|NCT02875405|postoperative|postoperative
4757874|NCT02875405|pericardiotomy|pericardiotomy
4757875|NCT02875405|prevention|prevention
4757876|NCT02875405|cardiac surgery|cardiac surgery
4757877|NCT02875405|left|left
4757878|NCT02875405|posterior|posterior
4757879|NCT02875379|Noninvasive Ventilation|noninvasive ventilation
4757880|NCT02875379|Mechanical Ventilation|mechanical ventilation
4757881|NCT02875353|Post-Polypectomy|post-polypectomy
4757882|NCT02875353|Colon bleeding|colon bleeding
4757883|NCT02875353|Stigmata of recent hemorrhage|stigmata of recent hemorrhage
4757884|NCT02875327|SEER|seer
4757885|NCT02875327|Medicaid|medicaid
4757886|NCT02875327|Cancer|cancer
4757887|NCT02875327|Health Services Research|health services research
4757888|NCT02875327|Epidemiology|epidemiology
4757889|NCT02875301|Exercise|exercise
4757890|NCT02875301|Brain Health|brain health
4757891|NCT02875301|Dose Response|dose response
4757892|NCT02875301|Cognition|cognition
4757893|NCT02875262|intracranial aneurysm|intracranial aneurysm
4757894|NCT02875262|subarachnoid hemorrhage|subarachnoid hemorrhage
4757895|NCT02875262|stroke|stroke
4757896|NCT02875262|chelator|chelator
4757897|NCT02875249|post-antibiotic diarrhea|post-antibiotic diarrhea
4757898|NCT02875249|intestinal microbiome|intestinal microbiome
4757899|NCT02875223|Safety|safety
4757900|NCT02875223|CC-90011|cc-90011
4757901|NCT02875223|Relapsed and/or Refractory Solid Tumors|relapsed and/or refractory solid tumors
4757902|NCT02875223|Non-Hodgkin's Lymphomas|non-hodgkin's lymphomas
4757903|NCT02875210|Anterior Cruciate Ligament|anterior cruciate ligament
4757904|NCT02875210|A02.835.583.512.100|a02.835.583.512.100
4757905|NCT02875197|Kinetics|kinetics
4757906|NCT02875197|Biomechanics|biomechanics
4757907|NCT02875197|Amputation|amputation
4757908|NCT02875197|Prosthesis|prosthesis
4757909|NCT02875197|Transtibial|transtibial
4757910|NCT02875184|Psoriatic Arthritis|psoriatic arthritis
4757911|NCT02875184|Apremilast|apremilast
4757912|NCT02875184|CC-10004|cc-10004
4757913|NCT02875171|Anthracyclines; Cardiotoxicity; 2-D Echocardiography|anthracyclines; cardiotoxicity; 2-d echocardiography
4757914|NCT02875145|Corneal Transplantation|corneal transplantation
4757915|NCT02875145|Graft Survival|graft survival
4757916|NCT02875106|Sinus rhythm|sinus rhythm
4757917|NCT02875041|rehabilitation|rehabilitation
4757918|NCT02875041|balance|balance
4757919|NCT02875028|Coagulations|coagulations
4757920|NCT02875028|Platelets|platelets
4757921|NCT02875028|Inflammation|inflammation
4757922|NCT02875028|endotoxemia|endotoxemia
4757923|NCT02875028|vorapaxar|vorapaxar
4757924|NCT02875015|Anesthetics|anesthetics
4757925|NCT02875015|Anesthetic Effects|anesthetic effects
4757926|NCT02875015|Mid-urethral sling|mid-urethral sling
4757927|NCT02874976|sedentary lifestyle|sedentary lifestyle
4757928|NCT02874963|Diabetes|diabetes
4757929|NCT02874963|Oral Hygiene|oral hygiene
4757930|NCT02874963|Periodontal Surgery|periodontal surgery
4757931|NCT02874963|Periodontal Medicine|periodontal medicine
4757932|NCT02874950|Exercise|exercise
4757933|NCT02874937|Syncope|syncope
4757934|NCT02874937|Vasovagal|vasovagal
4757935|NCT02874937|Atomoxetine|atomoxetine
4757936|NCT02874924|Geriatrics|geriatrics
4757937|NCT02874911|Exergaming|exergaming
4757938|NCT02874911|Neurodegenerative diseases|neurodegenerative diseases
4757939|NCT02874911|Rare disease|rare disease
4757940|NCT02874911|Motor exercises|motor exercises
4757941|NCT02874911|Training|training
4757942|NCT02874911|Spinocerebellar ataxia|spinocerebellar ataxia
4757943|NCT02874885|Locally-advanced rectal cancer|locally-advanced rectal cancer
4757944|NCT02874885|LARC|larc
4757945|NCT02874885|Colorectal cancer|colorectal cancer
4757946|NCT02874885|CRC|crc
4757947|NCT02874885|Rectosigmoid cancer|rectosigmoid cancer
4757948|NCT02874885|No known diagnosis of colorectal cancer|no known diagnosis of colorectal cancer
4757949|NCT02874885|Blood draws|blood draws
4757950|NCT02874885|Blood samples|blood samples
4757951|NCT02874885|Circulating tumor cells (CTC)|circulating tumor cells (ctc)
4757953|NCT02874872|Nursing homes|nursing homes
4757954|NCT02874872|Antibiotic Stewardship|antibiotic stewardship
4757955|NCT02874872|Antibiotic Resistance|antibiotic resistance
4757956|NCT02874859|DIABETIC RETINOPATHY|diabetic retinopathy
4757957|NCT02874859|Intravitreal aflibercept|intravitreal aflibercept
4757958|NCT02874833|Depression|depression
4757959|NCT02874833|Unipolar depression|unipolar depression
4757960|NCT02874833|Bipolar affective disorder|bipolar affective disorder
4757961|NCT02874833|Exercise|exercise
4757962|NCT02874833|Internet-based intervention|internet-based intervention
4757963|NCT02874820|Imidazoline Receptor 2|imidazoline receptor 2
4757964|NCT02874820|(4,5-dihydro-1H-imidazol-2-yl)-1-methyl-1H-indole|(4,5-dihydro-1h-imidazol-2-yl)-1-methyl-1h-indole
4757965|NCT02874820|BU99008|bu99008
4757966|NCT02874820|[11C]-BU99008|[11c]-bu99008
4757967|NCT02874820|Radionuclide Imaging|radionuclide imaging
4757968|NCT02874820|Molecular Imaging|molecular imaging
4757969|NCT02874807|Hyponatremia|hyponatremia
4757970|NCT02874807|SGLT2 inhibitor|sglt2 inhibitor
4757971|NCT02874794|Heart Failure|heart failure
4757972|NCT02874794|Reduced Ejection Fraction|reduced ejection fraction
4757973|NCT02874794|Central Aortic Stiffness|central aortic stiffness
4757974|NCT02874794|Vascular|vascular
4757975|NCT02874794|Echocardiogram|echocardiogram
4757976|NCT02874755|Quality of Care|quality of care
4757977|NCT02874755|Standardized Patients|standardized patients
4757978|NCT02874729|Biomarkers, Tumor|biomarkers, tumor
4757979|NCT02874729|Biological Assay|biological assay
4757980|NCT02874716|Quality of Care|quality of care
4757981|NCT02874716|Standardized Patients|standardized patients
4757982|NCT02874677|Multiple sclerosis|multiple sclerosis
4757983|NCT02874677|Ventilatory threshold|ventilatory threshold
4757984|NCT02874677|Effort Reeducation|effort reeducation
4757985|NCT02874651|Nasopharyngeal Carcinoma|nasopharyngeal carcinoma
4757986|NCT02874651|EB Virus|eb virus
4757987|NCT02874651|DNA|dna
4757988|NCT02874651|vascular endothecial growth factor receptor inhibitor|vascular endothecial growth factor receptor inhibitor
4757989|NCT02874651|Apatinib|apatinib
4757990|NCT02874612|Young Adults|young adults
4757991|NCT02874612|Psychosocial Functioning|psychosocial functioning
4757992|NCT02874573|Inflammation|inflammation
4757993|NCT02874573|Schizophrenia|schizophrenia
4757994|NCT02874560|CNS|cns
4757995|NCT02874560|Antipsychotic|antipsychotic
4757996|NCT02874560|Functional remission|functional remission
4757997|NCT02874560|Observational study|observational study
4757998|NCT02874560|FROGS|frogs
4757999|NCT02874560|PSP|psp
4758000|NCT02874560|Functioning|functioning
4758001|NCT02874560|Schizophrenia|schizophrenia
4758002|NCT02874508|leukocyte subpopulations|leukocyte subpopulations
4758003|NCT02874508|perioperative myocardial infarction|perioperative myocardial infarction
4758004|NCT02874508|non-cardiac surgery|non-cardiac surgery
4758005|NCT02874508|perioperative cardiovascular risk|perioperative cardiovascular risk
4758006|NCT02874495|Crohn's disease|crohn's disease
4758007|NCT02874495|Rectal Distension|rectal distension
4758008|NCT02874495|Remission|remission
4758009|NCT02874495|Anticipation|anticipation
4758010|NCT02874495|Painful|painful
4758011|NCT02874482|Schizophrenia|schizophrenia
4758012|NCT02874482|Change blindness|change blindness
4758013|NCT02874482|Eye tracking|eye tracking
4758014|NCT02874482|Implicit response|implicit response
4758015|NCT02874469|sudden death|sudden death
4758016|NCT02874469|post-traumatic stress disorder|post-traumatic stress disorder
4758017|NCT02874469|psychological distress|psychological distress
4758018|NCT02874469|diary|diary
4758019|NCT02874469|resuscitation|resuscitation
4758020|NCT02874456|Zyca virus|zyca virus
4758021|NCT02874352|intensive care|intensive care
4758022|NCT02874352|tracheostomy|tracheostomy
4758023|NCT02874339|Acute cardiogenic pulmonary|acute cardiogenic pulmonary
4758024|NCT02874339|Respiratory failure|respiratory failure
4758025|NCT02874339|Hypercapnia|hypercapnia
4758026|NCT02874339|High flow nasal oxygen|high flow nasal oxygen
4758027|NCT02874339|Non invasive ventilation|non invasive ventilation
4758028|NCT02874339|Emergency department|emergency department
4758029|NCT02874326|Sandostatin LAR|sandostatin lar
4758030|NCT02874326|Somatostatin|somatostatin
4758031|NCT02874326|Octreotide|octreotide
4758032|NCT02874313|CPAP|cpap
4758033|NCT02874313|Sleep apnea|sleep apnea
4758034|NCT02874313|Diabetes|diabetes
4758035|NCT02874313|Diabetic retinopathy|diabetic retinopathy
4758036|NCT02874287|Coronary Artery Disease|coronary artery disease
4758037|NCT02874287|Hydroxychloroquine|hydroxychloroquine
4758038|NCT02874274|Corticobasal syndrome|corticobasal syndrome
4758039|NCT02874274|Dementia with Lewy Bodies|dementia with lewy bodies
4758040|NCT02874274|Home Visit Program (HVP)|home visit program (hvp)
4758041|NCT02874274|Multidimensional Caregiver Strain Index|multidimensional caregiver strain index
4758042|NCT02874274|Parkinson's Disease Dementia|parkinson's disease dementia
4758043|NCT02874274|Progressive Supranuclear Palsy|progressive supranuclear palsy
4758044|NCT02874222|aromatase inhibitors|aromatase inhibitors
4758045|NCT02874183|Heart Failure|heart failure
4758046|NCT02874183|HF|hf
4758047|NCT02874183|CHF|chf
4758048|NCT02874183|RCT|rct
4758049|NCT02874183|Self-efficacy|self-efficacy
4758050|NCT02874183|Pharmacy|pharmacy
4758051|NCT02874183|Pharmacist|pharmacist
4758052|NCT02874183|Transition of Care|transition of care
4758053|NCT02874183|Readmission|readmission
4758054|NCT02874131|Posttraumatic Stress Disorder|posttraumatic stress disorder
4758055|NCT02874131|Major Depressive Disorder|major depressive disorder
4758056|NCT02874131|Behavioral Activation|behavioral activation
4758057|NCT02874131|Cognitive Processing Therapy|cognitive processing therapy
4758058|NCT02874131|Comorbidity|comorbidity
4758059|NCT02874131|Military|military
4758060|NCT02874105|Medical treatment|medical treatment
4758061|NCT02874105|physiotherapy|physiotherapy
4758062|NCT02874092|Methotrexate (MTX)|methotrexate (mtx)
4758063|NCT02874092|Ticagrelor|ticagrelor
4758064|NCT02874066|Hepatitis C virus|hepatitis c virus
4758065|NCT02874066|Hemodialysis|hemodialysis
4758066|NCT02874066|Direct acting antiviral agents|direct acting antiviral agents
4758067|NCT02874053|Risk Perceptions|risk perceptions
4758068|NCT02874053|Medical Tradeoffs|medical tradeoffs
4758069|NCT02874053|Regulatory Focus|regulatory focus
4758070|NCT02874053|Integral Affect|integral affect
4758071|NCT02874027|gut microbiota|gut microbiota
4758072|NCT02874027|depression|depression
4758073|NCT02874027|gut-brain axis|gut-brain axis
4758074|NCT02874027|circadian rhythm|circadian rhythm
4758075|NCT02874027|Traumatic Brain Injury|traumatic brain injury
4758076|NCT02874001|psychology|psychology
4758077|NCT02874001|caregiver support time|caregiver support time
4758078|NCT02873975|Advanced Cancers|advanced cancers
4758079|NCT02873975|Solid tumors|solid tumors
4758080|NCT02873975|MYC amplification|myc amplification
4758081|NCT02873975|CCNE1 amplification|ccne1 amplification
4758082|NCT02873975|Rb loss|rb loss
4758083|NCT02873975|FBXW7 mutation|fbxw7 mutation
4758084|NCT02873975|BRCA1 mutation|brca1 mutation
4758085|NCT02873975|BRCA2 mutation|brca2 mutation
4758086|NCT02873975|PALB2 mutation|palb2 mutation
4758087|NCT02873975|RAD51C mutation|rad51c mutation
4758088|NCT02873975|RAD51D mutation|rad51d mutation
4758089|NCT02873975|ATR mutation|atr mutation
4758090|NCT02873975|ATM mutation|atm mutation
4758091|NCT02873975|CHK2 mutation|chk2 mutation
4758092|NCT02873975|Fanconi anemia|fanconi anemia
4758093|NCT02873962|Relapsed Ovarian Cancer|relapsed ovarian cancer
4758094|NCT02873949|immunology factors|immunology factors
4758095|NCT02873949|TREM|trem
4758096|NCT02873949|stress|stress
4758097|NCT02873923|clinical trial|clinical trial
4758098|NCT02873923|surrogate endpoints|surrogate endpoints
4758099|NCT02873923|meta analysis|meta analysis
4758100|NCT02873897|elderly|elderly
4758101|NCT02873858|elderly|elderly
4758102|NCT02873780|Pulmonary rehabilitation|pulmonary rehabilitation
4758103|NCT02873780|COPD|copd
4758104|NCT02873780|Evaluation|evaluation
4758105|NCT02873780|oxygen desaturation|oxygen desaturation
4758106|NCT02873780|exercise capacity|exercise capacity
4758107|NCT02873767|First in human|first in human
4758108|NCT02873767|Healthy volunteers|healthy volunteers
4758109|NCT02873741|Sexually Transmitted Diseases (STDs)|sexually transmitted diseases (stds)
4758110|NCT02873741|Cancer|cancer
4758111|NCT02873741|AIDS|aids
4758112|NCT02873728|chronic ulcer|chronic ulcer
4758113|NCT02873728|diabetic ulcer|diabetic ulcer
4758114|NCT02873728|venous ulcer|venous ulcer
4758115|NCT02873728|remote ischemic conditioning|remote ischemic conditioning
4758116|NCT02873715|Childhood weight control|childhood weight control
4758117|NCT02873702|Drug therapy|drug therapy
4758118|NCT02873689|Drug therapy|drug therapy
4758119|NCT02873676|prevalence; lifestyle modification; clinical outcomes|prevalence; lifestyle modification; clinical outcomes
4758120|NCT02873650|Hepatic impairment|hepatic impairment
4758121|NCT02873650|Healthy volunteers|healthy volunteers
4758122|NCT02873650|Clinical pharmacology study|clinical pharmacology study
4758123|NCT02873650|DRB436|drb436
4758124|NCT02873650|dabrafenib|dabrafenib
4758125|NCT02873650|normal hepatic function|normal hepatic function
4758126|NCT02873650|impaired hepatic function|impaired hepatic function
4758127|NCT02873637|total knee replacement|total knee replacement
4758128|NCT02873637|anesthesia|anesthesia
4758129|NCT02873637|catheter|catheter
4758130|NCT02873624|Acute Kidney Injury , Laparoscopic Cholecystectomy|acute kidney injury , laparoscopic cholecystectomy
4758131|NCT02873598|Induction Chemotherapy|induction chemotherapy
4758132|NCT02873598|Stereotactic Body Radiotherapy (SBRT)|stereotactic body radiotherapy (sbrt)
4758133|NCT02873598|Dose Escalation|dose escalation
4758134|NCT02873598|Locally Advanced Pancreatic Cancer (LAPC)|locally advanced pancreatic cancer (lapc)
4758135|NCT02873598|Maximum Tolerated Dose (MTD)|maximum tolerated dose (mtd)
4758136|NCT02873572|Online poker|online poker
4758137|NCT02873572|Casino|casino
4758138|NCT02873572|Massively Multiplayer Online Role-Playing Game (MMORPG)|massively multiplayer online role-playing game (mmorpg)
4758139|NCT02873572|Iowa Gambling Task (IGT)|iowa gambling task (igt)
4758140|NCT02873572|High Resolution Electroencephalography (HR-EEG)|high resolution electroencephalography (hr-eeg)
4758141|NCT02873559|older|older
4758142|NCT02873559|frail|frail
4758143|NCT02873559|men|men
4758144|NCT02873559|progressive muscle training|progressive muscle training
4758145|NCT02873559|muscle training|muscle training
4758146|NCT02873559|exercise|exercise
4758147|NCT02873559|testosterone|testosterone
4758148|NCT02873520|Precision Cell Immunotherapy|precision cell immunotherapy
4758149|NCT02873520|Chemotherapy|chemotherapy
4758150|NCT02873520|Advanced Gastric Cancer|advanced gastric cancer
4758151|NCT02873507|transplantation, liver|transplantation, liver
4758152|NCT02873494|Hemodynamic monitoring|hemodynamic monitoring
4758153|NCT02873494|cardiac output|cardiac output
4758154|NCT02873494|Transthoracic echocardiography|transthoracic echocardiography
4758155|NCT02873494|Impedance cardiography|impedance cardiography
4758156|NCT02873494|Child|child
4758157|NCT02873494|Physioflow|physioflow
4758158|NCT02873494|pediatric intensive care unit|pediatric intensive care unit
4758159|NCT02873442|Precision Cell Immunotherapy|precision cell immunotherapy
4758160|NCT02873442|Transcatheter Arterial Chemoembolization|transcatheter arterial chemoembolization
4758161|NCT02873442|Advanced Liver Cancer|advanced liver cancer
4758162|NCT02873416|Precision Cell Immunotherapy|precision cell immunotherapy
4758163|NCT02873416|Chemotherapy|chemotherapy
4758164|NCT02873416|Advanced Lung Cancer|advanced lung cancer
4758165|NCT02873390|PD-1 Antibody|pd-1 antibody
4758166|NCT02873390|CAR-T Cells|car-t cells
4758167|NCT02873390|EGFR family|egfr family
4758168|NCT02873390|Advanced Malignancies|advanced malignancies
4758169|NCT02873377|Hispanics|hispanics
4758170|NCT02873377|Construction workers|construction workers
4758171|NCT02873377|Tobacco Quitline|tobacco quitline
4758172|NCT02873377|Nicotine replacement therapy|nicotine replacement therapy
4758173|NCT02873351|L-DOPA|l-dopa
4758174|NCT02873351|GPR143|gpr143
4758175|NCT02873351|PEDF|pedf
4758176|NCT02873351|VEGF|vegf
4758177|NCT02873325|ADV|adv
4758178|NCT02873325|CMV|cmv
4758179|NCT02873325|HSCT|hsct
4758180|NCT02873299|PTSD, Post Traumatic Stress Disorder|ptsd, post traumatic stress disorder
4758181|NCT02873286|RSV Vaccines|rsv vaccines
4758182|NCT02873286|Respiratory Syncytial Virus Vaccines|respiratory syncytial virus vaccines
4758183|NCT02873260|Dengue Vaccine|dengue vaccine
4758184|NCT02873234|Telemedicine|telemedicine
4758185|NCT02873234|Chinese Medicine syndrome differentiation|chinese medicine syndrome differentiation
4758186|NCT02873234|Long-term study|long-term study
4758187|NCT02873234|Relapse rate|relapse rate
4758188|NCT02873234|Suicide rate|suicide rate
4758189|NCT02873234|Antidepressants|antidepressants
4758190|NCT02873208|Alkermes|alkermes
4758191|NCT02873208|ALKS 3831|alks 3831
4758192|NCT02873208|Samidorphan|samidorphan
4758193|NCT02873208|Schizophrenia|schizophrenia
4758194|NCT02873208|Safety|safety
4758195|NCT02873182|Intraoperative monitoring|intraoperative monitoring
4758196|NCT02873182|Intraoperative neuromonitoring|intraoperative neuromonitoring
4758197|NCT02873182|Autonomic nervous system|autonomic nervous system
4758198|NCT02873182|Spine surgery|spine surgery
4758199|NCT02873182|Pelvic surgery|pelvic surgery
4758200|NCT02873182|Sexual function|sexual function
4758201|NCT02873182|Bowel function|bowel function
4758202|NCT02873182|Bladder function|bladder function
4758203|NCT02873169|Left ventricular assist device|left ventricular assist device
4758204|NCT02873169|Ventricular Arrhythmias|ventricular arrhythmias
4758205|NCT02873169|Implantable Cardioverter-defibrillator|implantable cardioverter-defibrillator
4758206|NCT02873156|E2027|e2027
4758207|NCT02873156|Healthy participants|healthy participants
4758208|NCT02873156|Pharmacokinetics|pharmacokinetics
4758209|NCT02873156|Pharmacodynamics|pharmacodynamics
4758210|NCT02873117|Benign prostate hyperplasia|benign prostate hyperplasia
4758211|NCT02873117|5 alpha reductase inhibitor|5 alpha reductase inhibitor
4758212|NCT02873117|prostate cancer|prostate cancer
4758213|NCT02873117|Symptomatic|symptomatic
4758214|NCT02873117|treated|treated
4758215|NCT02873013|prostate cancer|prostate cancer
4758216|NCT02873013|observational study|observational study
4758217|NCT02873000|incentive spirometry|incentive spirometry
4758218|NCT02873000|outcome|outcome
4758219|NCT02873000|length of stay,|length of stay,
4758220|NCT02873000|hospital complication|hospital complication
4758221|NCT02873000|general internal medicine|general internal medicine
4758222|NCT02873000|hospital medicine|hospital medicine
4758223|NCT02873000|non-critically-ill|non-critically-ill
4758224|NCT02872974|Cardiovascular diseases|cardiovascular diseases
4758225|NCT02872974|Gestational diabetes mellitus|gestational diabetes mellitus
4758226|NCT02872974|Pediatrics|pediatrics
4758227|NCT02872974|Fetal programming|fetal programming
4758228|NCT02872974|Cohort study|cohort study
4758229|NCT02872948|Non invasive prenatal testing|non invasive prenatal testing
4758230|NCT02872948|Down Syndrome|down syndrome
4758232|NCT02872922|Endothelial function|endothelial function
4758233|NCT02872922|Ultrasonic Therapy|ultrasonic therapy
4758234|NCT02872922|Vascular endothelium|vascular endothelium
4758235|NCT02872922|Nitric oxide|nitric oxide
4758236|NCT02872922|Ultrasound|ultrasound
4758237|NCT02872883|Prelabour rupture of membranes|prelabour rupture of membranes
4758238|NCT02872883|term pregnancy|term pregnancy
4758239|NCT02872883|management|management
4758240|NCT02872883|vaginal examination|vaginal examination
4758241|NCT02872883|induction of labour|induction of labour
4758242|NCT02872883|expectant management|expectant management
4758243|NCT02872870|language disorders|language disorders
4758244|NCT02872870|developmental disorders of oral and written language|developmental disorders of oral and written language
4758245|NCT02872831|Fine needle aspiration|fine needle aspiration
4758246|NCT02872818|Apoptotic signal pathway|apoptotic signal pathway
4758247|NCT02872818|Survivin|survivin
4758248|NCT02872818|Bcl-2|bcl-2
4758249|NCT02872818|Bax|bax
4758250|NCT02872818|c-Myc|c-myc
4758251|NCT02872818|Caspase-9|caspase-9
4758252|NCT02872818|endometrial hyperplasia|endometrial hyperplasia
4758253|NCT02872818|endometrium cancer|endometrium cancer
4758254|NCT02872792|cycloergometer|cycloergometer
4758255|NCT02872753|Autologous Conditioned Plasma|autologous conditioned plasma
4758256|NCT02872753|meniscectomy|meniscectomy
4758257|NCT02872753|randomized controlled trial|randomized controlled trial
4758258|NCT02872753|intra-op injection|intra-op injection
4758259|NCT02872714|Urothelial carcinoma|urothelial carcinoma
4758260|NCT02872714|fibroblast growth factor (FGF)|fibroblast growth factor (fgf)
4758261|NCT02872714|fibroblast growth factor receptor (FGFR)|fibroblast growth factor receptor (fgfr)
4758262|NCT02872714|FGF/FGFR alterations|fgf/fgfr alterations
4758263|NCT02872675|Asthma|asthma
4758264|NCT02872675|Exercise-Induced Asthma|exercise-induced asthma
4758265|NCT02872675|Gut Bacteria|gut bacteria
4758266|NCT02872675|Bimuno® Galactooligosaccharide|bimuno® galactooligosaccharide
4758267|NCT02872675|Pulmonary Function|pulmonary function
4758268|NCT02872675|Prebiotics|prebiotics
4758269|NCT02872675|Exercise-Induced Bronchoconstriction|exercise-induced bronchoconstriction
4758270|NCT02872675|Gut Microbiota|gut microbiota
4758271|NCT02872675|Nutritional Intervention|nutritional intervention
4758272|NCT02872675|Eucapnic Voluntary Hyperpnoea|eucapnic voluntary hyperpnoea
4758273|NCT02872675|Systemic Inflammation|systemic inflammation
4758274|NCT02872675|Systemic Immune Function|systemic immune function
4758275|NCT02872675|Regulatory T Cells|regulatory t cells
4758276|NCT02872675|TH1 Cells|th1 cells
4758277|NCT02872675|TH2 Cells|th2 cells
4758278|NCT02872675|Short-Chain Fatty Acids|short-chain fatty acids
4758279|NCT02872675|Acetate|acetate
4758280|NCT02872675|Propionate|propionate
4758281|NCT02872675|Butyrate|butyrate
4758282|NCT02872675|Metabolomics|metabolomics
4758283|NCT02872675|Airway Inflammation|airway inflammation
4758284|NCT02872675|Intestinal Permeability|intestinal permeability
4758285|NCT02872610|suicidal thoughts|suicidal thoughts
4758286|NCT02872610|suicidal ideation|suicidal ideation
4758287|NCT02872610|Internet intervention|internet intervention
4758288|NCT02872610|self-help|self-help
4758289|NCT02872571|islet of Langerhans|islet of langerhans
4758290|NCT02872571|transplantation|transplantation
4758291|NCT02872571|muscle|muscle
4758292|NCT02872506|Quality of life|quality of life
4758293|NCT02872506|Crohn's disease|crohn's disease
4758294|NCT02872506|Ileocecal resection|ileocecal resection
4758295|NCT02872506|Anti TNF|anti tnf
4758296|NCT02872493|obesity|obesity
4758297|NCT02872493|bariatric surgery|bariatric surgery
4758298|NCT02872493|bowel length|bowel length
4758299|NCT02872480|Concussion|concussion
4758300|NCT02872480|Exercise|exercise
4758301|NCT02872467|Cocaine|cocaine
4758302|NCT02872467|Mothers|mothers
4758303|NCT02872467|Pregnant women|pregnant women
4758304|NCT02872467|Postpartum women|postpartum women
4758305|NCT02872467|Oxytocin|oxytocin
4758306|NCT02872467|Substance use disorders|substance use disorders
4758307|NCT02872467|Substance abuse|substance abuse
4758308|NCT02872467|Prenatal substance use|prenatal substance use
4758309|NCT02872467|stress|stress
4758310|NCT02872454|Major Depression|major depression
4758311|NCT02872454|Text Messaging|text messaging
4758312|NCT02872454|Guided Self-Help|guided self-help
4758313|NCT02872402|gestational diabetes|gestational diabetes
4758314|NCT02872402|dietary modification|dietary modification
4758315|NCT02872402|weight loss|weight loss
4758316|NCT02872402|physical activity|physical activity
4758317|NCT02872402|breastfeeding|breastfeeding
4758318|NCT02872376|Anemia|anemia
4758319|NCT02872376|Crohn's disease|crohn's disease
4758320|NCT02872376|Ulcerative colitis|ulcerative colitis
4758321|NCT02872363|breast screening|breast screening
4758322|NCT02872363|breast cancer|breast cancer
4758323|NCT02872363|mammogram|mammogram
4758324|NCT02872363|uptake|uptake
4758325|NCT02872363|reminder|reminder
4758326|NCT02872363|text message|text message
4758327|NCT02872363|SMS|sms
4758328|NCT02872311|Vaccine|vaccine
4758329|NCT02872311|Influenza|influenza
4758330|NCT02872311|High Dose|high dose
4758331|NCT02872311|Adjuvanted|adjuvanted
4758332|NCT02872311|Recombinant|recombinant
4758333|NCT02872298|Severe|severe
4758334|NCT02872298|Refractory|refractory
4758335|NCT02872259|metastatic melanoma|metastatic melanoma
4758336|NCT02872259|advanced Non-resectable melanoma|advanced non-resectable melanoma
4758337|NCT02872181|Maternal Position|maternal position
4758338|NCT02872181|Tilt|tilt
4758339|NCT02872181|Left Uterine Displacement|left uterine displacement
4758340|NCT02872181|Cesarean Delivery|cesarean delivery
4758341|NCT02872181|Cesarean Section|cesarean section
4758342|NCT02872155|contrast-induced nephropathy|contrast-induced nephropathy
4758343|NCT02872155|renal insufficiency|renal insufficiency
4758344|NCT02872155|computed tomography|computed tomography
4758345|NCT02872129|Fibromyalgia|fibromyalgia
4758346|NCT02872129|chronic widespread pain|chronic widespread pain
4758347|NCT02872129|follow-up|follow-up
4758348|NCT02872129|pain|pain
4758349|NCT02872129|fatigue|fatigue
4758350|NCT02872129|symptoms|symptoms
4758351|NCT02872129|workability|workability
4758352|NCT02872129|physical function|physical function
4758353|NCT02872090|COPD|copd
4758354|NCT02872090|bronchodilatators|bronchodilatators
4758355|NCT02872090|autonomic nervous system|autonomic nervous system
4758356|NCT02872090|cardiovascular system|cardiovascular system
4758357|NCT02872077|AA for NAS|aa for nas
4758358|NCT02872064|Early breast cancer|early breast cancer
4758359|NCT02872064|Photodynamic therapy|photodynamic therapy
4758360|NCT02872064|PDT|pdt
4758361|NCT02872064|Visudyne|visudyne
4758362|NCT02872064|Verteporfin|verteporfin
4758363|NCT02872051|Vocational Rehabilitation|vocational rehabilitation
4758364|NCT02872051|Anxiety|anxiety
4758365|NCT02872051|Depression|depression
4758366|NCT02872051|Common Mental Disorders|common mental disorders
4758367|NCT02872051|Cognitive Behavior Therapy|cognitive behavior therapy
4758368|NCT02872051|Return to Work|return to work
4758369|NCT02872051|Mental Health Services|mental health services
4758370|NCT02872051|Integration|integration
4758371|NCT02871999|Acupuncture Therapy|acupuncture therapy
4758372|NCT02871999|Pain degree after surgery|pain degree after surgery
4758373|NCT02871973|parenting|parenting
4758374|NCT02871973|child development|child development
4758375|NCT02871973|language|language
4758376|NCT02871947|severe asthma|severe asthma
4758377|NCT02871934|Pharmacogenetics|pharmacogenetics
4758378|NCT02871934|SLCO1B1 protein, human|slco1b1 protein, human
4758379|NCT02871934|OATP1B1 protein, human|oatp1b1 protein, human
4758380|NCT02871934|Simvastatin|simvastatin
4758381|NCT02871934|Cardiovascular disease|cardiovascular disease
4758382|NCT02871934|Cholesterol|cholesterol
4758383|NCT02871934|Statin-related myotoxicity|statin-related myotoxicity
4758384|NCT02871934|Veterans|veterans
4758385|NCT02871934|Point-of-care|point-of-care
4758386|NCT02871921|Behavioral prevention|behavioral prevention
4758387|NCT02871921|social interaction|social interaction
4758388|NCT02871921|dementia|dementia
4758389|NCT02871921|MRI|mri
4758390|NCT02871895|sepsis|sepsis
4758391|NCT02871895|severe sepsis|severe sepsis
4758392|NCT02871895|septic shock|septic shock
4758393|NCT02871895|multiple organ failure|multiple organ failure
4758394|NCT02871869|Cinobufacini Tablets|cinobufacini tablets
4758395|NCT02871869|CHOP protocol|chop protocol
4758396|NCT02871856|Screening|screening
4758397|NCT02871856|Computed tomography|computed tomography
4758398|NCT02871856|Lung cancer|lung cancer
4758399|NCT02871830|Physical activity|physical activity
4758400|NCT02871830|Walking|walking
4758401|NCT02871830|Intervention|intervention
4758402|NCT02871830|Adolescent girls|adolescent girls
4758403|NCT02871830|Randomised trial|randomised trial
4758404|NCT02871817|Near Corrected Visual Acuity|near corrected visual acuity
4758405|NCT02871817|Early Treatment Diabetes Retinopathy Study|early treatment diabetes retinopathy study
4758406|NCT02871817|Amsler Grid|amsler grid
4758407|NCT02871817|Home Monitoring|home monitoring
4758408|NCT02871791|Her2-negative metastatic breast cancer|her2-negative metastatic breast cancer
4758409|NCT02871791|Hormone receptor (HR)-positive breast cancer|hormone receptor (hr)-positive breast cancer
4758410|NCT02871765|Patient education|patient education
4758411|NCT02871765|Knowledge|knowledge
4758412|NCT02871765|Life distress|life distress
4758413|NCT02871765|Quality of life|quality of life
4758414|NCT02871752|prostate cancer|prostate cancer
4758415|NCT02871752|active surveillance|active surveillance
4758416|NCT02871752|MBSR|mbsr
4758417|NCT02871752|couples|couples
4758418|NCT02871752|health promotion|health promotion
4758419|NCT02871752|quality of life|quality of life
4758420|NCT02871752|mindfulness|mindfulness
4758421|NCT02871739|Communication skills training|communication skills training
4758422|NCT02871739|Shared Decision Making|shared decision making
4758423|NCT02871739|Decision making|decision making
4758424|NCT02871739|Decision Aids|decision aids
4758425|NCT02871739|lung cancer screening|lung cancer screening
4758426|NCT02871726|Prostate Cancer Detection|prostate cancer detection
4758427|NCT02871726|Prostate Biopsy|prostate biopsy
4758428|NCT02871726|Prostate Cancer|prostate cancer
4758429|NCT02871726|Transrectal Ultrasound|transrectal ultrasound
4758430|NCT02871713|quadratus lumborum block|quadratus lumborum block
4758431|NCT02871700|stroke|stroke
4758432|NCT02871700|translational rehabilitation|translational rehabilitation
4758433|NCT02871700|mirror neuron system|mirror neuron system
4758434|NCT02871700|action observation|action observation
4758435|NCT02871700|mirror therapy|mirror therapy
4758436|NCT02871700|MEG|meg
4758437|NCT02871674|Behavioural interventions|behavioural interventions
4758438|NCT02871674|Sleep difficulties|sleep difficulties
4758439|NCT02871674|Children|children
4758440|NCT02871674|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
4758441|NCT02871674|Randomised controlled trial|randomised controlled trial
4758442|NCT02871674|Saudi Arabia|saudi arabia
4758443|NCT02871674|Behavioural Insomnia|behavioural insomnia
4758444|NCT02871661|vulvodynia|vulvodynia
4758445|NCT02871661|pelvic floor muscles|pelvic floor muscles
4758446|NCT02871661|kinesiotherapy|kinesiotherapy
4758447|NCT02871661|electrical therapy|electrical therapy
4758448|NCT02871661|physical therapy|physical therapy
4758449|NCT02871661|amitriptyline|amitriptyline
4758450|NCT02871661|female sexual dysfunction.|female sexual dysfunction.
4758451|NCT02871648|Healthy|healthy
4758452|NCT02871609|Biofilm|biofilm
4758453|NCT02871609|Morbidity|morbidity
4758454|NCT02871609|Ureteral Catheterization|ureteral catheterization
4758455|NCT02871570|Hepatic Impairment|hepatic impairment
4758456|NCT02871570|Rivipansel|rivipansel
4758457|NCT02871544|BNP|bnp
4758458|NCT02871544|NGAL|ngal
4758459|NCT02871544|Sepsis|sepsis
4758460|NCT02871544|Mortality|mortality
4758461|NCT02871531|retinal detachment|retinal detachment
4758462|NCT02871531|pneumatic retinopexy|pneumatic retinopexy
4758463|NCT02871531|vitrectomy|vitrectomy
4758464|NCT02871479|Atopic Dermatitis|atopic dermatitis
4758465|NCT02871479|Eczema|eczema
4758466|NCT02871453|Ischemic Stroke|ischemic stroke
4758467|NCT02871453|Motor Dysfunction|motor dysfunction
4758468|NCT02871453|Scalp Acupuncture|scalp acupuncture
4758469|NCT02871427|Lewy body dementia|lewy body dementia
4758470|NCT02871427|Dementia with Lewy bodies|dementia with lewy bodies
4758471|NCT02871427|Parkinson's disease dementia|parkinson's disease dementia
4758472|NCT02871427|Visual hallucinations|visual hallucinations
4758473|NCT02871427|REM sleep behavior disorder|rem sleep behavior disorder
4758474|NCT02871401|IPF|ipf
4758475|NCT02871401|Herpesvirus|herpesvirus
4758476|NCT02871401|Valganciclovir|valganciclovir
4758477|NCT02871388|Physical activity|physical activity
4758478|NCT02871388|Diet|diet
4758479|NCT02871388|Nutrition|nutrition
4758480|NCT02871388|Breast cancer prevention|breast cancer prevention
4758481|NCT02871388|Mammography screening|mammography screening
4758482|NCT02871375|myopia|myopia
4758483|NCT02871375|presbyopia|presbyopia
4758484|NCT02871349|Autism|autism
4758485|NCT02871349|ASD|asd
4758486|NCT02871336|Cata collection|cata collection
4758487|NCT02871336|Pancreatic cancer surgery|pancreatic cancer surgery
4758488|NCT02871323|Myelofibrosis Transformation in Essential Thrombocythemia|myelofibrosis transformation in essential thrombocythemia
4758489|NCT02871297|adolescent|adolescent
4758490|NCT02871297|children|children
4758491|NCT02871284|cancer|cancer
4758492|NCT02871284|anticancer treatment|anticancer treatment
4758493|NCT02871284|exercise|exercise
4758494|NCT02871284|physical activity|physical activity
4758495|NCT02871284|sensorimotor training|sensorimotor training
4758496|NCT02871284|chemotherapy-induced polyneuropathy|chemotherapy-induced polyneuropathy
4758497|NCT02871245|Acupuncture Therapy|acupuncture therapy
4758498|NCT02871245|Laparoscopic Surgery|laparoscopic surgery
4758499|NCT02871245|Gastrointestinal Tract Recovery of Function|gastrointestinal tract recovery of function
4758500|NCT02871219|Follicular lymphoma|follicular lymphoma
4758501|NCT02871219|Obinutuzumab|obinutuzumab
4758502|NCT02871219|GA101|ga101
4758503|NCT02871219|Gazyva|gazyva
4758504|NCT02871219|Lenalidomide|lenalidomide
4758505|NCT02871219|CC-5013|cc-5013
4758506|NCT02871219|Revlimid|revlimid
4758507|NCT02871193|paravertebral block|paravertebral block
4758508|NCT02871193|patient controlled analgesia|patient controlled analgesia
4758509|NCT02871193|ropivacaine|ropivacaine
4758510|NCT02871193|dexamethasone|dexamethasone
4758511|NCT02871180|Hypoglycemia|hypoglycemia
4758512|NCT02871180|Type 1 diabetes|type 1 diabetes
4758513|NCT02871167|oocyte/embryo cryopreservation|oocyte/embryo cryopreservation
4758514|NCT02871128|Hemoglobin|hemoglobin
4758515|NCT02871128|serum iron|serum iron
4758516|NCT02871128|serum ferritin|serum ferritin
4758517|NCT02871128|Hematocrit|hematocrit
4758518|NCT02871128|antioxidant|antioxidant
4758519|NCT02871115|Cancer Care|cancer care
4758520|NCT02871102|mechanical ventilation|mechanical ventilation
4758521|NCT02871102|respiratory mechanics|respiratory mechanics
4758522|NCT02871102|acute respiratory distress syndrome|acute respiratory distress syndrome
4758523|NCT02871102|positive end-expiratory pressure|positive end-expiratory pressure
4758524|NCT02871102|tidal volume|tidal volume
4758525|NCT02871089|Type 1 Diabetes|type 1 diabetes
4758526|NCT02871089|Closed-loop glucose control|closed-loop glucose control
4758527|NCT02871089|Artificial Pancreas|artificial pancreas
4758528|NCT02871089|Continuous subcutaneous insulin infusion|continuous subcutaneous insulin infusion
4758529|NCT02871089|Multiple daily injection therapy|multiple daily injection therapy
4758530|NCT02871089|New onset type 1 diabetes|new onset type 1 diabetes
4758630|NCT02870387|chronic illness|chronic illness
4758531|NCT02871089|Residual C-Peptide secretion|residual c-peptide secretion
4758532|NCT02871089|Beta-cell function preservation|beta-cell function preservation
4758533|NCT02871089|Continuous glucose monitoring|continuous glucose monitoring
4758534|NCT02871050|Biobank|biobank
4758535|NCT02871050|biorepository|biorepository
4758536|NCT02871050|Castlebank|castlebank
4758537|NCT02871050|Castleman Disease|castleman disease
4758538|NCT02871050|CD|cd
4758539|NCT02871050|MCD|mcd
4758540|NCT02871050|iMCD|imcd
4758541|NCT02871050|Castleman|castleman
4758542|NCT02871050|Castleman's Disease|castleman's disease
4758543|NCT02871050|multicentric Castleman's disease|multicentric castleman's disease
4758544|NCT02871050|multicentric Castleman disease|multicentric castleman disease
4758545|NCT02871050|Angiofollicular Lymph Hyperplasia|angiofollicular lymph hyperplasia
4758546|NCT02871024|Polymyxin B|polymyxin b
4758547|NCT02871024|Pneumonia|pneumonia
4758548|NCT02871024|Sepsis|sepsis
4758549|NCT02871024|Urinary tract infection|urinary tract infection
4758550|NCT02871011|Tinea Bronchodilator Agents|tinea bronchodilator agents
4758551|NCT02871011|Tinea Pedis|tinea pedis
4758552|NCT02871011|Nitric Oxide|nitric oxide
4758553|NCT02871011|Dermatomycoses|dermatomycoses
4758554|NCT02871011|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors
4758555|NCT02871011|Infectious|infectious
4758556|NCT02871011|Infection|infection
4758557|NCT02871011|Mycoses|mycoses
4758558|NCT02871011|Skin Diseases|skin diseases
4758559|NCT02871011|Foot Dermatoses|foot dermatoses
4758560|NCT02871011|Foot Diseases|foot diseases
4758561|NCT02871011|Pruritus|pruritus
4758562|NCT02871011|Skin Manifestations Signs and Symptoms|skin manifestations signs and symptoms
4758563|NCT02870946|Extracorporeal Membrane Oxygenation|extracorporeal membrane oxygenation
4758564|NCT02870946|Cardiogenic Shock|cardiogenic shock
4758565|NCT02870946|Renal Replacement Therapy|renal replacement therapy
4758566|NCT02870933|CD 133+|cd 133+
4758567|NCT02870933|Transepicardial with Transseptal Implantation|transepicardial with transseptal implantation
4758568|NCT02870933|CABG|cabg
4758569|NCT02870907|primary enucleation|primary enucleation
4758570|NCT02870907|retinoblastoma|retinoblastoma
4758571|NCT02870868|slow breathing|slow breathing
4758572|NCT02870868|yoga|yoga
4758573|NCT02870868|mind-body practicers|mind-body practicers
4758574|NCT02870842|ultrasonography|ultrasonography
4758575|NCT02870842|child|child
4758576|NCT02870842|perioperative period|perioperative period
4758577|NCT02870842|general anesthesia|general anesthesia
4758578|NCT02870842|lung|lung
4758579|NCT02870777|MRD|mrd
4758580|NCT02870777|Acute myeloid leukemia|acute myeloid leukemia
4758581|NCT02870764|Danshenduofensuanyan|danshenduofensuanyan
4758582|NCT02870764|Lp-PLA2|lp-pla2
4758583|NCT02870764|coronary artery disease|coronary artery disease
4758584|NCT02870764|Salvia miltiorrhiza|salvia miltiorrhiza
4758585|NCT02870751|ETEC|etec
4758586|NCT02870751|human challenge study|human challenge study
4758587|NCT02870751|heat stable toxin|heat stable toxin
4758588|NCT02870751|tourist diarrhea|tourist diarrhea
4758589|NCT02870751|diarrhea|diarrhea
4758590|NCT02870751|enterotoxigenic|enterotoxigenic
4758591|NCT02870725|chronic headaches, migraines, depression|chronic headaches, migraines, depression
4758592|NCT02870712|perineal tear of first degree|perineal tear of first degree
4758593|NCT02870712|suture|suture
4758594|NCT02870699|chemotherapy neoadjuvant|chemotherapy neoadjuvant
4758595|NCT02870686|ERCP|ercp
4758596|NCT02870686|EUS guided ERCP without fluoroscopy|eus guided ercp without fluoroscopy
4758597|NCT02870673|acupuncture|acupuncture
4758598|NCT02870673|electrical stimulation|electrical stimulation
4758599|NCT02870673|carpal tunnel syndrome|carpal tunnel syndrome
4758600|NCT02870608|Elastography|elastography
4758601|NCT02870556|cervical epidural, laryngectomy, pharyngocutaneous fistula|cervical epidural, laryngectomy, pharyngocutaneous fistula
4758602|NCT02870543|Bruxism|bruxism
4758603|NCT02870543|Sleep bruxism|sleep bruxism
4758604|NCT02870543|Sleep related bruxism|sleep related bruxism
4758605|NCT02870543|Homeopathy|homeopathy
4758606|NCT02870504|laser peripheral iridoplasty|laser peripheral iridoplasty
4758607|NCT02870504|treatment|treatment
4758608|NCT02870491|Child Diarrhea|child diarrhea
4758609|NCT02870491|Cluster Randomized Controlled Trial|cluster randomized controlled trial
4758610|NCT02870491|Oral Rehydration|oral rehydration
4758611|NCT02870491|ORS|ors
4758612|NCT02870491|Zinc|zinc
4758613|NCT02870491|Brac|brac
4758614|NCT02870491|Community Health Workers|community health workers
4758615|NCT02870491|Uganda|uganda
4758616|NCT02870465|outpatient versus operating room|outpatient versus operating room
4758617|NCT02870465|k wire infection|k wire infection
4758618|NCT02870465|closed reduction internal fixation|closed reduction internal fixation
4758619|NCT02870452|Haemophilia|haemophilia
4758620|NCT02870452|RCT|rct
4758621|NCT02870452|Pain|pain
4758622|NCT02870452|Hemarthrosis|hemarthrosis
4758623|NCT02870452|Hypnosis|hypnosis
4758624|NCT02870452|Cognitive-Behavioral Therapy|cognitive-behavioral therapy
4758625|NCT02870452|Quality of Life|quality of life
4758626|NCT02870452|Distress|distress
4758627|NCT02870452|Cytokines|cytokines
4758628|NCT02870426|Olfactory ensheathing cells|olfactory ensheathing cells
4758629|NCT02870413|telehealth|telehealth
4758631|NCT02870387|children|children
4758632|NCT02870387|children with medical complexity|children with medical complexity
4758633|NCT02870387|medical home|medical home
4758634|NCT02870387|inpatient consultation|inpatient consultation
4758635|NCT02870335|low back|low back
4758636|NCT02870335|manual therapy|manual therapy
4758637|NCT02870335|stretching|stretching
4758638|NCT02870322|overweight|overweight
4758639|NCT02870322|obesity|obesity
4758640|NCT02870322|lifestyle prescription|lifestyle prescription
4758641|NCT02870322|prevention|prevention
4758642|NCT02870322|physical activity|physical activity
4758643|NCT02870322|healthy eating|healthy eating
4758644|NCT02870283|Cost effectiveness|cost effectiveness
4758645|NCT02870283|Bipolar disorder|bipolar disorder
4758646|NCT02870283|Mixed episodes|mixed episodes
4758647|NCT02870283|Quality of life|quality of life
4758648|NCT02870270|saliva|saliva
4758649|NCT02870270|microflora|microflora
4758650|NCT02870270|diet|diet
4758651|NCT02870270|quality of life|quality of life
4758652|NCT02870270|oral cancer|oral cancer
4758653|NCT02870244|Melanoma|melanoma
4758654|NCT02870244|Gene Therapy|gene therapy
4758655|NCT02870244|Adoptive T-Cell Transfer|adoptive t-cell transfer
4758656|NCT02870244|IL-2|il-2
4758657|NCT02870192|Rectal Prolapse|rectal prolapse
4758658|NCT02870179|Pulse Oximetry|pulse oximetry
4758659|NCT02870179|Temperature|temperature
4758660|NCT02870179|Respiratory Rate|respiratory rate
4758661|NCT02870179|Respiratory Gases|respiratory gases
4758662|NCT02870179|This study determines the measurement accuracy of the physiological parameters|this study determines the measurement accuracy of the physiological parameters
4758663|NCT02870140|CAD|cad
4758664|NCT02870140|ACS|acs
4758665|NCT02870140|All comers|all comers
4758666|NCT02870140|PCI|pci
4758667|NCT02870114|Haemophilia|haemophilia
4758668|NCT02870114|Quality of Life|quality of life
4758669|NCT02870114|Distress|distress
4758670|NCT02870114|Hemarthrosis|hemarthrosis
4758671|NCT02870114|Pain|pain
4758672|NCT02870101|Nucleic acid amplification tests|nucleic acid amplification tests
4758673|NCT02870101|Neisseria gonorrhoeae infection|neisseria gonorrhoeae infection
4758674|NCT02870101|Chlamydia trachomatis infection|chlamydia trachomatis infection
4758675|NCT02870101|Sexually transmitted diseases|sexually transmitted diseases
4758676|NCT02870101|Pharynx|pharynx
4758677|NCT02870101|Rectum|rectum
4758678|NCT02870101|Gram-Negative Bacterial Infections|gram-negative bacterial infections
4758679|NCT02870101|Bacterial Infections|bacterial infections
4758680|NCT02870101|Genital Diseases, Male|genital diseases, male
4758681|NCT02870101|Genital Diseases, Female|genital diseases, female
4758682|NCT02870062|Chlorhexidine baths|chlorhexidine baths
4758683|NCT02870062|Critical patient|critical patient
4758684|NCT02870062|Healthcare associated infections|healthcare associated infections
4758685|NCT02870062|Critical care environment|critical care environment
4758686|NCT02870062|Patient colonization|patient colonization
4758687|NCT02870049|early detection|early detection
4758688|NCT02869971|Prostatic artery embolization|prostatic artery embolization
4758689|NCT02869971|Combined Therapy|combined therapy
4758690|NCT02869971|IPSS|ipss
4758691|NCT02869958|Asthma|asthma
4758692|NCT02869958|Exacerbation|exacerbation
4758693|NCT02869958|Treatment|treatment
4758694|NCT02869958|Internet|internet
4758695|NCT02869958|Emergency care|emergency care
4758696|NCT02869945|de novo untreated Parkinson Disease|de novo untreated parkinson disease
4758697|NCT02869945|genetic|genetic
4758698|NCT02869945|COMT Polymorphism|comt polymorphism
4758699|NCT02869945|gene|gene
4758700|NCT02869945|brain MRI|brain mri
4758701|NCT02869945|brain MPET|brain mpet
4758702|NCT02869841|laparotomy|laparotomy
4758703|NCT02869841|pain|pain
4758704|NCT02869841|rectus sheath block|rectus sheath block
4758705|NCT02869815|Methylene blue|methylene blue
4758706|NCT02869815|Indocyanine green|indocyanine green
4758707|NCT02869815|Neoadjuvant Therapy|neoadjuvant therapy
4758708|NCT02869815|Sentinel Lymph Node Biopsy|sentinel lymph node biopsy
4758709|NCT02869815|Breast Neoplasms|breast neoplasms
4758710|NCT02869802|Cancer|cancer
4758711|NCT02869802|Pancreatic Cancer|pancreatic cancer
4758712|NCT02869802|Advanced Pancreatic Ductal Adenocarcinoma|advanced pancreatic ductal adenocarcinoma
4758713|NCT02869802|PDAC|pdac
4758714|NCT02869802|Genomic Analysis|genomic analysis
4758715|NCT02869802|Molecular subtyping|molecular subtyping
4758716|NCT02869763|Ethanol|ethanol
4758717|NCT02869763|Steroid profile|steroid profile
4758718|NCT02869763|Pharmacokinetics|pharmacokinetics
4758719|NCT02869737|Point of Care Device; post traumatic coagulopathy|point of care device; post traumatic coagulopathy
4758720|NCT02869724|IMV : voluntary drug intoxications|imv : voluntary drug intoxications
4758721|NCT02869724|Drug|drug
4758722|NCT02869724|Divided prescription|divided prescription
4758723|NCT02869672|safety|safety
4758724|NCT02869672|immunogenicity|immunogenicity
4758725|NCT02869672|vaccine|vaccine
4758726|NCT02869659|obesity|obesity
4758727|NCT02869659|pre-diabetes|pre-diabetes
4758728|NCT02869659|overweight|overweight
4758729|NCT02869659|lifestyle change|lifestyle change
4758730|NCT02869659|glucose|glucose
4758731|NCT02869646|PTSD|ptsd
4758732|NCT02869646|acupuncture|acupuncture
4758733|NCT02869646|integrative medicine|integrative medicine
4758734|NCT02869464|Aneurysm|aneurysm
4758735|NCT02869464|Intracranial Aneurysm|intracranial aneurysm
4758736|NCT02869464|Abdominal Aortic Aneurysm|abdominal aortic aneurysm
4758737|NCT02869438|Asthma, Bronchial Diseases, Respiratory Tract Diseases, Lung Diseases, Obstructive Lung Diseases|asthma, bronchial diseases, respiratory tract diseases, lung diseases, obstructive lung diseases
4758738|NCT02869399|head and neck cancer, nutritional intervention|head and neck cancer, nutritional intervention
4758739|NCT02869386|stroke|stroke
4758740|NCT02869386|prehospital|prehospital
4758741|NCT02869386|telemedicine|telemedicine
4758742|NCT02869386|thrombolysis|thrombolysis
4758743|NCT02869386|thrombectomy|thrombectomy
4758744|NCT02869386|endovascular treatment|endovascular treatment
4758745|NCT02869386|functional outcome|functional outcome
4758746|NCT02869347|recombinant C1 esterase inhibitor|recombinant c1 esterase inhibitor
4758747|NCT02869347|acute kidney injury|acute kidney injury
4758748|NCT02869347|coronary angiography|coronary angiography
4758749|NCT02869347|contrast media|contrast media
4758750|NCT02869347|Conestat alfa|conestat alfa
4758751|NCT02869347|inflammation|inflammation
4758752|NCT02869308|Cardiomyopathy|cardiomyopathy
4758753|NCT02869308|Chemotherapy|chemotherapy
4758754|NCT02869308|Left ventricular ejection fraction|left ventricular ejection fraction
4758755|NCT02869295|Metastatic Solid Tumors|metastatic solid tumors
4758756|NCT02869295|Locally Advanced Solid Tumors|locally advanced solid tumors
4758757|NCT02869256|chronic myeloid leukemia|chronic myeloid leukemia
4758758|NCT02869256|practices evaluation|practices evaluation
4758759|NCT02869243|A malignant growing astrocytoma of central nervous system|a malignant growing astrocytoma of central nervous system
4758760|NCT02869230|Breast cancer|breast cancer
4758761|NCT02869230|Non palpable breast lesions|non palpable breast lesions
4758762|NCT02869230|radioguided occult lesion localization|radioguided occult lesion localization
4758763|NCT02869217|NY-ESO-1 expressing solid tumors in HLA-A2 positive patients|ny-eso-1 expressing solid tumors in hla-a2 positive patients
4758764|NCT02869165|Postmenopausal|postmenopausal
4758765|NCT02869152|sentinel lymph node|sentinel lymph node
4758766|NCT02869152|lymphatic mapping|lymphatic mapping
4758767|NCT02869152|rectal tumor|rectal tumor
4758768|NCT02869152|rectal cancer|rectal cancer
4758769|NCT02869152|early stage|early stage
4758770|NCT02869139|Thirst|thirst
4758771|NCT02869139|Ice|ice
4758772|NCT02869139|Menthol|menthol
4758773|NCT02869139|Perioperative Nursing.|perioperative nursing.
4758774|NCT02869139|Recovery Room|recovery room
4758775|NCT02869126|99mTc-Sestamibi|99mtc-sestamibi
4758776|NCT02869126|thallium-201|thallium-201
4758777|NCT02869126|semiconductor camera|semiconductor camera
4758778|NCT02869100|magnetic resonance imaging|magnetic resonance imaging
4758779|NCT02869100|sodium fluoride positron emission tomography|sodium fluoride positron emission tomography
4758780|NCT02869074|von Willebrand disease (VWD)|von willebrand disease (vwd)
4758781|NCT02869074|von Willebrand factor (VWF)|von willebrand factor (vwf)
4758782|NCT02869074|von Willebrand factor gene|von willebrand factor gene
4758783|NCT02869074|next generation sequencing|next generation sequencing
4758784|NCT02869074|diagnosis|diagnosis
4758785|NCT02869074|VWD Spanish Cohort|vwd spanish cohort
4758786|NCT02869061|Bladder neck obstruction|bladder neck obstruction
4758787|NCT02869061|Bladder outlet obstruction|bladder outlet obstruction
4758788|NCT02869061|Benign prostatic hyperplasia|benign prostatic hyperplasia
4758789|NCT02869061|Urinary bladder neck obstruction|urinary bladder neck obstruction
4758790|NCT02869061|Bladder neck contracture|bladder neck contracture
4758791|NCT02869061|Bladder neck stricture|bladder neck stricture
4758792|NCT02869061|Bladder neck stenosis|bladder neck stenosis
4758793|NCT02869061|Transurethral resection of the prostate|transurethral resection of the prostate
4758794|NCT02869061|Prostatectomy|prostatectomy
4758795|NCT02869061|Stromal vascular fraction (SVF)|stromal vascular fraction (svf)
4758796|NCT02869061|Adipose-derived regenerative cells (ADRC)|adipose-derived regenerative cells (adrc)
4758797|NCT02869061|Adipose tissue|adipose tissue
4758798|NCT02869061|Stem cells|stem cells
4758799|NCT02869048|Biological Specimen Banks|biological specimen banks
4758800|NCT02869048|Innate Immunity|innate immunity
4758801|NCT02869048|Clinical Study|clinical study
4758802|NCT02869048|Complement system proteins|complement system proteins
4758803|NCT02869048|Amyotrophic lateral sclerosis|amyotrophic lateral sclerosis
4758804|NCT02869048|Neurodegenerative disease|neurodegenerative disease
4758805|NCT02869048|Motor neuron disease|motor neuron disease
4758806|NCT02869035|PET|pet
4758807|NCT02869035|Serotonin|serotonin
4758808|NCT02869035|5-HT4R|5-ht4r
4758809|NCT02869035|MRI|mri
4758810|NCT02869035|fMRI|fmri
4758811|NCT02869035|EEG|eeg
4758812|NCT02869035|Cortisol awakening response|cortisol awakening response
4758813|NCT02869035|Oxidative stress|oxidative stress
4758814|NCT02869035|Mental health|mental health
4758815|NCT02869035|Prediction of treatment response|prediction of treatment response
4758816|NCT02869035|Inflammation|inflammation
4758817|NCT02869035|5-HTTLPR|5-httlpr
4758818|NCT02869035|Brain imaging|brain imaging
4758819|NCT02869035|Early life stress|early life stress
4758820|NCT02869035|Selective Serotonin Reuptake Inhibitor|selective serotonin reuptake inhibitor
4758821|NCT02869035|Escitalopram|escitalopram
4760122|NCT02861248|Burn Scar|burn scar
4758822|NCT02869035|Psychometrics|psychometrics
4758823|NCT02869035|Moderate depression|moderate depression
4758824|NCT02869035|Severe depression|severe depression
4758825|NCT02869035|ERP|erp
4758826|NCT02869035|rsfMRI|rsfmri
4758827|NCT02869035|11C-SB207145|11c-sb207145
4758828|NCT02869035|Sexual function|sexual function
4758829|NCT02869035|MDD|mdd
4758830|NCT02869035|Affective cognition|affective cognition
4758831|NCT02869035|Cold cognition|cold cognition
4758832|NCT02869035|Social cognition|social cognition
4758833|NCT02869035|Anxiety|anxiety
4758834|NCT02869009|stroke|stroke
4758835|NCT02869009|clopidogrel|clopidogrel
4758836|NCT02869009|antiplatelets|antiplatelets
4758837|NCT02868957|CAD|cad
4758838|NCT02868957|Digital imaging|digital imaging
4758839|NCT02868957|Prosthetic Dentistry|prosthetic dentistry
4758840|NCT02868931|self-management|self-management
4758841|NCT02868931|empowerment|empowerment
4758842|NCT02868931|treatment and education program|treatment and education program
4758843|NCT02868931|insulin pump|insulin pump
4758844|NCT02868931|diabetes education|diabetes education
4758845|NCT02868866|physical activity|physical activity
4758846|NCT02868866|nutrition|nutrition
4758847|NCT02868866|fruits and vegetables|fruits and vegetables
4758848|NCT02868866|faith-based|faith-based
4758849|NCT02868866|churches|churches
4758850|NCT02868853|diet|diet
4758851|NCT02868853|weight loss|weight loss
4758852|NCT02868853|tracking|tracking
4758853|NCT02868853|mobile|mobile
4758854|NCT02868853|calories|calories
4758855|NCT02868840|stroke|stroke
4758856|NCT02868840|Tai ji|tai ji
4758857|NCT02868840|postural balance|postural balance
4758858|NCT02868840|cognition|cognition
4758859|NCT02868827|cholecalciferol and critical illness|cholecalciferol and critical illness
4758860|NCT02868827|Mortality and cholecalciferol supplementation|mortality and cholecalciferol supplementation
4758861|NCT02868801|Pregabalin|pregabalin
4758862|NCT02868788|inflammation|inflammation
4758863|NCT02868788|insulin resistance|insulin resistance
4758864|NCT02868788|type 2 diabetes|type 2 diabetes
4758865|NCT02868788|obesity|obesity
4758866|NCT02868762|neck pain, voice disorder|neck pain, voice disorder
4758867|NCT02868749|Hyaluronic Acid|hyaluronic acid
4758868|NCT02868749|histology|histology
4758869|NCT02868749|ultrasound|ultrasound
4758870|NCT02868749|subcutaneous|subcutaneous
4758871|NCT02868749|adipose tissue|adipose tissue
4758872|NCT02868723|cerebrovascular disease|cerebrovascular disease
4758873|NCT02868723|patient management|patient management
4758874|NCT02868723|stroke management|stroke management
4758875|NCT02868723|prognosis|prognosis
4758876|NCT02868723|3D Carotid Doppler Imaging|3d carotid doppler imaging
4758877|NCT02868723|Randomization|randomization
4758878|NCT02868710|primary prevention|primary prevention
4758879|NCT02868671|mild TBI|mild tbi
4758880|NCT02868671|Post-traumatic Stress Disorders|post-traumatic stress disorders
4758881|NCT02868671|Acupuncture|acupuncture
4758882|NCT02868658|Influenza|influenza
4758883|NCT02868658|health care workers|health care workers
4758884|NCT02868658|nosocomial|nosocomial
4758885|NCT02868658|asymptomatic|asymptomatic
4758886|NCT02868658|France|france
4758887|NCT02868632|Unresectable|unresectable
4758888|NCT02868632|Locally Advanced|locally advanced
4758889|NCT02868632|Non-Metastatic|non-metastatic
4758890|NCT02868619|fMRI|fmri
4758891|NCT02868619|Deep brain stimulation|deep brain stimulation
4758892|NCT02868619|Food|food
4758893|NCT02868619|Eating|eating
4758894|NCT02868619|Reward|reward
4758895|NCT02868580|ALS|als
4758896|NCT02868580|Antiretroviral Therapy, Triumeq|antiretroviral therapy, triumeq
4758897|NCT02868541|microorganisms|microorganisms
4758898|NCT02868541|pilgrim|pilgrim
4758899|NCT02868541|hajj|hajj
4758900|NCT02868528|advanced age women|advanced age women
4758901|NCT02868528|blastocyst culture|blastocyst culture
4758902|NCT02868528|PGS|pgs
4758903|NCT02868528|live birth rate|live birth rate
4758904|NCT02868502|Glaucoma|glaucoma
4758905|NCT02868502|Open Angle Glaucoma|open angle glaucoma
4758906|NCT02868502|Intra Ocular Pressure|intra ocular pressure
4758907|NCT02868502|Ocular Hypotensive Drops|ocular hypotensive drops
4758908|NCT02868502|Trabeculectomy|trabeculectomy
4758909|NCT02868502|Cyclophotocoagulation|cyclophotocoagulation
4758910|NCT02868502|Glaucoma Drainage Device|glaucoma drainage device
4758911|NCT02868489|Microbiota|microbiota
4758912|NCT02868463|oxygen tension|oxygen tension
4758913|NCT02868463|Female Urinary Microbiome|female urinary microbiome
4758914|NCT02868463|Urinary Tract Symptoms|urinary tract symptoms
4758915|NCT02868463|Urine Oxygen Level|urine oxygen level
4758916|NCT02868398|Ulcerative Colitis|ulcerative colitis
4758917|NCT02868398|Golimumab|golimumab
4758918|NCT02868398|Deep and prolonged remission|deep and prolonged remission
4758919|NCT02868385|Schistosomiasis|schistosomiasis
4758920|NCT02868385|Schistosoma mansoni|schistosoma mansoni
4758921|NCT02868385|Bilharzia|bilharzia
4758922|NCT02868372|Cesarean section|cesarean section
4758923|NCT02868372|Betadine|betadine
4758924|NCT02868372|Wound infection|wound infection
4758925|NCT02868320|SMS|sms
4758926|NCT02868320|text messaging|text messaging
4758927|NCT02868320|diabetes self management|diabetes self management
4758928|NCT02868320|glycemic control|glycemic control
4758929|NCT02868320|mHealth|mhealth
4758930|NCT02868320|mobile health|mobile health
4758931|NCT02868320|diabetes education|diabetes education
4758932|NCT02868281|Cluster Randomization|cluster randomization
4758933|NCT02868281|Peak Expiratory Flow|peak expiratory flow
4758934|NCT02868281|Forced Expiratory Volume|forced expiratory volume
4758935|NCT02868281|Standardized Asthma Quality of Life Questionnaire|standardized asthma quality of life questionnaire
4758936|NCT02868281|Asthma Control Test|asthma control test
4758937|NCT02868268|Neuroblastoma|neuroblastoma
4758938|NCT02868255|Biobank analyses|biobank analyses
4758939|NCT02868255|Effect evaluation of the drug|effect evaluation of the drug
4758940|NCT02868255|patient-derived cells|patient-derived cells
4758941|NCT02868255|SIRPα/CD47 expression|sirpα/cd47 expression
4758942|NCT02868242|HCV genotype 1 or 4 (GT-1 or GT-4)|hcv genotype 1 or 4 (gt-1 or gt-4)
4758943|NCT02868242|Direct Acting Antiviral|direct acting antiviral
4758944|NCT02868242|Combination Therapy|combination therapy
4758945|NCT02868242|Hepatitis C, Chronic|hepatitis c, chronic
4758946|NCT02868242|Liver Diseases|liver diseases
4758947|NCT02868242|Virus Diseases|virus diseases
4758948|NCT02868177|Prevention|prevention
4758949|NCT02868151|Oral mucositis, chemo radiotherapy, vitamin c,|oral mucositis, chemo radiotherapy, vitamin c,
4758950|NCT02868138|Sickle cell disease|sickle cell disease
4758951|NCT02868138|Hydroxyurea|hydroxyurea
4758952|NCT02868138|Compliance|compliance
4758953|NCT02868125|pertrochanteric|pertrochanteric
4758954|NCT02868125|radiography|radiography
4758955|NCT02868112|Cancer Care|cancer care
4758956|NCT02868112|Palliative Care|palliative care
4758957|NCT02868112|Geriatrics|geriatrics
4758958|NCT02868112|Quality of Life|quality of life
4758959|NCT02868086|Age-related macular degeneration|age-related macular degeneration
4758960|NCT02868086|Optical coherence tomography angiography|optical coherence tomography angiography
4758961|NCT02868047|chronic pancreatitis|chronic pancreatitis
4758962|NCT02868047|endoscopic ultrasound|endoscopic ultrasound
4758963|NCT02868034|Low Back Pain|low back pain
4758964|NCT02868034|Spinal Manipulation|spinal manipulation
4758965|NCT02868034|Exercise|exercise
4758966|NCT02868021|Elderly|elderly
4758967|NCT02868021|Exercise|exercise
4758968|NCT02868008|multimodal imaging|multimodal imaging
4758969|NCT02868008|surgical risk|surgical risk
4758970|NCT02868008|arteriovenous malformations|arteriovenous malformations
4758971|NCT02867982|platform switching|platform switching
4758972|NCT02867982|crestal bone remodeling|crestal bone remodeling
4758973|NCT02867982|soft tissue thickness|soft tissue thickness
4758974|NCT02867982|dental implant|dental implant
4758975|NCT02867969|Spinocerebellar ataxia|spinocerebellar ataxia
4758976|NCT02867969|Exergaming|exergaming
4758977|NCT02867969|Neurodegenerative diseases|neurodegenerative diseases
4758978|NCT02867969|Rare disease|rare disease
4758979|NCT02867969|Motor exercises|motor exercises
4758980|NCT02867969|Premanifest stage|premanifest stage
4758981|NCT02867969|Training|training
4758982|NCT02867956|Ovarian cancer|ovarian cancer
4758983|NCT02867956|Apatinib|apatinib
4758984|NCT02867956|Etoposide|etoposide
4758985|NCT02867956|Chemotherapy|chemotherapy
4758986|NCT02867943|sepsis, shock,Lactate,volume controlled ventilation|sepsis, shock,lactate,volume controlled ventilation
4758987|NCT02867930|Echocardiography|echocardiography
4758988|NCT02867930|Transesophageal|transesophageal
4758989|NCT02867930|Dexmedetomidine|dexmedetomidine
4758990|NCT02867930|Ketamine|ketamine
4758991|NCT02867930|Propofol|propofol
4758992|NCT02867917|Fibers|fibers
4758993|NCT02867917|Constipation|constipation
4758994|NCT02867891|FLT3-ITD|flt3-itd
4758996|NCT02867891|allo-HSCT|allo-hsct
4758997|NCT02867839|Gastric cancer|gastric cancer
4758998|NCT02867839|Adjuvant chemotherapy|adjuvant chemotherapy
4758999|NCT02867839|S1|s1
4759000|NCT02867839|Oxaliplatin|oxaliplatin
4759001|NCT02867826|Endoscopy|endoscopy
4759002|NCT02867826|Ampulla of Vater|ampulla of vater
4759003|NCT02867826|Duodenoscopy|duodenoscopy
4759004|NCT02867813|High Cholesterol|high cholesterol
4759005|NCT02867813|Treatment for high cholesterol|treatment for high cholesterol
4759006|NCT02867813|Lowering cholesterol|lowering cholesterol
4759007|NCT02867813|Lowering high cholesterol|lowering high cholesterol
4759008|NCT02867813|Hypercholesterolemia|hypercholesterolemia
4759009|NCT02867800|Sickle Cell Disease|sickle cell disease
4759010|NCT02867800|Graft Versus Host Disease|graft versus host disease
4759011|NCT02867800|Abatacept|abatacept
4759012|NCT02867800|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
4759013|NCT02867787|Shoulder Joint|shoulder joint
4759014|NCT02867787|A02.835.583.748|a02.835.583.748
4759015|NCT02867774|chronic pelvic pain|chronic pelvic pain
4759016|NCT02867774|central pain amplification|central pain amplification
4759017|NCT02867774|exercise|exercise
4759018|NCT02867774|physical activity|physical activity
4759019|NCT02867761|COPD|copd
4759020|NCT02867761|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
4759021|NCT02867761|Pulmonary Function Tests|pulmonary function tests
4759022|NCT02867761|Current Smoker|current smoker
4759023|NCT02867761|Former Smoker|former smoker
4759024|NCT02867761|Chronic Obstructive Airway Disease|chronic obstructive airway disease
4759025|NCT02867761|Respiratory Symptoms|respiratory symptoms
4759026|NCT02867748|tvt abbrevo , Serasis|tvt abbrevo , serasis
4759027|NCT02867735|Macular Edema|macular edema
4759028|NCT02867735|Diabetic Macular Edema (DME)|diabetic macular edema (dme)
4759029|NCT02867735|Neovascular age-related Macular Degeneration(AMD)|neovascular age-related macular degeneration(amd)
4759030|NCT02867735|Retinal Vein Occlusions(RVO)|retinal vein occlusions(rvo)
4759031|NCT02867696|Bariatric Surgery|bariatric surgery
4759032|NCT02867696|Physical Activity|physical activity
4759033|NCT02867696|Weight Management|weight management
4759034|NCT02867696|Weight Loss|weight loss
4759035|NCT02867683|vibrotactile feedback|vibrotactile feedback
4759036|NCT02867683|vestibular rehabilitation|vestibular rehabilitation
4759037|NCT02867683|balance|balance
4759038|NCT02867670|Transcranial Magnetic Stimulation (TMS)|transcranial magnetic stimulation (tms)
4759039|NCT02867644|conversational hypnosis|conversational hypnosis
4759040|NCT02867644|imaging|imaging
4759041|NCT02867644|care|care
4759042|NCT02867644|breast neoplasia|breast neoplasia
4759043|NCT02867644|anxiety|anxiety
4759044|NCT02867644|pain|pain
4759045|NCT02867631|Intervention study|intervention study
4759046|NCT02867631|Maternal obesity|maternal obesity
4759047|NCT02867631|Nutrition|nutrition
4759048|NCT02867631|Maternal child health|maternal child health
4759049|NCT02867514|tobacco|tobacco
4759050|NCT02867514|craving|craving
4759051|NCT02867514|tDCS|tdcs
4759052|NCT02867514|attentional tasks|attentional tasks
4759053|NCT02867501|venous distension|venous distension
4759054|NCT02867501|venous reflux|venous reflux
4759055|NCT02867488|carotenoids|carotenoids
4759056|NCT02867488|phylloquinone|phylloquinone
4759057|NCT02867488|tocopherols|tocopherols
4759058|NCT02867488|vitamin A|vitamin a
4759059|NCT02867384|Graft vs. Host Disease|graft vs. host disease
4759060|NCT02867358|acute uncomplicated influenza|acute uncomplicated influenza
4759061|NCT02867319|safety|safety
4759062|NCT02867319|vaccine|vaccine
4759063|NCT02867306|methotrexate (MTX)|methotrexate (mtx)
4759064|NCT02867306|Pharmacokinetics|pharmacokinetics
4759065|NCT02867306|ASP1707|asp1707
4759066|NCT02867306|Rheumatoid Arthritis (RA)|rheumatoid arthritis (ra)
4759067|NCT02867280|Sorafenib|sorafenib
4759068|NCT02867280|Microvascular invasion|microvascular invasion
4759069|NCT02867280|adjuvant therapy|adjuvant therapy
4759070|NCT02867280|hepatocellular carcinoma|hepatocellular carcinoma
4759071|NCT02867267|thymosin alpha 1; thymalfasin; sepsis; immunodepression|thymosin alpha 1; thymalfasin; sepsis; immunodepression
4759072|NCT02867254|candida|candida
4759073|NCT02867254|endodontic lesion|endodontic lesion
4759074|NCT02867254|diabetes|diabetes
4759075|NCT02867202|intrauterine balloon|intrauterine balloon
4759076|NCT02867202|intrauterine contraceptive device|intrauterine contraceptive device
4759077|NCT02867202|Asherman Syndrome|asherman syndrome
4759078|NCT02867189|anterior chamber flare|anterior chamber flare
4759079|NCT02867189|cataract|cataract
4759080|NCT02867189|intraocular pressure|intraocular pressure
4759081|NCT02867189|micro-instrument|micro-instrument
4759082|NCT02867189|photograph-based atlas|photograph-based atlas
4759083|NCT02867189|visual|visual
4759084|NCT02867189|training nurse|training nurse
4759085|NCT02867111|sperm selection|sperm selection
4759086|NCT02867111|ICSI|icsi
4759087|NCT02867111|Assisted Reproductive Techniques|assisted reproductive techniques
4759088|NCT02867098|healthy|healthy
4759089|NCT02867098|volunteer|volunteer
4759091|NCT02867085|Myelodysplastic Syndromes|myelodysplastic syndromes
4759092|NCT02867033|desmoid tumour|desmoid tumour
4759093|NCT02867020|apalutamide|apalutamide
4759094|NCT02867020|abiraterone|abiraterone
4759095|NCT02867020|prostate cancer|prostate cancer
4759096|NCT02867007|KW-0761|kw-0761
4759097|NCT02867007|KHK2455|khk2455
4759098|NCT02867007|Metastatic Solid Tumors|metastatic solid tumors
4759099|NCT02867007|Locally Advanced Solid Tumors|locally advanced solid tumors
4759100|NCT02867007|Mogamulizumab|mogamulizumab
4759101|NCT02867007|Oncology|oncology
4759102|NCT02867007|Anti-Tumor|anti-tumor
4759103|NCT02866994|Women|women
4759104|NCT02866981|Brain Metastases|brain metastases
4759105|NCT02866955|aromatase inhibitors|aromatase inhibitors
4759106|NCT02866955|Metastases|metastases
4759107|NCT02866929|orthodontics|orthodontics
4759108|NCT02866929|periodontics|periodontics
4759109|NCT02866929|piezosurgery|piezosurgery
4759110|NCT02866929|accelerated orthodontics|accelerated orthodontics
4759111|NCT02866929|Surgically Accelerated Orthodontic Treatment|surgically accelerated orthodontic treatment
4759112|NCT02866903|Peritoneal carcinosis|peritoneal carcinosis
4759113|NCT02866903|intraperitoneal (IP) OXAliplatin|intraperitoneal (ip) oxaliplatin
4759114|NCT02866903|Phase I/II dose escalation trial|phase i/ii dose escalation trial
4759115|NCT02866903|FOLFIRI Bevacizumab chemotherapy|folfiri bevacizumab chemotherapy
4759116|NCT02866890|Laryngeal Tube Suction|laryngeal tube suction
4759117|NCT02866890|seal pressure|seal pressure
4759118|NCT02866890|mechanical ventilation|mechanical ventilation
4759119|NCT02866877|augmented renal clearance|augmented renal clearance
4759120|NCT02866864|Allergen|allergen
4759121|NCT02866864|Veterinary|veterinary
4759122|NCT02866864|Allergy|allergy
4759123|NCT02866864|Animals|animals
4759124|NCT02866838|Tranexamic acid|tranexamic acid
4759125|NCT02866838|NOAC|noac
4759126|NCT02866838|Direct Oral Anticoagulant (DOAC)|direct oral anticoagulant (doac)
4759127|NCT02866838|Direct oral anticoagulants|direct oral anticoagulants
4759128|NCT02866838|Non-Vitamin K antagonist oral anticoagulants|non-vitamin k antagonist oral anticoagulants
4759129|NCT02866825|Inflammation|inflammation
4759130|NCT02866825|Systemic Inflammatory Response Syndrome|systemic inflammatory response syndrome
4759131|NCT02866825|Pathologic Processes|pathologic processes
4759132|NCT02866825|Organ Dysfunction|organ dysfunction
4759133|NCT02866799|Multimorbidity|multimorbidity
4759134|NCT02866799|Primary Health Care|primary health care
4759135|NCT02866799|Polypharmacy|polypharmacy
4759136|NCT02866799|Comorbidity|comorbidity
4759137|NCT02866799|Medication Adherence|medication adherence
4759138|NCT02866799|Medication Appropriateness Index|medication appropriateness index
4759139|NCT02866799|Patient-Centered Care|patient-centered care
4759140|NCT02866773|Family|family
4759141|NCT02866773|well-being|well-being
4759142|NCT02866773|Physical activity|physical activity
4759143|NCT02866773|Diet|diet
4759144|NCT02866760|Smoking Cessation|smoking cessation
4759145|NCT02866734|Diabetic Retinopathy|diabetic retinopathy
4759146|NCT02866734|Screening|screening
4759147|NCT02866734|Fee for screening|fee for screening
4759148|NCT02866734|Private practice|private practice
4759149|NCT02866721|Human Mesenchymal Stem Cells|human mesenchymal stem cells
4759150|NCT02866695|Actinic Keratosis|actinic keratosis
4759151|NCT02866695|lung transplant|lung transplant
4759152|NCT02866695|kidney transplant|kidney transplant
4759153|NCT02866643|contraceptive implant|contraceptive implant
4759154|NCT02866643|postpartum contraception|postpartum contraception
4759155|NCT02866643|breastfeeding and contraception|breastfeeding and contraception
4759156|NCT02866630|Sevoflurane|sevoflurane
4759157|NCT02866630|Desflurane|desflurane
4759158|NCT02866630|Coronary Sinus|coronary sinus
4759159|NCT02866630|Oxygenator Exhaust|oxygenator exhaust
4759160|NCT02866630|Lactate|lactate
4759161|NCT02866630|Cardiopulmonary bypass|cardiopulmonary bypass
4759162|NCT02866617|Quality of Life|quality of life
4759163|NCT02866617|Vacuum formed thermoplastic retainer|vacuum formed thermoplastic retainer
4759164|NCT02866617|Orthodontic study model|orthodontic study model
4759165|NCT02866617|3D reconstructed study model|3d reconstructed study model
4759166|NCT02866604|Traumatic brain injury|traumatic brain injury
4759167|NCT02866604|isotonic balanced fluid|isotonic balanced fluid
4759168|NCT02866591|mammography|mammography
4759169|NCT02866591|pain|pain
4759170|NCT02866591|quality of life|quality of life
4759171|NCT02866591|screening|screening
4759172|NCT02866591|image quality|image quality
4759173|NCT02866591|radiology|radiology
4759174|NCT02866526|adolescents|adolescents
4759175|NCT02866526|young adults|young adults
4759176|NCT02866448|Cardiovascular disease|cardiovascular disease
4759177|NCT02866448|Flavonoid|flavonoid
4759178|NCT02866448|Isoquercetin|isoquercetin
4759179|NCT02866448|Aspirin|aspirin
4759180|NCT02866448|Platelet function|platelet function
4759181|NCT02866448|Vascular function|vascular function
4759182|NCT02866448|Blood pressure|blood pressure
4759183|NCT02866435|MRI|mri
4759184|NCT02866422|OCD|ocd
4759185|NCT02866409|dexmedetomidine|dexmedetomidine
4759186|NCT02866409|nerve block|nerve block
4759187|NCT02866409|anesthesia infiltration|anesthesia infiltration
4759188|NCT02866396|chronic pain|chronic pain
4759189|NCT02866396|oxycodone|oxycodone
4759190|NCT02866396|pregabalin|pregabalin
4759191|NCT02866396|lumbar spine surgery|lumbar spine surgery
4759192|NCT02866396|multimodal analgesia|multimodal analgesia
4759193|NCT02866344|Microwave ablation|microwave ablation
4759194|NCT02866344|Ablation techniques|ablation techniques
4759195|NCT02866344|Operative surgical procedures|operative surgical procedures
4759196|NCT02866344|Hepatic resection|hepatic resection
4759197|NCT02866344|Surgery|surgery
4759198|NCT02866344|Outcomes assessment|outcomes assessment
4759199|NCT02866305|primary spontaneous pneumothorax|primary spontaneous pneumothorax
4759200|NCT02866305|epidemiology|epidemiology
4759201|NCT02866305|genetics|genetics
4759202|NCT02866305|risk factors|risk factors
4759203|NCT02866292|Pelvic Floor|pelvic floor
4759204|NCT02866292|Pregnancy|pregnancy
4759205|NCT02866292|Physical Therapy Specialty|physical therapy specialty
4759206|NCT02866253|Dehydroepiandrosterone（DHEA）|dehydroepiandrosterone（dhea）
4759207|NCT02866253|DOR（Diminished Ovarian Reserve)|dor（diminished ovarian reserve)
4759208|NCT02866253|IVF(In vitro fertilization)|ivf(in vitro fertilization)
4759209|NCT02866253|BMP-15(Bone Morphogenetic Protein 15)|bmp-15(bone morphogenetic protein 15)
4759210|NCT02866227|Bacterial|bacterial
4759211|NCT02866227|Candidiasis|candidiasis
4759212|NCT02866227|Gel|gel
4759213|NCT02866227|Insert|insert
4759214|NCT02866227|TOL-463|tol-463
4759215|NCT02866227|Vaginal|vaginal
4759216|NCT02866227|Vaginitis|vaginitis
4759217|NCT02866227|Vaginoses|vaginoses
4759218|NCT02866227|Vulvovaginal|vulvovaginal
4759219|NCT02866201|Turista|turista
4759220|NCT02866175|percutaneous intervention|percutaneous intervention
4759221|NCT02866175|vitamin K antagonist|vitamin k antagonist
4759222|NCT02866149|Cancer|cancer
4759223|NCT02866149|circulating tumor biomarkers|circulating tumor biomarkers
4759224|NCT02866149|circulating tumor DNA|circulating tumor dna
4759225|NCT02866149|Circulating tumor Cell (CTC)|circulating tumor cell (ctc)
4759226|NCT02866097|integrated community case management|integrated community case management
4759227|NCT02866097|Mobile Health (mHealth)|mobile health (mhealth)
4759228|NCT02866097|rapid diagnostic test|rapid diagnostic test
4759229|NCT02866097|artemether-lumefantrine|artemether-lumefantrine
4759230|NCT02866097|amoxicillin|amoxicillin
4759231|NCT02866097|zinc|zinc
4759232|NCT02866097|oral rehydration solution (ORS)|oral rehydration solution (ors)
4759233|NCT02866097|District Health Information System 2 (DHIS2)|district health information system 2 (dhis2)
4759234|NCT02866097|iCCM-DHIS2|iccm-dhis2
4759235|NCT02866097|ZCAHRD|zcahrd
4759236|NCT02866084|vestibular migraines|vestibular migraines
4759237|NCT02866084|dizziness|dizziness
4759238|NCT02866084|migraine headache|migraine headache
4759239|NCT02866045|Subepithelial lesions|subepithelial lesions
4759240|NCT02866045|Endoscopic Ultrasound-Guided Fine Needle Aspiration|endoscopic ultrasound-guided fine needle aspiration
4759241|NCT02866006|HPV|hpv
4759242|NCT02866006|Type 16, 18|type 16, 18
4759243|NCT02866006|E6E7|e6e7
4759244|NCT02866006|Immune therapeutic vaccine|immune therapeutic vaccine
4759245|NCT02865993|cesarean section|cesarean section
4759246|NCT02865993|cesarean section complications|cesarean section complications
4759247|NCT02865993|betadine irrigation|betadine irrigation
4759248|NCT02865980|inflammation, infection|inflammation, infection
4759249|NCT02865967|Decision Support Techniques|decision support techniques
4759250|NCT02865967|Delayed Diagnosis|delayed diagnosis
4759251|NCT02865967|Natural Language Processing|natural language processing
4759252|NCT02865967|Geographic Information Systems|geographic information systems
4759253|NCT02865941|Target Fortification|target fortification
4759254|NCT02865941|Breast milk analysis|breast milk analysis
4759255|NCT02865941|Nutrition|nutrition
4759256|NCT02865941|Macronutrient intake|macronutrient intake
4759257|NCT02865941|Protein accretion|protein accretion
4759258|NCT02865915|Acne|acne
4759259|NCT02865915|Hirsutism|hirsutism
4759260|NCT02865915|Menstrual Irregularity|menstrual irregularity
4759261|NCT02865915|Alopecia|alopecia
4759262|NCT02865902|Low level laser therapy|low level laser therapy
4759263|NCT02865902|wound healing|wound healing
4759264|NCT02865902|periodontology|periodontology
4759265|NCT02865889|laparoscopic surgery|laparoscopic surgery
4759266|NCT02865889|Uterine Neoplasms|uterine neoplasms
4759267|NCT02865876|Infectious keratitis|infectious keratitis
4759268|NCT02865876|Cross-linking|cross-linking
4759269|NCT02865863|Multivitamin|multivitamin
4759270|NCT02865863|Eurycomalongifoliawater extract|eurycomalongifoliawater extract
4759271|NCT02865863|Quality of Life|quality of life
4759272|NCT02865863|Mood|mood
4759273|NCT02865850|vadadustat|vadadustat
4759274|NCT02865850|AKB-6548|akb-6548
4759275|NCT02865850|anemia|anemia
4759276|NCT02865850|chronic kidney disease|chronic kidney disease
4759277|NCT02865850|CKD|ckd
4759278|NCT02865850|chronic renal insufficiency|chronic renal insufficiency
4759279|NCT02865850|renal impairment|renal impairment
4759280|NCT02865850|erythropoietin|erythropoietin
4759281|NCT02865850|kidney|kidney
4759282|NCT02865850|renal|renal
4759283|NCT02865850|oral anemia treatment|oral anemia treatment
4759284|NCT02865850|hemoglobin|hemoglobin
4759285|NCT02865850|hypoxia-inducible factor|hypoxia-inducible factor
4759286|NCT02865850|HIF|hif
4759287|NCT02865850|efficacy|efficacy
4759288|NCT02865850|safety|safety
4759289|NCT02865850|phase 3|phase 3
4759290|NCT02865850|cardiovascular|cardiovascular
4759291|NCT02865837|Brachytherapy|brachytherapy
4759292|NCT02865837|Organs at Risk|organs at risk
4759293|NCT02865837|Bladder volume|bladder volume
4759294|NCT02865837|Cervical cancer|cervical cancer
4759295|NCT02865824|Colonoscopy|colonoscopy
4759296|NCT02865811|Ovarian Cancer|ovarian cancer
4759297|NCT02865798|Heart Valve Diseases|heart valve diseases
4759298|NCT02865798|Cardiovascular Diseases|cardiovascular diseases
4759299|NCT02865798|Heart Disease|heart disease
4759300|NCT02865798|Valvular Heart Diseases|valvular heart diseases
4759301|NCT02865785|recurrent implantation failure|recurrent implantation failure
4759302|NCT02865785|intralipid|intralipid
4759303|NCT02865785|uterine natural killer cells|uterine natural killer cells
4759304|NCT02865746|Steroids|steroids
4759305|NCT02865746|Pain measurement|pain measurement
4759306|NCT02865733|Remodulin®|remodulin®
4759307|NCT02865733|pulmonary vascular resistance|pulmonary vascular resistance
4759308|NCT02865733|univentricular physiology|univentricular physiology
4759309|NCT02865707|ulcerative colitis|ulcerative colitis
4759310|NCT02865707|prebiotics|prebiotics
4759311|NCT02865707|b-fructans|b-fructans
4759312|NCT02865707|inulin|inulin
4759313|NCT02865707|oligofructose|oligofructose
4759314|NCT02865707|intestinal microbiota|intestinal microbiota
4759315|NCT02865681|Infertility|infertility
4759316|NCT02865681|Gonadotropins|gonadotropins
4759317|NCT02865681|Menopur|menopur
4759318|NCT02865681|Ovarian stimulation|ovarian stimulation
4759319|NCT02865642|Stroke|stroke
4759320|NCT02865642|Serotonin|serotonin
4759321|NCT02865642|Hand Paresis|hand paresis
4759322|NCT02865616|CDI|cdi
4759323|NCT02865616|recurrent infection|recurrent infection
4759324|NCT02865616|MET-2|met-2
4759325|NCT02865616|C. difficile|c. difficile
4759326|NCT02865590|Maxillary Sinus/surgery|maxillary sinus/surgery
4759327|NCT02865590|Bone Substitutes|bone substitutes
4759328|NCT02865590|Radiography, Panoramic|radiography, panoramic
4759329|NCT02865564|Probiotics|probiotics
4759330|NCT02865564|Anti-Bacterial Agents|anti-bacterial agents
4759331|NCT02865564|Infant, Newborn|infant, newborn
4759332|NCT02865564|Gastrointestinal Microbiome|gastrointestinal microbiome
4759333|NCT02865564|Colic|colic
4759334|NCT02865564|Gastrointestinal Diseases|gastrointestinal diseases
4759335|NCT02865564|Body Composition|body composition
4759336|NCT02865564|Bone Density|bone density
4759337|NCT02865564|Randomized Controlled Trial|randomized controlled trial
4759338|NCT02865564|Lactobacillus reuteri|lactobacillus reuteri
4759339|NCT02865564|Pediatrics|pediatrics
4759340|NCT02865564|Feces|feces
4759341|NCT02865564|ultrasonography|ultrasonography
4759342|NCT02865564|High-Throughput Nucleotide Sequencing|high-throughput nucleotide sequencing
4759343|NCT02865564|Electric Impedance|electric impedance
4759344|NCT02865564|Surveys and Questionnaires|surveys and questionnaires
4759345|NCT02865538|Hot flashes|hot flashes
4759346|NCT02865538|Post-menopausal|post-menopausal
4759347|NCT02865525|Surveys and Questionnaires|surveys and questionnaires
4759348|NCT02865525|Patient Education as Topic|patient education as topic
4759349|NCT02865525|Medication Adherence|medication adherence
4759350|NCT02865525|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
4759351|NCT02865525|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
4759352|NCT02865525|Heart failure|heart failure
4759353|NCT02865512|thoracic epidural injection|thoracic epidural injection
4759354|NCT02865512|patient position|patient position
4759355|NCT02865486|Gastric emptying|gastric emptying
4759356|NCT02865486|MRI|mri
4759357|NCT02865486|lipid emulsions|lipid emulsions
4759358|NCT02865486|breath test|breath test
4759359|NCT02865486|GI peptide hormones|gi peptide hormones
4759360|NCT02865473|Schlemm's canal lumen area|schlemm's canal lumen area
4759361|NCT02865473|PEX|pex
4759362|NCT02865460|Chronic Pain|chronic pain
4759363|NCT02865460|Cognitive Disorders|cognitive disorders
4759364|NCT02865460|Inflammation|inflammation
4759365|NCT02865460|Neurologic manifestations|neurologic manifestations
4759366|NCT02865460|Dementia|dementia
4759367|NCT02865460|Mental Disorders|mental disorders
4759368|NCT02865460|Ubiquinol/ubiquinone|ubiquinol/ubiquinone
4759369|NCT02865460|Pathologic Processes|pathologic processes
4759370|NCT02865460|Nervous System Diseases|nervous system diseases
4759371|NCT02865460|Hormones, Hormone Substitutes, and Hormone Antagon|hormones, hormone substitutes, and hormone antagon
4759372|NCT02865460|Anti-Inflammatory Agents|anti-inflammatory agents
4759373|NCT02865460|Pharmacologic Actions|pharmacologic actions
4759374|NCT02865460|Therapeutic Uses|therapeutic uses
4759375|NCT02865460|Physiological Effects of Drugs|physiological effects of drugs
4759376|NCT02865460|Gulf war illness|gulf war illness
4759377|NCT02865460|Chronic fatigue|chronic fatigue
4759378|NCT02865447|dual energy x-ray absorptiometry|dual energy x-ray absorptiometry
4759379|NCT02865447|DEXA|dexa
4759380|NCT02865447|DXA|dxa
4759381|NCT02865447|total hip arthroplasty|total hip arthroplasty
4759382|NCT02865447|PROFEMUR|profemur
4759383|NCT02865447|PRESERVE|preserve
4759384|NCT02865447|bone mineral density|bone mineral density
4759385|NCT02865447|BMD|bmd
4759386|NCT02865447|osteoarthritis|osteoarthritis
4759387|NCT02865447|THA|tha
4759388|NCT02865447|musculoskeletal disease|musculoskeletal disease
4759389|NCT02865408|Amino acids|amino acids
4759390|NCT02865408|critically-ill|critically-ill
4759391|NCT02865408|catabolic|catabolic
4759392|NCT02865408|nutrition|nutrition
4759393|NCT02865408|anabolic|anabolic
4759394|NCT02865395|Belladonna and Opium Suppositories|belladonna and opium suppositories
4759395|NCT02865382|Adenoma detection rate|adenoma detection rate
4759396|NCT02865382|Optical Enhancement Technonogy|optical enhancement technonogy
4759397|NCT02865382|Colonoscopy|colonoscopy
4759398|NCT02865369|chronic hepatitis C|chronic hepatitis c
4759399|NCT02865369|Daclatasvir|daclatasvir
4759400|NCT02865369|Asunaprevir|asunaprevir
4759401|NCT02865369|fibrosis|fibrosis
4759402|NCT02865369|transient elastography|transient elastography
4759403|NCT02865356|atopic dermatitis|atopic dermatitis
4759404|NCT02865356|eczema|eczema
4759405|NCT02865356|children|children
4759406|NCT02865356|skin|skin
4759407|NCT02865356|topical|topical
4759408|NCT02865356|cyclosporine|cyclosporine
4759409|NCT02865343|Functional Electrical Stimulation (FES)-Rowing|functional electrical stimulation (fes)-rowing
4759410|NCT02865330|Intermediate Risk Prostate Cancer|intermediate risk prostate cancer
4759411|NCT02865330|Low Risk Prostate Cancer|low risk prostate cancer
4759412|NCT02865330|Active Surveillance|active surveillance
4759413|NCT02865304|metastatic breast cancer|metastatic breast cancer
4759414|NCT02865304|HER-2-negative|her-2-negative
4759415|NCT02865304|endostar|endostar
4759416|NCT02865252|manual therapy|manual therapy
4759417|NCT02865252|mobilization with movement|mobilization with movement
4759418|NCT02865239|Imaging, Three-Dimensional|imaging, three-dimensional
4759419|NCT02865239|Magnetic Resonance Imaging/methods*|magnetic resonance imaging/methods*
4759420|NCT02865239|Breast Neoplasms/diagnosis*|breast neoplasms/diagnosis*
4759421|NCT02865239|Prone Position|prone position
4759422|NCT02865239|Prospective Studies|prospective studies
4759423|NCT02865226|thoracic surgery|thoracic surgery
4759424|NCT02865226|thoracotomy|thoracotomy
4759425|NCT02865213|Open bite|open bite
4759426|NCT02865213|Molar intrusion|molar intrusion
4759427|NCT02865213|Temporary anchorage devices|temporary anchorage devices
4759428|NCT02865200|Nutrition|nutrition
4759429|NCT02865200|Public Health|public health
4759430|NCT02865187|Vitamin D|vitamin d
4759431|NCT02865187|polycystic ovary syndrome|polycystic ovary syndrome
4759432|NCT02865187|polycystic ovarian syndrome|polycystic ovarian syndrome
4759433|NCT02865187|PCOS|pcos
4759434|NCT02865187|sexual dysfunction|sexual dysfunction
4759435|NCT02865187|female sexual dysfunction|female sexual dysfunction
4759436|NCT02865187|low libido|low libido
4759437|NCT02865174|Thrombin-gelatin matrix|thrombin-gelatin matrix
4759438|NCT02865174|Floseal|floseal
4759439|NCT02865174|Tranexamic Acid|tranexamic acid
4759440|NCT02865174|Total Knee Arthroplasty|total knee arthroplasty
4759441|NCT02865135|HPV Related Head and Neck|hpv related head and neck
4759442|NCT02865135|Cervical|cervical
4759443|NCT02865135|Anal Cancer|anal cancer
4759444|NCT02865109|Spinal Muscular Atrophy|spinal muscular atrophy
4759445|NCT02865109|SMA|sma
4759446|NCT02865109|SMN|smn
4759447|NCT02865109|SMNRx|smnrx
4759448|NCT02865109|ISIS-SMNRx|isis-smnrx
4759449|NCT02865109|ISIS-SMN Rx|isis-smn rx
4759450|NCT02865109|ISIS 396443|isis 396443
4759451|NCT02865109|ISIS-396443|isis-396443
4759452|NCT02865109|ENDEAR|endear
4759453|NCT02865109|IONIS-SMNRx|ionis-smnrx
4759454|NCT02865109|IONIS-SMN Rx|ionis-smn rx
4759455|NCT02865109|EMBRACE|embrace
4759456|NCT02865109|NURTURE|nurture
4759457|NCT02865109|IONIS|ionis
4759458|NCT02865109|BIOGEN|biogen
4759459|NCT02865109|SHINE|shine
4759460|NCT02865109|Nusinersen|nusinersen
4759461|NCT02865070|premature|premature
4759462|NCT02865070|wireless vitals|wireless vitals
4759463|NCT02865070|vitals monitor|vitals monitor
4759464|NCT02865044|Fatty Acids|fatty acids
4759465|NCT02865044|Fish Oil|fish oil
4759466|NCT02865044|Marine Copepod|marine copepod
4759467|NCT02865044|Fatty Acid Absorption|fatty acid absorption
4759468|NCT02865018|Neuromyelitis Optica|neuromyelitis optica
4759469|NCT02865018|Cetirizine|cetirizine
4759470|NCT02864992|lung|lung
4759471|NCT02864992|neoplasm|neoplasm
4759472|NCT02864992|cancer|cancer
4759473|NCT02864992|tumor|tumor
4759474|NCT02864992|adenocarcinoma|adenocarcinoma
4759475|NCT02864992|MET exon 14|met exon 14
4759476|NCT02864992|METex14|metex14
4759477|NCT02864992|pulmonary|pulmonary
4759478|NCT02864992|stage III|stage iii
4759479|NCT02864992|stage IV|stage iv
4759480|NCT02864992|c-Met|c-met
4759481|NCT02864992|cMET|cmet
4759482|NCT02864992|NSCLC|nsclc
4759483|NCT02864992|advanced non-small cell lung cancer|advanced non-small cell lung cancer
4759484|NCT02864992|MET amplification|met amplification
4759485|NCT02864966|Safety study|safety study
4759486|NCT02864966|new product|new product
4759487|NCT02864966|normal healthy skin.|normal healthy skin.
4759488|NCT02864953|Stroke|stroke
4759489|NCT02864953|Infarction|infarction
4759490|NCT02864953|Cerebrovascular Disorders|cerebrovascular disorders
4759491|NCT02864953|Brain Diseases|brain diseases
4759492|NCT02864953|Brain Edema Ischemia|brain edema ischemia
4759493|NCT02864953|Pathological Processes Necrosis|pathological processes necrosis
4759494|NCT02864953|Central Nervous System Diseases|central nervous system diseases
4759495|NCT02864953|Vascular Diseases|vascular diseases
4759496|NCT02864953|Cardiovascular Diseases|cardiovascular diseases
4759497|NCT02864953|Glyburide|glyburide
4759498|NCT02864953|Hypoglycemic Agents|hypoglycemic agents
4759499|NCT02864953|Physiological Effects of Drugs|physiological effects of drugs
4759500|NCT02864940|Memory|memory
4759501|NCT02864940|aneurysm|aneurysm
4759502|NCT02864940|deficits|deficits
4759503|NCT02864940|trouble|trouble
4759504|NCT02864940|forgetful|forgetful
4759505|NCT02864940|ruptured|ruptured
4759506|NCT02864940|subarachnoid|subarachnoid
4759507|NCT02864940|hemorrhage|hemorrhage
4759508|NCT02864927|Meningitis|meningitis
4759509|NCT02864927|Meningococcal Meningitis|meningococcal meningitis
4759510|NCT02864927|Meningococcal Infections|meningococcal infections
4759511|NCT02864927|Menactra®|menactra®
4759512|NCT02864927|Meningococcal Vaccine|meningococcal vaccine
4759513|NCT02864888|Diffuse, intrinsic brain stem glioma|diffuse, intrinsic brain stem glioma
4759514|NCT02864888|QT/QTc interval|qt/qtc interval
4759515|NCT02864888|Radiation|radiation
4759516|NCT02864888|Antineoplaston therapy|antineoplaston therapy
4759517|NCT02864875|Trauma|trauma
4759518|NCT02864875|Coagulopathy|coagulopathy
4759519|NCT02864875|Fibrinogen|fibrinogen
4759520|NCT02864875|Fibrinogen Concentrate|fibrinogen concentrate
4759521|NCT02864875|Thromboelastometry|thromboelastometry
4759522|NCT02864875|Hypofibrinogenemia|hypofibrinogenemia
4759523|NCT02864875|Early Fibrinogen Replacement|early fibrinogen replacement
4759524|NCT02864849|Rectal cancer|rectal cancer
4759525|NCT02864849|neoadjuvant|neoadjuvant
4759526|NCT02864849|radiotherapy|radiotherapy
4759527|NCT02864849|chemotherapy|chemotherapy
4759528|NCT02864849|toxicity|toxicity
4759529|NCT02864836|Copper|copper
4759530|NCT02864836|isotopic distribution|isotopic distribution
4759531|NCT02864836|cancer|cancer
4759532|NCT02864823|Scleromalacia perforans|scleromalacia perforans
4759533|NCT02864823|Necrotizing Scleritis|necrotizing scleritis
4759534|NCT02864823|Perichondrium|perichondrium
4759535|NCT02864797|Health related quality of life|health related quality of life
4759536|NCT02864797|patient reported outcomes|patient reported outcomes
4759537|NCT02864797|cohort|cohort
4759538|NCT02864797|e-health|e-health
4759539|NCT02864771|Ventricular Arrhythmias|ventricular arrhythmias
4759540|NCT02864771|ICD|icd
4759541|NCT02864771|Biological markers|biological markers
4759542|NCT02864745|early rehabilitation|early rehabilitation
4759543|NCT02864745|critically ill|critically ill
4759544|NCT02864745|muscle weakness|muscle weakness
4759545|NCT02864745|neuromuscular stimulation|neuromuscular stimulation
4759546|NCT02864745|functional electrical stimulation-assisted cycle ergometry|functional electrical stimulation-assisted cycle ergometry
4759547|NCT02864745|ICUAW|icuaw
4759548|NCT02864732|Low back pain|low back pain
4759549|NCT02864732|stabilization exercises|stabilization exercises
4759550|NCT02864732|neuromuscular electrical stimulation|neuromuscular electrical stimulation
4759551|NCT02864719|Heart arrest|heart arrest
4759552|NCT02864719|Cardiac arrest|cardiac arrest
4759553|NCT02864719|Fatigue|fatigue
4759554|NCT02864693|Microprocessor Controlled Ankle|microprocessor controlled ankle
4759555|NCT02864693|Transtibial Amputee|transtibial amputee
4759556|NCT02864693|Pacifica LP|pacifica lp
4759557|NCT02864693|Kinnex|kinnex
4759558|NCT02864680|cannabis|cannabis
4759559|NCT02864680|magnocellular pathway|magnocellular pathway
4759560|NCT02864654|Critical lower limb ischemia|critical lower limb ischemia
4759561|NCT02864654|Atherosclerosis obliterans|atherosclerosis obliterans
4759562|NCT02864654|Diabetic angiopathies|diabetic angiopathies
4759563|NCT02864654|Thromboangiitis obliterans|thromboangiitis obliterans
4759564|NCT02864654|Ischemic ulcers|ischemic ulcers
4759565|NCT02864654|Peripheral arterial disease|peripheral arterial disease
4759566|NCT02864654|Indirect revascularisation|indirect revascularisation
4759567|NCT02864654|Intramuscular injection|intramuscular injection
4759568|NCT02864654|Ankle-brachial index|ankle-brachial index
4759569|NCT02864654|Transcutaneous oxygen tension|transcutaneous oxygen tension
4759570|NCT02864654|Stromal vascular fraction (SVF)|stromal vascular fraction (svf)
4759571|NCT02864654|Adipose-derived regenerative cells (ADRC)|adipose-derived regenerative cells (adrc)
4759572|NCT02864654|Adipose tissue|adipose tissue
4759573|NCT02864654|Stem cells|stem cells
4759574|NCT02864641|chronic kidney disease|chronic kidney disease
4759575|NCT02864641|adolescents|adolescents
4759576|NCT02864641|renal disease|renal disease
4759577|NCT02864641|CKD|ckd
4759578|NCT02864628|RSV Vaccines|rsv vaccines
4759579|NCT02864628|Respiratory Syncytial Virus Vaccines|respiratory syncytial virus vaccines
4759580|NCT02864615|renal cell carcinoma|renal cell carcinoma
4759581|NCT02864615|metastasis|metastasis
4759582|NCT02864615|stereotactic body radiation therapy|stereotactic body radiation therapy
4759583|NCT02864615|targted therapy|targted therapy
4759584|NCT02864615|immune checkpoint inhibitors|immune checkpoint inhibitors
4759585|NCT02864602|Regional anesthesia|regional anesthesia
4759586|NCT02864602|Adjuvant|adjuvant
4759587|NCT02864602|Dexamethasone|dexamethasone
4759588|NCT02864589|Tourette, Tic, Tics|tourette, tic, tics
4759589|NCT02864550|Men who have sex with men|men who have sex with men
4759590|NCT02864550|Human immunodeficiency virus|human immunodeficiency virus
4759591|NCT02864550|Doxycycline|doxycycline
4759592|NCT02864550|Tetracycline|tetracycline
4759593|NCT02864537|warfarin|warfarin
4759594|NCT02864537|self-management|self-management
4759595|NCT02864537|Conventional management|conventional management
4759596|NCT02864537|Training|training
4759597|NCT02864537|TTR|ttr
4759598|NCT02864537|Complications|complications
4759599|NCT02864537|Quality of life|quality of life
4759600|NCT02864524|Physical Therapy Modalities|physical therapy modalities
4759601|NCT02864524|Exercises|exercises
4759602|NCT02864524|Musculoskeletal Manipulations|musculoskeletal manipulations
4759603|NCT02864485|Live donor liver transplantation|live donor liver transplantation
4759604|NCT02864459|Ultrasonography|ultrasonography
4759605|NCT02864459|Weaning|weaning
4759606|NCT02864433|cholera|cholera
4759607|NCT02864433|oral cholera vaccine|oral cholera vaccine
4759608|NCT02864433|diarrhea|diarrhea
4759609|NCT02864420|home hospital|home hospital
4759610|NCT02864420|acute care home|acute care home
4759611|NCT02864420|care redesign|care redesign
4759612|NCT02864420|delivery innovation|delivery innovation
4759613|NCT02864420|heart failure|heart failure
4759614|NCT02864420|pneumonia|pneumonia
4759615|NCT02864420|cellulitis|cellulitis
4759616|NCT02864420|urinary tract infections|urinary tract infections
4759617|NCT02864342|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
4759618|NCT02864342|COPD|copd
4759619|NCT02864342|Respiratory|respiratory
4759620|NCT02864342|adherence|adherence
4759621|NCT02864342|medication reminders|medication reminders
4759622|NCT02864329|Male Infertility|male infertility
4759623|NCT02864329|micro RNAs|micro rnas
4759624|NCT02864329|small interfering RNAs|small interfering rnas
4759625|NCT02864329|miRNA|mirna
4759626|NCT02864329|siRNA|sirna
4759627|NCT02864316|radiation-induced solid tumors|radiation-induced solid tumors
4759628|NCT02864316|Nivolumab|nivolumab
4759629|NCT02864316|Phase 2 study|phase 2 study
4759630|NCT02864303|Alzheimer's disease|alzheimer's disease
4759631|NCT02864303|Mild Cognitive Impairment|mild cognitive impairment
4759632|NCT02864303|Saliva|saliva
4759633|NCT02864303|Amyloid peptides|amyloid peptides
4759634|NCT02864303|Diagnosis|diagnosis
4759635|NCT02864290|Pharmacokinetics of AGS62P1|pharmacokinetics of ags62p1
4759636|NCT02864290|AGS62P1|ags62p1
4759637|NCT02864290|AML|aml
4759638|NCT02864290|Acute Myeloid Leukemia|acute myeloid leukemia
4759639|NCT02864277|Gynecology|gynecology
4759640|NCT02864277|Cancer|cancer
4759641|NCT02864277|General Surgery|general surgery
4759642|NCT02864277|Recovery Quality|recovery quality
4759643|NCT02864277|Length of hospital stay|length of hospital stay
4759644|NCT02864238|electronic milestone pathway|electronic milestone pathway
4759645|NCT02864238|cardiac valve surgery|cardiac valve surgery
4759646|NCT02864186|Pain|pain
4759647|NCT02864186|Quality of life|quality of life
4759648|NCT02864186|wound healing|wound healing
4759649|NCT02864173|Postoperative cognitive dysfunction|postoperative cognitive dysfunction
4759650|NCT02864173|Postoperative cognitive decline|postoperative cognitive decline
4759651|NCT02864173|Postoperative delirium|postoperative delirium
4759652|NCT02864173|Cognitive outcome|cognitive outcome
4759653|NCT02864173|Neuropsychology|neuropsychology
4759654|NCT02864173|Genetics|genetics
4759655|NCT02864160|Language Concordance|language concordance
4759656|NCT02864160|Diabetes Self-Management|diabetes self-management
4759657|NCT02864160|Health Coaching|health coaching
4759658|NCT02864160|Latinos|latinos
4759659|NCT02864134|Optic neuritis|optic neuritis
4759660|NCT02864134|ganglion cell layer|ganglion cell layer
4759661|NCT02864121|High-risk human papillomavirus|high-risk human papillomavirus
4759662|NCT02864121|Integration of HR-HPV DNA|integration of hr-hpv dna
4759663|NCT02864121|biomarker of severity|biomarker of severity
4759664|NCT02864121|biomarker of evolution|biomarker of evolution
4759665|NCT02864095|Arthroplasty, Replacement, Hip|arthroplasty, replacement, hip
4759666|NCT02864095|Epinephrine|epinephrine
4759667|NCT02864095|Tranexamic acid|tranexamic acid
4759668|NCT02864082|X-linked, lamellar|x-linked, lamellar
4759669|NCT02864043|Barrett's Esophagus|barrett's esophagus
4759670|NCT02864043|Barrett's|barrett's
4759671|NCT02864043|OCT|oct
4759672|NCT02864043|VLE|vle
4759673|NCT02864030|Eribulin mesylate|eribulin mesylate
4759674|NCT02864030|Halaven|halaven
4759675|NCT02864030|Polymorphisms|polymorphisms
4759676|NCT02864030|Tolerability|tolerability
4759677|NCT02864004|Parkinson disease|parkinson disease
4759678|NCT02864004|Quality of Life|quality of life
4759679|NCT02864004|Apomorphine infusion|apomorphine infusion
4759680|NCT02863978|Sepsis|sepsis
4759681|NCT02863978|Neonates|neonates
4759682|NCT02863978|Cardio-respiratory maturation|cardio-respiratory maturation
4759683|NCT02863978|Neurobehavioral maturation|neurobehavioral maturation
4759684|NCT02863926|BKA|bka
4759685|NCT02863926|amputation|amputation
4759686|NCT02863926|MarrowStim|marrowstim
4759687|NCT02863926|below knee amputation|below knee amputation
4759688|NCT02863926|wound complication|wound complication
4759689|NCT02863926|vascular disease|vascular disease
4759690|NCT02863926|critical limb ischemia|critical limb ischemia
4759691|NCT02863926|peripheral artery disease|peripheral artery disease
4759692|NCT02863926|AKA|aka
4759693|NCT02863926|stem cells|stem cells
4759694|NCT02863926|bone marrow|bone marrow
4759695|NCT02863887|Weight Loss|weight loss
4759696|NCT02863887|African American|african american
4759697|NCT02863887|Community Based|community based
4759698|NCT02863887|Mobile technology|mobile technology
4759699|NCT02863887|Translational science|translational science
4759700|NCT02863874|Perineal tear|perineal tear
4759701|NCT02863874|Labor|labor
4759702|NCT02863874|Triclosan|triclosan
4759703|NCT02863861|Sedation|sedation
4759704|NCT02863861|Pediatric Patients|pediatric patients
4759705|NCT02863822|Functional Dyspepsia|functional dyspepsia
4759706|NCT02863822|Low FODMAP|low fodmap
4759707|NCT02863822|Dietary Modification|dietary modification
4759708|NCT02863809|Keratolysis|keratolysis
4759709|NCT02863809|Corneal Melting|corneal melting
4759710|NCT02863809|Boston KPro|boston kpro
4759711|NCT02863809|Keratoprosthesis|keratoprosthesis
4759712|NCT02863770|endosonography|endosonography
4759713|NCT02863744|mmp-8|mmp-8
4759714|NCT02863744|early stages of wound healing|early stages of wound healing
4759715|NCT02863744|wound healing marker|wound healing marker
4759716|NCT02863731|postural changes|postural changes
4759717|NCT02863731|alternating postures|alternating postures
4759718|NCT02863731|Cognitive performance|cognitive performance
4759719|NCT02863731|Height-adjustable desk|height-adjustable desk
4759720|NCT02863731|Worksite|worksite
4759721|NCT02863718|CLL|cll
4759722|NCT02863692|CLL|cll
4759723|NCT02863692|B-PLL|b-pll
4759724|NCT02863692|T-PLL|t-pll
4759725|NCT02863692|SLL|sll
4759726|NCT02863692|T-NK-LGL|t-nk-lgl
4759727|NCT02863692|HCL|hcl
4759728|NCT02863692|Richter´s Transformation|richter´s transformation
4759729|NCT02863679|tetracaine hydrochloride gel|tetracaine hydrochloride gel
4759730|NCT02863679|analgesia|analgesia
4759731|NCT02863679|intrauterine balloon|intrauterine balloon
4759732|NCT02863679|hysteroscope operation|hysteroscope operation
4759733|NCT02863666|Cariopulmonary, cardiac arrest|cariopulmonary, cardiac arrest
4759734|NCT02863653|social participation|social participation
4759735|NCT02863653|International Classification of Functioning|international classification of functioning
4759736|NCT02863640|Senile macular degeneration|senile macular degeneration
4759737|NCT02863640|Parkinson's disease|parkinson's disease
4759738|NCT02863627|Emergencies|emergencies
4759739|NCT02863627|newborn|newborn
4759740|NCT02863627|care|care
4759741|NCT02863601|Buprenorphine|buprenorphine
4759742|NCT02863601|Opiate Substitution Treatment|opiate substitution treatment
4759743|NCT02863575|third molar extraction|third molar extraction
4759744|NCT02863575|ibuprofen|ibuprofen
4759745|NCT02863575|ibuprofen/caffeine|ibuprofen/caffeine
4759746|NCT02863575|post-surgical dental pain|post-surgical dental pain
4759747|NCT02863536|Recurrence of Bacterial Vaginosis|recurrence of bacterial vaginosis
4759748|NCT02863510|Carbon dioxide angiography|carbon dioxide angiography
4759749|NCT02863510|Renal sympathetic denervation|renal sympathetic denervation
4759750|NCT02863510|Uncontrolled hypertension|uncontrolled hypertension
4759751|NCT02863510|Chronic kidney disease|chronic kidney disease
4759752|NCT02863471|Pancreas|pancreas
4759753|NCT02863471|Adenocarcinoma|adenocarcinoma
4759754|NCT02863471|Hyperthermic intraperitoneal chemotherapy|hyperthermic intraperitoneal chemotherapy
4759755|NCT02863471|HIPEC|hipec
4759756|NCT02863471|Pancreatic surgery|pancreatic surgery
4759757|NCT02863471|Gemcitabine|gemcitabine
4759758|NCT02863458|MDS|mds
4759759|NCT02863458|AML|aml
4759760|NCT02863458|hypomethylating agents (HMA)|hypomethylating agents (hma)
4759761|NCT02863458|Surveillance Epidemiology and End Results (SEER)|surveillance epidemiology and end results (seer)
4759762|NCT02863445|Obesity|obesity
4759763|NCT02863445|Body weight|body weight
4759764|NCT02863445|Emergency contraception|emergency contraception
4759765|NCT02863445|Levonogestrel|levonogestrel
4759766|NCT02863445|Ulipristal acetate|ulipristal acetate
4759767|NCT02863406|Dust rate|dust rate
4759768|NCT02863406|Microscopic analysis|microscopic analysis
4759769|NCT02863380|Individualized Medicine|individualized medicine
4759770|NCT02863380|Transcranial Magnetic Stimulation, Repetitive|transcranial magnetic stimulation, repetitive
4759771|NCT02863380|Transcranial Direct Current Stimulation Monocentric|transcranial direct current stimulation monocentric
4759772|NCT02863380|Compariative Cross-Over 3 Arms Study Randomized, Single-Blind Method|compariative cross-over 3 arms study randomized, single-blind method
4759773|NCT02863380|Functional Neuroimaging|functional neuroimaging
4759774|NCT02863302|Acute Myeloid Leukemia, Reflexology|acute myeloid leukemia, reflexology
4759775|NCT02863263|foam dressing|foam dressing
4759776|NCT02863263|MedifoamⓇ|medifoamⓡ
4759777|NCT02863263|BetafoamⓇ|betafoamⓡ
4759778|NCT02863263|povidone iodine|povidone iodine
4759779|NCT02863237|brain injury|brain injury
4759780|NCT02863237|mechanical ventilation|mechanical ventilation
4759781|NCT02863237|weaning|weaning
4759782|NCT02863198|unexplained infertility|unexplained infertility
4759783|NCT02863198|endometrial injury|endometrial injury
4759784|NCT02863198|pregnancy|pregnancy
4759785|NCT02863185|chronic kidney disease|chronic kidney disease
4759786|NCT02863185|pitavastatin|pitavastatin
4759787|NCT02863185|erythrocyte membrane fatty acid|erythrocyte membrane fatty acid
4759788|NCT02863172|Hereditary colorectal cancer syndrome|hereditary colorectal cancer syndrome
4759789|NCT02863172|Questionnaires|questionnaires
4759790|NCT02863172|Surveys|surveys
4759791|NCT02863172|Blood sample|blood sample
4759792|NCT02863172|Saliva sample|saliva sample
4759793|NCT02863146|locally advanced breast cancer|locally advanced breast cancer
4759794|NCT02863146|alopecia|alopecia
4759795|NCT02863146|eribulin|eribulin
4759796|NCT02863120|Bupivacaine|bupivacaine
4759797|NCT02863120|Osteoarthritis|osteoarthritis
4759798|NCT02863120|Arthritis|arthritis
4759799|NCT02863120|Joint Diseases|joint diseases
4759800|NCT02863120|Ropivacaine|ropivacaine
4759801|NCT02863120|Anesthetics, Local|anesthetics, local
4759802|NCT02863120|Anesthetics|anesthetics
4759803|NCT02863107|Colon Cancer|colon cancer
4759804|NCT02863107|Rectal Cancer|rectal cancer
4759805|NCT02863107|Questionnaires|questionnaires
4759806|NCT02863107|Surveys|surveys
4759807|NCT02863107|Blood draw|blood draw
4759808|NCT02863094|schizophrenia|schizophrenia
4759809|NCT02863094|auditory hallucinations|auditory hallucinations
4759810|NCT02863094|functional magnetic resonance imaging|functional magnetic resonance imaging
4759811|NCT02863094|transcranial magnetic stimulation|transcranial magnetic stimulation
4759812|NCT02863068|Sickle cell disease|sickle cell disease
4759813|NCT02863068|sodium nitrite|sodium nitrite
4759814|NCT02863068|wound healing|wound healing
4759815|NCT02863068|Ulcer|ulcer
4759816|NCT02863055|MPM|mpm
4759817|NCT02863055|Unresectable|unresectable
4759818|NCT02863055|Phase II|phase ii
4759819|NCT02863055|Randomized|randomized
4759820|NCT02863055|Maintenance|maintenance
4759821|NCT02863029|Intestinal stem cells|intestinal stem cells
4759822|NCT02863016|dialysis|dialysis
4759823|NCT02863016|hemodiafiltration|hemodiafiltration
4759824|NCT02862990|Breast cancer|breast cancer
4759825|NCT02862990|Fertility|fertility
4759826|NCT02862964|back pain|back pain
4759827|NCT02862951|pregnancy|pregnancy
4759828|NCT02862925|fetal monitoring|fetal monitoring
4759829|NCT02862925|cesarean delivery|cesarean delivery
4759830|NCT02862925|obstetrics|obstetrics
4759831|NCT02862925|midwifery|midwifery
4759832|NCT02862925|developing countries|developing countries
4759833|NCT02862912|Chloroprocaine|chloroprocaine
4759834|NCT02862912|cervical cerclage|cervical cerclage
4759835|NCT02862912|spinal anesthesia|spinal anesthesia
4759836|NCT02862912|Bupivacaine|bupivacaine
4759837|NCT02862873|Spinal anaesthesia|spinal anaesthesia
4759838|NCT02862821|biomarkers of psychiatric disorder|biomarkers of psychiatric disorder
4759839|NCT02862821|gambling addiction|gambling addiction
4759840|NCT02862821|high resolution-ElectroEncephaloGraphy (HR-EEG)|high resolution-electroencephalography (hr-eeg)
4759841|NCT02862808|Whole exome sequencing|whole exome sequencing
4759842|NCT02862808|Molecular diagnostic|molecular diagnostic
4759843|NCT02862808|Genetic counselling|genetic counselling
4759844|NCT02862795|colonoscopy|colonoscopy
4759845|NCT02862730|diabetes|diabetes
4759846|NCT02862730|closed-loop|closed-loop
4759847|NCT02862730|dual hormone|dual hormone
4759848|NCT02862730|exercise|exercise
4759849|NCT02862717|Cost effectiveness|cost effectiveness
4759850|NCT02862717|cost utility|cost utility
4759851|NCT02862717|ESRD|esrd
4759852|NCT02862717|hemodialysis|hemodialysis
4759853|NCT02862717|ICER|icer
4759854|NCT02862717|Markov model|markov model
4759855|NCT02862717|peritoneal dialysis|peritoneal dialysis
4759856|NCT02862691|toothache|toothache
4759857|NCT02862626|Diabetic children|diabetic children
4759858|NCT02862626|Mothers|mothers
4759859|NCT02862613|Precision Cells|precision cells
4759860|NCT02862613|Transcatheter Arterial Chemoembolization|transcatheter arterial chemoembolization
4759861|NCT02862613|Advanced Liver Cancer|advanced liver cancer
4759862|NCT02862600|hypertrophic cardiomyopathy|hypertrophic cardiomyopathy
4759863|NCT02862600|heart failure|heart failure
4759864|NCT02862600|cardiopulmonary exercise testing|cardiopulmonary exercise testing
4759865|NCT02862600|6 minute walk test|6 minute walk test
4759866|NCT02862600|perhexiline|perhexiline
4759867|NCT02862600|carnitine palmitoyltransferase|carnitine palmitoyltransferase
4759868|NCT02862600|mixed ion channel effects|mixed ion channel effects
4759869|NCT02862600|late sodium current inhibitor|late sodium current inhibitor
4759870|NCT02862600|calcium channel inhibition|calcium channel inhibition
4759871|NCT02862587|Precision Cells|precision cells
4759872|NCT02862587|Chemotherapy|chemotherapy
4759873|NCT02862587|Advanced Lung Cancer|advanced lung cancer
4759874|NCT02862574|Rheumatoid Arthritis|rheumatoid arthritis
4759875|NCT02862574|Tumor Necrosis Factor Inhibitor|tumor necrosis factor inhibitor
4759876|NCT02862574|TNF-IR|tnf-ir
4759877|NCT02862574|Methotrexate|methotrexate
4759878|NCT02862561|Precision Cell Immunotherapy|precision cell immunotherapy
4759879|NCT02862561|Chemotherapy|chemotherapy
4759880|NCT02862561|Advanced Malignancies|advanced malignancies
4759881|NCT02862522|uric acid|uric acid
4759882|NCT02862522|microvascular dysfunction|microvascular dysfunction
4759883|NCT02862522|inflammation|inflammation
4759884|NCT02862509|Post-frontal sinus operation chronic rhinosinusitis patients|post-frontal sinus operation chronic rhinosinusitis patients
4759885|NCT02862509|Budesonide nasal instillation|budesonide nasal instillation
4759886|NCT02862509|Vertex to floor position|vertex to floor position
4759887|NCT02862496|Hyperemesis Gravidarum|hyperemesis gravidarum
4759888|NCT02862496|Bone Health|bone health
4759889|NCT02862496|Urine N-telopeptide|urine n-telopeptide
4759890|NCT02862496|Serum calcium|serum calcium
4759891|NCT02862496|Serum parathormone|serum parathormone
4759892|NCT02862496|Serum vit D|serum vit d
4759893|NCT02862470|Lovastatin|lovastatin
4759894|NCT02862470|Vildagliptin|vildagliptin
4759895|NCT02862470|Exosome|exosome
4759896|NCT02862470|Anaplastic thyroid cancer|anaplastic thyroid cancer
4759897|NCT02862470|Proteomics|proteomics
4759898|NCT02862470|Urine|urine
4759899|NCT02862470|Biological marker|biological marker
4759900|NCT02862457|Advanced Solid Tumors|advanced solid tumors
4759901|NCT02862457|PD-1|pd-1
4759902|NCT02862457|PD1|pd1
4759903|NCT02862457|Programmed Cell Death-1|programmed cell death-1
4759904|NCT02862457|Programmed Cell Death 1|programmed cell death 1
4759905|NCT02862457|Programmed Cell Death-Ligand 1 (PD-L1)|programmed cell death-ligand 1 (pd-l1)
4759906|NCT02862457|Programmed Cell Death-Ligand 2 (PD-L2)|programmed cell death-ligand 2 (pd-l2)
4759907|NCT02862457|PDL1|pdl1
4759908|NCT02862457|PDL2|pdl2
4759909|NCT02862418|MRI|mri
4759910|NCT02862418|UTE MRI|ute mri
4759911|NCT02862418|Pulmonary|pulmonary
4759912|NCT02862405|Vision loss|vision loss
4759913|NCT02862405|Object recognition|object recognition
4759914|NCT02862405|Space recognition|space recognition
4759915|NCT02862392|Scoliosis|scoliosis
4759916|NCT02862392|Adolescent|adolescent
4759917|NCT02862392|Idiopathic scoliosis|idiopathic scoliosis
4759918|NCT02862392|Predictive factors|predictive factors
4759919|NCT02862366|myeloproliferative neoplasms|myeloproliferative neoplasms
4760414|NCT02859233|Spinal Puncture|spinal puncture
4759920|NCT02862366|Circulating Procoagulants Microparticles|circulating procoagulants microparticles
4759921|NCT02862353|Validation new test|validation new test
4759922|NCT02862327|anaesthetic techniques|anaesthetic techniques
4759923|NCT02862327|regional anesthesia|regional anesthesia
4759924|NCT02862327|brachial plexus block|brachial plexus block
4759925|NCT02862327|Local Anesthetic|local anesthetic
4759926|NCT02862327|ropivacaine|ropivacaine
4759927|NCT02862327|analgesia|analgesia
4759928|NCT02862327|steroid|steroid
4759929|NCT02862327|dexamethasone|dexamethasone
4759930|NCT02862327|placebo|placebo
4759931|NCT02862327|adjuvant|adjuvant
4759932|NCT02862327|ultrasound guided|ultrasound guided
4759933|NCT02862314|Procalcitonin|procalcitonin
4759934|NCT02862301|Histone Deacetylases|histone deacetylases
4759935|NCT02862301|Histone Acetyltransferases|histone acetyltransferases
4759936|NCT02862223|Coagulation|coagulation
4759937|NCT02862223|Circulatory Function|circulatory function
4759938|NCT02862223|Blood Pressure|blood pressure
4759939|NCT02862223|Inflammatory response|inflammatory response
4759940|NCT02862223|Blood Glucose|blood glucose
4759941|NCT02862223|Healthy vascular function|healthy vascular function
4759942|NCT02862210|Lithium|lithium
4759943|NCT02862210|Lithium Carbonate|lithium carbonate
4759944|NCT02862145|Biosy accessible melanoma|biosy accessible melanoma
4759945|NCT02862132|VDZ: Vedolizumab|vdz: vedolizumab
4759946|NCT02862132|UC: Ulcerative colitis|uc: ulcerative colitis
4759947|NCT02862132|CD: Crohn's disease|cd: crohn's disease
4759948|NCT02862132|TDM: Therapeutic drug monitoring|tdm: therapeutic drug monitoring
4759949|NCT02862119|percutaneous coronary intervention|percutaneous coronary intervention
4759950|NCT02862119|fractional flow reserve|fractional flow reserve
4759951|NCT02862119|all cause mortality|all cause mortality
4759952|NCT02862119|myocardial infarction|myocardial infarction
4759953|NCT02862119|registry-based randomized clinical trial|registry-based randomized clinical trial
4759954|NCT02862106|Chronic Hepatitis B|chronic hepatitis b
4759955|NCT02862106|HBeAg positive|hbeag positive
4759956|NCT02862106|Therapeutic HBV Vaccine|therapeutic hbv vaccine
4759957|NCT02862106|HBV-specific Cytotoxic T Lymphocyte|hbv-specific cytotoxic t lymphocyte
4759959|NCT02862067|type 2 diabetes mellitus|type 2 diabetes mellitus
4759960|NCT02862067|systolic heart failure|systolic heart failure
4759961|NCT02862067|heart failure with reduced ejection fraction|heart failure with reduced ejection fraction
4759962|NCT02862054|haemophagocytic lymphohistiocytosis|haemophagocytic lymphohistiocytosis
4759963|NCT02862054|splenectomy|splenectomy
4759964|NCT02862054|unknown etiology|unknown etiology
4759965|NCT02862028|PD-1 antibody|pd-1 antibody
4759966|NCT02862028|CAR-T cells|car-t cells
4759967|NCT02862028|EGFR family|egfr family
4759968|NCT02862028|advanced solid tumor|advanced solid tumor
4759969|NCT02862002|opioid therapy|opioid therapy
4759970|NCT02862002|medical oncology.|medical oncology.
4759971|NCT02861989|osteoporosis|osteoporosis
4759972|NCT02861989|prevention|prevention
4759973|NCT02861989|care management|care management
4759974|NCT02861989|focus groups|focus groups
4759975|NCT02861963|Femoral Allogenic Vein Valve Conduit|femoral allogenic vein valve conduit
4759976|NCT02861963|Rehabilitation of native pulmonary arteries|rehabilitation of native pulmonary arteries
4759977|NCT02861950|hypospadias|hypospadias
4759978|NCT02861950|caudal|caudal
4759979|NCT02861950|urethrocutaneous fistula|urethrocutaneous fistula
4759980|NCT02861950|penile nerve block|penile nerve block
4759981|NCT02861911|Muscle function|muscle function
4759982|NCT02861911|Oxidative stress|oxidative stress
4759983|NCT02861911|Quality of life|quality of life
4759984|NCT02861911|Physical activities|physical activities
4759985|NCT02861898|EGFR|egfr
4759986|NCT02861898|Epidermal Growth Factor Receptor|epidermal growth factor receptor
4759987|NCT02861898|EGFRvIII|egfrviii
4759988|NCT02861885|Colonoscopy|colonoscopy
4759989|NCT02861885|sessile serrated lesions|sessile serrated lesions
4759990|NCT02861885|chromoendoscopy|chromoendoscopy
4759991|NCT02861885|narrow band imaging|narrow band imaging
4759992|NCT02861885|Indigo Carmin®|indigo carmin®
4759993|NCT02861885|Pit pattern|pit pattern
4759994|NCT02861885|Kudo classification|kudo classification
4759995|NCT02861885|NICE classification|nice classification
4759996|NCT02861885|neoplasms by histologic type|neoplasms by histologic type
4759997|NCT02861872|Ovarian|ovarian
4759998|NCT02861872|Ovarian cancer|ovarian cancer
4759999|NCT02861872|Chemotherapy|chemotherapy
4760000|NCT02861872|Intraperitoneal chemotherapy|intraperitoneal chemotherapy
4760001|NCT02861872|pharmacokinetics|pharmacokinetics
4760002|NCT02861859|Breast cancer|breast cancer
4760003|NCT02861859|Breast Carcinoma|breast carcinoma
4760004|NCT02861859|Breast Tumors|breast tumors
4760005|NCT02861859|Chemotherapy|chemotherapy
4760006|NCT02861859|Antiemetic effects|antiemetic effects
4760007|NCT02861859|Antiemetic drugs|antiemetic drugs
4760008|NCT02861859|Drug Therapy|drug therapy
4760009|NCT02861846|epilepsy|epilepsy
4760010|NCT02861846|Alzheimer|alzheimer
4760011|NCT02861846|biomarkers|biomarkers
4760012|NCT02861846|predictive value|predictive value
4760013|NCT02861820|fMRI|fmri
4760014|NCT02861820|brain networks|brain networks
4760015|NCT02861820|biomarker|biomarker
4760016|NCT02861820|relapse|relapse
4760017|NCT02861820|stimulants|stimulants
4760018|NCT02861794|Total Knee Arthroplasty (TKA)|total knee arthroplasty (tka)
4760019|NCT02861794|Total Knee Replacement (TKR)|total knee replacement (tkr)
4760020|NCT02861794|Kinematics|kinematics
4760021|NCT02861794|RSA|rsa
4760022|NCT02861794|Knee arthroplasty|knee arthroplasty
4760023|NCT02861794|Implant stability|implant stability
4760024|NCT02861781|Bariatric surgery|bariatric surgery
4760025|NCT02861755|Depression|depression
4760026|NCT02861755|Depressive Disorder|depressive disorder
4760027|NCT02861755|Psychological Stress|psychological stress
4760028|NCT02861755|Behavioral Symptoms|behavioral symptoms
4760029|NCT02861755|Mental Disorders|mental disorders
4760030|NCT02861755|Mood Disorders|mood disorders
4760031|NCT02861729|Partial coverage restoration|partial coverage restoration
4760032|NCT02861729|Crown|crown
4760033|NCT02861729|Posterior teeth|posterior teeth
4760034|NCT02861729|All ceramic|all ceramic
4760035|NCT02861729|Zirconia reinforced lithium silicate|zirconia reinforced lithium silicate
4760036|NCT02861729|Lithium disilicate|lithium disilicate
4760037|NCT02861729|CAD/CAM|cad/cam
4760038|NCT02861690|Esophageal Cancer|esophageal cancer
4760039|NCT02861690|nedaplatin|nedaplatin
4760040|NCT02861690|Liposomal Paclitaxel|liposomal paclitaxel
4760041|NCT02861638|Total hip replacement|total hip replacement
4760042|NCT02861638|Action observation treatment|action observation treatment
4760043|NCT02861638|Rehabilitation|rehabilitation
4760044|NCT02861638|Arthroplasty|arthroplasty
4760045|NCT02861612|peripheral nerves|peripheral nerves
4760046|NCT02861612|quadriplegia|quadriplegia
4760047|NCT02861612|nerve transfer|nerve transfer
4760048|NCT02861612|surgical procedures, operative|surgical procedures, operative
4760049|NCT02861612|hand|hand
4760050|NCT02861612|upper extremity|upper extremity
4760051|NCT02861612|quality of life|quality of life
4760052|NCT02861586|Chikungunya, infectious disease|chikungunya, infectious disease
4760053|NCT02861573|Metastatic Castration-Resistant Prostate Cancer|metastatic castration-resistant prostate cancer
4760054|NCT02861573|mCRPC|mcrpc
4760055|NCT02861573|PD1|pd1
4760056|NCT02861573|PD-1|pd-1
4760057|NCT02861573|PDL1|pdl1
4760058|NCT02861573|PD-L1|pd-l1
4760059|NCT02861508|Ultrasonography|ultrasonography
4760060|NCT02861495|upper extremity fracture|upper extremity fracture
4760061|NCT02861482|PPH, Bakri Ballon|pph, bakri ballon
4760062|NCT02861469|qualitative study, end of life, ethics, palliative care|qualitative study, end of life, ethics, palliative care
4760063|NCT02861456|Adolescent|adolescent
4760064|NCT02861456|Low Back Pain|low back pain
4760065|NCT02861456|Athlete|athlete
4760066|NCT02861430|colon cancer|colon cancer
4760067|NCT02861430|sentinel node|sentinel node
4760068|NCT02861417|Other diseases of blood and blood-forming organs|other diseases of blood and blood-forming organs
4760069|NCT02861417|Acute myeloid leukemia|acute myeloid leukemia
4760070|NCT02861417|AML|aml
4760071|NCT02861417|Acute lymphocytic leukemia|acute lymphocytic leukemia
4760072|NCT02861417|ALL|all
4760073|NCT02861417|Chronic myeloid leukemia|chronic myeloid leukemia
4760074|NCT02861417|CML|cml
4760075|NCT02861417|Chronic lymphocytic leukemia|chronic lymphocytic leukemia
4760076|NCT02861417|CLL|cll
4760077|NCT02861417|Myelodysplastic syndrome|myelodysplastic syndrome
4760078|NCT02861417|MDS|mds
4760079|NCT02861417|Myeloproliferative syndrome|myeloproliferative syndrome
4760080|NCT02861417|Non-Hodgkins lymphoma|non-hodgkins lymphoma
4760081|NCT02861417|NHL|nhl
4760082|NCT02861417|Hodgkins lymphoma|hodgkins lymphoma
4760083|NCT02861417|HL|hl
4760084|NCT02861417|Multiple myeloma|multiple myeloma
4760085|NCT02861417|MM|mm
4760086|NCT02861417|Stem cell infusion|stem cell infusion
4760087|NCT02861417|Stem cell transplant|stem cell transplant
4760088|NCT02861417|Haploidentical donor|haploidentical donor
4760089|NCT02861417|Matched donor|matched donor
4760090|NCT02861417|Thiotepa|thiotepa
4760091|NCT02861417|Mycophenolate Mofetil|mycophenolate mofetil
4760092|NCT02861417|MMF|mmf
4760093|NCT02861417|CellCept|cellcept
4760094|NCT02861417|Busulfan|busulfan
4760095|NCT02861417|Busulfex|busulfex
4760096|NCT02861417|Myleran|myleran
4760097|NCT02861417|Fludarabine|fludarabine
4760098|NCT02861417|Fludarabine phosphate|fludarabine phosphate
4760099|NCT02861417|Fludara|fludara
4760100|NCT02861417|Mesna|mesna
4760101|NCT02861417|Mesnex|mesnex
4760102|NCT02861417|Cyclophosphamide|cyclophosphamide
4760103|NCT02861417|Cytoxan|cytoxan
4760104|NCT02861417|Neosar|neosar
4760105|NCT02861417|Tacrolimus|tacrolimus
4760106|NCT02861417|Prograf|prograf
4760107|NCT02861417|G-CSF|g-csf
4760108|NCT02861417|Filgrastim|filgrastim
4760109|NCT02861417|Neupogen|neupogen
4760110|NCT02861404|HPV|hpv
4760111|NCT02861378|anaesthesia, dental|anaesthesia, dental
4760112|NCT02861378|lidocaine|lidocaine
4760113|NCT02861352|Zinc|zinc
4760114|NCT02861352|DNA Integrity|dna integrity
4760115|NCT02861352|Gene Expression|gene expression
4760116|NCT02861352|diet zinc|diet zinc
4760117|NCT02861352|nutrition requirements|nutrition requirements
4760118|NCT02861326|chronic periodontitis, dental scaling, periodontal pockets|chronic periodontitis, dental scaling, periodontal pockets
4760119|NCT02861300|CB-839|cb-839
4760120|NCT02861300|PIK3CA|pik3ca
4760121|NCT02861300|capecitabine|capecitabine
4760123|NCT02861248|Micro-plasma Radiofrequency Therapy|micro-plasma radiofrequency therapy
4760124|NCT02861183|sodium hyaluronate|sodium hyaluronate
4760125|NCT02861183|OVT|ovt
4760126|NCT02861183|hyaluronic acid|hyaluronic acid
4760127|NCT02861170|Mindfulness|mindfulness
4760128|NCT02861170|Chronic Pain|chronic pain
4760129|NCT02861170|Chronic Hip Pain|chronic hip pain
4760130|NCT02861170|Total Hip Arthroplasty|total hip arthroplasty
4760131|NCT02861170|Disability|disability
4760132|NCT02861170|Quality of Life|quality of life
4760133|NCT02861157|Type 1 Diabetes|type 1 diabetes
4760134|NCT02861157|Adolescents|adolescents
4760135|NCT02861157|T1D|t1d
4760136|NCT02861131|Sugammadex|sugammadex
4760137|NCT02861131|Neuromuscular Blockade|neuromuscular blockade
4760138|NCT02861118|Drug Therapy|drug therapy
4760139|NCT02861092|Serious adverse event|serious adverse event
4760140|NCT02861092|bone and joint infection|bone and joint infection
4760141|NCT02861092|obesity|obesity
4760142|NCT02861092|dose adjustment|dose adjustment
4760143|NCT02861066|Mindfulness-based Intervention|mindfulness-based intervention
4760144|NCT02861066|Wellbeing|wellbeing
4760145|NCT02861066|Treatment|treatment
4760146|NCT02861027|Osteoarthritis|osteoarthritis
4760147|NCT02861027|Total hip arthroplasty|total hip arthroplasty
4760148|NCT02861027|Physiotherapy|physiotherapy
4760149|NCT02861027|Functional Electrical Stimulation|functional electrical stimulation
4760150|NCT02861001|tracheotomy|tracheotomy
4760151|NCT02861001|bronchoscopy|bronchoscopy
4760152|NCT02861001|critical care|critical care
4760153|NCT02860975|Prolonged Hypoxia|prolonged hypoxia
4760154|NCT02860975|Safety|safety
4760155|NCT02860975|Mitochondrial function|mitochondrial function
4760156|NCT02860949|Local anesthetic infiltration|local anesthetic infiltration
4760157|NCT02860949|Posterior capsular infiltration|posterior capsular infiltration
4760158|NCT02860949|Multimodal anesthesia|multimodal anesthesia
4760159|NCT02860949|Knee arthroplasty|knee arthroplasty
4760160|NCT02860949|Pain control|pain control
4760161|NCT02860949|Osteoarthritis, Knee|osteoarthritis, knee
4760162|NCT02860923|glucagon-like peptide-1|glucagon-like peptide-1
4760163|NCT02860923|exenatide|exenatide
4760164|NCT02860923|placebo|placebo
4760165|NCT02860923|multicenter trial|multicenter trial
4760166|NCT02860910|hot flashes|hot flashes
4760167|NCT02860910|postmenopause|postmenopause
4760168|NCT02860910|perimenopause|perimenopause
4760169|NCT02860832|Cyberbullying|cyberbullying
4760170|NCT02860832|Traditional bullying|traditional bullying
4760171|NCT02860832|Depression|depression
4760172|NCT02860819|Multiple relapsed/refractory testicular germ cell tumors|multiple relapsed/refractory testicular germ cell tumors
4760173|NCT02860819|PARP inhibition|parp inhibition
4760174|NCT02860819|Chemotherapy|chemotherapy
4760175|NCT02860819|Gemcitabine|gemcitabine
4760176|NCT02860819|Carboplatin|carboplatin
4760177|NCT02860793|PTK7|ptk7
4760178|NCT02860793|Acute Myeloid Leukemia|acute myeloid leukemia
4760179|NCT02860767|Prosthesis-Related Infections|prosthesis-related infections
4760180|NCT02860767|Antibiotic dosing|antibiotic dosing
4760181|NCT02860767|Reimplantation|reimplantation
4760182|NCT02860767|Knee-prothesis|knee-prothesis
4760183|NCT02860767|Hip-prothesis|hip-prothesis
4760184|NCT02860741|Sub-Clinical Depression|sub-clinical depression
4760185|NCT02860728|COPD|copd
4760186|NCT02860728|Resistance Training|resistance training
4760187|NCT02860728|Exercise Training|exercise training
4760188|NCT02860728|Dyspnea|dyspnea
4760189|NCT02860715|Safety|safety
4760190|NCT02860715|Pharmacodynamics|pharmacodynamics
4760191|NCT02860715|Dose-Limiting Toxicity (DLT)|dose-limiting toxicity (dlt)
4760192|NCT02860715|Immunogenicity|immunogenicity
4760193|NCT02860715|Pharmacokinetics|pharmacokinetics
4760194|NCT02860702|Single Ventricle|single ventricle
4760195|NCT02860702|Congenital Heart Defect|congenital heart defect
4760196|NCT02860689|Sexuality|sexuality
4760197|NCT02860689|Spinal cord injuries|spinal cord injuries
4760198|NCT02860689|Penile erection|penile erection
4760199|NCT02860689|erectile dysfunction|erectile dysfunction
4760200|NCT02860689|Psychological Sexual Dysfunctions|psychological sexual dysfunctions
4760201|NCT02860676|CLL|cll
4760202|NCT02860676|cancer|cancer
4760203|NCT02860676|UC-961|uc-961
4760204|NCT02860676|cirmtuzumab|cirmtuzumab
4760205|NCT02860637|Sexuality|sexuality
4760206|NCT02860637|Spinal cord injuries|spinal cord injuries
4760207|NCT02860637|Penile erection|penile erection
4760208|NCT02860637|erectile dysfunction|erectile dysfunction
4760209|NCT02860624|GERD|gerd
4760210|NCT02860611|Type 1 diabetes|type 1 diabetes
4760211|NCT02860611|Type 2 diabetes|type 2 diabetes
4760212|NCT02860611|T helper 1 cytokines|t helper 1 cytokines
4760213|NCT02860598|ESAs|esas
4760214|NCT02860598|erythropoietin|erythropoietin
4760215|NCT02860598|AML|aml
4760216|NCT02860598|HSCT|hsct
4760217|NCT02860585|Metastatic breast cancer|metastatic breast cancer
4760218|NCT02860585|high-dose chemotherapy|high-dose chemotherapy
4760219|NCT02860585|autologous haematopoietic progenitor cell transplantation|autologous haematopoietic progenitor cell transplantation
4760220|NCT02860572|fluid therapy|fluid therapy
4760221|NCT02860572|oliguria|oliguria
4760222|NCT02860572|endothelial injury|endothelial injury
4760520|NCT02858622|pain|pain
4760223|NCT02860559|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
4760224|NCT02860559|Severe Combined Immunodeficiency|severe combined immunodeficiency
4760225|NCT02860546|Refractory|refractory
4760226|NCT02860546|Metastatic|metastatic
4760227|NCT02860546|Colorectal cancer|colorectal cancer
4760228|NCT02860546|TAS-102|tas-102
4760229|NCT02860546|Nivolumab|nivolumab
4760230|NCT02860546|Microsatellite Stable|microsatellite stable
4760231|NCT02860546|Programmed cell death protein1 (PD 1)|programmed cell death protein1 (pd 1)
4760232|NCT02860533|Blood pressure|blood pressure
4760233|NCT02860533|smartphone App|smartphone app
4760234|NCT02860533|Hypertension|hypertension
4760235|NCT02860533|Stress testing|stress testing
4760236|NCT02860533|Prevention|prevention
4760237|NCT02860533|Cardiovascular risk factors|cardiovascular risk factors
4760238|NCT02860520|Retinitis pigmentosa:|retinitis pigmentosa:
4760239|NCT02860494|Tuberous sclerosis complex (TSC)|tuberous sclerosis complex (tsc)
4760240|NCT02860494|topical everolimus|topical everolimus
4760241|NCT02860494|seamless design|seamless design
4760242|NCT02860494|dose-escalation study|dose-escalation study
4760243|NCT02860494|m-TOR inhibitor|m-tor inhibitor
4760244|NCT02860455|CO poisoning|co poisoning
4760245|NCT02860455|CO-oximetry|co-oximetry
4760246|NCT02860455|Pulse oximetry|pulse oximetry
4760247|NCT02860455|Carbon monoxide saturation (SpCO)|carbon monoxide saturation (spco)
4760248|NCT02860455|Emergency Department|emergency department
4760249|NCT02860455|Sensitivity|sensitivity
4760250|NCT02860455|Specificity|specificity
4760251|NCT02860442|Alcohol misuse|alcohol misuse
4760252|NCT02860442|Smartphone app|smartphone app
4760253|NCT02860442|Screening, Brief Intervention, Referral to Treatment (SBIRT)|screening, brief intervention, referral to treatment (sbirt)
4760254|NCT02860416|Neurology|neurology
4760255|NCT02860403|Cervical spinal cord injury|cervical spinal cord injury
4760256|NCT02860403|Motor imagery|motor imagery
4760257|NCT02860403|Magnetoencephalography|magnetoencephalography
4760258|NCT02860377|emergence agitation|emergence agitation
4760259|NCT02860377|emergence time|emergence time
4760260|NCT02860377|pediatric|pediatric
4760261|NCT02860351|subclavian vein|subclavian vein
4760262|NCT02860338|Psuedobulbar affect, PBA|psuedobulbar affect, pba
4760263|NCT02860299|patients|patients
4760264|NCT02860273|Pulmonary Rehabilitation|pulmonary rehabilitation
4760265|NCT02860273|COPD|copd
4760266|NCT02860273|High Flow Nasal Cannula|high flow nasal cannula
4760267|NCT02860273|HFNC|hfnc
4760268|NCT02860273|Aerobic capacity|aerobic capacity
4760269|NCT02860260|BDNF|bdnf
4760270|NCT02860247|antibiotic|antibiotic
4760271|NCT02860247|MALDI-TOF MS|maldi-tof ms
4760272|NCT02860247|susceptibility testing|susceptibility testing
4760273|NCT02860234|Rectal cancer|rectal cancer
4760274|NCT02860234|neoadjuvant|neoadjuvant
4760275|NCT02860234|radiotherapy|radiotherapy
4760276|NCT02860234|chemotherapy|chemotherapy
4760277|NCT02860234|organ preservation|organ preservation
4760278|NCT02860221|Arthroplasty, Replacement, Knee|arthroplasty, replacement, knee
4760279|NCT02860221|Epinephrine|epinephrine
4760280|NCT02860221|Tranexamic acid|tranexamic acid
4760281|NCT02860208|Peri-Implantitis|peri-implantitis
4760282|NCT02860208|Surgical therapy|surgical therapy
4760283|NCT02860208|Follow-up|follow-up
4760284|NCT02860208|Supportive peri-implant therapy|supportive peri-implant therapy
4760285|NCT02860130|Regional Citrate Anticoagulation (RCA)|regional citrate anticoagulation (rca)
4760286|NCT02860130|Continuous Renal Replacement Therapy (CRRT)|continuous renal replacement therapy (crrt)
4760287|NCT02860130|Acute Kidney Injury|acute kidney injury
4760288|NCT02860117|ketamine|ketamine
4760289|NCT02860117|continuous infusion|continuous infusion
4760290|NCT02860117|severe burned patients|severe burned patients
4760291|NCT02860104|microwave ablation|microwave ablation
4760292|NCT02860104|breast|breast
4760293|NCT02860104|multicenter|multicenter
4760294|NCT02860091|ropivacaine infusion|ropivacaine infusion
4760295|NCT02860091|regional anesthesia|regional anesthesia
4760296|NCT02860091|paravertebral block|paravertebral block
4760297|NCT02860078|pain|pain
4760298|NCT02860078|epidural|epidural
4760299|NCT02860078|ultrasound|ultrasound
4760300|NCT02860013|Telemedicine|telemedicine
4760301|NCT02860013|Effectiveness|effectiveness
4760302|NCT02860013|Cost-effectiveness|cost-effectiveness
4760303|NCT02859987|US|us
4760304|NCT02859987|Nursing Services|nursing services
4760305|NCT02859974|Paradoxical vocal fold motion disorder (PVFMD)|paradoxical vocal fold motion disorder (pvfmd)
4760306|NCT02859974|vocal cord dysfunction (VCD)|vocal cord dysfunction (vcd)
4760307|NCT02859974|Respiratory retraining|respiratory retraining
4760308|NCT02859974|Respiratory disorders|respiratory disorders
4760309|NCT02859948|AML|aml
4760310|NCT02859935|HIV|hiv
4760311|NCT02859935|drug abuse|drug abuse
4760312|NCT02859935|MSM|msm
4760313|NCT02859935|Risk behavior|risk behavior
4760314|NCT02859935|Sexually transmitted diseases|sexually transmitted diseases
4760315|NCT02859935|Sexually transmitted infections|sexually transmitted infections
4760316|NCT02859922|Laryngeal Tube Supreme Spontaneous Ventilation|laryngeal tube supreme spontaneous ventilation
4760317|NCT02859857|Glioblastoma Multiforme|glioblastoma multiforme
4760318|NCT02859857|Solid Tumors|solid tumors
4760319|NCT02859857|Ependymoma|ependymoma
4760320|NCT02859727|APDS; PASLI; PI3Kdelta; p110delta-activating mutation causing senescent T cells, lymphadenopathy and immunodeficiency; Activated PI3Kdelta Syndrome;|apds; pasli; pi3kdelta; p110delta-activating mutation causing senescent t cells, lymphadenopathy and immunodeficiency; activated pi3kdelta syndrome;
4760321|NCT02859662|abdominal compartment syndrome|abdominal compartment syndrome
4760322|NCT02859662|abdominal aortic aneurysm|abdominal aortic aneurysm
4760323|NCT02859662|ruptured aneurysm|ruptured aneurysm
4760324|NCT02859649|working memory|working memory
4760325|NCT02859649|short term memory|short term memory
4760326|NCT02859649|gesture|gesture
4760327|NCT02859584|Acute hepatitis|acute hepatitis
4760328|NCT02859584|acute liver failure|acute liver failure
4760329|NCT02859584|adrenal dysfunction|adrenal dysfunction
4760330|NCT02859584|salivary cortisol|salivary cortisol
4760331|NCT02859584|serum free cortisol|serum free cortisol
4760332|NCT02859545|chronic pain|chronic pain
4760333|NCT02859545|pain|pain
4760334|NCT02859545|validation|validation
4760335|NCT02859545|couples|couples
4760336|NCT02859545|romantic relationships|romantic relationships
4760337|NCT02859545|emotional validation|emotional validation
4760338|NCT02859532|blood coagulation|blood coagulation
4760339|NCT02859532|Endogenous Thrombin Potential|endogenous thrombin potential
4760340|NCT02859532|rotational thromboelastometry|rotational thromboelastometry
4760341|NCT02859480|Rosuvastatin Calcium|rosuvastatin calcium
4760342|NCT02859480|Percutaneous Coronary Intervention|percutaneous coronary intervention
4760343|NCT02859480|Drug-Eluting Stents|drug-eluting stents
4760344|NCT02859480|Patient Outcome Assessment|patient outcome assessment
4760345|NCT02859480|Biomarkers|biomarkers
4760346|NCT02859480|Hyperlipidemias|hyperlipidemias
4760347|NCT02859480|Dyslipidemias|dyslipidemias
4760348|NCT02859480|Atherosclerosis|atherosclerosis
4760349|NCT02859480|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors
4760350|NCT02859480|Anticholesteremic Agents|anticholesteremic agents
4760351|NCT02859480|Hypolipidemic Agents|hypolipidemic agents
4760352|NCT02859480|Lipid Regulating Agents|lipid regulating agents
4760353|NCT02859467|Physical Therapy Modalities|physical therapy modalities
4760354|NCT02859467|Exercise|exercise
4760355|NCT02859467|Electrical Stimulation Therapy|electrical stimulation therapy
4760356|NCT02859467|Bandages|bandages
4760357|NCT02859454|PD-L1 Expression|pd-l1 expression
4760358|NCT02859454|Human Papilloma Virus (HPV)|human papilloma virus (hpv)
4760359|NCT02859454|Juvenile-onset Disease|juvenile-onset disease
4760360|NCT02859454|Papillomatous Lesions|papillomatous lesions
4760361|NCT02859454|Monoclonal Antibody|monoclonal antibody
4760362|NCT02859441|Intravitreal Injection|intravitreal injection
4760363|NCT02859441|Retinal Capillary Hemangioma|retinal capillary hemangioma
4760364|NCT02859428|Hereditary Spastic Paraplegia|hereditary spastic paraplegia
4760365|NCT02859415|Metastatic Colorectal Cancer|metastatic colorectal cancer
4760366|NCT02859415|Metastatic Renal Cell Cancer|metastatic renal cell cancer
4760367|NCT02859415|Sarcoma|sarcoma
4760368|NCT02859415|ABCB4 Liver Toxicity|abcb4 liver toxicity
4760369|NCT02859415|ABCB11 Heptatoxicity|abcb11 heptatoxicity
4760370|NCT02859402|T-cell Non-Hodgkin Lymphoma|t-cell non-hodgkin lymphoma
4760371|NCT02859402|NK/T-cell Non-Hodgkin Lymphoma|nk/t-cell non-hodgkin lymphoma
4760372|NCT02859402|Relapsed, refractory|relapsed, refractory
4760373|NCT02859402|Conditioning|conditioning
4760374|NCT02859402|Allogeneic stem cell transplantation|allogeneic stem cell transplantation
4760375|NCT02859389|Leukemia|leukemia
4760376|NCT02859389|Down Syndrome|down syndrome
4760377|NCT02859389|Neurocognitive|neurocognitive
4760378|NCT02859389|Survivorship|survivorship
4760379|NCT02859389|Attention|attention
4760380|NCT02859389|Executive function|executive function
4760381|NCT02859389|Late effects|late effects
4760382|NCT02859376|Preterm infants|preterm infants
4760383|NCT02859376|Pain|pain
4760384|NCT02859376|Sucrose|sucrose
4760385|NCT02859350|Plasmodium falciparum|plasmodium falciparum
4760386|NCT02859350|PfSPZ Vaccine|pfspz vaccine
4760387|NCT02859350|PfSPZ Challenge (NF54)|pfspz challenge (nf54)
4760388|NCT02859350|CHMI|chmi
4760389|NCT02859350|Chloroquine|chloroquine
4760390|NCT02859350|Chemoprophylaxis|chemoprophylaxis
4760391|NCT02859350|PfSPZ-CVac|pfspz-cvac
4760392|NCT02859337|obesity|obesity
4760393|NCT02859337|body weight|body weight
4760394|NCT02859337|BMI|bmi
4760395|NCT02859337|emergency contraception|emergency contraception
4760396|NCT02859337|levonorgestrel|levonorgestrel
4760397|NCT02859337|ulipristal acetate|ulipristal acetate
4760398|NCT02859324|CC-122|cc-122
4760399|NCT02859324|Nivolumab|nivolumab
4760400|NCT02859324|Hepatocellular Carcinoma|hepatocellular carcinoma
4760401|NCT02859324|Phase 1/2|phase 1/2
4760402|NCT02859324|Safety|safety
4760403|NCT02859311|Recovery|recovery
4760404|NCT02859298|Premature Delivery|premature delivery
4760405|NCT02859298|Polarimetric Imaging|polarimetric imaging
4760406|NCT02859298|Polarimetric colposcope|polarimetric colposcope
4760407|NCT02859298|Diagnostic tool|diagnostic tool
4760408|NCT02859285|Arousal|arousal
4760409|NCT02859285|Orgasm|orgasm
4760410|NCT02859285|Clitoral|clitoral
4760411|NCT02859285|Estradiol|estradiol
4760412|NCT02859285|Post Menopausal|post menopausal
4760413|NCT02859272|Suspension, benign hysterectomy, post operative prolapse|suspension, benign hysterectomy, post operative prolapse
4760415|NCT02859233|Dural puncture|dural puncture
4760416|NCT02859233|Nursing|nursing
4760417|NCT02859220|hemodialysis|hemodialysis
4760418|NCT02859220|PTH|pth
4760419|NCT02859207|Early Alzheimer's disease|early alzheimer's disease
4760420|NCT02859207|E2609|e2609
4760421|NCT02859207|Mild and Moderate Hepatic Impairment|mild and moderate hepatic impairment
4760422|NCT02859181|Increased Metabolic Requirement|increased metabolic requirement
4760423|NCT02859168|Neck|neck
4760424|NCT02859168|Shoulder|shoulder
4760425|NCT02859168|Manual Therapies|manual therapies
4760426|NCT02859142|Varenicline|varenicline
4760427|NCT02859129|Epanova|epanova
4760428|NCT02859129|omega-3 carboxylic acids|omega-3 carboxylic acids
4760429|NCT02859129|Vascepa|vascepa
4760430|NCT02859129|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester
4760431|NCT02859129|Crestor|crestor
4760432|NCT02859129|rosuvastatin|rosuvastatin
4760433|NCT02859116|Metabolic diseases|metabolic diseases
4760434|NCT02859077|NSCLC|nsclc
4760435|NCT02859077|BIM|bim
4760436|NCT02859077|EGFR mutation|egfr mutation
4760437|NCT02859064|radioembolization|radioembolization
4760438|NCT02859064|somatostatin analogs|somatostatin analogs
4760439|NCT02859064|carcinoid|carcinoid
4760440|NCT02859064|neuroendocrine|neuroendocrine
4760441|NCT02859064|liver-directed therapy|liver-directed therapy
4760442|NCT02859051|Cognitive Behavioral Support provided by Robot|cognitive behavioral support provided by robot
4760443|NCT02859025|Alveolar cleft|alveolar cleft
4760444|NCT02859025|Osteoplasty|osteoplasty
4760445|NCT02859025|Tissue engineering|tissue engineering
4760446|NCT02859025|Stem cells|stem cells
4760447|NCT02859025|Regenerative medicine|regenerative medicine
4760448|NCT02859025|Bone|bone
4760449|NCT02859025|Lateral ramus|lateral ramus
4760450|NCT02858999|primary plasma cell leukaemia|primary plasma cell leukaemia
4760451|NCT02858999|treatment|treatment
4760452|NCT02858960|High Flow Nasal Cannula|high flow nasal cannula
4760453|NCT02858960|COPD|copd
4760454|NCT02858960|Pulmonary rehabilitation|pulmonary rehabilitation
4760455|NCT02858960|HFNC|hfnc
4760456|NCT02858960|Oxygen|oxygen
4760457|NCT02858947|composite resin|composite resin
4760458|NCT02858947|bulk-fill|bulk-fill
4760459|NCT02858947|teeth endodontically-treated|teeth endodontically-treated
4760460|NCT02858934|Short preoperative tomotherapy|short preoperative tomotherapy
4760461|NCT02858934|Radiotherapy|radiotherapy
4760462|NCT02858921|Neoadjuvant Therapy|neoadjuvant therapy
4760463|NCT02858921|Pembrolizumab|pembrolizumab
4760464|NCT02858921|Dabrafenib|dabrafenib
4760465|NCT02858921|Trametinib|trametinib
4760466|NCT02858921|Pathological response|pathological response
4760467|NCT02858921|RECIST|recist
4760468|NCT02858921|Immune response|immune response
4760469|NCT02858921|BRAF|braf
4760470|NCT02858921|Randomised|randomised
4760471|NCT02858921|Stage IIIB/C|stage iiib/c
4760472|NCT02858921|Biomarkers, Tumour|biomarkers, tumour
4760473|NCT02858921|Biomarkers, Drug response|biomarkers, drug response
4760474|NCT02858921|Metabolic Response|metabolic response
4760475|NCT02858895|High grade glioma|high grade glioma
4760476|NCT02858895|malignant glioma|malignant glioma
4760477|NCT02858895|recurrent glioblastoma|recurrent glioblastoma
4760478|NCT02858895|recurrent GBM|recurrent gbm
4760479|NCT02858895|recurrent GB|recurrent gb
4760480|NCT02858895|glioblastoma (GB)|glioblastoma (gb)
4760481|NCT02858895|glioblastoma multiforme (GBM)|glioblastoma multiforme (gbm)
4760482|NCT02858895|progressive glioblastoma|progressive glioblastoma
4760483|NCT02858895|Brain tumor|brain tumor
4760484|NCT02858895|Brain cancer|brain cancer
4760485|NCT02858895|immunotherapy|immunotherapy
4760486|NCT02858895|targeted|targeted
4760487|NCT02858895|IL4R|il4r
4760488|NCT02858843|genetics|genetics
4760489|NCT02858830|FPL|fpl
4760490|NCT02858830|adipose tissue|adipose tissue
4760491|NCT02858830|diabetes|diabetes
4760492|NCT02858830|dyslipidemia|dyslipidemia
4760493|NCT02858830|metabolic|metabolic
4760494|NCT02858830|hyperinsulinemia|hyperinsulinemia
4760495|NCT02858804|mantle cell lymphoma|mantle cell lymphoma
4760496|NCT02858804|EDOCH|edoch
4760497|NCT02858804|DHAP|dhap
4760498|NCT02858804|maintenance therapy|maintenance therapy
4760499|NCT02858778|Palliative Care|palliative care
4760500|NCT02858778|Emergency Department|emergency department
4760501|NCT02858752|Attention|attention
4760502|NCT02858752|Short-term memory|short-term memory
4760503|NCT02858752|Aural Memory|aural memory
4760504|NCT02858752|Visual Memory|visual memory
4760505|NCT02858752|Child|child
4760506|NCT02858752|EEG|eeg
4760507|NCT02858726|Hemodialysis|hemodialysis
4760508|NCT02858726|CR845|cr845
4760509|NCT02858726|Kappa opioid|kappa opioid
4760510|NCT02858726|Anti-itch|anti-itch
4760511|NCT02858713|psoriasis|psoriasis
4760512|NCT02858700|neonatal bacterial infection|neonatal bacterial infection
4760513|NCT02858700|procalcitonin|procalcitonin
4760514|NCT02858635|Suicidal behaviour|suicidal behaviour
4760515|NCT02858635|Impulsivity|impulsivity
4760516|NCT02858635|Genetics|genetics
4760517|NCT02858635|Serotonin|serotonin
4760518|NCT02858622|pediatric|pediatric
4760519|NCT02858622|renal transplant|renal transplant
4760521|NCT02858622|dual TAB|dual tab
4760522|NCT02858583|Chest Compression|chest compression
4760523|NCT02858583|Newborn|newborn
4760524|NCT02858583|Infant|infant
4760525|NCT02858583|Sustained Inflation|sustained inflation
4760526|NCT02858570|Meningococcal Vaccines|meningococcal vaccines
4760527|NCT02858570|Immunogenicity, Reactogenicity and Safety of Vaccine|immunogenicity, reactogenicity and safety of vaccine
4760528|NCT02858544|Mild traumatic brain injury|mild traumatic brain injury
4760529|NCT02858518|anticoagulant|anticoagulant
4760530|NCT02858492|efficacy|efficacy
4760531|NCT02858492|safety|safety
4760532|NCT02858492|pharmacokinetics|pharmacokinetics
4760533|NCT02858492|pharmacodynamics|pharmacodynamics
4760534|NCT02858492|Rheumatoid Arthritis|rheumatoid arthritis
4760535|NCT02858492|autoimmune|autoimmune
4760536|NCT02858453|Interstitial cystitis|interstitial cystitis
4760537|NCT02858453|Bladder pain syndrome|bladder pain syndrome
4760538|NCT02858453|Painful bladder syndrome|painful bladder syndrome
4760539|NCT02858453|Interstitial Cystitis/Bladder Pain Syndrome (IC/BPS)|interstitial cystitis/bladder pain syndrome (ic/bps)
4760540|NCT02858453|AQX-1125|aqx-1125
4760541|NCT02858453|SHIP1|ship1
4760542|NCT02858453|Chronic interstitial cystitis|chronic interstitial cystitis
4760543|NCT02858440|Primary dose|primary dose
4760544|NCT02858440|Reactogenicity|reactogenicity
4760545|NCT02858440|Immunogenicity|immunogenicity
4760546|NCT02858440|Booster dose|booster dose
4760547|NCT02858440|Combined vaccine|combined vaccine
4760548|NCT02858440|Russian Infants|russian infants
4760549|NCT02858440|Infanrix®-IPV/Hib|infanrix®-ipv/hib
4760550|NCT02858427|cognitive inhibition|cognitive inhibition
4760551|NCT02858427|elderly|elderly
4760552|NCT02858427|suicide attempt|suicide attempt
4760553|NCT02858427|depression|depression
4760554|NCT02858388|Otitis Media with Effusion|otitis media with effusion
4760555|NCT02858388|Exudative otitis media|exudative otitis media
4760556|NCT02858375|quality of life|quality of life
4760557|NCT02858375|botulinum toxin|botulinum toxin
4760558|NCT02858375|provoked vulvodynia|provoked vulvodynia
4760559|NCT02858362|DMD|dmd
4760560|NCT02858362|Muscular Dystrophy|muscular dystrophy
4760561|NCT02858362|Utrophin|utrophin
4760562|NCT02858362|Duchenne|duchenne
4760563|NCT02858362|PhaseOut DMD|phaseout dmd
4760564|NCT02858336|Luteinizing Hormone (LH)|luteinizing hormone (lh)
4760565|NCT02858336|Functional Hypothalamic Amenorrhea (HA)|functional hypothalamic amenorrhea (ha)
4760566|NCT02858336|Energy Deficiency|energy deficiency
4760567|NCT02858336|Gonadotropin-Releasing Hormone|gonadotropin-releasing hormone
4760568|NCT02858336|Leptin|leptin
4760569|NCT02858323|Alloimmunization|alloimmunization
4760570|NCT02858323|Refractoriness|refractoriness
4760571|NCT02858323|Corrected Count Increment|corrected count increment
4760572|NCT02858323|HLA-Compatible|hla-compatible
4760573|NCT02858310|Vulvar High Grade Squamous Intraepithelial Lesion|vulvar high grade squamous intraepithelial lesion
4760574|NCT02858310|Vulvar Intraepithelial Neoplasia|vulvar intraepithelial neoplasia
4760575|NCT02858310|Vaccine|vaccine
4760576|NCT02858310|Immunotherapy|immunotherapy
4760577|NCT02858310|Human Papillomavirus|human papillomavirus
4760578|NCT02858297|Oral lichen planus|oral lichen planus
4760579|NCT02858297|Glucosamine|glucosamine
4760580|NCT02858297|IL-8|il-8
4760581|NCT02858258|MCL|mcl
4760582|NCT02858245|MitraClip|mitraclip
4760583|NCT02858245|Structural Heart Failure|structural heart failure
4760584|NCT02858245|Degenerative Mitral Regurgitation (DMR)|degenerative mitral regurgitation (dmr)
4760585|NCT02858245|Actigraphy|actigraphy
4760586|NCT02858232|MASCT-I|masct-i
4760587|NCT02858232|Solid Tumors|solid tumors
4760588|NCT02858219|Botulinum toxin|botulinum toxin
4760589|NCT02858219|Pain improvement|pain improvement
4760590|NCT02858206|Locally advanced esophageal cancer|locally advanced esophageal cancer
4760591|NCT02858206|Radiotherapy and nimotuzumab|radiotherapy and nimotuzumab
4760592|NCT02858206|Concurrent chemoradiotherapy|concurrent chemoradiotherapy
4760593|NCT02858154|OSA|osa
4760594|NCT02858154|obstructive sleep apnea|obstructive sleep apnea
4760595|NCT02858154|infants|infants
4760596|NCT02858154|high flow nasal cannula|high flow nasal cannula
4760597|NCT02858154|HFNC|hfnc
4760598|NCT02858141|oncogeriatric evaluation|oncogeriatric evaluation
4760599|NCT02858141|pancreatic cancer|pancreatic cancer
4760600|NCT02858141|Database|database
4760601|NCT02858102|Schizophrenia|schizophrenia
4760602|NCT02858102|Psychosis|psychosis
4760603|NCT02858102|Obesity|obesity
4760604|NCT02858102|Neurocognition|neurocognition
4760605|NCT02858102|Depression|depression
4760606|NCT02858102|Bipolar disorder|bipolar disorder
4760607|NCT02858102|Metabolomics|metabolomics
4760608|NCT02858102|Biomarkers|biomarkers
4760609|NCT02858102|Hypertension|hypertension
4760610|NCT02858102|Dyslipidemia|dyslipidemia
4760611|NCT02858102|Hyperglycemia|hyperglycemia
4760612|NCT02858102|Hypertriglyceridemia|hypertriglyceridemia
4760613|NCT02858076|Anti-VEGF|anti-vegf
4760614|NCT02858076|Vitrectomy|vitrectomy
4760615|NCT02858063|Breast cancer|breast cancer
4760616|NCT02858063|Quality Of Life|quality of life
4760617|NCT02858063|Women|women
4760618|NCT02858063|Partner|partner
4760619|NCT02858011|behavior change communication|behavior change communication
4760620|NCT02858011|cash transfer|cash transfer
4760621|NCT02858011|household welfare|household welfare
4760622|NCT02858011|child nutrition status|child nutrition status
4760623|NCT02857985|Myocardial Infarction|myocardial infarction
4760624|NCT02857985|MRI|mri
4760625|NCT02857985|rotational angiography|rotational angiography
4760626|NCT02857972|Menstruation, Female Barrier, Sanitary pads|menstruation, female barrier, sanitary pads
4760627|NCT02857933|cerebral palsy|cerebral palsy
4760628|NCT02857933|motor impairments|motor impairments
4760629|NCT02857920|Vascular Endothelial Growth Factor (VEGF) antibody|vascular endothelial growth factor (vegf) antibody
4760630|NCT02857920|solid tumor|solid tumor
4760631|NCT02857920|NK Immunotherapy|nk immunotherapy
4760632|NCT02857907|Kidney transplantation|kidney transplantation
4760633|NCT02857907|Immunosuppressive treatment|immunosuppressive treatment
4760634|NCT02857894|Polypoidal choroidal vasculopathy|polypoidal choroidal vasculopathy
4760635|NCT02857881|keratoconus|keratoconus
4760636|NCT02857881|photokeratectomy|photokeratectomy
4760637|NCT02857881|de-epithelization|de-epithelization
4760638|NCT02857868|Hepatic Impairment|hepatic impairment
4760639|NCT02857868|ABL001|abl001
4760640|NCT02857868|Child-Pugh|child-pugh
4760641|NCT02857868|healthy subjects with normal hepatic function|healthy subjects with normal hepatic function
4760642|NCT02857855|liver transplantation|liver transplantation
4760643|NCT02857855|postoperative infection|postoperative infection
4760644|NCT02857855|biliary complications|biliary complications
4760645|NCT02857855|patient survival|patient survival
4760646|NCT02857855|graft survival|graft survival
4760647|NCT02857855|supplemental oxygen|supplemental oxygen
4760648|NCT02857829|Cognition|cognition
4760649|NCT02857829|working memory|working memory
4760650|NCT02857829|nootropic|nootropic
4760651|NCT02857829|reaction time|reaction time
4760652|NCT02857829|healthy individuals|healthy individuals
4760653|NCT02857829|cognitive enhancement|cognitive enhancement
4760654|NCT02857803|Virtual Reality|virtual reality
4760655|NCT02857803|Cognitive Rehabilitation|cognitive rehabilitation
4760656|NCT02857803|Motor Rehabilitation|motor rehabilitation
4760657|NCT02857803|Ecological validity|ecological validity
4760658|NCT02857803|Personalisation|personalisation
4760659|NCT02857790|Rotablation|rotablation
4760660|NCT02857790|High speed rotational atherectomy|high speed rotational atherectomy
4760661|NCT02857790|Type IV myocardial infarction|type iv myocardial infarction
4760662|NCT02857790|Cardiac magnetic resonance imaging|cardiac magnetic resonance imaging
4760663|NCT02857790|CMR|cmr
4760664|NCT02857790|Percutaneous Coronary Intervention|percutaneous coronary intervention
4760665|NCT02857751|depression|depression
4760666|NCT02857751|PTSD|ptsd
4760667|NCT02857751|anxiety|anxiety
4760668|NCT02857751|surf therapy|surf therapy
4760669|NCT02857699|Quality of life|quality of life
4760670|NCT02857699|Phase I trials|phase i trials
4760671|NCT02857673|Children with Special Health Care Needs|children with special health care needs
4760672|NCT02857673|Violence Prevention|violence prevention
4760673|NCT02857660|Sarcopenia|sarcopenia
4760674|NCT02857660|Obesity|obesity
4760675|NCT02857660|Whole-Body Electromyostimulation|whole-body electromyostimulation
4760676|NCT02857660|Protein Supplementation|protein supplementation
4760677|NCT02857660|community dwelling men|community dwelling men
4760678|NCT02857647|Bariatric surgery|bariatric surgery
4760679|NCT02857647|Anxiety|anxiety
4760680|NCT02857647|Nutrition knowledge|nutrition knowledge
4760681|NCT02857647|Weight loss expectations|weight loss expectations
4760682|NCT02857634|Urinary Bladder cancer|urinary bladder cancer
4760683|NCT02857634|diagnosis|diagnosis
4760684|NCT02857634|Cellvizio Dual Band|cellvizio dual band
4760685|NCT02857582|Antibiotic-induced diarrhea|antibiotic-induced diarrhea
4760686|NCT02857582|Clostridium-difficile toxin|clostridium-difficile toxin
4760687|NCT02857582|Pseudomembranous colitis|pseudomembranous colitis
4760688|NCT02857504|double lumen tube|double lumen tube
4760689|NCT02857504|hook|hook
4760690|NCT02857439|Trauma of the shoulder|trauma of the shoulder
4760691|NCT02857413|Xerostomia|xerostomia
4760692|NCT02857413|Radiotherapy|radiotherapy
4760693|NCT02857348|decision making|decision making
4760694|NCT02857348|heuristics|heuristics
4760695|NCT02857283|Air pollution|air pollution
4760696|NCT02857283|Air pollutant exposure|air pollutant exposure
4760697|NCT02857283|Ozone|ozone
4760698|NCT02857270|MAPK|mapk
4760699|NCT02857270|RAS|ras
4760700|NCT02857270|BRAF|braf
4760701|NCT02857257|IBS|ibs
4760702|NCT02857257|Microbiota|microbiota
4760703|NCT02857244|Freezing of Gait|freezing of gait
4760704|NCT02857231|Bioimpedance spectroscopy|bioimpedance spectroscopy
4760705|NCT02857205|Hirschsprung Associated EnteroColitis (HAEC)|hirschsprung associated enterocolitis (haec)
4760706|NCT02857179|bariatric surgery|bariatric surgery
4760707|NCT02857179|follow-up|follow-up
4760708|NCT02857179|weight loss|weight loss
4760709|NCT02857179|complications|complications
4760710|NCT02857179|comorbidities evolution|comorbidities evolution
4760711|NCT02857166|JS001|js001
4760712|NCT02857166|solid tumors|solid tumors
4760713|NCT02857153|MAP|map
4760714|NCT02857153|Blood loss|blood loss
4760715|NCT02857153|Postoperative delirium|postoperative delirium
4760716|NCT02857153|Elderly patients|elderly patients
4761219|NCT02854072|GV1001|gv1001
4760717|NCT02857153|Noncardiothoracic surgery|noncardiothoracic surgery
4760718|NCT02857127|Low income population|low income population
4760719|NCT02857127|Motor Activity|motor activity
4760720|NCT02857127|Primary Health Care|primary health care
4760721|NCT02857088|depression|depression
4760722|NCT02857088|emotional reactivity|emotional reactivity
4760723|NCT02857036|rhythm|rhythm
4760724|NCT02857036|depression|depression
4760725|NCT02857036|antidepressant treatment|antidepressant treatment
4760726|NCT02857023|Neurocognitive|neurocognitive
4760727|NCT02857023|Working memory|working memory
4760728|NCT02857023|Cogmed|cogmed
4760729|NCT02857023|Cognitive training|cognitive training
4760730|NCT02856984|Pregnancy|pregnancy
4760731|NCT02856984|Infant|infant
4760732|NCT02856971|Hinge Knee Prosthesis|hinge knee prosthesis
4760733|NCT02856971|TKA infection|tka infection
4760734|NCT02856971|rotating hinge prosthesis|rotating hinge prosthesis
4760735|NCT02856971|hinge knee arthroplasty|hinge knee arthroplasty
4760736|NCT02856945|fracture|fracture
4760737|NCT02856945|children|children
4760738|NCT02856945|knee|knee
4760739|NCT02856945|clinical criteria|clinical criteria
4760740|NCT02856945|decision making|decision making
4760741|NCT02856906|Orofacial Pain|orofacial pain
4760742|NCT02856906|Electromyography|electromyography
4760743|NCT02856906|dental occlusion|dental occlusion
4760744|NCT02856893|AZD9291|azd9291
4760745|NCT02856893|Osimertinib|osimertinib
4760746|NCT02856893|Gefitinib|gefitinib
4760747|NCT02856893|NSCLC|nsclc
4760748|NCT02856893|liquid biopsy|liquid biopsy
4760749|NCT02856893|ctDNA|ctdna
4760750|NCT02856841|epithelial ovarian cancer|epithelial ovarian cancer
4760751|NCT02856841|optimum cytoreduction|optimum cytoreduction
4760752|NCT02856815|Immuncell-LC|immuncell-lc
4760753|NCT02856815|Transarterial Chemoembolization|transarterial chemoembolization
4760754|NCT02856789|Fibrin structure|fibrin structure
4760755|NCT02856789|Coag-Lysis assay|coag-lysis assay
4760756|NCT02856789|Fibrin formation|fibrin formation
4760757|NCT02856789|Fibrinolysis|fibrinolysis
4760758|NCT02856789|TEG 5000|teg 5000
4760759|NCT02856789|TEG 6S|teg 6s
4760760|NCT02856789|Coagulo-lytic balance|coagulo-lytic balance
4760761|NCT02856789|Normal range|normal range
4760762|NCT02856789|Thromboelastography|thromboelastography
4760763|NCT02856776|Vitamin D|vitamin d
4760764|NCT02856776|Metabolomics|metabolomics
4760765|NCT02856776|Microbiota|microbiota
4760766|NCT02856776|Gene Expression|gene expression
4760767|NCT02856711|Group Prenatal Visits,CenteringPregnancy|group prenatal visits,centeringpregnancy
4760768|NCT02856698|Acute heart failure|acute heart failure
4760769|NCT02856698|morphine|morphine
4760770|NCT02856698|midazolam|midazolam
4760771|NCT02856698|in-hospital mortality|in-hospital mortality
4760772|NCT02856672|Laryngeal Tube Supreme Laryngeal Mask Airway Leak Pressure|laryngeal tube supreme laryngeal mask airway leak pressure
4760773|NCT02856620|cardiac mechanics|cardiac mechanics
4760774|NCT02856620|circulating biomarkers|circulating biomarkers
4760775|NCT02856620|frailty|frailty
4760776|NCT02856542|Psoriasis vulgaris, scalp, topical, applicator, device|psoriasis vulgaris, scalp, topical, applicator, device
4760777|NCT02856503|DCIS|dcis
4760778|NCT02856503|IBC|ibc
4760779|NCT02856503|Breast Cancer|breast cancer
4760780|NCT02856503|Invasive Breast Carcinoma|invasive breast carcinoma
4760781|NCT02856503|High Grade Ductal Carcinoma in-situ|high grade ductal carcinoma in-situ
4760782|NCT02856412|Stress Disorders, Post-Traumatic|stress disorders, post-traumatic
4760783|NCT02856412|Exercise|exercise
4760784|NCT02856412|Mindfulness|mindfulness
4760785|NCT02856399|methadone|methadone
4760786|NCT02856399|cancer pain|cancer pain
4760787|NCT02856399|long term effect|long term effect
4760788|NCT02856373|Denervation|denervation
4760789|NCT02856373|Renal Artery|renal artery
4760790|NCT02856360|Football|football
4760791|NCT02856360|Cleats|cleats
4760792|NCT02856360|Stiffness|stiffness
4760793|NCT02856347|Medullary Thyroid Cancer|medullary thyroid cancer
4760794|NCT02856347|PET F-DOPA|pet f-dopa
4760795|NCT02856347|18-FDOPA|18-fdopa
4760796|NCT02856334|chronic pelvic pain|chronic pelvic pain
4760797|NCT02856334|vulvodynia|vulvodynia
4760798|NCT02856334|pelvic pain|pelvic pain
4760799|NCT02856334|psychosocial factors|psychosocial factors
4760800|NCT02856334|central sensitization|central sensitization
4760801|NCT02856295|postpartum venous thromboembolism|postpartum venous thromboembolism
4760802|NCT02856295|prophylactic dose of low molecular weight heparin|prophylactic dose of low molecular weight heparin
4760803|NCT02856295|anti 10a|anti 10a
4760804|NCT02856269|Zinc|zinc
4760805|NCT02856256|Energy drink|energy drink
4760806|NCT02856256|Choroid|choroid
4760807|NCT02856230|Critical limb ischemia|critical limb ischemia
4760808|NCT02856230|bellow-the-knee angioplasty|bellow-the-knee angioplasty
4760809|NCT02856230|drug-eluting balloon|drug-eluting balloon
4760810|NCT02856165|infant|infant
4760811|NCT02856165|oxygen therapy|oxygen therapy
4760812|NCT02856165|High flow nasal canula oxygen therapy|high flow nasal canula oxygen therapy
4760813|NCT02856165|Bronchiolitis|bronchiolitis
4760814|NCT02856152|Healthy Volunteer|healthy volunteer
4760815|NCT02856139|ultra-widefield fluorescein angiography|ultra-widefield fluorescein angiography
4761528|NCT02852265|adherence|adherence
4760816|NCT02856139|peripheral retina|peripheral retina
4760817|NCT02856139|normal eyes|normal eyes
4760818|NCT02856126|Hepatic arterial infusion chemotherapy|hepatic arterial infusion chemotherapy
4760819|NCT02856126|Transarterial Chemoembolization|transarterial chemoembolization
4760820|NCT02856113|Drug therapy|drug therapy
4760821|NCT02856087|acute pain|acute pain
4760822|NCT02856087|postoperative|postoperative
4760823|NCT02856087|surgery|surgery
4760824|NCT02856048|GnRH agonist|gnrh agonist
4760825|NCT02856048|Ovarian reserve|ovarian reserve
4760826|NCT02856048|Fertility Preservation|fertility preservation
4760827|NCT02856048|Alkylating Agents|alkylating agents
4760828|NCT02856035|chronic stroke|chronic stroke
4760829|NCT02856035|functional MRI|functional mri
4760830|NCT02856035|functional NIRS|functional nirs
4760831|NCT02856035|motor learning|motor learning
4760832|NCT02856035|FES|fes
4760833|NCT02856035|upper extremity|upper extremity
4760834|NCT02856035|neural feedback|neural feedback
4760835|NCT02856035|arm/hand functional training|arm/hand functional training
4760836|NCT02856022|electrical ilioinguinal nerve stimulation|electrical ilioinguinal nerve stimulation
4760837|NCT02856022|bladder pain syndrome|bladder pain syndrome
4760838|NCT02856022|intravesical irrigation|intravesical irrigation
4760839|NCT02855996|fatherhood|fatherhood
4760840|NCT02855996|father involvement|father involvement
4760841|NCT02855996|economic stability|economic stability
4760842|NCT02855996|co-parenting|co-parenting
4760843|NCT02855996|healthy relationships|healthy relationships
4760844|NCT02855996|father-child engagement|father-child engagement
4760845|NCT02855957|Alpha-Hemoglobin Stabilizing Protein|alpha-hemoglobin stabilizing protein
4760846|NCT02855957|alpha-Hb pool|alpha-hb pool
4760847|NCT02855957|thalassemias|thalassemias
4760848|NCT02855957|diagnostic method|diagnostic method
4760849|NCT02855957|biomarker|biomarker
4760850|NCT02855944|ovarian cancer|ovarian cancer
4760851|NCT02855944|fallopian tube cancer|fallopian tube cancer
4760852|NCT02855944|primary peritoneal cancer|primary peritoneal cancer
4760853|NCT02855944|peritoneal cancer|peritoneal cancer
4760854|NCT02855944|platinum sensitive|platinum sensitive
4760855|NCT02855944|relapsed disease|relapsed disease
4760856|NCT02855944|PARP Inhibitor|parp inhibitor
4760857|NCT02855944|PARP|parp
4760858|NCT02855944|rucaparib|rucaparib
4760859|NCT02855944|ruca|ruca
4760860|NCT02855944|homologous recombination|homologous recombination
4760861|NCT02855944|homologous recombination deficiency|homologous recombination deficiency
4760862|NCT02855944|genomic scarring|genomic scarring
4760863|NCT02855944|loss of heterozygosity|loss of heterozygosity
4760864|NCT02855944|CO-338|co-338
4760865|NCT02855944|PF-01367338|pf-01367338
4760866|NCT02855944|PF 01367338|pf 01367338
4760867|NCT02855944|CO-338-043|co-338-043
4760868|NCT02855944|platinum sensitive ovarian cancer|platinum sensitive ovarian cancer
4760869|NCT02855944|platinum sensitive fallopian tube cancer|platinum sensitive fallopian tube cancer
4760870|NCT02855944|platinum sensitive primary peritoneal cancer|platinum sensitive primary peritoneal cancer
4760871|NCT02855944|platinum sensitive peritoneal cancer|platinum sensitive peritoneal cancer
4760872|NCT02855944|gynecological cancer|gynecological cancer
4760873|NCT02855944|Clovis|clovis
4760874|NCT02855944|Clovis oncology|clovis oncology
4760875|NCT02855944|ARIEL2|ariel2
4760876|NCT02855944|ARIEL 2|ariel 2
4760877|NCT02855944|ARIEL-2|ariel-2
4760878|NCT02855944|ARIEL-3|ariel-3
4760879|NCT02855944|ARIEL 3|ariel 3
4760880|NCT02855944|ARIEL3|ariel3
4760881|NCT02855944|ARIEL4|ariel4
4760882|NCT02855944|ARIEL-4|ariel-4
4760883|NCT02855944|ARIEL 4|ariel 4
4760884|NCT02855944|A4|a4
4760885|NCT02855944|advanced OC|advanced oc
4760886|NCT02855944|platinum resistant ovarian cancer|platinum resistant ovarian cancer
4760887|NCT02855944|platinum resistant primary ovarian cancer|platinum resistant primary ovarian cancer
4760888|NCT02855944|Rubraca|rubraca
4760889|NCT02855944|High grade serous|high grade serous
4760890|NCT02855944|Partially platinum sensitive|partially platinum sensitive
4760891|NCT02855918|Psychiatry|psychiatry
4760892|NCT02855918|Depressive disorder|depressive disorder
4760893|NCT02855918|Suicidal behavior|suicidal behavior
4760894|NCT02855918|Genetics|genetics
4760895|NCT02855905|Exercise|exercise
4760896|NCT02855905|Cold Temperature|cold temperature
4760897|NCT02855892|GV1001|gv1001
4760898|NCT02855892|BPH|bph
4760899|NCT02855892|Benign prostatic hyperplasia|benign prostatic hyperplasia
4760900|NCT02855788|gastric cancer|gastric cancer
4760901|NCT02855788|gastroesophageal cancer|gastroesophageal cancer
4760902|NCT02855788|metastatic|metastatic
4760903|NCT02855788|advanced|advanced
4760904|NCT02855736|Suicidal inpatients|suicidal inpatients
4760905|NCT02855736|Positive Psychology|positive psychology
4760906|NCT02855736|Gratitude|gratitude
4760907|NCT02855736|Psychological pain|psychological pain
4760908|NCT02855723|Squamous carcinoma of oral cavity and oropharynx|squamous carcinoma of oral cavity and oropharynx
4760909|NCT02855723|Sentinel lymph node|sentinel lymph node
4760910|NCT02855723|Lymph node dissection|lymph node dissection
4760911|NCT02855723|Equivalence|equivalence
4760912|NCT02855671|microcirculation|microcirculation
4760913|NCT02855671|thermal|thermal
4760914|NCT02855671|temperature|temperature
4761725|NCT02850562|sarcopenia|sarcopenia
4760915|NCT02855658|Sjögren's syndrome|sjögren's syndrome
4760916|NCT02855658|Gan-Lu-Yin|gan-lu-yin
4760917|NCT02855658|Sang-Ju-Yin|sang-ju-yin
4760918|NCT02855658|Xuefu-Zhuyu-Decoction|xuefu-zhuyu-decoction
4760919|NCT02855658|Oxidative stress|oxidative stress
4760920|NCT02855658|Immune regulation|immune regulation
4760921|NCT02855658|Gene modulation|gene modulation
4760922|NCT02855658|SS-1|ss-1
4760923|NCT02855645|Trichosanthes root|trichosanthes root
4760924|NCT02855645|Traditional Chinese Medicine|traditional chinese medicine
4760925|NCT02855645|Clinical trial|clinical trial
4760926|NCT02855632|G-CSF|g-csf
4760927|NCT02855632|adhesion reformation|adhesion reformation
4760928|NCT02855632|Asherman syndrome|asherman syndrome
4760929|NCT02855619|inspiratory muscles training programs|inspiratory muscles training programs
4760930|NCT02855619|Ventilator-induced diaphragmatic dysfunction|ventilator-induced diaphragmatic dysfunction
4760931|NCT02855619|Weaning|weaning
4760932|NCT02855619|Intensive care unit|intensive care unit
4760933|NCT02855606|Oral PrEP|oral prep
4760934|NCT02855606|TGW|tgw
4760935|NCT02855606|Thai MSM|thai msm
4760936|NCT02855593|acupuncture|acupuncture
4760937|NCT02855580|Pharmacogenomic|pharmacogenomic
4760938|NCT02855580|child|child
4760939|NCT02855580|psychiatry|psychiatry
4760940|NCT02855580|Obsessive Compulsive Disorder|obsessive compulsive disorder
4760941|NCT02855580|Depression|depression
4760942|NCT02855580|Anxiety|anxiety
4760943|NCT02855580|CYP2D6|cyp2d6
4760944|NCT02855580|CYP2C19|cyp2c19
4760945|NCT02855580|Selective serotonin reuptake inhibitor|selective serotonin reuptake inhibitor
4760946|NCT02855580|SSRI|ssri
4760947|NCT02855567|surgery|surgery
4760948|NCT02855567|acupuncture|acupuncture
4760949|NCT02855567|gynecology|gynecology
4760950|NCT02855567|pain|pain
4760951|NCT02855567|narcotics|narcotics
4760952|NCT02855554|myocardial tissue characterization|myocardial tissue characterization
4760953|NCT02855541|Blood Glucose|blood glucose
4760954|NCT02855541|Physical Fitness|physical fitness
4760955|NCT02855541|Body Composition|body composition
4760956|NCT02855541|Lipids|lipids
4760957|NCT02855528|Tin Filter|tin filter
4761083|NCT02854904|Immune effect|immune effect
4760958|NCT02855528|Coronary Artery Calcium Scoring|coronary artery calcium scoring
4760959|NCT02855528|Radiation dose reduction|radiation dose reduction
4760960|NCT02855515|drug-induced sleep endoscopy|drug-induced sleep endoscopy
4760961|NCT02855515|obstructive sleep apnoea|obstructive sleep apnoea
4760962|NCT02855515|VOTE classification|vote classification
4760964|NCT02855515|BMI|bmi
4760965|NCT02855489|Condom Use|condom use
4760966|NCT02855489|HIV/STD|hiv/std
4760967|NCT02855489|Intervention|intervention
4760968|NCT02855489|Theory of Planned Behavior|theory of planned behavior
4760969|NCT02855489|Dismantling Study Design|dismantling study design
4760970|NCT02855463|Giant virus|giant virus
4760971|NCT02855463|Amoeba|amoeba
4760972|NCT02855424|stroke|stroke
4760973|NCT02855424|exercise capacity|exercise capacity
4760974|NCT02855385|Rectal bleeding, , ,|rectal bleeding, , ,
4760975|NCT02855385|Attitude|attitude
4760976|NCT02855385|Health seeking behaviour|health seeking behaviour
4760977|NCT02855385|Nigeria|nigeria
4760978|NCT02855385|Screening|screening
4760979|NCT02855385|high risk patients|high risk patients
4760980|NCT02855359|Antibodies, Monoclonal|antibodies, monoclonal
4760981|NCT02855359|SGN-19A|sgn-19a
4760982|NCT02855359|Denintuzumab Mafodotin|denintuzumab mafodotin
4760983|NCT02855359|DLBCL|dlbcl
4760984|NCT02855359|Antibody-Drug Conjugate|antibody-drug conjugate
4760985|NCT02855359|Antigens, CD19|antigens, cd19
4760986|NCT02855359|Hematologic Diseases|hematologic diseases
4760987|NCT02855359|Immune System Diseases|immune system diseases
4760988|NCT02855359|Immunoproliferative Disorders|immunoproliferative disorders
4760989|NCT02855359|Immunotherapy|immunotherapy
4760990|NCT02855359|Lymphatic Diseases|lymphatic diseases
4760991|NCT02855359|Lymphoma|lymphoma
4760992|NCT02855359|Lymphoma, B-Cell|lymphoma, b-cell
4760993|NCT02855359|Lymphoma, Large B-Cell, Diffuse|lymphoma, large b-cell, diffuse
4760994|NCT02855359|Lymphoma, Non-Hodgkin|lymphoma, non-hodgkin
4760995|NCT02855359|Monomethyl auristatin F|monomethyl auristatin f
4760996|NCT02855359|Neoplasms|neoplasms
4760997|NCT02855359|Neoplasms by Histologic Type|neoplasms by histologic type
4760998|NCT02855359|Transformed Lymphoma / DLBCL|transformed lymphoma / dlbcl
4760999|NCT02855359|Cyclophosphamide|cyclophosphamide
4761000|NCT02855359|Doxorubicin|doxorubicin
4761001|NCT02855359|Liposomal doxorubicin|liposomal doxorubicin
4761002|NCT02855359|Prednisone|prednisone
4761003|NCT02855359|Rituximab|rituximab
4761004|NCT02855359|Vincristine|vincristine
4761005|NCT02855359|Alkylating Agents|alkylating agents
4761006|NCT02855359|Anti-Inflammatory Agents|anti-inflammatory agents
4761007|NCT02855359|Antibiotic, Antineoplastic|antibiotic, antineoplastic
4761008|NCT02855359|Antimitotic Agents|antimitotic agents
4761009|NCT02855359|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating
4761010|NCT02855359|Antineoplastic Agents|antineoplastic agents
4761011|NCT02855359|Phytogenic Antirheumatic Agents|phytogenic antirheumatic agents
4761012|NCT02855359|Glucocorticoids|glucocorticoids
4761013|NCT02855359|Drug Therapy|drug therapy
4761014|NCT02855359|Follicular Lymphoma Grade 3b|follicular lymphoma grade 3b
4761015|NCT02855359|immunosuppressive agents|immunosuppressive agents
4761016|NCT02855333|Merendino procedure|merendino procedure
4761017|NCT02855333|Feasibility, Safety and QoL of the Merendino procedure|feasibility, safety and qol of the merendino procedure
4761018|NCT02855320|Biologics safety|biologics safety
4761019|NCT02855320|Rheumatoid arthritis|rheumatoid arthritis
4761020|NCT02855320|Spondyloarthritis|spondyloarthritis
4761021|NCT02855320|patient education|patient education
4761022|NCT02855320|self-management|self-management
4761023|NCT02855307|Closed-loop system|closed-loop system
4761024|NCT02855307|Artificial pancreas|artificial pancreas
4761025|NCT02855307|Exercise|exercise
4761026|NCT02855307|Hypoglycemia|hypoglycemia
4761027|NCT02855307|Insulin|insulin
4761028|NCT02855307|Type 1 diabetes|type 1 diabetes
4761029|NCT02855294|oral contraceptive pills|oral contraceptive pills
4761030|NCT02855294|Joint stability|joint stability
4761031|NCT02855268|Kidney disease|kidney disease
4761032|NCT02855268|Nephritis|nephritis
4761033|NCT02855268|Hereditary nephritis|hereditary nephritis
4761034|NCT02855268|Hereditary kidney disease|hereditary kidney disease
4761035|NCT02855229|Translational|translational
4761036|NCT02855229|Electrophysiology|electrophysiology
4761037|NCT02855216|Physiotherapy|physiotherapy
4761038|NCT02855216|Range of motion|range of motion
4761039|NCT02855216|Inhibition sub-occipital techniques|inhibition sub-occipital techniques
4761040|NCT02855190|Ga68-citrate|ga68-citrate
4761041|NCT02855190|FDG|fdg
4761042|NCT02855190|PET/MR and PET/CT|pet/mr and pet/ct
4761043|NCT02855190|Periprosthetic joint infection|periprosthetic joint infection
4761044|NCT02855177|Hyperlipidemia|hyperlipidemia
4761045|NCT02855164|LJN452|ljn452
4761046|NCT02855164|non-alcoholic steatohepatitis|non-alcoholic steatohepatitis
4761047|NCT02855164|NASH|nash
4761048|NCT02855164|phase 2|phase 2
4761049|NCT02855164|adaptive design|adaptive design
4761050|NCT02855164|randomized|randomized
4761051|NCT02855151|EUS|eus
4761052|NCT02855138|isotretinoin|isotretinoin
4761053|NCT02855138|PCOS|pcos
4761054|NCT02855138|acne vulgaris|acne vulgaris
4761055|NCT02855125|NSCLC|nsclc
4761056|NCT02855125|phase 2 study|phase 2 study
4761057|NCT02855125|TAS-114|tas-114
4761058|NCT02855125|S-1|s-1
4761059|NCT02855073|adipose-derived mesenchymal progenitor cells|adipose-derived mesenchymal progenitor cells
4761060|NCT02855073|Artz|artz
4761061|NCT02855034|child and infant|child and infant
4761062|NCT02855034|Blood samples|blood samples
4761063|NCT02855021|Dementia|dementia
4761064|NCT02855021|Cerebral metabolism|cerebral metabolism
4761065|NCT02855021|PET scan|pet scan
4761066|NCT02855008|Social Problem-Solving|social problem-solving
4761067|NCT02855008|Intellectual Disability|intellectual disability
4761068|NCT02855008|Problem Behaviors|problem behaviors
4761069|NCT02855008|Community based intervention|community based intervention
4761070|NCT02855008|Prevention|prevention
4761071|NCT02854956|phenotype|phenotype
4761072|NCT02854956|X-linked mental retardation|x-linked mental retardation
4761073|NCT02854956|neuronal networks|neuronal networks
4761074|NCT02854956|cognitive processes|cognitive processes
4761075|NCT02854930|Clinical death|clinical death
4761076|NCT02854930|state of consciousness|state of consciousness
4761077|NCT02854904|Immunomodulatory|immunomodulatory
4761078|NCT02854904|dexmedetomidine|dexmedetomidine
4761079|NCT02854904|anesthesia|anesthesia
4761080|NCT02854904|alpha-2 agonist|alpha-2 agonist
4761081|NCT02854904|arthrodesis|arthrodesis
4761082|NCT02854904|spinal fusion|spinal fusion
4761084|NCT02854904|double randomized clinical trials|double randomized clinical trials
4761085|NCT02854891|Effects|effects
4761086|NCT02854891|Heat|heat
4761087|NCT02854891|Light|light
4761088|NCT02854826|Frail Older Adults, Interprofessional Team|frail older adults, interprofessional team
4761089|NCT02854813|overactive bladder|overactive bladder
4761090|NCT02854813|coronary artery disease|coronary artery disease
4761091|NCT02854813|gensini score|gensini score
4761092|NCT02854800|varenicline|varenicline
4761093|NCT02854800|buprenorphine|buprenorphine
4761094|NCT02854787|Spinal anesthesia|spinal anesthesia
4761095|NCT02854787|cesarean|cesarean
4761096|NCT02854787|blood pressure|blood pressure
4761097|NCT02854787|Norepinephrine|norepinephrine
4761098|NCT02854787|Phenylephrine|phenylephrine
4761099|NCT02854735|Head and Neck Neoplasms|head and neck neoplasms
4761100|NCT02854735|Total body composition|total body composition
4761101|NCT02854735|Dual-Energy X-Ray Absorptiometry|dual-energy x-ray absorptiometry
4761102|NCT02854735|Malnutrition|malnutrition
4761103|NCT02854735|Muscle quantification|muscle quantification
4761104|NCT02854722|deferasirox|deferasirox
4761105|NCT02854722|iron accumulation|iron accumulation
4761106|NCT02854696|Islet cell Transplantation|islet cell transplantation
4761107|NCT02854696|cost-effectiveness analysis|cost-effectiveness analysis
4761108|NCT02854696|Cost-utility analysis|cost-utility analysis
4761109|NCT02854696|Type 1 Diabetes|type 1 diabetes
4761110|NCT02854683|Chronic Fatigue Syndrome (CFS)|chronic fatigue syndrome (cfs)
4761111|NCT02854683|Myalgic Encephalomyelitis (ME)|myalgic encephalomyelitis (me)
4761112|NCT02854683|Postural Tachycardia Syndrome (POTS)|postural tachycardia syndrome (pots)
4761113|NCT02854683|Neurally Mediated Syncope (NMS)|neurally mediated syncope (nms)
4761114|NCT02854683|Systemic Exertion Intolerance Disease (SEID)|systemic exertion intolerance disease (seid)
4761115|NCT02854683|Orthostatic Intolerance (OI)|orthostatic intolerance (oi)
4761116|NCT02854683|Oral Rehydration Solution (ORS)|oral rehydration solution (ors)
4761117|NCT02854683|Lower Body Negative Pressure (LBNP)|lower body negative pressure (lbnp)
4761118|NCT02854670|capsaicin|capsaicin
4761119|NCT02854670|pain improvement|pain improvement
4761120|NCT02854670|provoked vulvodynia|provoked vulvodynia
4761121|NCT02854657|melanoma|melanoma
4761122|NCT02854657|skin self-examination|skin self-examination
4761123|NCT02854631|Cirrhosis|cirrhosis
4761124|NCT02854631|Prednisone|prednisone
4761125|NCT02854631|Jaundice|jaundice
4761126|NCT02854605|Non-alcoholic fatty liver disease (NAFLD)|non-alcoholic fatty liver disease (nafld)
4761127|NCT02854605|Fibrosis|fibrosis
4761128|NCT02854605|GS-9674|gs-9674
4761129|NCT02854592|rtPA|rtpa
4761130|NCT02854592|urokinase|urokinase
4761131|NCT02854579|Hypoxic-Ischemic Encephalopathy|hypoxic-ischemic encephalopathy
4761132|NCT02854579|progenitor cell|progenitor cell
4761133|NCT02854579|paracrine factor|paracrine factor
4761134|NCT02854579|adipose mesenchymal stem cell|adipose mesenchymal stem cell
4761135|NCT02854579|neonate|neonate
4761136|NCT02854566|periprosthetic fracture of the femur|periprosthetic fracture of the femur
4761137|NCT02854566|hip prosthesis|hip prosthesis
4761138|NCT02854540|hyperhidrosis|hyperhidrosis
4761139|NCT02854540|palmar|palmar
4761140|NCT02854540|sweating|sweating
4761141|NCT02854540|iontophoresis|iontophoresis
4761142|NCT02854540|sweat gland diseases|sweat gland diseases
4761143|NCT02854540|skin diseases|skin diseases
4761144|NCT02854514|endometrial -cytokines|endometrial -cytokines
4761145|NCT02854501|Homocysteine|homocysteine
4761146|NCT02854501|Preeclampsia|preeclampsia
4761147|NCT02854501|poor placentation|poor placentation
4761148|NCT02854475|skin parameters|skin parameters
4761149|NCT02854475|cholesterol|cholesterol
4761150|NCT02854475|Raman spectroscopy|raman spectroscopy
4761151|NCT02854462|Language Development|language development
4761152|NCT02854462|Shared Picture Book reading|shared picture book reading
4761153|NCT02854462|Preschoolers|preschoolers
4761154|NCT02854462|Inference making|inference making
4761155|NCT02854449|Immune Marker|immune marker
4761156|NCT02854449|Immunologic Marker|immunologic marker
4761157|NCT02854449|Radiotherapy|radiotherapy
4761158|NCT02854449|Dose Hypofractionation|dose hypofractionation
4761159|NCT02854436|Prostate cancer|prostate cancer
4761160|NCT02854436|CRPC|crpc
4761161|NCT02854436|Metastatic castrate-resistant prostate cancer|metastatic castrate-resistant prostate cancer
4761162|NCT02854436|Prostate neoplasm|prostate neoplasm
4761163|NCT02854436|Galahad|galahad
4761164|NCT02854436|Niraparib|niraparib
4761165|NCT02854436|DNA anomalies|dna anomalies
4761166|NCT02854436|DNA defect|dna defect
4761167|NCT02854436|PARP inhibitor|parp inhibitor
4761168|NCT02854436|PARPi|parpi
4761169|NCT02854410|dietary sodium nitrate|dietary sodium nitrate
4761170|NCT02854410|radiotherapy|radiotherapy
4761171|NCT02854410|nasopharyngeal carcinoma|nasopharyngeal carcinoma
4761172|NCT02854384|Epilepsy|epilepsy
4761173|NCT02854384|Mobile phone|mobile phone
4761174|NCT02854371|gadoxetic acid|gadoxetic acid
4761175|NCT02854371|T1 map|t1 map
4761176|NCT02854371|MRI|mri
4761177|NCT02854345|CZT camera|czt camera
4761178|NCT02854345|pinhole|pinhole
4761179|NCT02854332|Pain|pain
4761180|NCT02854332|Analgesic|analgesic
4761181|NCT02854332|Stimulation|stimulation
4761182|NCT02854332|Motor Cortex|motor cortex
4761183|NCT02854306|Bariatric surgery|bariatric surgery
4761184|NCT02854306|Mindfulness|mindfulness
4761185|NCT02854306|Obese|obese
4761186|NCT02854293|palliative care|palliative care
4761187|NCT02854293|cancer|cancer
4761188|NCT02854293|quality of life|quality of life
4761189|NCT02854280|Hypoxia|hypoxia
4761190|NCT02854280|Brain|brain
4761191|NCT02854280|Effort|effort
4761192|NCT02854267|organ procurement|organ procurement
4761193|NCT02854267|brain death|brain death
4761194|NCT02854267|organ donation|organ donation
4761195|NCT02854267|next of kins|next of kins
4761196|NCT02854254|phlebitis|phlebitis
4761197|NCT02854254|catheter|catheter
4761198|NCT02854254|congestive heart failure|congestive heart failure
4761199|NCT02854254|dobutamine|dobutamine
4761200|NCT02854241|MRI|mri
4761201|NCT02854241|HCC|hcc
4761202|NCT02854241|surveillance|surveillance
4761203|NCT02854228|Pituitary tumor|pituitary tumor
4761204|NCT02854228|pituitary carcinoma|pituitary carcinoma
4761205|NCT02854228|acromegaly|acromegaly
4761206|NCT02854228|cushing|cushing
4761207|NCT02854228|prolactinoma|prolactinoma
4761208|NCT02854163|Secukinumab|secukinumab
4761209|NCT02854163|Neutrophils|neutrophils
4761210|NCT02854163|Vitamin D|vitamin d
4761211|NCT02854124|Melanoma|melanoma
4761212|NCT02854124|Dissemination|dissemination
4761213|NCT02854124|Initiating stem cells|initiating stem cells
4761214|NCT02854098|BHJS, constipation|bhjs, constipation
4761215|NCT02854085|Prevention of Cognitive Decline|prevention of cognitive decline
4761216|NCT02854085|Art Therapy|art therapy
4761217|NCT02854085|Music Reminiscence Activity|music reminiscence activity
4761218|NCT02854085|Elderly|elderly
4761220|NCT02854059|Asymptomatic antibody-mediated TTP|asymptomatic antibody-mediated ttp
4761221|NCT02854046|calcific uremic arteriolopathy|calcific uremic arteriolopathy
4761222|NCT02854046|case-control study|case-control study
4761223|NCT02854046|cohort study|cohort study
4761224|NCT02854033|amyloid|amyloid
4761225|NCT02854033|plaques|plaques
4761226|NCT02854033|neuroimaging|neuroimaging
4761227|NCT02854033|biomarkers|biomarkers
4761228|NCT02854033|cognition disorder|cognition disorder
4761229|NCT02854033|early detection|early detection
4761230|NCT02854033|pre-dementia|pre-dementia
4761231|NCT02854033|dementia|dementia
4761232|NCT02854033|Alzheimer's disease|alzheimer's disease
4761233|NCT02854033|tau|tau
4761234|NCT02854020|Aircraft|aircraft
4761235|NCT02854020|Emergency|emergency
4761236|NCT02854020|First aid|first aid
4761237|NCT02854020|Cabin crew|cabin crew
4761238|NCT02854020|Burn|burn
4761239|NCT02854020|Cardiac arrest|cardiac arrest
4761240|NCT02854007|Coronary artery disease|coronary artery disease
4761241|NCT02854007|Angioplasty|angioplasty
4761242|NCT02854007|Bioresorbable coronary device|bioresorbable coronary device
4761243|NCT02854007|QALY (Quality-Adjusted Life Years)|qaly (quality-adjusted life years)
4761244|NCT02853994|DCB|dcb
4761245|NCT02853994|DEB|deb
4761246|NCT02853994|Sirolimus|sirolimus
4761247|NCT02853994|PCI|pci
4761248|NCT02853994|ISR|isr
4761249|NCT02853994|SVD|svd
4761250|NCT02853994|Restenosis|restenosis
4761251|NCT02853994|Bifurcation|bifurcation
4761252|NCT02853994|CAD|cad
4761253|NCT02853994|Coronary artery|coronary artery
4761254|NCT02853968|Unlock the Cell|unlock the cell
4761255|NCT02853968|Castleman's Disease|castleman's disease
4761256|NCT02853968|CD|cd
4761257|NCT02853968|Castleman Disease|castleman disease
4761258|NCT02853968|MCD|mcd
4761259|NCT02853968|iMCD|imcd
4761260|NCT02853968|Angiofollicular Lymph Hyperplasia|angiofollicular lymph hyperplasia
4761261|NCT02853968|multicentric Castleman's disease|multicentric castleman's disease
4761262|NCT02853968|multicentric Castleman disease|multicentric castleman disease
4761263|NCT02853968|idiopathic multicentric Castleman disease|idiopathic multicentric castleman disease
4761264|NCT02853929|Pertussis|pertussis
4761265|NCT02853929|Immunogenicity|immunogenicity
4761266|NCT02853929|Poliomyelitis|poliomyelitis
4761267|NCT02853929|Tetanus|tetanus
4761268|NCT02853929|Hepatitis B|hepatitis b
4761269|NCT02853929|Diptheria|diptheria
4761270|NCT02853903|solid tumor|solid tumor
4761271|NCT02853903|NK immunotherapy|nk immunotherapy
4761272|NCT02853890|Birth|birth
4761273|NCT02853890|obstetric analgesia|obstetric analgesia
4761274|NCT02853890|obstetric anesthesia|obstetric anesthesia
4761275|NCT02853864|Gender|gender
4761276|NCT02853864|Propofol|propofol
4761277|NCT02853864|Dexmedetomidine|dexmedetomidine
4761278|NCT02853864|Interaction|interaction
4761279|NCT02853851|Stress factors,|stress factors,
4761280|NCT02853851|intensive care units,|intensive care units,
4761281|NCT02853851|scale,|scale,
4761282|NCT02853851|quality of care|quality of care
4761283|NCT02853838|acute viral bronchiolitis|acute viral bronchiolitis
4761284|NCT02853838|respiratory syncytial virus|respiratory syncytial virus
4761285|NCT02853838|chest physiotherapy|chest physiotherapy
4761286|NCT02853812|tinnitus|tinnitus
4761287|NCT02853812|residual inhibition|residual inhibition
4761288|NCT02853786|cochlear implant|cochlear implant
4761289|NCT02853786|language environment|language environment
4761290|NCT02853786|speech therapy assessment|speech therapy assessment
4761291|NCT02853786|LENA technology|lena technology
4761292|NCT02853773|sweeteners|sweeteners
4761293|NCT02853773|sugar|sugar
4761294|NCT02853773|EEG|eeg
4761295|NCT02853773|food viewing|food viewing
4761296|NCT02853773|food intake|food intake
4761297|NCT02853747|arterial stiffness|arterial stiffness
4761298|NCT02853747|retinal vessels|retinal vessels
4761299|NCT02853747|physical activity|physical activity
4761300|NCT02853747|children|children
4761301|NCT02853708|E. coli|e. coli
4761302|NCT02853708|extended-spectrum beta-lactamase|extended-spectrum beta-lactamase
4761303|NCT02853708|molecular epidemiology|molecular epidemiology
4761304|NCT02853708|risk factors|risk factors
4761305|NCT02853695|Hysteroscopy|hysteroscopy
4761306|NCT02853695|Diffusion|diffusion
4761307|NCT02853695|Implementation|implementation
4761308|NCT02853695|Diagnostic hysteroscopy|diagnostic hysteroscopy
4761309|NCT02853695|Operative hysteroscopy|operative hysteroscopy
4761310|NCT02853682|glycocalyx|glycocalyx
4761311|NCT02853682|capillary leak syndrome|capillary leak syndrome
4761312|NCT02853656|preterm birth|preterm birth
4761313|NCT02853656|gestation|gestation
4761314|NCT02853617|S. pneumoniae|s. pneumoniae
4761315|NCT02853617|N. meningitidis|n. meningitidis
4761316|NCT02853617|H. influenza|h. influenza
4761317|NCT02853617|B. pertussis|b. pertussis
4761318|NCT02853617|C. tetani|c. tetani
4761319|NCT02853617|MRSA|mrsa
4761320|NCT02853591|laparoscopy|laparoscopy
4761321|NCT02853591|hysterectomy|hysterectomy
4761322|NCT02853500|Liver Cancer|liver cancer
4761323|NCT02853487|Cluster headache|cluster headache
4761324|NCT02853487|actigraphy|actigraphy
4761325|NCT02853487|circadian rhythm|circadian rhythm
4761326|NCT02853461|biofilm|biofilm
4761327|NCT02853461|periprosthetic joint infection|periprosthetic joint infection
4761328|NCT02853461|hip|hip
4761329|NCT02853461|endoprothesis|endoprothesis
4761330|NCT02853461|ceramic|ceramic
4761331|NCT02853461|bearing components|bearing components
4761332|NCT02853461|sonication|sonication
4761333|NCT02853461|low grade infection|low grade infection
4761334|NCT02853461|joint aspiration|joint aspiration
4761335|NCT02853448|Plasma|plasma
4761336|NCT02853448|Serum|serum
4761337|NCT02853448|Effective Blood Draws|effective blood draws
4761338|NCT02853435|Cross-over|cross-over
4761339|NCT02853435|Gepotidacin|gepotidacin
4761340|NCT02853435|Pharmacokinetics|pharmacokinetics
4761341|NCT02853435|Relative Bioavailability|relative bioavailability
4761342|NCT02853435|non-compartmental PK analysis|non-compartmental pk analysis
4761343|NCT02853435|High shear wet granulation|high shear wet granulation
4761344|NCT02853396|internalised stigma|internalised stigma
4761345|NCT02853396|self stigma|self stigma
4761346|NCT02853396|inpatients|inpatients
4761348|NCT02853396|Cognitive therapy|cognitive therapy
4761349|NCT02853383|Chronic Obstructive Pulmonary Diseases, COPD|chronic obstructive pulmonary diseases, copd
4761350|NCT02853357|Thoracic manipulation|thoracic manipulation
4761351|NCT02853357|Low back pain|low back pain
4761352|NCT02853357|Core strengthening|core strengthening
4761353|NCT02853357|Thoracic spine thrust manipulation|thoracic spine thrust manipulation
4761354|NCT02853344|PD1|pd1
4761355|NCT02853344|PD-1|pd-1
4761356|NCT02853344|PDL1|pdl1
4761357|NCT02853344|PD-L1|pd-l1
4761358|NCT02853331|PD1|pd1
4761359|NCT02853331|PD-1|pd-1
4761360|NCT02853331|PDL1|pdl1
4761361|NCT02853331|PD-L1|pd-l1
4761362|NCT02853331|VEGFR TKI|vegfr tki
4761363|NCT02853305|PD1|pd1
4761364|NCT02853305|PD-1|pd-1
4761365|NCT02853305|PDL1|pdl1
4761366|NCT02853305|PD-L1|pd-l1
4761367|NCT02853266|Kawasaki disease|kawasaki disease
4761368|NCT02853266|non-cruzi-related antibody (NCRA)|non-cruzi-related antibody (ncra)
4761369|NCT02853253|Preterm neonates|preterm neonates
4761370|NCT02853240|Cerebral palsy|cerebral palsy
4761371|NCT02853240|children|children
4761372|NCT02853240|muscle spasticity|muscle spasticity
4761373|NCT02853240|botulinum toxin injection|botulinum toxin injection
4761374|NCT02853227|Telemark score, reliability|telemark score, reliability
4761375|NCT02853214|Dysglobulinemia|dysglobulinemia
4761376|NCT02853214|Multiple Myeloma|multiple myeloma
4761377|NCT02853214|MGUS|mgus
4761378|NCT02853214|Waldenström|waldenström
4761379|NCT02853214|genetic factors|genetic factors
4761380|NCT02853214|Sequencing|sequencing
4761381|NCT02853201|Extubation|extubation
4761382|NCT02853201|Intercostal Muscles|intercostal muscles
4761383|NCT02853201|Diaphragm|diaphragm
4761384|NCT02853201|Sternocleidomastoid Muscle|sternocleidomastoid muscle
4761385|NCT02853162|Stereotactic body radiotherapy|stereotactic body radiotherapy
4761386|NCT02853162|MRI|mri
4761387|NCT02853162|Renal cell carcinoma|renal cell carcinoma
4761388|NCT02853149|Spinal Cord Injury|spinal cord injury
4761389|NCT02853149|disability|disability
4761390|NCT02853149|obesity|obesity
4761391|NCT02853149|cardiometabolic|cardiometabolic
4761392|NCT02853149|Caregiver|caregiver
4761393|NCT02853110|MRI, stereotactic body radiotherapy, hypofractionation|mri, stereotactic body radiotherapy, hypofractionation
4761394|NCT02853084|Auto-inflammatory diseases|auto-inflammatory diseases
4761395|NCT02853084|IL-1 inhibitors|il-1 inhibitors
4761396|NCT02853084|HL2351|hl2351
4761397|NCT02853084|Cryopyrin‑Associated Periodic Syndromes (CAPS)|cryopyrin‑associated periodic syndromes (caps)
4761398|NCT02853084|Neonatal Onset Multisystem Inflammatory Disease (NOMID)|neonatal onset multisystem inflammatory disease (nomid)
4761399|NCT02853084|Muckle-Wells Syndrome (MWS)|muckle-wells syndrome (mws)
4761400|NCT02853084|Familial Cold Autoinflammatory Syndrome (FCAS)|familial cold autoinflammatory syndrome (fcas)
4761401|NCT02853058|stillbirth|stillbirth
4761402|NCT02853058|hemorrhage|hemorrhage
4761403|NCT02853019|Emotion|emotion
4761404|NCT02853019|motivation|motivation
4761405|NCT02853019|cognition|cognition
4761406|NCT02853019|schizophrenia|schizophrenia
4761407|NCT02853006|Cancer lung|cancer lung
4761408|NCT02853006|Fluids|fluids
4761409|NCT02853006|LungCancerTest|lungcancertest
4761410|NCT02853006|radiological anomalies|radiological anomalies
4761411|NCT02853006|non-cancerous|non-cancerous
4761412|NCT02853006|carriers|carriers
4761413|NCT02853006|Patient reference|patient reference
4761414|NCT02852993|Erythrocyte Transfusion|erythrocyte transfusion
4761415|NCT02852993|Survival|survival
4761416|NCT02852967|Skin Diseases|skin diseases
4761417|NCT02852967|Auto-Immune Diseases|auto-immune diseases
4761418|NCT02852967|Plaque|plaque
4761419|NCT02852967|Dermatology|dermatology
4761420|NCT02852954|Progesterone Induced Blocking Factor|progesterone induced blocking factor
4761421|NCT02852954|Endometrial Cancer|endometrial cancer
4761422|NCT02852941|Impedance|impedance
4761423|NCT02852941|Kidney Transplantation|kidney transplantation
4761424|NCT02852928|ILD; chILD|ild; child
4761425|NCT02852915|Colonic Neoplasms|colonic neoplasms
4761426|NCT02852915|Laparoscopic Surgery|laparoscopic surgery
4761427|NCT02852915|T4|t4
4761428|NCT02852902|Bloodstream infections caused by MDR Enterobacteriaceae|bloodstream infections caused by mdr enterobacteriaceae
4761429|NCT02852902|Extended-spectrum β-lactamase-producers|extended-spectrum β-lactamase-producers
4761430|NCT02852902|Carbapenemase-producing organisms|carbapenemase-producing organisms
4761431|NCT02852902|Solid Organ Transplantation|solid organ transplantation
4761432|NCT02852902|Multidrug-resistant Enterobacteriaceae|multidrug-resistant enterobacteriaceae
4761433|NCT02852902|Anti-Infective Agents|anti-infective agents
4761434|NCT02852889|internal jugular vein distensibility,haemodynamics|internal jugular vein distensibility,haemodynamics
4761435|NCT02852876|Safety of ASP2151|safety of asp2151
4761436|NCT02852876|Phase 1|phase 1
4761437|NCT02852876|Pharmacokinetics|pharmacokinetics
4761438|NCT02852876|Healthy male subjects|healthy male subjects
4761439|NCT02852876|Tolerability|tolerability
4761440|NCT02852876|Food effect of ASP2151|food effect of asp2151
4761441|NCT02852811|Climacteric|climacteric
4761442|NCT02852811|Education|education
4761443|NCT02852811|Mental health|mental health
4761444|NCT02852811|Menopause|menopause
4761445|NCT02852772|Cognitive impairment|cognitive impairment
4761446|NCT02852772|HIV|hiv
4761447|NCT02852772|Microalbuminuria|microalbuminuria
4761448|NCT02852772|Chronic kidney disease|chronic kidney disease
4761449|NCT02852720|Pharmacokinetics|pharmacokinetics
4761450|NCT02852720|levobupivacaine|levobupivacaine
4761451|NCT02852720|Pregnancy|pregnancy
4761452|NCT02852720|Cesarean section|cesarean section
4761453|NCT02852720|Electrocardiography|electrocardiography
4761454|NCT02852668|elderly|elderly
4761455|NCT02852668|strength training|strength training
4761456|NCT02852668|power training|power training
4761457|NCT02852668|functional capacity|functional capacity
4761458|NCT02852668|gait biomechanics|gait biomechanics
4761459|NCT02852655|Brain Tumor|brain tumor
4761460|NCT02852642|power training|power training
4761461|NCT02852642|plyometric training|plyometric training
4761462|NCT02852642|functional capacity|functional capacity
4761463|NCT02852629|decision-support sheet|decision-support sheet
4761464|NCT02852616|Course|course
4761465|NCT02852616|Posttraumatic Stress Disorder|posttraumatic stress disorder
4761466|NCT02852616|Narrative Exposure Therapy|narrative exposure therapy
4761467|NCT02852603|dissection|dissection
4761468|NCT02852603|aneurysm|aneurysm
4761469|NCT02852603|thoracic aorta|thoracic aorta
4761470|NCT02852590|Observational|observational
4761471|NCT02852590|Pediatric|pediatric
4761472|NCT02852590|Off-Label Use|off-label use
4761473|NCT02852590|Unlicensed drug use|unlicensed drug use
4761474|NCT02852590|Adverse Drug Reaction|adverse drug reaction
4761475|NCT02852590|Hospitalized Children|hospitalized children
4761476|NCT02852590|Pediatric inpatients|pediatric inpatients
4761477|NCT02852577|panic disorder|panic disorder
4761478|NCT02852577|agoraphobia|agoraphobia
4761479|NCT02852577|clonazepam|clonazepam
4761480|NCT02852577|paroxetine|paroxetine
4761481|NCT02852564|Non-Muscle|non-muscle
4761482|NCT02852564|Invasive|invasive
4761483|NCT02852564|Bladder|bladder
4761484|NCT02852564|Cancer|cancer
4761485|NCT02852564|Muscle|muscle
4761486|NCT02852564|Surgery|surgery
4761487|NCT02852564|Transurethral|transurethral
4761488|NCT02852564|Resection|resection
4761489|NCT02852564|Tumor|tumor
4761490|NCT02852564|Ethacrynic|ethacrynic
4761491|NCT02852564|Acid|acid
4761492|NCT02852564|Mitomycin|mitomycin
4761493|NCT02852564|Urine|urine
4761494|NCT02852564|NMIBC|nmibc
4761495|NCT02852512|Laparoscopic Sacrocolpopexy|laparoscopic sacrocolpopexy
4761496|NCT02852512|Robotic Assisted Sacrocolpopexy|robotic assisted sacrocolpopexy
4761497|NCT02852512|Pelvic Organ Prolapse|pelvic organ prolapse
4761498|NCT02852499|environmental epidemiology|environmental epidemiology
4761499|NCT02852499|cohort|cohort
4761500|NCT02852499|atmospheric pollutant|atmospheric pollutant
4761501|NCT02852499|chemical pollutant|chemical pollutant
4761502|NCT02852499|growth, neuro-development, respiratory health|growth, neuro-development, respiratory health
4761503|NCT02852499|big data|big data
4761504|NCT02852499|biological samples (RNA, DNA, urines ...)|biological samples (rna, dna, urines ...)
4761505|NCT02852499|e-dohad and exposome|e-dohad and exposome
4761506|NCT02852486|BCR-ABL Positive|bcr-abl positive
4761507|NCT02852486|Leukemia, Chronic Myeloid|leukemia, chronic myeloid
4761508|NCT02852486|Imatinib|imatinib
4761509|NCT02852486|Pioglitazone|pioglitazone
4761510|NCT02852473|Continuous Positive Airway Pressure|continuous positive airway pressure
4761511|NCT02852473|Radiotherapy|radiotherapy
4761512|NCT02852473|Proton Therapy|proton therapy
4761513|NCT02852382|scalp block|scalp block
4761514|NCT02852382|local infiltration|local infiltration
4761515|NCT02852330|Voltage tomography|voltage tomography
4761516|NCT02852304|liver|liver
4761517|NCT02852304|transplant|transplant
4761518|NCT02852304|Lysosomal Acid Lipase|lysosomal acid lipase
4761519|NCT02852278|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
4761520|NCT02852278|ALS|als
4761521|NCT02852278|motor neuron diseases|motor neuron diseases
4761522|NCT02852278|Progressive Muscular Atrophy|progressive muscular atrophy
4761523|NCT02852278|Primary Lateral Sclerosis|primary lateral sclerosis
4761524|NCT02852278|Hereditary Spastic Paraplegia|hereditary spastic paraplegia
4761525|NCT02852265|oral contraceptive|oral contraceptive
4761526|NCT02852265|contraceptive implant|contraceptive implant
4761527|NCT02852265|contraception|contraception
4761529|NCT02852265|adverse event|adverse event
4761530|NCT02852239|Renal impairment|renal impairment
4761531|NCT02852239|Healthy volunteers|healthy volunteers
4761532|NCT02852239|Clinical pharmacology study|clinical pharmacology study
4761533|NCT02852239|DRB436|drb436
4761534|NCT02852239|dabrafenib|dabrafenib
4761535|NCT02852239|normal renal function|normal renal function
4761536|NCT02852239|impaired renal function|impaired renal function
4761537|NCT02852213|AADC|aadc
4761538|NCT02852213|gene therapy|gene therapy
4761539|NCT02852187|Intervertebral Disc Degeneration|intervertebral disc degeneration
4761540|NCT02852187|Lumbar Spinal Disease|lumbar spinal disease
4761541|NCT02852148|Wound|wound
4761542|NCT02852148|Pressure Ulcer|pressure ulcer
4761543|NCT02852148|Diabetic Foot Ulcer|diabetic foot ulcer
4761544|NCT02852148|Venous Leg Ulcer|venous leg ulcer
4761545|NCT02852148|Burn|burn
4761546|NCT02852148|Quality of Life|quality of life
4761547|NCT02852135|Laryngeal Mask Airway|laryngeal mask airway
4761548|NCT02852135|lateral position|lateral position
4761549|NCT02852135|laparoscopic surgery|laparoscopic surgery
4761550|NCT02852122|prostate cancer|prostate cancer
4761551|NCT02852122|C11 Choline PET/MR|c11 choline pet/mr
4761552|NCT02852122|staging|staging
4761553|NCT02852122|biochemical failure|biochemical failure
4761554|NCT02852096|gastric cancer|gastric cancer
4761555|NCT02852096|Her2/neu|her2/neu
4761556|NCT02852096|dual paraffin blocks|dual paraffin blocks
4761557|NCT02852096|trastuzumab|trastuzumab
4761558|NCT02852070|bronchoalveolar lavage|bronchoalveolar lavage
4761559|NCT02852070|lower respiratory tract infections|lower respiratory tract infections
4761560|NCT02851979|premature newborns|premature newborns
4761561|NCT02851979|apneas prevention|apneas prevention
4761562|NCT02851979|olfactory stimulation|olfactory stimulation
4761563|NCT02851979|latin square design|latin square design
4761564|NCT02851966|Non-obstructive Azoospermia|non-obstructive azoospermia
4761565|NCT02851966|Sperm Retrieval|sperm retrieval
4761566|NCT02851966|Infertility, Male|infertility, male
4761567|NCT02851966|Semen|semen
4761568|NCT02851966|Biomarkers|biomarkers
4761569|NCT02851966|Proteomics|proteomics
4761570|NCT02851966|Enzyme-Linked Immunosorbent Assay|enzyme-linked immunosorbent assay
4761571|NCT02851953|cervix, cervical dilation, balloon catheter|cervix, cervical dilation, balloon catheter
4761572|NCT02851940|Pain|pain
4761573|NCT02851940|Bleeding|bleeding
4761574|NCT02851940|Hemorrhoids|hemorrhoids
4761575|NCT02851940|Band Ligation|band ligation
4761576|NCT02851940|hypertonic saline sclerotherapy|hypertonic saline sclerotherapy
4761577|NCT02851836|attachment|attachment
4761578|NCT02851836|adolescent|adolescent
4761579|NCT02851836|picture|picture
4761580|NCT02851823|Er-YAG lasers|er-yag lasers
4761581|NCT02851823|Nd-YAG lasers|nd-yag lasers
4761582|NCT02851823|chronic periodontitis|chronic periodontitis
4761583|NCT02851823|nonsurgical periodontal debridement|nonsurgical periodontal debridement
4761584|NCT02851810|attachment|attachment
4761585|NCT02851810|oculomotor marker|oculomotor marker
4761586|NCT02851810|emotion regulation|emotion regulation
4761587|NCT02851784|hepatocellular carcinoma|hepatocellular carcinoma
4761588|NCT02851784|ablation|ablation
4761589|NCT02851784|immunotherapy|immunotherapy
4761590|NCT02851784|cytokine induced kill cell|cytokine induced kill cell
4761591|NCT02851732|Quality Improvement|quality improvement
4761592|NCT02851732|Cluster Analysis|cluster analysis
4761593|NCT02851719|Urinary Incontinence, Stress|urinary incontinence, stress
4761594|NCT02851719|Pelvic Floor|pelvic floor
4761595|NCT02851719|Exercise|exercise
4761596|NCT02851719|Patient Compliance|patient compliance
4761597|NCT02851706|Brain Tumor|brain tumor
4761599|NCT02851706|Astrocytoma|astrocytoma
4761600|NCT02851706|Brain Cancer|brain cancer
4761601|NCT02851706|Spine Cander|spine cander
4761602|NCT02851615|Anemia, Sickle Cell|anemia, sickle cell
4761603|NCT02851615|Self Care|self care
4761604|NCT02851615|Adolescent|adolescent
4761605|NCT02851615|Young Adult|young adult
4761606|NCT02851615|Disease Management|disease management
4761607|NCT02851615|Behavioral Activation|behavioral activation
4761608|NCT02851615|Peer Communication|peer communication
4761609|NCT02851576|Adenovirus|adenovirus
4761610|NCT02851550|liver|liver
4761611|NCT02851550|transplant|transplant
4761612|NCT02851550|Lysosomal Acid Lipase|lysosomal acid lipase
4761613|NCT02851472|TRAGI (transfusion related acute gut injury)|tragi (transfusion related acute gut injury)
4761614|NCT02851472|inhaled nitric oxide (iNO)|inhaled nitric oxide (ino)
4761615|NCT02851472|prematurity|prematurity
4761616|NCT02851472|PRBC transfusion|prbc transfusion
4761617|NCT02851472|NEC (necrotizing enterocolitis)|nec (necrotizing enterocolitis)
4761618|NCT02851472|NIRS (near infrared spectroscopy)|nirs (near infrared spectroscopy)
4761619|NCT02851472|ELGAN (extremely low gestational age neonate)|elgan (extremely low gestational age neonate)
4761620|NCT02851459|Vaccines|vaccines
4761621|NCT02851407|stem cell transplant|stem cell transplant
4761622|NCT02851407|hematopoietic stem cell transplant (HSCT)|hematopoietic stem cell transplant (hsct)
4761623|NCT02851407|veno-occlusive disease (VOD)|veno-occlusive disease (vod)
4761624|NCT02851407|sinosoidial obstruction syndrome (SOS)|sinosoidial obstruction syndrome (sos)
4761625|NCT02851368|Indocyanine Green|indocyanine green
4761916|NCT02849522|IPSS Score|ipss score
4761626|NCT02851368|Fluorescence Imaging|fluorescence imaging
4761627|NCT02851342|Cognition|cognition
4761628|NCT02851342|MEG|meg
4761629|NCT02851329|stage IV EGFR-mutant|stage iv egfr-mutant
4761630|NCT02851329|EGFR TKIs|egfr tkis
4761631|NCT02851329|progression-free survival|progression-free survival
4761632|NCT02851329|prognosis|prognosis
4761633|NCT02851329|computed tomography|computed tomography
4761634|NCT02851290|Hypospadias|hypospadias
4761635|NCT02851290|Caudal block|caudal block
4761636|NCT02851290|Dorsal penile nerve block|dorsal penile nerve block
4761637|NCT02851290|Anesthesia|anesthesia
4761638|NCT02851290|Urethrocutaneous fistula|urethrocutaneous fistula
4761639|NCT02851290|Urethral stricture|urethral stricture
4761640|NCT02851290|Meatal stenosis|meatal stenosis
4761641|NCT02851290|Glanular dehiscence|glanular dehiscence
4761642|NCT02851277|Peanut Allergy|peanut allergy
4761643|NCT02851277|ASP0892|asp0892
4761644|NCT02851264|Early Esophageal Squamous Neoplasia|early esophageal squamous neoplasia
4761645|NCT02851264|optical enhancement technology|optical enhancement technology
4761646|NCT02851264|virtual chromoendoscopy|virtual chromoendoscopy
4761647|NCT02851251|eye disease|eye disease
4761648|NCT02851251|neonatal eye disease|neonatal eye disease
4761649|NCT02851251|newborn|newborn
4761650|NCT02851251|screening|screening
4761651|NCT02851251|multicenter|multicenter
4761652|NCT02851134|genetic|genetic
4761653|NCT02851121|Neurophysiological|neurophysiological
4761654|NCT02851121|Perception-action|perception-action
4761655|NCT02851121|Link|link
4761656|NCT02851108|falciparum malaria|falciparum malaria
4761657|NCT02851108|sub saharan|sub saharan
4761658|NCT02851108|africa|africa
4761659|NCT02851108|elimination disorder|elimination disorder
4761660|NCT02851082|Training Program|training program
4761661|NCT02851082|Endurance|endurance
4761662|NCT02851082|Von Willebrand factor|von willebrand factor
4761663|NCT02851069|Chronic Hepatitis C|chronic hepatitis c
4761664|NCT02851069|Paritaprevir/r - Ombitasvir, ± Dasabuvir|paritaprevir/r - ombitasvir, ± dasabuvir
4761665|NCT02851069|Sustained Virological Response|sustained virological response
4761666|NCT02851069|Observational Study|observational study
4761667|NCT02851069|Chronic Hepatitis C genotype 1|chronic hepatitis c genotype 1
4761668|NCT02851056|Myeloma|myeloma
4761669|NCT02851056|Vaccine|vaccine
4761670|NCT02851056|Dendritic cell|dendritic cell
4761671|NCT02851056|autologous hematopoietic cell transplant|autologous hematopoietic cell transplant
4761672|NCT02851056|HCT|hct
4761673|NCT02851030|Child, Preschool|child, preschool
4761674|NCT02851030|Child Care|child care
4761675|NCT02850991|Esophageal cancer, radiation, chemotherapy|esophageal cancer, radiation, chemotherapy
4761676|NCT02850939|Breast cancer|breast cancer
4761677|NCT02850939|Endocrine hormonal therapy|endocrine hormonal therapy
4761678|NCT02850939|mHealth|mhealth
4761679|NCT02850926|Concussion|concussion
4761680|NCT02850926|Soccer|soccer
4761681|NCT02850926|Adolescent|adolescent
4761682|NCT02850874|hyperthermic intraperitoneal chemotherapy|hyperthermic intraperitoneal chemotherapy
4761683|NCT02850874|perioperative systemic chemotherapy|perioperative systemic chemotherapy
4761684|NCT02850874|peritoneal disease|peritoneal disease
4761685|NCT02850848|Pharmacokinetic|pharmacokinetic
4761686|NCT02850835|Decision Aid|decision aid
4761687|NCT02850835|Pelvic Organ Prolapse (POP)|pelvic organ prolapse (pop)
4761688|NCT02850822|chemotherapy|chemotherapy
4761689|NCT02850809|radiofrequency ablation|radiofrequency ablation
4761690|NCT02850809|complications|complications
4761691|NCT02850796|Mindfulness|mindfulness
4761692|NCT02850796|self-compassion|self-compassion
4761693|NCT02850796|Acceptance and Commitment Therapy|acceptance and commitment therapy
4761694|NCT02850796|weight self-stigma|weight self-stigma
4761695|NCT02850796|quality-of-life|quality-of-life
4761696|NCT02850783|colon cancer|colon cancer
4761697|NCT02850757|Modified William's airway|modified william's airway
4761698|NCT02850757|fiberoptic bronchoscope|fiberoptic bronchoscope
4761699|NCT02850757|U shape Guedls airway|u shape guedls airway
4761700|NCT02850757|oral airways|oral airways
4761701|NCT02850757|efficacy and safety|efficacy and safety
4761702|NCT02850705|Neuromyelitis Optica|neuromyelitis optica
4761703|NCT02850705|Myelitis|myelitis
4761704|NCT02850705|Optic Neuritis|optic neuritis
4761705|NCT02850705|autoantibody|autoantibody
4761706|NCT02850705|demyelination|demyelination
4761707|NCT02850679|Atrial Fibrillation|atrial fibrillation
4761708|NCT02850679|Cardioversion|cardioversion
4761709|NCT02850666|social skills|social skills
4761710|NCT02850666|child|child
4761711|NCT02850666|theory of mind|theory of mind
4761712|NCT02850666|drama|drama
4761713|NCT02850666|occupational therapy|occupational therapy
4761714|NCT02850666|Speech-language pathology|speech-language pathology
4761715|NCT02850653|Acute Endophthalmitis.|acute endophthalmitis.
4761716|NCT02850653|PCR|pcr
4761717|NCT02850653|Ocular sampling|ocular sampling
4761718|NCT02850627|acute coronary syndrome|acute coronary syndrome
4761719|NCT02850627|Tongguan capsule|tongguan capsule
4761720|NCT02850627|miRNAs|mirnas
4761721|NCT02850601|Oral lichen planus|oral lichen planus
4761722|NCT02850601|Dexamethasone solution|dexamethasone solution
4761723|NCT02850562|body composition,|body composition,
4761724|NCT02850562|Dual-Energy X-Ray Absorptiometry|dual-energy x-ray absorptiometry
4761726|NCT02850562|peripheral quantitative computed tomography|peripheral quantitative computed tomography
4761727|NCT02850562|muscle density|muscle density
4761728|NCT02850562|elderly|elderly
4761729|NCT02850549|neck pain|neck pain
4761730|NCT02850549|cervical|cervical
4761731|NCT02850549|classification|classification
4761732|NCT02850549|outcomes|outcomes
4761733|NCT02850549|physical therapy|physical therapy
4761734|NCT02850536|Colorectal Cancer|colorectal cancer
4761735|NCT02850536|Liver Metastases|liver metastases
4761736|NCT02850536|Breast Cancer|breast cancer
4761737|NCT02850536|Gastric Cancer|gastric cancer
4761738|NCT02850536|Pancreas Cancer|pancreas cancer
4761739|NCT02850536|Carcinoembryonic antigen|carcinoembryonic antigen
4761740|NCT02850536|CAR-T|car-t
4761741|NCT02850536|Immunotherapy|immunotherapy
4761742|NCT02850510|Harsh discipline|harsh discipline
4761743|NCT02850510|parental competence|parental competence
4761744|NCT02850510|positive parenting|positive parenting
4761745|NCT02850497|optical coherence tomography|optical coherence tomography
4761746|NCT02850497|malapposition|malapposition
4761747|NCT02850497|endothelization|endothelization
4761748|NCT02850471|Postoperative pulmonary complications|postoperative pulmonary complications
4761749|NCT02850471|Transcutaneous electric acupoint stimulation|transcutaneous electric acupoint stimulation
4761750|NCT02850471|pulmonary protection|pulmonary protection
4761751|NCT02850432|Magnetic resonance imaging|magnetic resonance imaging
4761752|NCT02850432|Extracellular volume matrix fraction|extracellular volume matrix fraction
4761753|NCT02850432|Peripheral artery disease|peripheral artery disease
4761754|NCT02850432|Blood-oxygen level dependent|blood-oxygen level dependent
4761755|NCT02850432|Cardiac function|cardiac function
4761756|NCT02850393|suppression mnemonic|suppression mnemonic
4761757|NCT02850393|emotional response|emotional response
4761758|NCT02850393|inhibitory control of failures|inhibitory control of failures
4761759|NCT02850393|neurological alterations|neurological alterations
4761760|NCT02850341|Physical Activity|physical activity
4761761|NCT02850341|Mental Health|mental health
4761762|NCT02850341|Health Behavior|health behavior
4761763|NCT02850341|Walking|walking
4761764|NCT02850341|Physical Exercise|physical exercise
4761765|NCT02850341|Mental disorder|mental disorder
4761766|NCT02850315|optimal coherence tomography|optimal coherence tomography
4761767|NCT02850315|myocardial reperfusion|myocardial reperfusion
4761768|NCT02850276|HIV disease|hiv disease
4761769|NCT02850276|gastrointestinal problems|gastrointestinal problems
4761770|NCT02850263|Diabetic Retinopathy|diabetic retinopathy
4761771|NCT02850263|Diabetic Macular Oedema|diabetic macular oedema
4761772|NCT02850263|Diabetic Macular Edema|diabetic macular edema
4761773|NCT02850263|Aflibercept|aflibercept
4761774|NCT02850250|Observational|observational
4761775|NCT02850250|pharmacokinetic|pharmacokinetic
4761776|NCT02850250|cardiac|cardiac
4761777|NCT02850250|Cefuroxime|cefuroxime
4761778|NCT02850250|Paediatric|paediatric
4761779|NCT02850237|cerebral saturation|cerebral saturation
4761780|NCT02850237|capnography|capnography
4761781|NCT02850237|pre-hospital|pre-hospital
4761782|NCT02850198|ischemic stroke|ischemic stroke
4761783|NCT02850185|COPD|copd
4761784|NCT02850185|hydrogen|hydrogen
4761785|NCT02850172|nutrition|nutrition
4761786|NCT02850172|exercise|exercise
4761787|NCT02850172|inspiratory muscle training|inspiratory muscle training
4761788|NCT02850146|tau|tau
4761789|NCT02850146|cognition|cognition
4761790|NCT02850146|longitudinal|longitudinal
4761791|NCT02850146|cognitive decline|cognitive decline
4761792|NCT02850146|observational|observational
4761793|NCT02850146|imaging|imaging
4761794|NCT02850120|surgical mesh|surgical mesh
4761795|NCT02850120|observational study|observational study
4761796|NCT02850120|intraoperative complications|intraoperative complications
4761797|NCT02850120|postoperative complications|postoperative complications
4761798|NCT02850107|Atherectomy, Drug-Coated Balloon|atherectomy, drug-coated balloon
4761799|NCT02850094|Physical activity|physical activity
4761800|NCT02850094|Exercise|exercise
4761801|NCT02850094|Financial Incentives|financial incentives
4761802|NCT02850081|Carotid endarterectomy|carotid endarterectomy
4761803|NCT02850081|CEA|cea
4761804|NCT02850081|stroke|stroke
4761805|NCT02850081|asymptomatic stenosis|asymptomatic stenosis
4761806|NCT02850055|physiotherapy, Temporomandibular Joint Disorder, tinnitus.|physiotherapy, temporomandibular joint disorder, tinnitus.
4761807|NCT02850042|motor recovery|motor recovery
4761808|NCT02850042|human|human
4761809|NCT02850042|occupation-based practice|occupation-based practice
4761810|NCT02850042|motor training|motor training
4761811|NCT02850042|transcranial magnetic stimulation|transcranial magnetic stimulation
4761812|NCT02850029|antimicrobial|antimicrobial
4761813|NCT02850029|intensive care units|intensive care units
4761814|NCT02850016|Romidepsin|romidepsin
4761815|NCT02850016|3BNC117|3bnc117
4761816|NCT02850016|Broadly neutralizing antibody|broadly neutralizing antibody
4761817|NCT02849977|POMC|pomc
4761818|NCT02849977|PCSK1|pcsk1
4761819|NCT02849977|Pro-opiomelanocortin|pro-opiomelanocortin
4761820|NCT02849964|Incidence|incidence
4761821|NCT02849964|Renal Replacement Therapy|renal replacement therapy
4761822|NCT02849964|Socioeconomic Factors|socioeconomic factors
4761823|NCT02849964|Clinical Practice Pattern|clinical practice pattern
4761824|NCT02849951|Colitis|colitis
4761825|NCT02849951|Colitis, Ulcerative|colitis, ulcerative
4761826|NCT02849951|Ulcer|ulcer
4761827|NCT02849951|Colonic Diseases|colonic diseases
4761828|NCT02849951|Digestive System Diseases|digestive system diseases
4761829|NCT02849951|Gastroenteritis|gastroenteritis
4761830|NCT02849951|Gastrointestinal Diseases|gastrointestinal diseases
4761831|NCT02849951|Inflammatory Bowel Diseases|inflammatory bowel diseases
4761832|NCT02849951|Intestinal Diseases|intestinal diseases
4761833|NCT02849951|Pathologic Processes|pathologic processes
4761834|NCT02849951|Mesalamine|mesalamine
4761835|NCT02849938|children with medical complexity|children with medical complexity
4761836|NCT02849938|Telemedicine|telemedicine
4761837|NCT02849938|Tracheostomy|tracheostomy
4761838|NCT02849925|Pit and Fissure Sealants|pit and fissure sealants
4761839|NCT02849925|Caries|caries
4761840|NCT02849925|Glass ionomer|glass ionomer
4761841|NCT02849925|Resin|resin
4761842|NCT02849886|GvHD|gvhd
4761843|NCT02849886|Suicide gene|suicide gene
4761844|NCT02849886|Dimerizer drug AP1903|dimerizer drug ap1903
4761845|NCT02849886|Hematological stem cell transplantation|hematological stem cell transplantation
4761846|NCT02849834|Neuropathic Pain|neuropathic pain
4761847|NCT02849834|Stimulation of the Motor Cortex (SCM)|stimulation of the motor cortex (scm)
4761848|NCT02849834|Pharmacoresistant|pharmacoresistant
4761849|NCT02849834|rTMS|rtms
4761850|NCT02849808|Corneal Transplantation|corneal transplantation
4761851|NCT02849795|Obesity, Abdominal|obesity, abdominal
4761852|NCT02849795|Adipokines|adipokines
4761853|NCT02849795|Risk of cardiovascular diseases|risk of cardiovascular diseases
4761854|NCT02849782|Gait analysis|gait analysis
4761855|NCT02849782|Fampridine|fampridine
4761856|NCT02849782|Fatigue|fatigue
4761857|NCT02849782|Daily activity|daily activity
4761858|NCT02849782|Cognition|cognition
4761859|NCT02849756|Intensive care|intensive care
4761860|NCT02849756|elderly|elderly
4761861|NCT02849756|autonomy|autonomy
4761862|NCT02849756|Future|future
4761863|NCT02849756|older patients|older patients
4761864|NCT02849756|intensive care unit|intensive care unit
4761865|NCT02849743|oxytocin|oxytocin
4761866|NCT02849743|hypothalamic obesity|hypothalamic obesity
4761867|NCT02849743|craniopharyngioma|craniopharyngioma
4761868|NCT02849743|metabolism|metabolism
4761869|NCT02849730|Epi-PCA|epi-pca
4761870|NCT02849730|Patient controlled analgesia|patient controlled analgesia
4761871|NCT02849730|Epidural patient controlled analgesia|epidural patient controlled analgesia
4761872|NCT02849730|Elderly patient|elderly patient
4761873|NCT02849730|Side effect|side effect
4761874|NCT02849730|Postoperative pain|postoperative pain
4761875|NCT02849704|Chronic Pancreatitis|chronic pancreatitis
4761876|NCT02849704|Pancreatic Function|pancreatic function
4761877|NCT02849704|Reduced Exocrine Pancreatic Function|reduced exocrine pancreatic function
4761878|NCT02849704|Pancreatic Insufficiency|pancreatic insufficiency
4761879|NCT02849678|Postoperative Pain|postoperative pain
4761880|NCT02849678|Bowel Surgery|bowel surgery
4761881|NCT02849678|Regional Anesthesia|regional anesthesia
4761882|NCT02849665|Kangaroo-Mother Care Method; child development|kangaroo-mother care method; child development
4761883|NCT02849652|Smoking cessation|smoking cessation
4761884|NCT02849652|Nicotine dependence|nicotine dependence
4761885|NCT02849652|Organizational change|organizational change
4761886|NCT02849652|Mental Healthcare|mental healthcare
4761887|NCT02849626|Partial-Onset Seizures|partial-onset seizures
4761888|NCT02849626|Primary Generalized Tonic-Clonic Seizures|primary generalized tonic-clonic seizures
4761889|NCT02849626|Adjunctive Therapy|adjunctive therapy
4761890|NCT02849626|Epilepsy|epilepsy
4761891|NCT02849613|cell therapy|cell therapy
4761892|NCT02849613|stem cell|stem cell
4761893|NCT02849613|transplantation|transplantation
4761894|NCT02849613|graft|graft
4761895|NCT02849613|recovery|recovery
4761896|NCT02849613|repair|repair
4761897|NCT02849613|stroke|stroke
4761898|NCT02849613|mesenchymal stem cell|mesenchymal stem cell
4761899|NCT02849613|regenerative|regenerative
4761900|NCT02849600|Vital pulp therapy,Young permanent tooth,Treatment outcome|vital pulp therapy,young permanent tooth,treatment outcome
4761901|NCT02849587|Driving Under the Influence|driving under the influence
4761902|NCT02849587|Memory Impairment|memory impairment
4761903|NCT02849587|Reaction Time|reaction time
4761904|NCT02849587|Time Perception|time perception
4761905|NCT02849561|Pupillary light reflex|pupillary light reflex
4761906|NCT02849561|Cardio respiratory arrest|cardio respiratory arrest
4761907|NCT02849535|Oral chemotherapy|oral chemotherapy
4761908|NCT02849535|Relative dose intensity|relative dose intensity
4761909|NCT02849535|Health related program|health related program
4761910|NCT02849535|Secured drug intake|secured drug intake
4761911|NCT02849522|Lower Urinary Tract Symptoms caused by Benign Prostatic Enlargement (LUTS BPE)|lower urinary tract symptoms caused by benign prostatic enlargement (luts bpe)
4761912|NCT02849522|Prostate Artery Embolisation (PAE)|prostate artery embolisation (pae)
4761913|NCT02849522|Transurethral Resection of the Prostate (TURP)|transurethral resection of the prostate (turp)
4761914|NCT02849522|Open prostatectomy|open prostatectomy
4761915|NCT02849522|Laser enucleation or ablation of the prostate (Green Light, KTP, HoLEP)|laser enucleation or ablation of the prostate (green light, ktp, holep)
4761917|NCT02849522|IIEF Score|iief score
4761918|NCT02849522|Complications|complications
4761919|NCT02849522|Quality of Life|quality of life
4761920|NCT02849483|PONV|ponv
4761921|NCT02849483|digestive signs and symptoms|digestive signs and symptoms
4761922|NCT02849483|vomiting|vomiting
4761923|NCT02849483|antiemetics|antiemetics
4761924|NCT02849483|nausea|nausea
4761925|NCT02849483|ramosetron|ramosetron
4761926|NCT02849470|Adipose Stem/Stromal Cells|adipose stem/stromal cells
4761927|NCT02849470|PRP|prp
4761928|NCT02849470|SVF|svf
4761929|NCT02849470|Cell Therapy|cell therapy
4761930|NCT02849470|Alopecia|alopecia
4761931|NCT02849470|GF|gf
4761932|NCT02849444|renal function|renal function
4761933|NCT02849444|Relapsed Multiple myeloma|relapsed multiple myeloma
4761934|NCT02849444|anti-MM therapy|anti-mm therapy
4761935|NCT02849431|mindfulness|mindfulness
4761936|NCT02849418|Botulinum toxin type A|botulinum toxin type a
4761937|NCT02849418|Urinary Incontinence|urinary incontinence
4761938|NCT02849418|Neurogenic Detrusor Overactivity|neurogenic detrusor overactivity
4761939|NCT02849392|Pistachio|pistachio
4761940|NCT02849392|Body composition|body composition
4761941|NCT02849392|Erythrocyte membrane incorporation of fatty acids|erythrocyte membrane incorporation of fatty acids
4761942|NCT02849392|Dietary quality/micronutrient quality|dietary quality/micronutrient quality
4761943|NCT02849392|Blood lipids|blood lipids
4761944|NCT02849392|Inflammatory markers|inflammatory markers
4761945|NCT02849392|Bone density|bone density
4761946|NCT02849392|Bone turnover markers|bone turnover markers
4761947|NCT02849392|Satiety|satiety
4761948|NCT02849379|tongue cancer|tongue cancer
4761949|NCT02849379|cryosurgery|cryosurgery
4761950|NCT02849379|NK immunotherapy|nk immunotherapy
4761951|NCT02849366|Sarcoma|sarcoma
4761952|NCT02849366|Cryosurgery|cryosurgery
4761953|NCT02849366|NK Immunotherapy|nk immunotherapy
4761954|NCT02849353|Ovarian Cancer|ovarian cancer
4761955|NCT02849353|cryosurgery|cryosurgery
4761956|NCT02849353|NK immunotherapy|nk immunotherapy
4761957|NCT02849340|Cervical Cancer|cervical cancer
4761958|NCT02849340|cryosurgery|cryosurgery
4761959|NCT02849340|NK immunotherapy|nk immunotherapy
4761960|NCT02849327|Pharyngeal cancer|pharyngeal cancer
4761961|NCT02849327|Cryosurgery|cryosurgery
4761962|NCT02849327|NK immunotherapy|nk immunotherapy
4761963|NCT02849314|laryngeal cancer|laryngeal cancer
4761964|NCT02849314|cryosurgery|cryosurgery
4761965|NCT02849314|NK immunotherapy|nk immunotherapy
4761967|NCT02849249|Immunotherapy|immunotherapy
4761968|NCT02849249|SCIT|scit
4761969|NCT02849236|PECS block,|pecs block,
4761970|NCT02849236|pectoral block,|pectoral block,
4761971|NCT02849236|breast augmentation|breast augmentation
4761972|NCT02849223|Mild Traumatic Brain Injury|mild traumatic brain injury
4761973|NCT02849223|Transcranial Direct Current Stimulation|transcranial direct current stimulation
4761974|NCT02849223|Working Memory|working memory
4761975|NCT02849197|pilonidal sinus|pilonidal sinus
4761976|NCT02849197|complication|complication
4761977|NCT02849197|recurrence|recurrence
4761978|NCT02849171|11C-Choline (11C-CH) PET|11c-choline (11c-ch) pet
4761979|NCT02849171|16-676|16-676
4761980|NCT02849171|High-grade Gliomas|high-grade gliomas
4761981|NCT02849158|Rectoscopy|rectoscopy
4761982|NCT02849158|Proctectomy|proctectomy
4761983|NCT02849158|Fibroblasts|fibroblasts
4761984|NCT02849145|Circulating tumor DNA|circulating tumor dna
4761985|NCT02849119|Robot; Laparoscopic|robot; laparoscopic
4761986|NCT02849119|Partial nephrectomy|partial nephrectomy
4761987|NCT02849119|Transperitoneal|transperitoneal
4761988|NCT02849119|Retroperitoneal|retroperitoneal
4761989|NCT02849119|Laparoscopic Surgery|laparoscopic surgery
4761990|NCT02849119|Surgical Procedures, Robotic|surgical procedures, robotic
4761991|NCT02849119|Nephrectomy|nephrectomy
4761992|NCT02849106|3D culture|3d culture
4761993|NCT02849106|chemogram|chemogram
4761994|NCT02849106|FOLFOX|folfox
4761995|NCT02849106|FOLFIRI|folfiri
4761996|NCT02849093|Optical coherence tomography|optical coherence tomography
4761997|NCT02849093|imaging of ocular structures|imaging of ocular structures
4761998|NCT02849067|ischaemic heart disease|ischaemic heart disease
4761999|NCT02849067|comedy session|comedy session
4762000|NCT02849067|laughter therapy|laughter therapy
4762001|NCT02849041|Circulating Tumor Cells|circulating tumor cells
4762002|NCT02849041|Lung|lung
4762003|NCT02849028|gut microbiota|gut microbiota
4762004|NCT02849028|sleep disorder|sleep disorder
4762005|NCT02849028|gut-brain axis|gut-brain axis
4762006|NCT02849028|circadian rhythm|circadian rhythm
4762007|NCT02849028|Traumatic Brain Injury|traumatic brain injury
4762008|NCT02849015|liver tumor|liver tumor
4762009|NCT02849015|cryosurgery|cryosurgery
4762010|NCT02849015|NK immunotherapy|nk immunotherapy
4762011|NCT02849002|Concussion|concussion
4762012|NCT02848989|Breast Cancer Surgery Pain|breast cancer surgery pain
4762013|NCT02848989|Breast Cancer|breast cancer
4762014|NCT02848950|Metformin|metformin
4762015|NCT02848950|fecundability|fecundability
4762016|NCT02848950|uterine doppler|uterine doppler
4762017|NCT02848937|calcium balance|calcium balance
4762018|NCT02848937|dialysis|dialysis
4762019|NCT02848937|concentrate with citrate|concentrate with citrate
4762020|NCT02848924|prevalence|prevalence
4762021|NCT02848924|surgery|surgery
4762022|NCT02848924|Treatments|treatments
4762023|NCT02848911|acute lymphoblastic leukemia|acute lymphoblastic leukemia
4762024|NCT02848898|Focal Vibrations|focal vibrations
4762025|NCT02848898|Neurorehabilitation|neurorehabilitation
4762026|NCT02848898|Spasticity|spasticity
4762027|NCT02848898|Multiple Sclerosis|multiple sclerosis
4762028|NCT02848885|Magnetic resonance imaging|magnetic resonance imaging
4762029|NCT02848885|Anosognosia|anosognosia
4762030|NCT02848885|Electrical stimulation of the brain|electrical stimulation of the brain
4762031|NCT02848872|Tumor-infiltrating lymphocytes (TILs)|tumor-infiltrating lymphocytes (tils)
4762032|NCT02848859|cognitive behavioral therapy for insomnia|cognitive behavioral therapy for insomnia
4762033|NCT02848859|randomized controlled trial|randomized controlled trial
4762034|NCT02848846|Amputees|amputees
4762035|NCT02848820|Appendicitis|appendicitis
4762036|NCT02848820|Appendectomy|appendectomy
4762037|NCT02848820|Antibiotics|antibiotics
4762038|NCT02848781|Sudden Cardiac Death|sudden cardiac death
4762039|NCT02848781|ICD Therapy|icd therapy
4762040|NCT02848781|VT Ablation|vt ablation
4762041|NCT02848690|Sodium restriction|sodium restriction
4762042|NCT02848690|Dietary sodium restriction questionnaire (DSRQ)|dietary sodium restriction questionnaire (dsrq)
4762043|NCT02848690|Low-sodium diet|low-sodium diet
4762044|NCT02848690|Adherence|adherence
4762045|NCT02848690|Educational intervention|educational intervention
4762046|NCT02848677|advanced glycation end-products|advanced glycation end-products
4762047|NCT02848677|Cardiovascular disease|cardiovascular disease
4762048|NCT02848677|Low Sodium Diet|low sodium diet
4762049|NCT02848677|vascular inflammation|vascular inflammation
4762050|NCT02848638|PET, Yttrium-90|pet, yttrium-90
4762051|NCT02848625|Idiopathic Pulmonary Fibrosis|idiopathic pulmonary fibrosis
4762052|NCT02848625|Yoga|yoga
4762053|NCT02848625|Quality of life|quality of life
4762054|NCT02848612|anticoagulation|anticoagulation
4762055|NCT02848612|aneurysmal subarachnoid haemorrhage|aneurysmal subarachnoid haemorrhage
4762056|NCT02848612|interventional neuroradiology|interventional neuroradiology
4762057|NCT02848612|coil embolization|coil embolization
4762058|NCT02848599|postoperative analgesia|postoperative analgesia
4762059|NCT02848599|postoperative cognitive disfunction|postoperative cognitive disfunction
4762060|NCT02848586|HIV|hiv
4762061|NCT02848586|ECIGS|ecigs
4762062|NCT02848586|e-cigarettes|e-cigarettes
4762063|NCT02848586|lung inflammation|lung inflammation
4762064|NCT02848560|Cystic Fibrosis|cystic fibrosis
4762065|NCT02848560|orkambi|orkambi
4762066|NCT02848560|129Xe MRI|129xe mri
4762067|NCT02848560|hyperpolarized xenon|hyperpolarized xenon
4762068|NCT02848560|LCI|lci
4762069|NCT02848560|CFTR modulator therapy|cftr modulator therapy
4762070|NCT02848534|fever|fever
4762071|NCT02848534|hyperthermia|hyperthermia
4762072|NCT02848534|inflammatory syndrome|inflammatory syndrome
4762073|NCT02848521|ADPKD|adpkd
4762074|NCT02848521|CKD|ckd
4762075|NCT02848521|Rapid progressor|rapid progressor
4762076|NCT02848521|quality of life|quality of life
4762077|NCT02848521|DCE|dce
4762078|NCT02848508|Metformin|metformin
4762079|NCT02848508|moderate renal failure|moderate renal failure
4762080|NCT02848508|severe renal failure|severe renal failure
4762081|NCT02848508|chronic kidney disease|chronic kidney disease
4762082|NCT02848508|hyperlactatemia|hyperlactatemia
4762083|NCT02848508|lactic acidosis|lactic acidosis
4762084|NCT02848495|Aneurysm|aneurysm
4762085|NCT02848495|Biocollection|biocollection
4762086|NCT02848495|Familial Form|familial form
4762087|NCT02848482|Photodynamic therapy|photodynamic therapy
4762088|NCT02848456|Manipulation, Spinal|manipulation, spinal
4762089|NCT02848456|H-Reflex|h-reflex
4762090|NCT02848456|Muscle Contraction|muscle contraction
4762091|NCT02848456|Muscle Strength Dynamometer|muscle strength dynamometer
4762092|NCT02848443|metastatic|metastatic
4762093|NCT02848443|colorectal|colorectal
4762094|NCT02848443|cancer|cancer
4762095|NCT02848443|oxaliplatin|oxaliplatin
4762096|NCT02848443|dose-escalation|dose-escalation
4762097|NCT02848443|Lonsurf|lonsurf
4762098|NCT02848443|nivolumab|nivolumab
4762099|NCT02848443|bevacizumab|bevacizumab
4762100|NCT02848430|Humulus lupulus|humulus lupulus
4762101|NCT02848404|Mild cognitive impairment|mild cognitive impairment
4762102|NCT02848404|Cognitive rehabilitation|cognitive rehabilitation
4762103|NCT02848404|Cognitive therapy|cognitive therapy
4762104|NCT02848404|Alzheimer's disease|alzheimer's disease
4762105|NCT02848404|Memory enhancement|memory enhancement
4762106|NCT02848404|Categorical language fluency|categorical language fluency
4762107|NCT02848378|Advanced Oxidation Protein Products|advanced oxidation protein products
4762108|NCT02848378|Gingival crevicular fluid|gingival crevicular fluid
4762109|NCT02848378|Monocyte chemoattractant protein-1|monocyte chemoattractant protein-1
4762110|NCT02848378|Periodontal Disease|periodontal disease
4762111|NCT02848365|Measurement|measurement
4762112|NCT02848248|Acute Myeloid Leukemia|acute myeloid leukemia
4762113|NCT02848248|Antibody-Drug Conjugate|antibody-drug conjugate
4762114|NCT02848248|CD123 Antigen|cd123 antigen
4762115|NCT02848248|Drug Therapy|drug therapy
4762116|NCT02848248|AML|aml
4762117|NCT02848248|Leukemia, Myeloid, Acute|leukemia, myeloid, acute
4762118|NCT02848235|Prevention of Mother to Child Transmission|prevention of mother to child transmission
4762119|NCT02848235|Antenatal Care for HIV positive women|antenatal care for hiv positive women
4762120|NCT02848235|Kenya|kenya
4762121|NCT02848222|contact lens discomfort|contact lens discomfort
4762122|NCT02848222|dry eye disease|dry eye disease
4762123|NCT02848222|meibomian gland dysfunction|meibomian gland dysfunction
4762124|NCT02848222|Bruder mask|bruder mask
4762125|NCT02848209|Peeling|peeling
4762126|NCT02848209|Histological skin changes|histological skin changes
4762127|NCT02848209|Trichloroacetic acid peel|trichloroacetic acid peel
4762128|NCT02848209|phenol/croton oil peel|phenol/croton oil peel
4762129|NCT02848170|essential hypertension|essential hypertension
4762130|NCT02848170|mineralocorticoid receptor antagonist|mineralocorticoid receptor antagonist
4762131|NCT02848170|Developmental Phase III|developmental phase iii
4762132|NCT02848157|dexmedetomidine|dexmedetomidine
4762133|NCT02848157|pudendal block|pudendal block
4762134|NCT02848157|hypospadias|hypospadias
4762135|NCT02848144|Immunoparalysis|immunoparalysis
4762136|NCT02848144|immune response|immune response
4762137|NCT02848144|sepsis|sepsis
4762138|NCT02848144|toxic shock syndrome|toxic shock syndrome
4762139|NCT02848118|Hypoventilation|hypoventilation
4762140|NCT02848118|capnography|capnography
4762141|NCT02848118|bronchoscopy|bronchoscopy
4762142|NCT02848105|aGVHD|agvhd
4762143|NCT02848105|valproic acid|valproic acid
4762144|NCT02848092|Visual Attention|visual attention
4762145|NCT02848092|Automobile Driving|automobile driving
4762146|NCT02848001|CC-90009|cc-90009
4762147|NCT02848001|Hematologic Cancers|hematologic cancers
4762148|NCT02848001|Leukemia|leukemia
4762149|NCT02848001|Acute Myeloid Leukemia|acute myeloid leukemia
4762150|NCT02848001|Myelodysplastic Syndrome|myelodysplastic syndrome
4762151|NCT02848001|AML|aml
4762152|NCT02848001|MDS|mds
4762153|NCT02847988|muscle strength|muscle strength
4762154|NCT02847988|muscle function|muscle function
4762155|NCT02847988|functional status|functional status
4762156|NCT02847975|Becker|becker
4762157|NCT02847975|dystrophy|dystrophy
4762158|NCT02847975|sympatholysis|sympatholysis
4762159|NCT02847962|Fortified-blended foods|fortified-blended foods
4762160|NCT02847962|Extrusion|extrusion
4762161|NCT02847962|Sorghum|sorghum
4762162|NCT02847962|Cowpea|cowpea
4762163|NCT02847962|Vitamin A|vitamin a
4762164|NCT02847962|Iron|iron
4762165|NCT02847962|Protein|protein
4762166|NCT02847962|Food Aid|food aid
4762167|NCT02847962|Anemia, Iron-Deficiency|anemia, iron-deficiency
4762168|NCT02847962|Deficiency, Vitamin A|deficiency, vitamin a
4762169|NCT02847962|Growth Velocity|growth velocity
4762170|NCT02847962|Stunting|stunting
4762171|NCT02847962|Wasting|wasting
4762172|NCT02847962|Protein-Energy Malnutrition|protein-energy malnutrition
4762173|NCT02847962|Complementary Feeding|complementary feeding
4762174|NCT02847962|Corn|corn
4762175|NCT02847962|Soy|soy
4762176|NCT02847962|Fortified Foods|fortified foods
4762177|NCT02847962|Food assistance|food assistance
4762178|NCT02847936|triclosan|triclosan
4762179|NCT02847936|sutures|sutures
4762180|NCT02847936|infection|infection
4762181|NCT02847923|Mobile Devices|mobile devices
4762182|NCT02847923|Augmentative and Alternative Communication|augmentative and alternative communication
4762183|NCT02847923|Cerebral Palsy|cerebral palsy
4762184|NCT02847910|tissue suction tube|tissue suction tube
4762185|NCT02847910|disposable instrument|disposable instrument
4762186|NCT02847910|induced abortion|induced abortion
4762187|NCT02847884|IBD|ibd
4762188|NCT02847884|Crohn's disease|crohn's disease
4762189|NCT02847884|Remicade|remicade
4762190|NCT02847884|Infliximab|infliximab
4762191|NCT02847884|Level|level
4762192|NCT02847884|Drug Level|drug level
4762193|NCT02847884|Children|children
4762194|NCT02847871|mobility|mobility
4762195|NCT02847871|exercise|exercise
4762196|NCT02847871|nutrition|nutrition
4762197|NCT02847871|primary care|primary care
4762198|NCT02847871|prevention|prevention
4762199|NCT02847871|care pathway|care pathway
4762200|NCT02847871|elderly patient|elderly patient
4762201|NCT02847858|unsafe sex|unsafe sex
4762202|NCT02847858|unprotected sex|unprotected sex
4762203|NCT02847858|adolescents|adolescents
4762204|NCT02847858|Latinas|latinas
4762205|NCT02847858|Hispanic|hispanic
4762206|NCT02847858|mobile health applications|mobile health applications
4762207|NCT02847858|unintended pregnancy|unintended pregnancy
4762208|NCT02847858|teen pregnancy prevention|teen pregnancy prevention
4762209|NCT02847858|school-based health centers|school-based health centers
4762210|NCT02847845|chronic fatigue syndrome|chronic fatigue syndrome
4762211|NCT02847845|idiopathic chronic fatigue|idiopathic chronic fatigue
4762212|NCT02847845|red ginseng|red ginseng
4762213|NCT02847845|cortisol|cortisol
4762214|NCT02847845|anti-oxidant|anti-oxidant
4762215|NCT02847832|Adnexal Diseases|adnexal diseases
4762216|NCT02847832|Ovary|ovary
4762217|NCT02847832|Ovarian Neoplasms|ovarian neoplasms
4762218|NCT02847832|Ovarian Cysts|ovarian cysts
4762219|NCT02847832|Ovarian Diseases|ovarian diseases
4762220|NCT02847832|Ultrasonography|ultrasonography
4762221|NCT02847832|Ultrasonography, Doppler|ultrasonography, doppler
4762222|NCT02847832|Diagnosis|diagnosis
4762223|NCT02847832|Early Diagnosis|early diagnosis
4762224|NCT02847832|Early Detection of Cancer|early detection of cancer
4762225|NCT02847832|Genital Neoplasms, Female|genital neoplasms, female
4762226|NCT02847832|Genital Diseases, Female|genital diseases, female
4762227|NCT02847832|Urogenital Neoplasms|urogenital neoplasms
4762228|NCT02847832|Cysts|cysts
4762229|NCT02847832|Endocrine System Diseases|endocrine system diseases
4762230|NCT02847832|Gonadal Disorders|gonadal disorders
4762231|NCT02847832|Neoplasms|neoplasms
4762232|NCT02847832|Endocrine Gland Neoplasms|endocrine gland neoplasms
4762233|NCT02847832|International Ovarian Tumor Analysis|international ovarian tumor analysis
4762234|NCT02847832|Simple Rules|simple rules
4762235|NCT02847832|Preoperative evaluation|preoperative evaluation
4762236|NCT02847832|Prediction Models|prediction models
4762237|NCT02847832|Logistic Regression Models|logistic regression models
4762238|NCT02847832|Mathematical Models|mathematical models
4762239|NCT02847832|Adnexal Masses|adnexal masses
4762240|NCT02847832|Ovarian Tumors|ovarian tumors
4762241|NCT02847832|Risk of Malignancy|risk of malignancy
4762242|NCT02847793|Attentional Bias Modification (ABM)|attentional bias modification (abm)
4762243|NCT02847793|Cognitive Bias Modification (CBM)|cognitive bias modification (cbm)
4762244|NCT02847793|Depression|depression
4762245|NCT02847793|Dysphoria|dysphoria
4762246|NCT02847793|Gaze patterns|gaze patterns
4762247|NCT02847793|Eye-tracking|eye-tracking
4762248|NCT02847767|Liver Perfusion|liver perfusion
4762249|NCT02847767|Hepatocellular Carcinoma|hepatocellular carcinoma
4762250|NCT02847767|Dynamic Contrast-Enhanced Computed Tomography|dynamic contrast-enhanced computed tomography
4762251|NCT02847754|bony metastases|bony metastases
4762252|NCT02847754|physical exercise|physical exercise
4762253|NCT02847741|Depression|depression
4762254|NCT02847741|Cholesterol|cholesterol
4762255|NCT02847741|Suicidal behavior|suicidal behavior
4762256|NCT02847741|Predictive factor|predictive factor
4762257|NCT02847715|PRO|pro
4762258|NCT02847715|PROM|prom
4762259|NCT02847715|Adverse event|adverse event
4762260|NCT02847715|QTool|qtool
4762261|NCT02847715|Aftercare|aftercare
4762262|NCT02847702|Osteoarthritis|osteoarthritis
4762263|NCT02847702|Pain|pain
4762264|NCT02847702|Osteoarthritis, knee|osteoarthritis, knee
4762265|NCT02847689|Premature Birth|premature birth
4762266|NCT02847689|Obstetric Labor, Premature|obstetric labor, premature
4762267|NCT02847689|Obstetric Labor Complications|obstetric labor complications
4762268|NCT02847689|Pregnancy Complications|pregnancy complications
4762269|NCT02847676|Peritoneal adhesions|peritoneal adhesions
4762270|NCT02847676|Stem cells|stem cells
4762271|NCT02847676|MSC|msc
4762272|NCT02847663|Cold|cold
4762273|NCT02847663|recovery|recovery
4762274|NCT02847650|Early Parkinson Disease|early parkinson disease
4762275|NCT02847650|Phase 2|phase 2
4762276|NCT02847637|Hemophilia A|hemophilia a
4762277|NCT02847637|Emicizumab|emicizumab
4762278|NCT02847611|Dynamometer mechanic|dynamometer mechanic
4762279|NCT02847611|Strength of prehension|strength of prehension
4762280|NCT02847611|Comparison|comparison
4762281|NCT02847611|Device|device
4762282|NCT02847611|Diagnosis|diagnosis
4762283|NCT02847611|Healthy Volunteers|healthy volunteers
4762284|NCT02847598|CLE, SLE, Cutaneous Lupus Erythematosus, Systemic Lupus Erythematosus, Lupus|cle, sle, cutaneous lupus erythematosus, systemic lupus erythematosus, lupus
4762285|NCT02847585|water-soluble ubiquinol supplementation|water-soluble ubiquinol supplementation
4762286|NCT02847585|pediatric cardiomyopathy|pediatric cardiomyopathy
4762287|NCT02847585|antioxidant|antioxidant
4762288|NCT02847585|inflammation|inflammation
4762289|NCT02847585|complementary therapy|complementary therapy
4762290|NCT02847533|resistant depression|resistant depression
4762291|NCT02847533|inflammation|inflammation
4762292|NCT02847520|Disorders related to gaming and gambling; poker|disorders related to gaming and gambling; poker
4762293|NCT02847507|HIV|hiv
4762294|NCT02847507|Hepatitis E|hepatitis e
4762295|NCT02847481|Fecal Microbiota Transplantation|fecal microbiota transplantation
4762296|NCT02847455|Ilaprazole|ilaprazole
4762297|NCT02847455|Proton pump inhibitor|proton pump inhibitor
4762298|NCT02847455|Duodenal ulcer|duodenal ulcer
4762299|NCT02847455|Acid suppression|acid suppression
4762300|NCT02847455|Randomized trial|randomized trial
4762301|NCT02847442|Ongentys|ongentys
4762302|NCT02847403|dysglycemia|dysglycemia
4762303|NCT02847403|MCI|mci
4762304|NCT02847403|exenatide LAR|exenatide lar
4762305|NCT02847403|GLP-1|glp-1
4762306|NCT02847390|diabetes mellitus|diabetes mellitus
4762307|NCT02847390|physician education|physician education
4762308|NCT02847390|nursing education|nursing education
4762309|NCT02847390|hyperglycemia|hyperglycemia
4762310|NCT02847390|hypoglycemia|hypoglycemia
4762311|NCT02847390|inpatient|inpatient
4762312|NCT02847390|hospital|hospital
4762313|NCT02847390|glycemic control|glycemic control
4762314|NCT02847364|chewing gum|chewing gum
4762315|NCT02847364|prevention|prevention
4762316|NCT02847351|arabinoxylan, HOMA index, glycemic control, obesity.|arabinoxylan, homa index, glycemic control, obesity.
4762317|NCT02847338|Hypertension|hypertension
4762318|NCT02847312|Oat|oat
4762319|NCT02847312|Phenolic acid|phenolic acid
4762320|NCT02847312|Avenanthramide|avenanthramide
4762321|NCT02847312|FMD|fmd
4762322|NCT02847312|LDI|ldi
4762323|NCT02847312|Gut microbiota|gut microbiota
4762324|NCT02847312|Blood Pressure|blood pressure
4762325|NCT02847312|Renin Angiotensin|renin angiotensin
4762326|NCT02847312|Nitric Oxide|nitric oxide
4762327|NCT02847299|cough help|cough help
4762328|NCT02847299|mechanical insufflation|mechanical insufflation
4762329|NCT02847299|mechanical ventilation|mechanical ventilation
4762330|NCT02847299|neuromuscular diseases|neuromuscular diseases
4762331|NCT02847299|peak cough flow|peak cough flow
4762332|NCT02847273|NIRS|nirs
4762333|NCT02847273|Regional oxygen saturation|regional oxygen saturation
4762334|NCT02847273|cardiac surgery with bypass|cardiac surgery with bypass
4762335|NCT02847247|healthy|healthy
4762336|NCT02847234|Cervical necrotizing fasciitis|cervical necrotizing fasciitis
4762337|NCT02847234|mediastinitis|mediastinitis
4762338|NCT02847221|cough peak flow|cough peak flow
4762339|NCT02847221|scheduled weaning trial|scheduled weaning trial
4762340|NCT02847221|scheduled extubation|scheduled extubation
4762341|NCT02847221|prognosis|prognosis
4762342|NCT02847208|cystic fibrosis|cystic fibrosis
4762343|NCT02847208|contraception|contraception
4762344|NCT02847208|gynaecological follow-up|gynaecological follow-up
4762345|NCT02847208|screening|screening
4762346|NCT02847208|Pap smear|pap smear
4762347|NCT02847208|counselling|counselling
4762348|NCT02847195|pediatric intensive care|pediatric intensive care
4762349|NCT02847195|pain assessment|pain assessment
4762350|NCT02847195|tracheal aspiration|tracheal aspiration
4762351|NCT02847195|sedation|sedation
4762352|NCT02847195|pupillometer|pupillometer
4762353|NCT02847156|cystic fibrosis|cystic fibrosis
4762354|NCT02847156|viruses|viruses
4762355|NCT02847156|respiratory viral infection|respiratory viral infection
4762356|NCT02847156|children|children
4762357|NCT02847143|Attachement|attachement
4762358|NCT02847143|Oxytocin|oxytocin
4762359|NCT02847143|fMRI|fmri
4762360|NCT02847117|Natural Mastiha, Bioavailability|natural mastiha, bioavailability
4762361|NCT02847091|Ipragliflozin|ipragliflozin
4762362|NCT02847091|SGLT2 inhibitor|sglt2 inhibitor
4762363|NCT02847091|Type 2 diabetes mellitus|type 2 diabetes mellitus
4762364|NCT02847091|ASP1941|asp1941
4762365|NCT02847078|Coronary Disease|coronary disease
4762366|NCT02847078|percutaneous coronary intervention|percutaneous coronary intervention
4762367|NCT02847078|secondary prevention|secondary prevention
4762368|NCT02847078|smart phone app|smart phone app
4762369|NCT02847026|inactivated poliovirus vaccine|inactivated poliovirus vaccine
4762370|NCT02847026|fractional inactivated poliovirus vaccine|fractional inactivated poliovirus vaccine
4762371|NCT02847026|Rotavirus|rotavirus
4762372|NCT02847026|Rotarix|rotarix
4762373|NCT02847026|RotaTeq|rotateq
4762374|NCT02847026|fIPV|fipv
4762375|NCT02847026|IPV|ipv
4762376|NCT02847013|Postcesarean Section|postcesarean section
4762377|NCT02847013|Postoperative|postoperative
4762378|NCT02847000|Decitabine|decitabine
4762379|NCT02847000|Tetrahydrouridine|tetrahydrouridine
4762380|NCT02847000|Epigenetic Therapy|epigenetic therapy
4762381|NCT02846987|Abemaciclib i|abemaciclib i
4762382|NCT02846987|LY2835219|ly2835219
4762383|NCT02846987|16-376|16-376
4762384|NCT02846974|Pulse Oximetry|pulse oximetry
4762385|NCT02846974|Free and Open Source|free and open source
4762386|NCT02846961|inflammatory bowel disease|inflammatory bowel disease
4762387|NCT02846961|biosimilar|biosimilar
4762388|NCT02846961|anti-drug antibody|anti-drug antibody
4762389|NCT02846961|trough drug concentration|trough drug concentration
4762390|NCT02846948|sepsis|sepsis
4762391|NCT02846948|echocardiography|echocardiography
4762392|NCT02846948|urgent|urgent
4762393|NCT02846948|abdominal surgery|abdominal surgery
4762394|NCT02846935|p16/CDKN2A|p16/cdkn2a
4762395|NCT02846935|TP53|tp53
4762396|NCT02846935|THU|thu
4762397|NCT02846935|Decitabine|decitabine
4762398|NCT02846935|Tetrahydrouridine|tetrahydrouridine
4762399|NCT02846935|DEC|dec
4762400|NCT02846883|aneurysms|aneurysms
4762401|NCT02846857|Closed-loop system|closed-loop system
4762402|NCT02846857|Artificial pancreas|artificial pancreas
4762403|NCT02846857|Type 1 diabetes|type 1 diabetes
4762404|NCT02846857|Hypoglycemia|hypoglycemia
4762405|NCT02846857|Insulin|insulin
4762406|NCT02846857|Glucagon|glucagon
4762407|NCT02846831|Type 1 diabetes|type 1 diabetes
4762408|NCT02846831|Artificial pancreas|artificial pancreas
4762409|NCT02846831|Closed-loop system|closed-loop system
4762410|NCT02846831|Hypoglycemia|hypoglycemia
4762411|NCT02846831|Insulin|insulin
4762412|NCT02846818|Microdialysis|microdialysis
4762413|NCT02846818|Cardiac surgery|cardiac surgery
4762414|NCT02846818|Lactate to pyruvate ratio|lactate to pyruvate ratio
4762415|NCT02846818|Cardiopulmonary bypass|cardiopulmonary bypass
4762416|NCT02846818|Neurological complications|neurological complications
4762417|NCT02846779|Insulin persistence|insulin persistence
4762418|NCT02846779|Telepharmacy|telepharmacy
4762419|NCT02846766|advanced cancer|advanced cancer
4762420|NCT02846766|FGF|fgf
4762421|NCT02846766|FGFR|fgfr
4762422|NCT02846766|Fibroblast Growth Factor Receptor|fibroblast growth factor receptor
4762423|NCT02846740|cranial electric stimulation|cranial electric stimulation
4762424|NCT02846740|suicide|suicide
4762425|NCT02846740|psychiatric inpatients|psychiatric inpatients
4762426|NCT02846727|Hypoperfusion|hypoperfusion
4762427|NCT02846727|Sepsis|sepsis
4762428|NCT02846714|Education|education
4762429|NCT02846714|Prevention and Control|prevention and control
4762430|NCT02846714|Behavioral Research|behavioral research
4762431|NCT02846701|Neuropathic pain|neuropathic pain
4762432|NCT02846701|Antidepressant|antidepressant
4762433|NCT02846701|Duloxetine|duloxetine
4762434|NCT02846701|Liquid Chromatography|liquid chromatography
4762435|NCT02846701|Mass Spectrometry|mass spectrometry
4762436|NCT02846675|SVF|svf
4762437|NCT02846675|Stromal Vascular Fraction|stromal vascular fraction
4762438|NCT02846675|osteoarthritis(OA)|osteoarthritis(oa)
4762439|NCT02846675|knee|knee
4762440|NCT02846675|adipose|adipose
4762441|NCT02846662|depression|depression
4762442|NCT02846662|mobile technology|mobile technology
4762443|NCT02846662|community trial|community trial
4762444|NCT02846623|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
4762445|NCT02846623|CLL|cll
4762446|NCT02846623|Relapsed, Refractory|relapsed, refractory
4762447|NCT02846623|High-risk Untreated|high-risk untreated
4762448|NCT02846623|High-risk molecular features|high-risk molecular features
4762449|NCT02846623|Genetic mutation|genetic mutation
4762450|NCT02846623|17p/TP53 deletion|17p/tp53 deletion
4762451|NCT02846623|Obinutuzumab|obinutuzumab
4762452|NCT02846623|GA101|ga101
4762453|NCT02846623|Gazyva|gazyva
4762454|NCT02846623|Atezolizumab|atezolizumab
4762455|NCT02846623|MPDL3280A|mpdl3280a
4762456|NCT02846623|Tencentriq|tencentriq
4762457|NCT02846623|Small Lymphocytic Lymphoma|small lymphocytic lymphoma
4762458|NCT02846623|SLL|sll
4762459|NCT02846610|anesthesia|anesthesia
4762460|NCT02846610|continuous regional anesthesia|continuous regional anesthesia
4762461|NCT02846610|complications|complications
4762462|NCT02846610|epidural analgesia|epidural analgesia
4762463|NCT02846610|antibiotics|antibiotics
4762464|NCT02846597|Respiratory distress syndrome|respiratory distress syndrome
4762465|NCT02846597|Sustained lung inflation|sustained lung inflation
4762466|NCT02846597|Delivery room|delivery room
4762467|NCT02846584|CAR T|car t
4762468|NCT02846584|HSCT|hsct
4762469|NCT02846571|Islet Transplantation|islet transplantation
4762470|NCT02846571|Type 1 Diabetes|type 1 diabetes
4762471|NCT02846571|Immune Tolerance Induction|immune tolerance induction
4762472|NCT02846571|Diabetes Complications|diabetes complications
4762473|NCT02846571|Intraocular Transplantation|intraocular transplantation
4762474|NCT02846571|Eye Anterior Chamber|eye anterior chamber
4762475|NCT02846571|Kidney Transplantation|kidney transplantation
4762476|NCT02846571|Immunosuppression|immunosuppression
4762477|NCT02846571|Type 2 Diabetes|type 2 diabetes
4762478|NCT02846558|calorie restriction|calorie restriction
4762479|NCT02846558|weight loss|weight loss
4762480|NCT02846532|Thromboembolism|thromboembolism
4762481|NCT02846532|Fontan Procedure|fontan procedure
4762482|NCT02846532|Children|children
4762483|NCT02846493|Ovarian hyperstimulation syndrome|ovarian hyperstimulation syndrome
4762484|NCT02846493|Dexamethasone|dexamethasone
4762485|NCT02846467|Informed consent|informed consent
4762486|NCT02846467|Patient Education|patient education
4762487|NCT02846467|Mobile applications|mobile applications
4762488|NCT02846441|posthepatectomy liver failure|posthepatectomy liver failure
4762489|NCT02846441|ALPPS|alpps
4762490|NCT02846441|hepatobiliary scintigraphy|hepatobiliary scintigraphy
4762491|NCT02846441|SPECT|spect
4762492|NCT02846441|mebrofenin|mebrofenin
4762493|NCT02846415|Dementia|dementia
4762494|NCT02846415|Play and Playthings|play and playthings
4762495|NCT02846415|Cognition|cognition
4762496|NCT02846415|Memory|memory
4762497|NCT02846402|HIV testing|hiv testing
4762498|NCT02846402|Female sex workers|female sex workers
4762499|NCT02846402|HIV self-testing|hiv self-testing
4762500|NCT02846389|Radiation therapy for Breast Cancer|radiation therapy for breast cancer
4762501|NCT02846363|stroke|stroke
4762502|NCT02846363|public awareness campaign|public awareness campaign
4762503|NCT02846363|call to EMS|call to ems
4762504|NCT02846337|cardio-renal syndrome|cardio-renal syndrome
4762505|NCT02846337|hemodialysis|hemodialysis
4762506|NCT02846337|peritoneal dialysis|peritoneal dialysis
4762507|NCT02846337|hemofiltration|hemofiltration
4762508|NCT02846337|composite endpoint|composite endpoint
4762509|NCT02846311|test|test
4762510|NCT02846311|winter|winter
4762511|NCT02846311|season|season
4762512|NCT02846298|Drug Monitoring|drug monitoring
4762513|NCT02846298|ICU|icu
4762514|NCT02846298|Pharmacokinetic|pharmacokinetic
4762515|NCT02846298|Pharmacodynamic|pharmacodynamic
4762516|NCT02846298|antibiotic|antibiotic
4762517|NCT02846298|Glycopeptides|glycopeptides
4762518|NCT02846298|β-lactam-aminoglycoside|β-lactam-aminoglycoside
4762519|NCT02846285|Bleeding|bleeding
4762520|NCT02846259|intracranial aneurysm|intracranial aneurysm
4762521|NCT02846259|cerebral ischemia|cerebral ischemia
4762522|NCT02846259|aspirin|aspirin
4762523|NCT02846246|aged care|aged care
4762524|NCT02846246|health|health
4762525|NCT02846246|home care services|home care services
4762526|NCT02846246|person-centred care|person-centred care
4762527|NCT02846220|Medication Adherence|medication adherence
4762528|NCT02846220|Middle Aged 45-64|middle aged 45-64
4762529|NCT02846220|Aged 65-79|aged 65-79
4762530|NCT02846220|Aged, 80 and over|aged, 80 and over
4762531|NCT02846207|cerebral infarction|cerebral infarction
4762532|NCT02846207|syndrome of qi deficiency and blood stasis|syndrome of qi deficiency and blood stasis
4762533|NCT02846207|Buyanghuanwu decoction|buyanghuanwu decoction
4762534|NCT02846207|clinical effects and mechanisms|clinical effects and mechanisms
4762535|NCT02846194|Fibromyalgia|fibromyalgia
4762536|NCT02846194|Guided Imagery|guided imagery
4762537|NCT02846194|chronic pain|chronic pain
4762538|NCT02846155|preparation|preparation
4762539|NCT02846155|capsule endoscopy|capsule endoscopy
4762540|NCT02846129|multiple gestation|multiple gestation
4762541|NCT02846129|complications|complications
4762542|NCT02846129|cesarean delivery|cesarean delivery
4762543|NCT02846116|all ceramic crown|all ceramic crown
4762544|NCT02846116|Lithium disilicate|lithium disilicate
4762545|NCT02846116|e-max|e-max
4762546|NCT02846116|vita suprinity|vita suprinity
4762547|NCT02846077|sleep|sleep
4762548|NCT02846077|social networks|social networks
4762549|NCT02846077|undergraduates|undergraduates
4762550|NCT02846077|mood|mood
4762551|NCT02846077|circadian rhythms|circadian rhythms
4762552|NCT02846051|varicose vein|varicose vein
4762553|NCT02846051|physical activity|physical activity
4762554|NCT02846038|Pediatric cancer|pediatric cancer
4762555|NCT02846038|Childhood cancer|childhood cancer
4762556|NCT02846038|High-risk disease|high-risk disease
4762557|NCT02846038|Prognosis|prognosis
4762558|NCT02846038|Communication|communication
4762559|NCT02846038|Bad news|bad news
4762560|NCT02846038|Pediatric oncologist|pediatric oncologist
4762561|NCT02846038|Parent|parent
4762562|NCT02846038|Relapse|relapse
4762563|NCT02846038|Progression|progression
4762564|NCT02845999|natural killer cells|natural killer cells
4762565|NCT02845999|adoptive transfer|adoptive transfer
4762566|NCT02845999|allogenic immunotherapy|allogenic immunotherapy
4762567|NCT02845999|gastrointestinal cancer EGFR+|gastrointestinal cancer egfr+
4762568|NCT02845986|Stomach Neoplasms|stomach neoplasms
4762569|NCT02845986|Laparoscopy|laparoscopy
4762570|NCT02845986|Spleen-Preserving|spleen-preserving
4762571|NCT02845986|No.10 Lymph Node Dissection|no.10 lymph node dissection
4762572|NCT02845973|gut microbiota|gut microbiota
4762573|NCT02845921|Propofol|propofol
4762574|NCT02845921|Hypotension|hypotension
4762575|NCT02845921|Induction of anaesthesia|induction of anaesthesia
4762576|NCT02845921|Leg elevation|leg elevation
4762577|NCT02845921|Leg wrapping|leg wrapping
4762578|NCT02845895|Screening for nutritional disorder|screening for nutritional disorder
4762579|NCT02845895|Comparison of two organizations|comparison of two organizations
4762580|NCT02845895|Indicator IPAQSS|indicator ipaqss
4762581|NCT02845856|recurrent lung cancer|recurrent lung cancer
4762582|NCT02845856|EGFR mutation|egfr mutation
4762583|NCT02845856|Cetuximab|cetuximab
4762584|NCT02845856|NK immunotherapy|nk immunotherapy
4762585|NCT02845843|Middle East Respiratory Syndrome Coronavirus|middle east respiratory syndrome coronavirus
4762586|NCT02845843|MERS-CoV|mers-cov
4762587|NCT02845843|Clinical trial|clinical trial
4762588|NCT02845843|Lopinavir|lopinavir
4762589|NCT02845843|Ritonavir|ritonavir
4762590|NCT02845843|Interferon beta|interferon beta
4762591|NCT02845830|dementia|dementia
4762592|NCT02845830|elderly|elderly
4762593|NCT02845830|quality of life|quality of life
4762594|NCT02845830|assessment|assessment
4762595|NCT02845830|factor|factor
4762596|NCT02845830|trajectory|trajectory
4762597|NCT02845830|change|change
4762598|NCT02845830|early stage|early stage
4762599|NCT02845804|coronary artery disease|coronary artery disease
4762600|NCT02845804|percutaneous coronary intervention|percutaneous coronary intervention
4762601|NCT02845804|everolimus-eluting stents|everolimus-eluting stents
4762602|NCT02845778|melatonin|melatonin
4762603|NCT02845778|pharmacokinetics|pharmacokinetics
4762604|NCT02845765|Erectile Dysfunction|erectile dysfunction
4762606|NCT02845765|Fundus Oculi|fundus oculi
4762607|NCT02845765|Retinal Vascularization|retinal vascularization
4762608|NCT02845765|International Index of Erectile Function Questionnaire|international index of erectile function questionnaire
4762609|NCT02845765|IIEF|iief
4762610|NCT02845765|Dynamic Vessel Analyzer|dynamic vessel analyzer
4762611|NCT02845765|DVA|dva
4762612|NCT02845765|Phosphodiesterase type 5 Inhibitor|phosphodiesterase type 5 inhibitor
4762613|NCT02845765|PDE5Is|pde5is
4762614|NCT02845739|kidney transplantation|kidney transplantation
4762615|NCT02845739|human papillomavirus|human papillomavirus
4762616|NCT02845687|nicotine addiction|nicotine addiction
4762617|NCT02845687|cigarette smoking|cigarette smoking
4762618|NCT02845661|Narcotrend index|narcotrend index
4762619|NCT02845661|OAA/S scale|oaa/s scale
4762620|NCT02845661|Dexmedetomidine|dexmedetomidine
4762621|NCT02845661|Sedation|sedation
4762622|NCT02845648|anticholinergics|anticholinergics
4762623|NCT02845648|awakener|awakener
4762624|NCT02845622|Hazelnut|hazelnut
4762625|NCT02845622|Cocoa|cocoa
4762626|NCT02845622|Flavonoid|flavonoid
4762627|NCT02845622|Lipids|lipids
4762628|NCT02845622|Vascular Reactivity|vascular reactivity
4762629|NCT02845609|Congenital macrothrombocytopenia|congenital macrothrombocytopenia
4762630|NCT02845609|Sialic acid|sialic acid
4762631|NCT02845609|Bleeding|bleeding
4762632|NCT02845583|Nursing|nursing
4762633|NCT02845583|Diagnosis Related Group|diagnosis related group
4762634|NCT02845583|Activity based costing|activity based costing
4762635|NCT02845557|Youth|youth
4762636|NCT02845557|Type 2 Diabetes|type 2 diabetes
4762637|NCT02845557|glucose homeostasis|glucose homeostasis
4762638|NCT02845557|incretin effect|incretin effect
4762639|NCT02845544|Postural Balance|postural balance
4762640|NCT02845531|Variant angina|variant angina
4762641|NCT02845531|Aborted sudden cardiac death|aborted sudden cardiac death
4762642|NCT02845531|Implantable Cardioverter Defibrillator|implantable cardioverter defibrillator
4762643|NCT02845531|Optimal Medical Therapy|optimal medical therapy
4762644|NCT02845531|ICD|icd
4762645|NCT02845505|intravascular ultrasonography|intravascular ultrasonography
4762646|NCT02845505|Computed Tomography|computed tomography
4762647|NCT02845492|Exercise|exercise
4762648|NCT02845492|Qigong|qigong
4762649|NCT02845492|Mind-Body|mind-body
4762650|NCT02845492|Fatigue|fatigue
4762651|NCT02845492|Cancer|cancer
4762652|NCT02845492|EEG|eeg
4762653|NCT02845492|HRV|hrv
4762654|NCT02845466|Venous Leg Ulcer|venous leg ulcer
4762655|NCT02845466|Diabetic Foot Ulcer|diabetic foot ulcer
4762656|NCT02845466|Wound Healing|wound healing
4762657|NCT02845466|Growth Factor|growth factor
4762658|NCT02845466|Protease Inhibitor|protease inhibitor
4762659|NCT02845453|youth|youth
4762660|NCT02845453|adolescent|adolescent
4762661|NCT02845453|young adult|young adult
4762662|NCT02845453|substance use disorder|substance use disorder
4762663|NCT02845453|bipolar disorder|bipolar disorder
4762664|NCT02845453|quetiapine|quetiapine
4762665|NCT02845453|mood dysregulation|mood dysregulation
4762666|NCT02845440|Pragmatic Trial|pragmatic trial
4762667|NCT02845440|Community Health Workers|community health workers
4762668|NCT02845440|Academic Detailing|academic detailing
4762669|NCT02845427|Closed Suction Drain|closed suction drain
4762670|NCT02845427|Wound Hematoma|wound hematoma
4762671|NCT02845388|IVF|ivf
4762672|NCT02845362|Neuromuscular|neuromuscular
4762673|NCT02845362|dysphagia|dysphagia
4762674|NCT02845362|Swallowing disorders|swallowing disorders
4762675|NCT02845362|Questionnaire|questionnaire
4762676|NCT02845362|Assessment|assessment
4762677|NCT02845284|adolescent|adolescent
4762678|NCT02845284|reproductive health|reproductive health
4762679|NCT02845245|Comminuted intra-articular distal tibia fractures|comminuted intra-articular distal tibia fractures
4762680|NCT02845245|3D printing|3d printing
4762681|NCT02845245|pre-operative planning|pre-operative planning
4762682|NCT02845232|Acute myeloid leukemia|acute myeloid leukemia
4762683|NCT02845232|Therapy|therapy
4762684|NCT02845232|Blood transfusion|blood transfusion
4762685|NCT02845232|Cost-effectiveness|cost-effectiveness
4762686|NCT02845232|Prognosis|prognosis
4762687|NCT02845206|Total Knee Replacement|total knee replacement
4762688|NCT02845206|Patient Specific Instrumentation|patient specific instrumentation
4762689|NCT02845180|lipectomy|lipectomy
4762690|NCT02845180|panniculectomy|panniculectomy
4762691|NCT02845154|Ischemia reperfusion|ischemia reperfusion
4762692|NCT02845154|post-reperfusion syndrome|post-reperfusion syndrome
4762693|NCT02845154|living donor liver transplantation|living donor liver transplantation
4762694|NCT02845154|patient outcome|patient outcome
4762695|NCT02845141|ACL|acl
4762696|NCT02845141|Revision surgery|revision surgery
4762697|NCT02845141|tunnel enlargement|tunnel enlargement
4762698|NCT02845141|bone substitute material|bone substitute material
4762699|NCT02845141|bone graft|bone graft
4762700|NCT02845115|Middle Ear Implant|middle ear implant
4762701|NCT02845115|laser velocimetry|laser velocimetry
4762702|NCT02845102|Chronic Illness|chronic illness
4762703|NCT02845102|Chronic Pain|chronic pain
4762704|NCT02845102|Depression|depression
4762705|NCT02845102|Comorbid Depression|comorbid depression
4762706|NCT02845102|Cognitive Behavioral Therapy|cognitive behavioral therapy
4762707|NCT02845102|Relational Agent Technology|relational agent technology
4762708|NCT02845102|CBT|cbt
4762709|NCT02845102|Virtual Counselor|virtual counselor
4762710|NCT02845076|Noninvasive ventilation|noninvasive ventilation
4762711|NCT02845076|Respiratory insufficiency|respiratory insufficiency
4762712|NCT02845076|Hypercapnia|hypercapnia
4762713|NCT02845076|ventilator weaning|ventilator weaning
4762714|NCT02845063|muscle plasticity|muscle plasticity
4762715|NCT02845063|exercise|exercise
4762716|NCT02845063|rehabilitation|rehabilitation
4762717|NCT02845063|perfusion|perfusion
4762718|NCT02845063|ACE|ace
4762719|NCT02845063|genotype|genotype
4762720|NCT02845063|hypertension|hypertension
4762721|NCT02845063|molecular biology|molecular biology
4762722|NCT02845050|neo-adjuvant|neo-adjuvant
4762723|NCT02845050|vinflunine|vinflunine
4762724|NCT02845050|cisplatin|cisplatin
4762725|NCT02845050|radical cystectomy|radical cystectomy
4762726|NCT02845050|muscle-invasive bladder cancer|muscle-invasive bladder cancer
4762727|NCT02845050|JaNEO|janeo
4762728|NCT02845011|Cardio first angle|cardio first angle
4762730|NCT02845011|Cardiopulmonary Arrest|cardiopulmonary arrest
4762731|NCT02845011|Clinical trial|clinical trial
4762732|NCT02844998|intravaginal ejaculatory latency time|intravaginal ejaculatory latency time
4763036|NCT02843347|Genetics|genetics
4762733|NCT02844998|international physical activity questionnaire|international physical activity questionnaire
4762734|NCT02844998|premature ejaculation diagnostic tool|premature ejaculation diagnostic tool
4762735|NCT02844985|Sexual Addiction|sexual addiction
4762736|NCT02844985|Genomics|genomics
4762737|NCT02844985|Personality|personality
4762738|NCT02844985|Polymorphism|polymorphism
4762739|NCT02844972|arrest or limitation of active treatment|arrest or limitation of active treatment
4762740|NCT02844972|emergency treatment|emergency treatment
4762741|NCT02844959|Atrial Fibrillation|atrial fibrillation
4762742|NCT02844959|Biomarkers|biomarkers
4762743|NCT02844959|Inflammatory Response|inflammatory response
4762744|NCT02844959|C-reactive protein|c-reactive protein
4762745|NCT02844959|FGF2|fgf2
4762746|NCT02844959|MMP8|mmp8
4762747|NCT02844959|troponin I|troponin i
4762748|NCT02844959|body temperature|body temperature
4762749|NCT02844946|Acceptance and Commitment Therapy|acceptance and commitment therapy
4762750|NCT02844946|mild Traumatic Brain Injury|mild traumatic brain injury
4762751|NCT02844946|Veterans|veterans
4762752|NCT02844946|Post Traumatic Stress Disorder|post traumatic stress disorder
4762753|NCT02844907|Incretins|incretins
4762754|NCT02844907|GLP-1|glp-1
4762755|NCT02844907|Exendin-9|exendin-9
4762756|NCT02844907|Insulin Resistance|insulin resistance
4762757|NCT02844894|intubation, ischemia modified albumine, dexmedetomidine, esmolol|intubation, ischemia modified albumine, dexmedetomidine, esmolol
4762758|NCT02844868|stroke|stroke
4762759|NCT02844868|hemiplegia|hemiplegia
4762760|NCT02844868|transcranial direct current stimulation (tDCS)|transcranial direct current stimulation (tdcs)
4762761|NCT02844868|rehabilitation|rehabilitation
4762762|NCT02844868|lower extremity|lower extremity
4762763|NCT02844868|gait training|gait training
4762764|NCT02844855|Alzheimer|alzheimer
4762765|NCT02844855|Parkinson|parkinson
4762766|NCT02844855|Action memory|action memory
4762767|NCT02844842|mild or moderate|mild or moderate
4762768|NCT02844829|Prostate Cancer|prostate cancer
4762769|NCT02844829|Magnetic Resonance Imaging|magnetic resonance imaging
4762770|NCT02844777|topical ointment|topical ointment
4762771|NCT02844777|skin|skin
4762772|NCT02844777|hexokinase|hexokinase
4762773|NCT02844777|precancerous conditions|precancerous conditions
4762774|NCT02844777|carcinoma, squamous cell|carcinoma, squamous cell
4762775|NCT02844712|Drug hypersensitivity|drug hypersensitivity
4762776|NCT02844712|Betalactam|betalactam
4762777|NCT02844712|Drug provocation test|drug provocation test
4762778|NCT02844699|prostate cancer|prostate cancer
4762779|NCT02844699|adenovirus|adenovirus
4762780|NCT02844699|TLR5|tlr5
4762781|NCT02844699|immunotherapy|immunotherapy
4762782|NCT02844699|Ad5|ad5
4762783|NCT02844686|Myocardial perfusion imaging|myocardial perfusion imaging
4762784|NCT02844686|Single-Photon Emission Computer-Assisted Tomography|single-photon emission computer-assisted tomography
4762785|NCT02844673|Sickle cell disease|sickle cell disease
4762786|NCT02844673|Hydroxyurea|hydroxyurea
4762787|NCT02844673|Adherence|adherence
4762788|NCT02844673|randomized trial|randomized trial
4762789|NCT02844673|medication possession ratio|medication possession ratio
4762790|NCT02844660|Diabetes Mellitus|diabetes mellitus
4762791|NCT02844660|Foot Diseases|foot diseases
4762792|NCT02844660|Foot Ulcer|foot ulcer
4762793|NCT02844634|pre-exposure prophylaxis|pre-exposure prophylaxis
4762794|NCT02844634|men who have sex with men|men who have sex with men
4762795|NCT02844634|HIV prevention|hiv prevention
4762796|NCT02844634|sexually transmitted infection|sexually transmitted infection
4762797|NCT02844634|syphilis|syphilis
4762798|NCT02844608|Health-related quality of life|health-related quality of life
4762799|NCT02844608|Oncology clinical practice|oncology clinical practice
4762800|NCT02844608|Electronic collection|electronic collection
4762801|NCT02844595|Smoking, psychological treatment, depression|smoking, psychological treatment, depression
4762802|NCT02844569|Dental Implants|dental implants
4762803|NCT02844569|Bone Grafting|bone grafting
4762804|NCT02844556|SMILE surgery|smile surgery
4762805|NCT02844556|FS-LASIK surgery|fs-lasik surgery
4762806|NCT02844556|multicenter|multicenter
4762807|NCT02844543|concussion, eye-tracking, athletes, vision|concussion, eye-tracking, athletes, vision
4762808|NCT02844530|adults|adults
4762809|NCT02844517|Artificial Pancreas|artificial pancreas
4762810|NCT02844517|Closed Loop Control|closed loop control
4762811|NCT02844517|Continuous Glucose Monitor (CGM)|continuous glucose monitor (cgm)
4762812|NCT02844504|Fatigue|fatigue
4762813|NCT02844504|Breast cancer|breast cancer
4762814|NCT02844504|Force|force
4762815|NCT02844504|Motor imagery|motor imagery
4762816|NCT02844504|Cancer Treatment|cancer treatment
4762817|NCT02844478|Caregiving|caregiving
4762818|NCT02844478|Family caregiving|family caregiving
4762819|NCT02844478|Stress|stress
4762820|NCT02844478|dementia caregiving|dementia caregiving
4762821|NCT02844478|Hispanics|hispanics
4762822|NCT02844478|Spanish|spanish
4762823|NCT02844478|Telomere|telomere
4762824|NCT02844465|epilepsy|epilepsy
4762825|NCT02844465|laser ablation|laser ablation
4762826|NCT02844465|Visualase|visualase
4762827|NCT02844465|laser interstitial thermal therapy|laser interstitial thermal therapy
4762828|NCT02844452|Atopic Dermatitis|atopic dermatitis
4762829|NCT02844452|acupuncture|acupuncture
4762830|NCT02844452|visit frequency|visit frequency
4762831|NCT02844452|adult patient with AD|adult patient with ad
4762832|NCT02844426|synbiotic|synbiotic
4762833|NCT02844426|soluble dietary fiber|soluble dietary fiber
4762834|NCT02844426|slow transit constipation|slow transit constipation
4762835|NCT02844426|microbiota|microbiota
4762836|NCT02844387|cancer|cancer
4762837|NCT02844387|brain|brain
4762838|NCT02844387|arginine|arginine
4762839|NCT02844387|radiation|radiation
4762840|NCT02844374|Epilepsy|epilepsy
4762841|NCT02844374|Surgery candidate|surgery candidate
4762842|NCT02844374|EEG's Signal|eeg's signal
4762843|NCT02844361|high-risk|high-risk
4762844|NCT02844361|ASCT|asct
4762845|NCT02844348|Pain|pain
4762846|NCT02844348|Hypnosis|hypnosis
4762847|NCT02844348|Chronic Dialysis|chronic dialysis
4762848|NCT02844348|Arterial Disease|arterial disease
4762849|NCT02844335|Breast Cancer|breast cancer
4762850|NCT02844335|Cryosurgery|cryosurgery
4762851|NCT02844335|NK Immunotherapy|nk immunotherapy
4762852|NCT02844296|short-bout exercise|short-bout exercise
4762853|NCT02844296|craving|craving
4762854|NCT02844296|handgrip|handgrip
4762855|NCT02844296|smoking cessation|smoking cessation
4762856|NCT02844296|RCT|rct
4762857|NCT02844283|HGF,myocardial infarction|hgf,myocardial infarction
4762858|NCT02844257|Acute myeloid leukaemia|acute myeloid leukaemia
4762859|NCT02844257|Transfusion dependency|transfusion dependency
4762860|NCT02844257|Transfusion intensity|transfusion intensity
4762861|NCT02844257|Prognosis|prognosis
4762862|NCT02844257|Chemotherapy|chemotherapy
4762863|NCT02844244|family well-being|family well-being
4762864|NCT02844244|positive psychology|positive psychology
4762865|NCT02844218|Acute myeloid leukemia|acute myeloid leukemia
4762866|NCT02844218|Chemotherapy|chemotherapy
4762867|NCT02844218|Low-intensity therapy|low-intensity therapy
4762868|NCT02844218|Older patients|older patients
4762869|NCT02844218|Prognosis|prognosis
4762870|NCT02844218|Supportive care|supportive care
4762871|NCT02844205|nursing care|nursing care
4762872|NCT02844205|observational scale|observational scale
4762873|NCT02844205|neonate|neonate
4762874|NCT02844205|premature infant|premature infant
4762875|NCT02844205|developmental care|developmental care
4762876|NCT02844192|Vancomycin|vancomycin
4762877|NCT02844192|under dosage|under dosage
4762878|NCT02844192|intensive care unit|intensive care unit
4762879|NCT02844192|pharmacokinetics|pharmacokinetics
4762880|NCT02844153|Metformin|metformin
4762881|NCT02844153|type 2 diabetes|type 2 diabetes
4762882|NCT02844153|chronic kidney disease|chronic kidney disease
4762883|NCT02844153|antidiabetic medications|antidiabetic medications
4762884|NCT02844153|lactic acidosis|lactic acidosis
4762885|NCT02844114|Ganoderma Lucidum Spore|ganoderma lucidum spore
4762886|NCT02844114|Carcinoma, Non-Small-Cell Lung|carcinoma, non-small-cell lung
4762887|NCT02844114|Chemotherapy|chemotherapy
4762888|NCT02844114|Gemcitabine|gemcitabine
4762889|NCT02844114|Cisplatin|cisplatin
4762890|NCT02844088|meningococcus C|meningococcus c
4762891|NCT02844075|Esophageal Squamous Cell Carcinoma|esophageal squamous cell carcinoma
4762892|NCT02844075|pembrolizumab|pembrolizumab
4762893|NCT02844075|PD-1|pd-1
4762894|NCT02844075|neoadjuvant|neoadjuvant
4762895|NCT02844075|chemoradiation|chemoradiation
4762896|NCT02844049|Deep Brain Stimulation|deep brain stimulation
4762897|NCT02844049|Quality of Life|quality of life
4762898|NCT02844036|Distal Lesions|distal lesions
4762899|NCT02844036|Post-embolic HTP|post-embolic htp
4762900|NCT02844036|Angioplasty|angioplasty
4762901|NCT02844023|Arteritis|arteritis
4762902|NCT02844023|Biomarker|biomarker
4762903|NCT02844023|Horton disease|horton disease
4762904|NCT02843997|Bipolar disorder|bipolar disorder
4762905|NCT02843997|Endophenotype|endophenotype
4762906|NCT02843997|Family|family
4762907|NCT02843997|Autosomal dominant expression|autosomal dominant expression
4762908|NCT02843997|Sequencing|sequencing
4762909|NCT02843997|Heritability|heritability
4762910|NCT02843984|Amniocentesis|amniocentesis
4762911|NCT02843971|Water Drinking Test|water drinking test
4762912|NCT02843971|Intraocular Pressure|intraocular pressure
4762913|NCT02843971|Sensimed Triggerfish|sensimed triggerfish
4762914|NCT02843958|Medical device|medical device
4762915|NCT02843958|Hemoptic|hemoptic
4762916|NCT02843958|Vitamin K antagonist|vitamin k antagonist
4762917|NCT02843958|Diagnostic in vitro|diagnostic in vitro
4762918|NCT02843945|brachytherapy|brachytherapy
4762919|NCT02843945|CivaSheet|civasheet
4762920|NCT02843945|CivaTech|civatech
4762921|NCT02843945|whipple|whipple
4762922|NCT02843945|radiation|radiation
4762923|NCT02843945|borderline resectable|borderline resectable
4762924|NCT02843945|locally advanced|locally advanced
4762925|NCT02843945|Pd-103|pd-103
4762926|NCT02843945|intraoperative radiation|intraoperative radiation
4762927|NCT02843932|Somatoform|somatoform
4762928|NCT02843932|Psychogenic|psychogenic
4762929|NCT02843919|Electrocardiography|electrocardiography
4762930|NCT02843919|Electroencephalography|electroencephalography
4762931|NCT02843919|Neural Correlates|neural correlates
4762932|NCT02843919|Mental Workload|mental workload
4762933|NCT02843906|alzheimer disease|alzheimer disease
4762934|NCT02843906|bipolar disorders|bipolar disorders
4762935|NCT02843906|mild cognitive impairement|mild cognitive impairement
4762936|NCT02843893|Pupillary|pupillary
4762937|NCT02843893|Reflexes|reflexes
4762938|NCT02843893|Analgesia|analgesia
4762939|NCT02843893|Sedation|sedation
4762940|NCT02843880|CMV reactivation|cmv reactivation
4762941|NCT02843880|CMV disease|cmv disease
4762942|NCT02843880|Predictive factors|predictive factors
4762943|NCT02843880|Critically ill patients|critically ill patients
4762944|NCT02843880|Septic shock|septic shock
4762945|NCT02843867|Transplantation|transplantation
4762946|NCT02843867|Immunology|immunology
4762947|NCT02843867|Atherosclerosis|atherosclerosis
4762948|NCT02843828|Exoskeleton Device|exoskeleton device
4762949|NCT02843828|elderly|elderly
4762950|NCT02843828|stroke|stroke
4762951|NCT02843828|gait rehabilitation|gait rehabilitation
4762952|NCT02843815|Non-small cell lung cancer|non-small cell lung cancer
4762953|NCT02843815|Cryosurgery|cryosurgery
4762954|NCT02843815|NK Immunotherapy|nk immunotherapy
4762955|NCT02843802|Metastatic liver cancer|metastatic liver cancer
4762956|NCT02843802|Cryosurgery|cryosurgery
4762957|NCT02843802|NK Immunotherapy|nk immunotherapy
4762958|NCT02843789|Adipokines|adipokines
4762959|NCT02843789|Tocilizumab|tocilizumab
4762960|NCT02843776|Palliative Care|palliative care
4762961|NCT02843776|Euthanasia|euthanasia
4762962|NCT02843776|Epidemiologic Studies|epidemiologic studies
4762963|NCT02843750|Rehabilitation|rehabilitation
4762964|NCT02843750|Inspiratory Muscle Training|inspiratory muscle training
4762965|NCT02843724|Uncontrolled Type 2 Diabetes|uncontrolled type 2 diabetes
4762966|NCT02843724|HbA1c >7.0%|hba1c >7.0%
4762967|NCT02843711|Lungcarta Panel|lungcarta panel
4762968|NCT02843711|lung adenocarcinoma|lung adenocarcinoma
4762969|NCT02843672|metatarsalgia|metatarsalgia
4762970|NCT02843672|surgery|surgery
4762971|NCT02843672|weil|weil
4762972|NCT02843672|MIS|mis
4762973|NCT02843672|percutaneous|percutaneous
4762974|NCT02843672|DMMO|dmmo
4762975|NCT02843646|gait training|gait training
4762976|NCT02843646|stepping|stepping
4762977|NCT02843633|Acute Coronary Syndrome|acute coronary syndrome
4762978|NCT02843633|Percutaneous Coronary Intervention|percutaneous coronary intervention
4762979|NCT02843633|Drug Coated Stent|drug coated stent
4762980|NCT02843633|Drug Eluting Stent|drug eluting stent
4762981|NCT02843620|Native Collagen|native collagen
4762982|NCT02843620|Joint|joint
4762983|NCT02843620|Joint Discomfort|joint discomfort
4762984|NCT02843607|Kidney Cancer|kidney cancer
4762985|NCT02843607|Cryosurgery|cryosurgery
4762986|NCT02843607|NK Immunotherapy|nk immunotherapy
4762987|NCT02843581|Esophageal Cancer|esophageal cancer
4762988|NCT02843581|NK immunotherapy|nk immunotherapy
4762989|NCT02843581|Safety|safety
4762990|NCT02843581|Efficacy|efficacy
4762991|NCT02843555|Leukodystrophy|leukodystrophy
4762992|NCT02843555|Myelin Gene|myelin gene
4762993|NCT02843555|Myelin Protein|myelin protein
4762994|NCT02843555|Sural Nerve Biopsy|sural nerve biopsy
4762995|NCT02843555|Undiagnosed Disease|undiagnosed disease
4762996|NCT02843555|Schwann Cell|schwann cell
4762997|NCT02843555|White Matter Pathology|white matter pathology
4762998|NCT02843555|Motor Delay|motor delay
4762999|NCT02843555|Cognitive Regression|cognitive regression
4763000|NCT02843555|Motor Deterioration|motor deterioration
4763001|NCT02843555|Unknown Disease|unknown disease
4763002|NCT02843542|Positron emission tomography-magnetic resonance imaging (PET-MR)|positron emission tomography-magnetic resonance imaging (pet-mr)
4763003|NCT02843542|Hyperthyroidism|hyperthyroidism
4763004|NCT02843542|Positron emission tomography-computed tomography (PET-CT)|positron emission tomography-computed tomography (pet-ct)
4763005|NCT02843529|biomarkers|biomarkers
4763006|NCT02843529|CSF|csf
4763007|NCT02843529|EEG|eeg
4763008|NCT02843529|MRI|mri
4763009|NCT02843529|Digital biomarkers|digital biomarkers
4763010|NCT02843490|neovascular age-related macular edema|neovascular age-related macular edema
4763011|NCT02843490|biomarker|biomarker
4763012|NCT02843490|ranibizumab|ranibizumab
4763013|NCT02843490|lucentis|lucentis
4763014|NCT02843438|Toxoplasmosis|toxoplasmosis
4763015|NCT02843438|Uveitis|uveitis
4763016|NCT02843438|Chorioretinitis|chorioretinitis
4763017|NCT02843438|Infection|infection
4763018|NCT02843425|Cancer Prevention|cancer prevention
4763019|NCT02843425|Precancerous colorectal polyps|precancerous colorectal polyps
4763020|NCT02843425|Canned beans|canned beans
4763021|NCT02843425|Questionnaires|questionnaires
4763022|NCT02843425|Surveys|surveys
4763023|NCT02843425|Stool samples|stool samples
4763024|NCT02843412|Gastric cancer|gastric cancer
4763025|NCT02843412|Her2/neu|her2/neu
4763026|NCT02843412|Dual paraffin blocks|dual paraffin blocks
4763027|NCT02843412|Trastuzumab|trastuzumab
4763028|NCT02843412|Clinical Prospective Multicenter Cohort Study|clinical prospective multicenter cohort study
4763029|NCT02843399|Diabetes Mellitus Type 2|diabetes mellitus type 2
4763030|NCT02843386|Uveal melanoma|uveal melanoma
4763031|NCT02843386|High risk of metastasis|high risk of metastasis
4763032|NCT02843386|Genomic high risk signature|genomic high risk signature
4763033|NCT02843386|Adjuvant chemotherapy|adjuvant chemotherapy
4763034|NCT02843360|public health|public health
4763035|NCT02843347|Biorepository|biorepository
4763037|NCT02843334|Fabry disease|fabry disease
4763038|NCT02843334|End Stage Renal Disease|end stage renal disease
4763039|NCT02843334|chronic dialysis|chronic dialysis
4763040|NCT02843334|alpha galactosidase A|alpha galactosidase a
4763041|NCT02843334|Lyso-GB3|lyso-gb3
4763042|NCT02843334|GLA mutation|gla mutation
4763043|NCT02843334|Prevalence|prevalence
4763044|NCT02843321|infection|infection
4763045|NCT02843308|hoarding disorder|hoarding disorder
4763046|NCT02843308|hoarding|hoarding
4763047|NCT02843308|clutter|clutter
4763048|NCT02843295|renal transplantation|renal transplantation
4763049|NCT02843295|immunology|immunology
4763050|NCT02843295|rejection|rejection
4763051|NCT02843269|RCT|rct
4763052|NCT02843269|Multi-component intervention|multi-component intervention
4763053|NCT02843269|Health personnel|health personnel
4763054|NCT02843269|Physical exercise training|physical exercise training
4763055|NCT02843230|Brain Tumor|brain tumor
4763056|NCT02843204|solid tumor|solid tumor
4763057|NCT02843204|anti-PD-L1|anti-pd-l1
4763058|NCT02843204|NK immunotherapy|nk immunotherapy
4763059|NCT02843191|Rectal Cancer|rectal cancer
4763060|NCT02843191|Consolidation Chemotherapy|consolidation chemotherapy
4763061|NCT02843178|nutrition|nutrition
4763062|NCT02843178|food security|food security
4763063|NCT02843178|behavioral economics|behavioral economics
4763064|NCT02843165|stereotactic body radiation therapy|stereotactic body radiation therapy
4763065|NCT02843165|checkpoint blockade immunotherapy|checkpoint blockade immunotherapy
4763066|NCT02843139|Circulating microRNA|circulating microrna
4763067|NCT02843139|Childhood obesity|childhood obesity
4763068|NCT02843139|Adulthood diabetes|adulthood diabetes
4763069|NCT02843126|recurrent breast cancer|recurrent breast cancer
4763070|NCT02843126|Her-2 positive|her-2 positive
4763071|NCT02843126|Trastuzumab|trastuzumab
4763072|NCT02843126|NK immunotherapy|nk immunotherapy
4763073|NCT02843113|single father|single father
4763074|NCT02843113|parenting behavior|parenting behavior
4763075|NCT02843100|Crohn's Disease|crohn's disease
4763076|NCT02843100|Pediatric|pediatric
4763077|NCT02843100|Exclusive Enteral Nutrition|exclusive enteral nutrition
4763078|NCT02843100|Diet|diet
4763079|NCT02843100|Microbiome|microbiome
4763080|NCT02843087|Breastfeeding|breastfeeding
4763081|NCT02843087|Microbiome|microbiome
4763082|NCT02843087|BEACH|beach
4763083|NCT02843087|Human milk|human milk
4763084|NCT02843087|Pediatric Obesity|pediatric obesity
4763085|NCT02843074|B-cell tumors|b-cell tumors
4763086|NCT02843074|autologous stem cell transplantation|autologous stem cell transplantation
4763087|NCT02843074|blood cancers|blood cancers
4763088|NCT02843061|B lymphoma|b lymphoma
4763089|NCT02843061|Rituximab|rituximab
4763090|NCT02843061|NK immunotherapy|nk immunotherapy
4763091|NCT02843048|Osteoporosis|osteoporosis
4763092|NCT02843048|Bariatric Surgery|bariatric surgery
4763093|NCT02843048|Physical exercise|physical exercise
4763094|NCT02843048|Obesity|obesity
4763095|NCT02843022|postpartum|postpartum
4763096|NCT02843022|nursing|nursing
4763097|NCT02843022|follow-up|follow-up
4763098|NCT02842983|Esmolol|esmolol
4763099|NCT02842983|Hypotension|hypotension
4763100|NCT02842983|Shock, Septic|shock, septic
4763101|NCT02842983|Sepsis|sepsis
4763225|NCT02842060|Prevention & Control|prevention & control
4763102|NCT02842983|Systemic Inflammatory Response Syndrome|systemic inflammatory response syndrome
4763103|NCT02842983|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists
4763104|NCT02842983|Adrenergic Antagonists|adrenergic antagonists
4763105|NCT02842983|Pharmacologic Actions|pharmacologic actions
4763106|NCT02842983|Physiological Effects of Drugs|physiological effects of drugs
4763107|NCT02842931|DLBCL, R-DA-EPOCH-21, R-mNHL-BFM-90, auto-SCT|dlbcl, r-da-epoch-21, r-mnhl-bfm-90, auto-sct
4763108|NCT02842918|Thoracic Spine Manipulation|thoracic spine manipulation
4763109|NCT02842918|Neurodynamics|neurodynamics
4763110|NCT02842918|Sham|sham
4763111|NCT02842866|Meningitis|meningitis
4763112|NCT02842866|Meningococcal Meningitis|meningococcal meningitis
4763113|NCT02842866|Meningococcal Infections|meningococcal infections
4763114|NCT02842866|MenACYW conjugate vaccine|menacyw conjugate vaccine
4763115|NCT02842866|Menomune® - A/C/Y/W-135|menomune® - a/c/y/w-135
4763116|NCT02842853|Meningitis|meningitis
4763117|NCT02842853|Meningococcal Meningitis|meningococcal meningitis
4763118|NCT02842853|Meningococcal Infections|meningococcal infections
4763119|NCT02842853|MenACYW conjugate vaccine|menacyw conjugate vaccine
4763120|NCT02842853|Licensed MCV4 vaccine|licensed mcv4 vaccine
4763121|NCT02842827|LSD1|lsd1
4763122|NCT02842814|Systemic Lupus Erythematosus|systemic lupus erythematosus
4763123|NCT02842814|Stable|stable
4763124|NCT02842814|Relapse Risk|relapse risk
4763125|NCT02842814|Glucocorticoid Withdrawal|glucocorticoid withdrawal
4763126|NCT02842788|prone position|prone position
4763127|NCT02842788|acute respiratory distress syndrome (ARDS)|acute respiratory distress syndrome (ards)
4763128|NCT02842788|mechanical ventilation|mechanical ventilation
4763129|NCT02842788|ICU|icu
4763130|NCT02842788|prevalence|prevalence
4763131|NCT02842775|rehabilitation|rehabilitation
4763132|NCT02842762|Echocardiography, Three-dimensional|echocardiography, three-dimensional
4763133|NCT02842762|Cardiac Surgical Procedures|cardiac surgical procedures
4763134|NCT02842762|Cardiac Pacing, Artificial|cardiac pacing, artificial
4763135|NCT02842762|Anesthesia|anesthesia
4763136|NCT02842736|heavy menstrual bleeding|heavy menstrual bleeding
4763137|NCT02842736|endometrial ablation|endometrial ablation
4763138|NCT02842723|craniopharyngioma|craniopharyngioma
4763139|NCT02842723|protontherapy|protontherapy
4763140|NCT02842697|clinically significant portal hypertension|clinically significant portal hypertension
4763141|NCT02842697|hepatic venous pressure gradient|hepatic venous pressure gradient
4763142|NCT02842697|computed tomographic angiography|computed tomographic angiography
4763143|NCT02842671|autism|autism
4763144|NCT02842671|ambassador|ambassador
4763145|NCT02842658|Chemotherapy|chemotherapy
4763146|NCT02842658|Exercise|exercise
4763147|NCT02842645|Foetal Exposure During Pregnancy|foetal exposure during pregnancy
4763148|NCT02842645|Health|health
4763149|NCT02842645|Growth|growth
4763150|NCT02842580|colorectal|colorectal
4763151|NCT02842580|cancer|cancer
4763152|NCT02842580|metastasis|metastasis
4763153|NCT02842554|PDN|pdn
4763154|NCT02842554|Painful Diabetic Neuropathy|painful diabetic neuropathy
4763155|NCT02842554|Diabetes|diabetes
4763156|NCT02842502|Skin Substitutes|skin substitutes
4763157|NCT02842489|colonoscopy insertion|colonoscopy insertion
4763158|NCT02842489|tilt-down position|tilt-down position
4763159|NCT02842476|pulse oximetry|pulse oximetry
4763160|NCT02842437|dexmedetomidine|dexmedetomidine
4763161|NCT02842437|sepsis|sepsis
4763162|NCT02842437|respiration|respiration
4763163|NCT02842424|Ramipril|ramipril
4763164|NCT02842424|Angiotensin-converting enzyme|angiotensin-converting enzyme
4763165|NCT02842424|Claudication|claudication
4763166|NCT02842424|Myopathy|myopathy
4763167|NCT02842424|Peripheral Arterial Disease|peripheral arterial disease
4763168|NCT02842411|bowel preparation|bowel preparation
4763169|NCT02842411|chronic constipation|chronic constipation
4763170|NCT02842411|risk factor|risk factor
4763171|NCT02842398|gait|gait
4763172|NCT02842398|balance|balance
4763173|NCT02842398|street-crossing|street-crossing
4763174|NCT02842385|soft tissue thickness|soft tissue thickness
4763175|NCT02842385|dental implant|dental implant
4763176|NCT02842385|crestal bone loss|crestal bone loss
4763177|NCT02842372|Acute Graft Versus Host Disease in Skin|acute graft versus host disease in skin
4763178|NCT02842372|GvHD|gvhd
4763179|NCT02842372|Ectoin|ectoin
4763180|NCT02842372|Dermatitis|dermatitis
4763181|NCT02842372|Inflammation of the skin|inflammation of the skin
4763182|NCT02842372|Topical therapy skin GvHD|topical therapy skin gvhd
4763183|NCT02842346|Ultrasound; umbilical Doppler; resistance index; fetal growth|ultrasound; umbilical doppler; resistance index; fetal growth
4763184|NCT02842307|Acupuncture|acupuncture
4763185|NCT02842307|Expertise-based randomized controlled trial|expertise-based randomized controlled trial
4763186|NCT02842307|Nausea|nausea
4763187|NCT02842307|Vomiting|vomiting
4763188|NCT02842307|Cancer|cancer
4763189|NCT02842294|bevacizumab|bevacizumab
4763190|NCT02842294|health related quality of life|health related quality of life
4763191|NCT02842255|Sleep apnea|sleep apnea
4763192|NCT02842255|Oximeter|oximeter
4763193|NCT02842255|Calibration|calibration
4763194|NCT02842255|Oxygen partial pressure|oxygen partial pressure
4763195|NCT02842229|Myelodysplastic Syndromes|myelodysplastic syndromes
4763196|NCT02842229|Leukemia Myeloid Acute|leukemia myeloid acute
4763197|NCT02842229|Multiple Myeloma|multiple myeloma
4763198|NCT02842229|Leukemia, Lymphocytic, Chronic|leukemia, lymphocytic, chronic
4763199|NCT02842229|Elderly Patients|elderly patients
4763200|NCT02842229|Haematological malignancy|haematological malignancy
4763201|NCT02842229|Elderly|elderly
4763202|NCT02842229|Health Status|health status
4763203|NCT02842229|Scale validation|scale validation
4763204|NCT02842229|Retrospective|retrospective
4763205|NCT02842216|Pharmaceutical preparations|pharmaceutical preparations
4763206|NCT02842216|Dietary supplements|dietary supplements
4763207|NCT02842203|colorectal cancer|colorectal cancer
4763208|NCT02842190|Neonatal|neonatal
4763209|NCT02842190|NIPPV|nippv
4763210|NCT02842190|BIPAP|bipap
4763211|NCT02842190|Extubation failure|extubation failure
4763212|NCT02842151|IOL|iol
4763213|NCT02842125|Head and Neck Squamous Cell Cancer|head and neck squamous cell cancer
4763214|NCT02842125|solid tumors|solid tumors
4763215|NCT02842125|nivolumab|nivolumab
4763216|NCT02842125|Ad-P53|ad-p53
4763217|NCT02842125|metastatic|metastatic
4763218|NCT02842125|capecitabine|capecitabine
4763219|NCT02842125|pembrolizumab|pembrolizumab
4763220|NCT02842112|Acute myeloid leukemia|acute myeloid leukemia
4763221|NCT02842112|prognosis|prognosis
4763222|NCT02842112|stem cell harvest|stem cell harvest
4763223|NCT02842112|autologous transplant|autologous transplant
4763224|NCT02842112|leukemia stem cell|leukemia stem cell
4763226|NCT02842060|Young Adult|young adult
4763227|NCT02842060|Internet|internet
4763228|NCT02842047|caregiver|caregiver
4763229|NCT02842047|end of life|end of life
4763230|NCT02842034|schizophrenia|schizophrenia
4763231|NCT02842034|rTMS|rtms
4763232|NCT02842008|Exercise Therapy|exercise therapy
4763233|NCT02842008|Shoulder pain|shoulder pain
4763234|NCT02842008|Shoulder injuries|shoulder injuries
4763235|NCT02842008|Shoulder function|shoulder function
4763236|NCT02842008|Prevention|prevention
4763237|NCT02842008|Wheelchair users|wheelchair users
4763238|NCT02841995|cGVHD|cgvhd
4763239|NCT02841995|Allogeneic hematopoietic stem cell transplantation|allogeneic hematopoietic stem cell transplantation
4763240|NCT02841995|Immune System Diseases|immune system diseases
4763241|NCT02841995|Steroid refractory chronic graft vs host disease (cGVHD)|steroid refractory chronic graft vs host disease (cgvhd)
4763242|NCT02841995|Bone Marrow Transplantation|bone marrow transplantation
4763243|NCT02841995|Anti-Inflammatory Agents|anti-inflammatory agents
4763244|NCT02841995|Glucocorticoids|glucocorticoids
4763245|NCT02841995|Corticosteroids|corticosteroids
4763246|NCT02841969|Ulcer|ulcer
4763247|NCT02841969|Electrolysed|electrolysed
4763248|NCT02841969|Water|water
4763249|NCT02841943|Fluid responsiveness|fluid responsiveness
4763250|NCT02841943|Near-infrared spectroscopy|near-infrared spectroscopy
4763251|NCT02841943|Thoracic surgery|thoracic surgery
4763252|NCT02841943|Hypovolemia|hypovolemia
4763253|NCT02841943|veno-arterial carbon dioxide gradient|veno-arterial carbon dioxide gradient
4763254|NCT02841943|arterio-venous oxygen gradient|arterio-venous oxygen gradient
4763255|NCT02841943|hypercarbia|hypercarbia
4763256|NCT02841943|Carotid artery|carotid artery
4763257|NCT02841943|ultrasonography|ultrasonography
4763258|NCT02841943|Doppler|doppler
4763259|NCT02841930|Healthcare Access|healthcare access
4763260|NCT02841930|Undocumented Immigrants|undocumented immigrants
4763261|NCT02841930|Primary Prevention|primary prevention
4763262|NCT02841800|radiofrequency ablation|radiofrequency ablation
4763263|NCT02841800|malignant biliary stenosis|malignant biliary stenosis
4763264|NCT02841787|Depression|depression
4763265|NCT02841787|Web-based intervention|web-based intervention
4763266|NCT02841787|Aging|aging
4763267|NCT02841787|Geriatrics|geriatrics
4763268|NCT02841787|Social network|social network
4763269|NCT02841787|Older adults|older adults
4763270|NCT02841748|Pembrolizumab|pembrolizumab
4763271|NCT02841748|HNSCC|hnscc
4763272|NCT02841735|brief intervention|brief intervention
4763273|NCT02841735|web-based interventions|web-based interventions
4763274|NCT02841735|harm reduction|harm reduction
4763275|NCT02841735|young adult|young adult
4763276|NCT02841735|college student|college student
4763277|NCT02841709|insomnia|insomnia
4763278|NCT02841709|elderly|elderly
4763279|NCT02841709|Polysomnography|polysomnography
4763280|NCT02841696|Heart failure|heart failure
4763281|NCT02841696|Systolic dysfunction|systolic dysfunction
4763282|NCT02841696|GLS|gls
4763283|NCT02841696|Arterial stiffness|arterial stiffness
4763284|NCT02841696|Left ventricular hypertrophy|left ventricular hypertrophy
4763285|NCT02841657|3 Dimensional Laparoscopy|3 dimensional laparoscopy
4763286|NCT02841657|Visual work load|visual work load
4763287|NCT02841657|Nasa Task Load Index|nasa task load index
4763288|NCT02841657|Simulator Sickness Questionnaire|simulator sickness questionnaire
4763289|NCT02841553|Endoplasmic Reticulum Stress|endoplasmic reticulum stress
4763290|NCT02841540|Myelodysplastic Syndromes|myelodysplastic syndromes
4763291|NCT02841540|Acute Myeloid Leukemia|acute myeloid leukemia
4763292|NCT02841540|Chronic Myelomonocytic Leukemia|chronic myelomonocytic leukemia
4763293|NCT02841540|H3B-8800|h3b-8800
4763294|NCT02841540|Splicing Modulator|splicing modulator
4763295|NCT02841540|CMML|cmml
4763296|NCT02841540|AML|aml
4763297|NCT02841540|MDS|mds
4763298|NCT02841501|Gene Expression Profiling|gene expression profiling
4763299|NCT02841501|Genome-Wide Association Study|genome-wide association study
4763300|NCT02841501|Polymorphism, Single Nucleotide|polymorphism, single nucleotide
4763301|NCT02841501|Drug Resistance, Fungal|drug resistance, fungal
4763302|NCT02841475|Atrial Fibrillation , Comorbidities|atrial fibrillation , comorbidities
4763303|NCT02841462|thermal ablation|thermal ablation
4763304|NCT02841462|recurrent Bursitis|recurrent bursitis
4763305|NCT02841462|chronic Bursitis|chronic bursitis
4763306|NCT02841462|olecranon|olecranon
4763307|NCT02841462|intra-bursal perfusion|intra-bursal perfusion
4763308|NCT02841449|Hydration|hydration
4763309|NCT02841449|Glycemic control|glycemic control
4763310|NCT02841449|Appetite|appetite
4763311|NCT02841449|Endocrinology|endocrinology
4763312|NCT02841436|irreversible electroporation|irreversible electroporation
4763313|NCT02841436|pancreatic cancer|pancreatic cancer
4763314|NCT02841423|physical status I-III;|physical status i-iii;
4763315|NCT02841423|age > 55 yr)|age > 55 yr)
4763316|NCT02841423|undergoing surgery (duration, > 1 h)|undergoing surgery (duration, > 1 h)
4763317|NCT02841410|Food|food
4763318|NCT02841410|Emotion|emotion
4763319|NCT02841410|Health|health
4763320|NCT02841410|Nutrition|nutrition
4763321|NCT02841410|Heuristic|heuristic
4763322|NCT02841410|Reasoning|reasoning
4763323|NCT02841410|Magnetic Resonance Imaging|magnetic resonance imaging
4763324|NCT02841384|patellofemoral pain syndrome|patellofemoral pain syndrome
4763325|NCT02841384|postural balance|postural balance
4763326|NCT02841384|knee|knee
4763327|NCT02841384|physiotherapy|physiotherapy
4763328|NCT02841371|estimated glomerular filtration rate|estimated glomerular filtration rate
4763329|NCT02841371|serum creatinine|serum creatinine
4763330|NCT02841371|serum cystatin C|serum cystatin c
4763331|NCT02841371|chronic kidney disease|chronic kidney disease
4763741|NCT02838550|Pedometers|pedometers
4763332|NCT02841358|Niemann-Pick Disease, Type C|niemann-pick disease, type c
4763333|NCT02841358|Psychiatric|psychiatric
4763334|NCT02841358|Psychotic disorders|psychotic disorders
4763335|NCT02841345|emotional processing|emotional processing
4763336|NCT02841345|action|action
4763337|NCT02841332|Recurrent Glioblastoma|recurrent glioblastoma
4763338|NCT02841332|Positron emission tomography|positron emission tomography
4763339|NCT02841332|Fluoro misonidazole|fluoro misonidazole
4763340|NCT02841332|MRI multimodal|mri multimodal
4763341|NCT02841319|Virtual reality|virtual reality
4763342|NCT02841319|Hemiplegic|hemiplegic
4763343|NCT02841319|Cerebral Palsy|cerebral palsy
4763344|NCT02841319|upper extremity|upper extremity
4763345|NCT02841319|hand function|hand function
4763346|NCT02841293|Anorectal cancer|anorectal cancer
4763347|NCT02841293|perineal morbidity|perineal morbidity
4763348|NCT02841293|cost-utility analysis|cost-utility analysis
4763349|NCT02841293|biological meshes|biological meshes
4763350|NCT02841241|esmolol|esmolol
4763351|NCT02841241|adrenergic storm|adrenergic storm
4763352|NCT02841241|septic shock|septic shock
4763353|NCT02841228|SIB-IMRT|sib-imrt
4763354|NCT02841228|NSCLC|nsclc
4763355|NCT02841228|Radiochemothearpy|radiochemothearpy
4763356|NCT02841215|Gale|gale
4763357|NCT02841215|Severe forms of scabies|severe forms of scabies
4763358|NCT02841215|Oral parasitic drug|oral parasitic drug
4763359|NCT02841215|Ivermectin|ivermectin
4763360|NCT02841202|optical coherence tomography|optical coherence tomography
4763361|NCT02841202|oral contraceptive pills|oral contraceptive pills
4763362|NCT02841163|Magnetic Resonance Imaging|magnetic resonance imaging
4763363|NCT02841163|Patient Satisfaction|patient satisfaction
4763364|NCT02841163|Numeric Rating Scale|numeric rating scale
4763365|NCT02841124|Decision making|decision making
4763366|NCT02841098|Carotid stenosis,stroke,endarterectomy,medical therapy|carotid stenosis,stroke,endarterectomy,medical therapy
4763367|NCT02841085|Genetic|genetic
4763368|NCT02841085|Thrombophilia|thrombophilia
4763369|NCT02841059|quality of life|quality of life
4763370|NCT02841059|urinary incontinence|urinary incontinence
4763371|NCT02841059|POP|pop
4763372|NCT02841046|stroke volume variation|stroke volume variation
4763373|NCT02841046|cardiac index|cardiac index
4763374|NCT02841046|non-severe patients|non-severe patients
4763375|NCT02841046|gastrointestinal surgery|gastrointestinal surgery
4763376|NCT02841033|Daratumumab|daratumumab
4763377|NCT02840994|CV301, NSCLC, Pembrolizumab, Nivolumab|cv301, nsclc, pembrolizumab, nivolumab
4763378|NCT02840955|Atopic dermatitis|atopic dermatitis
4763379|NCT02840955|Staphylococcus aureus|staphylococcus aureus
4763380|NCT02840955|Microbiome|microbiome
4763381|NCT02840955|Staphefekt|staphefekt
4763382|NCT02840942|intravenous line|intravenous line
4763383|NCT02840942|robot|robot
4763384|NCT02840916|Laser acupuncture|laser acupuncture
4763385|NCT02840916|Postpartum weight retention|postpartum weight retention
4763386|NCT02840916|Obesity|obesity
4763387|NCT02840903|CTA|cta
4763388|NCT02840903|Computed Tomographic Angiography|computed tomographic angiography
4763389|NCT02840877|tuberculosis culture|tuberculosis culture
4763390|NCT02840877|alcohol use|alcohol use
4763391|NCT02840851|Magnetic Resonance Imaging|magnetic resonance imaging
4763392|NCT02840851|Transcranial Doppler Ultrasound|transcranial doppler ultrasound
4763393|NCT02840851|Hypercapnia|hypercapnia
4763394|NCT02840799|Heart Failure|heart failure
4763395|NCT02840799|Exercise Intolerance|exercise intolerance
4763396|NCT02840799|Ejection Fraction|ejection fraction
4763397|NCT02840786|stents|stents
4763398|NCT02840786|atherectomy|atherectomy
4763399|NCT02840786|femoral artery|femoral artery
4763400|NCT02840786|popliteal artery|popliteal artery
4763401|NCT02840773|RANKL|rankl
4763402|NCT02840773|OPG|opg
4763403|NCT02840773|Peri-implant crevicular fluid|peri-implant crevicular fluid
4763404|NCT02840760|tardive dyskinesia.|tardive dyskinesia.
4763405|NCT02840760|rTMS|rtms
4763406|NCT02840747|Lymphomatoid Papulosis|lymphomatoid papulosis
4763407|NCT02840747|Sézary Syndrome|sézary syndrome
4763408|NCT02840747|T-Cell Lymphoma|t-cell lymphoma
4763409|NCT02840734|Kinesio taping|kinesio taping
4763410|NCT02840734|Obese adults|obese adults
4763411|NCT02840734|Muscular function|muscular function
4763412|NCT02840734|Fatigue|fatigue
4763413|NCT02840682|resource limited setting|resource limited setting
4763414|NCT02840682|Thailand-Myanmar border|thailand-myanmar border
4763415|NCT02840669|Cardiomyopathy|cardiomyopathy
4763416|NCT02840643|hemispherectomy|hemispherectomy
4763417|NCT02840643|brain|brain
4763418|NCT02840643|hand function|hand function
4763419|NCT02840630|n3 LC-PUFA|n3 lc-pufa
4763420|NCT02840630|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
4763421|NCT02840630|South Asian|south asian
4763422|NCT02840630|HbA1c|hba1c
4763423|NCT02840630|Omega 3 status|omega 3 status
4763424|NCT02840617|ICG|icg
4763425|NCT02840617|prostate cancer|prostate cancer
4763426|NCT02840591|Citicoline, Ramelteon, Rozerem|citicoline, ramelteon, rozerem
4763427|NCT02840539|Mantle cell lymphoma|mantle cell lymphoma
4763428|NCT02840539|Bortezomib|bortezomib
4763429|NCT02840539|Cytarabine|cytarabine
4763430|NCT02840526|PVB|pvb
4763431|NCT02840526|PCA|pca
4763432|NCT02840526|nephrectomy|nephrectomy
4763742|NCT02838537|Triptan|triptan
4763433|NCT02840526|postoperative pain|postoperative pain
4763434|NCT02840513|Smartphone app|smartphone app
4763435|NCT02840513|CO self-monitoring|co self-monitoring
4763436|NCT02840500|Breakthrough Cancer Pain|breakthrough cancer pain
4763437|NCT02840500|Quality of life|quality of life
4763438|NCT02840500|Palliative Care Units|palliative care units
4763439|NCT02840487|Zika Infection|zika infection
4763440|NCT02840487|Flavivirus|flavivirus
4763441|NCT02840487|Vaccine-Mediated Protection|vaccine-mediated protection
4763442|NCT02840487|Immune Response|immune response
4763443|NCT02840487|Arthropod-Borne Virus|arthropod-borne virus
4763444|NCT02840474|HIV Viral Load|hiv viral load
4763445|NCT02840474|Antiviral|antiviral
4763446|NCT02840474|CD4 Count|cd4 count
4763447|NCT02840474|HIV-1 Infection|hiv-1 infection
4763448|NCT02840448|Williams Syndrome|williams syndrome
4763449|NCT02840448|Blood Flow|blood flow
4763450|NCT02840448|Brain|brain
4763451|NCT02840448|Arterial Stiffness|arterial stiffness
4763452|NCT02840435|Nicotine addiction|nicotine addiction
4763453|NCT02840435|Cigarette smoking|cigarette smoking
4763454|NCT02840422|Hyaluronic acid|hyaluronic acid
4763455|NCT02840422|Knee osteoarthritis|knee osteoarthritis
4763456|NCT02840422|Quality of life|quality of life
4763457|NCT02840396|language|language
4763458|NCT02840396|DLPFC|dlpfc
4763459|NCT02840396|rTMS|rtms
4763460|NCT02840396|Executive Functions|executive functions
4763461|NCT02840370|transcranial direct current stimulation|transcranial direct current stimulation
4763462|NCT02840370|aphasia|aphasia
4763463|NCT02840370|language production|language production
4763464|NCT02840370|prefrontal cortex|prefrontal cortex
4763465|NCT02840357|Chronic inflammation|chronic inflammation
4763466|NCT02840357|Adults|adults
4763467|NCT02840357|overweight|overweight
4763468|NCT02840357|obese|obese
4763469|NCT02840344|Couple Functioning|couple functioning
4763470|NCT02840344|Stress Reduction|stress reduction
4763471|NCT02840331|Gastric carcinoma|gastric carcinoma
4763472|NCT02840331|Peritoneal carcinomatosis|peritoneal carcinomatosis
4763473|NCT02840331|Photodynamic diagnosis|photodynamic diagnosis
4763474|NCT02840331|Photodynamic therapy|photodynamic therapy
4763475|NCT02840331|St. John's Wort|st. john's wort
4763476|NCT02840331|Peritoneal metastasis|peritoneal metastasis
4763477|NCT02840318|Terminal care|terminal care
4763478|NCT02840318|Residential facilities|residential facilities
4763479|NCT02840318|Integrated health care systems|integrated health care systems
4763480|NCT02840318|Interdisciplinary health team|interdisciplinary health team
4763481|NCT02840318|Palliative care|palliative care
4763482|NCT02840305|Natural scenes|natural scenes
4763483|NCT02840305|Brain bases|brain bases
4763484|NCT02840305|Visual perception|visual perception
4763485|NCT02840305|MRI|mri
4763486|NCT02840292|Late Preterms|late preterms
4763487|NCT02840292|Neurobehavioral Assessment of Preterm Infants (NAPI)|neurobehavioral assessment of preterm infants (napi)
4763488|NCT02840279|cognition|cognition
4763489|NCT02840279|dementia|dementia
4763490|NCT02840279|phosphodiesterase type 4D|phosphodiesterase type 4d
4763491|NCT02840279|PDE4D|pde4d
4763492|NCT02840227|Cancer|cancer
4763493|NCT02840227|General anesthesia|general anesthesia
4763494|NCT02840227|Epidural anesthesia|epidural anesthesia
4763495|NCT02840201|biomarkers|biomarkers
4763496|NCT02840188|goalkeeper's fracture|goalkeeper's fracture
4763497|NCT02840175|Treatment tapering|treatment tapering
4763498|NCT02840175|Oligoarticular|oligoarticular
4763499|NCT02840175|Juvenile Idiopathic Arthritis|juvenile idiopathic arthritis
4763500|NCT02840175|Inactive disease|inactive disease
4763501|NCT02840175|Biologic therapy|biologic therapy
4763502|NCT02840162|prostate cancer|prostate cancer
4763503|NCT02840162|NSAIDs|nsaids
4763504|NCT02840162|chemoprevention|chemoprevention
4763505|NCT02840162|celecoxib|celecoxib
4763506|NCT02840162|COX-2 inhibitors|cox-2 inhibitors
4763507|NCT02840149|68Ga-DOTA-TATE, PET/CT|68ga-dota-tate, pet/ct
4763508|NCT02840136|Respiratory infection|respiratory infection
4763509|NCT02840136|Antibiotic therapy|antibiotic therapy
4763510|NCT02840136|LC-MS/MS|lc-ms/ms
4763511|NCT02840136|Sputum antibiotic concentrations|sputum antibiotic concentrations
4763512|NCT02840097|Brain injuries|brain injuries
4763513|NCT02840097|Wounds and injuries|wounds and injuries
4763514|NCT02840097|Hemorrhage|hemorrhage
4763515|NCT02840097|Tranexamic acid|tranexamic acid
4763516|NCT02840097|Child|child
4763517|NCT02840084|breast implant capsular contracture|breast implant capsular contracture
4763518|NCT02840045|electroencephalography (EEG)|electroencephalography (eeg)
4763519|NCT02840019|Fetal MRI|fetal mri
4763520|NCT02840019|Pregnancy|pregnancy
4763521|NCT02840019|Pregnant Women|pregnant women
4763522|NCT02840019|MRI Coil|mri coil
4763523|NCT02840019|MRI Sequence Development/Testing|mri sequence development/testing
4763524|NCT02840019|Abnormal Fetuses|abnormal fetuses
4763525|NCT02840019|Typically Developing Fetuses|typically developing fetuses
4763526|NCT02840019|Fetal MRI Technology Development|fetal mri technology development
4763527|NCT02840006|Vasoconstrictor Agents|vasoconstrictor agents
4763528|NCT02840006|Vasodilator Agents|vasodilator agents
4763529|NCT02839993|tDCS effects|tdcs effects
4763530|NCT02839993|associative learning|associative learning
4763531|NCT02839980|oropharyngeal colonization|oropharyngeal colonization
4763532|NCT02839915|Language Impairment|language impairment
4763533|NCT02839850|Arthroplasty|arthroplasty
4763534|NCT02839850|replacement|replacement
4763535|NCT02839850|Knee|knee
4763536|NCT02839850|function|function
4763537|NCT02839850|radiographic|radiographic
4763538|NCT02839850|survivorship|survivorship
4763539|NCT02839837|Depression|depression
4763540|NCT02839837|Depressive Disorder|depressive disorder
4763541|NCT02839837|Exercise|exercise
4763542|NCT02839837|Neuroplasticity|neuroplasticity
4763543|NCT02839837|Non-invasive brain stimulation|non-invasive brain stimulation
4763544|NCT02839837|Healthy Control|healthy control
4763545|NCT02839824|bowel cleansing|bowel cleansing
4763546|NCT02839824|bowel preparation|bowel preparation
4763547|NCT02839811|Betalactams|betalactams
4763548|NCT02839811|In vitro diagnosis|in vitro diagnosis
4763549|NCT02839798|sTMS|stms
4763550|NCT02839798|NEST|nest
4763551|NCT02839798|NeoSync|neosync
4763552|NCT02839798|synchronous|synchronous
4763553|NCT02839798|non-invasive neuromodulation|non-invasive neuromodulation
4763554|NCT02839798|TMS|tms
4763555|NCT02839798|transcranial magnetic stimulation|transcranial magnetic stimulation
4763556|NCT02839798|EEG|eeg
4763557|NCT02839798|bipolar|bipolar
4763558|NCT02839798|depression|depression
4763559|NCT02839785|Cerebral palsy|cerebral palsy
4763560|NCT02839785|Physiotherapy|physiotherapy
4763561|NCT02839785|Children|children
4763562|NCT02839785|Ibuprofen|ibuprofen
4763563|NCT02839785|Pain|pain
4763564|NCT02839785|Anxiety|anxiety
4763565|NCT02839772|podoconiosis|podoconiosis
4763566|NCT02839772|glycerine|glycerine
4763567|NCT02839772|RCT|rct
4763568|NCT02839772|SBF|sbf
4763569|NCT02839772|TEWL|tewl
4763570|NCT02839772|SC hydration|sc hydration
4763571|NCT02839759|Hearing loss|hearing loss
4763572|NCT02839759|Presbycusis|presbycusis
4763573|NCT02839759|Aging|aging
4763574|NCT02839759|Teleaudiology|teleaudiology
4763575|NCT02839733|Brain Imaging|brain imaging
4763576|NCT02839733|Adult|adult
4763577|NCT02839733|DNA Testing|dna testing
4763578|NCT02839733|Children|children
4763579|NCT02839694|Lung Resection|lung resection
4763580|NCT02839694|Surgery|surgery
4763581|NCT02839694|Bilateral Lung Metastases|bilateral lung metastases
4763582|NCT02839681|Lung Adenocarcinoma|lung adenocarcinoma
4763583|NCT02839681|Immunotoxin|immunotoxin
4763584|NCT02839681|Immunotherapy|immunotherapy
4763585|NCT02839668|breast cancer|breast cancer
4763586|NCT02839668|angiogenesis|angiogenesis
4763587|NCT02839668|VEGF|vegf
4763588|NCT02839603|Visceral leishmaniasis|visceral leishmaniasis
4763589|NCT02839603|HIV co-infection|hiv co-infection
4763590|NCT02839603|Asymptomatic|asymptomatic
4763591|NCT02839590|Glaucoma|glaucoma
4763592|NCT02839590|Ocular hypertension|ocular hypertension
4763593|NCT02839590|Aqueous dynamics|aqueous dynamics
4763594|NCT02839564|chronic abdominal pain|chronic abdominal pain
4763595|NCT02839564|laparoscopic adhesiolysis|laparoscopic adhesiolysis
4763596|NCT02839564|placebo|placebo
4763597|NCT02839551|Betalactams|betalactams
4763598|NCT02839551|Drug hypersensitivity|drug hypersensitivity
4763599|NCT02839551|Drug provocation test|drug provocation test
4763600|NCT02839551|Reactive dose|reactive dose
4763601|NCT02839538|infiltration|infiltration
4763602|NCT02839538|hemorrhoidectomy|hemorrhoidectomy
4763603|NCT02839538|postoperative pain|postoperative pain
4763604|NCT02839525|Eccentric exercise|eccentric exercise
4763605|NCT02839525|Dietary supplement|dietary supplement
4763606|NCT02839525|Muscle damage|muscle damage
4763607|NCT02839499|seniors|seniors
4763608|NCT02839499|mixed food|mixed food
4763609|NCT02839499|normal texture food|normal texture food
4763610|NCT02839486|antibiotic prophylaxis|antibiotic prophylaxis
4763611|NCT02839486|pharmacokinetics|pharmacokinetics
4763612|NCT02839486|cardiopulmonary bypass|cardiopulmonary bypass
4763613|NCT02839447|semen|semen
4763614|NCT02839447|sperm|sperm
4763615|NCT02839447|oxidative stress|oxidative stress
4763616|NCT02839447|reactive oxygen species|reactive oxygen species
4763617|NCT02839447|idiopathic male infertility|idiopathic male infertility
4763618|NCT02839408|periodontitis|periodontitis
4763619|NCT02839408|azithromycin|azithromycin
4763620|NCT02839408|probiotic|probiotic
4763621|NCT02839395|screen illumination|screen illumination
4763622|NCT02839395|melatonin|melatonin
4763623|NCT02839395|body temperature|body temperature
4763624|NCT02839395|cognitive functioning|cognitive functioning
4763625|NCT02839395|light pollution|light pollution
4763626|NCT02839369|walking performance|walking performance
4763627|NCT02839369|Cerebral Palsy, Typically Developed|cerebral palsy, typically developed
4763628|NCT02839330|Influenza|influenza
4763629|NCT02839330|Vaccine|vaccine
4763631|NCT02839330|Avian|avian
4763632|NCT02839330|Pandemic|pandemic
4763633|NCT02839330|H5N1|h5n1
4763634|NCT02839330|MF59|mf59
4763635|NCT02839317|Dysbiosis|dysbiosis
4763636|NCT02839317|Crohn's disease|crohn's disease
4763637|NCT02839317|Age|age
4763638|NCT02839278|Immunomodulation|immunomodulation
4763639|NCT02839226|ulcers|ulcers
4763640|NCT02839226|wounds|wounds
4763641|NCT02839226|diabetes|diabetes
4763642|NCT02839226|venous ulcers|venous ulcers
4763643|NCT02839226|arterial ulcers|arterial ulcers
4763644|NCT02839226|granulation tissue|granulation tissue
4763645|NCT02839226|protein kinase c|protein kinase c
4763646|NCT02839200|Insomnia|insomnia
4763647|NCT02839200|Polysomnography|polysomnography
4763648|NCT02839174|low carbohydrate diet|low carbohydrate diet
4763649|NCT02839161|Hookworm|hookworm
4763650|NCT02839161|Vaccine|vaccine
4763651|NCT02839161|Na-GST-1|na-gst-1
4763652|NCT02839161|Na-APR-1|na-apr-1
4763653|NCT02839161|Necator americanus|necator americanus
4763654|NCT02839148|Appetite, Stunting, Satiety, Children|appetite, stunting, satiety, children
4763655|NCT02839122|Dutasteride|dutasteride
4763656|NCT02839122|Tadalafil|tadalafil
4763657|NCT02839070|Sleep|sleep
4763658|NCT02839070|Learning|learning
4763659|NCT02839070|Circadian Rhythms|circadian rhythms
4763660|NCT02839057|Axis fractures|axis fractures
4763661|NCT02839057|Elderly|elderly
4763662|NCT02839057|Mortality|mortality
4763663|NCT02839057|Surgical treatment|surgical treatment
4763664|NCT02839031|diabetes mellitus|diabetes mellitus
4763665|NCT02839031|glycaemia|glycaemia
4763666|NCT02839031|cognitive-behavioral treatment|cognitive-behavioral treatment
4763667|NCT02839031|coping|coping
4763668|NCT02839031|parents|parents
4763669|NCT02839031|children|children
4763670|NCT02839005|Wound Closure Thechnical|wound closure thechnical
4763671|NCT02839005|Wound Healing|wound healing
4763672|NCT02838992|Cyclophosphamide|cyclophosphamide
4763673|NCT02838992|Umbilical Cord Blood|umbilical cord blood
4763674|NCT02838992|ATG|atg
4763675|NCT02838979|Glutamine|glutamine
4763676|NCT02838979|Chronic Kidney Disease|chronic kidney disease
4763677|NCT02838966|immunomodulation|immunomodulation
4763678|NCT02838966|immunonutrition|immunonutrition
4763679|NCT02838953|Ultrasonography|ultrasonography
4763680|NCT02838953|Respiratory Function Tests|respiratory function tests
4763681|NCT02838953|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
4763682|NCT02838953|Rehabilitation|rehabilitation
4763683|NCT02838927|Hypoparathyroidism|hypoparathyroidism
4763684|NCT02838927|Epidemiology|epidemiology
4763685|NCT02838927|Medication Therapy Management|medication therapy management
4763686|NCT02838914|Right atrium|right atrium
4763687|NCT02838914|Echocardiography|echocardiography
4763688|NCT02838914|Remodeling|remodeling
4763689|NCT02838888|Adenoma|adenoma
4763690|NCT02838888|computer|computer
4763691|NCT02838888|automatic|automatic
4763692|NCT02838888|polyp|polyp
4763693|NCT02838888|detection|detection
4763694|NCT02838862|Neuroendocrine Tumors|neuroendocrine tumors
4763695|NCT02838862|MALDI-MS|maldi-ms
4763696|NCT02838862|Proteomics|proteomics
4763697|NCT02838862|Biomarkers, Tumor|biomarkers, tumor
4763698|NCT02838862|Precision Medicine|precision medicine
4763699|NCT02838836|Cancer|cancer
4763700|NCT02838836|Circulating tumor cells (CTCs)|circulating tumor cells (ctcs)
4763701|NCT02838836|Disseminated tumor cells (DTCs)|disseminated tumor cells (dtcs)
4763702|NCT02838836|Circulating tumor DNA (ctDNA)|circulating tumor dna (ctdna)
4763703|NCT02838823|anti-PD-1 monoclonal antibody|anti-pd-1 monoclonal antibody
4763704|NCT02838823|triple negative breast cancer|triple negative breast cancer
4763705|NCT02838823|safety|safety
4763706|NCT02838810|peginterferon alfa|peginterferon alfa
4763707|NCT02838810|Chronic Hepatitis B|chronic hepatitis b
4763708|NCT02838797|Parkinson's disease|parkinson's disease
4763709|NCT02838797|Gastroparesis|gastroparesis
4763710|NCT02838797|Constipation|constipation
4763711|NCT02838797|Prokinetic|prokinetic
4763712|NCT02838797|5-HT4-receptor partial agonist|5-ht4-receptor partial agonist
4763713|NCT02838771|Swallowing Disorder|swallowing disorder
4763714|NCT02838771|Dysphagia|dysphagia
4763715|NCT02838758|Morton's neuroma|morton's neuroma
4763716|NCT02838758|Intermetatarsal neuroma|intermetatarsal neuroma
4763717|NCT02838758|forefoot pain|forefoot pain
4763718|NCT02838758|ultrasound guided cryoablation|ultrasound guided cryoablation
4763719|NCT02838758|ultrasound guided perineural lidocaine injection|ultrasound guided perineural lidocaine injection
4763720|NCT02838706|postoperative anemia|postoperative anemia
4763721|NCT02838706|perfusion index|perfusion index
4763722|NCT02838680|aortic stenosis|aortic stenosis
4763723|NCT02838680|transcatheter aortic valve replacement (TAVR)|transcatheter aortic valve replacement (tavr)
4763724|NCT02838654|cervical epidural space|cervical epidural space
4763725|NCT02838654|wave form analysis|wave form analysis
4763726|NCT02838615|spinal stenosis|spinal stenosis
4763727|NCT02838615|epidural steroid injection|epidural steroid injection
4763728|NCT02838602|carbon ions therapy|carbon ions therapy
4763729|NCT02838602|radiotherapy|radiotherapy
4763730|NCT02838602|radioresistant tumors|radioresistant tumors
4763731|NCT02838602|cancer|cancer
4763732|NCT02838602|randomized trial|randomized trial
4763733|NCT02838589|Cerebrovascular Stroke|cerebrovascular stroke
4763734|NCT02838589|Ischemic Stroke|ischemic stroke
4763735|NCT02838589|Glucagon like peptide - 1|glucagon like peptide - 1
4763736|NCT02838563|Dementia|dementia
4763737|NCT02838563|Alzheimer|alzheimer
4763738|NCT02838563|Well-Being|well-being
4763739|NCT02838550|Physical Activity|physical activity
4763740|NCT02838550|Motivational Online Intervention|motivational online intervention
4763743|NCT02838537|Drug utilization|drug utilization
4763744|NCT02838537|Elderly|elderly
4763745|NCT02838537|Drug abuse|drug abuse
4763746|NCT02838537|Cardiovascular disease|cardiovascular disease
4763747|NCT02838524|Spontaneous Breathing Trial|spontaneous breathing trial
4763748|NCT02838524|Inspiratory Effort|inspiratory effort
4763749|NCT02838524|Mechanical Ventilation|mechanical ventilation
4763750|NCT02838524|Respiratory muscle load-capacity balance|respiratory muscle load-capacity balance
4763751|NCT02838498|ERCP|ercp
4763752|NCT02838498|EMS|ems
4763753|NCT02838498|Cannulation|cannulation
4763754|NCT02838498|Successful rate|successful rate
4763755|NCT02838498|Trainee|trainee
4763756|NCT02838407|Chronic lower respiratory tract infection|chronic lower respiratory tract infection
4763757|NCT02838407|Bonchoalveolar lavage|bonchoalveolar lavage
4763758|NCT02838407|Nasopharyngeal swabs|nasopharyngeal swabs
4763759|NCT02838290|Burnout|burnout
4763760|NCT02838290|Psychiatric morbidity|psychiatric morbidity
4763761|NCT02838290|Anxiety|anxiety
4763762|NCT02838290|Grief|grief
4763763|NCT02838290|Alcohol and drug use|alcohol and drug use
4763764|NCT02838277|lymphatic vessels|lymphatic vessels
4763765|NCT02838277|leaky vessels|leaky vessels
4763766|NCT02838277|hypertrophic adipocyte|hypertrophic adipocyte
4763767|NCT02838212|adverse drug reaction|adverse drug reaction
4763768|NCT02838212|hospital mortality|hospital mortality
4763769|NCT02838212|incidence|incidence
4763770|NCT02838199|Transcatheter aortic valve replacement|transcatheter aortic valve replacement
4763771|NCT02838199|TAVR|tavr
4763772|NCT02838199|TAVI|tavi
4763773|NCT02838199|SAVR|savr
4763774|NCT02838186|colonoscopy|colonoscopy
4763775|NCT02838186|right colon retroflexion|right colon retroflexion
4763776|NCT02838186|adenoma detection rate|adenoma detection rate
4763777|NCT02838186|feasibility|feasibility
4763778|NCT02838186|surveillance interval|surveillance interval
4763779|NCT02838160|educational strategies|educational strategies
4763780|NCT02838160|KAP|kap
4763781|NCT02838160|psychological and clinical outcomes|psychological and clinical outcomes
4763782|NCT02838160|intensive care unit|intensive care unit
4763783|NCT02838160|follow-up study|follow-up study
4763784|NCT02838160|RCT|rct
4763785|NCT02838134|Laparoscopic donor nephrectomy|laparoscopic donor nephrectomy
4763786|NCT02838134|Early quality of recovery|early quality of recovery
4763787|NCT02838121|bisphosphonate|bisphosphonate
4763788|NCT02838121|Total hip replacement|total hip replacement
4763789|NCT02838121|functional outcomes|functional outcomes
4763790|NCT02838121|bone mineral density|bone mineral density
4763791|NCT02838095|nap|nap
4763792|NCT02838095|sleep restriction|sleep restriction
4763793|NCT02838095|recovery sleep|recovery sleep
4763794|NCT02838095|cognitive performance|cognitive performance
4763795|NCT02838095|subjective sleepiness|subjective sleepiness
4763796|NCT02838095|mood|mood
4763797|NCT02838095|neurobehavioural functions|neurobehavioural functions
4763798|NCT02838082|traumatic brain injury|traumatic brain injury
4763799|NCT02838082|sleep-wake cycle disturbance|sleep-wake cycle disturbance
4763800|NCT02838082|circadian disruption|circadian disruption
4763801|NCT02838056|anesthesia, epidural|anesthesia, epidural
4763802|NCT02838056|skin temperature|skin temperature
4763803|NCT02838030|Preeclampsia|preeclampsia
4763804|NCT02838030|L-arginine|l-arginine
4763805|NCT02838004|Refractive lens exchange (RLE) or cataract surgery|refractive lens exchange (rle) or cataract surgery
4763806|NCT02837991|Kidney Cancer|kidney cancer
4763807|NCT02837991|Celldex|celldex
4763808|NCT02837991|Dose Escalation|dose escalation
4763809|NCT02837991|Ovarian Cancer|ovarian cancer
4763810|NCT02837991|Ovarian Carcinoma|ovarian carcinoma
4763811|NCT02837991|Kidney Diseases|kidney diseases
4763812|NCT02837978|Arthritis, Rheumatoid|arthritis, rheumatoid
4763813|NCT02837978|Tacrolimus|tacrolimus
4763814|NCT02837978|Treatment outcome|treatment outcome
4763815|NCT02837978|Safety|safety
4763816|NCT02837952|Ibuprofen, acetaminophen, pain, molar extraction|ibuprofen, acetaminophen, pain, molar extraction
4763817|NCT02837913|Perioperative Warming|perioperative warming
4763818|NCT02837887|Cancer|cancer
4763819|NCT02837887|Depression|depression
4763820|NCT02837874|Gastric cancer|gastric cancer
4763821|NCT02837874|gastrojejunostomy|gastrojejunostomy
4763822|NCT02837874|isoperistaltic|isoperistaltic
4763823|NCT02837874|antiperistaltic|antiperistaltic
4763824|NCT02837861|Metabolic Support|metabolic support
4763825|NCT02837861|Nutritional Support|nutritional support
4763826|NCT02837861|Neuro-endocrine Event|neuro-endocrine event
4763827|NCT02837861|Enteral feedings|enteral feedings
4763828|NCT02837861|Parenteral feeding|parenteral feeding
4763829|NCT02837848|Rotator Cuff Tendinopathy|rotator cuff tendinopathy
4763830|NCT02837848|Exercises|exercises
4763831|NCT02837848|Coactivation|coactivation
4763832|NCT02837848|Strengthening|strengthening
4763833|NCT02837822|Spinal Cord Stimulation|spinal cord stimulation
4763834|NCT02837822|Quantitative Sensory Testing|quantitative sensory testing
4763835|NCT02837809|low-dose computed tomography|low-dose computed tomography
4763836|NCT02837809|lung|lung
4763837|NCT02837809|randomized controlled trial|randomized controlled trial
4763838|NCT02837809|neoplasms|neoplasms
4763839|NCT02837809|screening|screening
4763840|NCT02837809|smoking|smoking
4763841|NCT02837770|pain|pain
4763842|NCT02837770|intravitreal injection|intravitreal injection
4763843|NCT02837770|anti-VEGF|anti-vegf
4763844|NCT02837770|diclofenac eye drops|diclofenac eye drops
4763845|NCT02837770|oral diclofenac|oral diclofenac
4763846|NCT02837770|Short Form of McGill Pain Questionnaire|short form of mcgill pain questionnaire
4763847|NCT02837653|cardiovascular Risk|cardiovascular risk
4763848|NCT02837640|Retinitis Pigmentosa|retinitis pigmentosa
4763849|NCT02837640|Levodopa|levodopa
4763850|NCT02837627|gastroesophageal reflux|gastroesophageal reflux
4763851|NCT02837627|tube enteral feeding|tube enteral feeding
4763852|NCT02837627|preterm infants|preterm infants
4763853|NCT02837601|Laparoscopic surgical procedures|laparoscopic surgical procedures
4763854|NCT02837601|Shoulder Pain|shoulder pain
4763855|NCT02837601|Abdominal Pain|abdominal pain
4763856|NCT02837601|Pediatrics|pediatrics
4763857|NCT02837588|chronic pelvic pain|chronic pelvic pain
4763858|NCT02837588|trigger points|trigger points
4763859|NCT02837588|hiperthermy|hiperthermy
4763860|NCT02837575|HSV-2|hsv-2
4763861|NCT02837575|Genital Herpes|genital herpes
4763862|NCT02837575|Herpes|herpes
4763863|NCT02837575|Herpes Simplex Virus, Type 2|herpes simplex virus, type 2
4763864|NCT02837562|Radiation exposure|radiation exposure
4763865|NCT02837562|Cardiac catheterization|cardiac catheterization
4763866|NCT02837523|Cystinosis Disease|cystinosis disease
4763867|NCT02837523|Biomarker|biomarker
4763868|NCT02837497|pediatric|pediatric
4763869|NCT02837497|heart arrest|heart arrest
4763870|NCT02837471|Pedometer usability|pedometer usability
4763871|NCT02837471|Usability and feasibility|usability and feasibility
4763872|NCT02837471|web application|web application
4763873|NCT02837458|Electric current|electric current
4763874|NCT02837458|Nerve block|nerve block
4763875|NCT02837458|somatosensory evaluation|somatosensory evaluation
4763876|NCT02837432|Depression|depression
4763877|NCT02837432|Cortisol|cortisol
4763878|NCT02837432|Sadness|sadness
4763879|NCT02837432|Genetics|genetics
4763880|NCT02837432|Stress|stress
4763881|NCT02837419|extracorporeal life support|extracorporeal life support
4763882|NCT02837419|health related quality of life|health related quality of life
4763883|NCT02837380|Long-acting muscarinic antagonist|long-acting muscarinic antagonist
4763884|NCT02837380|Long-acting beta2 agonist|long-acting beta2 agonist
4763885|NCT02837380|Dry powder inhaler|dry powder inhaler
4763886|NCT02837380|Inhaled corticosteroid|inhaled corticosteroid
4763887|NCT02837367|nutrigenetics|nutrigenetics
4763888|NCT02837367|medical foods|medical foods
4763889|NCT02837367|obesity|obesity
4763890|NCT02837367|children|children
4763891|NCT02837367|adults|adults
4763892|NCT02837354|Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy|cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy
4763893|NCT02837341|medical device|medical device
4763894|NCT02837328|Magnesium Supplementation|magnesium supplementation
4763895|NCT02837328|Magnesium|magnesium
4763896|NCT02837328|Dietary Supplement|dietary supplement
4763897|NCT02837328|Arrhythmia|arrhythmia
4763898|NCT02837302|Liver cirrhosis|liver cirrhosis
4763899|NCT02837302|Branched chain amino acid|branched chain amino acid
4763900|NCT02837302|End-Stage Liver Disease score|end-stage liver disease score
4763901|NCT02837289|patellofemoral pain syndrome|patellofemoral pain syndrome
4763902|NCT02837289|therapy taping|therapy taping
4763903|NCT02837289|knee|knee
4763904|NCT02837289|physical therapy|physical therapy
4763905|NCT02837289|runners|runners
4763906|NCT02837276|Intermittent Hypoxemia|intermittent hypoxemia
4763907|NCT02837276|Acute Kidney Injury|acute kidney injury
4763908|NCT02837276|Preterm infant|preterm infant
4763909|NCT02837250|HIV|hiv
4763910|NCT02837250|Substance Use|substance use
4763911|NCT02837224|retained surgical sponge|retained surgical sponge
4763912|NCT02837224|adverse event|adverse event
4763913|NCT02837185|Cervical dystonia|cervical dystonia
4763914|NCT02837185|Transcranial magnetic stimulation|transcranial magnetic stimulation
4763915|NCT02837185|Electromyography|electromyography
4763916|NCT02837185|TMS|tms
4763917|NCT02837185|EMG|emg
4763918|NCT02837159|colorectal cancer|colorectal cancer
4763919|NCT02837159|Health Life Style Habits|health life style habits
4763920|NCT02837159|Health|health
4763921|NCT02837146|RA|ra
4763922|NCT02837120|retrospective study|retrospective study
4763923|NCT02837120|acute myocardial infarction|acute myocardial infarction
4763924|NCT02837120|acute aortic dissection|acute aortic dissection
4763925|NCT02837120|pulmonary embolism|pulmonary embolism
4763926|NCT02837120|unstable angina|unstable angina
4763927|NCT02837068|Hemiplegia|hemiplegia
4763928|NCT02837068|shoulder pain|shoulder pain
4763929|NCT02837068|wheelchair|wheelchair
4763930|NCT02837068|stroke|stroke
4763931|NCT02837068|rehabilitation|rehabilitation
4763932|NCT02837055|intubation, intratracheal|intubation, intratracheal
4763933|NCT02837055|critical care|critical care
4763934|NCT02837042|penile cancer|penile cancer
4763935|NCT02837042|Pembrolizumab|pembrolizumab
4763936|NCT02837042|penile squamous cell carcinoma|penile squamous cell carcinoma
4763937|NCT02837042|squamous cell cancer|squamous cell cancer
4763938|NCT02837016|Self-Control|self-control
4763939|NCT02837016|Biofeedback|biofeedback
4763940|NCT02837016|Respiration|respiration
4763941|NCT02837003|Drug-Eluting Stent|drug-eluting stent
4763942|NCT02836977|tegafur-uracil|tegafur-uracil
4763943|NCT02836925|hepatitis C|hepatitis c
4763944|NCT02836925|NHL|nhl
4763945|NCT02836925|Indolent B-cell lymphoma|indolent b-cell lymphoma
4763946|NCT02836912|Rehabilitation|rehabilitation
4763947|NCT02836899|acute kidney injury; nitric oxide; cardiopulmonary bypass; endothelial dysfunction; cardiac surgery|acute kidney injury; nitric oxide; cardiopulmonary bypass; endothelial dysfunction; cardiac surgery
4763948|NCT02836834|immunotherapy|immunotherapy
4763949|NCT02836834|check point inhibitor|check point inhibitor
4763950|NCT02836834|PD-1 antibody|pd-1 antibody
4763951|NCT02836834|solid tumor|solid tumor
4763952|NCT02836834|lymphoma|lymphoma
4763953|NCT02836834|phase 1 trial|phase 1 trial
4763954|NCT02836808|Multidisciplinary interventions|multidisciplinary interventions
4763955|NCT02836808|Long term control|long term control
4763956|NCT02836808|Empowerment|empowerment
4763957|NCT02836795|anti-PD-1 monoclonal antibody|anti-pd-1 monoclonal antibody
4763958|NCT02836795|advanced solid tumors|advanced solid tumors
4763959|NCT02836795|safety|safety
4763960|NCT02836782|HIV/HCV|hiv/hcv
4763961|NCT02836782|Antiretroviral therapy|antiretroviral therapy
4763962|NCT02836782|HIV-DNA|hiv-dna
4763963|NCT02836782|Direct acting antiviral|direct acting antiviral
4763964|NCT02836769|Rehabilitation|rehabilitation
4763965|NCT02836769|Head and neck cancer|head and neck cancer
4763966|NCT02836769|Quality of life|quality of life
4763967|NCT02836769|self-efficacy|self-efficacy
4763968|NCT02836743|REM sleep behavior disorder|rem sleep behavior disorder
4763969|NCT02836743|Melatonin|melatonin
4763970|NCT02836717|sacral nerve modulation|sacral nerve modulation
4763971|NCT02836717|quality of life|quality of life
4763972|NCT02836717|stimulator maintenance|stimulator maintenance
4763973|NCT02836717|SNM|snm
4763974|NCT02836691|Autonomic nervous system|autonomic nervous system
4763975|NCT02836691|Uncontrolled severe asthma|uncontrolled severe asthma
4763976|NCT02836691|Paucigranulocitic asthma phenotype|paucigranulocitic asthma phenotype
4763977|NCT02836691|Stress|stress
4763978|NCT02836665|Emergency Room|emergency room
4763979|NCT02836665|Manchester Triage System|manchester triage system
4763980|NCT02836665|Telemedicine|telemedicine
4763981|NCT02836665|Patients|patients
4763982|NCT02836652|HeartMate II (HMII)|heartmate ii (hmii)
4764107|NCT02835989|Lift Assists|lift assists
4763983|NCT02836652|Left Ventricular Assist Device (LVAD)|left ventricular assist device (lvad)
4763984|NCT02836600|notch inhibitor|notch inhibitor
4763985|NCT02836548|advanced melanoma|advanced melanoma
4763986|NCT02836548|BRAF V600 mutation|braf v600 mutation
4763987|NCT02836548|vorinostat|vorinostat
4763988|NCT02836548|HDAC inhibitor|hdac inhibitor
4763989|NCT02836535|complications|complications
4763990|NCT02836535|surgery|surgery
4763991|NCT02836522|Health-Related Symptom Index|health-related symptom index
4763992|NCT02836522|ANCHOR( ANal Cancer HSIL (high grade squamous intraepithelial lesions) Outcomes Research study)|anchor( anal cancer hsil (high grade squamous intraepithelial lesions) outcomes research study)
4763993|NCT02836509|Low Back Pain|low back pain
4763994|NCT02836509|Ibuprofen|ibuprofen
4763995|NCT02836509|Paracetamol|paracetamol
4763996|NCT02836509|Emergency Medicine|emergency medicine
4763997|NCT02836496|Safety|safety
4763998|NCT02836496|Mepolizumab|mepolizumab
4763999|NCT02836496|Hypereosinophilic syndrome|hypereosinophilic syndrome
4764000|NCT02836496|HES flare|hes flare
4764001|NCT02836496|Efficacy|efficacy
4764002|NCT02836470|Post-operative Ileus|post-operative ileus
4764003|NCT02836470|Post-Operative Abdominal Adhesions|post-operative abdominal adhesions
4764004|NCT02836470|Return of Gastrointestinal Function|return of gastrointestinal function
4764005|NCT02836470|Anastomosis|anastomosis
4764006|NCT02836470|Enterotomy|enterotomy
4764007|NCT02836470|Enterostomy|enterostomy
4764008|NCT02836470|Colorectal Surgery|colorectal surgery
4764009|NCT02836470|Intestines Surgery|intestines surgery
4764010|NCT02836431|Pediatric|pediatric
4764011|NCT02836431|Sedation|sedation
4764012|NCT02836431|Dexmedetomidine|dexmedetomidine
4764013|NCT02836418|FSHD|fshd
4764014|NCT02836418|LGMD|lgmd
4764015|NCT02836405|Autism|autism
4764016|NCT02836405|ASD|asd
4764017|NCT02836405|Autistic Disorder|autistic disorder
4764018|NCT02836405|Pervasive Development Disorders|pervasive development disorders
4764019|NCT02836405|Pervasive Child Development Disorders|pervasive child development disorders
4764020|NCT02836405|Asperger's Syndrome|asperger's syndrome
4764021|NCT02836405|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
4764022|NCT02836405|TMS|tms
4764023|NCT02836405|Autism Spectrum Disorder|autism spectrum disorder
4764024|NCT02836379|Breakthrough Cancer Pain|breakthrough cancer pain
4764025|NCT02836379|Quality of life|quality of life
4764026|NCT02836379|Radiotherapy|radiotherapy
4764027|NCT02836366|Proximal humerus|proximal humerus
4764028|NCT02836366|Fracture|fracture
4764029|NCT02836366|Nailing|nailing
4764030|NCT02836340|neuroprotection|neuroprotection
4764031|NCT02836327|MRI|mri
4764032|NCT02836327|Multiple Sclerosis|multiple sclerosis
4764033|NCT02836327|Neuromyelitis Optica Spectrum Disorders|neuromyelitis optica spectrum disorders
4764034|NCT02836327|Multimodel|multimodel
4764035|NCT02836314|Anorganic bovine bone mineral;|anorganic bovine bone mineral;
4764036|NCT02836314|Graft|graft
4764037|NCT02836314|Intrabony periodontal defect|intrabony periodontal defect
4764038|NCT02836314|platelet rich fibrin|platelet rich fibrin
4764039|NCT02836288|Ketamine|ketamine
4764040|NCT02836288|Treatment of Depression|treatment of depression
4764041|NCT02836275|Adnexal Diseases|adnexal diseases
4764042|NCT02836275|Ovary|ovary
4764043|NCT02836275|Ovarian Neoplasms|ovarian neoplasms
4764044|NCT02836275|Ovarian Cysts|ovarian cysts
4764045|NCT02836275|Ovarian Diseases|ovarian diseases
4764046|NCT02836275|Ultrasonography|ultrasonography
4764047|NCT02836275|Ultrasonography, Doppler|ultrasonography, doppler
4764048|NCT02836275|Magnetic Resonance Imaging|magnetic resonance imaging
4764049|NCT02836275|Diffusion Magnetic Resonance Imaging|diffusion magnetic resonance imaging
4764050|NCT02836275|Diagnosis|diagnosis
4764051|NCT02836275|Early Diagnosis|early diagnosis
4764052|NCT02836275|Early Detection of Cancer|early detection of cancer
4764053|NCT02836275|Genital Neoplasms, Female|genital neoplasms, female
4764054|NCT02836275|Genital Diseases, Female|genital diseases, female
4764055|NCT02836275|Urogenital Neoplasms|urogenital neoplasms
4764056|NCT02836275|Cysts|cysts
4764057|NCT02836275|Endocrine System Diseases|endocrine system diseases
4764058|NCT02836275|Gonadal Disorders|gonadal disorders
4764059|NCT02836275|Neoplasms|neoplasms
4764060|NCT02836275|Endocrine Gland Neoplasms|endocrine gland neoplasms
4764061|NCT02836275|International Ovarian Tumor Analysis|international ovarian tumor analysis
4764062|NCT02836275|Simple Rules|simple rules
4764063|NCT02836275|Preoperative Evaluation|preoperative evaluation
4764064|NCT02836275|Perfusion -and Diffusion-weighted Imaging|perfusion -and diffusion-weighted imaging
4764065|NCT02836275|Adnexal Masses|adnexal masses
4764066|NCT02836275|Ovarian Tumors|ovarian tumors
4764067|NCT02836249|Hepatitis|hepatitis
4764068|NCT02836249|Tenofovir|tenofovir
4764069|NCT02836249|Viread|viread
4764070|NCT02836236|Hepatitis|hepatitis
4764071|NCT02836236|Tenofovir|tenofovir
4764072|NCT02836236|Viread|viread
4764073|NCT02836210|27-gauge Pars plana vitrectomy|27-gauge pars plana vitrectomy
4764074|NCT02836197|Uncertainty;hope;cancer;communication skills training;physicians|uncertainty;hope;cancer;communication skills training;physicians
4764075|NCT02836184|Hemodialysis,Hyperphosphatemia,Nicotinic Acids|hemodialysis,hyperphosphatemia,nicotinic acids
4764076|NCT02836119|Gut Microbiota|gut microbiota
4764077|NCT02836119|Gut Microbiome|gut microbiome
4764078|NCT02836119|Sleep|sleep
4764079|NCT02836119|Infancy|infancy
4764080|NCT02836119|Development|development
4764081|NCT02836106|Healthy Volunteers|healthy volunteers
4764082|NCT02836106|Obese Volunteers|obese volunteers
4764083|NCT02836093|Exercise|exercise
4764084|NCT02836093|Radiation Treatment|radiation treatment
4764085|NCT02836093|16-941|16-941
4764086|NCT02836080|Mental Health|mental health
4764087|NCT02836080|Randomized|randomized
4764088|NCT02836080|Pragmatic|pragmatic
4764089|NCT02836080|Integrated Collaborative Care|integrated collaborative care
4764090|NCT02836080|Addiction|addiction
4764091|NCT02836080|Youth|youth
4764092|NCT02836054|biomarkers|biomarkers
4764093|NCT02836054|CSF|csf
4764094|NCT02836054|MRI|mri
4764095|NCT02836054|Alzheimer's disease|alzheimer's disease
4764096|NCT02836054|bipolar disorder|bipolar disorder
4764097|NCT02836054|cognitive functions|cognitive functions
4764098|NCT02836041|assess sleep|assess sleep
4764099|NCT02836041|Sleep Deprivation|sleep deprivation
4764100|NCT02836041|16-866|16-866
4764101|NCT02836015|Shared Medical Visits|shared medical visits
4764102|NCT02836015|Spanish-speaking|spanish-speaking
4764103|NCT02835989|Community Paramedicine|community paramedicine
4764104|NCT02835989|Paramedic|paramedic
4764105|NCT02835989|Emergency Medical Services|emergency medical services
4764106|NCT02835989|High Frequency Callers|high frequency callers
4764108|NCT02835963|acute heart failure|acute heart failure
4764109|NCT02835963|dyspnea|dyspnea
4764110|NCT02835963|predictive value|predictive value
4764111|NCT02835924|regorafenib|regorafenib
4764112|NCT02835924|metastatic colorectal cancer|metastatic colorectal cancer
4764113|NCT02835872|fiber|fiber
4764114|NCT02835872|cholesterol|cholesterol
4764115|NCT02835859|Obesity, sweet taste receptors|obesity, sweet taste receptors
4764116|NCT02835846|Overactive Bladder Syndrome|overactive bladder syndrome
4764117|NCT02835846|Female Urinary Microbiome|female urinary microbiome
4764118|NCT02835846|Urinary Urgency|urinary urgency
4764119|NCT02835846|Estrogen|estrogen
4764120|NCT02835846|Nocturia|nocturia
4764121|NCT02835846|Incontinence|incontinence
4764122|NCT02835833|advanced solid tumors|advanced solid tumors
4764123|NCT02835833|Nintedanib|nintedanib
4764124|NCT02835833|Bevacizumab|bevacizumab
4764125|NCT02835833|dose escalation|dose escalation
4764126|NCT02835820|HIV|hiv
4764127|NCT02835820|Neurocognitive|neurocognitive
4764128|NCT02835820|Ketogenic Diet|ketogenic diet
4764129|NCT02835807|skin cancer|skin cancer
4764130|NCT02835794|Myelodysplastic Syndromes|myelodysplastic syndromes
4764131|NCT02835781|Breast Implants|breast implants
4764132|NCT02835781|Acellular Dermal Matrix|acellular dermal matrix
4764133|NCT02835729|AML|aml
4764134|NCT02835716|Phosphodiesterase type 4 inhibitor|phosphodiesterase type 4 inhibitor
4764135|NCT02835716|ustekinumab|ustekinumab
4764136|NCT02835716|secukinumab|secukinumab
4764137|NCT02835716|P40 subunit|p40 subunit
4764138|NCT02835716|Interleukin IL-12|interleukin il-12
4764139|NCT02835716|Interleukin IL-23|interleukin il-23
4764140|NCT02835716|Apoprotein e4|apoprotein e4
4764141|NCT02835716|Interleukin IL-17A|interleukin il-17a
4764142|NCT02835703|Congenital heart disease|congenital heart disease
4764143|NCT02835703|Coarctation of aorta|coarctation of aorta
4764144|NCT02835703|Aortic arch hypoplasia|aortic arch hypoplasia
4764145|NCT02835703|Cerebral selective antegrade perfusion|cerebral selective antegrade perfusion
4764146|NCT02835703|Double arterial cannulation|double arterial cannulation
4764147|NCT02835690|PD1|pd1
4764148|NCT02835690|PD-1|pd-1
4764149|NCT02835690|PDL1|pdl1
4764150|NCT02835690|PD-L1|pd-l1
4764151|NCT02835677|Caregivers|caregivers
4764152|NCT02835677|Activities of Daily Living|activities of daily living
4764153|NCT02835664|Nicotinamide Riboside|nicotinamide riboside
4764154|NCT02835664|Obesity|obesity
4764155|NCT02835664|Metabolic health|metabolic health
4764156|NCT02835664|Insulin resistance|insulin resistance
4764157|NCT02835664|Mitochondrial function|mitochondrial function
4764158|NCT02835664|Brown adipose tissue|brown adipose tissue
4764159|NCT02835664|Energy expenditure|energy expenditure
4764160|NCT02835664|Ectopic lipid accumulation|ectopic lipid accumulation
4764161|NCT02835664|Cardiovascular risk|cardiovascular risk
4764162|NCT02835664|Acetylcarnitine|acetylcarnitine
4764163|NCT02835651|Palmitic acid|palmitic acid
4764164|NCT02835651|Stearic acid|stearic acid
4764165|NCT02835651|HDL-metabolism|hdl-metabolism
4764166|NCT02835651|Human intervention study|human intervention study
4764167|NCT02835625|Diagnostic Imaging|diagnostic imaging
4764168|NCT02835625|Mammography|mammography
4764169|NCT02835625|Randomized Controlled Trial|randomized controlled trial
4764170|NCT02835625|Tomosynthesis|tomosynthesis
4764171|NCT02835625|Early performance measures|early performance measures
4764172|NCT02835625|Recall|recall
4764173|NCT02835625|Radiation dose|radiation dose
4764174|NCT02835625|Cancer detection|cancer detection
4764175|NCT02835625|Sensitivity|sensitivity
4764176|NCT02835625|Specificity|specificity
4764177|NCT02835625|Cost|cost
4764178|NCT02835625|Economy|economy
4764179|NCT02835586|paclitaxel|paclitaxel
4764180|NCT02835586|critical ischemia|critical ischemia
4764181|NCT02835586|restenosis|restenosis
4764182|NCT02835586|femoropopliteal artery lesions TASC C and D|femoropopliteal artery lesions tasc c and d
4764183|NCT02835547|cardiovascular event|cardiovascular event
4764184|NCT02835547|risk factors|risk factors
4764185|NCT02835547|inflammatory diseases and acquired dysimmune|inflammatory diseases and acquired dysimmune
4764186|NCT02835534|acute ST elevation myocardial infarction|acute st elevation myocardial infarction
4764187|NCT02835456|CAUTI|cauti
4764188|NCT02835456|Biofilm|biofilm
4764189|NCT02835456|Urinary tract infections|urinary tract infections
4764190|NCT02835456|micropattern|micropattern
4764191|NCT02835456|Catheter|catheter
4764192|NCT02835443|Ischemic Stroke|ischemic stroke
4764193|NCT02835443|Deep Brain Stimulation|deep brain stimulation
4764194|NCT02835443|DBS|dbs
4764195|NCT02835443|Physical Therapy|physical therapy
4764196|NCT02835443|Rehab|rehab
4764197|NCT02835443|Brain Stimulation|brain stimulation
4764198|NCT02835430|Coronally advanced flap|coronally advanced flap
4764199|NCT02835430|Gingival recession|gingival recession
4764200|NCT02835430|Bone, demineralized|bone, demineralized
4764201|NCT02835430|Bone, freeze-dried|bone, freeze-dried
4764202|NCT02835430|platelet-rich fibrin|platelet-rich fibrin
4764203|NCT02835430|root coverage procedures|root coverage procedures
4764204|NCT02835417|fetal heart rate variability|fetal heart rate variability
4764205|NCT02835417|entropy|entropy
4764206|NCT02835417|multifractal analysis|multifractal analysis
4764207|NCT02835417|scattering transform|scattering transform
4764208|NCT02835417|sparse vector machine|sparse vector machine
4764209|NCT02835417|acidosis|acidosis
4764210|NCT02835378|bilateral upper limb amputation|bilateral upper limb amputation
4764211|NCT02835378|prosthetic fitting|prosthetic fitting
4764212|NCT02835378|epidemiology|epidemiology
4764213|NCT02835378|clinical practices|clinical practices
4764214|NCT02835378|totally non-functional hand|totally non-functional hand
4764215|NCT02835365|baclofen|baclofen
4764216|NCT02835365|alcohol|alcohol
4764217|NCT02835365|withdrawal|withdrawal
4764218|NCT02835352|anxiety|anxiety
4764219|NCT02835326|Older Adults|older adults
4764220|NCT02835326|Weight Loss|weight loss
4764221|NCT02835326|Exercise|exercise
4764222|NCT02835326|Knee pain|knee pain
4764223|NCT02835300|Asthma|asthma
4764224|NCT02835300|Adolescents|adolescents
4764225|NCT02835300|e-Health|e-health
4764226|NCT02835300|Intervention|intervention
4764227|NCT02835274|parkinson disease|parkinson disease
4764228|NCT02835274|deep brain stimulation|deep brain stimulation
4764229|NCT02835274|directional stimulation|directional stimulation
4764230|NCT02835261|Obesity|obesity
4764231|NCT02835261|Metabolic Disorders|metabolic disorders
4764232|NCT02835209|spontaneous breathing test|spontaneous breathing test
4764233|NCT02835209|premature infant|premature infant
4764234|NCT02835209|work of breathing|work of breathing
4764235|NCT02835170|Immunoglobulin G|immunoglobulin g
4764236|NCT02835170|Treatment|treatment
4764237|NCT02835157|Normal saline|normal saline
4764238|NCT02835157|Balanced saline|balanced saline
4764239|NCT02835157|Septic shock|septic shock
4764240|NCT02835157|Children|children
4764241|NCT02835157|Hyperchloremia|hyperchloremia
4764242|NCT02835157|Acute kidney injury|acute kidney injury
4764243|NCT02835131|hyperinsulinemia|hyperinsulinemia
4764244|NCT02835131|hypoglycemia|hypoglycemia
4764245|NCT02835131|somatostatin|somatostatin
4764246|NCT02835131|pasireotide|pasireotide
4764247|NCT02835131|congenital|congenital
4764248|NCT02835079|Duchenne Tamoxifen|duchenne tamoxifen
4764249|NCT02835066|Stage I|stage i
4764250|NCT02835066|Stage II|stage ii
4764251|NCT02835066|Stage IIIA|stage iiia
4764252|NCT02835066|Stage IIIB|stage iiib
4764253|NCT02835066|Stage IV|stage iv
4764254|NCT02835066|Non-Small Cell|non-small cell
4764255|NCT02835040|Corticosteroid|corticosteroid
4764256|NCT02835040|Antibiotic|antibiotic
4764257|NCT02835040|Early mobilization|early mobilization
4764258|NCT02835040|Malnutrition|malnutrition
4764259|NCT02835027|Acute limb ischaemia(ALI)|acute limb ischaemia(ali)
4764260|NCT02835027|Acute ischaemia of the lower extremity|acute ischaemia of the lower extremity
4764261|NCT02835027|Thrombosis|thrombosis
4764262|NCT02835027|Emboli|emboli
4764263|NCT02835027|Endovascular surgery|endovascular surgery
4764264|NCT02835027|Surgery|surgery
4764265|NCT02835027|Amputation free survival|amputation free survival
4764266|NCT02835027|Long time survival|long time survival
4764267|NCT02835027|Demographics|demographics
4764268|NCT02835014|Diabetes Mellitus Type I|diabetes mellitus type i
4764269|NCT02835014|Adolescents|adolescents
4764270|NCT02835014|Mental Health|mental health
4764271|NCT02835014|Self efficacy|self efficacy
4764272|NCT02835014|parenting styles|parenting styles
4764273|NCT02834988|Endometrial Cancer|endometrial cancer
4764274|NCT02834988|Sentinel Lymph Node Dissection|sentinel lymph node dissection
4764275|NCT02834988|SLND|slnd
4764276|NCT02834975|Fallopian Tube Carcinoma|fallopian tube carcinoma
4764277|NCT02834975|Peritoneal Carcinoma|peritoneal carcinoma
4764278|NCT02834975|Epithelial Ovarian Cancer|epithelial ovarian cancer
4764279|NCT02834962|Anterior Cruciate Ligament Reconstruction|anterior cruciate ligament reconstruction
4764280|NCT02834897|EOS imagery|eos imagery
4764281|NCT02834884|rare cancer|rare cancer
4764282|NCT02834884|biomarker|biomarker
4764283|NCT02834884|molecular screening|molecular screening
4764284|NCT02834884|cancer|cancer
4764285|NCT02834884|biobanking|biobanking
4764286|NCT02834858|Umbilical Cord Mesenchymal Stem Cells|umbilical cord mesenchymal stem cells
4764287|NCT02834819|bronchiolitis|bronchiolitis
4764288|NCT02834819|hypoxia|hypoxia
4764289|NCT02834819|hypertonic saline|hypertonic saline
4764290|NCT02834793|Lennox-Gastaut Syndrome (LGS)|lennox-gastaut syndrome (lgs)
4764291|NCT02834793|Inadequately controlled seizures|inadequately controlled seizures
4764292|NCT02834780|Advanced Hepatocellular Carcinoma|advanced hepatocellular carcinoma
4764293|NCT02834780|H3B-6527|h3b-6527
4764294|NCT02834780|Intrahepatic Cholangiocarcinoma|intrahepatic cholangiocarcinoma
4764295|NCT02834780|FGFR4|fgfr4
4764296|NCT02834780|FGF19|fgf19
4764297|NCT02834754|post-operative|post-operative
4764298|NCT02834715|Diabetes|diabetes
4764299|NCT02834715|Stevia|stevia
4764300|NCT02834715|insulin secretion|insulin secretion
4764301|NCT02834715|insulin sensitivity|insulin sensitivity
4764302|NCT02834715|Sweetener|sweetener
4764303|NCT02834702|sinew acupuncture|sinew acupuncture
4764304|NCT02834702|neck pain|neck pain
4764305|NCT02834702|chronic pain|chronic pain
4764306|NCT02834676|DiscoGel(R)|discogel(r)
4764307|NCT02834676|gelified ethanol|gelified ethanol
4764308|NCT02834676|percutaneous treatment|percutaneous treatment
4764309|NCT02834676|Oswestry Disability Index (ODI)|oswestry disability index (odi)
4764310|NCT02834676|Visual analog Scale (VAS)|visual analog scale (vas)
4764311|NCT02834676|Neuropathic Pain Questionnaire (DN-4)|neuropathic pain questionnaire (dn-4)
4764312|NCT02834676|cervical|cervical
4764314|NCT02834637|cervical cancer|cervical cancer
4764315|NCT02834637|vaccines|vaccines
4764316|NCT02834637|HPV vaccine|hpv vaccine
4764317|NCT02834637|dose reduction|dose reduction
4764318|NCT02834637|Human papilloma virus vaccine schedules|human papilloma virus vaccine schedules
4764319|NCT02834624|surfactant|surfactant
4764320|NCT02834624|respiratory distress syndrome|respiratory distress syndrome
4764321|NCT02834624|inflammation|inflammation
4764322|NCT02834624|c-reactive protein|c-reactive protein
4764323|NCT02834624|lipid peroxidation|lipid peroxidation
4764324|NCT02834546|Hepatocellular Carcinoma|hepatocellular carcinoma
4764325|NCT02834546|Sorafenib|sorafenib
4764326|NCT02834546|Toxicity|toxicity
4764327|NCT02834546|Plasmatic concentration|plasmatic concentration
4764328|NCT02834533|Lokomat;|lokomat;
4764329|NCT02834533|robotic rehabilitation.|robotic rehabilitation.
4764330|NCT02834533|Multiple Sclerosis;|multiple sclerosis;
4764331|NCT02834533|Virtual reality|virtual reality
4764332|NCT02834494|locally advanced breast cancer|locally advanced breast cancer
4764333|NCT02834494|neoadjuvant chemotherapy|neoadjuvant chemotherapy
4764334|NCT02834481|Pain Care|pain care
4764335|NCT02834481|Pediatric and Neonatal Intensive Care Units|pediatric and neonatal intensive care units
4764336|NCT02834468|Dexamethasone|dexamethasone
4764337|NCT02834468|Rituximab|rituximab
4764338|NCT02834468|Cyclosporin|cyclosporin
4764339|NCT02834468|Intravenous Immunoglobulin|intravenous immunoglobulin
4764340|NCT02834455|Thoracoscopy|thoracoscopy
4764341|NCT02834403|breast cancer|breast cancer
4764342|NCT02834403|nitric oxide synthase|nitric oxide synthase
4764343|NCT02834403|docetaxel|docetaxel
4764344|NCT02834403|L-NMMA|l-nmma
4764345|NCT02834390|AML|aml
4764346|NCT02834390|phase 1|phase 1
4764347|NCT02834390|hematology|hematology
4764348|NCT02834390|malignancy|malignancy
4764349|NCT02834390|newly diagnosed|newly diagnosed
4764350|NCT02834377|Cardiac Output|cardiac output
4764351|NCT02834377|Hemodynamics|hemodynamics
4764352|NCT02834377|Perioperative Care|perioperative care
4764353|NCT02834338|activity tracking|activity tracking
4764354|NCT02834338|postoperative recovery|postoperative recovery
4764355|NCT02834338|ERAS|eras
4764356|NCT02834338|fast-track surgery|fast-track surgery
4764357|NCT02834325|high flow nasal cannula|high flow nasal cannula
4764358|NCT02834325|success|success
4764359|NCT02834325|failure|failure
4764360|NCT02834325|ROX index|rox index
4764361|NCT02834312|Estetrol|estetrol
4764362|NCT02834312|Vasomotor symptoms|vasomotor symptoms
4764363|NCT02834312|Menopause|menopause
4764364|NCT02834260|absorbable implant|absorbable implant
4764365|NCT02834260|subconjunctival|subconjunctival
4764366|NCT02834260|immune rejection|immune rejection
4764367|NCT02834260|safety profile|safety profile
4764368|NCT02834260|dexamethasone|dexamethasone
4764369|NCT02834234|mesothelioma|mesothelioma
4764370|NCT02834234|peritoneum|peritoneum
4764371|NCT02834234|genomic|genomic
4764372|NCT02834234|CGH arrays|cgh arrays
4764373|NCT02834221|Femoral vein puncture|femoral vein puncture
4764374|NCT02834195|Cerebral palsy|cerebral palsy
4764375|NCT02834195|reliability|reliability
4764376|NCT02834195|upper limb and hand patterns|upper limb and hand patterns
4764377|NCT02834195|classification|classification
4764378|NCT02834169|Rare peritoneal surface malignancies|rare peritoneal surface malignancies
4764379|NCT02834169|pseudomyxoma peritonei|pseudomyxoma peritonei
4764380|NCT02834169|peritoneal mesothelioma|peritoneal mesothelioma
4764381|NCT02834169|desmoplastic small round cell tumor|desmoplastic small round cell tumor
4764382|NCT02834169|psammocarcinoma|psammocarcinoma
4764383|NCT02834169|primary peritoneal serous carcinoma|primary peritoneal serous carcinoma
4764384|NCT02834169|diffuse peritoneal leiomyomatosis|diffuse peritoneal leiomyomatosis
4764385|NCT02834169|appendiceal mucinous neoplasms|appendiceal mucinous neoplasms
4764386|NCT02834169|registry|registry
4764387|NCT02834169|population-based database|population-based database
4764388|NCT02834143|vascular|vascular
4764389|NCT02834143|Limb Ischemia|limb ischemia
4764390|NCT02834117|Ovulation Induction|ovulation induction
4764391|NCT02834117|quality of life|quality of life
4764392|NCT02834117|Reproductive Physiological Processes|reproductive physiological processes
4764393|NCT02834117|fertility|fertility
4764394|NCT02834078|HbA1c|hba1c
4764395|NCT02834078|Pre Diabetes|pre diabetes
4764396|NCT02834078|Berberine|berberine
4764397|NCT02834065|Postoperative Cognitive Decline|postoperative cognitive decline
4764398|NCT02834065|Deep Hypothermic Circulatory Arrest|deep hypothermic circulatory arrest
4764399|NCT02834065|Cardiovascular Surgical Procedures|cardiovascular surgical procedures
4764400|NCT02834065|Functional Magnetic Resonance Imaging|functional magnetic resonance imaging
4764401|NCT02834065|Small Ubiquitin-Related Modifier Proteins|small ubiquitin-related modifier proteins
4764402|NCT02834052|Immunotherapy|immunotherapy
4764403|NCT02834052|Anti-programmed death 1 (PD-1) inhibitor|anti-programmed death 1 (pd-1) inhibitor
4764404|NCT02834052|Immunostimulant|immunostimulant
4764405|NCT02834052|monoclonal antibody|monoclonal antibody
4764406|NCT02834052|TLR3 agonist|tlr3 agonist
4764407|NCT02834052|Immunologic factors|immunologic factors
4764408|NCT02834039|Tidal volume|tidal volume
4764409|NCT02834039|renal transplant|renal transplant
4764410|NCT02834039|donor|donor
4764411|NCT02834039|nephrectomy|nephrectomy
4764412|NCT02834039|ventilation|ventilation
4764413|NCT02834039|Living renal transplant donor patient|living renal transplant donor patient
4764414|NCT02834026|Muscle Strength|muscle strength
4764415|NCT02834026|Muscle Strength Dynamometer|muscle strength dynamometer
4764416|NCT02834026|Chronic Renal Disease|chronic renal disease
4764417|NCT02834026|Exercise|exercise
4764418|NCT02834026|Physical therapy modalities|physical therapy modalities
4764419|NCT02833987|Direct oral anticoagulants|direct oral anticoagulants
4764420|NCT02833987|Safety|safety
4764421|NCT02833987|Major bleed|major bleed
4764422|NCT02833987|Adverse events|adverse events
4764423|NCT02833974|GSK2245035|gsk2245035
4764424|NCT02833974|TLR7 agonist|tlr7 agonist
4764425|NCT02833974|allergic asthma|allergic asthma
4764426|NCT02833974|FEV1|fev1
4764427|NCT02833948|Heart Valve Disease|heart valve disease
4764428|NCT02833948|Randomized Controlled Trial|randomized controlled trial
4764429|NCT02833948|Transcatheter Aortic Valve Replacement|transcatheter aortic valve replacement
4764430|NCT02833948|TAVR|tavr
4764431|NCT02833948|Valve Thrombosis|valve thrombosis
4764432|NCT02833935|spinal cord injury|spinal cord injury
4764433|NCT02833935|physical activity|physical activity
4764434|NCT02833935|self-determination theory|self-determination theory
4764435|NCT02833935|life satisfaction|life satisfaction
4764436|NCT02833883|Enzalutamide|enzalutamide
4764437|NCT02833883|CC-115|cc-115
4764438|NCT02833883|16-074|16-074
4764439|NCT02833857|Secondary Hyperparathyroidism, chronic kidney disease, hemodialysis|secondary hyperparathyroidism, chronic kidney disease, hemodialysis
4764440|NCT02833844|Hyperlipidemia|hyperlipidemia
4764441|NCT02833844|Dyslipidemia|dyslipidemia
4764442|NCT02833844|Proprotein convertase subtilisin/kexin type 9 (PCSK9)|proprotein convertase subtilisin/kexin type 9 (pcsk9)
4764443|NCT02833844|Inhibition|inhibition
4764444|NCT02833844|HIV infection|hiv infection
4764445|NCT02833844|Cluster of differentiation|cluster of differentiation
4764446|NCT02833844|Viral load|viral load
4764447|NCT02833805|immunosuppression|immunosuppression
4764448|NCT02833805|nonmyeloablative|nonmyeloablative
4764449|NCT02833805|non-myeloablative|non-myeloablative
4764450|NCT02833805|allogeneic|allogeneic
4764451|NCT02833805|tacrolimus|tacrolimus
4764452|NCT02833805|bone marrow|bone marrow
4764453|NCT02833805|bone marrow transplant|bone marrow transplant
4764454|NCT02833805|cyclophosphamide|cyclophosphamide
4764455|NCT02833805|thymoglobulin|thymoglobulin
4764457|NCT02833805|fludarabine|fludarabine
4764458|NCT02833766|Breast Cancer|breast cancer
4764459|NCT02833766|advanced triple Negative, EGFR positive breast cancer|advanced triple negative, egfr positive breast cancer
4764460|NCT02833766|doxorubicin|doxorubicin
4764461|NCT02833766|triple negative breast cancer (TNBC)|triple negative breast cancer (tnbc)
4764462|NCT02833740|Mid-Upper Arm Circumference (MUAC)|mid-upper arm circumference (muac)
4764463|NCT02833740|Mother MUAC|mother muac
4764464|NCT02833740|Community screening for acute malnutrition|community screening for acute malnutrition
4764465|NCT02833727|asthma; smoking; Eosinophils; health care costs|asthma; smoking; eosinophils; health care costs
4764466|NCT02833675|angioedema|angioedema
4764467|NCT02833675|C1Inhibitor|c1inhibitor
4764468|NCT02833675|bradykinin|bradykinin
4764469|NCT02833675|Histamin|histamin
4764470|NCT02833662|Hypoxia|hypoxia
4764471|NCT02833662|Perioperative outcomes|perioperative outcomes
4764472|NCT02833649|Keratoconus|keratoconus
4764473|NCT02833649|Crosslinking|crosslinking
4764474|NCT02833649|Toric ICL|toric icl
4764475|NCT02833623|Helicobacter Pylori eradication rate|helicobacter pylori eradication rate
4764476|NCT02833623|Efficacy of Short-message-based Re-education (SMRE)|efficacy of short-message-based re-education (smre)
4764477|NCT02833610|Multiple Myeloma|multiple myeloma
4764478|NCT02833597|peripheral artery disease|peripheral artery disease
4764479|NCT02833597|transcutaneous oxygen pressure|transcutaneous oxygen pressure
4764480|NCT02833597|claudication|claudication
4764481|NCT02833597|rowing ergometer|rowing ergometer
4764482|NCT02833584|Paracetamol|paracetamol
4764483|NCT02833558|Endoscopy, Gastrointestinal|endoscopy, gastrointestinal
4764484|NCT02833558|Endoscopic Submucosal Dissection|endoscopic submucosal dissection
4764485|NCT02833558|Bleeding|bleeding
4764486|NCT02833519|pregnant women|pregnant women
4764487|NCT02833519|exercise|exercise
4764488|NCT02833519|depression|depression
4764490|NCT02833493|Magnetic Resonance Imaging|magnetic resonance imaging
4764491|NCT02833493|Iron overload|iron overload
4764492|NCT02833493|Iron chelation therapy|iron chelation therapy
4764493|NCT02833493|Follow-up|follow-up
4764494|NCT02833467|Circulating Tumor DNA|circulating tumor dna
4764495|NCT02833467|Heterogeneous|heterogeneous
4764496|NCT02833467|Multiple primary lung cancer|multiple primary lung cancer
4764497|NCT02833454|Anterior Cruciate Ligament Reconstruction|anterior cruciate ligament reconstruction
4764498|NCT02833454|Direct Insertion of Anterior Cruciate Ligament|direct insertion of anterior cruciate ligament
4764499|NCT02833415|Visceral|visceral
4764500|NCT02833415|Obesity|obesity
4764501|NCT02833415|Adipose|adipose
4764502|NCT02833415|Diabetes|diabetes
4764503|NCT02833402|Sacral Neuromodulation|sacral neuromodulation
4764504|NCT02833402|Urinary leakage|urinary leakage
4764505|NCT02833402|Urinary incontinence|urinary incontinence
4764506|NCT02833402|Urinary microbiome|urinary microbiome
4764507|NCT02833376|microbiota|microbiota
4764508|NCT02833376|ethanol|ethanol
4764509|NCT02833376|chlorhexidine|chlorhexidine
4764510|NCT02833363|gastric microbiota|gastric microbiota
4764511|NCT02833363|Helicobacter pylori|helicobacter pylori
4764512|NCT02833363|Non-atrophic Gasrititis|non-atrophic gasrititis
4764513|NCT02833363|Atrophic gastritis|atrophic gastritis
4764514|NCT02833363|Intestinal metaplasia|intestinal metaplasia
4764515|NCT02833363|intraepithelial neoplasia|intraepithelial neoplasia
4764516|NCT02833363|Gastric cancer|gastric cancer
4764517|NCT02833337|Bone|bone
4764518|NCT02833337|Maxilla|maxilla
4764519|NCT02833337|Cone-Beam Computed Tomography|cone-beam computed tomography
4764520|NCT02833337|Regeneration|regeneration
4764521|NCT02833324|Postoperative Period|postoperative period
4764522|NCT02833324|Colorectal Surgery|colorectal surgery
4764523|NCT02833324|Surgery|surgery
4764524|NCT02833311|Neuromusculoskeletal condition|neuromusculoskeletal condition
4764525|NCT02833298|Sustained Virological Response|sustained virological response
4764526|NCT02833298|SVR|svr
4764527|NCT02833298|patient navigation|patient navigation
4764528|NCT02833298|screening|screening
4764529|NCT02833298|HCC|hcc
4764530|NCT02833298|HCV|hcv
4764531|NCT02833272|benzodiazepines|benzodiazepines
4764532|NCT02833272|Z-drugs|z-drugs
4764533|NCT02833259|Pneumonia|pneumonia
4764534|NCT02833259|Patient readmission|patient readmission
4764535|NCT02833259|Community-acquired infections|community-acquired infections
4764536|NCT02833259|Observational study|observational study
4764537|NCT02833259|Quality of health care|quality of health care
4764538|NCT02833259|Models, Statistical|models, statistical
4764539|NCT02833246|texting|texting
4764540|NCT02833246|Adherence to Oral Anticancer Medications|adherence to oral anticancer medications
4764541|NCT02833246|16-810|16-810
4764542|NCT02833233|Early stage|early stage
4764543|NCT02833233|Resectable|resectable
4764544|NCT02833233|Ipilimumab|ipilimumab
4764545|NCT02833233|Nivolumab|nivolumab
4764546|NCT02833233|Cryoablation|cryoablation
4764547|NCT02833233|16-495|16-495
4764548|NCT02833220|blood pressure|blood pressure
4764549|NCT02833220|heart rate variability|heart rate variability
4764550|NCT02833220|single-pulse transcranial magnetic stimulation|single-pulse transcranial magnetic stimulation
4764551|NCT02833220|non-invasive brain stimulation|non-invasive brain stimulation
4764552|NCT02833207|blood flow|blood flow
4764553|NCT02833207|vasodilation|vasodilation
4764554|NCT02833207|Doppler Ultrasound|doppler ultrasound
4764555|NCT02833207|endothelium dependent dilation|endothelium dependent dilation
4764556|NCT02833168|Neuromuscular disorders|neuromuscular disorders
4764557|NCT02833168|Sleep disordered breathing|sleep disordered breathing
4764558|NCT02833168|Dyspnea|dyspnea
4764559|NCT02833155|entinostat|entinostat
4764560|NCT02833155|breast cancer|breast cancer
4764561|NCT02833142|Healthy Volunteer|healthy volunteer
4764562|NCT02833142|opicinumab|opicinumab
4764563|NCT02833116|radiculalgia|radiculalgia
4764564|NCT02833116|chronic pain|chronic pain
4764565|NCT02833116|quality of life|quality of life
4764566|NCT02833103|Pinaverium Bromide|pinaverium bromide
4764567|NCT02833103|cholecystectomy|cholecystectomy
4764568|NCT02833103|Sphincter of Oddi Dysfunction|sphincter of oddi dysfunction
4764569|NCT02833012|Healthy volunteers|healthy volunteers
4764570|NCT02833012|Caprylic triglyceride oil|caprylic triglyceride oil
4764571|NCT02833012|AC-1202|ac-1202
4764572|NCT02833012|AC-1204|ac-1204
4764573|NCT02833012|Pharmacokinetic|pharmacokinetic
4764574|NCT02833012|ketone body|ketone body
4764575|NCT02833012|Axona|axona
4764576|NCT02832999|Diabetes|diabetes
4764577|NCT02832999|GLP-1|glp-1
4764578|NCT02832999|Insulin secretion|insulin secretion
4764579|NCT02832999|insulin sensitivity|insulin sensitivity
4764580|NCT02832999|Africa|africa
4764581|NCT02832999|Liraglutide|liraglutide
4764582|NCT02832999|Vildaglipin|vildaglipin
4764583|NCT02832986|Frailty consultation|frailty consultation
4764584|NCT02832973|Hypertension Resistant to Conventional Therapy|hypertension resistant to conventional therapy
4764585|NCT02832973|Natriuretic Agents|natriuretic agents
4764586|NCT02832973|Renin-Angiotensin System|renin-angiotensin system
4764587|NCT02832973|Bisoprolol|bisoprolol
4764588|NCT02832960|Thyroid Dysfunction|thyroid dysfunction
4764589|NCT02832960|Atherosclerosis|atherosclerosis
4764590|NCT02832960|Heart Failure|heart failure
4764591|NCT02832960|Cardiovascular imaging|cardiovascular imaging
4764592|NCT02832960|Randomized Controlled Trial|randomized controlled trial
4764593|NCT02832934|Thyroid Dysfunction|thyroid dysfunction
4764594|NCT02832934|Atherosclerosis|atherosclerosis
4764595|NCT02832934|Heart Failure|heart failure
4764596|NCT02832934|Cardiovascular Imaging|cardiovascular imaging
4764597|NCT02832934|Randomized Controlled Trial|randomized controlled trial
4764598|NCT02832921|Alzheimer's disease|alzheimer's disease
4764599|NCT02832921|virtual reality|virtual reality
4764600|NCT02832921|cognitive training|cognitive training
4764601|NCT02832895|Adults|adults
4764602|NCT02832895|Frontal bone window|frontal bone window
4764603|NCT02832895|Transcranial doppler|transcranial doppler
4764604|NCT02832882|HCC|hcc
4764605|NCT02832882|RFA|rfa
4764606|NCT02832869|Polyp detection rate|polyp detection rate
4764607|NCT02832869|Adenoma detection rate|adenoma detection rate
4764608|NCT02832869|Boston Bowel Preparation Scale|boston bowel preparation scale
4764609|NCT02832830|bony metastases|bony metastases
4764610|NCT02832830|palliative radiotherapy|palliative radiotherapy
4764611|NCT02832817|Oxygen therapy|oxygen therapy
4764612|NCT02832817|Pulse oximeter|pulse oximeter
4764613|NCT02832817|Hypoxia|hypoxia
4764614|NCT02832817|Hypoxemia|hypoxemia
4764615|NCT02832817|Arterial blood gas|arterial blood gas
4764616|NCT02832791|ANTERIOR CRUCIATE LIGAMENT RECONSTRUCTION|anterior cruciate ligament reconstruction
4764617|NCT02832791|QUADRICEPS TENDON|quadriceps tendon
4764618|NCT02832791|HAMSTRING TENDON|hamstring tendon
4764619|NCT02832765|Palliative radiotherapy|palliative radiotherapy
4764620|NCT02832765|Bone metastases|bone metastases
4764621|NCT02832739|Technology acceptance|technology acceptance
4764622|NCT02832739|Usability|usability
4764623|NCT02832739|eHealth|ehealth
4764624|NCT02832739|self-management support in chronic illness|self-management support in chronic illness
4764625|NCT02832739|prevention|prevention
4764626|NCT02832739|Special Orthopaedic Co-Morbidity after hip/knee replacement|special orthopaedic co-morbidity after hip/knee replacement
4764627|NCT02832726|absorption of Vitamin B12|absorption of vitamin b12
4764628|NCT02832713|Knee osteoarthritis|knee osteoarthritis
4764629|NCT02832713|Intra-articular botulinum toxin|intra-articular botulinum toxin
4764630|NCT02832713|Hyaluronic acid|hyaluronic acid
4764631|NCT02832713|Pain|pain
4764632|NCT02832713|Function|function
4764633|NCT02832700|glycopeptides|glycopeptides
4764634|NCT02832700|dietary proteins|dietary proteins
4764635|NCT02832700|whey protein|whey protein
4764636|NCT02832700|caseinomacropeptide|caseinomacropeptide
4764637|NCT02832700|antiinflammatories|antiinflammatories
4764638|NCT02832700|human microbiome|human microbiome
4764639|NCT02832661|renal allograft|renal allograft
4764640|NCT02832661|graft injuries|graft injuries
4764641|NCT02832661|biopsy|biopsy
4764642|NCT02832661|biomarkers|biomarkers
4764643|NCT02832661|omics approach|omics approach
4764644|NCT02832635|brain metastasis|brain metastasis
4764645|NCT02832635|whole-brain radiotherapy|whole-brain radiotherapy
4764646|NCT02832635|TMZ|tmz
4764647|NCT02832635|avoidance of hippocampus|avoidance of hippocampus
4764648|NCT02832622|MultiPoint Pacing|multipoint pacing
4764649|NCT02832622|Heart Failure|heart failure
4764650|NCT02832622|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
4764651|NCT02832622|SJM Quadripolar Biventricular Pacing|sjm quadripolar biventricular pacing
4764652|NCT02832609|closing volume|closing volume
4764653|NCT02832609|expiratory flow limitation|expiratory flow limitation
4764654|NCT02832609|obesity|obesity
4764655|NCT02832609|orthopnea|orthopnea
4764656|NCT02832596|Anesthesia|anesthesia
4764657|NCT02832596|Blood pressure|blood pressure
4764658|NCT02832596|Plasma Volume|plasma volume
4764659|NCT02832596|Vasopressor agents|vasopressor agents
4764660|NCT02832596|Coronary artery bypass|coronary artery bypass
4764661|NCT02832596|Glycocalyx|glycocalyx
4764662|NCT02832596|ANP|anp
4764663|NCT02832596|Coagulation|coagulation
4764664|NCT02832583|PRP, hyaluronic acid, mesotherapy, skin wrinkle, skin rejuvenation|prp, hyaluronic acid, mesotherapy, skin wrinkle, skin rejuvenation
4764665|NCT02832557|Autism|autism
4764666|NCT02832557|Asperger's Syndrome|asperger's syndrome
4764667|NCT02832557|microRNA|microrna
4764668|NCT02832557|epigenetic|epigenetic
4764669|NCT02832557|biomarker|biomarker
4764670|NCT02832544|atrial fibrillation|atrial fibrillation
4764671|NCT02832544|stroke|stroke
4764672|NCT02832531|atrial fibrillation|atrial fibrillation
4764673|NCT02832531|stroke|stroke
4764674|NCT02832492|disorders of consciousness|disorders of consciousness
4764675|NCT02832492|unresponsive wakefulness syndrome|unresponsive wakefulness syndrome
4764676|NCT02832492|pupil near response|pupil near response
4764677|NCT02832492|prognosis of consciousness recovery|prognosis of consciousness recovery
4764678|NCT02832453|High intensity physical exercise|high intensity physical exercise
4764679|NCT02832453|Primary health care|primary health care
4764680|NCT02832453|Behaviour change interventions|behaviour change interventions
4764681|NCT02832427|Coronary artery bypass grafting|coronary artery bypass grafting
4764682|NCT02832427|Heart valve surgery|heart valve surgery
4764683|NCT02832427|Postoperative morbidity|postoperative morbidity
4764684|NCT02832427|Operative mortality|operative mortality
4764685|NCT02832401|event-related potentials|event-related potentials
4764686|NCT02832401|EEG|eeg
4764687|NCT02832401|caffeine|caffeine
4764688|NCT02832401|psychosis|psychosis
4764689|NCT02832401|schizophrenia|schizophrenia
4764690|NCT02832336|Caffeine|caffeine
4764691|NCT02832336|Caffeine citrate|caffeine citrate
4764692|NCT02832336|Neurological disorder|neurological disorder
4764693|NCT02832336|Excessive daytime sleepiness|excessive daytime sleepiness
4764694|NCT02832336|Orexin|orexin
4764695|NCT02832336|adenosine antagonist|adenosine antagonist
4764696|NCT02832323|hemodialysis|hemodialysis
4764697|NCT02832323|EPO|epo
4764698|NCT02832323|MIRCERA|mircera
4764699|NCT02832310|valsalva|valsalva
4764700|NCT02832258|Enterobacteria|enterobacteria
4764701|NCT02832258|Children|children
4764702|NCT02832258|Febrile urinary tract infection|febrile urinary tract infection
4764703|NCT02832258|Cystitis|cystitis
4764704|NCT02832258|Extended-spectrum beta-lactamase-producing Enterobacteriaceae|extended-spectrum beta-lactamase-producing enterobacteriaceae
4764705|NCT02832232|Physiotherapy|physiotherapy
4764706|NCT02832232|Manual Therapy|manual therapy
4764707|NCT02832232|Neck Pain|neck pain
4764708|NCT02832219|Overweight|overweight
4764709|NCT02832219|Molecular hydrogen|molecular hydrogen
4764710|NCT02832219|Insulin|insulin
4764711|NCT02832206|Atrial fibrillation|atrial fibrillation
4764712|NCT02832206|Hybrid ablation|hybrid ablation
4764713|NCT02832180|Rheumatoid|rheumatoid
4764714|NCT02832141|Skin blood flow|skin blood flow
4764715|NCT02832141|Skin redness|skin redness
4764716|NCT02832141|Sympathetic nervous system|sympathetic nervous system
4764717|NCT02832141|Regional Blood Flow|regional blood flow
4764718|NCT02832128|Cochlear Implant|cochlear implant
4764719|NCT02832115|Radial Artery Spasm|radial artery spasm
4764720|NCT02832115|Cardiac Catheterization|cardiac catheterization
4764721|NCT02832115|Vascular Access Site Complications|vascular access site complications
4764722|NCT02832115|Vasodilator|vasodilator
4764723|NCT02832115|Nitroglycerine|nitroglycerine
4764724|NCT02832115|Lidocaine|lidocaine
4764725|NCT02832102|prognostic modelling|prognostic modelling
4764726|NCT02832102|radiomics|radiomics
4764727|NCT02832102|clinical decision support system|clinical decision support system
4764728|NCT02832102|big data analysis|big data analysis
4764836|NCT02831582|Stage IIA|stage iia
4764729|NCT02832102|multiscale prognostic signatures|multiscale prognostic signatures
4764730|NCT02832102|patient-clinician co-decision tools|patient-clinician co-decision tools
4764731|NCT02832089|atrial fibrillation|atrial fibrillation
4764732|NCT02832089|rate reduction|rate reduction
4764733|NCT02832050|play|play
4764734|NCT02832050|therapy|therapy
4764735|NCT02832024|stents|stents
4764736|NCT02832024|atherectomy|atherectomy
4764737|NCT02832024|femoral artery|femoral artery
4764738|NCT02832024|popliteal artery|popliteal artery
4764739|NCT02832024|In-stent Restenosis|in-stent restenosis
4764740|NCT02831985|Child|child
4764741|NCT02831985|Middle ear ventilation|middle ear ventilation
4764742|NCT02831985|Follow-up studies|follow-up studies
4764743|NCT02831985|General practitioners|general practitioners
4764744|NCT02831972|Healthy Volunteers|healthy volunteers
4764745|NCT02831959|Non-Small Cell Lung Cancer|non-small cell lung cancer
4764746|NCT02831959|NSCLC|nsclc
4764747|NCT02831959|Brain metastases|brain metastases
4764748|NCT02831959|Treatment|treatment
4764749|NCT02831959|Minimal toxicity|minimal toxicity
4764750|NCT02831959|TTFields|ttfields
4764752|NCT02831959|Tumor Treating Fields|tumor treating fields
4764753|NCT02831959|Novocure|novocure
4764754|NCT02831959|SRS|srs
4764755|NCT02831959|Stereotactic radiosurgery|stereotactic radiosurgery
4764756|NCT02831946|skin closure|skin closure
4764757|NCT02831946|intracuticular suture|intracuticular suture
4764758|NCT02831946|glue (dermabond)|glue (dermabond)
4764759|NCT02831933|lung cancer|lung cancer
4764760|NCT02831933|metastatic|metastatic
4764761|NCT02831933|gene therapy|gene therapy
4764762|NCT02831933|immunotherapy|immunotherapy
4764763|NCT02831933|melanoma|melanoma
4764764|NCT02831933|uveal|uveal
4764765|NCT02831920|Prostate Cancer|prostate cancer
4764766|NCT02831920|MRI|mri
4764767|NCT02831920|CEUS|ceus
4764768|NCT02831920|Contrast Ultrasound|contrast ultrasound
4764769|NCT02831920|Fusion|fusion
4764770|NCT02831920|targeted biopsy|targeted biopsy
4764771|NCT02831907|Ultrasonography|ultrasonography
4764772|NCT02831907|Portal vein Doppler|portal vein doppler
4764773|NCT02831907|Renal Doppler|renal doppler
4764774|NCT02831907|Cardio-Intestinal syndrome|cardio-intestinal syndrome
4764775|NCT02831907|Delirium|delirium
4764776|NCT02831907|Renal congestion|renal congestion
4764777|NCT02831907|Intra-renal hemodynamics|intra-renal hemodynamics
4764778|NCT02831894|insomnia|insomnia
4764779|NCT02831894|sedative hypnotics|sedative hypnotics
4764780|NCT02831894|hypnotic tapering|hypnotic tapering
4764781|NCT02831855|Rheumatoid Arthritis|rheumatoid arthritis
4764782|NCT02831855|Tofacitinib|tofacitinib
4764783|NCT02831855|CP-690,550|cp-690,550
4764784|NCT02831855|Xeljanz|xeljanz
4764785|NCT02831855|methotrexate withdrawal|methotrexate withdrawal
4764786|NCT02831855|withdrawal study|withdrawal study
4764787|NCT02831829|cardiac rehabilitation|cardiac rehabilitation
4764788|NCT02831829|coronary artery disease|coronary artery disease
4764789|NCT02831777|non-invasive blood pressure|non-invasive blood pressure
4764790|NCT02831764|tolerability|tolerability
4764791|NCT02831764|HIV 1|hiv 1
4764792|NCT02831764|efficacy|efficacy
4764793|NCT02831764|treatment naïve|treatment naïve
4764794|NCT02831764|two-drug regimen|two-drug regimen
4764795|NCT02831764|safety|safety
4764796|NCT02831764|non inferiority|non inferiority
4764797|NCT02831751|Influenza|influenza
4764798|NCT02831751|Human|human
4764799|NCT02831751|RNA Virus Infections|rna virus infections
4764800|NCT02831751|Immulogic|immulogic
4764801|NCT02831751|Immunogenic Factors|immunogenic factors
4764802|NCT02831751|Physiological Effects of Drug|physiological effects of drug
4764803|NCT02831751|Virus Diseases|virus diseases
4764804|NCT02831751|Orthomyxoviridae Infections|orthomyxoviridae infections
4764805|NCT02831751|Infection|infection
4764806|NCT02831738|Fiber|fiber
4764807|NCT02831738|Polydextrose|polydextrose
4764808|NCT02831738|Glycemic Index|glycemic index
4764809|NCT02831712|NTBI|ntbi
4764810|NCT02831712|Iron status|iron status
4764811|NCT02831712|Iron supplement|iron supplement
4764812|NCT02831699|Zika|zika
4764813|NCT02831699|Guillain Barré|guillain barré
4764814|NCT02831686|Selinexor (KPT-330)|selinexor (kpt-330)
4764815|NCT02831686|Ixazomib|ixazomib
4764816|NCT02831686|dexamethasone|dexamethasone
4764817|NCT02831686|15-310|15-310
4764818|NCT02831673|safety|safety
4764819|NCT02831673|treatment naïve|treatment naïve
4764820|NCT02831673|HIV 1|hiv 1
4764821|NCT02831673|dolutegravir plus lamivudine|dolutegravir plus lamivudine
4764822|NCT02831673|non inferiority|non inferiority
4764823|NCT02831673|tolerability|tolerability
4764824|NCT02831673|dolutegravir plus tenofovir/emtricitabine|dolutegravir plus tenofovir/emtricitabine
4764825|NCT02831673|efficacy|efficacy
4764826|NCT02831634|Breast cancer|breast cancer
4764827|NCT02831634|cutaneous melanoma|cutaneous melanoma
4764828|NCT02831621|overweight|overweight
4764829|NCT02831621|ectopic fat|ectopic fat
4764830|NCT02831621|exercise|exercise
4764831|NCT02831621|diet|diet
4764832|NCT02831582|Breast Cancer|breast cancer
4764833|NCT02831582|Postmenopausal|postmenopausal
4764834|NCT02831582|Stage IA|stage ia
4764835|NCT02831582|Stage IB|stage ib
4764837|NCT02831582|Stage IIB|stage iib
4764838|NCT02831582|Stage IIIA|stage iiia
4764839|NCT02831582|Stage IIIB|stage iiib
4764840|NCT02831582|Stage IIIC|stage iiic
4764841|NCT02831556|Ultrasound|ultrasound
4764842|NCT02831556|Abdomen|abdomen
4764843|NCT02831556|Pelvis|pelvis
4764844|NCT02831556|3D|3d
4764845|NCT02831504|Myotonic Dystrophy type 1|myotonic dystrophy type 1
4764846|NCT02831504|DM1|dm1
4764847|NCT02831504|Muscular Dystrophy|muscular dystrophy
4764848|NCT02831504|Neuromuscular Diseases|neuromuscular diseases
4764849|NCT02831491|metastatic|metastatic
4764850|NCT02831465|Dynamic hyperinflation|dynamic hyperinflation
4764851|NCT02831465|Maximal Voluntary Ventilation|maximal voluntary ventilation
4764852|NCT02831465|Inspiratory capacity|inspiratory capacity
4764853|NCT02831465|healthy subjects|healthy subjects
4764854|NCT02831452|pelvic floor muscles|pelvic floor muscles
4764855|NCT02831452|evaluation|evaluation
4764856|NCT02831452|dynamometer|dynamometer
4764857|NCT02831452|perineometer|perineometer
4764858|NCT02831439|Choosing Wisely|choosing wisely
4764859|NCT02831439|Breast cancer|breast cancer
4764860|NCT02831439|Controlled trial|controlled trial
4764861|NCT02831439|High-value health care|high-value health care
4764862|NCT02831439|Health services research|health services research
4764863|NCT02831348|Asthma|asthma
4764864|NCT02831348|Allergic rhinitis|allergic rhinitis
4764865|NCT02831348|Rhinitis|rhinitis
4764866|NCT02831348|Pneumonia|pneumonia
4764867|NCT02831348|Cystic fibrosis|cystic fibrosis
4764868|NCT02831322|Transradial|transradial
4764869|NCT02831322|ﬂow-mediated vasodilation|ﬂow-mediated vasodilation
4764870|NCT02831309|physical activity|physical activity
4764872|NCT02831296|Werdnig-Hoffmann disease|werdnig-hoffmann disease
4764873|NCT02831296|Kugelberg-Welander disease|kugelberg-welander disease
4764874|NCT02831283|inflammation|inflammation
4764875|NCT02831283|aging|aging
4764876|NCT02831283|mild cognitive impairment|mild cognitive impairment
4764877|NCT02831270|cardiac surgery|cardiac surgery
4764878|NCT02831270|acute normovolemic hemodilution|acute normovolemic hemodilution
4764879|NCT02831257|Neurofibromatosis 2|neurofibromatosis 2
4764880|NCT02831218|bioresorbable vascular scaffold|bioresorbable vascular scaffold
4764881|NCT02831218|coronary artery disease|coronary artery disease
4764882|NCT02831205|bioresorbable vascular scaffold|bioresorbable vascular scaffold
4764883|NCT02831205|coronary artery disease|coronary artery disease
4764884|NCT02831166|Vascular closure devices|vascular closure devices
4764885|NCT02831166|Transradial approach|transradial approach
4764886|NCT02831166|Transfemoral approach|transfemoral approach
4764887|NCT02831140|Fast track|fast track
4764888|NCT02831140|rehabilitation|rehabilitation
4764889|NCT02831140|post operative complications|post operative complications
4764890|NCT02831127|short message service; adherence; stent exchange; ERCP|short message service; adherence; stent exchange; ercp
4764891|NCT02831101|BIS|bis
4764892|NCT02831101|Elderly|elderly
4764893|NCT02831101|Propofol|propofol
4764894|NCT02831101|Sufentanil|sufentanil
4764895|NCT02831101|Loss of consciousness|loss of consciousness
4764896|NCT02831088|Neu2000KWL|neu2000kwl
4764897|NCT02831088|Neuroprotection|neuroprotection
4764898|NCT02831088|endovascular therapy|endovascular therapy
4764899|NCT02831088|glutamate|glutamate
4764900|NCT02831088|free radical|free radical
4764901|NCT02831075|Adipose-derived Stem Cells|adipose-derived stem cells
4764902|NCT02831062|nutrition|nutrition
4764903|NCT02831062|progression|progression
4764904|NCT02831049|Reconsolidation|reconsolidation
4764905|NCT02831010|prematurity|prematurity
4764906|NCT02830971|standardized learning curve|standardized learning curve
4764907|NCT02830971|Nurse|nurse
4764908|NCT02830971|intensive care unit|intensive care unit
4764909|NCT02830971|Mastery|mastery
4764910|NCT02830971|Training|training
4764911|NCT02830971|Developing|developing
4764912|NCT02830971|Skills|skills
4764913|NCT02830919|Osteoarthritis of knee|osteoarthritis of knee
4764914|NCT02830919|Glucosamine sulfate|glucosamine sulfate
4764915|NCT02830919|Chondroitin sulfate|chondroitin sulfate
4764916|NCT02830906|Total Knee Arthroplasty|total knee arthroplasty
4764917|NCT02830906|Intrathecal Morphine|intrathecal morphine
4764918|NCT02830906|Ramosetron|ramosetron
4764919|NCT02830906|Ondansetron|ondansetron
4764920|NCT02830906|postoperative nausea and vomiting|postoperative nausea and vomiting
4764921|NCT02830880|Imaging|imaging
4764922|NCT02830880|Nuclear medicine|nuclear medicine
4764923|NCT02830880|Oncology|oncology
4764924|NCT02830880|Radiology|radiology
4764925|NCT02830880|Urogenital disorders|urogenital disorders
4764926|NCT02830867|glutathione|glutathione
4764927|NCT02830867|glutathione synthetase deficiency|glutathione synthetase deficiency
4764928|NCT02830867|autosomal inheritance|autosomal inheritance
4764929|NCT02830867|recessive|recessive
4764930|NCT02830841|RIPC|ripc
4764931|NCT02830841|hepatic ischemic and reperfusion injury|hepatic ischemic and reperfusion injury
4764932|NCT02830841|pediatric living donor liver transplantation|pediatric living donor liver transplantation
4764933|NCT02830815|Broadband click stimulus testing|broadband click stimulus testing
4764934|NCT02830815|General Anesthesia|general anesthesia
4764935|NCT02830815|Sevoflurane|sevoflurane
4764936|NCT02830815|Propofol|propofol
4765136|NCT02829840|Azacitidine|azacitidine
4764937|NCT02830815|Amplitude latency|amplitude latency
4764938|NCT02830815|Wave V|wave v
4764939|NCT02830776|dermatochalasis|dermatochalasis
4764940|NCT02830776|bimatoprost|bimatoprost
4764941|NCT02830776|blepharoplasty|blepharoplasty
4764942|NCT02830763|neutral lipid storage disease|neutral lipid storage disease
4764943|NCT02830763|CNT-02|cnt-02
4764944|NCT02830763|primary triglyceride deposit cardiomyovasculopathy (TGCV)|primary triglyceride deposit cardiomyovasculopathy (tgcv)
4764945|NCT02830763|neutral lipid storage disease with myopathy (NLSD-M)|neutral lipid storage disease with myopathy (nlsd-m)
4764946|NCT02830737|Small Hepatocellular Carcinoma|small hepatocellular carcinoma
4764947|NCT02830737|No-touch RFA|no-touch rfa
4764948|NCT02830737|Traditional RFA|traditional rfa
4764949|NCT02830737|Recurrence rate|recurrence rate
4764950|NCT02830724|Metastatic Solid Cancers|metastatic solid cancers
4764951|NCT02830724|Renal Cell Cancer|renal cell cancer
4764952|NCT02830724|Cell Therapy|cell therapy
4764953|NCT02830724|CAR T Cells|car t cells
4764954|NCT02830711|happiness|happiness
4764955|NCT02830711|anger|anger
4764956|NCT02830711|sadness|sadness
4764957|NCT02830711|anticipation|anticipation
4764958|NCT02830698|Nervous System|nervous system
4764959|NCT02830698|Hypnosis|hypnosis
4764960|NCT02830698|Electrocardiography, Ambulatory|electrocardiography, ambulatory
4764961|NCT02830685|pre-pectoral breast reconstruction|pre-pectoral breast reconstruction
4764962|NCT02830685|subcutaneous breast reconstruction|subcutaneous breast reconstruction
4764963|NCT02830633|laparoscopy|laparoscopy
4764964|NCT02830633|rectal cancer|rectal cancer
4764965|NCT02830633|pelvic autonomic nerve|pelvic autonomic nerve
4764966|NCT02830568|Kidney transplantation|kidney transplantation
4764967|NCT02830568|Surgical procedures|surgical procedures
4764968|NCT02830568|Kidney living donors|kidney living donors
4764969|NCT02830568|Quality of life|quality of life
4764970|NCT02830542|Clostridium difficile|clostridium difficile
4764971|NCT02830542|C Diff|c diff
4764972|NCT02830542|CDI|cdi
4764973|NCT02830529|Mindfulness|mindfulness
4764974|NCT02830529|African American|african american
4764975|NCT02830529|fMRI|fmri
4764976|NCT02830477|Previously treated patients|previously treated patients
4764977|NCT02830451|Registry|registry
4764978|NCT02830451|Spine|spine
4764979|NCT02830451|Surgery|surgery
4764980|NCT02830451|Medical Oncology|medical oncology
4764981|NCT02830451|Radiation Oncology|radiation oncology
4764982|NCT02830451|Neoplasms|neoplasms
4764983|NCT02830451|Metastasis|metastasis
4764984|NCT02830451|Chemotherapy|chemotherapy
4764985|NCT02830451|Radiation Therapy|radiation therapy
4764986|NCT02830451|Tumor Markers|tumor markers
4764987|NCT02830438|kidney disease|kidney disease
4764988|NCT02830438|fibrosis|fibrosis
4764989|NCT02830438|ultrasound|ultrasound
4764990|NCT02830438|elastography|elastography
4764991|NCT02830425|Multimorbidity|multimorbidity
4764992|NCT02830425|Polypharmacy|polypharmacy
4764993|NCT02830425|Appropriateness|appropriateness
4764994|NCT02830425|STOPP|stopp
4764995|NCT02830425|START|start
4764996|NCT02830399|treatment-resistant-depression|treatment-resistant-depression
4764997|NCT02830399|rTMS|rtms
4764998|NCT02830399|ECT|ect
4764999|NCT02830399|Augmentation strategy|augmentation strategy
4765000|NCT02830373|LVIS stents|lvis stents
4765001|NCT02830373|Intracranial aneurysm|intracranial aneurysm
4765002|NCT02830373|Unruptured aneurysm|unruptured aneurysm
4765003|NCT02830373|Wide-necked aneurysm|wide-necked aneurysm
4765004|NCT02830360|Antiarrhythmic drug therapy|antiarrhythmic drug therapy
4765005|NCT02830360|VT Catheter ablation|vt catheter ablation
4765006|NCT02830360|ICD Therapy|icd therapy
4765007|NCT02830360|Ischemic Heart Disease|ischemic heart disease
4765008|NCT02830347|antibiotic resistance|antibiotic resistance
4765009|NCT02830347|oral microbiome|oral microbiome
4765010|NCT02830334|Suicide|suicide
4765011|NCT02830334|Youth Suicide|youth suicide
4765012|NCT02830308|Hormones|hormones
4765013|NCT02830308|Endocrine|endocrine
4765014|NCT02830308|Hypercortisolism|hypercortisolism
4765015|NCT02830308|Bone|bone
4765016|NCT02830308|Hypothalamic-Pituitary Dysfunction|hypothalamic-pituitary dysfunction
4765017|NCT02830295|body awareness therapy|body awareness therapy
4765018|NCT02830295|physical therapy|physical therapy
4765019|NCT02830295|movement therapy|movement therapy
4765020|NCT02830269|Neuro-ICU|neuro-icu
4765021|NCT02830269|Third ventricle|third ventricle
4765022|NCT02830269|Computer Tomography|computer tomography
4765023|NCT02830269|Transcranial Doppler ultrasonography|transcranial doppler ultrasonography
4765024|NCT02830256|Intensive care unit|intensive care unit
4765025|NCT02830256|Neuro-ICU|neuro-icu
4765026|NCT02830256|Pain|pain
4765027|NCT02830256|Intubation|intubation
4765028|NCT02830256|critical care|critical care
4765029|NCT02830256|patients|patients
4765030|NCT02830217|STEMI|stemi
4765031|NCT02830217|primary PCI|primary pci
4765032|NCT02830217|sST2|sst2
4765033|NCT02830217|prognosis|prognosis
4765034|NCT02830204|mitral valve regurgitation|mitral valve regurgitation
4765035|NCT02830204|mitral valve stenosis|mitral valve stenosis
4765036|NCT02830191|Cyclosporine, Dried blood spot|cyclosporine, dried blood spot
4765037|NCT02830152|Stroke|stroke
4765137|NCT02829840|5-aza|5-aza
4765038|NCT02830152|intracerebral hemorrhage|intracerebral hemorrhage
4765039|NCT02830152|left atrial appendage occlusion|left atrial appendage occlusion
4765040|NCT02830152|atrial fibrillation|atrial fibrillation
4765041|NCT02830152|oral anticoagulation|oral anticoagulation
4765042|NCT02830152|preventive therapy|preventive therapy
4765043|NCT02830126|Outcomes|outcomes
4765044|NCT02830126|Information technology|information technology
4765045|NCT02830113|periodontitis|periodontitis
4765046|NCT02830113|diabetes|diabetes
4765047|NCT02830113|prevention|prevention
4765048|NCT02830113|impaired glucose tolerance|impaired glucose tolerance
4765049|NCT02830113|insulin resistance|insulin resistance
4765050|NCT02830100|Intern speech|intern speech
4765051|NCT02830100|Speech and visual imaging|speech and visual imaging
4765052|NCT02830100|Mind and oral drift|mind and oral drift
4765053|NCT02830100|Cognitive performance|cognitive performance
4765054|NCT02830100|Magnetic Resonance Imaging|magnetic resonance imaging
4765055|NCT02830087|randomized controlled trial|randomized controlled trial
4765056|NCT02830087|tourniquet|tourniquet
4765057|NCT02830087|tourniquet cuff pressure|tourniquet cuff pressure
4765058|NCT02830087|total knee arthroplasty|total knee arthroplasty
4765059|NCT02830087|total knee replacement|total knee replacement
4765060|NCT02830087|pain, postoperative|pain, postoperative
4765061|NCT02830087|range of motion, articular|range of motion, articular
4765062|NCT02830087|blood loss, surgical|blood loss, surgical
4765063|NCT02830087|muscle strength, quadriceps|muscle strength, quadriceps
4765064|NCT02830087|walking|walking
4765065|NCT02830087|manipulation, orthopedic/therapeutic use|manipulation, orthopedic/therapeutic use
4765066|NCT02830087|wound healing/surgery|wound healing/surgery
4765067|NCT02830074|Sleep Apnea Syndromes|sleep apnea syndromes
4765068|NCT02830074|Spinal Cord Injuries|spinal cord injuries
4765069|NCT02830074|Sleep|sleep
4765070|NCT02830074|Quality of life|quality of life
4765071|NCT02830061|Cancer|cancer
4765072|NCT02830061|Teenage|teenage
4765073|NCT02830061|Young Adult|young adult
4765074|NCT02830061|Fertility|fertility
4765075|NCT02830061|Cryopreservation|cryopreservation
4765076|NCT02830061|Experience|experience
4765077|NCT02830048|diabetes|diabetes
4765078|NCT02830048|glibenclamide|glibenclamide
4765079|NCT02830048|glucagon|glucagon
4765080|NCT02830035|ultrasound guided|ultrasound guided
4765081|NCT02830035|spinal anesthesia|spinal anesthesia
4765082|NCT02830035|neuraxial block|neuraxial block
4765083|NCT02830035|paramedian|paramedian
4765084|NCT02830022|autism spectrum disorder|autism spectrum disorder
4765085|NCT02829996|glaucoma|glaucoma
4765086|NCT02829996|primary open-angle glaucoma|primary open-angle glaucoma
4765087|NCT02829996|ocular hypertension|ocular hypertension
4765088|NCT02829996|adenosine agonist|adenosine agonist
4765089|NCT02829996|eye drop|eye drop
4765090|NCT02829996|trabodenoson|trabodenoson
4765091|NCT02829996|trabecular meshwork|trabecular meshwork
4765092|NCT02829983|clarithromycin|clarithromycin
4765093|NCT02829983|periodontal debridement|periodontal debridement
4765094|NCT02829983|aggressive periodontitis|aggressive periodontitis
4765095|NCT02829970|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
4765096|NCT02829970|Alcohol-Related Disorders|alcohol-related disorders
4765097|NCT02829970|Substance-Related Disorders|substance-related disorders
4765098|NCT02829970|Motivational Interviewing|motivational interviewing
4765099|NCT02829970|Behavior Therapy|behavior therapy
4765100|NCT02829944|Cesarean section|cesarean section
4765101|NCT02829931|recurrent glioma|recurrent glioma
4765102|NCT02829931|high grade glioma|high grade glioma
4765103|NCT02829931|head and neck disease|head and neck disease
4765104|NCT02829931|grade III glioma|grade iii glioma
4765105|NCT02829931|grade IV glioma|grade iv glioma
4765106|NCT02829931|radiation therapy|radiation therapy
4765107|NCT02829918|advanced biliary tract cancer|advanced biliary tract cancer
4765108|NCT02829918|refractory biliary tract cancer|refractory biliary tract cancer
4765109|NCT02829918|digestive diseases|digestive diseases
4765110|NCT02829918|immunotherapy|immunotherapy
4765111|NCT02829905|mass screening|mass screening
4765112|NCT02829905|patient satisfaction|patient satisfaction
4765113|NCT02829905|radiography|radiography
4765114|NCT02829905|mammography|mammography
4765115|NCT02829879|Dentin Sensitivity|dentin sensitivity
4765116|NCT02829879|Arginin|arginin
4765117|NCT02829879|Potassium Nitrate|potassium nitrate
4765118|NCT02829879|Dentifrice|dentifrice
4765119|NCT02829879|RCT|rct
4765120|NCT02829853|SARCOIDOSIS|sarcoidosis
4765121|NCT02829853|GRANULOMA DISEASES|granuloma diseases
4765122|NCT02829853|GENETICS|genetics
4765123|NCT02829853|PREDISPOSITION|predisposition
4765124|NCT02829853|EXOME (WES-NGS)|exome (wes-ngs)
4765125|NCT02829840|Leukemia|leukemia
4765126|NCT02829840|FLT3-Mutated Acute Myeloid Leukemia|flt3-mutated acute myeloid leukemia
4765127|NCT02829840|FLT3-Mutated High-Risk Myelodysplastic Syndrome|flt3-mutated high-risk myelodysplastic syndrome
4765128|NCT02829840|Acute Myeloid Leukemia|acute myeloid leukemia
4765129|NCT02829840|AML|aml
4765130|NCT02829840|Myelodysplastic Syndrome|myelodysplastic syndrome
4765131|NCT02829840|MDS|mds
4765132|NCT02829840|Ponatinib|ponatinib
4765133|NCT02829840|Iclusig|iclusig
4765134|NCT02829840|AP24534|ap24534
4765135|NCT02829840|5-azacytidine|5-azacytidine
4765138|NCT02829840|Vidaza|vidaza
4765139|NCT02829840|5-AZC|5-azc
4765140|NCT02829840|AZA-CR|aza-cr
4765141|NCT02829840|Ladakamycin|ladakamycin
4765142|NCT02829840|NSC-102816|nsc-102816
4765143|NCT02829840|Azacytidine|azacytidine
4765144|NCT02829827|Radiprodil|radiprodil
4765145|NCT02829827|Infantile spasms|infantile spasms
4765146|NCT02829827|IS|is
4765147|NCT02829827|Infantile|infantile
4765148|NCT02829827|Spasms|spasms
4765149|NCT02829827|Epilepsy|epilepsy
4765150|NCT02829827|Paediatrics|paediatrics
4765151|NCT02829827|Drug-resistant|drug-resistant
4765152|NCT02829827|West Syndrome|west syndrome
4765153|NCT02829827|Hypsarrhythmia|hypsarrhythmia
4765154|NCT02829814|Pain|pain
4765155|NCT02829814|Sleep|sleep
4765156|NCT02829814|Fibromyalgia|fibromyalgia
4765157|NCT02829814|FM|fm
4765158|NCT02829801|animal assisted therapy|animal assisted therapy
4765159|NCT02829801|well-being|well-being
4765160|NCT02829801|Alzheimer's Disease|alzheimer's disease
4765161|NCT02829788|Digestive peritoneal carcinomatosis|digestive peritoneal carcinomatosis
4765162|NCT02829788|laparoscopy|laparoscopy
4765163|NCT02829788|laparotomy|laparotomy
4765164|NCT02829788|peritoneal cancer index (PCI)|peritoneal cancer index (pci)
4765165|NCT02829788|staging|staging
4765166|NCT02829762|isolated|isolated
4765167|NCT02829762|at risk of isolation|at risk of isolation
4765168|NCT02829762|patients|patients
4765169|NCT02829749|Heart Valve Diseases|heart valve diseases
4765170|NCT02829749|Heart failure|heart failure
4765171|NCT02829749|Heart diseases|heart diseases
4765172|NCT02829749|Mitral valve insufficiency|mitral valve insufficiency
4765173|NCT02829736|lung neoplasm|lung neoplasm
4765174|NCT02829736|lung metastasis|lung metastasis
4765175|NCT02829736|enhanced recovery after surgery|enhanced recovery after surgery
4765176|NCT02829736|fast-track surgery|fast-track surgery
4765177|NCT02829736|intraoperative chest tube removal|intraoperative chest tube removal
4765178|NCT02829736|pain|pain
4765179|NCT02829736|lung function|lung function
4765180|NCT02829736|reasons for admission|reasons for admission
4765181|NCT02829723|Phase I/II|phase i/ii
4765182|NCT02829723|BLZ945|blz945
4765183|NCT02829723|PDR001|pdr001
4765184|NCT02829723|CSF-1R|csf-1r
4765185|NCT02829723|PD-1|pd-1
4765186|NCT02829710|Analgesia|analgesia
4765187|NCT02829710|intensive care units|intensive care units
4765188|NCT02829710|clinical protocol|clinical protocol
4765189|NCT02829710|deep sedation|deep sedation
4765190|NCT02829710|nursing assessment|nursing assessment
4765191|NCT02829697|Regional anaesthesia|regional anaesthesia
4765192|NCT02829671|Loneliness|loneliness
4765193|NCT02829671|Suicidal behavior|suicidal behavior
4765194|NCT02829671|Depression|depression
4765195|NCT02829645|eating disoders|eating disoders
4765196|NCT02829645|neuropsychology|neuropsychology
4765197|NCT02829645|pronostic|pronostic
4765198|NCT02829632|mobile technology|mobile technology
4765199|NCT02829632|feedback message|feedback message
4765200|NCT02829632|self-monitoring|self-monitoring
4765201|NCT02829619|Obesity|obesity
4765202|NCT02829619|Nutrigenetics|nutrigenetics
4765203|NCT02829619|Food Timing|food timing
4765204|NCT02829619|Weight loss|weight loss
4765205|NCT02829606|Age-related Macular Degeneration|age-related macular degeneration
4765206|NCT02829606|Central Scotoma|central scotoma
4765207|NCT02829606|Head Mounted Display|head mounted display
4765208|NCT02829580|endothelial function|endothelial function
4765209|NCT02829580|flow-mediated dilation|flow-mediated dilation
4765210|NCT02829580|vascular elastic properties|vascular elastic properties
4765211|NCT02829554|Emotion|emotion
4765212|NCT02829554|Judgment|judgment
4765213|NCT02829554|Decision Making|decision making
4765214|NCT02829541|Single Ascending Dose (SAD), Healthy Volunteers|single ascending dose (sad), healthy volunteers
4765215|NCT02829502|Cerebrovascular disease|cerebrovascular disease
4765216|NCT02829502|Glucagon like peptide 1|glucagon like peptide 1
4765217|NCT02829489|nutrition|nutrition
4765218|NCT02829489|foregut tumors|foregut tumors
4765219|NCT02829489|patient related outcomes|patient related outcomes
4765220|NCT02829489|audit|audit
4765221|NCT02829476|Adolescent idiopathic Scoliosis|adolescent idiopathic scoliosis
4765222|NCT02829476|Ghrelin|ghrelin
4765223|NCT02829450|peritoneal ultrafiltration|peritoneal ultrafiltration
4765224|NCT02829450|congestive heart failure|congestive heart failure
4765225|NCT02829450|chronic kidney disease|chronic kidney disease
4765226|NCT02829398|cerebral ischemia|cerebral ischemia
4765227|NCT02829385|Apatinib|apatinib
4765228|NCT02829385|XELOX Regimen|xelox regimen
4765229|NCT02829385|metastatic colorectal cancer|metastatic colorectal cancer
4765230|NCT02829346|Tranexamic acid|tranexamic acid
4765231|NCT02829346|Peri-articular injection|peri-articular injection
4765232|NCT02829346|Total knee arthroplasty|total knee arthroplasty
4765233|NCT02829346|Blood loss|blood loss
4765234|NCT02829346|Osteoarthritis, Knee|osteoarthritis, knee
4765235|NCT02829333|analgesia|analgesia
4765236|NCT02829333|anesthesia|anesthesia
4765237|NCT02829333|leiomyomas|leiomyomas
4765238|NCT02829333|tumor|tumor
4765239|NCT02829333|vascular endothelial growth factor|vascular endothelial growth factor
4765240|NCT02829333|anesthesia technique on tumor|anesthesia technique on tumor
4765241|NCT02829320|efficacy|efficacy
4765242|NCT02829320|hemodialysis (HD)|hemodialysis (hd)
4765243|NCT02829320|hemoglobin (Hgb)|hemoglobin (hgb)
4765244|NCT02829320|erythropoiesis-stimulating agents (ESAs)|erythropoiesis-stimulating agents (esas)
4765245|NCT02829320|GSK1278863|gsk1278863
4765246|NCT02829307|89Zirconium|89zirconium
4765247|NCT02829307|Open label|open label
4765248|NCT02829307|Pharmacokinetics|pharmacokinetics
4765249|NCT02829307|Radioactive|radioactive
4765250|NCT02829307|Clearance|clearance
4765251|NCT02829307|Biodistribution|biodistribution
4765252|NCT02829281|knee osteoarthritis|knee osteoarthritis
4765253|NCT02829281|Intra-articular injection|intra-articular injection
4765254|NCT02829281|Botulinum Toxin Type A|botulinum toxin type a
4765255|NCT02829281|Corticosteroid|corticosteroid
4765256|NCT02829268|Wolfram syndrome|wolfram syndrome
4765257|NCT02829268|Diabetes Mellitus|diabetes mellitus
4765258|NCT02829268|Optic Nerve Atrophy|optic nerve atrophy
4765259|NCT02829268|Ataxia|ataxia
4765260|NCT02829268|Endoplasmic Reticulum Stress|endoplasmic reticulum stress
4765261|NCT02829255|High altitude|high altitude
4765262|NCT02829255|Cerebral autoregulation|cerebral autoregulation
4765263|NCT02829255|Transfer function analysis|transfer function analysis
4765264|NCT02829242|Near Infrared Spectroscopy|near infrared spectroscopy
4765265|NCT02829242|Somatic Saturation|somatic saturation
4765266|NCT02829242|Well Leg Compartment Syndrome|well leg compartment syndrome
4765267|NCT02829242|Robotic Assisted Laparoscopic Surgery|robotic assisted laparoscopic surgery
4765268|NCT02829242|Trendelenburg Position|trendelenburg position
4765269|NCT02829216|myelosuppression|myelosuppression
4765270|NCT02829216|mesenchymal stromal cells|mesenchymal stromal cells
4765271|NCT02829203|Frailty|frailty
4765272|NCT02829203|Surgery|surgery
4765273|NCT02829190|External carotid artery|external carotid artery
4765274|NCT02829190|Facial artery|facial artery
4765275|NCT02829190|Lingual artery|lingual artery
4765276|NCT02829190|Superior thyroid artery|superior thyroid artery
4765277|NCT02829190|Internal maxillary artery|internal maxillary artery
4765278|NCT02829190|Phase-contrast MRI|phase-contrast mri
4765279|NCT02829190|Rate of flow|rate of flow
4765280|NCT02829190|Superficial temporal artery|superficial temporal artery
4765281|NCT02829177|Type 1 diabetes|type 1 diabetes
4765282|NCT02829177|Diabetic nephropathy|diabetic nephropathy
4765283|NCT02829177|Albuminuria|albuminuria
4765284|NCT02829177|Allopurinol|allopurinol
4765285|NCT02829164|Tonsillectomy|tonsillectomy
4765286|NCT02829164|primary IgA nephropathy|primary iga nephropathy
4765287|NCT02829164|primary nephropathy|primary nephropathy
4765288|NCT02829164|IgA|iga
4765289|NCT02829164|Berger's disease|berger's disease
4765290|NCT02829164|Purpura rheumatoid|purpura rheumatoid
4765291|NCT02829164|kidney failure|kidney failure
4765292|NCT02829151|Peripheral artery disease|peripheral artery disease
4765293|NCT02829151|Critical limb ischemia|critical limb ischemia
4765294|NCT02829151|Angioplasty|angioplasty
4765295|NCT02829151|Antiplatelet therapy|antiplatelet therapy
4765296|NCT02829125|Early rehabilitation|early rehabilitation
4765297|NCT02829125|abdominal surgery|abdominal surgery
4765298|NCT02829125|ERAS|eras
4765299|NCT02829112|Shulman|shulman
4765300|NCT02829112|fasciitis|fasciitis
4765301|NCT02829112|Shulman fasciitis|shulman fasciitis
4765302|NCT02829112|eosinophilic fasciitis|eosinophilic fasciitis
4765303|NCT02829112|inflammatory disease|inflammatory disease
4765304|NCT02829112|prevalence|prevalence
4765305|NCT02829073|Tinnitus|tinnitus
4765306|NCT02829073|Double-blind|double-blind
4765307|NCT02829073|Neuromonic Tinnitus Treatment Program|neuromonic tinnitus treatment program
4765308|NCT02829073|Oasis™|oasis™
4765309|NCT02829060|nephrolithiasis|nephrolithiasis
4765310|NCT02829060|percutaneous nephrolithiasis|percutaneous nephrolithiasis
4765311|NCT02829060|urinary tract infection (UTI)|urinary tract infection (uti)
4765312|NCT02829060|Sepsis|sepsis
4765313|NCT02829034|pulmonary hypertension|pulmonary hypertension
4765314|NCT02829034|right ventricular function|right ventricular function
4765315|NCT02829034|ranolazine|ranolazine
4765316|NCT02829021|Sensitivity|sensitivity
4765317|NCT02829021|Specificity|specificity
4765318|NCT02829021|Breast cancer|breast cancer
4765319|NCT02829021|Mammography|mammography
4765320|NCT02829021|Thermography|thermography
4765321|NCT02829021|Infrared|infrared
4765322|NCT02829021|Dynamic|dynamic
4765323|NCT02829021|Diagnostic accuracy|diagnostic accuracy
4765324|NCT02829021|Diagnostic odds ratio|diagnostic odds ratio
4765325|NCT02829008|HER2 negative breast cancer|her2 negative breast cancer
4765326|NCT02829008|low-dose bevacizumab|low-dose bevacizumab
4765327|NCT02829008|pemetrexed|pemetrexed
4765328|NCT02828995|Diabetes Mellitus|diabetes mellitus
4765329|NCT02828995|Stigma|stigma
4765330|NCT02828995|Social Determinants of Health|social determinants of health
4765331|NCT02828982|powered ankle prosthesis|powered ankle prosthesis
4765332|NCT02828982|activity monitoring|activity monitoring
4765333|NCT02828982|muscle fatigue|muscle fatigue
4765334|NCT02828982|below knee amputation|below knee amputation
4765335|NCT02828969|Trajectory|trajectory
4765336|NCT02828969|Emergency room|emergency room
4765337|NCT02828969|Conduct disorder|conduct disorder
4765338|NCT02828969|Care management|care management
4765744|NCT02825849|endometrium|endometrium
4765339|NCT02828956|eating disorders|eating disorders
4765340|NCT02828956|ANSOCQ|ansocq
4765341|NCT02828956|anorexia nervosa|anorexia nervosa
4765342|NCT02828878|Apoptosis|apoptosis
4765343|NCT02828878|FAS Ligand|fas ligand
4765344|NCT02828878|Bone marrow transplantation|bone marrow transplantation
4765345|NCT02828878|GvHD|gvhd
4765346|NCT02828878|Stem cells|stem cells
4765347|NCT02828865|Hepatocellular Carcinoma|hepatocellular carcinoma
4765348|NCT02828865|irreversible electroporation|irreversible electroporation
4765349|NCT02828865|liver cancer|liver cancer
4765350|NCT02828852|pregnancy|pregnancy
4765351|NCT02828852|platelets|platelets
4765352|NCT02828839|Transperineal|transperineal
4765353|NCT02828839|Transrectal|transrectal
4765354|NCT02828839|Needle Guide|needle guide
4765355|NCT02828839|Biopsy|biopsy
4765356|NCT02828761|chest pain|chest pain
4765357|NCT02828761|calcium score|calcium score
4765358|NCT02828761|coronary calcium score|coronary calcium score
4765359|NCT02828761|coronary calcium scoring|coronary calcium scoring
4765360|NCT02828761|calcium scoring|calcium scoring
4765361|NCT02828761|cacs|cacs
4765362|NCT02828761|ccs|ccs
4765363|NCT02828748|cannabinoids|cannabinoids
4765364|NCT02828748|inflammatory bowel disease|inflammatory bowel disease
4765365|NCT02828722|Circadian rhythm|circadian rhythm
4765366|NCT02828722|Critical Illness|critical illness
4765367|NCT02828722|Mechanical ventilation|mechanical ventilation
4765368|NCT02828722|Environmental modulation|environmental modulation
4765369|NCT02828696|CAD-CAM composites|cad-cam composites
4765370|NCT02828696|Worn dentition|worn dentition
4765371|NCT02828696|minimally invasive treatment|minimally invasive treatment
4765372|NCT02828683|DES|des
4765373|NCT02828683|PCI|pci
4765374|NCT02828683|STEMI|stemi
4765375|NCT02828683|Interventional Cardiology|interventional cardiology
4765376|NCT02828657|ORBERA|orbera
4765377|NCT02828644|ADHD|adhd
4765378|NCT02828592|SAA|saa
4765379|NCT02828579|obesity|obesity
4765380|NCT02828579|bariatric surgery|bariatric surgery
4765381|NCT02828579|non-alcoholic fatty liver disease|non-alcoholic fatty liver disease
4765382|NCT02828553|Wearable device|wearable device
4765383|NCT02828553|Fitbit|fitbit
4765384|NCT02828553|Inpatient|inpatient
4765385|NCT02828540|HT047|ht047
4765386|NCT02828540|Pueraria lobata|pueraria lobata
4765387|NCT02828540|Scutellaria baicalensis|scutellaria baicalensis
4765388|NCT02828501|Pain Threshold|pain threshold
4765389|NCT02828436|Hypertension|hypertension
4765390|NCT02828436|High Blood Pressure|high blood pressure
4765391|NCT02828423|periodontal regeneration|periodontal regeneration
4765392|NCT02828410|serum bovine immunoglobulin protein isolate|serum bovine immunoglobulin protein isolate
4765393|NCT02828410|IPAA|ipaa
4765394|NCT02828410|quality of life|quality of life
4765395|NCT02828384|fodmap diet|fodmap diet
4765396|NCT02828332|Autism Spectrum Disorders|autism spectrum disorders
4765397|NCT02828332|Cohort|cohort
4765398|NCT02828306|stroke|stroke
4765399|NCT02828306|head trauma|head trauma
4765400|NCT02828306|Patient Specific Implant|patient specific implant
4765401|NCT02828306|skull defect|skull defect
4765402|NCT02828267|Tanzania|tanzania
4765403|NCT02828267|Alcohol Use|alcohol use
4765404|NCT02828267|Brief Intervention|brief intervention
4765405|NCT02828228|obesity|obesity
4765406|NCT02828228|weight loss|weight loss
4765407|NCT02828228|vitamin D deficiency|vitamin d deficiency
4765408|NCT02828228|body composition|body composition
4765409|NCT02828202|Melanoma|melanoma
4765410|NCT02828202|Skin|skin
4765411|NCT02828202|Biobank|biobank
4765412|NCT02828189|Physical Therapy Modalities|physical therapy modalities
4765413|NCT02828189|Breast Cancer Treatment|breast cancer treatment
4765414|NCT02828189|Exercise Therapy|exercise therapy
4765415|NCT02828189|Dyspnea|dyspnea
4765416|NCT02828176|cardiometry|cardiometry
4765417|NCT02828176|uterine displacement|uterine displacement
4765418|NCT02828111|Gorlin Syndrome|gorlin syndrome
4765419|NCT02828111|Basal Cell Nevus Syndrome BCNS|basal cell nevus syndrome bcns
4765420|NCT02828111|nevoid basal cell carcinoma syndrome|nevoid basal cell carcinoma syndrome
4765421|NCT02828111|Basal cell carcinoma|basal cell carcinoma
4765422|NCT02828111|Hedgehog inhibitor|hedgehog inhibitor
4765423|NCT02828111|Surgically Eligible Basal Cell Carcinomas|surgically eligible basal cell carcinomas
4765424|NCT02828098|aggressive solid tumors|aggressive solid tumors
4765425|NCT02828059|Caesarean section|caesarean section
4765426|NCT02828007|EIT|eit
4765427|NCT02828007|NIV|niv
4765428|NCT02827968|PDL-1|pdl-1
4765429|NCT02827942|pylori|pylori
4765430|NCT02827903|Metformin|metformin
4765431|NCT02827903|Rosuvastatin|rosuvastatin
4765432|NCT02827903|type 2 diabetes|type 2 diabetes
4765433|NCT02827903|dyslipidemia|dyslipidemia
4765434|NCT02827864|Mirror therapy|mirror therapy
4765435|NCT02827864|transcranial direct current stimulation|transcranial direct current stimulation
4765436|NCT02827864|stroke|stroke
4765437|NCT02827864|neurorehabilitation|neurorehabilitation
4765438|NCT02827851|Damage of articular cartilage|damage of articular cartilage
4765439|NCT02827851|Cartilage degeneration|cartilage degeneration
4765440|NCT02827851|Intraarticular injection|intraarticular injection
4765441|NCT02827851|SVF|svf
4766043|NCT02824159|idelalisib|idelalisib
4765442|NCT02827851|Stromal vascular fraction|stromal vascular fraction
4765443|NCT02827851|Adipose-derived regenerative cells (ADRC)|adipose-derived regenerative cells (adrc)
4765444|NCT02827851|Adipose tissue|adipose tissue
4765445|NCT02827851|Stem cells|stem cells
4765446|NCT02827825|Neurosurgical|neurosurgical
4765447|NCT02827825|Intensive Care|intensive care
4765448|NCT02827799|heart failure|heart failure
4765449|NCT02827799|insomnia|insomnia
4765450|NCT02827799|sleep disorders|sleep disorders
4765451|NCT02827799|actigraphy|actigraphy
4765452|NCT02827799|cardiomyopathy|cardiomyopathy
4765453|NCT02827799|depression|depression
4765454|NCT02827799|sleepiness|sleepiness
4765455|NCT02827799|anxiety|anxiety
4765456|NCT02827799|fatigue|fatigue
4765457|NCT02827786|hepatic tumours|hepatic tumours
4765458|NCT02827773|Literacy|literacy
4765459|NCT02827747|Keratoconus progression|keratoconus progression
4765460|NCT02827747|Vitamins and keratoconus|vitamins and keratoconus
4765461|NCT02827747|Vitamin supplementation|vitamin supplementation
4765462|NCT02827682|IoC|ioc
4765463|NCT02827682|monitor|monitor
4765464|NCT02827682|elderly|elderly
4765465|NCT02827682|postoperative effectiveness|postoperative effectiveness
4765466|NCT02827656|Fertilization in vitro|fertilization in vitro
4765467|NCT02827656|Luteal Phase|luteal phase
4765468|NCT02827656|ovarian hyperstimulation syndrome|ovarian hyperstimulation syndrome
4765469|NCT02827617|Ibrutinib|ibrutinib
4765470|NCT02827617|TP53|tp53
4765471|NCT02827617|Chronic lymphocytic leukemia|chronic lymphocytic leukemia
4765472|NCT02827604|Caesarean section|caesarean section
4765473|NCT02827604|lower uterine segment|lower uterine segment
4765474|NCT02827604|sonography|sonography
4765475|NCT02827591|repeat cesarean section|repeat cesarean section
4765476|NCT02827591|lower uterine segment|lower uterine segment
4765477|NCT02827591|quantitative sonography|quantitative sonography
4765478|NCT02827565|colorectal cancer|colorectal cancer
4765479|NCT02827565|Kras mutation|kras mutation
4765480|NCT02827565|Nras mutation|nras mutation
4765481|NCT02827565|Braf mutation|braf mutation
4765482|NCT02827552|pediatric oncology|pediatric oncology
4765483|NCT02827552|radiotherapy|radiotherapy
4765484|NCT02827552|radiosensitivity|radiosensitivity
4765485|NCT02827513|Centanafadine|centanafadine
4765486|NCT02827513|Adult attention-deficit hyperactivity disorder|adult attention-deficit hyperactivity disorder
4765487|NCT02827513|Healthy participants|healthy participants
4765488|NCT02827448|Left Ventricular Assist Device|left ventricular assist device
4765489|NCT02827448|Heart Transplantation|heart transplantation
4765490|NCT02827448|Perioperative|perioperative
4765491|NCT02827448|Acute Kidney Injury|acute kidney injury
4765492|NCT02827448|Renal|renal
4765493|NCT02827448|Kidney|kidney
4765494|NCT02827448|Total Artificial Heart|total artificial heart
4765495|NCT02827422|therapeutic hypothermia|therapeutic hypothermia
4765496|NCT02827409|Delayed cord clamping|delayed cord clamping
4765497|NCT02827396|Disability|disability
4765498|NCT02827396|children|children
4765499|NCT02827396|parents|parents
4765500|NCT02827396|depression|depression
4765501|NCT02827396|knowledge|knowledge
4765502|NCT02827396|psychosocial intervention|psychosocial intervention
4765503|NCT02827344|PD-1/PD-L1|pd-1/pd-l1
4765504|NCT02827344|Immune checkpoints|immune checkpoints
4765505|NCT02827344|Immunotherapy|immunotherapy
4765506|NCT02827344|lung cancer|lung cancer
4765507|NCT02827344|circulating tumor cells|circulating tumor cells
4765508|NCT02827344|immunocytochemistry|immunocytochemistry
4765509|NCT02827344|ISET|iset
4765510|NCT02827344|MDSC|mdsc
4765511|NCT02827344|Stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
4765512|NCT02827331|Benzodiazepines|benzodiazepines
4765513|NCT02827331|Fracture|fracture
4765514|NCT02827318|Blood glucose|blood glucose
4765515|NCT02827305|antiplaque|antiplaque
4765516|NCT02827305|antigingivitis|antigingivitis
4765517|NCT02827292|music|music
4765518|NCT02827292|inflammation|inflammation
4765519|NCT02827279|Autism Spectrum Disorder|autism spectrum disorder
4765520|NCT02827279|Emotion|emotion
4765521|NCT02827253|brain|brain
4765522|NCT02827253|haemodialysis|haemodialysis
4765523|NCT02827253|intradialytic hypotension|intradialytic hypotension
4765524|NCT02827240|Female sex workers|female sex workers
4765525|NCT02827240|HIV testing|hiv testing
4765526|NCT02827240|HIV self-test|hiv self-test
4765527|NCT02827227|HIV-infected patients|hiv-infected patients
4765528|NCT02827227|cART|cart
4765529|NCT02827227|immune restoration|immune restoration
4765530|NCT02827227|markers|markers
4765531|NCT02827214|Thoracolumbar spine|thoracolumbar spine
4765532|NCT02827214|Burst fractures|burst fractures
4765533|NCT02827214|Conservative treatment|conservative treatment
4765534|NCT02827214|Surgical treatment|surgical treatment
4765535|NCT02827214|Thoracic or lumbar vertebrae|thoracic or lumbar vertebrae
4765536|NCT02827201|pancreatic cancer|pancreatic cancer
4765537|NCT02827162|Dengue Fever|dengue fever
4765538|NCT02827162|Dengue Haemorrhagic Fever|dengue haemorrhagic fever
4765539|NCT02827162|Tetravalent Dengue Vaccine|tetravalent dengue vaccine
4765540|NCT02827149|HSCT|hsct
4765541|NCT02827149|high resolution HLA typing|high resolution hla typing
4765542|NCT02827149|unrelated donor|unrelated donor
4765543|NCT02827084|electromyography|electromyography
4765544|NCT02827084|torque|torque
4765545|NCT02827084|quadriceps muscle|quadriceps muscle
4765546|NCT02827058|Delivery, obstetric|delivery, obstetric
4765547|NCT02827058|Analgesia, Epidural|analgesia, epidural
4765548|NCT02827058|Injections, Epidural|injections, epidural
4765549|NCT02827058|Needles|needles
4765550|NCT02827058|Cesarean Section|cesarean section
4765551|NCT02827032|Hypertension|hypertension
4765552|NCT02827006|Bone graft|bone graft
4765553|NCT02827006|Calcium phosphate bone cement|calcium phosphate bone cement
4765554|NCT02827006|RCT|rct
4765555|NCT02827006|Xray|xray
4765556|NCT02827006|CT|ct
4765557|NCT02826993|PillCAM2|pillcam2
4765558|NCT02826967|Hydro-San Plus colonic irrigation system|hydro-san plus colonic irrigation system
4765559|NCT02826967|Screening colonoscopy|screening colonoscopy
4765560|NCT02826954|Paranasal Sinus Diseases|paranasal sinus diseases
4765561|NCT02826954|Nasal Obstruction|nasal obstruction
4765562|NCT02826941|hypothermia treatment|hypothermia treatment
4765563|NCT02826915|newborn|newborn
4765564|NCT02826915|infant|infant
4765565|NCT02826915|child|child
4765566|NCT02826915|EEG|eeg
4765567|NCT02826915|NIRS|nirs
4765568|NCT02826902|Total intravenous anesthesia|total intravenous anesthesia
4765569|NCT02826902|desflurane|desflurane
4765570|NCT02826902|QoR-40|qor-40
4765571|NCT02826902|cosmetic lower limb lengthening|cosmetic lower limb lengthening
4765572|NCT02826889|Fluid responsiveness|fluid responsiveness
4765573|NCT02826889|corrected flow time|corrected flow time
4765574|NCT02826889|pleth variability index|pleth variability index
4765575|NCT02826889|prone position|prone position
4765576|NCT02826876|Laparoscopic surgery|laparoscopic surgery
4765577|NCT02826863|seizure|seizure
4765578|NCT02826863|tonic-atonic|tonic-atonic
4765579|NCT02826863|epilepsy|epilepsy
4765580|NCT02826863|myoclonic|myoclonic
4765581|NCT02826863|encephalopathy|encephalopathy
4765582|NCT02826850|Osteoarthritis, Knee|osteoarthritis, knee
4765583|NCT02826850|Pulsed Radiofrequency Treatment|pulsed radiofrequency treatment
4765584|NCT02826850|Ultrasonography, Interventional|ultrasonography, interventional
4765585|NCT02826837|Advanced Colorectal Cancer|advanced colorectal cancer
4765586|NCT02826824|corpus callosum agenesis|corpus callosum agenesis
4765587|NCT02826824|agenesis|agenesis
4765588|NCT02826824|corpus callosum|corpus callosum
4765589|NCT02826811|Graft dysfunction|graft dysfunction
4765590|NCT02826811|Graft loss|graft loss
4765591|NCT02826811|kidney|kidney
4765592|NCT02826811|Transplantation|transplantation
4765593|NCT02826811|BKV|bkv
4765594|NCT02826811|Anti-BKV|anti-bkv
4765595|NCT02826811|Nephropathy|nephropathy
4765596|NCT02826811|Immunosuppression|immunosuppression
4765597|NCT02826811|Prognostic markers|prognostic markers
4765598|NCT02826798|VBI-1501A|vbi-1501a
4765599|NCT02826798|VBI-1501|vbi-1501
4765600|NCT02826798|prophylactic vaccine|prophylactic vaccine
4765601|NCT02826798|virus diseases|virus diseases
4765602|NCT02826798|cytomegalovirus|cytomegalovirus
4765603|NCT02826798|CMV|cmv
4765604|NCT02826798|cytomegalovirus infections|cytomegalovirus infections
4765605|NCT02826798|cytomegalovirus vaccines|cytomegalovirus vaccines
4765606|NCT02826798|Herpesviridae Infections|herpesviridae infections
4765607|NCT02826798|Phase 1|phase 1
4765608|NCT02826798|Human Herpesvirus 5|human herpesvirus 5
4765609|NCT02826798|HHV5|hhv5
4765610|NCT02826798|Vaccines, virus-like particle|vaccines, virus-like particle
4765611|NCT02826798|VLP|vlp
4765612|NCT02826798|enveloped virus-like particle|enveloped virus-like particle
4765613|NCT02826798|eVLP|evlp
4765614|NCT02826759|sphingolipid|sphingolipid
4765615|NCT02826759|diabetes mellitus|diabetes mellitus
4765616|NCT02826759|biomarker|biomarker
4765617|NCT02826759|obesity|obesity
4765618|NCT02826759|insulin resistance|insulin resistance
4765619|NCT02826733|preterm infants|preterm infants
4765620|NCT02826733|term infants|term infants
4765621|NCT02826733|hemispheric dominance|hemispheric dominance
4765622|NCT02826720|HDL cholesterol|hdl cholesterol
4765623|NCT02826720|Hyperlipidemia|hyperlipidemia
4765624|NCT02826720|LDL cholesterol|ldl cholesterol
4765625|NCT02826720|Periodontal disease|periodontal disease
4765626|NCT02826720|Triglyceride|triglyceride
4765627|NCT02826655|WF-OCT|wf-oct
4765628|NCT02826655|OCT|oct
4765629|NCT02826655|diabetic retinopathy|diabetic retinopathy
4765630|NCT02826655|diabetic macular edema|diabetic macular edema
4765631|NCT02826642|newly diagnosed acute myeloid leukemia|newly diagnosed acute myeloid leukemia
4765632|NCT02826642|AML|aml
4765633|NCT02826642|myeloid dysplastic syndrome|myeloid dysplastic syndrome
4765634|NCT02826642|MDS|mds
4765635|NCT02826642|IDH305|idh305
4765636|NCT02826642|standard of care in IDH1 mutant acute myeloid leukemia|standard of care in idh1 mutant acute myeloid leukemia
4765637|NCT02826629|Sensorimotor Integration|sensorimotor integration
4765638|NCT02826629|Schizophrenia|schizophrenia
4765639|NCT02826629|TMS|tms
4765640|NCT02826629|Oculomotor|oculomotor
4765641|NCT02826629|Motor Control|motor control
4765642|NCT02826616|Trimetazidine|trimetazidine
4765643|NCT02826616|ST-segment elevation myocardial|st-segment elevation myocardial
4765644|NCT02826616|Reperfusion injury|reperfusion injury
4766044|NCT02824159|side effect|side effect
4765645|NCT02826616|Percutaneous coronary intervention|percutaneous coronary intervention
4765646|NCT02826603|Plaque psoriasis,|plaque psoriasis,
4765647|NCT02826603|secukinumab,|secukinumab,
4765648|NCT02826603|ustekinumab|ustekinumab
4765649|NCT02826564|radiotherapy|radiotherapy
4765650|NCT02826564|immunotherapy|immunotherapy
4765651|NCT02826512|BRCA1-like|brca1-like
4765652|NCT02826512|HER2 negative|her2 negative
4765653|NCT02826499|Pediguard|pediguard
4765654|NCT02826499|Pedicular screws|pedicular screws
4765655|NCT02826499|Fluoroscopy|fluoroscopy
4765656|NCT02826473|Dementia|dementia
4765657|NCT02826473|Dementia screening|dementia screening
4765658|NCT02826473|General Hospital|general hospital
4765659|NCT02826473|Inpatients|inpatients
4765660|NCT02826460|Transplant|transplant
4765661|NCT02826460|Adherence|adherence
4765662|NCT02826434|Breast Cancer|breast cancer
4765663|NCT02826434|vaccine|vaccine
4765664|NCT02826434|immunotherapy|immunotherapy
4765665|NCT02826434|PD-L1 Inhibitor|pd-l1 inhibitor
4765666|NCT02826434|triple negative breast cancer|triple negative breast cancer
4765667|NCT02826421|Intraocular lens|intraocular lens
4765668|NCT02826395|Prostate cancer|prostate cancer
4765669|NCT02826395|diagnostic|diagnostic
4765670|NCT02826395|imaging|imaging
4765671|NCT02826395|PET/CT|pet/ct
4765672|NCT02826395|Acetate carbon-11|acetate carbon-11
4765673|NCT02826369|Algorithms|algorithms
4765674|NCT02826369|Image Processing, Computer-Assisted/methods*|image processing, computer-assisted/methods*
4765675|NCT02826369|Magnetic Resonance Imaging/methods*|magnetic resonance imaging/methods*
4765676|NCT02826369|Data Compression|data compression
4765677|NCT02826369|Breast Neoplasms|breast neoplasms
4765678|NCT02826356|Angioedema|angioedema
4765679|NCT02826356|Emergency treatment|emergency treatment
4765680|NCT02826356|Treatment availability|treatment availability
4765681|NCT02826356|Health Equity|health equity
4765682|NCT02826343|COPD|copd
4765683|NCT02826330|Crohn's Disease|crohn's disease
4765684|NCT02826330|Healthy relatives|healthy relatives
4765685|NCT02826330|Dysbiosis|dysbiosis
4765686|NCT02826330|Biomarkers|biomarkers
4765687|NCT02826304|Vaginal Hysterectomy|vaginal hysterectomy
4765688|NCT02826304|Laparoscopic assisted vaginal hysterectomy|laparoscopic assisted vaginal hysterectomy
4765689|NCT02826304|Large uteri|large uteri
4765690|NCT02826291|OSNA|osna
4765691|NCT02826291|sentinel|sentinel
4765692|NCT02826291|lymph|lymph
4765693|NCT02826291|node|node
4765694|NCT02826291|endometrial|endometrial
4765695|NCT02826291|cancer|cancer
4765696|NCT02826278|Newborn genitalia|newborn genitalia
4765697|NCT02826278|reference charts|reference charts
4765698|NCT02826252|Pulmonary Arterial Hypertension (PAH)|pulmonary arterial hypertension (pah)
4765699|NCT02826213|Renal infusion|renal infusion
4765700|NCT02826213|Renal infusion device|renal infusion device
4765701|NCT02826200|Transcatheter aortic valve implantation|transcatheter aortic valve implantation
4765702|NCT02826200|Transcatheter aortic valve replacement|transcatheter aortic valve replacement
4765703|NCT02826200|Prosthetic Cardiac Valve Thrombosis|prosthetic cardiac valve thrombosis
4765704|NCT02826200|Cerebrovascular Accident|cerebrovascular accident
4765705|NCT02826200|Prosthetic Valve Malfunction|prosthetic valve malfunction
4765706|NCT02826200|Four-dimensional volume rendered cardiac CT|four-dimensional volume rendered cardiac ct
4765707|NCT02826200|Transesophageal echocardiography|transesophageal echocardiography
4765708|NCT02826200|Transthoracic echocardiography|transthoracic echocardiography
4765709|NCT02826200|Brain MRI|brain mri
4765710|NCT02826187|Acetabular implant|acetabular implant
4765711|NCT02826161|Neoplasms|neoplasms
4765712|NCT02826161|Neoplasms by Site|neoplasms by site
4765713|NCT02826161|Lung Neoplasms|lung neoplasms
4765714|NCT02826161|Thoracic Neoplasms|thoracic neoplasms
4765715|NCT02826161|Respiratory Tract Neoplasms|respiratory tract neoplasms
4765716|NCT02826161|Bronchial Neoplasms|bronchial neoplasms
4765717|NCT02826096|Psychiatry|psychiatry
4765718|NCT02826096|psychological|psychological
4765719|NCT02826096|psychotherapy|psychotherapy
4765720|NCT02826096|randomize|randomize
4765721|NCT02826096|Biofeedback|biofeedback
4765722|NCT02826070|Chronic Hepatitis B|chronic hepatitis b
4765723|NCT02826031|Sodium Hyaluronate|sodium hyaluronate
4765724|NCT02826031|mild to moderate knee osteoarthritis|mild to moderate knee osteoarthritis
4765725|NCT02826018|RNAi therapeutic|rnai therapeutic
4765726|NCT02826018|Hepatitis B|hepatitis b
4765727|NCT02826018|Chronic Hepatitis B|chronic hepatitis b
4765728|NCT02826018|Hepatitis B, Chronic|hepatitis b, chronic
4765729|NCT02826018|Hepatitis B Infection|hepatitis b infection
4765730|NCT02826018|HBV|hbv
4765731|NCT02825927|Dysphagia|dysphagia
4765732|NCT02825927|Oral screen|oral screen
4765733|NCT02825927|Intervention|intervention
4765734|NCT02825927|Oral Health|oral health
4765735|NCT02825927|Food Intake|food intake
4765736|NCT02825927|Quality of life|quality of life
4765737|NCT02825927|Elderly|elderly
4765738|NCT02825927|Short-term care facilities|short-term care facilities
4765739|NCT02825914|glycopeptides|glycopeptides
4765740|NCT02825914|human microbiome|human microbiome
4765741|NCT02825914|caseinomacropeptide|caseinomacropeptide
4765742|NCT02825914|whey protein|whey protein
4765743|NCT02825914|dietary proteins|dietary proteins
4765745|NCT02825849|thin uterine lining|thin uterine lining
4765746|NCT02825849|uterine scarring|uterine scarring
4765747|NCT02825836|M7583|m7583
4765748|NCT02825836|Bruton's Tyrosine Kinase Inhibitor|bruton's tyrosine kinase inhibitor
4765749|NCT02825836|Lymphoma|lymphoma
4765750|NCT02825836|Open|open
4765751|NCT02825836|Phase I|phase i
4765752|NCT02825810|breast cancer|breast cancer
4765753|NCT02825810|long-term survival|long-term survival
4765754|NCT02825810|motor control|motor control
4765755|NCT02825810|cervical pain|cervical pain
4765756|NCT02825797|Broadly neutralizing antibody|broadly neutralizing antibody
4765757|NCT02825797|3BNC117|3bnc117
4765758|NCT02825797|10-1074|10-1074
4765759|NCT02825784|potassium chronic kidney disease CKD children|potassium chronic kidney disease ckd children
4765760|NCT02825758|Micronutrients|micronutrients
4765761|NCT02825758|restricted|restricted
4765762|NCT02825758|ketogenic|ketogenic
4765763|NCT02825758|diet|diet
4765764|NCT02825758|acceptability|acceptability
4765765|NCT02825732|Alzheimer's disease or related disorder|alzheimer's disease or related disorder
4765766|NCT02825732|Comorbidity|comorbidity
4765767|NCT02825732|Charlson comorbidity index|charlson comorbidity index
4765768|NCT02825732|Caregiver burden|caregiver burden
4765769|NCT02825732|Cohort|cohort
4765770|NCT02825732|Dementia|dementia
4765771|NCT02825732|Behavioral disorders|behavioral disorders
4765772|NCT02825732|Functional dependency|functional dependency
4765773|NCT02825719|Fibroid|fibroid
4765774|NCT02825719|Ulipristal|ulipristal
4765775|NCT02825719|Selective progesterone receptor modulator|selective progesterone receptor modulator
4765776|NCT02825719|Chinese|chinese
4765777|NCT02825706|Hemophilia|hemophilia
4765778|NCT02825706|Educational Physiotherapy|educational physiotherapy
4765779|NCT02825706|Pain|pain
4765780|NCT02825706|Quality of life|quality of life
4765781|NCT02825706|Illness Behaviour|illness behaviour
4765782|NCT02825706|Elbow|elbow
4765783|NCT02825680|Weight Loss|weight loss
4765784|NCT02825680|Body Weight Maintenance|body weight maintenance
4765785|NCT02825680|Quality Improvement|quality improvement
4765786|NCT02825667|Haemophilia|haemophilia
4765787|NCT02825667|Ankle|ankle
4765788|NCT02825667|Arthropathy|arthropathy
4765789|NCT02825667|Pain|pain
4765790|NCT02825667|Range of motion|range of motion
4765791|NCT02825667|Myofascial techniques|myofascial techniques
4765792|NCT02825654|Pulmonary|pulmonary
4765793|NCT02825654|Lung|lung
4765794|NCT02825654|Military and environmental exposures|military and environmental exposures
4765795|NCT02825654|Epidemiologic|epidemiologic
4765796|NCT02825654|Observational|observational
4765797|NCT02825654|Interview or questionnaire|interview or questionnaire
4765798|NCT02825654|Deployment related|deployment related
4765799|NCT02825654|Enduring Freedom|enduring freedom
4765800|NCT02825654|Iraqi Freedom|iraqi freedom
4765801|NCT02825615|radial artery cannulation|radial artery cannulation
4765802|NCT02825615|ultrasound guided|ultrasound guided
4765803|NCT02825615|first success rate|first success rate
4765804|NCT02825615|systolic blood pressure|systolic blood pressure
4765805|NCT02825615|shock|shock
4765806|NCT02825602|Vietnam veteran|vietnam veteran
4765807|NCT02825602|aging|aging
4765808|NCT02825602|health|health
4765809|NCT02825602|War Injury|war injury
4765810|NCT02825602|Conventional Warfare|conventional warfare
4765811|NCT02825602|Toxic Effect|toxic effect
4765812|NCT02825602|Chemical|chemical
4765813|NCT02825589|BIA|bia
4765814|NCT02825589|chronic hemodialysis|chronic hemodialysis
4765815|NCT02825589|sleep quality|sleep quality
4765816|NCT02825550|Hepatoma|hepatoma
4765817|NCT02825550|Transcatheter Arterial chemo-embolization|transcatheter arterial chemo-embolization
4765818|NCT02825550|Microsphere|microsphere
4765819|NCT02825511|basal cell carcinoma, histological diagnosis, prognostic impact|basal cell carcinoma, histological diagnosis, prognostic impact
4765820|NCT02825472|Congenital Heart Disease|congenital heart disease
4765821|NCT02825472|Sport|sport
4765822|NCT02825472|Exercise training|exercise training
4765823|NCT02825459|abstinence|abstinence
4765824|NCT02825459|abuse liability|abuse liability
4765825|NCT02825459|electronic cigarette|electronic cigarette
4765826|NCT02825459|e-cigarette|e-cigarette
4765827|NCT02825459|electronic nicotine delivery device|electronic nicotine delivery device
4765828|NCT02825459|harm reduction|harm reduction
4765829|NCT02825459|nicotine|nicotine
4765830|NCT02825459|nicotine dependence|nicotine dependence
4765831|NCT02825459|smoking|smoking
4765832|NCT02825459|smoking cessation|smoking cessation
4765833|NCT02825459|tobacco|tobacco
4765834|NCT02825459|vape|vape
4765835|NCT02825459|vaping|vaping
4765836|NCT02825459|withdrawal|withdrawal
4765837|NCT02825446|radio frequency denervation|radio frequency denervation
4765838|NCT02825446|tibial arteries|tibial arteries
4765839|NCT02825446|atherosclerosis of the peripheral arteries|atherosclerosis of the peripheral arteries
4765840|NCT02825381|Arthroplasty|arthroplasty
4765841|NCT02825381|Hip|hip
4765842|NCT02825355|robotic surgery procedure|robotic surgery procedure
4765843|NCT02825355|indocyanine green|indocyanine green
4765844|NCT02825355|sentinel lymph node mapping|sentinel lymph node mapping
4765845|NCT02825342|Gastroesophageal Reflux Disease (GERD)|gastroesophageal reflux disease (gerd)
4765846|NCT02825342|Proton Pump Inhibitor (PPI)|proton pump inhibitor (ppi)
4765847|NCT02825316|Crohn's disease|crohn's disease
4765848|NCT02825316|inflammatory bowel diseases|inflammatory bowel diseases
4765849|NCT02825316|Mediterranean diet|mediterranean diet
4765850|NCT02825316|microbiome|microbiome
4765851|NCT02825303|postural changes|postural changes
4765852|NCT02825303|Height adjustable desk|height adjustable desk
4765853|NCT02825303|Prolonged sitting|prolonged sitting
4765854|NCT02825303|Cognitive performance|cognitive performance
4765855|NCT02825290|Frozen-thawed embryo transfer (FET)|frozen-thawed embryo transfer (fet)
4765856|NCT02825290|Luteal support|luteal support
4765857|NCT02825290|Progesterone|progesterone
4765858|NCT02825290|Natural cycle|natural cycle
4765859|NCT02825290|Cryopreservation|cryopreservation
4765860|NCT02825290|IVF|ivf
4765861|NCT02825290|hCG|hcg
4765862|NCT02825290|GnRH-Agonist|gnrh-agonist
4765863|NCT02825290|Pregnancy rate|pregnancy rate
4765864|NCT02825277|3D Power Doppler|3d power doppler
4765865|NCT02825277|uteroplacental vascularization|uteroplacental vascularization
4765866|NCT02825277|preeclampsia|preeclampsia
4765867|NCT02825277|intra-uterine growth restriction|intra-uterine growth restriction
4765868|NCT02825277|placental morphology|placental morphology
4765869|NCT02825264|Glaucoma Drainage Device|glaucoma drainage device
4765870|NCT02825264|STARflo|starflo
4765871|NCT02825238|exercise|exercise
4765872|NCT02825238|osteoarthritis|osteoarthritis
4765873|NCT02825238|knee|knee
4765874|NCT02825238|patellofemoral pain|patellofemoral pain
4765875|NCT02825225|Prostatic Neoplasms|prostatic neoplasms
4765876|NCT02825225|Biopsy|biopsy
4765877|NCT02825225|Anesthesia|anesthesia
4765878|NCT02825225|Detection|detection
4765879|NCT02825212|Hepatitis C|hepatitis c
4765880|NCT02825212|Cryoglobulinemia|cryoglobulinemia
4765881|NCT02825160|Iloprost|iloprost
4765882|NCT02825160|Ventavis|ventavis
4765883|NCT02825160|Prostacycline analogue|prostacycline analogue
4765884|NCT02825160|Pulmonary arterial hypertension|pulmonary arterial hypertension
4765885|NCT02825160|Japan|japan
4765886|NCT02825160|Post-marketing surveillance|post-marketing surveillance
4765887|NCT02825147|pegaspargase,methotrexate|pegaspargase,methotrexate
4765888|NCT02825134|heart valve disease|heart valve disease
4765889|NCT02825134|valvular bioprosthesis|valvular bioprosthesis
4765890|NCT02825134|aortic valve replacement|aortic valve replacement
4765891|NCT02825134|Randomized clinical trial|randomized clinical trial
4765892|NCT02825108|human chorionic gonadotropin (hCG), implantation rate intrauterine hCG clinical pregnancy rate frozen embryo transfer cycles|human chorionic gonadotropin (hcg), implantation rate intrauterine hcg clinical pregnancy rate frozen embryo transfer cycles
4765893|NCT02825095|malignant pleural effusion,talc pleurodesis,quality of life|malignant pleural effusion,talc pleurodesis,quality of life
4765894|NCT02825082|Emergency general surgery|emergency general surgery
4765895|NCT02825082|Geriatric|geriatric
4765896|NCT02825082|Outcomes|outcomes
4765897|NCT02825082|Frailty|frailty
4765898|NCT02825043|COPD|copd
4765899|NCT02825004|Burnout|burnout
4765900|NCT02825004|Health Care Workers|health care workers
4765901|NCT02825004|Coping Skills|coping skills
4765902|NCT02825004|Clinical Trial|clinical trial
4765903|NCT02824952|Tagrisso|tagrisso
4765904|NCT02824952|AZD9291|azd9291
4765905|NCT02824952|EGFRm|egfrm
4765906|NCT02824952|NSCLC|nsclc
4765907|NCT02824900|Vibration Stimuli|vibration stimuli
4765908|NCT02824900|Contraversive Pusher Syndrome|contraversive pusher syndrome
4765909|NCT02824887|Electroacupuncture|electroacupuncture
4765910|NCT02824887|Deep needling|deep needling
4765911|NCT02824887|Lumbar disc herniation five points|lumbar disc herniation five points
4765912|NCT02824887|Long term effect|long term effect
4765913|NCT02824887|Prospective cohort study|prospective cohort study
4765914|NCT02824848|congenital muscular torticollis|congenital muscular torticollis
4765915|NCT02824848|infants|infants
4765916|NCT02824848|passive stretching|passive stretching
4765917|NCT02824848|perception-action approach|perception-action approach
4765918|NCT02824822|Sudden Unexpected Death in Epilepsy|sudden unexpected death in epilepsy
4765919|NCT02824822|SUDEP|sudep
4765920|NCT02824822|Sudden Cardiac Arrest|sudden cardiac arrest
4765921|NCT02824822|Sudden Cardiac Death|sudden cardiac death
4765922|NCT02824822|Sleep|sleep
4765923|NCT02824822|Ion channel disease|ion channel disease
4765924|NCT02824822|Long QT syndrome|long qt syndrome
4765925|NCT02824822|Brugada|brugada
4765926|NCT02824822|Catecholaminergic Polymorphic Ventricular Tachycardia|catecholaminergic polymorphic ventricular tachycardia
4765927|NCT02824809|hypogonadism|hypogonadism
4765928|NCT02824809|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
4765929|NCT02824809|Severity of Illness Index|severity of illness index
4765930|NCT02824809|Testosterone|testosterone
4765931|NCT02824796|ADHD|adhd
4765932|NCT02824783|colorectal surgery|colorectal surgery
4765933|NCT02824783|enhanced recovery|enhanced recovery
4765934|NCT02824757|interstitial lung disease|interstitial lung disease
4765935|NCT02824757|glucocorticcoid|glucocorticcoid
4765936|NCT02824757|glucose|glucose
4765937|NCT02824757|continuous glucose monitor|continuous glucose monitor
4765938|NCT02824744|Bronchiolitis|bronchiolitis
4765939|NCT02824744|High flow nasal canula|high flow nasal canula
4765940|NCT02824731|brain tumors|brain tumors
4765941|NCT02824731|proton radiotherapy|proton radiotherapy
4765942|NCT02824731|photon radiotherapy|photon radiotherapy
4765943|NCT02824718|Hypoparathyroidism|hypoparathyroidism
4765944|NCT02824718|PTH(1-34)|pth(1-34)
4765945|NCT02824718|Thiazides|thiazides
4765946|NCT02824718|Hypercalciuria|hypercalciuria
4765947|NCT02824718|Calcium sensing receptor|calcium sensing receptor
4765948|NCT02824705|Heart|heart
4765949|NCT02824705|multiple organ dysfunction syndrome|multiple organ dysfunction syndrome
4765950|NCT02824705|pediatric critical care|pediatric critical care
4765951|NCT02824705|congenital heart disease|congenital heart disease
4765952|NCT02824679|Normal labour|normal labour
4765953|NCT02824679|Augmentation of labour|augmentation of labour
4765954|NCT02824679|Hyoscine butylbromide|hyoscine butylbromide
4765955|NCT02824653|acute GVHD|acute gvhd
4765956|NCT02824653|chronic GVHD|chronic gvhd
4765957|NCT02824653|steroid-refractory|steroid-refractory
4765958|NCT02824653|Mesenchymal Stem Cells|mesenchymal stem cells
4765959|NCT02824640|Addiction|addiction
4765960|NCT02824640|Adherence|adherence
4765961|NCT02824640|Adverse Effects|adverse effects
4765962|NCT02824640|Direct Acting Antiviral Agent|direct acting antiviral agent
4765963|NCT02824640|Chronic Hepatitis C|chronic hepatitis c
4765964|NCT02824640|Resistance Development|resistance development
4765965|NCT02824640|Methadone Clinic|methadone clinic
4765966|NCT02824640|Primary Care|primary care
4765967|NCT02824640|Directly Observed Therapy|directly observed therapy
4765968|NCT02824640|Randomized Controlled Trial|randomized controlled trial
4765969|NCT02824640|Resistance|resistance
4765970|NCT02824640|Reinfection|reinfection
4765971|NCT02824640|Treatment Outcome|treatment outcome
4765972|NCT02824640|Patient Navigation|patient navigation
4765973|NCT02824640|Multi-Site|multi-site
4765974|NCT02824640|Liver Disease|liver disease
4765975|NCT02824640|Intervention|intervention
4765976|NCT02824640|Sustained Viral Response|sustained viral response
4765977|NCT02824588|Pain|pain
4765978|NCT02824588|Working memory|working memory
4765979|NCT02824575|breast cancer|breast cancer
4765980|NCT02824575|chemotherapy|chemotherapy
4765981|NCT02824575|metastasis|metastasis
4765982|NCT02824575|tumor micro-environment|tumor micro-environment
4765983|NCT02824549|Flash glucose monitoring|flash glucose monitoring
4765984|NCT02824549|skin reactions|skin reactions
4765985|NCT02824549|usability|usability
4765986|NCT02824549|accuracy|accuracy
4765987|NCT02824536|3BNC117|3bnc117
4765988|NCT02824536|10-1074|10-1074
4765989|NCT02824536|Broadly neutralizing antibody|broadly neutralizing antibody
4765990|NCT02824536|HIV Prevention|hiv prevention
4765991|NCT02824523|asthma|asthma
4765992|NCT02824523|nasal polyps|nasal polyps
4765993|NCT02824523|aspirin sensitivity|aspirin sensitivity
4765994|NCT02824523|AERD|aerd
4765995|NCT02824484|Guided written disclosure protocol|guided written disclosure protocol
4765996|NCT02824484|Emotional disclosure|emotional disclosure
4765997|NCT02824484|Meaning|meaning
4765998|NCT02824484|Post-Traumatic Growth|post-traumatic growth
4765999|NCT02824484|Cancer|cancer
4766000|NCT02824471|Sickle Cell Disease|sickle cell disease
4766001|NCT02824471|Biofluidic Chip Technology|biofluidic chip technology
4766002|NCT02824458|EGFR tyrosine kinase inhibitors|egfr tyrosine kinase inhibitors
4766003|NCT02824458|VEGFR inhibitor|vegfr inhibitor
4766004|NCT02824458|NSCLC|nsclc
4766005|NCT02824406|Sickle Cell Anemia|sickle cell anemia
4766006|NCT02824406|Cerebrovascular Reserve|cerebrovascular reserve
4766007|NCT02824406|Perfusion|perfusion
4766008|NCT02824406|Vasculopathy|vasculopathy
4766009|NCT02824406|Magnetic Resonance Imaging|magnetic resonance imaging
4766010|NCT02824393|Mesenchymal stem cell|mesenchymal stem cell
4766011|NCT02824393|Chronic autoimmune urticaria|chronic autoimmune urticaria
4766012|NCT02824367|Parkinson|parkinson
4766013|NCT02824367|Perfectionism|perfectionism
4766014|NCT02824341|Parkinson 's disease|parkinson 's disease
4766015|NCT02824341|REM sleep behavior disorder|rem sleep behavior disorder
4766016|NCT02824341|Reward system|reward system
4766017|NCT02824341|Functional MRI|functional mri
4766018|NCT02824289|skin cancer|skin cancer
4766019|NCT02824289|prevention|prevention
4766020|NCT02824289|worksite|worksite
4766021|NCT02824289|policy|policy
4766022|NCT02824263|obstructive sleep apnea|obstructive sleep apnea
4766023|NCT02824263|CPAP|cpap
4766024|NCT02824263|metabolism|metabolism
4766025|NCT02824250|Migraine|migraine
4766026|NCT02824250|Mindfulness|mindfulness
4766027|NCT02824250|MBSR|mbsr
4766028|NCT02824224|levonorgestrel|levonorgestrel
4766029|NCT02824224|breakthrough bleeding|breakthrough bleeding
4766030|NCT02824198|Dengue Hemorrhagic Fever|dengue hemorrhagic fever
4766031|NCT02824198|Dengue Virus|dengue virus
4766032|NCT02824198|CYD Dengue Vaccine|cyd dengue vaccine
4766033|NCT02824185|FCH-PET/MRI|fch-pet/mri
4766034|NCT02824185|primary HCC|primary hcc
4766035|NCT02824185|curative treatment|curative treatment
4766036|NCT02824185|resection|resection
4766037|NCT02824185|thermo-ablation|thermo-ablation
4766038|NCT02824185|transplantation|transplantation
4766039|NCT02824172|Cast immobilization|cast immobilization
4766040|NCT02824172|Complete rest|complete rest
4766041|NCT02824172|Osgood Schlatter|osgood schlatter
4766042|NCT02824159|ibrutinib|ibrutinib
4766045|NCT02824159|pharmacokinetic|pharmacokinetic
4766046|NCT02824159|plasma balance mean concentration|plasma balance mean concentration
4766047|NCT02824146|atelectasis|atelectasis
4766048|NCT02824146|children|children
4766049|NCT02824146|lung ultrasound|lung ultrasound
4766050|NCT02824146|lung recruitment|lung recruitment
4766051|NCT02824133|Glioma grade III|glioma grade iii
4766052|NCT02824133|Glioma grade IV|glioma grade iv
4766053|NCT02824133|Glioma recurrent|glioma recurrent
4766054|NCT02824133|IDHwt|idhwt
4766055|NCT02824133|FGFR-TACC fusion|fgfr-tacc fusion
4766056|NCT02824120|ischemic heart disease|ischemic heart disease
4766057|NCT02824120|laugh therapy|laugh therapy
4766058|NCT02824094|Expanded Access Protocol|expanded access protocol
4766059|NCT02824094|crizotinib|crizotinib
4766060|NCT02824094|Xalkori|xalkori
4766061|NCT02824094|ROS1|ros1
4766062|NCT02824094|Japanese|japanese
4766063|NCT02824094|A8081064|a8081064
4766064|NCT02824081|Psychiatry|psychiatry
4766065|NCT02824081|Depressive disorder|depressive disorder
4766066|NCT02824081|Suicide|suicide
4766067|NCT02824081|Inflammation|inflammation
4766068|NCT02824042|Phase 1|phase 1
4766069|NCT02824042|Solid tumors|solid tumors
4766070|NCT02824042|Mesothelin|mesothelin
4766071|NCT02824042|Itraconazole|itraconazole
4766072|NCT02824042|PK DDI|pk ddi
4766073|NCT02824042|ECG thorough QTC|ecg thorough qtc
4766074|NCT02823977|ketamine|ketamine
4766075|NCT02823977|dexmedetomidine|dexmedetomidine
4766076|NCT02823977|alcohol|alcohol
4766077|NCT02823964|exocrine pancreatic insufficiency|exocrine pancreatic insufficiency
4766078|NCT02823964|cystic fibrosis|cystic fibrosis
4766079|NCT02823964|pancreatic enzyme replacement therapy|pancreatic enzyme replacement therapy
4766080|NCT02823912|Capsaicin|capsaicin
4766081|NCT02823912|Dyslipidemia|dyslipidemia
4766082|NCT02823912|Inflammatory cytokines|inflammatory cytokines
4766083|NCT02823899|cholera vaccine|cholera vaccine
4766084|NCT02823899|hikojima serotype|hikojima serotype
4766085|NCT02823899|randomized trial|randomized trial
4766086|NCT02823899|immunogenicity|immunogenicity
4766087|NCT02823886|myocardial infarction|myocardial infarction
4766088|NCT02823886|MRI|mri
4766089|NCT02823886|inflammatory biomarkers|inflammatory biomarkers
4766090|NCT02823873|Hypertension|hypertension
4766091|NCT02823873|Pregnant|pregnant
4766092|NCT02823873|Preeclampsia|preeclampsia
4766093|NCT02823873|Gestational Hypertension|gestational hypertension
4766094|NCT02823873|Blood Pressure|blood pressure
4766095|NCT02823873|Pregnant Women|pregnant women
4766096|NCT02823873|Postpartum Women|postpartum women
4766097|NCT02823860|Peritoneal carcinomatosis|peritoneal carcinomatosis
4766098|NCT02823860|Biobanking|biobanking
4766099|NCT02823860|Biospecimen research|biospecimen research
4766100|NCT02823860|Prospective clinical database|prospective clinical database
4766101|NCT02823860|Tissue banking|tissue banking
4766102|NCT02823860|Quality of Life|quality of life
4766103|NCT02823860|various histological subtypes|various histological subtypes
4766104|NCT02823847|Malignant neoplasms of mesothelial and soft tissue|malignant neoplasms of mesothelial and soft tissue
4766105|NCT02823847|Human immunodeficiency virus|human immunodeficiency virus
4766106|NCT02823847|HIV|hiv
4766107|NCT02823847|Carbon monoxide test|carbon monoxide test
4766108|NCT02823847|Self-help materials|self-help materials
4766109|NCT02823847|Visual Oral Screening Examination|visual oral screening examination
4766110|NCT02823847|Direct Fluorescent Oral Visualization Examination|direct fluorescent oral visualization examination
4766111|NCT02823847|Oral Biopsy|oral biopsy
4766112|NCT02823834|osteoarthritis|osteoarthritis
4766113|NCT02823834|avascular necrosis|avascular necrosis
4766114|NCT02823834|ankylosis|ankylosis
4766115|NCT02823834|protrusio acetabuli|protrusio acetabuli
4766116|NCT02823834|painful hip dysplasia|painful hip dysplasia
4766117|NCT02823834|rheumatoid arthritis|rheumatoid arthritis
4766118|NCT02823834|correction of functional deformity|correction of functional deformity
4766119|NCT02823821|End-Stage Kidney Disease|end-stage kidney disease
4766120|NCT02823821|Hemodialysis|hemodialysis
4766121|NCT02823821|Dialysate|dialysate
4766122|NCT02823821|Sodium|sodium
4766123|NCT02823821|Cluster-randomisation|cluster-randomisation
4766124|NCT02823795|Patient participation|patient participation
4766125|NCT02823795|Empowerment|empowerment
4766126|NCT02823795|Medication management|medication management
4766127|NCT02823795|Symptom management|symptom management
4766128|NCT02823795|Self determination theory|self determination theory
4766129|NCT02823795|Motivational Interviewing|motivational interviewing
4766130|NCT02823782|Laminar HP|laminar hp
4766131|NCT02823782|Complex HP|complex hp
4766132|NCT02823769|clinical study|clinical study
4766133|NCT02823769|dental fillings|dental fillings
4766134|NCT02823743|recurrent pregnancy loss, Habitual abortion|recurrent pregnancy loss, habitual abortion
4766135|NCT02823704|Sepsis|sepsis
4766136|NCT02823704|Chest pain|chest pain
4766137|NCT02823704|Abdominal pain|abdominal pain
4766138|NCT02823704|Electrolyte disturbances|electrolyte disturbances
4766139|NCT02823704|Stroke|stroke
4766140|NCT02823704|Triage|triage
4766141|NCT02823704|Risk for death|risk for death
4766142|NCT02823691|NETs|nets
4766143|NCT02823665|gastric bypass surgery|gastric bypass surgery
4766144|NCT02823665|Hypoglycemia|hypoglycemia
4766145|NCT02823665|sleeve gastrectomy|sleeve gastrectomy
4766146|NCT02823665|glucose tolerance|glucose tolerance
4766147|NCT02823613|ENaC|enac
4766148|NCT02823613|Exosomes|exosomes
4766149|NCT02823613|Urinary biomarker|urinary biomarker
4766150|NCT02823613|Salt regulation|salt regulation
4766151|NCT02823600|retinal screening|retinal screening
4766152|NCT02823600|outpatient dialysis|outpatient dialysis
4766153|NCT02823587|Bronchiectasis|bronchiectasis
4766154|NCT02823587|Mucociliary clearance|mucociliary clearance
4766155|NCT02823587|Exercise|exercise
4766156|NCT02823587|Inflammation|inflammation
4766157|NCT02823535|military|military
4766158|NCT02823535|veteran|veteran
4766159|NCT02823535|military spouse|military spouse
4766160|NCT02823444|Magnetic Resonance Imaging|magnetic resonance imaging
4766161|NCT02823444|Magnetic Resonance Angiography|magnetic resonance angiography
4766162|NCT02823431|voiding efficiency|voiding efficiency
4766163|NCT02823431|detrusor underactivity|detrusor underactivity
4766164|NCT02823431|urodynamics|urodynamics
4766165|NCT02823418|primipara|primipara
4766166|NCT02823418|childbirth|childbirth
4766167|NCT02823418|neuraxial labor analgesia|neuraxial labor analgesia
4766168|NCT02823418|postpartum depression|postpartum depression
4766169|NCT02823405|Advance malignancy|advance malignancy
4766170|NCT02823392|unexpected difficult bag mask ventilation|unexpected difficult bag mask ventilation
4766171|NCT02823392|difficult intubation|difficult intubation
4766172|NCT02823392|predictors|predictors
4766173|NCT02823392|pediatric anesthesia|pediatric anesthesia
4766174|NCT02823379|physical activity|physical activity
4766175|NCT02823379|overweight|overweight
4766176|NCT02823379|obese|obese
4766177|NCT02823379|exercise|exercise
4766178|NCT02823379|women|women
4766179|NCT02823379|African American|african american
4766180|NCT02823379|Smartphone|smartphone
4766181|NCT02823379|cardiovascular disease risk|cardiovascular disease risk
4766182|NCT02823366|PBC|pbc
4766183|NCT02823366|UDCA|udca
4766184|NCT02823366|Fenofibrate|fenofibrate
4766185|NCT02823353|PBC|pbc
4766186|NCT02823353|UDCA|udca
4766187|NCT02823353|Fenofibrate|fenofibrate
4766188|NCT02823288|intimate partner violence|intimate partner violence
4766189|NCT02823288|masculinity|masculinity
4766190|NCT02823288|community mobilization|community mobilization
4766191|NCT02823288|social intervention|social intervention
4766192|NCT02823288|rape|rape
4766193|NCT02823262|Breast Cancer|breast cancer
4766194|NCT02823262|Estrogen Receptor Positive Breast Cancer|estrogen receptor positive breast cancer
4766195|NCT02823262|Node-negative Breast Cancer|node-negative breast cancer
4766196|NCT02823262|Human Epidermal Growth Factor 2 Negative Carcinoma of Breast|human epidermal growth factor 2 negative carcinoma of breast
4766197|NCT02823236|Keloid|keloid
4766198|NCT02823236|Scar|scar
4766199|NCT02823223|Endobronchial Valve|endobronchial valve
4766200|NCT02823197|determinants|determinants
4766201|NCT02823197|active transport|active transport
4766202|NCT02823197|intervention|intervention
4766203|NCT02823197|adolescents|adolescents
4766204|NCT02823184|Myeloproliferative neoplasms|myeloproliferative neoplasms
4766205|NCT02823184|Endoplasmic reticulum stress|endoplasmic reticulum stress
4766206|NCT02823171|Bioequivalence Study|bioequivalence study
4766207|NCT02823171|Healthy subjects|healthy subjects
4766208|NCT02823158|Parkinson Disease|parkinson disease
4766209|NCT02823158|Morbus Parkinson|morbus parkinson
4766210|NCT02823158|Basal Ganglia|basal ganglia
4766211|NCT02823158|Pallidal Stimulation|pallidal stimulation
4766212|NCT02823145|seizure|seizure
4766213|NCT02823145|tonic clonic|tonic clonic
4766214|NCT02823145|epilepsy|epilepsy
4766215|NCT02823145|myoclonic|myoclonic
4766216|NCT02823145|encephalopathy|encephalopathy
4766217|NCT02823119|Mini-hysteroscopy|mini-hysteroscopy
4766218|NCT02823119|Office hysteroscopy|office hysteroscopy
4766219|NCT02823119|Pain|pain
4766220|NCT02823093|vascular calcification|vascular calcification
4766221|NCT02823093|aortic calcification|aortic calcification
4766222|NCT02823093|vitamin K antagonist|vitamin k antagonist
4766223|NCT02823093|fluindione|fluindione
4766224|NCT02823093|warfarin|warfarin
4766225|NCT02823093|matrix gla protein|matrix gla protein
4766226|NCT02823067|Pemphigoid|pemphigoid
4766227|NCT02823067|Bullous pemphigoid|bullous pemphigoid
4766228|NCT02823067|Pruritus|pruritus
4766229|NCT02823067|Senile pruritus|senile pruritus
4766230|NCT02823067|Neuropsychiatric symptoms|neuropsychiatric symptoms
4766231|NCT02823054|elective surgery|elective surgery
4766232|NCT02823054|CABG|cabg
4766233|NCT02823054|One-lung ventilation|one-lung ventilation
4766234|NCT02823054|EZ Blockers|ez blockers
4766235|NCT02823054|pleural effusion|pleural effusion
4766236|NCT02823041|cognitive training|cognitive training
4766237|NCT02823041|aerobic exercise|aerobic exercise
4766238|NCT02823041|neurotrophic factors|neurotrophic factors
4766239|NCT02823041|randomized controlled trial|randomized controlled trial
4766240|NCT02823041|functional outcome|functional outcome
4766241|NCT02823028|Smoking|smoking
4766242|NCT02823028|Social Media|social media
4766243|NCT02823028|Twitter|twitter
4766244|NCT02823028|Behavior Change|behavior change
4766245|NCT02823028|Social Support|social support
4766246|NCT02822989|Lupus Erythematosus, Systemic|lupus erythematosus, systemic
4766247|NCT02822989|Musculoskeletal Pain|musculoskeletal pain
4766248|NCT02822989|Inflammation|inflammation
4766249|NCT02822963|Transurethral resection of the prostate|transurethral resection of the prostate
4766250|NCT02822963|Anticoagulants|anticoagulants
4766251|NCT02822963|Platelet aggregation inhibitors|platelet aggregation inhibitors
4766252|NCT02822911|elderly|elderly
4766253|NCT02822911|chronic alcoholism|chronic alcoholism
4766254|NCT02822911|Carbohydrate Deficient Transferrin|carbohydrate deficient transferrin
4766255|NCT02822911|Biological Detection / Diagnosis|biological detection / diagnosis
4766256|NCT02822898|Maintenance|maintenance
4766257|NCT02822898|Intravenous solutions|intravenous solutions
4766258|NCT02822898|Intravenous fluids|intravenous fluids
4766259|NCT02822898|Tonicity|tonicity
4766260|NCT02822898|Potassium|potassium
4766261|NCT02822898|Sodium|sodium
4766262|NCT02822898|Fluid retention|fluid retention
4766263|NCT02822872|infertility|infertility
4766264|NCT02822872|stress|stress
4766265|NCT02822872|scalp hair|scalp hair
4766266|NCT02822872|cortisol|cortisol
4766267|NCT02822846|Lung ultrasound|lung ultrasound
4766268|NCT02822846|Sliding lung|sliding lung
4766269|NCT02822846|Probe position|probe position
4766270|NCT02822755|Exercise|exercise
4766271|NCT02822755|Adherence|adherence
4766272|NCT02822755|Physical Therapy|physical therapy
4766273|NCT02822703|smoking cessation|smoking cessation
4766274|NCT02822703|tobacco use disorder|tobacco use disorder
4766275|NCT02822703|delay discounting|delay discounting
4766276|NCT02822703|repetitive transcranial magnetic stimulation|repetitive transcranial magnetic stimulation
4766277|NCT02822703|relapse prevention|relapse prevention
4766278|NCT02822690|palliative care|palliative care
4766279|NCT02822690|Quality of dying|quality of dying
4766280|NCT02822664|Brain, pedophilia, neuroimaging|brain, pedophilia, neuroimaging
4766281|NCT02822638|Myocardial infarction|myocardial infarction
4766282|NCT02822638|biomarkers|biomarkers
4766283|NCT02822638|STEMI|stemi
4766284|NCT02822625|Capsaicin|capsaicin
4766285|NCT02822625|QUTENZA®|qutenza®
4766286|NCT02822625|Hypnosis|hypnosis
4766287|NCT02822625|Peripheral Neuropathic|peripheral neuropathic
4766288|NCT02822612|optical coherence tomography|optical coherence tomography
4766289|NCT02822612|optical imaging|optical imaging
4766290|NCT02822612|retinal imaging|retinal imaging
4766291|NCT02822599|CBP, congenital heart defects, cardiopulmonary bypass|cbp, congenital heart defects, cardiopulmonary bypass
4766292|NCT02822586|CD30-positive|cd30-positive
4766293|NCT02822586|Stage IB to Stage IVA|stage ib to stage iva
4766294|NCT02822560|Endovascular Aortic Repair (EVAR)|endovascular aortic repair (evar)
4766295|NCT02822560|percutaneous EVAR (pEVAR)|percutaneous evar (pevar)
4766296|NCT02822560|cost analysis|cost analysis
4766297|NCT02822560|procedure time|procedure time
4766298|NCT02822521|Rheumatoid Arthritis|rheumatoid arthritis
4766299|NCT02822521|Mobile Health|mobile health
4766300|NCT02822521|Pain|pain
4766301|NCT02822521|Arthritis|arthritis
4766302|NCT02822495|Lymphoproliferative Disorders|lymphoproliferative disorders
4766303|NCT02822495|Epstein-Barr Virus|epstein-barr virus
4766304|NCT02822495|Epstein-Barr Viremia|epstein-barr viremia
4766305|NCT02822495|Post Transplant Lymphoproliferative Disorder|post transplant lymphoproliferative disorder
4766306|NCT02822495|EBV-PTLD|ebv-ptld
4766307|NCT02822495|Solid Organ Transplant|solid organ transplant
4766308|NCT02822495|Hematopoietic Cell Transplant|hematopoietic cell transplant
4766309|NCT02822495|primary immunodeficiency|primary immunodeficiency
4766310|NCT02822495|acquired immunodeficiency|acquired immunodeficiency
4766311|NCT02822495|Epstein-Barr Virus Lymphoma|epstein-barr virus lymphoma
4766312|NCT02822495|HIV/AIDS lymphoma|hiv/aids lymphoma
4766313|NCT02822495|Rheumatoid arthritis AND lymphoma|rheumatoid arthritis and lymphoma
4766314|NCT02822495|Allogeneic, off-the-shelf T-cell immunotherapy|allogeneic, off-the-shelf t-cell immunotherapy
4766315|NCT02822495|TNF-alpha inhibitors AND lymphoma|tnf-alpha inhibitors and lymphoma
4766316|NCT02822495|Inflammatory bowel disease AND lymphoma|inflammatory bowel disease and lymphoma
4766317|NCT02822469|TMD Infrared Thermography Physical Therapy Modalities|tmd infrared thermography physical therapy modalities
4766318|NCT02822456|dysphagia|dysphagia
4766319|NCT02822456|intermittent tube|intermittent tube
4766320|NCT02822456|individual 3D printed guiding tube|individual 3d printed guiding tube
4766321|NCT02822430|Pain|pain
4766322|NCT02822430|Psychiatric disorders|psychiatric disorders
4766323|NCT02822417|Recover time|recover time
4766324|NCT02822404|kidney toxicity|kidney toxicity
4766325|NCT02822378|Postmenopausal Osteoporosis|postmenopausal osteoporosis
4766326|NCT02822378|Human|human
4766327|NCT02822378|Female|female
4766328|NCT02822378|Non-pharmacologic therapy|non-pharmacologic therapy
4766329|NCT02822326|Leukemia|leukemia
4766330|NCT02822326|CART CD19|cart cd19
4766331|NCT02822326|Chemotherapy Resistant|chemotherapy resistant
4766332|NCT02822326|Chemotherapy Refractory|chemotherapy refractory
4766333|NCT02822326|CD19 +|cd19 +
4766334|NCT02822326|Lymphoma|lymphoma
4766335|NCT02822235|Drug Therapy|drug therapy
4766336|NCT02822222|essential hypertension|essential hypertension
4766337|NCT02822222|hypertension|hypertension
4766633|NCT02820363|fracture|fracture
4766338|NCT02822222|high blood pressure|high blood pressure
4766339|NCT02822222|cardiovascular diseases|cardiovascular diseases
4766340|NCT02822222|RMJH-111b|rmjh-111b
4766341|NCT02822222|magnesium|magnesium
4766342|NCT02822222|magnesium citrate|magnesium citrate
4766343|NCT02822222|calcium channel blockers|calcium channel blockers
4766344|NCT02822222|vasodilators|vasodilators
4766345|NCT02822222|antihypertensive agents|antihypertensive agents
4766346|NCT02822209|coordinating nurse of thoracic oncology|coordinating nurse of thoracic oncology
4766347|NCT02822209|quality of care in thoracic oncology|quality of care in thoracic oncology
4766348|NCT02822209|lung cancer quality of life|lung cancer quality of life
4766349|NCT02822144|ischemic stroke|ischemic stroke
4766350|NCT02822144|thrombectomy|thrombectomy
4766351|NCT02822144|anesthesia|anesthesia
4766352|NCT02822144|sedation|sedation
4766353|NCT02822118|IBS-D; Chang'an I Recipe; Placebo|ibs-d; chang'an i recipe; placebo
4766354|NCT02822066|Effectivity|effectivity
4766355|NCT02822066|safety|safety
4766356|NCT02822066|irreversible electroporation|irreversible electroporation
4766357|NCT02822066|liver|liver
4766358|NCT02822066|pancreas|pancreas
4766359|NCT02822053|Ultrasonography-guided Laser Ablation|ultrasonography-guided laser ablation
4766360|NCT02822040|Root Resorption|root resorption
4766361|NCT02822040|Panoramic Radiograph|panoramic radiograph
4766362|NCT02822001|Sugammadex|sugammadex
4766363|NCT02821975|Depression|depression
4766364|NCT02821975|Cognitive function|cognitive function
4766365|NCT02821975|Work|work
4766366|NCT02821962|Sedentary behaviour|sedentary behaviour
4766367|NCT02821949|Non Small Cells Lung Cancer|non small cells lung cancer
4766368|NCT02821949|Procalcitonin|procalcitonin
4766369|NCT02821936|positron emission tomography|positron emission tomography
4766370|NCT02821936|parametric imaging|parametric imaging
4766371|NCT02821936|lung cancer|lung cancer
4766372|NCT02821884|Stroke|stroke
4766373|NCT02821884|Transcranial direct current stimulation|transcranial direct current stimulation
4766374|NCT02821884|Neuromuscular electrical stimulation|neuromuscular electrical stimulation
4766375|NCT02821884|upper extremity motor recovery|upper extremity motor recovery
4766376|NCT02821832|Tuberculosis|tuberculosis
4766377|NCT02821832|PET/CT Scanning|pet/ct scanning
4766378|NCT02821832|Immunological Markers|immunological markers
4766379|NCT02821832|4-Month Treatment Completion|4-month treatment completion
4766380|NCT02821819|ovarian stimulation|ovarian stimulation
4766381|NCT02821819|random|random
4766382|NCT02821819|egg donation|egg donation
4766383|NCT02821819|antagonist|antagonist
4766384|NCT02821819|gnrh agonist trigger|gnrh agonist trigger
4766385|NCT02821806|Normal Volunteer|normal volunteer
4766386|NCT02821806|Donation|donation
4766387|NCT02821806|Adoptive T Cell Therapy|adoptive t cell therapy
4766388|NCT02821806|Peripheral Blood Mononuclear Cells|peripheral blood mononuclear cells
4766389|NCT02821780|Stroke|stroke
4766390|NCT02821780|progressive white matter degeneration, and debilitating dementia.|progressive white matter degeneration, and debilitating dementia.
4766391|NCT02821780|progressive chronic hypoperfusion|progressive chronic hypoperfusion
4766392|NCT02821780|Biospecimen Procurement|biospecimen procurement
4766393|NCT02821780|Laboratory Research Specimens|laboratory research specimens
4766394|NCT02821767|Pathogenesis|pathogenesis
4766395|NCT02821767|Ocular Disorders|ocular disorders
4766396|NCT02821767|Eye|eye
4766397|NCT02821767|Eye Diseases|eye diseases
4766398|NCT02821754|PDL1-Mediated Adaptive Resistance|pdl1-mediated adaptive resistance
4766399|NCT02821754|Monoclonal Antibody|monoclonal antibody
4766400|NCT02821754|CTLA-4|ctla-4
4766401|NCT02821754|Ablative Therapy|ablative therapy
4766402|NCT02821754|Combination of Tremelimumab and Durvalumab|combination of tremelimumab and durvalumab
4766403|NCT02821741|Sensory Stimulation|sensory stimulation
4766404|NCT02821728|Prostate|prostate
4766405|NCT02821728|Sulphate|sulphate
4766406|NCT02821728|ATP|atp
4766407|NCT02821728|PTEN|pten
4766408|NCT02821702|placenta accreta|placenta accreta
4766409|NCT02821702|cesarean section|cesarean section
4766410|NCT02821702|artery embolization|artery embolization
4766411|NCT02821689|Dermatopolymyositis|dermatopolymyositis
4766412|NCT02821689|Interstitial lung disease|interstitial lung disease
4766413|NCT02821689|Pirfenidone|pirfenidone
4766414|NCT02821637|teens|teens
4766415|NCT02821637|effort rehabilitation|effort rehabilitation
4766416|NCT02821637|quality of life|quality of life
4766417|NCT02821637|wellbeing|wellbeing
4766418|NCT02821637|physical skills assessment|physical skills assessment
4766419|NCT02821611|Student Stress|student stress
4766420|NCT02821611|Meditation|meditation
4766421|NCT02821611|Sleep Quality|sleep quality
4766422|NCT02821611|Blood Pressure|blood pressure
4766423|NCT02821559|Colorectal cancer|colorectal cancer
4766424|NCT02821559|raltitrexed|raltitrexed
4766425|NCT02821559|oxaliplatin|oxaliplatin
4766426|NCT02821559|bevacizumab|bevacizumab
4766427|NCT02821559|biweekly|biweekly
4766428|NCT02821559|triweekly|triweekly
4766429|NCT02821520|Polypoidal Choroidal Vasculopathy|polypoidal choroidal vasculopathy
4766430|NCT02821520|Photodynamic Therapy|photodynamic therapy
4766431|NCT02821520|Conbercept|conbercept
4766432|NCT02821520|Efficacy|efficacy
4766433|NCT02821520|Safety|safety
4766533|NCT02820870|Primary Prevention|primary prevention
4766434|NCT02821520|vascular endothelial growth factor|vascular endothelial growth factor
4766435|NCT02821494|HPV|hpv
4766436|NCT02821494|Vaccination|vaccination
4766437|NCT02821494|Immunotherapy|immunotherapy
4766438|NCT02821481|Neuromuscular|neuromuscular
4766439|NCT02821481|Supplementation|supplementation
4766440|NCT02821481|Elderly|elderly
4766441|NCT02821455|Isoflurane|isoflurane
4766442|NCT02821455|Sevoflurane|sevoflurane
4766443|NCT02821455|Bispectral Index|bispectral index
4766444|NCT02821455|Pulmonary Surgical Procedures|pulmonary surgical procedures
4766445|NCT02821442|Electroacupuncture|electroacupuncture
4766446|NCT02821442|Neuropathic Pain|neuropathic pain
4766447|NCT02821442|Chemotherapy Induced Peripheral Neuropathy|chemotherapy induced peripheral neuropathy
4766448|NCT02821429|Respiratory weaning|respiratory weaning
4766449|NCT02821429|Pulmonary ventilation|pulmonary ventilation
4766450|NCT02821416|asthma|asthma
4766451|NCT02821390|intravitreal injection|intravitreal injection
4766452|NCT02821390|pain|pain
4766453|NCT02821390|non-steroidal anti-inflammatory drugs|non-steroidal anti-inflammatory drugs
4766454|NCT02821390|anti-VEGF|anti-vegf
4766455|NCT02821390|nepafenac|nepafenac
4766456|NCT02821377|cirrhosis|cirrhosis
4766457|NCT02821377|ascites|ascites
4766458|NCT02821377|immunology|immunology
4766459|NCT02821377|inflammation|inflammation
4766460|NCT02821377|nutrition|nutrition
4766461|NCT02821351|Afib|afib
4766462|NCT02821338|Bioequivalence|bioequivalence
4766463|NCT02821338|Lamotrigine Extended Release|lamotrigine extended release
4766464|NCT02821338|Generic|generic
4766465|NCT02821338|Pharmacokinetic|pharmacokinetic
4766466|NCT02821299|Laryngeal transplantation|laryngeal transplantation
4766467|NCT02821299|Laryngeal function|laryngeal function
4766468|NCT02821299|Swallowing|swallowing
4766469|NCT02821299|Voice production|voice production
4766470|NCT02821299|Respiration|respiration
4766471|NCT02821299|Quality of life|quality of life
4766472|NCT02821247|Treatment Naïve Patients|treatment naïve patients
4766473|NCT02821234|Insomnia|insomnia
4766474|NCT02821234|Hyperarousal|hyperarousal
4766475|NCT02821208|Psychogenic nonepileptic seizure, quality of life|psychogenic nonepileptic seizure, quality of life
4766476|NCT02821169|sinus surgery|sinus surgery
4766477|NCT02821169|sphenopalatin ganglion|sphenopalatin ganglion
4766478|NCT02821169|ropivacaine|ropivacaine
4766479|NCT02821169|local anesthesia|local anesthesia
4766480|NCT02821143|Telemedicine|telemedicine
4766481|NCT02821143|Nursing Home|nursing home
4766482|NCT02821143|Hospitalization|hospitalization
4766483|NCT02821130|Dyspnea|dyspnea
4766484|NCT02821130|Exercise|exercise
4766485|NCT02821130|Cystic Fibrosis|cystic fibrosis
4766486|NCT02821117|Diabetes Mellitus, Paediatric|diabetes mellitus, paediatric
4766487|NCT02821117|Sensing Technology|sensing technology
4766488|NCT02821104|Complement|complement
4766489|NCT02821104|endothelial function|endothelial function
4766490|NCT02821104|insulin sensitivity|insulin sensitivity
4766491|NCT02821104|adolescents|adolescents
4766492|NCT02821104|inflammation|inflammation
4766493|NCT02821078|phase-contrast MRI|phase-contrast mri
4766494|NCT02821078|blood flow|blood flow
4766495|NCT02821078|velocity mapping|velocity mapping
4766496|NCT02821078|abdominal imaging|abdominal imaging
4766497|NCT02821078|Quantitative MRI|quantitative mri
4766498|NCT02821039|Idiopathic Pulmonary Fibrosis, Usual Interstitial Pneumonia|idiopathic pulmonary fibrosis, usual interstitial pneumonia
4766499|NCT02821000|PD1|pd1
4766500|NCT02821000|PD-1|pd-1
4766501|NCT02821000|PDL1|pdl1
4766502|NCT02821000|PD-L1|pd-l1
4766503|NCT02820987|Septic shock, Beta Lactams, Extended infusion, PK/PD|septic shock, beta lactams, extended infusion, pk/pd
4766504|NCT02820961|Breast Neoplasms|breast neoplasms
4766505|NCT02820961|Breast Diseases|breast diseases
4766506|NCT02820961|Exemestane|exemestane
4766507|NCT02820961|Protein Kinase Inhibitors|protein kinase inhibitors
4766508|NCT02820961|Aromatase Inhibitors|aromatase inhibitors
4766509|NCT02820961|entinostat|entinostat
4766510|NCT02820961|Cancer of the Breast|cancer of the breast
4766511|NCT02820961|Metastatic Breast Cancer|metastatic breast cancer
4766512|NCT02820961|Hormone Receptor Positive Breast Cancer|hormone receptor positive breast cancer
4766513|NCT02820961|Estrogen Receptor|estrogen receptor
4766514|NCT02820961|ER+ Breast Cancer|er+ breast cancer
4766515|NCT02820961|Breast Tumor|breast tumor
4766516|NCT02820935|Cytochrome P450|cytochrome p450
4766517|NCT02820935|Pharmacokinetics|pharmacokinetics
4766518|NCT02820935|CC-220|cc-220
4766519|NCT02820935|Healthy Subjects|healthy subjects
4766520|NCT02820922|Emergency orthopedic surgery|emergency orthopedic surgery
4766521|NCT02820922|anesthesia|anesthesia
4766522|NCT02820922|general anesthesia|general anesthesia
4766523|NCT02820922|regional anesthesia|regional anesthesia
4766524|NCT02820909|ultrasound guidance|ultrasound guidance
4766525|NCT02820909|emergency wards|emergency wards
4766526|NCT02820909|arterial and venous catheters|arterial and venous catheters
4766527|NCT02820909|femoral|femoral
4766528|NCT02820909|complications|complications
4766529|NCT02820870|Cardiovascular Disease|cardiovascular disease
4766530|NCT02820870|Quality Improvement|quality improvement
4766531|NCT02820870|Decision Support Tool|decision support tool
4766532|NCT02820870|Performance Measurement|performance measurement
4766534|NCT02820857|Gastroentero-pancreatic neuroendocrine carcinomas|gastroentero-pancreatic neuroendocrine carcinomas
4766535|NCT02820857|Second-line treatment|second-line treatment
4766536|NCT02820857|Bevacizumab|bevacizumab
4766537|NCT02820857|Folfiri|folfiri
4766538|NCT02820844|Overactive bladder|overactive bladder
4766539|NCT02820844|Botulinum toxin type A|botulinum toxin type a
4766540|NCT02820844|Urinary incontinence|urinary incontinence
4766541|NCT02820831|Frail Elderly|frail elderly
4766542|NCT02820831|Peripheral Vascular Surgery|peripheral vascular surgery
4766543|NCT02820831|Risk Assessment|risk assessment
4766544|NCT02820831|Functional status|functional status
4766545|NCT02820818|thoracic magnetic resonance imaging|thoracic magnetic resonance imaging
4766546|NCT02820818|pulmonary function test|pulmonary function test
4766547|NCT02820805|children|children
4766548|NCT02820805|dietary carbohydrates|dietary carbohydrates
4766549|NCT02820805|solanum tuberosum|solanum tuberosum
4766550|NCT02820805|cognition|cognition
4766551|NCT02820805|memory|memory
4766552|NCT02820805|emotions|emotions
4766553|NCT02820805|blood glucose|blood glucose
4766554|NCT02820779|Willis|willis
4766555|NCT02820779|Intracranial aneurysms|intracranial aneurysms
4766556|NCT02820766|Posterior Stabilized Knee|posterior stabilized knee
4766557|NCT02820766|Total Knee Arthroscopy|total knee arthroscopy
4766558|NCT02820766|Journey II BCS|journey ii bcs
4766559|NCT02820753|Universal Medication Schedule|universal medication schedule
4766560|NCT02820753|Health Literacy|health literacy
4766561|NCT02820753|Medication adherence|medication adherence
4766562|NCT02820740|Epilepsy|epilepsy
4766563|NCT02820740|Medial Temporal Lobe Epilepsy|medial temporal lobe epilepsy
4766564|NCT02820740|Seizure|seizure
4766565|NCT02820740|NeuroBlate|neuroblate
4766566|NCT02820740|LITT|litt
4766567|NCT02820740|Quality of Life|quality of life
4766568|NCT02820701|Osteopathic Manipulation|osteopathic manipulation
4766569|NCT02820701|Somatic Dysfunction|somatic dysfunction
4766570|NCT02820701|Musculoskeletal Ultrasound|musculoskeletal ultrasound
4766571|NCT02820688|Local Anesthtetics|local anesthtetics
4766572|NCT02820688|Nerve Block|nerve block
4766573|NCT02820688|Bupivacaine|bupivacaine
4766574|NCT02820688|Prilocaine|prilocaine
4766575|NCT02820675|quality improvement|quality improvement
4766576|NCT02820675|routine data|routine data
4766577|NCT02820675|risk adjustment|risk adjustment
4766578|NCT02820675|sepsis, severe sepsis, septic shock|sepsis, severe sepsis, septic shock
4766579|NCT02820675|quality of coding|quality of coding
4766580|NCT02820649|Exercise training|exercise training
4766581|NCT02820649|Endothelial function|endothelial function
4766582|NCT02820623|implementation|implementation
4766583|NCT02820623|fidelity|fidelity
4766584|NCT02820623|cognitive behavioral therapy|cognitive behavioral therapy
4766585|NCT02820558|Neuropeptide|neuropeptide
4766586|NCT02820558|Therapy|therapy
4766587|NCT02820558|Onset|onset
4766588|NCT02820545|patient safety culture|patient safety culture
4766589|NCT02820545|hospital|hospital
4766590|NCT02820545|patient perception|patient perception
4766591|NCT02820545|healthcare professional perception|healthcare professional perception
4766592|NCT02820545|sociological|sociological
4766593|NCT02820545|qualitative|qualitative
4766594|NCT02820545|questionnaire construct|questionnaire construct
4766595|NCT02820545|psychometrics|psychometrics
4766596|NCT02820519|Neuropathic pain|neuropathic pain
4766597|NCT02820519|Loxapine|loxapine
4766598|NCT02820519|Antipsychotics|antipsychotics
4766599|NCT02820519|Co-Analgesics|co-analgesics
4766600|NCT02820519|Tolerability|tolerability
4766601|NCT02820519|Analgesic efficacy|analgesic efficacy
4766602|NCT02820506|robotic surgery procedures|robotic surgery procedures
4766603|NCT02820506|indocyanine green|indocyanine green
4766604|NCT02820506|sentinel lymph node mapping|sentinel lymph node mapping
4766605|NCT02820480|stroke|stroke
4766606|NCT02820480|rehabilitation|rehabilitation
4766607|NCT02820480|robotics|robotics
4766608|NCT02820480|cerebral palsy|cerebral palsy
4766609|NCT02820480|therapy|therapy
4766610|NCT02820467|Indocyanine|indocyanine
4766611|NCT02820467|Angiography|angiography
4766612|NCT02820467|Ischemia|ischemia
4766613|NCT02820454|AGuIX|aguix
4766614|NCT02820454|polysiloxane gadolinium-chelates based nanoparticles|polysiloxane gadolinium-chelates based nanoparticles
4766615|NCT02820415|aneuploidy|aneuploidy
4766616|NCT02820415|next generation sequencing|next generation sequencing
4766617|NCT02820415|oocyte vitrification|oocyte vitrification
4766618|NCT02820415|preimplantation genetic diagnosis|preimplantation genetic diagnosis
4766619|NCT02820415|preimplantation genetic screening|preimplantation genetic screening
4766620|NCT02820402|Pregnancy|pregnancy
4766621|NCT02820402|Obesity|obesity
4766622|NCT02820402|Diet|diet
4766623|NCT02820402|Maternal/child health|maternal/child health
4766624|NCT02820402|Asthma/allergy|asthma/allergy
4766625|NCT02820402|Air pollution|air pollution
4766626|NCT02820402|Epigenetics|epigenetics
4766627|NCT02820402|Cognition/behavior|cognition/behavior
4766628|NCT02820376|4D computed tomography|4d computed tomography
4766629|NCT02820376|Kidney function tests|kidney function tests
4766630|NCT02820376|Living Donors|living donors
4766631|NCT02820363|wound|wound
4766632|NCT02820363|open fracture|open fracture
4766634|NCT02820363|tibial|tibial
4766635|NCT02820350|Acute Renal Failure|acute renal failure
4766636|NCT02820350|Acute kidney injury|acute kidney injury
4766637|NCT02820350|Continuous Renal Replacement Therapy|continuous renal replacement therapy
4766638|NCT02820350|Selective cytopheretic device|selective cytopheretic device
4766639|NCT02820350|Pediatric|pediatric
4766640|NCT02820311|Thorough QT (TQT)|thorough qt (tqt)
4766641|NCT02820311|cardiac safety|cardiac safety
4766642|NCT02820272|Cold water|cold water
4766643|NCT02820272|Negative pressure wound therapy|negative pressure wound therapy
4766644|NCT02820272|pain|pain
4766645|NCT02820246|nutrition assessment|nutrition assessment
4766646|NCT02820246|nutrition therapy|nutrition therapy
4766647|NCT02820246|nutrition surveys|nutrition surveys
4766648|NCT02820246|patient outcome assessment|patient outcome assessment
4766649|NCT02820246|outcome and process assessment|outcome and process assessment
4766650|NCT02820246|benchmarking|benchmarking
4766651|NCT02820246|risk assessment|risk assessment
4766652|NCT02820246|scoring system|scoring system
4766653|NCT02820220|Knowledge|knowledge
4766654|NCT02820220|Programs|programs
4766655|NCT02820220|Patients|patients
4766656|NCT02820220|Students|students
4766657|NCT02820220|Nurses|nurses
4766658|NCT02820207|Carotid Artery Plaque|carotid artery plaque
4766659|NCT02820207|Contrast Enhanced Ultrasound|contrast enhanced ultrasound
4766660|NCT02820207|Plague Histopathology|plague histopathology
4766661|NCT02820181|tracheostomy ties|tracheostomy ties
4766662|NCT02820168|Designing|designing
4766663|NCT02820168|Patient-Oriented|patient-oriented
4766664|NCT02820168|Prescriptions|prescriptions
4766665|NCT02820155|Alzheimer's disease,cognitive function|alzheimer's disease,cognitive function
4766666|NCT02820142|biomarker|biomarker
4766667|NCT02820142|Renal Function|renal function
4766668|NCT02820129|polypharmacy|polypharmacy
4766669|NCT02820129|wallet card|wallet card
4766670|NCT02820129|medication|medication
4766671|NCT02820129|self-efficacy|self-efficacy
4766672|NCT02820129|patient enablement|patient enablement
4766673|NCT02820103|Patient delay|patient delay
4766674|NCT02820103|Behaviour change|behaviour change
4766675|NCT02820103|Intervention Modelling Experiment|intervention modelling experiment
4766676|NCT02820090|Inflammatory Factor|inflammatory factor
4766677|NCT02820090|Mechanical Ventilation|mechanical ventilation
4766678|NCT02820077|Endoscopy, Gastrointestinal|endoscopy, gastrointestinal
4766679|NCT02820051|bronchoscopy|bronchoscopy
4766680|NCT02820051|conscious sedation|conscious sedation
4766681|NCT02820051|midazolam|midazolam
4766682|NCT02820051|patient comfort|patient comfort
4766683|NCT02820051|propofol|propofol
4766684|NCT02820012|Scoliosis|scoliosis
4766685|NCT02820012|ST2R|st2r
4766686|NCT02819986|occupational functioning|occupational functioning
4766687|NCT02819986|Worries|worries
4766688|NCT02819986|Pain|pain
4766689|NCT02819986|Disability|disability
4766690|NCT02819973|Patient Education|patient education
4766691|NCT02819973|ICD|icd
4766692|NCT02819973|Implantable Cardioverter Defibrillator|implantable cardioverter defibrillator
4766693|NCT02819973|Video|video
4766694|NCT02819973|Decision|decision
4766695|NCT02819973|Decision making|decision making
4766696|NCT02819960|probiotics|probiotics
4766697|NCT02819960|irinotecan|irinotecan
4766698|NCT02819960|diarrhea|diarrhea
4766699|NCT02819960|Lactobacillus rhamnosus|lactobacillus rhamnosus
4766700|NCT02819960|Bifidobacterium animalis|bifidobacterium animalis
4766701|NCT02819960|prevention|prevention
4766702|NCT02819960|chemotherapy|chemotherapy
4766703|NCT02819947|systemic sclerosis|systemic sclerosis
4766704|NCT02819947|cohort|cohort
4766705|NCT02819947|Korean|korean
4766706|NCT02819921|Hot Flashes|hot flashes
4766707|NCT02819921|Breast Neoplasms|breast neoplasms
4766708|NCT02819921|Tamoxifen|tamoxifen
4766709|NCT02819921|Desvenlafaxine Succinate|desvenlafaxine succinate
4766710|NCT02819895|Phone Appointment Reminder|phone appointment reminder
4766711|NCT02819895|Immunization Rates|immunization rates
4766712|NCT02819895|mHealth|mhealth
4766713|NCT02819882|Unresectable|unresectable
4766714|NCT02819882|locally|locally
4766715|NCT02819882|advanced|advanced
4766716|NCT02819882|metastatic disease|metastatic disease
4766717|NCT02819843|T-VEC (Talimogene Laherparepvec)|t-vec (talimogene laherparepvec)
4766718|NCT02819843|Radiotherapy|radiotherapy
4766719|NCT02819843|16-224|16-224
4766720|NCT02819830|Aerobic exercise|aerobic exercise
4766721|NCT02819830|Strength training|strength training
4766722|NCT02819830|Inflammation|inflammation
4766723|NCT02819830|cardiovascular disease|cardiovascular disease
4766724|NCT02819817|Aloe Vera, wound, healing|aloe vera, wound, healing
4766725|NCT02819791|Cardiovascular|cardiovascular
4766726|NCT02819791|therapeutic education|therapeutic education
4766727|NCT02819778|Diagnosis|diagnosis
4766728|NCT02819778|Craniocerebral Trauma|craniocerebral trauma
4766729|NCT02819778|Pediatrics|pediatrics
4766730|NCT02819778|S100B|s100b
4766731|NCT02819778|mild traumatic brain injury|mild traumatic brain injury
4766732|NCT02819752|squamous cell carcinoma|squamous cell carcinoma
4766733|NCT02819752|squamous cell carcinoma of the head and neck|squamous cell carcinoma of the head and neck
4766935|NCT02818582|Liberia|liberia
4766734|NCT02819726|an inadquate response to anti -TNF therapy|an inadquate response to anti -tnf therapy
4766735|NCT02819713|Prostate Biopsy|prostate biopsy
4766736|NCT02819713|NRS-score|nrs-score
4766737|NCT02819713|instillagel|instillagel
4766738|NCT02819713|ultrasound conductive gel|ultrasound conductive gel
4766739|NCT02819700|behavioural disorders|behavioural disorders
4766740|NCT02819687|Phase I|phase i
4766741|NCT02819687|Healthy|healthy
4766742|NCT02819687|Pharmacokinetics|pharmacokinetics
4766743|NCT02819687|Pharmacodynamics|pharmacodynamics
4766744|NCT02819674|hypertension|hypertension
4766745|NCT02819674|early onset|early onset
4766746|NCT02819674|target organ damage|target organ damage
4766747|NCT02819661|Elective Caesarean Section|elective caesarean section
4766748|NCT02819661|obese women|obese women
4766749|NCT02819661|BMI≥30|bmi≥30
4766750|NCT02819661|spinal anesthesia combined with intrathecal morphine|spinal anesthesia combined with intrathecal morphine
4766751|NCT02819648|symptomatic|symptomatic
4766752|NCT02819648|irreversible|irreversible
4766753|NCT02819635|Upadacitinib (ABT-494)|upadacitinib (abt-494)
4766754|NCT02819635|Moderately to Severely Active UC|moderately to severely active uc
4766755|NCT02819570|early-onset neonatal sepsis|early-onset neonatal sepsis
4766756|NCT02819570|Prophylactic antibiotics|prophylactic antibiotics
4766757|NCT02819570|Pregnancy|pregnancy
4766758|NCT02819570|PPROM|pprom
4766760|NCT02819544|Digestive System|digestive system
4766761|NCT02819531|Coronary Atherectomy|coronary atherectomy
4766762|NCT02819531|percutaneous coronary intervention|percutaneous coronary intervention
4766763|NCT02819518|PD1|pd1
4766764|NCT02819518|PD-1|pd-1
4766765|NCT02819518|PDL1|pdl1
4766766|NCT02819518|PD-L1|pd-l1
4766767|NCT02819505|beta-alanine|beta-alanine
4766768|NCT02819505|carnosine|carnosine
4766769|NCT02819505|neuromuscular|neuromuscular
4766770|NCT02819505|stimulation|stimulation
4766771|NCT02819505|skeletal muscle|skeletal muscle
4766772|NCT02819492|Adenoma|adenoma
4766773|NCT02819492|Colonoscopy|colonoscopy
4766774|NCT02819492|Withdrawal|withdrawal
4766775|NCT02819492|Proximal|proximal
4766776|NCT02819492|Observation Time|observation time
4766777|NCT02819479|Radiation necrosis|radiation necrosis
4766778|NCT02819479|Radiation adverse event|radiation adverse event
4766779|NCT02819479|Intra-arterial chemotherapy|intra-arterial chemotherapy
4766780|NCT02819479|Bevacizumab|bevacizumab
4766781|NCT02819479|Blood brain barrier disruption|blood brain barrier disruption
4766782|NCT02819479|Blood brain barrier breakdown|blood brain barrier breakdown
4766783|NCT02819466|intragastric volume|intragastric volume
4766784|NCT02819466|stomach|stomach
4766785|NCT02819466|fasting|fasting
4766786|NCT02819453|Corticosteroid|corticosteroid
4766787|NCT02819427|Spectroscopy, Near-Infrared|spectroscopy, near-infrared
4766788|NCT02819427|Electroencephalography|electroencephalography
4766789|NCT02819427|children|children
4766790|NCT02819388|randomized control trial; contraception; inequalities|randomized control trial; contraception; inequalities
4766791|NCT02819375|propofol|propofol
4766792|NCT02819375|ketamine|ketamine
4766793|NCT02819375|remifentanil|remifentanil
4766794|NCT02819349|Relapse Prevention|relapse prevention
4766795|NCT02819349|People with Schizophrenia|people with schizophrenia
4766796|NCT02819349|Text-Messaging|text-messaging
4766797|NCT02819349|Assertive Community Treatment (ACT)|assertive community treatment (act)
4766798|NCT02819336|urinary incontinence|urinary incontinence
4766799|NCT02819336|electroacupuncture|electroacupuncture
4766800|NCT02819336|stroke|stroke
4766801|NCT02819336|complications|complications
4766802|NCT02819336|randomized controlled trial|randomized controlled trial
4766803|NCT02819336|pilot projects|pilot projects
4766804|NCT02819284|Ocular Discomfort|ocular discomfort
4766805|NCT02819284|Pain|pain
4766806|NCT02819284|Corticosteroid|corticosteroid
4766807|NCT02819284|Hyperemia|hyperemia
4766808|NCT02819284|Dry Eye|dry eye
4766809|NCT02819219|Dietary Supplements|dietary supplements
4766810|NCT02819219|Exercise|exercise
4766811|NCT02819193|Breastfeeding|breastfeeding
4766812|NCT02819193|mother's milk|mother's milk
4766813|NCT02819193|breast milk|breast milk
4766814|NCT02819193|raw milk|raw milk
4766815|NCT02819193|neonate|neonate
4766816|NCT02819193|Neonatal intensive care unit (NICU)|neonatal intensive care unit (nicu)
4766817|NCT02819180|Influenza|influenza
4766818|NCT02819167|ischemic stroke|ischemic stroke
4766819|NCT02819167|brain reserve|brain reserve
4766820|NCT02819167|cognitive reserve|cognitive reserve
4766821|NCT02819167|cognitive prognosis|cognitive prognosis
4766822|NCT02819115|Influenza|influenza
4766823|NCT02819089|anterior cervical spine surgery|anterior cervical spine surgery
4766824|NCT02819089|ACDF|acdf
4766825|NCT02819089|Dexmedetomidine|dexmedetomidine
4766826|NCT02819089|Anesthesia|anesthesia
4766827|NCT02819089|Agitation|agitation
4766828|NCT02819089|Riker sedation agitation scores|riker sedation agitation scores
4766829|NCT02819050|CPAP|cpap
4766830|NCT02819050|Extremely Low Birth Weight Infant (ELBW)|extremely low birth weight infant (elbw)
4766831|NCT02819050|Non-invasive respiratory support|non-invasive respiratory support
4766832|NCT02819050|Premature infants|premature infants
4766833|NCT02819050|Non invasive ventilation weaning|non invasive ventilation weaning
4766834|NCT02819037|Gastric bypass|gastric bypass
4766835|NCT02819037|Intestinal Bacterial Overgrowth Syndrome|intestinal bacterial overgrowth syndrome
4766836|NCT02819037|Gas chromatography|gas chromatography
4766837|NCT02819011|Ankle Foot Orthoses|ankle foot orthoses
4766838|NCT02819011|falls|falls
4766839|NCT02819011|Fall Prevention|fall prevention
4766840|NCT02819011|Frailty|frailty
4766841|NCT02819011|Concern for falls|concern for falls
4766842|NCT02819011|Footwear|footwear
4766843|NCT02819011|Mobility|mobility
4766844|NCT02818998|Diabetic macular edema|diabetic macular edema
4766845|NCT02818998|DME|dme
4766846|NCT02818959|Aortic Valve Disease|aortic valve disease
4766847|NCT02818959|Aortic Valve Replacement|aortic valve replacement
4766848|NCT02818959|Transcatheter|transcatheter
4766849|NCT02818959|Transfemoral|transfemoral
4766850|NCT02818959|Aortic Stenosis|aortic stenosis
4766851|NCT02818946|MRI|mri
4766852|NCT02818946|Spontaneous Nipple Discharge|spontaneous nipple discharge
4766853|NCT02818946|Breast Cancer|breast cancer
4766854|NCT02818933|24-hour diet recall|24-hour diet recall
4766855|NCT02818933|Adolescents|adolescents
4766856|NCT02818933|Web-based diet recall|web-based diet recall
4766857|NCT02818920|Pembrolizumab|pembrolizumab
4766858|NCT02818920|Neoadjuvant|neoadjuvant
4766859|NCT02818920|Tumor Infiltrating Lymphocytes (TILs)|tumor infiltrating lymphocytes (tils)
4766860|NCT02818894|THA, Hip Replacement, Spinal Anesthesia|tha, hip replacement, spinal anesthesia
4766861|NCT02818894|Total hip arthroplasty|total hip arthroplasty
4766862|NCT02818894|anterior total hip replacement|anterior total hip replacement
4766863|NCT02818881|aerobic|aerobic
4766864|NCT02818881|muscle activity|muscle activity
4766865|NCT02818881|energy expenditure|energy expenditure
4766866|NCT02818855|Root coverage|root coverage
4766867|NCT02818855|Gingival recession|gingival recession
4766868|NCT02818855|Plastic surgery|plastic surgery
4766869|NCT02818855|Connective tissue graft|connective tissue graft
4766870|NCT02818855|Mucograft|mucograft
4766871|NCT02818842|Database|database
4766872|NCT02818842|Birth defects|birth defects
4766873|NCT02818842|Neonatal pathologies|neonatal pathologies
4766874|NCT02818829|Adenocarcinoma|adenocarcinoma
4766875|NCT02818829|Endoscopic ultrasonography|endoscopic ultrasonography
4766876|NCT02818829|Fine-needle aspiration|fine-needle aspiration
4766877|NCT02818829|Biomarkers|biomarkers
4766878|NCT02818829|Epidemiology|epidemiology
4766879|NCT02818829|DNA tumors|dna tumors
4766880|NCT02818816|Brimonidine tartrate|brimonidine tartrate
4766881|NCT02818816|Intraocular pressure|intraocular pressure
4766882|NCT02818816|Prostate Cancer|prostate cancer
4766883|NCT02818816|Prostatectomy|prostatectomy
4766884|NCT02818803|propolis|propolis
4766885|NCT02818803|therapeutic|therapeutic
4766886|NCT02818803|miconazole|miconazole
4766887|NCT02818803|denture stomatitis|denture stomatitis
4766888|NCT02818790|mHealth|mhealth
4766889|NCT02818790|Motivational Interviewing|motivational interviewing
4766890|NCT02818790|Obesity|obesity
4766891|NCT02818790|Prevention|prevention
4766892|NCT02818790|Diet|diet
4766893|NCT02818790|Physical Activity|physical activity
4766894|NCT02818790|Health Preventive System|health preventive system
4766895|NCT02818777|Parkinson's Disease|parkinson's disease
4766896|NCT02818777|Tremor|tremor
4766897|NCT02818777|tolerability|tolerability
4766898|NCT02818777|safety|safety
4766899|NCT02818777|cognition|cognition
4766900|NCT02818777|anxiety|anxiety
4766901|NCT02818777|psychosis|psychosis
4766902|NCT02818777|mood|mood
4766903|NCT02818777|dyskinesia|dyskinesia
4766904|NCT02818777|cannabidiol|cannabidiol
4766905|NCT02818777|cannabis|cannabis
4766906|NCT02818777|efficacy|efficacy
4766907|NCT02818777|sleep|sleep
4766908|NCT02818777|motor symptoms|motor symptoms
4766909|NCT02818777|non-motor symptoms|non-motor symptoms
4766910|NCT02818777|quality of life|quality of life
4766911|NCT02818777|marijuana|marijuana
4766912|NCT02818764|serum biomarkers|serum biomarkers
4766913|NCT02818764|cerebral blood flow|cerebral blood flow
4766914|NCT02818764|modified Blessed Dementia Rating scale|modified blessed dementia rating scale
4766915|NCT02818764|Confusion Assessment Method|confusion assessment method
4766916|NCT02818764|Delirium Rating Scale-98|delirium rating scale-98
4766917|NCT02818751|Anxiety|anxiety
4766918|NCT02818751|Adolescents with Anxiety|adolescents with anxiety
4766919|NCT02818738|Idiopathic nephrotic syndrome|idiopathic nephrotic syndrome
4766920|NCT02818738|Steroid sensitive nephrotic syndrome|steroid sensitive nephrotic syndrome
4766921|NCT02818738|Levamisole|levamisole
4766922|NCT02818738|Prednisone|prednisone
4766923|NCT02818738|Children|children
4766924|NCT02818686|Ulcerative Colitis, Active Moderate and Severe|ulcerative colitis, active moderate and severe
4766925|NCT02818673|diagnostic performances|diagnostic performances
4766926|NCT02818673|ascites|ascites
4766927|NCT02818647|tonsillectomy|tonsillectomy
4766928|NCT02818647|electrocautery|electrocautery
4766929|NCT02818647|postoperative pain|postoperative pain
4766930|NCT02818647|visual analogue scale|visual analogue scale
4766931|NCT02818608|Cerebrovascular Accident|cerebrovascular accident
4766932|NCT02818608|Cerebrovascular Stroke|cerebrovascular stroke
4766933|NCT02818608|Cerebral Stroke|cerebral stroke
4766934|NCT02818595|voice recognition|voice recognition
4766936|NCT02818582|EBV|ebv
4766937|NCT02818582|Semen|semen
4766938|NCT02818504|obesity|obesity
4766939|NCT02818504|dysglycemia|dysglycemia
4766940|NCT02818504|hypercholesterolemia|hypercholesterolemia
4766941|NCT02818504|lifestyle|lifestyle
4766942|NCT02818504|smoking|smoking
4766943|NCT02818504|physical activity|physical activity
4766944|NCT02818439|Old person|old person
4766945|NCT02818426|cancer immunotherapy|cancer immunotherapy
4766946|NCT02818426|CD4 T lymphocyte helper|cd4 t lymphocyte helper
4766947|NCT02818426|telomerase|telomerase
4766948|NCT02818413|Stool microbiome|stool microbiome
4766949|NCT02818413|Stool metabolome|stool metabolome
4766950|NCT02818413|Single nucleotide polymorphisms|single nucleotide polymorphisms
4766951|NCT02818400|maxillofacial surgery|maxillofacial surgery
4766952|NCT02818400|face graft|face graft
4766953|NCT02818400|composite tissue|composite tissue
4766954|NCT02818400|stem cell infusion|stem cell infusion
4766955|NCT02818400|allotransplantation|allotransplantation
4766956|NCT02818400|microsurgery|microsurgery
4766957|NCT02818387|propofol|propofol
4766958|NCT02818387|midazolam|midazolam
4766959|NCT02818387|remifentanil|remifentanil
4766960|NCT02818387|combination|combination
4766961|NCT02818387|synergic|synergic
4766962|NCT02818387|pharmacodynamics|pharmacodynamics
4766963|NCT02818387|Loss of consciousness|loss of consciousness
4766964|NCT02818361|Rheumatoid Arthritis|rheumatoid arthritis
4766965|NCT02818361|Tripterygium wilfordii Hook F|tripterygium wilfordii hook f
4766966|NCT02818361|double-blinded|double-blinded
4766967|NCT02818361|randomized controlled trial|randomized controlled trial
4766968|NCT02818361|Tripterygium|tripterygium
4766969|NCT02818361|Administration|administration
4766970|NCT02818361|Topical|topical
4766971|NCT02818348|HIV infection|hiv infection
4766972|NCT02818348|Darunavir/cobicistat|darunavir/cobicistat
4766973|NCT02818348|Etravirine, drug-drug interactions|etravirine, drug-drug interactions
4766974|NCT02818348|Population PK analysis|population pk analysis
4766975|NCT02818296|Intolerance of uncertainty|intolerance of uncertainty
4766976|NCT02818296|Anxiety|anxiety
4766977|NCT02818283|Human Immunodeficiency Virus|human immunodeficiency virus
4766978|NCT02818283|hypercholesterolemia|hypercholesterolemia
4766979|NCT02818283|pretzels|pretzels
4766980|NCT02818283|nutritional study|nutritional study
4766981|NCT02818283|dietary soy|dietary soy
4766982|NCT02818283|antiretroviral therapy|antiretroviral therapy
4766983|NCT02818244|commercial heart monitors|commercial heart monitors
4766984|NCT02818244|accuracy|accuracy
4766985|NCT02818244|EKG|ekg
4766986|NCT02818244|varying degrees of exertion|varying degrees of exertion
4766987|NCT02818166|magnetic resonance|magnetic resonance
4766988|NCT02818166|right mini-thoracotomy|right mini-thoracotomy
4766989|NCT02818153|Allergic rhinitis|allergic rhinitis
4766990|NCT02818140|Postoperative pain|postoperative pain
4766991|NCT02818140|Transmuscular quadratus lumborum block|transmuscular quadratus lumborum block
4766992|NCT02818140|Block|block
4766993|NCT02818140|Ropivacaine|ropivacaine
4766994|NCT02818140|TQL|tql
4766995|NCT02818140|percutaneous nephrolithotomy|percutaneous nephrolithotomy
4766996|NCT02818140|PNL|pnl
4766997|NCT02818140|Ultrasound-guided|ultrasound-guided
4766998|NCT02818114|PTSD|ptsd
4766999|NCT02818114|Prolonged Exposure|prolonged exposure
4767000|NCT02818114|Peer Support|peer support
4767001|NCT02818075|Peer support|peer support
4767002|NCT02818075|Postpartum Depression|postpartum depression
4767003|NCT02818075|Adolescent Pregnancy|adolescent pregnancy
4767004|NCT02818062|Endophthalmitis|endophthalmitis
4767005|NCT02818062|Cytokines|cytokines
4767006|NCT02818062|Chemokines|chemokines
4767007|NCT02818062|Inflammation|inflammation
4767008|NCT02818062|Regulation|regulation
4767009|NCT02818049|Bronchioalveolar Lavage|bronchioalveolar lavage
4767010|NCT02818010|physical activity|physical activity
4767011|NCT02818010|chronic kidney disease|chronic kidney disease
4767012|NCT02818010|nephrology|nephrology
4767013|NCT02818010|stage 3|stage 3
4767014|NCT02818010|stage 4|stage 4
4767015|NCT02818010|stage 5|stage 5
4767016|NCT02817997|patient registry|patient registry
4767017|NCT02817997|ACCELERATE study|accelerate study
4767018|NCT02817997|CD|cd
4767019|NCT02817997|MCD|mcd
4767020|NCT02817997|iMCD|imcd
4767021|NCT02817997|Castleman|castleman
4767022|NCT02817997|Castleman's Disease|castleman's disease
4767023|NCT02817997|Angiofollicular Lymph Hyperplasia|angiofollicular lymph hyperplasia
4767024|NCT02817997|multicentric Castleman's disease|multicentric castleman's disease
4767025|NCT02817997|multicentric Castleman disease|multicentric castleman disease
4767026|NCT02817984|Abdominoplasty|abdominoplasty
4767027|NCT02817971|feedback|feedback
4767028|NCT02817971|pneumonia|pneumonia
4767029|NCT02817971|quality of care|quality of care
4767030|NCT02817958|inguinal lymph nodes|inguinal lymph nodes
4767031|NCT02817958|penile cancer|penile cancer
4767032|NCT02817958|squamous|squamous
4767033|NCT02817958|TIP chemotherapy|tip chemotherapy
4767034|NCT02817945|TATE-RGD|tate-rgd
4767035|NCT02817945|SSTR2|sstr2
4767036|NCT02817945|integrin αvβ3|integrin αvβ3
4767037|NCT02817919|Pharmacovigilance|pharmacovigilance
4767038|NCT02817919|Africa|africa
4767039|NCT02817893|∆POP: variation of the plethysmographic waveform of pulse oximetry|∆pop: variation of the plethysmographic waveform of pulse oximetry
4767040|NCT02817893|∆PP: pulse pressure variation|∆pp: pulse pressure variation
4767041|NCT02817893|pulse oximetry plethysmographic|pulse oximetry plethysmographic
4767042|NCT02817893|abdominal surgery|abdominal surgery
4767043|NCT02817880|rTMS, tDCS, tsDCS, pain, algoneurodystrophy , neurostimulation|rtms, tdcs, tsdcs, pain, algoneurodystrophy , neurostimulation
4767044|NCT02817841|Estetrol|estetrol
4767045|NCT02817841|Drospirenone|drospirenone
4767046|NCT02817841|Prevention of pregnancy|prevention of pregnancy
4767047|NCT02817841|Oral contraception|oral contraception
4767048|NCT02817828|Estetrol|estetrol
4767049|NCT02817815|Atrial fibrillation, blood platelet|atrial fibrillation, blood platelet
4767050|NCT02817802|Registry|registry
4767051|NCT02817802|Magmaris|magmaris
4767052|NCT02817802|Coronary Artery Disease|coronary artery disease
4767053|NCT02817802|PCI|pci
4767054|NCT02817789|TAVI|tavi
4767055|NCT02817789|Antiplatelet agent|antiplatelet agent
4767056|NCT02817789|Ticagrelor|ticagrelor
4767057|NCT02817789|Cerebrovascular events|cerebrovascular events
4767058|NCT02817776|Interventional|interventional
4767059|NCT02817776|Radiofrequency Ablation|radiofrequency ablation
4767060|NCT02817776|Persistent Atrial Fibrillation|persistent atrial fibrillation
4767061|NCT02817750|volunteers|volunteers
4767062|NCT02817750|Pharmacokinetics|pharmacokinetics
4767063|NCT02817724|Breast Neoplasms|breast neoplasms
4767064|NCT02817724|survivor|survivor
4767065|NCT02817724|occupational therapy|occupational therapy
4767066|NCT02817724|mobile applications|mobile applications
4767067|NCT02817724|Quality of Life|quality of life
4767068|NCT02817711|infection|infection
4767069|NCT02817711|bone and joint infection|bone and joint infection
4767070|NCT02817711|relapse|relapse
4767071|NCT02817711|adverse event|adverse event
4767072|NCT02817698|smoking|smoking
4767073|NCT02817698|cannabis|cannabis
4767074|NCT02817698|cocaine|cocaine
4767075|NCT02817685|surveillance|surveillance
4767076|NCT02817685|hepatocellular carcinoma|hepatocellular carcinoma
4767077|NCT02817685|ultrasound|ultrasound
4767078|NCT02817685|cirrhosis|cirrhosis
4767079|NCT02817685|chronic hepatitis B|chronic hepatitis b
4767080|NCT02817672|Human|human
4767081|NCT02817672|Mental Disorders|mental disorders
4767082|NCT02817672|intervention|intervention
4767083|NCT02817672|digital health|digital health
4767084|NCT02817659|Glucagon|glucagon
4767085|NCT02817646|Intensive Care Unit|intensive care unit
4767086|NCT02817646|Critical Illness|critical illness
4767087|NCT02817646|Body composition|body composition
4767088|NCT02817646|Protein nutrition|protein nutrition
4767089|NCT02817633|Anitibodies|anitibodies
4767090|NCT02817633|TSR-022|tsr-022
4767091|NCT02817633|Advanced solid tumors|advanced solid tumors
4767092|NCT02817633|Metastatic solid tumors|metastatic solid tumors
4767093|NCT02817633|Immunotherapy|immunotherapy
4767094|NCT02817633|PD-1|pd-1
4767095|NCT02817633|Anti-PD-1|anti-pd-1
4767096|NCT02817633|colorectal cancer|colorectal cancer
4767097|NCT02817633|non-small cell lung cancer|non-small cell lung cancer
4767098|NCT02817633|Melanoma|melanoma
4767099|NCT02817607|Sensation|sensation
4767100|NCT02817594|Chronic Hepatitis C|chronic hepatitis c
4767101|NCT02817594|Paritaprevir/r - Ombitasvir, ± Dasabuvir|paritaprevir/r - ombitasvir, ± dasabuvir
4767102|NCT02817594|Sustained Virological Response|sustained virological response
4767103|NCT02817594|Observational Study|observational study
4767104|NCT02817594|Chronic Hepatitis C genotype 1|chronic hepatitis c genotype 1
4767105|NCT02817594|Chronic Hepatitis C genotype 4|chronic hepatitis c genotype 4
4767106|NCT02817581|National Early Warning Score (NEWS)|national early warning score (news)
4767107|NCT02817581|Lactate|lactate
4767108|NCT02817581|Emergency Department|emergency department
4767109|NCT02817568|Aggressive Periodontitis|aggressive periodontitis
4767110|NCT02817568|C-C chemokine receptor 2|c-c chemokine receptor 2
4767111|NCT02817568|Gene expression|gene expression
4767112|NCT02817568|monocyte chemoattractant protein-1,|monocyte chemoattractant protein-1,
4767113|NCT02817568|restriction fragment length polymorphism|restriction fragment length polymorphism
4767114|NCT02817555|Anemia|anemia
4767115|NCT02817555|Hemodialysis|hemodialysis
4767116|NCT02817555|Erythropoiesis Stimulating Agent|erythropoiesis stimulating agent
4767117|NCT02817555|Cost|cost
4767118|NCT02817516|Drug Therapy|drug therapy
4767119|NCT02817503|hypertension|hypertension
4767120|NCT02817503|BP titration|bp titration
4767121|NCT02817503|intensive blood pressure control|intensive blood pressure control
4767122|NCT02817503|primary prevention|primary prevention
4767123|NCT02817503|China|china
4767124|NCT02817503|H-type Hypertension|h-type hypertension
4767125|NCT02817490|hypermobility|hypermobility
4767126|NCT02817490|Ehlers-Danlos Syndrome|ehlers-danlos syndrome
4767127|NCT02817490|patient education program|patient education program
4767128|NCT02817477|Intranasal Ketamine, Analgesia, Trauma, Morphine, Mass Casualty|intranasal ketamine, analgesia, trauma, morphine, mass casualty
4767129|NCT02817451|Diphtheria|diphtheria
4767130|NCT02817451|Tetanus|tetanus
4767131|NCT02817451|Pertussis|pertussis
4767132|NCT02817451|Hepatitis B|hepatitis b
4767133|NCT02817451|DTaP IPV HB PRP-T Combined Vaccine|dtap ipv hb prp-t combined vaccine
4767134|NCT02817451|Human Immunodeficiency Virus|human immunodeficiency virus
4767135|NCT02817425|S-1|s-1
4767136|NCT02817425|Adjuvant Chemotherapy|adjuvant chemotherapy
4767137|NCT02817425|TEGAFOX|tegafox
4767138|NCT02817412|binge eating|binge eating
4767139|NCT02817412|obesity|obesity
4767140|NCT02817412|overeating|overeating
4767141|NCT02817399|anterior cruciate ligament reconstruction|anterior cruciate ligament reconstruction
4767142|NCT02817399|Functional Electrical stimulation|functional electrical stimulation
4767143|NCT02817399|Gait analysis|gait analysis
4767144|NCT02817399|Physical therapy|physical therapy
4767145|NCT02817386|postoperative delirium|postoperative delirium
4767146|NCT02817386|microRNA|microrna
4767147|NCT02817373|IVF|ivf
4767148|NCT02817373|embryo transfer|embryo transfer
4767149|NCT02817373|ultrasound|ultrasound
4767150|NCT02817373|implantation|implantation
4767151|NCT02817334|Near-infrared fluorescence|near-infrared fluorescence
4767152|NCT02817334|Indocyanine green, ICG|indocyanine green, icg
4767153|NCT02817334|breast cancer|breast cancer
4767154|NCT02817308|Antigen, CA-19-9|antigen, ca-19-9
4767155|NCT02817308|Salivas|salivas
4767156|NCT02817308|body fluids|body fluids
4767157|NCT02817269|Shoulder pain|shoulder pain
4767158|NCT02817269|Trigger points|trigger points
4767159|NCT02817269|Referred pain|referred pain
4767160|NCT02817269|Visual analogue scale|visual analogue scale
4767161|NCT02817191|age-related cataract|age-related cataract
4767162|NCT02817191|Holy-Comod|holy-comod
4767163|NCT02817191|Tears Naturale Forte|tears naturale forte
4767164|NCT02817191|phacoemulsification|phacoemulsification
4767165|NCT02817191|inflammatory mediators|inflammatory mediators
4767166|NCT02817165|Probiotics, diarrhea, antibiotic, children, hospital|probiotics, diarrhea, antibiotic, children, hospital
4767167|NCT02817152|periodontal treatment|periodontal treatment
4767168|NCT02817152|low-level light therapy|low-level light therapy
4767169|NCT02817126|Minimally Invasive Surgical Procedures|minimally invasive surgical procedures
4767170|NCT02817126|Robotic Surgical Procedures|robotic surgical procedures
4767171|NCT02817126|Laparoscopic Surgical Procedures|laparoscopic surgical procedures
4767172|NCT02817126|Rectal Cancer|rectal cancer
4767173|NCT02817126|Intraoperative Complications|intraoperative complications
4767174|NCT02817126|Postoperative Complications|postoperative complications
4767175|NCT02817126|Recovery of Function|recovery of function
4767176|NCT02817126|Recurrence|recurrence
4767177|NCT02817126|Disease Progression|disease progression
4767178|NCT02817126|Survival|survival
4767179|NCT02817087|Stroke|stroke
4767180|NCT02817061|no keywords for disease type and/or category|no keywords for disease type and/or category
4767181|NCT02817035|interstitial lung disease|interstitial lung disease
4767182|NCT02817035|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
4767183|NCT02817035|mechanical ventilation|mechanical ventilation
4767184|NCT02817035|expiratory delay|expiratory delay
4767185|NCT02817035|neural inspiratory time|neural inspiratory time
4767186|NCT02817022|Developmentally Supportive Care|developmentally supportive care
4767187|NCT02817009|Behavioral Health Intervention|behavioral health intervention
4767188|NCT02817009|Randomized Control Trial|randomized control trial
4767189|NCT02817009|Family Intervention|family intervention
4767190|NCT02817009|Nutrition|nutrition
4767191|NCT02817009|Weight Management|weight management
4767192|NCT02817009|Multidisciplinary Program|multidisciplinary program
4767193|NCT02816944|Endoscopic ultrasonography|endoscopic ultrasonography
4767194|NCT02816944|Laser ablation|laser ablation
4767195|NCT02816931|Treatment|treatment
4767196|NCT02816931|Drug Monitoring|drug monitoring
4767197|NCT02816931|Minimum Inhibitory Concentration|minimum inhibitory concentration
4767198|NCT02816931|Dried Blood Spot Method|dried blood spot method
4767199|NCT02816931|Pharmacokinetics|pharmacokinetics
4767200|NCT02816931|Pharmacodynamics|pharmacodynamics
4767201|NCT02816905|intraocular pressure|intraocular pressure
4767202|NCT02816905|topical steroids|topical steroids
4767203|NCT02816905|strabismus|strabismus
4767204|NCT02816892|aortic dissection|aortic dissection
4767205|NCT02816892|biomarkers|biomarkers
4767206|NCT02816892|diagnosis|diagnosis
4767207|NCT02816866|childhood cancer|childhood cancer
4767208|NCT02816866|survivorship care|survivorship care
4767209|NCT02816866|health services|health services
4767210|NCT02816866|barriers|barriers
4767211|NCT02816840|prostate cancer|prostate cancer
4767212|NCT02816840|radiotherapy|radiotherapy
4767213|NCT02816840|PET-CT/MRI|pet-ct/mri
4767214|NCT02816814|Menopause|menopause
4767215|NCT02816814|Diet|diet
4767216|NCT02816814|Lipidomic profile|lipidomic profile
4767217|NCT02816814|Vasomotor symptoms|vasomotor symptoms
4767218|NCT02816814|Omega-3 fatty acids|omega-3 fatty acids
4767219|NCT02816788|PTSD|ptsd
4767220|NCT02816788|Equine Assisted Therapy|equine assisted therapy
4767221|NCT02816775|hemodynamics|hemodynamics
4767222|NCT02816775|QT interval|qt interval
4767223|NCT02816762|CPAP|cpap
4767224|NCT02816762|Sleep apnea|sleep apnea
4767225|NCT02816762|Diabetes|diabetes
4767226|NCT02816762|Nephropathy|nephropathy
4767227|NCT02816762|Albuminuria|albuminuria
4767228|NCT02816749|Diabetic Foot|diabetic foot
4767229|NCT02816749|Wound Healing|wound healing
4767230|NCT02816749|Larva|larva
4767231|NCT02816749|Occlusive Dressings|occlusive dressings
4767232|NCT02816736|Heart Failure|heart failure
4767233|NCT02816736|Heart Diseases|heart diseases
4767234|NCT02816736|Cardiovascular Diseases|cardiovascular diseases
4767235|NCT02816736|Valsartan|valsartan
4767236|NCT02816736|Entresto|entresto
4767237|NCT02816723|mindfulness|mindfulness
4767238|NCT02816723|aging|aging
4767239|NCT02816723|Veterans|veterans
4767240|NCT02816697|Smoking Habits|smoking habits
4767241|NCT02816684|phobic disorders|phobic disorders
4767242|NCT02816684|anxiety disorders|anxiety disorders
4767243|NCT02816645|Parkinson's Disease|parkinson's disease
4767244|NCT02816645|Biomarker|biomarker
4767245|NCT02816645|Iron|iron
4767246|NCT02816645|R2*|r2*
4767247|NCT02816645|MRI|mri
4767248|NCT02816645|Patients|patients
4767249|NCT02816645|UK Parkinson's Disease Society Brain Bank|uk parkinson's disease society brain bank
4767250|NCT02816632|functional Magnetic Resonance Imaging|functional magnetic resonance imaging
4767251|NCT02816632|Galvanic Vestibular Stimulation|galvanic vestibular stimulation
4767252|NCT02816632|Feedback Processing|feedback processing
4767253|NCT02816632|Reward, Social, Vestibular System|reward, social, vestibular system
4767254|NCT02816632|Cingulate Cortex|cingulate cortex
4767255|NCT02816632|Decision-making|decision-making
4767256|NCT02816619|Parkinson's disease|parkinson's disease
4767257|NCT02816619|Physical activity|physical activity
4767258|NCT02816619|Physical exercise|physical exercise
4767259|NCT02816606|ACL reconstruction|acl reconstruction
4767260|NCT02816593|carbamide peroxide|carbamide peroxide
4767261|NCT02816593|Hydrogen peroxide|hydrogen peroxide
4767262|NCT02816593|Quality of life|quality of life
4767263|NCT02816554|Japanese Encephalitis|japanese encephalitis
4767264|NCT02816554|JECEVAX|jecevax
4767265|NCT02816554|Vietnam|vietnam
4767266|NCT02816528|Antibiotics|antibiotics
4767267|NCT02816528|Primary care|primary care
4767268|NCT02816528|Stewardship|stewardship
4767269|NCT02816528|General practitioners|general practitioners
4767270|NCT02816515|Non interventional study|non interventional study
4767271|NCT02816515|Ectoin|ectoin
4767272|NCT02816515|Mouth wash|mouth wash
4767273|NCT02816515|Mucositis|mucositis
4767274|NCT02816515|Chemotherapy|chemotherapy
4767275|NCT02816515|Radiotherapy|radiotherapy
4767276|NCT02816502|childhood|childhood
4767277|NCT02816502|adversity|adversity
4767278|NCT02816450|Water|water
4767279|NCT02816450|Children|children
4767280|NCT02816450|Cognition|cognition
4767281|NCT02816450|Hydration|hydration
4767282|NCT02816424|Screening and Brief Intervention|screening and brief intervention
4767283|NCT02816424|Motivational Interviewing|motivational interviewing
4767284|NCT02816424|Teen Pregnancy Prevention|teen pregnancy prevention
4767285|NCT02816385|PV-loops (pressure-volume loops)|pv-loops (pressure-volume loops)
4767286|NCT02816385|Myocardial contractility|myocardial contractility
4767287|NCT02816385|Cardioplegia|cardioplegia
4767288|NCT02816385|Induced|induced
4767289|NCT02816359|Position patient|position patient
4767290|NCT02816359|Esophageal pressure|esophageal pressure
4767291|NCT02816346|shigella|shigella
4767292|NCT02816320|hospital mortality|hospital mortality
4767293|NCT02816320|standardized mortality ratios|standardized mortality ratios
4767294|NCT02816320|patient safety|patient safety
4767295|NCT02816320|healthcare quality|healthcare quality
4767296|NCT02816320|hospital performance|hospital performance
4767297|NCT02816320|administrative data|administrative data
4767298|NCT02816281|Surgical case cancellation|surgical case cancellation
4767299|NCT02816281|Pre-operative assessment clinic|pre-operative assessment clinic
4767300|NCT02816242|Concept Map|concept map
4767301|NCT02816242|critical thinking|critical thinking
4767302|NCT02816242|medical student teaching|medical student teaching
4767303|NCT02816229|Haemoptysis|haemoptysis
4767304|NCT02816229|Aspergillus|aspergillus
4767305|NCT02816229|Endobronchial valve|endobronchial valve
4767306|NCT02816229|Interventional pulmonology|interventional pulmonology
4767307|NCT02816229|Tuberculosis|tuberculosis
4767308|NCT02816138|Geriatrics|geriatrics
4767309|NCT02816138|Depression|depression
4767310|NCT02816138|Elderly|elderly
4767311|NCT02816138|Cognition|cognition
4767312|NCT02816138|Memory|memory
4767313|NCT02816125|breast cancer|breast cancer
4767314|NCT02816125|fatty acids|fatty acids
4767315|NCT02816125|omega-3|omega-3
4767316|NCT02816060|pain measurement|pain measurement
4767317|NCT02816047|wearable cardioverter defibrillator|wearable cardioverter defibrillator
4767318|NCT02816047|LifeVest|lifevest
4767319|NCT02816047|sudden death|sudden death
4767320|NCT02816047|defibrillator|defibrillator
4767321|NCT02816034|Learning|learning
4767322|NCT02816034|Cerebellum|cerebellum
4767323|NCT02816021|Melanoma and other malignant neoplasms of skin|melanoma and other malignant neoplasms of skin
4767324|NCT02816021|Metastatic melanoma|metastatic melanoma
4767325|NCT02816021|Advanced melanoma|advanced melanoma
4767326|NCT02816021|Azacitidine|azacitidine
4767327|NCT02816021|5-azacytidine|5-azacytidine
4767328|NCT02816021|5-aza|5-aza
4767329|NCT02816021|Vidaza|vidaza
4767330|NCT02816021|5-AZC|5-azc
4767331|NCT02816021|Ladakamycin|ladakamycin
4767332|NCT02816021|NSC-102816|nsc-102816
4767333|NCT02816021|Azacytidine|azacytidine
4767334|NCT02816021|Pembrolizumab|pembrolizumab
4767335|NCT02816021|Keytruda|keytruda
4767336|NCT02816021|MK-3475|mk-3475
4767337|NCT02816021|SCH-900475|sch-900475
4767338|NCT02816008|cognitive rehabilitation|cognitive rehabilitation
4767339|NCT02816008|memory|memory
4767340|NCT02816008|attention|attention
4767341|NCT02816008|spatial neglect|spatial neglect
4767342|NCT02816008|executive dysfunctioning|executive dysfunctioning
4767343|NCT02815995|Malignant neoplasms of bone and articular cartilage|malignant neoplasms of bone and articular cartilage
4767344|NCT02815995|Multiple sarcoma subtypes|multiple sarcoma subtypes
4767345|NCT02815995|Advanced and/or metastatic sarcoma|advanced and/or metastatic sarcoma
4767346|NCT02815995|Adipocytic tumors|adipocytic tumors
4767347|NCT02815995|Vascular tumors|vascular tumors
4767348|NCT02815995|Leiomyosarcoma|leiomyosarcoma
4767349|NCT02815995|Angiosarcoma|angiosarcoma
4767350|NCT02815995|Epithelioid hemangioendothelioma|epithelioid hemangioendothelioma
4767351|NCT02815995|Undifferentiated pleomorphic sarcoma|undifferentiated pleomorphic sarcoma
4767352|NCT02815995|Synovial sarcoma|synovial sarcoma
4767353|NCT02815995|Osteosarcoma|osteosarcoma
4767354|NCT02815995|Other sarcoma histologies|other sarcoma histologies
4767355|NCT02815995|Durvalumab|durvalumab
4767356|NCT02815995|Tremelimumab|tremelimumab
4767357|NCT02815969|neuroendocrine tumors|neuroendocrine tumors
4767358|NCT02815969|indol profile|indol profile
4767359|NCT02815969|catecholamines|catecholamines
4767360|NCT02815969|LC-MS/MS|lc-ms/ms
4767361|NCT02815956|percutaneous tibial nerve stimulation|percutaneous tibial nerve stimulation
4767362|NCT02815956|randomized|randomized
4767363|NCT02815956|controlled study|controlled study
4767364|NCT02815930|High cost user (HCU)|high cost user (hcu)
4767365|NCT02815930|Healthcare utilization|healthcare utilization
4767366|NCT02815930|Healthcare expenditures|healthcare expenditures
4767367|NCT02815930|Medication use|medication use
4767368|NCT02815930|Medication expenditures|medication expenditures
4767369|NCT02815930|Multimorbidity|multimorbidity
4767370|NCT02815930|Observational study|observational study
4767371|NCT02815904|Neonates|neonates
4767372|NCT02815904|physical therapy|physical therapy
4767373|NCT02815904|neonatal intensive care units|neonatal intensive care units
4767374|NCT02815904|yakson touch|yakson touch
4767375|NCT02815904|kinesthetic stimulation|kinesthetic stimulation
4767376|NCT02815865|Primiparous|primiparous
4767377|NCT02815865|Foley catheter|foley catheter
4767378|NCT02815865|Dinoprostone|dinoprostone
4767379|NCT02815865|Induction|induction
4767380|NCT02815852|breast cancer in women under 40 years old|breast cancer in women under 40 years old
4767381|NCT02815852|biopsy|biopsy
4767382|NCT02815852|ultrasonography|ultrasonography
4767383|NCT02815852|Magnetic Resonance Imaging|magnetic resonance imaging
4767384|NCT02815839|urate transporter 1|urate transporter 1
4767385|NCT02815839|SHR4640|shr4640
4767386|NCT02815839|single ascending dose|single ascending dose
4767387|NCT02815839|pharmacokinetics|pharmacokinetics
4767388|NCT02815839|pharmacodynamics|pharmacodynamics
4767389|NCT02815813|Serious Mental Illness|serious mental illness
4767390|NCT02815813|Young Adults|young adults
4767391|NCT02815813|Obesity|obesity
4767392|NCT02815813|Cardiometabolic Risk|cardiometabolic risk
4767393|NCT02815813|Physical Activity|physical activity
4767394|NCT02815813|Weight Loss|weight loss
4767395|NCT02815813|Fitness|fitness
4767396|NCT02815813|Peer Support|peer support
4767397|NCT02815813|Smartphone|smartphone
4767398|NCT02815813|Mobile Technology|mobile technology
4767399|NCT02815813|mHealth|mhealth
4767400|NCT02815813|Social Media|social media
4767401|NCT02815813|Facebook|facebook
4767402|NCT02815813|Lifestyle Intervention|lifestyle intervention
4767403|NCT02815800|Treatment|treatment
4767404|NCT02815800|Motor signs|motor signs
4767405|NCT02815800|Non motor signs|non motor signs
4767406|NCT02815800|Fluctuations|fluctuations
4767407|NCT02815800|Open labelled|open labelled
4767408|NCT02815787|SP2086|sp2086
4767409|NCT02815787|Glyburide|glyburide
4767410|NCT02815787|drug-drug interaction|drug-drug interaction
4767411|NCT02815774|SP2086|sp2086
4767412|NCT02815774|Renal Insufficiency|renal insufficiency
4767413|NCT02815774|Pharmacokinetic|pharmacokinetic
4767414|NCT02815748|SP2086|sp2086
4767415|NCT02815748|Metabolite identification|metabolite identification
4767416|NCT02815748|Material balance|material balance
4767417|NCT02815722|SP2086|sp2086
4767418|NCT02815722|Simvastatin|simvastatin
4767419|NCT02815722|drug-drug interaction|drug-drug interaction
4767420|NCT02815696|MRI T2 weighted|mri t2 weighted
4767421|NCT02815696|intervertebral disc|intervertebral disc
4767422|NCT02815696|glycosaminoglycans|glycosaminoglycans
4767423|NCT02815683|Bronchoscopy|bronchoscopy
4767424|NCT02815683|Emphysema|emphysema
4767425|NCT02815657|SP2086|sp2086
4767426|NCT02815657|Valsartan|valsartan
4767427|NCT02815657|Drug-drug Interaction|drug-drug interaction
4767428|NCT02815631|fractional flow reserve|fractional flow reserve
4767429|NCT02815631|cardiogoniometry|cardiogoniometry
4767430|NCT02815618|Time-resolved spectroscopy|time-resolved spectroscopy
4767431|NCT02815618|Diffuse correlation spectroscopy|diffuse correlation spectroscopy
4767432|NCT02815618|Neonatology|neonatology
4767433|NCT02815579|HIV|hiv
4767434|NCT02815579|Food insecurity|food insecurity
4767435|NCT02815579|Microcredit loan|microcredit loan
4767436|NCT02815579|Agriculture|agriculture
4767437|NCT02815579|Livelihoods|livelihoods
4767438|NCT02815566|kidney, antiretroviral agent, tenofovir, osteoporosis, women|kidney, antiretroviral agent, tenofovir, osteoporosis, women
4767439|NCT02815527|enteral nutrition|enteral nutrition
4767440|NCT02815527|intensive care unit|intensive care unit
4767441|NCT02815527|whey|whey
4767442|NCT02815527|protein|protein
4767443|NCT02815527|muscle mass|muscle mass
4767444|NCT02815527|leucin|leucin
4767445|NCT02815527|energy expenditure|energy expenditure
4767446|NCT02815514|aortic valve stenosis|aortic valve stenosis
4767447|NCT02815514|aortic valve insufficiency|aortic valve insufficiency
4767448|NCT02815514|transapical aortic valve implantation|transapical aortic valve implantation
4767449|NCT02815514|aortic valve replacement|aortic valve replacement
4767450|NCT02815514|percutaneous aortic valve replacement|percutaneous aortic valve replacement
4767451|NCT02815514|aortic valve valvuloplasty|aortic valve valvuloplasty
4767452|NCT02815501|Thyroid dysfunction|thyroid dysfunction
4767453|NCT02815501|obstetric complications|obstetric complications
4767454|NCT02815462|Frequent hospital admissions|frequent hospital admissions
4767455|NCT02815462|Risk stratification|risk stratification
4767456|NCT02815462|Readmissions|readmissions
4767457|NCT02815449|Iron fortification|iron fortification
4767458|NCT02815449|Bioavailability|bioavailability
4767459|NCT02815449|Nigeria|nigeria
4767460|NCT02815449|Women|women
4767461|NCT02815449|Bouillon cubes|bouillon cubes
4767462|NCT02815410|Glioblastoma Multiforme|glioblastoma multiforme
4767463|NCT02815410|Levetiracetam|levetiracetam
4767464|NCT02815410|Temozolomide|temozolomide
4767465|NCT02815410|Survival outcome|survival outcome
4767466|NCT02815397|Double Hit DLBCL|double hit dlbcl
4767467|NCT02815319|Dexamethasone|dexamethasone
4767468|NCT02815319|Chemotherapy|chemotherapy
4767469|NCT02815306|Congenital idiopathic clubfoot|congenital idiopathic clubfoot
4767470|NCT02815306|Pirani score|pirani score
4767471|NCT02815306|infant|infant
4767472|NCT02815306|polyaxial brace|polyaxial brace
4767473|NCT02815293|EDE|ede
4767474|NCT02815293|evaporative dry eye|evaporative dry eye
4767475|NCT02815280|acne|acne
4767476|NCT02815267|acne|acne
4767477|NCT02815254|Physiotherapy|physiotherapy
4767478|NCT02815254|hip fracture|hip fracture
4767479|NCT02815254|rehabilitation|rehabilitation
4767480|NCT02815254|high dose exercise|high dose exercise
4767481|NCT02815254|low dose exercise|low dose exercise
4767482|NCT02815215|congenital clubfoot|congenital clubfoot
4767483|NCT02815189|pain|pain
4767484|NCT02815176|Plasminogen activator inhibitor-1|plasminogen activator inhibitor-1
4767485|NCT02815176|Wide angle fluorescein angiography|wide angle fluorescein angiography
4767486|NCT02815176|Choroid|choroid
4767487|NCT02815137|Digital PCR|digital pcr
4767488|NCT02815137|classical|classical
4767489|NCT02815137|Hodgkin Lymphoma|hodgkin lymphoma
4767490|NCT02815137|mutation|mutation
4767491|NCT02815085|heart failure|heart failure
4767492|NCT02815085|mHealth|mhealth
4767493|NCT02815072|Fontan palliation|fontan palliation
4767494|NCT02815072|Marfan's syndrome|marfan's syndrome
4767495|NCT02815046|urgency urinary incontinence|urgency urinary incontinence
4767496|NCT02815046|stress urinary incontinence|stress urinary incontinence
4767497|NCT02815046|Botulinum toxin A|botulinum toxin a
4767498|NCT02815046|Bulkamid|bulkamid
4767499|NCT02815033|Hormono-Sensitive prostate cancer|hormono-sensitive prostate cancer
4767500|NCT02815033|Enzalutamide|enzalutamide
4767501|NCT02815033|Imaging|imaging
4767502|NCT02815033|PET/CT|pet/ct
4767503|NCT02815033|Whole body MRI|whole body mri
4767504|NCT02815033|Circulating tumour cells|circulating tumour cells
4767505|NCT02815033|Cell-free tumour DNA|cell-free tumour dna
4767506|NCT02815020|Primary care|primary care
4767507|NCT02815020|Self-management support|self-management support
4767508|NCT02815020|Care coordination|care coordination
4767509|NCT02815020|Practice-based research network|practice-based research network
4767510|NCT02814994|Mechanical Ventilation|mechanical ventilation
4767511|NCT02814994|ARDS|ards
4767512|NCT02814994|Ventilator Strategy|ventilator strategy
4767513|NCT02814994|Outcome|outcome
4767514|NCT02814981|hydroxyzine|hydroxyzine
4767515|NCT02814981|Long QT|long qt
4767516|NCT02814968|Castration-resistant prostate cancer|castration-resistant prostate cancer
4767517|NCT02814968|Enzalutamide|enzalutamide
4767518|NCT02814968|Imaging|imaging
4767519|NCT02814968|PET/CT|pet/ct
4767520|NCT02814968|Whole body MRI|whole body mri
4767521|NCT02814968|Circulating tumour cells|circulating tumour cells
4767522|NCT02814968|Cell-free tumour DNA|cell-free tumour dna
4767523|NCT02814955|atrial fibrillation|atrial fibrillation
4767524|NCT02814955|pulmonary veins|pulmonary veins
4767525|NCT02814955|oral anticoagulant|oral anticoagulant
4767526|NCT02814955|electrophysiology|electrophysiology
4767527|NCT02814955|anticoagulant drugs|anticoagulant drugs
4767528|NCT02814929|ROP|rop
4767529|NCT02814929|Risk factors|risk factors
4767530|NCT02814929|Incidence|incidence
4767531|NCT02814929|Turkey|turkey
4767532|NCT02814916|Acute Bacterial Skin and Skin Structure Infection (ABSSSI)|acute bacterial skin and skin structure infection (absssi)
4767533|NCT02814903|aldosterone|aldosterone
4767534|NCT02814903|cardiac surgery|cardiac surgery
4767535|NCT02814903|atrial fibrillation|atrial fibrillation
4767536|NCT02814903|galectin-3|galectin-3
4767537|NCT02814903|mitochondria|mitochondria
4767538|NCT02814903|ngal|ngal
4767539|NCT02814903|acute kidney failure|acute kidney failure
4767540|NCT02814903|epicardial fat|epicardial fat
4767541|NCT02814903|right atrial sample|right atrial sample
4767542|NCT02814890|Thoracic paravertebral block|thoracic paravertebral block
4767543|NCT02814890|Dexmedetomidine|dexmedetomidine
4767544|NCT02814890|Video-assisted Pneumonectomy|video-assisted pneumonectomy
4767545|NCT02814890|Ropivacaine|ropivacaine
4767546|NCT02814890|Pain, Postoperative|pain, postoperative
4767547|NCT02814877|Antibiotic stewardship|antibiotic stewardship
4767548|NCT02814877|cost-effectiveness evaluation|cost-effectiveness evaluation
4767549|NCT02814877|Antibiotic use|antibiotic use
4767550|NCT02814864|Hematology|hematology
4767551|NCT02814864|Mesenchymal Stromal Cell|mesenchymal stromal cell
4767552|NCT02814864|radiotherapy|radiotherapy
4767553|NCT02814864|gastro-intestinal complications|gastro-intestinal complications
4767554|NCT02814864|lower digestive tract cancers|lower digestive tract cancers
4767555|NCT02814864|colitis|colitis
4767556|NCT02814864|bleeding|bleeding
4767557|NCT02814864|diarrhea|diarrhea
4767558|NCT02814864|pelvic radiation disease|pelvic radiation disease
4767559|NCT02814851|Left atrium appendage (LAA) occlusion|left atrium appendage (laa) occlusion
4767560|NCT02814851|Transesophageal echocardiography|transesophageal echocardiography
4767561|NCT02814851|Cardiac output hemodynamic measurement|cardiac output hemodynamic measurement
4767562|NCT02814851|Leycom Pressure/Volume Combination Catheter|leycom pressure/volume combination catheter
4767563|NCT02814838|Diabetes mellitus Type 1|diabetes mellitus type 1
4767564|NCT02814838|Beta cells function|beta cells function
4767565|NCT02814825|ViviGen|vivigen
4767566|NCT02814825|ACDF|acdf
4767567|NCT02814825|Cervical|cervical
4767568|NCT02814760|acute ischemic stroke|acute ischemic stroke
4767569|NCT02814760|stepped-wedge|stepped-wedge
4767570|NCT02814760|interactive training|interactive training
4767571|NCT02814760|implementation|implementation
4767572|NCT02814760|emergency department|emergency department
4767573|NCT02814734|Intra-Abdominal Hypertension|intra-abdominal hypertension
4767574|NCT02814734|Abdominal Compartment Syndrome|abdominal compartment syndrome
4767575|NCT02814734|Round Belly Sign|round belly sign
4767576|NCT02814734|Radiology|radiology
4767577|NCT02814734|CT findings|ct findings
4767578|NCT02814734|Intensive Care|intensive care
4767579|NCT02814708|Sepsis|sepsis
4767580|NCT02814708|Vaccination|vaccination
4767581|NCT02814695|Male infertility|male infertility
4767582|NCT02814695|oxidative stress|oxidative stress
4767583|NCT02814695|antioxidants|antioxidants
4767584|NCT02814695|probiotics|probiotics
4767585|NCT02814695|Vitamin E|vitamin e
4767586|NCT02814695|Baker's Yeast|baker's yeast
4767587|NCT02814682|palliative care|palliative care
4767588|NCT02814682|quality|quality
4767589|NCT02814682|indicator|indicator
4767590|NCT02814682|multi-dimensional|multi-dimensional
4767591|NCT02814656|muscarinic receptor antagonist and β2 adrenoceptor agonist [MABA]|muscarinic receptor antagonist and β2 adrenoceptor agonist [maba]
4767592|NCT02814656|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
4767593|NCT02814656|Asthma (in combination with an inhaled corticosteroid [ICS]|asthma (in combination with an inhaled corticosteroid [ics]
4767594|NCT02814656|alpha-lactose monohydrate|alpha-lactose monohydrate
4767595|NCT02814656|dry powder inhaler|dry powder inhaler
4767596|NCT02814656|long-acting β2-agonist (LABA)|long-acting β2-agonist (laba)
4767597|NCT02814656|long-acting muscarinic antagonist (LAMA)|long-acting muscarinic antagonist (lama)
4767598|NCT02814656|fixed-dose combination (FDC)|fixed-dose combination (fdc)
4767599|NCT02814643|Male and female adolescent patients|male and female adolescent patients
4767600|NCT02814643|severe asthma|severe asthma
4767601|NCT02814604|Front-of-Pack Labelling|front-of-pack labelling
4767602|NCT02814604|Star rating system|star rating system
4767603|NCT02814604|Traffic light rating system|traffic light rating system
4767604|NCT02814604|Consumer Behavior|consumer behavior
4767605|NCT02814604|Health Literacy|health literacy
4767606|NCT02814604|Mobile Apps|mobile apps
4767607|NCT02814604|Nutrition Labeling|nutrition labeling
4767608|NCT02814604|Healthy food choices|healthy food choices
4767609|NCT02814578|OCT|oct
4767610|NCT02814578|IVUS|ivus
4767611|NCT02814578|BVS|bvs
4767612|NCT02814565|Drug therapy|drug therapy
4767613|NCT02814526|exercise|exercise
4767614|NCT02814513|Children|children
4767615|NCT02814513|Adolescents|adolescents
4767616|NCT02814487|DAM|dam
4767617|NCT02814487|multiple sclerosis|multiple sclerosis
4767618|NCT02814487|MSFC|msfc
4767619|NCT02814487|application|application
4767620|NCT02814487|smartphone|smartphone
4767621|NCT02814474|PET/CT|pet/ct
4767622|NCT02814474|Heart failure|heart failure
4767623|NCT02814474|hydroxybutyrate|hydroxybutyrate
4767624|NCT02814435|Retina|retina
4767625|NCT02814435|Retinal Degeneration|retinal degeneration
4767626|NCT02814435|Quality of Life Measures|quality of life measures
4767627|NCT02814422|Triglyceride-rich lipoprotein|triglyceride-rich lipoprotein
4767628|NCT02814422|dementia|dementia
4767629|NCT02814422|Alzheimer's disease|alzheimer's disease
4767630|NCT02814422|mild cognition impairment|mild cognition impairment
4767631|NCT02814422|amyloid-beta|amyloid-beta
4767632|NCT02814396|Ventricular|ventricular
4767633|NCT02814396|CVD|cvd
4767634|NCT02814396|Ventricular arrhythmias|ventricular arrhythmias
4767635|NCT02814383|Prematurity|prematurity
4767636|NCT02814383|Extremely Low Birth Weight (ELBW)|extremely low birth weight (elbw)
4767637|NCT02814383|Cerebral Perfusion|cerebral perfusion
4767638|NCT02814383|Cerebral Autoregulation|cerebral autoregulation
4767639|NCT02814357|Blood glucose, serum insulin|blood glucose, serum insulin
4767640|NCT02814344|labour|labour
4767641|NCT02814331|Video-EEG|video-eeg
4767642|NCT02814331|near-infrared spectroscopy (NIRS)|near-infrared spectroscopy (nirs)
4767643|NCT02814318|Vancomycin|vancomycin
4767644|NCT02814318|Penicillin|penicillin
4767645|NCT02814318|Clindamycin|clindamycin
4767646|NCT02814318|Group B streptococcal infection|group b streptococcal infection
4767647|NCT02814318|Rectovaginal GBS colonization|rectovaginal gbs colonization
4767648|NCT02814318|Vaginal GBS colonization|vaginal gbs colonization
4767649|NCT02814318|Intrapartum|intrapartum
4767650|NCT02814318|Prophylaxis|prophylaxis
4767651|NCT02814227|obstructive sleep apnea screening device|obstructive sleep apnea screening device
4767652|NCT02814201|Motor slowing|motor slowing
4767653|NCT02814201|Computerized mental chronometry paradigm|computerized mental chronometry paradigm
4767654|NCT02814188|Exercise|exercise
4767655|NCT02814175|Psoriatic Arthritis|psoriatic arthritis
4767656|NCT02814162|Subarachnoid Hemorrhage, Aneurysmal|subarachnoid hemorrhage, aneurysmal
4767657|NCT02814162|Predictive|predictive
4767658|NCT02814162|Adiponectin|adiponectin
4767659|NCT02814149|delayed implant|delayed implant
4767660|NCT02814149|esthetics|esthetics
4767661|NCT02814149|immediate implant|immediate implant
4767662|NCT02814149|bone augmentation|bone augmentation
4767663|NCT02814123|Diabetes Mellitus, Type 1|diabetes mellitus, type 1
4767664|NCT02814123|Pramlintide|pramlintide
4767665|NCT02814123|Artificial Pancreas|artificial pancreas
4767666|NCT02814123|Closed-Loop System|closed-loop system
4767667|NCT02814123|Insulin|insulin
4767668|NCT02814110|Granulocyte colony-stimulating factor|granulocyte colony-stimulating factor
4767669|NCT02814110|muscular dystrophy|muscular dystrophy
4767670|NCT02814110|muscle strength|muscle strength
4767671|NCT02814110|children|children
4767672|NCT02814110|adolescents|adolescents
4767673|NCT02814097|Heart Failure|heart failure
4767674|NCT02814097|HFpEF|hfpef
4767675|NCT02814097|elamipretide|elamipretide
4767676|NCT02814097|MTP-131|mtp-131
4767677|NCT02814097|Bendavia™|bendavia™
4767678|NCT02814071|Early Feeding|early feeding
4767679|NCT02814071|Acute Pancreatitis|acute pancreatitis
4767680|NCT02814071|Pediatric|pediatric
4767681|NCT02814058|pharmacokinetics|pharmacokinetics
4767682|NCT02814058|Healthy Volunteers|healthy volunteers
4767683|NCT02814045|biomarkers, sleep fragmentation, intermittent hypoxia|biomarkers, sleep fragmentation, intermittent hypoxia
4767684|NCT02814032|proteomic|proteomic
4767685|NCT02814032|cervical lymph node metastasis|cervical lymph node metastasis
4767686|NCT02814019|respiratory function in DMD|respiratory function in dmd
4767687|NCT02814006|marital relationship|marital relationship
4767688|NCT02813993|infertility|infertility
4767689|NCT02813993|fertility awareness|fertility awareness
4767690|NCT02813993|preconceptional care|preconceptional care
4767691|NCT02813993|health interventions|health interventions
4767692|NCT02813993|couples|couples
4767693|NCT02813980|SUDEP|sudep
4767694|NCT02813980|Sudden cardiac death|sudden cardiac death
4767695|NCT02813980|Sudden unexpected death in epilepsy|sudden unexpected death in epilepsy
4767696|NCT02813980|Sleep|sleep
4767697|NCT02813980|Polysomnography|polysomnography
4767698|NCT02813980|Autonomic|autonomic
4767699|NCT02813980|Cardiovascular|cardiovascular
4767700|NCT02813941|Randomized controlled trial|randomized controlled trial
4767701|NCT02813941|Systematic review|systematic review
4767702|NCT02813941|Summary of finding tables|summary of finding tables
4767703|NCT02813941|GRADE|grade
4767704|NCT02813941|AHRQ|ahrq
4767705|NCT02813928|ColoRectal Cancer|colorectal cancer
4767706|NCT02813928|Cancerology|cancerology
4767707|NCT02813928|Translational Research|translational research
4767708|NCT02813928|ccfDNA|ccfdna
4767709|NCT02813915|cardiac monitoring, Cheetah Medical, passive leg raises|cardiac monitoring, cheetah medical, passive leg raises
4767710|NCT02813889|infant|infant
4767711|NCT02813889|baby|baby
4767712|NCT02813889|developmental delay|developmental delay
4767713|NCT02813889|robotics|robotics
4767714|NCT02813889|cerebral palsy|cerebral palsy
4767715|NCT02813850|sickle cell disease|sickle cell disease
4767716|NCT02813850|oxygen therapy|oxygen therapy
4767717|NCT02813850|pregnancy|pregnancy
4767718|NCT02813850|pregnancy in sickle cell disease|pregnancy in sickle cell disease
4767719|NCT02813837|relapsed|relapsed
4767720|NCT02813837|refractory|refractory
4767721|NCT02813837|CD19+|cd19+
4767722|NCT02813837|leukemia|leukemia
4767723|NCT02813837|lymphoma|lymphoma
4767724|NCT02813811|Temperature-controlled Laminar Airflow|temperature-controlled laminar airflow
4767725|NCT02813811|Exacerbation frequency|exacerbation frequency
4767726|NCT02813798|Renal Insufficiency|renal insufficiency
4767727|NCT02813772|infants|infants
4767728|NCT02813772|colic|colic
4767729|NCT02813759|GLYCEMIA|glycemia
4767730|NCT02813759|SATIETY|satiety
4767731|NCT02813759|C PEPTIDE|c peptide
4767732|NCT02813759|PRELOAD|preload
4767733|NCT02813759|INSULIN|insulin
4767734|NCT02813746|Obesity|obesity
4767735|NCT02813746|Tobacco|tobacco
4767736|NCT02813746|Epigenetic|epigenetic
4767737|NCT02813746|Transcriptomic|transcriptomic
4767738|NCT02813746|microRNAs|micrornas
4767739|NCT02813746|miRNAs|mirnas
4767740|NCT02813733|thyroid surgery|thyroid surgery
4767741|NCT02813733|surgical outcomes|surgical outcomes
4767742|NCT02813733|patient safety|patient safety
4767743|NCT02813733|healthcare quality|healthcare quality
4767744|NCT02813733|surgeons performance|surgeons performance
4767745|NCT02813720|Erosions|erosions
4767746|NCT02813720|Onycholysis|onycholysis
4767747|NCT02813720|HR-pQCT|hr-pqct
4767748|NCT02813720|Psoriatic arthritis|psoriatic arthritis
4767749|NCT02813707|Vitamins|vitamins
4767750|NCT02813707|Mineral|mineral
4767751|NCT02813707|Surgery|surgery
4767752|NCT02813694|Pneumonia|pneumonia
4767753|NCT02813694|CABP|cabp
4767754|NCT02813694|CAP|cap
4767755|NCT02813694|Community acquired bacterial pneumonia|community acquired bacterial pneumonia
4767756|NCT02813681|Acute Pain|acute pain
4767757|NCT02813681|ultrasonography|ultrasonography
4767758|NCT02813668|Nutrition|nutrition
4767759|NCT02813668|Occupational Health|occupational health
4767760|NCT02813655|tetracosactide|tetracosactide
4767761|NCT02813655|Synacthène®|synacthène®
4767762|NCT02813655|cosyntropin|cosyntropin
4767763|NCT02813655|post-dural syndrom|post-dural syndrom
4767764|NCT02813655|post-dural puncture headache|post-dural puncture headache
4767765|NCT02813642|chronic kidney disease starting dialysis|chronic kidney disease starting dialysis
4767766|NCT02813642|cardiovascular risk|cardiovascular risk
4767767|NCT02813642|bone mineral metabolism markers|bone mineral metabolism markers
4767768|NCT02813629|transcranial Direct Current Stimulation|transcranial direct current stimulation
4767769|NCT02813629|Peripheral Electrical Stimulation|peripheral electrical stimulation
4767770|NCT02813629|Sickle Cell Disease|sickle cell disease
4767771|NCT02813629|Transcutaneous Electrical Nerve Stimulation|transcutaneous electrical nerve stimulation
4767772|NCT02813629|quantitative Electroencephalography|quantitative electroencephalography
4767773|NCT02813603|EBUS-TBNA|ebus-tbna
4767774|NCT02813603|staging|staging
4767775|NCT02813603|lymph node metastases|lymph node metastases
4767776|NCT02813577|Legs|legs
4767777|NCT02813577|Drug Coated Angioplasty Balloon|drug coated angioplasty balloon
4767778|NCT02813577|Experimental|experimental
4767779|NCT02813577|Standard Angioplasty Balloon|standard angioplasty balloon
4767780|NCT02813564|Autism|autism
4767781|NCT02813564|Cognitive Training|cognitive training
4767782|NCT02813564|Brain|brain
4767783|NCT02813564|fMRI|fmri
4767784|NCT02813551|Preeclampsia, puerperium|preeclampsia, puerperium
4767785|NCT02813538|Thrombelastography|thrombelastography
4767786|NCT02813538|Antithrombin proteins|antithrombin proteins
4767787|NCT02813538|Liver surgery|liver surgery
4767788|NCT02813538|Liver function tests|liver function tests
4767789|NCT02813525|Aortic Isthmus|aortic isthmus
4767790|NCT02813525|Isthmic Systolic Index|isthmic systolic index
4767791|NCT02813525|feasibility|feasibility
4767792|NCT02813525|reproducibility|reproducibility
4767793|NCT02813525|mortality|mortality
4767794|NCT02813525|delivery|delivery
4767795|NCT02813499|Acute Coronary Syndrome|acute coronary syndrome
4767796|NCT02813473|SYNTAX Score II|syntax score ii
4767797|NCT02813473|Multi Slice Computed Tomography|multi slice computed tomography
4767798|NCT02813473|MSCT|msct
4767799|NCT02813473|Heart Team|heart team
4767800|NCT02813473|Fractional Flow Reserve Computed Tomography|fractional flow reserve computed tomography
4767801|NCT02813473|FFR|ffr
4767802|NCT02813473|FFR MSCT|ffr msct
4767803|NCT02813473|PCI|pci
4767804|NCT02813473|CABG|cabg
4767805|NCT02813473|Percutaneous Coronary Intervention|percutaneous coronary intervention
4767806|NCT02813473|Coronary Artery Bypass Graft|coronary artery bypass graft
4767807|NCT02813434|Cerebral amyloid imaging|cerebral amyloid imaging
4767808|NCT02813434|Florbetapir|florbetapir
4767809|NCT02813434|18F-AV-45|18f-av-45
4767810|NCT02813434|poststroke|poststroke
4767811|NCT02813421|CGM|cgm
4767812|NCT02813382|bupivacaine|bupivacaine
4767813|NCT02813382|prilocaine|prilocaine
4767814|NCT02813382|2-chloroprocaine|2-chloroprocaine
4767815|NCT02813330|Women|women
4767816|NCT02813330|severe|severe
4767817|NCT02813330|low back ache|low back ache
4767818|NCT02813330|labor|labor
4767819|NCT02813317|Surgery|surgery
4767820|NCT02813317|Breast cancer|breast cancer
4767821|NCT02813317|Quality of life|quality of life
4767822|NCT02813317|Care pathway|care pathway
4767823|NCT02813317|Economic evaluation|economic evaluation
4767824|NCT02813304|Acute|acute
4767825|NCT02813304|rotator cuff tendinopathy|rotator cuff tendinopathy
4767826|NCT02813304|exercise|exercise
4767827|NCT02813304|loading|loading
4767828|NCT02813304|ice|ice
4767829|NCT02813304|cryotherapy|cryotherapy
4767830|NCT02813304|randomised control trial|randomised control trial
4767831|NCT02813291|Motor imagery|motor imagery
4768037|NCT02812108|flow diversion|flow diversion
4767832|NCT02813291|transcranial direct current stimulation|transcranial direct current stimulation
4767833|NCT02813291|motor learning|motor learning
4767834|NCT02813291|aging|aging
4767835|NCT02813265|Ocular Discomfort|ocular discomfort
4767836|NCT02813265|Pain|pain
4767837|NCT02813265|Corticosteroid|corticosteroid
4767838|NCT02813265|Hyperemia|hyperemia
4767839|NCT02813265|Dry Eye|dry eye
4767840|NCT02813252|long-term follow-up|long-term follow-up
4767841|NCT02813252|chimeric antigen receptor (CAR) T cells|chimeric antigen receptor (car) t cells
4767842|NCT02813252|JCAR015|jcar015
4767843|NCT02813239|IVF|ivf
4767844|NCT02813239|Dual trigger|dual trigger
4767845|NCT02813239|GnRH agonist|gnrh agonist
4767846|NCT02813239|hCG|hcg
4767847|NCT02813239|mature oocytes|mature oocytes
4767848|NCT02813226|castration-resistant|castration-resistant
4767849|NCT02813226|molecular imaging|molecular imaging
4767850|NCT02813226|abiraterone acetate|abiraterone acetate
4767851|NCT02813226|enzalutamide|enzalutamide
4767852|NCT02813226|metabolic response|metabolic response
4767853|NCT02813213|skin transplantation|skin transplantation
4767854|NCT02813213|grafting skin|grafting skin
4767855|NCT02813200|COPD, inhaler device, handling|copd, inhaler device, handling
4767856|NCT02813187|venous leg ulcer|venous leg ulcer
4767857|NCT02813187|venous|venous
4767858|NCT02813187|QCDR|qcdr
4767859|NCT02813187|quality measure|quality measure
4767860|NCT02813187|wound|wound
4767861|NCT02813187|Outcome|outcome
4767862|NCT02813187|Lymphedema|lymphedema
4767863|NCT02813161|diabetic foot ulcer|diabetic foot ulcer
4767864|NCT02813161|diabetes|diabetes
4767865|NCT02813161|arterial disease|arterial disease
4767866|NCT02813161|neuropathy|neuropathy
4767867|NCT02813161|amputation|amputation
4767868|NCT02813161|QCDR|qcdr
4767869|NCT02813161|quality measure|quality measure
4767870|NCT02813161|wound|wound
4767871|NCT02813096|HCC|hcc
4767872|NCT02813096|PVTT|pvtt
4767873|NCT02813096|Folofox4|folofox4
4767874|NCT02813096|Early Recurrence|early recurrence
4767875|NCT02813044|anesthesia|anesthesia
4767876|NCT02813044|intravenous|intravenous
4767877|NCT02813044|neurosurgery|neurosurgery
4767878|NCT02813044|pituitary neoplasm|pituitary neoplasm
4767879|NCT02813044|postoperative period|postoperative period
4767880|NCT02813031|functional meat products|functional meat products
4767881|NCT02813031|hypocaloric fats|hypocaloric fats
4767882|NCT02813031|diglyceride|diglyceride
4767884|NCT02813018|child|child
4767885|NCT02813018|analgesia|analgesia
4767886|NCT02813018|epidural|epidural
4767887|NCT02813018|pain|pain
4767888|NCT02813018|postoperative|postoperative
4767889|NCT02813018|orthopedics|orthopedics
4767890|NCT02813005|High frequency jet ventilation|high frequency jet ventilation
4767891|NCT02812966|peripheral arterial disease|peripheral arterial disease
4767892|NCT02812966|drug coated balloon|drug coated balloon
4767893|NCT02812927|Glycemic lability index|glycemic lability index
4767894|NCT02812927|Continuous glucose monitoring system|continuous glucose monitoring system
4767895|NCT02812927|intensive care|intensive care
4767896|NCT02812927|Insulin|insulin
4767897|NCT02812888|Hyperthyroidism|hyperthyroidism
4767898|NCT02812888|Betatrophin|betatrophin
4767899|NCT02812836|anorectal manometry|anorectal manometry
4767900|NCT02812836|children|children
4767901|NCT02812836|constipation|constipation
4767902|NCT02812823|manometry|manometry
4767903|NCT02812823|children|children
4767904|NCT02812823|constipation|constipation
4767905|NCT02812823|functional disorders|functional disorders
4767906|NCT02812797|Adipokines|adipokines
4767907|NCT02812797|Chronic Heart Failure|chronic heart failure
4767908|NCT02812797|Prognosis|prognosis
4767909|NCT02812784|Nephrocheck™|nephrocheck™
4767910|NCT02812784|acute kidney injury|acute kidney injury
4767911|NCT02812758|sedation depth|sedation depth
4767912|NCT02812758|indices of preload dependence|indices of preload dependence
4767913|NCT02812745|anaesthesia|anaesthesia
4767914|NCT02812732|HPV vaccination|hpv vaccination
4767915|NCT02812732|provider education|provider education
4767916|NCT02812667|Metastatic|metastatic
4767917|NCT02812667|NSCLC|nsclc
4767918|NCT02812667|nivolumab|nivolumab
4767919|NCT02812667|plinabulin|plinabulin
4767920|NCT02812667|BPI-2358|bpi-2358
4767921|NCT02812667|opdivo|opdivo
4767922|NCT02812667|Non-Small Cell Lung Cancer|non-small cell lung cancer
4767923|NCT02812667|cancer|cancer
4767924|NCT02812654|Sarcoma|sarcoma
4767925|NCT02812654|soft tissue sarcoma|soft tissue sarcoma
4767926|NCT02812654|neoadjuvant chemotherapy|neoadjuvant chemotherapy
4767927|NCT02812654|neoadjuvant radiotherapy|neoadjuvant radiotherapy
4767928|NCT02812654|hypofractionated radiotherapy|hypofractionated radiotherapy
4767929|NCT02812641|Concurrent chemoradiation|concurrent chemoradiation
4767930|NCT02812641|Esophageal squamous cell carcinoma|esophageal squamous cell carcinoma
4767931|NCT02812641|Vascular endothelial growth factor|vascular endothelial growth factor
4767932|NCT02812628|laparoscopic surgery|laparoscopic surgery
4767933|NCT02812628|abdominoperineal resection|abdominoperineal resection
4767934|NCT02812628|rectal cancer|rectal cancer
4767935|NCT02812628|individualized surgery|individualized surgery
4767936|NCT02812628|levator muscle|levator muscle
4767937|NCT02812615|Environmental Enteric Dysfunction|environmental enteric dysfunction
4767938|NCT02812602|Total Knee Replacement|total knee replacement
4767939|NCT02812602|Stitch|stitch
4767940|NCT02812602|Removal|removal
4767941|NCT02812602|Pain|pain
4767942|NCT02812589|MRI|mri
4767943|NCT02812576|Group B streptococcus|group b streptococcus
4767944|NCT02812576|Infants|infants
4767945|NCT02812576|China|china
4767946|NCT02812550|full-spectrum endoscopy|full-spectrum endoscopy
4767947|NCT02812550|polyp detection rate|polyp detection rate
4767948|NCT02812550|colorectal cancer|colorectal cancer
4767949|NCT02812550|colorectal screening|colorectal screening
4767950|NCT02812550|adenoma detection rate|adenoma detection rate
4767951|NCT02812550|endoscopic innovations|endoscopic innovations
4767952|NCT02812537|Trajectories|trajectories
4767953|NCT02812537|emergency room|emergency room
4767954|NCT02812537|conduct disorder|conduct disorder
4767955|NCT02812537|care management|care management
4767956|NCT02812524|Immunotherapy|immunotherapy
4767957|NCT02812524|Yervoy|yervoy
4767958|NCT02812524|Head and neck cancer|head and neck cancer
4767959|NCT02812524|Pre-operative|pre-operative
4767960|NCT02812498|teleconsultation|teleconsultation
4767961|NCT02812498|insulin therapy|insulin therapy
4767962|NCT02812498|HbA1c|hba1c
4767963|NCT02812459|Electrical Stimulation Therapy|electrical stimulation therapy
4767964|NCT02812459|Kinesio taping|kinesio taping
4767965|NCT02812459|Exercise|exercise
4767966|NCT02812446|biofilm|biofilm
4767967|NCT02812446|staphylokinase|staphylokinase
4767968|NCT02812446|Staphylococcus aureus|staphylococcus aureus
4767969|NCT02812446|microarrays|microarrays
4767970|NCT02812446|bone binding sialoprotein|bone binding sialoprotein
4767971|NCT02812446|bone and joint infection|bone and joint infection
4767972|NCT02812446|blood group|blood group
4767973|NCT02812433|birth asphyxia|birth asphyxia
4767974|NCT02812433|brain|brain
4767975|NCT02812433|hypoxic-ischemic encephalopathy|hypoxic-ischemic encephalopathy
4767976|NCT02812433|neonate|neonate
4767977|NCT02812433|neuroprotection|neuroprotection
4767978|NCT02812433|neurorestoration|neurorestoration
4767979|NCT02812433|newborn|newborn
4767980|NCT02812433|sildenafil|sildenafil
4767981|NCT02812420|Malignant neoplasms of urinary tract|malignant neoplasms of urinary tract
4767982|NCT02812420|Urothelial Carcinoma|urothelial carcinoma
4767983|NCT02812420|Muscle-invasive, high-risk bladder cancer|muscle-invasive, high-risk bladder cancer
4767984|NCT02812420|Ineligible for neoadjuvant cisplatin-containing chemotherapies|ineligible for neoadjuvant cisplatin-containing chemotherapies
4767985|NCT02812420|Bladder cancer|bladder cancer
4767986|NCT02812420|Cystectomy|cystectomy
4767987|NCT02812420|Bladder cancer surgery|bladder cancer surgery
4767988|NCT02812420|Durvalumab|durvalumab
4767989|NCT02812420|MEDI4736|medi4736
4767990|NCT02812420|Tremelimumab|tremelimumab
4767991|NCT02812420|Phone calls|phone calls
4767992|NCT02812394|Parkinson's disease|parkinson's disease
4767993|NCT02812394|Episodic motor fluctuations (OFF periods)|episodic motor fluctuations (off periods)
4767994|NCT02812381|Trigger Points, movement|trigger points, movement
4767995|NCT02812355|off-pump|off-pump
4767996|NCT02812355|coronary artery bypass|coronary artery bypass
4767997|NCT02812355|heparinization|heparinization
4767998|NCT02812342|Alopecia|alopecia
4767999|NCT02812316|Myopia|myopia
4768000|NCT02812316|Scleral lens|scleral lens
4768001|NCT02812316|Astigmatism|astigmatism
4768002|NCT02812316|Presbyopia|presbyopia
4768003|NCT02812290|antibody mediated rejection, T cell mediated rejection|antibody mediated rejection, t cell mediated rejection
4768004|NCT02812277|anastrozole|anastrozole
4768005|NCT02812277|letrozole|letrozole
4768006|NCT02812277|postmenopausal patients|postmenopausal patients
4768007|NCT02812238|Inflammasome|inflammasome
4768008|NCT02812238|Sirt3|sirt3
4768009|NCT02812238|Nicotinamide Riboside|nicotinamide riboside
4768010|NCT02812238|Fasting|fasting
4768011|NCT02812212|ureteropelvic junction obstruction|ureteropelvic junction obstruction
4768012|NCT02812212|cortical transit time|cortical transit time
4768013|NCT02812186|Neuromuscular blockade|neuromuscular blockade
4768014|NCT02812173|urinary drainage|urinary drainage
4768015|NCT02812173|urethral catheter|urethral catheter
4768016|NCT02812173|suprapubic tube|suprapubic tube
4768017|NCT02812173|pain|pain
4768018|NCT02812173|discomfort|discomfort
4768019|NCT02812173|radical prostatectomy|radical prostatectomy
4768020|NCT02812173|robotic surgery|robotic surgery
4768021|NCT02812173|urinary infection|urinary infection
4768022|NCT02812147|L-dihydoxyphenylserine|l-dihydoxyphenylserine
4768023|NCT02812147|L-DOPS|l-dops
4768024|NCT02812147|Northera|northera
4768025|NCT02812134|phosphorus supplementation|phosphorus supplementation
4768026|NCT02812134|FGF23|fgf23
4768027|NCT02812134|anorexic|anorexic
4768028|NCT02812134|adolescents|adolescents
4768029|NCT02812134|undernutrition|undernutrition
4768030|NCT02812108|intracranial aneurysm|intracranial aneurysm
4768031|NCT02812108|endovascular treatment|endovascular treatment
4768032|NCT02812108|recanalization|recanalization
4768033|NCT02812108|outcome|outcome
4768034|NCT02812108|hemodynamics|hemodynamics
4768035|NCT02812108|computational fluid dynamic|computational fluid dynamic
4768036|NCT02812108|stent|stent
4768038|NCT02812082|Web-based|web-based
4768039|NCT02812082|patient education application|patient education application
4768040|NCT02812082|16-769|16-769
4768041|NCT02812056|Malignant neoplasms of digestive organs|malignant neoplasms of digestive organs
4768042|NCT02812056|Malignant neoplasms of female genital organs|malignant neoplasms of female genital organs
4768043|NCT02812056|Malignant neoplasms of lip oral cavity and pharynx|malignant neoplasms of lip oral cavity and pharynx
4768044|NCT02812056|Malignant neoplasms of male genital organs|malignant neoplasms of male genital organs
4768045|NCT02812056|Human papilloma virus associated malignancies|human papilloma virus associated malignancies
4768046|NCT02812056|HPV|hpv
4768047|NCT02812056|Alisertib|alisertib
4768048|NCT02812056|MLN8237|mln8237
4768049|NCT02812056|TAK-228|tak-228
4768050|NCT02812056|MLN0128|mln0128
4768051|NCT02812043|onychomycosis|onychomycosis
4768052|NCT02812043|amorolfine|amorolfine
4768053|NCT02812043|long-pulsed Nd:YAG|long-pulsed nd:yag
4768054|NCT02812043|fungal infection|fungal infection
4768055|NCT02812030|Observational Study|observational study
4768056|NCT02812030|aflibercept|aflibercept
4768057|NCT02812030|Diabetic Retinopathy|diabetic retinopathy
4768058|NCT02812030|Visual Acuity|visual acuity
4768059|NCT02812017|educational intervention|educational intervention
4768060|NCT02812017|language development|language development
4768061|NCT02812017|postpartum|postpartum
4768062|NCT02812017|parental attachment|parental attachment
4768063|NCT02812017|achievement gap|achievement gap
4768064|NCT02812017|language gap|language gap
4768065|NCT02812017|school readiness|school readiness
4768066|NCT02812004|Vitreous Floaters|vitreous floaters
4768067|NCT02812004|Mouches Voulantes|mouches voulantes
4768068|NCT02811991|paracetamol|paracetamol
4768069|NCT02811991|post-operative analgesia|post-operative analgesia
4768070|NCT02811965|heel|heel
4768071|NCT02811965|pressure ulcer|pressure ulcer
4768072|NCT02811965|pressure mapping|pressure mapping
4768073|NCT02811952|bladder cancer|bladder cancer
4768074|NCT02811939|Cannabis|cannabis
4768075|NCT02811939|Marijuana|marijuana
4768076|NCT02811939|THC|thc
4768077|NCT02811939|Dronabinol|dronabinol
4768078|NCT02811939|Pregnenolone|pregnenolone
4768079|NCT02811939|PREG|preg
4768080|NCT02811939|Psychotic Disorders|psychotic disorders
4768081|NCT02811926|parastomal bulging|parastomal bulging
4768082|NCT02811926|peristomal bulging|peristomal bulging
4768083|NCT02811926|ileostomy|ileostomy
4768084|NCT02811926|colostomy|colostomy
4768085|NCT02811926|enterostomy|enterostomy
4768086|NCT02811926|incidence|incidence
4768087|NCT02811926|risk factor|risk factor
4768088|NCT02811913|sensory impairment|sensory impairment
4768089|NCT02811913|sensory deficit|sensory deficit
4768090|NCT02811913|upper limb|upper limb
4768091|NCT02811913|transcranial magnetic stimulation|transcranial magnetic stimulation
4768092|NCT02811913|brain stimulation|brain stimulation
4768093|NCT02811913|rehabilitation|rehabilitation
4768094|NCT02811900|obesity surgery|obesity surgery
4768095|NCT02811900|Roux en Y gastric bypass|roux en y gastric bypass
4768096|NCT02811900|sleeve gastrectomy|sleeve gastrectomy
4768097|NCT02811900|excess weight loss|excess weight loss
4768098|NCT02811900|quality of life|quality of life
4768099|NCT02811874|diabetes education|diabetes education
4768100|NCT02811874|community health workers|community health workers
4768101|NCT02811874|diabetes control|diabetes control
4768102|NCT02811861|Renal Cell Carcinoma (RCC)|renal cell carcinoma (rcc)
4768103|NCT02811861|Lenvatinib|lenvatinib
4768104|NCT02811861|First-line RCC|first-line rcc
4768105|NCT02811861|Treatment-naive RCC|treatment-naive rcc
4768106|NCT02811861|Everolimus|everolimus
4768107|NCT02811861|Pembrolizumab|pembrolizumab
4768108|NCT02811861|Sunitinib|sunitinib
4768109|NCT02811861|Phase 3 RCC|phase 3 rcc
4768110|NCT02811861|Phase 3 first-line RCC|phase 3 first-line rcc
4768111|NCT02811861|Phase 3 treatment-naive RCC|phase 3 treatment-naive rcc
4768112|NCT02811822|GMI-1271|gmi-1271
4768113|NCT02811822|bortezomib|bortezomib
4768114|NCT02811822|carfilzomib|carfilzomib
4768115|NCT02811822|multiple myeloma|multiple myeloma
4768116|NCT02811809|Prostate cancer|prostate cancer
4768117|NCT02811809|Apalutamide|apalutamide
4768118|NCT02811809|IHT|iht
4768119|NCT02811809|BCR|bcr
4768120|NCT02811809|Biochemical recurrence|biochemical recurrence
4768121|NCT02811809|intermittent hormone therapy|intermittent hormone therapy
4768122|NCT02811796|drug eluting stents|drug eluting stents
4768123|NCT02811796|flow fractional reserve|flow fractional reserve
4768124|NCT02811796|prognosis|prognosis
4768125|NCT02811796|angio-based FFR|angio-based ffr
4768126|NCT02811783|Pruritus|pruritus
4768127|NCT02811783|Mycosis Fungoides|mycosis fungoides
4768128|NCT02811783|CTCL|ctcl
4768129|NCT02811783|naloxone|naloxone
4768130|NCT02811783|opiate antagonist|opiate antagonist
4768131|NCT02811783|Sézary Syndrome|sézary syndrome
4768132|NCT02811718|Stress Management|stress management
4768133|NCT02811718|Resiliency|resiliency
4768134|NCT02811718|Skype|skype
4768135|NCT02811692|Database|database
4768136|NCT02811692|Diabetic Macular Edema (DME)|diabetic macular edema (dme)
4768137|NCT02811692|Wet Age-related Macular Degeneration (wAMD)|wet age-related macular degeneration (wamd)
4768138|NCT02811692|Retinal Diseases|retinal diseases
4768139|NCT02811692|Optic Nerve Diseases|optic nerve diseases
4768140|NCT02811692|Corneal Diseases|corneal diseases
4768141|NCT02811692|Vision Disorders|vision disorders
4768142|NCT02811679|Lymphoma|lymphoma
4768143|NCT02811653|Motor slowing|motor slowing
4768144|NCT02811640|Intra-Abdominal Pressure|intra-abdominal pressure
4768145|NCT02811640|Stryker Pressure Monitor|stryker pressure monitor
4768146|NCT02811627|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
4768147|NCT02811627|Memantine|memantine
4768148|NCT02811627|Treatment prediction biomarker|treatment prediction biomarker
4768149|NCT02811614|intracerebral hemorrhage,hypertensive|intracerebral hemorrhage,hypertensive
4768150|NCT02811614|minimally invasive surgery|minimally invasive surgery
4768151|NCT02811614|neuroendoscopic surgery|neuroendoscopic surgery
4768152|NCT02811614|stereotactic aspiration|stereotactic aspiration
4768153|NCT02811601|Minimally Invasive Surgical Procedures|minimally invasive surgical procedures
4768154|NCT02811575|Coloscopy|coloscopy
4768155|NCT02811549|Cochlear Implant|cochlear implant
4768156|NCT02811549|HiRes™ 90K Advantage Implant|hires™ 90k advantage implant
4768157|NCT02811549|HiFocus™ Mid-Scala electrode|hifocus™ mid-scala electrode
4768158|NCT02811549|HiFocus™ 1J electrode|hifocus™ 1j electrode
4768159|NCT02811549|HiFocus Helix™ electrode|hifocus helix™ electrode
4768160|NCT02811549|Cochlear Implantation|cochlear implantation
4768161|NCT02811549|Listening Benefits|listening benefits
4768162|NCT02811549|Adults|adults
4768163|NCT02811549|Cochlear Implant Benefit|cochlear implant benefit
4768164|NCT02811549|Electrical Stimulation|electrical stimulation
4768165|NCT02811549|HiRes™ Ultra Implant with HiFocus™ Mid‐Scala electrode|hires™ ultra implant with hifocus™ mid‐scala electrode
4768166|NCT02811484|Obesity|obesity
4768167|NCT02811458|Panic Disorder|panic disorder
4768168|NCT02811458|Agoraphobia|agoraphobia
4768169|NCT02811458|Social Anxiety Disorder|social anxiety disorder
4768170|NCT02811458|Generalized Anxiety Disorder|generalized anxiety disorder
4768171|NCT02811458|Cognitive-Behavioral Therapy|cognitive-behavioral therapy
4768172|NCT02811445|microbiome, metabolome, aging, lean mass, physical function|microbiome, metabolome, aging, lean mass, physical function
4768173|NCT02811432|Kangaroo mother care|kangaroo mother care
4768174|NCT02811432|Neonates|neonates
4768175|NCT02811432|Low birth weight|low birth weight
4768176|NCT02811432|Unstable|unstable
4768177|NCT02811393|Bariatric surgery, sarcopenia|bariatric surgery, sarcopenia
4768178|NCT02811380|CVC|cvc
4768179|NCT02811380|Healthcare associated infections (HAI)|healthcare associated infections (hai)
4768180|NCT02811380|CLABSI|clabsi
4768181|NCT02811380|Noble metal alloy coating|noble metal alloy coating
4768182|NCT02811380|CVC related thrombosis|cvc related thrombosis
4768183|NCT02811341|Scopolamine butylbromide PCLE|scopolamine butylbromide pcle
4768184|NCT02811276|High-protein diet|high-protein diet
4768185|NCT02811276|Energy metabolism|energy metabolism
4768186|NCT02811276|Substrate oxidation|substrate oxidation
4768187|NCT02811250|Renal cancer|renal cancer
4768188|NCT02811250|Stereotactic radiotherapy|stereotactic radiotherapy
4768189|NCT02811185|PET|pet
4768190|NCT02811185|CT|ct
4768191|NCT02811185|PET/CT|pet/ct
4768192|NCT02811172|Biological multi-paradigm model|biological multi-paradigm model
4768193|NCT02811172|Biomarkers|biomarkers
4768194|NCT02811172|Triglycerides|triglycerides
4768195|NCT02811172|Cholesterol|cholesterol
4768196|NCT02811172|Prolactin|prolactin
4768197|NCT02811172|Glucose|glucose
4768198|NCT02811146|Heart Failure|heart failure
4768199|NCT02811146|Noninvasive Ventilation|noninvasive ventilation
4768200|NCT02811146|Positive- Pressure Respiration|positive- pressure respiration
4768201|NCT02811133|inositol|inositol
4768202|NCT02811120|meningococcal|meningococcal
4768203|NCT02811120|conjugate|conjugate
4768204|NCT02811120|vaccine|vaccine
4768205|NCT02811120|quadrivalent|quadrivalent
4768206|NCT02811120|meningococcal quadrivalent conjugate vaccine|meningococcal quadrivalent conjugate vaccine
4768207|NCT02811107|anxiety|anxiety
4768208|NCT02811107|pain|pain
4768209|NCT02811107|preoperative area|preoperative area
4768210|NCT02811107|premedication|premedication
4768211|NCT02811068|HPV|hpv
4768212|NCT02811068|vaccine|vaccine
4768213|NCT02811068|Human Papillomavirus Virus Vaccine|human papillomavirus virus vaccine
4768214|NCT02811029|neurological|neurological
4768215|NCT02811029|difficulties|difficulties
4768216|NCT02811016|High Altitude|high altitude
4768217|NCT02811016|budesonide|budesonide
4768218|NCT02811016|hypoxia|hypoxia
4768219|NCT02811003|Insertional Achilles|insertional achilles
4768220|NCT02810990|bosutinib|bosutinib
4768221|NCT02810990|chronic myeloid leukemia|chronic myeloid leukemia
4768222|NCT02810977|gastric volume|gastric volume
4768223|NCT02810977|gastric content|gastric content
4768224|NCT02810977|ultrasound|ultrasound
4768225|NCT02810977|perioperative fasting|perioperative fasting
4768226|NCT02810964|Schizophrenia|schizophrenia
4768227|NCT02810964|Schizoaffective Disorder|schizoaffective disorder
4768228|NCT02810964|Sulforaphane|sulforaphane
4768229|NCT02810964|Sulforaphane supplement|sulforaphane supplement
4768230|NCT02810951|RDEB|rdeb
4768231|NCT02810938|Ablation|ablation
4768232|NCT02810938|Mifi technology|mifi technology
4768233|NCT02810938|maximum voltage-guided ablation|maximum voltage-guided ablation
4768234|NCT02810899|child|child
4768235|NCT02810899|craniotomy|craniotomy
4768236|NCT02810899|intelligence tests|intelligence tests
4768237|NCT02810899|dexmedetomidine|dexmedetomidine
4768238|NCT02810899|Disruption|disruption
4768239|NCT02810899|Dehiscence|dehiscence
4768240|NCT02810899|Mild Cognitive Disorder|mild cognitive disorder
4768241|NCT02810886|Prostate Cancer|prostate cancer
4768242|NCT02810860|laparoscopic cholecystectomy|laparoscopic cholecystectomy
4768243|NCT02810847|Amblyopia|amblyopia
4768244|NCT02810847|strabismus|strabismus
4768245|NCT02810847|virtual reality|virtual reality
4768246|NCT02810847|computer games|computer games
4768247|NCT02810834|Executive Function|executive function
4768248|NCT02810834|Academic Performance|academic performance
4768249|NCT02810821|Gonadal hormones|gonadal hormones
4768250|NCT02810821|Gonadotropins|gonadotropins
4768251|NCT02810821|Cardiovascular diseases|cardiovascular diseases
4768252|NCT02810821|Lipids|lipids
4768253|NCT02810821|Obesity|obesity
4768254|NCT02810821|Atherosclerosis|atherosclerosis
4768255|NCT02810821|Glucose metabolism disorders|glucose metabolism disorders
4768256|NCT02810821|Metabolic syndrome|metabolic syndrome
4768257|NCT02810821|Non-alcoholic fatty liver disease|non-alcoholic fatty liver disease
4768258|NCT02810808|Neovascular Age-related Macular Degeneration|neovascular age-related macular degeneration
4768259|NCT02810808|Ranibizumab|ranibizumab
4768260|NCT02810808|Pro Re Nata|pro re nata
4768261|NCT02810795|Coronary|coronary
4768262|NCT02810795|Artery|artery
4768263|NCT02810795|Computed tomography|computed tomography
4768264|NCT02810795|FFR|ffr
4768265|NCT02810795|CT myocardial perfusion|ct myocardial perfusion
4768266|NCT02810795|Dynamic|dynamic
4768267|NCT02810782|opiate dependence|opiate dependence
4768268|NCT02810782|withdrawal|withdrawal
4768269|NCT02810782|newborn|newborn
4768270|NCT02810730|pancreas|pancreas
4768271|NCT02810730|adenocarcinoma|adenocarcinoma
4768272|NCT02810704|Anticoagulant|anticoagulant
4768273|NCT02810704|Venous Thromboembolism|venous thromboembolism
4768274|NCT02810704|Pulmonary Embolism|pulmonary embolism
4768275|NCT02810704|Total Knee Arthroplasty|total knee arthroplasty
4768276|NCT02810704|Total Hip Arthroplasty|total hip arthroplasty
4768277|NCT02810691|Diabetes|diabetes
4768278|NCT02810691|Fiber|fiber
4768279|NCT02810691|Supplementation|supplementation
4768280|NCT02810691|Soluble fiber|soluble fiber
4768281|NCT02810691|Post-prandial blood glucose|post-prandial blood glucose
4768282|NCT02810691|Nutrition|nutrition
4768283|NCT02810678|Tuberculosis|tuberculosis
4768284|NCT02810665|Repeatability|repeatability
4768285|NCT02810665|Concordance|concordance
4768286|NCT02810665|Agreement|agreement
4768287|NCT02810665|ETDRS visual acuity chart|etdrs visual acuity chart
4768288|NCT02810665|numeric|numeric
4768289|NCT02810665|Landolt C|landolt c
4768290|NCT02810665|Roman alphabet|roman alphabet
4768291|NCT02810652|Cancer Surgery Care|cancer surgery care
4768292|NCT02810639|pain|pain
4768293|NCT02810587|Endophthalmitis|endophthalmitis
4768294|NCT02810587|Intravitreous injection|intravitreous injection
4768295|NCT02810587|anti-vascular endothelial growth factor|anti-vascular endothelial growth factor
4768296|NCT02810587|topical antibiotics|topical antibiotics
4768297|NCT02810561|Troponin|troponin
4768298|NCT02810535|Local IgE|local ige
4768299|NCT02810535|Non-allergic rhinitis|non-allergic rhinitis
4768300|NCT02810535|Allergic rhinitis to house dust mite|allergic rhinitis to house dust mite
4768301|NCT02810509|Wafarin|wafarin
4768302|NCT02810509|Cardioembolic (CE) stroke|cardioembolic (ce) stroke
4768303|NCT02810509|ischemic stroke|ischemic stroke
4768304|NCT02810483|Prader-Willi|prader-willi
4768305|NCT02810483|SPW|spw
4768306|NCT02810483|impulsivity|impulsivity
4768307|NCT02810483|eating disorders|eating disorders
4768308|NCT02810483|topiramate|topiramate
4768309|NCT02810457|Cancer|cancer
4768310|NCT02810457|Bevacizumab|bevacizumab
4768311|NCT02810457|Carboplatin|carboplatin
4768312|NCT02810457|Paclitaxel|paclitaxel
4768313|NCT02810418|Immunotoxin|immunotoxin
4768314|NCT02810418|Mesothelin|mesothelin
4768315|NCT02810418|Antibody-based Therapeutics|antibody-based therapeutics
4768316|NCT02810418|Advanced Cancer|advanced cancer
4768317|NCT02810405|Sample|sample
4768318|NCT02810405|Storage|storage
4768319|NCT02810405|Molecular Profiling|molecular profiling
4768320|NCT02810405|Biopsy|biopsy
4768321|NCT02810405|Repository|repository
4768322|NCT02810379|informed consent|informed consent
4768323|NCT02810379|ERCP|ercp
4768324|NCT02810379|video|video
4768325|NCT02810366|Verbal Autopsy|verbal autopsy
4768326|NCT02810366|Physician-coded verbal autopsy|physician-coded verbal autopsy
4768327|NCT02810366|Computer-coded verbal autopsy|computer-coded verbal autopsy
4768328|NCT02810366|InterVA|interva
4768329|NCT02810366|Naive Bayes Classifier (NBC)|naive bayes classifier (nbc)
4768330|NCT02810366|Tariff|tariff
4768331|NCT02810366|InSilicoVA|insilicova
4768332|NCT02810366|Randomised Control Trial|randomised control trial
4768333|NCT02810366|SmartVA|smartva
4768334|NCT02810366|King-Lu|king-lu
4768335|NCT02810327|Alpha-1 antitrypsin deficiency|alpha-1 antitrypsin deficiency
4768336|NCT02810327|AATD|aatd
4768337|NCT02810327|Alpha-1|alpha-1
4768338|NCT02810327|SERPINA1|serpina1
4768339|NCT02810327|MZ|mz
4768340|NCT02810327|Carrier|carrier
4768341|NCT02810327|Heterozygote|heterozygote
4768342|NCT02810327|Smoking|smoking
4768343|NCT02810327|COPD|copd
4768344|NCT02810327|Emphysema|emphysema
4768345|NCT02810327|Sequencing|sequencing
4768346|NCT02810301|gluten|gluten
4768347|NCT02810301|non-celiac|non-celiac
4768348|NCT02810301|gluten sensitivity|gluten sensitivity
4768349|NCT02810288|Airway anatomy|airway anatomy
4768350|NCT02810288|difficult intubation|difficult intubation
4768351|NCT02810288|congenital syndromes|congenital syndromes
4768352|NCT02810262|Lung cancer|lung cancer
4768353|NCT02810262|Bone metastases|bone metastases
4768354|NCT02810262|EGFR|egfr
4768355|NCT02810262|KRAS|kras
4768356|NCT02810262|Bone biomarkers|bone biomarkers
4768357|NCT02810262|Metabolic parameters|metabolic parameters
4768358|NCT02810249|African American YMSM|african american ymsm
4768359|NCT02810249|PrEP|prep
4768360|NCT02810249|HIV Pre-Exposure Prophylaxis|hiv pre-exposure prophylaxis
4768361|NCT02810249|Common Sense Model|common sense model
4768362|NCT02810249|Healthcare|healthcare
4768363|NCT02810249|HIV Prevention|hiv prevention
4768364|NCT02810236|Focal breast pain|focal breast pain
4768365|NCT02810236|Directed Ultrasound|directed ultrasound
4768366|NCT02810236|Reassurance|reassurance
4768367|NCT02810236|Anxiety|anxiety
4768368|NCT02810210|Zika|zika
4768369|NCT02810210|microcephaly|microcephaly
4768370|NCT02810210|congenital abnormalities|congenital abnormalities
4768371|NCT02810210|new-born|new-born
4768372|NCT02810210|infant|infant
4768373|NCT02810184|bone augmentation|bone augmentation
4768374|NCT02810184|long-term bone volume changes|long-term bone volume changes
4768375|NCT02810184|immediate provisional implant|immediate provisional implant
4768376|NCT02810171|anxiety|anxiety
4768377|NCT02810171|social anxiety disorder|social anxiety disorder
4768378|NCT02810171|generalized anxiety disorder|generalized anxiety disorder
4768379|NCT02810171|phobias|phobias
4768380|NCT02810171|fears|fears
4768381|NCT02810171|worry|worry
4768382|NCT02810145|traumatic brain injury|traumatic brain injury
4768383|NCT02810145|cerebral desaturation|cerebral desaturation
4768384|NCT02810145|intensive care|intensive care
4768385|NCT02810145|hemodynamics|hemodynamics
4768386|NCT02810145|Loss|loss
4768387|NCT02810145|Consciousness|consciousness
4768388|NCT02810106|Spect|spect
4768389|NCT02810106|Stress Test|stress test
4768390|NCT02810106|Myocardial Perfusion CT|myocardial perfusion ct
4768391|NCT02810106|CT angiography|ct angiography
4768392|NCT02810093|Breast cancer|breast cancer
4768393|NCT02810093|Text mining|text mining
4768394|NCT02810093|Big Data|big data
4768395|NCT02810093|Machine Learning|machine learning
4768396|NCT02810054|regeneration|regeneration
4768397|NCT02810054|intrabony defects|intrabony defects
4768398|NCT02810054|enamel matrix derivative|enamel matrix derivative
4768399|NCT02810054|MIST|mist
4768400|NCT02810028|Limb girdle muscular dystrophy|limb girdle muscular dystrophy
4768401|NCT02810028|Becker's muscular dystrophy|becker's muscular dystrophy
4768402|NCT02810028|Facioscapulohumeral muscular dystrophy|facioscapulohumeral muscular dystrophy
4768403|NCT02810028|Inclusion-body myositis|inclusion-body myositis
4768404|NCT02810028|Acceptance and Commitment Therapy|acceptance and commitment therapy
4768405|NCT02810028|ACT|act
4768406|NCT02809950|postoperative nausea and vomiting, oral carbohydrate beverage|postoperative nausea and vomiting, oral carbohydrate beverage
4768407|NCT02809937|aged|aged
4768408|NCT02809937|surgical procedures, operative|surgical procedures, operative
4768409|NCT02809937|delirium|delirium
4768410|NCT02809937|dexmedetomidine|dexmedetomidine
4768411|NCT02809937|long-term outcome|long-term outcome
4768412|NCT02809924|endotracheal intubation|endotracheal intubation
4768413|NCT02809924|teaching|teaching
4768414|NCT02809924|just-in-time|just-in-time
4768415|NCT02809898|Biomarkers, Neoplasms|biomarkers, neoplasms
4768416|NCT02809885|Hepatitis E|hepatitis e
4768417|NCT02809885|Pediatric|pediatric
4768418|NCT02809885|Transplantation|transplantation
4768419|NCT02809885|Prevalence|prevalence
4768420|NCT02809820|ACS|acs
4768421|NCT02809820|Beta Blockers|beta blockers
4768422|NCT02809820|platelet aggregation|platelet aggregation
4768423|NCT02809820|light transmission aggregometry|light transmission aggregometry
4768424|NCT02809820|Beta-Adrenergic Blockers|beta-adrenergic blockers
4768425|NCT02809807|Work of Breathing; Hypoxemia; Respiratory Acidosis; Respiratory effort; COPD|work of breathing; hypoxemia; respiratory acidosis; respiratory effort; copd
4768426|NCT02809781|ankylosing spondylitis|ankylosing spondylitis
4768427|NCT02809781|mesenchymal stem cell|mesenchymal stem cell
4768428|NCT02809781|etanercept|etanercept
4768429|NCT02809768|Healthy participants|healthy participants
4768430|NCT02809768|Pharmacokinetic Drug-Drug Interaction|pharmacokinetic drug-drug interaction
4768431|NCT02809768|Avatrombopag|avatrombopag
4768432|NCT02809755|Obesity|obesity
4768433|NCT02809755|laparoscopic gastric banding|laparoscopic gastric banding
4768434|NCT02809755|band revision|band revision
4768435|NCT02809755|laparoscopic gastric banding sleeve gastrectomy|laparoscopic gastric banding sleeve gastrectomy
4768436|NCT02809742|Pregnant|pregnant
4768437|NCT02809742|Labor|labor
4768438|NCT02809742|Epidural|epidural
4768439|NCT02809742|Analgesia|analgesia
4769147|NCT02805465|HBP|hbp
4768440|NCT02809742|Intermittent|intermittent
4768441|NCT02809651|Infrascanner|infrascanner
4768442|NCT02809651|Intracranial hemorrhage|intracranial hemorrhage
4768443|NCT02809625|Dynamic contrast -enhanced MRI|dynamic contrast -enhanced mri
4768444|NCT02809625|brucella spondylitis|brucella spondylitis
4768445|NCT02809599|vertigo|vertigo
4768446|NCT02809599|dizziness|dizziness
4768447|NCT02809586|Alcohol|alcohol
4768448|NCT02809586|Teens|teens
4768449|NCT02809586|Young Adults|young adults
4768450|NCT02809586|Social Media|social media
4768451|NCT02809573|peripheral T-cell lymphoma|peripheral t-cell lymphoma
4768452|NCT02809573|PTCL|ptcl
4768453|NCT02809573|chidamide|chidamide
4768454|NCT02809573|CHOP|chop
4768455|NCT02809573|phase Ib|phase ib
4768456|NCT02809560|Lymphocytes Th2|lymphocytes th2
4768457|NCT02809560|Cav1 channels|cav1 channels
4768458|NCT02809534|Anlotinib|anlotinib
4768459|NCT02809534|AL3818|al3818
4768460|NCT02809508|Omega-3|omega-3
4768461|NCT02809508|Child nutrition|child nutrition
4768462|NCT02809508|Dietary recommendations|dietary recommendations
4768463|NCT02809508|Cardiovascular risk markers|cardiovascular risk markers
4768464|NCT02809508|Cognitive function|cognitive function
4768465|NCT02809508|Mental health|mental health
4768466|NCT02809482|Volunteers|volunteers
4768467|NCT02809443|Zika|zika
4768468|NCT02809443|Vaccine|vaccine
4768469|NCT02809443|DNA|dna
4768470|NCT02809391|Postural Balance|postural balance
4768471|NCT02809391|Gait|gait
4768472|NCT02809391|Foot Orthotic|foot orthotic
4768473|NCT02809391|Proprioception|proprioception
4768474|NCT02809391|Somatosensory|somatosensory
4768475|NCT02809365|insulin treated|insulin treated
4768476|NCT02809339|Chemotherapy|chemotherapy
4768477|NCT02809339|ovarian cancer|ovarian cancer
4768478|NCT02809339|Patient reported outcome|patient reported outcome
4768479|NCT02809339|Quality of Care|quality of care
4768480|NCT02809326|efficiency|efficiency
4768481|NCT02809326|exposure therapy|exposure therapy
4768482|NCT02809326|PTSD|ptsd
4768483|NCT02809326|combat|combat
4768484|NCT02809326|veterans|veterans
4768485|NCT02809313|gingivitis|gingivitis
4768486|NCT02809313|probiotic|probiotic
4768487|NCT02809313|non- surgical treatment|non- surgical treatment
4768488|NCT02809274|iron deficiency|iron deficiency
4768489|NCT02809274|polycythemia vera|polycythemia vera
4768490|NCT02809261|Carpal Tunnel Syndrome|carpal tunnel syndrome
4768491|NCT02809261|Perineural injection|perineural injection
4768492|NCT02809261|Dextrose|dextrose
4768493|NCT02809248|LTX Study|ltx study
4768494|NCT02809235|asthma|asthma
4768495|NCT02809235|smooth muscle|smooth muscle
4768496|NCT02809235|lauric acid|lauric acid
4768497|NCT02809235|dietary supplement|dietary supplement
4768498|NCT02809222|Myelodysplastic syndrome|myelodysplastic syndrome
4768499|NCT02809222|Ascorbic acid|ascorbic acid
4768500|NCT02809222|Oxidative stress|oxidative stress
4768501|NCT02809222|Preleukemia|preleukemia
4768502|NCT02809196|Food Habits|food habits
4768503|NCT02809196|Adolescents|adolescents
4768504|NCT02809196|Digital Communication|digital communication
4768505|NCT02809183|metabolic acidosis|metabolic acidosis
4768506|NCT02809183|serum bicarbonate|serum bicarbonate
4768507|NCT02809183|kidney disease|kidney disease
4768508|NCT02809131|CIED infection|cied infection
4768509|NCT02809118|Deafness|deafness
4768510|NCT02809118|Hearing Loss|hearing loss
4768511|NCT02809118|Hearing Loss, Sensorineural|hearing loss, sensorineural
4768512|NCT02809118|Ear Diseases|ear diseases
4768513|NCT02809118|Hearing Disorders|hearing disorders
4768514|NCT02809118|Nervous System Diseases|nervous system diseases
4768515|NCT02809118|Neurologic Manifestations|neurologic manifestations
4768516|NCT02809118|Otorhinolaryngologic Diseases|otorhinolaryngologic diseases
4768517|NCT02809118|Sensation Disorders|sensation disorders
4768518|NCT02809118|Signs and Symptoms|signs and symptoms
4768519|NCT02809118|Hearing and Speech Impairment|hearing and speech impairment
4768520|NCT02809118|Hearing Loss, Unilateral|hearing loss, unilateral
4768521|NCT02809105|Chronic constipation|chronic constipation
4768522|NCT02809105|Linaclotide|linaclotide
4768523|NCT02809105|ASP0456|asp0456
4768524|NCT02809092|Acute Myeloid Leukemia, Natural Killer Cells|acute myeloid leukemia, natural killer cells
4768525|NCT02809066|premenstrual syndrome|premenstrual syndrome
4768526|NCT02809066|calcium|calcium
4768527|NCT02809066|quality of life|quality of life
4768528|NCT02809053|low tumor burden follicular lymphoma (LTBFL)|low tumor burden follicular lymphoma (ltbfl)
4768529|NCT02809014|Fluoride|fluoride
4768530|NCT02809014|Dental caries|dental caries
4768531|NCT02809014|Dentifrice|dentifrice
4768532|NCT02809001|Fat grafting|fat grafting
4768533|NCT02809001|Expansion-related complications|expansion-related complications
4768534|NCT02808988|Bisphosphonate|bisphosphonate
4768535|NCT02808988|osteoporosis|osteoporosis
4768536|NCT02808988|RANKL|rankl
4768537|NCT02808988|OPG|opg
4768538|NCT02808988|periodontitis|periodontitis
4768539|NCT02808975|Hidradenitis Suppurativa|hidradenitis suppurativa
4768540|NCT02808975|axilla|axilla
4768541|NCT02808975|inguinal region|inguinal region
4768542|NCT02808975|Hurley Stage I, II, or III|hurley stage i, ii, or iii
4768543|NCT02808975|adalimumab|adalimumab
4768544|NCT02808975|secondary intention|secondary intention
4768545|NCT02808975|abcess and inflammatory nodule (AN) count|abcess and inflammatory nodule (an) count
4768546|NCT02808949|Prevention|prevention
4768547|NCT02808949|Lactating Women|lactating women
4768548|NCT02808949|Healthy|healthy
4768549|NCT02808936|remote ischemic conditioning|remote ischemic conditioning
4768550|NCT02808936|orthopedic surgery|orthopedic surgery
4768551|NCT02808936|ischemic heart disease|ischemic heart disease
4768552|NCT02808910|behavior|behavior
4768553|NCT02808910|food intake|food intake
4768554|NCT02808910|salt|salt
4768555|NCT02808910|vegetables|vegetables
4768556|NCT02808910|portion size|portion size
4768557|NCT02808910|weight loss|weight loss
4768558|NCT02808910|habits|habits
4768559|NCT02808897|Chest tubes|chest tubes
4768560|NCT02808897|Atrial fibrillation|atrial fibrillation
4768561|NCT02808897|Thoracic surgery|thoracic surgery
4768562|NCT02808897|Critical care|critical care
4768563|NCT02808871|TRAIL1|trail1
4768564|NCT02808871|TRAIL|trail
4768565|NCT02808871|Pirfenidone|pirfenidone
4768566|NCT02808858|MDS|mds
4768567|NCT02808858|Myelodisplastic Syndrome|myelodisplastic syndrome
4768568|NCT02808845|coronary angiography|coronary angiography
4768569|NCT02808845|contrast-induced acute kidney injury|contrast-induced acute kidney injury
4768570|NCT02808845|microalbuminuria|microalbuminuria
4768571|NCT02808832|Human papillomavirus (HPV) vaccine|human papillomavirus (hpv) vaccine
4768572|NCT02808832|Cervical cancer screening|cervical cancer screening
4768573|NCT02808832|Provider intervention|provider intervention
4768574|NCT02808819|Asthma|asthma
4768575|NCT02808819|Bronchial Diseases|bronchial diseases
4768576|NCT02808819|Respiratory Tract Diseases|respiratory tract diseases
4768577|NCT02808819|Lung Diseases|lung diseases
4768578|NCT02808819|Obstructive Lung Diseases|obstructive lung diseases
4768579|NCT02808806|stroke|stroke
4768580|NCT02808806|cerebral infarction|cerebral infarction
4768581|NCT02808806|brain infarction|brain infarction
4768582|NCT02808806|ischemic stroke|ischemic stroke
4768583|NCT02808806|treatment|treatment
4768584|NCT02808806|intravenous thrombolysis|intravenous thrombolysis
4768585|NCT02808806|intraarterial thrombectomy|intraarterial thrombectomy
4768586|NCT02808806|delay|delay
4768587|NCT02808806|total system delay|total system delay
4768588|NCT02808806|pre-hospital delay|pre-hospital delay
4768589|NCT02808806|in-hospital delay|in-hospital delay
4768590|NCT02808806|feedback|feedback
4768591|NCT02808806|real-time feedback|real-time feedback
4768592|NCT02808806|visual feedback|visual feedback
4768593|NCT02808793|ISM|ism
4768594|NCT02808793|Mastocytosis|mastocytosis
4768595|NCT02808793|Indolent Mastocytosis|indolent mastocytosis
4768596|NCT02808780|Ulcerative Colitis|ulcerative colitis
4768597|NCT02808780|Simponi (Golimumab)|simponi (golimumab)
4768598|NCT02808780|Thiopurines|thiopurines
4768599|NCT02808780|Lymphoma|lymphoma
4768600|NCT02808780|Malignancies|malignancies
4768601|NCT02808767|Acute myocardial infarction|acute myocardial infarction
4768602|NCT02808767|Primary coronary intervention|primary coronary intervention
4768603|NCT02808767|Antiplatelet therapy|antiplatelet therapy
4768604|NCT02808728|Total Knee Arthroplasty|total knee arthroplasty
4768605|NCT02808728|Total Knee Replacement|total knee replacement
4768606|NCT02808728|Exparel|exparel
4768607|NCT02808728|Liposomal Bupivacaine|liposomal bupivacaine
4768608|NCT02808728|Ropivacaine|ropivacaine
4768609|NCT02808728|Postoperative Pain Management|postoperative pain management
4768610|NCT02808702|Attention|attention
4768611|NCT02808702|Cognitive behavioral therapy|cognitive behavioral therapy
4768612|NCT02808702|Neuroimaging|neuroimaging
4768613|NCT02808689|Moderate|moderate
4768614|NCT02808689|Severe|severe
4768615|NCT02808676|Cognitive training|cognitive training
4768616|NCT02808676|Vitamin D|vitamin d
4768617|NCT02808676|Exercise|exercise
4768618|NCT02808637|Pain management|pain management
4768619|NCT02808637|vaccination|vaccination
4768620|NCT02808637|manual pressure|manual pressure
4768621|NCT02808637|needle aspiration|needle aspiration
4768622|NCT02808624|Oxaliplatin, peripheral neuropathy, L-CARNOSINE|oxaliplatin, peripheral neuropathy, l-carnosine
4768623|NCT02808598|Clinical Trials|clinical trials
4768624|NCT02808598|Education|education
4768625|NCT02808598|Hispanic Americans|hispanic americans
4768626|NCT02808598|African Americans|african americans
4768627|NCT02808598|Health Disparities|health disparities
4768628|NCT02808598|Patient Participation|patient participation
4768629|NCT02808598|Refusal to Participate|refusal to participate
4768630|NCT02808572|chronic kidney disease|chronic kidney disease
4768631|NCT02808572|vascular calcifications|vascular calcifications
4768632|NCT02808572|cardiovascular risk|cardiovascular risk
4768633|NCT02808546|Gallbladder stone|gallbladder stone
4768634|NCT02808546|Risk factor|risk factor
4768635|NCT02808546|Case-control study|case-control study
4768636|NCT02808546|Obesity|obesity
4768637|NCT02808546|Hypertension|hypertension
4768638|NCT02808546|Alcohol consumption|alcohol consumption
4768639|NCT02808520|Social participation|social participation
4768640|NCT02808520|Children and adolescents with cancer|children and adolescents with cancer
4768641|NCT02808520|Quality of life with hodgkin-lymphoma|quality of life with hodgkin-lymphoma
4768732|NCT02807857|primary care,|primary care,
4768642|NCT02808520|Social inequalities and cancer|social inequalities and cancer
4768643|NCT02808494|Preeclampsia|preeclampsia
4768644|NCT02808494|Fetal Growth Restriction|fetal growth restriction
4768645|NCT02808481|systemic sclerosis|systemic sclerosis
4768646|NCT02808481|cardiac disease|cardiac disease
4768647|NCT02808481|Heart transplantation|heart transplantation
4768648|NCT02808481|primitive cardiac damage|primitive cardiac damage
4768649|NCT02808468|Sexual assault|sexual assault
4768650|NCT02808468|Posttraumatic Stress Disorder|posttraumatic stress disorder
4768651|NCT02808468|Alcohol use|alcohol use
4768652|NCT02808468|Cognitive therapy|cognitive therapy
4768653|NCT02808429|Atacicept|atacicept
4768654|NCT02808429|IgA Nephropathy|iga nephropathy
4768655|NCT02808429|Berger´s disease|berger´s disease
4768656|NCT02808429|Glomerulonephritis|glomerulonephritis
4768657|NCT02808429|Proteinuria|proteinuria
4768658|NCT02808416|Solid tumors|solid tumors
4768659|NCT02808416|Brain metastases|brain metastases
4768660|NCT02808416|DC vaccine|dc vaccine
4768661|NCT02808416|Personalized vaccine|personalized vaccine
4768662|NCT02808416|Tumor antigens|tumor antigens
4768663|NCT02808416|PBMCs|pbmcs
4768664|NCT02808364|Recurrent glioblastoma|recurrent glioblastoma
4768665|NCT02808364|DC vaccine|dc vaccine
4768666|NCT02808364|tumor antigen|tumor antigen
4768667|NCT02808364|personalized vaccine|personalized vaccine
4768668|NCT02808299|statin|statin
4768669|NCT02808299|hepatitis B virus|hepatitis b virus
4768670|NCT02808273|Bemiparine|bemiparine
4768671|NCT02808273|Antithrombotic microsurgery protocol|antithrombotic microsurgery protocol
4768672|NCT02808273|Comparative study|comparative study
4768673|NCT02808273|Anticoagulant microsurgery protocol|anticoagulant microsurgery protocol
4768674|NCT02808260|sub-clinical atrial fibrillation|sub-clinical atrial fibrillation
4768675|NCT02808260|biomarkers|biomarkers
4768676|NCT02808260|implanted pacemaker or defibrillator|implanted pacemaker or defibrillator
4768677|NCT02808247|advanced metastatic soft tissue sarcoma|advanced metastatic soft tissue sarcoma
4768678|NCT02808221|Heart failure|heart failure
4768679|NCT02808221|heart disease|heart disease
4768680|NCT02808221|left ventricular|left ventricular
4768681|NCT02808195|Cerebral Palsy|cerebral palsy
4768682|NCT02808195|Neurological Rehabilitation|neurological rehabilitation
4768683|NCT02808195|Upper Extremity|upper extremity
4768684|NCT02808156|Cerebral Palsy,|cerebral palsy,
4768685|NCT02808156|Upper limb neurorehabilitation|upper limb neurorehabilitation
4768686|NCT02808156|Upper Extremity|upper extremity
4768687|NCT02808156|Neurological Rehabilitation|neurological rehabilitation
4768688|NCT02808130|hyperlipidemia, periodontal disease, oxidative stress,|hyperlipidemia, periodontal disease, oxidative stress,
4768689|NCT02808117|microfinance institution|microfinance institution
4768690|NCT02808117|MFI|mfi
4768691|NCT02808078|Instrumented treadmill|instrumented treadmill
4768692|NCT02808078|Augmented reality|augmented reality
4768693|NCT02808078|Neurorehabilitation|neurorehabilitation
4768694|NCT02808078|Gait disorders|gait disorders
4768695|NCT02808065|Kidney transplant|kidney transplant
4768696|NCT02808065|Kidney transplantation|kidney transplantation
4768697|NCT02808065|Renal transplant|renal transplant
4768698|NCT02808065|Renal transplantation|renal transplantation
4768699|NCT02808052|Bacterial infections|bacterial infections
4768700|NCT02808026|severe hypertension|severe hypertension
4768701|NCT02808026|grade III hypertension|grade iii hypertension
4768702|NCT02808026|mineralocorticoid receptor antagonist|mineralocorticoid receptor antagonist
4768703|NCT02807987|Mineralocorticoid receptor antagonist|mineralocorticoid receptor antagonist
4768704|NCT02807987|Moderate renal impairment|moderate renal impairment
4768705|NCT02807987|Hypertension|hypertension
4768706|NCT02807974|Hypertension with Type 2 Diabetes and Albuminuria|hypertension with type 2 diabetes and albuminuria
4768707|NCT02807974|Diabetic nephropathy|diabetic nephropathy
4768708|NCT02807974|Diabetic renal disease|diabetic renal disease
4768709|NCT02807974|Albuminuria|albuminuria
4768710|NCT02807974|Mineralocorticoid receptor antagonist|mineralocorticoid receptor antagonist
4768711|NCT02807961|Translational read through|translational read through
4768712|NCT02807948|MRI Scan, pacemakers, ICD, CRT|mri scan, pacemakers, icd, crt
4768713|NCT02807922|Palliative Care|palliative care
4768714|NCT02807922|zopiclone|zopiclone
4768715|NCT02807896|biomarker|biomarker
4768716|NCT02807896|pancreatic cancer|pancreatic cancer
4768717|NCT02807896|bile duct cancer|bile duct cancer
4768718|NCT02807896|miRNA|mirna
4768719|NCT02807883|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
4768720|NCT02807883|ALL|all
4768721|NCT02807883|B-lineage Acute Lymphoblastic Leukemia|b-lineage acute lymphoblastic leukemia
4768722|NCT02807883|Malignant neoplasms stated as primary lymphoid haematopoietic|malignant neoplasms stated as primary lymphoid haematopoietic
4768723|NCT02807883|Blinatumomab|blinatumomab
4768724|NCT02807883|Blincyto|blincyto
4768725|NCT02807883|Post allogeneic stem cell transplant|post allogeneic stem cell transplant
4768726|NCT02807870|Parental training|parental training
4768727|NCT02807870|Preschool age|preschool age
4768728|NCT02807870|Attention Deficit/Hyperactivity Disorder (ADHD)|attention deficit/hyperactivity disorder (adhd)
4768729|NCT02807857|low-interventional observational study,|low-interventional observational study,
4768730|NCT02807857|CHF,|chf,
4768731|NCT02807857|heart failure,|heart failure,
4768838|NCT02807441|Surgery|surgery
4768733|NCT02807857|ESC guidelines,|esc guidelines,
4768734|NCT02807857|Europe,|europe,
4768735|NCT02807857|NT-proBNP,|nt-probnp,
4768736|NCT02807857|reduced ventricular ejection fraction (EF),|reduced ventricular ejection fraction (ef),
4768737|NCT02807844|Triple negative breast cancer|triple negative breast cancer
4768738|NCT02807844|Pancreatic carcinoma|pancreatic carcinoma
4768739|NCT02807844|Melanoma|melanoma
4768740|NCT02807844|Endometrial Carcinoma|endometrial carcinoma
4768741|NCT02807844|Immuno oncology|immuno oncology
4768742|NCT02807844|Monoclonal antibody|monoclonal antibody
4768743|NCT02807844|PDR001|pdr001
4768744|NCT02807844|MCS110|mcs110
4768745|NCT02807831|Executive Function|executive function
4768746|NCT02807831|Language|language
4768747|NCT02807831|Preschool child|preschool child
4768748|NCT02807831|Development|development
4768749|NCT02807818|Child development|child development
4768750|NCT02807818|Infant|infant
4768751|NCT02807818|Mother-Child Relations|mother-child relations
4768752|NCT02807805|castration resistant prostate cancer|castration resistant prostate cancer
4768753|NCT02807792|Perianal surgery|perianal surgery
4768754|NCT02807779|angioplasty|angioplasty
4768755|NCT02807779|peripheral artery disease|peripheral artery disease
4768885|NCT02807077|Healthy subjects|healthy subjects
4768756|NCT02807779|peripheral vascular disease|peripheral vascular disease
4768757|NCT02807779|atherosclerosis|atherosclerosis
4768758|NCT02807779|balloon angioplasty|balloon angioplasty
4768759|NCT02807779|dexamethasone|dexamethasone
4768760|NCT02807779|drug coated balloon|drug coated balloon
4768761|NCT02807779|paclitaxel|paclitaxel
4768762|NCT02807779|walking|walking
4768763|NCT02807779|claudication|claudication
4768764|NCT02807766|autism|autism
4768765|NCT02807766|Brain Plasticity|brain plasticity
4768766|NCT02807766|Behavioral Intervention|behavioral intervention
4768767|NCT02807766|Magnetic Resonance Imaging|magnetic resonance imaging
4768768|NCT02807753|Hemophilia|hemophilia
4768769|NCT02807753|Arthropathy|arthropathy
4768770|NCT02807753|Pediatric|pediatric
4768771|NCT02807740|Virtual Reality|virtual reality
4768772|NCT02807740|Rehabilitation|rehabilitation
4768773|NCT02807740|Cardiocirculatory system|cardiocirculatory system
4768774|NCT02807740|Parkinson Disease|parkinson disease
4768775|NCT02807688|health promotion|health promotion
4768776|NCT02807688|lifestyles|lifestyles
4768777|NCT02807688|physical comorbidity|physical comorbidity
4768778|NCT02807688|risk factors|risk factors
4768779|NCT02807688|behavioural change|behavioural change
4768780|NCT02807662|posttraumatic stress disorder|posttraumatic stress disorder
4768781|NCT02807662|prenatal care|prenatal care
4768782|NCT02807636|Urothelial carcinoma|urothelial carcinoma
4768783|NCT02807636|Bladder cancer|bladder cancer
4768784|NCT02807636|Anti-PD-L1|anti-pd-l1
4768785|NCT02807636|Transitional carcinoma|transitional carcinoma
4768786|NCT02807636|Tecentriq|tecentriq
4768787|NCT02807636|Atezolizumab|atezolizumab
4768788|NCT02807636|IMvigor130|imvigor130
4768789|NCT02807610|Etomidate lipuro|etomidate lipuro
4768790|NCT02807610|Induction characteristics|induction characteristics
4768791|NCT02807584|Wound|wound
4768792|NCT02807584|burns|burns
4768793|NCT02807584|acute|acute
4768794|NCT02807584|chronic|chronic
4768795|NCT02807584|foam|foam
4768796|NCT02807584|adhesive|adhesive
4768797|NCT02807584|dressing|dressing
4768798|NCT02807571|Hand|hand
4768799|NCT02807558|AML|aml
4768800|NCT02807558|MDS|mds
4768801|NCT02807545|Scoliosis-Specific Exercises|scoliosis-specific exercises
4768802|NCT02807545|Schroth|schroth
4768803|NCT02807519|Oral health|oral health
4768804|NCT02807519|Saliva|saliva
4768805|NCT02807519|Biomarker|biomarker
4768806|NCT02807519|Cytokines|cytokines
4768807|NCT02807519|Cancer|cancer
4768808|NCT02807519|children|children
4768809|NCT02807506|elders|elders
4768810|NCT02807506|robotics|robotics
4768811|NCT02807506|low income population|low income population
4768812|NCT02807506|activities of daily living|activities of daily living
4768813|NCT02807506|instrumental activities of daily living|instrumental activities of daily living
4768814|NCT02807506|social robotics|social robotics
4768815|NCT02807506|stroke|stroke
4768816|NCT02807506|aged|aged
4768817|NCT02807506|Retirement|retirement
4768818|NCT02807506|Housing for elderly|housing for elderly
4768819|NCT02807506|Homes for the aged|homes for the aged
4768820|NCT02807493|Pregnancy|pregnancy
4768821|NCT02807493|Labor and Delivery|labor and delivery
4768822|NCT02807493|Occlusal Support Device|occlusal support device
4768823|NCT02807467|reduction|reduction
4768824|NCT02807467|delirium|delirium
4768825|NCT02807467|duration|duration
4768826|NCT02807467|severity|severity
4768827|NCT02807454|Phase 2|phase 2
4768828|NCT02807454|Open-Label|open-label
4768829|NCT02807454|Durvalumab|durvalumab
4768830|NCT02807454|Daratumumab|daratumumab
4768831|NCT02807454|Multiple Myeloma|multiple myeloma
4768832|NCT02807454|Relapsed and Refractory (RRMM)|relapsed and refractory (rrmm)
4768833|NCT02807454|FUSION MM-003|fusion mm-003
4768834|NCT02807454|PD-L1|pd-l1
4768835|NCT02807441|Bleeding|bleeding
4768836|NCT02807441|Aspirin|aspirin
4768837|NCT02807441|Spine|spine
4768839|NCT02807428|post-surgical pain|post-surgical pain
4768840|NCT02807428|total knee arthroplasty|total knee arthroplasty
4768841|NCT02807428|total knee replacement|total knee replacement
4768842|NCT02807415|cystic fibrosis|cystic fibrosis
4768843|NCT02807415|CFTR|cftr
4768844|NCT02807415|CFTR modulation|cftr modulation
4768845|NCT02807415|sweat test|sweat test
4768846|NCT02807415|intestinal current measurement, ICM|intestinal current measurement, icm
4768847|NCT02807415|nasal transepithelial potential difference measurement, NPD|nasal transepithelial potential difference measurement, npd
4768848|NCT02807402|Ombitasvir|ombitasvir
4768849|NCT02807402|Dasabuvir|dasabuvir
4768850|NCT02807402|Paritaprevir|paritaprevir
4768851|NCT02807402|HCV|hcv
4768852|NCT02807402|Chronic Hepatitis C|chronic hepatitis c
4768853|NCT02807363|endometriosis|endometriosis
4768854|NCT02807363|gonadotropin-releasing hormone agonist|gonadotropin-releasing hormone agonist
4768855|NCT02807363|healthy volunteers|healthy volunteers
4768856|NCT02807363|leuprolide oral tablet|leuprolide oral tablet
4768857|NCT02807350|Intermittent Exotropia|intermittent exotropia
4768858|NCT02807350|IXT|ixt
4768859|NCT02807350|overminus|overminus
4768860|NCT02807337|Oral mucositis|oral mucositis
4768861|NCT02807311|Malnutrition|malnutrition
4768862|NCT02807311|Undernutrition|undernutrition
4768863|NCT02807311|lung transplantation|lung transplantation
4768864|NCT02807311|artificial nutrition|artificial nutrition
4768865|NCT02807311|nutritional supplements|nutritional supplements
4768866|NCT02807311|enteral nutrition|enteral nutrition
4768867|NCT02807298|Intarligamentary|intarligamentary
4768868|NCT02807298|Articaine|articaine
4768869|NCT02807298|Lidocaine|lidocaine
4768870|NCT02807246|Probiotic|probiotic
4768871|NCT02807246|Neonatal Hyperbilirubinemia|neonatal hyperbilirubinemia
4768872|NCT02807220|Imuneks|imuneks
4768873|NCT02807207|To Study pharmacokinetics and Cardiac safety pacritinib study|to study pharmacokinetics and cardiac safety pacritinib study
4768874|NCT02807155|Transitional Care|transitional care
4768875|NCT02807155|Young Adult|young adult
4768876|NCT02807155|Guided Imagery|guided imagery
4768877|NCT02807116|Drug-Interaction Study|drug-interaction study
4768878|NCT02807103|Rituximab|rituximab
4768879|NCT02807103|remission induction|remission induction
4768880|NCT02807103|eosinophilic granulomatosis with polyangiitis|eosinophilic granulomatosis with polyangiitis
4768881|NCT02807090|Low Back Pain|low back pain
4768882|NCT02807090|Exercise|exercise
4768883|NCT02807090|Dance Therapy|dance therapy
4768884|NCT02807090|Physical Therapy|physical therapy
4768886|NCT02807038|Respiratory Function Tests|respiratory function tests
4768887|NCT02807038|Air pollution|air pollution
4768888|NCT02807038|Pregnancy|pregnancy
4768889|NCT02807038|Spirometry|spirometry
4768890|NCT02807012|Home care services|home care services
4768891|NCT02807012|Nursing|nursing
4768892|NCT02807012|Clinical trial|clinical trial
4768893|NCT02807012|Geriatric nursing|geriatric nursing
4768894|NCT02807012|Family caregiver|family caregiver
4768895|NCT02807012|Aged|aged
4768896|NCT02806999|Heart disease|heart disease
4768897|NCT02806999|Postoperative period|postoperative period
4768898|NCT02806999|Hyperglycemia|hyperglycemia
4768899|NCT02806999|Berberine|berberine
4768900|NCT02806999|Insulin|insulin
4768901|NCT02806999|Clinical trials as topic|clinical trials as topic
4768902|NCT02806947|Acute GVHD|acute gvhd
4768903|NCT02806947|Standard-Risk|standard-risk
4768904|NCT02806947|Sirolimus|sirolimus
4768905|NCT02806947|Refined Minnesota Risk Criteria|refined minnesota risk criteria
4768906|NCT02806947|Ann Arbor|ann arbor
4768907|NCT02806947|Biomarker|biomarker
4768908|NCT02806947|Steroid-Free|steroid-free
4768909|NCT02806921|Scleral Contact Lens|scleral contact lens
4768910|NCT02806921|Tear Proteases|tear proteases
4768911|NCT02806921|Tear Cytokines|tear cytokines
4768912|NCT02806908|Driving|driving
4768913|NCT02806895|Driving|driving
4768914|NCT02806856|Middle Cerebral Artery Stroke|middle cerebral artery stroke
4768915|NCT02806856|tDCS|tdcs
4768916|NCT02806856|Acute|acute
4768917|NCT02806843|stroke|stroke
4768918|NCT02806843|hemiplegia|hemiplegia
4768919|NCT02806843|healthy|healthy
4768920|NCT02806843|robotics|robotics
4768921|NCT02806843|rehabilitation|rehabilitation
4768922|NCT02806843|therapy|therapy
4768923|NCT02806830|Intravitreal injection|intravitreal injection
4768924|NCT02806830|AMD|amd
4768925|NCT02806830|Diabetic Retinopathy|diabetic retinopathy
4768926|NCT02806830|Retinal Artery Occlusion|retinal artery occlusion
4768927|NCT02806830|Myopia, Degenerative|myopia, degenerative
4768928|NCT02806830|eye drops|eye drops
4768929|NCT02806804|vaccine|vaccine
4768930|NCT02806804|safety|safety
4768931|NCT02806804|immunogenicity|immunogenicity
4768932|NCT02806791|Patients|patients
4768933|NCT02806778|cardiac arrest|cardiac arrest
4768934|NCT02806778|jugular venous oximetry|jugular venous oximetry
4768935|NCT02806778|hypoxic brain injury|hypoxic brain injury
4768936|NCT02806765|Dynamic Stability|dynamic stability
4768937|NCT02806765|Postural Stability|postural stability
4768938|NCT02806765|Gait Speed|gait speed
4768939|NCT02806765|Hand Grip Strength|hand grip strength
4768940|NCT02806765|Timed Get-up and Go|timed get-up and go
4768941|NCT02806765|Older Adults|older adults
4768942|NCT02806752|Polypoidal Choroidal Vasculopathy|polypoidal choroidal vasculopathy
4768943|NCT02806739|Soy protein|soy protein
4768944|NCT02806739|isoflavones|isoflavones
4768945|NCT02806739|gestational diabetes|gestational diabetes
4768946|NCT02806700|Diabetes|diabetes
4768947|NCT02806700|Social Media|social media
4768948|NCT02806687|Locally advanced pancreatic adenocarcinoma|locally advanced pancreatic adenocarcinoma
4768949|NCT02806687|gene therapy|gene therapy
4768950|NCT02806687|gemcitabine|gemcitabine
4768951|NCT02806687|chemosensitization|chemosensitization
4768952|NCT02806674|Helicobacter pylori|helicobacter pylori
4768953|NCT02806674|Antibiotic resistance|antibiotic resistance
4768954|NCT02806674|Sequencing|sequencing
4768955|NCT02806661|Robotic surgery|robotic surgery
4768956|NCT02806661|Vagus nerve preserving|vagus nerve preserving
4768957|NCT02806635|Relationship Distress|relationship distress
4768958|NCT02806635|Relationship Satisfaction|relationship satisfaction
4768959|NCT02806635|Marriage|marriage
4768960|NCT02806635|Web-based|web-based
4768961|NCT02806635|Internet|internet
4768962|NCT02806622|Sports|sports
4768963|NCT02806622|University|university
4768964|NCT02806622|Lower Extremity|lower extremity
4768965|NCT02806622|Hip Joint|hip joint
4768966|NCT02806609|football|football
4768967|NCT02806609|cryotherapy|cryotherapy
4768968|NCT02806609|balance|balance
4768969|NCT02806609|electromyography|electromyography
4768970|NCT02806557|Neoplasms|neoplasms
4768971|NCT02806557|Neutropenia|neutropenia
4768972|NCT02806557|drug therapy|drug therapy
4768973|NCT02806557|Hematologic tests|hematologic tests
4768974|NCT02806557|Point-of-care Systems|point-of-care systems
4768975|NCT02806557|Febrile neutropenia|febrile neutropenia
4768976|NCT02806544|Breast neoplasms|breast neoplasms
4768977|NCT02806544|Breast cancer|breast cancer
4768978|NCT02806544|Locally advanced breast cancer|locally advanced breast cancer
4768979|NCT02806544|Neoadjuvant endocrine therapy|neoadjuvant endocrine therapy
4768980|NCT02806544|Tamoxifen|tamoxifen
4768981|NCT02806544|Low and middle income country|low and middle income country
4768982|NCT02806531|vaccine|vaccine
4768983|NCT02806531|safety|safety
4768984|NCT02806518|DIEP|diep
4768985|NCT02806518|Computed Tomography|computed tomography
4768986|NCT02806518|Doppler|doppler
4768987|NCT02806518|Thermography|thermography
4768988|NCT02806440|Low dose naltrexone|low dose naltrexone
4768989|NCT02806440|Pain|pain
4768990|NCT02806375|Myelofibrosis|myelofibrosis
4768991|NCT02806375|Ruxolitinib|ruxolitinib
4768992|NCT02806375|Cyclophosphamide|cyclophosphamide
4768993|NCT02806375|Immunosuppressive Agents|immunosuppressive agents
4768994|NCT02806375|Immune System Diseases|immune system diseases
4768995|NCT02806375|Busulfan|busulfan
4768996|NCT02806375|Fludarabine|fludarabine
4768997|NCT02806375|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating
4768998|NCT02806375|Myeloablative Agonists|myeloablative agonists
4768999|NCT02806375|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
4769000|NCT02806375|Allogeneic|allogeneic
4769001|NCT02806362|Non-cirrhotic|non-cirrhotic
4769002|NCT02806362|End Stage Renal Disease (ESRD)|end stage renal disease (esrd)
4769003|NCT02806362|moderate fibrosis|moderate fibrosis
4769004|NCT02806362|Chronic Hepatitis C Virus ( HCV)|chronic hepatitis c virus ( hcv)
4769005|NCT02806362|Chronic Hepatitis C Genotype 1b|chronic hepatitis c genotype 1b
4769006|NCT02806349|American ginseng|american ginseng
4769007|NCT02806349|Konjac glucomannan fiber|konjac glucomannan fiber
4769008|NCT02806336|exercise training|exercise training
4769009|NCT02806336|assistive device|assistive device
4769010|NCT02806336|weight loss|weight loss
4769011|NCT02806336|function|function
4769012|NCT02806336|mobility|mobility
4769013|NCT02806310|Aortic Valve|aortic valve
4769014|NCT02806310|Bicuspid|bicuspid
4769015|NCT02806297|cholecystectomy|cholecystectomy
4769016|NCT02806284|vaccination|vaccination
4769017|NCT02806284|Streptococcus pneumoniae|streptococcus pneumoniae
4769018|NCT02806271|Worry Postponement|worry postponement
4769019|NCT02806271|Stimulus Control|stimulus control
4769020|NCT02806245|Congenital Heart Disease (CHD)|congenital heart disease (chd)
4769021|NCT02806245|Cardiopulmonary Bypass (CPB)|cardiopulmonary bypass (cpb)
4769022|NCT02806245|Cardiac Index|cardiac index
4769023|NCT02806245|Hemodynamics|hemodynamics
4769024|NCT02806245|Pediatrics|pediatrics
4769025|NCT02806232|Praziquantel ODT formulation|praziquantel odt formulation
4769026|NCT02806232|Biltricide|biltricide
4769027|NCT02806219|Bioequivalence|bioequivalence
4769028|NCT02806219|Certolizumab pegol|certolizumab pegol
4769029|NCT02806219|Human Volunteers|human volunteers
4769030|NCT02806193|cardiovascular|cardiovascular
4769031|NCT02806193|cardiac|cardiac
4769032|NCT02806193|MRI|mri
4769033|NCT02806193|CMR|cmr
4769034|NCT02806193|CT|ct
4769035|NCT02806193|ECG|ecg
4769036|NCT02806193|magnetic resonance|magnetic resonance
4769037|NCT02806193|imaging|imaging
4769038|NCT02806154|Cancer|cancer
4769039|NCT02806154|Chemotherapy toxicity|chemotherapy toxicity
4769040|NCT02806154|Elderly patients|elderly patients
4769041|NCT02806154|DEXA|dexa
4769042|NCT02806154|muscle mass|muscle mass
4769043|NCT02806141|Aerosolized colistin|aerosolized colistin
4769044|NCT02806141|Intravenous colistin|intravenous colistin
4769045|NCT02806128|cerebral infarction|cerebral infarction
4769046|NCT02806128|kallikrein|kallikrein
4769047|NCT02806128|KLK|klk
4769048|NCT02806089|chronic kidney disease|chronic kidney disease
4769049|NCT02806089|malnutrition inflammation atherogenesis syndrome|malnutrition inflammation atherogenesis syndrome
4769050|NCT02806089|muscle strength|muscle strength
4769051|NCT02806089|muscle mass|muscle mass
4769052|NCT02806089|lean body mass|lean body mass
4769053|NCT02806089|physical activity|physical activity
4769054|NCT02806076|HCC|hcc
4769055|NCT02806076|RFA|rfa
4769056|NCT02806063|Prosthesis|prosthesis
4769057|NCT02806063|joint infection|joint infection
4769058|NCT02806063|perioperative samples|perioperative samples
4769059|NCT02806050|FES PET|fes pet
4769060|NCT02806050|Palbociclib|palbociclib
4769061|NCT02805985|Degenerative Disc Disease|degenerative disc disease
4769062|NCT02805985|Spondylolisthesis|spondylolisthesis
4769063|NCT02805985|Retrolisthesis|retrolisthesis
4769064|NCT02805972|Obesity|obesity
4769065|NCT02805972|Binge eating|binge eating
4769066|NCT02805868|Severe|severe
4769067|NCT02805868|Anemia|anemia
4769068|NCT02805868|Aplastic|aplastic
4769069|NCT02805868|Post-Polycythemic|post-polycythemic
4769070|NCT02805868|Transformation|transformation
4769071|NCT02805868|Thrombocythemia|thrombocythemia
4769072|NCT02805868|Essential|essential
4769073|NCT02805842|non adherence|non adherence
4769074|NCT02805842|Tacrolimus|tacrolimus
4769075|NCT02805842|Advagraf|advagraf
4769076|NCT02805829|NK cells|nk cells
4769077|NCT02805829|Trastuzumab|trastuzumab
4769078|NCT02805816|Celiac disease|celiac disease
4769079|NCT02805816|Tissue transglutaminase|tissue transglutaminase
4769080|NCT02805816|Histology|histology
4769081|NCT02805790|Primary Mitochondrial Disease|primary mitochondrial disease
4769082|NCT02805790|Mitochondrial Myopathy|mitochondrial myopathy
4769083|NCT02805790|Elamipretide|elamipretide
4769084|NCT02805790|MTP-131|mtp-131
4769085|NCT02805790|Bendavia™|bendavia™
4769086|NCT02805764|obstructive sleep apnea|obstructive sleep apnea
4769087|NCT02805764|malocclusion|malocclusion
4769088|NCT02805764|polysomnography|polysomnography
4769089|NCT02805764|quality of life|quality of life
4769090|NCT02805751|Achilles|achilles
4769091|NCT02805751|Tendon|tendon
4769092|NCT02805751|Loading|loading
4769093|NCT02805751|Rehabilitation|rehabilitation
4769094|NCT02805738|Chronic Hepatitis B|chronic hepatitis b
4769095|NCT02805738|tenofovir|tenofovir
4769096|NCT02805738|CKD-390|ckd-390
4769097|NCT02805725|Advanced solid tumor|advanced solid tumor
4769098|NCT02805725|Advanced pretreated soft tissue sarcomas|advanced pretreated soft tissue sarcomas
4769099|NCT02805725|Phase I/II trial|phase i/ii trial
4769100|NCT02805725|Dose escalation|dose escalation
4769101|NCT02805725|PK study|pk study
4769102|NCT02805712|Heart Failure|heart failure
4769103|NCT02805712|Palliative Care|palliative care
4769104|NCT02805699|Clinical Efficacy|clinical efficacy
4769105|NCT02805699|Baofeikang Granules|baofeikang granules
4769106|NCT02805699|Combined Pulmonary Fibrosis and Emphysema|combined pulmonary fibrosis and emphysema
4769107|NCT02805686|Toxicity, Drug|toxicity, drug
4769108|NCT02805673|Osteopathy|osteopathy
4769109|NCT02805673|Support|support
4769110|NCT02805673|Treatment|treatment
4769111|NCT02805673|Pain|pain
4769112|NCT02805673|Quality of Life|quality of life
4769113|NCT02805660|MGCD0103|mgcd0103
4769114|NCT02805660|MEDI4736|medi4736
4769115|NCT02805660|Mocetinostat|mocetinostat
4769116|NCT02805660|Durvalumab|durvalumab
4769117|NCT02805660|HDAC Inhibitor|hdac inhibitor
4769118|NCT02805660|PD-L1 Inhibitor|pd-l1 inhibitor
4769119|NCT02805660|Phase 1|phase 1
4769120|NCT02805660|Phase 2|phase 2
4769121|NCT02805660|Metastatic Solid Tumor|metastatic solid tumor
4769122|NCT02805660|Non-small cell lung cancer|non-small cell lung cancer
4769123|NCT02805660|immunotherapy|immunotherapy
4769124|NCT02805660|checkpoint inhibitor|checkpoint inhibitor
4769125|NCT02805647|25-Hydroxy-vitamin D, children, bone fractures, vitamin D receptor polymorphism|25-hydroxy-vitamin d, children, bone fractures, vitamin d receptor polymorphism
4769126|NCT02805634|nine holes peg|nine holes peg
4769127|NCT02805634|triple stimulation|triple stimulation
4769128|NCT02805634|multiple sclerosis|multiple sclerosis
4769129|NCT02805582|Peripheral Nerve Block|peripheral nerve block
4769130|NCT02805569|videolaryngoscope|videolaryngoscope
4769131|NCT02805569|intubation stylet|intubation stylet
4769132|NCT02805569|articulating stylet|articulating stylet
4769133|NCT02805569|difficult airway|difficult airway
4769134|NCT02805530|oligometastatic disease, radical treatment|oligometastatic disease, radical treatment
4769135|NCT02805517|Minimally Invasive Surgical Procedures|minimally invasive surgical procedures
4769136|NCT02805517|Transplant Donors|transplant donors
4769137|NCT02805504|Bupivacaine|bupivacaine
4769138|NCT02805504|Minimally Invasive Surgical Procedures|minimally invasive surgical procedures
4769139|NCT02805491|Hypospadias|hypospadias
4769140|NCT02805491|newborns|newborns
4769141|NCT02805491|pesticide|pesticide
4769142|NCT02805491|Picardie|picardie
4769143|NCT02805465|Heart Failure|heart failure
4769144|NCT02805465|Atrial Fibrillation|atrial fibrillation
4769145|NCT02805465|CRT|crt
4769146|NCT02805465|BiVP|bivp
4769148|NCT02805387|labor dystocia|labor dystocia
4769149|NCT02805374|Pharmacokinetics|pharmacokinetics
4769150|NCT02805374|ASP1517|asp1517
4769151|NCT02805374|Food effect|food effect
4769152|NCT02805348|Kiklin|kiklin
4769153|NCT02805348|Bixalomer|bixalomer
4769154|NCT02805348|Chronic Kidney Disease|chronic kidney disease
4769155|NCT02805335|Central Venous Catheter|central venous catheter
4769156|NCT02805335|Catheter Bloodstream Related Infection|catheter bloodstream related infection
4769157|NCT02805335|Economic evaluation|economic evaluation
4769158|NCT02805309|Transcatheter Aortic Valve Replacement|transcatheter aortic valve replacement
4769159|NCT02805309|Exercise|exercise
4769160|NCT02805309|Frailty|frailty
4769161|NCT02805309|Functional Outcomes|functional outcomes
4769162|NCT02805309|Cognitive Behavioral Intervention|cognitive behavioral intervention
4769163|NCT02805283|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
4769164|NCT02805270|adverse drug events, preventable, potential, counselling, medication reconciliation|adverse drug events, preventable, potential, counselling, medication reconciliation
4769165|NCT02805244|JTZ-951|jtz-951
4769166|NCT02805244|Pharmacokinetics|pharmacokinetics
4769167|NCT02805244|14C-JTZ-951|14c-jtz-951
4769168|NCT02805244|Mass balance|mass balance
4769169|NCT02805244|Time course|time course
4769170|NCT02805205|PEG-rhG-CSF neutropenia|peg-rhg-csf neutropenia
4769171|NCT02805192|Emergency Department|emergency department
4769172|NCT02805192|Estimation of age and weight|estimation of age and weight
4769173|NCT02805192|Size measurement|size measurement
4769174|NCT02805166|PEG-rhG-CSF|peg-rhg-csf
4769175|NCT02805153|PEG-rhG-CSF|peg-rhg-csf
4769176|NCT02805140|mother|mother
4769177|NCT02805140|social support|social support
4769178|NCT02805140|mobile app|mobile app
4769179|NCT02805140|videoconference|videoconference
4769180|NCT02805140|sedentary|sedentary
4769181|NCT02805140|physical activity|physical activity
4769182|NCT02805127|Asthma|asthma
4769183|NCT02805127|COPD|copd
4769184|NCT02805127|Capnography|capnography
4769185|NCT02805114|Asthma|asthma
4769186|NCT02805114|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
4769187|NCT02805114|Capnography|capnography
4769188|NCT02805062|Trapped Lung|trapped lung
4769189|NCT02805036|alveolar recruitment|alveolar recruitment
4769190|NCT02805036|stroke volume/physiology|stroke volume/physiology
4769191|NCT02805036|cardiac output/physiology|cardiac output/physiology
4769192|NCT02804997|non-invasive ventilation|non-invasive ventilation
4769193|NCT02804997|cardiac surgery|cardiac surgery
4769194|NCT02804984|idiopathic cytopenia of undetermined significance (ICUS)|idiopathic cytopenia of undetermined significance (icus)
4769195|NCT02804984|molecular defects|molecular defects
4769196|NCT02804958|ST-segment elevation myocardial infarction|st-segment elevation myocardial infarction
4769197|NCT02804958|Primary percutaneous coronary intervention|primary percutaneous coronary intervention
4769198|NCT02804958|Clinical outcomes|clinical outcomes
4769199|NCT02804945|Blood And Marrow Transplantation|blood and marrow transplantation
4769200|NCT02804945|Adult Respiratory Distress Syndrome|adult respiratory distress syndrome
4769201|NCT02804945|ARDS|ards
4769202|NCT02804945|Allogeneic human mesenchymal stem cells|allogeneic human mesenchymal stem cells
4769203|NCT02804945|hMSCs|hmscs
4769204|NCT02804945|Placebo|placebo
4769205|NCT02804945|Plasma-Lyte A solution|plasma-lyte a solution
4769206|NCT02804945|Standard of Care|standard of care
4769207|NCT02804945|Recent onset pulmonary toxicity|recent onset pulmonary toxicity
4769208|NCT02804893|Lung cancer, video-assisted thoracoscopic surgery, robotic-assisted thoracoscopic surgery|lung cancer, video-assisted thoracoscopic surgery, robotic-assisted thoracoscopic surgery
4769209|NCT02804880|Smoking cessation|smoking cessation
4769210|NCT02804880|Quit to Win|quit to win
4769211|NCT02804880|Brief intervention|brief intervention
4769212|NCT02804880|Personalized active referral|personalized active referral
4769213|NCT02804880|Instant messaging|instant messaging
4769214|NCT02804880|SMS|sms
4769215|NCT02804880|Smoking Cessation Intervention|smoking cessation intervention
4769216|NCT02804841|Vitamin D supplementation|vitamin d supplementation
4769217|NCT02804841|Cognitive function|cognitive function
4769218|NCT02804841|Physical function|physical function
4769219|NCT02804841|Successful ageing|successful ageing
4769220|NCT02804841|Prevention|prevention
4769221|NCT02804841|Cholecalciferol|cholecalciferol
4769222|NCT02804841|Dementia|dementia
4769223|NCT02804841|Muscle mass|muscle mass
4769224|NCT02804815|Aspirin|aspirin
4769225|NCT02804815|prostate|prostate
4769226|NCT02804815|colorectal|colorectal
4769227|NCT02804815|breast|breast
4769228|NCT02804815|gastro-oesophageal|gastro-oesophageal
4769229|NCT02804815|recurrence|recurrence
4769230|NCT02804789|Prevention|prevention
4769231|NCT02804763|Systemic Lupus Erythematosus (SLE)|systemic lupus erythematosus (sle)
4769232|NCT02804763|Dapirolizumab Pegol (DZP)|dapirolizumab pegol (dzp)
4769233|NCT02804750|Cushing's Syndrome|cushing's syndrome
4769234|NCT02804750|Cushing's Disease|cushing's disease
4769235|NCT02804750|Cushings|cushings
4769236|NCT02804750|Hypercortisolemia|hypercortisolemia
4769237|NCT02804750|Cushingoid|cushingoid
4769238|NCT02804750|Type 2 Diabetes|type 2 diabetes
4769239|NCT02804750|Impaired Glucose Intolerance|impaired glucose intolerance
4769240|NCT02804750|Hypertension|hypertension
4769537|NCT02802748|letrozole|letrozole
4769241|NCT02804750|Adrenal Corticotrophic Hormone (ACTH)|adrenal corticotrophic hormone (acth)
4769242|NCT02804750|Adrenocortical Carcinoma|adrenocortical carcinoma
4769243|NCT02804750|Primary Pigmented Nodular Adrenal Disease (PPNAD)|primary pigmented nodular adrenal disease (ppnad)
4769244|NCT02804750|Moon Facies|moon facies
4769245|NCT02804750|Dorsocervical Fat Pad|dorsocervical fat pad
4769246|NCT02804750|Adrenal Adenoma|adrenal adenoma
4769247|NCT02804750|Adrenal Carcinoma|adrenal carcinoma
4769248|NCT02804750|Adrenal Autonomy|adrenal autonomy
4769249|NCT02804750|Cortisol|cortisol
4769250|NCT02804724|HIV|hiv
4769251|NCT02804724|Human immunodeficiency virus|human immunodeficiency virus
4769252|NCT02804724|Late diagnosis|late diagnosis
4769253|NCT02804672|Cardiovascular health|cardiovascular health
4769254|NCT02804672|Diet|diet
4769255|NCT02804672|Functional limitations|functional limitations
4769256|NCT02804672|Frailty|frailty
4769257|NCT02804672|Older adults|older adults
4769258|NCT02804659|micro-RNA|micro-rna
4769259|NCT02804646|Recombinant human endostatin(Endostar)|recombinant human endostatin(endostar)
4769260|NCT02804646|Durative transfusion|durative transfusion
4769261|NCT02804646|adenocarcinoma of lung|adenocarcinoma of lung
4769262|NCT02804633|IV acetaminophen|iv acetaminophen
4769263|NCT02804633|Colorectal Surgery|colorectal surgery
4769264|NCT02804633|Enhance Recovery|enhance recovery
4769265|NCT02804633|Opioid Consumption|opioid consumption
4769266|NCT02804633|Pain Management|pain management
4769267|NCT02804607|burn|burn
4769268|NCT02804607|child|child
4769269|NCT02804607|graft|graft
4769270|NCT02804607|development|development
4769271|NCT02804607|complications|complications
4769272|NCT02804607|autonomy|autonomy
4769273|NCT02804568|Schizophrenia|schizophrenia
4769274|NCT02804568|Alkermes|alkermes
4769275|NCT02804568|ALK 3831|alk 3831
4769276|NCT02804568|Samidorphan|samidorphan
4769277|NCT02804555|reactive oxygen species|reactive oxygen species
4769278|NCT02804555|elective cesarean section|elective cesarean section
4769279|NCT02804555|oxygen therapy|oxygen therapy
4769280|NCT02804555|newborn|newborn
4769281|NCT02804542|fascia iliaca blocks|fascia iliaca blocks
4769282|NCT02804529|Laparoscopic entry|laparoscopic entry
4769283|NCT02804529|Meng's point|meng's point
4769284|NCT02804529|Veress needle|veress needle
4769285|NCT02804477|adherence|adherence
4769286|NCT02804477|opioid|opioid
4769287|NCT02804477|MMAS 8, morisky medication adherence scale|mmas 8, morisky medication adherence scale
4769288|NCT02804477|validation|validation
4769289|NCT02804425|Medical Education|medical education
4769290|NCT02804425|Simulation|simulation
4769291|NCT02804425|Anesthesia crisis management|anesthesia crisis management
4769292|NCT02804425|Learning outcomes|learning outcomes
4769293|NCT02804412|communication disorders|communication disorders
4769294|NCT02804412|language and speech disorder rehabilitation|language and speech disorder rehabilitation
4769295|NCT02804412|stroke|stroke
4769296|NCT02804399|rifampin|rifampin
4769297|NCT02804399|pharmacokinetics|pharmacokinetics
4769298|NCT02804399|PF-06463922|pf-06463922
4769299|NCT02804399|drug interaction|drug interaction
4769300|NCT02804386|HCV|hcv
4769301|NCT02804386|safety|safety
4769302|NCT02804386|efficacy|efficacy
4769303|NCT02804386|EVR|evr
4769304|NCT02804386|SVR|svr
4769305|NCT02804373|oxytocin|oxytocin
4769306|NCT02804373|adults|adults
4769307|NCT02804347|Olfactory Dysfunction|olfactory dysfunction
4769308|NCT02804347|Electroconvulsive Therapy|electroconvulsive therapy
4769309|NCT02804347|Theta Burst Stimulation|theta burst stimulation
4769310|NCT02804321|catheter ablation|catheter ablation
4769311|NCT02804321|galectin 3|galectin 3
4769312|NCT02804321|ngal|ngal
4769313|NCT02804321|aldosterone|aldosterone
4769314|NCT02804321|atrial fibrillation|atrial fibrillation
4769315|NCT02804308|Combined Training|combined training
4769316|NCT02804308|Breast Cancer|breast cancer
4769317|NCT02804308|Body Composition|body composition
4769318|NCT02804308|Postmenopausal Women|postmenopausal women
4769319|NCT02804308|Aromatase Inhibitors|aromatase inhibitors
4769320|NCT02804308|Quality of life|quality of life
4769321|NCT02804295|Prescription Drug|prescription drug
4769322|NCT02804295|Misuse|misuse
4769323|NCT02804269|Healthy Volunteer|healthy volunteer
4769324|NCT02804269|Dilated cardiomyopathy|dilated cardiomyopathy
4769325|NCT02804269|Hypertrophic cardiomyopathy|hypertrophic cardiomyopathy
4769326|NCT02804269|ischemic heart disease|ischemic heart disease
4769327|NCT02804269|Cardiovascular Magnetic Resonance Imaging|cardiovascular magnetic resonance imaging
4769328|NCT02804243|nasal high flow therapy|nasal high flow therapy
4769329|NCT02804243|rehabilitation|rehabilitation
4769330|NCT02804243|exercise endurance|exercise endurance
4769331|NCT02804178|ATR-101|atr-101
4769332|NCT02804178|classic congenital adrenal hyperplasia|classic congenital adrenal hyperplasia
4769333|NCT02804178|21-hydroxylase deficiency|21-hydroxylase deficiency
4769334|NCT02804178|CAH|cah
4769335|NCT02804165|Type 1 diabetes|type 1 diabetes
4769336|NCT02804165|Enterovirus|enterovirus
4769337|NCT02804165|Genetics|genetics
4769338|NCT02804165|Gene-Virus interaction|gene-virus interaction
4769339|NCT02804152|pregnancy|pregnancy
4769340|NCT02804152|pain|pain
4769341|NCT02804152|prescription opioid|prescription opioid
4769342|NCT02804139|Cesarean Section|cesarean section
4769343|NCT02804139|Postpartum issues|postpartum issues
4769344|NCT02804126|acute pain|acute pain
4769345|NCT02804126|transversus abdominis plane block|transversus abdominis plane block
4769346|NCT02804126|quadratus lumborum block|quadratus lumborum block
4769347|NCT02804126|neuropathic pain|neuropathic pain
4769348|NCT02804100|Circulating Tumor DNA|circulating tumor dna
4769349|NCT02804100|Lung cancer|lung cancer
4769350|NCT02804100|Plasma DNA|plasma dna
4769351|NCT02804061|nutrition|nutrition
4769352|NCT02804061|exercise|exercise
4769353|NCT02804061|behavior change|behavior change
4769354|NCT02804061|adherence|adherence
4769355|NCT02804048|Dyspareunia|dyspareunia
4769356|NCT02804048|Pelvic floor muscles|pelvic floor muscles
4769357|NCT02804048|Women|women
4769358|NCT02804022|Respiratory Depression|respiratory depression
4769359|NCT02804009|anxiety|anxiety
4769360|NCT02804009|coronary angiography|coronary angiography
4769361|NCT02803957|Degenerative|degenerative
4769362|NCT02803957|Mitral Regurgitation|mitral regurgitation
4769363|NCT02803944|azithromycin|azithromycin
4769364|NCT02803944|cystic fibrosis|cystic fibrosis
4769365|NCT02803944|pulmonary function|pulmonary function
4769366|NCT02803931|Cardiogoniometry|cardiogoniometry
4769367|NCT02803931|Electrocardiography|electrocardiography
4769368|NCT02803879|cardiac resynchronisation therapy|cardiac resynchronisation therapy
4769369|NCT02803879|cardiogoniometry|cardiogoniometry
4769370|NCT02803866|Parenting Self-efficacy|parenting self-efficacy
4769371|NCT02803866|Parent training program|parent training program
4769372|NCT02803866|Perceived self-efficacy tool|perceived self-efficacy tool
4769373|NCT02803853|Native American|native american
4769374|NCT02803853|Obesity|obesity
4769375|NCT02803853|Multi level|multi level
4769376|NCT02803853|Policy|policy
4769377|NCT02803853|Schools|schools
4769378|NCT02803853|Worksite|worksite
4769379|NCT02803853|Social Media|social media
4769380|NCT02803853|Food Store|food store
4769381|NCT02803840|Large B-Cell|large b-cell
4769382|NCT02803840|Diffuse|diffuse
4769383|NCT02803827|diarrhoea|diarrhoea
4769384|NCT02803827|gastroenteritis|gastroenteritis
4769385|NCT02803827|rapid diagnostics|rapid diagnostics
4769386|NCT02803827|probiotics|probiotics
4769387|NCT02803814|Pancreatoduodenectomy|pancreatoduodenectomy
4769388|NCT02803814|Pancreatic tumors|pancreatic tumors
4769389|NCT02803814|Periampullary tumors|periampullary tumors
4769390|NCT02803801|Parents' ability to guide their child|parents' ability to guide their child
4769391|NCT02803801|Parent perception of competence|parent perception of competence
4769392|NCT02803801|Parent understanding of their child's unique learning style|parent understanding of their child's unique learning style
4769393|NCT02803788|ramosetron, ondansetron, dexamethasone,|ramosetron, ondansetron, dexamethasone,
4769394|NCT02803762|ADME|adme
4769395|NCT02803762|Pacritinib|pacritinib
4769396|NCT02803671|preterm neonates|preterm neonates
4769397|NCT02803671|EEG-NIRS|eeg-nirs
4769398|NCT02803658|smoking|smoking
4769399|NCT02803645|healthy subjects|healthy subjects
4769400|NCT02803645|cardiovascular risk factors|cardiovascular risk factors
4769401|NCT02803645|markers of arterial inflammation|markers of arterial inflammation
4769402|NCT02803645|markers of oxidative stress|markers of oxidative stress
4769403|NCT02803632|young|young
4769404|NCT02803632|disruptive mood dysregulation disorder|disruptive mood dysregulation disorder
4769405|NCT02803632|actigraphic profile|actigraphic profile
4769406|NCT02803619|Non-small cell lung cancer|non-small cell lung cancer
4769407|NCT02803619|leptomeningeal metastasis|leptomeningeal metastasis
4769408|NCT02803619|EGFR sensitive mutations|egfr sensitive mutations
4769409|NCT02803606|hypothermia|hypothermia
4769410|NCT02803606|routine care|routine care
4769411|NCT02803606|preterm neonates|preterm neonates
4769412|NCT02803593|a technology-based intervention|a technology-based intervention
4769413|NCT02803593|Asian American|asian american
4769414|NCT02803593|survivorship|survivorship
4769415|NCT02803541|chronic kidney disease|chronic kidney disease
4769416|NCT02803541|exercise|exercise
4769417|NCT02803541|pediatrics|pediatrics
4769418|NCT02803541|summer camp|summer camp
4769419|NCT02803515|intra peritonal chemo hyperthermia|intra peritonal chemo hyperthermia
4769420|NCT02803515|peritoneal carcinomatosis|peritoneal carcinomatosis
4769421|NCT02803515|ovarian cancer|ovarian cancer
4769422|NCT02803502|thrombin generation test|thrombin generation test
4769423|NCT02803502|factor VIII|factor viii
4769424|NCT02803502|hemophilia|hemophilia
4769425|NCT02803489|chronic heart failure|chronic heart failure
4769426|NCT02803489|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
4769427|NCT02803489|diabetes|diabetes
4769428|NCT02803476|PCO|pco
4769429|NCT02803476|Vitamin D|vitamin d
4769430|NCT02803476|Insulin resistance|insulin resistance
4769431|NCT02803463|peritoneal closure|peritoneal closure
4769432|NCT02803463|appendectomy|appendectomy
4769433|NCT02803463|postoperative pain|postoperative pain
4769434|NCT02803463|life quality|life quality
4769435|NCT02803450|Effects of; Anesthesia|effects of; anesthesia
4769436|NCT02803450|spinal and epidural|spinal and epidural
4769437|NCT02803437|Castration-resistant prostate cancer|castration-resistant prostate cancer
4769536|NCT02802748|metronomic vinorelbine|metronomic vinorelbine
4769438|NCT02803424|robot-assisted laparoscopic radical prostatectomy|robot-assisted laparoscopic radical prostatectomy
4769439|NCT02803424|Autoflow|autoflow
4769440|NCT02803424|trendelenburg position|trendelenburg position
4769441|NCT02803424|pneumoperitoneum|pneumoperitoneum
4769442|NCT02803411|Coronary Heart Disease|coronary heart disease
4769443|NCT02803411|Coronary Computed Tomography Angiography (CCTA)|coronary computed tomography angiography (ccta)
4769444|NCT02803411|Coronary Atherosclerotic Plaque|coronary atherosclerotic plaque
4769445|NCT02803411|coronary atherosclerosis|coronary atherosclerosis
4769446|NCT02803398|Compression bandages|compression bandages
4769447|NCT02803385|Patient Controlled Epidural Analgesia|patient controlled epidural analgesia
4769448|NCT02803385|Continous Epidural Infusion Analgesia|continous epidural infusion analgesia
4769449|NCT02803372|partial nephrectomy|partial nephrectomy
4769450|NCT02803372|acute kidney injury|acute kidney injury
4769451|NCT02803372|LiDCOrapid|lidcorapid
4769452|NCT02803372|circulatory management|circulatory management
4769453|NCT02803359|Laryngeal evoked brainstem response (LEBR)|laryngeal evoked brainstem response (lebr)
4769454|NCT02803359|laryngopharyngeal sensory discrimination testing (LPSDT)|laryngopharyngeal sensory discrimination testing (lpsdt)
4769455|NCT02803359|brainstem activity|brainstem activity
4769456|NCT02803346|sepsis|sepsis
4769457|NCT02803346|septic shock|septic shock
4769458|NCT02803346|immunosuppression|immunosuppression
4769459|NCT02803346|HLA-DR|hla-dr
4769460|NCT02803346|lymphopenia|lymphopenia
4769461|NCT02803333|NSCLC|nsclc
4769462|NCT02803333|Carcinoma, Non-Small-Cell Lung|carcinoma, non-small-cell lung
4769463|NCT02803333|Lung Diseases|lung diseases
4769464|NCT02803333|Thoracic Neoplasms|thoracic neoplasms
4769465|NCT02803320|Sunscreen active|sunscreen active
4769466|NCT02803307|osteoarthritis of the knee|osteoarthritis of the knee
4769467|NCT02803307|TLC599|tlc599
4769468|NCT02803307|Dexamethasone|dexamethasone
4769469|NCT02803307|DSP|dsp
4769470|NCT02803255|Injuries|injuries
4769471|NCT02803255|Spinal Cord|spinal cord
4769472|NCT02803242|copd|copd
4769473|NCT02803242|emphysema|emphysema
4769474|NCT02803242|bronchitis|bronchitis
4769475|NCT02803242|bronchiectasis|bronchiectasis
4769476|NCT02803203|Osimertinib|osimertinib
4769477|NCT02803203|bevacizumab|bevacizumab
4769478|NCT02803203|metastatic|metastatic
4769479|NCT02803203|16-033|16-033
4769480|NCT02803190|Spine curve|spine curve
4769481|NCT02803190|Posture|posture
4769482|NCT02803190|Fracture|fracture
4769483|NCT02803190|sarcopenia|sarcopenia
4769484|NCT02803190|Exercise|exercise
4769485|NCT02803177|large bone defect|large bone defect
4769486|NCT02803177|bone marrow-derived mononuclear cells|bone marrow-derived mononuclear cells
4769487|NCT02803151|Stereotactic ablative radiotherapy|stereotactic ablative radiotherapy
4769488|NCT02803151|Lymph node metastasis|lymph node metastasis
4769489|NCT02803151|T cell immunity|t cell immunity
4769490|NCT02803151|cell-free DNA|cell-free dna
4769491|NCT02803138|Chronic Hepatitis C|chronic hepatitis c
4769492|NCT02803138|Paritaprevir/r - Ombitasvir, ± Dasabuvir|paritaprevir/r - ombitasvir, ± dasabuvir
4769493|NCT02803138|Sustained Virological Response|sustained virological response
4769494|NCT02803138|Observational Study|observational study
4769495|NCT02803138|Chronic Hepatitis C genotype 1|chronic hepatitis c genotype 1
4769496|NCT02803138|Chronic Hepatitis C genotype 4|chronic hepatitis c genotype 4
4769497|NCT02803125|PTSD|ptsd
4769498|NCT02803125|Aging|aging
4769499|NCT02803125|Veteran|veteran
4769500|NCT02803125|Intervention|intervention
4769501|NCT02803086|Prostate cancer|prostate cancer
4769502|NCT02803086|Radiotherapy|radiotherapy
4769503|NCT02803086|Hematopoietic stem cells|hematopoietic stem cells
4769504|NCT02803086|Radiotoxicity|radiotoxicity
4769505|NCT02802982|Thrombocytopenia|thrombocytopenia
4769506|NCT02802982|Neonates|neonates
4769507|NCT02802956|Life participation|life participation
4769508|NCT02802943|CLL, Peptid Vaccination|cll, peptid vaccination
4769509|NCT02802917|Eye stinging potential|eye stinging potential
4769510|NCT02802904|Healthy subjects|healthy subjects
4769511|NCT02802891|Asthma|asthma
4769512|NCT02802891|Allergy|allergy
4769513|NCT02802891|Diagnosis|diagnosis
4769514|NCT02802891|Endocrine disruptors|endocrine disruptors
4769515|NCT02802891|Children|children
4769516|NCT02802839|Virtual Reality|virtual reality
4769517|NCT02802839|venipuncture|venipuncture
4769518|NCT02802826|Exercise|exercise
4769519|NCT02802826|Chemotherapy|chemotherapy
4769520|NCT02802826|Physical Activity|physical activity
4769521|NCT02802826|Breast Cancer|breast cancer
4769522|NCT02802813|Single-blinded controlled trial|single-blinded controlled trial
4769523|NCT02802813|Primaquine|primaquine
4769524|NCT02802787|Quality of life|quality of life
4769525|NCT02802787|Occupation|occupation
4769526|NCT02802787|Pain|pain
4769527|NCT02802787|Fatigue|fatigue
4769528|NCT02802774|Post-operative treatment|post-operative treatment
4769529|NCT02802748|Early Breast Cancer|early breast cancer
4769530|NCT02802748|Hormone Receptor-positive|hormone receptor-positive
4769531|NCT02802748|Window-of-opportunity|window-of-opportunity
4769532|NCT02802748|PAM50|pam50
4769533|NCT02802748|Luminal A|luminal a
4769534|NCT02802748|Luminal B|luminal b
4769535|NCT02802748|proliferation signature|proliferation signature
4769538|NCT02802735|Pharmacokinetics|pharmacokinetics
4769539|NCT02802735|Apremilast|apremilast
4769540|NCT02802735|Healthy Adult Male|healthy adult male
4769541|NCT02802735|Korean Subjects|korean subjects
4769542|NCT02802722|convalescence|convalescence
4769543|NCT02802722|inflammation|inflammation
4769544|NCT02802722|resolution|resolution
4769545|NCT02802722|vitamin D|vitamin d
4769546|NCT02802709|knee|knee
4769547|NCT02802696|Transfusion|transfusion
4769548|NCT02802696|Transfusion Medicine|transfusion medicine
4769549|NCT02802696|Diuretic|diuretic
4769550|NCT02802683|Hypotension|hypotension
4769551|NCT02802683|cesarean section|cesarean section
4769552|NCT02802657|Age-related Macular Degeneration|age-related macular degeneration
4769553|NCT02802657|Conbercept|conbercept
4769554|NCT02802657|Treat-and-Extend Regimen|treat-and-extend regimen
4769555|NCT02802657|Pro Re Nata|pro re nata
4769556|NCT02802631|Bacterial infections|bacterial infections
4769557|NCT02802618|Validity|validity
4769558|NCT02802618|Reliability|reliability
4769559|NCT02802618|Rehabilitation|rehabilitation
4769560|NCT02802618|Translation|translation
4769561|NCT02802618|Education|education
4769562|NCT02802579|obesity|obesity
4769563|NCT02802579|dual source CT|dual source ct
4769564|NCT02802579|coronary CT angiography|coronary ct angiography
4769565|NCT02802579|prognosis|prognosis
4769566|NCT02802579|bariatric surgery|bariatric surgery
4769567|NCT02802579|gastric bypass surgery|gastric bypass surgery
4769568|NCT02802579|coronary arterial disease|coronary arterial disease
4769569|NCT02802579|major adverse coronary event|major adverse coronary event
4769570|NCT02802566|Maternal Obesity|maternal obesity
4769571|NCT02802566|Inflammation|inflammation
4769572|NCT02802553|SmartGoggles|smartgoggles
4769573|NCT02802553|sentinel lymph nodes|sentinel lymph nodes
4769574|NCT02802553|indocyanine green|indocyanine green
4769575|NCT02802553|Cardio-Green|cardio-green
4769576|NCT02802553|Spy Elite|spy elite
4769577|NCT02802540|nabilone|nabilone
4769578|NCT02802540|anorexia|anorexia
4769579|NCT02802540|Non-Small Cell Lung Cancer|non-small cell lung cancer
4769580|NCT02802514|Gastrointestinal|gastrointestinal
4769581|NCT02802514|Glucagon like peptide|glucagon like peptide
4769582|NCT02802514|Nausea|nausea
4769583|NCT02802514|Magnetic resonance imaging|magnetic resonance imaging
4769584|NCT02802501|Safety|safety
4769585|NCT02802501|Artemisinin Combination Therapy|artemisinin combination therapy
4769586|NCT02802501|Efficacy|efficacy
4769587|NCT02802501|Tafenoquine|tafenoquine
4769588|NCT02802501|Superiority|superiority
4769589|NCT02802501|Primaquine|primaquine
4769590|NCT02802501|Radical cure|radical cure
4769591|NCT02802501|Vivax|vivax
4769592|NCT02802501|ACT|act
4769593|NCT02802501|Plasmodium vivax malaria|plasmodium vivax malaria
4769594|NCT02802501|Dihydroartemisinin-piperaquine|dihydroartemisinin-piperaquine
4769595|NCT02802488|D-dimers|d-dimers
4769596|NCT02802488|Atrial fibrillation|atrial fibrillation
4769597|NCT02802475|antibodies|antibodies
4769598|NCT02802475|auto-immune encephalitis|auto-immune encephalitis
4769599|NCT02802475|epilepsy|epilepsy
4769600|NCT02802475|limbic encephalitis|limbic encephalitis
4769601|NCT02802462|endothelial progenitor cell|endothelial progenitor cell
4769602|NCT02802462|hemodynamic|hemodynamic
4769603|NCT02802462|Exercise|exercise
4769604|NCT02802462|HIIT|hiit
4769605|NCT02802449|Vitamin D|vitamin d
4769606|NCT02802449|Hypovitaminosis D|hypovitaminosis d
4769607|NCT02802449|HTN|htn
4769608|NCT02802423|TNBC|tnbc
4769609|NCT02802423|Breast cancer|breast cancer
4769610|NCT02802423|Triple negative|triple negative
4769611|NCT02802397|Early ovarian reserve decreased|early ovarian reserve decreased
4769612|NCT02802384|Paget's Disease of Bone|paget's disease of bone
4769613|NCT02802384|Healthy controls|healthy controls
4769614|NCT02802371|caregiver burden|caregiver burden
4769615|NCT02802371|Alzheimer disease and related disorders|alzheimer disease and related disorders
4769616|NCT02802371|elderly|elderly
4769617|NCT02802371|pharmaceutical care|pharmaceutical care
4769618|NCT02802371|optimization of drug prescribing|optimization of drug prescribing
4769619|NCT02802371|psychosocial intervention|psychosocial intervention
4769620|NCT02802358|Falls|falls
4769621|NCT02802358|Functionality|functionality
4769622|NCT02802332|neonatal|neonatal
4769623|NCT02802332|preterm|preterm
4769624|NCT02802332|Nepal|nepal
4769625|NCT02802332|family-initiated identification|family-initiated identification
4769626|NCT02802332|basic newborn care|basic newborn care
4769627|NCT02802306|Angioplasty|angioplasty
4769628|NCT02802306|Peripheral Artery Disease|peripheral artery disease
4769629|NCT02802306|PAD|pad
4769630|NCT02802306|Lesion|lesion
4769631|NCT02802306|Claudication|claudication
4769632|NCT02802293|Repetitive Transcranial Magnetic Stimulation|repetitive transcranial magnetic stimulation
4769633|NCT02802293|Major Depressive Disorder|major depressive disorder
4769634|NCT02802280|endothelial dysfunction|endothelial dysfunction
4769635|NCT02802254|physical activity|physical activity
4769636|NCT02802254|patient feedback|patient feedback
4769637|NCT02802254|risk perception|risk perception
4769638|NCT02802254|pedometer|pedometer
4769639|NCT02802215|Diabetes Mellitus|diabetes mellitus
4769640|NCT02802215|Pregnancy|pregnancy
4769641|NCT02802202|Palpation|palpation
4769642|NCT02802202|Chronic Pain|chronic pain
4769643|NCT02802202|Muscle|muscle
4769644|NCT02802189|Chronic Mechanical Neck Pain|chronic mechanical neck pain
4769645|NCT02802189|exercise|exercise
4769646|NCT02802189|Integrated Neuromuscular Inhibition Technique|integrated neuromuscular inhibition technique
4769647|NCT02802163|untreated multiple myeloma|untreated multiple myeloma
4769648|NCT02802163|newly diagnosed myeloma|newly diagnosed myeloma
4769649|NCT02802163|transplant eligible|transplant eligible
4769650|NCT02802150|Zanthoxylum schinifolium seed Oil|zanthoxylum schinifolium seed oil
4769651|NCT02802150|soy bean oil|soy bean oil
4769652|NCT02802150|omega-3 fatty acid|omega-3 fatty acid
4769653|NCT02802150|dry eye disease|dry eye disease
4769654|NCT02802137|tafluprost|tafluprost
4769655|NCT02802137|dorzolamide|dorzolamide
4769656|NCT02802137|timolol|timolol
4769657|NCT02802137|FC|fc
4769658|NCT02802124|hepatocellular carcinoma|hepatocellular carcinoma
4769659|NCT02802124|carbon-ion radiotherapy|carbon-ion radiotherapy
4769660|NCT02802124|toxicity|toxicity
4769661|NCT02802124|efficacy|efficacy
4769662|NCT02802111|Beta Agonists|beta agonists
4769663|NCT02802111|Asthma|asthma
4769664|NCT02802111|Albuterol|albuterol
4769665|NCT02802111|Levalbuterol|levalbuterol
4769666|NCT02802098|Metastatic breast cancer|metastatic breast cancer
4769667|NCT02802098|bevacizumab maintenance|bevacizumab maintenance
4769668|NCT02802098|Durvalumab|durvalumab
4769669|NCT02802085|Total Knee Arthroplasty|total knee arthroplasty
4769670|NCT02802085|Total Knee Replacement|total knee replacement
4769671|NCT02802085|TKA|tka
4769672|NCT02802085|TKR|tkr
4769673|NCT02802085|Stiffness of Knee|stiffness of knee
4769674|NCT02802085|Deformity|deformity
4769675|NCT02802085|Knee Joint|knee joint
4769676|NCT02802085|Instability|instability
4769677|NCT02802085|Post-traumatic|post-traumatic
4769678|NCT02802085|Arthrosis|arthrosis
4769679|NCT02802046|FFRCT|ffrct
4769680|NCT02802046|Angina pectoris grade|angina pectoris grade
4769681|NCT02802046|Fractional flow reserve|fractional flow reserve
4769682|NCT02802046|CCTA|ccta
4769683|NCT02802033|Registry|registry
4769684|NCT02802033|Spine|spine
4769685|NCT02802033|Osteobiologics|osteobiologics
4769686|NCT02802033|Spinal Fusion|spinal fusion
4769687|NCT02801994|Patient-ventilator interaction|patient-ventilator interaction
4769688|NCT02801994|Inspiratory muscles|inspiratory muscles
4769689|NCT02801994|Electromyogram|electromyogram
4769690|NCT02801994|Mechanical ventilation|mechanical ventilation
4769691|NCT02801994|Proportional Assist Ventilation|proportional assist ventilation
4769692|NCT02801981|tolerability|tolerability
4769693|NCT02801981|healthy volunteers|healthy volunteers
4769694|NCT02801981|Cholestasis|cholestasis
4769695|NCT02801981|safety|safety
4769696|NCT02801955|gastric adenocarcinoma|gastric adenocarcinoma
4769697|NCT02801955|tumor markers|tumor markers
4769698|NCT02801955|peritoneal cytology|peritoneal cytology
4769699|NCT02801942|Biomarker|biomarker
4769700|NCT02801942|Immune Profile|immune profile
4769701|NCT02801942|Biopsy|biopsy
4769702|NCT02801942|Leukocyte subsets|leukocyte subsets
4769703|NCT02801942|Inguinal lymph nodes|inguinal lymph nodes
4769704|NCT02801942|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
4769705|NCT02801916|Humans|humans
4769706|NCT02801916|Glycemic response|glycemic response
4769707|NCT02801916|Oat beta-glucan|oat beta-glucan
4769708|NCT02801877|Depression|depression
4769709|NCT02801877|Anxiety|anxiety
4769710|NCT02801877|Behavior Therapy|behavior therapy
4769711|NCT02801877|Technology Assisted|technology assisted
4769712|NCT02801877|Mobile Phone|mobile phone
4769713|NCT02801877|Cellular Phone|cellular phone
4769714|NCT02801877|Smartphone|smartphone
4769715|NCT02801877|App|app
4769716|NCT02801877|Coach|coach
4769717|NCT02801864|tDCS|tdcs
4769718|NCT02801864|transcranial direct current stimulation|transcranial direct current stimulation
4769719|NCT02801864|intensive speech therapy|intensive speech therapy
4769720|NCT02801864|chronic|chronic
4769721|NCT02801864|post stroke|post stroke
4769722|NCT02801864|aphasia|aphasia
4769723|NCT02801864|production|production
4769724|NCT02801864|language|language
4769725|NCT02801851|Delirium|delirium
4769726|NCT02801838|Inspiratory muscles|inspiratory muscles
4769727|NCT02801838|Patient-ventilator interaction|patient-ventilator interaction
4769728|NCT02801838|Electromyogram|electromyogram
4769729|NCT02801838|Mechanical ventilation|mechanical ventilation
4769730|NCT02801825|axillay artery|axillay artery
4769731|NCT02801825|cannulation|cannulation
4769732|NCT02801825|femoral artery|femoral artery
4769733|NCT02801812|Nailfold Capillaroscopy|nailfold capillaroscopy
4769734|NCT02801799|Anaesthesia|anaesthesia
4769735|NCT02801799|Analgesia|analgesia
4769736|NCT02801799|Nerve blocks|nerve blocks
4769737|NCT02801799|Peripheral nerve blocks|peripheral nerve blocks
4769738|NCT02801799|Regional anaesthesia|regional anaesthesia
4769739|NCT02801799|therapeutic techniques|therapeutic techniques
4769740|NCT02801799|ropivacaine|ropivacaine
4769741|NCT02801799|nerve block duration|nerve block duration
4769742|NCT02801799|lower limb|lower limb
4769743|NCT02801799|Postoperative pain|postoperative pain
4769744|NCT02801786|Mammography|mammography
4769745|NCT02801786|Premedication|premedication
4769746|NCT02801786|Pain|pain
4769747|NCT02801786|Discomfort|discomfort
4769748|NCT02801786|Breast|breast
4769749|NCT02801773|gingivitis|gingivitis
4769750|NCT02801773|probiotic|probiotic
4769751|NCT02801773|non- surgical treatment|non- surgical treatment
4769752|NCT02801760|HIV|hiv
4769753|NCT02801760|Self-Consent|self-consent
4769754|NCT02801760|PrEP|prep
4769755|NCT02801760|Autonomous Research Consent|autonomous research consent
4769756|NCT02801760|Participation-associated Outcomes|participation-associated outcomes
4769757|NCT02801747|HIV care continuum|hiv care continuum
4769758|NCT02801747|antiretroviral therapy|antiretroviral therapy
4769759|NCT02801747|engagement in HIV care|engagement in hiv care
4769760|NCT02801747|Multiphase Optimization Strategy (MOST)|multiphase optimization strategy (most)
4769761|NCT02801708|Embolic stroke of undetermined source|embolic stroke of undetermined source
4769762|NCT02801708|Atrial fibrillation|atrial fibrillation
4769763|NCT02801695|pre-eclampsia|pre-eclampsia
4769764|NCT02801695|citrulline|citrulline
4769765|NCT02801695|pregnancy|pregnancy
4769766|NCT02801669|anticoagulants|anticoagulants
4769767|NCT02801669|DU-176b|du-176b
4769768|NCT02801669|edoxaban|edoxaban
4769769|NCT02801669|factor Xa|factor xa
4769770|NCT02801669|oral|oral
4769771|NCT02801669|prevention|prevention
4769772|NCT02801669|atrial fibrillation|atrial fibrillation
4769773|NCT02801643|PET|pet
4769774|NCT02801643|dopamine|dopamine
4769775|NCT02801643|fMRI|fmri
4769776|NCT02801643|reward|reward
4769777|NCT02801617|Latanoprost|latanoprost
4769778|NCT02801617|Glaucoma|glaucoma
4769779|NCT02801617|Ocular hypertension|ocular hypertension
4769780|NCT02801617|Crossover study|crossover study
4769781|NCT02801578|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
4769782|NCT02801578|CLL|cll
4769783|NCT02801578|Malignant neoplasms stated as primary lymphoid haematopoietic|malignant neoplasms stated as primary lymphoid haematopoietic
4769784|NCT02801578|Ibrutinib|ibrutinib
4769785|NCT02801578|PCI-32765|pci-32765
4769786|NCT02801578|Imbruvica|imbruvica
4769787|NCT02801578|Pharmacodynamics|pharmacodynamics
4769788|NCT02801552|regenerative endodontic treatment|regenerative endodontic treatment
4769789|NCT02801552|platelet-rich fibrin|platelet-rich fibrin
4769790|NCT02801552|Immature permanent tooth|immature permanent tooth
4769791|NCT02801552|apical periodontitis|apical periodontitis
4769792|NCT02801513|mindfulness|mindfulness
4769793|NCT02801513|EEG|eeg
4769794|NCT02801513|error-related negativity|error-related negativity
4769795|NCT02801513|late positive potential|late positive potential
4769796|NCT02801513|long-range temporal correlations|long-range temporal correlations
4769797|NCT02801500|bilioenteric anastomosis|bilioenteric anastomosis
4769798|NCT02801487|Carbon Ion Therapy|carbon ion therapy
4769799|NCT02801487|Concurrent Chemoradiotherapy|concurrent chemoradiotherapy
4769800|NCT02801435|EGFR inhibitor|egfr inhibitor
4769801|NCT02801435|topical agent|topical agent
4769802|NCT02801435|psoriasis|psoriasis
4769803|NCT02801435|phase 1|phase 1
4769804|NCT02801422|cannabis|cannabis
4769805|NCT02801422|fMRI|fmri
4769806|NCT02801422|addiction|addiction
4769807|NCT02801422|relapse|relapse
4769808|NCT02801409|Lung Cancer|lung cancer
4769809|NCT02801409|Surgical Resection|surgical resection
4769810|NCT02801409|Epidural Anesthesia and Analgesia|epidural anesthesia and analgesia
4769811|NCT02801409|Long-Term Outcome|long-term outcome
4769812|NCT02801357|substance withdrawal syndrome|substance withdrawal syndrome
4769813|NCT02801357|opiate addiction|opiate addiction
4769814|NCT02801357|opiate dependence|opiate dependence
4769815|NCT02801357|opioid withdrawal syndrome|opioid withdrawal syndrome
4769816|NCT02801357|buprenorphine|buprenorphine
4769817|NCT02801344|exercise|exercise
4769818|NCT02801344|performance|performance
4769819|NCT02801344|recovery|recovery
4769820|NCT02801344|muscle|muscle
4769821|NCT02801344|protein|protein
4769822|NCT02801331|Stochastic Resonance|stochastic resonance
4769823|NCT02801331|Fetus/Newborn Infant|fetus/newborn infant
4769824|NCT02801331|Drug Withdrawal|drug withdrawal
4769825|NCT02801331|Substance Abuse|substance abuse
4769826|NCT02801318|Patient|patient
4769827|NCT02801305|Scleroderma|scleroderma
4769828|NCT02801305|Diltiazem|diltiazem
4769829|NCT02801305|Nitroglycerin|nitroglycerin
4769830|NCT02801305|Topical|topical
4769831|NCT02801279|Cerebral Palsy|cerebral palsy
4769832|NCT02801279|Occupational Therapy|occupational therapy
4769833|NCT02801279|Upper Limb Motor Training|upper limb motor training
4769834|NCT02801266|Contraception|contraception
4769835|NCT02801266|Reproductive and Sexual Health|reproductive and sexual health
4769836|NCT02801266|Counseling|counseling
4769837|NCT02801266|Contraceptive Counseling|contraceptive counseling
4769838|NCT02801240|Inflammatory Bowel Disease|inflammatory bowel disease
4769839|NCT02801227|premature rupture of membrane|premature rupture of membrane
4769840|NCT02801227|primipara|primipara
4769841|NCT02801227|term|term
4769842|NCT02801227|bishop|bishop
4769843|NCT02801214|cannabis|cannabis
4769844|NCT02801214|fMRI|fmri
4769845|NCT02801214|emotion|emotion
4769846|NCT02801201|sedation|sedation
4769847|NCT02801201|spinal anesthesia|spinal anesthesia
4769848|NCT02801162|arterial blood gas|arterial blood gas
4769849|NCT02801123|Complimentary Cancer Therapies|complimentary cancer therapies
4769850|NCT02801123|Psychosocial Oncology|psychosocial oncology
4769851|NCT02801123|Behavioural Medicine|behavioural medicine
4769852|NCT02801123|Mindfulness Based Cancer Recovery|mindfulness based cancer recovery
4769853|NCT02801123|Tai Chi|tai chi
4769854|NCT02801123|Qigong|qigong
4769855|NCT02801123|Mindfulness-Based Stress Reduction|mindfulness-based stress reduction
4769856|NCT02801123|Yoga|yoga
4769857|NCT02801123|Preference-based trial|preference-based trial
4769858|NCT02801084|Reduced|reduced
4769859|NCT02801084|Environmental|environmental
4769860|NCT02801084|Stimulation|stimulation
4769861|NCT02801071|Post-Polio Syndrome|post-polio syndrome
4769862|NCT02801071|PPS|pps
4769863|NCT02801058|Osteopathic manipulative treatment|osteopathic manipulative treatment
4769864|NCT02801058|Abdominal Diaphragm mobility|abdominal diaphragm mobility
4769865|NCT02801058|Thoracic Ultrasounds|thoracic ultrasounds
4769866|NCT02800980|lymphocele|lymphocele
4769867|NCT02800980|sclerotherapy|sclerotherapy
4769868|NCT02800980|drainage|drainage
4769869|NCT02800980|percutaneous|percutaneous
4769870|NCT02800967|platelet activation|platelet activation
4769871|NCT02800967|platelet aggregation|platelet aggregation
4769872|NCT02800967|Aronia|aronia
4769873|NCT02800967|flow cytometry|flow cytometry
4769874|NCT02800967|polyphenols|polyphenols
4769875|NCT02800967|cardiovascular disease risk|cardiovascular disease risk
4769876|NCT02800954|Multiple Myeloma|multiple myeloma
4769877|NCT02800954|bone lesions|bone lesions
4769878|NCT02800954|Macrophage-Colony Stimulating Factor|macrophage-colony stimulating factor
4769879|NCT02800941|Pulmonary Arterial hypertension|pulmonary arterial hypertension
4769880|NCT02800941|Oral anticoagulants|oral anticoagulants
4769881|NCT02800941|Major bleedings|major bleedings
4769882|NCT02800915|Spinal Cord Injury|spinal cord injury
4769883|NCT02800915|Pressure Ulcer|pressure ulcer
4769884|NCT02800915|Health Related Quality of Life|health related quality of life
4769885|NCT02800915|Telemedicine|telemedicine
4769886|NCT02800915|Service Innovation|service innovation
4769887|NCT02800915|Rehabilitation|rehabilitation
4769888|NCT02800915|Interdisciplinary collaboration|interdisciplinary collaboration
4769889|NCT02800915|User- participation|user- participation
4769890|NCT02800915|Activity and participation|activity and participation
4769891|NCT02800915|Health economics|health economics
4769892|NCT02800889|relapsed|relapsed
4769893|NCT02800889|refractory|refractory
4769894|NCT02800889|solid tumors|solid tumors
4769895|NCT02800850|Dementia|dementia
4769896|NCT02800850|Depression|depression
4769897|NCT02800850|Agitation|agitation
4769898|NCT02800850|Bright Light|bright light
4769899|NCT02800837|left main|left main
4769900|NCT02800837|stent|stent
4769901|NCT02800837|self-expandable|self-expandable
4769902|NCT02800837|DES|des
4769903|NCT02800837|Stentys|stentys
4769904|NCT02800811|FR104|fr104
4769905|NCT02800811|CD28|cd28
4769906|NCT02800811|immunomodulation|immunomodulation
4769907|NCT02800811|T regulatory cell|t regulatory cell
4769908|NCT02800811|Pegylated monovalent anti-CD28 Fab antibody|pegylated monovalent anti-cd28 fab antibody
4769909|NCT02800798|Obstructive sleep apnea|obstructive sleep apnea
4769910|NCT02800798|Preeclampsia|preeclampsia
4769911|NCT02800798|Pregnancy|pregnancy
4769912|NCT02800798|Stopbang|stopbang
4769913|NCT02800772|pancreatic duct|pancreatic duct
4769914|NCT02800772|ERCP|ercp
4769915|NCT02800772|acetic acid|acetic acid
4769916|NCT02800746|Prognathic surgery|prognathic surgery
4769917|NCT02800746|intravenous iron|intravenous iron
4769918|NCT02800720|Fibromyalgia Syndromey|fibromyalgia syndromey
4769919|NCT02800681|Asperger Syndrome|asperger syndrome
4769920|NCT02800681|Autism Spectrum Disorder|autism spectrum disorder
4769921|NCT02800681|Schizotypal disorder|schizotypal disorder
4769922|NCT02800681|Schizophrenia Spectrum Disorder|schizophrenia spectrum disorder
4769923|NCT02800681|Psychopathology|psychopathology
4769924|NCT02800681|Examination of Anomalous Self Disorder|examination of anomalous self disorder
4769925|NCT02800681|Autism Diagnostic Observation Schedule|autism diagnostic observation schedule
4769926|NCT02800681|Phenomenology|phenomenology
4769927|NCT02800681|Differential diagnosis|differential diagnosis
4769928|NCT02800681|Young Adult|young adult
4769929|NCT02800668|Duodenal Jejunal Bypass Liner|duodenal jejunal bypass liner
4769930|NCT02800668|obesity|obesity
4769931|NCT02800668|weight loss therapy|weight loss therapy
4769932|NCT02800655|ARV treatment Naive|arv treatment naive
4769933|NCT02800655|Medication Adherence|medication adherence
4769934|NCT02800655|Digital Health Feedback System|digital health feedback system
4769935|NCT02800655|Proteus Digital Health|proteus digital health
4769936|NCT02800642|Bayer|bayer
4769937|NCT02800642|Aflibercept|aflibercept
4769938|NCT02800642|Eylea|eylea
4769939|NCT02800642|Intravitreal|intravitreal
4769940|NCT02800616|Academic Achievement|academic achievement
4769941|NCT02800616|Accelerometry|accelerometry
4769942|NCT02800616|Children|children
4769943|NCT02800616|Primary school Intervention|primary school intervention
4769944|NCT02800616|Nutrition|nutrition
4769945|NCT02800616|Obesity|obesity
4769946|NCT02800616|Physical Activity|physical activity
4769947|NCT02800616|Prevention|prevention
4769948|NCT02800616|School Health|school health
4769949|NCT02800603|preschool mental health|preschool mental health
4769950|NCT02800603|emotional and behaviour problems|emotional and behaviour problems
4769951|NCT02800590|Adult participants|adult participants
4769952|NCT02800590|Sedation|sedation
4769953|NCT02800590|elective|elective
4769954|NCT02800525|Benign pigmented lesions|benign pigmented lesions
4769955|NCT02800525|Picosecond laser|picosecond laser
4769956|NCT02800525|Q-switched laser|q-switched laser
4769957|NCT02800512|pelvic organ prolapse|pelvic organ prolapse
4769958|NCT02800512|cystocele|cystocele
4769959|NCT02800512|rectocele|rectocele
4769960|NCT02800512|enterocele|enterocele
4769961|NCT02800473|Bladder cancer|bladder cancer
4769962|NCT02800473|Hexvix|hexvix
4769963|NCT02800473|Bimodal Endoscopic Imager|bimodal endoscopic imager
4769964|NCT02800473|Cystoscopy|cystoscopy
4769965|NCT02800460|Subthalamic nucleus|subthalamic nucleus
4769966|NCT02800460|Basal ganglia|basal ganglia
4769967|NCT02800460|Parkinson disease|parkinson disease
4769968|NCT02800460|Magnetic Resonance Imaging|magnetic resonance imaging
4769969|NCT02800460|Susceptibility-Weighted Imaging|susceptibility-weighted imaging
4769970|NCT02800434|allograft|allograft
4769971|NCT02800434|hands|hands
4769972|NCT02800434|immunosuppression|immunosuppression
4769973|NCT02800434|fMRI|fmri
4769974|NCT02800395|Alzheimer|alzheimer
4769975|NCT02800395|oxydative stress|oxydative stress
4769976|NCT02800395|nutrition|nutrition
4769977|NCT02800395|biomarkers|biomarkers
4769978|NCT02800382|paraoxonase|paraoxonase
4769979|NCT02800382|lung diseases|lung diseases
4769980|NCT02800369|Human papillomavirus|human papillomavirus
4769981|NCT02800369|cervical intraepithelial neoplasia|cervical intraepithelial neoplasia
4769982|NCT02800369|zinc finger nuclease|zinc finger nuclease
4769983|NCT02800356|Age-Related Macular Degeneration|age-related macular degeneration
4769984|NCT02800356|Geographic Atrophy|geographic atrophy
4769985|NCT02800356|Reticular pseudodrusen|reticular pseudodrusen
4769986|NCT02800356|Lasers|lasers
4769987|NCT02800356|PASCAL 577|pascal 577
4769988|NCT02800304|malnutrition|malnutrition
4769989|NCT02800304|food intake|food intake
4769990|NCT02800304|frailty|frailty
4769991|NCT02800291|food intake|food intake
4769992|NCT02800265|healthy volunteer|healthy volunteer
4769993|NCT02800265|healthy|healthy
4769994|NCT02800265|cancer prevention|cancer prevention
4769995|NCT02800265|prevention|prevention
4769996|NCT02800252|fatty acids|fatty acids
4769997|NCT02800252|aspirin|aspirin
4769998|NCT02800252|diabetes mellitus|diabetes mellitus
4769999|NCT02800252|chronic periodontitis|chronic periodontitis
4770000|NCT02800252|periodontal debridement|periodontal debridement
4770001|NCT02800200|platelet rich plasma|platelet rich plasma
4770002|NCT02800200|extracorporeal shock wave|extracorporeal shock wave
4770003|NCT02800122|acute dyspnea|acute dyspnea
4770004|NCT02800122|emergency|emergency
4770005|NCT02800122|acute heart failure|acute heart failure
4770006|NCT02800109|Fetal growth|fetal growth
4770007|NCT02800109|Newborn growth|newborn growth
4770008|NCT02800070|autologous stem cell transplant|autologous stem cell transplant
4770009|NCT02800070|gene therapy|gene therapy
4770010|NCT02800070|Fabry disease|fabry disease
4770011|NCT02800070|lentivirus|lentivirus
4770012|NCT02800070|haematopoietic stem cell transplant|haematopoietic stem cell transplant
4770013|NCT02800018|hypothermia therapy|hypothermia therapy
4770014|NCT02800018|perinatal asphyxia|perinatal asphyxia
4770015|NCT02800005|gastric cancer|gastric cancer
4770016|NCT02800005|gastrectomy|gastrectomy
4770017|NCT02800005|laparotomy|laparotomy
4770018|NCT02800005|surgical outcome|surgical outcome
4770019|NCT02800005|survival|survival
4770020|NCT02800005|abdominal fat area|abdominal fat area
4770021|NCT02800005|Body Mass Index|body mass index
4770022|NCT02799953|diabetes mellitus and hypertension|diabetes mellitus and hypertension
4770023|NCT02799953|consumer health information technology|consumer health information technology
4770024|NCT02799953|self-monitoring|self-monitoring
4770025|NCT02799953|randomized controlled trial|randomized controlled trial
4770026|NCT02799927|Indirect Pulp Treatment|indirect pulp treatment
4770027|NCT02799927|Primary Teeth|primary teeth
4770028|NCT02799927|Biodentine|biodentine
4770029|NCT02799927|Calcium Hydroxide|calcium hydroxide
4770030|NCT02799927|Split-Mouth design|split-mouth design
4770031|NCT02799901|advanced melanoma|advanced melanoma
4770032|NCT02799901|high dose radiotherapy|high dose radiotherapy
4770033|NCT02799901|Nivolumab|nivolumab
4770034|NCT02799888|Graft-versus-host Disease|graft-versus-host disease
4770035|NCT02799888|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
4770036|NCT02799888|Acute Leukemia|acute leukemia
4770037|NCT02799888|Myelodysplastic syndrome|myelodysplastic syndrome
4770038|NCT02799888|Lymphoma|lymphoma
4770039|NCT02799875|respiratory distress syndrome|respiratory distress syndrome
4770040|NCT02799875|permissive hypercapnia|permissive hypercapnia
4770041|NCT02799875|ventilator strategy|ventilator strategy
4770042|NCT02799862|metastatic|metastatic
4770043|NCT02799862|locally advanced|locally advanced
4770044|NCT02799862|unresectable|unresectable
4770045|NCT02799862|NSCLC|nsclc
4770046|NCT02799849|narcolepsy|narcolepsy
4770047|NCT02799849|metabolism|metabolism
4770048|NCT02799823|aortic stenosis|aortic stenosis
4770049|NCT02799823|transcatheter aortic valve replacement|transcatheter aortic valve replacement
4770050|NCT02799810|lung transplantation|lung transplantation
4770051|NCT02799810|psychosocial functioning|psychosocial functioning
4770052|NCT02799810|longitudinal|longitudinal
4770053|NCT02799810|TERS|ters
4770054|NCT02799810|adherence|adherence
4770055|NCT02799810|Quality of life|quality of life
4770056|NCT02799797|adductor canal block|adductor canal block
4770057|NCT02799784|tiotropium|tiotropium
4770058|NCT02799784|COPD|copd
4770059|NCT02799784|olodaterol|olodaterol
4770060|NCT02799784|Umeclidinium bromide|umeclidinium bromide
4770061|NCT02799784|efficacy|efficacy
4770062|NCT02799784|vilanterol|vilanterol
4770063|NCT02799771|Pulmonary arterial hypertension|pulmonary arterial hypertension
4770064|NCT02799771|Interstitial lung disease at HRCT|interstitial lung disease at hrct
4770065|NCT02799745|Therapeutic Cancer Progression|therapeutic cancer progression
4770066|NCT02799745|Pathological Cancer Progression|pathological cancer progression
4770067|NCT02799745|Enzalutamide|enzalutamide
4770068|NCT02799745|Prostate Cancer|prostate cancer
4770069|NCT02799745|Active surveillance|active surveillance
4770070|NCT02799732|Feasibility Study|feasibility study
4770071|NCT02799732|HPV vaccine|hpv vaccine
4770072|NCT02799732|1Dose Trial|1dose trial
4770073|NCT02799719|Fat mass|fat mass
4770074|NCT02799719|hemodialysis patients|hemodialysis patients
4770075|NCT02799719|inflammation|inflammation
4770076|NCT02799719|adipocytokines|adipocytokines
4770077|NCT02799719|bioimpedance spectroscopy|bioimpedance spectroscopy
4770078|NCT02799706|Prostate cancer|prostate cancer
4770079|NCT02799706|GnRH antagonist|gnrh antagonist
4770080|NCT02799706|GnRH agonist|gnrh agonist
4770081|NCT02799706|radiation therapy|radiation therapy
4770082|NCT02799706|very high risk localized prostate cancer|very high risk localized prostate cancer
4770083|NCT02799706|locally advanced prostate cancer|locally advanced prostate cancer
4770084|NCT02799693|Catheter Ablation|catheter ablation
4770085|NCT02799693|Ventricular Tachycardia|ventricular tachycardia
4770086|NCT02799693|Intramural Needle Catheter|intramural needle catheter
4770087|NCT02799680|CART|cart
4770088|NCT02799680|AML|aml
4770089|NCT02799667|negative pressure wound therapy|negative pressure wound therapy
4770090|NCT02799667|cesarean delivery|cesarean delivery
4770091|NCT02799654|Total Hip Arthroplasty|total hip arthroplasty
4770092|NCT02799641|Contraception|contraception
4770093|NCT02799641|IUD|iud
4770094|NCT02799641|levonorgestrel releasing intrauterine device|levonorgestrel releasing intrauterine device
4770095|NCT02799641|lidocaine|lidocaine
4770096|NCT02799641|valium|valium
4770097|NCT02799641|diazepam|diazepam
4770098|NCT02799641|pain|pain
4770099|NCT02799641|VAS|vas
4770100|NCT02799641|visual analog scale|visual analog scale
4770101|NCT02799628|Trust|trust
4770102|NCT02799628|Low Back Pain|low back pain
4770103|NCT02799628|Treatment Outcome|treatment outcome
4770104|NCT02799602|Metastatic hormone sensitive prostate cancer|metastatic hormone sensitive prostate cancer
4770105|NCT02799576|Ultrasound|ultrasound
4770106|NCT02799576|Regional blockade|regional blockade
4770107|NCT02799576|Infraclavicular brachial plexus|infraclavicular brachial plexus
4770108|NCT02799550|CART|cart
4770109|NCT02799550|ALL|all
4770110|NCT02799550|elderly|elderly
4770111|NCT02799550|Relapsed|relapsed
4770112|NCT02799550|Refractory|refractory
4770113|NCT02799550|CD19+|cd19+
4770114|NCT02799511|biological markers|biological markers
4770115|NCT02799498|etanercept|etanercept
4770116|NCT02799498|healthy subject|healthy subject
4770117|NCT02799498|open-label|open-label
4770118|NCT02799498|randomized|randomized
4770119|NCT02799498|PK|pk
4770120|NCT02799498|auto-injection|auto-injection
4770121|NCT02799498|pharmacokinetic|pharmacokinetic
4770122|NCT02799472|GSK3196165|gsk3196165
4770123|NCT02799472|magnetic resonance imaging (MRI)|magnetic resonance imaging (mri)
4770124|NCT02799472|disease-modifying antirheumatic drugs (DMARDs)|disease-modifying antirheumatic drugs (dmards)
4770125|NCT02799472|granulocyte-macrophage colony stimulating factor (GM-CSF)|granulocyte-macrophage colony stimulating factor (gm-csf)
4770126|NCT02799472|Rheumatoid Arthritis|rheumatoid arthritis
4770127|NCT02799472|Methotrexate|methotrexate
4770128|NCT02799459|Hypnoanesthesia|hypnoanesthesia
4770129|NCT02799459|Hypnosis|hypnosis
4770130|NCT02799459|conization|conization
4770131|NCT02799446|sinusitis, rhinitis, rhinosinusitis, chronic|sinusitis, rhinitis, rhinosinusitis, chronic
4770132|NCT02799433|Water|water
4770133|NCT02799433|Physical activity|physical activity
4770134|NCT02799433|Child care|child care
4770135|NCT02799433|Weight change|weight change
4770136|NCT02799420|confocal laser endomicroscopy|confocal laser endomicroscopy
4770137|NCT02799420|undifferentiated gastric cancer|undifferentiated gastric cancer
4770138|NCT02799420|target biopsy|target biopsy
4770139|NCT02799381|carbidopa|carbidopa
4770140|NCT02799381|levodopa|levodopa
4770141|NCT02799381|efficacy|efficacy
4770142|NCT02799381|levodopa-carbidopa intestinal gel|levodopa-carbidopa intestinal gel
4770143|NCT02799381|Advanced Parkinson's Disease|advanced parkinson's disease
4770144|NCT02799303|screening|screening
4770145|NCT02799303|biopsy|biopsy
4770146|NCT02799303|magnetic resonance imaging|magnetic resonance imaging
4770147|NCT02799303|prostate specific antigen|prostate specific antigen
4770148|NCT02799264|fasted|fasted
4770149|NCT02799264|healthy volunteers|healthy volunteers
4770150|NCT02799264|cabotegravir|cabotegravir
4770151|NCT02799264|high fat|high fat
4770152|NCT02799264|pharmacokinetics|pharmacokinetics
4770153|NCT02799264|randomized|randomized
4770154|NCT02799264|Phase I|phase i
4770155|NCT02799264|two way crossover|two way crossover
4770156|NCT02799251|lymphopenia|lymphopenia
4770157|NCT02799251|postoperative infection|postoperative infection
4770158|NCT02799251|thoracic cancer surgery|thoracic cancer surgery
4770159|NCT02799251|digestive cancer surgery|digestive cancer surgery
4770160|NCT02799238|glioblastoma, GBM, immunotherapy, autologous lymphoid effector cells specific against tumour cells, ALECSAT, Stupp regimen, TMZ, radiotherapy/TMZ|glioblastoma, gbm, immunotherapy, autologous lymphoid effector cells specific against tumour cells, alecsat, stupp regimen, tmz, radiotherapy/tmz
4770161|NCT02799225|carbapenems|carbapenems
4770162|NCT02799212|Hepatocellular carcinoma|hepatocellular carcinoma
4770163|NCT02799212|Hepatectomy|hepatectomy
4770164|NCT02799212|Ascites|ascites
4770165|NCT02799212|Somatostatin|somatostatin
4770166|NCT02799186|Spontaneous Coronary Artery Dissection|spontaneous coronary artery dissection
4770167|NCT02799186|haematoma|haematoma
4770168|NCT02799186|Fibromuscular Dysplasia|fibromuscular dysplasia
4770169|NCT02799186|genetic analysis|genetic analysis
4770170|NCT02799186|Acute Coronary Syndrome|acute coronary syndrome
4770171|NCT02799173|cardiovascular calcification|cardiovascular calcification
4770172|NCT02799173|RANK: Receptor Activator of Nuclear Factor kappa B|rank: receptor activator of nuclear factor kappa b
4770173|NCT02799173|RANKL: Receptor Activator of Nuclear Factor kappa B Ligand|rankl: receptor activator of nuclear factor kappa b ligand
4770174|NCT02799173|OPG: Osteoprotegerin|opg: osteoprotegerin
4770175|NCT02799173|SLE: Systemic lupus erythematosus|sle: systemic lupus erythematosus
4770176|NCT02799147|Allogeneic Transplantation|allogeneic transplantation
4770177|NCT02799147|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
4770178|NCT02799147|Leukemia, Acute Lymphoblastic|leukemia, acute lymphoblastic
4770179|NCT02799147|Acute Myeloid Leukemia|acute myeloid leukemia
4770180|NCT02799147|Mixed-Lineage Acute Leukemias|mixed-lineage acute leukemias
4770181|NCT02799147|Immune System Diseases|immune system diseases
4770182|NCT02799147|Immunosuppressive Agents|immunosuppressive agents
4770183|NCT02799147|Myeloablative Agonists|myeloablative agonists
4770184|NCT02799147|Busulfan|busulfan
4770185|NCT02799147|Fludarabine|fludarabine
4770186|NCT02799147|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating
4770187|NCT02799147|Bendamustine Hydrochloride|bendamustine hydrochloride
4770188|NCT02799134|Cortisol Awakening Response suppression|cortisol awakening response suppression
4770189|NCT02799134|Dexamethasone Suppression Test|dexamethasone suppression test
4770190|NCT02799134|high-order cognition|high-order cognition
4770191|NCT02799134|social cognition|social cognition
4770192|NCT02799108|children|children
4770193|NCT02799108|language|language
4770194|NCT02799108|NIRS|nirs
4770195|NCT02799095|Immunotherapy|immunotherapy
4770196|NCT02799095|IL-2|il-2
4770197|NCT02799095|Interleukin-2|interleukin-2
4770198|NCT02799095|Solid tumors|solid tumors
4770199|NCT02799056|Airway Extubation|airway extubation
4770200|NCT02799056|Ultrasonography|ultrasonography
4770201|NCT02799056|Ventilator Weaning|ventilator weaning
4770202|NCT02799043|FIRMap, Rotor, FIRM-guided procedure|firmap, rotor, firm-guided procedure
4770203|NCT02799017|Aphasia|aphasia
4770204|NCT02799017|Reading|reading
4770205|NCT02799017|Writing|writing
4770206|NCT02799017|Naming|naming
4770207|NCT02799017|Language|language
4770208|NCT02799017|Chronic post stroke|chronic post stroke
4770209|NCT02799017|Phonology|phonology
4770210|NCT02799017|Semantic Feature Analysis|semantic feature analysis
4770211|NCT02799017|Recovery|recovery
4770212|NCT02798991|REarranged during Transfection Growth Factor Receptor Tyrosine Kinase Inhibitor|rearranged during transfection growth factor receptor tyrosine kinase inhibitor
4770213|NCT02798978|pharmacokinetics|pharmacokinetics
4770214|NCT02798978|TLR4 agonist|tlr4 agonist
4770215|NCT02798978|cancer|cancer
4770216|NCT02798978|tolerability|tolerability
4770217|NCT02798978|GSK1795091|gsk1795091
4770218|NCT02798978|pharmacodynamics|pharmacodynamics
4770219|NCT02798978|safety|safety
4770220|NCT02798965|parvovirus genome|parvovirus genome
4770221|NCT02798952|Hepatitis B antibodies|hepatitis b antibodies
4770222|NCT02798952|Safety|safety
4770223|NCT02798952|Challenge dose|challenge dose
4770224|NCT02798952|Persistence|persistence
4770225|NCT02798952|Engerix B Kinder|engerix b kinder
4770226|NCT02798952|Infanrix hexa|infanrix hexa
4770227|NCT02798952|Immunogenicity|immunogenicity
4770228|NCT02798952|Adolescents|adolescents
4770229|NCT02798939|spontaneous bacterial peritonitis|spontaneous bacterial peritonitis
4770230|NCT02798939|lactoferrin|lactoferrin
4770231|NCT02798939|procalcitonin|procalcitonin
4770232|NCT02798939|Aution® urine dipsticks|aution® urine dipsticks
4770233|NCT02798926|hypothermia|hypothermia
4770234|NCT02798926|central venous catheter placement|central venous catheter placement
4770235|NCT02798926|Polyethylene bag|polyethylene bag
4770236|NCT02798913|dual antiplatelet therapy|dual antiplatelet therapy
4770237|NCT02798913|peripheral transluminal angioplasty|peripheral transluminal angioplasty
4770238|NCT02798900|Task-specific exercise|task-specific exercise
4770239|NCT02798900|Ultrasonic Waves|ultrasonic waves
4770240|NCT02798900|Biomechanics|biomechanics
4770241|NCT02798900|Gait|gait
4770242|NCT02798900|Rehabilitation|rehabilitation
4770243|NCT02798900|Exercise therapy|exercise therapy
4770244|NCT02798887|Regeneration|regeneration
4770245|NCT02798887|Bone regeneration|bone regeneration
4770246|NCT02798887|Grafting, Bone|grafting, bone
4770247|NCT02798887|Allograft|allograft
4770248|NCT02798887|Xenograft|xenograft
4770249|NCT02798874|Ticagrelor|ticagrelor
4770250|NCT02798874|No-reflow|no-reflow
4770251|NCT02798874|Acute ST-segment elevation myocardial|acute st-segment elevation myocardial
4770252|NCT02798874|Reperfusion injury|reperfusion injury
4770253|NCT02798874|Percutaneous coronary intervention|percutaneous coronary intervention
4770254|NCT02798796|breast cancer|breast cancer
4770255|NCT02798796|conservative surgery|conservative surgery
4770256|NCT02798796|MRI|mri
4770257|NCT02798783|Vestibular Aqueduct|vestibular aqueduct
4770258|NCT02798783|SLC26A4|slc26a4
4770259|NCT02798783|FOXI1|foxi1
4770260|NCT02798783|Temporal Bone|temporal bone
4770261|NCT02798731|Heart transplant|heart transplant
4770262|NCT02798731|Microvascular dysfunction|microvascular dysfunction
4770263|NCT02798731|Cardiac allograft vasculopathy|cardiac allograft vasculopathy
4770264|NCT02798731|Fractional flow reserve|fractional flow reserve
4770265|NCT02798731|Coronary flow reserve|coronary flow reserve
4770266|NCT02798731|Index of microvascular resistance|index of microvascular resistance
4770267|NCT02798705|Cardiac amyloidosis|cardiac amyloidosis
4770268|NCT02798705|Fractional flow reserve|fractional flow reserve
4770269|NCT02798705|Microvascular dysfunction|microvascular dysfunction
4770270|NCT02798705|Coronary flow reserve|coronary flow reserve
4770271|NCT02798705|Index of microcirculatory resistance|index of microcirculatory resistance
4770272|NCT02798692|Prevention|prevention
4770273|NCT02798666|Physical fitness|physical fitness
4770274|NCT02798666|Respiratory exchange ratio|respiratory exchange ratio
4770275|NCT02798666|Insulin sensitivity|insulin sensitivity
4770276|NCT02798666|High intensity interval training|high intensity interval training
4770277|NCT02798666|Continuous exercise training|continuous exercise training
4770278|NCT02798601|Cerebral edema|cerebral edema
4770279|NCT02798601|Hypernatremia|hypernatremia
4770280|NCT02798601|Extended Glasgow Outcome Scale|extended glasgow outcome scale
4770281|NCT02798601|Intracranial pressure|intracranial pressure
4770282|NCT02798601|Mannitol|mannitol
4770283|NCT02798601|Hypertonic saline|hypertonic saline
4770284|NCT02798601|Mortality|mortality
4770285|NCT02798588|coma|coma
4770286|NCT02798588|prognosis|prognosis
4770287|NCT02798588|comparative study|comparative study
4770288|NCT02798588|functional imaging|functional imaging
4770289|NCT02798588|PET-MRI|pet-mri
4770290|NCT02798588|electrophysiology|electrophysiology
4770291|NCT02798575|COPD|copd
4770292|NCT02798575|invasive ventilation|invasive ventilation
4770293|NCT02798575|exacerbation|exacerbation
4770294|NCT02798575|home care|home care
4770295|NCT02798575|mechanical ventilation|mechanical ventilation
4770296|NCT02798575|unsuccessful weaning|unsuccessful weaning
4770297|NCT02798575|ventilatory parameters|ventilatory parameters
4770298|NCT02798562|low dose CT|low dose ct
4770299|NCT02798562|contrast-enhanced|contrast-enhanced
4770300|NCT02798562|breast cancer screening|breast cancer screening
4770301|NCT02798562|computer tomography|computer tomography
4770302|NCT02798549|HBV|hbv
4770303|NCT02798549|liver|liver
4770304|NCT02798536|Immunotoxin|immunotoxin
4770305|NCT02798536|Mesothelin|mesothelin
4770306|NCT02798536|Targeted Therapy|targeted therapy
4770307|NCT02798523|Methylprednisolone|methylprednisolone
4770308|NCT02798523|Immunologic|immunologic
4770309|NCT02798523|Infusion|infusion
4770310|NCT02798523|Topical|topical
4770311|NCT02798523|Intravenous|intravenous
4770312|NCT02798510|Gallbladder Carcinoma|gallbladder carcinoma
4770313|NCT02798510|Extrahepatic Cholangiocarcinoma|extrahepatic cholangiocarcinoma
4770314|NCT02798510|Chemoradiotherapy|chemoradiotherapy
4770315|NCT02798497|PVL|pvl
4770316|NCT02798497|Pneumonias|pneumonias
4770317|NCT02798497|Staphylococcus aureus|staphylococcus aureus
4770318|NCT02798484|Diffusion Weighted Magnetic Resonance Imaging|diffusion weighted magnetic resonance imaging
4770319|NCT02798484|Breast cancer|breast cancer
4770320|NCT02798484|Neo-adjuvant therapy|neo-adjuvant therapy
4770321|NCT02798471|Pediatric|pediatric
4770322|NCT02798471|Venous thrombolism|venous thrombolism
4770323|NCT02798471|Pulmonary embolism|pulmonary embolism
4770324|NCT02798458|Fabry's Disease|fabry's disease
4770325|NCT02798458|Fabry|fabry
4770326|NCT02798445|venous ulcer|venous ulcer
4770327|NCT02798445|vein|vein
4770328|NCT02798445|juxta cures|juxta cures
4770329|NCT02798445|foam|foam
4770330|NCT02798445|laser|laser
4770331|NCT02798432|Total Knee Arthroplasty|total knee arthroplasty
4770332|NCT02798432|Hybrid|hybrid
4770333|NCT02798432|Cemented|cemented
4770334|NCT02798432|Fixation|fixation
4770335|NCT02798406|brain|brain
4770336|NCT02798406|Central Nervous System (CNS) diseases|central nervous system (cns) diseases
4770337|NCT02798406|Central Nervous System (CNS) neoplasms|central nervous system (cns) neoplasms
4770338|NCT02798406|CNS|cns
4770339|NCT02798406|conditionally replicative adenovirus|conditionally replicative adenovirus
4770340|NCT02798406|DNX-2401|dnx-2401
4770341|NCT02798406|pembrolizumab|pembrolizumab
4770342|NCT02798406|KEYTRUDA|keytruda
4770343|NCT02798406|MK-3475|mk-3475
4770344|NCT02798406|SCH 900475|sch 900475
4770345|NCT02798406|lambrolizumab|lambrolizumab
4770346|NCT02798406|neoplasm, germ cell and embryonal|neoplasm, germ cell and embryonal
4770347|NCT02798406|neoplasm, granular and epithelial|neoplasm, granular and epithelial
4770348|NCT02798406|Alcyone|alcyone
4770349|NCT02798406|Alcyone Lifesciences|alcyone lifesciences
4770350|NCT02798406|AMC|amc
4770351|NCT02798406|cannula|cannula
4770352|NCT02798406|MEMS cannula|mems cannula
4770353|NCT02798406|DNX-2401 + pembrolizumab|dnx-2401 + pembrolizumab
4770354|NCT02798406|Delta-24|delta-24
4770355|NCT02798406|Delta-24-RGD|delta-24-rgd
4770356|NCT02798406|Checkpoint inhibitor|checkpoint inhibitor
4770357|NCT02798406|anti-PD1/PD-L1|anti-pd1/pd-l1
4770358|NCT02798406|immunotherapy|immunotherapy
4770359|NCT02798406|monoclonal antibody|monoclonal antibody
4770360|NCT02798406|KEYNOTE-192|keynote-192
4770361|NCT02798367|insomnia|insomnia
4770362|NCT02798367|cognitive behavioral therapy for insomnia|cognitive behavioral therapy for insomnia
4770363|NCT02798367|melatonin|melatonin
4770364|NCT02798354|Depression|depression
4770365|NCT02798354|Blood Pressure|blood pressure
4770366|NCT02798354|Anemias, Iron-Deficiency|anemias, iron-deficiency
4770367|NCT02798354|Streptococcal Infections|streptococcal infections
4770368|NCT02798354|Sexually Transmitted Diseases|sexually transmitted diseases
4770369|NCT02798354|Lead Poisoning, Nervous System, Childhood|lead poisoning, nervous system, childhood
4770370|NCT02798354|Thyrotropin|thyrotropin
4770371|NCT02798315|Paritaprevir/r - Ombitasvir, ± Dasabuvir|paritaprevir/r - ombitasvir, ± dasabuvir
4770372|NCT02798315|Sustained Virological Response|sustained virological response
4770373|NCT02798315|Chronic Hepatitis C genotype 4|chronic hepatitis c genotype 4
4770374|NCT02798315|Observational Study|observational study
4770375|NCT02798315|Chronic Hepatitis C genotype 1|chronic hepatitis c genotype 1
4770376|NCT02798315|Chronic Hepatitis C|chronic hepatitis c
4770377|NCT02798276|Myocardial infarction|myocardial infarction
4770378|NCT02798276|Cardiac regeneration|cardiac regeneration
4770379|NCT02798276|Cardiac surgery|cardiac surgery
4770380|NCT02798250|Type 1 diabetes|type 1 diabetes
4770381|NCT02798250|Artificial pancreas|artificial pancreas
4770382|NCT02798250|Closed-loop system|closed-loop system
4770383|NCT02798250|Postprandial glucose control|postprandial glucose control
4770384|NCT02798250|Hypoglycemia|hypoglycemia
4770385|NCT02798250|Insulin|insulin
4770386|NCT02798250|Glucagon|glucagon
4770387|NCT02798237|exercise|exercise
4770388|NCT02798237|walking|walking
4770389|NCT02798237|health|health
4770390|NCT02798224|Colorectal Cancer Screening|colorectal cancer screening
4770391|NCT02798224|CRC Screening|crc screening
4770392|NCT02798224|Rectum|rectum
4770393|NCT02798224|Colon|colon
4770394|NCT02798224|Screening|screening
4770395|NCT02798224|Populations at Risk|populations at risk
4770396|NCT02798224|CRC|crc
4770397|NCT02798224|colorectal cancer (CRC)|colorectal cancer (crc)
4770398|NCT02798211|PsA, ACR, CASPAR|psa, acr, caspar
4770399|NCT02798159|Sexual Dysfunction|sexual dysfunction
4770400|NCT02798159|Physiological Sexual Dysfunctions|physiological sexual dysfunctions
4770401|NCT02798159|Psychological Sexual and Gender Disorders|psychological sexual and gender disorders
4770402|NCT02798159|Sildenafil|sildenafil
4770403|NCT02798146|in-vitro fertilization|in-vitro fertilization
4770404|NCT02798146|luteal phase|luteal phase
4770405|NCT02798081|augmentative and alternative communication|augmentative and alternative communication
4770406|NCT02798081|social inclusion|social inclusion
4770407|NCT02798081|serious games|serious games
4770408|NCT02798081|Information and communication technologies|information and communication technologies
4770409|NCT02798068|Steroids|steroids
4770410|NCT02798068|Cardiac surgery|cardiac surgery
4770411|NCT02798068|Endothelial dysfunction|endothelial dysfunction
4770412|NCT02798068|Glycocalyx|glycocalyx
4770413|NCT02798068|Flow mediated vasodilation|flow mediated vasodilation
4770414|NCT02798029|Brain Metastases|brain metastases
4770415|NCT02798029|Parenchymal Brain Metastases|parenchymal brain metastases
4770416|NCT02798029|Oligometastatic brain metastases|oligometastatic brain metastases
4770417|NCT02798029|Frameless Fractionated Stereotactic Radiation Therapy|frameless fractionated stereotactic radiation therapy
4770418|NCT02798029|FFSRT|ffsrt
4770419|NCT02798003|Cachexia|cachexia
4770420|NCT02798003|Food reward|food reward
4770421|NCT02797990|[G08.686.785.760.769.500]|[g08.686.785.760.769.500]
4770422|NCT02797990|[G08.686.785.760.769]|[g08.686.785.760.769]
4770423|NCT02797990|[N02.360]|[n02.360]
4770424|NCT02797990|[C25.775.650]|[c25.775.650]
4770425|NCT02797990|[C25.775.793]|[c25.775.793]
4770426|NCT02797990|[C25.775.635]|[c25.775.635]
4770427|NCT02797990|[C25.775.675]|[c25.775.675]
4770428|NCT02797990|[C25.775.300]|[c25.775.300]
4770429|NCT02797990|[C25.775.467]|[c25.775.467]
4770430|NCT02797990|[C25.775.225]|[c25.775.225]
4770431|NCT02797990|[C25.775.100]|[c25.775.100]
4770432|NCT02797990|[C25.775]|[c25.775]
4770433|NCT02797977|Replication Stress|replication stress
4770434|NCT02797977|Advanced solid tumors|advanced solid tumors
4770435|NCT02797977|CCNE1|ccne1
4770436|NCT02797977|TP53|tp53
4770437|NCT02797977|BRCA1|brca1
4770438|NCT02797977|BRCA2|brca2
4770439|NCT02797977|MYC|myc
4770440|NCT02797977|RAD50|rad50
4770441|NCT02797977|Fanconi anemia|fanconi anemia
4770442|NCT02797977|Cell Cycle|cell cycle
4770443|NCT02797977|Urothelial carcinoma|urothelial carcinoma
4770444|NCT02797977|Small cell lung cancer|small cell lung cancer
4770445|NCT02797977|Soft tissue sarcoma|soft tissue sarcoma
4770446|NCT02797977|Cervical/anogenital cancer|cervical/anogenital cancer
4770447|NCT02797977|Phase 1|phase 1
4770448|NCT02797977|Phase 2|phase 2
4770449|NCT02797977|Dose escalation|dose escalation
4770450|NCT02797977|Chk1 inhibitor|chk1 inhibitor
4770451|NCT02797977|Checkpoint Kinase 1|checkpoint kinase 1
4770452|NCT02797977|Synthetic lethality|synthetic lethality
4770453|NCT02797977|Next-Generation Sequencing|next-generation sequencing
4770454|NCT02797977|Genetic biomarkers|genetic biomarkers
4770455|NCT02797964|Replication stress|replication stress
4770456|NCT02797964|Advanced solid tumors|advanced solid tumors
4770457|NCT02797964|CCNE1|ccne1
4770458|NCT02797964|TP53|tp53
4770459|NCT02797964|BRCA1|brca1
4770460|NCT02797964|BRCA2|brca2
4770461|NCT02797964|MYC|myc
4770462|NCT02797964|RAD50|rad50
4770463|NCT02797964|Fanconi anemia|fanconi anemia
4770464|NCT02797964|Cell cycle|cell cycle
4770465|NCT02797964|Metastatic Colorectal Cancer|metastatic colorectal cancer
4770466|NCT02797964|Platinum-Resistant or Intolerant High Grade Serious Ovarian Cancer|platinum-resistant or intolerant high grade serious ovarian cancer
4770467|NCT02797964|Advanced Non-Small Cell Lung Cancer|advanced non-small cell lung cancer
4770468|NCT02797964|Metastatic Castration-Resistant Prostate Cancer|metastatic castration-resistant prostate cancer
4770469|NCT02797964|Head and Neck Squamous Cell Carcinoma|head and neck squamous cell carcinoma
4770470|NCT02797964|Squamous Cell Carcinoma of the Anus|squamous cell carcinoma of the anus
4770471|NCT02797964|Phase 1|phase 1
4770472|NCT02797964|Phase 2|phase 2
4770473|NCT02797964|Dose escalation|dose escalation
4770474|NCT02797964|Chk1 inhibitor|chk1 inhibitor
4770475|NCT02797964|Checkpoint kinase 1|checkpoint kinase 1
4770476|NCT02797964|Synthetic lethality|synthetic lethality
4770477|NCT02797964|Next-Generation Sequencing|next-generation sequencing
4770478|NCT02797964|Genetic biomarkers|genetic biomarkers
4770479|NCT02797951|cluster headache|cluster headache
4770480|NCT02797951|headache|headache
4770481|NCT02797951|brain diseases|brain diseases
4770482|NCT02797951|central nervous system diseases|central nervous system diseases
4770483|NCT02797951|headache disorders|headache disorders
4770484|NCT02797951|headache disorders, primary|headache disorders, primary
4770485|NCT02797951|nervous system diseases|nervous system diseases
4770486|NCT02797951|neurologic manifestations|neurologic manifestations
4770487|NCT02797951|pain|pain
4770488|NCT02797951|trigeminal autonomic cephalalgias|trigeminal autonomic cephalalgias
4770489|NCT02797925|Achilles tendon|achilles tendon
4770490|NCT02797925|Patella tendon|patella tendon
4770491|NCT02797925|Inflammation|inflammation
4770492|NCT02797925|Edema|edema
4770493|NCT02797925|Clinical|clinical
4770494|NCT02797925|Structural|structural
4770495|NCT02797912|pulmonary function|pulmonary function
4770496|NCT02797912|respiratory muscle function|respiratory muscle function
4770497|NCT02797912|body composition|body composition
4770498|NCT02797912|exercise tolerance|exercise tolerance
4770499|NCT02797886|Hemiplegia|hemiplegia
4770500|NCT02797886|Drop foot|drop foot
4770501|NCT02797886|Foot drop|foot drop
4770502|NCT02797860|Transabdominal cervicoisthmic cerclage|transabdominal cervicoisthmic cerclage
4770503|NCT02797860|Rocuronium|rocuronium
4770504|NCT02797860|Pregnant Women|pregnant women
4770505|NCT02797847|TTR-mediated Amyloidosis|ttr-mediated amyloidosis
4770506|NCT02797847|Amyloidosis, Hereditary|amyloidosis, hereditary
4770507|NCT02797847|Amyloid Neuropathies, Familial|amyloid neuropathies, familial
4770508|NCT02797847|Familial Amyloid Polyneuropathies|familial amyloid polyneuropathies
4770509|NCT02797847|Amyloid Neuropathies|amyloid neuropathies
4770510|NCT02797847|Amyloidosis, Hereditary, Transthyretin-Related|amyloidosis, hereditary, transthyretin-related
4770511|NCT02797847|Familial Amyloidosis|familial amyloidosis
4770512|NCT02797847|RNAi therapeutic|rnai therapeutic
4770513|NCT02797834|Extracellular vesicles|extracellular vesicles
4770514|NCT02797834|Endometrial fluid|endometrial fluid
4770515|NCT02797834|Menstrual cycle|menstrual cycle
4770516|NCT02797834|Exosomes|exosomes
4770517|NCT02797834|Microvesicles|microvesicles
4770518|NCT02797834|Apoptotic bodies|apoptotic bodies
4770520|NCT02797821|asfotase alfa|asfotase alfa
4770521|NCT02797808|OCD|ocd
4770522|NCT02797743|Healthy Volunteers|healthy volunteers
4770523|NCT02797730|Art Therapy|art therapy
4770524|NCT02797730|Caregiver's|caregiver's
4770525|NCT02797691|Cognitive Behavior Therapy|cognitive behavior therapy
4770526|NCT02797691|Depression|depression
4770527|NCT02797691|Anxiety|anxiety
4770528|NCT02797691|Pashto|pashto
4770529|NCT02797691|Pakistani|pakistani
4770530|NCT02797691|Afghan|afghan
4770531|NCT02797652|Breast cancer|breast cancer
4770532|NCT02797652|ctDNA|ctdna
4770533|NCT02797652|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
4770534|NCT02797652|Adjuvant chemotherapy|adjuvant chemotherapy
4770535|NCT02797639|Intellectual Disability|intellectual disability
4770536|NCT02797639|Collaborative Consultation|collaborative consultation
4770537|NCT02797639|Participation|participation
4770538|NCT02797600|Appalachia|appalachia
4770539|NCT02797587|Alcohol Use|alcohol use
4770540|NCT02797587|Tobacco Use|tobacco use
4770541|NCT02797587|Smoking|smoking
4770542|NCT02797587|Inflammation|inflammation
4770543|NCT02797587|Coronary Heart Disease|coronary heart disease
4770544|NCT02797587|Russia|russia
4770545|NCT02797587|Varenicline|varenicline
4770546|NCT02797587|Cytisine|cytisine
4770547|NCT02797587|Nicotine Replacement Therapy|nicotine replacement therapy
4770548|NCT02797587|Partial Agonist Therapy|partial agonist therapy
4770549|NCT02797587|HIV|hiv
4770550|NCT02797587|Reynolds risk score|reynolds risk score
4770551|NCT02797587|VACS index|vacs index
4770552|NCT02797561|Fractional flow reserve|fractional flow reserve
4770553|NCT02797561|Tandem|tandem
4770554|NCT02797561|Percutaneous Coronary Intervention|percutaneous coronary intervention
4770555|NCT02797548|drug-eluting stent|drug-eluting stent
4770556|NCT02797548|antiplatelet therapy|antiplatelet therapy
4770557|NCT02797548|noncardiac surgery|noncardiac surgery
4770558|NCT02797509|Intensive Care Unit|intensive care unit
4770559|NCT02797496|Parkinson's disease|parkinson's disease
4770560|NCT02797496|Mild to moderate stage|mild to moderate stage
4770561|NCT02797496|Asymmetric Motor Strengthening|asymmetric motor strengthening
4770562|NCT02797496|Rehabilitation|rehabilitation
4770563|NCT02797457|Bilateral amputation of the forearms|bilateral amputation of the forearms
4770564|NCT02797457|Bilateral allograft|bilateral allograft
4770565|NCT02797457|Prosthetic forehands|prosthetic forehands
4770566|NCT02797457|Medical economic evaluation|medical economic evaluation
4770567|NCT02797418|Attentional disorders, intellectual deficiency|attentional disorders, intellectual deficiency
4770568|NCT02797405|radiation therapy|radiation therapy
4770569|NCT02797405|radiosensitivity|radiosensitivity
4770570|NCT02797405|in vitro diagnostic medical devices|in vitro diagnostic medical devices
4770571|NCT02797405|Adverse Event post radiotherapy|adverse event post radiotherapy
4770572|NCT02797392|Tailored lifestyle intervention|tailored lifestyle intervention
4770573|NCT02797392|Selective prevention|selective prevention
4770574|NCT02797392|Primary care|primary care
4770575|NCT02797392|Web based health risk assessment|web based health risk assessment
4770576|NCT02797392|Patient-centered health information system|patient-centered health information system
4770577|NCT02797392|Lifestyle intervention|lifestyle intervention
4770578|NCT02797392|preventive treatment|preventive treatment
4770579|NCT02797379|Psychoeducation|psychoeducation
4770580|NCT02797379|Self-help|self-help
4770581|NCT02797327|Molecular signature|molecular signature
4770582|NCT02797327|Thailand-Myanmar border|thailand-myanmar border
4770583|NCT02797314|Type 2 diabetes|type 2 diabetes
4770584|NCT02797314|Bone quality|bone quality
4770585|NCT02797314|Bone biopsies|bone biopsies
4770586|NCT02797314|Vertebral fractures|vertebral fractures
4770587|NCT02797314|Osteodensitometry|osteodensitometry
4770588|NCT02797314|Trabecular Bone Score|trabecular bone score
4770589|NCT02797301|early reading skills|early reading skills
4770590|NCT02797249|preeclampsia|preeclampsia
4770591|NCT02797249|low dose aspirin|low dose aspirin
4770592|NCT02797249|prevention|prevention
4770593|NCT02797236|Phase I|phase i
4770594|NCT02797236|conjugate vaccine|conjugate vaccine
4770595|NCT02797236|Shigella flexneri 2a|shigella flexneri 2a
4770596|NCT02797236|safety|safety
4770597|NCT02797236|Immunogenicity|immunogenicity
4770598|NCT02797236|Healthy adults|healthy adults
4770599|NCT02797223|alopecia|alopecia
4770600|NCT02797223|chemotherapy|chemotherapy
4770601|NCT02797223|breast cancer|breast cancer
4770602|NCT02797158|TAVI|tavi
4770603|NCT02797158|Aortic stenosis|aortic stenosis
4770604|NCT02797158|Coronary artery disease|coronary artery disease
4770605|NCT02797158|Coronary angiography|coronary angiography
4770606|NCT02797158|Percutaneous Coronary Intervention|percutaneous coronary intervention
4770607|NCT02797158|Myocardial ischemia|myocardial ischemia
4770608|NCT02797158|SPECT|spect
4770609|NCT02797158|Coronary revascularization|coronary revascularization
4770610|NCT02797145|Digoxin|digoxin
4770611|NCT02797132|CF|cf
4770612|NCT02797119|Tranexamic acid|tranexamic acid
4770613|NCT02797119|Fibrinolysis|fibrinolysis
4770614|NCT02797119|Cesarean section|cesarean section
4770615|NCT02797119|Pharmacokinetics|pharmacokinetics
4770616|NCT02797119|D dimers|d dimers
4770617|NCT02797119|Fibrinogen|fibrinogen
4770618|NCT02797119|Plasmin|plasmin
4770619|NCT02797119|Transfusion|transfusion
4770620|NCT02797106|Drooling|drooling
4770621|NCT02797106|Cerebral palsy|cerebral palsy
4770622|NCT02797106|Botulinium toxin|botulinium toxin
4770623|NCT02797106|Practice survey of health professionals|practice survey of health professionals
4770624|NCT02797106|Children|children
4770625|NCT02797093|anti-retroviral therapy|anti-retroviral therapy
4770626|NCT02797080|ACTIMMUNE|actimmune
4770627|NCT02797080|interferon y-1b|interferon y-1b
4770628|NCT02797067|Extracorporeal Shock Wave lithotripsy(ESWL)|extracorporeal shock wave lithotripsy(eswl)
4770629|NCT02797067|Prophylaxis|prophylaxis
4770630|NCT02797067|Indomethacin|indomethacin
4770631|NCT02797067|Chronic pancreatitis|chronic pancreatitis
4770632|NCT02797054|HPV vaccination|hpv vaccination
4770633|NCT02797054|Vaccination decision-making|vaccination decision-making
4770634|NCT02797054|Tailored health messaging|tailored health messaging
4770635|NCT02797054|Barriers to vaccination|barriers to vaccination
4770636|NCT02797054|Attitudes|attitudes
4770637|NCT02797041|Multiple myeloma|multiple myeloma
4770638|NCT02797041|Bortezomib|bortezomib
4770639|NCT02797041|Relapsed multiple myeloma|relapsed multiple myeloma
4770640|NCT02797041|Rechallenge|rechallenge
4770641|NCT02797028|Hyperuricemia|hyperuricemia
4770642|NCT02797028|endothelial function|endothelial function
4770643|NCT02797028|anthocyanidins|anthocyanidins
4770644|NCT02797015|MS|ms
4770645|NCT02797015|RMS|rms
4770646|NCT02797015|Multiple Sclerosis|multiple sclerosis
4770647|NCT02797015|Relapsing Multiple Sclerosis|relapsing multiple sclerosis
4770648|NCT02796976|arterial stiffness|arterial stiffness
4770649|NCT02796976|retinal vessels|retinal vessels
4770650|NCT02796976|physical activity|physical activity
4770651|NCT02796976|ageing|ageing
4770652|NCT02796963|HIV|hiv
4770653|NCT02796963|MSM|msm
4770654|NCT02796963|test uptake|test uptake
4770655|NCT02796963|crowdsourcing|crowdsourcing
4770656|NCT02796950|Acipimox|acipimox
4770657|NCT02796950|GLP-1|glp-1
4770658|NCT02796950|Insulin secretion|insulin secretion
4770659|NCT02796937|Pulmonary Emphysema|pulmonary emphysema
4770660|NCT02796937|Alpha-1 Antitrypsin Deficiency|alpha-1 antitrypsin deficiency
4770661|NCT02796937|AATD|aatd
4770662|NCT02796937|Alpha-1 PI Deficiency|alpha-1 pi deficiency
4770663|NCT02796937|Alpha-1 Proteinase Inhibitor|alpha-1 proteinase inhibitor
4770664|NCT02796924|Psychogenic Non-Epileptic Seizure|psychogenic non-epileptic seizure
4770665|NCT02796924|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
4770666|NCT02796924|Brain Stimulation|brain stimulation
4770667|NCT02796898|Prostate Cancer|prostate cancer
4770668|NCT02796898|PSA|psa
4770669|NCT02796898|Androgen Deprivation Therapy (ADT)|androgen deprivation therapy (adt)
4770670|NCT02796859|Inflammation|inflammation
4770671|NCT02796859|Psychosis|psychosis
4770672|NCT02796859|Schizophrenia|schizophrenia
4770673|NCT02796846|CPAP (continuous positive airway pressure)|cpap (continuous positive airway pressure)
4770674|NCT02796846|OSA (Obstructive sleep apnea)|osa (obstructive sleep apnea)
4770675|NCT02796833|Home parenteral nutrition|home parenteral nutrition
4770676|NCT02796833|Liver injury|liver injury
4770677|NCT02796833|Intravenous Lipid Emulsions|intravenous lipid emulsions
4770678|NCT02796833|Catheter-related infections|catheter-related infections
4770679|NCT02796833|Safety|safety
4770680|NCT02796820|Huaier Granule|huaier granule
4770681|NCT02796820|After radical surgery|after radical surgery
4770682|NCT02796820|Prevention of Recurrence and Metastasis|prevention of recurrence and metastasis
4770683|NCT02796820|Efficacy and safety|efficacy and safety
4770684|NCT02796794|Enteral nutrition|enteral nutrition
4770685|NCT02796794|Genistein|genistein
4770686|NCT02796794|Cytokine|cytokine
4770687|NCT02796755|Central Nervous System (CNS) Glutamate|central nervous system (cns) glutamate
4770688|NCT02796755|Breast Cancer Treatment|breast cancer treatment
4770689|NCT02796755|Fatigue|fatigue
4770690|NCT02796755|Cognitive Dysfunction|cognitive dysfunction
4770691|NCT02796755|Behavioral|behavioral
4770692|NCT02796755|Psychometrics|psychometrics
4770693|NCT02796755|Imaging Technology|imaging technology
4770694|NCT02796755|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
4770695|NCT02796742|SSTIs|sstis
4770696|NCT02796742|Methicillin-resistant Staphylococcus aureus (MRSA)|methicillin-resistant staphylococcus aureus (mrsa)
4770697|NCT02796742|Methicillin susceptible Staphylococcus aureus (MSSA)|methicillin susceptible staphylococcus aureus (mssa)
4770698|NCT02796742|the toxin Panton-Valentine Leukocidin (PVL)|the toxin panton-valentine leukocidin (pvl)
4770699|NCT02796742|Emergency Departments|emergency departments
4770700|NCT02796716|Wounded warriors|wounded warriors
4770701|NCT02796716|Battlefield infection|battlefield infection
4770702|NCT02796716|ESBL|esbl
4770703|NCT02796716|MRSA|mrsa
4770704|NCT02796716|KPC|kpc
4770705|NCT02796690|nasal carriage|nasal carriage
4770706|NCT02796690|Staphylococcus aureus|staphylococcus aureus
4770707|NCT02796690|good hygiene practices|good hygiene practices
4770708|NCT02796677|Safety|safety
4770709|NCT02796677|Efficacy|efficacy
4770710|NCT02796677|Aclidinium bromide|aclidinium bromide
4770711|NCT02796677|Formoterol fumarate|formoterol fumarate
4770712|NCT02796677|Tiotropium|tiotropium
4770713|NCT02796677|Bronchodilation|bronchodilation
4770714|NCT02796677|COPD|copd
4770715|NCT02796664|Ginseng|ginseng
4770716|NCT02796664|Stroke|stroke
4770717|NCT02796664|Quantitative MR flow analysis|quantitative mr flow analysis
4770718|NCT02796651|Perforomist|perforomist
4770719|NCT02796651|Pressair|pressair
4770720|NCT02796651|COPD|copd
4770721|NCT02796651|Cigarette smoking|cigarette smoking
4770722|NCT02796651|Formoterol fumarate|formoterol fumarate
4770723|NCT02796651|long-acting β2-adrenergic agonists (LABA)|long-acting β2-adrenergic agonists (laba)
4770724|NCT02796651|long-acting muscarinic antagonists (LAMA)|long-acting muscarinic antagonists (lama)
4770725|NCT02796638|Acute Heart Failure|acute heart failure
4770726|NCT02796638|Positive-Pressure Ventilation|positive-pressure ventilation
4770727|NCT02796638|Adaptive Servo-Ventilation|adaptive servo-ventilation
4770728|NCT02796625|EEG|eeg
4770729|NCT02796625|healthy subjects|healthy subjects
4770730|NCT02796612|anxiety|anxiety
4770731|NCT02796612|breast cancer, suspected|breast cancer, suspected
4770732|NCT02796612|breast biopsy|breast biopsy
4770733|NCT02796612|empathy|empathy
4770734|NCT02796612|standardized and structured information|standardized and structured information
4770735|NCT02796612|anxiety reduction|anxiety reduction
4770736|NCT02796586|Refugee Health|refugee health
4770737|NCT02796586|Resettled Refugee|resettled refugee
4770738|NCT02796586|Family Planning|family planning
4770739|NCT02796586|Contraception|contraception
4770740|NCT02796586|Group Counseling|group counseling
4770741|NCT02796586|Group contraceptive counseling|group contraceptive counseling
4770742|NCT02796573|blended care|blended care
4770743|NCT02796573|CBT|cbt
4770744|NCT02796573|B-CBT|b-cbt
4770745|NCT02796573|depression|depression
4770746|NCT02796560|Drugs, Generic|drugs, generic
4770747|NCT02796560|Generic Equivalency|generic equivalency
4770748|NCT02796547|Episiotomy|episiotomy
4770749|NCT02796547|Levobupivacaine|levobupivacaine
4770750|NCT02796534|Obstructive Sleep Apnea Syndrome|obstructive sleep apnea syndrome
4770751|NCT02796521|malnutrition|malnutrition
4770752|NCT02796521|aging|aging
4770753|NCT02796521|diet therapy|diet therapy
4770754|NCT02796508|Healthy aging|healthy aging
4770755|NCT02796508|Cognitive training|cognitive training
4770756|NCT02796508|Video-games|video-games
4770757|NCT02796508|Attention|attention
4770758|NCT02796508|Working memory|working memory
4770759|NCT02796508|Wellbeing|wellbeing
4770760|NCT02796495|Neuroplasticity|neuroplasticity
4770761|NCT02796495|Sensory Feedback|sensory feedback
4770762|NCT02796495|Nerve stimulation|nerve stimulation
4770763|NCT02796495|Robotic Hand|robotic hand
4770764|NCT02796456|apelin|apelin
4770765|NCT02796456|colostrum|colostrum
4770766|NCT02796456|plasma|plasma
4770767|NCT02796456|glycemic markers|glycemic markers
4770768|NCT02796456|lipidic markers|lipidic markers
4770769|NCT02796456|pregnancy|pregnancy
4770770|NCT02796456|postpartum|postpartum
4770771|NCT02796443|acute cholecystitis|acute cholecystitis
4770772|NCT02796443|early versus delayed surgery|early versus delayed surgery
4770773|NCT02796430|Indirect calorimetry|indirect calorimetry
4770774|NCT02796430|critical care|critical care
4770775|NCT02796430|mechanical ventilation|mechanical ventilation
4770776|NCT02796430|energy expenditure|energy expenditure
4770777|NCT02796430|ICALIC study|icalic study
4770778|NCT02796404|home monitoring|home monitoring
4770779|NCT02796404|cardiac monitoring|cardiac monitoring
4770780|NCT02796391|nicotine|nicotine
4770781|NCT02796391|cigarettes|cigarettes
4770782|NCT02796391|very low nicotine content (VLNC)|very low nicotine content (vlnc)
4770783|NCT02796391|smoking cessation|smoking cessation
4770784|NCT02796378|physical activity|physical activity
4770785|NCT02796378|statin therapy|statin therapy
4770786|NCT02796378|diabetes mellitus|diabetes mellitus
4770787|NCT02796378|cardiovascular disease|cardiovascular disease
4770788|NCT02796378|Q10-supplementation|q10-supplementation
4770789|NCT02796365|Exercise|exercise
4770790|NCT02796365|Cancer|cancer
4770791|NCT02796365|Cardiotoxicity|cardiotoxicity
4770792|NCT02796365|Cardiomyopathy|cardiomyopathy
4770793|NCT02796365|Cardiac Rehabilitation|cardiac rehabilitation
4770794|NCT02796339|Inflammatory Bowel Diseases|inflammatory bowel diseases
4770795|NCT02796339|natural Mastiha|natural mastiha
4770796|NCT02796339|supplement|supplement
4770797|NCT02796326|tracheal stenosis|tracheal stenosis
4770798|NCT02796326|tracheal dilatation|tracheal dilatation
4770799|NCT02796326|ventilation|ventilation
4770800|NCT02796300|bioflo|bioflo
4770801|NCT02796300|Duramax catheter|duramax catheter
4770802|NCT02796300|dialysis|dialysis
4770803|NCT02796287|Amnesia|amnesia
4770804|NCT02796287|transient global amnesia|transient global amnesia
4770805|NCT02796261|Anaplastic Astrocytoma|anaplastic astrocytoma
4770806|NCT02796261|Grade 3 Glioma|grade 3 glioma
4770807|NCT02796261|Glioma|glioma
4770808|NCT02796261|Eflornithine|eflornithine
4770809|NCT02796261|Brain Cancer|brain cancer
4770810|NCT02796261|Brain Tumor|brain tumor
4770811|NCT02796261|Neuro-oncology|neuro-oncology
4770812|NCT02796261|Progressive Anaplastic Astrocytoma|progressive anaplastic astrocytoma
4770813|NCT02796261|Recurrent Anaplastic Astrocytoma|recurrent anaplastic astrocytoma
4770814|NCT02796261|Progressive Glioma|progressive glioma
4770815|NCT02796261|Recurrent Glioma|recurrent glioma
4770816|NCT02796261|Malignant Glioma|malignant glioma
4770817|NCT02796261|Progressive Brain Tumor|progressive brain tumor
4770818|NCT02796261|Recurrent Brain Tumor|recurrent brain tumor
4770819|NCT02796248|type 1 diabetes|type 1 diabetes
4770820|NCT02796248|glucose control|glucose control
4770821|NCT02796248|stigma|stigma
4770822|NCT02796248|youth|youth
4770823|NCT02796222|Hemophilia|hemophilia
4770824|NCT02796222|Recombinant factor VIII|recombinant factor viii
4770825|NCT02796222|Recombinant factor VIII Fc|recombinant factor viii fc
4770826|NCT02796222|Recombinant factor IX|recombinant factor ix
4770827|NCT02796222|Patient-reported outcomes|patient-reported outcomes
4770828|NCT02796222|Recombinant factor IX Fc|recombinant factor ix fc
4770829|NCT02796209|atomoxetine|atomoxetine
4770830|NCT02796209|autonomic failure|autonomic failure
4770831|NCT02796196|Hematopoietic|hematopoietic
4770832|NCT02796196|Recipient|recipient
4770833|NCT02796170|SGLT-2 inhibitor|sglt-2 inhibitor
4770834|NCT02796170|urinary angiotensinogen|urinary angiotensinogen
4770835|NCT02796157|bioresorbable vascular scaffold, drug eluting stent, coronary artery disease|bioresorbable vascular scaffold, drug eluting stent, coronary artery disease
4770836|NCT02796144|schizophrenia|schizophrenia
4770837|NCT02796144|schizoaffective disorder|schizoaffective disorder
4770838|NCT02796144|overweight|overweight
4770839|NCT02796144|obesity|obesity
4770840|NCT02796144|weight loss|weight loss
4770841|NCT02796144|metformin|metformin
4770842|NCT02796144|lorcaserin|lorcaserin
4770843|NCT02796131|Phase I|phase i
4770844|NCT02796131|Healthy|healthy
4770845|NCT02796131|Pharmacodynamics|pharmacodynamics
4770846|NCT02796118|Pharmacokinetics|pharmacokinetics
4770847|NCT02796118|Healthy non-elderly and elderly subjects|healthy non-elderly and elderly subjects
4770848|NCT02796118|ASP2151|asp2151
4770849|NCT02796118|Safety|safety
4770850|NCT02796092|Pelvic Congestion Syndrome|pelvic congestion syndrome
4770851|NCT02796092|Pelvic Venous Insufficiency|pelvic venous insufficiency
4770852|NCT02796092|Chronic pelvic pain|chronic pelvic pain
4770853|NCT02796066|Acne, topical, SCD-1 inhibitor, moderate, severe|acne, topical, scd-1 inhibitor, moderate, severe
4770854|NCT02796040|Parkinson's disease|parkinson's disease
4770855|NCT02796040|Impulse control disorders|impulse control disorders
4770856|NCT02796040|Diffusion tensor imaging|diffusion tensor imaging
4770857|NCT02796040|MRI|mri
4770858|NCT02796040|Mesocorticolimbic pathway|mesocorticolimbic pathway
4770859|NCT02796027|Health Services Research|health services research
4770860|NCT02795988|Secondary|secondary
4770861|NCT02795962|Endovascular Procedures|endovascular procedures
4770862|NCT02795962|Emergency Medical Services|emergency medical services
4770863|NCT02795949|Enterobacteriaceae|enterobacteriaceae
4770864|NCT02795949|Bacteremia|bacteremia
4770865|NCT02795949|Escalation|escalation
4770866|NCT02795949|Bacterial resistance|bacterial resistance
4770867|NCT02795949|Bloodstream infection|bloodstream infection
4770868|NCT02795949|Recurrence|recurrence
4770869|NCT02795936|rehabilitation|rehabilitation
4770870|NCT02795936|exercise|exercise
4770871|NCT02795897|genetics|genetics
4770872|NCT02795897|genomics|genomics
4770873|NCT02795897|amyotrophic lateral sclerosis (ALS)|amyotrophic lateral sclerosis (als)
4770874|NCT02795897|primary lateral sclerosis (PLS)|primary lateral sclerosis (pls)
4770875|NCT02795897|progressive muscular atrophy (PMA)|progressive muscular atrophy (pma)
4770876|NCT02795897|motor neuron disease|motor neuron disease
4770877|NCT02795884|Lung cancer|lung cancer
4770878|NCT02795884|NSCLC|nsclc
4770879|NCT02795884|adjuvant treatment|adjuvant treatment
4770880|NCT02795871|Congenital Adrenal Hyperplasia|congenital adrenal hyperplasia
4770881|NCT02795871|Prenatal treatment|prenatal treatment
4770882|NCT02795871|Dexamethasone|dexamethasone
4770883|NCT02795871|Neuropsychological assessment|neuropsychological assessment
4770884|NCT02795871|Cognitive development|cognitive development
4770885|NCT02795858|Carcinoid Tumors|carcinoid tumors
4770886|NCT02795806|Address|address
4770887|NCT02795793|appendicitis|appendicitis
4770888|NCT02795793|non-operative management|non-operative management
4770889|NCT02795793|children|children
4770890|NCT02795793|pediatric|pediatric
4770891|NCT02795754|GSK2838232|gsk2838232
4770892|NCT02795754|HIV|hiv
4770893|NCT02795754|repeated dose escalation|repeated dose escalation
4770894|NCT02795754|immediate release tablet|immediate release tablet
4770895|NCT02795754|single dose escalation|single dose escalation
4770896|NCT02795715|tDCS|tdcs
4770897|NCT02795702|tDCS|tdcs
4770898|NCT02795676|Glomerular filtration rate|glomerular filtration rate
4770899|NCT02795676|Proteinuria|proteinuria
4770900|NCT02795676|PRX-102|prx-102
4770901|NCT02795676|pegunigalsidase alfa|pegunigalsidase alfa
4770902|NCT02795676|Fabry Disease|fabry disease
4770903|NCT02795663|Near-InfraRed Spectroscopy (NIRS)|near-infrared spectroscopy (nirs)
4770904|NCT02795663|Deep brain stimulation of SubThalamic Nucleus (DBS)|deep brain stimulation of subthalamic nucleus (dbs)
4770905|NCT02795650|Metastatic|metastatic
4770906|NCT02795650|Pancreas|pancreas
4770907|NCT02795637|Attention deficit hyperactivity disorder (ADHD),|attention deficit hyperactivity disorder (adhd),
4770908|NCT02795637|Binge-Eating Disorder (BED)|binge-eating disorder (bed)
4770909|NCT02795611|Family-centered|family-centered
4770910|NCT02795611|Autism spectrum disorder|autism spectrum disorder
4770911|NCT02795611|Occupational therapy|occupational therapy
4770912|NCT02795611|Participation|participation
4770913|NCT02795611|Play|play
4770914|NCT02795585|Fractional Flow Reserve|fractional flow reserve
4770915|NCT02795585|Coronary Artery Disease|coronary artery disease
4770916|NCT02795572|Breast Neoplasms|breast neoplasms
4770917|NCT02795572|Peripheral Neuropathies|peripheral neuropathies
4770918|NCT02795559|Nutrition|nutrition
4770919|NCT02795559|Humans|humans
4770920|NCT02795559|Obesity|obesity
4770921|NCT02795559|Blood glucose|blood glucose
4770922|NCT02795559|Dietary fiber|dietary fiber
4770923|NCT02795559|Appetite|appetite
4770924|NCT02795559|Short chain fatty acids|short chain fatty acids
4770925|NCT02795546|periodontal regeneration|periodontal regeneration
4770926|NCT02795533|Cognitive function|cognitive function
4770927|NCT02795533|Quality of Life|quality of life
4770928|NCT02795507|cross education|cross education
4770929|NCT02795507|visual feedback|visual feedback
4770930|NCT02795468|Peripheral|peripheral
4770931|NCT02795468|Arterial|arterial
4770932|NCT02795468|Catheterization|catheterization
4770933|NCT02795455|Eating Disorders|eating disorders
4770934|NCT02795455|Food Avoidance|food avoidance
4770935|NCT02795455|Reward Learning|reward learning
4770936|NCT02795455|Reward System|reward system
4770937|NCT02795455|Family-based treatment|family-based treatment
4770938|NCT02795455|interoceptive exposure|interoceptive exposure
4770939|NCT02795455|insula-amygdala-ventral striatum subcircuits|insula-amygdala-ventral striatum subcircuits
4770940|NCT02795429|Phase Ib/II|phase ib/ii
4770941|NCT02795429|INC280|inc280
4770942|NCT02795429|PDR001|pdr001
4770943|NCT02795429|checkpoint inhibitor|checkpoint inhibitor
4770944|NCT02795429|PD-1|pd-1
4770945|NCT02795416|Moderate to severe plaque psoriasis, PASI, secukinumab, monoclonal antibody, Turkish population|moderate to severe plaque psoriasis, pasi, secukinumab, monoclonal antibody, turkish population
4770946|NCT02795403|HCV, liver|hcv, liver
4770947|NCT02795390|Chinese herbal medicine formula|chinese herbal medicine formula
4770948|NCT02795390|MaZiRenWan|mazirenwan
4770949|NCT02795390|Randomized controlled trial|randomized controlled trial
4770950|NCT02795390|Constipation|constipation
4770951|NCT02795390|Palliative care in cancer|palliative care in cancer
4770952|NCT02795377|arterial hypertension|arterial hypertension
4770953|NCT02795377|microparticle|microparticle
4770954|NCT02795377|endothelial function|endothelial function
4770955|NCT02795364|High Grade Glioma|high grade glioma
4770956|NCT02795364|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
4770957|NCT02795364|Surgical resection|surgical resection
4770958|NCT02795364|Prognosis|prognosis
4770959|NCT02795325|Primary Hyperoxaluria Type 1|primary hyperoxaluria type 1
4770960|NCT02795325|PH1|ph1
4770961|NCT02795325|Calcium Oxalate Stones|calcium oxalate stones
4770962|NCT02795325|Kidney Stones|kidney stones
4770963|NCT02795325|Liver Enzyme Deficiency|liver enzyme deficiency
4770964|NCT02795325|Genetic Diseases|genetic diseases
4770965|NCT02795325|Inborn Kidney Diseases|inborn kidney diseases
4770966|NCT02795325|Metabolic Diseases|metabolic diseases
4770967|NCT02795325|Inborn Errors|inborn errors
4770968|NCT02795325|Urological Diseases|urological diseases
4770969|NCT02795325|Carbohydrate Metabolism|carbohydrate metabolism
4770970|NCT02795325|Hyperoxaluria|hyperoxaluria
4770971|NCT02795325|AGT|agt
4770972|NCT02795325|RNAi|rnai
4770973|NCT02795325|siRNA|sirna
4770974|NCT02795325|DCR-PH1|dcr-ph1
4770975|NCT02795312|Cigarette Smoking|cigarette smoking
4770976|NCT02795286|Chronic Kidney Disease (CKD)|chronic kidney disease (ckd)
4770977|NCT02795286|End Stage Renal Disease (ESRD)|end stage renal disease (esrd)
4770978|NCT02795286|Chronic Hemodialysis|chronic hemodialysis
4770979|NCT02795286|In-center HD|in-center hd
4770980|NCT02795286|Sodium|sodium
4770981|NCT02795286|Isotonic Dialysis|isotonic dialysis
4770982|NCT02795273|Rhinitis|rhinitis
4770983|NCT02795273|Conjunctivitis|conjunctivitis
4770984|NCT02795273|Grass|grass
4770985|NCT02795273|Allergy|allergy
4770986|NCT02795260|ESAT6|esat6
4770987|NCT02795260|CFP10|cfp10
4770988|NCT02795260|skin test|skin test
4770989|NCT02795260|diagnostic test|diagnostic test
4770990|NCT02795195|re-irradiation|re-irradiation
4770991|NCT02795195|carbon ion therapy|carbon ion therapy
4770992|NCT02795182|Relapsed|relapsed
4770993|NCT02795182|Refractory|refractory
4770994|NCT02795156|regorafenib|regorafenib
4770995|NCT02795156|afatinib|afatinib
4770996|NCT02795156|targeted therapy|targeted therapy
4770997|NCT02795156|cabozantinib|cabozantinib
4770998|NCT02795143|TEN|ten
4770999|NCT02795104|RISE|rise
4771000|NCT02795091|clean supplies|clean supplies
4771001|NCT02795091|ICU floor|icu floor
4771002|NCT02795091|bacteria colony|bacteria colony
4771003|NCT02795091|catheter associated with infection|catheter associated with infection
4771004|NCT02795078|Atherosclerotic Intracranial Arterial Stenosis|atherosclerotic intracranial arterial stenosis
4771005|NCT02795078|Intracranial Aneurysms|intracranial aneurysms
4771006|NCT02795052|Neurologic Disease|neurologic disease
4771007|NCT02795052|Cerebral Vascular Accident|cerebral vascular accident
4771008|NCT02795052|Stroke|stroke
4771009|NCT02795052|Traumatic Brain Injury|traumatic brain injury
4771010|NCT02795052|Multiple Sclerosis|multiple sclerosis
4771011|NCT02795052|Parkinsons Disease|parkinsons disease
4771012|NCT02795052|Neuropathy|neuropathy
4771013|NCT02795052|Neurodegeneration|neurodegeneration
4771014|NCT02795052|Diabetic Neuropathy|diabetic neuropathy
4771015|NCT02795052|Cerebral Ischemia|cerebral ischemia
4771016|NCT02795026|dry needling|dry needling
4771017|NCT02795026|vulvodynia|vulvodynia
4771018|NCT02795026|pelvic pain chronic|pelvic pain chronic
4771019|NCT02795013|Genetic studies|genetic studies
4771020|NCT02795013|Pediatric|pediatric
4771021|NCT02795000|Primary Ovarian Insufficiency|primary ovarian insufficiency
4771022|NCT02795000|nomogram|nomogram
4771023|NCT02794987|Bile duct|bile duct
4771024|NCT02794987|indeterminate stricture|indeterminate stricture
4771025|NCT02794987|cholangioscopy|cholangioscopy
4771026|NCT02794987|Spyglass|spyglass
4771027|NCT02794948|primary ovarian insufficiency|primary ovarian insufficiency
4771028|NCT02794948|TCM intervention|tcm intervention
4771029|NCT02794935|inspiratory muscle training|inspiratory muscle training
4771030|NCT02794935|heart failure|heart failure
4771031|NCT02794935|obstructive sleep apnea|obstructive sleep apnea
4771032|NCT02794922|Vitamin B|vitamin b
4771033|NCT02794922|Temporomandibular joint disorder|temporomandibular joint disorder
4771034|NCT02794922|trpv1|trpv1
4771035|NCT02794909|Point-of-care ultrasound|point-of-care ultrasound
4771036|NCT02794909|ED|ed
4771037|NCT02794909|Low and middle-income country|low and middle-income country
4771038|NCT02794909|Echocardiography|echocardiography
4771039|NCT02794909|Lung ultrasound|lung ultrasound
4771040|NCT02794909|Resuscitation|resuscitation
4771041|NCT02794857|ALS|als
4771042|NCT02794857|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
4771043|NCT02794857|Motor Neuron Disease|motor neuron disease
4771044|NCT02794857|Central Nervous System Diseases|central nervous system diseases
4771045|NCT02794857|Nervous System Diseases|nervous system diseases
4771046|NCT02794857|Neurodegenerative Diseases|neurodegenerative diseases
4771047|NCT02794857|Neuromuscular Diseases|neuromuscular diseases
4771048|NCT02794857|Inflammation|inflammation
4771049|NCT02794857|C-Reactive Protein|c-reactive protein
4771050|NCT02794831|NSAIDs|nsaids
4771051|NCT02794831|Bacterial Infections|bacterial infections
4771052|NCT02794831|Severity|severity
4771053|NCT02794831|Self Medication|self medication
4771054|NCT02794818|Prevention|prevention
4771055|NCT02794818|Nutrition|nutrition
4771056|NCT02794792|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
4771057|NCT02794792|ASP1941|asp1941
4771058|NCT02794792|Ipragliflozin|ipragliflozin
4771059|NCT02794779|cesarean section|cesarean section
4771060|NCT02794779|labor|labor
4771061|NCT02794779|oxytocin|oxytocin
4771062|NCT02794753|Trichotillomania|trichotillomania
4771063|NCT02794753|Hair-pulling Disorder|hair-pulling disorder
4771064|NCT02794753|Cognitive Training|cognitive training
4771065|NCT02794753|Neuroplasticity|neuroplasticity
4771066|NCT02794753|Working Memory|working memory
4771067|NCT02794740|Osteoarthritis|osteoarthritis
4771068|NCT02794714|Laparoscopic Gynecologic Surgeries|laparoscopic gynecologic surgeries
4771069|NCT02794688|Non-lactating|non-lactating
4771070|NCT02794688|idiopathic granulomatous mastitis|idiopathic granulomatous mastitis
4771071|NCT02794688|periductal mastitis|periductal mastitis
4771072|NCT02794688|ductal lavage|ductal lavage
4771073|NCT02794675|resectable|resectable
4771074|NCT02794675|Cesium 131|cesium 131
4771075|NCT02794675|brachytherapy|brachytherapy
4771076|NCT02794662|Oxygen Delivery System, Nasal Cannula|oxygen delivery system, nasal cannula
4771077|NCT02794662|Oxygen Delivery System, Incubator|oxygen delivery system, incubator
4771078|NCT02794623|cochlear implants|cochlear implants
4771079|NCT02794623|hearing loss|hearing loss
4771080|NCT02794610|Tacrolimus|tacrolimus
4771081|NCT02794610|Ocular penetration|ocular penetration
4771082|NCT02794610|Topical|topical
4771083|NCT02794597|Unplanned Pregnancy, LARC|unplanned pregnancy, larc
4771084|NCT02794558|Breast Cancer, MRgFus, Focused Ultrasound|breast cancer, mrgfus, focused ultrasound
4771085|NCT02794519|Asthma Control Questionnaire|asthma control questionnaire
4771086|NCT02794519|interleukin-6|interleukin-6
4771087|NCT02794519|Sirukumab|sirukumab
4771088|NCT02794519|severe, poorly controlled asthma|severe, poorly controlled asthma
4771089|NCT02794519|asthma|asthma
4771090|NCT02794519|ACQ|acq
4771091|NCT02794506|Diabetes mellitus|diabetes mellitus
4771092|NCT02794506|Chronic periodontitis|chronic periodontitis
4771093|NCT02794506|Propolis|propolis
4771094|NCT02794480|ELLIPTA|ellipta
4771095|NCT02794480|metered dose inhaler|metered dose inhaler
4771096|NCT02794480|Dry powder inhaler|dry powder inhaler
4771097|NCT02794467|Heavy menstrual bleeding|heavy menstrual bleeding
4771098|NCT02794467|Adenomyosis|adenomyosis
4771099|NCT02794467|Safety|safety
4771100|NCT02794467|Epelsiban|epelsiban
4771101|NCT02794467|Tolerability|tolerability
4771102|NCT02794467|Proof of concept|proof of concept
4771103|NCT02794428|Gastric adenocarcinoma|gastric adenocarcinoma
4771104|NCT02794428|Gastric intestinal metaplasia|gastric intestinal metaplasia
4771105|NCT02794428|Atrophic gastritis|atrophic gastritis
4771106|NCT02794428|Gastric premalignant lesion|gastric premalignant lesion
4771107|NCT02794415|HIV|hiv
4771108|NCT02794415|disability|disability
4771109|NCT02794415|rehabilitation|rehabilitation
4771110|NCT02794415|exercise|exercise
4771111|NCT02794389|Acetylcysteine|acetylcysteine
4771112|NCT02794376|IBS|ibs
4771113|NCT02794350|RBANS-H|rbans-h
4771114|NCT02794350|Cochlear implantation|cochlear implantation
4771115|NCT02794350|Cognition|cognition
4771116|NCT02794350|Older adults|older adults
4771117|NCT02794350|RBANS|rbans
4771118|NCT02794285|Lupus Erythematosus, Systemic Autoimmune Diseases, Connective Tissue Diseases,Immune System Diseases|lupus erythematosus, systemic autoimmune diseases, connective tissue diseases,immune system diseases
4771119|NCT02794272|GABA concentration|gaba concentration
4771120|NCT02794272|tDCS|tdcs
4771121|NCT02794259|GABA concentration|gaba concentration
4771122|NCT02794259|tDCS|tdcs
4771123|NCT02794233|Deep Brain Stimulation|deep brain stimulation
4771124|NCT02794233|Electric Impedance|electric impedance
4771125|NCT02794233|Parkinson disease|parkinson disease
4771126|NCT02794220|E-cigarette|e-cigarette
4771127|NCT02794220|healthy volunteer study|healthy volunteer study
4771128|NCT02794220|Pharmacokinetics|pharmacokinetics
4771129|NCT02794220|Nicorette|nicorette
4771130|NCT02794207|Pediatric|pediatric
4771131|NCT02794207|Cancer|cancer
4771132|NCT02794207|AML|aml
4771133|NCT02794207|Qualitative Interview|qualitative interview
4771134|NCT02794194|Chronic Ankle Instability|chronic ankle instability
4771135|NCT02794194|Whole Body Vibration|whole body vibration
4771136|NCT02794194|Proprioception|proprioception
4771137|NCT02794181|Transfusion-Transmitted Infections|transfusion-transmitted infections
4771138|NCT02794181|Dengue Virus|dengue virus
4771139|NCT02794181|Chikungunya Virus|chikungunya virus
4771140|NCT02794181|Natural History|natural history
4771141|NCT02794181|Blood Transfusion|blood transfusion
4771142|NCT02794142|hemodialysis|hemodialysis
4771143|NCT02794142|muscle dysfunction|muscle dysfunction
4771144|NCT02794142|mitochondria|mitochondria
4771145|NCT02794142|oxidative stress|oxidative stress
4771146|NCT02794142|inflammation|inflammation
4771147|NCT02794142|renal transplantation|renal transplantation
4771148|NCT02794103|Virtual reality|virtual reality
4771149|NCT02794103|Immersive distraction|immersive distraction
4771150|NCT02794103|Virtual world|virtual world
4771151|NCT02794103|Virtual environment|virtual environment
4771152|NCT02794103|Procedural pain|procedural pain
4771153|NCT02794103|Procedural anxiety|procedural anxiety
4771154|NCT02794103|Acute pain|acute pain
4771155|NCT02794103|Pain management|pain management
4771156|NCT02794103|Anxiety|anxiety
4771157|NCT02794103|Children, Child|children, child
4771158|NCT02794103|Kid, Kids|kid, kids
4771159|NCT02794103|Pediatric, Pediatrics|pediatric, pediatrics
4771160|NCT02794103|Young children|young children
4771161|NCT02794103|Burns|burns
4771162|NCT02794103|Burn injuries|burn injuries
4771163|NCT02794103|Burn unit|burn unit
4771164|NCT02794103|Hydrotherapy|hydrotherapy
4771165|NCT02794103|Burn dressing|burn dressing
4771166|NCT02794103|Non-pharmacological|non-pharmacological
4771167|NCT02794103|Clinical Research|clinical research
4771168|NCT02794103|Nursing Practice|nursing practice
4771169|NCT02794090|Behavioral treatment|behavioral treatment
4771170|NCT02794090|Telephone coaching|telephone coaching
4771171|NCT02794090|Outpatient clinic|outpatient clinic
4771172|NCT02794077|Nasopharyngeal undifferentiated carcinoma|nasopharyngeal undifferentiated carcinoma
4771173|NCT02793947|Peri-incisional injection|peri-incisional injection
4771174|NCT02793947|Multimodal analgesia|multimodal analgesia
4771175|NCT02793947|Femur fracture|femur fracture
4771176|NCT02793934|Rehabilitation|rehabilitation
4771177|NCT02793934|ICF|icf
4771178|NCT02793934|Pilot project|pilot project
4771179|NCT02793934|Stroke|stroke
4771180|NCT02793934|Acute myocardial infarction|acute myocardial infarction
4771181|NCT02793934|Total hip replacement|total hip replacement
4771182|NCT02793921|Alteration|alteration
4771183|NCT02793921|Cognitive Function|cognitive function
4771184|NCT02793921|Exercise|exercise
4771185|NCT02793908|Endometriosis|endometriosis
4771186|NCT02793908|Subcutaneous progesterone|subcutaneous progesterone
4771187|NCT02793908|luteal phase|luteal phase
4771188|NCT02793895|Atrial fibrillation/flutter|atrial fibrillation/flutter
4771189|NCT02793895|Postoperative atrial arrhythmia|postoperative atrial arrhythmia
4771190|NCT02793895|Cardiac surgery|cardiac surgery
4771191|NCT02793895|Stroke prevention|stroke prevention
4771192|NCT02793895|Oral anticoagulation|oral anticoagulation
4771193|NCT02793895|Cardiac rhythm monitoring|cardiac rhythm monitoring
4771194|NCT02793869|congenital cataract;anterior segment characteristics|congenital cataract;anterior segment characteristics
4771195|NCT02793856|lung cancer|lung cancer
4771196|NCT02793856|immune checkpoint|immune checkpoint
4771197|NCT02793856|PD-1|pd-1
4771198|NCT02793856|CRISPER|crisper
4771199|NCT02793856|autologous cell infusion|autologous cell infusion
4771200|NCT02793830|medication adherence|medication adherence
4771201|NCT02793830|mHealth|mhealth
4771202|NCT02793830|China|china
4771203|NCT02793830|heart disease|heart disease
4771204|NCT02793817|postsurgical|postsurgical
4771205|NCT02793817|postoperative|postoperative
4771206|NCT02793817|ocular|ocular
4771207|NCT02793817|cataract|cataract
4771208|NCT02793817|inflammation|inflammation
4771209|NCT02793817|pain|pain
4771210|NCT02793817|corticosteroid|corticosteroid
4771211|NCT02793804|HIV self-testing|hiv self-testing
4771212|NCT02793804|HIV|hiv
4771213|NCT02793804|Zambia|zambia
4771214|NCT02793791|high grade dysplastic nodule (HGDN)|high grade dysplastic nodule (hgdn)
4771215|NCT02793791|low grade dysplastic nodule (LGDN)|low grade dysplastic nodule (lgdn)
4771216|NCT02793778|Crohn's Disease|crohn's disease
4771217|NCT02793778|Digestive System Diseases|digestive system diseases
4771218|NCT02793778|Gastrointestinal Diseases|gastrointestinal diseases
4771219|NCT02793778|Intestinal Diseases|intestinal diseases
4771220|NCT02793778|mucosal healing|mucosal healing
4771221|NCT02793778|inflammatory bowel disease|inflammatory bowel disease
4771222|NCT02793778|Medical Food|medical food
4771223|NCT02793778|Nutritional intervention|nutritional intervention
4771224|NCT02793765|Advanced Prostate Cancer|advanced prostate cancer
4771225|NCT02793765|Castration-Resistant Prostate Cancer|castration-resistant prostate cancer
4771226|NCT02793765|Adenocarcinoma of the prostate|adenocarcinoma of the prostate
4771227|NCT02793765|Metastatic disease|metastatic disease
4771228|NCT02793765|CRPC|crpc
4771229|NCT02793752|IVF|ivf
4771230|NCT02793752|In vitro fertilization|in vitro fertilization
4771231|NCT02793752|Cumulus Cells|cumulus cells
4771232|NCT02793752|Oocyte|oocyte
4771233|NCT02793752|Embryo|embryo
4771234|NCT02793752|Fertility|fertility
4771235|NCT02793739|Safety|safety
4771236|NCT02793739|Efficacy|efficacy
4771237|NCT02793739|Longevity|longevity
4771238|NCT02793726|Hip Prosthesis|hip prosthesis
4771239|NCT02793713|EBUS|ebus
4771240|NCT02793713|Prediction|prediction
4771241|NCT02793713|malignancy|malignancy
4771242|NCT02793713|lymph nodes|lymph nodes
4771243|NCT02793713|lung cancer|lung cancer
4771244|NCT02793713|Diagnostic Techniques, Respiratory System|diagnostic techniques, respiratory system
4771245|NCT02793700|Betamethasone|betamethasone
4771246|NCT02793674|effort of breathing|effort of breathing
4771247|NCT02793674|high flow nasal cannula|high flow nasal cannula
4771248|NCT02793674|respiratory distress|respiratory distress
4771249|NCT02793648|Depression|depression
4771250|NCT02793648|Elderly|elderly
4771251|NCT02793635|Paraplegia|paraplegia
4771252|NCT02793635|Gait|gait
4771253|NCT02793635|Exoskeleton|exoskeleton
4771254|NCT02793622|Chemoprevention|chemoprevention
4771255|NCT02793622|Malaria|malaria
4771256|NCT02793622|Sulfadoxine-Pyrimethamine|sulfadoxine-pyrimethamine
4771257|NCT02793622|Dihydroartemisinin-Piperaquine|dihydroartemisinin-piperaquine
4771258|NCT02793609|induction of labor|induction of labor
4771259|NCT02793609|double balloon catheter|double balloon catheter
4771260|NCT02793609|mechanical ripening|mechanical ripening
4771261|NCT02793505|metformin|metformin
4771262|NCT02793505|pregnancy outcomes|pregnancy outcomes
4771263|NCT02793505|birth defects|birth defects
4771264|NCT02793505|spontaneous abortion|spontaneous abortion
4771265|NCT02793505|pharmacoepidemiology|pharmacoepidemiology
4771266|NCT02793466|Durvalumab|durvalumab
4771267|NCT02793466|solid tumors|solid tumors
4771268|NCT02793466|Immunotherapy|immunotherapy
4771269|NCT02793466|Check Point Inhibitor|check point inhibitor
4771270|NCT02793466|pediatrics|pediatrics
4771271|NCT02793466|children|children
4771272|NCT02793401|High Intensity Laser|high intensity laser
4771273|NCT02793401|Ultrasound|ultrasound
4771274|NCT02793401|Chronic Shoulder Pain|chronic shoulder pain
4771275|NCT02793375|Montelukast|montelukast
4771276|NCT02793375|Tonsillectomy|tonsillectomy
4771277|NCT02793349|angioplasty|angioplasty
4771278|NCT02793349|stents|stents
4771279|NCT02793349|polymers|polymers
4771280|NCT02793349|absorbable implants|absorbable implants
4771281|NCT02793271|Depression|depression
4771282|NCT02793271|Primary Health Care|primary health care
4771283|NCT02793271|Social Stigma|social stigma
4771284|NCT02793271|Stereotyping|stereotyping
4771285|NCT02793271|Health Care Quality|health care quality
4771286|NCT02793271|Access|access
4771287|NCT02793271|Evaluation|evaluation
4771288|NCT02793258|tDCS|tdcs
4771289|NCT02793258|neuromodulation|neuromodulation
4771290|NCT02793258|depression|depression
4771291|NCT02793258|cognition|cognition
4771292|NCT02793232|Safety|safety
4771293|NCT02793232|Tolerability|tolerability
4771294|NCT02793232|Pharmacokinetics|pharmacokinetics
4771295|NCT02793232|Alzheimer's disease|alzheimer's disease
4771296|NCT02793219|Advanced Prostate Cancer|advanced prostate cancer
4771297|NCT02793219|Castration-Resistant Prostate Cancer|castration-resistant prostate cancer
4771298|NCT02793219|CRPC|crpc
4771299|NCT02793219|Adenocarcinoma of the prostate|adenocarcinoma of the prostate
4771300|NCT02793219|Metastatic disease|metastatic disease
4771301|NCT02793206|Drusen|drusen
4771302|NCT02793206|SD-OCT|sd-oct
4771303|NCT02793167|acute kidney injury|acute kidney injury
4771304|NCT02793167|medication alert systems|medication alert systems
4771305|NCT02793154|gastric emptying|gastric emptying
4771306|NCT02793154|albiglutide|albiglutide
4771307|NCT02793154|GMA|gma
4771308|NCT02793154|exenatide|exenatide
4771309|NCT02793154|type 2 diabetes mellitus|type 2 diabetes mellitus
4771310|NCT02793141|Pneumonia|pneumonia
4771311|NCT02793141|Intensive Care Unit|intensive care unit
4771312|NCT02793141|Nosocomial pneumonia|nosocomial pneumonia
4771313|NCT02793141|Hospital-acquired pneumonia|hospital-acquired pneumonia
4771314|NCT02793141|Ventilator-associated pneumonia|ventilator-associated pneumonia
4771315|NCT02793141|ICU|icu
4771316|NCT02793141|HAP|hap
4771317|NCT02793141|VAP|vap
4771318|NCT02793141|Critical Care|critical care
4771319|NCT02793128|TC-3|tc-3
4771320|NCT02793128|Mitogel|mitogel
4771321|NCT02793128|UTUC|utuc
4771322|NCT02793128|Ureteral|ureteral
4771323|NCT02793128|Upper Tract|upper tract
4771324|NCT02793128|Carcinoma|carcinoma
4771325|NCT02793128|Kidney|kidney
4771326|NCT02793128|Renal|renal
4771327|NCT02793128|Gel|gel
4771328|NCT02793128|Local|local
4771329|NCT02793128|Mitomycin C|mitomycin c
4771330|NCT02793128|Prolonged Release|prolonged release
4771331|NCT02793128|Slow Release|slow release
4771332|NCT02793128|Kidney Sparing|kidney sparing
4771333|NCT02793128|T1|t1
4771334|NCT02793128|T0|t0
4771335|NCT02793128|Low Grade|low grade
4771336|NCT02793128|Transitional Cell Carcinoma of Renal Pelvis|transitional cell carcinoma of renal pelvis
4771337|NCT02793128|TCC|tcc
4771338|NCT02793102|mental anorexia|mental anorexia
4771339|NCT02793102|sensory workshops|sensory workshops
4771340|NCT02793102|BMI|bmi
4771341|NCT02793076|Posture|posture
4771342|NCT02793076|Body image|body image
4771343|NCT02793076|Dancing|dancing
4771344|NCT02793076|Group|group
4771345|NCT02793076|Survivors|survivors
4771346|NCT02793063|Brittle Bone|brittle bone
4771347|NCT02793063|Osteogenesis Imperfecta|osteogenesis imperfecta
4771348|NCT02793063|BBD|bbd
4771349|NCT02793063|OI|oi
4771350|NCT02793063|Congenital Abnormalities|congenital abnormalities
4771351|NCT02793063|Congenital Bone Disorder|congenital bone disorder
4771352|NCT02793063|Lobstein Syndrome|lobstein syndrome
4771353|NCT02793050|Trabectedin|trabectedin
4771354|NCT02793050|Soft Tissue Sarcoma|soft tissue sarcoma
4771355|NCT02793050|Observational|observational
4771356|NCT02793037|zirconia|zirconia
4771357|NCT02793037|resin bonded bridge|resin bonded bridge
4771358|NCT02793024|food shopping intervention|food shopping intervention
4771359|NCT02792972|Analgesic|analgesic
4771360|NCT02792972|Medicinal plants|medicinal plants
4771361|NCT02792972|Skin|skin
4771362|NCT02792972|Antimicrobial agents|antimicrobial agents
4771363|NCT02792972|Pain Measurement|pain measurement
4771364|NCT02792907|Foot Surgery|foot surgery
4771365|NCT02792907|Compliance|compliance
4771366|NCT02792907|Compressive Stockings|compressive stockings
4771367|NCT02792894|cluster randomized trial|cluster randomized trial
4771368|NCT02792894|developmental delays|developmental delays
4771369|NCT02792894|neurodevelopmental disorders|neurodevelopmental disorders
4771370|NCT02792894|autism|autism
4771371|NCT02792894|intellectual disability|intellectual disability
4771372|NCT02792894|low resource settings|low resource settings
4771373|NCT02792894|family volunteers|family volunteers
4771374|NCT02792881|Stomach Neoplasms|stomach neoplasms
4771375|NCT02792881|Laparoscopy|laparoscopy
4771376|NCT02792881|Remnant gastric cancer|remnant gastric cancer
4771377|NCT02792855|Snifﬁng Position|snifﬁng position
4771378|NCT02792855|Simple Head Extension|simple head extension
4771379|NCT02792829|Bioavailability of Lenvatinib suspension|bioavailability of lenvatinib suspension
4771380|NCT02792829|Palatability of Lenvatinib suspension|palatability of lenvatinib suspension
4771381|NCT02792829|Lenvatinib|lenvatinib
4771382|NCT02792829|Lenvima|lenvima
4771383|NCT02792829|E7080|e7080
4771384|NCT02792829|Capsule formulation|capsule formulation
4771385|NCT02792829|Healthy volunteers|healthy volunteers
4771386|NCT02792803|POAG|poag
4771387|NCT02792803|Primary open angle glaucoma|primary open angle glaucoma
4771388|NCT02792803|Ocular Hypertension|ocular hypertension
4771389|NCT02792803|Xalatan|xalatan
4771390|NCT02792803|Latanoprost|latanoprost
4771391|NCT02792803|Ocular Hyperemia|ocular hyperemia
4771392|NCT02792803|IOP|iop
4771393|NCT02792803|Intraocular Pressure|intraocular pressure
4771394|NCT02792803|Allergan|allergan
4771395|NCT02792803|prostaglandin|prostaglandin
4771396|NCT02792790|Amyloidosis|amyloidosis
4771397|NCT02792790|Carpal tunnel syndrome|carpal tunnel syndrome
4771398|NCT02792777|Concept Mapping|concept mapping
4771399|NCT02792777|VOICe|voice
4771400|NCT02792777|Interviews|interviews
4771401|NCT02792777|Patient-Centered Research|patient-centered research
4771402|NCT02792764|port|port
4771403|NCT02792764|peripheral intravenous lines|peripheral intravenous lines
4771404|NCT02792764|oncology|oncology
4771405|NCT02792751|Depth of anesthesia|depth of anesthesia
4771406|NCT02792751|BIS|bis
4771407|NCT02792751|ERCP|ercp
4771408|NCT02792751|Positive Regulation|positive regulation
4771409|NCT02792712|Acute myocardial infarction|acute myocardial infarction
4771410|NCT02792712|Antiplatelet agents|antiplatelet agents
4771411|NCT02792712|Magnetic resonance imaging (MRI)|magnetic resonance imaging (mri)
4771412|NCT02792686|Healthy Volunteers|healthy volunteers
4771413|NCT02792673|Embryo transfer media|embryo transfer media
4771414|NCT02792673|improvement of embryo transfer technique|improvement of embryo transfer technique
4771415|NCT02792673|improvement of implantation|improvement of implantation
4771416|NCT02792673|"Hyaluronan-enriched media Embryo Glue®"|"hyaluronan-enriched media embryo glue®"
4771417|NCT02792673|"30% Protein-supplemented Culture Medium Global Total®"|"30% protein-supplemented culture medium global total®"
4771418|NCT02792673|Autologous Follicular Fluid as embryo transfer medium|autologous follicular fluid as embryo transfer medium
4771419|NCT02792634|Bariatric surgery|bariatric surgery
4771420|NCT02792634|Nonalcoholic Steatohepatitis|nonalcoholic steatohepatitis
4771421|NCT02792634|Obesity|obesity
4771422|NCT02792608|Mindfulness-based Therapy|mindfulness-based therapy
4771423|NCT02792608|Brain Tumour Survivors|brain tumour survivors
4771424|NCT02792608|Depressive Symptoms|depressive symptoms
4771425|NCT02792608|Quality of Life|quality of life
4771426|NCT02792608|Perceived Stress|perceived stress
4771427|NCT02792608|Wellbeing|wellbeing
4771428|NCT02792608|Treatment|treatment
4771429|NCT02792582|Brain tumor|brain tumor
4771430|NCT02792582|Pediatrics|pediatrics
4771431|NCT02792582|Radiation therapy|radiation therapy
4771432|NCT02792582|Proton therapy|proton therapy
4771433|NCT02792582|Surgery|surgery
4771434|NCT02792569|IVA|iva
4771435|NCT02792569|Hippo Pathway|hippo pathway
4771436|NCT02792569|Follicle activation|follicle activation
4771437|NCT02792569|Low Responder|low responder
4771438|NCT02792569|POI|poi
4771439|NCT02792569|Poor Ovarian Reserve|poor ovarian reserve
4771440|NCT02792569|Poor Ovarian Response|poor ovarian response
4771441|NCT02792569|Salvador/Warts/Hippo pathway|salvador/warts/hippo pathway
4771442|NCT02792556|drug abortion|drug abortion
4771443|NCT02792556|urine pregnancy test|urine pregnancy test
4771444|NCT02792556|negative predictive value|negative predictive value
4771445|NCT02792556|check Top test|check top test
4771446|NCT02792556|transvaginal ultrasound|transvaginal ultrasound
4771447|NCT02792543|nutrition|nutrition
4771448|NCT02792543|double enterostomy|double enterostomy
4771449|NCT02792543|chyme reinfusion|chyme reinfusion
4771450|NCT02792543|randomized controlled trial|randomized controlled trial
4771451|NCT02792439|Fitness|fitness
4771452|NCT02792439|Health kit|health kit
4771453|NCT02792439|Researchkit|researchkit
4771454|NCT02792439|Walking|walking
4771455|NCT02792426|Smoking Cessation|smoking cessation
4771456|NCT02792426|Nicotine Dependence|nicotine dependence
4771457|NCT02792426|Tobacco Dependence|tobacco dependence
4771458|NCT02792413|osteoporosis|osteoporosis
4771459|NCT02792413|chronic kidney disease|chronic kidney disease
4771460|NCT02792413|anti-RANK ligand antibody|anti-rank ligand antibody
4771461|NCT02792413|bone mineral density|bone mineral density
4771462|NCT02792413|vascular calcifications|vascular calcifications
4771463|NCT02792387|cardio-renal syndrome|cardio-renal syndrome
4771464|NCT02792387|right heart dysfunction|right heart dysfunction
4771465|NCT02792387|central venous pressure|central venous pressure
4771466|NCT02792387|eGFR|egfr
4771467|NCT02792387|low-flow theory|low-flow theory
4771468|NCT02792374|Dental patients|dental patients
4771469|NCT02792374|Psychological Profile|psychological profile
4771470|NCT02792361|Post-Operative Pterional Craniotomy|post-operative pterional craniotomy
4771471|NCT02792361|Suction Drain|suction drain
4771472|NCT02792361|Benefits|benefits
4771473|NCT02792348|congenital urine flow impairment|congenital urine flow impairment
4771474|NCT02792348|urinary metabolomics profile|urinary metabolomics profile
4771475|NCT02792348|Nuclear Magnetic Resonance|nuclear magnetic resonance
4771476|NCT02792322|Cancer|cancer
4771477|NCT02792322|Oropharynx|oropharynx
4771478|NCT02792270|Surgery|surgery
4771479|NCT02792231|Relapsing multiple sclerosis|relapsing multiple sclerosis
4771480|NCT02792231|Ofatumumab|ofatumumab
4771481|NCT02792218|Relapsing multiple sclerosis|relapsing multiple sclerosis
4771482|NCT02792218|Ofatumumab|ofatumumab
4771483|NCT02792205|Willebrand factor deficiency|willebrand factor deficiency
4771484|NCT02792205|hematology|hematology
4771485|NCT02792205|Willebrand:Collagen-binding|willebrand:collagen-binding
4771486|NCT02792166|Morbid obesity|morbid obesity
4771487|NCT02792166|Metabolic syndrome|metabolic syndrome
4771488|NCT02792166|Metabolic surgery|metabolic surgery
4771489|NCT02792166|Bariatric surgery|bariatric surgery
4771490|NCT02792166|SADI|sadi
4771491|NCT02792166|BPD-DS|bpd-ds
4771492|NCT02792153|estrogen|estrogen
4771493|NCT02792153|anxiety|anxiety
4771494|NCT02792153|amenorrhea|amenorrhea
4771495|NCT02792153|eating disorders|eating disorders
4771496|NCT02792140|Psychology|psychology
4771497|NCT02792140|Dreams|dreams
4771498|NCT02792127|Social Anxiety|social anxiety
4771499|NCT02792127|Cognitive Behaviour Therapy|cognitive behaviour therapy
4771500|NCT02792127|Online Program|online program
4771501|NCT02792114|T-Cell|t-cell
4771502|NCT02792114|Chimeric antigen receptor (CAR)|chimeric antigen receptor (car)
4771503|NCT02792114|CAR T cells|car t cells
4771504|NCT02792114|Triple-negative breast cancer|triple-negative breast cancer
4771505|NCT02792114|Immunotherapy T-cell therapy|immunotherapy t-cell therapy
4771506|NCT02792114|16-040|16-040
4771507|NCT02792114|immunotherapy|immunotherapy
4771508|NCT02792114|CAR|car
4771509|NCT02792088|HBV|hbv
4771510|NCT02792075|Coronary Stenosis|coronary stenosis
4771511|NCT02792075|Intracoronary Imaging|intracoronary imaging
4771512|NCT02792075|VH-IVUS|vh-ivus
4771513|NCT02792075|OCT|oct
4771514|NCT02792075|NIRS|nirs
4771515|NCT02792075|gray scale IVUS|gray scale ivus
4771516|NCT02792062|Drug therapy|drug therapy
4771517|NCT02792023|Colorectal cancer|colorectal cancer
4771518|NCT02792023|Immunochemical occult blood test|immunochemical occult blood test
4771519|NCT02792010|T1rho MRI|t1rho mri
4771520|NCT02792010|hip|hip
4771521|NCT02792010|cartilage|cartilage
4771522|NCT02792010|Healthy participants|healthy participants
4771523|NCT02791997|Audition|audition
4771524|NCT02791997|Stroke|stroke
4771525|NCT02791997|Migraine|migraine
4771526|NCT02791997|Attention|attention
4771527|NCT02791997|Short-term memory,|short-term memory,
4771528|NCT02791997|Emotions|emotions
4771529|NCT02791997|EEG|eeg
4771530|NCT02791997|MEG|meg
4771531|NCT02791984|Suprasternal|suprasternal
4771532|NCT02791984|echography|echography
4771533|NCT02791984|fluid responsiveness|fluid responsiveness
4771534|NCT02791971|Contraception|contraception
4771535|NCT02791971|Birth control|birth control
4771536|NCT02791971|Social communication|social communication
4771537|NCT02791971|Adolescent|adolescent
4771538|NCT02791971|Social network|social network
4771539|NCT02791971|Health education|health education
4771540|NCT02791971|Reproductive health|reproductive health
4771541|NCT02791945|TBI|tbi
4771542|NCT02791945|hazardous and harmful alcohol use|hazardous and harmful alcohol use
4771543|NCT02791945|Veterans|veterans
4771544|NCT02791945|co-occurring disorders|co-occurring disorders
4771545|NCT02791945|pharmacotherapy|pharmacotherapy
4771546|NCT02791932|Pregnancy|pregnancy
4771547|NCT02791932|Postpartum period|postpartum period
4771548|NCT02791932|Depression|depression
4771549|NCT02791906|Chronic Kidney Diseases|chronic kidney diseases
4771550|NCT02791906|Chronic Kidney Insufficiency|chronic kidney insufficiency
4771551|NCT02791906|Chronic Renal Diseases|chronic renal diseases
4771552|NCT02791906|Chronic Renal Insufficiency|chronic renal insufficiency
4771553|NCT02791906|Kidney Insufficiency, Chronic|kidney insufficiency, chronic
4771554|NCT02791906|Cardiac Failure|cardiac failure
4771555|NCT02791906|Congestive Heart Failure|congestive heart failure
4771556|NCT02791906|Heart Decompensation|heart decompensation
4771557|NCT02791906|Heart Failure, Congestive|heart failure, congestive
4771558|NCT02791906|Myocardial Failure|myocardial failure
4771559|NCT02791880|acute kidney injury|acute kidney injury
4771560|NCT02791880|transcatheter aortic valve replacement|transcatheter aortic valve replacement
4771561|NCT02791880|genomics|genomics
4771562|NCT02791880|biomarker|biomarker
4771563|NCT02791841|Reading|reading
4771564|NCT02791841|Developmental Dyslexia,|developmental dyslexia,
4771565|NCT02791841|Music|music
4771566|NCT02791841|Rhythm|rhythm
4771567|NCT02791841|Action Video Games|action video games
4771568|NCT02791841|Hemisphere-Specific Stimulation|hemisphere-specific stimulation
4771569|NCT02791815|selexipag|selexipag
4771570|NCT02791815|pharmacokinetics|pharmacokinetics
4771571|NCT02791815|midazolam|midazolam
4771572|NCT02791802|Lipoprotein(a)|lipoprotein(a)
4771573|NCT02791802|lipoprotein/lipid apheresis|lipoprotein/lipid apheresis
4771574|NCT02791802|CV disease|cv disease
4771575|NCT02791789|Autism Spectrum Disorder|autism spectrum disorder
4771576|NCT02791789|SEMATIC|sematic
4771577|NCT02791789|software|software
4771578|NCT02791776|scoliosis|scoliosis
4771579|NCT02791763|Renal Anemia|renal anemia
4771580|NCT02791763|Japanese|japanese
4771581|NCT02791763|chronic kidney disease|chronic kidney disease
4771582|NCT02791763|Peritoneal dialysis|peritoneal dialysis
4771583|NCT02791763|GSK1278863|gsk1278863
4771584|NCT02791763|Non-dialysis|non-dialysis
4771585|NCT02791750|hormone replacement therapy|hormone replacement therapy
4771586|NCT02791750|breast cancer|breast cancer
4771587|NCT02791750|follow up|follow up
4771588|NCT02791737|Hematologic Malignancy|hematologic malignancy
4771589|NCT02791737|Exercise|exercise
4771590|NCT02791737|Decreased Physical Activity|decreased physical activity
4771591|NCT02791711|Bronchiolitis|bronchiolitis
4771592|NCT02791711|Continuous Positive Airway Pressure|continuous positive airway pressure
4771593|NCT02791711|HFNC|hfnc
4771594|NCT02791698|cortisol|cortisol
4771595|NCT02791698|hair|hair
4771596|NCT02791698|urinary|urinary
4771597|NCT02791685|Cardiac Rehabilitation|cardiac rehabilitation
4771598|NCT02791672|Perioperative Care|perioperative care
4771599|NCT02791672|Breast Reconstruction|breast reconstruction
4771600|NCT02791659|radiation exposure|radiation exposure
4771601|NCT02791659|ERCP|ercp
4771602|NCT02791659|prone|prone
4771603|NCT02791659|left lateral decubitus|left lateral decubitus
4771604|NCT02791607|Circulating tumor cells|circulating tumor cells
4771605|NCT02791607|Head and neck cancer|head and neck cancer
4771606|NCT02791607|Survival Prognosis|survival prognosis
4771607|NCT02791607|P16Ink4A|p16ink4a
4771608|NCT02791607|HPV|hpv
4771609|NCT02791555|pradaxa|pradaxa
4771610|NCT02791555|warfarin|warfarin
4771611|NCT02791542|Asthma|asthma
4771612|NCT02791516|Osteoporosis.|osteoporosis.
4771613|NCT02791516|Osteoporosis-Postmenopausal.|osteoporosis-postmenopausal.
4771614|NCT02791516|Bone Diseases-Metabolic.|bone diseases-metabolic.
4771615|NCT02791516|Bone Diseases.|bone diseases.
4771616|NCT02791516|Musculoskeletal Diseases.|musculoskeletal diseases.
4771617|NCT02791503|Irreversible electroporation (IRE|irreversible electroporation (ire
4771618|NCT02791503|Stereotactic ablative radiotherapy (SABR|stereotactic ablative radiotherapy (sabr
4771619|NCT02791503|Efficacy|efficacy
4771620|NCT02791503|Tumor ablation|tumor ablation
4771621|NCT02791503|Chemotherapy|chemotherapy
4771622|NCT02791503|Locally advanced pancreatic cancer (LAPC)|locally advanced pancreatic cancer (lapc)
4771623|NCT02791477|Attune|attune
4771624|NCT02791464|Meditation|meditation
4771625|NCT02791464|TM|tm
4771626|NCT02791464|PTSD|ptsd
4771627|NCT02791464|Trauma|trauma
4771628|NCT02791464|Female Prisoners|female prisoners
4771629|NCT02791451|COPD|copd
4771630|NCT02791451|telemonitoring|telemonitoring
4771631|NCT02791451|exacerbation|exacerbation
4771632|NCT02791425|Brain-Computer Interface|brain-computer interface
4771633|NCT02791425|Intratracheal intubation|intratracheal intubation
4771634|NCT02791425|Mechanical ventilation|mechanical ventilation
4771635|NCT02791425|Nonverbal communication|nonverbal communication
4771636|NCT02791425|Critical illness|critical illness
4771637|NCT02791425|Electroencephalography|electroencephalography
4771638|NCT02791425|Visual Evoked Potential|visual evoked potential
4771639|NCT02791412|left main|left main
4771640|NCT02791412|unprotected|unprotected
4771641|NCT02791412|percutaneous coronary intervention|percutaneous coronary intervention
4771642|NCT02791412|coronary-artery bypass graft|coronary-artery bypass graft
4771643|NCT02791399|opioid safety|opioid safety
4771644|NCT02791399|opioid misuse|opioid misuse
4771645|NCT02791399|opioid abuse|opioid abuse
4771646|NCT02791399|patient-centered|patient-centered
4771647|NCT02791399|opioid|opioid
4771648|NCT02791399|opiate|opiate
4771649|NCT02791399|chronic pain|chronic pain
4771650|NCT02791399|primary care|primary care
4771651|NCT02791399|Veteran|veteran
4771652|NCT02791399|clinical care|clinical care
4771653|NCT02791360|Brain|brain
4771654|NCT02791360|Radiotherapy|radiotherapy
4771655|NCT02791360|MRI|mri
4771656|NCT02791360|Sequelae|sequelae
4771657|NCT02791334|PDL1|pdl1
4771658|NCT02791334|PD-L1|pd-l1
4771659|NCT02791295|Type 2 diabetes|type 2 diabetes
4771660|NCT02791295|lifestyle intervention|lifestyle intervention
4771661|NCT02791295|insulin pump treatment|insulin pump treatment
4771662|NCT02791295|body weight|body weight
4771663|NCT02791295|body composition|body composition
4771664|NCT02791282|Chronic Thromboembolic Pulmonary Hypertension (CTEPH)|chronic thromboembolic pulmonary hypertension (cteph)
4771665|NCT02791282|MRI|mri
4771666|NCT02791282|SPECT|spect
4771667|NCT02791230|amyloidosis|amyloidosis
4771668|NCT02791230|amyloid|amyloid
4771669|NCT02791230|transthyretin|transthyretin
4771670|NCT02791230|TTR|ttr
4771671|NCT02791230|ATTR-CM|attr-cm
4771672|NCT02791191|BACE inhibitor|bace inhibitor
4771673|NCT02791100|height|height
4771674|NCT02791100|weight|weight
4771675|NCT02791100|diet|diet
4771676|NCT02791100|complementary foods|complementary foods
4771677|NCT02791100|protein|protein
4771678|NCT02791100|calcium|calcium
4771679|NCT02791009|HF|hf
4771680|NCT02791009|HFrEF|hfref
4771681|NCT02791009|HFpEF|hfpef
4771682|NCT02791009|MRI|mri
4771683|NCT02791009|biomarker|biomarker
4771684|NCT02790996|sepsis|sepsis
4771685|NCT02790996|neonate|neonate
4771686|NCT02790996|vancomycin|vancomycin
4771687|NCT02790983|Registry|registry
4771688|NCT02790983|Spine|spine
4771689|NCT02790983|Surgery|surgery
4771690|NCT02790983|Medical Oncology|medical oncology
4771691|NCT02790983|Radiation Oncology|radiation oncology
4771692|NCT02790983|Neoplasms|neoplasms
4771693|NCT02790944|Germline|germline
4771694|NCT02790944|Pancreatic|pancreatic
4771695|NCT02790944|Genetic Testing|genetic testing
4771696|NCT02790931|diabetic foot|diabetic foot
4771697|NCT02790931|therapeutic exercises|therapeutic exercises
4771698|NCT02790931|foot|foot
4771699|NCT02790931|preventive care|preventive care
4771700|NCT02790931|rehabilitation|rehabilitation
4771701|NCT02790931|Diabetic Neuropathy|diabetic neuropathy
4771702|NCT02790918|Pulmonary Hypertension|pulmonary hypertension
4771703|NCT02790918|MRI|mri
4771704|NCT02790905|pregnant and post-partum women|pregnant and post-partum women
4771705|NCT02790905|Validation questionnaires|validation questionnaires
4771706|NCT02790905|Thai-Myanmar border|thai-myanmar border
4771707|NCT02790892|type 1 diabetes|type 1 diabetes
4771708|NCT02790892|type 2 diabetes|type 2 diabetes
4771709|NCT02790892|children|children
4771710|NCT02790892|adolescents|adolescents
4771711|NCT02790892|young adults|young adults
4771712|NCT02790892|youth|youth
4771713|NCT02790892|transition|transition
4771714|NCT02790892|art therapy|art therapy
4771715|NCT02790892|behavioral therapy|behavioral therapy
4771716|NCT02790879|Transitional care|transitional care
4771717|NCT02790879|teenagers|teenagers
4771718|NCT02790879|cystic fibrosis|cystic fibrosis
4771719|NCT02790879|pulmonary function|pulmonary function
4771720|NCT02790879|nutritional function|nutritional function
4771721|NCT02790879|Patients who experiment a transition pediatric - adult care|patients who experiment a transition pediatric - adult care
4771722|NCT02790866|Decision Aid|decision aid
4771723|NCT02790866|Informed Decision Making|informed decision making
4771724|NCT02790866|Shared Decision making|shared decision making
4771725|NCT02790866|Screening|screening
4771726|NCT02790853|Cancer of Head and Neck|cancer of head and neck
4771727|NCT02790853|Oral Potentially Malignant Disorders|oral potentially malignant disorders
4771728|NCT02790853|OPMD|opmd
4771729|NCT02790853|Multimodal Imaging|multimodal imaging
4771730|NCT02790853|Suspicious oral mucosal lesion|suspicious oral mucosal lesion
4771731|NCT02790853|Pathologic diagnosis of dysplasia|pathologic diagnosis of dysplasia
4771732|NCT02790853|History of resected oral cancer|history of resected oral cancer
4771733|NCT02790853|White Light Examination|white light examination
4771734|NCT02790853|WL|wl
4771735|NCT02790853|Wide-field auto-fluorescence imaging device PS2.1/PS3|wide-field auto-fluorescence imaging device ps2.1/ps3
4771736|NCT02790853|Proflavine Hemisulfate|proflavine hemisulfate
4771737|NCT02790853|High-Resolution Optical System|high-resolution optical system
4771738|NCT02790853|HRME|hrme
4771739|NCT02790853|Brush Biopsy|brush biopsy
4771740|NCT02790853|Tissue Biopsy|tissue biopsy
4771741|NCT02790840|Volunteers|volunteers
4771742|NCT02790801|chronic heart failure|chronic heart failure
4771743|NCT02790801|atrial fibrillation|atrial fibrillation
4771744|NCT02790801|anticoagulant|anticoagulant
4771745|NCT02790762|stem cells|stem cells
4771746|NCT02790762|Mesenchymal Stem Cells|mesenchymal stem cells
4771747|NCT02790762|Umbilical Cord-Mesenchymal Stem Cells|umbilical cord-mesenchymal stem cells
4771748|NCT02790762|Pneumoconiosis|pneumoconiosis
4771749|NCT02790749|Developmental hip dysplasia|developmental hip dysplasia
4771750|NCT02790749|Intra-articular pathology|intra-articular pathology
4771751|NCT02790749|Adult hip dysplasia|adult hip dysplasia
4771752|NCT02790749|Labral tear, hip|labral tear, hip
4771753|NCT02790749|Chondromalacia, hip|chondromalacia, hip
4771754|NCT02790736|propranolol|propranolol
4771755|NCT02790736|public speaking anxiety|public speaking anxiety
4771756|NCT02790710|propanolol|propanolol
4771757|NCT02790710|obsessive-compulsive disorder|obsessive-compulsive disorder
4771758|NCT02790697|Indirect calorimetry|indirect calorimetry
4771759|NCT02790697|ICALIC Study|icalic study
4771760|NCT02790697|Energy expenditure|energy expenditure
4771761|NCT02790697|VO2|vo2
4771762|NCT02790697|VCO2|vco2
4771763|NCT02790697|Respiratory quotient|respiratory quotient
4771764|NCT02790658|Grumixama|grumixama
4771765|NCT02790658|Urolithins|urolithins
4771766|NCT02790658|Anthocyanins|anthocyanins
4771767|NCT02790658|Metabolomic Approach|metabolomic approach
4771768|NCT02790658|Ellagitannins|ellagitannins
4771769|NCT02790658|Subjects|subjects
4771770|NCT02790645|Type 1 diabetes|type 1 diabetes
4771771|NCT02790645|Health technologies|health technologies
4771772|NCT02790645|Continuous subcutaneous insulin infusion|continuous subcutaneous insulin infusion
4771773|NCT02790645|Telemedicine|telemedicine
4771774|NCT02790645|Glycemic variability|glycemic variability
4771775|NCT02790645|Inflammatory markers,|inflammatory markers,
4771776|NCT02790645|Oxidative stress|oxidative stress
4771777|NCT02790645|Depression|depression
4771778|NCT02790645|Quality of life|quality of life
4771779|NCT02790645|Cost-effectiveness|cost-effectiveness
4771780|NCT02790632|Aneurysm, Ruptured|aneurysm, ruptured
4771781|NCT02790632|Nimodipine|nimodipine
4771782|NCT02790632|Subarachnoid Hemorrhage|subarachnoid hemorrhage
4771783|NCT02790567|diagnostic performance|diagnostic performance
4771784|NCT02790567|heparin-induced thrombocytopenia|heparin-induced thrombocytopenia
4771785|NCT02790567|rapid immunological diagnostic method|rapid immunological diagnostic method
4771786|NCT02790567|immunoassay|immunoassay
4771787|NCT02790567|pretest scoring systems|pretest scoring systems
4771788|NCT02790567|4Ts score|4ts score
4771789|NCT02790567|HEP score|hep score
4771790|NCT02790541|aging|aging
4771791|NCT02790541|HBOT|hbot
4771792|NCT02790541|reverse|reverse
4771793|NCT02790541|angiogenesis|angiogenesis
4771794|NCT02790541|elderly|elderly
4771795|NCT02790541|mitochohndria|mitochohndria
4771796|NCT02790528|statin|statin
4771797|NCT02790528|vasospastic angina|vasospastic angina
4771798|NCT02790476|Safe|safe
4771799|NCT02790476|Prescribing|prescribing
4771800|NCT02790476|Opioids|opioids
4771801|NCT02790463|Allopurinol|allopurinol
4771802|NCT02790398|Transdiagnostic treatment protocol|transdiagnostic treatment protocol
4771803|NCT02790398|Transdiagnostic treatment protocol + PA component|transdiagnostic treatment protocol + pa component
4771804|NCT02790372|Nursing homes|nursing homes
4771805|NCT02790372|Norway|norway
4771806|NCT02790359|Carbon dioxide|carbon dioxide
4771807|NCT02790359|Air|air
4771808|NCT02790359|Colonoscopy|colonoscopy
4771809|NCT02790346|hemiparesis|hemiparesis
4771810|NCT02790346|deformity of the foot and ankle|deformity of the foot and ankle
4771811|NCT02790320|Eribulin mesylate|eribulin mesylate
4771812|NCT02790320|Halaven|halaven
4771813|NCT02790320|Breast cancer|breast cancer
4771814|NCT02790307|multiple sclerosis|multiple sclerosis
4771815|NCT02790307|overactive bladder|overactive bladder
4771816|NCT02790307|urinary incontinence|urinary incontinence
4771817|NCT02790307|tibial nerve stimulation|tibial nerve stimulation
4771818|NCT02790294|magnetic resonance imaging|magnetic resonance imaging
4771819|NCT02790268|Cionni Ring|cionni ring
4771820|NCT02790268|Ultrasound Biomicroscopy|ultrasound biomicroscopy
4771821|NCT02790242|Mechanical Circulatory Support Device (MCSD)|mechanical circulatory support device (mcsd)
4771822|NCT02790242|ventricular Assist Device (VAD)|ventricular assist device (vad)
4771823|NCT02790229|rehabilitation, anti-gravity treadmill|rehabilitation, anti-gravity treadmill
4771824|NCT02790216|Image guided brachytherapy|image guided brachytherapy
4771825|NCT02790151|working memory, recollection training, transfer|working memory, recollection training, transfer
4771826|NCT02790138|Drug Therapy|drug therapy
4771827|NCT02790112|Body Mass Index|body mass index
4771828|NCT02790112|Body Composition|body composition
4771829|NCT02790112|Glucose Metabolism Disorders|glucose metabolism disorders
4771830|NCT02790112|Bone Development|bone development
4771831|NCT02790112|Gonadal Disorders|gonadal disorders
4771832|NCT02790112|Fertility|fertility
4771833|NCT02790112|Overweight|overweight
4771834|NCT02790112|Obesity|obesity
4771835|NCT02790112|Menarche|menarche
4771836|NCT02790099|Pain|pain
4771837|NCT02790099|Postoperative pain control|postoperative pain control
4771838|NCT02790099|Rectus sheath block|rectus sheath block
4771839|NCT02790099|Intrathecal morphine|intrathecal morphine
4771840|NCT02790099|Caesarean section|caesarean section
4771841|NCT02790086|hypothermia|hypothermia
4771842|NCT02790086|prevalence|prevalence
4771843|NCT02790086|perioperative|perioperative
4771844|NCT02790086|anemia|anemia
4771845|NCT02790086|myocardial injury|myocardial injury
4771846|NCT02790086|troponin T|troponin t
4771847|NCT02790086|noncardiac surgery|noncardiac surgery
4771848|NCT02790073|Calciphylaxis|calciphylaxis
4771849|NCT02790073|Calcific Uremic Arteriolopathy|calcific uremic arteriolopathy
4771850|NCT02790073|Dialysis|dialysis
4771851|NCT02790073|End Stage Renal Disease|end stage renal disease
4771852|NCT02790073|Rare disease (ORPHA280062)|rare disease (orpha280062)
4771853|NCT02790073|Calcification|calcification
4771854|NCT02790073|Calcium Metabolism Disorders|calcium metabolism disorders
4771855|NCT02790073|Calcinosis|calcinosis
4771856|NCT02790073|Metabolic Diseases|metabolic diseases
4771857|NCT02790060|diabetes|diabetes
4771858|NCT02790047|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
4771859|NCT02790047|Exercise Therapy|exercise therapy
4771860|NCT02790047|Positive Expiratory Pressure|positive expiratory pressure
4771861|NCT02790047|Physical Fitness|physical fitness
4771862|NCT02790047|Quality of Life|quality of life
4771863|NCT02790008|echocardiography|echocardiography
4771864|NCT02790008|magnetic resonance imaging|magnetic resonance imaging
4771865|NCT02790008|cardiopulmonary exercise test|cardiopulmonary exercise test
4771866|NCT02789995|Intensive Care Unit - Acquired Weakness (ICU-AW)|intensive care unit - acquired weakness (icu-aw)
4771867|NCT02789982|PTSD|ptsd
4771868|NCT02789982|Trauma related disorders|trauma related disorders
4771869|NCT02789982|Reconsolidation blockade|reconsolidation blockade
4771870|NCT02789982|Paris attacks|paris attacks
4771871|NCT02789956|Internal connection|internal connection
4771872|NCT02789956|Cobalt/Chrome|cobalt/chrome
4771873|NCT02789956|Cad-cam Framework|cad-cam framework
4771874|NCT02789956|marginal bone level|marginal bone level
4771875|NCT02789943|IHD Normal EF|ihd normal ef
4771876|NCT02789930|Weight estimation|weight estimation
4771877|NCT02789930|Patient safety|patient safety
4771878|NCT02789917|ACS|acs
4771879|NCT02789917|Triple-Therapy|triple-therapy
4771880|NCT02789917|AF|af
4771881|NCT02789917|oral anticoagulation (OAC)|oral anticoagulation (oac)
4771882|NCT02789917|non-vitamin-K oral anticoagulant (NOAC)|non-vitamin-k oral anticoagulant (noac)
4771883|NCT02789878|Neoadjuvant therapy|neoadjuvant therapy
4771884|NCT02789878|High-risk Prostate Cancer|high-risk prostate cancer
4771885|NCT02789865|Acute appendicitis|acute appendicitis
4771886|NCT02789865|Endoscopic retrograde appendicitis therapy|endoscopic retrograde appendicitis therapy
4771887|NCT02789865|Endoscopic retrograde appendicography|endoscopic retrograde appendicography
4771888|NCT02789865|Endoscopic therapy|endoscopic therapy
4771889|NCT02789865|Appendectomy|appendectomy
4771890|NCT02789865|Antibiotic Therapy|antibiotic therapy
4771891|NCT02789787|Cleft Lip|cleft lip
4771892|NCT02789787|Palate|palate
4771893|NCT02789787|Class III|class iii
4771894|NCT02789787|Malocclusion|malocclusion
4771895|NCT02789787|Protraction|protraction
4771896|NCT02789761|Flow-mediated dilatation (FMD)|flow-mediated dilatation (fmd)
4771897|NCT02789761|Vascular function|vascular function
4771898|NCT02789761|cognitive function|cognitive function
4771899|NCT02789735|Pregnancy|pregnancy
4771900|NCT02789735|laser therapy|laser therapy
4771901|NCT02789735|persistent pain|persistent pain
4771902|NCT02789735|pelvic pain|pelvic pain
4771903|NCT02789722|Mate|mate
4771904|NCT02789722|Vascular protection|vascular protection
4771905|NCT02789722|Endothelial function|endothelial function
4771906|NCT02789722|Ilex paraguariensis|ilex paraguariensis
4771907|NCT02789657|neoadjuvant breast cancer|neoadjuvant breast cancer
4771908|NCT02789657|stage I-III breast cancer|stage i-iii breast cancer
4771909|NCT02789657|HER 2 positive breast cancer|her 2 positive breast cancer
4771910|NCT02789644|Ursodeoxycholic acid|ursodeoxycholic acid
4771911|NCT02789644|Metabolomics/biomarker|metabolomics/biomarker
4771912|NCT02789644|Pharmacokinetics|pharmacokinetics
4771913|NCT02789605|Aphthous Stomatitis [C07.465.864.750]|aphthous stomatitis [c07.465.864.750]
4771914|NCT02789592|REM Sleep Behavior Disorder|rem sleep behavior disorder
4771915|NCT02789592|Parkinson Disease|parkinson disease
4771916|NCT02789592|Randomized Controlled Trial|randomized controlled trial
4771917|NCT02789592|Clinical Trial|clinical trial
4771918|NCT02789592|Melatonin|melatonin
4771919|NCT02789592|Clonazepam|clonazepam
4771920|NCT02789579|prophylactic|prophylactic
4771921|NCT02789579|Urinary Tract Infections|urinary tract infections
4771922|NCT02789579|Minimally invasive upper tract lithotomy|minimally invasive upper tract lithotomy
4771923|NCT02789566|Primaquine|primaquine
4771924|NCT02789566|Pharmacokinetic|pharmacokinetic
4771925|NCT02789553|Glucose digestion|glucose digestion
4771926|NCT02789553|Bypass surgery|bypass surgery
4771927|NCT02789553|C13-glucose tracer|c13-glucose tracer
4771928|NCT02789553|Insulin secretion|insulin secretion
4771929|NCT02789540|COPD symptoms|copd symptoms
4771930|NCT02789527|healthy volunteers|healthy volunteers
4771931|NCT02789514|esophagogastroduodenoscopy|esophagogastroduodenoscopy
4771932|NCT02789514|paediatric|paediatric
4771933|NCT02789501|Catheter|catheter
4771934|NCT02789501|Dysfunctions|dysfunctions
4771935|NCT02789501|Blood Stream Infections|blood stream infections
4771936|NCT02789501|Haemodialysis|haemodialysis
4771937|NCT02789501|Taurolidine|taurolidine
4771938|NCT02789501|Tunneled|tunneled
4771939|NCT02789436|halitosis|halitosis
4771940|NCT02789436|chronic periodontitis|chronic periodontitis
4771941|NCT02789436|probiotic|probiotic
4771942|NCT02789410|Cesarean delivery|cesarean delivery
4771943|NCT02789410|Analgesia|analgesia
4771944|NCT02789410|Intrathecal opioids|intrathecal opioids
4771945|NCT02789397|Granulomatous and lymphocytic interstitial lung disease|granulomatous and lymphocytic interstitial lung disease
4771946|NCT02789397|common variable immunodeficiency|common variable immunodeficiency
4771947|NCT02789397|Rituximab|rituximab
4771948|NCT02789397|Azathioprine|azathioprine
4771949|NCT02789397|primary immunodeficiency|primary immunodeficiency
4771950|NCT02789397|GLIILD|gliild
4771951|NCT02789397|CVID|cvid
4771952|NCT02789384|soft-tissue sarcomas|soft-tissue sarcomas
4771953|NCT02789384|CINSARC|cinsarc
4771954|NCT02789384|biomarker|biomarker
4771955|NCT02789384|efficacy|efficacy
4771956|NCT02789384|pronostic|pronostic
4771957|NCT02789371|EUS-FNA|eus-fna
4771958|NCT02789371|modified wet suction technique|modified wet suction technique
4771959|NCT02789371|dry suction technique|dry suction technique
4771960|NCT02789358|cryotherapy|cryotherapy
4771961|NCT02789345|T790M|t790m
4771962|NCT02789345|epidermal growth factor receptor (EGFR)|epidermal growth factor receptor (egfr)
4771963|NCT02789332|carboplatin|carboplatin
4771964|NCT02789332|olaparib|olaparib
4771965|NCT02789332|pCR|pcr
4771966|NCT02789332|neoadjuvant|neoadjuvant
4771967|NCT02789332|triple-negative|triple-negative
4771968|NCT02789332|hormonreceptor-positive|hormonreceptor-positive
4771969|NCT02789332|BRCA1/2|brca1/2
4771970|NCT02789332|HRD, homologous recominant deficient|hrd, homologous recominant deficient
4771971|NCT02789332|breast cancer|breast cancer
4771972|NCT02789332|genetic testing (somatic and germline mutations)|genetic testing (somatic and germline mutations)
4771973|NCT02789319|Blood Glucose Monitoring System|blood glucose monitoring system
4771974|NCT02789319|BGMS|bgms
4771975|NCT02789319|Diabetes|diabetes
4771976|NCT02789319|Patient Use|patient use
4771977|NCT02789306|Preventive therapy|preventive therapy
4771978|NCT02789306|Dental implants|dental implants
4771979|NCT02789293|Glaucoma|glaucoma
4771980|NCT02789293|Ultrasound|ultrasound
4771981|NCT02789293|Ciliary body|ciliary body
4771982|NCT02789267|Head and Neck Cancer|head and neck cancer
4771983|NCT02789267|Quality of Life|quality of life
4771984|NCT02789267|Dietary support|dietary support
4771985|NCT02789254|acute myeloid leukemia|acute myeloid leukemia
4771986|NCT02789254|Fms-like receptor tyrosine kinase (FLT3)|fms-like receptor tyrosine kinase (flt3)
4771987|NCT02789254|stem cell transplantation|stem cell transplantation
4771988|NCT02789254|complete remission|complete remission
4771989|NCT02789254|CD135|cd135
4771990|NCT02789254|antibodies|antibodies
4771991|NCT02789254|Leukemia|leukemia
4771992|NCT02789254|AML|aml
4771993|NCT02789254|Fc-optimized|fc-optimized
4771994|NCT02789241|Endotoxin|endotoxin
4771995|NCT02789241|healthy|healthy
4771996|NCT02789241|volunteers|volunteers
4771997|NCT02789241|males|males
4771998|NCT02789241|females|females
4771999|NCT02789215|Child care food costs|child care food costs
4772000|NCT02789215|Meal participation rates|meal participation rates
4772001|NCT02789215|Child and Adult Care Food Program|child and adult care food program
4772002|NCT02789202|dental caries|dental caries
4772003|NCT02789202|deciduous tooth|deciduous tooth
4772004|NCT02789176|Phenobarbital|phenobarbital
4772005|NCT02789176|EEG|eeg
4772006|NCT02789176|family impact|family impact
4772007|NCT02789176|neurodevelopment|neurodevelopment
4772008|NCT02789163|breast|breast
4772009|NCT02789163|ultrasound|ultrasound
4772010|NCT02789163|diagnostic exam|diagnostic exam
4772011|NCT02789163|automated volume breast scanner|automated volume breast scanner
4772012|NCT02789137|metastatic renal cell carcinoma|metastatic renal cell carcinoma
4772013|NCT02789124|fluid responsiveness|fluid responsiveness
4772014|NCT02789124|carotid artery flow time|carotid artery flow time
4772015|NCT02789124|passive leg raise|passive leg raise
4772016|NCT02789098|ST Elevation Myocardial Infarction|st elevation myocardial infarction
4772017|NCT02789098|Ventricular remodeling|ventricular remodeling
4772018|NCT02789098|Biomarkers|biomarkers
4772019|NCT02789098|Coronary endothelial function|coronary endothelial function
4772020|NCT02789098|Positron Emission Tomography|positron emission tomography
4772021|NCT02789085|TENS|tens
4772022|NCT02789085|ULF-TENS|ulf-tens
4772023|NCT02789085|ANS|ans
4772024|NCT02789085|Dentistry|dentistry
4772025|NCT02789085|TMD|tmd
4772026|NCT02789059|Becker muscular dystrophy|becker muscular dystrophy
4772027|NCT02789059|Facioscapulohumeral dystrophy|facioscapulohumeral dystrophy
4772028|NCT02789059|congenital myopathy|congenital myopathy
4772029|NCT02789059|motor neurone diseases|motor neurone diseases
4772030|NCT02789046|adult|adult
4772031|NCT02789046|vascular access|vascular access
4772032|NCT02789046|preoperative period|preoperative period
4772033|NCT02789046|peripheral venous catheterization|peripheral venous catheterization
4772034|NCT02789033|diabetic foot ulcers|diabetic foot ulcers
4772035|NCT02789033|chitosan|chitosan
4772036|NCT02789033|isosorbide dinitrate spray|isosorbide dinitrate spray
4772037|NCT02789020|Rasagiline|rasagiline
4772038|NCT02788981|triple-negative breast cancer|triple-negative breast cancer
4772039|NCT02788981|advanced breast cancer|advanced breast cancer
4772040|NCT02788981|nab-paclitaxel|nab-paclitaxel
4772041|NCT02788981|mifepristone|mifepristone
4772042|NCT02788981|glucocorticoid receptor-positive breast cancer|glucocorticoid receptor-positive breast cancer
4772043|NCT02788968|Psychology and Cognitive Neuroscience of development|psychology and cognitive neuroscience of development
4772044|NCT02788968|Adolescent and young adult healthy volunteers|adolescent and young adult healthy volunteers
4772045|NCT02788968|Anatomical and functionally Magnetic Resonance Imaging (MRI)|anatomical and functionally magnetic resonance imaging (mri)
4772046|NCT02788968|Conflict detection|conflict detection
4772047|NCT02788968|Reasoning|reasoning
4772048|NCT02788955|Protein|protein
4772049|NCT02788955|Diet intervention|diet intervention
4772050|NCT02788955|Muscle|muscle
4772051|NCT02788955|Colorectal cancer|colorectal cancer
4772052|NCT02788942|Port|port
4772053|NCT02788942|Infection|infection
4772054|NCT02788942|cholecystectomy|cholecystectomy
4772055|NCT02788929|Percutaneous Transluminal Coronary Intervention|percutaneous transluminal coronary intervention
4772056|NCT02788929|Cardiac Rehabilitation|cardiac rehabilitation
4772057|NCT02788929|Fitbit Charge HR|fitbit charge hr
4772058|NCT02788916|Drug Therapy|drug therapy
4772059|NCT02788903|Obesity Counseling|obesity counseling
4772060|NCT02788864|Forest ranger|forest ranger
4772061|NCT02788864|P.falciparum|p.falciparum
4772062|NCT02788864|P.vivax|p.vivax
4772063|NCT02788864|Dihydroartemisinine-piperaquine (DP)|dihydroartemisinine-piperaquine (dp)
4772064|NCT02788864|Primaquine|primaquine
4772065|NCT02788851|Stimulant Medication|stimulant medication
4772066|NCT02788851|Exercise|exercise
4772067|NCT02788851|Functional Outcome|functional outcome
4772068|NCT02788851|Effectiveness|effectiveness
4772069|NCT02788851|Symptoms|symptoms
4772070|NCT02788838|Magnetic Resonance Imaging|magnetic resonance imaging
4772071|NCT02788838|Energy Intake|energy intake
4772072|NCT02788838|Commercials|commercials
4772073|NCT02788838|Children|children
4772074|NCT02788799|ST Elevation|st elevation
4772075|NCT02788799|LCX Artery|lcx artery
4772076|NCT02788786|chlorhexidine|chlorhexidine
4772077|NCT02788786|cetylpyridinium chloride|cetylpyridinium chloride
4772078|NCT02788786|gingival crevicular fluid|gingival crevicular fluid
4772079|NCT02788734|carpal tunnel syndrome|carpal tunnel syndrome
4772080|NCT02788734|CTS|cts
4772081|NCT02788734|inherited peripheral neuropathy|inherited peripheral neuropathy
4772082|NCT02788734|Charcot-Marie-Tooth disease|charcot-marie-tooth disease
4772083|NCT02788734|Hereditary Neuropathy|hereditary neuropathy
4772084|NCT02788734|Pressure Palsies|pressure palsies
4772085|NCT02788734|CMT|cmt
4772086|NCT02788734|HNPP|hnpp
4772087|NCT02788708|paclitaxel|paclitaxel
4772088|NCT02788708|lenvatinib|lenvatinib
4772089|NCT02788695|Visual Nonspecific|visual nonspecific
4772090|NCT02788682|VDBP|vdbp
4772091|NCT02788682|single nucleotide polymorphisms (SNPs)|single nucleotide polymorphisms (snps)
4772092|NCT02788682|interferon based therapy|interferon based therapy
4772093|NCT02788682|Egypt|egypt
4772094|NCT02788656|heart failure|heart failure
4772095|NCT02788656|neprilysin|neprilysin
4772096|NCT02788656|implantable hemodynamic monitor|implantable hemodynamic monitor
4772097|NCT02788656|angiotensin-receptor blocker|angiotensin-receptor blocker
4772098|NCT02788656|angiotensin-converting enzyme inhibitor|angiotensin-converting enzyme inhibitor
4772099|NCT02788604|psychosocial screening, quality of life|psychosocial screening, quality of life
4772100|NCT02788552|Neurological|neurological
4772101|NCT02788552|Diet and Nutrition|diet and nutrition
4772102|NCT02788552|Mental Health|mental health
4772103|NCT02788539|Chronic Pain|chronic pain
4772104|NCT02788539|mhealth|mhealth
4772105|NCT02788539|Integrative Medicine|integrative medicine
4772106|NCT02788539|MBSR|mbsr
4772107|NCT02788539|Mindfulness Based Stress Reduction|mindfulness based stress reduction
4772108|NCT02788539|Web based|web based
4772109|NCT02788539|Internet Based|internet based
4772110|NCT02788526|Carcinoma,Hepatocellular|carcinoma,hepatocellular
4772111|NCT02788526|Chemoembolization|chemoembolization
4772112|NCT02788526|Adjuvant therapy|adjuvant therapy
4772113|NCT02788526|Hepatocellular|hepatocellular
4772114|NCT02788526|Microvessels invasion|microvessels invasion
4772115|NCT02788500|Epidemiology|epidemiology
4772116|NCT02788500|Sports medicine|sports medicine
4772117|NCT02788500|Research protocol|research protocol
4772118|NCT02788500|Athletic injuries|athletic injuries
4772119|NCT02788500|Sports for persons with disabilities|sports for persons with disabilities
4772120|NCT02788448|Percutaneous vascular closure device|percutaneous vascular closure device
4772121|NCT02788448|Large hole closure device|large hole closure device
4772122|NCT02788396|STEMI|stemi
4772123|NCT02788396|PPCI|ppci
4772124|NCT02788396|post-dilatation|post-dilatation
4772125|NCT02788396|coronary microcirculation|coronary microcirculation
4772126|NCT02788370|Positive expiratory pressure|positive expiratory pressure
4772127|NCT02788370|Cardiopulmonary responses|cardiopulmonary responses
4772128|NCT02788370|Exercise|exercise
4772129|NCT02788370|Older people|older people
4772130|NCT02788357|motor training|motor training
4772131|NCT02788357|motor recovery|motor recovery
4772132|NCT02788357|human|human
4772133|NCT02788357|neuroplasticity|neuroplasticity
4772134|NCT02788357|transcranial magnetic stimulation|transcranial magnetic stimulation
4772135|NCT02788344|Observational study|observational study
4772136|NCT02788344|Myocardial revascularization|myocardial revascularization
4772137|NCT02788344|Thrombolytic therapy|thrombolytic therapy
4772138|NCT02788344|Hospital mortality|hospital mortality
4772139|NCT02788344|Hemorrhage|hemorrhage
4772140|NCT02788344|Quality of health care|quality of health care
4772141|NCT02788344|Angioplasty|angioplasty
4772142|NCT02788318|Epilepsy|epilepsy
4772143|NCT02788318|SUDEP|sudep
4772144|NCT02788318|Serotonin|serotonin
4772145|NCT02788292|acetylcysteine|acetylcysteine
4772146|NCT02788292|three-dimensional reconstruction|three-dimensional reconstruction
4772147|NCT02788292|autologous fat grafting|autologous fat grafting
4772148|NCT02788279|Locally advanced or Metastatic colorectal adenocarcinoma|locally advanced or metastatic colorectal adenocarcinoma
4772149|NCT02788266|Cervical lesion|cervical lesion
4772150|NCT02788266|gingival recession|gingival recession
4772151|NCT02788266|restorative materials|restorative materials
4772152|NCT02788253|Mallampati|mallampati
4772153|NCT02788253|Intubation difficult|intubation difficult
4772154|NCT02788253|Mask ventilation difficult|mask ventilation difficult
4772155|NCT02788227|Ebola Vaccine|ebola vaccine
4772156|NCT02788214|Gastric Cancer|gastric cancer
4772157|NCT02788214|Bacterial Risk Factors|bacterial risk factors
4772158|NCT02788214|DNA Methylation|dna methylation
4772159|NCT02788214|DNA Sequencing|dna sequencing
4772160|NCT02788214|Biobank|biobank
4772161|NCT02788201|COXEN|coxen
4772162|NCT02788201|Bladder Cancer|bladder cancer
4772163|NCT02788201|Molecular Profiles|molecular profiles
4772164|NCT02788201|Algorithm|algorithm
4772165|NCT02788201|Biomarkers|biomarkers
4772166|NCT02788188|First in Human|first in human
4772167|NCT02788188|Middle East Respiratory Syndrome (MERS)|middle east respiratory syndrome (mers)
4772168|NCT02788188|Tc Bovine-Derived|tc bovine-derived
4772169|NCT02788188|Transchromosomic Cattle|transchromosomic cattle
4772170|NCT02788175|HIV Immune Therapy|hiv immune therapy
4772171|NCT02788175|Monoclonal Antibody|monoclonal antibody
4772172|NCT02788175|Integrin|integrin
4772173|NCT02788149|Ultrasonography|ultrasonography
4772174|NCT02788149|Submental|submental
4772175|NCT02788149|Lateral Parapharyngeal wall|lateral parapharyngeal wall
4772176|NCT02788149|Tongue base thickness|tongue base thickness
4772177|NCT02788149|Polysomnography|polysomnography
4772178|NCT02788123|De-Nol|de-nol
4772179|NCT02788123|NSAID-induced gastropathy|nsaid-induced gastropathy
4772180|NCT02788123|Pantoprazole|pantoprazole
4772181|NCT02788123|Bismuth tripotassium dicitrate|bismuth tripotassium dicitrate
4772182|NCT02788123|Russia|russia
4772183|NCT02788097|blastocysts|blastocysts
4772184|NCT02788097|progesterone|progesterone
4772185|NCT02788097|implantation|implantation
4772186|NCT02788097|artificial frozen embryo transfer|artificial frozen embryo transfer
4772187|NCT02788084|Next Generation Sequencing|next generation sequencing
4772188|NCT02788084|Cell free DNA|cell free dna
4772189|NCT02788071|Irritable Bowel Syndrome|irritable bowel syndrome
4772190|NCT02788071|Fecal Microbiota Transplantation|fecal microbiota transplantation
4772191|NCT02788071|Microbiota|microbiota
4772192|NCT02788058|Hypofractionated Radiotherapy|hypofractionated radiotherapy
4772193|NCT02788058|EGFR Positive|egfr positive
4772194|NCT02788058|Lung Adenocarcinoma|lung adenocarcinoma
4772195|NCT02788058|Limited Metastases|limited metastases
4772196|NCT02788019|Adductor canal block, nerve block|adductor canal block, nerve block
4772197|NCT02787941|acute coronary syndrome|acute coronary syndrome
4772198|NCT02787941|medication adherence|medication adherence
4772199|NCT02787941|pharmacist-led interventions|pharmacist-led interventions
4772200|NCT02787941|Vietnam|vietnam
4772201|NCT02787915|dendritic cells|dendritic cells
4772202|NCT02787915|cytotoxic T lymphocyte|cytotoxic t lymphocyte
4772203|NCT02787915|DC vaccine|dc vaccine
4772204|NCT02787863|Pneumococcal vaccine|pneumococcal vaccine
4772205|NCT02787863|Polioxidonium|polioxidonium
4772206|NCT02787837|Castration Resistant Prostate Cancer|castration resistant prostate cancer
4772207|NCT02787837|Abiraterone Acetate|abiraterone acetate
4772208|NCT02787837|Biomarkers|biomarkers
4772209|NCT02787824|iron deficiency|iron deficiency
4772210|NCT02787824|hemodialysis|hemodialysis
4772212|NCT02787811|Pregnancy rate|pregnancy rate
4772213|NCT02787811|predictors|predictors
4772214|NCT02787798|Nervous System|nervous system
4772215|NCT02787798|Cardiac disease|cardiac disease
4772216|NCT02787785|Subcutaneous|subcutaneous
4772217|NCT02787785|Implantable Cardioverter Defibrillator|implantable cardioverter defibrillator
4772218|NCT02787785|MADIT|madit
4772219|NCT02787785|Diabetes|diabetes
4772220|NCT02787785|Myocardial Infarction|myocardial infarction
4772221|NCT02787759|stroke|stroke
4772222|NCT02787759|walking|walking
4772223|NCT02787759|balance|balance
4772224|NCT02787759|exercise|exercise
4772225|NCT02787746|AD|ad
4772226|NCT02787746|Donepezil|donepezil
4772227|NCT02787746|Safety|safety
4772228|NCT02787733|performance|performance
4772229|NCT02787733|recovery|recovery
4772230|NCT02787720|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
4772231|NCT02787720|Pulmonary Rehabilitation|pulmonary rehabilitation
4772232|NCT02787720|Rehabilitation Plan|rehabilitation plan
4772233|NCT02787720|Rehabilitation Techniques|rehabilitation techniques
4772234|NCT02787720|Survivor|survivor
4772235|NCT02787720|Randomized Controlled Trial|randomized controlled trial
4772236|NCT02787707|Breast cancer|breast cancer
4772237|NCT02787707|Traditional medicine|traditional medicine
4772238|NCT02787707|Chemotherapy Induced Nausea and Vomiting|chemotherapy induced nausea and vomiting
4772239|NCT02787707|Bunium Persicum|bunium persicum
4772240|NCT02787707|Rhus Coriaria|rhus coriaria
4772241|NCT02787694|stroke|stroke
4772242|NCT02787694|walking|walking
4772243|NCT02787694|balance|balance
4772244|NCT02787694|exercise|exercise
4772245|NCT02787668|childhood obesity|childhood obesity
4772246|NCT02787668|Non-alcoholic fatty liver disease|non-alcoholic fatty liver disease
4772247|NCT02787668|insulin resistance|insulin resistance
4772248|NCT02787668|carbohydrate-restriction|carbohydrate-restriction
4772249|NCT02787655|Aging|aging
4772250|NCT02787642|Advanced soft-tissue sarcoma|advanced soft-tissue sarcoma
4772251|NCT02787642|Unresectable Soft-tissue Sarcoma|unresectable soft-tissue sarcoma
4772252|NCT02787629|D007440|d007440
4772253|NCT02787590|Neurology|neurology
4772254|NCT02787577|Sleep Duration|sleep duration
4772255|NCT02787577|Sleep Quality|sleep quality
4772256|NCT02787577|Body Composition|body composition
4772257|NCT02787577|Energy Intake|energy intake
4772258|NCT02787577|Energy Expenditure|energy expenditure
4772259|NCT02787577|Energy Balance|energy balance
4772260|NCT02787577|Cardiovascular Risk|cardiovascular risk
4772261|NCT02787564|fruit, vegetables|fruit, vegetables
4772262|NCT02787538|Rheumatoid Arthritis|rheumatoid arthritis
4772263|NCT02787538|Decision Aids|decision aids
4772264|NCT02787538|Biologics|biologics
4772265|NCT02787512|ERCP|ercp
4772266|NCT02787512|stent|stent
4772267|NCT02787512|preoperative biliary drainage|preoperative biliary drainage
4772268|NCT02787499|Drug resistance|drug resistance
4772269|NCT02787499|Standard of care|standard of care
4772270|NCT02787499|sub-saharan africa|sub-saharan africa
4772271|NCT02787499|antiretroviral therapy|antiretroviral therapy
4772272|NCT02787499|diagnostics|diagnostics
4772273|NCT02787499|implementation|implementation
4772274|NCT02787486|Down syndrome|down syndrome
4772275|NCT02787486|Edwards syndrome|edwards syndrome
4772276|NCT02787486|Patau syndrome|patau syndrome
4772277|NCT02787486|Klinefelter syndrome|klinefelter syndrome
4772278|NCT02787486|DiGeorge syndrome|digeorge syndrome
4772279|NCT02787486|Chromosome Deletion|chromosome deletion
4772280|NCT02787486|Aneuploidy|aneuploidy
4772281|NCT02787473|Squamous cell lung cancer|squamous cell lung cancer
4772282|NCT02787473|Pemetrexed|pemetrexed
4772283|NCT02787473|Radiosensitivity|radiosensitivity
4772284|NCT02787460|Parenting|parenting
4772285|NCT02787460|Family Relations|family relations
4772286|NCT02787460|Marriage|marriage
4772287|NCT02787460|Relationships|relationships
4772288|NCT02787447|Hypofractionated Radiotherapy|hypofractionated radiotherapy
4772289|NCT02787447|Thymosin Alpha 1|thymosin alpha 1
4772290|NCT02787447|Lung Adenocarcinoma|lung adenocarcinoma
4772291|NCT02787447|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors
4772292|NCT02787434|African american men|african american men
4772293|NCT02787434|prostate cancer screening|prostate cancer screening
4772294|NCT02787434|web-based decision aid|web-based decision aid
4772295|NCT02787434|informed decision making|informed decision making
4772296|NCT02787434|shared decision-making|shared decision-making
4772297|NCT02787421|Reconstructive Surgery|reconstructive surgery
4772298|NCT02787421|Rhinoplasty|rhinoplasty
4772299|NCT02787382|cytomegalovirus|cytomegalovirus
4772300|NCT02787382|TORCH|torch
4772301|NCT02787382|prenatal diagnosis|prenatal diagnosis
4772302|NCT02787382|congenital infections|congenital infections
4772303|NCT02787382|fetal abnormalities|fetal abnormalities
4772304|NCT02787382|echocardiography|echocardiography
4772305|NCT02787382|myocardial deformation|myocardial deformation
4772306|NCT02787369|Refractory Leukemia|refractory leukemia
4772307|NCT02787369|Leukemia|leukemia
4772308|NCT02787356|Skin Diseases, Erythema|skin diseases, erythema
4772309|NCT02787330|pediatric cancer|pediatric cancer
4772310|NCT02787330|psychosocial|psychosocial
4772311|NCT02787330|siblings|siblings
4772312|NCT02787317|bivalirudin|bivalirudin
4772313|NCT02787317|myocardial injure|myocardial injure
4772314|NCT02787304|NAFLD activity score|nafld activity score
4772315|NCT02787304|ASBTi|asbti
4772316|NCT02787304|MRI PDFF|mri pdff
4772317|NCT02787304|NAS|nas
4772318|NCT02787304|NAFLD|nafld
4772319|NCT02787304|liver disease|liver disease
4772320|NCT02787304|ASBT|asbt
4772321|NCT02787304|MRI proton density fat fraction|mri proton density fat fraction
4772322|NCT02787304|nonalcoholic steatohepatitis|nonalcoholic steatohepatitis
4772727|NCT02785068|Oncology|oncology
4772323|NCT02787304|apical sodium dependent bile acid transporter inhibitor|apical sodium dependent bile acid transporter inhibitor
4772324|NCT02787304|fatty liver|fatty liver
4772325|NCT02787304|NASH|nash
4772326|NCT02787278|rtPA|rtpa
4772327|NCT02787278|Intracranial hemorrhage|intracranial hemorrhage
4772328|NCT02787265|High density spinal cord stimulation|high density spinal cord stimulation
4772329|NCT02787265|Virtual expert registry|virtual expert registry
4772330|NCT02787226|liposomal bupivacaine|liposomal bupivacaine
4772331|NCT02787226|analgesia for total shoulder arthroplasty|analgesia for total shoulder arthroplasty
4772332|NCT02787226|peripheral nerve blocks for total shoulder arthroplasty|peripheral nerve blocks for total shoulder arthroplasty
4772333|NCT02787213|proteomics|proteomics
4772334|NCT02787213|pregnancy|pregnancy
4772335|NCT02787213|biomarkers|biomarkers
4772336|NCT02787213|preterm birth|preterm birth
4772337|NCT02787200|electroencephalogram (EEG),Human brain,Brain-Computer Interface|electroencephalogram (eeg),human brain,brain-computer interface
4772338|NCT02787187|Standard lymphadenectomy|standard lymphadenectomy
4772339|NCT02787187|extended lymphadenectomy|extended lymphadenectomy
4772340|NCT02787187|pancreaticoduodenectomy|pancreaticoduodenectomy
4772341|NCT02787174|Asthma|asthma
4772342|NCT02787174|Medication adherence|medication adherence
4772343|NCT02787174|Intervention study|intervention study
4772344|NCT02787161|Chronic Kidney Disease|chronic kidney disease
4772345|NCT02787161|Hemodialysis|hemodialysis
4772346|NCT02787161|Hemodiafiltration|hemodiafiltration
4772347|NCT02787161|Renal Replacement Therapy|renal replacement therapy
4772348|NCT02787161|Physical Activity|physical activity
4772349|NCT02787161|Accelerometer|accelerometer
4772350|NCT02787148|cognitive behavioral therapy|cognitive behavioral therapy
4772351|NCT02787148|psychotherapy|psychotherapy
4772352|NCT02787148|cardiovascular health|cardiovascular health
4772353|NCT02787148|psychoneuroimmunology|psychoneuroimmunology
4772354|NCT02787135|Delusions|delusions
4772355|NCT02787135|Schizophrenia|schizophrenia
4772356|NCT02787135|Cognitive Behavior Therapy|cognitive behavior therapy
4772357|NCT02787135|Emotion|emotion
4772358|NCT02787135|Emotion regulation|emotion regulation
4772359|NCT02787135|self-esteem|self-esteem
4772360|NCT02787135|sleep quality|sleep quality
4772361|NCT02787135|Efficacy of change|efficacy of change
4772362|NCT02787122|Schizophrenia|schizophrenia
4772363|NCT02787122|psychotic disorders|psychotic disorders
4772364|NCT02787122|Cognitive Behavior Therapy|cognitive behavior therapy
4772365|NCT02787122|emotion regulation|emotion regulation
4772366|NCT02787122|self-esteem|self-esteem
4772367|NCT02787122|randomized-controlled trial|randomized-controlled trial
4772368|NCT02787109|Safety|safety
4772369|NCT02787109|Immunogenicity|immunogenicity
4772370|NCT02787109|Phase I|phase i
4772371|NCT02787096|dynamic knee laxity measurement|dynamic knee laxity measurement
4772372|NCT02787096|laxi-MRI|laxi-mri
4772373|NCT02787096|partial anterior cruciate ligament tear|partial anterior cruciate ligament tear
4772374|NCT02787083|Interstitial Cystitis|interstitial cystitis
4772375|NCT02787044|influenza vaccine|influenza vaccine
4772376|NCT02787044|cardiopulmonary hospitalization|cardiopulmonary hospitalization
4772377|NCT02787044|heart failure|heart failure
4772378|NCT02787044|myocardial infarction|myocardial infarction
4772379|NCT02787044|clinical trial|clinical trial
4772380|NCT02787031|hip fracture|hip fracture
4772381|NCT02787031|geriatric|geriatric
4772382|NCT02787031|epidemiology|epidemiology
4772383|NCT02787031|practice variation|practice variation
4772384|NCT02787031|anesthesia|anesthesia
4772385|NCT02787018|Brachial plexus block|brachial plexus block
4772386|NCT02787018|Ropivacaine|ropivacaine
4772387|NCT02787018|Dexmedetomidine|dexmedetomidine
4772388|NCT02787018|Dexamethasone|dexamethasone
4772389|NCT02787018|Adjuvants, anesthesia|adjuvants, anesthesia
4772390|NCT02787005|PD1|pd1
4772391|NCT02787005|PD-1|pd-1
4772392|NCT02787005|PDL1|pdl1
4772393|NCT02787005|PD-L1|pd-l1
4772394|NCT02786992|Misoprostol|misoprostol
4772395|NCT02786992|Oxytocin|oxytocin
4772396|NCT02786992|Carbetocin|carbetocin
4772397|NCT02786992|Prevention|prevention
4772398|NCT02786992|Post-partum hemorrhage|post-partum hemorrhage
4772399|NCT02786979|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
4772400|NCT02786979|Arteriosclerosis|arteriosclerosis
4772401|NCT02786979|beraprost|beraprost
4772402|NCT02786979|Aspirin|aspirin
4772403|NCT02786966|Cervical spine injuries|cervical spine injuries
4772404|NCT02786966|Canadian C-spine Rule|canadian c-spine rule
4772405|NCT02786966|Emergency Medical Services|emergency medical services
4772406|NCT02786966|Paramedic|paramedic
4772407|NCT02786966|Cervical spine fracture|cervical spine fracture
4772408|NCT02786953|Sleep|sleep
4772409|NCT02786953|Adherence|adherence
4772410|NCT02786953|Diabetes Management|diabetes management
4772411|NCT02786953|Adolescent|adolescent
4772412|NCT02786940|remote|remote
4772413|NCT02786940|cardiac monitoring|cardiac monitoring
4772414|NCT02786940|mortality|mortality
4772415|NCT02786927|HANDIHALER|handihaler
4772416|NCT02786927|Dry Powder Inhaler|dry powder inhaler
4772417|NCT02786927|COPD|copd
4772418|NCT02786927|ELLIPTA|ellipta
4772419|NCT02786927|Inhaler preference attributes|inhaler preference attributes
4772420|NCT02786875|lifestyle|lifestyle
4772421|NCT02786875|low glycemic index diet|low glycemic index diet
4772422|NCT02786875|exercise|exercise
4772423|NCT02786875|vitamin D|vitamin d
4772424|NCT02786875|breast cancer|breast cancer
4772425|NCT02786875|Mediterranean diet|mediterranean diet
4772426|NCT02786862|mechanical ventilation|mechanical ventilation
4772427|NCT02786862|independent ventilation|independent ventilation
4772428|NCT02786862|ventilation/perfusion mismatch|ventilation/perfusion mismatch
4772429|NCT02786862|thoracic anesthesia|thoracic anesthesia
4772430|NCT02786849|Electric Stimulation|electric stimulation
4772431|NCT02786849|Electric Stimulation Therapy|electric stimulation therapy
4772432|NCT02786836|acute liver failure|acute liver failure
4772433|NCT02786836|methacetin|methacetin
4772434|NCT02786836|breath test|breath test
4772435|NCT02786836|severe acute liver injury|severe acute liver injury
4772436|NCT02786836|hepatic encephalopathy|hepatic encephalopathy
4772437|NCT02786836|ALFSG Registry|alfsg registry
4772438|NCT02786836|acetaminophen toxicity|acetaminophen toxicity
4772439|NCT02786797|breast cancer|breast cancer
4772440|NCT02786797|mindfulness-based stress reduction|mindfulness-based stress reduction
4772441|NCT02786797|cognitive impairment|cognitive impairment
4772442|NCT02786771|Stress Management|stress management
4772443|NCT02786771|Mindfulness|mindfulness
4772444|NCT02786771|Meditation|meditation
4772445|NCT02786771|Stress Resilience|stress resilience
4772446|NCT02786732|Psoriasis|psoriasis
4772447|NCT02786719|Sargramostim|sargramostim
4772448|NCT02786719|Cyclophosphamide|cyclophosphamide
4772449|NCT02786719|Topotecan|topotecan
4772450|NCT02786719|Cisplatin|cisplatin
4772451|NCT02786719|Dexrazoxane|dexrazoxane
4772452|NCT02786719|Doxorubicin|doxorubicin
4772453|NCT02786719|Etoposide|etoposide
4772454|NCT02786719|Filgrastim|filgrastim
4772455|NCT02786719|Vincristine|vincristine
4772456|NCT02786719|Mesna|mesna
4772457|NCT02786706|Traumatic Brain Injury|traumatic brain injury
4772458|NCT02786706|Intracranial Pressure|intracranial pressure
4772459|NCT02786706|Ultrasonography|ultrasonography
4772460|NCT02786706|Computer-Assisted Image Analysis|computer-assisted image analysis
4772461|NCT02786706|Intracranial Hypertension|intracranial hypertension
4772462|NCT02786706|Acute brain injuries|acute brain injuries
4772463|NCT02786693|TEP-scan|tep-scan
4772464|NCT02786654|Acute myocardial infarction|acute myocardial infarction
4772465|NCT02786654|mortality|mortality
4772466|NCT02786654|evidence-based care|evidence-based care
4772467|NCT02786654|Myocardial Ischaemia National Audit Project|myocardial ischaemia national audit project
4772468|NCT02786654|β blockers|β blockers
4772469|NCT02786641|nasopharyngeal carcinoma|nasopharyngeal carcinoma
4772470|NCT02786641|induction chemotherapy|induction chemotherapy
4772471|NCT02786641|concurrent chemotherapy|concurrent chemotherapy
4772472|NCT02786641|docetaxel|docetaxel
4772473|NCT02786641|cisplatin|cisplatin
4772474|NCT02786641|xeloda|xeloda
4772475|NCT02786641|nomogram|nomogram
4772476|NCT02786615|men who have sex with men (MSM)|men who have sex with men (msm)
4772477|NCT02786589|Lung cancer Immunotherapy|lung cancer immunotherapy
4772478|NCT02786589|Plasmodium vivax|plasmodium vivax
4772479|NCT02786589|Immunotherapy|immunotherapy
4772480|NCT02786576|Moderate to Severe Hidradenitis Suppurativa|moderate to severe hidradenitis suppurativa
4772481|NCT02786576|Adalimumab|adalimumab
4772482|NCT02786563|power doppler (PD)|power doppler (pd)
4772483|NCT02786563|ultrasonographic (US)|ultrasonographic (us)
4772484|NCT02786563|rheumatoid arthritis (RA)|rheumatoid arthritis (ra)
4772485|NCT02786563|disease activity scale (DAS)|disease activity scale (das)
4772486|NCT02786563|C-reactive protein (CRP)|c-reactive protein (crp)
4772487|NCT02786550|Lower blepharoplasty, Botulinum toxin, Scar|lower blepharoplasty, botulinum toxin, scar
4772488|NCT02786537|Hepatitis C|hepatitis c
4772489|NCT02786524|Palliative Care|palliative care
4772490|NCT02786524|Triage|triage
4772491|NCT02786524|Symptom Evaluation|symptom evaluation
4772492|NCT02786524|Chemotherapy|chemotherapy
4772493|NCT02786524|Patient Distress|patient distress
4772494|NCT02786498|Tibial Shaft|tibial shaft
4772495|NCT02786498|Tibia|tibia
4772496|NCT02786498|Femoral Shaft|femoral shaft
4772497|NCT02786498|Femur|femur
4772498|NCT02786498|Vitamin D|vitamin d
4772499|NCT02786498|Fracture Healing|fracture healing
4772500|NCT02786485|BPX-501|bpx-501
4772501|NCT02786485|Rimiducid|rimiducid
4772502|NCT02786485|AP1903|ap1903
4772503|NCT02786485|Hematological malignancies|hematological malignancies
4772504|NCT02786485|Hematologic diseases|hematologic diseases
4772505|NCT02786485|Leukemias and Myelodysplastic Syndromes|leukemias and myelodysplastic syndromes
4772506|NCT02786485|Lymphomas|lymphomas
4772507|NCT02786485|Multiple myeloma|multiple myeloma
4772508|NCT02786472|Bystander behaviors|bystander behaviors
4772509|NCT02786472|Incoming students|incoming students
4772510|NCT02786472|CampusSave|campussave
4772511|NCT02786472|Prevention|prevention
4772512|NCT02786472|Sexual Assault|sexual assault
4772513|NCT02786472|Incapacitation|incapacitation
4772514|NCT02786459|Prostate|prostate
4772515|NCT02786459|Local Recurrence|local recurrence
4772516|NCT02786459|Radical Prostatectomy|radical prostatectomy
4772517|NCT02786446|Lidocaine gel|lidocaine gel
4772518|NCT02786446|Extracorporeal shockwave lithotripsy|extracorporeal shockwave lithotripsy
4772519|NCT02786446|Naproxen sodium|naproxen sodium
4772520|NCT02786446|Pain score|pain score
4772521|NCT02786420|pregnancy|pregnancy
4772522|NCT02786420|magnetic resonance imaging|magnetic resonance imaging
4772523|NCT02786420|environmental air pollutants|environmental air pollutants
4772524|NCT02786407|overactive bladder|overactive bladder
4772525|NCT02786407|Botulinum Toxin Type A for Injection|botulinum toxin type a for injection
4772526|NCT02786368|Food Production|food production
4772527|NCT02786368|Inadequacy|inadequacy
4772528|NCT02786368|Dietary zinc|dietary zinc
4772529|NCT02786368|Iron|iron
4772530|NCT02786368|vitamin A|vitamin a
4772531|NCT02786342|Hepatocellular Carcinoma|hepatocellular carcinoma
4772532|NCT02786342|Sorafenib|sorafenib
4772533|NCT02786342|HCC|hcc
4772534|NCT02786342|Angiogenesis|angiogenesis
4772535|NCT02786342|Polymorphisms|polymorphisms
4772536|NCT02786329|colorectal cancer|colorectal cancer
4772537|NCT02786329|TIVA|tiva
4772538|NCT02786329|sevoflurane|sevoflurane
4772539|NCT02786329|lidocaine|lidocaine
4772540|NCT02786264|transcatheter aortic valve replacement|transcatheter aortic valve replacement
4772541|NCT02786264|anesthesia|anesthesia
4772542|NCT02786264|conscious sedation|conscious sedation
4772543|NCT02786264|managed anesthesia care|managed anesthesia care
4772544|NCT02786199|Hepatocellular Carcinoma(HCC)|hepatocellular carcinoma(hcc)
4772545|NCT02786199|Ultrasound|ultrasound
4772546|NCT02786199|Backscatter|backscatter
4772547|NCT02786199|Differentiation grade|differentiation grade
4772548|NCT02786199|Survival|survival
4772549|NCT02786186|Psoriasis|psoriasis
4772550|NCT02786186|Plaque Psoriasis|plaque psoriasis
4772551|NCT02786186|Chronic Plaque Psoriasis|chronic plaque psoriasis
4772552|NCT02786186|Cosentyx|cosentyx
4772553|NCT02786186|Secukinumab|secukinumab
4772554|NCT02786186|Moderate to severe plaque psoriasis|moderate to severe plaque psoriasis
4772555|NCT02786186|PURE registry|pure registry
4772556|NCT02786186|Registry|registry
4772557|NCT02786173|PRIME|prime
4772558|NCT02786173|PAD|pad
4772559|NCT02786173|PVD|pvd
4772560|NCT02786173|Observational|observational
4772561|NCT02786173|CLI|cli
4772562|NCT02786173|PRIME Registry|prime registry
4772563|NCT02786147|Breast Cancer|breast cancer
4772564|NCT02786147|Ovarian Cancer|ovarian cancer
4772565|NCT02786147|B-RST|b-rst
4772566|NCT02786121|hip replacement,|hip replacement,
4772567|NCT02786121|rehabilitation,|rehabilitation,
4772568|NCT02786121|early ambulation,|early ambulation,
4772569|NCT02786108|left gastric artery|left gastric artery
4772570|NCT02786108|embolization|embolization
4772571|NCT02786108|obesity|obesity
4772572|NCT02786095|Atrial fibrillation|atrial fibrillation
4772573|NCT02786095|anti arrhythmic drug|anti arrhythmic drug
4772574|NCT02786095|NOAC|noac
4772575|NCT02786095|warfarin|warfarin
4772576|NCT02786095|coumadin|coumadin
4772577|NCT02786056|Respiratory Function Tests|respiratory function tests
4772578|NCT02786056|Lung|lung
4772579|NCT02785965|electroacupuncture|electroacupuncture
4772580|NCT02785965|lifestyle modification|lifestyle modification
4772581|NCT02785965|diet|diet
4772582|NCT02785965|exercise|exercise
4772583|NCT02785965|Dai Meridian|dai meridian
4772584|NCT02785926|pesticide exposure|pesticide exposure
4772585|NCT02785926|respiratory control|respiratory control
4772586|NCT02785926|sleep|sleep
4772587|NCT02785900|Antibodies, monoclonal|antibodies, monoclonal
4772588|NCT02785900|Antibody drug conjugate|antibody drug conjugate
4772589|NCT02785900|Antigens, cluster of differentiation 33 (CD33)|antigens, cluster of differentiation 33 (cd33)
4772590|NCT02785900|Drug therapy|drug therapy
4772591|NCT02785900|Immunotherapy|immunotherapy
4772592|NCT02785887|Breast cancer|breast cancer
4772593|NCT02785887|lung cancer|lung cancer
4772594|NCT02785887|Gastrointestinal Cancer|gastrointestinal cancer
4772595|NCT02785887|Ovarian cancer|ovarian cancer
4772596|NCT02785887|Prostate cancer|prostate cancer
4772597|NCT02785887|bladder cancer|bladder cancer
4772598|NCT02785861|hormonal therapy|hormonal therapy
4772599|NCT02785861|walking|walking
4772600|NCT02785861|fatigue|fatigue
4772601|NCT02785822|Reproductive Techniques, Assisted|reproductive techniques, assisted
4772602|NCT02785809|Oral contraceptives|oral contraceptives
4772603|NCT02785809|long-term use|long-term use
4772604|NCT02785809|AMH|amh
4772605|NCT02785809|Ovarian reserve parameters|ovarian reserve parameters
4772606|NCT02785783|EndoRings™|endorings™
4772607|NCT02785757|adenocarcinoma|adenocarcinoma
4772608|NCT02785757|venous thromboembolism|venous thromboembolism
4772609|NCT02785757|thrombin generation assay|thrombin generation assay
4772610|NCT02785731|pelvic mass|pelvic mass
4772611|NCT02785731|ovarian cancer|ovarian cancer
4772612|NCT02785731|gynecological cancer|gynecological cancer
4772613|NCT02785731|risk prediction|risk prediction
4772614|NCT02785718|Contact system|contact system
4772615|NCT02785718|Factor XI deficiency|factor xi deficiency
4772616|NCT02785718|Factor XII deficiency|factor xii deficiency
4772617|NCT02785718|Global haemostasis assays|global haemostasis assays
4772618|NCT02785705|immunization|immunization
4772619|NCT02785705|vaccine schedule|vaccine schedule
4772620|NCT02785705|poliomyelitis|poliomyelitis
4772621|NCT02785705|polio|polio
4772622|NCT02785705|oral polio vaccine|oral polio vaccine
4772623|NCT02785705|inactivated polio vaccine|inactivated polio vaccine
4772624|NCT02785692|soft tissue sarcoma|soft tissue sarcoma
4772625|NCT02785692|IMRT and sarcoma|imrt and sarcoma
4772626|NCT02785692|preoperative highly conformal radiation therapy|preoperative highly conformal radiation therapy
4772627|NCT02785692|soft tissue sarcoma and wound healing|soft tissue sarcoma and wound healing
4772628|NCT02785692|postoperative complications|postoperative complications
4772629|NCT02785692|treatment tolerance of soft tissue IMRT|treatment tolerance of soft tissue imrt
4772630|NCT02785679|Allergy|allergy
4772631|NCT02785679|Cow's milk|cow's milk
4772632|NCT02785679|breast feeding|breast feeding
4772633|NCT02785679|Cow's milk formula|cow's milk formula
4772634|NCT02785679|prevention|prevention
4772635|NCT02785666|Men who have sex with men|men who have sex with men
4772636|NCT02785666|Elimination|elimination
4772637|NCT02785653|sevoflurane|sevoflurane
4772638|NCT02785653|rocuronium|rocuronium
4772639|NCT02785653|intubation|intubation
4772640|NCT02785627|Bone health|bone health
4772641|NCT02785627|Bone microarchitecture|bone microarchitecture
4772642|NCT02785627|Androgen deprivation therapy (ADT)|androgen deprivation therapy (adt)
4772643|NCT02785588|MRI Scanner|mri scanner
4772644|NCT02785588|NICU|nicu
4772645|NCT02785562|PDL1 expression : Protein Death Ligand 1 expression .|pdl1 expression : protein death ligand 1 expression .
4772646|NCT02785549|Acute diverticulitis|acute diverticulitis
4772647|NCT02785549|Antibiotic|antibiotic
4772648|NCT02785549|Outpatient treatment|outpatient treatment
4772649|NCT02785536|minority health|minority health
4772650|NCT02785536|social class|social class
4772651|NCT02785536|healthcare disparities|healthcare disparities
4772652|NCT02785536|tobacco use disorder|tobacco use disorder
4772653|NCT02785497|Electrical stimulation|electrical stimulation
4772654|NCT02785497|wound healing|wound healing
4772655|NCT02785497|Polarity current|polarity current
4772656|NCT02785497|Burn|burn
4772657|NCT02785497|Chronic ulcer|chronic ulcer
4772658|NCT02785484|Cigarette smoking|cigarette smoking
4772659|NCT02785484|Smoking|smoking
4772660|NCT02785484|Tobacco use|tobacco use
4772661|NCT02785471|Suicide prevention|suicide prevention
4772662|NCT02785471|men's mental health|men's mental health
4772663|NCT02785471|depression|depression
4772664|NCT02785471|suicide ideation and behaviors|suicide ideation and behaviors
4772665|NCT02785419|Rehabilitation|rehabilitation
4772666|NCT02785419|Upper Extremity|upper extremity
4772667|NCT02785419|Physical Therapy|physical therapy
4772668|NCT02785406|cocaine|cocaine
4772669|NCT02785406|sleep|sleep
4772670|NCT02785406|anxiety|anxiety
4772671|NCT02785406|craving|craving
4772672|NCT02785406|addiction|addiction
4772673|NCT02785406|orexin|orexin
4772674|NCT02785406|cue reactivity|cue reactivity
4772675|NCT02785406|suvorexant|suvorexant
4772676|NCT02785406|Belsomra|belsomra
4772677|NCT02785393|Methamphetamine|methamphetamine
4772678|NCT02785393|Dependence|dependence
4772679|NCT02785341|adapted physical activity|adapted physical activity
4772680|NCT02785328|Memory|memory
4772681|NCT02785328|sleep|sleep
4772682|NCT02785328|narcolepsy|narcolepsy
4772683|NCT02785328|apnea|apnea
4772684|NCT02785328|epilepsy|epilepsy
4772685|NCT02785302|Pediatric|pediatric
4772686|NCT02785302|HIV|hiv
4772687|NCT02785302|Transition|transition
4772688|NCT02785302|Adult Care|adult care
4772689|NCT02785263|Anal cancer|anal cancer
4772690|NCT02785263|Shared decision making|shared decision making
4772691|NCT02785250|vaccine|vaccine
4772692|NCT02785250|immunotherapy|immunotherapy
4772693|NCT02785250|IDO1 inhibitor|ido1 inhibitor
4772694|NCT02785250|ovarian|ovarian
4772695|NCT02785250|fallopian tube|fallopian tube
4772696|NCT02785250|peritoneal|peritoneal
4772697|NCT02785250|cancer|cancer
4772698|NCT02785250|recurrent|recurrent
4772699|NCT02785250|tumor|tumor
4772700|NCT02785250|measurable|measurable
4772701|NCT02785237|Drug-eluting stent|drug-eluting stent
4772702|NCT02785237|OCT|oct
4772703|NCT02785237|Re-endothelialization|re-endothelialization
4772704|NCT02785146|Huaier Granule|huaier granule
4772705|NCT02785146|After radical surgery|after radical surgery
4772706|NCT02785146|Prevention of recurrence and metastasis|prevention of recurrence and metastasis
4772707|NCT02785146|Efficacy and safety|efficacy and safety
4772708|NCT02785120|Phase 2|phase 2
4772709|NCT02785120|Efficacy|efficacy
4772710|NCT02785120|Safety|safety
4772711|NCT02785120|Ischemic Stroke|ischemic stroke
4772712|NCT02785107|Exercise|exercise
4772713|NCT02785107|Habit|habit
4772714|NCT02785107|MVPA|mvpa
4772715|NCT02785107|M-PAC|m-pac
4772716|NCT02785107|Automaticity|automaticity
4772717|NCT02785107|Physical Activity|physical activity
4772718|NCT02785094|Caesarean Section Rate|caesarean section rate
4772719|NCT02785094|Primigravida|primigravida
4772720|NCT02785081|Thoracic epidural|thoracic epidural
4772721|NCT02785081|Magnetic Resonance Imaging|magnetic resonance imaging
4772722|NCT02785081|Children|children
4772723|NCT02785068|Phase I|phase i
4772724|NCT02785068|Cancer|cancer
4772725|NCT02785068|EGFR|egfr
4772726|NCT02785068|Metastatic Colorectal Cancer|metastatic colorectal cancer
4772728|NCT02785068|RAS/RAF Wild-Type|ras/raf wild-type
4772729|NCT02785068|Nal-IRI|nal-iri
4772730|NCT02785068|EGFR Inhibitor|egfr inhibitor
4772731|NCT02785068|Oligoclonal Antibody|oligoclonal antibody
4772732|NCT02785068|Nanoliposome|nanoliposome
4772733|NCT02785068|Nanoliposomal Irinotecan|nanoliposomal irinotecan
4772734|NCT02785016|Stress Urinary Incontinence|stress urinary incontinence
4772735|NCT02785016|Suburethral Sling|suburethral sling
4772736|NCT02785003|Colorectal Surgery|colorectal surgery
4772737|NCT02785003|Acute Pain|acute pain
4772738|NCT02785003|Pain|pain
4772739|NCT02785003|post-operative pain|post-operative pain
4772740|NCT02785003|ketamine|ketamine
4772741|NCT02784938|Employment|employment
4772742|NCT02784938|Mental Illness|mental illness
4772743|NCT02784938|Photovoice|photovoice
4772744|NCT02784912|Biomarkers|biomarkers
4772745|NCT02784912|Ventricular Dysfunction|ventricular dysfunction
4772746|NCT02784912|Ventricular Tachycardia|ventricular tachycardia
4772747|NCT02784912|Electrical Storm|electrical storm
4772748|NCT02784912|ST2|st2
4772749|NCT02784912|Galectin-3|galectin-3
4772750|NCT02784912|NT-proBNP|nt-probnp
4772751|NCT02784912|Iron Deficiency|iron deficiency
4772752|NCT02784912|hs-CRP|hs-crp
4772753|NCT02784912|hs-TnT|hs-tnt
4772754|NCT02784886|Placenta accreta|placenta accreta
4772755|NCT02784886|previous caesarean|previous caesarean
4772756|NCT02784886|placenta praevia|placenta praevia
4772757|NCT02784886|Cell-free fetal DNA|cell-free fetal dna
4772758|NCT02784886|Biological markers|biological markers
4772759|NCT02784873|High intensity interval training|high intensity interval training
4772760|NCT02784873|Coronary heart disease|coronary heart disease
4772761|NCT02784873|Exercise training|exercise training
4772762|NCT02784873|Cardiac rehabilitation|cardiac rehabilitation
4772763|NCT02784873|Interval training|interval training
4772764|NCT02784860|colonoscopy|colonoscopy
4772765|NCT02784860|lidocaine|lidocaine
4772766|NCT02784860|propofol|propofol
4772767|NCT02784860|sedation|sedation
4772768|NCT02784834|CLL|cll
4772769|NCT02784834|cancer|cancer
4772770|NCT02784834|DMF|dmf
4772771|NCT02784834|SLL|sll
4772772|NCT02784834|dimethylfumarate|dimethylfumarate
4772773|NCT02784834|relapsed|relapsed
4772774|NCT02784834|refractory|refractory
4772775|NCT02784795|Notch Inhibitor|notch inhibitor
4772776|NCT02784782|Spinal|spinal
4772777|NCT02784782|Vertebral|vertebral
4772778|NCT02784782|Burstfracture|burstfracture
4772779|NCT02784782|Orthesis|orthesis
4772780|NCT02784782|Brace|brace
4772781|NCT02784782|Thoracolumbar|thoracolumbar
4772782|NCT02784756|Quantiferon-CMV|quantiferon-cmv
4772783|NCT02784756|solid organ transplant|solid organ transplant
4772784|NCT02784756|CMV Disease|cmv disease
4772785|NCT02784743|Wuchereria bancrofti|wuchereria bancrofti
4772786|NCT02784743|Anopheles|anopheles
4772787|NCT02784743|Albendazole|albendazole
4772788|NCT02784743|Ivermectin|ivermectin
4772789|NCT02784743|MDA|mda
4772790|NCT02784730|breast cancer|breast cancer
4772791|NCT02784730|chemotherapy|chemotherapy
4772792|NCT02784730|peripherally inserted central catheter|peripherally inserted central catheter
4772793|NCT02784730|implantable device|implantable device
4772794|NCT02784730|randomized controlled trial|randomized controlled trial
4772795|NCT02784730|iterative placement|iterative placement
4772796|NCT02784730|Catheterization, Central Venous|catheterization, central venous
4772797|NCT02784717|rivaroxaban,|rivaroxaban,
4772798|NCT02784717|non-interventional,|non-interventional,
4772799|NCT02784717|atrial fibrillation,|atrial fibrillation,
4772800|NCT02784717|stroke prevention,|stroke prevention,
4772801|NCT02784665|CSC|csc
4772802|NCT02784665|Micropulse Laser|micropulse laser
4772803|NCT02784665|Traditional Laser|traditional laser
4772804|NCT02784639|KRAS/BRAF mutational status|kras/braf mutational status
4772805|NCT02784626|Dexmedetomidine|dexmedetomidine
4772806|NCT02784626|Propofol|propofol
4772807|NCT02784626|Pain, Postoperative|pain, postoperative
4772808|NCT02784600|Partial-thickness|partial-thickness
4772809|NCT02784600|Full-thickness|full-thickness
4772810|NCT02784587|stellate ganglion block|stellate ganglion block
4772811|NCT02784587|cardiac surgery|cardiac surgery
4772812|NCT02784574|Rehabilitation|rehabilitation
4772813|NCT02784574|Aftercare|aftercare
4772814|NCT02784561|allogeneic peripheral blood stem cell transplantation|allogeneic peripheral blood stem cell transplantation
4772815|NCT02784561|conditioning regimen|conditioning regimen
4772816|NCT02784561|acute leukemia|acute leukemia
4772817|NCT02784561|relapsed/refractory|relapsed/refractory
4772818|NCT02784535|norepinephrine transporter inhibitors|norepinephrine transporter inhibitors
4772819|NCT02784509|Physical Activity|physical activity
4772820|NCT02784509|Sedentary Behavior|sedentary behavior
4772821|NCT02784509|Cardiometabolic Risk Factors|cardiometabolic risk factors
4772822|NCT02784509|Childhood and Adolescence|childhood and adolescence
4772823|NCT02784496|Myelofibrosis|myelofibrosis
4772824|NCT02784496|Primary Myelofibrosis|primary myelofibrosis
4772825|NCT02784496|PMF|pmf
4772826|NCT02784496|Post Polycythemia Vera/Essential Thrombocythemia Myelofibrosis|post polycythemia vera/essential thrombocythemia myelofibrosis
4772827|NCT02784496|Post-PV/ET MF|post-pv/et mf
4772828|NCT02784496|Ruxolitinib|ruxolitinib
4772829|NCT02784496|Jakafi|jakafi
4772830|NCT02784496|INCB018424|incb018424
4772831|NCT02784496|INC424|inc424
4772832|NCT02784496|Questionnaires|questionnaires
4772833|NCT02784496|Surveys|surveys
4772834|NCT02784444|NASH|nash
4772835|NCT02784405|percutaneous coronary intervention|percutaneous coronary intervention
4772836|NCT02784405|stent implantation|stent implantation
4772837|NCT02784379|Mastalgia|mastalgia
4772838|NCT02784379|electromyography|electromyography
4772839|NCT02784379|Pectoral|pectoral
4772840|NCT02784366|Cancer immunotherapy|cancer immunotherapy
4772841|NCT02784366|Ipilimumab|ipilimumab
4772842|NCT02784353|Rehabilitation|rehabilitation
4772843|NCT02784353|Quality of life|quality of life
4772844|NCT02784353|Surgery|surgery
4772845|NCT02784353|Hepatic neoplasms|hepatic neoplasms
4772846|NCT02784353|Biliary tract neoplasms|biliary tract neoplasms
4772847|NCT02784353|Pancreatic neoplasms|pancreatic neoplasms
4772848|NCT02784340|Postoperative pain|postoperative pain
4772849|NCT02784340|dexamethasone|dexamethasone
4772850|NCT02784340|cesarean section|cesarean section
4772851|NCT02784314|Clinically localized prostate cancer|clinically localized prostate cancer
4772852|NCT02784314|Robotic-assisted prostatectomy|robotic-assisted prostatectomy
4772853|NCT02784314|Laparoscopic prostatectomy|laparoscopic prostatectomy
4772854|NCT02784314|Erectile function ;|erectile function ;
4772855|NCT02784314|Cost efficacy study|cost efficacy study
4772856|NCT02784288|head and neck neoplasms|head and neck neoplasms
4772857|NCT02784288|HPV|hpv
4772858|NCT02784288|human papilloma virus|human papilloma virus
4772859|NCT02784288|de-escalation|de-escalation
4772860|NCT02784288|low-risk|low-risk
4772861|NCT02784288|oropharyngeal cancer|oropharyngeal cancer
4772862|NCT02784262|Botulinum Toxin Type A|botulinum toxin type a
4772863|NCT02784262|Block|block
4772864|NCT02784262|Sphenopalatine Ganglion|sphenopalatine ganglion
4772865|NCT02784249|Glaucoma|glaucoma
4772866|NCT02784249|glaucoma surgery|glaucoma surgery
4772867|NCT02784249|ab interno|ab interno
4772868|NCT02784223|F18-choline|f18-choline
4772869|NCT02784223|Surgery|surgery
4772870|NCT02784223|Indeterminate|indeterminate
4772871|NCT02784223|Thyroid node|thyroid node
4772872|NCT02784210|Multiple Sclerosis|multiple sclerosis
4772873|NCT02784210|Corticosteroids|corticosteroids
4772874|NCT02784184|Hypothalamic-pituitary-gonadal axis|hypothalamic-pituitary-gonadal axis
4772875|NCT02784158|Non-small cell lung cancer|non-small cell lung cancer
4772876|NCT02784158|Non-small cell lung carcinoma|non-small cell lung carcinoma
4772877|NCT02784158|Epithelial lung cancer|epithelial lung cancer
4772878|NCT02784158|Squamous cell carcinoma|squamous cell carcinoma
4772879|NCT02784158|Large cell carcinoma|large cell carcinoma
4772880|NCT02784158|Adenocarcinoma|adenocarcinoma
4772881|NCT02784158|Anaplastic lymphoma kinase (ALK)|anaplastic lymphoma kinase (alk)
4772882|NCT02784158|Carcinoma|carcinoma
4772883|NCT02784158|Advanced Cancers|advanced cancers
4772884|NCT02784158|Brigatinib|brigatinib
4772885|NCT02784158|AP26113|ap26113
4772886|NCT02784119|temporary porto-caval shunt|temporary porto-caval shunt
4772887|NCT02784119|liver graft|liver graft
4772888|NCT02784119|extended criteria donor|extended criteria donor
4772889|NCT02784106|Rheumatoid Arthritis|rheumatoid arthritis
4772890|NCT02784106|M2951|m2951
4772891|NCT02784106|Bruton's Tyrosine Kinase (BTK)|bruton's tyrosine kinase (btk)
4772892|NCT02784093|Chronic Constipation|chronic constipation
4772893|NCT02784093|Fecal impaction|fecal impaction
4772894|NCT02784093|Gastrografin|gastrografin
4772895|NCT02784093|Randomized Controlled Trial|randomized controlled trial
4772896|NCT02784080|Liver Transplantation|liver transplantation
4772897|NCT02784080|HLA alloantibodies|hla alloantibodies
4772898|NCT02784080|donor specific antibodies|donor specific antibodies
4772899|NCT02784080|Mortality|mortality
4772900|NCT02784080|Re-transplantation|re-transplantation
4772901|NCT02784080|Rejection|rejection
4772902|NCT02784080|Acute rejection|acute rejection
4772903|NCT02784080|Chronic rejection|chronic rejection
4772904|NCT02784080|Biliary complications|biliary complications
4772905|NCT02784080|Biliary stricture|biliary stricture
4772906|NCT02784080|Arterial thrombosis|arterial thrombosis
4772907|NCT02784080|Arterial stenosis|arterial stenosis
4772908|NCT02784080|Portal vein thrombosis|portal vein thrombosis
4772909|NCT02784080|Fibrosis|fibrosis
4772910|NCT02784080|Single antigen bead|single antigen bead
4772911|NCT02784080|Cross-match|cross-match
4772912|NCT02784041|knee arthroplasty|knee arthroplasty
4772913|NCT02784041|adductor canal block|adductor canal block
4772914|NCT02784041|periarticular infiltration|periarticular infiltration
4772915|NCT02784028|Peritoneal Carcinomatosis|peritoneal carcinomatosis
4772916|NCT02784028|SGM-101|sgm-101
4772917|NCT02783989|Endothelial function|endothelial function
4772918|NCT02783989|Inflammation|inflammation
4772919|NCT02783989|Genes related to vascular risk|genes related to vascular risk
4772920|NCT02783963|Coronary Artery Disease|coronary artery disease
4772921|NCT02783963|Coronary Thrombosis|coronary thrombosis
4772922|NCT02783963|Coronary Stenosis|coronary stenosis
4772923|NCT02783963|Tomography, Optical Coherence|tomography, optical coherence
4772924|NCT02783963|Magnetic Resonance Imaging|magnetic resonance imaging
4772925|NCT02783950|Genomics|genomics
4772926|NCT02783950|Adjuvant Treatment|adjuvant treatment
4772927|NCT02783937|Premature|premature
4772928|NCT02783937|Ovarian|ovarian
4772929|NCT02783937|Failure|failure
4772930|NCT02783937|Filgrastim|filgrastim
4772931|NCT02783924|vitamin D|vitamin d
4772932|NCT02783924|genomics|genomics
4772933|NCT02783924|proteomics|proteomics
4772934|NCT02783924|metabolomics|metabolomics
4772935|NCT02783924|adipose tissue|adipose tissue
4772936|NCT02783911|Clinical and Radiograph|clinical and radiograph
4772937|NCT02783898|pre syncope, palpitations|pre syncope, palpitations
4772938|NCT02783859|Children|children
4772939|NCT02783859|Anti-Bacterial Agents|anti-bacterial agents
4772940|NCT02783859|Indigenous Population|indigenous population
4772941|NCT02783859|Hospitals|hospitals
4772942|NCT02783846|Propofol|propofol
4772943|NCT02783846|Dexmedetomidine|dexmedetomidine
4772944|NCT02783846|Dose|dose
4772945|NCT02783846|Bispectral index monitor|bispectral index monitor
4772946|NCT02783833|malaria, induced blood stage model challenge|malaria, induced blood stage model challenge
4772947|NCT02783820|malaria, single ascending dose,|malaria, single ascending dose,
4772948|NCT02783794|BP-C1|bp-c1
4772949|NCT02783794|CDBPA|cdbpa
4772950|NCT02783794|Cis-coordinated complexes of platinum(II) with polymer of benzene polycarboxylic acids derived from lignin|cis-coordinated complexes of platinum(ii) with polymer of benzene polycarboxylic acids derived from lignin
4772951|NCT02783794|Benzene polycarboxylic acids complex with cis-diammineplatinum(II)|benzene polycarboxylic acids complex with cis-diammineplatinum(ii)
4772952|NCT02783794|Metastatic Breast Cancer|metastatic breast cancer
4772953|NCT02783794|Platinum analogue|platinum analogue
4772954|NCT02783794|Metronomic chemotherapy|metronomic chemotherapy
4772955|NCT02783794|Breast cancer|breast cancer
4772956|NCT02783794|Cisplatin|cisplatin
4772957|NCT02783781|Cardiac surgery (extracorporeal circulation; beating heart)|cardiac surgery (extracorporeal circulation; beating heart)
4772958|NCT02783781|Biological data|biological data
4772959|NCT02783781|Preoperative biological variables|preoperative biological variables
4772960|NCT02783781|EuroSCORE II|euroscore ii
4772961|NCT02783781|Risk prediction|risk prediction
4772962|NCT02783768|E-cigarettes|e-cigarettes
4772963|NCT02783768|COPD|copd
4772964|NCT02783755|pain|pain
4772965|NCT02783755|coping|coping
4772966|NCT02783755|mhealth|mhealth
4772967|NCT02783755|Breast cancer|breast cancer
4772968|NCT02783742|provider-patient communication|provider-patient communication
4772969|NCT02783742|coaching|coaching
4772970|NCT02783742|feedback|feedback
4772971|NCT02783742|burnout|burnout
4772972|NCT02783729|E2006|e2006
4772973|NCT02783729|Lemborexant|lemborexant
4772974|NCT02783729|zolpidem tartrate|zolpidem tartrate
4772975|NCT02783729|Ambien CR|ambien cr
4772976|NCT02783729|Insomnia|insomnia
4772977|NCT02783703|Insulin resistance|insulin resistance
4772978|NCT02783664|Breast Cancer|breast cancer
4772979|NCT02783664|BRCA1|brca1
4772980|NCT02783664|BRCA2|brca2
4772981|NCT02783664|stress|stress
4772982|NCT02783664|gene testing|gene testing
4772983|NCT02783664|genetic screening|genetic screening
4772984|NCT02783664|psychological support|psychological support
4772985|NCT02783664|State-Trait Anxiety Inventory|state-trait anxiety inventory
4772986|NCT02783664|Cancer Worry Scale|cancer worry scale
4772987|NCT02783664|Health Anxiety Inventory|health anxiety inventory
4772988|NCT02783664|gene mutations|gene mutations
4772989|NCT02783625|Duvelisib|duvelisib
4772990|NCT02783625|Romidepsin|romidepsin
4772991|NCT02783625|Bortezomib|bortezomib
4772992|NCT02783625|16-042|16-042
4772993|NCT02783573|dementia|dementia
4772994|NCT02783573|brain diseases|brain diseases
4772995|NCT02783573|neurodegenerative diseases|neurodegenerative diseases
4772996|NCT02783573|central nervous system diseases|central nervous system diseases
4772997|NCT02783573|nervous system diseases|nervous system diseases
4772998|NCT02783573|mental disorders|mental disorders
4772999|NCT02783573|delirium, dementia, amnestic, cognitive|delirium, dementia, amnestic, cognitive
4773000|NCT02783573|tauopathies|tauopathies
4773001|NCT02783573|memory|memory
4773002|NCT02783573|amyloid|amyloid
4773003|NCT02783560|Sleep|sleep
4773004|NCT02783560|Electrodermal Activity|electrodermal activity
4773005|NCT02783560|Mealtimes|mealtimes
4773006|NCT02783534|Acupuncture|acupuncture
4773007|NCT02783534|Primary Dysmenorrhea|primary dysmenorrhea
4773008|NCT02783534|Randomized Controlled Trial|randomized controlled trial
4773009|NCT02783534|Placebo Effect|placebo effect
4773010|NCT02783521|Hispanic men|hispanic men
4773011|NCT02783521|Weight loss|weight loss
4773012|NCT02783521|Diet|diet
4773013|NCT02783521|Physical activity|physical activity
4773014|NCT02783521|Intervention|intervention
4773015|NCT02783508|Labor analgesia|labor analgesia
4773016|NCT02783508|Nitrous Oxide|nitrous oxide
4773017|NCT02783508|Meperidine|meperidine
4773018|NCT02783508|Multiparous|multiparous
4773019|NCT02783508|Visual analogue scale|visual analogue scale
4773020|NCT02783495|glioma|glioma
4773021|NCT02783495|neurocognitive|neurocognitive
4773022|NCT02783495|quality of life|quality of life
4773023|NCT02783456|renal hemodynamic|renal hemodynamic
4773024|NCT02783456|central hemodynamic|central hemodynamic
4773025|NCT02783456|pilot study|pilot study
4773026|NCT02783456|flight noise|flight noise
4773027|NCT02783456|healthy participant|healthy participant
4773028|NCT02783456|renal plasma flow|renal plasma flow
4773029|NCT02783456|filtration fraction|filtration fraction
4773030|NCT02783456|renal vascular resistance|renal vascular resistance
4773031|NCT02783456|calculated intra glomerular pressure|calculated intra glomerular pressure
4773032|NCT02783443|Anesthesia, glycocalyx, perfused boundary region|anesthesia, glycocalyx, perfused boundary region
4773033|NCT02783430|Ketamine|ketamine
4773034|NCT02783430|Palliative care|palliative care
4773035|NCT02783430|Supportive care|supportive care
4773036|NCT02783430|Early palliative care|early palliative care
4773037|NCT02783430|Fast acting antidepressant|fast acting antidepressant
4773038|NCT02783430|End of life care|end of life care
4773039|NCT02783430|Cancer|cancer
4773040|NCT02783430|psychological distress|psychological distress
4773041|NCT02783430|antidepressant|antidepressant
4773042|NCT02783430|serotonin norepinephrine reuptake inhibitors|serotonin norepinephrine reuptake inhibitors
4773043|NCT02783417|Visceral fat|visceral fat
4773044|NCT02783404|bacteraemia|bacteraemia
4773045|NCT02783404|endocarditis|endocarditis
4773046|NCT02783404|antibiotic prophylaxis|antibiotic prophylaxis
4773047|NCT02783404|dentistry|dentistry
4773048|NCT02783378|impedance metry|impedance metry
4773049|NCT02783378|gaviscon|gaviscon
4773050|NCT02783339|Next Generation Neuroform Stent System|next generation neuroform stent system
4773051|NCT02783339|Intracranial|intracranial
4773052|NCT02783339|Stent system|stent system
4773053|NCT02783339|Saccular aneurysm|saccular aneurysm
4773054|NCT02783339|Stent assisted coiling|stent assisted coiling
4773055|NCT02783326|Chronic Disease Obstructive Pulmonary|chronic disease obstructive pulmonary
4773056|NCT02783326|Rehabilitation|rehabilitation
4773057|NCT02783326|Physical Therapy|physical therapy
4773058|NCT02783313|pathogen inactivation|pathogen inactivation
4773059|NCT02783313|platelets|platelets
4773060|NCT02783300|GSK3326595|gsk3326595
4773061|NCT02783300|glioblastoma multiforme (GBM)|glioblastoma multiforme (gbm)
4773062|NCT02783300|Solid tumor|solid tumor
4773063|NCT02783300|Non-Hodgkin's lymphoma (NHL)|non-hodgkin's lymphoma (nhl)
4773064|NCT02783300|breast cancer|breast cancer
4773065|NCT02783300|bladder cancer|bladder cancer
4773066|NCT02783300|dose escalation|dose escalation
4773067|NCT02783287|Exercise adherence|exercise adherence
4773068|NCT02783287|Medication adherence|medication adherence
4773069|NCT02783287|Mobile health|mobile health
4773070|NCT02783287|Cardiac rehabilitation|cardiac rehabilitation
4773071|NCT02783261|radioembolization|radioembolization
4773072|NCT02783261|hypertrophy|hypertrophy
4773073|NCT02783261|Y90|y90
4773074|NCT02783248|Percutaneous mitral commissurotomy|percutaneous mitral commissurotomy
4773075|NCT02783248|Mitral Stenosis|mitral stenosis
4773076|NCT02783235|VIA|via
4773077|NCT02783235|Cervical Cancer|cervical cancer
4773078|NCT02783235|Training|training
4773079|NCT02783222|breast cancer|breast cancer
4773080|NCT02783222|elderly patients|elderly patients
4773081|NCT02783170|Tdap vaccine|tdap vaccine
4773082|NCT02783170|Flu vaccine|flu vaccine
4773083|NCT02783170|vaccines in pregnancy|vaccines in pregnancy
4773084|NCT02783170|immunizations in pregnancy|immunizations in pregnancy
4773085|NCT02783170|Whooping Cough|whooping cough
4773086|NCT02783170|Pertussis|pertussis
4773087|NCT02783170|Influenza|influenza
4773088|NCT02783157|Autonomic|autonomic
4773089|NCT02783157|Vagal nerve stimulation|vagal nerve stimulation
4773090|NCT02783157|Postoperative atrial fibrillation|postoperative atrial fibrillation
4773091|NCT02783144|Analgesia|analgesia
4773092|NCT02783144|Dexamethasone|dexamethasone
4773093|NCT02783144|Levobupivacaine|levobupivacaine
4773094|NCT02783144|Ultrasound-guided|ultrasound-guided
4773095|NCT02783144|Tranversus Abdominis|tranversus abdominis
4773096|NCT02783131|inventions|inventions
4773097|NCT02783131|Simulation Training|simulation training
4773098|NCT02783131|Postpartum Haemorrhage|postpartum haemorrhage
4773099|NCT02783131|Non Technical Skills|non technical skills
4773100|NCT02783131|teamwork|teamwork
4773101|NCT02783131|Crew Resource Management, Healthcare|crew resource management, healthcare
4773102|NCT02783118|Depression|depression
4773103|NCT02783118|Prevention|prevention
4773104|NCT02783118|CBT|cbt
4773105|NCT02783118|Smartphone app|smartphone app
4773106|NCT02783105|Music therapy|music therapy
4773107|NCT02783105|Paroxysmal sympathetic hyperactivity|paroxysmal sympathetic hyperactivity
4773108|NCT02783105|Traumatic brain injury|traumatic brain injury
4773109|NCT02783079|Breast Cancer|breast cancer
4773110|NCT02783079|Prostate Cancer|prostate cancer
4773111|NCT02783079|Colon Cancer|colon cancer
4773112|NCT02783079|Lung Cancer|lung cancer
4773113|NCT02783079|Gynecologic Cancer|gynecologic cancer
4773114|NCT02783014|overactive bladder|overactive bladder
4773115|NCT02782988|Olfaction|olfaction
4773116|NCT02782988|CMV|cmv
4773117|NCT02782962|nystagmus|nystagmus
4773118|NCT02782962|vertigo|vertigo
4773119|NCT02782962|unsteadiness|unsteadiness
4773120|NCT02782962|emergency duplex ultrasonography|emergency duplex ultrasonography
4773121|NCT02782936|Work of Breathing; Hypoxemia; Respiratory Acidosis; Respiratory effort|work of breathing; hypoxemia; respiratory acidosis; respiratory effort
4773122|NCT02782923|Cervical Spine Surgery|cervical spine surgery
4773123|NCT02782923|Simulation|simulation
4773124|NCT02782897|intravenous immunoglobulin|intravenous immunoglobulin
4773125|NCT02782897|intracerebral hemorrhage|intracerebral hemorrhage
4773126|NCT02782897|perihematomal edema|perihematomal edema
4773127|NCT02782884|post-operative pain|post-operative pain
4773128|NCT02782871|Transfer|transfer
4773129|NCT02782871|Intra-hospital|intra-hospital
4773130|NCT02782871|Ventilator|ventilator
4773131|NCT02782871|Manual ventilation|manual ventilation
4773132|NCT02782871|Head and neck surgery|head and neck surgery
4773133|NCT02782858|Multiple Sclerosis|multiple sclerosis
4773134|NCT02782858|Multiple Sclerosis Relapsing-Remitting|multiple sclerosis relapsing-remitting
4773135|NCT02782858|GNbAC1|gnbac1
4773136|NCT02782858|MRI|mri
4773137|NCT02782858|Monoclonal antibody|monoclonal antibody
4773138|NCT02782858|Multiple Sclerosis associated retrovirus MSRV|multiple sclerosis associated retrovirus msrv
4773139|NCT02782858|MS|ms
4773140|NCT02782858|RRMS|rrms
4773141|NCT02782858|HERV-W|herv-w
4773142|NCT02782832|Neuromuscular|neuromuscular
4773143|NCT02782832|Blockade|blockade
4773144|NCT02782832|Surgery|surgery
4773145|NCT02782819|Shock resuscitation|shock resuscitation
4773146|NCT02782819|colloid|colloid
4773147|NCT02782819|crystalloid|crystalloid
4773148|NCT02782793|Endoscopic|endoscopic
4773149|NCT02782793|Mucosal|mucosal
4773150|NCT02782793|Resection|resection
4773151|NCT02782780|insomnia|insomnia
4773152|NCT02782780|insomnia disorder|insomnia disorder
4773153|NCT02782780|Gulf War Illness|gulf war illness
4773154|NCT02782780|Chronic Multisymptom Illness|chronic multisymptom illness
4773155|NCT02782728|intimate partner violence|intimate partner violence
4773156|NCT02782728|reproductive coercion|reproductive coercion
4773157|NCT02782728|women's health|women's health
4773158|NCT02782728|relationship abuse|relationship abuse
4773159|NCT02782702|Botulism Toxin|botulism toxin
4773160|NCT02782663|Crohn's Disease|crohn's disease
4773161|NCT02782663|Efficacy|efficacy
4773162|NCT02782663|Safety|safety
4773163|NCT02782663|Tolerability|tolerability
4773164|NCT02782663|ABT-494|abt-494
4773165|NCT02782650|Limits|limits
4773166|NCT02782650|Prenatal Counseling|prenatal counseling
4773167|NCT02782650|Decision-making|decision-making
4773168|NCT02782650|Foetal Complications|foetal complications
4773169|NCT02782650|Counseling|counseling
4773170|NCT02782650|Viability|viability
4773171|NCT02782637|limits of viability|limits of viability
4773172|NCT02782637|Prenatal Counseling|prenatal counseling
4773173|NCT02782637|Decision-making|decision-making
4773174|NCT02782637|Viability|viability
4773175|NCT02782637|Counseling|counseling
4773176|NCT02782611|Happiness|happiness
4773177|NCT02782611|Subjective Well-Being|subjective well-being
4773178|NCT02782611|Psychological Flourishing|psychological flourishing
4773179|NCT02782611|Well-Being|well-being
4773180|NCT02782611|Health|health
4773181|NCT02782611|Behavioral Change|behavioral change
4773182|NCT02782611|Life Satisfaction|life satisfaction
4773183|NCT02782611|Affect|affect
4773184|NCT02782611|Emotion|emotion
4773185|NCT02782611|Goals|goals
4773186|NCT02782611|Meaning in Life|meaning in life
4773187|NCT02782598|Negative|negative
4773188|NCT02782598|Atrioventricular|atrioventricular
4773189|NCT02782598|Hysteresis|hysteresis
4773190|NCT02782598|Cardiac Resynchronization|cardiac resynchronization
4773191|NCT02782598|MultiPoint|multipoint
4773192|NCT02782585|neck pain|neck pain
4773193|NCT02782585|Manual therapy|manual therapy
4773194|NCT02782585|psychological interaction|psychological interaction
4773195|NCT02782572|Exercise|exercise
4773196|NCT02782572|Cardiac Rehabilitation|cardiac rehabilitation
4773197|NCT02782572|Non-invasive ventilation|non-invasive ventilation
4773198|NCT02782520|Cardiopulmonary bypass|cardiopulmonary bypass
4773199|NCT02782520|Swan Ganz|swan ganz
4773200|NCT02782520|Fluid expansion|fluid expansion
4773201|NCT02782520|hypertonic saline solution|hypertonic saline solution
4773202|NCT02782507|pilot study|pilot study
4773203|NCT02782507|CBT trial|cbt trial
4773204|NCT02782494|Latent tuberculosis infection, dialysis|latent tuberculosis infection, dialysis
4773205|NCT02782468|Drug Therapy|drug therapy
4773206|NCT02782442|cognitive training|cognitive training
4773207|NCT02782429|ketamine|ketamine
4773208|NCT02782429|Cardiac Surgery|cardiac surgery
4773209|NCT02782429|Neurocognitive Disorders|neurocognitive disorders
4773210|NCT02782416|Renal|renal
4773211|NCT02782416|Latent|latent
4773212|NCT02782416|Tuberculosis|tuberculosis
4773213|NCT02782403|Leukemia|leukemia
4773214|NCT02782403|Chronic Myeloid Leukemia|chronic myeloid leukemia
4773215|NCT02782403|CML|cml
4773216|NCT02782403|Chronic Myeloid Leukemia, Chronic Phase|chronic myeloid leukemia, chronic phase
4773217|NCT02782403|CML-CP|cml-cp
4773218|NCT02782403|Chronic Myeloid Leukemia in Accelerated Phase|chronic myeloid leukemia in accelerated phase
4773219|NCT02782403|CML-AP|cml-ap
4773220|NCT02782403|Chronic Myeloid Leukemia in Blast Phase|chronic myeloid leukemia in blast phase
4773221|NCT02782403|CML-BP|cml-bp
4773222|NCT02782403|Axitinib|axitinib
4773223|NCT02782403|AG-013736|ag-013736
4773224|NCT02782403|Inlyta|inlyta
4773225|NCT02782403|Bosutinib|bosutinib
4773226|NCT02782403|SKI-606|ski-606
4773227|NCT02782390|Stainless dental crown|stainless dental crown
4773228|NCT02782390|Composite Resin|composite resin
4773229|NCT02782390|Primary teeth|primary teeth
4773230|NCT02782377|Faecal Incontinence|faecal incontinence
4773231|NCT02782377|Obstructive Defaecation|obstructive defaecation
4773232|NCT02782377|Rectal Prolapse|rectal prolapse
4773233|NCT02782364|Faecal Incontinence|faecal incontinence
4773234|NCT02782338|warfarin|warfarin
4773235|NCT02782338|Voltaren eye drops|voltaren eye drops
4773236|NCT02782338|INR|inr
4773237|NCT02782312|Bronchiectasis|bronchiectasis
4773238|NCT02782312|ICS+LABA|ics+laba
4773239|NCT02782299|Decision aid|decision aid
4773240|NCT02782299|Shared decision making|shared decision making
4773241|NCT02782299|Older adult patients|older adult patients
4773242|NCT02782299|Distal radius fracture|distal radius fracture
4773243|NCT02782286|ketorolac|ketorolac
4773244|NCT02782286|pain relieve|pain relieve
4773245|NCT02782286|morphine|morphine
4773246|NCT02782273|ketorolac|ketorolac
4773247|NCT02782273|pain relieve|pain relieve
4773248|NCT02782273|morphine|morphine
4773249|NCT02782221|lipolysis|lipolysis
4773250|NCT02782221|ATGL|atgl
4773251|NCT02782182|Pancreatic ductal adenocarcinoma|pancreatic ductal adenocarcinoma
4773252|NCT02782182|FOLFIRINOX|folfirinox
4773253|NCT02782182|resectable pancreatic cancer|resectable pancreatic cancer
4773254|NCT02782156|Process Evaluation|process evaluation
4773255|NCT02782156|alcohol withdrawal syndrome|alcohol withdrawal syndrome
4773256|NCT02782143|delirium detection|delirium detection
4773257|NCT02782130|HIV|hiv
4773258|NCT02782130|YMSM|ymsm
4773259|NCT02782130|Trans women|trans women
4773260|NCT02782130|ART Adherence|art adherence
4773261|NCT02782130|Intervention|intervention
4773262|NCT02782104|Depressive Disorder, Treatment-Resistant|depressive disorder, treatment-resistant
4773263|NCT02782104|Esketamine|esketamine
4773264|NCT02782104|JNJ-54135419|jnj-54135419
4773265|NCT02782091|MET|met
4773266|NCT02782091|Prognosis|prognosis
4773267|NCT02782091|Cognition|cognition
4773268|NCT02782091|Ecological|ecological
4773269|NCT02782091|Executive function|executive function
4773270|NCT02782078|osteoarticular infection|osteoarticular infection
4773271|NCT02782078|rifampicin|rifampicin
4773272|NCT02782078|clindamycin|clindamycin
4773273|NCT02782078|enzymatic induction|enzymatic induction
4773274|NCT02782078|antibiotherapy resistance|antibiotherapy resistance
4773275|NCT02782065|validation|validation
4773276|NCT02782065|pediatrics|pediatrics
4773277|NCT02782065|asthma severity|asthma severity
4773278|NCT02782052|pulmonary arterial hypertension|pulmonary arterial hypertension
4773279|NCT02782052|spirometry|spirometry
4773280|NCT02782052|dynamic lung hyperinflation|dynamic lung hyperinflation
4773281|NCT02782052|bronchodilator|bronchodilator
4773282|NCT02782052|dyspnoea|dyspnoea
4773283|NCT02782052|Idiopathic|idiopathic
4773284|NCT02782052|heritable|heritable
4773285|NCT02782052|PAH|pah
4773286|NCT02782026|pulmonary hypertension|pulmonary hypertension
4773287|NCT02782026|early detection|early detection
4773288|NCT02782013|community acquired pneumonia|community acquired pneumonia
4773289|NCT02782013|CAP|cap
4773290|NCT02782013|disease progression|disease progression
4773291|NCT02782000|dementia|dementia
4773292|NCT02782000|early recognition|early recognition
4773293|NCT02782000|general practitioner|general practitioner
4773294|NCT02782000|training|training
4773295|NCT02781935|unresectable colorectal liver metastasis|unresectable colorectal liver metastasis
4773296|NCT02781935|diffusion weighted MRI|diffusion weighted mri
4773297|NCT02781935|disappearing liver metastasis|disappearing liver metastasis
4773298|NCT02781922|cardiac stem/progenitor cells|cardiac stem/progenitor cells
4773299|NCT02781922|autologous cell therapy|autologous cell therapy
4773300|NCT02781922|functional single ventricle|functional single ventricle
4773301|NCT02781922|congenital heart disease|congenital heart disease
4773302|NCT02781909|NSAIDS|nsaids
4773303|NCT02781909|tuberculosis treatment|tuberculosis treatment
4773304|NCT02781909|anti-inflammatories|anti-inflammatories
4773305|NCT02781909|Host-directed therapies|host-directed therapies
4773306|NCT02781909|TB|tb
4773307|NCT02781896|TAVI|tavi
4773308|NCT02781896|aortic valve bioprothesis|aortic valve bioprothesis
4773309|NCT02781896|TAVI simplification|tavi simplification
4773310|NCT02781896|aortic stenosis|aortic stenosis
4773311|NCT02781896|rapid left ventricular pacing|rapid left ventricular pacing
4773312|NCT02781896|TAVR|tavr
4773313|NCT02781883|Liposomal Grb-2 treatment of AML|liposomal grb-2 treatment of aml
4773314|NCT02781883|Liposomal Grb-2 with LDAC for AML|liposomal grb-2 with ldac for aml
4773315|NCT02781857|Exhaled Breath|exhaled breath
4773316|NCT02781857|Mass Spectrometry|mass spectrometry
4773317|NCT02781857|Fingerprinting|fingerprinting
4773318|NCT02781818|hidradenitis|hidradenitis
4773319|NCT02781818|intralesional|intralesional
4773320|NCT02781818|triamcinolone|triamcinolone
4773321|NCT02781779|Cardiac Implantable Electronic Device|cardiac implantable electronic device
4773322|NCT02781779|Implant|implant
4773323|NCT02781766|Haemophilia A|haemophilia a
4773324|NCT02781766|prophylaxis|prophylaxis
4773325|NCT02781766|thrombin generation assay|thrombin generation assay
4773326|NCT02781766|factor VIII|factor viii
4773327|NCT02781766|prophylactic therapy|prophylactic therapy
4773328|NCT02781740|Continous Positive Airway Pressure|continous positive airway pressure
4773329|NCT02781740|CPAP|cpap
4773330|NCT02781740|Sham CPAP|sham cpap
4773331|NCT02781740|CPAP withdrawal|cpap withdrawal
4773332|NCT02781740|suboptimal CPAP|suboptimal cpap
4773333|NCT02781727|Human Growth Hormone|human growth hormone
4773334|NCT02781727|hGH|hgh
4773335|NCT02781727|GHD|ghd
4773336|NCT02781727|rHGH|rhgh
4773337|NCT02781727|Pediatric Growth Hormone Deficiency|pediatric growth hormone deficiency
4773338|NCT02781727|Long Acting Growth Hormone|long acting growth hormone
4773339|NCT02781727|Somatropin|somatropin
4773340|NCT02781727|Prodrug|prodrug
4773341|NCT02781727|Growth Failure|growth failure
4773342|NCT02781727|Growth Hormone Replacement Therapy|growth hormone replacement therapy
4773343|NCT02781727|Sustained Release|sustained release
4773344|NCT02781727|Sustained Release Growth Hormone|sustained release growth hormone
4773345|NCT02781727|Growth Hormone Deficiency|growth hormone deficiency
4773346|NCT02781714|contraception|contraception
4773347|NCT02781714|postpartum period|postpartum period
4773348|NCT02781714|mobile health|mobile health
4773349|NCT02781714|mHealth|mhealth
4773350|NCT02781714|Kenya|kenya
4773351|NCT02781714|couples|couples
4773352|NCT02781675|Diet|diet
4773353|NCT02781675|Mediterranean|mediterranean
4773354|NCT02781675|Cholesterol|cholesterol
4773355|NCT02781675|Inflammation|inflammation
4773356|NCT02781662|Safety|safety
4773357|NCT02781662|Hospitalization|hospitalization
4773358|NCT02781662|Older Persons|older persons
4773359|NCT02781662|High-Risk|high-risk
4773360|NCT02781649|Renal|renal
4773361|NCT02781649|Transplants|transplants
4773362|NCT02781649|Hepatitis C|hepatitis c
4773363|NCT02781649|HCV-negative|hcv-negative
4773364|NCT02781649|Infected|infected
4773365|NCT02781649|Donors|donors
4773366|NCT02781636|Efficacy|efficacy
4773367|NCT02781636|Implantable|implantable
4773368|NCT02781636|Wireless|wireless
4773369|NCT02781636|Neuromodulation|neuromodulation
4773370|NCT02781636|Device|device
4773371|NCT02781636|Tibial|tibial
4773372|NCT02781623|Quadriceps|quadriceps
4773373|NCT02781623|Tibial Plateau|tibial plateau
4773374|NCT02781623|Fracture|fracture
4773375|NCT02781610|Cystic fibrosis|cystic fibrosis
4773376|NCT02781610|Pulmonary exacerbation|pulmonary exacerbation
4773377|NCT02781610|Antibiotic|antibiotic
4773378|NCT02781610|Treatment duration|treatment duration
4773379|NCT02781610|Lung infection|lung infection
4773380|NCT02781610|Cystic Fibrosis Foundation|cystic fibrosis foundation
4773381|NCT02781610|Cystic Fibrosis Foundation National Patient Registry|cystic fibrosis foundation national patient registry
4773382|NCT02781597|Hemoptysis|hemoptysis
4773383|NCT02781597|Tranexamic acid|tranexamic acid
4773384|NCT02781597|VAS score|vas score
4773385|NCT02781545|Child Development|child development
4773386|NCT02781545|Psychomotor Performance|psychomotor performance
4773387|NCT02781545|Newborns|newborns
4773388|NCT02781545|Surgery|surgery
4773389|NCT02781493|Prucalopride|prucalopride
4773390|NCT02781493|Polyethylene Glycol|polyethylene glycol
4773391|NCT02781493|bowel preparation|bowel preparation
4773392|NCT02781467|Acute Myeloid|acute myeloid
4773393|NCT02781467|Leukemia|leukemia
4773394|NCT02781467|PNK-007|pnk-007
4773395|NCT02781467|Human IL-2|human il-2
4773396|NCT02781467|RHIL-2|rhil-2
4773397|NCT02781467|Fludarabine|fludarabine
4773398|NCT02781467|Cyclophosphamide|cyclophosphamide
4773399|NCT02781454|SALS|sals
4773400|NCT02781454|Mexiletine|mexiletine
4773401|NCT02781454|TMS|tms
4773402|NCT02781454|NCS|ncs
4773403|NCT02781402|Overweight BMI Individuals|overweight bmi individuals
4773404|NCT02781402|Normal BMI Individuals|normal bmi individuals
4773405|NCT02781402|Recovery Heart Rate|recovery heart rate
4773406|NCT02781389|Basal cell carcinoma (BCC)|basal cell carcinoma (bcc)
4773407|NCT02781389|advanced BCC (aBCC)|advanced bcc (abcc)
4773408|NCT02781376|Primary Care|primary care
4773409|NCT02781376|Computer Decision Support System|computer decision support system
4773410|NCT02781376|Guidelines|guidelines
4773411|NCT02781376|Snoring|snoring
4773412|NCT02781363|thoracic ultrasound|thoracic ultrasound
4773413|NCT02781363|children|children
4773414|NCT02781363|efficacy|efficacy
4773415|NCT02781363|emergency service|emergency service
4773416|NCT02781350|high fat diet|high fat diet
4773417|NCT02781350|insulinogenesis|insulinogenesis
4773418|NCT02781350|Fiber|fiber
4773419|NCT02781350|inflammation|inflammation
4773420|NCT02781324|Ultrasonic Bone Scalpel|ultrasonic bone scalpel
4773421|NCT02781324|Adolescent Idiopathic Scoliosis|adolescent idiopathic scoliosis
4773422|NCT02781324|Posterior Spinal Fusion|posterior spinal fusion
4773423|NCT02781324|Estimated Blood Loss|estimated blood loss
4773424|NCT02781272|pelvic mass|pelvic mass
4773425|NCT02781272|ovarian cancer|ovarian cancer
4773426|NCT02781272|gynecological cancer|gynecological cancer
4773427|NCT02781272|risk prediction|risk prediction
4773428|NCT02781259|Sentinel Lymph Node Biopsy|sentinel lymph node biopsy
4773429|NCT02781259|Fluorescence|fluorescence
4773430|NCT02781259|Breast Neoplasms|breast neoplasms
4773431|NCT02781259|Indocyanine Green|indocyanine green
4773433|NCT02781220|Dementia|dementia
4773434|NCT02781220|amyloid PET|amyloid pet
4773435|NCT02781220|physician diagnosis|physician diagnosis
4773436|NCT02781220|Alzheimer's disease|alzheimer's disease
4773437|NCT02781220|AD|ad
4773438|NCT02781220|PET imaging|pet imaging
4773439|NCT02781220|Appropriate Use Criteria|appropriate use criteria
4773440|NCT02781220|patient-reported outcomes|patient-reported outcomes
4773441|NCT02781220|patient adherence|patient adherence
4773442|NCT02781207|syncope|syncope
4773443|NCT02781207|point-of-care ultrasound|point-of-care ultrasound
4773444|NCT02781181|Stenting|stenting
4773445|NCT02781181|Protection device|protection device
4773446|NCT02781181|EPD usage|epd usage
4773447|NCT02781168|Premature newborn|premature newborn
4773448|NCT02781168|Cortisol|cortisol
4773449|NCT02781168|Stress|stress
4773450|NCT02781155|Health related quality of life|health related quality of life
4773451|NCT02781155|Moxibustion|moxibustion
4773452|NCT02781155|Cancer|cancer
4773453|NCT02781155|Chemotherapy|chemotherapy
4773454|NCT02781155|Neutropenia|neutropenia
4773455|NCT02781155|Anaemia|anaemia
4773456|NCT02781155|Thrombocytopenia|thrombocytopenia
4773457|NCT02781155|Self management|self management
4773458|NCT02781155|Wellbeing|wellbeing
4773459|NCT02781129|Memory|memory
4773460|NCT02781129|Responsive Neurostimulator System|responsive neurostimulator system
4773461|NCT02781090|HIV|hiv
4773462|NCT02781090|Tobacco|tobacco
4773463|NCT02781090|Cigarette|cigarette
4773464|NCT02781090|Smoking|smoking
4773465|NCT02781090|Social Network|social network
4773466|NCT02781090|Internet|internet
4773467|NCT02781090|Cessation|cessation
4773468|NCT02781077|Stroke|stroke
4773469|NCT02781077|walking competency|walking competency
4773470|NCT02781077|Task-oriented exercise program|task-oriented exercise program
4773471|NCT02781077|Exercise intensity|exercise intensity
4773472|NCT02781012|Pancreatic Disease|pancreatic disease
4773473|NCT02781012|Pancreas|pancreas
4773474|NCT02781012|Borderline Resectable|borderline resectable
4773475|NCT02781012|Pancreatic Cancer|pancreatic cancer
4773476|NCT02781012|Pancreatitis|pancreatitis
4773477|NCT02781012|Family history of pancreatic cancer|family history of pancreatic cancer
4773478|NCT02781012|Healthy|healthy
4773479|NCT02781012|Healthy at risk|healthy at risk
4773480|NCT02780999|Osteoarthritis|osteoarthritis
4773481|NCT02780999|hand|hand
4773482|NCT02780999|orthotic|orthotic
4773483|NCT02780999|rehabilitation|rehabilitation
4773484|NCT02780986|female entertainment worker|female entertainment worker
4773485|NCT02780986|heterosexual men|heterosexual men
4773486|NCT02780986|entertainment establishment|entertainment establishment
4773487|NCT02780986|condom use|condom use
4773488|NCT02780986|sexually transmitted infection|sexually transmitted infection
4773489|NCT02780986|Singapore|singapore
4773490|NCT02780947|Ventricular tachycardia|ventricular tachycardia
4773491|NCT02780947|Ablation|ablation
4773492|NCT02780947|Myocardial Infarction|myocardial infarction
4773493|NCT02780947|Heart Failure|heart failure
4773494|NCT02780934|Pressure Dressing|pressure dressing
4773495|NCT02780934|Post-operative Care|post-operative care
4773496|NCT02780934|Simple Adhesive Dressing|simple adhesive dressing
4773497|NCT02780934|Mohs|mohs
4773498|NCT02780921|Prehabilitation|prehabilitation
4773499|NCT02780921|Oesophageal cancer|oesophageal cancer
4773500|NCT02780921|Gastric cancer|gastric cancer
4773501|NCT02780921|Fitness|fitness
4773502|NCT02780921|Preconditionning|preconditionning
4773503|NCT02780921|two parallel arms|two parallel arms
4773504|NCT02780895|Parkinson Disease|parkinson disease
4773505|NCT02780895|stereotactic surgery|stereotactic surgery
4773506|NCT02780895|human allogeneic fetal derived stem cells|human allogeneic fetal derived stem cells
4773507|NCT02780882|Pasireotide|pasireotide
4773508|NCT02780882|Ectopic ACTH|ectopic acth
4773509|NCT02780882|SOM230|som230
4773510|NCT02780882|ectopic ACTH-dependent Cushing's syndrome|ectopic acth-dependent cushing's syndrome
4773511|NCT02780856|Caries Activity Demineralisation|caries activity demineralisation
4773512|NCT02780856|Demineralisation|demineralisation
4773513|NCT02780843|Stroke|stroke
4773514|NCT02780843|Tomography, X-Ray Computed|tomography, x-ray computed
4773515|NCT02780843|Magnetic Resonance Imaging|magnetic resonance imaging
4773516|NCT02780843|Thrombolytic Therapy|thrombolytic therapy
4773517|NCT02780830|Lymphoma|lymphoma
4773518|NCT02780830|Diffuse Large B-Cell Lymphoma|diffuse large b-cell lymphoma
4773519|NCT02780830|non-GCB Diffuse Large B-Cell Lymphoma|non-gcb diffuse large b-cell lymphoma
4773520|NCT02780830|Relapsed or Refractory non-GCB Diffuse Large B-Cell Lymphoma|relapsed or refractory non-gcb diffuse large b-cell lymphoma
4773521|NCT02780830|Vistusertib|vistusertib
4773522|NCT02780830|AZD2014|azd2014
4773523|NCT02780830|Ibrutinib|ibrutinib
4773524|NCT02780830|Imbruvica|imbruvica
4773525|NCT02780791|Infertility|infertility
4773526|NCT02780791|Ovarian Failure, Premature|ovarian failure, premature
4773527|NCT02780791|Ovarian Follicle|ovarian follicle
4773528|NCT02780791|Ovary|ovary
4773529|NCT02780791|Tissue Transplantation|tissue transplantation
4773530|NCT02780791|Cryopreservation|cryopreservation
4773531|NCT02780791|Pelvis|pelvis
4773532|NCT02780791|Chemotherapy|chemotherapy
4773533|NCT02780791|Pregnancy Rate|pregnancy rate
4773534|NCT02780791|Folliculogenesis|folliculogenesis
4773535|NCT02780791|Endometrium|endometrium
4773536|NCT02780791|Estrogens|estrogens
4773537|NCT02780791|Progestins|progestins
4773538|NCT02780791|Follicle Stimulating Hormone|follicle stimulating hormone
4773539|NCT02780791|Estradiol|estradiol
4773540|NCT02780791|Progesterone|progesterone
4773541|NCT02780791|Hormones|hormones
4773542|NCT02780791|Maturation of Follicles|maturation of follicles
4773543|NCT02780791|Pregnant Women|pregnant women
4773544|NCT02780791|Premature Menopause|premature menopause
4773545|NCT02780791|Ovarian Insufficiency|ovarian insufficiency
4773546|NCT02780791|Ovarian Insufficiency, Premature|ovarian insufficiency, premature
4773547|NCT02780791|Cytotoxic therapy|cytotoxic therapy
4773548|NCT02780791|Fertility Protection|fertility protection
4773549|NCT02780791|Reproductive Medicine|reproductive medicine
4773550|NCT02780791|Reproductive Techniques|reproductive techniques
4773551|NCT02780791|Reproductive Technology|reproductive technology
4773552|NCT02780791|Cryotherapy|cryotherapy
4773553|NCT02780791|Pregnancy|pregnancy
4773554|NCT02780739|Psychological Tests|psychological tests
4773555|NCT02780739|Neuropsychological Tests|neuropsychological tests
4773556|NCT02780739|Transcranial Direct Current Stimulation|transcranial direct current stimulation
4773557|NCT02780739|Exercise|exercise
4773558|NCT02780739|Circuit-Based Exercise|circuit-based exercise
4773559|NCT02780739|Video Games|video games
4773560|NCT02780739|Magnetic Resonance Imaging|magnetic resonance imaging
4773561|NCT02780739|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
4773562|NCT02780739|Cognition|cognition
4773563|NCT02780739|Executive Function|executive function
4773564|NCT02780739|Learning|learning
4773565|NCT02780739|Problem Solving|problem solving
4773566|NCT02780739|Transfer (Psychology)|transfer (psychology)
4773567|NCT02780739|Decision Making|decision making
4773568|NCT02780739|Brain|brain
4773569|NCT02780739|Gray Matter|gray matter
4773570|NCT02780739|White Matter|white matter
4773571|NCT02780726|Peritoneal dialysis|peritoneal dialysis
4773572|NCT02780726|Roxadustat|roxadustat
4773573|NCT02780726|Renal anemia|renal anemia
4773574|NCT02780726|ASP1517|asp1517
4773575|NCT02780713|Breast cancer|breast cancer
4773576|NCT02780713|Healthy volunteers|healthy volunteers
4773577|NCT02780713|Pharmacokinetics|pharmacokinetics
4773578|NCT02780713|AZD9496|azd9496
4773579|NCT02780713|Safety|safety
4773580|NCT02780713|Tolerability|tolerability
4773581|NCT02780674|Polymyositis, dermatomyositis, Sjogren's syndrome, SLE, SSc|polymyositis, dermatomyositis, sjogren's syndrome, sle, ssc
4773582|NCT02780648|stereotactic radiotherapy|stereotactic radiotherapy
4773583|NCT02780648|pancreatic adenocarcinoma|pancreatic adenocarcinoma
4773584|NCT02780635|family, caregiving, ptsd, couples|family, caregiving, ptsd, couples
4773585|NCT02780609|autologous hematopoietic cell transplantation (HCT)|autologous hematopoietic cell transplantation (hct)
4773586|NCT02780609|high-dose melphalan|high-dose melphalan
4773587|NCT02780609|selinexor|selinexor
4773588|NCT02780596|Infant|infant
4773589|NCT02780596|Toddler|toddler
4773590|NCT02780596|Primary Care|primary care
4773591|NCT02780570|SVPE|svpe
4773592|NCT02780570|intravenous immunoglobulin|intravenous immunoglobulin
4773593|NCT02780570|plasmapheresis|plasmapheresis
4773594|NCT02780557|Vocabulary|vocabulary
4773595|NCT02780557|Book reading|book reading
4773596|NCT02780557|Infancy|infancy
4773597|NCT02780557|Parenting|parenting
4773598|NCT02780544|Infant, premature|infant, premature
4773599|NCT02780544|Pain|pain
4773600|NCT02780544|Stress, physiological|stress, physiological
4773601|NCT02780544|Stress, psychological|stress, psychological
4773602|NCT02780544|skin-to-skin contact|skin-to-skin contact
4773603|NCT02780518|oxygen|oxygen
4773604|NCT02780518|carbon dioxide|carbon dioxide
4773605|NCT02780492|Duchenne muscular dystrophy|duchenne muscular dystrophy
4773606|NCT02780492|Natural history|natural history
4773607|NCT02780492|Outcome measures|outcome measures
4773608|NCT02780492|North Star Ambulatory Assessment (NSAA)|north star ambulatory assessment (nsaa)
4773609|NCT02780492|6 minute walk distance (6MWD)|6 minute walk distance (6mwd)
4773610|NCT02780492|Myoset|myoset
4773611|NCT02780492|Exon skipping|exon skipping
4773612|NCT02780479|Prednisone|prednisone
4773613|NCT02780479|Dexamethasone|dexamethasone
4773614|NCT02780479|Asthma exacerbation|asthma exacerbation
4773615|NCT02780479|Hospitalized|hospitalized
4773616|NCT02780466|Septic shock|septic shock
4773617|NCT02780466|Endotracheal intubation|endotracheal intubation
4773618|NCT02780466|Outcome|outcome
4773619|NCT02780440|Post Stroke Recovery|post stroke recovery
4773620|NCT02780440|Mirror Therapy|mirror therapy
4773621|NCT02780440|Unimanual mirror therapy|unimanual mirror therapy
4773622|NCT02780440|Bimanual mirror therapy|bimanual mirror therapy
4773623|NCT02780440|Stroke|stroke
4773624|NCT02780427|Dose-Response Relationship, Drug|dose-response relationship, drug
4773625|NCT02780414|Hypertension|hypertension
4773626|NCT02780414|Proteinuria|proteinuria
4773627|NCT02780414|Thrombocytopenia|thrombocytopenia
4773628|NCT02780414|Renal Insufficiency|renal insufficiency
4773629|NCT02780414|Impaired Liver Function|impaired liver function
4773630|NCT02780414|Pulmonary Edema|pulmonary edema
4773631|NCT02780401|Stage I|stage i
4773632|NCT02780401|Stage II|stage ii
4773633|NCT02780401|Stage III|stage iii
4773634|NCT02780388|MEDI4920, CD40L, RA, rheumatoid arthritis|medi4920, cd40l, ra, rheumatoid arthritis
4773635|NCT02780375|Transcriptional Responses|transcriptional responses
4773636|NCT02780375|Radiation|radiation
4773637|NCT02780323|Celecoxib|celecoxib
4773638|NCT02780323|CELBESTA|celbesta
4773639|NCT02780310|Lenvatinib|lenvatinib
4773640|NCT02780310|15-327|15-327
4773641|NCT02780297|primary hyperoxaluria|primary hyperoxaluria
4773642|NCT02780297|Dent Disease|dent disease
4773643|NCT02780297|enteric hyperoxaluria|enteric hyperoxaluria
4773644|NCT02780297|cystinuria|cystinuria
4773645|NCT02780297|Lowe Syndrome|lowe syndrome
4773646|NCT02780297|Adenine phosphoribosyltransferase deficiency|adenine phosphoribosyltransferase deficiency
4773647|NCT02780297|PH|ph
4773648|NCT02780297|APRTd|aprtd
4773649|NCT02780297|APRT|aprt
4773650|NCT02780297|hyperoxaluria|hyperoxaluria
4773651|NCT02780297|oxalate|oxalate
4773652|NCT02780297|oxalosis|oxalosis
4773653|NCT02780297|PH type 1|ph type 1
4773654|NCT02780297|PH type 2|ph type 2
4773655|NCT02780297|PH type 3|ph type 3
4773656|NCT02780297|Dents|dents
4773657|NCT02780297|Dent|dent
4773658|NCT02780297|Dent 1|dent 1
4773659|NCT02780297|Dent 2|dent 2
4773660|NCT02780297|APRT deficiency|aprt deficiency
4773661|NCT02780284|Gut Microbiota|gut microbiota
4773662|NCT02780284|Butyrate|butyrate
4773663|NCT02780284|Physical activity|physical activity
4773664|NCT02780271|Breast Cancer|breast cancer
4773665|NCT02780271|Cancer survivor|cancer survivor
4773666|NCT02780271|e-communication|e-communication
4773667|NCT02780271|diet and physical activity|diet and physical activity
4773668|NCT02780271|fruits/vegetables daily servings|fruits/vegetables daily servings
4773669|NCT02780271|energy density|energy density
4773670|NCT02780245|Caesarean Section|caesarean section
4773671|NCT02780245|Tranexamic Acid|tranexamic acid
4773672|NCT02780245|Postpartum Hemorrhage|postpartum hemorrhage
4773673|NCT02780245|Ecbolics|ecbolics
4773674|NCT02780232|Depression|depression
4773675|NCT02780232|Adolescence|adolescence
4773676|NCT02780232|Prevention|prevention
4773677|NCT02780232|Early intervention|early intervention
4773678|NCT02780232|E-Mental Health|e-mental health
4773679|NCT02780180|Aminopeptidase A inhibitor|aminopeptidase a inhibitor
4773680|NCT02780180|Heart Failure|heart failure
4773681|NCT02780180|Up-titration|up-titration
4773682|NCT02780180|Dose-Response Relationship, Drug|dose-response relationship, drug
4773683|NCT02780180|Pharmacokinetics|pharmacokinetics
4773684|NCT02780180|Patient Safety|patient safety
4773685|NCT02780180|Treatment Efficacy|treatment efficacy
4773686|NCT02780167|Phase 2|phase 2
4773687|NCT02780167|randomized|randomized
4773688|NCT02780167|double-blind|double-blind
4773689|NCT02780167|placebo|placebo
4773690|NCT02780167|atopic dermatitis|atopic dermatitis
4773691|NCT02780167|safety|safety
4773692|NCT02780167|efficacy|efficacy
4773693|NCT02780167|JAK|jak
4773694|NCT02780167|janus kinase|janus kinase
4773695|NCT02780167|moderate|moderate
4773696|NCT02780167|severe|severe
4773697|NCT02780154|7G8 clone|7g8 clone
4773698|NCT02780154|NF54 strain|nf54 strain
4773699|NCT02780154|Non-immune|non-immune
4773700|NCT02780154|PCR|pcr
4773701|NCT02780154|PfSPZ Challenge|pfspz challenge
4773702|NCT02780154|Plasmodium falciparum|plasmodium falciparum
4773703|NCT02780154|qPCR|qpcr
4773704|NCT02780154|Sporozoites|sporozoites
4773705|NCT02780141|Renal anemia|renal anemia
4773706|NCT02780141|Roxadustat|roxadustat
4773707|NCT02780141|ASP1517|asp1517
4773708|NCT02780141|Hemodialysis|hemodialysis
4773709|NCT02780128|neuroblastoma|neuroblastoma
4773710|NCT02780128|cancer|cancer
4773711|NCT02780128|genetic profiling|genetic profiling
4773712|NCT02780128|ceritinib|ceritinib
4773713|NCT02780128|ribociclib|ribociclib
4773714|NCT02780128|trametinib|trametinib
4773715|NCT02780128|HDM201|hdm201
4773716|NCT02780102|ADHD|adhd
4773717|NCT02780102|Cognitive-motor rehabilitation|cognitive-motor rehabilitation
4773718|NCT02780102|Active Control Group|active control group
4773719|NCT02780102|Stimulant Medication|stimulant medication
4773720|NCT02780089|Metastatic|metastatic
4773721|NCT02780089|Unresectable|unresectable
4773722|NCT02780063|Dilation|dilation
4773723|NCT02780063|Intraocular|intraocular
4773724|NCT02780063|Ophthalmology|ophthalmology
4773725|NCT02780050|cardiopulmonary resuscitation|cardiopulmonary resuscitation
4773726|NCT02780050|manikins|manikins
4773727|NCT02780050|physical fitness|physical fitness
4773728|NCT02780024|Neo-Adjuvant Metformin|neo-adjuvant metformin
4773729|NCT02780024|Neo-Adjuvant Temozolomide|neo-adjuvant temozolomide
4773730|NCT02780024|Temozolomide and accelerated hypofractionation|temozolomide and accelerated hypofractionation
4773731|NCT02780024|Metformin and accelerated hypofractionation|metformin and accelerated hypofractionation
4773732|NCT02780024|Adjuvant Temozolomide|adjuvant temozolomide
4773733|NCT02780024|Adjuvant Metformin|adjuvant metformin
4773734|NCT02780011|CD30+|cd30+
4773735|NCT02780011|Relapsed|relapsed
4773736|NCT02780011|Refractory|refractory
4773737|NCT02780011|ALCL|alcl
4773738|NCT02779985|Lycium Barbarum|lycium barbarum
4773739|NCT02779985|Energy expenditure|energy expenditure
4773740|NCT02779985|Postprandial metabolism|postprandial metabolism
4773741|NCT02779972|Cardiac Physiology|cardiac physiology
4773742|NCT02779972|Physiology|physiology
4773743|NCT02779933|Hospital-acquired Pneumonia|hospital-acquired pneumonia
4773744|NCT02779933|Epidemiology|epidemiology
4773745|NCT02779933|Risk Factors|risk factors
4773746|NCT02779920|refractory gastroparesis|refractory gastroparesis
4773747|NCT02779920|per oral pyloromyotomy|per oral pyloromyotomy
4773748|NCT02779907|Paediatric|paediatric
4773749|NCT02779907|Malawi|malawi
4773750|NCT02779894|Sleep Apnea|sleep apnea
4773751|NCT02779894|Communication Based Technology|communication based technology
4773752|NCT02779894|ICT|ict
4773753|NCT02779868|body composition|body composition
4773754|NCT02779868|functional capacity|functional capacity
4773755|NCT02779868|quality of life|quality of life
4773756|NCT02779855|triple negative breast cancer (TNBC)|triple negative breast cancer (tnbc)
4773757|NCT02779855|estrogen receptor|estrogen receptor
4773758|NCT02779855|progesterone receptor|progesterone receptor
4773759|NCT02779855|invasive ductal carcinoma|invasive ductal carcinoma
4773760|NCT02779855|breast cancer tumors|breast cancer tumors
4773761|NCT02779790|Systematic Review and Meta-Analysis|systematic review and meta-analysis
4773762|NCT02779790|Evidence-Based Medicine|evidence-based medicine
4773763|NCT02779790|Evidence-Based Nutrition|evidence-based nutrition
4773764|NCT02779790|Clinical Practice Guidelines|clinical practice guidelines
4773765|NCT02779790|Liquid Meal Replacements|liquid meal replacements
4773766|NCT02779790|Body Weight|body weight
4773767|NCT02779790|Systolic Blood Pressure|systolic blood pressure
4773768|NCT02779790|Diastolic Blood Pressure|diastolic blood pressure
4773769|NCT02779790|Fasting Blood Glucose|fasting blood glucose
4773770|NCT02779790|Fasting Blood Insulin|fasting blood insulin
4773771|NCT02779790|HbA1c|hba1c
4773772|NCT02779790|Total Cholesterol|total cholesterol
4773773|NCT02779790|Triglycerides|triglycerides
4773774|NCT02779790|LDL-C|ldl-c
4773775|NCT02779790|HDL-C|hdl-c
4773776|NCT02779790|Controlled Feeding Trials|controlled feeding trials
4773777|NCT02779764|Hemodialysis|hemodialysis
4773778|NCT02779764|ASP1517|asp1517
4773779|NCT02779764|Roxadustat|roxadustat
4773780|NCT02779764|Renal anemia|renal anemia
4773781|NCT02779725|Symptom Management|symptom management
4773782|NCT02779712|Remote ischaemic conditioning|remote ischaemic conditioning
4773783|NCT02779686|Macular Degeneration|macular degeneration
4773784|NCT02779686|Genetic testing|genetic testing
4773785|NCT02779686|Age-Related Macular degeneration|age-related macular degeneration
4773786|NCT02779686|Age-Related Maculopathies|age-related maculopathies
4773787|NCT02779660|Atrial Fibrillation|atrial fibrillation
4773788|NCT02779647|Overweight, obesity, play, physical activity, accelerometry.|overweight, obesity, play, physical activity, accelerometry.
4773789|NCT02779608|malignant ascites|malignant ascites
4773790|NCT02779582|Progesterone|progesterone
4773791|NCT02779582|Menstrual Flow|menstrual flow
4773792|NCT02779556|Health Literacy|health literacy
4773793|NCT02779556|Diabetes|diabetes
4773794|NCT02779543|In lab sleep studies|in lab sleep studies
4773795|NCT02779517|upper extremity|upper extremity
4773796|NCT02779517|stroke|stroke
4773797|NCT02779517|rehabilitation|rehabilitation
4773798|NCT02779517|robotics|robotics
4773799|NCT02779517|telepresence|telepresence
4773800|NCT02779517|elderly|elderly
4773801|NCT02779517|aged|aged
4773802|NCT02779517|Housing for the elderly|housing for the elderly
4773803|NCT02779517|retirement|retirement
4773804|NCT02779517|homes for the aged|homes for the aged
4773805|NCT02779491|fruit and vegetables|fruit and vegetables
4773806|NCT02779491|food intake|food intake
4773807|NCT02779491|knowledge|knowledge
4773808|NCT02779478|chronic obstructive pulmonary disease (COPD)|chronic obstructive pulmonary disease (copd)
4773809|NCT02779478|cavitary|cavitary
4773810|NCT02779478|nodular bronchiectatic disease|nodular bronchiectatic disease
4773812|NCT02779465|vitamin D treatment|vitamin d treatment
4773813|NCT02779465|chronic hepatitis B|chronic hepatitis b
4773814|NCT02779452|neurodevelopment|neurodevelopment
4773815|NCT02779452|electroencephalography|electroencephalography
4773816|NCT02779452|gestational diabetes mellitus|gestational diabetes mellitus
4773817|NCT02779452|omega 3 polyunsaturated fatty acids|omega 3 polyunsaturated fatty acids
4773818|NCT02779426|Atopic dermatitis|atopic dermatitis
4773819|NCT02779426|Text Messages|text messages
4773820|NCT02779426|Health literacy|health literacy
4773821|NCT02779400|INR|inr
4773822|NCT02779400|coagulation|coagulation
4773823|NCT02779400|vitamin K antagonist|vitamin k antagonist
4773824|NCT02779387|GnRH-a|gnrh-a
4773825|NCT02779387|endometriosis|endometriosis
4773826|NCT02779387|efficiency|efficiency
4773827|NCT02779374|ovarian insufficiency Bone Marrow|ovarian insufficiency bone marrow
4773828|NCT02779361|green tea|green tea
4773829|NCT02779361|steroid profile|steroid profile
4773830|NCT02779348|Nebicapone|nebicapone
4773831|NCT02779348|Warfarin|warfarin
4773832|NCT02779335|tube-fed|tube-fed
4773833|NCT02779335|Formula Tolerance|formula tolerance
4773834|NCT02779335|Pediatric Patients|pediatric patients
4773835|NCT02779322|gastric bypass|gastric bypass
4773836|NCT02779322|hospital charges|hospital charges
4773837|NCT02779322|mini gastric bypass|mini gastric bypass
4773838|NCT02779309|Frail Older Adults|frail older adults
4773839|NCT02779309|Mortality|mortality
4773840|NCT02779309|Home Care|home care
4773841|NCT02779309|Survival Analysis|survival analysis
4773842|NCT02779309|Clinical Prediction Rule|clinical prediction rule
4773843|NCT02779296|Cyanoacrylates|cyanoacrylates
4773844|NCT02779296|Mammaplasty|mammaplasty
4773845|NCT02779296|Mastectomy|mastectomy
4773846|NCT02779257|hypoglycemia|hypoglycemia
4773847|NCT02779244|Orthopedic|orthopedic
4773848|NCT02779244|Post-operative|post-operative
4773849|NCT02779244|Weight bearing|weight bearing
4773850|NCT02779244|Range of motion|range of motion
4773851|NCT02779218|Hemiplegia|hemiplegia
4773852|NCT02779205|Cell therapy|cell therapy
4773853|NCT02779205|Stromal Cells|stromal cells
4773854|NCT02779205|Stem cells|stem cells
4773855|NCT02779205|Adipose tissue|adipose tissue
4773856|NCT02779205|Children|children
4773857|NCT02779192|Acute Noise Induced Hearing Loss|acute noise induced hearing loss
4773858|NCT02779192|Prevent Acute Noise Induced Hearing Loss|prevent acute noise induced hearing loss
4773859|NCT02779166|hip arthroscopy|hip arthroscopy
4773860|NCT02779153|SLE|sle
4773861|NCT02779153|H.P. Acthar Gel|h.p. acthar gel
4773862|NCT02779140|BoNT|bont
4773863|NCT02779140|botulinum|botulinum
4773864|NCT02779140|Botulism|botulism
4773865|NCT02779140|Clostridium|clostridium
4773866|NCT02779140|Neurotoxin|neurotoxin
4773867|NCT02779140|NTM-1632|ntm-1632
4773868|NCT02779127|Smoking|smoking
4773869|NCT02779127|Endothelium|endothelium
4773870|NCT02779127|Passive smoking|passive smoking
4773871|NCT02779114|Rheumatoid Arthritis|rheumatoid arthritis
4773872|NCT02779114|Remission|remission
4773873|NCT02779114|Dose reduction|dose reduction
4773874|NCT02779101|Central nervous system lymphoma|central nervous system lymphoma
4773875|NCT02779101|Pembrolizumab|pembrolizumab
4773876|NCT02779075|Sleeve Gastrectomy|sleeve gastrectomy
4773877|NCT02779075|Roux-en-Y Gastric Bypass|roux-en-y gastric bypass
4773878|NCT02779036|Stroke|stroke
4773879|NCT02779036|task-oriented home exercise|task-oriented home exercise
4773880|NCT02779036|walking competency|walking competency
4773881|NCT02779036|Usual Physiotherapy care|usual physiotherapy care
4773882|NCT02778997|Shunt|shunt
4773883|NCT02778997|CSF|csf
4773884|NCT02778997|Dysfunction|dysfunction
4773885|NCT02778997|Complication|complication
4773886|NCT02778984|Anesthesia|anesthesia
4773887|NCT02778984|facial mask|facial mask
4773888|NCT02778971|MCI|mci
4773889|NCT02778971|Dementia|dementia
4773890|NCT02778971|amyloid PET|amyloid pet
4773891|NCT02778971|physician diagnosis|physician diagnosis
4773892|NCT02778971|Alzheimer's disease|alzheimer's disease
4773893|NCT02778971|AD|ad
4773894|NCT02778971|PET imaging|pet imaging
4773895|NCT02778971|Appropriate Use Criteria|appropriate use criteria
4773896|NCT02778971|patient-reported outcomes|patient-reported outcomes
4773897|NCT02778958|bariatric surgery|bariatric surgery
4773898|NCT02778958|morbid obesity|morbid obesity
4773899|NCT02778958|nonopioid analgesics|nonopioid analgesics
4773900|NCT02778945|spinal surgery|spinal surgery
4773901|NCT02778945|sugammadex|sugammadex
4773902|NCT02778945|deep neuromuscular block|deep neuromuscular block
4773903|NCT02778945|shear wave elastography|shear wave elastography
4773904|NCT02778945|neuromuscular monitoring|neuromuscular monitoring
4773905|NCT02778919|Endometriosis|endometriosis
4773906|NCT02778906|Abatacept|abatacept
4773907|NCT02778893|Conmana|conmana
4773908|NCT02778893|Thalidomide|thalidomide
4773909|NCT02778893|NSCLC|nsclc
4773910|NCT02778893|EGFR mutation|egfr mutation
4773911|NCT02778854|NSCLC|nsclc
4773912|NCT02778854|liquid biopsy|liquid biopsy
4773913|NCT02778854|driver mutation|driver mutation
4773914|NCT02778828|linezolide|linezolide
4773915|NCT02778828|tuberculosis|tuberculosis
4773916|NCT02778828|MDR-TB|mdr-tb
4773917|NCT02778802|Pulmonary Hypertension|pulmonary hypertension
4773918|NCT02778802|Emphysema|emphysema
4773919|NCT02778802|COPD|copd
4773920|NCT02778776|Metformin|metformin
4773921|NCT02778776|Agave Inulin|agave inulin
4773922|NCT02778776|METS|mets
4773923|NCT02778776|Inflammation parameters|inflammation parameters
4773924|NCT02778776|Urodynamic parameters|urodynamic parameters
4773925|NCT02778776|Prostate hyperplasia|prostate hyperplasia
4773926|NCT02778763|Breast cancer|breast cancer
4773927|NCT02778763|TLR2|tlr2
4773928|NCT02778763|Neutropenia|neutropenia
4773929|NCT02778750|Cystic Fibrosis (CF)|cystic fibrosis (cf)
4773930|NCT02778737|ACT, CBT, Randomized controlled trial, Chronic Pain|act, cbt, randomized controlled trial, chronic pain
4773931|NCT02778711|anti-IL-17|anti-il-17
4773932|NCT02778711|secukinumab|secukinumab
4773933|NCT02778672|bacterial pneumonia|bacterial pneumonia
4773934|NCT02778672|children|children
4773935|NCT02778672|diagnosing pneumonia|diagnosing pneumonia
4773936|NCT02778672|thermal imaging|thermal imaging
4773937|NCT02778633|Volume responsiveness mean systemic filling pressure|volume responsiveness mean systemic filling pressure
4773938|NCT02778620|Volume responsiveness mean systemic filling pressure|volume responsiveness mean systemic filling pressure
4773939|NCT02778607|Atypical Parkinsonism Syndrome (APS)|atypical parkinsonism syndrome (aps)
4773940|NCT02778581|Cognitive Impairment, Alzheimer's Disease, Vegetal Oil|cognitive impairment, alzheimer's disease, vegetal oil
4773941|NCT02778542|Automated Hovering|automated hovering
4773942|NCT02778542|Remote Monitoring|remote monitoring
4773943|NCT02778542|Bidirectional Text Messaging|bidirectional text messaging
4773944|NCT02778529|stroke|stroke
4773945|NCT02778529|amputees|amputees
4773946|NCT02778529|spinal cord injuries|spinal cord injuries
4773947|NCT02778529|cerebral palsy|cerebral palsy
4773948|NCT02778529|robotics|robotics
4773949|NCT02778529|rehabilitation|rehabilitation
4773950|NCT02778503|Tooth, Deciduous|tooth, deciduous
4773951|NCT02778503|Dentition, Permanent|dentition, permanent
4773952|NCT02778503|Dental Atraumatic Restorative Treatment|dental atraumatic restorative treatment
4773953|NCT02778503|Glass Ionomer Cements|glass ionomer cements
4773954|NCT02778503|Dental Caries|dental caries
4773955|NCT02778490|sleeve gastrectomy, bariatric surgery|sleeve gastrectomy, bariatric surgery
4773956|NCT02778464|Inflammatory Bowel Disease|inflammatory bowel disease
4773957|NCT02778464|Pregnancy|pregnancy
4773958|NCT02778464|Stool markers|stool markers
4773959|NCT02778464|Calprotectin|calprotectin
4773960|NCT02778464|Faecal S100A12 (f-SA12)|faecal s100a12 (f-sa12)
4773961|NCT02778464|Faecal calprotectin (f-Cp)|faecal calprotectin (f-cp)
4773962|NCT02778425|partial splenic embolization|partial splenic embolization
4773963|NCT02778412|Thyroid cancer|thyroid cancer
4773964|NCT02778412|Thyroid nodules|thyroid nodules
4773965|NCT02778412|Thyroid neoplasia|thyroid neoplasia
4773966|NCT02778412|Thyroiditis|thyroiditis
4773967|NCT02778399|Pelvic Pain|pelvic pain
4773968|NCT02778399|Endometriosis|endometriosis
4773969|NCT02778399|Dysmenorrhea|dysmenorrhea
4773970|NCT02778399|Dyspareunia|dyspareunia
4773971|NCT02778360|Attention deficit|attention deficit
4773972|NCT02778360|Neurofeedback|neurofeedback
4773973|NCT02778360|ADHD|adhd
4773974|NCT02778360|Methylphenidate|methylphenidate
4773975|NCT02778347|Palliative care|palliative care
4773976|NCT02778347|Need assessment|need assessment
4773977|NCT02778347|Tools|tools
4773978|NCT02778347|Validity|validity
4773979|NCT02778347|Quality of care|quality of care
4773980|NCT02778308|Gallbladder cancer, adjuvant chemotherapy, gemcitabine|gallbladder cancer, adjuvant chemotherapy, gemcitabine
4773981|NCT02778269|ECG|ecg
4773982|NCT02778269|CGM|cgm
4773983|NCT02778269|Hypoglycaemia|hypoglycaemia
4773984|NCT02778269|Sudden Cardiac Death|sudden cardiac death
4773985|NCT02778256|depression, bipolar disorder|depression, bipolar disorder
4773986|NCT02778230|fiber|fiber
4773987|NCT02778230|gastrointestinal|gastrointestinal
4773988|NCT02778230|microbiota|microbiota
4773989|NCT02778191|Head and neck squamous cell carcinoma|head and neck squamous cell carcinoma
4773990|NCT02778191|cisplatin|cisplatin
4773991|NCT02778191|carboplatin|carboplatin
4773992|NCT02778191|5-fluorouracil|5-fluorouracil
4773993|NCT02778087|motor recovery|motor recovery
4773994|NCT02778087|mirror therapy|mirror therapy
4773995|NCT02778087|upper extremity|upper extremity
4773996|NCT02778074|Internet Cognitive Behavioural Therapy|internet cognitive behavioural therapy
4773997|NCT02778061|Intra Uterine Ball|intra uterine ball
4773998|NCT02778061|IUD|iud
4773999|NCT02778061|copper|copper
4774000|NCT02778061|contraception|contraception
4774001|NCT02778022|Child behavior disorders|child behavior disorders
4774002|NCT02778022|Parent child relationship|parent child relationship
4774003|NCT02778022|Primary care|primary care
4774004|NCT02778009|Medical student|medical student
4774005|NCT02778009|Activity Monitor|activity monitor
4774006|NCT02778009|Medical school|medical school
4774007|NCT02778009|Fitness|fitness
4774008|NCT02777996|screening|screening
4774009|NCT02777983|patient education|patient education
4774010|NCT02777983|low back pain|low back pain
4774011|NCT02777983|technology|technology
4774012|NCT02777970|Acute pain|acute pain
4774013|NCT02777970|Acute moderate to severe pain|acute moderate to severe pain
4774014|NCT02777970|Postoperative pain|postoperative pain
4774015|NCT02777970|Dexketoprofen Tramadol|dexketoprofen tramadol
4774016|NCT02777970|Dexketoprofen trometamol|dexketoprofen trometamol
4774017|NCT02777970|Tramadol hydrochloride|tramadol hydrochloride
4774018|NCT02777970|Multimodal analgesia|multimodal analgesia
4774019|NCT02777970|Third molar extraction|third molar extraction
4774020|NCT02777970|Fixed drug combination|fixed drug combination
4774021|NCT02777970|Paracetamol|paracetamol
4774022|NCT02777970|Analgesics|analgesics
4774023|NCT02777957|Echocardiography|echocardiography
4774024|NCT02777957|Lung Transplantation|lung transplantation
4774025|NCT02777944|motivation|motivation
4774026|NCT02777944|attendance|attendance
4774027|NCT02777918|food intake|food intake
4774028|NCT02777905|late life|late life
4774029|NCT02777905|mindfulness meditation|mindfulness meditation
4774030|NCT02777879|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
4774031|NCT02777853|tea|tea
4774032|NCT02777853|cardiovascular|cardiovascular
4774033|NCT02777853|vascular|vascular
4774034|NCT02777853|metabolism|metabolism
4774035|NCT02777853|microcirculation|microcirculation
4774036|NCT02777853|physical inactivity|physical inactivity
4774037|NCT02777853|polyphenols|polyphenols
4774038|NCT02777853|conduit artery|conduit artery
4774039|NCT02777853|endothelial function|endothelial function
4774040|NCT02777853|cerebrovascular|cerebrovascular
4774041|NCT02777853|insulin sensitivity|insulin sensitivity
4774042|NCT02777827|Abediterol|abediterol
4774043|NCT02777827|Dry powder inhaler|dry powder inhaler
4774044|NCT02777827|Pressured metered-dose inhaler|pressured metered-dose inhaler
4774045|NCT02777827|Pharmacokinetic|pharmacokinetic
4774046|NCT02777827|Pharmacodynamic|pharmacodynamic
4774047|NCT02777827|Safety|safety
4774048|NCT02777814|colorectal cancer|colorectal cancer
4774049|NCT02777814|Entecavir|entecavir
4774050|NCT02777814|Hepatitis B Carrier|hepatitis b carrier
4774051|NCT02777801|gastric cancer|gastric cancer
4774052|NCT02777801|hepatitis B carrier|hepatitis b carrier
4774053|NCT02777801|entecavir|entecavir
4774054|NCT02777788|Chinese Traditional Medicine|chinese traditional medicine
4774056|NCT02777775|CNF|cnf
4774057|NCT02777775|PNF|pnf
4774058|NCT02777775|Skin Tumors|skin tumors
4774059|NCT02777736|Lymphoma, B cell|lymphoma, b cell
4774060|NCT02777736|Central nervous system relapse|central nervous system relapse
4774061|NCT02777736|Methotrexate|methotrexate
4774062|NCT02777736|Intrathecal chemotherapy|intrathecal chemotherapy
4774063|NCT02777723|Dry Eye Syndrome|dry eye syndrome
4774064|NCT02777723|Sodium Hyaluronate|sodium hyaluronate
4774065|NCT02777723|CKD-350|ckd-350
4774066|NCT02777697|cancer treatment protocols|cancer treatment protocols
4774067|NCT02777697|chronic cancer pain|chronic cancer pain
4774068|NCT02777697|cognitive function|cognitive function
4774069|NCT02777697|quality of life|quality of life
4774070|NCT02777697|anxiety|anxiety
4774071|NCT02777697|depression|depression
4774072|NCT02777684|Physical activity|physical activity
4774073|NCT02777684|Knee osteoarthritis|knee osteoarthritis
4774074|NCT02777684|Non pharmacological treatment|non pharmacological treatment
4774075|NCT02777684|Qualitative study|qualitative study
4774076|NCT02777658|Epidermal Growth Factor Receptor (EGFR), non-small cell lung cancer (NSCLC), EGFR T790M, EGFR Mutation-Positive Locally Advanced or Advanced NSCLC|epidermal growth factor receptor (egfr), non-small cell lung cancer (nsclc), egfr t790m, egfr mutation-positive locally advanced or advanced nsclc
4774077|NCT02777619|Pharmacodynamic|pharmacodynamic
4774078|NCT02777619|Dexmedetomidine|dexmedetomidine
4774079|NCT02777619|Propofol|propofol
4774080|NCT02777619|Target-controlled Infusion Intravenous Anesthesia|target-controlled infusion intravenous anesthesia
4774081|NCT02777606|Severe Sepsis|severe sepsis
4774082|NCT02777606|Sini Decoction|sini decoction
4774083|NCT02777606|Immune Function|immune function
4774084|NCT02777606|Mortality|mortality
4774085|NCT02777580|Thrombolytic Therapy|thrombolytic therapy
4774086|NCT02777580|Primary PCI|primary pci
4774087|NCT02777554|Healthy Subjects|healthy subjects
4774088|NCT02777554|Apremilast|apremilast
4774089|NCT02777554|Pharmacokinetic|pharmacokinetic
4774090|NCT02777541|early enteral nutrition|early enteral nutrition
4774091|NCT02777541|children|children
4774092|NCT02777541|percutaneous endoscopic gastrostomy|percutaneous endoscopic gastrostomy
4774093|NCT02777515|electronic cigarette|electronic cigarette
4774094|NCT02777489|obesity|obesity
4774095|NCT02777489|perindopril|perindopril
4774096|NCT02777489|carboxypeptidase D|carboxypeptidase d
4774097|NCT02777489|genotyping|genotyping
4774098|NCT02777489|theranostic|theranostic
4774099|NCT02777450|low back pain|low back pain
4774100|NCT02777450|physical examination|physical examination
4774101|NCT02777450|local anesthesia|local anesthesia
4774102|NCT02777437|Colonic Neoplasms|colonic neoplasms
4774103|NCT02777437|Laparoscopic Surgery|laparoscopic surgery
4774104|NCT02777437|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
4774105|NCT02777437|T4|t4
4774106|NCT02777411|Vaccines|vaccines
4774107|NCT02777411|Hand, Foot and Mouth Disease|hand, foot and mouth disease
4774108|NCT02777411|EV71 enteroviruses vaccine|ev71 enteroviruses vaccine
4774109|NCT02777398|Intra-spinal Canal|intra-spinal canal
4774110|NCT02777398|Tumor|tumor
4774111|NCT02777398|Minimal Invasive Surgery|minimal invasive surgery
4774112|NCT02777398|Clinical Trial|clinical trial
4774113|NCT02777398|Quadrant Channel|quadrant channel
4774114|NCT02777385|Head and Neck|head and neck
4774115|NCT02777385|Locally Advanced|locally advanced
4774116|NCT02777385|Squamous Cell Carcinoma|squamous cell carcinoma
4774117|NCT02777385|SCCHN|scchn
4774118|NCT02777385|Untreated|untreated
4774119|NCT02777385|High Risk|high risk
4774120|NCT02777385|Intermediate Risk|intermediate risk
4774121|NCT02777385|Radiation Therapy|radiation therapy
4774122|NCT02777385|Cisplatin|cisplatin
4774123|NCT02777372|Zoloft|zoloft
4774124|NCT02777372|PMS|pms
4774125|NCT02777372|Menses|menses
4774126|NCT02777359|patent foramen ovale|patent foramen ovale
4774127|NCT02777359|migraine|migraine
4774128|NCT02777359|treatment|treatment
4774129|NCT02777346|WOUNDS, PENETRATING|wounds, penetrating
4774130|NCT02777346|CHILD, PRESCHOOL|child, preschool
4774131|NCT02777346|CHILD|child
4774132|NCT02777346|INFANT|infant
4774133|NCT02777346|ADOLESCENT|adolescent
4774134|NCT02777346|SUTURES|sutures
4774135|NCT02777346|POLYGLACTIN 910|polyglactin 910
4774136|NCT02777346|POLYPROPYLENES|polypropylenes
4774137|NCT02777333|Simulation|simulation
4774138|NCT02777333|Arthroscopy|arthroscopy
4774139|NCT02777333|Motion analysis|motion analysis
4774140|NCT02777320|Sciatica|sciatica
4774141|NCT02777320|Ibuprofen|ibuprofen
4774142|NCT02777320|Paracetamol|paracetamol
4774143|NCT02777320|Emergency Medicine|emergency medicine
4774144|NCT02777307|Laparoscopic|laparoscopic
4774145|NCT02777307|Cholecistectomy|cholecistectomy
4774146|NCT02777307|Collection|collection
4774147|NCT02777307|Bleeding|bleeding
4774148|NCT02777307|reoperation|reoperation
4774149|NCT02777281|Shoulder Pain|shoulder pain
4774150|NCT02777281|Wheelchair|wheelchair
4774151|NCT02777281|Spinal Cord injury|spinal cord injury
4774152|NCT02777242|Hypogonadism|hypogonadism
4774153|NCT02777242|Testosterone enanthate|testosterone enanthate
4774154|NCT02777216|RDN|rdn
4774155|NCT02777203|morcellation|morcellation
4774156|NCT02777203|myomectomy|myomectomy
4774157|NCT02777203|hysterectomy|hysterectomy
4774158|NCT02777190|misoprostol|misoprostol
4774159|NCT02777190|cytotec|cytotec
4774160|NCT02777190|cervical ripening|cervical ripening
4774161|NCT02777190|labor, induced|labor, induced
4774162|NCT02777190|active labor|active labor
4774163|NCT02777138|Adipose tissue|adipose tissue
4774164|NCT02777138|Inflammation|inflammation
4774165|NCT02777138|Age Comparison|age comparison
4774166|NCT02777138|Macrophages|macrophages
4774167|NCT02777138|T-lymphocytes|t-lymphocytes
4774168|NCT02777138|Adipose Progenitors|adipose progenitors
4774169|NCT02777125|pediatrics|pediatrics
4774170|NCT02777125|metered dose inhalers|metered dose inhalers
4774171|NCT02777125|breath actuated nebulizers|breath actuated nebulizers
4774172|NCT02777112|high-risk|high-risk
4774173|NCT02777112|early prevention|early prevention
4774174|NCT02777112|productivity|productivity
4774175|NCT02777112|return on investment|return on investment
4774176|NCT02777112|workplace|workplace
4774177|NCT02777112|e-mental health program|e-mental health program
4774178|NCT02777112|job coach|job coach
4774179|NCT02777099|remote ischemic postconditioning|remote ischemic postconditioning
4774180|NCT02777099|autonomic function|autonomic function
4774181|NCT02777099|heart rate variability|heart rate variability
4774182|NCT02777099|acute ischemic stroke|acute ischemic stroke
4774183|NCT02777099|prognosis|prognosis
4774184|NCT02777086|HIV|hiv
4774185|NCT02777086|Risk Behaviors|risk behaviors
4774186|NCT02777086|Decision-making|decision-making
4774187|NCT02777073|Diabetic ketoacidosis|diabetic ketoacidosis
4774188|NCT02777073|Insulin|insulin
4774189|NCT02777073|Type 1 Diabetes|type 1 diabetes
4774190|NCT02777073|glucose (sugar) control|glucose (sugar) control
4774191|NCT02777073|SGLT-2 inhibitors|sglt-2 inhibitors
4774192|NCT02777060|virtual reality|virtual reality
4774193|NCT02777060|sensor-based balance training|sensor-based balance training
4774194|NCT02777060|gait|gait
4774195|NCT02777060|balance|balance
4774196|NCT02777047|Thromboembolism|thromboembolism
4774197|NCT02777047|Medication Safety|medication safety
4774198|NCT02777047|Hospital-community collaboration|hospital-community collaboration
4774199|NCT02777047|Pilot RCT|pilot rct
4774200|NCT02777047|Telehealth|telehealth
4774201|NCT02777034|Laparoscopy|laparoscopy
4774202|NCT02777034|Enhanced Recovery|enhanced recovery
4774203|NCT02777034|Fast-track|fast-track
4774204|NCT02777021|Pediatric|pediatric
4774205|NCT02777021|Acute Myeloid Leukemia|acute myeloid leukemia
4774206|NCT02777021|Quality of Life|quality of life
4774207|NCT02777021|Neutropenia Management|neutropenia management
4774208|NCT02777021|Patient Centered Outcomes|patient centered outcomes
4774209|NCT02777021|Chemotherapy|chemotherapy
4774210|NCT02776982|Gastroesophageal reflux disease|gastroesophageal reflux disease
4774211|NCT02776982|GERD|gerd
4774212|NCT02776982|Barrett's Esophagus|barrett's esophagus
4774213|NCT02776982|Esophageal adenocarcinoma|esophageal adenocarcinoma
4774214|NCT02776969|Papillary Carcinoma|papillary carcinoma
4774215|NCT02776969|Gene Hunting|gene hunting
4774216|NCT02776969|Familial|familial
4774217|NCT02776956|atrial fibrillation;left atrial function|atrial fibrillation;left atrial function
4774218|NCT02776930|Injury Prediction|injury prediction
4774219|NCT02776930|Return to Work|return to work
4774220|NCT02776930|Injury Prevention|injury prevention
4774221|NCT02776917|metastatic breast cancer|metastatic breast cancer
4774222|NCT02776917|locally advanced, unresectable breast cancer|locally advanced, unresectable breast cancer
4774223|NCT02776917|HER2/NEU negative|her2/neu negative
4774224|NCT02776904|Concussion|concussion
4774225|NCT02776904|Football player|football player
4774226|NCT02776904|Movement assessment|movement assessment
4774227|NCT02776904|Soccer player|soccer player
4774228|NCT02776891|lymphoma|lymphoma
4774229|NCT02776891|gallium citrate|gallium citrate
4774230|NCT02776891|PET|pet
4774231|NCT02776865|suprascapular nerve block|suprascapular nerve block
4774232|NCT02776813|CD20+|cd20+
4774233|NCT02776813|B-cell|b-cell
4774234|NCT02776813|ACTR087|actr087
4774235|NCT02776813|Relapsed|relapsed
4774236|NCT02776813|Refractory|refractory
4774237|NCT02776800|Wound|wound
4774238|NCT02776800|Surgical Wound|surgical wound
4774239|NCT02776800|Trauma Wound|trauma wound
4774240|NCT02776800|Home Health Care|home health care
4774241|NCT02776800|Home Health Nurse|home health nurse
4774242|NCT02776800|Pressure Ulcer|pressure ulcer
4774243|NCT02776800|Diabetic Foot Ulcer|diabetic foot ulcer
4774244|NCT02776800|Venous Leg Ulcer|venous leg ulcer
4774245|NCT02776800|Arterial Ulcer|arterial ulcer
4774246|NCT02776800|Wound Dehiscence|wound dehiscence
4774247|NCT02776800|Open Wound|open wound
4774248|NCT02776774|spine|spine
4774249|NCT02776748|Tenofovir disoproxil|tenofovir disoproxil
4774250|NCT02776748|Pre-exposure prophylaxis|pre-exposure prophylaxis
4774251|NCT02776748|Breastfeeding|breastfeeding
4774252|NCT02776748|Emtricitabine|emtricitabine
4774253|NCT02776748|Tenofovir|tenofovir
4774254|NCT02776748|Post-partum|post-partum
4774255|NCT02776748|HIV prevention|hiv prevention
4774256|NCT02776748|Women|women
4774257|NCT02776748|Pharmacokinetics|pharmacokinetics
4774258|NCT02776722|Systematic Review and Meta-analysis|systematic review and meta-analysis
4774259|NCT02776722|randomized controlled trial|randomized controlled trial
4774260|NCT02776722|Evidence-Based Medicine|evidence-based medicine
4774261|NCT02776722|carbohydrate metabolism|carbohydrate metabolism
4774262|NCT02776722|postprandial|postprandial
4774263|NCT02776722|glycemic response|glycemic response
4774264|NCT02776722|glycemic control|glycemic control
4774265|NCT02776722|insulin sensitivity|insulin sensitivity
4774266|NCT02776722|beta-cell function|beta-cell function
4774267|NCT02776722|sugars|sugars
4774268|NCT02776722|fructose|fructose
4774269|NCT02776722|allulose|allulose
4774270|NCT02776722|tagatose|tagatose
4774271|NCT02776722|sorbose|sorbose
4774272|NCT02776696|Closed Loop|closed loop
4774273|NCT02776696|Artificial Pancreas|artificial pancreas
4774274|NCT02776644|renal cell carcinoma|renal cell carcinoma
4774275|NCT02776644|sunitinib, pazopanib|sunitinib, pazopanib
4774276|NCT02776644|temsirolimus|temsirolimus
4774277|NCT02776644|sorafenib|sorafenib
4774278|NCT02776644|everolimus|everolimus
4774279|NCT02776644|interferon alpha|interferon alpha
4774280|NCT02776644|interleukin 2|interleukin 2
4774281|NCT02776592|Healthy Children|healthy children
4774282|NCT02776579|Resistance Training; Muscle Strength|resistance training; muscle strength
4774283|NCT02776566|Anticoagulation|anticoagulation
4774284|NCT02776566|Anticoagulation Management|anticoagulation management
4774285|NCT02776566|Self-Testing|self-testing
4774286|NCT02776566|Self-Management|self-management
4774287|NCT02776566|Warfarin|warfarin
4774288|NCT02776566|Thromboembolism|thromboembolism
4774289|NCT02776566|Blood Coagulation Disorders|blood coagulation disorders
4774290|NCT02776566|Health Disparities|health disparities
4774291|NCT02776566|Minorities|minorities
4774292|NCT02776566|African American|african american
4774293|NCT02776566|Hispanic|hispanic
4774294|NCT02776566|Cardiovascular Disease|cardiovascular disease
4774295|NCT02776566|Models of Anticoagulation Care|models of anticoagulation care
4774296|NCT02776566|Tele-Health|tele-health
4774297|NCT02776566|Home Self-Testing|home self-testing
4774298|NCT02776527|Gastric cancer|gastric cancer
4774299|NCT02776527|D2 Lymphadenectomy|d2 lymphadenectomy
4774300|NCT02776527|postoprative adjuvant chemotherapy|postoprative adjuvant chemotherapy
4774301|NCT02776527|Apatinib|apatinib
4774302|NCT02776527|disease free survival|disease free survival
4774303|NCT02776488|brain trauma, metabolic therapy|brain trauma, metabolic therapy
4774304|NCT02776462|Eye Tracking|eye tracking
4774305|NCT02776462|Concussion|concussion
4774306|NCT02776462|Outcome Measures|outcome measures
4774307|NCT02776410|sustainable healthy eating|sustainable healthy eating
4774308|NCT02776410|consumer behaviour|consumer behaviour
4774309|NCT02776410|consumer attitudes|consumer attitudes
4774310|NCT02776384|Heart Failure|heart failure
4774311|NCT02776384|Biomarkers|biomarkers
4774312|NCT02776384|Echocardiography|echocardiography
4774313|NCT02776384|Cardiopulmonary Function Tests|cardiopulmonary function tests
4774314|NCT02776371|Helicobacter pylori|helicobacter pylori
4774315|NCT02776371|Sequential therapy|sequential therapy
4774316|NCT02776371|Modified non-clarithromycin triple therapy|modified non-clarithromycin triple therapy
4774317|NCT02776345|calcific tendonitis|calcific tendonitis
4774318|NCT02776345|rotator cuff calcific tendonitis|rotator cuff calcific tendonitis
4774319|NCT02776332|breastfeeding|breastfeeding
4774320|NCT02776332|premature infants|premature infants
4774321|NCT02776332|manual expression|manual expression
4774322|NCT02776319|Non-invasive brain stimulation|non-invasive brain stimulation
4774323|NCT02776319|tobacco use disorder|tobacco use disorder
4774324|NCT02776319|craving|craving
4774325|NCT02776280|water|water
4774326|NCT02776280|salt|salt
4774327|NCT02776280|oral fluids|oral fluids
4774328|NCT02776280|plaque|plaque
4774329|NCT02776280|dental caries|dental caries
4774330|NCT02776254|anti-retroviral therapy|anti-retroviral therapy
4774331|NCT02776254|differentiated care|differentiated care
4774332|NCT02776241|ADPKD|adpkd
4774333|NCT02776241|total kidney volume|total kidney volume
4774334|NCT02776241|kidney disease|kidney disease
4774335|NCT02776189|Anaesthesia|anaesthesia
4774336|NCT02776189|MRI|mri
4774337|NCT02776189|Brain|brain
4774338|NCT02776176|enhanced recovery after surgery|enhanced recovery after surgery
4774339|NCT02776176|hirschsprung disease|hirschsprung disease
4774340|NCT02776163|Salivary Gland Tumors|salivary gland tumors
4774341|NCT02776163|Head-an-Neck cancer|head-an-neck cancer
4774342|NCT02776163|Concurrent Chemoradiotherapy|concurrent chemoradiotherapy
4774343|NCT02776163|High-Risk|high-risk
4774344|NCT02776163|Cisplatin|cisplatin
4774345|NCT02776163|Docetaxel|docetaxel
4774346|NCT02776150|probe melting curve|probe melting curve
4774347|NCT02776150|Drug resistance|drug resistance
4774348|NCT02776150|Tuberculosis, Pulmonary|tuberculosis, pulmonary
4774349|NCT02776137|Docetaxel|docetaxel
4774350|NCT02776137|Concurrent Chemoradiotherapy|concurrent chemoradiotherapy
4774351|NCT02776137|High-Risk|high-risk
4774352|NCT02776137|Squamous Cell Carcinoma|squamous cell carcinoma
4774353|NCT02776137|Head-and-Neck Cancer|head-and-neck cancer
4774354|NCT02776124|Nutritional status|nutritional status
4774355|NCT02776124|nasopharyngeal carcinoma|nasopharyngeal carcinoma
4774356|NCT02776124|Nutritional Counseling|nutritional counseling
4774357|NCT02776124|concurrent chemoradiotherapy|concurrent chemoradiotherapy
4774358|NCT02776124|oral nutritional supplements|oral nutritional supplements
4774359|NCT02776111|Kidney Transplant|kidney transplant
4774360|NCT02776098|Cystic Fibrosis|cystic fibrosis
4774361|NCT02776098|Glucose Intolerance|glucose intolerance
4774362|NCT02776098|Muscle Accrual|muscle accrual
4774363|NCT02776098|Cystic Fibrosis-related Diabetes|cystic fibrosis-related diabetes
4774364|NCT02776098|Healthy Controls|healthy controls
4774365|NCT02776098|Healthy Participants|healthy participants
4774366|NCT02776085|optic nerve sheath diameter|optic nerve sheath diameter
4774367|NCT02776085|ultrasound|ultrasound
4774368|NCT02776085|shunt failure|shunt failure
4774369|NCT02776072|Tecfidera, DMF, dimethyl fumarate, Fingolimod, Glatiramer acetate, Teriflunomide, Gilenya, Copaxone, Aubagio|tecfidera, dmf, dimethyl fumarate, fingolimod, glatiramer acetate, teriflunomide, gilenya, copaxone, aubagio
4774370|NCT02776059|survival|survival
4774371|NCT02776059|pegfilgrastim|pegfilgrastim
4774372|NCT02776059|cirrhosis, alcoholic|cirrhosis, alcoholic
4774373|NCT02776046|Oxygen, surgical site infection, postoperative complication, recruitment maneuvers, open lung strategy|oxygen, surgical site infection, postoperative complication, recruitment maneuvers, open lung strategy
4774374|NCT02776033|tolerability|tolerability
4774375|NCT02776033|safety|safety
4774376|NCT02776033|GSK2982772|gsk2982772
4774377|NCT02776033|RIP1 kinase inhibitor|rip1 kinase inhibitor
4774378|NCT02776033|psoriasis|psoriasis
4774379|NCT02776007|Continuous Glucose Monitoring System|continuous glucose monitoring system
4774380|NCT02775955|Pharmacokinetics|pharmacokinetics
4774381|NCT02775929|Tenofovir disoproxil|tenofovir disoproxil
4774382|NCT02775929|Emtricitabine|emtricitabine
4774383|NCT02775929|Pre-exposure Prophylaxis|pre-exposure prophylaxis
4774384|NCT02775929|Antiretroviral Therapy|antiretroviral therapy
4774385|NCT02775929|HIV Prevention|hiv prevention
4774386|NCT02775929|FTC TDF|ftc tdf
4774387|NCT02775929|PrEP|prep
4774388|NCT02775929|HIV Infected Partners|hiv infected partners
4774389|NCT02775929|HIV Uninfected Partners|hiv uninfected partners
4774390|NCT02775903|MEDI4736|medi4736
4774391|NCT02775903|Durvalumab|durvalumab
4774392|NCT02775903|Myelodysplastic Syndromes|myelodysplastic syndromes
4774393|NCT02775903|Acute Myeloid Leukemia|acute myeloid leukemia
4774394|NCT02775903|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
4774395|NCT02775903|Azacitidine|azacitidine
4774396|NCT02775903|Safety|safety
4774397|NCT02775903|Efficacy|efficacy
4774398|NCT02775903|PD-L1|pd-l1
4774399|NCT02775877|PCOS|pcos
4774400|NCT02775877|letrozole|letrozole
4774401|NCT02775877|clomiphene|clomiphene
4774402|NCT02775786|Pancreatic Adenocarcinoma|pancreatic adenocarcinoma
4774403|NCT02775786|Pancreatic Cancer|pancreatic cancer
4774404|NCT02775773|TXA|txa
4774405|NCT02775773|PPH|pph
4774406|NCT02775760|brain|brain
4774407|NCT02775760|brain mapping|brain mapping
4774408|NCT02775760|cognition|cognition
4774409|NCT02775760|exercise|exercise
4774410|NCT02775760|physical activity|physical activity
4774411|NCT02775760|hippocampus|hippocampus
4774412|NCT02775760|entorhinal cortex|entorhinal cortex
4774413|NCT02775760|spatial navigation|spatial navigation
4774414|NCT02775760|learning|learning
4774415|NCT02775760|memory|memory
4774416|NCT02775760|magnetic resonance imaging|magnetic resonance imaging
4774417|NCT02775760|functional neuroimaging|functional neuroimaging
4774418|NCT02775760|physical endurance|physical endurance
4774419|NCT02775760|physical fitness|physical fitness
4774420|NCT02775760|resistance training|resistance training
4774421|NCT02775760|walking|walking
4774422|NCT02775760|muscle stretching exercises|muscle stretching exercises
4774423|NCT02775760|exercise test|exercise test
4774424|NCT02775760|neuropsychological tests|neuropsychological tests
4774425|NCT02775760|executive function|executive function
4774426|NCT02775760|attention|attention
4774427|NCT02775760|body composition|body composition
4774428|NCT02775734|Polycystic Ovary Syndrome|polycystic ovary syndrome
4774429|NCT02775734|N-acetyl-cysteine|n-acetyl-cysteine
4774430|NCT02775734|Clomiphene citrate|clomiphene citrate
4774431|NCT02775734|Clomiphene citrate resistant|clomiphene citrate resistant
4774432|NCT02775734|Laparoscopic ovarian drilling|laparoscopic ovarian drilling
4774433|NCT02775734|therapy|therapy
4774434|NCT02775721|Nursing Education|nursing education
4774435|NCT02775721|Weight Loss|weight loss
4774436|NCT02775721|Gastrostomy Tube Care|gastrostomy tube care
4774437|NCT02775695|pancreatic cancer|pancreatic cancer
4774438|NCT02775695|Resectable Pancreatic Cancer|resectable pancreatic cancer
4774439|NCT02775695|Doxycycline|doxycycline
4774440|NCT02775695|Metakaryote cells|metakaryote cells
4774441|NCT02775695|Eukaryotic cells|eukaryotic cells
4774442|NCT02775695|Cancer Stem Cells|cancer stem cells
4774443|NCT02775695|Targeted Cancer Stem Cell Therapy|targeted cancer stem cell therapy
4774444|NCT02775695|Multi-metakaryocide therapy|multi-metakaryocide therapy
4774445|NCT02775695|Doxycycline Hyclate|doxycycline hyclate
4774446|NCT02775695|Tetracycline|tetracycline
4774447|NCT02775682|epilepsy, dynamic cerebral autoregulation|epilepsy, dynamic cerebral autoregulation
4774448|NCT02775669|noninvasive ICP monitoring|noninvasive icp monitoring
4774449|NCT02775656|Cimzia®|cimzia®
4774450|NCT02775656|CZP|czp
4774451|NCT02775656|Pregnancy Follow up study|pregnancy follow up study
4774452|NCT02775656|Autoimmune diseases|autoimmune diseases
4774453|NCT02775656|Pregnancy outcomes|pregnancy outcomes
4774454|NCT02775656|major congenital malformations|major congenital malformations
4774455|NCT02775656|birth outcomes|birth outcomes
4774456|NCT02775656|malformation|malformation
4774457|NCT02775656|birth defect|birth defect
4774458|NCT02775643|Melanoma|melanoma
4774459|NCT02775643|Spitzoid Melanoma|spitzoid melanoma
4774460|NCT02775643|Congenital Melanoma|congenital melanoma
4774461|NCT02775643|Melanoma Arising in Giant Nevi|melanoma arising in giant nevi
4774462|NCT02775643|Melanocytic lesions with indeterminate biological behavior|melanocytic lesions with indeterminate biological behavior
4774463|NCT02775643|Pigment synthesizing melanomas|pigment synthesizing melanomas
4774464|NCT02775604|fall risks at home|fall risks at home
4774465|NCT02775604|video technology|video technology
4774466|NCT02775604|home assessment|home assessment
4774467|NCT02775578|heart failure|heart failure
4774468|NCT02775578|coronary artery disease|coronary artery disease
4774469|NCT02775578|biomarkers|biomarkers
4774470|NCT02775578|Percutaneous Coronary Intervention, PCI|percutaneous coronary intervention, pci
4774471|NCT02775578|Coronary Artery Bypass Grafting, CABG|coronary artery bypass grafting, cabg
4774472|NCT02775552|Child Nutrition|child nutrition
4774473|NCT02775552|Breastfeeding|breastfeeding
4774474|NCT02775552|Complementary Feeding|complementary feeding
4774475|NCT02775552|Infant and Young Child Feeding|infant and young child feeding
4774476|NCT02775552|Social and Behavior Change Communication|social and behavior change communication
4774477|NCT02775552|Ethiopia|ethiopia
4774478|NCT02775539|Pulmonary hypertension|pulmonary hypertension
4774479|NCT02775539|Mirabegron|mirabegron
4774480|NCT02775539|Heart failure|heart failure
4774481|NCT02775539|B3 adrenergic|b3 adrenergic
4774482|NCT02775526|Mixed urinary incontinence|mixed urinary incontinence
4774483|NCT02775526|Transobturator tape (TOT)|transobturator tape (tot)
4774484|NCT02775526|Tension-Free Vaginal Tape (TVT)|tension-free vaginal tape (tvt)
4774485|NCT02775526|Burch colposuspension|burch colposuspension
4774486|NCT02775526|Urinary incontinence|urinary incontinence
4774487|NCT02775500|pregnancy|pregnancy
4774488|NCT02775500|apremilast|apremilast
4774489|NCT02775500|Otezla|otezla
4774490|NCT02775500|autoimmune disease|autoimmune disease
4774491|NCT02775500|psoriatic arthritis|psoriatic arthritis
4774492|NCT02775500|psoriasis|psoriasis
4774493|NCT02775500|TNF|tnf
4774494|NCT02775500|tumor necrosis factor|tumor necrosis factor
4774495|NCT02775500|birth outcome|birth outcome
4774496|NCT02775500|birth defect|birth defect
4774497|NCT02775487|COPD|copd
4774498|NCT02775487|Air quality|air quality
4774499|NCT02775474|Methadone|methadone
4774500|NCT02775474|Pain, Postoperative|pain, postoperative
4774501|NCT02775474|Chronic Pain|chronic pain
4774502|NCT02775474|Bariatric Surgery|bariatric surgery
4774503|NCT02775461|Pancreas Cancer|pancreas cancer
4774504|NCT02775461|Chronic Pancreatitis|chronic pancreatitis
4774505|NCT02775461|Pancreatic Cyst|pancreatic cyst
4774506|NCT02775461|BRCA1|brca1
4774507|NCT02775461|BRCA2|brca2
4774508|NCT02775461|Lynch Syndrome|lynch syndrome
4774509|NCT02775461|Peutz-Jeghers syndrome|peutz-jeghers syndrome
4774510|NCT02775461|ATM mutation|atm mutation
4774511|NCT02775461|FAMMM Syndrome|fammm syndrome
4774512|NCT02775461|Pancreatitis|pancreatitis
4774513|NCT02775461|Family History of Pancreas Cancer|family history of pancreas cancer
4774514|NCT02775461|Family History of Cancer|family history of cancer
4774515|NCT02775448|Homeopathy|homeopathy
4774516|NCT02775448|Carduus marianus|carduus marianus
4774517|NCT02775448|Dyslipidemia|dyslipidemia
4774518|NCT02775448|Climacteric|climacteric
4774519|NCT02775448|Obesity|obesity
4774520|NCT02775448|Triglycerides|triglycerides
4774521|NCT02775448|Cholesterol|cholesterol
4774522|NCT02775448|Insulin resistance|insulin resistance
4774523|NCT02775448|LDL-cholesterol|ldl-cholesterol
4774524|NCT02775448|HDL-cholesterol|hdl-cholesterol
4774525|NCT02775435|PD1|pd1
4774526|NCT02775435|PD-1|pd-1
4774527|NCT02775435|PDL1|pdl1
4774528|NCT02775435|PD-L1|pd-l1
4774529|NCT02775383|National MDS Study|national mds study
4774530|NCT02775383|MDS|mds
4774531|NCT02775383|Idiopathic|idiopathic
4774532|NCT02775383|cytopenia|cytopenia
4774533|NCT02775383|cytopenias|cytopenias
4774534|NCT02775383|ICUS|icus
4774535|NCT02775383|MDS/MPN|mds/mpn
4774536|NCT02775383|Myeloproliferative Neoplasm|myeloproliferative neoplasm
4774537|NCT02775383|Biorepository|biorepository
4774538|NCT02775344|Laparoscopy|laparoscopy
4774539|NCT02775344|ovarian cystectomy|ovarian cystectomy
4774540|NCT02775344|three dimension laparoscopy|three dimension laparoscopy
4774541|NCT02775331|shift scheduling|shift scheduling
4774542|NCT02775331|work-life interaction|work-life interaction
4774543|NCT02775331|working time control|working time control
4774544|NCT02775331|public sector|public sector
4774545|NCT02775318|Stellate Ganglion|stellate ganglion
4774546|NCT02775318|Digital Subtraction Angiography|digital subtraction angiography
4774547|NCT02775318|Transcranial Doppler Ultrasonography|transcranial doppler ultrasonography
4774548|NCT02775279|acute coronary syndrome, telomere length, predictive factor|acute coronary syndrome, telomere length, predictive factor
4774549|NCT02775253|Brown adipose tissue|brown adipose tissue
4774550|NCT02775253|Subcutaneous white adipose tissue|subcutaneous white adipose tissue
4774551|NCT02775253|White adipose tissue|white adipose tissue
4774552|NCT02775240|Maribavir|maribavir
4774553|NCT02775214|Storz C-MAC|storz c-mac
4774554|NCT02775214|direct laryngoscopy|direct laryngoscopy
4774555|NCT02775214|pyloromyotomy|pyloromyotomy
4774556|NCT02775214|rapid sequence|rapid sequence
4774557|NCT02775201|plantaris|plantaris
4774558|NCT02775201|Tendinopathy|tendinopathy
4774559|NCT02775201|Achilles|achilles
4774560|NCT02775201|Release|release
4774561|NCT02775175|Ramadan|ramadan
4774562|NCT02775175|Fasting|fasting
4774563|NCT02775175|Nutrition|nutrition
4774564|NCT02775175|Quality of Life|quality of life
4774565|NCT02775136|brain injuries|brain injuries
4774566|NCT02775136|neurological monitoring|neurological monitoring
4774567|NCT02775084|n-3|n-3
4774568|NCT02775084|Polyunsaturated|polyunsaturated
4774569|NCT02775084|Fatty acids|fatty acids
4774570|NCT02775084|Antigens|antigens
4774571|NCT02775084|Cognition|cognition
4774572|NCT02775084|CD4|cd4
4774573|NCT02775045|EoE|eoe
4774574|NCT02775032|advance care planning|advance care planning
4774575|NCT02775032|general practice|general practice
4774576|NCT02775032|family practice|family practice
4774577|NCT02775032|palliative care|palliative care
4774578|NCT02775032|end-of-life care|end-of-life care
4774579|NCT02774967|root coverage|root coverage
4774580|NCT02774967|gingival recession|gingival recession
4774581|NCT02774967|periodontal surgery|periodontal surgery
4774582|NCT02774954|Change the cycle|change the cycle
4774583|NCT02774954|social learning theory|social learning theory
4774584|NCT02774954|people who inject drugs|people who inject drugs
4774585|NCT02774954|injection drug use|injection drug use
4774586|NCT02774954|Information, Motivation, Behavior Skills Model|information, motivation, behavior skills model
4774587|NCT02774954|Longitudinal cohort study|longitudinal cohort study
4774588|NCT02774928|Pulmonary Hypertension|pulmonary hypertension
4774589|NCT02774928|COPD|copd
4774590|NCT02774928|ILD|ild
4774591|NCT02774928|OSA|osa
4774592|NCT02774902|Drug Therapy|drug therapy
4774593|NCT02774889|Falls Prevention|falls prevention
4774594|NCT02774889|Stepping On|stepping on
4774595|NCT02774889|Health Promotion|health promotion
4774596|NCT02774889|Implementation|implementation
4774597|NCT02774889|Health Maintenance|health maintenance
4774598|NCT02774876|Closed-loop system|closed-loop system
4774599|NCT02774876|Artificial pancreas|artificial pancreas
4774600|NCT02774876|Glucose control|glucose control
4774601|NCT02774876|Meal|meal
4774602|NCT02774850|Pediatric|pediatric
4774603|NCT02774850|Neutropenia Management|neutropenia management
4774604|NCT02774850|Acute Myeloid Leukemia|acute myeloid leukemia
4774605|NCT02774850|Chart Abstraction|chart abstraction
4774606|NCT02774850|Chemotherapy|chemotherapy
4774607|NCT02774837|nucleoside analogues|nucleoside analogues
4774608|NCT02774837|tenofovir|tenofovir
4774609|NCT02774837|telbivudine|telbivudine
4774610|NCT02774837|quantitative HBsAg|quantitative hbsag
4774611|NCT02774837|combination therapy|combination therapy
4774612|NCT02774798|Rectal Prolapse|rectal prolapse
4774613|NCT02774798|Rectal Intussuception|rectal intussuception
4774614|NCT02774759|Malignant neoplasms of female genital organs|malignant neoplasms of female genital organs
4774615|NCT02774759|Endometrial cancer survivors|endometrial cancer survivors
4774616|NCT02774759|Obese|obese
4774617|NCT02774759|Weight loss intervention|weight loss intervention
4774618|NCT02774759|Resistance training|resistance training
4774619|NCT02774759|Aerobic exercise|aerobic exercise
4774620|NCT02774759|Questionnaires|questionnaires
4774621|NCT02774759|Surveys|surveys
4774622|NCT02774759|Accelerometer|accelerometer
4774623|NCT02774759|Fitness Test|fitness test
4774624|NCT02774759|Telephone Coaching|telephone coaching
4774625|NCT02774759|Video Chat Sessions|video chat sessions
4774626|NCT02774707|Dry eye|dry eye
4774627|NCT02774694|nociceptive flexion reflex|nociceptive flexion reflex
4774628|NCT02774694|interventional pain management|interventional pain management
4774629|NCT02774668|gender|gender
4774630|NCT02774668|arterial stiffness|arterial stiffness
4774631|NCT02774668|blood pressure|blood pressure
4774632|NCT02774668|weight loss|weight loss
4774633|NCT02774668|uric acid|uric acid
4774634|NCT02774655|healthy volunteers|healthy volunteers
4774635|NCT02774655|patient compliance|patient compliance
4774636|NCT02774655|exercise|exercise
4774637|NCT02774655|motivation|motivation
4774638|NCT02774642|PTSD|ptsd
4774639|NCT02774642|insomnia|insomnia
4774640|NCT02774642|CBT-I|cbt-i
4774641|NCT02774642|Prolonged Exposure|prolonged exposure
4774642|NCT02774642|Veteran|veteran
4774643|NCT02774629|food allergy|food allergy
4774644|NCT02774629|skin prick test|skin prick test
4774645|NCT02774629|atopy patch test|atopy patch test
4774646|NCT02774590|Acne vulgaris|acne vulgaris
4774647|NCT02774590|Rosacea|rosacea
4774648|NCT02774577|Oxygen Consumption|oxygen consumption
4774649|NCT02774577|Aged|aged
4774650|NCT02774577|Whole Body Vibration|whole body vibration
4774651|NCT02774551|Body composition|body composition
4774652|NCT02774551|Muscle strength|muscle strength
4774653|NCT02774551|Health related quality of life|health related quality of life
4774654|NCT02774538|Cervical HPV infection|cervical hpv infection
4774655|NCT02774538|Oral HPV infection|oral hpv infection
4774656|NCT02774538|Sexually transmitted infection|sexually transmitted infection
4774657|NCT02774525|child welfare system|child welfare system
4774658|NCT02774525|parental substance use problem|parental substance use problem
4774659|NCT02774525|child maltreatment|child maltreatment
4774660|NCT02774525|parenting|parenting
4774661|NCT02774473|Metastatic|metastatic
4774662|NCT02774473|Rb+|rb+
4774663|NCT02774473|Breast Cancer|breast cancer
4774664|NCT02774408|backup ventilation|backup ventilation
4774665|NCT02774408|preterm infants|preterm infants
4774666|NCT02774408|functional residual capacity|functional residual capacity
4774667|NCT02774408|chronic lung disease|chronic lung disease
4774668|NCT02774382|Recurrence|recurrence
4774669|NCT02774382|Infection|infection
4774670|NCT02774369|cancer|cancer
4774671|NCT02774369|insomnia|insomnia
4774672|NCT02774369|sleep|sleep
4774673|NCT02774369|physical exercise|physical exercise
4774674|NCT02774369|aerobic|aerobic
4774675|NCT02774369|cognitive-behavioral therapy|cognitive-behavioral therapy
4774676|NCT02774369|self-help|self-help
4774677|NCT02774369|RCT|rct
4774678|NCT02774356|Brainstem|brainstem
4774679|NCT02774356|Encoding|encoding
4774680|NCT02774356|Pitch|pitch
4774681|NCT02774304|elastance|elastance
4774682|NCT02774304|fluid responsiveness|fluid responsiveness
4774683|NCT02774265|Fracture|fracture
4774684|NCT02774265|Prophylaxis|prophylaxis
4774685|NCT02774226|Flow-Mediated Dilation|flow-mediated dilation
4774686|NCT02774226|Kuvan|kuvan
4774687|NCT02774226|Antioxidant|antioxidant
4774688|NCT02774226|FEV1|fev1
4774689|NCT02774187|Hepatocellular Carcinoma|hepatocellular carcinoma
4774690|NCT02774187|Hepatic arterial infusion chemotherapy|hepatic arterial infusion chemotherapy
4774691|NCT02774187|Sorafenib|sorafenib
4774692|NCT02774174|Proximal Humerus|proximal humerus
4774693|NCT02774109|low back pain|low back pain
4774694|NCT02774109|fish oil|fish oil
4774695|NCT02774109|omega 3|omega 3
4774696|NCT02774096|Aortic dissection|aortic dissection
4774697|NCT02774096|Cerebral and Spinal Protection|cerebral and spinal protection
4774698|NCT02774096|Post-conditioning|post-conditioning
4774699|NCT02774083|older people|older people
4774700|NCT02774083|cognitive training|cognitive training
4774701|NCT02774070|AAJ RA MRI synovitis|aaj ra mri synovitis
4774702|NCT02774057|Captafer®|captafer®
4774703|NCT02774057|Iron Sulfate|iron sulfate
4774704|NCT02774057|Iron deficiency anemia|iron deficiency anemia
4774705|NCT02774057|inflammatory bowel disease|inflammatory bowel disease
4774706|NCT02774044|preterm neonates, surfactant|preterm neonates, surfactant
4774707|NCT02774031|Anesthesia, Inhalation|anesthesia, inhalation
4774708|NCT02774031|Laparoscopy|laparoscopy
4774709|NCT02774031|Prostatectomy|prostatectomy
4774710|NCT02774031|Cystectomy|cystectomy
4774711|NCT02774031|Gynecologic Surgical Procedures|gynecologic surgical procedures
4774712|NCT02774018|Mindfulness|mindfulness
4774713|NCT02774018|Elderly|elderly
4774714|NCT02774018|Psychopathology|psychopathology
4774715|NCT02773992|Solitary Pulmonary Nodule|solitary pulmonary nodule
4774716|NCT02773992|Itos|itos
4774717|NCT02773992|lung cancer|lung cancer
4774718|NCT02773979|challenge|challenge
4774719|NCT02773979|malaria|malaria
4774720|NCT02773979|P. falciparum|p. falciparum
4774721|NCT02773979|PfSPZ|pfspz
4774722|NCT02773979|sporozoites|sporozoites
4774723|NCT02773979|vaccine|vaccine
4774724|NCT02773953|CPAP|cpap
4774725|NCT02773953|Telemonitoring|telemonitoring
4774726|NCT02773927|Agave inulin|agave inulin
4774727|NCT02773927|Adiponectin|adiponectin
4774728|NCT02773927|Metabolic syndrome|metabolic syndrome
4774729|NCT02773927|Metformin|metformin
4774730|NCT02773927|Insulin resistance|insulin resistance
4774731|NCT02773914|Activity of Daily Living (ADL)|activity of daily living (adl)
4774732|NCT02773914|Comprehensive Geriatric Assessment|comprehensive geriatric assessment
4774733|NCT02773914|Elderly|elderly
4774734|NCT02773914|Frailty|frailty
4774735|NCT02773914|Randomized controlled study|randomized controlled study
4774736|NCT02773901|intracranial pressure|intracranial pressure
4774737|NCT02773901|noninvasive monitoring|noninvasive monitoring
4774738|NCT02773901|lumbar puncture|lumbar puncture
4774739|NCT02773888|intracranial pressure|intracranial pressure
4774740|NCT02773888|noninvasive monitoring|noninvasive monitoring
4774741|NCT02773875|artificial pancreas|artificial pancreas
4774742|NCT02773862|brain injuries|brain injuries
4774743|NCT02773862|noninvasive monitoring|noninvasive monitoring
4774744|NCT02773862|intracranial pressure|intracranial pressure
4774745|NCT02773849|IFN|ifn
4774746|NCT02773849|BCG-unresponsive|bcg-unresponsive
4774747|NCT02773849|Non-Muscle Invasive Bladder Cancer|non-muscle invasive bladder cancer
4774748|NCT02773836|tobacco use|tobacco use
4774749|NCT02773836|e-cigarettes|e-cigarettes
4774750|NCT02773836|public policy|public policy
4774751|NCT02773836|ITC|itc
4774752|NCT02773823|obesity|obesity
4774753|NCT02773823|children|children
4774754|NCT02773823|cardiovascular health|cardiovascular health
4774755|NCT02773823|intervention study|intervention study
4774756|NCT02773797|Sedation|sedation
4774757|NCT02773797|Dexmedetomidine|dexmedetomidine
4774758|NCT02773771|Muscle Atrophy|muscle atrophy
4774759|NCT02773771|Critical Illness|critical illness
4774760|NCT02773771|Ultrasound|ultrasound
4774761|NCT02773771|beta-hydroxy-beta-methylbutyrate|beta-hydroxy-beta-methylbutyrate
4774762|NCT02773771|ICU|icu
4774763|NCT02773680|respiration|respiration
4774764|NCT02773680|monitoring, physiologic|monitoring, physiologic
4774765|NCT02773680|diagnostic techniques, respiratory system|diagnostic techniques, respiratory system
4774766|NCT02773654|shoulder|shoulder
4774767|NCT02773654|motion|motion
4774768|NCT02773654|measurement|measurement
4774769|NCT02773654|healthy shoulder|healthy shoulder
4774770|NCT02773654|shoulder motion|shoulder motion
4774771|NCT02773602|Analgesia|analgesia
4774772|NCT02773602|caudal analgesia|caudal analgesia
4774773|NCT02773602|ropivacaine|ropivacaine
4774774|NCT02773602|clonidine|clonidine
4774775|NCT02773602|dexamethasone|dexamethasone
4774776|NCT02773550|Multiple Myeloma|multiple myeloma
4774777|NCT02773524|Metastatic|metastatic
4774778|NCT02773524|Locally recurrent|locally recurrent
4774779|NCT02773524|Oesophago-gastric junction|oesophago-gastric junction
4774780|NCT02773524|Stomach|stomach
4774781|NCT02773524|Adenocarcinoma|adenocarcinoma
4774782|NCT02773524|Undifferentiated Carcinoma|undifferentiated carcinoma
4774783|NCT02773472|colorectal|colorectal
4774784|NCT02773472|electroacupuncture|electroacupuncture
4774785|NCT02773472|laparoscopic surgery|laparoscopic surgery
4774786|NCT02773446|ETEC|etec
4774787|NCT02773446|Escherichia coli|escherichia coli
4774788|NCT02773446|enteritis|enteritis
4774789|NCT02773446|Challenge|challenge
4774790|NCT02773446|CS6|cs6
4774791|NCT02773446|Enterotoxigenic|enterotoxigenic
4774792|NCT02773407|Undifferentiated febrile illness|undifferentiated febrile illness
4774793|NCT02773407|Azithromycin|azithromycin
4774794|NCT02773407|Cotrimoxazole|cotrimoxazole
4774795|NCT02773407|Efficacy|efficacy
4774796|NCT02773407|Enteric fever|enteric fever
4774797|NCT02773407|Fever clearance time|fever clearance time
4774798|NCT02773394|Hepatitis C Virus|hepatitis c virus
4774799|NCT02773394|Observational|observational
4774800|NCT02773394|Brazil|brazil
4774801|NCT02773342|Invasive Pulmonal Aspergillosis|invasive pulmonal aspergillosis
4774802|NCT02773342|Neutropenic Patients|neutropenic patients
4774803|NCT02773342|Haematological Malignancies|haematological malignancies
4774804|NCT02773342|Chest Computed Tomography|chest computed tomography
4774805|NCT02773329|chemotherapy induced peripheral neuropathy|chemotherapy induced peripheral neuropathy
4774806|NCT02773329|Cancer|cancer
4774807|NCT02773329|game-based exercise|game-based exercise
4774808|NCT02773329|exercise|exercise
4774809|NCT02773329|wearable sensors|wearable sensors
4774810|NCT02773329|balance|balance
4774811|NCT02773329|falls|falls
4774812|NCT02773329|virtual reality|virtual reality
4774813|NCT02773303|Neurofeedback|neurofeedback
4774814|NCT02773303|balance, postural|balance, postural
4774815|NCT02773303|postural equilibrium|postural equilibrium
4774817|NCT02773290|Aplastic Anemia|aplastic anemia
4774818|NCT02773251|Postoperative adhesion|postoperative adhesion
4774819|NCT02773251|Laparoscopy|laparoscopy
4774820|NCT02773251|Adhesion barrier|adhesion barrier
4774821|NCT02773225|non severe Aplastic Anemia,|non severe aplastic anemia,
4774822|NCT02773186|postoperative|postoperative
4774823|NCT02773186|behavioral changes|behavioral changes
4774824|NCT02773173|Colorectal Laparoscopic Surgery|colorectal laparoscopic surgery
4774825|NCT02773134|Post-operative Bracing|post-operative bracing
4774826|NCT02773134|Rigid Lumbosacral Orthosis|rigid lumbosacral orthosis
4774827|NCT02773134|Posterior Spine Fusion|posterior spine fusion
4774828|NCT02773134|Quality of Life|quality of life
4774829|NCT02773134|Lumbar Degenerative Conditions|lumbar degenerative conditions
4774830|NCT02773121|Cognition|cognition
4774831|NCT02773121|Learning|learning
4774832|NCT02773121|Memory|memory
4774833|NCT02773121|Executive Function|executive function
4774834|NCT02773121|Attention|attention
4774835|NCT02773121|Neuropsychological Tests|neuropsychological tests
4774836|NCT02773121|Physical Activity|physical activity
4774837|NCT02773121|Physical Fitness|physical fitness
4774838|NCT02773121|Exercise|exercise
4774839|NCT02773121|Resistance Training|resistance training
4774840|NCT02773121|Walking|walking
4774841|NCT02773121|Muscle Stretching Exercises|muscle stretching exercises
4774842|NCT02773121|Exercise Test|exercise test
4774843|NCT02773121|Balance|balance
4774844|NCT02773121|Flexibility|flexibility
4774845|NCT02773121|Body Composition|body composition
4774846|NCT02773095|Novartis Access|novartis access
4774847|NCT02773095|noncommunicable disease burden|noncommunicable disease burden
4774848|NCT02773095|medicine availability and price|medicine availability and price
4774849|NCT02773095|Kenya|kenya
4774850|NCT02773082|Treatment-Resistant|treatment-resistant
4774851|NCT02773082|Anxiety|anxiety
4774852|NCT02773056|transfemoral|transfemoral
4774853|NCT02773056|amputation|amputation
4774854|NCT02773056|perspiration|perspiration
4774855|NCT02773056|socket|socket
4774856|NCT02773056|socket comfort|socket comfort
4774857|NCT02773030|Multiple Myeloma|multiple myeloma
4774858|NCT02773030|Relapsed|relapsed
4774859|NCT02773030|Refractory|refractory
4774860|NCT02773030|Pharmacokinetics|pharmacokinetics
4774861|NCT02773030|Safety|safety
4774862|NCT02773030|Efficacy|efficacy
4774863|NCT02773030|CC-220|cc-220
4774864|NCT02773030|Relapsed and refractory multiple myeloma|relapsed and refractory multiple myeloma
4774865|NCT02773017|sedation|sedation
4774866|NCT02773017|age|age
4774867|NCT02773017|dexmedetomidine|dexmedetomidine
4774868|NCT02773004|Genomic test|genomic test
4774869|NCT02773004|Chemotherapy decision|chemotherapy decision
4774870|NCT02772978|decision making|decision making
4774871|NCT02772978|impulsivity|impulsivity
4774872|NCT02772926|Benfotiamine|benfotiamine
4774873|NCT02772926|Advanced glycation end products|advanced glycation end products
4774874|NCT02772926|Soluble receptor for AGEs|soluble receptor for ages
4774875|NCT02772926|Endogenous secretory receptor for AGEs|endogenous secretory receptor for ages
4774876|NCT02772900|Aging|aging
4774877|NCT02772900|Beetroot|beetroot
4774878|NCT02772900|Dietary Nitrate|dietary nitrate
4774879|NCT02772900|Functional Food|functional food
4774880|NCT02772900|Vascular Function|vascular function
4774881|NCT02772887|pregnancy|pregnancy
4774882|NCT02772887|type 2 diabetes|type 2 diabetes
4774883|NCT02772887|asymmetric dimethylarginine|asymmetric dimethylarginine
4774884|NCT02772887|L-arginine|l-arginine
4774885|NCT02772887|L-citrulline|l-citrulline
4774886|NCT02772887|placental growth factor (PlGF)|placental growth factor (plgf)
4774887|NCT02772887|blood pressure|blood pressure
4774888|NCT02772874|fecal incontinence|fecal incontinence
4774889|NCT02772874|severity|severity
4774890|NCT02772874|ultrasound|ultrasound
4774891|NCT02772874|anorectal manometry|anorectal manometry
4774892|NCT02772874|classification|classification
4774893|NCT02772835|nCPAP|ncpap
4774894|NCT02772835|nHFOV|nhfov
4774895|NCT02772835|Preterm|preterm
4774896|NCT02772835|RDS|rds
4774897|NCT02772835|CO2 Elimination|co2 elimination
4774898|NCT02772809|stroke|stroke
4774899|NCT02772809|hemiplegia|hemiplegia
4774900|NCT02772809|rehabilitation|rehabilitation
4774901|NCT02772809|robotics|robotics
4774902|NCT02772809|neuroplasticity|neuroplasticity
4774903|NCT02772796|Pharmacokinetics|pharmacokinetics
4774904|NCT02772796|Healthy Volunteer Study|healthy volunteer study
4774905|NCT02772783|brain|brain
4774906|NCT02772783|fMRI|fmri
4774907|NCT02772783|carbohydrate|carbohydrate
4774908|NCT02772783|insulin clamp|insulin clamp
4774909|NCT02772783|intake regulation|intake regulation
4774910|NCT02772783|overweight|overweight
4774911|NCT02772783|glycemic index|glycemic index
4774912|NCT02772757|hearing loss|hearing loss
4774913|NCT02772757|hearing aids|hearing aids
4774914|NCT02772757|outcome assessment|outcome assessment
4774915|NCT02772744|Hepatitis C virus genotype 4|hepatitis c virus genotype 4
4774916|NCT02772744|Antiviral|antiviral
4774917|NCT02772744|Virologic Response|virologic response
4774918|NCT02772731|mastectomy|mastectomy
4774919|NCT02772718|Hypoglycemia|hypoglycemia
4774920|NCT02772705|Standardized Uptake Value|standardized uptake value
4774921|NCT02772705|Diagnosis|diagnosis
4774922|NCT02772679|Diabetes|diabetes
4774923|NCT02772679|Treg|treg
4774924|NCT02772679|Proluekin|proluekin
4774925|NCT02772666|Relative afferent pupillary defect (RAPD)|relative afferent pupillary defect (rapd)
4774926|NCT02772666|Multiple sclerosis|multiple sclerosis
4774927|NCT02772666|Glaucoma|glaucoma
4774928|NCT02772653|Microcirculation|microcirculation
4774929|NCT02772653|Videomicroscopy|videomicroscopy
4774930|NCT02772653|Spectroscopy, Near-Infrared|spectroscopy, near-infrared
4774931|NCT02772653|B-Type Natriuretic Peptide|b-type natriuretic peptide
4774932|NCT02772653|Thromboelastometry|thromboelastometry
4774933|NCT02772653|Trauma|trauma
4774934|NCT02772653|Resuscitation|resuscitation
4774935|NCT02772653|Hypovolemic shock|hypovolemic shock
4774936|NCT02772640|Hypercholesterolemia|hypercholesterolemia
4774937|NCT02772640|Rosuvastatin|rosuvastatin
4774938|NCT02772640|Statin|statin
4774939|NCT02772640|Ezetimibe|ezetimibe
4774940|NCT02772640|Compliance|compliance
4774941|NCT02772640|Cholesterol|cholesterol
4774942|NCT02772640|Secondary prevention|secondary prevention
4774943|NCT02772640|Coronary artery disease|coronary artery disease
4774944|NCT02772640|Cholesterol absorption inhibitor|cholesterol absorption inhibitor
4774945|NCT02772627|Parkinson's disease, Nebicapone|parkinson's disease, nebicapone
4774946|NCT02772614|Nebicapone, Parkinson's disease|nebicapone, parkinson's disease
4774947|NCT02772601|ABBV-066|abbv-066
4774948|NCT02772601|BI 655066|bi 655066
4774949|NCT02772601|risankizumab|risankizumab
4774950|NCT02772588|ARN-509|arn-509
4774951|NCT02772588|Abiraterone|abiraterone
4774952|NCT02772588|Leuprolide|leuprolide
4774953|NCT02772588|Intensity-Modulated and Image-Guided Radiation Therapy|intensity-modulated and image-guided radiation therapy
4774954|NCT02772588|15-334|15-334
4774955|NCT02772588|apalutamide,|apalutamide,
4774956|NCT02772588|JNJ-56021927|jnj-56021927
4774957|NCT02772575|MOLECULAR PREDICTORS|molecular predictors
4774958|NCT02772575|Hepatic trans-arterial embolization (TAE)|hepatic trans-arterial embolization (tae)
4774959|NCT02772575|16-385|16-385
4774960|NCT02772562|prostate cancer|prostate cancer
4774961|NCT02772549|Diagnosis|diagnosis
4774962|NCT02772536|Chronic Tinnitus Tinted Light Change in Perception|chronic tinnitus tinted light change in perception
4774963|NCT02772523|Primary Prevention|primary prevention
4774964|NCT02772510|Stroke|stroke
4774965|NCT02772510|Rehabilitation|rehabilitation
4774966|NCT02772510|Hand|hand
4774967|NCT02772510|Game|game
4774968|NCT02772510|Functional electrical stimulation|functional electrical stimulation
4774969|NCT02772510|Virtual reality|virtual reality
4774970|NCT02772497|DME|dme
4774971|NCT02772497|Anti VEGF|anti vegf
4774972|NCT02772497|VEGF trap|vegf trap
4774973|NCT02772497|Diabetes|diabetes
4774974|NCT02772497|Diabetic retinopathy|diabetic retinopathy
4774975|NCT02772497|ZALTRAP|zaltrap
4774976|NCT02772497|Ziv aflibercept|ziv aflibercept
4774977|NCT02772484|noninvasive monitoring|noninvasive monitoring
4774978|NCT02772471|intracranial pressure|intracranial pressure
4774979|NCT02772471|noninvasive monitoring|noninvasive monitoring
4774980|NCT02772458|Crohn's Disease|crohn's disease
4774981|NCT02772458|gut brain axis|gut brain axis
4774982|NCT02772458|reduced appetite|reduced appetite
4774983|NCT02772445|Empowerment|empowerment
4774984|NCT02772445|Caregiver|caregiver
4774985|NCT02772432|resiliency training|resiliency training
4774986|NCT02772432|parenting|parenting
4774987|NCT02772432|special learning disability|special learning disability
4774988|NCT02772406|ulcerative colitis|ulcerative colitis
4774989|NCT02772406|colonoscopy|colonoscopy
4774990|NCT02772406|Dysplasia|dysplasia
4774991|NCT02772406|Diagnosis|diagnosis
4774992|NCT02772367|cardiotoxicity|cardiotoxicity
4774993|NCT02772367|16-025|16-025
4774994|NCT02772354|Pediatric population, ablation|pediatric population, ablation
4774995|NCT02772341|Asthma|asthma
4774996|NCT02772341|Halotherapy|halotherapy
4774997|NCT02772341|Airway hyper-reactivity|airway hyper-reactivity
4774998|NCT02772341|Metacholine|metacholine
4774999|NCT02772328|Testing|testing
4775000|NCT02772328|Access|access
4775001|NCT02772315|genomics|genomics
4775002|NCT02772315|proteomics|proteomics
4775003|NCT02772315|metabolomics|metabolomics
4775004|NCT02772315|endocrine hypertension|endocrine hypertension
4775005|NCT02772315|primary aldosteronism|primary aldosteronism
4775006|NCT02772315|Cushing syndrom|cushing syndrom
4775007|NCT02772315|pheochromocytoma|pheochromocytoma
4775008|NCT02772289|Mesenchyme Stem Cells|mesenchyme stem cells
4775009|NCT02772289|Cesarean Section|cesarean section
4775010|NCT02772289|Scars|scars
4775011|NCT02772276|Glomerular Filtration Rate|glomerular filtration rate
4775012|NCT02772263|Paramedicine|paramedicine
4775013|NCT02772263|Community Paramedic|community paramedic
4775014|NCT02772263|Elderly|elderly
4775015|NCT02772250|bowel preparation|bowel preparation
4775016|NCT02772250|polyethylene glycol|polyethylene glycol
4775017|NCT02772250|face-to-face re-education|face-to-face re-education
4775018|NCT02772250|telephone re-education|telephone re-education
4775019|NCT02772250|Boston Bowel Preparation Scale|boston bowel preparation scale
4775020|NCT02772237|concussion|concussion
4775021|NCT02772237|sports-related concussion|sports-related concussion
4775022|NCT02772237|mTBI|mtbi
4775023|NCT02772237|Riboflavin|riboflavin
4775024|NCT02772237|Vitamin B2|vitamin b2
4775025|NCT02772159|COPD|copd
4775026|NCT02772159|ADME|adme
4775027|NCT02772159|Healthy Normal Males|healthy normal males
4775028|NCT02772159|Phase 1|phase 1
4775029|NCT02772120|Infertility|infertility
4775030|NCT02772120|In vitro fertilization|in vitro fertilization
4775031|NCT02772120|Embryo transfer|embryo transfer
4775032|NCT02772120|Blastocyst|blastocyst
4775033|NCT02772120|Progesterone|progesterone
4775034|NCT02772120|Crinone|crinone
4775035|NCT02772107|Small Cell Lung Carcinoma|small cell lung carcinoma
4775036|NCT02772094|glioblastoma multiforme|glioblastoma multiforme
4775037|NCT02772094|glioblastoma|glioblastoma
4775038|NCT02772094|newly diagnosed glioblastoma|newly diagnosed glioblastoma
4775039|NCT02772094|immunotherapy|immunotherapy
4775040|NCT02772094|dendritic cells|dendritic cells
4775041|NCT02772094|grade IV astrocytoma|grade iv astrocytoma
4775042|NCT02772094|oncology|oncology
4775043|NCT02772094|neurology|neurology
4775044|NCT02772094|glioma|glioma
4775045|NCT02772094|brain tumor|brain tumor
4775046|NCT02772094|ADCTA-G|adcta-g
4775047|NCT02772055|Moxa smoke|moxa smoke
4775048|NCT02772055|Moxibustion|moxibustion
4775049|NCT02772055|Knee osteoarthritis|knee osteoarthritis
4775050|NCT02772042|Manual Therapy|manual therapy
4775051|NCT02772042|Physiotherapy|physiotherapy
4775052|NCT02772042|Manipulation|manipulation
4775053|NCT02771990|Back Pain|back pain
4775054|NCT02771964|outcome assessment|outcome assessment
4775055|NCT02771964|postoperative period|postoperative period
4775056|NCT02771951|Childhood|childhood
4775057|NCT02771951|Obesity|obesity
4775058|NCT02771938|radiotherapy, breast cancer, DIEP flap|radiotherapy, breast cancer, diep flap
4775059|NCT02771925|Gabapentin|gabapentin
4775060|NCT02771925|Alcohol Dependence|alcohol dependence
4775061|NCT02771899|Imaging, Three-Dimensional|imaging, three-dimensional
4775062|NCT02771899|Spine|spine
4775063|NCT02771899|Scoliosis|scoliosis
4775064|NCT02771886|mindfulness|mindfulness
4775065|NCT02771886|urges|urges
4775066|NCT02771886|adolescents|adolescents
4775067|NCT02771886|risk behaviors|risk behaviors
4775068|NCT02771886|therapy intervention|therapy intervention
4775069|NCT02771860|denosumab|denosumab
4775070|NCT02771860|RANKL-blockade|rankl-blockade
4775071|NCT02771834|Postural balance|postural balance
4775072|NCT02771834|Osteoporosis|osteoporosis
4775073|NCT02771834|Postmenopause|postmenopause
4775074|NCT02771834|Vitamin D|vitamin d
4775075|NCT02771834|Kyfhosis|kyfhosis
4775076|NCT02771834|Muscle strength|muscle strength
4775077|NCT02771808|CABG|cabg
4775078|NCT02771795|HER2|her2
4775079|NCT02771795|Trastuzumab|trastuzumab
4775080|NCT02771795|Biosimilar|biosimilar
4775081|NCT02771795|Cancer|cancer
4775082|NCT02771795|Breast|breast
4775083|NCT02771795|Positive|positive
4775084|NCT02771782|BCG|bcg
4775085|NCT02771782|TDaP-IPV|tdap-ipv
4775086|NCT02771782|DPT Vaccine|dpt vaccine
4775087|NCT02771769|cell-free DNA|cell-free dna
4775088|NCT02771769|copy number instability|copy number instability
4775089|NCT02771769|liquid biopsy|liquid biopsy
4775090|NCT02771769|cancer|cancer
4775091|NCT02771756|Breast cancer|breast cancer
4775092|NCT02771756|Lung cancer|lung cancer
4775093|NCT02771756|Nutritional support|nutritional support
4775094|NCT02771756|Safety|safety
4775095|NCT02771756|Effectiveness|effectiveness
4775096|NCT02771743|Neuroblastoma|neuroblastoma
4775097|NCT02771743|High risk|high risk
4775098|NCT02771743|Tandem high dose chemotherapy|tandem high dose chemotherapy
4775099|NCT02771691|Adolescent|adolescent
4775100|NCT02771652|Multiple Sclerosis|multiple sclerosis
4775101|NCT02771652|Quality of Life|quality of life
4775102|NCT02771652|exercise|exercise
4775103|NCT02771652|internet|internet
4775104|NCT02771639|Hip arthroplasty|hip arthroplasty
4775105|NCT02771639|periprosthetic joint infection|periprosthetic joint infection
4775106|NCT02771639|outcome|outcome
4775107|NCT02771626|RCC|rcc
4775108|NCT02771626|MEL|mel
4775109|NCT02771626|NSCLC|nsclc
4775110|NCT02771626|Immuno-Oncology|immuno-oncology
4775111|NCT02771626|Tumor Metabolism|tumor metabolism
4775112|NCT02771626|Glutaminase|glutaminase
4775113|NCT02771626|Glutaminase Inhibitor|glutaminase inhibitor
4775114|NCT02771613|Morbidity Mortality Review|morbidity mortality review
4775115|NCT02771613|medical simulation|medical simulation
4775116|NCT02771613|in situ simulation|in situ simulation
4775117|NCT02771613|multi professional simulation|multi professional simulation
4775118|NCT02771613|hospital adverse event|hospital adverse event
4775119|NCT02771600|Procedural pain|procedural pain
4775120|NCT02771600|Procedural anxiety|procedural anxiety
4775121|NCT02771600|Pediatrics|pediatrics
4775122|NCT02771600|Needle-related procedures|needle-related procedures
4775123|NCT02771587|alcohol|alcohol
4775124|NCT02771587|energy drink|energy drink
4775125|NCT02771587|coagulability|coagulability
4775126|NCT02771587|caffeine|caffeine
4775127|NCT02771587|taurine|taurine
4775128|NCT02771587|driving performance|driving performance
4775129|NCT02771574|Bariatric surgery complications|bariatric surgery complications
4775130|NCT02771574|Glucose Metabolism Disorders|glucose metabolism disorders
4775131|NCT02771574|Exendin (9-39)|exendin (9-39)
4775132|NCT02771574|GLP-1|glp-1
4775133|NCT02771561|Patent Foramen Ovale|patent foramen ovale
4775134|NCT02771561|Obstructive Sleep Apnea|obstructive sleep apnea
4775135|NCT02771561|Apnea-Hypopnea Index|apnea-hypopnea index
4775136|NCT02771561|Oxygen Desaturation Index|oxygen desaturation index
4775137|NCT02771561|Epworth Sleepiness Scale|epworth sleepiness scale
4775138|NCT02771561|Quality of life|quality of life
4775139|NCT02771561|Continuous Positive Airway Pressure|continuous positive airway pressure
4775140|NCT02771561|Obstructive Sleep Apnea-Hypopnea Syndrome|obstructive sleep apnea-hypopnea syndrome
4775141|NCT02771561|Gore™ septal occluder device|gore™ septal occluder device
4775142|NCT02771548|Knee injuries|knee injuries
4775143|NCT02771548|Rehabilitation|rehabilitation
4775144|NCT02771548|Return to sport|return to sport
4775145|NCT02771548|Biomechanics|biomechanics
4775146|NCT02771522|Caries, Acitivity, Demineralsiation|caries, acitivity, demineralsiation
4775147|NCT02771509|CPB|cpb
4775148|NCT02771509|Cardiac Surgery|cardiac surgery
4775149|NCT02771509|Acute Kidney Injury|acute kidney injury
4775150|NCT02771470|Gut microflora|gut microflora
4775151|NCT02771470|Lung cancer|lung cancer
4775152|NCT02771470|Chemotherapy|chemotherapy
4775153|NCT02771470|Immunity|immunity
4775154|NCT02771470|Nutrition|nutrition
4775155|NCT02771457|Influximab|influximab
4775156|NCT02771457|IFX|ifx
4775157|NCT02771457|Remicade|remicade
4775158|NCT02771418|Carotid endarterectomy|carotid endarterectomy
4775159|NCT02771418|postoperative cognitive dysfunction|postoperative cognitive dysfunction
4775160|NCT02771405|HCV-HCC-DAAs|hcv-hcc-daas
4775161|NCT02771366|neuroinflammation|neuroinflammation
4775162|NCT02771366|cognitive function|cognitive function
4775163|NCT02771366|aging adults|aging adults
4775164|NCT02771314|NSCLC|nsclc
4775165|NCT02771314|AZD9291|azd9291
4775166|NCT02771314|>= 2nd line|>= 2nd line
4775167|NCT02771314|liquid biopsy|liquid biopsy
4775168|NCT02771314|EGFR TKIs|egfr tkis
4775169|NCT02771314|EGFR mutant|egfr mutant
4775170|NCT02771301|IDH1R132H Dendritic cell glioma|idh1r132h dendritic cell glioma
4775171|NCT02771288|Kawasaki disease|kawasaki disease
4775172|NCT02771288|optical coherence tomography|optical coherence tomography
4775173|NCT02771288|multislice computed tomography|multislice computed tomography
4775174|NCT02771249|Latent Tuberculosis Infection (LTBI)|latent tuberculosis infection (ltbi)
4775175|NCT02771249|Antiretrovirals (ARVs)|antiretrovirals (arvs)
4775176|NCT02771249|HIV|hiv
4775177|NCT02771249|UGT1A1|ugt1a1
4775178|NCT02771249|Drug-Drug Interaction (DDI)|drug-drug interaction (ddi)
4775179|NCT02771236|Inherited Eye Disease|inherited eye disease
4775180|NCT02771210|Active psoriatic arthritis|active psoriatic arthritis
4775181|NCT02771210|Axial spondyloarthritides|axial spondyloarthritides
4775182|NCT02771210|Subcutaneous|subcutaneous
4775183|NCT02771210|Secukinumab in prefilled syringe|secukinumab in prefilled syringe
4775184|NCT02771210|Enthesitis|enthesitis
4775185|NCT02771210|Achilles tendon|achilles tendon
4775186|NCT02771197|AML|aml
4775187|NCT02771171|Pediatric Airway, Three-dimensional Imaging, CT Scan|pediatric airway, three-dimensional imaging, ct scan
4775188|NCT02771158|critical care|critical care
4775189|NCT02771158|shock, septic|shock, septic
4775190|NCT02771158|sepsis|sepsis
4775191|NCT02771158|hypotension|hypotension
4775192|NCT02771158|midodrine|midodrine
4775193|NCT02771093|Type 2, Diabetes, Diabetes Mellitus|type 2, diabetes, diabetes mellitus
4775194|NCT02771041|Hip prothesis|hip prothesis
4775195|NCT02771002|critically ill patients|critically ill patients
4775196|NCT02771002|septic shock|septic shock
4775197|NCT02771002|peripheral perfusion index|peripheral perfusion index
4775198|NCT02771002|capillary refill time|capillary refill time
4775199|NCT02771002|mottling score|mottling score
4775200|NCT02771002|microcirculation|microcirculation
4775201|NCT02770989|Cardiac Ablation|cardiac ablation
4775202|NCT02770989|Safety|safety
4775203|NCT02770989|Performance|performance
4775204|NCT02770989|Laser|laser
4775205|NCT02770963|discogenic|discogenic
4775206|NCT02770963|Acupuncture Therapy|acupuncture therapy
4775207|NCT02770963|randomized controlled trial|randomized controlled trial
4775208|NCT02770950|Knee Osteoarthritis|knee osteoarthritis
4775209|NCT02770937|laparoscopy, simulator|laparoscopy, simulator
4775210|NCT02770924|cataract|cataract
4775211|NCT02770924|phacoemulsification|phacoemulsification
4775212|NCT02770924|AT LISA TRI TORIC|at lisa tri toric
4775213|NCT02770924|IOL|iol
4775214|NCT02770911|Rectal Carcinoma|rectal carcinoma
4775215|NCT02770911|Laparoscopy|laparoscopy
4775216|NCT02770911|Anastomotic Leak|anastomotic leak
4775217|NCT02770911|Double-stapling technique|double-stapling technique
4775218|NCT02770898|probation|probation
4775219|NCT02770898|evidence-based|evidence-based
4775220|NCT02770898|well-being|well-being
4775221|NCT02770898|physical exercise|physical exercise
4775222|NCT02770898|family well-being|family well-being
4775223|NCT02770872|serum amyloid a|serum amyloid a
4775224|NCT02770872|lipoprotein|lipoprotein
4775225|NCT02770872|insulin resistance|insulin resistance
4775226|NCT02770872|dyslipidemia|dyslipidemia
4775227|NCT02770859|Achalasia|achalasia
4775228|NCT02770833|Proteins (seafood and meat)|proteins (seafood and meat)
4775229|NCT02770833|GI|gi
4775230|NCT02770833|Energy expenditure|energy expenditure
4775231|NCT02770833|Energy balance|energy balance
4775232|NCT02770833|Thermogenesis (DIT)|thermogenesis (dit)
4775233|NCT02770833|Appetite regulating hormones|appetite regulating hormones
4775234|NCT02770833|Appetite sensations|appetite sensations
4775235|NCT02770833|Glucose allostatis|glucose allostatis
4775236|NCT02770833|Amino acid metabolism|amino acid metabolism
4775237|NCT02770833|Satiety|satiety
4775238|NCT02770833|Food preferences|food preferences
4775239|NCT02770807|Ataxia Teleangiectasia|ataxia teleangiectasia
4775240|NCT02770807|AT|at
4775241|NCT02770807|EryDex system|erydex system
4775242|NCT02770807|Dexamethasone|dexamethasone
4775243|NCT02770807|Dexamethasone sodium phosphate|dexamethasone sodium phosphate
4775244|NCT02770781|survivors|survivors
4775245|NCT02770781|physical fitness|physical fitness
4775246|NCT02770768|HSDD (Hypoactive Sexual Desire Disorder)|hsdd (hypoactive sexual desire disorder)
4775247|NCT02770768|EEG (Electroencephalogram)|eeg (electroencephalogram)
4775248|NCT02770742|patient satisfaction|patient satisfaction
4775249|NCT02770742|unsedated colonoscopy|unsedated colonoscopy
4775250|NCT02770742|intestinal diseases|intestinal diseases
4775251|NCT02770729|intracameral moxifloxacin|intracameral moxifloxacin
4775252|NCT02770729|endophthalmitis|endophthalmitis
4775253|NCT02770729|Vigamox|vigamox
4775254|NCT02770729|endothelial cell density|endothelial cell density
4775255|NCT02770677|Yoga|yoga
4775256|NCT02770677|COPD|copd
4775257|NCT02770677|rehabilitation|rehabilitation
4775258|NCT02770651|optical coherence tomography|optical coherence tomography
4775259|NCT02770651|everolimus-eluting stent|everolimus-eluting stent
4775260|NCT02770651|zotarolimus-eluting stent|zotarolimus-eluting stent
4775261|NCT02770638|Healthy|healthy
4775262|NCT02770638|Sport|sport
4775263|NCT02770638|Athlete|athlete
4775264|NCT02770638|Male|male
4775265|NCT02770638|University|university
4775266|NCT02770638|Adults|adults
4775267|NCT02770638|Rugby Football Union|rugby football union
4775268|NCT02770638|Professional|professional
4775269|NCT02770638|Competitive sport|competitive sport
4775270|NCT02770638|Scoop Stretcher|scoop stretcher
4775271|NCT02770638|Ferno Scoop Stretcher|ferno scoop stretcher
4775272|NCT02770638|Long back spinal board|long back spinal board
4775273|NCT02770638|Emergency Medical Services|emergency medical services
4775274|NCT02770638|Long backboard|long backboard
4775275|NCT02770638|Patient Extrication|patient extrication
4775276|NCT02770638|Triple Immobilisation|triple immobilisation
4775277|NCT02770638|Pre hospital Medicine|pre hospital medicine
4775278|NCT02770638|Rigid Cervical Collar|rigid cervical collar
4775279|NCT02770638|Pressure Testing|pressure testing
4775280|NCT02770638|Tissue Pressure Testing|tissue pressure testing
4775281|NCT02770638|Visual Analogue Scale|visual analogue scale
4775282|NCT02770638|Pressure Sores|pressure sores
4775283|NCT02770638|Pressure area damage|pressure area damage
4775284|NCT02770638|Tissue Viability|tissue viability
4775285|NCT02770638|Tissue Interface Pressure|tissue interface pressure
4775286|NCT02770638|Comfort|comfort
4775287|NCT02770638|Pain|pain
4775288|NCT02770625|Type I Gaucher|type i gaucher
4775289|NCT02770625|ISU302|isu302
4775290|NCT02770625|Imiglucerase|imiglucerase
4775291|NCT02770599|IBD|ibd
4775292|NCT02770599|HRQoL|hrqol
4775293|NCT02770599|QoC|qoc
4775294|NCT02770599|Adherence|adherence
4775295|NCT02770599|IBD nurse|ibd nurse
4775296|NCT02770599|MDT|mdt
4775297|NCT02770573|nano-hydroxyapatite|nano-hydroxyapatite
4775298|NCT02770508|antiretroviral naive|antiretroviral naive
4775299|NCT02770508|dual therapy|dual therapy
4775300|NCT02770482|dementia|dementia
4775301|NCT02770482|biomarkers|biomarkers
4775302|NCT02770482|cerebrospinal fluid|cerebrospinal fluid
4775303|NCT02770469|Breast Cancer|breast cancer
4775304|NCT02770469|Korean Americans|korean americans
4775305|NCT02770469|Survivorship|survivorship
4775306|NCT02770469|Quality of Life|quality of life
4775307|NCT02770469|Coping Skills|coping skills
4775308|NCT02770469|Perceived Stress|perceived stress
4775309|NCT02770456|fish oil, preterm birth, pregnancy, China, prevention|fish oil, preterm birth, pregnancy, china, prevention
4775310|NCT02770443|Recovered LVEF|recovered lvef
4775311|NCT02770443|DCM|dcm
4775312|NCT02770391|HSD3B1 Genotype|hsd3b1 genotype
4775313|NCT02770391|Steroid Metabolism|steroid metabolism
4775314|NCT02770391|High-risk Prostate Cancer|high-risk prostate cancer
4775315|NCT02770391|ARN-509|arn-509
4775316|NCT02770378|Temozolomide|temozolomide
4775317|NCT02770378|Recurrent Glioblastoma|recurrent glioblastoma
4775318|NCT02770352|retrospective chart review|retrospective chart review
4775319|NCT02770352|prospective chart review|prospective chart review
4775320|NCT02770352|fistula formation and repair|fistula formation and repair
4775321|NCT02770352|database|database
4775322|NCT02770352|demographics of women with fistulas|demographics of women with fistulas
4775323|NCT02770352|internationally accepted risks factors for fistula formation|internationally accepted risks factors for fistula formation
4775324|NCT02770339|Pharmacogenomics|pharmacogenomics
4775325|NCT02770339|Psychiatric crisis|psychiatric crisis
4775326|NCT02770339|Drug overdose|drug overdose
4775327|NCT02770339|Psychotropic medications|psychotropic medications
4775328|NCT02770326|Safety of Stool Transplant|safety of stool transplant
4775329|NCT02770326|Fecal Microbiota Transplantation (FMT)|fecal microbiota transplantation (fmt)
4775330|NCT02770326|15-337|15-337
4775331|NCT02770300|automatic|automatic
4775332|NCT02770300|personalized|personalized
4775333|NCT02770300|robotic therapy|robotic therapy
4775334|NCT02770261|DP-R208|dp-r208
4775335|NCT02770222|Pharmacokinetics|pharmacokinetics
4775336|NCT02770196|Community-Supported Agriculture|community-supported agriculture
4775337|NCT02770196|Local Food System|local food system
4775338|NCT02770196|Vegetable|vegetable
4775339|NCT02770196|Fruit|fruit
4775340|NCT02770196|Childhood Obesity|childhood obesity
4775341|NCT02770183|Myocardial stunning|myocardial stunning
4775342|NCT02770183|Echocardiography, Transesophageal|echocardiography, transesophageal
4775343|NCT02770183|Extracorporeal Circulation|extracorporeal circulation
4775344|NCT02770144|Child Quality of Life|child quality of life
4775345|NCT02770144|Financial Coaching|financial coaching
4775346|NCT02770144|Socioeconomic Status|socioeconomic status
4775347|NCT02770144|Social Determinants of Health|social determinants of health
4775348|NCT02770131|hypercholesterolaemia|hypercholesterolaemia
4775349|NCT02770131|lipid-lowering therapies|lipid-lowering therapies
4775350|NCT02770118|sleep restriction|sleep restriction
4775351|NCT02770118|obesity|obesity
4775352|NCT02770118|brown adipose tissue|brown adipose tissue
4775353|NCT02770105|L-theanine|l-theanine
4775354|NCT02770105|caffeine|caffeine
4775355|NCT02770105|selective attention|selective attention
4775356|NCT02770105|fMRI|fmri
4775357|NCT02770105|RVRT|rvrt
4775358|NCT02770079|Insulin sensitivity|insulin sensitivity
4775359|NCT02770053|Foraminal enlargement|foraminal enlargement
4775360|NCT02770053|Root canal treatment|root canal treatment
4775361|NCT02770040|Acute Severe Ulcerative Colitis|acute severe ulcerative colitis
4775362|NCT02770040|Steroid Refractory Ulcerative Colitis|steroid refractory ulcerative colitis
4775363|NCT02770027|Colon Surgery|colon surgery
4775364|NCT02770027|blood viscosity|blood viscosity
4775365|NCT02770014|Non-Small Cell Lung Cancer|non-small cell lung cancer
4775366|NCT02770014|Epidermal Growth Factor Receptor|epidermal growth factor receptor
4775367|NCT02770001|Admixture|admixture
4775368|NCT02770001|African American|african american
4775369|NCT02770001|African American Genetics|african american genetics
4775370|NCT02769988|Adolescents|adolescents
4775371|NCT02769988|Health Information Literacy|health information literacy
4775372|NCT02769988|Health Education|health education
4775373|NCT02769975|Endocrinology|endocrinology
4775374|NCT02769975|Obesity|obesity
4775375|NCT02769975|Pediatric|pediatric
4775376|NCT02769975|Growth Disorder|growth disorder
4775377|NCT02769975|Pubertal Development|pubertal development
4775378|NCT02769962|PARP Inhibitor|parp inhibitor
4775379|NCT02769962|Topoisomerase I (Top1)|topoisomerase i (top1)
4775380|NCT02769962|Camptothecins|camptothecins
4775381|NCT02769962|Nanoparticle Drug Conjugate|nanoparticle drug conjugate
4775382|NCT02769949|Genetics|genetics
4775383|NCT02769949|Metabolic|metabolic
4775384|NCT02769949|Dysmorphic Syndromes|dysmorphic syndromes
4775385|NCT02769949|Developmental Delay|developmental delay
4775386|NCT02769949|Genetic Counseling|genetic counseling
4775387|NCT02769936|Receptors|receptors
4775388|NCT02769936|N-Methyl-D-Aspartate|n-methyl-d-aspartate
4775389|NCT02769923|WestPharma ID-adapter|westpharma id-adapter
4775390|NCT02769923|Star ID syringe|star id syringe
4775391|NCT02769923|BCG needle syringe|bcg needle syringe
4775392|NCT02769923|fractional dose IPV|fractional dose ipv
4775393|NCT02769923|fIPV|fipv
4775394|NCT02769923|polio|polio
4775395|NCT02769923|Polio Endgame|polio endgame
4775396|NCT02769923|IPV|ipv
4775397|NCT02769884|artificial pancreas|artificial pancreas
4775398|NCT02769832|Abraxane|abraxane
4775399|NCT02769832|Albumin-bound Paclitaxel|albumin-bound paclitaxel
4775400|NCT02769832|SCLC|sclc
4775401|NCT02769832|Gemzar|gemzar
4775402|NCT02769819|Flexible fiberscope|flexible fiberscope
4775403|NCT02769754|LIVER|liver
4775404|NCT02769754|RESECTION|resection
4775405|NCT02769754|SURGERY|surgery
4775406|NCT02769741|Cashew|cashew
4775407|NCT02769741|Lipoprotein|lipoprotein
4775408|NCT02769715|Removable partial dentures|removable partial dentures
4775409|NCT02769715|partial edentulism|partial edentulism
4775410|NCT02769702|Uveitis|uveitis
4775411|NCT02769689|Multiple sclerosis|multiple sclerosis
4775412|NCT02769689|Natalizumab|natalizumab
4775413|NCT02769689|Fingolimod|fingolimod
4775414|NCT02769689|Methylprednisolone|methylprednisolone
4775415|NCT02769650|Coronary stenosis|coronary stenosis
4775416|NCT02769650|Drug-eluting stent|drug-eluting stent
4775417|NCT02769650|Coronary angioplasty with stenting|coronary angioplasty with stenting
4775418|NCT02769650|Ischemic Heart Disease|ischemic heart disease
4775419|NCT02769650|Chronic total occlusion|chronic total occlusion
4775420|NCT02769650|Right coronary artery|right coronary artery
4775421|NCT02769650|Stress-MRI|stress-mri
4775422|NCT02769637|upper gastrointestinal tract|upper gastrointestinal tract
4775423|NCT02769637|lung microbiota and inflammation|lung microbiota and inflammation
4775424|NCT02769624|Congenital heart disease|congenital heart disease
4775425|NCT02769598|Pain|pain
4775426|NCT02769598|Nociception|nociception
4775427|NCT02769598|Pediatric intensive care|pediatric intensive care
4775428|NCT02769598|Pain assessment scale|pain assessment scale
4775429|NCT02769598|ANI index|ani index
4775430|NCT02769585|Obesity|obesity
4775431|NCT02769585|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
4775432|NCT02769585|weight reduction|weight reduction
4775433|NCT02769572|Knee osteoarthritis|knee osteoarthritis
4775434|NCT02769572|moxibustion|moxibustion
4775435|NCT02769572|diclofenac sodium gel|diclofenac sodium gel
4775436|NCT02769520|squamous cell carcinoma head and neck|squamous cell carcinoma head and neck
4775437|NCT02769520|pembrolizumab|pembrolizumab
4775438|NCT02769494|Oral ulcer|oral ulcer
4775439|NCT02769494|Crohn's disease|crohn's disease
4775440|NCT02769468|Temperature-Probe Placement-preterm infant-case room|temperature-probe placement-preterm infant-case room
4775441|NCT02769455|Food Labelling|food labelling
4775442|NCT02769442|Intravenous|intravenous
4775443|NCT02769442|Catheter|catheter
4775444|NCT02769442|Puncture|puncture
4775445|NCT02769442|Peripheral Catheterization|peripheral catheterization
4775446|NCT02769442|First Stick Success|first stick success
4775447|NCT02769442|Contamination|contamination
4775448|NCT02769442|Terumo|terumo
4775449|NCT02769442|SurFlash|surflash
4775450|NCT02769416|spinal cord injury|spinal cord injury
4775451|NCT02769416|traumatic brain injury|traumatic brain injury
4775452|NCT02769403|Job Satisfaction|job satisfaction
4775453|NCT02769403|Job Performance|job performance
4775454|NCT02769403|Primary Care|primary care
4775455|NCT02769390|Analgesia|analgesia
4775456|NCT02769390|Bupivacaine|bupivacaine
4775457|NCT02769390|Clonidine|clonidine
4775559|NCT02768766|Selumetinib|selumetinib
4775458|NCT02769377|diabetes, glucometer, mobile-phone|diabetes, glucometer, mobile-phone
4775459|NCT02769364|Advanced or Metastatic Breast Cancer|advanced or metastatic breast cancer
4775460|NCT02769364|Eribulin|eribulin
4775461|NCT02769351|volume overload|volume overload
4775462|NCT02769351|heart failure|heart failure
4775463|NCT02769351|cardiac decompensation|cardiac decompensation
4775464|NCT02769351|ultrafiltration|ultrafiltration
4775465|NCT02769338|Implementation|implementation
4775466|NCT02769338|Quality Improvement|quality improvement
4775467|NCT02769338|Stroke|stroke
4775468|NCT02769338|Transient Ischemic Attack|transient ischemic attack
4775469|NCT02769338|TIA|tia
4775470|NCT02769338|System Redesign|system redesign
4775471|NCT02769338|QI Intervention|qi intervention
4775472|NCT02769325|atropine|atropine
4775473|NCT02769325|pain, postoperative|pain, postoperative
4775474|NCT02769312|Quality of Life|quality of life
4775475|NCT02769312|Post-Traumatic Stress Disorder|post-traumatic stress disorder
4775476|NCT02769312|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
4775477|NCT02769312|Feasibility studies|feasibility studies
4775478|NCT02769260|pyrosequencing|pyrosequencing
4775479|NCT02769260|16S DNA gene|16s dna gene
4775480|NCT02769260|Confocal Laser Scanning Microscope|confocal laser scanning microscope
4775481|NCT02769260|bacterial viability|bacterial viability
4775482|NCT02769260|bacterial diversity|bacterial diversity
4775483|NCT02769247|naproxen|naproxen
4775484|NCT02769247|lidocaine|lidocaine
4775485|NCT02769247|intrauterine device|intrauterine device
4775486|NCT02769247|IUD|iud
4775487|NCT02769247|pain|pain
4775488|NCT02769234|EEG|eeg
4775489|NCT02769234|ERP|erp
4775490|NCT02769234|Event-related Potentials|event-related potentials
4775491|NCT02769234|Alzheimer's|alzheimer's
4775492|NCT02769234|P300|p300
4775493|NCT02769208|Air Pollution|air pollution
4775494|NCT02769208|Air Filtration|air filtration
4775495|NCT02769208|Exposure Assessment|exposure assessment
4775496|NCT02769208|HEPA Filter|hepa filter
4775497|NCT02769208|Electrostatic Precipitator|electrostatic precipitator
4775498|NCT02769208|Cardiovascular Disease Biomarkers|cardiovascular disease biomarkers
4775499|NCT02769208|Respiratory Disease Biomarkers|respiratory disease biomarkers
4775500|NCT02769182|Older adults|older adults
4775501|NCT02769182|falls|falls
4775502|NCT02769182|cognition|cognition
4775503|NCT02769182|smart phone|smart phone
4775504|NCT02769169|Ranibizumab, regression of the polyps|ranibizumab, regression of the polyps
4775505|NCT02769143|Postmenopausal|postmenopausal
4775506|NCT02769143|Bone Density|bone density
4775507|NCT02769143|Exercise|exercise
4775508|NCT02769104|aromatase inhibitors|aromatase inhibitors
4775509|NCT02769104|chemotherapy|chemotherapy
4775510|NCT02769104|neoadjuvant|neoadjuvant
4775511|NCT02769104|postmenopausal|postmenopausal
4775512|NCT02769104|breast cancer|breast cancer
4775513|NCT02769078|Anticoagulation|anticoagulation
4775514|NCT02769065|Drug Therapy|drug therapy
4775515|NCT02769052|endometriosis|endometriosis
4775516|NCT02769052|dyspareunia|dyspareunia
4775517|NCT02769052|physical therapy|physical therapy
4775518|NCT02769052|sexuality|sexuality
4775519|NCT02769052|transcutaneous electrical nerve stimulation|transcutaneous electrical nerve stimulation
4775520|NCT02769013|Schistosoma haematobium plasmodium falciparum transmission|schistosoma haematobium plasmodium falciparum transmission
4775521|NCT02768987|exercise|exercise
4775522|NCT02768987|physical activity|physical activity
4775523|NCT02768987|behavior modification|behavior modification
4775524|NCT02768987|coping skills|coping skills
4775525|NCT02768987|self management|self management
4775526|NCT02768987|glycemic control|glycemic control
4775527|NCT02768987|overweight|overweight
4775528|NCT02768987|obesity|obesity
4775529|NCT02768987|body composition|body composition
4775530|NCT02768987|adherence|adherence
4775531|NCT02768961|sofosbuvir|sofosbuvir
4775532|NCT02768961|ledipasvir|ledipasvir
4775533|NCT02768961|ribavirin|ribavirin
4775534|NCT02768961|prisoner|prisoner
4775535|NCT02768961|hepatitis c|hepatitis c
4775536|NCT02768961|prevalence|prevalence
4775537|NCT02768961|hepatitis b|hepatitis b
4775538|NCT02768922|Telemedicine|telemedicine
4775539|NCT02768922|Telerehabilitation|telerehabilitation
4775540|NCT02768922|Speech and language therapy|speech and language therapy
4775541|NCT02768883|Childhood asthma|childhood asthma
4775542|NCT02768883|Latino|latino
4775543|NCT02768844|Stochastic Resonance|stochastic resonance
4775544|NCT02768844|Fetus/Newborn Infant|fetus/newborn infant
4775545|NCT02768844|Drug Withdrawal|drug withdrawal
4775546|NCT02768844|Substance Abuse|substance abuse
4775547|NCT02768818|Maternal Obesity Complicating Pregnancy|maternal obesity complicating pregnancy
4775548|NCT02768805|Influenza|influenza
4775549|NCT02768805|Human|human
4775550|NCT02768805|RNA Virus Infections|rna virus infections
4775551|NCT02768805|Immunologic|immunologic
4775552|NCT02768805|Immunogenic Factors|immunogenic factors
4775553|NCT02768805|Physiological Effects of Drug|physiological effects of drug
4775554|NCT02768805|Virus Diseases|virus diseases
4775555|NCT02768805|Orthomyxoviridae Infections|orthomyxoviridae infections
4775556|NCT02768805|Infection|infection
4775557|NCT02768779|hair|hair
4775558|NCT02768766|MEK inhibitor|mek inhibitor
4775560|NCT02768766|hyd-sulfate AZD6244|hyd-sulfate azd6244
4775561|NCT02768766|Uveal melanoma|uveal melanoma
4775562|NCT02768766|Melanoma|melanoma
4775563|NCT02768753|Robotic thyroidectomy|robotic thyroidectomy
4775564|NCT02768753|Robotic central neck dissection|robotic central neck dissection
4775565|NCT02768753|Axillary bilateral-breast approach|axillary bilateral-breast approach
4775566|NCT02768753|Bilateral axillo-breast approach|bilateral axillo-breast approach
4775567|NCT02768727|neurocognitive function|neurocognitive function
4775568|NCT02768727|neural inertia|neural inertia
4775569|NCT02768727|xenon gas|xenon gas
4775570|NCT02768714|Breast Cancer High risk Stage II or Stage III / IV|breast cancer high risk stage ii or stage iii / iv
4775571|NCT02768701|Pembrolizumab|pembrolizumab
4775572|NCT02768701|cyclophosphamide|cyclophosphamide
4775573|NCT02768688|Human Brain|human brain
4775574|NCT02768688|Magnetic Resonance Imaging (MRI)|magnetic resonance imaging (mri)
4775575|NCT02768688|Dexmedetomidine|dexmedetomidine
4775576|NCT02768688|Cerebral blood flow|cerebral blood flow
4775577|NCT02768675|Kyphotic|kyphotic
4775578|NCT02768675|Corrective Surgery|corrective surgery
4775579|NCT02768675|Spinal fractures|spinal fractures
4775580|NCT02768636|Omega-3, ANS, HRV, SDNN|omega-3, ans, hrv, sdnn
4775581|NCT02768610|dexmedetomidine|dexmedetomidine
4775582|NCT02768584|severe mental illness|severe mental illness
4775583|NCT02768584|nursing|nursing
4775584|NCT02768584|therapeutic alliance|therapeutic alliance
4775585|NCT02768584|psychiatric diseases|psychiatric diseases
4775586|NCT02768571|cerebrolysin, stroke, motor function|cerebrolysin, stroke, motor function
4775587|NCT02768558|Lung Cancer|lung cancer
4775588|NCT02768558|NSCLC|nsclc
4775589|NCT02768558|Nivolumab|nivolumab
4775590|NCT02768545|Hepatitis C|hepatitis c
4775591|NCT02768545|Ezetimibe|ezetimibe
4775592|NCT02768545|Cholesterol|cholesterol
4775593|NCT02768545|Enterohepatic Circulation|enterohepatic circulation
4775594|NCT02768545|Bile|bile
4775595|NCT02768545|Feces|feces
4775596|NCT02768532|Crohn's disease|crohn's disease
4775597|NCT02768532|Vedolizumab|vedolizumab
4775598|NCT02768532|TNF (Tumor Necrosis Factor)|tnf (tumor necrosis factor)
4775599|NCT02768532|Clinical response|clinical response
4775600|NCT02768532|Clinical remission|clinical remission
4775601|NCT02768519|Participants|participants
4775602|NCT02768506|obesity, malabsorption, gastric bypass, SADI-S|obesity, malabsorption, gastric bypass, sadi-s
4775603|NCT02768480|Diabetes|diabetes
4775604|NCT02768480|phone calls|phone calls
4775605|NCT02768480|glycemic control|glycemic control
4775606|NCT02768467|Alloderm graft|alloderm graft
4775607|NCT02768467|Allograft|allograft
4775608|NCT02768467|Buccal Mucosa|buccal mucosa
4775609|NCT02768454|broad-spectrum antimicrobial|broad-spectrum antimicrobial
4775610|NCT02768454|antibiotics pharmacist|antibiotics pharmacist
4775611|NCT02768428|Knowledge [K01.468]|knowledge [k01.468]
4775612|NCT02768428|Video-Audio Media [V01.255.500]|video-audio media [v01.255.500]
4775613|NCT02768428|Handbooks [V02.520]|handbooks [v02.520]
4775614|NCT02768402|Mitral Valve Regurgitation|mitral valve regurgitation
4775615|NCT02768402|Primary MR|primary mr
4775616|NCT02768402|Secondary MR|secondary mr
4775617|NCT02768402|MR|mr
4775618|NCT02768402|Heart Failure|heart failure
4775619|NCT02768402|Structural Heart|structural heart
4775620|NCT02768402|Secondary Mitral Valve Regurgitation|secondary mitral valve regurgitation
4775621|NCT02768402|Primary Mitral Valve Regurgitation|primary mitral valve regurgitation
4775622|NCT02768402|Transseptal|transseptal
4775623|NCT02768402|Transcatheter|transcatheter
4775624|NCT02768389|Modified Atkins Diet|modified atkins diet
4775625|NCT02768389|MAD|mad
4775626|NCT02768389|Brain Tumor|brain tumor
4775627|NCT02768389|Glioblastoma|glioblastoma
4775628|NCT02768363|Immunotherapy|immunotherapy
4775629|NCT02768363|Tumor vaccine|tumor vaccine
4775630|NCT02768363|Immuno-oncology|immuno-oncology
4775631|NCT02768363|Cytotoxicity|cytotoxicity
4775632|NCT02768363|Prostate cancer|prostate cancer
4775633|NCT02768363|Active Surveillance|active surveillance
4775634|NCT02768350|lung collapse|lung collapse
4775635|NCT02768350|ventilator hyper inflation|ventilator hyper inflation
4775636|NCT02768350|hemodynamic responses|hemodynamic responses
4775637|NCT02768350|ventilatory responses|ventilatory responses
4775638|NCT02768350|trauma patients|trauma patients
4775639|NCT02768337|brain metastasis|brain metastasis
4775640|NCT02768337|operable brain metastasis|operable brain metastasis
4775641|NCT02768324|sepsis|sepsis
4775642|NCT02768324|Gastrointestinal Microbiome|gastrointestinal microbiome
4775643|NCT02768324|Gut microbiota|gut microbiota
4775644|NCT02768324|Gut Flora|gut flora
4775645|NCT02768324|Intestinal Flora|intestinal flora
4775646|NCT02768311|Instrumentation Post-operative pain Root canal preparation|instrumentation post-operative pain root canal preparation
4775647|NCT02768298|Heart failure|heart failure
4775648|NCT02768298|systolic heart failure|systolic heart failure
4775649|NCT02768298|heart failure with reduced ejection fraction|heart failure with reduced ejection fraction
4775650|NCT02768298|exercise capacity|exercise capacity
4775651|NCT02768285|apical patency|apical patency
4775652|NCT02768285|root canal treatment|root canal treatment
4775653|NCT02768233|Medication-overuse Headache|medication-overuse headache
4775654|NCT02768233|Educational Programme|educational programme
4775941|NCT02766088|Dengue|dengue
4775655|NCT02768233|Personality Profiles|personality profiles
4775656|NCT02768181|nutrition-specific behaviour change communication|nutrition-specific behaviour change communication
4775657|NCT02768181|dietary supplements|dietary supplements
4775658|NCT02768168|Dezocine|dezocine
4775659|NCT02768168|Dexamethasone 21-phosphate|dexamethasone 21-phosphate
4775660|NCT02768168|Pain|pain
4775661|NCT02768168|Pruritus|pruritus
4775662|NCT02768155|OA, Osteoarthritis, Knee|oa, osteoarthritis, knee
4775663|NCT02768116|Active Transfer of Plaque|active transfer of plaque
4775664|NCT02768103|upper extremity|upper extremity
4775665|NCT02768103|spinal cord injury|spinal cord injury
4775666|NCT02768103|surgical reconstruction|surgical reconstruction
4775667|NCT02768103|MRI, functional|mri, functional
4775668|NCT02768103|rehabilitation|rehabilitation
4775669|NCT02768077|melatonin|melatonin
4775670|NCT02768077|sleep disturbances|sleep disturbances
4775671|NCT02768025|smoking cessation|smoking cessation
4775672|NCT02768025|tobacco control|tobacco control
4775673|NCT02768025|acupuncture|acupuncture
4775674|NCT02768025|Korean Medicine|korean medicine
4775675|NCT02768025|Traditional & Complementary Medicine|traditional & complementary medicine
4775676|NCT02767999|Acute ischemic stroke|acute ischemic stroke
4775677|NCT02767986|Hispanic|hispanic
4775678|NCT02767986|Health Belief Model|health belief model
4775679|NCT02767986|Cultural Consensus Theory|cultural consensus theory
4775680|NCT02767986|Cancer Genetics|cancer genetics
4775681|NCT02767986|Qualitative|qualitative
4775682|NCT02767960|Tenascin-C|tenascin-c
4775683|NCT02767908|Tobacco|tobacco
4775684|NCT02767908|Smoking Cessation|smoking cessation
4775685|NCT02767869|Metabolic syndrome|metabolic syndrome
4775686|NCT02767869|central obesity|central obesity
4775687|NCT02767869|Banaba|banaba
4775688|NCT02767869|insulin secretion|insulin secretion
4775689|NCT02767869|insulin sensitivity|insulin sensitivity
4775690|NCT02767804|ALK-positive NSCLC|alk-positive nsclc
4775691|NCT02767778|Acute ischemic stroke|acute ischemic stroke
4775692|NCT02767778|Neuroprotection|neuroprotection
4775693|NCT02767778|Extremely low frequency magnetic fields|extremely low frequency magnetic fields
4775694|NCT02767752|Resectable pancreatic cancer|resectable pancreatic cancer
4775695|NCT02767752|Adjuvant|adjuvant
4775696|NCT02767713|Cognition Disorders|cognition disorders
4775697|NCT02767713|Cardiac Surgical Procedures|cardiac surgical procedures
4775698|NCT02767713|dexamethasone|dexamethasone
4775699|NCT02767687|Postoperative Care|postoperative care
4775700|NCT02767687|Postoperative Period|postoperative period
4775701|NCT02767687|Heart Surgery|heart surgery
4775702|NCT02767674|R-Gemox|r-gemox
4775703|NCT02767674|R-miniCHOP|r-minichop
4775704|NCT02767674|elderly patients with diffuse large B cell lymphoma|elderly patients with diffuse large b cell lymphoma
4775705|NCT02767661|metronomic capecitabine|metronomic capecitabine
4775706|NCT02767661|aromatase inhibitor|aromatase inhibitor
4775707|NCT02767661|first line treatment|first line treatment
4775708|NCT02767661|metastatic breast cancer|metastatic breast cancer
4775709|NCT02767648|cholestasis|cholestasis
4775710|NCT02767648|neonatal|neonatal
4775711|NCT02767648|infant|infant
4775712|NCT02767596|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
4775713|NCT02767596|treatment|treatment
4775714|NCT02767596|GLP-1|glp-1
4775715|NCT02767583|Neuropathology|neuropathology
4775716|NCT02767570|Osteoarthritis, Knee|osteoarthritis, knee
4775717|NCT02767570|Arthritis|arthritis
4775718|NCT02767570|Joint Diseases|joint diseases
4775719|NCT02767570|Musculoskeletal Diseases|musculoskeletal diseases
4775720|NCT02767570|Rheumatic Diseases|rheumatic diseases
4775721|NCT02767544|laparoscopic hysterectomy|laparoscopic hysterectomy
4775722|NCT02767544|postoperative pain|postoperative pain
4775723|NCT02767544|local analgesia|local analgesia
4775724|NCT02767544|vaginal wound|vaginal wound
4775725|NCT02767479|eradication rates|eradication rates
4775726|NCT02767479|rabeprazole|rabeprazole
4775727|NCT02767479|esomeprazole|esomeprazole
4775728|NCT02767453|Shoulder arthroplasty|shoulder arthroplasty
4775729|NCT02767453|Closed suction drainage|closed suction drainage
4775730|NCT02767453|Glenohumeral|glenohumeral
4775731|NCT02767453|Drainage tube|drainage tube
4775732|NCT02767427|Infection Control|infection control
4775733|NCT02767427|Preoperative Care|preoperative care
4775734|NCT02767427|Chlorhexidine|chlorhexidine
4775735|NCT02767427|Pre-Surgical Wash|pre-surgical wash
4775736|NCT02767427|Spine Surgery|spine surgery
4775737|NCT02767427|Surgical site infections|surgical site infections
4775738|NCT02767427|Cutaneous bacterial load on skin|cutaneous bacterial load on skin
4775739|NCT02767401|PET-CT|pet-ct
4775740|NCT02767401|Cardiac magnetic resonance (CMR) imaging|cardiac magnetic resonance (cmr) imaging
4775741|NCT02767401|Major adverse cardiac events (MACEs)|major adverse cardiac events (maces)
4775742|NCT02767401|coronary artery disease|coronary artery disease
4775743|NCT02767375|Hepatocellular Carcinoma|hepatocellular carcinoma
4775744|NCT02767375|Hepatic arterial infusion chemotherapy|hepatic arterial infusion chemotherapy
4775745|NCT02767362|atorvastatin|atorvastatin
4775746|NCT02767362|endometrium|endometrium
4775747|NCT02767362|endometrial cancer|endometrial cancer
4775748|NCT02767310|Bioequivalence|bioequivalence
4775749|NCT02767310|two rosuvastatin-containing products|two rosuvastatin-containing products
4775942|NCT02766088|Household|household
4775750|NCT02767284|Contrast Sensitivity|contrast sensitivity
4775751|NCT02767284|Diagnostic Techniques, Ophthalmological|diagnostic techniques, ophthalmological
4775752|NCT02767258|Dry eye|dry eye
4775753|NCT02767258|Diseases of the eye and adnexa|diseases of the eye and adnexa
4775754|NCT02767245|Thiamine|thiamine
4775755|NCT02767245|Congestive heart failure|congestive heart failure
4775756|NCT02767245|Atrial fibrillation|atrial fibrillation
4775757|NCT02767245|Graves' disease|graves' disease
4775758|NCT02767232|PHLO|phlo
4775759|NCT02767232|deep vein thrombosis|deep vein thrombosis
4775760|NCT02767232|deep venous thrombosis|deep venous thrombosis
4775761|NCT02767232|blood clot|blood clot
4775762|NCT02767232|catheter-directed thrombolysis|catheter-directed thrombolysis
4775763|NCT02767232|thrombolysis|thrombolysis
4775764|NCT02767232|post-thrombotic syndrome|post-thrombotic syndrome
4775765|NCT02767232|PTS|pts
4775766|NCT02767232|recombinant tissue plasminogen activator|recombinant tissue plasminogen activator
4775767|NCT02767232|rt-PA|rt-pa
4775768|NCT02767232|Activase|activase
4775769|NCT02767232|Alteplase|alteplase
4775770|NCT02767219|Ophthalmology|ophthalmology
4775771|NCT02767206|Transnasal endoscopy|transnasal endoscopy
4775772|NCT02767206|ultrathin endoscopes|ultrathin endoscopes
4775773|NCT02767206|esophageal varices|esophageal varices
4775774|NCT02767206|gastric varices|gastric varices
4775775|NCT02767167|Cow's milk|cow's milk
4775776|NCT02767167|Iodine|iodine
4775777|NCT02767167|Selenium|selenium
4775778|NCT02767167|Women|women
4775779|NCT02767167|Child-bearing age|child-bearing age
4775780|NCT02767154|extracorporeal circulation|extracorporeal circulation
4775781|NCT02767141|Hunger|hunger
4775782|NCT02767141|food insecurity|food insecurity
4775783|NCT02767141|behaviors|behaviors
4775784|NCT02767128|pharmacokinetics|pharmacokinetics
4775785|NCT02767128|healthy adult volunteer|healthy adult volunteer
4775786|NCT02767102|Mediterranean diet|mediterranean diet
4775787|NCT02767102|indoleamine|indoleamine
4775788|NCT02767102|nutraceuticals|nutraceuticals
4775789|NCT02767102|nutrition|nutrition
4775790|NCT02767102|oxidative stress|oxidative stress
4775791|NCT02767089|Glucocorticoids, Biomarkers, Dissociated Agonist of the Glucocorticoid Receptor|glucocorticoids, biomarkers, dissociated agonist of the glucocorticoid receptor
4775792|NCT02767076|paramedian spinal anesthesia|paramedian spinal anesthesia
4775793|NCT02767076|real time|real time
4775794|NCT02767076|ultrasound|ultrasound
4775795|NCT02767076|knee surgeries|knee surgeries
4775796|NCT02767076|conventional|conventional
4775797|NCT02767050|DENTAL CARIES|dental caries
4775798|NCT02767050|TOBACCO USERS|tobacco users
4775799|NCT02767050|SMOKERS|smokers
4775800|NCT02767050|SMOKELESS TOBACCO CHEWERS|smokeless tobacco chewers
4775801|NCT02767011|surgical site infection|surgical site infection
4775802|NCT02766985|FSHD|fshd
4775803|NCT02766985|muscular dystrophy|muscular dystrophy
4775804|NCT02766972|Intracranial Aneurysm|intracranial aneurysm
4775805|NCT02766972|Surgical Clipping|surgical clipping
4775806|NCT02766972|Rapid Ventricular Pacing|rapid ventricular pacing
4775807|NCT02766959|chronic rhinosinusitis|chronic rhinosinusitis
4775808|NCT02766959|airway physiology|airway physiology
4775809|NCT02766959|taste receptors|taste receptors
4775810|NCT02766959|tas2r|tas2r
4775811|NCT02766959|epithelial biology|epithelial biology
4775812|NCT02766959|upper respiratory disease|upper respiratory disease
4775813|NCT02766946|Mechanical Ventilation|mechanical ventilation
4775814|NCT02766933|tenofovir|tenofovir
4775815|NCT02766933|hepatocellular carcinoma|hepatocellular carcinoma
4775816|NCT02766933|cirrhosis|cirrhosis
4775817|NCT02766881|Ductal Carcinoma in Situ|ductal carcinoma in situ
4775818|NCT02766881|DSC|dsc
4775819|NCT02766881|Breast Conserving Surgery|breast conserving surgery
4775820|NCT02766855|cysteamine|cysteamine
4775821|NCT02766855|nephropathic cystinosis|nephropathic cystinosis
4775822|NCT02766855|cystine crystals|cystine crystals
4775823|NCT02766842|SharkCore|sharkcore
4775824|NCT02766842|ProCore|procore
4775825|NCT02766829|spinal|spinal
4775826|NCT02766829|anesthesia|anesthesia
4775827|NCT02766829|sitting|sitting
4775828|NCT02766829|cross leg|cross leg
4775829|NCT02766829|spinal-bone contact|spinal-bone contact
4775830|NCT02766738|residential aged care|residential aged care
4775831|NCT02766738|mobility|mobility
4775832|NCT02766738|social participation|social participation
4775833|NCT02766738|functional capability|functional capability
4775834|NCT02766712|catheter ablation|catheter ablation
4775835|NCT02766712|atrial fibrillation|atrial fibrillation
4775836|NCT02766699|Astrocytoma, Grade IV|astrocytoma, grade iv
4775837|NCT02766699|Doxorubicin|doxorubicin
4775838|NCT02766699|Glioblastoma|glioblastoma
4775839|NCT02766699|Neoplasms|neoplasms
4775840|NCT02766699|Neoplasms by Site|neoplasms by site
4775841|NCT02766699|Antineoplastic Agents|antineoplastic agents
4775842|NCT02766699|Drug Delivery Systems|drug delivery systems
4775843|NCT02766699|Molecular Targeted Therapy|molecular targeted therapy
4775844|NCT02766699|Nanoparticles|nanoparticles
4775845|NCT02766699|Disease Progression|disease progression
4775846|NCT02766699|Recurrence|recurrence
4775847|NCT02766699|Brain Neoplasms|brain neoplasms
4775848|NCT02766699|Immunotherapy|immunotherapy
4777050|NCT02759757|EMG|emg
4775849|NCT02766699|Receptor, Epidermal Growth Factor|receptor, epidermal growth factor
4775850|NCT02766699|Antibodies, Bispecific|antibodies, bispecific
4775851|NCT02766686|Prostate cancer|prostate cancer
4775852|NCT02766686|proton radiotherapy|proton radiotherapy
4775853|NCT02766686|photon radiotherapy|photon radiotherapy
4775854|NCT02766660|Thyroid ophthalmopathy|thyroid ophthalmopathy
4775855|NCT02766660|optical coherence tomography|optical coherence tomography
4775856|NCT02766647|Filgrastim|filgrastim
4775857|NCT02766634|filgrastim|filgrastim
4775858|NCT02766621|First in human, Phase 1, Healthy volunteers|first in human, phase 1, healthy volunteers
4775859|NCT02766608|COPD|copd
4775860|NCT02766582|Ovarian|ovarian
4775861|NCT02766582|platinum|platinum
4775862|NCT02766582|pembrolizumab|pembrolizumab
4775863|NCT02766582|taxane|taxane
4775864|NCT02766569|IRFACODE II, ASD closure, ASD device, erosion, arrhythmia|irfacode ii, asd closure, asd device, erosion, arrhythmia
4775865|NCT02766543|prostate cancer|prostate cancer
4775866|NCT02766543|high intensity transurethral ultrasound ablation|high intensity transurethral ultrasound ablation
4775867|NCT02766543|MRI-guided|mri-guided
4775868|NCT02766543|minimally invasive|minimally invasive
4775869|NCT02766543|real-time temperature feedback control|real-time temperature feedback control
4775870|NCT02766491|Stretching|stretching
4775871|NCT02766465|Sickle Cell Disease|sickle cell disease
4775872|NCT02766465|Young Adults|young adults
4775873|NCT02766465|Phase II Trial|phase ii trial
4775874|NCT02766465|Hematopoietic Cell Transplantation (HCT)|hematopoietic cell transplantation (hct)
4775875|NCT02766465|Human Leukocyte Antigen (HLA)|human leukocyte antigen (hla)
4775876|NCT02766400|Stroke|stroke
4775877|NCT02766400|Rehabilitation|rehabilitation
4775878|NCT02766400|Cognition|cognition
4775879|NCT02766400|Disability|disability
4775880|NCT02766400|Intervention|intervention
4775881|NCT02766374|Asthma|asthma
4775882|NCT02766374|Biofeedback|biofeedback
4775883|NCT02766374|Heart rate variability biofeedback|heart rate variability biofeedback
4775884|NCT02766374|Inhaled corticosteroids|inhaled corticosteroids
4775885|NCT02766361|Bipolar disorder|bipolar disorder
4775886|NCT02766361|Psychotherapy|psychotherapy
4775887|NCT02766361|Cognitive rehabilitation|cognitive rehabilitation
4775888|NCT02766348|DC-CTL, NSCLC|dc-ctl, nsclc
4775889|NCT02766322|Alcohol metabolism|alcohol metabolism
4775890|NCT02766322|Bariatric surgery|bariatric surgery
4775891|NCT02766322|Effects of alcohol on driving|effects of alcohol on driving
4775892|NCT02766309|Self-assessment of health, Sf12-v2|self-assessment of health, sf12-v2
4775893|NCT02766296|PTSD|ptsd
4775894|NCT02766296|trauma|trauma
4775895|NCT02766296|working memory|working memory
4775896|NCT02766296|working memory training|working memory training
4775897|NCT02766283|Children|children
4775898|NCT02766283|Iodinated contrast agents|iodinated contrast agents
4775899|NCT02766270|Grade II/III Glioma|grade ii/iii glioma
4775900|NCT02766270|IDH|idh
4775901|NCT02766270|TERT|tert
4775902|NCT02766270|Chemoradiotherapy|chemoradiotherapy
4775903|NCT02766270|Temozolomide|temozolomide
4775904|NCT02766218|toddler obesity|toddler obesity
4775905|NCT02766218|responsive feeding|responsive feeding
4775906|NCT02766218|behavioral weight control|behavioral weight control
4775907|NCT02766218|pregnancy weight gain|pregnancy weight gain
4775908|NCT02766218|early life risk factors|early life risk factors
4775909|NCT02766205|Embolic Stroke of Undetermined Source|embolic stroke of undetermined source
4775910|NCT02766205|Atrial fibrillation|atrial fibrillation
4775911|NCT02766205|prognostic score|prognostic score
4775912|NCT02766192|ketamine|ketamine
4775913|NCT02766192|mindfulness based cognitive therapy|mindfulness based cognitive therapy
4775914|NCT02766192|PTSD|ptsd
4775915|NCT02766192|trauma memory|trauma memory
4775916|NCT02766192|memory extinction|memory extinction
4775917|NCT02766192|memory re-consolidation|memory re-consolidation
4775918|NCT02766192|metabolomics|metabolomics
4775919|NCT02766192|TIMBER (Trauma Intervention using Mindfulness Based Extinction and Re-consolidation of trauma memories)|timber (trauma intervention using mindfulness based extinction and re-consolidation of trauma memories)
4775920|NCT02766127|radiotherapy|radiotherapy
4775921|NCT02766114|CTS|cts
4775922|NCT02766114|Carpal tunnel syndrome|carpal tunnel syndrome
4775923|NCT02766114|Carpal tunnel release|carpal tunnel release
4775924|NCT02766114|Mini incision of carpal tunnel release|mini incision of carpal tunnel release
4775925|NCT02766114|Cosmetic surgery of carpal tunnel syndrome|cosmetic surgery of carpal tunnel syndrome
4775926|NCT02766114|endoscopic carpal tunnel surgery|endoscopic carpal tunnel surgery
4776055|NCT02765529|Environmental Pollution|environmental pollution
4775927|NCT02766114|Carpal Tunnel Release Through Mini Transverse Approach|carpal tunnel release through mini transverse approach
4775928|NCT02766114|Dr. Sayed Issa's Approach|dr. sayed issa's approach
4775929|NCT02766114|CTRMTA|ctrmta
4775930|NCT02766114|OCTR|octr
4775931|NCT02766114|ECTR|ectr
4775932|NCT02766114|Open Carpal Tunnel Release|open carpal tunnel release
4775933|NCT02766114|Endoscopic Carpal Tunnel Release|endoscopic carpal tunnel release
4775934|NCT02766114|Syria|syria
4775935|NCT02766114|Cosmetic|cosmetic
4775936|NCT02766114|Safety|safety
4775937|NCT02766114|Rehabilitation,|rehabilitation,
4775938|NCT02766114|Complications|complications
4775939|NCT02766114|Surgery|surgery
4775940|NCT02766114|Satisfaction|satisfaction
4775943|NCT02766088|Southeast Asia|southeast asia
4775944|NCT02766088|Latin America|latin america
4775945|NCT02766088|Surveillance|surveillance
4775946|NCT02766075|Transcatheter Aortic Valve Disease|transcatheter aortic valve disease
4775947|NCT02766075|Supervised TAVR Exercise Program|supervised tavr exercise program
4775948|NCT02766062|Postoperative cognitive dysfunction|postoperative cognitive dysfunction
4775949|NCT02766062|metabolic syndrome|metabolic syndrome
4775950|NCT02766062|propofol|propofol
4775951|NCT02766062|sevoflurane|sevoflurane
4775953|NCT02766049|immunotherapy|immunotherapy
4775954|NCT02766049|clinical trial|clinical trial
4775955|NCT02766049|dendritic cell|dendritic cell
4775956|NCT02766036|Proteinuria|proteinuria
4775957|NCT02766036|Propolis|propolis
4775958|NCT02766036|Chronic Kidney Disease|chronic kidney disease
4775959|NCT02766023|CTV-05|ctv-05
4775960|NCT02766023|LACTIN-V|lactin-v
4775961|NCT02766023|Lactobacillus|lactobacillus
4775962|NCT02766023|MetroGel®|metrogel®
4775963|NCT02766023|Vaginitis|vaginitis
4775964|NCT02765997|AML|aml
4775965|NCT02765997|ALL|all
4775966|NCT02765997|MDS|mds
4775967|NCT02765984|implantation site|implantation site
4775968|NCT02765984|placental site|placental site
4775969|NCT02765984|Doppler|doppler
4775970|NCT02765971|chewing gums|chewing gums
4775971|NCT02765971|laxatives|laxatives
4775972|NCT02765971|bowel function|bowel function
4775973|NCT02765945|Exercise|exercise
4775974|NCT02765945|Osteoporosis|osteoporosis
4775975|NCT02765945|Cytokines|cytokines
4775976|NCT02765932|Hip|hip
4775977|NCT02765932|Knee|knee
4775978|NCT02765932|replacement|replacement
4775979|NCT02765932|surgery|surgery
4775980|NCT02765919|Carcinoma cervix|carcinoma cervix
4775981|NCT02765919|RCT(randomised controlled trial)|rct(randomised controlled trial)
4775982|NCT02765919|9 Gray|9 gray
4775983|NCT02765919|Brachytherapy|brachytherapy
4775984|NCT02765906|video|video
4775985|NCT02765906|educational tool|educational tool
4775986|NCT02765906|preeclampsia|preeclampsia
4775987|NCT02765906|hypertension|hypertension
4775988|NCT02765906|pregnancy|pregnancy
4775989|NCT02765906|patient education|patient education
4775990|NCT02765906|graphic card|graphic card
4775991|NCT02765906|eclampsia|eclampsia
4775992|NCT02765906|HELLP|hellp
4775993|NCT02765906|anxiety|anxiety
4775994|NCT02765906|anxiety assessment|anxiety assessment
4775995|NCT02765906|STAI 6|stai 6
4775996|NCT02765841|HoFH|hofh
4775997|NCT02765815|TKA|tka
4775998|NCT02765815|Knee replacement|knee replacement
4775999|NCT02765815|Arthritis|arthritis
4776000|NCT02765815|Knee|knee
4776001|NCT02765776|Anti-HIV Drugs|anti-hiv drugs
4776002|NCT02765776|Raltegravir Potassium|raltegravir potassium
4776003|NCT02765776|Aged|aged
4776004|NCT02765776|Retrospective Study|retrospective study
4776005|NCT02765776|Medical Records|medical records
4776006|NCT02765750|Emergence agitation|emergence agitation
4776007|NCT02765711|ticagrelor|ticagrelor
4776008|NCT02765711|acute coronary syndrome|acute coronary syndrome
4776009|NCT02765698|Magnetic Resonance Imaging|magnetic resonance imaging
4776010|NCT02765672|Combat Veterans|combat veterans
4776011|NCT02765672|Automobile Driving|automobile driving
4776012|NCT02765672|Fitness to Drive|fitness to drive
4776013|NCT02765659|HIV|hiv
4776014|NCT02765659|Prevention|prevention
4776015|NCT02765659|Implementation|implementation
4776016|NCT02765659|Community based participatory research|community based participatory research
4776017|NCT02765620|Positron-Emission Tomography|positron-emission tomography
4776018|NCT02765620|Response Criteria|response criteria
4776019|NCT02765620|solid tumor|solid tumor
4776020|NCT02765607|Blood circulation|blood circulation
4776021|NCT02765607|Cardiac surgical procedures|cardiac surgical procedures
4776022|NCT02765607|Homeostasis|homeostasis
4776023|NCT02765594|Glomerulonephritis, IGA|glomerulonephritis, iga
4776024|NCT02765594|Kidney Diseases|kidney diseases
4776025|NCT02765594|Autoimmune Diseases|autoimmune diseases
4776026|NCT02765594|Glomerulonephritis|glomerulonephritis
4776027|NCT02765594|Nephritis|nephritis
4776028|NCT02765594|Immune System Diseases|immune system diseases
4776029|NCT02765594|Urologic Diseases|urologic diseases
4776030|NCT02765594|Hydroxychloroquine|hydroxychloroquine
4776031|NCT02765594|Anti-Infective Agents|anti-infective agents
4776032|NCT02765594|Antimalarials|antimalarials
4776033|NCT02765594|Antiparasitic Agents|antiparasitic agents
4776034|NCT02765594|Antiprotozoal Agents|antiprotozoal agents
4776035|NCT02765594|Antirheumatic Agents|antirheumatic agents
4776036|NCT02765594|Enzyme Inhibitors|enzyme inhibitors
4776037|NCT02765594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
4776038|NCT02765594|Pharmacologic Actions|pharmacologic actions
4776039|NCT02765594|Therapeutic Uses|therapeutic uses
4776040|NCT02765594|interleukin-6|interleukin-6
4776041|NCT02765594|interferon-alpha|interferon-alpha
4776042|NCT02765594|tumor necrosis factor-alpha|tumor necrosis factor-alpha
4776043|NCT02765581|Acupuncture|acupuncture
4776044|NCT02765581|Migraine without aura|migraine without aura
4776045|NCT02765581|Efficacy|efficacy
4776046|NCT02765581|Randomized controlled trial|randomized controlled trial
4776152|NCT02765009|Multiple organ failure|multiple organ failure
4776047|NCT02765581|Non-penetrating sham acupuncture|non-penetrating sham acupuncture
4776048|NCT02765568|Coronary Artery Disease|coronary artery disease
4776049|NCT02765568|Percutaneous Coronary Intervention (PCI)|percutaneous coronary intervention (pci)
4776050|NCT02765542|Depression|depression
4776051|NCT02765542|mHealth|mhealth
4776052|NCT02765542|Interactive Voice Response|interactive voice response
4776053|NCT02765542|Bolivia|bolivia
4776054|NCT02765542|Mental health|mental health
4776056|NCT02765529|Fine particles|fine particles
4776057|NCT02765529|Biomarkers|biomarkers
4776058|NCT02765529|Elderly|elderly
4776059|NCT02765490|Hepatitis C, Chronic|hepatitis c, chronic
4776060|NCT02765490|AL-335|al-335
4776061|NCT02765490|Odalasvir|odalasvir
4776062|NCT02765490|Simeprevir|simeprevir
4776063|NCT02765490|ODV|odv
4776064|NCT02765490|SMV|smv
4776065|NCT02765490|ACH-3102|ach-3102
4776066|NCT02765490|ACH-0143102|ach-0143102
4776067|NCT02765490|TMC435|tmc435
4776068|NCT02765477|Acute myocardial infarction|acute myocardial infarction
4776069|NCT02765477|ST Elevation Myocardial Infarction|st elevation myocardial infarction
4776070|NCT02765477|Acute Coronary Occlusion|acute coronary occlusion
4776071|NCT02765477|Electrocardiogram|electrocardiogram
4776072|NCT02765477|Ventricular Paced Rhythm|ventricular paced rhythm
4776073|NCT02765477|Modified Sgarbossa Criteria|modified sgarbossa criteria
4776074|NCT02765451|non-academic|non-academic
4776075|NCT02765451|health institution|health institution
4776076|NCT02765451|development|development
4776077|NCT02765451|clinical research|clinical research
4776078|NCT02765451|cancer|cancer
4776079|NCT02765451|private hospital|private hospital
4776080|NCT02765451|public hospital|public hospital
4776081|NCT02765451|northwestern france|northwestern france
4776082|NCT02765451|france|france
4776083|NCT02765451|hospitals|hospitals
4776084|NCT02765412|decision support|decision support
4776085|NCT02765412|patient preferences|patient preferences
4776086|NCT02765412|risk adjustment|risk adjustment
4776087|NCT02765386|Cochlear implants|cochlear implants
4776088|NCT02765386|Hybrid fittings|hybrid fittings
4776089|NCT02765386|Cross-over frequency|cross-over frequency
4776090|NCT02765373|aromatase inhibitors|aromatase inhibitors
4776091|NCT02765373|lipid levels|lipid levels
4776092|NCT02765360|EIT|eit
4776093|NCT02765360|NIV|niv
4776094|NCT02765308|Uveitis|uveitis
4776095|NCT02765308|Glaucoma|glaucoma
4776096|NCT02765308|Aqueous humor dynamics|aqueous humor dynamics
4776097|NCT02765295|Hydrogen|hydrogen
4776098|NCT02765295|Inhalation|inhalation
4776099|NCT02765295|bronchiectasis|bronchiectasis
4776100|NCT02765282|Deep brain stimulation (DBS)|deep brain stimulation (dbs)
4776101|NCT02765282|Kinesia|kinesia
4776102|NCT02765269|cancer pain|cancer pain
4776103|NCT02765269|mobile applications|mobile applications
4776104|NCT02765243|neuroblastoma|neuroblastoma
4776105|NCT02765243|GD2|gd2
4776106|NCT02765243|Chimeric antigen receptor|chimeric antigen receptor
4776107|NCT02765243|Immunotherapy|immunotherapy
4776108|NCT02765243|Cyclophosphamide|cyclophosphamide
4776109|NCT02765243|Fludarabine|fludarabine
4776110|NCT02765217|Antibiotic associated diarrhea|antibiotic associated diarrhea
4776111|NCT02765217|Children|children
4776112|NCT02765217|Prevention|prevention
4776113|NCT02765217|Lactobacillus reuteri DSM 17938|lactobacillus reuteri dsm 17938
4776114|NCT02765217|Probiotic|probiotic
4776115|NCT02765191|Magnetic Resonance Imaging|magnetic resonance imaging
4776116|NCT02765191|Norepinephrine|norepinephrine
4776117|NCT02765191|Fluid Therapy|fluid therapy
4776118|NCT02765191|Renal Circulation|renal circulation
4776119|NCT02765165|Phase 1|phase 1
4776120|NCT02765165|Phase 2|phase 2
4776121|NCT02765165|Glioblastoma Multiforme|glioblastoma multiforme
4776122|NCT02765165|Glioblastoma|glioblastoma
4776123|NCT02765165|GBM|gbm
4776124|NCT02765165|Brain Tumor|brain tumor
4776125|NCT02765165|Brain Cancer|brain cancer
4776126|NCT02765165|Tumor|tumor
4776127|NCT02765165|Solid Tumor|solid tumor
4776128|NCT02765165|Tumour|tumour
4776129|NCT02765165|Lomustine|lomustine
4776130|NCT02765165|CCNU|ccnu
4776131|NCT02765165|CXCR4|cxcr4
4776132|NCT02765165|Phase 1 Clinical Trial|phase 1 clinical trial
4776133|NCT02765165|Phase 2 Clinical Trial|phase 2 clinical trial
4776134|NCT02765152|exercise|exercise
4776135|NCT02765152|rhythmic movement|rhythmic movement
4776136|NCT02765152|discrete movement|discrete movement
4776137|NCT02765100|Bipolar Disorder|bipolar disorder
4776138|NCT02765100|Obesity|obesity
4776139|NCT02765100|Depression|depression
4776140|NCT02765074|subcutaneous tocilizumab|subcutaneous tocilizumab
4776141|NCT02765074|High Resolution peripheral QCT (HR-pQCT)|high resolution peripheral qct (hr-pqct)
4776142|NCT02765074|bone erosion|bone erosion
4776143|NCT02765074|bone microarchitecture|bone microarchitecture
4776144|NCT02765074|rheumatoid arthritis|rheumatoid arthritis
4776145|NCT02765048|Adolescent girls|adolescent girls
4776146|NCT02765048|Child welfare|child welfare
4776147|NCT02765048|Trauma treatment|trauma treatment
4776148|NCT02765048|PTSD|ptsd
4776149|NCT02765048|Depression|depression
4776150|NCT02765048|Social problem-solving|social problem-solving
4776151|NCT02765009|Fluid overload|fluid overload
4776153|NCT02765009|Diuretics|diuretics
4776154|NCT02765009|Fluid restriction|fluid restriction
4776155|NCT02765009|Body weight|body weight
4776156|NCT02764983|Combat Veterans|combat veterans
4776157|NCT02764983|Automobile Driving|automobile driving
4776158|NCT02764983|Fitness to Drive|fitness to drive
4776159|NCT02764905|Diabetes|diabetes
4776160|NCT02764905|Cognitive-physical rehabilitation|cognitive-physical rehabilitation
4776161|NCT02764905|Self care management|self care management
4776162|NCT02764879|Omega 3 fatty acids|omega 3 fatty acids
4776163|NCT02764879|Root planning|root planning
4776164|NCT02764879|chronic periodontitis|chronic periodontitis
4776165|NCT02764866|Lung cancer|lung cancer
4776166|NCT02764866|Sleep apnea|sleep apnea
4776167|NCT02764866|Sleep disordered breathing|sleep disordered breathing
4776168|NCT02764853|HIV|hiv
4776169|NCT02764853|Black|black
4776170|NCT02764853|African American|african american
4776171|NCT02764853|Women|women
4776172|NCT02764853|Cognitive Behavioral Therapy|cognitive behavioral therapy
4776173|NCT02764853|Racism|racism
4776174|NCT02764853|Stigma|stigma
4776175|NCT02764853|Discrimination|discrimination
4776176|NCT02764853|Gender related stressors|gender related stressors
4776177|NCT02764853|Resilience|resilience
4776178|NCT02764853|Behavioral Medicine|behavioral medicine
4776179|NCT02764827|skin prick test|skin prick test
4776180|NCT02764827|grass and weed pollens|grass and weed pollens
4776181|NCT02764788|Auriculotherapy|auriculotherapy
4776182|NCT02764762|Drug Therapy|drug therapy
4776183|NCT02764749|vascular function|vascular function
4776184|NCT02764749|endothelial function|endothelial function
4776185|NCT02764749|polyphenols|polyphenols
4776186|NCT02764697|Glaucoma associated with uveitis|glaucoma associated with uveitis
4776187|NCT02764671|recombinant hepatitis B vaccine|recombinant hepatitis b vaccine
4776189|NCT02764671|immunogenicity|immunogenicity
4776190|NCT02764645|Cardiopulmonary Bypass|cardiopulmonary bypass
4776191|NCT02764619|Upstream therapy, spironolactone|upstream therapy, spironolactone
4776192|NCT02764619|Atrial remodelling|atrial remodelling
4776193|NCT02764619|Modified look-locker inversion recover (MOLLI) sequences|modified look-locker inversion recover (molli) sequences
4776194|NCT02764619|T1 mapping|t1 mapping
4776195|NCT02764619|Diffuse myocardial fibrosis|diffuse myocardial fibrosis
4776196|NCT02764606|Lung Cancer|lung cancer
4776197|NCT02764606|Biomarkers|biomarkers
4776198|NCT02764606|Bone|bone
4776199|NCT02764606|Metastases|metastases
4776200|NCT02764593|Head and Neck Squamous Cell Carcinoma|head and neck squamous cell carcinoma
4776201|NCT02764593|HNSCC|hnscc
4776202|NCT02764593|Nivolumab|nivolumab
4776203|NCT02764554|Post-Marketing Surveillance|post-marketing surveillance
4776204|NCT02764554|Lenvima|lenvima
4776205|NCT02764554|Lenvatinib|lenvatinib
4776206|NCT02764554|E7080|e7080
4776207|NCT02764554|Differentiated thyroid carcinoma|differentiated thyroid carcinoma
4776208|NCT02764554|Refractory to radioactive iodine|refractory to radioactive iodine
4776209|NCT02764554|Progressive|progressive
4776210|NCT02764554|locally recurrent|locally recurrent
4776211|NCT02764554|metastatic|metastatic
4776212|NCT02764541|Breast Cancer|breast cancer
4776213|NCT02764541|Invasive Lobular Carcinoma|invasive lobular carcinoma
4776214|NCT02764528|Hygiene|hygiene
4776215|NCT02764515|Kunxian Capsule|kunxian capsule
4776216|NCT02764515|efficacy|efficacy
4776217|NCT02764515|rheumatoid arthritis|rheumatoid arthritis
4776218|NCT02764515|Methotrexate|methotrexate
4776219|NCT02764502|Epidural Identification pressure gauge|epidural identification pressure gauge
4776220|NCT02764476|psychogenic|psychogenic
4776221|NCT02764476|non-epileptic seizures|non-epileptic seizures
4776222|NCT02764476|functional neurological symptom disorder|functional neurological symptom disorder
4776223|NCT02764476|PNES|pnes
4776224|NCT02764476|PMD|pmd
4776225|NCT02764476|virtual reality|virtual reality
4776226|NCT02764476|3D augmented reality|3d augmented reality
4776227|NCT02764476|mirror therapy|mirror therapy
4776228|NCT02764463|Fiber Reinforced Composites|fiber reinforced composites
4776229|NCT02764463|Resin cements|resin cements
4776230|NCT02764463|Survival|survival
4776231|NCT02764450|composite|composite
4776232|NCT02764450|restoration|restoration
4776233|NCT02764450|polymerization|polymerization
4776234|NCT02764424|Newborn|newborn
4776235|NCT02764424|Heart Rate Variability (HRV)|heart rate variability (hrv)
4776236|NCT02764424|Analgesic Nociception Index (ANI)|analgesic nociception index (ani)
4776237|NCT02764424|Autonomous Nervous System (ANS)|autonomous nervous system (ans)
4776238|NCT02764411|Capillary malformations|capillary malformations
4776239|NCT02764411|Onrealtea|onrealtea
4776240|NCT02764411|port-wine stain|port-wine stain
4776241|NCT02764411|treatment|treatment
4776242|NCT02764411|topical|topical
4776243|NCT02764372|Arm rehabilitation|arm rehabilitation
4776244|NCT02764372|Serious games|serious games
4776245|NCT02764372|stroke|stroke
4776246|NCT02764372|Multiple sclerosis|multiple sclerosis
4776247|NCT02764346|Arthritis|arthritis
4776248|NCT02764346|Self-management|self-management
4776249|NCT02764346|Pain|pain
4776250|NCT02764333|TPIV200/huFR-1|tpiv200/hufr-1
4776251|NCT02764333|Anti-PD-L1|anti-pd-l1
4776252|NCT02764333|vaccine|vaccine
4776253|NCT02764333|16-011|16-011
4776254|NCT02764294|anxiety|anxiety
4776255|NCT02764294|pain|pain
4776256|NCT02764294|satisfaction|satisfaction
4776257|NCT02764294|cystoscopy|cystoscopy
4776258|NCT02764294|music|music
4776259|NCT02764294|video|video
4776260|NCT02764294|stress ball|stress ball
4776261|NCT02764294|nursing|nursing
4776262|NCT02764268|Gastric Cancer|gastric cancer
4776263|NCT02764268|Pharmacokinetics|pharmacokinetics
4776264|NCT02764268|Dose titration|dose titration
4776265|NCT02764242|insect sting allergy|insect sting allergy
4776266|NCT02764242|recombinant venom allergen|recombinant venom allergen
4776267|NCT02764203|Dark Chocolate|dark chocolate
4776268|NCT02764203|Blood Pressure|blood pressure
4776269|NCT02764203|Wearable Devices|wearable devices
4776270|NCT02764203|Digital Health|digital health
4776271|NCT02764164|TDCS|tdcs
4776272|NCT02764151|GBM|gbm
4776273|NCT02764151|malignant glioma|malignant glioma
4776274|NCT02764151|glioma|glioma
4776275|NCT02764151|anaplastic glioma|anaplastic glioma
4776276|NCT02764151|astrocytoma|astrocytoma
4776277|NCT02764151|IDO|ido
4776278|NCT02764151|IDO1|ido1
4776279|NCT02764151|PF-06840003|pf-06840003
4776280|NCT02764138|poverty|poverty
4776281|NCT02764138|discrimination|discrimination
4776282|NCT02764125|Parkinson's Disease|parkinson's disease
4776283|NCT02764125|Wearing-off|wearing-off
4776284|NCT02764112|warfarin|warfarin
4776285|NCT02764073|Heart failure|heart failure
4776286|NCT02764073|Bioimpedance|bioimpedance
4776287|NCT02764073|Lung ultrasonography|lung ultrasonography
4776288|NCT02764060|Periodontitis|periodontitis
4776289|NCT02764060|Tongue coating|tongue coating
4776290|NCT02764060|Tongue cleaning|tongue cleaning
4776291|NCT02764060|Bacterial load|bacterial load
4776292|NCT02764047|Non-alcoholic Fatty Liver Disease|non-alcoholic fatty liver disease
4776293|NCT02764047|Nonalcoholic Steatohepatitis|nonalcoholic steatohepatitis
4776294|NCT02764047|NAFLD|nafld
4776295|NCT02764047|NASH|nash
4776296|NCT02764034|Low level Laser|low level laser
4776297|NCT02764034|Tissue culture|tissue culture
4776298|NCT02764034|Endometrial receptivity|endometrial receptivity
4776299|NCT02764021|HbA1c|hba1c
4776300|NCT02764021|Diabetes-Releated Complications|diabetes-releated complications
4776301|NCT02764021|Diet, Low Carbohydrate|diet, low carbohydrate
4776302|NCT02764021|Carbohydrate-Restricted Diet|carbohydrate-restricted diet
4776303|NCT02764021|Diabetes Mellitus|diabetes mellitus
4776304|NCT02764021|Metabolic Disorder|metabolic disorder
4776305|NCT02764021|Glucose Metabolism Disorders|glucose metabolism disorders
4776306|NCT02764021|Endocrine System Diseases|endocrine system diseases
4776307|NCT02764008|Postoperative Analgesia|postoperative analgesia
4776308|NCT02764008|Peritubal infiltration|peritubal infiltration
4776309|NCT02764008|Ultrasound guided low thoracic paravertebral block|ultrasound guided low thoracic paravertebral block
4776310|NCT02764008|Percutaneous Nephrolithotomy pain|percutaneous nephrolithotomy pain
4776311|NCT02763995|HIV|hiv
4776312|NCT02763995|pharmaceutical care|pharmaceutical care
4776313|NCT02763995|older patients|older patients
4776314|NCT02763995|cardiovascular risk|cardiovascular risk
4776315|NCT02763995|pharmacotherapy follow up|pharmacotherapy follow up
4776316|NCT02763982|left ventricular ejection fraction|left ventricular ejection fraction
4776317|NCT02763982|peak oxygen uptake|peak oxygen uptake
4776318|NCT02763982|respiratory muscles|respiratory muscles
4776319|NCT02763982|quality of life|quality of life
4776320|NCT02763956|Gelstix, Hydrogel|gelstix, hydrogel
4776321|NCT02763930|Cardiovascular disease|cardiovascular disease
4776322|NCT02763930|Blood pressure|blood pressure
4776323|NCT02763930|Hypertension|hypertension
4776324|NCT02763930|Dairy products|dairy products
4776325|NCT02763930|Milk|milk
4776326|NCT02763930|Cheese|cheese
4776327|NCT02763891|Balance|balance
4776328|NCT02763891|Mobility|mobility
4776329|NCT02763891|Trunk control|trunk control
4776330|NCT02763878|Uncut Roux-en-Y|uncut roux-en-y
4776331|NCT02763878|Billroth II anastomosis|billroth ii anastomosis
4776332|NCT02763878|Distal gastric cancer|distal gastric cancer
4776333|NCT02763878|Nutrition status|nutrition status
4776334|NCT02763878|Postoperative complications|postoperative complications
4776335|NCT02763852|Parkinson's Disease|parkinson's disease
4776336|NCT02763852|Nebicapone|nebicapone
4776337|NCT02763839|Parkinson's disease|parkinson's disease
4776338|NCT02763839|Nebicapone|nebicapone
4776339|NCT02763826|Transcranial Direct Current Stimulation|transcranial direct current stimulation
4776340|NCT02763826|tDCS|tdcs
4776341|NCT02763800|Parkinson's disease|parkinson's disease
4776342|NCT02763800|Nebicapone|nebicapone
4776343|NCT02763774|coronary artery bypass|coronary artery bypass
4776344|NCT02763774|sistemic inflammatory response syndrome|sistemic inflammatory response syndrome
4776345|NCT02763774|left ventricular dysfunction|left ventricular dysfunction
4776346|NCT02763774|postoperative complications|postoperative complications
4776347|NCT02763774|physical fitness|physical fitness
4776348|NCT02763735|Pulmonary arterial hypertension|pulmonary arterial hypertension
4776349|NCT02763735|Right ventricle|right ventricle
4776350|NCT02763735|Right ventricular function|right ventricular function
4776351|NCT02763735|Metabolism|metabolism
4776352|NCT02763735|Non-invasive imaging|non-invasive imaging
4776353|NCT02763735|Healthy Subjects|healthy subjects
4776354|NCT02763722|atopic dermatitis|atopic dermatitis
4776553|NCT02762409|discomforts|discomforts
4776355|NCT02763722|allergic contact dermatitis|allergic contact dermatitis
4776356|NCT02763722|cosmetics|cosmetics
4776357|NCT02763722|transepidermal water loos|transepidermal water loos
4776358|NCT02763696|Metagenomics|metagenomics
4776359|NCT02763696|Vaginal microflora|vaginal microflora
4776360|NCT02763696|High-throughput sequencing|high-throughput sequencing
4776361|NCT02763683|Parkinsons Disease|parkinsons disease
4776362|NCT02763683|PET Imaging|pet imaging
4776363|NCT02763683|PIB|pib
4776364|NCT02763683|VAT|vat
4776365|NCT02763683|Dementia|dementia
4776366|NCT02763670|Heart failure|heart failure
4776367|NCT02763670|patient education as topic|patient education as topic
4776368|NCT02763670|patient care management|patient care management
4776369|NCT02763657|fMRI|fmri
4776370|NCT02763657|reasoning|reasoning
4776371|NCT02763657|development|development
4776372|NCT02763644|transplant associated microangiopathy|transplant associated microangiopathy
4776373|NCT02763618|Neurofeedback|neurofeedback
4776374|NCT02763618|theta/beta ratio|theta/beta ratio
4776375|NCT02763618|multiple baseline|multiple baseline
4776376|NCT02763605|Acanthamoeba Keratitis|acanthamoeba keratitis
4776377|NCT02763605|in vivo confocal microscopic|in vivo confocal microscopic
4776378|NCT02763592|Localized Neuropathic pain|localized neuropathic pain
4776379|NCT02763592|5% lidocaine medicated plaster|5% lidocaine medicated plaster
4776380|NCT02763592|Knee surgery|knee surgery
4776381|NCT02763566|Hormone Receptor-Positive|hormone receptor-positive
4776382|NCT02763566|HER2-Negative|her2-negative
4776383|NCT02763566|CDK4|cdk4
4776384|NCT02763566|CDK6|cdk6
4776385|NCT02763553|Ketone Bodies|ketone bodies
4776386|NCT02763553|Enteral Nutrition|enteral nutrition
4776387|NCT02763553|Ketogenic Diet|ketogenic diet
4776388|NCT02763540|ILD|ild
4776389|NCT02763540|Pathology|pathology
4776390|NCT02763540|diagnosis|diagnosis
4776391|NCT02763540|lung biopsy|lung biopsy
4776392|NCT02763527|smoking cessation|smoking cessation
4776393|NCT02763501|bariatric surgery|bariatric surgery
4776394|NCT02763501|gastric bypass|gastric bypass
4776395|NCT02763501|intestinal obstruction|intestinal obstruction
4776396|NCT02763501|postoperative complication|postoperative complication
4776397|NCT02763501|methods|methods
4776398|NCT02763501|laparoscopy|laparoscopy
4776399|NCT02763488|blood flow restriction training|blood flow restriction training
4776400|NCT02763488|occlusion training|occlusion training
4776401|NCT02763488|total knee arthroplasty|total knee arthroplasty
4776402|NCT02763488|post-operative rehabilitation|post-operative rehabilitation
4776403|NCT02763475|Killer Cells, Natural|killer cells, natural
4776404|NCT02763475|Consolidation treatment|consolidation treatment
4776405|NCT02763475|cytologic remission|cytologic remission
4776406|NCT02763475|Haploidentical NK Cells|haploidentical nk cells
4776407|NCT02763475|allogeneic|allogeneic
4776408|NCT02763475|IL-2 Expanded NK Cells|il-2 expanded nk cells
4776409|NCT02763462|Acute Febrile Illness|acute febrile illness
4776410|NCT02763436|term infant, neonatal transition, cord clamping, NIRS, arterial oxygen saturation, regional cerebral oxygen saturation, cerebral blood volume|term infant, neonatal transition, cord clamping, nirs, arterial oxygen saturation, regional cerebral oxygen saturation, cerebral blood volume
4776411|NCT02763423|umbilical cord stem cell|umbilical cord stem cell
4776412|NCT02763423|diabetic ketoacidosis|diabetic ketoacidosis
4776413|NCT02763371|high GI lunch|high gi lunch
4776414|NCT02763371|low GI lunch|low gi lunch
4776415|NCT02763358|obesity|obesity
4776416|NCT02763358|weight loss|weight loss
4776417|NCT02763332|Fibromyalgia|fibromyalgia
4776418|NCT02763332|Efficacy|efficacy
4776419|NCT02763332|Taping|taping
4776420|NCT02763319|Diffuse Large B-cell Lymphoma|diffuse large b-cell lymphoma
4776421|NCT02763319|bendamustine|bendamustine
4776422|NCT02763319|rituximab|rituximab
4776423|NCT02763319|combination therapy|combination therapy
4776424|NCT02763319|CD19 monoclonal antibody|cd19 monoclonal antibody
4776425|NCT02763319|transplant ineligible|transplant ineligible
4776426|NCT02763293|pain|pain
4776427|NCT02763293|effectiveness|effectiveness
4776428|NCT02763293|manual therapy|manual therapy
4776429|NCT02763267|Insulin sensitivity|insulin sensitivity
4776430|NCT02763267|Insulin secretion|insulin secretion
4776431|NCT02763267|Pregnancy|pregnancy
4776432|NCT02763267|Placental proteins|placental proteins
4776433|NCT02763254|Epstein-Barr Virus|epstein-barr virus
4776434|NCT02763254|DLBCL|dlbcl
4776435|NCT02763254|PTLD|ptld
4776436|NCT02763254|EBV|ebv
4776437|NCT02763254|CIVIC|civic
4776438|NCT02763254|HL|hl
4776439|NCT02763254|T cell|t cell
4776440|NCT02763241|rhinitis|rhinitis
4776441|NCT02763228|Physical Activity|physical activity
4776442|NCT02763228|Breast Cancer|breast cancer
4776443|NCT02763228|minority|minority
4776444|NCT02763228|African American|african american
4776445|NCT02763202|transition of care|transition of care
4776446|NCT02763202|pragmatic clinical trial|pragmatic clinical trial
4776447|NCT02763202|telemedicine|telemedicine
4776448|NCT02763202|emergency medical technician|emergency medical technician
4776449|NCT02763189|Mentoring|mentoring
4776450|NCT02763189|Endotracheal Tube Exchange|endotracheal tube exchange
4776451|NCT02763189|Training|training
4776452|NCT02763176|hCG testing, multi-level pregnancy test|hcg testing, multi-level pregnancy test
4776453|NCT02763150|Gestational Diabetes Prevention|gestational diabetes prevention
4776454|NCT02763124|Pseudophakic|pseudophakic
4776455|NCT02763111|ankylosing spondylitis|ankylosing spondylitis
4776456|NCT02763111|interleukin 17|interleukin 17
4776457|NCT02763111|monoclonal antibody|monoclonal antibody
4776458|NCT02763098|cardiovascular responses|cardiovascular responses
4776459|NCT02763098|analgesics opioid|analgesics opioid
4776460|NCT02763098|remifentanil|remifentanil
4776461|NCT02763046|Ankylosing Spondylitis|ankylosing spondylitis
4776462|NCT02763046|NSAID|nsaid
4776463|NCT02763046|ASAS|asas
4776464|NCT02763046|Secukinumab|secukinumab
4776465|NCT02763046|Subcutaneous|subcutaneous
4776466|NCT02763020|high glycemic index, polyphenols, blood glucose, satiety|high glycemic index, polyphenols, blood glucose, satiety
4776467|NCT02762994|interleukin 17|interleukin 17
4776468|NCT02762994|monoclonal antibody|monoclonal antibody
4776469|NCT02762994|psoriasis|psoriasis
4776470|NCT02762981|CORT125134|cort125134
4776471|NCT02762981|nabpaclitaxel|nabpaclitaxel
4776472|NCT02762981|Triple-Negative Breast Cancer|triple-negative breast cancer
4776473|NCT02762981|Ovarian Epithelial Cancer|ovarian epithelial cancer
4776474|NCT02762981|GR Antagonist|gr antagonist
4776475|NCT02762981|Glucocorticoid Receptor Antagonist|glucocorticoid receptor antagonist
4776476|NCT02762981|Pancreatic Cancer|pancreatic cancer
4776477|NCT02762981|Solid Tumors|solid tumors
4776478|NCT02762955|adalimumab|adalimumab
4776479|NCT02762955|biosimilar|biosimilar
4776480|NCT02762955|BCD-057|bcd-057
4776481|NCT02762955|psoriasis|psoriasis
4776482|NCT02762955|tumor necrosis factor|tumor necrosis factor
4776483|NCT02762955|monoclonal antibody|monoclonal antibody
4776484|NCT02762942|cervical ripening|cervical ripening
4776485|NCT02762942|misoprostol|misoprostol
4776486|NCT02762942|supracervical balloon|supracervical balloon
4776487|NCT02762942|Foley catheter|foley catheter
4776488|NCT02762929|Analgesia|analgesia
4776489|NCT02762929|Bunionectomy|bunionectomy
4776490|NCT02762903|Shoulder arthroplasty|shoulder arthroplasty
4776491|NCT02762903|Lesser Tuberosity Osteotomy|lesser tuberosity osteotomy
4776492|NCT02762903|Subscapularis tenotomy|subscapularis tenotomy
4776493|NCT02762864|aspirin|aspirin
4776494|NCT02762864|ticagrelor|ticagrelor
4776495|NCT02762864|clopidogrel|clopidogrel
4776496|NCT02762851|Influenza|influenza
4776497|NCT02762851|Vaccine|vaccine
4776498|NCT02762851|Heart failure|heart failure
4776499|NCT02762851|Vascular|vascular
4776500|NCT02762799|neutrophil count|neutrophil count
4776501|NCT02762799|filgrastim|filgrastim
4776502|NCT02762799|granulocyte colony-stimulating factor|granulocyte colony-stimulating factor
4776503|NCT02762747|Hernia, Inguinal|hernia, inguinal
4776504|NCT02762747|Extraperitoneal Hernioplasty|extraperitoneal hernioplasty
4776505|NCT02762747|Drain|drain
4776506|NCT02762747|Mesh Repair|mesh repair
4776507|NCT02762747|Laparoscopic|laparoscopic
4776508|NCT02762734|adolescent|adolescent
4776509|NCT02762734|suicide|suicide
4776510|NCT02762721|FGFR2 fusion|fgfr2 fusion
4776511|NCT02762721|iCCA|icca
4776512|NCT02762721|mixed HCC-CCA|mixed hcc-cca
4776513|NCT02762721|Intrahepatic Cholangiocarcinoma|intrahepatic cholangiocarcinoma
4776514|NCT02762721|Mixed Hepatocellular Cholangiocarcinoma|mixed hepatocellular cholangiocarcinoma
4776515|NCT02762721|Cholangiocarcinoma|cholangiocarcinoma
4776516|NCT02762721|ArQule|arqule
4776517|NCT02762708|Bariatric Surgery|bariatric surgery
4776518|NCT02762708|Weight loss|weight loss
4776519|NCT02762695|Hypertension|hypertension
4776520|NCT02762695|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
4776521|NCT02762695|Case Management|case management
4776522|NCT02762669|Uterine contraction|uterine contraction
4776523|NCT02762669|Oxytocin desensitization|oxytocin desensitization
4776524|NCT02762643|DP-R213|dp-r213
4776525|NCT02762617|Healthy Volunteers|healthy volunteers
4776526|NCT02762617|Women's Health|women's health
4776527|NCT02762552|Stroke|stroke
4776528|NCT02762552|Etiology|etiology
4776529|NCT02762552|Recurrence|recurrence
4776530|NCT02762552|Transcranial holter|transcranial holter
4776531|NCT02762552|Microembolic signals|microembolic signals
4776532|NCT02762526|lipectomy|lipectomy
4776533|NCT02762526|abdominoplasty|abdominoplasty
4776534|NCT02762526|plethysmography optoelectronics|plethysmography optoelectronics
4776535|NCT02762526|diaphragmatic mobility|diaphragmatic mobility
4776536|NCT02762526|lung function|lung function
4776537|NCT02762526|respiratory muscles|respiratory muscles
4776538|NCT02762474|nab-paclitaxel|nab-paclitaxel
4776539|NCT02762474|IMRT|imrt
4776540|NCT02762474|esophageal cancer|esophageal cancer
4776541|NCT02762461|Fertilization in Vitro|fertilization in vitro
4776542|NCT02762461|Sperm Injections, Intracytoplasmic|sperm injections, intracytoplasmic
4776543|NCT02762461|Endometriosis|endometriosis
4776544|NCT02762422|endothelial function|endothelial function
4776545|NCT02762422|iron stores|iron stores
4776546|NCT02762422|red blood cell|red blood cell
4776547|NCT02762422|blood donation|blood donation
4776548|NCT02762409|critical care|critical care
4776549|NCT02762409|reduction of depression syndrome|reduction of depression syndrome
4776550|NCT02762409|anxiety|anxiety
4776551|NCT02762409|quality of life|quality of life
4776552|NCT02762409|post traumatic stress|post traumatic stress
4776554|NCT02762396|Young ischemic stroke|young ischemic stroke
4776555|NCT02762396|Risk factors|risk factors
4776556|NCT02762396|Causes|causes
4776557|NCT02762396|Consequences|consequences
4776558|NCT02762370|osteoarthritis|osteoarthritis
4776559|NCT02762370|knee|knee
4776560|NCT02762370|pain|pain
4776561|NCT02762370|diabetes|diabetes
4776562|NCT02762370|intra-articular|intra-articular
4776563|NCT02762370|injection|injection
4776564|NCT02762370|corticosteroid|corticosteroid
4776565|NCT02762357|Novosyn Quick|novosyn quick
4776566|NCT02762357|Episiotomy|episiotomy
4776567|NCT02762331|Vitamin C|vitamin c
4776568|NCT02762331|Coronary Artery Bypass Grafting|coronary artery bypass grafting
4776569|NCT02762331|Atrial Fibrillation|atrial fibrillation
4776570|NCT02762331|Cardiac Valve Repair|cardiac valve repair
4776571|NCT02762305|fall risk|fall risk
4776572|NCT02762305|RSVP bone builders|rsvp bone builders
4776573|NCT02762305|Group Exercise|group exercise
4776574|NCT02762305|Older adults|older adults
4776575|NCT02762305|Balance confidence|balance confidence
4776576|NCT02762305|life satisfaction|life satisfaction
4776577|NCT02762305|balance|balance
4776578|NCT02762292|Mechanical ventilation|mechanical ventilation
4776579|NCT02762292|Children|children
4776580|NCT02762292|Work of breathing|work of breathing
4776581|NCT02762279|Mechanical ventilation|mechanical ventilation
4776582|NCT02762279|Children|children
4776583|NCT02762279|Esophageal Pressure|esophageal pressure
4776584|NCT02762279|Pleural Pressure|pleural pressure
4776585|NCT02762240|Accreditation|accreditation
4776586|NCT02762240|Certification|certification
4776587|NCT02762240|General Practice|general practice
4776588|NCT02762240|Family Medicine|family medicine
4776589|NCT02762240|Randomized Controlled Trial|randomized controlled trial
4776590|NCT02762227|CEUS|ceus
4776591|NCT02762227|CT|ct
4776592|NCT02762227|gallbladder cholesterol polyps|gallbladder cholesterol polyps
4776593|NCT02762227|adenoma|adenoma
4776594|NCT02762227|gallbladder cancer|gallbladder cancer
4776595|NCT02762214|Uterin manipulator|uterin manipulator
4776596|NCT02762214|Endometrial Cancer|endometrial cancer
4776597|NCT02762214|Laparoscopy|laparoscopy
4776598|NCT02762214|Robotic|robotic
4776599|NCT02762188|wet ARMD|wet armd
4776600|NCT02762188|VEGF|vegf
4776601|NCT02762188|intra vitreal injections|intra vitreal injections
4776602|NCT02762175|maxillomandibular advancement|maxillomandibular advancement
4776603|NCT02762175|obstructive sleep apnea|obstructive sleep apnea
4776604|NCT02762175|apnea-hypopnea index|apnea-hypopnea index
4776605|NCT02762175|quality of life|quality of life
4776606|NCT02762162|antiplatelet|antiplatelet
4776607|NCT02762162|stent thrombosis|stent thrombosis
4776608|NCT02762149|Tsui Test|tsui test
4776609|NCT02762149|Labour|labour
4776610|NCT02762149|Epidural catheter|epidural catheter
4776611|NCT02762097|polyps|polyps
4776612|NCT02762097|saline sonography|saline sonography
4776613|NCT02762097|infertility|infertility
4776614|NCT02762084|Gorlin Syndrome|gorlin syndrome
4776615|NCT02762084|Basal Cell|basal cell
4776616|NCT02762084|Nevus Syndrome|nevus syndrome
4776617|NCT02762084|BCNS|bcns
4776618|NCT02762084|nevoid basal cell carcinoma syndrome|nevoid basal cell carcinoma syndrome
4776619|NCT02762084|Basal cell carcinoma|basal cell carcinoma
4776620|NCT02762084|Hedgehog|hedgehog
4776621|NCT02762084|Surgically Eligible Basal Cell Carcinomas|surgically eligible basal cell carcinomas
4776622|NCT02762058|Acquired Brain Injury|acquired brain injury
4776623|NCT02762058|Stroke Rehabilitation|stroke rehabilitation
4776624|NCT02762045|Therapeutic Vaccine HIV Adenovirus type 5 vector|therapeutic vaccine hiv adenovirus type 5 vector
4776625|NCT02762032|Skin Biopsy|skin biopsy
4776626|NCT02762032|PrimaVie|primavie
4776627|NCT02762032|Herbal Supplement|herbal supplement
4776628|NCT02762019|Stomatitis|stomatitis
4776629|NCT02762019|Laser|laser
4776630|NCT02762019|Children|children
4776631|NCT02762019|Chemotherapy|chemotherapy
4776632|NCT02762019|Treatment|treatment
4776633|NCT02762006|durvalumab|durvalumab
4776634|NCT02762006|tremelimumab|tremelimumab
4776635|NCT02762006|Phase Ib|phase ib
4776636|NCT02762006|Locally Advanced|locally advanced
4776637|NCT02761980|ibuprofen; acetaminophen; induced fever; fever|ibuprofen; acetaminophen; induced fever; fever
4776638|NCT02761967|Physical activity|physical activity
4776639|NCT02761967|Pregnancy|pregnancy
4776640|NCT02761967|Childbirth|childbirth
4776641|NCT02761967|Postpartum period|postpartum period
4776642|NCT02761967|Exercise|exercise
4776643|NCT02761954|regional anesthesia|regional anesthesia
4776644|NCT02761954|caudal block|caudal block
4776645|NCT02761928|Facet Joint|facet joint
4776646|NCT02761928|Sacroiliac Joint|sacroiliac joint
4776647|NCT02761928|Myofascial Trigger Point Pain|myofascial trigger point pain
4776648|NCT02761928|Injectables|injectables
4776649|NCT02761915|Neuroblastoma|neuroblastoma
4776650|NCT02761915|Immunotherapy|immunotherapy
4776651|NCT02761915|1RG-CART|1rg-cart
4776652|NCT02761915|Cyclophosphamide|cyclophosphamide
4776653|NCT02761915|Fludarabine|fludarabine
4776654|NCT02761915|CAR T-cells|car t-cells
4776655|NCT02761915|Anti-GD2|anti-gd2
4776656|NCT02761915|GD2|gd2
4776657|NCT02761915|CAR|car
4776658|NCT02761915|Chimeric Antigen Receptor|chimeric antigen receptor
4776659|NCT02761902|Children|children
4776660|NCT02761902|Polysomnography|polysomnography
4776661|NCT02761902|sleep|sleep
4776662|NCT02761902|obstructive sleep apnea;|obstructive sleep apnea;
4776663|NCT02761902|Chinese|chinese
4776664|NCT02761863|Mesothelioma|mesothelioma
4776665|NCT02761863|CD 74|cd 74
4776666|NCT02761863|VEGF|vegf
4776667|NCT02761824|Quality of Life|quality of life
4776668|NCT02761824|Occupation|occupation
4776669|NCT02761772|Preimplantation Factor|preimplantation factor
4776670|NCT02761746|HIV|hiv
4776671|NCT02761746|Adherence|adherence
4776672|NCT02761746|Health Outcomes|health outcomes
4776673|NCT02761733|Shared Decision Making|shared decision making
4776674|NCT02761733|Case Management|case management
4776675|NCT02761733|Decision Aid|decision aid
4776676|NCT02761694|AKT1|akt1
4776677|NCT02761694|AKT2|akt2
4776678|NCT02761694|AKT3|akt3
4776679|NCT02761694|PI3K|pi3k
4776680|NCT02761694|PTEN-null|pten-null
4776681|NCT02761694|solid tumors|solid tumors
4776682|NCT02761694|cancer|cancer
4776683|NCT02761694|ARQ 751|arq 751
4776684|NCT02761694|ArQule|arqule
4776685|NCT02761694|PTEN|pten
4776686|NCT02761681|Acceptance and Commitment Therapy|acceptance and commitment therapy
4776687|NCT02761681|Mindfulness|mindfulness
4776688|NCT02761681|Guided self-help|guided self-help
4776689|NCT02761681|College students|college students
4776690|NCT02761681|Focused Interviews|focused interviews
4776691|NCT02761681|RCT Control Condition|rct control condition
4776692|NCT02761681|RCT ACT-CL Condition|rct act-cl condition
4776693|NCT02761668|Pathological tooth migration|pathological tooth migration
4776694|NCT02761668|periodontal regenerative surgery|periodontal regenerative surgery
4776695|NCT02761668|vertical infrabony defects|vertical infrabony defects
4776696|NCT02761668|xenogeneic bone graft|xenogeneic bone graft
4776697|NCT02761668|orthodontic therapy|orthodontic therapy
4776698|NCT02761655|Dementia|dementia
4776699|NCT02761655|Medication Adherence|medication adherence
4776700|NCT02761655|Perspective Memory|perspective memory
4776701|NCT02761590|intermuscular fat|intermuscular fat
4776702|NCT02761590|circuit training|circuit training
4776703|NCT02761590|adipokines|adipokines
4776704|NCT02761590|inflammation|inflammation
4776705|NCT02761590|computed tomography scan|computed tomography scan
4776706|NCT02761577|Acetylcysteine|acetylcysteine
4776707|NCT02761577|Sodium Bicarbonate|sodium bicarbonate
4776708|NCT02761577|Lipocalins|lipocalins
4776709|NCT02761577|Creatinine|creatinine
4776710|NCT02761577|Blood Urea Nitrogen|blood urea nitrogen
4776711|NCT02761564|Cardiac surgery|cardiac surgery
4776712|NCT02761564|Blood transfusion|blood transfusion
4776713|NCT02761564|ScvO2|scvo2
4776714|NCT02761538|obesity|obesity
4776715|NCT02761538|Overweight|overweight
4776716|NCT02761538|ICTs|icts
4776717|NCT02761538|Cost-effectiveness|cost-effectiveness
4776718|NCT02761525|silver nanoparticles antimicrobial activity|silver nanoparticles antimicrobial activity
4776719|NCT02761486|aspirin|aspirin
4776720|NCT02761486|gut microbiome|gut microbiome
4776721|NCT02761486|inflammation|inflammation
4776722|NCT02761486|placebo|placebo
4776723|NCT02761486|circulating biomarker|circulating biomarker
4776724|NCT02761447|Motor control Laterality|motor control laterality
4776725|NCT02761447|Pain Perception|pain perception
4776726|NCT02761447|Lower Extremity|lower extremity
4776727|NCT02761447|Complementary Therapies|complementary therapies
4776728|NCT02761447|Physical Therapy Modalities|physical therapy modalities
4776729|NCT02761434|copeptin|copeptin
4776730|NCT02761434|vasopressin|vasopressin
4776731|NCT02761434|dehydration|dehydration
4776732|NCT02761434|insulin resistance|insulin resistance
4776733|NCT02761434|Diabetes|diabetes
4776734|NCT02761434|Glucose regulation|glucose regulation
4776735|NCT02761421|IOPD|iopd
4776736|NCT02761408|Head and neck cancer|head and neck cancer
4776737|NCT02761408|Asian|asian
4776738|NCT02761408|ALDH2|aldh2
4776739|NCT02761369|food addiction|food addiction
4776740|NCT02761369|obesity|obesity
4776741|NCT02761369|deep TMS|deep tms
4776742|NCT02761369|PAS|pas
4776743|NCT02761369|Food Stroop|food stroop
4776744|NCT02761369|brain laterality|brain laterality
4776745|NCT02761369|EEG|eeg
4776746|NCT02761369|INP|inp
4776747|NCT02761343|cardiac arrhythmia|cardiac arrhythmia
4776748|NCT02761343|cardiac ablation|cardiac ablation
4776749|NCT02761343|congenital cardiac disease|congenital cardiac disease
4776750|NCT02761343|cardiac ablation lesions under Magnetic Resonance imaging|cardiac ablation lesions under magnetic resonance imaging
4776751|NCT02761330|Anesthesia|anesthesia
4776752|NCT02761330|Electroconvulsive therapy|electroconvulsive therapy
4776753|NCT02761330|Delirium|delirium
4776754|NCT02761330|Electroencephalography|electroencephalography
4776755|NCT02761330|Seizures|seizures
4776756|NCT02761330|Depression|depression
4776757|NCT02761330|Ketamine|ketamine
4776758|NCT02761330|Etomidate|etomidate
4776759|NCT02761330|Physiological Effects of Drugs|physiological effects of drugs
4776760|NCT02761330|Pharmacologic Actions|pharmacologic actions
4776761|NCT02761330|Confusion|confusion
4776762|NCT02761330|Mental Disorders|mental disorders
4776763|NCT02761330|Neurobehavioral Manifestations|neurobehavioral manifestations
4776764|NCT02761330|Signs and Symptoms|signs and symptoms
4776765|NCT02761330|Neurologic Manifestations|neurologic manifestations
4776766|NCT02761330|Cognitive Disorders|cognitive disorders
4776767|NCT02761317|bowel preparation|bowel preparation
4776768|NCT02761317|bisacodyl|bisacodyl
4776769|NCT02761317|polyethyleneglycol|polyethyleneglycol
4776770|NCT02761317|colorectal surgery|colorectal surgery
4776771|NCT02761291|Nasopharyngeal carcinoma|nasopharyngeal carcinoma
4776772|NCT02761291|EB virus|eb virus
4776773|NCT02761291|metastasis|metastasis
4776774|NCT02761291|recurrence|recurrence
4776775|NCT02761291|cytolytic viral activation therapy|cytolytic viral activation therapy
4776776|NCT02761291|gemcitabine|gemcitabine
4776777|NCT02761291|valproic acid|valproic acid
4776778|NCT02761291|ganciclovir|ganciclovir
4776779|NCT02761291|valganciclovir|valganciclovir
4776780|NCT02761265|Degenerative Adult Scoliosis|degenerative adult scoliosis
4776781|NCT02761265|Gait Analysis|gait analysis
4776782|NCT02761265|Balance Analysis|balance analysis
4776783|NCT02761265|Biomechanics|biomechanics
4776784|NCT02761265|Neuromuscular Control|neuromuscular control
4776785|NCT02761265|Thoracolumbar Deformity|thoracolumbar deformity
4776786|NCT02761252|Bilastine|bilastine
4776787|NCT02761252|Montelukast|montelukast
4776788|NCT02761252|total symptom score|total symptom score
4776789|NCT02761252|AQLQ|aqlq
4776790|NCT02761239|cricopharyngeal muscle|cricopharyngeal muscle
4776791|NCT02761239|innervation by EBSLN|innervation by ebsln
4776792|NCT02761239|A prospective case-controlled study|a prospective case-controlled study
4776793|NCT02761226|platform switching|platform switching
4776794|NCT02761226|dental implant|dental implant
4776795|NCT02761226|crestal bone level|crestal bone level
4776796|NCT02761226|implant stability|implant stability
4776797|NCT02761226|postoperative complication|postoperative complication
4776798|NCT02761187|Drug Therapy|drug therapy
4776799|NCT02761174|Vascular lesions|vascular lesions
4776800|NCT02761174|inflammation|inflammation
4776801|NCT02761174|IPL|ipl
4776802|NCT02761161|PTSD|ptsd
4776803|NCT02761161|Sleep|sleep
4776804|NCT02761161|Refugee|refugee
4776805|NCT02761161|IRT|irt
4776806|NCT02761161|Mianserin|mianserin
4776807|NCT02761148|white matter hyperintensity|white matter hyperintensity
4776808|NCT02761148|brain network|brain network
4776809|NCT02761148|MRI|mri
4776810|NCT02761148|cognition|cognition
4776811|NCT02761148|emotion|emotion
4776812|NCT02761135|Biopsy technique|biopsy technique
4776813|NCT02761135|Transrectal ultrasonography probe|transrectal ultrasonography probe
4776814|NCT02761135|Side-fire|side-fire
4776815|NCT02761135|Prostate cancer|prostate cancer
4776816|NCT02761135|End-fire|end-fire
4776817|NCT02761083|Eye surgery|eye surgery
4776818|NCT02761083|Suture material|suture material
4776819|NCT02761083|Novosyn Quick|novosyn quick
4776820|NCT02761083|Vicryl Rapid|vicryl rapid
4776821|NCT02761070|glioblastoma|glioblastoma
4776822|NCT02761070|recurrent|recurrent
4776823|NCT02761070|dose-dense temozolomide|dose-dense temozolomide
4776824|NCT02761070|bevacizumab|bevacizumab
4776825|NCT02761031|Heart rate variability|heart rate variability
4776826|NCT02761031|Electrocardiography|electrocardiography
4776827|NCT02761031|Observational study|observational study
4776828|NCT02761031|Non-interventional study|non-interventional study
4776829|NCT02761031|Risk assessment|risk assessment
4776830|NCT02761031|Perioperative|perioperative
4776831|NCT02761005|Eradication therapy|eradication therapy
4776832|NCT02761005|Mutation of 23S rRNA of H. pylori|mutation of 23s rrna of h. pylori
4776833|NCT02761005|Personalized therapy|personalized therapy
4776834|NCT02760979|knee arthroplasty|knee arthroplasty
4776835|NCT02760953|Bladder Cancer|bladder cancer
4776836|NCT02760953|Cryoablation|cryoablation
4776837|NCT02760940|Inflammatory bowel diseases|inflammatory bowel diseases
4776838|NCT02760940|Anemia|anemia
4776839|NCT02760940|Crohn's disease|crohn's disease
4776840|NCT02760940|Ulcerative colitis|ulcerative colitis
4776841|NCT02760940|Oral iron|oral iron
4776842|NCT02760940|Quality of life|quality of life
4776843|NCT02760914|adipose tissue|adipose tissue
4776844|NCT02760914|inflammatory mediators|inflammatory mediators
4776845|NCT02760914|gene expression|gene expression
4776846|NCT02760875|Achilles Tendon Rupture|achilles tendon rupture
4776847|NCT02760875|Conservative treatment|conservative treatment
4776848|NCT02760875|early weight bearing|early weight bearing
4776849|NCT02760875|Achilles Tendon Length|achilles tendon length
4776850|NCT02760875|Ultrasound|ultrasound
4776851|NCT02760875|Foot Pressure Mapping|foot pressure mapping
4776852|NCT02760875|ATRA|atra
4776853|NCT02760875|Heel Raise Work|heel raise work
4776854|NCT02760849|Hereditary Breast and Ovarian Cancer Syndrome|hereditary breast and ovarian cancer syndrome
4776855|NCT02760849|HBOC|hboc
4776856|NCT02760849|Deleterious mutation in ovarian cancer genes|deleterious mutation in ovarian cancer genes
4776857|NCT02760849|Changes in female sexual function|changes in female sexual function
4776858|NCT02760849|Salpingectomy with delayed oophorectomy|salpingectomy with delayed oophorectomy
4776859|NCT02760849|ISDO|isdo
4776860|NCT02760849|Risk-reducing salpingo-oophorectomy (RRSO)|risk-reducing salpingo-oophorectomy (rrso)
4776861|NCT02760849|RRSO|rrso
4776862|NCT02760849|Questionnaires|questionnaires
4776863|NCT02760849|Surveys|surveys
4776864|NCT02760836|Crohn's disease|crohn's disease
4776865|NCT02760836|disease outcomes|disease outcomes
4776866|NCT02760784|Achilles Tendon Rupture|achilles tendon rupture
4776867|NCT02760784|Conservative treatment|conservative treatment
4776868|NCT02760784|early weight bearing|early weight bearing
4776869|NCT02760784|Dynamic|dynamic
4776870|NCT02760784|ATRS|atrs
4776871|NCT02760784|ATRA|atra
4776872|NCT02760784|Heel Raise Work|heel raise work
4776873|NCT02760771|THV (trans-catheter heart valve)|thv (trans-catheter heart valve)
4776874|NCT02760771|severe aortic stenosis|severe aortic stenosis
4776875|NCT02760771|pre-dilation|pre-dilation
4776876|NCT02760771|rapid pacing|rapid pacing
4776877|NCT02760771|BAV (balloon artery valvuloplasty|bav (balloon artery valvuloplasty
4776878|NCT02760758|non-nucleoside inhibitor|non-nucleoside inhibitor
4776879|NCT02760758|NNI|nni
4776880|NCT02760758|HCV|hcv
4776881|NCT02760758|DAA|daa
4776882|NCT02760745|fever|fever
4776883|NCT02760745|shivering|shivering
4776884|NCT02760745|chills|chills
4776885|NCT02760745|rigors|rigors
4776886|NCT02760745|severe bacterial infection|severe bacterial infection
4776887|NCT02760719|3% hypertonic solution|3% hypertonic solution
4776888|NCT02760719|duration of hospitalisation|duration of hospitalisation
4776889|NCT02760693|bipolar disorder, naturalistic cohort study,|bipolar disorder, naturalistic cohort study,
4776890|NCT02760693|defined catchment area,long term treatment|defined catchment area,long term treatment
4776891|NCT02760680|Chronic Heart Failure|chronic heart failure
4776892|NCT02760680|Sleep-Disordered Breathing|sleep-disordered breathing
4776893|NCT02760680|Peripheral Arterial Tone|peripheral arterial tone
4776894|NCT02760667|Oropharyngeal cancer|oropharyngeal cancer
4776895|NCT02760667|Laryngeal cancer|laryngeal cancer
4776896|NCT02760641|obesity|obesity
4776897|NCT02760641|low carbohydrate diet|low carbohydrate diet
4776898|NCT02760641|metabolism|metabolism
4776899|NCT02760641|body composition|body composition
4776900|NCT02760641|visceral fat|visceral fat
4776901|NCT02760641|older adults|older adults
4776902|NCT02760641|insulin sensitivity|insulin sensitivity
4776903|NCT02760615|Drug therapy|drug therapy
4776904|NCT02760602|anti-amyloid|anti-amyloid
4776905|NCT02760602|monoclonal antibody|monoclonal antibody
4776906|NCT02760589|ACL tear|acl tear
4776907|NCT02760589|ACL lesion|acl lesion
4776908|NCT02760589|ACL reconstruction|acl reconstruction
4776909|NCT02760589|InternalBrace|internalbrace
4776910|NCT02760589|functional performance test|functional performance test
4776911|NCT02760589|anterior cruciate ligament|anterior cruciate ligament
4776912|NCT02760537|Liver Neoplasms|liver neoplasms
4776913|NCT02760537|Hepatitis B|hepatitis b
4776914|NCT02760537|Hepatitis B vaccination|hepatitis b vaccination
4776915|NCT02760537|Asian Americans|asian americans
4776916|NCT02760537|Lay health workers|lay health workers
4776917|NCT02760537|Community health workers|community health workers
4776918|NCT02760511|Randomized Controlled Trial|randomized controlled trial
4776919|NCT02760511|Anthocyanin|anthocyanin
4776920|NCT02760511|Antioxidants|antioxidants
4776921|NCT02760485|Diffuse large B-cell lymphoma|diffuse large b-cell lymphoma
4776922|NCT02760485|Relapsed Diffuse large B-cell lymphoma|relapsed diffuse large b-cell lymphoma
4776923|NCT02760485|Refractory Diffuse large B-cell lymphoma|refractory diffuse large b-cell lymphoma
4776924|NCT02760485|activated B cell|activated b cell
4776925|NCT02760485|germinal center B-cell|germinal center b-cell
4776926|NCT02760485|non-Hodgkin lymphoma|non-hodgkin lymphoma
4776927|NCT02760485|JAK1 inhibitor|jak1 inhibitor
4776928|NCT02760485|Bruton's tyrosine kinase (BTK) inhibitor|bruton's tyrosine kinase (btk) inhibitor
4776929|NCT02760472|Retinopathy of Prematurity|retinopathy of prematurity
4776930|NCT02760472|Preterm|preterm
4776931|NCT02760472|Fatty acids|fatty acids
4776932|NCT02760433|moderate Rheumatoid Arthritis|moderate rheumatoid arthritis
4776933|NCT02760433|severe Rheumatoid Arthritis|severe rheumatoid arthritis
4776934|NCT02760433|Olokizumab|olokizumab
4776935|NCT02760407|moderate Rheumatoid Arthritis|moderate rheumatoid arthritis
4776936|NCT02760407|severe Rheumatoid Arthritis|severe rheumatoid arthritis
4776937|NCT02760407|subcutaneous|subcutaneous
4776938|NCT02760407|Olokizumab|olokizumab
4776939|NCT02760394|chronic ischemic heart disease|chronic ischemic heart disease
4776940|NCT02760394|coronary bypass|coronary bypass
4776941|NCT02760394|refractory stable angina|refractory stable angina
4776942|NCT02760394|HBOT|hbot
4776943|NCT02760394|reperfusion|reperfusion
4776944|NCT02760394|neoangiogenesis|neoangiogenesis
4776945|NCT02760394|microvascular|microvascular
4776946|NCT02760394|myocardial perfusion|myocardial perfusion
4776947|NCT02760368|moderate Rheumatoid Arthritis|moderate rheumatoid arthritis
4776948|NCT02760368|severe Rheumatoid Arthritis|severe rheumatoid arthritis
4776949|NCT02760368|subcutaneous|subcutaneous
4776950|NCT02760368|Olokizumab|olokizumab
4776951|NCT02760342|Pharmacokinetics|pharmacokinetics
4776952|NCT02760342|Metformin|metformin
4776953|NCT02760342|Drug-drug interaction|drug-drug interaction
4776954|NCT02760342|ASP015K|asp015k
4776955|NCT02760329|asthma|asthma
4776956|NCT02760329|COPD|copd
4776957|NCT02760329|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
4776958|NCT02760329|lung disease|lung disease
4776959|NCT02760329|chronic airways disease|chronic airways disease
4776960|NCT02760329|obstructive lung disease|obstructive lung disease
4776961|NCT02760316|Healthy Volunteers|healthy volunteers
4776962|NCT02760316|Obese|obese
4776963|NCT02760316|Insulin Resistant Subjects|insulin resistant subjects
4776964|NCT02760316|Rheumatoid Arthritis|rheumatoid arthritis
4776965|NCT02760303|insulin dependent diabetes mellitus|insulin dependent diabetes mellitus
4776966|NCT02760303|adolescents and young adults|adolescents and young adults
4776967|NCT02760303|stress reduction|stress reduction
4776968|NCT02760303|metabolic control|metabolic control
4776969|NCT02760290|Forced Expiratory Volume in 1 second|forced expiratory volume in 1 second
4776970|NCT02760290|Forced expiratory vital capacity|forced expiratory vital capacity
4776971|NCT02760290|Peak expiratory flow|peak expiratory flow
4776972|NCT02760277|Duchenne muscular dystrophy|duchenne muscular dystrophy
4776973|NCT02760277|vamorolone|vamorolone
4776974|NCT02760264|Duchenne Muscular Dystrophy|duchenne muscular dystrophy
4776975|NCT02760264|vamorolone|vamorolone
4776976|NCT02760251|immunomodulation|immunomodulation
4776977|NCT02760238|myeloproliferative neoplasm|myeloproliferative neoplasm
4776978|NCT02760238|myelodysplastic syndrome|myelodysplastic syndrome
4776979|NCT02760238|registry|registry
4776980|NCT02760238|leukemia|leukemia
4776981|NCT02760238|Bone Marrow Diseases|bone marrow diseases
4776982|NCT02760238|Hematologic Diseases|hematologic diseases
4776983|NCT02760238|Neoplasms|neoplasms
4776984|NCT02760225|Pembrolizumab|pembrolizumab
4776985|NCT02760225|PET imaging|pet imaging
4776986|NCT02760225|Melanoma|melanoma
4776987|NCT02760225|Non-small cell lung cancer|non-small cell lung cancer
4776988|NCT02760212|Shockwave therapy|shockwave therapy
4776989|NCT02760212|fMRI|fmri
4776990|NCT02760212|blood biomarkers|blood biomarkers
4776991|NCT02760173|verticality perception|verticality perception
4776992|NCT02760147|Pressure Support Ventilation|pressure support ventilation
4776993|NCT02760134|Super-Mini Percutaneous Nephrolithotomy(SMP)|super-mini percutaneous nephrolithotomy(smp)
4776994|NCT02760134|Renal Pelvic Pressure|renal pelvic pressure
4776995|NCT02760121|Acetazolamide|acetazolamide
4776996|NCT02760121|Methazolamide|methazolamide
4776997|NCT02760121|Control of breathing|control of breathing
4776998|NCT02760121|Hypoxic pulmonary vasoconstriction|hypoxic pulmonary vasoconstriction
4776999|NCT02760108|Early onset Parkinson's disease|early onset parkinson's disease
4777000|NCT02760108|Familial Parkinson's disease|familial parkinson's disease
4777001|NCT02760108|Parkinson's disease|parkinson's disease
4777002|NCT02760108|Genetics|genetics
4777003|NCT02760095|environmental enteric dysfunction|environmental enteric dysfunction
4777004|NCT02760095|environmental enteropathy|environmental enteropathy
4777005|NCT02760095|zinc|zinc
4777006|NCT02760095|vitamin A|vitamin a
4777007|NCT02760095|Bangladesh|bangladesh
4777008|NCT02760082|Multiple Sclerosis|multiple sclerosis
4777009|NCT02760082|Qualitative study|qualitative study
4777010|NCT02760082|Motivation|motivation
4777011|NCT02760056|Thyroid hormone|thyroid hormone
4777012|NCT02760056|Remyelination|remyelination
4777013|NCT02760004|Depression|depression
4777014|NCT02759991|Hepatitis E virus|hepatitis e virus
4777015|NCT02759991|Viral Hepatitis Vaccines|viral hepatitis vaccines
4777016|NCT02759978|Imaging|imaging
4777017|NCT02759978|Computed Tomography|computed tomography
4777018|NCT02759978|Magnetic Resonance Imaging|magnetic resonance imaging
4777019|NCT02759978|Positron Emission Tomography|positron emission tomography
4777020|NCT02759978|Leukocyte Scintigraphy|leukocyte scintigraphy
4777021|NCT02759978|Microbiological diagnostics|microbiological diagnostics
4777022|NCT02759978|Sonication|sonication
4777023|NCT02759978|Drug Monitoring|drug monitoring
4777024|NCT02759978|Cardiac Surgery|cardiac surgery
4777025|NCT02759952|retinitis pigmentosa|retinitis pigmentosa
4777026|NCT02759952|PDE6A|pde6a
4777027|NCT02759952|gene therapy trial|gene therapy trial
4777028|NCT02759939|Shared Decision-Making|shared decision-making
4777029|NCT02759939|Patient-Provider Communication|patient-provider communication
4777030|NCT02759926|Healthy volunteers|healthy volunteers
4777031|NCT02759926|Obesity|obesity
4777032|NCT02759926|Bitter|bitter
4777033|NCT02759913|neuromuscular diseases|neuromuscular diseases
4777034|NCT02759848|COPD, tuberculosis, mortality|copd, tuberculosis, mortality
4777035|NCT02759835|EGFR Tyrosine Kinase Inhibitors|egfr tyrosine kinase inhibitors
4777036|NCT02759835|T790M Mutation|t790m mutation
4777037|NCT02759835|Local Ablative Therapies|local ablative therapies
4777038|NCT02759835|Oligoprogressive Disease|oligoprogressive disease
4777039|NCT02759835|Acquired Resistance|acquired resistance
4777040|NCT02759822|Haploidentical Hematopoietic Stem Cell Transplantation|haploidentical hematopoietic stem cell transplantation
4777041|NCT02759822|Partially Matched Hematopoietic Stem Cell Transplantation|partially matched hematopoietic stem cell transplantation
4777042|NCT02759822|Post-transplant Cyclophosphamide|post-transplant cyclophosphamide
4777043|NCT02759822|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
4777044|NCT02759783|Radiotherapy|radiotherapy
4777045|NCT02759783|oligometastases|oligometastases
4777046|NCT02759783|SBRT|sbrt
4777047|NCT02759757|Kinesio Taping|kinesio taping
4777048|NCT02759757|Low back Pain|low back pain
4777049|NCT02759757|Electromyographic|electromyographic
4777051|NCT02759744|Thermal Ablation|thermal ablation
4777052|NCT02759744|Localized Prostate Cancer|localized prostate cancer
4777053|NCT02759744|Medtronic-Visualase|medtronic-visualase
4777054|NCT02759744|Thermal Damage|thermal damage
4777055|NCT02759744|PSA Levels|psa levels
4777056|NCT02759731|Murine Models|murine models
4777057|NCT02759731|Rheumatoid Arthritis|rheumatoid arthritis
4777058|NCT02759731|Corticosteroids|corticosteroids
4777059|NCT02759731|Systemic Therapy|systemic therapy
4777060|NCT02759731|Inflammatory Cytokines|inflammatory cytokines
4777061|NCT02759718|pancreatic neuroendocrine tumor|pancreatic neuroendocrine tumor
4777062|NCT02759718|chromogranin A|chromogranin a
4777063|NCT02759705|fertility|fertility
4777064|NCT02759705|sexuality|sexuality
4777065|NCT02759705|male|male
4777066|NCT02759705|exstrophy-epispadias complex|exstrophy-epispadias complex
4777067|NCT02759705|bladder exstrophy|bladder exstrophy
4777068|NCT02759705|epispadias|epispadias
4777069|NCT02759666|PARP|parp
4777070|NCT02759666|advanced solid tumor|advanced solid tumor
4777071|NCT02759640|c-Met kinase inhibitor|c-met kinase inhibitor
4777072|NCT02759640|Advanced solid tumors|advanced solid tumors
4777073|NCT02759627|Rehabilitation|rehabilitation
4777074|NCT02759627|Gait|gait
4777075|NCT02759627|Ambulation|ambulation
4777076|NCT02759627|Exercise Therapy|exercise therapy
4777077|NCT02759627|Physical Exertion|physical exertion
4777078|NCT02759627|Motor Skills|motor skills
4777079|NCT02759601|HDAC Inhibitor|hdac inhibitor
4777080|NCT02759601|Tefinostat|tefinostat
4777081|NCT02759601|Inflammation|inflammation
4777082|NCT02759601|Hepatocellular Carcinoma|hepatocellular carcinoma
4777083|NCT02759601|Cancer associated Inflammation in Hepatocellular Carcinoma|cancer associated inflammation in hepatocellular carcinoma
4777084|NCT02759588|GL-ONC1|gl-onc1
4777085|NCT02759588|oncolytic virus|oncolytic virus
4777086|NCT02759588|virotherapy|virotherapy
4777087|NCT02759588|Viral therapy|viral therapy
4777088|NCT02759588|immunotherapy|immunotherapy
4777089|NCT02759588|immune therapy|immune therapy
4777090|NCT02759588|vaccinia|vaccinia
4777091|NCT02759588|vaccinia virus|vaccinia virus
4777092|NCT02759588|Genelux|genelux
4777093|NCT02759588|ovarian cancer|ovarian cancer
4777094|NCT02759588|platinum resistant|platinum resistant
4777095|NCT02759588|platinum refractory|platinum refractory
4777096|NCT02759588|peritoneal carcinomatosis|peritoneal carcinomatosis
4777097|NCT02759588|fallopian cancer|fallopian cancer
4777098|NCT02759588|cancer|cancer
4777099|NCT02759588|abdominal cancer|abdominal cancer
4777100|NCT02759588|imaging|imaging
4777101|NCT02759588|carcinoma|carcinoma
4777102|NCT02759588|DNA virus|dna virus
4777103|NCT02759588|neoplasms|neoplasms
4777104|NCT02759588|neoplasms by histological type|neoplasms by histological type
4777105|NCT02759588|neoplasms, Glandular and Epithelial|neoplasms, glandular and epithelial
4777106|NCT02759588|Poxviridae infections|poxviridae infections
4777107|NCT02759588|Virus diseases|virus diseases
4777108|NCT02759588|recurrent ovarian cancer|recurrent ovarian cancer
4777109|NCT02759588|intermediate platinum-sensitive|intermediate platinum-sensitive
4777110|NCT02759549|Radiation Therapy|radiation therapy
4777111|NCT02759523|Magnetic Resonance Imaging|magnetic resonance imaging
4777112|NCT02759523|Portion Size|portion size
4777113|NCT02759523|Energy Intake|energy intake
4777114|NCT02759510|cardiac output|cardiac output
4777115|NCT02759510|norepinephrin|norepinephrin
4777116|NCT02759510|cesarean section|cesarean section
4777117|NCT02759484|CHWs|chws
4777118|NCT02759484|Health Education|health education
4777119|NCT02759484|Disease Self Management|disease self management
4777120|NCT02759445|alcohol induced cardiomyopathy|alcohol induced cardiomyopathy
4777121|NCT02759445|myocardial deformation imaging|myocardial deformation imaging
4777122|NCT02759432|high-intensity interval training|high-intensity interval training
4777123|NCT02759432|adolescents|adolescents
4777124|NCT02759432|physical fitness|physical fitness
4777125|NCT02759432|quality of life|quality of life
4777126|NCT02759432|school-based intervention|school-based intervention
4777127|NCT02759367|Nutrition|nutrition
4777128|NCT02759367|Potassium|potassium
4777129|NCT02759354|Immune response|immune response
4777130|NCT02759328|Stroke|stroke
4777131|NCT02759328|Rehabilitation|rehabilitation
4777132|NCT02759328|Serious games|serious games
4777133|NCT02759328|Virtual reality|virtual reality
4777134|NCT02759328|Xbox Kinect™|xbox kinect™
4777135|NCT02759302|MRI|mri
4777136|NCT02759302|LGMD|lgmd
4777137|NCT02759302|POMT2|pomt2
4777138|NCT02759289|Arsenic|arsenic
4777139|NCT02759276|Nailfold Videocapillaroscopy|nailfold videocapillaroscopy
4777140|NCT02759276|Venous Occlusion Plethysmography|venous occlusion plethysmography
4777141|NCT02759276|Endothelial Function|endothelial function
4777142|NCT02759276|Microcirculation|microcirculation
4777143|NCT02759276|Inflammatory Biomarkers|inflammatory biomarkers
4777144|NCT02759185|PTSD|ptsd
4777145|NCT02759185|marijuana|marijuana
4777146|NCT02759185|cannabis|cannabis
4777147|NCT02759185|sleep|sleep
4777148|NCT02759185|THC|thc
4777149|NCT02759185|CBD|cbd
4777150|NCT02759172|Suicide prevention|suicide prevention
4777151|NCT02759172|Jail|jail
4777347|NCT02758028|Youth|youth
4777152|NCT02759120|Idiopathic Pulmonary Fibrosis|idiopathic pulmonary fibrosis
4777153|NCT02759120|IPF|ipf
4777154|NCT02759120|pulmonary fibrosis|pulmonary fibrosis
4777155|NCT02759120|antimicrobial therapy|antimicrobial therapy
4777156|NCT02759120|doxycycline|doxycycline
4777157|NCT02759120|co-trimoxazole|co-trimoxazole
4777158|NCT02759094|GERD|gerd
4777159|NCT02759094|Implantable medical device|implantable medical device
4777160|NCT02759094|RefluxStop|refluxstop
4777161|NCT02759094|Reflux|reflux
4777162|NCT02759094|Gastroesophageal Reflux|gastroesophageal reflux
4777163|NCT02759094|Laparoscopy|laparoscopy
4777164|NCT02759094|pH-Monitoring|ph-monitoring
4777165|NCT02759094|PPI proton pump inhibitors|ppi proton pump inhibitors
4777166|NCT02759068|vegetative state|vegetative state
4777167|NCT02759068|minimally conscious state|minimally conscious state
4777168|NCT02759068|music|music
4777169|NCT02759068|preference|preference
4777170|NCT02758990|Food|food
4777171|NCT02758990|Nutrigenomics|nutrigenomics
4777172|NCT02758990|Precision Medicine|precision medicine
4777173|NCT02758990|Pharmacogenetics|pharmacogenetics
4777174|NCT02758990|Lifestyle|lifestyle
4777175|NCT02758977|Colorectal liver metastases|colorectal liver metastases
4777176|NCT02758977|Liver Surgery|liver surgery
4777177|NCT02758977|ALPPS|alpps
4777178|NCT02758977|Two Stage Hepatectomy|two stage hepatectomy
4777179|NCT02758977|Surgical Oncology|surgical oncology
4777180|NCT02758977|Hepatectomy|hepatectomy
4777181|NCT02758964|TAVR|tavr
4777182|NCT02758964|TAVI|tavi
4777183|NCT02758964|Transcatheter Aortic Valve Replacement|transcatheter aortic valve replacement
4777184|NCT02758964|Intracranial Embolism|intracranial embolism
4777185|NCT02758951|Induction Chemotherapy|induction chemotherapy
4777186|NCT02758951|Chemotherapy, Adjuvant|chemotherapy, adjuvant
4777187|NCT02758951|Molecular Targeted Therapy|molecular targeted therapy
4777188|NCT02758951|Colorectal Surgery|colorectal surgery
4777189|NCT02758951|Cytoreductive Surgery|cytoreductive surgery
4777312|NCT02758327|Tear Osmolarity|tear osmolarity
4777190|NCT02758951|Hyperthermic Intraperitoneal Chemotherapy|hyperthermic intraperitoneal chemotherapy
4777191|NCT02758951|Peritoneum|peritoneum
4777192|NCT02758951|Peritoneal Lavage|peritoneal lavage
4777193|NCT02758951|Peritoneal Cavity|peritoneal cavity
4777194|NCT02758951|Ascitic Fluid|ascitic fluid
4777195|NCT02758951|Chemotherapy, Cancer, Regional Perfusion|chemotherapy, cancer, regional perfusion
4777196|NCT02758951|Antineoplastic Combined Chemotherapy Protocols|antineoplastic combined chemotherapy protocols
4777197|NCT02758951|Drug Therapy, Combination|drug therapy, combination
4777198|NCT02758951|Drug Therapy|drug therapy
4777199|NCT02758951|Morbidity|morbidity
4777200|NCT02758951|Mortality|mortality
4777201|NCT02758951|Hospital Mortality|hospital mortality
4777202|NCT02758951|Chemically-Induced Disorders|chemically-induced disorders
4777203|NCT02758951|Drug-Related Side Effects and Adverse Reactions|drug-related side effects and adverse reactions
4777204|NCT02758951|Laparotomy|laparotomy
4777205|NCT02758899|Anterior cervical discectomy|anterior cervical discectomy
4777206|NCT02758899|Anterior cervical fusion|anterior cervical fusion
4777207|NCT02758860|Colonoscopy|colonoscopy
4777208|NCT02758860|Diverticular disease of the colon|diverticular disease of the colon
4777209|NCT02758860|Classification|classification
4777210|NCT02758847|critical lower limb ischemia with tissue loss|critical lower limb ischemia with tissue loss
4777211|NCT02758834|Preterm Infants|preterm infants
4777212|NCT02758834|Phytosterols|phytosterols
4777213|NCT02758834|Parenteral Nutrition|parenteral nutrition
4777214|NCT02758821|C-reactive protein|c-reactive protein
4777215|NCT02758821|antibiotic|antibiotic
4777216|NCT02758795|protein|protein
4777217|NCT02758795|inflammation|inflammation
4777218|NCT02758795|anti-inflammatory agents|anti-inflammatory agents
4777219|NCT02758743|smoking|smoking
4777220|NCT02758743|tobacco|tobacco
4777221|NCT02758743|smoking cessation|smoking cessation
4777222|NCT02758730|GBA mutation|gba mutation
4777223|NCT02758704|Intubation|intubation
4777224|NCT02758704|Neonatal|neonatal
4777225|NCT02758704|Teaching|teaching
4777226|NCT02758704|Stress|stress
4777227|NCT02758704|Simulation|simulation
4777228|NCT02758691|memory|memory
4777229|NCT02758691|insulin|insulin
4777230|NCT02758678|P-selectin|p-selectin
4777231|NCT02758678|Lung Cancer|lung cancer
4777232|NCT02758678|Raman Spectroscopy|raman spectroscopy
4777233|NCT02758665|CLL|cll
4777234|NCT02758665|chronic lymphocytic leukemia|chronic lymphocytic leukemia
4777235|NCT02758665|ibrutinib|ibrutinib
4777236|NCT02758665|venetoclax|venetoclax
4777237|NCT02758665|obinutuzumab|obinutuzumab
4777238|NCT02758665|TP53 Deletion|tp53 deletion
4777239|NCT02758652|chemoresistance|chemoresistance
4777240|NCT02758652|miRNA|mirna
4777241|NCT02758652|microRNA|microrna
4777242|NCT02758639|parental cancer|parental cancer
4777243|NCT02758639|children psychosocial adjustment|children psychosocial adjustment
4777244|NCT02758639|psychosocial intervention|psychosocial intervention
4777245|NCT02758574|acute pulmonary embolism|acute pulmonary embolism
4777246|NCT02758574|submassive pulmonary embolism|submassive pulmonary embolism
4777247|NCT02758574|thrombolysis|thrombolysis
4777248|NCT02758574|catheter directed thrombolysis|catheter directed thrombolysis
4777654|NCT02756286|Attention|attention
4777249|NCT02758574|ultrasound assisted thrombolysis|ultrasound assisted thrombolysis
4777250|NCT02758561|decisional aid|decisional aid
4777251|NCT02758561|workshops|workshops
4777252|NCT02758561|urinary incontinence|urinary incontinence
4777253|NCT02758561|pelvic organ prolapse|pelvic organ prolapse
4777254|NCT02758561|pelvic floor dysfunction|pelvic floor dysfunction
4777255|NCT02758561|decisional conflict|decisional conflict
4777256|NCT02758548|Total IgE measurement|total ige measurement
4777257|NCT02758548|Novel Point-of-care test device|novel point-of-care test device
4777258|NCT02758548|atopic conditions|atopic conditions
4777259|NCT02758548|in vitro diagnostic test|in vitro diagnostic test
4777260|NCT02758522|Diabetes Mellitus|diabetes mellitus
4777261|NCT02758522|Hospital Hyperglycemia|hospital hyperglycemia
4777262|NCT02758496|Autism, chart review, transcranial magnetic stimulation (TMS)|autism, chart review, transcranial magnetic stimulation (tms)
4777263|NCT02758470|Muscle Fatigue|muscle fatigue
4777264|NCT02758470|Acetazolamide|acetazolamide
4777265|NCT02758470|Methazolamide|methazolamide
4777266|NCT02758457|cad/cam|cad/cam
4777267|NCT02758457|dental porcelain|dental porcelain
4777268|NCT02758457|zirconia|zirconia
4777269|NCT02758457|press on metal|press on metal
4777270|NCT02758444|environmental enteric dysfunction|environmental enteric dysfunction
4777271|NCT02758444|environmental enteropathy|environmental enteropathy
4777272|NCT02758444|zinc absorption|zinc absorption
4777273|NCT02758444|Bangladesh|bangladesh
4777274|NCT02758444|toddlers|toddlers
4777275|NCT02758444|zinc isotope|zinc isotope
4777276|NCT02758431|testosterone|testosterone
4777277|NCT02758418|Adjustment disorders online|adjustment disorders online
4777278|NCT02758418|Psychological Treatments|psychological treatments
4777279|NCT02758418|Information and Communication Technologies|information and communication technologies
4777280|NCT02758418|Internet|internet
4777281|NCT02758405|Epidural|epidural
4777282|NCT02758405|Labor analgesia|labor analgesia
4777283|NCT02758405|Programmed intermittent epidural bolus|programmed intermittent epidural bolus
4777284|NCT02758392|Healthy|healthy
4777285|NCT02758392|JNJ-61178104|jnj-61178104
4777286|NCT02758392|Placebo|placebo
4777287|NCT02758392|Safety|safety
4777288|NCT02758379|coronary artery disease|coronary artery disease
4777289|NCT02758379|calcified lesions|calcified lesions
4777290|NCT02758379|lithotripsy|lithotripsy
4777291|NCT02758366|glioblastoma multiforme|glioblastoma multiforme
4777292|NCT02758366|high grade glioma|high grade glioma
4777293|NCT02758366|diffuse intrinsic pontine glioma|diffuse intrinsic pontine glioma
4777294|NCT02758366|DIPG|dipg
4777295|NCT02758366|doxorubicin|doxorubicin
4777296|NCT02758366|temozolomide|temozolomide
4777297|NCT02758366|malignant glioma|malignant glioma
4777298|NCT02758366|Brainstem Glioma|brainstem glioma
4777299|NCT02758366|diffuse spinal glioma|diffuse spinal glioma
4777300|NCT02758366|bilateral thalamic glioma|bilateral thalamic glioma
4777301|NCT02758366|Anaplastic Astrocytoma|anaplastic astrocytoma
4777302|NCT02758366|Gliomatosis Cerebri|gliomatosis cerebri
4777303|NCT02758366|Midline Diffuse Glioma|midline diffuse glioma
4777304|NCT02758353|Malaria in Pregnancy|malaria in pregnancy
4777305|NCT02758353|Nigeria|nigeria
4777306|NCT02758353|Sulfadoxine-Pyrimethamine|sulfadoxine-pyrimethamine
4777307|NCT02758353|Scale up|scale up
4777308|NCT02758353|Primary Health Care|primary health care
4777309|NCT02758340|induction of labor|induction of labor
4777310|NCT02758340|misoprostol|misoprostol
4777311|NCT02758340|foley's balloon catheter|foley's balloon catheter
4777313|NCT02758327|Keratitis Sicca|keratitis sicca
4777314|NCT02758327|Ocular Surface Disease|ocular surface disease
4777315|NCT02758327|TheraTears|theratears
4777316|NCT02758314|PD-1|pd-1
4777317|NCT02758314|PD-L1|pd-l1
4777318|NCT02758314|NSCLC|nsclc
4777319|NCT02758288|Kidney transplant|kidney transplant
4777320|NCT02758288|BK Viremia|bk viremia
4777321|NCT02758288|BK Nephropathy|bk nephropathy
4777322|NCT02758275|Medication adherence|medication adherence
4777323|NCT02758275|Patient compliance|patient compliance
4777324|NCT02758275|Diabetes mellitus, Type 2|diabetes mellitus, type 2
4777325|NCT02758275|Hypertension|hypertension
4777326|NCT02758275|Nursing|nursing
4777327|NCT02758275|Nursing process|nursing process
4777328|NCT02758275|Teaching|teaching
4777329|NCT02758275|Randomized controlled trial|randomized controlled trial
4777330|NCT02758210|Bradycardia|bradycardia
4777331|NCT02758210|Atrial Tachyarrhythmia|atrial tachyarrhythmia
4777332|NCT02758210|Smart Phone|smart phone
4777333|NCT02758210|Tablet|tablet
4777334|NCT02758197|Mindfulness|mindfulness
4777335|NCT02758197|Chronic Pain|chronic pain
4777336|NCT02758197|Quality of Life|quality of life
4777337|NCT02758197|Immune Function|immune function
4777338|NCT02758197|Cancer survivors|cancer survivors
4777339|NCT02758197|Disability|disability
4777340|NCT02758132|Castrate-resistant prostate cancer with bone metastases|castrate-resistant prostate cancer with bone metastases
4777341|NCT02758106|chest wall oscillation|chest wall oscillation
4777342|NCT02758106|acute respiratory failure|acute respiratory failure
4777343|NCT02758106|airway secretion|airway secretion
4777344|NCT02758080|Personalized medicine|personalized medicine
4777345|NCT02758080|Next generation sequencing|next generation sequencing
4777346|NCT02758041|Acne|acne
4777348|NCT02758028|Adventure-based training|adventure-based training
4777349|NCT02758028|WhatsApp messages|whatsapp messages
4777350|NCT02758015|betaine|betaine
4777351|NCT02758015|betaine hydrochloride|betaine hydrochloride
4777352|NCT02758015|healthy volunteer|healthy volunteer
4777353|NCT02758015|gastric pH|gastric ph
4777354|NCT02758002|atrial fibrillation ablation|atrial fibrillation ablation
4777355|NCT02758002|ablation|ablation
4777356|NCT02758002|atrial fibrillation rotors|atrial fibrillation rotors
4777357|NCT02757989|Low risk MDS|low risk mds
4777358|NCT02757989|Transplantation|transplantation
4777359|NCT02757963|Screening tool|screening tool
4777360|NCT02757963|International Prostate Symptom Score|international prostate symptom score
4777361|NCT02757963|Lower urinary tract symptoms|lower urinary tract symptoms
4777362|NCT02757963|BPO|bpo
4777363|NCT02757963|BPE|bpe
4777364|NCT02757963|Benign prostatic enlargement|benign prostatic enlargement
4777365|NCT02757963|Benign prostatic obstruction|benign prostatic obstruction
4777366|NCT02757963|LUTS|luts
4777367|NCT02757963|Benign prostatic hyperplasia|benign prostatic hyperplasia
4777368|NCT02757963|IPSS|ipss
4777369|NCT02757963|BPH|bph
4777370|NCT02757950|exposed and unexposed cohorts|exposed and unexposed cohorts
4777371|NCT02757950|post-marketing, maternal immunization|post-marketing, maternal immunization
4777372|NCT02757950|neonate related Adverse Events|neonate related adverse events
4777373|NCT02757950|Congenital anomaly|congenital anomaly
4777374|NCT02757950|RefortrixTM|refortrixtm
4777375|NCT02757950|Pregnancy related Adverse Events|pregnancy related adverse events
4777376|NCT02757937|Medication Adherence|medication adherence
4777377|NCT02757937|Self-efficacy|self-efficacy
4777378|NCT02757937|Behavior|behavior
4777379|NCT02757937|Diabetes|diabetes
4777380|NCT02757937|Diabetes Mellitus|diabetes mellitus
4777381|NCT02757911|XCGD|xcgd
4777382|NCT02757898|Red Blood Cell (RBC) transfusion|red blood cell (rbc) transfusion
4777383|NCT02757898|Biotin labeled red blood cells|biotin labeled red blood cells
4777384|NCT02757885|bone marrow transplant|bone marrow transplant
4777385|NCT02757872|Hypertension|hypertension
4777386|NCT02757872|Kidney Diseases|kidney diseases
4777387|NCT02757872|Vitamin D|vitamin d
4777388|NCT02757872|Omega 3 fatty acids|omega 3 fatty acids
4777389|NCT02757846|Radiomics|radiomics
4777390|NCT02757846|prognosis|prognosis
4777391|NCT02757846|medical images|medical images
4777392|NCT02757846|Hepatocellular carcinoma|hepatocellular carcinoma
4777393|NCT02757820|anesthesia; airway; laryngeal mask airway; I-gel; Air-Q|anesthesia; airway; laryngeal mask airway; i-gel; air-q
4777394|NCT02757807|Erectile Dysfunction|erectile dysfunction
4777395|NCT02757781|Patient empowerment|patient empowerment
4777396|NCT02757781|Patient involvement|patient involvement
4777397|NCT02757781|Patient participation|patient participation
4777398|NCT02757781|Healthcare professional attitudes|healthcare professional attitudes
4777399|NCT02757781|Chronic diseases|chronic diseases
4777400|NCT02757768|Myrbetriq|myrbetriq
4777401|NCT02757768|Lower Urinary Tract Symptoms|lower urinary tract symptoms
4777402|NCT02757768|Benign Prostatic Hyperplasia|benign prostatic hyperplasia
4777403|NCT02757768|Overactive Bladder|overactive bladder
4777404|NCT02757768|Betmiga|betmiga
4777405|NCT02757768|Mirabegron|mirabegron
4777406|NCT02757768|Tamsulosin Hydrochloride|tamsulosin hydrochloride
4777407|NCT02757742|sudden cardiac death|sudden cardiac death
4777408|NCT02757742|ventricular arrhythmias|ventricular arrhythmias
4777409|NCT02757742|cardiopathy|cardiopathy
4777410|NCT02757742|late gadolinium enhancement|late gadolinium enhancement
4777411|NCT02757716|addiction remission|addiction remission
4777412|NCT02757716|addiction transfer|addiction transfer
4777413|NCT02757703|somatostatin|somatostatin
4777414|NCT02757703|variceal bleeding|variceal bleeding
4777415|NCT02757703|terlipressin|terlipressin
4777416|NCT02757664|achilles|achilles
4777417|NCT02757664|tendinopathy|tendinopathy
4777418|NCT02757664|Physical Therapy Modalities|physical therapy modalities
4777419|NCT02757664|High-Energy Shock Waves|high-energy shock waves
4777420|NCT02757612|laser diode, pain|laser diode, pain
4777421|NCT02757586|chronic lymphocytic leukemia|chronic lymphocytic leukemia
4777422|NCT02757586|XPO1|xpo1
4777423|NCT02757586|in vitro|in vitro
4777424|NCT02757586|in vivo|in vivo
4777425|NCT02757560|saturated fat|saturated fat
4777426|NCT02757560|acute insulin resistance|acute insulin resistance
4777427|NCT02757560|insulin suppression test|insulin suppression test
4777428|NCT02757560|dietary fatty acids|dietary fatty acids
4777429|NCT02757521|Bipolar Depressive Disorder|bipolar depressive disorder
4777430|NCT02757521|Treatment- Resistant Bipolar Disorder|treatment- resistant bipolar disorder
4777431|NCT02757521|Nitrous Oxide|nitrous oxide
4777432|NCT02757495|sevoflurane emergence agitation|sevoflurane emergence agitation
4777433|NCT02757495|caudal dexmedetomidine|caudal dexmedetomidine
4777434|NCT02757482|Patient training|patient training
4777435|NCT02757482|Warfarin|warfarin
4777436|NCT02757482|International Normalized Ratio|international normalized ratio
4777437|NCT02757482|Nursing|nursing
4777438|NCT02757456|exercise|exercise
4777439|NCT02757456|hemodialysis|hemodialysis
4777440|NCT02757456|pulse wave velocity|pulse wave velocity
4777441|NCT02757456|micro RNAs|micro rnas
4777442|NCT02757443|Phosphocreatine|phosphocreatine
4777443|NCT02757443|Creatine Phosphate|creatine phosphate
4777444|NCT02757443|Neoton|neoton
4777445|NCT02757443|Phosphate, Creatine|phosphate, creatine
4777446|NCT02757443|Phosphorylcreatine|phosphorylcreatine
4777447|NCT02757404|botulinum toxin|botulinum toxin
4777448|NCT02757404|spasticity|spasticity
4777449|NCT02757404|injection technique|injection technique
4777450|NCT02757404|neuronox|neuronox
4777451|NCT02757404|meditoxin|meditoxin
4777452|NCT02757391|Advanced gastrointestinal malignancies|advanced gastrointestinal malignancies
4777453|NCT02757391|Metastatic gastrointestinal tumor|metastatic gastrointestinal tumor
4777454|NCT02757391|Adoptive T cell infusion|adoptive t cell infusion
4777455|NCT02757391|Cyclophosphamide|cyclophosphamide
4777456|NCT02757391|Cytoxan|cytoxan
4777457|NCT02757391|Neosar|neosar
4777458|NCT02757391|IL-2|il-2
4777459|NCT02757391|Aldesleukin|aldesleukin
4777460|NCT02757391|Interleukin-2|interleukin-2
4777461|NCT02757391|Proleukin|proleukin
4777462|NCT02757391|Pembrolizumab|pembrolizumab
4777463|NCT02757391|Keytruda|keytruda
4777464|NCT02757391|MK-3475|mk-3475
4777465|NCT02757391|SCH-900475|sch-900475
4777466|NCT02757391|Phone calls|phone calls
4777467|NCT02757378|Pain|pain
4777468|NCT02757378|Brain|brain
4777469|NCT02757378|Plasticity|plasticity
4777470|NCT02757378|Education|education
4777471|NCT02757378|Manual Therapy|manual therapy
4777472|NCT02757378|Straight Leg Raise|straight leg raise
4777473|NCT02757378|Remapping|remapping
4777474|NCT02757365|aspirin|aspirin
4777475|NCT02757352|ankylosing|ankylosing
4777476|NCT02757352|nonradiographic spondyloarthritis|nonradiographic spondyloarthritis
4777477|NCT02757339|neurobiology|neurobiology
4777478|NCT02757339|PTSD|ptsd
4777479|NCT02757339|DID|did
4777480|NCT02757326|sphingosine kinase 2 inhibitor|sphingosine kinase 2 inhibitor
4777481|NCT02757326|sphingosine kinase 2|sphingosine kinase 2
4777482|NCT02757326|SK2 inhibitor|sk2 inhibitor
4777483|NCT02757326|SK2|sk2
4777484|NCT02757313|marijuana|marijuana
4777485|NCT02757313|driving|driving
4777486|NCT02757313|THC|thc
4777487|NCT02757313|cannabis|cannabis
4777488|NCT02757313|intoxication|intoxication
4777489|NCT02757313|MRI|mri
4777490|NCT02757287|Ovarian stimulation|ovarian stimulation
4777491|NCT02757287|LH inhibition|lh inhibition
4777492|NCT02757274|Urologic Surgical Procedure|urologic surgical procedure
4777493|NCT02757274|Male|male
4777494|NCT02757261|Bruxism|bruxism
4777495|NCT02757261|Child|child
4777496|NCT02757261|Occlusal splint|occlusal splint
4777497|NCT02757261|Bite force|bite force
4777498|NCT02757261|Acunpuncture|acunpuncture
4777499|NCT02757261|Laser|laser
4777500|NCT02757261|Muscle actvity|muscle actvity
4777501|NCT02757261|Salivary Cortisol|salivary cortisol
4777502|NCT02757235|chronic subdural hematoma|chronic subdural hematoma
4777503|NCT02757235|irrigation|irrigation
4777504|NCT02757235|recurrence|recurrence
4777505|NCT02757235|burr hole evacuation|burr hole evacuation
4777506|NCT02757235|temperature|temperature
4777507|NCT02757209|ASTHMA|asthma
4777508|NCT02757209|COPD|copd
4777509|NCT02757209|budesonide|budesonide
4777510|NCT02757209|formoterol|formoterol
4777511|NCT02757209|Salmeterol|salmeterol
4777512|NCT02757209|Fluticasone|fluticasone
4777513|NCT02757209|Spiromax|spiromax
4777514|NCT02757209|DPI|dpi
4777515|NCT02757209|Diskus|diskus
4777516|NCT02757196|Immune Thrombocytopenia|immune thrombocytopenia
4777517|NCT02757196|Rituximab|rituximab
4777518|NCT02757196|methylprednisolone|methylprednisolone
4777519|NCT02757157|Hydrotherapy|hydrotherapy
4777520|NCT02757157|Walking|walking
4777521|NCT02757131|Mobility|mobility
4777522|NCT02757131|Elderly|elderly
4777523|NCT02757131|Hospitalized patient|hospitalized patient
4777524|NCT02757118|Cardiac Surgery, blood viscosity|cardiac surgery, blood viscosity
4777525|NCT02757092|Pulmonary rehabilitation|pulmonary rehabilitation
4777526|NCT02757092|lung cancer|lung cancer
4777527|NCT02757092|Thoracoscopy|thoracoscopy
4777528|NCT02757079|Melatonin|melatonin
4777529|NCT02757079|NPC-15|npc-15
4777530|NCT02757079|Sleep disorders|sleep disorders
4777531|NCT02757079|Neurodevelopmental disorder|neurodevelopmental disorder
4777532|NCT02757079|Sleep latency|sleep latency
4777533|NCT02757079|DSM-5|dsm-5
4777534|NCT02757066|Melatonin|melatonin
4777535|NCT02757066|NPC-15|npc-15
4777536|NCT02757066|Sleep disorders|sleep disorders
4777537|NCT02757066|Autism spectrum disorders|autism spectrum disorders
4777538|NCT02757066|DSM-5|dsm-5
4777539|NCT02757053|Brain Concussion|brain concussion
4777540|NCT02757053|Brain Injuries|brain injuries
4777541|NCT02757053|Diffuse Axonal Injury|diffuse axonal injury
4777542|NCT02757053|Football|football
4777543|NCT02757053|Head Protective Devices|head protective devices
4777544|NCT02757053|Magnetic Resonance Imaging|magnetic resonance imaging
4777545|NCT02757053|Helmet|helmet
4777546|NCT02757053|Third party add-on|third party add-on
4777547|NCT02757040|chronic lymphocytic leukemia|chronic lymphocytic leukemia
4777548|NCT02757040|ibrutinib|ibrutinib
4777549|NCT02757040|arsenic trioxide|arsenic trioxide
4777550|NCT02757040|phosphatidylinositol 3-kinase|phosphatidylinositol 3-kinase
4777551|NCT02757027|CABG surgery|cabg surgery
4777552|NCT02757027|blood viscosity|blood viscosity
4777553|NCT02757001|Retrievable Inferior Vena Cava Filters|retrievable inferior vena cava filters
4777554|NCT02757001|Pulmonary Embolism|pulmonary embolism
4777555|NCT02756923|Male Infertility|male infertility
4777556|NCT02756923|Spermatogonial stem cell|spermatogonial stem cell
4777557|NCT02756910|open abdominal surgery|open abdominal surgery
4777558|NCT02756910|anesthesia, general|anesthesia, general
4777559|NCT02756897|Leukemia|leukemia
4777560|NCT02756897|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
4777561|NCT02756897|CLL|cll
4777562|NCT02756897|Small Lymphocytic Lymphoma|small lymphocytic lymphoma
4777563|NCT02756897|SLL|sll
4777564|NCT02756897|Refractory and/or relapsed|refractory and/or relapsed
4777565|NCT02756897|Ibrutinib|ibrutinib
4777566|NCT02756897|PCI-32765|pci-32765
4777567|NCT02756897|Imbruvica|imbruvica
4777568|NCT02756897|Venetoclax|venetoclax
4777570|NCT02756897|GDC-0199|gdc-0199
4777571|NCT02756845|Non CNS Tumor|non cns tumor
4777572|NCT02756832|Drug Therapy|drug therapy
4777573|NCT02756819|Drug Therapy|drug therapy
4777574|NCT02756806|Tattoo removal, Picosecond Laser, Q-switched Laser|tattoo removal, picosecond laser, q-switched laser
4777575|NCT02756780|Remission|remission
4777576|NCT02756780|Carer|carer
4777577|NCT02756780|Psychological|psychological
4777578|NCT02756780|Bereaved|bereaved
4777579|NCT02756780|Cancer|cancer
4777580|NCT02756780|Breast|breast
4777581|NCT02756780|Prostate|prostate
4777582|NCT02756780|Colorectal|colorectal
4777583|NCT02756780|Music|music
4777584|NCT02756741|Cirrhosis|cirrhosis
4777585|NCT02756741|hepatitis B virus|hepatitis b virus
4777586|NCT02756741|Alcohol|alcohol
4777587|NCT02756741|varices|varices
4777588|NCT02756702|TKA|tka
4777589|NCT02756702|TKR|tkr
4777590|NCT02756702|All-Poly|all-poly
4777591|NCT02756702|posterior stabilized|posterior stabilized
4777592|NCT02756689|Mechanical cervical ripening|mechanical cervical ripening
4777593|NCT02756689|Transcervical catheter|transcervical catheter
4777594|NCT02756689|Foley catheter for labor induction|foley catheter for labor induction
4777595|NCT02756689|Cervical ripening|cervical ripening
4777596|NCT02756689|Induction of labor|induction of labor
4777597|NCT02756676|Parkinson Disease|parkinson disease
4777598|NCT02756676|Quality of Life|quality of life
4777599|NCT02756676|Rehabilitation|rehabilitation
4777600|NCT02756663|multiple myeloma|multiple myeloma
4777601|NCT02756663|MM|mm
4777602|NCT02756663|relapsed|relapsed
4777603|NCT02756663|relapsed and refractory|relapsed and refractory
4777604|NCT02756663|panobinostat|panobinostat
4777605|NCT02756663|LBH589|lbh589
4777606|NCT02756663|histone deacetylase inhibitor|histone deacetylase inhibitor
4777607|NCT02756663|carfilzomib|carfilzomib
4777608|NCT02756663|proteasome inhibitor|proteasome inhibitor
4777609|NCT02756650|Behcet Disease|behcet disease
4777610|NCT02756650|Inflammation|inflammation
4777611|NCT02756650|Immune system|immune system
4777612|NCT02756650|Arthritis|arthritis
4777613|NCT02756611|Oncology|oncology
4777614|NCT02756611|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
4777615|NCT02756611|17p Deletion|17p deletion
4777616|NCT02756611|TP53 Mutation|tp53 mutation
4777617|NCT02756611|Relapsed|relapsed
4777618|NCT02756611|Refractory|refractory
4777619|NCT02756611|B-Cell receptor inhibitor|b-cell receptor inhibitor
4777620|NCT02756598|sufentanil|sufentanil
4777621|NCT02756598|propofol|propofol
4777622|NCT02756598|personality/stress test|personality/stress test
4777623|NCT02756598|fast-track|fast-track
4777624|NCT02756585|computed tomography|computed tomography
4777625|NCT02756585|perfusion imaging|perfusion imaging
4777626|NCT02756585|brain death|brain death
4777627|NCT02756585|traumatic brain injury|traumatic brain injury
4777628|NCT02756559|sepsis|sepsis
4777629|NCT02756559|microRNAs|micrornas
4777630|NCT02756520|chronic kidney disease, pre-dialytic|chronic kidney disease, pre-dialytic
4777631|NCT02756520|Ketosteril, keto-acids|ketosteril, keto-acids
4777632|NCT02756520|diet, protein-restricted|diet, protein-restricted
4777633|NCT02756520|renal function|renal function
4777634|NCT02756507|anxiety symptoms|anxiety symptoms
4777635|NCT02756507|depression symptoms|depression symptoms
4777636|NCT02756507|internalizing symptoms|internalizing symptoms
4777637|NCT02756468|pancreatic cancer|pancreatic cancer
4777638|NCT02756468|procalcitonin|procalcitonin
4777639|NCT02756455|gastric cancer|gastric cancer
4777640|NCT02756455|procalcitonin|procalcitonin
4777641|NCT02756429|atrial fibrillation|atrial fibrillation
4777642|NCT02756429|stroke|stroke
4777643|NCT02756429|thromboembolism|thromboembolism
4777644|NCT02756429|inflammation|inflammation
4777645|NCT02756416|Reversible Cerebral Vasoconstriction Syndrome (RCVS)|reversible cerebral vasoconstriction syndrome (rcvs)
4777646|NCT02756416|Arterial spin labeling (ASL) MRI|arterial spin labeling (asl) mri
4777647|NCT02756390|Insomnia cancer Survivor|insomnia cancer survivor
4777648|NCT02756364|Drug Therapy|drug therapy
4777649|NCT02756325|Azoospermia, IVF, MRI|azoospermia, ivf, mri
4777650|NCT02756299|Sleep Apnea|sleep apnea
4777651|NCT02756299|Positive Airway Pressure|positive airway pressure
4777652|NCT02756299|Patient Education|patient education
4777653|NCT02756286|Electroencephalography|electroencephalography
4777655|NCT02756273|ileostomy|ileostomy
4777656|NCT02756273|morbidity|morbidity
4777657|NCT02756273|colorectal surgery|colorectal surgery
4777658|NCT02756247|Buparlisib|buparlisib
4777659|NCT02756247|BKM120|bkm120
4777660|NCT02756247|Ibrutinib|ibrutinib
4777661|NCT02756247|16-009|16-009
4777662|NCT02756221|symptoms|symptoms
4777663|NCT02756208|vaccine|vaccine
4777664|NCT02756208|healthy volunteer|healthy volunteer
4777665|NCT02756195|Patient safety|patient safety
4777666|NCT02756195|adverse events|adverse events
4777667|NCT02756195|pediatric surgery|pediatric surgery
4777668|NCT02756195|quality improvement|quality improvement
4777669|NCT02756195|health systems|health systems
4777670|NCT02756195|observational study|observational study
4777671|NCT02756195|non-routine event|non-routine event
4777672|NCT02756195|National Surgical Improvement Program|national surgical improvement program
4777673|NCT02756169|Obesity|obesity
4777674|NCT02756169|Breastfeeding|breastfeeding
4777675|NCT02756169|Grow up|grow up
4777676|NCT02756169|Milk composition|milk composition
4777677|NCT02756169|Mexico|mexico
4777678|NCT02756156|interscalene|interscalene
4777679|NCT02756156|infraclavicular|infraclavicular
4777680|NCT02756156|humerus surgery|humerus surgery
4777681|NCT02756143|fetal heart|fetal heart
4777682|NCT02756143|cesarean section|cesarean section
4777683|NCT02756143|exercise|exercise
4777684|NCT02756143|pregnancy|pregnancy
4777685|NCT02756091|Intracranial Artery Dissection|intracranial artery dissection
4777686|NCT02756091|IAD|iad
4777687|NCT02756091|Stroke|stroke
4777688|NCT02756091|Observational Study|observational study
4777689|NCT02756065|Bipolar|bipolar
4777690|NCT02756065|schizophrenia|schizophrenia
4777691|NCT02756065|schizoaffective|schizoaffective
4777692|NCT02756026|Breast milk|breast milk
4777693|NCT02756026|mineral|mineral
4777694|NCT02756026|vitamin|vitamin
4777695|NCT02756013|chemotherapy dosing|chemotherapy dosing
4777696|NCT02756013|Body surface area|body surface area
4777698|NCT02756013|paclitaxel|paclitaxel
4777699|NCT02756013|carboplatin|carboplatin
4777700|NCT02756013|dose dense|dose dense
4777701|NCT02756000|myocardial infarction|myocardial infarction
4777702|NCT02756000|percutaneous coronary intervention|percutaneous coronary intervention
4777703|NCT02756000|multivessel coronary artery disease|multivessel coronary artery disease
4777704|NCT02756000|dobutamine stress echocardiography|dobutamine stress echocardiography
4777705|NCT02755961|End-stage renal disease|end-stage renal disease
4777706|NCT02755961|Phosphate binders|phosphate binders
4777707|NCT02755961|Hyperphosphatemia|hyperphosphatemia
4777708|NCT02755961|Dietary education|dietary education
4777709|NCT02755922|Mesenchymal Stem Cells|mesenchymal stem cells
4777710|NCT02755922|Treatment|treatment
4777711|NCT02755909|Cardiac surgery, anxiety, education|cardiac surgery, anxiety, education
4777712|NCT02755883|Physical activity|physical activity
4777713|NCT02755883|non-small lung cancer|non-small lung cancer
4777714|NCT02755883|positive affect|positive affect
4777715|NCT02755857|Prophylaxis|prophylaxis
4777716|NCT02755857|Bioavailability|bioavailability
4777717|NCT02755857|Pharmacokinetics|pharmacokinetics
4777718|NCT02755844|endometrial carcinomas|endometrial carcinomas
4777719|NCT02755844|metronomic cyclophosphamide|metronomic cyclophosphamide
4777720|NCT02755844|metformin|metformin
4777721|NCT02755844|olaparib|olaparib
4777722|NCT02755844|dose-escalation study|dose-escalation study
4777723|NCT02755818|high density lipoprotein (HDL)|high density lipoprotein (hdl)
4777724|NCT02755818|lipid|lipid
4777725|NCT02755818|insulin resistance|insulin resistance
4777726|NCT02755818|glomerular filtration rate (GFR)|glomerular filtration rate (gfr)
4777727|NCT02755818|obesity|obesity
4777728|NCT02755805|Stroke|stroke
4777729|NCT02755805|Rehabilitation|rehabilitation
4777730|NCT02755805|Cognition|cognition
4777731|NCT02755805|Intervention|intervention
4777732|NCT02755805|Strategy training|strategy training
4777733|NCT02755792|Mild Cognitive Impairment|mild cognitive impairment
4777734|NCT02755792|Cognitive training|cognitive training
4777735|NCT02755792|Calligraphy|calligraphy
4777736|NCT02755792|Emotional calmness|emotional calmness
4777737|NCT02755792|Working memory|working memory
4777738|NCT02755753|Rebamipide|rebamipide
4777739|NCT02755740|female|female
4777740|NCT02755688|atrial fibrillation|atrial fibrillation
4777741|NCT02755688|catheter ablation|catheter ablation
4777742|NCT02755688|thoracoscopic surgical ablation|thoracoscopic surgical ablation
4777743|NCT02755688|long standing persistent atrial fibrillation|long standing persistent atrial fibrillation
4777744|NCT02755662|Obstructive Sleep Apnea Syndrome|obstructive sleep apnea syndrome
4777745|NCT02755662|mandibular repositioning device|mandibular repositioning device
4777746|NCT02755636|Health Behavior Change|health behavior change
4777747|NCT02755636|Primary Health Care|primary health care
4777748|NCT02755636|Patient Participation|patient participation
4777749|NCT02755636|Provider-Patient Communication|provider-patient communication
4777750|NCT02755636|Cluster-Randomized Trial|cluster-randomized trial
4777751|NCT02755636|Mobile Health|mobile health
4777752|NCT02755610|Peritoneal Dialysis|peritoneal dialysis
4777753|NCT02755610|Checklist|checklist
4777754|NCT02755597|relapsed/refractory multiple myeloma|relapsed/refractory multiple myeloma
4777755|NCT02755597|relapsed multiple myeloma|relapsed multiple myeloma
4777756|NCT02755597|refractory multiple myeloma|refractory multiple myeloma
4777757|NCT02755597|multiple myeloma|multiple myeloma
4777758|NCT02755584|Aging|aging
4777759|NCT02755584|Senescent Cells|senescent cells
4777760|NCT02755532|Pharmacokinetics|pharmacokinetics
4777761|NCT02755532|Bupivacaine|bupivacaine
4777762|NCT02755532|Axillary brachial plexus block|axillary brachial plexus block
4777763|NCT02755519|primary aldosteronism|primary aldosteronism
4777764|NCT02755519|confirmatory test|confirmatory test
4777765|NCT02755519|hypertension|hypertension
4777766|NCT02755506|Ultrasound elastography|ultrasound elastography
4777767|NCT02755506|Thoracic lesions|thoracic lesions
4777768|NCT02755506|EBUS-TBNA|ebus-tbna
4777769|NCT02755480|bone marrow transplant|bone marrow transplant
4777770|NCT02755480|infection|infection
4777771|NCT02755480|computed tomography|computed tomography
4777772|NCT02755480|radiation dose|radiation dose
4777773|NCT02755441|Diagnosis|diagnosis
4777774|NCT02755441|Prognosis|prognosis
4777775|NCT02755441|Biomarker|biomarker
4777776|NCT02755415|Rehabilitation|rehabilitation
4777777|NCT02755415|Robotic|robotic
4777778|NCT02755415|Gait|gait
4777779|NCT02755415|Quality of Life|quality of life
4777780|NCT02755389|Tracheal intubation|tracheal intubation
4777781|NCT02755389|High flow nasal oxygen|high flow nasal oxygen
4777782|NCT02755389|Airway management|airway management
4777783|NCT02755389|Apneic oxygenation|apneic oxygenation
4777784|NCT02755363|COPD|copd
4777785|NCT02755363|residual volume|residual volume
4777786|NCT02755363|osteopathy|osteopathy
4777787|NCT02755363|hyperinflation|hyperinflation
4777788|NCT02755350|PrEP|prep
4777789|NCT02755350|HIV Prevention|hiv prevention
4777790|NCT02755350|combination prevention|combination prevention
4777791|NCT02755350|demonstration project|demonstration project
4777792|NCT02755337|adenocarcinoma|adenocarcinoma
4777793|NCT02755337|non-adenocarcinoma|non-adenocarcinoma
4777794|NCT02755298|Treatment Outcome|treatment outcome
4777795|NCT02755298|Acetazolamide|acetazolamide
4777796|NCT02755272|Triple Negative Breast Cancer|triple negative breast cancer
4777797|NCT02755259|Acetazolamide|acetazolamide
4777798|NCT02755259|Hemodynamics|hemodynamics
4777799|NCT02755246|subjective cognitive decline|subjective cognitive decline
4777800|NCT02755246|dementia|dementia
4777801|NCT02755246|lifestyle|lifestyle
4777802|NCT02755246|polyamine|polyamine
4777803|NCT02755246|memory|memory
4777804|NCT02755246|elderly|elderly
4777805|NCT02755246|prevention|prevention
4777806|NCT02755246|treatment|treatment
4777807|NCT02755246|dietary supplement|dietary supplement
4777808|NCT02755246|Polyamine-enriched diet|polyamine-enriched diet
4777809|NCT02755194|pharmacokinetics|pharmacokinetics
4777810|NCT02755194|Drug-in-milk|drug-in-milk
4777811|NCT02755194|breastfeeding|breastfeeding
4777812|NCT02755194|drug safety|drug safety
4777813|NCT02755194|population pharmacokinetics|population pharmacokinetics
4777814|NCT02755155|acute circulatory failure requiring norepinephrine|acute circulatory failure requiring norepinephrine
4777815|NCT02755155|SIRS|sirs
4777816|NCT02755155|Albumin, therapeutic|albumin, therapeutic
4777817|NCT02755116|Nausea|nausea
4777818|NCT02755116|Vomiting|vomiting
4777819|NCT02755103|Mindfulness|mindfulness
4777820|NCT02755103|Comorbid PTSD and SUD|comorbid ptsd and sud
4777821|NCT02755103|Meditation|meditation
4777822|NCT02755090|nitrous|nitrous
4777823|NCT02755090|pain|pain
4777824|NCT02755077|Anesthesia induction|anesthesia induction
4777825|NCT02755077|Airway|airway
4777826|NCT02755077|Mask ventilation|mask ventilation
4777827|NCT02755038|postmenopausal women|postmenopausal women
4777828|NCT02755038|scalp hair|scalp hair
4777829|NCT02755038|estrogen|estrogen
4777830|NCT02755038|progesterone|progesterone
4777831|NCT02755025|Sepsis|sepsis
4777832|NCT02755025|SOFA score|sofa score
4777833|NCT02755025|Automated calculation|automated calculation
4777834|NCT02755012|Maternal Health|maternal health
4777835|NCT02755012|Guatemala|guatemala
4777836|NCT02755012|Indigenous Population|indigenous population
4777837|NCT02755012|Stunting|stunting
4777838|NCT02755012|Food Insecurity|food insecurity
4777839|NCT02755012|Poverty|poverty
4777840|NCT02755012|Social Support|social support
4777841|NCT02755012|Maternal Autonomy|maternal autonomy
4777842|NCT02755012|Paternal Support|paternal support
4777843|NCT02755012|Cortisol Rhythm|cortisol rhythm
4777844|NCT02754986|heart rate variability|heart rate variability
4777845|NCT02754960|Gastrointestinal bleeding|gastrointestinal bleeding
4777846|NCT02754960|Vascular malformation|vascular malformation
4777847|NCT02754960|Angiodysplasia|angiodysplasia
4777848|NCT02754960|Thalidomide|thalidomide
4777849|NCT02754947|Assessment and Consultation Team (ACT)|assessment and consultation team (act)
4777850|NCT02754947|Rapid Response Team (RRT)|rapid response team (rrt)
4777851|NCT02754947|Perioperative complications|perioperative complications
4777852|NCT02754947|Respiratory insufficiency|respiratory insufficiency
4777853|NCT02754947|ASA status|asa status
4777854|NCT02754934|chronic|chronic
4777855|NCT02754895|acute coronary syndrome|acute coronary syndrome
4777856|NCT02754895|health behavior|health behavior
4777857|NCT02754895|factorial design|factorial design
4777858|NCT02754895|positive psychology|positive psychology
4777859|NCT02754882|NSCLC|nsclc
4777860|NCT02754882|bevacizumab|bevacizumab
4777861|NCT02754882|avastin|avastin
4777862|NCT02754856|Colorectal Cancer|colorectal cancer
4777863|NCT02754856|Liver Metastases|liver metastases
4777864|NCT02754856|Resectable liver metastases|resectable liver metastases
4777865|NCT02754856|Tremelimumab|tremelimumab
4777866|NCT02754856|Fluorouracil|fluorouracil
4777867|NCT02754856|5-Fluorouracil|5-fluorouracil
4777868|NCT02754856|5-FU|5-fu
4777869|NCT02754856|Adrucil|adrucil
4777870|NCT02754856|Efudex|efudex
4777871|NCT02754856|Leucovorin|leucovorin
4777872|NCT02754856|Citrovorum|citrovorum
4777873|NCT02754856|Wellcovorin|wellcovorin
4777874|NCT02754856|Oxaliplatin|oxaliplatin
4777875|NCT02754856|Eloxatin|eloxatin
4777876|NCT02754856|Bevacizumab|bevacizumab
4777877|NCT02754856|Avastin|avastin
4777878|NCT02754856|Anti-VEGF monoclonal antibody|anti-vegf monoclonal antibody
4777879|NCT02754856|MEDI4736|medi4736
4777880|NCT02754856|Durvalumab|durvalumab
4777881|NCT02754778|arterial stiffness|arterial stiffness
4777882|NCT02754778|preeclampsia|preeclampsia
4777883|NCT02754778|HELLP-syndrome|hellp-syndrome
4777884|NCT02754778|pulse wave velocity|pulse wave velocity
4777885|NCT02754778|advanced glycation endproducts|advanced glycation endproducts
4777886|NCT02754778|skin autofluorescence|skin autofluorescence
4777887|NCT02754778|conditional workout|conditional workout
4777888|NCT02754778|postpartum|postpartum
4777889|NCT02754778|cardiovascular risk|cardiovascular risk
4777890|NCT02754778|pregnancy|pregnancy
4777891|NCT02754778|vicorder|vicorder
4777892|NCT02754778|age reader|age reader
4777893|NCT02754752|Malignant neoplasm of breast|malignant neoplasm of breast
4777894|NCT02754752|Electro-acupuncture|electro-acupuncture
4777895|NCT02754752|Questionnaires|questionnaires
4777896|NCT02754752|Surveys|surveys
4777897|NCT02754752|Standard of care|standard of care
4777898|NCT02754752|Chronic Pain|chronic pain
4777899|NCT02754739|Pravastatin|pravastatin
4777900|NCT02754739|Insulin Resistance|insulin resistance
4777901|NCT02754700|Anterior Cruciate Ligament|anterior cruciate ligament
4777902|NCT02754687|male contraception|male contraception
4777903|NCT02754687|healthy men|healthy men
4777904|NCT02754687|androgen|androgen
4777905|NCT02754687|Nortestosterone|nortestosterone
4777906|NCT02754687|Dodecylcarbonate|dodecylcarbonate
4777907|NCT02754687|11-Beta|11-beta
4777908|NCT02754687|11β|11β
4777909|NCT02754687|contraception|contraception
4777910|NCT02754661|Polyps; Capsule endoscopy; CT Colonography; Colonoscopy; Average risk patients for colorectal cancer screening|polyps; capsule endoscopy; ct colonography; colonoscopy; average risk patients for colorectal cancer screening
4777911|NCT02754635|Abnormal first or second trimester biochemical markers|abnormal first or second trimester biochemical markers
4777912|NCT02754635|maternal and perinatal morbidity/mortality|maternal and perinatal morbidity/mortality
4777913|NCT02754622|Rehabilitation|rehabilitation
4777914|NCT02754609|Celiac Disease|celiac disease
4777915|NCT02754609|Necator americanus|necator americanus
4777916|NCT02754609|Helminths|helminths
4777917|NCT02754609|Autoimmunity|autoimmunity
4777918|NCT02754609|Clinical Trials, Phase I|clinical trials, phase i
4777919|NCT02754609|Randomized Controlled Trial|randomized controlled trial
4777920|NCT02754583|trachoma|trachoma
4777921|NCT02754583|soil transmitted helminths|soil transmitted helminths
4777922|NCT02754583|sanitation|sanitation
4777923|NCT02754583|face washing|face washing
4777924|NCT02754583|antibiotics|antibiotics
4777925|NCT02754570|Open-angle glaucoma|open-angle glaucoma
4777926|NCT02754570|Ocular hypertension|ocular hypertension
4777927|NCT02754570|Latanoprost|latanoprost
4777928|NCT02754570|Pilocarpine|pilocarpine
4777929|NCT02754544|Brain tumor|brain tumor
4777930|NCT02754544|Metastatic brain tumor|metastatic brain tumor
4777931|NCT02754544|Neurosurgery|neurosurgery
4777932|NCT02754544|Electrocorticogram|electrocorticogram
4777933|NCT02754544|ECoG|ecog
4777934|NCT02754544|Transcranial magnetic stimulation|transcranial magnetic stimulation
4777935|NCT02754544|TMS|tms
4777936|NCT02754544|Direct electrical stimulation|direct electrical stimulation
4777937|NCT02754544|DES|des
4777938|NCT02754544|Functional MRI|functional mri
4777939|NCT02754544|fMRI|fmri
4777940|NCT02754544|PMT High-Resolution Grids|pmt high-resolution grids
4777941|NCT02754544|CorTec High-Resolution Hybrid Grids|cortec high-resolution hybrid grids
4777942|NCT02754544|Digital glove|digital glove
4777943|NCT02754544|Neurological exam|neurological exam
4777944|NCT02754544|Ad-Tech Grids|ad-tech grids
4777945|NCT02754544|Grip Sensor|grip sensor
4777946|NCT02754531|Cole formula|cole formula
4777947|NCT02754531|Pediatric patients|pediatric patients
4777948|NCT02754531|intubation|intubation
4777949|NCT02754531|Ultrasonography|ultrasonography
4777950|NCT02754531|Endotracheal tube|endotracheal tube
4777951|NCT02754531|uncuffed|uncuffed
4777952|NCT02754531|pediatric|pediatric
4777953|NCT02754505|Keywords: intensive care, muscle wasting, discharge, neuromuscular weakness, mobilization|keywords: intensive care, muscle wasting, discharge, neuromuscular weakness, mobilization
4777954|NCT02754453|Weight Regain|weight regain
4777955|NCT02754453|Group Treatment|group treatment
4777956|NCT02754453|Weight Loss|weight loss
4777957|NCT02754427|Surveillance|surveillance
4777958|NCT02754427|Physiotherapy|physiotherapy
4777959|NCT02754427|Arm morbidity|arm morbidity
4777960|NCT02754414|platelets|platelets
4777961|NCT02754414|transfusion|transfusion
4777962|NCT02754414|cold storage|cold storage
4777963|NCT02754414|apheresis|apheresis
4777964|NCT02754401|public health|public health
4777965|NCT02754401|periodontitis|periodontitis
4777966|NCT02754401|self-reported questionnaire|self-reported questionnaire
4777967|NCT02754388|LDCT, screening, health behavior, psychological factors|ldct, screening, health behavior, psychological factors
4777968|NCT02754375|biological markers|biological markers
4777969|NCT02754375|rTMS|rtms
4777970|NCT02754362|Poly-ICLC and bevacizumab|poly-iclc and bevacizumab
4777971|NCT02754362|humanized monoclonal antibody|humanized monoclonal antibody
4777972|NCT02754349|pulse wave velocity|pulse wave velocity
4777973|NCT02754349|augmentation index|augmentation index
4777974|NCT02754349|central pulse pressure|central pulse pressure
4777975|NCT02754310|Education, medical|education, medical
4777976|NCT02754310|Simulation Training|simulation training
4777977|NCT02754297|Neuroendocrine tumors|neuroendocrine tumors
4777978|NCT02754297|Personalized|personalized
4777979|NCT02754297|Peptide receptor radionuclide therapy|peptide receptor radionuclide therapy
4777980|NCT02754297|PRRT|prrt
4777981|NCT02754297|177Lu-DOTATATE|177lu-dotatate
4777982|NCT02754297|177Lu-octreotate|177lu-octreotate
4777983|NCT02754245|multicenter study|multicenter study
4777984|NCT02754245|emergency department|emergency department
4777985|NCT02754245|overcrowding status|overcrowding status
4777986|NCT02754245|estimation tool|estimation tool
4777987|NCT02754245|validation|validation
4777988|NCT02754232|Physical training|physical training
4777989|NCT02754232|Telemedicine|telemedicine
4777990|NCT02754232|Daily activities|daily activities
4777991|NCT02754232|Cross sectoral|cross sectoral
4777992|NCT02754219|Diabetes Mellitus, Type II|diabetes mellitus, type ii
4777993|NCT02754193|Venous-Arterial ExtraCorporeal Membrane Oxygenation|venous-arterial extracorporeal membrane oxygenation
4777994|NCT02754180|adjuvant|adjuvant
4777995|NCT02754180|pancreatic cancer|pancreatic cancer
4777996|NCT02754180|R1 resection|r1 resection
4777997|NCT02754180|positive lymph nodes|positive lymph nodes
4777998|NCT02754167|Hepcidin|hepcidin
4777999|NCT02754167|hemoglobin|hemoglobin
4778000|NCT02754167|iron|iron
4778001|NCT02754167|anemia of chronic disease|anemia of chronic disease
4778002|NCT02754089|Body weight changes|body weight changes
4778003|NCT02754089|Medicine, Traditional|medicine, traditional
4778004|NCT02754089|Herbal medicine|herbal medicine
4778005|NCT02754089|Rhus|rhus
4778006|NCT02754089|Waist Circumference|waist circumference
4778007|NCT02754089|Waist-Hip Ratio|waist-hip ratio
4778008|NCT02754089|Body mass index|body mass index
4778009|NCT02754076|Sanfilippo Syndrome Type B|sanfilippo syndrome type b
4778010|NCT02754024|Stemless shoulder prosthesis|stemless shoulder prosthesis
4778011|NCT02754011|HER2 negative|her2 negative
4778012|NCT02754011|Locally advanced or metastatic|locally advanced or metastatic
4778013|NCT02753998|Stenosis of arteriovenous fistula|stenosis of arteriovenous fistula
4778014|NCT02753998|Angioplasty|angioplasty
4778015|NCT02753998|Paclitaxel-Coated Balloon Angioplasty|paclitaxel-coated balloon angioplasty
4778016|NCT02753920|voiding trial|voiding trial
4778017|NCT02753920|prolapse|prolapse
4778018|NCT02753894|Dose-finding|dose-finding
4778019|NCT02753894|Hemodialysis|hemodialysis
4778020|NCT02753894|ASP1585|asp1585
4778021|NCT02753894|Chronic kidney disease|chronic kidney disease
4778022|NCT02753868|Intradialytic exercise|intradialytic exercise
4778023|NCT02753868|Cardiac and arterial function|cardiac and arterial function
4778024|NCT02753842|Sexually Transmitted Infections|sexually transmitted infections
4778025|NCT02753842|Condoms|condoms
4778026|NCT02753842|Contraceptive Devices|contraceptive devices
4778027|NCT02753842|HIV|hiv
4778028|NCT02753816|Tranexamic Acid|tranexamic acid
4778029|NCT02753816|Burn|burn
4778030|NCT02753816|Surgery|surgery
4778031|NCT02753816|Tangential|tangential
4778032|NCT02753816|Excision|excision
4778033|NCT02753790|Brain|brain
4778034|NCT02753790|Metastasis|metastasis
4778035|NCT02753790|IMRT|imrt
4778036|NCT02753790|Radiation|radiation
4778037|NCT02753790|Cancer|cancer
4778038|NCT02753790|Hippocampus|hippocampus
4778039|NCT02753790|Intensity modulated radiotherapy|intensity modulated radiotherapy
4778040|NCT02753790|Quality of life|quality of life
4778041|NCT02753790|QOL|qol
4778042|NCT02753712|Small airway disease|small airway disease
4778043|NCT02753712|asthma|asthma
4778044|NCT02753699|Chronic hepatitis C|chronic hepatitis c
4778045|NCT02753686|HR+ HER2|hr+ her2
4778046|NCT02753686|postmenopausal|postmenopausal
4778047|NCT02753686|advanced breast cancer|advanced breast cancer
4778048|NCT02753686|non steroidal aromatase inhibitor (NSAI) exposure|non steroidal aromatase inhibitor (nsai) exposure
4778049|NCT02753686|metastatic|metastatic
4778050|NCT02753686|endocrine therapy|endocrine therapy
4778051|NCT02753686|targeted therapy|targeted therapy
4778052|NCT02753686|prospective|prospective
4778053|NCT02753686|observational|observational
4778054|NCT02753686|registry|registry
4778055|NCT02753686|real world setting|real world setting
4778056|NCT02753686|non-interventional|non-interventional
4778057|NCT02753686|Canadian|canadian
4778058|NCT02753673|Breast Conserving Therapy|breast conserving therapy
4778059|NCT02753673|Reported Outcomes Instrument|reported outcomes instrument
4778060|NCT02753673|16-325|16-325
4778061|NCT02753660|spinal, anesthesia, pendant, spinal-bone contact, puncture|spinal, anesthesia, pendant, spinal-bone contact, puncture
4778062|NCT02753608|exhaled breath condensate|exhaled breath condensate
4778063|NCT02753608|volatile organic compounds|volatile organic compounds
4778064|NCT02753595|PEGylated Recombinant Human Hyaluronidase|pegylated recombinant human hyaluronidase
4778065|NCT02753595|Eribulin Mesylate|eribulin mesylate
4778066|NCT02753595|E7389|e7389
4778067|NCT02753595|PEGPH20|pegph20
4778068|NCT02753595|Human Epidermal Growth Factor Receptor 2-Negative|human epidermal growth factor receptor 2-negative
4778069|NCT02753595|High-Hyaluronan|high-hyaluronan
4778070|NCT02753582|Elderly, pre-frail, SOD|elderly, pre-frail, sod
4778071|NCT02753569|Magnetic Resonance Imaging|magnetic resonance imaging
4778072|NCT02753569|PET/CT|pet/ct
4778073|NCT02753569|non-small cell lung cancer|non-small cell lung cancer
4778074|NCT02753556|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
4778075|NCT02753556|COPD|copd
4778076|NCT02753556|ScreenFlow|screenflow
4778077|NCT02753556|Screening|screening
4778078|NCT02753556|Lung Disease|lung disease
4778079|NCT02753556|Mobile Health|mobile health
4778080|NCT02753556|Peak Flow Meter|peak flow meter
4778081|NCT02753556|Usability|usability
4778082|NCT02753517|hepatobiliary scintigraphy|hepatobiliary scintigraphy
4778083|NCT02753517|extended hepatectomy|extended hepatectomy
4778084|NCT02753517|volumetry|volumetry
4778085|NCT02753504|Dyslipidemia|dyslipidemia
4778086|NCT02753491|short interview, diabetes, lifestyle changes, primary care|short interview, diabetes, lifestyle changes, primary care
4778087|NCT02753478|hypothermia|hypothermia
4778088|NCT02753465|Rectal Neoplasms|rectal neoplasms
4778089|NCT02753465|anastomosis|anastomosis
4778090|NCT02753465|OS|os
4778091|NCT02753465|DFS|dfs
4778092|NCT02753465|LCA|lca
4778093|NCT02753465|laparoscopic surgery|laparoscopic surgery
4778094|NCT02753452|youth|youth
4778095|NCT02753452|disability|disability
4778096|NCT02753452|transition|transition
4778097|NCT02753452|life skills|life skills
4778098|NCT02753452|adolescence|adolescence
4778099|NCT02753413|Vaccine|vaccine
4778100|NCT02753413|Safety|safety
4778101|NCT02753413|Reactogenicity|reactogenicity
4778102|NCT02753413|Respiratory syncytial virus (RSV)|respiratory syncytial virus (rsv)
4778103|NCT02753387|mouthwash|mouthwash
4778104|NCT02753387|head and neck cancer|head and neck cancer
4778105|NCT02753387|chlorhexidine|chlorhexidine
4778106|NCT02753387|pathogens germs|pathogens germs
4778107|NCT02753374|cystic fibrosis, Chinese, children|cystic fibrosis, chinese, children
4778108|NCT02753361|Ultrasound|ultrasound
4778109|NCT02753361|regional blockade|regional blockade
4778110|NCT02753361|lipoma|lipoma
4778111|NCT02753335|CRPS, graded motor imagery, desensitization, fMRI, DMN|crps, graded motor imagery, desensitization, fmri, dmn
4778112|NCT02753322|Dual task training|dual task training
4778113|NCT02753322|Dual task interference|dual task interference
4778114|NCT02753322|Sub-acute stroke|sub-acute stroke
4778115|NCT02753322|Physiotherapy training|physiotherapy training
4778116|NCT02753322|Community ambulation|community ambulation
4778117|NCT02753322|Balance|balance
4778118|NCT02753309|BCG|bcg
4778119|NCT02753309|Rapamycin|rapamycin
4778120|NCT02753296|Cancer|cancer
4778121|NCT02753296|Fertility Preservation|fertility preservation
4778122|NCT02753296|Patient Decision Aid|patient decision aid
4778123|NCT02753283|Bone loss|bone loss
4778124|NCT02753283|Frail Geriatric Patients|frail geriatric patients
4778125|NCT02753283|Nursing Home Patients|nursing home patients
4778126|NCT02753283|Long-term Care Patients|long-term care patients
4778127|NCT02753283|Osteoporosis|osteoporosis
4778128|NCT02753283|Osteoporotic Fractures|osteoporotic fractures
4778129|NCT02753257|stroke|stroke
4778130|NCT02753257|stroke mimic|stroke mimic
4778131|NCT02753244|Cognitive VideoGames|cognitive videogames
4778132|NCT02753179|Bilateral vestibular hypofunction|bilateral vestibular hypofunction
4778133|NCT02753179|Video Head Impulse Test|video head impulse test
4778134|NCT02753179|Covert-saccades|covert-saccades
4778135|NCT02753179|Quality of life|quality of life
4778136|NCT02753179|Dynamic visual acuity|dynamic visual acuity
4778137|NCT02753166|PTSD (Post Traumatic Stress Disorder)|ptsd (post traumatic stress disorder)
4778138|NCT02753166|Emergency Department|emergency department
4778139|NCT02753127|Colorectal Neoplasms|colorectal neoplasms
4778140|NCT02753127|Colonic Diseases|colonic diseases
4778141|NCT02753127|Digestive System Diseases|digestive system diseases
4778142|NCT02753127|Digestive System Neoplasms|digestive system neoplasms
4778143|NCT02753127|Gastrointestinal Diseases|gastrointestinal diseases
4778144|NCT02753127|Gastrointestinal Neoplasms|gastrointestinal neoplasms
4778145|NCT02753127|Intestinal Diseases|intestinal diseases
4778146|NCT02753127|Intestinal Neoplasms|intestinal neoplasms
4778147|NCT02753127|Neoplasms|neoplasms
4778148|NCT02753127|Neoplasms by Histologic Type|neoplasms by histologic type
4778149|NCT02753127|Neoplasms by Site|neoplasms by site
4778150|NCT02753127|Neoplasms, Glandular and Epithelial|neoplasms, glandular and epithelial
4778151|NCT02753127|Rectal Diseases|rectal diseases
4778152|NCT02753114|Ketamine|ketamine
4778153|NCT02753114|Intranasal|intranasal
4778154|NCT02753114|Emergency Medical Services|emergency medical services
4778155|NCT02753114|Pain|pain
4778156|NCT02753114|Analgesia|analgesia
4778157|NCT02753101|Positron Emission Tomography|positron emission tomography
4778158|NCT02753101|Magnetic Resonance Imaging|magnetic resonance imaging
4778159|NCT02753101|PET/MRI|pet/mri
4778160|NCT02753101|sigma-1 receptor|sigma-1 receptor
4778161|NCT02753101|radiopharmaceutical|radiopharmaceutical
4778162|NCT02753101|complex regional pain syndrome|complex regional pain syndrome
4778163|NCT02753101|sciatica|sciatica
4778164|NCT02753101|chronic pain|chronic pain
4778165|NCT02753088|Equivalence|equivalence
4778166|NCT02753088|BCD-063|bcd-063
4778167|NCT02753088|Copaxone-Teva|copaxone-teva
4778168|NCT02753049|HIV|hiv
4778169|NCT02753049|AIDS|aids
4778170|NCT02753049|Adolescent|adolescent
4778171|NCT02753049|Adherence|adherence
4778172|NCT02753049|Retention|retention
4778173|NCT02753049|mHealth|mhealth
4778174|NCT02753036|cognition|cognition
4778175|NCT02753036|chemotherapy|chemotherapy
4778176|NCT02753036|polyneuropathy|polyneuropathy
4778177|NCT02753036|paclitaxel|paclitaxel
4778178|NCT02753036|cancer|cancer
4778179|NCT02753036|chemobrain|chemobrain
4778180|NCT02752984|Peripherally inserted central venous catheter|peripherally inserted central venous catheter
4778181|NCT02752932|Head and neck cancer|head and neck cancer
4778182|NCT02752932|Patient derived Xenograft|patient derived xenograft
4778183|NCT02752932|Chemotherapy|chemotherapy
4778184|NCT02752932|Metastases|metastases
4778185|NCT02752906|Meningitis|meningitis
4778186|NCT02752906|Meningococcal Meningitis|meningococcal meningitis
4778187|NCT02752906|Meningococcal Infections|meningococcal infections
4778188|NCT02752906|MenACYW conjugate vaccine|menacyw conjugate vaccine
4778189|NCT02752906|Licensed Meningococcal Conjugate Vaccine (MCV4)|licensed meningococcal conjugate vaccine (mcv4)
4778190|NCT02752893|estrogen|estrogen
4778191|NCT02752893|estrogen receptor|estrogen receptor
4778192|NCT02752893|ER+|er+
4778193|NCT02752893|HER2|her2
4778194|NCT02752893|HER2-|her2-
4778195|NCT02752893|HER2-negative|her2-negative
4778196|NCT02752893|xenograft|xenograft
4778197|NCT02752893|co-clinical|co-clinical
4778198|NCT02752893|mice|mice
4778199|NCT02752893|patient-derived xenograft|patient-derived xenograft
4778200|NCT02752893|patient-derived|patient-derived
4778201|NCT02752893|breast cancer|breast cancer
4778202|NCT02752893|precision medicine|precision medicine
4778203|NCT02752893|personalized medicine|personalized medicine
4778204|NCT02752867|traditional Chinese medicine granules|traditional chinese medicine granules
4778205|NCT02752867|Cognitive Impairment|cognitive impairment
4778206|NCT02752867|Acute cerebral infraction|acute cerebral infraction
4778207|NCT02752867|treatment|treatment
4778208|NCT02752854|pain scores|pain scores
4778209|NCT02752854|pressure algometer|pressure algometer
4778210|NCT02752854|healthy volunteer adults|healthy volunteer adults
4778211|NCT02752802|Contrast Media|contrast media
4778212|NCT02752802|Angiography|angiography
4778213|NCT02752789|alloantibodies|alloantibodies
4778214|NCT02752789|donor specific antibodies (DSA)-preformed, de novo|donor specific antibodies (dsa)-preformed, de novo
4778215|NCT02752789|self-antigens|self-antigens
4778216|NCT02752789|chronic allograft function|chronic allograft function
4778217|NCT02752776|Moderate to severe plaque psoriasis|moderate to severe plaque psoriasis
4778218|NCT02752763|Dry eye|dry eye
4778219|NCT02752763|isotretinoin, AS|isotretinoin, as
4778220|NCT02752763|Autologous serum|autologous serum
4778221|NCT02752724|major depressive disorder|major depressive disorder
4778222|NCT02752724|electroconvulsive therapy|electroconvulsive therapy
4778223|NCT02752724|metabolomics|metabolomics
4778224|NCT02752724|treatment resistant depression|treatment resistant depression
4778225|NCT02752724|anesthesiology|anesthesiology
4778226|NCT02752724|ketamine|ketamine
4778227|NCT02752724|prospective randomized clinical trial|prospective randomized clinical trial
4778228|NCT02752711|Minor head trauma|minor head trauma
4778229|NCT02752711|Children|children
4778230|NCT02752711|Clinical decision rule|clinical decision rule
4778231|NCT02752685|Nab-Paclitaxel|nab-paclitaxel
4778232|NCT02752685|Abraxane|abraxane
4778233|NCT02752685|MK-3475|mk-3475
4778234|NCT02752672|dithranol|dithranol
4778235|NCT02752672|therapeutic mechanisms|therapeutic mechanisms
4778236|NCT02752659|Monitoring|monitoring
4778237|NCT02752646|cataract|cataract
4778238|NCT02752633|Xanthine dehydrogenase inhibitor treatment, pharmacotherapy|xanthine dehydrogenase inhibitor treatment, pharmacotherapy
4778239|NCT02752620|osteopathic manipulative treatment|osteopathic manipulative treatment
4778240|NCT02752620|Chronic nonspecific low back pain|chronic nonspecific low back pain
4778241|NCT02752620|low back pain|low back pain
4778242|NCT02752594|probiotic|probiotic
4778243|NCT02752594|mutans streptococci|mutans streptococci
4778244|NCT02752594|bacillus coagulans|bacillus coagulans
4778245|NCT02752594|caries|caries
4778246|NCT02752581|suction drain|suction drain
4778247|NCT02752581|knee arthroscopy|knee arthroscopy
4778248|NCT02752581|knee pain|knee pain
4778249|NCT02752555|Oligoasthenoteratozoospermia|oligoasthenoteratozoospermia
4778250|NCT02752555|Male factor managment|male factor managment
4778251|NCT02752555|Intacytoplasmic sperm injection|intacytoplasmic sperm injection
4778252|NCT02752529|Liver Transplantation|liver transplantation
4778253|NCT02752529|Individualized Therapy|individualized therapy
4778254|NCT02752529|Polymorphism|polymorphism
4778255|NCT02752477|Opioid-sparing|opioid-sparing
4778256|NCT02752464|Weight Loss|weight loss
4778257|NCT02752464|Health Status Disparities|health status disparities
4778258|NCT02752438|high frequency oscillatory ventilation|high frequency oscillatory ventilation
4778259|NCT02752438|rescue|rescue
4778260|NCT02752438|newborn|newborn
4778261|NCT02752425|Speech disorders|speech disorders
4778262|NCT02752425|Speech therapy|speech therapy
4778263|NCT02752425|Visual feedback|visual feedback
4778264|NCT02752425|Buccopharyngeal surgery|buccopharyngeal surgery
4778265|NCT02752425|Central nervous system damage|central nervous system damage
4778266|NCT02752373|GTC Seizures|gtc seizures
4778267|NCT02752360|intestinal reconstruction|intestinal reconstruction
4778268|NCT02752360|end to end anastomosis|end to end anastomosis
4778269|NCT02752321|patient discharge|patient discharge
4778270|NCT02752321|patient engagement|patient engagement
4778271|NCT02752321|patient satisfaction|patient satisfaction
4778272|NCT02752321|continuity of patient care|continuity of patient care
4778273|NCT02752321|hospital discharge|hospital discharge
4778274|NCT02752321|health technology|health technology
4778275|NCT02752321|eDischarge|edischarge
4778276|NCT02752321|multimedia|multimedia
4778277|NCT02752321|mobile applications|mobile applications
4778278|NCT02752321|software applications|software applications
4778279|NCT02752321|portable electronic applications|portable electronic applications
4778280|NCT02752282|Family Planning|family planning
4778281|NCT02752282|LNG-IUS|lng-ius
4778282|NCT02752282|Health Education|health education
4778283|NCT02752256|tissue plasminogen activator|tissue plasminogen activator
4778284|NCT02752243|acute leukemia|acute leukemia
4778285|NCT02752243|myelodysplastic syndrome (MDS)|myelodysplastic syndrome (mds)
4778286|NCT02752243|Stem Cell Transplantation|stem cell transplantation
4778287|NCT02752230|Post operative pain|post operative pain
4778288|NCT02752230|Bariatric Surgery|bariatric surgery
4778289|NCT02752204|Relapsed|relapsed
4778290|NCT02752204|Refractory|refractory
4778291|NCT02752204|Lymphoma|lymphoma
4778292|NCT02752191|ferumoxytol|ferumoxytol
4778293|NCT02752178|Depression|depression
4778294|NCT02752178|Major depressive disorder|major depressive disorder
4778295|NCT02752178|MDD|mdd
4778296|NCT02752152|Counseling|counseling
4778297|NCT02752139|Sleep Disorders|sleep disorders
4778298|NCT02752139|Cerebral Hemodynamics|cerebral hemodynamics
4778299|NCT02752139|Dynamic Cerebral Auto-Regulation|dynamic cerebral auto-regulation
4778300|NCT02752139|Stroke|stroke
4778301|NCT02752126|Esophageal sparing|esophageal sparing
4778302|NCT02752126|Conventional radiotherapy|conventional radiotherapy
4778303|NCT02752126|Palliative radiation|palliative radiation
4778304|NCT02752126|Central lung tumors|central lung tumors
4778305|NCT02752113|diabetes mellitus type 2|diabetes mellitus type 2
4778306|NCT02752113|Metformin|metformin
4778307|NCT02752113|Micro- and macrocirculation|micro- and macrocirculation
4778308|NCT02752113|HbA1c >= 7%|hba1c >= 7%
4778309|NCT02752100|Lower Extremity Arterial Occlusive Disease|lower extremity arterial occlusive disease
4778310|NCT02752100|Interventional Therapy|interventional therapy
4778311|NCT02752074|Melanoma|melanoma
4778312|NCT02752074|Metastatic Melanoma|metastatic melanoma
4778313|NCT02752035|AML|aml
4778314|NCT02752035|ASP2215|asp2215
4778315|NCT02752035|Newly Diagnosed AML|newly diagnosed aml
4778316|NCT02752035|gilteritinib|gilteritinib
4778317|NCT02752035|Acute Myeloid Leukemia (AML)|acute myeloid leukemia (aml)
4778318|NCT02752035|FLT3|flt3
4778319|NCT02752022|e-cigarettes|e-cigarettes
4778320|NCT02752022|nitrosamines|nitrosamines
4778321|NCT02752022|smoking cessation|smoking cessation
4778322|NCT02752009|Breast Cancer|breast cancer
4778323|NCT02752009|Armpit lymph nodes Cancer|armpit lymph nodes cancer
4778324|NCT02751996|Chronic Hepatitis|chronic hepatitis
4778325|NCT02751996|HBV|hbv
4778326|NCT02751996|Double blind|double blind
4778327|NCT02751983|Suicide|suicide
4778328|NCT02751983|Psychiatric Rehabilitation|psychiatric rehabilitation
4778329|NCT02751983|Acceptance and Commitment Therapy|acceptance and commitment therapy
4778330|NCT02751983|Brief Psychotherapy|brief psychotherapy
4778331|NCT02751983|Inpatients|inpatients
4778332|NCT02751970|Dental adhesive|dental adhesive
4778333|NCT02751970|adhesive systems|adhesive systems
4778334|NCT02751970|Dental Restoration Failure|dental restoration failure
4778335|NCT02751944|exercise-induced|exercise-induced
4778336|NCT02751944|joint pain|joint pain
4778337|NCT02751944|joint stiffness|joint stiffness
4778338|NCT02751944|post-menopausal|post-menopausal
4778339|NCT02751944|women|women
4778340|NCT02751944|cartilage turnover|cartilage turnover
4778341|NCT02751944|CTX-II|ctx-ii
4778342|NCT02751931|Pediatrics|pediatrics
4778343|NCT02751931|Urodynamics|urodynamics
4778344|NCT02751931|Mirabegron|mirabegron
4778345|NCT02751931|Phase 3|phase 3
4778346|NCT02751931|Neurogenic Detrusor Overactivity|neurogenic detrusor overactivity
4778347|NCT02751918|Mesothelin-expressing platinum-resistant cancer|mesothelin-expressing platinum-resistant cancer
4778348|NCT02751814|Childcare Center Regulations|childcare center regulations
4778349|NCT02751814|Physical Activity|physical activity
4778350|NCT02751814|Sedentary Behavior|sedentary behavior
4778351|NCT02751814|Screen-time Behavior|screen-time behavior
4778352|NCT02751788|childcare center regulations|childcare center regulations
4778353|NCT02751788|physical activity|physical activity
4778354|NCT02751788|sedentary behavior|sedentary behavior
4778355|NCT02751788|screen-time behavior|screen-time behavior
4778356|NCT02751775|Childcare center regulations|childcare center regulations
4778357|NCT02751775|Physical Activity|physical activity
4778358|NCT02751775|Sedentary Behavior|sedentary behavior
4778359|NCT02751775|Screen-Time Behavior|screen-time behavior
4778360|NCT02751775|Focus groups|focus groups
4778361|NCT02751723|cancer disease|cancer disease
4778362|NCT02751723|palliative care|palliative care
4778363|NCT02751723|palliative therapy|palliative therapy
4778364|NCT02751723|cancer|cancer
4778365|NCT02751723|patient´s needs|patient´s needs
4778366|NCT02751723|patient care|patient care
4778367|NCT02751723|disease burden|disease burden
4778368|NCT02751684|Rapid Sequence Induction|rapid sequence induction
4778369|NCT02751684|European|european
4778370|NCT02751684|Evaluation|evaluation
4778371|NCT02751684|EUROpE RSI|europe rsi
4778372|NCT02751684|Standards|standards
4778373|NCT02751684|RSI|rsi
4778374|NCT02751645|Pediatric|pediatric
4778375|NCT02751645|Cardiac|cardiac
4778376|NCT02751645|Surgery|surgery
4778377|NCT02751632|Ultra High Risk of Psychosis|ultra high risk of psychosis
4778378|NCT02751632|Prodrome|prodrome
4778379|NCT02751619|Pre-emptive analgesia|pre-emptive analgesia
4778380|NCT02751619|Post-thoracotomy pain|post-thoracotomy pain
4778381|NCT02751619|Lidocaine patch|lidocaine patch
4778382|NCT02751606|Ferumoxtran|ferumoxtran
4778383|NCT02751606|MRI Scans|mri scans
4778384|NCT02751593|pregnancy|pregnancy
4778385|NCT02751593|Immune Thrombocytopenia|immune thrombocytopenia
4778386|NCT02751593|dexamethasone|dexamethasone
4778387|NCT02751528|Breast Cancer|breast cancer
4778388|NCT02751528|Breast Cancer male|breast cancer male
4778389|NCT02751528|Breast Neoplasms|breast neoplasms
4778390|NCT02751528|Breast Neoplasms male|breast neoplasms male
4778391|NCT02751528|Vaccine|vaccine
4778392|NCT02751528|HER2|her2
4778393|NCT02751528|Metastatic|metastatic
4778394|NCT02751528|Locally Advanced|locally advanced
4778395|NCT02751528|Unresectable|unresectable
4778396|NCT02751528|Solid Tumor|solid tumor
4778397|NCT02751528|Phase 1|phase 1
4778398|NCT02751528|Cancer Vaccine|cancer vaccine
4778399|NCT02751502|Children|children
4778400|NCT02751502|Pediatrics|pediatrics
4778401|NCT02751502|Arm|arm
4778402|NCT02751502|Upper limb|upper limb
4778403|NCT02751502|bimanual training|bimanual training
4778404|NCT02751502|physical training|physical training
4778405|NCT02751437|preterm|preterm
4778406|NCT02751437|arginine|arginine
4778407|NCT02751437|immune function|immune function
4778408|NCT02751437|nutrition|nutrition
4778409|NCT02751424|Multidrug-resistant|multidrug-resistant
4778410|NCT02751424|Gram negative bacterial infection|gram negative bacterial infection
4778411|NCT02751424|Safety|safety
4778412|NCT02751424|Pharmacokinetic|pharmacokinetic
4778413|NCT02751333|Esophageal stricture|esophageal stricture
4778414|NCT02751333|Esophageal leak|esophageal leak
4778415|NCT02751333|Esophageal perforation|esophageal perforation
4778416|NCT02751333|Esophageal fistula|esophageal fistula
4778417|NCT02751333|Endostitch|endostitch
4778418|NCT02751333|Esophageal stent|esophageal stent
4778419|NCT02751307|metformin|metformin
4778420|NCT02751307|clozapine|clozapine
4778421|NCT02751307|schizophrenia|schizophrenia
4778422|NCT02751307|metabolic traits|metabolic traits
4778423|NCT02751294|Healthy Volunteer|healthy volunteer
4778424|NCT02751294|Malaria|malaria
4778425|NCT02751294|Pharmacokinetics|pharmacokinetics
4778426|NCT02751294|Tafenoquine|tafenoquine
4778427|NCT02751281|pneumatic|pneumatic
4778428|NCT02751281|ultra-sonic|ultra-sonic
4778429|NCT02751281|percutaneous nephrolithotomy|percutaneous nephrolithotomy
4778430|NCT02751268|infraorbital nerve block|infraorbital nerve block
4778431|NCT02751268|infratrochlear nerve block|infratrochlear nerve block
4778432|NCT02751268|septorhinoplasty|septorhinoplasty
4778433|NCT02751268|general anesthesia|general anesthesia
4778434|NCT02751268|postoperative analgesia|postoperative analgesia
4778435|NCT02751242|Diuretic Resistance|diuretic resistance
4778436|NCT02751242|Emergency Medicine|emergency medicine
4778437|NCT02751229|Mental illness|mental illness
4778438|NCT02751229|adolescents|adolescents
4778439|NCT02751229|intervention|intervention
4778440|NCT02751229|stigma|stigma
4778441|NCT02751229|disclosure|disclosure
4778442|NCT02751229|secrecy|secrecy
4778568|NCT02750358|15-307|15-307
4778443|NCT02751216|high frequency / high density spinal cord stimulation|high frequency / high density spinal cord stimulation
4778444|NCT02751216|EEG|eeg
4778445|NCT02751216|conditioned pain modulation|conditioned pain modulation
4778446|NCT02751177|KRAS gene mutation|kras gene mutation
4778447|NCT02751177|NRAS gene mutation|nras gene mutation
4778448|NCT02751177|BRAF gene mutation|braf gene mutation
4778449|NCT02751138|Immune phenotype|immune phenotype
4778450|NCT02751138|Cytokines|cytokines
4778451|NCT02751138|Genetic aberration|genetic aberration
4778452|NCT02751138|Overall survival|overall survival
4778453|NCT02751138|Progression free survival|progression free survival
4778454|NCT02751125|Mesenchymal stem cells|mesenchymal stem cells
4778455|NCT02751125|bone augmentation|bone augmentation
4778456|NCT02751125|bone regeneration|bone regeneration
4778457|NCT02751086|minimally invasive surgery|minimally invasive surgery
4778458|NCT02751086|gastrectomy|gastrectomy
4778459|NCT02751086|robotic surgery|robotic surgery
4778460|NCT02751086|laparoscopic surgery|laparoscopic surgery
4778461|NCT02751086|laparoscopy|laparoscopy
4778462|NCT02751086|robot-assisted|robot-assisted
4778463|NCT02751086|robotic|robotic
4778464|NCT02751086|robotic gastrectomy|robotic gastrectomy
4778465|NCT02751086|laparoscopic gastrectomy|laparoscopic gastrectomy
4778466|NCT02751086|minimally invasive gastrectomy|minimally invasive gastrectomy
4778467|NCT02751073|Microbiota|microbiota
4778468|NCT02751073|Proteome|proteome
4778469|NCT02751034|Wrinkle Severity Rating Scale|wrinkle severity rating scale
4778470|NCT02751034|Global Aesthetic Improvement Scale|global aesthetic improvement scale
4778471|NCT02751034|Hyaluronic acid filler|hyaluronic acid filler
4778472|NCT02751034|filler|filler
4778473|NCT02751034|Nasolabial Fold|nasolabial fold
4778474|NCT02750995|myelodysplastic syndrome|myelodysplastic syndrome
4778475|NCT02750995|acute myeloid leukemia|acute myeloid leukemia
4778476|NCT02750995|azacitidine|azacitidine
4778477|NCT02750995|peptide vaccine|peptide vaccine
4778478|NCT02750995|cancer testis antigen|cancer testis antigen
4778479|NCT02750995|cancer vaccine|cancer vaccine
4778480|NCT02750995|immunotherapy|immunotherapy
4778481|NCT02750995|combination therapy|combination therapy
4778482|NCT02750995|NY-ESO-1|ny-eso-1
4778483|NCT02750995|PRAME|prame
4778484|NCT02750995|MAGE-A3|mage-a3
4778485|NCT02750995|WT-1|wt-1
4778486|NCT02750995|vaccine|vaccine
4778487|NCT02750969|tinnitus|tinnitus
4778488|NCT02750969|lidocain patch|lidocain patch
4778489|NCT02750956|endocan protein|endocan protein
4778490|NCT02750956|VEGF A|vegf a
4778491|NCT02750956|TNF-alpha|tnf-alpha
4778492|NCT02750956|after treatment|after treatment
4778493|NCT02750930|Extension|extension
4778494|NCT02750930|Long-term Safety|long-term safety
4778495|NCT02750930|Pharmacodynamics|pharmacodynamics
4778496|NCT02750930|Albiglutide|albiglutide
4778497|NCT02750930|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
4778498|NCT02750917|postoperative pain|postoperative pain
4778499|NCT02750917|lornoxicam|lornoxicam
4778500|NCT02750917|etoricoxib|etoricoxib
4778501|NCT02750917|total knee arthroplasty|total knee arthroplasty
4778502|NCT02750904|Smoking Cessation|smoking cessation
4778503|NCT02750904|Acceptance & Commitment Therapy|acceptance & commitment therapy
4778504|NCT02750904|Cognitive Behavioral Therapy|cognitive behavioral therapy
4778505|NCT02750904|Bipolar Disorder|bipolar disorder
4778506|NCT02750891|high grade glioma|high grade glioma
4778507|NCT02750891|HGG|hgg
4778508|NCT02750891|DIPG|dipg
4778509|NCT02750878|Urinary Incontinence, Stress [C13.351.968.934.814.500]|urinary incontinence, stress [c13.351.968.934.814.500]
4778510|NCT02750865|biomedical technology|biomedical technology
4778511|NCT02750865|palliative care|palliative care
4778512|NCT02750800|Rheumatoid arthritis|rheumatoid arthritis
4778513|NCT02750800|Ankylosing spondylitis|ankylosing spondylitis
4778514|NCT02750800|Psoriatic arthritis|psoriatic arthritis
4778515|NCT02750800|Psoriasis|psoriasis
4778516|NCT02750800|Crohn's disease|crohn's disease
4778517|NCT02750800|Ulcerative colitis|ulcerative colitis
4778518|NCT02750800|Patient support program|patient support program
4778519|NCT02750800|Quality of life|quality of life
4778520|NCT02750800|Patient related outcomes|patient related outcomes
4778521|NCT02750800|Observational study|observational study
4778522|NCT02750722|Exercise|exercise
4778523|NCT02750722|Lung diffusion capacity|lung diffusion capacity
4778524|NCT02750722|Sputum viscoelasticity|sputum viscoelasticity
4778525|NCT02750722|Lung disease|lung disease
4778526|NCT02750709|HT-1|ht-1
4778527|NCT02750709|Tyrosinemia|tyrosinemia
4778528|NCT02750709|Nitisinone|nitisinone
4778529|NCT02750709|Bioequivalence|bioequivalence
4778530|NCT02750709|Healthy Volunteer|healthy volunteer
4778531|NCT02750709|Orfadin|orfadin
4778532|NCT02750696|Acetaminophen|acetaminophen
4778533|NCT02750696|Analgesia|analgesia
4778534|NCT02750696|Codeine|codeine
4778535|NCT02750696|Drug Combinations|drug combinations
4778536|NCT02750696|Endodontics|endodontics
4778537|NCT02750696|Periapical abscess|periapical abscess
4778538|NCT02750696|Randomized Controlled Trial|randomized controlled trial
4778539|NCT02750696|Tramadol|tramadol
4778540|NCT02750696|Visual analog scale|visual analog scale
4778541|NCT02750683|inotropic effect, norepinephrine, septic shock,|inotropic effect, norepinephrine, septic shock,
4778542|NCT02750670|Lymphoma|lymphoma
4778543|NCT02750670|Non-Hodgkin's|non-hodgkin's
4778544|NCT02750670|CD20+|cd20+
4778545|NCT02750670|Obinutuzumab|obinutuzumab
4778546|NCT02750670|GDP Chemotherapy|gdp chemotherapy
4778547|NCT02750670|Refractory and aggressive non-Hodgkin lymphoma|refractory and aggressive non-hodgkin lymphoma
4778548|NCT02750631|depression|depression
4778549|NCT02750631|melatonin|melatonin
4778550|NCT02750631|light therapy|light therapy
4778551|NCT02750631|Wake Therapy|wake therapy
4778655|NCT02749838|Cancer|cancer
4778552|NCT02750631|chronobiology|chronobiology
4778553|NCT02750592|Ankylosing Spondylitis|ankylosing spondylitis
4778554|NCT02750540|Tenofovir enema|tenofovir enema
4778555|NCT02750501|CF, EPI, diabetes, PERT, LCPUFA, DHA, EPA, Omega-3 index|cf, epi, diabetes, pert, lcpufa, dha, epa, omega-3 index
4778556|NCT02750423|Cardiology|cardiology
4778557|NCT02750423|Surgery|surgery
4778558|NCT02750397|HIV|hiv
4778559|NCT02750397|Kidney Transplant|kidney transplant
4778560|NCT02750397|Liver Transplant|liver transplant
4778561|NCT02750397|Transplant|transplant
4778562|NCT02750371|Cavernous sinus meningioma|cavernous sinus meningioma
4778563|NCT02750371|Pituitary adenoma|pituitary adenoma
4778564|NCT02750371|Hippocampus|hippocampus
4778565|NCT02750371|Irradiation|irradiation
4778566|NCT02750371|Autobiographical memory|autobiographical memory
4778567|NCT02750358|Enzalutamide|enzalutamide
4778569|NCT02750345|HT-1|ht-1
4778570|NCT02750345|Tyrosinemia|tyrosinemia
4778571|NCT02750345|Nitisinone|nitisinone
4778572|NCT02750345|Bioavailability|bioavailability
4778573|NCT02750345|Healthy Volunteer|healthy volunteer
4778574|NCT02750345|Food-Effect|food-effect
4778575|NCT02750332|HT-1|ht-1
4778576|NCT02750332|Tyrosinemia|tyrosinemia
4778577|NCT02750332|Nitisinone|nitisinone
4778578|NCT02750332|Bioavailability|bioavailability
4778579|NCT02750332|Healthy Volunteer|healthy volunteer
4778580|NCT02750332|Food-Effect|food-effect
4778581|NCT02750319|Amiodarone|amiodarone
4778582|NCT02750319|N-Acetylcysteine|n-acetylcysteine
4778583|NCT02750319|16-307|16-307
4778584|NCT02750293|vitamin D|vitamin d
4778585|NCT02750293|blood pressure|blood pressure
4778586|NCT02750293|serum lipids|serum lipids
4778587|NCT02750293|glucose metabolism|glucose metabolism
4778588|NCT02750293|muscle function|muscle function
4778589|NCT02750293|arterial stiffness|arterial stiffness
4778590|NCT02750293|depression|depression
4778591|NCT02750293|psoriasis|psoriasis
4778592|NCT02750293|sleep|sleep
4778593|NCT02750293|bone density|bone density
4778594|NCT02750267|Type 1 Diabetes Mellitus (T1DM)|type 1 diabetes mellitus (t1dm)
4778595|NCT02750267|Artificial Pancreas Project (APP)|artificial pancreas project (app)
4778596|NCT02750267|Diabetes Assistant (DiAs)|diabetes assistant (dias)
4778597|NCT02750267|Closed-Loop Control (CLC)|closed-loop control (clc)
4778598|NCT02750267|Continuous Glucose Monitor|continuous glucose monitor
4778599|NCT02750267|Pediatric|pediatric
4778600|NCT02750267|Insulin Pump|insulin pump
4778601|NCT02750241|active video game|active video game
4778602|NCT02750241|mHealth|mhealth
4778603|NCT02750241|cancer survivor|cancer survivor
4778604|NCT02750241|women's health|women's health
4778605|NCT02750241|breast cancer|breast cancer
4778606|NCT02750241|physical activity|physical activity
4778607|NCT02750241|support group|support group
4778608|NCT02750241|survivorship|survivorship
4778609|NCT02750215|MET exon 14 skipping|met exon 14 skipping
4778610|NCT02750215|Stage IV non-small cell lung cancer NSCLC|stage iv non-small cell lung cancer nsclc
4778611|NCT02750202|Genital warts|genital warts
4778612|NCT02750202|HPV types|hpv types
4778613|NCT02750202|HPV vaccine|hpv vaccine
4778614|NCT02750202|Cervical cytology|cervical cytology
4778615|NCT02750202|Therapeutic vaccine|therapeutic vaccine
4778616|NCT02750202|Quadrivalent HPV vaccine|quadrivalent hpv vaccine
4778617|NCT02750176|Rehabilitation|rehabilitation
4778618|NCT02750176|Closed chain exercises|closed chain exercises
4778619|NCT02750137|Tetracaine|tetracaine
4778620|NCT02750124|participation|participation
4778621|NCT02750124|self sampling|self sampling
4778622|NCT02750124|Screening|screening
4778623|NCT02750098|Diabetes Mellitus, Cataract, Aqueous humor|diabetes mellitus, cataract, aqueous humor
4778624|NCT02750085|Hemophilia A|hemophilia a
4778625|NCT02750085|pharmacokinetics|pharmacokinetics
4778626|NCT02750085|myPKFiT|mypkfit
4778627|NCT02750020|Telephone survey|telephone survey
4778628|NCT02749955|HIV prevention|hiv prevention
4778629|NCT02749955|Pre exposure prophylaxis|pre exposure prophylaxis
4778630|NCT02749955|Men who have sex with men|men who have sex with men
4778631|NCT02749955|Partner services|partner services
4778632|NCT02749955|Linkage to care|linkage to care
4778633|NCT02749955|Seronegative|seronegative
4778634|NCT02749955|Sexually transmitted diseases|sexually transmitted diseases
4778635|NCT02749942|Diabetes|diabetes
4778636|NCT02749942|Remote Ischemic Conditioning|remote ischemic conditioning
4778637|NCT02749942|Neuropathy|neuropathy
4778638|NCT02749942|Angiopathy|angiopathy
4778639|NCT02749929|Distal radius fracture, Low Level Laser Therapy|distal radius fracture, low level laser therapy
4778640|NCT02749916|SWI|swi
4778641|NCT02749916|MP-RAGE|mp-rage
4778642|NCT02749916|DANTE T1-SPACE|dante t1-space
4778643|NCT02749877|Pediatric Cancer|pediatric cancer
4778644|NCT02749877|Training|training
4778645|NCT02749877|Working Memory|working memory
4778646|NCT02749877|Physical Activity|physical activity
4778647|NCT02749877|Brain Tumor|brain tumor
4778648|NCT02749877|Physical Exercise|physical exercise
4778649|NCT02749864|Hepatitis|hepatitis
4778650|NCT02749864|Prevalence|prevalence
4778651|NCT02749864|Epidemiology|epidemiology
4778652|NCT02749864|Infectious diseases|infectious diseases
4778653|NCT02749851|pregnancy|pregnancy
4778654|NCT02749851|growth restriction|growth restriction
4778656|NCT02749838|Genomic testing|genomic testing
4778657|NCT02749838|Genetic testing|genetic testing
4778658|NCT02749838|Molecular screening|molecular screening
4778659|NCT02749838|Molecular Profiling|molecular profiling
4778660|NCT02749838|Biomarker|biomarker
4778661|NCT02749838|Biopsy|biopsy
4778662|NCT02749838|Tumor sampling|tumor sampling
4778663|NCT02749838|Registry|registry
4778664|NCT02749825|Prostate|prostate
4778665|NCT02749825|Cancer|cancer
4778666|NCT02749825|Trelstar|trelstar
4778667|NCT02749760|Ulnar collateral ligament|ulnar collateral ligament
4778668|NCT02749760|elbow injuries|elbow injuries
4778669|NCT02749760|dynamic elbow stabilizers|dynamic elbow stabilizers
4778670|NCT02749760|Tommy John's procedure|tommy john's procedure
4778671|NCT02749760|elbow injuries in pitchers|elbow injuries in pitchers
4778672|NCT02749747|Menopause|menopause
4778673|NCT02749747|nonhormonal treatment|nonhormonal treatment
4778674|NCT02749747|sulpiride|sulpiride
4778675|NCT02749734|Human embryo stem cell derived retinal pigment epitheliums|human embryo stem cell derived retinal pigment epitheliums
4778676|NCT02749734|Subretinal transplantation|subretinal transplantation
4778677|NCT02749734|Wet Age related Macular degeneration|wet age related macular degeneration
4778678|NCT02749734|Stargardt's macular dystrophy|stargardt's macular dystrophy
4778679|NCT02749721|depression|depression
4778680|NCT02749721|brain network activation|brain network activation
4778681|NCT02749721|vortioxetine|vortioxetine
4778682|NCT02749708|IRX5183|irx5183
4778683|NCT02749708|relapsed/refractory AML|relapsed/refractory aml
4778684|NCT02749708|high-risk MDS|high-risk mds
4778685|NCT02749695|menopause, climacteric syndrome, insomnia, placental extract|menopause, climacteric syndrome, insomnia, placental extract
4778686|NCT02749682|Nyhus classification|nyhus classification
4778687|NCT02749682|constipation severity scale|constipation severity scale
4778688|NCT02749682|groin hernia|groin hernia
4778689|NCT02749669|Inappropriate hospitalization|inappropriate hospitalization
4778690|NCT02749669|elderly|elderly
4778691|NCT02749669|mild or moderate cognitive impairment|mild or moderate cognitive impairment
4778692|NCT02749669|qualitative research|qualitative research
4778693|NCT02749669|economic evaluation|economic evaluation
4778694|NCT02749656|Scalp psoriasis|scalp psoriasis
4778695|NCT02749656|0.25% Desoximetasone cream|0.25% desoximetasone cream
4778696|NCT02749591|stroke rehabilitation|stroke rehabilitation
4778697|NCT02749591|spasticity|spasticity
4778698|NCT02749591|Botulinum toxin type A injection|botulinum toxin type a injection
4778699|NCT02749591|robot-assisted therapy|robot-assisted therapy
4778700|NCT02749591|mirror therapy|mirror therapy
4778701|NCT02749591|randomized controlled trial|randomized controlled trial
4778702|NCT02749565|asthma|asthma
4778703|NCT02749565|fibrocyte|fibrocyte
4778704|NCT02749565|airway remodeling|airway remodeling
4778705|NCT02749565|OSA|osa
4778706|NCT02749565|hypoxia|hypoxia
4778707|NCT02749539|Mastectomy|mastectomy
4778708|NCT02749539|Shoulder Pain|shoulder pain
4778709|NCT02749539|ROM|rom
4778710|NCT02749539|Kinesio Tape|kinesio tape
4778711|NCT02749526|Recombinant human endostatin，Endo|recombinant human endostatin，endo
4778712|NCT02749500|Motor control|motor control
4778713|NCT02749487|Critical Care|critical care
4778714|NCT02749487|Neutrophils|neutrophils
4778715|NCT02749487|Lymphocytes|lymphocytes
4778716|NCT02749461|preterm infants|preterm infants
4778717|NCT02749461|pain|pain
4778718|NCT02749461|assessment|assessment
4778719|NCT02749461|contextual factors|contextual factors
4778720|NCT02749461|diagnostic accuracy|diagnostic accuracy
4778721|NCT02749435|Digital disease management tool|digital disease management tool
4778722|NCT02749435|Type 2 diabetes mellitus/ T2DM|type 2 diabetes mellitus/ t2dm
4778723|NCT02749435|HbA1c|hba1c
4778724|NCT02749435|Standard care|standard care
4778725|NCT02749435|PRO questionnaires|pro questionnaires
4778726|NCT02749435|Smart phone/ personal computer with internet access|smart phone/ personal computer with internet access
4778727|NCT02749422|cognitive dysfunction|cognitive dysfunction
4778728|NCT02749422|memory loss|memory loss
4778729|NCT02749422|non-invasive transcranial magnetic stimulation (TMS)|non-invasive transcranial magnetic stimulation (tms)
4778730|NCT02749422|rTMS|rtms
4778731|NCT02749422|Magstim Rapid2|magstim rapid2
4778732|NCT02749357|gait|gait
4778733|NCT02749357|robotic orthosis|robotic orthosis
4778734|NCT02749344|Frozen Embryo Transfer, Progesterone, Endometrium|frozen embryo transfer, progesterone, endometrium
4778735|NCT02749318|Behavior Modification|behavior modification
4778736|NCT02749318|Genetic Testing|genetic testing
4778737|NCT02749318|Risk Management|risk management
4778738|NCT02749318|Oral Health Care|oral health care
4778739|NCT02749292|rituximab|rituximab
4778740|NCT02749292|maintenance|maintenance
4778741|NCT02749292|remission|remission
4778742|NCT02749266|chiropractic, cognition|chiropractic, cognition
4778743|NCT02749253|Post Traumatic Stress Disorder (PTSD)|post traumatic stress disorder (ptsd)
4778744|NCT02749253|Sudarshan Kriya Yoga (SKY)|sudarshan kriya yoga (sky)
4778745|NCT02749227|Clinically non-functioning pituitary adenomas (CNFAs)|clinically non-functioning pituitary adenomas (cnfas)
4778746|NCT02749227|silent corticotroph adenomas|silent corticotroph adenomas
4778747|NCT02749201|Obesity|obesity
4778748|NCT02749201|sleeve gastrectomy|sleeve gastrectomy
4778749|NCT02749188|Urine Specimen Collection/methods|urine specimen collection/methods
4778750|NCT02749188|Infant|infant
4778751|NCT02749188|Newborn|newborn
4778752|NCT02749188|Feasibility Studies|feasibility studies
4778753|NCT02749188|Bladder stimulation|bladder stimulation
4778754|NCT02749175|cricoid pressure|cricoid pressure
4778755|NCT02749149|Cardiac|cardiac
4778756|NCT02749149|Surgery|surgery
4778757|NCT02749149|Frailty|frailty
4778758|NCT02749149|Frail|frail
4778759|NCT02749149|Patients|patients
4778760|NCT02749149|Recovery|recovery
4778761|NCT02749149|Morbidity|morbidity
4778762|NCT02749149|Outcomes|outcomes
4778763|NCT02749149|Mortality|mortality
4778764|NCT02749149|Heart|heart
4778765|NCT02749149|Perioperative|perioperative
4778766|NCT02749149|Disability|disability
4778767|NCT02749149|WHODAS|whodas
4778768|NCT02749136|Pancreatic adenocarcinoma|pancreatic adenocarcinoma
4778769|NCT02749136|Borderline resectable|borderline resectable
4778770|NCT02749136|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
4778771|NCT02749136|FOLFIRINOX|folfirinox
4778772|NCT02749110|Mass screening|mass screening
4778773|NCT02749110|Family medicine|family medicine
4778774|NCT02749110|Human Papillomavirus DNA tests|human papillomavirus dna tests
4778775|NCT02749110|Papanicolaou test|papanicolaou test
4778776|NCT02749110|Early detection of cancer/methods*|early detection of cancer/methods*
4778777|NCT02749110|Specimen Handling/methods*|specimen handling/methods*
4778778|NCT02749110|Patient compliance|patient compliance
4778779|NCT02749110|Adult|adult
4778780|NCT02749110|Female|female
4778781|NCT02749110|Humans|humans
4778782|NCT02749110|Randomized controlled trial|randomized controlled trial
4778783|NCT02749084|chronic graft versus host disease|chronic graft versus host disease
4778784|NCT02749084|T regulatory cell|t regulatory cell
4778785|NCT02749058|capsulectomy|capsulectomy
4778786|NCT02749058|capsulotomy|capsulotomy
4778787|NCT02749019|BBN-RGD|bbn-rgd
4778788|NCT02749019|GRPR|grpr
4778789|NCT02749019|integrin αvβ3|integrin αvβ3
4778790|NCT02749006|Bipolar disorder|bipolar disorder
4778791|NCT02749006|Depression|depression
4778792|NCT02749006|intermittent Theta-Burst Stimulation (rTMS)|intermittent theta-burst stimulation (rtms)
4778793|NCT02749006|neuromodulatory technique|neuromodulatory technique
4778794|NCT02748967|Healthy|healthy
4778795|NCT02748967|ExPEC4V|expec4v
4778796|NCT02748967|JNJ-63871860|jnj-63871860
4778797|NCT02748967|Safety|safety
4778798|NCT02748941|unstable/stable atherosclerotic plaque|unstable/stable atherosclerotic plaque
4778799|NCT02748941|HITS|hits
4778800|NCT02748941|GSM|gsm
4778801|NCT02748941|CEUS|ceus
4778802|NCT02748941|HR MRI|hr mri
4778803|NCT02748941|mi-RNA|mi-rna
4778804|NCT02748915|Cochlear Implant|cochlear implant
4778805|NCT02748915|ECAP|ecap
4778806|NCT02748915|EABR|eabr
4778807|NCT02748915|perceptual levels|perceptual levels
4778808|NCT02748915|hearing performances|hearing performances
4778809|NCT02748902|Verruca vulgaris|verruca vulgaris
4778810|NCT02748902|Common warts|common warts
4778811|NCT02748902|Verruca|verruca
4778812|NCT02748902|Warts|warts
4778813|NCT02748902|Papilloma virus|papilloma virus
4778814|NCT02748902|ingenol mebutate 0.05% gel|ingenol mebutate 0.05% gel
4778815|NCT02748902|hands|hands
4778816|NCT02748889|SCLC|sclc
4778817|NCT02748889|Small Cell|small cell
4778818|NCT02748889|Lung Cancer|lung cancer
4778819|NCT02748889|MPDL3280A|mpdl3280a
4778820|NCT02748889|atezolizumab|atezolizumab
4778821|NCT02748863|psoriasis|psoriasis
4778822|NCT02748863|secukinumab|secukinumab
4778823|NCT02748863|pre-filled syringes|pre-filled syringes
4778824|NCT02748850|apheresis patients|apheresis patients
4778825|NCT02748824|Age- Related Macular Degeneration; Diabetic Retinopathy; Glaucoma; Cataract|age- related macular degeneration; diabetic retinopathy; glaucoma; cataract
4778826|NCT02748811|elderly|elderly
4778827|NCT02748811|intervention study|intervention study
4778828|NCT02748811|geriatrics|geriatrics
4778829|NCT02748811|chemotherapy|chemotherapy
4778830|NCT02748772|Anti-angiogenesis Drugs|anti-angiogenesis drugs
4778831|NCT02748772|Advanced Colorectal Cancer|advanced colorectal cancer
4778832|NCT02748772|Endostar|endostar
4778833|NCT02748772|Thalidomide|thalidomide
4778834|NCT02748772|Vascular Endothelial Growth Factor A|vascular endothelial growth factor a
4778835|NCT02748759|Continous Passive Motion|continous passive motion
4778836|NCT02748759|Manual Physical Therapy|manual physical therapy
4778837|NCT02748759|Range of Motion, Articular|range of motion, articular
4778838|NCT02748759|Anterior Cruciate Ligament Reconstruction|anterior cruciate ligament reconstruction
4778839|NCT02748759|Rehabilitation|rehabilitation
4778840|NCT02748759|Kaltenborn Manual Therapy|kaltenborn manual therapy
4778841|NCT02748746|Lymphedema|lymphedema
4778842|NCT02748746|Electric Impedance|electric impedance
4778843|NCT02748746|Breast Cancer|breast cancer
4778844|NCT02748733|Adapted APD|adapted apd
4778845|NCT02748733|Dialytic Sodium Removal|dialytic sodium removal
4778846|NCT02748733|Ultrafiltration|ultrafiltration
4778847|NCT02748733|Clearance rate|clearance rate
4778848|NCT02748733|Intraperitoneal pressure|intraperitoneal pressure
4778849|NCT02748720|Premature|premature
4778850|NCT02748720|Respiratory Function Monitor|respiratory function monitor
4778851|NCT02748694|Drug Therapy|drug therapy
4778852|NCT02748681|obstructive sleep apnea|obstructive sleep apnea
4778853|NCT02748681|CPAP|cpap
4778854|NCT02748681|stroke|stroke
4778855|NCT02748681|telemedicine|telemedicine
4778856|NCT02748681|neurorehabilitation|neurorehabilitation
4778857|NCT02748681|systolic blood pressure|systolic blood pressure
4778858|NCT02748629|inguinal hernia|inguinal hernia
4778859|NCT02748629|mesh|mesh
4778860|NCT02748629|lichtenstein|lichtenstein
4778861|NCT02748629|hernia repair|hernia repair
4778862|NCT02748629|selfgripping mesh|selfgripping mesh
4778863|NCT02748616|Colitis|colitis
4778864|NCT02748616|Bile|bile
4778865|NCT02748577|Migraines|migraines
4778866|NCT02748577|Pain responses|pain responses
4778867|NCT02748551|Gastric cancer|gastric cancer
4778868|NCT02748551|locally advanced gastric cancer|locally advanced gastric cancer
4778869|NCT02748551|laparoscopic surgery|laparoscopic surgery
4778870|NCT02748551|laparoscopic procedure|laparoscopic procedure
4778871|NCT02748551|comparison laparoscopic with open procedure|comparison laparoscopic with open procedure
4778872|NCT02748551|multicenter trials|multicenter trials
4778873|NCT02748486|schizophrenia|schizophrenia
4778874|NCT02748486|randomized controlled trial|randomized controlled trial
4778875|NCT02748486|metacognitive training|metacognitive training
4778876|NCT02748486|single sessions|single sessions
4778877|NCT02748473|Pilates exercises|pilates exercises
4778878|NCT02748473|pelvic floor muscle contraction|pelvic floor muscle contraction
4778879|NCT02748434|iPro2 Continuous Blood Glucose Recorder|ipro2 continuous blood glucose recorder
4778880|NCT02748434|Subclinical|subclinical
4778881|NCT02748421|retina surgery|retina surgery
4778882|NCT02748421|image guided surgery|image guided surgery
4778883|NCT02748421|optical coherence tomography assisted|optical coherence tomography assisted
4778884|NCT02748369|TCA cycle flux|tca cycle flux
4778885|NCT02748369|in vivo measurements|in vivo measurements
4778886|NCT02748369|Stable isotopes|stable isotopes
4778887|NCT02748369|Arteriovenous balance|arteriovenous balance
4778888|NCT02748369|Metabolome|metabolome
4778889|NCT02748369|Proteome|proteome
4778890|NCT02748369|Exosomes|exosomes
4778891|NCT02748356|Spina Bifida|spina bifida
4778892|NCT02748356|Spinal Cord Injury|spinal cord injury
4778893|NCT02748317|Spina Bifida|spina bifida
4778894|NCT02748317|Spinal Cord Injury|spinal cord injury
4778895|NCT02748317|Lower Urinary Tract Symptoms|lower urinary tract symptoms
4778896|NCT02748317|Probiotics|probiotics
4778897|NCT02748317|Intermittent Catheterization|intermittent catheterization
4778898|NCT02748291|Sedentary|sedentary
4778899|NCT02748291|Knee osteoarthritis|knee osteoarthritis
4778900|NCT02748291|Knee pain|knee pain
4778901|NCT02748291|Gonarthritis|gonarthritis
4778902|NCT02748291|Arthritis|arthritis
4778903|NCT02748291|Walking|walking
4778904|NCT02748291|Pedometer|pedometer
4778905|NCT02748291|Physical Activity|physical activity
4778906|NCT02748291|Activities of Daily Function|activities of daily function
4778907|NCT02748291|Department of Health Physical Activity Guidelines|department of health physical activity guidelines
4778908|NCT02748291|Improve pain|improve pain
4778909|NCT02748291|Decrease pain|decrease pain
4778910|NCT02748291|Improve function|improve function
4778911|NCT02748291|Increase function|increase function
4778912|NCT02748291|Activity Monitoring|activity monitoring
4778913|NCT02748291|Monitoring, Ambulatory/instrumentation|monitoring, ambulatory/instrumentation
4778914|NCT02748278|subfertility|subfertility
4778915|NCT02748278|In-vitro fertilization|in-vitro fertilization
4778916|NCT02748239|diabetes self-management education|diabetes self-management education
4778917|NCT02748239|insulin therapy|insulin therapy
4778918|NCT02748174|Migraine|migraine
4778919|NCT02748174|Curelator|curelator
4778920|NCT02748161|Hepatocellular carcinoma|hepatocellular carcinoma
4778921|NCT02748161|DEB-TACE|deb-tace
4778922|NCT02748161|QED|qed
4778923|NCT02748148|Medication Therapy Management|medication therapy management
4778924|NCT02748148|Pharmacogenomics|pharmacogenomics
4778925|NCT02748122|Adolescents|adolescents
4778926|NCT02748122|Insulin|insulin
4778927|NCT02748122|T2DM|t2dm
4778928|NCT02748109|Physical Therapy|physical therapy
4778929|NCT02748109|Balance Disorder|balance disorder
4778930|NCT02748109|Concussion|concussion
4778931|NCT02748109|Mild Traumatic Brain Injury|mild traumatic brain injury
4778932|NCT02748096|Unicompartmental Knee Replacement|unicompartmental knee replacement
4778933|NCT02748096|Patient Specific Instrumentation|patient specific instrumentation
4778934|NCT02748083|tDCS|tdcs
4778935|NCT02748083|schizophrenia|schizophrenia
4778936|NCT02748083|cognition|cognition
4778937|NCT02748083|fMRI|fmri
4778938|NCT02748031|Congenital cataracts|congenital cataracts
4778939|NCT02748031|Opacity location|opacity location
4778940|NCT02748031|Opacity shape|opacity shape
4778941|NCT02748031|Classification|classification
4778942|NCT02748031|Clinical applicability|clinical applicability
4778943|NCT02748005|Fenugreek seed extract|fenugreek seed extract
4778944|NCT02748005|testosterone|testosterone
4778945|NCT02748005|protodioscin|protodioscin
4778946|NCT02748005|hypogonadism|hypogonadism
4778947|NCT02747979|hemodialysis|hemodialysis
4778948|NCT02747979|hyperparathyroidism|hyperparathyroidism
4778949|NCT02747979|refractory pruritus|refractory pruritus
4778950|NCT02747979|ostalgia|ostalgia
4778951|NCT02747979|insomnia|insomnia
4778952|NCT02747979|CVD incidence|cvd incidence
4778953|NCT02747979|life quality|life quality
4778954|NCT02747966|access flow|access flow
4778955|NCT02747966|access recirculation|access recirculation
4778956|NCT02747966|cardiac output|cardiac output
4778957|NCT02747966|cardiac index|cardiac index
4778958|NCT02747966|hemodialysis|hemodialysis
4778959|NCT02747927|Drug therapy|drug therapy
4778960|NCT02747901|KINESIOTAPING|kinesiotaping
4778961|NCT02747901|COLD THERAPY|cold therapy
4778962|NCT02747901|FUNCTIONAL PERFORMANCE|functional performance
4778964|NCT02747875|pediatric|pediatric
4778965|NCT02747875|cardiac bypass surgery|cardiac bypass surgery
4778966|NCT02747875|methadone|methadone
4778967|NCT02747875|fentanyl|fentanyl
4778968|NCT02747875|morphine|morphine
4778969|NCT02747862|Attenuated Familial Adenomatous Polyposis|attenuated familial adenomatous polyposis
4778970|NCT02747862|AFAP|afap
4778971|NCT02747862|Deleterious Familial Adenomatous Polyposis|deleterious familial adenomatous polyposis
4778972|NCT02747862|FAP|fap
4778973|NCT02747862|Chart review|chart review
4778974|NCT02747797|Advanced Cancer|advanced cancer
4778975|NCT02747797|Lucitanib (E3810)|lucitanib (e3810)
4778976|NCT02747797|Fibroblast Growth Factor Receptor|fibroblast growth factor receptor
4778977|NCT02747797|FGFR|fgfr
4778978|NCT02747797|Vascular Endothelial Growth Factor Receptor|vascular endothelial growth factor receptor
4778979|NCT02747797|VEGFR|vegfr
4778980|NCT02747797|Platelet Derived Growth Factor Receptor|platelet derived growth factor receptor
4778981|NCT02747797|PDGFR|pdgfr
4778982|NCT02747797|metastatic malignancy|metastatic malignancy
4778983|NCT02747784|cognitive dysfunction|cognitive dysfunction
4778984|NCT02747784|cognitive training|cognitive training
4778985|NCT02747771|effectiveness|effectiveness
4778986|NCT02747771|trichotillomania|trichotillomania
4778987|NCT02747771|hair pulling|hair pulling
4778988|NCT02747771|habit reversal training|habit reversal training
4778989|NCT02747771|acceptance and commitment therapy|acceptance and commitment therapy
4778990|NCT02747771|cognitive behavioral therapy|cognitive behavioral therapy
4778991|NCT02747758|neuropathic pain|neuropathic pain
4778992|NCT02747758|neuralgia|neuralgia
4778993|NCT02747758|tDCS|tdcs
4778994|NCT02747758|transcranial direct current stimulation|transcranial direct current stimulation
4778995|NCT02747745|Caregivers|caregivers
4778996|NCT02747745|Case Management|case management
4778997|NCT02747745|Community Dwelling|community dwelling
4778998|NCT02747706|peer mentor|peer mentor
4778999|NCT02747706|health coach|health coach
4779000|NCT02747706|parent support|parent support
4779001|NCT02747706|parent mentor|parent mentor
4779002|NCT02747680|type 1 diabetes|type 1 diabetes
4779003|NCT02747680|hypoglycemia unawareness|hypoglycemia unawareness
4779004|NCT02747680|healthy control|healthy control
4779005|NCT02747667|iol dislocation|iol dislocation
4779006|NCT02747667|iol complication|iol complication
4779007|NCT02747667|intraocular lens|intraocular lens
4779008|NCT02747667|Implant or Graft|implant or graft
4779009|NCT02747667|Eye|eye
4779010|NCT02747654|NAT2 genotype guided dosing|nat2 genotype guided dosing
4779011|NCT02747628|Transdermal nicotine|transdermal nicotine
4779012|NCT02747628|Transdermal melatonin|transdermal melatonin
4779013|NCT02747628|Postoperative pain|postoperative pain
4779014|NCT02747628|Laparoscopic cholecystectomy|laparoscopic cholecystectomy
4779015|NCT02747615|Preoperative autologous blood donation, allogeneic blood transfusion, parenteral iron, tranexamic acid, revision total hip arthroplasty, hemoglobin, hematocrit|preoperative autologous blood donation, allogeneic blood transfusion, parenteral iron, tranexamic acid, revision total hip arthroplasty, hemoglobin, hematocrit
4779016|NCT02747602|Healthy volunteers|healthy volunteers
4779017|NCT02747602|Caprylic triglyceride oil|caprylic triglyceride oil
4779018|NCT02747602|AC-1204|ac-1204
4779019|NCT02747602|Pharmacokinetic|pharmacokinetic
4779020|NCT02747602|Ketone body|ketone body
4779021|NCT02747576|Childhood Cancer Survivor|childhood cancer survivor
4779022|NCT02747576|Social-cognition|social-cognition
4779023|NCT02747576|Healthy Volunteers|healthy volunteers
4779024|NCT02747563|prostate cancer|prostate cancer
4779025|NCT02747563|PSA|psa
4779026|NCT02747563|digital rectal examination|digital rectal examination
4779027|NCT02747472|GIP|gip
4779028|NCT02747472|GIP receptor antagonist|gip receptor antagonist
4779029|NCT02747446|fructose, triglyceride, oral glucose tolerance|fructose, triglyceride, oral glucose tolerance
4779030|NCT02747433|robot-assisted therapy|robot-assisted therapy
4779031|NCT02747433|task-oriented training|task-oriented training
4779032|NCT02747433|motor learning|motor learning
4779033|NCT02747420|Posterior Tibial Nerve Stimulation, Bladder|posterior tibial nerve stimulation, bladder
4779034|NCT02747368|Wet age-related macular degeneration|wet age-related macular degeneration
4779035|NCT02747368|Age-related macular degeneration|age-related macular degeneration
4779036|NCT02747368|Ocusweep|ocusweep
4779037|NCT02747368|Driving health|driving health
4779038|NCT02747368|Visual field|visual field
4779039|NCT02747368|Contrast sensitivity|contrast sensitivity
4779040|NCT02747342|Metastatic castration-resistant prostate cancer|metastatic castration-resistant prostate cancer
4779041|NCT02747342|Monotherapy|monotherapy
4779042|NCT02747329|BuMA Supreme|buma supreme
4779043|NCT02747329|Xience V/Prime|xience v/prime
4779044|NCT02747329|OCT|oct
4779045|NCT02747329|neointima formation|neointima formation
4779046|NCT02747316|Iron bioavailability|iron bioavailability
4779047|NCT02747316|Hepcidin|hepcidin
4779048|NCT02747316|Iron absorption|iron absorption
4779049|NCT02747303|brain metastases|brain metastases
4779050|NCT02747303|Stereotactic Radiosurgery|stereotactic radiosurgery
4779051|NCT02747290|BBN-RGD|bbn-rgd
4779052|NCT02747290|PET|pet
4779053|NCT02747290|integrin αvβ3|integrin αvβ3
4779054|NCT02747290|GRPR|grpr
4779055|NCT02747264|eRAPID|erapid
4779056|NCT02747264|PRO|pro
4779057|NCT02747264|PROM|prom
4779058|NCT02747264|Adverse event|adverse event
4779059|NCT02747264|QTool|qtool
4779060|NCT02747264|CTCAE|ctcae
4779061|NCT02747251|"Shoulder Impingement Syndrome[Mesh]"|"shoulder impingement syndrome[mesh]"
4779062|NCT02747251|"Rehabilitation[Mesh]"|"rehabilitation[mesh]"
4779063|NCT02747251|"Exercise[Mesh]"|"exercise[mesh]"
4779064|NCT02747251|"Rotator Cuff[Mesh]"|"rotator cuff[mesh]"
4779065|NCT02747238|Pregnancy|pregnancy
4779066|NCT02747238|Epidural|epidural
4779067|NCT02747238|Labor|labor
4779068|NCT02747225|electrical properties|electrical properties
4779069|NCT02747225|malignant tissues|malignant tissues
4779070|NCT02747225|in vivo|in vivo
4779071|NCT02747212|electrical properties|electrical properties
4779072|NCT02747212|malignant tissues|malignant tissues
4779073|NCT02747212|ex vivo|ex vivo
4779074|NCT02747199|SYNERGY|synergy
4779075|NCT02747199|Neointimal formation|neointimal formation
4779076|NCT02747199|OCT|oct
4779077|NCT02747199|coronary angioscopy|coronary angioscopy
4779078|NCT02747199|coronary artery disease|coronary artery disease
4779079|NCT02747186|lidocaine, jaw|lidocaine, jaw
4779080|NCT02747173|metastatic, bone metastases|metastatic, bone metastases
4779081|NCT02747160|Cancer|cancer
4779082|NCT02747160|Anxiety|anxiety
4779083|NCT02747160|Cognitive behavior therapy|cognitive behavior therapy
4779084|NCT02747160|Elderly|elderly
4779085|NCT02747160|Caregivers|caregivers
4779086|NCT02747121|External inspections|external inspections
4779087|NCT02747108|Veterans|veterans
4779088|NCT02747108|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
4779089|NCT02747108|Prediabetes|prediabetes
4779090|NCT02747108|Decision-making|decision-making
4779091|NCT02747108|Motivation|motivation
4779092|NCT02747108|Health Promotion|health promotion
4779093|NCT02747108|Prevention and Control|prevention and control
4779094|NCT02747095|CT|ct
4779095|NCT02747095|Spectral Images|spectral images
4779096|NCT02747082|endodontic retreatment|endodontic retreatment
4779097|NCT02747082|sodium hypochlorite|sodium hypochlorite
4779098|NCT02747082|chlorhexidine|chlorhexidine
4779099|NCT02747082|calcium hydroxide|calcium hydroxide
4779100|NCT02747082|Retreatment|retreatment
4779101|NCT02747069|Heart rate|heart rate
4779102|NCT02747069|Electronic Stethoscope|electronic stethoscope
4779103|NCT02747069|Electrocardiogram|electrocardiogram
4779104|NCT02747069|Resuscitation|resuscitation
4779105|NCT02747030|Central retinal vein occlusion|central retinal vein occlusion
4779106|NCT02747030|Retinal endovascular surgery|retinal endovascular surgery
4779107|NCT02747030|Retinal vein cannulation|retinal vein cannulation
4779108|NCT02747030|Ocriplasmin|ocriplasmin
4779109|NCT02747017|transplant|transplant
4779110|NCT02746965|magnetic seizure therapy|magnetic seizure therapy
4779111|NCT02746965|randomized controlled trials|randomized controlled trials
4779112|NCT02746965|schizophrenia|schizophrenia
4779113|NCT02746965|cognition|cognition
4779114|NCT02746939|program evaluation|program evaluation
4779115|NCT02746939|health literacy|health literacy
4779116|NCT02746939|fitness|fitness
4779117|NCT02746939|nutrition|nutrition
4779118|NCT02746939|education|education
4779119|NCT02746913|Pelvic, Urodynamic, Vaginal Wall|pelvic, urodynamic, vaginal wall
4779120|NCT02746874|Total Knee Replacement, Replacement of the knee joint,|total knee replacement, replacement of the knee joint,
4779121|NCT02746861|peer mentor|peer mentor
4779122|NCT02746861|peer supporter|peer supporter
4779123|NCT02746861|peer coach|peer coach
4779124|NCT02746861|peer-to-peer mentoring|peer-to-peer mentoring
4779125|NCT02746848|cornea epithelium healing Amniotic Membrane Eye Drop|cornea epithelium healing amniotic membrane eye drop
4779126|NCT02746835|physical condition|physical condition
4779127|NCT02746835|self-efficacy|self-efficacy
4779128|NCT02746835|fall risk|fall risk
4779129|NCT02746835|exercise program|exercise program
4779130|NCT02746822|acute myocardial infarction,|acute myocardial infarction,
4779131|NCT02746822|thrombus aspiration|thrombus aspiration
4779132|NCT02746679|Asherman syndrome|asherman syndrome
4779133|NCT02746679|Mindfulness|mindfulness
4779134|NCT02746679|Anxiety|anxiety
4779135|NCT02746679|Depression|depression
4779136|NCT02746679|Quality of Life|quality of life
4779137|NCT02746653|Fascia Closure Device, hernia,|fascia closure device, hernia,
4779138|NCT02746614|adaptive behavior|adaptive behavior
4779139|NCT02746614|motor proficiency|motor proficiency
4779140|NCT02746614|psychomotor therapy|psychomotor therapy
4779141|NCT02746614|intellectual disability|intellectual disability
4779142|NCT02746588|miscarriage|miscarriage
4779143|NCT02746588|uterine abnormalities|uterine abnormalities
4779144|NCT02746588|Chronic infection|chronic infection
4779145|NCT02746562|Assisted reproduction|assisted reproduction
4779146|NCT02746562|In vitro fertilisation|in vitro fertilisation
4779147|NCT02746562|Frozen embryo transfer (FET)|frozen embryo transfer (fet)
4779148|NCT02746536|COPD|copd
4779149|NCT02746536|Inspiratory capacity|inspiratory capacity
4779150|NCT02746536|Exercise|exercise
4779151|NCT02746523|NHL|nhl
4779152|NCT02746523|Concussion|concussion
4779153|NCT02746523|Biomarkers|biomarkers
4779154|NCT02746497|Menopause|menopause
4779155|NCT02746497|Hot flushes|hot flushes
4779156|NCT02746497|Acupuncture|acupuncture
4779157|NCT02746497|Randomized controlled trial|randomized controlled trial
4779158|NCT02746458|Blood Flow Restriction|blood flow restriction
4779159|NCT02746458|Muscle Weakness|muscle weakness
4779160|NCT02746458|Physical therapy techniques|physical therapy techniques
4779161|NCT02746458|closed femoral fracture injuries|closed femoral fracture injuries
4779162|NCT02746445|Autism|autism
4779163|NCT02746445|ASD|asd
4779164|NCT02746445|Autism Spectrum Disorder|autism spectrum disorder
4779165|NCT02746432|CRC-Insulin|crc-insulin
4779166|NCT02746354|Chronic Pain|chronic pain
4779167|NCT02746354|Analgesics, Opioid|analgesics, opioid
4779168|NCT02746354|Primary Health Care|primary health care
4779169|NCT02746276|malnutrition|malnutrition
4779170|NCT02746276|antibiotics|antibiotics
4779171|NCT02746276|antimicrobial resistance|antimicrobial resistance
4779172|NCT02746276|pharmacokinetics|pharmacokinetics
4779173|NCT02746263|Elective total knee arthroplasty|elective total knee arthroplasty
4779174|NCT02746237|Serotonin|serotonin
4779175|NCT02746237|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
4779176|NCT02746237|Pharmacokinetics|pharmacokinetics
4779177|NCT02746237|Phase 1|phase 1
4779178|NCT02746237|Healthy Volunteers|healthy volunteers
4779179|NCT02746224|Colorectal cancer|colorectal cancer
4779180|NCT02746224|Colorectal surgery|colorectal surgery
4779181|NCT02746211|immunology|immunology
4779182|NCT02746211|pathogenicity|pathogenicity
4779183|NCT02746198|Probiotics, Antibiotics, AAD, Helicobacter p.|probiotics, antibiotics, aad, helicobacter p.
4779184|NCT02746185|cancer|cancer
4779185|NCT02746185|venous thromboembolism|venous thromboembolism
4779186|NCT02746185|low-molecular weight heparin|low-molecular weight heparin
4779187|NCT02746185|rivaroxaban|rivaroxaban
4779188|NCT02746172|cochlear implants|cochlear implants
4779189|NCT02746172|Mapping|mapping
4779190|NCT02746172|in-situ audiometry|in-situ audiometry
4779191|NCT02746107|shared decision making|shared decision making
4779192|NCT02746107|oral anticoagulant|oral anticoagulant
4779193|NCT02746107|atrial fibrillation|atrial fibrillation
4779194|NCT02746107|stroke|stroke
4779195|NCT02746107|decision to treat|decision to treat
4779196|NCT02746081|BAY1436032|bay1436032
4779197|NCT02746081|Solid tumors|solid tumors
4779198|NCT02746081|IDH1|idh1
4779199|NCT02746081|Cancer|cancer
4779200|NCT02746081|Safety|safety
4779201|NCT02746081|Tolerability|tolerability
4779202|NCT02746081|Pharmacokinetics|pharmacokinetics
4779203|NCT02746081|Pharmacodynamics|pharmacodynamics
4779204|NCT02746081|Efficacy|efficacy
4779205|NCT02746081|Food-effect|food-effect
4779206|NCT02746068|Bone Marrow Lesions|bone marrow lesions
4779207|NCT02746068|AXS02|axs02
4779208|NCT02746068|Axsome|axsome
4779209|NCT02746068|Knee OA|knee oa
4779210|NCT02746068|Osteoarthritis|osteoarthritis
4779211|NCT02746042|chronic rhinosinusitis|chronic rhinosinusitis
4779212|NCT02746042|Sinupret extract|sinupret extract
4779213|NCT02746042|herbal medicinal product|herbal medicinal product
4779214|NCT02746003|drinking water|drinking water
4779215|NCT02746003|salinity|salinity
4779216|NCT02745990|erythropoietin|erythropoietin
4779217|NCT02745990|preterm|preterm
4779218|NCT02745990|brain injury|brain injury
4779219|NCT02745990|cerebral palsy|cerebral palsy
4779220|NCT02745990|PVL|pvl
4779221|NCT02745951|cardiopulmonary bypass|cardiopulmonary bypass
4779222|NCT02745951|cardioplegia|cardioplegia
4779223|NCT02745951|cardioprotection|cardioprotection
4779224|NCT02745951|coronary artery bypass graft surgery|coronary artery bypass graft surgery
4779225|NCT02745951|heliox|heliox
4779226|NCT02745938|Exercise test|exercise test
4779227|NCT02745938|GDF-15|gdf-15
4779228|NCT02745938|Growth and Differentiation Factor 15|growth and differentiation factor 15
4779229|NCT02745925|Iron bioavailability|iron bioavailability
4779230|NCT02745925|Inflammation|inflammation
4779231|NCT02745925|Hepcidin|hepcidin
4779232|NCT02745925|Iron absorption|iron absorption
4779233|NCT02745912|Drug Therapy|drug therapy
4779234|NCT02745899|asthma|asthma
4779235|NCT02745899|cow milk|cow milk
4779236|NCT02745899|pulmonary function testing|pulmonary function testing
4779237|NCT02745899|children|children
4779238|NCT02745899|mucus|mucus
4779239|NCT02745860|selexipag|selexipag
4779240|NCT02745860|pharmacokinetics|pharmacokinetics
4779241|NCT02745821|coronary flow reserve|coronary flow reserve
4779242|NCT02745821|fractional flow reserve|fractional flow reserve
4779243|NCT02745821|diabetes mellitus|diabetes mellitus
4779244|NCT02745821|coronary artery disease|coronary artery disease
4779245|NCT02745821|percutaneous coronary intervention|percutaneous coronary intervention
4779246|NCT02745821|coronary physiology|coronary physiology
4779247|NCT02745821|index of microcirculatory resistance|index of microcirculatory resistance
4779248|NCT02745795|Motivational interview|motivational interview
4779249|NCT02745795|adolescents|adolescents
4779250|NCT02745795|obesity|obesity
4779251|NCT02745795|overweight|overweight
4779252|NCT02745795|physical activity|physical activity
4779253|NCT02745795|diet|diet
4779254|NCT02745782|Pulpitis|pulpitis
4779255|NCT02745782|Syncope|syncope
4779256|NCT02745782|Trigeminal Cardio-Reflex|trigeminal cardio-reflex
4779257|NCT02745756|Children|children
4779258|NCT02745756|Cancer|cancer
4779259|NCT02745756|High-risk neuroblastoma|high-risk neuroblastoma
4779260|NCT02745743|Phase 1|phase 1
4779261|NCT02745743|Dose escalation|dose escalation
4779262|NCT02745743|Dose expansion|dose expansion
4779263|NCT02745743|Positive transcription elongation factor b inhibitor|positive transcription elongation factor b inhibitor
4779264|NCT02745743|Cyclin-dependent kinase 9 inhibitor|cyclin-dependent kinase 9 inhibitor
4779265|NCT02745717|Severe aplastic anemia|severe aplastic anemia
4779266|NCT02745717|immunosuppressive therapy|immunosuppressive therapy
4779267|NCT02745717|cord blood transfusion|cord blood transfusion
4779268|NCT02745704|chronic hepatitis B|chronic hepatitis b
4779269|NCT02745704|peginterferon alfa|peginterferon alfa
4779270|NCT02745691|quality of life|quality of life
4779271|NCT02745691|psychometric validation|psychometric validation
4779272|NCT02745691|international field study|international field study
4779273|NCT02745691|patient-reported outcome (PRO)|patient-reported outcome (pro)
4779274|NCT02745678|Enema|enema
4779275|NCT02745678|Ulcerative Colitis|ulcerative colitis
4779276|NCT02745652|median nerve|median nerve
4779277|NCT02745652|wrist joint|wrist joint
4779278|NCT02745652|carpal tunnel|carpal tunnel
4779279|NCT02745639|rectal cancer|rectal cancer
4779280|NCT02745639|radiotherapy|radiotherapy
4779281|NCT02745639|chemotherapy|chemotherapy
4779282|NCT02745639|VMAT|vmat
4779283|NCT02745639|toxicity|toxicity
4779284|NCT02745600|RFA|rfa
4779285|NCT02745600|Liver|liver
4779286|NCT02745600|Ablation Techniques|ablation techniques
4779287|NCT02745600|Treatment Simulation|treatment simulation
4779288|NCT02745600|Computer assisted therapy|computer assisted therapy
4779289|NCT02745574|should and upper abdominal pain, post-laparoscopy|should and upper abdominal pain, post-laparoscopy
4779290|NCT02745561|Endostatin|endostatin
4779291|NCT02745561|Oxaliplatin|oxaliplatin
4779292|NCT02745561|Esophageal Cancer|esophageal cancer
4779293|NCT02745561|chemoradiotherapy|chemoradiotherapy
4779294|NCT02745548|Lung Cancer|lung cancer
4779295|NCT02745548|NSCLC (Non Small Cell Lung Cancer)|nsclc (non small cell lung cancer)
4779296|NCT02745548|SABR (Stereotactic ablative radiotherapy)|sabr (stereotactic ablative radiotherapy)
4779297|NCT02745535|Hepatitis C relapse|hepatitis c relapse
4779298|NCT02745522|Placebo analgesia|placebo analgesia
4779299|NCT02745522|Working memory|working memory
4779300|NCT02745509|Extensive Intraoperative Peritoneal Lavage|extensive intraoperative peritoneal lavage
4779301|NCT02745509|EIPL|eipl
4779302|NCT02745509|Gastric Cancer|gastric cancer
4779303|NCT02745496|Image-guided biopsy|image-guided biopsy
4779304|NCT02745496|Tumour detection|tumour detection
4779305|NCT02745496|Diagnostic|diagnostic
4779306|NCT02745496|Biomarkers|biomarkers
4779307|NCT02745483|RFA|rfa
4779308|NCT02745470|lean/obese diabetes mellitus|lean/obese diabetes mellitus
4779309|NCT02745470|functional MRI|functional mri
4779310|NCT02745470|GLP-1|glp-1
4779311|NCT02745470|appetite|appetite
4779312|NCT02745470|activation of brain|activation of brain
4779313|NCT02745470|connectivity|connectivity
4779314|NCT02745444|Living kidney transplantation|living kidney transplantation
4779315|NCT02745444|Chronic kidney disease|chronic kidney disease
4779316|NCT02745444|Acute kidney injury|acute kidney injury
4779317|NCT02745431|Likeability|likeability
4779318|NCT02745431|Being liked|being liked
4779319|NCT02745405|Weight Stigma|weight stigma
4779320|NCT02745405|Cortisol Reactivity|cortisol reactivity
4779321|NCT02745405|Eating Behavior|eating behavior
4779322|NCT02745392|migraine|migraine
4779323|NCT02745392|migraine headache|migraine headache
4779324|NCT02745392|acute migraine|acute migraine
4779325|NCT02745392|acute migraine headache|acute migraine headache
4779326|NCT02745353|Cancer|cancer
4779327|NCT02745353|Constipation|constipation
4779328|NCT02745353|Opioid|opioid
4779329|NCT02745327|oral vaccination|oral vaccination
4779330|NCT02745327|nutrition|nutrition
4779331|NCT02745314|Aortic Stenosis, Frailty, Elderly, moertality|aortic stenosis, frailty, elderly, moertality
4779332|NCT02745275|Peer Education|peer education
4779333|NCT02745275|Health Coaches|health coaches
4779334|NCT02745275|Community Dwelling Seniors|community dwelling seniors
4779335|NCT02745275|Health Literacy|health literacy
4779336|NCT02745275|Health Education|health education
4779337|NCT02745275|Healthy Ageing|healthy ageing
4779338|NCT02745236|Atrial Fibrillation|atrial fibrillation
4779339|NCT02745236|Health Related Quality of Life|health related quality of life
4779340|NCT02745236|Nurse Practitioner|nurse practitioner
4779341|NCT02745236|Sustainable Models of Healthcare|sustainable models of healthcare
4779342|NCT02745236|Patient Satisfaction|patient satisfaction
4779343|NCT02745171|Parkinson's disease|parkinson's disease
4779344|NCT02745171|Quality of life|quality of life
4779345|NCT02745171|Functional mobility|functional mobility
4779346|NCT02745171|Follow up|follow up
4779444|NCT02744833|DVT|dvt
4779347|NCT02745158|Fibrodysplasia ossificans progressiva|fibrodysplasia ossificans progressiva
4779348|NCT02745158|FOP|fop
4779349|NCT02745158|International FOP Association|international fop association
4779350|NCT02745158|Patient Advocacy Group|patient advocacy group
4779351|NCT02745158|Patient Registry|patient registry
4779352|NCT02745158|Natural History|natural history
4779353|NCT02745158|Patient-Reported Outcomes|patient-reported outcomes
4779354|NCT02745158|Observational Database|observational database
4779355|NCT02745158|Bone Morphogenetic Protein|bone morphogenetic protein
4779356|NCT02745158|BMP|bmp
4779357|NCT02745158|Bone Growth|bone growth
4779358|NCT02745158|Joint|joint
4779359|NCT02745158|Mobility|mobility
4779360|NCT02745158|Flare-Up|flare-up
4779361|NCT02745158|Heterotopic Ossification|heterotopic ossification
4779362|NCT02745158|Ectopic Bone|ectopic bone
4779363|NCT02745158|Osteochondroma|osteochondroma
4779364|NCT02745158|Hallux Valgus|hallux valgus
4779365|NCT02745158|ALK2|alk2
4779366|NCT02745158|ACVR1|acvr1
4779367|NCT02745158|Activin A|activin a
4779368|NCT02745158|IFOPA|ifopa
4779369|NCT02745158|Activin A Receptor Type I|activin a receptor type i
4779370|NCT02745158|Activin Receptor-like Kinase-2|activin receptor-like kinase-2
4779371|NCT02745145|Double-Blind Method|double-blind method
4779372|NCT02745145|Interstitial Lung Diseases|interstitial lung diseases
4779373|NCT02745145|Systemic Scleroderma|systemic scleroderma
4779374|NCT02745145|Abituzumab|abituzumab
4779375|NCT02745145|Mycophenolate|mycophenolate
4779376|NCT02745145|Efficacy, Safety|efficacy, safety
4779377|NCT02745132|Chronic, Cognition Disorders|chronic, cognition disorders
4779378|NCT02745132|Neurocognition Disorders|neurocognition disorders
4779379|NCT02745132|Cognitive Impairments|cognitive impairments
4779380|NCT02745132|Diffusion Magnetic Resonance Imaging|diffusion magnetic resonance imaging
4779381|NCT02745132|MRI functional|mri functional
4779382|NCT02745132|Verbal fluency|verbal fluency
4779383|NCT02745106|Chronic thromboembolic pulmonary hypertension, Navigation system, Ablation|chronic thromboembolic pulmonary hypertension, navigation system, ablation
4779384|NCT02745093|Abortion induced|abortion induced
4779385|NCT02745093|Patient Acceptance of Healthcare|patient acceptance of healthcare
4779386|NCT02745093|safety|safety
4779387|NCT02745093|effectiveness|effectiveness
4779388|NCT02745093|misoprostol|misoprostol
4779389|NCT02745093|mifepristone|mifepristone
4779390|NCT02745080|Psoriatic Arthritis|psoriatic arthritis
4779391|NCT02745080|secukinumab|secukinumab
4779392|NCT02745080|adalimumab|adalimumab
4779393|NCT02745080|monoclonal antibody|monoclonal antibody
4779394|NCT02745080|CASPAR|caspar
4779395|NCT02745054|oral anticoagulants|oral anticoagulants
4779396|NCT02745054|bleeding|bleeding
4779397|NCT02745054|anticoagulation reversal|anticoagulation reversal
4779398|NCT02745041|Fibrinogen|fibrinogen
4779399|NCT02745041|Cryoprecipitate|cryoprecipitate
4779400|NCT02745028|delayed gastric emptying|delayed gastric emptying
4779401|NCT02745028|children|children
4779402|NCT02745028|monosodium glutamate|monosodium glutamate
4779403|NCT02745015|periodontitis|periodontitis
4779404|NCT02745015|diabetes|diabetes
4779405|NCT02745015|HbA1c|hba1c
4779406|NCT02745015|inflammation|inflammation
4779407|NCT02745002|Bronchoscopy|bronchoscopy
4779408|NCT02745002|Bronchoscopes|bronchoscopes
4779409|NCT02744989|Schizophrenia|schizophrenia
4779410|NCT02744989|Transcranial direct-current stimulation (tDCS)|transcranial direct-current stimulation (tdcs)
4779411|NCT02744989|Sham|sham
4779412|NCT02744989|Positive and Negative Syndrome Scale (PANSS)|positive and negative syndrome scale (panss)
4779413|NCT02744989|Functional Magnetic Resonance Imaging (fRMI)|functional magnetic resonance imaging (frmi)
4779414|NCT02744989|Brain-Derived-Neurotrophic Factor (BDNF)|brain-derived-neurotrophic factor (bdnf)
4779415|NCT02744976|Coronary artery disease|coronary artery disease
4779416|NCT02744976|Atherosclerosis|atherosclerosis
4779417|NCT02744976|Prediabetes|prediabetes
4779418|NCT02744976|Intravascular ultrasound|intravascular ultrasound
4779419|NCT02744976|Insulin resistance|insulin resistance
4779420|NCT02744976|Percutaneous coronary intervention|percutaneous coronary intervention
4779421|NCT02744976|Metformin|metformin
4779422|NCT02744950|pulley|pulley
4779423|NCT02744950|scalp defects|scalp defects
4779424|NCT02744911|speech problems|speech problems
4779425|NCT02744898|uterus|uterus
4779426|NCT02744898|gynecological|gynecological
4779427|NCT02744898|corpus uteri|corpus uteri
4779428|NCT02744872|lung transplantation|lung transplantation
4779429|NCT02744872|chronic renal insufficiency|chronic renal insufficiency
4779430|NCT02744859|Decision Making|decision making
4779431|NCT02744859|Consumption|consumption
4779432|NCT02744859|Economics|economics
4779433|NCT02744846|antibiotics|antibiotics
4779434|NCT02744846|children|children
4779435|NCT02744846|pediatric|pediatric
4779436|NCT02744846|body mass index|body mass index
4779437|NCT02744846|Observational Study|observational study
4779438|NCT02744846|Comparative Effectiveness Research|comparative effectiveness research
4779439|NCT02744846|Obesity|obesity
4779440|NCT02744846|Growth Trajectory|growth trajectory
4779441|NCT02744846|Cohort Study|cohort study
4779442|NCT02744846|Electronic Medical Record|electronic medical record
4779443|NCT02744846|Qualitative Research|qualitative research
4779445|NCT02744807|intrauterine adhesions|intrauterine adhesions
4779446|NCT02744807|Chronic endometritis|chronic endometritis
4779447|NCT02744807|infections|infections
4779448|NCT02744807|Hysteroscopy|hysteroscopy
4779449|NCT02744781|Muscular Atrophy|muscular atrophy
4779450|NCT02744781|Asymmetry|asymmetry
4779451|NCT02744781|Athletes|athletes
4779452|NCT02744768|Acute Lymphoblastic Leukemia, adult, dasatinib, blinatumomab|acute lymphoblastic leukemia, adult, dasatinib, blinatumomab
4779453|NCT02744716|intrauterine balloon|intrauterine balloon
4779454|NCT02744716|uterine endometrial repair|uterine endometrial repair
4779455|NCT02744716|intrauterine adhesion|intrauterine adhesion
4779456|NCT02744716|aspirin|aspirin
4779457|NCT02744690|Eye Disease|eye disease
4779458|NCT02744690|Intraocular Pressure|intraocular pressure
4779459|NCT02744690|Visual Acuity|visual acuity
4779460|NCT02744690|Trabeculectomy|trabeculectomy
4779461|NCT02744677|Tetralogy of Fallot|tetralogy of fallot
4779462|NCT02744677|Aortic Valve Defect/Disease Resulting in Ross Procedure|aortic valve defect/disease resulting in ross procedure
4779463|NCT02744677|Pulmonary Atresia|pulmonary atresia
4779464|NCT02744677|Pulmonary Stenosis|pulmonary stenosis
4779465|NCT02744677|Truncus Arteriosus|truncus arteriosus
4779466|NCT02744677|Transposition of the Great Arteries|transposition of the great arteries
4779467|NCT02744677|Transcatheter pulmonary valve implantation|transcatheter pulmonary valve implantation
4779468|NCT02744677|Transcatheter pulmonary valve replacement|transcatheter pulmonary valve replacement
4779469|NCT02744677|TPV|tpv
4779470|NCT02744677|TPVR|tpvr
4779471|NCT02744677|TPVI|tpvi
4779472|NCT02744664|Lung Neoplasms|lung neoplasms
4779473|NCT02744664|EGFR mutation|egfr mutation
4779474|NCT02744664|Cryotherapy|cryotherapy
4779475|NCT02744664|Icotinib|icotinib
4779476|NCT02744638|bacterial vaginosis|bacterial vaginosis
4779477|NCT02744638|probiotics|probiotics
4779478|NCT02744638|Amsel Score|amsel score
4779479|NCT02744638|Nugent Score|nugent score
4779480|NCT02744599|Feasibility trial|feasibility trial
4779481|NCT02744586|Sexually transmitted infections|sexually transmitted infections
4779482|NCT02744586|Neglected tropical diseases|neglected tropical diseases
4779483|NCT02744586|Non-communicable diseases|non-communicable diseases
4779484|NCT02744534|Prostate Cancer|prostate cancer
4779485|NCT02744534|Imaging Technology|imaging technology
4779486|NCT02744534|Oncology|oncology
4779487|NCT02744534|Prostate Biopsy|prostate biopsy
4779488|NCT02744508|palonosetron, dexamethasone, PONV (postoperative nausea and vomiting)|palonosetron, dexamethasone, ponv (postoperative nausea and vomiting)
4779489|NCT02744495|cardiac surgery|cardiac surgery
4779490|NCT02744495|corticoids|corticoids
4779491|NCT02744495|droperidol|droperidol
4779492|NCT02744495|antiemetics|antiemetics
4779493|NCT02744495|Postoperative Vomiting|postoperative vomiting
4779494|NCT02744495|Postoperative Nausea|postoperative nausea
4779495|NCT02744495|Postoperative Emesis|postoperative emesis
4779496|NCT02744495|prophylaxis|prophylaxis
4779497|NCT02744469|Tuberculosis|tuberculosis
4779498|NCT02744469|population structure|population structure
4779499|NCT02744469|implications|implications
4779500|NCT02744469|lineages|lineages
4779501|NCT02744469|spoligotyping|spoligotyping
4779502|NCT02744469|sputum|sputum
4779503|NCT02744469|resistance|resistance
4779504|NCT02744469|culture|culture
4779505|NCT02744469|diagnostics|diagnostics
4779506|NCT02744469|outcome|outcome
4779507|NCT02744469|new/retreatment patient|new/retreatment patient
4779508|NCT02744456|Hydrochlorothiazide tablet|hydrochlorothiazide tablet
4779509|NCT02744456|Norvasc|norvasc
4779510|NCT02744456|Cozaar|cozaar
4779511|NCT02744456|amlodipine besylate tablets|amlodipine besylate tablets
4779512|NCT02744456|losartan potassium tablets|losartan potassium tablets
4779513|NCT02744456|Hypertension|hypertension
4779514|NCT02744456|High Blood Pressure|high blood pressure
4779515|NCT02744430|Medical expulsive therapy|medical expulsive therapy
4779516|NCT02744430|ureteral stone|ureteral stone
4779517|NCT02744430|stent pain|stent pain
4779518|NCT02744417|smoking cessation|smoking cessation
4779519|NCT02744417|tobacco|tobacco
4779520|NCT02744417|periodontal|periodontal
4779521|NCT02744417|subgingival microorganisms|subgingival microorganisms
4779522|NCT02744352|infraclavicular brachial plexus block|infraclavicular brachial plexus block
4779523|NCT02744352|quality of recovery score|quality of recovery score
4779524|NCT02744352|pain score|pain score
4779525|NCT02744352|disability assessment of shoulder and hand questionnaire|disability assessment of shoulder and hand questionnaire
4779526|NCT02744339|PH-HFpEF|ph-hfpef
4779527|NCT02744300|Gestational diabetes mellitus (GDM) in most recent pregnancy|gestational diabetes mellitus (gdm) in most recent pregnancy
4779528|NCT02744287|Non Resectable Pancreatic Cancer|non resectable pancreatic cancer
4779529|NCT02744287|BPX-601|bpx-601
4779530|NCT02744287|AP1903|ap1903
4779531|NCT02744287|CAR T|car t
4779532|NCT02744287|PSCA-CAR|psca-car
4779533|NCT02744274|acupuncture|acupuncture
4779534|NCT02744274|chemotherapy|chemotherapy
4779535|NCT02744274|peripheral neuropathy|peripheral neuropathy
4779536|NCT02744274|randomized clinical trial|randomized clinical trial
4779537|NCT02744274|numbness|numbness
4779538|NCT02744261|HIV|hiv
4779539|NCT02744261|STI|sti
4779540|NCT02744261|Primary Prevention|primary prevention
4780150|NCT02740374|blood loss|blood loss
4779541|NCT02744261|Topical Microbicides|topical microbicides
4779542|NCT02744261|User Experience|user experience
4779543|NCT02744261|Drug Delivery Systems|drug delivery systems
4779544|NCT02744248|Magnetic Resonance Imaging (MRI)|magnetic resonance imaging (mri)
4779545|NCT02744196|rheumatoid arthritis|rheumatoid arthritis
4779546|NCT02744196|rheumatism|rheumatism
4779547|NCT02744196|Acellbia|acellbia
4779548|NCT02744196|methotrexate|methotrexate
4779549|NCT02744196|biologic therapy|biologic therapy
4779550|NCT02744196|monoclonal antibody|monoclonal antibody
4779551|NCT02744196|rituximab|rituximab
4779552|NCT02744183|Exercise|exercise
4779553|NCT02744183|Fasted|fasted
4779554|NCT02744183|Glucose|glucose
4779555|NCT02744183|Energy Balance|energy balance
4779556|NCT02744170|COPD|copd
4779557|NCT02744170|Incremental Shuttle Walk Test|incremental shuttle walk test
4779558|NCT02744170|Endurance Shuttle Walk Test|endurance shuttle walk test
4779559|NCT02744170|oxygen therapy|oxygen therapy
4779560|NCT02744131|PCOS|pcos
4779561|NCT02744131|Metformin|metformin
4779562|NCT02744131|OCP|ocp
4779563|NCT02744131|metabolic parameters|metabolic parameters
4779564|NCT02744118|Media Use|media use
4779565|NCT02744092|Rivaroxaban (Xarelto)|rivaroxaban (xarelto)
4779566|NCT02744092|Apixaban (Eliquis)|apixaban (eliquis)
4779567|NCT02744092|Edoxaban (Savaysa)|edoxaban (savaysa)
4779568|NCT02744092|Dabigatran (Pradaxa)|dabigatran (pradaxa)
4779569|NCT02744092|Warfarin (Coumadin)|warfarin (coumadin)
4779570|NCT02744092|Low molecular weight heparin (LMWH)|low molecular weight heparin (lmwh)
4779571|NCT02744079|diet|diet
4779572|NCT02744079|dietary intervention|dietary intervention
4779573|NCT02744079|carbohydrate restriction|carbohydrate restriction
4779574|NCT02744079|low carbohydrate|low carbohydrate
4779575|NCT02744079|fat restriction|fat restriction
4779576|NCT02744079|low fat|low fat
4779577|NCT02744079|cancer|cancer
4779578|NCT02744079|breast cancer|breast cancer
4779579|NCT02744079|pre-surgical window|pre-surgical window
4779580|NCT02744079|biomarker|biomarker
4779581|NCT02744053|Breast Cancer|breast cancer
4779582|NCT02744053|Malignant neoplasm of breast|malignant neoplasm of breast
4779583|NCT02744053|Triple Negative Breast Cancer|triple negative breast cancer
4779584|NCT02744053|TNBC|tnbc
4779585|NCT02744053|Tc99m Sestamibi Molecular Breast Imaging|tc99m sestamibi molecular breast imaging
4779587|NCT02744053|Dynamic Contrast Enhanced Molecular Resonance Imaging|dynamic contrast enhanced molecular resonance imaging
4779588|NCT02744053|DCE-MRI|dce-mri
4779589|NCT02744040|HIV reservoir|hiv reservoir
4779590|NCT02744040|alcohol|alcohol
4779591|NCT02744040|ART|art
4779592|NCT02744027|Generalized Lymphatic Anomaly|generalized lymphatic anomaly
4779593|NCT02744027|Kaposiform Lymphangiomatosis|kaposiform lymphangiomatosis
4779594|NCT02744027|Dynamic Contrast Enhanced Magnetic Resonance Lymphangiogram|dynamic contrast enhanced magnetic resonance lymphangiogram
4779595|NCT02744027|Magnetic Resonance Imaging|magnetic resonance imaging
4779596|NCT02743988|cerebral oxygenation|cerebral oxygenation
4779597|NCT02743988|NIRS|nirs
4779598|NCT02743988|near-infrared spectroscopy|near-infrared spectroscopy
4779599|NCT02743988|bradycardia|bradycardia
4779600|NCT02743988|hypoxemia|hypoxemia
4779601|NCT02743988|cerebral perfusion|cerebral perfusion
4779602|NCT02743988|cardiac output|cardiac output
4779603|NCT02743988|apnea|apnea
4779604|NCT02743988|desaturation|desaturation
4779605|NCT02743988|oxygen saturation target range|oxygen saturation target range
4779606|NCT02743949|Drug therapy|drug therapy
4779607|NCT02743910|preoperative|preoperative
4779608|NCT02743910|neoadjuvant|neoadjuvant
4779609|NCT02743910|plasma tumor DNA|plasma tumor dna
4779610|NCT02743910|ptDNA|ptdna
4779611|NCT02743897|end-stage renal disease|end-stage renal disease
4779612|NCT02743871|FIH, Pharmacokinetics, Pharmacodynamics, Safety, Tolerability, Atopic Dermatitis, Chronic Rhinosinusitis, Nasal Polyps|fih, pharmacokinetics, pharmacodynamics, safety, tolerability, atopic dermatitis, chronic rhinosinusitis, nasal polyps
4779613|NCT02743858|Lymphedema|lymphedema
4779614|NCT02743858|Surveillance Program|surveillance program
4779615|NCT02743858|Axillary Lymph Node Dissection|axillary lymph node dissection
4779616|NCT02743858|16-220|16-220
4779617|NCT02743845|Rare|rare
4779618|NCT02743845|Undiagnosed|undiagnosed
4779619|NCT02743845|Orphan Disease|orphan disease
4779620|NCT02743845|Genomic Sequencing|genomic sequencing
4779621|NCT02743832|Surgery, Oral|surgery, oral
4779622|NCT02743832|Tumor budding|tumor budding
4779623|NCT02743819|Melanoma|melanoma
4779624|NCT02743819|Pembrolizumab|pembrolizumab
4779625|NCT02743819|Ipilimumab|ipilimumab
4779626|NCT02743806|Drug Therapy|drug therapy
4779627|NCT02743793|single organ liver or kidney allograft|single organ liver or kidney allograft
4779628|NCT02743793|operationally tolerant allograft recipients|operationally tolerant allograft recipients
4779629|NCT02743793|longitudinal follow-up|longitudinal follow-up
4779630|NCT02743780|Ocular Hypertension|ocular hypertension
4779631|NCT02743780|Open-Angle Glaucoma|open-angle glaucoma
4779632|NCT02743780|POAG|poag
4779633|NCT02743780|Glaucoma|glaucoma
4779634|NCT02743767|Airway management|airway management
4779635|NCT02743767|General anaesthesia|general anaesthesia
4779636|NCT02743767|Critical incidents|critical incidents
4779637|NCT02743767|Complications|complications
4779638|NCT02743741|Somatostatin Receptor Positive Neuroendocrine Tumors|somatostatin receptor positive neuroendocrine tumors
4779639|NCT02743728|perinatal stroke|perinatal stroke
4779640|NCT02743728|transcranial magnetic stimulation|transcranial magnetic stimulation
4779641|NCT02743728|magnetic resonance imaging|magnetic resonance imaging
4779642|NCT02743728|diffusion tensor imaging|diffusion tensor imaging
4779643|NCT02743728|non-invasive brain stimulation|non-invasive brain stimulation
4779644|NCT02743728|infant|infant
4779645|NCT02743715|Obsessive-Compulsive Disorder|obsessive-compulsive disorder
4779646|NCT02743715|Transcranial direct current stimulation|transcranial direct current stimulation
4779647|NCT02743715|Neuromodulation|neuromodulation
4779648|NCT02743702|Effectiveness|effectiveness
4779649|NCT02743702|Physical therapy modalities|physical therapy modalities
4779650|NCT02743702|neuromuscular diseases|neuromuscular diseases
4779651|NCT02743689|Postoperative|postoperative
4779652|NCT02743689|Cardiac surgery|cardiac surgery
4779653|NCT02743676|Avian Influenza|avian influenza
4779654|NCT02743663|pediatric|pediatric
4779655|NCT02743663|lung ventilation inhomogeneity|lung ventilation inhomogeneity
4779656|NCT02743663|preschool|preschool
4779657|NCT02743663|asthma|asthma
4779658|NCT02743663|wheeze|wheeze
4779659|NCT02743650|Low Serum Bicarbonate Level|low serum bicarbonate level
4779660|NCT02743650|Sodium Bicarbonate|sodium bicarbonate
4779661|NCT02743637|Cancer|cancer
4779662|NCT02743637|Oncology|oncology
4779663|NCT02743637|Solid Tumors|solid tumors
4779664|NCT02743637|Phase 1|phase 1
4779665|NCT02743637|SDX-7320|sdx-7320
4779666|NCT02743637|SynDevRx|syndevrx
4779667|NCT02743637|MetAP2|metap2
4779668|NCT02743637|Breast|breast
4779669|NCT02743637|Post menopausal|post menopausal
4779670|NCT02743637|Colorectal|colorectal
4779671|NCT02743637|Pancreatic|pancreatic
4779672|NCT02743637|Ovarian|ovarian
4779673|NCT02743637|Endometrial|endometrial
4779674|NCT02743637|Esophageal|esophageal
4779675|NCT02743637|Lung|lung
4779676|NCT02743637|Renal|renal
4779677|NCT02743637|Prostate|prostate
4779678|NCT02743637|Liver|liver
4779679|NCT02743611|BPX-701|bpx-701
4779680|NCT02743611|AP1903|ap1903
4779681|NCT02743611|Rimiducid|rimiducid
4779682|NCT02743611|AML|aml
4779683|NCT02743611|MDS|mds
4779684|NCT02743611|Primary Refractory AML|primary refractory aml
4779685|NCT02743611|Relapsed AML|relapsed aml
4779686|NCT02743611|Refractory Myeloid Neoplasms|refractory myeloid neoplasms
4779687|NCT02743598|HIV infection|hiv infection
4779688|NCT02743598|Diabetes Mellitus type 2|diabetes mellitus type 2
4779689|NCT02743598|Obesity|obesity
4779690|NCT02743598|Neurocognitive function|neurocognitive function
4779691|NCT02743572|premature infant|premature infant
4779692|NCT02743572|anemia|anemia
4779693|NCT02743572|iron-fortification|iron-fortification
4779694|NCT02743572|parenteral nutrition|parenteral nutrition
4779695|NCT02743572|randomized controlled trial|randomized controlled trial
4779696|NCT02743546|B-Cell, Malignancy|b-cell, malignancy
4779697|NCT02743546|Lymphoma, Large B-Cell, Diffuse|lymphoma, large b-cell, diffuse
4779698|NCT02743546|Lymphoma, Mantle-Cell|lymphoma, mantle-cell
4779699|NCT02743546|Lymphoma, Follicular|lymphoma, follicular
4779700|NCT02743546|Lymphocytic, Chronic, B-Cell|lymphocytic, chronic, b-cell
4779701|NCT02743546|JNJ-64052781|jnj-64052781
4779702|NCT02743546|Ibrutinib|ibrutinib
4779703|NCT02743533|cardiovascular diseases, prognosis|cardiovascular diseases, prognosis
4779704|NCT02743520|sleep apnea|sleep apnea
4779705|NCT02743481|Pesticide|pesticide
4779706|NCT02743481|Agriculture|agriculture
4779707|NCT02743481|Cancer|cancer
4779708|NCT02743481|Childhood|childhood
4779709|NCT02743481|Leukemia|leukemia
4779710|NCT02743468|Bronchoscopy|bronchoscopy
4779711|NCT02743468|Pollutants|pollutants
4779712|NCT02743468|Human Pulmonary Cells|human pulmonary cells
4779713|NCT02743468|Cytochrome P450|cytochrome p450
4779714|NCT02743468|Soluble Epoxide Hydrolase|soluble epoxide hydrolase
4779715|NCT02743455|Fever|fever
4779716|NCT02743455|Immunogenicity|immunogenicity
4779717|NCT02743455|MVA-BN|mva-bn
4779718|NCT02743455|Reactogenicity|reactogenicity
4779719|NCT02743455|Vaccine|vaccine
4779720|NCT02743455|Yellow|yellow
4779721|NCT02743429|ch14.18/CHO|ch14.18/cho
4779722|NCT02743429|neuroblastoma|neuroblastoma
4779723|NCT02743429|long term infusion|long term infusion
4779724|NCT02743416|Screening|screening
4779725|NCT02743416|Stroke prevention|stroke prevention
4779726|NCT02743416|Cost effectiveness|cost effectiveness
4779727|NCT02743390|blood pressure|blood pressure
4779728|NCT02743390|inflammation|inflammation
4779729|NCT02743390|tumor Necrosis Factor-alpha|tumor necrosis factor-alpha
4779730|NCT02743377|GsI+/-|gsi+/-
4779731|NCT02743377|Camp|camp
4779732|NCT02743377|GNAS|gnas
4779733|NCT02743351|Cell Transplants|cell transplants
4779734|NCT02743351|Hematopoietic Cell Transplant|hematopoietic cell transplant
4779735|NCT02743351|HSCT|hsct
4779736|NCT02743351|Hematologic Malignancies|hematologic malignancies
4779737|NCT02743351|Hematologic Malignancy|hematologic malignancy
4779738|NCT02743351|Acute Myeloid Leukemia|acute myeloid leukemia
4779739|NCT02743351|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
4779740|NCT02743351|ALL|all
4779741|NCT02743351|AML|aml
4779742|NCT02743351|Myelodysplastic Syndrome|myelodysplastic syndrome
4779743|NCT02743351|MDS|mds
4779744|NCT02743351|Allogeneic|allogeneic
4779745|NCT02743351|CML|cml
4779746|NCT02743351|Stem Cell Transplant|stem cell transplant
4779747|NCT02743351|Transplant|transplant
4779748|NCT02743338|Sleep Restriction|sleep restriction
4779749|NCT02743338|Sleep Compression|sleep compression
4779750|NCT02743338|Cognitive Behavioral Therapy|cognitive behavioral therapy
4779751|NCT02743312|Balance-Based Torso-Weighting|balance-based torso-weighting
4779752|NCT02743312|Physical Activity|physical activity
4779753|NCT02743312|Neurorehabilitation|neurorehabilitation
4779754|NCT02743286|sedentary behavior|sedentary behavior
4779755|NCT02743286|sitting|sitting
4779756|NCT02743286|feasibility|feasibility
4779757|NCT02743286|endothelial function|endothelial function
4779758|NCT02743286|metabolism|metabolism
4779759|NCT02743260|phenotype|phenotype
4779760|NCT02743260|transporter|transporter
4779761|NCT02743260|cocktail|cocktail
4779762|NCT02743247|Healthy volunteer|healthy volunteer
4779763|NCT02743221|metastatic|metastatic
4779764|NCT02743221|colorectal|colorectal
4779765|NCT02743221|cancer|cancer
4779766|NCT02743221|untreated|untreated
4779767|NCT02743221|first-line|first-line
4779768|NCT02743221|S95005|s95005
4779769|NCT02743221|bevacizumab|bevacizumab
4779770|NCT02743221|capecitabine|capecitabine
4779771|NCT02743208|Arthroplasty, Replacement, Hip|arthroplasty, replacement, hip
4779772|NCT02743208|Surgical Procedures, Operative|surgical procedures, operative
4779773|NCT02743208|Hip Prosthesis|hip prosthesis
4779774|NCT02743169|Geographic Information Systems|geographic information systems
4779775|NCT02743169|Spatial Analysis|spatial analysis
4779776|NCT02743169|Emergency Medical Services|emergency medical services
4779777|NCT02743156|IVUS|ivus
4779778|NCT02743156|Acute Renal Failure|acute renal failure
4779779|NCT02743156|Angioplasty|angioplasty
4779780|NCT02743156|stent|stent
4779781|NCT02743156|contrast|contrast
4779782|NCT02743156|percutaneous coronary intervention|percutaneous coronary intervention
4779783|NCT02743156|intravascular ultrasound|intravascular ultrasound
4779784|NCT02743143|Exercise therapy|exercise therapy
4779785|NCT02743143|Cardiovascular disease|cardiovascular disease
4779786|NCT02743143|Risk|risk
4779787|NCT02743130|Berries|berries
4779788|NCT02743130|Blackcurrant (Ribes nigrum)|blackcurrant (ribes nigrum)
4779789|NCT02743130|Lingonberry (Vaccinium vitis-idaea)|lingonberry (vaccinium vitis-idaea)
4779790|NCT02743130|Sucrose|sucrose
4779791|NCT02743130|Inverted sugar|inverted sugar
4779792|NCT02743130|Postprandial glucose response|postprandial glucose response
4779793|NCT02743130|Postprandial insulin response|postprandial insulin response
4779794|NCT02743117|Trivalent|trivalent
4779795|NCT02743117|Influenza|influenza
4779796|NCT02743117|FluMist Quadrivalent|flumist quadrivalent
4779797|NCT02743117|Vaccine|vaccine
4779798|NCT02743117|Prevention|prevention
4779799|NCT02743117|Healthy|healthy
4779800|NCT02743117|Monovalent|monovalent
4779801|NCT02743091|heart failure|heart failure
4779802|NCT02743091|survival|survival
4779803|NCT02743091|end-stage kidney disease|end-stage kidney disease
4779804|NCT02743078|Glioblastoma|glioblastoma
4779805|NCT02743078|Glioma|glioma
4779806|NCT02743078|Gliosarcoma|gliosarcoma
4779807|NCT02743078|Optune|optune
4779808|NCT02743078|TTFields|ttfields
4779809|NCT02743065|HepaSphere|hepasphere
4779810|NCT02743039|Low income|low income
4779811|NCT02743039|Education|education
4779812|NCT02743039|Poverty|poverty
4779813|NCT02743039|Children|children
4779814|NCT02743039|Parents|parents
4779815|NCT02743039|Head Start|head start
4779816|NCT02743000|fMRI|fmri
4779817|NCT02743000|emotion conflict task|emotion conflict task
4779818|NCT02743000|monetary incentive delay|monetary incentive delay
4779819|NCT02742974|Trauma|trauma
4779820|NCT02742974|Minimally Invasive Hemodynamic Monitoring|minimally invasive hemodynamic monitoring
4779821|NCT02742974|Perioperative|perioperative
4779822|NCT02742974|Complications|complications
4779823|NCT02742974|Hemodynamics|hemodynamics
4779824|NCT02742974|Operative procedures|operative procedures
4779825|NCT02742961|orthopedics|orthopedics
4779826|NCT02742961|anesthesiology|anesthesiology
4779827|NCT02742961|nerve block|nerve block
4779828|NCT02742961|length of stay|length of stay
4779829|NCT02742961|Patient readmission|patient readmission
4779830|NCT02742948|elective caesarean section|elective caesarean section
4779831|NCT02742948|antibiotics|antibiotics
4779832|NCT02742948|endometritis|endometritis
4779833|NCT02742922|self harm|self harm
4779834|NCT02742922|culturally adapted therapy|culturally adapted therapy
4779835|NCT02742922|problem solving therapy|problem solving therapy
4779836|NCT02742922|low and middle income countries|low and middle income countries
4779837|NCT02742896|Erectile dysfunction|erectile dysfunction
4779838|NCT02742896|cognitive function|cognitive function
4779839|NCT02742870|Diffusion MRI|diffusion mri
4779840|NCT02742870|ADC histograms|adc histograms
4779841|NCT02742870|Adnexal tumor|adnexal tumor
4779842|NCT02742844|phase I/IIa|phase i/iia
4779843|NCT02742844|mesenchymal stem cells|mesenchymal stem cells
4779844|NCT02742844|ABCB5+|abcb5+
4779845|NCT02742844|APZ2|apz2
4779846|NCT02742844|chronic venous ulcer|chronic venous ulcer
4779847|NCT02742844|varicose ulcer|varicose ulcer
4779848|NCT02742844|skin ulcer|skin ulcer
4779849|NCT02742844|advanced therapy medicinal product|advanced therapy medicinal product
4779850|NCT02742844|APZ2-II-01|apz2-ii-01
4779851|NCT02742844|autologous use|autologous use
4779852|NCT02742844|somatic cell therapy|somatic cell therapy
4779853|NCT02742818|forced-air warming|forced-air warming
4779854|NCT02742818|hypothermia|hypothermia
4779855|NCT02742818|endovascular surgery|endovascular surgery
4779856|NCT02742818|blanket|blanket
4779857|NCT02742805|hives|hives
4779858|NCT02742792|sleep apnea|sleep apnea
4779859|NCT02742792|elderly|elderly
4779860|NCT02742792|exercise|exercise
4779861|NCT02742766|Dose escalation study|dose escalation study
4779862|NCT02742766|Safety|safety
4779863|NCT02742766|Pharmacodynamics|pharmacodynamics
4779864|NCT02742766|Pharmacokinetics|pharmacokinetics
4779865|NCT02742766|GSK3008356|gsk3008356
4779866|NCT02742766|Tolerability|tolerability
4779867|NCT02742753|Otitis|otitis
4779868|NCT02742753|Vaccine|vaccine
4779869|NCT02742753|Sweden|sweden
4779870|NCT02742753|Database|database
4779871|NCT02742675|prostate cancer|prostate cancer
4779872|NCT02742675|androgen deprivation therapy|androgen deprivation therapy
4779873|NCT02742675|local treatment|local treatment
4779874|NCT02742662|Obesity|obesity
4779875|NCT02742662|Overweight|overweight
4779876|NCT02742662|Prediabetes|prediabetes
4779877|NCT02742662|Smartphone application|smartphone application
4779878|NCT02742662|Technology|technology
4779879|NCT02742662|Weight Loss|weight loss
4779880|NCT02742662|Lifestyle Intervention|lifestyle intervention
4779881|NCT02742623|Cancer|cancer
4779882|NCT02742623|Deep Venous Thrombosis|deep venous thrombosis
4779883|NCT02742623|Pulmonary Embolism|pulmonary embolism
4779884|NCT02742584|cough stress test|cough stress test
4779885|NCT02742584|urodynamics|urodynamics
4779886|NCT02742584|pad test|pad test
4779887|NCT02742571|Biological evaluation of denutrition|biological evaluation of denutrition
4779888|NCT02742571|Denutrition|denutrition
4779889|NCT02742571|PINI score|pini score
4779890|NCT02742558|cholera vaccine|cholera vaccine
4779891|NCT02742558|randomized trial|randomized trial
4779892|NCT02742558|immunogenicity|immunogenicity
4779893|NCT02742506|Brain-damaged|brain-damaged
4779894|NCT02742506|Disorders of consciousness|disorders of consciousness
4779895|NCT02742506|Post-coma|post-coma
4779896|NCT02742506|consciousness|consciousness
4779897|NCT02742506|coma|coma
4779898|NCT02742506|vegetative state|vegetative state
4779899|NCT02742506|minimally conscious state|minimally conscious state
4779900|NCT02742506|music|music
4779901|NCT02742506|P300|p300
4779902|NCT02742493|relapse|relapse
4779903|NCT02742493|irregularity|irregularity
4779904|NCT02742493|recession|recession
4779905|NCT02742493|retention|retention
4779906|NCT02742480|stroke|stroke
4779907|NCT02742480|oral anticoagulants|oral anticoagulants
4779908|NCT02742480|cardioembolic|cardioembolic
4779909|NCT02742454|Umbilical Cord Clamping|umbilical cord clamping
4779910|NCT02742454|Intraventricular Hemorrhage|intraventricular hemorrhage
4779911|NCT02742454|Extremely Preterm Infants|extremely preterm infants
4779912|NCT02742337|Epigenetic|epigenetic
4779913|NCT02742324|efficacy|efficacy
4779914|NCT02742324|safety|safety
4779915|NCT02742298|Neuromuscular Ultrasound|neuromuscular ultrasound
4779916|NCT02742298|Electrical Impedance Myography|electrical impedance myography
4779917|NCT02742285|antimalarials|antimalarials
4779918|NCT02742285|blood samples|blood samples
4779919|NCT02742285|drug concentrations|drug concentrations
4779920|NCT02742285|pharmacokinetics|pharmacokinetics
4779921|NCT02742285|lumefantrine|lumefantrine
4779922|NCT02742285|healthy volunteers|healthy volunteers
4779923|NCT02742233|Diabetes|diabetes
4779924|NCT02742233|Wound Healing|wound healing
4779925|NCT02742233|Dipeptidyl Peptidase 4 Inhibition|dipeptidyl peptidase 4 inhibition
4779926|NCT02742220|intermittent claudication|intermittent claudication
4779927|NCT02742220|exercise|exercise
4779928|NCT02742220|blood pressure|blood pressure
4779929|NCT02742220|cardiovascular system|cardiovascular system
4779930|NCT02742194|ginger obesity|ginger obesity
4779931|NCT02742194|ginger inflammation|ginger inflammation
4779932|NCT02742194|treatment of obesity|treatment of obesity
4779933|NCT02742155|Family Research|family research
4779934|NCT02742116|Expanded carrier screening|expanded carrier screening
4779936|NCT02742025|Coronary Angiography|coronary angiography
4779937|NCT02742012|electroencephalogram|electroencephalogram
4779938|NCT02742012|hemodynamic monitoring|hemodynamic monitoring
4779939|NCT02742012|respiratory monitoring|respiratory monitoring
4779940|NCT02741986|risk assessment|risk assessment
4779941|NCT02741986|sepsis|sepsis
4779942|NCT02741986|acute kidney injury (AKI)|acute kidney injury (aki)
4779943|NCT02741973|Yoga|yoga
4779944|NCT02741973|Stress|stress
4779945|NCT02741973|Adolescents|adolescents
4779946|NCT02741973|School|school
4779947|NCT02741973|Children|children
4779948|NCT02741960|metformin|metformin
4779949|NCT02741960|systemic lupus erythematosus|systemic lupus erythematosus
4779950|NCT02741947|Parkinson|parkinson
4779951|NCT02741947|Therapeutic Equivalence|therapeutic equivalence
4779952|NCT02741947|Levodopa|levodopa
4779953|NCT02741895|Biosensing Techniques|biosensing techniques
4779954|NCT02741895|Patient Readmission|patient readmission
4779955|NCT02741882|Microcephaly|microcephaly
4779956|NCT02741882|zika Virus|zika virus
4779957|NCT02741882|Case-control study|case-control study
4779958|NCT02741869|Staphylococcus aureus; nare carriage|staphylococcus aureus; nare carriage
4779959|NCT02741804|Memory|memory
4779960|NCT02741791|AXS-05|axs-05
4779961|NCT02741791|Major Depressive Disorder|major depressive disorder
4779962|NCT02741791|Treatment Resistant Depression|treatment resistant depression
4779963|NCT02741791|TRD|trd
4779964|NCT02741791|MDD|mdd
4779965|NCT02741791|Axsome|axsome
4779966|NCT02741791|NMDA receptor|nmda receptor
4779967|NCT02741791|Refractory depression|refractory depression
4779968|NCT02741791|Resistant depression|resistant depression
4779969|NCT02741791|Depression|depression
4779970|NCT02741778|Esophagogastric Junction|esophagogastric junction
4779971|NCT02741778|Adenocarcinoma|adenocarcinoma
4779972|NCT02741778|Cardia|cardia
4779973|NCT02741765|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
4779974|NCT02741765|Exercise|exercise
4779975|NCT02741765|Brain Plasticity|brain plasticity
4779976|NCT02741752|histomorphometry|histomorphometry
4779977|NCT02741739|Drug concentration|drug concentration
4779978|NCT02741739|REGN1033|regn1033
4779979|NCT02741739|blood|blood
4779980|NCT02741700|Adherence|adherence
4779981|NCT02741700|Disparities|disparities
4779982|NCT02741700|Patient Outcomes|patient outcomes
4779983|NCT02741687|stress hyperglycemia|stress hyperglycemia
4779984|NCT02741687|blood glucose|blood glucose
4779985|NCT02741674|Observational Study|observational study
4779986|NCT02741674|Comparative Effectiveness Research|comparative effectiveness research
4779987|NCT02741648|Red Blood Cell Transfusion|red blood cell transfusion
4779988|NCT02741648|Digestive tract problems|digestive tract problems
4779989|NCT02741648|Extremely Low Birth Weight|extremely low birth weight
4779990|NCT02741622|Exercise therapy|exercise therapy
4779991|NCT02741609|Borrelia|borrelia
4779992|NCT02741609|spirochetes|spirochetes
4779993|NCT02741609|culture|culture
4779994|NCT02741609|immunostaining|immunostaining
4779995|NCT02741596|DX-2930(SHP643)|dx-2930(shp643)
4779996|NCT02741596|Dyax|dyax
4779997|NCT02741596|Hereditary Angioedema|hereditary angioedema
4779998|NCT02741557|Fixed-dose Combination (FDC)|fixed-dose combination (fdc)
4779999|NCT02741557|Bioequivalence|bioequivalence
4780000|NCT02741557|Dolutegravir|dolutegravir
4780001|NCT02741557|Rilpivirine|rilpivirine
4780002|NCT02741544|Second primary cancers|second primary cancers
4780003|NCT02741544|Cataracts|cataracts
4780004|NCT02741544|Newly-diagnosed multiple myeloma|newly-diagnosed multiple myeloma
4780005|NCT02741544|Revlimid capsules|revlimid capsules
4780006|NCT02741518|obesity|obesity
4780007|NCT02741518|FMT|fmt
4780008|NCT02741505|cerebrospinal fluid (CSF)|cerebrospinal fluid (csf)
4780009|NCT02741505|sleep|sleep
4780010|NCT02741505|Obstructive Sleep Apnea (OSA)|obstructive sleep apnea (osa)
4780011|NCT02741505|Sleep Disordered Breathing (SDB)|sleep disordered breathing (sdb)
4780012|NCT02741505|Period Limb Movement during Sleep (PLMS)|period limb movement during sleep (plms)
4780013|NCT02741479|dancers|dancers
4780014|NCT02741440|Spinocerebellar Ataxia|spinocerebellar ataxia
4780015|NCT02741427|Tooth discoloration|tooth discoloration
4780016|NCT02741427|Toothpaste|toothpaste
4780017|NCT02741427|Tooth bleaching|tooth bleaching
4780018|NCT02741427|Clinical trial|clinical trial
4780019|NCT02741414|Helicobacter pylori|helicobacter pylori
4780020|NCT02741414|Antibiotic resistance|antibiotic resistance
4780021|NCT02741414|Sequencing|sequencing
4780022|NCT02741414|Mechanism|mechanism
4780023|NCT02741401|Complementary therapies|complementary therapies
4780024|NCT02741401|Massage|massage
4780025|NCT02741401|Gastrointestinal cancer|gastrointestinal cancer
4780026|NCT02741388|selinexor|selinexor
4780027|NCT02741388|lymphoma|lymphoma
4780028|NCT02741388|inhibitor of nuclear export|inhibitor of nuclear export
4780029|NCT02741362|Type III hypersensitivity autoimmune disease|type iii hypersensitivity autoimmune disease
4780030|NCT02741349|Atrial fibrillation|atrial fibrillation
4780031|NCT02741349|Risk score|risk score
4780032|NCT02741323|HIV-infected with end-stage kidney disease|hiv-infected with end-stage kidney disease
4780033|NCT02741297|Spinal Cord Stimulation|spinal cord stimulation
4780034|NCT02741297|Chronic Pain|chronic pain
4780035|NCT02741232|analgesics, opioids|analgesics, opioids
4780036|NCT02741232|pectoral block|pectoral block
4780037|NCT02741206|psycho-education|psycho-education
4780038|NCT02741206|maternal depression|maternal depression
4780039|NCT02741206|Reach Out Stay Strong Essentials|reach out stay strong essentials
4780040|NCT02741193|Transcranial magnet stimulation (nTMS)|transcranial magnet stimulation (ntms)
4780041|NCT02741193|Brainsight Neuronavigation|brainsight neuronavigation
4780042|NCT02741193|Electromyography|electromyography
4780043|NCT02741193|EMG|emg
4780044|NCT02741167|peritoneal surface malignancies|peritoneal surface malignancies
4780045|NCT02741167|cytoreductive surgery|cytoreductive surgery
4780046|NCT02741167|hyperthermic intraperitoneal chemotherapy|hyperthermic intraperitoneal chemotherapy
4780545|NCT02737787|Montanide|montanide
4780047|NCT02741154|aromataze inhibitor, poor responder ,induction|aromataze inhibitor, poor responder ,induction
4780048|NCT02741128|Dengue Fever|dengue fever
4780049|NCT02741128|Dengue Hemorrhagic Fever|dengue hemorrhagic fever
4780050|NCT02741128|Human Immunodeficiency Virus|human immunodeficiency virus
4780051|NCT02741128|CYD Dengue Vaccine|cyd dengue vaccine
4780052|NCT02741115|Fontan|fontan
4780053|NCT02741115|Maximal Oxygen Consumption|maximal oxygen consumption
4780054|NCT02741115|Vascular Function|vascular function
4780055|NCT02741115|EndoPAT|endopat
4780056|NCT02741115|Myocardial Performance|myocardial performance
4780057|NCT02741102|Infertility|infertility
4780058|NCT02741102|AUFI|aufi
4780059|NCT02741089|Analgosedation|analgosedation
4780060|NCT02741089|Internal Quality Assurance|internal quality assurance
4780061|NCT02741063|oxytocin|oxytocin
4780062|NCT02741063|attentional bias|attentional bias
4780063|NCT02741063|Autism|autism
4780064|NCT02741011|Cone-Beam Computed Tomography|cone-beam computed tomography
4780065|NCT02741011|Mentally Handicapped|mentally handicapped
4780066|NCT02740998|Microbiome|microbiome
4780067|NCT02740998|Progestin|progestin
4780068|NCT02740998|Long-acting contraception|long-acting contraception
4780069|NCT02740985|AZD4635|azd4635
4780070|NCT02740985|durvalumab|durvalumab
4780071|NCT02740985|non-small cell lung cancer|non-small cell lung cancer
4780072|NCT02740985|advanced solid malignancies|advanced solid malignancies
4780073|NCT02740985|prostate cancer|prostate cancer
4780074|NCT02740985|colorectal cancer|colorectal cancer
4780075|NCT02740933|Brain Tumor Surgery|brain tumor surgery
4780076|NCT02740868|Magnetic Resonance Imaging,cystic fibrosis,asthma,healthy|magnetic resonance imaging,cystic fibrosis,asthma,healthy
4780077|NCT02740855|sclerotherapy|sclerotherapy
4780078|NCT02740855|ethanol|ethanol
4780079|NCT02740855|pulmonal hypertension|pulmonal hypertension
4780080|NCT02740790|Human papillomavirus|human papillomavirus
4780081|NCT02740790|vaccine|vaccine
4780082|NCT02740790|cervical infection|cervical infection
4780083|NCT02740790|cervical cancer|cervical cancer
4780084|NCT02740764|Functional autonomy level|functional autonomy level
4780085|NCT02740764|Lawton Instrumental Activities of Daily Living|lawton instrumental activities of daily living
4780086|NCT02740764|Cognitive disorders|cognitive disorders
4780087|NCT02740764|Potentially inappropriate medication|potentially inappropriate medication
4780088|NCT02740764|elderly|elderly
4780089|NCT02740764|Optimization of drug prescribing|optimization of drug prescribing
4780090|NCT02740738|Knee Arthroplasty|knee arthroplasty
4780091|NCT02740738|Hip Arthroplasty|hip arthroplasty
4780092|NCT02740725|Amblyopia|amblyopia
4780093|NCT02740725|Interaction Binocular Treatment (I-BiTTM)|interaction binocular treatment (i-bittm)
4780094|NCT02740725|Patch Therapy|patch therapy
4780095|NCT02740712|rucaparib|rucaparib
4780096|NCT02740712|CO-338|co-338
4780097|NCT02740712|Clovis|clovis
4780098|NCT02740712|Clovis Oncology|clovis oncology
4780099|NCT02740712|PARP Inhibitor|parp inhibitor
4780100|NCT02740712|Drug-Drug Interaction|drug-drug interaction
4780101|NCT02740699|Cholesterol|cholesterol
4780102|NCT02740699|Heart Disease|heart disease
4780103|NCT02740699|CT Scan|ct scan
4780104|NCT02740699|Crestor|crestor
4780105|NCT02740699|Lipitor|lipitor
4780106|NCT02740686|COPD|copd
4780107|NCT02740686|Exercise|exercise
4780108|NCT02740686|Immunity|immunity
4780109|NCT02740686|Inflammation|inflammation
4780110|NCT02740686|Biomarkers|biomarkers
4780111|NCT02740660|Albuterol|albuterol
4780112|NCT02740660|Caffeine|caffeine
4780113|NCT02740660|Lean Body Mass|lean body mass
4780114|NCT02740660|Fat Mass|fat mass
4780115|NCT02740634|PCA|pca
4780116|NCT02740634|LPA|lpa
4780117|NCT02740595|nicotine|nicotine
4780118|NCT02740595|endothelial function|endothelial function
4780119|NCT02740595|oxidative stress|oxidative stress
4780120|NCT02740569|scleroderma|scleroderma
4780121|NCT02740569|sleep apnea|sleep apnea
4780122|NCT02740569|pulmonary disease|pulmonary disease
4780123|NCT02740556|Hepatitis C|hepatitis c
4780124|NCT02740556|Adherence|adherence
4780125|NCT02740556|Adheretech|adheretech
4780126|NCT02740556|HepCure|hepcure
4780127|NCT02740556|Telehealth|telehealth
4780128|NCT02740556|Health apps|health apps
4780129|NCT02740543|World Trade Center|world trade center
4780130|NCT02740543|WTC|wtc
4780131|NCT02740543|Induced Sputum|induced sputum
4780132|NCT02740543|Exhaled Breath Condensate|exhaled breath condensate
4780133|NCT02740504|Respiration rate|respiration rate
4780134|NCT02740465|ACE|ace
4780135|NCT02740465|Anxiety|anxiety
4780136|NCT02740465|COPD|copd
4780137|NCT02740452|Rupture|rupture
4780138|NCT02740452|Anterior Cruciate Ligament (ACL)|anterior cruciate ligament (acl)
4780139|NCT02740452|Laxity knee|laxity knee
4780140|NCT02740452|Instability knee|instability knee
4780141|NCT02740400|Endobronchial ultrasonography|endobronchial ultrasonography
4780142|NCT02740400|guided sheath|guided sheath
4780143|NCT02740400|diagnosis|diagnosis
4780144|NCT02740400|accuracy|accuracy
4780145|NCT02740400|complication|complication
4780146|NCT02740374|ROTEM|rotem
4780147|NCT02740374|Thromboelastometry|thromboelastometry
4780148|NCT02740374|spine surgery|spine surgery
4780149|NCT02740374|allogenic blood transfusion|allogenic blood transfusion
4780151|NCT02740374|red blood cell transfusion|red blood cell transfusion
4780152|NCT02740335|anticoagulant reversal|anticoagulant reversal
4780153|NCT02740335|urgent surgery|urgent surgery
4780154|NCT02740335|invasive procedures|invasive procedures
4780155|NCT02740335|vitamin K|vitamin k
4780156|NCT02740335|prothrombin complex concentrate|prothrombin complex concentrate
4780157|NCT02740335|four-factor prothrombin complex concentrate (4F-PCC)|four-factor prothrombin complex concentrate (4f-pcc)
4780158|NCT02740322|Hum Test, Weber test, audiogram|hum test, weber test, audiogram
4780159|NCT02740309|inflammatory bowel disease|inflammatory bowel disease
4780160|NCT02740309|childhood chronic disease|childhood chronic disease
4780161|NCT02740309|adolescent depression|adolescent depression
4780162|NCT02740309|adolescent anxiety|adolescent anxiety
4780163|NCT02740309|integrated brief behavioral therapy|integrated brief behavioral therapy
4780164|NCT02740309|adolescent psychosocial risks|adolescent psychosocial risks
4780165|NCT02740309|adolescent chronic disease|adolescent chronic disease
4780166|NCT02740309|childhood depression|childhood depression
4780167|NCT02740309|childhood anxiety|childhood anxiety
4780168|NCT02740309|childhood psychosocial risks|childhood psychosocial risks
4780169|NCT02740283|Gestational Diabetes Mellitus|gestational diabetes mellitus
4780170|NCT02740283|Oral Glucose Tolerance Test|oral glucose tolerance test
4780171|NCT02740270|advanced solid tumors|advanced solid tumors
4780172|NCT02740270|lymphomas|lymphomas
4780173|NCT02740270|GWN323|gwn323
4780174|NCT02740270|PDR001|pdr001
4780175|NCT02740270|advanced malignancies|advanced malignancies
4780176|NCT02740270|anti-GITR|anti-gitr
4780177|NCT02740270|anti-PD-1|anti-pd-1
4780178|NCT02740270|adults|adults
4780179|NCT02740231|viscosupplement|viscosupplement
4780180|NCT02740231|osteoarthritis|osteoarthritis
4780181|NCT02740231|knee|knee
4780182|NCT02740231|intra-articular injection|intra-articular injection
4780183|NCT02740231|arthritis|arthritis
4780184|NCT02740231|degenerative|degenerative
4780185|NCT02740218|Psoriasis|psoriasis
4780186|NCT02740218|Apremilast|apremilast
4780187|NCT02740218|APPRECIATE|appreciate
4780188|NCT02740218|Dermatology|dermatology
4780189|NCT02740218|Retrospective|retrospective
4780190|NCT02740218|Observational|observational
4780191|NCT02740205|Patients with Enteral Feeding|patients with enteral feeding
4780192|NCT02740179|Eplerenone|eplerenone
4780193|NCT02740179|Cardiovascular Disease|cardiovascular disease
4780194|NCT02740179|Mineralocorticoid Receptor Antagonist|mineralocorticoid receptor antagonist
4780195|NCT02740179|Coronary Vasculature|coronary vasculature
4780196|NCT02740179|Myocardial Inflammation|myocardial inflammation
4780197|NCT02740179|Myocardial Fibrosis|myocardial fibrosis
4780198|NCT02740179|Atherosclerosis|atherosclerosis
4780199|NCT02740179|Aldosterone|aldosterone
4780200|NCT02740166|Esophageal Varices; propranolol; banding ligation|esophageal varices; propranolol; banding ligation
4780201|NCT02740140|chronic coinfection|chronic coinfection
4780202|NCT02740127|Malignant neoplasms of male genital organs|malignant neoplasms of male genital organs
4780203|NCT02740127|Adult Penile Prosthesis Surgery|adult penile prosthesis surgery
4780204|NCT02740127|Caudal nerve block|caudal nerve block
4780205|NCT02740127|CNB|cnb
4780206|NCT02740127|General anesthesia|general anesthesia
4780207|NCT02740127|GA|ga
4780208|NCT02740127|Ropivacaine|ropivacaine
4780209|NCT02740127|Naropin|naropin
4780210|NCT02740127|Epinephrine|epinephrine
4780211|NCT02740127|Decadron|decadron
4780212|NCT02740127|Dexamethasone|dexamethasone
4780213|NCT02740127|Clonidine|clonidine
4780214|NCT02740127|Propofol|propofol
4780215|NCT02740127|Diprivan|diprivan
4780216|NCT02740114|Malignant neoplasms of female genital organs|malignant neoplasms of female genital organs
4780217|NCT02740114|Open gynecologic surgery|open gynecologic surgery
4780218|NCT02740114|Local wound infiltration|local wound infiltration
4780219|NCT02740114|Gynecologic cancer|gynecologic cancer
4780220|NCT02740114|Bupivacaine|bupivacaine
4780221|NCT02740114|Liposomal Bupivacaine|liposomal bupivacaine
4780222|NCT02740114|Oxycodone|oxycodone
4780223|NCT02740114|ETH-Oxydose [DSC]|eth-oxydose [dsc]
4780224|NCT02740114|OxyContin|oxycontin
4780225|NCT02740114|OxyIR|oxyir
4780226|NCT02740114|Roxicodone|roxicodone
4780227|NCT02740114|Questionnaires|questionnaires
4780228|NCT02740114|Surveys|surveys
4780229|NCT02740114|MD Anderson Symptom Inventory|md anderson symptom inventory
4780230|NCT02740114|MDASI|mdasi
4780231|NCT02740114|Pill diary|pill diary
4780232|NCT02740114|Medication log|medication log
4780233|NCT02740101|oxytocin|oxytocin
4780234|NCT02740101|social reward|social reward
4780235|NCT02740101|social punishment|social punishment
4780236|NCT02740075|Mechanical versus hand ventilation|mechanical versus hand ventilation
4780237|NCT02740075|Transport ventilation|transport ventilation
4780238|NCT02740049|Epithelial Cells|epithelial cells
4780239|NCT02740010|MIOL|miol
4780240|NCT02740010|extended depth of focus|extended depth of focus
4780241|NCT02740010|cataract|cataract
4780242|NCT02740010|visual acuity|visual acuity
4780243|NCT02740010|halos|halos
4780244|NCT02739984|diabetes|diabetes
4780245|NCT02739984|type 2 diabetes|type 2 diabetes
4780246|NCT02739984|high blood cholesterol|high blood cholesterol
4780247|NCT02739984|hypercholesterolemia|hypercholesterolemia
4780248|NCT02739984|mixed dyslipidemia|mixed dyslipidemia
4780249|NCT02739984|high cholesterol|high cholesterol
4780250|NCT02739984|statin intolerant|statin intolerant
4780251|NCT02739945|Ulnar Nerve Compression, Cubital Tunnel|ulnar nerve compression, cubital tunnel
4780252|NCT02739932|Attenuated Psychotic Symptoms|attenuated psychotic symptoms
4780253|NCT02739919|Kidney stones|kidney stones
4780254|NCT02739919|Renal Calculi|renal calculi
4780255|NCT02739880|Vaginal discomfort|vaginal discomfort
4780256|NCT02739880|Vaginal dryness|vaginal dryness
4780257|NCT02739867|occult cancer|occult cancer
4780258|NCT02739867|venous thromboembolism|venous thromboembolism
4780259|NCT02739867|tumor-educated platelets|tumor-educated platelets
4780260|NCT02739867|platelet RNA profiling|platelet rna profiling
4780261|NCT02739867|early diagnosis|early diagnosis
4780262|NCT02739867|screening|screening
4780263|NCT02739854|trauma|trauma
4780264|NCT02739854|atelectasis|atelectasis
4780265|NCT02739841|hemodynamic response|hemodynamic response
4780266|NCT02739828|Quality of life|quality of life
4780267|NCT02739815|Caesarean Section|caesarean section
4780268|NCT02739815|Tranexamic Acid|tranexamic acid
4780269|NCT02739815|Postpartum Hemorrhage|postpartum hemorrhage
4780270|NCT02739815|Ecbolics|ecbolics
4780271|NCT02739789|tDCS rejection affect mood fMRI|tdcs rejection affect mood fmri
4780272|NCT02739763|PfSPZ|pfspz
4780273|NCT02739763|Semi-immune adults|semi-immune adults
4780274|NCT02739763|Kenya|kenya
4780275|NCT02739763|challenge|challenge
4780276|NCT02739763|CHMI|chmi
4780277|NCT02739763|malaria|malaria
4780278|NCT02739737|Bias|bias
4780279|NCT02739737|Orthopedics|orthopedics
4780280|NCT02739737|Peer Review|peer review
4780281|NCT02739698|ovarian cancer|ovarian cancer
4780282|NCT02739659|prostate carcinoma|prostate carcinoma
4780283|NCT02739659|carbon-ion radiotherapy|carbon-ion radiotherapy
4780284|NCT02739659|efficacy|efficacy
4780285|NCT02739659|toxicity|toxicity
4780286|NCT02739633|Chemotherapy|chemotherapy
4780287|NCT02739633|Gemcitabine|gemcitabine
4780288|NCT02739633|Recurrent and metastatic adenocarcinoma of the pancreas|recurrent and metastatic adenocarcinoma of the pancreas
4780289|NCT02739633|Genexol-PM|genexol-pm
4780290|NCT02739633|Paclitaxel|paclitaxel
4780291|NCT02739607|emotional disorders|emotional disorders
4780292|NCT02739607|internet-delivered intervention|internet-delivered intervention
4780293|NCT02739607|anxiety|anxiety
4780294|NCT02739607|depression|depression
4780295|NCT02739607|transdiagnostic|transdiagnostic
4780296|NCT02739568|EDS|eds
4780297|NCT02739568|OSA|osa
4780298|NCT02739555|Osteoid osteoma|osteoid osteoma
4780299|NCT02739555|Bisphophonates|bisphophonates
4780300|NCT02739542|Radiologically Isolated Syndrome (RIS)|radiologically isolated syndrome (ris)
4780301|NCT02739490|physiotherapeutic techniques|physiotherapeutic techniques
4780302|NCT02739490|pelvis|pelvis
4780303|NCT02739490|Muscle strength|muscle strength
4780304|NCT02739477|Favipiravir|favipiravir
4780305|NCT02739477|Tolerance|tolerance
4780306|NCT02739477|Survivor|survivor
4780307|NCT02739477|Ebola Virus|ebola virus
4780308|NCT02739477|Genital reservoir|genital reservoir
4780309|NCT02739477|Guinea|guinea
4780310|NCT02739464|Burn|burn
4780311|NCT02739464|Exercise|exercise
4780312|NCT02739464|Ergometer|ergometer
4780313|NCT02739464|MP-10|mp-10
4780314|NCT02739451|immunocompromized patients|immunocompromized patients
4780315|NCT02739451|critically ill patients|critically ill patients
4780316|NCT02739438|Pulmonary inflammation|pulmonary inflammation
4780317|NCT02739438|Endothelial dysfunction|endothelial dysfunction
4780318|NCT02739438|Electronic Cigarettes|electronic cigarettes
4780319|NCT02739425|Sentinel lymph node biopsy (SLNB)|sentinel lymph node biopsy (slnb)
4780320|NCT02739425|Superparamagnetic iron oxide (SPIO) tracer|superparamagnetic iron oxide (spio) tracer
4780321|NCT02739399|phenylephrine|phenylephrine
4780322|NCT02739399|alpha mimetics|alpha mimetics
4780323|NCT02739399|pulse pressure variation|pulse pressure variation
4780324|NCT02739399|venous return|venous return
4780325|NCT02739347|tDCS|tdcs
4780326|NCT02739347|cognitive control|cognitive control
4780327|NCT02739347|working memory|working memory
4780328|NCT02739347|EEG|eeg
4780329|NCT02739347|gamma oscillations|gamma oscillations
4780330|NCT02739321|Autism|autism
4780331|NCT02739321|ASD|asd
4780332|NCT02739321|Sleep|sleep
4780333|NCT02739321|Mattress|mattress
4780334|NCT02739308|proprioception|proprioception
4780335|NCT02739308|ankle sprain|ankle sprain
4780336|NCT02739308|fencing|fencing
4780337|NCT02739269|ovarian response|ovarian response
4780338|NCT02739269|anti-Mullerian hormone|anti-mullerian hormone
4780339|NCT02739269|antral follicle count|antral follicle count
4780340|NCT02739256|voiding trial|voiding trial
4780341|NCT02739256|pelvic organ prolapse|pelvic organ prolapse
4780342|NCT02739256|post-operative catheterization|post-operative catheterization
4780343|NCT02739204|Celecoxib|celecoxib
4780344|NCT02739204|Relapse-free OSCC patient|relapse-free oscc patient
4780345|NCT02739204|Recurrence|recurrence
4780346|NCT02739204|Survival|survival
4780347|NCT02739204|Prognosis|prognosis
4780348|NCT02739191|NPWT|npwt
4780349|NCT02739165|Acute exacerbations|acute exacerbations
4780350|NCT02739165|Idiopathic pulmonary fibrosis|idiopathic pulmonary fibrosis
4780351|NCT02739165|Recombinant human soluble thrombomodulin|recombinant human soluble thrombomodulin
4780352|NCT02739165|ART-123|art-123
4780353|NCT02739152|Sepsis|sepsis
4780354|NCT02739152|Severe sepsis|severe sepsis
4780355|NCT02739152|Infections|infections
4780356|NCT02739152|Worsening|worsening
4780357|NCT02739126|Diagnosis|diagnosis
4780358|NCT02739113|OMECs|omecs
4780359|NCT02739113|Cornea|cornea
4780360|NCT02739113|Amniotic membrane|amniotic membrane
4780361|NCT02739113|Collagenase|collagenase
4780362|NCT02739100|pharmacokinetics|pharmacokinetics
4780363|NCT02739100|bioequivalence|bioequivalence
4780364|NCT02739087|radiation free cardiac catheterization|radiation free cardiac catheterization
4780365|NCT02739061|pathogenesis|pathogenesis
4780366|NCT02739061|cognitive behavioral group therapy|cognitive behavioral group therapy
4780367|NCT02738996|Diabetes|diabetes
4780368|NCT02738996|Sedentary Lifestyle|sedentary lifestyle
4780369|NCT02738983|Non-small cell lung cancer|non-small cell lung cancer
4780370|NCT02738983|epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI)|epidermal growth factor receptor tyrosine kinase inhibitor (egfr-tki)
4780371|NCT02738983|Radiotherapy|radiotherapy
4780372|NCT02738983|wild type|wild type
4780373|NCT02738931|dolutegravir|dolutegravir
4780374|NCT02738931|lamivudine|lamivudine
4780375|NCT02738931|Bioavailability|bioavailability
4780376|NCT02738931|fixed dose combinations|fixed dose combinations
4780377|NCT02738918|Renal Transplant|renal transplant
4780378|NCT02738918|Anti HLA antibodies|anti hla antibodies
4780379|NCT02738918|Humoral rejection|humoral rejection
4780380|NCT02738892|Pregnancy|pregnancy
4780381|NCT02738892|Stillbirth|stillbirth
4780382|NCT02738892|Preterm birth|preterm birth
4780383|NCT02738866|breast cancer|breast cancer
4780384|NCT02738866|Metastatic Breast Cancer|metastatic breast cancer
4780385|NCT02738866|palbociclib|palbociclib
4780386|NCT02738866|fulvestrant|fulvestrant
4780387|NCT02738814|emergence agitation|emergence agitation
4780388|NCT02738814|emergence delirium|emergence delirium
4780389|NCT02738814|PAED scale|paed scale
4780390|NCT02738814|The Modified Aldrete Scoring System|the modified aldrete scoring system
4780391|NCT02738814|treatment|treatment
4780392|NCT02738814|pediatric|pediatric
4780393|NCT02738814|sevoflurane|sevoflurane
4780394|NCT02738801|Idiopathic Pulmonary Fibrosis|idiopathic pulmonary fibrosis
4780395|NCT02738801|GLPG1690|glpg1690
4780396|NCT02738801|Autotaxin|autotaxin
4780397|NCT02738788|airway|airway
4780398|NCT02738788|airway changes|airway changes
4780399|NCT02738788|MMS|mms
4780400|NCT02738788|prone position|prone position
4780401|NCT02738788|Trendelenburg position|trendelenburg position
4780402|NCT02738775|multiple sclerosis|multiple sclerosis
4780403|NCT02738762|intensive care|intensive care
4780404|NCT02738762|glutamine|glutamine
4780405|NCT02738762|length of stay|length of stay
4780406|NCT02738749|sudden cardiac death, sodium channel splicing variant|sudden cardiac death, sodium channel splicing variant
4780407|NCT02738723|Limited-stage small cell lung cancer|limited-stage small cell lung cancer
4780408|NCT02738723|Stereotactic body radiation therapy|stereotactic body radiation therapy
4780409|NCT02738723|Intensity modulated radiation therapy|intensity modulated radiation therapy
4780410|NCT02738723|Radiation|radiation
4780411|NCT02738723|Chemotherapy|chemotherapy
4780412|NCT02738697|Carcinoma,Hepatocellular|carcinoma,hepatocellular
4780413|NCT02738697|Adjuvant chemotherapy|adjuvant chemotherapy
4780414|NCT02738697|Microvessels invasion|microvessels invasion
4780415|NCT02738697|Survival|survival
4780416|NCT02738697|Recurrence|recurrence
4780417|NCT02738684|lung cancer|lung cancer
4780418|NCT02738684|adenocarcinoma|adenocarcinoma
4780419|NCT02738684|EGFR|egfr
4780420|NCT02738684|plasma free nucleic acids|plasma free nucleic acids
4780421|NCT02738671|functional MRI|functional mri
4780422|NCT02738671|olfactory function|olfactory function
4780423|NCT02738671|bariatric surgery|bariatric surgery
4780424|NCT02738658|Coronary microcirculatory dysfunction|coronary microcirculatory dysfunction
4780425|NCT02738658|Coronary endothelium dysfunction|coronary endothelium dysfunction
4780426|NCT02738619|allergic rhinitis|allergic rhinitis
4780427|NCT02738619|immunotherapy|immunotherapy
4780428|NCT02738619|vitamin D|vitamin d
4780429|NCT02738606|Colorectal Cancer|colorectal cancer
4780430|NCT02738606|Other diseases of intestines|other diseases of intestines
4780431|NCT02738606|Liver and Unresectable Pulmonary Metastases|liver and unresectable pulmonary metastases
4780432|NCT02738606|Resectable liver metastases|resectable liver metastases
4780433|NCT02738606|Liver resection|liver resection
4780434|NCT02738606|Chemotherapy|chemotherapy
4780435|NCT02738554|HBV|hbv
4780436|NCT02738554|treatment cessation|treatment cessation
4780437|NCT02738554|HBsAg|hbsag
4780438|NCT02738554|HBcrAg|hbcrag
4780439|NCT02738554|nucleoside analogue|nucleoside analogue
4780440|NCT02738554|entecavir|entecavir
4780441|NCT02738554|tenofovir|tenofovir
4780442|NCT02738502|HIV|hiv
4780443|NCT02738502|prevention of mother-to-child transmission|prevention of mother-to-child transmission
4780444|NCT02738502|Ritonavir boosted darunavir monotherapy|ritonavir boosted darunavir monotherapy
4780445|NCT02738489|PD-1/PD-L1 advanced Melanoma immunotherapy|pd-1/pd-l1 advanced melanoma immunotherapy
4780446|NCT02738463|ferritin LBW|ferritin lbw
4780447|NCT02738450|cognitive decline|cognitive decline
4780448|NCT02738437|osteogenesis|osteogenesis
4780449|NCT02738437|Positron-Emission Tomography|positron-emission tomography
4780450|NCT02738437|Radiostereometric analysis|radiostereometric analysis
4780451|NCT02738424|Low Back Pain|low back pain
4780452|NCT02738424|MRI|mri
4780453|NCT02738372|Chronic Pain|chronic pain
4780454|NCT02738372|Biopsychosocial Factors|biopsychosocial factors
4780455|NCT02738372|Shoulder pain|shoulder pain
4780456|NCT02738372|Prognosis|prognosis
4780457|NCT02738372|Central Nervous System Sensitization|central nervous system sensitization
4780458|NCT02738359|colon cancer|colon cancer
4780459|NCT02738359|rectum cancer|rectum cancer
4780460|NCT02738359|colonoscopy|colonoscopy
4780461|NCT02738359|fecal immunological test|fecal immunological test
4780462|NCT02738359|colon capsule|colon capsule
4780463|NCT02738346|Small Cell Lung Cancer|small cell lung cancer
4780464|NCT02738346|Topotecan|topotecan
4780465|NCT02738346|Etoposide|etoposide
4780466|NCT02738307|High Altitude|high altitude
4780467|NCT02738307|Attention|attention
4780468|NCT02738307|Cognitive Function|cognitive function
4780469|NCT02738307|Acclimatization|acclimatization
4780470|NCT02738307|Sleep|sleep
4780471|NCT02738255|Obstructive sleep apnea|obstructive sleep apnea
4780472|NCT02738255|Mouth breathing|mouth breathing
4780473|NCT02738255|Apnea-Hypopnea Index (AHI)|apnea-hypopnea index (ahi)
4780474|NCT02738242|Functional Electrical Stimulation|functional electrical stimulation
4780475|NCT02738242|Upper motor neuron injury or disease|upper motor neuron injury or disease
4780476|NCT02738242|Drop foot|drop foot
4780477|NCT02738242|Thigh muscle weakness|thigh muscle weakness
4780478|NCT02738203|Pain Management|pain management
4780479|NCT02738203|IUD insertion|iud insertion
4780480|NCT02738190|albumin|albumin
4780481|NCT02738190|fresh frozen plasma|fresh frozen plasma
4780482|NCT02738190|extracorporeal circulation|extracorporeal circulation
4780483|NCT02738190|cardiovascular surgery|cardiovascular surgery
4780484|NCT02738190|pediatric population|pediatric population
4780485|NCT02738177|misopristol|misopristol
4780486|NCT02738177|effox|effox
4780487|NCT02738177|cervical ripening|cervical ripening
4780488|NCT02738138|HCV Genotype 3|hcv genotype 3
4780489|NCT02738138|Non-cirrhotic|non-cirrhotic
4780490|NCT02738138|HCV Genotype 1|hcv genotype 1
4780491|NCT02738138|HCV Genotype 6|hcv genotype 6
4780492|NCT02738138|Human Immunodeficiency Virus (HIV) Infection|human immunodeficiency virus (hiv) infection
4780493|NCT02738138|HCV Genotype 5|hcv genotype 5
4780494|NCT02738138|HCV Treatment Naive|hcv treatment naive
4780495|NCT02738138|HCV Genotype 4|hcv genotype 4
4780496|NCT02738138|HCV Treatment Experienced|hcv treatment experienced
4780497|NCT02738138|HCV Genotype 2|hcv genotype 2
4780498|NCT02738138|Hepatitis C Virus (HCV) Infection|hepatitis c virus (hcv) infection
4780499|NCT02738138|Compensated Cirrhosis|compensated cirrhosis
4780500|NCT02738125|Adalimumab|adalimumab
4780501|NCT02738125|Ulcerative Colitis|ulcerative colitis
4780502|NCT02738125|SOTHIS|sothis
4780503|NCT02738125|Effectiveness|effectiveness
4780504|NCT02738086|Amputation|amputation
4780505|NCT02738086|Physical Activity|physical activity
4780506|NCT02738086|Rehabilitation|rehabilitation
4780507|NCT02738034|Hypertension|hypertension
4780508|NCT02738034|Cognition|cognition
4780509|NCT02738034|Computerized Training|computerized training
4780510|NCT02738034|Cogmed|cogmed
4780511|NCT02738021|Psychosocial|psychosocial
4780512|NCT02738021|Psychotherapy|psychotherapy
4780513|NCT02738021|Maternal|maternal
4780514|NCT02737995|Iron deficiency|iron deficiency
4780515|NCT02737982|coronary heart disease|coronary heart disease
4780516|NCT02737982|gender|gender
4780517|NCT02737982|platelet|platelet
4780518|NCT02737982|microvascular dysfunction|microvascular dysfunction
4780519|NCT02737982|sexual hormones|sexual hormones
4780520|NCT02737982|cardiac magnetic resonance|cardiac magnetic resonance
4780521|NCT02737982|percutaneous coronary interventions|percutaneous coronary interventions
4780522|NCT02737969|Transesophageal Echocardiography/angiography (TEE/Angio)|transesophageal echocardiography/angiography (tee/angio)
4780523|NCT02737943|Skin graft|skin graft
4780524|NCT02737943|Burn|burn
4780525|NCT02737943|MEBO|mebo
4780526|NCT02737943|Wound dressing|wound dressing
4780527|NCT02737943|Wound care|wound care
4780528|NCT02737943|Raw Area|raw area
4780529|NCT02737930|Acute ischemic stroke|acute ischemic stroke
4780530|NCT02737930|Homonymous hemianopia|homonymous hemianopia
4780531|NCT02737930|Homonymous quadrantanopia|homonymous quadrantanopia
4780532|NCT02737930|Visual field loss|visual field loss
4780533|NCT02737930|Post-stroke recovery|post-stroke recovery
4780534|NCT02737930|Fluoxetine|fluoxetine
4780535|NCT02737930|Selective serotonin reuptake inhibitor|selective serotonin reuptake inhibitor
4780536|NCT02737904|Muscle spasticity|muscle spasticity
4780537|NCT02737865|Focal nodular hyperplasia|focal nodular hyperplasia
4780538|NCT02737865|Ultrasonography|ultrasonography
4780539|NCT02737865|Superb-Microvascular imaging|superb-microvascular imaging
4780540|NCT02737865|Contrast-enhanced ultrasonography|contrast-enhanced ultrasonography
4780541|NCT02737813|isobaric marcaine|isobaric marcaine
4780542|NCT02737813|hyperbaric marcaine|hyperbaric marcaine
4780543|NCT02737787|Second or Greater Remission|second or greater remission
4780544|NCT02737787|WT1 Analog Peptide Vaccine|wt1 analog peptide vaccine
4780546|NCT02737787|GM-CSF|gm-csf
4780547|NCT02737787|Nivolumab|nivolumab
4780548|NCT02737787|15-247|15-247
4780549|NCT02737774|Icotinib|icotinib
4780550|NCT02737774|chemotherapy|chemotherapy
4780551|NCT02737774|EGFR|egfr
4780552|NCT02737761|Heart Failure|heart failure
4780553|NCT02737761|Positive Psychology|positive psychology
4780554|NCT02737761|Adherence to Health Behaviors|adherence to health behaviors
4780555|NCT02737748|Donor Site Wounds|donor site wounds
4780556|NCT02737696|prescription opioid|prescription opioid
4780557|NCT02737696|prevention|prevention
4780558|NCT02737696|computer-based|computer-based
4780559|NCT02737696|adolescent|adolescent
4780560|NCT02737683|Disease|disease
4780561|NCT02737683|anxiety|anxiety
4780562|NCT02737683|depression|depression
4780563|NCT02737683|combine|combine
4780564|NCT02737683|negative emotional states|negative emotional states
4780565|NCT02737683|functional dyspepsia|functional dyspepsia
4780566|NCT02737657|Canagliflozin|canagliflozin
4780567|NCT02737657|Metformin|metformin
4780568|NCT02737657|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
4780569|NCT02737657|INVOKANA|invokana
4780570|NCT02737657|Sulfonylurea|sulfonylurea
4780571|NCT02737644|Congenital Heart Disease|congenital heart disease
4780572|NCT02737644|Key Nutritional Factors|key nutritional factors
4780573|NCT02737644|conception|conception
4780574|NCT02737644|pregnant|pregnant
4780575|NCT02737605|Esketamine|esketamine
4780576|NCT02737605|Healthy|healthy
4780577|NCT02737605|Pharmacokinetics|pharmacokinetics
4780578|NCT02737605|Electrocardiogram|electrocardiogram
4780579|NCT02737605|Repolarization|repolarization
4780580|NCT02737579|cardiac catheterization|cardiac catheterization
4780581|NCT02737579|cardiac MRI|cardiac mri
4780582|NCT02737566|Smoking Cessation|smoking cessation
4780583|NCT02737566|Financial Incentives|financial incentives
4780584|NCT02737566|Contingency Management|contingency management
4780585|NCT02737566|Vulnerable Populations|vulnerable populations
4780586|NCT02737566|Medically Uninsured|medically uninsured
4780587|NCT02737566|Medicaid|medicaid
4780588|NCT02737527|ultrasound|ultrasound
4780589|NCT02737527|lumbar sympathetic block|lumbar sympathetic block
4780590|NCT02737514|adenoma detection rate|adenoma detection rate
4780591|NCT02737514|colonoscopy|colonoscopy
4780592|NCT02737514|water exchange|water exchange
4780593|NCT02737501|Non-small cell lung cancer|non-small cell lung cancer
4780594|NCT02737501|Non-small cell lung carcinoma|non-small cell lung carcinoma
4780595|NCT02737501|Epithelial lung cancer|epithelial lung cancer
4780596|NCT02737501|Squamous cell carcinoma|squamous cell carcinoma
4780597|NCT02737501|Large cell carcinoma|large cell carcinoma
4780598|NCT02737501|Adenocarcinoma|adenocarcinoma
4780599|NCT02737501|Carcinoma|carcinoma
4780600|NCT02737501|Anaplastic Lymphoma Kinase (ALK)|anaplastic lymphoma kinase (alk)
4780601|NCT02737501|Advanced Cancers|advanced cancers
4780602|NCT02737501|Brigatinib|brigatinib
4780603|NCT02737501|AP26113|ap26113
4780604|NCT02737488|Therapy|therapy
4780605|NCT02737488|Trauma Systems Therapy|trauma systems therapy
4780606|NCT02737410|Resilience|resilience
4780607|NCT02737410|Coping|coping
4780608|NCT02737410|Psychosomatic|psychosomatic
4780609|NCT02737410|Hypnosis|hypnosis
4780610|NCT02737410|Construct Validation|construct validation
4780611|NCT02737384|Combined immunodeficiencies|combined immunodeficiencies
4780612|NCT02737384|hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
4780613|NCT02737384|CD45RA|cd45ra
4780614|NCT02737384|primitive immunodeficiencies|primitive immunodeficiencies
4780615|NCT02737384|pediatric transplantation|pediatric transplantation
4780616|NCT02737384|CD45RA depletion|cd45ra depletion
4780617|NCT02737358|nicotine|nicotine
4780618|NCT02737358|tobacco|tobacco
4780619|NCT02737358|smoking|smoking
4780620|NCT02737358|cessation|cessation
4780621|NCT02737358|N-acetylcysteine|n-acetylcysteine
4780622|NCT02737358|NAC|nac
4780623|NCT02737358|pharmacotherapy|pharmacotherapy
4780624|NCT02737358|relapse|relapse
4780625|NCT02737358|tobacco use disorder|tobacco use disorder
4780626|NCT02737345|fibrinolysis|fibrinolysis
4780627|NCT02737345|liver transplant|liver transplant
4780628|NCT02737345|thromboelastometry|thromboelastometry
4780629|NCT02737319|Contrast,nephropathy, angioplasty, stable coronary|contrast,nephropathy, angioplasty, stable coronary
4780630|NCT02737306|RIC Allogeneic Stem-Cell Transplantation|ric allogeneic stem-cell transplantation
4780631|NCT02737280|infant|infant
4780632|NCT02737280|high flow nasal cannulae|high flow nasal cannulae
4780633|NCT02737280|oxygen therapy|oxygen therapy
4780634|NCT02737280|bronchiolitis|bronchiolitis
4780635|NCT02737267|Genetics|genetics
4780636|NCT02737267|Polymorphism|polymorphism
4780637|NCT02737267|Epigenetics|epigenetics
4780638|NCT02737267|Metagenomics|metagenomics
4780639|NCT02737267|Metabolomics|metabolomics
4780640|NCT02737267|Metabolic syndrome conditions|metabolic syndrome conditions
4780641|NCT02737267|Precision nutrition|precision nutrition
4780642|NCT02737254|Attachment|attachment
4780643|NCT02737254|Oxytocin|oxytocin
4780644|NCT02737254|Cognitive bias modification|cognitive bias modification
4780645|NCT02737254|Middle childhood|middle childhood
4780646|NCT02737241|Prostate|prostate
4780647|NCT02737241|Laser|laser
4780648|NCT02737241|Enucleation|enucleation
4780649|NCT02737202|LAM|lam
4780650|NCT02737189|Basilar Artery Occlusion|basilar artery occlusion
4780651|NCT02737189|Ischemic Stroke|ischemic stroke
4780652|NCT02737189|Mechanical Embolectomy|mechanical embolectomy
4780653|NCT02737176|Smoking Cessation|smoking cessation
4780654|NCT02737176|Mouth Diseases|mouth diseases
4780655|NCT02737176|Periodontal Diseases|periodontal diseases
4780656|NCT02737176|Leukoplakia|leukoplakia
4780657|NCT02737176|Keratosis|keratosis
4780658|NCT02737176|Implant|implant
4780659|NCT02737176|Lichen Planus|lichen planus
4780660|NCT02737163|Programmable shunts|programmable shunts
4780661|NCT02737163|Strata valve|strata valve
4780662|NCT02737124|Acetaminophen|acetaminophen
4780663|NCT02737124|Surgery|surgery
4780664|NCT02737124|Meniscectomy|meniscectomy
4780665|NCT02737098|PTSD|ptsd
4780666|NCT02737098|virtual care|virtual care
4780667|NCT02737098|implementation|implementation
4780668|NCT02737098|telepsychiatry|telepsychiatry
4780669|NCT02737098|telepsychology|telepsychology
4780670|NCT02737085|CD19-targeted CAR-T Cell|cd19-targeted car-t cell
4780671|NCT02737085|CD20-targeted CAR-T Cell|cd20-targeted car-t cell
4780672|NCT02737085|Diffuse Large B Cell Lymphoma|diffuse large b cell lymphoma
4780673|NCT02737072|immuno-oncology|immuno-oncology
4780674|NCT02737046|Adult T-cell Leukemia-Lymphoma|adult t-cell leukemia-lymphoma
4780675|NCT02737046|ATLL|atll
4780676|NCT02737033|ADHD|adhd
4780677|NCT02737033|Adults|adults
4780678|NCT02737033|Treatment|treatment
4780679|NCT02737033|Rhodiola|rhodiola
4780680|NCT02737020|ADHD|adhd
4780681|NCT02737020|Adults|adults
4780682|NCT02737020|Treatment|treatment
4780683|NCT02737020|Rhodiola rosea|rhodiola rosea
4780684|NCT02737007|Malaria|malaria
4780685|NCT02737007|Microdose|microdose
4780686|NCT02737007|GSK3191607|gsk3191607
4780687|NCT02736994|edentulous|edentulous
4780688|NCT02736994|patients|patients
4780689|NCT02736994|with full|with full
4780690|NCT02736981|Obesity|obesity
4780691|NCT02736981|Weight Loss|weight loss
4780692|NCT02736981|Young Adults|young adults
4780693|NCT02736968|Amebic|amebic
4780694|NCT02736968|Auranofin|auranofin
4780695|NCT02736968|GI Protozoa|gi protozoa
4780696|NCT02736968|Giardiasis|giardiasis
4780697|NCT02736968|Reprofiled|reprofiled
4780698|NCT02736890|Botulinum Toxin A|botulinum toxin a
4780699|NCT02736890|Neuropathic pain|neuropathic pain
4780700|NCT02736890|Spinal cord injury|spinal cord injury
4780701|NCT02736890|Pain management|pain management
4780702|NCT02736890|Rehabilitation|rehabilitation
4780703|NCT02736877|keratoconus|keratoconus
4780704|NCT02736877|bullous keratopathy|bullous keratopathy
4780705|NCT02736877|corneal dystrophy|corneal dystrophy
4780706|NCT02736851|disability|disability
4780707|NCT02736851|home|home
4780708|NCT02736851|stretching exercises|stretching exercises
4780709|NCT02736838|Pressure|pressure
4780710|NCT02736838|Pressure Ulcer|pressure ulcer
4780711|NCT02736838|Skin perfusion|skin perfusion
4780712|NCT02736838|Skin oxygenation|skin oxygenation
4780713|NCT02736812|Randomized controlled trial|randomized controlled trial
4780714|NCT02736812|Lyophilized Plasma|lyophilized plasma
4780715|NCT02736812|Advanced Trauma Life Support Care|advanced trauma life support care
4780716|NCT02736786|proton|proton
4780717|NCT02736773|Guided Bone|guided bone
4780718|NCT02736773|Pre-implant referred|pre-implant referred
4780719|NCT02736773|Regeneration|regeneration
4780720|NCT02736747|Stroke|stroke
4780721|NCT02736747|Muscle Spasticity|muscle spasticity
4780722|NCT02736747|Cryotherapy|cryotherapy
4780723|NCT02736747|Gait|gait
4780724|NCT02736747|Muscle Weakness|muscle weakness
4780725|NCT02736747|Proprioception|proprioception
4780726|NCT02736708|Primary sclerosing cholangitis|primary sclerosing cholangitis
4780727|NCT02736695|PPA|ppa
4780728|NCT02736669|weight loss|weight loss
4780729|NCT02736669|body weight|body weight
4780730|NCT02736669|behavioral|behavioral
4780731|NCT02736643|LDCT, screening|ldct, screening
4780732|NCT02736630|general anaesthesia|general anaesthesia
4780733|NCT02736630|elective surgery|elective surgery
4780734|NCT02736630|national epidemiology|national epidemiology
4780735|NCT02736630|turkey|turkey
4780736|NCT02736565|metastatic|metastatic
4780737|NCT02736565|askin tumor|askin tumor
4780738|NCT02736565|neuroectodermal tumor|neuroectodermal tumor
4780739|NCT02736565|pNET|pnet
4780740|NCT02736565|sarcoma|sarcoma
4780741|NCT02736565|soft tissue|soft tissue
4780742|NCT02736552|Gastric cancer|gastric cancer
4780743|NCT02736552|Adjuvant chemotherapy|adjuvant chemotherapy
4780744|NCT02736552|S-1|s-1
4780745|NCT02736552|D2 resection|d2 resection
4780746|NCT02736526|moderate intermittent exotropia|moderate intermittent exotropia
4780747|NCT02736526|surgical treatment|surgical treatment
4780748|NCT02736526|observation|observation
4780749|NCT02736513|Tagrisso|tagrisso
4780750|NCT02736513|AZD9291|azd9291
4780751|NCT02736513|EGFRm|egfrm
4780752|NCT02736513|brain metastases|brain metastases
4780753|NCT02736513|NSCLC|nsclc
4780754|NCT02736500|neuroendocrine tumors|neuroendocrine tumors
4780755|NCT02736500|gastro entero pancreatic neuroendocrine tumors|gastro entero pancreatic neuroendocrine tumors
4780756|NCT02736500|Radioisotope therapy|radioisotope therapy
4780757|NCT02736500|177Lu-DOTATATE|177lu-dotatate
4780758|NCT02736500|METRONOMIC CAPECITABINE|metronomic capecitabine
4780759|NCT02736487|Air Pollution|air pollution
4780760|NCT02736487|Exposure Assessment|exposure assessment
4780761|NCT02736487|Filtration|filtration
4780762|NCT02736487|Cardiovascular Outcomes|cardiovascular outcomes
4780763|NCT02736487|Respiratory Outcomes|respiratory outcomes
4780764|NCT02736487|Short-term Intervention|short-term intervention
4780765|NCT02736461|Orbital fractures|orbital fractures
4780766|NCT02736461|Strabismus|strabismus
4780767|NCT02736461|Predicting factors|predicting factors
4780768|NCT02736461|orbital floor fractures|orbital floor fractures
4780769|NCT02736448|GEP-NET tumors|gep-net tumors
4780770|NCT02736448|Lu-PRRT|lu-prrt
4780771|NCT02736448|177Lutethium - Peptide Receptor Radionuclide Therapy|177lutethium - peptide receptor radionuclide therapy
4780772|NCT02736448|gastro-entero-pancreatic neuroendocrine tumors|gastro-entero-pancreatic neuroendocrine tumors
4780773|NCT02736448|18-FDG Positron Emission Tomography (PET) positive|18-fdg positron emission tomography (pet) positive
4780774|NCT02736448|low dose of capecitabine|low dose of capecitabine
4780775|NCT02736435|Magnetic Resonance Guided High Intensity Focused Ultrasound|magnetic resonance guided high intensity focused ultrasound
4780776|NCT02736435|MR-HIFU|mr-hifu
4780777|NCT02736435|Fibroids|fibroids
4780778|NCT02736435|Leuprolide Acetate|leuprolide acetate
4780779|NCT02736357|Lymphoma|lymphoma
4780780|NCT02736357|Cohort|cohort
4780781|NCT02736357|non-Hodgkin|non-hodgkin
4780782|NCT02736344|coronary luminal diameter|coronary luminal diameter
4780783|NCT02736344|lesions|lesions
4780784|NCT02736344|vessels|vessels
4780785|NCT02736331|Cognitive performance|cognitive performance
4780786|NCT02736331|Metabolic control|metabolic control
4780787|NCT02736331|Pharmacokinetic profile|pharmacokinetic profile
4780788|NCT02736331|Anthocyanins|anthocyanins
4780789|NCT02736305|ovarian|ovarian
4780790|NCT02736305|regorafenib|regorafenib
4780791|NCT02736305|platinum resistant|platinum resistant
4780792|NCT02736305|clear cell|clear cell
4780793|NCT02736305|endometrioid|endometrioid
4780794|NCT02736266|Muscle-invasive|muscle-invasive
4780795|NCT02736266|Urothelial bladder carcinoma|urothelial bladder carcinoma
4780796|NCT02736266|Neoadjuvant therapy|neoadjuvant therapy
4780797|NCT02736266|Radical cystectomy|radical cystectomy
4780798|NCT02736253|foot amputation|foot amputation
4780799|NCT02736253|Osteomyelitis|osteomyelitis
4780800|NCT02736253|Diabetic Foot|diabetic foot
4780801|NCT02736227|liver transplantation|liver transplantation
4780802|NCT02736227|immunosuppression|immunosuppression
4780803|NCT02736227|everolimus|everolimus
4780804|NCT02736227|tacrolimus|tacrolimus
4780805|NCT02736227|kidney function|kidney function
4780806|NCT02736227|liver function|liver function
4780807|NCT02736227|biomarkers|biomarkers
4780808|NCT02736188|GNE Myopathy|gne myopathy
4780809|NCT02736188|GNEM|gnem
4780810|NCT02736188|Nonaka|nonaka
4780811|NCT02736188|Hereditary Inclusion Body Myopathy|hereditary inclusion body myopathy
4780812|NCT02736188|HIBM|hibm
4780813|NCT02736188|DMRV|dmrv
4780814|NCT02736188|QSM|qsm
4780815|NCT02736162|Perampanel|perampanel
4780816|NCT02736162|E2007|e2007
4780817|NCT02736162|Phase 4|phase 4
4780818|NCT02736162|Fycompa|fycompa
4780819|NCT02736136|maternal parenting self-efficacy|maternal parenting self-efficacy
4780820|NCT02736136|parental stress|parental stress
4780821|NCT02736136|maternal sensitivity|maternal sensitivity
4780822|NCT02736136|mother-infant bond|mother-infant bond
4780823|NCT02736110|Osteoarthritis, knee|osteoarthritis, knee
4780824|NCT02736084|optimism|optimism
4780825|NCT02736084|positive affect|positive affect
4780826|NCT02736084|adherence|adherence
4780827|NCT02736084|health behavior|health behavior
4780828|NCT02736084|diabetes|diabetes
4780829|NCT02736006|Alveolo-capillar membrane|alveolo-capillar membrane
4780830|NCT02736006|decompression illness|decompression illness
4780831|NCT02736006|diving|diving
4780832|NCT02736006|occupational|occupational
4780833|NCT02735993|Celution|celution
4780834|NCT02735993|ADRC|adrc
4780835|NCT02735993|Heart Failure|heart failure
4780836|NCT02735993|Device|device
4780837|NCT02735980|SCLC|sclc
4780838|NCT02735980|LY2606368|ly2606368
4780839|NCT02735980|CHK1|chk1
4780840|NCT02735915|Immunogenicity|immunogenicity
4780841|NCT02735915|Safety|safety
4780842|NCT02735915|Long term follow-up|long term follow-up
4780843|NCT02735915|Adults|adults
4780844|NCT02735915|Herpes zoster|herpes zoster
4780845|NCT02735902|antivitamins K|antivitamins k
4780846|NCT02735876|Bruton tyrosine kinase inhibitor|bruton tyrosine kinase inhibitor
4780847|NCT02735876|Btk|btk
4780848|NCT02735876|ACP-196|acp-196
4780849|NCT02735876|Mantle Cell Lymphoma|mantle cell lymphoma
4780850|NCT02735876|MCL|mcl
4780851|NCT02735811|Implantable defibrillator|implantable defibrillator
4780852|NCT02735811|Cardiomyopathies|cardiomyopathies
4780853|NCT02735720|thoracic endovascular aortic repair|thoracic endovascular aortic repair
4780854|NCT02735720|endograft|endograft
4780855|NCT02735720|cardiac remodelling|cardiac remodelling
4780856|NCT02735720|thoracic aortic aneurysm|thoracic aortic aneurysm
4780857|NCT02735720|penetrating aortic ulcer|penetrating aortic ulcer
4780858|NCT02735720|MRI|mri
4780859|NCT02735707|Pneumonia|pneumonia
4780860|NCT02735707|Lung Diseases|lung diseases
4780861|NCT02735707|Respiratory Tract Diseases|respiratory tract diseases
4780862|NCT02735707|Respiratory Tract Infections|respiratory tract infections
4780863|NCT02735707|Anti-Bacterial Agents|anti-bacterial agents
4780864|NCT02735707|Moxifloxacin|moxifloxacin
4780865|NCT02735707|Levofloxacin|levofloxacin
4780866|NCT02735707|Cephalosporins|cephalosporins
4780867|NCT02735707|Antibiotics|antibiotics
4780868|NCT02735707|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate
4780869|NCT02735707|Hydrocortisone acetate|hydrocortisone acetate
4780870|NCT02735707|Cortisol succinate|cortisol succinate
4780871|NCT02735707|Hydrocortisone|hydrocortisone
4780872|NCT02735707|Anti-Infective Agents|anti-infective agents
4780873|NCT02735694|Sleep apnea|sleep apnea
4780874|NCT02735694|Hypoglossal Nerve|hypoglossal nerve
4780875|NCT02735694|N-methyl-D-aspartate receptors|n-methyl-d-aspartate receptors
4780876|NCT02735694|Cycloserine|cycloserine
4780877|NCT02735694|Short-term potentiation|short-term potentiation
4780878|NCT02735668|Shoulder Pain|shoulder pain
4780879|NCT02735668|Pattern Motor|pattern motor
4780880|NCT02735668|Physical Therapy Modalities|physical therapy modalities
4780881|NCT02735668|Breast Cancer Treatment|breast cancer treatment
4780882|NCT02735655|endoscopy|endoscopy
4780883|NCT02735655|Education|education
4780884|NCT02735655|capsule endoscopy|capsule endoscopy
4780885|NCT02735655|Cholangiopancreatography, Endoscopic Retrograde|cholangiopancreatography, endoscopic retrograde
4780886|NCT02735655|esophagogastroduodenoscopy|esophagogastroduodenoscopy
4780887|NCT02735655|colonoscopy|colonoscopy
4780888|NCT02735655|Double-Balloon Enteroscopy|double-balloon enteroscopy
4780889|NCT02735655|Global status|global status
4780890|NCT02735655|unmet need|unmet need
4780891|NCT02735616|heart rate variability|heart rate variability
4780892|NCT02735616|stroke|stroke
4780893|NCT02735577|Alcohol|alcohol
4780894|NCT02735577|Craving|craving
4780895|NCT02735577|Functional MRI|functional mri
4780896|NCT02735577|Cognitive control|cognitive control
4780897|NCT02735577|Risky decision-making|risky decision-making
4780898|NCT02735577|Disulfiram|disulfiram
4780899|NCT02735564|Weight Loss|weight loss
4780900|NCT02735564|Magnetic Resonance Imaging|magnetic resonance imaging
4780901|NCT02735564|gut microbiota|gut microbiota
4780902|NCT02735551|LARC|larc
4780903|NCT02735551|IUD|iud
4780904|NCT02735551|Contraceptive Implant|contraceptive implant
4780905|NCT02735551|Contraception|contraception
4780906|NCT02735551|Community college|community college
4780907|NCT02735525|telemedicine|telemedicine
4780908|NCT02735525|smartphone|smartphone
4780909|NCT02735499|onabotulinum toxin A|onabotulinum toxin a
4780910|NCT02735499|Urinary bladder|urinary bladder
4780911|NCT02735499|EMDA|emda
4780912|NCT02735499|iontophoresis|iontophoresis
4780913|NCT02735499|electrophoresis|electrophoresis
4780914|NCT02735499|Urinary incontinence|urinary incontinence
4780915|NCT02735486|Ginger|ginger
4780916|NCT02735486|blood pressure|blood pressure
4780917|NCT02735486|flow mediated dilatation|flow mediated dilatation
4780918|NCT02735434|Health anxiety|health anxiety
4780919|NCT02735434|illness anxiety disorder|illness anxiety disorder
4780920|NCT02735434|ACT|act
4780921|NCT02735434|internet|internet
4780922|NCT02735421|acne|acne
4780923|NCT02735421|scars|scars
4780924|NCT02735395|Periodontal Diseases|periodontal diseases
4780925|NCT02735395|Metronidazole|metronidazole
4780926|NCT02735395|Amoxicillin|amoxicillin
4780927|NCT02735395|Chronic periodontitis|chronic periodontitis
4780928|NCT02735395|Root Planing|root planing
4780929|NCT02735382|Translational Medical Research|translational medical research
4780930|NCT02735382|Clinical Practice Guidelines|clinical practice guidelines
4780931|NCT02735382|Electronic Health Records|electronic health records
4780932|NCT02735382|Smoking|smoking
4780933|NCT02735382|Tobacco|tobacco
4780934|NCT02735382|Quitline|quitline
4780935|NCT02735330|CCP|ccp
4780936|NCT02735317|Nasopharyngeal carcinoma (NPC)|nasopharyngeal carcinoma (npc)
4780937|NCT02735317|radiotherapy|radiotherapy
4780938|NCT02735317|oral mucositis (OM)|oral mucositis (om)
4780939|NCT02735291|Leukemia CAR-T|leukemia car-t
4780940|NCT02735265|Rehabilitation|rehabilitation
4780941|NCT02735265|Virtual reality|virtual reality
4780942|NCT02735252|Castration Resistant|castration resistant
4780943|NCT02735252|Metastatic|metastatic
4780944|NCT02735239|Oesophageal Cancer|oesophageal cancer
4780945|NCT02735239|Oesophageal adenocarcinoma|oesophageal adenocarcinoma
4780946|NCT02735239|Oesophageal squamous cell carcinoma|oesophageal squamous cell carcinoma
4780947|NCT02735239|Immunotherapy|immunotherapy
4780948|NCT02735239|Cytotoxic T-lymphocyte-associated protein 4 (CTLA-4)|cytotoxic t-lymphocyte-associated protein 4 (ctla-4)
4780949|NCT02735239|Programmed cell death protein 1 (PD-1)|programmed cell death protein 1 (pd-1)
4780950|NCT02735239|Programmed death ligand 1 (PD-L1)|programmed death ligand 1 (pd-l1)
4780951|NCT02735226|stroke|stroke
4780952|NCT02735226|Shanghai Healthcare|shanghai healthcare
4780953|NCT02735226|Healthcare Quality, Access, and Evaluation|healthcare quality, access, and evaluation
4780954|NCT02735213|Central Serous Choroidopathy|central serous choroidopathy
4780955|NCT02735213|Micropulse Laser Treatment|micropulse laser treatment
4780956|NCT02735213|Traditional laser Treatment|traditional laser treatment
4780957|NCT02735213|optical coherence tomography|optical coherence tomography
4780958|NCT02735174|Telehealth|telehealth
4780959|NCT02735174|Sensor cap|sensor cap
4780960|NCT02735174|School based care|school based care
4780961|NCT02735174|Community health|community health
4780962|NCT02735174|AsthmaTreatSmart Application|asthmatreatsmart application
4780963|NCT02735161|Sarcoidosis|sarcoidosis
4780964|NCT02735161|Fatigue|fatigue
4780965|NCT02735161|Exercise|exercise
4780966|NCT02735148|Postural balance|postural balance
4780967|NCT02735148|Accidental falls|accidental falls
4780968|NCT02735148|Rehabilitation|rehabilitation
4780969|NCT02735148|Cerebrovascular Accident|cerebrovascular accident
4780970|NCT02735148|Walking|walking
4780971|NCT02735148|Mobility limitation|mobility limitation
4780972|NCT02735135|bedridden|bedridden
4780973|NCT02735109|VIN|vin
4780974|NCT02735096|Bilateral Vestibular Hypofunction|bilateral vestibular hypofunction
4780975|NCT02735096|Unilateral Vestibular Hypofunction|unilateral vestibular hypofunction
4780976|NCT02735096|Imbalance|imbalance
4780977|NCT02735070|Common cold treatment|common cold treatment
4780978|NCT02735057|oesophagus cancer|oesophagus cancer
4780979|NCT02735031|Glucagon-Like Peptide 1|glucagon-like peptide 1
4780980|NCT02735031|Impaired hypoglycemic awareness|impaired hypoglycemic awareness
4780981|NCT02734992|Migraines|migraines
4780982|NCT02734992|Tension-type Headache|tension-type headache
4780983|NCT02734992|Acceptance|acceptance
4780984|NCT02734979|lymphedema|lymphedema
4780985|NCT02734979|edema|edema
4780986|NCT02734966|Drug-Induced|drug-induced
4780987|NCT02734966|Acute Liver Injury|acute liver injury
4780988|NCT02734953|Inhaled nitric oxide|inhaled nitric oxide
4780989|NCT02734953|Exercise|exercise
4780990|NCT02734953|6 minute walk test|6 minute walk test
4780991|NCT02734953|CardioMems|cardiomems
4780992|NCT02734927|schizophrenia|schizophrenia
4780993|NCT02734927|motivation|motivation
4780994|NCT02734927|executive control|executive control
4780995|NCT02734901|polyphenols|polyphenols
4780996|NCT02734901|vascular function|vascular function
4780997|NCT02734901|endothelial function|endothelial function
4780998|NCT02734901|raspberry|raspberry
4780999|NCT02734888|arterial inflammation|arterial inflammation
4781000|NCT02734888|electronic cigarettes|electronic cigarettes
4781001|NCT02734888|PET scan|pet scan
4781002|NCT02734875|anticoagulants|anticoagulants
4781003|NCT02734875|NOACs|noacs
4781004|NCT02734875|warfarin|warfarin
4781005|NCT02734875|randomized designed delay|randomized designed delay
4781006|NCT02734875|intervention|intervention
4781007|NCT02734875|machine learning algorithm|machine learning algorithm
4781008|NCT02734875|primary care|primary care
4781009|NCT02734862|mycoses|mycoses
4781010|NCT02734810|Exocrine Pancreatic Insufficiency|exocrine pancreatic insufficiency
4781011|NCT02734810|Cystic Fibrosis|cystic fibrosis
4781012|NCT02734810|Liprotamase|liprotamase
4781013|NCT02734810|Pancreatic Enzyme Replacement Therapy (PERT)|pancreatic enzyme replacement therapy (pert)
4781014|NCT02734771|DLBCL|dlbcl
4781015|NCT02734745|diabetes type 1|diabetes type 1
4781016|NCT02734745|flash glucose monitoring|flash glucose monitoring
4781017|NCT02734732|Prostate|prostate
4781018|NCT02734732|Biopsy|biopsy
4781019|NCT02734732|Infection|infection
4781020|NCT02734732|Prophylaxis|prophylaxis
4781021|NCT02734732|Antibiotic|antibiotic
4781022|NCT02734693|Attention-Deficit Hyperactivity Disorder (ADHD)|attention-deficit hyperactivity disorder (adhd)
4781023|NCT02734680|Pancreatic cancer|pancreatic cancer
4781024|NCT02734680|Intraoperative radiotherapy(IORT)|intraoperative radiotherapy(iort)
4781025|NCT02734680|Postoperative radiochemotherapy|postoperative radiochemotherapy
4781026|NCT02734654|oxidative stress|oxidative stress
4781027|NCT02734654|lung lobectomy|lung lobectomy
4781028|NCT02734615|LSZ102|lsz102
4781029|NCT02734615|LEE011|lee011
4781030|NCT02734615|ribociclib|ribociclib
4781031|NCT02734615|Kisqali|kisqali
4781032|NCT02734615|BYL719|byl719
4781033|NCT02734615|alpelisib|alpelisib
4781034|NCT02734615|ER+ breast cancer|er+ breast cancer
4781035|NCT02734615|advanced ER+ breast cancer|advanced er+ breast cancer
4781036|NCT02734615|metastatic ER+ breast cancer|metastatic er+ breast cancer
4781037|NCT02734615|SERD|serd
4781038|NCT02734615|SERM|serm
4781039|NCT02734615|fulvestrant|fulvestrant
4781040|NCT02734615|tamoxifen|tamoxifen
4781041|NCT02734615|aromatase inhibitor|aromatase inhibitor
4781042|NCT02734615|ESR1|esr1
4781043|NCT02734615|estrogen receptor|estrogen receptor
4781044|NCT02734615|endocrine therapy|endocrine therapy
4781045|NCT02734602|depression|depression
4781046|NCT02734602|post-traumatic stress disorder|post-traumatic stress disorder
4781047|NCT02734602|sv2a|sv2a
4781048|NCT02734602|ketamine|ketamine
4781049|NCT02734602|PET|pet
4781050|NCT02734589|Ulcerative Colitis|ulcerative colitis
4781051|NCT02734589|Nutrition|nutrition
4781052|NCT02734589|microbiome|microbiome
4781053|NCT02734576|Venous Sinus Stenting|venous sinus stenting
4781054|NCT02734576|Dural Sinus Stenting|dural sinus stenting
4781055|NCT02734550|Sepsis|sepsis
4781056|NCT02734550|Invasive Candida Infection|invasive candida infection
4781057|NCT02734550|Biomarker|biomarker
4781058|NCT02734550|(1,3)-β-D-glucan|(1,3)-β-d-glucan
4781059|NCT02734550|Antifungal therapy|antifungal therapy
4781060|NCT02734550|Intensive care medicine|intensive care medicine
4781061|NCT02734550|Critically ill|critically ill
4781062|NCT02734524|Natural killer cells|natural killer cells
4781063|NCT02734524|NSCLC|nsclc
4781064|NCT02734524|NCT|nct
4781065|NCT02734524|Combined therapy|combined therapy
4781066|NCT02734485|Progressive supranuclear palsy|progressive supranuclear palsy
4781067|NCT02734485|Deep transcranial magnetic stimulation|deep transcranial magnetic stimulation
4781068|NCT02734472|blood pressure|blood pressure
4781069|NCT02734472|Hypertrophy, Left Ventricular|hypertrophy, left ventricular
4781070|NCT02734472|Vascular Stiffness|vascular stiffness
4781071|NCT02734472|Proteinuria|proteinuria
4781072|NCT02734472|Carotid Artery Diseases|carotid artery diseases
4781073|NCT02734446|Bronchial Inflammation|bronchial inflammation
4781074|NCT02734446|Asthma|asthma
4781075|NCT02734446|Childhood Asthma Control Test (C-ACT)|childhood asthma control test (c-act)
4781076|NCT02734446|Asthma Exacerbations|asthma exacerbations
4781077|NCT02734433|Advanced solid tumors|advanced solid tumors
4781078|NCT02734433|Asian subjects|asian subjects
4781079|NCT02734433|Developmental Phase I|developmental phase i
4781080|NCT02734420|Dental caries|dental caries
4781081|NCT02734420|PDT|pdt
4781082|NCT02734420|LLLT|lllt
4781083|NCT02734420|pediatric dentistry|pediatric dentistry
4781084|NCT02734394|exercise|exercise
4781085|NCT02734394|body composition|body composition
4781086|NCT02734394|metabolism|metabolism
4781087|NCT02734394|nutrition|nutrition
4781088|NCT02734381|elderly patients|elderly patients
4781089|NCT02734381|prevalence|prevalence
4781090|NCT02734381|emergency department use|emergency department use
4781091|NCT02734381|main presenting disease|main presenting disease
4781092|NCT02734355|atrial fibrillation|atrial fibrillation
4781093|NCT02734355|catheter ablation|catheter ablation
4781094|NCT02734355|left atrium|left atrium
4781095|NCT02734355|mechanical function|mechanical function
4781096|NCT02734355|contractility|contractility
4781097|NCT02734329|Nephron sparing surgery|nephron sparing surgery
4781098|NCT02734329|Zero ischemia|zero ischemia
4781099|NCT02734329|Warm ischemia|warm ischemia
4781100|NCT02734329|Laparoscopic|laparoscopic
4781101|NCT02734329|Radiofrequency ablation|radiofrequency ablation
4781102|NCT02734329|Microwave ablation|microwave ablation
4781103|NCT02734303|Dietary Radioactivity|dietary radioactivity
4781104|NCT02734303|Dietary Assessment|dietary assessment
4781105|NCT02734303|Retrospective Recall|retrospective recall
4781106|NCT02734303|Focus Group|focus group
4781107|NCT02734290|metastatic|metastatic
4781108|NCT02734290|Human epidermal growth factor receptor 2 (Her2) negative breast cancer|human epidermal growth factor receptor 2 (her2) negative breast cancer
4781109|NCT02734290|Estrogen Receptor (ER) negative breast cancer|estrogen receptor (er) negative breast cancer
4781110|NCT02734290|Progesterone Receptor (PR) negative breast cancer|progesterone receptor (pr) negative breast cancer
4781111|NCT02734290|Immunotherapy|immunotherapy
4781112|NCT02734290|Breast Cancer|breast cancer
4781113|NCT02734277|Insulin|insulin
4781114|NCT02734277|Glucose Intolerance|glucose intolerance
4781115|NCT02734277|Prior ITN027AI Study Participants-NCT00129259|prior itn027ai study participants-nct00129259
4781116|NCT02734277|Prior ITN045AI Study Participants-NCT00965458|prior itn045ai study participants-nct00965458
4781117|NCT02734251|Healthy mood|healthy mood
4781118|NCT02734251|Stress management|stress management
4781119|NCT02734251|Relora|relora
4781120|NCT02734251|Healthy subjects|healthy subjects
4781121|NCT02734225|total knee replacement|total knee replacement
4781122|NCT02734225|total knee arthroplasty|total knee arthroplasty
4781123|NCT02734225|rehabilitation|rehabilitation
4781124|NCT02734225|physical therapy|physical therapy
4781125|NCT02734225|balance|balance
4781126|NCT02734212|Stigmatization|stigmatization
4781127|NCT02734199|Birth Control|birth control
4781128|NCT02734199|Contraception|contraception
4781129|NCT02734199|IUD|iud
4781130|NCT02734186|Filariasis|filariasis
4781131|NCT02734186|Schistosoma Mansoni|schistosoma mansoni
4781132|NCT02734186|Coinfection|coinfection
4781133|NCT02734160|immunotherapy|immunotherapy
4781134|NCT02734160|check point inhibitors|check point inhibitors
4781135|NCT02734160|transforming growth factor (TGF)-beta R1 kinase inhibitor|transforming growth factor (tgf)-beta r1 kinase inhibitor
4781136|NCT02734134|Periprosthetic joint infection|periprosthetic joint infection
4781137|NCT02734121|breast cancer|breast cancer
4781138|NCT02734121|breast reconstruction|breast reconstruction
4781139|NCT02734121|shared decision making|shared decision making
4781140|NCT02734121|decision support intervention|decision support intervention
4781141|NCT02734108|Sever anorexia nervosa|sever anorexia nervosa
4781142|NCT02734082|stroke|stroke
4781143|NCT02734082|ischemia|ischemia
4781144|NCT02734082|Berne|berne
4781145|NCT02734069|carboplatin|carboplatin
4781146|NCT02734043|bundled payment|bundled payment
4781147|NCT02734030|Anterior Knee Pain Syndrome|anterior knee pain syndrome
4781148|NCT02734030|Quadriceps Femoris|quadriceps femoris
4781149|NCT02734030|Muscle Inhibition|muscle inhibition
4781150|NCT02734030|Interpolated Twitch Technique|interpolated twitch technique
4781151|NCT02734030|Muscle Architecture|muscle architecture
4781152|NCT02734030|Single Leg Squat|single leg squat
4781153|NCT02734030|Women Knee Pain|women knee pain
4781154|NCT02734004|MEDIOLA|mediola
4781155|NCT02734004|Olaparib|olaparib
4781156|NCT02734004|MEDI4736|medi4736
4781157|NCT02734004|Bevacizumab|bevacizumab
4781158|NCT02734004|Ovarian cancer|ovarian cancer
4781159|NCT02734004|Breast cancer|breast cancer
4781160|NCT02734004|Small Cell Lung Cancer|small cell lung cancer
4781161|NCT02734004|Gastric Cancer|gastric cancer
4781162|NCT02734004|Phase I/II, Adults|phase i/ii, adults
4781163|NCT02734004|PDL-1|pdl-1
4781164|NCT02733978|Ozone oxygen|ozone oxygen
4781165|NCT02733978|ulcer healing|ulcer healing
4781166|NCT02733965|clinical pharmacy consultations|clinical pharmacy consultations
4781167|NCT02733965|oral anti-cancer therapy|oral anti-cancer therapy
4781168|NCT02733965|serious adverse events|serious adverse events
4781169|NCT02733965|medication reconciliation|medication reconciliation
4781170|NCT02733939|technology|technology
4781171|NCT02733939|informal care|informal care
4781172|NCT02733939|caregiver burden|caregiver burden
4781173|NCT02733913|atrial fibrillation|atrial fibrillation
4781174|NCT02733913|pulmonary vein isolation|pulmonary vein isolation
4781175|NCT02733913|heart rate turbulence|heart rate turbulence
4781176|NCT02733913|baroreflex sensitivity|baroreflex sensitivity
4781177|NCT02733900|aseptic osteonecrosis|aseptic osteonecrosis
4781178|NCT02733900|femoral head|femoral head
4781179|NCT02733900|micro scanner|micro scanner
4781180|NCT02733900|Raman spectrometry|raman spectrometry
4781181|NCT02733900|MRI|mri
4781182|NCT02733861|dental implant|dental implant
4781183|NCT02733861|stability|stability
4781184|NCT02733861|implant stability quotient|implant stability quotient
4781185|NCT02733848|Roux-en-Y gastric bypass|roux-en-y gastric bypass
4781186|NCT02733848|Hypoglycemia|hypoglycemia
4781187|NCT02733848|Creon|creon
4781188|NCT02733822|opiate|opiate
4781189|NCT02733822|heroin|heroin
4781190|NCT02733822|opioid|opioid
4781191|NCT02733822|overdose|overdose
4781192|NCT02733822|naloxone|naloxone
4781193|NCT02733809|Hepatocellular Carcinoma|hepatocellular carcinoma
4781194|NCT02733809|Sorafenib|sorafenib
4781195|NCT02733796|zika virus|zika virus
4781196|NCT02733796|semen analysis|semen analysis
4781197|NCT02733796|sexual transmission|sexual transmission
4781198|NCT02733757|Clonidine|clonidine
4781199|NCT02733757|Sub-Tenon's and Peribulbar block|sub-tenon's and peribulbar block
4781200|NCT02733757|IOP|iop
4781201|NCT02733757|OPP|opp
4781202|NCT02733757|OPA|opa
4781203|NCT02733744|Stem cell transplant|stem cell transplant
4781204|NCT02733744|fecal microbiota transplantation|fecal microbiota transplantation
4781205|NCT02733718|Necrotizing enterocolitis|necrotizing enterocolitis
4781206|NCT02733718|Transfusion|transfusion
4781207|NCT02733718|Mesenteric Oxygenisation|mesenteric oxygenisation
4781208|NCT02733705|Pain|pain
4781209|NCT02733705|TRUS biopsy|trus biopsy
4781210|NCT02733692|HIV|hiv
4781211|NCT02733692|STDs|stds
4781212|NCT02733692|web-based app|web-based app
4781214|NCT02733666|Absorbable screw|absorbable screw
4781215|NCT02733666|Internal fixation|internal fixation
4781216|NCT02733666|Children|children
4781217|NCT02733653|Superficial Femoral Artery|superficial femoral artery
4781218|NCT02733653|Proximal Popliteal Artery|proximal popliteal artery
4781219|NCT02733653|Endovascular therapy|endovascular therapy
4781220|NCT02733653|Atherectomy|atherectomy
4781221|NCT02733601|breast cancer epidemiology algeria registry|breast cancer epidemiology algeria registry
4781222|NCT02733588|hypoglycemia|hypoglycemia
4781223|NCT02733588|glucagon|glucagon
4781224|NCT02733588|glucose metabolism disorders|glucose metabolism disorders
4781225|NCT02733588|hormones|hormones
4781226|NCT02733588|gastrointestinal agents|gastrointestinal agents
4781227|NCT02733588|bariatric surgery|bariatric surgery
4781228|NCT02733588|incretins|incretins
4781229|NCT02733536|endotracheal intubation|endotracheal intubation
4781230|NCT02733536|trauma|trauma
4781231|NCT02733536|paramedic|paramedic
4781232|NCT02733510|kidney transplantation|kidney transplantation
4781233|NCT02733510|subclinical rejection|subclinical rejection
4781234|NCT02733510|steroid pulse therapy|steroid pulse therapy
4781235|NCT02733497|sympathectomy, sympathicotomy, heart rate variability,|sympathectomy, sympathicotomy, heart rate variability,
4781236|NCT02733484|Obesity,Probiotics,Treatment|obesity,probiotics,treatment
4781237|NCT02733471|Lidocaine|lidocaine
4781238|NCT02733471|Endoscopy|endoscopy
4781239|NCT02733471|Tolerance|tolerance
4781240|NCT02733393|Thoracotomy|thoracotomy
4781241|NCT02733393|Postoperative|postoperative
4781242|NCT02733393|Lidocaine|lidocaine
4781243|NCT02733393|Sphenopalatine Ganglion Block|sphenopalatine ganglion block
4781244|NCT02733380|Diffuse Large B-Cell Lymphoma|diffuse large b-cell lymphoma
4781245|NCT02733380|Relapsed and refractory|relapsed and refractory
4781246|NCT02733380|Histone deacetylase inhibitor|histone deacetylase inhibitor
4781247|NCT02733380|Chidamide|chidamide
4781248|NCT02733341|Adenosine Diphosphate|adenosine diphosphate
4781249|NCT02733341|Cardiovascular Magnetic Resonance (CMR)|cardiovascular magnetic resonance (cmr)
4781250|NCT02733341|Index of microvascular resistance (IMR)|index of microvascular resistance (imr)
4781251|NCT02733341|Vasodilator stimulated phosphoprotein phosphorylation (VASP)|vasodilator stimulated phosphoprotein phosphorylation (vasp)
4781252|NCT02733341|Pharmacodynamic|pharmacodynamic
4781253|NCT02733341|Antiplatelet|antiplatelet
4781254|NCT02733341|Myocardial Infarction (MI)|myocardial infarction (mi)
4781255|NCT02733341|Cangrelor|cangrelor
4781256|NCT02733341|Ticagrelor|ticagrelor
4781257|NCT02733341|Coronary artery bypass graft (CABG)|coronary artery bypass graft (cabg)
4781258|NCT02733341|Primary percutaneous coronary intervention (PPCI)|primary percutaneous coronary intervention (ppci)
4781259|NCT02733328|Cardio-pulmonary bypass (CPB)|cardio-pulmonary bypass (cpb)
4781260|NCT02733328|renal replacement therapy (RRT)|renal replacement therapy (rrt)
4781261|NCT02733328|enzyme-linked immunosorbent assay (ELISA)|enzyme-linked immunosorbent assay (elisa)
4781262|NCT02733263|gut microbiota|gut microbiota
4781263|NCT02733263|fiber|fiber
4781264|NCT02733263|diet quality|diet quality
4781265|NCT02733263|immunity|immunity
4781266|NCT02733250|NSCLC|nsclc
4781267|NCT02733250|Pembrolizumab|pembrolizumab
4781268|NCT02733250|Nab-paclitaxel|nab-paclitaxel
4781269|NCT02733237|oxytocin|oxytocin
4781270|NCT02733237|infidelity|infidelity
4781271|NCT02733224|lenalidomide adherence MEMS|lenalidomide adherence mems
4781272|NCT02733211|Closed Loop|closed loop
4781273|NCT02733185|chelation|chelation
4781274|NCT02733172|Vulvodynia|vulvodynia
4781275|NCT02733172|Endophenotypes|endophenotypes
4781276|NCT02733172|functional MRI|functional mri
4781277|NCT02733159|Performance Status 2|performance status 2
4781278|NCT02733159|Pembrolizumab|pembrolizumab
4781279|NCT02733159|MK-3475|mk-3475
4781280|NCT02733133|Testosterone|testosterone
4781281|NCT02733133|AndroGel|androgel
4781282|NCT02733133|Transference|transference
4781283|NCT02733133|Women|women
4781284|NCT02733133|Children|children
4781285|NCT02733107|Non-small Cell Lung Cancer|non-small cell lung cancer
4781286|NCT02733107|Apatinib|apatinib
4781287|NCT02733107|Etoposide|etoposide
4781288|NCT02733081|Long Acting Reversible Contraception|long acting reversible contraception
4781289|NCT02733081|Intrauterine Device (IUD)|intrauterine device (iud)
4781290|NCT02733081|Intrauterine Device (IUD) Insertion|intrauterine device (iud) insertion
4781291|NCT02733081|Family Planning|family planning
4781292|NCT02733081|International Family Planning|international family planning
4781293|NCT02733055|Postural Equilibrium|postural equilibrium
4781294|NCT02733055|Musculoskeletal Equilibrium|musculoskeletal equilibrium
4781295|NCT02733055|Eye Movements|eye movements
4781296|NCT02733055|Saccades|saccades
4781297|NCT02733055|Pursuit, Smooth|pursuit, smooth
4781298|NCT02733042|Lymphoma|lymphoma
4781299|NCT02733042|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
4781300|NCT02733042|Durvalumab|durvalumab
4781301|NCT02733042|Anti-PD-L1 Antibody|anti-pd-l1 antibody
4781302|NCT02733042|MEDI4736|medi4736
4781303|NCT02733042|Immune Checkpoint|immune checkpoint
4781304|NCT02733042|Lymphatic Disease|lymphatic disease
4781305|NCT02733042|B-Cell Malignancies|b-cell malignancies
4781306|NCT02733042|Abscopal Effect|abscopal effect
4781307|NCT02733042|Lenalidomide|lenalidomide
4781308|NCT02733042|Bendamustine|bendamustine
4781309|NCT02733042|Rituximab|rituximab
4781310|NCT02733042|Ibrutinib|ibrutinib
4781311|NCT02733042|Lymphoma, B-Cell|lymphoma, b-cell
4781312|NCT02733042|Lymphoma, Non Hodgkin,|lymphoma, non hodgkin,
4781313|NCT02733042|Hodgkin Disease|hodgkin disease
4781314|NCT02733042|Leukemia, Lymphocytic, Chronic, B-Cell,|leukemia, lymphocytic, chronic, b-cell,
4781315|NCT02733042|Lymphoma, Follicular|lymphoma, follicular
4781316|NCT02733042|Lymphoma, Diffuse Large B-Cell|lymphoma, diffuse large b-cell
4781317|NCT02733042|Lymphoma, Mantle Cell|lymphoma, mantle cell
4781318|NCT02733042|Lymphoma, Small Lymphocytic|lymphoma, small lymphocytic
4781319|NCT02733042|Immune System Diseases|immune system diseases
4781320|NCT02733042|Immunoproliferative Disorders|immunoproliferative disorders
4781321|NCT02733042|Lymphoproliferative Disorders|lymphoproliferative disorders
4781322|NCT02733003|Implementation Science|implementation science
4781323|NCT02733003|HIV|hiv
4781324|NCT02733003|Sexual Risk|sexual risk
4781325|NCT02733003|Sexually Transmitted Diseases|sexually transmitted diseases
4781326|NCT02733003|Substance Abuse|substance abuse
4781327|NCT02733003|Violence and Victimization|violence and victimization
4781328|NCT02733003|Linkage to care|linkage to care
4781329|NCT02733003|Gender-based Violence|gender-based violence
4781330|NCT02733003|Antiretroviral Therapy (ART)|antiretroviral therapy (art)
4781331|NCT02732990|Training|training
4781332|NCT02732990|One-legged exercise|one-legged exercise
4781333|NCT02732990|Peripheral blood flow|peripheral blood flow
4781334|NCT02732990|Cardiac function|cardiac function
4781335|NCT02732990|Muscle metaboreflex|muscle metaboreflex
4781336|NCT02732964|satisfaction|satisfaction
4781337|NCT02732938|CCR2i, nab-paclitaxel, Abraxane, gemcitabine, pancreas|ccr2i, nab-paclitaxel, abraxane, gemcitabine, pancreas
4781338|NCT02732925|Vertebral Compression Fracture|vertebral compression fracture
4781339|NCT02732925|Balloon Kyphoplasty|balloon kyphoplasty
4781340|NCT02732925|Conservative treatment|conservative treatment
4781341|NCT02732925|Sham procedure|sham procedure
4781342|NCT02732925|VCFs|vcfs
4781343|NCT02732925|Multiple Myeloma|multiple myeloma
4781344|NCT02732912|falls|falls
4781345|NCT02732912|sleep|sleep
4781346|NCT02732899|AMD|amd
4781347|NCT02732886|foam dressing|foam dressing
4781442|NCT02732262|surgery|surgery
4781348|NCT02732860|personalized patient-derived xenografts (pPDX)|personalized patient-derived xenografts (ppdx)
4781349|NCT02732860|molecular profiling|molecular profiling
4781350|NCT02732860|epigenetic analysis|epigenetic analysis
4781351|NCT02732860|drug sensitivity testing|drug sensitivity testing
4781352|NCT02732860|triple negative|triple negative
4781353|NCT02732860|metastatic|metastatic
4781354|NCT02732860|serous|serous
4781355|NCT02732847|Respiratory infections|respiratory infections
4781356|NCT02732847|Primary care|primary care
4781357|NCT02732847|Antibiotics|antibiotics
4781358|NCT02732847|Delayed prescriptions|delayed prescriptions
4781359|NCT02732834|Clinician-Patient Communication|clinician-patient communication
4781360|NCT02732834|16-001|16-001
4781361|NCT02732821|Gastroparesis|gastroparesis
4781362|NCT02732821|G-POEM|g-poem
4781363|NCT02732821|Gastric Per Oral Endoscopic Myotomy|gastric per oral endoscopic myotomy
4781364|NCT02732808|Double stimulations|double stimulations
4781365|NCT02732808|luteal-phase ovarian stimulation|luteal-phase ovarian stimulation
4781366|NCT02732808|poor ovarian response|poor ovarian response
4781367|NCT02732782|Achilles tendon|achilles tendon
4781368|NCT02732782|isometric muscle training|isometric muscle training
4781369|NCT02732782|competitive sports|competitive sports
4781370|NCT02732782|strength training|strength training
4781371|NCT02732782|eccentric exercise|eccentric exercise
4781372|NCT02732782|isometric exercise|isometric exercise
4781373|NCT02732782|chronic condition|chronic condition
4781374|NCT02732782|regeneration|regeneration
4781375|NCT02732782|tendon|tendon
4781376|NCT02732782|tendon properties|tendon properties
4781377|NCT02732782|tendinopathy|tendinopathy
4781378|NCT02732782|tendinosis|tendinosis
4781379|NCT02732782|intervention|intervention
4781380|NCT02732782|training load|training load
4781381|NCT02732782|high performance sports|high performance sports
4781382|NCT02732756|ADHD|adhd
4781383|NCT02732756|Sleep|sleep
4781384|NCT02732756|Attention|attention
4781385|NCT02732756|Adolescence|adolescence
4781386|NCT02732743|childhod constipation|childhod constipation
4781387|NCT02732730|ART (Antir-retroviral therapy)|art (antir-retroviral therapy)
4781388|NCT02732730|PrEP (Pre-Exposure Prophylaxis)|prep (pre-exposure prophylaxis)
4781389|NCT02732730|DAIDS (Division of AIDS)|daids (division of aids)
4781390|NCT02732730|HPTN (HIV Prevention Trials Network)|hptn (hiv prevention trials network)
4781391|NCT02732704|Aortic Valve Disease|aortic valve disease
4781392|NCT02732704|Aortic Regurgitation|aortic regurgitation
4781393|NCT02732691|Aortic Valve Disease|aortic valve disease
4781394|NCT02732691|Aortic Valve Stenosis|aortic valve stenosis
4781395|NCT02732613|Laryngeal Mask Airway|laryngeal mask airway
4781396|NCT02732613|Body weight|body weight
4781397|NCT02732613|Complication|complication
4781398|NCT02732600|Veterans|veterans
4781399|NCT02732600|Veterans Health|veterans health
4781400|NCT02732600|Patient Compliance|patient compliance
4781401|NCT02732600|Primary Health Care|primary health care
4781402|NCT02732600|Health Care Providers|health care providers
4781403|NCT02732600|Health Promotion|health promotion
4781404|NCT02732522|misoprostol|misoprostol
4781405|NCT02732522|induction of labor|induction of labor
4781406|NCT02732522|sublingual|sublingual
4781407|NCT02732496|Attention-Deficit/Hyperactivity Disorder|attention-deficit/hyperactivity disorder
4781408|NCT02732496|Tourette Syndrome|tourette syndrome
4781409|NCT02732496|Working Memory Training|working memory training
4781410|NCT02732483|gastric cancer|gastric cancer
4781411|NCT02732483|bleeding|bleeding
4781412|NCT02732483|gastrointestinal hemorrhage|gastrointestinal hemorrhage
4781413|NCT02732470|Systemic Lupus Erythematous|systemic lupus erythematous
4781414|NCT02732470|Qi Gong|qi gong
4781415|NCT02732470|Quality of life|quality of life
4781416|NCT02732457|HIV|hiv
4781417|NCT02732457|Persistence|persistence
4781418|NCT02732457|Reservoirs|reservoirs
4781419|NCT02732457|Stem Cell Transplant|stem cell transplant
4781420|NCT02732457|Functional Cure|functional cure
4781421|NCT02732444|Erythrocytes Membranes Stability|erythrocytes membranes stability
4781422|NCT02732444|Oxidative Stress|oxidative stress
4781423|NCT02732444|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
4781424|NCT02732444|Advanced Pulmonary Disease (APD)|advanced pulmonary disease (apd)
4781425|NCT02732444|Long-Term Home Oxygen Therapy (LTOT)|long-term home oxygen therapy (ltot)
4781426|NCT02732418|CI-contraceptive injection|ci-contraceptive injection
4781427|NCT02732418|DMPA-Depot medroxyprogesterone acetate|dmpa-depot medroxyprogesterone acetate
4781428|NCT02732418|MPA-Medroxyprogesterone Acetate|mpa-medroxyprogesterone acetate
4781429|NCT02732418|subQ-subcutaneous|subq-subcutaneous
4781430|NCT02732379|Postoperative Nausea and Vomiting|postoperative nausea and vomiting
4781431|NCT02732379|Aromatherapy|aromatherapy
4781432|NCT02732379|Quality of Health Care|quality of health care
4781433|NCT02732366|aged [MeSH term]|aged [mesh term]
4781434|NCT02732366|exercise [MeSH term]|exercise [mesh term]
4781435|NCT02732340|triple-branched stent graft|triple-branched stent graft
4781436|NCT02732340|the occluded rate of false lumen|the occluded rate of false lumen
4781437|NCT02732275|Relapsed non-hodgkin lymphoma.|relapsed non-hodgkin lymphoma.
4781438|NCT02732275|phase 1|phase 1
4781439|NCT02732275|oncology|oncology
4781440|NCT02732262|acute pain|acute pain
4781441|NCT02732262|postoperative|postoperative
4781443|NCT02732249|Helicobacter pylori|helicobacter pylori
4781444|NCT02732249|Clarithromycin|clarithromycin
4781445|NCT02732249|Amoxicillin|amoxicillin
4781446|NCT02732249|Metronidazole|metronidazole
4781447|NCT02732249|Eradication|eradication
4781448|NCT02732236|marginal zone lymphoma|marginal zone lymphoma
4781449|NCT02732236|Cohort|cohort
4781450|NCT02732236|Rituximab|rituximab
4781451|NCT02732236|HBV|hbv
4781452|NCT02732223|Atherosclerosis|atherosclerosis
4781453|NCT02732223|omega 3|omega 3
4781454|NCT02732223|plant sterols|plant sterols
4781455|NCT02732223|polyphenols|polyphenols
4781457|NCT02732184|MDS|mds
4781458|NCT02732158|Novel laboratory methods|novel laboratory methods
4781459|NCT02732145|Three-Vulvar-Rings|three-vulvar-rings
4781460|NCT02732145|Three-Rings-Vulvoscopy|three-rings-vulvoscopy
4781461|NCT02732145|N-S-P scheme|n-s-p scheme
4781462|NCT02732145|Vulvoscopy Index|vulvoscopy index
4781463|NCT02732145|Vulvar Dermatosis|vulvar dermatosis
4781464|NCT02732145|Vulvar Lichen Sclerosus|vulvar lichen sclerosus
4781465|NCT02732145|Lichen Planus|lichen planus
4781466|NCT02732145|Lichen Simplex Chronicus|lichen simplex chronicus
4781467|NCT02732145|Vulvodynia|vulvodynia
4781468|NCT02732145|Provoked Vestibulodynia|provoked vestibulodynia
4781469|NCT02732145|Vulvar Vestibulitis|vulvar vestibulitis
4781470|NCT02732145|Vulvar Diseases|vulvar diseases
4781471|NCT02732119|HR-positive|hr-positive
4781472|NCT02732119|HER2-negative|her2-negative
4781473|NCT02732119|Advanced breast cancer|advanced breast cancer
4781474|NCT02732119|LEE011|lee011
4781475|NCT02732119|ribociclib|ribociclib
4781476|NCT02732119|everolimus|everolimus
4781477|NCT02732119|Afinitor|afinitor
4781478|NCT02732119|exemestane|exemestane
4781479|NCT02732119|Aromasin|aromasin
4781480|NCT02732119|CDK|cdk
4781481|NCT02732119|CDK4|cdk4
4781482|NCT02732119|CDK6|cdk6
4781483|NCT02732119|CDK4/6|cdk4/6
4781484|NCT02732119|CDK4/6 inhibitor|cdk4/6 inhibitor
4781485|NCT02732119|Phase III|phase iii
4781486|NCT02732119|ER-positive|er-positive
4781487|NCT02732119|PR-positive|pr-positive
4781488|NCT02732119|Postmenopausal|postmenopausal
4781489|NCT02732106|ADRCs, cell characterization|adrcs, cell characterization
4781490|NCT02732080|primary percutaneous coronary intervention|primary percutaneous coronary intervention
4781491|NCT02732080|microvascular obstruction|microvascular obstruction
4781492|NCT02732080|myocardial edema|myocardial edema
4781493|NCT02732080|microvascular resistance|microvascular resistance
4781494|NCT02732080|acute myocardial infarction|acute myocardial infarction
4781495|NCT02732067|Anesthesia|anesthesia
4781496|NCT02732054|HBV vaccination, immunity|hbv vaccination, immunity
4781497|NCT02732015|Sarcoma|sarcoma
4781498|NCT02732015|Locally advanced|locally advanced
4781499|NCT02732015|High risk for relapse|high risk for relapse
4781500|NCT02732015|Metastatic|metastatic
4781501|NCT02732015|Questionnaires|questionnaires
4781502|NCT02732015|Surveys|surveys
4781503|NCT02732015|Rolapitant|rolapitant
4781504|NCT02732015|Fosaprepitant|fosaprepitant
4781505|NCT02732015|Dexamethasone|dexamethasone
4781506|NCT02732015|Decadron|decadron
4781507|NCT02732015|Ondansetron|ondansetron
4781508|NCT02732015|Zofran|zofran
4781509|NCT02732015|Doxorubicin|doxorubicin
4781510|NCT02732015|Adriamycin PFS|adriamycin pfs
4781511|NCT02732015|Adriamycin RDF|adriamycin rdf
4781512|NCT02732015|Rubex|rubex
4781513|NCT02732015|Mesna|mesna
4781514|NCT02732015|Mesnex|mesnex
4781515|NCT02732015|Ifosfamide|ifosfamide
4781516|NCT02732015|Ifex|ifex
4781517|NCT02732015|Vincristine|vincristine
4781518|NCT02732015|Nausea|nausea
4781519|NCT02732015|Vomiting|vomiting
4781520|NCT02732002|shoulder|shoulder
4781521|NCT02732002|rotator cuff- injury|rotator cuff- injury
4781522|NCT02732002|management|management
4781523|NCT02732002|rehabilitation model|rehabilitation model
4781524|NCT02731976|Gluten-Free diet|gluten-free diet
4781525|NCT02731976|Healthy individuals|healthy individuals
4781526|NCT02731963|Outcomes|outcomes
4781527|NCT02731963|Bowel preparation|bowel preparation
4781528|NCT02731950|Sternotomy , cardiac surgery , pain|sternotomy , cardiac surgery , pain
4781529|NCT02731924|Appendicitis|appendicitis
4781530|NCT02731924|Ultrasound|ultrasound
4781531|NCT02731924|Emergency Department|emergency department
4781532|NCT02731872|COPD|copd
4781533|NCT02731872|oxygen treatment|oxygen treatment
4781534|NCT02731872|quality of life|quality of life
4781535|NCT02731846|Efficacy|efficacy
4781536|NCT02731846|Triple therapy|triple therapy
4781537|NCT02731846|Parallel|parallel
4781538|NCT02731846|Respiratory|respiratory
4781539|NCT02731820|potassium citrate|potassium citrate
4781540|NCT02731807|TA-65|ta-65
4781541|NCT02731807|Telemorase|telemorase
4781542|NCT02731807|Dietary Supplement|dietary supplement
4781543|NCT02731794|cardiopulmonary bypass|cardiopulmonary bypass
4781544|NCT02731794|coronary artery bypass grafting|coronary artery bypass grafting
4781545|NCT02731794|inflammatory response|inflammatory response
4781546|NCT02731794|cardiac dysfunction|cardiac dysfunction
4781547|NCT02731781|OUTCOME|outcome
4781548|NCT02731781|PROGNOSIS|prognosis
4781549|NCT02731781|PEDIATRIC HEAd injury|pediatric head injury
4781550|NCT02731781|CT SCAN|ct scan
4781551|NCT02731755|Oats|oats
4781552|NCT02731755|Phenolic acid|phenolic acid
4781553|NCT02731755|FMD|fmd
4781554|NCT02731755|LDI|ldi
4781555|NCT02731755|Renin angiotensin|renin angiotensin
4781556|NCT02731755|Nitric oxide|nitric oxide
4781557|NCT02731729|Ipilimumab|ipilimumab
4781558|NCT02731729|Nivolumab|nivolumab
4781559|NCT02731729|Stage III-IV Melanoma|stage iii-iv melanoma
4781560|NCT02731729|Progressed or Relapsed on PD-1 Inhibitor Therapy|progressed or relapsed on pd-1 inhibitor therapy
4781561|NCT02731729|16-043|16-043
4781562|NCT02731703|overdenture|overdenture
4781563|NCT02731703|overlay|overlay
4781564|NCT02731703|implant supported|implant supported
4781565|NCT02731703|denture|denture
4781566|NCT02731703|dental prosthesis|dental prosthesis
4781567|NCT02731703|maxillary|maxillary
4781568|NCT02731690|GNE Myopathy|gne myopathy
4781569|NCT02731690|Nonaka|nonaka
4781570|NCT02731690|GNEM|gnem
4781571|NCT02731690|Hereditary Inclusion Body Myopathy|hereditary inclusion body myopathy
4781572|NCT02731690|HIBM|hibm
4781573|NCT02731690|DMRV|dmrv
4781574|NCT02731690|QSM|qsm
4781575|NCT02731664|Irritable bowel syndrome|irritable bowel syndrome
4781576|NCT02731664|Functional dyspepsia|functional dyspepsia
4781577|NCT02731664|Gastric emptying|gastric emptying
4781578|NCT02731664|Gastrointestinal peptide hormones|gastrointestinal peptide hormones
4781579|NCT02731638|cornea|cornea
4781580|NCT02731638|ulcer|ulcer
4781581|NCT02731638|fungal|fungal
4781582|NCT02731638|keratitis|keratitis
4781583|NCT02731625|Kettlebell training|kettlebell training
4781584|NCT02731625|High-intensity interval training|high-intensity interval training
4781585|NCT02731612|Bipolar Disorder|bipolar disorder
4781586|NCT02731612|Cognition|cognition
4781587|NCT02731612|Euthymic|euthymic
4781588|NCT02731612|Lurasidone|lurasidone
4781589|NCT02731599|Parkinson Disease|parkinson disease
4781590|NCT02731599|treadmill|treadmill
4781591|NCT02731599|Rehabilitation|rehabilitation
4781592|NCT02731586|Dental Implants|dental implants
4781593|NCT02731586|Allogenic mesenchymal stem cells|allogenic mesenchymal stem cells
4781594|NCT02731586|osseointegration|osseointegration
4781595|NCT02731586|primary stability|primary stability
4781596|NCT02731586|resonance frequency analysis|resonance frequency analysis
4781597|NCT02731586|RFA|rfa
4781598|NCT02731586|implants and stem cells|implants and stem cells
4781599|NCT02731586|use of stem cells|use of stem cells
4781600|NCT02731586|stem cells|stem cells
4781601|NCT02731573|Mediastenitis|mediastenitis
4781602|NCT02731560|Pakistan, Rituximab|pakistan, rituximab
4781603|NCT02731560|RA|ra
4781604|NCT02731521|MRS Biomarkers|mrs biomarkers
4781605|NCT02731508|Transcranial Direct Current Stimulation|transcranial direct current stimulation
4781606|NCT02731508|Neuroplasticity|neuroplasticity
4781607|NCT02731482|Bronchiectasis|bronchiectasis
4781608|NCT02731482|Rehabilitation|rehabilitation
4781609|NCT02731482|Quality of Life|quality of life
4781610|NCT02731482|Physiotherapy Specialty|physiotherapy specialty
4781611|NCT02731456|high altitude|high altitude
4781612|NCT02731456|cognition|cognition
4781613|NCT02731456|sleep|sleep
4781614|NCT02731443|dreaming|dreaming
4781615|NCT02731443|epilepsy|epilepsy
4781616|NCT02731443|neurosurgery|neurosurgery
4781617|NCT02731443|temporal lobectomy|temporal lobectomy
4781618|NCT02731378|erythropoietin|erythropoietin
4781619|NCT02731378|iron supplementation|iron supplementation
4781620|NCT02731378|inadequately responsive|inadequately responsive
4781621|NCT02731378|chemotherapy-induced anaemia|chemotherapy-induced anaemia
4781622|NCT02731365|Parkinson's Disease|parkinson's disease
4781623|NCT02731300|Transcranial direct current stimulation|transcranial direct current stimulation
4781624|NCT02731300|Cathodal stimulation|cathodal stimulation
4781625|NCT02731300|Childhood Pharmacoresistant epilepsy|childhood pharmacoresistant epilepsy
4781626|NCT02731300|Lennox-Gastaut syndrome|lennox-gastaut syndrome
4781627|NCT02731235|Stroke|stroke
4781628|NCT02731235|stroke, acute|stroke, acute
4781629|NCT02731235|Cerebral small vessel disease|cerebral small vessel disease
4781630|NCT02731222|CEAP classification|ceap classification
4781631|NCT02731222|CVD: Chronic Venous Disease|cvd: chronic venous disease
4781632|NCT02731222|Onychodystrophy|onychodystrophy
4781633|NCT02731222|Body Mass Index|body mass index
4781634|NCT02731196|exercise|exercise
4781635|NCT02731196|lumbar microdiscectomy|lumbar microdiscectomy
4781636|NCT02731183|Fecal Microbiota Transplantation|fecal microbiota transplantation
4781637|NCT02731183|Chronic intestinal pseudo obstruction|chronic intestinal pseudo obstruction
4781638|NCT02731183|Efficacy and safety|efficacy and safety
4781639|NCT02731170|Parkinson Disease|parkinson disease
4781640|NCT02731170|Advanced Stages|advanced stages
4781641|NCT02731170|Rehabilitation|rehabilitation
4781642|NCT02731144|Loss of Physical Function|loss of physical function
4781643|NCT02731118|glaucoma|glaucoma
4781644|NCT02731118|intraocular pressure lowering treatment|intraocular pressure lowering treatment
4781645|NCT02731118|antisectory factor (AF)|antisectory factor (af)
4781646|NCT02731118|Salovum|salovum
4781647|NCT02731105|acne|acne
4781648|NCT02731105|vulgaris|vulgaris
4781649|NCT02731105|Clindamycin|clindamycin
4781650|NCT02731105|Tretinoin|tretinoin
4781651|NCT02731105|Adapalen|adapalen
4781652|NCT02731105|Benzoylperoxid|benzoylperoxid
4781653|NCT02731105|Epiduo|epiduo
4781654|NCT02731105|Acnatac|acnatac
4781655|NCT02731092|lactoferrin|lactoferrin
4781656|NCT02731092|very low birth weight infants|very low birth weight infants
4781657|NCT02731092|preterm infants|preterm infants
4781658|NCT02731079|Sleeve gastrectomy stapler Covidien Ethicon bleeding leak|sleeve gastrectomy stapler covidien ethicon bleeding leak
4781659|NCT02731053|Depression|depression
4781660|NCT02731053|Prevention|prevention
4781661|NCT02731053|Adolescents|adolescents
4781662|NCT02731053|School|school
4781663|NCT02731053|Effectiveness|effectiveness
4781664|NCT02731014|Dry Needling|dry needling
4781665|NCT02730975|pharmacokinetics|pharmacokinetics
4781666|NCT02730975|food-effect|food-effect
4781667|NCT02730975|fat diet|fat diet
4781668|NCT02730975|abiraterone acetate|abiraterone acetate
4781669|NCT02730949|D-Chiro-Inositol, type 1 diabetes|d-chiro-inositol, type 1 diabetes
4781670|NCT02730923|Clinical Trials, Randomized|clinical trials, randomized
4781671|NCT02730923|Clinical Trial, Phase I|clinical trial, phase i
4781672|NCT02730923|Clinical Trial, Phase II|clinical trial, phase ii
4781673|NCT02730923|Multicenter Trials|multicenter trials
4781674|NCT02730923|Aromatase Inhibitors|aromatase inhibitors
4781675|NCT02730923|mTOR kinase inhibitor|mtor kinase inhibitor
4781676|NCT02730910|Bioavailability|bioavailability
4781677|NCT02730910|adults|adults
4781678|NCT02730897|Surgery|surgery
4781679|NCT02730897|Thoracotomy|thoracotomy
4781680|NCT02730897|VATS|vats
4781681|NCT02730884|Leukemia|leukemia
4781682|NCT02730884|Myelofibrosis|myelofibrosis
4781683|NCT02730884|MF|mf
4781684|NCT02730884|Anemia|anemia
4781685|NCT02730884|Splenomegaly|splenomegaly
4781686|NCT02730884|Post-polycythemia vera MF|post-polycythemia vera mf
4781687|NCT02730884|post-PV|post-pv
4781688|NCT02730884|post-essential thrombocythemia MF|post-essential thrombocythemia mf
4781689|NCT02730884|post-ET|post-et
4781690|NCT02730884|Rigosertib|rigosertib
4781691|NCT02730884|ON 01910.Na|on 01910.na
4781692|NCT02730884|Questionnaire|questionnaire
4781693|NCT02730884|Survey|survey
4781694|NCT02730858|Metastatic Breast Cancer|metastatic breast cancer
4781695|NCT02730858|Palliative Care|palliative care
4781696|NCT02730858|Breast Cancer|breast cancer
4781697|NCT02730858|End of life|end of life
4781698|NCT02730858|Health service research|health service research
4781699|NCT02730845|Elective|elective
4781700|NCT02730845|local anesthesia|local anesthesia
4781701|NCT02730845|knee arthroscopy|knee arthroscopy
4781702|NCT02730845|Dexmedetomidine|dexmedetomidine
4781703|NCT02730793|Cystic Fibrosis|cystic fibrosis
4781704|NCT02730793|P. aeruginosa (PA)|p. aeruginosa (pa)
4781705|NCT02730754|Mood Disorders|mood disorders
4781706|NCT02730754|Illness Perception|illness perception
4781707|NCT02730754|Primary Care|primary care
4781708|NCT02730754|Medication Adherence|medication adherence
4781709|NCT02730741|diarrhoea|diarrhoea
4781710|NCT02730741|metfomin|metfomin
4781711|NCT02730741|type 2 diabetes|type 2 diabetes
4781712|NCT02730741|microbiota|microbiota
4781713|NCT02730728|adductor canal block|adductor canal block
4781714|NCT02730728|tinetti score|tinetti score
4781715|NCT02730728|time to up and go test|time to up and go test
4781716|NCT02730728|Ambulation distance|ambulation distance
4781717|NCT02730728|pain score|pain score
4781718|NCT02730728|quality of recovery score|quality of recovery score
4781719|NCT02730689|DP-R207|dp-r207
4781720|NCT02730689|Rosuvastatin|rosuvastatin
4781721|NCT02730689|Ezetimibe|ezetimibe
4781722|NCT02730676|electronic cigarettes|electronic cigarettes
4781723|NCT02730676|e-cigarette|e-cigarette
4781724|NCT02730676|combustible cigarette|combustible cigarette
4781725|NCT02730676|cigarette|cigarette
4781726|NCT02730676|menthol|menthol
4781727|NCT02730676|cig-alike|cig-alike
4781728|NCT02730676|subjective measures|subjective measures
4781729|NCT02730676|pharmacokinetics|pharmacokinetics
4781730|NCT02730676|craving|craving
4781731|NCT02730663|Endoscopic ultrasound guided transluminal drainage|endoscopic ultrasound guided transluminal drainage
4781732|NCT02730650|FACE-Q|face-q
4781733|NCT02730650|Platelet Rich Therapy|platelet rich therapy
4781734|NCT02730650|PRT|prt
4781735|NCT02730624|piperacillin/tazobactam|piperacillin/tazobactam
4781736|NCT02730624|critically ill|critically ill
4781737|NCT02730624|severe sepsis|severe sepsis
4781738|NCT02730624|septic shock|septic shock
4781739|NCT02730611|Vertical sleeve gastrectomy|vertical sleeve gastrectomy
4781740|NCT02730611|Metabolic syndrome|metabolic syndrome
4781741|NCT02730611|Disorder of Bile Acid and Cholesterol Metabolism|disorder of bile acid and cholesterol metabolism
4781742|NCT02730611|Cholangiocarcinoma|cholangiocarcinoma
4781743|NCT02730611|Hepatocellular carcinoma|hepatocellular carcinoma
4781744|NCT02730585|C-reactive protein|c-reactive protein
4781745|NCT02730572|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
4781746|NCT02730572|Methylphenidate|methylphenidate
4781747|NCT02730559|Motivational Interviewing|motivational interviewing
4781748|NCT02730533|endoscopic submucosal dissection|endoscopic submucosal dissection
4781749|NCT02730533|proton pump inhibitor|proton pump inhibitor
4781750|NCT02730533|bleeding|bleeding
4781751|NCT02730520|respiratory disease|respiratory disease
4781954|NCT02729168|Vaccine|vaccine
4781752|NCT02730520|allergen sensitization|allergen sensitization
4781753|NCT02730520|aging|aging
4781754|NCT02730520|skin tests|skin tests
4781755|NCT02730520|air allergens|air allergens
4781756|NCT02730494|mycosis|mycosis
4781757|NCT02730494|Candidiasis|candidiasis
4781758|NCT02730494|Lcr35®|lcr35®
4781759|NCT02730494|Lcr Regenerans®|lcr regenerans®
4781760|NCT02730455|Stroke|stroke
4781761|NCT02730351|Fluticasone furoate|fluticasone furoate
4781762|NCT02730351|activity monitoring|activity monitoring
4781763|NCT02730351|Vilanterol|vilanterol
4781764|NCT02730351|Cross-over|cross-over
4781765|NCT02730351|exercise-induced bronchoconstriction|exercise-induced bronchoconstriction
4781766|NCT02730351|exercise challenge|exercise challenge
4781767|NCT02730351|double-dummy|double-dummy
4781768|NCT02730351|asthma|asthma
4781769|NCT02730351|spirometry|spirometry
4781770|NCT02730351|fluticasone propionate|fluticasone propionate
4781771|NCT02730338|Castrate-Resistant|castrate-resistant
4781772|NCT02730325|CDI|cdi
4781773|NCT02730325|C. diff|c. diff
4781774|NCT02730325|Ulcerative Colitis|ulcerative colitis
4781775|NCT02730325|UC|uc
4781776|NCT02730325|IBD|ibd
4781777|NCT02730325|Inflammatory Bowel Disease|inflammatory bowel disease
4781778|NCT02730312|AML|aml
4781779|NCT02730312|B-ALL|b-all
4781780|NCT02730312|BPDCN|bpdcn
4781781|NCT02730312|CML|cml
4781782|NCT02730312|Blast Crisis|blast crisis
4781783|NCT02730286|human activity|human activity
4781784|NCT02730286|International Classification of Functioning|international classification of functioning
4781785|NCT02730260|Directive coaching|directive coaching
4781786|NCT02730260|Nondirective coaching|nondirective coaching
4781787|NCT02730260|smoking cessation quitline|smoking cessation quitline
4781788|NCT02730260|social support|social support
4781789|NCT02730247|ramucirumab|ramucirumab
4781790|NCT02730247|docetaxel|docetaxel
4781791|NCT02730221|Administrative workload|administrative workload
4781792|NCT02730221|Patient data management system|patient data management system
4781793|NCT02730221|Intensive Care Unit|intensive care unit
4781794|NCT02730221|Work sampling method|work sampling method
4781795|NCT02730221|Nursing Activity Score|nursing activity score
4781796|NCT02730182|postural control|postural control
4781797|NCT02730182|high altitude|high altitude
4781798|NCT02730169|Hypogonadotropic|hypogonadotropic
4781799|NCT02730169|hypogonadism|hypogonadism
4781800|NCT02730169|testosterone|testosterone
4781801|NCT02730143|Altitude|altitude
4781802|NCT02730143|Nocturnal breathing pattern|nocturnal breathing pattern
4781803|NCT02730130|Pembrolizumab|pembrolizumab
4781804|NCT02730130|Radiotherapy|radiotherapy
4781805|NCT02730130|16-032|16-032
4781806|NCT02730117|Acute kidney injury|acute kidney injury
4781807|NCT02730117|Furosemide stress test|furosemide stress test
4781808|NCT02730117|critical care|critical care
4781809|NCT02730078|Mood Disorders|mood disorders
4781810|NCT02730078|Self Care|self care
4781811|NCT02730078|Primary Care|primary care
4781812|NCT02730065|Cerebral small vessel disease|cerebral small vessel disease
4781813|NCT02730065|Lifestyle modification|lifestyle modification
4781814|NCT02730065|Physical activity|physical activity
4781815|NCT02730065|Primary prevention|primary prevention
4781816|NCT02730065|Aerobic dance|aerobic dance
4781817|NCT02730065|Cognition|cognition
4781818|NCT02730065|Depression|depression
4781819|NCT02730065|Activities of daily living|activities of daily living
4781820|NCT02730065|Cerebral autoregulation|cerebral autoregulation
4781821|NCT02730052|Blood pressure control|blood pressure control
4781822|NCT02730052|Hypertension|hypertension
4781823|NCT02730052|Office blood pressure|office blood pressure
4781824|NCT02730052|Self-measured blood pressure,|self-measured blood pressure,
4781825|NCT02730052|Telemonitoring|telemonitoring
4781826|NCT02730039|Cancer Care Providers|cancer care providers
4781827|NCT02730039|Psychotherapy|psychotherapy
4781828|NCT02730039|15-321|15-321
4781829|NCT02730026|Ketofrofen|ketofrofen
4781830|NCT02730026|Omeprazole|omeprazole
4781831|NCT02730026|Lower Third Molar|lower third molar
4781832|NCT02730026|Oral Surgery|oral surgery
4781833|NCT02730013|Older adults|older adults
4781834|NCT02730013|Square stepping exercise|square stepping exercise
4781835|NCT02730013|Mind-motor exercise|mind-motor exercise
4781836|NCT02730013|Long-term care|long-term care
4781837|NCT02730013|Global cognitive functioning|global cognitive functioning
4781838|NCT02730000|Dental Atraumatic Restorative Treatment|dental atraumatic restorative treatment
4781839|NCT02730000|Primary Teeth|primary teeth
4781840|NCT02730000|Clinical Efficacy|clinical efficacy
4781841|NCT02730000|Cost Analysis|cost analysis
4781842|NCT02730000|Glass Ionomer Cement|glass ionomer cement
4781843|NCT02729987|online|online
4781844|NCT02729987|internet|internet
4781846|NCT02729987|Stress|stress
4781847|NCT02729987|Work|work
4781848|NCT02729987|Internet based treatment|internet based treatment
4781849|NCT02729974|thromboelastography|thromboelastography
4781850|NCT02729935|Parecoxib|parecoxib
4781851|NCT02729935|Bladder Discomfort|bladder discomfort
4781852|NCT02729909|Drug therapy|drug therapy
4781853|NCT02729870|Ketones|ketones
4781854|NCT02729870|Gastroenteritis|gastroenteritis
4781855|NCT02729844|Incidence|incidence
4781856|NCT02729844|Risk factors|risk factors
4781857|NCT02729844|Outcome|outcome
4781858|NCT02729831|decision making|decision making
4781859|NCT02729831|decision aids|decision aids
4781860|NCT02729831|decision quality instruments|decision quality instruments
4781861|NCT02729831|osteoarthritis|osteoarthritis
4781862|NCT02729831|shared decision making|shared decision making
4781863|NCT02729818|Retina|retina
4781864|NCT02729818|Microperimetry|microperimetry
4781865|NCT02729818|Visual Fields|visual fields
4781866|NCT02729805|ketamine|ketamine
4781867|NCT02729805|chronic pain|chronic pain
4781868|NCT02729805|mastectomy|mastectomy
4781869|NCT02729805|acute pain|acute pain
4781870|NCT02729792|depression|depression
4781871|NCT02729792|treatment resistance|treatment resistance
4781872|NCT02729792|biomarkers|biomarkers
4781873|NCT02729792|repetitive transcranial magnetic stimulation|repetitive transcranial magnetic stimulation
4781874|NCT02729766|Hyponatremia|hyponatremia
4781875|NCT02729766|SGLT2 inhibitor|sglt2 inhibitor
4781876|NCT02729740|Penumbra Smart coils|penumbra smart coils
4781877|NCT02729740|PC 400|pc 400
4781878|NCT02729740|AV malformations|av malformations
4781879|NCT02729740|AV fistulae|av fistulae
4781880|NCT02729688|Venous insufficiency|venous insufficiency
4781881|NCT02729688|Compression|compression
4781882|NCT02729688|Bandaging|bandaging
4781883|NCT02729675|fruit & vegetable, market, education, worksite, food access|fruit & vegetable, market, education, worksite, food access
4781884|NCT02729597|neuromuscular disorders|neuromuscular disorders
4781885|NCT02729597|MRI|mri
4781886|NCT02729597|white matter|white matter
4781887|NCT02729597|brain|brain
4781888|NCT02729597|myotonic dystrophy|myotonic dystrophy
4781889|NCT02729558|brain metastases|brain metastases
4781890|NCT02729558|radiotherapy|radiotherapy
4781891|NCT02729558|resection|resection
4781892|NCT02729545|acupuncture, POCS|acupuncture, pocs
4781893|NCT02729532|Extra-pulmonary tuberculosis|extra-pulmonary tuberculosis
4781894|NCT02729532|multiple drug resistant tuberculosis|multiple drug resistant tuberculosis
4781895|NCT02729532|mycobacterium tuberculosis|mycobacterium tuberculosis
4781896|NCT02729532|human immunodeficiency virus|human immunodeficiency virus
4781897|NCT02729506|hepatocellular carcinoma|hepatocellular carcinoma
4781898|NCT02729506|transarterial radioembolization|transarterial radioembolization
4781899|NCT02729506|chemoembolization chemoembolization|chemoembolization chemoembolization
4781900|NCT02729506|clinical trial|clinical trial
4781901|NCT02729493|Liver Cancer CAR-T|liver cancer car-t
4781902|NCT02729467|Healthy|healthy
4781903|NCT02729467|JNJ-53718678|jnj-53718678
4781904|NCT02729467|Itraconazole|itraconazole
4781905|NCT02729467|Rifampicin|rifampicin
4781906|NCT02729467|Pharmacokinetics|pharmacokinetics
4781907|NCT02729428|Aging|aging
4781908|NCT02729428|White Matter Hyperintensity Volume|white matter hyperintensity volume
4781909|NCT02729428|Default Mode Network Connectivity|default mode network connectivity
4781910|NCT02729428|Cognitive Function|cognitive function
4781911|NCT02729428|Cardiorespiratory Fitness|cardiorespiratory fitness
4781912|NCT02729428|Magnetic Resonance Imaging|magnetic resonance imaging
4781913|NCT02729415|Hair Diseases|hair diseases
4781914|NCT02729415|Alopecia|alopecia
4781915|NCT02729402|Adults|adults
4781916|NCT02729389|Social Status|social status
4781917|NCT02729389|Hispanics|hispanics
4781918|NCT02729389|Energy Balance|energy balance
4781919|NCT02729389|Stress|stress
4781920|NCT02729376|Healthy Volunteers|healthy volunteers
4781921|NCT02729337|technology|technology
4781922|NCT02729337|adolescent|adolescent
4781923|NCT02729337|developing country|developing country
4781924|NCT02729337|hiv prevention|hiv prevention
4781925|NCT02729337|mHealth|mhealth
4781926|NCT02729324|nasopharyngeal carcinoma (NPC)|nasopharyngeal carcinoma (npc)
4781927|NCT02729324|radiation dermatitis|radiation dermatitis
4781928|NCT02729324|intensity modulated radiation therapy (IMRT)|intensity modulated radiation therapy (imrt)
4781929|NCT02729311|exercise|exercise
4781930|NCT02729311|function|function
4781931|NCT02729311|quality of life|quality of life
4781932|NCT02729311|caregiver|caregiver
4781933|NCT02729298|Tolero|tolero
4781934|NCT02729298|Phase 1a / 1b|phase 1a / 1b
4781935|NCT02729298|First in human|first in human
4781936|NCT02729298|Solid Tumors with immunotherapy progression|solid tumors with immunotherapy progression
4781937|NCT02729298|AXL inhibitor|axl inhibitor
4781938|NCT02729298|Advanced Malignancy|advanced malignancy
4781939|NCT02729298|Cancer|cancer
4781940|NCT02729298|EGFR+ NSCLC with progression on ≤2 lines of oral TKIs|egfr+ nsclc with progression on ≤2 lines of oral tkis
4781941|NCT02729298|BRAF-Mutated CRC|braf-mutated crc
4781942|NCT02729298|KRAS-Mutated CRC|kras-mutated crc
4781943|NCT02729298|NRAS-Mutated CRC|nras-mutated crc
4781944|NCT02729298|Persistent/Recurrent Ovarian Cancer|persistent/recurrent ovarian cancer
4781945|NCT02729298|BRAF-Mutated Melanoma with immunotherapy progression|braf-mutated melanoma with immunotherapy progression
4781946|NCT02729259|VRD|vrd
4781947|NCT02729233|mucosal barrier function|mucosal barrier function
4781948|NCT02729220|Aging|aging
4781949|NCT02729220|Oxidative stress|oxidative stress
4781950|NCT02729220|Proteases|proteases
4781951|NCT02729220|Bronchoscopy|bronchoscopy
4781952|NCT02729207|NSAID Patch|nsaid patch
4781953|NCT02729168|Rabies|rabies
4781955|NCT02729168|Safety|safety
4781956|NCT02729168|INDIRAB|indirab
4781957|NCT02729168|Vietnam|vietnam
4781958|NCT02729155|Ischemic Preconditioning|ischemic preconditioning
4781959|NCT02729155|Postconditioning|postconditioning
4781960|NCT02729155|Angioplasty|angioplasty
4781961|NCT02729155|Angiography|angiography
4781962|NCT02729155|Contrast-Induced Nephropathy|contrast-induced nephropathy
4781963|NCT02729142|HRpQCT|hrpqct
4781964|NCT02729142|transplant|transplant
4781965|NCT02729142|bone microarchitecture|bone microarchitecture
4781966|NCT02729129|Diesel exhaust|diesel exhaust
4781967|NCT02729129|Air pollution|air pollution
4781968|NCT02729129|Intervention|intervention
4781969|NCT02729129|Plethysmography|plethysmography
4781970|NCT02729116|Extended-Spectrum ß-lactamase-producing Escherichia coli|extended-spectrum ß-lactamase-producing escherichia coli
4781971|NCT02729116|Extended-Spectrum ß-lactamase-producing Klebsiella pneumoniae|extended-spectrum ß-lactamase-producing klebsiella pneumoniae
4781972|NCT02729116|Kidney Transplantation|kidney transplantation
4781973|NCT02729116|Urinary Tract Infections|urinary tract infections
4781974|NCT02729090|Peripheral Arterial Disease, exercise|peripheral arterial disease, exercise
4781975|NCT02729064|Intranasal Insulin|intranasal insulin
4781976|NCT02729064|Insulin concentration|insulin concentration
4781977|NCT02729064|Blood glucose|blood glucose
4781978|NCT02729064|Cerebro Spinal Fluid insulin|cerebro spinal fluid insulin
4781979|NCT02729064|Intraoperative blood glucose|intraoperative blood glucose
4781980|NCT02729064|Cardiac Surgery|cardiac surgery
4781981|NCT02729064|Thoracic Surgery|thoracic surgery
4781982|NCT02729051|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
4781983|NCT02729051|fluticasone furoate/umeclidinium bromide/vilanterol (FF/UMEC/VI)|fluticasone furoate/umeclidinium bromide/vilanterol (ff/umec/vi)
4781984|NCT02729051|Umeclidinium bromide (UMEC)|umeclidinium bromide (umec)
4781985|NCT02729051|Closed triple therapy|closed triple therapy
4781986|NCT02729051|Placebo|placebo
4781987|NCT02729051|Open triple therapy|open triple therapy
4781988|NCT02729051|fluticasone furoate/vilanterol (FF/VI)|fluticasone furoate/vilanterol (ff/vi)
4781989|NCT02729038|Normal Renal Function|normal renal function
4781990|NCT02729038|end stage renal disease (ESRD)|end stage renal disease (esrd)
4781991|NCT02729038|Pharmacokinetics|pharmacokinetics
4781992|NCT02729038|Gepotidacin|gepotidacin
4781993|NCT02729038|Renal Impairment|renal impairment
4781994|NCT02729025|Hyperlipidemia|hyperlipidemia
4781995|NCT02729025|Dyslipidemia|dyslipidemia
4781996|NCT02729025|Proprotein convertase subtilisin/kexin type 9 (PCSK9) Inhibition|proprotein convertase subtilisin/kexin type 9 (pcsk9) inhibition
4781997|NCT02729025|Arterial Wall Inflamation|arterial wall inflamation
4781998|NCT02729025|Elevated lipoprotein a|elevated lipoprotein a
4781999|NCT02729012|Children|children
4782000|NCT02728999|Trendelenburg position|trendelenburg position
4782001|NCT02728999|Robotic assisted gynecologic procedures|robotic assisted gynecologic procedures
4782002|NCT02728999|benign gynecologic conditions|benign gynecologic conditions
4782003|NCT02728986|Costs and Cost Analysis|costs and cost analysis
4782004|NCT02728986|Humans|humans
4782005|NCT02728986|Health Care Costs|health care costs
4782006|NCT02728986|varicose ulcer|varicose ulcer
4782007|NCT02728986|Compression Bandages|compression bandages
4782008|NCT02728973|colorectal resection|colorectal resection
4782009|NCT02728973|enhanced recovery after surgery|enhanced recovery after surgery
4782010|NCT02728973|Postoperative Complications|postoperative complications
4782011|NCT02728973|length of hospital stay|length of hospital stay
4782012|NCT02728947|Parkinson's Disease|parkinson's disease
4782013|NCT02728934|Rheumatoid Arthritis|rheumatoid arthritis
4782014|NCT02728934|Golimumab|golimumab
4782015|NCT02728934|Infliximab|infliximab
4782016|NCT02728895|Drug Therapy|drug therapy
4782017|NCT02728882|Lymphoma CAR-T|lymphoma car-t
4782018|NCT02728843|Parkinson's disease|parkinson's disease
4782019|NCT02728843|Deferiprone|deferiprone
4782020|NCT02728830|gynecologic cancers|gynecologic cancers
4782021|NCT02728830|mullerian cancers|mullerian cancers
4782022|NCT02728830|tumoral immunoprofile|tumoral immunoprofile
4782023|NCT02728817|Vascular access|vascular access
4782024|NCT02728817|Hemodialysis|hemodialysis
4782025|NCT02728817|Arteriovenous fistula|arteriovenous fistula
4782026|NCT02728817|Stenosis|stenosis
4782027|NCT02728817|Failure|failure
4782028|NCT02728752|DM|dm
4782029|NCT02728726|Postoperative respiratory depression|postoperative respiratory depression
4782030|NCT02728726|Neuromuscular Agents|neuromuscular agents
4782031|NCT02728713|Cranial manipulation|cranial manipulation
4782032|NCT02728713|Visual function|visual function
4782033|NCT02728687|peripheral neuropathy|peripheral neuropathy
4782034|NCT02728687|Diabetes|diabetes
4782035|NCT02728687|Pain|pain
4782036|NCT02728674|COPD|copd
4782037|NCT02728674|Breathlessness|breathlessness
4782038|NCT02728674|Symptom|symptom
4782039|NCT02728674|Opioids|opioids
4782040|NCT02728674|Gender bias|gender bias
4782041|NCT02728648|Pain Management|pain management
4782042|NCT02728648|Pharmacokinetics|pharmacokinetics
4782043|NCT02728648|Pharmacodynamics|pharmacodynamics
4782044|NCT02728635|Adipose tissue, epigenetic, abdominal gluteal fat|adipose tissue, epigenetic, abdominal gluteal fat
4782045|NCT02728622|ovarian cancer|ovarian cancer
4782046|NCT02728622|platinum-resistant|platinum-resistant
4782047|NCT02728622|endocrine treatment|endocrine treatment
4782048|NCT02728622|chemotherapy|chemotherapy
4782049|NCT02728622|tamoxifen|tamoxifen
4782050|NCT02728583|Plant sterols|plant sterols
4782051|NCT02728583|Fish oil|fish oil
4782052|NCT02728583|Blood lipids|blood lipids
4782053|NCT02728570|flavonoids|flavonoids
4782054|NCT02728570|insulin resistance|insulin resistance
4782055|NCT02728570|plasma lipids|plasma lipids
4782056|NCT02728570|intestinal microbiome|intestinal microbiome
4782057|NCT02728570|intestinal inflammation|intestinal inflammation
4782058|NCT02728570|subclinical inflammation|subclinical inflammation
4782059|NCT02728557|Therapeutic alliance|therapeutic alliance
4782060|NCT02728557|Psychotherapy|psychotherapy
4782061|NCT02728557|Psychodynamic psychotherapy|psychodynamic psychotherapy
4782062|NCT02728557|supportive-expressive treatment|supportive-expressive treatment
4782063|NCT02728557|Process research|process research
4782064|NCT02728557|Attachment theory|attachment theory
4782065|NCT02728557|Attachment orientation|attachment orientation
4782066|NCT02728557|Mechanism of change in psychotherapy|mechanism of change in psychotherapy
4782067|NCT02728466|flavanols|flavanols
4782068|NCT02728466|cocoa procyanidins|cocoa procyanidins
4782069|NCT02728466|vascular function|vascular function
4782070|NCT02728466|endothelial function|endothelial function
4782071|NCT02728427|Suprapubic Catheterization|suprapubic catheterization
4782072|NCT02728427|Transurethral Catheterization|transurethral catheterization
4782073|NCT02728427|Rectal Cancer|rectal cancer
4782074|NCT02728427|Laparoscopic Surgery|laparoscopic surgery
4782075|NCT02728414|Diabetes Mellitus, Type 2, Probiotics, Treatment|diabetes mellitus, type 2, probiotics, treatment
4782076|NCT02728401|inflammation|inflammation
4782077|NCT02728401|sepsis|sepsis
4782078|NCT02728401|pediatric|pediatric
4782079|NCT02728401|transcripts|transcripts
4782080|NCT02728401|serum proteins|serum proteins
4782081|NCT02728401|cardiopulmonary bypass|cardiopulmonary bypass
4782082|NCT02728388|NF1|nf1
4782083|NCT02728388|Neurofibroma|neurofibroma
4782084|NCT02728388|Neurofibromatosis Type 1|neurofibromatosis type 1
4782085|NCT02728362|tibial shaft fractures|tibial shaft fractures
4782086|NCT02728284|Magnetic Resonance Imaging (MRI)|magnetic resonance imaging (mri)
4782087|NCT02728219|Recurrent Hepatocellular Carcinoma|recurrent hepatocellular carcinoma
4782088|NCT02728219|transcatheter arterial chemoembolization|transcatheter arterial chemoembolization
4782089|NCT02728219|AFP conversion|afp conversion
4782090|NCT02728193|treatments|treatments
4782091|NCT02728193|hepatocellular carcinoma|hepatocellular carcinoma
4782092|NCT02728180|Acute Ischemic Stroke|acute ischemic stroke
4782093|NCT02728180|Xingnaojing injection|xingnaojing injection
4782094|NCT02728180|Randomized Controlled Trial|randomized controlled trial
4782095|NCT02728180|Traditional Chinese Medicine|traditional chinese medicine
4782096|NCT02728167|Hepatectomy|hepatectomy
4782097|NCT02728167|Liver metastasis|liver metastasis
4782098|NCT02728167|High-Intensity Focused Ultrasound|high-intensity focused ultrasound
4782099|NCT02728167|Liver metastases (LM) requiring surgery|liver metastases (lm) requiring surgery
4782100|NCT02728154|pre-clinical diastolic dysfunction (pre-HFpEF)|pre-clinical diastolic dysfunction (pre-hfpef)
4782101|NCT02728128|Milrinone|milrinone
4782102|NCT02728115|Huntington's Disease|huntington's disease
4782103|NCT02728115|Stem Cell|stem cell
4782104|NCT02728115|Dental Pulp Stem Cells|dental pulp stem cells
4782105|NCT02728102|Multiple Myeloma|multiple myeloma
4782106|NCT02728102|Lenalidomide|lenalidomide
4782107|NCT02728102|Maintenance Therapy|maintenance therapy
4782108|NCT02728102|Hematologic Disorders|hematologic disorders
4782109|NCT02728102|Vaccine|vaccine
4782110|NCT02728102|GM-CSF|gm-csf
4782111|NCT02728102|Transplant|transplant
4782112|NCT02728102|Anti-Myeloma Agents|anti-myeloma agents
4782113|NCT02728076|Breast Cancer|breast cancer
4782114|NCT02728076|Accelerated Partial Breast Irradiation|accelerated partial breast irradiation
4782115|NCT02728037|Myofascial Trigger Points|myofascial trigger points
4782116|NCT02728037|Myofascial Pain|myofascial pain
4782117|NCT02728037|Intramuscular Anesthetic Injection|intramuscular anesthetic injection
4782118|NCT02727998|PTSD|ptsd
4782119|NCT02727972|depression|depression
4782120|NCT02727972|bipolar|bipolar
4782121|NCT02727972|post-traumatic stress disorder|post-traumatic stress disorder
4782122|NCT02727972|mood disorders|mood disorders
4782123|NCT02727972|PET|pet
4782124|NCT02727972|mGluRr|mglurr
4782125|NCT02727972|glutamate system|glutamate system
4782126|NCT02727972|MRI|mri
4782127|NCT02727959|UC|uc
4782128|NCT02727959|CD|cd
4782129|NCT02727959|IBD|ibd
4782130|NCT02727894|Screening|screening
4782131|NCT02727894|pTNM|ptnm
4782132|NCT02727894|Metastasis|metastasis
4782133|NCT02727894|Chemotherapy|chemotherapy
4782134|NCT02727894|Resection Margins|resection margins
4782135|NCT02727881|AMD, CNV, choroidal neovascularization, retinal eye disease|amd, cnv, choroidal neovascularization, retinal eye disease
4782136|NCT02727855|Cholera|cholera
4782137|NCT02727855|Vaccine|vaccine
4782138|NCT02727855|Strategy|strategy
4782139|NCT02727842|cochlear implant|cochlear implant
4782140|NCT02727842|Sound Processor|sound processor
4782141|NCT02727803|Acute Myelogenous Leukemia|acute myelogenous leukemia
4782142|NCT02727803|AML|aml
4782347|NCT02726841|Stents|stents
4782143|NCT02727803|Myelodysplastic syndrome|myelodysplastic syndrome
4782144|NCT02727803|MDS|mds
4782145|NCT02727803|Multiple myeloma|multiple myeloma
4782146|NCT02727803|MM|mm
4782147|NCT02727803|Umbilical cord blood transplant|umbilical cord blood transplant
4782148|NCT02727803|UCB|ucb
4782149|NCT02727803|Natural killer cells|natural killer cells
4782150|NCT02727803|NK|nk
4782151|NCT02727803|Busulfan|busulfan
4782152|NCT02727803|Busulfex|busulfex
4782153|NCT02727803|Myleran|myleran
4782154|NCT02727803|Fludarabine|fludarabine
4782155|NCT02727803|Fludarabine Phosphate|fludarabine phosphate
4782156|NCT02727803|Fludara|fludara
4782157|NCT02727803|Clofarabine|clofarabine
4782158|NCT02727803|Clofarex|clofarex
4782159|NCT02727803|Clolar|clolar
4782160|NCT02727803|Rabbit ATB|rabbit atb
4782161|NCT02727803|ATG (Rabbit)|atg (rabbit)
4782162|NCT02727803|Rabbit Antithymocyte Globulin|rabbit antithymocyte globulin
4782163|NCT02727803|Rabbit Antilymphocyte Globulin|rabbit antilymphocyte globulin
4782164|NCT02727803|rATG Thymoglobulin|ratg thymoglobulin
4782165|NCT02727803|Total Body Irradiation|total body irradiation
4782166|NCT02727803|TBI|tbi
4782167|NCT02727803|Radiation therapy|radiation therapy
4782168|NCT02727803|XRT|xrt
4782169|NCT02727803|Rituximab|rituximab
4782170|NCT02727803|Rituxan|rituxan
4782171|NCT02727803|Cyclophosphamide|cyclophosphamide
4782172|NCT02727803|Cytoxan|cytoxan
4782173|NCT02727803|Neosar|neosar
4782174|NCT02727803|Melphalan|melphalan
4782175|NCT02727803|Alkeran|alkeran
4782176|NCT02727777|Lymphoma|lymphoma
4782177|NCT02727777|Relapsed Lymphoma|relapsed lymphoma
4782178|NCT02727777|MLN0128|mln0128
4782179|NCT02727777|Blood sugar|blood sugar
4782180|NCT02727777|Glucometer|glucometer
4782181|NCT02727777|TK228|tk228
4782182|NCT02727764|Arthritis|arthritis
4782183|NCT02727764|Gene therapy|gene therapy
4782184|NCT02727764|Phase Ib|phase ib
4782185|NCT02727764|Intra-articular|intra-articular
4782186|NCT02727738|Hyperthyroidism|hyperthyroidism
4782187|NCT02727738|Methimazole|methimazole
4782188|NCT02727738|Selenium|selenium
4782189|NCT02727712|coronary artery bypass graft|coronary artery bypass graft
4782190|NCT02727712|thoracic paravertebral block|thoracic paravertebral block
4782191|NCT02727699|Mild Dementia|mild dementia
4782192|NCT02727699|Actinogen|actinogen
4782193|NCT02727699|Alzheimer's Disease|alzheimer's disease
4782194|NCT02727699|Xanamem|xanamem
4782195|NCT02727699|Cortisol|cortisol
4782196|NCT02727699|UE2343|ue2343
4782197|NCT02727699|XanADu|xanadu
4782198|NCT02727686|transsphenoidal pituitary surgery|transsphenoidal pituitary surgery
4782199|NCT02727673|cancer stem cells|cancer stem cells
4782200|NCT02727660|COPD|copd
4782201|NCT02727647|Moderate hemophilia A|moderate hemophilia a
4782202|NCT02727647|Severe hemophilia A|severe hemophilia a
4782203|NCT02727647|Intermediate dose prophylaxis|intermediate dose prophylaxis
4782204|NCT02727647|Low dose prophylaxis|low dose prophylaxis
4782205|NCT02727634|Hemodynamics|hemodynamics
4782206|NCT02727634|Echocardiography, Doppler, Pulsed|echocardiography, doppler, pulsed
4782207|NCT02727621|Dexmedetomidine|dexmedetomidine
4782208|NCT02727621|Cardiac|cardiac
4782209|NCT02727621|Coronary Artery Bypass Grapht|coronary artery bypass grapht
4782210|NCT02727621|Sedation|sedation
4782211|NCT02727621|Propofol|propofol
4782212|NCT02727621|Intravenous Anesthetics|intravenous anesthetics
4782213|NCT02727582|MDR|mdr
4782214|NCT02727556|skin conductance response|skin conductance response
4782215|NCT02727556|facial muscle activity|facial muscle activity
4782216|NCT02727556|heart rate variability|heart rate variability
4782217|NCT02727556|eyetracking|eyetracking
4782218|NCT02727543|Hypertension|hypertension
4782219|NCT02727543|mHealth|mhealth
4782220|NCT02727543|Medication Non-adherence|medication non-adherence
4782221|NCT02727530|Infant Colic|infant colic
4782222|NCT02727530|Manual Therapy|manual therapy
4782223|NCT02727530|Effectiveness|effectiveness
4782224|NCT02727517|Resuscitation|resuscitation
4782225|NCT02727517|Cord clamping|cord clamping
4782226|NCT02727504|Aortic valve stenosis|aortic valve stenosis
4782227|NCT02727504|low flow|low flow
4782228|NCT02727504|dobutamine stress echocardiography|dobutamine stress echocardiography
4782229|NCT02727491|opioid analgesics,|opioid analgesics,
4782230|NCT02727491|opioid consumption|opioid consumption
4782231|NCT02727491|adverse effects|adverse effects
4782232|NCT02727491|postoperative pain|postoperative pain
4782233|NCT02727491|tonsillectomy|tonsillectomy
4782234|NCT02727478|Balance|balance
4782235|NCT02727478|Rehabilitation|rehabilitation
4782236|NCT02727478|Exercise|exercise
4782237|NCT02727478|basal ganglia|basal ganglia
4782238|NCT02727478|Gait|gait
4782239|NCT02727478|Training|training
4782240|NCT02727478|physical activity|physical activity
4782241|NCT02727439|microvascular function|microvascular function
4782242|NCT02727439|laser Doppler flowmetry|laser doppler flowmetry
4782243|NCT02727439|exercise|exercise
4782244|NCT02727426|microvascular function|microvascular function
4782245|NCT02727426|laser Doppler flowmetry|laser doppler flowmetry
4782246|NCT02727426|high salt diet|high salt diet
4782247|NCT02727374|Fear to Fall|fear to fall
4782248|NCT02727374|Geriatric|geriatric
4782249|NCT02727374|Rehabilitation|rehabilitation
4782250|NCT02727374|Psychology|psychology
4782251|NCT02727361|Dystonia|dystonia
4782252|NCT02727361|Binding potential|binding potential
4782253|NCT02727361|FEOBV|feobv
4782254|NCT02727348|femoral sciatic block spinal diabetic foot haemodynamic pain|femoral sciatic block spinal diabetic foot haemodynamic pain
4782255|NCT02727335|Non-squamous non-small cell lung cancer|non-squamous non-small cell lung cancer
4782256|NCT02727335|crizotinib|crizotinib
4782257|NCT02727309|Apatinib|apatinib
4782258|NCT02727309|Second-line Treatment|second-line treatment
4782259|NCT02727309|Hepatocellular Cancer|hepatocellular cancer
4782260|NCT02727309|TACE|tace
4782261|NCT02727283|Healthy volunteer|healthy volunteer
4782262|NCT02727283|Safety|safety
4782263|NCT02727283|Pharmacokinetics|pharmacokinetics
4782264|NCT02727283|Dose escalation|dose escalation
4782265|NCT02727283|GSK3179106|gsk3179106
4782266|NCT02727283|Rearranged during Transfection|rearranged during transfection
4782267|NCT02727283|Irritable Bowel Syndrome|irritable bowel syndrome
4782268|NCT02727283|Adults|adults
4782269|NCT02727270|Movement disorders|movement disorders
4782270|NCT02727270|Metabolic Stress|metabolic stress
4782271|NCT02727257|Parkinson's disease|parkinson's disease
4782272|NCT02727257|rehabilitation|rehabilitation
4782273|NCT02727257|attention|attention
4782274|NCT02727257|executive functions|executive functions
4782275|NCT02727244|Pain Catastrophizing Scale|pain catastrophizing scale
4782276|NCT02727231|closed loop glucose control|closed loop glucose control
4782277|NCT02727231|hypoglycemia|hypoglycemia
4782278|NCT02727231|type 1 diabetes|type 1 diabetes
4782279|NCT02727231|HbA1C<7.5%|hba1c<7.5%
4782280|NCT02727166|intestinal gas|intestinal gas
4782281|NCT02727166|functional gut symptoms|functional gut symptoms
4782282|NCT02727166|intestinal sensitivity|intestinal sensitivity
4782283|NCT02727166|intestinal motility|intestinal motility
4782284|NCT02727153|Colonic cancer|colonic cancer
4782285|NCT02727153|E.R.A.S. programs|e.r.a.s. programs
4782286|NCT02727153|Safety|safety
4782287|NCT02727114|skin thickness|skin thickness
4782288|NCT02727114|high-frequency ultrasound|high-frequency ultrasound
4782289|NCT02727101|Focal epilepsy, Perampanel|focal epilepsy, perampanel
4782290|NCT02727088|Dental Pulp Disease|dental pulp disease
4782291|NCT02727088|Endodontics|endodontics
4782292|NCT02727088|Pulp Capping|pulp capping
4782293|NCT02727088|Pulpotomy|pulpotomy
4782294|NCT02727088|Pulpectomy|pulpectomy
4782295|NCT02727075|Occult Gastrointestinal Bleeding|occult gastrointestinal bleeding
4782296|NCT02727075|Iron Deficiency Anemia|iron deficiency anemia
4782297|NCT02727075|Aged 75 Years and Older|aged 75 years and older
4782298|NCT02727062|pain|pain
4782299|NCT02727062|radiation|radiation
4782300|NCT02727062|head and neck cancer|head and neck cancer
4782301|NCT02727062|smartphone pain app|smartphone pain app
4782302|NCT02727062|OM Pain App|om pain app
4782303|NCT02727023|Healthy|healthy
4782304|NCT02727010|Motor disability|motor disability
4782305|NCT02727010|Motor impairment|motor impairment
4782306|NCT02727010|Pregnancy|pregnancy
4782307|NCT02727010|Parenthood|parenthood
4782308|NCT02727010|Child psychology|child psychology
4782309|NCT02726997|Malignant neoplasms of female genital organs|malignant neoplasms of female genital organs
4782310|NCT02726997|Ovarian Cancer|ovarian cancer
4782311|NCT02726997|Primary Peritoneal Carcinoma|primary peritoneal carcinoma
4782312|NCT02726997|Fallopian Tube Cancer|fallopian tube cancer
4782313|NCT02726997|High-grade epithelial non-mucinous ovarian cancer|high-grade epithelial non-mucinous ovarian cancer
4782314|NCT02726997|Laparoscopy surgery|laparoscopy surgery
4782315|NCT02726997|Durvalumab|durvalumab
4782316|NCT02726997|MEDI4736|medi4736
4782317|NCT02726997|Carboplatin|carboplatin
4782318|NCT02726997|Paraplatin|paraplatin
4782319|NCT02726997|Paclitaxel|paclitaxel
4782320|NCT02726997|Taxol|taxol
4782321|NCT02726984|stroke|stroke
4782322|NCT02726984|carotid plaque|carotid plaque
4782323|NCT02726984|18F-sodium fluoride PET/MR|18f-sodium fluoride pet/mr
4782324|NCT02726971|Intrauterine Adhesion|intrauterine adhesion
4782325|NCT02726971|Oestrogen Artificial Periodic Therapy|oestrogen artificial periodic therapy
4782326|NCT02726958|aortic valve replacement|aortic valve replacement
4782327|NCT02726958|percutaneous valve|percutaneous valve
4782328|NCT02726958|blood glucose variability|blood glucose variability
4782329|NCT02726958|TAVI|tavi
4782330|NCT02726932|Peritonitis|peritonitis
4782331|NCT02726932|Inflammatory Markers|inflammatory markers
4782332|NCT02726932|Patient Outcome Assessment|patient outcome assessment
4782333|NCT02726932|Classification|classification
4782334|NCT02726932|Multiple Organ Failure|multiple organ failure
4782335|NCT02726932|Intraabdominal Infections|intraabdominal infections
4782336|NCT02726919|focal epilepsy|focal epilepsy
4782337|NCT02726919|clobazam|clobazam
4782338|NCT02726906|Alzheimer's disease|alzheimer's disease
4782339|NCT02726906|Mild Cognitive Impairment|mild cognitive impairment
4782340|NCT02726906|Brain Imaging|brain imaging
4782341|NCT02726867|refractory status epilepticus|refractory status epilepticus
4782342|NCT02726867|levetiracetam|levetiracetam
4782343|NCT02726867|lacosamide|lacosamide
4782344|NCT02726867|ketamine|ketamine
4782345|NCT02726841|Thoracic aorta|thoracic aorta
4782346|NCT02726841|Abdominal aorta|abdominal aorta
4782348|NCT02726789|nucleic acid polymer REP 2139 HBsAg hepatitis B|nucleic acid polymer rep 2139 hbsag hepatitis b
4782349|NCT02726763|Transcranial Direct Current Stimulation (tDCS)|transcranial direct current stimulation (tdcs)
4782350|NCT02726763|Cognitive Training|cognitive training
4782351|NCT02726763|16-034|16-034
4782352|NCT02726750|Monoclonal gammopathy of unknown significance|monoclonal gammopathy of unknown significance
4782353|NCT02726750|MGUS|mgus
4782354|NCT02726750|Smoldering multiple myeloma|smoldering multiple myeloma
4782355|NCT02726750|SMM|smm
4782356|NCT02726750|Asymptomatic monoclonal gammopathies|asymptomatic monoclonal gammopathies
4782357|NCT02726750|Biomarker testing|biomarker testing
4782358|NCT02726750|Blood collection|blood collection
4782359|NCT02726750|Blood draw|blood draw
4782360|NCT02726737|inferior alveolar nerve block|inferior alveolar nerve block
4782361|NCT02726737|irreversible pulpitis|irreversible pulpitis
4782362|NCT02726737|local anesthesia|local anesthesia
4782363|NCT02726737|sodium bicarbonate|sodium bicarbonate
4782364|NCT02726724|Stress-Resident performance-Observers|stress-resident performance-observers
4782365|NCT02726685|respiratory training|respiratory training
4782366|NCT02726685|functional performance|functional performance
4782367|NCT02726672|inspiratory muscles|inspiratory muscles
4782368|NCT02726672|multiple sclerosis|multiple sclerosis
4782369|NCT02726672|rehabilitation|rehabilitation
4782370|NCT02726646|Local Drug Delivery|local drug delivery
4782371|NCT02726646|Antibiotics|antibiotics
4782372|NCT02726646|Doxycycline|doxycycline
4782373|NCT02726646|Smokers|smokers
4782374|NCT02726646|Chronic Periodontitis|chronic periodontitis
4782375|NCT02726620|Decision support|decision support
4782376|NCT02726620|Decision Support Systems, Clinical|decision support systems, clinical
4782377|NCT02726620|Decision Support Techniques|decision support techniques
4782378|NCT02726620|Hypotension|hypotension
4782379|NCT02726620|Intraoperative Hypotension|intraoperative hypotension
4782380|NCT02726620|Acute Kidney Injury|acute kidney injury
4782381|NCT02726620|Postoperative Myocardial Injury|postoperative myocardial injury
4782382|NCT02726620|Postoperative Mortality|postoperative mortality
4782383|NCT02726620|Blood Pressure|blood pressure
4782384|NCT02726607|Prevention of mother-to-child transmission (PMTCT)|prevention of mother-to-child transmission (pmtct)
4782385|NCT02726607|Kenya|kenya
4782386|NCT02726607|HITSystem 2.0|hitsystem 2.0
4782387|NCT02726607|retention through PMTCT cascade of care|retention through pmtct cascade of care
4782388|NCT02726607|Early Infant Diagnosis|early infant diagnosis
4782389|NCT02726607|eHealth system-level intervention|ehealth system-level intervention
4782390|NCT02726594|Magnetic Resonance Imaging, Patient Satisfaction|magnetic resonance imaging, patient satisfaction
4782391|NCT02726568|EGFR-TKI|egfr-tki
4782392|NCT02726568|NSCLC|nsclc
4782393|NCT02726568|Icotinib|icotinib
4782394|NCT02726555|Red yeast rice|red yeast rice
4782395|NCT02726555|Atorvastatin|atorvastatin
4782396|NCT02726555|Mild cardiovascular disease|mild cardiovascular disease
4782397|NCT02726542|obesity|obesity
4782398|NCT02726542|adolescence|adolescence
4782399|NCT02726542|fatty liver|fatty liver
4782400|NCT02726542|growth hormone|growth hormone
4782401|NCT02726516|Performance|performance
4782402|NCT02726503|anaplastic thyroid cancer, lenvatinib|anaplastic thyroid cancer, lenvatinib
4782403|NCT02726490|gestational diabetes, pregnancy, diabetes|gestational diabetes, pregnancy, diabetes
4782404|NCT02726464|Platelet-rich Plasma|platelet-rich plasma
4782405|NCT02726464|Cell-Derived Microparticles|cell-derived microparticles
4782406|NCT02726464|Pain Management|pain management
4782407|NCT02726464|Blood Platelets|blood platelets
4782408|NCT02726464|Therapeutics|therapeutics
4782409|NCT02726464|Inflammation|inflammation
4782410|NCT02726464|ThromboLUX|thrombolux
4782411|NCT02726464|Dynamic Light Scattering|dynamic light scattering
4782412|NCT02726425|Diabetes self management|diabetes self management
4782413|NCT02726425|Second Life platform|second life platform
4782414|NCT02726425|Medical group visits|medical group visits
4782415|NCT02726399|Ramucirumab|ramucirumab
4782416|NCT02726399|Trastuzumab|trastuzumab
4782417|NCT02726399|Capecitabine|capecitabine
4782418|NCT02726399|Cisplatin|cisplatin
4782419|NCT02726399|HER2-Positive|her2-positive
4782420|NCT02726399|15-301|15-301
4782421|NCT02726360|Communication|communication
4782422|NCT02726360|15-316|15-316
4782423|NCT02726360|Physician|physician
4782424|NCT02726360|Use|use
4782425|NCT02726360|Non-English|non-english
4782426|NCT02726360|Language Skills|language skills
4782427|NCT02726334|Metastatic|metastatic
4782428|NCT02726308|Dexamethasone|dexamethasone
4782429|NCT02726308|Super-hydration|super-hydration
4782430|NCT02726308|Laparoscopic Cholecystectomy|laparoscopic cholecystectomy
4782431|NCT02726308|Nausea|nausea
4782432|NCT02726308|Vomiting|vomiting
4782433|NCT02726308|Postoperative|postoperative
4782434|NCT02726269|Helicobacter Pylory infections|helicobacter pylory infections
4782435|NCT02726269|Levofloxacin|levofloxacin
4782436|NCT02726269|Antibiotic resistance|antibiotic resistance
4782437|NCT02726269|Clarithromycin|clarithromycin
4782438|NCT02726269|Mutations|mutations
4782439|NCT02726269|Fluorescence|fluorescence
4782440|NCT02726269|Hybridization|hybridization
4782441|NCT02726256|Diabetes|diabetes
4782442|NCT02726256|DM complication|dm complication
4783042|NCT02723136|Internship|internship
4782443|NCT02726243|Inflammatory bowel disease|inflammatory bowel disease
4782444|NCT02726243|Crohn's Disease|crohn's disease
4782445|NCT02726243|Ulcerative Colitis|ulcerative colitis
4782446|NCT02726243|colorectal cancer|colorectal cancer
4782447|NCT02726243|primary sclerosing cholangitis|primary sclerosing cholangitis
4782448|NCT02726217|CareSmarts|caresmarts
4782449|NCT02726217|SMS-based mobile|sms-based mobile
4782450|NCT02726178|Apnea|apnea
4782451|NCT02726178|bradycardia|bradycardia
4782452|NCT02726178|immunization|immunization
4782453|NCT02726178|inflammation|inflammation
4782454|NCT02726178|preterms|preterms
4782455|NCT02726152|Diagnostic laparoscopy|diagnostic laparoscopy
4782456|NCT02726152|Acute appendicitis|acute appendicitis
4782457|NCT02726152|Appendiceal stump|appendiceal stump
4782458|NCT02726139|Factor VIII|factor viii
4782459|NCT02726139|inhibitor|inhibitor
4782460|NCT02726139|assay|assay
4782461|NCT02726126|Transdermal fentanyl|transdermal fentanyl
4782462|NCT02726126|Transdermal melatonin|transdermal melatonin
4782463|NCT02726126|Postoperative pain|postoperative pain
4782464|NCT02726126|lumber laminectomy|lumber laminectomy
4782465|NCT02726126|Relief|relief
4782466|NCT02726113|prostate cancer|prostate cancer
4782467|NCT02726113|vitamin D|vitamin d
4782468|NCT02726100|Telemedicine|telemedicine
4782469|NCT02726100|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
4782470|NCT02726100|Decision Support Systems, Clinical|decision support systems, clinical
4782471|NCT02726100|Family Health Promoter|family health promoter
4782472|NCT02726100|Primary Health Care|primary health care
4782473|NCT02726087|Ministernotomy|ministernotomy
4782474|NCT02726087|aortic valve stenosis|aortic valve stenosis
4782475|NCT02726087|quality of life|quality of life
4782476|NCT02726087|satisfaction|satisfaction
4782477|NCT02726087|cardiac surgery|cardiac surgery
4782478|NCT02726074|epilepsy|epilepsy
4782479|NCT02726074|partial-onset seizures|partial-onset seizures
4782480|NCT02726074|secondarily generalized seizures|secondarily generalized seizures
4782481|NCT02726035|Self-injurious behavior|self-injurious behavior
4782482|NCT02726035|Self mutilation|self mutilation
4782483|NCT02726035|naltrexone|naltrexone
4782484|NCT02725996|Hepatocellular Carcinoma|hepatocellular carcinoma
4782485|NCT02725996|Natural Killer cells|natural killer cells
4782486|NCT02725983|Gingivitis|gingivitis
4782487|NCT02725983|Oral Hygiene|oral hygiene
4782488|NCT02725983|Intra oral camera|intra oral camera
4782489|NCT02725983|Self regulation|self regulation
4782490|NCT02725983|bleeding|bleeding
4782491|NCT02725970|HEALTH|health
4782492|NCT02725970|barriers|barriers
4782493|NCT02725970|facilitators|facilitators
4782494|NCT02725970|DGA|dga
4782495|NCT02725970|BMI|bmi
4782496|NCT02725970|Public Schools|public schools
4782497|NCT02725957|Bioblast|bioblast
4782498|NCT02725944|Cryptogenic stroke|cryptogenic stroke
4782499|NCT02725944|Occult paroxysmal atrial fibrillation|occult paroxysmal atrial fibrillation
4782500|NCT02725931|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
4782501|NCT02725931|COPD|copd
4782502|NCT02725931|Pulmonary rehabilitation|pulmonary rehabilitation
4782503|NCT02725931|Physical activity|physical activity
4782504|NCT02725931|Exercise|exercise
4782505|NCT02725918|NSCLC|nsclc
4782506|NCT02725918|EGFR-TKI failure|egfr-tki failure
4782507|NCT02725918|chemotherapy|chemotherapy
4782508|NCT02725905|Weight Management Counseling|weight management counseling
4782509|NCT02725905|Medical School Education|medical school education
4782510|NCT02725892|lung cancer epidemiology algeria registry|lung cancer epidemiology algeria registry
4782511|NCT02725866|Observational Study|observational study
4782512|NCT02725866|Sustained Virological Response|sustained virological response
4782513|NCT02725866|Chronic Hepatitis C genotype 1|chronic hepatitis c genotype 1
4782514|NCT02725866|Chronic Hepatitis C|chronic hepatitis c
4782515|NCT02725866|Paritaprevir/r - Ombitasvir, ± Dasabuvir,|paritaprevir/r - ombitasvir, ± dasabuvir,
4782516|NCT02725866|Chronic Hepatitis C genotype 4|chronic hepatitis c genotype 4
4782517|NCT02725853|Transcranial Direct Current Stimulation|transcranial direct current stimulation
4782518|NCT02725853|Arm Training|arm training
4782519|NCT02725853|Virtual Reality Exposure Therapy|virtual reality exposure therapy
4782520|NCT02725840|pulmonary vasculature|pulmonary vasculature
4782521|NCT02725840|radiation late effects|radiation late effects
4782522|NCT02725840|proton therapy|proton therapy
4782523|NCT02725814|Sucrose|sucrose
4782524|NCT02725814|Effectiveness|effectiveness
4782525|NCT02725814|Healthcare Delivery|healthcare delivery
4782526|NCT02725814|Neonates|neonates
4782527|NCT02725814|Nursing|nursing
4782528|NCT02725775|Orange Juice, Polyphenol, Cognition|orange juice, polyphenol, cognition
4782529|NCT02725762|Dry AMD|dry amd
4782530|NCT02725762|Vision Loss|vision loss
4782531|NCT02725762|AMD|amd
4782532|NCT02725749|shoulder|shoulder
4782533|NCT02725749|low level laser therapy|low level laser therapy
4782534|NCT02725749|exercises|exercises
4782535|NCT02725710|uterine aspiration|uterine aspiration
4782536|NCT02725658|Neoadjuvant Therapy|neoadjuvant therapy
4782537|NCT02725658|Diffuse Optical Spectroscopic Imaging|diffuse optical spectroscopic imaging
4782538|NCT02725658|DOSI|dosi
4782539|NCT02725658|Neoadjuvant Chemotherapy|neoadjuvant chemotherapy
4783147|NCT02722551|Heart valve|heart valve
4782540|NCT02725645|Surface electromyography|surface electromyography
4782541|NCT02725645|children|children
4782542|NCT02725645|backpack|backpack
4782543|NCT02725632|Sodium channel|sodium channel
4782544|NCT02725632|splicing variant|splicing variant
4782545|NCT02725632|sleep apnea syndrome|sleep apnea syndrome
4782546|NCT02725606|Neutropenia|neutropenia
4782547|NCT02725606|Breast Cancer|breast cancer
4782548|NCT02725606|GW003|gw003
4782549|NCT02725593|Diabetes Mellitus|diabetes mellitus
4782550|NCT02725593|Dapagliflozin|dapagliflozin
4782551|NCT02725593|Placebo|placebo
4782552|NCT02725593|Insulin resistance|insulin resistance
4782553|NCT02725593|Metabolic Diseases|metabolic diseases
4782554|NCT02725580|Neuronal ceroid lipofuscinosis|neuronal ceroid lipofuscinosis
4782555|NCT02725580|NCL|ncl
4782556|NCT02725580|Gene Transfer|gene transfer
4782557|NCT02725580|Gray Foundation|gray foundation
4782558|NCT02725541|HER2 equivocal|her2 equivocal
4782559|NCT02725541|Trastuzumab emtansine|trastuzumab emtansine
4782560|NCT02725541|Breast cancer|breast cancer
4782561|NCT02725502|T1DM|t1dm
4782562|NCT02725502|Linagliptin|linagliptin
4782563|NCT02725502|mix meal test|mix meal test
4782564|NCT02725489|Vigil|vigil
4782565|NCT02725489|durvalumab|durvalumab
4782566|NCT02725489|MEDI4736|medi4736
4782567|NCT02725489|PD-L1|pd-l1
4782568|NCT02725489|anti PD-L1|anti pd-l1
4782569|NCT02725489|immunotherapy|immunotherapy
4782570|NCT02725489|PD-L1 inhibitor|pd-l1 inhibitor
4782571|NCT02725489|breast cancer|breast cancer
4782572|NCT02725489|ovarian cancer|ovarian cancer
4782573|NCT02725489|fallopian tube cancer|fallopian tube cancer
4782574|NCT02725489|primary peritoneal cancer|primary peritoneal cancer
4782575|NCT02725489|uterine cancer|uterine cancer
4782576|NCT02725489|cervical cancer|cervical cancer
4782577|NCT02725489|endometrial cancer|endometrial cancer
4782578|NCT02725463|vestibular|vestibular
4782579|NCT02725463|implant|implant
4782580|NCT02725463|prosthesis|prosthesis
4782581|NCT02725463|labyrinth|labyrinth
4782582|NCT02725463|ototoxicity|ototoxicity
4782583|NCT02725463|gentamicin|gentamicin
4782584|NCT02725463|oscillopsia|oscillopsia
4782585|NCT02725463|disequilibrium|disequilibrium
4782586|NCT02725463|dizziness|dizziness
4782587|NCT02725463|vestibulopathy|vestibulopathy
4782588|NCT02725463|inner ear|inner ear
4782589|NCT02725450|Motor Imagery|motor imagery
4782590|NCT02725450|Fine motor skills|fine motor skills
4782591|NCT02725450|Disabled|disabled
4782592|NCT02725411|Chronic low back pain|chronic low back pain
4782593|NCT02725411|Chronic pain|chronic pain
4782594|NCT02725398|Buscopan|buscopan
4782595|NCT02725398|probe-based confocal laser endomicroscopy|probe-based confocal laser endomicroscopy
4782596|NCT02725398|Imaging Quality|imaging quality
4782597|NCT02725385|No Evidence of Disease|no evidence of disease
4782598|NCT02725372|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
4782599|NCT02725372|PAH|pah
4782600|NCT02725372|Inhaled Nitric Oxide|inhaled nitric oxide
4782601|NCT02725372|iNO|ino
4782602|NCT02725372|long term oxygen therapy|long term oxygen therapy
4782603|NCT02725372|oxygen therapy|oxygen therapy
4782604|NCT02725359|Thyroidectomy pain|thyroidectomy pain
4782605|NCT02725359|Tizanidine|tizanidine
4782606|NCT02725359|Postoperative analgesia|postoperative analgesia
4782607|NCT02725359|Ultrasound guided Superficial cervical plexus block|ultrasound guided superficial cervical plexus block
4782608|NCT02725346|Surgical Planning Solution|surgical planning solution
4782609|NCT02725346|Acromioplasty|acromioplasty
4782610|NCT02725346|Shoulder Surgery|shoulder surgery
4782611|NCT02725346|Critical Shoulder Angle|critical shoulder angle
4782612|NCT02725333|Glenohumeral stabilization|glenohumeral stabilization
4782613|NCT02725333|Computer tomography|computer tomography
4782614|NCT02725333|Subtle or minor instability|subtle or minor instability
4782615|NCT02725333|Unstable painful shoulder|unstable painful shoulder
4782616|NCT02725333|Apprehension|apprehension
4782617|NCT02725333|Dislocation|dislocation
4782618|NCT02725333|Subluxation|subluxation
4782619|NCT02725333|Kinematics modeling|kinematics modeling
4782620|NCT02725333|Biomechanics|biomechanics
4782621|NCT02725333|Motion capture|motion capture
4782622|NCT02725333|3D simulation|3d simulation
4782623|NCT02725320|rotator cuff|rotator cuff
4782624|NCT02725320|shoulder reconstruction|shoulder reconstruction
4782625|NCT02725294|exacerbation|exacerbation
4782626|NCT02725294|access to care|access to care
4782627|NCT02725294|telemedicine|telemedicine
4782628|NCT02725268|Drug Therapy|drug therapy
4782629|NCT02725229|Postoperative pain|postoperative pain
4782630|NCT02725229|Parasternal block|parasternal block
4782631|NCT02725229|Sternotomy|sternotomy
4782632|NCT02725229|TENS|tens
4782633|NCT02725203|Cardiovascular risk management|cardiovascular risk management
4782634|NCT02725203|behaviour change techniques|behaviour change techniques
4782635|NCT02725203|self-management|self-management
4782636|NCT02725203|physical activity|physical activity
4782637|NCT02725203|nurse-led|nurse-led
4782638|NCT02725203|behaviour change wheel|behaviour change wheel
4782639|NCT02725203|primary care|primary care
4782640|NCT02725203|clustered RCT|clustered rct
4782641|NCT02725177|Ocular Sarcoidosis|ocular sarcoidosis
4782642|NCT02725164|oxygen|oxygen
4782643|NCT02725164|nitrous oxide|nitrous oxide
4782644|NCT02725164|sevoflurane|sevoflurane
4782645|NCT02725164|carbon dioxide|carbon dioxide
4782646|NCT02725164|endotracheal tube|endotracheal tube
4782647|NCT02725164|respiration|respiration
4782648|NCT02725151|inferior vena cava ultrasound|inferior vena cava ultrasound
4782649|NCT02725151|acute|acute
4782650|NCT02725151|heart failure|heart failure
4782651|NCT02725151|management|management
4782652|NCT02725151|decompensation|decompensation
4782653|NCT02725138|Helicobacter pylori|helicobacter pylori
4782654|NCT02725138|probiotic|probiotic
4782655|NCT02725138|bacterial density|bacterial density
4782656|NCT02725125|Stomach Cancer CAR-T|stomach cancer car-t
4782657|NCT02725099|STEMI|stemi
4782658|NCT02725060|POTS|pots
4782659|NCT02725060|Orthostatic Intolerance|orthostatic intolerance
4782660|NCT02725060|Orthostatic Tachycardia|orthostatic tachycardia
4782661|NCT02725047|Osteoarthritis, Knee|osteoarthritis, knee
4782662|NCT02725047|Cryotherapy|cryotherapy
4782663|NCT02725047|Thermotherapy|thermotherapy
4782664|NCT02725047|Hypothermia|hypothermia
4782665|NCT02725047|Knee|knee
4782666|NCT02725047|Physiotherapy|physiotherapy
4782667|NCT02725021|tobacco prevention|tobacco prevention
4782668|NCT02725008|Asthma|asthma
4782669|NCT02725008|Pediatric|pediatric
4782670|NCT02725008|Emergency Department|emergency department
4782671|NCT02725008|Dexamethasone|dexamethasone
4782672|NCT02725008|Steroid|steroid
4782673|NCT02724982|Self esteem|self esteem
4782674|NCT02724982|Body mass index|body mass index
4782675|NCT02724969|text messaging|text messaging
4782676|NCT02724969|short message service|short message service
4782677|NCT02724956|supraglottic airway device (SGAD) insertion|supraglottic airway device (sgad) insertion
4782678|NCT02724956|SGAD|sgad
4782679|NCT02724956|ventilation and intubation|ventilation and intubation
4782680|NCT02724956|gastric drainage channel|gastric drainage channel
4782681|NCT02724956|fiberoptic assessment|fiberoptic assessment
4782682|NCT02724943|child obesity|child obesity
4782683|NCT02724943|primary prevention|primary prevention
4782684|NCT02724943|primary care|primary care
4782685|NCT02724943|weight management|weight management
4782686|NCT02724943|child overweight|child overweight
4782687|NCT02724943|BMI|bmi
4782688|NCT02724930|low back pain, chronic pain, cognitive behavior therapy|low back pain, chronic pain, cognitive behavior therapy
4782689|NCT02724904|Allogeneic hematopoietic stem cell transplantation|allogeneic hematopoietic stem cell transplantation
4782690|NCT02724904|CNS Non-Hodgkin lymphoma|cns non-hodgkin lymphoma
4782691|NCT02724891|Pelvic Floor Dysfunction|pelvic floor dysfunction
4782692|NCT02724878|Kidney Cancer|kidney cancer
4782693|NCT02724865|Oral Appliance Therapy|oral appliance therapy
4782694|NCT02724852|MMR|mmr
4782695|NCT02724852|vaccination|vaccination
4782696|NCT02724852|HIV|hiv
4782697|NCT02724852|Serologic response|serologic response
4782698|NCT02724826|Expectations|expectations
4782699|NCT02724826|Outcomes|outcomes
4782700|NCT02724826|Qigong|qigong
4782701|NCT02724826|Exercise therapy|exercise therapy
4782702|NCT02724826|Disability|disability
4782703|NCT02724826|Neck movements,|neck movements,
4782704|NCT02724800|Insomnia|insomnia
4782705|NCT02724800|Veterans|veterans
4782706|NCT02724800|Cognitive Behavioral Therapy for Insomnia|cognitive behavioral therapy for insomnia
4782707|NCT02724800|Brief Behavioral Treatment for Insomnia|brief behavioral treatment for insomnia
4782708|NCT02724800|Comparative Effectiveness Research|comparative effectiveness research
4782709|NCT02724787|Post-traumatic stress disorder|post-traumatic stress disorder
4782710|NCT02724787|Veterans|veterans
4782711|NCT02724787|Aggression|aggression
4782712|NCT02724787|Emotion regulation|emotion regulation
4782713|NCT02724774|infants|infants
4782714|NCT02724774|mental health|mental health
4782715|NCT02724774|postpartum period|postpartum period
4782716|NCT02724748|Aggression|aggression
4782717|NCT02724748|Mental Health|mental health
4782718|NCT02724748|Education, Continuing|education, continuing
4782719|NCT02724735|Depression|depression
4782720|NCT02724735|Major Depressive Disorder (MDD)|major depressive disorder (mdd)
4782721|NCT02724735|Major Depressive Disorder|major depressive disorder
4782722|NCT02724735|Neurogenesis|neurogenesis
4782723|NCT02724735|Synaptogenesis|synaptogenesis
4782724|NCT02724735|NSI-189|nsi-189
4782725|NCT02724735|Neuralstem|neuralstem
4782726|NCT02724722|melamine|melamine
4782727|NCT02724722|phthalate|phthalate
4782728|NCT02724709|Automatic Data Processing|automatic data processing
4782729|NCT02724709|Three-Dimensional Echocardiography|three-dimensional echocardiography
4782730|NCT02724709|Aortic Valve|aortic valve
4782731|NCT02724683|ascites|ascites
4782732|NCT02724683|drainage|drainage
4782733|NCT02724683|catheter|catheter
4782734|NCT02724683|symptoms|symptoms
4782735|NCT02724683|management|management
4782736|NCT02724683|quality of life|quality of life
4782737|NCT02724683|malignant|malignant
4782738|NCT02724683|cancer|cancer
4782739|NCT02724657|Child|child
4782740|NCT02724657|Breathing exercises|breathing exercises
4782741|NCT02724631|Clogged enteral access devices|clogged enteral access devices
4782742|NCT02724631|Occluded enteral access device|occluded enteral access device
4782743|NCT02724631|Enteral nutrition|enteral nutrition
4782744|NCT02724631|Enteral access device|enteral access device
4782745|NCT02724631|Tube Feeding|tube feeding
4782746|NCT02724631|Gastric Feeding Tubes|gastric feeding tubes
4782747|NCT02724618|Curcumin|curcumin
4782748|NCT02724618|Protection, Radiation|protection, radiation
4782749|NCT02724618|Controlled Clinical Trials, Randomized|controlled clinical trials, randomized
4782750|NCT02724618|Radiation Therapy|radiation therapy
4782751|NCT02724618|Prostate Cancer|prostate cancer
4782752|NCT02724605|RBCS,|rbcs,
4782753|NCT02724605|Transfusion,|transfusion,
4782754|NCT02724605|Pediatric|pediatric
4782755|NCT02724605|Changes|changes
4782756|NCT02724566|Type 2 diabetic volunteers|type 2 diabetic volunteers
4782757|NCT02724527|Cystic Fibrosis|cystic fibrosis
4782758|NCT02724527|N91115|n91115
4782759|NCT02724527|Cavosonstat|cavosonstat
4782760|NCT02724488|Advanced cancer|advanced cancer
4782761|NCT02724488|Advanced solid tumors|advanced solid tumors
4782762|NCT02724488|Phase I clinical trial candidates|phase i clinical trial candidates
4782763|NCT02724488|Phase II clinical trial candidates|phase ii clinical trial candidates
4782764|NCT02724488|Phase III clinical trial candidates|phase iii clinical trial candidates
4782765|NCT02724488|Head and Neck|head and neck
4782766|NCT02724488|Melanoma|melanoma
4782767|NCT02724488|Upper Aerodigestive cancer|upper aerodigestive cancer
4782768|NCT02724488|Oral Cavity|oral cavity
4782769|NCT02724488|Immune Checkpoint Inhibitors|immune checkpoint inhibitors
4782770|NCT02724488|ICIs|icis
4782771|NCT02724488|ctDNA|ctdna
4782772|NCT02724488|Whole Exome Sequencing|whole exome sequencing
4782773|NCT02724488|Molecular Profiling|molecular profiling
4782774|NCT02724475|Laser Ablation|laser ablation
4782775|NCT02724475|Portal Vein Tumor|portal vein tumor
4782776|NCT02724475|Thrombus|thrombus
4782777|NCT02724462|smoking cessation|smoking cessation
4782778|NCT02724462|app for quitting smoking|app for quitting smoking
4782780|NCT02724449|Fecal incontinence|fecal incontinence
4782781|NCT02724436|Yittrium-90|yittrium-90
4782782|NCT02724436|Hepatocellular Carcinoma|hepatocellular carcinoma
4782783|NCT02724423|epilepsy|epilepsy
4782784|NCT02724423|seizure|seizure
4782785|NCT02724410|appendectomy|appendectomy
4782786|NCT02724397|Colon cancer|colon cancer
4782787|NCT02724397|Diagnosis|diagnosis
4782788|NCT02724397|Adenoma|adenoma
4782789|NCT02724397|Serrated lesions|serrated lesions
4782790|NCT02724358|Carcinoma|carcinoma
4782791|NCT02724358|Hepatocellular|hepatocellular
4782792|NCT02724358|Notch1|notch1
4782793|NCT02724345|Cell keratin 18|cell keratin 18
4782794|NCT02724332|Aspartate beta hydroxylase|aspartate beta hydroxylase
4782795|NCT02724332|transcatheter arterial chemoembolization|transcatheter arterial chemoembolization
4782796|NCT02724319|percutaneous coronary intervention|percutaneous coronary intervention
4782797|NCT02724319|clopidogrel|clopidogrel
4782798|NCT02724319|loss-of-function allele|loss-of-function allele
4782799|NCT02724267|131I-chTNT-1/B treatment|131i-chtnt-1/b treatment
4782800|NCT02724254|Genital warts|genital warts
4782801|NCT02724254|HPV types|hpv types
4782802|NCT02724254|Sexually Transmitted Disease|sexually transmitted disease
4782803|NCT02724254|Papillomavirus Infections|papillomavirus infections
4782804|NCT02724254|Viral Disease|viral disease
4782805|NCT02724254|Anogenital warts|anogenital warts
4782806|NCT02724254|AGW|agw
4782807|NCT02724254|HPV6|hpv6
4782808|NCT02724254|HPV11|hpv11
4782809|NCT02724254|Human papillomavirus infection|human papillomavirus infection
4782810|NCT02724254|HPV|hpv
4782811|NCT02724254|Aviragen Therapeutics, Inc.|aviragen therapeutics, inc.
4782812|NCT02724254|Aviragen Therapeutics|aviragen therapeutics
4782813|NCT02724254|Aviragen|aviragen
4782814|NCT02724241|nicotine|nicotine
4782815|NCT02724241|autonomic tone|autonomic tone
4782816|NCT02724241|oxidative stress|oxidative stress
4782817|NCT02724228|Achondroplasia|achondroplasia
4782818|NCT02724228|Dwarfism|dwarfism
4782819|NCT02724228|Bone Diseases, Developmental|bone diseases, developmental
4782820|NCT02724228|Bone Diseases|bone diseases
4782821|NCT02724215|Subarachnoid hemorrhage|subarachnoid hemorrhage
4782822|NCT02724215|Sleep Apnea|sleep apnea
4782823|NCT02724202|Curcumin|curcumin
4782824|NCT02724202|5FU|5fu
4782825|NCT02724202|5-fluorouracil|5-fluorouracil
4782826|NCT02724202|Adracil|adracil
4782827|NCT02724202|5FU Resistant|5fu resistant
4782828|NCT02724202|Metastatic Colon Cancer|metastatic colon cancer
4782829|NCT02724202|Colon Cancer|colon cancer
4782830|NCT02724189|electronic pre-assessment|electronic pre-assessment
4782831|NCT02724189|preoperative assessment|preoperative assessment
4782832|NCT02724163|Acute Myeloid Leukaemia|acute myeloid leukaemia
4782833|NCT02724163|Children|children
4782834|NCT02724163|Gemtuzumab ozogamicin|gemtuzumab ozogamicin
4782835|NCT02724163|Liposomal daunorubicin|liposomal daunorubicin
4782836|NCT02724163|Mitoxantrone|mitoxantrone
4782837|NCT02724163|Randomised controlled trial|randomised controlled trial
4782838|NCT02724163|Risk stratification|risk stratification
4782839|NCT02724163|Minimal residual disease|minimal residual disease
4782840|NCT02724163|Stem cell transplant|stem cell transplant
4782841|NCT02724150|Gastroduodenal Ulcer|gastroduodenal ulcer
4782842|NCT02724150|Marginal Ulcer|marginal ulcer
4782843|NCT02724150|Peptic Ulcer Hemorrhage|peptic ulcer hemorrhage
4782844|NCT02724150|Peptic Ulcer|peptic ulcer
4782845|NCT02724137|Total Knee Replacement|total knee replacement
4782846|NCT02724137|Physical Therapy|physical therapy
4782847|NCT02724137|Fitbit®|fitbit®
4782848|NCT02724124|exercise muscle stretching|exercise muscle stretching
4782849|NCT02724124|electromyography|electromyography
4782850|NCT02724111|Neuromuscular blockade|neuromuscular blockade
4782851|NCT02724111|Surgical rating scale|surgical rating scale
4782852|NCT02724111|Rocuronium|rocuronium
4782853|NCT02724111|Sugammadex|sugammadex
4782854|NCT02724111|Spinal surgery|spinal surgery
4782855|NCT02724111|General anesthesia|general anesthesia
4782856|NCT02724098|Palliative Therapy|palliative therapy
4782857|NCT02724072|Thoracic Surgery|thoracic surgery
4782858|NCT02724072|Aortic Arch|aortic arch
4782859|NCT02724072|Frozen Elephant Trunk|frozen elephant trunk
4782860|NCT02724072|Performance Goal|performance goal
4782861|NCT02724046|Neisseria meningitidis|neisseria meningitidis
4782862|NCT02724046|Ciprofloxacin|ciprofloxacin
4782863|NCT02724046|Chemoprevention|chemoprevention
4782864|NCT02724033|post operative nausea vomiting|post operative nausea vomiting
4782865|NCT02724033|Inner ear surgery|inner ear surgery
4782866|NCT02724020|Drug therapy|drug therapy
4782867|NCT02724007|Trauma|trauma
4782868|NCT02724007|India|india
4782869|NCT02724007|ICISS|iciss
4782870|NCT02723994|B-cell acute lymphoblastic leukemia (ALL)|b-cell acute lymphoblastic leukemia (all)
4782871|NCT02723994|pediatric|pediatric
4782872|NCT02723994|multi-agent chemotherapy|multi-agent chemotherapy
4782873|NCT02723994|JAK inhibitor|jak inhibitor
4782874|NCT02723981|Stent , COMBO Stent, anticoagulation|stent , combo stent, anticoagulation
4782875|NCT02723955|ICOS receptor agonist antibody|icos receptor agonist antibody
4782876|NCT02723955|Pembrolizumab|pembrolizumab
4782877|NCT02723955|KEYNOTE-478|keynote-478
4782878|NCT02723955|GSK3359609|gsk3359609
4782879|NCT02723955|Cohort expansion|cohort expansion
4782880|NCT02723955|Dose escalation|dose escalation
4782881|NCT02723942|glypican-3(GPC3)|glypican-3(gpc3)
4782882|NCT02723942|chimeric antigen receptor-modified T cell(CAR-T)|chimeric antigen receptor-modified t cell(car-t)
4782883|NCT02723942|hepatocellular carcinoma(HCC)|hepatocellular carcinoma(hcc)
4782884|NCT02723929|transcranial direct current stimulation|transcranial direct current stimulation
4782885|NCT02723929|transcranial ultrasound|transcranial ultrasound
4782886|NCT02723929|non-invasive brain stimulation|non-invasive brain stimulation
4782887|NCT02723916|Parents|parents
4782888|NCT02723916|Child|child
4782889|NCT02723916|Preschool|preschool
4782890|NCT02723916|eHealth|ehealth
4782891|NCT02723903|somatization symptom score|somatization symptom score
4782892|NCT02723903|SSS checklist|sss checklist
4782893|NCT02723903|coronary angiography|coronary angiography
4782894|NCT02723903|Patient Health Questionnaire|patient health questionnaire
4782895|NCT02723903|Generalized Anxiety Disorder 7-items|generalized anxiety disorder 7-items
4782896|NCT02723877|TNBC|tnbc
4782897|NCT02723864|Pharmacodynamic|pharmacodynamic
4782898|NCT02723864|DNA Damage Repair|dna damage repair
4782899|NCT02723864|BRCA Null|brca null
4782900|NCT02723864|Apoptosis|apoptosis
4782901|NCT02723864|Combination Therapy|combination therapy
4782902|NCT02723838|Bladder|bladder
4782903|NCT02723838|Cancer|cancer
4782904|NCT02723838|REOLYSIN®|reolysin®
4782905|NCT02723838|Gemcitabine|gemcitabine
4782906|NCT02723838|Cisplatin|cisplatin
4782907|NCT02723838|Reovirus|reovirus
4782908|NCT02723838|Oncolytic virus|oncolytic virus
4782909|NCT02723825|Distal tibia|distal tibia
4782910|NCT02723825|fractures|fractures
4782911|NCT02723825|epiphyses|epiphyses
4782912|NCT02723825|children|children
4782913|NCT02723812|Influenza|influenza
4782914|NCT02723812|GCFLU|gcflu
4782915|NCT02723812|vaccine|vaccine
4782916|NCT02723812|Vietnam|vietnam
4782917|NCT02723799|Hope|hope
4782918|NCT02723786|Delayed Graft Function|delayed graft function
4782919|NCT02723786|Renal Transplantation|renal transplantation
4782920|NCT02723786|Prevention|prevention
4782921|NCT02723786|GSK1070806|gsk1070806
4782922|NCT02723773|Efficacy|efficacy
4782923|NCT02723773|Immunogenicity|immunogenicity
4782924|NCT02723773|Safety|safety
4782925|NCT02723773|Adults|adults
4782926|NCT02723773|Herpes zoster|herpes zoster
4782927|NCT02723747|myocardial ischemia|myocardial ischemia
4782928|NCT02723747|magnetic resonance imaging|magnetic resonance imaging
4782929|NCT02723747|perfusion|perfusion
4782930|NCT02723747|software|software
4782931|NCT02723734|Decipher®|decipher®
4782932|NCT02723734|African-American men|african-american men
4782933|NCT02723734|prostate|prostate
4782934|NCT02723734|low risk PCa|low risk pca
4782935|NCT02723734|intermediate risk PCa|intermediate risk pca
4782936|NCT02723734|genomic classifier (GC)|genomic classifier (gc)
4782937|NCT02723721|Lentigo maligna|lentigo maligna
4782938|NCT02723695|Cochlear implant|cochlear implant
4782939|NCT02723695|Perception|perception
4782940|NCT02723695|Posture|posture
4782941|NCT02723695|Quality of life|quality of life
4782942|NCT02723669|Relative Bioavailability|relative bioavailability
4782943|NCT02723656|smoking|smoking
4782944|NCT02723656|cancer|cancer
4782945|NCT02723656|cancer registry|cancer registry
4782946|NCT02723656|smoking cessation|smoking cessation
4782947|NCT02723643|Hypertension|hypertension
4782948|NCT02723643|Essential hypertension|essential hypertension
4782949|NCT02723643|Blood pressure|blood pressure
4782950|NCT02723643|Cardiovascular diseases|cardiovascular diseases
4782951|NCT02723630|Bioequivalence|bioequivalence
4782952|NCT02723630|Lenvatinib|lenvatinib
4782953|NCT02723630|Healthy Volunteers|healthy volunteers
4782954|NCT02723630|Lenvima|lenvima
4782955|NCT02723630|E7080|e7080
4782956|NCT02723591|FK506|fk506
4782957|NCT02723591|Kidney Transplantation|kidney transplantation
4782958|NCT02723591|Tacrolimus|tacrolimus
4782959|NCT02723591|Astagraf XL|astagraf xl
4782960|NCT02723552|preeclampsia|preeclampsia
4782961|NCT02723552|young adult hypertension|young adult hypertension
4782962|NCT02723552|preterm birth|preterm birth
4782963|NCT02723526|Metastatic Hormone-Sensitive Prostate Cancer；circulating tumor cells；Prognosis；Liquid biopsy|metastatic hormone-sensitive prostate cancer；circulating tumor cells；prognosis；liquid biopsy
4782964|NCT02723513|Proton MRI|proton mri
4782965|NCT02723513|Noble Gas MRI|noble gas mri
4782966|NCT02723513|Pulmonary Function|pulmonary function
4782967|NCT02723500|Magnetic Resonance Imaging|magnetic resonance imaging
4782968|NCT02723500|Pulmonary Function|pulmonary function
4782969|NCT02723487|TAP block|tap block
4782970|NCT02723487|pediatric|pediatric
4782971|NCT02723487|Laparoscopic|laparoscopic
4782972|NCT02723487|postoperative pain|postoperative pain
4782973|NCT02723474|Magnetic Resonance Imaging|magnetic resonance imaging
4782974|NCT02723474|Pulmonary Function|pulmonary function
4782975|NCT02723396|Parkinson's disease|parkinson's disease
4782976|NCT02723396|Sleep Benefit|sleep benefit
4782977|NCT02723383|alcoholism|alcoholism
4782978|NCT02723383|intensive care|intensive care
4782979|NCT02723383|Baclofen|baclofen
4782980|NCT02723383|restlessness|restlessness
4782981|NCT02723383|Delirium tremens|delirium tremens
4782982|NCT02723383|Alcohol withdrawal syndrome|alcohol withdrawal syndrome
4782983|NCT02723370|Quality of Healthcare|quality of healthcare
4782984|NCT02723370|Colorectal neoplasms|colorectal neoplasms
4782985|NCT02723370|Health Literacy|health literacy
4782986|NCT02723370|Teach-Back Communication|teach-back communication
4782987|NCT02723370|Evidence Based Practice|evidence based practice
4782988|NCT02723370|Colonoscopy|colonoscopy
4782989|NCT02723357|Financial Coaching|financial coaching
4782990|NCT02723357|Mental Health|mental health
4782991|NCT02723357|Social Determinants|social determinants
4782992|NCT02723357|Medical-Financial Partnership|medical-financial partnership
4782993|NCT02723357|Toxic Stress|toxic stress
4782994|NCT02723344|PTSD|ptsd
4782995|NCT02723344|Mild TBI|mild tbi
4782996|NCT02723344|Probiotic|probiotic
4782997|NCT02723344|Inflammation|inflammation
4782998|NCT02723331|Stereotactic Body Radiation Therapy|stereotactic body radiation therapy
4782999|NCT02723331|Perioperative Therapy|perioperative therapy
4783000|NCT02723331|Resectable Pancreas Ductal Adenocarcinoma|resectable pancreas ductal adenocarcinoma
4783001|NCT02723331|Borderline Resectable Pancreas Ductal Adenocarcinoma|borderline resectable pancreas ductal adenocarcinoma
4783002|NCT02723331|Nab-paclitaxel|nab-paclitaxel
4783003|NCT02723331|Abraxane|abraxane
4783004|NCT02723331|Gemcitabine|gemcitabine
4783005|NCT02723331|Neoadjuvant Therapy|neoadjuvant therapy
4783006|NCT02723331|Adjuvant Therapy|adjuvant therapy
4783007|NCT02723318|Cognition|cognition
4783008|NCT02723318|Financial Coaching|financial coaching
4783009|NCT02723318|Social Determinants of Health|social determinants of health
4783010|NCT02723318|Socioeconomic Status|socioeconomic status
4783011|NCT02723305|Klinefelter syndrome|klinefelter syndrome
4783012|NCT02723305|XXY|xxy
4783013|NCT02723305|Sex chromosome aneuploidy|sex chromosome aneuploidy
4783014|NCT02723305|sex chromosome variation|sex chromosome variation
4783015|NCT02723305|hypogonadism|hypogonadism
4783016|NCT02723305|cardiometabolic|cardiometabolic
4783017|NCT02723305|body composition|body composition
4783018|NCT02723305|exercise capacity|exercise capacity
4783019|NCT02723279|Urgency-frequency Syndrome|urgency-frequency syndrome
4783020|NCT02723279|Electrical Pudendal Nerve Stimulation|electrical pudendal nerve stimulation
4783021|NCT02723279|Tolterodine Tartrate|tolterodine tartrate
4783022|NCT02723266|American Indian, Alaska Native Adolescents|american indian, alaska native adolescents
4783023|NCT02723266|Preconception Counseling|preconception counseling
4783024|NCT02723266|Reproductive Health|reproductive health
4783025|NCT02723266|Gestational Diabetes Mellitus|gestational diabetes mellitus
4783026|NCT02723253|rectal cancer|rectal cancer
4783027|NCT02723253|radiotherapy|radiotherapy
4783028|NCT02723253|chemotherapy|chemotherapy
4783029|NCT02723253|Raltitrexed|raltitrexed
4783030|NCT02723253|Oxaliplatin|oxaliplatin
4783031|NCT02723240|NUC-3373|nuc-3373
4783032|NCT02723240|Dose escalation|dose escalation
4783033|NCT02723240|Nucleotide Analogue|nucleotide analogue
4783034|NCT02723227|Parenting Stress|parenting stress
4783035|NCT02723227|Stress|stress
4783036|NCT02723227|Social Determinants|social determinants
4783037|NCT02723227|Socioeconomic status|socioeconomic status
4783038|NCT02723227|Financial Coaching|financial coaching
4783039|NCT02723175|Fibromyalgia|fibromyalgia
4783040|NCT02723175|Pain|pain
4783041|NCT02723136|Smartphone|smartphone
4783043|NCT02723136|Internal Medicine|internal medicine
4783044|NCT02723123|CPAP|cpap
4783045|NCT02723123|NIPPV|nippv
4783046|NCT02723123|Extubation failure|extubation failure
4783047|NCT02723123|Cardiorespiratory behaviour|cardiorespiratory behaviour
4783048|NCT02723123|NIV-NAVA|niv-nava
4783049|NCT02723110|Type 2 Diabetes Risk|type 2 diabetes risk
4783050|NCT02723084|Hepatitis C Virus|hepatitis c virus
4783051|NCT02723084|Non-cirrhotic|non-cirrhotic
4783052|NCT02723084|Hepatitis C Genotype 2|hepatitis c genotype 2
4783053|NCT02723084|Chronic Hepatitis C Virus|chronic hepatitis c virus
4783054|NCT02723058|Depression|depression
4783055|NCT02723058|Homelessness|homelessness
4783056|NCT02723058|Primary care|primary care
4783057|NCT02723006|Drug Therapy|drug therapy
4783058|NCT02722954|malignancy|malignancy
4783059|NCT02722954|metastatic|metastatic
4783060|NCT02722954|Demcizumab|demcizumab
4783061|NCT02722954|Pembrolizumab|pembrolizumab
4783062|NCT02722954|Phase 1b|phase 1b
4783063|NCT02722941|autologous hematopoietic cell transplant (HCT)|autologous hematopoietic cell transplant (hct)
4783064|NCT02722941|autologous|autologous
4783065|NCT02722928|Postoperative pneumocephalus|postoperative pneumocephalus
4783066|NCT02722928|Fraction of inspired oxygen|fraction of inspired oxygen
4783067|NCT02722928|Intracranial surgery|intracranial surgery
4783068|NCT02722915|fMRI|fmri
4783069|NCT02722915|neurofeedback|neurofeedback
4783070|NCT02722915|hallucination|hallucination
4783071|NCT02722915|schizophrenia|schizophrenia
4783072|NCT02722902|Metabolic flexibility|metabolic flexibility
4783073|NCT02722902|Insulin sensitivity|insulin sensitivity
4783074|NCT02722889|Ascending aorta|ascending aorta
4783075|NCT02722889|Elongation of the aorta|elongation of the aorta
4783076|NCT02722889|Type A dissection|type a dissection
4783077|NCT02722889|Aortic rupture|aortic rupture
4783078|NCT02722889|Aortic length|aortic length
4783079|NCT02722876|Rehabilitation|rehabilitation
4783080|NCT02722876|Cross-education|cross-education
4783081|NCT02722850|breast cancer|breast cancer
4783082|NCT02722850|cancer survivorship|cancer survivorship
4783083|NCT02722850|dietary intake|dietary intake
4783084|NCT02722850|physical activity|physical activity
4783085|NCT02722850|quality of life|quality of life
4783086|NCT02722824|motor symptoms|motor symptoms
4783087|NCT02722811|Etanercept|etanercept
4783088|NCT02722811|Osteoarthritis Of Knee|osteoarthritis of knee
4783089|NCT02722811|TNF-α|tnf-α
4783090|NCT02722811|IL-1α|il-1α
4783091|NCT02722811|Subcutaneous Injection|subcutaneous injection
4783092|NCT02722785|Exercise training|exercise training
4783093|NCT02722785|Surgical complications|surgical complications
4783094|NCT02722785|Cancer prognosis|cancer prognosis
4783095|NCT02722785|Muscle function|muscle function
4783096|NCT02722785|Body composition|body composition
4783097|NCT02722785|Pulmonary function|pulmonary function
4783098|NCT02722785|Quality of life|quality of life
4783099|NCT02722772|Intra-Articular Injection|intra-articular injection
4783100|NCT02722772|Etanercept|etanercept
4783101|NCT02722772|TNF-α|tnf-α
4783102|NCT02722772|IL-1|il-1
4783103|NCT02722772|Osteoarthritis of Knee|osteoarthritis of knee
4783104|NCT02722746|Epidural Analgesia|epidural analgesia
4783105|NCT02722733|Hodgkin's lymphoma|hodgkin's lymphoma
4783106|NCT02722733|Non-Hodgkin's lymphoma|non-hodgkin's lymphoma
4783107|NCT02722733|mobilization|mobilization
4783108|NCT02722733|G-CSF|g-csf
4783109|NCT02722733|filgrastim|filgrastim
4783110|NCT02722733|cytosine arabinoside|cytosine arabinoside
4783111|NCT02722733|autologous stem cell transplantation|autologous stem cell transplantation
4783112|NCT02722720|Carotid atherosclerosis|carotid atherosclerosis
4783113|NCT02722720|Carotid stenosis|carotid stenosis
4783114|NCT02722720|Ischemic attack|ischemic attack
4783115|NCT02722720|Stroke|stroke
4783116|NCT02722720|Carotid stenting|carotid stenting
4783117|NCT02722720|Transradial approach|transradial approach
4783118|NCT02722720|Transfemoral approach|transfemoral approach
4783119|NCT02722720|Bleeding|bleeding
4783120|NCT02722720|Thromboembolism|thromboembolism
4783121|NCT02722720|Embolism|embolism
4783122|NCT02722720|Neurocognitive disorders|neurocognitive disorders
4783123|NCT02722668|AML|aml
4783124|NCT02722668|ALL|all
4783125|NCT02722668|CML|cml
4783126|NCT02722668|CLL|cll
4783127|NCT02722668|SLL|sll
4783128|NCT02722655|Pediatrics|pediatrics
4783129|NCT02722629|COPD|copd
4783130|NCT02722629|Respiratory Aspiration|respiratory aspiration
4783131|NCT02722629|COPD acute exacerbation|copd acute exacerbation
4783132|NCT02722616|Ultrasound|ultrasound
4783133|NCT02722590|Epilepsy|epilepsy
4783134|NCT02722590|Partial-onset seizures|partial-onset seizures
4783135|NCT02722590|secondarily generalized seizures|secondarily generalized seizures
4783136|NCT02722551|Mitral|mitral
4783137|NCT02722551|Regurgitation|regurgitation
4783138|NCT02722551|Insufficiency|insufficiency
4783139|NCT02722551|Degenerative|degenerative
4783140|NCT02722551|Functional|functional
4783141|NCT02722551|Primary|primary
4783142|NCT02722551|Secondary|secondary
4783143|NCT02722551|Organic|organic
4783144|NCT02722551|Transcatheter|transcatheter
4783145|NCT02722551|TMVR|tmvr
4783146|NCT02722551|TMVI|tmvi
4783148|NCT02722551|Mitral valve|mitral valve
4783149|NCT02722551|Transapical|transapical
4783150|NCT02722551|Transfemoral|transfemoral
4783151|NCT02722551|Transeptal|transeptal
4783152|NCT02722551|Severe|severe
4783153|NCT02722525|ADT|adt
4783154|NCT02722525|Prostate cancer|prostate cancer
4783155|NCT02722499|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
4783156|NCT02722499|Diabetes Mellitus, Adult-Onset|diabetes mellitus, adult-onset
4783157|NCT02722499|Diabetes Mellitus, Non-Insulin-Dependent|diabetes mellitus, non-insulin-dependent
4783158|NCT02722499|Diabetes Mellitus, Noninsulin Dependent|diabetes mellitus, noninsulin dependent
4783159|NCT02722499|Diabetes Mellitus, Type II|diabetes mellitus, type ii
4783160|NCT02722499|African American|african american
4783161|NCT02722499|Blacks|blacks
4783162|NCT02722499|non-Hispanic Blacks|non-hispanic blacks
4783163|NCT02722499|Randomized Control Trial|randomized control trial
4783164|NCT02722499|Controlled Clinical Trial|controlled clinical trial
4783165|NCT02722499|Behavioral Research|behavioral research
4783166|NCT02722499|Behavioral Medicine|behavioral medicine
4783167|NCT02722421|efavirenz|efavirenz
4783168|NCT02722421|levonorgestrel|levonorgestrel
4783169|NCT02722421|contraceptive implant|contraceptive implant
4783170|NCT02722408|LDL-C|ldl-c
4783171|NCT02722408|Lipid Regulator|lipid regulator
4783172|NCT02722382|Chronic Kidney Disease|chronic kidney disease
4783173|NCT02722291|presbyopia|presbyopia
4783174|NCT02722265|Essential hypertension|essential hypertension
4783175|NCT02722265|Long-term treatment|long-term treatment
4783176|NCT02722265|Mineralocorticoid receptor antagonist|mineralocorticoid receptor antagonist
4783177|NCT02722252|In Vitro Fertilization with ICSI|in vitro fertilization with icsi
4783178|NCT02722239|Xigduo;|xigduo;
4783179|NCT02722239|bioequivalence;|bioequivalence;
4783180|NCT02722239|crossover;|crossover;
4783181|NCT02722239|Russia|russia
4783182|NCT02722226|High fidelity simulation|high fidelity simulation
4783183|NCT02722226|Sedation|sedation
4783184|NCT02722226|Medical education|medical education
4783185|NCT02722200|fMRI obesity|fmri obesity
4783186|NCT02722148|Eosinophilic Esophagitis|eosinophilic esophagitis
4783187|NCT02722148|Diet Elimination Therapy|diet elimination therapy
4783188|NCT02722122|Cystic Fibrosis|cystic fibrosis
4783189|NCT02722122|CF|cf
4783190|NCT02722122|AIR DNase™|air dnase™
4783191|NCT02722122|Digestive System Diseases|digestive system diseases
4783192|NCT02722122|Genetic Diseases, Inborn|genetic diseases, inborn
4783193|NCT02722122|Infant, New born, Diseases|infant, new born, diseases
4783194|NCT02722122|Lung diseases|lung diseases
4783195|NCT02722122|Pancreatic Diseases|pancreatic diseases
4783196|NCT02722122|Respiratory Tract Diseases|respiratory tract diseases
4783197|NCT02722096|arteriovenous fistula|arteriovenous fistula
4783198|NCT02722096|regional anesthesia|regional anesthesia
4783199|NCT02722096|local anesthesia|local anesthesia
4783200|NCT02722096|early complication|early complication
4783201|NCT02722031|intensive care|intensive care
4783202|NCT02722031|prevalence|prevalence
4783203|NCT02722031|hypoxemia|hypoxemia
4783204|NCT02722031|ARDS|ards
4783205|NCT02722005|Health related quality of life|health related quality of life
4783206|NCT02722005|Financial Coaching|financial coaching
4783207|NCT02722005|Medical Financial Partnership|medical financial partnership
4783208|NCT02722005|Social Determinants of Health|social determinants of health
4783209|NCT02722005|Socioeconomic status|socioeconomic status
4783210|NCT02721966|Assessment of spondyloarthritis international society (ASAS)|assessment of spondyloarthritis international society (asas)
4783211|NCT02721966|ASAS|asas
4783212|NCT02721966|axial|axial
4783213|NCT02721966|Psoriatic Arthritis (PsA)|psoriatic arthritis (psa)
4783214|NCT02721966|PsA|psa
4783215|NCT02721966|Magnetic resonance imaging (MRI)|magnetic resonance imaging (mri)
4783216|NCT02721966|MRI|mri
4783217|NCT02721927|refugees|refugees
4783218|NCT02721927|Syrian|syrian
4783219|NCT02721927|cost|cost
4783220|NCT02721927|visit|visit
4783221|NCT02721914|low-back pain|low-back pain
4783222|NCT02721914|massage therapy|massage therapy
4783223|NCT02721914|Gymnastics|gymnastics
4783224|NCT02721914|disability|disability
4783225|NCT02721901|Gastrointestinal Disorders|gastrointestinal disorders
4783226|NCT02721901|Nutrition|nutrition
4783227|NCT02721901|Behavioral|behavioral
4783228|NCT02721862|gallstones|gallstones
4783229|NCT02721862|cholelithiasis|cholelithiasis
4783230|NCT02721862|sleeve gastrectomy|sleeve gastrectomy
4783231|NCT02721797|hypermobility|hypermobility
4783232|NCT02721797|collagen|collagen
4783233|NCT02721797|joint|joint
4783234|NCT02721797|hyperflexation|hyperflexation
4783235|NCT02721784|MRI|mri
4783236|NCT02721784|Radiotherapy|radiotherapy
4783237|NCT02721758|Motivational Interviewing|motivational interviewing
4783238|NCT02721758|Health Behavior|health behavior
4783239|NCT02721758|Cardiac Rehabilitation|cardiac rehabilitation
4783240|NCT02721732|Advanced Cancers|advanced cancers
4783241|NCT02721732|Rare tumors|rare tumors
4783242|NCT02721732|Squamous cell carcinoma of the skin|squamous cell carcinoma of the skin
4783243|NCT02721732|Anaplastic thyroid cancer|anaplastic thyroid cancer
4783244|NCT02721732|Adrenocortical carcinoma|adrenocortical carcinoma
4783245|NCT02721732|Medullary renal cell carcinoma|medullary renal cell carcinoma
4783246|NCT02721732|Carcinoma of unknown primary|carcinoma of unknown primary
4783247|NCT02721732|Penile carcinoma|penile carcinoma
4783248|NCT02721732|Thymoma|thymoma
4783249|NCT02721732|Testicular carcinoma|testicular carcinoma
4783250|NCT02721732|Paraganglioma-pheochromocytoma|paraganglioma-pheochromocytoma
4783251|NCT02721732|Pembrolizumab|pembrolizumab
4783252|NCT02721732|Keytruda|keytruda
4783253|NCT02721732|MK-3475|mk-3475
4783254|NCT02721732|SCH-900475|sch-900475
4783255|NCT02721719|Ulcerative Colitis|ulcerative colitis
4783256|NCT02721719|UC|uc
4783257|NCT02721719|Vedolizumab|vedolizumab
4783258|NCT02721719|Entyvio|entyvio
4783259|NCT02721719|Inflammatory Bowl Disease|inflammatory bowl disease
4783260|NCT02721719|IBD|ibd
4783261|NCT02721719|T-Lymphocytes, Regulatory|t-lymphocytes, regulatory
4783262|NCT02721706|Nutrition assessment|nutrition assessment
4783263|NCT02721706|inpatients|inpatients
4783264|NCT02721706|cost-benefit analysis|cost-benefit analysis
4783265|NCT02721706|quality of life|quality of life
4783266|NCT02721706|body composition|body composition
4783267|NCT02721706|mass screening|mass screening
4783268|NCT02721693|Troponin|troponin
4783269|NCT02721693|Exercise|exercise
4783270|NCT02721667|Blood pressure|blood pressure
4783271|NCT02721667|Telemonitoring|telemonitoring
4783272|NCT02721667|Case management|case management
4783273|NCT02721667|Seniors|seniors
4783274|NCT02721654|Plasma-Lyte|plasma-lyte
4783275|NCT02721654|Sodium chloride|sodium chloride
4783276|NCT02721654|Saline|saline
4783277|NCT02721654|Fluid resuscitation|fluid resuscitation
4783278|NCT02721654|Intravenous fluid therapy|intravenous fluid therapy
4783279|NCT02721654|Critically ill|critically ill
4783280|NCT02721654|Critical care|critical care
4783281|NCT02721628|Keratoconus|keratoconus
4783282|NCT02721615|intra spinal pressure|intra spinal pressure
4783283|NCT02721615|spinal cord perfusion pressure|spinal cord perfusion pressure
4783284|NCT02721615|microdialysis|microdialysis
4783285|NCT02721615|duroplasty|duroplasty
4783286|NCT02721537|Brain Nicotinamide Adenine Dinucleotide (NAD+)|brain nicotinamide adenine dinucleotide (nad+)
4783287|NCT02721537|Adenosine Triphosphate (ATP) Depletion|adenosine triphosphate (atp) depletion
4783288|NCT02721537|Polyadenosine Diphosphate-Ribosepolymerase (PARP) Activation|polyadenosine diphosphate-ribosepolymerase (parp) activation
4783289|NCT02721524|Ring Annuloplasty|ring annuloplasty
4783290|NCT02721524|Suture Annuloplasty|suture annuloplasty
4783291|NCT02721524|Functional Tricuspid Regurgitation|functional tricuspid regurgitation
4783292|NCT02721498|Respiratory Physiotherapy|respiratory physiotherapy
4783293|NCT02721498|Airway clearance techniques|airway clearance techniques
4783294|NCT02721498|Outcome measures|outcome measures
4783295|NCT02721485|Ringer's Lactate|ringer's lactate
4783296|NCT02721485|Normal Saline|normal saline
4783297|NCT02721485|resuscitation fluids|resuscitation fluids
4783298|NCT02721485|hypovolemia|hypovolemia
4783299|NCT02721459|unresectable melanoma|unresectable melanoma
4783300|NCT02721459|stage III melanoma|stage iii melanoma
4783301|NCT02721459|stage IV melanoma|stage iv melanoma
4783302|NCT02721459|AJCC melanoma staging|ajcc melanoma staging
4783303|NCT02721459|American Joint Committee on Cancer (AJCC)|american joint committee on cancer (ajcc)
4783304|NCT02721459|BRAF V600 E mutation|braf v600 e mutation
4783305|NCT02721459|BRAF V600 K mutation|braf v600 k mutation
4783306|NCT02721394|Challenging Behaviour|challenging behaviour
4783307|NCT02721394|Functional Communication Training|functional communication training
4783308|NCT02721394|Positive Behavioural Support|positive behavioural support
4783309|NCT02721394|Family carer training|family carer training
4783310|NCT02721381|Autism Spectrum Disorder|autism spectrum disorder
4783311|NCT02721381|Parent training|parent training
4783312|NCT02721381|Telehealth|telehealth
4783313|NCT02721381|RCT|rct
4783314|NCT02721355|Chronic gastritis|chronic gastritis
4783315|NCT02721355|Gastric ulcer|gastric ulcer
4783316|NCT02721355|Helicobacter pylori|helicobacter pylori
4783317|NCT02721355|IgY|igy
4783318|NCT02721342|Chronic proteinuric nephropathies|chronic proteinuric nephropathies
4783319|NCT02721329|Obstructive Sleep Apnea|obstructive sleep apnea
4783320|NCT02721329|OSA|osa
4783321|NCT02721329|Insomnia|insomnia
4783322|NCT02721329|CPAP|cpap
4783323|NCT02721329|SensAwake|sensawake
4783324|NCT02721290|Knee surgery|knee surgery
4783325|NCT02721277|Parenteral nutrition, Total|parenteral nutrition, total
4783326|NCT02721277|Infant, newborn|infant, newborn
4783327|NCT02721277|Cholestasis|cholestasis
4783328|NCT02721277|Enterocolitis, Necrotizing|enterocolitis, necrotizing
4783329|NCT02721251|exercise|exercise
4783330|NCT02721251|weight loss|weight loss
4783331|NCT02721251|sleep apnea|sleep apnea
4783332|NCT02721212|Robotic|robotic
4783333|NCT02721212|Stroke|stroke
4783334|NCT02721212|Upper Limb Rehabilitation|upper limb rehabilitation
4783335|NCT02721186|Malaria|malaria
4783336|NCT02721186|Plasmodium|plasmodium
4783337|NCT02721186|Mass drug administration|mass drug administration
4783338|NCT02721186|Malaria elimination|malaria elimination
4783339|NCT02721186|Zanzibar|zanzibar
4783340|NCT02721186|Dihydroartemisinin-Piperaquine|dihydroartemisinin-piperaquine
4783341|NCT02721186|Single low dose Primaquine|single low dose primaquine
4783342|NCT02721173|Tazarotene|tazarotene
4783343|NCT02721173|Adapalene|adapalene
4783344|NCT02721173|Clindamycin|clindamycin
4783345|NCT02721160|performance-based financing|performance-based financing
4783346|NCT02721160|malnutrition|malnutrition
4783347|NCT02721160|impact evaluation|impact evaluation
4783348|NCT02721108|Mindfulness|mindfulness
4783349|NCT02721108|Headspace|headspace
4783350|NCT02721108|Psychological approaches|psychological approaches
4783351|NCT02721108|Progressive muscle relaxation|progressive muscle relaxation
4783352|NCT02721082|tobacco treatment|tobacco treatment
4783353|NCT02721069|Seizures|seizures
4783354|NCT02721069|Epilepsy|epilepsy
4783355|NCT02721043|Personalized vaccine|personalized vaccine
4783356|NCT02721043|Poly-ICLC|poly-iclc
4783357|NCT02721043|Immunotherapy|immunotherapy
4783358|NCT02721043|Cancer|cancer
4783359|NCT02721030|Heartfailure|heartfailure
4783360|NCT02721030|1-year mortality|1-year mortality
4783361|NCT02721030|heartfailure quality of life|heartfailure quality of life
4783362|NCT02721030|sub-Saharan Africa|sub-saharan africa
4783363|NCT02721017|Nuss|nuss
4783364|NCT02721017|Nuss Procedure|nuss procedure
4783365|NCT02721017|pectus excavatum|pectus excavatum
4783366|NCT02721017|cryoanalgesia|cryoanalgesia
4783367|NCT02721004|Rheumatoid arthritis|rheumatoid arthritis
4783368|NCT02721004|RoActemra|roactemra
4783369|NCT02721004|Tocilizumab|tocilizumab
4783370|NCT02720965|Pain Acute|pain acute
4783371|NCT02720965|Orthopedic Surgery|orthopedic surgery
4783372|NCT02720965|Satisfaction Nerve Blocks|satisfaction nerve blocks
4783373|NCT02720913|Time|time
4783374|NCT02720913|COR-KNOT|cor-knot
4783375|NCT02720913|Standard|standard
4783376|NCT02720913|Cost|cost
4783377|NCT02720887|pregnant women|pregnant women
4783378|NCT02720887|nanoparticles|nanoparticles
4783379|NCT02720887|amniotic fluid|amniotic fluid
4783380|NCT02720861|RNF213 rs112735431 Gene|rnf213 rs112735431 gene
4783381|NCT02720861|Acute Non-embolic ischemic stroke|acute non-embolic ischemic stroke
4783382|NCT02720848|double-balloon enteroscopy|double-balloon enteroscopy
4783383|NCT02720809|micronutrients|micronutrients
4783384|NCT02720809|blood pressure|blood pressure
4783385|NCT02720809|allergy|allergy
4783386|NCT02720809|lung function|lung function
4783388|NCT02720796|TumorGraft|tumorgraft
4783389|NCT02720796|Patient derived xenograft|patient derived xenograft
4783390|NCT02720796|sarcoma|sarcoma
4783391|NCT02720783|Pharmacokinetics|pharmacokinetics
4783392|NCT02720783|Econazole nitrate 150mg|econazole nitrate 150mg
4783393|NCT02720783|Benzydamine HCl 6mg|benzydamine hcl 6mg
4783394|NCT02720783|Vaginal pessary|vaginal pessary
4783395|NCT02720783|Tolerability|tolerability
4783396|NCT02720770|growth hormone|growth hormone
4783397|NCT02720718|Gastric Bypass Status for Obesity Complicating Pregnancy, Childbirth and the Puerperium|gastric bypass status for obesity complicating pregnancy, childbirth and the puerperium
4783398|NCT02720718|Laparoscopy|laparoscopy
4783399|NCT02720718|Suture Techniques|suture techniques
4783400|NCT02720718|Sutures|sutures
4783401|NCT02720705|sevoflurane emergence agitation|sevoflurane emergence agitation
4783402|NCT02720692|Pain|pain
4783403|NCT02720692|Analgesia|analgesia
4783404|NCT02720692|N1539|n1539
4783405|NCT02720692|Phase 3|phase 3
4783406|NCT02720679|Genetics|genetics
4783407|NCT02720679|Whole genome sequencing|whole genome sequencing
4783408|NCT02720679|Pediatrics and hematology|pediatrics and hematology
4783409|NCT02720627|acne|acne
4783410|NCT02720627|cortexolone|cortexolone
4783411|NCT02720627|anti-androgen|anti-androgen
4783412|NCT02720614|accelerated hypofractionated radiotherapy|accelerated hypofractionated radiotherapy
4783413|NCT02720614|three-dimensional conformal radiation therapy|three-dimensional conformal radiation therapy
4783414|NCT02720614|concurrent radiochemotherapy|concurrent radiochemotherapy
4783415|NCT02720601|irinotecan|irinotecan
4783416|NCT02720601|capecitabine|capecitabine
4783417|NCT02720601|gemcitabine|gemcitabine
4783418|NCT02720601|biliary tract cancer|biliary tract cancer
4783419|NCT02720601|gallbladder cancer|gallbladder cancer
4783420|NCT02720601|second-line|second-line
4783421|NCT02720575|Vitamin D|vitamin d
4783422|NCT02720575|Bioavailability|bioavailability
4783423|NCT02720575|Fortified Bread|fortified bread
4783424|NCT02720536|Anemia.|anemia.
4783425|NCT02720536|Myelodysplastic Syndrome|myelodysplastic syndrome
4783426|NCT02720536|Thalassemia|thalassemia
4783427|NCT02720536|Film coated tablet|film coated tablet
4783428|NCT02720523|rheumatoid arthritis|rheumatoid arthritis
4783429|NCT02720523|ABT-494|abt-494
4783430|NCT02720523|Japanese|japanese
4783431|NCT02720523|Antirheumatic agents|antirheumatic agents
4783432|NCT02720510|multiple myeloma|multiple myeloma
4783433|NCT02720510|farydak|farydak
4783434|NCT02720510|panobinostat|panobinostat
4783435|NCT02720510|LBH589|lbh589
4783436|NCT02720510|ASCT|asct
4783437|NCT02720510|transplant|transplant
4783438|NCT02720471|local analgesia|local analgesia
4783439|NCT02720471|total hip replacement|total hip replacement
4783440|NCT02720471|local infiltrations|local infiltrations
4783441|NCT02720458|Hypnotics withdrawal in insomniac patients|hypnotics withdrawal in insomniac patients
4783442|NCT02720458|Cognitive-Behavioural Therapy (CBT)|cognitive-behavioural therapy (cbt)
4783443|NCT02720458|Internet-delivered self-help program|internet-delivered self-help program
4783444|NCT02720458|Sleep restriction|sleep restriction
4783445|NCT02720458|Stimulus control|stimulus control
4783446|NCT02720458|Half-life benzodiazepine|half-life benzodiazepine
4783447|NCT02720458|Z-drug|z-drug
4783448|NCT02720445|Alzheimer's Disease|alzheimer's disease
4783449|NCT02720445|Nicotine|nicotine
4783450|NCT02720445|Transdermal Patch|transdermal patch
4783451|NCT02720432|early intervention, infant|early intervention, infant
4783452|NCT02720419|drug eluting stent|drug eluting stent
4783453|NCT02720419|percutaneous coronary intervention|percutaneous coronary intervention
4783454|NCT02720419|real world|real world
4783455|NCT02720380|Asthma|asthma
4783456|NCT02720380|Physical Therapy Specialty|physical therapy specialty
4783457|NCT02720380|Breathing Exercises|breathing exercises
4783458|NCT02720380|Child|child
4783459|NCT02720380|Clinical Trail|clinical trail
4783460|NCT02720302|Overweight|overweight
4783461|NCT02720302|Children|children
4783462|NCT02720302|Treatment|treatment
4783463|NCT02720302|Prevention|prevention
4783464|NCT02720302|Lifestyle intervention|lifestyle intervention
4783465|NCT02720289|injury prevention|injury prevention
4783466|NCT02720276|stroke|stroke
4783467|NCT02720276|exercise|exercise
4783468|NCT02720276|walking|walking
4783469|NCT02720276|mobility|mobility
4783470|NCT02720263|Schizophrenia|schizophrenia
4783471|NCT02720263|ASP4345|asp4345
4783472|NCT02720250|omega-3 fatty acids, microcirculation, laser Doppler flowmetry, lipid profile|omega-3 fatty acids, microcirculation, laser doppler flowmetry, lipid profile
4783473|NCT02720237|Alcohol use|alcohol use
4783474|NCT02720237|HIV|hiv
4783475|NCT02720237|Viral Load|viral load
4783476|NCT02720237|ART|art
4783477|NCT02720211|headache|headache
4783478|NCT02720211|photophobia|photophobia
4783479|NCT02720211|migraine|migraine
4783480|NCT02720211|light sensitivity|light sensitivity
4783481|NCT02720211|tints|tints
4783482|NCT02720211|thin films|thin films
4783483|NCT02720146|Dry eye|dry eye
4783484|NCT02720133|ramadan fasting|ramadan fasting
4783485|NCT02720133|variation of biochemical parameters|variation of biochemical parameters
4783486|NCT02720133|variation of hematological parameters|variation of hematological parameters
4783487|NCT02720133|verify now assay|verify now assay
4783488|NCT02720107|fingolimod,|fingolimod,
4783489|NCT02720107|Biomarker,|biomarker,
4783490|NCT02720107|Multiple sclerosis,|multiple sclerosis,
4783491|NCT02720107|Relapsing-remitting multiple sclerosis|relapsing-remitting multiple sclerosis
4783492|NCT02720094|Pre-Exposure Prophylaxis|pre-exposure prophylaxis
4783493|NCT02720094|PrEP|prep
4783494|NCT02720068|PD1|pd1
4783495|NCT02720068|PD-1|pd-1
4783496|NCT02720068|PDL1|pdl1
4783497|NCT02720068|PD-L1|pd-l1
4783498|NCT02720055|Distal Radius Fracture|distal radius fracture
4783499|NCT02720055|Outcomes|outcomes
4783500|NCT02720055|Psychological Intervention|psychological intervention
4783501|NCT02720029|aspiration|aspiration
4783502|NCT02720029|reflux|reflux
4783503|NCT02720016|Post Traumatic Stress Disorder|post traumatic stress disorder
4783504|NCT02720016|Marital Therapy|marital therapy
4783505|NCT02720016|Veterans|veterans
4783506|NCT02720016|Telemedicine|telemedicine
4783507|NCT02720016|Couples|couples
4783508|NCT02720003|Atherosclerosis|atherosclerosis
4783509|NCT02720003|Superficial Femoral Artery|superficial femoral artery
4783510|NCT02720003|Proximal Popliteal Artery|proximal popliteal artery
4783511|NCT02719990|VRS-317|vrs-317
4783512|NCT02719990|Long Acting Growth Hormone|long acting growth hormone
4783513|NCT02719990|Versartis|versartis
4783514|NCT02719990|somavaratan|somavaratan
4783515|NCT02719990|Growth Hormone Deficiency|growth hormone deficiency
4783516|NCT02719990|Adult Growth Hormone Deficiency|adult growth hormone deficiency
4783517|NCT02719990|AGHD|aghd
4783518|NCT02719990|Growth Hormone Replacement|growth hormone replacement
4783519|NCT02719990|Growth Hormone Replacement Therapy|growth hormone replacement therapy
4783520|NCT02719990|XTEN|xten
4783521|NCT02719964|Cognitive Training|cognitive training
4783522|NCT02719964|Traumatic Brain Injury|traumatic brain injury
4783523|NCT02719964|Video Games|video games
4783524|NCT02719951|autism|autism
4783525|NCT02719951|fragile X syndrome (FXS)|fragile x syndrome (fxs)
4783526|NCT02719951|PET (Positron Emission Tomography)|pet (positron emission tomography)
4783527|NCT02719951|glutamate|glutamate
4783528|NCT02719925|magnesium deficiency|magnesium deficiency
4783529|NCT02719925|stress psycological|stress psycological
4783530|NCT02719925|sleep duration and quality|sleep duration and quality
4783531|NCT02719925|mineral water rich in magnesium|mineral water rich in magnesium
4783532|NCT02719899|NLRP3 Inflammasome|nlrp3 inflammasome
4783533|NCT02719899|Sirtuin 3|sirtuin 3
4783534|NCT02719899|T-Cell Polarity|t-cell polarity
4783535|NCT02719899|Caloric Restriction|caloric restriction
4783536|NCT02719873|obesity , pregnancy , maternal and fetal outcome|obesity , pregnancy , maternal and fetal outcome
4783537|NCT02719847|Lung cancer|lung cancer
4783538|NCT02719847|Non-Small Cell Lung|non-small cell lung
4783539|NCT02719847|NSCLC|nsclc
4783540|NCT02719847|Suspected non small cell lung cancer|suspected non small cell lung cancer
4783541|NCT02719847|Endobronchial ultrasound-guided transbronchial needle aspiration|endobronchial ultrasound-guided transbronchial needle aspiration
4783542|NCT02719847|EBUS-TBNA|ebus-tbna
4783543|NCT02719821|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
4783544|NCT02719821|Fatigue|fatigue
4783545|NCT02719821|Insomnia|insomnia
4783546|NCT02719821|Depression|depression
4783547|NCT02719821|Behavioral Intervention|behavioral intervention
4783548|NCT02719808|Vertical infection transmission|vertical infection transmission
4783549|NCT02719808|Tenofovir|tenofovir
4783550|NCT02719795|Breast Neoplasms|breast neoplasms
4783551|NCT02719795|Nerve block|nerve block
4783552|NCT02719795|Anesthesia|anesthesia
4783553|NCT02719769|Positive Blood Culture|positive blood culture
4783554|NCT02719743|children|children
4783555|NCT02719743|H5N1|h5n1
4783556|NCT02719743|observer-blind|observer-blind
4783557|NCT02719743|Influenza|influenza
4783558|NCT02719743|dose-ranging|dose-ranging
4783559|NCT02719717|VATS lobectomy|vats lobectomy
4783560|NCT02719717|vascular sealing|vascular sealing
4783561|NCT02719717|energy|energy
4783562|NCT02719717|pulmonary artery|pulmonary artery
4783563|NCT02719691|MLN0128|mln0128
4783564|NCT02719691|Dual TORC1/2 Inhibitor|dual torc1/2 inhibitor
4783565|NCT02719691|MLN8237|mln8237
4783566|NCT02719691|Aurora A inhibitor|aurora a inhibitor
4783567|NCT02719691|Alisertib|alisertib
4783568|NCT02719691|Triple-Negative Breast Cancer|triple-negative breast cancer
4783569|NCT02719665|peripheral arterial disease|peripheral arterial disease
4783570|NCT02719665|claudication|claudication
4783571|NCT02719665|PAD|pad
4783572|NCT02719665|Vascular Disease|vascular disease
4783573|NCT02719665|Vascular Occlusion|vascular occlusion
4783574|NCT02719665|Vacular Calcification|vacular calcification
4783575|NCT02719665|intermittent claudication|intermittent claudication
4783576|NCT02719652|intracranial atherosclerotic disease（ICAD）|intracranial atherosclerotic disease（icad）
4783577|NCT02719652|vulnerable plaque|vulnerable plaque
4783578|NCT02719652|high-resolution magnetic resonance imaging （HR-MRI）|high-resolution magnetic resonance imaging （hr-mri）
4783579|NCT02719626|senior|senior
4783580|NCT02719626|nutrition|nutrition
4783581|NCT02719626|home delivered meals|home delivered meals
4783582|NCT02719626|food safety|food safety
4783583|NCT02719626|emergency prep|emergency prep
4783584|NCT02719600|Virtual Reality|virtual reality
4783585|NCT02719587|saliva|saliva
4783586|NCT02719587|omega-3|omega-3
4783587|NCT02719574|AML|aml
4783588|NCT02719574|MDS|mds
4783589|NCT02719574|IDH1|idh1
4783590|NCT02719574|IDH|idh
4783591|NCT02719535|corneal reshaping therapy|corneal reshaping therapy
4783592|NCT02719535|corneal biomechanics|corneal biomechanics
4783593|NCT02719483|Children|children
4783594|NCT02719483|Spasticity|spasticity
4783595|NCT02719483|Extracorporeal shock wave therapy|extracorporeal shock wave therapy
4783596|NCT02719483|Cerebral palsy|cerebral palsy
4783597|NCT02719483|Gross motor function|gross motor function
4783598|NCT02719470|Cognition Impairment|cognition impairment
4783599|NCT02719470|Rehabilitation|rehabilitation
4783600|NCT02719470|Parkinson's Disease|parkinson's disease
4783601|NCT02719457|Exercise testing|exercise testing
4783602|NCT02719457|COPD|copd
4783603|NCT02719457|Upper and Lower limb exercise|upper and lower limb exercise
4783604|NCT02719418|Thromboembolism|thromboembolism
4783605|NCT02719418|Venous Thrombosis|venous thrombosis
4783606|NCT02719418|Embolism and Thrombosis|embolism and thrombosis
4783607|NCT02719418|Chronic Renal Diseases|chronic renal diseases
4783608|NCT02719418|Kidney Failure, Chronic|kidney failure, chronic
4783609|NCT02719418|Renal Failure, Chronic|renal failure, chronic
4783610|NCT02719418|Venous Thromboembolism|venous thromboembolism
4783611|NCT02719418|Tinzaparin|tinzaparin
4783612|NCT02719418|Innohep|innohep
4783613|NCT02719418|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight
4783614|NCT02719405|milk|milk
4783615|NCT02719405|allergy|allergy
4783616|NCT02719405|tolerance|tolerance
4783617|NCT02719327|Alzheimer's disease|alzheimer's disease
4783618|NCT02719327|Cerebrospinal fluid|cerebrospinal fluid
4783619|NCT02719327|brain blood flow|brain blood flow
4783620|NCT02719327|cognition|cognition
4783621|NCT02719327|icosapent ethyl|icosapent ethyl
4783622|NCT02719327|Vascepa|vascepa
4783623|NCT02719327|omega-3 fatty acids|omega-3 fatty acids
4783624|NCT02719327|eicosapentaenoic acid|eicosapentaenoic acid
4783625|NCT02719262|Melamine|melamine
4783626|NCT02719262|Renal damage|renal damage
4783627|NCT02719262|Workplace intervention|workplace intervention
4783628|NCT02719249|ESRD|esrd
4783629|NCT02719249|Fabry disease|fabry disease
4783630|NCT02719236|Coxarthrosis|coxarthrosis
4783631|NCT02719236|Hip arthroplasty|hip arthroplasty
4783632|NCT02719236|Direct Anterior Approach|direct anterior approach
4783633|NCT02719236|Direct Lateral Approach|direct lateral approach
4783634|NCT02719223|Intradialytic hypotension|intradialytic hypotension
4783635|NCT02719223|hemodynamic parameters|hemodynamic parameters
4783636|NCT02719223|Hemodiafiltration|hemodiafiltration
4783637|NCT02719223|NICAS device (non-invasive cardiac system)|nicas device (non-invasive cardiac system)
4783638|NCT02719158|Acute otitis media with tympanostomy tubes|acute otitis media with tympanostomy tubes
4783639|NCT02719158|OTIPRIO|otiprio
4783640|NCT02719145|micro RNA|micro rna
4783641|NCT02719145|asthma|asthma
4783642|NCT02719145|COPD|copd
4783643|NCT02719132|Diabetes Mellitus type 2, dapagliflozin, quality of life|diabetes mellitus type 2, dapagliflozin, quality of life
4783644|NCT02719106|real world data|real world data
4783645|NCT02719106|percutaneous coronary intervention|percutaneous coronary intervention
4783646|NCT02719106|drug eluting stent|drug eluting stent
4783647|NCT02719093|Infertility Male|infertility male
4783648|NCT02719093|Receptors FSH|receptors fsh
4783649|NCT02719093|Varicocele|varicocele
4783650|NCT02719093|FSH therapy|fsh therapy
4783651|NCT02719080|anaesthetists, surgeons, stress, burnout|anaesthetists, surgeons, stress, burnout
4783652|NCT02719067|neuropsychological function|neuropsychological function
4783653|NCT02719067|neuroimage|neuroimage
4783654|NCT02719067|developmental changes|developmental changes
4783655|NCT02719054|Depression|depression
4783656|NCT02719054|Child Development|child development
4783657|NCT02719054|Stimulation|stimulation
4783658|NCT02719054|CBT|cbt
4783659|NCT02719054|Bangladesh|bangladesh
4783660|NCT02719015|Melanoma|melanoma
4783661|NCT02719015|Refractory Metastatic Melanoma|refractory metastatic melanoma
4783662|NCT02719015|rAd.CD40L|rad.cd40l
4783663|NCT02719015|ISF35|isf35
4783664|NCT02719015|Intratumoral|intratumoral
4783665|NCT02719015|IT|it
4783666|NCT02719015|Pembrolizumab|pembrolizumab
4783667|NCT02719015|Keytruda|keytruda
4783668|NCT02719015|MK-3475|mk-3475
4783669|NCT02719015|SCH-900475|sch-900475
4783670|NCT02719015|MM|mm
4783671|NCT02718989|H-reflex|h-reflex
4783672|NCT02718989|TENS|tens
4783673|NCT02718989|Tone|tone
4783674|NCT02718976|Hip surgery anesthesia|hip surgery anesthesia
4783675|NCT02718976|Perioperative analgesia|perioperative analgesia
4783676|NCT02718950|Brown Adipose Tissue|brown adipose tissue
4783677|NCT02718950|Hypothalamic Activation|hypothalamic activation
4783678|NCT02718950|Non-shivering Thermogenesis|non-shivering thermogenesis
4783679|NCT02718950|Basal Metabolic Rate|basal metabolic rate
4783680|NCT02718950|Liraglutide|liraglutide
4783681|NCT02718950|Victoza|victoza
4783682|NCT02718950|Body Composition|body composition
4783683|NCT02718950|Body weight|body weight
4783684|NCT02718950|Adipose Tissue Biopsy|adipose tissue biopsy
4783685|NCT02718937|Viral diseases|viral diseases
4783686|NCT02718937|Antiviral|antiviral
4783687|NCT02718937|Paramyxoviridae infections|paramyxoviridae infections
4783688|NCT02718937|RSV|rsv
4783689|NCT02718937|Aviragen Therapeutics, Inc.|aviragen therapeutics, inc.
4783690|NCT02718937|Aviragen Therapeutics|aviragen therapeutics
4783691|NCT02718937|Aviragen|aviragen
4783692|NCT02718924|Thromboelastometry|thromboelastometry
4783693|NCT02718924|pregnancy|pregnancy
4783694|NCT02718924|obesity|obesity
4783695|NCT02718898|genital|genital
4783696|NCT02718885|inulin-type fructans|inulin-type fructans
4783697|NCT02718885|hemodialysis|hemodialysis
4783698|NCT02718885|gut microbiome|gut microbiome
4783699|NCT02718885|mineral and bone disorder|mineral and bone disorder
4783700|NCT02718859|advanced pancreatic cancer|advanced pancreatic cancer
4783701|NCT02718859|nature killer cell|nature killer cell
4783702|NCT02718859|irreversible electroporation|irreversible electroporation
4783703|NCT02718833|Multiple Myeloma|multiple myeloma
4783704|NCT02718833|Relapse|relapse
4783705|NCT02718807|Patient Care|patient care
4783706|NCT02718807|Education|education
4783707|NCT02718794|Simulation Training [I02.903.847]|simulation training [i02.903.847]
4783708|NCT02718794|Problem-Based Learning [F02.463.425.720]|problem-based learning [f02.463.425.720]
4783709|NCT02718794|Airway Management [E02.041]|airway management [e02.041]
4783710|NCT02718755|Hematologic malignancy|hematologic malignancy
4783711|NCT02718755|Relapsed and refractory hematologic malignancies|relapsed and refractory hematologic malignancies
4783712|NCT02718755|Acute myeloid leukemia|acute myeloid leukemia
4783713|NCT02718755|AML|aml
4783714|NCT02718755|Acute lymphoblastic leukemia|acute lymphoblastic leukemia
4783715|NCT02718755|ALL|all
4783716|NCT02718755|Burkitt's leukemia/lymphoma|burkitt's leukemia/lymphoma
4783717|NCT02718755|Prolymphocytic leukemia|prolymphocytic leukemia
4783844|NCT02718001|Heart Valve|heart valve
4783718|NCT02718755|Biphenotypic acute leukemia|biphenotypic acute leukemia
4783719|NCT02718755|Blast-phase of chronic myeloid leukemia|blast-phase of chronic myeloid leukemia
4783720|NCT02718755|CML|cml
4783721|NCT02718755|B-cell lymphoma|b-cell lymphoma
4783722|NCT02718755|Richter's transformation of chronic lymphocytic leukemia|richter's transformation of chronic lymphocytic leukemia
4783723|NCT02718755|CLL|cll
4783724|NCT02718755|Fludarabine|fludarabine
4783725|NCT02718755|Fludarabine phosphate|fludarabine phosphate
4783726|NCT02718755|Fludara|fludara
4783727|NCT02718755|Cytarabine|cytarabine
4783728|NCT02718755|Ara-C|ara-c
4783729|NCT02718755|Cytosar|cytosar
4783730|NCT02718755|DepoCyt|depocyt
4783731|NCT02718755|Cytosine arabinosine hydrochloride|cytosine arabinosine hydrochloride
4783732|NCT02718729|Anastomotic leakage|anastomotic leakage
4783733|NCT02718729|Rectal cancer|rectal cancer
4783734|NCT02718729|Laparoscopic|laparoscopic
4783735|NCT02718729|Rectal resection|rectal resection
4783736|NCT02718716|ITP|itp
4783737|NCT02718690|H-Reflex|h-reflex
4783738|NCT02718690|Current Density|current density
4783739|NCT02718690|TENS|tens
4783740|NCT02718651|ALK rearrangement|alk rearrangement
4783741|NCT02718651|Circulating tumor DNA|circulating tumor dna
4783742|NCT02718651|Plasma DNA|plasma dna
4783743|NCT02718651|Non-small cell lung cancer|non-small cell lung cancer
4783744|NCT02718651|Tyrosine kinase inhibitors|tyrosine kinase inhibitors
4783745|NCT02718625|Pressure Ulcers|pressure ulcers
4783746|NCT02718625|Bed sores|bed sores
4783747|NCT02718625|Long-term care|long-term care
4783748|NCT02718625|Nursing home|nursing home
4783749|NCT02718612|Uraemic Sarcopenia|uraemic sarcopenia
4783750|NCT02718612|Sarcopenic Obesity|sarcopenic obesity
4783751|NCT02718586|Myokines|myokines
4783752|NCT02718586|Protein Energy Wasting|protein energy wasting
4783753|NCT02718586|Hemodialysis|hemodialysis
4783754|NCT02718573|Hepatitis C|hepatitis c
4783755|NCT02718573|Interferon-free|interferon-free
4783756|NCT02718573|DDA's|dda's
4783757|NCT02718547|Diabetes mellitus|diabetes mellitus
4783758|NCT02718547|Diabetic macular edema|diabetic macular edema
4783759|NCT02718547|Intra ocular pressure|intra ocular pressure
4783760|NCT02718547|Ocular perfusion pressure|ocular perfusion pressure
4783761|NCT02718547|Retinal perfusion|retinal perfusion
4783762|NCT02718521|contrast-induced nephropathy|contrast-induced nephropathy
4783763|NCT02718521|hydration therapy combined with intravenous infusion of isosorbide|hydration therapy combined with intravenous infusion of isosorbide
4783764|NCT02718521|percutaneous coronary intervention|percutaneous coronary intervention
4783765|NCT02718469|Ebola|ebola
4783766|NCT02718469|VSV|vsv
4783767|NCT02718469|Vesicular Stomatitis Virus|vesicular stomatitis virus
4783768|NCT02718469|Vaccine|vaccine
4783769|NCT02718469|Zaire|zaire
4783770|NCT02718417|untreated epithelial ovarian|untreated epithelial ovarian
4783771|NCT02718417|fallopian tube|fallopian tube
4783772|NCT02718417|primary peritoneal cancer|primary peritoneal cancer
4783773|NCT02718404|MR-HIFU|mr-hifu
4783774|NCT02718404|bone metastases|bone metastases
4783775|NCT02718404|pain treatment|pain treatment
4783776|NCT02718391|Intradermal Autologous Dendritic Cell Vaccine|intradermal autologous dendritic cell vaccine
4783777|NCT02718391|Malignant Melanoma|malignant melanoma
4783778|NCT02718391|Adjuvant|adjuvant
4783779|NCT02718391|vaccin|vaccin
4783780|NCT02718391|therapy|therapy
4783781|NCT02718391|randomized trial|randomized trial
4783782|NCT02718391|observation|observation
4783783|NCT02718378|safety|safety
4783784|NCT02718378|pharmacokinetics|pharmacokinetics
4783785|NCT02718378|pharmacodynamics|pharmacodynamics
4783786|NCT02718378|randomized|randomized
4783787|NCT02718365|Lung Neoplasms|lung neoplasms
4783788|NCT02718365|Surgery|surgery
4783789|NCT02718365|VATS|vats
4783790|NCT02718365|GGO|ggo
4783791|NCT02718365|GGN|ggn
4783792|NCT02718365|Segmentectomy|segmentectomy
4783793|NCT02718365|Wedge Resection|wedge resection
4783794|NCT02718365|Prognosis|prognosis
4783795|NCT02718313|intraventricular conduction delay|intraventricular conduction delay
4783796|NCT02718300|Primary myelofibrosis (PMF)|primary myelofibrosis (pmf)
4783797|NCT02718300|post-polycythemia vera myelofibrosis (PPV-MF)|post-polycythemia vera myelofibrosis (ppv-mf)
4783798|NCT02718300|post-essential thrombocythemia myelofibrosis (PET-MF)|post-essential thrombocythemia myelofibrosis (pet-mf)
4783799|NCT02718300|myeloproliferative neoplasms (MPNs)|myeloproliferative neoplasms (mpns)
4783800|NCT02718300|phosphoinositide 3-kinase (PI3K) inhibitor|phosphoinositide 3-kinase (pi3k) inhibitor
4783801|NCT02718300|Janus kinase (JAK) inhibitor|janus kinase (jak) inhibitor
4783802|NCT02718287|language development|language development
4783803|NCT02718287|socio-emotional development|socio-emotional development
4783804|NCT02718287|cognitive development|cognitive development
4783805|NCT02718287|motor skills|motor skills
4783806|NCT02718274|HIV self-testing|hiv self-testing
4783807|NCT02718274|Malawi|malawi
4783808|NCT02718274|HIV|hiv
4783809|NCT02718248|self-harm|self-harm
4783810|NCT02718248|problem-solving therapy|problem-solving therapy
4783811|NCT02718248|emergency department|emergency department
4783812|NCT02718248|e-therapy|e-therapy
4783813|NCT02718248|suicide prevention|suicide prevention
4783814|NCT02718222|Post-partum intrauterine device (PPIUD)|post-partum intrauterine device (ppiud)
4783815|NCT02718157|Polymerase Chain Reaction (PCR)|polymerase chain reaction (pcr)
4783816|NCT02718157|GBS|gbs
4783817|NCT02718157|Streptococcus agalactiae|streptococcus agalactiae
4783818|NCT02718157|Antepartum women|antepartum women
4783819|NCT02718144|dose-escalation|dose-escalation
4783820|NCT02718144|safety|safety
4783821|NCT02718144|dose-limiting toxicity|dose-limiting toxicity
4783822|NCT02718131|Tibial Pseudarthrosis|tibial pseudarthrosis
4783823|NCT02718105|KIR HLA-C|kir hla-c
4783824|NCT02718105|ART|art
4783825|NCT02718066|HBI-8000|hbi-8000
4783826|NCT02718066|Nivolumab|nivolumab
4783827|NCT02718066|Melanoma|melanoma
4783828|NCT02718066|Renal Cell Carcinoma|renal cell carcinoma
4783829|NCT02718066|Non-Small Cell Lung Cancer|non-small cell lung cancer
4783830|NCT02718027|Alport Syndrome|alport syndrome
4783831|NCT02718027|Biomarker|biomarker
4783832|NCT02718014|Non Surgical Therapy|non surgical therapy
4783833|NCT02718001|Mitral|mitral
4783834|NCT02718001|Regurgitation|regurgitation
4783835|NCT02718001|Insufficiency|insufficiency
4783836|NCT02718001|Degenerative|degenerative
4783837|NCT02718001|Functional|functional
4783838|NCT02718001|Primary|primary
4783839|NCT02718001|Secondary|secondary
4783840|NCT02718001|Organic|organic
4783841|NCT02718001|Transcatheter|transcatheter
4783842|NCT02718001|TMVR|tmvr
4783843|NCT02718001|TMVI|tmvi
4783845|NCT02718001|Mitral Valve|mitral valve
4783846|NCT02718001|Transseptal|transseptal
4783847|NCT02718001|Trans-Septal|trans-septal
4783848|NCT02718001|Transeptal|transeptal
4783849|NCT02718001|Severe|severe
4783850|NCT02717988|rheumatoid arthritis|rheumatoid arthritis
4783851|NCT02717988|healthy volunteers|healthy volunteers
4783852|NCT02717988|moderately to severely active|moderately to severely active
4783853|NCT02717975|Urinary retention|urinary retention
4783854|NCT02717975|trial removal of catheter|trial removal of catheter
4783855|NCT02717975|valve|valve
4783856|NCT02717962|Glioma|glioma
4783857|NCT02717962|Glioblastoma|glioblastoma
4783858|NCT02717962|Glioblastoma multiforme|glioblastoma multiforme
4783859|NCT02717962|GBM|gbm
4783860|NCT02717962|brain tumor|brain tumor
4783861|NCT02717962|brain cancer|brain cancer
4783862|NCT02717962|recurrent brain tumor|recurrent brain tumor
4783863|NCT02717962|recurrent brain cancer|recurrent brain cancer
4783864|NCT02717962|refractory brain tumor|refractory brain tumor
4783865|NCT02717962|refractory brain cancer|refractory brain cancer
4783866|NCT02717962|recurrent GBM|recurrent gbm
4783867|NCT02717962|refractory GBM|refractory gbm
4783868|NCT02717962|recurrent glioma|recurrent glioma
4783869|NCT02717962|refractory glioma|refractory glioma
4783870|NCT02717962|recurrent glioblastoma|recurrent glioblastoma
4783871|NCT02717962|refractory glioblastoma|refractory glioblastoma
4783872|NCT02717962|recurrent glioblastoma multiforme|recurrent glioblastoma multiforme
4783873|NCT02717962|refractory glioblastoma multiforme|refractory glioblastoma multiforme
4783874|NCT02717962|failed bevacizumab|failed bevacizumab
4783875|NCT02717962|temodar failure|temodar failure
4783876|NCT02717962|temozolomide failure|temozolomide failure
4783877|NCT02717949|hepatitis C|hepatitis c
4783878|NCT02717949|low-grade lymphoma|low-grade lymphoma
4783879|NCT02717936|squamous cell carcinoma|squamous cell carcinoma
4783880|NCT02717936|dermatosurgery|dermatosurgery
4783881|NCT02717936|immunohistochemistry|immunohistochemistry
4783882|NCT02717923|metastatic colorectal cancer|metastatic colorectal cancer
4783883|NCT02717923|maintenance treatment|maintenance treatment
4783884|NCT02717923|cetuximab|cetuximab
4783885|NCT02717910|Games|games
4783886|NCT02717910|Adolescent|adolescent
4783887|NCT02717910|Health education|health education
4783888|NCT02717910|Smoking|smoking
4783889|NCT02717910|Health literacy|health literacy
4783890|NCT02717884|AML|aml
4783891|NCT02717884|MDS|mds
4783892|NCT02717884|relapsed|relapsed
4783893|NCT02717884|trans-retinoic acid ATRA|trans-retinoic acid atra
4783894|NCT02717884|epigenetic treatment|epigenetic treatment
4783895|NCT02717884|non-M3 AML blasts|non-m3 aml blasts
4783896|NCT02717884|tranylcypromine TCP|tranylcypromine tcp
4783897|NCT02717884|LSD1|lsd1
4783898|NCT02717884|refractory|refractory
4783899|NCT02717871|Collagen cross-linking, PACK-CXL, infectious keratitis, CXL.|collagen cross-linking, pack-cxl, infectious keratitis, cxl.
4783900|NCT02717845|varus malignment|varus malignment
4783901|NCT02717845|osteoarthritis|osteoarthritis
4783902|NCT02717845|knee|knee
4783903|NCT02717819|Sarcopenia|sarcopenia
4783904|NCT02717819|Muscular atrophy|muscular atrophy
4783905|NCT02717819|Frailty|frailty
4783906|NCT02717819|Acute illness|acute illness
4783907|NCT02717819|Ageing|ageing
4783908|NCT02717819|Protein supplementation|protein supplementation
4783909|NCT02717819|Whey protein|whey protein
4783910|NCT02717819|Resistance training|resistance training
4783911|NCT02717819|Strength training|strength training
4783912|NCT02717767|pneumonia|pneumonia
4783913|NCT02717767|diagnosis|diagnosis
4783914|NCT02717767|prognosis|prognosis
4783915|NCT02717767|tracheal aspirate|tracheal aspirate
4783916|NCT02717767|bronchoalveolar lavage|bronchoalveolar lavage
4783917|NCT02717663|Reinforcement|reinforcement
4783918|NCT02717663|Walking|walking
4783919|NCT02717663|Exercise|exercise
4783920|NCT02717663|Built Environment|built environment
4783921|NCT02717663|Adaptive|adaptive
4783922|NCT02717663|Financial incentive|financial incentive
4783923|NCT02717663|Walkability|walkability
4783924|NCT02717650|Exercise Testing|exercise testing
4783925|NCT02717650|Maximal Exercise Testing|maximal exercise testing
4783926|NCT02717650|Maximal Exercise Capacity|maximal exercise capacity
4783927|NCT02717650|Peak Exercise Capacity|peak exercise capacity
4783928|NCT02717650|Adults|adults
4783929|NCT02717650|Step Tests|step tests
4783930|NCT02717637|oxycodone, caesarean, spinal anesthesia|oxycodone, caesarean, spinal anesthesia
4783931|NCT02717624|Bruton tyrosine kinase inhibitor|bruton tyrosine kinase inhibitor
4783932|NCT02717624|Btk|btk
4783933|NCT02717624|ACP-196|acp-196
4783934|NCT02717624|Mantle Cell Lymphoma|mantle cell lymphoma
4783935|NCT02717624|MCL|mcl
4783936|NCT02717624|acalabrutinib|acalabrutinib
4783937|NCT02717624|ACE-LY-106|ace-ly-106
4783938|NCT02717611|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
4783939|NCT02717611|Ibrutinib Intolerant|ibrutinib intolerant
4783940|NCT02717598|cold snare polypectomy|cold snare polypectomy
4783941|NCT02717598|hot snare polypectomy|hot snare polypectomy
4783942|NCT02717585|Continuous Positive Airway Pressure therapy|continuous positive airway pressure therapy
4783943|NCT02717585|Chronic Pain|chronic pain
4783944|NCT02717585|Sleep Disturbance|sleep disturbance
4783945|NCT02717559|Anterior cruciate ligament / injuries|anterior cruciate ligament / injuries
4783946|NCT02717559|Anterior cruciate ligament / surgery|anterior cruciate ligament / surgery
4783947|NCT02717559|knee injuries / surgery|knee injuries / surgery
4783948|NCT02717559|outcomes research|outcomes research
4783949|NCT02717559|prospective studies|prospective studies
4783950|NCT02717559|osteoarthritis|osteoarthritis
4783951|NCT02717546|Distal Tibia Fracture Screw|distal tibia fracture screw
4783952|NCT02717520|glass hybrid|glass hybrid
4783953|NCT02717520|composite|composite
4783954|NCT02717494|PPV-23|ppv-23
4783955|NCT02717494|PCV-10|pcv-10
4783956|NCT02717494|HIV|hiv
4783957|NCT02717494|Immunization|immunization
4783958|NCT02717494|Pregnancy|pregnancy
4783959|NCT02717455|Diffuse Intrinsic Pontine Glioma|diffuse intrinsic pontine glioma
4783960|NCT02717442|Meniere's Disease|meniere's disease
4783961|NCT02717442|Vertigo|vertigo
4783962|NCT02717416|upper gastrointestinal bleeding|upper gastrointestinal bleeding
4783963|NCT02717416|endoscopic hemostasis|endoscopic hemostasis
4783964|NCT02717416|hemostatic powder|hemostatic powder
4783965|NCT02717403|Chronic Disease Management|chronic disease management
4783966|NCT02717403|Rheumatoid Arthritis|rheumatoid arthritis
4783967|NCT02717403|Facebook|facebook
4783968|NCT02717403|Social networking|social networking
4783969|NCT02717403|Internet|internet
4783970|NCT02717403|Questionnaires|questionnaires
4783971|NCT02717403|Surveys|surveys
4783972|NCT02717403|Phone interview|phone interview
4783973|NCT02717390|Reading|reading
4783974|NCT02717390|Early Childhood development|early childhood development
4783975|NCT02717390|Talking|talking
4783976|NCT02717390|Playing|playing
4783977|NCT02717390|Praising|praising
4783978|NCT02717390|Safety|safety
4783979|NCT02717390|Injury prevention|injury prevention
4783980|NCT02717377|Micro bouts|micro bouts
4783981|NCT02717377|Physical Activity|physical activity
4783982|NCT02717338|blood donor|blood donor
4783983|NCT02717338|retention|retention
4783984|NCT02717338|motivation|motivation
4783985|NCT02717338|self-determination theory|self-determination theory
4783986|NCT02717247|tRNS|trns
4783987|NCT02717247|Food addiction,|food addiction,
4783988|NCT02717247|Obesity|obesity
4783989|NCT02717247|Craving|craving
4783990|NCT02717247|functional magnetic resonance imaging (fMRI)|functional magnetic resonance imaging (fmri)
4783991|NCT02717182|self management program|self management program
4783992|NCT02717182|patient education|patient education
4783993|NCT02717182|self care program|self care program
4783994|NCT02717169|health promotion|health promotion
4783995|NCT02717169|health action process|health action process
4783996|NCT02717169|activity tracker|activity tracker
4783997|NCT02717169|sleep regulation|sleep regulation
4783998|NCT02717143|Acute myocarditis|acute myocarditis
4783999|NCT02717143|Dilated cardiomyopathy|dilated cardiomyopathy
4784000|NCT02717143|Magnetic resonance imaging|magnetic resonance imaging
4784001|NCT02717117|Motility|motility
4784002|NCT02717117|MRI|mri
4784003|NCT02717117|Gut peptides|gut peptides
4784004|NCT02717117|Feeding|feeding
4784005|NCT02717104|femoropopliteal|femoropopliteal
4784006|NCT02717078|diet|diet
4784007|NCT02717078|carbohydrate|carbohydrate
4784008|NCT02717065|Neuromodulation|neuromodulation
4784009|NCT02717065|Noninvasive|noninvasive
4784010|NCT02717065|Plasticity|plasticity
4784011|NCT02717065|Hearing|hearing
4784012|NCT02717065|Hyperacusis|hyperacusis
4784013|NCT02717013|Muscle|muscle
4784014|NCT02717013|Bone|bone
4784015|NCT02717013|Fat|fat
4784016|NCT02716974|Lupron|lupron
4784017|NCT02716974|Bicalutamide|bicalutamide
4784018|NCT02716974|Docetaxel|docetaxel
4784019|NCT02716896|cystectomy|cystectomy
4784020|NCT02716896|radiation|radiation
4784021|NCT02716896|chemotherapy|chemotherapy
4784022|NCT02716883|keratitis|keratitis
4784023|NCT02716883|AMT|amt
4784024|NCT02716883|bacterial keratitis|bacterial keratitis
4784025|NCT02716883|medication|medication
4784026|NCT02716870|Systematic review and meta-analysis|systematic review and meta-analysis
4784027|NCT02716870|Evidence-based medicine (EBM)|evidence-based medicine (ebm)
4784028|NCT02716870|Evidence-based nutrition (EBN)|evidence-based nutrition (ebn)
4784029|NCT02716870|Clinical practice guidelines|clinical practice guidelines
4784030|NCT02716870|Clinical trials|clinical trials
4784031|NCT02716870|Dietary sugars|dietary sugars
4784032|NCT02716870|Fructose|fructose
4784033|NCT02716870|High fructose corn syrup|high fructose corn syrup
4784034|NCT02716870|Fruit|fruit
4784035|NCT02716870|Isocaloric|isocaloric
4784036|NCT02716870|Hypercaloric|hypercaloric
4784037|NCT02716870|Cardiometabolic risk factors|cardiometabolic risk factors
4784038|NCT02716870|Triglycerides|triglycerides
4784039|NCT02716870|Cholesterol|cholesterol
4784040|NCT02716870|Glycemic control|glycemic control
4784041|NCT02716870|Insulin resistance|insulin resistance
4784042|NCT02716870|Body weight|body weight
4784043|NCT02716870|Uric acid|uric acid
4784044|NCT02716870|Blood pressure|blood pressure
4784045|NCT02716870|Fatty liver|fatty liver
4784046|NCT02716870|Fasting|fasting
4784047|NCT02716870|Postprandial|postprandial
4784048|NCT02716844|Osteoporosis|osteoporosis
4784049|NCT02716844|Clinic Pilates Exercise|clinic pilates exercise
4784050|NCT02716844|Kinesiophobia|kinesiophobia
4784051|NCT02716844|Pain|pain
4784052|NCT02716831|Bulimia Nervosa|bulimia nervosa
4784053|NCT02716831|Eating Disorders|eating disorders
4784054|NCT02716831|Binge Eating|binge eating
4784055|NCT02716831|Bulimia|bulimia
4784056|NCT02716831|Purging|purging
4784057|NCT02716818|Glucocorticoid therapy|glucocorticoid therapy
4784058|NCT02716805|autologous stem cell transplant|autologous stem cell transplant
4784059|NCT02716805|HDT/ASCT|hdt/asct
4784060|NCT02716805|CTLA-4|ctla-4
4784061|NCT02716805|PD-L1|pd-l1
4784062|NCT02716805|peripheral blood mononuclear cells|peripheral blood mononuclear cells
4784063|NCT02716805|PBMC|pbmc
4784064|NCT02716805|ASCT|asct
4784065|NCT02716766|Sorafenib|sorafenib
4784066|NCT02716766|Drug Therapy|drug therapy
4784067|NCT02716740|Post-obesity surgery|post-obesity surgery
4784068|NCT02716740|Leucine-enriched amino acid supplementation|leucine-enriched amino acid supplementation
4784069|NCT02716740|Anabolic substance|anabolic substance
4784070|NCT02716740|Physical training|physical training
4784071|NCT02716740|Muscular mass|muscular mass
4784072|NCT02716740|Loss of weight|loss of weight
4784073|NCT02716714|Korean|korean
4784074|NCT02716701|Exercise|exercise
4784075|NCT02716688|Esophageal cancer|esophageal cancer
4784076|NCT02716688|Radiotherapy|radiotherapy
4784077|NCT02716688|elder|elder
4784078|NCT02716688|S-1|s-1
4784079|NCT02716675|HIV-1 Infections|hiv-1 infections
4784080|NCT02716649|Trauma|trauma
4784081|NCT02716649|ICISS|iciss
4784082|NCT02716649|India|india
4784083|NCT02716649|ICD-10|icd-10
4784084|NCT02716597|albumin, septic shock|albumin, septic shock
4784085|NCT02716571|Healthy Subjects|healthy subjects
4784086|NCT02716571|Healthy Participants|healthy participants
4784087|NCT02716545|Gastrointestinal vascular malformation|gastrointestinal vascular malformation
4784088|NCT02716545|Endoscopic Therapy|endoscopic therapy
4784089|NCT02716519|Diabetes|diabetes
4784090|NCT02716519|diabetic foot ulcer|diabetic foot ulcer
4784091|NCT02716519|foot sore|foot sore
4784092|NCT02716519|type 2 diabetes|type 2 diabetes
4784093|NCT02716519|type 1 diabetes|type 1 diabetes
4784094|NCT02716519|DFU|dfu
4784095|NCT02716519|pressure ulcers|pressure ulcers
4784096|NCT02716519|bed sores|bed sores
4784097|NCT02716506|POP surgery|pop surgery
4784098|NCT02716493|Telerehabilitation|telerehabilitation
4784099|NCT02716480|Nutrition|nutrition
4784100|NCT02716480|Physical activity|physical activity
4784101|NCT02716480|Bariatric surgery|bariatric surgery
4784102|NCT02716480|Obesity|obesity
4784103|NCT02716480|Health technology|health technology
4784104|NCT02716480|Health-connected devices|health-connected devices
4784105|NCT02716467|nursing|nursing
4784106|NCT02716467|intercessory prayer|intercessory prayer
4784107|NCT02716467|spirituality|spirituality
4784108|NCT02716467|clinical trials|clinical trials
4784109|NCT02716454|Early surgery|early surgery
4784110|NCT02716454|Crohn's disease|crohn's disease
4784111|NCT02716454|Step-up therapy|step-up therapy
4784112|NCT02716415|neonates|neonates
4784113|NCT02716415|infants|infants
4784114|NCT02716402|Cyanotic congenital heart disease|cyanotic congenital heart disease
4784115|NCT02716402|pulmonary thrombosis|pulmonary thrombosis
4784116|NCT02716402|cerebral thrombosis|cerebral thrombosis
4784117|NCT02716376|Head and neck neoplasms|head and neck neoplasms
4784118|NCT02716376|Radiotherapy|radiotherapy
4784119|NCT02716376|Otitis media|otitis media
4784120|NCT02716337|human milk target fortification|human milk target fortification
4784121|NCT02716324|Attention-Deficit/Hyperactivity Disorder|attention-deficit/hyperactivity disorder
4784122|NCT02716324|Shared-Decision Making|shared-decision making
4784123|NCT02716324|Care Manager|care manager
4784124|NCT02716324|Children|children
4784125|NCT02716324|Parents|parents
4784126|NCT02716324|Teachers|teachers
4784127|NCT02716311|EGFR|egfr
4784128|NCT02716311|Lung Cancer|lung cancer
4784129|NCT02716285|Irritable Bowel Syndrome|irritable bowel syndrome
4784130|NCT02716285|Abdominal pain|abdominal pain
4784131|NCT02716285|Targeted Delivery|targeted delivery
4784132|NCT02716285|Peppermint oil|peppermint oil
4784133|NCT02716272|mesothelioma|mesothelioma
4784134|NCT02716272|immunotherapy|immunotherapy
4784135|NCT02716272|nivolumab|nivolumab
4784136|NCT02716272|ipilimumab|ipilimumab
4784137|NCT02716259|Periodontitis|periodontitis
4784138|NCT02716259|Cardiovascular diseases|cardiovascular diseases
4784139|NCT02716259|Bacteremia|bacteremia
4784140|NCT02716259|Scaling and root planing|scaling and root planing
4784141|NCT02716259|Flow-mediated dilation|flow-mediated dilation
4784142|NCT02716259|carotid intima-media thickness|carotid intima-media thickness
4784143|NCT02716259|Porphyromonas gingivalis|porphyromonas gingivalis
4784144|NCT02716259|Aggregatibacter actinomycetemcomitans|aggregatibacter actinomycetemcomitans
4784145|NCT02716246|MPS IIIA|mps iiia
4784146|NCT02716220|DREAMS 2G|dreams 2g
4784147|NCT02716220|Scaffold|scaffold
4784148|NCT02716220|Drug Eluting Absorbable Metal Scaffold|drug eluting absorbable metal scaffold
4784149|NCT02716220|Coronary Artery Disease|coronary artery disease
4784150|NCT02716207|Stereotactic Body Radiotherapy (SBRT)|stereotactic body radiotherapy (sbrt)
4784151|NCT02716207|CyberKnife|cyberknife
4784152|NCT02716207|Dose Escalation|dose escalation
4784153|NCT02716181|Atopic Dermatitis|atopic dermatitis
4784154|NCT02716181|Topical therapy|topical therapy
4784155|NCT02716168|Cancer|cancer
4784156|NCT02716168|tele-health|tele-health
4784157|NCT02716168|Shared care|shared care
4784158|NCT02716168|Continuity|continuity
4784159|NCT02716116|NSCLC|nsclc
4784160|NCT02716116|EGFR|egfr
4784161|NCT02716116|HER2|her2
4784162|NCT02716116|human epidermal growth factor receptor 2|human epidermal growth factor receptor 2
4784163|NCT02716116|exon 20 insertions|exon 20 insertions
4784164|NCT02716116|exon 19 deletions|exon 19 deletions
4784165|NCT02716116|exon 21 substitution|exon 21 substitution
4784166|NCT02716116|T790M|t790m
4784167|NCT02716116|ErbB-2|erbb-2
4784168|NCT02716116|Epidermal Growth Factor Receptor|epidermal growth factor receptor
4784169|NCT02716103|AL amyloidosis, systemic primary amyloidosis|al amyloidosis, systemic primary amyloidosis
4784170|NCT02716064|chronic conditions, self-management, PHR|chronic conditions, self-management, phr
4784171|NCT02716038|Non-Small Cell Lung Cancer|non-small cell lung cancer
4784172|NCT02716038|Non-Small-Cell Lung Carcinoma|non-small-cell lung carcinoma
4784173|NCT02716038|Nonsmall Cell Lung Cancer|nonsmall cell lung cancer
4784174|NCT02716038|NSCLC|nsclc
4784175|NCT02716012|Oligonucleotide|oligonucleotide
4784176|NCT02716012|RNA|rna
4784177|NCT02716012|saRNA|sarna
4784178|NCT02716012|Fibrosis|fibrosis
4784179|NCT02716012|Cirrhosis|cirrhosis
4784180|NCT02715986|ECT|ect
4784181|NCT02715986|Diffusion Tensor Imaging (DTI)|diffusion tensor imaging (dti)
4784182|NCT02715986|fMRI|fmri
4784183|NCT02715947|Psoriasis Vulgaris|psoriasis vulgaris
4784184|NCT02715947|Methotrexate|methotrexate
4784185|NCT02715934|Diabetes Education|diabetes education
4784186|NCT02715934|Chronic Disease Management|chronic disease management
4784187|NCT02715934|Health Care Delivery|health care delivery
4784188|NCT02715934|Patient-Centered Medical Home|patient-centered medical home
4784189|NCT02715934|Primary Care|primary care
4784190|NCT02715895|Infant|infant
4784191|NCT02715895|Growth|growth
4784192|NCT02715895|Body Weight Changes|body weight changes
4784193|NCT02715895|Infant Formula|infant formula
4784194|NCT02715895|Randomized Controlled Trial|randomized controlled trial
4784195|NCT02715882|Colorectal cancer|colorectal cancer
4784196|NCT02715882|TLR5|tlr5
4784197|NCT02715882|Immunotherapy|immunotherapy
4784198|NCT02715869|Myocardial Preconditioning, inotropic score|myocardial preconditioning, inotropic score
4784199|NCT02715856|Bone metastases|bone metastases
4784200|NCT02715856|Intramedullary nailing surgery|intramedullary nailing surgery
4784201|NCT02715856|IM|im
4784202|NCT02715856|Physical tasks|physical tasks
4784203|NCT02715856|Surveys|surveys
4784204|NCT02715856|Questionnaires|questionnaires
4784205|NCT02715856|Smartphone|smartphone
4784206|NCT02715856|Tablet|tablet
4784207|NCT02715856|Telemedicine|telemedicine
4784208|NCT02715856|Telemonitoring|telemonitoring
4784209|NCT02715843|CD20|cd20
4784210|NCT02715843|immunotoxin|immunotoxin
4784211|NCT02715843|NHL|nhl
4784212|NCT02715843|non-Hodgkin's lymphoma|non-hodgkin's lymphoma
4784213|NCT02715843|lymphoma|lymphoma
4784214|NCT02715843|cancer|cancer
4784215|NCT02715843|antibodies|antibodies
4784216|NCT02715843|immunotherapy|immunotherapy
4784217|NCT02715843|safety|safety
4784218|NCT02715843|pharmacokinetics|pharmacokinetics
4784219|NCT02715843|MT-3724|mt-3724
4784220|NCT02715843|relapsed|relapsed
4784221|NCT02715843|refractory|refractory
4784222|NCT02715817|Stroke|stroke
4784223|NCT02715817|Hemiparesis|hemiparesis
4784224|NCT02715817|Physical Therapy|physical therapy
4784225|NCT02715817|Virtual Reality Exposure Therapy|virtual reality exposure therapy
4784226|NCT02715817|Video Games|video games
4784227|NCT02715804|Pancreatic ductal adenocarcinoma (PDA)|pancreatic ductal adenocarcinoma (pda)
4784228|NCT02715804|Pancreatic ductal carcinoma|pancreatic ductal carcinoma
4784474|NCT02714374|Surgery|surgery
4784229|NCT02715804|PEGylated Recombinant Human Hyaluronidase (PEGPH20)|pegylated recombinant human hyaluronidase (pegph20)
4784230|NCT02715804|Nab-paclitaxel|nab-paclitaxel
4784231|NCT02715804|Gemcitabine|gemcitabine
4784232|NCT02715804|Metastatic|metastatic
4784233|NCT02715804|Stage IV|stage iv
4784234|NCT02715791|Self-Management|self-management
4784235|NCT02715791|Health Connectors|health connectors
4784236|NCT02715791|Volunteers|volunteers
4784237|NCT02715791|Technology|technology
4784238|NCT02715791|Interprofessional team|interprofessional team
4784239|NCT02715791|Chronic disease|chronic disease
4784240|NCT02715791|Self-efficacy|self-efficacy
4784241|NCT02715791|Patient-centredness|patient-centredness
4784242|NCT02715791|Community Engagement|community engagement
4784243|NCT02715739|Trauma|trauma
4784244|NCT02715739|India|india
4784245|NCT02715739|ICISS|iciss
4784246|NCT02715713|Autonomic neuropathy, Testosterone Deficiency|autonomic neuropathy, testosterone deficiency
4784247|NCT02715661|blood flow|blood flow
4784248|NCT02715661|brain health|brain health
4784249|NCT02715661|exercise|exercise
4784250|NCT02715661|endothelial activation|endothelial activation
4784251|NCT02715596|head and neck|head and neck
4784252|NCT02715596|eicosapentanoic acid|eicosapentanoic acid
4784253|NCT02715596|body composition|body composition
4784254|NCT02715570|Aspergillus species|aspergillus species
4784255|NCT02715570|Filamentous fungi|filamentous fungi
4784256|NCT02715570|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors
4784257|NCT02715570|Anti-Infective Agents|anti-infective agents
4784258|NCT02715570|Antifungal Agents|antifungal agents
4784259|NCT02715570|Enzyme Inhibitors|enzyme inhibitors
4784260|NCT02715570|Aspergillosis|aspergillosis
4784261|NCT02715570|Allergic Bronchopulmonary|allergic bronchopulmonary
4784262|NCT02715570|Asthma|asthma
4784263|NCT02715544|Intervention|intervention
4784264|NCT02715544|Physical activity|physical activity
4784265|NCT02715544|Eating habit|eating habit
4784266|NCT02715544|Connectedness to nature|connectedness to nature
4784267|NCT02715518|Acute ST-segment elevation myocardial infarction|acute st-segment elevation myocardial infarction
4784268|NCT02715518|Acute myocardial infarction|acute myocardial infarction
4784269|NCT02715518|Fractional flow reserve|fractional flow reserve
4784270|NCT02715518|Percutaneous coronary intervention|percutaneous coronary intervention
4784271|NCT02715518|Multivessel disease|multivessel disease
4784272|NCT02715518|STEMI|stemi
4784273|NCT02715518|NSTEMI|nstemi
4784274|NCT02715505|Hurler syndrome, MLD, Krabbe, cALD, Hematopoietic Stem Cell Transplantation (HSCT)|hurler syndrome, mld, krabbe, cald, hematopoietic stem cell transplantation (hsct)
4784275|NCT02715453|Frailty|frailty
4784276|NCT02715453|Acute myocardial infarction|acute myocardial infarction
4784277|NCT02715440|Benzodiazepines|benzodiazepines
4784278|NCT02715440|drugs|drugs
4784279|NCT02715440|withdrawal|withdrawal
4784280|NCT02715440|nursing home|nursing home
4784281|NCT02715440|elderly|elderly
4784282|NCT02715440|therapy elderly|therapy elderly
4784283|NCT02715440|Adverse Effect|adverse effect
4784284|NCT02715440|pharmacokinetics|pharmacokinetics
4784285|NCT02715440|Decreased Drug Tolerance|decreased drug tolerance
4784286|NCT02715375|asthma environment|asthma environment
4784287|NCT02715362|immunotherapy GPC3 CAR-T HCC|immunotherapy gpc3 car-t hcc
4784288|NCT02715349|schizophrenia|schizophrenia
4784289|NCT02715349|psychoeducation|psychoeducation
4784290|NCT02715349|Vietnam|vietnam
4784291|NCT02715336|In vitro fertilization|in vitro fertilization
4784292|NCT02715336|IVF|ivf
4784293|NCT02715336|Assisted Reproductive Technologies|assisted reproductive technologies
4784294|NCT02715336|ART|art
4784295|NCT02715336|OHSS|ohss
4784296|NCT02715336|Ovarian hyperstimulation|ovarian hyperstimulation
4784297|NCT02715336|dual triggering|dual triggering
4784298|NCT02715336|GnRH|gnrh
4784299|NCT02715323|dry eye|dry eye
4784300|NCT02715323|immunological profile|immunological profile
4784301|NCT02715323|autoimmune|autoimmune
4784302|NCT02715297|glioblastoma|glioblastoma
4784303|NCT02715297|GBM|gbm
4784304|NCT02715297|radiotherapy|radiotherapy
4784305|NCT02715297|Re-irradiation|re-irradiation
4784306|NCT02715297|progression|progression
4784307|NCT02715284|Metastatic solid tumors|metastatic solid tumors
4784308|NCT02715284|Advanced solid tumors|advanced solid tumors
4784309|NCT02715284|anti-PD-1|anti-pd-1
4784310|NCT02715284|TSR-042|tsr-042
4784311|NCT02715284|Immunotherapy|immunotherapy
4784312|NCT02715284|PD-1|pd-1
4784313|NCT02715284|Endometrial|endometrial
4784314|NCT02715284|Non-small cell lung cancer, NSCLC|non-small cell lung cancer, nsclc
4784315|NCT02715284|MSI-High|msi-high
4784316|NCT02715245|home rehabilitation|home rehabilitation
4784317|NCT02715245|Primary Health Care|primary health care
4784318|NCT02715245|Physiotherapy|physiotherapy
4784319|NCT02715245|chronic disease|chronic disease
4784320|NCT02715206|rural adolescents, substance use, prevention, adaptation|rural adolescents, substance use, prevention, adaptation
4784321|NCT02715154|Epidural Anaesthesia|epidural anaesthesia
4784322|NCT02715154|Cesarean Section|cesarean section
4784323|NCT02715154|Dexmedetomidine|dexmedetomidine
4784324|NCT02715141|surveillance, molecular stool testing|surveillance, molecular stool testing
4784325|NCT02715115|Autism|autism
4784326|NCT02715115|Rett's syndrome|rett's syndrome
4784327|NCT02715115|Rett disorder|rett disorder
4784328|NCT02715115|Rett's disorder|rett's disorder
4784329|NCT02715115|Ataxia|ataxia
4784330|NCT02715102|lung cancer|lung cancer
4784331|NCT02715102|lung neoplasms|lung neoplasms
4784332|NCT02715102|lung nodules|lung nodules
4784333|NCT02715102|screening tests for cancer|screening tests for cancer
4784334|NCT02715089|NGS|ngs
4784335|NCT02715089|Liver Neoplasms|liver neoplasms
4784336|NCT02715089|Biliary Tract Neoplasms|biliary tract neoplasms
4784337|NCT02715089|Hepatobiliary Neoplasms|hepatobiliary neoplasms
4784338|NCT02715076|Thoracic Surgery|thoracic surgery
4784339|NCT02715076|Thoracic surgery, Video assisted|thoracic surgery, video assisted
4784340|NCT02715076|Open Abdominal Surgery|open abdominal surgery
4784341|NCT02715076|Anesthesia, General|anesthesia, general
4784342|NCT02715050|phototherapy|phototherapy
4784343|NCT02715050|photobiostimulation|photobiostimulation
4784344|NCT02715050|muscle training|muscle training
4784345|NCT02715050|muscular adaptation|muscular adaptation
4784346|NCT02715037|fusobacterium necrophorum|fusobacterium necrophorum
4784347|NCT02715037|acute tonsillitis|acute tonsillitis
4784348|NCT02715037|peritonsillar cellulitis|peritonsillar cellulitis
4784349|NCT02715037|infectious mononucleosis|infectious mononucleosis
4784350|NCT02715037|microbiology|microbiology
4784351|NCT02715037|antibody development|antibody development
4784352|NCT02715024|Tamsulosin|tamsulosin
4784353|NCT02715024|Solifenacin|solifenacin
4784354|NCT02715024|Lower urinary tract symptoms|lower urinary tract symptoms
4784355|NCT02715024|Overactive bladder|overactive bladder
4784356|NCT02715011|Leukemia, Myeloid, Acute|leukemia, myeloid, acute
4784357|NCT02715011|JNJ-63709178|jnj-63709178
4784358|NCT02714998|ectopic pregnancy|ectopic pregnancy
4784359|NCT02714998|ovarian reserve|ovarian reserve
4784360|NCT02714998|salpingectomy|salpingectomy
4784361|NCT02714998|methotrexate|methotrexate
4784362|NCT02714985|chikungunya virus|chikungunya virus
4784363|NCT02714985|RT-PCR|rt-pcr
4784364|NCT02714985|urine|urine
4784365|NCT02714985|diagnosis|diagnosis
4784366|NCT02714946|Thyroid Nodule|thyroid nodule
4784367|NCT02714946|Percutaneous radiofrequency ablation (RFA)|percutaneous radiofrequency ablation (rfa)
4784368|NCT02714946|Percutaneous laser ablation (LA)|percutaneous laser ablation (la)
4784369|NCT02714933|pulmonary|pulmonary
4784370|NCT02714933|parenchyma|parenchyma
4784371|NCT02714933|MRI sequence Advanced ZTE|mri sequence advanced zte
4784372|NCT02714933|chest computed tomography|chest computed tomography
4784373|NCT02714920|DNA Repair Enzyme Signature|dna repair enzyme signature
4784374|NCT02714920|instrinsic radio- or chemo-resistance|instrinsic radio- or chemo-resistance
4784375|NCT02714920|treatment-induced radio- or chemo-resistance|treatment-induced radio- or chemo-resistance
4784376|NCT02714894|magnetic resonance imaging|magnetic resonance imaging
4784377|NCT02714894|magnetic resonance spectroscopy|magnetic resonance spectroscopy
4784378|NCT02714868|repeated measures|repeated measures
4784379|NCT02714868|matched comparison|matched comparison
4784380|NCT02714868|manualized intervention|manualized intervention
4784381|NCT02714868|self-determination|self-determination
4784382|NCT02714868|participation|participation
4784383|NCT02714868|advocacy|advocacy
4784384|NCT02714868|problem-solving|problem-solving
4784385|NCT02714868|commuinity participation|commuinity participation
4784386|NCT02714868|occupational therapy|occupational therapy
4784387|NCT02714868|environment|environment
4784388|NCT02714829|Injectable Ceramics Bone Graft Substitute Containing rhBMP-2|injectable ceramics bone graft substitute containing rhbmp-2
4784389|NCT02714790|Acute Myeloid Leukemia|acute myeloid leukemia
4784390|NCT02714790|Minimal Residual Disease|minimal residual disease
4784391|NCT02714790|Wilms Tumor|wilms tumor
4784392|NCT02714777|General anesthesia|general anesthesia
4784393|NCT02714777|Autonomic nervous system|autonomic nervous system
4784394|NCT02714777|Children|children
4784395|NCT02714764|Alexander Disease|alexander disease
4784396|NCT02714738|Brachial plexus block|brachial plexus block
4784397|NCT02714738|Regional anesthesia|regional anesthesia
4784398|NCT02714738|Ultrasound|ultrasound
4784399|NCT02714725|Dexmedetomidine|dexmedetomidine
4784400|NCT02714725|Microcirculation|microcirculation
4784401|NCT02714725|On Pump|on pump
4784402|NCT02714725|CABG|cabg
4784403|NCT02714686|Fertility|fertility
4784404|NCT02714686|Total Contraception Prevalence Rate|total contraception prevalence rate
4784405|NCT02714686|Family planning methods|family planning methods
4784406|NCT02714686|Birth Control|birth control
4784407|NCT02714686|Mass Media Campaign|mass media campaign
4784408|NCT02714686|Demand for contraception|demand for contraception
4784409|NCT02714686|Modern Contraception Prevalence Rate|modern contraception prevalence rate
4784410|NCT02714686|Birth intervals|birth intervals
4784411|NCT02714647|motor learning|motor learning
4784412|NCT02714647|attention|attention
4784413|NCT02714647|priming|priming
4784414|NCT02714647|rehabilitation|rehabilitation
4784415|NCT02714621|Magnetic Resonance Imaging (MRI)|magnetic resonance imaging (mri)
4784416|NCT02714621|High Intensity Focused Ultrasound (HIFU)|high intensity focused ultrasound (hifu)
4784417|NCT02714621|Focused Ultrasound Surgery|focused ultrasound surgery
4784418|NCT02714595|cefiderocol|cefiderocol
4784419|NCT02714595|Bloodstream infections (BSI)|bloodstream infections (bsi)
4784420|NCT02714595|Complicated urinary tract infection (cUTI)|complicated urinary tract infection (cuti)
4784421|NCT02714595|Ventilator associated pneumonia (VAP)|ventilator associated pneumonia (vap)
4784422|NCT02714595|Hospital acquired pneumonia (HAP)|hospital acquired pneumonia (hap)
4784423|NCT02714595|Sepsis|sepsis
4784424|NCT02714595|multi-drug resistant pathogens|multi-drug resistant pathogens
4784425|NCT02714595|S-649266|s-649266
4784426|NCT02714595|Gram-negative pathogens|gram-negative pathogens
4784427|NCT02714595|Healthcare-associated pneumonia (HCAP)|healthcare-associated pneumonia (hcap)
4784428|NCT02714595|carbapenem resistant pathogens|carbapenem resistant pathogens
4784429|NCT02714582|Shift report|shift report
4784430|NCT02714582|Bedside|bedside
4784431|NCT02714582|Nursing|nursing
4784432|NCT02714582|Matched controlled trial|matched controlled trial
4784433|NCT02714582|Mixed method|mixed method
4784434|NCT02714582|Patient participation|patient participation
4784435|NCT02714556|Lung volume|lung volume
4784436|NCT02714556|Lung Clearance Index|lung clearance index
4784437|NCT02714556|Functional Residual Capacity|functional residual capacity
4784438|NCT02714556|Respiratory function|respiratory function
4784439|NCT02714543|OSMF|osmf
4784440|NCT02714543|Aloevera|aloevera
4784441|NCT02714543|Hydrocortisone|hydrocortisone
4784442|NCT02714543|Hyaluronidase|hyaluronidase
4784443|NCT02714504|Prophylaxis|prophylaxis
4784444|NCT02714465|Hyperbaric Oxygen Therapy; Gamma Knife Radiosurgery|hyperbaric oxygen therapy; gamma knife radiosurgery
4784445|NCT02714452|Person-centred care|person-centred care
4784446|NCT02714452|Thriving|thriving
4784447|NCT02714452|Satisfaction with care|satisfaction with care
4784448|NCT02714452|Residential aged care|residential aged care
4784449|NCT02714452|Caring environment|caring environment
4784450|NCT02714439|Malignant neoplasms of female genital organs|malignant neoplasms of female genital organs
4784451|NCT02714439|Cervical Cancer Prevention|cervical cancer prevention
4784452|NCT02714439|Abnormal Pap test|abnormal pap test
4784453|NCT02714439|Positive HPV test|positive hpv test
4784454|NCT02714439|History of cervical dysplasia|history of cervical dysplasia
4784455|NCT02714439|Colposcopy|colposcopy
4784456|NCT02714439|Proflavine|proflavine
4784457|NCT02714439|Proflavine hemisulfate|proflavine hemisulfate
4784458|NCT02714439|High-Resolution Microendoscopy|high-resolution microendoscopy
4784459|NCT02714439|HRME|hrme
4784460|NCT02714439|Human papillomavirus|human papillomavirus
4784461|NCT02714426|Cognitive Aging|cognitive aging
4784462|NCT02714426|Attention|attention
4784463|NCT02714426|Mindfulness|mindfulness
4784464|NCT02714413|D-allulose|d-allulose
4784465|NCT02714413|Caucasian|caucasian
4784466|NCT02714413|African American|african american
4784467|NCT02714400|Obstructive Sleep Apnea|obstructive sleep apnea
4784468|NCT02714400|Arousal threshold|arousal threshold
4784469|NCT02714400|Venlafaxine|venlafaxine
4784470|NCT02714387|Non traumatic acute brain injury|non traumatic acute brain injury
4784471|NCT02714374|GL-ONC1|gl-onc1
4784472|NCT02714374|Solid Organ Cancer|solid organ cancer
4784473|NCT02714374|Cancer|cancer
4784475|NCT02714374|Oncolytic Virus|oncolytic virus
4784476|NCT02714374|Soliris|soliris
4784477|NCT02714374|Metastatic melanoma|metastatic melanoma
4784478|NCT02714374|Esophageal and gastric adenocarcinoma (Stage III/IV)|esophageal and gastric adenocarcinoma (stage iii/iv)
4784479|NCT02714374|Cholangiocarcinoma|cholangiocarcinoma
4784480|NCT02714374|Pancreatic adenocarcinoma|pancreatic adenocarcinoma
4784481|NCT02714374|Gallbladder cancer|gallbladder cancer
4784482|NCT02714374|Colorectal cancer (Stage IV)|colorectal cancer (stage iv)
4784483|NCT02714374|High-grade mucinous appendix cancer|high-grade mucinous appendix cancer
4784484|NCT02714374|High-grade gastrointestinal neuroendocrine cancer|high-grade gastrointestinal neuroendocrine cancer
4784485|NCT02714374|Mesothelioma|mesothelioma
4784486|NCT02714374|High-grade soft tissue sarcoma|high-grade soft tissue sarcoma
4784487|NCT02714374|Stage III or IV|stage iii or iv
4784488|NCT02714361|Iron deficiency|iron deficiency
4784489|NCT02714361|Vitamin D|vitamin d
4784490|NCT02714361|Iron absorption|iron absorption
4784491|NCT02714361|Hepcidin|hepcidin
4784492|NCT02714348|Helminth infection|helminth infection
4784493|NCT02714348|Vaccination|vaccination
4784494|NCT02714322|Adalimumab|adalimumab
4784495|NCT02714322|Biologics|biologics
4784496|NCT02714322|Biosimilar|biosimilar
4784497|NCT02714309|Postprandial glycemia|postprandial glycemia
4784498|NCT02714309|Metabolic health measures|metabolic health measures
4784499|NCT02714296|colon preparation for endoscopy|colon preparation for endoscopy
4784500|NCT02714296|enteral feeding|enteral feeding
4784501|NCT02714296|sip feeding|sip feeding
4784502|NCT02714296|nutridrink|nutridrink
4784503|NCT02714296|nutridrink compact protein|nutridrink compact protein
4784504|NCT02714283|nontuberculous mycobacteria|nontuberculous mycobacteria
4784505|NCT02714283|corticosteroids|corticosteroids
4784506|NCT02714283|macrolides|macrolides
4784507|NCT02714283|antibiotics|antibiotics
4784508|NCT02714205|Hot flash|hot flash
4784509|NCT02714153|Lead extraction|lead extraction
4784510|NCT02714153|Superior Vena Cava Tear|superior vena cava tear
4784511|NCT02714153|Pacemaker/Defibrillator lead extraction|pacemaker/defibrillator lead extraction
4784512|NCT02714127|Human Papillomavirus|human papillomavirus
4784513|NCT02714127|Biomarker|biomarker
4784514|NCT02714127|Self-sampling|self-sampling
4784515|NCT02714127|First-void urine|first-void urine
4784516|NCT02714127|Cervicovaginal fluid|cervicovaginal fluid
4784517|NCT02714127|Colposcopy|colposcopy
4784518|NCT02714114|Antibodies|antibodies
4784519|NCT02714114|Vaccination|vaccination
4784520|NCT02714114|Self-sampling|self-sampling
4784521|NCT02714114|First-void urine|first-void urine
4784522|NCT02714114|Serum|serum
4784523|NCT02714088|High-intensity interval training|high-intensity interval training
4784524|NCT02714088|Functional fitness|functional fitness
4784525|NCT02714088|Quality of life|quality of life
4784526|NCT02714088|Older adults|older adults
4784527|NCT02714062|Adolescent Obesity|adolescent obesity
4784528|NCT02714062|Childhood Obesity|childhood obesity
4784529|NCT02714062|Qsymia|qsymia
4784530|NCT02714062|Pharmacokinetics|pharmacokinetics
4784531|NCT02714062|VI-0521|vi-0521
4784532|NCT02714062|Phentermine|phentermine
4784533|NCT02714062|Topiramate|topiramate
4784534|NCT02714049|hypoactive sexual desire disorder|hypoactive sexual desire disorder
4784535|NCT02714049|Addyi|addyi
4784536|NCT02714049|flibanserin|flibanserin
4784537|NCT02714049|low sexual desire|low sexual desire
4784538|NCT02714049|HSDD|hsdd
4784539|NCT02714036|ALS|als
4784540|NCT02714010|EGFR-TKI|egfr-tki
4784541|NCT02714010|whole brain radiotherapy|whole brain radiotherapy
4784542|NCT02714010|brain metastasis|brain metastasis
4784543|NCT02714010|non-small cell lung cancer|non-small cell lung cancer
4784544|NCT02713984|HER2 CAR-T|her2 car-t
4784545|NCT02713984|safety|safety
4784546|NCT02713984|efficiency|efficiency
4784547|NCT02713984|refractory and relapsed cancer|refractory and relapsed cancer
4784548|NCT02713971|Rehabilitation|rehabilitation
4784549|NCT02713971|Balance|balance
4784550|NCT02713971|Gait|gait
4784551|NCT02713971|Biofeedback|biofeedback
4784552|NCT02713958|Telerehabilitation|telerehabilitation
4784553|NCT02713958|Elbow fractures|elbow fractures
4784554|NCT02713958|Arthrolysis|arthrolysis
4784555|NCT02713958|MediTouch|meditouch
4784556|NCT02713958|Occupational Therapy|occupational therapy
4784557|NCT02713958|Active exercises|active exercises
4784558|NCT02713945|Simvastatin|simvastatin
4784559|NCT02713945|Ras|ras
4784560|NCT02713945|MAPK|mapk
4784561|NCT02713932|Aortic valve stenosis|aortic valve stenosis
4784562|NCT02713932|Aortic valve regurgitation|aortic valve regurgitation
4784563|NCT02713932|Transcatheter aortic valve implantation|transcatheter aortic valve implantation
4784564|NCT02713919|Cancer|cancer
4784565|NCT02713919|Outpatients|outpatients
4784566|NCT02713919|Family Caregivers|family caregivers
4784567|NCT02713893|Pharmacokinetics|pharmacokinetics
4784568|NCT02713893|Econazole nitrate 1%|econazole nitrate 1%
4784569|NCT02713893|Benzydamine HCl 0.12%|benzydamine hcl 0.12%
4784570|NCT02713893|Intravaginal cream|intravaginal cream
4784571|NCT02713893|Antimycotic|antimycotic
4784572|NCT02713893|Tolerability|tolerability
4784573|NCT02713880|Amyloid Neuropathies|amyloid neuropathies
4784574|NCT02713880|Biomarker|biomarker
4784575|NCT02713854|Subfertility|subfertility
4784576|NCT02713854|In-vitro fertilization|in-vitro fertilization
4784577|NCT02713854|BAP-EB|bap-eb
4784578|NCT02713854|Endometrial epithelial cells|endometrial epithelial cells
4784579|NCT02713854|Repeated implantation failure|repeated implantation failure
4784580|NCT02713828|gpNMB-Expressing Squamous Cell Carcinoma of the Lung|gpnmb-expressing squamous cell carcinoma of the lung
4784581|NCT02713828|Stage IIIb|stage iiib
4784582|NCT02713828|Stage IV|stage iv
4784583|NCT02713828|Advanced Squamous Cell Cancer of the Lung|advanced squamous cell cancer of the lung
4784584|NCT02713828|Metastatic Squamous Cell Cancer of the Lung|metastatic squamous cell cancer of the lung
4784585|NCT02713828|gpNMB-Expressing|gpnmb-expressing
4784586|NCT02713828|Glembatumumab Vedotin|glembatumumab vedotin
4784587|NCT02713815|Amphetamine-type stimulants|amphetamine-type stimulants
4784588|NCT02713815|prefrontal-striatal circuits|prefrontal-striatal circuits
4784589|NCT02713815|Glutamate/GABA|glutamate/gaba
4784590|NCT02713815|motivational and cognitive intervention|motivational and cognitive intervention
4784591|NCT02713815|rTMS|rtms
4784592|NCT02713789|ED|ed
4784593|NCT02713776|High-Output Enterostomy|high-output enterostomy
4784594|NCT02713776|Pasireotide|pasireotide
4784595|NCT02713776|Somatostatin Analogues|somatostatin analogues
4784596|NCT02713763|Sunitinib|sunitinib
4784597|NCT02713750|Combined Oral Contraceptives|combined oral contraceptives
4784598|NCT02713750|Highly Active Antiretroviral Therapy|highly active antiretroviral therapy
4784599|NCT02713750|Hormonal Contraception|hormonal contraception
4784600|NCT02713750|Human Immunodeficiency Virus|human immunodeficiency virus
4784601|NCT02713750|Intrauterine Device|intrauterine device
4784602|NCT02713750|Pharmacokinetic|pharmacokinetic
4784603|NCT02713750|Sexually Transmitted Diseases|sexually transmitted diseases
4784604|NCT02713750|Reproductive Health|reproductive health
4784605|NCT02713737|hypoxemia|hypoxemia
4784606|NCT02713737|high-flow|high-flow
4784607|NCT02713737|atrial fibrillation|atrial fibrillation
4784608|NCT02713737|sleep|sleep
4784609|NCT02713711|Psoriasis|psoriasis
4784610|NCT02713711|balneotherapy|balneotherapy
4784611|NCT02713711|phototherapy|phototherapy
4784612|NCT02713711|balneophototherapy|balneophototherapy
4784613|NCT02713698|Anaesthetics|anaesthetics
4784614|NCT02713698|Intravenous|intravenous
4784615|NCT02713698|Propofol|propofol
4784616|NCT02713698|Pharmacokinetics|pharmacokinetics
4784617|NCT02713698|Pharmacodynamics|pharmacodynamics
4784618|NCT02713698|Propofol pharmacokinetic-pharmacodynamic model|propofol pharmacokinetic-pharmacodynamic model
4784619|NCT02713685|regional anesthesia|regional anesthesia
4784620|NCT02713685|lower limb surgery|lower limb surgery
4784621|NCT02713685|Bupivacaine|bupivacaine
4784622|NCT02713659|Literacy|literacy
4784623|NCT02713659|Child Development|child development
4784624|NCT02713659|Reading|reading
4784625|NCT02713646|MRI|mri
4784626|NCT02713646|Virtual Endoscopy|virtual endoscopy
4784627|NCT02713646|Pain Measurement|pain measurement
4784628|NCT02713620|HBV vaccination, immunity|hbv vaccination, immunity
4784629|NCT02713581|Proximal venous thromboembolism|proximal venous thromboembolism
4784630|NCT02713568|Macrosomia|macrosomia
4784631|NCT02713568|Magnetic Resonance- Estimated Fetal Weight|magnetic resonance- estimated fetal weight
4784632|NCT02713568|Ultrasound-Estimated Fetal Weight|ultrasound-estimated fetal weight
4784633|NCT02713568|Large-for-date fetus|large-for-date fetus
4784634|NCT02713529|Solid Tumor|solid tumor
4784635|NCT02713529|Pancreatic Cancer|pancreatic cancer
4784636|NCT02713529|Colorectal Cancer|colorectal cancer
4784637|NCT02713529|Non-Small Cell Lung Cancer|non-small cell lung cancer
4784638|NCT02713516|Anxiety|anxiety
4784639|NCT02713516|OCD|ocd
4784640|NCT02713516|Obsessive Compulsive Disorder|obsessive compulsive disorder
4784641|NCT02713516|Generalized Anxiety|generalized anxiety
4784642|NCT02713516|Social Phobia|social phobia
4784643|NCT02713516|Separation Anxiety|separation anxiety
4784644|NCT02713516|GAD|gad
4784645|NCT02713516|Youth|youth
4784646|NCT02713516|Teen|teen
4784647|NCT02713516|Therapy|therapy
4784648|NCT02713451|Oxygen|oxygen
4784649|NCT02713438|Physical activity|physical activity
4784650|NCT02713438|Planning|planning
4784651|NCT02713438|Implementation intention|implementation intention
4784652|NCT02713438|Quality of life|quality of life
4784653|NCT02713438|Body weight|body weight
4784654|NCT02713425|Anxiety|anxiety
4784655|NCT02713425|Social Phobia|social phobia
4784656|NCT02713425|Separation Anxiety|separation anxiety
4784657|NCT02713425|Generalized Anxiety|generalized anxiety
4784658|NCT02713425|GAD|gad
4784659|NCT02713425|Phobia|phobia
4784660|NCT02713425|video game|video game
4784661|NCT02713425|teen|teen
4784662|NCT02713425|youth|youth
4784663|NCT02713425|child|child
4784664|NCT02713425|adolescent|adolescent
4784665|NCT02713347|Quality of Life|quality of life
4784666|NCT02713347|Symptom Assessment|symptom assessment
4784667|NCT02713347|Palliative Care|palliative care
4784668|NCT02713347|Disease Management|disease management
4784669|NCT02713347|Delivery of Health Care|delivery of health care
4784670|NCT02713347|Advance Care Planning|advance care planning
4784671|NCT02713334|Decision Making|decision making
4784672|NCT02713334|Communication|communication
4784673|NCT02713334|16-080|16-080
4784674|NCT02713321|diabetes|diabetes
4784675|NCT02713321|vulnerable populations|vulnerable populations
4784676|NCT02713321|comorbidity|comorbidity
4784677|NCT02713321|patient-centered outcomes research|patient-centered outcomes research
4784678|NCT02713321|Medicaid reform|medicaid reform
4784679|NCT02713321|health disparities|health disparities
4784680|NCT02713295|Moderate Plaque Psoriasis|moderate plaque psoriasis
4784681|NCT02713295|Severe Plaque Psoriasis|severe plaque psoriasis
4784682|NCT02713295|Plaque Psoriasis|plaque psoriasis
4784683|NCT02713282|Schizophrenia|schizophrenia
4784684|NCT02713282|R092670|r092670
4784685|NCT02713282|Paliperidone Palmitate|paliperidone palmitate
4784686|NCT02713269|Secondary Malignant Neoplasm of Vertebral Column|secondary malignant neoplasm of vertebral column
4784687|NCT02713269|Spine Metastases|spine metastases
4784688|NCT02713269|Epidural spinal cord compression|epidural spinal cord compression
4784689|NCT02713269|Stereotactic spine radiosurgery|stereotactic spine radiosurgery
4784690|NCT02713269|SSRS|ssrs
4784691|NCT02713269|Thermal ablation|thermal ablation
4784692|NCT02713269|Symptom questionnaire|symptom questionnaire
4784693|NCT02713269|Surveys|surveys
4784694|NCT02713256|Graves' disease|graves' disease
4784695|NCT02713256|Hyperthyroidism|hyperthyroidism
4784696|NCT02713256|CFZ533|cfz533
4784697|NCT02713256|TSH|tsh
4784698|NCT02713243|Primary bile acid diarrhea,|primary bile acid diarrhea,
4784699|NCT02713243|FXR agonist,|fxr agonist,
4784700|NCT02713243|bile acid malabsorption.|bile acid malabsorption.
4784701|NCT02713217|depressive disorder|depressive disorder
4784702|NCT02713217|alcohol-related disorders|alcohol-related disorders
4784703|NCT02713217|telemedicine|telemedicine
4784704|NCT02713217|rural health|rural health
4784705|NCT02713217|collaborative care|collaborative care
4784706|NCT02713217|post-traumatic stress disorder (PTSD)|post-traumatic stress disorder (ptsd)
4784707|NCT02713191|Bronchoscopy|bronchoscopy
4784708|NCT02713191|Sedation|sedation
4784709|NCT02713191|Dexmedetomidine|dexmedetomidine
4784710|NCT02713165|Gut Microbiota|gut microbiota
4784711|NCT02713139|vaginal|vaginal
4784712|NCT02713139|discharge|discharge
4784713|NCT02713139|women|women
4784714|NCT02713048|Cardiac arrest|cardiac arrest
4784715|NCT02713048|Troponin I|troponin i
4784716|NCT02713048|coronary anatomy|coronary anatomy
4784717|NCT02713022|DEXA Scan|dexa scan
4784718|NCT02713022|15-235|15-235
4784719|NCT02713009|Maternal body weight|maternal body weight
4784720|NCT02713009|Vitamin D|vitamin d
4784721|NCT02713009|Pregnancy|pregnancy
4784722|NCT02712996|Traumatic Brain Injury|traumatic brain injury
4784723|NCT02712996|Attention Deficit|attention deficit
4784724|NCT02712996|TBI|tbi
4784725|NCT02712996|Vyvanse|vyvanse
4784848|NCT02712268|Polypharmacy|polypharmacy
4784726|NCT02712983|Inhaled tobramycin; tobramycin inhalation powder; bronchiectasis; pulmonary Pseudomonas aeruginosa infection; dose-finding study|inhaled tobramycin; tobramycin inhalation powder; bronchiectasis; pulmonary pseudomonas aeruginosa infection; dose-finding study
4784727|NCT02712918|Depression|depression
4784728|NCT02712918|Inpatient|inpatient
4784729|NCT02712918|Acute|acute
4784730|NCT02712918|Brief Behavioral Activation Treatment for Depression|brief behavioral activation treatment for depression
4784731|NCT02712905|Acute myeloid leukemia (AML)|acute myeloid leukemia (aml)
4784732|NCT02712905|myelodysplastic syndrome (MDS)|myelodysplastic syndrome (mds)
4784733|NCT02712905|small cell lung cancer (SCLC)|small cell lung cancer (sclc)
4784734|NCT02712905|myelofibrosis (MF)|myelofibrosis (mf)
4784735|NCT02712905|solid tumor, lysine-specific demethylase 1 (LSD1) inhibitor|solid tumor, lysine-specific demethylase 1 (lsd1) inhibitor
4784736|NCT02712840|Single embryo transfer|single embryo transfer
4784737|NCT02712840|Freeze-all|freeze-all
4784738|NCT02712840|Fresh|fresh
4784739|NCT02712840|Vitrification|vitrification
4784740|NCT02712840|Clinical Pregnancy|clinical pregnancy
4784741|NCT02712840|Blastocyst|blastocyst
4784742|NCT02712827|self-gripping mesh, fibrin glue, total extraperitoneal|self-gripping mesh, fibrin glue, total extraperitoneal
4784743|NCT02712801|HIV|hiv
4784744|NCT02712801|antiretroviral treatment|antiretroviral treatment
4784745|NCT02712801|child|child
4784746|NCT02712801|testing|testing
4784747|NCT02712788|Subarachnoid Hemorrhage|subarachnoid hemorrhage
4784748|NCT02712788|Cerebral Vasospasm|cerebral vasospasm
4784749|NCT02712788|Milrinone|milrinone
4784750|NCT02712788|Hyperdynamic Therapy|hyperdynamic therapy
4784751|NCT02712762|immunological profiles|immunological profiles
4784752|NCT02712749|Binaural Beat|binaural beat
4784753|NCT02712749|Elderly|elderly
4784754|NCT02712749|preoperative medication|preoperative medication
4784755|NCT02712736|Primary Sclerosing Cholangitis|primary sclerosing cholangitis
4784756|NCT02712723|ER+, HER2-negative breast cancer|er+, her2-negative breast cancer
4784757|NCT02712723|Stage II or III|stage ii or iii
4784758|NCT02712723|Letrozole|letrozole
4784759|NCT02712723|Femara|femara
4784760|NCT02712723|Ribociclib|ribociclib
4784761|NCT02712723|LEE011|lee011
4784762|NCT02712723|Neo-adjuvant|neo-adjuvant
4784763|NCT02712710|knee, osteoarthritis, brace|knee, osteoarthritis, brace
4784764|NCT02712697|liver-kidney yin deficiency syndrome|liver-kidney yin deficiency syndrome
4784765|NCT02712697|primary severe IgA nephropathy|primary severe iga nephropathy
4784766|NCT02712697|Lee's grade Ⅲ|lee's grade ⅲ
4784767|NCT02712671|Cost-Benefit Analysis|cost-benefit analysis
4784768|NCT02712671|Quality of Life|quality of life
4784769|NCT02712593|Healthy participants|healthy participants
4784770|NCT02712593|Dietary supplement|dietary supplement
4784771|NCT02712593|Bioavailability|bioavailability
4784772|NCT02712593|Niagen™|niagen™
4784773|NCT02712593|Nicotinamide riboside|nicotinamide riboside
4784774|NCT02712593|N-methylnicotinamide|n-methylnicotinamide
4784775|NCT02712580|pediatric burns|pediatric burns
4784776|NCT02712580|deep dermal wounds|deep dermal wounds
4784777|NCT02712580|wound healing|wound healing
4784778|NCT02712580|ChildPain Measurement|childpain measurement
4784779|NCT02712580|Treatment Outcome Wound Healing/physiology|treatment outcome wound healing/physiology
4784780|NCT02712580|wireless electric stimulation|wireless electric stimulation
4784781|NCT02712580|wireless current stimulation|wireless current stimulation
4784782|NCT02712580|wireless technology|wireless technology
4784783|NCT02712580|children|children
4784784|NCT02712580|conservative treatment|conservative treatment
4784785|NCT02712580|deep dermal scalds|deep dermal scalds
4784786|NCT02712580|humans|humans
4784787|NCT02712580|deep dermal burns|deep dermal burns
4784788|NCT02712580|burns|burns
4784789|NCT02712580|wound healing process|wound healing process
4784790|NCT02712554|Pain|pain
4784791|NCT02712554|Nausea|nausea
4784792|NCT02712554|Vomiting|vomiting
4784793|NCT02712541|Caregiver burden Index|caregiver burden index
4784794|NCT02712528|bispectral index|bispectral index
4784795|NCT02712528|extubation|extubation
4784796|NCT02712528|recovery|recovery
4784797|NCT02712528|remifentanil|remifentanil
4784798|NCT02712489|HAART-treated participants|haart-treated participants
4784799|NCT02712489|Tat|tat
4784800|NCT02712489|Therapeutic immunization|therapeutic immunization
4784801|NCT02712476|Mannitol|mannitol
4784802|NCT02712476|Furosemid|furosemid
4784803|NCT02712476|Brain Relaxation|brain relaxation
4784804|NCT02712463|Schizophrenia|schizophrenia
4784805|NCT02712463|Oral antipsychotics|oral antipsychotics
4784806|NCT02712463|Long acting Injectable antipsychotics|long acting injectable antipsychotics
4784807|NCT02712450|geriatric|geriatric
4784808|NCT02712450|emergency|emergency
4784809|NCT02712450|clinical pathway|clinical pathway
4784810|NCT02712450|regulation|regulation
4784811|NCT02712450|SAMU|samu
4784812|NCT02712450|training|training
4784813|NCT02712437|Insomnia|insomnia
4784814|NCT02712437|Quality of Life|quality of life
4784815|NCT02712437|Cognitive behavioral therapy|cognitive behavioral therapy
4784816|NCT02712424|Vaccine|vaccine
4784817|NCT02712372|AZD4831 oral suspension|azd4831 oral suspension
4784818|NCT02712372|Healthy male subjects|healthy male subjects
4784819|NCT02712372|Safety|safety
4784820|NCT02712372|Tolerability|tolerability
4784821|NCT02712372|Pharmacokinetics|pharmacokinetics
4784822|NCT02712372|Pharmacodynamics|pharmacodynamics
4784823|NCT02712359|Havrix|havrix
4784824|NCT02712359|Cross-sectional seroprevalence survey|cross-sectional seroprevalence survey
4784825|NCT02712359|Panama|panama
4784826|NCT02712359|Long-term persistence|long-term persistence
4784827|NCT02712359|Hepatitis|hepatitis
4784828|NCT02712346|Sickle Cell Anemia|sickle cell anemia
4784829|NCT02712346|Sickle Cell Thalassemia|sickle cell thalassemia
4784830|NCT02712346|Sickle Beta Thalassemia|sickle beta thalassemia
4784831|NCT02712346|Proteinuria|proteinuria
4784832|NCT02712346|Sickle nephropathy|sickle nephropathy
4784833|NCT02712333|PM2.5|pm2.5
4784834|NCT02712333|air purification|air purification
4784835|NCT02712333|randomized controlled trial|randomized controlled trial
4784836|NCT02712333|metabolomics|metabolomics
4784837|NCT02712333|Metabolites|metabolites
4784838|NCT02712333|exhaled nitric oxide|exhaled nitric oxide
4784839|NCT02712320|Prostate Neoplasm Cancer Carcinoma|prostate neoplasm cancer carcinoma
4784840|NCT02712320|Safety Extension|safety extension
4784841|NCT02712294|pulmonary hypertension|pulmonary hypertension
4784842|NCT02712294|peripheral muscle electrostimulation|peripheral muscle electrostimulation
4784843|NCT02712294|capacity of the exercises|capacity of the exercises
4784844|NCT02712294|quality of life|quality of life
4784845|NCT02712281|Food Selectivity|food selectivity
4784846|NCT02712281|Autism MEAL Plan|autism meal plan
4784847|NCT02712281|Parent Education|parent education
4784849|NCT02712268|Clinical decision-making|clinical decision-making
4784850|NCT02712255|Physical activity|physical activity
4784851|NCT02712255|Quality of life|quality of life
4784852|NCT02712255|Planning|planning
4784853|NCT02712255|Implementation intentions|implementation intentions
4784854|NCT02712255|Cardiovascular disease|cardiovascular disease
4784855|NCT02712255|Diabetes|diabetes
4784856|NCT02712203|Measles vaccine|measles vaccine
4784857|NCT02712203|Priorix|priorix
4784858|NCT02712203|Priorix-Tetra|priorix-tetra
4784859|NCT02712203|Age at vaccination|age at vaccination
4784860|NCT02712177|vaccine safety|vaccine safety
4784861|NCT02712177|interaction|interaction
4784862|NCT02712164|Split-thickness skin graft|split-thickness skin graft
4784863|NCT02712164|STSG|stsg
4784864|NCT02712164|donor site|donor site
4784865|NCT02712164|negative-pressure wound therapy|negative-pressure wound therapy
4784866|NCT02712164|NPWT|npwt
4784867|NCT02712164|dressing|dressing
4784868|NCT02712151|transversus abdominal plane block|transversus abdominal plane block
4784869|NCT02712138|Hyperbilirubinemia|hyperbilirubinemia
4784870|NCT02712138|Unconjugated Benign Bilirubinemia|unconjugated benign bilirubinemia
4784871|NCT02712060|Ehlers-Danlos Syndrome|ehlers-danlos syndrome
4784872|NCT02712060|Obstructive Sleep Apnea|obstructive sleep apnea
4784873|NCT02712060|Prevalence|prevalence
4784874|NCT02712060|Children|children
4784875|NCT02712060|Pediatric|pediatric
4784876|NCT02712060|Adolescents|adolescents
4784877|NCT02712047|Fluticasone furoate/vilanterol|fluticasone furoate/vilanterol
4784878|NCT02712047|Asthma|asthma
4784879|NCT02712047|fraction of exhaled nitric oxide|fraction of exhaled nitric oxide
4784880|NCT02712047|cross-over|cross-over
4784881|NCT02712034|Medication-assisted treatment (MAT)|medication-assisted treatment (mat)
4784882|NCT02712034|Buprenorphine|buprenorphine
4784883|NCT02712034|Methadone|methadone
4784884|NCT02712034|Naltrexone|naltrexone
4784885|NCT02712021|Cerebral Palsy|cerebral palsy
4784886|NCT02712021|Lycra|lycra
4784887|NCT02712021|Motor Function|motor function
4784888|NCT02712021|Static Balance|static balance
4784889|NCT02711995|botulinum toxin|botulinum toxin
4784890|NCT02711995|injection augmentation|injection augmentation
4784891|NCT02711995|essential voice tremor|essential voice tremor
4784892|NCT02711956|Metastatic Castration-Resistant Prostate Cancer (mCRPC)|metastatic castration-resistant prostate cancer (mcrpc)
4784893|NCT02711956|Phase 1b/2a|phase 1b/2a
4784894|NCT02711956|Prostate Cancer|prostate cancer
4784895|NCT02711956|Pharmacokinetics (PK)|pharmacokinetics (pk)
4784896|NCT02711956|ZEN003694|zen003694
4784897|NCT02711956|ZEN-3694|zen-3694
4784898|NCT02711956|Metastatic Castrate-Resistant Prostate Cancer|metastatic castrate-resistant prostate cancer
4784899|NCT02711956|BET inhibitor (BETi)|bet inhibitor (beti)
4784900|NCT02711956|Bromodomain|bromodomain
4784901|NCT02711956|Pharmacodynamics (PD)|pharmacodynamics (pd)
4784902|NCT02711956|Enzalutamide|enzalutamide
4784903|NCT02711956|XTANDI|xtandi
4784904|NCT02711956|MDV3100|mdv3100
4784905|NCT02711956|Epigenetics|epigenetics
4784906|NCT02711930|intra-ocular pressure|intra-ocular pressure
4784907|NCT02711930|prone ventilation|prone ventilation
4784908|NCT02711917|Propofol|propofol
4784909|NCT02711917|Sevoflurane|sevoflurane
4784910|NCT02711917|Etomidate|etomidate
4784911|NCT02711917|Rocuronium|rocuronium
4784913|NCT02711917|Closed loop infusion system|closed loop infusion system
4784914|NCT02711904|Extubation|extubation
4784915|NCT02711904|Cough|cough
4784916|NCT02711904|Target Controlled Anesthesia (TACAN)|target controlled anesthesia (tacan)
4784917|NCT02711891|fingerstick|fingerstick
4784918|NCT02711891|opioid|opioid
4784919|NCT02711891|heelstick|heelstick
4784920|NCT02711891|loperamide|loperamide
4784921|NCT02711891|topical opioid|topical opioid
4784922|NCT02711826|graft inflammation|graft inflammation
4784923|NCT02711826|Treg|treg
4784924|NCT02711826|polyclonally expanded Tregs (polyTregs)|polyclonally expanded tregs (polytregs)
4784925|NCT02711826|darTregs|dartregs
4784926|NCT02711826|calcineurin inhibitors (CNIs)|calcineurin inhibitors (cnis)
4784927|NCT02711826|mTOR inhibitors|mtor inhibitors
4784928|NCT02711787|Hand|hand
4784929|NCT02711787|Paralysis|paralysis
4784930|NCT02711787|Stroke|stroke
4784931|NCT02711722|Neurally adjusted ventilatory assist|neurally adjusted ventilatory assist
4784932|NCT02711709|Intra-abdominal sepsis|intra-abdominal sepsis
4784933|NCT02711709|Surgical ICU|surgical icu
4784934|NCT02711696|Celiac Disease,|celiac disease,
4784935|NCT02711696|Gluten Free Diet|gluten free diet
4784936|NCT02711696|Gluten contamination|gluten contamination
4784937|NCT02711670|nephrolithiasis|nephrolithiasis
4784938|NCT02711670|calcium stones|calcium stones
4784939|NCT02711670|kidney stones|kidney stones
4784940|NCT02711670|hypercalciuria|hypercalciuria
4784941|NCT02711670|thiazide|thiazide
4784942|NCT02711657|Fibrocytes|fibrocytes
4784943|NCT02711657|Interstitial Lung Diseases|interstitial lung diseases
4784944|NCT02711657|Rheumatoid Arthritis|rheumatoid arthritis
4784945|NCT02711657|Asthma|asthma
4784946|NCT02711644|Pregnancy|pregnancy
4784947|NCT02711644|Prenatal|prenatal
4784948|NCT02711644|Nutrition|nutrition
4784949|NCT02711631|coronary angioplasty|coronary angioplasty
4784950|NCT02711631|cardiac rehabilitation|cardiac rehabilitation
4784951|NCT02711631|coronary artery bypass graft|coronary artery bypass graft
4784952|NCT02711605|ultrasound|ultrasound
4784953|NCT02711605|fat|fat
4784954|NCT02711592|Orthopaedic Pain Management|orthopaedic pain management
4784955|NCT02711566|Rehabilitation|rehabilitation
4784956|NCT02711566|Robot-assisted therapy|robot-assisted therapy
4784957|NCT02711501|post-operative pain|post-operative pain
4784958|NCT02711501|diode laser|diode laser
4784959|NCT02711488|school-based intervention|school-based intervention
4784960|NCT02711488|sedentary behavior|sedentary behavior
4784961|NCT02711488|physical activity|physical activity
4784962|NCT02711488|sugar sweetened beverages|sugar sweetened beverages
4784963|NCT02711462|Healthy Subjects|healthy subjects
4784964|NCT02711449|acute surgery|acute surgery
4784965|NCT02711449|laparoscopy|laparoscopy
4784966|NCT02711371|addiction|addiction
4784967|NCT02711371|cannabis|cannabis
4784968|NCT02711371|fMRI|fmri
4784969|NCT02711345|LTT462|ltt462
4784970|NCT02711345|ERK|erk
4784971|NCT02711345|MAPK|mapk
4784972|NCT02711345|solid tumor|solid tumor
4784973|NCT02711267|Open Flow Microperfusion|open flow microperfusion
4784974|NCT02711241|Gastroenteritis|gastroenteritis
4784975|NCT02711241|Analgesia|analgesia
4784976|NCT02711241|Emergency department|emergency department
4784977|NCT02711189|Addiction|addiction
4784978|NCT02711189|Oxytocin|oxytocin
4784979|NCT02711189|Functional Magnetic Resonance Imaging (fMRI)|functional magnetic resonance imaging (fmri)
4784980|NCT02711189|Alcohol|alcohol
4784981|NCT02711189|Cue Reactivity|cue reactivity
4784982|NCT02711137|Solid tumor|solid tumor
4784983|NCT02711137|lymphoma|lymphoma
4784984|NCT02711137|leukemia|leukemia
4784985|NCT02711137|AML|aml
4784986|NCT02711137|myelodysplastic syndrome (MDS)|myelodysplastic syndrome (mds)
4784987|NCT02711137|multiple myeloma|multiple myeloma
4784988|NCT02711137|myeloproliferative neoplasm (MPN)|myeloproliferative neoplasm (mpn)
4784989|NCT02711137|MDS/MPN|mds/mpn
4784990|NCT02711137|myelofibrosis (MF)|myelofibrosis (mf)
4784991|NCT02711137|pancreatic cancer|pancreatic cancer
4784992|NCT02711137|colorectal cancer|colorectal cancer
4784993|NCT02711137|non-small cell lung cancer|non-small cell lung cancer
4784994|NCT02711137|prostate cancer|prostate cancer
4784995|NCT02711137|breast cancer|breast cancer
4784996|NCT02711137|ovarian cancer|ovarian cancer
4784997|NCT02711137|glioblastoma multiforme (GBM)|glioblastoma multiforme (gbm)
4784998|NCT02711137|NUT midline carcinoma|nut midline carcinoma
4784999|NCT02711137|non-Hodgkin lymphoma|non-hodgkin lymphoma
4785000|NCT02711137|diffuse large B-cell lymphoma (DLBCL)|diffuse large b-cell lymphoma (dlbcl)
4785001|NCT02711137|double-hit|double-hit
4785002|NCT02711137|triple-hit|triple-hit
4785003|NCT02711137|myc|myc
4785004|NCT02711137|bromodomain and extra-terminal (BET) inhibitor|bromodomain and extra-terminal (bet) inhibitor
4785005|NCT02711124|hemoglobin A1c|hemoglobin a1c
4785006|NCT02711124|coronary artery bypass grafting|coronary artery bypass grafting
4785007|NCT02711124|impedance aggregometry|impedance aggregometry
4785008|NCT02711124|platelet reactivity|platelet reactivity
4785009|NCT02711124|clinical outcomes|clinical outcomes
4785010|NCT02711098|cardiac arrest|cardiac arrest
4785011|NCT02711098|hypothermia|hypothermia
4785012|NCT02711098|critical care|critical care
4785013|NCT02711059|hyperparathyroidism|hyperparathyroidism
4785014|NCT02711059|insulin resistance|insulin resistance
4785015|NCT02711020|Depressive symptoms|depressive symptoms
4785016|NCT02711020|Fibromyalgia|fibromyalgia
4785017|NCT02711020|Cognitive Behavioral Therapy|cognitive behavioral therapy
4785018|NCT02711020|Personal Constructs Therapy|personal constructs therapy
4785019|NCT02711020|Differential Efficacy|differential efficacy
4785020|NCT02711007|osteosarcoma|osteosarcoma
4785021|NCT02711007|metastasis|metastasis
4785022|NCT02711007|advanced|advanced
4785023|NCT02711007|apatinib|apatinib
4785024|NCT02710994|Immediate release omeprazole|immediate release omeprazole
4785025|NCT02710994|Integrated gastric acidity|integrated gastric acidity
4785026|NCT02710981|Sildenafil vaginal gel|sildenafil vaginal gel
4785027|NCT02710981|endometrium|endometrium
4785028|NCT02710981|clomiphene|clomiphene
4785029|NCT02710981|anovulation|anovulation
4785030|NCT02710968|FETO|feto
4785031|NCT02710916|Optical Coherence Tomography|optical coherence tomography
4785032|NCT02710916|Intraocular pressure|intraocular pressure
4785033|NCT02710916|Optic Nerve Head|optic nerve head
4785034|NCT02710916|Nerve fiber layer|nerve fiber layer
4785035|NCT02710916|Bruch Membrane Opening -Minimum Rim Width|bruch membrane opening -minimum rim width
4785036|NCT02710903|Periodontitis|periodontitis
4785037|NCT02710903|SNP|snp
4785038|NCT02710903|Pathogenesis|pathogenesis
4785039|NCT02710903|IL29|il29
4785040|NCT02710903|IL28B|il28b
4785041|NCT02710890|Epilepsy|epilepsy
4785042|NCT02710890|pediatric|pediatric
4785043|NCT02710890|intravenous|intravenous
4785044|NCT02710890|children|children
4785045|NCT02710890|Lacosamide|lacosamide
4785046|NCT02710890|VIMPAT®|vimpat®
4785047|NCT02710890|seizure|seizure
4785048|NCT02710877|epidural analgesia|epidural analgesia
4785049|NCT02710877|patient controlled analgesia|patient controlled analgesia
4785050|NCT02710877|obstetric outcome|obstetric outcome
4785051|NCT02710864|Cytomegalovirus|cytomegalovirus
4785052|NCT02710851|human papillomavirus vaccine|human papillomavirus vaccine
4785053|NCT02710851|condylomata acuminata|condylomata acuminata
4785054|NCT02710838|Early gastric cancer|early gastric cancer
4785055|NCT02710838|Infrared endoscope|infrared endoscope
4785056|NCT02710799|Endocrinology|endocrinology
4785057|NCT02710799|Referral list|referral list
4785058|NCT02710799|Teleconsultation|teleconsultation
4785059|NCT02710799|Telemedicine|telemedicine
4785060|NCT02710799|Cluster randomized clinical trial|cluster randomized clinical trial
4785061|NCT02710773|Gait|gait
4785062|NCT02710773|Randomized controlled trial|randomized controlled trial
4785063|NCT02710773|Chronic Stroke|chronic stroke
4785064|NCT02710773|Treadmill training|treadmill training
4785065|NCT02710760|Biomarkers|biomarkers
4785066|NCT02710760|Child Nutrition Sciences|child nutrition sciences
4785067|NCT02710760|Economics, Behavioral|economics, behavioral
4785068|NCT02710747|warfarin|warfarin
4785069|NCT02710747|Chinese patients|chinese patients
4785070|NCT02710747|heart valve replacement|heart valve replacement
4785071|NCT02710734|Urothelial|urothelial
4785072|NCT02710721|Fasting|fasting
4785073|NCT02710721|Prostatic Neoplasms|prostatic neoplasms
4785074|NCT02710721|Complementary Therapies|complementary therapies
4785075|NCT02710721|Urology|urology
4785076|NCT02710708|birth control,|birth control,
4785077|NCT02710708|contraceptives safety,|contraceptives safety,
4785078|NCT02710708|contraceptives efficacy,|contraceptives efficacy,
4785079|NCT02710708|moderate acne vulgaris|moderate acne vulgaris
4785080|NCT02710682|Lateral Epicondylitis of the elbow|lateral epicondylitis of the elbow
4785081|NCT02710682|Tendon Fenestration|tendon fenestration
4785082|NCT02710682|Minimally invasive Surgery|minimally invasive surgery
4785083|NCT02710682|Ultrasound-guided procedure|ultrasound-guided procedure
4785084|NCT02710682|Ultrasonography|ultrasonography
4785085|NCT02710682|Elastography|elastography
4785086|NCT02710669|ablation|ablation
4785087|NCT02710656|Atherosclerosis|atherosclerosis
4785088|NCT02710656|SFA|sfa
4785089|NCT02710656|Poplitea|poplitea
4785090|NCT02710656|Drug coated balloon|drug coated balloon
4785091|NCT02710656|Angioplasty|angioplasty
4785092|NCT02710656|Restenosis|restenosis
4785093|NCT02710656|Peripheral artery disease (PAD)|peripheral artery disease (pad)
4785094|NCT02710643|Follicular|follicular
4785095|NCT02710643|Lymphoma|lymphoma
4785096|NCT02710643|Grade 1|grade 1
4785097|NCT02710643|Grade 2|grade 2
4785098|NCT02710643|Grade 3A|grade 3a
4785099|NCT02710604|chronic hepatitis B(CHB)|chronic hepatitis b(chb)
4785100|NCT02710591|Rimeporide|rimeporide
4785101|NCT02710578|Alcohol impaired driving|alcohol impaired driving
4785102|NCT02710578|Driving simulation|driving simulation
4785103|NCT02710578|Residual effects of alcohol|residual effects of alcohol
4785104|NCT02710578|Acute psychomotor effects of alcohol|acute psychomotor effects of alcohol
4785105|NCT02710578|Young drivers|young drivers
4785106|NCT02710565|Endo bronchial ultrasound|endo bronchial ultrasound
4785107|NCT02710565|Trans bronchial needle aspiration|trans bronchial needle aspiration
4785108|NCT02710565|Cell line|cell line
4785109|NCT02710565|Lung cancer|lung cancer
4785110|NCT02710552|arterial hypertension|arterial hypertension
4785111|NCT02710552|antihypertensive drugs|antihypertensive drugs
4785112|NCT02710539|arterial hypertension|arterial hypertension
4785113|NCT02710539|antihypertensive drugs|antihypertensive drugs
4785114|NCT02710513|beta-glucans|beta-glucans
4785115|NCT02710513|gut microbiota|gut microbiota
4785116|NCT02710513|p-cresyl sulphate (pCS)|p-cresyl sulphate (pcs)
4785117|NCT02710513|indoxyl sulphate (IS)|indoxyl sulphate (is)
4785118|NCT02710513|short-chain fatty acid (SCFA)|short-chain fatty acid (scfa)
4785119|NCT02710500|LGMD2B|lgmd2b
4785120|NCT02710500|Limb Girdle Muscular Dystrophy|limb girdle muscular dystrophy
4785121|NCT02710500|Miyoshi|miyoshi
4785122|NCT02710500|Gene Transfer|gene transfer
4785123|NCT02710500|Dysferlin|dysferlin
4785124|NCT02710487|Parkinson's disease, Sleep Benefit|parkinson's disease, sleep benefit
4785125|NCT02710474|preterm birth|preterm birth
4785126|NCT02710474|NICU|nicu
4785127|NCT02710474|neonatal|neonatal
4785128|NCT02710474|kangaroo care|kangaroo care
4785129|NCT02710474|separation stress|separation stress
4785130|NCT02710474|family nurture|family nurture
4785131|NCT02710474|maternal confidence|maternal confidence
4785132|NCT02710474|maternal competence|maternal competence
4785133|NCT02710474|calming cycle|calming cycle
4785134|NCT02710474|infant neurodevelopment|infant neurodevelopment
4785135|NCT02710474|infant psychological development|infant psychological development
4785324|NCT02709369|hot flashes|hot flashes
4785136|NCT02710474|mother-infant co-regulation|mother-infant co-regulation
4785137|NCT02710474|post-partum depression|post-partum depression
4785138|NCT02710461|Polyphenols|polyphenols
4785139|NCT02710461|Grape|grape
4785140|NCT02710461|Pomegranate|pomegranate
4785141|NCT02710461|Metabolic syndrome|metabolic syndrome
4785142|NCT02710461|Abdominal obesity|abdominal obesity
4785143|NCT02710461|Postprandial glucose|postprandial glucose
4785144|NCT02710461|Insulin resistance|insulin resistance
4785145|NCT02710435|Coronary Sinus|coronary sinus
4785146|NCT02710435|Reducer|reducer
4785147|NCT02710435|Refractory Angina|refractory angina
4785148|NCT02710435|Angina Pectoris|angina pectoris
4785149|NCT02710435|Angina Pectoris, Stable|angina pectoris, stable
4785150|NCT02710435|Chronic Stable Angina|chronic stable angina
4785151|NCT02710435|Persistent Angina|persistent angina
4785152|NCT02710435|Neovasc Reducer System|neovasc reducer system
4785153|NCT02710435|Refractory Angina Pectoris|refractory angina pectoris
4785154|NCT02710435|Coronary Sinus Narrowing|coronary sinus narrowing
4785155|NCT02710435|Reversible Ischemic Heart Disease|reversible ischemic heart disease
4785156|NCT02710435|Chronic Angina|chronic angina
4785157|NCT02710435|End Stage Angina|end stage angina
4785158|NCT02710435|Coronary Sinus Reduction|coronary sinus reduction
4785159|NCT02710435|Coronary Sinus Reducer|coronary sinus reducer
4785160|NCT02710435|Chronic Refractory Angina|chronic refractory angina
4785161|NCT02710435|Chronic Refractory Angina Pectoris|chronic refractory angina pectoris
4785162|NCT02710422|Prostate Cancer|prostate cancer
4785163|NCT02710422|Amniotic Membrane Placement|amniotic membrane placement
4785164|NCT02710422|Robotic Assisted Radical Prostatectomy|robotic assisted radical prostatectomy
4785165|NCT02710422|RARP|rarp
4785166|NCT02710422|Human Amniotic Membrane Allograft|human amniotic membrane allograft
4785167|NCT02710409|safety, immunogenicity , quadrivalent influenza vaccine|safety, immunogenicity , quadrivalent influenza vaccine
4785168|NCT02710396|Carcinoma, Non-Small-Cell Lung|carcinoma, non-small-cell lung
4785169|NCT02710396|Non-Small Cell Lung Cancer|non-small cell lung cancer
4785170|NCT02710396|Non-Small-Cell Lung Carcinoma|non-small-cell lung carcinoma
4785171|NCT02710396|Nonsmall Cell Lung Cancer|nonsmall cell lung cancer
4785172|NCT02710396|NSCLC|nsclc
4785173|NCT02710396|Cancer of Neck|cancer of neck
4785174|NCT02710396|Neoplasms, Head and Neck|neoplasms, head and neck
4785175|NCT02710396|Cancer of the Head|cancer of the head
4785176|NCT02710396|Cancer of the Head and Neck|cancer of the head and neck
4785177|NCT02710396|Head, Neck Neoplasms|head, neck neoplasms
4785178|NCT02710396|Bladder Cancer|bladder cancer
4785179|NCT02710396|Bladder Neoplasms|bladder neoplasms
4785180|NCT02710396|Malignant Tumor of Urinary Bladder|malignant tumor of urinary bladder
4785181|NCT02710396|Urinary Bladder Cancer|urinary bladder cancer
4785182|NCT02710396|Esophageal Squamous Cell Carcinoma|esophageal squamous cell carcinoma
4785183|NCT02710396|Carcinoma, Transitional Cell|carcinoma, transitional cell
4785184|NCT02710370|Bariatric Surgery|bariatric surgery
4785185|NCT02710370|Gastric Bypass|gastric bypass
4785186|NCT02710370|Obesity/surgery|obesity/surgery
4785187|NCT02710370|Endoscopy, Digestive System|endoscopy, digestive system
4785188|NCT02710370|Blood Glucose/metabolism|blood glucose/metabolism
4785189|NCT02710370|Diabetes Mellitus, Experimental/metabolism|diabetes mellitus, experimental/metabolism
4785190|NCT02710370|Energy Metabolism|energy metabolism
4785191|NCT02710370|Glucose/metabolism|glucose/metabolism
4785192|NCT02710370|Jejunum/metabolism|jejunum/metabolism
4785193|NCT02710370|Metabolomics|metabolomics
4785194|NCT02710370|Gene Expression|gene expression
4785195|NCT02710357|Mandibular Prosthesis Implantation|mandibular prosthesis implantation
4785196|NCT02710357|Prostheses and Implants|prostheses and implants
4785197|NCT02710357|Denture, Complete, Lower|denture, complete, lower
4785198|NCT02710279|Psychiatry|psychiatry
4785199|NCT02710279|Depressive disorder|depressive disorder
4785200|NCT02710279|Suicide|suicide
4785201|NCT02710266|Synthetic Protease Inhibitor|synthetic protease inhibitor
4785202|NCT02710266|Hepatectomy|hepatectomy
4785203|NCT02710266|Postoperative Complications|postoperative complications
4785204|NCT02710253|Metastatic cancer|metastatic cancer
4785205|NCT02710253|Prior treatment with immunotherapy agent|prior treatment with immunotherapy agent
4785206|NCT02710253|Salvage radiation therapy|salvage radiation therapy
4785207|NCT02710253|Radiation therapy|radiation therapy
4785208|NCT02710253|XRT|xrt
4785209|NCT02710253|Progressive disease|progressive disease
4785210|NCT02710253|PD|pd
4785211|NCT02710253|Stereotactic radiation|stereotactic radiation
4785212|NCT02710253|External beam radiation|external beam radiation
4785213|NCT02710253|Whole brain radiation therapy|whole brain radiation therapy
4785214|NCT02710253|WBRT|wbrt
4785215|NCT02710214|Hot flash|hot flash
4785216|NCT02710214|Estrogen|estrogen
4785217|NCT02710214|Women|women
4785218|NCT02710149|CAR-T|car-t
4785219|NCT02710149|Leukemia|leukemia
4785220|NCT02710149|Lymphoma|lymphoma
4785221|NCT02710136|Asthma|asthma
4785222|NCT02710136|Glycerinated German cockroach allergenic extract|glycerinated german cockroach allergenic extract
4785223|NCT02710136|Cockroach Nasal Allergen Challenge|cockroach nasal allergen challenge
4785224|NCT02710058|support group|support group
4785225|NCT02710058|15-246|15-246
4785325|NCT02709369|headache|headache
4785326|NCT02709369|insomnia|insomnia
4785226|NCT02710058|The Arab American Breast Cancer Education and Referral Program (AMBER)|the arab american breast cancer education and referral program (amber)
4785227|NCT02710045|Immunity, Innate|immunity, innate
4785228|NCT02710045|Immunity, Non-Specific|immunity, non-specific
4785229|NCT02710045|Transcriptome|transcriptome
4785230|NCT02710045|Antibodies|antibodies
4785231|NCT02710045|Cytokines|cytokines
4785232|NCT02710045|Immunity, Cellular|immunity, cellular
4785233|NCT02710032|Transgender women|transgender women
4785234|NCT02710032|HIV Pre-Exposure Prophylaxis|hiv pre-exposure prophylaxis
4785235|NCT02710032|Adherence|adherence
4785236|NCT02710032|Peru|peru
4785237|NCT02710032|Social Networks|social networks
4785238|NCT02710019|substance use|substance use
4785239|NCT02710019|psychosis|psychosis
4785240|NCT02710019|youth|youth
4785241|NCT02710019|video game|video game
4785242|NCT02710006|Uterus|uterus
4785243|NCT02710006|Ultrasound|ultrasound
4785244|NCT02709980|Brain Injury|brain injury
4785245|NCT02709980|Insomnia|insomnia
4785246|NCT02709980|Sleep|sleep
4785247|NCT02709941|Obstructive Sleep Apnea|obstructive sleep apnea
4785248|NCT02709941|Inspiratory Muscle Strength Training|inspiratory muscle strength training
4785249|NCT02709941|Baroreceptor Sensitivity|baroreceptor sensitivity
4785250|NCT02709941|Blood Pressure|blood pressure
4785251|NCT02709928|Multiple ascending dose|multiple ascending dose
4785252|NCT02709850|ANGPTL-3|angptl-3
4785253|NCT02709837|bioavailability|bioavailability
4785254|NCT02709837|amino acid|amino acid
4785255|NCT02709837|carnosine|carnosine
4785256|NCT02709837|lycopene|lycopene
4785257|NCT02709837|mastication|mastication
4785258|NCT02709837|meat|meat
4785259|NCT02709798|Shenfu Injection|shenfu injection
4785260|NCT02709798|Reperfusion Injury|reperfusion injury
4785261|NCT02709798|Myocardial Protection|myocardial protection
4785262|NCT02709798|Percutaneous Coronary Intervention|percutaneous coronary intervention
4785263|NCT02709746|paediatric patients|paediatric patients
4785264|NCT02709733|Virtual Reality|virtual reality
4785265|NCT02709733|Negative Symptoms|negative symptoms
4785266|NCT02709720|Lung Cancer|lung cancer
4785267|NCT02709720|Cancer Lung Disease|cancer lung disease
4785268|NCT02709720|NORA|nora
4785269|NCT02709720|GECP 15/02|gecp 15/02
4785270|NCT02709720|Metronomic administration|metronomic administration
4785271|NCT02709707|Diabetes, Blood Sugar|diabetes, blood sugar
4785272|NCT02709681|Sickle Cell Disease|sickle cell disease
4785273|NCT02709681|Hydroxyurea|hydroxyurea
4785274|NCT02709668|MTHFR depression vitamins Homocysteine|mthfr depression vitamins homocysteine
4785275|NCT02709655|paediatric|paediatric
4785276|NCT02709616|Glioblastoma|glioblastoma
4785277|NCT02709616|DC vaccine|dc vaccine
4785278|NCT02709616|tumor antigen|tumor antigen
4785279|NCT02709616|personalized vaccine|personalized vaccine
4785280|NCT02709551|corporate health management|corporate health management
4785281|NCT02709551|hrv|hrv
4785282|NCT02709551|mindfulness|mindfulness
4785283|NCT02709525|hyaluronic acid|hyaluronic acid
4785284|NCT02709525|bone repair|bone repair
4785285|NCT02709525|dental socket|dental socket
4785286|NCT02709525|cone beam computed tomography|cone beam computed tomography
4785287|NCT02709512|Malignant Pleural Mesothelioma with Low Argininosuccinate Synthetase 1 Expression|malignant pleural mesothelioma with low argininosuccinate synthetase 1 expression
4785288|NCT02709486|Osteoarthritis, pain, tanezumab.|osteoarthritis, pain, tanezumab.
4785289|NCT02709473|propofol|propofol
4785290|NCT02709473|remifentanil|remifentanil
4785291|NCT02709473|rocuronium|rocuronium
4785292|NCT02709460|hematoma|hematoma
4785293|NCT02709460|complication|complication
4785294|NCT02709460|hysterectomy|hysterectomy
4785295|NCT02709447|Intimate Partner Violence|intimate partner violence
4785296|NCT02709447|Juvenile Delinquency|juvenile delinquency
4785297|NCT02709447|Sexual Behavior|sexual behavior
4785298|NCT02709421|post-Endoscopic Retrograde cholangiopancreatography pancreatitis|post-endoscopic retrograde cholangiopancreatography pancreatitis
4785299|NCT02709421|Risk factors|risk factors
4785300|NCT02709421|Indomethacin|indomethacin
4785301|NCT02709408|Carbapenem resistance|carbapenem resistance
4785302|NCT02709408|Enterobacteriaceae|enterobacteriaceae
4785303|NCT02709408|Acinetobacter baumannii|acinetobacter baumannii
4785304|NCT02709408|Bloodstream infections|bloodstream infections
4785305|NCT02709408|Intrabdominal infections|intrabdominal infections
4785306|NCT02709408|Urinary tract infections|urinary tract infections
4785307|NCT02709408|Pneumonia|pneumonia
4785308|NCT02709408|Risk factors|risk factors
4785309|NCT02709408|Outcome|outcome
4785310|NCT02709408|Hospitalised patients|hospitalised patients
4785311|NCT02709408|Mortality|mortality
4785312|NCT02709408|Clinical response|clinical response
4785313|NCT02709408|Length of hospital stay|length of hospital stay
4785314|NCT02709369|HIRREM|hirrem
4785315|NCT02709369|Neuro-technology|neuro-technology
4785316|NCT02709369|Closed-loop|closed-loop
4785317|NCT02709369|Acoustic stimulation|acoustic stimulation
4785318|NCT02709369|Allostatic|allostatic
4785319|NCT02709369|heart rate variability|heart rate variability
4785320|NCT02709369|baroreflex sensitivity|baroreflex sensitivity
4785321|NCT02709369|traumatic brain injury|traumatic brain injury
4785322|NCT02709369|sports concussion|sports concussion
4785323|NCT02709369|PTSD|ptsd
4785327|NCT02709304|urinary catheter discomfort|urinary catheter discomfort
4785328|NCT02709278|BCG|bcg
4785329|NCT02709278|Aerosol|aerosol
4785330|NCT02709278|Tuberculosis|tuberculosis
4785331|NCT02709278|Challenge|challenge
4785332|NCT02709226|Brain Tumor|brain tumor
4785333|NCT02709226|Astrocytoma|astrocytoma
4785334|NCT02709226|GBM|gbm
4785335|NCT02709226|Radiation Therapy|radiation therapy
4785336|NCT02709213|Inflammatory chronic bowel disease|inflammatory chronic bowel disease
4785337|NCT02709213|ICBD|icbd
4785338|NCT02709213|Colorectal cancer|colorectal cancer
4785339|NCT02709213|Infectious colitis|infectious colitis
4785340|NCT02709187|DP-R208|dp-r208
4785341|NCT02709174|Pulmonary Embolism|pulmonary embolism
4785342|NCT02709174|Pregnancy|pregnancy
4785343|NCT02709174|D-Dimer|d-dimer
4785344|NCT02709161|neurofeedback|neurofeedback
4785345|NCT02709161|major depressive disorder|major depressive disorder
4785346|NCT02709161|amygdala|amygdala
4785347|NCT02709148|Parkinson's Disease|parkinson's disease
4785348|NCT02709070|highly-purified CTL|highly-purified ctl
4785349|NCT02709044|Acute pancreatitis|acute pancreatitis
4785350|NCT02709044|Fluid resuscitation|fluid resuscitation
4785351|NCT02709044|Crystalloids|crystalloids
4785352|NCT02709031|Cicletanine|cicletanine
4785353|NCT02709031|Magnesium|magnesium
4785354|NCT02709031|Metabolic disease|metabolic disease
4785355|NCT02709018|posttraumatic stress disorder|posttraumatic stress disorder
4785356|NCT02709018|losartan|losartan
4785357|NCT02709018|angiotensin receptor blocker|angiotensin receptor blocker
4785358|NCT02709005|Bacterial Vaginosis|bacterial vaginosis
4785359|NCT02709005|Monolaurin Vaginal Gel|monolaurin vaginal gel
4785360|NCT02708992|Azithromycin|azithromycin
4785361|NCT02708992|Cefixime|cefixime
4785362|NCT02708992|Duration|duration
4785363|NCT02708992|High-Dose|high-dose
4785364|NCT02708992|Neisseria gonorrhoeae|neisseria gonorrhoeae
4785365|NCT02708992|Pharmacokinetics|pharmacokinetics
4785366|NCT02708992|Susceptibility|susceptibility
4785367|NCT02708979|Stress|stress
4785368|NCT02708979|Eating|eating
4785369|NCT02708966|Gymnema Sylvestre|gymnema sylvestre
4785370|NCT02708966|Glycemic control|glycemic control
4785371|NCT02708927|social integration|social integration
4785372|NCT02708927|cognitive impairment|cognitive impairment
4785373|NCT02708927|emotional processing|emotional processing
4785374|NCT02708927|quality of life|quality of life
4785375|NCT02708901|Autism Spectrum Disorder|autism spectrum disorder
4785376|NCT02708901|Probiotic Vivomixx®|probiotic vivomixx®
4785377|NCT02708901|Gastrointestinal Symptoms|gastrointestinal symptoms
4785378|NCT02708901|Gut-Brain Axis|gut-brain axis
4785379|NCT02708901|Endophenotypes|endophenotypes
4785380|NCT02708888|Trunk|trunk
4785381|NCT02708888|Biomechanical Phenomena|biomechanical phenomena
4785382|NCT02708888|Gait|gait
4785383|NCT02708888|Electromyography|electromyography
4785384|NCT02708888|Rehabilitation|rehabilitation
4785385|NCT02708888|Balance|balance
4785386|NCT02708875|Microvascular|microvascular
4785387|NCT02708875|Insulin resistance|insulin resistance
4785388|NCT02708875|Mixed Meal|mixed meal
4785389|NCT02708875|Glucose tolerance|glucose tolerance
4785390|NCT02708823|Postoperative delirium|postoperative delirium
4785391|NCT02708823|Risk assessment|risk assessment
4785392|NCT02708823|Clinical screening tool|clinical screening tool
4785393|NCT02708823|Tablet computer|tablet computer
4785394|NCT02708810|radiosurgery (RS)|radiosurgery (rs)
4785395|NCT02708810|trigeminal neuralgia (TGN)|trigeminal neuralgia (tgn)
4785396|NCT02708797|Cerebral autoregulation|cerebral autoregulation
4785397|NCT02708797|MRI|mri
4785398|NCT02708797|VBM|vbm
4785399|NCT02708797|Doppler Transcranial|doppler transcranial
4785400|NCT02708784|Glykogen storage disease type 2)|glykogen storage disease type 2)
4785401|NCT02708784|Dystrophia Myotonica|dystrophia myotonica
4785402|NCT02708784|Muscular disorders|muscular disorders
4785403|NCT02708784|MR-imaging|mr-imaging
4785404|NCT02708784|Muscle strength|muscle strength
4785405|NCT02708784|Myopathies|myopathies
4785406|NCT02708745|communication|communication
4785407|NCT02708745|immunization|immunization
4785408|NCT02708719|COPD|copd
4785409|NCT02708719|MID|mid
4785410|NCT02708719|1-minute sit-to-stand-test|1-minute sit-to-stand-test
4785411|NCT02708706|adhesive capsulitis|adhesive capsulitis
4785412|NCT02708706|hyaluronic acid|hyaluronic acid
4785413|NCT02708667|non-small cell lung cancer|non-small cell lung cancer
4785414|NCT02708667|crizotinib|crizotinib
4785415|NCT02708667|hepatic toxicity|hepatic toxicity
4785416|NCT02708654|Remote monitoring|remote monitoring
4785417|NCT02708654|Incentives|incentives
4785418|NCT02708628|scar prevention|scar prevention
4785419|NCT02708628|sectio|sectio
4785420|NCT02708628|extract of allium cepae|extract of allium cepae
4785421|NCT02708628|allantoin|allantoin
4785422|NCT02708628|heparin|heparin
4785423|NCT02708602|β2-adrenergic receptor|β2-adrenergic receptor
4785424|NCT02708602|genetic polymorphisms|genetic polymorphisms
4785425|NCT02708602|labor progress|labor progress
4785426|NCT02708563|meconium|meconium
4785427|NCT02708563|neonatal resuscitation|neonatal resuscitation
4785428|NCT02708498|Palliative care|palliative care
4785429|NCT02708498|Frail elderly|frail elderly
4785430|NCT02708498|Comorbidity|comorbidity
4785431|NCT02708498|Staff Development|staff development
4785432|NCT02708498|Nursing Homes|nursing homes
4785433|NCT02708472|Generalized Anxiety Disorder|generalized anxiety disorder
4785434|NCT02708472|synchronized Transcranial Magnetic Stimulation|synchronized transcranial magnetic stimulation
4785435|NCT02708472|Anxiety|anxiety
4785436|NCT02708472|Neurostimulation|neurostimulation
4785437|NCT02708472|TMS|tms
4785438|NCT02708446|Second Trimester|second trimester
4785439|NCT02708446|Abortion|abortion
4785440|NCT02708446|Misoprostol|misoprostol
4785441|NCT02708446|Sublingual|sublingual
4785442|NCT02708446|Buccal|buccal
4785443|NCT02708433|lidocaine, jaw|lidocaine, jaw
4785444|NCT02708420|Glidescope|glidescope
4785445|NCT02708420|Cardiovascular surgery|cardiovascular surgery
4785446|NCT02708420|Macintosh Laryngoscope|macintosh laryngoscope
4785447|NCT02708420|Hemodynamic response|hemodynamic response
4785448|NCT02708420|Anesthesia|anesthesia
4785449|NCT02708381|Population 70 years and older|population 70 years and older
4785450|NCT02708381|Geriatric|geriatric
4785451|NCT02708381|Oncogeriatric|oncogeriatric
4785452|NCT02708381|Senior adult|senior adult
4785453|NCT02708368|Chronic Kidney Disease - Mineral Bone Disorder (CKD-MBD)|chronic kidney disease - mineral bone disorder (ckd-mbd)
4785454|NCT02708329|Coronary stenosis|coronary stenosis
4785455|NCT02708329|Drug-eluting stent|drug-eluting stent
4785456|NCT02708329|Coronary angioplasty with stenting|coronary angioplasty with stenting
4785457|NCT02708329|Ischemic Heart Disease|ischemic heart disease
4785458|NCT02708329|Chronic total occlusion|chronic total occlusion
4785459|NCT02708329|Bifurcational lesion|bifurcational lesion
4785460|NCT02708329|Bifurcational stenting|bifurcational stenting
4785461|NCT02708303|Esophageal Reflux|esophageal reflux
4785462|NCT02708303|Gastric Acid Reflux|gastric acid reflux
4785463|NCT02708303|Gastric Acid Reflux Disease|gastric acid reflux disease
4785464|NCT02708303|Gastro-Esophageal Reflux|gastro-esophageal reflux
4785465|NCT02708303|Gastro-oesophageal Reflux|gastro-oesophageal reflux
4785466|NCT02708303|Gastroesophageal Reflux Disease|gastroesophageal reflux disease
4785467|NCT02708303|Reflux, Gastroesophageal|reflux, gastroesophageal
4785468|NCT02708303|Esophageal Hernia|esophageal hernia
4785469|NCT02708303|Hernia, Esophageal|hernia, esophageal
4785470|NCT02708303|Hernia, Paraesophageal|hernia, paraesophageal
4785471|NCT02708303|Hiatal Hernia|hiatal hernia
4785472|NCT02708303|Sliding Hiatal Hernia|sliding hiatal hernia
4785473|NCT02708303|Sliding Esophageal Hernia|sliding esophageal hernia
4785474|NCT02708303|Hernia, Hiatus|hernia, hiatus
4785475|NCT02708303|Paraesophageal Hiatal Hernia|paraesophageal hiatal hernia
4785476|NCT02708303|Questionnaires|questionnaires
4785477|NCT02708277|intrauterine contraceptive device|intrauterine contraceptive device
4785478|NCT02708277|intrauterine balloon|intrauterine balloon
4785479|NCT02708238|Infantile colics|infantile colics
4785480|NCT02708199|Drug resistance malaria|drug resistance malaria
4785481|NCT02708199|Myanmar Artemisinin Resistance Containment Zone|myanmar artemisinin resistance containment zone
4785482|NCT02708199|Asymptomatic malaria|asymptomatic malaria
4785483|NCT02708199|Serology|serology
4785484|NCT02708186|Dementia with Lewy bodies|dementia with lewy bodies
4785485|NCT02708186|Lewy bodies|lewy bodies
4785486|NCT02708186|REM sleep behavior disorder|rem sleep behavior disorder
4785487|NCT02708186|Parkinson's disease dementia|parkinson's disease dementia
4785488|NCT02708173|vaccine|vaccine
4785489|NCT02708173|safety|safety
4785490|NCT02708134|Chest compressions|chest compressions
4785491|NCT02708134|Cardiopulmonary Resuscitation|cardiopulmonary resuscitation
4785492|NCT02708069|Autism Spectrum Disorder|autism spectrum disorder
4785493|NCT02708056|Sugammadex|sugammadex
4785494|NCT02708056|Rocuronium|rocuronium
4785495|NCT02708056|Infant patients|infant patients
4785496|NCT02708017|Subcostal TAP block|subcostal tap block
4785497|NCT02708017|Posterior TAP block|posterior tap block
4785498|NCT02708017|Ultrasound|ultrasound
4785499|NCT02708017|Laparoscopic cholecystectomy|laparoscopic cholecystectomy
4785500|NCT02707991|Continuity of Patient Care|continuity of patient care
4785501|NCT02707991|Treatment Cascade|treatment cascade
4785502|NCT02707978|Dementia|dementia
4785503|NCT02707978|Brain Diseases|brain diseases
4785504|NCT02707978|Central Nervous System Diseases|central nervous system diseases
4785505|NCT02707978|Mild Cognitive Impairment|mild cognitive impairment
4785506|NCT02707978|tauopathies|tauopathies
4785507|NCT02707978|Neurodegenerative Disease|neurodegenerative disease
4785508|NCT02707965|Generic brittle|generic brittle
4785509|NCT02707965|Anti-epileptic drug|anti-epileptic drug
4785510|NCT02707965|Bioequivalence|bioequivalence
4785511|NCT02707952|Compensated cirrhosis|compensated cirrhosis
4785512|NCT02707952|Non-cirrhotic|non-cirrhotic
4785513|NCT02707952|Renal impairment|renal impairment
4785514|NCT02707952|Hepatitis C virus (HCV)|hepatitis c virus (hcv)
4785515|NCT02707952|Hepatitis C|hepatitis c
4785516|NCT02707952|Chronic Hepatitis C|chronic hepatitis c
4785517|NCT02707952|Hepatitis C Genotype 1|hepatitis c genotype 1
4785518|NCT02707952|Hepatitis C Genotype 2|hepatitis c genotype 2
4785519|NCT02707952|Hepatitis C Genotype 3|hepatitis c genotype 3
4785520|NCT02707952|Hepatitis C Genotype 4|hepatitis c genotype 4
4785521|NCT02707952|Hepatitis C Genotype 5|hepatitis c genotype 5
4785522|NCT02707952|Hepatitis C Genotype 6|hepatitis c genotype 6
4785523|NCT02707952|DAA-experienced|daa-experienced
4785524|NCT02707900|Vorinostat|vorinostat
4785525|NCT02707900|AGS-004|ags-004
4785526|NCT02707900|HIV virus|hiv virus
4785527|NCT02707900|AIDS|aids
4785528|NCT02707887|Mental Disorders|mental disorders
4785529|NCT02707887|Mood Disorders|mood disorders
4785530|NCT02707887|Behavioral Activation|behavioral activation
4785531|NCT02707861|HIV|hiv
4785532|NCT02707861|Resistant|resistant
4785533|NCT02707861|Salvage|salvage
4785534|NCT02707861|ibalizumab|ibalizumab
4785535|NCT02707861|antibody|antibody
4785536|NCT02707861|AIDS|aids
4785537|NCT02707835|Edema,taping,ultrasound|edema,taping,ultrasound
4785538|NCT02707822|tacrolimus|tacrolimus
4785539|NCT02707822|pharmacokinetics|pharmacokinetics
4785540|NCT02707822|gene polymorphism|gene polymorphism
4785541|NCT02707822|clinical factors|clinical factors
4785542|NCT02707796|oxygen reserve index, partial oxygen pressure, hemicolectomy|oxygen reserve index, partial oxygen pressure, hemicolectomy
4785543|NCT02707783|stable and unstable angina|stable and unstable angina
4785544|NCT02707783|bioresorbable vascular scaffold|bioresorbable vascular scaffold
4785545|NCT02707783|BVS|bvs
4785546|NCT02707783|PCI|pci
4785547|NCT02707770|COPD, pulmonary rehabilitation, ambulatory oxygen therapy|copd, pulmonary rehabilitation, ambulatory oxygen therapy
4785548|NCT02707757|Haemodialysis|haemodialysis
4785549|NCT02707757|Anaemia|anaemia
4785550|NCT02707757|Iron|iron
4785551|NCT02707757|Erythropoeitin stimulating agents|erythropoeitin stimulating agents
4785552|NCT02707744|Heart Failure|heart failure
4785553|NCT02707744|Atrial Fibrillation|atrial fibrillation
4785554|NCT02707744|Ambulatory ECG monitor|ambulatory ecg monitor
4785555|NCT02707718|sepsis|sepsis
4785556|NCT02707718|biomarker|biomarker
4785557|NCT02707718|prognostic|prognostic
4785558|NCT02707718|emergency department|emergency department
4785559|NCT02707718|diagnosis|diagnosis
4785560|NCT02707692|HIV|hiv
4785561|NCT02707692|AIDS|aids
4785562|NCT02707692|Immune Stimulation|immune stimulation
4785563|NCT02707692|HIV Reservoir|hiv reservoir
4785564|NCT02707679|Knee|knee
4785565|NCT02707679|Mobilization|mobilization
4785566|NCT02707679|Taping|taping
4785567|NCT02707679|Function|function
4785568|NCT02707679|Balance|balance
4785569|NCT02707666|resectable malignant pleural mesothelioma|resectable malignant pleural mesothelioma
4785570|NCT02707666|Pembrolizumab|pembrolizumab
4785571|NCT02707627|Pediatric|pediatric
4785572|NCT02707627|Laser|laser
4785573|NCT02707627|Burn|burn
4785574|NCT02707627|Scar|scar
4785575|NCT02707627|Photothermolysis|photothermolysis
4785576|NCT02707601|HIV|hiv
4785577|NCT02707601|HCV|hcv
4785578|NCT02707601|Antiretroviral therapy|antiretroviral therapy
4785579|NCT02707601|HCV direct acting antiviral(s) (DAA)|hcv direct acting antiviral(s) (daa)
4785580|NCT02707588|Determine the tolerance and efficacy of Pembrolizumab|determine the tolerance and efficacy of pembrolizumab
4785581|NCT02707575|Keratin|keratin
4785582|NCT02707575|Ranibizumab|ranibizumab
4785583|NCT02707562|Cystic fibrosis G551D mutation|cystic fibrosis g551d mutation
4785584|NCT02707562|GLPG1837|glpg1837
4785585|NCT02707549|crystalloid solutions|crystalloid solutions
4785586|NCT02707549|acid-base imbalance|acid-base imbalance
4785587|NCT02707549|water-electrolyte Imbalance|water-electrolyte imbalance
4785588|NCT02707523|RSV|rsv
4785589|NCT02707523|respiratory support|respiratory support
4785590|NCT02707523|RSV induced respiratory failure|rsv induced respiratory failure
4785591|NCT02707510|logotherapy|logotherapy
4785592|NCT02707510|cognitive behavior therapy|cognitive behavior therapy
4785593|NCT02707510|metastatic breast cancer|metastatic breast cancer
4785594|NCT02707497|sepsis|sepsis
4785595|NCT02707497|thrombocytopenia|thrombocytopenia
4785596|NCT02707497|recombinant human thrombopoietin|recombinant human thrombopoietin
4785597|NCT02707497|platelet|platelet
4785598|NCT02707497|28-day mortality|28-day mortality
4785599|NCT02707484|Gastrointestinal vascular malformation|gastrointestinal vascular malformation
4785600|NCT02707484|thalidomide|thalidomide
4785601|NCT02707484|Small intestinal bleeding|small intestinal bleeding
4785602|NCT02707458|apolipoprotein E|apolipoprotein e
4785603|NCT02707458|Alzheimer|alzheimer
4785604|NCT02707458|pre-clinical|pre-clinical
4785605|NCT02707458|pre-symptomatic|pre-symptomatic
4785606|NCT02707458|dose-finding|dose-finding
4785607|NCT02707458|prevention|prevention
4785608|NCT02707432|Cardiovascular Diseases|cardiovascular diseases
4785609|NCT02707432|Community-Based Participatory Research|community-based participatory research
4785610|NCT02707432|African Americans|african americans
4785611|NCT02707419|Total knee replacement|total knee replacement
4785612|NCT02707419|Action observation treatment|action observation treatment
4785613|NCT02707419|Rehabilitation|rehabilitation
4785614|NCT02707393|stem cell transplantation|stem cell transplantation
4785615|NCT02707393|pediatrics|pediatrics
4785616|NCT02707354|GVHD|gvhd
4785617|NCT02707354|confocal endomicroscopy|confocal endomicroscopy
4785618|NCT02707341|psoriasis|psoriasis
4785619|NCT02707341|disease registry|disease registry
4785620|NCT02707328|Gemcitabine|gemcitabine
4785621|NCT02707328|Gemzar|gemzar
4785622|NCT02707328|CyberKnife|cyberknife
4785623|NCT02707328|Cyber knife|cyber knife
4785624|NCT02707328|CK|ck
4785625|NCT02707328|abraxane|abraxane
4785626|NCT02707328|nab-paclitaxel|nab-paclitaxel
4785627|NCT02707315|Cyber Knife|cyber knife
4785628|NCT02707315|CyberKnife|cyberknife
4785629|NCT02707315|Stereotactic Radiosurgery|stereotactic radiosurgery
4785630|NCT02707315|CK|ck
4785631|NCT02707276|Bipolar Depression|bipolar depression
4785632|NCT02707276|Geriatric|geriatric
4785633|NCT02707276|Low Field Magnetic Stimulation|low field magnetic stimulation
4785634|NCT02707263|heparin|heparin
4785635|NCT02707250|pethidine|pethidine
4785636|NCT02707250|laparoscopic cholecystectomy|laparoscopic cholecystectomy
4785637|NCT02707250|bupivacaine|bupivacaine
4785638|NCT02707224|DP-R208|dp-r208
4785639|NCT02707172|Diethylhexyl Phthalate|diethylhexyl phthalate
4785640|NCT02707172|Hand hygiene|hand hygiene
4785641|NCT02707172|Soaps|soaps
4785642|NCT02707172|N-of-1 design|n-of-1 design
4785643|NCT02707172|Cross-Over Studies|cross-over studies
4785644|NCT02707159|Circulating tumor cells|circulating tumor cells
4785645|NCT02707159|Nab-paclitaxel|nab-paclitaxel
4785646|NCT02707159|Metastatic pancreatic cancer|metastatic pancreatic cancer
4785647|NCT02707159|Gemcitabine|gemcitabine
4785648|NCT02707120|PRGF, Neurotrophic Keratitis, platelet rich plasma, PRP|prgf, neurotrophic keratitis, platelet rich plasma, prp
4785649|NCT02707094|back|back
4785650|NCT02707094|pain|pain
4785651|NCT02707094|chronic|chronic
4785652|NCT02707068|Quality of Life|quality of life
4785653|NCT02707068|Self-help intervention|self-help intervention
4785654|NCT02707055|Alcohol Consumption|alcohol consumption
4785655|NCT02707055|Alcohol Treatment|alcohol treatment
4785656|NCT02707055|Alcoholism|alcoholism
4785657|NCT02707055|Ghrelin|ghrelin
4785658|NCT02707055|Ghrelin Antagonism|ghrelin antagonism
4785659|NCT02707042|Microbiome|microbiome
4785660|NCT02707042|Amoxicillin|amoxicillin
4785661|NCT02707042|Azithromycin|azithromycin
4785662|NCT02707042|Metagenome|metagenome
4785663|NCT02707042|Metabolic|metabolic
4785664|NCT02707029|Screening Protocol|screening protocol
4785665|NCT02707029|Pain|pain
4785666|NCT02707029|Phenotypes|phenotypes
4785667|NCT02707016|Emergence delirium|emergence delirium
4785668|NCT02707016|Sevoflurane|sevoflurane
4785669|NCT02707016|Pediatric anesthesia|pediatric anesthesia
4785670|NCT02707003|Post-operative respiratory distress|post-operative respiratory distress
4785671|NCT02706977|Ophthalmology|ophthalmology
4785672|NCT02706964|metastasis|metastasis
4785673|NCT02706964|3D imaging|3d imaging
4785674|NCT02706964|early detection|early detection
4785675|NCT02706951|Musculoskeletal Disease|musculoskeletal disease
4785676|NCT02706951|Arthritis|arthritis
4785677|NCT02706951|Joint Disease|joint disease
4785678|NCT02706951|anti-inflammatory agents|anti-inflammatory agents
4785679|NCT02706951|antirheumatic agents|antirheumatic agents
4785680|NCT02706938|Gastroesophageal reflux disease|gastroesophageal reflux disease
4785681|NCT02706938|Head of bed elevation|head of bed elevation
4785682|NCT02706938|Quality of life|quality of life
4785683|NCT02706938|Nocturnal symptoms|nocturnal symptoms
4785684|NCT02706938|Lifestyle measures|lifestyle measures
4785685|NCT02706912|Stroke|stroke
4785686|NCT02706912|Hemiparesis|hemiparesis
4785687|NCT02706912|Activities of Daily Living|activities of daily living
4785688|NCT02706912|Virtual World|virtual world
4785689|NCT02706912|Occupational Therapy|occupational therapy
4785690|NCT02706899|Antibody-Drug Conjugate CD33 Antigen|antibody-drug conjugate cd33 antigen
4785691|NCT02706886|PH1|ph1
4785692|NCT02706886|Primary Hyperoxaluria|primary hyperoxaluria
4785693|NCT02706886|RNAi therapeutic|rnai therapeutic
4785694|NCT02706886|siRNA|sirna
4785695|NCT02706886|AGT|agt
4785696|NCT02706873|Musculoskeletal disease|musculoskeletal disease
4785697|NCT02706873|Arthritis|arthritis
4785698|NCT02706873|Joint disease|joint disease
4785699|NCT02706873|Anti-inflammatory agents|anti-inflammatory agents
4785700|NCT02706873|Antirheumatic agents|antirheumatic agents
4785701|NCT02706847|Musculoskeletal Disease|musculoskeletal disease
4785702|NCT02706847|Arthritis|arthritis
4785703|NCT02706847|Joint Disease|joint disease
4785704|NCT02706847|Anti-inflammatory agents|anti-inflammatory agents
4785705|NCT02706847|Antirheumatic agents|antirheumatic agents
4785706|NCT02706834|Drug therapy|drug therapy
4785707|NCT02706821|prediabetes|prediabetes
4785708|NCT02706821|blood glucose|blood glucose
4785709|NCT02706821|clinical trial|clinical trial
4785710|NCT02706808|chronic kidney disease|chronic kidney disease
4785711|NCT02706808|hemodialysis|hemodialysis
4785712|NCT02706808|conservative treatment|conservative treatment
4785713|NCT02706808|resistance starch|resistance starch
4785714|NCT02706795|Cervical dystonia|cervical dystonia
4785715|NCT02706795|Spasmodic torticollis|spasmodic torticollis
4785716|NCT02706704|Intravitreal Adalimumab|intravitreal adalimumab
4785717|NCT02706704|Subcutaneous Adalimumab|subcutaneous adalimumab
4785718|NCT02706678|FK506|fk506
4785719|NCT02706678|Renal transplant recipients|renal transplant recipients
4785720|NCT02706678|cyclosporin|cyclosporin
4785721|NCT02706665|Anesthetics|anesthetics
4785722|NCT02706665|Propofol|propofol
4785723|NCT02706665|Electroencephalography|electroencephalography
4785724|NCT02706665|SEDline monitor|sedline monitor
4785725|NCT02706652|Screening|screening
4785726|NCT02706652|Genotype|genotype
4785727|NCT02706652|Drug Dosing|drug dosing
4785728|NCT02706652|Trial Selection|trial selection
4785729|NCT02706639|Biospecimen Procurement|biospecimen procurement
4785730|NCT02706639|Laboratory Research Specimens|laboratory research specimens
4785731|NCT02706639|Sample Collection|sample collection
4785732|NCT02706639|Rare Diseases|rare diseases
4785733|NCT02706587|Critical illness polyneuropathy|critical illness polyneuropathy
4785734|NCT02706587|Neuromuscular Electrical Stimulation|neuromuscular electrical stimulation
4785735|NCT02706574|Eye Tracking|eye tracking
4785736|NCT02706574|Blood-based Biomarkers|blood-based biomarkers
4785737|NCT02706574|CSF-based Biomarkers|csf-based biomarkers
4785738|NCT02706574|Magnetic Resonance Imaging|magnetic resonance imaging
4785739|NCT02706574|Computed Tomography Scan|computed tomography scan
4785740|NCT02706574|Outcome Measures|outcome measures
4785741|NCT02706561|15-317|15-317
4785742|NCT02706548|occupational therapy|occupational therapy
4785743|NCT02706548|medication adherence|medication adherence
4785744|NCT02706548|intervention studies|intervention studies
4785745|NCT02706535|Itraconazole|itraconazole
4785746|NCT02706535|Rifampicin|rifampicin
4785747|NCT02706535|Pharmacokinetics|pharmacokinetics
4785748|NCT02706535|Cross-over|cross-over
4785749|NCT02706496|aging of elderly|aging of elderly
4785750|NCT02706496|falling prevention|falling prevention
4785751|NCT02706496|electroencephalography|electroencephalography
4785752|NCT02706496|postural control|postural control
4785753|NCT02706496|biomechanics|biomechanics
4785754|NCT02706470|recurrent miscarriage; immunology|recurrent miscarriage; immunology
4785755|NCT02706457|intensive care|intensive care
4785756|NCT02706457|functionality|functionality
4785757|NCT02706405|PD-L1|pd-l1
4785758|NCT02706405|immunotherapy|immunotherapy
4785759|NCT02706405|non-Hodgkin lymphoma|non-hodgkin lymphoma
4785760|NCT02706353|Melanoma|melanoma
4785761|NCT02706353|Metastatic Melanoma|metastatic melanoma
4785762|NCT02706353|Intratumoral APX005M|intratumoral apx005m
4785763|NCT02706353|Pembrolizumab|pembrolizumab
4785764|NCT02706353|Keytruda|keytruda
4785765|NCT02706353|MK-3475|mk-3475
4785766|NCT02706353|SCH-900475|sch-900475
4785767|NCT02706327|orthotic insoles|orthotic insoles
4785768|NCT02706327|pain|pain
4785769|NCT02706327|quality of life|quality of life
4785770|NCT02706327|athletic performance|athletic performance
4785771|NCT02706301|colorectal cancer survivor|colorectal cancer survivor
4785772|NCT02706301|cancer pain|cancer pain
4785773|NCT02706301|psychological distress|psychological distress
4785774|NCT02706301|coping skills training|coping skills training
4785775|NCT02706301|symptom management|symptom management
4785776|NCT02706301|cancer survivorship|cancer survivorship
4785777|NCT02706210|Mild Cognitive Impairment|mild cognitive impairment
4785778|NCT02706210|Diffusion Tensor Imaging|diffusion tensor imaging
4785779|NCT02706197|Electron Paramagnetic Resonance|electron paramagnetic resonance
4785780|NCT02706197|Hypoxia|hypoxia
4785781|NCT02706197|OxyChip|oxychip
4785782|NCT02706184|gastric cancer|gastric cancer
4785783|NCT02706184|colorectal cancer|colorectal cancer
4785784|NCT02706184|chemotherapy induced diarrhea|chemotherapy induced diarrhea
4785785|NCT02706184|5-Fluoruracil|5-fluoruracil
4785786|NCT02706184|chemotherapeutic remedy|chemotherapeutic remedy
4785787|NCT02706145|social norms|social norms
4785788|NCT02706145|youth violence|youth violence
4785789|NCT02706145|media|media
4785790|NCT02706132|Mesenchymal stromal cells|mesenchymal stromal cells
4785791|NCT02706132|Liver Transplantation|liver transplantation
4785792|NCT02706132|ABO blood group|abo blood group
4785793|NCT02706119|total parenteral nutrition|total parenteral nutrition
4785794|NCT02706119|glargine insulin|glargine insulin
4785795|NCT02706119|insulin|insulin
4785796|NCT02706080|Antithrombotic agents|antithrombotic agents
4785797|NCT02706080|VKA|vka
4785798|NCT02706080|Direct Oral Anticoagulant|direct oral anticoagulant
4785799|NCT02706080|Antiplatelet|antiplatelet
4785800|NCT02706080|Bleeding|bleeding
4785801|NCT02706080|Emergency|emergency
4785802|NCT02706041|Exploratory Lap (Ex Lap)|exploratory lap (ex lap)
4785803|NCT02706041|Damage Control Laparotomy (DCL)|damage control laparotomy (dcl)
4785804|NCT02706041|Definitive|definitive
4785805|NCT02706028|underwater ultrasound|underwater ultrasound
4785806|NCT02706028|rheumatoid arthritis|rheumatoid arthritis
4785807|NCT02706015|Headache|headache
4785808|NCT02706015|Aura|aura
4785809|NCT02706015|Migraine|migraine
4785810|NCT02705937|xerostomia, Saliva, iatrogenic oral dryness, dairy product|xerostomia, saliva, iatrogenic oral dryness, dairy product
4785811|NCT02705898|alcohol use disorders|alcohol use disorders
4785812|NCT02705898|physical activity|physical activity
4785813|NCT02705898|women's health|women's health
4785814|NCT02705885|IgY|igy
4785815|NCT02705885|Periodontitis|periodontitis
4785816|NCT02705885|Porphyromonas gingivalis|porphyromonas gingivalis
4785817|NCT02705885|gingipains|gingipains
4785818|NCT02705885|Efficacy|efficacy
4785819|NCT02705872|Epidural|epidural
4785820|NCT02705872|Programmed intermittent boluses|programmed intermittent boluses
4785821|NCT02705872|Cesarian section|cesarian section
4785822|NCT02705872|Instrumented delivery|instrumented delivery
4785823|NCT02705846|BRCA1|brca1
4785824|NCT02705846|BRCA2|brca2
4785825|NCT02705846|Lynch Syndrome|lynch syndrome
4785826|NCT02705820|Metastatic, Lung Cancer, Switch, Maintenance, Pembrolizumab.|metastatic, lung cancer, switch, maintenance, pembrolizumab.
4785827|NCT02705807|Pulmonary Arterial Hypertension (PAH)|pulmonary arterial hypertension (pah)
4785828|NCT02705807|safety|safety
4785829|NCT02705807|FLOLAN|flolan
4785830|NCT02705807|New Thermostable Formulation|new thermostable formulation
4785831|NCT02705807|dose adjustment|dose adjustment
4785832|NCT02705807|reformulated diluents|reformulated diluents
4785833|NCT02705807|currently marketed diluent|currently marketed diluent
4785834|NCT02705794|intubation, laryngoscopy|intubation, laryngoscopy
4785835|NCT02705768|Neuron-specific enolase (NSE)|neuron-specific enolase (nse)
4785836|NCT02705768|Carbamazepine|carbamazepine
4785837|NCT02705768|Oxcarbazepine|oxcarbazepine
4785838|NCT02705755|Neurogenic Orthostatic Hypotension (nOH)|neurogenic orthostatic hypotension (noh)
4785839|NCT02705755|Multiple System Atrophy (MSA)|multiple system atrophy (msa)
4785840|NCT02705755|Pure Autonomic Failure|pure autonomic failure
4785841|NCT02705755|Parkinson Disease(PD)|parkinson disease(pd)
4785842|NCT02705755|nOH|noh
4785843|NCT02705755|MSA|msa
4785844|NCT02705755|PD|pd
4785845|NCT02705755|PAF|paf
4785846|NCT02705755|Orthostatic Hypotension|orthostatic hypotension
4785847|NCT02705742|Mesenchymal stem cells|mesenchymal stem cells
4785848|NCT02705742|Liver cirrhosis|liver cirrhosis
4785849|NCT02705742|Hepatitis C|hepatitis c
4785850|NCT02705729|dental caries|dental caries
4785851|NCT02705729|proximal surfaces|proximal surfaces
4785852|NCT02705729|posterior teeth|posterior teeth
4785853|NCT02705729|carious lesions|carious lesions
4785854|NCT02705729|tooth diseases|tooth diseases
4785855|NCT02705729|dental restorations|dental restorations
4785856|NCT02705729|glass-ionomer|glass-ionomer
4785857|NCT02705664|Onychomycosis|onychomycosis
4785858|NCT02705612|Cervical cancer|cervical cancer
4785859|NCT02705612|cisplatin|cisplatin
4785860|NCT02705612|nimotuzumab|nimotuzumab
4785861|NCT02705599|Ischemic stroke|ischemic stroke
4785862|NCT02705599|High resolution MRI|high resolution mri
4785863|NCT02705599|Perfusion|perfusion
4785864|NCT02705599|Mechanism|mechanism
4785865|NCT02705586|Movement disorders|movement disorders
4785866|NCT02705586|Metabolic Stress|metabolic stress
4785867|NCT02705547|Friedreich Ataxia|friedreich ataxia
4785868|NCT02705534|Hepatitis C|hepatitis c
4785869|NCT02705534|Cirrhosis|cirrhosis
4785870|NCT02705534|Sofosbuvir|sofosbuvir
4785871|NCT02705534|Ledipasvir|ledipasvir
4785872|NCT02705534|Ribavirin|ribavirin
4785873|NCT02705521|shoulder|shoulder
4785874|NCT02705521|impingement|impingement
4785875|NCT02705521|rehabilitation|rehabilitation
4785876|NCT02705521|physiotherapy|physiotherapy
4785877|NCT02705521|gamification|gamification
4785878|NCT02705521|activation|activation
4785879|NCT02705521|engagement|engagement
4785880|NCT02705508|extranodal natural killer/T-cell lymphoma|extranodal natural killer/t-cell lymphoma
4785881|NCT02705508|nasal type|nasal type
4785882|NCT02705508|chemotherapy|chemotherapy
4785883|NCT02705508|radiotherapy|radiotherapy
4785884|NCT02705482|Advanced solid tumors|advanced solid tumors
4785885|NCT02705482|MEDI0562|medi0562
4785886|NCT02705482|durvalumab|durvalumab
4785887|NCT02705482|tremelimumab|tremelimumab
4785888|NCT02705482|OX40|ox40
4785889|NCT02705482|PD-L1|pd-l1
4785890|NCT02705482|CTLA-4|ctla-4
4785891|NCT02705482|immuno-oncology|immuno-oncology
4785892|NCT02705482|Cancer|cancer
4785893|NCT02705469|Metastatic Castration-Resistant Prostate Cancer (mCRPC)|metastatic castration-resistant prostate cancer (mcrpc)
4785894|NCT02705469|Phase 1|phase 1
4785895|NCT02705469|Prostate Cancer|prostate cancer
4785896|NCT02705469|Pharmacokinetics (PK)|pharmacokinetics (pk)
4785897|NCT02705469|ZEN003694|zen003694
4785898|NCT02705469|ZEN-3694|zen-3694
4785899|NCT02705469|Metastatic Castrate-Resistant Prostate Cancer|metastatic castrate-resistant prostate cancer
4785900|NCT02705469|BET inhibitor (BETi)|bet inhibitor (beti)
4785901|NCT02705469|Bromodomain|bromodomain
4785902|NCT02705469|Pharmacodynamics (PD)|pharmacodynamics (pd)
4785903|NCT02705469|Epigenetics|epigenetics
4785904|NCT02705456|Dental Caries|dental caries
4785905|NCT02705456|Tooth Paste|tooth paste
4785906|NCT02705456|Orthodontics|orthodontics
4785907|NCT02705456|Fluorides|fluorides
4785908|NCT02705417|arteriovenous fistula|arteriovenous fistula
4785909|NCT02705417|colour Doppler|colour doppler
4785910|NCT02705417|physical examination|physical examination
4785911|NCT02705417|renal dialysis|renal dialysis
4785912|NCT02705417|retrospective studies|retrospective studies
4785913|NCT02705404|multifocal|multifocal
4785914|NCT02705404|genetic|genetic
4785915|NCT02705404|bronchoalveolar carcinoma|bronchoalveolar carcinoma
4785916|NCT02705404|adenocarcinoma in situ|adenocarcinoma in situ
4785917|NCT02705404|ground glass opacity|ground glass opacity
4785918|NCT02705404|next generation sequencing|next generation sequencing
4785919|NCT02705378|Intensive care unit|intensive care unit
4785920|NCT02705378|ICU|icu
4785921|NCT02705378|Critical Illness|critical illness
4785922|NCT02705378|Constipation|constipation
4785923|NCT02705365|Lung Screening|lung screening
4785924|NCT02705365|Low-Dose Computer Tomography|low-dose computer tomography
4785925|NCT02705365|Patient Navigation|patient navigation
4785926|NCT02705352|Skin graft|skin graft
4785927|NCT02705352|5-Fluorouracil|5-fluorouracil
4785928|NCT02705352|Periocular reconstruction|periocular reconstruction
4785929|NCT02705313|neuroendocrine tumors|neuroendocrine tumors
4785930|NCT02705313|177Lu-DOTA0-Tyr3-Octreotate|177lu-dota0-tyr3-octreotate
4785931|NCT02705313|PRRT|prrt
4785932|NCT02705287|vitamin D|vitamin d
4785933|NCT02705287|half life|half life
4785934|NCT02705287|kinetics|kinetics
4785935|NCT02705261|child|child
4785936|NCT02705261|behavior therapy|behavior therapy
4785937|NCT02705261|cognitive therapy|cognitive therapy
4785938|NCT02705261|parent|parent
4785939|NCT02705261|anxiety|anxiety
4785940|NCT02705222|Abnormal uterine bleeding|abnormal uterine bleeding
4785941|NCT02705222|Dilatation and curettage|dilatation and curettage
4785942|NCT02705222|Hysteroscopy|hysteroscopy
4785943|NCT02705196|oncolytic|oncolytic
4785944|NCT02705196|adenovirus|adenovirus
4785945|NCT02705196|pancreatic|pancreatic
4785946|NCT02705196|cancer|cancer
4785947|NCT02705196|LOKON|lokon
4785948|NCT02705196|LOAd703|load703
4785949|NCT02705183|surgical treatment|surgical treatment
4785950|NCT02705183|post-operative radiotherapy|post-operative radiotherapy
4785951|NCT02705183|quality of life|quality of life
4785952|NCT02705183|complications|complications
4785953|NCT02705183|survival|survival
4785954|NCT02705183|long bones|long bones
4785955|NCT02705170|index of microvascular resistance|index of microvascular resistance
4785956|NCT02705157|long bones|long bones
4785957|NCT02705157|survival|survival
4785958|NCT02705157|prognosis|prognosis
4785959|NCT02705157|treatment|treatment
4785960|NCT02705157|quality of life|quality of life
4785961|NCT02705131|Cervical radiculopathy|cervical radiculopathy
4785962|NCT02705131|Balance chiropractic therapy|balance chiropractic therapy
4785963|NCT02705118|radiofrequency ablation|radiofrequency ablation
4785964|NCT02705118|image fusion|image fusion
4785965|NCT02705105|Metastatic Solid Tumors|metastatic solid tumors
4785966|NCT02705105|Advanced Solid Tumors|advanced solid tumors
4785967|NCT02705105|KW-0761|kw-0761
4785968|NCT02705105|ONO-4538/BMS-936558|ono-4538/bms-936558
4785969|NCT02705105|Anti-tumor|anti-tumor
4785970|NCT02705105|Mogamulizumab|mogamulizumab
4785971|NCT02705105|Nivolumab|nivolumab
4785972|NCT02705105|Oncology|oncology
4785973|NCT02705105|HCC|hcc
4785974|NCT02705105|Hepatocellular carcinoma|hepatocellular carcinoma
4785975|NCT02705053|Diabetes Mellitus, Type 1|diabetes mellitus, type 1
4785976|NCT02705053|Artificial Pancreas|artificial pancreas
4785977|NCT02705053|Autoimmune Diseases|autoimmune diseases
4785978|NCT02705053|Diabetes Mellitus|diabetes mellitus
4785979|NCT02705053|Hyperglycemia|hyperglycemia
4785980|NCT02705053|Hypoglycemia|hypoglycemia
4785981|NCT02705040|male osteoporosis|male osteoporosis
4785982|NCT02705040|miRNA|mirna
4785983|NCT02705040|biomarker|biomarker
4785984|NCT02705014|pituitary stalk interruption syndrome|pituitary stalk interruption syndrome
4785985|NCT02705014|pulsatile GnRH therapy|pulsatile gnrh therapy
4785986|NCT02705014|hypogonadotropic hypogonadism|hypogonadotropic hypogonadism
4785987|NCT02705014|hypopituitarism|hypopituitarism
4785988|NCT02704975|Dry Needling, Shoulder Stabilization|dry needling, shoulder stabilization
4785989|NCT02704962|schizophrenia|schizophrenia
4785990|NCT02704962|olanzapine|olanzapine
4785991|NCT02704962|trifluoperazine|trifluoperazine
4785992|NCT02704962|antipsychotic polypharmacy|antipsychotic polypharmacy
4785993|NCT02704949|Urolithiasis|urolithiasis
4785994|NCT02704949|Fluoroscopy|fluoroscopy
4785995|NCT02704949|Radiation|radiation
4785996|NCT02704949|Ureteroscopy|ureteroscopy
4785997|NCT02704923|Atropine|atropine
4785998|NCT02704923|Pneumonia|pneumonia
4785999|NCT02704923|Ventilator|ventilator
4786000|NCT02704923|Adults|adults
4786001|NCT02704923|Intensive care unit.|intensive care unit.
4786002|NCT02704871|SeptiCyte|septicyte
4786003|NCT02704858|recurrent glioblastoma|recurrent glioblastoma
4786004|NCT02704858|recurrent GBM|recurrent gbm
4786005|NCT02704845|Inflammatory back pain|inflammatory back pain
4786006|NCT02704845|Ankylosing spondylitis|ankylosing spondylitis
4786007|NCT02704845|Non-specific low back pain|non-specific low back pain
4786008|NCT02704845|Pain experience|pain experience
4786009|NCT02704845|Disability|disability
4786010|NCT02704845|Behavioural|behavioural
4786011|NCT02704845|Psychological|psychological
4786012|NCT02704845|Biopsychosocial|biopsychosocial
4786013|NCT02704845|Pain profiles|pain profiles
4786014|NCT02704832|Geriatric oncology|geriatric oncology
4786015|NCT02704832|Intervention|intervention
4786016|NCT02704832|Case management|case management
4786017|NCT02704819|Decision Support System|decision support system
4786018|NCT02704819|Dizziness|dizziness
4786019|NCT02704819|Vertigo|vertigo
4786020|NCT02704819|Balance|balance
4786021|NCT02704780|Retained placenta|retained placenta
4786022|NCT02704780|Misoprostol|misoprostol
4786023|NCT02704780|double blind|double blind
4786024|NCT02704780|Randomization|randomization
4786025|NCT02704780|Haemorrhage|haemorrhage
4786026|NCT02704715|postoperative pain|postoperative pain
4786027|NCT02704715|general anesthesia|general anesthesia
4786028|NCT02704702|Fimasartan|fimasartan
4786029|NCT02704676|CA-125|ca-125
4786030|NCT02704676|Pre-Eclampsia|pre-eclampsia
4786031|NCT02704663|adnexal mass|adnexal mass
4786032|NCT02704663|laparoscopy|laparoscopy
4786033|NCT02704663|removal route|removal route
4786034|NCT02704663|postoperative pain|postoperative pain
4786035|NCT02704637|vasospasm|vasospasm
4786036|NCT02704624|Crohn Disease|crohn disease
4786037|NCT02704624|Fatigue|fatigue
4786038|NCT02704624|Osteopenia|osteopenia
4786039|NCT02704624|Exercise Tolerance|exercise tolerance
4786040|NCT02704624|Vitamin d|vitamin d
4786041|NCT02704585|Neonatal resuscitation|neonatal resuscitation
4786042|NCT02704585|Pulse oximetry|pulse oximetry
4786043|NCT02704572|Herpes zoster vaccine|herpes zoster vaccine
4786044|NCT02704572|cell-mediated immunity|cell-mediated immunity
4786045|NCT02704533|Plasmodium falciparum|plasmodium falciparum
4786046|NCT02704533|PfSPZ Vaccine|pfspz vaccine
4786047|NCT02704533|PfSPZ Challenge (NF54)|pfspz challenge (nf54)
4786048|NCT02704533|PfSPZ Challenge (7G8)|pfspz challenge (7g8)
4786049|NCT02704533|CHMI|chmi
4786050|NCT02704520|Rectal Cancer|rectal cancer
4786051|NCT02704520|Magnetic Resonance Imaging|magnetic resonance imaging
4786052|NCT02704520|Chemoradiotherapy|chemoradiotherapy
4786053|NCT02704520|Chemotherapy|chemotherapy
4786054|NCT02704520|Diagnostic Imaging|diagnostic imaging
4786055|NCT02704507|tretinoin|tretinoin
4786056|NCT02704507|topical steroid|topical steroid
4786057|NCT02704507|irritation|irritation
4786058|NCT02704507|retinoid induced irritation|retinoid induced irritation
4786059|NCT02704494|Resveratrol|resveratrol
4786060|NCT02704494|Diabetes mellitus|diabetes mellitus
4786061|NCT02704494|Diabetes complications|diabetes complications
4786062|NCT02704494|Diabetic nephropathies|diabetic nephropathies
4786063|NCT02704494|Proteinuria|proteinuria
4786064|NCT02704494|Albuminuria|albuminuria
4786065|NCT02704494|renal insufficiency|renal insufficiency
4786066|NCT02704481|mifepristone|mifepristone
4786067|NCT02704481|misoprostol|misoprostol
4786068|NCT02704481|medical abortion|medical abortion
4786069|NCT02704468|CAVI|cavi
4786070|NCT02704468|FGF-21|fgf-21
4786071|NCT02704468|arterial stiffness|arterial stiffness
4786072|NCT02704468|renal transplant|renal transplant
4786073|NCT02704455|children|children
4786074|NCT02704442|anesthesiology|anesthesiology
4786075|NCT02704442|ophthalmology|ophthalmology
4786076|NCT02704416|Ventricular arrhythmias|ventricular arrhythmias
4786077|NCT02704416|aborted cardiac arrest|aborted cardiac arrest
4786078|NCT02704416|cardiac death|cardiac death
4786079|NCT02704403|Elafibranor|elafibranor
4786080|NCT02704403|NASH|nash
4786081|NCT02704403|Nonalcoholic steatohepatitis|nonalcoholic steatohepatitis
4786082|NCT02704403|Fatty liver disease|fatty liver disease
4786083|NCT02704403|Fibrosis|fibrosis
4786084|NCT02704390|ORADUR®-Methylphenidate|oradur®-methylphenidate
4786085|NCT02704377|Prostate Cancer Survivor|prostate cancer survivor
4786086|NCT02704338|Autoimmune Diseases, Treg|autoimmune diseases, treg
4786088|NCT02704325|Duchenne Muscular Dystrophy|duchenne muscular dystrophy
4786089|NCT02704273|MTM|mtm
4786090|NCT02704273|XLMTM|xlmtm
4786091|NCT02704208|Antiretroviral Therapy|antiretroviral therapy
4786092|NCT02704208|Medication Adherence|medication adherence
4786093|NCT02704208|Technology-based Intervention|technology-based intervention
4786094|NCT02704195|Parkinson disease|parkinson disease
4786095|NCT02704195|Deep brain stimulation|deep brain stimulation
4786096|NCT02704195|Freezing of Gait|freezing of gait
4786097|NCT02704182|Arthroplasties, Knee Replacement|arthroplasties, knee replacement
4786098|NCT02704169|head and neck cancer|head and neck cancer
4786099|NCT02704169|H&N cancer|h&n cancer
4786100|NCT02704156|Stereotactic body radiation therapy|stereotactic body radiation therapy
4786101|NCT02704156|CyberKnife|cyberknife
4786102|NCT02704156|Initial treatment|initial treatment
4786103|NCT02704130|Therapeutic Embolization|therapeutic embolization
4786104|NCT02704130|Ablation Techniques|ablation techniques
4786105|NCT02704130|Transarterial Embolization|transarterial embolization
4786107|NCT02704130|Microwave Ablation|microwave ablation
4786108|NCT02704130|MWA|mwa
4786109|NCT02704104|topical hemostat|topical hemostat
4786110|NCT02704104|self-assembling peptide barrier|self-assembling peptide barrier
4786111|NCT02704065|amyloidosis|amyloidosis
4786112|NCT02704065|renal transplantation|renal transplantation
4786113|NCT02704026|Body composition|body composition
4786114|NCT02704026|Nutritional status|nutritional status
4786115|NCT02704013|Neurotrophins|neurotrophins
4786116|NCT02704013|Nerve Growth Factor|nerve growth factor
4786117|NCT02704013|Brain-Derived Neurotrophic Factor|brain-derived neurotrophic factor
4786118|NCT02704013|Urinary Biomarkers|urinary biomarkers
4786119|NCT02704013|Urodynamics|urodynamics
4786120|NCT02704013|Anticholinergics|anticholinergics
4786121|NCT02704013|Children|children
4786122|NCT02703961|CCRT|ccrt
4786123|NCT02703961|adjuvant chemotherapy|adjuvant chemotherapy
4786124|NCT02703961|cisplatin and docetaxel|cisplatin and docetaxel
4786125|NCT02703909|morbid obesity|morbid obesity
4786126|NCT02703909|laparoscopic surgery|laparoscopic surgery
4786127|NCT02703909|neuromuscular blockade|neuromuscular blockade
4786128|NCT02703896|g a, bile reflux. PPIs, H2RAs, prokinetic agents|g a, bile reflux. ppis, h2ras, prokinetic agents
4786129|NCT02703831|adult spine deformity|adult spine deformity
4786130|NCT02703831|time-driven activity-based costing|time-driven activity-based costing
4786131|NCT02703831|three-column posterior osteotomy|three-column posterior osteotomy
4786132|NCT02703805|Community program|community program
4786133|NCT02703805|Wellness|wellness
4786134|NCT02703805|Exercise|exercise
4786135|NCT02703805|Physical Activity|physical activity
4786136|NCT02703805|Education|education
4786137|NCT02703805|Stroke|stroke
4786138|NCT02703805|Self-management|self-management
4786139|NCT02703779|Multiple Myeloma|multiple myeloma
4786140|NCT02703779|Bortezomib|bortezomib
4786141|NCT02703779|Autologous|autologous
4786142|NCT02703779|Stem Cell|stem cell
4786143|NCT02703779|Purging|purging
4786144|NCT02703779|In-vivo purging|in-vivo purging
4786145|NCT02703779|Ex-vivo purging|ex-vivo purging
4786146|NCT02703779|Leukapheresis|leukapheresis
4786147|NCT02703779|Contaminated|contaminated
4786148|NCT02703779|Stem Cell Harvest|stem cell harvest
4786149|NCT02703779|Stem Cell Transplant|stem cell transplant
4786150|NCT02703779|Transplantation|transplantation
4786151|NCT02703727|polypharmacy|polypharmacy
4786152|NCT02703727|polymedication check|polymedication check
4786153|NCT02703727|anticoagulation treatment|anticoagulation treatment
4786154|NCT02703714|Advanced|advanced
4786155|NCT02703714|Locally-advanced|locally-advanced
4786156|NCT02703714|Not eligible for resection|not eligible for resection
4786157|NCT02703714|Prior chemotherapy treatment|prior chemotherapy treatment
4786158|NCT02703701|Patient Satisfaction|patient satisfaction
4786159|NCT02703701|Emergency Department efficiency|emergency department efficiency
4786160|NCT02703662|Biologic mesh|biologic mesh
4786161|NCT02703662|abdominal wall reconstruction|abdominal wall reconstruction
4786162|NCT02703649|Aromatase inhibitor|aromatase inhibitor
4786163|NCT02703649|induction of ovulation|induction of ovulation
4786164|NCT02703636|Alzheimer's disease|alzheimer's disease
4786165|NCT02703623|Prostate cancer|prostate cancer
4786166|NCT02703623|Metastatic castration-resistant prostate cancer to the bone|metastatic castration-resistant prostate cancer to the bone
4786167|NCT02703623|mCRPC|mcrpc
4786168|NCT02703623|Adenocarcinoma of the prostate|adenocarcinoma of the prostate
4786169|NCT02703623|Biomarkers|biomarkers
4786170|NCT02703623|Abiraterone Acetate|abiraterone acetate
4786171|NCT02703623|Zytiga|zytiga
4786172|NCT02703623|Prednisone|prednisone
4786173|NCT02703623|ARN509|arn509
4786174|NCT02703623|Ipilimumab|ipilimumab
4786175|NCT02703623|Yervoy|yervoy
4786176|NCT02703623|BMS-734016|bms-734016
4786177|NCT02703623|MDX010|mdx010
4786178|NCT02703623|Cabazitaxel|cabazitaxel
4786179|NCT02703623|Jevtana|jevtana
4786180|NCT02703623|Carboplatin|carboplatin
4786181|NCT02703623|Paraplatin|paraplatin
4786182|NCT02703610|Pain|pain
4786183|NCT02703610|Elderly|elderly
4786184|NCT02703597|Cigarette Smoking Behavior|cigarette smoking behavior
4786185|NCT02703597|Smoking curiosity|smoking curiosity
4786186|NCT02703597|Smoking Cessation|smoking cessation
4786187|NCT02703597|Smoking Prevention|smoking prevention
4786188|NCT02703597|Health improvement|health improvement
4786189|NCT02703597|Smoking prevention interactive experience|smoking prevention interactive experience
4786190|NCT02703597|ASPIRE|aspire
4786191|NCT02703597|Game-based social activities|game-based social activities
4786192|NCT02703597|GSA's|gsa's
4786193|NCT02703597|Surveys|surveys
4786194|NCT02703597|Questionnaires|questionnaires
4786195|NCT02703597|Interviews|interviews
4786196|NCT02703584|Double trigger|double trigger
4786197|NCT02703571|Trametinib|trametinib
4786198|NCT02703571|Ribociclib|ribociclib
4786199|NCT02703571|LEE011|lee011
4786200|NCT02703571|TMT212|tmt212
4786201|NCT02703571|advanced solid tumors|advanced solid tumors
4786202|NCT02703571|pancreatic cancer|pancreatic cancer
4786203|NCT02703571|KRAS-mutant colorectal cancer|kras-mutant colorectal cancer
4786204|NCT02703571|colorectal cancer|colorectal cancer
4786205|NCT02703571|advanced pancreatic cancer|advanced pancreatic cancer
4786206|NCT02703571|metastatic pancreatic cancer|metastatic pancreatic cancer
4786207|NCT02703545|familial pancreas cancer|familial pancreas cancer
4786208|NCT02703545|pancreatic cyst|pancreatic cyst
4786209|NCT02703532|Therapy|therapy
4786210|NCT02703532|Rehabilitation|rehabilitation
4786211|NCT02703532|Caregiver|caregiver
4786212|NCT02703519|cesarean section, repeat|cesarean section, repeat
4786213|NCT02703519|uterine scar tissue|uterine scar tissue
4786214|NCT02703519|transvaginal ultrasound|transvaginal ultrasound
4786215|NCT02703519|uterine rupture|uterine rupture
4786216|NCT02703519|placenta accreta|placenta accreta
4786217|NCT02703519|placenta percreta|placenta percreta
4786218|NCT02703519|placenta increta|placenta increta
4786219|NCT02703467|Exhaled hydrogen sulphide|exhaled hydrogen sulphide
4786220|NCT02703428|Abdominal|abdominal
4786221|NCT02703428|Aortic|aortic
4786222|NCT02703428|Aneurysm|aneurysm
4786223|NCT02703415|immune|immune
4786224|NCT02703415|interleukin|interleukin
4786225|NCT02703415|tramadol|tramadol
4786226|NCT02703415|postoperartive analgesia|postoperartive analgesia
4786227|NCT02703415|pediatric|pediatric
4786228|NCT02703415|caudal bupivacaine|caudal bupivacaine
4786229|NCT02703402|low back pain|low back pain
4786230|NCT02703402|physical exercise and quality of life|physical exercise and quality of life
4786231|NCT02703389|knowledge translation|knowledge translation
4786232|NCT02703389|antimicrobial stewardship|antimicrobial stewardship
4786233|NCT02703311|Valtech Cardio|valtech cardio
4786234|NCT02703311|Cardioband|cardioband
4786235|NCT02703311|Mitral Valve|mitral valve
4786236|NCT02703298|Advanced Solid Malignancy|advanced solid malignancy
4786237|NCT02703298|Safety and Tolerability|safety and tolerability
4786238|NCT02703298|Tumor Response|tumor response
4786239|NCT02703298|Oncology|oncology
4786240|NCT02703272|Lymphoma, Non-Hodgkin|lymphoma, non-hodgkin
4786241|NCT02703272|Ibrutinib|ibrutinib
4786242|NCT02703272|JNJ-54179060|jnj-54179060
4786243|NCT02703246|Hysterectomy, Vaginal|hysterectomy, vaginal
4786244|NCT02703246|Hysterectomy, Abdominal|hysterectomy, abdominal
4786245|NCT02703220|sleep apnea|sleep apnea
4786246|NCT02703220|chemoresponsiveness|chemoresponsiveness
4786247|NCT02703220|cerebrovascular response|cerebrovascular response
4786248|NCT02703220|hyperoxia|hyperoxia
4786249|NCT02703220|acetazolamide|acetazolamide
4786250|NCT02703220|finasteride|finasteride
4786251|NCT02703220|apneic threshold|apneic threshold
4786252|NCT02703220|carbon-dioxide reserve|carbon-dioxide reserve
4786253|NCT02703207|obstructive sleep apnea|obstructive sleep apnea
4786254|NCT02703207|COPD|copd
4786255|NCT02703207|Overlap syndrome|overlap syndrome
4786256|NCT02703207|quality of life|quality of life
4786257|NCT02703207|neurocognitive function|neurocognitive function
4786258|NCT02703207|sleepiness|sleepiness
4786259|NCT02703207|elderly|elderly
4786260|NCT02703194|IgG4-related disease|igg4-related disease
4786261|NCT02703194|IgG4-related sclerosing cholangitis|igg4-related sclerosing cholangitis
4786262|NCT02703194|Mikulicz disease|mikulicz disease
4786263|NCT02703194|Pancreatitis|pancreatitis
4786264|NCT02703194|Retroperitoneal fibrosis|retroperitoneal fibrosis
4786265|NCT02703194|Lymphadenopathy|lymphadenopathy
4786266|NCT02703181|Safety|safety
4786267|NCT02703181|Dose Escalation|dose escalation
4786268|NCT02703181|Repeat Dosing|repeat dosing
4786269|NCT02703181|Epelsiban|epelsiban
4786270|NCT02703181|Pharmacokinetics|pharmacokinetics
4786271|NCT02703181|Healthy Women Volunteers|healthy women volunteers
4786272|NCT02703181|Tolerability|tolerability
4786273|NCT02703181|Oxytocin|oxytocin
4786274|NCT02703168|Dental implants|dental implants
4786275|NCT02703142|esophagogastrostomy|esophagogastrostomy
4786276|NCT02703142|gastric conduit ischemia|gastric conduit ischemia
4786277|NCT02703142|endoscopy|endoscopy
4786278|NCT02703129|Migraine|migraine
4786279|NCT02703129|Diet quality|diet quality
4786280|NCT02703129|Nutritional intervention|nutritional intervention
4786281|NCT02703129|Severity of disease|severity of disease
4786282|NCT02703129|Depressive symptoms|depressive symptoms
4786283|NCT02703116|HIV|hiv
4786284|NCT02703116|Substance Use|substance use
4786285|NCT02703103|cardiopulmonary resuscitation|cardiopulmonary resuscitation
4786286|NCT02703103|chest compression|chest compression
4786287|NCT02703103|adult|adult
4786288|NCT02703103|simulation|simulation
4786289|NCT02703064|Furocyst|furocyst
4786290|NCT02703064|PCOS|pcos
4786291|NCT02703038|cardiogenic shock|cardiogenic shock
4786292|NCT02703038|observatory|observatory
4786293|NCT02703025|Obesity, green coffee bean extract, weight management|obesity, green coffee bean extract, weight management
4786294|NCT02702973|Characteristic analysis|characteristic analysis
4786295|NCT02702960|FL-HCC|fl-hcc
4786296|NCT02702960|living donor liver transplant|living donor liver transplant
4786297|NCT02702960|HLA matched first degree relative|hla matched first degree relative
4786298|NCT02702960|Milan Criteria|milan criteria
4786299|NCT02702960|Ephraim Fuchs|ephraim fuchs
4786300|NCT02702960|Fibrolamellar Cancer Foundation|fibrolamellar cancer foundation
4786301|NCT02702960|fibrolamellar|fibrolamellar
4786302|NCT02702960|non-fibrolamellar|non-fibrolamellar
4786303|NCT02702947|BPH|bph
4786304|NCT02702947|Prunus Domestica extract|prunus domestica extract
4786305|NCT02702882|Fenugreek seed extract, hypogonadism, protodioscin, testosterone|fenugreek seed extract, hypogonadism, protodioscin, testosterone
4786306|NCT02702869|cleft lip|cleft lip
4786307|NCT02702869|cleft palate|cleft palate
4786308|NCT02702869|cleft lip and palate|cleft lip and palate
4786309|NCT02702869|cleft alveolus|cleft alveolus
4786310|NCT02702869|multidisciplinary team|multidisciplinary team
4786311|NCT02702869|interdisciplinary team|interdisciplinary team
4786312|NCT02702856|Prostate Cancer|prostate cancer
4786313|NCT02702856|Gleason Grade|gleason grade
4786314|NCT02702856|Prostatic Neoplasms|prostatic neoplasms
4786315|NCT02702817|Alzheimer's disease, biomarkers, cognitive decline, pre-clinical|alzheimer's disease, biomarkers, cognitive decline, pre-clinical
4786316|NCT02702791|Physical activity|physical activity
4786317|NCT02702791|Pulmonary rehabilitation|pulmonary rehabilitation
4786318|NCT02702791|COPD|copd
4786319|NCT02702778|Polymyalgia Rheumatica (PMR)|polymyalgia rheumatica (pmr)
4786320|NCT02702765|sCD163|scd163
4786321|NCT02702765|liver cirrhosis|liver cirrhosis
4786322|NCT02702765|disease severity|disease severity
4786323|NCT02702752|Heart diseases stromal differentiation factor alpha 1|heart diseases stromal differentiation factor alpha 1
4786324|NCT02702713|bioactive|bioactive
4786325|NCT02702713|enriched foods|enriched foods
4786326|NCT02702713|anthocyanins (AC)|anthocyanins (ac)
4786327|NCT02702713|beta-glucans (BG)|beta-glucans (bg)
4786328|NCT02702713|docosahexaenoic acid (DHA)|docosahexaenoic acid (dha)
4786329|NCT02702687|Asthma|asthma
4786330|NCT02702687|Childhood Asthma|childhood asthma
4786331|NCT02702687|Bronchial Diseases|bronchial diseases
4786332|NCT02702687|Immune System Diseases|immune system diseases
4786333|NCT02702687|Lung Diseases|lung diseases
4786334|NCT02702687|Lung Diseases, Obstructive|lung diseases, obstructive
4786335|NCT02702687|Respiratory Tract Diseases|respiratory tract diseases
4786336|NCT02702687|Peak Flow Meter|peak flow meter
4786337|NCT02702687|Symptom Perception|symptom perception
4786338|NCT02702687|Illness Representation|illness representation
4786339|NCT02702661|Fascia Iliaca Block|fascia iliaca block
4786340|NCT02702661|Local Anaesthetic Infiltration|local anaesthetic infiltration
4786341|NCT02702661|Hip Arthroscopy|hip arthroscopy
4786342|NCT02702648|healthy subjects|healthy subjects
4786343|NCT02702648|first-in-man|first-in-man
4786344|NCT02702648|safety|safety
4786345|NCT02702622|bananas|bananas
4786346|NCT02702622|biofortified|biofortified
4786347|NCT02702622|carotenoids|carotenoids
4786348|NCT02702622|vitamin A|vitamin a
4786349|NCT02702583|Myelosuppressive Chemotherapy|myelosuppressive chemotherapy
4786350|NCT02702583|Febrile Neutropenia|febrile neutropenia
4786351|NCT02702583|Solid Tumors|solid tumors
4786352|NCT02702583|Dental Infection|dental infection
4786353|NCT02702583|Oral Infection|oral infection
4786354|NCT02702557|Frail Elderly|frail elderly
4786355|NCT02702557|Elastic Band Exercises|elastic band exercises
4786356|NCT02702557|Unsupervised Exercises|unsupervised exercises
4786357|NCT02702557|Monitoring Technology|monitoring technology
4786358|NCT02702557|Bandcizer|bandcizer
4786359|NCT02702557|Adherence|adherence
4786360|NCT02702557|Feasibility|feasibility
4786361|NCT02702531|Laparoscopic Surgery|laparoscopic surgery
4786362|NCT02702531|FloShield Defogging and Cleaning System|floshield defogging and cleaning system
4786363|NCT02702531|Clearify Defogging and Cleaning System|clearify defogging and cleaning system
4786364|NCT02702531|gynecologic|gynecologic
4786365|NCT02702518|rhDNase I, Pulmozyme, oGVHD, Dry Eye|rhdnase i, pulmozyme, ogvhd, dry eye
4786367|NCT02702505|pulpotomies|pulpotomies
4786368|NCT02702505|mineral trioxide aggregate|mineral trioxide aggregate
4786369|NCT02702492|PAK4|pak4
4786370|NCT02702492|KPT-9274|kpt-9274
4786371|NCT02702492|Karyopharm|karyopharm
4786372|NCT02702492|NHL|nhl
4786373|NCT02702492|solid tumors|solid tumors
4786374|NCT02702492|NAMPT|nampt
4786375|NCT02702479|Systematic review and meta-analysis|systematic review and meta-analysis
4786376|NCT02702479|Evidence-based medicine (EBM)|evidence-based medicine (ebm)
4786377|NCT02702479|Evidence-based nutrition (EBN)|evidence-based nutrition (ebn)
4786378|NCT02702479|Clinical practice guidelines|clinical practice guidelines
4786379|NCT02702479|Clinical trials|clinical trials
4786380|NCT02702479|Dietary sugars|dietary sugars
4786381|NCT02702479|Fructose|fructose
4786382|NCT02702479|High fructose corn syrup|high fructose corn syrup
4786383|NCT02702479|Isocaloric|isocaloric
4786384|NCT02702479|Hypercaloric|hypercaloric
4786385|NCT02702479|Cardiometabolic Risk Factors|cardiometabolic risk factors
4786386|NCT02702479|Triglycerides|triglycerides
4786387|NCT02702479|Cholesterol|cholesterol
4786388|NCT02702479|Glycemic control|glycemic control
4786389|NCT02702479|Body weight|body weight
4786390|NCT02702479|Uric acid|uric acid
4786391|NCT02702479|Blood pressure|blood pressure
4786392|NCT02702479|Fatty liver|fatty liver
4786393|NCT02702479|Fasting|fasting
4786394|NCT02702479|Postprandial|postprandial
4786395|NCT02702466|Upper limb musculoskeletal disorders|upper limb musculoskeletal disorders
4786396|NCT02702466|Spa treatment|spa treatment
4786397|NCT02702466|Randomized controlled trials|randomized controlled trials
4786398|NCT02702466|Education|education
4786399|NCT02702466|Self- management|self- management
4786400|NCT02702466|Self-care|self-care
4786401|NCT02702466|Exercise|exercise
4786402|NCT02702466|Non pharmacological treatment|non pharmacological treatment
4786403|NCT02702440|Systematic review and meta-analysis|systematic review and meta-analysis
4786404|NCT02702440|Sugars|sugars
4786405|NCT02702440|Liquid calories|liquid calories
4786406|NCT02702440|Solid calories|solid calories
4786407|NCT02702440|Clinical trials|clinical trials
4786408|NCT02702440|Body weight|body weight
4786409|NCT02702440|Body Mass Index|body mass index
4786410|NCT02702440|Evidence-base nutrition (EBN)|evidence-base nutrition (ebn)
4786411|NCT02702440|Evidence-base medicine (EBM)|evidence-base medicine (ebm)
4786412|NCT02702440|Clinical practice guidelines|clinical practice guidelines
4786413|NCT02702427|viral infections post HSCT, virus-specific T-cells|viral infections post hsct, virus-specific t-cells
4786414|NCT02702414|PD1|pd1
4786415|NCT02702414|PD-1|pd-1
4786416|NCT02702414|PDL1|pdl1
4786417|NCT02702414|PD-L1|pd-l1
4786418|NCT02702401|PD1|pd1
4786419|NCT02702401|PD-1|pd-1
4786420|NCT02702401|PDL1|pdl1
4786421|NCT02702401|PD-L1|pd-l1
4786422|NCT02702388|Lenvatinib|lenvatinib
4786423|NCT02702388|E7080|e7080
4786424|NCT02702388|Iodine-131 Refractory Differentiated Thyroid Cancer|iodine-131 refractory differentiated thyroid cancer
4786425|NCT02702388|Lenvima|lenvima
4786426|NCT02702388|Phase 2|phase 2
4786427|NCT02702388|RR-DTC|rr-dtc
4786724|NCT02700672|Ageing|ageing
4786428|NCT02702375|Systematic review and meta-analysis|systematic review and meta-analysis
4786429|NCT02702375|Evidence-based medicine (EBM)|evidence-based medicine (ebm)
4786430|NCT02702375|Evidence-based nutrition (EBN)|evidence-based nutrition (ebn)
4786431|NCT02702375|Clinical practice guidelines|clinical practice guidelines
4786432|NCT02702375|Prospective cohort studies|prospective cohort studies
4786433|NCT02702375|Dietary sugars|dietary sugars
4786434|NCT02702375|Fructose|fructose
4786435|NCT02702375|Sucrose|sucrose
4786436|NCT02702375|High fructose corn syrup|high fructose corn syrup
4786437|NCT02702375|HFCS|hfcs
4786438|NCT02702375|Cohort studies|cohort studies
4786439|NCT02702375|Prospective studies|prospective studies
4786440|NCT02702375|Diabetes Mellitus|diabetes mellitus
4786441|NCT02702375|Metabolic syndrome|metabolic syndrome
4786442|NCT02702375|Coronary heart disease|coronary heart disease
4786443|NCT02702375|Stroke|stroke
4786444|NCT02702375|Hypertension|hypertension
4786445|NCT02702375|Gout|gout
4786446|NCT02702362|disorders of consciousness|disorders of consciousness
4786447|NCT02702362|minimally conscious state|minimally conscious state
4786448|NCT02702362|traumatic brain injury|traumatic brain injury
4786449|NCT02702362|stroke|stroke
4786450|NCT02702362|transcranial direct current stimulation|transcranial direct current stimulation
4786451|NCT02702323|hepatocellular carcinoma|hepatocellular carcinoma
4786452|NCT02702323|pulmonary metastasis|pulmonary metastasis
4786453|NCT02702323|Apatinib|apatinib
4786454|NCT02702323|efficacy|efficacy
4786455|NCT02702323|safety|safety
4786456|NCT02702297|Preterm premature rupture of the membranes|preterm premature rupture of the membranes
4786457|NCT02702297|PPROM|pprom
4786458|NCT02702297|PROM|prom
4786459|NCT02702297|fetal membranes|fetal membranes
4786460|NCT02702297|premature rupture|premature rupture
4786461|NCT02702297|neonatal early onset sepsis|neonatal early onset sepsis
4786462|NCT02702297|amniotic fluid|amniotic fluid
4786463|NCT02702297|amniotic infection|amniotic infection
4786464|NCT02702297|fetal inflammatory response syndrome|fetal inflammatory response syndrome
4786465|NCT02702297|adverse neonatal outcome|adverse neonatal outcome
4786466|NCT02702297|FIRS|firs
4786467|NCT02702284|Advance Directives|advance directives
4786468|NCT02702284|Healthcare power of attorney|healthcare power of attorney
4786469|NCT02702258|mindfulness|mindfulness
4786470|NCT02702258|blood pressure|blood pressure
4786471|NCT02702258|hypertension|hypertension
4786472|NCT02702258|prehypertension|prehypertension
4786473|NCT02702206|Shoulder pain|shoulder pain
4786474|NCT02702206|subdeltoid bursitis|subdeltoid bursitis
4786475|NCT02702206|subacromial bursitis|subacromial bursitis
4786476|NCT02702206|intra-bursa injection|intra-bursa injection
4786477|NCT02702167|brain stimulation|brain stimulation
4786478|NCT02702167|rTMS|rtms
4786479|NCT02702154|brain stimulation|brain stimulation
4786480|NCT02702154|rTMS|rtms
4786481|NCT02702141|Non-hodgkin lymphoma|non-hodgkin lymphoma
4786482|NCT02702141|Antibody-drug conjugate|antibody-drug conjugate
4786483|NCT02702141|CD19|cd19
4786484|NCT02702141|Diffuse large B-cell lymphoma|diffuse large b-cell lymphoma
4786485|NCT02702141|DLBCL|dlbcl
4786486|NCT02702141|Grade 3 follicular lymphoma|grade 3 follicular lymphoma
4786487|NCT02702128|Bleeding perioperative|bleeding perioperative
4786488|NCT02702128|EXACYL|exacyl
4786489|NCT02702128|Oorthognathism surgery|oorthognathism surgery
4786490|NCT02702128|Hematoma|hematoma
4786491|NCT02702115|gene specific targeted insertion|gene specific targeted insertion
4786492|NCT02702115|Mucopolysaccharidosis I|mucopolysaccharidosis i
4786493|NCT02702115|MPS I|mps i
4786494|NCT02702115|Hurler-Scheie syndrome|hurler-scheie syndrome
4786495|NCT02702115|Hurler|hurler
4786496|NCT02702115|Scheie syndrome|scheie syndrome
4786497|NCT02702115|gene therapy|gene therapy
4786498|NCT02702115|gene editing|gene editing
4786499|NCT02702115|zinc finger|zinc finger
4786500|NCT02702115|SB-318|sb-318
4786501|NCT02702115|rare|rare
4786502|NCT02702115|genetic|genetic
4786503|NCT02702115|DNA|dna
4786504|NCT02702115|Sangamo|sangamo
4786505|NCT02702115|Scheie|scheie
4786506|NCT02702115|Genome editing|genome editing
4786507|NCT02702115|Empowers|empowers
4786508|NCT02702115|Hurler syndrome|hurler syndrome
4786509|NCT02702076|Apomorphine|apomorphine
4786510|NCT02702050|Physiotherapy|physiotherapy
4786511|NCT02702050|Mechanical Stimulation|mechanical stimulation
4786512|NCT02702050|Mastectomy Scar|mastectomy scar
4786513|NCT02702024|efficacy|efficacy
4786514|NCT02702024|double incision technique|double incision technique
4786515|NCT02702024|uterus preserving surgery|uterus preserving surgery
4786516|NCT02701998|Ischemic Stroke|ischemic stroke
4786517|NCT02701998|Transient Ischemic Attack|transient ischemic attack
4786518|NCT02701998|Physical Activity|physical activity
4786519|NCT02701998|Sedentary Behavior|sedentary behavior
4786520|NCT02701998|Lifestyle|lifestyle
4786521|NCT02701998|Behavior|behavior
4786522|NCT02701959|Nitric oxide|nitric oxide
4786523|NCT02701959|Dietary intervention trail|dietary intervention trail
4786524|NCT02701946|Blood loss|blood loss
4786525|NCT02701946|Total knee arthroplasty|total knee arthroplasty
4786526|NCT02701946|Bandage|bandage
4786527|NCT02701946|Dressing|dressing
4786725|NCT02700672|Cognition|cognition
4786528|NCT02701920|Premature Birth|premature birth
4786529|NCT02701920|Infant|infant
4786530|NCT02701920|Heart rate|heart rate
4786531|NCT02701881|Femoropopliteal Artery|femoropopliteal artery
4786532|NCT02701881|Drug-eluting Stent|drug-eluting stent
4786533|NCT02701881|Endovascular Therapy|endovascular therapy
4786534|NCT02701868|Infant Formula|infant formula
4786535|NCT02701829|taxi cab drivers|taxi cab drivers
4786536|NCT02701829|high blood pressure|high blood pressure
4786537|NCT02701829|16-038|16-038
4786538|NCT02701816|Peripheral Artery Disease|peripheral artery disease
4786539|NCT02701816|Femoropopliteal Artery|femoropopliteal artery
4786540|NCT02701816|Nitinol Stent|nitinol stent
4786541|NCT02701816|Restenosis|restenosis
4786542|NCT02701777|spike timing dependant plasticity|spike timing dependant plasticity
4786543|NCT02701764|laser-assisted in situ keratomileusis|laser-assisted in situ keratomileusis
4786544|NCT02701764|dry eye symptoms|dry eye symptoms
4786545|NCT02701764|LASIK|lasik
4786546|NCT02701764|prevention|prevention
4786547|NCT02701712|magnetic resonance|magnetic resonance
4786548|NCT02701712|external beam radiotherapy|external beam radiotherapy
4786549|NCT02701712|brachytherapy|brachytherapy
4786550|NCT02701712|radiotherapy|radiotherapy
4786551|NCT02701699|Lung Cancer|lung cancer
4786552|NCT02701699|FAZA PET Imaging|faza pet imaging
4786553|NCT02701699|Lung Radiotherapy|lung radiotherapy
4786554|NCT02701686|smoking cessation|smoking cessation
4786555|NCT02701673|Refractory or Relapsed Lymphoma|refractory or relapsed lymphoma
4786556|NCT02701673|Busulfan|busulfan
4786557|NCT02701673|Busulfex|busulfex
4786558|NCT02701673|Myleran|myleran
4786559|NCT02701673|Caphosol|caphosol
4786560|NCT02701673|Glutamine|glutamine
4786561|NCT02701673|Enterex|enterex
4786562|NCT02701673|Glutapak-10|glutapak-10
4786563|NCT02701673|NutreStore|nutrestore
4786564|NCT02701673|Resource|resource
4786565|NCT02701673|GlutaSolve|glutasolve
4786566|NCT02701673|Sympt-X-G.I.|sympt-x-g.i.
4786567|NCT02701673|Sympt-X|sympt-x
4786568|NCT02701673|Pyridoxine|pyridoxine
4786569|NCT02701673|Belinostat|belinostat
4786570|NCT02701673|Azacitidine|azacitidine
4786571|NCT02701673|5-azacytidine|5-azacytidine
4786572|NCT02701673|5-aza|5-aza
4786573|NCT02701673|Azacytidine|azacytidine
4786574|NCT02701673|Vidaza|vidaza
4786575|NCT02701673|5-AZC|5-azc
4786576|NCT02701673|AZA-CR|aza-cr
4786577|NCT02701673|Ladakamycin|ladakamycin
4786578|NCT02701673|Gemcitabine|gemcitabine
4786579|NCT02701673|Gemcitabine Hydrochloride|gemcitabine hydrochloride
4786580|NCT02701673|Gemzar|gemzar
4786581|NCT02701673|Stem cell transplant|stem cell transplant
4786582|NCT02701673|SCT|sct
4786583|NCT02701673|Melphalan|melphalan
4786584|NCT02701673|Alkeran|alkeran
4786585|NCT02701660|Pharmaceutical Care|pharmaceutical care
4786586|NCT02701660|Adherence|adherence
4786587|NCT02701660|Polypharmacy|polypharmacy
4786588|NCT02701660|e-Health|e-health
4786589|NCT02701660|opioid substitution therapy|opioid substitution therapy
4786590|NCT02701647|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
4786591|NCT02701634|Chronic Graft Versus Host Disease (cGVHD)|chronic graft versus host disease (cgvhd)
4786592|NCT02701634|newly diagnosed cGVHD|newly diagnosed cgvhd
4786593|NCT02701634|immune reconstitution|immune reconstitution
4786594|NCT02701634|Immune System Diseases|immune system diseases
4786595|NCT02701634|allogeneic stem cell transplantation|allogeneic stem cell transplantation
4786596|NCT02701634|SYK inhibitor|syk inhibitor
4786597|NCT02701621|Parkinson's disease, aquatic therapy, balance, MIRT|parkinson's disease, aquatic therapy, balance, mirt
4786598|NCT02701517|conditioning treatment|conditioning treatment
4786599|NCT02701517|alemtuzumab|alemtuzumab
4786600|NCT02701517|allogeneic hematopoietic stem cell transplantation|allogeneic hematopoietic stem cell transplantation
4786601|NCT02701517|chronic lymphoproliferative disorders|chronic lymphoproliferative disorders
4786602|NCT02701504|sleep apnea|sleep apnea
4786603|NCT02701504|coronary artery bypass grafting|coronary artery bypass grafting
4786604|NCT02701504|outcomes|outcomes
4786605|NCT02701465|Shoulder|shoulder
4786606|NCT02701465|Exercise therapy|exercise therapy
4786607|NCT02701452|GnRH agonist triggering|gnrh agonist triggering
4786608|NCT02701426|Macrosomia|macrosomia
4786609|NCT02701426|Weight gain|weight gain
4786610|NCT02701426|Participation|participation
4786611|NCT02701426|Adhesion|adhesion
4786612|NCT02701426|Physical activity|physical activity
4786613|NCT02701426|Nutrition|nutrition
4786614|NCT02701413|Apex M|apex m
4786615|NCT02701413|Postpartum|postpartum
4786616|NCT02701413|Pelvic Floor rehabilitation|pelvic floor rehabilitation
4786617|NCT02701387|bone implant interaction|bone implant interaction
4786618|NCT02701387|implant stability|implant stability
4786619|NCT02701387|resonance frequency analysis (RFA)|resonance frequency analysis (rfa)
4786620|NCT02701387|implant stability quotient (ISQ)|implant stability quotient (isq)
4786621|NCT02701374|TRK-700|trk-700
4786622|NCT02701374|Post-Herpetic Neuralgia|post-herpetic neuralgia
4786623|NCT02701361|mindfulness|mindfulness
4786624|NCT02701361|critical illness|critical illness
4786625|NCT02701361|intensive care unit|intensive care unit
4786626|NCT02701361|mindfulness-based stress reduction|mindfulness-based stress reduction
4786627|NCT02701348|neoadjuvant endocrine|neoadjuvant endocrine
4786628|NCT02701335|Osteoarthritis|osteoarthritis
4786629|NCT02701335|Hand|hand
4786630|NCT02701335|Rehabilitation|rehabilitation
4786631|NCT02701322|Velopharyngeal Insufficiency|velopharyngeal insufficiency
4786632|NCT02701322|Fluoroscopy|fluoroscopy
4786633|NCT02701309|Iron deficiency|iron deficiency
4786634|NCT02701309|Child|child
4786635|NCT02701309|Infancy|infancy
4786636|NCT02701309|Preschool children|preschool children
4786637|NCT02701309|iron deficiency anemia|iron deficiency anemia
4786638|NCT02701296|Infiltration between popliteal artery and capsule of knee (iPACK)|infiltration between popliteal artery and capsule of knee (ipack)
4786639|NCT02701270|Glycemic Index|glycemic index
4786640|NCT02701270|Dietary Fiber|dietary fiber
4786641|NCT02701257|Bionic Pancreas|bionic pancreas
4786642|NCT02701257|Insulin|insulin
4786643|NCT02701257|Glucagon|glucagon
4786644|NCT02701257|Continuous Glucose Monitor|continuous glucose monitor
4786645|NCT02701244|Infiltrating Ductal Carcinoma|infiltrating ductal carcinoma
4786646|NCT02701244|Ductal Carcinoma In Situ|ductal carcinoma in situ
4786647|NCT02701244|Brachytherapy|brachytherapy
4786648|NCT02701244|Breast Neoplasms|breast neoplasms
4786649|NCT02701244|Breast Diseases|breast diseases
4786650|NCT02701244|Neoplasms|neoplasms
4786651|NCT02701244|Neoplasms by Site|neoplasms by site
4786652|NCT02701231|lung cancer|lung cancer
4786653|NCT02701231|Low-frequency rotating magnetic therapy system|low-frequency rotating magnetic therapy system
4786654|NCT02701231|systemic anti-tumor therapy|systemic anti-tumor therapy
4786655|NCT02701218|Canalith repositioning procedure (CRP)|canalith repositioning procedure (crp)
4786656|NCT02701218|BPPV|bppv
4786657|NCT02701205|Plaque Psoriasis|plaque psoriasis
4786658|NCT02701205|Skin Disease|skin disease
4786659|NCT02701192|coccygodynia|coccygodynia
4786660|NCT02701192|coccygectomy|coccygectomy
4786661|NCT02701192|coccyx|coccyx
4786662|NCT02701179|Lignocaine|lignocaine
4786663|NCT02701166|Pruritus|pruritus
4786664|NCT02701166|itch|itch
4786665|NCT02701166|cholestasis|cholestasis
4786666|NCT02701075|peripheral neuropathy|peripheral neuropathy
4786667|NCT02701075|traumatic tissue injury|traumatic tissue injury
4786668|NCT02701075|radiculopathy|radiculopathy
4786669|NCT02701036|sporadic ataxia|sporadic ataxia
4786670|NCT02701036|MSAc|msac
4786671|NCT02701036|SAOA|saoa
4786672|NCT02701036|multiple system atrophy of cerebellar type|multiple system atrophy of cerebellar type
4786673|NCT02701036|natural history|natural history
4786674|NCT02701010|behavioral therapy|behavioral therapy
4786675|NCT02701010|overactive bladder|overactive bladder
4786676|NCT02701010|urinary incontinence|urinary incontinence
4786677|NCT02700958|Remote ischemic preconditioning|remote ischemic preconditioning
4786678|NCT02700958|Contrast-induced Nephropathy|contrast-induced nephropathy
4786679|NCT02700958|Stable coronary artery disease|stable coronary artery disease
4786680|NCT02700958|Lower extremity arterial disease|lower extremity arterial disease
4786681|NCT02700958|Low molecular weight metabolites|low molecular weight metabolites
4786682|NCT02700958|Functional properties of arteries|functional properties of arteries
4786683|NCT02700932|non-invasive|non-invasive
4786684|NCT02700906|Lateral epicondylitis|lateral epicondylitis
4786685|NCT02700906|tennis elbow|tennis elbow
4786686|NCT02700906|Lidocaine|lidocaine
4786687|NCT02700906|corticosteroid|corticosteroid
4786688|NCT02700880|wearable cardioverter defibrillator|wearable cardioverter defibrillator
4786689|NCT02700880|ischemic cardiomyopathy|ischemic cardiomyopathy
4786690|NCT02700880|new onset heart failure|new onset heart failure
4786691|NCT02700880|sudden cardiac death|sudden cardiac death
4786692|NCT02700867|intraosseous access|intraosseous access
4786693|NCT02700867|cardiopulmonary resuscitation|cardiopulmonary resuscitation
4786694|NCT02700867|paramedic|paramedic
4786695|NCT02700867|simulation|simulation
4786696|NCT02700867|cadaver|cadaver
4786697|NCT02700854|Hypothermia treatment|hypothermia treatment
4786698|NCT02700854|Hypocapnia|hypocapnia
4786699|NCT02700854|Inhaled CO2|inhaled co2
4786700|NCT02700854|Neuroprotection|neuroprotection
4786701|NCT02700828|Hypothermia treatment|hypothermia treatment
4786702|NCT02700828|Circulatory failure|circulatory failure
4786703|NCT02700828|Neonatal hypotension|neonatal hypotension
4786704|NCT02700828|Relative adrenal insufficiency|relative adrenal insufficiency
4786705|NCT02700828|Hydrocortisone supplementation|hydrocortisone supplementation
4786706|NCT02700802|food insecurity|food insecurity
4786707|NCT02700802|informal caregiver health|informal caregiver health
4786708|NCT02700802|clinic-to-community linkages|clinic-to-community linkages
4786709|NCT02700802|community resources|community resources
4786710|NCT02700789|diagnostic accuracy|diagnostic accuracy
4786711|NCT02700789|double decidual sac sign|double decidual sac sign
4786712|NCT02700789|intrauterine pregnancy|intrauterine pregnancy
4786713|NCT02700776|screening mammogram|screening mammogram
4786714|NCT02700776|GP88|gp88
4786715|NCT02700776|breast cancer|breast cancer
4786716|NCT02700763|Brain metastasis|brain metastasis
4786717|NCT02700737|cardiovascular modeling|cardiovascular modeling
4786718|NCT02700737|aortic coarctation|aortic coarctation
4786719|NCT02700737|virtual stenting|virtual stenting
4786720|NCT02700698|Mitochondria|mitochondria
4786721|NCT02700698|women|women
4786722|NCT02700698|muscle|muscle
4786723|NCT02700698|PBMC|pbmc
4786726|NCT02700672|Executive Function|executive function
4786727|NCT02700672|Gait|gait
4786728|NCT02700620|emotional eating|emotional eating
4786729|NCT02700620|restrictive eating|restrictive eating
4786730|NCT02700620|body dissatisfaction|body dissatisfaction
4786731|NCT02700607|cerebral aneurysm, coiling embolization, blood viscosity|cerebral aneurysm, coiling embolization, blood viscosity
4786732|NCT02700555|colorectal cancer|colorectal cancer
4786733|NCT02700555|diabetes|diabetes
4786734|NCT02700555|metabolic parameters|metabolic parameters
4786735|NCT02700555|Surveillance|surveillance
4786736|NCT02700542|asthma|asthma
4786737|NCT02700542|pest management|pest management
4786738|NCT02700503|Diabetes prevention|diabetes prevention
4786739|NCT02700503|type 2 diabetes|type 2 diabetes
4786740|NCT02700503|prediabetes|prediabetes
4786741|NCT02700503|family|family
4786742|NCT02700477|Type-2 Diabetic|type-2 diabetic
4786743|NCT02700477|HbA1c|hba1c
4786744|NCT02700477|FBS|fbs
4786745|NCT02700477|PPBS|ppbs
4786746|NCT02700477|C-peptide|c-peptide
4786747|NCT02700451|IV acetaminophen|iv acetaminophen
4786748|NCT02700451|IV Ketorolac|iv ketorolac
4786749|NCT02700451|Post-operative analgesia|post-operative analgesia
4786750|NCT02700451|Opioid use|opioid use
4786751|NCT02700425|Wide QRS|wide qrs
4786752|NCT02700425|Ventricular Dyssynchrony|ventricular dyssynchrony
4786753|NCT02700399|Rehabilitation|rehabilitation
4786754|NCT02700386|Breast|breast
4786755|NCT02700386|Cancer|cancer
4786756|NCT02700386|Hypofractionated|hypofractionated
4786757|NCT02700386|Node-Positive Breast Cancer|node-positive breast cancer
4786758|NCT02700386|Radiation Therapy|radiation therapy
4786759|NCT02700386|Comprehensive Radiation Therapy|comprehensive radiation therapy
4786760|NCT02700360|EC-18|ec-18
4786761|NCT02700360|Hematology|hematology
4786762|NCT02700360|Cancer|cancer
4786763|NCT02700360|Neutropenia|neutropenia
4786764|NCT02700334|Prediabetes|prediabetes
4786765|NCT02700334|Impaired fasting glucose|impaired fasting glucose
4786766|NCT02700334|Hyperglycemia|hyperglycemia
4786767|NCT02700334|Impaired glucose tolerance|impaired glucose tolerance
4786768|NCT02700334|Glucose intolerance|glucose intolerance
4786769|NCT02700334|Dapagliflozin|dapagliflozin
4786770|NCT02700334|Sodium glucose cotransporter 2 inhibitor|sodium glucose cotransporter 2 inhibitor
4786771|NCT02700334|SGLT2|sglt2
4786772|NCT02700321|non severely hypoxemic respiratory failure|non severely hypoxemic respiratory failure
4786773|NCT02700321|preoxygenation|preoxygenation
4786774|NCT02700321|crash induction|crash induction
4786775|NCT02700308|Solid tumors|solid tumors
4786776|NCT02700308|Spine metastasis|spine metastasis
4786777|NCT02700308|Vertebroplasty|vertebroplasty
4786778|NCT02700308|kyphoplasty|kyphoplasty
4786779|NCT02700308|randomization|randomization
4786780|NCT02700295|Orthokeratology|orthokeratology
4786781|NCT02700282|Cystic fibrosis|cystic fibrosis
4786782|NCT02700282|Backpack carrying|backpack carrying
4786783|NCT02700282|Respiratory function|respiratory function
4786784|NCT02700282|Children|children
4786785|NCT02700256|surgery|surgery
4786786|NCT02700256|15-315|15-315
4786787|NCT02700243|Cystic Fibrosis|cystic fibrosis
4786788|NCT02700243|Exercise|exercise
4786789|NCT02700243|Fitbit|fitbit
4786790|NCT02700217|Donor Nephrectomy|donor nephrectomy
4786791|NCT02700139|Myopia control, aspheric lenses, children|myopia control, aspheric lenses, children
4786792|NCT02700126|propofol|propofol
4786793|NCT02700126|total intravenous anesthesia|total intravenous anesthesia
4786794|NCT02700126|cerebral aneurysm|cerebral aneurysm
4786795|NCT02700126|single nucleotide polymorphism|single nucleotide polymorphism
4786796|NCT02700087|Laryngomalacia|laryngomalacia
4786797|NCT02700061|Induced Constraint Therapy|induced constraint therapy
4786798|NCT02700061|Robotic Occupational Therapy|robotic occupational therapy
4786799|NCT02700061|Neuroplasticity|neuroplasticity
4786800|NCT02700048|type 1 diabetes|type 1 diabetes
4786801|NCT02700048|hypoglycemia|hypoglycemia
4786802|NCT02700048|hypoglycemia unawareness|hypoglycemia unawareness
4786803|NCT02700035|Intervention|intervention
4786804|NCT02700035|Prevention|prevention
4786805|NCT02700035|Randomized Controlled Trial|randomized controlled trial
4786806|NCT02700035|Bii-Zin-Da-De-Dah|bii-zin-da-de-dah
4786807|NCT02700022|Lineberger Comprehensive Cancer Center|lineberger comprehensive cancer center
4786808|NCT02700022|Alisertib|alisertib
4786809|NCT02699905|Sepsis|sepsis
4786810|NCT02699905|Septic Shock|septic shock
4786811|NCT02699905|Multiple Organ Dysfunction|multiple organ dysfunction
4786812|NCT02699905|FFA2|ffa2
4786813|NCT02699905|GPR43|gpr43
4786814|NCT02699866|Small diameter implant|small diameter implant
4786815|NCT02699840|Meningitis|meningitis
4786816|NCT02699840|Meningococcal Meningitis|meningococcal meningitis
4786817|NCT02699840|Meningococcal Infections|meningococcal infections
4786818|NCT02699840|Menactra®|menactra®
4786819|NCT02699840|Meningococcal Vaccine|meningococcal vaccine
4786820|NCT02699827|Levobupivacaine|levobupivacaine
4786821|NCT02699827|Magnesium|magnesium
4786822|NCT02699827|Preeclampsia|preeclampsia
4786823|NCT02699827|Epidural|epidural
4786824|NCT02699814|Depression|depression
4786825|NCT02699814|Children|children
4786826|NCT02699814|Anxiety|anxiety
4786827|NCT02699775|Botulinum toxin injections|botulinum toxin injections
4786828|NCT02699775|Stroke|stroke
4786829|NCT02699775|3D motion analysis|3d motion analysis
4786830|NCT02699775|Gait pattern|gait pattern
4786831|NCT02699762|self rehabilitation|self rehabilitation
4786832|NCT02699762|stroke|stroke
4786833|NCT02699762|botulinum toxin injection|botulinum toxin injection
4786834|NCT02699762|arm functions|arm functions
4786835|NCT02699749|Drug Therapy|drug therapy
4786836|NCT02699736|HIV|hiv
4786837|NCT02699736|HIV-1|hiv-1
4786838|NCT02699736|Hepatitis C|hepatitis c
4786839|NCT02699736|HCV|hcv
4786840|NCT02699736|prospective|prospective
4786841|NCT02699736|cohort|cohort
4786842|NCT02699736|coinfection|coinfection
4786843|NCT02699671|Bioresorbable Vascular Scaffold|bioresorbable vascular scaffold
4786844|NCT02699671|Routine Clinical Practice|routine clinical practice
4786845|NCT02699671|Angioplasty, Transluminal, Percutaneous Coronary|angioplasty, transluminal, percutaneous coronary
4786846|NCT02699671|Coronary Artery Disease|coronary artery disease
4786847|NCT02699671|drug eluting stent|drug eluting stent
4786848|NCT02699671|acute myocardial infarction|acute myocardial infarction
4786849|NCT02699658|levofloxacin|levofloxacin
4786850|NCT02699658|population pharmacokinetics|population pharmacokinetics
4786851|NCT02699658|pharmacodynamics|pharmacodynamics
4786852|NCT02699632|Survey|survey
4786853|NCT02699619|Undisplaced|undisplaced
4786854|NCT02699606|Tumor|tumor
4786855|NCT02699606|Fibroblast Growth Factor Receptor (FGFR)|fibroblast growth factor receptor (fgfr)
4786856|NCT02699606|Non-Small Cell Lung Cancer (NSCLC)|non-small cell lung cancer (nsclc)
4786857|NCT02699606|Erdafitinib|erdafitinib
4786858|NCT02699606|Urothelial Cancer|urothelial cancer
4786859|NCT02699606|Esophageal Cancer|esophageal cancer
4786860|NCT02699606|Cholangiocarcinoma|cholangiocarcinoma
4786861|NCT02699580|Biodegradable collagen implant|biodegradable collagen implant
4786862|NCT02699580|scleral thinning|scleral thinning
4786863|NCT02699580|strabismus surgery|strabismus surgery
4786864|NCT02699567|taste perception|taste perception
4786865|NCT02699567|individual differences|individual differences
4786866|NCT02699567|fat|fat
4786867|NCT02699567|genetics|genetics
4786868|NCT02699541|Diabetes Self-Management Education|diabetes self-management education
4786869|NCT02699541|Behavioural change theory|behavioural change theory
4786870|NCT02699541|IMB model|imb model
4786871|NCT02699541|Diabetes Type 2|diabetes type 2
4786872|NCT02699515|MSB0011359C|msb0011359c
4786873|NCT02699476|NFL|nfl
4786874|NCT02699476|veterans|veterans
4786875|NCT02699476|cognitive training|cognitive training
4786876|NCT02699476|TBI|tbi
4786877|NCT02699476|concussion|concussion
4786878|NCT02699437|Preeclampsia|preeclampsia
4786879|NCT02699437|Antiphospholipid Antibodies|antiphospholipid antibodies
4786880|NCT02699411|ligament anterior cruciate , dry needling, physioterapy, propioception, knee arthroplasty, vastus medialis.|ligament anterior cruciate , dry needling, physioterapy, propioception, knee arthroplasty, vastus medialis.
4786881|NCT02699385|Gastroenteritis|gastroenteritis
4786882|NCT02699385|Domperidone|domperidone
4786883|NCT02699385|Pediatric participants|pediatric participants
4786884|NCT02699372|Healthy Volunteers|healthy volunteers
4786885|NCT02699359|concussion|concussion
4786886|NCT02699359|mild traumatic brain injuries|mild traumatic brain injuries
4786887|NCT02699346|concussion|concussion
4786888|NCT02699346|mild traumatic brain injuries|mild traumatic brain injuries
4786889|NCT02699320|Short bowel syndrome|short bowel syndrome
4786890|NCT02699320|Intestinal microbiota|intestinal microbiota
4786891|NCT02699320|immune|immune
4786892|NCT02699307|physical activity|physical activity
4786893|NCT02699294|Pain Threshold|pain threshold
4786894|NCT02699294|Pectoralis Minor|pectoralis minor
4786895|NCT02699294|Proprioceptive Neuromuscular Facilitation (PNF) Stretching|proprioceptive neuromuscular facilitation (pnf) stretching
4786896|NCT02699294|Physiotherapy|physiotherapy
4786897|NCT02699294|Rehabilitation|rehabilitation
4786898|NCT02699242|Fiberoptic intubation Training Simulation Performance|fiberoptic intubation training simulation performance
4786899|NCT02699216|Macular Degeneration|macular degeneration
4786900|NCT02699216|Eye Diseases|eye diseases
4786901|NCT02699216|Retinal Degeneration|retinal degeneration
4786902|NCT02699216|Retinal Diseases|retinal diseases
4786903|NCT02699190|Leukodystrophy|leukodystrophy
4786904|NCT02699190|White Matter Disease|white matter disease
4786905|NCT02699190|Whole Genome Sequencing|whole genome sequencing
4786906|NCT02699190|WGS|wgs
4786907|NCT02699177|ciliary beat frequency,|ciliary beat frequency,
4786908|NCT02699164|non surgical spinal decompression therapy|non surgical spinal decompression therapy
4786909|NCT02699164|deep friction massage|deep friction massage
4786910|NCT02699164|exercise|exercise
4786911|NCT02699099|Children|children
4786912|NCT02699099|Infants|infants
4786913|NCT02699099|SB257049|sb257049
4786914|NCT02699099|Malaria|malaria
4786915|NCT02699099|Immunogenicity|immunogenicity
4786916|NCT02699099|Surveillance|surveillance
4786917|NCT02699099|Efficacy|efficacy
4786918|NCT02699099|Safety|safety
4786919|NCT02699099|Africa|africa
4786920|NCT02699099|Plasmodium falciparum|plasmodium falciparum
4786921|NCT02699073|colorectal cancer|colorectal cancer
4786922|NCT02699073|metastatic|metastatic
4786923|NCT02699073|regorafenib|regorafenib
4786924|NCT02699073|CHOI criteria|choi criteria
4786925|NCT02699073|RECIST criteria|recist criteria
4786926|NCT02699060|GERD|gerd
4786927|NCT02699060|Barrett`s esophagus|barrett`s esophagus
4786928|NCT02699060|macrophage|macrophage
4786929|NCT02699060|FSSG questionnaire|fssg questionnaire
4786930|NCT02699047|Gastrointestinal cancer|gastrointestinal cancer
4786931|NCT02699047|Fish oil|fish oil
4786932|NCT02699047|Oxidative stress|oxidative stress
4786933|NCT02699047|Inflammation|inflammation
4786934|NCT02699047|Quality of life|quality of life
4786935|NCT02699047|Nutritional status|nutritional status
4786936|NCT02699047|Colorectal cancer|colorectal cancer
4786937|NCT02699047|Stomach cancer|stomach cancer
4786938|NCT02699047|Chemotherapy|chemotherapy
4786939|NCT02699047|polyunsaturated fatty acids n-3|polyunsaturated fatty acids n-3
4786940|NCT02699034|real-time MRI|real-time mri
4786941|NCT02699034|electrophysiology study|electrophysiology study
4786942|NCT02699034|atrial flutter ablation|atrial flutter ablation
4786943|NCT02699034|active tracking|active tracking
4786944|NCT02699008|clopidogrel；antiplatelet therapy|clopidogrel；antiplatelet therapy
4786945|NCT02698982|elderly|elderly
4786946|NCT02698982|postoperative cognitive dysfunction|postoperative cognitive dysfunction
4786947|NCT02698982|postoperative delirium|postoperative delirium
4786948|NCT02698982|depth of anesthesia|depth of anesthesia
4786949|NCT02698982|intraoperative blood pressure monitoring|intraoperative blood pressure monitoring
4786950|NCT02698969|Sugammadex|sugammadex
4786951|NCT02698969|Post-operative residual curarization|post-operative residual curarization
4786952|NCT02698969|Diaphragm Ultrasonography|diaphragm ultrasonography
4786953|NCT02698956|SAPIEN 3 THV|sapien 3 thv
4786954|NCT02698956|TAVI|tavi
4786955|NCT02698956|Transfemoral|transfemoral
4786956|NCT02698956|Transaortic|transaortic
4786957|NCT02698956|Transapical|transapical
4786958|NCT02698956|Aortic valve|aortic valve
4786959|NCT02698943|cataract; intraocular lens; posterior capsule opacification; glistening; ENVISTA|cataract; intraocular lens; posterior capsule opacification; glistening; envista
4786960|NCT02698930|Infective endocarditis|infective endocarditis
4786961|NCT02698930|acute kidney injury|acute kidney injury
4786962|NCT02698930|dexmedetomidine|dexmedetomidine
4786963|NCT02698917|Out-of-Hospital Cardiac Arrest|out-of-hospital cardiac arrest
4786964|NCT02698917|Resuscitation|resuscitation
4786965|NCT02698917|Hypoxia-Ischemia, Brain|hypoxia-ischemia, brain
4786966|NCT02698904|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
4786967|NCT02698904|Relaxation Technique|relaxation technique
4786968|NCT02698904|Anxiety|anxiety
4786969|NCT02698891|Early Stage Breast Cancer|early stage breast cancer
4786970|NCT02698878|Lupin Protein|lupin protein
4786971|NCT02698878|Glucose Metabolism|glucose metabolism
4786972|NCT02698878|GLUT4|glut4
4786973|NCT02698878|Muscle Unloading|muscle unloading
4786974|NCT02698878|Neuromuscular Electrical Stimulation|neuromuscular electrical stimulation
4786975|NCT02698852|Drug eluting stents|drug eluting stents
4786976|NCT02698852|Interventional Cardiology|interventional cardiology
4786977|NCT02698839|Drug eluting stents|drug eluting stents
4786978|NCT02698839|Interventional Cardiology|interventional cardiology
4786979|NCT02698826|Cardiac Arrest, Hyperoxia, Ischemia-reperfusion Injury, Reactive Oxygen Species, Oxidative Stress, Neuropsychological Tests|cardiac arrest, hyperoxia, ischemia-reperfusion injury, reactive oxygen species, oxidative stress, neuropsychological tests
4786980|NCT02698761|Vaso-Occlusive Crises|vaso-occlusive crises
4786981|NCT02698761|Sickle Cell Disease|sickle cell disease
4786982|NCT02698761|Decreasing Length of Stay|decreasing length of stay
4786983|NCT02698761|Comprehensive Care Plan|comprehensive care plan
4786984|NCT02698748|Chloroquine|chloroquine
4786985|NCT02698748|Malaria Elimination|malaria elimination
4786986|NCT02698748|P.falciparum|p.falciparum
4786987|NCT02698748|Clinical Trial|clinical trial
4786988|NCT02698748|Mozambique|mozambique
4786989|NCT02698748|Adults|adults
4786990|NCT02698709|Keratoconus|keratoconus
4786991|NCT02698709|Corneal Topography|corneal topography
4786992|NCT02698709|Diagnosis|diagnosis
4786993|NCT02698709|Keratomileusis, Laser In Situ|keratomileusis, laser in situ
4786994|NCT02698696|Cognitive Remediation|cognitive remediation
4786995|NCT02698696|Mood disorders|mood disorders
4786996|NCT02698696|Neuropsychology|neuropsychology
4786997|NCT02698683|Nutrition|nutrition
4786998|NCT02698683|Lymphocyte Count|lymphocyte count
4786999|NCT02698683|Immunoparalysis|immunoparalysis
4787000|NCT02698683|nutritional status of septic patients|nutritional status of septic patients
4787001|NCT02698670|Cardiac Arrhythmias|cardiac arrhythmias
4787002|NCT02698670|Cardiovascular Disease|cardiovascular disease
4787003|NCT02698670|Radiofrequency Ablation|radiofrequency ablation
4787004|NCT02698670|Cardiac Mapping|cardiac mapping
4787005|NCT02698657|Rheumatoid arthritis (RA)|rheumatoid arthritis (ra)
4787006|NCT02698657|Methotrexate|methotrexate
4787007|NCT02698657|ASP5094|asp5094
4787008|NCT02698631|Catheter Ablation|catheter ablation
4787009|NCT02698631|Radiofrequency|radiofrequency
4787010|NCT02698631|Fibrosis|fibrosis
4787011|NCT02698631|Late-gadolinium enhanced MRI|late-gadolinium enhanced mri
4787012|NCT02698618|Diabetes|diabetes
4787013|NCT02698618|IMR|imr
4787014|NCT02698618|Microcirculation|microcirculation
4787015|NCT02698618|Ticagrelor|ticagrelor
4787016|NCT02698618|CFR|cfr
4787017|NCT02698618|FFR|ffr
4787018|NCT02698618|Coronary microcirculation|coronary microcirculation
4787019|NCT02698592|atrial flutter|atrial flutter
4787020|NCT02698592|ablation|ablation
4787021|NCT02698592|Thermocool SF catheter|thermocool sf catheter
4787022|NCT02698579|Adrenoleukodystrophy|adrenoleukodystrophy
4787023|NCT02698579|X-linked Adrenoleukodystrophy|x-linked adrenoleukodystrophy
4787024|NCT02698579|Hematopoietic Stem Cells|hematopoietic stem cells
4787025|NCT02698553|Major depressive disorder|major depressive disorder
4787026|NCT02698553|Extended release Bupropion|extended release bupropion
4787027|NCT02698527|lidocaine|lidocaine
4787028|NCT02698501|Asthma|asthma
4787029|NCT02698501|Airway hyperresponsiveness|airway hyperresponsiveness
4787030|NCT02698501|TSLP|tslp
4787031|NCT02698501|Mast cell|mast cell
4787032|NCT02698501|Eosinophil|eosinophil
4787033|NCT02698475|Psoriasis|psoriasis
4787034|NCT02698475|Ustekinumab|ustekinumab
4787035|NCT02698475|STELARA|stelara
4787036|NCT02698462|Advanced neoplasia|advanced neoplasia
4787037|NCT02698462|Colorectal cancer|colorectal cancer
4787038|NCT02698462|Population screening|population screening
4787039|NCT02698462|Family history|family history
4787040|NCT02698436|Acne|acne
4787041|NCT02698371|composite resins|composite resins
4787042|NCT02698371|dental restoration|dental restoration
4787043|NCT02698371|adhesives|adhesives
4787044|NCT02698371|non-carious cervical lesions|non-carious cervical lesions
4787045|NCT02698371|clinical effectiveness|clinical effectiveness
4787046|NCT02698371|Adhese universal|adhese universal
4787047|NCT02698371|Futurabond U|futurabond u
4787048|NCT02698371|Futurabond DC|futurabond dc
4787049|NCT02698371|self-etch|self-etch
4787050|NCT02698371|multimode/universal|multimode/universal
4787051|NCT02698371|clinical trial|clinical trial
4787052|NCT02698358|Peripheral artery disease, Iliac artery, nitinol stent, restenosis|peripheral artery disease, iliac artery, nitinol stent, restenosis
4787053|NCT02698345|Popliteal artery disease, drug-eluting balloon, angioplasty|popliteal artery disease, drug-eluting balloon, angioplasty
4787054|NCT02698319|Triage|triage
4787055|NCT02698319|Systematic Triage|systematic triage
4787056|NCT02698280|Bevacizumab|bevacizumab
4787057|NCT02698280|Nimustine|nimustine
4787058|NCT02698280|Pathology, Molecular|pathology, molecular
4787059|NCT02698254|Brain cancer|brain cancer
4787060|NCT02698254|Recurrent brain tumor|recurrent brain tumor
4787061|NCT02698254|Prior radiation treatment to brain|prior radiation treatment to brain
4787062|NCT02698254|Radiation therapy|radiation therapy
4787063|NCT02698254|XRT|xrt
4787064|NCT02698254|Questionnaires|questionnaires
4787065|NCT02698254|Surveys|surveys
4787066|NCT02698241|Cardiac Resynchronization Therapy Defibrillator (CRT-D)|cardiac resynchronization therapy defibrillator (crt-d)
4787067|NCT02698241|heart failure|heart failure
4787068|NCT02698241|integrated diagnostics|integrated diagnostics
4787069|NCT02698241|chronic medication management|chronic medication management
4787070|NCT02698228|anesthesia|anesthesia
4787071|NCT02698202|Tomosynthesis,sensitivity,specificity,screening,mammography|tomosynthesis,sensitivity,specificity,screening,mammography
4787072|NCT02698176|OTX015|otx015
4787073|NCT02698176|MK-8628|mk-8628
4787074|NCT02698163|Root Canal Therapy|root canal therapy
4787075|NCT02698150|Mitral regurgitation|mitral regurgitation
4787076|NCT02698150|Mitraclip|mitraclip
4787077|NCT02698150|Remote monitoring|remote monitoring
4787078|NCT02698150|Wearables|wearables
4787079|NCT02698111|nasopharyngeal carcinoma,donafeinib|nasopharyngeal carcinoma,donafeinib
4787080|NCT02698098|Malaysia|malaysia
4787081|NCT02698098|Asia|asia
4787082|NCT02698098|Southeast Asia|southeast asia
4787083|NCT02698098|Compulsory Drug Detention Centers|compulsory drug detention centers
4787084|NCT02698098|Compulsory Centers for Drug Users|compulsory centers for drug users
4787085|NCT02698098|Methadone|methadone
4787086|NCT02698098|Drug Relapse|drug relapse
4787087|NCT02698098|Drug and Narcotic Control|drug and narcotic control
4787088|NCT02698098|Opiate Substitution Treatment|opiate substitution treatment
4787089|NCT02698098|Prisons|prisons
4787090|NCT02698085|carpal tunnel syndrome|carpal tunnel syndrome
4787091|NCT02698085|physiotherapy|physiotherapy
4787092|NCT02698085|manual therapy|manual therapy
4787093|NCT02698072|Stiffness|stiffness
4787094|NCT02698072|Pain|pain
4787095|NCT02698072|Disfunction|disfunction
4787096|NCT02698046|Heart failure|heart failure
4787097|NCT02698046|Iron|iron
4787098|NCT02698046|Anemia|anemia
4787099|NCT02698046|Chronic disease|chronic disease
4787100|NCT02698033|food allergy|food allergy
4787101|NCT02698033|peanut|peanut
4787102|NCT02698033|food challenge|food challenge
4787103|NCT02698020|Newborn|newborn
4787104|NCT02698020|Anesthesia|anesthesia
4787105|NCT02698020|Oxygen|oxygen
4787106|NCT02698020|Hyperoxia|hyperoxia
4787107|NCT02697994|Sterile Water Injection|sterile water injection
4787108|NCT02697994|Midwifery|midwifery
4787109|NCT02697981|sleeve gastrectomy|sleeve gastrectomy
4787110|NCT02697929|Rocuronium|rocuronium
4787111|NCT02697916|aspirin|aspirin
4787112|NCT02697916|ACSD|acsd
4787113|NCT02697916|PCORI|pcori
4787114|NCT02697903|Creatine kinase supplementation|creatine kinase supplementation
4787115|NCT02697903|C-reactive protein|c-reactive protein
4787116|NCT02697903|resistance training|resistance training
4787117|NCT02697903|Pomegranate supplementation|pomegranate supplementation
4787118|NCT02697903|pomegranate juice|pomegranate juice
4787119|NCT02697903|muscle damage response|muscle damage response
4787120|NCT02697786|Aortic valve surgery|aortic valve surgery
4787121|NCT02697773|osteoarthritis of the knee|osteoarthritis of the knee
4787122|NCT02697773|osteoarthritis of the hip|osteoarthritis of the hip
4787123|NCT02697773|nerve growth factor inhibitor|nerve growth factor inhibitor
4787124|NCT02697773|tanezumab|tanezumab
4787125|NCT02697760|cadmium-zinc-telluride，CZT cameras|cadmium-zinc-telluride，czt cameras
4787126|NCT02697760|myocardial blood flow，MBF|myocardial blood flow，mbf
4787127|NCT02697760|myocardial flow reserve，MFR|myocardial flow reserve，mfr
4787128|NCT02697747|Ultrasound|ultrasound
4787129|NCT02697747|Palpation|palpation
4787130|NCT02697747|Analgesia|analgesia
4787131|NCT02697747|Epidural|epidural
4787132|NCT02697734|Cushing's disease|cushing's disease
4787133|NCT02697734|LCI699|lci699
4787134|NCT02697734|osilodrostat|osilodrostat
4787135|NCT02697734|Pituitary Gland|pituitary gland
4787136|NCT02697734|Adrenocorticotropic|adrenocorticotropic
4787137|NCT02697734|Hormone|hormone
4787138|NCT02697734|ACTH|acth
4787139|NCT02697734|UFC|ufc
4787140|NCT02697721|Caregivers|caregivers
4787141|NCT02697721|Behavioral symptoms|behavioral symptoms
4787142|NCT02697721|Dementia|dementia
4787143|NCT02697721|Alzheimer disease|alzheimer disease
4787144|NCT02697721|Physical activity|physical activity
4787145|NCT02697721|Depressive symptoms|depressive symptoms
4787146|NCT02697721|Powerful Tools for Caregivers|powerful tools for caregivers
4787147|NCT02697721|Chronic Disease Self-Management Program|chronic disease self-management program
4787148|NCT02697695|chronic inflammation|chronic inflammation
4787149|NCT02697695|fatty liver index|fatty liver index
4787150|NCT02697669|Heart failure|heart failure
4787151|NCT02697669|myocardial perfusion|myocardial perfusion
4787152|NCT02697669|single-photon emission tomography|single-photon emission tomography
4787153|NCT02697643|clinical decision support|clinical decision support
4787154|NCT02697643|substance use|substance use
4787155|NCT02697643|opioid|opioid
4787156|NCT02697630|Uveal melanoma|uveal melanoma
4787157|NCT02697591|Solid tumor|solid tumor
4787158|NCT02697591|adenocarcinoma of the endometrium|adenocarcinoma of the endometrium
4787159|NCT02697591|melanoma, non-small cell lung cancer (NSCLC)|melanoma, non-small cell lung cancer (nsclc)
4787160|NCT02697591|renal cell carcinoma (RCC)|renal cell carcinoma (rcc)
4787161|NCT02697591|glucocorticoid-induced tumor necrosis factor receptor (GITR)|glucocorticoid-induced tumor necrosis factor receptor (gitr)
4787162|NCT02697565|childhood obesity|childhood obesity
4787163|NCT02697565|obesity|obesity
4787164|NCT02697565|prevention|prevention
4787165|NCT02697565|nutrition|nutrition
4787166|NCT02697565|health|health
4787167|NCT02697565|preschool|preschool
4787168|NCT02697565|childcare|childcare
4787169|NCT02697565|role model|role model
4787170|NCT02697565|pediatric obesity|pediatric obesity
4787171|NCT02697565|weight|weight
4787172|NCT02697565|overweight|overweight
4787173|NCT02697565|early childhood|early childhood
4787174|NCT02697565|train the trainer|train the trainer
4787175|NCT02697526|radial artery|radial artery
4787176|NCT02697526|occlusion|occlusion
4787177|NCT02697526|functional|functional
4787178|NCT02697526|complications|complications
4787179|NCT02697526|consequences|consequences
4787180|NCT02697487|Depression|depression
4787181|NCT02697487|Cohort|cohort
4787182|NCT02697474|Hepatitis B|hepatitis b
4787183|NCT02697474|DTaP-IPV-Hep B-PRP-T Hexavalent Vaccine|dtap-ipv-hep b-prp-t hexavalent vaccine
4787184|NCT02697474|Euvax-B®|euvax-b®
4787185|NCT02697474|Hexaxim®|hexaxim®
4787186|NCT02697474|Infanrix® hexa|infanrix® hexa
4787187|NCT02697435|Chronic Low Back Pain|chronic low back pain
4787188|NCT02697435|Aged|aged
4787189|NCT02697435|Elderly|elderly
4787190|NCT02697435|Primary Care|primary care
4787191|NCT02697435|Assessment|assessment
4787192|NCT02697435|Lumbar|lumbar
4787193|NCT02697435|Spinal Stenosis|spinal stenosis
4787194|NCT02697435|Hip Osteoarthritis|hip osteoarthritis
4787195|NCT02697435|Myofascial Pain Syndrome|myofascial pain syndrome
4787196|NCT02697435|Fibromyalgia|fibromyalgia
4787197|NCT02697435|Depression|depression
4787198|NCT02697435|Maladaptive Coping|maladaptive coping
4787199|NCT02697435|Lumbar Spinal Stenosis|lumbar spinal stenosis
4787200|NCT02697435|Insomnia|insomnia
4787201|NCT02697435|Sacroiliac Joint Pain|sacroiliac joint pain
4787202|NCT02697435|Lateral Hip and Thigh Pain|lateral hip and thigh pain
4787203|NCT02697435|Anxiety|anxiety
4787204|NCT02697435|Dementia|dementia
4787205|NCT02697435|Recent Leg Length Discrepancy|recent leg length discrepancy
4787206|NCT02697422|Smoking (tobacco use)|smoking (tobacco use)
4787207|NCT02697422|Peer health coach|peer health coach
4787208|NCT02697422|Systolic blood pressure|systolic blood pressure
4787209|NCT02697422|Framingham Cardiovascular risk score|framingham cardiovascular risk score
4787210|NCT02697422|Lipid|lipid
4787211|NCT02697422|Health related quality of life|health related quality of life
4787212|NCT02697422|Health care utilization|health care utilization
4787213|NCT02697422|Medication adherence|medication adherence
4787214|NCT02697422|Physical activity|physical activity
4787215|NCT02697422|Nutrition|nutrition
4787216|NCT02697422|Alcohol use|alcohol use
4787217|NCT02697422|Stress management|stress management
4787218|NCT02697396|Social Marketing Campaign|social marketing campaign
4787219|NCT02697396|Mexican American Children|mexican american children
4787220|NCT02697396|16-069|16-069
4787221|NCT02697383|Ixazomib (MLN9708)|ixazomib (mln9708)
4787222|NCT02697383|Dexamethasone|dexamethasone
4787223|NCT02697383|15-294|15-294
4787224|NCT02697370|Haemophilia A prophylaxis pharmacokinetic dosing|haemophilia a prophylaxis pharmacokinetic dosing
4787225|NCT02697357|Emotion Regulation Therapy|emotion regulation therapy
4787226|NCT02697357|Distress Among Caregivers|distress among caregivers
4787227|NCT02697357|15-219|15-219
4787228|NCT02697331|Short cervix, twins, progesterone|short cervix, twins, progesterone
4787229|NCT02697305|Insulin response|insulin response
4787230|NCT02697305|Incretin effect|incretin effect
4787231|NCT02697305|GLP-1|glp-1
4787232|NCT02697305|GIP|gip
4787233|NCT02697305|Valine|valine
4787234|NCT02697305|Leucine|leucine
4787235|NCT02697305|Isoleucine|isoleucine
4787236|NCT02697305|Branched chain amino acids|branched chain amino acids
4787237|NCT02697292|Intravenous Immunoglobulin|intravenous immunoglobulin
4787238|NCT02697292|VGKC|vgkc
4787239|NCT02697292|Autoimmune epilepsy|autoimmune epilepsy
4787240|NCT02697292|Gamumex-C|gamumex-c
4787241|NCT02697279|Abscess|abscess
4787242|NCT02697279|Loop|loop
4787243|NCT02697279|Drainage|drainage
4787244|NCT02697253|Roux-en-Y Bariatric Surgery|roux-en-y bariatric surgery
4787245|NCT02697253|Psychosocial Variables|psychosocial variables
4787246|NCT02697253|Behavioral Variables|behavioral variables
4787247|NCT02697253|Weight Loss|weight loss
4787248|NCT02697253|Food Intake|food intake
4787249|NCT02697253|GLP-1|glp-1
4787250|NCT02697253|Reinforcing Value of Food|reinforcing value of food
4787251|NCT02697253|Exendin 9-39|exendin 9-39
4787252|NCT02697240|sickle cell disease|sickle cell disease
4787253|NCT02697240|citrulline|citrulline
4787254|NCT02697227|Smoking cessation|smoking cessation
4787255|NCT02697227|Smoking behavior|smoking behavior
4787256|NCT02697227|Behavioral Activation Treatment|behavioral activation treatment
4787257|NCT02697227|BATS|bats
4787258|NCT02697227|Standard Smoking Cessation Counseling|standard smoking cessation counseling
4787259|NCT02697227|SC|sc
4787260|NCT02697227|Nicotine Replacement Therapy|nicotine replacement therapy
4787261|NCT02697227|NRT|nrt
4787262|NCT02697227|Nicotine patch|nicotine patch
4787263|NCT02697227|Questionnaires|questionnaires
4787264|NCT02697227|Surveys|surveys
4787265|NCT02697227|CO Level|co level
4787266|NCT02697227|Cotinine Level|cotinine level
4787267|NCT02697227|Saliva test|saliva test
4787268|NCT02697214|commercial heart rate monitors|commercial heart rate monitors
4787269|NCT02697214|accuracy|accuracy
4787270|NCT02697214|EKG|ekg
4787271|NCT02697214|varying degrees of exertion|varying degrees of exertion
4787272|NCT02697201|Mitochondrial Dynamics|mitochondrial dynamics
4787273|NCT02697201|Insulin Resistance|insulin resistance
4787274|NCT02697188|testosterone|testosterone
4787275|NCT02697188|male hypogonadism|male hypogonadism
4787276|NCT02697188|low testosterone|low testosterone
4787277|NCT02697175|live video-colposcopy|live video-colposcopy
4787278|NCT02697175|cervical dysplasia|cervical dysplasia
4787279|NCT02697175|anxiety|anxiety
4787280|NCT02697175|randomized controlled trial|randomized controlled trial
4787281|NCT02697175|colposcopy|colposcopy
4787282|NCT02697162|Intermittent catheterisation|intermittent catheterisation
4787283|NCT02697162|Antiseptic|antiseptic
4787284|NCT02697162|Octenidine chloride|octenidine chloride
4787285|NCT02697162|Children|children
4787286|NCT02697149|ERCP|ercp
4787287|NCT02697149|nonradiation-to-endoscopist|nonradiation-to-endoscopist
4787288|NCT02697149|gallstones|gallstones
4787289|NCT02697136|Low HDL|low hdl
4787290|NCT02697136|Low apoA-I|low apoa-i
4787291|NCT02697136|ABCA-1 mutations|abca-1 mutations
4787292|NCT02697136|ApoA-I mutations|apoa-i mutations
4787293|NCT02697123|Venous Thrombosis|venous thrombosis
4787294|NCT02697123|Pregnancy|pregnancy
4787295|NCT02697123|postpartum|postpartum
4787296|NCT02697123|antepartum|antepartum
4787297|NCT02697110|Cognition|cognition
4787298|NCT02697110|Brain Stimulation|brain stimulation
4787299|NCT02697110|Early Child Development|early child development
4787300|NCT02697097|Hip Muscle Strength|hip muscle strength
4787301|NCT02697097|FAI|fai
4787302|NCT02697071|Ketamine|ketamine
4787303|NCT02697071|Migraine|migraine
4787304|NCT02697071|Headache|headache
4787305|NCT02697071|Emergency Department|emergency department
4787306|NCT02697045|Schizophrenia|schizophrenia
4787307|NCT02697045|Quality of Life|quality of life
4787308|NCT02697045|Functionality|functionality
4787309|NCT02697045|Long Acting Injectable|long acting injectable
4787310|NCT02697045|Aripiprazole|aripiprazole
4787311|NCT02697045|Naturalistic|naturalistic
4787312|NCT02697045|Open-label|open-label
4787313|NCT02697045|Single Arm|single arm
4787314|NCT02697045|Uncontrolled Study|uncontrolled study
4787315|NCT02697032|FDHT|fdht
4787316|NCT02697032|PET|pet
4787317|NCT02697032|Breast cancer|breast cancer
4787318|NCT02697032|Bicalutamide|bicalutamide
4787319|NCT02697019|Nonsuicidal Self-Injury (NSSI), Deliberate Self-Harm (DSH), Self-harm, Self-injury|nonsuicidal self-injury (nssi), deliberate self-harm (dsh), self-harm, self-injury
4787320|NCT02696993|Metastatic Brain Cancer|metastatic brain cancer
4787321|NCT02696993|Non-small cell lung cancer with brain metastasis|non-small cell lung cancer with brain metastasis
4787322|NCT02696993|NSCLC|nsclc
4787323|NCT02696993|Intracranial disease|intracranial disease
4787324|NCT02696993|Stereotactic radiosurgery|stereotactic radiosurgery
4787325|NCT02696993|SRS|srs
4787326|NCT02696993|Whole brain radiation therapy|whole brain radiation therapy
4787327|NCT02696993|WBRT|wbrt
4787328|NCT02696993|Neurocognitive exam|neurocognitive exam
4787329|NCT02696993|Nivolumab|nivolumab
4787330|NCT02696993|BMS-936558|bms-936558
4787331|NCT02696993|Opdivo|opdivo
4787332|NCT02696993|Ipilimumab|ipilimumab
4787333|NCT02696993|Yervoy|yervoy
4787334|NCT02696993|BMS-734016|bms-734016
4787335|NCT02696993|MDX010|mdx010
4787336|NCT02696980|obesity|obesity
4787337|NCT02696980|asthma|asthma
4787338|NCT02696967|Heart Failure|heart failure
4787339|NCT02696954|Artemether-lumefantrine|artemether-lumefantrine
4787340|NCT02696954|Amodiaquine|amodiaquine
4787341|NCT02696954|Primaquine|primaquine
4787342|NCT02696902|Pseudomonas aeruginosa, Pneumonia|pseudomonas aeruginosa, pneumonia
4787343|NCT02696889|Infertility|infertility
4787344|NCT02696889|Premature Ovarian Failure|premature ovarian failure
4787345|NCT02696889|Stem Cells|stem cells
4787346|NCT02696889|Amenorrhea|amenorrhea
4787347|NCT02696876|Cartilage|cartilage
4787348|NCT02696876|Mesenchymal stromal cell|mesenchymal stromal cell
4787349|NCT02696876|Microfracture|microfracture
4787350|NCT02696876|Knee|knee
4787351|NCT02696876|Defect|defect
4787352|NCT02696876|Injury|injury
4787353|NCT02696876|Stem cell|stem cell
4787354|NCT02696876|Autologous|autologous
4787355|NCT02696876|Minimally manipulated|minimally manipulated
4787356|NCT02696850|sinusitis|sinusitis
4787357|NCT02696850|rhinosinusitis|rhinosinusitis
4787358|NCT02696850|rhinitis|rhinitis
4787359|NCT02696850|nasal lavage|nasal lavage
4787360|NCT02696811|cancer|cancer
4787361|NCT02696811|inflammation|inflammation
4787362|NCT02696811|dietary intervention trial|dietary intervention trial
4787363|NCT02696798|Ankylosing Spondylitis|ankylosing spondylitis
4787364|NCT02696785|Ankylosing Spondylitis|ankylosing spondylitis
4787365|NCT02696759|Breast|breast
4787366|NCT02696759|Cancer|cancer
4787367|NCT02696733|TURBT|turbt
4787368|NCT02696733|ultrasound guided|ultrasound guided
4787370|NCT02696733|interadductor approach|interadductor approach
4787371|NCT02696720|lidocaine|lidocaine
4787372|NCT02696720|phantom limb pain (PLP)|phantom limb pain (plp)
4787373|NCT02696720|Primary/secondary scar hyperalgesia|primary/secondary scar hyperalgesia
4787374|NCT02696707|cardiac toxicities|cardiac toxicities
4787375|NCT02696668|multisensory exercises|multisensory exercises
4787376|NCT02696668|group-based balance exercise programme|group-based balance exercise programme
4787377|NCT02696655|transplantation|transplantation
4787378|NCT02696642|mesothelin-expressing advanced solid cancers|mesothelin-expressing advanced solid cancers
4787379|NCT02696629|Ventilatory control|ventilatory control
4787380|NCT02696629|Obstructive sleep apnea|obstructive sleep apnea
4787381|NCT02696629|Loop gain|loop gain
4787382|NCT02696629|Upper airway|upper airway
4787383|NCT02696629|Surgery|surgery
4787384|NCT02696603|Health app research|health app research
4787385|NCT02696603|mHealth research|mhealth research
4787386|NCT02696603|Mobile health research|mobile health research
4787387|NCT02696603|Mobile application health research|mobile application health research
4787388|NCT02696564|COPD|copd
4787389|NCT02696564|emphysema|emphysema
4787390|NCT02696564|HRCT|hrct
4787391|NCT02696564|losartan|losartan
4787392|NCT02696551|Medical education|medical education
4787393|NCT02696551|Spondyloarthritis|spondyloarthritis
4787394|NCT02696551|Physician action|physician action
4787395|NCT02696538|Fall risk|fall risk
4787396|NCT02696538|Rehabiliation|rehabiliation
4787397|NCT02696538|Physical Therapy|physical therapy
4787398|NCT02696538|Functional Gait Assessment|functional gait assessment
4787399|NCT02696538|mini-Balance Evaluation Systems Test|mini-balance evaluation systems test
4787400|NCT02696538|Berg Balance Scale|berg balance scale
4787401|NCT02696538|Psychometric properties|psychometric properties
4787402|NCT02696538|Validity|validity
4787403|NCT02696538|Inter-rater reliability|inter-rater reliability
4787404|NCT02696538|Montreal Cognitive Assessment|montreal cognitive assessment
4787405|NCT02696525|Circulating Tumor DNA|circulating tumor dna
4787406|NCT02696525|Lung cancer|lung cancer
4787407|NCT02696525|lead time|lead time
4787408|NCT02696512|Severe Disorders of Consciousness (SDOC)|severe disorders of consciousness (sdoc)
4787409|NCT02696512|Coma|coma
4787410|NCT02696512|Vegetative State|vegetative state
4787411|NCT02696512|Minimally Conscious State|minimally conscious state
4787412|NCT02696499|Uremic pruritus|uremic pruritus
4787413|NCT02696499|Pruritus|pruritus
4787414|NCT02696499|Chronic itch|chronic itch
4787415|NCT02696499|Itch|itch
4787416|NCT02696499|Hemodialysis|hemodialysis
4787417|NCT02696499|End-stage renal disease|end-stage renal disease
4787418|NCT02696473|Bioavailability|bioavailability
4787909|NCT02693717|NSC-698037|nsc-698037
4787419|NCT02696473|Polyacetylenes|polyacetylenes
4787420|NCT02696473|Falcarinol|falcarinol
4787421|NCT02696473|Falcarindiol|falcarindiol
4787422|NCT02696473|Falcarindiol-3-acetate|falcarindiol-3-acetate
4787423|NCT02696473|Carrot|carrot
4787424|NCT02696473|Biological Availability|biological availability
4787425|NCT02696460|debridement|debridement
4787426|NCT02696460|analgesia|analgesia
4787427|NCT02696447|Radiation therapy|radiation therapy
4787428|NCT02696447|Thrombosis|thrombosis
4787429|NCT02696434|naltrexone|naltrexone
4787430|NCT02696434|VIVITROL|vivitrol
4787431|NCT02696434|buprenorphine|buprenorphine
4787432|NCT02696434|opioid|opioid
4787433|NCT02696434|addiction|addiction
4787434|NCT02696408|Mucositis|mucositis
4787435|NCT02696408|Low level laser therapy|low level laser therapy
4787436|NCT02696408|Autograft|autograft
4787437|NCT02696408|Allograft|allograft
4787438|NCT02696382|Veterans|veterans
4787439|NCT02696382|Progressive High Intensity Physical Therapy|progressive high intensity physical therapy
4787440|NCT02696382|Gait Speed|gait speed
4787441|NCT02696382|Acute Hospitalization|acute hospitalization
4787442|NCT02696382|Hospital Associated Deconditioning|hospital associated deconditioning
4787443|NCT02696356|HLA-A*02|hla-a*02
4787444|NCT02696343|somatosensory stimulation|somatosensory stimulation
4787445|NCT02696343|orocutaneous|orocutaneous
4787446|NCT02696343|gene expression|gene expression
4787447|NCT02696291|Dengue|dengue
4787448|NCT02696291|Arbovirus Infections|arbovirus infections
4787449|NCT02696291|Flaviviridae Infections|flaviviridae infections
4787450|NCT02696291|Flavivirus Infections|flavivirus infections
4787451|NCT02696291|Hemorrhagic Fevers, Viral|hemorrhagic fevers, viral
4787452|NCT02696291|RNA Virus Infections|rna virus infections
4787453|NCT02696291|Virus Diseases|virus diseases
4787454|NCT02696291|Pharmaceutical Solutions|pharmaceutical solutions
4787455|NCT02696291|Pharmacologic Actions|pharmacologic actions
4787456|NCT02696291|Therapeutic Uses|therapeutic uses
4787457|NCT02696278|gut microbiota|gut microbiota
4787458|NCT02696278|obesity|obesity
4787459|NCT02696278|toddlers|toddlers
4787460|NCT02696278|fiber|fiber
4787461|NCT02696278|unsaturated fats|unsaturated fats
4787462|NCT02696265|Atrial Fibrillation|atrial fibrillation
4787463|NCT02696265|Complex Fractionated Atrial Electrocardiograms|complex fractionated atrial electrocardiograms
4787464|NCT02696265|Pulmonary Vein Isolation|pulmonary vein isolation
4787465|NCT02696265|Ablation|ablation
4787466|NCT02696265|CFAE/spatiotemporal dispersion guided ablation|cfae/spatiotemporal dispersion guided ablation
4787467|NCT02696252|Endocrine System Diseases|endocrine system diseases
4787468|NCT02696252|Glucose Metabolism Disorders|glucose metabolism disorders
4787469|NCT02696252|Metabolic Diseases|metabolic diseases
4787470|NCT02696239|vaginal cuff closure|vaginal cuff closure
4787471|NCT02696239|Robotic Hysterectomy|robotic hysterectomy
4787472|NCT02696200|Concussion|concussion
4787473|NCT02696187|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
4787474|NCT02696187|Feasibility|feasibility
4787475|NCT02696187|Health promotion tool|health promotion tool
4787476|NCT02696187|Self management|self management
4787477|NCT02696187|Evidence based care|evidence based care
4787478|NCT02696187|Knowledge transfer|knowledge transfer
4787479|NCT02696187|Implementation|implementation
4787480|NCT02696161|platelet rich plasma|platelet rich plasma
4787481|NCT02696161|Perineural injection therapy|perineural injection therapy
4787482|NCT02696135|hypertrophic cardiomyopathy|hypertrophic cardiomyopathy
4787483|NCT02696135|clinical outcomes|clinical outcomes
4787484|NCT02696135|multi-omics|multi-omics
4787485|NCT02696135|risk stratification|risk stratification
4787486|NCT02696122|Pain, postoperative|pain, postoperative
4787487|NCT02696122|Hernia, abdominal|hernia, abdominal
4787488|NCT02696122|Anesthesia, spinal|anesthesia, spinal
4787489|NCT02696122|Anesthesia, local|anesthesia, local
4787490|NCT02696122|Anesthesia, general|anesthesia, general
4787491|NCT02696122|Quality of life|quality of life
4787492|NCT02696122|Anesthesia recovery period|anesthesia recovery period
4787493|NCT02696122|Personal satisfaction|personal satisfaction
4787494|NCT02696122|Postoperative complications|postoperative complications
4787495|NCT02696122|Quality of recovery|quality of recovery
4787496|NCT02696109|Transition age youth|transition age youth
4787497|NCT02696109|Mental health|mental health
4787498|NCT02696109|Mental health services|mental health services
4787499|NCT02696109|Engagement|engagement
4787500|NCT02696070|Pain|pain
4787501|NCT02696070|Diabetic Neuropathy|diabetic neuropathy
4787502|NCT02696070|Pulsed Electromagnetic Energy Field|pulsed electromagnetic energy field
4787503|NCT02696070|PEMF|pemf
4787504|NCT02696070|PPDN|ppdn
4787505|NCT02696044|Gastrointestinal Disorders|gastrointestinal disorders
4787506|NCT02696031|non-radiographic spondyloarthritis|non-radiographic spondyloarthritis
4787507|NCT02696031|axial spondyloarthritis|axial spondyloarthritis
4787508|NCT02696018|Diaphragm|diaphragm
4787509|NCT02696018|Ultrasound|ultrasound
4787510|NCT02696018|Critically ill patients|critically ill patients
4787511|NCT02695992|Rate control in atrial fibrillation|rate control in atrial fibrillation
4787512|NCT02695992|Beta blockers|beta blockers
4787513|NCT02695992|Calcium channel blockers|calcium channel blockers
4787514|NCT02695992|Permanent atrial fibrillation|permanent atrial fibrillation
4787515|NCT02695992|Management of atrial fibrillation|management of atrial fibrillation
4787516|NCT02695992|Atrial fibrillation and biomarkers|atrial fibrillation and biomarkers
4787517|NCT02695992|Arrhythmias, cardiac|arrhythmias, cardiac
4787518|NCT02695992|Heart Diseases|heart diseases
4787519|NCT02695992|Pathological processes|pathological processes
4787520|NCT02695992|Diltiazem|diltiazem
4787521|NCT02695992|Metoprolol|metoprolol
4787522|NCT02695992|Adrenergic Agents|adrenergic agents
4787523|NCT02695992|Adrenergic Antagonists|adrenergic antagonists
4787524|NCT02695992|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists
4787525|NCT02695992|Adrenergic beta-Antagonists|adrenergic beta-antagonists
4787526|NCT02695992|Anti-Arrhythmia Agents|anti-arrhythmia agents
4787527|NCT02695992|Antihypertensive Agents|antihypertensive agents
4787528|NCT02695992|Autonomic Agents|autonomic agents
4787529|NCT02695992|Cardiovascular Agents|cardiovascular agents
4787530|NCT02695992|Membrane Transport Modulators|membrane transport modulators
4787531|NCT02695992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
4787532|NCT02695992|Neurotransmitter Agents|neurotransmitter agents
4787533|NCT02695992|Peripheral Nervous System Agents|peripheral nervous system agents
4787534|NCT02695992|Physiological Effects of Drugs|physiological effects of drugs
4787535|NCT02695992|Sympatholytics|sympatholytics
4787536|NCT02695992|Therapeutic Uses|therapeutic uses
4787537|NCT02695992|Vasodilator Agents|vasodilator agents
4787538|NCT02695992|Troponins|troponins
4787539|NCT02695992|NT-proBNP|nt-probnp
4787540|NCT02695992|Biomarkers|biomarkers
4787541|NCT02695953|PTSD|ptsd
4787542|NCT02695953|biomarker|biomarker
4787543|NCT02695953|Cognitive Processing Therapy|cognitive processing therapy
4787544|NCT02695914|Inflammatory markers|inflammatory markers
4787545|NCT02695901|Plaque index|plaque index
4787546|NCT02695901|Melaleuca alternifolia oil.|melaleuca alternifolia oil.
4787547|NCT02695901|Nanoparticles|nanoparticles
4787548|NCT02695875|Fibromyalgia|fibromyalgia
4787549|NCT02695875|Pain|pain
4787550|NCT02695875|Postural balance|postural balance
4787551|NCT02695875|Physical therapy|physical therapy
4787552|NCT02695875|Aquatic therapy|aquatic therapy
4787553|NCT02695849|Non-small cell lung cancer (NSCLC)|non-small cell lung cancer (nsclc)
4787554|NCT02695836|Audit and Feedback|audit and feedback
4787555|NCT02695836|Nursing Homes|nursing homes
4787556|NCT02695836|Organizational Context|organizational context
4787557|NCT02695836|Quality Improvement|quality improvement
4787558|NCT02695836|Care Aides|care aides
4787559|NCT02695836|Leadership|leadership
4787560|NCT02695836|Resident Assessment Instrument (RAI)|resident assessment instrument (rai)
4787561|NCT02695836|Alberta Context Tool (ACT)|alberta context tool (act)
4787562|NCT02695823|intracranial hypertension|intracranial hypertension
4787563|NCT02695823|liver transplantation|liver transplantation
4787564|NCT02695823|transcranial Doppler|transcranial doppler
4787565|NCT02695823|optic nerve sheath diameter|optic nerve sheath diameter
4787566|NCT02695797|Intractable cryptogenic epilepsy with autoimmune antibody|intractable cryptogenic epilepsy with autoimmune antibody
4787567|NCT02695797|Immunotherapy|immunotherapy
4787568|NCT02695771|bladder tumors|bladder tumors
4787569|NCT02695771|urinary tumors|urinary tumors
4787570|NCT02695771|non-muscle invasive bladder tumors|non-muscle invasive bladder tumors
4787571|NCT02695771|NMIBC|nmibc
4787572|NCT02695732|Esophageal and Gastric Varices|esophageal and gastric varices
4787573|NCT02695732|Primary Prophylaxis|primary prophylaxis
4787574|NCT02695732|Carvedilol|carvedilol
4787575|NCT02695732|Endoscopy|endoscopy
4787576|NCT02695719|Drug therapy|drug therapy
4787577|NCT02695706|Diabetes|diabetes
4787578|NCT02695706|Skin acceptability|skin acceptability
4787579|NCT02695706|Clinical Research|clinical research
4787580|NCT02695680|Lung Cancer|lung cancer
4787581|NCT02695680|SBRT|sbrt
4787582|NCT02695680|Motion Management|motion management
4787583|NCT02695641|Arteriovenous Fistula|arteriovenous fistula
4787584|NCT02695641|Arteriovenous Graft|arteriovenous graft
4787585|NCT02695641|Bevacizumab|bevacizumab
4787586|NCT02695641|Hemodialysis|hemodialysis
4787587|NCT02695641|VEGF|vegf
4787588|NCT02695641|Avastin|avastin
4787589|NCT02695615|cesarean operation|cesarean operation
4787590|NCT02695615|Spielberger State Trait Anxiety Inventory|spielberger state trait anxiety inventory
4787591|NCT02695615|pain|pain
4787592|NCT02695563|Amniocentesis|amniocentesis
4787593|NCT02695524|Rehabilitation|rehabilitation
4787594|NCT02695524|Shoulder|shoulder
4787595|NCT02695498|migraine with aura|migraine with aura
4787596|NCT02695498|migraine without aura|migraine without aura
4787597|NCT02695498|pain|pain
4787598|NCT02695498|controls|controls
4787599|NCT02695498|mind-body|mind-body
4787600|NCT02695485|dorsal digital island flap|dorsal digital island flap
4787601|NCT02695485|sensory reconstruction|sensory reconstruction
4787602|NCT02695472|Depression|depression
4787603|NCT02695472|Major Depressive Disorder (MDD)|major depressive disorder (mdd)
4787604|NCT02695472|Major Depressive Disorder|major depressive disorder
4787605|NCT02695472|Neurogenesis|neurogenesis
4787606|NCT02695472|Synaptogenesis|synaptogenesis
4787607|NCT02695472|NSI-189|nsi-189
4787608|NCT02695472|Neuralstem|neuralstem
4787609|NCT02695433|Pre-diabetes|pre-diabetes
4787610|NCT02695433|Metabolic syndrome|metabolic syndrome
4787611|NCT02695433|Matsuda composite index of insulin sensitivity (MISI)|matsuda composite index of insulin sensitivity (misi)
4787612|NCT02695433|Blood glucose|blood glucose
4787613|NCT02695433|Insulin response|insulin response
4787614|NCT02695433|HbA1c|hba1c
4787615|NCT02695433|Lipid|lipid
4787616|NCT02695433|Inflammation|inflammation
4787617|NCT02695420|Heart Failure|heart failure
4787618|NCT02695407|artery cannulation|artery cannulation
4787619|NCT02695407|haemodynamic monitoring|haemodynamic monitoring
4787620|NCT02695342|Balance|balance
4787621|NCT02695342|Falls|falls
4787622|NCT02695342|Exercise|exercise
4787623|NCT02695342|COPD|copd
4787624|NCT02695329|navigation system|navigation system
4787625|NCT02695329|palm-sized|palm-sized
4787626|NCT02695329|total knee arthroplasty|total knee arthroplasty
4787627|NCT02695316|Migrants|migrants
4787628|NCT02695316|Communication Barriers|communication barriers
4787629|NCT02695316|Maternal Health Services|maternal health services
4787630|NCT02695316|Health Services Needs and Demand|health services needs and demand
4787631|NCT02695316|Access to Health Care|access to health care
4787632|NCT02695316|Professional-Patient Relations|professional-patient relations
4787633|NCT02695316|Eritrea|eritrea
4787634|NCT02695316|Kosovo|kosovo
4787635|NCT02695316|Switzerland|switzerland
4787636|NCT02695277|Atrial Fibrillation|atrial fibrillation
4787637|NCT02695277|Persistent and Longstanding Persistent AF|persistent and longstanding persistent af
4787638|NCT02695277|Hybrid Procedure|hybrid procedure
4787639|NCT02695277|Catheter Ablation|catheter ablation
4787640|NCT02695264|intracranial pressure|intracranial pressure
4787641|NCT02695264|intracranial hypertension|intracranial hypertension
4787642|NCT02695264|severe traumatic brain injury|severe traumatic brain injury
4787643|NCT02695199|Doppler Ultrasound|doppler ultrasound
4787644|NCT02695199|Laparoscopic|laparoscopic
4787645|NCT02695199|Microscopic Subinguinal Varicocelectomy|microscopic subinguinal varicocelectomy
4787646|NCT02695186|Intestinal metaplasia|intestinal metaplasia
4787647|NCT02695186|Metabolic syndrome|metabolic syndrome
4787648|NCT02695186|Oxidative stress|oxidative stress
4787649|NCT02695108|Scapula|scapula
4787650|NCT02695108|Neck|neck
4787651|NCT02695108|Pain|pain
4787652|NCT02695108|Therapy|therapy
4787653|NCT02695108|Kinematic|kinematic
4787654|NCT02695069|Complete Placenta Previa|complete placenta previa
4787655|NCT02695069|Random Placenta Margin Incision|random placenta margin incision
4787656|NCT02695069|Cesarean Section|cesarean section
4787657|NCT02695069|Hemorrhage|hemorrhage
4787658|NCT02694991|surgery|surgery
4787659|NCT02694991|outcome|outcome
4787660|NCT02694991|pain|pain
4787661|NCT02694991|osteopathic manipulative treatment|osteopathic manipulative treatment
4787662|NCT02694978|iron deficiency anemia|iron deficiency anemia
4787663|NCT02694978|IDA|ida
4787664|NCT02694978|ferumoxytol|ferumoxytol
4787665|NCT02694978|ferric carboxymaltose|ferric carboxymaltose
4787666|NCT02694978|FCM|fcm
4787667|NCT02694978|Injectafer|injectafer
4787668|NCT02694978|Feraheme|feraheme
4787669|NCT02694978|Ferinject|ferinject
4787670|NCT02694926|adrenal crisis|adrenal crisis
4787671|NCT02694926|education programme|education programme
4787672|NCT02694887|Capillary blood|capillary blood
4787673|NCT02694887|Venous blood|venous blood
4787674|NCT02694887|Lactate|lactate
4787675|NCT02694887|Emergency Department|emergency department
4787676|NCT02694874|Adjunctive treatment|adjunctive treatment
4787677|NCT02694874|Severe malaria|severe malaria
4787678|NCT02694861|Angina Pectoris|angina pectoris
4787679|NCT02694861|Angina, Stable|angina, stable
4787680|NCT02694861|Chest Pain|chest pain
4787681|NCT02694796|Web and smartphone-based physical activity program|web and smartphone-based physical activity program
4787682|NCT02694796|Connected devices|connected devices
4787683|NCT02694796|Balneotherapy|balneotherapy
4787684|NCT02694783|JC VIRUS|jc virus
4787685|NCT02694783|Progressive Multifocal Encephalopathy (PML)|progressive multifocal encephalopathy (pml)
4787686|NCT02694770|aGvHD|agvhd
4787687|NCT02694770|GvHD|gvhd
4787688|NCT02694770|sr-aGvHD|sr-agvhd
4787689|NCT02694770|biologics|biologics
4787690|NCT02694770|monoclonal antibody|monoclonal antibody
4787691|NCT02694757|Ostom-i|ostom-i
4787692|NCT02694757|OIA device|oia device
4787693|NCT02694744|Treatment of Hyperkalemia|treatment of hyperkalemia
4787694|NCT02694744|Hyperkalemia|hyperkalemia
4787695|NCT02694744|Potassium|potassium
4787696|NCT02694744|Chronic Kidney Disease|chronic kidney disease
4787697|NCT02694731|Craving|craving
4787698|NCT02694731|Mobile Apps|mobile apps
4787699|NCT02694705|Oxygen Inhalation Therapy|oxygen inhalation therapy
4787700|NCT02694705|Intubation|intubation
4787701|NCT02694705|Emergency Medicine|emergency medicine
4787702|NCT02694679|social networks, maternal and child health, global health|social networks, maternal and child health, global health
4787703|NCT02694653|C/section, Acetaminophen|c/section, acetaminophen
4787704|NCT02694640|Breast cancer|breast cancer
4787705|NCT02694640|Exercise|exercise
4787706|NCT02694640|Physical activity|physical activity
4787707|NCT02694640|Community volunteers|community volunteers
4787708|NCT02694640|Peer mentors|peer mentors
4787709|NCT02694640|Peer coaches|peer coaches
4787710|NCT02694640|Social support|social support
4787711|NCT02694640|Exercise maintenance|exercise maintenance
4787712|NCT02694627|gender, caregiving, MNCH, violence, sexual and reproductive health, parenting|gender, caregiving, mnch, violence, sexual and reproductive health, parenting
4787713|NCT02694614|weight loss|weight loss
4787714|NCT02694614|individualised dietary coaching|individualised dietary coaching
4787715|NCT02694614|smartphone-assisted dietary coaching|smartphone-assisted dietary coaching
4787716|NCT02694614|health behavior change|health behavior change
4787717|NCT02694588|Vedolizumab|vedolizumab
4787718|NCT02694588|Infliximab|infliximab
4787719|NCT02694562|Metastatic Colorectal Carcinoma|metastatic colorectal carcinoma
4787720|NCT02694549|Vascular Closure Devices|vascular closure devices
4787721|NCT02694549|Catheterization Closure Devices|catheterization closure devices
4787722|NCT02694549|Vascular Access Devices|vascular access devices
4787723|NCT02694523|Psoriasis|psoriasis
4787724|NCT02694523|Skin Diseases|skin diseases
4787725|NCT02694523|Skin Diseases, Papulosquamous|skin diseases, papulosquamous
4787726|NCT02694523|Adalimumab|adalimumab
4787727|NCT02694523|Anti-Inflammatory Agents|anti-inflammatory agents
4787728|NCT02694523|ABBV-066|abbv-066
4787729|NCT02694523|BI 655066|bi 655066
4787730|NCT02694523|Risankizumab|risankizumab
4787731|NCT02694510|Preterm infants|preterm infants
4787732|NCT02694510|Oxidative stress|oxidative stress
4787733|NCT02694510|Parenteral nutrition|parenteral nutrition
4787734|NCT02694497|transmission|transmission
4787735|NCT02694497|women|women
4787736|NCT02694497|genital|genital
4787737|NCT02694497|anorectal|anorectal
4787738|NCT02694484|Cytomegalovirus|cytomegalovirus
4787739|NCT02694484|Stool sample|stool sample
4787740|NCT02694484|Healthy Volunteers|healthy volunteers
4787741|NCT02694484|Fecal microbiota transplant|fecal microbiota transplant
4787742|NCT02694471|Ageing|ageing
4787743|NCT02694471|Physical inactivity|physical inactivity
4787744|NCT02694471|Functional decline|functional decline
4787745|NCT02694471|Reconditioning|reconditioning
4787746|NCT02694458|Vancomycin|vancomycin
4787747|NCT02694458|Children|children
4787748|NCT02694458|Infection|infection
4787749|NCT02694458|Antibiotic|antibiotic
4787750|NCT02694458|Methicillin-resistant Staphylococcus aureus (MRSA)|methicillin-resistant staphylococcus aureus (mrsa)
4787751|NCT02694458|Population-based pharmacokinetic modeling|population-based pharmacokinetic modeling
4787752|NCT02694458|Pharmacokinetics|pharmacokinetics
4787753|NCT02694458|Pharmacodynamics|pharmacodynamics
4787754|NCT02694458|Bayesian approach|bayesian approach
4787755|NCT02694458|Therapeutic drug monitoring|therapeutic drug monitoring
4787756|NCT02694432|high blood pressure, systolic, diastolic|high blood pressure, systolic, diastolic
4787757|NCT02694432|complementary therapies, meditation|complementary therapies, meditation
4787758|NCT02694419|endometrium|endometrium
4787759|NCT02694406|Diagnosis|diagnosis
4787760|NCT02694367|genetic basis|genetic basis
4787761|NCT02694341|Management|management
4787762|NCT02694328|Alkermes|alkermes
4787763|NCT02694328|ALKS 3831|alks 3831
4787764|NCT02694328|Samidorphan|samidorphan
4787765|NCT02694328|Schizophrenia|schizophrenia
4787766|NCT02694328|Olanzapine|olanzapine
4787767|NCT02694328|Weight|weight
4787768|NCT02694302|Stroke|stroke
4787769|NCT02694250|cervical|cervical
4787770|NCT02694250|fusion|fusion
4787771|NCT02694250|radiculopathy|radiculopathy
4787772|NCT02694250|DTRAX|dtrax
4787773|NCT02694224|breast cancer|breast cancer
4787774|NCT02694224|triple negative|triple negative
4787775|NCT02694224|neoadjuvant|neoadjuvant
4787776|NCT02694211|work related stress|work related stress
4787777|NCT02694185|Medication Adherence|medication adherence
4787778|NCT02694185|Randomized Controlled Trial|randomized controlled trial
4787779|NCT02694185|Veterans|veterans
4787780|NCT02694172|diabetes mellitus type 2|diabetes mellitus type 2
4787781|NCT02694172|healthy subjects|healthy subjects
4787782|NCT02694172|human microbiome|human microbiome
4787783|NCT02694172|cereal bar|cereal bar
4787784|NCT02694146|platelet-rich plasma (PRP)|platelet-rich plasma (prp)
4787785|NCT02694146|hyaluronic acid (Hylan G-F 20).|hyaluronic acid (hylan g-f 20).
4787786|NCT02694146|NSAIDs|nsaids
4787787|NCT02694146|WOMAC|womac
4787788|NCT02694133|telerehabilitation|telerehabilitation
4787789|NCT02694133|aphasia|aphasia
4787790|NCT02694133|speech therapy|speech therapy
4787791|NCT02694133|rehabilitation device|rehabilitation device
4787792|NCT02694133|visual action therapy|visual action therapy
4787793|NCT02694133|naming drills|naming drills
4787794|NCT02694094|cholesterol|cholesterol
4787795|NCT02694094|seizure|seizure
4787796|NCT02694094|epilepsy|epilepsy
4787797|NCT02694094|ketogenic|ketogenic
4787798|NCT02694094|diet|diet
4787799|NCT02694081|reflux|reflux
4787800|NCT02694081|residue|residue
4787801|NCT02694081|Gastric stasis|gastric stasis
4787802|NCT02694081|Emptying time|emptying time
4787803|NCT02694068|Peritoneal Dialysis|peritoneal dialysis
4787804|NCT02694068|Genetic|genetic
4787805|NCT02694068|Peritoneal Membrane|peritoneal membrane
4787806|NCT02694068|Peritoneal Equilibrium Test|peritoneal equilibrium test
4787807|NCT02694068|Ultrafiltration Capacity|ultrafiltration capacity
4787808|NCT02694068|End Stage Renal Disease (ESRD)|end stage renal disease (esrd)
4787910|NCT02693717|Folic Acid|folic acid
4787809|NCT02694055|Community Health Workers|community health workers
4787810|NCT02694055|Community Case Management|community case management
4787811|NCT02694055|Proactive Case Detection|proactive case detection
4787812|NCT02694055|Under-five Child Mortality|under-five child mortality
4787813|NCT02694055|Access to Health Care|access to health care
4787814|NCT02694042|Pediatric inflammatory bowel disease|pediatric inflammatory bowel disease
4787815|NCT02694042|Crohn's disease|crohn's disease
4787816|NCT02694042|Ulcerative colitis|ulcerative colitis
4787817|NCT02694042|Web-based teaching and support|web-based teaching and support
4787818|NCT02694042|disease self-management|disease self-management
4787819|NCT02694042|peer support|peer support
4787820|NCT02694016|Remote ischemic preconditioning|remote ischemic preconditioning
4787821|NCT02694016|Neuroprotection|neuroprotection
4787822|NCT02694003|Autism Spectrum Disorder (ASD)|autism spectrum disorder (asd)
4787823|NCT02694003|Fetal Alcohol Spectrum Disorder (FASD)|fetal alcohol spectrum disorder (fasd)
4787824|NCT02694003|Cerebral Palsy (CP)|cerebral palsy (cp)
4787825|NCT02694003|Attention-Deficit/Hyperactivity Disorder (ADHD)|attention-deficit/hyperactivity disorder (adhd)
4787826|NCT02694003|Behavioural Insomnia|behavioural insomnia
4787827|NCT02694003|Neurodevelopmental Disorders|neurodevelopmental disorders
4787828|NCT02693990|Tumor lining the brain|tumor lining the brain
4787829|NCT02693990|Meningioma|meningioma
4787830|NCT02693990|Brain Tumor|brain tumor
4787831|NCT02693977|OSA|osa
4787832|NCT02693977|sleep apnea|sleep apnea
4787833|NCT02693977|AT|at
4787834|NCT02693977|adenotonsillectomy|adenotonsillectomy
4787835|NCT02693977|pediatric|pediatric
4787836|NCT02693964|Type 1 Diabetes|type 1 diabetes
4787837|NCT02693964|Menopause|menopause
4787838|NCT02693964|Cardiovascular Risk|cardiovascular risk
4787839|NCT02693964|Bone Density|bone density
4787840|NCT02693951|gastric varices|gastric varices
4787841|NCT02693951|endoscopic injection of tissue adhesive|endoscopic injection of tissue adhesive
4787842|NCT02693938|diabetes|diabetes
4787843|NCT02693938|menstrual cycle|menstrual cycle
4787844|NCT02693938|insulin|insulin
4787845|NCT02693912|efferocytosis|efferocytosis
4787846|NCT02693912|macrophage|macrophage
4787847|NCT02693873|Osteoarthritis, Hip|osteoarthritis, hip
4787848|NCT02693873|Osteoarthritis, Knee|osteoarthritis, knee
4787849|NCT02693873|Patient Education|patient education
4787850|NCT02693873|Exercise, Neuromuscular|exercise, neuromuscular
4787851|NCT02693873|Disease Management|disease management
4787852|NCT02693873|Evidence-Based Health Care|evidence-based health care
4787853|NCT02693873|Pilot Study|pilot study
4787854|NCT02693847|HCV|hcv
4787855|NCT02693847|HIV|hiv
4787856|NCT02693847|Liver cirrhosis|liver cirrhosis
4787857|NCT02693847|Hepatocellular carcinoma|hepatocellular carcinoma
4787858|NCT02693847|Liver transplant|liver transplant
4787859|NCT02693847|Liver stiffness|liver stiffness
4787860|NCT02693847|Transient elastography|transient elastography
4787861|NCT02693834|foot drop|foot drop
4787862|NCT02693834|Subacute stroke|subacute stroke
4787863|NCT02693834|AFO|afo
4787864|NCT02693834|gait symmetry|gait symmetry
4787865|NCT02693834|Gait endurance|gait endurance
4787866|NCT02693821|Gabapentin|gabapentin
4787867|NCT02693821|prevention|prevention
4787868|NCT02693821|incidence|incidence
4787869|NCT02693808|Temporal hollowing|temporal hollowing
4787870|NCT02693808|Lateral orbital wall decompression|lateral orbital wall decompression
4787871|NCT02693808|Thyroid eye disease|thyroid eye disease
4787872|NCT02693795|myocardial infarction|myocardial infarction
4787873|NCT02693795|left ventricular remodeling|left ventricular remodeling
4787874|NCT02693782|Fibre|fibre
4787875|NCT02693782|Wheat Bran Extract|wheat bran extract
4787876|NCT02693782|Microbiota|microbiota
4787877|NCT02693782|Microbiota metabolites|microbiota metabolites
4787878|NCT02693782|Gastrointestinal tolerance|gastrointestinal tolerance
4787879|NCT02693743|suicidality|suicidality
4787880|NCT02693743|rTMS|rtms
4787881|NCT02693743|suicide ideation|suicide ideation
4787882|NCT02693730|Irritable Bowel Syndrome|irritable bowel syndrome
4787883|NCT02693730|IBS|ibs
4787884|NCT02693730|Ulcerative Colitis|ulcerative colitis
4787885|NCT02693730|UC|uc
4787886|NCT02693730|Inflammatory Bowel Disease|inflammatory bowel disease
4787887|NCT02693730|IBD|ibd
4787888|NCT02693730|Healthy Control|healthy control
4787889|NCT02693730|HC|hc
4787890|NCT02693730|Visceral Pain|visceral pain
4787891|NCT02693730|Gut|gut
4787892|NCT02693730|Neuroimaging|neuroimaging
4787893|NCT02693730|fMRI|fmri
4787894|NCT02693730|resting state|resting state
4787895|NCT02693730|structural MRI|structural mri
4787896|NCT02693730|functional MRI|functional mri
4787897|NCT02693730|diffusion tensor imaging|diffusion tensor imaging
4787898|NCT02693730|MR Spectroscopy|mr spectroscopy
4787899|NCT02693717|Cancer of urethra|cancer of urethra
4787900|NCT02693717|Cancer of ureters|cancer of ureters
4787901|NCT02693717|MTAP-deficient bladder cancer|mtap-deficient bladder cancer
4787902|NCT02693717|MTAP wild-type bladder cancer|mtap wild-type bladder cancer
4787903|NCT02693717|Metastatic|metastatic
4787904|NCT02693717|Pemetrexed|pemetrexed
4787905|NCT02693717|LY231514|ly231514
4787906|NCT02693717|Alimta|alimta
4787907|NCT02693717|MTA|mta
4787908|NCT02693717|Multitargeted Antifolate|multitargeted antifolate
4787911|NCT02693717|Folinic Acid|folinic acid
4787912|NCT02693717|Vitamin B12|vitamin b12
4787913|NCT02693717|Dexamethasone|dexamethasone
4787914|NCT02693717|Decadron|decadron
4787915|NCT02693678|Proprioception|proprioception
4787916|NCT02693678|Doms|doms
4787917|NCT02693678|Pain|pain
4787918|NCT02693678|Massage|massage
4787919|NCT02693678|Diathermy|diathermy
4787920|NCT02693665|pediatric advance care planning|pediatric advance care planning
4787921|NCT02693665|adolescent|adolescent
4787922|NCT02693665|family|family
4787923|NCT02693665|palliative care|palliative care
4787924|NCT02693665|end of life|end of life
4787925|NCT02693665|communication|communication
4787926|NCT02693665|decision making|decision making
4787927|NCT02693665|surrogate decision maker|surrogate decision maker
4787928|NCT02693665|health care proxy|health care proxy
4787929|NCT02693665|intervention|intervention
4787930|NCT02693665|randomized clinical trial|randomized clinical trial
4787931|NCT02693665|cancer|cancer
4787932|NCT02693665|quality of life|quality of life
4787933|NCT02693665|spiritual|spiritual
4787934|NCT02693665|religion|religion
4787935|NCT02693665|treatment congruence|treatment congruence
4787936|NCT02693665|treatment preferences|treatment preferences
4787937|NCT02693665|FAmily CEntered (FACE) Advance Care Planning|family centered (face) advance care planning
4787938|NCT02693639|PANX1|panx1
4787939|NCT02693639|Infection|infection
4787940|NCT02693639|Liver transplantation|liver transplantation
4787941|NCT02693626|mobile phone-based text message interventions|mobile phone-based text message interventions
4787942|NCT02693626|'Happy Quit'|'happy quit'
4787943|NCT02693626|smoking cessation|smoking cessation
4787944|NCT02693613|Drug-drug interaction|drug-drug interaction
4787945|NCT02693613|Kremezin|kremezin
4787946|NCT02693613|Pharmacokinetics|pharmacokinetics
4787947|NCT02693613|ASP1517|asp1517
4787948|NCT02693600|Total Trapeziectomy|total trapeziectomy
4787949|NCT02693600|Partial Trapeziectomy|partial trapeziectomy
4787950|NCT02693600|Ligamentoplasty|ligamentoplasty
4787951|NCT02693574|Helicobacter pylori|helicobacter pylori
4787952|NCT02693574|Helicobacter Infections|helicobacter infections
4787953|NCT02693574|Proton Pump Inhibitors|proton pump inhibitors
4787954|NCT02693561|Self-help book|self-help book
4787955|NCT02693561|Deep breathing|deep breathing
4787956|NCT02693548|Familial Hypercholesterolaemia|familial hypercholesterolaemia
4787957|NCT02693548|Prognosis|prognosis
4787958|NCT02693548|Cardiovascular disease|cardiovascular disease
4787959|NCT02693535|cancer|cancer
4787960|NCT02693535|off-label|off-label
4787961|NCT02693535|precision medicine|precision medicine
4787962|NCT02693535|targeted therapy|targeted therapy
4787963|NCT02693496|ResearchKit|researchkit
4787964|NCT02693496|CT screening|ct screening
4787965|NCT02693496|Early Diagnosis|early diagnosis
4787966|NCT02693496|Lung Cancer|lung cancer
4787967|NCT02693392|Fenugreek seed extract|fenugreek seed extract
4787968|NCT02693392|HbA1c|hba1c
4787969|NCT02693392|Blood glucose|blood glucose
4787970|NCT02693379|cervical cancer|cervical cancer
4787971|NCT02693379|HPV|hpv
4787972|NCT02693379|VIA|via
4787973|NCT02693379|screening|screening
4787974|NCT02693379|smartphone|smartphone
4787975|NCT02693379|telemedicine|telemedicine
4787976|NCT02693366|bone marrow cells, stem cells, cell therapy|bone marrow cells, stem cells, cell therapy
4787977|NCT02693366|Glomerulosclerosis, Focal Segmental|glomerulosclerosis, focal segmental
4787978|NCT02693366|Renal Insufficiency, Chronic|renal insufficiency, chronic
4787979|NCT02693327|Gut Microbiome|gut microbiome
4787980|NCT02693327|Mental Disorder|mental disorder
4787981|NCT02693327|Dysbiosis|dysbiosis
4787982|NCT02693314|Jarro-Dophilus|jarro-dophilus
4787983|NCT02693314|probiotic|probiotic
4787984|NCT02693314|microbiota|microbiota
4787985|NCT02693314|gastrointestinal|gastrointestinal
4787986|NCT02693301|Asthma|asthma
4787987|NCT02693301|Respiratory symptoms|respiratory symptoms
4787988|NCT02693301|Exercise program|exercise program
4787989|NCT02693301|Functional capacity|functional capacity
4787990|NCT02693301|Body composition|body composition
4787991|NCT02693288|Wrist fracture|wrist fracture
4787992|NCT02693288|postoperative pain|postoperative pain
4787993|NCT02693288|local anesthesia|local anesthesia
4787994|NCT02693275|Community Sampling|community sampling
4787995|NCT02693262|defibrillator|defibrillator
4787996|NCT02693262|heart failure|heart failure
4787997|NCT02693262|ICD|icd
4787998|NCT02693262|CRT-D|crt-d
4787999|NCT02693262|cardiac resynchronization therapy|cardiac resynchronization therapy
4788000|NCT02693262|rate response|rate response
4788001|NCT02693262|CLS|cls
4788002|NCT02693262|closed-loop stimulation|closed-loop stimulation
4788003|NCT02693262|accelerometer|accelerometer
4788004|NCT02693262|chronotropic incompetence|chronotropic incompetence
4788005|NCT02693249|accidents|accidents
4788006|NCT02693249|adolescents|adolescents
4788007|NCT02693249|children|children
4788008|NCT02693249|posttraumatic cognitions|posttraumatic cognitions
4788009|NCT02693223|stroke|stroke
4788010|NCT02693197|Hepatic Impairment|hepatic impairment
4788011|NCT02693145|HIV/AIDS|hiv/aids
4788012|NCT02693145|re-engagement in care|re-engagement in care
4788013|NCT02693145|data to care|data to care
4788014|NCT02693132|Obesity|obesity
4788015|NCT02693132|Exercise|exercise
4788016|NCT02693119|LHON|lhon
4788017|NCT02693119|Ocuvia™|ocuvia™
4788018|NCT02693119|elamipretide|elamipretide
4788019|NCT02693119|MTP-131|mtp-131
4788020|NCT02693041|Probiotics|probiotics
4788021|NCT02693041|inflammation|inflammation
4788022|NCT02693041|immunological response|immunological response
4788023|NCT02693041|preterm birth|preterm birth
4788024|NCT02693041|preeclampsia|preeclampsia
4788025|NCT02693028|Microbiome|microbiome
4788026|NCT02693028|probiotic|probiotic
4788027|NCT02692976|Castration-resistant prostate cancer|castration-resistant prostate cancer
4788028|NCT02692976|Dendritic Cells|dendritic cells
4788029|NCT02692976|Immunotherapy|immunotherapy
4788030|NCT02692976|Vaccines|vaccines
4788031|NCT02692937|Neurosurgical Procedures|neurosurgical procedures
4788032|NCT02692937|Nerve Block|nerve block
4788033|NCT02692937|Exercise therapy|exercise therapy
4788034|NCT02692937|Physical Therapy Specialty|physical therapy specialty
4788035|NCT02692924|Pregnancy Complications|pregnancy complications
4788036|NCT02692924|Ultrasound|ultrasound
4788037|NCT02692911|Gallbaldder|gallbaldder
4788038|NCT02692911|Cancer|cancer
4788039|NCT02692911|Gallstones|gallstones
4788040|NCT02692911|Cholecystectomy|cholecystectomy
4788041|NCT02692911|Inflammation|inflammation
4788042|NCT02692898|Brain Tumor|brain tumor
4788043|NCT02692898|Molecular Pathology|molecular pathology
4788044|NCT02692898|Clinical Data|clinical data
4788045|NCT02692898|Imaging Data|imaging data
4788046|NCT02692885|Phenotype|phenotype
4788047|NCT02692885|Adipose Tissue|adipose tissue
4788048|NCT02692885|Brown Adipose Tissue|brown adipose tissue
4788049|NCT02692872|Alpha Thalassemia|alpha thalassemia
4788050|NCT02692872|alpha globin|alpha globin
4788051|NCT02692846|CONNECTIVE TISSUE DISEASES|connective tissue diseases
4788052|NCT02692846|Cardiovascular Disease|cardiovascular disease
4788053|NCT02692846|Elastin Gene Mutation|elastin gene mutation
4788054|NCT02692846|Multisystem Developmental Disorder|multisystem developmental disorder
4788055|NCT02692833|Telomere|telomere
4788056|NCT02692833|Telomerase|telomerase
4788057|NCT02692833|DNA methylation|dna methylation
4788058|NCT02692833|Cell aging|cell aging
4788059|NCT02692833|Thoracic Surgery|thoracic surgery
4788060|NCT02692820|Preterm|preterm
4788061|NCT02692820|Probiotic|probiotic
4788062|NCT02692807|hip arthroscopy|hip arthroscopy
4788063|NCT02692807|femoroacetabular impingement|femoroacetabular impingement
4788064|NCT02692807|exercise therapy after hip arthroscopy|exercise therapy after hip arthroscopy
4788065|NCT02692807|rehabilitation after hip arthroscopy|rehabilitation after hip arthroscopy
4788066|NCT02692794|sinusitis|sinusitis
4788067|NCT02692794|oximetry|oximetry
4788068|NCT02692794|paranasal sinus diseases|paranasal sinus diseases
4788069|NCT02692781|Obesity|obesity
4788070|NCT02692768|total shoulder arthroplasty|total shoulder arthroplasty
4788071|NCT02692768|total shoulder replacement|total shoulder replacement
4788072|NCT02692768|adult|adult
4788073|NCT02692768|reverse shoulder arthroplasty|reverse shoulder arthroplasty
4788074|NCT02692755|African American|african american
4788075|NCT02692742|Chemotherapy|chemotherapy
4788076|NCT02692742|Chemotherapy-induced Neutropenia|chemotherapy-induced neutropenia
4788077|NCT02692742|Supportive Care|supportive care
4788078|NCT02692742|Myelosuppression|myelosuppression
4788079|NCT02692742|CIN|cin
4788080|NCT02692703|HCV Treatment Experienced|hcv treatment experienced
4788081|NCT02692703|Hepatitis C|hepatitis c
4788082|NCT02692703|HCV Genotype 3|hcv genotype 3
4788083|NCT02692703|Without cirrhosis|without cirrhosis
4788084|NCT02692703|Non-cirrhotic|non-cirrhotic
4788085|NCT02692703|HCV Genotype 2|hcv genotype 2
4788086|NCT02692703|Renal Transplant|renal transplant
4788087|NCT02692703|HCV Treatment Naive|hcv treatment naive
4788088|NCT02692703|Post transplant|post transplant
4788089|NCT02692703|HCV Genotype 6|hcv genotype 6
4788090|NCT02692703|Liver Transplant|liver transplant
4788091|NCT02692703|HCV Genotype 5|hcv genotype 5
4788092|NCT02692703|HCV Genotype 4|hcv genotype 4
4788093|NCT02692703|Kidney Transplant|kidney transplant
4788094|NCT02692703|HCV Genotype 1|hcv genotype 1
4788095|NCT02692677|Healthy|healthy
4788096|NCT02692677|JNJ-42756493|jnj-42756493
4788097|NCT02692664|iliac side branch|iliac side branch
4788098|NCT02692651|vancomycin|vancomycin
4788099|NCT02692651|fidaxomicin|fidaxomicin
4788100|NCT02692651|CDI|cdi
4788101|NCT02692651|diarrhea|diarrhea
4788102|NCT02692599|live attenuated mumps vaccine|live attenuated mumps vaccine
4788103|NCT02692599|safety|safety
4788104|NCT02692599|immunogenicity|immunogenicity
4788105|NCT02692599|infant|infant
4788106|NCT02692586|Thromboembolism|thromboembolism
4788107|NCT02692586|Thrombectomy|thrombectomy
4788108|NCT02692586|Right Heart Strain|right heart strain
4788109|NCT02692586|Submassive PE|submassive pe
4788110|NCT02692586|Right Ventricle Dysfunction|right ventricle dysfunction
4788111|NCT02692586|Massive PE|massive pe
4788112|NCT02692560|Sedentary time|sedentary time
4788113|NCT02692560|Sit-to-stand transitions|sit-to-stand transitions
4788114|NCT02692534|Anesthesia|anesthesia
4788115|NCT02692534|Cocaine Use|cocaine use
4788116|NCT02692508|cardiovascular MRI|cardiovascular mri
4788117|NCT02692508|apical hypertrophic cardiomyopathy|apical hypertrophic cardiomyopathy
4788118|NCT02692508|giant negative T-wave|giant negative t-wave
4788119|NCT02692508|wall thickness|wall thickness
4788120|NCT02692508|Nuclear Magnetic Resonance|nuclear magnetic resonance
4788121|NCT02692508|Early Diagnosis|early diagnosis
4788122|NCT02692508|Prognosis|prognosis
4788123|NCT02692495|body odor|body odor
4788124|NCT02692495|halitosis|halitosis
4788125|NCT02692495|dysbiosis|dysbiosis
4788126|NCT02692495|leaky gut|leaky gut
4788127|NCT02692495|microbiome|microbiome
4788128|NCT02692495|PATM|patm
4788129|NCT02692495|breath odor|breath odor
4788130|NCT02692469|Bariatric Surgery, Obesity, Laparoscopy|bariatric surgery, obesity, laparoscopy
4788131|NCT02692443|Congenital Heart Disease|congenital heart disease
4788132|NCT02692443|Magnetic Brain Resonance|magnetic brain resonance
4788133|NCT02692443|CHD|chd
4788134|NCT02692443|MRI|mri
4788135|NCT02692443|Neurodevelopmental|neurodevelopmental
4788136|NCT02692430|Portosystemic Shunt|portosystemic shunt
4788137|NCT02692430|Hepatic encephalopathy|hepatic encephalopathy
4788138|NCT02692430|Portal hypertension|portal hypertension
4788139|NCT02692430|Liver cirrhosis|liver cirrhosis
4788140|NCT02692417|hypoactive desire disorder|hypoactive desire disorder
4788141|NCT02692417|female sexual dysfunction|female sexual dysfunction
4788142|NCT02692417|genital arousal disorder|genital arousal disorder
4788143|NCT02692417|sexual|sexual
4788144|NCT02692417|dysfunction|dysfunction
4788145|NCT02692417|female|female
4788146|NCT02692417|arousal|arousal
4788147|NCT02692417|electrical stimulation|electrical stimulation
4788148|NCT02692417|transcutaneous electrical stimulation|transcutaneous electrical stimulation
4788149|NCT02692417|women|women
4788150|NCT02692404|Postpartum Depression|postpartum depression
4788151|NCT02692404|Perinatal Depression|perinatal depression
4788152|NCT02692404|Pregnancy|pregnancy
4788153|NCT02692404|Anesthesia|anesthesia
4788154|NCT02692404|Obstetric|obstetric
4788155|NCT02692404|Pain|pain
4788156|NCT02692404|Analgesia|analgesia
4788157|NCT02692404|Epidural|epidural
4788158|NCT02692404|Midwife|midwife
4788159|NCT02692404|Infant Development|infant development
4788160|NCT02692404|Pain Management|pain management
4788161|NCT02692391|Acute pancreatitis|acute pancreatitis
4788162|NCT02692391|Indomethacin|indomethacin
4788163|NCT02692391|Organ failure|organ failure
4788164|NCT02692391|Prevention|prevention
4788165|NCT02692378|Haemodialysis|haemodialysis
4788166|NCT02692378|sodium bicarbonate|sodium bicarbonate
4788167|NCT02692378|potassium|potassium
4788168|NCT02692378|arrhythmia|arrhythmia
4788169|NCT02692378|muscle|muscle
4788170|NCT02692378|symptoms|symptoms
4788171|NCT02692339|Relapsed Multiple Myeloma|relapsed multiple myeloma
4788172|NCT02692339|Refractory Multiple Myeloma|refractory multiple myeloma
4788173|NCT02692339|Lenalidomide|lenalidomide
4788174|NCT02692339|Dexamethasone|dexamethasone
4788175|NCT02692339|Observational Study|observational study
4788176|NCT02692339|Safety of Len/Dex|safety of len/dex
4788177|NCT02692326|intrahepatic cholestasis|intrahepatic cholestasis
4788178|NCT02692326|infant newborn|infant newborn
4788179|NCT02692326|cyclic parenteral nutrition|cyclic parenteral nutrition
4788180|NCT02692313|epinephrine|epinephrine
4788181|NCT02692313|counterregulation|counterregulation
4788182|NCT02692313|dose responses|dose responses
4788183|NCT02692300|anesthesia|anesthesia
4788184|NCT02692300|delirium|delirium
4788185|NCT02692300|surgery|surgery
4788186|NCT02692300|electroencephalography|electroencephalography
4788187|NCT02692300|burst suppression|burst suppression
4788188|NCT02692300|PTSD|ptsd
4788189|NCT02692300|anxiety|anxiety
4788190|NCT02692300|depression|depression
4788191|NCT02692300|falls|falls
4788192|NCT02692274|Point-of-care diagnostics|point-of-care diagnostics
4788193|NCT02692274|Rural primary health care|rural primary health care
4788194|NCT02692274|Access|access
4788195|NCT02692274|Need|need
4788196|NCT02692274|Usage|usage
4788197|NCT02692274|Maternal Health|maternal health
4788198|NCT02692235|carnitine|carnitine
4788199|NCT02692235|leucine|leucine
4788200|NCT02692222|pulse pressure variation monitoring|pulse pressure variation monitoring
4788201|NCT02692222|Captesia|captesia
4788202|NCT02692222|cardiac output monitoring|cardiac output monitoring
4788203|NCT02692209|Mammography|mammography
4788204|NCT02692196|Neurofeedback|neurofeedback
4788205|NCT02692196|Emotion processing|emotion processing
4788206|NCT02692196|Real-time|real-time
4788207|NCT02692196|fMRI|fmri
4788208|NCT02692183|Parkinson's disease|parkinson's disease
4788209|NCT02692183|ET|et
4788210|NCT02692183|EEG|eeg
4788211|NCT02692183|FUS|fus
4788212|NCT02692183|BNA|bna
4788213|NCT02692183|Essential tremor|essential tremor
4788214|NCT02692131|Left Ventricle strain, speckle strain|left ventricle strain, speckle strain
4788215|NCT02692105|prostate adenocarcinoma|prostate adenocarcinoma
4788216|NCT02692105|intermediate risk group|intermediate risk group
4788217|NCT02692105|brachytherapy|brachytherapy
4788218|NCT02692105|High Dose Rate vs Low Dose Rate|high dose rate vs low dose rate
4788219|NCT02692105|Quality of Life|quality of life
4788220|NCT02692092|Complications|complications
4788318|NCT02691325|GSK2269557|gsk2269557
4788221|NCT02692092|Arthroplasty, Hip Replacement|arthroplasty, hip replacement
4788222|NCT02692092|Arthroplasty, Knee Replacement|arthroplasty, knee replacement
4788223|NCT02692079|Angiogenesis|angiogenesis
4788224|NCT02692079|Bilateral infrabony defect|bilateral infrabony defect
4788225|NCT02692079|Flap surgery|flap surgery
4788226|NCT02692079|Titanium-prepared, platelet-rich ﬁbrin|titanium-prepared, platelet-rich ﬁbrin
4788227|NCT02692040|obesity|obesity
4788228|NCT02692040|diabetes mellitus|diabetes mellitus
4788229|NCT02692040|glucagon-like peptide-1|glucagon-like peptide-1
4788230|NCT02692027|Community-based initiation of antiretroviral therapy|community-based initiation of antiretroviral therapy
4788231|NCT02692027|Home-based HIV testing and counseling|home-based hiv testing and counseling
4788232|NCT02692027|Lesotho|lesotho
4788233|NCT02692027|Sub-sahara Africa|sub-sahara africa
4788234|NCT02692027|antiretroviral therapy|antiretroviral therapy
4788235|NCT02692027|AIDS|aids
4788236|NCT02692027|Test and treat|test and treat
4788237|NCT02691988|Inhaled corticosteroids|inhaled corticosteroids
4788238|NCT02691988|General practice|general practice
4788239|NCT02691988|Primary care|primary care
4788240|NCT02691988|Pharmacotherapy|pharmacotherapy
4788241|NCT02691936|Genitourinary symptoms of menopause|genitourinary symptoms of menopause
4788242|NCT02691936|Menopause|menopause
4788243|NCT02691936|Atrophic vaginitis|atrophic vaginitis
4788244|NCT02691923|High Grade Glioma|high grade glioma
4788245|NCT02691923|Low Grade Glioma|low grade glioma
4788246|NCT02691923|Brain Tumor|brain tumor
4788247|NCT02691910|malaria|malaria
4788248|NCT02691910|Plasmodium vivax|plasmodium vivax
4788249|NCT02691910|treatment|treatment
4788250|NCT02691910|Chloroquine|chloroquine
4788251|NCT02691910|Primaquine|primaquine
4788252|NCT02691897|Diabetes mellitus|diabetes mellitus
4788253|NCT02691897|Melatonin|melatonin
4788254|NCT02691897|Blood Glucose|blood glucose
4788255|NCT02691897|Therapeutics|therapeutics
4788256|NCT02691897|Pineal gland|pineal gland
4788257|NCT02691884|Heart Rate, Fetal|heart rate, fetal
4788258|NCT02691884|Electronic Fetal Monitoring|electronic fetal monitoring
4788259|NCT02691884|Transducers, Pressure|transducers, pressure
4788260|NCT02691858|Intussusception|intussusception
4788261|NCT02691819|jailed-balloon technique|jailed-balloon technique
4788262|NCT02691754|Paracetamol|paracetamol
4788263|NCT02691754|PPI|ppi
4788264|NCT02691754|Opioids|opioids
4788265|NCT02691754|NSAID|nsaid
4788266|NCT02691754|Drug Prescription|drug prescription
4788267|NCT02691702|Multiple Ascending Dose Study|multiple ascending dose study
4788268|NCT02691702|Safety and Tolerability|safety and tolerability
4788269|NCT02691702|Pharmacokinetics|pharmacokinetics
4788270|NCT02691702|Pharmacodynamics|pharmacodynamics
4788271|NCT02691702|Melatonin|melatonin
4788272|NCT02691702|Plasma|plasma
4788273|NCT02691702|Dim Light Melatonin Onset|dim light melatonin onset
4788274|NCT02691676|crystalloids, fluid therapy, Plasmalyte, Ringerfundin|crystalloids, fluid therapy, plasmalyte, ringerfundin
4788275|NCT02691663|Geriatric|geriatric
4788276|NCT02691663|bicarbonate|bicarbonate
4788277|NCT02691650|serum cholinesterase|serum cholinesterase
4788278|NCT02691650|plasma cholinesterase|plasma cholinesterase
4788279|NCT02691650|pseudocholinesterase|pseudocholinesterase
4788280|NCT02691650|systemic inflammation|systemic inflammation
4788281|NCT02691650|SIRS|sirs
4788282|NCT02691650|polytrauma|polytrauma
4788283|NCT02691637|Helicobacter pylori infection|helicobacter pylori infection
4788284|NCT02691637|Eradication treatment|eradication treatment
4788285|NCT02691637|Reversibility|reversibility
4788286|NCT02691637|atrophic gastritis|atrophic gastritis
4788287|NCT02691637|intestinal metaplasia|intestinal metaplasia
4788288|NCT02691624|Lymphedema of Upper Arm|lymphedema of upper arm
4788289|NCT02691624|Breast cancer|breast cancer
4788290|NCT02691624|Breast cancer-related Lymphedema|breast cancer-related lymphedema
4788291|NCT02691624|Lymphoscintigraphy|lymphoscintigraphy
4788292|NCT02691546|Chronic Kidney Diseases|chronic kidney diseases
4788293|NCT02691546|Older|older
4788294|NCT02691546|Geriatric assessment|geriatric assessment
4788295|NCT02691546|Biomarkers|biomarkers
4788296|NCT02691533|Acute|acute
4788297|NCT02691520|Treatment Resistant Depression|treatment resistant depression
4788298|NCT02691507|Eczema, Itchy Skin|eczema, itchy skin
4788299|NCT02691494|Elagolix|elagolix
4788300|NCT02691494|Elagolix Sodium|elagolix sodium
4788301|NCT02691494|Heavy uterine bleeding|heavy uterine bleeding
4788302|NCT02691494|Heavy menstrual bleeding|heavy menstrual bleeding
4788303|NCT02691494|Leiomyomata|leiomyomata
4788304|NCT02691494|Menorrhagia|menorrhagia
4788305|NCT02691494|ABT-620|abt-620
4788306|NCT02691494|Elagolix + E2/NETA|elagolix + e2/neta
4788307|NCT02691494|Elagolix + Norethindrone acetate|elagolix + norethindrone acetate
4788308|NCT02691494|HMB|hmb
4788309|NCT02691468|one lung ventilation|one lung ventilation
4788310|NCT02691468|double lumen endobronchial tube|double lumen endobronchial tube
4788311|NCT02691468|displacement|displacement
4788312|NCT02691468|Fiberoptic bronchoscope|fiberoptic bronchoscope
4788313|NCT02691442|Peripheral nerve block|peripheral nerve block
4788314|NCT02691429|Vitreoretinal surgery|vitreoretinal surgery
4788315|NCT02691429|euterpe oleracea|euterpe oleracea
4788316|NCT02691429|chromovitrectomy|chromovitrectomy
4788317|NCT02691325|ELLIPTA|ellipta
4788319|NCT02691325|Tolerability|tolerability
4788320|NCT02691325|Safety|safety
4788321|NCT02691325|Dry powder Inhaler (DPI)|dry powder inhaler (dpi)
4788322|NCT02691325|Pharmacokinetics|pharmacokinetics
4788323|NCT02691312|type 1 diabetes|type 1 diabetes
4788324|NCT02691312|retinopathy|retinopathy
4788325|NCT02691299|NSCLC|nsclc
4788326|NCT02691260|obesity|obesity
4788327|NCT02691260|behavioral intervention|behavioral intervention
4788328|NCT02691260|diet|diet
4788329|NCT02691247|T1DM|t1dm
4788330|NCT02691247|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
4788331|NCT02691247|T regulatory cell|t regulatory cell
4788332|NCT02691247|Immunotherapy|immunotherapy
4788333|NCT02691247|Cell therapy|cell therapy
4788334|NCT02691247|T-Reg|t-reg
4788335|NCT02691221|Suicidal behavior, Mobile Application, Mobile Health Tool|suicidal behavior, mobile application, mobile health tool
4788336|NCT02691208|acupuncture|acupuncture
4788337|NCT02691208|breast cancer|breast cancer
4788338|NCT02691208|rehabilitation|rehabilitation
4788339|NCT02691208|pain|pain
4788340|NCT02691195|Ultrasound|ultrasound
4788341|NCT02691195|Serratus Plane Block|serratus plane block
4788342|NCT02691195|Quality of recovery|quality of recovery
4788343|NCT02691156|Hematofluorometer|hematofluorometer
4788344|NCT02691130|influenza|influenza
4788345|NCT02691130|vaccine|vaccine
4788346|NCT02691130|universal|universal
4788347|NCT02691130|peptide|peptide
4788348|NCT02691130|prime|prime
4788349|NCT02691130|boost|boost
4788350|NCT02691130|HAI|hai
4788351|NCT02691130|CMI|cmi
4788352|NCT02691130|UNISEC|unisec
4788353|NCT02691117|Alopecia Areata|alopecia areata
4788354|NCT02691117|Garlic concentrate|garlic concentrate
4788355|NCT02691052|pancreatic cancer|pancreatic cancer
4788356|NCT02691052|metastatic|metastatic
4788357|NCT02691026|MPNST|mpnst
4788358|NCT02691026|Pembrolizumab|pembrolizumab
4788359|NCT02691000|depression|depression
4788360|NCT02691000|depressive symptoms|depressive symptoms
4788361|NCT02691000|stage b heart failure|stage b heart failure
4788362|NCT02691000|bright white light|bright white light
4788363|NCT02691000|light therapy|light therapy
4788364|NCT02690987|tobacco|tobacco
4788365|NCT02690987|GLP1|glp1
4788366|NCT02690987|ghrelin|ghrelin
4788367|NCT02690987|alcohol|alcohol
4788368|NCT02690987|appetite|appetite
4788369|NCT02690987|reward|reward
4788370|NCT02690987|addiction|addiction
4788371|NCT02690987|hormone|hormone
4788372|NCT02690987|cigarette|cigarette
4788373|NCT02690987|fMRI|fmri
4788374|NCT02690974|HFrEF,|hfref,
4788375|NCT02690974|ACEi,|acei,
4788376|NCT02690974|ACE inhibitor,|ace inhibitor,
4788377|NCT02690974|ARBs,|arbs,
4788378|NCT02690974|systolic heart failure,|systolic heart failure,
4788379|NCT02690974|chronic heart failure,|chronic heart failure,
4788380|NCT02690974|CHF,|chf,
4788381|NCT02690974|reduced EF,|reduced ef,
4788382|NCT02690974|Ejection Fraction|ejection fraction
4788383|NCT02690961|Healthy|healthy
4788384|NCT02690935|grass pollen|grass pollen
4788385|NCT02690935|homeopathy|homeopathy
4788386|NCT02690935|placebo|placebo
4788387|NCT02690935|quality of life|quality of life
4788388|NCT02690909|Uncontrolled Hypertension|uncontrolled hypertension
4788389|NCT02690909|Resistant Hypertension|resistant hypertension
4788390|NCT02690909|Renal Denervation|renal denervation
4788391|NCT02690896|caregiver burden|caregiver burden
4788392|NCT02690896|caregiver support groups|caregiver support groups
4788393|NCT02690870|tamoxifen|tamoxifen
4788394|NCT02690870|clomiphene|clomiphene
4788395|NCT02690870|mild stimulation|mild stimulation
4788396|NCT02690870|poor ovarian response|poor ovarian response
4788397|NCT02690870|clinical pregnancy rate|clinical pregnancy rate
4788398|NCT02690831|Asthma|asthma
4788399|NCT02690831|Inspiratory Muscle Training|inspiratory muscle training
4788400|NCT02690831|Manual Therapies|manual therapies
4788401|NCT02690818|Tuberculosis|tuberculosis
4788402|NCT02690818|Latent Tuberculosis|latent tuberculosis
4788403|NCT02690818|Texting|texting
4788404|NCT02690818|Adherence|adherence
4788405|NCT02690818|Medication|medication
4788406|NCT02690792|Healthy|healthy
4788407|NCT02690792|NAFLD|nafld
4788408|NCT02690792|NASH|nash
4788409|NCT02690792|Liver Metabolism|liver metabolism
4788410|NCT02690792|Vitamin E|vitamin e
4788411|NCT02690766|Cancer|cancer
4788412|NCT02690766|Breast Cancer|breast cancer
4788413|NCT02690766|Endometrial cancer,|endometrial cancer,
4788414|NCT02690766|Type 2 Diabetes|type 2 diabetes
4788415|NCT02690753|Repositioning|repositioning
4788416|NCT02690753|Incontinence care|incontinence care
4788417|NCT02690753|Prevention|prevention
4788418|NCT02690740|titrated quantitative conjunctival provocation test|titrated quantitative conjunctival provocation test
4788419|NCT02690727|Fasting|fasting
4788420|NCT02690727|Fed condition|fed condition
4788421|NCT02690727|Pharmacokinetics|pharmacokinetics
4788422|NCT02690701|psoriasis|psoriasis
4788423|NCT02690701|plaque psoriasis|plaque psoriasis
4788424|NCT02690701|secukinumab|secukinumab
4788425|NCT02690701|AIN457|ain457
4788426|NCT02690701|biologic|biologic
4788427|NCT02690701|monoclonal antibody|monoclonal antibody
4788930|NCT02687867|Stroke|stroke
4788428|NCT02690688|Pulse Pressure Variation|pulse pressure variation
4788429|NCT02690688|NIRS|nirs
4788430|NCT02690688|Pneumoperitoneum|pneumoperitoneum
4788431|NCT02690688|Abdominal surgery|abdominal surgery
4788432|NCT02690675|Neurodevelopment|neurodevelopment
4788433|NCT02690675|Bayley Scale|bayley scale
4788434|NCT02690675|Growth|growth
4788435|NCT02690675|Iron fortification|iron fortification
4788436|NCT02690662|Obesity|obesity
4788437|NCT02690662|Kidney stones|kidney stones
4788438|NCT02690662|Diet|diet
4788439|NCT02690649|anticoagulants|anticoagulants
4788440|NCT02690649|Personal Health Records|personal health records
4788441|NCT02690623|hospitalist|hospitalist
4788442|NCT02690623|pediatric inpatient care|pediatric inpatient care
4788443|NCT02690610|EBUS, Mediastinal lesions, Mediastinal lymph node|ebus, mediastinal lesions, mediastinal lymph node
4788444|NCT02690597|Anxiety analogic visual scale|anxiety analogic visual scale
4788445|NCT02690597|Pain|pain
4788446|NCT02690597|State Trait Inventory anxiety scale|state trait inventory anxiety scale
4788447|NCT02690597|Anxiety|anxiety
4788448|NCT02690584|Psychotherapy|psychotherapy
4788449|NCT02690571|Air Pollution|air pollution
4788450|NCT02690571|Biodiesel exhaust|biodiesel exhaust
4788451|NCT02690571|Bronchoscopy|bronchoscopy
4788452|NCT02690571|Metabolomics|metabolomics
4788453|NCT02690558|muscle-invasive|muscle-invasive
4788454|NCT02690545|CAR T cells|car t cells
4788455|NCT02690545|CD30|cd30
4788456|NCT02690545|Lymphoma|lymphoma
4788457|NCT02690545|T Lymphocytes|t lymphocytes
4788458|NCT02690532|Celiac|celiac
4788459|NCT02690532|Gluten|gluten
4788460|NCT02690532|Sensitivity|sensitivity
4788461|NCT02690532|Permeability|permeability
4788462|NCT02690532|Non-celiac gluten intolerance|non-celiac gluten intolerance
4788463|NCT02690532|Gastrointestinal Diseases|gastrointestinal diseases
4788464|NCT02690532|Digestive System Diseases|digestive system diseases
4788465|NCT02690519|Cystic fibrosis S1251N mutation|cystic fibrosis s1251n mutation
4788466|NCT02690519|GLPG1837|glpg1837
4788467|NCT02690506|pregabalin|pregabalin
4788468|NCT02690506|spinal anesthesia|spinal anesthesia
4788469|NCT02690480|fulvestrant|fulvestrant
4788470|NCT02690480|palbociclib|palbociclib
4788471|NCT02690480|metastases|metastases
4788472|NCT02690480|postmenopausal|postmenopausal
4788473|NCT02690480|breast cancer|breast cancer
4788474|NCT02690480|hormone receptor positive|hormone receptor positive
4788475|NCT02690467|Insulin therapy|insulin therapy
4788476|NCT02690467|Needle|needle
4788477|NCT02690454|ticagrelor|ticagrelor
4788478|NCT02690454|ticagrelor active metabolite (AR-C124910XX)|ticagrelor active metabolite (ar-c124910xx)
4788479|NCT02690454|platelet function tests|platelet function tests
4788480|NCT02690454|the flow cytometric VASP assay|the flow cytometric vasp assay
4788481|NCT02690454|the VerifyNow® device|the verifynow® device
4788482|NCT02690454|the Multiplate® analyzer|the multiplate® analyzer
4788483|NCT02690454|pharmacokinetics|pharmacokinetics
4788484|NCT02690454|pharmacodynamics|pharmacodynamics
4788485|NCT02690454|Multiplate® ADPtest|multiplate® adptest
4788486|NCT02690454|VerifyNow® PRUTest™|verifynow® prutest™
4788487|NCT02690454|Platelet VASP/P2Y12 assay|platelet vasp/p2y12 assay
4788488|NCT02690441|GAD|gad
4788489|NCT02690441|CBT|cbt
4788490|NCT02690441|Physical exercise|physical exercise
4788491|NCT02690441|Older adults|older adults
4788492|NCT02690428|Hyperthermia, Induced|hyperthermia, induced
4788493|NCT02690428|Laser Coagulation|laser coagulation
4788494|NCT02690428|Laser Therapy|laser therapy
4788495|NCT02690389|Acupuncture|acupuncture
4788496|NCT02690389|Flumazenil|flumazenil
4788497|NCT02690389|Narcotrend|narcotrend
4788498|NCT02690389|General Anaesthesia|general anaesthesia
4788499|NCT02690389|Sedation|sedation
4788500|NCT02690337|Advanced solid malignant tumors|advanced solid malignant tumors
4788501|NCT02690337|phase 1|phase 1
4788502|NCT02690337|oncology|oncology
4788503|NCT02690337|refractory|refractory
4788504|NCT02690337|no standard treatment|no standard treatment
4788505|NCT02690272|kidney transplant|kidney transplant
4788506|NCT02690272|psychic process|psychic process
4788507|NCT02690259|Sentinel Lymph Node Biopsy|sentinel lymph node biopsy
4788508|NCT02690233|endothelial dysfunction|endothelial dysfunction
4788509|NCT02690233|surgery|surgery
4788510|NCT02690233|cardiovascular complications|cardiovascular complications
4788511|NCT02690233|EndoPat|endopat
4788512|NCT02690233|myocardial injury|myocardial injury
4788513|NCT02690233|myocardial infarction|myocardial infarction
4788514|NCT02690220|polypropylene mesh|polypropylene mesh
4788515|NCT02690220|prolapse|prolapse
4788516|NCT02690220|cystocele|cystocele
4788517|NCT02690220|surgical mesh|surgical mesh
4788518|NCT02690207|Herpes Zoster|herpes zoster
4788519|NCT02690207|Safety|safety
4788520|NCT02690207|Adults|adults
4788521|NCT02690207|Cross-vaccination|cross-vaccination
4788522|NCT02690194|Buddhify|buddhify
4788523|NCT02690194|Stress|stress
4788524|NCT02690194|Anxiety|anxiety
4788525|NCT02690194|Relaxation Technique|relaxation technique
4788526|NCT02690168|Fasting|fasting
4788527|NCT02690168|Carbon-13 Magnetic Resonance Spectroscopy|carbon-13 magnetic resonance spectroscopy
4788528|NCT02690168|Neuroimaging|neuroimaging
4789029|NCT02687035|Certitude|certitude
4788529|NCT02690155|Non-valvular atrial fibrillation (NVAF)|non-valvular atrial fibrillation (nvaf)
4788530|NCT02690155|Prevention|prevention
4788531|NCT02690155|Stroke|stroke
4788532|NCT02690129|progesterone|progesterone
4788533|NCT02690129|threatened abortion|threatened abortion
4788534|NCT02690116|Meditative movement|meditative movement
4788535|NCT02690116|Breast cancer survivors|breast cancer survivors
4788536|NCT02690116|Qigong|qigong
4788537|NCT02690116|Tai Chi Easy|tai chi easy
4788538|NCT02690116|Fatigue|fatigue
4788539|NCT02690103|Arabinoxylan|arabinoxylan
4788541|NCT02690103|Viremia|viremia
4788542|NCT02690103|Biobran|biobran
4788543|NCT02690103|PEG interferon|peg interferon
4788544|NCT02690090|Deep Vein Thrombosis|deep vein thrombosis
4788545|NCT02690090|Prophylaxis|prophylaxis
4788546|NCT02690090|Critically ill adults|critically ill adults
4788547|NCT02690077|Patient Satisfaction|patient satisfaction
4788548|NCT02690077|Earlier Family Bond Initiation|earlier family bond initiation
4788549|NCT02690077|Maternal and Neonatal Outcomes|maternal and neonatal outcomes
4788550|NCT02690064|Endothelial Function|endothelial function
4788551|NCT02690064|Maximal Exercise Capacity|maximal exercise capacity
4788552|NCT02690064|Flow Mediated Dilation|flow mediated dilation
4788553|NCT02690064|Antioxidant|antioxidant
4788554|NCT02690064|FEV1|fev1
4788555|NCT02690038|AECOPD|aecopd
4788556|NCT02690038|COPD|copd
4788557|NCT02689999|Gastroesophageal Reflux Disease (GERD), GERD, impedence|gastroesophageal reflux disease (gerd), gerd, impedence
4788558|NCT02689986|Cold agglutinin|cold agglutinin
4788559|NCT02689986|Cold agglutinin disease|cold agglutinin disease
4788560|NCT02689986|Anemia|anemia
4788561|NCT02689986|Hemolytic|hemolytic
4788562|NCT02689986|Autoimmune|autoimmune
4788563|NCT02689986|Bendamustine|bendamustine
4788564|NCT02689986|Rituximab|rituximab
4788565|NCT02689973|adolescence|adolescence
4788566|NCT02689973|body fat|body fat
4788567|NCT02689973|physical activity|physical activity
4788568|NCT02689973|psychosocial intervention|psychosocial intervention
4788569|NCT02689973|self-efficacy|self-efficacy
4788570|NCT02689973|planning|planning
4788571|NCT02689960|addison disease|addison disease
4788572|NCT02689960|adrenal crisis|adrenal crisis
4788573|NCT02689960|prednisone|prednisone
4788574|NCT02689934|hypercholesterolemia|hypercholesterolemia
4788575|NCT02689934|bifidobacterium longum BB536|bifidobacterium longum bb536
4788576|NCT02689934|red yeast rice|red yeast rice
4788577|NCT02689934|monacolin K|monacolin k
4788578|NCT02689934|lactoflorene colesterolo|lactoflorene colesterolo
4788579|NCT02689908|Thorax CT|thorax ct
4788580|NCT02689908|Low Dose|low dose
4788581|NCT02689908|Body Mass Index|body mass index
4788582|NCT02689908|Neck Circumference|neck circumference
4788583|NCT02689895|adolescents|adolescents
4788584|NCT02689895|second line treatment failure|second line treatment failure
4788585|NCT02689895|adherence|adherence
4788586|NCT02689895|drug resistance|drug resistance
4788587|NCT02689882|nicotinamide riboside|nicotinamide riboside
4788588|NCT02689882|nicotinamide ribonucleoside|nicotinamide ribonucleoside
4788589|NCT02689882|Nicotinamide-Adenine Dinucleotide|nicotinamide-adenine dinucleotide
4788590|NCT02689869|indolent lymphoma|indolent lymphoma
4788591|NCT02689869|novel agents|novel agents
4788592|NCT02689869|chemotherapy free treatment|chemotherapy free treatment
4788593|NCT02689869|ibrutinib|ibrutinib
4788594|NCT02689869|obinutuzumab|obinutuzumab
4788595|NCT02689869|GA101|ga101
4788596|NCT02689843|Inflammation|inflammation
4788597|NCT02689843|Complement system proteins|complement system proteins
4788598|NCT02689843|Homocysteine|homocysteine
4788599|NCT02689843|C-Reactive Protein|c-reactive protein
4788600|NCT02689843|Cyproterone|cyproterone
4788601|NCT02689843|Ethinyl Estradiol|ethinyl estradiol
4788602|NCT02689843|Androgen Antagonists|androgen antagonists
4788603|NCT02689843|Metformin|metformin
4788604|NCT02689843|Thiazolidinediones|thiazolidinediones
4788605|NCT02689843|Pioglitazone|pioglitazone
4788606|NCT02689817|Pressure ulcer|pressure ulcer
4788607|NCT02689817|Monitoring|monitoring
4788608|NCT02689817|Pressure|pressure
4788609|NCT02689817|Physiologic feedback|physiologic feedback
4788610|NCT02689804|Emergency contraception|emergency contraception
4788611|NCT02689791|Appetite|appetite
4788612|NCT02689791|Food Intake|food intake
4788613|NCT02689791|Satiety Hormones|satiety hormones
4788614|NCT02689778|Pirfenidone|pirfenidone
4788615|NCT02689778|Diabetic nephropathy|diabetic nephropathy
4788616|NCT02689752|mass balance|mass balance
4788617|NCT02689752|14C|14c
4788618|NCT02689713|Burn Pain|burn pain
4788619|NCT02689713|Hyperalgesia|hyperalgesia
4788620|NCT02689713|TRPV1|trpv1
4788621|NCT02689713|OLAMs|olams
4788622|NCT02689700|Human Cytomegalovirus|human cytomegalovirus
4788623|NCT02689700|Varicella Zoster Virus|varicella zoster virus
4788624|NCT02689700|Materno-fetal antibody transfer|materno-fetal antibody transfer
4788625|NCT02689700|Pregnancy|pregnancy
4788626|NCT02689700|Gestational age|gestational age
4788627|NCT02689622|Hematology|hematology
4788628|NCT02689622|Elderly|elderly
4788629|NCT02689622|High Risk Myelodysplastic Syndrome|high risk myelodysplastic syndrome
4788630|NCT02689609|Nasopharyngeal carcinoma|nasopharyngeal carcinoma
4789030|NCT02687035|TAVR|tavr
4788631|NCT02689609|Intensity-modulated radiation therapy|intensity-modulated radiation therapy
4788632|NCT02689609|Hypothyroidism|hypothyroidism
4788633|NCT02689609|Predictors|predictors
4788634|NCT02689583|Helicobacter pylori|helicobacter pylori
4788635|NCT02689583|Antibiotic resistance|antibiotic resistance
4788636|NCT02689583|Sequencing|sequencing
4788637|NCT02689583|Mechanism|mechanism
4788638|NCT02689583|Cause|cause
4788639|NCT02689570|type 1 diabetes|type 1 diabetes
4788640|NCT02689570|coronary artery calcifications|coronary artery calcifications
4788641|NCT02689570|diastolic dysfunction|diastolic dysfunction
4788642|NCT02689570|adipokines|adipokines
4788643|NCT02689570|visceral adipose tissue|visceral adipose tissue
4788644|NCT02689544|exercise muscle stretching|exercise muscle stretching
4788645|NCT02689544|range of motion|range of motion
4788646|NCT02689544|dynamometer of muscle strength|dynamometer of muscle strength
4788647|NCT02689544|electromyography|electromyography
4788648|NCT02689518|AMD|amd
4788649|NCT02689518|Wet AMD|wet amd
4788650|NCT02689518|Macular degeneration|macular degeneration
4788651|NCT02689518|Wet macular degeneration|wet macular degeneration
4788652|NCT02689518|Neovascularization|neovascularization
4788653|NCT02689518|Retina|retina
4788654|NCT02689518|Retinal degeneration|retinal degeneration
4788655|NCT02689479|Clinical Islet Transplantation|clinical islet transplantation
4788656|NCT02689479|Positron Emission Tomography (PET) Computed Tomography (CT) imaging|positron emission tomography (pet) computed tomography (ct) imaging
4788657|NCT02689466|Adult|adult
4788658|NCT02689466|Acetylcholine|acetylcholine
4788659|NCT02689466|Movement Disorder|movement disorder
4788660|NCT02689466|Magnetic Resonance Imaging (MRI)|magnetic resonance imaging (mri)
4788661|NCT02689466|PET Imaging|pet imaging
4788662|NCT02689453|T-cell Lymphoproliferative Disorder|t-cell lymphoproliferative disorder
4788663|NCT02689453|CD4/CD25 Expressing T-cells in Blood and Lymphoid Tissues|cd4/cd25 expressing t-cells in blood and lymphoid tissues
4788664|NCT02689453|Anti-CD52 Monoclonal Antibody|anti-cd52 monoclonal antibody
4788665|NCT02689453|Antibody Dependent Cellular Cytotoxicity|antibody dependent cellular cytotoxicity
4788666|NCT02689440|Chronic Myelogenous Leukemia|chronic myelogenous leukemia
4788667|NCT02689440|CML|cml
4788668|NCT02689440|Ph-positive chronic myelogenous leukemia|ph-positive chronic myelogenous leukemia
4788669|NCT02689440|BCR-ABL positive chronic myelogenous leukemia|bcr-abl positive chronic myelogenous leukemia
4788670|NCT02689440|Dasatinib|dasatinib
4788671|NCT02689440|BMS-354825|bms-354825
4788672|NCT02689440|Sprycel|sprycel
4788673|NCT02689440|Venetoclax|venetoclax
4788674|NCT02689440|ABT-199|abt-199
4788675|NCT02689440|GDC-0199|gdc-0199
4788676|NCT02689427|Breast cancer|breast cancer
4788677|NCT02689427|Invasive carcinoma of the breast|invasive carcinoma of the breast
4788678|NCT02689427|Triple-negative breast cancer|triple-negative breast cancer
4788679|NCT02689427|TNBC|tnbc
4788680|NCT02689427|Enzalutamide|enzalutamide
4788681|NCT02689427|MDV3100|mdv3100
4788682|NCT02689427|XTANDI|xtandi
4788683|NCT02689427|Paclitaxel|paclitaxel
4788684|NCT02689427|Taxol|taxol
4788685|NCT02689414|Atherosclerosis|atherosclerosis
4788686|NCT02689401|Esophageal Cancer|esophageal cancer
4788687|NCT02689401|lymph nodes tumor|lymph nodes tumor
4788688|NCT02689388|analgesia|analgesia
4788689|NCT02689388|regional analgesia|regional analgesia
4788690|NCT02689388|femoral nerve block|femoral nerve block
4788691|NCT02689388|older persons|older persons
4788692|NCT02689388|frail|frail
4788693|NCT02689362|Diabetes Mellitus Type 2|diabetes mellitus type 2
4788694|NCT02689349|hearing|hearing
4788695|NCT02689349|implant|implant
4788696|NCT02689349|moderate degree|moderate degree
4788697|NCT02689349|severe degree|severe degree
4788698|NCT02689310|Wound Care|wound care
4788699|NCT02689310|Medical Grade Honey|medical grade honey
4788700|NCT02689310|Pressure Ulcers|pressure ulcers
4788701|NCT02689284|Stomach Cancer|stomach cancer
4788702|NCT02689284|Gastroesophageal Junction|gastroesophageal junction
4788703|NCT02689284|Gastric Cancer|gastric cancer
4788704|NCT02689284|Cancer of the Stomach|cancer of the stomach
4788705|NCT02689284|Cancer of Stomach|cancer of stomach
4788706|NCT02689284|Stomach|stomach
4788707|NCT02689284|Pembrolizumab|pembrolizumab
4788708|NCT02689284|Keytruda|keytruda
4788709|NCT02689284|HER2+|her2+
4788710|NCT02689284|GEJ|gej
4788711|NCT02689284|HER2 positive|her2 positive
4788712|NCT02689284|Metastatic|metastatic
4788713|NCT02689284|Margetuximab|margetuximab
4788714|NCT02689284|Immunotherapy|immunotherapy
4788715|NCT02689284|Trastuzumab|trastuzumab
4788716|NCT02689284|Human epidermal growth factor receptor 2|human epidermal growth factor receptor 2
4788717|NCT02689284|Human epidermal growth factor receptor 2-positive|human epidermal growth factor receptor 2-positive
4788718|NCT02689284|gastroesophageal junction cancer|gastroesophageal junction cancer
4788719|NCT02689284|Pembro|pembro
4788720|NCT02689284|PD-L1|pd-l1
4788721|NCT02689284|PD-1|pd-1
4788722|NCT02689284|PD|pd
4788723|NCT02689284|Tumor|tumor
4788724|NCT02689284|Cancer|cancer
4788725|NCT02689271|MRI|mri
4788726|NCT02689271|Magnetic resonance imaging|magnetic resonance imaging
4788727|NCT02689271|Biomarkers|biomarkers
4788728|NCT02689271|Fluidics|fluidics
4788729|NCT02689271|Diffusion MRI|diffusion mri
4788730|NCT02689219|Antigens, CD30, Embryonal Germ Cell Tumors|antigens, cd30, embryonal germ cell tumors
4788731|NCT02689206|Chronic kidney disease|chronic kidney disease
4788732|NCT02689206|Efficacy|efficacy
4788733|NCT02689206|Erythropoiesis-stimulating agent|erythropoiesis-stimulating agent
4788734|NCT02689206|GSK1278863|gsk1278863
4788735|NCT02689206|Safety|safety
4788736|NCT02689206|Hemodialysis-dependent anemia|hemodialysis-dependent anemia
4788737|NCT02689206|Pharmacokinetics|pharmacokinetics
4788738|NCT02689193|Proteomics|proteomics
4788739|NCT02689193|Rapid Diagnostic Test|rapid diagnostic test
4788740|NCT02689193|Salmonellosis|salmonellosis
4788741|NCT02689180|heart failure|heart failure
4788742|NCT02689180|diuretics|diuretics
4788743|NCT02689180|furosemide|furosemide
4788744|NCT02689167|renal cell carcinoma|renal cell carcinoma
4788745|NCT02689167|sunitinib|sunitinib
4788746|NCT02689167|metastatic|metastatic
4788747|NCT02689167|schedule|schedule
4788748|NCT02689167|toxicity|toxicity
4788749|NCT02689167|safety|safety
4788750|NCT02689154|Pediatric Obesity|pediatric obesity
4788751|NCT02689154|Food Addiction|food addiction
4788752|NCT02689154|Mobile Health (mHealth)|mobile health (mhealth)
4788753|NCT02689154|Weight Management|weight management
4788754|NCT02689141|chronic lymphocytic leukemia CLL|chronic lymphocytic leukemia cll
4788755|NCT02689141|untreated chronic lymphocytic leukemia|untreated chronic lymphocytic leukemia
4788756|NCT02689141|relapsed chronic lymphocytic leukemia|relapsed chronic lymphocytic leukemia
4788757|NCT02689141|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
4788758|NCT02689128|Anesthesia|anesthesia
4788759|NCT02689128|postoperative|postoperative
4788760|NCT02689128|nausea|nausea
4788761|NCT02689128|vomiting|vomiting
4788762|NCT02689115|Nuclear factor Kappa B|nuclear factor kappa b
4788763|NCT02689115|IKK epsilon|ikk epsilon
4788764|NCT02689102|Optical coherence tomography|optical coherence tomography
4788765|NCT02689102|Confocal laser endomicroscopy|confocal laser endomicroscopy
4788766|NCT02689076|Patient transfer|patient transfer
4788767|NCT02689076|Patient care management|patient care management
4788768|NCT02689076|Health information exchange|health information exchange
4788769|NCT02689063|Analgesic|analgesic
4788770|NCT02689024|Nerve block|nerve block
4788771|NCT02689024|Analgesia|analgesia
4788772|NCT02689011|Total Knee Arthroplasty|total knee arthroplasty
4788773|NCT02689011|Femoral Nerve Block|femoral nerve block
4788774|NCT02689011|Epidural Analgesia|epidural analgesia
4788775|NCT02689011|Urinary Retention|urinary retention
4788776|NCT02689011|Lumbar Epidural|lumbar epidural
4788777|NCT02688998|HER2 negative|her2 negative
4788778|NCT02688959|motor attention training|motor attention training
4788779|NCT02688959|exercise|exercise
4788780|NCT02688959|tai chi|tai chi
4788781|NCT02688959|ADHD|adhd
4788782|NCT02688855|Bone Growth Stimulator|bone growth stimulator
4788783|NCT02688855|Ankle Fracture|ankle fracture
4788784|NCT02688829|stents,percutaneous coronary intervention|stents,percutaneous coronary intervention
4788785|NCT02688816|visual inspection with acetic acid|visual inspection with acetic acid
4788786|NCT02688816|Xpert HPV|xpert hpv
4788787|NCT02688816|OncoE6|oncoe6
4788788|NCT02688816|screening|screening
4788789|NCT02688803|HER2 Negative|her2 negative
4788790|NCT02688777|Rehabilitation|rehabilitation
4788791|NCT02688777|Gait|gait
4788792|NCT02688777|Postural Balance|postural balance
4788793|NCT02688777|Exercise|exercise
4788794|NCT02688777|Accidental Falls|accidental falls
4788795|NCT02688777|Kinesiology, Applied|kinesiology, applied
4788796|NCT02688764|PA21|pa21
4788797|NCT02688764|phosphate binder|phosphate binder
4788798|NCT02688712|IIA|iia
4788799|NCT02688712|Xeloda|xeloda
4788800|NCT02688712|radiation therapy|radiation therapy
4788801|NCT02688712|LY2157299|ly2157299
4788802|NCT02688712|tumor resection|tumor resection
4788803|NCT02688712|capecitabine|capecitabine
4788804|NCT02688712|5FU|5fu
4788805|NCT02688712|Fluorouracil|fluorouracil
4788806|NCT02688712|IIB|iib
4788807|NCT02688712|IIC|iic
4788808|NCT02688712|IV|iv
4788809|NCT02688712|neoadjuvant|neoadjuvant
4788810|NCT02688712|Rectal cancer|rectal cancer
4788811|NCT02688712|Immunotherapy|immunotherapy
4788812|NCT02688660|Pediatrics|pediatrics
4788813|NCT02688660|Neuroimaging|neuroimaging
4788814|NCT02688647|Pulmonary Fibrosis|pulmonary fibrosis
4788815|NCT02688647|Fibrosis|fibrosis
4788816|NCT02688647|Idiopathic Interstitial Pneumonias|idiopathic interstitial pneumonias
4788817|NCT02688647|Lung Diseases|lung diseases
4788818|NCT02688634|Cleft Palate Surgery|cleft palate surgery
4788819|NCT02688634|Antibiotic treatment|antibiotic treatment
4788820|NCT02688621|weight loss|weight loss
4788821|NCT02688621|financial incentives|financial incentives
4788822|NCT02688621|internet weight loss|internet weight loss
4788823|NCT02688595|Infant, Newborn|infant, newborn
4788824|NCT02688595|Ultrasonography|ultrasonography
4788825|NCT02688582|Target Controlled Infusion|target controlled infusion
4788826|NCT02688582|Pharmacokinetics|pharmacokinetics
4788827|NCT02688582|Cefepime|cefepime
4788828|NCT02688582|critically ill patients|critically ill patients
4788829|NCT02688556|KCS|kcs
4788830|NCT02688556|dry eye|dry eye
4788831|NCT02688556|cyclosporine|cyclosporine
4788832|NCT02688543|radio frequency treatment|radio frequency treatment
4788833|NCT02688543|genicular nerves|genicular nerves
4788834|NCT02688543|osteoarthritis of the knee|osteoarthritis of the knee
4788835|NCT02688504|labelled medicines|labelled medicines
4788836|NCT02688504|drivers involved in serious and non-serious road accidents|drivers involved in serious and non-serious road accidents
4788837|NCT02688504|relevance and effectiveness of pictograms on medicines packaging|relevance and effectiveness of pictograms on medicines packaging
4788838|NCT02688478|Phthalate|phthalate
4788839|NCT02688478|Dibutylphthalate (DBP)|dibutylphthalate (dbp)
4788840|NCT02688478|Airway responsiveness|airway responsiveness
4788841|NCT02688478|Allergies|allergies
4788842|NCT02688452|strenuous exercise|strenuous exercise
4788843|NCT02688452|muscle soreness|muscle soreness
4788844|NCT02688413|Virtual reality|virtual reality
4788845|NCT02688413|Stroke|stroke
4788846|NCT02688413|Neurorehabilitation|neurorehabilitation
4788847|NCT02688413|Upper-limb rehabilitation|upper-limb rehabilitation
4788848|NCT02688413|Training games|training games
4788849|NCT02688400|Osteoarthritis|osteoarthritis
4788850|NCT02688400|Knee|knee
4788851|NCT02688400|Osteoarthritis, Knee|osteoarthritis, knee
4788852|NCT02688400|Diacerein|diacerein
4788853|NCT02688400|Celecoxib|celecoxib
4788854|NCT02688400|Phase III|phase iii
4788855|NCT02688400|Phase IV|phase iv
4788856|NCT02688400|Phase III-IV|phase iii-iv
4788857|NCT02688400|Canada|canada
4788858|NCT02688400|Spain|spain
4788859|NCT02688400|Austria|austria
4788860|NCT02688400|Czech Republic|czech republic
4788861|NCT02688400|WOMAC|womac
4788862|NCT02688387|Ambrisentan|ambrisentan
4788863|NCT02688387|Bioavailability|bioavailability
4788864|NCT02688387|Tadalafil|tadalafil
4788865|NCT02688387|Fixed Dose combination|fixed dose combination
4788866|NCT02688322|sulbactam|sulbactam
4788867|NCT02688322|pharmacokinetics|pharmacokinetics
4788868|NCT02688322|pharmacodynamics|pharmacodynamics
4788869|NCT02688322|Acinetobacter infections|acinetobacter infections
4788870|NCT02688257|Magnetic Resonance Imaging|magnetic resonance imaging
4788871|NCT02688257|Ultrasound|ultrasound
4788872|NCT02688257|Breast Cancer|breast cancer
4788873|NCT02688244|complicated appendicitis|complicated appendicitis
4788874|NCT02688244|laparoscopic appendectomy|laparoscopic appendectomy
4788875|NCT02688244|irrigation|irrigation
4788876|NCT02688244|suction|suction
4788877|NCT02688244|abdominal abscess|abdominal abscess
4788878|NCT02688231|Multiple Sclerosis|multiple sclerosis
4788879|NCT02688231|Upper limb rehabilitation|upper limb rehabilitation
4788880|NCT02688218|exercise|exercise
4788881|NCT02688218|artificial pancreas|artificial pancreas
4788882|NCT02688218|hypoglycemia|hypoglycemia
4788883|NCT02688218|type 1 diabetes|type 1 diabetes
4788884|NCT02688205|Cyriax's functional examination|cyriax's functional examination
4788885|NCT02688205|Ultrasound|ultrasound
4788886|NCT02688205|Correlation|correlation
4788887|NCT02688205|Resisted test|resisted test
4788888|NCT02688153|Aortic Valve Replacement|aortic valve replacement
4788889|NCT02688153|Aortic Stenosis|aortic stenosis
4788890|NCT02688153|EDWARDS INTUITY|edwards intuity
4788891|NCT02688140|APL|apl
4788892|NCT02688140|acute promyelocytic leukemia (M3)|acute promyelocytic leukemia (m3)
4788893|NCT02688140|high-risk acute promyelocytic leukemia (APL/AML M3)|high-risk acute promyelocytic leukemia (apl/aml m3)
4788894|NCT02688140|acute myeloid leukemia with t(15;17)(q22;q12)|acute myeloid leukemia with t(15;17)(q22;q12)
4788895|NCT02688140|newly diagnosed|newly diagnosed
4788896|NCT02688140|high-risk|high-risk
4788897|NCT02688127|obstetric bleeding placenta previa|obstetric bleeding placenta previa
4788898|NCT02688075|Diabetes Mellitus Type 2|diabetes mellitus type 2
4788899|NCT02688075|Canagliflozin|canagliflozin
4788900|NCT02688075|Observational Study|observational study
4788901|NCT02688036|Limited Disease Small Cell Lung Cancer|limited disease small cell lung cancer
4788902|NCT02688036|concurrent chemoradiotherapy|concurrent chemoradiotherapy
4788903|NCT02688036|dose fractionation|dose fractionation
4788904|NCT02688023|5-fluorouracil|5-fluorouracil
4788905|NCT02688023|Irinotecan|irinotecan
4788906|NCT02688023|Oxaliplatin|oxaliplatin
4788907|NCT02688023|Colorectal cancer|colorectal cancer
4788908|NCT02688023|neoadjuvant|neoadjuvant
4788909|NCT02688023|chemotherapy|chemotherapy
4788910|NCT02688010|noise|noise
4788911|NCT02688010|sound|sound
4788912|NCT02688010|cycled light|cycled light
4788913|NCT02688010|preterm infants|preterm infants
4788914|NCT02688010|neonatal care|neonatal care
4788915|NCT02688010|growth|growth
4788916|NCT02688010|visual development|visual development
4788917|NCT02687984|Schizophrenia|schizophrenia
4788918|NCT02687984|Long-acting Risperidone|long-acting risperidone
4788919|NCT02687984|Atrigel|atrigel
4788920|NCT02687958|GEP/ NEC|gep/ nec
4788921|NCT02687932|Functional Mitral Regurgitation|functional mitral regurgitation
4788922|NCT02687932|Ischemic Mitral Regurgitation|ischemic mitral regurgitation
4788923|NCT02687919|diet (gluten-free)|diet (gluten-free)
4788924|NCT02687919|diet therapy|diet therapy
4788925|NCT02687919|quality of life|quality of life
4788926|NCT02687893|Sleep|sleep
4788927|NCT02687893|Exercise|exercise
4788928|NCT02687867|Non-valvular atrial fibrillation (NVAF)|non-valvular atrial fibrillation (nvaf)
4788929|NCT02687867|Prevention|prevention
4788931|NCT02687854|Non-valvular atrial fibrillation (NVAF)|non-valvular atrial fibrillation (nvaf)
4788932|NCT02687854|Prevention|prevention
4788933|NCT02687854|Stroke|stroke
4788934|NCT02687841|acute kidney injury|acute kidney injury
4788935|NCT02687841|indoxylsulfate|indoxylsulfate
4788936|NCT02687841|p-cresol|p-cresol
4788937|NCT02687841|AST-120|ast-120
4788938|NCT02687828|Intestinal Behcet's Disease (BD)|intestinal behcet's disease (bd)
4788939|NCT02687828|Adalimumab|adalimumab
4788940|NCT02687828|Safety|safety
4788941|NCT02687828|Effectiveness|effectiveness
4788942|NCT02687828|AMORE study|amore study
4788943|NCT02687815|Vitamin D, severe asthma exacerbations, children|vitamin d, severe asthma exacerbations, children
4788944|NCT02687802|respiratory mechanics|respiratory mechanics
4788945|NCT02687802|Respiratory Insufficiency|respiratory insufficiency
4788946|NCT02687802|artificial, ventilation|artificial, ventilation
4788947|NCT02687789|Bacterial Vaginosis|bacterial vaginosis
4788948|NCT02687789|BV|bv
4788949|NCT02687776|Copeptin, human|copeptin, human
4788950|NCT02687763|vaccines|vaccines
4788951|NCT02687763|ProQuad|proquad
4788952|NCT02687763|immunosuppressed|immunosuppressed
4788953|NCT02687763|solid organ transplant|solid organ transplant
4788954|NCT02687763|MMRV|mmrv
4788955|NCT02687737|Tongue|tongue
4788956|NCT02687737|Genioglossus|genioglossus
4788957|NCT02687737|genioglossus recruitment|genioglossus recruitment
4788958|NCT02687711|Non-interventional (NIS)|non-interventional (nis)
4788959|NCT02687711|Epilepsy|epilepsy
4788960|NCT02687711|Partial Onset Seizures (POS)|partial onset seizures (pos)
4788961|NCT02687711|add-on therapy|add-on therapy
4788962|NCT02687685|Skin to Skin Contact|skin to skin contact
4788963|NCT02687685|Infant, Newborn|infant, newborn
4788964|NCT02687607|Endovascular|endovascular
4788965|NCT02687607|Brain aneurysm|brain aneurysm
4788966|NCT02687607|Ruptured aneurysm|ruptured aneurysm
4788967|NCT02687542|Parkinson Disease|parkinson disease
4788968|NCT02687542|Motor Fluctuation|motor fluctuation
4788969|NCT02687529|Tuberculosis|tuberculosis
4788970|NCT02687529|TB|tb
4788971|NCT02687516|Treatment|treatment
4788972|NCT02687516|Child|child
4788973|NCT02687516|Obesity|obesity
4788974|NCT02687516|Behavioral treatment|behavioral treatment
4788975|NCT02687503|Immune system|immune system
4788976|NCT02687503|Probiotics|probiotics
4788977|NCT02687464|Pediatric Surgery|pediatric surgery
4788978|NCT02687464|Pediatrics|pediatrics
4788979|NCT02687464|Randomized controlled trial,|randomized controlled trial,
4788980|NCT02687464|Antibiotics|antibiotics
4788981|NCT02687464|Cost effectiveness|cost effectiveness
4788982|NCT02687451|Surgical Pain|surgical pain
4788983|NCT02687451|Acute Post-Surgical Pain|acute post-surgical pain
4788984|NCT02687438|Steroid-eluting implant Mometasone Furoate|steroid-eluting implant mometasone furoate
4788985|NCT02687425|Pioglitazone|pioglitazone
4788986|NCT02687425|Chronic Myeloid Leukemia|chronic myeloid leukemia
4788987|NCT02687412|Fast-track surgery|fast-track surgery
4788988|NCT02687412|Gynecological oncology|gynecological oncology
4788989|NCT02687412|Hospitalization post-operation|hospitalization post-operation
4788990|NCT02687412|Complication|complication
4788991|NCT02687399|knee arthroplasty|knee arthroplasty
4788992|NCT02687386|Recurrent|recurrent
4788993|NCT02687386|Refractory|refractory
4788994|NCT02687373|Plasmodium falciparum|plasmodium falciparum
4788995|NCT02687373|PfSPZ Vaccine|pfspz vaccine
4788996|NCT02687308|Prostatic cancer|prostatic cancer
4788997|NCT02687308|Radical prostatectomy|radical prostatectomy
4788998|NCT02687308|Minimally invasive prostate cancer surgery|minimally invasive prostate cancer surgery
4788999|NCT02687282|Modified Mallampati score|modified mallampati score
4789000|NCT02687282|Cesarean delivery|cesarean delivery
4789001|NCT02687269|myocardial protection|myocardial protection
4789002|NCT02687269|coronary artery bypass grafting|coronary artery bypass grafting
4789003|NCT02687243|pediatrics|pediatrics
4789004|NCT02687243|anxiety|anxiety
4789005|NCT02687243|anesthesia|anesthesia
4789006|NCT02687243|preoperative|preoperative
4789007|NCT02687217|PerioperativeHyperoxygenation|perioperativehyperoxygenation
4789008|NCT02687217|Wound Site Infection|wound site infection
4789009|NCT02687217|Appendicitis|appendicitis
4789010|NCT02687191|safety, maximum tolerated dose, modified continual reassessment method, intracerebral, hemorrhage, hematoma|safety, maximum tolerated dose, modified continual reassessment method, intracerebral, hemorrhage, hematoma
4789011|NCT02687113|ablation|ablation
4789012|NCT02687113|fusion|fusion
4789013|NCT02687100|intubation|intubation
4789014|NCT02687100|intensive care|intensive care
4789015|NCT02687100|cardiac surgery|cardiac surgery
4789016|NCT02687100|sore throat|sore throat
4789017|NCT02687087|Radiotherapy Induced Xerostomia (RIX)|radiotherapy induced xerostomia (rix)
4789018|NCT02687074|HFNC|hfnc
4789019|NCT02687074|Respiratory Failure|respiratory failure
4789020|NCT02687074|Intubation|intubation
4789021|NCT02687074|Mortality|mortality
4789022|NCT02687061|Recall study|recall study
4789023|NCT02687061|Lost to follow-up|lost to follow-up
4789024|NCT02687048|mindful meditation|mindful meditation
4789025|NCT02687035|S3iCAP|s3icap
4789026|NCT02687035|SAPIEN 3|sapien 3
4789027|NCT02687035|Transfemoral|transfemoral
4789028|NCT02687035|Commander|commander
4789031|NCT02687035|TAVI|tavi
4789032|NCT02687035|Aortic stenosis|aortic stenosis
4789033|NCT02687035|THV|thv
4789034|NCT02687035|Transcatheter Heart Valve|transcatheter heart valve
4789035|NCT02687035|TVT|tvt
4789036|NCT02687035|TVTR|tvtr
4789037|NCT02687009|colon cancer|colon cancer
4789038|NCT02687009|Wnt pathway|wnt pathway
4789039|NCT02687009|Frizzled|frizzled
4789040|NCT02686996|carnosine|carnosine
4789041|NCT02686996|Insulin sensitivity|insulin sensitivity
4789042|NCT02686996|low grade inflammation|low grade inflammation
4789043|NCT02686996|Oxidative stress|oxidative stress
4789044|NCT02686996|Advanced glycation|advanced glycation
4789045|NCT02686996|Type 2 diabetes|type 2 diabetes
4789046|NCT02686996|Cardiovascular disease|cardiovascular disease
4789047|NCT02686970|Family|family
4789048|NCT02686970|Quality|quality
4789049|NCT02686970|Validate|validate
4789050|NCT02686970|ICU|icu
4789051|NCT02686944|GIST|gist
4789052|NCT02686931|Developmental delayed|developmental delayed
4789053|NCT02686931|Orthopedic disease|orthopedic disease
4789054|NCT02686931|Longitudinal study|longitudinal study
4789055|NCT02686892|Inflamatory bowel disease|inflamatory bowel disease
4789056|NCT02686892|Crohns disease|crohns disease
4789057|NCT02686892|ulcerative colitis|ulcerative colitis
4789058|NCT02686892|incidence|incidence
4789059|NCT02686892|epidemiology|epidemiology
4789060|NCT02686879|hyperopes|hyperopes
4789061|NCT02686879|axial length|axial length
4789062|NCT02686879|peripheral defocus|peripheral defocus
4789063|NCT02686853|Intrathecal administration|intrathecal administration
4789064|NCT02686853|Liposomal amphotericin B|liposomal amphotericin b
4789065|NCT02686853|Without Acquired Immune Deficiency Syndrome|without acquired immune deficiency syndrome
4789066|NCT02686814|Valvular heart disease|valvular heart disease
4789067|NCT02686814|Severe aortic stenosis|severe aortic stenosis
4789068|NCT02686814|Aortic valve replacement|aortic valve replacement
4789069|NCT02686801|nutrition|nutrition
4789070|NCT02686801|prematurity|prematurity
4789071|NCT02686801|body composition|body composition
4789072|NCT02686788|multiple sclerosis|multiple sclerosis
4789073|NCT02686788|relapsing remitting|relapsing remitting
4789074|NCT02686788|nonsteroidal anti-inflammatory drug|nonsteroidal anti-inflammatory drug
4789075|NCT02686788|contrast enhancing lesions|contrast enhancing lesions
4789076|NCT02686762|NASH|nash
4789077|NCT02686736|internet-based educational intervention|internet-based educational intervention
4789078|NCT02686736|risky sexual behaviors|risky sexual behaviors
4789079|NCT02686736|prevention|prevention
4789080|NCT02686723|ACL injury|acl injury
4789081|NCT02686723|Return to sport|return to sport
4789082|NCT02686723|Motion analysis|motion analysis
4789083|NCT02686723|Isokinetic evaluation|isokinetic evaluation
4789084|NCT02686723|Risk factor|risk factor
4789085|NCT02686697|L-Carnosine|l-carnosine
4789086|NCT02686697|Schizophrenia|schizophrenia
4789087|NCT02686697|Psychosis|psychosis
4789088|NCT02686697|Cognition|cognition
4789089|NCT02686671|Bursitis|bursitis
4789090|NCT02686671|Injections|injections
4789091|NCT02686671|Shoulder Pain|shoulder pain
4789092|NCT02686658|Geographic Atrophy (GA)|geographic atrophy (ga)
4789093|NCT02686658|Dry age-related macular degeneration|dry age-related macular degeneration
4789094|NCT02686658|AMD|amd
4789095|NCT02686658|Zimura|zimura
4789096|NCT02686658|Anti-inflammatory|anti-inflammatory
4789097|NCT02686658|complement factor C5 inhibitor|complement factor c5 inhibitor
4789098|NCT02686658|ARC1905|arc1905
4789099|NCT02686658|avacincaptad pegol|avacincaptad pegol
4789100|NCT02686645|Fecal Microbiota Transplantation|fecal microbiota transplantation
4789101|NCT02686632|Denture Stomatitis|denture stomatitis
4789102|NCT02686632|Denture Erythematous Stomatitis|denture erythematous stomatitis
4789103|NCT02686632|Prosthesis Stomatitis|prosthesis stomatitis
4789104|NCT02686632|Oral Candidiasis|oral candidiasis
4789105|NCT02686632|Palatal inflammation|palatal inflammation
4789106|NCT02686593|Clofarabine|clofarabine
4789107|NCT02686593|Acute Myeloid Leukemia|acute myeloid leukemia
4789108|NCT02686567|transanal drainage tube|transanal drainage tube
4789109|NCT02686567|anastomotic leakage|anastomotic leakage
4789110|NCT02686567|laparoscopic anterior resection|laparoscopic anterior resection
4789111|NCT02686567|rectal cancer|rectal cancer
4789112|NCT02686554|Biomarker|biomarker
4789113|NCT02686528|total hip arthroplasty|total hip arthroplasty
4789114|NCT02686528|hip precautions|hip precautions
4789115|NCT02686528|posterior approach|posterior approach
4789116|NCT02686515|balance|balance
4789117|NCT02686476|Empagliflozin, Fatty Liver Disease|empagliflozin, fatty liver disease
4789118|NCT02686463|malignant ovarian cancer|malignant ovarian cancer
4789119|NCT02686463|laparoscopy|laparoscopy
4789120|NCT02686463|laparotomy|laparotomy
4789121|NCT02686437|shoulder dysfunction|shoulder dysfunction
4789122|NCT02686437|kinesiology tape|kinesiology tape
4789123|NCT02686437|rehabilitation|rehabilitation
4789124|NCT02686424|MAGE-A3 protein|mage-a3 protein
4789125|NCT02686424|NY-ESO-1 protein|ny-eso-1 protein
4789126|NCT02686424|WT1 Proteins|wt1 proteins
4789127|NCT02686424|PRAME protein|prame protein
4789128|NCT02686411|Benign neoplasms|benign neoplasms
4789129|NCT02686411|In situ neoplasms|in situ neoplasms
4789225|NCT02685826|Newly-Diagnosed (NDMM)|newly-diagnosed (ndmm)
4789130|NCT02686411|Malignant neoplasms of independent (primary) multiple sites|malignant neoplasms of independent (primary) multiple sites
4789131|NCT02686411|Consult with palliative care doctor|consult with palliative care doctor
4789132|NCT02686411|Palliative care unit|palliative care unit
4789133|NCT02686411|PCU|pcu
4789134|NCT02686411|Questionnaires|questionnaires
4789135|NCT02686411|Surveys|surveys
4789136|NCT02686398|Influenza Vaccines|influenza vaccines
4789137|NCT02686398|MF59 oil emulsion|mf59 oil emulsion
4789138|NCT02686398|End Stage Renal Failure on Dialysis|end stage renal failure on dialysis
4789139|NCT02686372|hepatocellular carcinoma|hepatocellular carcinoma
4789140|NCT02686359|physiology|physiology
4789141|NCT02686359|pain|pain
4789142|NCT02686359|analgesia|analgesia
4789143|NCT02686359|saliva|saliva
4789144|NCT02686359|opiorphin|opiorphin
4789145|NCT02686346|Relapsed|relapsed
4789146|NCT02686346|Refractory|refractory
4789147|NCT02686333|Meditation|meditation
4789148|NCT02686333|Dialysis|dialysis
4789149|NCT02686320|Rheumatoid arthritis|rheumatoid arthritis
4789150|NCT02686320|Elderly|elderly
4789151|NCT02686320|infections|infections
4789152|NCT02686320|cardio-vascular disease|cardio-vascular disease
4789153|NCT02686320|osteoporosis|osteoporosis
4789154|NCT02686320|cancer|cancer
4789155|NCT02686268|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
4789156|NCT02686268|ALS|als
4789157|NCT02686268|C9ORF72 gene mutation|c9orf72 gene mutation
4789158|NCT02686268|Chromosome 9 open reading frame 72 protein|chromosome 9 open reading frame 72 protein
4789159|NCT02686268|Natural history|natural history
4789160|NCT02686268|Biomarkers|biomarkers
4789161|NCT02686268|Amyotrophic Lateral Sclerosis, Familial|amyotrophic lateral sclerosis, familial
4789162|NCT02686268|Amyotrophic Lateral Sclerosis, Sporadic|amyotrophic lateral sclerosis, sporadic
4789163|NCT02686268|Frontotemporal Dementia-Amyotrophic Lateral Sclerosis|frontotemporal dementia-amyotrophic lateral sclerosis
4789164|NCT02686242|cesarean section|cesarean section
4789165|NCT02686242|spinal anesthesia|spinal anesthesia
4789166|NCT02686242|general anesthesia|general anesthesia
4789167|NCT02686229|Low grade glioma, registry, neurosurgery, brain tumor|low grade glioma, registry, neurosurgery, brain tumor
4789168|NCT02686216|F-18 THK-5351 PET|f-18 thk-5351 pet
4789169|NCT02686190|Alzheimer; luxtherapy, sleep disturbance, behaviour disturbance|alzheimer; luxtherapy, sleep disturbance, behaviour disturbance
4789170|NCT02686177|Type 2 diabetes|type 2 diabetes
4789171|NCT02686177|Angiogenesis|angiogenesis
4789172|NCT02686177|Liraglutide|liraglutide
4789173|NCT02686177|Glucagon like peptide 1 receptor agonist|glucagon like peptide 1 receptor agonist
4789174|NCT02686164|Lenvatinib|lenvatinib
4789175|NCT02686164|Lenvima|lenvima
4789176|NCT02686164|E7080|e7080
4789177|NCT02686164|Phase 1|phase 1
4789178|NCT02686164|Solid tumors|solid tumors
4789179|NCT02686164|Midazolam|midazolam
4789180|NCT02686164|CYP3A4|cyp3a4
4789181|NCT02686151|Letrozole|letrozole
4789182|NCT02686151|OHSS|ohss
4789183|NCT02686099|Rigid Fixation|rigid fixation
4789184|NCT02686099|Sternal Plating|sternal plating
4789185|NCT02686099|Sternal Closure|sternal closure
4789186|NCT02686099|Sternalock|sternalock
4789187|NCT02686073|BMI|bmi
4789188|NCT02686073|progress of labor|progress of labor
4789189|NCT02686073|nulliparous women|nulliparous women
4789190|NCT02686047|Knee osteoarthritis|knee osteoarthritis
4789191|NCT02686047|Hyaluronic acid|hyaluronic acid
4789192|NCT02686047|Viscosupplementation|viscosupplementation
4789193|NCT02686034|Migraine|migraine
4789194|NCT02686034|Non-invasive vagus nerve stimulation|non-invasive vagus nerve stimulation
4789195|NCT02686034|Vagus nerve stimulation|vagus nerve stimulation
4789196|NCT02686034|Vagal nerve stimulation|vagal nerve stimulation
4789197|NCT02686034|gammaCore|gammacore
4789198|NCT02686034|episodic migraine|episodic migraine
4789199|NCT02685982|Unipolar|unipolar
4789200|NCT02685982|Depression|depression
4789201|NCT02685982|Depressive Disorder|depressive disorder
4789202|NCT02685982|Behavioural Symptoms|behavioural symptoms
4789203|NCT02685982|Mood Disorder|mood disorder
4789204|NCT02685982|Adjunctive Therapy|adjunctive therapy
4789205|NCT02685982|Music Therapy|music therapy
4789206|NCT02685982|Brain Stimulation|brain stimulation
4789207|NCT02685969|Prevention|prevention
4789208|NCT02685969|Positron Emission Tomography|positron emission tomography
4789209|NCT02685930|invasive mechanical ventilation|invasive mechanical ventilation
4789210|NCT02685878|urinary continence|urinary continence
4789211|NCT02685878|prevalence of depression|prevalence of depression
4789212|NCT02685878|reproductive outcomes|reproductive outcomes
4789213|NCT02685878|quality of life|quality of life
4789214|NCT02685878|HIV status|hiv status
4789215|NCT02685878|obstetric fistula|obstetric fistula
4789216|NCT02685865|pancreatic fluid collection; pancreatic necrosis; stent;|pancreatic fluid collection; pancreatic necrosis; stent;
4789217|NCT02685839|frailty syndrome, Intelligent POWER Rehabilitation Cluster Machine, Internet of Things, wearable|frailty syndrome, intelligent power rehabilitation cluster machine, internet of things, wearable
4789218|NCT02685826|Open-label|open-label
4789219|NCT02685826|Phase 1/2|phase 1/2
4789220|NCT02685826|Durvalumab|durvalumab
4789221|NCT02685826|MEDI4736|medi4736
4789222|NCT02685826|Lenalidomide (Len)|lenalidomide (len)
4789223|NCT02685826|Dexamethasone (dex)|dexamethasone (dex)
4789224|NCT02685826|Multiple Myeloma|multiple myeloma
4789226|NCT02685826|Transplant Non-eligible (TNE)|transplant non-eligible (tne)
4789227|NCT02685826|PD-L1|pd-l1
4789228|NCT02685813|Ultra sound|ultra sound
4789229|NCT02685813|birth defects|birth defects
4789230|NCT02685787|Care-giver burden|care-giver burden
4789231|NCT02685787|Dementia|dementia
4789232|NCT02685787|Alzheimer's disease|alzheimer's disease
4789233|NCT02685787|Care-giver depression|care-giver depression
4789234|NCT02685787|Care-giver anxiety|care-giver anxiety
4789235|NCT02685709|Octreotide Capsules|octreotide capsules
4789236|NCT02685709|Acromegaly|acromegaly
4789237|NCT02685709|Somatostatin|somatostatin
4789238|NCT02685709|Mpowered|mpowered
4789239|NCT02685709|OOC-ACM-302|ooc-acm-302
4789240|NCT02685683|Crohn's Disease|crohn's disease
4789241|NCT02685683|GED-0301|ged-0301
4789242|NCT02685683|Open-label|open-label
4789243|NCT02685683|Pharmacodynamic|pharmacodynamic
4789244|NCT02685683|Mongersen|mongersen
4789245|NCT02685644|endometrioma|endometrioma
4789246|NCT02685644|laparoscopy|laparoscopy
4789247|NCT02685644|anti-mullerian hormone|anti-mullerian hormone
4789248|NCT02685644|ovarian reserve|ovarian reserve
4789249|NCT02685631|Hepatocellular carcinoma|hepatocellular carcinoma
4789250|NCT02685631|Colorectal cancer|colorectal cancer
4789251|NCT02685631|Neuroendocrine tumor|neuroendocrine tumor
4789252|NCT02685631|Cholangiocarcinoma|cholangiocarcinoma
4789253|NCT02685631|Breast cancer|breast cancer
4789254|NCT02685631|Tumor of unknown primary|tumor of unknown primary
4789255|NCT02685631|Pancreatic cancer|pancreatic cancer
4789256|NCT02685605|Glioblastoma|glioblastoma
4789257|NCT02685605|Intraoperative Radiotherapy|intraoperative radiotherapy
4789258|NCT02685605|Radiotherapy Dose Escalation|radiotherapy dose escalation
4789259|NCT02685592|Lentigo Maligna|lentigo maligna
4789260|NCT02685592|Photodynamic Therapy|photodynamic therapy
4789261|NCT02685592|Hyperspectral Imaging|hyperspectral imaging
4789262|NCT02685566|Mammography|mammography
4789263|NCT02685540|Anesthesia|anesthesia
4789264|NCT02685540|mortality|mortality
4789265|NCT02685514|HIFU|hifu
4789266|NCT02685514|Graves' disease|graves' disease
4789267|NCT02685514|treatment|treatment
4789268|NCT02685475|Diabetes mellitus|diabetes mellitus
4789269|NCT02685475|Axillary brachial plexus block|axillary brachial plexus block
4789270|NCT02685475|Block duration|block duration
4789271|NCT02685475|Time-to-first pain|time-to-first pain
4789272|NCT02685475|Postoperative analgesia|postoperative analgesia
4789273|NCT02685449|diabetes type 1|diabetes type 1
4789274|NCT02685449|insulin pump|insulin pump
4789275|NCT02685449|prandial insulin requirement|prandial insulin requirement
4789276|NCT02685449|pure protein meal|pure protein meal
4789277|NCT02685449|high protein meal|high protein meal
4789278|NCT02685449|square bolus|square bolus
4789279|NCT02685449|square-wave bolus|square-wave bolus
4789280|NCT02685449|insulin bolus|insulin bolus
4789281|NCT02685449|dietary protein|dietary protein
4789282|NCT02685423|Amblyopia|amblyopia
4789283|NCT02685423|Lazy Eye|lazy eye
4789284|NCT02685423|Anisometropia|anisometropia
4789285|NCT02685384|healthcare access|healthcare access
4789286|NCT02685384|healthcare utilization|healthcare utilization
4789287|NCT02685384|health expenditures|health expenditures
4789288|NCT02685384|preventive services|preventive services
4789289|NCT02685384|biomarkers|biomarkers
4789290|NCT02685358|Stress Disorders, Post-traumatic|stress disorders, post-traumatic
4789291|NCT02685358|Primary Health Care|primary health care
4789292|NCT02685358|Mobile Applications|mobile applications
4789293|NCT02685358|Veterans|veterans
4789294|NCT02685345|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
4789295|NCT02685345|sitagliptin|sitagliptin
4789296|NCT02685345|adult|adult
4789297|NCT02685345|Phase 2|phase 2
4789298|NCT02685280|rechargeable neurostimulators|rechargeable neurostimulators
4789299|NCT02685254|Group Therapy|group therapy
4789300|NCT02685254|Structured Skills Training|structured skills training
4789301|NCT02685254|Dialectic Behavioural Therapy|dialectic behavioural therapy
4789302|NCT02685241|Exhaled breath|exhaled breath
4789303|NCT02685241|Biomarker|biomarker
4789304|NCT02685215|intensive care unit|intensive care unit
4789305|NCT02685215|muscular dystrophy|muscular dystrophy
4789306|NCT02685215|mortality|mortality
4789307|NCT02685215|prognosis|prognosis
4789308|NCT02685215|tracheostomy|tracheostomy
4789309|NCT02685202|orofacial pain|orofacial pain
4789310|NCT02685202|sleep-disordered breathing|sleep-disordered breathing
4789311|NCT02685202|temporomandibular disorder|temporomandibular disorder
4789312|NCT02685202|oral appliance|oral appliance
4789313|NCT02685202|upper airway collapse|upper airway collapse
4789314|NCT02685176|hypothermia|hypothermia
4789315|NCT02685176|rewarming|rewarming
4789316|NCT02685176|non-shivering|non-shivering
4789317|NCT02685150|Endoscopic Tri-Modal Imaging|endoscopic tri-modal imaging
4789318|NCT02685150|Gastric juice|gastric juice
4789319|NCT02685150|Functional dyspepsia|functional dyspepsia
4789320|NCT02685150|Acid reflux disease|acid reflux disease
4789321|NCT02685150|Bile reflux|bile reflux
4789322|NCT02685137|Kernicterus|kernicterus
4789323|NCT02685137|Neonatal Jaundice|neonatal jaundice
4789324|NCT02685137|Newborn Jaundice|newborn jaundice
4789325|NCT02685137|Hyperbilirubinemia|hyperbilirubinemia
4789430|NCT02684682|Gingivitis|gingivitis
4789326|NCT02685137|Stannsoporfin|stannsoporfin
4789327|NCT02685111|Breast cancer|breast cancer
4789328|NCT02685111|Adjuvant|adjuvant
4789329|NCT02685111|Docetaxel|docetaxel
4789330|NCT02685111|Adriamycin|adriamycin
4789331|NCT02685111|Cyclophosphamide|cyclophosphamide
4789332|NCT02685111|Neutropenia|neutropenia
4789333|NCT02685111|Filgrastim|filgrastim
4789334|NCT02685111|Pegfilgrastim|pegfilgrastim
4789335|NCT02685098|Stem cells|stem cells
4789336|NCT02685098|MSCs|mscs
4789337|NCT02685098|Mesenchymal|mesenchymal
4789338|NCT02685098|Amputation|amputation
4789339|NCT02685098|BKA|bka
4789340|NCT02685098|below knee amputation|below knee amputation
4789341|NCT02685098|CHAMP|champ
4789342|NCT02685072|Smoking Cessation|smoking cessation
4789343|NCT02685072|Nicotine Cessation|nicotine cessation
4789344|NCT02685059|breast cancer|breast cancer
4789345|NCT02685059|Medi4736|medi4736
4789346|NCT02685059|Anti PD-L1|anti pd-l1
4789347|NCT02685059|Nab-Paclitaxel|nab-paclitaxel
4789348|NCT02685059|Placebo|placebo
4789349|NCT02685059|triple negative|triple negative
4789350|NCT02685033|Osteomyelitis|osteomyelitis
4789351|NCT02685033|dalbavancin|dalbavancin
4789352|NCT02685033|antibiotic|antibiotic
4789353|NCT02685020|Healthy|healthy
4789354|NCT02685020|Human Immunodeficiency Virus|human immunodeficiency virus
4789355|NCT02685020|adenovirus serotype 26|adenovirus serotype 26
4789356|NCT02685020|Ad26.Mos.HIV|ad26.mos.hiv
4789357|NCT02685020|Vaccine|vaccine
4789358|NCT02685020|Placebo|placebo
4789359|NCT02685020|Glycoprotein|glycoprotein
4789360|NCT02685020|IPCAVD010|ipcavd010
4789361|NCT02685007|minimal invasive surgery|minimal invasive surgery
4789362|NCT02684994|Trauma|trauma
4789363|NCT02684994|Sexual assault|sexual assault
4789364|NCT02684994|Sexual abuse|sexual abuse
4789365|NCT02684994|Physical assault|physical assault
4789366|NCT02684994|Physical abuse|physical abuse
4789367|NCT02684994|PTSD|ptsd
4789368|NCT02684994|Interpersonal Violence|interpersonal violence
4789369|NCT02684994|Women|women
4789370|NCT02684955|cardiac arrest|cardiac arrest
4789371|NCT02684955|near-infrared spectroscopy|near-infrared spectroscopy
4789372|NCT02684955|automated infrared pupillometry|automated infrared pupillometry
4789373|NCT02684955|prognostication|prognostication
4789374|NCT02684942|Meperidine|meperidine
4789375|NCT02684942|Fentanyl|fentanyl
4789376|NCT02684942|Pain management|pain management
4789377|NCT02684942|brachytherapy|brachytherapy
4789378|NCT02684929|insulin resistance|insulin resistance
4789379|NCT02684929|bcaa|bcaa
4789380|NCT02684929|mitochondrial biogenesis|mitochondrial biogenesis
4789381|NCT02684916|Chiropractic spinal manipulation|chiropractic spinal manipulation
4789382|NCT02684916|Children|children
4789383|NCT02684916|Pediatric|pediatric
4789384|NCT02684916|Headache|headache
4789385|NCT02684903|Child Abuse|child abuse
4789386|NCT02684903|Parent Child Interaction Therapy (PCIT)|parent child interaction therapy (pcit)
4789387|NCT02684903|Evidenced Based Intervention|evidenced based intervention
4789388|NCT02684903|Self-control|self-control
4789389|NCT02684877|Fatigue|fatigue
4789390|NCT02684877|Quality of life|quality of life
4789391|NCT02684877|Critically ill patients|critically ill patients
4789392|NCT02684864|biomarker|biomarker
4789393|NCT02684864|inflammation|inflammation
4789394|NCT02684864|knee|knee
4789395|NCT02684864|prognosis|prognosis
4789396|NCT02684838|Gliadel, Carmustine wafer implant|gliadel, carmustine wafer implant
4789397|NCT02684825|Stroke|stroke
4789398|NCT02684825|ischemic stroke|ischemic stroke
4789399|NCT02684825|atrial fibrillation|atrial fibrillation
4789400|NCT02684825|continuous cardiac monitoring|continuous cardiac monitoring
4789401|NCT02684825|insertable cardiac monitoring|insertable cardiac monitoring
4789402|NCT02684825|implantable loop recorder|implantable loop recorder
4789403|NCT02684825|antithrombotics|antithrombotics
4789404|NCT02684825|anticoagulants|anticoagulants
4789405|NCT02684825|stroke subtype|stroke subtype
4789406|NCT02684825|atherothrombotic stroke|atherothrombotic stroke
4789407|NCT02684825|lacunar stroke|lacunar stroke
4789408|NCT02684812|antifibrinolytic therapy|antifibrinolytic therapy
4789409|NCT02684812|recurrent bleeding|recurrent bleeding
4789410|NCT02684812|tranexamic acid|tranexamic acid
4789411|NCT02684773|Hemodialysis|hemodialysis
4789412|NCT02684773|Left Ventricular Mass|left ventricular mass
4789413|NCT02684773|Cardiac Magnetic resonance Imaging|cardiac magnetic resonance imaging
4789414|NCT02684760|Inflammatory Bowel Disease|inflammatory bowel disease
4789415|NCT02684747|Healthy Volunteers|healthy volunteers
4789416|NCT02684747|Sports Medicine|sports medicine
4789417|NCT02684747|Athletes|athletes
4789418|NCT02684747|Anti-doping|anti-doping
4789419|NCT02684734|Ulcerative Colitis|ulcerative colitis
4789420|NCT02684734|UC|uc
4789421|NCT02684734|Cytomegalovirus|cytomegalovirus
4789422|NCT02684734|CMV|cmv
4789423|NCT02684721|rehabilitation|rehabilitation
4789424|NCT02684721|physical capacity|physical capacity
4789425|NCT02684721|quality of life|quality of life
4789426|NCT02684695|Magnetic resonance imaging|magnetic resonance imaging
4789427|NCT02684695|Imaging biomarker|imaging biomarker
4789428|NCT02684695|Diffusion-weighted imaging|diffusion-weighted imaging
4789429|NCT02684682|Toothbrushing|toothbrushing
4789431|NCT02684682|Dental Plaque|dental plaque
4789432|NCT02684682|Periodontal Diseases|periodontal diseases
4789433|NCT02684682|Clinical Trial|clinical trial
4789434|NCT02684669|burn injury|burn injury
4789435|NCT02684669|controlled trial|controlled trial
4789436|NCT02684669|latent sensitization|latent sensitization
4789437|NCT02684669|naloxone|naloxone
4789438|NCT02684669|secondary hyperalgesia|secondary hyperalgesia
4789439|NCT02684669|volunteers|volunteers
4789440|NCT02684656|Oxalate|oxalate
4789441|NCT02684656|Inflammation|inflammation
4789442|NCT02684656|Hemodiafiltration|hemodiafiltration
4789443|NCT02684656|Hemodialysis|hemodialysis
4789444|NCT02684656|Oxalate Blood Sample|oxalate blood sample
4789445|NCT02684643|individualised therapy|individualised therapy
4789446|NCT02684643|hyperphosphatemia|hyperphosphatemia
4789447|NCT02684643|hemodialysis|hemodialysis
4789448|NCT02684643|clinical trials|clinical trials
4789449|NCT02684643|restricted phosphate diet|restricted phosphate diet
4789450|NCT02684643|phosphate binders|phosphate binders
4789451|NCT02684565|pre-diabetes|pre-diabetes
4789452|NCT02684565|blood glucose regulation|blood glucose regulation
4789453|NCT02684565|branching chain amino acids|branching chain amino acids
4789454|NCT02684565|diabetes|diabetes
4789455|NCT02684565|lower blood sugar|lower blood sugar
4789456|NCT02684513|Well-being|well-being
4789457|NCT02684513|Quality of Recovery|quality of recovery
4789458|NCT02684513|Maternal complications|maternal complications
4789459|NCT02684500|aSAH|asah
4789460|NCT02684487|vitamin D|vitamin d
4789461|NCT02684487|vitamin D3|vitamin d3
4789462|NCT02684487|sepsis|sepsis
4789463|NCT02684487|severe sepsis|severe sepsis
4789464|NCT02684487|critical illness|critical illness
4789465|NCT02684487|ICU|icu
4789466|NCT02684396|Drug therapy|drug therapy
4789467|NCT02684383|Dengue Vaccine|dengue vaccine
4789468|NCT02684370|Psoriasis|psoriasis
4789469|NCT02684370|Skin Diseases|skin diseases
4789470|NCT02684370|Skin Diseases, Papulosquamous|skin diseases, papulosquamous
4789471|NCT02684370|ustekinumab|ustekinumab
4789472|NCT02684370|Dermatologic Agents|dermatologic agents
4789473|NCT02684370|ABBV-066|abbv-066
4789474|NCT02684370|BI 655066|bi 655066
4789475|NCT02684370|risankizumab|risankizumab
4789476|NCT02684357|ABBV-066|abbv-066
4789477|NCT02684357|BI 655066|bi 655066
4789478|NCT02684357|risankizumab|risankizumab
4789479|NCT02684344|Post-Operative Urinary Retention|post-operative urinary retention
4789480|NCT02684292|PD1|pd1
4789481|NCT02684292|PD-1|pd-1
4789482|NCT02684292|PDL1|pdl1
4789483|NCT02684292|PD-L1|pd-l1
4789484|NCT02684266|neoplasm, Cycline-Dependent Kinase|neoplasm, cycline-dependent kinase
4789485|NCT02684253|Nivolumab|nivolumab
4789486|NCT02684253|Stereotactic Body Radiotherapy (SBRT)|stereotactic body radiotherapy (sbrt)
4789487|NCT02684253|15-253|15-253
4789488|NCT02684227|Endometrial cancer|endometrial cancer
4789489|NCT02684227|Advanced Stage Endometrioid Endometrial Cancer|advanced stage endometrioid endometrial cancer
4789490|NCT02684227|Recurrent Endometrioid Endometrial Cancer|recurrent endometrioid endometrial cancer
4789491|NCT02684227|Enzalutamide|enzalutamide
4789492|NCT02684227|MDV3100|mdv3100
4789493|NCT02684227|XTANDI|xtandi
4789494|NCT02684227|Carboplatin|carboplatin
4789495|NCT02684227|Paclitaxel|paclitaxel
4789496|NCT02684227|Taxol|taxol
4789497|NCT02684214|food security|food security
4789498|NCT02684201|Phantom Limb|phantom limb
4789499|NCT02684201|Upper Amputee|upper amputee
4789500|NCT02684201|Electrodes|electrodes
4789502|NCT02684201|Pain|pain
4789503|NCT02684175|Audiometry|audiometry
4789504|NCT02684175|Cochlear Implants|cochlear implants
4789505|NCT02684175|Adult|adult
4789506|NCT02684175|Telemedicine|telemedicine
4789507|NCT02684175|Health Services Accessibility|health services accessibility
4789508|NCT02684175|Rural Population|rural population
4789509|NCT02684175|Technology Assessment, Biomedical|technology assessment, biomedical
4789510|NCT02684162|Leukemia|leukemia
4789511|NCT02684162|Myeloproliferative Diseases|myeloproliferative diseases
4789512|NCT02684162|Acute myelogenous leukemia|acute myelogenous leukemia
4789513|NCT02684162|AML|aml
4789514|NCT02684162|Myelodysplastic syndrome|myelodysplastic syndrome
4789515|NCT02684162|MDS|mds
4789516|NCT02684162|Donor lymphocyte infusion|donor lymphocyte infusion
4789517|NCT02684162|DLI|dli
4789518|NCT02684162|Allogeneic stem cell transplant|allogeneic stem cell transplant
4789519|NCT02684162|Stem cell transplantation|stem cell transplantation
4789520|NCT02684162|AlloSCT|allosct
4789521|NCT02684149|Intensive care|intensive care
4789522|NCT02684149|Arterial puncture|arterial puncture
4789523|NCT02684149|Cross-over|cross-over
4789524|NCT02684149|Relational touch|relational touch
4789525|NCT02684149|Pain|pain
4789526|NCT02684136|insomnia|insomnia
4789527|NCT02684136|fibromyalgia|fibromyalgia
4789528|NCT02684136|polysomnography|polysomnography
4789529|NCT02684136|pain management|pain management
4789530|NCT02684123|Alopecia areata|alopecia areata
4789531|NCT02684097|Alopecia, Alopecia Totalis, Alopecia Universalis|alopecia, alopecia totalis, alopecia universalis
4789532|NCT02684084|Diabetic Macular Edema|diabetic macular edema
4789533|NCT02684084|Ozurdex|ozurdex
4789534|NCT02684084|Lucentis|lucentis
4789535|NCT02684071|medulloblastoma, ependymoma, AT/RT, embryonal|medulloblastoma, ependymoma, at/rt, embryonal
4789536|NCT02684058|Malignant glioma|malignant glioma
4789537|NCT02684058|BRAF mutant positive|braf mutant positive
4789538|NCT02684058|High grade glioma|high grade glioma
4789539|NCT02684058|Low grade glioma|low grade glioma
4789540|NCT02684058|Dabrafenib|dabrafenib
4789541|NCT02684058|Trametinib|trametinib
4789542|NCT02684058|Pediatrics|pediatrics
4789543|NCT02684058|Brain neoplasma|brain neoplasma
4789544|NCT02684032|PI3K (phosphoinositide 3-kinase)|pi3k (phosphoinositide 3-kinase)
4789545|NCT02684032|mTOR (mechanistic target of rapamycin)|mtor (mechanistic target of rapamycin)
4789546|NCT02684032|PI3K/mTOR|pi3k/mtor
4789547|NCT02684032|metastatic breast cancer (MBC)|metastatic breast cancer (mbc)
4789548|NCT02684032|ER+ (estrogen receptor positive)|er+ (estrogen receptor positive)
4789549|NCT02684032|HER2- (human epidermal growth factor receptor 2 negative)|her2- (human epidermal growth factor receptor 2 negative)
4789550|NCT02684019|Endoscopic retrograde cholangiopancreatography|endoscopic retrograde cholangiopancreatography
4789551|NCT02684019|sedation|sedation
4789552|NCT02684019|dexmedetomidine|dexmedetomidine
4789553|NCT02684019|propofol|propofol
4789554|NCT02684019|Magnesium sulphate|magnesium sulphate
4789555|NCT02684019|Bispectral index monitoring|bispectral index monitoring
4789556|NCT02684006|Cancer|cancer
4789557|NCT02684006|renal cell cancer|renal cell cancer
4789558|NCT02684006|kidney disease|kidney disease
4789559|NCT02684006|kidney neoplasms|kidney neoplasms
4789560|NCT02684006|axitinib, sunitinib|axitinib, sunitinib
4789561|NCT02683915|Acute kidney injury|acute kidney injury
4789562|NCT02683915|Perinatal asphyxia|perinatal asphyxia
4789563|NCT02683915|Therapeutic hypothermia|therapeutic hypothermia
4789564|NCT02683915|Serum NGAL|serum ngal
4789565|NCT02683915|Serum cystatin-C|serum cystatin-c
4789566|NCT02683902|prediabetes|prediabetes
4789567|NCT02683902|tDCS|tdcs
4789568|NCT02683902|transcranial direct current stimulation|transcranial direct current stimulation
4789569|NCT02683902|obesity|obesity
4789570|NCT02683902|diabetes|diabetes
4789571|NCT02683876|body odor, malodor, halitosis|body odor, malodor, halitosis
4789572|NCT02683837|Intraoperative Neurophysiological Monitoring|intraoperative neurophysiological monitoring
4789573|NCT02683837|Reflex, Pupillary|reflex, pupillary
4789574|NCT02683837|remifentanil|remifentanil
4789575|NCT02683811|adolescence|adolescence
4789576|NCT02683811|prevention|prevention
4789577|NCT02683811|wellbeing|wellbeing
4789578|NCT02683811|evaluation|evaluation
4789579|NCT02683811|effectiveness|effectiveness
4789580|NCT02683811|school-based program|school-based program
4789581|NCT02683798|Weight loss maintenance|weight loss maintenance
4789582|NCT02683785|Pain intensity|pain intensity
4789583|NCT02683785|Hand Osteoarthritis|hand osteoarthritis
4789584|NCT02683785|GSK3196165|gsk3196165
4789585|NCT02683785|AUSCAN|auscan
4789586|NCT02683785|GM-CSF|gm-csf
4789587|NCT02683785|Numerical Rating Scale|numerical rating scale
4789588|NCT02683772|NIV, NIPPV, ventilation|niv, nippv, ventilation
4789589|NCT02683746|Pharmacodynamics|pharmacodynamics
4789590|NCT02683746|Safety|safety
4789591|NCT02683746|Albiglutide|albiglutide
4789592|NCT02683746|Tolerability|tolerability
4789593|NCT02683746|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
4789594|NCT02683746|Efficacy|efficacy
4789595|NCT02683707|Percutaneous Coronary Intervention|percutaneous coronary intervention
4789596|NCT02683707|Blood Platelets|blood platelets
4789597|NCT02683707|Fentanyl|fentanyl
4789598|NCT02683694|Epiretinal membrane|epiretinal membrane
4789599|NCT02683694|lamellar holes of the macula|lamellar holes of the macula
4789600|NCT02683694|macular holes|macular holes
4789601|NCT02683694|vitreomacular traction syndrome|vitreomacular traction syndrome
4789602|NCT02683668|Inhalers|inhalers
4789603|NCT02683668|Tiotropium|tiotropium
4789604|NCT02683629|Parkinson's Disease|parkinson's disease
4789605|NCT02683629|Xenotransplantation|xenotransplantation
4789606|NCT02683629|choroid plexus|choroid plexus
4789607|NCT02683603|colistin|colistin
4789608|NCT02683603|aerosol|aerosol
4789609|NCT02683603|ventilator associated pneumonia|ventilator associated pneumonia
4789610|NCT02683603|nephrotoxicity|nephrotoxicity
4789611|NCT02683603|intravenous|intravenous
4789612|NCT02683590|Sternectomie|sternectomie
4789613|NCT02683590|Ceramic Implant|ceramic implant
4789614|NCT02683590|Bones Tumors|bones tumors
4789615|NCT02683538|RFA|rfa
4789616|NCT02683525|Allogeneic|allogeneic
4789617|NCT02683525|Sitagliptin|sitagliptin
4789618|NCT02683499|Tooth preparation|tooth preparation
4789619|NCT02683499|Prosthodontics|prosthodontics
4789620|NCT02683447|Continuing Medical Education|continuing medical education
4789621|NCT02683447|Simulation|simulation
4789622|NCT02683447|Non-technical Skills|non-technical skills
4789623|NCT02683447|Crisis Resource Management|crisis resource management
4789624|NCT02683434|soccer|soccer
4789625|NCT02683421|Rheumatoid arthritis|rheumatoid arthritis
4789626|NCT02683421|tilmanocept|tilmanocept
4789627|NCT02683421|imaging|imaging
4789628|NCT02683395|PLX51107|plx51107
4789629|NCT02683395|Acute Myeloid Leukemia|acute myeloid leukemia
4789630|NCT02683395|Myelodysplastic Syndrome|myelodysplastic syndrome
4789631|NCT02683395|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
4789830|NCT02682186|Pain|pain
4789632|NCT02683369|Non-anemic Iron Deficiency, Iron Supplementation|non-anemic iron deficiency, iron supplementation
4789633|NCT02683356|Percutaneous Coronary Intervention|percutaneous coronary intervention
4789634|NCT02683356|Stents|stents
4789635|NCT02683330|PD|pd
4789636|NCT02683330|Parkinson's|parkinson's
4789637|NCT02683317|DHA|dha
4789638|NCT02683317|Retinopathy of Prematurity|retinopathy of prematurity
4789639|NCT02683291|Kidney transplantation|kidney transplantation
4789640|NCT02683291|sirolimus|sirolimus
4789641|NCT02683291|cytomegalovirus|cytomegalovirus
4789642|NCT02683291|aged|aged
4789643|NCT02683252|Magnetic resonance imaging|magnetic resonance imaging
4789644|NCT02683252|perfusion|perfusion
4789645|NCT02683252|quantitative|quantitative
4789646|NCT02683213|fluoxetine|fluoxetine
4789647|NCT02683213|outcome|outcome
4789648|NCT02683213|depression|depression
4789649|NCT02683213|plasticity|plasticity
4789650|NCT02683187|insulin secretion|insulin secretion
4789651|NCT02683187|GLP-1|glp-1
4789652|NCT02683187|alpha cell|alpha cell
4789653|NCT02683187|paracrine effect|paracrine effect
4789654|NCT02683187|Glucagon-Like Peptide 1|glucagon-like peptide 1
4789655|NCT02683174|syncope|syncope
4789656|NCT02683122|Organ dysfunction scores|organ dysfunction scores
4789657|NCT02683122|Pneumonia, Ventilator-Associated|pneumonia, ventilator-associated
4789658|NCT02683122|Intensive care units|intensive care units
4789659|NCT02683070|Catheter-related bladder discomfort|catheter-related bladder discomfort
4789660|NCT02683070|Pudendal nerve block|pudendal nerve block
4789661|NCT02683070|Tramadol|tramadol
4789662|NCT02683070|Randomized controlled trial|randomized controlled trial
4789663|NCT02683070|catheter-related bladder discomfort prevention|catheter-related bladder discomfort prevention
4789664|NCT02683044|Erectile dysfunction|erectile dysfunction
4789665|NCT02683044|Low-Density Shock Waves|low-density shock waves
4789666|NCT02683044|Randomized Clinical Trial|randomized clinical trial
4789667|NCT02683031|fertilization arrest|fertilization arrest
4789668|NCT02683031|Cleavage failure|cleavage failure
4789669|NCT02683031|Embryonic development|embryonic development
4789670|NCT02683031|Calcium ionophore|calcium ionophore
4789671|NCT02683005|treatment|treatment
4789672|NCT02683005|pharmacokinetics|pharmacokinetics
4789673|NCT02682979|therapeutic limitation code|therapeutic limitation code
4789674|NCT02682979|emergency unit admittance|emergency unit admittance
4789675|NCT02682966|troponin|troponin
4789676|NCT02682966|coronary artery disease|coronary artery disease
4789677|NCT02682966|pulmonary embolism|pulmonary embolism
4789678|NCT02682966|Computed Tomography Angiography|computed tomography angiography
4789679|NCT02682966|postoperative myocardial injury|postoperative myocardial injury
4789680|NCT02682927|seizure|seizure
4789681|NCT02682927|tonic-atonic|tonic-atonic
4789682|NCT02682927|clonic|clonic
4789683|NCT02682927|epilepsy|epilepsy
4789684|NCT02682927|myoclonic|myoclonic
4789685|NCT02682927|encephalopathy|encephalopathy
4789686|NCT02682914|Psychological distress|psychological distress
4789687|NCT02682914|Stroke etiology|stroke etiology
4789688|NCT02682914|Young patients|young patients
4789689|NCT02682888|brain functional connectivity changes|brain functional connectivity changes
4789690|NCT02682862|tiotropium|tiotropium
4789691|NCT02682862|olodaterol|olodaterol
4789692|NCT02682862|smoker|smoker
4789693|NCT02682862|cigarette|cigarette
4789694|NCT02682862|bronchodilator|bronchodilator
4789695|NCT02682836|physical activity|physical activity
4789696|NCT02682836|chemotherapy|chemotherapy
4789697|NCT02682836|fatigue|fatigue
4789698|NCT02682810|HIV|hiv
4789699|NCT02682810|point-of-care HIV diagnosis|point-of-care hiv diagnosis
4789700|NCT02682810|Alere Q|alere q
4789701|NCT02682810|diagnostic|diagnostic
4789702|NCT02682810|children|children
4789703|NCT02682771|gastroplasty, breathing exercices, positive pressure|gastroplasty, breathing exercices, positive pressure
4789704|NCT02682758|xenon|xenon
4789705|NCT02682758|transpulmonary pressure|transpulmonary pressure
4789706|NCT02682758|electrical impedance tomography|electrical impedance tomography
4789707|NCT02682758|tidal volume|tidal volume
4789708|NCT02682758|esophageal pressure measurement|esophageal pressure measurement
4789709|NCT02682732|Acute Myeloid Leukemia|acute myeloid leukemia
4789710|NCT02682732|PET/CT Scan|pet/ct scan
4789711|NCT02682719|Natriuretic peptide, brain|natriuretic peptide, brain
4789712|NCT02682719|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
4789713|NCT02682719|Hypertension|hypertension
4789714|NCT02682719|Cardiovascular prevention|cardiovascular prevention
4789715|NCT02682719|Left atrial volume index|left atrial volume index
4789716|NCT02682719|Angiotensin receptor neprilysin inhibitor|angiotensin receptor neprilysin inhibitor
4789717|NCT02682719|LCZ696|lcz696
4789718|NCT02682719|Valsartan|valsartan
4789719|NCT02682719|Sacubitril|sacubitril
4789720|NCT02682706|brown adipose tissue|brown adipose tissue
4789721|NCT02682706|magnetic resonance imaging|magnetic resonance imaging
4789722|NCT02682706|energy expenditure|energy expenditure
4789723|NCT02682706|non-shivering thermogenesis|non-shivering thermogenesis
4789724|NCT02682680|diabetes|diabetes
4789725|NCT02682680|hyperlipidaemia|hyperlipidaemia
4789726|NCT02682680|colesevelam|colesevelam
4789727|NCT02682680|ezetimibe|ezetimibe
4789728|NCT02682680|LDL cholesterol|ldl cholesterol
4790030|NCT02680795|beleodaq|beleodaq
4789729|NCT02682680|glycated hemoglobin|glycated hemoglobin
4789730|NCT02682667|Apheresis Products|apheresis products
4789731|NCT02682667|Immunological|immunological
4789732|NCT02682667|Diverse Malignan|diverse malignan
4789733|NCT02682667|Premalignant|premalignant
4789734|NCT02682667|Protein|protein
4789735|NCT02682654|Pain|pain
4789736|NCT02682654|Ankle|ankle
4789737|NCT02682654|Knee|knee
4789738|NCT02682654|Brace|brace
4789739|NCT02682615|Cardiac Index|cardiac index
4789740|NCT02682615|Noninvasive|noninvasive
4789741|NCT02682615|esCCO|escco
4789742|NCT02682615|PiCCO|picco
4789743|NCT02682615|Thermodilution|thermodilution
4789744|NCT02682602|total hip arthroplasty|total hip arthroplasty
4789745|NCT02682589|Complete Mesocolic Excision|complete mesocolic excision
4789746|NCT02682589|locally advanced Colon Cancer|locally advanced colon cancer
4789747|NCT02682589|Laparoscopic|laparoscopic
4789748|NCT02682576|brachial artery ultrasound imaging|brachial artery ultrasound imaging
4789749|NCT02682576|flow-mediated dilation|flow-mediated dilation
4789750|NCT02682576|endothelium|endothelium
4789751|NCT02682563|SGLT-2 inhibition, Renal, Cardiovascular, Type 2 diabetes, forxiga, dapagliflozin|sglt-2 inhibition, renal, cardiovascular, type 2 diabetes, forxiga, dapagliflozin
4789752|NCT02682550|polytrauma|polytrauma
4789753|NCT02682550|hemorrhagic shock|hemorrhagic shock
4789754|NCT02682550|sepsis|sepsis
4789755|NCT02682550|MODS|mods
4789756|NCT02682537|Resting energy expenditure|resting energy expenditure
4789757|NCT02682537|Calorie requirements|calorie requirements
4789758|NCT02682537|Indirect Calorimetry|indirect calorimetry
4789759|NCT02682511|Ifetroban|ifetroban
4789760|NCT02682511|Scleroderma|scleroderma
4789761|NCT02682511|Systemic Sclerosis|systemic sclerosis
4789762|NCT02682498|Knee Arthroplasty, Total|knee arthroplasty, total
4789763|NCT02682498|Liposomal Bupivicaine|liposomal bupivicaine
4789764|NCT02682485|Rectal Cancer|rectal cancer
4789765|NCT02682485|low anterior resection|low anterior resection
4789766|NCT02682485|SES|ses
4789767|NCT02682485|SES-DTA|ses-dta
4789768|NCT02682485|anastomotic leak|anastomotic leak
4789769|NCT02682485|anastomotic healing|anastomotic healing
4789770|NCT02682485|intestinal healing|intestinal healing
4789771|NCT02682485|anastomosis|anastomosis
4789772|NCT02682459|Extracapillary glomerulonephritis|extracapillary glomerulonephritis
4789773|NCT02682459|crescentic glomerulonephritis|crescentic glomerulonephritis
4789774|NCT02682459|rapidly progressive renal failure|rapidly progressive renal failure
4789775|NCT02682459|chronic kidney disease|chronic kidney disease
4789776|NCT02682459|ACE-inhibitors|ace-inhibitors
4789777|NCT02682459|fibrosis|fibrosis
4789778|NCT02682446|Early gastric cancer|early gastric cancer
4789779|NCT02682446|endoscopic submucosal dissection|endoscopic submucosal dissection
4789780|NCT02682446|serum pepsinogen|serum pepsinogen
4789781|NCT02682446|Helicobacter pylori|helicobacter pylori
4789782|NCT02682407|IgAN|igan
4789783|NCT02682407|MN|mn
4789784|NCT02682407|C3 Glomerulopathy|c3 glomerulopathy
4789785|NCT02682407|Lupus Nephritis|lupus nephritis
4789786|NCT02682394|Cancer of pancreas|cancer of pancreas
4789787|NCT02682394|steatosis|steatosis
4789788|NCT02682394|MRI|mri
4789789|NCT02682381|Teduglutide|teduglutide
4789790|NCT02682381|pediatric|pediatric
4789791|NCT02682381|GLP-2|glp-2
4789792|NCT02682381|parenteral support|parenteral support
4789793|NCT02682381|Short Bowel Syndrome|short bowel syndrome
4789794|NCT02682381|short gut syndrome|short gut syndrome
4789795|NCT02682381|short gut|short gut
4789796|NCT02682381|SBS|sbs
4789797|NCT02682381|parenteral nutrition|parenteral nutrition
4789798|NCT02682368|Surgeon performed ultrasound|surgeon performed ultrasound
4789799|NCT02682368|Point of care ultrasound|point of care ultrasound
4789800|NCT02682329|Peroxide|peroxide
4789801|NCT02682316|undergoing laparotomy|undergoing laparotomy
4789802|NCT02682316|15-309|15-309
4789803|NCT02682303|Adhesive elastic bandaging|adhesive elastic bandaging
4789804|NCT02682303|balance|balance
4789805|NCT02682303|posturography|posturography
4789806|NCT02682290|SPUTUM|sputum
4789807|NCT02682290|RHEOLOGY|rheology
4789808|NCT02682277|obesity|obesity
4789809|NCT02682277|body weight|body weight
4789810|NCT02682277|overweight|overweight
4789811|NCT02682277|weight loss|weight loss
4789812|NCT02682277|polyglucosamine|polyglucosamine
4789813|NCT02682277|L112|l112
4789814|NCT02682277|caloric restriction|caloric restriction
4789815|NCT02682277|physical activity|physical activity
4789816|NCT02682264|acne|acne
4789817|NCT02682251|Cardiac Resynchronization Therapy Devices|cardiac resynchronization therapy devices
4789818|NCT02682251|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
4789819|NCT02682225|Esketamine|esketamine
4789820|NCT02682225|Placebo|placebo
4789821|NCT02682225|Racemic ketamine|racemic ketamine
4789822|NCT02682225|Pharmacokinetics|pharmacokinetics
4789823|NCT02682212|Pelvic floor|pelvic floor
4789824|NCT02682212|obstetrics|obstetrics
4789825|NCT02682212|perineal tear|perineal tear
4789826|NCT02682212|physiotherapy|physiotherapy
4789827|NCT02682186|Prosthetic breast surgery|prosthetic breast surgery
4789828|NCT02682186|Locoregional anesthesia|locoregional anesthesia
4789829|NCT02682186|Pectoral nerve block|pectoral nerve block
4789831|NCT02682186|Postoperative analgesia|postoperative analgesia
4789832|NCT02682160|bariatric surgery|bariatric surgery
4789833|NCT02682134|Sore Throat|sore throat
4789834|NCT02682134|Intubation|intubation
4789835|NCT02682134|Xylocaine|xylocaine
4789836|NCT02682134|Dexamethasone|dexamethasone
4789837|NCT02682108|Hepatitis B|hepatitis b
4789838|NCT02682108|Hepatitis C|hepatitis c
4789839|NCT02682108|Fibrosis, Liver|fibrosis, liver
4789840|NCT02682108|Magnetic Resonance Imaging|magnetic resonance imaging
4789841|NCT02682095|Hypertension|hypertension
4789842|NCT02682095|Blood Pressure Control|blood pressure control
4789843|NCT02682095|Adherence|adherence
4789844|NCT02682095|Mixed Methods|mixed methods
4789845|NCT02682082|Pancreatic cancer|pancreatic cancer
4789846|NCT02682082|Pain Management|pain management
4789847|NCT02682082|Celiac plexus neurolysis|celiac plexus neurolysis
4789848|NCT02682082|Bupivacaine|bupivacaine
4789849|NCT02682082|Palliative treatment|palliative treatment
4789850|NCT02682069|Diabetic foot ulcer|diabetic foot ulcer
4789851|NCT02682069|venous leg ulcer|venous leg ulcer
4789852|NCT02682069|fluorescence imaging|fluorescence imaging
4789853|NCT02682069|wound imaging|wound imaging
4789854|NCT02682056|Pediatrics|pediatrics
4789855|NCT02682056|Endocrinology|endocrinology
4789856|NCT02682056|Adolescent|adolescent
4789857|NCT02682056|Microneedle|microneedle
4789858|NCT02682030|Airway Clearance Devices|airway clearance devices
4789859|NCT02682030|High Frequency Chest Compression Devices|high frequency chest compression devices
4789860|NCT02682030|Cough Assist|cough assist
4789861|NCT02682017|Seaweed|seaweed
4789862|NCT02682017|Pork|pork
4789863|NCT02682017|Fucoidan|fucoidan
4789864|NCT02682017|Laminarin|laminarin
4789865|NCT02682017|Functional Food|functional food
4789866|NCT02682017|Antioxidant activity|antioxidant activity
4789867|NCT02681913|Cardioplegia|cardioplegia
4789868|NCT02681913|Cardiac Surgery|cardiac surgery
4789869|NCT02681913|Adenosine|adenosine
4789870|NCT02681913|Therapeutic Uses|therapeutic uses
4789871|NCT02681913|Intermittent warm blood cardioplegia|intermittent warm blood cardioplegia
4789872|NCT02681913|Minimally Invasive Surgery|minimally invasive surgery
4789998|NCT02681016|Calypso|calypso
4789873|NCT02681913|minimally invasive mitral valve plasty (mini-MPL)|minimally invasive mitral valve plasty (mini-mpl)
4789874|NCT02681913|minimally invasive mitral valve replacement (mini-MVR)|minimally invasive mitral valve replacement (mini-mvr)
4789875|NCT02681874|dietary pattern|dietary pattern
4789876|NCT02681874|stress|stress
4789877|NCT02681874|nutrition|nutrition
4789878|NCT02681874|health|health
4789879|NCT02681874|obesity|obesity
4789880|NCT02681874|children|children
4789881|NCT02681874|minority|minority
4789882|NCT02681874|pre-schoolers|pre-schoolers
4789883|NCT02681861|Pharmacodynamics|pharmacodynamics
4789884|NCT02681861|Pharmacokinetics|pharmacokinetics
4789885|NCT02681861|ASP6294|asp6294
4789886|NCT02681861|Maximum tolerated dose|maximum tolerated dose
4789887|NCT02681861|Healthy subjects|healthy subjects
4789888|NCT02681848|Primary care attendance|primary care attendance
4789889|NCT02681848|All-cause|all-cause
4789890|NCT02681848|Cause specific|cause specific
4789891|NCT02681848|Hospital attendance|hospital attendance
4789892|NCT02681822|Genome-wide association studies|genome-wide association studies
4789893|NCT02681822|Environmental factors|environmental factors
4789894|NCT02681822|Behavioral Assessment|behavioral assessment
4789895|NCT02681822|Pathway analysis|pathway analysis
4789896|NCT02681783|aflibercept|aflibercept
4789897|NCT02681770|kidney transplantation|kidney transplantation
4789898|NCT02681770|adherence|adherence
4789899|NCT02681770|quality of life|quality of life
4789900|NCT02681770|couples|couples
4789901|NCT02681770|fundamental frequency|fundamental frequency
4789902|NCT02681770|communication|communication
4789903|NCT02681770|social support|social support
4789904|NCT02681757|pediatric hand burn|pediatric hand burn
4789905|NCT02681757|pediatric foot burn|pediatric foot burn
4789906|NCT02681757|mepitel Ag|mepitel ag
4789907|NCT02681757|soft cast technique for burn wound heaing|soft cast technique for burn wound heaing
4789908|NCT02681718|A1C≥9%|a1c≥9%
4789909|NCT02681718|minorities|minorities
4789910|NCT02681718|economically disadvantaged|economically disadvantaged
4789911|NCT02681692|colonoscopy|colonoscopy
4789912|NCT02681692|colonoscopy education|colonoscopy education
4789913|NCT02681692|magnetic endoscope imaging|magnetic endoscope imaging
4789914|NCT02681692|Colonic Diseases|colonic diseases
4789915|NCT02681666|FODMAP Diet|fodmap diet
4789916|NCT02681666|Bowel Habit|bowel habit
4789917|NCT02681666|Rome IV Criteria|rome iv criteria
4789918|NCT02681666|Mindfulness|mindfulness
4789919|NCT02681666|Abdominal pain|abdominal pain
4789920|NCT02681666|Irritable Bowel Syndrome|irritable bowel syndrome
4789921|NCT02681653|Statins|statins
4789922|NCT02681653|Septic Shock|septic shock
4789923|NCT02681614|Imaging|imaging
4789924|NCT02681614|Prostate|prostate
4789925|NCT02681614|Multiparametric MRI|multiparametric mri
4789926|NCT02681614|brachytherapy|brachytherapy
4789927|NCT02681601|Diet, Food, and Nutrition|diet, food, and nutrition
4789928|NCT02681588|diabetes, obesity, skinfold, newborn|diabetes, obesity, skinfold, newborn
4789929|NCT02681562|olaparib|olaparib
4789930|NCT02681510|medication tolerability|medication tolerability
4789931|NCT02681497|canagliflozin|canagliflozin
4789932|NCT02681497|diabetes|diabetes
4789933|NCT02681497|SGLT2|sglt2
4789934|NCT02681497|real-world data|real-world data
4789935|NCT02681471|Monopolar|monopolar
4789936|NCT02681471|Bipolar|bipolar
4789937|NCT02681471|TURP syndrome|turp syndrome
4789938|NCT02681471|hyponatremia|hyponatremia
4789939|NCT02681432|HIPEC|hipec
4789940|NCT02681432|ovarian cancer|ovarian cancer
4789941|NCT02681432|peritoneal carcinomatosis|peritoneal carcinomatosis
4789942|NCT02681393|Physical activity, brochures, telephone support, stroke|physical activity, brochures, telephone support, stroke
4789943|NCT02681380|simulated patient|simulated patient
4789944|NCT02681380|Balint|balint
4789945|NCT02681380|empathy|empathy
4789946|NCT02681380|medical student|medical student
4789947|NCT02681367|Recurrent implantation failure|recurrent implantation failure
4789948|NCT02681367|Freeze all policy|freeze all policy
4789949|NCT02681367|endometrial receptivity|endometrial receptivity
4789950|NCT02681367|implantation|implantation
4789951|NCT02681367|clinical outcome|clinical outcome
4789952|NCT02681354|elderly|elderly
4789953|NCT02681289|infant|infant
4789954|NCT02681289|risk|risk
4789955|NCT02681289|rehabilitation|rehabilitation
4789956|NCT02681276|Irrigation during root canal treatment|irrigation during root canal treatment
4789957|NCT02681276|Sodium Hypochlorite|sodium hypochlorite
4789958|NCT02681250|Zirconium|zirconium
4789959|NCT02681250|Randomized Controlled Trial|randomized controlled trial
4789960|NCT02681250|Dental Implants|dental implants
4789961|NCT02681250|Dental Material|dental material
4789962|NCT02681250|Titanium|titanium
4789963|NCT02681211|migraine headache|migraine headache
4789964|NCT02681211|acupuncture|acupuncture
4789965|NCT02681198|Healthy|healthy
4789966|NCT02681198|Lofexidine|lofexidine
4789967|NCT02681198|Paroxetine|paroxetine
4789968|NCT02681198|Volunteer|volunteer
4789969|NCT02681172|CSF|csf
4789970|NCT02681172|Alzheimer's Disease (AD) and related dementia|alzheimer's disease (ad) and related dementia
4789971|NCT02681172|HAS recommendations|has recommendations
4789972|NCT02681159|Anesthesia|anesthesia
4789973|NCT02681146|education|education
4789974|NCT02681146|physiotherapy|physiotherapy
4789975|NCT02681133|Physical activity level|physical activity level
4789976|NCT02681133|Knee osteoarthritis|knee osteoarthritis
4789977|NCT02681133|Non pharmacological treatment|non pharmacological treatment
4789978|NCT02681133|Survey|survey
4789979|NCT02681133|Socio-demographic, clinical variables|socio-demographic, clinical variables
4789980|NCT02681133|Barriers, facilitators Fears and beliefs|barriers, facilitators fears and beliefs
4789981|NCT02681133|Function|function
4789982|NCT02681120|Biomarkers|biomarkers
4789983|NCT02681120|Breast imaging|breast imaging
4789984|NCT02681107|Radiation therapy|radiation therapy
4789985|NCT02681107|Accelerated partial breast irradiation (APBI)|accelerated partial breast irradiation (apbi)
4789986|NCT02681107|Breast conserving surgery|breast conserving surgery
4789987|NCT02681107|Stage 1|stage 1
4789988|NCT02681094|Diabetes Mellitus Type 2,|diabetes mellitus type 2,
4789989|NCT02681094|saxagliptin,|saxagliptin,
4789990|NCT02681094|dapagliflozin,|dapagliflozin,
4789991|NCT02681094|metformin|metformin
4789992|NCT02681081|Neuroplasticity|neuroplasticity
4789993|NCT02681068|Fecal microbiota transplantation (FMT)|fecal microbiota transplantation (fmt)
4789994|NCT02681068|Clostridium difficile associated diarrhea (CDAD)|clostridium difficile associated diarrhea (cdad)
4789995|NCT02681055|NASH|nash
4789996|NCT02681055|NAFLD|nafld
4789997|NCT02681029|Cleavage stage blastocyst transfer cryopreservation|cleavage stage blastocyst transfer cryopreservation
4789999|NCT02681016|Xience|xience
4790000|NCT02681016|Coronary stenosis|coronary stenosis
4790001|NCT02681016|Drug-eluting stent|drug-eluting stent
4790002|NCT02681016|Coronary angioplasty with stenting|coronary angioplasty with stenting
4790003|NCT02681016|Ischemic Heart Disease|ischemic heart disease
4790004|NCT02680977|Mucuna pruriens|mucuna pruriens
4790005|NCT02680977|Levodopa|levodopa
4790006|NCT02680951|Pediatric|pediatric
4790007|NCT02680951|Adolescent|adolescent
4790008|NCT02680912|Bi syndrome|bi syndrome
4790009|NCT02680899|science education|science education
4790010|NCT02680899|health promotion|health promotion
4790011|NCT02680899|mental health promotion|mental health promotion
4790012|NCT02680899|stigmatization|stigmatization
4790013|NCT02680899|behavioral intervention|behavioral intervention
4790014|NCT02680886|Rapid Absorbable Suture Material|rapid absorbable suture material
4790015|NCT02680886|Children / Adults|children / adults
4790016|NCT02680886|Novosyn Quick|novosyn quick
4790017|NCT02680873|type 2 diabetes , obesity , SASI|type 2 diabetes , obesity , sasi
4790018|NCT02680847|Pediatric|pediatric
4790019|NCT02680847|pain indication|pain indication
4790020|NCT02680847|controlled release oxycodone|controlled release oxycodone
4790021|NCT02680834|venous stasis ulcer|venous stasis ulcer
4790022|NCT02680834|wound|wound
4790023|NCT02680834|chronic venous insufficiency|chronic venous insufficiency
4790024|NCT02680821|Laxity|laxity
4790025|NCT02680821|Knee|knee
4790026|NCT02680821|Rupture|rupture
4790027|NCT02680821|ALL|all
4790028|NCT02680795|UGT1A1*28|ugt1a1*28
4790029|NCT02680795|Belinostat|belinostat
4790031|NCT02680795|wild type genotypes|wild type genotypes
4790032|NCT02680795|heterozygous genotypes|heterozygous genotypes
4790033|NCT02680795|homozygous genotypes|homozygous genotypes
4790034|NCT02680782|Healthy Volunteers|healthy volunteers
4790035|NCT02680782|Comparison|comparison
4790036|NCT02680782|Once-Daily|once-daily
4790037|NCT02680782|Twice-Daily|twice-daily
4790038|NCT02680782|X4P-001|x4p-001
4790039|NCT02680756|Iron Deficiency|iron deficiency
4790040|NCT02680756|Anaemia|anaemia
4790041|NCT02680756|Crohn's Disease|crohn's disease
4790042|NCT02680756|Deficiency Diseases|deficiency diseases
4790043|NCT02680756|Inflammatory Bowel Diseases|inflammatory bowel diseases
4790044|NCT02680756|Intestinal Diseases|intestinal diseases
4790045|NCT02680730|Autonomic nervous system|autonomic nervous system
4790046|NCT02680730|Auditory processing disorder|auditory processing disorder
4790047|NCT02680730|Social behavior|social behavior
4790048|NCT02680691|infratentorial stroke|infratentorial stroke
4790049|NCT02680691|robot|robot
4790050|NCT02680691|postural balance|postural balance
4790051|NCT02680691|Rehabilitation|rehabilitation
4790052|NCT02680652|CVID|cvid
4790053|NCT02680652|Common Variable Immune Deficiency|common variable immune deficiency
4790054|NCT02680639|High-Frequency Ventilation|high-frequency ventilation
4790055|NCT02680639|Biphasic Continuous Positive Airway Pressure|biphasic continuous positive airway pressure
4790056|NCT02680613|Behaviour Change|behaviour change
4790057|NCT02680613|Secondary Prevention|secondary prevention
4790058|NCT02680613|mHealth|mhealth
4790059|NCT02680587|Prostate Cancer|prostate cancer
4790060|NCT02680587|Stereotactic Body Radiation Therapy|stereotactic body radiation therapy
4790061|NCT02680587|Stereotactic Ablative Radiotherapy|stereotactic ablative radiotherapy
4790062|NCT02680587|Oligometastasis|oligometastasis
4790063|NCT02680574|vadadustat|vadadustat
4790064|NCT02680574|AKB-6548|akb-6548
4790065|NCT02680574|Chronic kidney disease|chronic kidney disease
4790066|NCT02680574|anemia|anemia
4790067|NCT02680574|CKD|ckd
4790068|NCT02680574|chronic renal insufficiency|chronic renal insufficiency
4790069|NCT02680574|renal impairment|renal impairment
4790070|NCT02680574|erythropoietin|erythropoietin
4790071|NCT02680574|kidney|kidney
4790072|NCT02680574|renal|renal
4790073|NCT02680574|oral anemia treatment|oral anemia treatment
4790074|NCT02680574|hemoglobin|hemoglobin
4790075|NCT02680574|hypoxia-inducible factor|hypoxia-inducible factor
4790076|NCT02680574|HIF|hif
4790077|NCT02680574|hypoxia-inducible factor prolyl-hydroxylase inhibitor|hypoxia-inducible factor prolyl-hydroxylase inhibitor
4790078|NCT02680574|HIF-PHI|hif-phi
4790079|NCT02680574|efficacy|efficacy
4790080|NCT02680574|safety|safety
4790081|NCT02680574|Phase 3|phase 3
4790082|NCT02680574|cardiovascular|cardiovascular
4790083|NCT02680574|NDD-CKD|ndd-ckd
4790084|NCT02680548|ankle pain|ankle pain
4790085|NCT02680548|foot pain|foot pain
4790086|NCT02680548|methylprednisolone|methylprednisolone
4790087|NCT02680548|neuropathic pain|neuropathic pain
4790088|NCT02680522|Parkinson's disease|parkinson's disease
4790089|NCT02680522|Heart Rate Variability|heart rate variability
4790090|NCT02680522|Physiotherapy|physiotherapy
4790091|NCT02680496|Robot-Assistance|robot-assistance
4790092|NCT02680496|Gait [MeSH]|gait [mesh]
4790093|NCT02680496|Energy Consumption|energy consumption
4790094|NCT02680496|Cardiorespiratory Load|cardiorespiratory load
4790095|NCT02680496|Stroke [MeSH]|stroke [mesh]
4790096|NCT02680483|Atrial fibrillation|atrial fibrillation
4790097|NCT02680483|Registry|registry
4790098|NCT02680483|Middle East|middle east
4790099|NCT02680483|Jordan|jordan
4790100|NCT02680483|risk factors|risk factors
4790101|NCT02680483|in hospital management|in hospital management
4790102|NCT02680483|long term management|long term management
4790103|NCT02680470|Tuberculosis|tuberculosis
4790104|NCT02680470|Management|management
4790105|NCT02680470|Observed therapy|observed therapy
4790106|NCT02680444|Mindfulness|mindfulness
4790107|NCT02680444|Primary Promotion|primary promotion
4790108|NCT02680444|Mental Health|mental health
4790109|NCT02680444|Well-being|well-being
4790110|NCT02680444|Positive Reappraisal|positive reappraisal
4790111|NCT02680392|Pulsed and Continuous Radiofrequency Treatment|pulsed and continuous radiofrequency treatment
4790112|NCT02680392|Continuous adductor canal block|continuous adductor canal block
4790113|NCT02680392|Postoperative pain|postoperative pain
4790114|NCT02680392|Functional recovery|functional recovery
4790115|NCT02680392|Total Knee Joint Replacement|total knee joint replacement
4790116|NCT02680379|Fragile X Syndrome|fragile x syndrome
4790117|NCT02680379|Autism|autism
4790118|NCT02680379|FMR1|fmr1
4790119|NCT02680379|FRAXA|fraxa
4790120|NCT02680340|Total Hip Arthroplasty THA|total hip arthroplasty tha
4790121|NCT02680314|unripe cervix|unripe cervix
4790122|NCT02680301|Wet Wraps|wet wraps
4790123|NCT02680301|Topical Steroid|topical steroid
4790124|NCT02680288|Psychostimulant, Craving, Cocaine.|psychostimulant, craving, cocaine.
4790125|NCT02680275|Chronic endometritis|chronic endometritis
4790126|NCT02680275|Miscarriage|miscarriage
4790127|NCT02680275|Infertility|infertility
4790128|NCT02680262|HPV self-sampling, cervical cancer screening|hpv self-sampling, cervical cancer screening
4790129|NCT02680249|Safety, Bioavailability and Pharmacokinetics|safety, bioavailability and pharmacokinetics
4790130|NCT02680236|Pain|pain
4790131|NCT02680236|Cancer|cancer
4790132|NCT02680236|Chemotherapy|chemotherapy
4790133|NCT02680236|Anxiety|anxiety
4790134|NCT02680236|Depression|depression
4790135|NCT02680236|Isolation|isolation
4790136|NCT02680197|COPD|copd
4790137|NCT02680184|Malignant melanoma|malignant melanoma
4790138|NCT02680171|Cognitive Rehabilitation|cognitive rehabilitation
4790139|NCT02680171|Prism Adaptation|prism adaptation
4790140|NCT02680171|Stroke|stroke
4790141|NCT02680171|Spatial Neglect|spatial neglect
4790142|NCT02680145|Pessary|pessary
4790143|NCT02680145|Prolapse|prolapse
4790144|NCT02680145|Cystocele|cystocele
4790145|NCT02680106|Nanofibers|nanofibers
4790146|NCT02680106|Dressing|dressing
4790147|NCT02680106|Donor site|donor site
4790148|NCT02680106|Polycaprolactone|polycaprolactone
4790149|NCT02680067|Healthy Individual|healthy individual
4790150|NCT02680067|Lymphatic Transport|lymphatic transport
4790151|NCT02680067|Near InfraRed|near infrared
4790152|NCT02680067|Imaging|imaging
4790153|NCT02680067|Indocyanine Green|indocyanine green
4790154|NCT02680067|ICG|icg
4790155|NCT02680067|NIR|nir
4790156|NCT02680067|NIR-ICG|nir-icg
4790157|NCT02680067|MSImager|msimager
4790158|NCT02680067|rheumatoid arthritis|rheumatoid arthritis
4790159|NCT02680015|PEERS|peers
4790160|NCT02680015|friendships|friendships
4790161|NCT02680015|brain|brain
4790162|NCT02679989|Insulin sensitivity|insulin sensitivity
4790163|NCT02679989|Weight loss|weight loss
4790164|NCT02679989|Intermittent fasting|intermittent fasting
4790165|NCT02679989|Sympathetic nervous system|sympathetic nervous system
4790166|NCT02679950|Next generation genome sequencing|next generation genome sequencing
4790167|NCT02679950|Late relapse|late relapse
4790168|NCT02679950|Genetic profiles|genetic profiles
4790169|NCT02679937|U.S. Military|u.s. military
4790170|NCT02679937|Overweight|overweight
4790171|NCT02679937|Obesity|obesity
4790172|NCT02679937|Service Members|service members
4790173|NCT02679937|Prevention|prevention
4790174|NCT02679911|Onychomycosis|onychomycosis
4790175|NCT02679898|Arterial function|arterial function
4790176|NCT02679898|Whole-body vibration training|whole-body vibration training
4790177|NCT02679898|Aortic blood pressures|aortic blood pressures
4790178|NCT02679898|Wave reflection|wave reflection
4790179|NCT02679898|Muscle strength|muscle strength
4790180|NCT02679898|Endothelial function|endothelial function
4790181|NCT02679898|Blood flow|blood flow
4790182|NCT02679872|Non-technical skills|non-technical skills
4790183|NCT02679872|Patient safety|patient safety
4790184|NCT02679872|Video-assisted thoracoscopic surgery|video-assisted thoracoscopic surgery
4790185|NCT02679872|Operating theatre team|operating theatre team
4790186|NCT02679872|Operating room|operating room
4790187|NCT02679859|Natriuretic Peptide, Brain|natriuretic peptide, brain
4790188|NCT02679859|Surgery|surgery
4790189|NCT02679846|withdrawal of antiepileptic drugs|withdrawal of antiepileptic drugs
4790190|NCT02679846|monitoring VEEG|monitoring veeg
4790191|NCT02679846|safety|safety
4790192|NCT02679846|adverse event|adverse event
4790193|NCT02679846|standardized protocol|standardized protocol
4790194|NCT02679833|Cobalamin biomarkers|cobalamin biomarkers
4790195|NCT02679833|Anemia|anemia
4790196|NCT02679833|Vegan diet|vegan diet
4790197|NCT02679833|Subclinical|subclinical
4790198|NCT02679833|Metabolic functional markers|metabolic functional markers
4790199|NCT02679833|Holotranscobalamin|holotranscobalamin
4790200|NCT02679833|Methylmalonic acid|methylmalonic acid
4790201|NCT02679755|Hormone receptor positive advanced breast cancer|hormone receptor positive advanced breast cancer
4790202|NCT02679742|beta hydroxy beta methylbutyrate|beta hydroxy beta methylbutyrate
4790203|NCT02679742|older people|older people
4790204|NCT02679742|muscle mass|muscle mass
4790205|NCT02679742|muscle strength|muscle strength
4790206|NCT02679742|post-acute|post-acute
4790207|NCT02679729|inhaled dose|inhaled dose
4790208|NCT02679729|intravenous dose|intravenous dose
4790209|NCT02679729|healthy subjects|healthy subjects
4790210|NCT02679729|safety|safety
4790211|NCT02679729|tolerability|tolerability
4790212|NCT02679729|pharmacokinetics|pharmacokinetics
4790213|NCT02679729|AZD5634|azd5634
4790214|NCT02679729|jet nebulizer|jet nebulizer
4790215|NCT02679677|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
4790216|NCT02679677|Randomized controlled trial|randomized controlled trial
4790217|NCT02679677|Physical activity|physical activity
4790218|NCT02679638|breast cancer|breast cancer
4790219|NCT02679638|treatment choice|treatment choice
4790220|NCT02679638|factor|factor
4790221|NCT02679638|perception|perception
4790222|NCT02679573|Pneumonia|pneumonia
4790223|NCT02679560|femur fracture, hip fracture, exparel, liposomal bupivacaine|femur fracture, hip fracture, exparel, liposomal bupivacaine
4790224|NCT02679547|Appendix|appendix
4790225|NCT02679547|Breastfeeding|breastfeeding
4790226|NCT02679547|Adult|adult
4790227|NCT02679534|pain|pain
4790228|NCT02679534|thoracic surgery|thoracic surgery
4790229|NCT02679534|massage|massage
4790230|NCT02679521|Extracorporeal Shock Wave Therapy|extracorporeal shock wave therapy
4790231|NCT02679521|Painful Heel|painful heel
4790232|NCT02679521|Plantar fasciitis|plantar fasciitis
4790233|NCT02679508|Esophagitis|esophagitis
4790234|NCT02679495|early gastric cancer|early gastric cancer
4790235|NCT02679495|lifestyle|lifestyle
4790236|NCT02679482|Primary Open Angle Glaucoma|primary open angle glaucoma
4790237|NCT02679482|Selective Laser Trabeculoplasty|selective laser trabeculoplasty
4790238|NCT02679482|Pattern Scan Laser Trabeculoplasty|pattern scan laser trabeculoplasty
4790239|NCT02679443|Lung Adenocarcinoma|lung adenocarcinoma
4790240|NCT02679443|Non-squamous NSCLC|non-squamous nsclc
4790241|NCT02679443|Chemotherapy|chemotherapy
4790242|NCT02679443|Pemetrexed|pemetrexed
4790243|NCT02679443|Vitamin B12|vitamin b12
4790244|NCT02679443|Folate|folate
4790245|NCT02679443|Supplementation|supplementation
4790246|NCT02679443|Cytopenia|cytopenia
4790247|NCT02679417|Aminotransferase|aminotransferase
4790248|NCT02679417|Fibrosis, liver|fibrosis, liver
4790249|NCT02679417|Anthropometry|anthropometry
4790250|NCT02679417|Exercise|exercise
4790251|NCT02679404|Biological aortic valves|biological aortic valves
4790252|NCT02679404|Mechanical aortic valves|mechanical aortic valves
4790253|NCT02679404|Aortic conduits|aortic conduits
4790254|NCT02679404|Sutureless Aortic Valve|sutureless aortic valve
4790255|NCT02679391|Abdominoplasty|abdominoplasty
4790256|NCT02679391|Early complications|early complications
4790257|NCT02679391|Guidelines|guidelines
4790258|NCT02679391|Sequelae|sequelae
4790259|NCT02679391|bariatric patients|bariatric patients
4790260|NCT02679326|Therapeutic ultrasound, Treatment, Plantar fasciitis|therapeutic ultrasound, treatment, plantar fasciitis
4790261|NCT02679300|Chronic Low Back Pain|chronic low back pain
4790262|NCT02679300|Virtual Reality|virtual reality
4790263|NCT02679300|Serious Gaming|serious gaming
4790264|NCT02679300|Exercise Therapy|exercise therapy
4790265|NCT02679300|Distraction|distraction
4790266|NCT02679287|Closed-Loop Control (CLC)|closed-loop control (clc)
4790267|NCT02679287|Sensor-Augmented Therapy (SAP)|sensor-augmented therapy (sap)
4790268|NCT02679287|USS Virginia|uss virginia
4790269|NCT02679287|Continuous Glucose Monitor (CGM)|continuous glucose monitor (cgm)
4790270|NCT02679287|Insulin Pump|insulin pump
4790271|NCT02679287|Artificial Pancreas (AP)|artificial pancreas (ap)
4790272|NCT02679274|Aging, Frailty, Hypogonadism|aging, frailty, hypogonadism
4790273|NCT02679261|Aortic dilation|aortic dilation
4790274|NCT02679261|Statins|statins
4790275|NCT02679261|Aortic degeneration|aortic degeneration
4790276|NCT02679248|Pre-hypertension|pre-hypertension
4790277|NCT02679248|Mild hypertension|mild hypertension
4790278|NCT02679248|Dietary supplement|dietary supplement
4790279|NCT02679248|Efficacy|efficacy
4790280|NCT02679248|Nitric oxide|nitric oxide
4790281|NCT02679248|Neo40 Daily|neo40 daily
4790282|NCT02679170|ALK+|alk+
4790283|NCT02679157|Posttraumatic stress disorder|posttraumatic stress disorder
4790284|NCT02679157|Depression|depression
4790285|NCT02679157|Anxiety|anxiety
4790286|NCT02679157|ADL|adl
4790287|NCT02679157|Health-related quality of life|health-related quality of life
4790288|NCT02679157|ICU survivorship|icu survivorship
4790289|NCT02679131|relapsed/refractory solid tumors|relapsed/refractory solid tumors
4790290|NCT02679131|beleodaq|beleodaq
4790291|NCT02679131|renal impairment|renal impairment
4790292|NCT02679131|belinostat|belinostat
4790293|NCT02679131|hematological malignancies|hematological malignancies
4790294|NCT02679118|intestinal perforation|intestinal perforation
4790295|NCT02679118|bariatric surgery|bariatric surgery
4790296|NCT02679118|gastric bypass|gastric bypass
4790297|NCT02679118|gastric perforation|gastric perforation
4790298|NCT02679118|colonic perforation|colonic perforation
4790299|NCT02679092|Induced Abortion|induced abortion
4790300|NCT02679092|Mifepristone|mifepristone
4790301|NCT02679092|Dilation and Evacuation|dilation and evacuation
4790302|NCT02679092|Cervical Preparation|cervical preparation
4790303|NCT02679092|Osmotic Dilators|osmotic dilators
4790304|NCT02679092|Misoprostol|misoprostol
4790305|NCT02678962|Multifocal Intraocular Lenses|multifocal intraocular lenses
4790306|NCT02678962|bilateral implantation|bilateral implantation
4790307|NCT02678897|Abortion, Drug-Induced|abortion, drug-induced
4790308|NCT02678897|Pain Management|pain management
4790309|NCT02678884|Head and Neck Squamous Cell Carcinoma|head and neck squamous cell carcinoma
4790310|NCT02678884|Radiation therapy|radiation therapy
4790311|NCT02678884|Head and Neck Cancers|head and neck cancers
4790312|NCT02678871|Aortic Valve Stenosis|aortic valve stenosis
4790313|NCT02678871|Left atrial appendage|left atrial appendage
4790314|NCT02678858|social cognition|social cognition
4790315|NCT02678858|social skills|social skills
4790316|NCT02678858|cognitive remediation|cognitive remediation
4790317|NCT02678858|functional outcome|functional outcome
4790318|NCT02678858|treatment adherence|treatment adherence
4790319|NCT02678767|HIV|hiv
4790320|NCT02678767|Dementia|dementia
4790321|NCT02678767|Neuroimaging|neuroimaging
4790322|NCT02678702|Sleep|sleep
4790323|NCT02678702|Depression|depression
4790324|NCT02678702|Comorbid Insomnia|comorbid insomnia
4790325|NCT02678702|Cognitive Behavioral Therapy|cognitive behavioral therapy
4790326|NCT02678702|Sleep Restriction|sleep restriction
4790327|NCT02678702|Stimulus Control therapy|stimulus control therapy
4790328|NCT02678702|Relaxation|relaxation
4790329|NCT02678676|Drug Therapy|drug therapy
4790330|NCT02678663|Colon polyp|colon polyp
4790331|NCT02678663|Polypectomy|polypectomy
4790332|NCT02678663|Cold snare|cold snare
4790333|NCT02678663|Endoscopic mucosal resection|endoscopic mucosal resection
4790334|NCT02678650|Volatile Anesthetics|volatile anesthetics
4790335|NCT02678650|MicroRNA|microrna
4790336|NCT02678650|Off-pump Coronary Artery Bypass Surgery|off-pump coronary artery bypass surgery
4790337|NCT02678650|Internal Mammary Artery|internal mammary artery
4790338|NCT02678650|Ascending Aorta|ascending aorta
4790339|NCT02678637|MRI|mri
4790340|NCT02678637|CCSA|ccsa
4790341|NCT02678637|Contractile Cross Sectional Area|contractile cross sectional area
4790342|NCT02678637|Strength|strength
4790343|NCT02678637|Calf muscle|calf muscle
4790344|NCT02678611|Healthy participants|healthy participants
4790345|NCT02678611|Dietary supplement|dietary supplement
4790346|NCT02678611|Safety|safety
4790347|NCT02678611|Tolerability|tolerability
4790348|NCT02678611|Older Adults|older adults
4790349|NCT02678611|Basis|basis
4790350|NCT02678611|Nicotinamide riboside|nicotinamide riboside
4790351|NCT02678611|Pterostilbene|pterostilbene
4790352|NCT02678598|Micafungin|micafungin
4790353|NCT02678598|Candida|candida
4790354|NCT02678598|Aspergillosis|aspergillosis
4790355|NCT02678598|Antifungal|antifungal
4790356|NCT02678572|uveal liver PHP hepatic perfusion chemosaturation Delcath|uveal liver php hepatic perfusion chemosaturation delcath
4790357|NCT02678559|Alveolar recruitment manoeuvre|alveolar recruitment manoeuvre
4790358|NCT02678559|Lung recruitment|lung recruitment
4790359|NCT02678559|Preload dependency|preload dependency
4790360|NCT02678559|Cardiac surgery|cardiac surgery
4790361|NCT02678559|Transoesophageal echocardiography|transoesophageal echocardiography
4790362|NCT02678546|Traditional Chinese Medicine|traditional chinese medicine
4790363|NCT02678533|Fanconi Anemia|fanconi anemia
4790364|NCT02678533|CD34+ cells mobilization|cd34+ cells mobilization
4790365|NCT02678533|G-CSF|g-csf
4790366|NCT02678533|Plerixafor|plerixafor
4790367|NCT02678533|gene therapy|gene therapy
4790368|NCT02678520|Prostate Cancer|prostate cancer
4790369|NCT02678520|Post Operative|post operative
4790370|NCT02678520|Radiation|radiation
4790371|NCT02678520|Prostatectomy|prostatectomy
4790372|NCT02678520|3-D CRT|3-d crt
4790373|NCT02678520|IMRT|imrt
4790374|NCT02678520|RT|rt
4790375|NCT02678520|CRT|crt
4790376|NCT02678520|Conformal Radiation Therapy|conformal radiation therapy
4790377|NCT02678520|Intensity Modulated Radiation Therapy|intensity modulated radiation therapy
4790378|NCT02678520|Hormone|hormone
4790379|NCT02678520|Surgery|surgery
4790380|NCT02678520|Hormonal Therapy|hormonal therapy
4790381|NCT02678494|Spinal Cord Injury|spinal cord injury
4790382|NCT02678481|multiparametric magnetic resonance imaging|multiparametric magnetic resonance imaging
4790383|NCT02678481|MR-targeted prostate biopsy|mr-targeted prostate biopsy
4790384|NCT02678481|saturation TRUS-guided prostate biopsy|saturation trus-guided prostate biopsy
4790385|NCT02678455|Dengue Virus|dengue virus
4790386|NCT02678416|comparison|comparison
4790387|NCT02678403|peripheral artery disease|peripheral artery disease
4790388|NCT02678403|transcutaneous electrical nerve stimulation|transcutaneous electrical nerve stimulation
4790389|NCT02678403|walking ability|walking ability
4790390|NCT02678403|endothelial function|endothelial function
4790391|NCT02678364|Vitamin D-biofortified eggs|vitamin d-biofortified eggs
4790392|NCT02678364|Vitamin D status|vitamin d status
4790393|NCT02678364|RCT|rct
4790394|NCT02678312|Pediatric Heart failure,|pediatric heart failure,
4790395|NCT02678312|systemic left ventricle,|systemic left ventricle,
4790396|NCT02678312|reduced ejection fraction|reduced ejection fraction
4790397|NCT02678286|Abdominoplasty|abdominoplasty
4790398|NCT02678286|Pain|pain
4790399|NCT02678286|Analgesia|analgesia
4790400|NCT02678286|N1539|n1539
4790401|NCT02678286|Phase 3|phase 3
4790402|NCT02678273|population|population
4790403|NCT02678273|Singapore|singapore
4790404|NCT02678260|Advanced malignancies|advanced malignancies
4790405|NCT02678260|PDR001|pdr001
4790406|NCT02678260|Japanese patients|japanese patients
4790407|NCT02678260|adults|adults
4790408|NCT02678247|prosthesis|prosthesis
4790409|NCT02678247|prosthetic socket|prosthetic socket
4790410|NCT02678247|transfemoral amputation|transfemoral amputation
4790411|NCT02678247|socket comfort|socket comfort
4790412|NCT02678247|gait biomechanics|gait biomechanics
4790413|NCT02678156|Dura mater substitute|dura mater substitute
4790414|NCT02678156|Graft|graft
4790415|NCT02678156|Lyoplant|lyoplant
4790416|NCT02678156|Lyostypt|lyostypt
4790417|NCT02678156|Lyoplant onlay|lyoplant onlay
4790418|NCT02678156|Xenograft|xenograft
4790419|NCT02678130|Intervertebral disc degeneration|intervertebral disc degeneration
4790420|NCT02678130|Bone Disease|bone disease
4790421|NCT02678130|Musculoskeletal disease|musculoskeletal disease
4790422|NCT02678130|Spinal disease|spinal disease
4790423|NCT02678104|Dry Socket|dry socket
4790424|NCT02678104|Honey|honey
4790425|NCT02678104|Tooth Extraction|tooth extraction
4790426|NCT02678078|cancer|cancer
4790427|NCT02678078|diagnosis|diagnosis
4790428|NCT02678078|biopsy|biopsy
4790429|NCT02678078|chemotherapy drugs|chemotherapy drugs
4790430|NCT02678078|tumor|tumor
4790533|NCT02677363|Older|older
4790431|NCT02678052|Drug therapy|drug therapy
4790432|NCT02677961|sarcoma|sarcoma
4790433|NCT02677961|registry|registry
4790434|NCT02677922|Acute Myeloid Leukemia|acute myeloid leukemia
4790435|NCT02677922|Leukemia|leukemia
4790436|NCT02677922|Azacitidine|azacitidine
4790437|NCT02677922|AG-120|ag-120
4790438|NCT02677922|AG-221|ag-221
4790439|NCT02677909|Parenteral Nutrition|parenteral nutrition
4790440|NCT02677909|Critical Care|critical care
4790441|NCT02677896|Androgen Deprivation Therapy (ADT)|androgen deprivation therapy (adt)
4790442|NCT02677896|Metastatic hormone sensitive prostate cancer|metastatic hormone sensitive prostate cancer
4790443|NCT02677896|Xtandi|xtandi
4790444|NCT02677896|Enzalutamide|enzalutamide
4790445|NCT02677870|Saproterin dihydrochloride|saproterin dihydrochloride
4790446|NCT02677870|Kuvan|kuvan
4790447|NCT02677870|Amish|amish
4790448|NCT02677831|Physical functioning|physical functioning
4790449|NCT02677831|Neuropsychiatric Disorders|neuropsychiatric disorders
4790450|NCT02677831|Frailty|frailty
4790451|NCT02677818|Plasma Factor VIII Levels|plasma factor viii levels
4790452|NCT02677818|Ischemic stroke|ischemic stroke
4790453|NCT02677818|Antithrombotic therapy|antithrombotic therapy
4790454|NCT02677818|Bleeding|bleeding
4790455|NCT02677766|Occupational Therapy|occupational therapy
4790456|NCT02677766|Complex patients|complex patients
4790457|NCT02677766|Randomized controlled trial|randomized controlled trial
4790458|NCT02677766|Occupational performance problem|occupational performance problem
4790459|NCT02677766|Rehabilitation Complexity Scale|rehabilitation complexity scale
4790460|NCT02677740|MRI|mri
4790461|NCT02677740|MRS|mrs
4790462|NCT02677740|rTMS|rtms
4790463|NCT02677727|Cisplatin-based chemotherapy|cisplatin-based chemotherapy
4790464|NCT02677727|Chemotherapy-induced peripheral neuropathy|chemotherapy-induced peripheral neuropathy
4790465|NCT02677688|systemic lupus erythematosus|systemic lupus erythematosus
4790466|NCT02677688|autologous anti-EBV CTL|autologous anti-ebv ctl
4790467|NCT02677688|adoptive therapy|adoptive therapy
4790468|NCT02677688|phase 1 -2|phase 1 -2
4790469|NCT02677662|Diesel exhaust|diesel exhaust
4790470|NCT02677662|Oxidative stress|oxidative stress
4790471|NCT02677662|Systemic inflammation|systemic inflammation
4790472|NCT02677662|Air pollution|air pollution
4790473|NCT02677649|cranberry, microbiome, polyphenols, healthy|cranberry, microbiome, polyphenols, healthy
4790474|NCT02677636|Dermatitis, Atopic|dermatitis, atopic
4790475|NCT02677636|Eczema|eczema
4790476|NCT02677636|Dermatitis|dermatitis
4790477|NCT02677636|Pruritus|pruritus
4790478|NCT02677636|Genetic Diseases, Inborn|genetic diseases, inborn
4790479|NCT02677636|Hypersensitivity|hypersensitivity
4790480|NCT02677636|Hypersensitivity, Immediate|hypersensitivity, immediate
4790481|NCT02677636|Immune System Diseases|immune system diseases
4790482|NCT02677636|Skin Diseases, Eczematous|skin diseases, eczematous
4790483|NCT02677636|Skin Diseases, Genetic|skin diseases, genetic
4790484|NCT02677636|Skin Diseases|skin diseases
4790485|NCT02677636|Itching|itching
4790486|NCT02677636|Rash|rash
4790487|NCT02677636|Steroid|steroid
4790488|NCT02677610|Dermatitis, Atopic|dermatitis, atopic
4790489|NCT02677610|Eczema|eczema
4790490|NCT02677610|Dermatitis|dermatitis
4790491|NCT02677610|Pruritus|pruritus
4790492|NCT02677610|Genetic Diseases, Inborn|genetic diseases, inborn
4790493|NCT02677610|Hypersensitivity|hypersensitivity
4790494|NCT02677610|Hypersensitivity, Immediate|hypersensitivity, immediate
4790495|NCT02677610|Immune System Diseases|immune system diseases
4790496|NCT02677610|Skin Diseases, Eczematous|skin diseases, eczematous
4790497|NCT02677610|Skin Diseases, Genetic|skin diseases, genetic
4790498|NCT02677610|Skin Diseases|skin diseases
4790499|NCT02677610|Itching|itching
4790500|NCT02677610|Rash|rash
4790501|NCT02677610|Steroid|steroid
4790502|NCT02677584|caffeine|caffeine
4790503|NCT02677584|apnea|apnea
4790504|NCT02677584|preterm infant|preterm infant
4790505|NCT02677558|Pregnancy|pregnancy
4790506|NCT02677558|Obesity|obesity
4790507|NCT02677558|Echocardiography|echocardiography
4790508|NCT02677519|ADHD|adhd
4790509|NCT02677519|children|children
4790510|NCT02677519|methylphenidate|methylphenidate
4790511|NCT02677506|elbow|elbow
4790512|NCT02677480|Microflora|microflora
4790513|NCT02677480|Probiotics|probiotics
4790514|NCT02677480|Hyposalivation|hyposalivation
4790515|NCT02677480|Lactobacilli|lactobacilli
4790516|NCT02677480|Mutans streptococci|mutans streptococci
4790517|NCT02677480|pH-rising components|ph-rising components
4790518|NCT02677454|Blood Glucose|blood glucose
4790519|NCT02677454|Blood Glucose Self-Monitoring|blood glucose self-monitoring
4790520|NCT02677428|Veterans|veterans
4790521|NCT02677428|world wide web|world wide web
4790522|NCT02677428|Counseling|counseling
4790523|NCT02677428|Workman's Compensation|workman's compensation
4790524|NCT02677415|Ischemic Stroke|ischemic stroke
4790525|NCT02677415|Anesthesia|anesthesia
4790526|NCT02677415|Endovascular Procedures|endovascular procedures
4790527|NCT02677402|femoral vein|femoral vein
4790528|NCT02677402|saphenous vein|saphenous vein
4790529|NCT02677402|hydrostatic pressure|hydrostatic pressure
4790530|NCT02677402|temperature|temperature
4790531|NCT02677402|recovery|recovery
4790532|NCT02677363|Elderly|elderly
4790534|NCT02677363|Adults|adults
4790535|NCT02677363|Resistant Exercise|resistant exercise
4790536|NCT02677363|Strength Training|strength training
4790537|NCT02677363|Cognitive function|cognitive function
4790538|NCT02677324|Waldenstrom Macroglobulinemia|waldenstrom macroglobulinemia
4790539|NCT02677324|WM|wm
4790540|NCT02677272|Nursing home|nursing home
4790541|NCT02677272|emergency department|emergency department
4790542|NCT02677272|inappropriate transfer|inappropriate transfer
4790543|NCT02677272|elderly|elderly
4790544|NCT02677259|luteal phase|luteal phase
4790545|NCT02677259|estradiol|estradiol
4790546|NCT02677259|pregnancy rate|pregnancy rate
4790547|NCT02677246|Bone marrow transplantation|bone marrow transplantation
4790548|NCT02677246|Children|children
4790549|NCT02677246|Bone complications|bone complications
4790550|NCT02677246|Denosumab.|denosumab.
4790551|NCT02677181|ATG|atg
4790552|NCT02677181|Matched sibling donor|matched sibling donor
4790553|NCT02677181|peripheral blood stem cell transplantation|peripheral blood stem cell transplantation
4790554|NCT02677168|obstructive sleep apnea|obstructive sleep apnea
4790555|NCT02677168|sleep apnea|sleep apnea
4790556|NCT02677168|OSA|osa
4790557|NCT02677168|cNEP|cnep
4790558|NCT02677168|continuous negative external pressure|continuous negative external pressure
4790559|NCT02677155|Follicular lymphoma|follicular lymphoma
4790560|NCT02677155|Intranodal therapy|intranodal therapy
4790561|NCT02677155|Autologous dendritic cells|autologous dendritic cells
4790562|NCT02677155|Rituximab|rituximab
4790563|NCT02677155|Immunotherapy|immunotherapy
4790564|NCT02677155|Cancer vaccine|cancer vaccine
4790565|NCT02677155|Anti-PD1|anti-pd1
4790566|NCT02677155|Pembrolizumab|pembrolizumab
4790567|NCT02677155|Radiotherapy|radiotherapy
4790568|NCT02677142|pediatric|pediatric
4790569|NCT02677142|Childhood Brain Tumour Survivors|childhood brain tumour survivors
4790570|NCT02677142|Social Skills Rating System|social skills rating system
4790571|NCT02677142|social skills intervention program (SSIP)|social skills intervention program (ssip)
4790572|NCT02677103|Radial shock wave therapy,calcific tendinitis, ultrasound guidance|radial shock wave therapy,calcific tendinitis, ultrasound guidance
4790573|NCT02677090|Fiber tolerability|fiber tolerability
4790574|NCT02677090|Children|children
4790575|NCT02677077|RRMS|rrms
4790576|NCT02677077|MRI|mri
4790577|NCT02677064|Allogeneic Hematopoietic Stem Cell Transplantation|allogeneic hematopoietic stem cell transplantation
4790578|NCT02677064|Identify Barriers|identify barriers
4790579|NCT02677064|16-024|16-024
4790580|NCT02677038|Pancreatic Cancer|pancreatic cancer
4790581|NCT02677038|Stage IV pancreatic ductal adenocarcinoma (PDAC) with BRCAness|stage iv pancreatic ductal adenocarcinoma (pdac) with brcaness
4790582|NCT02677038|PDAC|pdac
4790583|NCT02677038|Metastatic adenocarcinoma of the pancreas|metastatic adenocarcinoma of the pancreas
4790584|NCT02677038|Family history of breast cancer|family history of breast cancer
4790585|NCT02677038|Family history of ovarian cancer|family history of ovarian cancer
4790586|NCT02677038|Family history of pancreatic cancer|family history of pancreatic cancer
4790587|NCT02677038|Family history of gastric cancer|family history of gastric cancer
4790588|NCT02677038|Family history of prostate cancer|family history of prostate cancer
4790589|NCT02677038|Olaparib|olaparib
4790590|NCT02677038|Lynparza|lynparza
4790591|NCT02677025|HIV|hiv
4790592|NCT02677025|Sexual Risk|sexual risk
4790593|NCT02677025|Sexually Transmitted Diseases|sexually transmitted diseases
4790594|NCT02677025|Substance Abuse|substance abuse
4790595|NCT02677025|Violence and Victimization|violence and victimization
4790596|NCT02677012|Autologous fat grafting|autologous fat grafting
4790597|NCT02677012|AFG|afg
4790598|NCT02677012|Reconstructive surgery|reconstructive surgery
4790599|NCT02677012|Fatty tissue processing|fatty tissue processing
4790600|NCT02676986|Primary Breast Cancer|primary breast cancer
4790601|NCT02676986|ER|er
4790602|NCT02676986|AR|ar
4790603|NCT02676986|TNBC|tnbc
4790604|NCT02676973|pelvic organ prolapse|pelvic organ prolapse
4790605|NCT02676973|POP|pop
4790606|NCT02676973|vault prolapse|vault prolapse
4790607|NCT02676973|cystocele|cystocele
4790608|NCT02676973|vaginal prolapse|vaginal prolapse
4790609|NCT02676973|post-hysterectomy vaginal prolapse|post-hysterectomy vaginal prolapse
4790610|NCT02676921|sinus membrane|sinus membrane
4790611|NCT02676921|osteogenic|osteogenic
4790612|NCT02676908|endovenous ablation|endovenous ablation
4790613|NCT02676908|laser|laser
4790614|NCT02676908|radiofrequency|radiofrequency
4790615|NCT02676908|stockings|stockings
4790616|NCT02676882|Depressive Disorder|depressive disorder
4790617|NCT02676882|Depression|depression
4790618|NCT02676882|Antidepressants|antidepressants
4790619|NCT02676882|Pregnancy|pregnancy
4790620|NCT02676882|Folate|folate
4790621|NCT02676882|Dietary Supplements|dietary supplements
4790622|NCT02676882|Omega-3 Fatty Acids|omega-3 fatty acids
4790623|NCT02676882|Women's Health|women's health
4790624|NCT02676882|Vitamins|vitamins
4790625|NCT02676856|acute myeloid leukemia|acute myeloid leukemia
4790626|NCT02676856|hematopoietic stem cell microtransplantation|hematopoietic stem cell microtransplantation
4790627|NCT02676817|colitis|colitis
4790628|NCT02676817|endoscopy|endoscopy
4790629|NCT02676804|Exercise|exercise
4790630|NCT02676778|Peripheral T-cell lymphoma|peripheral t-cell lymphoma
4790631|NCT02676778|Cutaneous T-cell lymphoma|cutaneous t-cell lymphoma
4790633|NCT02676778|Phase 2|phase 2
4790634|NCT02676765|Allergic rhinitis|allergic rhinitis
4790635|NCT02676765|Immunotherapy, Allergen|immunotherapy, allergen
4790636|NCT02676765|Sublingual Immunotherapy|sublingual immunotherapy
4790637|NCT02676752|head and neck cancer|head and neck cancer
4790638|NCT02676752|lymphedema and fibrosis|lymphedema and fibrosis
4790639|NCT02676726|extraperitoneal|extraperitoneal
4790640|NCT02676726|transperitoneal|transperitoneal
4790641|NCT02676726|laparoscopic aortic lymphadenectomy|laparoscopic aortic lymphadenectomy
4790642|NCT02676726|endometrial cancer|endometrial cancer
4790643|NCT02676726|ovarian cancer|ovarian cancer
4790644|NCT02676726|surgical staging|surgical staging
4790645|NCT02676713|Traditional Chinese Medicine|traditional chinese medicine
4790646|NCT02676713|Chinese Herbal|chinese herbal
4790647|NCT02676700|Urinary stress incontinence|urinary stress incontinence
4790648|NCT02676700|pelvic floor muscle|pelvic floor muscle
4790649|NCT02676700|Kaatsu training|kaatsu training
4790650|NCT02676687|surgery, noneloquent area|surgery, noneloquent area
4790651|NCT02676661|peri-implant disease|peri-implant disease
4790652|NCT02676661|risk factors|risk factors
4790653|NCT02676661|prevalence|prevalence
4790654|NCT02676622|Crohn's Disease|crohn's disease
4790655|NCT02676622|Autologous Hematopoietic Stem cell Transplant|autologous hematopoietic stem cell transplant
4790656|NCT02676622|Cyclophosphamide|cyclophosphamide
4790657|NCT02676622|IL-2|il-2
4790658|NCT02676622|Aldesleukin|aldesleukin
4790659|NCT02676622|Proleukin|proleukin
4790660|NCT02676622|PCDAI|pcdai
4790661|NCT02676609|Type 1 diabetes|type 1 diabetes
4790662|NCT02676609|Smart phone application|smart phone application
4790663|NCT02676609|carbohydrate counting|carbohydrate counting
4790664|NCT02676609|meal insulin dose|meal insulin dose
4790665|NCT02676583|pain|pain
4790666|NCT02676583|tonsillectomy|tonsillectomy
4790667|NCT02676583|tonsillar fossa|tonsillar fossa
4790668|NCT02676583|suture|suture
4790669|NCT02676583|tonsil fossa closure|tonsil fossa closure
4790670|NCT02676544|Prostate Artery Embolization (PAE)|prostate artery embolization (pae)
4790671|NCT02676544|Benign Prostatic Hyperplasia (BPH)|benign prostatic hyperplasia (bph)
4790672|NCT02676544|Lower Urinary Tract Symptoms (LUTS)|lower urinary tract symptoms (luts)
4790673|NCT02676544|PAE|pae
4790674|NCT02676544|BPH|bph
4790675|NCT02676544|LUTS|luts
4790676|NCT02676544|Prostate Artery Embolization|prostate artery embolization
4790677|NCT02676544|Embospheres|embospheres
4790678|NCT02676531|Walking Meditation|walking meditation
4790679|NCT02676531|Vascular Function|vascular function
4790680|NCT02676531|Flow-mediated dilatation|flow-mediated dilatation
4790681|NCT02676531|Breast Cancer Patients|breast cancer patients
4790682|NCT02676531|Anthracyclines Chemotherapy|anthracyclines chemotherapy
4790683|NCT02676518|polycystic ovary syndrome|polycystic ovary syndrome
4790684|NCT02676518|Serum anti-Mullerian hormone|serum anti-mullerian hormone
4790685|NCT02676518|glucose intolerance|glucose intolerance
4790686|NCT02676518|metabolic syndrome|metabolic syndrome
4790687|NCT02676466|Mobility|mobility
4790688|NCT02676440|Oral Health|oral health
4790689|NCT02676401|Diabetic Nephropathy|diabetic nephropathy
4790690|NCT02676388|Slow Transit Constipation|slow transit constipation
4790691|NCT02676388|Freeze-dried, Capsulized FMT|freeze-dried, capsulized fmt
4790692|NCT02676388|Fresh FMT|fresh fmt
4790693|NCT02676349|mFolfirinox|mfolfirinox
4790694|NCT02676349|Chemoradiotherapy|chemoradiotherapy
4790695|NCT02676349|Neoadjuvant treatment|neoadjuvant treatment
4790696|NCT02676349|Borderline|borderline
4790697|NCT02676336|FBC|fbc
4790698|NCT02676336|cyclic mastalgia|cyclic mastalgia
4790699|NCT02676336|breast discomfort|breast discomfort
4790700|NCT02676323|Maximum tolerated dose|maximum tolerated dose
4790701|NCT02676323|Childhood leukemia|childhood leukemia
4790702|NCT02676323|Hematological malignancies|hematological malignancies
4790703|NCT02676297|inhalation|inhalation
4790704|NCT02676297|anticholinergic|anticholinergic
4790705|NCT02676258|silicone hydrogel daily disposable soft contact lens|silicone hydrogel daily disposable soft contact lens
4790706|NCT02676245|Prenatal Education|prenatal education
4790707|NCT02676245|Residual Specimens|residual specimens
4790708|NCT02676232|Online Intervention|online intervention
4790709|NCT02676232|Recurrent Abdominal Pain|recurrent abdominal pain
4790710|NCT02676232|Children|children
4790711|NCT02676193|Tobacco Smoking|tobacco smoking
4790712|NCT02676193|Cigarettes|cigarettes
4790713|NCT02676193|Packaging|packaging
4790714|NCT02676193|Text messaging|text messaging
4790715|NCT02676193|Graphic Images|graphic images
4790716|NCT02676193|Sensor-Based Assessments|sensor-based assessments
4790717|NCT02676167|HIV prevention|hiv prevention
4790718|NCT02676167|men who have sex with men|men who have sex with men
4790719|NCT02676167|pre-exposure prophylaxis|pre-exposure prophylaxis
4790720|NCT02676167|PrEP|prep
4790721|NCT02676167|Greece|greece
4790722|NCT02676167|people who inject drugs|people who inject drugs
4790723|NCT02676154|Episodic Hypertension|episodic hypertension
4790724|NCT02676154|Spinal Cord Injury|spinal cord injury
4790725|NCT02676154|Traumatic Spinal Cord Injury|traumatic spinal cord injury
4790726|NCT02676154|Blood Pressure|blood pressure
4790727|NCT02676154|Fesoterodine|fesoterodine
4790728|NCT02676154|Neurogenic Detrusor Overactivity|neurogenic detrusor overactivity
4790729|NCT02676154|Autonomic Dysreflexia|autonomic dysreflexia
4790730|NCT02676154|Urodynamic Studies|urodynamic studies
4790731|NCT02676154|24 Hour Ambulatory Blood Pressure Monitoring|24 hour ambulatory blood pressure monitoring
4790732|NCT02676154|Cerebral Blood Flow|cerebral blood flow
4790733|NCT02676128|HIV|hiv
4790734|NCT02676128|Medication Adherence|medication adherence
4790735|NCT02676128|Mobile Health|mobile health
4790736|NCT02676115|Cosmetic Wound Healing|cosmetic wound healing
4790737|NCT02676115|anterior cruciate ligament (ACL)|anterior cruciate ligament (acl)
4790738|NCT02676102|barber shops|barber shops
4790739|NCT02676102|organ transplant|organ transplant
4790740|NCT02676102|transplants|transplants
4790741|NCT02676102|organ donor registration|organ donor registration
4790742|NCT02676089|Asthma, Anticholinergics, Triple combination|asthma, anticholinergics, triple combination
4790743|NCT02676076|asthma, anticholinergics, triple combination|asthma, anticholinergics, triple combination
4790744|NCT02676063|predictive factors|predictive factors
4790745|NCT02676063|neurodevelopmental disabilities|neurodevelopmental disabilities
4790746|NCT02676011|Atropine|atropine
4790747|NCT02676011|Succinycholine|succinycholine
4790748|NCT02676011|Laparoscopy|laparoscopy
4790749|NCT02676011|Gynecology|gynecology
4790750|NCT02675985|Physical Therapy, early intervention|physical therapy, early intervention
4790751|NCT02675972|stroke, blood pressure, prognosis|stroke, blood pressure, prognosis
4790752|NCT02675959|stem cell transplantation|stem cell transplantation
4790753|NCT02675959|sickle cell disease|sickle cell disease
4790754|NCT02675959|haploidentical|haploidentical
4790755|NCT02675959|defibrotide|defibrotide
4790756|NCT02675946|WNT inhibitor|wnt inhibitor
4790757|NCT02675920|surveillance|surveillance
4790758|NCT02675920|ultrasonography|ultrasonography
4790759|NCT02675920|computed tomography|computed tomography
4790760|NCT02675907|Bunion|bunion
4790761|NCT02675907|Bunionectomy|bunionectomy
4790762|NCT02675907|Pain|pain
4790763|NCT02675907|Analgesia|analgesia
4790764|NCT02675907|N1539|n1539
4790765|NCT02675907|Phase 3|phase 3
4790766|NCT02675894|RFA|rfa
4790767|NCT02675881|RFA|rfa
4790768|NCT02675868|noradrenaline|noradrenaline
4790769|NCT02675868|vasopressin|vasopressin
4790770|NCT02675868|phenylephrine|phenylephrine
4790771|NCT02675868|endotoxemia|endotoxemia
4790772|NCT02675868|Lipopolysaccharide|lipopolysaccharide
4790773|NCT02675868|vasopressor|vasopressor
4790774|NCT02675855|Grafix|grafix
4790775|NCT02675829|HER2 mutant|her2 mutant
4790776|NCT02675829|HER2 amplified|her2 amplified
4790777|NCT02675829|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine
4790778|NCT02675829|15-335|15-335
4790779|NCT02675816|Obstructive Sleep Apnea|obstructive sleep apnea
4790780|NCT02675816|OSA|osa
4790781|NCT02675816|neurostimulation|neurostimulation
4790782|NCT02675816|hypoglossal nerve|hypoglossal nerve
4790783|NCT02675816|tongue|tongue
4790784|NCT02675816|upper airway stimulation|upper airway stimulation
4790785|NCT02675816|surgery|surgery
4790786|NCT02675803|Rheumatoid arthritis|rheumatoid arthritis
4790787|NCT02675790|hydroxyurea|hydroxyurea
4790788|NCT02675790|sub-Saharan Africa|sub-saharan africa
4790789|NCT02675790|secondary stroke prevention|secondary stroke prevention
4790790|NCT02675777|Alcohol misuse|alcohol misuse
4790791|NCT02675777|Unhealthy alcohol use|unhealthy alcohol use
4790792|NCT02675777|Alcoholism|alcoholism
4790793|NCT02675777|Alcohol dependence|alcohol dependence
4790794|NCT02675777|Alcohol abuse|alcohol abuse
4790795|NCT02675777|Risky drinking|risky drinking
4790796|NCT02675764|hand function|hand function
4790797|NCT02675751|myopia|myopia
4790798|NCT02675673|Enteral Feeding|enteral feeding
4790799|NCT02675673|G-Tube|g-tube
4790800|NCT02675673|GJ Tube|gj tube
4790801|NCT02675660|kinetic data|kinetic data
4790802|NCT02675660|volunteers|volunteers
4790803|NCT02675608|vaccine efficacy|vaccine efficacy
4790804|NCT02675608|inflammation|inflammation
4790805|NCT02675608|aging|aging
4790806|NCT02675608|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
4790807|NCT02675608|flu vaccine|flu vaccine
4790808|NCT02675569|Vascular access|vascular access
4790809|NCT02675569|Hemodialysis|hemodialysis
4790810|NCT02675569|Kidney failure|kidney failure
4790811|NCT02675569|Catheter|catheter
4790812|NCT02675569|Fistula|fistula
4790813|NCT02675556|Depression|depression
4790814|NCT02675530|NMDA|nmda
4790815|NCT02675530|glutamate|glutamate
4790816|NCT02675530|schizophrenia|schizophrenia
4790817|NCT02675504|scary scale|scary scale
4790818|NCT02675491|Advanced solid tumor|advanced solid tumor
4790819|NCT02675491|DS-6051b|ds-6051b
4790820|NCT02675491|ROS1|ros1
4790821|NCT02675491|NTRK|ntrk
4790822|NCT02675491|refractory to standard therapy|refractory to standard therapy
4790823|NCT02675491|no standard therapy|no standard therapy
4790824|NCT02675478|AML|aml
4790825|NCT02675478|phase 1|phase 1
4790826|NCT02675478|oncology|oncology
4790827|NCT02675465|Pompe, rhGAA|pompe, rhgaa
4790828|NCT02675426|Musculoskeletal Disease|musculoskeletal disease
4790829|NCT02675426|Arthritis|arthritis
4790830|NCT02675426|Joint Disease|joint disease
4790831|NCT02675426|Anti-inflammatory agents|anti-inflammatory agents
4790832|NCT02675426|Antirheumatic agents|antirheumatic agents
4790833|NCT02675413|Cerebral Spinal Fluid|cerebral spinal fluid
4790834|NCT02675413|Dimethyl Fumarate|dimethyl fumarate
4790835|NCT02675413|Tecfidera|tecfidera
4790836|NCT02675413|Multiple Sclerosis|multiple sclerosis
4790837|NCT02675413|Relapsing MS|relapsing ms
4790838|NCT02675413|RRMS|rrms
4790839|NCT02675413|Mechanism of Action|mechanism of action
4790840|NCT02675400|ADHD|adhd
4790841|NCT02675400|ADD|add
4790842|NCT02675400|Attention Deficit/Hyperactivity Disorder|attention deficit/hyperactivity disorder
4790843|NCT02675400|Attention|attention
4790844|NCT02675400|Hyperactivity|hyperactivity
4790845|NCT02675374|Cardiac surgery|cardiac surgery
4790846|NCT02675374|cardiopulmonary bypass|cardiopulmonary bypass
4790847|NCT02675374|dexchlorpheniramine|dexchlorpheniramine
4790848|NCT02675374|H1 blockers|h1 blockers
4790849|NCT02675374|norepinephrine|norepinephrine
4790850|NCT02675374|histamine release|histamine release
4790851|NCT02675361|Transfer to adult care|transfer to adult care
4790852|NCT02675361|Continuity of patient care|continuity of patient care
4790853|NCT02675361|Transition program|transition program
4790854|NCT02675335|Diabetic foot ulcer, Sitagliptin|diabetic foot ulcer, sitagliptin
4790855|NCT02675296|outcome|outcome
4790856|NCT02675283|Point of care test|point of care test
4790857|NCT02675283|Diagnosis|diagnosis
4790858|NCT02675283|Case finding|case finding
4790859|NCT02675257|Diabetes mellitus|diabetes mellitus
4790860|NCT02675257|Affective disorders|affective disorders
4790861|NCT02675257|Depressive symptoms|depressive symptoms
4790862|NCT02675257|Diabetes distress|diabetes distress
4790863|NCT02675257|Hyperglycaemia|hyperglycaemia
4790864|NCT02675257|Dysglycaemia|dysglycaemia
4790865|NCT02675257|Glycaemic control|glycaemic control
4790866|NCT02675257|Self-care behaviour|self-care behaviour
4790867|NCT02675257|Quality of Life|quality of life
4790868|NCT02675257|Diabetes acceptance|diabetes acceptance
4790869|NCT02675257|Diabetes complications|diabetes complications
4790870|NCT02675257|Low-grade inflammation|low-grade inflammation
4790871|NCT02675257|Inflammatory markers|inflammatory markers
4790872|NCT02675257|Stress reactivity|stress reactivity
4790873|NCT02675257|Health-care costs|health-care costs
4790874|NCT02675244|Tricuspid Valve Regurgitation|tricuspid valve regurgitation
4790875|NCT02675192|sarcopenia|sarcopenia
4790876|NCT02675192|elderly|elderly
4790877|NCT02675192|muscle biopsy|muscle biopsy
4790878|NCT02675166|Childhood cancer|childhood cancer
4790879|NCT02675166|Sequels|sequels
4790880|NCT02675166|Complications|complications
4790881|NCT02675166|Surgery|surgery
4790882|NCT02675166|Radiotherapy|radiotherapy
4790883|NCT02675166|Chemotherapy|chemotherapy
4790884|NCT02675166|Cancer|cancer
4790885|NCT02675153|Inflammatory Bowel Disease|inflammatory bowel disease
4790886|NCT02675153|stenosis|stenosis
4790887|NCT02675153|sirolimus|sirolimus
4790888|NCT02675153|rapamycin|rapamycin
4790889|NCT02675153|stricture|stricture
4790890|NCT02675114|Sapien 3|sapien 3
4790891|NCT02675114|cardiovascular disease|cardiovascular disease
4790892|NCT02675114|heart disease|heart disease
4790893|NCT02675114|aortic stenosis|aortic stenosis
4790894|NCT02675114|SAVR|savr
4790895|NCT02675114|TAVR|tavr
4790896|NCT02675088|Extensive Stage Small Cell Lung Cancer|extensive stage small cell lung cancer
4790897|NCT02675088|thoracic radiotherapy|thoracic radiotherapy
4790898|NCT02675088|radiotherapy regimen|radiotherapy regimen
4790899|NCT02675075|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
4790900|NCT02675075|Voice|voice
4790901|NCT02675075|Voice Quality|voice quality
4790902|NCT02675075|Total Lung Capacity|total lung capacity
4790903|NCT02675062|Accelerometry|accelerometry
4790904|NCT02675062|Osteoarthritis|osteoarthritis
4790905|NCT02675062|Habitual physical activity|habitual physical activity
4790906|NCT02675062|Sedentary behaviour|sedentary behaviour
4790907|NCT02675062|Knee arthroplasty|knee arthroplasty
4790908|NCT02675049|Intranasal|intranasal
4790909|NCT02675049|Dexmedetomidine|dexmedetomidine
4790910|NCT02675049|Anaesthesia|anaesthesia
4790911|NCT02675049|Breast Lumpectomy|breast lumpectomy
4790912|NCT02675036|ectopiccanine teeth, impacted teeth, tooth eruption, orthodontics|ectopiccanine teeth, impacted teeth, tooth eruption, orthodontics
4790913|NCT02674997|Goal setting|goal setting
4790914|NCT02674997|Feasibility|feasibility
4790915|NCT02674997|Standardized Goal Attainment Scaling menu for Hemophilia (GAS-Hem)|standardized goal attainment scaling menu for hemophilia (gas-hem)
4790916|NCT02674997|Patient reported outcome (PRO)|patient reported outcome (pro)
4790917|NCT02674997|Goal attainment scaling (GAS)|goal attainment scaling (gas)
4790918|NCT02674958|endothelial progenitor cells|endothelial progenitor cells
4790919|NCT02674958|aspirin|aspirin
4790920|NCT02674958|acetylsalicylic acid|acetylsalicylic acid
4790921|NCT02674958|alcohol septal ablation|alcohol septal ablation
4790922|NCT02674945|fitbit|fitbit
4790923|NCT02674945|activity tracker|activity tracker
4790924|NCT02674945|sleep|sleep
4790925|NCT02674945|quality of life|quality of life
4790926|NCT02674919|Repeated-sprint ability|repeated-sprint ability
4790927|NCT02674919|Nordic Hamstring exercise|nordic hamstring exercise
4790928|NCT02674919|Eccentric hamstring muscle strength|eccentric hamstring muscle strength
4790929|NCT02674893|BMI>27|bmi>27
4790930|NCT02674893|Treatment with Liraglutide|treatment with liraglutide
4790931|NCT02674841|Adolescent|adolescent
4790932|NCT02674841|Physical therapy modalities|physical therapy modalities
4790933|NCT02674841|Exercise intervention|exercise intervention
4790934|NCT02674841|Auditive feedback|auditive feedback
4790935|NCT02674841|Visual feedback|visual feedback
4790936|NCT02674815|Exercise|exercise
4790937|NCT02674815|Preoperative|preoperative
4790938|NCT02674815|High Intensity Interval Training|high intensity interval training
4790939|NCT02674815|Colorectal|colorectal
4790940|NCT02674815|Thoracic|thoracic
4790941|NCT02674815|Postoperative|postoperative
4790942|NCT02674802|Reinfection|reinfection
4790943|NCT02674802|Eradication therapy|eradication therapy
4790944|NCT02674802|C-urea breath test|c-urea breath test
4790945|NCT02674802|Helicobacter Pylori|helicobacter pylori
4790946|NCT02674789|Exercise|exercise
4790947|NCT02674789|Athletes|athletes
4790948|NCT02674789|Ionized Magnesium|ionized magnesium
4790949|NCT02674789|Variation|variation
4790950|NCT02674789|Blood|blood
4790951|NCT02674763|Acute Myeloid Leukemia|acute myeloid leukemia
4790952|NCT02674763|AML|aml
4790953|NCT02674763|IMGN779|imgn779
4790954|NCT02674763|ImmunoGen|immunogen
4790955|NCT02674763|Phase 1|phase 1
4790956|NCT02674763|Relapsed|relapsed
4790957|NCT02674763|Refractory|refractory
4790958|NCT02674763|CD33|cd33
4790959|NCT02674763|Dose Escalation|dose escalation
4790960|NCT02674763|Dose Expansion|dose expansion
4790961|NCT02674750|DLBCL|dlbcl
4790962|NCT02674750|MYC|myc
4790963|NCT02674724|Resistance Training|resistance training
4790964|NCT02674724|Postural Balance|postural balance
4790965|NCT02674724|Exercise|exercise
4790966|NCT02674711|patient education|patient education
4790967|NCT02674711|low back pain|low back pain
4790968|NCT02674711|post-surgical pain|post-surgical pain
4790969|NCT02674711|chronic opioid use|chronic opioid use
4790970|NCT02674711|Neck Pain|neck pain
4790971|NCT02674672|VenaTech® Retrievable Vena Cava Filter|venatech® retrievable vena cava filter
4790972|NCT02674672|safety|safety
4790973|NCT02674672|efficacy|efficacy
4790974|NCT02674659|resistance training, PCSK9, coronary artery bypass|resistance training, pcsk9, coronary artery bypass
4790975|NCT02674633|ADHD|adhd
4790976|NCT02674594|Anticoagulation|anticoagulation
4790977|NCT02674568|SCLC|sclc
4790978|NCT02674568|Small Cell Lung Cancer|small cell lung cancer
4790979|NCT02674568|DLL3|dll3
4790980|NCT02674568|Relapsed|relapsed
4790981|NCT02674568|Refractory|refractory
4790982|NCT02674555|Phase 1|phase 1
4790983|NCT02674555|Metabolism|metabolism
4790984|NCT02674555|Excretion|excretion
4790985|NCT02674555|Absorption|absorption
4790986|NCT02674555|[14C]-radioactivity|[14c]-radioactivity
4790987|NCT02674555|Pharmacokinetics|pharmacokinetics
4790988|NCT02674555|naquotinib|naquotinib
4790989|NCT02674555|Oncology|oncology
4790990|NCT02674542|Family planning|family planning
4790991|NCT02674542|Birth spacing|birth spacing
4790992|NCT02674529|Depression|depression
4790993|NCT02674529|Neuroimaging biomarkers|neuroimaging biomarkers
4790994|NCT02674529|MDD|mdd
4790995|NCT02674529|Neurofeedback|neurofeedback
4790996|NCT02674516|antisocial behavior|antisocial behavior
4790997|NCT02674516|aggression|aggression
4790998|NCT02674516|transcranial direct current stimulation|transcranial direct current stimulation
4790999|NCT02674516|dorsolateral prefrontal cortex|dorsolateral prefrontal cortex
4791000|NCT02674516|associated risk factors|associated risk factors
4791001|NCT02674503|Walking|walking
4791002|NCT02674503|Hospitalization|hospitalization
4791003|NCT02674503|Randomized controlled trial|randomized controlled trial
4791004|NCT02674490|aphasia, language|aphasia, language
4791005|NCT02674373|gastric cancer|gastric cancer
4791006|NCT02674373|biomarker|biomarker
4791007|NCT02674373|Circulating tumor DNA|circulating tumor dna
4791008|NCT02674373|Chemotherapy|chemotherapy
4791009|NCT02674373|Prognosis|prognosis
4791010|NCT02674373|Predictive|predictive
4791011|NCT02674334|orthopedic procedures|orthopedic procedures
4791012|NCT02674321|Tourette Syndrome|tourette syndrome
4791013|NCT02674321|adolescents|adolescents
4791014|NCT02674308|Drug therapy|drug therapy
4791015|NCT02674295|Healthy|healthy
4791016|NCT02674295|JNJ-54135419|jnj-54135419
4791017|NCT02674295|Esketamine|esketamine
4791018|NCT02674282|anterior cruciate ligament reconstruction|anterior cruciate ligament reconstruction
4791019|NCT02674282|anterior cruciate ligament|anterior cruciate ligament
4791020|NCT02674282|sports medicine|sports medicine
4791021|NCT02674282|soccer|soccer
4791022|NCT02674282|maximum oxygen uptake|maximum oxygen uptake
4791023|NCT02674282|return to play|return to play
4791024|NCT02674269|Overactive bladder|overactive bladder
4791025|NCT02674269|Botox|botox
4791026|NCT02674269|TC-3 Gel|tc-3 gel
4791027|NCT02674269|Intravesical|intravesical
4791028|NCT02674269|UroGen Pharma|urogen pharma
4791029|NCT02674269|Botulinum Toxin|botulinum toxin
4791030|NCT02674269|Urgency|urgency
4791031|NCT02674269|OAB|oab
4791032|NCT02674269|Incontinence|incontinence
4791033|NCT02674269|I-QOL|i-qol
4791034|NCT02674269|KHQ|khq
4791035|NCT02674269|TBS|tbs
4791036|NCT02674269|RTG|rtg
4791037|NCT02674256|health|health
4791038|NCT02674256|age between 18 to 60 years old|age between 18 to 60 years old
4791039|NCT02674256|no history of gastrointestinal symptoms or complaints|no history of gastrointestinal symptoms or complaints
4791040|NCT02674243|Malignant pleural effusion|malignant pleural effusion
4791041|NCT02674243|Pleurodesis|pleurodesis
4791042|NCT02674243|Talc|talc
4791043|NCT02674243|Iodopovidone solution|iodopovidone solution
4791044|NCT02674243|Povidone-iodine|povidone-iodine
4791045|NCT02674204|Statin therapy|statin therapy
4791046|NCT02674204|trastuzumab|trastuzumab
4791047|NCT02674191|miniplates ,molar intrusion, hyperdivergent|miniplates ,molar intrusion, hyperdivergent
4791048|NCT02674139|post placental-caesarean-IUD|post placental-caesarean-iud
4791049|NCT02674126|Cardiac Surgery|cardiac surgery
4791050|NCT02674126|Maternal sound|maternal sound
4791051|NCT02674126|Cortisol|cortisol
4791052|NCT02674126|Blood sugar|blood sugar
4791053|NCT02674126|Stress|stress
4791054|NCT02674061|PD1|pd1
4791055|NCT02674061|PD-1|pd-1
4791056|NCT02674061|PDL1|pdl1
4791057|NCT02674061|PD-L1|pd-l1
4791058|NCT02674035|Abdominoplasty|abdominoplasty
4791059|NCT02674035|Sutures|sutures
4791060|NCT02674035|Abdominal deformities|abdominal deformities
4791061|NCT02674035|Plication|plication
4791062|NCT02674035|Monofilament nylon suture|monofilament nylon suture
4791063|NCT02674035|Barbed suture|barbed suture
4791064|NCT02674022|Maternal Health|maternal health
4791065|NCT02674022|Autistic Disorder|autistic disorder
4791066|NCT02674022|Metabolism|metabolism
4791067|NCT02674022|Folic Acid|folic acid
4791068|NCT02673996|antibody|antibody
4791069|NCT02673996|autoimmune|autoimmune
4791070|NCT02673996|adrenergic|adrenergic
4791071|NCT02673996|autonomic|autonomic
4791072|NCT02673983|Intestinal|intestinal
4791073|NCT02673983|Biopsy|biopsy
4791074|NCT02673983|full thickness|full thickness
4791075|NCT02673983|endoscopic|endoscopic
4791076|NCT02673970|Melanoma|melanoma
4791077|NCT02673931|Open Heart Surgery|open heart surgery
4791078|NCT02673931|Organ protection|organ protection
4791079|NCT02673918|Rehabilitation|rehabilitation
4791080|NCT02673918|Home-Based Intervention|home-based intervention
4791081|NCT02673905|nasal chondrocytes|nasal chondrocytes
4791082|NCT02673905|articular chondral lesions|articular chondral lesions
4791083|NCT02673905|tissue engineering|tissue engineering
4791084|NCT02673905|femoral condyle|femoral condyle
4791085|NCT02673905|trochlea|trochlea
4791086|NCT02673892|discharge|discharge
4791087|NCT02673892|transitions|transitions
4791088|NCT02673892|patient experience|patient experience
4791089|NCT02673866|Diabetic Peripheral Neuropathic Pain (DPNP)|diabetic peripheral neuropathic pain (dpnp)
4791090|NCT02673866|Diabetes|diabetes
4791091|NCT02673866|Pregabalin|pregabalin
4791092|NCT02673866|Spontaneous Pain|spontaneous pain
4791093|NCT02673866|Hyperalgesia|hyperalgesia
4791094|NCT02673866|Allodynia|allodynia
4791095|NCT02673866|Average Daily Pain Score (ADPS)|average daily pain score (adps)
4791096|NCT02673866|Pain Associated Sleep Interference|pain associated sleep interference
4791097|NCT02673853|Supraglottic airway|supraglottic airway
4791098|NCT02673853|Mini-dose atracurium|mini-dose atracurium
4791099|NCT02673853|Postoperative residual paralysis|postoperative residual paralysis
4791100|NCT02673840|dengue fever|dengue fever
4791101|NCT02673840|dengue hemorrhagic fever|dengue hemorrhagic fever
4791102|NCT02673840|ketotifen|ketotifen
4791103|NCT02673840|vascular leakage|vascular leakage
4791104|NCT02673840|pleural effusion|pleural effusion
4791105|NCT02673840|plasma leakage|plasma leakage
4791106|NCT02673801|Referral and Consultation|referral and consultation
4791107|NCT02673801|Orthopedics|orthopedics
4791108|NCT02673775|Macrophage|macrophage
4791109|NCT02673749|Lactose maldigestion|lactose maldigestion
4791110|NCT02673749|Dairy intolerance|dairy intolerance
4791111|NCT02673749|Intolerance to milk|intolerance to milk
4791112|NCT02673749|Intolerance to dairy|intolerance to dairy
4791113|NCT02673749|Milk intolerance|milk intolerance
4791114|NCT02673749|GI disorder|gi disorder
4791115|NCT02673749|Lactose metabolism|lactose metabolism
4791116|NCT02673749|GI symptoms after dairy ingestion|gi symptoms after dairy ingestion
4791117|NCT02673736|PLX73086|plx73086
4791118|NCT02673736|Synovitis, Pigmented Villonodular|synovitis, pigmented villonodular
4791119|NCT02673736|Tenosynovial Giant Cell Tumor|tenosynovial giant cell tumor
4791120|NCT02673736|Joint Diseases|joint diseases
4791121|NCT02673736|Neoplasms|neoplasms
4791122|NCT02673736|Synovitis|synovitis
4791123|NCT02673723|docozine|docozine
4791124|NCT02673697|Sutureless valve|sutureless valve
4791125|NCT02673658|infant development, early intervention|infant development, early intervention
4791126|NCT02673645|Educational Achievement|educational achievement
4791127|NCT02673632|Anti-Müllerian hormone|anti-müllerian hormone
4791128|NCT02673632|Ovarian stimulation|ovarian stimulation
4791129|NCT02673632|Polycystic ovary syndrome|polycystic ovary syndrome
4791130|NCT02673632|Intracytoplasmic sperm injection|intracytoplasmic sperm injection
4791131|NCT02673619|Topical|topical
4791132|NCT02673619|Palmar Hyperhidrosis|palmar hyperhidrosis
4791133|NCT02673619|Umeclidinium|umeclidinium
4791134|NCT02673593|Safety|safety
4791135|NCT02673593|Pharmacokinetics|pharmacokinetics
4791136|NCT02673593|Food Effect|food effect
4791137|NCT02673554|Glucose-dependent Insulinotropic Polypeptide (GIP)|glucose-dependent insulinotropic polypeptide (gip)
4791138|NCT02673554|Glucagon-Like Peptide 1 (GLP-1)|glucagon-like peptide 1 (glp-1)
4791139|NCT02673554|Incretin|incretin
4791140|NCT02673554|Insulin secretion|insulin secretion
4791141|NCT02673554|Tachyphylaxis|tachyphylaxis
4791142|NCT02673528|appendectomy|appendectomy
4791143|NCT02673528|laparoscopy|laparoscopy
4791144|NCT02673528|laparoscopic assisted appendectomy|laparoscopic assisted appendectomy
4791145|NCT02673528|cost utility|cost utility
4791146|NCT02673515|Alternate Day Fasting|alternate day fasting
4791147|NCT02673502|Carbohydrate drink|carbohydrate drink
4791148|NCT02673502|Post operative complication|post operative complication
4791149|NCT02673502|insulin resistance|insulin resistance
4791150|NCT02673502|Fasting blood glucose|fasting blood glucose
4791151|NCT02673437|Acute coronary syndrome|acute coronary syndrome
4791152|NCT02673411|elastography|elastography
4791153|NCT02673411|ultrasonography|ultrasonography
4791154|NCT02673372|Geriatric, Pain, Ketamine, Emergency Medicine|geriatric, pain, ketamine, emergency medicine
4791155|NCT02673359|Preterm labor|preterm labor
4791156|NCT02673359|Short cervix|short cervix
4791157|NCT02673359|Progesterone|progesterone
4791158|NCT02673359|Cervical cerclage|cervical cerclage
4791159|NCT02673333|Pembrolizumab|pembrolizumab
4791160|NCT02673333|15-286|15-286
4791161|NCT02673320|Acute Traumatic Cervical Central Cord Syndrom Injury|acute traumatic cervical central cord syndrom injury
4791162|NCT02673320|Delay of Surgery|delay of surgery
4791163|NCT02673320|Decompressive Surgery|decompressive surgery
4791164|NCT02673320|Canal Stenosis|canal stenosis
4791165|NCT02673320|Schneider Syndrom|schneider syndrom
4791166|NCT02673320|Quality of life|quality of life
4791167|NCT02673320|Functional Outcome|functional outcome
4791168|NCT02673281|walnuts|walnuts
4791169|NCT02673281|brain|brain
4791170|NCT02673281|appetite|appetite
4791171|NCT02673281|energy intake|energy intake
4791172|NCT02673281|obesity|obesity
4791173|NCT02673255|Plasma|plasma
4791174|NCT02673255|Plasma Donor|plasma donor
4791175|NCT02673255|Plasma Donation|plasma donation
4791176|NCT02673255|Tetanus|tetanus
4791177|NCT02673255|Td|td
4791178|NCT02673255|Immunoglobulin|immunoglobulin
4791179|NCT02673255|Hyper-immunization|hyper-immunization
4791180|NCT02673229|Santyl|santyl
4791181|NCT02673229|Burn|burn
4791182|NCT02673229|Partial Thickness Burn|partial thickness burn
4791183|NCT02673229|Second Degree Burn|second degree burn
4791184|NCT02673229|Minor Burn Bacitracin|minor burn bacitracin
4791185|NCT02673229|Scar Appearance|scar appearance
4791186|NCT02673203|glucose monitoring|glucose monitoring
4791187|NCT02673203|hunger levels|hunger levels
4791188|NCT02673203|food intake|food intake
4791189|NCT02673177|robot-assisted total mesorectal excision(RTME)|robot-assisted total mesorectal excision(rtme)
4791190|NCT02673177|laparoscopic total mesorectal excision(LTME)|laparoscopic total mesorectal excision(ltme)
4791191|NCT02673177|urinary function|urinary function
4791192|NCT02673177|sexual function|sexual function
4791193|NCT02673177|sphincter- preservation|sphincter- preservation
4791194|NCT02673177|low rectal cancer|low rectal cancer
4791195|NCT02673164|Heart failure|heart failure
4791196|NCT02673164|stem cell|stem cell
4791197|NCT02673164|adipose derived stem cell|adipose derived stem cell
4791198|NCT02673164|Stem cell therapy|stem cell therapy
4791199|NCT02673164|ischemic heart disease|ischemic heart disease
4791200|NCT02673125|Preimplantation Genetic Screening|preimplantation genetic screening
4791201|NCT02673112|Concussion|concussion
4791202|NCT02673112|mild traumatic brain injury|mild traumatic brain injury
4791203|NCT02673112|post concussion syndrome|post concussion syndrome
4791204|NCT02673112|child|child
4791205|NCT02673099|HDF online|hdf online
4791206|NCT02673099|ESRD|esrd
4791207|NCT02673099|Hemodialysis|hemodialysis
4791208|NCT02673099|oxidative stress|oxidative stress
4791209|NCT02673099|quality of life|quality of life
4791210|NCT02673099|Hemodialysis treatment|hemodialysis treatment
4791211|NCT02673086|retroclavicular approach|retroclavicular approach
4791212|NCT02673086|coracoid approach|coracoid approach
4791213|NCT02673086|ultrasound|ultrasound
4791214|NCT02673086|upper limb surgery|upper limb surgery
4791215|NCT02673086|needle visibility|needle visibility
4791216|NCT02673086|infraclavicular brachial plexus block|infraclavicular brachial plexus block
4791217|NCT02673073|Heart failure|heart failure
4791218|NCT02673073|patient's diary|patient's diary
4791219|NCT02673073|self awareness|self awareness
4791220|NCT02672995|stereotactic radiosurgery,Bevacizumab|stereotactic radiosurgery,bevacizumab
4791221|NCT02672969|smoke evacuation system|smoke evacuation system
4791222|NCT02672969|surgical smoke|surgical smoke
4791223|NCT02672943|Parkinson disease|parkinson disease
4791224|NCT02672943|Autonomic nervous system|autonomic nervous system
4791225|NCT02672943|MicroRNA|microrna
4791226|NCT02672943|Inflammation|inflammation
4791227|NCT02672943|Oxidative stress|oxidative stress
4791228|NCT02672943|noradrenergic network|noradrenergic network
4791229|NCT02672943|Rehabilitation treatment|rehabilitation treatment
4791230|NCT02672930|calcium gluconate|calcium gluconate
4791231|NCT02672930|hyperpotassemia treatment|hyperpotassemia treatment
4791232|NCT02672917|CA19-9 Positive Malignancies|ca19-9 positive malignancies
4791233|NCT02672904|vocal cord|vocal cord
4791234|NCT02672904|carcinoma|carcinoma
4791235|NCT02672904|ktp laser|ktp laser
4791236|NCT02672904|co2 laser|co2 laser
4791237|NCT02672904|endoscopic surgery|endoscopic surgery
4791238|NCT02672891|Postpartum Hemorrhage|postpartum hemorrhage
4791239|NCT02672891|Uterine Tamponade|uterine tamponade
4791240|NCT02672891|Condom Catheter|condom catheter
4791241|NCT02672878|In-stent restenosis|in-stent restenosis
4791242|NCT02672878|Bioresorbable vascular scaffold|bioresorbable vascular scaffold
4791243|NCT02672878|Stent|stent
4791244|NCT02672878|Drug-eluting stent|drug-eluting stent
4791245|NCT02672878|Coronary angiography|coronary angiography
4791246|NCT02672852|ABBV-066|abbv-066
4791247|NCT02672852|BI 655066|bi 655066
4791248|NCT02672852|risankizumab|risankizumab
4791249|NCT02672813|Pectoral nerve I and II blocks|pectoral nerve i and ii blocks
4791250|NCT02672813|Breast surgery|breast surgery
4791251|NCT02672813|Ropivacaine|ropivacaine
4791252|NCT02672813|Postoperative opioid consumption|postoperative opioid consumption
4791253|NCT02672787|Antihypertensive adherence|antihypertensive adherence
4791254|NCT02672787|Emergency medicine|emergency medicine
4791255|NCT02672787|Antihypertensives|antihypertensives
4791256|NCT02672748|garden|garden
4791257|NCT02672748|Native American|native american
4791258|NCT02672748|BMI|bmi
4791259|NCT02672748|Emotional health|emotional health
4791260|NCT02672748|Physical health|physical health
4791261|NCT02672735|corrective exercise program|corrective exercise program
4791262|NCT02672735|movement efficiency|movement efficiency
4791263|NCT02672722|This term was found doing the MeSH search and is the only thing that fits since we will be working with healthy subjects with no conditions.|this term was found doing the mesh search and is the only thing that fits since we will be working with healthy subjects with no conditions.
4791264|NCT02672709|Factor Xa Inhibitors|factor xa inhibitors
4791265|NCT02672709|Renal Dialysis|renal dialysis
4791266|NCT02672696|Navigation|navigation
4791267|NCT02672696|Gamma Nail|gamma nail
4791268|NCT02672657|Health-Related Quality of life|health-related quality of life
4791269|NCT02672657|Cancer|cancer
4791270|NCT02672657|Elderly|elderly
4791271|NCT02672657|Caregivers|caregivers
4791272|NCT02672618|heart failure|heart failure
4791273|NCT02672618|infrared thermal imaging|infrared thermal imaging
4791274|NCT02672592|Metabolic syndrome X|metabolic syndrome x
4791275|NCT02672592|Hypogonadism|hypogonadism
4791276|NCT02672592|Testosterone|testosterone
4791277|NCT02672592|Inflammation|inflammation
4791278|NCT02672592|Obesity|obesity
4791279|NCT02672566|Fetal Growth Retardation|fetal growth retardation
4791280|NCT02672566|enoxaparin|enoxaparin
4791281|NCT02672553|Aortic Valve Replacement|aortic valve replacement
4791282|NCT02672553|Minimal Invasive Sternotomy|minimal invasive sternotomy
4791283|NCT02672540|Sickle Cell|sickle cell
4791284|NCT02672540|Anemia|anemia
4791285|NCT02672540|VOC|voc
4791286|NCT02672540|Vaso occlusive crisis|vaso occlusive crisis
4791287|NCT02672501|immunotherapy|immunotherapy
4791288|NCT02672501|CAR-T|car-t
4791289|NCT02672501|leukemia|leukemia
4791290|NCT02672449|Prostate cancer|prostate cancer
4791291|NCT02672449|Carbon ions|carbon ions
4791292|NCT02672449|Radiobiology|radiobiology
4791293|NCT02672449|Radiotherapy|radiotherapy
4791294|NCT02672436|Diabetic Foot Ulcer|diabetic foot ulcer
4791295|NCT02672436|Diabetes Mellitus|diabetes mellitus
4791296|NCT02672436|Wound Healing|wound healing
4791297|NCT02672397|Epidural|epidural
4791298|NCT02672397|Ethnicity|ethnicity
4791299|NCT02672397|Education|education
4791300|NCT02672397|Labor|labor
4791301|NCT02672397|obstetrical analgesia|obstetrical analgesia
4791302|NCT02672384|Intensive care unit|intensive care unit
4791303|NCT02672384|Invasive mechanical ventilation|invasive mechanical ventilation
4791304|NCT02672384|Chronic periodontitis|chronic periodontitis
4791305|NCT02672384|Point of Care P. gingivalis test|point of care p. gingivalis test
4791306|NCT02672358|Non-Small-Cell Lung Cancer|non-small-cell lung cancer
4791307|NCT02672358|NSCLC|nsclc
4791308|NCT02672358|dabrafenib|dabrafenib
4791309|NCT02672358|trametinib|trametinib
4791310|NCT02672358|Japanese patients|japanese patients
4791311|NCT02672358|BRAF V600E mutation positive metastatic|braf v600e mutation positive metastatic
4791312|NCT02672358|stage IV|stage iv
4791313|NCT02672345|Sevoflurane|sevoflurane
4791314|NCT02672345|MicroRNAs|micrornas
4791315|NCT02672345|Inflammatory Response|inflammatory response
4791316|NCT02672345|Cytokines|cytokines
4791317|NCT02672345|Anesthetics, Inhalation|anesthetics, inhalation
4791318|NCT02672345|Macrophage Inflammatory Proteins|macrophage inflammatory proteins
4791319|NCT02672267|AMI, hBMMSCs, stem cells,|ami, hbmmscs, stem cells,
4791320|NCT02672241|Radiation Therapy|radiation therapy
4791321|NCT02672241|Brainstem Tumor in Children|brainstem tumor in children
4791322|NCT02672202|Chronic Pain|chronic pain
4791323|NCT02672202|Pain Modulation Profile|pain modulation profile
4791324|NCT02672202|CPM|cpm
4791325|NCT02672202|acute post operative pain|acute post operative pain
4791326|NCT02672189|Climacteric symptoms|climacteric symptoms
4791327|NCT02672189|Menopause|menopause
4791328|NCT02672189|Breast Cancer Survivors|breast cancer survivors
4791329|NCT02672189|Internet-based|internet-based
4791330|NCT02672189|Cognitive behavioral therapy|cognitive behavioral therapy
4791331|NCT02672189|Psychosocial intervention|psychosocial intervention
4791332|NCT02672176|Diabetes mellitus|diabetes mellitus
4791333|NCT02672176|Motivational Interviewing|motivational interviewing
4791334|NCT02672176|Mobile Health Technology|mobile health technology
4791335|NCT02672176|Patient-generated Health Data (PGHD)|patient-generated health data (pghd)
4791336|NCT02672163|autologous micrografts|autologous micrografts
4791337|NCT02672163|heart failure|heart failure
4791338|NCT02672163|coronary artery bypass surgery|coronary artery bypass surgery
4791339|NCT02672163|cell therapy|cell therapy
4791340|NCT02672163|atrial appendage|atrial appendage
4791341|NCT02672163|epicardial cell delivery|epicardial cell delivery
4791342|NCT02672150|evidence-based practice implementation|evidence-based practice implementation
4791343|NCT02672150|system change|system change
4791344|NCT02672150|interagency collaboration|interagency collaboration
4791345|NCT02672150|substance use|substance use
4791346|NCT02672150|treatment services|treatment services
4791347|NCT02672150|data-driven decision making|data-driven decision making
4791348|NCT02672150|juvenile justice|juvenile justice
4791349|NCT02672150|adolescents|adolescents
4791350|NCT02672150|justice-involved youth|justice-involved youth
4791351|NCT02672150|cluster randomized trial|cluster randomized trial
4791352|NCT02672137|myocardial infarction|myocardial infarction
4791353|NCT02672137|knowledge transfer|knowledge transfer
4791354|NCT02672137|acute coronary syndromes|acute coronary syndromes
4791355|NCT02672020|pheochromocytoma|pheochromocytoma
4791356|NCT02672020|paraganglioma|paraganglioma
4791357|NCT02672020|adrenocortical carcinoma|adrenocortical carcinoma
4791358|NCT02672007|Respiratory rate measurement methods.|respiratory rate measurement methods.
4791359|NCT02671994|Geriatric Assessment|geriatric assessment
4791360|NCT02671994|G8 screening|g8 screening
4791361|NCT02671994|Oncologic treatment|oncologic treatment
4791362|NCT02671968|CGM|cgm
4791363|NCT02671968|hypoglycemic events|hypoglycemic events
4791364|NCT02671955|Advanced Cancer|advanced cancer
4791365|NCT02671955|JNJ-61610588|jnj-61610588
4791366|NCT02671942|roflumilast|roflumilast
4791367|NCT02671916|QoL and Survival one year after ICU stay|qol and survival one year after icu stay
4791368|NCT02671864|Incretin-based therapy|incretin-based therapy
4791369|NCT02671864|GLP1|glp1
4791370|NCT02671864|Angiogenesis Inflammation|angiogenesis inflammation
4791371|NCT02671864|Hypoglycaemic treatment|hypoglycaemic treatment
4791372|NCT02671851|Thoracic Paravertebral Blocks|thoracic paravertebral blocks
4791373|NCT02671851|Ultrasound Guidance|ultrasound guidance
4791374|NCT02671851|Reduction Mammoplasty|reduction mammoplasty
4791375|NCT02671851|Time to First Pain|time to first pain
4791376|NCT02671851|Postoperative Analgesia|postoperative analgesia
4791377|NCT02671825|Pharmacokinetics|pharmacokinetics
4791378|NCT02671812|dental implant|dental implant
4791379|NCT02671812|patient satisfaction|patient satisfaction
4791380|NCT02671812|treatment outcome|treatment outcome
4791381|NCT02671812|cytokine profile|cytokine profile
4791382|NCT02671812|risk factor|risk factor
4791383|NCT02671812|risk predictor|risk predictor
4791384|NCT02671786|Severe Acute Malnutrition|severe acute malnutrition
4791385|NCT02671786|Severe Underweight|severe underweight
4791386|NCT02671786|IAP Grade III-IV|iap grade iii-iv
4791387|NCT02671786|Severe Stunting|severe stunting
4791388|NCT02671786|Village Health Workers|village health workers
4791389|NCT02671786|MAHAN RUTF & MAHAN Vit-Mim mix|mahan rutf & mahan vit-mim mix
4791390|NCT02671773|Microbiota|microbiota
4791391|NCT02671760|Short-term insomnia|short-term insomnia
4791392|NCT02671760|difficulty sleeping|difficulty sleeping
4791393|NCT02671760|sedative|sedative
4791394|NCT02671760|hypnotic|hypnotic
4791395|NCT02671734|endoscopy|endoscopy
4791396|NCT02671682|Immunoadsorption|immunoadsorption
4791397|NCT02671682|Plasmapheresis|plasmapheresis
4791398|NCT02671656|Uricemia|uricemia
4791399|NCT02671630|Cognitive function|cognitive function
4791400|NCT02671630|Depression|depression
4791401|NCT02671630|Quality of life|quality of life
4791402|NCT02671630|Community-based computerized cognitive training program|community-based computerized cognitive training program
4791403|NCT02671630|Randomized controlled trial|randomized controlled trial
4791404|NCT02671617|Abdominal Cavity|abdominal cavity
4791405|NCT02671617|Aged|aged
4791406|NCT02671604|acute renal failure|acute renal failure
4791407|NCT02671604|prostatectomy|prostatectomy
4791408|NCT02671604|minimal invasive surgery|minimal invasive surgery
4791409|NCT02671578|nitrous oxide|nitrous oxide
4791410|NCT02671578|conscious sedation|conscious sedation
4791411|NCT02671578|pain|pain
4791412|NCT02671578|anxiety|anxiety
4791413|NCT02671565|Intraarticular hyaluronic acid injections|intraarticular hyaluronic acid injections
4791414|NCT02671565|Total knee replacement|total knee replacement
4791415|NCT02671565|Observational study|observational study
4791416|NCT02671565|Intraarticular corticosteroid injections|intraarticular corticosteroid injections
4791417|NCT02671565|Comparative effectiveness|comparative effectiveness
4791418|NCT02671539|gene therapy|gene therapy
4791419|NCT02671539|hereditary retinal degeneration|hereditary retinal degeneration
4791420|NCT02671539|rAAV2.REP1|raav2.rep1
4791421|NCT02671513|Melanoma|melanoma
4791422|NCT02671513|Cycline-Dependent Kinase|cycline-dependent kinase
4791423|NCT02671487|Problem Behavior|problem behavior
4791424|NCT02671487|Aggression|aggression
4791425|NCT02671487|Posttraumatic Stress Disorder|posttraumatic stress disorder
4791426|NCT02671487|Adolescents|adolescents
4791427|NCT02671448|Homebound|homebound
4791428|NCT02671448|Homecare|homecare
4791429|NCT02671448|15-022|15-022
4791430|NCT02671435|Colorectal cancer, colon cancer, CRC, solid tumors, check point inhibitors, immunotherapy, chemotherapy, metastatic|colorectal cancer, colon cancer, crc, solid tumors, check point inhibitors, immunotherapy, chemotherapy, metastatic
4791431|NCT02671396|Virtual Reality|virtual reality
4791432|NCT02671396|Postural Stability|postural stability
4791433|NCT02671396|Balance Training|balance training
4791434|NCT02671396|Parkinson's Disease|parkinson's disease
4791435|NCT02671383|Antiretroviral Agents|antiretroviral agents
4791436|NCT02671383|Treatment|treatment
4791437|NCT02671383|Viral Load|viral load
4791438|NCT02671357|pancreatic surgery; neoplasms|pancreatic surgery; neoplasms
4791439|NCT02671318|cytomegalovirus|cytomegalovirus
4791440|NCT02671318|sirolimus|sirolimus
4791441|NCT02671318|cytomegalovirus recurrence|cytomegalovirus recurrence
4791442|NCT02671318|kidney transplant|kidney transplant
4791443|NCT02671318|conversion|conversion
4791444|NCT02671305|delayed cord clamping|delayed cord clamping
4791445|NCT02671305|cord milking|cord milking
4791446|NCT02671305|bedside neonatal resuscitation|bedside neonatal resuscitation
4791447|NCT02671292|Loss of Control Eating|loss of control eating
4791448|NCT02671292|Binge Eating|binge eating
4791449|NCT02671292|Obesity|obesity
4791450|NCT02671292|Prevention|prevention
4791451|NCT02671292|Interpersonal Psychotherapy|interpersonal psychotherapy
4791452|NCT02671292|Adolescent|adolescent
4791453|NCT02671266|Oxytocin|oxytocin
4791454|NCT02671266|Body dysmorphic disorder|body dysmorphic disorder
4791455|NCT02671266|Obsessive-compulsive disorder|obsessive-compulsive disorder
4791456|NCT02671240|Parkinson disease|parkinson disease
4791457|NCT02671240|behavioral addiction|behavioral addiction
4791458|NCT02671240|akinéto-rigid syndrome|akinéto-rigid syndrome
4791459|NCT02671240|dopamine agonist|dopamine agonist
4791460|NCT02671214|guar gum|guar gum
4791461|NCT02671214|konjac mannan|konjac mannan
4791462|NCT02671214|blood glucose|blood glucose
4791463|NCT02671214|legume flour|legume flour
4791464|NCT02671188|C-C chemokine receptor|c-c chemokine receptor
4791465|NCT02671188|Psoriatic arthritis|psoriatic arthritis
4791466|NCT02671188|Chemokine (C-C motif) ligand 20|chemokine (c-c motif) ligand 20
4791467|NCT02671188|Monoclonal antibody|monoclonal antibody
4791468|NCT02671188|psoriasis|psoriasis
4791469|NCT02671188|Humanized Immunoglobulin G|humanized immunoglobulin g
4791470|NCT02671162|Pruritus|pruritus
4791471|NCT02671162|End-Stage Renal Disease|end-stage renal disease
4791472|NCT02671110|weight loss treatment|weight loss treatment
4791473|NCT02671110|Obesity|obesity
4791474|NCT02671084|Sevoflurane|sevoflurane
4791475|NCT02671084|Ck-MB|ck-mb
4791476|NCT02671071|Cervix Cancer|cervix cancer
4791477|NCT02671058|bioavailability|bioavailability
4791478|NCT02671045|lung cancer|lung cancer
4791479|NCT02671045|genomic profile|genomic profile
4791480|NCT02671045|targeted therapy|targeted therapy
4791481|NCT02671045|FoundationOne|foundationone
4791482|NCT02671032|Cochlear Prosthesis Implantation|cochlear prosthesis implantation
4791483|NCT02670980|Retina Implant|retina implant
4791484|NCT02670980|Visual Prosthesis|visual prosthesis
4791485|NCT02670941|aromatherapy|aromatherapy
4791486|NCT02670941|chemotherapy|chemotherapy
4791487|NCT02670941|ginger|ginger
4791488|NCT02670941|lavender|lavender
4791489|NCT02670941|orange|orange
4791490|NCT02670941|jojoba|jojoba
4791491|NCT02670941|essential oils|essential oils
4791492|NCT02670941|cancer|cancer
4791493|NCT02670928|Diabetes|diabetes
4791494|NCT02670928|lifestyle change|lifestyle change
4791495|NCT02670928|weight management|weight management
4791496|NCT02670928|control of glycemic in HbA1C and FPG|control of glycemic in hba1c and fpg
4791497|NCT02670889|Urea Cycle Disorder|urea cycle disorder
4791498|NCT02670850|Mild Cognitive Impairment|mild cognitive impairment
4791499|NCT02670850|Family caregiver|family caregiver
4791500|NCT02670850|Intervention program|intervention program
4791501|NCT02670850|Elders|elders
4791502|NCT02670811|Hypertension|hypertension
4791503|NCT02670811|Fermented Milk|fermented milk
4791504|NCT02670811|Clinical Study|clinical study
4791505|NCT02670811|Randomized|randomized
4791506|NCT02670811|Double-blind|double-blind
4791507|NCT02670798|neuromuscular|neuromuscular
4791508|NCT02670798|scoliosis|scoliosis
4791509|NCT02670772|Antiretroviral Agents|antiretroviral agents
4791510|NCT02670746|Pancreatic Cancer|pancreatic cancer
4791511|NCT02670746|Observational|observational
4791512|NCT02670746|Nab-Paclitaxel|nab-paclitaxel
4791513|NCT02670746|Abraxane|abraxane
4791514|NCT02670746|ABI-007|abi-007
4791515|NCT02670746|Gemcitabine|gemcitabine
4791516|NCT02670746|Non-interventional|non-interventional
4791517|NCT02670746|Netherlands|netherlands
4791518|NCT02670746|Quality of Life|quality of life
4791519|NCT02670733|mechanical ventilation|mechanical ventilation
4791520|NCT02670733|positive end-expiratory pressure|positive end-expiratory pressure
4791521|NCT02670720|BCX4161|bcx4161
4791522|NCT02670720|avoralstat|avoralstat
4791523|NCT02670720|HAE|hae
4791524|NCT02670720|hereditary angioedema|hereditary angioedema
4791525|NCT02670720|prophylaxis|prophylaxis
4791526|NCT02670707|vinblastine|vinblastine
4791527|NCT02670707|prednisone|prednisone
4791528|NCT02670707|cytarabine|cytarabine
4791529|NCT02670707|Langerhans Cell Histiocytosis (LCH)|langerhans cell histiocytosis (lch)
4791530|NCT02670694|Rett Syndrome|rett syndrome
4791531|NCT02670694|Prader-Willi Syndrome|prader-willi syndrome
4791532|NCT02670694|Angelman Syndrome|angelman syndrome
4791533|NCT02670694|Sleep Problems|sleep problems
4791534|NCT02670681|Exercise|exercise
4791535|NCT02670681|Aerobic Exercise|aerobic exercise
4791536|NCT02670668|BRCA1/2;Mutations;Neoadjuvant chemotherapy;TNBC|brca1/2;mutations;neoadjuvant chemotherapy;tnbc
4791537|NCT02670655|Ablative fractional laser|ablative fractional laser
4791538|NCT02670655|Iontophoresis|iontophoresis
4791539|NCT02670655|Actinic keratosis|actinic keratosis
4791540|NCT02670655|Photodynamic therapy|photodynamic therapy
4791541|NCT02670629|Pediatric orthopedics|pediatric orthopedics
4791542|NCT02670577|stage I|stage i
4791543|NCT02670577|stage II|stage ii
4791544|NCT02670577|HER2 positive|her2 positive
4791545|NCT02670577|Triple Negative|triple negative
4791546|NCT02670564|pharmacogenetics|pharmacogenetics
4791547|NCT02670564|busulfan|busulfan
4791548|NCT02670564|treosulfan|treosulfan
4791549|NCT02670564|hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
4791550|NCT02670564|fludarabine|fludarabine
4791551|NCT02670564|pediatric patients|pediatric patients
4791552|NCT02670564|TBI|tbi
4791553|NCT02670564|leukemia|leukemia
4791554|NCT02670564|leukemia, lymphoid|leukemia, lymphoid
4791555|NCT02670564|precursor cell lymphoblastic Leukemia-Lymphoma|precursor cell lymphoblastic leukemia-lymphoma
4791556|NCT02670564|Immune System disease|immune system disease
4791557|NCT02670564|Immunoproliferative Disorders|immunoproliferative disorders
4791558|NCT02670564|stem cell transplantation|stem cell transplantation
4791559|NCT02670564|children and adolescent|children and adolescent
4791560|NCT02670564|high risk acute lymphoblastic leukemia|high risk acute lymphoblastic leukemia
4791561|NCT02670564|NCT01949129 add-on|nct01949129 add-on
4791562|NCT02670564|ALL SCTped FORUM|all sctped forum
4791563|NCT02670525|Recurrent, Refractory, or High Risk Leukemias|recurrent, refractory, or high risk leukemias
4791564|NCT02670525|Matched targeted therapy|matched targeted therapy
4791565|NCT02670512|End-Stage Renal Disease|end-stage renal disease
4791566|NCT02670512|Peritoneal Dialysis|peritoneal dialysis
4791567|NCT02670512|Telehomecare|telehomecare
4791568|NCT02670512|Telehome Monitoring|telehome monitoring
4791569|NCT02670486|Overactive bladder|overactive bladder
4791570|NCT02670486|Urge urinary incontinence|urge urinary incontinence
4791571|NCT02670486|Urodynamics|urodynamics
4791572|NCT02670408|Heart transplant|heart transplant
4791573|NCT02670408|global gene expression|global gene expression
4791574|NCT02670408|molecular diagnostics|molecular diagnostics
4791575|NCT02670395|Healthy|healthy
4791576|NCT02670395|JNJ-54416076|jnj-54416076
4791577|NCT02670395|Ascending Dose|ascending dose
4791578|NCT02670369|Sedentary time|sedentary time
4791579|NCT02670369|Sit-to-stand transitions|sit-to-stand transitions
4791580|NCT02670356|fish oil|fish oil
4791581|NCT02670356|EPA|epa
4791582|NCT02670356|DHA|dha
4791583|NCT02670356|krill oil|krill oil
4791584|NCT02670356|Metabolic Syndrome|metabolic syndrome
4791585|NCT02670330|Epidermolysis Bullosa|epidermolysis bullosa
4791586|NCT02670330|Simplex|simplex
4791587|NCT02670330|Recessive Dystrophic|recessive dystrophic
4791588|NCT02670330|Junctional non-Herlitz|junctional non-herlitz
4791589|NCT02670317|DLBCL|dlbcl
4791590|NCT02670317|large B cell lymphoma|large b cell lymphoma
4791591|NCT02670317|NHL|nhl
4791592|NCT02670304|letrozole|letrozole
4791593|NCT02670304|ovarian hyperstimulating syndrome|ovarian hyperstimulating syndrome
4791594|NCT02670291|auditory hallucinations|auditory hallucinations
4791595|NCT02670291|schizophrenia|schizophrenia
4791596|NCT02670291|cTBS|ctbs
4791597|NCT02670291|noninvasive brain stimulation|noninvasive brain stimulation
4791598|NCT02670265|malnutrition|malnutrition
4791599|NCT02670265|parenteral nutrition|parenteral nutrition
4791600|NCT02670265|weight loss|weight loss
4791601|NCT02670265|pancreatic cancer|pancreatic cancer
4791602|NCT02670265|biliary tract cancer|biliary tract cancer
4791603|NCT02670265|quality of life|quality of life
4791604|NCT02670226|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
4791605|NCT02670226|Muscle metabolism|muscle metabolism
4791606|NCT02670226|Metabolomics|metabolomics
4791607|NCT02670226|Transcriptomics|transcriptomics
4791608|NCT02670200|psychooncology|psychooncology
4791609|NCT02670200|mental health support|mental health support
4791610|NCT02670200|ICBT|icbt
4791611|NCT02670200|supportive treatment for cancer patients|supportive treatment for cancer patients
4791612|NCT02670200|depression|depression
4791613|NCT02670200|online-therapy|online-therapy
4791614|NCT02670200|Psycho-oncological support via internet|psycho-oncological support via internet
4791615|NCT02670200|internet-delivered cognitive behavior medicine|internet-delivered cognitive behavior medicine
4791616|NCT02670187|MERS CoV, Vaccine, DNA|mers cov, vaccine, dna
4791617|NCT02670174|Shoulder impingement syndrome|shoulder impingement syndrome
4791618|NCT02670174|Overhead athletes|overhead athletes
4791619|NCT02670174|Kinetic chain|kinetic chain
4791620|NCT02670174|Exercise treatment|exercise treatment
4791621|NCT02670148|Chiropractic Manipulative Therapy|chiropractic manipulative therapy
4791622|NCT02670148|Low back pain|low back pain
4791623|NCT02670148|Trunk muscle strength|trunk muscle strength
4791624|NCT02670148|Balance|balance
4791625|NCT02670148|Active military personnel|active military personnel
4791626|NCT02670122|Hepatocellular Carcinoma|hepatocellular carcinoma
4791627|NCT02670122|TACE|tace
4791628|NCT02670096|acetazolamide|acetazolamide
4791629|NCT02670096|Treatment Emergent Sleep Disordered Breathing|treatment emergent sleep disordered breathing
4791630|NCT02670096|Sleep Apnea|sleep apnea
4791631|NCT02670031|Hypertensive Heart Disease|hypertensive heart disease
4791632|NCT02670031|Hypertension|hypertension
4791633|NCT02670031|Left Ventricular Hypertrophy|left ventricular hypertrophy
4791634|NCT02670031|Myocardial Fibrosis|myocardial fibrosis
4791635|NCT02670031|Cardiovascular Magnetic Resonance Imaging|cardiovascular magnetic resonance imaging
4791636|NCT02669992|Ileostomy|ileostomy
4791637|NCT02669979|elderly|elderly
4791638|NCT02669979|oral care|oral care
4791639|NCT02669966|Kidney Transplantation|kidney transplantation
4791640|NCT02669940|Ombitasvir|ombitasvir
4791641|NCT02669940|Dasabuvir|dasabuvir
4791642|NCT02669940|Paritaprevir|paritaprevir
4791643|NCT02669927|hip surgery|hip surgery
4791644|NCT02669927|frail older people|frail older people
4791645|NCT02669901|Opioid-Related Disorders|opioid-related disorders
4791646|NCT02669901|Naloxone|naloxone
4791647|NCT02669901|Harm Reduction|harm reduction
4791648|NCT02669901|Drug Overdose Deaths|drug overdose deaths
4791649|NCT02669901|Opioid Misuse|opioid misuse
4791650|NCT02669901|Naloxone Coprescribing|naloxone coprescribing
4791651|NCT02669901|Universal Precautions|universal precautions
4791652|NCT02669901|Opioid Substance Use Disorder|opioid substance use disorder
4791653|NCT02669888|Indigo Naturalis|indigo naturalis
4791654|NCT02669888|Atopic Dermatitis|atopic dermatitis
4791656|NCT02669823|Diagnosis|diagnosis
4791657|NCT02669797|Childhood Obesity|childhood obesity
4791658|NCT02669797|Ecological Momentary Intervention|ecological momentary intervention
4791659|NCT02669797|Video Feedback|video feedback
4791660|NCT02669771|Xtandi|xtandi
4791661|NCT02669771|MDV3100|mdv3100
4791662|NCT02669771|long term use|long term use
4791663|NCT02669771|enzalutamide|enzalutamide
4791664|NCT02669758|Alkermes|alkermes
4791665|NCT02669758|ALKS 3831|alks 3831
4791666|NCT02669758|Samidorphan|samidorphan
4791667|NCT02669758|Schizophrenia|schizophrenia
4791668|NCT02669758|Safety|safety
4791669|NCT02669745|Chinese women|chinese women
4791670|NCT02669745|Breast cancer|breast cancer
4791671|NCT02669732|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
4791672|NCT02669732|Adult|adult
4791673|NCT02669732|Developmental Phase II|developmental phase ii
4791674|NCT02669719|Lung Cancer|lung cancer
4791675|NCT02669719|Chemotherapy|chemotherapy
4791676|NCT02669719|Immunotherapy|immunotherapy
4791677|NCT02669693|Olives, oleuropein|olives, oleuropein
4791678|NCT02669667|MEDI9314|medi9314
4791679|NCT02669667|Safety|safety
4791680|NCT02669667|Tolerability|tolerability
4791681|NCT02669667|Pharmacokinetics|pharmacokinetics
4791682|NCT02669667|Immunogenicity|immunogenicity
4791683|NCT02669641|Steatosis, Fatty liver, Steatohepatitis|steatosis, fatty liver, steatohepatitis
4791684|NCT02669615|multiple myeloma|multiple myeloma
4791685|NCT02669615|Melphalan HCl|melphalan hcl
4791686|NCT02669615|Autologous Transplantation|autologous transplantation
4791687|NCT02669602|Nutritional epidemiology|nutritional epidemiology
4791688|NCT02669602|Prospective|prospective
4791689|NCT02669589|CRRT|crrt
4791690|NCT02669589|AKI|aki
4791691|NCT02669589|anticoagulation|anticoagulation
4791692|NCT02669589|KDIGO|kdigo
4791693|NCT02669576|Breast cancer|breast cancer
4791694|NCT02669576|meopausal syptoms|meopausal syptoms
4791695|NCT02669576|mind body medecine|mind body medecine
4791696|NCT02669576|yoga|yoga
4791697|NCT02669576|acupuncture|acupuncture
4791698|NCT02669550|Fiberoptic bronchoscope|fiberoptic bronchoscope
4791699|NCT02669550|Disposcope endoscope|disposcope endoscope
4791700|NCT02669550|Awake orotracheal intubation|awake orotracheal intubation
4791701|NCT02669511|DLBCL|dlbcl
4791702|NCT02669485|ICG|icg
4791703|NCT02669485|colectomy|colectomy
4791704|NCT02669485|anastomotic leak|anastomotic leak
4791705|NCT02669485|anastomotic leakage rate|anastomotic leakage rate
4791706|NCT02669485|surgical decision|surgical decision
4791707|NCT02669459|Cervical Intraepithelial Neoplasia|cervical intraepithelial neoplasia
4791708|NCT02669459|Imiquimod|imiquimod
4791709|NCT02669459|Human papillomavirus|human papillomavirus
4791710|NCT02669459|quality of life|quality of life
4791711|NCT02669459|biological markers|biological markers
4791712|NCT02669446|Non interventional study|non interventional study
4791713|NCT02669446|Ectoin|ectoin
4791714|NCT02669446|Lozenges|lozenges
4791715|NCT02669446|pharyngitis|pharyngitis
4791716|NCT02669433|Dementia with Lewy bodies|dementia with lewy bodies
4791717|NCT02669433|Lewy bodies|lewy bodies
4791718|NCT02669433|intepirdine|intepirdine
4791719|NCT02669433|RVT-101|rvt-101
4791720|NCT02669433|dementia|dementia
4791721|NCT02669381|Phenylalanine|phenylalanine
4791722|NCT02669381|Direct Amino Acid Oxidation|direct amino acid oxidation
4791723|NCT02669381|Stable isotopes|stable isotopes
4791724|NCT02669355|White coat physician attire|white coat physician attire
4791725|NCT02669342|Infection|infection
4791726|NCT02669342|Urinary Catheter|urinary catheter
4791727|NCT02669342|Sharklet|sharklet
4791728|NCT02669316|diet|diet
4791729|NCT02669303|Subacromial injection|subacromial injection
4791730|NCT02669303|methylprednisolone|methylprednisolone
4791731|NCT02669303|treatment|treatment
4791732|NCT02669303|Platelet-rich plasma|platelet-rich plasma
4791733|NCT02669264|Loncastuximab tesirine|loncastuximab tesirine
4791734|NCT02669251|Optimal Biologic Dose|optimal biologic dose
4791735|NCT02669251|Safety|safety
4791736|NCT02669251|Chronic Graft-Versus-Host Disease (cGVHD)|chronic graft-versus-host disease (cgvhd)
4791737|NCT02669251|Inflammatory Lung Disease|inflammatory lung disease
4791738|NCT02669251|FEV1|fev1
4791739|NCT02669225|18 F florbetaben|18 f florbetaben
4791740|NCT02669225|Sleep Deprivation|sleep deprivation
4791741|NCT02669225|rested wakefulness|rested wakefulness
4791742|NCT02669225|glymphatic system|glymphatic system
4791743|NCT02669212|Chronic Fatigue Syndrome|chronic fatigue syndrome
4791744|NCT02669212|Lyme Disease|lyme disease
4791745|NCT02669212|Healthy Volunteers|healthy volunteers
4791746|NCT02669212|Movement Disorder|movement disorder
4791747|NCT02669186|analgesia|analgesia
4791748|NCT02669186|cancer|cancer
4791749|NCT02669186|natural killer cell|natural killer cell
4791750|NCT02669186|opioid|opioid
4791751|NCT02669173|Myeloid derived suppressor cells|myeloid derived suppressor cells
4791752|NCT02669173|brain tumor|brain tumor
4791753|NCT02669173|MDSC|mdsc
4791754|NCT02669173|GBM|gbm
4791755|NCT02669173|recurrent|recurrent
4791756|NCT02669160|Motorized Orthotic Devices|motorized orthotic devices
4791757|NCT02669160|Minors|minors
4791758|NCT02669160|CP (Cerebral Palsy)|cp (cerebral palsy)
4791759|NCT02669160|Exoskeleton Device|exoskeleton device
4791760|NCT02669134|cardiac resynchronization therapy|cardiac resynchronization therapy
4791761|NCT02669134|optimization|optimization
4791762|NCT02669134|heart failure|heart failure
4791763|NCT02669134|reverse left ventricular remodeling|reverse left ventricular remodeling
4791764|NCT02669121|Drug therapy|drug therapy
4791765|NCT02669108|testis|testis
4791766|NCT02669108|spermatogenesis|spermatogenesis
4791767|NCT02669082|Drug Therapy|drug therapy
4791768|NCT02669069|Bi-modal neuromodulation|bi-modal neuromodulation
4791769|NCT02669017|Loncastuximab tesirine|loncastuximab tesirine
4791770|NCT02669004|Analgesia, Epidural,Pain, Postoperative|analgesia, epidural,pain, postoperative
4791771|NCT02668991|Autism Spectrum Disorder|autism spectrum disorder
4791772|NCT02668991|Janssen Autism Knowledge Engine|janssen autism knowledge engine
4791773|NCT02668991|Autism Behavior Inventory|autism behavior inventory
4791774|NCT02668978|lung surgery|lung surgery
4791775|NCT02668978|air leak|air leak
4791776|NCT02668978|prevention|prevention
4791777|NCT02668965|Clinical pregnancy rate|clinical pregnancy rate
4791778|NCT02668913|gynaecology|gynaecology
4791779|NCT02668913|Oncology|oncology
4791780|NCT02668900|Feasibility trial|feasibility trial
4791781|NCT02668900|Cardiovascular disease|cardiovascular disease
4791782|NCT02668900|Decision Support|decision support
4791783|NCT02668900|Patient Decision Aid|patient decision aid
4791784|NCT02668900|implantable cardioverter defibrillator|implantable cardioverter defibrillator
4791785|NCT02668900|implantable cardioverter defibrillator replacement|implantable cardioverter defibrillator replacement
4791786|NCT02668874|Pit and Fissure sealants|pit and fissure sealants
4791787|NCT02668874|Isolation|isolation
4791788|NCT02668874|permanent teeth|permanent teeth
4791789|NCT02668874|children|children
4791790|NCT02668874|Isolite®|isolite®
4791791|NCT02668874|Dental caries|dental caries
4791792|NCT02668848|Stroke|stroke
4791793|NCT02668848|Dehydration|dehydration
4791794|NCT02668848|Fluid therapy|fluid therapy
4791795|NCT02668770|Advanced Cancers|advanced cancers
4791796|NCT02668770|Melanoma|melanoma
4791797|NCT02668770|Advanced solid malignancies|advanced solid malignancies
4791798|NCT02668770|Metastatic|metastatic
4791799|NCT02668770|MGN1703|mgn1703
4791800|NCT02668770|Ipilimumab|ipilimumab
4791801|NCT02668770|Yervoy|yervoy
4791802|NCT02668770|BMS-734016|bms-734016
4791803|NCT02668770|MDX010|mdx010
4791804|NCT02668770|Refractory|refractory
4791805|NCT02668770|Relapsed|relapsed
4791806|NCT02668718|radiotherapy, adjuvant|radiotherapy, adjuvant
4791807|NCT02668718|prostatectomy|prostatectomy
4791808|NCT02668692|LEO 80185 gel, calcipotriol, betamethasone|leo 80185 gel, calcipotriol, betamethasone
4791809|NCT02668679|Dream Doctors|dream doctors
4791810|NCT02668679|Medical Clown|medical clown
4791811|NCT02668679|Pediatrics|pediatrics
4791812|NCT02668679|Sedation|sedation
4791813|NCT02668679|Endoscopy|endoscopy
4791814|NCT02668666|Palbociclib|palbociclib
4791815|NCT02668666|Tamoxifen|tamoxifen
4791816|NCT02668666|CDK4/6 Inhibitor|cdk4/6 inhibitor
4791817|NCT02668653|Newly diagnosed Acute Myeloid Leukemia|newly diagnosed acute myeloid leukemia
4791818|NCT02668653|FLT3-ITD positive|flt3-itd positive
4791819|NCT02668653|Chemotherapy|chemotherapy
4791918|NCT02668094|pregabalin|pregabalin
4791820|NCT02668653|Induction chemotherapy|induction chemotherapy
4791821|NCT02668653|Consolidation chemotherapy|consolidation chemotherapy
4791822|NCT02668653|Maintenance chemotherapy|maintenance chemotherapy
4791823|NCT02668653|Quizartinib|quizartinib
4791824|NCT02668653|Receptor tyrosine kinase inhibitor|receptor tyrosine kinase inhibitor
4791825|NCT02668653|Feline McDonough sarcoma (FMS)-like tyrosine kinase 3|feline mcdonough sarcoma (fms)-like tyrosine kinase 3
4791826|NCT02668653|AC220|ac220
4791827|NCT02668653|FLT3-ITD|flt3-itd
4791828|NCT02668653|AML|aml
4791829|NCT02668640|Quality of life (QOL)|quality of life (qol)
4791830|NCT02668640|Rheumatoid arthritis (RA)|rheumatoid arthritis (ra)
4791831|NCT02668640|Work productivity|work productivity
4791832|NCT02668640|Adalimumab|adalimumab
4791833|NCT02668627|Stroke|stroke
4791834|NCT02668627|Collateral status|collateral status
4791835|NCT02668627|Endovascular treatment|endovascular treatment
4791836|NCT02668614|Detection|detection
4791837|NCT02668601|Gestational Diabetes Mellitus|gestational diabetes mellitus
4791838|NCT02668601|Childhood Obesity|childhood obesity
4791839|NCT02668601|Offspring|offspring
4791840|NCT02668575|Pulmonary Cystic Fibrosis|pulmonary cystic fibrosis
4791841|NCT02668562|acute coronary syndrome|acute coronary syndrome
4791842|NCT02668562|coronary artery bypass surgery|coronary artery bypass surgery
4791843|NCT02668562|ticagrelor|ticagrelor
4791844|NCT02668562|antiplatelet therapy|antiplatelet therapy
4791845|NCT02668562|platelet function testing|platelet function testing
4791846|NCT02668536|sunscreen|sunscreen
4791847|NCT02668536|melanoma|melanoma
4791848|NCT02668536|improved protection from uv rays|improved protection from uv rays
4791849|NCT02668523|Presbyopia|presbyopia
4791850|NCT02668523|Corneal Inlay|corneal inlay
4791851|NCT02668523|Pseudophakic|pseudophakic
4791852|NCT02668523|Pseudophakia|pseudophakia
4791853|NCT02668510|Heel Pain|heel pain
4791854|NCT02668510|extracorporeal shock wave therapy|extracorporeal shock wave therapy
4791855|NCT02668510|ESWT|eswt
4791856|NCT02668510|shock wave|shock wave
4791857|NCT02668510|Soldiers|soldiers
4791858|NCT02668510|Platelet rich plasma|platelet rich plasma
4791859|NCT02668510|PRP|prp
4791860|NCT02668510|Autologous conditioned plasma|autologous conditioned plasma
4791861|NCT02668510|Military|military
4791862|NCT02668497|Movement disorders|movement disorders
4791863|NCT02668497|Botulinum toxin type A|botulinum toxin type a
4791864|NCT02668497|Tremor|tremor
4791865|NCT02668497|Kinematics|kinematics
4791866|NCT02668484|TAVI|tavi
4791867|NCT02668484|trans-femoral|trans-femoral
4791868|NCT02668484|Sapien|sapien
4791869|NCT02668484|Lotus|lotus
4791870|NCT02668445|Concurrent|concurrent
4791871|NCT02668445|muscle|muscle
4791872|NCT02668445|glycogen|glycogen
4791873|NCT02668445|molecular|molecular
4791874|NCT02668406|Blood infection, melioidosis, rapid diagnostic test|blood infection, melioidosis, rapid diagnostic test
4791875|NCT02668380|Apatinib|apatinib
4791876|NCT02668380|metastatic gastric cancer|metastatic gastric cancer
4791877|NCT02668380|Non-interventionalStudy|non-interventionalstudy
4791878|NCT02668367|Viral Diseases|viral diseases
4791879|NCT02668367|Antiviral|antiviral
4791880|NCT02668367|Paramyxoviridae Infections|paramyxoviridae infections
4791881|NCT02668367|RSV|rsv
4791882|NCT02668367|Respiratory Syncytial Virus|respiratory syncytial virus
4791883|NCT02668367|Aviragen Therapeutics, Inc.|aviragen therapeutics, inc.
4791884|NCT02668367|Aviragen Therapeutics|aviragen therapeutics
4791885|NCT02668367|Aviragen|aviragen
4791886|NCT02668354|Childhood Cancer|childhood cancer
4791887|NCT02668354|Pediatric Oncology|pediatric oncology
4791888|NCT02668354|Infant tumors|infant tumors
4791889|NCT02668302|Steroid-eluting implant|steroid-eluting implant
4791890|NCT02668302|Mometasone furoate|mometasone furoate
4791891|NCT02668276|Prostatic neoplasms|prostatic neoplasms
4791892|NCT02668276|Oncotype DX|oncotype dx
4791893|NCT02668276|Treatment Decisions|treatment decisions
4791894|NCT02668263|Breast cancer|breast cancer
4791895|NCT02668263|mastectomy|mastectomy
4791896|NCT02668263|seromas|seromas
4791897|NCT02668211|osteoarthritis|osteoarthritis
4791898|NCT02668211|radiostereometric analysis|radiostereometric analysis
4791899|NCT02668211|correction of functional deformity|correction of functional deformity
4791900|NCT02668211|procedures|procedures
4791901|NCT02668211|total hip arthroplasty|total hip arthroplasty
4791902|NCT02668211|musculoskeletal diseases|musculoskeletal diseases
4791903|NCT02668198|Endoscopic mucosal resection, residual polyp, near focus imaging|endoscopic mucosal resection, residual polyp, near focus imaging
4791904|NCT02668172|pegvisomant|pegvisomant
4791905|NCT02668172|pasireotide LAR|pasireotide lar
4791906|NCT02668172|long acting somatostatin analogues|long acting somatostatin analogues
4791907|NCT02668146|essential tremor|essential tremor
4791908|NCT02668146|Perampanel|perampanel
4791909|NCT02668146|clinical trial|clinical trial
4791910|NCT02668133|zinc deficiency|zinc deficiency
4791911|NCT02668133|zinc absorption|zinc absorption
4791912|NCT02668120|chronic histiocytic intervillositis|chronic histiocytic intervillositis
4791913|NCT02668120|serum alkaline phosphatase|serum alkaline phosphatase
4791914|NCT02668120|placenta|placenta
4791915|NCT02668120|case-control study|case-control study
4791916|NCT02668094|propofol|propofol
4791917|NCT02668094|lidocaine|lidocaine
4791919|NCT02668081|Endoscopic sphincterotomy|endoscopic sphincterotomy
4791920|NCT02668081|Endoscopic papillary balloon dilation|endoscopic papillary balloon dilation
4791921|NCT02668081|Metagenomics|metagenomics
4791922|NCT02668068|Pneumoconiosis|pneumoconiosis
4791923|NCT02668068|Mesenchymal Stem Cells|mesenchymal stem cells
4791924|NCT02668068|whole-lung lavage (WLL)|whole-lung lavage (wll)
4791925|NCT02668055|TB4|tb4
4791926|NCT02668055|Difficult to heal|difficult to heal
4791927|NCT02668029|Oxygen therapy|oxygen therapy
4791928|NCT02668003|Prevention trial|prevention trial
4791929|NCT02668003|Cognitive Behaviour Therapy|cognitive behaviour therapy
4791930|NCT02668003|CWP|cwp
4791931|NCT02668003|Chronic widespread pain|chronic widespread pain
4791932|NCT02668003|RCT|rct
4791933|NCT02668003|Fibromyalgia|fibromyalgia
4791934|NCT02668003|Prevention|prevention
4791935|NCT02667990|metatarsalgia|metatarsalgia
4791936|NCT02667990|pedobar|pedobar
4791937|NCT02667990|foot|foot
4791938|NCT02667990|stiletto|stiletto
4791939|NCT02667990|insoles|insoles
4791940|NCT02667977|fluids, pediatric, gastroenteritis|fluids, pediatric, gastroenteritis
4791941|NCT02667951|Elderly|elderly
4791942|NCT02667951|Dementia|dementia
4791943|NCT02667951|Intervention program|intervention program
4791944|NCT02667925|ovarian cancer|ovarian cancer
4791945|NCT02667925|intraperitoneal chemotherapy|intraperitoneal chemotherapy
4791946|NCT02667912|Hypertension, Endovascular Procedures, Catheter Ablation, Renal Artery|hypertension, endovascular procedures, catheter ablation, renal artery
4791947|NCT02667899|disorders of consciousness|disorders of consciousness
4791948|NCT02667899|deep brain stimulation|deep brain stimulation
4791949|NCT02667899|transcranial magnetic stimulation|transcranial magnetic stimulation
4791950|NCT02667860|intracorporeal anastomosis|intracorporeal anastomosis
4791951|NCT02667860|laparoscopic colectomy|laparoscopic colectomy
4791952|NCT02667860|outcomes|outcomes
4791953|NCT02667860|length of stay|length of stay
4791954|NCT02667860|analgesia|analgesia
4791955|NCT02667860|aesthetic|aesthetic
4791956|NCT02667860|extracorporeal anastomosis|extracorporeal anastomosis
4791957|NCT02667860|laparoscopic|laparoscopic
4791958|NCT02667847|preoperative anxiety assessment|preoperative anxiety assessment
4791959|NCT02667847|levels of preoperative anxiety using two different scales|levels of preoperative anxiety using two different scales
4791960|NCT02667834|social cognition|social cognition
4791961|NCT02667834|cognitive remediation|cognitive remediation
4791962|NCT02667782|Mindfulness-based interventions|mindfulness-based interventions
4791963|NCT02667782|Dementia|dementia
4791964|NCT02667782|Caregiving|caregiving
4791965|NCT02667782|Burden|burden
4791966|NCT02667782|Stress|stress
4791967|NCT02667782|Anxiety|anxiety
4791968|NCT02667782|Depression|depression
4791969|NCT02667782|Community care|community care
4791970|NCT02667756|biomarker|biomarker
4791971|NCT02667756|inflammation|inflammation
4791972|NCT02667756|prognosis|prognosis
4791973|NCT02667756|knee|knee
4791974|NCT02667743|NSCLC|nsclc
4791975|NCT02667743|Paclitaxel Micelles for Injection|paclitaxel micelles for injection
4791976|NCT02667691|superoxyde dismutase|superoxyde dismutase
4791977|NCT02667691|melon concentrate|melon concentrate
4791978|NCT02667691|oxydative stress|oxydative stress
4791979|NCT02667691|overweight women|overweight women
4791980|NCT02667665|Alzheimer's Disease Dementia|alzheimer's disease dementia
4791981|NCT02667652|T2DM|t2dm
4791982|NCT02667652|RYGB|rygb
4791983|NCT02667652|RCT|rct
4791984|NCT02667639|safety|safety
4791985|NCT02667639|tolerability|tolerability
4791986|NCT02667639|RPH-104|rph-104
4791987|NCT02667639|RPH104|rph104
4791988|NCT02667626|Breast cancer survivor|breast cancer survivor
4791989|NCT02667626|Cancer survivorship|cancer survivorship
4791990|NCT02667626|Survivorship care plan|survivorship care plan
4791991|NCT02667626|Vaginal dryness|vaginal dryness
4791992|NCT02667626|Vulvovaginal atrophy|vulvovaginal atrophy
4791993|NCT02667626|Vasomotor symptom|vasomotor symptom
4791994|NCT02667626|Infertility|infertility
4791995|NCT02667626|Family planning|family planning
4791996|NCT02667613|motor skill learning|motor skill learning
4791997|NCT02667613|functional changes|functional changes
4791998|NCT02667613|neuroplastic changes|neuroplastic changes
4791999|NCT02667600|Cesarean|cesarean
4792000|NCT02667600|Blood Loss|blood loss
4792001|NCT02667600|Triton|triton
4792002|NCT02667574|basal cell carcinoma|basal cell carcinoma
4792003|NCT02667574|surgery|surgery
4792004|NCT02667574|stage|stage
4792005|NCT02667574|vismodegib|vismodegib
4792006|NCT02667548|percutaneous coronary intervention|percutaneous coronary intervention
4792007|NCT02667509|Evolutionary Model|evolutionary model
4792008|NCT02667483|Duchenne muscular dystrophy|duchenne muscular dystrophy
4792009|NCT02667483|DMD|dmd
4792010|NCT02667483|Oligonucleotides, Antisense|oligonucleotides, antisense
4792011|NCT02667483|Exon skipping|exon skipping
4792012|NCT02667470|Solifenacin|solifenacin
4792013|NCT02667470|Overactive bladder|overactive bladder
4792014|NCT02667431|SUI|sui
4792015|NCT02667418|Clostridium|clostridium
4792016|NCT02667418|Difficile|difficile
4792017|NCT02667418|Fidaxomicin|fidaxomicin
4792018|NCT02667418|Vancomycin|vancomycin
4792019|NCT02667418|Recurrent|recurrent
4792020|NCT02667418|Pulse|pulse
4792021|NCT02667418|Taper|taper
4792022|NCT02667392|Stroke|stroke
4792023|NCT02667392|Gait|gait
4792024|NCT02667392|Walking|walking
4792025|NCT02667392|Rehabilitation|rehabilitation
4792026|NCT02667392|Exercise|exercise
4792027|NCT02667392|Exercise Therapy|exercise therapy
4792028|NCT02667392|Physical Therapy Modalities|physical therapy modalities
4792029|NCT02667392|Exercise Movement Techniques|exercise movement techniques
4792030|NCT02667379|Cat|cat
4792031|NCT02667379|allergy|allergy
4792032|NCT02667379|dander|dander
4792033|NCT02667379|Fel d 1|fel d 1
4792034|NCT02667379|Felis domesticus|felis domesticus
4792035|NCT02667366|mild and moderate depression|mild and moderate depression
4792036|NCT02667353|electroconvulsive|electroconvulsive
4792037|NCT02667353|hippocampus|hippocampus
4792038|NCT02667353|elderly|elderly
4792039|NCT02667353|working mechanism|working mechanism
4792040|NCT02667340|exercise|exercise
4792041|NCT02667340|carbohydrate|carbohydrate
4792042|NCT02667340|Superstarch|superstarch
4792043|NCT02667327|diabetic foot ulcer|diabetic foot ulcer
4792044|NCT02667327|diabetic complications|diabetic complications
4792045|NCT02667327|diabetes|diabetes
4792046|NCT02667327|wound healing|wound healing
4792047|NCT02667327|Granexin gel|granexin gel
4792048|NCT02667327|FirstString Research|firststring research
4792049|NCT02667314|Cognition|cognition
4792050|NCT02667314|Cognitive Aging|cognitive aging
4792051|NCT02667314|Dementia|dementia
4792052|NCT02667314|Neurocognitive Disorders|neurocognitive disorders
4792053|NCT02667314|Cognitive Therapy|cognitive therapy
4792054|NCT02667314|Cognitive Reserve|cognitive reserve
4792055|NCT02667314|Cognitive Enrichment|cognitive enrichment
4792056|NCT02667314|Jigsaw Puzzles|jigsaw puzzles
4792057|NCT02667275|seborrheic keratosis|seborrheic keratosis
4792058|NCT02667249|cholecystectomy, check list|cholecystectomy, check list
4792059|NCT02667236|seborrheic keratosis|seborrheic keratosis
4792060|NCT02667223|pharmacokinetics|pharmacokinetics
4792061|NCT02667223|pharmacodynamics|pharmacodynamics
4792062|NCT02667223|RN316|rn316
4792063|NCT02667223|recombinant human hyaluronidase|recombinant human hyaluronidase
4792064|NCT02667145|hand osteoarthritis|hand osteoarthritis
4792065|NCT02667145|self care program|self care program
4792066|NCT02667145|assistive tecnology|assistive tecnology
4792067|NCT02667132|Granulomatous, Mastitis|granulomatous, mastitis
4792068|NCT02667132|C17.800.090.968.400|c17.800.090.968.400
4792069|NCT02667132|C13.703.844.603.400|c13.703.844.603.400
4792070|NCT02667093|Acute Leukemia|acute leukemia
4792071|NCT02667093|Acute Myeloid Leukemia|acute myeloid leukemia
4792072|NCT02667093|AML|aml
4792073|NCT02667080|Semen quality|semen quality
4792074|NCT02667080|Sexual Abstinence|sexual abstinence
4792075|NCT02667080|sperm motility|sperm motility
4792076|NCT02667080|DNA fragmentation|dna fragmentation
4792077|NCT02667015|Substance Use Disorders|substance use disorders
4792078|NCT02667015|Anxiety|anxiety
4792079|NCT02667015|Anxiety Sensitivity|anxiety sensitivity
4792080|NCT02667015|Brief Intervention|brief intervention
4792081|NCT02667015|Treatment|treatment
4792082|NCT02666989|Depression|depression
4792083|NCT02666989|Placebo|placebo
4792084|NCT02666989|Open-label|open-label
4792085|NCT02666989|Clinical practice|clinical practice
4792086|NCT02666976|Gastroesophageal reflux, proton pump inhibitors, ilaprazole|gastroesophageal reflux, proton pump inhibitors, ilaprazole
4792087|NCT02666963|RTA 901|rta 901
4792088|NCT02666963|RTA 901 capsules|rta 901 capsules
4792089|NCT02666898|Residual disease|residual disease
4792090|NCT02666885|Personalized Medicine|personalized medicine
4792091|NCT02666885|Radiation Oncology|radiation oncology
4792092|NCT02666885|Functional Imaging|functional imaging
4792093|NCT02666885|Biomarker|biomarker
4792094|NCT02666885|Decision Support System|decision support system
4792095|NCT02666885|Radiomics|radiomics
4792096|NCT02666872|Vaccination|vaccination
4792097|NCT02666872|Infant|infant
4792098|NCT02666872|Parents|parents
4792099|NCT02666872|Intention|intention
4792100|NCT02666846|UVB Pain Model|uvb pain model
4792101|NCT02666846|PK|pk
4792102|NCT02666846|Topical|topical
4792103|NCT02666846|NSAIDs|nsaids
4792104|NCT02666833|Skin Cancer|skin cancer
4792105|NCT02666833|Basal Cell Carcinoma|basal cell carcinoma
4792106|NCT02666833|Squamous Cell Carcinoma|squamous cell carcinoma
4792107|NCT02666833|Mohs Surgery|mohs surgery
4792108|NCT02666833|Imaging|imaging
4792109|NCT02666807|NF-κB|nf-κb
4792110|NCT02666807|Ginger|ginger
4792111|NCT02666794|analgesia|analgesia
4792112|NCT02666794|fetal bradycardia|fetal bradycardia
4792113|NCT02666794|hypertonic uterine|hypertonic uterine
4792114|NCT02666781|OSA, Surgery, Postoperative, Rostral Fluid Shift|osa, surgery, postoperative, rostral fluid shift
4792115|NCT02666755|Lung Neoplasms digital polymerase chain reaction|lung neoplasms digital polymerase chain reaction
4792116|NCT02666716|pharmacokinetics|pharmacokinetics
4792117|NCT02666716|fluconazole|fluconazole
4792118|NCT02666716|invasive fungal infection|invasive fungal infection
4792119|NCT02666716|candidiasis|candidiasis
4792120|NCT02666716|intensive care unit|intensive care unit
4792121|NCT02666703|cardiac surgery|cardiac surgery
4792122|NCT02666703|systemic inflammatory response|systemic inflammatory response
4792426|NCT02664935|Multi-arm|multi-arm
4792123|NCT02666703|immunoadsorption|immunoadsorption
4792124|NCT02666677|polytrauma, emergency medicine|polytrauma, emergency medicine
4792125|NCT02666664|hyperlipidemia|hyperlipidemia
4792126|NCT02666664|cholesterol|cholesterol
4792127|NCT02666664|heterozygous familial hypercholesterolemia|heterozygous familial hypercholesterolemia
4792128|NCT02666664|atherosclerotic cardiovascular disease|atherosclerotic cardiovascular disease
4792129|NCT02666664|ASCVD|ascvd
4792130|NCT02666664|HeFH|hefh
4792131|NCT02666664|LDL|ldl
4792132|NCT02666638|Magnetic Resonance Imaging (MRI)|magnetic resonance imaging (mri)
4792133|NCT02666612|Patients|patients
4792134|NCT02666599|F-18-FDG|f-18-fdg
4792135|NCT02666599|neoplasm|neoplasm
4792136|NCT02666599|probe|probe
4792137|NCT02666599|positron|positron
4792138|NCT02666599|diagnosis|diagnosis
4792139|NCT02666599|surgery|surgery
4792140|NCT02666599|radioguided surgery|radioguided surgery
4792141|NCT02666573|drug therapy|drug therapy
4792142|NCT02666573|Photosensitizing Agents|photosensitizing agents
4792143|NCT02666573|therapeutic use|therapeutic use
4792144|NCT02666560|Auditory Cueing|auditory cueing
4792145|NCT02666560|Gait|gait
4792146|NCT02666547|68Ga-NODAGA-RGD|68ga-nodaga-rgd
4792147|NCT02666547|18F-FDG|18f-fdg
4792148|NCT02666547|18F-FET|18f-fet
4792149|NCT02666547|PET/CT|pet/ct
4792150|NCT02666547|neoangiogenesis|neoangiogenesis
4792151|NCT02666534|Ablative fractional laser|ablative fractional laser
4792152|NCT02666534|microinvasive squamous cell carcinoma|microinvasive squamous cell carcinoma
4792153|NCT02666534|photodynamic therapy|photodynamic therapy
4792154|NCT02666521|Primary Health Care|primary health care
4792155|NCT02666508|plaque identifying toothpaste|plaque identifying toothpaste
4792156|NCT02666508|plaque score|plaque score
4792157|NCT02666508|C-reactive protein|c-reactive protein
4792158|NCT02666495|Schema Therapy|schema therapy
4792159|NCT02666482|smoking|smoking
4792160|NCT02666482|stop smoking|stop smoking
4792161|NCT02666482|tobacco use cessation|tobacco use cessation
4792162|NCT02666469|Hyperbaric oxygen treatment, rehabilitation|hyperbaric oxygen treatment, rehabilitation
4792163|NCT02666443|brachial plexus|brachial plexus
4792164|NCT02666443|supraclavicular|supraclavicular
4792165|NCT02666443|duration|duration
4792166|NCT02666443|dexamethasone|dexamethasone
4792167|NCT02666443|block|block
4792168|NCT02666417|Iron fortification|iron fortification
4792169|NCT02666417|Anemia|anemia
4792170|NCT02666417|Iron Deficiency|iron deficiency
4792171|NCT02666417|Iron Absorption|iron absorption
4792172|NCT02666417|Prebiotics|prebiotics
4792173|NCT02666417|Stable isotopes|stable isotopes
4792174|NCT02666404|Volume Resuscitation|volume resuscitation
4792175|NCT02666404|Shock|shock
4792176|NCT02666404|Body Impedance Measurement|body impedance measurement
4792177|NCT02666404|Renal Resistive Index|renal resistive index
4792178|NCT02666404|Acute Kidney Injury|acute kidney injury
4792179|NCT02666404|Renal Replacement Therapy|renal replacement therapy
4792180|NCT02666378|HER-2 Positive Breast Cancer|her-2 positive breast cancer
4792181|NCT02666365|anesthesia|anesthesia
4792182|NCT02666365|surgical antimicrobial prophylaxis|surgical antimicrobial prophylaxis
4792183|NCT02666365|surgical site infections|surgical site infections
4792184|NCT02666339|Hortitherapy|hortitherapy
4792185|NCT02666339|Care-garden|care-garden
4792186|NCT02666339|Anxiety|anxiety
4792187|NCT02666339|Therapeutic alliance|therapeutic alliance
4792188|NCT02666326|Acute Coronary Syndrome|acute coronary syndrome
4792189|NCT02666326|Prehospital emergency care|prehospital emergency care
4792190|NCT02666326|Biological markers|biological markers
4792191|NCT02666326|Copeptin|copeptin
4792192|NCT02666326|Troponin|troponin
4792193|NCT02666326|Rule-out|rule-out
4792194|NCT02666326|Point-of-Care systems|point-of-care systems
4792195|NCT02666326|Infarction|infarction
4792196|NCT02666326|Cardiovascular Diseases|cardiovascular diseases
4792197|NCT02666326|Heart Diseases|heart diseases
4792198|NCT02666326|Ischemia|ischemia
4792199|NCT02666326|Myocardial Ischemia|myocardial ischemia
4792200|NCT02666326|copeptins|copeptins
4792201|NCT02666326|Troponin T|troponin t
4792202|NCT02666326|Diagnostic Techniques (Cardiovascular)|diagnostic techniques (cardiovascular)
4792203|NCT02666326|High sensitivity troponin|high sensitivity troponin
4792204|NCT02666300|Postoperative sore throat,Anesthesia|postoperative sore throat,anesthesia
4792205|NCT02666287|Fluticasone furoate|fluticasone furoate
4792206|NCT02666287|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
4792207|NCT02666287|Batefenterol|batefenterol
4792208|NCT02666287|Dry Powder Inhaler|dry powder inhaler
4792209|NCT02666287|Respiratory|respiratory
4792210|NCT02666287|Pharmacokinetics|pharmacokinetics
4792211|NCT02666287|Ellipta|ellipta
4792212|NCT02666287|Healthy Subjects|healthy subjects
4792213|NCT02666274|carbapenem resistance|carbapenem resistance
4792214|NCT02666274|bacterial carriage|bacterial carriage
4792215|NCT02666274|multi-drug resistant gram negative bacteria|multi-drug resistant gram negative bacteria
4792216|NCT02666222|hearing loss|hearing loss
4792217|NCT02666222|sensorineural|sensorineural
4792218|NCT02666222|hearing implant|hearing implant
4792219|NCT02666209|Multiple Myeloma|multiple myeloma
4792220|NCT02666209|Relapsed Multiple Myeloma|relapsed multiple myeloma
4792723|NCT02663453|preterm|preterm
4792221|NCT02666209|Refractory Multiple Myeloma|refractory multiple myeloma
4792222|NCT02666183|cancer|cancer
4792223|NCT02666183|caregiver|caregiver
4792224|NCT02666183|videoconferencing|videoconferencing
4792225|NCT02666157|atrial fibrillation|atrial fibrillation
4792226|NCT02666157|stroke|stroke
4792227|NCT02666157|systemic embolism|systemic embolism
4792228|NCT02666157|bleeding|bleeding
4792229|NCT02666157|oral anticoagulant|oral anticoagulant
4792230|NCT02666131|diabetic foot ulcer|diabetic foot ulcer
4792231|NCT02666131|diabetic complications|diabetic complications
4792232|NCT02666131|diabetes|diabetes
4792233|NCT02666131|wound healing|wound healing
4792234|NCT02666131|Granexin gel|granexin gel
4792235|NCT02666131|FirstString Research|firststring research
4792236|NCT02666118|pain|pain
4792237|NCT02666118|pain management|pain management
4792238|NCT02666118|shoulder repair|shoulder repair
4792239|NCT02666118|nerve blockade|nerve blockade
4792240|NCT02666118|regional anesthesia|regional anesthesia
4792241|NCT02666118|pediatrics|pediatrics
4792242|NCT02666105|NSCLC|nsclc
4792243|NCT02666092|IgE|ige
4792244|NCT02666092|Immunoelectrophoresis|immunoelectrophoresis
4792245|NCT02666092|Western Blot|western blot
4792246|NCT02666092|ImmunoCAP|immunocap
4792247|NCT02666079|Wide local excision (WLE) for breast cancer|wide local excision (wle) for breast cancer
4792248|NCT02666027|Fluid monitoring|fluid monitoring
4792249|NCT02666014|PONV|ponv
4792250|NCT02666014|nausea|nausea
4792251|NCT02666014|vomiting|vomiting
4792252|NCT02666014|sugammadex|sugammadex
4792253|NCT02666014|neostigmine|neostigmine
4792254|NCT02665988|Transcranial Direct Current Stimulation|transcranial direct current stimulation
4792255|NCT02665975|Tinnitus treatment|tinnitus treatment
4792256|NCT02665975|Internet-intervention|internet-intervention
4792257|NCT02665975|CBT|cbt
4792258|NCT02665962|newly diagnosed patients|newly diagnosed patients
4792259|NCT02665936|epidural analgesia|epidural analgesia
4792260|NCT02665871|vaccine|vaccine
4792261|NCT02665871|safety|safety
4792262|NCT02665871|intranasal administration|intranasal administration
4792263|NCT02665806|Ciclesonide|ciclesonide
4792264|NCT02665806|Fluticasone propionate|fluticasone propionate
4792265|NCT02665806|Nasal Polyposis|nasal polyposis
4792266|NCT02665806|Chronic Sinuitis|chronic sinuitis
4792267|NCT02665806|Chronic rhinosinusitis|chronic rhinosinusitis
4792268|NCT02665793|Peanut allergy|peanut allergy
4792269|NCT02665793|Food allergy|food allergy
4792270|NCT02665793|Thresholds|thresholds
4792271|NCT02665793|Anaphylaxis|anaphylaxis
4792272|NCT02665780|halitosis, periodontal debridement, chemotherapeutics|halitosis, periodontal debridement, chemotherapeutics
4792273|NCT02665767|Telesonography, Appendix|telesonography, appendix
4792274|NCT02665754|Allergic rhinitis|allergic rhinitis
4792275|NCT02665754|Injection, intralymphatic|injection, intralymphatic
4792276|NCT02665754|Immunotherapy|immunotherapy
4792277|NCT02665754|Dermatophagoides farinae|dermatophagoides farinae
4792278|NCT02665754|Dermatophagoides pteronyssinus|dermatophagoides pteronyssinus
4792279|NCT02665754|Dogs|dogs
4792280|NCT02665754|Cats|cats
4792281|NCT02665741|distal colonoscope attachments, colon cancer screening, screening colonoscopy, adenoma detection|distal colonoscope attachments, colon cancer screening, screening colonoscopy, adenoma detection
4792282|NCT02665715|Reactive hypoglycemia|reactive hypoglycemia
4792283|NCT02665715|Hyperinsulinaemia|hyperinsulinaemia
4792284|NCT02665715|Diet|diet
4792285|NCT02665715|Glucagon-like Peptide-1|glucagon-like peptide-1
4792286|NCT02665715|Glucagon|glucagon
4792287|NCT02665715|Peptide YY|peptide yy
4792288|NCT02665715|Ghrelin|ghrelin
4792289|NCT02665689|Diabetic Macular Edema, Ranibizumab, Visual Acuity, Diabetic Control,|diabetic macular edema, ranibizumab, visual acuity, diabetic control,
4792290|NCT02665676|Childhood Cancer|childhood cancer
4792291|NCT02665676|Pediatric Oncology|pediatric oncology
4792292|NCT02665676|Embryonal Neoplasms|embryonal neoplasms
4792293|NCT02665676|Embryonic Neoplasms|embryonic neoplasms
4792294|NCT02665676|Embryonic Tumors|embryonic tumors
4792295|NCT02665676|Embryonal Tumors|embryonal tumors
4792296|NCT02665624|Bowel cleansing|bowel cleansing
4792297|NCT02665624|Colonoscopy|colonoscopy
4792298|NCT02665624|Stewed apricot juice|stewed apricot juice
4792299|NCT02665624|Senna|senna
4792300|NCT02665598|Posterior Reversible Encephalopathy Syndrome,Prognosis|posterior reversible encephalopathy syndrome,prognosis
4792301|NCT02665585|carotid disease|carotid disease
4792302|NCT02665585|stroke|stroke
4792303|NCT02665585|stent|stent
4792304|NCT02665585|carotid stenting|carotid stenting
4792305|NCT02665572|renal transplantation|renal transplantation
4792306|NCT02665572|defunctionalized bladder|defunctionalized bladder
4792307|NCT02665572|bladder recycling|bladder recycling
4792308|NCT02665559|HIV|hiv
4792309|NCT02665559|Hypogonadism|hypogonadism
4792310|NCT02665559|Metabolic Syndrom|metabolic syndrom
4792311|NCT02665559|Reservoirs|reservoirs
4792312|NCT02665559|Osteodensitometry|osteodensitometry
4792313|NCT02665559|Erectil dysfonction|erectil dysfonction
4792314|NCT02665559|Depression|depression
4792315|NCT02665546|Dyspnea|dyspnea
4792316|NCT02665546|pulmonary hypertension|pulmonary hypertension
4792317|NCT02665546|Histiocytosis Langerhans cells|histiocytosis langerhans cells
4792318|NCT02665546|exercise test|exercise test
4792319|NCT02665533|pain measurement|pain measurement
4792320|NCT02665533|edema|edema
4792321|NCT02665533|trismus|trismus
4792322|NCT02665520|stem cells injections|stem cells injections
4792323|NCT02665520|erectile dysfunction|erectile dysfunction
4792324|NCT02665507|Photobiomodulation|photobiomodulation
4792325|NCT02665507|Aviation|aviation
4792326|NCT02665481|Exercise|exercise
4792327|NCT02665481|Mindfulness|mindfulness
4792328|NCT02665481|Education|education
4792329|NCT02665481|Elderly|elderly
4792330|NCT02665468|Supported adoption|supported adoption
4792331|NCT02665468|Secure messaging|secure messaging
4792332|NCT02665468|Patient aligned care team (PACT)|patient aligned care team (pact)
4792333|NCT02665468|My HealtheVet Coordinator|my healthevet coordinator
4792334|NCT02665455|Diabetes Mellitus|diabetes mellitus
4792335|NCT02665455|Sensing Technology|sensing technology
4792336|NCT02665442|Esophageal Stylet|esophageal stylet
4792337|NCT02665442|EsoSure|esosure
4792338|NCT02665442|Atrial Fibrillation|atrial fibrillation
4792339|NCT02665442|Catheter Ablation|catheter ablation
4792340|NCT02665442|Mechanical esophageal displacement|mechanical esophageal displacement
4792341|NCT02665429|Emergency Medicine|emergency medicine
4792342|NCT02665390|lung cancer|lung cancer
4792343|NCT02665390|Percutaneous cryoablation|percutaneous cryoablation
4792344|NCT02665390|treatment of medically inoperable|treatment of medically inoperable
4792345|NCT02665338|transcranial magnetic stimulation|transcranial magnetic stimulation
4792346|NCT02665338|fMRI|fmri
4792347|NCT02665338|cue craving|cue craving
4792348|NCT02665325|TSH-suppressive therapy|tsh-suppressive therapy
4792349|NCT02665325|cognitive function|cognitive function
4792350|NCT02665312|cardiotoxicity|cardiotoxicity
4792351|NCT02665312|fluoropyrimidine|fluoropyrimidine
4792352|NCT02665312|colorectal cancer|colorectal cancer
4792353|NCT02665299|colon cancer|colon cancer
4792354|NCT02665299|colon polyps|colon polyps
4792355|NCT02665299|colon adenomas|colon adenomas
4792356|NCT02665299|colonoscopy|colonoscopy
4792357|NCT02665299|circulating tumor DNA|circulating tumor dna
4792358|NCT02665234|Dry Eye|dry eye
4792359|NCT02665221|Multiple Sclerosis|multiple sclerosis
4792360|NCT02665221|erythema|erythema
4792361|NCT02665208|cigarettes|cigarettes
4792362|NCT02665208|smoking|smoking
4792363|NCT02665208|opiate-dependence|opiate-dependence
4792364|NCT02665208|alcohol|alcohol
4792365|NCT02665208|detoxification|detoxification
4792366|NCT02665182|orchitis|orchitis
4792367|NCT02665182|testicular diseases|testicular diseases
4792368|NCT02665169|Postural Balance|postural balance
4792369|NCT02665169|Cost-Benefit Analysis|cost-benefit analysis
4792370|NCT02665169|Morbidity|morbidity
4792371|NCT02665169|Exercise|exercise
4792372|NCT02665143|acute myeloid leukemia|acute myeloid leukemia
4792373|NCT02665130|COPD|copd
4792374|NCT02665130|Pulmonary rehabilitation|pulmonary rehabilitation
4792375|NCT02665117|Hypokalemia|hypokalemia
4792376|NCT02665117|Isoprostanes|isoprostanes
4792377|NCT02665117|Insulin resistance|insulin resistance
4792378|NCT02665117|Aldosterone|aldosterone
4792379|NCT02665117|Hepatic fat|hepatic fat
4792380|NCT02665117|Muscle Magnesium|muscle magnesium
4792381|NCT02665117|Liver fat|liver fat
4792382|NCT02665104|Cerebral oxygen saturation|cerebral oxygen saturation
4792384|NCT02665104|NIRS|nirs
4792385|NCT02665104|Carotid endarterectomy|carotid endarterectomy
4792386|NCT02665078|Lung Cancer|lung cancer
4792387|NCT02665065|Acute Myeloid Leukemia|acute myeloid leukemia
4792388|NCT02665065|Leukemia, Acute Myeloid|leukemia, acute myeloid
4792389|NCT02665065|Myeloid Leukemia, Acute|myeloid leukemia, acute
4792390|NCT02665065|Bone Marrow Cell Transplantation|bone marrow cell transplantation
4792391|NCT02665065|Transplantation, Bone Marrow|transplantation, bone marrow
4792392|NCT02665065|HCT|hct
4792393|NCT02665065|HSCT|hsct
4792394|NCT02665065|Refractory AML|refractory aml
4792395|NCT02665065|Relapsed AML|relapsed aml
4792396|NCT02665065|BC8|bc8
4792397|NCT02665065|I-131|i-131
4792398|NCT02665065|Iomab|iomab
4792399|NCT02665065|Iomab-B|iomab-b
4792400|NCT02665065|CD45|cd45
4792401|NCT02665065|Iodine|iodine
4792402|NCT02665065|Iodine-131|iodine-131
4792403|NCT02665065|131-I|131-i
4792404|NCT02665065|AML|aml
4792405|NCT02665065|BMT|bmt
4792406|NCT02665065|radioimmunotherapy|radioimmunotherapy
4792407|NCT02665052|Rehabilitation|rehabilitation
4792408|NCT02665052|Motor Recovery|motor recovery
4792409|NCT02665052|upper extremity|upper extremity
4792410|NCT02664987|pain management, pain control, cancer|pain management, pain control, cancer
4792411|NCT02664961|TRC105|trc105
4792412|NCT02664961|CD105|cd105
4792413|NCT02664961|Endoglin|endoglin
4792414|NCT02664961|Angiogenesis inhibitor|angiogenesis inhibitor
4792415|NCT02664961|GTN|gtn
4792416|NCT02664961|Bevacizumab|bevacizumab
4792417|NCT02664961|Avastin|avastin
4792418|NCT02664948|early follow-up|early follow-up
4792419|NCT02664948|geriatrics|geriatrics
4792420|NCT02664935|NSCLC|nsclc
4792421|NCT02664935|Lung Cancer|lung cancer
4792422|NCT02664935|Adenocarcinoma|adenocarcinoma
4792423|NCT02664935|Matrix|matrix
4792424|NCT02664935|SMP2|smp2
4792425|NCT02664935|Umbrella Trial Design|umbrella trial design
4792427|NCT02664922|Electrophysiology|electrophysiology
4792428|NCT02664922|Anesthetics|anesthetics
4792429|NCT02664909|Hip Hemiarthroplasty|hip hemiarthroplasty
4792430|NCT02664909|Tranexamic Acid|tranexamic acid
4792431|NCT02664909|Topical|topical
4792432|NCT02664909|Blood Transfusion|blood transfusion
4792433|NCT02664896|Knee pain|knee pain
4792434|NCT02664896|Knee Osteoarthritis|knee osteoarthritis
4792435|NCT02664870|synovial fluid|synovial fluid
4792436|NCT02664870|biomarkers|biomarkers
4792437|NCT02664857|Vitamin D|vitamin d
4792438|NCT02664857|Postoperative Pain|postoperative pain
4792439|NCT02664857|Mental Motor Retardation|mental motor retardation
4792440|NCT02664844|Obesity|obesity
4792441|NCT02664844|Appetite regulation|appetite regulation
4792442|NCT02664844|Insulin sensitivity|insulin sensitivity
4792443|NCT02664844|Adolescents|adolescents
4792444|NCT02664844|Exercise|exercise
4792445|NCT02664831|cardiac arrest|cardiac arrest
4792446|NCT02664831|inflammation|inflammation
4792447|NCT02664831|obesity|obesity
4792448|NCT02664831|neuregulin|neuregulin
4792449|NCT02664831|lipids|lipids
4792450|NCT02664818|Heart failure|heart failure
4792451|NCT02664818|China|china
4792452|NCT02664818|Registry|registry
4792453|NCT02664818|Characteristic|characteristic
4792454|NCT02664818|Outcome|outcome
4792455|NCT02664792|Non-small cell lung carcinoma|non-small cell lung carcinoma
4792456|NCT02664792|PET/CT|pet/ct
4792457|NCT02664792|18F-FDG|18f-fdg
4792458|NCT02664766|Heavy drinking|heavy drinking
4792459|NCT02664766|Heavy drinking cessation|heavy drinking cessation
4792460|NCT02664766|Alcohol abuse|alcohol abuse
4792461|NCT02664766|alcohol use disorder|alcohol use disorder
4792462|NCT02664740|Phage Therapy|phage therapy
4792463|NCT02664727|alcohol|alcohol
4792464|NCT02664727|alcohol abuse|alcohol abuse
4792465|NCT02664727|alcohol dependence|alcohol dependence
4792466|NCT02664727|alcohol use disorder|alcohol use disorder
4792467|NCT02664727|heavy drinking|heavy drinking
4792468|NCT02664727|alcohol abuse cessation|alcohol abuse cessation
4792469|NCT02664714|physiotherapy, perineometer, adherence|physiotherapy, perineometer, adherence
4792470|NCT02664688|spondylolisthesis|spondylolisthesis
4792471|NCT02664688|low back pain|low back pain
4792472|NCT02664688|stabilization exercise|stabilization exercise
4792473|NCT02664662|Breast cancer|breast cancer
4792474|NCT02664662|Health literacy|health literacy
4792475|NCT02664662|Tailored education|tailored education
4792476|NCT02664662|Rehabilitation|rehabilitation
4792477|NCT02664662|International Classification of Functioning, Disability and Health|international classification of functioning, disability and health
4792478|NCT02664649|TAVR|tavr
4792479|NCT02664649|Apixaban|apixaban
4792480|NCT02664649|Anticoagulant|anticoagulant
4792481|NCT02664649|VKA|vka
4792482|NCT02664649|Antiplatelet therapy|antiplatelet therapy
4792483|NCT02664649|Aortic stenosis|aortic stenosis
4792484|NCT02664610|hypertension treatment|hypertension treatment
4792485|NCT02664610|stroke prevention|stroke prevention
4792486|NCT02664597|ADNEXMR SCORING system|adnexmr scoring system
4792487|NCT02664597|MRI|mri
4792488|NCT02664597|adnexal masses|adnexal masses
4792489|NCT02664519|Chronic Kidney Disease|chronic kidney disease
4792490|NCT02664519|Functional sympatholysis|functional sympatholysis
4792491|NCT02664519|Exercise training|exercise training
4792492|NCT02664519|Exercise intolerance|exercise intolerance
4792493|NCT02664519|Handgrip exercise|handgrip exercise
4792494|NCT02664519|Near infrared spectroscopy|near infrared spectroscopy
4792495|NCT02664519|Lower body negative pressure|lower body negative pressure
4792496|NCT02664493|kidney transplantation|kidney transplantation
4792497|NCT02664493|subclinical borderline rejection|subclinical borderline rejection
4792498|NCT02664493|steroid pulse therapy|steroid pulse therapy
4792499|NCT02664480|Salivary Alpha-amylase|salivary alpha-amylase
4792500|NCT02664480|ovulation|ovulation
4792501|NCT02664454|Elderly|elderly
4792502|NCT02664454|Health care organization|health care organization
4792503|NCT02664454|Primary care|primary care
4792504|NCT02664441|Obesity|obesity
4792505|NCT02664441|Drug intervention|drug intervention
4792506|NCT02664441|Children|children
4792507|NCT02664441|Adolescents|adolescents
4792508|NCT02664441|Young adults|young adults
4792509|NCT02664441|Hypothalamic lesion|hypothalamic lesion
4792510|NCT02664441|Change of weight status|change of weight status
4792511|NCT02664441|Food intake|food intake
4792512|NCT02664441|Energy expenditure|energy expenditure
4792513|NCT02664441|Hormonal changes|hormonal changes
4792514|NCT02664441|Glucagon-like peptide-1 agonist|glucagon-like peptide-1 agonist
4792515|NCT02664441|Bydureon|bydureon
4792516|NCT02664441|Weight Loss|weight loss
4792517|NCT02664441|Energy balance|energy balance
4792518|NCT02664415|Human Monoclonal Antibody|human monoclonal antibody
4792519|NCT02664402|Palliative Care|palliative care
4792520|NCT02664402|Pain|pain
4792521|NCT02664402|Community Health|community health
4792522|NCT02664376|sarcopenia|sarcopenia
4792523|NCT02664376|geriatry|geriatry
4792524|NCT02664311|Pulmonary Vein Isolation|pulmonary vein isolation
4792525|NCT02664311|Jet Ventilation|jet ventilation
4792526|NCT02664311|Atrial Fibrillation|atrial fibrillation
4792527|NCT02664298|severely atrophic jaw|severely atrophic jaw
4792528|NCT02664298|cranial bone-graft|cranial bone-graft
4792529|NCT02664298|dental implants|dental implants
4792530|NCT02664298|immediate loading|immediate loading
4792531|NCT02664298|augmentation maxilla/mandible|augmentation maxilla/mandible
4792532|NCT02664298|sinus-floor elevation/sinuslift|sinus-floor elevation/sinuslift
4792533|NCT02664298|dental prosthesis|dental prosthesis
4792534|NCT02664298|implant supported|implant supported
4792535|NCT02664298|provisional implants|provisional implants
4792536|NCT02664298|temporary implants|temporary implants
4792537|NCT02664298|one-stage surgery|one-stage surgery
4792538|NCT02664298|alveolar ridge augmentation|alveolar ridge augmentation
4792539|NCT02664298|maxilla|maxilla
4792540|NCT02664259|Endobronchial ultrasonography|endobronchial ultrasonography
4792541|NCT02664259|Peripheral pulmonary lesions|peripheral pulmonary lesions
4792542|NCT02664259|Ultrathin bronchoscopy|ultrathin bronchoscopy
4792543|NCT02664246|contrast-induced nephropathy|contrast-induced nephropathy
4792544|NCT02664246|Percutaneous coronary intervention|percutaneous coronary intervention
4792545|NCT02664246|risk factors|risk factors
4792546|NCT02664246|incidence|incidence
4792547|NCT02664233|Diabetes|diabetes
4792548|NCT02664233|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
4792549|NCT02664233|obesity|obesity
4792550|NCT02664233|self-monitoring|self-monitoring
4792551|NCT02664233|goal setting|goal setting
4792552|NCT02664233|mobile health|mobile health
4792553|NCT02664233|connected health|connected health
4792554|NCT02664220|Povidone-iodine irrigation|povidone-iodine irrigation
4792555|NCT02664207|Myelomeningocele repair|myelomeningocele repair
4792556|NCT02664207|Open Neural Tube Defect|open neural tube defect
4792557|NCT02664207|BMI of 35-40 kg/m2,|bmi of 35-40 kg/m2,
4792558|NCT02664207|Open Fetal Surgery|open fetal surgery
4792559|NCT02664207|Elevated body mass index|elevated body mass index
4792560|NCT02664194|Hypothermia|hypothermia
4792561|NCT02664194|Rewarming|rewarming
4792562|NCT02664194|Myocardial Infarction|myocardial infarction
4792563|NCT02664194|Percutaneous Cornonary Intervention|percutaneous cornonary intervention
4792564|NCT02664181|Cancer|cancer
4792565|NCT02664181|Nivolumab|nivolumab
4792566|NCT02664181|Decitabine|decitabine
4792567|NCT02664181|Tetrahydrouridine|tetrahydrouridine
4792568|NCT02664155|Renal insufficiency|renal insufficiency
4792569|NCT02664155|Direct oral anticoagulants (DOA)|direct oral anticoagulants (doa)
4792570|NCT02664155|Deep Vein Thrombosis (DVT)|deep vein thrombosis (dvt)
4792571|NCT02664155|Pulmonary Embolism (PE)|pulmonary embolism (pe)
4792572|NCT02664155|Venous Thromboembolism (VTE)|venous thromboembolism (vte)
4792573|NCT02664155|Heparins|heparins
4792574|NCT02664142|General Surgery|general surgery
4792575|NCT02664142|Child|child
4792576|NCT02664142|Anaesthesia|anaesthesia
4792577|NCT02664142|Depth of anaesthesia|depth of anaesthesia
4792578|NCT02664142|BIS monitoring|bis monitoring
4792579|NCT02664129|schizophrenia|schizophrenia
4792580|NCT02664129|awareness|awareness
4792581|NCT02664129|insight|insight
4792582|NCT02664129|video|video
4792583|NCT02664129|self-observation|self-observation
4792584|NCT02664116|Severe Migraine Headache|severe migraine headache
4792585|NCT02664090|acute respiratory distress syndrome|acute respiratory distress syndrome
4792586|NCT02664090|prone ventilation|prone ventilation
4792587|NCT02664090|trans-esophageal doppler|trans-esophageal doppler
4792588|NCT02664077|NSABP|nsabp
4792589|NCT02664077|Colon cancer|colon cancer
4792590|NCT02664077|Regorafenib|regorafenib
4792591|NCT02664077|Stage III|stage iii
4792592|NCT02664077|Adjuvant therapy|adjuvant therapy
4792593|NCT02664064|prediabetes, weight loss, behavior modification|prediabetes, weight loss, behavior modification
4792594|NCT02664038|AUD|aud
4792595|NCT02664038|Neuropsychology|neuropsychology
4792596|NCT02664038|Cognitive Remediation|cognitive remediation
4792597|NCT02664025|teaching vaginal examination|teaching vaginal examination
4792598|NCT02664012|adoption|adoption
4792599|NCT02664012|electronic cigarettes|electronic cigarettes
4792600|NCT02664012|e-cigarettes|e-cigarettes
4792601|NCT02664012|menthol|menthol
4792602|NCT02664012|combustible cigarettes|combustible cigarettes
4792603|NCT02664012|nicotine polacrilex|nicotine polacrilex
4792604|NCT02664012|own brand cigarette|own brand cigarette
4792605|NCT02664012|subjective measures|subjective measures
4792606|NCT02664012|pharmacokinetics|pharmacokinetics
4792607|NCT02664012|pharmacodynamics|pharmacodynamics
4792608|NCT02664012|cigarette|cigarette
4792609|NCT02663999|dose proportionality|dose proportionality
4792610|NCT02663999|diazepam nasal spray|diazepam nasal spray
4792611|NCT02663986|Organization, Time Management, and Planning (OTMP)|organization, time management, and planning (otmp)
4792612|NCT02663973|Breast cancer|breast cancer
4792613|NCT02663960|Regional citrate anticoagulation|regional citrate anticoagulation
4792614|NCT02663960|Protocol|protocol
4792615|NCT02663960|Filter lifespan|filter lifespan
4792616|NCT02663947|ventriculoperitoneal shunt|ventriculoperitoneal shunt
4792617|NCT02663947|optic nerve sheath diameter|optic nerve sheath diameter
4792618|NCT02663947|intracranial pressure|intracranial pressure
4792619|NCT02663934|HIV, AIDS, Cognition, Memory, Exercise, Stretching|hiv, aids, cognition, memory, exercise, stretching
4792620|NCT02663921|Fitzpatrick Skin-Type|fitzpatrick skin-type
4792621|NCT02663921|Melanin|melanin
4792818|NCT02662829|HIV|hiv
4792622|NCT02663921|Ultraviolet Light (UV)|ultraviolet light (uv)
4792623|NCT02663882|smoking|smoking
4792624|NCT02663882|self control|self control
4792625|NCT02663804|Total Knee Arthroplasty|total knee arthroplasty
4792626|NCT02663804|Patient Satisfaction|patient satisfaction
4792627|NCT02663804|PROMs|proms
4792628|NCT02663804|Implant Design|implant design
4792629|NCT02663791|Alcohol|alcohol
4792630|NCT02663791|Aortic stiffness|aortic stiffness
4792631|NCT02663791|Arterial stiffness|arterial stiffness
4792632|NCT02663791|Pulse wave velocity|pulse wave velocity
4792633|NCT02663791|Longitudinal|longitudinal
4792634|NCT02663752|deferasirox|deferasirox
4792635|NCT02663752|MDS|mds
4792636|NCT02663752|RNA expression|rna expression
4792637|NCT02663752|predictive biomarker|predictive biomarker
4792638|NCT02663739|Stanford type B aortic dissection|stanford type b aortic dissection
4792639|NCT02663739|Malperfusion|malperfusion
4792640|NCT02663739|Rupture|rupture
4792641|NCT02663739|Acute disease|acute disease
4792642|NCT02663739|Endovascular procedures|endovascular procedures
4792643|NCT02663726|Physically inactive|physically inactive
4792644|NCT02663726|Older adults|older adults
4792645|NCT02663713|Pharmacodynamics|pharmacodynamics
4792646|NCT02663713|Ticagrelor|ticagrelor
4792647|NCT02663713|Clopidogrel|clopidogrel
4792648|NCT02663713|MI|mi
4792649|NCT02663700|Burkina Faso|burkina faso
4792650|NCT02663700|healthy adults|healthy adults
4792651|NCT02663700|Irradiated|irradiated
4792652|NCT02663700|malaria|malaria
4792653|NCT02663700|PfSPZ Vaccine|pfspz vaccine
4792654|NCT02663700|Sanaria|sanaria
4792655|NCT02663700|Sporozoite|sporozoite
4792656|NCT02663700|Vaccine|vaccine
4792657|NCT02663674|CAP|cap
4792658|NCT02663674|Coccidioidomycosis|coccidioidomycosis
4792659|NCT02663674|Community Acquired Pneumonia|community acquired pneumonia
4792660|NCT02663674|FLEET|fleet
4792661|NCT02663674|Fluconazole|fluconazole
4792662|NCT02663674|Parent Study of 16-0008|parent study of 16-0008
4792663|NCT02663674|Pneumonia|pneumonia
4792664|NCT02663674|Valley Fever|valley fever
4792665|NCT02663661|Diabetes Mellitus, Type 1 (T1DM)|diabetes mellitus, type 1 (t1dm)
4792666|NCT02663661|TrialNet|trialnet
4792667|NCT02663661|Pathway to Prevention (PTP)|pathway to prevention (ptp)
4792668|NCT02663661|First and second degree relatives of persons with T1DM|first and second degree relatives of persons with t1dm
4792669|NCT02663661|Insulin-glucagon-glucose (IGG)|insulin-glucagon-glucose (igg)
4792670|NCT02663661|Immunological risk to develop T1DM|immunological risk to develop t1dm
4792671|NCT02663648|myeloproliferative disorders|myeloproliferative disorders
4792672|NCT02663648|cell cycle regulatory protein|cell cycle regulatory protein
4792673|NCT02663609|Cushing's Syndrome|cushing's syndrome
4792674|NCT02663609|Mifepristone|mifepristone
4792675|NCT02663609|Adrenal|adrenal
4792676|NCT02663609|Retrospective|retrospective
4792677|NCT02663609|Chart Review|chart review
4792678|NCT02663596|Pediatric|pediatric
4792679|NCT02663596|Continuous Renal Replacement Therapy|continuous renal replacement therapy
4792680|NCT02663596|Dialysis|dialysis
4792681|NCT02663596|Therapeutic drug monitoring|therapeutic drug monitoring
4792682|NCT02663596|Pharmacokinetics|pharmacokinetics
4792683|NCT02663596|Pharmacodynamics|pharmacodynamics
4792684|NCT02663583|Oropharynx squamous cell carcinoma|oropharynx squamous cell carcinoma
4792685|NCT02663583|OPSCC|opscc
4792686|NCT02663583|Actigraph accelerometer|actigraph accelerometer
4792687|NCT02663583|MD Anderson Symptom Inventory - Head and Neck module|md anderson symptom inventory - head and neck module
4792688|NCT02663583|MDASI-HN|mdasi-hn
4792689|NCT02663583|Intensity-Modulated Proton Therapy|intensity-modulated proton therapy
4792690|NCT02663583|IMPT|impt
4792691|NCT02663583|TransOral Robotic Surgery|transoral robotic surgery
4792692|NCT02663583|TORS|tors
4792693|NCT02663583|Surveys|surveys
4792694|NCT02663583|Questionnaires|questionnaires
4792695|NCT02663557|stroke, blood pressure, prognosis|stroke, blood pressure, prognosis
4792696|NCT02663544|Diabetes|diabetes
4792697|NCT02663544|Metabolic syndrome|metabolic syndrome
4792698|NCT02663544|Obesity|obesity
4792699|NCT02663544|NAFLD|nafld
4792700|NCT02663518|T-Cell|t-cell
4792701|NCT02663518|CTCL|ctcl
4792702|NCT02663518|PTCL|ptcl
4792703|NCT02663518|ALL|all
4792704|NCT02663518|Rituximab|rituximab
4792705|NCT02663518|Nivolumab|nivolumab
4792706|NCT02663518|TTI-621|tti-621
4792707|NCT02663518|Solid Tumor|solid tumor
4792708|NCT02663518|Hematologic Malignancies|hematologic malignancies
4792709|NCT02663518|Lymphoma|lymphoma
4792710|NCT02663518|Cutaneous T-Cell Lymphoma|cutaneous t-cell lymphoma
4792711|NCT02663518|Peripheral T-Cell Lymphoma|peripheral t-cell lymphoma
4792712|NCT02663518|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
4792713|NCT02663518|CD47|cd47
4792714|NCT02663492|Acupuncture|acupuncture
4792715|NCT02663492|electrical stimulation of acupoints|electrical stimulation of acupoints
4792716|NCT02663492|chemotherapy|chemotherapy
4792717|NCT02663492|Diyu Shengbai Pian|diyu shengbai pian
4792718|NCT02663492|nursing care|nursing care
4792719|NCT02663466|pilonidal sinus|pilonidal sinus
4792720|NCT02663466|Limberg flap|limberg flap
4792721|NCT02663466|off-midline closure concept|off-midline closure concept
4792722|NCT02663466|recurrence|recurrence
4792724|NCT02663453|parenteral nutrition|parenteral nutrition
4792725|NCT02663453|cholestasis|cholestasis
4792726|NCT02663453|fish oil|fish oil
4792727|NCT02663427|pepsinogen Ⅰ|pepsinogen ⅰ
4792728|NCT02663427|pepsinogen Ⅱ|pepsinogen ⅱ
4792729|NCT02663427|gastric cancer screening|gastric cancer screening
4792730|NCT02663427|helicobacter pylori|helicobacter pylori
4792731|NCT02663427|gastrin|gastrin
4792732|NCT02663375|TAVI|tavi
4792733|NCT02663375|Aortic Stenosis|aortic stenosis
4792734|NCT02663375|Transcatheter aortic valve replacement|transcatheter aortic valve replacement
4792735|NCT02663375|Transcatheter aortic valve implantation|transcatheter aortic valve implantation
4792736|NCT02663375|Transapical Access|transapical access
4792737|NCT02663362|magnetic resonance imaging|magnetic resonance imaging
4792738|NCT02663362|magnetic resonance spectroscopy|magnetic resonance spectroscopy
4792739|NCT02663336|masked hypertension, chronic kidney disease|masked hypertension, chronic kidney disease
4792740|NCT02663323|Coronary Artery Disease|coronary artery disease
4792741|NCT02663323|MeRes-1 Extend|meres-1 extend
4792742|NCT02663323|MeRes100|meres100
4792743|NCT02663323|Sirolimus Eluting Bioresorbable Vascular Scaffold System|sirolimus eluting bioresorbable vascular scaffold system
4792744|NCT02663310|spinal cord injury|spinal cord injury
4792745|NCT02663310|Kunming Locomotor Scale|kunming locomotor scale
4792746|NCT02663310|surgical decompression|surgical decompression
4792747|NCT02663310|untethering|untethering
4792748|NCT02663310|weight bearing rehabilitation|weight bearing rehabilitation
4792749|NCT02663297|CAR T cells|car t cells
4792750|NCT02663297|CD30|cd30
4792751|NCT02663297|Lymphoma|lymphoma
4792752|NCT02663297|T Lymphocytes|t lymphocytes
4792753|NCT02663245|Type 2 diabetes mellitus|type 2 diabetes mellitus
4792754|NCT02663245|glycemic control|glycemic control
4792755|NCT02663232|V600 BRAF mutation|v600 braf mutation
4792756|NCT02663232|Metastatic melanoma|metastatic melanoma
4792757|NCT02663219|MSM|msm
4792758|NCT02663219|ART|art
4792759|NCT02663219|CCM|ccm
4792760|NCT02663219|DAIDS|daids
4792761|NCT02663219|HPTN|hptn
4792762|NCT02663219|ACA|aca
4792763|NCT02663219|PAF|paf
4792764|NCT02663219|PEP|pep
4792765|NCT02663219|RDS|rds
4792766|NCT02663206|spastic esophageal disorders|spastic esophageal disorders
4792767|NCT02663206|achalasia|achalasia
4792768|NCT02663206|diffuse esophageal spasm|diffuse esophageal spasm
4792769|NCT02663206|hypercontractile (jackhammer) esophagus|hypercontractile (jackhammer) esophagus
4792770|NCT02663206|Botulinum toxin injection|botulinum toxin injection
4792771|NCT02663206|peroral endoscopic myotomy|peroral endoscopic myotomy
4792772|NCT02663193|Prostate Cancer|prostate cancer
4792773|NCT02663193|Observational study|observational study
4792774|NCT02663193|Enzalutamide|enzalutamide
4792775|NCT02663193|Abiraterone Acetate|abiraterone acetate
4792776|NCT02663193|Prednisone|prednisone
4792777|NCT02663193|Tolerability|tolerability
4792778|NCT02663154|Aromatherapy|aromatherapy
4792779|NCT02663102|Safety|safety
4792780|NCT02663102|Post-marketing|post-marketing
4792781|NCT02663102|Korea|korea
4792782|NCT02663102|Drug utilization study|drug utilization study
4792783|NCT02663102|Fluarix Tetra|fluarix tetra
4792784|NCT02663089|total radioactivity|total radioactivity
4792785|NCT02663089|[14C]-GSK961081|[14c]-gsk961081
4792786|NCT02663089|Pharmacokinetics|pharmacokinetics
4792787|NCT02663089|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
4792788|NCT02663089|Microtracer|microtracer
4792789|NCT02663063|Complementary and alternative medicine|complementary and alternative medicine
4792790|NCT02663063|Hospice Palliative Care|hospice palliative care
4792791|NCT02663050|Dysmenorrhea|dysmenorrhea
4792792|NCT02663050|kinesio tape|kinesio tape
4792793|NCT02663037|Segmentation|segmentation
4792794|NCT02663037|Health needs|health needs
4792795|NCT02662985|Power Doppler Ultrasonography, Psoriatic Arthritis, Enthesitis, Synovitis, Outcome Measures in Rheumatology, Spondyloarthritis Research Consortium of Canada|power doppler ultrasonography, psoriatic arthritis, enthesitis, synovitis, outcome measures in rheumatology, spondyloarthritis research consortium of canada
4792796|NCT02662972|Nerve block|nerve block
4792797|NCT02662972|Sphenopalatine Ganglion Block|sphenopalatine ganglion block
4792798|NCT02662972|Botulinum Toxins, Type A|botulinum toxins, type a
4792799|NCT02662959|Chemotherapy, metastatic gastric cancer, irinotecan|chemotherapy, metastatic gastric cancer, irinotecan
4792800|NCT02662907|Head and Neck Cancer|head and neck cancer
4792801|NCT02662907|Post-radiotherapy H&N cancer survivors|post-radiotherapy h&n cancer survivors
4792802|NCT02662907|Aspiration|aspiration
4792803|NCT02662907|Expiratory muscle strength training|expiratory muscle strength training
4792804|NCT02662907|EMST|emst
4792805|NCT02662907|Dysphagia therapy|dysphagia therapy
4792806|NCT02662907|Modified barium swallow|modified barium swallow
4792807|NCT02662907|Neurocognitive exams|neurocognitive exams
4792808|NCT02662907|Questionnaires|questionnaires
4792809|NCT02662907|Surveys|surveys
4792810|NCT02662907|Digital Manometer|digital manometer
4792811|NCT02662868|Breast cancer|breast cancer
4792812|NCT02662868|Metastasis|metastasis
4792813|NCT02662842|infusion set|infusion set
4792814|NCT02662842|continuous subcutaneous insulin infusion|continuous subcutaneous insulin infusion
4792815|NCT02662829|Lesotho|lesotho
4792816|NCT02662829|tuberculosis|tuberculosis
4792817|NCT02662829|TB|tb
4792819|NCT02662829|adherence|adherence
4792820|NCT02662829|community-based intervention|community-based intervention
4792821|NCT02662829|retention|retention
4792822|NCT02662816|Glutathione|glutathione
4792823|NCT02662816|Liver|liver
4792824|NCT02662816|Muscle|muscle
4792825|NCT02662816|Proton magnetic resonance spectroscopy|proton magnetic resonance spectroscopy
4792826|NCT02662816|Healthy human|healthy human
4792827|NCT02662803|Generalized Anxiety Disorder|generalized anxiety disorder
4792828|NCT02662803|GAD|gad
4792829|NCT02662803|physical exercise|physical exercise
4792830|NCT02662803|aerobe exercise|aerobe exercise
4792831|NCT02662803|mental disorder|mental disorder
4792832|NCT02662803|high-intensive aerobe exercise|high-intensive aerobe exercise
4792833|NCT02662777|esophageal anastomosis leakage|esophageal anastomosis leakage
4792834|NCT02662777|endoscopic vacuum therapy|endoscopic vacuum therapy
4792835|NCT02662777|esophageal perforation|esophageal perforation
4792836|NCT02662777|upper gastrointestinal tract|upper gastrointestinal tract
4792837|NCT02662777|esophageal leak|esophageal leak
4792838|NCT02662777|endoscopy|endoscopy
4792839|NCT02662738|Blood glucose|blood glucose
4792840|NCT02662725|melanoma|melanoma
4792841|NCT02662725|brain metastasis|brain metastasis
4792842|NCT02662725|stereotactic radiosurgery|stereotactic radiosurgery
4792843|NCT02662725|Ipilimumab|ipilimumab
4792844|NCT02662725|survival|survival
4792845|NCT02662725|safety|safety
4792846|NCT02662725|efficacy|efficacy
4792847|NCT02662712|Healthy|healthy
4792848|NCT02662712|Hepatitis, Chronic|hepatitis, chronic
4792849|NCT02662712|JNJ-56136379|jnj-56136379
4792850|NCT02662712|Placebo|placebo
4792851|NCT02662699|Anemia|anemia
4792852|NCT02662699|Hematologic Diseases|hematologic diseases
4792853|NCT02662699|Erythrocytes|erythrocytes
4792854|NCT02662699|Hemoglobin|hemoglobin
4792855|NCT02662699|Hemolytic|hemolytic
4792856|NCT02662686|Embryo Implantation|embryo implantation
4792857|NCT02662686|Mitochondrial genes|mitochondrial genes
4792858|NCT02662686|Mitochondrial DNA|mitochondrial dna
4792859|NCT02662686|MitoScore|mitoscore
4792860|NCT02662686|Embryo selection|embryo selection
4792861|NCT02662686|Embryo viability|embryo viability
4792862|NCT02662686|Embryo biomarker|embryo biomarker
4792863|NCT02662686|Diagnosis of embryo viability in euploids embryos|diagnosis of embryo viability in euploids embryos
4792864|NCT02662673|HIFU|hifu
4792865|NCT02662673|Prostate Cancer|prostate cancer
4792866|NCT02662673|Focal|focal
4792867|NCT02662673|Quality of life|quality of life
4792868|NCT02662673|Index study|index study
4792869|NCT02662647|demethylating agent|demethylating agent
4792870|NCT02662647|lymphocyte infusion|lymphocyte infusion
4792871|NCT02662634|NSCLC|nsclc
4792872|NCT02662634|resectable|resectable
4792873|NCT02662634|non-small cell lung cancer|non-small cell lung cancer
4792874|NCT02662634|immunotherapy|immunotherapy
4792875|NCT02662634|autologous|autologous
4792876|NCT02662634|dendritic cell|dendritic cell
4792877|NCT02662621|personalized care|personalized care
4792878|NCT02662621|early diagnosis|early diagnosis
4792879|NCT02662621|ovarian cancer|ovarian cancer
4792880|NCT02662621|breast cancer|breast cancer
4792881|NCT02662621|lung cancer|lung cancer
4792882|NCT02662621|Early Detection|early detection
4792883|NCT02662621|Cancer [E01.390.500]|cancer [e01.390.500]
4792884|NCT02662608|Brontictuzumab|brontictuzumab
4792885|NCT02662595|mHealth|mhealth
4792886|NCT02662595|mobile phones|mobile phones
4792887|NCT02662595|measles vaccination|measles vaccination
4792888|NCT02662582|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
4792889|NCT02662582|CK-2127107|ck-2127107
4792890|NCT02662582|COPD|copd
4792891|NCT02662543|rotavirus,|rotavirus,
4792892|NCT02662543|acute gastroenteritis|acute gastroenteritis
4792893|NCT02662543|vaccination|vaccination
4792894|NCT02662543|Estonia|estonia
4792895|NCT02662543|impact|impact
4792896|NCT02662543|severity scales|severity scales
4792897|NCT02662517|Neurotrophins|neurotrophins
4792898|NCT02662517|Stem Cells|stem cells
4792899|NCT02662517|Prematurity|prematurity
4792900|NCT02662504|mesothelioma|mesothelioma
4792901|NCT02662504|multimodal treatment|multimodal treatment
4792902|NCT02662504|PDT|pdt
4792903|NCT02662504|pleura|pleura
4792904|NCT02662478|Laparoscopic gastric resection|laparoscopic gastric resection
4792905|NCT02662478|gastrointestinal stromal tumor|gastrointestinal stromal tumor
4792906|NCT02662478|laparoscopic surgery|laparoscopic surgery
4792907|NCT02662465|Interventional|interventional
4792908|NCT02662465|Treatment|treatment
4792909|NCT02662465|Laser|laser
4792910|NCT02662439|Heart Failure|heart failure
4792911|NCT02662439|Bioimpedance analysis|bioimpedance analysis
4792912|NCT02662439|Fluid overload|fluid overload
4792913|NCT02662426|Seasonal Influenza|seasonal influenza
4792914|NCT02662426|Lingdancao|lingdancao
4792915|NCT02662426|RCT|rct
4792916|NCT02662361|peri-implant disease; risk factors; prevalence|peri-implant disease; risk factors; prevalence
4792917|NCT02662322|Communication|communication
4792918|NCT02662322|Confusion|confusion
4792919|NCT02662322|Intravenous Catheterization|intravenous catheterization
4792920|NCT02662322|Comfort|comfort
4792921|NCT02662309|Muscle invasive bladder cancer|muscle invasive bladder cancer
4792922|NCT02662309|Transitional cell carcinoma|transitional cell carcinoma
4792923|NCT02662283|IGA Nephropathy|iga nephropathy
4792924|NCT02662283|proteinurien|proteinurien
4792925|NCT02662283|Reh-acteoside|reh-acteoside
4792926|NCT02662283|Prednisolone|prednisolone
4792927|NCT02662270|Fibromyalgia|fibromyalgia
4792928|NCT02662270|QEEG|qeeg
4792929|NCT02662270|Brain activity|brain activity
4792930|NCT02662270|fMRI|fmri
4792931|NCT02662270|Diagnosis|diagnosis
4792932|NCT02662257|Sevoflurane|sevoflurane
4792933|NCT02662257|Propofol|propofol
4792934|NCT02662257|Aged|aged
4792935|NCT02662257|Neoplasm|neoplasm
4792936|NCT02662257|Surgical Procedure, Operative|surgical procedure, operative
4792937|NCT02662257|Delirium|delirium
4792938|NCT02662257|Postoperative Complications|postoperative complications
4792939|NCT02662257|Postoperative Cognitive Dysfunction|postoperative cognitive dysfunction
4792940|NCT02662231|Surgical Site Infection|surgical site infection
4792941|NCT02662231|General Surgery|general surgery
4792942|NCT02662231|Laparotomy|laparotomy
4792943|NCT02662231|Outcome and Process Assessment (Health Care)|outcome and process assessment (health care)
4792944|NCT02662231|Developing Countries|developing countries
4792945|NCT02662231|International Cooperation|international cooperation
4792946|NCT02662231|Specialties, Surgical|specialties, surgical
4792947|NCT02662231|Developed Countries|developed countries
4792948|NCT02662231|Quality of Health Care|quality of health care
4792949|NCT02662179|Elderly patients|elderly patients
4792950|NCT02662179|Onco-geriatrics|onco-geriatrics
4792951|NCT02662179|Fried criteria|fried criteria
4792952|NCT02662166|bladder cancer|bladder cancer
4792953|NCT02662166|MRI|mri
4792954|NCT02662166|TUR-BT|tur-bt
4792955|NCT02662166|cystectomy|cystectomy
4792956|NCT02662166|chemotherapy|chemotherapy
4792957|NCT02662075|alternative tobacco products (ATPs)|alternative tobacco products (atps)
4792958|NCT02662075|electronic cigarettes|electronic cigarettes
4792959|NCT02662062|Non-metastatic muscle invasive bladder cancer|non-metastatic muscle invasive bladder cancer
4792960|NCT02662023|Healthy Human Volunteers|healthy human volunteers
4792961|NCT02662010|AGEs|ages
4792962|NCT02662010|glycemic control|glycemic control
4792963|NCT02662010|T2DM|t2dm
4792964|NCT02661997|Tai Chi|tai chi
4792965|NCT02661997|Wellness|wellness
4792966|NCT02661997|Mind-body|mind-body
4792967|NCT02661997|Gulf War Illness|gulf war illness
4792968|NCT02661997|Gulf War Veteran's Illness|gulf war veteran's illness
4792969|NCT02661997|GWVI|gwvi
4792970|NCT02661984|FeNO, exhaled nitric oxide|feno, exhaled nitric oxide
4792971|NCT02661958|acne vulgaris|acne vulgaris
4792972|NCT02661958|acne|acne
4792973|NCT02661945|near focus with narrow band imaging|near focus with narrow band imaging
4792974|NCT02661945|tumor margin|tumor margin
4792975|NCT02661945|indigocarmine chromoendoscopy|indigocarmine chromoendoscopy
4792976|NCT02661932|Fertility preservation|fertility preservation
4792977|NCT02661932|letrozole|letrozole
4792978|NCT02661932|Ovarian stimulation|ovarian stimulation
4792979|NCT02661919|Epilepsy|epilepsy
4792980|NCT02661919|Seizure|seizure
4792981|NCT02661919|Seizures|seizures
4792982|NCT02661919|Mattress monitor|mattress monitor
4792983|NCT02661919|Bed monitor|bed monitor
4792984|NCT02661919|Bed alarm|bed alarm
4792985|NCT02661919|Generalized tonic-clonic seizure|generalized tonic-clonic seizure
4792986|NCT02661919|GTC|gtc
4792987|NCT02661893|Healthy|healthy
4792988|NCT02661893|JNJ-42847922|jnj-42847922
4792989|NCT02661893|Rifampin|rifampin
4792990|NCT02661893|Pharmacokinetics|pharmacokinetics
4792991|NCT02661867|Childbirth|childbirth
4792992|NCT02661867|Pelvic organ prolapse|pelvic organ prolapse
4792993|NCT02661867|Urinary incontinence|urinary incontinence
4792994|NCT02661867|Fecal incontinence|fecal incontinence
4792995|NCT02661854|Rhinitis / Rhinoconjunctivitis|rhinitis / rhinoconjunctivitis
4792996|NCT02661854|Vaccine|vaccine
4792997|NCT02661854|Immunotherapy|immunotherapy
4792998|NCT02661854|Mite|mite
4792999|NCT02661854|Allergy|allergy
4793000|NCT02661828|Tapering Antidepressant Regimen|tapering antidepressant regimen
4793001|NCT02661828|Antidepressant Discontinuation Syndrome|antidepressant discontinuation syndrome
4793002|NCT02661789|Mental health|mental health
4793003|NCT02661789|Brain Imaging|brain imaging
4793004|NCT02661789|Steroid hormones|steroid hormones
4793005|NCT02661789|Serotonin|serotonin
4793006|NCT02661789|PET|pet
4793007|NCT02661789|MRI|mri
4793008|NCT02661789|fMRI|fmri
4793009|NCT02661789|human|human
4793010|NCT02661789|gender|gender
4793011|NCT02661789|risk model|risk model
4793012|NCT02661776|natural killer cell|natural killer cell
4793013|NCT02661776|head and neck cancer|head and neck cancer
4793014|NCT02661776|opioid|opioid
4793015|NCT02661763|Rheumatic heart disease|rheumatic heart disease
4793016|NCT02661750|Cleansing the colon|cleansing the colon
4793017|NCT02661711|Macular Oedema Retinitis Pigmentosa|macular oedema retinitis pigmentosa
4793018|NCT02661685|Cancer immunotherapy|cancer immunotherapy
4793019|NCT02661685|IFN-γ-producing killer dendritic cell-like cells|ifn-γ-producing killer dendritic cell-like cells
4793020|NCT02661685|Natural killer cells|natural killer cells
4793021|NCT02661672|Intracranial hemorrhage|intracranial hemorrhage
4793022|NCT02661672|Neurosurgery|neurosurgery
4793023|NCT02661659|mesothelioma|mesothelioma
4793024|NCT02661659|multipeptide vaccine|multipeptide vaccine
4793025|NCT02661659|S-588210|s-588210
4793026|NCT02661646|Chronic Swelling|chronic swelling
4793027|NCT02661646|Leg Lymphedema|leg lymphedema
4793028|NCT02661646|Primary Lymphedema|primary lymphedema
4793029|NCT02661646|Secondary Lymphedema|secondary lymphedema
4793030|NCT02661620|REDAPT Femoral System modular stem implant|redapt femoral system modular stem implant
4793031|NCT02661620|Total Hip arthroplasty revision|total hip arthroplasty revision
4793032|NCT02661594|TQT|tqt
4793033|NCT02661594|amisulpride|amisulpride
4793034|NCT02661594|volunteer|volunteer
4793035|NCT02661594|ECG|ecg
4793036|NCT02661581|Diabetes|diabetes
4793037|NCT02661581|Peer Leader Support|peer leader support
4793038|NCT02661529|Shunt|shunt
4793039|NCT02661529|Echocardiogram|echocardiogram
4793040|NCT02661490|Norovirus|norovirus
4793041|NCT02661464|Healthy|healthy
4793042|NCT02661464|Ebola viruses|ebola viruses
4793043|NCT02661464|Ebola virus disease (EVD)|ebola virus disease (evd)
4793044|NCT02661464|Filoviruses|filoviruses
4793045|NCT02661464|Safety|safety
4793046|NCT02661464|Human adenovirus serotype 26 (Ad26) expressing the Ebola virus Mayinga variant glycoprotein (Ad26.ZEBOV)|human adenovirus serotype 26 (ad26) expressing the ebola virus mayinga variant glycoprotein (ad26.zebov)
4793047|NCT02661464|Modified Vaccinia Virus Ankara ‐ Bavarian Nordic Filo‐vector (MVA‐BN Filo)|modified vaccinia virus ankara ‐ bavarian nordic filo‐vector (mva‐bn filo)
4793048|NCT02661464|Hemorrhagic fever|hemorrhagic fever
4793049|NCT02661451|Valve|valve
4793050|NCT02661438|Usability Test|usability test
4793051|NCT02661425|IBS-D|ibs-d
4793052|NCT02661425|IBS|ibs
4793053|NCT02661412|immediate loading|immediate loading
4793054|NCT02661412|biological stability|biological stability
4793055|NCT02661412|mechanical stability|mechanical stability
4793056|NCT02661412|long-term|long-term
4793057|NCT02661412|marginal bone level|marginal bone level
4793058|NCT02661412|maxilla|maxilla
4793059|NCT02661412|immediate placement|immediate placement
4793060|NCT02661412|dental implant|dental implant
4793061|NCT02661412|fibre-reinforced provisional fixed prosthesis|fibre-reinforced provisional fixed prosthesis
4793062|NCT02661399|CIPN|cipn
4793063|NCT02661373|Antimalarial|antimalarial
4793064|NCT02661373|First-in-Human|first-in-human
4793065|NCT02661373|Pharmacokinetic|pharmacokinetic
4793066|NCT02661360|swaddling|swaddling
4793067|NCT02661347|First Episode|first episode
4793068|NCT02661347|Schizophreniform|schizophreniform
4793069|NCT02661347|Schizoaffective Disorder|schizoaffective disorder
4793070|NCT02661347|Psychosis|psychosis
4793071|NCT02661347|Schizophrenia|schizophrenia
4793072|NCT02661347|tDCS|tdcs
4793073|NCT02661347|Risperidone|risperidone
4793074|NCT02661347|Anti-psychotic medication|anti-psychotic medication
4793075|NCT02661334|creatine|creatine
4793076|NCT02661334|creatine monohydrate|creatine monohydrate
4793077|NCT02661334|supplement|supplement
4793078|NCT02661334|exercise|exercise
4793079|NCT02661334|fitness|fitness
4793080|NCT02661282|Glioblastoma|glioblastoma
4793081|NCT02661282|Gliosarcoma|gliosarcoma
4793082|NCT02661282|Brain tumor|brain tumor
4793083|NCT02661282|Cytomegalovirus stimulated adoptive T cells|cytomegalovirus stimulated adoptive t cells
4793084|NCT02661282|CMV|cmv
4793085|NCT02661282|Temozolomide|temozolomide
4793086|NCT02661282|Temodar|temodar
4793087|NCT02661282|TMZ|tmz
4793088|NCT02661282|Phone call|phone call
4793089|NCT02661282|T cell infusion|t cell infusion
4793090|NCT02661282|Surgery|surgery
4793091|NCT02661256|pharyngeal swallow|pharyngeal swallow
4793092|NCT02661256|airway compromise|airway compromise
4793093|NCT02661256|NICU|nicu
4793094|NCT02661243|Sjogren's Syndrome|sjogren's syndrome
4793095|NCT02661243|Dental Implants|dental implants
4793096|NCT02661230|exergaming|exergaming
4793097|NCT02661230|intensive care unit|intensive care unit
4793098|NCT02661230|feasibility acceptability|feasibility acceptability
4793099|NCT02661230|heart|heart
4793100|NCT02661230|brain function|brain function
4793101|NCT02661217|Acute decompensated heart failure|acute decompensated heart failure
4793102|NCT02661217|Reduced ejection fraction|reduced ejection fraction
4793103|NCT02661217|Pre-discharge treatment|pre-discharge treatment
4793104|NCT02661217|Post-discharge treatment|post-discharge treatment
4793105|NCT02661217|Angiotensin receptor neprilysine inhibitor|angiotensin receptor neprilysine inhibitor
4793106|NCT02661217|HFrEF|hfref
4793107|NCT02661191|asthma|asthma
4793108|NCT02661191|vitamin D|vitamin d
4793109|NCT02661191|exacerbations|exacerbations
4793110|NCT02661191|airway obstruction|airway obstruction
4793111|NCT02661178|Parasitic Diseases|parasitic diseases
4793112|NCT02661178|Helminthiasis|helminthiasis
4793113|NCT02661178|Nematode Infections|nematode infections
4793114|NCT02661178|Secernentea Infections|secernentea infections
4793115|NCT02661178|Spirurida Infections|spirurida infections
4793116|NCT02661178|Filariasis|filariasis
4793117|NCT02661178|Skin Diseases, Parasitic|skin diseases, parasitic
4793118|NCT02661178|Skin and Connective Tissue Diseases|skin and connective tissue diseases
4793119|NCT02661178|Skin Diseases|skin diseases
4793120|NCT02661178|Skin Diseases, Infectious|skin diseases, infectious
4793121|NCT02661178|Depsipeptides|depsipeptides
4793122|NCT02661178|Emodepside|emodepside
4793123|NCT02661178|Neglected disease|neglected disease
4793124|NCT02661178|Africa|africa
4793125|NCT02661178|New drug|new drug
4793126|NCT02661178|Oral drug|oral drug
4793127|NCT02661178|Parasite|parasite
4793128|NCT02661178|Anthelmintic drug|anthelmintic drug
4793129|NCT02661178|Cyclooctadepsipeptide|cyclooctadepsipeptide
4793130|NCT02661178|Single ascending dose|single ascending dose
4793131|NCT02661178|Volunteers|volunteers
4793132|NCT02661178|Phase 1|phase 1
4793133|NCT02661178|Safety|safety
4793134|NCT02661178|Tolerability|tolerability
4793135|NCT02661178|Pharmacokinetics|pharmacokinetics
4793136|NCT02661178|Relative bioavailability|relative bioavailability
4793137|NCT02661178|Onchocerciasis|onchocerciasis
4793138|NCT02661139|bisphosphonates and/or targeted therapy by monoclonal antibodies|bisphosphonates and/or targeted therapy by monoclonal antibodies
4793139|NCT02661139|jaw reconstruction|jaw reconstruction
4793140|NCT02661139|prosthetic rehabilitation|prosthetic rehabilitation
4793141|NCT02661139|quality of life|quality of life
4793142|NCT02661113|Brain|brain
4793143|NCT02661113|CNS Disease|cns disease
4793144|NCT02661113|CNS|cns
4793145|NCT02661113|Intracranial Supratentorial GBM|intracranial supratentorial gbm
4793146|NCT02661113|Gliosarcoma|gliosarcoma
4793147|NCT02661113|GS|gs
4793148|NCT02661113|Glioblastoma|glioblastoma
4793149|NCT02661113|GBM|gbm
4793150|NCT02661113|Dasatinib|dasatinib
4793151|NCT02661113|Sprycel|sprycel
4793152|NCT02661113|Temozolomide|temozolomide
4793153|NCT02661113|TMZ|tmz
4793154|NCT02661113|Temodar|temodar
4793155|NCT02661113|Radiation Therapy|radiation therapy
4793156|NCT02661113|Radiotherapy|radiotherapy
4793157|NCT02661113|RT|rt
4793158|NCT02661100|Vaccine|vaccine
4793159|NCT02661100|NY-ESO-1|ny-eso-1
4793160|NCT02661100|DEC-205|dec-205
4793161|NCT02661100|Poly-ICLC|poly-iclc
4793162|NCT02661100|Pembrolizumab|pembrolizumab
4793163|NCT02661100|Cancer|cancer
4793164|NCT02661087|submucosal myoma|submucosal myoma
4793165|NCT02661087|hysteroscopic resection|hysteroscopic resection
4793166|NCT02661087|bipolar energy|bipolar energy
4793167|NCT02661087|monopolar energy|monopolar energy
4793168|NCT02661074|Fisherman|fisherman
4793169|NCT02661074|Fish industry|fish industry
4793170|NCT02661061|ketamine|ketamine
4793171|NCT02661061|glutamate|glutamate
4793172|NCT02661061|relapse prevention|relapse prevention
4793173|NCT02661035|AML|aml
4793174|NCT02661035|ALL|all
4793175|NCT02661035|CML|cml
4793176|NCT02661035|MDS|mds
4793177|NCT02661035|CLL|cll
4793178|NCT02661035|SLL|sll
4793179|NCT02661035|NHL|nhl
4793180|NCT02661009|NSCLC|nsclc
4793181|NCT02661009|EGFR|egfr
4793182|NCT02661009|EGFR-TKI|egfr-tki
4793183|NCT02661009|PCR|pcr
4793184|NCT02660970|Iberogast|iberogast
4793185|NCT02660970|Acupressure|acupressure
4793186|NCT02660970|gut-brain-axis|gut-brain-axis
4793187|NCT02660957|Smoking cessation|smoking cessation
4793188|NCT02660931|Pediatrics|pediatrics
4793189|NCT02660905|HIV-HCV co-infected|hiv-hcv co-infected
4793190|NCT02660905|HCV|hcv
4793191|NCT02660905|HIV|hiv
4793192|NCT02660905|Hep C|hep c
4793193|NCT02660905|Hepatitis C|hepatitis c
4793194|NCT02660905|HCV positive|hcv positive
4793195|NCT02660892|IAAO|iaao
4793196|NCT02660892|Threonine|threonine
4793197|NCT02660892|Children|children
4793198|NCT02660879|Education|education
4793199|NCT02660879|Inhaler|inhaler
4793200|NCT02660866|intermittent claudication|intermittent claudication
4793201|NCT02660866|randomized controlled trial|randomized controlled trial
4793202|NCT02660853|Exacerbations|exacerbations
4793203|NCT02660814|Chemerin|chemerin
4793204|NCT02660814|Interleukin-6|interleukin-6
4793205|NCT02660814|Gingival crevicular fluid|gingival crevicular fluid
4793206|NCT02660801|spinal manipulation|spinal manipulation
4793207|NCT02660801|spinal mobilization|spinal mobilization
4793208|NCT02660801|spinal stiffness|spinal stiffness
4793209|NCT02660788|6-24 months overdue|6-24 months overdue
4793210|NCT02660788|screening mammography|screening mammography
4793211|NCT02660775|schizophrenia|schizophrenia
4793212|NCT02660736|Albiglutide|albiglutide
4793213|NCT02660736|Randomized|randomized
4793214|NCT02660736|Pharmacokinetics|pharmacokinetics
4793215|NCT02660736|GSK716155|gsk716155
4793216|NCT02660736|Bioequivalence study|bioequivalence study
4793217|NCT02660723|M01.774.500|m01.774.500
4793218|NCT02660723|Volunteers|volunteers
4793219|NCT02660710|single arm phase 2|single arm phase 2
4793220|NCT02660710|safety and efficacy|safety and efficacy
4793221|NCT02660710|R-CHOP|r-chop
4793222|NCT02660697|socket preservation, implant site development|socket preservation, implant site development
4793223|NCT02660684|Prograf|prograf
4793224|NCT02660684|Graft versus host disease|graft versus host disease
4793225|NCT02660684|Hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
4793226|NCT02660684|Prophylaxis|prophylaxis
4793227|NCT02660684|Peripheral hematopoietic stem cell transplantation|peripheral hematopoietic stem cell transplantation
4793228|NCT02660645|Cysview|cysview
4793229|NCT02660645|Hexaminolevulinate|hexaminolevulinate
4793230|NCT02660645|Hexvix|hexvix
4793231|NCT02660645|NMIBC|nmibc
4793232|NCT02660645|BLCC|blcc
4793233|NCT02660645|Blue Light Cystoscopy with Cysview|blue light cystoscopy with cysview
4793234|NCT02660645|Cystoscopy|cystoscopy
4793235|NCT02660645|TURBT|turbt
4793236|NCT02660645|TUR|tur
4793237|NCT02660645|Fluorescent cystoscopy|fluorescent cystoscopy
4793238|NCT02660645|Non-muscle invasive bladder cancer (NMIBC)|non-muscle invasive bladder cancer (nmibc)
4793239|NCT02660645|Transurethral resection (TUR)|transurethral resection (tur)
4793240|NCT02660593|Diabetes Mellitus|diabetes mellitus
4793241|NCT02660593|Chinese medicine|chinese medicine
4793242|NCT02660593|exercise|exercise
4793243|NCT02660593|diet|diet
4793244|NCT02660580|Adalimumab|adalimumab
4793245|NCT02660580|MSB11022|msb11022
4793246|NCT02660580|Psoriasis|psoriasis
4793247|NCT02660580|Phase III|phase iii
4793248|NCT02660567|postpartum hemorrhage|postpartum hemorrhage
4793249|NCT02660567|PPH|pph
4793250|NCT02660567|atonic|atonic
4793251|NCT02660567|new maneuver|new maneuver
4793252|NCT02660554|Pneumonia|pneumonia
4793253|NCT02660554|Methicillin-Resistant Staphylococcus aureus|methicillin-resistant staphylococcus aureus
4793254|NCT02660554|Polymerase Chain Reaction|polymerase chain reaction
4793255|NCT02660554|Intensive care units|intensive care units
4793256|NCT02660554|Drug Resistance|drug resistance
4793257|NCT02660541|Dressing for burn wounds|dressing for burn wounds
4793258|NCT02660515|complete articular distal radius fracture|complete articular distal radius fracture
4793259|NCT02660515|wrist arthroscopy|wrist arthroscopy
4793260|NCT02660489|CRTH2 antagonist|crth2 antagonist
4793261|NCT02660489|Prostaglandin D2 receptor|prostaglandin d2 receptor
4793262|NCT02660489|Anti-Asthmatic Agents|anti-asthmatic agents
4793263|NCT02660489|OC459|oc459
4793264|NCT02660489|Allergic asthma|allergic asthma
4793265|NCT02660489|Eosinophilia|eosinophilia
4793266|NCT02660476|Diet|diet
4793267|NCT02660476|Middle East and North Africa country|middle east and north africa country
4793268|NCT02660476|Health|health
4793269|NCT02660476|Complication|complication
4793270|NCT02660476|Cardiovascular disease|cardiovascular disease
4793271|NCT02660476|Obesity|obesity
4793272|NCT02660476|Stress|stress
4793273|NCT02660476|Obstructive Sleep Apnoea (OSA)|obstructive sleep apnoea (osa)
4793274|NCT02660463|incidence|incidence
4793275|NCT02660463|risk factors|risk factors
4793276|NCT02660437|COPD|copd
4793277|NCT02660437|Carbon dioxide partial pressure (pCO2)|carbon dioxide partial pressure (pco2)
4793278|NCT02660437|Cerebral blood flow (CBF)|cerebral blood flow (cbf)
4793279|NCT02660437|Cognitive dysfunction|cognitive dysfunction
4793280|NCT02660437|Mild/Moderate Cognitive Impairment (MCI)|mild/moderate cognitive impairment (mci)
4793281|NCT02660437|Pulmonary Rehabilitation (PR)|pulmonary rehabilitation (pr)
4793282|NCT02660437|Standardized Mini Mental State Examination (SMMSE)|standardized mini mental state examination (smmse)
4793283|NCT02660437|Addenbrooke's Cognitive Examination (ACE-R)|addenbrooke's cognitive examination (ace-r)
4793284|NCT02660437|Montreal Cognitive Assessment (MoCA)|montreal cognitive assessment (moca)
4793285|NCT02660437|Telephone Interview for Cognitive Status (TICS)|telephone interview for cognitive status (tics)
4793286|NCT02660437|Stroop test (Reaction Time)|stroop test (reaction time)
4793287|NCT02660411|Sevoflurane|sevoflurane
4793288|NCT02660411|Propofol|propofol
4793289|NCT02660411|Aged|aged
4793290|NCT02660411|Neoplasm|neoplasm
4793291|NCT02660411|Surgical Procedure, Operative|surgical procedure, operative
4793292|NCT02660411|Long-term survival|long-term survival
4793293|NCT02660385|pain|pain
4793294|NCT02660385|insomnia|insomnia
4793295|NCT02660385|cardiac failure|cardiac failure
4793296|NCT02660385|sleep|sleep
4793297|NCT02660385|fatigue|fatigue
4793298|NCT02660385|heart disease|heart disease
4793299|NCT02660385|anxiety|anxiety
4793300|NCT02660385|actigraphy|actigraphy
4793301|NCT02660385|psychomotor vigilance|psychomotor vigilance
4793302|NCT02660385|six minute walk|six minute walk
4793303|NCT02660385|depression|depression
4793304|NCT02660385|cognitive behavioral therapy|cognitive behavioral therapy
4793305|NCT02660385|self-management|self-management
4793306|NCT02660385|self-care|self-care
4793307|NCT02660346|IL-10|il-10
4793308|NCT02660346|MRSA|mrsa
4793309|NCT02660346|Bacteremia|bacteremia
4793310|NCT02660333|Obesity|obesity
4793311|NCT02660333|Inflammation|inflammation
4793312|NCT02660333|Nutritional status|nutritional status
4793313|NCT02660333|Prebiotic|prebiotic
4793314|NCT02660333|Synbiotic|synbiotic
4793315|NCT02660307|stress|stress
4793316|NCT02660307|work|work
4793317|NCT02660307|employees|employees
4793318|NCT02660307|mindfulness|mindfulness
4793319|NCT02660307|depression|depression
4793320|NCT02660307|anxiety|anxiety
4793321|NCT02660268|Clinical pathway|clinical pathway
4793322|NCT02660268|Infection|infection
4793323|NCT02660268|Hip|hip
4793324|NCT02660268|Prosthesis|prosthesis
4793325|NCT02660255|CBD|cbd
4793326|NCT02660255|Epidiolex|epidiolex
4793327|NCT02660255|Myoclonic|myoclonic
4793328|NCT02660255|Brain Disease|brain disease
4793329|NCT02660255|Central Nervous System Disease|central nervous system disease
4793330|NCT02660255|GWP42003|gwp42003
4793331|NCT02660242|T1D|t1d
4793332|NCT02660242|Type 1 Diabetes|type 1 diabetes
4793929|NCT02657200|Flanders|flanders
4793333|NCT02660242|Mini-dose Glucagon|mini-dose glucagon
4793334|NCT02660242|Adults|adults
4793335|NCT02660242|Exercise|exercise
4793336|NCT02660242|Hypoglycemia|hypoglycemia
4793337|NCT02660229|Intravenous injection in cancer pain|intravenous injection in cancer pain
4793338|NCT02660216|minimally invasive|minimally invasive
4793339|NCT02660216|le fort I osteotomy|le fort i osteotomy
4793340|NCT02660216|3D virtual treatment planning|3d virtual treatment planning
4793341|NCT02660216|accuracy|accuracy
4793342|NCT02660203|chest physiotherapy|chest physiotherapy
4793343|NCT02660203|post operative period|post operative period
4793344|NCT02660203|forced expiration|forced expiration
4793345|NCT02660203|pleural drainage duration|pleural drainage duration
4793346|NCT02660164|Concussion|concussion
4793347|NCT02660125|ICSI|icsi
4793348|NCT02660125|endometrial injury|endometrial injury
4793349|NCT02660125|implantation rate|implantation rate
4793350|NCT02660086|Weight|weight
4793351|NCT02660086|Prevention|prevention
4793352|NCT02660086|Food choice|food choice
4793353|NCT02660086|Nutrition|nutrition
4793354|NCT02660086|Behavior change|behavior change
4793355|NCT02660086|Behavioral economics|behavioral economics
4793356|NCT02660086|Feedback|feedback
4793357|NCT02660086|Incentives|incentives
4793358|NCT02660060|Pramipexole|pramipexole
4793359|NCT02660060|Bioequivalence|bioequivalence
4793360|NCT02660060|Pharmacokinetics|pharmacokinetics
4793361|NCT02660047|South Asian descent|south asian descent
4793362|NCT02660034|Dose Escalation|dose escalation
4793363|NCT02660034|Dose Expansion|dose expansion
4793364|NCT02660034|BGB-A317|bgb-a317
4793365|NCT02660034|BGB-290|bgb-290
4793366|NCT02660021|three-dimensional virtual treatment planning|three-dimensional virtual treatment planning
4793367|NCT02660021|orthognathic surgery|orthognathic surgery
4793368|NCT02659995|glycemic variability|glycemic variability
4793369|NCT02659995|infection|infection
4793370|NCT02659956|Multiple Sclerosis|multiple sclerosis
4793371|NCT02659956|Longitudinal Prospective Follow-Up|longitudinal prospective follow-up
4793372|NCT02659943|Gene Therapy|gene therapy
4793373|NCT02659943|Adoptive T Cell Therapy|adoptive t cell therapy
4793374|NCT02659943|Allogeneic Stem Cell Transplantation|allogeneic stem cell transplantation
4793375|NCT02659943|T-cell infusion|t-cell infusion
4793376|NCT02659943|Residual Malignancy|residual malignancy
4793377|NCT02659930|HIV|hiv
4793378|NCT02659930|AIDS|aids
4793379|NCT02659930|Multicentric Castleman Disease|multicentric castleman disease
4793380|NCT02659917|glass-ionomer cement|glass-ionomer cement
4793381|NCT02659917|atraumatic restorative treatment|atraumatic restorative treatment
4793382|NCT02659917|pit and fissure sealants|pit and fissure sealants
4793383|NCT02659904|Free gingival graft|free gingival graft
4793384|NCT02659904|Palatal donor site healing|palatal donor site healing
4793385|NCT02659878|Takotsubo cardiomyopathy;NT-proBNP;urine metanephrine|takotsubo cardiomyopathy;nt-probnp;urine metanephrine
4793386|NCT02659852|Hilar malignant biliary obstruction|hilar malignant biliary obstruction
4793387|NCT02659852|bilateral metal stent|bilateral metal stent
4793388|NCT02659852|stent in stent|stent in stent
4793389|NCT02659852|side by side|side by side
4793390|NCT02659839|Cancer|cancer
4793391|NCT02659839|Intensive care unit|intensive care unit
4793392|NCT02659839|Mortality|mortality
4793393|NCT02659826|Transcutaneous spinal direct current stimulation|transcutaneous spinal direct current stimulation
4793394|NCT02659826|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
4793395|NCT02659826|Gait Training|gait training
4793396|NCT02659826|Central Nervous System Excitability|central nervous system excitability
4793397|NCT02659826|Healthy|healthy
4793398|NCT02659813|Orthodontic wires|orthodontic wires
4793399|NCT02659774|Smoking cessation interventions|smoking cessation interventions
4793400|NCT02659761|Human Immunodeficiency Virus|human immunodeficiency virus
4793401|NCT02659761|Injection drug use|injection drug use
4793402|NCT02659761|Single-tablet antiretroviral treatment|single-tablet antiretroviral treatment
4793403|NCT02659761|Dolutegravir|dolutegravir
4793404|NCT02659761|Tolerability|tolerability
4793405|NCT02659761|Adherence|adherence
4793406|NCT02659761|Efficacy|efficacy
4793407|NCT02659748|Bioactive fatty acids|bioactive fatty acids
4793408|NCT02659748|Insulin sensitivity|insulin sensitivity
4793409|NCT02659748|Diet|diet
4793410|NCT02659748|Milk fat|milk fat
4793411|NCT02659748|Lipid metabolism|lipid metabolism
4793412|NCT02659748|Inflammation markers|inflammation markers
4793413|NCT02659748|Fecal microbiota composition|fecal microbiota composition
4793414|NCT02659735|Influenza A virus|influenza a virus
4793415|NCT02659735|JNJ-63623872|jnj-63623872
4793416|NCT02659735|Healthy|healthy
4793417|NCT02659722|INTERVERTEBRAL DISC DEGENERATION|intervertebral disc degeneration
4793418|NCT02659722|Bone Disease|bone disease
4793419|NCT02659722|Musculoskeletal disease|musculoskeletal disease
4793420|NCT02659722|Spinal disease|spinal disease
4793421|NCT02659709|Glaucoma|glaucoma
4793422|NCT02659709|Smartphone|smartphone
4793423|NCT02659709|Tablet|tablet
4793424|NCT02659709|Application|application
4793425|NCT02659631|P-cadherin|p-cadherin
4793426|NCT02659631|PF-06671008|pf-06671008
4793427|NCT02659631|solid tumors|solid tumors
4793428|NCT02659631|lung cancer|lung cancer
4793429|NCT02659631|breast cancer|breast cancer
4793430|NCT02659631|colorectal cancer|colorectal cancer
4793431|NCT02659631|NSCLC|nsclc
4793432|NCT02659631|TNBC|tnbc
4793433|NCT02659631|CRC|crc
4793434|NCT02659631|neoplasms|neoplasms
4793435|NCT02659631|Triple negative breast cancer|triple negative breast cancer
4793436|NCT02659631|Non-small cell lung cancer|non-small cell lung cancer
4793437|NCT02659618|Asthma|asthma
4793438|NCT02659605|pre-term birth|pre-term birth
4793439|NCT02659605|delayed cord clamping|delayed cord clamping
4793440|NCT02659605|skin to skin|skin to skin
4793441|NCT02659592|fertility preservation|fertility preservation
4793442|NCT02659592|ovarian tissue transplantation|ovarian tissue transplantation
4793443|NCT02659592|ovarian endocrine function|ovarian endocrine function
4793444|NCT02659592|assisted reproductive technology|assisted reproductive technology
4793445|NCT02659592|pregnancy and live birth|pregnancy and live birth
4793446|NCT02659579|Shared Book Reading|shared book reading
4793447|NCT02659579|Vocabulary|vocabulary
4793448|NCT02659579|Language Development|language development
4793449|NCT02659579|Young Children|young children
4793450|NCT02659579|Randomised Control Trial|randomised control trial
4793451|NCT02659566|Markers|markers
4793452|NCT02659566|Parasitemia|parasitemia
4793453|NCT02659566|Coartem|coartem
4793454|NCT02659566|Plasmodium|plasmodium
4793455|NCT02659566|Infection|infection
4793456|NCT02659553|Liver Transplantation - Steatosis - Fatty Liver|liver transplantation - steatosis - fatty liver
4793457|NCT02659540|Ipilimumab|ipilimumab
4793458|NCT02659540|Nivolumab|nivolumab
4793459|NCT02659540|Radiotherapy|radiotherapy
4793460|NCT02659514|Poziotinib|poziotinib
4793461|NCT02659514|Metastatic Breast Cancer|metastatic breast cancer
4793462|NCT02659514|HER2-positive|her2-positive
4793463|NCT02659514|Pan-HER inhibitor|pan-her inhibitor
4793464|NCT02659501|Breast reconstruction|breast reconstruction
4793465|NCT02659501|Bupivacaine|bupivacaine
4793466|NCT02659501|Liposomal bupivacaine|liposomal bupivacaine
4793467|NCT02659501|Postoperative analgesia|postoperative analgesia
4793468|NCT02659462|Repaired Congenital Heart Disease|repaired congenital heart disease
4793469|NCT02659462|Cardio Pulmonary Exercise Testing|cardio pulmonary exercise testing
4793470|NCT02659462|Fontan|fontan
4793471|NCT02659462|Fontan Palliation|fontan palliation
4793472|NCT02659462|functional capacity|functional capacity
4793473|NCT02659449|hands|hands
4793474|NCT02659436|Cognitive Behavioural Therapy|cognitive behavioural therapy
4793475|NCT02659423|Bystanding behaviors|bystanding behaviors
4793476|NCT02659423|Campus|campus
4793477|NCT02659423|Prevention|prevention
4793478|NCT02659423|Sexual Assault|sexual assault
4793479|NCT02659423|CampusSave|campussave
4793480|NCT02659410|Physiologically based pharmacokinetic modeling|physiologically based pharmacokinetic modeling
4793481|NCT02659410|Organic solvents|organic solvents
4793482|NCT02659397|LDL-cholesterol|ldl-cholesterol
4793483|NCT02659397|Hypercholesterolemia|hypercholesterolemia
4793484|NCT02659397|ETC-1002|etc-1002
4793485|NCT02659397|Adenosine triphosphate citrate lyase|adenosine triphosphate citrate lyase
4793486|NCT02659397|Atorvastatin|atorvastatin
4793487|NCT02659358|Advanced solid malignancy|advanced solid malignancy
4793488|NCT02659358|Activity monitor|activity monitor
4793489|NCT02659358|Biosensor|biosensor
4793490|NCT02659358|Fitbit|fitbit
4793491|NCT02659358|Patient Reported Outcomes (PRO)|patient reported outcomes (pro)
4793492|NCT02659358|Stage 3/4 cancer|stage 3/4 cancer
4793493|NCT02659358|Performance Status|performance status
4793494|NCT02659358|Eastern Cooperative Oncology Group Performance Status (ECOG-PS)|eastern cooperative oncology group performance status (ecog-ps)
4793495|NCT02659345|Art Therapy|art therapy
4793496|NCT02659345|Chemotherapy|chemotherapy
4793497|NCT02659319|Child overweight|child overweight
4793498|NCT02659319|Child obesity|child obesity
4793499|NCT02659319|Family dynamics|family dynamics
4793500|NCT02659319|Peer relationships|peer relationships
4793501|NCT02659319|Family intervention|family intervention
4793502|NCT02659319|School intervention|school intervention
4793503|NCT02659319|Parenting|parenting
4793504|NCT02659293|Multiple myeloma|multiple myeloma
4793505|NCT02659293|stem-cell transplant|stem-cell transplant
4793506|NCT02659293|Symptomatic myeloma|symptomatic myeloma
4793507|NCT02659293|lenalidomide|lenalidomide
4793508|NCT02659293|carfilzomib|carfilzomib
4793509|NCT02659293|dexamethasone|dexamethasone
4793510|NCT02659280|telerehabilitation|telerehabilitation
4793511|NCT02659267|Health Promotion|health promotion
4793512|NCT02659267|Physical Activity|physical activity
4793513|NCT02659267|Eating habits|eating habits
4793514|NCT02659267|Health System|health system
4793515|NCT02659267|Users from Health Academy Program|users from health academy program
4793516|NCT02659254|Drug-Eluting Stents,Absorbable Implants,Stents|drug-eluting stents,absorbable implants,stents
4793517|NCT02659241|Molecular results|molecular results
4793518|NCT02659241|DNA|dna
4793519|NCT02659241|RNA|rna
4793520|NCT02659241|Protein expression|protein expression
4793521|NCT02659241|AZD1775|azd1775
4793522|NCT02659215|Hyaluronic Acid|hyaluronic acid
4793523|NCT02659215|Cartilage Repair|cartilage repair
4793524|NCT02659215|Knee|knee
4793525|NCT02659202|Exercise|exercise
4793526|NCT02659202|Heart Failure|heart failure
4793527|NCT02659202|Blood Pressure|blood pressure
4793528|NCT02659163|cardiometabolic risk|cardiometabolic risk
4793529|NCT02659163|obesity|obesity
4793530|NCT02659163|mHealth|mhealth
4793531|NCT02659163|health behaviors|health behaviors
4793532|NCT02659150|tocilizumab|tocilizumab
4793533|NCT02659150|subcutaneous injection|subcutaneous injection
4793534|NCT02659150|rheumatoid arthritis|rheumatoid arthritis
4793535|NCT02659150|plaque inflammation|plaque inflammation
4793536|NCT02659150|atherosclerotic plaque|atherosclerotic plaque
4793537|NCT02659150|joint inflammation|joint inflammation
4793538|NCT02659150|FDG-PET|fdg-pet
4793539|NCT02659150|PET-MR|pet-mr
4793540|NCT02659150|ACTEMRA|actemra
4793541|NCT02659137|LBBB|lbbb
4793542|NCT02659137|TAVI|tavi
4793543|NCT02659124|facial laser|facial laser
4793544|NCT02659124|fraction ablative resurfacing|fraction ablative resurfacing
4793545|NCT02659124|total ablative resurfacing|total ablative resurfacing
4793546|NCT02659124|EpiFix|epifix
4793547|NCT02659124|rhytides|rhytides
4793548|NCT02659124|wrinkles|wrinkles
4793549|NCT02659124|AmnioFix|amniofix
4793550|NCT02659111|Exercise Therapy|exercise therapy
4793551|NCT02659098|Best Corrected Visual Acuity|best corrected visual acuity
4793552|NCT02659098|Geographic Atrophy|geographic atrophy
4793553|NCT02659098|Macular Degeneration|macular degeneration
4793554|NCT02659098|CNTO 2476|cnto 2476
4793555|NCT02659085|Depressive Disorder, Major|depressive disorder, major
4793556|NCT02659085|Antidepressive Agents/adverse effects|antidepressive agents/adverse effects
4793557|NCT02659085|Depressive Disorder, Major/drug therapy|depressive disorder, major/drug therapy
4793558|NCT02659085|Infusions, Intravenous|infusions, intravenous
4793559|NCT02659085|Ketamine/administration & dosage*|ketamine/administration & dosage*
4793560|NCT02659085|Ketamine/adverse effects|ketamine/adverse effects
4793561|NCT02659085|Treatment Outcome|treatment outcome
4793562|NCT02659085|Electroconvulsive therapy|electroconvulsive therapy
4793563|NCT02659046|Traumatic Brain Injury|traumatic brain injury
4793564|NCT02659033|microbiota|microbiota
4793565|NCT02659033|resistant bacteria|resistant bacteria
4793566|NCT02659007|yoga|yoga
4793567|NCT02659007|balance|balance
4793568|NCT02658968|Radioimmunotherapy|radioimmunotherapy
4793569|NCT02658968|Lu-177|lu-177
4793570|NCT02658968|Phase I study|phase i study
4793571|NCT02658968|Betalutin|betalutin
4793572|NCT02658968|ARC|arc
4793573|NCT02658968|Antibody Radionuclide Conjugate|antibody radionuclide conjugate
4793574|NCT02658968|HH1|hh1
4793575|NCT02658968|Rituximab|rituximab
4793576|NCT02658968|177Lu-DOTA-HH1|177lu-dota-hh1
4793577|NCT02658968|Lilotomab|lilotomab
4793578|NCT02658968|Lutetium (177Lu)-lilotomab satetraxetan|lutetium (177lu)-lilotomab satetraxetan
4793579|NCT02658968|Additional relevant MeSH terms:|additional relevant mesh terms:
4793580|NCT02658968|Lymphoma|lymphoma
4793581|NCT02658968|Lymphoma, Non-Hodgkin|lymphoma, non-hodgkin
4793582|NCT02658968|Immune System Diseases|immune system diseases
4793583|NCT02658968|Immunoproliferative Disorders|immunoproliferative disorders
4793584|NCT02658968|Diffuse Large B-Cell Lymphoma|diffuse large b-cell lymphoma
4793585|NCT02658968|Lymphatic Diseases|lymphatic diseases
4793586|NCT02658968|Lymphoproliferative Disorders|lymphoproliferative disorders
4793587|NCT02658968|Neoplasms|neoplasms
4793588|NCT02658968|Neoplasms by Histologic Type|neoplasms by histologic type
4793589|NCT02658968|DLBCL|dlbcl
4793590|NCT02658968|Refractory DLBCL|refractory dlbcl
4793591|NCT02658968|Relapsed DLBCL|relapsed dlbcl
4793592|NCT02658955|Abdominal wall closure|abdominal wall closure
4793593|NCT02658942|renal stones|renal stones
4793594|NCT02658942|lower calyx|lower calyx
4793595|NCT02658942|Ureteroscopy|ureteroscopy
4793596|NCT02658942|Shockwave lithotripsy|shockwave lithotripsy
4793597|NCT02658942|Holmium laser|holmium laser
4793598|NCT02658942|Adult|adult
4793599|NCT02658942|Kidney|kidney
4793600|NCT02658929|Multiple Myeloma|multiple myeloma
4793601|NCT02658929|Efficacy and Safety|efficacy and safety
4793602|NCT02658929|bb2121|bb2121
4793603|NCT02658929|CAR T Cell|car t cell
4793604|NCT02658929|BCMA|bcma
4793605|NCT02658903|Foley|foley
4793606|NCT02658903|Infection|infection
4793607|NCT02658903|Hospital acquired|hospital acquired
4793608|NCT02658903|catheter associated|catheter associated
4793609|NCT02658903|urinary|urinary
4793610|NCT02658877|Xolair|xolair
4793611|NCT02658877|corticosteroids|corticosteroids
4793612|NCT02658877|asthma|asthma
4793613|NCT02658877|long-acting beta-agonists|long-acting beta-agonists
4793614|NCT02658864|lafutidine tablet|lafutidine tablet
4793615|NCT02658864|pharmacokinetics|pharmacokinetics
4793616|NCT02658864|food|food
4793617|NCT02658864|safety|safety
4793618|NCT02658864|healthy subjects|healthy subjects
4793619|NCT02658851|lymphocele|lymphocele
4793620|NCT02658851|pelvic lymph node dissection|pelvic lymph node dissection
4793621|NCT02658851|robotic assisted radical prostatectomy|robotic assisted radical prostatectomy
4793622|NCT02658851|PLND|plnd
4793623|NCT02658851|RARP|rarp
4793624|NCT02658851|prostatectomy|prostatectomy
4793625|NCT02658851|Patel|patel
4793626|NCT02658825|Healthy|healthy
4793627|NCT02658825|JNJ-63623872|jnj-63623872
4793628|NCT02658825|Moxifloxacin|moxifloxacin
4793629|NCT02658812|Breast Cancer|breast cancer
4793630|NCT02658812|Inflammatory breast cancer|inflammatory breast cancer
4793631|NCT02658812|IBC|ibc
4793632|NCT02658812|Non-inflammatory breast cancer|non-inflammatory breast cancer
4793633|NCT02658812|Inoperable local recurrence|inoperable local recurrence
4793634|NCT02658812|Talimogene laherparepvec|talimogene laherparepvec
4793635|NCT02658812|T-VEC|t-vec
4793636|NCT02658812|OncoVEX GM-CSF|oncovex gm-csf
4793637|NCT02658799|periodontitis|periodontitis
4793638|NCT02658799|anti-inflammatory agents|anti-inflammatory agents
4793639|NCT02658760|Femoral Fractures|femoral fractures
4793640|NCT02658721|Systemic Tramadol|systemic tramadol
4793641|NCT02658721|Adjunct Tramadol|adjunct tramadol
4793642|NCT02658721|Lidocain|lidocain
4793643|NCT02658695|ICSI|icsi
4793644|NCT02658695|embryo transfer|embryo transfer
4793645|NCT02658695|air bubbles depth|air bubbles depth
4793646|NCT02658669|Insomnia|insomnia
4793647|NCT02658669|Injury, Brain, Traumatic Mild|injury, brain, traumatic mild
4793648|NCT02658656|Exoskeleton|exoskeleton
4793649|NCT02658643|biliodigestive anastomosis techniques|biliodigestive anastomosis techniques
4793650|NCT02658630|arm rehabilitation|arm rehabilitation
4793651|NCT02658630|recovery of function|recovery of function
4793652|NCT02658617|Empathy|empathy
4793653|NCT02658617|Interoceptive Awareness|interoceptive awareness
4793654|NCT02658617|fMRI|fmri
4793655|NCT02658617|MRS|mrs
4793656|NCT02658591|Food intake|food intake
4793657|NCT02658591|Satiety|satiety
4793658|NCT02658591|Appetite|appetite
4793659|NCT02658591|Glycemia|glycemia
4793660|NCT02658591|Faba bean|faba bean
4793661|NCT02658591|Protein|protein
4793662|NCT02658591|Snack|snack
4793663|NCT02658565|Intraoperative Consultation|intraoperative consultation
4793664|NCT02658552|HIFU|hifu
4793665|NCT02658552|Benign thyroid nodule|benign thyroid nodule
4793666|NCT02658552|Low risk|low risk
4793667|NCT02658552|New treatment|new treatment
4793668|NCT02658539|Body fat distribution|body fat distribution
4793669|NCT02658539|Bone mineral density|bone mineral density
4793670|NCT02658539|Dual-energy x-ray absorptiometry|dual-energy x-ray absorptiometry
4793671|NCT02658526|cognition|cognition
4793672|NCT02658526|anesthesia|anesthesia
4793673|NCT02658526|surgery|surgery
4793674|NCT02658526|stress|stress
4793675|NCT02658526|child|child
4793676|NCT02658500|early infant feeding|early infant feeding
4793677|NCT02658500|infant intestinal flora|infant intestinal flora
4793678|NCT02658500|infant health|infant health
4793679|NCT02658474|Chronic pain|chronic pain
4793680|NCT02658474|Acceptance and Commitment Therapy|acceptance and commitment therapy
4793681|NCT02658474|Multidisciplinary treatment|multidisciplinary treatment
4793682|NCT02658474|Group treatment|group treatment
4793683|NCT02658435|Malaria|malaria
4793684|NCT02658435|Retinal|retinal
4793685|NCT02658435|Ophthalmic|ophthalmic
4793686|NCT02658435|Plasmodium. vivax|plasmodium. vivax
4793687|NCT02658435|Tafenoquine|tafenoquine
4793688|NCT02658435|Pharmacodynamic|pharmacodynamic
4793689|NCT02658409|CCIV|cciv
4793690|NCT02658409|quadrivalent cell-culture based influenza vaccine|quadrivalent cell-culture based influenza vaccine
4793691|NCT02658409|Influenza vaccine|influenza vaccine
4793692|NCT02658409|Vaccination|vaccination
4793693|NCT02658396|Multiple Myeloma|multiple myeloma
4793694|NCT02658396|Relapsed Multiple Myeloma|relapsed multiple myeloma
4793695|NCT02658396|Refractory Multiple Myeloma|refractory multiple myeloma
4793696|NCT02658370|physical exercises|physical exercises
4793697|NCT02658370|physical therapy|physical therapy
4793698|NCT02658370|Wii game console|wii game console
4793699|NCT02658370|patients perspective|patients perspective
4793700|NCT02658344|Stem cell|stem cell
4793701|NCT02658344|adipose tissue derived mesenchymal stem cell|adipose tissue derived mesenchymal stem cell
4793702|NCT02658344|osteoarthritis|osteoarthritis
4793703|NCT02658344|degenerative arthritis|degenerative arthritis
4793704|NCT02658344|biostar|biostar
4793705|NCT02658344|Rbio|rbio
4793706|NCT02658331|Ebola Virus Disease|ebola virus disease
4793707|NCT02658331|Rapid Diagnosis|rapid diagnosis
4793708|NCT02658331|Point of care|point of care
4793709|NCT02658331|Molecular platform|molecular platform
4793710|NCT02658318|peri- and postoperative complications|peri- and postoperative complications
4793711|NCT02658318|airway obstruction|airway obstruction
4793712|NCT02658318|adapted Furlow palatoplasty|adapted furlow palatoplasty
4793713|NCT02658305|transoral approach|transoral approach
4793714|NCT02658305|transbuccal approach|transbuccal approach
4793715|NCT02658305|postoperative complications|postoperative complications
4793716|NCT02658292|fungus|fungus
4793717|NCT02658292|antifungal|antifungal
4793718|NCT02658292|skin infection|skin infection
4793719|NCT02658292|hair infection|hair infection
4793720|NCT02658292|dermatophyte|dermatophyte
4793721|NCT02658292|scalp|scalp
4793722|NCT02658292|skin|skin
4793723|NCT02658292|eyebrows|eyebrows
4793724|NCT02658292|eyelashes|eyelashes
4793725|NCT02658292|hair|hair
4793726|NCT02658292|Trichophyton|trichophyton
4793727|NCT02658292|Microsporum|microsporum
4793728|NCT02658292|Endothrix|endothrix
4793729|NCT02658292|spores|spores
4793730|NCT02658279|Pembrolizumab (MK-3475)|pembrolizumab (mk-3475)
4793731|NCT02658279|15-227|15-227
4793732|NCT02658279|Hypermutator Phenotype|hypermutator phenotype
4793733|NCT02658266|resistance training|resistance training
4793734|NCT02658266|adult|adult
4793735|NCT02658266|muscle strength|muscle strength
4793736|NCT02658266|muscle endurance|muscle endurance
4793737|NCT02658266|muscle metabolism|muscle metabolism
4793738|NCT02658253|Placental malaria vaccine|placental malaria vaccine
4793739|NCT02658253|Plasmodium|plasmodium
4793740|NCT02658253|PRIMALVAC|primalvac
4793741|NCT02658240|Nerve block|nerve block
4793742|NCT02658240|Periarticular infiltration|periarticular infiltration
4793743|NCT02658240|Ropivacaine|ropivacaine
4793744|NCT02658240|Pain|pain
4793745|NCT02658214|durvalumab, tremelimumab, metastatic, solid tumors, immuno-oncology, first-line chemotherapy, esophageal, pancreatic|durvalumab, tremelimumab, metastatic, solid tumors, immuno-oncology, first-line chemotherapy, esophageal, pancreatic
4793746|NCT02658188|Restless legs syndrome patients|restless legs syndrome patients
4793747|NCT02658188|ASP8825|asp8825
4793748|NCT02658188|XP13512|xp13512
4793749|NCT02658110|Postprandial glycemia|postprandial glycemia
4793750|NCT02658110|Metabolic health measures|metabolic health measures
4793751|NCT02658097|Lung Cancer|lung cancer
4793752|NCT02658097|pembrolizumab|pembrolizumab
4793753|NCT02658097|focal radiation|focal radiation
4793754|NCT02658097|RT|rt
4793755|NCT02658084|HER2-Positive|her2-positive
4793756|NCT02658084|Metastatic Breast Cancer|metastatic breast cancer
4793757|NCT02658071|exfoliative glaucoma|exfoliative glaucoma
4793758|NCT02658071|cataract|cataract
4793759|NCT02658071|ocular pressure|ocular pressure
4793760|NCT02658058|Ultrasound|ultrasound
4793761|NCT02658058|Spinal anesthesia|spinal anesthesia
4793762|NCT02658058|Elderly|elderly
4793763|NCT02658058|Landmark|landmark
4793764|NCT02658045|oxygen saturation|oxygen saturation
4793765|NCT02658045|monitoring|monitoring
4793766|NCT02658045|oximeter|oximeter
4793767|NCT02658019|Hepatocellular Carcinoma|hepatocellular carcinoma
4793768|NCT02658019|Advanced Hepatocellular Carcinoma|advanced hepatocellular carcinoma
4793769|NCT02658019|Unresectable Hepatocellular Carcinoma|unresectable hepatocellular carcinoma
4793770|NCT02658006|Near Infrared Spectroscopy|near infrared spectroscopy
4793771|NCT02658006|Ultrasonography|ultrasonography
4793772|NCT02658006|Hepatic vein Doppler|hepatic vein doppler
4793773|NCT02658006|Portal vein Doppler|portal vein doppler
4793774|NCT02658006|Lung ultrasound|lung ultrasound
4793775|NCT02658006|Positive fluid balance|positive fluid balance
4793776|NCT02658006|Mixed venous saturation|mixed venous saturation
4793777|NCT02657993|Breast Neoplasms|breast neoplasms
4793778|NCT02657993|Aromatase Inhibitors|aromatase inhibitors
4793779|NCT02657993|Musculoskeletal Pain|musculoskeletal pain
4793780|NCT02657993|Hypnosis|hypnosis
4793781|NCT02657993|Medication Adherence|medication adherence
4793782|NCT02657993|Cost-Benefit Analysis|cost-benefit analysis
4793783|NCT02657993|Treatment Outcomes|treatment outcomes
4793784|NCT02657980|Major Depressive Disorder|major depressive disorder
4793785|NCT02657980|tDCS|tdcs
4793786|NCT02657980|MDD|mdd
4793787|NCT02657980|transcranial Direct Current Stimulation|transcranial direct current stimulation
4793788|NCT02657954|Homeless persons|homeless persons
4793789|NCT02657954|Veterans|veterans
4793790|NCT02657954|Mental disorders|mental disorders
4793791|NCT02657954|Cognition|cognition
4793792|NCT02657954|Rehabilitation|rehabilitation
4793793|NCT02657941|Schizophrenia|schizophrenia
4793794|NCT02657941|Obesity|obesity
4793795|NCT02657941|Metabolic Syndrome|metabolic syndrome
4793796|NCT02657915|FF-VEP|ff-vep
4793797|NCT02657915|mfVEP|mfvep
4793798|NCT02657915|Human anti-LINGO-1|human anti-lingo-1
4793799|NCT02657915|BIIB033|biib033
4793800|NCT02657915|AON|aon
4793801|NCT02657889|PARP inhibitor|parp inhibitor
4793802|NCT02657889|PD-1|pd-1
4793803|NCT02657889|Niraparib|niraparib
4793804|NCT02657889|Pembrolizumab|pembrolizumab
4793805|NCT02657889|Keynote|keynote
4793806|NCT02657889|TOPACIO|topacio
4793807|NCT02657837|CF|cf
4793808|NCT02657837|Multiple Breath Washout|multiple breath washout
4793809|NCT02657837|Lung Clearance Index|lung clearance index
4793810|NCT02657837|Pediatrics|pediatrics
4793811|NCT02657824|Ejection fraction|ejection fraction
4793812|NCT02657824|mitral valve|mitral valve
4793813|NCT02657824|e-point septal separation|e-point septal separation
4793814|NCT02657811|Time-Lapse Imaging|time-lapse imaging
4793815|NCT02657811|Embryo Culture Techniques|embryo culture techniques
4793816|NCT02657811|Fertilization in Vitro|fertilization in vitro
4793817|NCT02657811|Embryology|embryology
4793818|NCT02657811|Assisted Reproductive Techniques|assisted reproductive techniques
4793819|NCT02657811|Infertility|infertility
4793820|NCT02657811|Preimplantation diagnosis|preimplantation diagnosis
4793821|NCT02657772|Target Ultra coils|target ultra coils
4793822|NCT02657772|small aneurysms|small aneurysms
4793823|NCT02657746|blood pressure monitoring|blood pressure monitoring
4793824|NCT02657746|high blood pressure|high blood pressure
4793825|NCT02657746|cardiovascular disease|cardiovascular disease
4793826|NCT02657746|Antihypertensive agents|antihypertensive agents
4793827|NCT02657746|Non-pharmacological treatment|non-pharmacological treatment
4793828|NCT02657746|community health care workers|community health care workers
4793829|NCT02657746|cost-effectiveness|cost-effectiveness
4793830|NCT02657733|Respiratory Conditions for Adults|respiratory conditions for adults
4793831|NCT02657720|Respiratory Conditions for Adults|respiratory conditions for adults
4793832|NCT02657707|stent|stent
4793833|NCT02657707|stenosis|stenosis
4793834|NCT02657707|artery|artery
4793835|NCT02657707|carotid|carotid
4793836|NCT02657668|Irritable Bowel Syndrome|irritable bowel syndrome
4793837|NCT02657668|Emotion Focused Therapy|emotion focused therapy
4793838|NCT02657668|Stress|stress
4793839|NCT02657668|Resilience|resilience
4793840|NCT02657668|Coping Strategies|coping strategies
4793841|NCT02657655|Parkinson's Disease|parkinson's disease
4793842|NCT02657655|Dyskinesia|dyskinesia
4793843|NCT02657655|Tremor|tremor
4793844|NCT02657655|Symptom Management|symptom management
4793845|NCT02657655|Technology|technology
4793846|NCT02657655|Wearable Sensors|wearable sensors
4793847|NCT02657655|Continuous Monitoring|continuous monitoring
4793848|NCT02657655|Mobility|mobility
4793849|NCT02657642|drug related problems, elderly|drug related problems, elderly
4793850|NCT02657603|Peripheral Nerve Blocks|peripheral nerve blocks
4793851|NCT02657577|Women|women
4793852|NCT02657577|Infants and Children|infants and children
4793853|NCT02657551|Thyroid Cancer|thyroid cancer
4793854|NCT02657538|Interproximal caries|interproximal caries
4793855|NCT02657538|Enamel caries|enamel caries
4793856|NCT02657538|Caries detection|caries detection
4793857|NCT02657538|Caries diagnostics|caries diagnostics
4793858|NCT02657538|Near-infrared light transillumination|near-infrared light transillumination
4793859|NCT02657538|DIAGNOcam|diagnocam
4793860|NCT02657512|Rivaroxaban, pharmacokinetics, activated charcoal, poisoning|rivaroxaban, pharmacokinetics, activated charcoal, poisoning
4793861|NCT02657499|healthcare access|healthcare access
4793862|NCT02657499|utilization|utilization
4793863|NCT02657499|expenditures|expenditures
4793864|NCT02657499|preventive services|preventive services
4793865|NCT02657486|BGJ398|bgj398
4793866|NCT02657486|15-090|15-090
4793867|NCT02657460|chemotherapy|chemotherapy
4793868|NCT02657460|microparticle|microparticle
4793869|NCT02657460|malignant pleural effusion|malignant pleural effusion
4793870|NCT02657447|Radioimmunotherapy|radioimmunotherapy
4793871|NCT02657447|Lu-177|lu-177
4793872|NCT02657447|Phase I study|phase i study
4793873|NCT02657447|Betalutin|betalutin
4793874|NCT02657447|ARC|arc
4793875|NCT02657447|Antibody Radionuclide Conjugate|antibody radionuclide conjugate
4793876|NCT02657447|HH1|hh1
4793877|NCT02657447|Rituximab|rituximab
4793878|NCT02657447|177Lu-DOTA-HH1|177lu-dota-hh1
4793879|NCT02657447|Lymphoma|lymphoma
4793880|NCT02657447|Lymphoma Non-Hodgkin|lymphoma non-hodgkin
4793881|NCT02657447|Immune System Diseases|immune system diseases
4793882|NCT02657447|Follicular Lymphoma|follicular lymphoma
4793883|NCT02657447|Marginal Zone Lymphoma|marginal zone lymphoma
4793884|NCT02657447|Lymphoplasmacytoid|lymphoplasmacytoid
4793885|NCT02657447|Lymphatic Diseases|lymphatic diseases
4793886|NCT02657447|Lymphoproliferative Disorders|lymphoproliferative disorders
4793887|NCT02657447|Neoplasms|neoplasms
4793888|NCT02657447|Neoplasms by Histological Type|neoplasms by histological type
4793889|NCT02657447|Small Lymphocytic Lymphoma|small lymphocytic lymphoma
4793890|NCT02657447|Classical Mantle Cell Lymphoma|classical mantle cell lymphoma
4793891|NCT02657447|Lilotomab|lilotomab
4793892|NCT02657447|Lutetium (177Lu) lilotomab satetraxetan|lutetium (177lu) lilotomab satetraxetan
4793893|NCT02657382|Biofeedback|biofeedback
4793894|NCT02657382|Myocardial Imaging|myocardial imaging
4793895|NCT02657369|Lenvatinib|lenvatinib
4793896|NCT02657369|Thyroid Cancer, Anaplastic|thyroid cancer, anaplastic
4793897|NCT02657369|Lenvima|lenvima
4793898|NCT02657369|E7080|e7080
4793899|NCT02657356|Pulmonary Hypertension|pulmonary hypertension
4793900|NCT02657356|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
4793901|NCT02657356|Connective Tissue Disease-Associated Pulmonary Arterial Hypertension|connective tissue disease-associated pulmonary arterial hypertension
4793902|NCT02657356|Bardoxolone methyl|bardoxolone methyl
4793903|NCT02657356|PAH|pah
4793904|NCT02657356|RTA 402|rta 402
4793905|NCT02657356|6-minute walk distance|6-minute walk distance
4793906|NCT02657343|Breast Cancer With Positive HER2|breast cancer with positive her2
4793907|NCT02657330|Locally Advanced|locally advanced
4793908|NCT02657330|Metastatic|metastatic
4793909|NCT02657317|chronic pain|chronic pain
4793910|NCT02657317|pain management|pain management
4793911|NCT02657317|trauma|trauma
4793912|NCT02657317|ptsd|ptsd
4793913|NCT02657317|tbi|tbi
4793914|NCT02657317|opioid medication|opioid medication
4793915|NCT02657304|Sleep Apnea|sleep apnea
4793916|NCT02657304|CPAP|cpap
4793917|NCT02657278|Peripheral arterial disease,|peripheral arterial disease,
4793918|NCT02657278|Cardipulmonary Exercise Test|cardipulmonary exercise test
4793919|NCT02657252|telangiectasis|telangiectasis
4793920|NCT02657252|varicose veins|varicose veins
4793921|NCT02657252|veins|veins
4793922|NCT02657252|glucose|glucose
4793923|NCT02657252|sclerotherapy|sclerotherapy
4793924|NCT02657239|Physical Function|physical function
4793925|NCT02657213|Diabetes, Type 1|diabetes, type 1
4793926|NCT02657213|Hypoglycemia|hypoglycemia
4793927|NCT02657213|Insulin Infusion Systems|insulin infusion systems
4793928|NCT02657200|miscarriage|miscarriage
4793930|NCT02657200|spontaneous abortion|spontaneous abortion
4793931|NCT02657200|KAP|kap
4793932|NCT02657200|midwives|midwives
4793933|NCT02657174|third molar|third molar
4793934|NCT02657174|auriculotherapy|auriculotherapy
4793935|NCT02657174|inflammation|inflammation
4793936|NCT02657174|pain|pain
4793937|NCT02657122|Single ascending dose|single ascending dose
4793938|NCT02657122|SAD|sad
4793939|NCT02657122|multiple ascending dose|multiple ascending dose
4793940|NCT02657122|MAD|mad
4793941|NCT02657122|Phase 1|phase 1
4793942|NCT02657122|first-in-human|first-in-human
4793943|NCT02657122|volunteers|volunteers
4793944|NCT02657122|TD-1473|td-1473
4793945|NCT02657109|valve replacement|valve replacement
4793946|NCT02657109|physical therapy|physical therapy
4793947|NCT02657109|early mobilization|early mobilization
4793948|NCT02657096|Chronic Periodontitis|chronic periodontitis
4793949|NCT02657096|Hybenx|hybenx
4793950|NCT02657096|Desiccant agent|desiccant agent
4793951|NCT02657096|Healing|healing
4793952|NCT02657096|Microbiology|microbiology
4793953|NCT02657096|Periodontal Diseases|periodontal diseases
4793954|NCT02657096|Periodontitis|periodontitis
4793955|NCT02657096|Split-mouth clinical Study|split-mouth clinical study
4793956|NCT02657070|Stroke|stroke
4793957|NCT02657070|learned non-use|learned non-use
4793958|NCT02657070|Virtual Reality|virtual reality
4793959|NCT02657070|Hemiparesis|hemiparesis
4793960|NCT02657057|neuromodulation|neuromodulation
4793961|NCT02657057|electrical estimulation|electrical estimulation
4793962|NCT02657057|percutaneous|percutaneous
4793963|NCT02657057|transcutaneous|transcutaneous
4793964|NCT02657057|OAB|oab
4793965|NCT02657044|EMR|emr
4793966|NCT02657044|ESD|esd
4793967|NCT02657044|endoscopic mucosal resection|endoscopic mucosal resection
4793968|NCT02657044|endoscopic submucosal resection|endoscopic submucosal resection
4793969|NCT02657044|colorectal adenomas|colorectal adenomas
4793970|NCT02657031|Headache, Migraine|headache, migraine
4793971|NCT02656992|Bronchiectasis|bronchiectasis
4793972|NCT02656992|High-intensity inspiratory muscle training|high-intensity inspiratory muscle training
4793973|NCT02656979|Glaucoma|glaucoma
4793974|NCT02656979|Blood flow|blood flow
4793975|NCT02656979|Pseudoexfoliation|pseudoexfoliation
4793976|NCT02656979|Intraocular pressure|intraocular pressure
4793977|NCT02656979|Brain perfusion|brain perfusion
4793978|NCT02656979|Magnetic Resonance Imaging|magnetic resonance imaging
4793979|NCT02656953|VDU workers|vdu workers
4793980|NCT02656953|VDU lenses|vdu lenses
4793981|NCT02656953|Neck complaints|neck complaints
4793982|NCT02656953|Visual complaints|visual complaints
4793983|NCT02656940|obesity|obesity
4793984|NCT02656940|lipids|lipids
4793985|NCT02656940|energy expenditure|energy expenditure
4793986|NCT02656940|gene expression|gene expression
4793987|NCT02656927|Spinal Cord Injury|spinal cord injury
4793988|NCT02656927|Yoga|yoga
4793989|NCT02656927|Psychological Flexibility|psychological flexibility
4793990|NCT02656927|Mindfulness|mindfulness
4793991|NCT02656927|Pain|pain
4793992|NCT02656849|Solid Tumor|solid tumor
4793993|NCT02656823|ANKYLOS|ankylos
4793994|NCT02656823|Simplant|simplant
4793995|NCT02656823|maxilla|maxilla
4793996|NCT02656823|edentulous|edentulous
4793997|NCT02656823|short implants|short implants
4793998|NCT02656797|Leishmania major|leishmania major
4793999|NCT02656797|Leishmania tropica|leishmania tropica
4794000|NCT02656797|Amphotericin B|amphotericin b
4794001|NCT02656771|THA|tha
4794002|NCT02656771|Hip|hip
4794003|NCT02656771|arthroplasties|arthroplasties
4794004|NCT02656745|Smoking|smoking
4794005|NCT02656745|Cigarette Smoking|cigarette smoking
4794006|NCT02656745|Tobacco Smoking|tobacco smoking
4794007|NCT02656745|Nicotine|nicotine
4794008|NCT02656745|Drug|drug
4794009|NCT02656745|Addiction|addiction
4794010|NCT02656745|Tobacco|tobacco
4794011|NCT02656719|tracheostomy|tracheostomy
4794012|NCT02656719|complications|complications
4794013|NCT02656719|ultrasound|ultrasound
4794014|NCT02656719|bronchoscopy|bronchoscopy
4794015|NCT02656706|Adjuvant melanoma|adjuvant melanoma
4794016|NCT02656706|Advanced melanoma|advanced melanoma
4794017|NCT02656693|Weight Reduction Programs|weight reduction programs
4794018|NCT02656693|Weight Loss Programs|weight loss programs
4794019|NCT02656693|Obesity|obesity
4794020|NCT02656667|COPD pulmonary rehabilitation|copd pulmonary rehabilitation
4794021|NCT02656667|neuromuscular electrical stimulation|neuromuscular electrical stimulation
4794022|NCT02656667|sit to stand test COPD|sit to stand test copd
4794023|NCT02656667|quadriceps strengthening|quadriceps strengthening
4794024|NCT02656602|Computer Assisted Instruction|computer assisted instruction
4794025|NCT02656602|Patient Counselling|patient counselling
4794026|NCT02656602|Endoscopy|endoscopy
4794027|NCT02656589|breast cancer|breast cancer
4794028|NCT02656589|herceptin|herceptin
4794029|NCT02656589|microRNA|microrna
4794030|NCT02656576|Human Papillomavirus|human papillomavirus
4794031|NCT02656576|oropharynx biopsy|oropharynx biopsy
4794032|NCT02656576|tonsillar lesion|tonsillar lesion
4794033|NCT02656550|Uterine Transplant|uterine transplant
4794034|NCT02656550|AUI|aui
4794035|NCT02656550|Rokitansky Syndrome|rokitansky syndrome
4794036|NCT02656524|Metastatic colorectal cancer|metastatic colorectal cancer
4794037|NCT02656511|immediate antiretroviral therapy|immediate antiretroviral therapy
4794038|NCT02656511|hyperacute infection|hyperacute infection
4794039|NCT02656498|Tau, neurodegeneration, positron emission computed tomography|tau, neurodegeneration, positron emission computed tomography
4794040|NCT02656472|Pediatric Cardiac surgery|pediatric cardiac surgery
4794041|NCT02656472|Inflammatory response|inflammatory response
4794042|NCT02656472|Tranexamic acid|tranexamic acid
4794043|NCT02656472|Epsilon Aminocaproic Acid|epsilon aminocaproic acid
4794044|NCT02656459|gene expression|gene expression
4794045|NCT02656446|Neuraxial|neuraxial
4794046|NCT02656446|Ultrasound|ultrasound
4794047|NCT02656433|QEEG|qeeg
4794048|NCT02656433|ERP|erp
4794049|NCT02656433|tRNS|trns
4794050|NCT02656433|Brain injury|brain injury
4794051|NCT02656433|Motor Impairment|motor impairment
4794052|NCT02656433|Transcranial Brain non-invasive stimulation|transcranial brain non-invasive stimulation
4794053|NCT02656433|electroencephalogram|electroencephalogram
4794054|NCT02656407|Functional Ultrasound|functional ultrasound
4794055|NCT02656407|Intraoperative|intraoperative
4794056|NCT02656407|Brain|brain
4794057|NCT02656407|Doppler|doppler
4794058|NCT02656407|Ultrasound|ultrasound
4794059|NCT02656394|ocular surface disease|ocular surface disease
4794060|NCT02656394|glaucoma medications|glaucoma medications
4794061|NCT02656381|Sarcoidosis|sarcoidosis
4794062|NCT02656381|Behcet's Disease|behcet's disease
4794063|NCT02656381|Natural History Study|natural history study
4794064|NCT02656381|Biological Specimens|biological specimens
4794065|NCT02656381|Immune System|immune system
4794066|NCT02656355|Gait Initiation|gait initiation
4794067|NCT02656355|Freezing of gait|freezing of gait
4794068|NCT02656355|Balance training|balance training
4794069|NCT02656355|Anticipatory postural adjustments|anticipatory postural adjustments
4794070|NCT02656342|OCD|ocd
4794071|NCT02656329|Heart Failure (HF)|heart failure (hf)
4794072|NCT02656329|Single photon emission computer tomography scan (SPECT)|single photon emission computer tomography scan (spect)
4794073|NCT02656329|Implantable cardioverter defibrillator (ICD)|implantable cardioverter defibrillator (icd)
4794074|NCT02656329|Left Ventricular ejection fraction (LVEF)|left ventricular ejection fraction (lvef)
4794075|NCT02656329|New York Health Association (NYHA)|new york health association (nyha)
4794076|NCT02656329|Metaiodobenzylguanidine (mIBG)|metaiodobenzylguanidine (mibg)
4794077|NCT02656329|123I-iobenguane|123i-iobenguane
4794078|NCT02656329|Heart-to-mediastinal ratio (H/M)|heart-to-mediastinal ratio (h/m)
4794079|NCT02656329|ADMIRE-ICD (AdreView Myocardial Imaging for Risk Evaluation - Implantable Cardioverter Defibrillator|admire-icd (adreview myocardial imaging for risk evaluation - implantable cardioverter defibrillator
4794080|NCT02656329|All-cause mortality|all-cause mortality
4794081|NCT02656329|Cardiac mortality|cardiac mortality
4794082|NCT02656251|biofilms|biofilms
4794083|NCT02656251|cross over trial|cross over trial
4794084|NCT02656251|chlorhexidine|chlorhexidine
4794085|NCT02656238|CTEPH|cteph
4794086|NCT02656238|Balloon pulmonary angioplasty|balloon pulmonary angioplasty
4794087|NCT02656238|Chronic thromboembolic pulmonary hypertension|chronic thromboembolic pulmonary hypertension
4794088|NCT02656238|Pulmonary endarterectomy|pulmonary endarterectomy
4794089|NCT02656238|BPA|bpa
4794090|NCT02656238|PEA|pea
4794091|NCT02656225|postpartum anemia|postpartum anemia
4794092|NCT02656225|hemoglobin|hemoglobin
4794093|NCT02656225|iron metabolism|iron metabolism
4794094|NCT02656225|Traditional Chinese Medicine|traditional chinese medicine
4794095|NCT02656225|Ejiao|ejiao
4794096|NCT02656212|epicatechin|epicatechin
4794097|NCT02656212|pre-diabetes|pre-diabetes
4794098|NCT02656199|Diaphragm|diaphragm
4794099|NCT02656199|Ventilators, Mechanical|ventilators, mechanical
4794100|NCT02656173|Tamsulosin|tamsulosin
4794101|NCT02656173|Overactive bladder|overactive bladder
4794102|NCT02656173|Benign prostatic hypertrophy|benign prostatic hypertrophy
4794103|NCT02656173|Mirabegron|mirabegron
4794104|NCT02656147|Leukemia|leukemia
4794105|NCT02656147|Lymphoma|lymphoma
4794106|NCT02656147|CAR γδT|car γδt
4794107|NCT02656134|Familial Adenomatous Polyposis|familial adenomatous polyposis
4794108|NCT02656121|PCOS, vitamin D|pcos, vitamin d
4794109|NCT02656082|Discoid lupus erythematosus|discoid lupus erythematosus
4794110|NCT02656082|Intradermal injection of etanercept|intradermal injection of etanercept
4794111|NCT02656017|kidney disease|kidney disease
4794112|NCT02656017|polycystic kidney disease|polycystic kidney disease
4794113|NCT02656017|autosomal dominant kidney disease|autosomal dominant kidney disease
4794114|NCT02656017|kidney cysts|kidney cysts
4794115|NCT02656017|PKD|pkd
4794116|NCT02656004|Eucalyptus|eucalyptus
4794117|NCT02656004|Autonomic nervous system|autonomic nervous system
4794118|NCT02656004|Isometric resistance exercise|isometric resistance exercise
4794119|NCT02655991|Stress Disorders, Post-Traumatic|stress disorders, post-traumatic
4794120|NCT02655991|Ambulatory Care|ambulatory care
4794121|NCT02655991|Telemedicine|telemedicine
4794122|NCT02655991|Remote Consultation|remote consultation
4794123|NCT02655991|Health Services Accessibility|health services accessibility
4794124|NCT02655965|Breast cancer|breast cancer
4794125|NCT02655965|lumpectomy|lumpectomy
4794126|NCT02655965|mastectomy|mastectomy
4794127|NCT02655965|PECS bloc|pecs bloc
4794128|NCT02655939|Gonarthrosis|gonarthrosis
4794129|NCT02655926|OCD|ocd
4794130|NCT02655926|DBS|dbs
4794131|NCT02655926|Deep Brain Stimulation|deep brain stimulation
4794132|NCT02655913|Sodium ascorbate|sodium ascorbate
4794133|NCT02655913|Non-Small-Cell Lung cancer|non-small-cell lung cancer
4794134|NCT02655913|Oncothermia|oncothermia
4794135|NCT02655913|Immune function|immune function
4794136|NCT02655913|Life quality|life quality
4794137|NCT02655913|Tumor marker|tumor marker
4794138|NCT02655913|Survival time|survival time
4794139|NCT02655900|Obstetric anal sphincter injury,|obstetric anal sphincter injury,
4794140|NCT02655900|Ultrasound diagnosis|ultrasound diagnosis
4794141|NCT02655874|Seasonal Influenza|seasonal influenza
4794142|NCT02655874|Antibody response|antibody response
4794143|NCT02655874|Influenza Vaccines|influenza vaccines
4794144|NCT02655874|Hemagglutination Inhibition|hemagglutination inhibition
4794145|NCT02655874|Elderly|elderly
4794146|NCT02655874|immunosenescence|immunosenescence
4794147|NCT02655874|Tropics|tropics
4794148|NCT02655848|Popeye|popeye
4794149|NCT02655848|Long Head Biceps Tendon|long head biceps tendon
4794150|NCT02655848|Arthroscopy|arthroscopy
4794151|NCT02655848|Functional result|functional result
4794152|NCT02655835|mindfulness|mindfulness
4794153|NCT02655835|meditation|meditation
4794154|NCT02655835|internet|internet
4794155|NCT02655822|NSCLC|nsclc
4794156|NCT02655822|MEL|mel
4794157|NCT02655822|RCC|rcc
4794158|NCT02655822|TNBC|tnbc
4794159|NCT02655822|Triple Negative Breast Neoplasms|triple negative breast neoplasms
4794160|NCT02655822|Neoplasms|neoplasms
4794161|NCT02655822|CRC|crc
4794162|NCT02655822|Lung Cancer|lung cancer
4794163|NCT02655822|Kidney Cancer|kidney cancer
4794164|NCT02655822|Colon Cancer|colon cancer
4794165|NCT02655822|Rectal Cancer|rectal cancer
4794166|NCT02655822|Skin Cancer|skin cancer
4794167|NCT02655822|Breast Cancer|breast cancer
4794168|NCT02655822|mCRPC|mcrpc
4794169|NCT02655822|Prostate Cancer|prostate cancer
4794170|NCT02655796|Accidental Falls|accidental falls
4794171|NCT02655796|Risk Assessment|risk assessment
4794172|NCT02655796|Frail Elderly|frail elderly
4794173|NCT02655783|induction of labor|induction of labor
4794174|NCT02655744|Neurobehavioral Assessment|neurobehavioral assessment
4794175|NCT02655744|Radiotherapy (RT)|radiotherapy (rt)
4794176|NCT02655744|Chemotherapy|chemotherapy
4794177|NCT02655744|Neurotoxicity|neurotoxicity
4794178|NCT02655718|ACS|acs
4794179|NCT02655718|Non obstructive coronary atherosclerosis|non obstructive coronary atherosclerosis
4794180|NCT02655705|Cyclosporine|cyclosporine
4794181|NCT02655705|Methotrexate|methotrexate
4794182|NCT02655692|PTSD|ptsd
4794183|NCT02655692|Ketamine|ketamine
4794184|NCT02655692|Veteran|veteran
4794185|NCT02655692|Military|military
4794186|NCT02655692|Clinical Trial|clinical trial
4794187|NCT02655679|eczema|eczema
4794188|NCT02655640|illness perceptions|illness perceptions
4794189|NCT02655627|Type 2 DM|type 2 dm
4794190|NCT02655627|internet based exercise training|internet based exercise training
4794191|NCT02655627|group exercise training|group exercise training
4794192|NCT02655627|glycemic control|glycemic control
4794193|NCT02655575|dizziness|dizziness
4794194|NCT02655575|cognitive therapy|cognitive therapy
4794195|NCT02655575|primary care|primary care
4794196|NCT02655575|vestibular rehabilitation|vestibular rehabilitation
4794197|NCT02655575|chronic|chronic
4794198|NCT02655484|COPD|copd
4794199|NCT02655484|noninvasive ventilation|noninvasive ventilation
4794200|NCT02655484|exercise|exercise
4794201|NCT02655484|CO2 rebreathing|co2 rebreathing
4794202|NCT02655458|Multiple Myeloma|multiple myeloma
4794203|NCT02655458|Induction Therapy|induction therapy
4794204|NCT02655458|Autologous Stem Cell Transplant|autologous stem cell transplant
4794205|NCT02655458|ASCT|asct
4794206|NCT02655458|Auto-SCT|auto-sct
4794207|NCT02655419|cIAIs in hospitalized adults|ciais in hospitalized adults
4794208|NCT02655406|Foam sclerotherapy|foam sclerotherapy
4794209|NCT02655406|Compression|compression
4794210|NCT02655367|MRI|mri
4794211|NCT02655367|oats|oats
4794212|NCT02655367|porridge|porridge
4794213|NCT02655367|satiety|satiety
4794214|NCT02655367|GI hormones|gi hormones
4794215|NCT02655367|processing|processing
4794216|NCT02655341|Dehydration|dehydration
4794217|NCT02655341|Primary PCI|primary pci
4794218|NCT02655341|Acute Myocardial Infarction|acute myocardial infarction
4794219|NCT02655341|Bioimpedance|bioimpedance
4794220|NCT02655341|Renal Angiography|renal angiography
4794221|NCT02655328|asthma|asthma
4794222|NCT02655328|athlete|athlete
4794223|NCT02655315|Parkinson|parkinson
4794224|NCT02655315|Deferiprone|deferiprone
4794225|NCT02655315|Chelation|chelation
4794226|NCT02655302|Interleukin-17|interleukin-17
4794227|NCT02655302|Interleukin-22|interleukin-22
4794228|NCT02655302|Microbiota|microbiota
4794229|NCT02655302|Exacerbations|exacerbations
4794230|NCT02655302|Immunity|immunity
4794231|NCT02655302|Mucosal|mucosal
4794232|NCT02655276|microencapsulated glycine|microencapsulated glycine
4794233|NCT02655276|attentional performance|attentional performance
4794234|NCT02655276|motoric activity|motoric activity
4794235|NCT02655276|hyperactivity|hyperactivity
4794236|NCT02655198|refractory childhood epilepsy|refractory childhood epilepsy
4794237|NCT02655198|Lennox Gastaut syndrome|lennox gastaut syndrome
4794238|NCT02655198|fenfluramine|fenfluramine
4794239|NCT02655198|anti-epileptic treatment|anti-epileptic treatment
4794240|NCT02655185|Lipids|lipids
4794241|NCT02655185|Atrial Fibrillation|atrial fibrillation
4794242|NCT02655185|Heart Failure|heart failure
4794243|NCT02655172|Schizophrenia, affordance,|schizophrenia, affordance,
4794244|NCT02655172|perception-action binding,|perception-action binding,
4794245|NCT02655172|stimulus-response-compatibility|stimulus-response-compatibility
4794246|NCT02655159|Breast Cancer|breast cancer
4794247|NCT02655159|Metastatic breast cancer|metastatic breast cancer
4794248|NCT02655159|nab-paclitaxel|nab-paclitaxel
4794249|NCT02655159|Abraxane|abraxane
4794250|NCT02655159|Observational|observational
4794251|NCT02655159|Retrospective|retrospective
4794252|NCT02655159|AMBER|amber
4794253|NCT02655146|Frozen embryo transfer,luteal support, GnRHa|frozen embryo transfer,luteal support, gnrha
4794254|NCT02655120|Femoral head necrosis|femoral head necrosis
4794255|NCT02655120|Autologous Bone Marrow|autologous bone marrow
4794256|NCT02655120|BMP7|bmp7
4794257|NCT02655107|blood gas monitoring|blood gas monitoring
4794258|NCT02655107|non-invasive|non-invasive
4794259|NCT02655107|hemoglobin|hemoglobin
4794260|NCT02655094|minimal-invasive surgery, mitral valve|minimal-invasive surgery, mitral valve
4794261|NCT02655081|Urinary diversion|urinary diversion
4794262|NCT02655081|Bladder Neoplasm|bladder neoplasm
4794263|NCT02655081|Nutritional Supplement|nutritional supplement
4794264|NCT02655081|Cystectomy|cystectomy
4794265|NCT02655068|Head and Neck Cancer|head and neck cancer
4794266|NCT02655068|Definitive Therapy|definitive therapy
4794267|NCT02655068|Positron Emission Tomography - Computed Tomography (PET/CT)|positron emission tomography - computed tomography (pet/ct)
4794268|NCT02655068|Computed Tomography (CT)|computed tomography (ct)
4794269|NCT02655055|apheresis|apheresis
4794270|NCT02655055|citrate anticoagulation|citrate anticoagulation
4794271|NCT02655055|blood donor|blood donor
4794272|NCT02655055|bone|bone
4794273|NCT02655016|Ovarian Cancer|ovarian cancer
4794274|NCT02655016|PARP Inhibitor|parp inhibitor
4794275|NCT02655016|HRD|hrd
4794276|NCT02655016|HRD positive|hrd positive
4794277|NCT02655016|PRIMA|prima
4794278|NCT02655016|PRIMA Clinical Trial|prima clinical trial
4794279|NCT02655016|PRIMA Study|prima study
4794280|NCT02655003|behavioral symptoms|behavioral symptoms
4794281|NCT02655003|psychological symptoms|psychological symptoms
4794282|NCT02655003|dementia|dementia
4794283|NCT02655003|neuropsychiatric symptoms|neuropsychiatric symptoms
4794284|NCT02654990|multiple myeloma|multiple myeloma
4794285|NCT02654990|relapsed or relapsed/refractory|relapsed or relapsed/refractory
4794286|NCT02654990|LBH589|lbh589
4794287|NCT02654990|panobinostat|panobinostat
4794288|NCT02654990|bortezomib|bortezomib
4794289|NCT02654990|dexamethasone|dexamethasone
4794290|NCT02654951|Stroke|stroke
4794291|NCT02654951|Rehabilitation Robotics|rehabilitation robotics
4794292|NCT02654951|Bimanual|bimanual
4794293|NCT02654951|Compensatory movements|compensatory movements
4794294|NCT02654951|Hemiplegia|hemiplegia
4794295|NCT02654951|Kinematics|kinematics
4794296|NCT02654951|Reaching|reaching
4794297|NCT02654951|Trunk|trunk
4794298|NCT02654938|prostate cancer|prostate cancer
4794299|NCT02654938|adenovirus|adenovirus
4794300|NCT02654938|TLR5|tlr5
4794301|NCT02654938|immunotherapy|immunotherapy
4794302|NCT02654912|malaria|malaria
4794303|NCT02654912|elimination|elimination
4794304|NCT02654912|surveillance and response|surveillance and response
4794305|NCT02654912|dihydroartemisinin+piperaquine|dihydroartemisinin+piperaquine
4794306|NCT02654899|Healthy subjects|healthy subjects
4794307|NCT02654899|Single Ascending Dose|single ascending dose
4794308|NCT02654899|Hyperlipidemia|hyperlipidemia
4794309|NCT02654899|Dyslipidemia|dyslipidemia
4794310|NCT02654886|exercise|exercise
4794311|NCT02654886|Pompe disease|pompe disease
4794312|NCT02654886|Pompe|pompe
4794313|NCT02654873|histopathology|histopathology
4794314|NCT02654873|gallbladder|gallbladder
4794315|NCT02654873|specimen|specimen
4794316|NCT02654847|vasopressor|vasopressor
4794317|NCT02654847|blood pressure|blood pressure
4794318|NCT02654847|Cesarean section|cesarean section
4794319|NCT02654847|spinal anesthesia|spinal anesthesia
4794320|NCT02654821|Melanoma|melanoma
4794321|NCT02654821|TCR|tcr
4794322|NCT02654808|gynecology|gynecology
4794323|NCT02654808|laparoscopy|laparoscopy
4794324|NCT02654808|pneumoperitoneum|pneumoperitoneum
4794325|NCT02654808|CO2 absorption|co2 absorption
4794326|NCT02654756|Risk Assessment|risk assessment
4794327|NCT02654704|Personalized Medicine|personalized medicine
4794328|NCT02654704|Precision Medicine|precision medicine
4794329|NCT02654691|Chemotherapy|chemotherapy
4794330|NCT02654639|Metastatic Colorectal Cancer|metastatic colorectal cancer
4794331|NCT02654639|Advanced Colorectal Cancer|advanced colorectal cancer
4794332|NCT02654600|cardiac surgery|cardiac surgery
4794333|NCT02654600|thoracopulmonary compliance|thoracopulmonary compliance
4794334|NCT02654587|Non-Small-Cell Lung Cancer|non-small-cell lung cancer
4794335|NCT02654587|NSCLC|nsclc
4794336|NCT02654587|Immunotherapy|immunotherapy
4794337|NCT02654587|Cancer vaccine|cancer vaccine
4794338|NCT02654587|Metastasis|metastasis
4794339|NCT02654574|Alzheimer's disease or related disorders|alzheimer's disease or related disorders
4794340|NCT02654574|Functional autonomy level|functional autonomy level
4794341|NCT02654574|Lawton Instrumental Activities of Daily Living|lawton instrumental activities of daily living
4794342|NCT02654574|The Functional autonomy level|the functional autonomy level
4794343|NCT02654561|Severe sepsis|severe sepsis
4794344|NCT02654561|Disseminated intravascular coagulation|disseminated intravascular coagulation
4794345|NCT02654561|Unfractionated heparin|unfractionated heparin
4794346|NCT02654535|Systematic review and meta-analysis|systematic review and meta-analysis
4794347|NCT02654535|Evidence-based medicine (EBM)|evidence-based medicine (ebm)
4794348|NCT02654535|Evidence-based nutrition (EBN)|evidence-based nutrition (ebn)
4794349|NCT02654535|Clinical practice guidelines|clinical practice guidelines
4794350|NCT02654535|Clinical trials|clinical trials
4794351|NCT02654535|Tree Nuts|tree nuts
4794352|NCT02654535|Peanuts|peanuts
4794353|NCT02654535|Body weight|body weight
4794354|NCT02654535|Prospective cohort studies|prospective cohort studies
4794355|NCT02654496|Gut Microbiota|gut microbiota
4794356|NCT02654496|Weight Regain|weight regain
4794357|NCT02654496|Gastric Bypass|gastric bypass
4794358|NCT02654457|Immunohistochemical|immunohistochemical
4794359|NCT02654457|Ki-67|ki-67
4794360|NCT02654457|Breast cancer|breast cancer
4794361|NCT02654457|IHC|ihc
4794362|NCT02654444|Immunohistochemical (IHC)|immunohistochemical (ihc)
4794363|NCT02654444|Her2/Neu|her2/neu
4794364|NCT02654444|Breast cancer|breast cancer
4794365|NCT02654431|Immunohistochemical (IHC)|immunohistochemical (ihc)
4794366|NCT02654431|ER/PR|er/pr
4794367|NCT02654431|Breast cancer|breast cancer
4794368|NCT02654418|colonic polyps ≥20 mm,|colonic polyps ≥20 mm,
4794369|NCT02654418|adenomas|adenomas
4794370|NCT02654418|polyps|polyps
4794371|NCT02654405|HDAC inhibitors|hdac inhibitors
4794372|NCT02654405|Inflammation|inflammation
4794373|NCT02654392|Omega-3|omega-3
4794374|NCT02654392|Omega-6|omega-6
4794375|NCT02654392|Exercise Performance|exercise performance
4794376|NCT02654366|Syringe exchange|syringe exchange
4794377|NCT02654366|HIV risk reduction|hiv risk reduction
4794378|NCT02654366|Drug-free community support|drug-free community support
4794379|NCT02654353|Persistent atrial fibrillation, catheter ablation, outcome|persistent atrial fibrillation, catheter ablation, outcome
4794380|NCT02654327|Extracorporeal|extracorporeal
4794381|NCT02654327|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
4794382|NCT02654327|Protective Lung Ventilation|protective lung ventilation
4794383|NCT02654327|Ventilator Induced Lung Injury|ventilator induced lung injury
4794384|NCT02654327|Carbon Dioxide Removal|carbon dioxide removal
4794385|NCT02654327|Lung|lung
4794386|NCT02654327|Lung Injury|lung injury
4794387|NCT02654314|prevention; delirium; in-patients; melatonin,|prevention; delirium; in-patients; melatonin,
4794388|NCT02654301|Xylose|xylose
4794389|NCT02654301|prediabetes|prediabetes
4794390|NCT02654301|postprandial hyperglycemia|postprandial hyperglycemia
4794391|NCT02654301|glucose|glucose
4794392|NCT02654288|pancreatic cancer|pancreatic cancer
4794393|NCT02654288|gemcitabine|gemcitabine
4794394|NCT02654288|chemotherapy|chemotherapy
4794395|NCT02654288|immunoglobulin G 4|immunoglobulin g 4
4794396|NCT02654249|Hemorrhoids grade III and IV|hemorrhoids grade iii and iv
4794397|NCT02654249|transanal hemorrhoidal dearterialization|transanal hemorrhoidal dearterialization
4794398|NCT02654249|hemorroidectomy|hemorroidectomy
4794399|NCT02654249|THD|thd
4794400|NCT02654249|LigaSure|ligasure
4794401|NCT02654223|Rhinitis / Rhinoconjunctivitis|rhinitis / rhinoconjunctivitis
4794402|NCT02654223|Vaccine|vaccine
4794403|NCT02654223|Immunotherapy|immunotherapy
4794404|NCT02654223|Grass pollen|grass pollen
4794405|NCT02654223|Allergy|allergy
4794406|NCT02654210|birth cohort|birth cohort
4794407|NCT02654210|infectious diseases|infectious diseases
4794408|NCT02654210|microbiome|microbiome
4794409|NCT02654210|immune system|immune system
4794410|NCT02654210|immune response|immune response
4794411|NCT02654184|Right lateral|right lateral
4794412|NCT02654184|Induction|induction
4794413|NCT02654184|Children|children
4794414|NCT02654184|Anesthesia|anesthesia
4794416|NCT02654171|AK0529|ak0529
4794417|NCT02654158|acute upper respiratory infection|acute upper respiratory infection
4794418|NCT02654145|mepolizumab|mepolizumab
4794419|NCT02654145|Omalizumab|omalizumab
4794420|NCT02654145|SGRQ|sgrq
4794421|NCT02654145|severe eosinophilic asthma|severe eosinophilic asthma
4794422|NCT02654145|ACQ|acq
4794423|NCT02654145|exacerbations|exacerbations
4794424|NCT02654106|multiple brain metastases|multiple brain metastases
4794425|NCT02654106|large brain metastases|large brain metastases
4794426|NCT02654106|meningeal metastases|meningeal metastases
4794427|NCT02654106|fractionated stereotactic radiotherapy|fractionated stereotactic radiotherapy
4794428|NCT02654106|temozolomide|temozolomide
4794429|NCT02654054|Elagolix|elagolix
4794430|NCT02654054|Elagolix Sodium|elagolix sodium
4794431|NCT02654054|Heavy Uterine Bleeding|heavy uterine bleeding
4794432|NCT02654054|Heavy Menstrual Bleeding|heavy menstrual bleeding
4794433|NCT02654054|Leiomyomata|leiomyomata
4794434|NCT02654054|Menorrhagia|menorrhagia
4794435|NCT02654054|ABT-620|abt-620
4794436|NCT02654054|Elagolix + E2/NETA|elagolix + e2/neta
4794437|NCT02654054|Elagolix + Norethindrone Acetate|elagolix + norethindrone acetate
4794438|NCT02654054|HMB|hmb
4794439|NCT02654015|intracranial hemorrhage|intracranial hemorrhage
4794440|NCT02654015|neurosurgery|neurosurgery
4794441|NCT02653963|Steroid, Triamcinolone, Ahmed Glaucoma valve|steroid, triamcinolone, ahmed glaucoma valve
4794442|NCT02653937|IBS|ibs
4794443|NCT02653937|MUPS|mups
4794444|NCT02653937|FSS|fss
4794445|NCT02653937|shigyakusan|shigyakusan
4794446|NCT02653937|Katsumi's points|katsumi's points
4794447|NCT02653937|Nakatani's N line|nakatani's n line
4794448|NCT02653924|Suture|suture
4794449|NCT02653924|bacteria|bacteria
4794450|NCT02653911|Acupuncture|acupuncture
4794451|NCT02653898|Malaria|malaria
4794452|NCT02653898|Antimalarials|antimalarials
4794453|NCT02653898|Malaria Elimination|malaria elimination
4794454|NCT02653898|Mass Drug Administration|mass drug administration
4794455|NCT02653898|Malaria Prophylaxis|malaria prophylaxis
4794456|NCT02653898|Mobile population|mobile population
4794457|NCT02653898|Drug resistance|drug resistance
4794458|NCT02653898|Focused screening and treatment|focused screening and treatment
4794459|NCT02653898|Monthly Malaria Prophylaxis|monthly malaria prophylaxis
4794460|NCT02653898|Mass screening and treatment|mass screening and treatment
4794461|NCT02653898|Primaquine|primaquine
4794462|NCT02653898|Malaria transmission|malaria transmission
4794463|NCT02653898|Permethrin insecticide|permethrin insecticide
4794464|NCT02653898|Thai-Cambodian border|thai-cambodian border
4794465|NCT02653898|Cambodia|cambodia
4794466|NCT02653898|AFRIMS|afrims
4794467|NCT02653885|cardiac surgery|cardiac surgery
4794468|NCT02653885|open heart surgery|open heart surgery
4794469|NCT02653885|hemogram|hemogram
4794470|NCT02653872|Non-randomized|non-randomized
4794471|NCT02653872|Verapamil|verapamil
4794472|NCT02653872|Itraconazole|itraconazole
4794473|NCT02653872|Diltiazem|diltiazem
4794474|NCT02653872|Safety|safety
4794475|NCT02653872|Tolerability|tolerability
4794476|NCT02653872|Pharmacokinetics|pharmacokinetics
4794477|NCT02653859|CTC|ctc
4794478|NCT02653859|PCR|pcr
4794479|NCT02653833|Becker|becker
4794480|NCT02653833|Muscular Dystrophy|muscular dystrophy
4794481|NCT02653833|Skeletal Muscle|skeletal muscle
4794482|NCT02653833|blood flow|blood flow
4794483|NCT02653833|Ultrasound|ultrasound
4794484|NCT02653807|manual therapy|manual therapy
4794485|NCT02653807|osteopathy|osteopathy
4794486|NCT02653807|mobilization with movement|mobilization with movement
4794487|NCT02653807|ankle|ankle
4794488|NCT02653807|stiffness|stiffness
4794489|NCT02653794|Juvenile Subjects'characteristics|juvenile subjects'characteristics
4794490|NCT02653768|Osteoarthritis, Knee|osteoarthritis, knee
4794491|NCT02653768|Exercise|exercise
4794492|NCT02653755|Breast Cancer Radiation|breast cancer radiation
4794493|NCT02653755|Radiotherapy for Favorable-Risk Breast cancer|radiotherapy for favorable-risk breast cancer
4794494|NCT02653755|Radiotherapy Omission|radiotherapy omission
4794495|NCT02653729|cognitive behaviour therapy|cognitive behaviour therapy
4794496|NCT02653729|first episode|first episode
4794497|NCT02653716|New Orleans Intervention Model|new orleans intervention model
4794498|NCT02653716|Case Management|case management
4794499|NCT02653716|Maltreatment|maltreatment
4794500|NCT02653716|Child|child
4794501|NCT02653664|Chronic Pain|chronic pain
4794502|NCT02653664|Sleep|sleep
4794503|NCT02653651|Ketamine|ketamine
4794504|NCT02653651|Lidocaine|lidocaine
4794505|NCT02653651|Nephrectomy|nephrectomy
4794506|NCT02653651|Chronic pain|chronic pain
4794507|NCT02653638|Cerebral Vasodilator Function|cerebral vasodilator function
4794508|NCT02653638|White Matter Hyperintensity Volume|white matter hyperintensity volume
4794509|NCT02653638|Default Mode Network Connectivity|default mode network connectivity
4794510|NCT02653638|Cognitive Function|cognitive function
4794511|NCT02653638|Cardiorespiratory Fitness|cardiorespiratory fitness
4794512|NCT02653638|Aging|aging
4794513|NCT02653625|Primary Sclerosing Cholangitis|primary sclerosing cholangitis
4794514|NCT02653612|surgery|surgery
4794515|NCT02653612|folate receptor|folate receptor
4794516|NCT02653586|resilience|resilience
4794517|NCT02653586|prevention program|prevention program
4794518|NCT02653586|body image|body image
4794519|NCT02653586|self esteem|self esteem
4794520|NCT02653573|young adult|young adult
4794521|NCT02653560|Potassium|potassium
4794522|NCT02653560|Magnesium|magnesium
4794523|NCT02653560|Citrate|citrate
4794524|NCT02653560|DASH|dash
4794525|NCT02653547|tinnitus|tinnitus
4794526|NCT02653547|transcranial random noise stimulation|transcranial random noise stimulation
4794527|NCT02653547|rTMS|rtms
4794528|NCT02653547|multisite stimulation|multisite stimulation
4794529|NCT02653547|non-invasive brain stimulation|non-invasive brain stimulation
4794530|NCT02653534|Kangaroo Mother Care in community|kangaroo mother care in community
4794531|NCT02653534|mortality|mortality
4794532|NCT02653521|Esophageal Cancer|esophageal cancer
4794533|NCT02653521|Adaptive Radiation Therapy|adaptive radiation therapy
4794534|NCT02653508|BMI: Body Mass Index|bmi: body mass index
4794535|NCT02653508|obesity|obesity
4794536|NCT02653508|adolescents|adolescents
4794537|NCT02653508|overweight|overweight
4794538|NCT02653508|CI:confidence interval|ci:confidence interval
4794539|NCT02653508|CDC: Center Disease Control|cdc: center disease control
4794540|NCT02653482|heart failure|heart failure
4794541|NCT02653482|dapagliflozin|dapagliflozin
4794542|NCT02653482|SGLT-2 inhibitors|sglt-2 inhibitors
4794543|NCT02653456|excimer laser|excimer laser
4794544|NCT02653456|percutaneous catheter|percutaneous catheter
4794545|NCT02653456|photoablation|photoablation
4794546|NCT02653456|chronic total occlusion|chronic total occlusion
4794547|NCT02653456|symptomatic infrainguinal lower extremity vascular disease|symptomatic infrainguinal lower extremity vascular disease
4794548|NCT02653443|INTERCEPT|intercept
4794549|NCT02653443|Platelet|platelet
4794550|NCT02653443|Pathogen Inactivation|pathogen inactivation
4794551|NCT02653443|Platelets Components Stored|platelets components stored
4794552|NCT02653443|Therapeutic Efficacy|therapeutic efficacy
4794553|NCT02653430|obesity|obesity
4794554|NCT02653430|BMI|bmi
4794555|NCT02653430|efficacy|efficacy
4794556|NCT02653430|bariatric surgery|bariatric surgery
4794557|NCT02653430|gut flora|gut flora
4794558|NCT02653430|fMRI|fmri
4794559|NCT02653391|Fuchs' Corneal Endothelial Dystrophy|fuchs' corneal endothelial dystrophy
4794560|NCT02653391|FCED|fced
4794561|NCT02653391|Ocuvia™|ocuvia™
4794562|NCT02653391|MTP-131|mtp-131
4794563|NCT02653352|randomized controlled trials|randomized controlled trials
4794564|NCT02653352|soft drinks|soft drinks
4794565|NCT02653352|hypercholesterolemia|hypercholesterolemia
4794566|NCT02653352|serum cholesterol|serum cholesterol
4794567|NCT02653352|blood glucose|blood glucose
4794568|NCT02653352|overweight|overweight
4794569|NCT02653352|carbonated beverages|carbonated beverages
4794570|NCT02653339|traditional Chinese medicine|traditional chinese medicine
4794571|NCT02653339|Loratadine|loratadine
4794572|NCT02653339|questionnaire survey|questionnaire survey
4794573|NCT02653326|Tertiary Prevention|tertiary prevention
4794574|NCT02653326|Telerehabilitation|telerehabilitation
4794575|NCT02653287|Fatigue, Physical Activity, Lupus|fatigue, physical activity, lupus
4794576|NCT02653274|MRI|mri
4794577|NCT02653274|blood glucose|blood glucose
4794578|NCT02653274|satiety|satiety
4794579|NCT02653274|breakfast|breakfast
4794580|NCT02653274|porridge|porridge
4794581|NCT02653274|grains|grains
4794582|NCT02653261|tranexamic acid|tranexamic acid
4794583|NCT02653261|Transurethral Resection of the Prostate (TURP)|transurethral resection of the prostate (turp)
4794584|NCT02653261|Transurethral Resection of a Bladder Tumor (TURBT)|transurethral resection of a bladder tumor (turbt)
4794585|NCT02653261|Hemorrhage|hemorrhage
4794586|NCT02653261|Blood Transfusion|blood transfusion
4794587|NCT02653222|Ethanol Sympathicolysis|ethanol sympathicolysis
4794588|NCT02653222|Computer Tomography guidance|computer tomography guidance
4794589|NCT02653222|Denervation|denervation
4794590|NCT02653222|Kidney Transplantation|kidney transplantation
4794591|NCT02653222|Dialysis|dialysis
4794592|NCT02653209|Type 2 diabetes|type 2 diabetes
4794593|NCT02653209|Stratification|stratification
4794594|NCT02653209|Biomarkers|biomarkers
4794595|NCT02653209|Pharmacogenetics|pharmacogenetics
4794596|NCT02653209|SGLT2 inhibitors|sglt2 inhibitors
4794597|NCT02653209|Thiazolidinediones|thiazolidinediones
4794598|NCT02653209|DPP4 inhibitors|dpp4 inhibitors
4794599|NCT02653170|acute stroke|acute stroke
4794600|NCT02653170|care transitions|care transitions
4794601|NCT02653170|patient engagement|patient engagement
4794602|NCT02653170|patient education|patient education
4794603|NCT02653170|caregivers|caregivers
4794604|NCT02653170|social workers|social workers
4794605|NCT02653157|multidrug resistance|multidrug resistance
4794606|NCT02653157|burns|burns
4794607|NCT02653157|infections, gram-negative bacilli|infections, gram-negative bacilli
4794608|NCT02653157|ventilator-associated pneumonia|ventilator-associated pneumonia
4794609|NCT02653157|ventilator-associated tracheobronchitis|ventilator-associated tracheobronchitis
4794610|NCT02653157|gram-negative bacilli colonization|gram-negative bacilli colonization
4794611|NCT02653144|post operative pain, Dexmedetomidine, Regional anesthesia|post operative pain, dexmedetomidine, regional anesthesia
4794612|NCT02653131|Short bowel syndrome|short bowel syndrome
4794613|NCT02653105|High risk of cancer, BRCA1 or 2 mutation, Olfactomedine 4|high risk of cancer, brca1 or 2 mutation, olfactomedine 4
4794614|NCT02653066|recruitment|recruitment
4794615|NCT02653040|Lighting|lighting
4794616|NCT02653040|Inpatients|inpatients
4794617|NCT02653040|Recovery|recovery
4794618|NCT02653040|Sleep|sleep
4794619|NCT02653027|Genetics|genetics
4794620|NCT02652988|tDCS|tdcs
4794621|NCT02652988|chronic pain|chronic pain
4794622|NCT02652988|fibromyalgia|fibromyalgia
4794623|NCT02652923|ultrasound contrast agent|ultrasound contrast agent
4794624|NCT02652923|lymphosonography|lymphosonography
4794625|NCT02652923|breast cancer|breast cancer
4794626|NCT02652897|bleeding|bleeding
4794627|NCT02652897|clotting tests|clotting tests
4794628|NCT02652897|neurosurgery|neurosurgery
4794629|NCT02652897|clotting time|clotting time
4794630|NCT02652897|maximum clot firmness|maximum clot firmness
4794631|NCT02652897|kinetics|kinetics
4794632|NCT02652897|lysis|lysis
4795026|NCT02650401|Pediatric|pediatric
4794633|NCT02652897|primary hemostasis|primary hemostasis
4794634|NCT02652897|platelet dysfunction|platelet dysfunction
4794635|NCT02652897|coagulation|coagulation
4794636|NCT02652884|transient hypoparathyroidism|transient hypoparathyroidism
4794637|NCT02652884|steroids|steroids
4794638|NCT02652884|total thyroidectomy|total thyroidectomy
4794639|NCT02652871|Leukemia|leukemia
4794640|NCT02652871|Acute Myeloid Leukemia|acute myeloid leukemia
4794641|NCT02652871|AML|aml
4794642|NCT02652871|Relapsed or Refractory|relapsed or refractory
4794643|NCT02652871|Acute myelogenous leukemia|acute myelogenous leukemia
4794644|NCT02652871|LY2510924|ly2510924
4794645|NCT02652871|Idarubicin|idarubicin
4794646|NCT02652871|Idamycin|idamycin
4794647|NCT02652871|Cytarabine|cytarabine
4794648|NCT02652871|Ara-C|ara-c
4794649|NCT02652871|Cytosar|cytosar
4794650|NCT02652871|DepoCyt|depocyt
4794651|NCT02652871|Cytosine Arabinosine Hydrochloride|cytosine arabinosine hydrochloride
4794652|NCT02652819|Chronic Kidney Disease|chronic kidney disease
4794653|NCT02652806|Chronic Kidney Disease|chronic kidney disease
4794654|NCT02652780|Leber Hereditary Optic Neuropathy|leber hereditary optic neuropathy
4794655|NCT02652780|Leber Hereditary Optic Atrophy|leber hereditary optic atrophy
4794656|NCT02652780|Heredity Optic Atrophy|heredity optic atrophy
4794657|NCT02652780|Eye Diseases|eye diseases
4794658|NCT02652780|Hereditary Eye Diseases|hereditary eye diseases
4794659|NCT02652780|Inborn Genetic Disease|inborn genetic disease
4794660|NCT02652780|Genetic Therapy|genetic therapy
4794661|NCT02652780|Intravitreal Injections|intravitreal injections
4794662|NCT02652780|Mitochondrial Disease|mitochondrial disease
4794663|NCT02652780|AAV2 Vectors|aav2 vectors
4794664|NCT02652780|Nervous System Diseases|nervous system diseases
4794665|NCT02652780|Neurodegenerative Disease|neurodegenerative disease
4794666|NCT02652780|Heredodegenerative Disorders of the Nervous System|heredodegenerative disorders of the nervous system
4794667|NCT02652767|Leber Hereditary Optic Neuropathy|leber hereditary optic neuropathy
4794668|NCT02652767|Leber Hereditary Optic Atrophy|leber hereditary optic atrophy
4794669|NCT02652767|Heredity Optic Atrophy|heredity optic atrophy
4794670|NCT02652767|Eye Diseases|eye diseases
4794671|NCT02652767|Hereditary Eye Diseases|hereditary eye diseases
4794672|NCT02652767|Inborn Genetic Disease|inborn genetic disease
4794673|NCT02652767|Genetic Therapy|genetic therapy
4794674|NCT02652767|Intravitreal Injections|intravitreal injections
4794675|NCT02652767|Mitochondrial Disease|mitochondrial disease
4794676|NCT02652767|AAV2 Vectors|aav2 vectors
4794677|NCT02652767|Nervous System Diseases|nervous system diseases
4794678|NCT02652767|Neurodegenerative Disease|neurodegenerative disease
4794679|NCT02652767|Heredodegenerative Disorders of the Nervous System|heredodegenerative disorders of the nervous system
4794680|NCT02652754|Granexin|granexin
4794681|NCT02652754|diabetic foot ulcers|diabetic foot ulcers
4794682|NCT02652754|pharmacokinetic study|pharmacokinetic study
4794683|NCT02652754|FirstString Research|firststring research
4794684|NCT02652702|circular stapler-assisted colostomy|circular stapler-assisted colostomy
4794685|NCT02652689|pulmonary embolism|pulmonary embolism
4794686|NCT02652689|pulmonary disease|pulmonary disease
4794687|NCT02652689|Lung Doppler signals|lung doppler signals
4794688|NCT02652676|Infant Cardiac Transplantation|infant cardiac transplantation
4794689|NCT02652676|End-stage Idiopathic Dilated Cardiomyopathy|end-stage idiopathic dilated cardiomyopathy
4794690|NCT02652676|Mechanical Circulatory Device|mechanical circulatory device
4794691|NCT02652676|End Stage Dilated Left Ventriculopathy|end stage dilated left ventriculopathy
4794692|NCT02652676|Acute-on-Chronic Left Ventricular Failure|acute-on-chronic left ventricular failure
4794693|NCT02652663|colorectal cancer|colorectal cancer
4794694|NCT02652663|liver|liver
4794695|NCT02652663|MRI|mri
4794696|NCT02652663|contrast|contrast
4794697|NCT02652663|gadoxetic acid|gadoxetic acid
4794698|NCT02652650|Healthy|healthy
4794699|NCT02652650|JNJ-63623872|jnj-63623872
4794700|NCT02652650|Ethinylestradiol|ethinylestradiol
4794701|NCT02652650|Norethindrone|norethindrone
4794702|NCT02652611|Screw Removal vs. Non-screw removal|screw removal vs. non-screw removal
4794703|NCT02652611|Complications|complications
4794704|NCT02652611|SI Screw Stabilization|si screw stabilization
4794705|NCT02652585|Alcoholism|alcoholism
4794706|NCT02652585|alcohol self-administration|alcohol self-administration
4794707|NCT02652572|Granexin|granexin
4794708|NCT02652572|venous leg ulcer|venous leg ulcer
4794709|NCT02652572|pharmacokinetic study|pharmacokinetic study
4794710|NCT02652572|FirstString Research|firststring research
4794711|NCT02652559|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
4794712|NCT02652559|Non-invasive ventilation|non-invasive ventilation
4794713|NCT02652559|Home initiation|home initiation
4794714|NCT02652546|HIV/AIDS|hiv/aids
4794715|NCT02652546|Immune Activation|immune activation
4794716|NCT02652546|Anti-Inflammatory|anti-inflammatory
4794717|NCT02652546|TNF|tnf
4794718|NCT02652546|Phosphodieterase Inhibitor|phosphodieterase inhibitor
4794719|NCT02652520|Kidney transplantation|kidney transplantation
4794720|NCT02652520|Organ preservation|organ preservation
4794721|NCT02652507|Sedation|sedation
4794722|NCT02652507|MRI|mri
4794723|NCT02652507|Dexmedetomidine|dexmedetomidine
4794724|NCT02652507|Ketamine|ketamine
4794725|NCT02652507|General anesthesia|general anesthesia
4794726|NCT02652507|MRI of Brain|mri of brain
4794727|NCT02652507|MRI of Brain/Spine|mri of brain/spine
4794728|NCT02652494|Psoriasis|psoriasis
4794729|NCT02652494|Observational|observational
4794730|NCT02652494|Apremilast|apremilast
4794731|NCT02652494|APRIL|april
4794732|NCT02652494|Non-Interventional|non-interventional
4794733|NCT02652494|The Netherlands|the netherlands
4794734|NCT02652455|cutaneous|cutaneous
4794735|NCT02652455|unresectable|unresectable
4794736|NCT02652455|mucosal metastatic stage III/IV melanoma|mucosal metastatic stage iii/iv melanoma
4794737|NCT02652442|dizziness|dizziness
4794738|NCT02652442|postural balance|postural balance
4794739|NCT02652442|rehabilitation|rehabilitation
4794740|NCT02652429|PAH|pah
4794741|NCT02652429|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
4794742|NCT02652429|Inhaled Nitric Oxide|inhaled nitric oxide
4794743|NCT02652429|iNO|ino
4794744|NCT02652403|Denture, Complete|denture, complete
4794745|NCT02652403|Mouth, Edentulous|mouth, edentulous
4794746|NCT02652351|Stem cell|stem cell
4794747|NCT02652351|Human Umbilical Cord Mesenchymal Stem Cell|human umbilical cord mesenchymal stem cell
4794748|NCT02652351|Mesenchymal Stem Cell|mesenchymal stem cell
4794749|NCT02652351|Hepatic Cirrhosis|hepatic cirrhosis
4794750|NCT02652338|heart rhythm disturbances and symptoms|heart rhythm disturbances and symptoms
4794751|NCT02652338|dietary supplement|dietary supplement
4794752|NCT02652312|Dexmedetomidine|dexmedetomidine
4794753|NCT02652312|Desflurane|desflurane
4794754|NCT02652312|Bispectral Index BIS|bispectral index bis
4794755|NCT02652299|Fibrocytes|fibrocytes
4794756|NCT02652299|Synovial biopsy|synovial biopsy
4794757|NCT02652286|VATS|vats
4794758|NCT02652286|Energy sealing|energy sealing
4794759|NCT02652247|trauma|trauma
4794760|NCT02652247|ventilator|ventilator
4794761|NCT02652247|surgical ICU|surgical icu
4794762|NCT02652208|decision making|decision making
4794763|NCT02652208|decision aids|decision aids
4794764|NCT02652208|shared decision making|shared decision making
4794765|NCT02652208|stable angina|stable angina
4794766|NCT02652208|cardiology|cardiology
4794767|NCT02652195|Neural correlates|neural correlates
4794768|NCT02652195|oxytocin administration|oxytocin administration
4794769|NCT02652156|transversus abdominis plane|transversus abdominis plane
4794770|NCT02652156|postoperative|postoperative
4794771|NCT02652156|pain|pain
4794772|NCT02652143|in vivo culture|in vivo culture
4794773|NCT02652130|GVHD, Graft versus Host Disease|gvhd, graft versus host disease
4794774|NCT02652104|Advanced|advanced
4794775|NCT02652104|Deep brain stimulation|deep brain stimulation
4794776|NCT02652091|Adherence|adherence
4794777|NCT02652091|Persistence|persistence
4794778|NCT02652091|Patient satisfaction|patient satisfaction
4794779|NCT02652065|Psoriasis|psoriasis
4794780|NCT02652065|Microcirculation|microcirculation
4794781|NCT02652065|TRPV1|trpv1
4794782|NCT02652026|dental root planing and scaling|dental root planing and scaling
4794783|NCT02652026|periodontal disease|periodontal disease
4794784|NCT02652026|type 2 diabetes mellitus|type 2 diabetes mellitus
4794785|NCT02652026|glycosylated hemoglobin A|glycosylated hemoglobin a
4794786|NCT02651974|neoplasm|neoplasm
4794787|NCT02651974|colorectal|colorectal
4794788|NCT02651974|cancer|cancer
4794789|NCT02651974|uninsured|uninsured
4794790|NCT02651974|FIT|fit
4794791|NCT02651974|fecal immunochemical test|fecal immunochemical test
4794792|NCT02651961|Total hip prosthesis|total hip prosthesis
4794793|NCT02651961|Total knee prosthesis|total knee prosthesis
4794794|NCT02651961|Chronic infection|chronic infection
4794795|NCT02651961|One stage exchange|one stage exchange
4794796|NCT02651961|Two stage exchange|two stage exchange
4794797|NCT02651961|Cost-effectiveness|cost-effectiveness
4794798|NCT02651935|Respiration, Artificial|respiration, artificial
4794799|NCT02651935|weaning|weaning
4794800|NCT02651935|critical care|critical care
4794801|NCT02651922|Nervous restlessness|nervous restlessness
4794802|NCT02651922|Pascoflair|pascoflair
4794803|NCT02651922|Passiflora incarnata|passiflora incarnata
4794804|NCT02651922|Benzodiazepine|benzodiazepine
4794805|NCT02651883|Cervical cancer screening|cervical cancer screening
4794806|NCT02651883|HPV testing|hpv testing
4794807|NCT02651883|Self-collection|self-collection
4794808|NCT02651870|Hypertension|hypertension
4794809|NCT02651844|Progesterone receptor isoforms|progesterone receptor isoforms
4794810|NCT02651844|Antiprogestins|antiprogestins
4794811|NCT02651844|Mifepristone|mifepristone
4794812|NCT02651844|Neoadjuvant|neoadjuvant
4794813|NCT02651844|Breast cancer|breast cancer
4794814|NCT02651831|ICMs|icms
4794815|NCT02651831|Immune checkpoint modulators|immune checkpoint modulators
4794816|NCT02651818|Goiter|goiter
4794817|NCT02651818|Thyroid disease|thyroid disease
4794818|NCT02651818|Struma|struma
4794819|NCT02651805|Palliative Care|palliative care
4794820|NCT02651805|Respiratory Secretion|respiratory secretion
4794821|NCT02651792|ketamine|ketamine
4794822|NCT02651792|propofol|propofol
4794823|NCT02651792|pethidine|pethidine
4794824|NCT02651792|ERCP|ercp
4794825|NCT02651792|endoscopist|endoscopist
4794826|NCT02651740|Rifaximin|rifaximin
4794827|NCT02651740|Fecal microbiota transplantation|fecal microbiota transplantation
4794828|NCT02651740|Gut microbiota|gut microbiota
4794829|NCT02651610|PPHM 1401|pphm 1401
4794830|NCT02651610|bavituximab|bavituximab
4794831|NCT02651610|Peregrine|peregrine
4794832|NCT02651610|Breast Cancer|breast cancer
4794833|NCT02651610|HER-2 Negative|her-2 negative
4794834|NCT02651610|HER2 Negative|her2 negative
4794835|NCT02651597|Oatmeal|oatmeal
4794836|NCT02651597|Beta glucan|beta glucan
4794837|NCT02651597|Postprandial Glycemic Response|postprandial glycemic response
4794838|NCT02651597|Blood Glucose|blood glucose
4794839|NCT02651571|Knee|knee
4794840|NCT02651571|Replacement|replacement
4794841|NCT02651571|Prosthesis|prosthesis
4794842|NCT02651571|Mobile-bearing|mobile-bearing
4794843|NCT02651532|Confocal Laser Endomicroscopy|confocal laser endomicroscopy
4794844|NCT02651532|inflammation|inflammation
4794845|NCT02651532|Irritable Bowel Syndrome|irritable bowel syndrome
4794846|NCT02651519|bispectral index|bispectral index
4794847|NCT02651519|regional cerebral oxygen saturation|regional cerebral oxygen saturation
4794848|NCT02651519|Stellate-ganglion block|stellate-ganglion block
4794849|NCT02651506|Lung cancer biopsy|lung cancer biopsy
4794850|NCT02651506|Electromagnetic Navigation Bronchoscopy|electromagnetic navigation bronchoscopy
4794851|NCT02651506|Transthoracic Needle Biopsy|transthoracic needle biopsy
4794852|NCT02651480|Diet, Vegetarian|diet, vegetarian
4794853|NCT02651480|Diet, Fat-Restricted|diet, fat-restricted
4794854|NCT02651480|Quality of Life|quality of life
4794855|NCT02651480|Glycemic Index|glycemic index
4794856|NCT02651454|metabolic syndrome|metabolic syndrome
4794857|NCT02651454|Daesiho-tang|daesiho-tang
4794858|NCT02651454|Taeeumjowi-tang|taeeumjowi-tang
4794859|NCT02651454|Korean medicine|korean medicine
4794860|NCT02651441|D-CIK|d-cik
4794861|NCT02651441|lung cancer|lung cancer
4794862|NCT02651428|Kidney Failure, Chronic|kidney failure, chronic
4794863|NCT02651428|Catheter-Related Infections|catheter-related infections
4794864|NCT02651428|Central Venous Catheter|central venous catheter
4794865|NCT02651415|Metastatic colorectal cancer|metastatic colorectal cancer
4794866|NCT02651415|Metastatic colorectal carcinoma|metastatic colorectal carcinoma
4794867|NCT02651415|mCRC|mcrc
4794868|NCT02651415|Regorafenib|regorafenib
4794869|NCT02651415|Stivarga|stivarga
4794870|NCT02651415|Perindopril|perindopril
4794871|NCT02651415|Perindopril erbumine|perindopril erbumine
4794872|NCT02651415|Coversyl|coversyl
4794873|NCT02651402|Anxiety Disorders|anxiety disorders
4794874|NCT02651402|Internalizing|internalizing
4794875|NCT02651402|Anxiety|anxiety
4794876|NCT02651389|Digital Orthoptic Platform|digital orthoptic platform
4794877|NCT02651389|Vision test|vision test
4794878|NCT02651376|Immunodeficiency|immunodeficiency
4794879|NCT02651376|Allogenic Mononuclear Cell Transplantation|allogenic mononuclear cell transplantation
4794880|NCT02651350|Drug-induced Liver Injury|drug-induced liver injury
4794881|NCT02651350|Recurrence|recurrence
4794882|NCT02651350|Methylprednisolone|methylprednisolone
4794883|NCT02651285|G-CSF|g-csf
4794884|NCT02651285|BLASTOCYST|blastocyst
4794885|NCT02651285|IVF|ivf
4794886|NCT02651272|Pulmonary Hypertension|pulmonary hypertension
4794887|NCT02651272|Sickle Cell Disease|sickle cell disease
4794888|NCT02651272|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
4794889|NCT02651272|Macitentan|macitentan
4794890|NCT02651194|Treatment-naïve|treatment-naïve
4794891|NCT02651194|HCV Gentoype 2|hcv gentoype 2
4794892|NCT02651194|Non-cirrhotic|non-cirrhotic
4794893|NCT02651194|Chronic Hepatitis C|chronic hepatitis c
4794894|NCT02651194|HCV Gentoype 5|hcv gentoype 5
4794895|NCT02651194|HCV Gentoype 4|hcv gentoype 4
4794896|NCT02651194|HCV Gentoype 6|hcv gentoype 6
4794897|NCT02651194|HCV Gentoype 1|hcv gentoype 1
4794898|NCT02651194|Compensated cirrhotic|compensated cirrhotic
4794899|NCT02651194|Treatment-experienced|treatment-experienced
4794900|NCT02651194|HCV Gentoype 3|hcv gentoype 3
4794901|NCT02651168|Diabetic Macular Edema|diabetic macular edema
4794902|NCT02651168|Ocular Cytokines|ocular cytokines
4794903|NCT02651168|aflibercept|aflibercept
4794904|NCT02651168|ranibizumab|ranibizumab
4794905|NCT02651155|Drug therapy|drug therapy
4794906|NCT02651129|noise|noise
4794907|NCT02651129|obstetric|obstetric
4794908|NCT02651129|operating rooms|operating rooms
4794909|NCT02651116|cough, acute cough, pediatric, Dextromethorphan Hydrobromide, antitussive, ambulatory cough recording device|cough, acute cough, pediatric, dextromethorphan hydrobromide, antitussive, ambulatory cough recording device
4794910|NCT02651090|contraindication for CECT|contraindication for cect
4794911|NCT02651090|contraindication for CEMRI|contraindication for cemri
4794912|NCT02651090|liver pathology|liver pathology
4794913|NCT02651090|renal failure|renal failure
4794914|NCT02651090|contrast enhanced ultrasound|contrast enhanced ultrasound
4794915|NCT02651090|sonazoid|sonazoid
4794916|NCT02651077|Endometriosis, chemical contaminants, BFRs|endometriosis, chemical contaminants, bfrs
4794917|NCT02651064|Supplemental Nutrition Assistance Program (SNAP)|supplemental nutrition assistance program (snap)
4794918|NCT02651064|fruits and vegetables|fruits and vegetables
4794919|NCT02651064|price incentive|price incentive
4794920|NCT02651051|Postprandial glycemia|postprandial glycemia
4794921|NCT02651051|Metabolic health measures|metabolic health measures
4794922|NCT02650973|Bioequivalence|bioequivalence
4794923|NCT02650947|Sucralose|sucralose
4794924|NCT02650947|Insulin Secretion|insulin secretion
4794925|NCT02650947|Insulin Sensitivity|insulin sensitivity
4794926|NCT02650947|Incretin|incretin
4794927|NCT02650947|Gut Microbiota|gut microbiota
4794928|NCT02650947|Food and Eating Behaviour|food and eating behaviour
4794929|NCT02650947|Healthy Volunteers|healthy volunteers
4794930|NCT02650934|STEMI, Heart Failure, Inflammation, Haptoglobin Polymorphisms, Adverse Remodeling, Genetics, GWAS, MRI|stemi, heart failure, inflammation, haptoglobin polymorphisms, adverse remodeling, genetics, gwas, mri
4794931|NCT02650908|Lesion|lesion
4794932|NCT02650908|Meniscus|meniscus
4794933|NCT02650908|Avivement|avivement
4794934|NCT02650908|Suturing area|suturing area
4794935|NCT02650882|Respiratory muscles|respiratory muscles
4794936|NCT02650882|athletic performance|athletic performance
4794937|NCT02650882|handball|handball
4794938|NCT02650869|Necrotizing Enterocolitis|necrotizing enterocolitis
4794939|NCT02650869|probiotics|probiotics
4794940|NCT02650869|very low birth weight|very low birth weight
4794941|NCT02650856|Blood loss|blood loss
4794942|NCT02650856|Tranexamic acid|tranexamic acid
4794943|NCT02650856|Platelet rich plasma|platelet rich plasma
4794944|NCT02650856|Total knee arthroplasty|total knee arthroplasty
4794945|NCT02650843|Parkinsonism|parkinsonism
4794946|NCT02650843|DAT Dopamine transporter|dat dopamine transporter
4794947|NCT02650843|SPECT|spect
4794948|NCT02650830|type 2 diabetes|type 2 diabetes
4794949|NCT02650830|prediabetes|prediabetes
4794950|NCT02650830|bile acids profile|bile acids profile
4794951|NCT02650830|GLP-1|glp-1
4794952|NCT02650830|FGF-19|fgf-19
4794953|NCT02650804|Cancer|cancer
4794954|NCT02650804|Advanced Pancreatic Cancer|advanced pancreatic cancer
4794955|NCT02650778|Breast Cancer|breast cancer
4794956|NCT02650778|Automated whole breast ultrasound|automated whole breast ultrasound
4794957|NCT02650778|BI-RADS category 3 lesions|bi-rads category 3 lesions
4794958|NCT02650765|Brain injury|brain injury
4794959|NCT02650765|Head injury|head injury
4794960|NCT02650765|Computed tomography|computed tomography
4794961|NCT02650765|Emergency department|emergency department
4794962|NCT02650752|Lapatinib|lapatinib
4794963|NCT02650752|Capecitabine|capecitabine
4794964|NCT02650752|HER2|her2
4794965|NCT02650752|15-278|15-278
4794966|NCT02650687|Postoperative Cognitive Dysfunction|postoperative cognitive dysfunction
4794967|NCT02650687|Elderly, geriatric|elderly, geriatric
4794968|NCT02650687|Anesthesia|anesthesia
4794969|NCT02650687|Anesthetic depth|anesthetic depth
4794970|NCT02650687|Bispectral index monitor|bispectral index monitor
4794971|NCT02650687|Function|function
4794972|NCT02650687|Recovery after surgery|recovery after surgery
4794973|NCT02650687|Surgery|surgery
4794974|NCT02650674|glycemic & insulin response|glycemic & insulin response
4794975|NCT02650674|SDS|sds
4794976|NCT02650674|cereal product|cereal product
4794977|NCT02650674|Nutrition|nutrition
4794978|NCT02650674|Carbohydrate|carbohydrate
4794979|NCT02650674|Absorption|absorption
4794980|NCT02650674|Intestine|intestine
4794981|NCT02650661|Cancer survivors|cancer survivors
4794982|NCT02650648|Humanized Anti-GD2 Antibody Hu3F8|humanized anti-gd2 antibody hu3f8
4794983|NCT02650648|Allogeneic Natural Killer Cells|allogeneic natural killer cells
4794984|NCT02650648|rIL-2|ril-2
4794985|NCT02650648|15-272|15-272
4794986|NCT02650622|Metabolism|metabolism
4794987|NCT02650622|Genetics|genetics
4794988|NCT02650622|Metabolomics|metabolomics
4794989|NCT02650622|Genomics|genomics
4794990|NCT02650609|chronic subdural hematomas|chronic subdural hematomas
4794991|NCT02650609|surgical treatment|surgical treatment
4794992|NCT02650609|corticosteroids|corticosteroids
4794993|NCT02650570|Cancer|cancer
4794994|NCT02650570|Cachexia|cachexia
4794995|NCT02650557|coronary slow flow|coronary slow flow
4794996|NCT02650557|P-wave dispersion|p-wave dispersion
4794997|NCT02650544|Carcinoma, Non-Small-Cell Lung|carcinoma, non-small-cell lung
4794998|NCT02650544|Depression|depression
4794999|NCT02650544|mirtazapine|mirtazapine
4795000|NCT02650544|patients health questionnaire (PHQ-9)|patients health questionnaire (phq-9)
4795001|NCT02650531|Follow up studies|follow up studies
4795002|NCT02650531|Risk factors|risk factors
4795003|NCT02650518|Catheter-Associated Urinary Tract Infections|catheter-associated urinary tract infections
4795004|NCT02650518|Antimicrobial Stewardship|antimicrobial stewardship
4795005|NCT02650518|Short-Course Antimicrobials|short-course antimicrobials
4795006|NCT02650492|Hyperthermia, Induced|hyperthermia, induced
4795007|NCT02650492|Laser Coagulation|laser coagulation
4795008|NCT02650492|Laser Therapy|laser therapy
4795009|NCT02650453|Stent|stent
4795010|NCT02650453|Angioplasty|angioplasty
4795011|NCT02650453|Endophlebectomy|endophlebectomy
4795012|NCT02650440|robotics|robotics
4795013|NCT02650440|locomotion|locomotion
4795014|NCT02650440|gait|gait
4795015|NCT02650440|walking|walking
4795016|NCT02650440|rehabilitation|rehabilitation
4795017|NCT02650414|Biological: CART 22|biological: cart 22
4795018|NCT02650401|TRK|trk
4795019|NCT02650401|Tyrosine kinase|tyrosine kinase
4795020|NCT02650401|NTRK|ntrk
4795021|NCT02650401|NTRK1|ntrk1
4795022|NCT02650401|NTRK2|ntrk2
4795023|NCT02650401|NTRK3|ntrk3
4795024|NCT02650401|ROS1|ros1
4795025|NCT02650401|ALK|alk
4795027|NCT02650401|Relapsed|relapsed
4795028|NCT02650401|Refractory|refractory
4795029|NCT02650401|Solid Tumor|solid tumor
4795030|NCT02650401|Metastatic Cancer|metastatic cancer
4795031|NCT02650401|Gene rearrangement|gene rearrangement
4795032|NCT02650401|Neuroblastoma|neuroblastoma
4795033|NCT02650401|Infantile fibrosarcoma|infantile fibrosarcoma
4795034|NCT02650401|Secretory breast cancer|secretory breast cancer
4795035|NCT02650401|Congenital mesoblastic nephroma|congenital mesoblastic nephroma
4795036|NCT02650401|Pontine glioma|pontine glioma
4795037|NCT02650401|Brain tumors|brain tumors
4795038|NCT02650401|CNS tumors|cns tumors
4795039|NCT02650401|Sarcoma|sarcoma
4795040|NCT02650401|Ewing sarcoma|ewing sarcoma
4795041|NCT02650401|Glial tumors|glial tumors
4795042|NCT02650401|Salivary Gland Cancer (MASC)|salivary gland cancer (masc)
4795043|NCT02650401|Papillary thyroid cancer|papillary thyroid cancer
4795044|NCT02650401|Medulloblastoma|medulloblastoma
4795045|NCT02650401|Wilms tumor (anaplastic)|wilms tumor (anaplastic)
4795046|NCT02650362|spinal cord stimulation|spinal cord stimulation
4795047|NCT02650362|resting state functional magnetic resonance|resting state functional magnetic resonance
4795048|NCT02650362|voxel-based magnetic resonance morphometry|voxel-based magnetic resonance morphometry
4795049|NCT02650349|spinal cord stimulation|spinal cord stimulation
4795050|NCT02650349|resting state functional magnetic resonance|resting state functional magnetic resonance
4795051|NCT02650349|voxel-based magnetic resonance morphometry|voxel-based magnetic resonance morphometry
4795052|NCT02650297|Lymphedema secondary to breast cancer|lymphedema secondary to breast cancer
4795053|NCT02650297|Breast cancer|breast cancer
4795054|NCT02650297|Body image|body image
4795055|NCT02650271|adjuvant|adjuvant
4795056|NCT02650271|entecavir|entecavir
4795057|NCT02650271|hepatocellular carcinoma|hepatocellular carcinoma
4795058|NCT02650271|hepatic resection|hepatic resection
4795059|NCT02650245|breath|breath
4795060|NCT02650245|gastroenterology|gastroenterology
4795061|NCT02650245|ammonia|ammonia
4795062|NCT02650245|blood|blood
4795063|NCT02650245|protein|protein
4795064|NCT02650245|cirrhosis|cirrhosis
4795065|NCT02650245|encephalopathy|encephalopathy
4795066|NCT02650232|Volunteers|volunteers
4795067|NCT02650206|diabetes|diabetes
4795068|NCT02650206|macrophage|macrophage
4795069|NCT02650206|inflammation|inflammation
4795070|NCT02650206|adipose tissue|adipose tissue
4795071|NCT02650206|weight loss|weight loss
4795072|NCT02650206|liraglutide|liraglutide
4795073|NCT02650193|HSP-130 Phase 1-2 Study in patients with Breast cancer|hsp-130 phase 1-2 study in patients with breast cancer
4795074|NCT02650180|Rehabilitation|rehabilitation
4795075|NCT02650154|sedation|sedation
4795076|NCT02650154|children|children
4795077|NCT02650154|infants|infants
4795078|NCT02650154|ketamine|ketamine
4795079|NCT02650154|neurotoxicity|neurotoxicity
4795080|NCT02650128|Coronary Artery Disease|coronary artery disease
4795081|NCT02650128|Calcified Coronary Lesions|calcified coronary lesions
4795082|NCT02650128|Coronary Arterial Stenosis|coronary arterial stenosis
4795083|NCT02650089|Resistance Exercise|resistance exercise
4795084|NCT02650089|Postexercise Hypotension|postexercise hypotension
4795085|NCT02650089|Sympathovagal balance|sympathovagal balance
4795086|NCT02650089|Professor|professor
4795087|NCT02650011|Chronic liver disease|chronic liver disease
4795088|NCT02650011|Liver cirrhosis|liver cirrhosis
4795089|NCT02649998|Fursemide|fursemide
4795090|NCT02649998|Isosorbide Dinitrate|isosorbide dinitrate
4795091|NCT02649998|Heart Decompensation|heart decompensation
4795092|NCT02649998|Clinical Trials, Randomized|clinical trials, randomized
4795093|NCT02649998|Clinical Efficacy|clinical efficacy
4795094|NCT02649972|Cobimetinib|cobimetinib
4795095|NCT02649972|15-216|15-216
4795096|NCT02649959|Autism|autism
4795097|NCT02649933|pregnancy|pregnancy
4795098|NCT02649933|obstructive sleep apnea|obstructive sleep apnea
4795099|NCT02649920|unfavorable cervix|unfavorable cervix
4795100|NCT02649920|obese pregnant women|obese pregnant women
4795101|NCT02649894|malignant pleural effusion|malignant pleural effusion
4795102|NCT02649881|macrophage|macrophage
4795103|NCT02649881|vulnerable coronary plaque|vulnerable coronary plaque
4795104|NCT02649868|Radio-Opaque Bland Beads|radio-opaque bland beads
4795105|NCT02649868|Thermal Ablation|thermal ablation
4795106|NCT02649868|Transarterial Embolization|transarterial embolization
4795107|NCT02649855|PSA|psa
4795108|NCT02649855|Vaccine|vaccine
4795109|NCT02649855|Immunotherapy|immunotherapy
4795110|NCT02649855|Immune Response|immune response
4795111|NCT02649855|Androgen Deprivation Therapy|androgen deprivation therapy
4795112|NCT02649829|dendritic cell vaccination|dendritic cell vaccination
4795113|NCT02649829|chemo-immunotherapy|chemo-immunotherapy
4795114|NCT02649829|Wilms' tumor 1 (WT1)|wilms' tumor 1 (wt1)
4795115|NCT02649816|Pit and fissure sealants|pit and fissure sealants
4795116|NCT02649816|Dental Caries|dental caries
4795117|NCT02649816|Prevention|prevention
4795118|NCT02649816|Dental undergraduate students|dental undergraduate students
4795119|NCT02649816|patient's caries risk|patient's caries risk
4795120|NCT02649803|pediatric|pediatric
4795121|NCT02649803|asthma control|asthma control
4795122|NCT02649803|community|community
4795123|NCT02649790|Multiple Myeloma|multiple myeloma
4795124|NCT02649790|Karyopharm|karyopharm
4795125|NCT02649790|KPT-8602|kpt-8602
4795126|NCT02649790|MM|mm
4795127|NCT02649790|Phase 1|phase 1
4795128|NCT02649790|Relapsed/ Refractory Multiple Myeloma|relapsed/ refractory multiple myeloma
4795129|NCT02649790|Myelodysplastic Syndrome|myelodysplastic syndrome
4795130|NCT02649790|MDS|mds
4795131|NCT02649790|Metastatic Castration Resistant Prostate Cancer|metastatic castration resistant prostate cancer
4795132|NCT02649790|mCRPC|mcrpc
4795133|NCT02649790|CRC|crc
4795134|NCT02649790|Metastatic Colorectal Cancer|metastatic colorectal cancer
4795135|NCT02649777|oxidative stress|oxidative stress
4795136|NCT02649764|Acute Myelogenous Leukemia|acute myelogenous leukemia
4795137|NCT02649764|AML|aml
4795138|NCT02649764|Relapsed/Refractory|relapsed/refractory
4795139|NCT02649764|High-Risk Myelodysplastic Syndrome|high-risk myelodysplastic syndrome
4795140|NCT02649764|HRMDS|hrmds
4795141|NCT02649764|LY2606368|ly2606368
4795142|NCT02649764|Fludarabine|fludarabine
4795143|NCT02649764|Fludarabine Phosphate|fludarabine phosphate
4795144|NCT02649764|Fludara|fludara
4795145|NCT02649764|Cytarabine|cytarabine
4795146|NCT02649764|Ara-C|ara-c
4795147|NCT02649764|Cytosar|cytosar
4795148|NCT02649764|DepoCyt|depocyt
4795149|NCT02649764|Cytosine Arabinosine Hydrochloride|cytosine arabinosine hydrochloride
4795150|NCT02649751|Cystic Fibrosis|cystic fibrosis
4795151|NCT02649751|Roscovitine|roscovitine
4795152|NCT02649751|Seliciclib|seliciclib
4795153|NCT02649751|CYC202|cyc202
4795154|NCT02649738|keratoconus|keratoconus
4795155|NCT02649738|corneal tissue inlay|corneal tissue inlay
4795156|NCT02649699|Primary Brain Cancer|primary brain cancer
4795157|NCT02649673|lung carcinoma|lung carcinoma
4795158|NCT02649673|topotecan|topotecan
4795159|NCT02649673|Hycamtin|hycamtin
4795160|NCT02649673|ovarian neoplasms|ovarian neoplasms
4795161|NCT02649673|LCL161|lcl161
4795162|NCT02649673|IAP inhibitors|iap inhibitors
4795163|NCT02649660|Fabry Disease|fabry disease
4795164|NCT02649660|Platelets|platelets
4795165|NCT02649660|Lipidomics|lipidomics
4795166|NCT02649660|Sphingolipids|sphingolipids
4795167|NCT02649660|α-Galactosidase A|α-galactosidase a
4795168|NCT02649660|Globotriaosylceramide|globotriaosylceramide
4795169|NCT02649660|Gb3|gb3
4795170|NCT02649660|GL-3|gl-3
4795171|NCT02649660|CD77|cd77
4795172|NCT02649660|Alpha-galactosidase|alpha-galactosidase
4795173|NCT02649660|Platelet activation|platelet activation
4795174|NCT02649660|Lysosomal storage disease|lysosomal storage disease
4795175|NCT02649660|LysoGb3|lysogb3
4795176|NCT02649660|Spingosine-1-Phosphate|spingosine-1-phosphate
4795177|NCT02649660|Platelet function|platelet function
4795178|NCT02649660|CD62P|cd62p
4795179|NCT02649660|P-selectin|p-selectin
4795180|NCT02649647|Rectal cancer|rectal cancer
4795181|NCT02649647|Neoadjuvant therapy|neoadjuvant therapy
4795182|NCT02649647|Chemoradiotherapy|chemoradiotherapy
4795183|NCT02649647|Resection margin|resection margin
4795184|NCT02649647|Bowel function|bowel function
4795185|NCT02649647|Anastomosis|anastomosis
4795186|NCT02649634|Motivational Interviewing|motivational interviewing
4795187|NCT02649634|Obesity|obesity
4795188|NCT02649634|Weight Loss|weight loss
4795189|NCT02649634|Behavioral Medicine|behavioral medicine
4795190|NCT02649621|Limbal Stem Cell Deficiency Amniotic Membrane Extract Eye Drop in vivo cultivation|limbal stem cell deficiency amniotic membrane extract eye drop in vivo cultivation
4795191|NCT02649595|Homeless|homeless
4795192|NCT02649595|Homelessness|homelessness
4795193|NCT02649595|Respite care|respite care
4795194|NCT02649595|EQ-5D|eq-5d
4795195|NCT02649595|Quality of life questionnaire|quality of life questionnaire
4795196|NCT02649595|Economic evaluation|economic evaluation
4795197|NCT02649595|Cost-utility analysis|cost-utility analysis
4795198|NCT02649582|Dendritic cells|dendritic cells
4795199|NCT02649582|Chemoimmunotherapy|chemoimmunotherapy
4795200|NCT02649582|Adjuvant therapy|adjuvant therapy
4795201|NCT02649556|Candidate modified risk tobacco product|candidate modified risk tobacco product
4795202|NCT02649556|Conventional cigarette|conventional cigarette
4795203|NCT02649556|Exposure response|exposure response
4795204|NCT02649556|Smoking|smoking
4795205|NCT02649556|Tobacco Heating System|tobacco heating system
4795206|NCT02649543|Surgical Wound Infection|surgical wound infection
4795207|NCT02649543|Negative-Pressure Wound Therapy|negative-pressure wound therapy
4795208|NCT02649543|Wound Closure Techniques|wound closure techniques
4795209|NCT02649543|Laparotomy.|laparotomy.
4795210|NCT02649543|Abdominal Wound Closure Techniques|abdominal wound closure techniques
4795211|NCT02649517|decompensated heart failure|decompensated heart failure
4795212|NCT02649517|ischemic heart disease|ischemic heart disease
4795213|NCT02649517|inflammatory cardiomyopathy|inflammatory cardiomyopathy
4795214|NCT02649491|Radiotherapy|radiotherapy
4795215|NCT02649491|Chemotherapy|chemotherapy
4795216|NCT02649491|Metabonomics|metabonomics
4795217|NCT02649491|Electronic Sensing|electronic sensing
4795218|NCT02649491|GI Toxicity|gi toxicity
4795219|NCT02649452|Whole body Vibration|whole body vibration
4795220|NCT02649439|Vaccine|vaccine
4795221|NCT02649439|PSA|psa
4795222|NCT02649439|Surveillance|surveillance
4795223|NCT02649439|Immunotherapy|immunotherapy
4795224|NCT02649426|denervation|denervation
4795225|NCT02649426|resistant hypertension|resistant hypertension
4795226|NCT02649426|essential hypertension|essential hypertension
4795227|NCT02649361|Anlotinib|anlotinib
4795228|NCT02649335|Non selective beta blockers|non selective beta blockers
4795229|NCT02649335|Ascites|ascites
4795230|NCT02649309|Ischemic Preconditioning|ischemic preconditioning
4795231|NCT02649309|Postconditioning|postconditioning
4795232|NCT02649309|Angioplasty|angioplasty
4795233|NCT02649270|Tolerability|tolerability
4795234|NCT02649270|Safety|safety
4795235|NCT02649270|Pharmacokinetic Study|pharmacokinetic study
4795236|NCT02649270|preliminary pharmacodynamic study|preliminary pharmacodynamic study
4795237|NCT02649270|Humanized Anti-CD6 Monoclonal Antibody(T1h)|humanized anti-cd6 monoclonal antibody(t1h)
4795238|NCT02649257|IOL rotation|iol rotation
4795239|NCT02649257|capsular tension ring|capsular tension ring
4795240|NCT02649257|IOL rotational stability|iol rotational stability
4795241|NCT02649218|QGE031|qge031
4795242|NCT02649218|chronic|chronic
4795243|NCT02649218|spontaneous|spontaneous
4795244|NCT02649218|Urticaria|urticaria
4795245|NCT02649218|CSU|csu
4795246|NCT02649218|adults|adults
4795247|NCT02649218|Safety|safety
4795248|NCT02649192|Children|children
4795249|NCT02649192|Vitamin Supplements|vitamin supplements
4795250|NCT02649192|Influenza virus vaccine|influenza virus vaccine
4795251|NCT02649166|Essential tremor|essential tremor
4795252|NCT02649166|Kinetic tremor|kinetic tremor
4795253|NCT02649166|Intention tremor|intention tremor
4795254|NCT02649140|24-hour urine|24-hour urine
4795255|NCT02649140|Calcium oxalate|calcium oxalate
4795256|NCT02649140|Vinegar|vinegar
4795257|NCT02649127|exercise|exercise
4795258|NCT02649127|biomarker|biomarker
4795259|NCT02649088|microcirculation|microcirculation
4795260|NCT02649088|tissue oxygenation|tissue oxygenation
4795261|NCT02649088|outcome|outcome
4795262|NCT02649075|IBD|ibd
4795263|NCT02649075|Inflammatory Bowel Disease|inflammatory bowel disease
4795264|NCT02649075|Crohn's|crohn's
4795265|NCT02649075|Crohns|crohns
4795266|NCT02649075|SBI|sbi
4795267|NCT02649075|Serum-derived bovine immunoglobulin / protein isolate|serum-derived bovine immunoglobulin / protein isolate
4795268|NCT02649075|EnteraGam|enteragam
4795269|NCT02649010|Type 1 Diabetes|type 1 diabetes
4795270|NCT02649010|Type 2 Diabetes|type 2 diabetes
4795271|NCT02649010|Enlite 3 Sensor|enlite 3 sensor
4795272|NCT02649010|Continuous Glucose Monitoring|continuous glucose monitoring
4795273|NCT02648997|Atypical Meningioma|atypical meningioma
4795274|NCT02648997|Anaplastic Meningioma|anaplastic meningioma
4795275|NCT02648984|Pulmonary vascular disease|pulmonary vascular disease
4795276|NCT02648971|knee|knee
4795277|NCT02648971|arthroscopy|arthroscopy
4795278|NCT02648971|portal|portal
4795279|NCT02648971|meniscus|meniscus
4795280|NCT02648971|cartilage injury|cartilage injury
4795281|NCT02648932|Acute Myeloid Leukemia (AML)|acute myeloid leukemia (aml)
4795282|NCT02648932|High-Risk Myelodysplastic Syndrome (MDS)|high-risk myelodysplastic syndrome (mds)
4795283|NCT02648932|hematopoietic cell transplantation|hematopoietic cell transplantation
4795284|NCT02648932|haplo-cord search|haplo-cord search
4795285|NCT02648932|matched unrelated donor search|matched unrelated donor search
4795286|NCT02648893|iron|iron
4795287|NCT02648893|zinc|zinc
4795288|NCT02648893|vitamin A|vitamin a
4795289|NCT02648893|biofortified|biofortified
4795290|NCT02648893|efficacy|efficacy
4795291|NCT02648893|India|india
4795292|NCT02648893|infant|infant
4795293|NCT02648893|trial|trial
4795294|NCT02648880|Exercise|exercise
4795295|NCT02648880|Physical Activity|physical activity
4795296|NCT02648841|gastric cancer|gastric cancer
4795297|NCT02648841|adjuvant chemo-radiotherapy|adjuvant chemo-radiotherapy
4795298|NCT02648828|Judgment|judgment
4795299|NCT02648828|risk assessment|risk assessment
4795300|NCT02648828|clinical deterioration|clinical deterioration
4795301|NCT02648828|cardiac arrest|cardiac arrest
4795302|NCT02648828|Rothman Index|rothman index
4795303|NCT02648815|Necrotizing pancreatitis|necrotizing pancreatitis
4795304|NCT02648815|Sepsis|sepsis
4795305|NCT02648815|Infection|infection
4795306|NCT02648815|Drainage|drainage
4795307|NCT02648802|breast-conserving surgery(BCS)|breast-conserving surgery(bcs)
4795308|NCT02648802|Cavity shave margin|cavity shave margin
4795309|NCT02648802|Proportion of positive margins|proportion of positive margins
4795310|NCT02648789|Primary oral cancer|primary oral cancer
4795311|NCT02648789|DNA methylation|dna methylation
4795312|NCT02648789|Recurrence oral cancer|recurrence oral cancer
4795313|NCT02648776|hypnotic agents|hypnotic agents
4795314|NCT02648776|sleep disorders|sleep disorders
4795315|NCT02648776|elderly|elderly
4795316|NCT02648750|self-management|self-management
4795317|NCT02648750|rehabilitation|rehabilitation
4795318|NCT02648737|Parkinson's disease|parkinson's disease
4795319|NCT02648737|Cognitive Behavioural therapy|cognitive behavioural therapy
4795320|NCT02648737|generalized anxiety disorder|generalized anxiety disorder
4795321|NCT02648737|social phobia|social phobia
4795322|NCT02648737|cerebral connectivity|cerebral connectivity
4795323|NCT02648724|Advanced Solid Tumor Malignancies|advanced solid tumor malignancies
4795324|NCT02648724|MET Gene Amplification|met gene amplification
4795325|NCT02648724|MET Amplification|met amplification
4795326|NCT02648724|Wild-type|wild-type
4795327|NCT02648724|NSCLC|nsclc
4795328|NCT02648724|METex14|metex14
4795329|NCT02648724|Non-Small Cell Lung Carcinoma|non-small cell lung carcinoma
4795330|NCT02648711|solid tumors|solid tumors
4795331|NCT02648698|chronic endometritis|chronic endometritis
4795332|NCT02648698|CD138|cd138
4795333|NCT02648685|post prandial glucose (PPG)|post prandial glucose (ppg)
4795334|NCT02648685|basal blood glucose (BBG)|basal blood glucose (bbg)
4795335|NCT02648685|overall glycaemia|overall glycaemia
4795336|NCT02648633|Brain Cancer|brain cancer
4795337|NCT02648633|Immunotherapy|immunotherapy
4795338|NCT02648633|Nivolumab|nivolumab
4795339|NCT02648633|Radiosurgery|radiosurgery
4795340|NCT02648633|Gamma Knife|gamma knife
4795341|NCT02648620|Paclitaxel|paclitaxel
4795342|NCT02648620|Percutaneous Transluminal Angioplasty|percutaneous transluminal angioplasty
4795343|NCT02648620|PAD|pad
4795344|NCT02648620|Peripheral Artery Disease|peripheral artery disease
4795345|NCT02648620|Pharmacokinetics|pharmacokinetics
4795346|NCT02648607|Pelvic Girdle Pain|pelvic girdle pain
4795347|NCT02648607|Chronic Pelvic Girdle Pain|chronic pelvic girdle pain
4795348|NCT02648607|Symphysis Pubis Dysfunction|symphysis pubis dysfunction
4795349|NCT02648607|Sacroiliac Joint Dysfunction|sacroiliac joint dysfunction
4795350|NCT02648607|Physiotherapy|physiotherapy
4795351|NCT02648607|Physical Therapy|physical therapy
4795352|NCT02648607|Orthoses|orthoses
4795353|NCT02648607|Orthosis|orthosis
4795354|NCT02648607|Orthotic Devices|orthotic devices
4795355|NCT02648594|lung|lung
4795356|NCT02648594|thoracoscopy|thoracoscopy
4795357|NCT02648594|hook wire localization|hook wire localization
4795358|NCT02648581|Behçet|behçet
4795359|NCT02648581|ulcers|ulcers
4795360|NCT02648581|uveitis|uveitis
4795361|NCT02648581|ustekinumab|ustekinumab
4795362|NCT02648581|biologics|biologics
4795363|NCT02648568|Sleepwalking|sleepwalking
4795364|NCT02648568|sleep terrors|sleep terrors
4795365|NCT02648568|arousal disorders|arousal disorders
4795366|NCT02648568|F513 (CIM-10)|f513 (cim-10)
4795367|NCT02648568|F514 (CIM-10)|f514 (cim-10)
4795368|NCT02648529|Benign childhood epilepsy with centro-temporal spikes|benign childhood epilepsy with centro-temporal spikes
4795369|NCT02648529|rolandic epilepsy|rolandic epilepsy
4795370|NCT02648529|brain development|brain development
4795371|NCT02648529|DTI|dti
4795372|NCT02648529|functional MRI|functional mri
4795373|NCT02648529|structural MRI|structural mri
4795374|NCT02648529|idiopathic focal epilepsy|idiopathic focal epilepsy
4795375|NCT02648529|cryptogenic epilepsy of childhood|cryptogenic epilepsy of childhood
4795376|NCT02648516|Immune Reconstitution|immune reconstitution
4795377|NCT02648516|Allogenic HLA-Mismatched Mononuclear Cells Transplantation|allogenic hla-mismatched mononuclear cells transplantation
4795378|NCT02648503|Sugammadex|sugammadex
4795379|NCT02648503|Post-operative Quality Recovery Scale (PQRS)|post-operative quality recovery scale (pqrs)
4795380|NCT02648490|metastatic or recurrent epithelial cancer|metastatic or recurrent epithelial cancer
4795381|NCT02648464|Hydroxychloroquine|hydroxychloroquine
4795382|NCT02648464|anti-inflammatory|anti-inflammatory
4795383|NCT02648464|Myocardial infarction|myocardial infarction
4795384|NCT02648464|cardiovascular diseases|cardiovascular diseases
4795385|NCT02648438|AZD7594|azd7594
4795386|NCT02648438|Bioavailability|bioavailability
4795387|NCT02648438|Healthy male subjects|healthy male subjects
4795388|NCT02648438|Safety|safety
4795389|NCT02648438|Tolerability|tolerability
4795390|NCT02648438|Pharmacokinetics|pharmacokinetics
4795391|NCT02648438|Monodose inhaler|monodose inhaler
4795392|NCT02648438|Multiple-dose dry powder inhaler|multiple-dose dry powder inhaler
4795393|NCT02648425|ASLAN001|aslan001
4795394|NCT02648399|thyroid carcinoma|thyroid carcinoma
4795395|NCT02648399|center lymph node dissection|center lymph node dissection
4795396|NCT02648360|exercise|exercise
4795397|NCT02648360|diet|diet
4795398|NCT02648360|patients, underserved|patients, underserved
4795399|NCT02648360|text messaging|text messaging
4795400|NCT02648347|vadadustat|vadadustat
4795401|NCT02648347|AKB-6548|akb-6548
4795402|NCT02648347|Chronic kidney disease|chronic kidney disease
4795403|NCT02648347|anemia|anemia
4795404|NCT02648347|CKD|ckd
4795405|NCT02648347|chronic renal insufficiency|chronic renal insufficiency
4795406|NCT02648347|renal impairment|renal impairment
4795407|NCT02648347|erythropoietin|erythropoietin
4795408|NCT02648347|kidney|kidney
4795409|NCT02648347|renal|renal
4795410|NCT02648347|oral anemia treatment|oral anemia treatment
4795411|NCT02648347|hemoglobin|hemoglobin
4795412|NCT02648347|hypoxia-inducible factor|hypoxia-inducible factor
4795413|NCT02648347|HIF|hif
4795414|NCT02648347|hypoxia-inducible factor prolyl-hydroxylase inhibitor|hypoxia-inducible factor prolyl-hydroxylase inhibitor
4795415|NCT02648347|HIF-PHI|hif-phi
4795416|NCT02648347|efficacy|efficacy
4795417|NCT02648347|safety|safety
4795418|NCT02648347|Phase 3|phase 3
4795419|NCT02648347|cardiovascular|cardiovascular
4795420|NCT02648347|NDD-CKD|ndd-ckd
4795421|NCT02648334|Drug-Coated Balloon|drug-coated balloon
4795422|NCT02648334|Superficial Femoral artery|superficial femoral artery
4795423|NCT02648334|popliteal peripheral Artery|popliteal peripheral artery
4795424|NCT02648321|Motivational Interviewing|motivational interviewing
4795425|NCT02648321|Exercise|exercise
4795426|NCT02648308|Education, Medical|education, medical
4795427|NCT02648282|vaccine|vaccine
4795428|NCT02648282|immunotherapy|immunotherapy
4795429|NCT02648282|antibody|antibody
4795430|NCT02648282|PD-1|pd-1
4795431|NCT02648282|radiation|radiation
4795432|NCT02648256|Pneumocystis jirovecii|pneumocystis jirovecii
4795433|NCT02648256|Polymerase Chain Reaction|polymerase chain reaction
4795434|NCT02648256|Oropharyngeal Rinse|oropharyngeal rinse
4795435|NCT02648243|Qatar|qatar
4795436|NCT02648243|Acute Coronary Syndrome|acute coronary syndrome
4795437|NCT02648243|Pharmacist|pharmacist
4795438|NCT02648243|Medication burden|medication burden
4795439|NCT02648243|Mortality|mortality
4795440|NCT02648243|Readmission|readmission
4795441|NCT02648243|Adherence|adherence
4795442|NCT02648243|Impact|impact
4795443|NCT02648230|Ischemia|ischemia
4795444|NCT02648230|Fractional Flow Reserve|fractional flow reserve
4795445|NCT02648230|Stent|stent
4795446|NCT02648191|Obesity|obesity
4795447|NCT02648191|Bariatric Surgery|bariatric surgery
4795448|NCT02648191|No invasive intra-auricular vagus nerve stimulation|no invasive intra-auricular vagus nerve stimulation
4795449|NCT02648191|Weight loss|weight loss
4795450|NCT02648191|Autonomic nervous system|autonomic nervous system
4795451|NCT02648113|Myocardial Infarction|myocardial infarction
4795452|NCT02648113|Anemia|anemia
4795453|NCT02648113|Blood Transfusion|blood transfusion
4795454|NCT02648100|Muscle invasive bladder cancer|muscle invasive bladder cancer
4795455|NCT02648100|Basal subtype|basal subtype
4795456|NCT02648100|Anti-EGFR treatment|anti-egfr treatment
4795457|NCT02648100|Nanostring|nanostring
4795458|NCT02648074|asthma|asthma
4795459|NCT02648074|eosinophils|eosinophils
4795460|NCT02648074|airway smooth muscle|airway smooth muscle
4795461|NCT02648074|airway remodelling|airway remodelling
4795462|NCT02648074|integrins|integrins
4795463|NCT02648074|cytokines|cytokines
4795464|NCT02648061|Blood circulation|blood circulation
4795465|NCT02648061|Follow-up studies|follow-up studies
4795466|NCT02648061|Biological markers|biological markers
4795467|NCT02648061|Hemodynamics|hemodynamics
4795468|NCT02648048|Idiopathic Pulmonary Fibrosis|idiopathic pulmonary fibrosis
4795469|NCT02648048|Vismodegib|vismodegib
4795470|NCT02648048|Pirfenidone|pirfenidone
4795471|NCT02648022|Care Integration|care integration
4795472|NCT02648022|Hepatitis C|hepatitis c
4795473|NCT02648022|Substance Use Disorder|substance use disorder
4795474|NCT02648022|PTSD|ptsd
4795475|NCT02647970|Energy metabolism|energy metabolism
4795476|NCT02647957|acute ischemic stroke|acute ischemic stroke
4795477|NCT02647957|quality|quality
4795478|NCT02647905|type 1 diabetes|type 1 diabetes
4795479|NCT02647905|type 2 diabetes|type 2 diabetes
4795480|NCT02647905|CGM|cgm
4795481|NCT02647905|implantable|implantable
4795482|NCT02647905|accuracy|accuracy
4795483|NCT02647905|longevity|longevity
4795484|NCT02647866|4083-002|4083-002
4795485|NCT02647866|Intestinal Diseases|intestinal diseases
4795486|NCT02647866|Ulcerative Colitis|ulcerative colitis
4795487|NCT02647866|UC|uc
4795488|NCT02647866|Mayo Clinic Scoring|mayo clinic scoring
4795489|NCT02647866|Gastrointestinal Tract|gastrointestinal tract
4795490|NCT02647840|dysphonia|dysphonia
4795491|NCT02647840|voice therapy|voice therapy
4795492|NCT02647827|Acupuncture|acupuncture
4795493|NCT02647827|Metformin|metformin
4795494|NCT02647827|Glucose metabolism|glucose metabolism
4795495|NCT02647827|Hba1c|hba1c
4795496|NCT02647814|Parent activation|parent activation
4795497|NCT02647814|Text-messages|text-messages
4795498|NCT02647814|LEP|lep
4795499|NCT02647814|Latino populations|latino populations
4795500|NCT02647814|pediatrics|pediatrics
4795501|NCT02647801|Network approach|network approach
4795502|NCT02647801|mindfulness|mindfulness
4795503|NCT02647801|self-control|self-control
4795504|NCT02647801|ambulatory assessment|ambulatory assessment
4795505|NCT02647788|Pain, Postoperative|pain, postoperative
4795506|NCT02647775|Thoracoscopic surgery|thoracoscopic surgery
4795507|NCT02647723|Omega-3|omega-3
4795508|NCT02647723|Fatty acid|fatty acid
4795509|NCT02647723|docosahexaenoic|docosahexaenoic
4795510|NCT02647723|Pregnant|pregnant
4795511|NCT02647723|neurodevelopment|neurodevelopment
4795512|NCT02647723|stress|stress
4795513|NCT02647723|urban|urban
4795514|NCT02647723|african-american|african-american
4795515|NCT02647723|supplement|supplement
4795516|NCT02647723|nutrition|nutrition
4795517|NCT02647723|mental health|mental health
4795518|NCT02647710|HIV Prevention|hiv prevention
4795519|NCT02647710|Juvenile Justice|juvenile justice
4795520|NCT02647710|Sexual Health|sexual health
4795521|NCT02647710|Evidence Based Intervention|evidence based intervention
4795522|NCT02647697|UCB3491|ucb3491
4795523|NCT02647697|Phase 1|phase 1
4795524|NCT02647697|Pharmacokinetics|pharmacokinetics
4795525|NCT02647697|Radiprodil|radiprodil
4795526|NCT02647697|Healthy volunteers|healthy volunteers
4795527|NCT02647684|Cancer|cancer
4795528|NCT02647684|Parenting|parenting
4795529|NCT02647684|Self-directed Triple P|self-directed triple p
4795530|NCT02647671|Colon polyp|colon polyp
4795531|NCT02647671|Colorectal cancer|colorectal cancer
4795532|NCT02647671|Chemoprevention|chemoprevention
4795533|NCT02647671|Natural product|natural product
4795534|NCT02647658|acute low back pain|acute low back pain
4795535|NCT02647658|primary care|primary care
4795536|NCT02647658|psychologically informed physical therapy|psychologically informed physical therapy
4795537|NCT02647658|cluster randomized pragmatic trial|cluster randomized pragmatic trial
4795538|NCT02647658|comparative effectiveness|comparative effectiveness
4795539|NCT02647658|secondary prevention|secondary prevention
4795540|NCT02647632|HCV genotype 1 or 4|hcv genotype 1 or 4
4795541|NCT02647632|failure to DAA|failure to daa
4795542|NCT02647619|Primary Dd disase|primary dd disase
4795543|NCT02647619|MCP joint|mcp joint
4795544|NCT02647580|Growth|growth
4795545|NCT02647580|Children|children
4795546|NCT02647580|Appetite-regulating hormones|appetite-regulating hormones
4795547|NCT02647580|Gut Microbiota|gut microbiota
4795548|NCT02647567|Cognitive|cognitive
4795549|NCT02647567|Aerobic Exercise|aerobic exercise
4795550|NCT02647567|Performance|performance
4795551|NCT02647554|sepsis|sepsis
4795552|NCT02647554|septic shock|septic shock
4795553|NCT02647554|Ulinastatin|ulinastatin
4795554|NCT02647554|adult|adult
4795555|NCT02647554|China|china
4795556|NCT02647541|Children|children
4795557|NCT02647541|Congenital heart disease|congenital heart disease
4795558|NCT02647541|Nutritional status|nutritional status
4795559|NCT02647541|Bioelectrical impedance|bioelectrical impedance
4795560|NCT02647476|immunonutrition|immunonutrition
4795561|NCT02647476|gastric cancer|gastric cancer
4795562|NCT02647476|enteral nutrition|enteral nutrition
4795563|NCT02647463|Attachment|attachment
4795564|NCT02647463|Cortisol|cortisol
4795565|NCT02647463|Parent sensitivity|parent sensitivity
4795566|NCT02647411|Prevalence|prevalence
4795567|NCT02647411|Myopia|myopia
4795568|NCT02647398|Cancer survivors|cancer survivors
4795569|NCT02647398|training|training
4795570|NCT02647398|exercise|exercise
4795571|NCT02647398|cancer-related fatigue|cancer-related fatigue
4795572|NCT02647385|serratus anterior plane block|serratus anterior plane block
4795573|NCT02647385|pectoral nerve block|pectoral nerve block
4795574|NCT02647385|breast surgery|breast surgery
4795575|NCT02647385|cancer|cancer
4795576|NCT02647385|analgesia|analgesia
4795577|NCT02647385|inflammatory cytokines|inflammatory cytokines
4795578|NCT02647372|parkinson|parkinson
4795579|NCT02647372|deep brain stimulation|deep brain stimulation
4795580|NCT02647372|globus pallidus|globus pallidus
4795581|NCT02647372|subthalamic nucleus|subthalamic nucleus
4795582|NCT02647320|type 2 diabetes mellitus|type 2 diabetes mellitus
4795583|NCT02647320|interventional|interventional
4795584|NCT02647320|double blind|double blind
4795585|NCT02647320|phase 2|phase 2
4795586|NCT02647281|Single dose|single dose
4795587|NCT02647281|Multiple ascending doses (MAD)|multiple ascending doses (mad)
4795588|NCT02647281|Pharmacokinetics|pharmacokinetics
4795589|NCT02647281|Safety|safety
4795590|NCT02647281|GSK3389404|gsk3389404
4795591|NCT02647281|Tolerability|tolerability
4795592|NCT02647268|Uterine contraction|uterine contraction
4795593|NCT02647268|Oxytocin|oxytocin
4795594|NCT02647268|Magnesium sulphate|magnesium sulphate
4795595|NCT02647255|crescentic IgA nephropathy|crescentic iga nephropathy
4795596|NCT02647255|plasma exchange treatment or plasmapheresis|plasma exchange treatment or plasmapheresis
4795597|NCT02647255|randomized controlled trial|randomized controlled trial
4795598|NCT02647255|intensive immunosuppressive treatment|intensive immunosuppressive treatment
4795599|NCT02647255|methylprednisolone pulse|methylprednisolone pulse
4795600|NCT02647216|Mindfulness Based Cognitive Therapy (MBCT)|mindfulness based cognitive therapy (mbct)
4795601|NCT02647216|anxiety|anxiety
4795602|NCT02647216|depression|depression
4795603|NCT02647203|Fluoride toothpaste|fluoride toothpaste
4795604|NCT02647203|Root caries|root caries
4795605|NCT02647203|Randomized clinical trial|randomized clinical trial
4795606|NCT02647190|Erwinia Chrysanthemi Asparaginase|erwinia chrysanthemi asparaginase
4795607|NCT02647190|15-107|15-107
4795608|NCT02647164|Non-small-cell lung carcinoma|non-small-cell lung carcinoma
4795609|NCT02647164|Circulating tumor cells|circulating tumor cells
4795610|NCT02647151|Acid Methyl Aminolevulinate (MAL)|acid methyl aminolevulinate (mal)
4795611|NCT02647151|Aminolevulinic Gel (ALA) and Actinic Keratosis|aminolevulinic gel (ala) and actinic keratosis
4795612|NCT02647112|Bladder cancer|bladder cancer
4795613|NCT02647112|Urine|urine
4795614|NCT02647112|Methylation|methylation
4795615|NCT02647099|Aspirin|aspirin
4795616|NCT02647099|PI3K signaling pathway|pi3k signaling pathway
4795617|NCT02647086|Eczema|eczema
4795618|NCT02647073|Mobile Monitoring|mobile monitoring
4795619|NCT02647073|Post-Opioid Consumption|post-opioid consumption
4795620|NCT02647073|Vital Signs|vital signs
4795621|NCT02647060|cardiopulmonary exercise testing|cardiopulmonary exercise testing
4795622|NCT02647060|right ventricle function|right ventricle function
4795623|NCT02647060|cardio output|cardio output
4795624|NCT02647060|pulmonary hypertension|pulmonary hypertension
4795625|NCT02647060|quality of life|quality of life
4795626|NCT02647047|spinal analgesia|spinal analgesia
4795627|NCT02647047|epidural analgesia|epidural analgesia
4795628|NCT02647047|laparotomic liver resection|laparotomic liver resection
4795629|NCT02647047|ERAS|eras
4795630|NCT02647047|length of stay|length of stay
4795631|NCT02647021|physical therapy|physical therapy
4795632|NCT02647021|cancer rehabilitation|cancer rehabilitation
4795633|NCT02647021|exercise|exercise
4795634|NCT02647008|outpatient hysteroscopy, TENS|outpatient hysteroscopy, tens
4795635|NCT02646982|Alzheimer's disease|alzheimer's disease
4795636|NCT02646982|Vascular function|vascular function
4795637|NCT02646982|Neuroinflammation|neuroinflammation
4795638|NCT02646956|Sweet Taste|sweet taste
4795639|NCT02646956|Psychophysics|psychophysics
4795640|NCT02646956|Genetics|genetics
4795641|NCT02646956|Diet|diet
4795642|NCT02646956|Age|age
4795643|NCT02646956|Nonnutritive Sweetener|nonnutritive sweetener
4795644|NCT02646943|Cohort|cohort
4795645|NCT02646943|Biomarkers|biomarkers
4795646|NCT02646943|Cardiomyopathy|cardiomyopathy
4795647|NCT02646930|chronic endometritis|chronic endometritis
4795648|NCT02646930|invitro fertilization|invitro fertilization
4795649|NCT02646930|spontaneous abortion|spontaneous abortion
4795650|NCT02646891|Rotavirus Vaccine|rotavirus vaccine
4795651|NCT02646878|Type 1 Diabetes|type 1 diabetes
4795652|NCT02646878|Type 2 Diabetes|type 2 diabetes
4795653|NCT02646878|Harmony Sensor|harmony sensor
4795654|NCT02646878|Continuous Glucose Monitoring|continuous glucose monitoring
4795655|NCT02646878|CGM|cgm
4795656|NCT02646865|social phobia|social phobia
4795657|NCT02646865|compassion|compassion
4795659|NCT02646839|Acute Lymphoblastic Leukemia (ALL)|acute lymphoblastic leukemia (all)
4795660|NCT02646839|Acute Myeloid Leukemia (AML)|acute myeloid leukemia (aml)
4795661|NCT02646839|Myelodysplastic Syndrome (MDS)|myelodysplastic syndrome (mds)
4795662|NCT02646839|KIR-Favorable|kir-favorable
4795663|NCT02646839|Haploidentical Transplantation|haploidentical transplantation
4795664|NCT02646839|Allogeneic Hematopoietic Cell Transplantation|allogeneic hematopoietic cell transplantation
4795665|NCT02646800|Micafungin|micafungin
4795666|NCT02646800|Candidiasis|candidiasis
4795667|NCT02646800|Aspergillosis|aspergillosis
4795668|NCT02646800|Antifungal|antifungal
4795669|NCT02646774|Aspergillosis|aspergillosis
4795670|NCT02646774|Antifungal|antifungal
4795671|NCT02646774|Micafungin|micafungin
4795672|NCT02646748|Advanced|advanced
4795673|NCT02646670|diabetic macular edema|diabetic macular edema
4795674|NCT02646670|aflibercept|aflibercept
4795675|NCT02646670|ranibizumab|ranibizumab
4795676|NCT02646605|Depression|depression
4795677|NCT02646605|AIDS|aids
4795678|NCT02646605|HIV|hiv
4795679|NCT02646579|Orthopedics|orthopedics
4795680|NCT02646527|dignity, end of life, existential, treatment|dignity, end of life, existential, treatment
4795681|NCT02646514|Cholangiocarcinoma, radiofrequency ablation, metal stent|cholangiocarcinoma, radiofrequency ablation, metal stent
4795682|NCT02646488|cholesterol|cholesterol
4795683|NCT02646488|smoking|smoking
4795684|NCT02646488|aspirin|aspirin
4795685|NCT02646488|chronic care model|chronic care model
4795686|NCT02646475|renin-angiotensin system|renin-angiotensin system
4795687|NCT02646475|angiotensin|angiotensin
4795688|NCT02646475|insulin resistance|insulin resistance
4795689|NCT02646475|blood pressure|blood pressure
4795690|NCT02646462|pancreas adenocarcinoma, lymph node metastases|pancreas adenocarcinoma, lymph node metastases
4795691|NCT02646449|Major Depressive Disorder|major depressive disorder
4795692|NCT02646449|Alcohol Use Disorder|alcohol use disorder
4795693|NCT02646436|unplanned peritoneal dialysis|unplanned peritoneal dialysis
4795694|NCT02646436|unplanned heamodialysis|unplanned heamodialysis
4795695|NCT02646423|Trial of labor after cesarean|trial of labor after cesarean
4795696|NCT02646423|Elective repeat cesarean delivery|elective repeat cesarean delivery
4795697|NCT02646423|Decision tool|decision tool
4795698|NCT02646423|Shared decision making|shared decision making
4795699|NCT02646410|malaria|malaria
4795700|NCT02646410|seasonal malaria chemoprevention|seasonal malaria chemoprevention
4795701|NCT02646410|immunity|immunity
4795702|NCT02646410|resistance|resistance
4795703|NCT02646410|sulfadoxine-pyrimethamine|sulfadoxine-pyrimethamine
4795704|NCT02646410|amodiaquine|amodiaquine
4795705|NCT02646410|delivery method|delivery method
4795706|NCT02646397|glomerular filtration rate|glomerular filtration rate
4795707|NCT02646397|hypertension|hypertension
4795708|NCT02646345|Checklist|checklist
4795709|NCT02646345|Mortality|mortality
4795710|NCT02646345|Latin America|latin america
4795711|NCT02646345|Surgery|surgery
4795712|NCT02646345|Morbidity|morbidity
4795713|NCT02646332|Helicobacter pylori|helicobacter pylori
4795714|NCT02646332|Eradication rate|eradication rate
4795715|NCT02646306|shoulder|shoulder
4795716|NCT02646306|proprioception|proprioception
4795717|NCT02646306|movement|movement
4795718|NCT02646306|reaching|reaching
4795719|NCT02646280|Low back pain|low back pain
4795720|NCT02646280|interoceptive awareness|interoceptive awareness
4795721|NCT02646280|motor imagery|motor imagery
4795722|NCT02646280|massage|massage
4795723|NCT02646267|Atrial fibrillation|atrial fibrillation
4795724|NCT02646267|Dabigatran|dabigatran
4795725|NCT02646267|Warfarin|warfarin
4795726|NCT02646267|Anticoagulation|anticoagulation
4795727|NCT02646267|Elderly|elderly
4795728|NCT02646254|tetralogy of fallot, cardioplegia|tetralogy of fallot, cardioplegia
4795729|NCT02646241|stomach neoplasm|stomach neoplasm
4795730|NCT02646241|biopsy|biopsy
4796211|NCT02643290|Orthosis|orthosis
4795731|NCT02646150|Magnetic Resonance perfusion imaging|magnetic resonance perfusion imaging
4795732|NCT02646150|distal perfusion|distal perfusion
4795733|NCT02646150|Critical Limb Ischemia|critical limb ischemia
4795734|NCT02646150|endovascular revascularization|endovascular revascularization
4795735|NCT02646124|benzodiazepine|benzodiazepine
4795736|NCT02646111|"Hepatitis C Virus"|"hepatitis c virus"
4795737|NCT02646111|"Triple Therapy"|"triple therapy"
4795738|NCT02646111|"PI Failure"|"pi failure"
4795739|NCT02646111|"Genotype 1"|"genotype 1"
4795740|NCT02646098|NHL|nhl
4795741|NCT02646098|mantle cell lymphoma|mantle cell lymphoma
4795742|NCT02646098|diffuse large B-cell lymphoma|diffuse large b-cell lymphoma
4795743|NCT02646072|diabetes mellitus|diabetes mellitus
4795744|NCT02646072|aqueous humor|aqueous humor
4795745|NCT02646072|inflammatory cytokines|inflammatory cytokines
4795746|NCT02646072|cystoid macular edema, postoperative|cystoid macular edema, postoperative
4795747|NCT02646072|nonsteroidal anti-inflammatory drugs|nonsteroidal anti-inflammatory drugs
4795748|NCT02646046|Cardiopulmonary Resuscitation|cardiopulmonary resuscitation
4795749|NCT02646046|Emergency Medical Services|emergency medical services
4795750|NCT02646046|Cell phones|cell phones
4795751|NCT02646046|Simulation Training|simulation training
4795752|NCT02646033|Intraocular Pressure, Trendelenburg position|intraocular pressure, trendelenburg position
4795753|NCT02646020|pruritus|pruritus
4795754|NCT02646020|Non-small Cell Lung Cancer|non-small cell lung cancer
4795755|NCT02646020|Receptor, Epidermal Growth Factor|receptor, epidermal growth factor
4795756|NCT02646020|tyrosine kinase inhibitor|tyrosine kinase inhibitor
4795757|NCT02646007|Autologous Cell therapy Kienböck's disease|autologous cell therapy kienböck's disease
4795758|NCT02646007|bone marrow derived mesenchymal stromal/stem cell|bone marrow derived mesenchymal stromal/stem cell
4795759|NCT02645994|Closed Loop Anesthesia Delivery System|closed loop anesthesia delivery system
4795760|NCT02645994|Target Controlled Infusion|target controlled infusion
4795761|NCT02645981|Donafeinb|donafeinb
4795762|NCT02645981|Sorafenib|sorafenib
4795763|NCT02645981|Phase 3|phase 3
4795764|NCT02645981|Overall Survival|overall survival
4795765|NCT02645968|Pneumology|pneumology
4795766|NCT02645968|Registry|registry
4795767|NCT02645968|EXCITING|exciting
4795768|NCT02645968|Interstitial lung disease|interstitial lung disease
4795769|NCT02645968|ILD|ild
4795770|NCT02645942|Carnitine|carnitine
4795771|NCT02645942|placebo|placebo
4795772|NCT02645942|risk factors|risk factors
4795773|NCT02645916|Cold Hypersensitivity in the Hands|cold hypersensitivity in the hands
4795774|NCT02645916|Korean medicine|korean medicine
4795775|NCT02645916|DSGOST|dsgost
4795776|NCT02645903|transversus abdominis plane block|transversus abdominis plane block
4795777|NCT02645903|living liver transplantation|living liver transplantation
4795778|NCT02645903|postoperative analgesia|postoperative analgesia
4795779|NCT02645890|Benign Prostatic Hyperplasia|benign prostatic hyperplasia
4795780|NCT02645890|Healthy Male Volunteer|healthy male volunteer
4795781|NCT02645890|Tamsulosin|tamsulosin
4795782|NCT02645890|Tadalafil|tadalafil
4795783|NCT02645877|Pre-hospital Care|pre-hospital care
4795784|NCT02645877|Diseases Spectrum|diseases spectrum
4795785|NCT02645877|Call Demands|call demands
4795786|NCT02645877|Emergency Response Time|emergency response time
4795787|NCT02645864|Esophageal squamous cell carcinoma|esophageal squamous cell carcinoma
4795788|NCT02645864|Apatinib|apatinib
4795789|NCT02645864|Irinotecan|irinotecan
4795790|NCT02645851|Fluid Therapy|fluid therapy
4795791|NCT02645851|Plasma Substitutes|plasma substitutes
4795792|NCT02645851|Fluid Balance|fluid balance
4795793|NCT02645838|Motivational Interviewing|motivational interviewing
4795794|NCT02645838|Smoking Cessation|smoking cessation
4795795|NCT02645825|superficial adenopathy - echography|superficial adenopathy - echography
4795796|NCT02645812|Fatigue|fatigue
4795797|NCT02645812|Brief Fatigue Inventory (BFI)|brief fatigue inventory (bfi)
4795798|NCT02645812|Primary care|primary care
4795799|NCT02645812|General Practitioners|general practitioners
4795800|NCT02645786|thyroid neoplasms|thyroid neoplasms
4795801|NCT02645786|heart|heart
4795802|NCT02645786|thyroxine|thyroxine
4795803|NCT02645786|thyrotoxicosis|thyrotoxicosis
4795804|NCT02645708|RIRS|rirs
4795805|NCT02645708|EPVL|epvl
4795806|NCT02645708|PDI(Percussion,Diuresis,Inversion)|pdi(percussion,diuresis,inversion)
4795807|NCT02645708|Randomized Controlled Trial|randomized controlled trial
4795808|NCT02645695|Pulmonary Rehabilitation|pulmonary rehabilitation
4795809|NCT02645695|Chest Physiotherapy|chest physiotherapy
4795810|NCT02645695|High Frequency Chest Wall Oscillation|high frequency chest wall oscillation
4795811|NCT02645682|central venous catheter (CVC)|central venous catheter (cvc)
4795812|NCT02645682|catheter-related bloodstream infection (CRBSI)|catheter-related bloodstream infection (crbsi)
4795813|NCT02645682|catheter-related thrombosis (CRT)|catheter-related thrombosis (crt)
4795814|NCT02645656|Oral Submucous Fibrosis|oral submucous fibrosis
4795815|NCT02645656|Curcumin|curcumin
4795816|NCT02645643|medical students|medical students
4795817|NCT02645643|professionalism|professionalism
4795818|NCT02645643|medical education|medical education
4795819|NCT02645643|study emotion|study emotion
4795820|NCT02645630|Cervical spine|cervical spine
4795821|NCT02645630|Spinal manipulation|spinal manipulation
4796212|NCT02643264|insula|insula
4795822|NCT02645604|Artemisinin Combination Therapy (ACT)|artemisinin combination therapy (act)
4795823|NCT02645591|Prostate cancer|prostate cancer
4795824|NCT02645591|Dehydrated human amnion/chorion membrane|dehydrated human amnion/chorion membrane
4795825|NCT02645591|dHACM|dhacm
4795826|NCT02645591|Robotic assisted laparoscopic radical prostatectomy|robotic assisted laparoscopic radical prostatectomy
4795827|NCT02645591|RARP|rarp
4795828|NCT02645591|AmnioFix®|amniofix®
4795829|NCT02645591|Sexual function score|sexual function score
4795830|NCT02645591|Neurovascular bundle inflammation|neurovascular bundle inflammation
4795831|NCT02645591|Questionnaire|questionnaire
4795832|NCT02645591|Survey|survey
4795833|NCT02645578|Coma|coma
4795834|NCT02645578|traumatic brain injury|traumatic brain injury
4795835|NCT02645578|median nerve stimulation|median nerve stimulation
4795836|NCT02645552|Traumatic brain injury|traumatic brain injury
4795837|NCT02645539|Heart failure|heart failure
4795838|NCT02645539|Bridge-to-transplant|bridge-to-transplant
4795839|NCT02645539|circulatory support|circulatory support
4795840|NCT02645539|VAD|vad
4795841|NCT02645539|IABP|iabp
4795842|NCT02645513|mHealth|mhealth
4795843|NCT02645513|text message|text message
4795844|NCT02645513|case management|case management
4795845|NCT02645500|Physical Activity|physical activity
4795846|NCT02645500|Family well-being|family well-being
4795847|NCT02645448|Resistance Exercise|resistance exercise
4795848|NCT02645448|Diabetes Mellitus|diabetes mellitus
4795849|NCT02645448|Heart Rate Variability|heart rate variability
4795850|NCT02645409|Fluorescence|fluorescence
4795851|NCT02645409|Imaging|imaging
4795852|NCT02645409|Partial nephrectomy|partial nephrectomy
4795853|NCT02645409|Radical nephrectomy|radical nephrectomy
4795854|NCT02645396|Cytomegalovirus|cytomegalovirus
4795855|NCT02645383|Pattern scan laser|pattern scan laser
4795856|NCT02645383|Proliferative diabetic retinopathy|proliferative diabetic retinopathy
4795857|NCT02645383|Pain|pain
4795858|NCT02645370|Migraine|migraine
4795859|NCT02645370|Danzhen|danzhen
4795860|NCT02645370|Topiramate|topiramate
4795861|NCT02645370|Headache diary APP|headache diary app
4795862|NCT02645370|preventive treatment|preventive treatment
4795863|NCT02645357|Oncology Patients|oncology patients
4795864|NCT02645357|evidence-based|evidence-based
4795865|NCT02645357|computerized|computerized
4795866|NCT02645357|decision|decision
4795867|NCT02645357|support system|support system
4795868|NCT02645357|linked|linked
4795869|NCT02645357|electronic health records|electronic health records
4795870|NCT02645344|Unilateral neglect|unilateral neglect
4795871|NCT02645344|Right hemiplegia|right hemiplegia
4795872|NCT02645318|Circulating Tumor DNA|circulating tumor dna
4795873|NCT02645318|Lung cancer|lung cancer
4795874|NCT02645318|Targeted sequencing|targeted sequencing
4795875|NCT02645305|Safety and Efficacy|safety and efficacy
4795876|NCT02645305|Adipose stem cells|adipose stem cells
4795877|NCT02645305|Stem Cell therapy|stem cell therapy
4795878|NCT02645279|newborn|newborn
4795879|NCT02645279|MRI|mri
4795880|NCT02645279|oral 30% glucose|oral 30% glucose
4795881|NCT02645253|Safety|safety
4795882|NCT02645253|Pharmacokinetics|pharmacokinetics
4795883|NCT02645253|Pharmacodynamics|pharmacodynamics
4795884|NCT02645253|Glucocorticoid receptor modulator|glucocorticoid receptor modulator
4795885|NCT02645253|Healthy male subjects|healthy male subjects
4795886|NCT02645201|probiotic|probiotic
4795887|NCT02645188|Electromyography|electromyography
4795888|NCT02645188|Exercise|exercise
4795889|NCT02645175|Paclitaxel|paclitaxel
4795890|NCT02645175|docetaxel|docetaxel
4795891|NCT02645175|vinorelbine|vinorelbine
4795892|NCT02645175|eribulin|eribulin
4795893|NCT02645162|Pakistan|pakistan
4795894|NCT02645162|Early Child Development, Care and Education|early child development, care and education
4795895|NCT02645162|Youth Leaders|youth leaders
4795896|NCT02645149|Metastatic Melanoma|metastatic melanoma
4795897|NCT02645149|Molecular Testing|molecular testing
4795898|NCT02645149|Targeted Therapy|targeted therapy
4795899|NCT02645123|spinal mobilization|spinal mobilization
4795900|NCT02645123|manual therapy|manual therapy
4795901|NCT02645123|gait analysis|gait analysis
4795902|NCT02645123|low back pain|low back pain
4795903|NCT02645123|chronic|chronic
4795904|NCT02645097|Adult|adult
4795905|NCT02645097|nerve blocks in foot and ankle surgery|nerve blocks in foot and ankle surgery
4795906|NCT02645097|saphenous|saphenous
4795907|NCT02645071|physical activity|physical activity
4795908|NCT02645071|family well being,|family well being,
4795909|NCT02645071|health|health
4795910|NCT02645058|Ureterorenoscopy|ureterorenoscopy
4795911|NCT02645058|extracorporeal shock waves lithotripsy|extracorporeal shock waves lithotripsy
4795912|NCT02645045|Dry eye|dry eye
4795913|NCT02645045|Lipiview|lipiview
4795914|NCT02645045|Tear Lipid Layer|tear lipid layer
4795915|NCT02645045|meibomian gland dysfunction|meibomian gland dysfunction
4795916|NCT02645032|Typhoid conjugate vaccine|typhoid conjugate vaccine
4795917|NCT02645032|Vi-DT|vi-dt
4795918|NCT02645032|Safety|safety
4795919|NCT02645032|Immunogenicuty|immunogenicuty
4795920|NCT02645006|falls|falls
4795921|NCT02645006|elderly|elderly
4795922|NCT02645006|Exercise,Physical|exercise,physical
4795923|NCT02645006|vitamin d|vitamin d
4795924|NCT02645006|home hazards|home hazards
4795925|NCT02645006|mediterranean diet|mediterranean diet
4795926|NCT02645006|body mass index|body mass index
4795927|NCT02645006|lower extremity exercise movement technics|lower extremity exercise movement technics
4795928|NCT02645006|vitamin D intake|vitamin d intake
4795929|NCT02645006|Short Physical Performance Battery (SPPB o Test de Guralnik)|short physical performance battery (sppb o test de guralnik)
4795930|NCT02644980|Target Controlled Infusion|target controlled infusion
4795931|NCT02644967|ILLUMINATE- 204|illuminate- 204
4795932|NCT02644954|psoriasis|psoriasis
4795933|NCT02644954|Metformin|metformin
4795934|NCT02644928|Chronic kidney disease|chronic kidney disease
4795935|NCT02644928|Bariatric Surgery Candidate|bariatric surgery candidate
4795936|NCT02644928|Caloric restriction|caloric restriction
4795937|NCT02644915|ischemia-reperfusion(I/R) injury|ischemia-reperfusion(i/r) injury
4795938|NCT02644915|Edaravone|edaravone
4795939|NCT02644902|Avatar assisted cascade training and supervision|avatar assisted cascade training and supervision
4795940|NCT02644902|maternal depression|maternal depression
4795941|NCT02644902|postconflict|postconflict
4795942|NCT02644902|THP|thp
4795943|NCT02644889|Epidermal growth factor receptor(EGFR)|epidermal growth factor receptor(egfr)
4795944|NCT02644889|NSCLC|nsclc
4795945|NCT02644876|Postoperative pulmonary complications|postoperative pulmonary complications
4795946|NCT02644876|Selective anticholinergic bronchodilator|selective anticholinergic bronchodilator
4795947|NCT02644876|High risk patients|high risk patients
4795948|NCT02644876|Postoperative period|postoperative period
4795949|NCT02644876|Postoperative complications|postoperative complications
4795950|NCT02644824|Congenital Heart Disease (CHD)|congenital heart disease (chd)
4795951|NCT02644824|Cardiopulmonary Bypass (CPB)|cardiopulmonary bypass (cpb)
4795952|NCT02644824|Cardiac Index|cardiac index
4795953|NCT02644824|Hemodynamics|hemodynamics
4795954|NCT02644824|Pediatrics|pediatrics
4795955|NCT02644811|Miniscrew|miniscrew
4795956|NCT02644811|Temporary anchorage device (TAD)|temporary anchorage device (tad)
4795957|NCT02644811|mini-implants|mini-implants
4795958|NCT02644811|Miniscrew implant (MSI)|miniscrew implant (msi)
4795959|NCT02644798|ARDS|ards
4795960|NCT02644798|Gene polymorphism|gene polymorphism
4795961|NCT02644785|cardiac by-pass|cardiac by-pass
4795962|NCT02644785|protamine|protamine
4795963|NCT02644785|tryptase|tryptase
4795964|NCT02644785|hypotension|hypotension
4795965|NCT02644785|anaphylaxis|anaphylaxis
4795966|NCT02644772|Acute Exacerbation of COPD|acute exacerbation of copd
4795967|NCT02644772|Clinical problems in COPD|clinical problems in copd
4795968|NCT02644759|Stem Cells|stem cells
4795969|NCT02644759|Transplantation|transplantation
4795970|NCT02644759|Immunomodulation|immunomodulation
4795971|NCT02644759|CD34|cd34
4795972|NCT02644759|CD133|cd133
4795973|NCT02644759|ClinicMACS|clinicmacs
4795974|NCT02644746|degenerative lumbar spinal stenosis|degenerative lumbar spinal stenosis
4795975|NCT02644746|acupuncture|acupuncture
4795976|NCT02644746|randomized controlled trial|randomized controlled trial
4795977|NCT02644655|Recurrent B-Cell Tumor|recurrent b-cell tumor
4795978|NCT02644655|Refractory B-Cell Tumor|refractory b-cell tumor
4795979|NCT02644655|New Cluster of Differentiation Antigen 19-chimeric Antigen Receptor T Cells|new cluster of differentiation antigen 19-chimeric antigen receptor t cells
4795980|NCT02644655|safety|safety
4795981|NCT02644655|prognosis|prognosis
4795982|NCT02644616|tolvaptan|tolvaptan
4795983|NCT02644616|safety and efficacy|safety and efficacy
4795984|NCT02644616|left heart valves replacement|left heart valves replacement
4795985|NCT02644603|Enhanced Recovery After Surgery|enhanced recovery after surgery
4795986|NCT02644603|hepatocellular carcinoma|hepatocellular carcinoma
4795987|NCT02644590|Melatonin|melatonin
4795988|NCT02644590|Nocturnal Hypertension|nocturnal hypertension
4795989|NCT02644590|Type 1 Diabetes Melitus|type 1 diabetes melitus
4795990|NCT02644577|Metformin|metformin
4795991|NCT02644577|antipsychotic-induced metabolic syndrome|antipsychotic-induced metabolic syndrome
4795992|NCT02644577|bipolar disorder|bipolar disorder
4795993|NCT02644564|Soft tissue shoulder injury|soft tissue shoulder injury
4795994|NCT02644564|Rotator cuff tear|rotator cuff tear
4795995|NCT02644564|Ultrasonography|ultrasonography
4795996|NCT02644538|HBsAg clearance|hbsag clearance
4795997|NCT02644525|Cameroon|cameroon
4795998|NCT02644525|Filaricidal|filaricidal
4795999|NCT02644525|Randomized|randomized
4796000|NCT02644525|Ivermectin|ivermectin
4796001|NCT02644525|Worm|worm
4796002|NCT02644434|Percutaneous Coronary Intervention|percutaneous coronary intervention
4796003|NCT02644434|Coronary Bifurcation Intervention|coronary bifurcation intervention
4796004|NCT02644434|Randomized Clinical Trial|randomized clinical trial
4796005|NCT02644421|Neuropathic Pain|neuropathic pain
4796006|NCT02644421|Sciatica|sciatica
4796007|NCT02644408|Chemoradiotherapy|chemoradiotherapy
4796008|NCT02644408|Esophageal Squamous Cancer|esophageal squamous cancer
4796009|NCT02644408|Megestrol|megestrol
4796010|NCT02644382|breast cancer|breast cancer
4796011|NCT02644382|decision making|decision making
4796012|NCT02644382|surgery|surgery
4796013|NCT02644382|qualitative|qualitative
4796014|NCT02644317|Motor development delay|motor development delay
4796015|NCT02644317|balance|balance
4796016|NCT02644317|flatfoot|flatfoot
4796017|NCT02644317|shoe insert|shoe insert
4796018|NCT02644291|medulloblastoma|medulloblastoma
4796019|NCT02644291|Diffuse Intrinsic Pontine Glioma (DIPG)|diffuse intrinsic pontine glioma (dipg)
4796020|NCT02644291|high grade glioma|high grade glioma
4796021|NCT02644291|glioblastoma|glioblastoma
4796022|NCT02644291|brain stem malignant glioma|brain stem malignant glioma
4796023|NCT02644278|VX15-984-001|vx15-984-001
4796024|NCT02644278|VX-984|vx-984
4796025|NCT02644278|M9831|m9831
4796026|NCT02644278|Advanced Solid Tumor|advanced solid tumor
4796027|NCT02644278|Pegylated liposomal doxorubicin|pegylated liposomal doxorubicin
4796028|NCT02644265|Acute acquired brain injury|acute acquired brain injury
4796029|NCT02644265|Disorders of consciousness|disorders of consciousness
4796030|NCT02644265|Traumatic brain injury|traumatic brain injury
4796031|NCT02644265|Non-traumatic brain injury|non-traumatic brain injury
4796032|NCT02644265|Anoxic-ischemic encephalopathy|anoxic-ischemic encephalopathy
4796033|NCT02644265|Stroke|stroke
4796034|NCT02644265|Vegetative state|vegetative state
4796035|NCT02644265|Minimal conscious state|minimal conscious state
4796036|NCT02644265|Locked-in syndrome|locked-in syndrome
4796037|NCT02644265|Functional magnetic resonance imaging|functional magnetic resonance imaging
4796038|NCT02644265|Electroencephalography|electroencephalography
4796039|NCT02644174|Obesity|obesity
4796040|NCT02644174|Lung function test|lung function test
4796041|NCT02644174|Bariatric surgery|bariatric surgery
4796042|NCT02644161|stroke|stroke
4796043|NCT02644161|depression|depression
4796044|NCT02644161|stroke sequelae|stroke sequelae
4796045|NCT02644161|acupuncture|acupuncture
4796046|NCT02644161|DCEAS|dceas
4796047|NCT02644161|CAI|cai
4796048|NCT02644161|LAS|las
4796049|NCT02644135|Healthy volunteer|healthy volunteer
4796050|NCT02644122|advanced cancer|advanced cancer
4796051|NCT02644122|metastatic cancer|metastatic cancer
4796052|NCT02644122|Squamous Cell Carcinoma of the Head and Neck|squamous cell carcinoma of the head and neck
4796053|NCT02644122|SCCHN|scchn
4796054|NCT02644122|gene mutation|gene mutation
4796055|NCT02644122|PIK3R1, PIK3R5 and PIK3AP1|pik3r1, pik3r5 and pik3ap1
4796056|NCT02644122|PIK3CG|pik3cg
4796057|NCT02644122|AKT and mTOR|akt and mtor
4796058|NCT02644122|PIK3CA gene|pik3ca gene
4796059|NCT02644122|PI-3 kinase inhibitor|pi-3 kinase inhibitor
4796060|NCT02644122|PI-3 kinase pathway genes|pi-3 kinase pathway genes
4796061|NCT02644096|Rehabilitation|rehabilitation
4796062|NCT02644096|RCT|rct
4796063|NCT02644096|User Involvement|user involvement
4796064|NCT02644096|Self-Rated Health|self-rated health
4796065|NCT02644070|Alveolar bone loss|alveolar bone loss
4796066|NCT02644070|Alveoloplasty|alveoloplasty
4796067|NCT02644070|Bone remodeling|bone remodeling
4796068|NCT02644070|Xenograft|xenograft
4796069|NCT02644070|Tooth socket|tooth socket
4796070|NCT02644070|Dental implant|dental implant
4796071|NCT02644044|Progressive multiple sclerosis|progressive multiple sclerosis
4796072|NCT02644044|methotrexate|methotrexate
4796073|NCT02644031|Instrumentation|instrumentation
4796074|NCT02644031|Post-operative pain|post-operative pain
4796075|NCT02644031|Root canal preparation|root canal preparation
4796076|NCT02644018|Ingavirin|ingavirin
4796077|NCT02644018|Common Cold|common cold
4796078|NCT02644018|Influenza|influenza
4796079|NCT02644018|Acute Respiratory Viral Infections|acute respiratory viral infections
4796080|NCT02644018|pediatric clinical trial|pediatric clinical trial
4796081|NCT02644018|Imidazolyl ethanamide pentandioic acid|imidazolyl ethanamide pentandioic acid
4796082|NCT02643979|Ketamine|ketamine
4796083|NCT02643979|Propofol|propofol
4796084|NCT02643979|Ketofol|ketofol
4796085|NCT02643979|Obese|obese
4796086|NCT02643979|Upper gastrointestinal endoscopy|upper gastrointestinal endoscopy
4796087|NCT02643979|Sedation|sedation
4796088|NCT02643979|Bariatric|bariatric
4796089|NCT02643966|whole breast ultrasound|whole breast ultrasound
4796090|NCT02643966|digital breast tomosynthesis|digital breast tomosynthesis
4796091|NCT02643966|breast density|breast density
4796092|NCT02643966|breast cancer screening|breast cancer screening
4796093|NCT02643953|Maternal Health|maternal health
4796094|NCT02643953|Maternal Mortality|maternal mortality
4796095|NCT02643953|Global Health|global health
4796096|NCT02643953|RCT|rct
4796097|NCT02643940|Percutaneous Coronary Intervention (PCI)|percutaneous coronary intervention (pci)
4796098|NCT02643940|Chronic Total Occlusion (CTO)|chronic total occlusion (cto)
4796099|NCT02643940|Cardiac MRI|cardiac mri
4796100|NCT02643940|Instantaneous wave-free ratio (iFR)|instantaneous wave-free ratio (ifr)
4796101|NCT02643875|myopia control|myopia control
4796102|NCT02643875|orthokeratology|orthokeratology
4796103|NCT02643823|Human Umbilical Cord Mesenchymal Stem Cell|human umbilical cord mesenchymal stem cell
4796104|NCT02643823|Mesenchymal Stem Cell|mesenchymal stem cell
4796105|NCT02643823|Rheumatoid Arthritis|rheumatoid arthritis
4796106|NCT02643810|exercise training|exercise training
4796107|NCT02643797|diabetes|diabetes
4796108|NCT02643797|medical assistant|medical assistant
4796109|NCT02643797|health coach|health coach
4796110|NCT02643797|glycemic control|glycemic control
4796111|NCT02643797|pragmatic trial|pragmatic trial
4796112|NCT02643784|acute ischemic stroke|acute ischemic stroke
4796113|NCT02643771|Dental Scaling|dental scaling
4796114|NCT02643771|Blood Glucose|blood glucose
4796517|NCT02641210|Hepcidin|hepcidin
4796115|NCT02643771|Hemoglobin A, Glycosylated|hemoglobin a, glycosylated
4796116|NCT02643758|Myopia control, bifocal soft contact lenses, children|myopia control, bifocal soft contact lenses, children
4796117|NCT02643745|acute kidney injury|acute kidney injury
4796118|NCT02643745|cardiac surgery|cardiac surgery
4796119|NCT02643732|Activity|activity
4796120|NCT02643719|migraine|migraine
4796121|NCT02643719|topiramate|topiramate
4796122|NCT02643706|Aldehyde dehydrogenase 2|aldehyde dehydrogenase 2
4796123|NCT02643706|contrast induced nephropathy|contrast induced nephropathy
4796124|NCT02643706|Gene polymorphism|gene polymorphism
4796125|NCT02643693|Conventional cigarette|conventional cigarette
4796126|NCT02643693|Nicotine lactate delivery system|nicotine lactate delivery system
4796127|NCT02643693|e-cigarette|e-cigarette
4796128|NCT02643693|VUSE|vuse
4796129|NCT02643693|Combustible cigarette|combustible cigarette
4796130|NCT02643680|Biocellulose|biocellulose
4796131|NCT02643680|Silk sericin|silk sericin
4796132|NCT02643680|Polyhexamethylene biguanide|polyhexamethylene biguanide
4796133|NCT02643680|Split thickness skin graft donor site|split thickness skin graft donor site
4796134|NCT02643667|Radical prostatectomy (RP)|radical prostatectomy (rp)
4796135|NCT02643654|interleukin-1alpha|interleukin-1alpha
4796136|NCT02643641|Grass pollen allergy|grass pollen allergy
4796137|NCT02643641|subcutaneous immunotherapy|subcutaneous immunotherapy
4796138|NCT02643641|allergy vaccine|allergy vaccine
4796139|NCT02643641|dose regimen|dose regimen
4796140|NCT02643615|Visual Evoked Potentials|visual evoked potentials
4796141|NCT02643589|haploidentical hematopoietic Stem Cell Transplantation Antithymocyte globulin|haploidentical hematopoietic stem cell transplantation antithymocyte globulin
4796142|NCT02643589|acute graft-versus-host disease|acute graft-versus-host disease
4796143|NCT02643589|antithymocyte globulin|antithymocyte globulin
4796144|NCT02643563|Brachial Plexus Block|brachial plexus block
4796145|NCT02643563|Anesthetics, Local|anesthetics, local
4796146|NCT02643524|Adult|adult
4796147|NCT02643524|CAM boot|cam boot
4796148|NCT02643524|controlled ankle movement|controlled ankle movement
4796149|NCT02643498|Stereotactic Body Radiotherapy (SBRT)|stereotactic body radiotherapy (sbrt)
4796150|NCT02643498|15-109|15-109
4796151|NCT02643472|neonate|neonate
4796152|NCT02643472|newborn|newborn
4796153|NCT02643472|neonatal intensive care unit|neonatal intensive care unit
4796154|NCT02643472|NICU|nicu
4796155|NCT02643472|NICU discharge|nicu discharge
4796156|NCT02643472|parent navigator|parent navigator
4796157|NCT02643472|peer to peer|peer to peer
4796158|NCT02643472|peer coaching|peer coaching
4796159|NCT02643459|Triage|triage
4796160|NCT02643459|Risk stratification|risk stratification
4796161|NCT02643459|Acute care|acute care
4796162|NCT02643459|suPAR|supar
4796163|NCT02643446|Poliovirus Vaccine, Inactivated|poliovirus vaccine, inactivated
4796164|NCT02643446|Poliovirus Vaccine, Oral|poliovirus vaccine, oral
4796165|NCT02643446|Immunity|immunity
4796166|NCT02643446|Seroconversion|seroconversion
4796167|NCT02643433|Immunogenicity|immunogenicity
4796168|NCT02643433|Coadministration|coadministration
4796169|NCT02643433|Measles|measles
4796170|NCT02643433|Rubella|rubella
4796171|NCT02643433|Japanese encephalitis|japanese encephalitis
4796172|NCT02643433|Vaccine|vaccine
4796173|NCT02643420|Neutropenia|neutropenia
4796174|NCT02643420|Breast Cancer|breast cancer
4796175|NCT02643420|Long-acting Myeloid Growth Factor|long-acting myeloid growth factor
4796176|NCT02643420|Early Stage Breast Cancer|early stage breast cancer
4796177|NCT02643420|Docetaxel + Cyclophosphamide (TC) chemotherapy|docetaxel + cyclophosphamide (tc) chemotherapy
4796178|NCT02643407|squamous cell carcinoma|squamous cell carcinoma
4796179|NCT02643407|nedaplatin|nedaplatin
4796180|NCT02643407|cisplatin|cisplatin
4796181|NCT02643407|docetaxel|docetaxel
4796182|NCT02643394|Acetaminophen|acetaminophen
4796183|NCT02643394|Postoperative pain|postoperative pain
4796184|NCT02643394|Sinus Surgery|sinus surgery
4796185|NCT02643381|etomidate|etomidate
4796186|NCT02643381|ketamine|ketamine
4796187|NCT02643381|endotracheal intubation|endotracheal intubation
4796188|NCT02643381|anesthesia induction medications|anesthesia induction medications
4796189|NCT02643368|Polio|polio
4796190|NCT02643368|Inactivated polio vaccine|inactivated polio vaccine
4796191|NCT02643368|oral polio vaccine|oral polio vaccine
4796192|NCT02643368|monovalent type 2 oral polio vaccine|monovalent type 2 oral polio vaccine
4796193|NCT02643355|Narcotic Withdrawal|narcotic withdrawal
4796194|NCT02643355|Opiate Withdrawal|opiate withdrawal
4796195|NCT02643355|Emergency Department|emergency department
4796196|NCT02643342|myopia control|myopia control
4796197|NCT02643342|orthokeratology|orthokeratology
4796198|NCT02643303|Durvalumab|durvalumab
4796199|NCT02643303|MEDI4736|medi4736
4796200|NCT02643303|Tremelimumab|tremelimumab
4796201|NCT02643303|PolyICLC|polyiclc
4796202|NCT02643303|Hiltonol|hiltonol
4796203|NCT02643303|Locally Recurrent Breast Cancer|locally recurrent breast cancer
4796204|NCT02643303|Metastatic Melanoma|metastatic melanoma
4796205|NCT02643303|In Situ|in situ
4796206|NCT02643303|CTLA-4 Antibody|ctla-4 antibody
4796207|NCT02643303|PD-L1 Antibody|pd-l1 antibody
4796208|NCT02643303|TLR3 Agonist|tlr3 agonist
4796209|NCT02643290|Adult Scoliosis|adult scoliosis
4796210|NCT02643290|Pain Management|pain management
4796213|NCT02643264|alcohol addiction|alcohol addiction
4796214|NCT02643264|transcranial magnetic stimulation|transcranial magnetic stimulation
4796215|NCT02643251|Diabetes Mellitus|diabetes mellitus
4796216|NCT02643251|Pain|pain
4796217|NCT02643251|Foot Pain|foot pain
4796218|NCT02643251|Neuropathy|neuropathy
4796219|NCT02643160|Trunk Training|trunk training
4796220|NCT02643160|Motor Function|motor function
4796221|NCT02643147|Heart Failure|heart failure
4796222|NCT02643147|Renal Failure|renal failure
4796223|NCT02643147|Biomarker guided-therapy|biomarker guided-therapy
4796224|NCT02643147|Loop diuretics|loop diuretics
4796225|NCT02643147|Carbohydrate antigen 125|carbohydrate antigen 125
4796226|NCT02643134|ESWL|eswl
4796227|NCT02643134|EPVL|epvl
4796228|NCT02643134|PDI(Percussion,Diuresis,Inversion)|pdi(percussion,diuresis,inversion)
4796229|NCT02643134|Randomized Controlled Trial(RCT)|randomized controlled trial(rct)
4796230|NCT02643108|Lateral episiotomy|lateral episiotomy
4796231|NCT02643108|Obstetrical anal sphincter injury|obstetrical anal sphincter injury
4796232|NCT02643108|Vacuum extraction|vacuum extraction
4796233|NCT02643108|Anal incontinence|anal incontinence
4796234|NCT02643069|Frailty|frailty
4796235|NCT02643069|Frailty tools|frailty tools
4796236|NCT02643069|Clinical settings|clinical settings
4796237|NCT02643069|Disability|disability
4796238|NCT02643069|Quality of life|quality of life
4796239|NCT02643069|Functional Autonomy|functional autonomy
4796240|NCT02643043|Next Generation Sequencing|next generation sequencing
4796241|NCT02643043|Genomic Analysis|genomic analysis
4796242|NCT02643017|cognitive function|cognitive function
4796243|NCT02643017|desflurane|desflurane
4796244|NCT02643017|dexmedetomidine|dexmedetomidine
4796245|NCT02642978|minimally invasive surgery|minimally invasive surgery
4796246|NCT02642978|colorectal liver metastasis|colorectal liver metastasis
4796247|NCT02642978|robotic surgery|robotic surgery
4796248|NCT02642978|Patients with resectable colorectal liver metastasis|patients with resectable colorectal liver metastasis
4796249|NCT02642952|arterial stiffness, central hemodynamics|arterial stiffness, central hemodynamics
4796250|NCT02642926|menorrhagia|menorrhagia
4796251|NCT02642926|higham PBAC score|higham pbac score
4796252|NCT02642926|endometrial ablation|endometrial ablation
4796253|NCT02642926|bipolar energy|bipolar energy
4796254|NCT02642926|monopolar energy|monopolar energy
4796255|NCT02642913|Enzalutamide|enzalutamide
4796256|NCT02642913|Sorafenib|sorafenib
4796257|NCT02642913|15-279|15-279
4796258|NCT02642900|Complete denture|complete denture
4796259|NCT02642900|Candida spp|candida spp
4796260|NCT02642900|Photodynamic therapy|photodynamic therapy
4796261|NCT02642887|gingival recession|gingival recession
4796262|NCT02642887|tunnel technique|tunnel technique
4796263|NCT02642887|Miller Class I and II|miller class i and ii
4796264|NCT02642835|mesh|mesh
4796265|NCT02642835|pelvic organ prolapse|pelvic organ prolapse
4796266|NCT02642822|Cytomegalovirus|cytomegalovirus
4796267|NCT02642796|Percutaneous Electric Nerve Stimulation|percutaneous electric nerve stimulation
4796268|NCT02642796|Lumbosacral plexus|lumbosacral plexus
4796269|NCT02642796|surgical wound|surgical wound
4796270|NCT02642796|postoperative analgesia|postoperative analgesia
4796271|NCT02642796|transcutaneous electrical stimulation|transcutaneous electrical stimulation
4796272|NCT02642783|laxatives|laxatives
4796273|NCT02642783|sensory evaluation|sensory evaluation
4796274|NCT02642783|acceptability|acceptability
4796275|NCT02642783|colonoscopy|colonoscopy
4796276|NCT02642770|Transesophageal echocardiography, Speckle tracking strain|transesophageal echocardiography, speckle tracking strain
4796277|NCT02642757|alcohol drinking|alcohol drinking
4796278|NCT02642757|hazardous alcohol use|hazardous alcohol use
4796279|NCT02642757|risky alcohol consumption|risky alcohol consumption
4796280|NCT02642757|heavy alcohol consumption|heavy alcohol consumption
4796281|NCT02642731|total knee arthroplasty|total knee arthroplasty
4796282|NCT02642731|Kidney function|kidney function
4796283|NCT02642731|Renal markers|renal markers
4796284|NCT02642718|preemptive analgesia|preemptive analgesia
4796285|NCT02642718|postoperative pain|postoperative pain
4796286|NCT02642718|NSAIDs|nsaids
4796287|NCT02642718|ketorolac|ketorolac
4796288|NCT02642718|abdominal hysterectomy|abdominal hysterectomy
4796289|NCT02642692|ACL reconstruction|acl reconstruction
4796290|NCT02642692|Single bundle|single bundle
4796291|NCT02642692|Clinical results|clinical results
4796292|NCT02642692|Soccer players|soccer players
4796293|NCT02642679|Split-thickness skin graft, donor site, chitosan, dressing|split-thickness skin graft, donor site, chitosan, dressing
4796294|NCT02642666|Attention|attention
4796295|NCT02642666|Hyperactivity|hyperactivity
4796296|NCT02642666|Impulsivity|impulsivity
4796297|NCT02642666|Yoga|yoga
4796298|NCT02642666|Preschool|preschool
4796299|NCT02642653|Fra(X) Syndrome|fra(x) syndrome
4796300|NCT02642653|Trinucleotide Repeat Expansion|trinucleotide repeat expansion
4796301|NCT02642653|Fragile X Syndrome|fragile x syndrome
4796302|NCT02642653|Fragile X Mental Retardation Syndrome|fragile x mental retardation syndrome
4796303|NCT02642653|Intellectual Disability|intellectual disability
4796304|NCT02642653|Parent Implemented Language Intervention (PILI)|parent implemented language intervention (pili)
4796305|NCT02642653|FXS|fxs
4796306|NCT02642653|Mental Retardation, X-linked|mental retardation, x-linked
4796307|NCT02642653|Genetic Diseases, X-linked|genetic diseases, x-linked
4796308|NCT02642653|Neurobehavioral Manifestations|neurobehavioral manifestations
4796309|NCT02642653|Chromosome Disorders|chromosome disorders
4796310|NCT02642601|indomethacin, ICSI, difficult embryo transfer|indomethacin, icsi, difficult embryo transfer
4796311|NCT02642562|Intravenous iron|intravenous iron
4796312|NCT02642562|PROBE design|probe design
4796313|NCT02642536|Veteran|veteran
4796314|NCT02642523|natriuretic peptide|natriuretic peptide
4796315|NCT02642523|insulin|insulin
4796316|NCT02642523|lipolysis|lipolysis
4796317|NCT02642523|hormones|hormones
4796318|NCT02642523|metabolism|metabolism
4796319|NCT02642497|postoperative analgesia|postoperative analgesia
4796320|NCT02642497|ketamine|ketamine
4796321|NCT02642497|total thyroidectomy|total thyroidectomy
4796322|NCT02642471|sentinel lymph node|sentinel lymph node
4796323|NCT02642471|pelvic lymphadenectomy|pelvic lymphadenectomy
4796324|NCT02642471|cervical carcinoma|cervical carcinoma
4796325|NCT02642471|surgery|surgery
4796326|NCT02642471|radiotherapy|radiotherapy
4796327|NCT02642445|Renal sympathetic denervation;hypertension|renal sympathetic denervation;hypertension
4796328|NCT02642432|HCV Genotype 1|hcv genotype 1
4796329|NCT02642432|HCV Genotype 4|hcv genotype 4
4796330|NCT02642432|HCV Genotype 2|hcv genotype 2
4796331|NCT02642432|Cirrhotic|cirrhotic
4796332|NCT02642432|Interferon-Free|interferon-free
4796333|NCT02642432|Compensated Cirrhosis|compensated cirrhosis
4796334|NCT02642432|HCV Genotype 5|hcv genotype 5
4796335|NCT02642432|Hepatitis C|hepatitis c
4796336|NCT02642432|HCV Genotype 6|hcv genotype 6
4796337|NCT02642393|SURE-PD3|sure-pd3
4796338|NCT02642393|Parkinson's disease|parkinson's disease
4796339|NCT02642393|PD|pd
4796340|NCT02642393|Inosine|inosine
4796341|NCT02642393|Urate|urate
4796342|NCT02642393|Parkinson Study Group (PSG)|parkinson study group (psg)
4796343|NCT02642380|ITP|itp
4796344|NCT02642380|high-dose dexamethasone|high-dose dexamethasone
4796345|NCT02642328|VO2Max|vo2max
4796346|NCT02642328|Aerobic Exercise|aerobic exercise
4796347|NCT02642328|Physical Conditioning|physical conditioning
4796348|NCT02642302|VO2Max|vo2max
4796349|NCT02642302|Aerobic Exercise|aerobic exercise
4796350|NCT02642302|Physical Conditioning|physical conditioning
4796351|NCT02642289|Probiotics|probiotics
4796352|NCT02642276|exercise training|exercise training
4796353|NCT02642250|safety|safety
4796354|NCT02642250|efficacy|efficacy
4796355|NCT02642237|Fluenz|fluenz
4796356|NCT02642237|innate immune response|innate immune response
4796357|NCT02642237|endotoxin tolerance|endotoxin tolerance
4796358|NCT02642237|priming|priming
4796359|NCT02642224|Violence|violence
4796360|NCT02642224|firearm|firearm
4796361|NCT02642224|guns|guns
4796362|NCT02642224|homicide|homicide
4796363|NCT02642224|trauma|trauma
4796364|NCT02642224|injury|injury
4796365|NCT02642198|NiBP|nibp
4796366|NCT02642185|microwave|microwave
4796367|NCT02642185|ablation|ablation
4796368|NCT02642185|resection|resection
4796369|NCT02642185|liver|liver
4796370|NCT02642185|colorectal|colorectal
4796371|NCT02642185|survival|survival
4796372|NCT02642185|metastasis|metastasis
4796373|NCT02642172|Inulin, OFS (oligofructose)|inulin, ofs (oligofructose)
4796374|NCT02642107|nasopharyngeal carcinoma|nasopharyngeal carcinoma
4796375|NCT02642107|elective neck irradiation|elective neck irradiation
4796376|NCT02642081|NSAIDs|nsaids
4796377|NCT02642081|Heart failure|heart failure
4796378|NCT02642081|Acute kidney injury|acute kidney injury
4796379|NCT02642068|Drug-naïve Adult ADHD|drug-naïve adult adhd
4796380|NCT02642068|Neuropsychology|neuropsychology
4796381|NCT02642068|Neurophysiology|neurophysiology
4796382|NCT02642068|Neuroimaging|neuroimaging
4796383|NCT02642068|Follow-up|follow-up
4796384|NCT02642055|ADHD|adhd
4796385|NCT02642055|Neurofeedback|neurofeedback
4796386|NCT02642055|Biofeedback|biofeedback
4796387|NCT02642055|Neuro+|neuro+
4796388|NCT02642055|Go/no-go|go/no-go
4796389|NCT02642055|Attention training|attention training
4796390|NCT02642029|time perception|time perception
4796391|NCT02642029|executive function|executive function
4796392|NCT02642029|psychosis|psychosis
4796393|NCT02642029|mood symptoms|mood symptoms
4796394|NCT02642016|KTN0158|ktn0158
4796395|NCT02642016|Advanced Cancer|advanced cancer
4796396|NCT02642016|Phase 1|phase 1
4796397|NCT02642016|Monoclonal Antibody|monoclonal antibody
4796398|NCT02642016|Safety and Pharmacokinetics|safety and pharmacokinetics
4796399|NCT02641925|Metabolic syndrome|metabolic syndrome
4796400|NCT02641925|gastric cancer|gastric cancer
4796401|NCT02641925|omentectomy|omentectomy
4796402|NCT02641899|Adult|adult
4796403|NCT02641899|Male|male
4796404|NCT02641899|Female|female
4796405|NCT02641899|Volunteers|volunteers
4796406|NCT02641886|traditional Chinese medicine granules|traditional chinese medicine granules
4796407|NCT02641886|Cognitive Impairment|cognitive impairment
4796408|NCT02641886|Acute cerebral infraction|acute cerebral infraction
4796409|NCT02641886|prevention|prevention
4796410|NCT02641873|metastatic Colorectal Cancer|metastatic colorectal cancer
4796411|NCT02641873|mCRC|mcrc
4796412|NCT02641847|triple negative breast cancer|triple negative breast cancer
4796413|NCT02641847|mRNA-lncRNA signature|mrna-lncrna signature
4796414|NCT02641847|chemotherapy|chemotherapy
4796415|NCT02641847|high risk|high risk
4796416|NCT02641834|diet|diet
4796417|NCT02641834|vegetarian|vegetarian
4796418|NCT02641834|cardiovascular risk|cardiovascular risk
4796419|NCT02641795|cochlear implantation|cochlear implantation
4796420|NCT02641795|robotics|robotics
4796421|NCT02641795|image guidance|image guidance
4796422|NCT02641782|High Risk Neuroblastoma|high risk neuroblastoma
4796423|NCT02641756|HIV reservoir|hiv reservoir
4796424|NCT02641756|phylogenetic analysis|phylogenetic analysis
4796425|NCT02641756|sequencing|sequencing
4796426|NCT02641730|Guselkumab|guselkumab
4796427|NCT02641730|CNTO 1959|cnto 1959
4796428|NCT02641730|Placebo|placebo
4796429|NCT02641730|Palmoplantar Pustulosis|palmoplantar pustulosis
4796430|NCT02641717|patient-collected|patient-collected
4796431|NCT02641717|self-collected|self-collected
4796432|NCT02641717|vaginitis|vaginitis
4796433|NCT02641717|vaginosis, bacterial|vaginosis, bacterial
4796434|NCT02641717|candidiasis|candidiasis
4796435|NCT02641717|trichomonas|trichomonas
4796436|NCT02641717|vaginal discharge|vaginal discharge
4796437|NCT02641678|Atrial Fibrillation|atrial fibrillation
4796438|NCT02641678|stroke|stroke
4796439|NCT02641678|implantable cardiac monitor|implantable cardiac monitor
4796440|NCT02641678|automated ECG analysis|automated ecg analysis
4796441|NCT02641652|paroxysmal hypertension|paroxysmal hypertension
4796442|NCT02641652|pseudopheochromocytoma|pseudopheochromocytoma
4796443|NCT02641626|cardiac arrest|cardiac arrest
4796444|NCT02641626|survival|survival
4796445|NCT02641626|neurologic prognosis|neurologic prognosis
4796446|NCT02641626|coronariography|coronariography
4796447|NCT02641626|hypothermia|hypothermia
4796448|NCT02641587|Smoking|smoking
4796449|NCT02641587|Combustible cigarette|combustible cigarette
4796450|NCT02641587|Reduced exposure|reduced exposure
4796451|NCT02641587|Confinement|confinement
4796452|NCT02641587|Ambulatory|ambulatory
4796453|NCT02641587|Carbon Heated Tobacco Product|carbon heated tobacco product
4796454|NCT02641561|Pancreatitis|pancreatitis
4796455|NCT02641561|ERCP|ercp
4796456|NCT02641561|Indomethacin|indomethacin
4796457|NCT02641561|Lactated ringer's|lactated ringer's
4796458|NCT02641522|T1D|t1d
4796459|NCT02641522|Type 1 diabetes|type 1 diabetes
4796460|NCT02641496|Obstructive Sleep Apnea|obstructive sleep apnea
4796461|NCT02641496|PTSD|ptsd
4796462|NCT02641496|Posttraumatic Stress Disorder|posttraumatic stress disorder
4796463|NCT02641496|Cognitive Behavioral Therapy|cognitive behavioral therapy
4796464|NCT02641496|Continuous Positive Airway Pressure|continuous positive airway pressure
4796465|NCT02641496|CPAP|cpap
4796466|NCT02641496|Cognition|cognition
4796467|NCT02641496|Memory|memory
4796468|NCT02641496|Quality of Life|quality of life
4796469|NCT02641496|Self Efficacy|self efficacy
4796470|NCT02641496|CBT|cbt
4796471|NCT02641496|OSA|osa
4796472|NCT02641496|Sleep Apnea|sleep apnea
4796473|NCT02641496|Education|education
4796474|NCT02641496|Psychotherapy|psychotherapy
4796475|NCT02641496|Post Traumatic Stress Disorder|post traumatic stress disorder
4796476|NCT02641496|Post-Traumatic Stress Disorder|post-traumatic stress disorder
4796477|NCT02641496|Therapy|therapy
4796478|NCT02641457|rubeosis iridis|rubeosis iridis
4796479|NCT02641457|glaucoma|glaucoma
4796480|NCT02641457|ranibizumab|ranibizumab
4796481|NCT02641457|aflibercept|aflibercept
4796482|NCT02641431|radiofrequency ablation|radiofrequency ablation
4796483|NCT02641431|mapping|mapping
4796484|NCT02641431|sudden death|sudden death
4796485|NCT02641431|syncope|syncope
4796486|NCT02641418|Exercise|exercise
4796487|NCT02641405|Gait analysis|gait analysis
4796488|NCT02641405|Proprioceptive focal stimulation|proprioceptive focal stimulation
4796489|NCT02641405|Parkinson|parkinson
4796490|NCT02641392|Crohn's Disease|crohn's disease
4796491|NCT02641392|GED 0301|ged 0301
4796492|NCT02641392|Mongersen|mongersen
4796493|NCT02641392|Safety|safety
4796494|NCT02641392|IBD|ibd
4796495|NCT02641353|Apremilast|apremilast
4796496|NCT02641353|Healthy volunteers|healthy volunteers
4796497|NCT02641353|Bioavailability|bioavailability
4796498|NCT02641353|Food effect|food effect
4796499|NCT02641353|Pharmacokinetic|pharmacokinetic
4796500|NCT02641327|Inhospital patients|inhospital patients
4796501|NCT02641314|high risk neuroblastoma|high risk neuroblastoma
4796502|NCT02641301|obesity|obesity
4796503|NCT02641301|Roux-en-Y-gastric bypass|roux-en-y-gastric bypass
4796504|NCT02641301|pharmacokinetics|pharmacokinetics
4796505|NCT02641301|Pain|pain
4796506|NCT02641301|morphine|morphine
4796507|NCT02641275|Parental stress|parental stress
4796508|NCT02641275|Muscular Dystrophies|muscular dystrophies
4796509|NCT02641275|Coping|coping
4796510|NCT02641275|Parental support|parental support
4796511|NCT02641262|Myocardial Infarction|myocardial infarction
4796512|NCT02641262|Angioplasty, Balloon, Coronary|angioplasty, balloon, coronary
4796513|NCT02641262|Drug Therapy|drug therapy
4796514|NCT02641236|Hematopoietic Stem Cell Transplantation (HSCT)|hematopoietic stem cell transplantation (hsct)
4796515|NCT02641236|Acute GVH Disease|acute gvh disease
4796516|NCT02641210|Chronic periodontitis|chronic periodontitis
4796518|NCT02641210|Hemoglobin|hemoglobin
4796519|NCT02641210|Inflammation|inflammation
4796520|NCT02641197|flow-mediated dilation|flow-mediated dilation
4796521|NCT02641197|AngioDefender|angiodefender
4796522|NCT02641197|device precision|device precision
4796523|NCT02641197|repeatability|repeatability
4796524|NCT02641197|reproducibility|reproducibility
4796525|NCT02641197|cardiovascular diseases|cardiovascular diseases
4796526|NCT02641184|Myocardial Infarction|myocardial infarction
4796527|NCT02641184|Cardiovascular Diseases|cardiovascular diseases
4796528|NCT02641184|Heart Diseases|heart diseases
4796529|NCT02641184|Infarction|infarction
4796530|NCT02641184|Diabetes|diabetes
4796531|NCT02641158|HIV|hiv
4796532|NCT02641158|Hepatitis C|hepatitis c
4796533|NCT02641158|Substance users|substance users
4796534|NCT02641158|Drug users|drug users
4796535|NCT02641145|amyloidosis|amyloidosis
4796536|NCT02641145|F-18 florbetapir|f-18 florbetapir
4796537|NCT02641145|Positron emission tomography|positron emission tomography
4796538|NCT02641145|cardiac magnetic resonance imaging|cardiac magnetic resonance imaging
4796539|NCT02641119|Albumin|albumin
4796540|NCT02641119|Resuscitation|resuscitation
4796541|NCT02641106|Telemedicine|telemedicine
4796542|NCT02641106|Mobile Phone|mobile phone
4796543|NCT02641106|Adherence|adherence
4796544|NCT02641106|Latent Tuberculosis Infection|latent tuberculosis infection
4796545|NCT02641106|Directly Observed Therapy|directly observed therapy
4796546|NCT02641106|Video DOT|video dot
4796547|NCT02641041|Japanese|japanese
4796548|NCT02641041|Single Ascending Dose (SAD)|single ascending dose (sad)
4796549|NCT02641041|Multiple Ascending Dose (MAD)|multiple ascending dose (mad)
4796550|NCT02641015|UTI|uti
4796551|NCT02641002|CC-90002|cc-90002
4796552|NCT02641002|Monoclonal|monoclonal
4796553|NCT02641002|Antibody|antibody
4796554|NCT02641002|CD47|cd47
4796555|NCT02641002|Hematologic Cancers|hematologic cancers
4796556|NCT02641002|Acute Myeloid Leukemia|acute myeloid leukemia
4796557|NCT02641002|AML|aml
4796558|NCT02641002|Myelodysplastic syndrome|myelodysplastic syndrome
4796559|NCT02641002|MDS|mds
4796560|NCT02641002|Blood disorder|blood disorder
4796561|NCT02640989|Influenza Vaccine|influenza vaccine
4796562|NCT02640989|Safety|safety
4796563|NCT02640989|Immunogenicity|immunogenicity
4796564|NCT02640976|in vitro fertilization|in vitro fertilization
4796565|NCT02640976|controlled ovarian hyperstimulation|controlled ovarian hyperstimulation
4796566|NCT02640976|poor ovarian response|poor ovarian response
4796567|NCT02640976|estrogen receptor 2 gene polymorphism|estrogen receptor 2 gene polymorphism
4796568|NCT02640976|follicle stimulating hormone receptor gene polymorphism|follicle stimulating hormone receptor gene polymorphism
4796569|NCT02640976|anti-mullerian hormone|anti-mullerian hormone
4796570|NCT02640963|exercise|exercise
4796571|NCT02640963|older adults|older adults
4796572|NCT02640963|physical performance|physical performance
4796573|NCT02640937|Staphylococcus epidermidis|staphylococcus epidermidis
4796574|NCT02640937|biofilm formation|biofilm formation
4796575|NCT02640937|antibiotic resistance|antibiotic resistance
4796576|NCT02640937|Orthopaedic device related infections|orthopaedic device related infections
4796577|NCT02640937|risk factor|risk factor
4796578|NCT02640924|Hepatocellular carcinoma|hepatocellular carcinoma
4796579|NCT02640924|Proton therapy|proton therapy
4796580|NCT02640924|Radiation therapy|radiation therapy
4796581|NCT02640924|Switching control radiofrequency ablation|switching control radiofrequency ablation
4796582|NCT02640872|sarcopenia|sarcopenia
4796583|NCT02640872|sarcopenic obesity|sarcopenic obesity
4796584|NCT02640872|osteoporosis|osteoporosis
4796585|NCT02640872|fracture|fracture
4796586|NCT02640872|cardiovascular disease|cardiovascular disease
4796587|NCT02640872|mortality|mortality
4796588|NCT02640846|Levosimendan|levosimendan
4796589|NCT02640846|Milrinone|milrinone
4796590|NCT02640846|Myocardial strain|myocardial strain
4796591|NCT02640846|Septic cardiomyopathy|septic cardiomyopathy
4796592|NCT02640833|Refractory Lymphoma|refractory lymphoma
4796593|NCT02640833|Relapsed Leukemia|relapsed leukemia
4796594|NCT02640820|HPV|hpv
4796595|NCT02640820|Verruca Vulgaris|verruca vulgaris
4796596|NCT02640807|sepsis lymphocytopenia IL-7|sepsis lymphocytopenia il-7
4796597|NCT02640807|immune reconstitution|immune reconstitution
4796598|NCT02640794|Transcatheter aortic valve implantation|transcatheter aortic valve implantation
4796599|NCT02640794|Antithrombotic treatment|antithrombotic treatment
4796600|NCT02640794|Clopidogrel|clopidogrel
4796601|NCT02640794|Aspirin/acetylsalicylic acid|aspirin/acetylsalicylic acid
4796602|NCT02640794|Myocardial Infarction|myocardial infarction
4796603|NCT02640794|Ischemic stroke|ischemic stroke
4796604|NCT02640794|Major bleeding|major bleeding
4796605|NCT02640768|in-hospital diabetes|in-hospital diabetes
4796606|NCT02640768|clinical and management model|clinical and management model
4796607|NCT02640755|Radiolabelled|radiolabelled
4796608|NCT02640729|Lewy body dementia|lewy body dementia
4796609|NCT02640729|Dementia with Lewy bodies|dementia with lewy bodies
4796610|NCT02640729|Parkinson's disease dementia|parkinson's disease dementia
4796611|NCT02640729|Lewy bodies|lewy bodies
4796612|NCT02640729|Visual hallucinations|visual hallucinations
4796613|NCT02640690|Stress Disorders, Post-traumatic|stress disorders, post-traumatic
4796614|NCT02640690|Yoga|yoga
4796615|NCT02640690|Cognitive Therapy|cognitive therapy
4796616|NCT02640690|Chronic Pain|chronic pain
4796617|NCT02640690|Veterans|veterans
4796618|NCT02640690|cytokines|cytokines
4796619|NCT02640690|acoustic startle reflex|acoustic startle reflex
4796620|NCT02640664|open-label, long-term, extension study|open-label, long-term, extension study
4796621|NCT02640664|intravitreal ranibizumab|intravitreal ranibizumab
4796622|NCT02640664|laser ablation therapy|laser ablation therapy
4796623|NCT02640664|retinopathy of prematurity|retinopathy of prematurity
4796624|NCT02640664|preterm infants|preterm infants
4796625|NCT02640664|RAINBOW|rainbow
4796626|NCT02640638|Racial disparities|racial disparities
4796627|NCT02640625|HIV|hiv
4796628|NCT02640625|Probiotics|probiotics
4796629|NCT02640625|Microbiota|microbiota
4796630|NCT02640625|Mucosal immunology|mucosal immunology
4796631|NCT02640625|Gut biopsy|gut biopsy
4796632|NCT02640599|Vestibular|vestibular
4796633|NCT02640599|Rehabilitation|rehabilitation
4796634|NCT02640560|Children|children
4796635|NCT02640560|Allergy|allergy
4796636|NCT02640560|Peanuts|peanuts
4796637|NCT02640560|Hazelnuts|hazelnuts
4796638|NCT02640560|Walnuts|walnuts
4796639|NCT02640560|Mollusks|mollusks
4796640|NCT02640560|Shellfish|shellfish
4796641|NCT02640560|Food|food
4796642|NCT02640547|Fibrosis|fibrosis
4796643|NCT02640547|Chronic Hepatitis C|chronic hepatitis c
4796644|NCT02640547|Cirrhosis|cirrhosis
4796645|NCT02640547|Work Ability|work ability
4796646|NCT02640547|Dasabuvir|dasabuvir
4796647|NCT02640547|Quality of Life|quality of life
4796648|NCT02640547|Observational Study|observational study
4796649|NCT02640547|Paritaprevir/r/Ombitasvir|paritaprevir/r/ombitasvir
4796650|NCT02640534|Prostate cancer|prostate cancer
4796651|NCT02640534|Cancer of the prostate|cancer of the prostate
4796652|NCT02640534|Metformin|metformin
4796653|NCT02640534|Enzalutamide|enzalutamide
4796654|NCT02640534|Xtandi|xtandi
4796655|NCT02640534|castration resistant prostate cancer|castration resistant prostate cancer
4796656|NCT02640534|phase II|phase ii
4796657|NCT02640534|Androgen deprivation therapy|androgen deprivation therapy
4796658|NCT02640495|Treatment Efficacy|treatment efficacy
4796659|NCT02640495|drug resistance|drug resistance
4796660|NCT02640495|Artemisinin|artemisinin
4796661|NCT02640482|Treatment-Naive|treatment-naive
4796662|NCT02640482|Hepatitis C Virus Genotype 2|hepatitis c virus genotype 2
4796663|NCT02640482|Sofosbuvir (SOF)-Experienced|sofosbuvir (sof)-experienced
4796664|NCT02640482|Treatment-Experienced|treatment-experienced
4796665|NCT02640482|Non-cirrhotic|non-cirrhotic
4796666|NCT02640469|chlorhexidine|chlorhexidine
4796667|NCT02640469|sterility|sterility
4796668|NCT02640469|sterile hands|sterile hands
4796669|NCT02640456|retropharyngeal abscess|retropharyngeal abscess
4796670|NCT02640456|parapharyngeal abscess|parapharyngeal abscess
4796671|NCT02640456|peritonsillar abscess|peritonsillar abscess
4796672|NCT02640456|bacteriology|bacteriology
4796673|NCT02640456|Fusobacterium necrophorum|fusobacterium necrophorum
4796674|NCT02640417|Nucleotides (uridine, cytidine)|nucleotides (uridine, cytidine)
4796675|NCT02640417|Vitamin B1|vitamin b1
4796676|NCT02640417|Vitamin B6|vitamin b6
4796677|NCT02640417|Vitamin B12|vitamin b12
4796678|NCT02640404|Meningitis|meningitis
4796679|NCT02640404|Meningococcal Meningitis|meningococcal meningitis
4796680|NCT02640404|Meningococcal Infections|meningococcal infections
4796681|NCT02640404|Menactra®|menactra®
4796682|NCT02640404|Meningococcal Vaccine|meningococcal vaccine
4796683|NCT02640391|Ulcerative colitis|ulcerative colitis
4796684|NCT02640391|fecal calprotectin|fecal calprotectin
4796685|NCT02640391|mucosal healing|mucosal healing
4796686|NCT02640365|cancer|cancer
4796687|NCT02640365|GERCOR|gercor
4796688|NCT02640365|unresectable|unresectable
4796689|NCT02640365|MM-398|mm-398
4796690|NCT02640365|CPT-11|cpt-11
4796691|NCT02640365|colorectal|colorectal
4796692|NCT02640365|non colorectal|non colorectal
4796693|NCT02640326|Urinary Catheterization|urinary catheterization
4796694|NCT02640326|Randomized Controlled Trial|randomized controlled trial
4796695|NCT02640326|Thoracic Surgery, Video-Assisted|thoracic surgery, video-assisted
4796696|NCT02640326|Quality Improvement|quality improvement
4796697|NCT02640326|Evidence-Based Practice|evidence-based practice
4796698|NCT02640326|Post-operative complications|post-operative complications
4796699|NCT02640313|18F-fluormethylcholine|18f-fluormethylcholine
4796700|NCT02640313|[F18] choline|[f18] choline
4796701|NCT02640313|[F18] fluormethylcholine|[f18] fluormethylcholine
4796702|NCT02640300|antipsychotics, clozapine, schizophrenia, switching strategy|antipsychotics, clozapine, schizophrenia, switching strategy
4796703|NCT02640274|Practise Patterns, Nurses'|practise patterns, nurses'
4796704|NCT02640274|Directive Counseling|directive counseling
4796705|NCT02640274|Self Care|self care
4796706|NCT02640261|r-hLH|r-hlh
4796707|NCT02640261|Cytokines|cytokines
4796708|NCT02640261|Follicular Fluid|follicular fluid
4796709|NCT02640235|Hemostasis|hemostasis
4796710|NCT02640235|Oxidized Cellulose Strip|oxidized cellulose strip
4796711|NCT02640235|Traumacel|traumacel
4796712|NCT02640235|Traumastem|traumastem
4796713|NCT02640235|Cardiothoracic Surgery|cardiothoracic surgery
4796714|NCT02640235|General Surgery|general surgery
4797114|NCT02637713|GERD|gerd
4796715|NCT02640235|Vascular Surgery|vascular surgery
4796716|NCT02640196|Laryngoscope|laryngoscope
4796717|NCT02640196|Macintosh|macintosh
4796718|NCT02640196|Glidescope|glidescope
4796719|NCT02640196|King Vision|king vision
4796720|NCT02640196|Airtraq|airtraq
4796721|NCT02640196|Double Lumen Tube|double lumen tube
4796722|NCT02640157|interferon free|interferon free
4796723|NCT02640157|Hepatitis C|hepatitis c
4796724|NCT02640157|daclatasvir|daclatasvir
4796725|NCT02640157|Sovaldi|sovaldi
4796726|NCT02640157|HCV|hcv
4796727|NCT02640157|Hepatitis C Virus|hepatitis c virus
4796728|NCT02640157|Hepatitis C Genotype 3|hepatitis c genotype 3
4796729|NCT02640157|Hep C|hep c
4796730|NCT02640157|sofosbuvir|sofosbuvir
4796731|NCT02640157|Chronic Hepatitis C|chronic hepatitis c
4796732|NCT02640157|Daklinza|daklinza
4796733|NCT02640144|Hyaluronic acid|hyaluronic acid
4796734|NCT02640144|Knee arthroscopy|knee arthroscopy
4796735|NCT02640144|pain reduction|pain reduction
4796736|NCT02640144|swelling|swelling
4796737|NCT02640144|osteoarthritis|osteoarthritis
4796738|NCT02640144|cartilage lesion|cartilage lesion
4796739|NCT02640144|rehabilitation following knee arthroscopy|rehabilitation following knee arthroscopy
4796740|NCT02640144|Hyaluronic acid injection|hyaluronic acid injection
4796741|NCT02640131|prostate cancer|prostate cancer
4796742|NCT02640131|radical prostatectomy|radical prostatectomy
4796743|NCT02640131|survivorship|survivorship
4796744|NCT02640131|quality of life|quality of life
4796745|NCT02640131|erectile dysfunction|erectile dysfunction
4796746|NCT02640131|sexual dysfunction|sexual dysfunction
4796747|NCT02640131|feasibility study|feasibility study
4796748|NCT02640079|Cognitive behavioral therapy|cognitive behavioral therapy
4796749|NCT02640079|Laboratory pain responsivity|laboratory pain responsivity
4796750|NCT02640014|Food allergy|food allergy
4796751|NCT02640014|Health-related quality of life (HRQL)|health-related quality of life (hrql)
4796752|NCT02640014|Quality-adjusted life-years (QALYs)|quality-adjusted life-years (qalys)
4796753|NCT02640014|Oral immunotherapy (OIT)|oral immunotherapy (oit)
4796754|NCT02640014|Cow´s milk allergy (CMA)|cow´s milk allergy (cma)
4796755|NCT02640014|Milk oral immunotherapy (MOIT)|milk oral immunotherapy (moit)
4796756|NCT02639988|type 2 diabetes mellitus|type 2 diabetes mellitus
4796757|NCT02639988|Rheumatoid arthritis|rheumatoid arthritis
4796758|NCT02639975|Adenosine A3 receptor antagonist|adenosine a3 receptor antagonist
4796759|NCT02639962|culprit lesion|culprit lesion
4796760|NCT02639962|arteriosclerosis|arteriosclerosis
4796761|NCT02639962|cardiac CT|cardiac ct
4796762|NCT02639923|TBI|tbi
4796763|NCT02639923|microRNA|microrna
4796764|NCT02639923|S-100B|s-100b
4796765|NCT02639910|CD19|cd19
4796766|NCT02639910|MOR208|mor208
4796767|NCT02639910|MOR00208|mor00208
4796768|NCT02639910|CLL|cll
4796769|NCT02639910|SLL|sll
4796770|NCT02639910|COSMOS|cosmos
4796771|NCT02639871|Huntington disease|huntington disease
4796772|NCT02639871|Neuroimaging metabolic biomarker|neuroimaging metabolic biomarker
4796773|NCT02639832|Triple Negative Breast Cancer|triple negative breast cancer
4796774|NCT02639832|Breast Cancer|breast cancer
4796775|NCT02639832|Natural Killer Cells|natural killer cells
4796776|NCT02639832|BRCA Mutation|brca mutation
4796777|NCT02639819|Intracerebral Hemorrhage|intracerebral hemorrhage
4796778|NCT02639819|Stroke|stroke
4796779|NCT02639819|Cerebrovascular|cerebrovascular
4796780|NCT02639806|stroke|stroke
4796781|NCT02639806|endovascular|endovascular
4796782|NCT02639806|thrombectomy|thrombectomy
4796783|NCT02639806|ischemic stroke|ischemic stroke
4796784|NCT02639806|general anesthetic|general anesthetic
4796785|NCT02639806|local anesthetic|local anesthetic
4796786|NCT02639806|recanalization|recanalization
4796787|NCT02639793|arrhythmias, quality of life|arrhythmias, quality of life
4796788|NCT02639767|Pemetrexed|pemetrexed
4796789|NCT02639767|Cisplatin|cisplatin
4796790|NCT02639767|Intensity Modulated Radiation Therapy|intensity modulated radiation therapy
4796791|NCT02639767|15-304|15-304
4796792|NCT02639741|Melatonin|melatonin
4796793|NCT02639741|Vitamin C|vitamin c
4796794|NCT02639741|Morphine consumption|morphine consumption
4796795|NCT02639728|Bowel surgery|bowel surgery
4796796|NCT02639728|Postoperative bowel recovery|postoperative bowel recovery
4796797|NCT02639702|Clozapine|clozapine
4796798|NCT02639702|Dosing|dosing
4796799|NCT02639702|Once daily|once daily
4796800|NCT02639702|Regimen|regimen
4796801|NCT02639702|Schizophrenia|schizophrenia
4796802|NCT02639689|Deficits of foot relievers of central origin|deficits of foot relievers of central origin
4796803|NCT02639689|Walkaide|walkaide
4796804|NCT02639676|Infant|infant
4796805|NCT02639676|Bronchopulmonary Dysplasia|bronchopulmonary dysplasia
4796806|NCT02639676|Premature|premature
4796807|NCT02639650|gestational trophoblastic tumor|gestational trophoblastic tumor
4796808|NCT02639650|paclitaxel|paclitaxel
4796809|NCT02639650|cisplatin|cisplatin
4796810|NCT02639650|carboplatin|carboplatin
4796811|NCT02639650|chemotherapy|chemotherapy
4796812|NCT02639637|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
4796813|NCT02639637|Sitagliptin|sitagliptin
4796814|NCT02639637|Dipeptidyl Peptidase IV Inhibitors|dipeptidyl peptidase iv inhibitors
4797311|NCT02636855|Screening|screening
4796815|NCT02639637|Angiotensin Converting Enzyme Inhibitors|angiotensin converting enzyme inhibitors
4796816|NCT02639637|Enalaprilat|enalaprilat
4796817|NCT02639637|Neuropeptide Y|neuropeptide y
4796818|NCT02639624|hemodialysis|hemodialysis
4796819|NCT02639624|kidney|kidney
4796820|NCT02639624|dialysis|dialysis
4796821|NCT02639611|Breast Expanders|breast expanders
4796822|NCT02639598|chronic migraine|chronic migraine
4796823|NCT02639598|prophylaxis|prophylaxis
4796824|NCT02639598|flunarizine|flunarizine
4796825|NCT02639598|topiramate|topiramate
4796826|NCT02639585|daclatasvir|daclatasvir
4796827|NCT02639585|asunaprevir|asunaprevir
4796828|NCT02639533|fibromyalgia|fibromyalgia
4796829|NCT02639533|pregabalin|pregabalin
4796830|NCT02639533|cortical excitability|cortical excitability
4796831|NCT02639533|functional near infrared spectroscopy|functional near infrared spectroscopy
4796832|NCT02639520|Uncomplicated urinary tract infection|uncomplicated urinary tract infection
4796833|NCT02639481|traumatic brain injury|traumatic brain injury
4796834|NCT02639481|stroke|stroke
4796835|NCT02639481|disorders of consciousness|disorders of consciousness
4796836|NCT02639481|rehabilitation|rehabilitation
4796837|NCT02639481|robotic rehabilitation device|robotic rehabilitation device
4796838|NCT02639416|severe acute malnutrition|severe acute malnutrition
4796839|NCT02639416|polymeric therapeutic formula|polymeric therapeutic formula
4796840|NCT02639416|elemental therapeutic formula|elemental therapeutic formula
4796841|NCT02639403|Rectal cancer|rectal cancer
4796842|NCT02639403|Radiotherapy|radiotherapy
4796843|NCT02639403|Occlusion|occlusion
4796844|NCT02639390|Robotics|robotics
4796845|NCT02639390|upper extremity|upper extremity
4796846|NCT02639390|neurorehabilitation|neurorehabilitation
4796847|NCT02639390|movement therapy|movement therapy
4796848|NCT02639377|Dental Implantation|dental implantation
4796849|NCT02639377|Chlorhexidine gluconate|chlorhexidine gluconate
4796850|NCT02639338|Chronic|chronic
4796851|NCT02639325|Brain Tumor|brain tumor
4796852|NCT02639325|Brain Cancer|brain cancer
4796853|NCT02639325|Seizure Disorder|seizure disorder
4796854|NCT02639325|Seizures|seizures
4796855|NCT02639312|Cranofacial|cranofacial
4796856|NCT02639312|Microsomia|microsomia
4796857|NCT02639312|Mandibular|mandibular
4796858|NCT02639312|Facial Defects|facial defects
4796859|NCT02639312|Hasburg Jaw|hasburg jaw
4796860|NCT02639299|Subjects|subjects
4796861|NCT02639299|Venipuncture|venipuncture
4796862|NCT02639299|Research|research
4796863|NCT02639299|Evaluate|evaluate
4796864|NCT02639299|Recruit|recruit
4796865|NCT02639286|Lipodystrophy|lipodystrophy
4796866|NCT02639286|Hypertriglyceridemia|hypertriglyceridemia
4796867|NCT02639273|Nalmefene|nalmefene
4796868|NCT02639273|fMRI|fmri
4796869|NCT02639273|Incentive Salience|incentive salience
4796870|NCT02639273|Reward Processing|reward processing
4796871|NCT02639273|Aversive Event Processing|aversive event processing
4796872|NCT02639260|Nephrotic Syndrome|nephrotic syndrome
4796873|NCT02639260|Glomerular Filtration Rate|glomerular filtration rate
4796874|NCT02639260|Sialic Acid|sialic acid
4796875|NCT02639260|Proteinuria|proteinuria
4796876|NCT02639247|Chronic|chronic
4796877|NCT02639208|Breast Cancer I|breast cancer i
4796878|NCT02639208|Breast Cancer Stage II|breast cancer stage ii
4796879|NCT02639208|Breast Cancer Stage III|breast cancer stage iii
4796880|NCT02639182|Axitinib|axitinib
4796881|NCT02639182|Metastatic Renal Cell Carcinoma|metastatic renal cell carcinoma
4796882|NCT02639182|AGS-16C3F|ags-16c3f
4796883|NCT02639169|music therapy|music therapy
4796884|NCT02639169|Distress|distress
4796885|NCT02639169|Mood|mood
4796886|NCT02639169|HSCT|hsct
4796887|NCT02639130|Gastric Inhibitory Polypeptide (GIP)|gastric inhibitory polypeptide (gip)
4796888|NCT02639130|Glucagon-Like Peptide 1 (GLP-1)|glucagon-like peptide 1 (glp-1)
4796889|NCT02639130|DPP-4 inhibition; Exendin [9-39]|dpp-4 inhibition; exendin [9-39]
4796890|NCT02639130|Gastric emptying|gastric emptying
4796891|NCT02639130|Glucagon|glucagon
4796892|NCT02639130|Incretin|incretin
4796893|NCT02639130|Insulin Secretion|insulin secretion
4796894|NCT02639130|Normal glucose-tolerant|normal glucose-tolerant
4796895|NCT02639117|basal cell carcinoma, photodynamic therapy, vismodegib|basal cell carcinoma, photodynamic therapy, vismodegib
4796896|NCT02639104|neck pain|neck pain
4796897|NCT02639104|cervical lordosis|cervical lordosis
4796898|NCT02639104|long thoracic nerve|long thoracic nerve
4796899|NCT02639091|Phase 1|phase 1
4796900|NCT02639091|Solid tumors|solid tumors
4796901|NCT02639091|Mesothelioma|mesothelioma
4796902|NCT02639091|Lung cancer|lung cancer
4796903|NCT02639091|Pemetrexed|pemetrexed
4796904|NCT02639091|Cisplatin|cisplatin
4796905|NCT02639078|Single ascending dose|single ascending dose
4796906|NCT02639078|volunteers|volunteers
4796907|NCT02639078|Phase 1|phase 1
4796908|NCT02639078|first-in-human|first-in-human
4796909|NCT02639078|TD-0714|td-0714
4796910|NCT02639065|Durvalumab|durvalumab
4796911|NCT02639065|MEDI4736|medi4736
4796912|NCT02639065|PD-L1 inhibitor|pd-l1 inhibitor
4796913|NCT02639052|Itch|itch
4796914|NCT02639052|Botox|botox
4796915|NCT02639052|Healthy Volunteers|healthy volunteers
4796916|NCT02638987|Dry needling|dry needling
4796917|NCT02638987|office workers|office workers
4796918|NCT02638987|myofascial pain|myofascial pain
4796919|NCT02638987|electromyography|electromyography
4796920|NCT02638961|heart failure with preserved ejection fraction|heart failure with preserved ejection fraction
4796921|NCT02638961|physical therapy|physical therapy
4796922|NCT02638961|exercise capacity|exercise capacity
4796923|NCT02638961|quality of life|quality of life
4796924|NCT02638935|Virtual Touch Tissue Imaging|virtual touch tissue imaging
4796925|NCT02638935|VTIQ|vtiq
4796926|NCT02638935|Elastography|elastography
4796927|NCT02638935|Breast Cancer|breast cancer
4796928|NCT02638935|BI-RADS|bi-rads
4796929|NCT02638935|Differentiation of breast lesions|differentiation of breast lesions
4796930|NCT02638935|Breast Lesion|breast lesion
4796931|NCT02638909|Gastrointestinal malignancies|gastrointestinal malignancies
4796932|NCT02638896|Ankylosing Spondylitis|ankylosing spondylitis
4796933|NCT02638896|Etanercept|etanercept
4796934|NCT02638896|Sulfasalazine|sulfasalazine
4796935|NCT02638896|Efficacy|efficacy
4796936|NCT02638896|Safety|safety
4796937|NCT02638896|dose|dose
4796938|NCT02638896|reduction|reduction
4796939|NCT02638857|Recurrence Hepatocellular Carcinoma|recurrence hepatocellular carcinoma
4796940|NCT02638857|Advanced Hepatocellular Carcinoma|advanced hepatocellular carcinoma
4796941|NCT02638857|Dendritic Cell -Precision Multiple Antigen T Cells|dendritic cell -precision multiple antigen t cells
4796942|NCT02638857|Transcatheter Arterial Chemoembolization|transcatheter arterial chemoembolization
4796943|NCT02638844|echocardiography|echocardiography
4796944|NCT02638831|Pain|pain
4796945|NCT02638831|Gonarthrosis|gonarthrosis
4796946|NCT02638831|Low Back Pain|low back pain
4796947|NCT02638831|Ketorolac Tromethamine|ketorolac tromethamine
4796948|NCT02638831|Ketoprofen|ketoprofen
4796949|NCT02638818|pancreaticoduodenectomy|pancreaticoduodenectomy
4796950|NCT02638818|Whipple|whipple
4796951|NCT02638779|Septic shock|septic shock
4796952|NCT02638779|severe trauma|severe trauma
4796953|NCT02638779|severe burn|severe burn
4796954|NCT02638779|major surgery|major surgery
4796955|NCT02638779|immunosuppression|immunosuppression
4796956|NCT02638779|Healthcare-Associated Infections|healthcare-associated infections
4796957|NCT02638766|metastatic|metastatic
4796958|NCT02638766|unresectable|unresectable
4796959|NCT02638766|KIT/PDGFR wild type GIST|kit/pdgfr wild type gist
4796960|NCT02638753|non specific chronic low back pain|non specific chronic low back pain
4796961|NCT02638753|education on pain neurophysiology|education on pain neurophysiology
4796962|NCT02638753|education on pain biology|education on pain biology
4796963|NCT02638753|education on pain neuroscience|education on pain neuroscience
4796964|NCT02638753|hypnosis|hypnosis
4796965|NCT02638727|vascular disease|vascular disease
4796966|NCT02638727|endothelial function|endothelial function
4796967|NCT02638727|L-Citrulline|l-citrulline
4796968|NCT02638714|Optic Neuropathies|optic neuropathies
4796969|NCT02638714|Stem Cell Therapy|stem cell therapy
4796970|NCT02638675|financial health incentives|financial health incentives
4796971|NCT02638675|physical activity|physical activity
4796972|NCT02638675|behavioral economics|behavioral economics
4796973|NCT02638675|randomized control trial|randomized control trial
4796974|NCT02638675|workplace health|workplace health
4796975|NCT02638649|lung ultrasound|lung ultrasound
4796976|NCT02638636|Cognitive behavior therapy|cognitive behavior therapy
4796977|NCT02638636|Randomized controlled trial|randomized controlled trial
4796978|NCT02638636|Exposure therapy|exposure therapy
4796979|NCT02638636|Fibromyalgia|fibromyalgia
4796980|NCT02638623|Knee Arthroplasty|knee arthroplasty
4796981|NCT02638623|Hip Arthroplasty|hip arthroplasty
4796982|NCT02638584|Ilaprazole|ilaprazole
4796983|NCT02638584|Gastric Adenoma|gastric adenoma
4796984|NCT02638584|Early Gastric Cancer|early gastric cancer
4796985|NCT02638584|Endoscopic Submucosal Dissection|endoscopic submucosal dissection
4796986|NCT02638532|Fat Pad|fat pad
4796987|NCT02638532|Fat Pad Atrophy|fat pad atrophy
4796988|NCT02638532|Foot|foot
4796989|NCT02638532|Feet|feet
4796990|NCT02638532|Heel|heel
4796991|NCT02638532|Forefoot|forefoot
4796992|NCT02638506|Headaches, Migraines, Fentanyl|headaches, migraines, fentanyl
4796993|NCT02638493|HIV|hiv
4796994|NCT02638493|tenofovir-emtricitabine|tenofovir-emtricitabine
4796995|NCT02638493|antiretroviral therapy|antiretroviral therapy
4796996|NCT02638493|Prevention|prevention
4796997|NCT02638493|tenofovir alafenamide|tenofovir alafenamide
4796998|NCT02638454|Exercise|exercise
4796999|NCT02638454|Anabolic Resistance|anabolic resistance
4797000|NCT02638454|Skeletal Muscle|skeletal muscle
4797001|NCT02638454|microRNA|microrna
4797002|NCT02638441|psychological health|psychological health
4797003|NCT02638441|women|women
4797004|NCT02638441|anxiety|anxiety
4797005|NCT02638441|depression|depression
4797006|NCT02638415|HVPG|hvpg
4797007|NCT02638402|glycosylation|glycosylation
4797008|NCT02638402|mucin|mucin
4797009|NCT02638402|receptor tyrosin kinases|receptor tyrosin kinases
4797010|NCT02638402|ovarian cancer|ovarian cancer
4797011|NCT02638402|endometrial cancer|endometrial cancer
4797012|NCT02638376|Keraroconus|keraroconus
4797013|NCT02638376|keratectasia|keratectasia
4797014|NCT02638376|treatment|treatment
4797015|NCT02638350|lung ultrasound|lung ultrasound
4797016|NCT02638350|Pulmonary Edema|pulmonary edema
4797017|NCT02638350|Respiratory Distress Syndrome|respiratory distress syndrome
4797018|NCT02638337|Vulvo-vaginal Atrophy|vulvo-vaginal atrophy
4797019|NCT02638337|menopause|menopause
4797020|NCT02638259|Biosimilars|biosimilars
4797021|NCT02638259|Rheumatoid Arthritis|rheumatoid arthritis
4797022|NCT02638259|Etanercept|etanercept
4797023|NCT02638233|CHC|chc
4797024|NCT02638233|IVDA (intravenous drug abuse)|ivda (intravenous drug abuse)
4797025|NCT02638233|Hepatitis C|hepatitis c
4797026|NCT02638233|Sofosbuvir|sofosbuvir
4797027|NCT02638233|Ledipasvir|ledipasvir
4797028|NCT02638233|Opiate Substitution Therapy|opiate substitution therapy
4797029|NCT02638220|Cerebrotendinous Xanthomatosis|cerebrotendinous xanthomatosis
4797030|NCT02638220|CTX Prevalence Study|ctx prevalence study
4797031|NCT02638220|CTX|ctx
4797032|NCT02638220|Idiopathic Bilateral Cataracts|idiopathic bilateral cataracts
4797033|NCT02638220|Cataracts|cataracts
4797034|NCT02638220|Bilateral Cataracts|bilateral cataracts
4797035|NCT02638220|Early-Onset Idiopathic Bilateral Cataracts|early-onset idiopathic bilateral cataracts
4797036|NCT02638220|Observational Study|observational study
4797037|NCT02638220|Ophthalmology|ophthalmology
4797038|NCT02638207|Chronic Inflammatory Demyelinating Poly Neuropathy (CIDP)|chronic inflammatory demyelinating poly neuropathy (cidp)
4797039|NCT02638194|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
4797040|NCT02638194|smoking|smoking
4797041|NCT02638194|secondhand smoke|secondhand smoke
4797042|NCT02638181|matrix metalloproteinase 13|matrix metalloproteinase 13
4797043|NCT02638181|tissue inhibitor of metalloproteinases 3|tissue inhibitor of metalloproteinases 3
4797044|NCT02638181|calcium-sensing receptor|calcium-sensing receptor
4797045|NCT02638181|trabecular meshwork|trabecular meshwork
4797046|NCT02638181|open-angle glaucoma|open-angle glaucoma
4797047|NCT02638142|loop diuretic|loop diuretic
4797048|NCT02638142|heart failure|heart failure
4797049|NCT02638142|renal dysfunction|renal dysfunction
4797050|NCT02638142|congestion signs|congestion signs
4797051|NCT02638142|BNP|bnp
4797052|NCT02638129|Drug therapy|drug therapy
4797053|NCT02638116|Ibrutinib|ibrutinib
4797054|NCT02638116|Proton pump inhibitors|proton pump inhibitors
4797055|NCT02638116|Pharmacokinetics|pharmacokinetics
4797056|NCT02638116|Drug Interaction|drug interaction
4797057|NCT02638090|advanced lung cancer|advanced lung cancer
4797058|NCT02638090|immune therapy naive|immune therapy naive
4797059|NCT02638090|immune therapy pre-treated|immune therapy pre-treated
4797060|NCT02638090|NSCLC|nsclc
4797061|NCT02638090|Stage IV lung cancer|stage iv lung cancer
4797062|NCT02638090|pembrolizumab|pembrolizumab
4797063|NCT02638090|vorinostat|vorinostat
4797064|NCT02638090|immunogenicity|immunogenicity
4797065|NCT02638077|Differentiated Thyroid Cancer|differentiated thyroid cancer
4797066|NCT02638077|the initial management|the initial management
4797067|NCT02638051|Peritoneal Carcinomatosis|peritoneal carcinomatosis
4797068|NCT02638051|Malignant Ascites|malignant ascites
4797069|NCT02638051|Modulated Electro-Hyperthermia|modulated electro-hyperthermia
4797070|NCT02638051|Traditional Chinese Medicine|traditional chinese medicine
4797071|NCT02637960|VA106483, fedovapagon, BPH, nocturia, EQUINOC|va106483, fedovapagon, bph, nocturia, equinoc
4797072|NCT02637921|bed rest|bed rest
4797073|NCT02637921|bone metabolism|bone metabolism
4797074|NCT02637908|Mindfulness|mindfulness
4797075|NCT02637908|Parents|parents
4797076|NCT02637908|Families|families
4797077|NCT02637895|PTSD,|ptsd,
4797078|NCT02637895|trauma|trauma
4797079|NCT02637895|stress disorder|stress disorder
4797080|NCT02637895|post-traumatic stress disorder|post-traumatic stress disorder
4797081|NCT02637895|anxiety disorder|anxiety disorder
4797082|NCT02637869|Health Expenditures|health expenditures
4797083|NCT02637869|Prospective Payment System|prospective payment system
4797084|NCT02637869|Health Care Utilization|health care utilization
4797085|NCT02637869|Health Care Quality, Access, and Evaluation|health care quality, access, and evaluation
4797086|NCT02637843|radial|radial
4797087|NCT02637843|angiography|angiography
4797088|NCT02637843|angioplasty|angioplasty
4797089|NCT02637843|randomized|randomized
4797090|NCT02637843|sheath|sheath
4797091|NCT02637843|slender|slender
4797092|NCT02637791|Stroke|stroke
4797093|NCT02637791|Rehabilitation|rehabilitation
4797094|NCT02637791|Virtual Reality|virtual reality
4797095|NCT02637778|nutrient profiles|nutrient profiles
4797096|NCT02637778|menu plans|menu plans
4797097|NCT02637778|n-3 LC-PUFA|n-3 lc-pufa
4797098|NCT02637778|SFA|sfa
4797099|NCT02637778|MUFA|mufa
4797100|NCT02637778|PUFA|pufa
4797101|NCT02637778|cardiovascular risk|cardiovascular risk
4797102|NCT02637765|Breast Cancer|breast cancer
4797103|NCT02637765|Physical Activity|physical activity
4797104|NCT02637765|Quality of life|quality of life
4797105|NCT02637752|Pediatric Obesity|pediatric obesity
4797106|NCT02637752|Body Mass Index|body mass index
4797107|NCT02637752|Dentistry|dentistry
4797108|NCT02637739|hysteroscope|hysteroscope
4797109|NCT02637726|Total intravenous anesthesia|total intravenous anesthesia
4797110|NCT02637726|Target Controlled Infusion|target controlled infusion
4797111|NCT02637726|Propofol|propofol
4797112|NCT02637726|Bispectral index|bispectral index
4797113|NCT02637726|Children|children
4797115|NCT02637713|sleeve gastrectomy|sleeve gastrectomy
4797116|NCT02637713|reflux|reflux
4797117|NCT02637713|morbidly obese|morbidly obese
4797118|NCT02637700|Small Fiber Neuropathy|small fiber neuropathy
4797119|NCT02637700|Painful Neuropathy|painful neuropathy
4797120|NCT02637700|Intravenous Immunoglobulin Therapy|intravenous immunoglobulin therapy
4797121|NCT02637687|Pediatric|pediatric
4797122|NCT02637687|NTRK1|ntrk1
4797123|NCT02637687|NTRK2|ntrk2
4797124|NCT02637687|NTRK3|ntrk3
4797125|NCT02637687|Fusion|fusion
4797126|NCT02637687|Tumors|tumors
4797127|NCT02637687|Solid Tumors|solid tumors
4797128|NCT02637687|CNS Tumors|cns tumors
4797129|NCT02637687|Central Nervous System Tumors|central nervous system tumors
4797130|NCT02637687|NTRK Fusion Positive|ntrk fusion positive
4797131|NCT02637687|TRKA|trka
4797132|NCT02637687|TRKB|trkb
4797133|NCT02637687|TRKC|trkc
4797134|NCT02637687|Infantile Fibrosarcoma|infantile fibrosarcoma
4797135|NCT02637687|NTRK Gene Rearrangements|ntrk gene rearrangements
4797136|NCT02637687|TRK Fusion|trk fusion
4797137|NCT02637687|NTRK1 fusion|ntrk1 fusion
4797138|NCT02637687|NTRK2 fusion|ntrk2 fusion
4797139|NCT02637687|NTRK3 fusion|ntrk3 fusion
4797140|NCT02637687|NTRK1 gene rearrangement|ntrk1 gene rearrangement
4797141|NCT02637687|NTRK2 gene rearrangement|ntrk2 gene rearrangement
4797142|NCT02637687|NTRK3 gene rearrangement|ntrk3 gene rearrangement
4797143|NCT02637687|ETV6-NTRK3|etv6-ntrk3
4797144|NCT02637687|ETV6|etv6
4797145|NCT02637687|ETV6 fusion|etv6 fusion
4797146|NCT02637687|ETV6 gene rearrangement|etv6 gene rearrangement
4797147|NCT02637687|Solid CNS tumor|solid cns tumor
4797148|NCT02637687|Primary CNS tumor|primary cns tumor
4797149|NCT02637687|Advanced CNS tumor|advanced cns tumor
4797150|NCT02637687|Metastatic CNS tumor|metastatic cns tumor
4797151|NCT02637687|Metastatic infantile fibrosarcoma|metastatic infantile fibrosarcoma
4797152|NCT02637687|Advanced infantile fibrosarcoma|advanced infantile fibrosarcoma
4797153|NCT02637687|Fibrosarcoma|fibrosarcoma
4797154|NCT02637687|Congenital mesoblastic nephroma|congenital mesoblastic nephroma
4797155|NCT02637687|Congenital nephroma|congenital nephroma
4797156|NCT02637687|Thyroid|thyroid
4797157|NCT02637687|Larotrectinib|larotrectinib
4797158|NCT02637687|Solid tumors Cancer of Unknown primary|solid tumors cancer of unknown primary
4797159|NCT02637674|allotransplantation|allotransplantation
4797160|NCT02637661|earlobe crease|earlobe crease
4797161|NCT02637661|acute myocardial infarction|acute myocardial infarction
4797162|NCT02637661|risk factor|risk factor
4797163|NCT02637635|Mammaplasty|mammaplasty
4797164|NCT02637635|Transplantation, Autologous|transplantation, autologous
4797165|NCT02637635|Mastectomy|mastectomy
4797166|NCT02637635|Breast Implants|breast implants
4797167|NCT02637635|Radiotherapy, Adjuvant|radiotherapy, adjuvant
4797168|NCT02637622|conjoint analysis|conjoint analysis
4797169|NCT02637622|stated-preference methods|stated-preference methods
4797170|NCT02637622|patient centered outcome research (PCOR)|patient centered outcome research (pcor)
4797171|NCT02637622|community-based participatory research (CBPR)|community-based participatory research (cbpr)
4797172|NCT02637622|patient preference|patient preference
4797173|NCT02637622|diabetes|diabetes
4797174|NCT02637609|conjoint analysis|conjoint analysis
4797175|NCT02637609|stated-preference methods|stated-preference methods
4797176|NCT02637609|patient centered outcome research (PCOR)|patient centered outcome research (pcor)
4797177|NCT02637609|community-based participatory research (CBPR)|community-based participatory research (cbpr)
4797178|NCT02637609|patient priority|patient priority
4797179|NCT02637609|diabetes|diabetes
4797180|NCT02637583|conjugate vaccine|conjugate vaccine
4797181|NCT02637583|polysaccharide vaccine|polysaccharide vaccine
4797182|NCT02637570|healthy male athletes|healthy male athletes
4797183|NCT02637570|18-35 years old|18-35 years old
4797184|NCT02637531|IPI-549|ipi-549
4797185|NCT02637531|Phase 1|phase 1
4797186|NCT02637531|Advanced Solid Tumor|advanced solid tumor
4797187|NCT02637531|Non-small cell lung cancer|non-small cell lung cancer
4797188|NCT02637531|Melanoma|melanoma
4797189|NCT02637531|PI3K|pi3k
4797190|NCT02637531|Squamous Cell Cancer of the Head and Neck|squamous cell cancer of the head and neck
4797191|NCT02637531|Triple Negative Breast Cancer|triple negative breast cancer
4797192|NCT02637531|Adrenocortical Carcinoma|adrenocortical carcinoma
4797193|NCT02637531|Mesothelioma|mesothelioma
4797194|NCT02637518|Frailty|frailty
4797195|NCT02637518|Frailty screening tools|frailty screening tools
4797196|NCT02637518|Clinical settings|clinical settings
4797197|NCT02637518|Social settings|social settings
4797198|NCT02637518|Geriatrics|geriatrics
4797199|NCT02637518|Functional autonomy|functional autonomy
4797200|NCT02637518|Disability|disability
4797201|NCT02637505|Articular cartilage|articular cartilage
4797202|NCT02637505|Focal cartilage injury|focal cartilage injury
4797203|NCT02637505|Focal cartilage injury in the knee|focal cartilage injury in the knee
4797204|NCT02637505|Knee cartilage|knee cartilage
4797205|NCT02637505|Microfracture|microfracture
4797206|NCT02637505|Debridement|debridement
4797207|NCT02637492|Critical limb ischaemia|critical limb ischaemia
4797208|NCT02637492|Peripheral occlusive arterial disease|peripheral occlusive arterial disease
4797209|NCT02637492|Clinical prediction|clinical prediction
4797210|NCT02637492|Ankle pressure|ankle pressure
4797211|NCT02637492|Transcutaneous oxygen pressure|transcutaneous oxygen pressure
4797212|NCT02637492|Toe pressure|toe pressure
4797213|NCT02637492|Microcirculation|microcirculation
4797214|NCT02637453|Paroxysmal Atrial Fibrillation;Additional Linear Ablation|paroxysmal atrial fibrillation;additional linear ablation
4797215|NCT02637427|Fresh frozen plasma|fresh frozen plasma
4797216|NCT02637427|Bleeding|bleeding
4797217|NCT02637414|Stress|stress
4797218|NCT02637414|Well-being|well-being
4797219|NCT02637414|Positive psychology|positive psychology
4797220|NCT02637388|Appetite|appetite
4797221|NCT02637388|Beta-glucans|beta-glucans
4797222|NCT02637388|Energy Intake|energy intake
4797223|NCT02637388|Glucagon-Like Peptide 1|glucagon-like peptide 1
4797224|NCT02637388|Glucose|glucose
4797225|NCT02637388|Insulin|insulin
4797226|NCT02637388|Incretins|incretins
4797227|NCT02637375|triple-negative breast cancer|triple-negative breast cancer
4797228|NCT02637336|Therapies. Autonomic nervous system. Cardiovascular stress|therapies. autonomic nervous system. cardiovascular stress
4797229|NCT02637323|osteoarthritis|osteoarthritis
4797230|NCT02637323|knee|knee
4797231|NCT02637323|pain|pain
4797232|NCT02637323|corticosteroid|corticosteroid
4797233|NCT02637323|intra-articular|intra-articular
4797234|NCT02637323|injection|injection
4797235|NCT02637284|Healthy volunteers|healthy volunteers
4797236|NCT02637271|Calorie restriction|calorie restriction
4797237|NCT02637271|Meal replacement|meal replacement
4797238|NCT02637271|fMRI|fmri
4797239|NCT02637271|Food-cue reactivity|food-cue reactivity
4797240|NCT02637271|Obesity|obesity
4797241|NCT02637258|optic nerve sheath diameter|optic nerve sheath diameter
4797242|NCT02637258|neurological outcome|neurological outcome
4797243|NCT02637258|OHCA|ohca
4797244|NCT02637245|diabetic macular edema|diabetic macular edema
4797245|NCT02637245|diabetic retinopathy|diabetic retinopathy
4797246|NCT02637206|Healthy Japanese|healthy japanese
4797247|NCT02637206|GSK2894512|gsk2894512
4797248|NCT02637206|skin safety|skin safety
4797249|NCT02637180|osteoporosis|osteoporosis
4797250|NCT02637180|fracture|fracture
4797251|NCT02637180|liaison service|liaison service
4797252|NCT02637167|Heart failure|heart failure
4797253|NCT02637167|inflammation|inflammation
4797254|NCT02637167|rifaximin|rifaximin
4797255|NCT02637167|Saccharomyces boulardii|saccharomyces boulardii
4797256|NCT02637167|gut microbiota|gut microbiota
4797257|NCT02637154|Adolescent|adolescent
4797258|NCT02637154|Type 1 diabetes|type 1 diabetes
4797259|NCT02637154|Metabolic control|metabolic control
4797260|NCT02637154|Motivational interviewing|motivational interviewing
4797261|NCT02637141|celiac|celiac
4797262|NCT02637141|gluten|gluten
4797263|NCT02637141|IL-15|il-15
4797264|NCT02637141|AMG 714|amg 714
4797265|NCT02637128|MALARIA, FALCIPARUM|malaria, falciparum
4797266|NCT02637128|MALAWI|malawi
4797267|NCT02637128|ARTEMETHER-LUMEFANTRINE|artemether-lumefantrine
4797268|NCT02637128|ARTESUNATE-AMODIAQUINE|artesunate-amodiaquine
4797269|NCT02637115|Gut microbiota|gut microbiota
4797270|NCT02637115|Akkermansia muciniphila|akkermansia muciniphila
4797271|NCT02637076|Xyrem|xyrem
4797272|NCT02637076|narcolepsy with cataplexy|narcolepsy with cataplexy
4797273|NCT02637076|positron emission tomography|positron emission tomography
4797274|NCT02637076|dopamine|dopamine
4797275|NCT02637063|Lifestyle behavior change|lifestyle behavior change
4797276|NCT02637050|Type IV Pulmonary Hypertension|type iv pulmonary hypertension
4797277|NCT02637050|Chronic Thromboembolic Pulmonary Hypertension|chronic thromboembolic pulmonary hypertension
4797278|NCT02637050|CTEPH|cteph
4797279|NCT02637037|dapagliflozin/metformin XR 5/500 mg|dapagliflozin/metformin xr 5/500 mg
4797280|NCT02637037|dapagliflozin/metformin XR10/1000 mg|dapagliflozin/metformin xr10/1000 mg
4797281|NCT02637037|bioequivalence|bioequivalence
4797282|NCT02637037|fixed dose combination tablets|fixed dose combination tablets
4797283|NCT02637037|pharmacokinetic|pharmacokinetic
4797284|NCT02637037|type 2 Diabetes Mellitus (T2DM)|type 2 diabetes mellitus (t2dm)
4797285|NCT02637037|safety|safety
4797286|NCT02637024|Breast Cancer|breast cancer
4797287|NCT02637024|DCIS|dcis
4797288|NCT02637024|Radiotherapy|radiotherapy
4797289|NCT02637024|Partial breast irradiation|partial breast irradiation
4797290|NCT02637024|Radiation fractions|radiation fractions
4797291|NCT02637011|acute respiratory distress syndrome|acute respiratory distress syndrome
4797292|NCT02637011|intensive care medicine|intensive care medicine
4797293|NCT02637011|critical illness|critical illness
4797294|NCT02637011|long-term outcomes|long-term outcomes
4797295|NCT02637011|quality of life|quality of life
4797296|NCT02637011|return to work|return to work
4797297|NCT02637011|quality of care|quality of care
4797298|NCT02636972|TLR2|tlr2
4797299|NCT02636972|TLR4|tlr4
4797300|NCT02636972|Biomarker|biomarker
4797301|NCT02636972|TLR responsiveness|tlr responsiveness
4797302|NCT02636972|Peripheral blood responsiveness|peripheral blood responsiveness
4797303|NCT02636972|Inflammatory pain|inflammatory pain
4797304|NCT02636933|Asthma|asthma
4797305|NCT02636933|Allergic Rhinitis|allergic rhinitis
4797306|NCT02636933|Children|children
4797307|NCT02636933|Atopy|atopy
4797308|NCT02636920|Asthma|asthma
4797309|NCT02636920|Children|children
4797310|NCT02636855|Solid and Hematological Malignancies|solid and hematological malignancies
4797312|NCT02636855|Metastatic|metastatic
4797313|NCT02636855|Previously Treated|previously treated
4797314|NCT02636855|NY-ESO-1|ny-eso-1
4797315|NCT02636855|MAGE A10|mage a10
4797316|NCT02636855|MAGE-A4|mage-a4
4797317|NCT02636842|Schizophrenia|schizophrenia
4797318|NCT02636842|Schizoaffective Disorder|schizoaffective disorder
4797319|NCT02636842|Aripiprazole Lauroxil|aripiprazole lauroxil
4797320|NCT02636842|Aripiprazole|aripiprazole
4797321|NCT02636842|ALKS 9072|alks 9072
4797322|NCT02636842|Alkermes|alkermes
4797323|NCT02636803|trichuris|trichuris
4797324|NCT02636803|hookworms|hookworms
4797325|NCT02636803|Ascaris|ascaris
4797326|NCT02636777|low back pain|low back pain
4797327|NCT02636777|chronic pain|chronic pain
4797328|NCT02636777|self-management|self-management
4797329|NCT02636777|longitudinal study|longitudinal study
4797330|NCT02636777|predictive modelling|predictive modelling
4797331|NCT02636751|Prehabilitation|prehabilitation
4797332|NCT02636751|Telemedicine|telemedicine
4797333|NCT02636751|Osteoarthritis|osteoarthritis
4797334|NCT02636751|Arthroplasty|arthroplasty
4797335|NCT02636751|Hip|hip
4797336|NCT02636751|Knee|knee
4797337|NCT02636725|Advanced Alveolar Soft Part Sarcoma|advanced alveolar soft part sarcoma
4797338|NCT02636725|ASPS|asps
4797339|NCT02636725|Soft Tissue Sarcomas|soft tissue sarcomas
4797340|NCT02636725|STS|sts
4797341|NCT02636725|Alveolar Soft Part Sarcoma|alveolar soft part sarcoma
4797342|NCT02636686|DMD|dmd
4797343|NCT02636686|Duchenne Muscular Dystrophy|duchenne muscular dystrophy
4797344|NCT02636686|Drisapersen|drisapersen
4797345|NCT02636686|Kyndrisa|kyndrisa
4797346|NCT02636686|exon-skipping|exon-skipping
4797347|NCT02636686|exon-51|exon-51
4797348|NCT02636686|BMN-051-302|bmn-051-302
4797349|NCT02636686|051-302|051-302
4797350|NCT02636660|Critical care|critical care
4797351|NCT02636660|Mechanical Ventilation|mechanical ventilation
4797352|NCT02636660|Quality of Life|quality of life
4797353|NCT02636660|Stressors|stressors
4797354|NCT02636660|Nursing Sensitive Outcomes|nursing sensitive outcomes
4797355|NCT02636660|Nursing|nursing
4797356|NCT02636647|hepatic encephalopathy|hepatic encephalopathy
4797357|NCT02636647|fecal transplant|fecal transplant
4797358|NCT02636647|cirrhosis|cirrhosis
4797359|NCT02636634|diagnostic strategy|diagnostic strategy
4797360|NCT02636634|brain metastases|brain metastases
4797361|NCT02636634|radiation necrosis|radiation necrosis
4797362|NCT02636634|relapse|relapse
4797363|NCT02636634|PET-FET and MSR|pet-fet and msr
4797364|NCT02636634|radiosurgery|radiosurgery
4797365|NCT02636621|Fatigue|fatigue
4797366|NCT02636621|excessive daytime sleepiness|excessive daytime sleepiness
4797367|NCT02636621|flow limitation|flow limitation
4797368|NCT02636608|Chronic Hepatitis C|chronic hepatitis c
4797369|NCT02636608|Dasabuvir|dasabuvir
4797370|NCT02636608|Paritaprevir/r/Ombitasvir|paritaprevir/r/ombitasvir
4797371|NCT02636608|Observational Study|observational study
4797372|NCT02636608|Quality of Life|quality of life
4797373|NCT02636608|Fibrosis|fibrosis
4797374|NCT02636608|Cirrhosis|cirrhosis
4797375|NCT02636608|Work Ability|work ability
4797376|NCT02636595|Hepatitis C Genotype 4|hepatitis c genotype 4
4797377|NCT02636595|Hepatitis C|hepatitis c
4797378|NCT02636595|Chronic Hepatitis C|chronic hepatitis c
4797379|NCT02636595|Hepatitis C Genotype 6|hepatitis c genotype 6
4797380|NCT02636595|Hepatitis C Genotype 5|hepatitis c genotype 5
4797381|NCT02636556|thymoma|thymoma
4797382|NCT02636556|thymic carcinoma|thymic carcinoma
4797383|NCT02636556|chemoradiotherapy|chemoradiotherapy
4797384|NCT02636556|inoperable|inoperable
4797385|NCT02636543|genetic diagnosis|genetic diagnosis
4797386|NCT02636543|information|information
4797387|NCT02636543|letter model|letter model
4797388|NCT02636517|Fecal Microbiota transplant|fecal microbiota transplant
4797389|NCT02636504|Pulp vitality|pulp vitality
4797390|NCT02636504|Pulp testing|pulp testing
4797391|NCT02636439|Diastolic heart failure|diastolic heart failure
4797392|NCT02636439|Heart Failure|heart failure
4797393|NCT02636439|Elderly|elderly
4797394|NCT02636439|Obesity|obesity
4797395|NCT02636426|phase I study|phase i study
4797396|NCT02636426|sorafenib|sorafenib
4797397|NCT02636426|high-dose schedule|high-dose schedule
4797398|NCT02636426|pharmacokinetics|pharmacokinetics
4797399|NCT02636426|drug monitoring|drug monitoring
4797400|NCT02636400|Infertility|infertility
4797401|NCT02636400|endometriosis|endometriosis
4797402|NCT02636348|Calcium|calcium
4797403|NCT02636348|Vitamin D|vitamin d
4797404|NCT02636322|Lymphoma|lymphoma
4797405|NCT02636322|High Risk Diffuse Large B-Cell Lymphoma|high risk diffuse large b-cell lymphoma
4797406|NCT02636322|DLBCL|dlbcl
4797407|NCT02636322|Rituximab|rituximab
4797408|NCT02636322|Rituxan|rituxan
4797409|NCT02636322|Ibrutinib|ibrutinib
4797410|NCT02636322|PCI-32765|pci-32765
4797411|NCT02636322|Imbruvica|imbruvica
4797412|NCT02636322|Lenalidomide|lenalidomide
4797413|NCT02636322|CC-5013|cc-5013
4797414|NCT02636322|Revlimid|revlimid
4797415|NCT02636322|Etoposide|etoposide
4797416|NCT02636322|VePesid|vepesid
4797417|NCT02636322|Prednisone|prednisone
4797418|NCT02636322|Vincristine|vincristine
4797419|NCT02636322|Oncovin|oncovin
4797420|NCT02636322|Cyclophosphamide|cyclophosphamide
4797421|NCT02636322|Cytoxan|cytoxan
4797422|NCT02636322|Neosar|neosar
4797423|NCT02636322|Doxorubicin|doxorubicin
4797424|NCT02636322|Hydroxydaunorubicin|hydroxydaunorubicin
4797425|NCT02636322|Adriamycin PFS|adriamycin pfs
4797426|NCT02636322|Adriamycin RDF|adriamycin rdf
4797427|NCT02636322|Adriamycin|adriamycin
4797428|NCT02636322|Rubex|rubex
4797429|NCT02636309|ergonomics|ergonomics
4797430|NCT02636309|multifaceted intervention|multifaceted intervention
4797431|NCT02636309|industry|industry
4797432|NCT02636309|physiotherapy|physiotherapy
4797433|NCT02636309|physical exercises|physical exercises
4797434|NCT02636309|workplace|workplace
4797435|NCT02636309|acupuncture|acupuncture
4797436|NCT02636309|work|work
4797437|NCT02636309|quality of life|quality of life
4797438|NCT02636309|absenteeism|absenteeism
4797439|NCT02636309|efficiency|efficiency
4797440|NCT02636309|musculoskeletal pain|musculoskeletal pain
4797441|NCT02636309|WMSD|wmsd
4797442|NCT02636296|Pilates method|pilates method
4797443|NCT02636296|elderly|elderly
4797444|NCT02636296|postural balance|postural balance
4797445|NCT02636257|Silicone Nasolacrimal Intubation|silicone nasolacrimal intubation
4797446|NCT02636257|Dacryocystorhinostomy|dacryocystorhinostomy
4797447|NCT02636231|Endostar|endostar
4797448|NCT02636231|IMRT|imrt
4797449|NCT02636231|recurrent|recurrent
4797450|NCT02636231|NPC|npc
4797451|NCT02636218|Ketamine|ketamine
4797452|NCT02636192|Sodium-glucose co-transporter 2 inhibitors|sodium-glucose co-transporter 2 inhibitors
4797453|NCT02636192|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
4797454|NCT02636179|In Vitro Fertilization, follow-up of children|in vitro fertilization, follow-up of children
4797455|NCT02636166|Pregnancy|pregnancy
4797456|NCT02636153|phosphorus,dietary|phosphorus,dietary
4797457|NCT02636153|circadian rhythm|circadian rhythm
4797458|NCT02636153|phosphorus|phosphorus
4797459|NCT02636088|Phase II study, clinical trial|phase ii study, clinical trial
4797460|NCT02636062|Coronary disease|coronary disease
4797461|NCT02636062|Coronary artery disease (CAD)|coronary artery disease (cad)
4797462|NCT02636062|Endothelial dysfunction|endothelial dysfunction
4797463|NCT02636062|Coronary artery calcium (CAC)|coronary artery calcium (cac)
4797464|NCT02636049|pharmacokinetics|pharmacokinetics
4797465|NCT02636049|healthy adult volunteer|healthy adult volunteer
4797466|NCT02635997|osteoporosis|osteoporosis
4797467|NCT02635997|ibandronate|ibandronate
4797468|NCT02635997|vitamine D|vitamine d
4797469|NCT02635997|calcium|calcium
4797470|NCT02635997|bone mineral density|bone mineral density
4797471|NCT02635997|health-related quality of life|health-related quality of life
4797472|NCT02635971|transcatheter arterial infusion|transcatheter arterial infusion
4797473|NCT02635971|randomized controlled trial|randomized controlled trial
4797474|NCT02635971|chemotherapy|chemotherapy
4797475|NCT02635958|Body Mass Index|body mass index
4797476|NCT02635958|BMI|bmi
4797477|NCT02635958|InBody|inbody
4797478|NCT02635958|iDXA|idxa
4797479|NCT02635958|validation|validation
4797480|NCT02635945|adenosine A1 receptor antagonist|adenosine a1 receptor antagonist
4797481|NCT02635945|adenosine receptor modulator|adenosine receptor modulator
4797482|NCT02635945|COPD|copd
4797483|NCT02635945|asthma|asthma
4797484|NCT02635919|Nicotine addiction|nicotine addiction
4797485|NCT02635919|Cigarette smoking|cigarette smoking
4797486|NCT02635919|Smoking cessation|smoking cessation
4797487|NCT02635919|Quit smoking|quit smoking
4797488|NCT02635906|BED REST|bed rest
4797489|NCT02635906|CORONARY ANGIOPLASTY|coronary angioplasty
4797490|NCT02635893|SCI|sci
4797491|NCT02635867|vital pulp|vital pulp
4797492|NCT02635867|reversible pulpitis|reversible pulpitis
4797493|NCT02635867|pulp capping|pulp capping
4797494|NCT02635867|deep cavity|deep cavity
4797495|NCT02635867|Management of Deep Dental Caries|management of deep dental caries
4797496|NCT02635854|leukocyte and platelet aggregates|leukocyte and platelet aggregates
4797497|NCT02635854|platelet activation|platelet activation
4797498|NCT02635841|Pantothenate Kinase-Associated Neurodegeneration|pantothenate kinase-associated neurodegeneration
4797499|NCT02635841|PKAN|pkan
4797500|NCT02635841|Neurodegeneration with Brain Iron Accumulation|neurodegeneration with brain iron accumulation
4797501|NCT02635841|NBIA|nbia
4797502|NCT02635841|Deferiprone|deferiprone
4797503|NCT02635841|Ferriprox|ferriprox
4797504|NCT02635828|Palonosetron|palonosetron
4797505|NCT02635828|Craniotomy|craniotomy
4797506|NCT02635828|Nausea|nausea
4797507|NCT02635828|Vomiting|vomiting
4797508|NCT02635802|remifentanil|remifentanil
4797509|NCT02635802|analgesia|analgesia
4797510|NCT02635802|intensive care units|intensive care units
4797511|NCT02635789|Sirolimus|sirolimus
4797512|NCT02635789|Skin lesions|skin lesions
4797513|NCT02635789|TSC|tsc
4797514|NCT02635789|Tuberous Sclerosis Complex|tuberous sclerosis complex
4797515|NCT02635789|NPC-12G|npc-12g
4797516|NCT02635789|Angiofibroma|angiofibroma
4797517|NCT02635789|Hypomelanotic macule|hypomelanotic macule
4797518|NCT02635789|Plaque|plaque
4797519|NCT02635776|AR101 (Characterized Peanut Allergen)|ar101 (characterized peanut allergen)
4797520|NCT02635776|Characterized Peanut Allergen|characterized peanut allergen
4797521|NCT02635776|CPNA (Characterized Peanut Allergen)|cpna (characterized peanut allergen)
4797522|NCT02635776|OIT (oral immunotherapy)|oit (oral immunotherapy)
4797523|NCT02635776|Oral Immunotherapy|oral immunotherapy
4797524|NCT02635776|Peanut Allergy|peanut allergy
4797525|NCT02635776|Allergy|allergy
4797526|NCT02635776|Peanut-Allergic Children|peanut-allergic children
4797527|NCT02635776|Peanut-Allergic Adults|peanut-allergic adults
4797528|NCT02635776|Desensitization|desensitization
4797529|NCT02635763|nerve block|nerve block
4797530|NCT02635763|general anesthesia|general anesthesia
4797531|NCT02635763|hip fracture|hip fracture
4797532|NCT02635763|recovery|recovery
4797533|NCT02635724|Acute uncomplicated|acute uncomplicated
4797534|NCT02635724|Elderly|elderly
4797535|NCT02635685|Atrial fibrillation|atrial fibrillation
4797536|NCT02635685|Stroke|stroke
4797780|NCT02634476|computerised training|computerised training
4797537|NCT02635685|Clinical Decision Support|clinical decision support
4797538|NCT02635685|Anticoagulants|anticoagulants
4797539|NCT02635672|Solid tumors|solid tumors
4797540|NCT02635672|Aggressive non-hodgkin's lymphoma (NHL)|aggressive non-hodgkin's lymphoma (nhl)
4797541|NCT02635659|food intake, satiety, satiation, nutrients, ileal brake|food intake, satiety, satiation, nutrients, ileal brake
4797542|NCT02635633|partial epilepsy|partial epilepsy
4797543|NCT02635633|unifocal neocortical|unifocal neocortical
4797544|NCT02635633|treatment resistant|treatment resistant
4797545|NCT02635633|transcranial magnetic stimulation|transcranial magnetic stimulation
4797546|NCT02635633|thetaburst stimulation|thetaburst stimulation
4797547|NCT02635620|e-cigarette, electronic cigarette, lung function|e-cigarette, electronic cigarette, lung function
4797548|NCT02635607|GnRH antagonist|gnrh antagonist
4797549|NCT02635607|fixed protocol|fixed protocol
4797550|NCT02635607|flexible protocol|flexible protocol
4797551|NCT02635542|Postoperative Pulmonary Complications|postoperative pulmonary complications
4797552|NCT02635542|Residual Neuromuscular Blockade|residual neuromuscular blockade
4797553|NCT02635542|Cardiac Surgical Procedures|cardiac surgical procedures
4797554|NCT02635503|colorectal cancer|colorectal cancer
4797555|NCT02635503|laparoscopic surgery|laparoscopic surgery
4797556|NCT02635503|natural orifice specimen extraction|natural orifice specimen extraction
4797557|NCT02635503|Inflammatory response|inflammatory response
4797558|NCT02635490|prophylactic antibiotics, urinary tract infection.|prophylactic antibiotics, urinary tract infection.
4797559|NCT02635451|vitamin c|vitamin c
4797560|NCT02635451|Preterm Premature Rupture of Membranes|preterm premature rupture of membranes
4797561|NCT02635438|Oropharyngeal Candidiasis|oropharyngeal candidiasis
4797562|NCT02635412|Placenta|placenta
4797563|NCT02635412|Accreta|accreta
4797564|NCT02635412|Morbidly|morbidly
4797565|NCT02635412|Adherent Placenta|adherent placenta
4797566|NCT02635399|pancreaticoduodenectomy, delayed gastric emptying, duodenojejunopexy|pancreaticoduodenectomy, delayed gastric emptying, duodenojejunopexy
4797567|NCT02635386|PCOS|pcos
4797568|NCT02635386|GLP1 agonists|glp1 agonists
4797569|NCT02635386|SGLT2 inhibitors|sglt2 inhibitors
4797570|NCT02635373|Calciphylaxis|calciphylaxis
4797571|NCT02635373|Rare disease (ORPHA280062)|rare disease (orpha280062)
4797572|NCT02635373|Renal insufficiency|renal insufficiency
4797573|NCT02635373|ESRD|esrd
4797574|NCT02635373|Calcification|calcification
4797575|NCT02635373|Chronic kidney disease|chronic kidney disease
4797576|NCT02635373|Dialysis|dialysis
4797577|NCT02635373|Vascular disease|vascular disease
4797578|NCT02635360|advanced|advanced
4797579|NCT02635360|cervical cancer|cervical cancer
4797580|NCT02635360|pembrolizumab|pembrolizumab
4797581|NCT02635360|chemoradiation|chemoradiation
4797582|NCT02635360|immunotherapy|immunotherapy
4797583|NCT02635347|Remote ischemic preconditioning|remote ischemic preconditioning
4797584|NCT02635347|Remote ischemic perconditioning|remote ischemic perconditioning
4797585|NCT02635347|Remote ischemic postconditioning|remote ischemic postconditioning
4797586|NCT02635347|Remote ischemic conditioning|remote ischemic conditioning
4797587|NCT02635347|Orthotopic liver transplant|orthotopic liver transplant
4797588|NCT02635347|Brain Death Organ Donor|brain death organ donor
4797590|NCT02635321|LGMD|lgmd
4797591|NCT02635321|GMPPB|gmppb
4797592|NCT02635308|hip fracture|hip fracture
4797593|NCT02635308|physical function|physical function
4797594|NCT02635308|muscle function|muscle function
4797595|NCT02635308|symmetry|symmetry
4797596|NCT02635295|Clinical practicum|clinical practicum
4797597|NCT02635295|Nursing student|nursing student
4797598|NCT02635295|Nurse teacher|nurse teacher
4797599|NCT02635295|Mobile technology|mobile technology
4797600|NCT02635295|Cooperation|cooperation
4797601|NCT02635295|Nurse competence|nurse competence
4797602|NCT02635269|Ergometry|ergometry
4797603|NCT02635269|Stable isotope tracers|stable isotope tracers
4797604|NCT02635256|hypofractionation|hypofractionation
4797605|NCT02635256|prostate cancer|prostate cancer
4797606|NCT02635256|radiotherapy|radiotherapy
4797607|NCT02635230|Atrial Fibrillations|atrial fibrillations
4797608|NCT02635230|Heart Valve Prostheses|heart valve prostheses
4797609|NCT02635230|Acute Coronary Syndromes|acute coronary syndromes
4797610|NCT02635230|Percutaneous Coronary Revascularization|percutaneous coronary revascularization
4797611|NCT02635230|Coronary Artery Bypass Grafting|coronary artery bypass grafting
4797612|NCT02635230|Coronary Artery Diseases|coronary artery diseases
4797613|NCT02635230|Myocardial Infarction|myocardial infarction
4797614|NCT02635230|Ischemic stroke|ischemic stroke
4797615|NCT02635230|Bleeding|bleeding
4797616|NCT02635230|Thrombosis|thrombosis
4797617|NCT02635230|Myocardial Ischemia|myocardial ischemia
4797618|NCT02635230|Heart Diseases|heart diseases
4797619|NCT02635230|Cardiovascular Diseases|cardiovascular diseases
4797620|NCT02635230|Embolism and Thrombosis|embolism and thrombosis
4797621|NCT02635230|Platelet Aggregation Inhibitors|platelet aggregation inhibitors
4797622|NCT02635230|Aspirin|aspirin
4797623|NCT02635230|Clopidogrel|clopidogrel
4797624|NCT02635230|Ticagrelor|ticagrelor
4797625|NCT02635230|Prasugrel|prasugrel
4797626|NCT02635230|Antithrombotic treatment|antithrombotic treatment
4797627|NCT02635230|Oral anticoagulation|oral anticoagulation
4797628|NCT02635230|Warfarin|warfarin
4797629|NCT02635230|Dabigatran etexilate mesylate|dabigatran etexilate mesylate
4797630|NCT02635230|Apixaban|apixaban
4797631|NCT02635230|Rivaroxaban|rivaroxaban
4797632|NCT02635230|Direct Factor Xa Inhibitors|direct factor xa inhibitors
4797633|NCT02635230|Direct Thrombin Inhibitors|direct thrombin inhibitors
4797634|NCT02635217|Colonoscopy|colonoscopy
4797635|NCT02635217|Esophagogastroduodenoscopy|esophagogastroduodenoscopy
4797636|NCT02635217|Patient satisfaction|patient satisfaction
4797637|NCT02635217|Bidirectional endoscopies|bidirectional endoscopies
4797638|NCT02635191|Helicobacter pylori|helicobacter pylori
4797639|NCT02635191|Therapy|therapy
4797640|NCT02635191|Children|children
4797641|NCT02635139|meal skipping|meal skipping
4797642|NCT02635139|isocaloric diet|isocaloric diet
4797643|NCT02635139|macronutrient oxidation|macronutrient oxidation
4797644|NCT02635139|glucose homeostasis|glucose homeostasis
4797645|NCT02635139|arterial stiffness|arterial stiffness
4797646|NCT02635113|balance|balance
4797647|NCT02635113|gait|gait
4797648|NCT02635113|falls|falls
4797649|NCT02635113|sensory deficits|sensory deficits
4797650|NCT02635113|vibration|vibration
4797651|NCT02635113|visual acuity|visual acuity
4797652|NCT02635113|dizziness|dizziness
4797653|NCT02635113|postural control|postural control
4797654|NCT02635113|proprioceptive function|proprioceptive function
4797655|NCT02635113|stereoacuity|stereoacuity
4797656|NCT02635113|depth perception|depth perception
4797657|NCT02635113|vestibular dysfunction|vestibular dysfunction
4797658|NCT02635100|Sleep Disordered Breathing|sleep disordered breathing
4797659|NCT02635100|Sleep Apnea|sleep apnea
4797660|NCT02635048|Percutaneous nephrolithotomy|percutaneous nephrolithotomy
4797661|NCT02635048|Kidney stones|kidney stones
4797662|NCT02635048|Efficacy|efficacy
4797663|NCT02635048|Safety|safety
4797664|NCT02635022|Fracture|fracture
4797665|NCT02635022|Sarcopenia|sarcopenia
4797666|NCT02635022|Osteoporosis|osteoporosis
4797667|NCT02635022|Care management|care management
4797668|NCT02635022|Medication adherence|medication adherence
4797669|NCT02634983|COPD|copd
4797670|NCT02634983|Smokers|smokers
4797671|NCT02634983|Ex-smokers|ex-smokers
4797672|NCT02634970|wet AMD, ranibizumab, aflibercept, neovascularization|wet amd, ranibizumab, aflibercept, neovascularization
4797673|NCT02634957|phonomicrosurgery|phonomicrosurgery
4797674|NCT02634957|benign vocal fold lesions|benign vocal fold lesions
4797675|NCT02634957|voice rest|voice rest
4797676|NCT02634957|vhi-10|vhi-10
4797677|NCT02634957|CPP|cpp
4797678|NCT02634944|Concussion|concussion
4797679|NCT02634944|Vestibular|vestibular
4797680|NCT02634944|Ocular-Motor|ocular-motor
4797681|NCT02634931|Sirolimus|sirolimus
4797682|NCT02634931|Skin lesions|skin lesions
4797683|NCT02634931|TSC|tsc
4797684|NCT02634931|Tuberous Sclerosis Complex|tuberous sclerosis complex
4797685|NCT02634931|NPC-12G|npc-12g
4797686|NCT02634931|Angiofibroma|angiofibroma
4797687|NCT02634931|Hypomelanotic Macule|hypomelanotic macule
4797688|NCT02634931|Plaque|plaque
4797689|NCT02634918|ultrasound,|ultrasound,
4797690|NCT02634918|ultrasonography|ultrasonography
4797691|NCT02634918|hemophilic joint|hemophilic joint
4797692|NCT02634918|Doppler|doppler
4797693|NCT02634905|atopic dermatitis|atopic dermatitis
4797694|NCT02634905|Therapeutic patient education|therapeutic patient education
4797695|NCT02634905|pediatric dermatology|pediatric dermatology
4797696|NCT02634892|Sacral|sacral
4797697|NCT02634892|Overlay Mattress|overlay mattress
4797698|NCT02634892|Cooling|cooling
4797699|NCT02634866|hypertension|hypertension
4797700|NCT02634866|exercise|exercise
4797701|NCT02634866|diastolic heart failure|diastolic heart failure
4797702|NCT02634853|Dry Eye|dry eye
4797703|NCT02634840|inferior alveolar nerve|inferior alveolar nerve
4797704|NCT02634840|neurosensory disturbance|neurosensory disturbance
4797705|NCT02634840|bilateral sagittal spilt osteotomy|bilateral sagittal spilt osteotomy
4797706|NCT02634840|mandibular surgery|mandibular surgery
4797707|NCT02634840|neurosensory function|neurosensory function
4797708|NCT02634801|Fumaderm|fumaderm
4797709|NCT02634788|Post-Surgical Pain|post-surgical pain
4797710|NCT02634788|Bunionectomy|bunionectomy
4797711|NCT02634775|Pediatrics|pediatrics
4797712|NCT02634775|Nephrology|nephrology
4797713|NCT02634775|Dialysis|dialysis
4797714|NCT02634749|Nordic countries|nordic countries
4797715|NCT02634749|Eating behavior|eating behavior
4797716|NCT02634749|Human microbiome|human microbiome
4797717|NCT02634749|Child nutrition|child nutrition
4797718|NCT02634749|Metabolic profile|metabolic profile
4797719|NCT02634749|Body composition|body composition
4797720|NCT02634710|soft tissue sarcoma|soft tissue sarcoma
4797721|NCT02634697|Atrial Fibrillation|atrial fibrillation
4797722|NCT02634697|Relaxation Response Resiliency Program Intervention|relaxation response resiliency program intervention
4797723|NCT02634697|AF Symptom Severity and Burden|af symptom severity and burden
4797724|NCT02634697|Stress, Anxiety, Depression and Hostility|stress, anxiety, depression and hostility
4797725|NCT02634697|Quality of Life|quality of life
4797726|NCT02634697|AF|af
4797727|NCT02634697|QOL|qol
4797728|NCT02634697|3RP|3rp
4797729|NCT02634684|Schizophrenia|schizophrenia
4797730|NCT02634684|Schizoaffective Disorder|schizoaffective disorder
4797731|NCT02634684|Mental Disorders|mental disorders
4797732|NCT02634684|Anti-Dyskinesia Agents|anti-dyskinesia agents
4797733|NCT02634684|Antiparkinson Agents|antiparkinson agents
4797734|NCT02634684|Central Nervous System Agents|central nervous system agents
4797735|NCT02634684|Dopamine Agents|dopamine agents
4797736|NCT02634684|Excitatory Amino Acid Agents|excitatory amino acid agents
4797737|NCT02634684|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists
4797738|NCT02634684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
4797739|NCT02634684|Neurotransmitter Agents|neurotransmitter agents
4797740|NCT02634684|Pharmacologic Actions|pharmacologic actions
4797741|NCT02634684|Physiological Effects of Drugs|physiological effects of drugs
4797742|NCT02634684|Therapeutic Uses|therapeutic uses
4797743|NCT02634684|Prepulse inhibition|prepulse inhibition
4797744|NCT02634684|Neurocognition|neurocognition
4797745|NCT02634684|Working memory|working memory
4797746|NCT02634684|Dextroamphetamine|dextroamphetamine
4797747|NCT02634684|MATRICS Consensus Cognitive Battery|matrics consensus cognitive battery
4797748|NCT02634684|Pharmacologic Augmentation of Cognitive Therapies|pharmacologic augmentation of cognitive therapies
4797749|NCT02634684|Sensory discrimination learning|sensory discrimination learning
4797750|NCT02634684|Targeted Cognitive Training|targeted cognitive training
4797751|NCT02634684|rs4680 polymorphism of catechol-O-methyltransferase (COMT)|rs4680 polymorphism of catechol-o-methyltransferase (comt)
4797752|NCT02634671|schizophrenia|schizophrenia
4797753|NCT02634671|Facial emotions|facial emotions
4797754|NCT02634619|urethral stricture|urethral stricture
4797755|NCT02634606|Cholesterol|cholesterol
4797756|NCT02634593|nutrition|nutrition
4797757|NCT02634580|Japanese|japanese
4797758|NCT02634580|High cholesterol|high cholesterol
4797759|NCT02634580|Treatment of high cholesterol|treatment of high cholesterol
4797760|NCT02634580|Lowering cholesterol|lowering cholesterol
4797761|NCT02634580|Lowering high cholesterol|lowering high cholesterol
4797762|NCT02634580|Hypercholesterolemia|hypercholesterolemia
4797763|NCT02634580|Statin intolerant|statin intolerant
4797764|NCT02634528|intermediate-acting human isophane insulin, biosimilar|intermediate-acting human isophane insulin, biosimilar
4797765|NCT02634515|soluble human insulin, biosimilar|soluble human insulin, biosimilar
4797766|NCT02634502|radiofrequency|radiofrequency
4797767|NCT02634502|chemotherapy|chemotherapy
4797768|NCT02634502|microRNA|microrna
4797769|NCT02634489|Bladder outlet obstruction|bladder outlet obstruction
4797770|NCT02634489|Overactive bladder|overactive bladder
4797771|NCT02634489|Urinary incontinence|urinary incontinence
4797772|NCT02634489|Omnic OCAS®|omnic ocas®
4797773|NCT02634489|Vesicare®|vesicare®
4797774|NCT02634489|Tamsulosin hydrochloride|tamsulosin hydrochloride
4797775|NCT02634489|Solifenacin succinate|solifenacin succinate
4797776|NCT02634476|Alcohol|alcohol
4797777|NCT02634476|Substance use disorder|substance use disorder
4797778|NCT02634476|cognitive bias|cognitive bias
4797779|NCT02634476|behavioral intervention|behavioral intervention
4797781|NCT02634463|Immunoassay|immunoassay
4797782|NCT02634463|Antipsychotic|antipsychotic
4797783|NCT02634463|Aripiprazole|aripiprazole
4797784|NCT02634463|Olanzapine|olanzapine
4797785|NCT02634463|Paliperidone|paliperidone
4797786|NCT02634463|Risperidone|risperidone
4797788|NCT02634450|Diagnostic|diagnostic
4797789|NCT02634450|children|children
4797790|NCT02634424|Hemophilia A|hemophilia a
4797791|NCT02634424|Prophylaxy|prophylaxy
4797792|NCT02634424|Pharmacokinetic|pharmacokinetic
4797793|NCT02634424|Bayesian|bayesian
4797794|NCT02634411|Ventilator Associated|ventilator associated
4797795|NCT02634411|Pneumonia|pneumonia
4797796|NCT02634411|Antibiotic treatment|antibiotic treatment
4797797|NCT02634411|Pseudomonas aeruginosa|pseudomonas aeruginosa
4797798|NCT02634372|Bipolar Disorder|bipolar disorder
4797799|NCT02634372|Traumatic event|traumatic event
4797800|NCT02634372|Eye Movement Desensitization Reprocessing|eye movement desensitization reprocessing
4797801|NCT02634372|Supportive therapy|supportive therapy
4797802|NCT02634372|Relapse prevention|relapse prevention
4797803|NCT02634346|Alkermes|alkermes
4797804|NCT02634346|ALKS 3831|alks 3831
4797805|NCT02634346|Samidorphan|samidorphan
4797806|NCT02634346|Schizophrenia|schizophrenia
4797807|NCT02634346|Acute Exacerbation of Schizophrenia|acute exacerbation of schizophrenia
4797808|NCT02634333|anti-vascular endothelial growth factor|anti-vascular endothelial growth factor
4797809|NCT02634333|nonproliferative diabetic retinopathy|nonproliferative diabetic retinopathy
4797810|NCT02634320|Alkermes|alkermes
4797811|NCT02634320|ARISTADA|aristada
4797812|NCT02634320|Aripiprazole Lauroxil|aripiprazole lauroxil
4797813|NCT02634320|Schizophrenia|schizophrenia
4797814|NCT02634307|Multiple Sclerosis|multiple sclerosis
4797815|NCT02634307|MS|ms
4797816|NCT02634307|Relapsing Remitting Multiple Sclerosis|relapsing remitting multiple sclerosis
4797817|NCT02634307|RRMS|rrms
4797818|NCT02634307|dimethyl fumarate|dimethyl fumarate
4797819|NCT02634307|DMF|dmf
4797820|NCT02634294|Hematological Neoplasms|hematological neoplasms
4797821|NCT02634294|recurrence|recurrence
4797822|NCT02634294|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
4797823|NCT02634294|peginterferon alfa-2b|peginterferon alfa-2b
4797824|NCT02634294|Graft vs Host Disease|graft vs host disease
4797825|NCT02634268|randomized controlled trial|randomized controlled trial
4797826|NCT02634268|diet|diet
4797827|NCT02634268|exercise|exercise
4797828|NCT02634268|obesity|obesity
4797829|NCT02634268|overweight|overweight
4797830|NCT02634268|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
4797831|NCT02634268|lifestyle|lifestyle
4797832|NCT02634255|rocuronium|rocuronium
4797833|NCT02634255|onset time|onset time
4797834|NCT02634255|anxiety|anxiety
4797835|NCT02634242|Si Wu Tang|si wu tang
4797836|NCT02634242|antioxidation|antioxidation
4797837|NCT02634242|anthropometric measurements|anthropometric measurements
4797838|NCT02634242|liver|liver
4797839|NCT02634242|skin|skin
4797840|NCT02634229|monogenic diabetes|monogenic diabetes
4797841|NCT02634229|MODY|mody
4797842|NCT02634229|beta-cell|beta-cell
4797843|NCT02634229|insulin secretion|insulin secretion
4797844|NCT02634216|Hyperglycemia|hyperglycemia
4797845|NCT02634216|Capros|capros
4797846|NCT02634216|Type 1 Diabetes|type 1 diabetes
4797847|NCT02634203|Chronic Thromboembolic Pulmonary Hypertension|chronic thromboembolic pulmonary hypertension
4797848|NCT02634203|Balloon Pulmonary Angioplasty|balloon pulmonary angioplasty
4797849|NCT02634203|Riociguat|riociguat
4797850|NCT02634190|Cervical cancer screening|cervical cancer screening
4797851|NCT02634190|High risk Human Papillomavirus|high risk human papillomavirus
4797852|NCT02634190|Aptima HPV Assay|aptima hpv assay
4797853|NCT02634177|Genotyping|genotyping
4797854|NCT02634177|Genecept Assay™|genecept assay™
4797855|NCT02634164|leucine|leucine
4797856|NCT02634164|isoleucine|isoleucine
4797857|NCT02634151|LDL‐C|ldl‐c
4797858|NCT02634151|Lipid Regulator|lipid regulator
4797859|NCT02634138|Peripheral Vascular Disease|peripheral vascular disease
4797860|NCT02634138|Critical Limb Ischaemia|critical limb ischaemia
4797861|NCT02634112|anastomotic leakage|anastomotic leakage
4797862|NCT02634112|rectal cancer surgery|rectal cancer surgery
4797863|NCT02634112|anastomotic leakage predictive score|anastomotic leakage predictive score
4797864|NCT02634099|major pediatric surgery|major pediatric surgery
4797865|NCT02634099|hemoglobin measurement|hemoglobin measurement
4797866|NCT02634086|Coronary artery disease|coronary artery disease
4797867|NCT02634086|Percutaneous coronary intervention|percutaneous coronary intervention
4797868|NCT02634086|Coronary artery bypass graft|coronary artery bypass graft
4797869|NCT02634086|Medication therapy|medication therapy
4797870|NCT02634073|Lamivudine|lamivudine
4797871|NCT02634073|Safety|safety
4797872|NCT02634073|Sorbitol|sorbitol
4797873|NCT02634073|Pharmacokinetics|pharmacokinetics
4797874|NCT02634060|adalimumab|adalimumab
4797875|NCT02634060|fecal calprotectin|fecal calprotectin
4797876|NCT02634060|home based|home based
4797877|NCT02634047|transesophageal echocardiography|transesophageal echocardiography
4797878|NCT02634047|videolaryngoscope|videolaryngoscope
4797879|NCT02634047|oropharyngeal injury|oropharyngeal injury
4797880|NCT02634008|Pangenotypic|pangenotypic
4797881|NCT02634008|Treatment|treatment
4797882|NCT02633956|Non-alcoholic Fatty Liver Disease|non-alcoholic fatty liver disease
4797883|NCT02633956|NAFLD|nafld
4797884|NCT02633956|Fatty Liver Disease|fatty liver disease
4797885|NCT02633956|NASH|nash
4797886|NCT02633930|helicobacter pylori|helicobacter pylori
4797887|NCT02633930|berberine-containing quadruple therapy|berberine-containing quadruple therapy
4797888|NCT02633930|clarithromycin-containing quadruple therapy|clarithromycin-containing quadruple therapy
4797889|NCT02633917|Low back pain|low back pain
4797890|NCT02633917|Motor control|motor control
4797891|NCT02633917|Joint mobilization|joint mobilization
4797892|NCT02633904|Hip Dislocation|hip dislocation
4797893|NCT02633904|Congenital|congenital
4797894|NCT02633904|osteotomy|osteotomy
4797895|NCT02633904|Femur Head Necrosis|femur head necrosis
4797896|NCT02633891|neuropathies|neuropathies
4797897|NCT02633891|metabolic diseases|metabolic diseases
4797898|NCT02633891|nervous system diseases|nervous system diseases
4797899|NCT02633891|peripheral nervous system diseases|peripheral nervous system diseases
4797900|NCT02633865|patient characteristics|patient characteristics
4797901|NCT02633852|Diabetic Macular Edema (DME)|diabetic macular edema (dme)
4797902|NCT02633852|Aflibercept (EYLEA)|aflibercept (eylea)
4797903|NCT02633839|Adults|adults
4797904|NCT02633826|alloreactive T cell|alloreactive t cell
4797905|NCT02633826|donor-specific antibody|donor-specific antibody
4797906|NCT02633813|Bioequivalence|bioequivalence
4797907|NCT02633813|Tinea pedis|tinea pedis
4797908|NCT02633813|Naftin|naftin
4797909|NCT02633800|Squamous cell cancer of the head and neck|squamous cell cancer of the head and neck
4797910|NCT02633800|Squamous cell carcinoma|squamous cell carcinoma
4797911|NCT02633800|Head and neck cancer|head and neck cancer
4797912|NCT02633800|Neoplasms by site|neoplasms by site
4797913|NCT02633787|Meningitis|meningitis
4797914|NCT02633787|Meningococcal Meningitis|meningococcal meningitis
4797915|NCT02633787|Meningococcal Infections|meningococcal infections
4797916|NCT02633787|Menactra®|menactra®
4797917|NCT02633761|Fetal death|fetal death
4797918|NCT02633761|mifepristone|mifepristone
4797919|NCT02633761|misoprostol|misoprostol
4797920|NCT02633735|Clinical Decision Support|clinical decision support
4797921|NCT02633696|Clinical trial|clinical trial
4797922|NCT02633696|Phase I|phase i
4797923|NCT02633696|Healthy volunteers|healthy volunteers
4797924|NCT02633696|Clinical Pharmacology|clinical pharmacology
4797925|NCT02633696|Bioavailability|bioavailability
4797926|NCT02633696|Silybin|silybin
4797927|NCT02633696|Liver Trasplantation|liver trasplantation
4797928|NCT02633683|Restless Legs Syndrome|restless legs syndrome
4797929|NCT02633683|RLS|rls
4797930|NCT02633657|Restless Legs Syndrome|restless legs syndrome
4797931|NCT02633657|RLS|rls
4797932|NCT02633644|Heart Failure|heart failure
4797933|NCT02633644|Cardiovascular Diseases|cardiovascular diseases
4797934|NCT02633644|Heart Diseases|heart diseases
4797935|NCT02633592|High Resolution Anorectal Manometry|high resolution anorectal manometry
4797936|NCT02633592|Magnetic Resonance Imaging|magnetic resonance imaging
4797937|NCT02633592|Balloon Expulsion|balloon expulsion
4797938|NCT02633592|Position|position
4797939|NCT02633579|Healthy volunteers|healthy volunteers
4797940|NCT02633566|Flatfoot|flatfoot
4797941|NCT02633566|orthoses|orthoses
4797942|NCT02633566|children|children
4797943|NCT02633553|thymoma|thymoma
4797944|NCT02633553|adjuvant radiotherapy|adjuvant radiotherapy
4797945|NCT02633553|complete resection|complete resection
4797946|NCT02633540|T1a Larynx Cancer|t1a larynx cancer
4797947|NCT02633540|T2a Larynx Cancer|t2a larynx cancer
4797948|NCT02633514|thymoma|thymoma
4797949|NCT02633514|thymic carcinoma|thymic carcinoma
4797950|NCT02633514|adjuvant radiotherapy|adjuvant radiotherapy
4797951|NCT02633514|adjuvant radiochemotherapy|adjuvant radiochemotherapy
4797952|NCT02633514|incomplete resection|incomplete resection
4797953|NCT02633475|interleukin-10|interleukin-10
4797954|NCT02633475|Polymorphism, Single Nucleotide|polymorphism, single nucleotide
4797955|NCT02633449|tDCS|tdcs
4797956|NCT02633449|cognitive behavioral therapy|cognitive behavioral therapy
4797957|NCT02633436|esophageal cancer|esophageal cancer
4797958|NCT02633436|SLC1A5|slc1a5
4797959|NCT02633423|Cardiopulmonary bypass|cardiopulmonary bypass
4797960|NCT02633423|Mechanical ventilation|mechanical ventilation
4797961|NCT02633423|Expiratory Flow Limitation|expiratory flow limitation
4797962|NCT02633423|Best PEEP|best peep
4797963|NCT02633397|SCD|scd
4797964|NCT02633397|Sickle Cell Disease|sickle cell disease
4797965|NCT02633397|Riociguat|riociguat
4797966|NCT02633397|Adempas|adempas
4797967|NCT02633384|Parenteral nutrition associated cholestasis|parenteral nutrition associated cholestasis
4797968|NCT02633384|Intravenous lipid emulsions|intravenous lipid emulsions
4797969|NCT02633384|Surgical neonates|surgical neonates
4797970|NCT02633384|Congenital gastrointestinal abnormalities|congenital gastrointestinal abnormalities
4797971|NCT02633358|Acute myocardial infarction, cardiogenic shock|acute myocardial infarction, cardiogenic shock
4797972|NCT02633319|Parenting|parenting
4797973|NCT02633319|Child maltreatment|child maltreatment
4797974|NCT02633319|Economic strengthening|economic strengthening
4797975|NCT02633319|Early childhood development|early childhood development
4797976|NCT02633319|Cluster randomized controlled trial|cluster randomized controlled trial
4797977|NCT02633319|Pilot evaluation|pilot evaluation
4797978|NCT02633306|trigeminal region pain|trigeminal region pain
4797979|NCT02633293|Treprostinil|treprostinil
4797980|NCT02633293|PH|ph
4797981|NCT02633293|ILD|ild
4797982|NCT02633293|CPFE|cpfe
4797983|NCT02633293|6 Minute Walk Test|6 minute walk test
4797984|NCT02633267|social anxiety|social anxiety
4797985|NCT02633267|unemployment|unemployment
4797986|NCT02633267|cognitive behavioral therapy|cognitive behavioral therapy
4797987|NCT02633267|group therapy|group therapy
4797988|NCT02633267|work|work
4797989|NCT02633267|vocation|vocation
4797990|NCT02633241|pediatrics|pediatrics
4797991|NCT02633241|sedation|sedation
4797992|NCT02633241|dexmedetomidine|dexmedetomidine
4797993|NCT02633241|propofol|propofol
4797994|NCT02633241|MRI|mri
4797995|NCT02633228|Multifocal Intraocular Lens|multifocal intraocular lens
4797996|NCT02633228|Binocular Trifocality|binocular trifocality
4797997|NCT02633228|Cataract Surgery|cataract surgery
4797998|NCT02633228|Spectacle Independence|spectacle independence
4797999|NCT02633228|Intermediate Vision|intermediate vision
4798000|NCT02633228|Photopic Vision|photopic vision
4798001|NCT02633228|Mesopic Vision|mesopic vision
4798002|NCT02633228|Scotopic Vision|scotopic vision
4798003|NCT02633228|Binocular Vision|binocular vision
4798004|NCT02633215|motor recovery|motor recovery
4798005|NCT02633215|neuroplasticity|neuroplasticity
4798006|NCT02633215|chronic|chronic
4798007|NCT02633215|human|human
4798008|NCT02633215|sensory|sensory
4798009|NCT02633202|Nasopharyngeal carcinoma|nasopharyngeal carcinoma
4798010|NCT02633202|Concurrent chemoradiotherapy|concurrent chemoradiotherapy
4798011|NCT02633202|intermediate risk|intermediate risk
4798012|NCT02633202|intensity-modulated radiotherapy|intensity-modulated radiotherapy
4798013|NCT02633189|stage IV|stage iv
4798014|NCT02633189|stage IIIB|stage iiib
4798015|NCT02633189|EGFR mutation|egfr mutation
4798016|NCT02633189|non-squamous|non-squamous
4798017|NCT02633189|liquid biopsy|liquid biopsy
4798018|NCT02633189|erlotinib|erlotinib
4798019|NCT02633189|bevacizumab|bevacizumab
4798020|NCT02633163|Systemic Lupus Erythematosus|systemic lupus erythematosus
4798021|NCT02633163|Stem Cell|stem cell
4798022|NCT02633163|Lupus|lupus
4798023|NCT02633150|Obesity|obesity
4798024|NCT02633150|insulinoresistant|insulinoresistant
4798025|NCT02633150|menopausal women|menopausal women
4798026|NCT02633150|polyphenol|polyphenol
4798027|NCT02633137|Lenalidomide|lenalidomide
4798028|NCT02633137|15-196|15-196
4798029|NCT02633124|Premature infants|premature infants
4798030|NCT02633124|Catheter-related bacteremia|catheter-related bacteremia
4798031|NCT02633124|Infusion device|infusion device
4798032|NCT02633124|Neonatal intensive care|neonatal intensive care
4798033|NCT02633124|Central Venous Catheter|central venous catheter
4798034|NCT02633124|Drug Infusion Systems|drug infusion systems
4798035|NCT02633111|DNA Sequencing|dna sequencing
4798036|NCT02633111|15-180|15-180
4798037|NCT02633098|Artesunate|artesunate
4798038|NCT02633098|Artemisinins|artemisinins
4798039|NCT02633098|Antimalarial|antimalarial
4798040|NCT02633098|Neoadjuvant|neoadjuvant
4798041|NCT02633098|Pre-operative|pre-operative
4798042|NCT02633085|Unicompartment Knee Replacement|unicompartment knee replacement
4798043|NCT02633072|Multifocal Intraocular Lens|multifocal intraocular lens
4798044|NCT02633072|Binocular Trifocality|binocular trifocality
4798045|NCT02633072|Cataract Surgery|cataract surgery
4798046|NCT02633072|Spectacle Independence|spectacle independence
4798047|NCT02633072|Intermediate Vision|intermediate vision
4798048|NCT02633072|Photopic Vision|photopic vision
4798049|NCT02633072|Mesopic Vision|mesopic vision
4798050|NCT02633072|Scotopic Vision|scotopic vision
4798051|NCT02633072|Binocular Vision|binocular vision
4798052|NCT02633046|FSGS|fsgs
4798053|NCT02633046|primary FSGS|primary fsgs
4798054|NCT02633046|idiopathic FSGS|idiopathic fsgs
4798055|NCT02633033|Multiple Sclerosis|multiple sclerosis
4798056|NCT02633033|Relapsing-Remitting|relapsing-remitting
4798057|NCT02633033|Acthar|acthar
4798058|NCT02633033|Corticotropin|corticotropin
4798059|NCT02633033|MS|ms
4798060|NCT02632981|Interleukin-32|interleukin-32
4798061|NCT02632981|periodontitis|periodontitis
4798062|NCT02632955|arteriovenous fistula|arteriovenous fistula
4798063|NCT02632955|hemodialysis|hemodialysis
4798064|NCT02632955|drug coated balloon|drug coated balloon
4798065|NCT02632942|arteriovenous fistula|arteriovenous fistula
4798066|NCT02632942|hemodialysis|hemodialysis
4798067|NCT02632942|maturation|maturation
4798068|NCT02632929|foot ulcer, diabetic|foot ulcer, diabetic
4798069|NCT02632929|wound healing|wound healing
4798070|NCT02632929|diabetic foot ulcer|diabetic foot ulcer
4798071|NCT02632877|pirfenidone|pirfenidone
4798072|NCT02632877|Modified oxide diallyl disulfide (MODD)|modified oxide diallyl disulfide (modd)
4798073|NCT02632877|ketanserin|ketanserin
4798074|NCT02632877|diabetic foot ulcer|diabetic foot ulcer
4798075|NCT02632851|inhalation|inhalation
4798076|NCT02632851|isotonic saline|isotonic saline
4798077|NCT02632851|NaCl solution 0.9 %|nacl solution 0.9 %
4798078|NCT02632851|Ectoin|ectoin
4798079|NCT02632851|bronchitis|bronchitis
4798080|NCT02632851|respiratory tract infection|respiratory tract infection
4798081|NCT02632838|Hypertension|hypertension
4798082|NCT02632838|mHealth|mhealth
4798083|NCT02632838|underserved community|underserved community
4798084|NCT02632825|Nasal High Flow|nasal high flow
4798085|NCT02632825|gas exchange|gas exchange
4798086|NCT02632825|newborn|newborn
4798087|NCT02632799|Nasal High Flow|nasal high flow
4798088|NCT02632799|CPAP|cpap
4798089|NCT02632799|airway pressure|airway pressure
4798090|NCT02632799|newborn|newborn
4798091|NCT02632786|amyloidosis|amyloidosis
4798092|NCT02632786|ntprobnp|ntprobnp
4798093|NCT02632786|NEOD001|neod001
4798094|NCT02632786|Prothena|prothena
4798095|NCT02632786|PRONTO|pronto
4798096|NCT02632786|amyloid|amyloid
4798097|NCT02632786|plasma cell dyscrasia|plasma cell dyscrasia
4798098|NCT02632786|immunotherapy|immunotherapy
4798099|NCT02632773|Language Intervention|language intervention
4798100|NCT02632773|Parent-Mediated Intervention|parent-mediated intervention
4798101|NCT02632734|alveolar bone preservation|alveolar bone preservation
4798102|NCT02632734|coral grafting device|coral grafting device
4798103|NCT02632708|Acute Myeloid Leukemia|acute myeloid leukemia
4798104|NCT02632708|AML|aml
4798105|NCT02632708|Untreated AML|untreated aml
4798106|NCT02632708|De novo AML|de novo aml
4798107|NCT02632708|Secondary AML|secondary aml
4798108|NCT02632708|Newly diagnosed AML|newly diagnosed aml
4798109|NCT02632708|IDH1|idh1
4798110|NCT02632708|IDH2|idh2
4798111|NCT02632708|Induction therapy|induction therapy
4798112|NCT02632708|Consolidation therapy|consolidation therapy
4798113|NCT02632708|IDH|idh
4798114|NCT02632682|probe-based confocal laser endomicroscopy|probe-based confocal laser endomicroscopy
4798115|NCT02632669|Focal brachytherapy|focal brachytherapy
4798116|NCT02632669|Seed implant|seed implant
4798117|NCT02632669|Quality of life|quality of life
4798118|NCT02632669|Toxicity|toxicity
4798119|NCT02632643|TMD|tmd
4798120|NCT02632643|HYPERTONIA|hypertonia
4798121|NCT02632643|PARAFUNCTIONS|parafunctions
4798122|NCT02632643|SENSORIMOTOR APPROACH|sensorimotor approach
4798123|NCT02632630|Peripheral Parenteral Nutrition|peripheral parenteral nutrition
4798124|NCT02632630|Oral nutritional supplementation|oral nutritional supplementation
4798125|NCT02632630|Acute Care hospitals|acute care hospitals
4798126|NCT02632617|Heart Valve Diseases|heart valve diseases
4798127|NCT02632617|Coronary Artery Disease|coronary artery disease
4798128|NCT02632617|Computed Tomographic Angiography|computed tomographic angiography
4798129|NCT02632617|Preoperative Procedure|preoperative procedure
4798130|NCT02632565|osteoarthritis|osteoarthritis
4798131|NCT02632565|lidocaine|lidocaine
4798132|NCT02632565|pain|pain
4798133|NCT02632565|ultrasound|ultrasound
4798134|NCT02632552|care transition|care transition
4798135|NCT02632552|technology|technology
4798136|NCT02632552|chronic heart failure|chronic heart failure
4798137|NCT02632552|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
4798138|NCT02632552|virtual nurse|virtual nurse
4798139|NCT02632552|texting|texting
4798140|NCT02632552|informatics|informatics
4798141|NCT02632552|Veterans|veterans
4798142|NCT02632539|ventilator associated pneumonia|ventilator associated pneumonia
4798143|NCT02632539|Subglottic Secretion Drainage|subglottic secretion drainage
4798144|NCT02632539|manual air-impingement operation|manual air-impingement operation
4798145|NCT02632526|AZD5718 oral suspension crystalline|azd5718 oral suspension crystalline
4798146|NCT02632526|AZD5718 oral suspension amorphous|azd5718 oral suspension amorphous
4798147|NCT02632526|Single ascending dose/multiple ascending dose (SAD/MAD)|single ascending dose/multiple ascending dose (sad/mad)
4798148|NCT02632526|Placebo-controlled|placebo-controlled
4798149|NCT02632526|Safety|safety
4798150|NCT02632526|Tolerability|tolerability
4798151|NCT02632526|Pharmacokinetics|pharmacokinetics
4798152|NCT02632526|Pharmacodynamics|pharmacodynamics
4798153|NCT02632513|continuous ultrasonic irrigation, syringe irrigation|continuous ultrasonic irrigation, syringe irrigation
4798154|NCT02632500|Cardio-Pulmonary Resuscitation|cardio-pulmonary resuscitation
4798155|NCT02632500|Cardiac Arrest|cardiac arrest
4798156|NCT02632500|Training|training
4798157|NCT02632474|HIV Infections|hiv infections
4798158|NCT02632474|Tenofovir|tenofovir
4798159|NCT02632474|Efavirenz|efavirenz
4798160|NCT02632461|Diet|diet
4798161|NCT02632461|Weight Loss|weight loss
4798162|NCT02632461|Tracking|tracking
4798163|NCT02632461|Calories|calories
4798164|NCT02632448|Metastatic cancer|metastatic cancer
4798165|NCT02632448|Advanced cancer|advanced cancer
4798166|NCT02632448|Recurrent cancer|recurrent cancer
4798167|NCT02632448|Colorectal neoplasms|colorectal neoplasms
4798168|NCT02632448|Triple negative breast cancer|triple negative breast cancer
4798169|NCT02632448|Ovarian neoplasms|ovarian neoplasms
4798170|NCT02632448|Colon neoplasms|colon neoplasms
4798171|NCT02632448|Rectal neoplasms|rectal neoplasms
4798172|NCT02632448|Triple negative breast neoplasms|triple negative breast neoplasms
4798173|NCT02632448|Gastrointestinal stromal tumor|gastrointestinal stromal tumor
4798174|NCT02632435|HER2 positive|her2 positive
4798175|NCT02632383|Diabetes type 1|diabetes type 1
4798176|NCT02632383|Transition|transition
4798177|NCT02632383|Telemedicine|telemedicine
4798178|NCT02632383|mHealth app|mhealth app
4798179|NCT02632383|Youth|youth
4798180|NCT02632383|Self-management|self-management
4798181|NCT02632370|Malignant Gliomas|malignant gliomas
4798182|NCT02632370|5-ALA|5-ala
4798183|NCT02632370|tumor resection|tumor resection
4798184|NCT02632370|malignant tumor|malignant tumor
4798185|NCT02632357|Neurodynamics|neurodynamics
4798186|NCT02632344|Laryngeal papilloma, recurrent|laryngeal papilloma, recurrent
4798187|NCT02632344|Respiratory papillomatosis|respiratory papillomatosis
4798188|NCT02632344|Juvenile-onset recurrent respiratory papillomatosis|juvenile-onset recurrent respiratory papillomatosis
4798189|NCT02632344|Human papillomavirus|human papillomavirus
4798190|NCT02632344|Virally-related diseases|virally-related diseases
4798191|NCT02632331|Food effect|food effect
4798192|NCT02632331|Pharmacokinetics|pharmacokinetics
4798193|NCT02632331|ASP8825|asp8825
4798194|NCT02632331|XP13512|xp13512
4798195|NCT02632305|unresectable biliary tract cancer|unresectable biliary tract cancer
4798196|NCT02632305|nab-paclitaxel|nab-paclitaxel
4798197|NCT02632305|cisplatin|cisplatin
4798198|NCT02632305|gemcitabine|gemcitabine
4798199|NCT02632279|Parkinson's disease|parkinson's disease
4798200|NCT02632279|Deep Brain Stimulation|deep brain stimulation
4798201|NCT02632279|Subthalamic nucleus|subthalamic nucleus
4798202|NCT02632279|Tryptophan depletion|tryptophan depletion
4798203|NCT02632279|Serotonin|serotonin
4798204|NCT02632266|prematurity|prematurity
4798205|NCT02632266|growth|growth
4798206|NCT02632266|nutrition|nutrition
4798207|NCT02632266|human milk fortifier|human milk fortifier
4798208|NCT02632253|exercise therapy|exercise therapy
4798209|NCT02632253|GUCH|guch
4798210|NCT02632253|ventricular ejection fraction|ventricular ejection fraction
4798211|NCT02632253|HIIT|hiit
4798212|NCT02632253|MICE|mice
4798213|NCT02632240|gingival recession|gingival recession
4798214|NCT02632240|mucogingival surgery|mucogingival surgery
4798215|NCT02632240|collagen matrix|collagen matrix
4798216|NCT02632240|connective tissue graft|connective tissue graft
4798217|NCT02632240|tunnel technique|tunnel technique
4798218|NCT02632214|Face processing|face processing
4798219|NCT02632214|asymmetry|asymmetry
4798220|NCT02632214|deaf|deaf
4798221|NCT02632214|fMRI|fmri
4798222|NCT02632201|gastric cancer|gastric cancer
4798223|NCT02632201|liver metastasis|liver metastasis
4798224|NCT02632201|PIK-HER2 cells|pik-her2 cells
4798225|NCT02632201|dendritic cell-precision multiple antigen T cells|dendritic cell-precision multiple antigen t cells
4798226|NCT02632188|Recurrence|recurrence
4798227|NCT02632188|Metastasis|metastasis
4798228|NCT02632188|liver cancer|liver cancer
4798229|NCT02632175|Ulcerative Colitis|ulcerative colitis
4798230|NCT02632149|PINS Vagus Nerve Stimulator|pins vagus nerve stimulator
4798231|NCT02632136|Laparoscopic|laparoscopic
4798232|NCT02632136|TAP Block|tap block
4798233|NCT02632136|Total extra peritoneal Inguinal hernia repair|total extra peritoneal inguinal hernia repair
4798234|NCT02632123|idiopathic pulmonary fibrosis|idiopathic pulmonary fibrosis
4798235|NCT02632123|outcome|outcome
4798236|NCT02632123|prognosis|prognosis
4798237|NCT02632123|survival|survival
4798238|NCT02632110|Actinic Keratosis|actinic keratosis
4798239|NCT02632097|inguinal hernia|inguinal hernia
4798240|NCT02632097|mesh fixation|mesh fixation
4798241|NCT02632097|glue|glue
4798242|NCT02632097|cyanoacrylate|cyanoacrylate
4798243|NCT02632097|Lichtenstein|lichtenstein
4798244|NCT02632097|ambulatory surgery|ambulatory surgery
4798245|NCT02632071|Breast Cancer|breast cancer
4798246|NCT02632071|Breast Carcinoma|breast carcinoma
4798247|NCT02632071|Breast tumors|breast tumors
4798248|NCT02632071|Cancer of the Breast|cancer of the breast
4798249|NCT02632071|Malignant tumor of the breast|malignant tumor of the breast
4798250|NCT02632071|Metastatic Breast Cancer|metastatic breast cancer
4798251|NCT02632071|Unresectable breast cancer|unresectable breast cancer
4798252|NCT02632045|Breast Neoplasms|breast neoplasms
4798253|NCT02632045|Breast Cancer|breast cancer
4798254|NCT02632045|Breast Carcinoma|breast carcinoma
4798255|NCT02632045|Breast tumors|breast tumors
4798256|NCT02632045|Cancer of the Breast|cancer of the breast
4798257|NCT02632032|Type 1 diabetes|type 1 diabetes
4798258|NCT02632032|children|children
4798259|NCT02632032|diabetes camps|diabetes camps
4798260|NCT02632032|glycemic control|glycemic control
4798261|NCT02632019|advanced biliary tract malignant tumor|advanced biliary tract malignant tumor
4798262|NCT02632019|dendritic cell|dendritic cell
4798263|NCT02632019|precision T cell for neo-antigen|precision t cell for neo-antigen
4798264|NCT02632006|PIK-PD-1 Cells|pik-pd-1 cells
4798265|NCT02632006|dendritic cell-precision multiple antigen T cells|dendritic cell-precision multiple antigen t cells
4798266|NCT02632006|advanced hepatocellular carcinoma|advanced hepatocellular carcinoma
4798267|NCT02631993|Psoralen|psoralen
4798268|NCT02631993|UVA|uva
4798269|NCT02631993|Time-to-treatment|time-to-treatment
4798270|NCT02631993|GVL|gvl
4798271|NCT02631980|Hepcidin|hepcidin
4798272|NCT02631967|Crohn disease|crohn disease
4798273|NCT02631967|ileocecal resection|ileocecal resection
4798274|NCT02631967|anastomosis|anastomosis
4798275|NCT02631967|Kono|kono
4798276|NCT02631928|biphasic human insulin|biphasic human insulin
4798277|NCT02631928|biosimilar|biosimilar
4798278|NCT02631902|Community-based intervention|community-based intervention
4798279|NCT02631902|Exercise program|exercise program
4798280|NCT02631902|Dietary intervention program|dietary intervention program
4798281|NCT02631902|Health promotion|health promotion
4798282|NCT02631902|Subjective well-being|subjective well-being
4798283|NCT02631902|Cardiovascular risk|cardiovascular risk
4798284|NCT02631876|Epithelial ovarian cancer|epithelial ovarian cancer
4798285|NCT02631876|Fallopian tube cancer|fallopian tube cancer
4798286|NCT02631876|Primary peritoneal cancer|primary peritoneal cancer
4798287|NCT02631876|IMGN853|imgn853
4798289|NCT02631876|Antibody drug conjugate|antibody drug conjugate
4798290|NCT02631876|ImmunoGen|immunogen
4798291|NCT02631876|Antibody|antibody
4798292|NCT02631876|Folate receptor alpha|folate receptor alpha
4798293|NCT02631876|mirvetuximab soravtansine|mirvetuximab soravtansine
4798294|NCT02631876|Phase 3|phase 3
4798295|NCT02631876|platinum-resistant|platinum-resistant
4798296|NCT02631850|Constraint-induced movement therapy|constraint-induced movement therapy
4798297|NCT02631850|gaming|gaming
4798298|NCT02631850|virtual reality|virtual reality
4798299|NCT02631850|upper extremity|upper extremity
4798300|NCT02631850|CI therapy|ci therapy
4798301|NCT02631850|rehabilitation|rehabilitation
4798302|NCT02631850|stroke|stroke
4798303|NCT02631850|hemiparesis|hemiparesis
4798304|NCT02631850|therapy|therapy
4798305|NCT02631837|NOTES|notes
4798306|NCT02631837|Laparoscopic surgery|laparoscopic surgery
4798307|NCT02631824|fragility fractures|fragility fractures
4798308|NCT02631824|hip fractures|hip fractures
4798309|NCT02631824|augmentation|augmentation
4798310|NCT02631824|tip-apex distance|tip-apex distance
4798311|NCT02631811|acute leukaemia|acute leukaemia
4798312|NCT02631811|supportive / palliative care|supportive / palliative care
4798313|NCT02631785|ANXIETY|anxiety
4798314|NCT02631785|CBT|cbt
4798315|NCT02631785|fMRI|fmri
4798316|NCT02631785|Fear conditioning|fear conditioning
4798317|NCT02631785|Fear extinction|fear extinction
4798318|NCT02631759|Acute intraCerebral Haemorrhage, Epileptic seizures, Lévétiracetam|acute intracerebral haemorrhage, epileptic seizures, lévétiracetam
4798319|NCT02631720|Chronic Lung Allograft Dysfunction (CLAD)|chronic lung allograft dysfunction (clad)
4798320|NCT02631720|Restrictive chronic lung allograft dysfunction (RCLAD)|restrictive chronic lung allograft dysfunction (rclad)
4798321|NCT02631720|Bronchiolitis Obliterans Syndrome (BOS)|bronchiolitis obliterans syndrome (bos)
4798322|NCT02631720|CLAD risk factors|clad risk factors
4798323|NCT02631720|observational study|observational study
4798324|NCT02631668|iron deficiency anemia, vitamin C, ferrous succinate|iron deficiency anemia, vitamin c, ferrous succinate
4798325|NCT02631629|Vitamin D|vitamin d
4798326|NCT02631629|Fortification|fortification
4798327|NCT02631616|Prostatic Neoplasma, Castration-Resistant|prostatic neoplasma, castration-resistant
4798328|NCT02631616|neuroendocrine differentiation|neuroendocrine differentiation
4798329|NCT02631616|68Ga-DOTATET|68ga-dotatet
4798330|NCT02631616|PET/CT|pet/ct
4798331|NCT02631590|intra-hepatic biliary system|intra-hepatic biliary system
4798332|NCT02631590|extra-hepatic biliary system|extra-hepatic biliary system
4798333|NCT02631590|gall bladder|gall bladder
4798334|NCT02631590|advanced biliary cancer|advanced biliary cancer
4798335|NCT02631590|unresectable|unresectable
4798336|NCT02631590|locally advanced|locally advanced
4798337|NCT02631590|metastatic disease|metastatic disease
4798338|NCT02631564|mCRC;TACE;hepatic infusion;raltitrexed|mcrc;tace;hepatic infusion;raltitrexed
4798339|NCT02631551|Seasonal Allergic Rhinitis|seasonal allergic rhinitis
4798340|NCT02631538|Subcutaneous|subcutaneous
4798341|NCT02631538|Rituximab|rituximab
4798342|NCT02631538|Intravenous|intravenous
4798343|NCT02631538|Safety|safety
4798344|NCT02631538|Efficacy|efficacy
4798345|NCT02631538|Sjogren's syndrome|sjogren's syndrome
4798346|NCT02631538|Belimumab|belimumab
4798347|NCT02631525|Airway extubation|airway extubation
4798348|NCT02631525|Anesthesia Recovery Period|anesthesia recovery period
4798349|NCT02631525|Desflurane|desflurane
4798350|NCT02631525|Propofol|propofol
4798351|NCT02631525|Intravenous anesthesia|intravenous anesthesia
4798352|NCT02631525|Balanced Anesthesia|balanced anesthesia
4798353|NCT02631499|Circulating Tumor Cells|circulating tumor cells
4798354|NCT02631499|Hepatoectomy|hepatoectomy
4798355|NCT02631499|TACE|tace
4798356|NCT02631499|prognosis|prognosis
4798357|NCT02631499|relapse|relapse
4798358|NCT02631499|Chemoembolization, Therapeutic|chemoembolization, therapeutic
4798359|NCT02631486|Rotator Cuff Tears|rotator cuff tears
4798360|NCT02631447|Metastatic Melanoma|metastatic melanoma
4798361|NCT02631447|BRAF mutation|braf mutation
4798362|NCT02631408|spinal fusion|spinal fusion
4798363|NCT02631408|topical antibiotics|topical antibiotics
4798364|NCT02631408|vancomycin|vancomycin
4798365|NCT02631408|surgical site infection|surgical site infection
4798366|NCT02631395|Exercise movement techniques|exercise movement techniques
4798367|NCT02631382|wet cupping Saudi Arabia|wet cupping saudi arabia
4798368|NCT02631343|Kangaroo mother care in the community|kangaroo mother care in the community
4798369|NCT02631330|Geriatric Assessment|geriatric assessment
4798370|NCT02631330|Physical Education and Training|physical education and training
4798371|NCT02631317|acute ischemic stroke|acute ischemic stroke
4798372|NCT02631317|intravenous rt-PA thrombolysis|intravenous rt-pa thrombolysis
4798373|NCT02631317|process reengineering|process reengineering
4798374|NCT02631317|door-to-needle time|door-to-needle time
4798375|NCT02631304|Postoperative delirium|postoperative delirium
4798376|NCT02631304|Cholinesterase activity|cholinesterase activity
4798377|NCT02631304|Buturylcholinesterase activity|buturylcholinesterase activity
4798378|NCT02631304|Acetylcholinesterase activity|acetylcholinesterase activity
4798379|NCT02631304|Elderly patients|elderly patients
4798380|NCT02631304|Cardiac surgery|cardiac surgery
4798381|NCT02631265|Type 1 diabetes|type 1 diabetes
4798382|NCT02631265|Exercise|exercise
4798383|NCT02631265|Hypoglycemia|hypoglycemia
4798384|NCT02631265|Insulin pump|insulin pump
4798385|NCT02631252|Leukemia|leukemia
4798386|NCT02631252|Acute Myelogenous|acute myelogenous
4798387|NCT02631252|Phase I|phase i
4798388|NCT02631252|Mitoxantrone|mitoxantrone
4798389|NCT02631252|Etoposide|etoposide
4798390|NCT02631252|Hydroxychloroquine|hydroxychloroquine
4798391|NCT02631252|Relapsed|relapsed
4798392|NCT02631252|Autophagy inhibitor|autophagy inhibitor
4798393|NCT02631252|AML|aml
4798394|NCT02631252|Relapsed AML|relapsed aml
4798395|NCT02631200|Advance Care Planning|advance care planning
4798396|NCT02631200|Palliative care|palliative care
4798397|NCT02631200|Frail Elderly|frail elderly
4798398|NCT02631200|Renal Dialysis|renal dialysis
4798399|NCT02631187|Grade 2 retraction of the pars tensa of the tympanic membrane|grade 2 retraction of the pars tensa of the tympanic membrane
4798400|NCT02631187|Grade 3 retraction of the pars tensa of the tympanic membrane|grade 3 retraction of the pars tensa of the tympanic membrane
4798401|NCT02631135|Dexmedetomidine|dexmedetomidine
4798402|NCT02631135|cognitive functions|cognitive functions
4798403|NCT02631135|MMSE|mmse
4798404|NCT02631122|Retroclavicular|retroclavicular
4798405|NCT02631122|Supraclavicular|supraclavicular
4798406|NCT02631122|Diagphram|diagphram
4798407|NCT02631122|hemiparesis|hemiparesis
4798408|NCT02631122|nerve block|nerve block
4798409|NCT02631122|regional anesthesia|regional anesthesia
4798410|NCT02631122|anesthesiology|anesthesiology
4798411|NCT02631109|Pegaspargase|pegaspargase
4798412|NCT02631109|hemophagocytic lymphohistiocytosis|hemophagocytic lymphohistiocytosis
4798413|NCT02631109|Epstein Barr virus|epstein barr virus
4798414|NCT02631070|Luspatercept|luspatercept
4798415|NCT02631070|Transfusion dependent|transfusion dependent
4798416|NCT02631070|Lower risk|lower risk
4798417|NCT02631070|Low risk|low risk
4798418|NCT02631070|Myelodysplastic Syndromes|myelodysplastic syndromes
4798419|NCT02631070|ESA refractory|esa refractory
4798420|NCT02631070|ESA intolerant|esa intolerant
4798421|NCT02631070|ESA ineligible|esa ineligible
4798422|NCT02631070|ACE-536|ace-536
4798423|NCT02631070|Anemia|anemia
4798424|NCT02631070|Ring Sideroblasts|ring sideroblasts
4798425|NCT02631070|Require Red Blood Cell Transfusions|require red blood cell transfusions
4798426|NCT02631070|MEDALIST|medalist
4798427|NCT02631070|MDS|mds
4798428|NCT02631070|IPSS-R very low/IPSS-R low/IPSS-R intermediate|ipss-r very low/ipss-r low/ipss-r intermediate
4798429|NCT02631044|JCAR017|jcar017
4798430|NCT02631044|chimeric antigen receptor|chimeric antigen receptor
4798431|NCT02631044|non-Hodgkin lymphoma|non-hodgkin lymphoma
4798432|NCT02631044|CAR|car
4798433|NCT02631044|CAR T cells|car t cells
4798434|NCT02631044|autologous T cell therapy|autologous t cell therapy
4798435|NCT02631044|cell therapy|cell therapy
4798436|NCT02631044|NHL|nhl
4798437|NCT02631031|Chronokinetics|chronokinetics
4798438|NCT02631031|chronodynamics|chronodynamics
4798439|NCT02631031|chronopharmacology|chronopharmacology
4798440|NCT02631031|valsartan|valsartan
4798441|NCT02631005|systemic lupus erythematosus|systemic lupus erythematosus
4798442|NCT02631005|exercise|exercise
4798443|NCT02630992|ear infections|ear infections
4798444|NCT02630992|antibiotics|antibiotics
4798445|NCT02630992|antibiotic resistance|antibiotic resistance
4798446|NCT02630992|pediatrics|pediatrics
4798447|NCT02630992|infants|infants
4798448|NCT02630992|children|children
4798449|NCT02630992|amoxicillin-clavulanate|amoxicillin-clavulanate
4798450|NCT02630966|Drug therapy|drug therapy
4798451|NCT02630953|Physical Activity|physical activity
4798452|NCT02630953|Latinas|latinas
4798453|NCT02630953|Spanish-language|spanish-language
4798454|NCT02630953|Text-Message|text-message
4798455|NCT02630953|English-language|english-language
4798456|NCT02630953|Exercise|exercise
4798457|NCT02630927|Safety and Tolerability|safety and tolerability
4798458|NCT02630927|Pharmacokinetic Study|pharmacokinetic study
4798459|NCT02630927|Healthy Volunteer|healthy volunteer
4798460|NCT02630927|Pyruvate Kinase|pyruvate kinase
4798461|NCT02630927|Rare Genetic|rare genetic
4798462|NCT02630914|Epicardial surgical removal|epicardial surgical removal
4798463|NCT02630914|Closure of the left atrial|closure of the left atrial
4798464|NCT02630914|Left atrial appendage (LAA)|left atrial appendage (laa)
4798465|NCT02630888|Bipolar Disorder|bipolar disorder
4798466|NCT02630888|Memantine|memantine
4798467|NCT02630888|Lithium|lithium
4798468|NCT02630888|Aripiprazole|aripiprazole
4798469|NCT02630888|Quetiapine|quetiapine
4798470|NCT02630888|Central Nervous System Agents|central nervous system agents
4798471|NCT02630888|Therapeutic Uses|therapeutic uses
4798472|NCT02630888|Pharmacologic Actions|pharmacologic actions
4798473|NCT02630888|Psychotropic Drugs|psychotropic drugs
4798474|NCT02630888|Cognitive effect of drugs|cognitive effect of drugs
4798475|NCT02630862|oxidative stress|oxidative stress
4798476|NCT02630862|atherosclerosis|atherosclerosis
4798477|NCT02630862|carotid stenosis|carotid stenosis
4798478|NCT02630862|oxysterols|oxysterols
4798479|NCT02630862|vitamin E|vitamin e
4798480|NCT02630862|lipid peroxidation|lipid peroxidation
4798481|NCT02630862|antioxidants|antioxidants
4798482|NCT02630862|aspirin|aspirin
4798483|NCT02630862|dipyridamole|dipyridamole
4798484|NCT02630836|mesenchymal stromal cells|mesenchymal stromal cells
4798485|NCT02630836|stem cells|stem cells
4798486|NCT02630836|elderly|elderly
4798487|NCT02630836|allogeneic|allogeneic
4798488|NCT02630836|bone marrow|bone marrow
4798489|NCT02630836|bone regeneration|bone regeneration
4798490|NCT02630836|fracture|fracture
4798491|NCT02630797|Bone Health|bone health
4798492|NCT02630797|Calcium|calcium
4798493|NCT02630797|Osteoporosis|osteoporosis
4798494|NCT02630797|Polyphenolics|polyphenolics
4798495|NCT02630784|Non-invasive ventilation|non-invasive ventilation
4798496|NCT02630784|NIV ventilator|niv ventilator
4798497|NCT02630784|Exhalation by a calibrated leak|exhalation by a calibrated leak
4798498|NCT02630784|ICU ventilator|icu ventilator
4798499|NCT02630784|Respiratory acidosis|respiratory acidosis
4798500|NCT02630784|ICU|icu
4798501|NCT02630758|depression|depression
4798502|NCT02630758|yoga|yoga
4798503|NCT02630758|mindfulness|mindfulness
4798504|NCT02630745|endodontic treatment|endodontic treatment
4798913|NCT02628652|prebiotic|prebiotic
4798505|NCT02630745|open flap debridement|open flap debridement
4798506|NCT02630732|Back School|back school
4798507|NCT02630732|Brain School|brain school
4798508|NCT02630732|Lumbar surgery|lumbar surgery
4798509|NCT02630732|Education|education
4798510|NCT02630719|headache|headache
4798511|NCT02630628|Lupus Nephritis|lupus nephritis
4798512|NCT02630628|mycophenolate mofetil|mycophenolate mofetil
4798513|NCT02630628|tacrolimus|tacrolimus
4798514|NCT02630615|Circulating tumor cells|circulating tumor cells
4798515|NCT02630589|tinnitus|tinnitus
4798516|NCT02630589|auditory brainstem implant|auditory brainstem implant
4798517|NCT02630589|electrical stimulation|electrical stimulation
4798518|NCT02630576|electromyography|electromyography
4798519|NCT02630576|neuromuscular blockade|neuromuscular blockade
4798520|NCT02630550|Cardiac output|cardiac output
4798521|NCT02630550|Intraoperative Monitoring|intraoperative monitoring
4798522|NCT02630550|Echocardiography, Transesophageal|echocardiography, transesophageal
4798523|NCT02630550|Vascular cross-clamping|vascular cross-clamping
4798524|NCT02630550|Endarterectomy|endarterectomy
4798525|NCT02630550|Monitoring, Physiologic/instrumentation|monitoring, physiologic/instrumentation
4798526|NCT02630550|Cardiography, Impedance|cardiography, impedance
4798527|NCT02630537|Cytomegalovirus|cytomegalovirus
4798528|NCT02630537|Epstein- Barr virus|epstein- barr virus
4798529|NCT02630537|Cell-mediated immunity|cell-mediated immunity
4798530|NCT02630537|T-Track® CMV|t-track® cmv
4798531|NCT02630537|T-Track® EBV|t-track® ebv
4798532|NCT02630537|hemodialysis|hemodialysis
4798533|NCT02630537|ELISpot|elispot
4798534|NCT02630498|pain|pain
4798535|NCT02630498|surgical|surgical
4798536|NCT02630498|brachial plexus|brachial plexus
4798537|NCT02630485|Randomized Controlled Trial|randomized controlled trial
4798538|NCT02630459|Migraine Prevention|migraine prevention
4798539|NCT02630459|Headache|headache
4798540|NCT02630459|Prophylaxis|prophylaxis
4798541|NCT02630446|respite care|respite care
4798542|NCT02630446|effectiveness|effectiveness
4798543|NCT02630446|cost-effectiveness|cost-effectiveness
4798544|NCT02630446|support|support
4798545|NCT02630446|caregiver|caregiver
4798546|NCT02630446|dementia|dementia
4798547|NCT02630446|community-based|community-based
4798548|NCT02630433|Biliary pancreatitis|biliary pancreatitis
4798549|NCT02630433|Cholecystectomy|cholecystectomy
4798550|NCT02630394|sickle cell disease|sickle cell disease
4798551|NCT02630394|acute chest syndrome|acute chest syndrome
4798552|NCT02630381|high-energy shock waves|high-energy shock waves
4798553|NCT02630368|Advanced Soft-tissue Sarcoma|advanced soft-tissue sarcoma
4798554|NCT02630368|Advanced Breast Cancer|advanced breast cancer
4798555|NCT02630368|Maximum Tolerated Dose|maximum tolerated dose
4798556|NCT02630368|Efficacy and safety|efficacy and safety
4798557|NCT02630342|Mock Scanner|mock scanner
4798558|NCT02630342|Child Life Specialist|child life specialist
4798559|NCT02630342|Patient Preparation|patient preparation
4798560|NCT02630342|Child, Preschool|child, preschool
4798561|NCT02630342|Child|child
4798562|NCT02630342|Anxiety|anxiety
4798563|NCT02630342|Human|human
4798564|NCT02630342|Anesthesia, General|anesthesia, general
4798565|NCT02630329|NOTES|notes
4798566|NCT02630329|Benign adnexal disease|benign adnexal disease
4798567|NCT02630329|Laparoscopy|laparoscopy
4798568|NCT02630316|Treprostinil|treprostinil
4798569|NCT02630316|PH|ph
4798570|NCT02630316|ILD|ild
4798571|NCT02630316|CPFE|cpfe
4798572|NCT02630316|6 Minute Walk Test|6 minute walk test
4798573|NCT02630303|light emitting diode-red light|light emitting diode-red light
4798574|NCT02630303|LED-RL|led-rl
4798575|NCT02630303|high fluence|high fluence
4798576|NCT02630303|skin fibrosis|skin fibrosis
4798577|NCT02630303|wound healing|wound healing
4798578|NCT02630303|scar|scar
4798579|NCT02630303|keloid|keloid
4798580|NCT02630303|RCT|rct
4798581|NCT02630290|Brachial plexus block|brachial plexus block
4798582|NCT02630290|Dexmedetomidine|dexmedetomidine
4798583|NCT02630290|Ropivacaine|ropivacaine
4798584|NCT02630290|ultrasound-guided nerve block|ultrasound-guided nerve block
4798585|NCT02630290|supraclavicular brachial plexus block|supraclavicular brachial plexus block
4798586|NCT02630277|Proliferative Diabetic Retinopathy|proliferative diabetic retinopathy
4798587|NCT02630277|High Risk PDR|high risk pdr
4798588|NCT02630277|aflibercept|aflibercept
4798589|NCT02630277|regression of retinal neovascularization|regression of retinal neovascularization
4798590|NCT02630264|clinical trial|clinical trial
4798591|NCT02630264|Recombinant Human Endostatin Adenovirus|recombinant human endostatin adenovirus
4798592|NCT02630264|randomized|randomized
4798593|NCT02630251|Cancer|cancer
4798594|NCT02630251|Safety|safety
4798595|NCT02630251|GSK2820151|gsk2820151
4798596|NCT02630251|Dose escalation|dose escalation
4798597|NCT02630251|Tolerability|tolerability
4798598|NCT02630251|Pharmacodynamics|pharmacodynamics
4798599|NCT02630251|Pharmacokinetics|pharmacokinetics
4798600|NCT02630238|Exercise|exercise
4798601|NCT02630238|Amino Acids, Branched-Chain|amino acids, branched-chain
4798602|NCT02630225|case management|case management
4798603|NCT02630225|motivational interviewing|motivational interviewing
4798604|NCT02630212|Aortic dissection|aortic dissection
4798711|NCT02629588|Persistent Vegetative State|persistent vegetative state
4798605|NCT02630212|Aldehyde dehydrogenase 2 polymorphism|aldehyde dehydrogenase 2 polymorphism
4798606|NCT02630212|Risk factor|risk factor
4798607|NCT02630212|aldehyde dehydrogenase 2|aldehyde dehydrogenase 2
4798608|NCT02630173|endodontic treatment|endodontic treatment
4798609|NCT02630173|scaling|scaling
4798610|NCT02630173|root planning|root planning
4798611|NCT02630147|Late preterm|late preterm
4798612|NCT02630147|Vanilla|vanilla
4798613|NCT02630147|Hypoxic intermittent events|hypoxic intermittent events
4798614|NCT02630108|HCC|hcc
4798615|NCT02630108|TACE|tace
4798616|NCT02630108|Thermal Ablation|thermal ablation
4798617|NCT02630108|Safety/Efficacy|safety/efficacy
4798618|NCT02630095|anticoagulation|anticoagulation
4798619|NCT02630082|HIV Preventive Vaccine|hiv preventive vaccine
4798620|NCT02630082|HIV Seronegativity|hiv seronegativity
4798621|NCT02630082|Immune Response, Mucosal|immune response, mucosal
4798622|NCT02630069|amphetamine type stimulant|amphetamine type stimulant
4798623|NCT02630069|adolescents|adolescents
4798624|NCT02630056|radiotherapy hematologic toxicity pelvic bone marrow|radiotherapy hematologic toxicity pelvic bone marrow
4798625|NCT02630004|Mucositis|mucositis
4798626|NCT02630004|Head and Neck cancer|head and neck cancer
4798627|NCT02630004|Chemoradiation|chemoradiation
4798628|NCT02629991|Prader-Willi Syndrome (PWS)|prader-willi syndrome (pws)
4798629|NCT02629991|Hyperphagia|hyperphagia
4798630|NCT02629978|pulmonary|pulmonary
4798631|NCT02629978|lung|lung
4798632|NCT02629978|cancer|cancer
4798633|NCT02629978|carcinoma|carcinoma
4798634|NCT02629978|nodule|nodule
4798635|NCT02629978|malignant|malignant
4798636|NCT02629978|radiofrequency ablation|radiofrequency ablation
4798637|NCT02629978|RFA|rfa
4798638|NCT02629952|glucose tolerance|glucose tolerance
4798639|NCT02629952|type 2 diabetes|type 2 diabetes
4798640|NCT02629952|blueberry tea|blueberry tea
4798641|NCT02629900|Weight Loss|weight loss
4798642|NCT02629900|Intermittent fasting|intermittent fasting
4798643|NCT02629887|supraglottic airway|supraglottic airway
4798644|NCT02629887|neonatal resuscitation|neonatal resuscitation
4798645|NCT02629887|ventilation|ventilation
4798646|NCT02629887|term infant|term infant
4798647|NCT02629874|EA-230|ea-230
4798648|NCT02629874|Inflammatory response|inflammatory response
4798649|NCT02629874|Kidney Injury|kidney injury
4798650|NCT02629874|Endotoxemia|endotoxemia
4798651|NCT02629848|Drug therapy|drug therapy
4798652|NCT02629809|Leukemia|leukemia
4798653|NCT02629809|Chronic lymphocytic leukemia|chronic lymphocytic leukemia
4798654|NCT02629809|CLL|cll
4798655|NCT02629809|Mutated immunoglobulin heavy chair variable region|mutated immunoglobulin heavy chair variable region
4798656|NCT02629809|IGHV|ighv
4798657|NCT02629809|non-del(17p) fluorescence in-situ hybridization|non-del(17p) fluorescence in-situ hybridization
4798658|NCT02629809|FISH|fish
4798659|NCT02629809|Obinutuzumab|obinutuzumab
4798660|NCT02629809|GA101|ga101
4798661|NCT02629809|Gazyva|gazyva
4798662|NCT02629809|Fludarabine|fludarabine
4798663|NCT02629809|Fludarabine Phosphate|fludarabine phosphate
4798664|NCT02629809|Fludara|fludara
4798665|NCT02629809|Cyclophosphamide|cyclophosphamide
4798666|NCT02629809|Cytoxan|cytoxan
4798667|NCT02629809|Neosar|neosar
4798668|NCT02629809|Ibrutinib|ibrutinib
4798669|NCT02629809|PCI-32765|pci-32765
4798670|NCT02629809|Imbruvica|imbruvica
4798671|NCT02629809|Allopurinol|allopurinol
4798672|NCT02629809|Lopurin|lopurin
4798673|NCT02629809|Zurinol|zurinol
4798674|NCT02629809|Zyloprim|zyloprim
4798675|NCT02629809|Valacyclovir|valacyclovir
4798676|NCT02629809|Valtrex|valtrex
4798677|NCT02629796|Biomarker|biomarker
4798678|NCT02629796|CIDP|cidp
4798679|NCT02629796|IVIG|ivig
4798680|NCT02629796|treatment response|treatment response
4798681|NCT02629757|High-grade glioma|high-grade glioma
4798682|NCT02629757|chemotherapy|chemotherapy
4798683|NCT02629757|β-elemene|β-elemene
4798684|NCT02629731|foot|foot
4798685|NCT02629731|ankle|ankle
4798686|NCT02629731|osteoarthritis|osteoarthritis
4798687|NCT02629731|flat foot|flat foot
4798688|NCT02629718|neoadjuvant chemotherapy|neoadjuvant chemotherapy
4798689|NCT02629718|radical surgery|radical surgery
4798690|NCT02629718|cervical carcinoma|cervical carcinoma
4798691|NCT02629653|carotid endarterectomy|carotid endarterectomy
4798692|NCT02629653|stroke|stroke
4798693|NCT02629653|hypothermia|hypothermia
4798694|NCT02629653|endovascular cooling|endovascular cooling
4798695|NCT02629640|vCJD|vcjd
4798696|NCT02629640|prion disease|prion disease
4798697|NCT02629640|dementia|dementia
4798698|NCT02629640|old-age|old-age
4798699|NCT02629640|surveillance|surveillance
4798700|NCT02629640|brain banking|brain banking
4798701|NCT02629640|public health|public health
4798702|NCT02629627|Conjugated Linoleic Acid|conjugated linoleic acid
4798703|NCT02629627|Leucine|leucine
4798704|NCT02629627|visceral fat area|visceral fat area
4798705|NCT02629627|Epicardial Fat|epicardial fat
4798706|NCT02629627|Hemodinamic Parameters|hemodinamic parameters
4798707|NCT02629601|physical activity|physical activity
4798708|NCT02629601|financial incentives|financial incentives
4798709|NCT02629601|behavioral economics|behavioral economics
4798710|NCT02629588|Coma|coma
4798712|NCT02629588|Sensory Stimulation|sensory stimulation
4798713|NCT02629497|platelets|platelets
4798714|NCT02629497|12-lipoxygenase|12-lipoxygenase
4798715|NCT02629497|fatty acids|fatty acids
4798716|NCT02629497|DGLA|dgla
4798717|NCT02629497|DHA|dha
4798718|NCT02629497|EPA|epa
4798719|NCT02629497|12-LOX|12-lox
4798720|NCT02629484|echocardiography|echocardiography
4798721|NCT02629484|hip fracture|hip fracture
4798722|NCT02629484|surgery|surgery
4798723|NCT02629484|outcomes|outcomes
4798724|NCT02629432|MRI|mri
4798725|NCT02629432|COPD|copd
4798726|NCT02629419|STAT3 deficient Hyper IgE syndrome|stat3 deficient hyper ige syndrome
4798727|NCT02629419|Gain of function STAT1 defects|gain of function stat1 defects
4798728|NCT02629419|Autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED)|autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (apeced)
4798729|NCT02629419|IL-17/IL-22 autoantibodies from thymoma|il-17/il-22 autoantibodies from thymoma
4798730|NCT02629419|Job's Syndrome (Hyperimmunoglobulin E Syndrome, Buckley Syndrome)|job's syndrome (hyperimmunoglobulin e syndrome, buckley syndrome)
4798731|NCT02629406|HIF|hif
4798732|NCT02629406|hypoxia|hypoxia
4798733|NCT02629406|chemoreflex|chemoreflex
4798734|NCT02629406|baroreflex|baroreflex
4798735|NCT02629406|MIR210|mir210
4798736|NCT02629393|Molybdenum Cofactor Deficiency (MoCD)|molybdenum cofactor deficiency (mocd)
4798737|NCT02629393|Molybdenum Cofactor (MoCo) biosynthesis|molybdenum cofactor (moco) biosynthesis
4798738|NCT02629393|sulfite oxidase (SO)|sulfite oxidase (so)
4798739|NCT02629393|S sulfocysteine (SSC)|s sulfocysteine (ssc)
4798740|NCT02629393|xanthine oxidoreductase|xanthine oxidoreductase
4798741|NCT02629393|aldehyde oxidase|aldehyde oxidase
4798742|NCT02629380|meniscectomy|meniscectomy
4798743|NCT02629380|hyaluronic acid|hyaluronic acid
4798744|NCT02629380|intra-op injection|intra-op injection
4798745|NCT02629380|randomized controlled trial|randomized controlled trial
4798746|NCT02629380|placebo|placebo
4798747|NCT02629341|woman osteopenia osteoporosis enriched calcium vit D yogurt|woman osteopenia osteoporosis enriched calcium vit d yogurt
4798748|NCT02629328|CardioCel|cardiocel
4798749|NCT02629328|FDA cleared|fda cleared
4798750|NCT02629328|Tri-leaflet repair|tri-leaflet repair
4798751|NCT02629328|Aortic valves|aortic valves
4798752|NCT02629289|HSP-130|hsp-130
4798753|NCT02629289|Pharmacodynamic and Pharmacokinetic equivalence|pharmacodynamic and pharmacokinetic equivalence
4798754|NCT02629289|Pegfilgrastim|pegfilgrastim
4798755|NCT02629276|neck pain|neck pain
4798756|NCT02629276|arm pain|arm pain
4798757|NCT02629276|neurodynamic tests|neurodynamic tests
4798758|NCT02629276|quantitative sensory testing|quantitative sensory testing
4798759|NCT02629276|somatosensory profile|somatosensory profile
4798760|NCT02629250|proximal femoral fracture|proximal femoral fracture
4798761|NCT02629250|goal-directed therapy|goal-directed therapy
4798762|NCT02629250|myocardial injury|myocardial injury
4798763|NCT02629250|supernormal oxygen delivery|supernormal oxygen delivery
4798764|NCT02629250|elders|elders
4798765|NCT02629250|stroke volume maximization|stroke volume maximization
4798766|NCT02629237|glaucoma surgery|glaucoma surgery
4798767|NCT02629237|educational intervention|educational intervention
4798768|NCT02629237|satisfaction|satisfaction
4798769|NCT02629237|rural|rural
4798770|NCT02629224|Impaired renal function|impaired renal function
4798771|NCT02629224|Haemodialysis|haemodialysis
4798772|NCT02629224|ASP8825|asp8825
4798773|NCT02629224|XP13512|xp13512
4798774|NCT02629211|Inflammatory Bowel Diseases|inflammatory bowel diseases
4798775|NCT02629211|Colitis, Ulcerative|colitis, ulcerative
4798776|NCT02629211|Crohn Disease|crohn disease
4798777|NCT02629211|Single-Balloon Enteroscopy|single-balloon enteroscopy
4798778|NCT02629211|NaviAid AB™ Device|naviaid ab™ device
4798779|NCT02629211|NaviAid AB™ Procedure|naviaid ab™ procedure
4798780|NCT02629211|AB Device|ab device
4798781|NCT02629211|Pediatric IBD|pediatric ibd
4798782|NCT02629211|Pediatric Enteroscopy|pediatric enteroscopy
4798783|NCT02629198|Vitamin D|vitamin d
4798784|NCT02629185|Bone|bone
4798785|NCT02629185|Vitamin D|vitamin d
4798786|NCT02629185|Cardiovascular|cardiovascular
4798787|NCT02629172|Hepatitis C Virus (HCV)|hepatitis c virus (hcv)
4798788|NCT02629172|Paritaprevir|paritaprevir
4798789|NCT02629172|Ombitasvir|ombitasvir
4798790|NCT02629172|Ritonavir|ritonavir
4798791|NCT02629172|Genotype 1|genotype 1
4798792|NCT02629159|Musculoskeletal disease|musculoskeletal disease
4798793|NCT02629159|Arthritis|arthritis
4798794|NCT02629159|Joint disease|joint disease
4798795|NCT02629159|Anti-inflammatory agents|anti-inflammatory agents
4798796|NCT02629159|Antirheumatic agents|antirheumatic agents
4798797|NCT02629146|Midazolam|midazolam
4798798|NCT02629146|Fentanyl|fentanyl
4798799|NCT02629133|Intimate Partner Violence|intimate partner violence
4798800|NCT02629133|Sheltered Battered Women|sheltered battered women
4798801|NCT02629133|Substance Use|substance use
4798802|NCT02629120|Chronic Granulomatous Disease|chronic granulomatous disease
4798803|NCT02629120|Allogeneic Stem Cell Transplantation|allogeneic stem cell transplantation
4798804|NCT02629120|Graft Versus Host Disease|graft versus host disease
4798805|NCT02629120|Matched Unrelated Donor BMT|matched unrelated donor bmt
4798806|NCT02629120|Nonmyeloablative Conditioning Regimen|nonmyeloablative conditioning regimen
4798807|NCT02629107|Sleep|sleep
4798808|NCT02629107|Functional Magnetic Resonance Imaging (fMRI)|functional magnetic resonance imaging (fmri)
4798809|NCT02629107|Electroencephalogram (EEG)|electroencephalogram (eeg)
4798810|NCT02629094|Hepatic Steatosis|hepatic steatosis
4798811|NCT02629094|Cardiac Steatosis|cardiac steatosis
4798812|NCT02629094|Aldosterone|aldosterone
4798813|NCT02629094|Eplerenone|eplerenone
4798814|NCT02629094|Mineralcorticoid Receptor|mineralcorticoid receptor
4798815|NCT02629081|heartburn|heartburn
4798816|NCT02629081|GERD|gerd
4798817|NCT02629081|NERD|nerd
4798818|NCT02629081|non-erosive reflux disease|non-erosive reflux disease
4798819|NCT02629068|Adolescent|adolescent
4798820|NCT02629068|Social Support|social support
4798821|NCT02629068|Social Media|social media
4798822|NCT02629068|Parents|parents
4798823|NCT02629068|Shame|shame
4798824|NCT02629068|Stigma|stigma
4798825|NCT02629055|Non-invasive ventilation|non-invasive ventilation
4798826|NCT02629055|Respiratory electromyography|respiratory electromyography
4798827|NCT02629042|Anesthesia|anesthesia
4798828|NCT02629042|Corticosteroids|corticosteroids
4798829|NCT02629042|Dental Emergency|dental emergency
4798830|NCT02629042|Irreversible Pulpitis|irreversible pulpitis
4798831|NCT02629042|Mandibulae|mandibulae
4798832|NCT02629042|Pain Management|pain management
4798833|NCT02629042|Partial Endodontic Treatment|partial endodontic treatment
4798834|NCT02629003|Positron Emission Tomography|positron emission tomography
4798835|NCT02629003|Serotonin|serotonin
4798836|NCT02629003|5-HT2A|5-ht2a
4798837|NCT02629003|Radioligand|radioligand
4798838|NCT02629003|Radiation dosimetry|radiation dosimetry
4798839|NCT02629003|Radiation dosage|radiation dosage
4798840|NCT02628964|smoking|smoking
4798841|NCT02628964|cigarettes|cigarettes
4798842|NCT02628938|Halitosis|halitosis
4798843|NCT02628938|Oral Malodor|oral malodor
4798844|NCT02628938|Miswak|miswak
4798845|NCT02628938|Salvadora Persica|salvadora persica
4798846|NCT02628925|mass screening|mass screening
4798847|NCT02628925|Nursing diagnosis|nursing diagnosis
4798848|NCT02628925|Psychiatric Status Rating Scale|psychiatric status rating scale
4798849|NCT02628912|Cardiopulmonary Fitness|cardiopulmonary fitness
4798850|NCT02628912|Long-Term Survivors|long-term survivors
4798851|NCT02628912|15-277|15-277
4798853|NCT02628912|Survivors|survivors
4798854|NCT02628886|maternal and neonatal pneumococcal conjugate vaccination|maternal and neonatal pneumococcal conjugate vaccination
4798855|NCT02628886|pneumococcal carriage|pneumococcal carriage
4798856|NCT02628873|HSG|hsg
4798857|NCT02628873|HyCoSy|hycosy
4798858|NCT02628873|Contraception|contraception
4798859|NCT02628873|Essure|essure
4798860|NCT02628873|Saline Infused sonography|saline infused sonography
4798861|NCT02628873|SIS|sis
4798862|NCT02628873|Air bubbles|air bubbles
4798863|NCT02628860|ferric carboxymaltose|ferric carboxymaltose
4798864|NCT02628860|Ferinject®|ferinject®
4798865|NCT02628860|pancreatoduodenectomy|pancreatoduodenectomy
4798866|NCT02628847|stroke|stroke
4798867|NCT02628847|rehabilitation|rehabilitation
4798868|NCT02628847|motor skills|motor skills
4798869|NCT02628847|sildenafil citrate|sildenafil citrate
4798870|NCT02628847|White matter|white matter
4798871|NCT02628834|Loading|loading
4798872|NCT02628834|Gait|gait
4798873|NCT02628834|Multiple Sclerosis|multiple sclerosis
4798874|NCT02628834|Manual Therapy|manual therapy
4798875|NCT02628808|autism|autism
4798876|NCT02628808|asperger|asperger
4798877|NCT02628808|Pervasive Developmental Disorder No Otherwise Specify|pervasive developmental disorder no otherwise specify
4798878|NCT02628808|gene|gene
4798879|NCT02628808|polymorphism|polymorphism
4798880|NCT02628808|mutation|mutation
4798881|NCT02628795|total hip arthroplasty|total hip arthroplasty
4798882|NCT02628795|total knee arthroplasty|total knee arthroplasty
4798883|NCT02628782|large bore endovascular catheterization procedures|large bore endovascular catheterization procedures
4798884|NCT02628782|Vascular Closure Device|vascular closure device
4798885|NCT02628769|Solithromycin|solithromycin
4798886|NCT02628769|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
4798887|NCT02628769|Inflammation|inflammation
4798888|NCT02628769|Macrolide|macrolide
4798889|NCT02628730|Atrial Fibrillation|atrial fibrillation
4798890|NCT02628730|Ablation|ablation
4798891|NCT02628730|Pulmonary vein isolation|pulmonary vein isolation
4798892|NCT02628730|Ablation Index|ablation index
4798893|NCT02628717|Hepatitis C|hepatitis c
4798894|NCT02628717|sofosbuvir|sofosbuvir
4798895|NCT02628717|ledipasvir|ledipasvir
4798896|NCT02628717|daclatasvir|daclatasvir
4798897|NCT02628717|simeprevir|simeprevir
4798898|NCT02628704|Karyopharm|karyopharm
4798899|NCT02628704|selinexor|selinexor
4798900|NCT02628704|KPT-330|kpt-330
4798901|NCT02628704|multiple myeloma|multiple myeloma
4798902|NCT02628704|SCORE|score
4798903|NCT02628678|Prebiotic|prebiotic
4798904|NCT02628678|FOS|fos
4798905|NCT02628678|fructooligosaccharide|fructooligosaccharide
4798906|NCT02628678|polyglycan|polyglycan
4798907|NCT02628678|microbiome|microbiome
4798908|NCT02628678|microbiota|microbiota
4798909|NCT02628678|Healthy Volunteers|healthy volunteers
4798910|NCT02628652|Microbiome|microbiome
4798911|NCT02628652|FOS|fos
4798912|NCT02628652|polyglycan|polyglycan
4798914|NCT02628652|Healthy Volunteers|healthy volunteers
4798915|NCT02628626|Incontinence|incontinence
4798916|NCT02628626|Diarrhea|diarrhea
4798917|NCT02628626|Bile acid|bile acid
4798918|NCT02628626|Microbiome|microbiome
4798919|NCT02628613|Breast cancer|breast cancer
4798920|NCT02628613|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
4798921|NCT02628613|TEKT4|tekt4
4798922|NCT02628587|Acute Coronary Syndrome|acute coronary syndrome
4798923|NCT02628587|Clopidogrel|clopidogrel
4798924|NCT02628587|Platelet reactivity|platelet reactivity
4798925|NCT02628574|Metastatic|metastatic
4798926|NCT02628574|Stage III or IV|stage iii or iv
4798927|NCT02628574|recurrent|recurrent
4798928|NCT02628574|refractory|refractory
4798929|NCT02628574|solid tumors|solid tumors
4798930|NCT02628535|B7-H3-expressing neoplasms|b7-h3-expressing neoplasms
4798931|NCT02628522|ADRC|adrc
4798932|NCT02628522|Celution|celution
4798933|NCT02628509|Acquired Von Willebrand|acquired von willebrand
4798934|NCT02628509|Trans aortic valve replacement|trans aortic valve replacement
4798935|NCT02628509|mechanical circulatory support|mechanical circulatory support
4798936|NCT02628470|Cervical pain, cervicalgia|cervical pain, cervicalgia
4798937|NCT02628457|occupation ratio|occupation ratio
4798938|NCT02628457|pseudoatrophy|pseudoatrophy
4798939|NCT02628444|Dengue Fever|dengue fever
4798940|NCT02628444|Dengue virus|dengue virus
4798941|NCT02628444|Dengue Hemorrhagic Fever|dengue hemorrhagic fever
4798942|NCT02628444|CYD Dengue Vaccine|cyd dengue vaccine
4798943|NCT02628418|Rehabilitation|rehabilitation
4798944|NCT02628418|Robotics|robotics
4798945|NCT02628392|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
4798946|NCT02628392|Adult|adult
4798947|NCT02628392|Developmental Phase II|developmental phase ii
4798948|NCT02628379|Genomic Testing|genomic testing
4798949|NCT02628379|Cancer of Unknown Primary|cancer of unknown primary
4798950|NCT02628379|CUP|cup
4798951|NCT02628366|Cluster Randomized Controlled Trial|cluster randomized controlled trial
4798952|NCT02628366|Personalized Dialysate Temperature|personalized dialysate temperature
4798953|NCT02628366|Cardiovascular Events|cardiovascular events
4798954|NCT02628366|Mortality|mortality
4798955|NCT02628353|Cardiovascular diseases|cardiovascular diseases
4798956|NCT02628353|endothelial function|endothelial function
4798957|NCT02628353|systolic blood pressure|systolic blood pressure
4798958|NCT02628353|metabolomics|metabolomics
4798959|NCT02628353|cardiovascular risk factor|cardiovascular risk factor
4798960|NCT02628353|bioavailability|bioavailability
4798961|NCT02628353|phenolic compounds|phenolic compounds
4798962|NCT02628353|hypertension|hypertension
4798963|NCT02628327|glaucoma care|glaucoma care
4798964|NCT02628327|quality of life|quality of life
4798965|NCT02628327|patient satisfaction|patient satisfaction
4798966|NCT02628301|Obesity|obesity
4798967|NCT02628301|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
4798968|NCT02628301|Hypercaloric diet|hypercaloric diet
4798969|NCT02628301|Microcirculation|microcirculation
4798970|NCT02628301|Microvascular dysfunction|microvascular dysfunction
4798971|NCT02628301|Insulin Resistance|insulin resistance
4798972|NCT02628301|Insulin Sensitivity|insulin sensitivity
4798973|NCT02628301|Insulin signaling|insulin signaling
4798974|NCT02628262|Macular hole|macular hole
4798975|NCT02628236|Actinic keratosis|actinic keratosis
4798976|NCT02628223|glaucoma|glaucoma
4798977|NCT02628223|Elevated IOP|elevated iop
4798978|NCT02628223|Selective Laser Trabeculoplasty|selective laser trabeculoplasty
4798979|NCT02628223|SLT|slt
4798980|NCT02628223|open angle glaucoma|open angle glaucoma
4798981|NCT02628223|ocular hypertension|ocular hypertension
4798982|NCT02628223|Glaucoma, Open Angle, Pseudo-exfoliative|glaucoma, open angle, pseudo-exfoliative
4798983|NCT02628223|pigment dispersion syndrome|pigment dispersion syndrome
4798984|NCT02628223|Pseudoexfoliation|pseudoexfoliation
4798985|NCT02628223|IOP ≥ 21 mmHg|iop ≥ 21 mmhg
4798986|NCT02628158|Epiretinal membrane|epiretinal membrane
4798987|NCT02628145|Sarcopenia|sarcopenia
4798988|NCT02628145|aging|aging
4798989|NCT02628145|resistance training|resistance training
4798990|NCT02628145|physical functioning|physical functioning
4798991|NCT02628132|triple negative|triple negative
4798992|NCT02628132|breast cancer|breast cancer
4798993|NCT02628132|durvalumab|durvalumab
4798994|NCT02628132|paclitaxel|paclitaxel
4798995|NCT02628132|safety|safety
4798996|NCT02628132|efficacy|efficacy
4798997|NCT02628132|PD-L1|pd-l1
4798998|NCT02628132|PD-1|pd-1
4798999|NCT02628132|Metastatic|metastatic
4799000|NCT02628132|AstraZeneca|astrazeneca
4799001|NCT02628132|MEDI4736|medi4736
4799002|NCT02628119|Hemodialysis|hemodialysis
4799003|NCT02628119|vascular access|vascular access
4799004|NCT02628119|access flow|access flow
4799005|NCT02628080|Hypoxia|hypoxia
4799006|NCT02628067|PD1|pd1
4799007|NCT02628067|PDL1|pdl1
4799008|NCT02628067|PD-1|pd-1
4799009|NCT02628067|PD-L1|pd-l1
4799010|NCT02628067|MSI|msi
4799011|NCT02628067|microsatellite instability|microsatellite instability
4799012|NCT02628067|MMR|mmr
4799013|NCT02628067|mismatch repair|mismatch repair
4799014|NCT02628067|anal carcinoma|anal carcinoma
4799015|NCT02628067|anal cancer|anal cancer
4799016|NCT02628067|biliary adenocarcinoma|biliary adenocarcinoma
4799017|NCT02628067|biliary cancer|biliary cancer
4799018|NCT02628067|cholangiocarcinoma|cholangiocarcinoma
4799019|NCT02628067|bile duct cancer|bile duct cancer
4799020|NCT02628067|neuroendocrine tumor|neuroendocrine tumor
4799021|NCT02628067|carcinoid tumor|carcinoid tumor
4799022|NCT02628067|endometrial carcinoma|endometrial carcinoma
4799023|NCT02628067|endometrial cancer|endometrial cancer
4799024|NCT02628067|cervical carcinoma|cervical carcinoma
4799025|NCT02628067|cervical cancer|cervical cancer
4799026|NCT02628067|vulvar carcinoma|vulvar carcinoma
4799027|NCT02628067|vulvar cancer|vulvar cancer
4799028|NCT02628067|small cell lung carcinoma|small cell lung carcinoma
4799029|NCT02628067|small cell lung cancer|small cell lung cancer
4799030|NCT02628067|SCLC|sclc
4799031|NCT02628067|mesothelioma|mesothelioma
4799032|NCT02628067|thyroid carcinoma|thyroid carcinoma
4799033|NCT02628067|thyroid cancer|thyroid cancer
4799034|NCT02628067|salivary gland carcinoma|salivary gland carcinoma
4799035|NCT02628067|salivary gland cancer|salivary gland cancer
4799036|NCT02628067|salivary cancer|salivary cancer
4799037|NCT02628067|parotid gland cancer|parotid gland cancer
4799038|NCT02628067|advanced solid tumors|advanced solid tumors
4799039|NCT02628054|PSG|psg
4799040|NCT02628054|Typhoid Vaccine|typhoid vaccine
4799041|NCT02628054|Depression|depression
4799042|NCT02628054|Inflammation|inflammation
4799043|NCT02628041|High-Dose-Rate Brachytherapy|high-dose-rate brachytherapy
4799044|NCT02628041|HDR Monotherapy|hdr monotherapy
4799045|NCT02628041|LDR monotherapy|ldr monotherapy
4799046|NCT02628015|Theory of Mind|theory of mind
4799047|NCT02628015|Very Low Birthweight Infants|very low birthweight infants
4799048|NCT02628002|antigravity treadmill|antigravity treadmill
4799049|NCT02628002|bruce protocol|bruce protocol
4799050|NCT02628002|stress myocardial perfusion imaging|stress myocardial perfusion imaging
4799051|NCT02628002|single photon emission computed tomography|single photon emission computed tomography
4799052|NCT02628002|cardiac catheterization|cardiac catheterization
4799053|NCT02628002|[E01.370.370.380.500]|[e01.370.370.380.500]
4799054|NCT02628002|[E01.370.370.380.250]|[e01.370.370.380.250]
4799055|NCT02628002|[E01.370.370.380.140]|[e01.370.370.380.140]
4799056|NCT02627937|Pediatric obstructive sleep apnea/hypopnea syndrome|pediatric obstructive sleep apnea/hypopnea syndrome
4799057|NCT02627937|Polysomnography|polysomnography
4799058|NCT02627924|Rheumatoid Arthritis|rheumatoid arthritis
4799059|NCT02627924|Work productivity|work productivity
4799060|NCT02627924|patient-reported QoL(Quality of Life)|patient-reported qol(quality of life)
4799061|NCT02627898|Green tea extract|green tea extract
4799062|NCT02627898|Arterial stiffness|arterial stiffness
4799063|NCT02627898|PWVao|pwvao
4799064|NCT02627885|internet treatment|internet treatment
4799065|NCT02627885|cognitive behavioral therapy|cognitive behavioral therapy
4799066|NCT02627885|level of functioning|level of functioning
4799067|NCT02627885|quality of life|quality of life
4799068|NCT02627833|induced Sputum|induced sputum
4799069|NCT02627833|lung clearance index|lung clearance index
4799070|NCT02627833|miRNA|mirna
4799071|NCT02627833|inflammation|inflammation
4799072|NCT02627833|chronic lung disease|chronic lung disease
4799073|NCT02627820|Senile|senile
4799074|NCT02627820|ATTRwt|attrwt
4799075|NCT02627820|wild-type transthyretin amyloidosis|wild-type transthyretin amyloidosis
4799076|NCT02627807|Nasopharyngeal carcinoma|nasopharyngeal carcinoma
4799077|NCT02627807|Intensity modulated radiotherapy|intensity modulated radiotherapy
4799078|NCT02627807|Clinical target volume|clinical target volume
4799079|NCT02627807|Clinical trial|clinical trial
4799080|NCT02627794|Middle Meatus|middle meatus
4799081|NCT02627794|Synechiae|synechiae
4799082|NCT02627794|Endoscopic Sinus Surgery|endoscopic sinus surgery
4799083|NCT02627794|Silastic spacer|silastic spacer
4799084|NCT02627794|Restora™ steroid eluting MM spacer|restora™ steroid eluting mm spacer
4799085|NCT02627781|acute appendicitis|acute appendicitis
4799086|NCT02627781|Alvarado Score|alvarado score
4799087|NCT02627781|negative appendectomy|negative appendectomy
4799088|NCT02627781|right abdominal pain|right abdominal pain
4799089|NCT02627768|STELARA|stelara
4799090|NCT02627768|Psoriatic Arthritis|psoriatic arthritis
4799091|NCT02627768|Ustekinumab|ustekinumab
4799092|NCT02627755|videolaryngoscopy|videolaryngoscopy
4799093|NCT02627755|difficult airway management|difficult airway management
4799094|NCT02627716|Psychiatric advanced directives|psychiatric advanced directives
4799095|NCT02627716|Joint crisis plan|joint crisis plan
4799096|NCT02627716|Schizophrenia|schizophrenia
4799097|NCT02627716|Primary care|primary care
4799098|NCT02627677|CML|cml
4799099|NCT02627677|CP-CML|cp-cml
4799100|NCT02627677|Leukemia|leukemia
4799101|NCT02627677|Leukemia, Myeloid|leukemia, myeloid
4799102|NCT02627677|Leukemia, Myelogenous, Chronic, BCR-ABL Positive|leukemia, myelogenous, chronic, bcr-abl positive
4799103|NCT02627677|Neoplasms by Histologic Type|neoplasms by histologic type
4799104|NCT02627677|Neoplasms|neoplasms
4799105|NCT02627677|Myeloproliferative Disorders|myeloproliferative disorders
4799106|NCT02627677|Bone Marrow Diseases|bone marrow diseases
4799107|NCT02627677|Hematologic Diseases|hematologic diseases
4799108|NCT02627664|Idiopathic early|idiopathic early
4799109|NCT02627664|Parkinson's Disease|parkinson's disease
4799110|NCT02627638|osteopathy|osteopathy
4799111|NCT02627638|complementary therapy|complementary therapy
4799112|NCT02627638|symptoms in cancer patients|symptoms in cancer patients
4799113|NCT02627625|inhalation|inhalation
4799114|NCT02627625|anticholinergic|anticholinergic
4799115|NCT02627612|veteran|veteran
4799116|NCT02627612|mentorship|mentorship
4799117|NCT02627612|Iraq/Afghanistan|iraq/afghanistan
4799118|NCT02627612|treatment|treatment
4799119|NCT02627612|PTSD|ptsd
4799120|NCT02627612|Suicide|suicide
4799121|NCT02627612|Criminal Activity|criminal activity
4799122|NCT02627599|COPD|copd
4799123|NCT02627599|LTOT|ltot
4799124|NCT02627599|Long-Term Oxygen Therapy|long-term oxygen therapy
4799125|NCT02627599|Oxygen Conserving Device|oxygen conserving device
4799126|NCT02627599|Quality of Life|quality of life
4799127|NCT02627599|Six Minute Walk Distance|six minute walk distance
4799128|NCT02627599|Portable Oxygen Source|portable oxygen source
4799129|NCT02627599|Oxygen Saturation|oxygen saturation
4799130|NCT02627599|Breath Responsive Variable Bolus Oxygen Conserving Device|breath responsive variable bolus oxygen conserving device
4799131|NCT02627599|BRVB-OCD|brvb-ocd
4799132|NCT02627599|Pulse Oximetry|pulse oximetry
4799133|NCT02627586|exercise therapy|exercise therapy
4799134|NCT02627586|left ventricular remodeling|left ventricular remodeling
4799135|NCT02627586|ventricular ejection fraction|ventricular ejection fraction
4799136|NCT02627586|high-intensity interval training|high-intensity interval training
4799137|NCT02627573|Cyclophosphamide|cyclophosphamide
4799138|NCT02627573|Thymoglobulin|thymoglobulin
4799139|NCT02627573|Myelodysplastic Syndromes|myelodysplastic syndromes
4799140|NCT02627573|Immunosuppressive Agents|immunosuppressive agents
4799141|NCT02627573|Immune System Diseases|immune system diseases
4799142|NCT02627573|Busulfan|busulfan
4799143|NCT02627573|Fludarabine|fludarabine
4799144|NCT02627573|Tacrolimus|tacrolimus
4799145|NCT02627573|Mycophenolate mofetil|mycophenolate mofetil
4799146|NCT02627573|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating
4799147|NCT02627573|Myeloablative Agonists|myeloablative agonists
4799148|NCT02627573|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
4799149|NCT02627573|Allogeneic Transplantation|allogeneic transplantation
4799150|NCT02627573|Leukemia, Chronic Myeloid|leukemia, chronic myeloid
4799151|NCT02627573|Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative|leukemia, myeloid, chronic, atypical, bcr-abl negative
4799152|NCT02627560|Administration, topical|administration, topical
4799153|NCT02627560|Tranexamic acid|tranexamic acid
4799154|NCT02627560|Postoperative care|postoperative care
4799155|NCT02627560|Mastectomy|mastectomy
4799156|NCT02627547|Flavanones|flavanones
4799157|NCT02627547|Endurance-trained athletes|endurance-trained athletes
4799158|NCT02627547|Biological availability|biological availability
4799159|NCT02627534|Photodynamic therapy|photodynamic therapy
4799160|NCT02627534|Ultrasonic debridement|ultrasonic debridement
4799161|NCT02627534|Chronic periodontitis|chronic periodontitis
4799162|NCT02627534|Type 2 diabetes|type 2 diabetes
4799163|NCT02627508|Autism Spectrum Disorder|autism spectrum disorder
4799164|NCT02627508|Autism|autism
4799165|NCT02627508|Pregnenolone|pregnenolone
4799166|NCT02627495|maladaptive plasticity|maladaptive plasticity
4799167|NCT02627495|Limb amputation|limb amputation
4799168|NCT02627495|phantom limb pain|phantom limb pain
4799169|NCT02627495|tDCS|tdcs
4799170|NCT02627495|non-invasive brain stimulation|non-invasive brain stimulation
4799171|NCT02627469|Microbiota|microbiota
4799172|NCT02627469|aged|aged
4799173|NCT02627469|oral health|oral health
4799174|NCT02627456|Malaria|malaria
4799175|NCT02627456|Cryopreserved|cryopreserved
4799176|NCT02627456|Infection|infection
4799177|NCT02627456|Human|human
4799178|NCT02627456|Immunization|immunization
4799179|NCT02627417|ITP|itp
4799180|NCT02627417|Dapsone|dapsone
4799181|NCT02627404|Bipolar disorders|bipolar disorders
4799182|NCT02627404|Genetic|genetic
4799183|NCT02627404|Biomarkers|biomarkers
4799184|NCT02627404|Circadian rhythm|circadian rhythm
4799185|NCT02627391|Aortic valve|aortic valve
4799186|NCT02627391|Stenosis|stenosis
4799187|NCT02627391|Surgery|surgery
4799188|NCT02627365|ART|art
4799189|NCT02627365|mobile messaging|mobile messaging
4799190|NCT02627365|behaviour|behaviour
4799191|NCT02627365|motivation|motivation
4799192|NCT02627352|Glaucoma|glaucoma
4799193|NCT02627352|Micropulse Transscleral Cyclophotocoagulation|micropulse transscleral cyclophotocoagulation
4799194|NCT02627352|Intraocular Pressure|intraocular pressure
4799195|NCT02627339|Contrast Sensitivity|contrast sensitivity
4799196|NCT02627326|chlorhexidine|chlorhexidine
4799197|NCT02627326|endodontic treatment|endodontic treatment
4799198|NCT02627313|Feasibility Studies|feasibility studies
4799199|NCT02627300|PID|pid
4799200|NCT02627261|residual disease|residual disease
4799201|NCT02627235|Physical Activity|physical activity
4799202|NCT02627235|Cancer Prevention|cancer prevention
4799203|NCT02627222|Pro-vitamin A|pro-vitamin a
4799204|NCT02627222|Cassava|cassava
4799205|NCT02627222|Vitamin A deficiency|vitamin a deficiency
4799206|NCT02627222|Retinol Isotope Dilution|retinol isotope dilution
4799207|NCT02627222|Preschool children|preschool children
4799208|NCT02627222|Nigeria|nigeria
4799411|NCT02626078|Elderly|elderly
4799209|NCT02627209|Angiotensin converting enzyme|angiotensin converting enzyme
4799210|NCT02627209|Lysozyme|lysozyme
4799211|NCT02627209|Ankylosing spondylitis|ankylosing spondylitis
4799212|NCT02627209|Behcet's disease|behcet's disease
4799213|NCT02627209|Sarcoidosis|sarcoidosis
4799214|NCT02627209|Syphilis|syphilis
4799215|NCT02627209|Tuberculosis|tuberculosis
4799216|NCT02627209|Ocular inflammation|ocular inflammation
4799217|NCT02627196|Heart Failure|heart failure
4799218|NCT02627196|BAROSTIM NEO®|barostim neo®
4799219|NCT02627196|Baroreceptor|baroreceptor
4799220|NCT02627196|Baroreflex|baroreflex
4799221|NCT02627196|Baroreflex Activation Therapy™|baroreflex activation therapy™
4799222|NCT02627196|New York Heart Associate Class III Heart Failure|new york heart associate class iii heart failure
4799223|NCT02627183|Atrial Fibrillation|atrial fibrillation
4799224|NCT02627170|Adults|adults
4799225|NCT02627144|Metastatic renal cell carcinoma|metastatic renal cell carcinoma
4799226|NCT02627144|Avastin|avastin
4799227|NCT02627144|Bevacizumab|bevacizumab
4799228|NCT02627131|Autism|autism
4799229|NCT02627131|Stem Cells|stem cells
4799230|NCT02627105|weight loss|weight loss
4799231|NCT02627066|Exercise|exercise
4799232|NCT02627066|Nutrition|nutrition
4799233|NCT02627066|Hemodialysis|hemodialysis
4799234|NCT02627014|Chronic Migraine|chronic migraine
4799235|NCT02627014|Temporomandibular Disorders|temporomandibular disorders
4799236|NCT02627014|Physical Therapy|physical therapy
4799237|NCT02627014|Manual Therapy|manual therapy
4799238|NCT02627014|Home physical Therapy|home physical therapy
4799239|NCT02626988|Diet Diversity|diet diversity
4799240|NCT02626988|Biodiversity|biodiversity
4799241|NCT02626988|Agrobiodiversity|agrobiodiversity
4799242|NCT02626988|Nutrition|nutrition
4799243|NCT02626988|Vietnam|vietnam
4799244|NCT02626975|knee|knee
4799245|NCT02626975|short hamstring autograft|short hamstring autograft
4799246|NCT02626975|ligament|ligament
4799247|NCT02626975|MRI|mri
4799248|NCT02626962|melanoma|melanoma
4799249|NCT02626949|HIV|hiv
4799250|NCT02626949|AIDS|aids
4799251|NCT02626949|Mindfulness|mindfulness
4799252|NCT02626949|Mindfulness-based stress reduction|mindfulness-based stress reduction
4799253|NCT02626949|Stress|stress
4799254|NCT02626949|Intervention|intervention
4799255|NCT02626949|Inflammation|inflammation
4799256|NCT02626936|Type 1 diabetes|type 1 diabetes
4799257|NCT02626936|Artificial pancreas|artificial pancreas
4799258|NCT02626936|Closed-loop system|closed-loop system
4799259|NCT02626936|Postprandial glucose control|postprandial glucose control
4799260|NCT02626936|Hypoglycemia|hypoglycemia
4799261|NCT02626936|Insulin|insulin
4799262|NCT02626936|Glucagon|glucagon
4799263|NCT02626910|Disability|disability
4799264|NCT02626910|Activity of Daily Living|activity of daily living
4799265|NCT02626910|Patient Satisfaction|patient satisfaction
4799266|NCT02626897|Sarcoidosis|sarcoidosis
4799267|NCT02626897|Daily activity|daily activity
4799268|NCT02626897|Exercise|exercise
4799269|NCT02626897|Accelerometer|accelerometer
4799270|NCT02626845|Granulomatosis with Polyangiitis|granulomatosis with polyangiitis
4799271|NCT02626845|Wegener's Granulomatosis|wegener's granulomatosis
4799272|NCT02626845|GPA|gpa
4799273|NCT02626845|Rituximab|rituximab
4799274|NCT02626845|Rituxan|rituxan
4799275|NCT02626845|ENT GPA|ent gpa
4799276|NCT02626832|vasopressin|vasopressin
4799277|NCT02626832|AVP|avp
4799278|NCT02626832|NMDA|nmda
4799279|NCT02626832|osmolality|osmolality
4799280|NCT02626819|Obesity|obesity
4799281|NCT02626819|Weight Management|weight management
4799282|NCT02626819|Primary Care|primary care
4799283|NCT02626819|Health Coach|health coach
4799284|NCT02626819|iPad|ipad
4799285|NCT02626819|Goal Setting|goal setting
4799286|NCT02626819|5As|5as
4799287|NCT02626819|technology|technology
4799288|NCT02626806|exercise test|exercise test
4799289|NCT02626806|HS -troponin|hs -troponin
4799290|NCT02626806|Coronary artery disease|coronary artery disease
4799291|NCT02626793|Plaque psoriasis|plaque psoriasis
4799292|NCT02626793|Apremilast|apremilast
4799293|NCT02626793|Otezla®|otezla®
4799294|NCT02626793|LAPIS-Pso|lapis-pso
4799295|NCT02626793|Observational|observational
4799296|NCT02626793|CC-10004|cc-10004
4799297|NCT02626793|non-interventional|non-interventional
4799298|NCT02626793|Germany|germany
4799299|NCT02626767|high-intensity interval training|high-intensity interval training
4799300|NCT02626767|adolescents|adolescents
4799301|NCT02626767|school-based exercise|school-based exercise
4799302|NCT02626767|cardiometabolic health|cardiometabolic health
4799303|NCT02626754|Sunitinib, 2/1 schedule, Renal cell carcinoma|sunitinib, 2/1 schedule, renal cell carcinoma
4799304|NCT02626702|immune modulators|immune modulators
4799305|NCT02626702|IVF outcomes|ivf outcomes
4799306|NCT02626702|relationship|relationship
4799307|NCT02626689|Beta-Thalassemia|beta-thalassemia
4799308|NCT02626689|Quality of Life|quality of life
4799309|NCT02626689|Healthcare Utilization|healthcare utilization
4799310|NCT02626689|Transfusion dependent (TD) β-thalassemia|transfusion dependent (td) β-thalassemia
4799311|NCT02626689|Non-transfusion dependent β-thalassemia|non-transfusion dependent β-thalassemia
4799706|NCT02624440|Infection|infection
4799312|NCT02626689|Standard of care|standard of care
4799313|NCT02626689|TransQoL|transqol
4799314|NCT02626689|SF36v2|sf36v2
4799315|NCT02626689|Fact-An|fact-an
4799316|NCT02626689|NTD beta-thalassemia PRO|ntd beta-thalassemia pro
4799317|NCT02626676|renal dialysis, hyperphosphatemia, educational programme|renal dialysis, hyperphosphatemia, educational programme
4799318|NCT02626637|children with cancer|children with cancer
4799319|NCT02626637|fatigue|fatigue
4799320|NCT02626637|physical activity|physical activity
4799321|NCT02626598|facial wrinkles|facial wrinkles
4799322|NCT02626598|photoaging|photoaging
4799323|NCT02626585|rhinoplasty|rhinoplasty
4799324|NCT02626585|postrhinoplasty taping|postrhinoplasty taping
4799325|NCT02626585|edema|edema
4799326|NCT02626585|draping|draping
4799327|NCT02626585|postoperative edema|postoperative edema
4799328|NCT02626585|nasal skin thickness|nasal skin thickness
4799329|NCT02626585|supratip fullness|supratip fullness
4799330|NCT02626585|postoperative swelling|postoperative swelling
4799331|NCT02626533|Cytokines|cytokines
4799332|NCT02626507|ER+/HER2|er+/her2
4799333|NCT02626481|Multiple Myeloma|multiple myeloma
4799334|NCT02626481|Cancer|cancer
4799335|NCT02626481|refractory|refractory
4799336|NCT02626481|daratumumab|daratumumab
4799337|NCT02626455|Clinical trial, Phase III|clinical trial, phase iii
4799338|NCT02626455|Phosphatidylinositol-3-kinase|phosphatidylinositol-3-kinase
4799339|NCT02626455|Non-Hodgkin's lymphoma|non-hodgkin's lymphoma
4799340|NCT02626455|Indolent B-cell non-Hodgkin's lymphoma|indolent b-cell non-hodgkin's lymphoma
4799341|NCT02626442|Cognition|cognition
4799342|NCT02626442|Exercise|exercise
4799343|NCT02626416|Telemedicine|telemedicine
4799344|NCT02626403|vegetative state|vegetative state
4799345|NCT02626403|minimally conscious state|minimally conscious state
4799346|NCT02626403|disorder of consciousness|disorder of consciousness
4799347|NCT02626403|transcranial current direct stimulation|transcranial current direct stimulation
4799348|NCT02626403|non invasive brain stimulation|non invasive brain stimulation
4799349|NCT02626403|neuromodulation|neuromodulation
4799350|NCT02626377|Informal caregivers|informal caregivers
4799351|NCT02626377|Elderly|elderly
4799352|NCT02626377|Quality of life|quality of life
4799353|NCT02626377|Cost effectiveness|cost effectiveness
4799354|NCT02626377|Cohort study|cohort study
4799355|NCT02626377|Randomized study|randomized study
4799356|NCT02626351|postnatal|postnatal
4799357|NCT02626312|Liver Cancer|liver cancer
4799358|NCT02626312|Impaired Liver Function|impaired liver function
4799359|NCT02626312|Liver tumors|liver tumors
4799360|NCT02626312|Hepatocellular carcinoma|hepatocellular carcinoma
4799361|NCT02626312|HCC|hcc
4799362|NCT02626312|Cholangiocarcinoma|cholangiocarcinoma
4799363|NCT02626312|Liver metastases|liver metastases
4799364|NCT02626312|Low functional liver volume|low functional liver volume
4799365|NCT02626312|Radiation therapy|radiation therapy
4799366|NCT02626312|XRT|xrt
4799367|NCT02626312|Chemotherapy|chemotherapy
4799368|NCT02626312|Questionnaire|questionnaire
4799369|NCT02626312|Survey|survey
4799370|NCT02626312|High dose radiotherapy|high dose radiotherapy
4799371|NCT02626299|Preterm birth, very low birth weight|preterm birth, very low birth weight
4799372|NCT02626286|HIV|hiv
4799373|NCT02626286|Men who have sex with men|men who have sex with men
4799374|NCT02626273|obesity|obesity
4799375|NCT02626273|adolescents|adolescents
4799376|NCT02626273|physical activity|physical activity
4799377|NCT02626273|adipocytes|adipocytes
4799378|NCT02626273|osteocytes|osteocytes
4799379|NCT02626273|weight loss|weight loss
4799380|NCT02626273|bone|bone
4799381|NCT02626273|fat|fat
4799382|NCT02626247|elderly|elderly
4799383|NCT02626234|cMET, INC280, rosuvastatin, digoxin|cmet, inc280, rosuvastatin, digoxin
4799384|NCT02626208|Contraceptive vaginal ring|contraceptive vaginal ring
4799385|NCT02626195|malnutrition|malnutrition
4799386|NCT02626195|nutrition|nutrition
4799387|NCT02626195|nutritional support|nutritional support
4799388|NCT02626195|hepatobiliary pancreatic cancer|hepatobiliary pancreatic cancer
4799389|NCT02626195|hepatobiliary pancreatic surgery|hepatobiliary pancreatic surgery
4799390|NCT02626169|15-epi-lipoxin A4|15-epi-lipoxin a4
4799391|NCT02626169|inflammation|inflammation
4799392|NCT02626169|atherosclerosis|atherosclerosis
4799393|NCT02626156|post healed venous leg ulcer|post healed venous leg ulcer
4799394|NCT02626156|posted healed diabetic foot ulcer|posted healed diabetic foot ulcer
4799395|NCT02626130|Kidney Cancer|kidney cancer
4799396|NCT02626130|Tremelimumab|tremelimumab
4799397|NCT02626130|Cryoablation|cryoablation
4799398|NCT02626130|Cryoprobe|cryoprobe
4799399|NCT02626104|lactoferrin|lactoferrin
4799400|NCT02626104|clostridium difficile|clostridium difficile
4799401|NCT02626104|antibiotic associated diarrhoea|antibiotic associated diarrhoea
4799402|NCT02626104|children|children
4799403|NCT02626104|antibiotic therapy|antibiotic therapy
4799404|NCT02626104|diarrhoea|diarrhoea
4799405|NCT02626091|Anastomotic perfusion|anastomotic perfusion
4799406|NCT02626091|ICG Fluorescence|icg fluorescence
4799407|NCT02626091|Enhanced reality|enhanced reality
4799408|NCT02626091|Left-sided colonic resection|left-sided colonic resection
4799409|NCT02626078|Malnutrition|malnutrition
4799410|NCT02626078|Food practices|food practices
4799412|NCT02626078|Nursing Home|nursing home
4799413|NCT02626078|Aging|aging
4799414|NCT02626078|Nutritional status|nutritional status
4799415|NCT02626078|Quality of life|quality of life
4799416|NCT02626065|Melanoma|melanoma
4799417|NCT02626065|Anti-PD1 monoclonal antibodies|anti-pd1 monoclonal antibodies
4799418|NCT02626065|Immune modulation|immune modulation
4799419|NCT02626065|BRAF|braf
4799420|NCT02626052|Skull vibration induced nystagmus test|skull vibration induced nystagmus test
4799421|NCT02626052|mastoid vibration test|mastoid vibration test
4799422|NCT02626039|Metastatic Breast Cancer|metastatic breast cancer
4799423|NCT02626039|CTCs|ctcs
4799424|NCT02626039|cfDNA|cfdna
4799425|NCT02626039|genomics|genomics
4799426|NCT02626039|somatic mutations|somatic mutations
4799427|NCT02626000|Recurrent Metastatic Squamous Cell Carcinoma Head and Neck|recurrent metastatic squamous cell carcinoma head and neck
4799428|NCT02625987|Appendicectomy, wound complications, skin closure|appendicectomy, wound complications, skin closure
4799429|NCT02625961|PD1|pd1
4799430|NCT02625961|PDL1|pdl1
4799431|NCT02625961|PD-L1|pd-l1
4799432|NCT02625961|PD-1|pd-1
4799433|NCT02625948|Intracerebral Hemorrhage|intracerebral hemorrhage
4799434|NCT02625948|tranexamic acid|tranexamic acid
4799435|NCT02625948|spot sign|spot sign
4799436|NCT02625935|Prosigna|prosigna
4799437|NCT02625935|estrogen receptor positive|estrogen receptor positive
4799438|NCT02625935|node negative|node negative
4799439|NCT02625935|HER2 negative|her2 negative
4799440|NCT02625922|Serelaxin,|serelaxin,
4799441|NCT02625922|Chronic heart failure,|chronic heart failure,
4799442|NCT02625922|Spiroergometry,|spiroergometry,
4799443|NCT02625922|Troponin,|troponin,
4799444|NCT02625922|New York Heart Association (NYHA) functional Class II/III,|new york heart association (nyha) functional class ii/iii,
4799445|NCT02625922|Left ventricular ejection fraction,|left ventricular ejection fraction,
4799446|NCT02625896|Aviation|aviation
4799447|NCT02625896|Parachuting|parachuting
4799448|NCT02625883|Resuscitation, quality of life|resuscitation, quality of life
4799449|NCT02625857|Prostatic Neoplasms, Castration-Resistant|prostatic neoplasms, castration-resistant
4799450|NCT02625857|JNJ-64041809|jnj-64041809
4799451|NCT02625857|Listeria monocytogenes|listeria monocytogenes
4799452|NCT02625831|ficolin-3|ficolin-3
4799453|NCT02625831|anti-ficolin-3 antibodies|anti-ficolin-3 antibodies
4799454|NCT02625831|lupus nephritis|lupus nephritis
4799455|NCT02625831|Lupus Erythematosus, Systemic|lupus erythematosus, systemic
4799456|NCT02625831|biomarker|biomarker
4799457|NCT02625818|Emergency Services, Psychiatric|emergency services, psychiatric
4799458|NCT02625818|Prognosis|prognosis
4799459|NCT02625818|Biological markers|biological markers
4799460|NCT02625818|Anxiety|anxiety
4799461|NCT02625818|Panic|panic
4799462|NCT02625818|Psychomotor Agitation|psychomotor agitation
4799463|NCT02625818|Self-injurious Behavior|self-injurious behavior
4799464|NCT02625792|Post ESD ulcer|post esd ulcer
4799465|NCT02625792|Bleeding|bleeding
4799466|NCT02625792|Prophylaxis|prophylaxis
4799467|NCT02625779|Bipolar depression|bipolar depression
4799468|NCT02625779|Cytidine|cytidine
4799469|NCT02625779|Creatine|creatine
4799470|NCT02625779|Magnetic resonance spectroscopy|magnetic resonance spectroscopy
4799471|NCT02625766|Operative vs. Non-operative|operative vs. non-operative
4799472|NCT02625766|LC pelvic fracture|lc pelvic fracture
4799473|NCT02625766|Complications|complications
4799474|NCT02625753|photorefractive keratectomy|photorefractive keratectomy
4799475|NCT02625753|pain|pain
4799476|NCT02625753|analgesia|analgesia
4799477|NCT02625753|opioid|opioid
4799478|NCT02625727|knee osteoarthritis|knee osteoarthritis
4799479|NCT02625727|hyaluronic acid|hyaluronic acid
4799480|NCT02625727|corticosteroid|corticosteroid
4799481|NCT02625727|intra-articular injection|intra-articular injection
4799482|NCT02625727|therapeutic effect|therapeutic effect
4799483|NCT02625701|operative mortality|operative mortality
4799484|NCT02625701|myocardial infarct, arrhythmia, heart failure, stroke|myocardial infarct, arrhythmia, heart failure, stroke
4799485|NCT02625701|pneumonia, atelectasis, acute lung injury|pneumonia, atelectasis, acute lung injury
4799486|NCT02625701|surgical site infection|surgical site infection
4799487|NCT02625701|acute kidney injury|acute kidney injury
4799488|NCT02625701|body weight|body weight
4799489|NCT02625662|muscular dystrophy|muscular dystrophy
4799490|NCT02625662|natural history|natural history
4799491|NCT02625662|genetic profilling|genetic profilling
4799492|NCT02625649|Roux-en-Y gastric bypass|roux-en-y gastric bypass
4799493|NCT02625649|obesity|obesity
4799494|NCT02625649|type 2 diabetes mellitus|type 2 diabetes mellitus
4799495|NCT02625649|diabetic nephropathy|diabetic nephropathy
4799496|NCT02625649|diabetic retinopathy|diabetic retinopathy
4799497|NCT02625623|Avelumab|avelumab
4799498|NCT02625623|Gastric cancer|gastric cancer
4799499|NCT02625623|Gastroesophageal junction adenocarcinoma|gastroesophageal junction adenocarcinoma
4799500|NCT02625610|Avelumab|avelumab
4799501|NCT02625610|Cancer|cancer
4799502|NCT02625610|Unresectable|unresectable
4799503|NCT02625610|Locally advanced|locally advanced
4799504|NCT02625610|Metastatic|metastatic
4799505|NCT02625610|Adenocarcinoma of the stomach|adenocarcinoma of the stomach
4799506|NCT02625610|Gastro-esophageal junction|gastro-esophageal junction
4799507|NCT02625584|Shared Book Reading|shared book reading
4799508|NCT02625584|Dialogic Reading|dialogic reading
4799509|NCT02625584|Language Development|language development
4799510|NCT02625584|Syntax|syntax
4799511|NCT02625584|Vocabulary|vocabulary
4799512|NCT02625584|Young Children|young children
4799513|NCT02625584|Randomised Control Trial|randomised control trial
4799514|NCT02625584|Language Intervention|language intervention
4799515|NCT02625558|riociguat|riociguat
4799516|NCT02625558|saph|saph
4799517|NCT02625558|sarcoidosis|sarcoidosis
4799518|NCT02625558|sarcoidosis associated pulmonary hypertension|sarcoidosis associated pulmonary hypertension
4799519|NCT02625532|Controlled Ovarian stimulation|controlled ovarian stimulation
4799520|NCT02625532|Follicular phase|follicular phase
4799521|NCT02625532|Luteal phase|luteal phase
4799522|NCT02625532|Reproductive Techniques, Assisted|reproductive techniques, assisted
4799523|NCT02625519|Controlled ovarian stimulation|controlled ovarian stimulation
4799524|NCT02625519|Follicle-stimulating hormone|follicle-stimulating hormone
4799525|NCT02625519|Receptor N680S follicle-stimulating hormone receptor (FSHR)|receptor n680s follicle-stimulating hormone receptor (fshr)
4799526|NCT02625519|Gene polymorphism|gene polymorphism
4799527|NCT02625519|Oocyte donors|oocyte donors
4799528|NCT02625493|Percutaneous coronary intervention|percutaneous coronary intervention
4799529|NCT02625493|Patient Preference|patient preference
4799530|NCT02625493|Radial access|radial access
4799531|NCT02625493|Femoral access|femoral access
4799532|NCT02625493|Coronary angiography|coronary angiography
4799533|NCT02625493|Shared decision making|shared decision making
4799534|NCT02625467|Keratoconus|keratoconus
4799535|NCT02625454|Acetaminophen|acetaminophen
4799536|NCT02625454|Labor|labor
4799537|NCT02625454|Intrapartum Fever|intrapartum fever
4799538|NCT02625454|Maternal Fever|maternal fever
4799539|NCT02625454|Fetal Tachycardia|fetal tachycardia
4799540|NCT02625454|Intravenous Acetaminophen|intravenous acetaminophen
4799541|NCT02625441|Breast cancer|breast cancer
4799542|NCT02625441|docetaxel|docetaxel
4799543|NCT02625441|pertuzumab|pertuzumab
4799544|NCT02625441|trastuzumab|trastuzumab
4799545|NCT02625441|HER2|her2
4799546|NCT02625402|decision making|decision making
4799547|NCT02625402|decision aids|decision aids
4799548|NCT02625402|decision quality instruments|decision quality instruments
4799549|NCT02625402|osteoarthritis|osteoarthritis
4799550|NCT02625402|shared decision making|shared decision making
4799551|NCT02625389|scheduled for selective transarterial catheterization|scheduled for selective transarterial catheterization
4799552|NCT02625363|Glycemic Index|glycemic index
4799553|NCT02625363|Water Intake|water intake
4799554|NCT02625363|Glycemic Response|glycemic response
4799555|NCT02625350|instant noodle|instant noodle
4799556|NCT02625350|water content|water content
4799557|NCT02625350|glycemic index|glycemic index
4799558|NCT02625350|serving method|serving method
4799559|NCT02625298|periapical diseases|periapical diseases
4799560|NCT02625298|dental injuries|dental injuries
4799561|NCT02625298|MTA|mta
4799562|NCT02625272|hand-assisted laparoscopic surgery|hand-assisted laparoscopic surgery
4799563|NCT02625272|right colon cancer|right colon cancer
4799564|NCT02625272|complete mesocolic excision|complete mesocolic excision
4799565|NCT02625272|no touch isolation|no touch isolation
4799566|NCT02625272|recurrence|recurrence
4799567|NCT02625272|overall survival|overall survival
4799568|NCT02625259|Drug therapy|drug therapy
4799569|NCT02625246|bronchiectasis|bronchiectasis
4799570|NCT02625246|mesenchymal stem cell|mesenchymal stem cell
4799571|NCT02625246|lung|lung
4799572|NCT02625246|pulmonary|pulmonary
4799573|NCT02625246|interstitial lung disease|interstitial lung disease
4799574|NCT02625207|Maraviroc, CYP3A5, pharmacokinetics, pharmacogenomics|maraviroc, cyp3a5, pharmacokinetics, pharmacogenomics
4799575|NCT02625181|Decision support|decision support
4799576|NCT02625181|Prediction models|prediction models
4799577|NCT02625181|PONV|ponv
4799578|NCT02625181|prophylaxis|prophylaxis
4799579|NCT02625181|Decision Support Systems, Clinical|decision support systems, clinical
4799580|NCT02625181|Decision Support Techniques|decision support techniques
4799581|NCT02625168|Afatinib|afatinib
4799582|NCT02625168|Erlotinib|erlotinib
4799583|NCT02625168|Metastatic non-small cell lung cancer|metastatic non-small cell lung cancer
4799584|NCT02625168|Efficacy|efficacy
4799585|NCT02625168|Safety|safety
4799586|NCT02625155|Pharmacogenomics|pharmacogenomics
4799587|NCT02625155|Urine Drug Testing|urine drug testing
4799588|NCT02625155|antidepressants|antidepressants
4799589|NCT02625155|benzodiazepines|benzodiazepines
4799590|NCT02625155|opioids|opioids
4799591|NCT02625155|muscle relaxants|muscle relaxants
4799592|NCT02625155|non-steroidal anti-inflammatory agents|non-steroidal anti-inflammatory agents
4799593|NCT02625155|TDRAE|tdrae
4799594|NCT02625142|Morning Rounds|morning rounds
4799595|NCT02625142|Patient-centered Care|patient-centered care
4799596|NCT02625142|Hospital Medicine|hospital medicine
4799597|NCT02625142|Pediatrics|pediatrics
4799598|NCT02625142|Hospitals, Pediatric|hospitals, pediatric
4799599|NCT02625116|Cohort|cohort
4799600|NCT02625103|Schizophrenia, Clozapine, TDM, Serum Concentration|schizophrenia, clozapine, tdm, serum concentration
4799601|NCT02625090|Drug-resistance|drug-resistance
4799602|NCT02625090|focal epilepsy|focal epilepsy
4799603|NCT02625090|partial-onset seizures|partial-onset seizures
4799604|NCT02625077|Valvuloplasty|valvuloplasty
4799605|NCT02625077|Fundoplication|fundoplication
4799606|NCT02625077|Acid reflux|acid reflux
4799607|NCT02625077|GERD|gerd
4799608|NCT02625077|Reflux disease|reflux disease
4799609|NCT02625077|Hiatal hernia|hiatal hernia
4799610|NCT02625064|ARDS|ards
4799611|NCT02625064|biomarkers|biomarkers
4799612|NCT02625064|proteomic|proteomic
4799613|NCT02625012|Ultraviolet Therapy|ultraviolet therapy
4799614|NCT02625012|Vitiligo|vitiligo
4799615|NCT02625012|Melanocytes|melanocytes
4799616|NCT02625012|Pigmentation|pigmentation
4799617|NCT02624999|Head and Neck Cancer|head and neck cancer
4799618|NCT02624999|SCCHN|scchn
4799619|NCT02624999|R/M SCCHN|r/m scchn
4799620|NCT02624999|Carcinoma|carcinoma
4799621|NCT02624973|neoadjuvant treatment|neoadjuvant treatment
4799622|NCT02624973|personalized medicine|personalized medicine
4799623|NCT02624947|RSV|rsv
4799624|NCT02624895|"metastatic colorectal cancer gene RAS not mutated WILD TYPE"|"metastatic colorectal cancer gene ras not mutated wild type"
4799625|NCT02624882|blistering distal dactylitis|blistering distal dactylitis
4799626|NCT02624882|Streptococcus pyogenes|streptococcus pyogenes
4799627|NCT02624882|antibiotics|antibiotics
4799628|NCT02624869|Hypercholesterolemia|hypercholesterolemia
4799629|NCT02624869|Elevated Cholesterol|elevated cholesterol
4799630|NCT02624869|High Cholesterol|high cholesterol
4799631|NCT02624869|PCSK9 mutations|pcsk9 mutations
4799632|NCT02624869|Severe Familial Hypercholesterolemia|severe familial hypercholesterolemia
4799633|NCT02624869|evolocumab|evolocumab
4799634|NCT02624869|Repatha|repatha
4799635|NCT02624869|Heterozygous Familial Hypercholesterolemia|heterozygous familial hypercholesterolemia
4799636|NCT02624869|Homozygous Familial Hypercholesterolemia|homozygous familial hypercholesterolemia
4799637|NCT02624869|Pediatric|pediatric
4799638|NCT02624869|Paediatric|paediatric
4799639|NCT02624856|primary total knee arthroplasty|primary total knee arthroplasty
4799640|NCT02624856|liposomal bupivacaine|liposomal bupivacaine
4799641|NCT02624804|Diabetes|diabetes
4799642|NCT02624791|astigmatism, contact lens, driving|astigmatism, contact lens, driving
4799643|NCT02624765|RCT A: Fetal Atrial Flutter without Hydrops|rct a: fetal atrial flutter without hydrops
4799644|NCT02624765|RCT B: Fetal Supraventricular Tachycardia without Hydrops|rct b: fetal supraventricular tachycardia without hydrops
4799645|NCT02624765|RCT C: Fetal Supraventricular Tachycardia with Hydrops|rct c: fetal supraventricular tachycardia with hydrops
4799646|NCT02624752|Oral Nutrition Supplementation|oral nutrition supplementation
4799647|NCT02624726|1st line|1st line
4799648|NCT02624726|FOLFIRI|folfiri
4799649|NCT02624726|Aflibercept|aflibercept
4799650|NCT02624726|mCRC|mcrc
4799651|NCT02624713|eating disorder|eating disorder
4799652|NCT02624713|childhood obesity|childhood obesity
4799653|NCT02624713|family based treatment|family based treatment
4799654|NCT02624700|ER-negative|er-negative
4799655|NCT02624700|PgR-negative|pgr-negative
4799656|NCT02624700|Human epidermal growth factor receptor 2 (HER2-negative)|human epidermal growth factor receptor 2 (her2-negative)
4799657|NCT02624700|Triple Negative Breast Cancer|triple negative breast cancer
4799658|NCT02624700|HER2-negative|her2-negative
4799659|NCT02624661|Trigeminal ganglion|trigeminal ganglion
4799660|NCT02624661|Glycerol|glycerol
4799661|NCT02624661|Nerve block|nerve block
4799662|NCT02624648|Sexual Dysfunction|sexual dysfunction
4799663|NCT02624648|Postmenopausal women|postmenopausal women
4799664|NCT02624648|Sexual desire|sexual desire
4799665|NCT02624635|Manual Therapy|manual therapy
4799666|NCT02624635|Pain|pain
4799667|NCT02624635|Hip|hip
4799668|NCT02624635|Muscle Strength|muscle strength
4799669|NCT02624622|omphalitis|omphalitis
4799670|NCT02624622|neonate|neonate
4799671|NCT02624622|developing countries|developing countries
4799672|NCT02624596|OCD|ocd
4799673|NCT02624583|Fasting|fasting
4799674|NCT02624583|Clopidogrel|clopidogrel
4799675|NCT02624570|AML|aml
4799676|NCT02624570|FLT3|flt3
4799677|NCT02624570|ITD|itd
4799678|NCT02624570|TKD|tkd
4799679|NCT02624570|acute myeloid leukemia|acute myeloid leukemia
4799680|NCT02624570|induction|induction
4799681|NCT02624570|consolidation|consolidation
4799682|NCT02624570|continuation|continuation
4799683|NCT02624570|EAP|eap
4799684|NCT02624570|ETP|etp
4799685|NCT02624570|midostaurin|midostaurin
4799686|NCT02624570|PKC412|pkc412
4799687|NCT02624557|Hepatic impairment|hepatic impairment
4799688|NCT02624557|Healthy volunteers|healthy volunteers
4799689|NCT02624557|Clinical pharmacology study|clinical pharmacology study
4799690|NCT02624557|BYL719|byl719
4799691|NCT02624557|alpelisib|alpelisib
4799692|NCT02624531|NACT|nact
4799693|NCT02624531|Cervical cancer|cervical cancer
4799694|NCT02624531|Fertility sparing|fertility sparing
4799695|NCT02624531|Pregnancy|pregnancy
4799696|NCT02624531|Treatment Strategy|treatment strategy
4799697|NCT02624479|Pharmacokinetics|pharmacokinetics
4799698|NCT02624466|Pediatrics|pediatrics
4799699|NCT02624466|Nephrology|nephrology
4799700|NCT02624466|Dialysis|dialysis
4799701|NCT02624453|cryptococcus|cryptococcus
4799702|NCT02624453|IMMY LFA|immy lfa
4799703|NCT02624453|meningitis|meningitis
4799704|NCT02624453|antigen|antigen
4799705|NCT02624440|Multiple Myeloma|multiple myeloma
4799707|NCT02624440|Clarithromycin|clarithromycin
4799708|NCT02624440|Trimethoprim-Sulfamethoxazole Combination|trimethoprim-sulfamethoxazole combination
4799709|NCT02624427|Glaucoma|glaucoma
4799710|NCT02624427|Intraocular Pressure|intraocular pressure
4799711|NCT02624388|Genistein|genistein
4799712|NCT02624388|Soy|soy
4799713|NCT02624388|Chemotherapy side-effects|chemotherapy side-effects
4799714|NCT02624388|Pediatric Cancer|pediatric cancer
4799715|NCT02624388|Isoflavone|isoflavone
4799716|NCT02624362|Odor|odor
4799717|NCT02624362|trigger|trigger
4799718|NCT02624362|inflammation|inflammation
4799719|NCT02624362|nocebo|nocebo
4799720|NCT02624336|periodontal disease|periodontal disease
4799721|NCT02624336|caries|caries
4799722|NCT02624323|ultrasonography|ultrasonography
4799723|NCT02624323|catheterization|catheterization
4799724|NCT02624323|central line|central line
4799725|NCT02624323|mechanical ventilation|mechanical ventilation
4799726|NCT02624323|intensive care|intensive care
4799727|NCT02624323|axillary vein|axillary vein
4799728|NCT02624323|jugular vein|jugular vein
4799729|NCT02624323|randomization|randomization
4799730|NCT02624297|Coronary artery disease|coronary artery disease
4799731|NCT02624297|Chemoreceptors|chemoreceptors
4799732|NCT02624297|Sympathetic nerve activity|sympathetic nerve activity
4799733|NCT02624297|Exercise|exercise
4799734|NCT02624271|gastric cancer|gastric cancer
4799735|NCT02624271|gastric precancerous lesions|gastric precancerous lesions
4799736|NCT02624271|blood test|blood test
4799737|NCT02624232|Anorectal malformation|anorectal malformation
4799738|NCT02624232|Anorectal atresia|anorectal atresia
4799739|NCT02624232|anorectal stenosis|anorectal stenosis
4799740|NCT02624232|Follow-Up Studies|follow-up studies
4799741|NCT02624219|A/H5N8|a/h5n8
4799742|NCT02624219|AS03|as03
4799743|NCT02624219|Controlled|controlled
4799744|NCT02624219|Double-Blind|double-blind
4799745|NCT02624219|Immunogenicity|immunogenicity
4799746|NCT02624219|Inactivated|inactivated
4799747|NCT02624219|Influenza|influenza
4799748|NCT02624219|MF59|mf59
4799749|NCT02624219|Monovalent|monovalent
4799750|NCT02624219|Randomized|randomized
4799751|NCT02624219|Reactogenicity|reactogenicity
4799752|NCT02624219|Safety|safety
4799753|NCT02624219|Trial|trial
4799754|NCT02624219|Vaccine|vaccine
4799755|NCT02624193|Treatment Adherence|treatment adherence
4799756|NCT02624193|Mental Health|mental health
4799757|NCT02624193|Well-being|well-being
4799758|NCT02624193|Emerging Adults|emerging adults
4799759|NCT02624193|Youth|youth
4799760|NCT02624128|head and neck cancer|head and neck cancer
4799761|NCT02624128|valproic acid|valproic acid
4799762|NCT02624128|recurrent|recurrent
4799763|NCT02624128|metastatic|metastatic
4799764|NCT02624102|Major depressive disorder|major depressive disorder
4799765|NCT02624102|Cognitive behavioral therapy|cognitive behavioral therapy
4799766|NCT02624102|Trial based cognitive therapy|trial based cognitive therapy
4799767|NCT02624102|Behavioral activation|behavioral activation
4799768|NCT02624076|unexplained infertility|unexplained infertility
4799769|NCT02624076|Acupuncture|acupuncture
4799770|NCT02624050|ACEI|acei
4799771|NCT02624050|ARB|arb
4799772|NCT02624050|Hypotension|hypotension
4799773|NCT02624050|General Anesthesia|general anesthesia
4799774|NCT02624050|Methohexital|methohexital
4799775|NCT02624050|Propofol|propofol
4799776|NCT02624037|Inflammatory Bowel Disease, Ulcerative Colitis|inflammatory bowel disease, ulcerative colitis
4799777|NCT02624037|Crohn's Disease|crohn's disease
4799778|NCT02624037|Pharmacokinetics, Individualized Dosage, Dashboard System|pharmacokinetics, individualized dosage, dashboard system
4799779|NCT02624037|Remicade, Infliximab|remicade, infliximab
4799780|NCT02623998|Diabetes|diabetes
4799781|NCT02623998|Insulin|insulin
4799782|NCT02623998|Glargine|glargine
4799783|NCT02623998|Metformin|metformin
4799784|NCT02623998|Sitagliptin|sitagliptin
4799785|NCT02623998|Diet|diet
4799786|NCT02623998|Excercise|excercise
4799787|NCT02623998|Lifestyle|lifestyle
4799788|NCT02623972|inflammatory breast cancer|inflammatory breast cancer
4799789|NCT02623972|Human Epidermal Growth Factor 2 Negative Carcinoma of Breast|human epidermal growth factor 2 negative carcinoma of breast
4799790|NCT02623959|Advanced Cancers|advanced cancers
4799791|NCT02623959|Malignant pleural effusions|malignant pleural effusions
4799793|NCT02623959|Indwelling pleural catheter|indwelling pleural catheter
4799794|NCT02623959|IPC|ipc
4799795|NCT02623959|Questionnaires|questionnaires
4799796|NCT02623959|Surveys|surveys
4799797|NCT02623959|Fentanyl patch|fentanyl patch
4799798|NCT02623959|Fentanyl by vein|fentanyl by vein
4799799|NCT02623959|Sublimaze|sublimaze
4799800|NCT02623959|Doxycycline|doxycycline
4799801|NCT02623959|Vibramycin|vibramycin
4799802|NCT02623959|Periostat|periostat
4799803|NCT02623959|Doryx|doryx
4799804|NCT02623959|:Phone calls|:phone calls
4799805|NCT02623946|motor evoked potentials|motor evoked potentials
4799806|NCT02623933|HDR monotherapy|hdr monotherapy
4799807|NCT02623933|MRI guidance|mri guidance
4799808|NCT02623933|Intraprostatic lesion|intraprostatic lesion
4799809|NCT02623933|dose paining|dose paining
4799810|NCT02623894|Vascular aging.|vascular aging.
4799811|NCT02623894|Arterial stiffness.|arterial stiffness.
4799812|NCT02623894|Lifestyles.|lifestyles.
4799813|NCT02623894|Vascular structure.|vascular structure.
4799814|NCT02623894|Telomere length,|telomere length,
4799815|NCT02623894|Psychological factors.|psychological factors.
4799816|NCT02623894|Inflammatory factors.|inflammatory factors.
4799817|NCT02623894|Oxidative stress|oxidative stress
4799818|NCT02623881|Cervical pessary|cervical pessary
4799819|NCT02623881|Vaginal progesterone|vaginal progesterone
4799820|NCT02623881|Twins|twins
4799821|NCT02623881|Premature birth|premature birth
4799822|NCT02623855|Parks|parks
4799823|NCT02623855|Well-being|well-being
4799824|NCT02623855|Stress|stress
4799825|NCT02623855|Physical Activity|physical activity
4799826|NCT02623855|Nature|nature
4799827|NCT02623855|Greenspace|greenspace
4799828|NCT02623842|urinary incontinence|urinary incontinence
4799829|NCT02623842|woman|woman
4799830|NCT02623842|radiofrequency|radiofrequency
4799831|NCT02623829|scar prophylaxis|scar prophylaxis
4799832|NCT02623829|Botulinum Toxin|botulinum toxin
4799833|NCT02623764|Alzheimer´s disease|alzheimer´s disease
4799834|NCT02623764|Lewy body dementia|lewy body dementia
4799835|NCT02623764|Parkinson dementia|parkinson dementia
4799836|NCT02623764|EEG|eeg
4799837|NCT02623764|Cholinergic index|cholinergic index
4799838|NCT02623725|Dengue Fever|dengue fever
4799839|NCT02623725|Dengue virus|dengue virus
4799840|NCT02623725|Dengue Hemorrhagic Fever|dengue hemorrhagic fever
4799841|NCT02623725|CYD Dengue Vaccine|cyd dengue vaccine
4799842|NCT02623699|IONIS-SOD1Rx|ionis-sod1rx
4799843|NCT02623699|SOD1|sod1
4799844|NCT02623699|ALS|als
4799845|NCT02623686|Sleep|sleep
4799846|NCT02623686|ICU|icu
4799847|NCT02623686|Massage Therapy|massage therapy
4799848|NCT02623686|Inhalation Patch|inhalation patch
4799849|NCT02623660|Inflammation|inflammation
4799850|NCT02623660|Edema|edema
4799851|NCT02623660|Arthroplasty|arthroplasty
4799852|NCT02623660|Rehabilitation|rehabilitation
4799853|NCT02623660|Replacement|replacement
4799854|NCT02623660|Knee|knee
4799855|NCT02623660|Total Knee Replacement|total knee replacement
4799856|NCT02623660|Pain, Postoperative|pain, postoperative
4799857|NCT02623660|Exercise Therapy|exercise therapy
4799858|NCT02623660|Therapeutics|therapeutics
4799859|NCT02623660|Early Ambulation|early ambulation
4799860|NCT02623660|Myofunctional Therapy|myofunctional therapy
4799861|NCT02623660|Electric Stimulation Therapy|electric stimulation therapy
4799862|NCT02623660|Orthopedic Procedures|orthopedic procedures
4799863|NCT02623660|Wound Healing|wound healing
4799864|NCT02623660|Total Knee Arthroplasty|total knee arthroplasty
4799865|NCT02623634|Cuff leak test, relative factors|cuff leak test, relative factors
4799866|NCT02623608|type 2 diabetes risk|type 2 diabetes risk
4799867|NCT02623608|cardiovascular disease risk|cardiovascular disease risk
4799868|NCT02623595|non-small cell lung cancer|non-small cell lung cancer
4799869|NCT02623595|Granulocyte-Macrophage Colony-Stimulating Factor|granulocyte-macrophage colony-stimulating factor
4799870|NCT02623595|Stereotactic body radiotherapy|stereotactic body radiotherapy
4799871|NCT02623595|abscopal effect|abscopal effect
4799872|NCT02623595|safety|safety
4799873|NCT02623595|immunotherapy|immunotherapy
4799874|NCT02623556|diagnosis of tuberculosis|diagnosis of tuberculosis
4799875|NCT02623556|ESAT6-CFP10|esat6-cfp10
4799876|NCT02623556|skin test|skin test
4799877|NCT02623556|diagnostic test|diagnostic test
4799878|NCT02623530|Nursing|nursing
4799879|NCT02623530|Nursing education research|nursing education research
4799880|NCT02623530|Critical thinking|critical thinking
4799881|NCT02623530|Decision Making|decision making
4799882|NCT02623517|CIED|cied
4799883|NCT02623517|AF|af
4799884|NCT02623517|arrhythmia|arrhythmia
4799885|NCT02623517|atrial fibrillation|atrial fibrillation
4799886|NCT02623517|cardiac device|cardiac device
4799887|NCT02623517|pacemaker|pacemaker
4799888|NCT02623517|defibrillator|defibrillator
4799889|NCT02623504|Carbamazepine|carbamazepine
4799890|NCT02623504|Equetro|equetro
4799891|NCT02623504|Bipolar I Disorder|bipolar i disorder
4799892|NCT02623504|Bipolar I Disorder in Children|bipolar i disorder in children
4799893|NCT02623491|JNJ-55375515|jnj-55375515
4799894|NCT02623491|Healthy|healthy
4799895|NCT02623491|Placebo|placebo
4799896|NCT02623439|hematologic malignancies|hematologic malignancies
4799897|NCT02623426|uveitic macular edema|uveitic macular edema
4799898|NCT02623426|uveitis|uveitis
4799899|NCT02623400|preterm birth|preterm birth
4799900|NCT02623400|perinatal stress|perinatal stress
4799901|NCT02623400|growth and development|growth and development
4799902|NCT02623387|paravertebral block|paravertebral block
4799903|NCT02623348|dialysis|dialysis
4799904|NCT02623348|end-stage renal disease|end-stage renal disease
4799905|NCT02623335|patient decision making|patient decision making
4799906|NCT02623335|surgical decision making|surgical decision making
4799907|NCT02623335|question prompt list|question prompt list
4799908|NCT02623335|shared decision making|shared decision making
4799909|NCT02623335|decision support techniques|decision support techniques
4799910|NCT02623257|Non-small Cell Lung Cancer|non-small cell lung cancer
4799911|NCT02623257|circulating tumor DNA|circulating tumor dna
4799912|NCT02623257|amplification refractory mutation system|amplification refractory mutation system
4799913|NCT02623244|ovarian endometrioma|ovarian endometrioma
4799914|NCT02623244|lower urinary tract symptoms|lower urinary tract symptoms
4799915|NCT02623244|sexual dysfunction|sexual dysfunction
4799916|NCT02623244|gastrointestinal symptoms|gastrointestinal symptoms
4799917|NCT02623218|traumatic brain injury|traumatic brain injury
4799918|NCT02623218|acupuncture|acupuncture
4799919|NCT02623218|transcranial doppler ultrasound|transcranial doppler ultrasound
4799920|NCT02623166|Pneumonia|pneumonia
4799921|NCT02623166|Fever|fever
4799922|NCT02623166|Diarrhoea|diarrhoea
4799923|NCT02623140|Coronary drug eluting stents|coronary drug eluting stents
4799924|NCT02623140|Outcomes|outcomes
4799925|NCT02623127|Thymic carcinoma|thymic carcinoma
4799926|NCT02623127|Sunitinib|sunitinib
4799927|NCT02623127|Metastatic|metastatic
4799928|NCT02623127|Recurrent|recurrent
4799929|NCT02623101|Reflectance confocal microscopy|reflectance confocal microscopy
4799930|NCT02623101|Basal cell carcinoma|basal cell carcinoma
4799931|NCT02623101|Biopsy|biopsy
4799932|NCT02623101|Diagnostics|diagnostics
4799933|NCT02623088|Obstructive Sleep Apnea|obstructive sleep apnea
4799934|NCT02623088|Endothelial dysfunction|endothelial dysfunction
4799935|NCT02623088|Arterial stiffness|arterial stiffness
4799936|NCT02623088|PAP therapies|pap therapies
4799937|NCT02623049|New oral anticoagulants|new oral anticoagulants
4799938|NCT02623049|Blood levels|blood levels
4799939|NCT02623049|Octogenarians|octogenarians
4799940|NCT02623036|chronotherapy|chronotherapy
4799941|NCT02623036|angiotensin converting enzyme inhibitors|angiotensin converting enzyme inhibitors
4799942|NCT02623036|ambulatory blood pressure monitoring|ambulatory blood pressure monitoring
4799943|NCT02623010|Primary CNS lymphoma|primary cns lymphoma
4799944|NCT02623010|Ibrutinib|ibrutinib
4799945|NCT02623010|Elderly|elderly
4799946|NCT02623010|Maintenance|maintenance
4799947|NCT02622997|HPV self-sampling|hpv self-sampling
4799948|NCT02622971|phototherapy|phototherapy
4799949|NCT02622971|cryotherapy|cryotherapy
4799950|NCT02622971|exercise|exercise
4799951|NCT02622971|fatigue|fatigue
4799952|NCT02622971|recovery|recovery
4799953|NCT02622958|Social Anxiety Disorder|social anxiety disorder
4799954|NCT02622958|Social Phobia|social phobia
4799955|NCT02622958|Performance Anxiety|performance anxiety
4799956|NCT02622958|Social Anxiety|social anxiety
4799957|NCT02622958|Anxiety|anxiety
4799958|NCT02622906|Gastrointestinal angiodysplasia|gastrointestinal angiodysplasia
4799959|NCT02622906|Pasireotide|pasireotide
4799960|NCT02622906|Gastrointestinal bleeding|gastrointestinal bleeding
4799961|NCT02622867|Lactobacillus plantarum|lactobacillus plantarum
4799962|NCT02622867|Maltodextrin|maltodextrin
4799963|NCT02622867|Probiotics|probiotics
4799964|NCT02622867|Randomized Controlled Trial|randomized controlled trial
4799965|NCT02622854|plasma exchange|plasma exchange
4799966|NCT02622854|hypertriglyceridemia|hypertriglyceridemia
4799967|NCT02622841|First in man|first in man
4799968|NCT02622841|Spinal metastases|spinal metastases
4799969|NCT02622841|Stereotactic bodyradiotherapy|stereotactic bodyradiotherapy
4799970|NCT02622841|Palliative care|palliative care
4799971|NCT02622841|Safety|safety
4799972|NCT02622841|Surgical stabilisation|surgical stabilisation
4799973|NCT02622828|wheelchairs|wheelchairs
4799974|NCT02622828|social participation|social participation
4799975|NCT02622815|Hypercoagulation|hypercoagulation
4799976|NCT02622815|Thrombosis|thrombosis
4799977|NCT02622815|Cancer Risk Assessment|cancer risk assessment
4799978|NCT02622815|Cancer Prognosis|cancer prognosis
4799979|NCT02622802|ex-vivo placenta perfusion|ex-vivo placenta perfusion
4799980|NCT02622802|transplacental transfer|transplacental transfer
4799981|NCT02622802|paracetamol|paracetamol
4799982|NCT02622802|erythromycin|erythromycin
4799983|NCT02622802|azithromycin|azithromycin
4799984|NCT02622789|Spinal alignment|spinal alignment
4799985|NCT02622789|Kinematics|kinematics
4799986|NCT02622789|Pilates|pilates
4799987|NCT02622789|Physical Therapy|physical therapy
4799988|NCT02622763|Tolerogenic Dendritic Cells|tolerogenic dendritic cells
4799989|NCT02622750|triple-branched stent graft|triple-branched stent graft
4799990|NCT02622750|total arch replace|total arch replace
4799991|NCT02622750|the occluded rate of false lumen|the occluded rate of false lumen
4799992|NCT02622737|Parkinson disease|parkinson disease
4799993|NCT02622737|Accidental Falls|accidental falls
4799994|NCT02622737|Exercise therapy|exercise therapy
4799995|NCT02622737|Virtual Reality Exposure Therapy|virtual reality exposure therapy
4799996|NCT02622724|ARDS, human|ards, human
4799997|NCT02622724|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
4799998|NCT02622724|Respiratory Insufficiency|respiratory insufficiency
4799999|NCT02622711|breast cancer|breast cancer
4800000|NCT02622711|obesity|obesity
4800001|NCT02622711|weight control|weight control
4800002|NCT02622711|exercise and physical fitness|exercise and physical fitness
4800003|NCT02622672|Antioxidation|antioxidation
4800004|NCT02622672|Anti-inflammation|anti-inflammation
4800005|NCT02622672|Blood glucose|blood glucose
4800006|NCT02622672|Blood lipids|blood lipids
4800007|NCT02622659|acute upper respiratory infection|acute upper respiratory infection
4800008|NCT02622620|dynamic contrast-enhanced MR imaging|dynamic contrast-enhanced mr imaging
4800113|NCT02622022|randomised|randomised
4800009|NCT02622620|three-dimensional arterial spin labeling|three-dimensional arterial spin labeling
4800010|NCT02622620|diffusion-weighted imaging|diffusion-weighted imaging
4800012|NCT02622607|Prevention|prevention
4800013|NCT02622607|lung cancer|lung cancer
4800014|NCT02622529|Awake craniotomy|awake craniotomy
4800015|NCT02622529|Psychological consequences|psychological consequences
4800016|NCT02622529|Fear and Anxiety|fear and anxiety
4800017|NCT02622516|Rehabilitation|rehabilitation
4800018|NCT02622516|Physical Therapy Specialty|physical therapy specialty
4800019|NCT02622516|Postural Balance|postural balance
4800020|NCT02622516|Vertigo|vertigo
4800021|NCT02622516|Dizziness|dizziness
4800022|NCT02622438|FSHD|fshd
4800023|NCT02622438|Usual care performed at Montpellier hospital|usual care performed at montpellier hospital
4800024|NCT02622438|Muscle function|muscle function
4800025|NCT02622438|Antioxidants|antioxidants
4800026|NCT02622438|Oxidative stress|oxidative stress
4800027|NCT02622438|Quality of life|quality of life
4800028|NCT02622438|Physical activities, development of food-based dietary guidelines|physical activities, development of food-based dietary guidelines
4800029|NCT02622438|Co-morbidity|co-morbidity
4800030|NCT02622425|Carotenoid|carotenoid
4800031|NCT02622425|Bacillus|bacillus
4800032|NCT02622425|Microbiota|microbiota
4800033|NCT02622425|Cardiovascular health|cardiovascular health
4800034|NCT02622412|Quality of Life|quality of life
4800035|NCT02622412|Palliative Therapy|palliative therapy
4800036|NCT02622412|Outpatient Services|outpatient services
4800037|NCT02622386|Psoriasis|psoriasis
4800038|NCT02622373|Pea Pod|pea pod
4800039|NCT02622373|Body composition|body composition
4800040|NCT02622308|Arterial leg ulcers|arterial leg ulcers
4800041|NCT02622308|Intermittent Negative Pressure|intermittent negative pressure
4800042|NCT02622308|Peripheral Circulation|peripheral circulation
4800043|NCT02622308|Wound healing|wound healing
4800044|NCT02622308|Peripheral blood flow|peripheral blood flow
4800045|NCT02622295|metabolism|metabolism
4800046|NCT02622295|glucose|glucose
4800047|NCT02622295|osteoporosis|osteoporosis
4800048|NCT02622295|secondary health conditions|secondary health conditions
4800049|NCT02622295|quality of life|quality of life
4800050|NCT02622295|standing|standing
4800051|NCT02622295|electrical stimulation|electrical stimulation
4800052|NCT02622295|diabetes|diabetes
4800053|NCT02622295|insulin|insulin
4800054|NCT02622295|skeletal muscle|skeletal muscle
4800055|NCT02622282|physical activity|physical activity
4800056|NCT02622282|physical inactivity|physical inactivity
4800057|NCT02622282|PAD|pad
4800058|NCT02622282|Diabetes|diabetes
4800059|NCT02622282|High blood pressure|high blood pressure
4800060|NCT02622282|High cholesterol|high cholesterol
4800061|NCT02622282|Smoking|smoking
4800062|NCT02622269|Urography|urography
4800063|NCT02622269|Radiation dosage|radiation dosage
4800064|NCT02622269|image enhancement|image enhancement
4800065|NCT02622256|Social Media|social media
4800066|NCT02622256|Twitter|twitter
4800067|NCT02622256|Hypertension|hypertension
4800068|NCT02622256|Cardiovascular|cardiovascular
4800069|NCT02622256|CVD|cvd
4800070|NCT02622256|HTN|htn
4800071|NCT02622230|Uygur Medicine|uygur medicine
4800072|NCT02622217|anesthesiology|anesthesiology
4800073|NCT02622217|non technical kills|non technical kills
4800074|NCT02622191|Glaucoma|glaucoma
4800075|NCT02622191|Optical Coherence Tomography|optical coherence tomography
4800076|NCT02622191|Primary Open Angle Glaucoma|primary open angle glaucoma
4800077|NCT02622191|Visual Field|visual field
4800078|NCT02622165|health promotion|health promotion
4800079|NCT02622165|nutrition|nutrition
4800080|NCT02622165|intervention|intervention
4800081|NCT02622165|adolescents|adolescents
4800082|NCT02622165|serious game|serious game
4800083|NCT02622152|Right lateral|right lateral
4800084|NCT02622152|Oxygenation|oxygenation
4800085|NCT02622152|Cardiac|cardiac
4800086|NCT02622152|Congenital|congenital
4800087|NCT02622152|Pediatric|pediatric
4800088|NCT02622152|Postoperative|postoperative
4800089|NCT02622139|Photoacoustics|photoacoustics
4800090|NCT02622139|Optoacoustics|optoacoustics
4800091|NCT02622139|Ultrasound|ultrasound
4800092|NCT02622126|Preloading|preloading
4800093|NCT02622126|Colloid|colloid
4800094|NCT02622126|Cesarean section|cesarean section
4800095|NCT02622126|D-dimer|d-dimer
4800096|NCT02622126|Hypotension|hypotension
4800097|NCT02622113|insulin resistance|insulin resistance
4800098|NCT02622100|Bioresorbable Vascular Scaffold|bioresorbable vascular scaffold
4800099|NCT02622100|Routine Clinical Practice|routine clinical practice
4800100|NCT02622100|Angioplasty, Transluminal, Percutaneous Coronary|angioplasty, transluminal, percutaneous coronary
4800101|NCT02622100|Coronary Artery Disease|coronary artery disease
4800102|NCT02622100|drug eluting stent|drug eluting stent
4800103|NCT02622074|PD1|pd1
4800104|NCT02622074|PD-1|pd-1
4800105|NCT02622074|PDL1|pdl1
4800106|NCT02622074|PD-L1|pd-l1
4800107|NCT02622074|Triple Negative Breast Cancer|triple negative breast cancer
4800108|NCT02622048|Mental Health|mental health
4800109|NCT02622048|Psychosis|psychosis
4800110|NCT02622048|Parent|parent
4800111|NCT02622035|Virtual Reality Technology|virtual reality technology
4800112|NCT02622035|Methodology|methodology
4800114|NCT02622022|placebo controlled|placebo controlled
4800115|NCT02622022|clinical trial|clinical trial
4800116|NCT02622009|stable COPD; bronchoalveolar lavage; biopsy; HRV; RSV|stable copd; bronchoalveolar lavage; biopsy; hrv; rsv
4800117|NCT02621996|Surface Electromyography|surface electromyography
4800118|NCT02621996|Hypotonia|hypotonia
4800119|NCT02621996|Patient Positioning|patient positioning
4800120|NCT02621983|Schizophrenia|schizophrenia
4800121|NCT02621983|Exercise|exercise
4800122|NCT02621983|Cognition|cognition
4800123|NCT02621905|Prophylaxis|prophylaxis
4800124|NCT02621905|Steady-State|steady-state
4800125|NCT02621905|Bioavailability|bioavailability
4800126|NCT02621866|hypertension|hypertension
4800127|NCT02621866|ultraviolet|ultraviolet
4800128|NCT02621853|Steatosis|steatosis
4800129|NCT02621827|vitamin D|vitamin d
4800130|NCT02621827|Africa|africa
4800131|NCT02621814|Infant|infant
4800132|NCT02621814|Growth|growth
4800133|NCT02621814|Body Weight Changes|body weight changes
4800134|NCT02621814|Infant Formula|infant formula
4800135|NCT02621814|Randomized Controlled Trial|randomized controlled trial
4800136|NCT02621788|mind/body medicine|mind/body medicine
4800137|NCT02621788|3RP|3rp
4800138|NCT02621788|stress management|stress management
4800139|NCT02621788|resident burnout|resident burnout
4800140|NCT02621775|Stress management|stress management
4800141|NCT02621775|Cognitive behavioural therapy (CBT)|cognitive behavioural therapy (cbt)
4800142|NCT02621775|Self-help|self-help
4800143|NCT02621775|e-health|e-health
4800144|NCT02621775|Adjustment disorder with anxiety|adjustment disorder with anxiety
4800145|NCT02621736|children|children
4800146|NCT02621736|desmopressin|desmopressin
4800147|NCT02621736|copeptin|copeptin
4800148|NCT02621723|Preventability|preventability
4800149|NCT02621697|dual task|dual task
4800150|NCT02621697|aging|aging
4800151|NCT02621671|Healthy Volunteers|healthy volunteers
4800152|NCT02621658|Colorectal Cancer|colorectal cancer
4800153|NCT02621658|Colonoscopy|colonoscopy
4800154|NCT02621658|Adenoma Detection Rate|adenoma detection rate
4800155|NCT02621658|Bowel Preparation|bowel preparation
4800156|NCT02621658|Time to Cecal Intubation|time to cecal intubation
4800157|NCT02621645|monochorionic|monochorionic
4800158|NCT02621645|TRAP|trap
4800159|NCT02621645|acardiac twin|acardiac twin
4800160|NCT02621632|Compression therapy|compression therapy
4800161|NCT02621619|Older adults|older adults
4800162|NCT02621619|Elderly|elderly
4800163|NCT02621619|Acute pain|acute pain
4800164|NCT02621619|IV acetaminophen|iv acetaminophen
4800165|NCT02621619|IV hydromorphone|iv hydromorphone
4800166|NCT02621619|Analgesia|analgesia
4800167|NCT02621619|Adjunctive analgesia|adjunctive analgesia
4800168|NCT02621593|Meibomian Gland Dysfunction|meibomian gland dysfunction
4800169|NCT02621593|Dry eye symptoms|dry eye symptoms
4800170|NCT02621593|Intense Pulsed Light|intense pulsed light
4800171|NCT02621580|Panretinal Photocoagulation|panretinal photocoagulation
4800172|NCT02621554|Memory|memory
4800173|NCT02621554|Resveratrol|resveratrol
4800174|NCT02621554|elderly|elderly
4800175|NCT02621554|cognition|cognition
4800176|NCT02621541|neuroendocrine tumor|neuroendocrine tumor
4800177|NCT02621541|pancreas|pancreas
4800178|NCT02621541|diagnosis|diagnosis
4800179|NCT02621541|positron emission tomography|positron emission tomography
4800180|NCT02621528|CeraFlex occluder|ceraflex occluder
4800181|NCT02621515|Nivolumab|nivolumab
4800182|NCT02621515|Brain metastasis|brain metastasis
4800183|NCT02621515|Melanoma|melanoma
4800184|NCT02621502|Quinoa|quinoa
4800185|NCT02621502|Satiety|satiety
4800186|NCT02621502|Visual analogue scale|visual analogue scale
4800187|NCT02621502|Cross-over studies|cross-over studies
4800188|NCT02621489|Glucagon-like peptide-1|glucagon-like peptide-1
4800189|NCT02621489|Endothelialization|endothelialization
4800190|NCT02621489|Cardiac Function|cardiac function
4800191|NCT02621489|Exenatide|exenatide
4800192|NCT02621489|Optical Coherence Tomography|optical coherence tomography
4800193|NCT02621450|chronic renal failure|chronic renal failure
4800194|NCT02621450|hypertension|hypertension
4800195|NCT02621450|ampulatory blood pressure|ampulatory blood pressure
4800196|NCT02621437|pain|pain
4800197|NCT02621437|quality of life|quality of life
4800198|NCT02621437|osteopathy|osteopathy
4800199|NCT02621437|oncology|oncology
4800200|NCT02621437|surgery|surgery
4800201|NCT02621437|breast|breast
4800202|NCT02621424|dementia|dementia
4800203|NCT02621424|Mild Cognitive Impairment (MCI)|mild cognitive impairment (mci)
4800204|NCT02621424|RTMS|rtms
4800205|NCT02621424|CVLT|cvlt
4800206|NCT02621411|Substance abuse|substance abuse
4800207|NCT02621411|Emergency operation|emergency operation
4800208|NCT02621411|Preoperative screen|preoperative screen
4800209|NCT02621320|Vitamin D|vitamin d
4800210|NCT02621320|Exercise Performance|exercise performance
4800211|NCT02621320|Wheelchair Athletes|wheelchair athletes
4800212|NCT02621320|Indoor sports|indoor sports
4800213|NCT02621320|Wingate|wingate
4800214|NCT02621320|Isokinetic Dynamometer|isokinetic dynamometer
4800215|NCT02621307|postprandial glycemia|postprandial glycemia
4800216|NCT02621307|subjective appetite|subjective appetite
4800217|NCT02621307|Salba|salba
4800218|NCT02621307|Flax|flax
4800219|NCT02621294|Protein|protein
4800220|NCT02621294|indicator amino acid oxidation method|indicator amino acid oxidation method
4800221|NCT02621294|athletes|athletes
4800222|NCT02621281|hypothermic machine perfusion|hypothermic machine perfusion
4800223|NCT02621281|Kidney Transplantation|kidney transplantation
4800224|NCT02621281|Delayed graft function|delayed graft function
4800225|NCT02621281|perfusion pressure|perfusion pressure
4800226|NCT02621229|Optimal rate of refeeding|optimal rate of refeeding
4800227|NCT02621229|inpatients|inpatients
4800228|NCT02621229|hospitalized|hospitalized
4800229|NCT02621216|percutaneous coronary intervention|percutaneous coronary intervention
4800230|NCT02621190|circulating tumor cells|circulating tumor cells
4800231|NCT02621190|predictive factor|predictive factor
4800232|NCT02621151|combination therapy|combination therapy
4800233|NCT02621151|immunotherapy|immunotherapy
4800234|NCT02621151|immune checkpoint inhibition|immune checkpoint inhibition
4800235|NCT02621099|handheld gamma camera|handheld gamma camera
4800236|NCT02621086|Oligosaccharide, Tolerability,|oligosaccharide, tolerability,
4800237|NCT02621073|lower extremity|lower extremity
4800238|NCT02621073|status-post ORIF|status-post orif
4800239|NCT02621060|Chlorogenic acid|chlorogenic acid
4800240|NCT02621060|Control glucose|control glucose
4800241|NCT02621060|Insulin Secretion|insulin secretion
4800242|NCT02621060|Insulin Sensitivity|insulin sensitivity
4800243|NCT02621047|Healthy volunteer|healthy volunteer
4800244|NCT02621047|Alectinib|alectinib
4800245|NCT02621047|Hepatic impairment|hepatic impairment
4800246|NCT02621034|Root canal treatment|root canal treatment
4800247|NCT02621034|pain|pain
4800248|NCT02621034|endodontic instruments|endodontic instruments
4800249|NCT02621021|Melanoma|melanoma
4800250|NCT02621021|Skin Cancer|skin cancer
4800251|NCT02621021|Immunotherapy|immunotherapy
4800252|NCT02621021|Cell Therapy|cell therapy
4800253|NCT02621008|diabetes|diabetes
4800254|NCT02621008|hypertension|hypertension
4800255|NCT02621008|obesity|obesity
4800256|NCT02621008|mobile phone|mobile phone
4800257|NCT02621008|stress|stress
4800258|NCT02621008|healthy living|healthy living
4800259|NCT02621008|pre-diabetes|pre-diabetes
4800260|NCT02620995|hypertension|hypertension
4800261|NCT02620995|endothelial dysfunction|endothelial dysfunction
4800262|NCT02620995|erectile dysfunction|erectile dysfunction
4800263|NCT02620995|sildenafil|sildenafil
4800264|NCT02620982|Shockwave|shockwave
4800265|NCT02620982|vascular ED|vascular ed
4800266|NCT02620982|Organic ED|organic ed
4800267|NCT02620969|Paediatrics|paediatrics
4800268|NCT02620969|Haemodialysis|haemodialysis
4800269|NCT02620969|Kinetics|kinetics
4800270|NCT02620943|Anemia|anemia
4800271|NCT02620943|Pregnancy Outcome|pregnancy outcome
4800272|NCT02620943|Pregnancy|pregnancy
4800273|NCT02620943|Dietary Diversity|dietary diversity
4800274|NCT02620943|Birth Weight|birth weight
4800275|NCT02620930|Sleep Disorders|sleep disorders
4800276|NCT02620930|Sleep Apnea|sleep apnea
4800277|NCT02620930|Apnea-Hypopnea Index (AHI)|apnea-hypopnea index (ahi)
4800278|NCT02620930|Respiratory Disturbance Index (RDI)|respiratory disturbance index (rdi)
4800279|NCT02620917|type 1 diabetes|type 1 diabetes
4800280|NCT02620917|CSII|csii
4800281|NCT02620904|mifepristone|mifepristone
4800282|NCT02620904|randomized controlled trial|randomized controlled trial
4800283|NCT02620904|vaginal delivery|vaginal delivery
4800284|NCT02620904|progesterone receptor modulator|progesterone receptor modulator
4800285|NCT02620904|induction of labor|induction of labor
4800286|NCT02620891|helium oxygen mixture|helium oxygen mixture
4800287|NCT02620891|Meconium aspiration syndrome|meconium aspiration syndrome
4800288|NCT02620878|Artificial pancreas|artificial pancreas
4800289|NCT02620878|SAP therapy|sap therapy
4800290|NCT02620878|children|children
4800291|NCT02620878|adolescents|adolescents
4800292|NCT02620878|type 1 diabetes|type 1 diabetes
4800293|NCT02620852|Breast screening|breast screening
4800294|NCT02620852|mammography|mammography
4800295|NCT02620852|prevention|prevention
4800296|NCT02620852|risk assessment|risk assessment
4800297|NCT02620852|DCIS|dcis
4800298|NCT02620852|Breast cancer|breast cancer
4800299|NCT02620852|Wisdom|wisdom
4800300|NCT02620839|CDKN2A-p16 Positive|cdkn2a-p16 positive
4800301|NCT02620839|Locally Advanced Solid Neoplasm|locally advanced solid neoplasm
4800302|NCT02620839|Metastatic Malignant Solid Neoplasm|metastatic malignant solid neoplasm
4800303|NCT02620813|acne|acne
4800304|NCT02620813|sebaceous gland|sebaceous gland
4800305|NCT02620813|lipid|lipid
4800306|NCT02620813|sebum|sebum
4800307|NCT02620800|Metastatic Pancreatic Cancer|metastatic pancreatic cancer
4800308|NCT02620800|Adenocarcinoma|adenocarcinoma
4800309|NCT02620800|Open-label|open-label
4800310|NCT02620800|Phase 1/2|phase 1/2
4800311|NCT02620800|Metronomic|metronomic
4800312|NCT02620800|Chemotherapy|chemotherapy
4800313|NCT02620800|ABI-007|abi-007
4800314|NCT02620800|nab-paclitaxel|nab-paclitaxel
4800315|NCT02620800|Abraxane|abraxane
4800316|NCT02620800|gemcitabine|gemcitabine
4800317|NCT02620800|Gemzar|gemzar
4800318|NCT02620800|bevacizumab|bevacizumab
4800319|NCT02620800|Avastin|avastin
4800320|NCT02620800|5-Fluorouracil (5-FU)|5-fluorouracil (5-fu)
4800321|NCT02620800|leucovorin|leucovorin
4800322|NCT02620800|oxaliplatin|oxaliplatin
4800323|NCT02620800|Eloxatin|eloxatin
4800324|NCT02620735|Exercise, health coaching, RCT, telehealth,|exercise, health coaching, rct, telehealth,
4800325|NCT02620722|tourniquet|tourniquet
4800326|NCT02620722|safety|safety
4800327|NCT02620722|personalized|personalized
4800328|NCT02620722|surgery|surgery
4800329|NCT02620709|Native Hawaiians|native hawaiians
4800330|NCT02620709|Community-based participatory research|community-based participatory research
4800331|NCT02620709|Health disparities|health disparities
4800332|NCT02620709|Minority populations|minority populations
4800333|NCT02620709|Chronic disease|chronic disease
4800334|NCT02620683|lidocaine, jaw|lidocaine, jaw
4800335|NCT02620670|Physical Activity|physical activity
4800336|NCT02620670|Glycemic Variability|glycemic variability
4800337|NCT02620644|no retinopathy|no retinopathy
4800338|NCT02620631|Morphine|morphine
4800340|NCT02620631|Pain|pain
4800341|NCT02620631|TKR|tkr
4800342|NCT02620631|Arthroplasty|arthroplasty
4800343|NCT02620618|Safety|safety
4800344|NCT02620618|Efficacy|efficacy
4800345|NCT02620618|intravitreal infliximab|intravitreal infliximab
4800346|NCT02620618|ocular behcets|ocular behcets
4800347|NCT02620618|refractory posterior uveitis|refractory posterior uveitis
4800348|NCT02620605|Cabergoline|cabergoline
4800349|NCT02620605|Ovarian Hyper Stimulation Syndrome (OHSS)|ovarian hyper stimulation syndrome (ohss)
4800350|NCT02620592|Healthy Subject|healthy subject
4800351|NCT02620592|ZYDPLA1|zydpla1
4800352|NCT02620592|DPPIV inhibitor|dppiv inhibitor
4800353|NCT02620592|Pharmacokinetics|pharmacokinetics
4800354|NCT02620592|Safety|safety
4800355|NCT02620579|Personalized Pharmaceutical|personalized pharmaceutical
4800356|NCT02620579|Personalized Education|personalized education
4800357|NCT02620566|caudal block|caudal block
4800358|NCT02620566|local wound infiltration|local wound infiltration
4800359|NCT02620566|hernia repair|hernia repair
4800360|NCT02620553|Type 1 Diabetes|type 1 diabetes
4800361|NCT02620553|Diabetes|diabetes
4800362|NCT02620553|Autoimmune Diabetes|autoimmune diabetes
4800363|NCT02620540|Broselow Tape|broselow tape
4800364|NCT02620540|Weight estimation|weight estimation
4800365|NCT02620540|Patient safety|patient safety
4800366|NCT02620527|Circulating Tumor DNA|circulating tumor dna
4800367|NCT02620527|Cancer|cancer
4800368|NCT02620527|Neoplasms|neoplasms
4800369|NCT02620527|Genomic Testing|genomic testing
4800370|NCT02620527|FoundationOne|foundationone
4800371|NCT02620527|Cell Free DNA|cell free dna
4800372|NCT02620527|ctDNA|ctdna
4800373|NCT02620527|cfDNA|cfdna
4800374|NCT02620514|Digestive Disease and Disorders|digestive disease and disorders
4800375|NCT02620514|Inflammation|inflammation
4800376|NCT02620501|EGD|egd
4800377|NCT02620501|topical lidocaine|topical lidocaine
4800378|NCT02620501|recovery time|recovery time
4800379|NCT02620501|intravenous sedation|intravenous sedation
4800380|NCT02620488|Pain Perception|pain perception
4800381|NCT02620488|Autonomic Nervous System|autonomic nervous system
4800382|NCT02620488|Sickle Cell Disease|sickle cell disease
4800383|NCT02620488|Hypnosis|hypnosis
4800384|NCT02620488|Guided Imagery|guided imagery
4800385|NCT02620462|Postural Balance|postural balance
4800386|NCT02620462|Pain|pain
4800387|NCT02620462|Gait|gait
4800388|NCT02620462|Physical Activity Level|physical activity level
4800389|NCT02620449|phosphorus|phosphorus
4800390|NCT02620449|fibroblast growth factor 23|fibroblast growth factor 23
4800391|NCT02620449|diet|diet
4800392|NCT02620436|Maternal & Child Health|maternal & child health
4800393|NCT02620436|Mother Shelters|mother shelters
4800394|NCT02620436|Maternity Waiting Homes|maternity waiting homes
4800395|NCT02620423|Pancreatic|pancreatic
4800396|NCT02620423|Cancer|cancer
4800397|NCT02620423|REOLYSIN®|reolysin®
4800398|NCT02620423|Chemotherapy|chemotherapy
4800399|NCT02620423|Pembrolizumab|pembrolizumab
4800400|NCT02620423|KEYTRUDA®|keytruda®
4800401|NCT02620423|Pelareorep|pelareorep
4800402|NCT02620423|Reovirus|reovirus
4800403|NCT02620423|Oncolytic virus|oncolytic virus
4800404|NCT02620410|OAB|oab
4800405|NCT02620384|Metolazone|metolazone
4800406|NCT02620384|Heart Failure|heart failure
4800407|NCT02620358|Mechanical Ventilation|mechanical ventilation
4800408|NCT02620358|Weaning|weaning
4800409|NCT02620345|Fibroids|fibroids
4800410|NCT02620319|bronchoscopy|bronchoscopy
4800411|NCT02620319|polydioxanone|polydioxanone
4800412|NCT02620319|absorbable implants|absorbable implants
4800413|NCT02620319|stents|stents
4800414|NCT02620280|Triple Negative Breast Cancer|triple negative breast cancer
4800415|NCT02620267|Mismatch Negativity|mismatch negativity
4800416|NCT02620267|Transcranial Direct Current Stimulation|transcranial direct current stimulation
4800417|NCT02620267|MMN|mmn
4800418|NCT02620267|tDCS|tdcs
4800419|NCT02620254|mastocytosis|mastocytosis
4800420|NCT02620254|cutaneous mastocytosis|cutaneous mastocytosis
4800421|NCT02620254|urticaria pigmentosa|urticaria pigmentosa
4800422|NCT02620254|telangiectasia macularis eruptiva perstans (TMEP)|telangiectasia macularis eruptiva perstans (tmep)
4800423|NCT02620254|diffuse cutaneous mastocytosis|diffuse cutaneous mastocytosis
4800424|NCT02620254|solitary cutaneous mastocytosis|solitary cutaneous mastocytosis
4800425|NCT02620254|systemic mastocytosis|systemic mastocytosis
4800426|NCT02620254|indolent systemic mastocytosis|indolent systemic mastocytosis
4800427|NCT02620254|smoldering systemic mastocytosis|smoldering systemic mastocytosis
4800428|NCT02620254|aggressive systemic mastocytosis|aggressive systemic mastocytosis
4800429|NCT02620254|systemic mastocytosis with associated clonal hematologic non-mast cell lineage disease|systemic mastocytosis with associated clonal hematologic non-mast cell lineage disease
4800430|NCT02620254|mast cell leukemia|mast cell leukemia
4800431|NCT02620241|gastro-oesophageal reflux|gastro-oesophageal reflux
4800432|NCT02620241|intrapulmonary percussive ventilation|intrapulmonary percussive ventilation
4800433|NCT02620241|positioning|positioning
4800434|NCT02620228|Bioimpedance|bioimpedance
4800435|NCT02620228|Biopsy|biopsy
4800436|NCT02620228|Liver tumour|liver tumour
4800437|NCT02620228|Biopsy needle guidance|biopsy needle guidance
4800438|NCT02620202|Troponin|troponin
4800439|NCT02620202|Myocardial infarction|myocardial infarction
4800440|NCT02620150|HIV|hiv
4800441|NCT02620150|AIDS|aids
4800442|NCT02620150|Depression|depression
4800443|NCT02620150|SSRI|ssri
4800444|NCT02620150|Escitalopram|escitalopram
4800445|NCT02620150|Immunity|immunity
4800446|NCT02620085|Graves' disease|graves' disease
4800447|NCT02620085|Hyperthyroidism|hyperthyroidism
4800448|NCT02620085|Personality traits|personality traits
4800449|NCT02620072|Type 1 diabetes|type 1 diabetes
4800450|NCT02620072|T1D|t1d
4800451|NCT02620072|diabetes mellitus|diabetes mellitus
4800452|NCT02620072|oral insulin|oral insulin
4800453|NCT02620072|oral tolerance|oral tolerance
4800454|NCT02620072|autoantigen|autoantigen
4800455|NCT02620072|self tolerance|self tolerance
4800456|NCT02620072|prevention|prevention
4800457|NCT02620072|at risk for developing type 1 diabetes|at risk for developing type 1 diabetes
4800458|NCT02620072|juvenile diabetes|juvenile diabetes
4800459|NCT02620072|dysglycemia|dysglycemia
4800460|NCT02620059|Postpartum Period|postpartum period
4800461|NCT02620046|Drug therapy|drug therapy
4800462|NCT02620033|Prostatectomy|prostatectomy
4800463|NCT02620033|Yoga therapy|yoga therapy
4800464|NCT02620033|Health related quality of life|health related quality of life
4800465|NCT02620007|Adult|adult
4800466|NCT02620007|AIEC|aiec
4800467|NCT02619994|MDR tuberculosis|mdr tuberculosis
4800468|NCT02619994|linezolid|linezolid
4800469|NCT02619994|delamanid|delamanid
4800470|NCT02619994|Korea|korea
4800471|NCT02619968|Chronic renal failure|chronic renal failure
4800472|NCT02619968|Arteriovenous fistula|arteriovenous fistula
4800473|NCT02619968|Isometric exercises|isometric exercises
4800474|NCT02619968|Vascular endothelium|vascular endothelium
4800475|NCT02619955|hepcidin deficiency|hepcidin deficiency
4800476|NCT02619955|genetic|genetic
4800477|NCT02619955|except C282Y Homozygosity|except c282y homozygosity
4800478|NCT02619942|Right colon cancer, Survival, Laparoscopic surgery|right colon cancer, survival, laparoscopic surgery
4800479|NCT02619929|Oral Vinorelbine|oral vinorelbine
4800480|NCT02619929|Advanced Non-Small-Cell Lung Cancer|advanced non-small-cell lung cancer
4800481|NCT02619929|Metastatic Breast Cancer|metastatic breast cancer
4800482|NCT02619916|Cancer|cancer
4800483|NCT02619916|Depression|depression
4800484|NCT02619916|MBCT|mbct
4800485|NCT02619916|CBT|cbt
4800486|NCT02619890|Adult Glioma|adult glioma
4800487|NCT02619890|MRI|mri
4800488|NCT02619838|Double Arthrodesis|double arthrodesis
4800489|NCT02619838|Triple Arthrodesis|triple arthrodesis
4800490|NCT02619838|Subtalar Arthrodesis|subtalar arthrodesis
4800491|NCT02619825|Child|child
4800492|NCT02619799|magnesium sulphate|magnesium sulphate
4800493|NCT02619799|intrathecal route|intrathecal route
4800494|NCT02619799|midazolam|midazolam
4800495|NCT02619773|Colorectal Surgery|colorectal surgery
4800496|NCT02619760|Percutaneous Coronary Intervention|percutaneous coronary intervention
4800497|NCT02619760|Platelet Aggregation Inhibitors|platelet aggregation inhibitors
4800498|NCT02619747|pH monitoring|ph monitoring
4800499|NCT02619734|Cell Therapy|cell therapy
4800500|NCT02619734|Sickle cell disease|sickle cell disease
4800501|NCT02619734|Autologous implantation|autologous implantation
4800502|NCT02619734|Mesenchymal stromal cell|mesenchymal stromal cell
4800503|NCT02619734|Edothelial Progenitor cell|edothelial progenitor cell
4800504|NCT02619721|PINS SNS OAB|pins sns oab
4800505|NCT02619708|immersive preoperative experience|immersive preoperative experience
4800506|NCT02619695|ketoprofen|ketoprofen
4800507|NCT02619695|gel|gel
4800508|NCT02619695|low back pain|low back pain
4800509|NCT02619695|emergency department|emergency department
4800510|NCT02619669|Neoadjuvant|neoadjuvant
4800511|NCT02619669|TAK-228 (MLN0128)|tak-228 (mln0128)
4800512|NCT02619669|Letrozole|letrozole
4800513|NCT02619669|ER+|er+
4800514|NCT02619669|HER2-|her2-
4800515|NCT02619656|PEG|peg
4800516|NCT02619656|CO2 insufflation|co2 insufflation
4800517|NCT02619656|Room Air insufflation|room air insufflation
4800518|NCT02619656|pneumoperitoneum|pneumoperitoneum
4800519|NCT02619617|Cluster Headache|cluster headache
4800520|NCT02619617|Patient Diary collection of headache pain|patient diary collection of headache pain
4800521|NCT02619578|Transcutaneous electric acupoint stimulation (TEAS)|transcutaneous electric acupoint stimulation (teas)
4801116|NCT02615522|primary TKR|primary tkr
4800522|NCT02619578|gynecological laparoscopic surgery|gynecological laparoscopic surgery
4800523|NCT02619578|QoQ-40|qoq-40
4800524|NCT02619578|MMSE|mmse
4800525|NCT02619578|VAS|vas
4800526|NCT02619565|Myelodysplastic syndromes|myelodysplastic syndromes
4800527|NCT02619565|mutations|mutations
4800528|NCT02619565|overall survival|overall survival
4800529|NCT02619565|prognosis|prognosis
4800530|NCT02619513|Paravertebral Blocks|paravertebral blocks
4800531|NCT02619513|Dexmedetomidine|dexmedetomidine
4800532|NCT02619513|Analgesia|analgesia
4800533|NCT02619513|Inflammatory response|inflammatory response
4800534|NCT02619513|Thoracotomy|thoracotomy
4800535|NCT02619474|Parent Satisfaction|parent satisfaction
4800536|NCT02619474|Patient Satisfaction|patient satisfaction
4800537|NCT02619474|Whiteboard|whiteboard
4800538|NCT02619474|Communication|communication
4800539|NCT02619448|inoperable|inoperable
4800540|NCT02619448|Solitary [T1bN0, T2aN0, T2bN0] lesion measuring 2-7 cm|solitary [t1bn0, t2an0, t2bn0] lesion measuring 2-7 cm
4800541|NCT02619435|RAS-mutant|ras-mutant
4800542|NCT02619422|Cardiac rehabilitation programs|cardiac rehabilitation programs
4800543|NCT02619422|Adherence to secondary preventive measures|adherence to secondary preventive measures
4800544|NCT02619422|Acute coronary syndrome|acute coronary syndrome
4800545|NCT02619422|More intensive cardiac rehabilitation program in less time|more intensive cardiac rehabilitation program in less time
4800546|NCT02619396|radiofrequency power|radiofrequency power
4800547|NCT02619396|lesion size index|lesion size index
4800548|NCT02619396|esophageal temperature alerts|esophageal temperature alerts
4800549|NCT02619383|HBOT|hbot
4800550|NCT02619383|hyperbaric oxygen|hyperbaric oxygen
4800552|NCT02619383|ED|ed
4800553|NCT02619383|erectile dysfunction|erectile dysfunction
4800554|NCT02619370|advance care planning|advance care planning
4800555|NCT02619370|advance directive|advance directive
4800556|NCT02619370|caregiving|caregiving
4800557|NCT02619357|Asthma|asthma
4800558|NCT02619357|wearable physical activity monitor|wearable physical activity monitor
4800559|NCT02619357|step counts|step counts
4800560|NCT02619357|Exercise|exercise
4800561|NCT02619357|energy expenditure|energy expenditure
4800562|NCT02619357|COPD|copd
4800563|NCT02619357|indirect calorimetry|indirect calorimetry
4800564|NCT02619318|Balancing Everyday Life (BEL)|balancing everyday life (bel)
4800565|NCT02619318|activity-based lifestyle intervention|activity-based lifestyle intervention
4800566|NCT02619318|standard occupational therapy|standard occupational therapy
4800567|NCT02619292|cancer survivor|cancer survivor
4800568|NCT02619292|immune function|immune function
4800569|NCT02619266|Cancer Anorexia Cachexia Syndrome|cancer anorexia cachexia syndrome
4800570|NCT02619266|Acupuncture|acupuncture
4800571|NCT02619266|Megestrol acetate|megestrol acetate
4800572|NCT02619266|Poor Appetite|poor appetite
4800573|NCT02619266|Anorexia|anorexia
4800574|NCT02619266|Randomized Controlled Trial|randomized controlled trial
4800575|NCT02619253|Immunotherapy|immunotherapy
4800576|NCT02619253|Safety|safety
4800577|NCT02619253|Pharmacodynamics|pharmacodynamics
4800578|NCT02619253|Efficacy|efficacy
4800579|NCT02619214|Oxidative Stress|oxidative stress
4800580|NCT02619214|Oxygen|oxygen
4800581|NCT02619214|General Anesthesia|general anesthesia
4800582|NCT02619201|vomiting in children|vomiting in children
4800583|NCT02619201|ondansetron|ondansetron
4800584|NCT02619201|metoclopramide|metoclopramide
4800585|NCT02619201|antiemetics|antiemetics
4800586|NCT02619188|Nutrition|nutrition
4800587|NCT02619188|Hyperemesis gravidarum|hyperemesis gravidarum
4800588|NCT02619188|Prealbumin|prealbumin
4800589|NCT02619188|Questionnaire|questionnaire
4800590|NCT02619162|breast cancer non metastatic|breast cancer non metastatic
4800591|NCT02619162|adjuvant letrozole|adjuvant letrozole
4800592|NCT02619162|Nintedanib BIFF1120|nintedanib biff1120
4800593|NCT02619136|Blood Transfusion|blood transfusion
4800594|NCT02619123|breast density|breast density
4800595|NCT02619123|breast cancer|breast cancer
4800596|NCT02619123|risk-based screening|risk-based screening
4800597|NCT02619123|Tailored breast cancer screening|tailored breast cancer screening
4800598|NCT02619123|premenopausal women|premenopausal women
4800599|NCT02619110|Chronic Stroke|chronic stroke
4800600|NCT02619110|cardiopulmonary|cardiopulmonary
4800601|NCT02619110|Berg Balance Scale (BBS)|berg balance scale (bbs)
4800602|NCT02619084|Tourette Syndrome|tourette syndrome
4800603|NCT02619084|Subthalamic Nucleus|subthalamic nucleus
4800604|NCT02619084|STN|stn
4800605|NCT02619084|Deep Brain Stimulation|deep brain stimulation
4800606|NCT02619084|DBS|dbs
4800607|NCT02619084|Tic|tic
4800608|NCT02619084|Obsessive-compulsive disorders|obsessive-compulsive disorders
4800609|NCT02619071|acute myeloid leukemia- refractory AML- relapsed AML- precision medecine-|acute myeloid leukemia- refractory aml- relapsed aml- precision medecine-
4800610|NCT02619058|NKT|nkt
4800611|NCT02619058|metastatic melanoma|metastatic melanoma
4800612|NCT02619032|remifentanil|remifentanil
4800613|NCT02619032|fentanyl|fentanyl
4800614|NCT02619032|dental surgery|dental surgery
4800615|NCT02619006|Anemia, Iron-Deficiency|anemia, iron-deficiency
4800616|NCT02619006|Myelination|myelination
4800617|NCT02619006|Ferritin|ferritin
4800618|NCT02619006|Umbilical cord clamping|umbilical cord clamping
4800619|NCT02619006|Umbilical Cord Milking|umbilical cord milking
4800620|NCT02619006|Placental Transfusion|placental transfusion
4800621|NCT02619006|Brain Development|brain development
4800622|NCT02618993|mandibular nerve block|mandibular nerve block
4800623|NCT02618993|mandibular osteotomy|mandibular osteotomy
4800624|NCT02618980|acute coronary syndrome|acute coronary syndrome
4800625|NCT02618980|gastrointestinal bleeding|gastrointestinal bleeding
4800626|NCT02618980|endoscopy|endoscopy
4800627|NCT02618967|Lupus|lupus
4800628|NCT02618967|Healthy Volunteer|healthy volunteer
4800629|NCT02618967|Safety Study|safety study
4800630|NCT02618967|Placebo Control|placebo control
4800631|NCT02618967|Phase 1|phase 1
4800632|NCT02618954|Rheumatoid arthritis|rheumatoid arthritis
4800633|NCT02618954|Articular ultrasound|articular ultrasound
4800634|NCT02618954|Synovitis|synovitis
4800635|NCT02618954|Relapse risk|relapse risk
4800636|NCT02618928|HCV|hcv
4800637|NCT02618928|Chronic Hepatitis C|chronic hepatitis c
4800638|NCT02618915|gene therapy|gene therapy
4800639|NCT02618915|Hemophilia B|hemophilia b
4800640|NCT02618902|patient safety|patient safety
4800641|NCT02618902|tolerogenic dendritic cells|tolerogenic dendritic cells
4800642|NCT02618902|tolDC|toldc
4800643|NCT02618850|metabolic response|metabolic response
4800644|NCT02618850|chemotherapy|chemotherapy
4800645|NCT02618850|PET|pet
4800646|NCT02618837|NSTEMI|nstemi
4800647|NCT02618837|NSTEACS|nsteacs
4800648|NCT02618837|prasugrel|prasugrel
4800649|NCT02618837|ticagrelor|ticagrelor
4800650|NCT02618837|Downstream versus Upstream strategy|downstream versus upstream strategy
4800651|NCT02618811|sarcopenia|sarcopenia
4800652|NCT02618811|myosteatosis|myosteatosis
4800653|NCT02618811|enhanced recovery after surgery|enhanced recovery after surgery
4800654|NCT02618811|colorectal cancer|colorectal cancer
4800655|NCT02618811|minimally invasive surgery|minimally invasive surgery
4800656|NCT02618811|complications|complications
4800657|NCT02618798|chronic liver disease|chronic liver disease
4800658|NCT02618798|CLD|cld
4800659|NCT02618798|platelet function|platelet function
4800660|NCT02618785|Hysterosalpingography|hysterosalpingography
4800661|NCT02618785|antispasmodic drug|antispasmodic drug
4800662|NCT02618785|infertile women|infertile women
4800663|NCT02618772|Pediatrics|pediatrics
4800664|NCT02618772|Laceration|laceration
4800665|NCT02618772|Anxiety|anxiety
4800666|NCT02618772|Anti-Anxiety Agents|anti-anxiety agents
4800667|NCT02618746|Telemonitoring|telemonitoring
4800668|NCT02618746|Home Rehabilitation|home rehabilitation
4800669|NCT02618746|Exacerbations|exacerbations
4800670|NCT02618746|Physical Activity|physical activity
4800671|NCT02618746|COPD|copd
4800672|NCT02618720|Antimicrobial prophylaxis|antimicrobial prophylaxis
4800673|NCT02618720|Colorectal surgery|colorectal surgery
4800674|NCT02618720|Surgical Site Infection|surgical site infection
4800675|NCT02618720|Postoperative morbidity|postoperative morbidity
4800676|NCT02618707|Lactate|lactate
4800677|NCT02618707|Congenital cardiac defect|congenital cardiac defect
4800679|NCT02618707|Pediatric|pediatric
4800680|NCT02618694|adrenal|adrenal
4800681|NCT02618694|supra-renal|supra-renal
4800682|NCT02618694|adrenalectomy|adrenalectomy
4800683|NCT02618694|retroperitoneoscopy|retroperitoneoscopy
4800684|NCT02618694|posterior retroperitoneoscopy|posterior retroperitoneoscopy
4800685|NCT02618694|Laparoscopic adrenalectomy|laparoscopic adrenalectomy
4800686|NCT02618681|earlobe crease|earlobe crease
4800687|NCT02618681|acute myocardial infarction|acute myocardial infarction
4800688|NCT02618655|TBDs；diagnosis|tbds；diagnosis
4800689|NCT02618642|muscle contraction|muscle contraction
4800690|NCT02618642|electrodiagnostic|electrodiagnostic
4800691|NCT02618642|i/t curve|i/t curve
4800692|NCT02618603|Stroke|stroke
4800693|NCT02618603|Should pain|should pain
4800694|NCT02618603|Botulinum Toxin|botulinum toxin
4800695|NCT02618590|non-small cell lung cancer|non-small cell lung cancer
4800696|NCT02618590|EGFR mutant type|egfr mutant type
4800697|NCT02618590|first/second line EGFR-TKI|first/second line egfr-tki
4800698|NCT02618577|Anticoagulation|anticoagulation
4800699|NCT02618577|atrial high rate episodes|atrial high rate episodes
4800700|NCT02618577|Atrial Fibrillation|atrial fibrillation
4800701|NCT02618577|VKA|vka
4800702|NCT02618577|NOAC|noac
4800703|NCT02618551|Thermoplasty|thermoplasty
4800704|NCT02618551|Severe asthma|severe asthma
4800705|NCT02618551|Dynamic hyperinflation|dynamic hyperinflation
4800706|NCT02618499|birth|birth
4800707|NCT02618499|oxytocin|oxytocin
4800708|NCT02618499|placental transfusion|placental transfusion
4800709|NCT02618499|umbilical cord clamping|umbilical cord clamping
4800710|NCT02618473|Coronary computed tomography angiography|coronary computed tomography angiography
4800711|NCT02618473|motion artifacts|motion artifacts
4800712|NCT02618473|motion correction algorithm|motion correction algorithm
4800713|NCT02618473|diagnostic utility|diagnostic utility
4800714|NCT02618460|Non-contrast enhanced MRI|non-contrast enhanced mri
4800715|NCT02618460|healthy volunteers|healthy volunteers
4800716|NCT02618460|renal diffusion|renal diffusion
4800717|NCT02618460|renal perfusion|renal perfusion
4800718|NCT02618369|High Intensity Focused Ultrasound|high intensity focused ultrasound
4800719|NCT02618317|renal dialysis|renal dialysis
4800720|NCT02618304|Meibomian gland dysfunction|meibomian gland dysfunction
4800721|NCT02618304|Lipiview|lipiview
4800722|NCT02618304|Tear Lipid Layer|tear lipid layer
4800723|NCT02618291|primary health care|primary health care
4800724|NCT02618265|stroke|stroke
4800725|NCT02618265|secondary prevention|secondary prevention
4800726|NCT02618265|platelet response polymorphism|platelet response polymorphism
4800727|NCT02618265|mobile terminal|mobile terminal
4800728|NCT02618252|difficult IV access|difficult iv access
4800729|NCT02618252|ultrasound|ultrasound
4800730|NCT02618252|veinviewer|veinviewer
4800731|NCT02618252|near infrared device|near infrared device
4800732|NCT02618239|intestinal gas|intestinal gas
4800733|NCT02618239|Healthy subjects|healthy subjects
4800734|NCT02618239|microbiota|microbiota
4800735|NCT02618239|prebiotics|prebiotics
4800736|NCT02618226|Traumatic Brain Injury|traumatic brain injury
4800737|NCT02618226|TBI|tbi
4800738|NCT02618226|Optic nerve ultrasound|optic nerve ultrasound
4800739|NCT02618226|ONUS|onus
4800740|NCT02618226|Intracranial pressure|intracranial pressure
4800741|NCT02618226|ICP|icp
4800742|NCT02618226|Intracranial hypertension|intracranial hypertension
4800743|NCT02618213|Continuous Positive Airway Pressure|continuous positive airway pressure
4800744|NCT02618213|High Flow Oxygenation therapy|high flow oxygenation therapy
4800745|NCT02618213|Bronchiolitis|bronchiolitis
4800746|NCT02618213|Children|children
4800747|NCT02618200|Prostate cancer|prostate cancer
4800748|NCT02618200|Computer-Aided Diagnosis|computer-aided diagnosis
4800749|NCT02618161|EBRT and HDR Brachytherapy|ebrt and hdr brachytherapy
4800750|NCT02618109|B acute lymphoblastic leukemia|b acute lymphoblastic leukemia
4800751|NCT02618109|leukemia relapse|leukemia relapse
4800752|NCT02618109|pediatric onco-hematology|pediatric onco-hematology
4800753|NCT02618096|membrane sweeping|membrane sweeping
4800754|NCT02618096|dinoprostone|dinoprostone
4800755|NCT02618096|multiparas|multiparas
4800756|NCT02618096|labor induction|labor induction
4800757|NCT02618096|cesarean delivery|cesarean delivery
4800758|NCT02618044|Gastroesophageal reflux|gastroesophageal reflux
4800759|NCT02618044|Obesity|obesity
4800760|NCT02618044|Esophageal manometry|esophageal manometry
4800761|NCT02618044|24 H impedance pH-monitoring|24 h impedance ph-monitoring
4800762|NCT02618044|Laparoscopic Roux-en-Y Gastric Bypass|laparoscopic roux-en-y gastric bypass
4800763|NCT02618031|capillary index score|capillary index score
4800764|NCT02618031|acute ischemic stroke|acute ischemic stroke
4800765|NCT02618031|collateral circulation|collateral circulation
4800766|NCT02618031|cerebral ischemia|cerebral ischemia
4800767|NCT02618031|diagnostic imaging|diagnostic imaging
4800768|NCT02618018|astigmatism|astigmatism
4800769|NCT02618018|toric intraocular lens|toric intraocular lens
4800770|NCT02618005|Astronauts|astronauts
4800771|NCT02618005|Probiotics|probiotics
4800772|NCT02618005|Immune function|immune function
4800773|NCT02618005|Intestinal microbiota|intestinal microbiota
4800774|NCT02617966|Retina|retina
4800775|NCT02617966|Retinal Degeneration|retinal degeneration
4800776|NCT02617966|Retinitis Pigmentosa|retinitis pigmentosa
4800777|NCT02617966|Stargardt's Disease|stargardt's disease
4800778|NCT02617966|Dark Adaptation|dark adaptation
4800779|NCT02617953|Tinnitus|tinnitus
4800780|NCT02617953|EEG|eeg
4800781|NCT02617953|ERP|erp
4800782|NCT02617940|dental caries|dental caries
4800783|NCT02617940|primary tooth|primary tooth
4800784|NCT02617940|resin-based sealants|resin-based sealants
4800785|NCT02617914|ARDS|ards
4800786|NCT02617914|PEEP|peep
4800787|NCT02617914|ECMO|ecmo
4800788|NCT02617901|Bone age|bone age
4800789|NCT02617901|Greulich & Pyle|greulich & pyle
4800790|NCT02617901|TW3|tw3
4800791|NCT02617901|Radiography|radiography
4800792|NCT02617901|Dual energy x-ray absorptiometry|dual energy x-ray absorptiometry
4800793|NCT02617888|radiation|radiation
4800794|NCT02617888|cardiac computed tomography|cardiac computed tomography
4800795|NCT02617888|CCTA|ccta
4800796|NCT02617888|breast shielding|breast shielding
4800797|NCT02617888|Myocardial perfusion scintigraphy|myocardial perfusion scintigraphy
4800798|NCT02617888|MPS|mps
4800799|NCT02617888|Invasive coronary angiography|invasive coronary angiography
4800800|NCT02617888|ICA|ica
4800801|NCT02617875|Pre-hospital|pre-hospital
4800802|NCT02617875|Emergency medical system|emergency medical system
4800803|NCT02617875|Telemedicine|telemedicine
4800804|NCT02617875|Tele consultation|tele consultation
4800805|NCT02617875|Remote treatment|remote treatment
4800806|NCT02617862|Diagnostic imaging|diagnostic imaging
4800807|NCT02617862|Retina|retina
4800808|NCT02617862|Pediatrics|pediatrics
4800809|NCT02617810|Healthy|healthy
4800810|NCT02617810|JNJ-42847922|jnj-42847922
4800811|NCT02617810|Midazolam|midazolam
4800812|NCT02617810|Warfarin|warfarin
4800813|NCT02617810|Pharmacokinetics|pharmacokinetics
4800814|NCT02617797|Urinary Stress Incontinence|urinary stress incontinence
4800815|NCT02617797|Radiofrequency|radiofrequency
4800816|NCT02617797|Women|women
4800817|NCT02617758|Healthy|healthy
4800818|NCT02617758|Bioequivalence Study|bioequivalence study
4800819|NCT02617758|JNJ-35685-AAA-G021|jnj-35685-aaa-g021
4800820|NCT02617758|DURAGESIC|duragesic
4800821|NCT02617745|Stupp protocol, glioblastoma, thrombocytopenia|stupp protocol, glioblastoma, thrombocytopenia
4800822|NCT02617732|glucose variability|glucose variability
4800823|NCT02617732|continuous glucose mornitoring system|continuous glucose mornitoring system
4800824|NCT02617732|traditional Chinese medicine|traditional chinese medicine
4800825|NCT02617706|Anorectal surgeries|anorectal surgeries
4800826|NCT02617706|infection|infection
4800827|NCT02617706|topical oxygen|topical oxygen
4800828|NCT02617680|Desflurane|desflurane
4800829|NCT02617680|end tidal concentration|end tidal concentration
4800830|NCT02617680|age|age
4800831|NCT02617680|anesthesia|anesthesia
4800832|NCT02617641|Secondary Prevention|secondary prevention
4800833|NCT02617641|Walking|walking
4800834|NCT02617641|Health Behavior|health behavior
4800835|NCT02617641|Internet|internet
4800836|NCT02617641|eHealth|ehealth
4800837|NCT02617641|Computer-Assisted Instruction|computer-assisted instruction
4800838|NCT02617641|Multicenter Study|multicenter study
4800839|NCT02617641|Randomized Controlled Trial|randomized controlled trial
4800840|NCT02617641|Intervention Studies|intervention studies
4800841|NCT02617641|Motivation|motivation
4800842|NCT02617641|Self Efficacy|self efficacy
4800843|NCT02617641|Theory, Nursing|theory, nursing
4800844|NCT02617641|Theory, Psychological|theory, psychological
4800845|NCT02617641|Nursing Research|nursing research
4800846|NCT02617628|opioid addiction|opioid addiction
4800847|NCT02617615|MB-110|mb-110
4800848|NCT02617602|Congenital heart defect|congenital heart defect
4800849|NCT02617602|Cardiopulmonary bypass|cardiopulmonary bypass
4800850|NCT02617602|Goal directed therapy|goal directed therapy
4800851|NCT02617602|Acute heart failure|acute heart failure
4800852|NCT02617563|spondylolisthesis|spondylolisthesis
4800853|NCT02617563|CD Horizon® Spinal Systems|cd horizon® spinal systems
4800854|NCT02617563|minimal invasive|minimal invasive
4800855|NCT02617563|Spinal Fusion|spinal fusion
4800856|NCT02617563|MAST procedure|mast procedure
4800857|NCT02617563|Lumbar fusion|lumbar fusion
4800858|NCT02617524|dedicated sheath|dedicated sheath
4800859|NCT02617498|living donor liver transplantation|living donor liver transplantation
4800860|NCT02617459|Safety|safety
4800861|NCT02617459|efficacy|efficacy
4800862|NCT02617459|Levobetaxolol eye drops|levobetaxolol eye drops
4800863|NCT02617459|Chinese patients|chinese patients
4800864|NCT02617446|safety|safety
4800865|NCT02617446|efficacy|efficacy
4800866|NCT02617446|istaroxime|istaroxime
4800867|NCT02617407|Dental Plaque|dental plaque
4800868|NCT02617407|Gingivitis|gingivitis
4800869|NCT02617407|Bacterial Infection|bacterial infection
4800870|NCT02617407|Oral Hygiene|oral hygiene
4800871|NCT02617407|HSCT|hsct
4800872|NCT02617407|Oral Microbiome|oral microbiome
4800873|NCT02617368|Keratoconus, Corneal crosslinking, Fourier Analysis of Topographic Data|keratoconus, corneal crosslinking, fourier analysis of topographic data
4800874|NCT02617342|Intervention|intervention
4800875|NCT02617342|Autism Spectrum Disorder|autism spectrum disorder
4800876|NCT02617342|Social Skills|social skills
4800877|NCT02617329|Extracorporeal shock wave therapy (ESWT), Neck Pain|extracorporeal shock wave therapy (eswt), neck pain
4800878|NCT02617316|running speeds, strike patterns|running speeds, strike patterns
4800879|NCT02617303|elderly|elderly
4800880|NCT02617303|accidental falls|accidental falls
4800881|NCT02617303|osteoporosis|osteoporosis
4800882|NCT02617303|fractures|fractures
4800883|NCT02617303|Primary Care|primary care
4800884|NCT02617303|Randomized clinical trial|randomized clinical trial
4800885|NCT02617303|Otago exercise programme|otago exercise programme
4800886|NCT02617290|Coronary Artery Disease (CAD)|coronary artery disease (cad)
4800887|NCT02617290|Percutaneous Coronary Intervention (PCI)|percutaneous coronary intervention (pci)
4800888|NCT02617277|AZD1775|azd1775
4800889|NCT02617277|MEDI4736|medi4736
4800890|NCT02617277|AZD1775 + MEDI4736|azd1775 + medi4736
4800891|NCT02617277|Advanced Solid Tumours|advanced solid tumours
4800892|NCT02617277|Durvalumab|durvalumab
4800893|NCT02617238|arterial stiffness|arterial stiffness
4800894|NCT02617238|cardiovascular risk|cardiovascular risk
4800895|NCT02617238|cardiovascular events|cardiovascular events
4800896|NCT02617238|renal events|renal events
4800897|NCT02617212|dental implant|dental implant
4800898|NCT02617212|bone preservation|bone preservation
4800899|NCT02617212|definitive abutment|definitive abutment
4800900|NCT02617212|one abutment one time|one abutment one time
4800901|NCT02617199|epidural anesthesia|epidural anesthesia
4800902|NCT02617199|pain management|pain management
4800903|NCT02617199|microcirculation|microcirculation
4800904|NCT02617160|Insulin Pump Treatment|insulin pump treatment
4800905|NCT02617160|Type 1 Diabetes|type 1 diabetes
4800906|NCT02617160|Insulin Pump Setting|insulin pump setting
4800907|NCT02617160|Pump Advisor|pump advisor
4800908|NCT02617108|uterine septum|uterine septum
4800909|NCT02617108|intrauterine adhesions|intrauterine adhesions
4800910|NCT02617108|Foley balloon|foley balloon
4800911|NCT02617082|breast cancer|breast cancer
4800912|NCT02617082|partial breast irradiation|partial breast irradiation
4800913|NCT02617082|DCIS|dcis
4800914|NCT02617069|Atrial fibrillation|atrial fibrillation
4800915|NCT02617069|botulinum toxin|botulinum toxin
4800916|NCT02617056|electrodermal response|electrodermal response
4800917|NCT02617043|breast cancer|breast cancer
4800918|NCT02617043|hypofractionated whole breast irradiation|hypofractionated whole breast irradiation
4800919|NCT02617017|Parkinson disease|parkinson disease
4800920|NCT02617017|Levodopa induce dyskinesia|levodopa induce dyskinesia
4800921|NCT02616952|Stress urinary incontinence|stress urinary incontinence
4800922|NCT02616952|Chinese Herb|chinese herb
4800923|NCT02616952|Traditional Chinese medicine|traditional chinese medicine
4800924|NCT02616952|Pelvic floor muscle training|pelvic floor muscle training
4801051|NCT02616042|Centella asiatica|centella asiatica
4800925|NCT02616939|Multidetector computed tomography|multidetector computed tomography
4800926|NCT02616926|hepatocellular carcinoma|hepatocellular carcinoma
4800927|NCT02616926|hepatectomy|hepatectomy
4800928|NCT02616926|transarterial chemoembolization|transarterial chemoembolization
4800929|NCT02616926|radiofrequency ablation|radiofrequency ablation
4800930|NCT02616874|HIV infection|hiv infection
4800931|NCT02616874|Early treatment|early treatment
4800932|NCT02616874|Romidepsin|romidepsin
4800933|NCT02616874|HDACi|hdaci
4800934|NCT02616874|Therapeutic Vaccines|therapeutic vaccines
4800935|NCT02616874|HIVconsv|hivconsv
4800936|NCT02616874|HIV reservoir|hiv reservoir
4800937|NCT02616874|Population PK/PD analysis|population pk/pd analysis
4800938|NCT02616848|Everolimus|everolimus
4800939|NCT02616848|eribulin|eribulin
4800940|NCT02616822|hypertension|hypertension
4800941|NCT02616822|endothelium|endothelium
4800942|NCT02616822|resveratrol|resveratrol
4800943|NCT02616822|clinical trials|clinical trials
4800944|NCT02616783|HIV 1 Infection|hiv 1 infection
4800945|NCT02616783|HIV|hiv
4800946|NCT02616783|Virologically-Suppressed|virologically-suppressed
4800947|NCT02616744|aromatase inhibitors|aromatase inhibitors
4800948|NCT02616744|breast cancer|breast cancer
4800949|NCT02616744|bone mineral density|bone mineral density
4800950|NCT02616692|HCC|hcc
4800951|NCT02616692|Patient preferences|patient preferences
4800952|NCT02616666|Type 2 diabetes mellitus|type 2 diabetes mellitus
4800953|NCT02616666|Randomised|randomised
4800954|NCT02616666|Pragmatic|pragmatic
4800955|NCT02616666|Standard of Care|standard of care
4800956|NCT02616666|Dapagliflozin|dapagliflozin
4800957|NCT02616666|FORXIGA|forxiga
4800958|NCT02616640|Multiple Myeloma|multiple myeloma
4800959|NCT02616640|Relapsed|relapsed
4800960|NCT02616640|Refractory|refractory
4800961|NCT02616640|MEDI4736|medi4736
4800962|NCT02616640|Durvalumab|durvalumab
4800963|NCT02616640|Pomalidomide (POM)|pomalidomide (pom)
4800964|NCT02616640|Dexamethasone (DEX)|dexamethasone (dex)
4800965|NCT02616640|PD-L1|pd-l1
4800966|NCT02616627|bone mineral density|bone mineral density
4800967|NCT02616627|chronic dialysis|chronic dialysis
4800968|NCT02616627|end-stage renal disease|end-stage renal disease
4800969|NCT02616627|body composition analysis|body composition analysis
4800970|NCT02616627|sarcopenia|sarcopenia
4800971|NCT02616588|advanced stage cancer,|advanced stage cancer,
4800972|NCT02616588|patient navigator,|patient navigator,
4800973|NCT02616588|social work|social work
4800974|NCT02616575|home care|home care
4800975|NCT02616575|monitoring system|monitoring system
4800976|NCT02616575|risk assessment|risk assessment
4800977|NCT02616575|telehealth|telehealth
4800978|NCT02616536|Flipped classroom|flipped classroom
4800979|NCT02616536|Teaching methods|teaching methods
4800980|NCT02616536|Knowledge gain|knowledge gain
4800981|NCT02616523|dexmedetomidine|dexmedetomidine
4800982|NCT02616523|lidocaine|lidocaine
4800983|NCT02616523|neuropathic pain|neuropathic pain
4800984|NCT02616523|laparoscopic intestine resection|laparoscopic intestine resection
4800985|NCT02616523|cognitive function|cognitive function
4800986|NCT02616497|aspirin|aspirin
4800987|NCT02616497|triflusal|triflusal
4800988|NCT02616497|antiplatelet drugs|antiplatelet drugs
4800989|NCT02616497|atherothrombosis|atherothrombosis
4800990|NCT02616497|secondary prevention|secondary prevention
4800991|NCT02616497|bleeding|bleeding
4800992|NCT02616484|Sodium Dichloroacetate|sodium dichloroacetate
4800993|NCT02616484|Treatment of PDCD with Dichloroacetate|treatment of pdcd with dichloroacetate
4800994|NCT02616471|Cheese|cheese
4800995|NCT02616471|Dairy|dairy
4800996|NCT02616471|Saturated fat|saturated fat
4800997|NCT02616471|Blood lipid concentrations|blood lipid concentrations
4800998|NCT02616471|Lipoprotein particle size|lipoprotein particle size
4800999|NCT02616471|Metabolic Syndrome|metabolic syndrome
4801000|NCT02616471|Insulin sensitivity|insulin sensitivity
4801001|NCT02616471|Blood glucose concentrations|blood glucose concentrations
4801002|NCT02616445|Xanamem|xanamem
4801003|NCT02616432|Tomosynthesis|tomosynthesis
4801004|NCT02616432|Digital Breast Tomosynthesis (DBT)|digital breast tomosynthesis (dbt)
4801005|NCT02616432|Breast Imaging|breast imaging
4801006|NCT02616432|Full-field digital mammography|full-field digital mammography
4801007|NCT02616432|Breast screening|breast screening
4801008|NCT02616419|Emergency Department|emergency department
4801009|NCT02616419|Procedural pain|procedural pain
4801010|NCT02616419|Procedural anxiety|procedural anxiety
4801011|NCT02616419|Needle-related procedures|needle-related procedures
4801012|NCT02616419|Clinical Nursing Research|clinical nursing research
4801013|NCT02616419|Nursing practice|nursing practice
4801014|NCT02616419|Non-pharmacological method|non-pharmacological method
4801015|NCT02616406|recovery of function|recovery of function
4801016|NCT02616380|Quality of life (QOL)|quality of life (qol)
4801221|NCT02614989|Tremor|tremor
4801017|NCT02616380|Work productivity|work productivity
4801018|NCT02616380|Rheumatoid arthritis (RA)|rheumatoid arthritis (ra)
4801019|NCT02616354|Pharmacokinetics; pharmacodynamic; imipenem; sepsis|pharmacokinetics; pharmacodynamic; imipenem; sepsis
4801020|NCT02616315|Drug therapy|drug therapy
4801021|NCT02616302|Drug therapy|drug therapy
4801022|NCT02616276|Glycemic Index|glycemic index
4801023|NCT02616276|Postprandial Period|postprandial period
4801024|NCT02616276|Vascular Stiffness|vascular stiffness
4801025|NCT02616276|Blood glucose|blood glucose
4801026|NCT02616276|Cognition|cognition
4801027|NCT02616237|Chinese population|chinese population
4801028|NCT02616237|acupressure|acupressure
4801029|NCT02616237|physical activity|physical activity
4801030|NCT02616237|nutrition|nutrition
4801031|NCT02616237|Facebook|facebook
4801032|NCT02616198|glass ionomers|glass ionomers
4801033|NCT02616198|surface coating|surface coating
4801034|NCT02616198|clinical trial|clinical trial
4801035|NCT02616120|Herbal therapy|herbal therapy
4801036|NCT02616120|Parkinson's Disease|parkinson's disease
4801037|NCT02616120|Non-motor Symptoms|non-motor symptoms
4801038|NCT02616120|Randomized controlled trial|randomized controlled trial
4801039|NCT02616107|Caregiver|caregiver
4801040|NCT02616107|Self-management|self-management
4801041|NCT02616107|Care options|care options
4801042|NCT02616107|Goals of care|goals of care
4801043|NCT02616107|Breast cancer|breast cancer
4801044|NCT02616107|Palliative care|palliative care
4801045|NCT02616081|Urinary Bladder|urinary bladder
4801046|NCT02616081|Neurogenic|neurogenic
4801047|NCT02616081|Quality of Life|quality of life
4801048|NCT02616081|Spinal cord injury|spinal cord injury
4801049|NCT02616081|incontinence|incontinence
4801050|NCT02616081|Bladder|bladder
4801052|NCT02616042|bamboo salt|bamboo salt
4801053|NCT02616042|dentifrice|dentifrice
4801054|NCT02616003|Morbid Obesity|morbid obesity
4801055|NCT02616003|Giant Obese|giant obese
4801056|NCT02616003|Preoperative Procedure|preoperative procedure
4801057|NCT02616003|Liraglutide|liraglutide
4801058|NCT02616003|Leucine|leucine
4801059|NCT02615977|Pavlovian conditioning, Operant conditioning|pavlovian conditioning, operant conditioning
4801060|NCT02615977|Pavlovian-to-instrumental transfer|pavlovian-to-instrumental transfer
4801061|NCT02615977|Functional imaging|functional imaging
4801062|NCT02615977|Relapse risk|relapse risk
4801063|NCT02615977|Behavioural Intervention|behavioural intervention
4801064|NCT02615951|Regulatory B cells (Breg)|regulatory b cells (breg)
4801065|NCT02615951|Genes|genes
4801066|NCT02615951|Cell surface proteins|cell surface proteins
4801067|NCT02615951|Nutrient transporters|nutrient transporters
4801068|NCT02615951|Chemokine receptors|chemokine receptors
4801069|NCT02615899|Older Adults, Falls|older adults, falls
4801070|NCT02615886|rice bran|rice bran
4801071|NCT02615886|infants|infants
4801072|NCT02615886|stool metabolome|stool metabolome
4801073|NCT02615886|stool microbiome|stool microbiome
4801074|NCT02615886|dietary intervention|dietary intervention
4801075|NCT02615873|Parkinson's Disease|parkinson's disease
4801076|NCT02615873|Fluctuating Parkinson's Disease|fluctuating parkinson's disease
4801077|NCT02615873|Carbidopa|carbidopa
4801078|NCT02615873|Levodopa|levodopa
4801079|NCT02615873|Accordion|accordion
4801080|NCT02615860|HIV-infection|hiv-infection
4801081|NCT02615860|anal cancer (AC)|anal cancer (ac)
4801082|NCT02615860|anal cancer prevention|anal cancer prevention
4801083|NCT02615860|anal dysplasia|anal dysplasia
4801084|NCT02615860|anal intraepithelial neoplasia (AIN)|anal intraepithelial neoplasia (ain)
4801085|NCT02615860|human papillomavirus (HPV)|human papillomavirus (hpv)
4801086|NCT02615860|HPV-induced anal cancer precursor lesions|hpv-induced anal cancer precursor lesions
4801087|NCT02615860|electrocautery (ECA)|electrocautery (eca)
4801088|NCT02615860|topical trichloroacetic acid (TCA) treatment.|topical trichloroacetic acid (tca) treatment.
4801089|NCT02615704|Brilique treatment adherence via electronic device application (APP)|brilique treatment adherence via electronic device application (app)
4801090|NCT02615678|neuropathy|neuropathy
4801091|NCT02615678|peripheral|peripheral
4801092|NCT02615678|chemotherapy|chemotherapy
4801093|NCT02615678|breast cancer|breast cancer
4801094|NCT02615665|NK-cells|nk-cells
4801095|NCT02615665|T-cells|t-cells
4801096|NCT02615639|HPDC-T cells|hpdc-t cells
4801097|NCT02615639|CHB|chb
4801098|NCT02615639|immuno therapy|immuno therapy
4801099|NCT02615626|Visfatin|visfatin
4801100|NCT02615626|GCF|gcf
4801101|NCT02615626|serum|serum
4801102|NCT02615626|Non-surgical Periodontal Treatment.|non-surgical periodontal treatment.
4801103|NCT02615613|Hedonics, Ghrelin, Hunger|hedonics, ghrelin, hunger
4801104|NCT02615600|tinnitus|tinnitus
4801105|NCT02615600|transcranial random noise stimulation|transcranial random noise stimulation
4801106|NCT02615600|tRNS|trns
4801107|NCT02615600|auditory cortex|auditory cortex
4801108|NCT02615600|non-invasive brain stimulation|non-invasive brain stimulation
4801109|NCT02615587|non-valvular Atrial Fibrillation|non-valvular atrial fibrillation
4801110|NCT02615561|Safety|safety
4801111|NCT02615561|Efficacy|efficacy
4801112|NCT02615561|Atopic dermatitis|atopic dermatitis
4801113|NCT02615561|Cosmetic products|cosmetic products
4801114|NCT02615548|exercises|exercises
4801115|NCT02615535|traumatic brain injury|traumatic brain injury
4801117|NCT02615496|Health Care Surveys|health care surveys
4801118|NCT02615496|Vascular Endothelial Growth Factor|vascular endothelial growth factor
4801119|NCT02615470|Pneumococcal Vaccines|pneumococcal vaccines
4801120|NCT02615470|Shingles|shingles
4801121|NCT02615470|Pharmacy|pharmacy
4801122|NCT02615470|Vaccine|vaccine
4801123|NCT02615470|Immunization|immunization
4801124|NCT02615444|Metabolic Syndrome X|metabolic syndrome x
4801125|NCT02615444|Overweight|overweight
4801126|NCT02615444|Waist Circumference|waist circumference
4801127|NCT02615444|Blood Pressure|blood pressure
4801128|NCT02615444|Cholesterol|cholesterol
4801129|NCT02615444|Oat beta glucan|oat beta glucan
4801130|NCT02615392|RCT|rct
4801131|NCT02615392|Park Prescription|park prescription
4801132|NCT02615392|Park Use|park use
4801133|NCT02615392|Physical Activity|physical activity
4801134|NCT02615392|Health Promotion|health promotion
4801135|NCT02615392|Health Behavior|health behavior
4801136|NCT02615392|Mental Well-Being|mental well-being
4801137|NCT02615392|Body composition|body composition
4801138|NCT02615392|Blood levels|blood levels
4801139|NCT02615392|Accelerometry|accelerometry
4801140|NCT02615392|Improving general physical and mental health|improving general physical and mental health
4801141|NCT02615379|instrumented spinal fusion|instrumented spinal fusion
4801142|NCT02615379|infection|infection
4801143|NCT02615379|topical oxygen|topical oxygen
4801144|NCT02615340|delirium|delirium
4801145|NCT02615340|melatonin|melatonin
4801146|NCT02615340|pharmacokinetics|pharmacokinetics
4801147|NCT02615340|feasibility|feasibility
4801148|NCT02615340|prevention|prevention
4801149|NCT02615327|Fiber|fiber
4801150|NCT02615327|Polydextrose|polydextrose
4801151|NCT02615327|Glycemic Index|glycemic index
4801152|NCT02615314|migraine|migraine
4801153|NCT02615314|benign paroxysmal positional vertigo|benign paroxysmal positional vertigo
4801154|NCT02615288|Vitamin D|vitamin d
4801155|NCT02615275|Head and Neck Cancer|head and neck cancer
4801156|NCT02615275|Bioelectrical impedance analysis|bioelectrical impedance analysis
4801157|NCT02615275|BIA|bia
4801158|NCT02615275|Eight-electrode BIA device|eight-electrode bia device
4801159|NCT02615275|SECA mBCA|seca mbca
4801160|NCT02615275|Computed tomography|computed tomography
4801161|NCT02615275|CT|ct
4801162|NCT02615275|Positron emission tomography|positron emission tomography
4801163|NCT02615275|PET|pet
4801164|NCT02615275|Symptom questionnaire|symptom questionnaire
4801165|NCT02615275|Survey|survey
4801166|NCT02615275|Radiation therapy|radiation therapy
4801167|NCT02615275|RT|rt
4801168|NCT02615275|XRT|xrt
4801169|NCT02615262|Pediatric cardiac surgery|pediatric cardiac surgery
4801170|NCT02615262|Dexamethasone|dexamethasone
4801171|NCT02615262|Steroids|steroids
4801172|NCT02615262|Cardiopulmonary bypass|cardiopulmonary bypass
4801173|NCT02615262|Congenital heart defects|congenital heart defects
4801174|NCT02615262|Infants|infants
4801175|NCT02615197|PTSD|ptsd
4801176|NCT02615197|Multi-diagnostic|multi-diagnostic
4801177|NCT02615197|Dialectical Behavior Therapy|dialectical behavior therapy
4801178|NCT02615197|Prolonged Exposure Therapy|prolonged exposure therapy
4801179|NCT02615184|Drug therapy|drug therapy
4801180|NCT02615158|Feeding practices|feeding practices
4801181|NCT02615158|Diet|diet
4801182|NCT02615158|Physical activity|physical activity
4801183|NCT02615158|Prevention|prevention
4801184|NCT02615145|Chronic Hepatitis C|chronic hepatitis c
4801185|NCT02615145|Dasabuvir|dasabuvir
4801186|NCT02615145|Ombitasvir+Paritaprevir+Ritonavir|ombitasvir+paritaprevir+ritonavir
4801187|NCT02615145|Observational Study|observational study
4801188|NCT02615145|Quality of life|quality of life
4801189|NCT02615145|Work-ability|work-ability
4801190|NCT02615145|Fibrosis|fibrosis
4801191|NCT02615145|Cirrhosis|cirrhosis
4801192|NCT02615119|heartbeat|heartbeat
4801193|NCT02615119|respiration|respiration
4801194|NCT02615119|interoception|interoception
4801195|NCT02615119|anxiety|anxiety
4801196|NCT02615119|eating|eating
4801197|NCT02615106|Radiation Therapy|radiation therapy
4801198|NCT02615106|Neuroblastoma|neuroblastoma
4801199|NCT02615067|Diagnostic|diagnostic
4801200|NCT02615067|Active surveillance|active surveillance
4801201|NCT02615067|Very low risk|very low risk
4801202|NCT02615067|Imaging|imaging
4801203|NCT02615067|PSMA|psma
4801204|NCT02615067|SPECT/CT|spect/ct
4801205|NCT02615067|99mTc|99mtc
4801206|NCT02615067|Newly Diagnosed|newly diagnosed
4801207|NCT02615067|Prostatectomy|prostatectomy
4801208|NCT02615067|Biopsy|biopsy
4801209|NCT02615054|Cardiovascular Impairment|cardiovascular impairment
4801210|NCT02615054|15-258|15-258
4801211|NCT02615041|Meropenem|meropenem
4801212|NCT02615041|Ventilator-Associated Pneumonia|ventilator-associated pneumonia
4801213|NCT02615041|population pharmacokinetics|population pharmacokinetics
4801214|NCT02615041|pharmacokinetics|pharmacokinetics
4801215|NCT02615041|pharmacodynamics|pharmacodynamics
4801216|NCT02615028|Force plate, Balance ability|force plate, balance ability
4801217|NCT02615015|Deoxyribonuclease|deoxyribonuclease
4801218|NCT02615002|Cognition|cognition
4801219|NCT02615002|mild Alzheimer's disease|mild alzheimer's disease
4801220|NCT02615002|Sleep|sleep
4801222|NCT02614989|Thalamotomy|thalamotomy
4801223|NCT02614963|Irritable Bowel Syndrome|irritable bowel syndrome
4801224|NCT02614963|Clostridium Butyricum|clostridium butyricum
4801225|NCT02614911|Early Onset Entheropathy|early onset entheropathy
4801226|NCT02614833|Hormone receptor positive|hormone receptor positive
4801227|NCT02614820|Ischemic preconditioning|ischemic preconditioning
4801228|NCT02614820|sefety|sefety
4801229|NCT02614820|efficacy|efficacy
4801230|NCT02614820|DMD|dmd
4801231|NCT02614807|Dietary Supplement|dietary supplement
4801232|NCT02614794|Tucatinib|tucatinib
4801233|NCT02614794|Capecitabine|capecitabine
4801234|NCT02614794|Trastuzumab|trastuzumab
4801235|NCT02614794|Xeloda|xeloda
4801236|NCT02614794|Herceptin|herceptin
4801237|NCT02614794|Breast Cancer|breast cancer
4801238|NCT02614794|ARRY-380|arry-380
4801239|NCT02614794|ONT-380|ont-380
4801240|NCT02614794|HER2 Positive Breast Carcinoma|her2 positive breast carcinoma
4801241|NCT02614794|HER2 Positive Locally Advanced Breast Cancer|her2 positive locally advanced breast cancer
4801242|NCT02614794|HER-2 Positive Breast Cancer|her-2 positive breast cancer
4801243|NCT02614794|HER-2 Positive Breast Carcinoma|her-2 positive breast carcinoma
4801244|NCT02614794|HER-2 Positive Locally Advanced Breast Cancer|her-2 positive locally advanced breast cancer
4801245|NCT02614794|Recurrent Breast Carcinoma|recurrent breast carcinoma
4801246|NCT02614794|Stage IV Breast Cancer|stage iv breast cancer
4801247|NCT02614794|Metastatic Breast Cancer|metastatic breast cancer
4801248|NCT02614794|Breast Carcinoma|breast carcinoma
4801249|NCT02614794|Metastatic Malignant Neoplasm in the Brain|metastatic malignant neoplasm in the brain
4801250|NCT02614794|Brain Metastases in Breast Cancer|brain metastases in breast cancer
4801251|NCT02614794|Asymptomatic Brain Metastases in Breast Cancer|asymptomatic brain metastases in breast cancer
4801252|NCT02614794|Low Symptomatic Brain Metastases in Breast Cancer|low symptomatic brain metastases in breast cancer
4801253|NCT02614768|Glucose Monitoring System|glucose monitoring system
4801254|NCT02614755|Older Adults Volunteers|older adults volunteers
4801255|NCT02614755|Seniors|seniors
4801256|NCT02614755|Brain Performance Test|brain performance test
4801257|NCT02614729|High Protein|high protein
4801258|NCT02614729|Satiety|satiety
4801259|NCT02614729|Appetite Control|appetite control
4801260|NCT02614729|Protein Distribution|protein distribution
4801261|NCT02614729|Cognitive Function|cognitive function
4801262|NCT02614729|Ad libitum Food Intake|ad libitum food intake
4801263|NCT02614729|Obesity prevention|obesity prevention
4801264|NCT02614729|Obesity treatment|obesity treatment
4801265|NCT02614703|Barrett's Esophagus|barrett's esophagus
4801266|NCT02614703|Acetic Acid Chromoendoscopy|acetic acid chromoendoscopy
4801267|NCT02614690|Fracture of the upper limb|fracture of the upper limb
4801268|NCT02614677|Disability Evaluation System|disability evaluation system
4801269|NCT02614677|SF-12|sf-12
4801270|NCT02614677|ICF model|icf model
4801271|NCT02614612|Acute Graft Versus Host Disease|acute graft versus host disease
4801272|NCT02614599|ADD|add
4801273|NCT02614599|ADHD|adhd
4801274|NCT02614599|Proteins|proteins
4801275|NCT02614599|Dietary|dietary
4801276|NCT02614599|Nutrition|nutrition
4801277|NCT02614599|QEEG|qeeg
4801278|NCT02614599|ERP|erp
4801279|NCT02614599|ICA|ica
4801280|NCT02614586|Drug Therapy|drug therapy
4801281|NCT02614573|Dependent|dependent
4801282|NCT02614573|Aged, 80 and over|aged, 80 and over
4801283|NCT02614573|Aged|aged
4801284|NCT02614560|acute myeloid leukemia|acute myeloid leukemia
4801285|NCT02614560|AML|aml
4801286|NCT02614560|antibody-drug conjugate|antibody-drug conjugate
4801287|NCT02614521|Pulmonary veins ablation|pulmonary veins ablation
4801288|NCT02614521|Paroxysmal atrial fibrillation|paroxysmal atrial fibrillation
4801289|NCT02614482|Children|children
4801290|NCT02614482|Antimuscarinics|antimuscarinics
4801291|NCT02614482|Antocholinergics|antocholinergics
4801292|NCT02614482|Overactive bladder|overactive bladder
4801293|NCT02614443|Depression|depression
4801294|NCT02614443|Anxiety|anxiety
4801295|NCT02614443|Stress|stress
4801296|NCT02614443|Online interventions|online interventions
4801297|NCT02614443|University students|university students
4801298|NCT02614443|CBT|cbt
4801299|NCT02614430|Rehabilitation|rehabilitation
4801300|NCT02614430|Prediction|prediction
4801301|NCT02614430|Inflammation|inflammation
4801302|NCT02614404|Plasmodium falciparum|plasmodium falciparum
4801303|NCT02614404|Uncomplicated malarial|uncomplicated malarial
4801304|NCT02614404|imatinib mesylate|imatinib mesylate
4801305|NCT02614404|antimalarials|antimalarials
4801306|NCT02614391|Procedural pain|procedural pain
4801307|NCT02614391|Phlebotomy|phlebotomy
4801308|NCT02614391|Distraction|distraction
4801309|NCT02614391|Videogame|videogame
4801310|NCT02614391|Computer tablet|computer tablet
4801311|NCT02614391|Child|child
4801312|NCT02614378|abortive effect|abortive effect
4801313|NCT02614326|Depression|depression
4801314|NCT02614326|Cognitive risk factors|cognitive risk factors
4801315|NCT02614326|Autobiographical memory|autobiographical memory
4801316|NCT02614326|Cognitive bias|cognitive bias
4801317|NCT02614326|Relapse prevention|relapse prevention
4801318|NCT02614313|Fructose|fructose
4801319|NCT02614313|Irritable Bowel Syndrome|irritable bowel syndrome
4801320|NCT02614313|Breath test|breath test
4801321|NCT02614313|Placebo|placebo
4801322|NCT02614300|pulmonary rehabilitation|pulmonary rehabilitation
4801323|NCT02614300|chest physiotherapy|chest physiotherapy
4801324|NCT02614300|non-cystic fibrosis bronchiectasis|non-cystic fibrosis bronchiectasis
4801325|NCT02614300|exercise tolerance|exercise tolerance
4801326|NCT02614300|bronchiectasis|bronchiectasis
4801327|NCT02614300|respiratory therapy|respiratory therapy
4801328|NCT02614287|prevention|prevention
4801329|NCT02614287|prophylaxis|prophylaxis
4801330|NCT02614287|headache|headache
4801331|NCT02614274|knee|knee
4801332|NCT02614274|pain|pain
4801333|NCT02614274|osteoarthritis|osteoarthritis
4801334|NCT02614274|nutraceutical|nutraceutical
4801335|NCT02614274|nutrition|nutrition
4801336|NCT02614274|supplement|supplement
4801337|NCT02614274|non-surgical|non-surgical
4801338|NCT02614274|biomarker|biomarker
4801339|NCT02614274|joint health|joint health
4801340|NCT02614261|prevention|prevention
4801341|NCT02614261|prophylaxis|prophylaxis
4801342|NCT02614261|headache|headache
4801343|NCT02614235|Cardiac Arrhythmia|cardiac arrhythmia
4801344|NCT02614235|Syncope|syncope
4801345|NCT02614235|Ambulatory Electrocardiography Monitoring|ambulatory electrocardiography monitoring
4801346|NCT02614222|Computer Assisted Instrument Guidance (CAIG)|computer assisted instrument guidance (caig)
4801347|NCT02614222|Peripheral Nerve Block|peripheral nerve block
4801348|NCT02614222|Clear Guide ONE|clear guide one
4801349|NCT02614222|Needle path|needle path
4801350|NCT02614222|Needle Guidance|needle guidance
4801351|NCT02614222|Ultrasound|ultrasound
4801352|NCT02614209|ED|ed
4801353|NCT02614209|BNP|bnp
4801354|NCT02614196|prevention|prevention
4801355|NCT02614196|prophylaxis|prophylaxis
4801356|NCT02614196|headache|headache
4801357|NCT02614183|prevention|prevention
4801358|NCT02614183|prophylaxis|prophylaxis
4801359|NCT02614183|headache|headache
4801360|NCT02614157|rectal cancer|rectal cancer
4801361|NCT02614157|lateral lymph node dissection|lateral lymph node dissection
4801362|NCT02614157|neoadjuvant chemoradiation|neoadjuvant chemoradiation
4801363|NCT02614157|total mesorectal excision|total mesorectal excision
4801364|NCT02614157|surgery|surgery
4801365|NCT02614157|recurrence|recurrence
4801366|NCT02614157|metastasis|metastasis
4801367|NCT02614157|overall survival|overall survival
4801368|NCT02614144|Hospital Acquired Pneumonia|hospital acquired pneumonia
4801369|NCT02614144|Mortality|mortality
4801370|NCT02614118|Endodontic treatment|endodontic treatment
4801371|NCT02614118|non steroid|non steroid
4801372|NCT02614118|pain|pain
4801373|NCT02614118|pre medication|pre medication
4801374|NCT02614092|Mild Cognitive Impairment|mild cognitive impairment
4801375|NCT02614092|memory impairment|memory impairment
4801376|NCT02614092|Physical Activity|physical activity
4801377|NCT02614092|Exercise|exercise
4801378|NCT02614092|Cognitive Training|cognitive training
4801379|NCT02614092|Veterans|veterans
4801380|NCT02614092|Older Adults|older adults
4801381|NCT02614079|lumbago|lumbago
4801382|NCT02614079|low back pain|low back pain
4801383|NCT02614079|leg pain|leg pain
4801384|NCT02614040|crystalloid|crystalloid
4801385|NCT02614040|acute kidney injury|acute kidney injury
4801386|NCT02614001|breathing training, congestive heart failure, stroke|breathing training, congestive heart failure, stroke
4801387|NCT02613988|Glioblastoma|glioblastoma
4801388|NCT02613988|MRI|mri
4801389|NCT02613988|standard treatment|standard treatment
4801390|NCT02613949|fibromyalgia|fibromyalgia
4801391|NCT02613949|pain|pain
4801392|NCT02613949|stimulation|stimulation
4801393|NCT02613936|traumatic brain injury|traumatic brain injury
4801394|NCT02613936|post concussive symptoms|post concussive symptoms
4801395|NCT02613936|depression|depression
4801396|NCT02613936|executive dysfunction|executive dysfunction
4801397|NCT02613936|brain stimulation|brain stimulation
4801398|NCT02613923|Breast Cancer|breast cancer
4801399|NCT02613923|GO! to sleep|go! to sleep
4801400|NCT02613923|sleep|sleep
4801401|NCT02613910|Ofatumumab|ofatumumab
4801402|NCT02613910|Pemphigus Vulgaris|pemphigus vulgaris
4801403|NCT02613910|Long-Term Extension Study|long-term extension study
4801404|NCT02613845|Postoperative delirium|postoperative delirium
4801405|NCT02613845|Cardiac surgery|cardiac surgery
4801406|NCT02613845|Cardiopulmonary bypass|cardiopulmonary bypass
4801407|NCT02613845|Risk factor|risk factor
4801408|NCT02613832|Noncooperative patients|noncooperative patients
4801409|NCT02613806|Dexmedetomidine|dexmedetomidine
4801410|NCT02613806|Coughing Response|coughing response
4801411|NCT02613806|Postoperative Recovery Quality|postoperative recovery quality
4801412|NCT02613806|Thyroid Surgery|thyroid surgery
4801413|NCT02613793|Preterm pre-eclampsia|preterm pre-eclampsia
4801414|NCT02613793|Neurological dysfunction|neurological dysfunction
4801415|NCT02613793|Saccadic reaction time|saccadic reaction time
4801416|NCT02613728|Colorectal cancer|colorectal cancer
4801417|NCT02613728|Colorectal cancer surgery|colorectal cancer surgery
4801418|NCT02613728|Polyp(s)|polyp(s)
4801419|NCT02613728|Accelerated Enhanced Recovery|accelerated enhanced recovery
4801420|NCT02613728|RecoverMI|recovermi
4801421|NCT02613728|Fluid diary|fluid diary
4801422|NCT02613728|Questionnaires|questionnaires
4801423|NCT02613728|Surveys|surveys
4801424|NCT02613728|RecoverMI device|recovermi device
4801425|NCT02613715|Flavonoids|flavonoids
4801426|NCT02613715|Anthocyanins|anthocyanins
4801427|NCT02613715|Blackberry Juice|blackberry juice
4801428|NCT02613715|Bioavailability|bioavailability
4801429|NCT02613715|Obesity|obesity
4801430|NCT02613702|Free gingival graft|free gingival graft
4801431|NCT02613702|keratinized gingival tissue|keratinized gingival tissue
4801432|NCT02613689|smokeless tobacco, text message, tobacco cessation, tobacco|smokeless tobacco, text message, tobacco cessation, tobacco
4801433|NCT02613637|lung cancer|lung cancer
4801434|NCT02613637|registry study|registry study
4801435|NCT02613637|Biological Disease Profile|biological disease profile
4801436|NCT02613624|KMC in community|kmc in community
4801437|NCT02613559|Neovascular Age-Related Macular Degeneration, Subfoveal CNV, TK001|neovascular age-related macular degeneration, subfoveal cnv, tk001
4801438|NCT02613546|cognitive-behavioral psychotherapy|cognitive-behavioral psychotherapy
4801439|NCT02613546|Sexual Dysfunctions|sexual dysfunctions
4801440|NCT02613546|Women|women
4801441|NCT02613520|PfSPZ Vaccine|pfspz vaccine
4801442|NCT02613520|Plasmodium falciparum|plasmodium falciparum
4801443|NCT02613494|clozapine|clozapine
4801444|NCT02613494|hypersalivation|hypersalivation
4801445|NCT02613494|refractory schizophrenia|refractory schizophrenia
4801446|NCT02613468|Pregnancy|pregnancy
4801447|NCT02613468|Low birth weight|low birth weight
4801448|NCT02613468|Gingivitis|gingivitis
4801449|NCT02613468|Inflammation|inflammation
4801450|NCT02613468|Periodontitis|periodontitis
4801451|NCT02613390|Epidural metastasis|epidural metastasis
4801452|NCT02613390|Magnetic resonance imaging|magnetic resonance imaging
4801453|NCT02613390|MRI|mri
4801454|NCT02613390|Guidance system|guidance system
4801455|NCT02613390|Spinal surgery|spinal surgery
4801456|NCT02613390|Questionnaires|questionnaires
4801457|NCT02613390|Surveys|surveys
4801458|NCT02613377|Transfusion-related acute lung injury, Red Blood Cell|transfusion-related acute lung injury, red blood cell
4801459|NCT02613351|Exercise Tolerance|exercise tolerance
4801460|NCT02613351|Lung Diseases, Obstructive|lung diseases, obstructive
4801461|NCT02613325|Melanoma|melanoma
4801462|NCT02613325|Imaging|imaging
4801463|NCT02613325|Pigmented Lesions|pigmented lesions
4801464|NCT02613325|Melanoma Management|melanoma management
4801465|NCT02613247|Viscosupplementation|viscosupplementation
4801466|NCT02613247|Hyaluronic acid|hyaluronic acid
4801467|NCT02613247|Synvisc|synvisc
4801468|NCT02613247|Synvisc-One|synvisc-one
4801469|NCT02613247|Patellofemoral pain syndrome|patellofemoral pain syndrome
4801470|NCT02613247|PFPS|pfps
4801471|NCT02613247|Anterior knee pain|anterior knee pain
4801472|NCT02613247|Runner's knee|runner's knee
4801473|NCT02613234|Epilepsy|epilepsy
4801474|NCT02613234|128-Channel EEG|128-channel eeg
4801475|NCT02613234|Dipole Localization|dipole localization
4801476|NCT02613234|Transcranial Direct Current Stimulation|transcranial direct current stimulation
4801477|NCT02613221|Metastatic colorectal cancer, Panitumumab, TAS-102|metastatic colorectal cancer, panitumumab, tas-102
4801478|NCT02613195|Ischemia-Reperfusion Injury|ischemia-reperfusion injury
4801479|NCT02613195|oxidative stress|oxidative stress
4801480|NCT02613195|organ preservation|organ preservation
4801481|NCT02613195|Hydrogen|hydrogen
4801482|NCT02613195|Kidney Transplantation|kidney transplantation
4801483|NCT02613169|M. tuberculosis infection|m. tuberculosis infection
4801484|NCT02613169|isoniazid|isoniazid
4801485|NCT02613169|HIV-exposed infants|hiv-exposed infants
4801486|NCT02613156|laparoscopic|laparoscopic
4801487|NCT02613156|hepatocellular carcinoma|hepatocellular carcinoma
4801488|NCT02613156|recurrence|recurrence
4801489|NCT02613143|malignant glaucoma|malignant glaucoma
4801490|NCT02613143|zonulo-hyaloido-vitrectomy|zonulo-hyaloido-vitrectomy
4801491|NCT02613091|volunteers|volunteers
4801492|NCT02613078|Children|children
4801493|NCT02613078|Functional Abdominal Pain Syndrome|functional abdominal pain syndrome
4801494|NCT02613078|Irritable Bowel Syndrome|irritable bowel syndrome
4801495|NCT02613078|Gut-Directed Hypnotherapy|gut-directed hypnotherapy
4801496|NCT02613078|Probiotic|probiotic
4801497|NCT02613065|Ad libitum|ad libitum
4801498|NCT02613065|Energy balance|energy balance
4801499|NCT02613065|Protein|protein
4801500|NCT02613039|oral contraceptives|oral contraceptives
4801501|NCT02613039|female sexuality|female sexuality
4801502|NCT02613026|Breast tumor|breast tumor
4801503|NCT02613026|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
4801504|NCT02613026|Pathological complete remission|pathological complete remission
4801505|NCT02612987|CBT|cbt
4801506|NCT02612987|Internet based|internet based
4801507|NCT02612974|Qurse mafasil|qurse mafasil
4801508|NCT02612974|leech therapy|leech therapy
4801509|NCT02612974|Hirudinaria granulosa|hirudinaria granulosa
4801510|NCT02612961|Mechanically ventilated patients|mechanically ventilated patients
4801511|NCT02612961|Normal Saline|normal saline
4801512|NCT02612961|Tracheostomy Tube Suctioning|tracheostomy tube suctioning
4801513|NCT02612922|Influenza|influenza
4801514|NCT02612909|Avian Influenza|avian influenza
4801515|NCT02612909|A/H5N1 vaccine|a/h5n1 vaccine
4801516|NCT02612909|IVAC|ivac
4801517|NCT02612896|Taenia solium|taenia solium
4801518|NCT02612896|control|control
4801519|NCT02612896|elimination|elimination
4801520|NCT02612896|One Health|one health
4801521|NCT02612883|Flux measurement|flux measurement
4801522|NCT02612870|Breast Cancer|breast cancer
4801523|NCT02612870|Sentinel Node|sentinel node
4801524|NCT02612870|Sentinel Node Biopsy|sentinel node biopsy
4801525|NCT02612870|Breast Surgery|breast surgery
4801526|NCT02612857|dermatomyositis|dermatomyositis
4801527|NCT02612857|IMO-8400|imo-8400
4801528|NCT02612857|Pioneer|pioneer
4801529|NCT02612818|coelioscopy|coelioscopy
4801530|NCT02612766|celiac disease|celiac disease
4801531|NCT02612766|oat|oat
4801532|NCT02612766|gluten free diet|gluten free diet
4801533|NCT02612753|Aphasia|aphasia
4801534|NCT02612753|Speaking therapy|speaking therapy
4801535|NCT02612753|Language therapy|language therapy
4801536|NCT02612753|transcranial Direct current stimulation|transcranial direct current stimulation
4801537|NCT02612740|Bio Oss|bio oss
4801538|NCT02612740|critical-size defect|critical-size defect
4801539|NCT02612740|bone grafting|bone grafting
4801540|NCT02612740|cyst|cyst
4801541|NCT02612740|CT bone analysis|ct bone analysis
4801542|NCT02612740|alveolar bone|alveolar bone
4801543|NCT02612727|Hyperbilirubinemia, Neonatal|hyperbilirubinemia, neonatal
4801544|NCT02612714|diabetes|diabetes
4801545|NCT02612714|hypercholesterolemia|hypercholesterolemia
4801546|NCT02612714|sexual dysfunction|sexual dysfunction
4801547|NCT02612714|statin|statin
4801548|NCT02612714|testosterone|testosterone
4801549|NCT02612701|Myocardial perfusion|myocardial perfusion
4801550|NCT02612701|Electronic cigarettes|electronic cigarettes
4801551|NCT02612701|Cigarettes|cigarettes
4801552|NCT02612701|Cigarette smoking|cigarette smoking
4801553|NCT02612688|Advance Care Planning|advance care planning
4801554|NCT02612688|Advance Directives|advance directives
4801555|NCT02612688|Alzheimer Disease|alzheimer disease
4801556|NCT02612688|Dementia|dementia
4801557|NCT02612688|Do-Not-Resuscitate Orders|do-not-resuscitate orders
4801558|NCT02612688|Enteral Nutrition|enteral nutrition
4801559|NCT02612688|Heart Failure|heart failure
4801560|NCT02612688|Hospices|hospices
4801561|NCT02612688|Hospitalization|hospitalization
4801562|NCT02612688|Instructional Films and Videos|instructional films and videos
4801563|NCT02612688|Intubation|intubation
4801564|NCT02612688|Nursing Homes|nursing homes
4801565|NCT02612688|Parenteral Nutrition|parenteral nutrition
4801566|NCT02612688|Pragmatic Clinical Trials|pragmatic clinical trials
4801567|NCT02612688|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
4801568|NCT02612688|Randomized Controlled Trials|randomized controlled trials
4801569|NCT02612688|Resuscitation Orders|resuscitation orders
4801570|NCT02612688|Skilled Nursing Facilities|skilled nursing facilities
4801571|NCT02612662|AZD4076|azd4076
4801572|NCT02612662|Healthy male subjects|healthy male subjects
4801573|NCT02612662|Safety|safety
4801574|NCT02612662|Subcutaneous|subcutaneous
4801575|NCT02612662|Tolerability|tolerability
4801576|NCT02612649|Irritable bowel syndrome|irritable bowel syndrome
4801577|NCT02612649|YM060|ym060
4801578|NCT02612649|Ramosetron|ramosetron
4801579|NCT02612649|Survey|survey
4801580|NCT02612636|Delirium|delirium
4801581|NCT02612636|Ear Plug|ear plug
4801582|NCT02612636|Eye Mask|eye mask
4801583|NCT02612636|Mechanical ventilation|mechanical ventilation
4801584|NCT02612636|Sleep|sleep
4801585|NCT02612597|before and after bedrest|before and after bedrest
4801586|NCT02612597|healthy untrained|healthy untrained
4801587|NCT02612597|before and after exercise training|before and after exercise training
4801588|NCT02612558|Warm antibody autoimmune hemolytic anemia (AIHA)|warm antibody autoimmune hemolytic anemia (aiha)
4801589|NCT02612545|Plasmodium Falciparum|plasmodium falciparum
4801590|NCT02612545|Artemisinin Combination Therapy|artemisinin combination therapy
4801591|NCT02612545|Triple Artemisinin Combination Therapy|triple artemisinin combination therapy
4801592|NCT02612545|Piperaquine|piperaquine
4801593|NCT02612545|Mefloquine|mefloquine
4801594|NCT02612493|obesity surgery|obesity surgery
4801595|NCT02612493|type I diabetes|type i diabetes
4801596|NCT02612493|weight loss|weight loss
4801597|NCT02612493|insulin dosage|insulin dosage
4801598|NCT02612493|postsurgery metabolic changes|postsurgery metabolic changes
4801599|NCT02612480|endotoxin|endotoxin
4801600|NCT02612480|LPS|lps
4801601|NCT02612480|ticagrelor|ticagrelor
4801602|NCT02612480|clopidogrel|clopidogrel
4801603|NCT02612480|acetylsalicyclic acid|acetylsalicyclic acid
4801604|NCT02612480|placebo|placebo
4801605|NCT02612467|start back tool|start back tool
4801606|NCT02612467|stratified care|stratified care
4801607|NCT02612467|targeted treatment|targeted treatment
4801608|NCT02612454|Eczema|eczema
4801609|NCT02612441|stroke|stroke
4801610|NCT02612389|COPD|copd
4801611|NCT02612389|Qigong|qigong
4801612|NCT02612389|ANS|ans
4801613|NCT02612389|Meditative Movement|meditative movement
4801614|NCT02612389|Flight Attendants|flight attendants
4801615|NCT02612389|Secondhand Smoke|secondhand smoke
4801616|NCT02612389|Nicotine|nicotine
4801617|NCT02612389|Blood Pressure|blood pressure
4801618|NCT02612389|6 minute walk test|6 minute walk test
4801619|NCT02612363|septic shock|septic shock
4801620|NCT02612363|sedation|sedation
4801621|NCT02612363|microcirculation|microcirculation
4801622|NCT02612350|ctDNA|ctdna
4801623|NCT02612350|high risk for developing cancer|high risk for developing cancer
4801624|NCT02612350|Plasma|plasma
4801625|NCT02612350|Relative Risk|relative risk
4801626|NCT02612350|Early Detection of Cancer|early detection of cancer
4801627|NCT02612350|Cancer Screening Tests|cancer screening tests
4801628|NCT02612350|Cancer Screening|cancer screening
4801629|NCT02612337|Meniere's Disease|meniere's disease
4801630|NCT02612337|Vertigo|vertigo
4801631|NCT02612324|adolescents|adolescents
4801632|NCT02612324|teen pregnancy prevention|teen pregnancy prevention
4801633|NCT02612324|sexually transmitted infections prevention|sexually transmitted infections prevention
4801634|NCT02612324|place-based programs|place-based programs
4801635|NCT02612324|health education|health education
4801636|NCT02612298|Essential Hypertension|essential hypertension
4801637|NCT02612298|Arotinolol|arotinolol
4801638|NCT02612298|Morning Blood Pressure|morning blood pressure
4801639|NCT02612233|Pain|pain
4801640|NCT02612220|liver resection|liver resection
4801641|NCT02612181|dexmedetomidine|dexmedetomidine
4801642|NCT02612181|microcirculation|microcirculation
4801643|NCT02612181|septic shock|septic shock
4801644|NCT02612168|Diagnosis|diagnosis
4801645|NCT02612168|skin imaging|skin imaging
4801646|NCT02612155|Hypoxic-ischemic encephalopathy|hypoxic-ischemic encephalopathy
4801647|NCT02612155|autologous cord blood cells|autologous cord blood cells
4801648|NCT02612155|newborn infants|newborn infants
4801649|NCT02612129|NPC1|npc1
4801650|NCT02612129|Niemann-Pick Type C|niemann-pick type c
4801651|NCT02612129|Niemann-Pick|niemann-pick
4801652|NCT02612129|arimoclomol|arimoclomol
4801653|NCT02612129|lysosomal storage disorder|lysosomal storage disorder
4801654|NCT02612129|lysosomal storage disease|lysosomal storage disease
4801655|NCT02612129|NPC2|npc2
4801656|NCT02612129|NP-C|np-c
4801657|NCT02612103|Biochemical markers|biochemical markers
4801658|NCT02612090|Nutrition|nutrition
4801659|NCT02612090|Polyphenols|polyphenols
4801660|NCT02612090|Berries|berries
4801661|NCT02612090|Lipid Panels|lipid panels
4801662|NCT02612051|patients|patients
4801663|NCT02612051|FTIH|ftih
4801664|NCT02612051|healthy volunteers|healthy volunteers
4801665|NCT02612051|GSK3008348|gsk3008348
4801666|NCT02612051|[18F]-FBA-A20FMDV2|[18f]-fba-a20fmdv2
4801667|NCT02612051|Idiopathic Pulmonary Fibrosis|idiopathic pulmonary fibrosis
4801668|NCT02612051|PET|pet
4801669|NCT02612038|Obstructive sleep apnea|obstructive sleep apnea
4801670|NCT02612038|Expiratory flow limitation|expiratory flow limitation
4801671|NCT02612012|breast cancer|breast cancer
4801672|NCT02612012|positive sentinel lymph nodes|positive sentinel lymph nodes
4801673|NCT02612012|axillary radiotherapy|axillary radiotherapy
4801674|NCT02611999|Physicians' ordering behavior with price information|physicians' ordering behavior with price information
4801675|NCT02611986|Airway management|airway management
4801676|NCT02611986|video laryngoscope|video laryngoscope
4801677|NCT02611973|Essential Thrombocythemia|essential thrombocythemia
4801678|NCT02611973|Aspirin|aspirin
4801679|NCT02611960|PD-1|pd-1
4801680|NCT02611960|PD1|pd1
4801681|NCT02611960|PD-L1|pd-l1
4801682|NCT02611960|PDL1|pdl1
4801683|NCT02611947|emphysema|emphysema
4801684|NCT02611947|airway remodelling|airway remodelling
4801685|NCT02611947|multidetector computed tomography|multidetector computed tomography
4801686|NCT02611921|Ketamine|ketamine
4801687|NCT02611921|Social Impairment|social impairment
4801688|NCT02611921|Autism|autism
4801689|NCT02611921|Autistic Disorder|autistic disorder
4801690|NCT02611908|CLL|cll
4801691|NCT02611908|cancer|cancer
4801692|NCT02611908|obinutuzumab|obinutuzumab
4801693|NCT02611908|ibrutinib|ibrutinib
4801694|NCT02611908|SLL|sll
4801695|NCT02611895|Aviremic HIV-1 infected patients|aviremic hiv-1 infected patients
4801696|NCT02611895|HAART|haart
4801697|NCT02611895|Integrase inhibitor Raltegravir|integrase inhibitor raltegravir
4801698|NCT02611895|Ongoing HIV infection|ongoing hiv infection
4801699|NCT02611856|twin to twin,|twin to twin,
4801700|NCT02611856|transfusion syndrome|transfusion syndrome
4801701|NCT02611843|peer support|peer support
4801702|NCT02611843|web-based treatment|web-based treatment
4801703|NCT02611843|veterans|veterans
4801704|NCT02611843|PTSD|ptsd
4801705|NCT02611843|Substance Use Disorders|substance use disorders
4801706|NCT02611830|Drug therapy|drug therapy
4801707|NCT02611817|Drug therapy|drug therapy
4801708|NCT02611791|Treatment by Pulsed Radio Frequency, Collagen, Female|treatment by pulsed radio frequency, collagen, female
4801709|NCT02611713|Advanced Parkinson's Disease|advanced parkinson's disease
4801710|NCT02611713|Duodopa/Duopa|duodopa/duopa
4801711|NCT02611713|carbidopa levodopa enteral suspension (CLES)|carbidopa levodopa enteral suspension (cles)
4801712|NCT02611713|levodopa-carbidopa intestinal gel (LCIG)|levodopa-carbidopa intestinal gel (lcig)
4801713|NCT02611713|OFF time|off time
4801714|NCT02611713|motor and non-motor symptoms|motor and non-motor symptoms
4801715|NCT02611713|dyskinesia|dyskinesia
4801716|NCT02611713|tremor|tremor
4801717|NCT02611713|Quality of Life|quality of life
4801718|NCT02611713|Observational|observational
4801719|NCT02611713|Long-term|long-term
4801720|NCT02611713|Caregiver Burden|caregiver burden
4801721|NCT02611713|effectiveness|effectiveness
4801722|NCT02611713|fluctuations|fluctuations
4801723|NCT02611635|non-valvular Atrial Fibrillation|non-valvular atrial fibrillation
4801724|NCT02611635|Patient treatment preference|patient treatment preference
4801725|NCT02611635|NOAC|noac
4801726|NCT02611635|VKA|vka
4801727|NCT02611583|TENS|tens
4801728|NCT02611570|Lung cancer|lung cancer
4801729|NCT02611570|Low dose computed tomography|low dose computed tomography
4801730|NCT02611570|Screening|screening
4801731|NCT02611570|Non-smoker|non-smoker
4801732|NCT02611570|Gender issue|gender issue
4801733|NCT02611557|MRI|mri
4801734|NCT02611557|lymphedema|lymphedema
4801735|NCT02611557|manual lymphatic drainage|manual lymphatic drainage
4801736|NCT02611544|Fear of Cancer Recurrence|fear of cancer recurrence
4801737|NCT02611544|Fear of Cancer Return|fear of cancer return
4801738|NCT02611544|Breast Cancer Survivor|breast cancer survivor
4801739|NCT02611544|Breast Cancer Remission|breast cancer remission
4801740|NCT02611518|Healthy|healthy
4801741|NCT02611518|JNJ-54861911|jnj-54861911
4801742|NCT02611518|Rosuvastatin|rosuvastatin
4801743|NCT02611518|Metformin|metformin
4801744|NCT02611505|Healthy|healthy
4801745|NCT02611505|Esketamine|esketamine
4801746|NCT02611505|Hepatic Impairment|hepatic impairment
4801747|NCT02611505|Pharmacokinetics|pharmacokinetics
4801748|NCT02611479|patient reported outcomes|patient reported outcomes
4801749|NCT02611466|Osteoarthritis|osteoarthritis
4801750|NCT02611466|ASP7962|asp7962
4801751|NCT02611453|choledocholithiasis|choledocholithiasis
4801752|NCT02611453|ERCP|ercp
4801753|NCT02611453|cholangiography|cholangiography
4801754|NCT02611453|biliary stricture|biliary stricture
4801755|NCT02611453|bile ducts|bile ducts
4801756|NCT02611453|carbon dioxide|carbon dioxide
4801757|NCT02611440|ischemic stroke|ischemic stroke
4801758|NCT02611440|medication adherence|medication adherence
4801759|NCT02611440|cardiovascular disease prevention|cardiovascular disease prevention
4801760|NCT02611427|spine|spine
4801761|NCT02611427|lumbar|lumbar
4801762|NCT02611427|postoperative|postoperative
4801763|NCT02611427|physical activity|physical activity
4801764|NCT02611414|functional dyspepsia|functional dyspepsia
4801765|NCT02611414|tDCS|tdcs
4801766|NCT02611401|multiple sclerosis|multiple sclerosis
4801767|NCT02611401|depression|depression
4801768|NCT02611401|mindfulness|mindfulness
4801769|NCT02611336|Left Ventricular Hypertrophy|left ventricular hypertrophy
4801770|NCT02611336|Diastolic Dysfunction|diastolic dysfunction
4801771|NCT02611336|Myocardial Fibrosis|myocardial fibrosis
4801772|NCT02611336|Acromegaly|acromegaly
4801773|NCT02611297|Cryoprobes|cryoprobes
4801774|NCT02611297|Cryobiopsy|cryobiopsy
4801775|NCT02611297|Transbronchial lung biopsy|transbronchial lung biopsy
4801776|NCT02611284|Beractant|beractant
4801777|NCT02611284|Feasibility Studies|feasibility studies
4801778|NCT02611284|Infant, Premature|infant, premature
4801779|NCT02611284|Noninvasive Ventilation|noninvasive ventilation
4801780|NCT02611258|Left Ventricular Hypertrophy|left ventricular hypertrophy
4801781|NCT02611258|Diastolic Dysfunction|diastolic dysfunction
4801782|NCT02611258|Myocardial Fibrosis|myocardial fibrosis
4801783|NCT02611258|Cushing's Syndrome|cushing's syndrome
4801784|NCT02611245|Thoracic Duct|thoracic duct
4801785|NCT02611245|Sentinel lymph node biopsy|sentinel lymph node biopsy
4801786|NCT02611232|Diabetes Type 1|diabetes type 1
4801787|NCT02611232|Diabetes, Insulin-Dependent|diabetes, insulin-dependent
4801788|NCT02611232|Liraglutide|liraglutide
4801789|NCT02611232|Preclinical Type 1 Diabetes|preclinical type 1 diabetes
4801790|NCT02611232|GLP-1 Analogue|glp-1 analogue
4801791|NCT02611206|rTMS|rtms
4801792|NCT02611167|mesenchymal stem cells|mesenchymal stem cells
4801793|NCT02611154|Healthy Volunteers|healthy volunteers
4801794|NCT02611154|Sports Medicine|sports medicine
4801795|NCT02611154|Men's Health|men's health
4801796|NCT02611154|Athletes|athletes
4801797|NCT02611154|Anti-Doping|anti-doping
4801798|NCT02611141|Retromolar Intubation|retromolar intubation
4801799|NCT02611115|Pulmonary Embolism|pulmonary embolism
4801800|NCT02611115|Multidetector Computed Tomography|multidetector computed tomography
4801801|NCT02611115|Radiation Dosage|radiation dosage
4801802|NCT02611115|Contrast Media|contrast media
4801803|NCT02611115|Individualized Medicine|individualized medicine
4801804|NCT02611089|Muscle connective tissue|muscle connective tissue
4801805|NCT02611089|Small leucine-rich proteoglycans|small leucine-rich proteoglycans
4801806|NCT02611089|Limb development|limb development
4801807|NCT02611076|smoking cessation|smoking cessation
4801808|NCT02611076|self-help|self-help
4801809|NCT02611076|Spanish language|spanish language
4801810|NCT02611063|allogeneic stem cell transplant|allogeneic stem cell transplant
4801811|NCT02611050|patient decision aid|patient decision aid
4801812|NCT02611050|multi-vessel coronary artery disease|multi-vessel coronary artery disease
4801813|NCT02611037|MPM|mpm
4801814|NCT02611037|Unresectable|unresectable
4801815|NCT02611037|Respiratory|respiratory
4801816|NCT02611037|Intrathoracic|intrathoracic
4801817|NCT02611037|Transarterial|transarterial
4801818|NCT02611037|Chemoperfusion|chemoperfusion
4801819|NCT02611024|lurbinectedin|lurbinectedin
4801820|NCT02611024|PM01183|pm01183
4801821|NCT02611024|tumors|tumors
4801822|NCT02611024|cancer|cancer
4801823|NCT02611024|Pharma Mar|pharma mar
4801824|NCT02611011|Congo Red Dot Test|congo red dot test
4801825|NCT02610985|Imaging, Three-Dimensional|imaging, three-dimensional
4801826|NCT02610985|Hysterectomy|hysterectomy
4801827|NCT02610985|laparoscopic hysterectomy|laparoscopic hysterectomy
4801828|NCT02610972|Congo Red test GV-005|congo red test gv-005
4801829|NCT02610946|pediatric|pediatric
4801830|NCT02610946|adolescent|adolescent
4801831|NCT02610946|compliance|compliance
4801832|NCT02610933|vascular calcification|vascular calcification
4801833|NCT02610933|hemodialysis|hemodialysis
4801834|NCT02610933|rivaroxaban|rivaroxaban
4801835|NCT02610933|vitamin K2|vitamin k2
4801836|NCT02610894|postoperative symptom management|postoperative symptom management
4801837|NCT02610894|symptom management|symptom management
4801838|NCT02610894|mHealth application|mhealth application
4801839|NCT02610868|Cerebral Palsy|cerebral palsy
4801840|NCT02610868|ALS|als
4801841|NCT02610868|Stroke|stroke
4801842|NCT02610868|Neuroleptics|neuroleptics
4801843|NCT02610803|stroke|stroke
4801844|NCT02610803|ischemic stroke|ischemic stroke
4801845|NCT02610803|recurrent stroke|recurrent stroke
4801846|NCT02610803|atrial fibrillation|atrial fibrillation
4801847|NCT02610803|premature atrial complexes|premature atrial complexes
4801848|NCT02610803|heart rhythm monitoring|heart rhythm monitoring
4801849|NCT02610803|cardiac telemetry|cardiac telemetry
4801850|NCT02610790|connected bracelets, footsteps|connected bracelets, footsteps
4801851|NCT02610777|Drug Therapy|drug therapy
4801852|NCT02610764|Circulating Tumor Cells|circulating tumor cells
4801853|NCT02610764|Response evaluation|response evaluation
4801854|NCT02610751|Maternal Smoking|maternal smoking
4801855|NCT02610751|Female Fetal Testosterone|female fetal testosterone
4801856|NCT02610751|Anogenital Distance|anogenital distance
4801857|NCT02610751|Maternal Testosterone|maternal testosterone
4801858|NCT02610751|Maternal Cotinine|maternal cotinine
4801859|NCT02610712|ketamine|ketamine
4801860|NCT02610712|treatment-resistant|treatment-resistant
4801861|NCT02610712|depression|depression
4801862|NCT02610712|spectroscopy|spectroscopy
4801863|NCT02610712|neuroinflammation|neuroinflammation
4801864|NCT02610686|Plasmodium vivax|plasmodium vivax
4801865|NCT02610686|recurrence|recurrence
4801866|NCT02610686|drug resistance|drug resistance
4801867|NCT02610634|Parkinson's disease|parkinson's disease
4801868|NCT02610634|Older adults|older adults
4801869|NCT02610634|Vision|vision
4801870|NCT02610634|Cognition|cognition
4801871|NCT02610634|Visual cues|visual cues
4801872|NCT02610634|Eye-tracking|eye-tracking
4801873|NCT02610634|Gait|gait
4801874|NCT02610634|Saccades|saccades
4801875|NCT02610634|Dual task|dual task
4801876|NCT02610634|Visual sampling|visual sampling
4801877|NCT02610621|Clinically node negative|clinically node negative
4801878|NCT02610621|T1 and T2 invasive breast cancer|t1 and t2 invasive breast cancer
4801879|NCT02610595|Idiopathic Membranous Nephropathy|idiopathic membranous nephropathy
4801880|NCT02610595|Jianpiyiqi Recipe|jianpiyiqi recipe
4801881|NCT02610595|Huoxuejiedu Recipe|huoxuejiedu recipe
4801882|NCT02610595|Effectiveness|effectiveness
4801883|NCT02610595|Safety|safety
4801884|NCT02610582|CNGA3-linked|cnga3-linked
4801885|NCT02610569|Colonic capsule|colonic capsule
4801886|NCT02610569|ulcerative colitis|ulcerative colitis
4801887|NCT02610569|mucosal healing|mucosal healing
4801888|NCT02610569|endoscopic score|endoscopic score
4801889|NCT02610556|NPC|npc
4801890|NCT02610556|concurrent chemotherapy|concurrent chemotherapy
4801891|NCT02610556|docetaxel|docetaxel
4801892|NCT02610556|cisplatin|cisplatin
4801893|NCT02610543|Primary Sjögren's Syndrome|primary sjögren's syndrome
4801894|NCT02610530|type 2 diabetes|type 2 diabetes
4801895|NCT02610530|metabolic surgery|metabolic surgery
4801896|NCT02610530|medical treatment|medical treatment
4801897|NCT02610517|Hazardous alcohol use|hazardous alcohol use
4801898|NCT02610517|Computer based intervention (CBI)|computer based intervention (cbi)
4801899|NCT02610517|Pharmacotherapy|pharmacotherapy
4801900|NCT02610504|degenerative arthritis|degenerative arthritis
4801901|NCT02610465|Computed Tomography|computed tomography
4801902|NCT02610465|Image Reconstruction|image reconstruction
4801903|NCT02610465|Iterative Reconstruction|iterative reconstruction
4801904|NCT02610452|clown therapy|clown therapy
4801905|NCT02610387|tDCS|tdcs
4801906|NCT02610387|stroke|stroke
4801907|NCT02610387|Spasticity|spasticity
4801908|NCT02610374|Gut microbiota composition|gut microbiota composition
4801909|NCT02610348|Hepatitis B|hepatitis b
4801910|NCT02610348|Hexaxim®|hexaxim®
4801911|NCT02610348|Hexyon®|hexyon®
4801912|NCT02610348|Hexacima®|hexacima®
4801913|NCT02610348|Prevnar®|prevnar®
4801914|NCT02610348|DTaP-IPV-HB-Hib hexavalent vaccine|dtap-ipv-hb-hib hexavalent vaccine
4801915|NCT02610335|lumbar spinal stenosis|lumbar spinal stenosis
4801916|NCT02610309|family-based crisis intervention|family-based crisis intervention
4801917|NCT02610309|adolescent suicide|adolescent suicide
4801918|NCT02610283|AKI|aki
4801919|NCT02610270|Sport|sport
4801920|NCT02610270|fatty acid|fatty acid
4801921|NCT02610270|omega 3|omega 3
4801922|NCT02610257|Parkinson's disease|parkinson's disease
4801923|NCT02610257|Freezing of gait|freezing of gait
4802026|NCT02609672|Resilience|resilience
4801924|NCT02610257|Motor blocks|motor blocks
4801925|NCT02610257|Somatosensory|somatosensory
4801926|NCT02610257|Proprioception|proprioception
4801927|NCT02610257|Muscle vibration|muscle vibration
4801928|NCT02610257|Handwriting|handwriting
4801929|NCT02610231|Parkinson's disease|parkinson's disease
4801930|NCT02610231|Moderate to Severe Parkinson's Disease|moderate to severe parkinson's disease
4801931|NCT02610218|Cell free DNA|cell free dna
4801932|NCT02610218|Circulating tumor cell|circulating tumor cell
4801933|NCT02610218|Therapeutic efficacy|therapeutic efficacy
4801934|NCT02610205|Caring touch|caring touch
4801935|NCT02610205|Tactile massage|tactile massage
4801936|NCT02610205|Healing touch|healing touch
4801937|NCT02610192|Autologous Protein Solution|autologous protein solution
4801938|NCT02610192|Patellofemoral Osteoarthritis|patellofemoral osteoarthritis
4801939|NCT02610192|Female|female
4801940|NCT02610114|Assisted reproductive technology (ART)|assisted reproductive technology (art)
4801941|NCT02610114|zygotes|zygotes
4801942|NCT02610114|Z-score (Zygote Score)|z-score (zygote score)
4801943|NCT02610114|Infertility|infertility
4801944|NCT02610088|Diabetes|diabetes
4801945|NCT02610088|Atherosclerosis|atherosclerosis
4801946|NCT02610088|Cardiovascular disease|cardiovascular disease
4801947|NCT02610088|Endothelial dysfunction|endothelial dysfunction
4801948|NCT02610088|Vascular function|vascular function
4801949|NCT02610088|Dapagliflozin|dapagliflozin
4801950|NCT02610088|Gliclazide|gliclazide
4801951|NCT02610075|AZD1775|azd1775
4801952|NCT02610075|Metastatic solid tumors|metastatic solid tumors
4801953|NCT02610075|Ovarian cancer|ovarian cancer
4801954|NCT02610062|AML|aml
4801955|NCT02610062|Acute Myeloid Leukemia|acute myeloid leukemia
4801956|NCT02610049|PTSD|ptsd
4801957|NCT02610036|diabetes|diabetes
4801958|NCT02610036|foot ulcer|foot ulcer
4801959|NCT02610010|NPC|npc
4801960|NCT02610010|concurrent chemotherapy|concurrent chemotherapy
4801961|NCT02610010|IMRT|imrt
4801962|NCT02610010|stage II|stage ii
4801963|NCT02609997|Intraocular lens|intraocular lens
4801964|NCT02609984|immunotherapy|immunotherapy
4801965|NCT02609984|CMB305|cmb305
4801966|NCT02609984|LV305|lv305
4801967|NCT02609984|GLA-SE|gla-se
4801968|NCT02609984|Atezolizumab|atezolizumab
4801969|NCT02609984|NY-ESO-1|ny-eso-1
4801970|NCT02609971|Anterior cruciate ligament|anterior cruciate ligament
4801971|NCT02609971|Neuromuscular Performance and balance|neuromuscular performance and balance
4801972|NCT02609945|Migraine attacks|migraine attacks
4801973|NCT02609932|Interferon-gamma|interferon-gamma
4801974|NCT02609932|innate immunity|innate immunity
4801975|NCT02609919|study of contrast reaction in children under 2 years of age|study of contrast reaction in children under 2 years of age
4801976|NCT02609919|safety|safety
4801977|NCT02609906|proximal humerus|proximal humerus
4801978|NCT02609906|AO 11-A3 fracture|ao 11-a3 fracture
4801979|NCT02609906|MultiLoc|multiloc
4801980|NCT02609906|Philos augmented|philos augmented
4801981|NCT02609893|HCV|hcv
4801982|NCT02609880|Psycho-Oncology|psycho-oncology
4801983|NCT02609880|Psychoneuroimmunology|psychoneuroimmunology
4801984|NCT02609880|Cognitive Behavioral Therapy|cognitive behavioral therapy
4801985|NCT02609880|Gynecologic Cancer|gynecologic cancer
4801986|NCT02609880|Insomnia|insomnia
4801987|NCT02609880|Pain|pain
4801988|NCT02609880|Distress|distress
4801989|NCT02609880|Cortisol|cortisol
4801990|NCT02609880|Cytokines|cytokines
4801991|NCT02609854|herniated disc|herniated disc
4801992|NCT02609854|sustained acoustic medicine|sustained acoustic medicine
4801993|NCT02609854|ultrasound|ultrasound
4801994|NCT02609854|CLBP|clbp
4801995|NCT02609828|Metastatic cancer bone pain|metastatic cancer bone pain
4801996|NCT02609828|Multiple myeloma|multiple myeloma
4801997|NCT02609789|Systemic Lupus Erythematosus|systemic lupus erythematosus
4801998|NCT02609789|JNJ-55920839|jnj-55920839
4801999|NCT02609789|Healthy Volunteers|healthy volunteers
4802000|NCT02609789|CNTO 6358|cnto 6358
4802001|NCT02609776|Non-Small-Cell Lung Cancer|non-small-cell lung cancer
4802002|NCT02609776|JNJ-61186372|jnj-61186372
4802003|NCT02609776|First-in-Human|first-in-human
4802004|NCT02609776|Human Bispecific Epidermal Growth Factor Receptor (EGFR)|human bispecific epidermal growth factor receptor (egfr)
4802005|NCT02609776|cMet Antibody|cmet antibody
4802006|NCT02609737|Radiolabeled Somatostatin Antagonists|radiolabeled somatostatin antagonists
4802007|NCT02609737|68Ga-DOTA-JR11|68ga-dota-jr11
4802008|NCT02609737|177Lu-DOTA-JR11|177lu-dota-jr11
4802009|NCT02609737|Pet scan|pet scan
4802010|NCT02609737|CT scan|ct scan
4802011|NCT02609737|15-161|15-161
4802012|NCT02609724|breast cancer|breast cancer
4802013|NCT02609724|lymphedema|lymphedema
4802014|NCT02609724|manual lymph drainage|manual lymph drainage
4802015|NCT02609724|near infrared fluorescence imaging|near infrared fluorescence imaging
4802016|NCT02609698|Stent|stent
4802017|NCT02609698|Polymer-free|polymer-free
4802018|NCT02609698|Antiplatelet therapy|antiplatelet therapy
4802019|NCT02609698|Clopidogrel|clopidogrel
4802020|NCT02609698|DES|des
4802021|NCT02609698|DAPT|dapt
4802022|NCT02609685|Thyroid cancer|thyroid cancer
4802023|NCT02609685|Active surveillance|active surveillance
4802024|NCT02609685|PTMC|ptmc
4802025|NCT02609672|Exercise|exercise
4802027|NCT02609659|Chronic Hepatitis C Infection|chronic hepatitis c infection
4802028|NCT02609646|Anti-Infective Agents|anti-infective agents
4802029|NCT02609646|Pharmacokinetics|pharmacokinetics
4802030|NCT02609646|Critically ill patients|critically ill patients
4802031|NCT02609594|human amniotic membrane|human amniotic membrane
4802032|NCT02609594|compression therapy|compression therapy
4802033|NCT02609594|venous leg ulcer|venous leg ulcer
4802034|NCT02609581|Non Interventional Study|non interventional study
4802035|NCT02609581|NIS|nis
4802036|NCT02609581|sublingual immunotherapy|sublingual immunotherapy
4802037|NCT02609581|allergen|allergen
4802038|NCT02609581|Mites|mites
4802039|NCT02609568|Children|children
4802040|NCT02609568|Head injury|head injury
4802041|NCT02609568|Salivary biomarker|salivary biomarker
4802042|NCT02609568|Trauma Brain Injury|trauma brain injury
4802043|NCT02609555|TEM|tem
4802044|NCT02609555|Rectopexy|rectopexy
4802045|NCT02609555|rectal prolapse|rectal prolapse
4802046|NCT02609542|oral language|oral language
4802047|NCT02609542|STOL|stol
4802048|NCT02609542|memory|memory
4802049|NCT02609542|eye tracking|eye tracking
4802050|NCT02609529|Irritable Bowel Syndrome|irritable bowel syndrome
4802051|NCT02609529|Pediatrics|pediatrics
4802052|NCT02609529|Nutrition|nutrition
4802053|NCT02609516|Multimorbidity|multimorbidity
4802054|NCT02609516|Health inequalities|health inequalities
4802055|NCT02609516|Ageing|ageing
4802056|NCT02609516|Mortality|mortality
4802057|NCT02609477|Recreational stimulant users|recreational stimulant users
4802058|NCT02609477|Recreational Drug Users|recreational drug users
4802059|NCT02609451|quality of life|quality of life
4802060|NCT02609451|feasibility|feasibility
4802061|NCT02609451|safety|safety
4802062|NCT02609451|protective ileostomy closure|protective ileostomy closure
4802063|NCT02609438|worksite|worksite
4802064|NCT02609438|intervention|intervention
4802065|NCT02609438|sitting|sitting
4802066|NCT02609399|Influenza|influenza
4802067|NCT02609399|Antiviral treatment|antiviral treatment
4802068|NCT02609399|Emergency department|emergency department
4802069|NCT02609399|Influenza therapeutics|influenza therapeutics
4802070|NCT02609399|Rapid influenza testing|rapid influenza testing
4802071|NCT02609386|Head and Neck Neoplasms|head and neck neoplasms
4802072|NCT02609386|Immunotherapy|immunotherapy
4802073|NCT02609386|Cancer|cancer
4802074|NCT02609386|Oral Cavity|oral cavity
4802075|NCT02609373|shiftwork|shiftwork
4802076|NCT02609373|sleep hygiene|sleep hygiene
4802077|NCT02609373|prevention|prevention
4802078|NCT02609373|intervention|intervention
4802079|NCT02609373|occupational|occupational
4802080|NCT02609373|biological|biological
4802081|NCT02609373|breast cancer|breast cancer
4802082|NCT02609373|lifestyle|lifestyle
4802083|NCT02609360|Acute Respiratory Failure|acute respiratory failure
4802084|NCT02609360|ARDS|ards
4802085|NCT02609360|ECMO|ecmo
4802086|NCT02609360|Lung transplantation|lung transplantation
4802087|NCT02609360|Acid-Base Equilibrium|acid-base equilibrium
4802088|NCT02609347|Manual Therapy|manual therapy
4802089|NCT02609347|Ankle Fracture|ankle fracture
4802090|NCT02609347|Hindfoot Fracture|hindfoot fracture
4802091|NCT02609321|Paravertebral|paravertebral
4802092|NCT02609321|Single injection|single injection
4802093|NCT02609321|Breast surgery|breast surgery
4802094|NCT02609321|Analgesia|analgesia
4802095|NCT02609308|ankle sprain|ankle sprain
4802096|NCT02609308|platelet-rich plasma|platelet-rich plasma
4802097|NCT02609308|ankle injuries|ankle injuries
4802098|NCT02609295|α-linolenic acid|α-linolenic acid
4802099|NCT02609295|perilla oil|perilla oil
4802100|NCT02609295|aPTT|aptt
4802101|NCT02609295|Collagen-epinephrine closure time|collagen-epinephrine closure time
4802102|NCT02609295|Lp-PLA2|lp-pla2
4802103|NCT02609282|Sedentary behaviour|sedentary behaviour
4802104|NCT02609282|sitting|sitting
4802105|NCT02609282|workplace|workplace
4802106|NCT02609282|prompts|prompts
4802107|NCT02609256|Intracranial hypertension|intracranial hypertension
4802108|NCT02609256|cerebral herniation|cerebral herniation
4802109|NCT02609256|Stereotactic infarct tissue aspiration|stereotactic infarct tissue aspiration
4802110|NCT02609256|fatality|fatality
4802111|NCT02609256|disability|disability
4802112|NCT02609243|prediabetes|prediabetes
4802113|NCT02609243|diabetes mellitus type 2|diabetes mellitus type 2
4802114|NCT02609243|obesity|obesity
4802115|NCT02609243|NAFLD|nafld
4802116|NCT02609243|dyslipoproteinemia|dyslipoproteinemia
4802117|NCT02609217|elective|elective
4802118|NCT02609217|cesarean|cesarean
4802119|NCT02609178|artificial crown|artificial crown
4802120|NCT02609178|biomorphic|biomorphic
4802121|NCT02609178|functional generated path|functional generated path
4802122|NCT02609178|muscle-action theory|muscle-action theory
4802123|NCT02609178|anatomic theory|anatomic theory
4802124|NCT02609126|osteoarthritis|osteoarthritis
4802125|NCT02609126|knee|knee
4802126|NCT02609113|Carpal Tunnel Syndrome|carpal tunnel syndrome
4802127|NCT02609074|bone substitute|bone substitute
4802128|NCT02609074|CPC|cpc
4802129|NCT02609074|rhBMP-2|rhbmp-2
4802130|NCT02609048|PBC|pbc
4802131|NCT02609022|Myasthenia Gravis|myasthenia gravis
4802336|NCT02607852|Burns|burns
4802132|NCT02609022|CV-MG01 therapeutic vaccine|cv-mg01 therapeutic vaccine
4802133|NCT02609022|Acetylcholine receptor mimetic peptides|acetylcholine receptor mimetic peptides
4802134|NCT02609022|Safety|safety
4802135|NCT02609022|Immunogenic response|immunogenic response
4802136|NCT02609022|First-in-Human|first-in-human
4802137|NCT02609022|Proof-of-Concept|proof-of-concept
4802138|NCT02609022|Myasterix|myasterix
4802139|NCT02609009|Back Pain|back pain
4802140|NCT02609009|Adolescent Idiopathic Scoliosis|adolescent idiopathic scoliosis
4802141|NCT02609009|Spinal Manipulation|spinal manipulation
4802142|NCT02608983|Seaweed|seaweed
4802143|NCT02608983|Hydrocolloid|hydrocolloid
4802144|NCT02608983|Functional Food|functional food
4802145|NCT02608983|Dietary Fibre|dietary fibre
4802146|NCT02608983|Prebiotic|prebiotic
4802147|NCT02608983|Low molecular weight polysaccharides|low molecular weight polysaccharides
4802148|NCT02608983|Alginate|alginate
4802149|NCT02608983|Agar|agar
4802150|NCT02608983|HYFFI|hyffi
4802151|NCT02608983|Low molecular weight seaweed derived hydrocolloids as functional food ingredients|low molecular weight seaweed derived hydrocolloids as functional food ingredients
4802152|NCT02608983|subjects|subjects
4802153|NCT02608931|delta-9-tetrahydrocannabinol (THC)|delta-9-tetrahydrocannabinol (thc)
4802154|NCT02608892|Breastfeeding|breastfeeding
4802155|NCT02608892|Skin to skin care|skin to skin care
4802156|NCT02608892|Sucrose|sucrose
4802157|NCT02608892|Newborn screening|newborn screening
4802158|NCT02608892|Blood test|blood test
4802159|NCT02608892|Neonate|neonate
4802160|NCT02608892|Infant|infant
4802161|NCT02608892|Knowledge translation|knowledge translation
4802162|NCT02608879|proinflammatory cytokines|proinflammatory cytokines
4802163|NCT02608879|microbiome|microbiome
4802164|NCT02608879|radiation therapy|radiation therapy
4802165|NCT02608866|stereotactic ablative radiotherapy|stereotactic ablative radiotherapy
4802166|NCT02608866|spine metastasis|spine metastasis
4802167|NCT02608840|slow-wave sleep|slow-wave sleep
4802168|NCT02608840|cognition|cognition
4802169|NCT02608840|auditory stimulation|auditory stimulation
4802170|NCT02608827|Hypertension; slow breathing; sympathetic nerve activity|hypertension; slow breathing; sympathetic nerve activity
4802171|NCT02608788|postoperative sore throat|postoperative sore throat
4802172|NCT02608788|American Society of Anesthesiologists status|american society of anesthesiologists status
4802173|NCT02608788|general anesthesia|general anesthesia
4802174|NCT02608788|post-anesthesia care unit(PACU)|post-anesthesia care unit(pacu)
4802175|NCT02608775|ANI|ani
4802176|NCT02608775|SPI|spi
4802177|NCT02608775|Autonomic balance|autonomic balance
4802178|NCT02608775|Nociception measurement|nociception measurement
4802179|NCT02608762|Pediatric brain tumors|pediatric brain tumors
4802180|NCT02608762|Radiation therapy|radiation therapy
4802181|NCT02608762|Neurobehavioral functions|neurobehavioral functions
4802182|NCT02608762|Proton radiotherapy|proton radiotherapy
4802183|NCT02608749|Osteoporosis|osteoporosis
4802184|NCT02608749|Fall|fall
4802185|NCT02608749|Fracture|fracture
4802186|NCT02608749|Sacopenia|sacopenia
4802187|NCT02608749|Body Composition|body composition
4802188|NCT02608736|head and neck squamous cell carcinoma|head and neck squamous cell carcinoma
4802189|NCT02608736|histone deacetylases|histone deacetylases
4802190|NCT02608736|valproic acid|valproic acid
4802191|NCT02608736|acetylation|acetylation
4802192|NCT02608736|chemoprevention|chemoprevention
4802193|NCT02608736|DNA methyltransferase|dna methyltransferase
4802194|NCT02608736|methylation|methylation
4802195|NCT02608723|shock wave|shock wave
4802196|NCT02608723|plantar fasciitis|plantar fasciitis
4802197|NCT02608723|placebo effect|placebo effect
4802198|NCT02608723|nocebo effect|nocebo effect
4802199|NCT02608684|immunotherapy|immunotherapy
4802200|NCT02608684|platinum-resistant ovarian cancer|platinum-resistant ovarian cancer
4802201|NCT02608684|immune checkpoint inhibitors|immune checkpoint inhibitors
4802202|NCT02608671|Episiotomy|episiotomy
4802203|NCT02608671|continuous suture|continuous suture
4802204|NCT02608671|Skin adhesive tape|skin adhesive tape
4802205|NCT02608658|Cirrhosis|cirrhosis
4802206|NCT02608658|Ascites|ascites
4802207|NCT02608658|SBP|sbp
4802208|NCT02608632|Renal denervation|renal denervation
4802209|NCT02608632|Ablation|ablation
4802210|NCT02608619|18F-fluorocholine|18f-fluorocholine
4802211|NCT02608619|Pet imaging|pet imaging
4802212|NCT02608619|Biopsy|biopsy
4802213|NCT02608619|15-268|15-268
4802214|NCT02608580|pediatric hospital care|pediatric hospital care
4802215|NCT02608580|adult hospital care|adult hospital care
4802216|NCT02608580|sickle cell disease|sickle cell disease
4802217|NCT02608554|Polycystic ovary sybdrome|polycystic ovary sybdrome
4802218|NCT02608554|Taichi|taichi
4802219|NCT02608541|Multiple Rib Fractures, Frail Chest|multiple rib fractures, frail chest
4802220|NCT02608476|acne|acne
4802221|NCT02608463|neuropathic pain|neuropathic pain
4802222|NCT02608463|pregnancy|pregnancy
4802223|NCT02608450|acne|acne
4802224|NCT02608437|melanoma|melanoma
4802225|NCT02608437|ipilimumab|ipilimumab
4802226|NCT02608437|SGI-110|sgi-110
4802227|NCT02608424|Foot mechanical stimulation|foot mechanical stimulation
4802228|NCT02608424|Autonomic nervous system|autonomic nervous system
4802229|NCT02608424|Inflammation|inflammation
4802230|NCT02608424|Parkinson's disease|parkinson's disease
4802231|NCT02608424|Spectral analysis|spectral analysis
4802232|NCT02608424|Heart rate variability|heart rate variability
4802233|NCT02608424|Blood pressure variability|blood pressure variability
4802234|NCT02608398|obesity|obesity
4802235|NCT02608398|weight-loss|weight-loss
4802236|NCT02608398|metabonomics|metabonomics
4802237|NCT02608398|gut microbiome|gut microbiome
4802238|NCT02608372|Seaweed|seaweed
4802239|NCT02608372|Insulin|insulin
4802240|NCT02608372|Glucose tolerance|glucose tolerance
4802241|NCT02608372|C-peptide|c-peptide
4802242|NCT02608372|Appetide|appetide
4802243|NCT02608372|Metabolomics|metabolomics
4802244|NCT02608359|Post-Marketing Surveillance|post-marketing surveillance
4802245|NCT02608359|Abiraterone Acetate|abiraterone acetate
4802246|NCT02608359|Zytiga|zytiga
4802247|NCT02608346|Circulating tumor DNA|circulating tumor dna
4802248|NCT02608346|BRCA1 mutation|brca1 mutation
4802249|NCT02608346|Circulating tumor cells|circulating tumor cells
4802250|NCT02608333|Early intervention|early intervention
4802251|NCT02608333|ESDM|esdm
4802252|NCT02608333|behavioral and developmental intervention|behavioral and developmental intervention
4802253|NCT02608320|Healthy|healthy
4802254|NCT02608320|JNJ-35685-AAA-G016|jnj-35685-aaa-g016
4802255|NCT02608320|JNJ-35685-AAA-G021|jnj-35685-aaa-g021
4802256|NCT02608320|DURAGESIC|duragesic
4802257|NCT02608320|Fentanyl|fentanyl
4802258|NCT02608307|Treatment Decision-Making|treatment decision-making
4802259|NCT02608307|Adolescents and Young Adult Oncology|adolescents and young adult oncology
4802260|NCT02608294|stroke|stroke
4802261|NCT02608294|gait|gait
4802262|NCT02608294|balance|balance
4802263|NCT02608281|Spectral Mammography|spectral mammography
4802264|NCT02608281|Dual energy|dual energy
4802265|NCT02608281|Contrast enhanced|contrast enhanced
4802266|NCT02608268|Solid tumors|solid tumors
4802267|NCT02608268|Melanoma|melanoma
4802268|NCT02608268|Non small cell lung cancer|non small cell lung cancer
4802269|NCT02608268|NSCLC|nsclc
4802270|NCT02608268|Renal cell carcinoma|renal cell carcinoma
4802271|NCT02608268|RCC|rcc
4802272|NCT02608268|Phase I-Ib/II|phase i-ib/ii
4802273|NCT02608268|MBG453|mbg453
4802274|NCT02608268|PDR001|pdr001
4802275|NCT02608268|Checkpoint inhibitor|checkpoint inhibitor
4802276|NCT02608268|PD-1|pd-1
4802277|NCT02608268|TIM-3|tim-3
4802278|NCT02608164|Healthy adults|healthy adults
4802279|NCT02608151|neurodevelopement|neurodevelopement
4802280|NCT02608151|Very preterm infant|very preterm infant
4802281|NCT02608138|iodine|iodine
4802282|NCT02608138|urine|urine
4802283|NCT02608138|children|children
4802284|NCT02608138|schools|schools
4802285|NCT02608138|cognitive performance|cognitive performance
4802286|NCT02608138|salt fortification|salt fortification
4802287|NCT02608125|FGFR|fgfr
4802288|NCT02608099|Atrial fibrillation|atrial fibrillation
4802289|NCT02608099|Non-valvular atrial fibrillation|non-valvular atrial fibrillation
4802290|NCT02608099|Catheter ablation|catheter ablation
4802291|NCT02608099|Apixaban|apixaban
4802292|NCT02608099|Warfarin|warfarin
4802293|NCT02608099|Harvard Clinical Research Institute|harvard clinical research institute
4802294|NCT02608086|PTSD|ptsd
4802295|NCT02608086|Trauma|trauma
4802296|NCT02608086|Emergency|emergency
4802297|NCT02608086|RCT|rct
4802298|NCT02608086|Psychological First Aid|psychological first aid
4802299|NCT02608021|Alzheimer's Disease|alzheimer's disease
4802300|NCT02608021|MRI|mri
4802301|NCT02608008|3D-Ultrasound|3d-ultrasound
4802302|NCT02608008|Live X-rays|live x-rays
4802303|NCT02608008|EchoNavigator System|echonavigator system
4802304|NCT02607982|Esophageal cancer|esophageal cancer
4802305|NCT02607982|Concurrent chemoradiotherapy|concurrent chemoradiotherapy
4802306|NCT02607982|Oxaliplatin|oxaliplatin
4802307|NCT02607982|Paclitaxel|paclitaxel
4802308|NCT02607982|Survival|survival
4802309|NCT02607982|Toxicity|toxicity
4802310|NCT02607969|Deformational Plagiocephaly,Treatment,Compliance|deformational plagiocephaly,treatment,compliance
4802311|NCT02607956|HIV|hiv
4802312|NCT02607943|acute stroke|acute stroke
4802313|NCT02607943|hyperglycemia|hyperglycemia
4802314|NCT02607943|regular insulin|regular insulin
4802315|NCT02607943|long-acting insulin|long-acting insulin
4802316|NCT02607930|HIV|hiv
4802317|NCT02607917|Cardiovascular Disease|cardiovascular disease
4802318|NCT02607904|Cannabidiol|cannabidiol
4802319|NCT02607904|GWP42003-P|gwp42003-p
4802320|NCT02607904|Epidiolex|epidiolex
4802321|NCT02607904|Stiripentol|stiripentol
4802322|NCT02607904|Valproate|valproate
4802323|NCT02607891|Cannabidiol|cannabidiol
4802324|NCT02607891|GWP42003-P|gwp42003-p
4802325|NCT02607891|Epidiolex|epidiolex
4802326|NCT02607891|Stiripentol|stiripentol
4802327|NCT02607891|Valproate|valproate
4802328|NCT02607878|Cardiac arrest|cardiac arrest
4802329|NCT02607878|Coma|coma
4802330|NCT02607878|Prognosis|prognosis
4802331|NCT02607878|Automated pupillometry|automated pupillometry
4802332|NCT02607878|EEG|eeg
4802333|NCT02607878|Evoked potentials|evoked potentials
4802334|NCT02607878|Targeted Temperature Management (TTM)|targeted temperature management (ttm)
4802335|NCT02607852|Patient Reported Outcomes Measure|patient reported outcomes measure
4802337|NCT02607839|lipid handling by the gut and liver|lipid handling by the gut and liver
4802338|NCT02607813|LXH254, CRAF, MAPK, solid tumor, PDR001|lxh254, craf, mapk, solid tumor, pdr001
4802339|NCT02607800|Chronic Hepatitis C Infection|chronic hepatitis c infection
4802340|NCT02607787|Exercise Rehabilitation|exercise rehabilitation
4802341|NCT02607774|Plaque psoriasis|plaque psoriasis
4802342|NCT02607774|disease-drug-drug-interaction|disease-drug-drug-interaction
4802343|NCT02607774|midazolam|midazolam
4802344|NCT02607774|secukinumab|secukinumab
4802345|NCT02607761|infertility|infertility
4802346|NCT02607761|fertility awareness|fertility awareness
4802347|NCT02607761|health interventions|health interventions
4802348|NCT02607761|young adults|young adults
4802349|NCT02607748|18F-NaF PET|18f-naf pet
4802350|NCT02607748|18F-sodium fluoride PET|18f-sodium fluoride pet
4802351|NCT02607748|Coronary CTA|coronary cta
4802352|NCT02607735|Chronic Hepatitis C Infection|chronic hepatitis c infection
4802353|NCT02607644|Intubation|intubation
4802354|NCT02607644|Ventilation|ventilation
4802355|NCT02607644|Cardiac arrest|cardiac arrest
4802356|NCT02607644|prehospital|prehospital
4802357|NCT02607644|Laryngeal Masks|laryngeal masks
4802358|NCT02607644|Laryngeal Tube|laryngeal tube
4802359|NCT02607644|airway management|airway management
4802360|NCT02607631|Thymic epithelial tumors|thymic epithelial tumors
4802361|NCT02607631|Pembrolizumab|pembrolizumab
4802362|NCT02607605|lung cancer|lung cancer
4802363|NCT02607605|leptomeningeal metastases|leptomeningeal metastases
4802364|NCT02607605|cell-free DNA|cell-free dna
4802365|NCT02607592|Non-Small-Cell Lung cancer|non-small-cell lung cancer
4802366|NCT02607592|overall toxicity value|overall toxicity value
4802367|NCT02607566|Diabetes|diabetes
4802368|NCT02607566|Yoga|yoga
4802369|NCT02607566|Walking|walking
4802370|NCT02607566|Stress|stress
4802371|NCT02607566|exercise|exercise
4802372|NCT02607566|glycemic control|glycemic control
4802373|NCT02607540|Chemoradiotherapy|chemoradiotherapy
4802374|NCT02607540|Esophageal Squamous Cancer|esophageal squamous cancer
4802375|NCT02607540|Cisplatin-5-fluorouracil|cisplatin-5-fluorouracil
4802376|NCT02607501|coil embolization|coil embolization
4802377|NCT02607501|bifurcation|bifurcation
4802378|NCT02607488|Obese patients|obese patients
4802379|NCT02607488|Undergoing bariatric surgery|undergoing bariatric surgery
4802380|NCT02607475|telesonography|telesonography
4802381|NCT02607475|ultrasound|ultrasound
4802382|NCT02607475|robotic telesonography|robotic telesonography
4802383|NCT02607449|MDR TB|mdr tb
4802384|NCT02607449|Tuberculosis|tuberculosis
4802385|NCT02607410|Type 2 diabetes|type 2 diabetes
4802386|NCT02607410|sitagliptin|sitagliptin
4802387|NCT02607410|NPH insulin|nph insulin
4802388|NCT02607410|GLP-1|glp-1
4802389|NCT02607371|Patient treatment preference|patient treatment preference
4802390|NCT02607371|Non-valvular Atrial Fibrillation|non-valvular atrial fibrillation
4802391|NCT02607371|NOAC|noac
4802392|NCT02607371|VKA|vka
4802393|NCT02607358|Clopidogrel|clopidogrel
4802394|NCT02607358|acetacylic acid|acetacylic acid
4802395|NCT02607358|antiplatelet therapy|antiplatelet therapy
4802396|NCT02607358|HOTPR|hotpr
4802397|NCT02607358|VerifyNow|verifynow
4802398|NCT02607332|single-center|single-center
4802399|NCT02607332|prospective|prospective
4802400|NCT02607332|single-arm|single-arm
4802401|NCT02607332|open-label|open-label
4802402|NCT02607332|phase II|phase ii
4802403|NCT02607319|Recurrent Implantation Failure|recurrent implantation failure
4802404|NCT02607319|Implantation|implantation
4802405|NCT02607319|low molecular weight heparin|low molecular weight heparin
4802406|NCT02607319|In vitro Fertilization|in vitro fertilization
4802407|NCT02607319|Assisted Reproductive Technology|assisted reproductive technology
4802408|NCT02607319|Pregnancy|pregnancy
4802409|NCT02607293|Polycystic Ovary Syndrome|polycystic ovary syndrome
4802410|NCT02607293|Gonadotropin releasing hormone agonist (GnRH-a)|gonadotropin releasing hormone agonist (gnrh-a)
4802411|NCT02607293|Gonal-f|gonal-f
4802412|NCT02607293|Assisted Reproductive Technology|assisted reproductive technology
4802413|NCT02607280|Diabetic peripheral neuropathic pain|diabetic peripheral neuropathic pain
4802414|NCT02607280|post-herpetic neuralgia|post-herpetic neuralgia
4802415|NCT02607280|renal impairment|renal impairment
4802416|NCT02607267|EOSS|eoss
4802417|NCT02607267|Metabolic Surgery|metabolic surgery
4802418|NCT02607267|postoperative outcome|postoperative outcome
4802419|NCT02607267|30 - day mortality|30 - day mortality
4802420|NCT02607241|drug-coated balloon|drug-coated balloon
4802421|NCT02607241|bioresorbable scaffold|bioresorbable scaffold
4802422|NCT02607241|fractional flow reserve|fractional flow reserve
4802423|NCT02607241|optical coherence tomography|optical coherence tomography
4802424|NCT02607150|Spinal Fusion|spinal fusion
4802425|NCT02607150|Cerebral Oxygenation|cerebral oxygenation
4802426|NCT02607150|Blood Transfusion|blood transfusion
4802427|NCT02607124|DIPG|dipg
4802428|NCT02607111|Dalteparin|dalteparin
4802429|NCT02607111|Dosage|dosage
4802430|NCT02607111|Home Hemodialysis|home hemodialysis
4802431|NCT02607072|APREMEC, aspirin, colorectal cancer, adjuvant therapy, recurrence, metastasis, survival|apremec, aspirin, colorectal cancer, adjuvant therapy, recurrence, metastasis, survival
4802432|NCT02607046|rehabilitation|rehabilitation
4802433|NCT02607046|exercise training|exercise training
4802434|NCT02607033|Exercise|exercise
4802435|NCT02607033|Weight Loss|weight loss
4802436|NCT02607033|Mobility Limitation|mobility limitation
4802437|NCT02607007|Dairy|dairy
4802438|NCT02607007|Post-prandial Glycemia|post-prandial glycemia
4802439|NCT02607007|Satiety|satiety
4802440|NCT02607007|Food Intake|food intake
4802441|NCT02607007|Insulin|insulin
4802442|NCT02607007|Milk|milk
4802443|NCT02607007|Greek yogurt|greek yogurt
4802444|NCT02607007|Cheese|cheese
4802445|NCT02607007|Soy beverage|soy beverage
4802446|NCT02606994|oral mucositis|oral mucositis
4802447|NCT02606994|chemotherapy|chemotherapy
4802448|NCT02606994|toothpaste|toothpaste
4802449|NCT02606981|Water treatment|water treatment
4802450|NCT02606981|Child growth|child growth
4802451|NCT02606981|Enteric infection|enteric infection
4802452|NCT02606955|Bioimpedance|bioimpedance
4802453|NCT02606955|Dry weight|dry weight
4802454|NCT02606955|Hemodialysis|hemodialysis
4802455|NCT02606955|Resistance|resistance
4802456|NCT02606942|chondromalacia patellae (CMP)|chondromalacia patellae (cmp)
4802457|NCT02606942|patella|patella
4802458|NCT02606916|Once-daily Simultaneous Modulated Accelerated Radiotherapy|once-daily simultaneous modulated accelerated radiotherapy
4802459|NCT02606916|S-1|s-1
4802460|NCT02606916|DDP|ddp
4802461|NCT02606916|elderly patients|elderly patients
4802462|NCT02606890|Magnetic Resonance Imaging|magnetic resonance imaging
4802463|NCT02606890|Stroke Lesion Pattern|stroke lesion pattern
4802464|NCT02606890|Atrial Fibrillation|atrial fibrillation
4802465|NCT02606890|Stroke|stroke
4802466|NCT02606851|Proton Pump Inhibitor, GERD, GERD Q|proton pump inhibitor, gerd, gerd q
4802467|NCT02606799|Esophagectomy Inflammation Hemoperfusion Cytokines|esophagectomy inflammation hemoperfusion cytokines
4802468|NCT02606786|stabilization exercises|stabilization exercises
4802469|NCT02606773|vitamin C supplementation|vitamin c supplementation
4802470|NCT02606760|Nail psoriasis|nail psoriasis
4802471|NCT02606747|DPN|dpn
4802472|NCT02606747|fall|fall
4802473|NCT02606747|fMRI|fmri
4802474|NCT02606747|balance|balance
4802475|NCT02606721|Food Hypersensitivity|food hypersensitivity
4802476|NCT02606721|Oral Food Challenge|oral food challenge
4802477|NCT02606721|Skin Prick Test|skin prick test
4802478|NCT02606721|Food Biomarkers|food biomarkers
4802479|NCT02606695|Spine Surgery Patients|spine surgery patients
4802480|NCT02606682|Phase 1|phase 1
4802481|NCT02606682|Safety|safety
4802482|NCT02606682|Tolerability|tolerability
4802483|NCT02606682|Pharmacokinetics|pharmacokinetics
4802484|NCT02606682|Parkinson's Disease|parkinson's disease
4802485|NCT02606630|Relapsing multiple sclerosis|relapsing multiple sclerosis
4802486|NCT02606617|Mosapride|mosapride
4802487|NCT02606617|blood glucose|blood glucose
4802488|NCT02606617|serum lipid|serum lipid
4802489|NCT02606604|Functional Electrical Stimulation|functional electrical stimulation
4802490|NCT02606604|Cycling|cycling
4802491|NCT02606591|Electroencephalograph|electroencephalograph
4802492|NCT02606591|EEG|eeg
4802493|NCT02606591|Hair sample|hair sample
4802494|NCT02606591|Cognitive tests|cognitive tests
4802495|NCT02606591|Cortisol analysis|cortisol analysis
4802496|NCT02606591|Brain activity|brain activity
4802497|NCT02606591|Stress hormones|stress hormones
4802498|NCT02606552|drug eluting stent|drug eluting stent
4802499|NCT02606552|atrial appendage closure|atrial appendage closure
4802500|NCT02606539|gestaional trophoblastic neoplasm|gestaional trophoblastic neoplasm
4802501|NCT02606539|hystrectomy|hystrectomy
4802502|NCT02606539|chemotherapy|chemotherapy
4802503|NCT02606539|methotrxate|methotrxate
4802504|NCT02606513|Computed Tomography Urography|computed tomography urography
4802505|NCT02606513|Magnetic Resonance Urography|magnetic resonance urography
4802506|NCT02606487|CF|cf
4802507|NCT02606487|Exacerbation|exacerbation
4802508|NCT02606487|Hyerpolarized xenon MRI|hyerpolarized xenon mri
4802509|NCT02606487|Pediatrics|pediatrics
4802510|NCT02606487|Lung Clearance Index|lung clearance index
4802511|NCT02606461|Advanced unresectable dedifferentiated liposarcoma|advanced unresectable dedifferentiated liposarcoma
4802512|NCT02606461|selinexor|selinexor
4802513|NCT02606461|KCP-330|kcp-330
4802514|NCT02606461|Karyopharm|karyopharm
4802515|NCT02606461|Phase 2 / 3|phase 2 / 3
4802516|NCT02606461|dedifferentiated liposarcoma|dedifferentiated liposarcoma
4802517|NCT02606461|Liposarcoma|liposarcoma
4802518|NCT02606448|pain control|pain control
4802519|NCT02606448|patient satisfaction|patient satisfaction
4802520|NCT02606448|liposomal bupivacaine|liposomal bupivacaine
4802521|NCT02606448|Anterior cruciate ligament reconstruction|anterior cruciate ligament reconstruction
4802522|NCT02606422|transcranial direct current stimulation (tDCS)|transcranial direct current stimulation (tdcs)
4802523|NCT02606422|neurodegeneration|neurodegeneration
4802524|NCT02606422|language therapy|language therapy
4802525|NCT02606422|Primary Progressive Aphasia (PPA)|primary progressive aphasia (ppa)
4802526|NCT02606370|Unstable Shoes;Trunk muscles;Lumbar lordosis;Low Back Pain|unstable shoes;trunk muscles;lumbar lordosis;low back pain
4802527|NCT02606318|Occupational Therapy|occupational therapy
4802528|NCT02606318|Quality of Life|quality of life
4802529|NCT02606305|Epithelial ovarian cancer|epithelial ovarian cancer
4802530|NCT02606305|Fallopian tube cancer|fallopian tube cancer
4802531|NCT02606305|Primary peritoneal cancer|primary peritoneal cancer
4802532|NCT02606305|IMGN853|imgn853
4802533|NCT02606305|ADC|adc
4802534|NCT02606305|Antibody drug conjugate|antibody drug conjugate
4802535|NCT02606305|ImmunoGen|immunogen
4802536|NCT02606305|Antibody|antibody
4802537|NCT02606305|Phase 1|phase 1
4802538|NCT02606305|Folate receptor alpha|folate receptor alpha
4802539|NCT02606253|loop diuretics|loop diuretics
4802540|NCT02606253|thiazide diuretics|thiazide diuretics
4802541|NCT02606253|vasopressin antagonists|vasopressin antagonists
4802542|NCT02606253|diuretic resistance|diuretic resistance
4802543|NCT02606253|heart failure|heart failure
4802544|NCT02606227|Pregnant smokers|pregnant smokers
4802545|NCT02606227|smoking cessation|smoking cessation
4802546|NCT02606227|financial incentives|financial incentives
4802547|NCT02606227|control group|control group
4802548|NCT02606227|randomized study|randomized study
4802549|NCT02606214|Tuberculosis|tuberculosis
4802550|NCT02606214|TBA-354|tba-354
4802551|NCT02606214|Pulmonary Tuberculosis|pulmonary tuberculosis
4802552|NCT02606214|TB|tb
4802553|NCT02606201|stress urinary incontinence|stress urinary incontinence
4802554|NCT02606201|intrinsic sphincter deficiency|intrinsic sphincter deficiency
4802555|NCT02606201|myofiber|myofiber
4802556|NCT02606201|autologous|autologous
4802557|NCT02606201|skeletal muscle precursor cells|skeletal muscle precursor cells
4802558|NCT02606201|autologous serum|autologous serum
4802559|NCT02606188|Modified High-flow nasal cannula|modified high-flow nasal cannula
4802560|NCT02606188|Bronchoscopy|bronchoscopy
4802561|NCT02606188|Oxygen therapy|oxygen therapy
4802562|NCT02606175|health literacy|health literacy
4802563|NCT02606175|patient medication knowledge|patient medication knowledge
4802564|NCT02606175|kidney transplantation|kidney transplantation
4802565|NCT02606175|medication adherence|medication adherence
4802566|NCT02606175|kidney transplant|kidney transplant
4802567|NCT02606175|renal transplantation|renal transplantation
4802568|NCT02606149|Lung cancer|lung cancer
4802569|NCT02606149|chemotherapy outcome|chemotherapy outcome
4802570|NCT02606149|ethics|ethics
4802571|NCT02606149|information|information
4802572|NCT02606136|Duchenne|duchenne
4802573|NCT02606136|muscular|muscular
4802574|NCT02606136|dystrophy|dystrophy
4802575|NCT02606136|DMD|dmd
4802576|NCT02606136|non-ambulatory|non-ambulatory
4802577|NCT02606123|Prostate Cancer|prostate cancer
4802578|NCT02606123|Metastatic castration-resistant prostate cancer|metastatic castration-resistant prostate cancer
4802579|NCT02606110|ReBuilder|rebuilder
4802580|NCT02606110|breast cancer|breast cancer
4802581|NCT02606110|chemotherapy induced|chemotherapy induced
4802582|NCT02606084|Renal Impairment|renal impairment
4802583|NCT02606084|Healthy|healthy
4802584|NCT02606084|Esketamine|esketamine
4802585|NCT02606071|cardiac resynchronization therapy|cardiac resynchronization therapy
4802586|NCT02606071|multipoint left ventricular pacing|multipoint left ventricular pacing
4802587|NCT02606045|menorrhagia|menorrhagia
4802588|NCT02606045|VWD|vwd
4802589|NCT02606032|Fecal Microbiota Transplant|fecal microbiota transplant
4802590|NCT02606032|Antibiotics|antibiotics
4802591|NCT02606019|Pentraxin 3|pentraxin 3
4802592|NCT02606019|Vascular Endothelial Growth Factor|vascular endothelial growth factor
4802593|NCT02606019|dengue|dengue
4802594|NCT02606006|Physical Therapy Modalities|physical therapy modalities
4802595|NCT02606006|Motivation|motivation
4802596|NCT02606006|Patient Participation|patient participation
4802597|NCT02606006|Animal Assisted Therapy|animal assisted therapy
4802598|NCT02605993|complement inhibitor|complement inhibitor
4802599|NCT02605967|PDR001,|pdr001,
4802600|NCT02605967|nasopharyngeal cancer,|nasopharyngeal cancer,
4802601|NCT02605967|moderately differentiated/undifferentiated,|moderately differentiated/undifferentiated,
4802602|NCT02605967|locally advanced,|locally advanced,
4802603|NCT02605967|recurrent or metastatic NPC,|recurrent or metastatic npc,
4802604|NCT02605967|after first- line platinum-based therapy|after first- line platinum-based therapy
4802605|NCT02605954|HIV 1 Infection|hiv 1 infection
4802606|NCT02605954|HIV|hiv
4802607|NCT02605954|Virologically-Suppressed|virologically-suppressed
4802608|NCT02605954|Antiretroviral agents|antiretroviral agents
4802609|NCT02605941|DNA methylation|dna methylation
4802610|NCT02605941|Cervical cancer|cervical cancer
4802611|NCT02605928|Arthritis|arthritis
4802612|NCT02605928|Bioimpedance|bioimpedance
4802613|NCT02605928|Glucocorticoid|glucocorticoid
4802614|NCT02605928|Intra-articular injection|intra-articular injection
4802615|NCT02605928|Needle Guidance|needle guidance
4802616|NCT02605902|Chronic tic disorders|chronic tic disorders
4802617|NCT02605902|Tourette syndrome|tourette syndrome
4802618|NCT02605876|anterior cruciate ligament reconstruction|anterior cruciate ligament reconstruction
4802619|NCT02605863|Enzalutamide|enzalutamide
4802620|NCT02605863|Non-Muscle Invasive Bladder Cancer|non-muscle invasive bladder cancer
4802621|NCT02605863|Androgen Deprivation Therapy|androgen deprivation therapy
4802622|NCT02605850|heart health|heart health
4802623|NCT02605811|limited small cell lung cancer|limited small cell lung cancer
4802624|NCT02605811|brain metastases|brain metastases
4802625|NCT02605811|prophylactic cranial radiotherapy|prophylactic cranial radiotherapy
4802626|NCT02605811|temozolomide|temozolomide
4802627|NCT02605785|PSP|psp
4802628|NCT02605733|Premature infant|premature infant
4802629|NCT02605733|Amplitude integrated EEG|amplitude integrated eeg
4802630|NCT02605733|Near-infrared spectroscopy|near-infrared spectroscopy
4802631|NCT02605707|Endothelial Progenitor Cells|endothelial progenitor cells
4802632|NCT02605707|Transplantation|transplantation
4802633|NCT02605707|Stroke|stroke
4802634|NCT02605681|midkine|midkine
4802635|NCT02605681|endothelial injury|endothelial injury
4802636|NCT02605681|sepsis|sepsis
4802637|NCT02605668|Anxiety Disorders|anxiety disorders
4802638|NCT02605668|Extinction Learning|extinction learning
4802639|NCT02605668|Optimized Extinction|optimized extinction
4802640|NCT02605668|Behavioral Therapy|behavioral therapy
4802641|NCT02605668|Massed Confrontation|massed confrontation
4802642|NCT02605668|Social Anxiety Disorder|social anxiety disorder
4802643|NCT02605668|Specific Phobia|specific phobia
4802644|NCT02605668|Panic Disorder|panic disorder
4802645|NCT02605668|Agoraphobia|agoraphobia
4802646|NCT02605655|obesity|obesity
4802647|NCT02605655|hyperlipidemia|hyperlipidemia
4802648|NCT02605655|hyperglycemia|hyperglycemia
4802649|NCT02605642|Inflectra|inflectra
4802650|NCT02605642|Infliximab|infliximab
4802651|NCT02605642|Observational|observational
4802652|NCT02605642|Remicade|remicade
4802653|NCT02605603|Gaucher Type 1, Gaucher Type 2, Gaucher Type 3|gaucher type 1, gaucher type 2, gaucher type 3
4802654|NCT02605577|late preterm infants|late preterm infants
4802655|NCT02605577|nutrition|nutrition
4802656|NCT02605577|systemic management|systemic management
4802657|NCT02605525|IgAN|igan
4802658|NCT02605512|Radiotherapy|radiotherapy
4802659|NCT02605512|Echocardiography|echocardiography
4802660|NCT02605512|Strain strain rate|strain strain rate
4802661|NCT02605512|Coronary computed tomography angiography|coronary computed tomography angiography
4802662|NCT02605512|Segments of coronary arteries|segments of coronary arteries
4802663|NCT02605512|Subclinical functional and anatomical cardiac lesions|subclinical functional and anatomical cardiac lesions
4802664|NCT02605512|Biomarkers|biomarkers
4802665|NCT02605512|Heart dosimetry|heart dosimetry
4802666|NCT02605486|palbociclib|palbociclib
4802667|NCT02605486|bicalutamide|bicalutamide
4802668|NCT02605486|AR(+)|ar(+)
4802669|NCT02605486|15-207|15-207
4802670|NCT02605473|Melanoma|melanoma
4802671|NCT02605473|Malignant melanoma|malignant melanoma
4802672|NCT02605473|Unresectable|unresectable
4802673|NCT02605473|Decitabine|decitabine
4802674|NCT02605473|PEG Interferon Alpha-2b|peg interferon alpha-2b
4802675|NCT02605473|PEG Intron|peg intron
4802676|NCT02605473|5-Aza-Deoxycytidine|5-aza-deoxycytidine
4802677|NCT02605473|Dacogen|dacogen
4802678|NCT02605460|Bone Marrow Transplantation|bone marrow transplantation
4802679|NCT02605460|Conditioning Regimen|conditioning regimen
4802680|NCT02605434|Parkinson's Disease|parkinson's disease
4802681|NCT02605434|Fluctuating Parkinson's Disease|fluctuating parkinson's disease
4802682|NCT02605434|Advanced Parkinson's Disease|advanced parkinson's disease
4802683|NCT02605434|Carbidopa|carbidopa
4802684|NCT02605434|Levodopa|levodopa
4802685|NCT02605434|Accordion|accordion
4802686|NCT02605434|Accordance|accordance
4802687|NCT02605421|High-risk neuroblastoma|high-risk neuroblastoma
4802688|NCT02605421|Neuroblastoma|neuroblastoma
4802689|NCT02605421|Myeloablative chemotherapy|myeloablative chemotherapy
4802690|NCT02605421|Myeloablative consolidation chemotherapy|myeloablative consolidation chemotherapy
4802691|NCT02605421|Autologous peripheral blood stem cell rescue|autologous peripheral blood stem cell rescue
4802692|NCT02605421|PBSC|pbsc
4802693|NCT02605421|Autologous stem cell rescue|autologous stem cell rescue
4802694|NCT02605395|Bioequivalence|bioequivalence
4802695|NCT02605395|Fed condition|fed condition
4802696|NCT02605395|PARIET 20 mg|pariet 20 mg
4802697|NCT02605395|IDIAZOLE 20mg|idiazole 20mg
4802698|NCT02605395|Rabeprazole|rabeprazole
4802699|NCT02605382|Dental Implantation|dental implantation
4802700|NCT02605382|Chlorhexidine gluconate|chlorhexidine gluconate
4802701|NCT02605356|Radium-223 dichloride|radium-223 dichloride
4802702|NCT02605356|bortezomib|bortezomib
4802703|NCT02605356|dexamethasone|dexamethasone
4802704|NCT02605356|early relapsed multiple myeloma|early relapsed multiple myeloma
4802705|NCT02605356|combination therapy multiple myeloma|combination therapy multiple myeloma
4802706|NCT02605343|PGx|pgx
4802707|NCT02605343|pharmacogenetic testing|pharmacogenetic testing
4802708|NCT02605343|Pain Management|pain management
4802709|NCT02605343|AltheaDx|altheadx
4802710|NCT02605343|Post-Operative Pain Management|post-operative pain management
4802711|NCT02605317|Emergency Physicians|emergency physicians
4802712|NCT02605317|Consulting Physicians|consulting physicians
4802713|NCT02605317|WhatsApp|whatsapp
4802714|NCT02605278|Primary Health Care, Patient Education, Care Managament|primary health care, patient education, care managament
4802715|NCT02605265|Neoadjuvant Chemoradiation|neoadjuvant chemoradiation
4802716|NCT02605265|Irinotecan|irinotecan
4802717|NCT02605265|UGT1A1|ugt1a1
4802718|NCT02605252|Chronic hepatitis B|chronic hepatitis b
4802719|NCT02605252|Peginterferon alfa-2b|peginterferon alfa-2b
4802720|NCT02605252|Nucleotide analogue|nucleotide analogue
4802721|NCT02605200|Diabetes|diabetes
4802722|NCT02605200|Endocrinology|endocrinology
4802723|NCT02605200|Pediatrics|pediatrics
4802724|NCT02605187|cesarean|cesarean
4802725|NCT02605187|postoperative pain|postoperative pain
4802726|NCT02605187|patient choice|patient choice
4802727|NCT02605161|Blood brain barrier|blood brain barrier
4802728|NCT02605161|movement disorder|movement disorder
4802729|NCT02605161|deep brain stimulation|deep brain stimulation
4802730|NCT02605161|essential tremor|essential tremor
4802731|NCT02605161|cervical dystonia|cervical dystonia
4802732|NCT02605161|magnetic resonance imaging|magnetic resonance imaging
4802733|NCT02605161|neostriatum|neostriatum
4802734|NCT02605148|Islet autoimmunity|islet autoimmunity
4802735|NCT02605148|gluten free diet|gluten free diet
4802736|NCT02605148|prediabetes|prediabetes
4802737|NCT02605148|prevention|prevention
4802738|NCT02605148|type 1 diabetes|type 1 diabetes
4802739|NCT02605148|glucose tolerance test|glucose tolerance test
4802740|NCT02605122|pneumonia|pneumonia
4802741|NCT02605122|macrolide|macrolide
4802742|NCT02605122|pediatric|pediatric
4802743|NCT02605109|MERS-CoV|mers-cov
4802744|NCT02605109|Infection control|infection control
4802745|NCT02605109|Case-control studies|case-control studies
4802746|NCT02605096|suspected scaphoid fracture|suspected scaphoid fracture
4802747|NCT02605083|Cancer|cancer
4802748|NCT02605083|Neoplasm|neoplasm
4802749|NCT02605083|Solid Tumor|solid tumor
4802750|NCT02605083|Breast|breast
4802751|NCT02605083|Head and Neck|head and neck
4802752|NCT02605083|Lung|lung
4802753|NCT02605083|Pancreatic|pancreatic
4802754|NCT02605083|Hepatic|hepatic
4802755|NCT02605083|Melanoma|melanoma
4802756|NCT02605083|Colon|colon
4802757|NCT02605083|Renal|renal
4802758|NCT02605083|Thyroid|thyroid
4802759|NCT02605083|Prostate|prostate
4802760|NCT02605083|Ovarian|ovarian
4802761|NCT02605083|MNK1|mnk1
4802762|NCT02605083|MNK2|mnk2
4802763|NCT02605083|eIF4E|eif4e
4802764|NCT02605005|interscalene block, general anesthesia, shoulder arthroscopy, cerebral oxygen saturation, beach chair position|interscalene block, general anesthesia, shoulder arthroscopy, cerebral oxygen saturation, beach chair position
4802765|NCT02604992|Comparative Bioavailability|comparative bioavailability
4802766|NCT02604966|P. falciparum|p. falciparum
4802767|NCT02604966|resistance to artemisinin|resistance to artemisinin
4802768|NCT02604966|Central Vietnam|central vietnam
4802769|NCT02604953|glaucoma|glaucoma
4802770|NCT02604953|VEP|vep
4802771|NCT02604953|PERG|perg
4802772|NCT02604953|SD-tVEP|sd-tvep
4802773|NCT02604953|ss-PERG|ss-perg
4802774|NCT02604940|Postoperative narcotic requirements|postoperative narcotic requirements
4802775|NCT02604940|Dexmedetomidine|dexmedetomidine
4802776|NCT02604940|Bariatric Surgery|bariatric surgery
4802777|NCT02604901|medication adherence|medication adherence
4802778|NCT02604901|community pharmacies|community pharmacies
4802779|NCT02604901|screening and brief intervention|screening and brief intervention
4802780|NCT02604888|Baldness|baldness
4802781|NCT02604888|Alopecia Areata|alopecia areata
4802782|NCT02604888|Alopecia|alopecia
4802783|NCT02604888|Hair loss|hair loss
4802784|NCT02604784|Pressurized Intra Peritoneal Air-flow Chemotherapy (PIPAC)|pressurized intra peritoneal air-flow chemotherapy (pipac)
4802785|NCT02604784|Chemotherapy|chemotherapy
4802786|NCT02604784|Peritoneal Carcinomatosis|peritoneal carcinomatosis
4802787|NCT02604758|Alcoholics [M01.066]|alcoholics [m01.066]
4802788|NCT02604745|degenerative mitral regurgitation|degenerative mitral regurgitation
4802789|NCT02604667|Biomarkers|biomarkers
4802790|NCT02604667|Mechanisms|mechanisms
4802791|NCT02604667|Transcranial Doppler|transcranial doppler
4802792|NCT02604641|skin rejuvenation|skin rejuvenation
4802793|NCT02604641|anti-ageing effects|anti-ageing effects
4802794|NCT02604641|minimal erythema dose|minimal erythema dose
4802795|NCT02604641|dermis structure|dermis structure
4802796|NCT02604641|physiological skin condition|physiological skin condition
4802797|NCT02604641|wrinkling|wrinkling
4802798|NCT02604641|dry skin|dry skin
4802799|NCT02604628|Pneumonia|pneumonia
4802800|NCT02604628|Antibiotic Stewardship|antibiotic stewardship
4802801|NCT02604628|Stepped wedge|stepped wedge
4802802|NCT02604628|Antibiotic|antibiotic
4802803|NCT02604615|Chemoradiotherapy|chemoradiotherapy
4802804|NCT02604615|Esophageal Squamous Cancer|esophageal squamous cancer
4802805|NCT02604615|Capecitabine and oxaliplatin|capecitabine and oxaliplatin
4802806|NCT02604615|Chinese|chinese
4802807|NCT02604615|Randomized Controlled Trials|randomized controlled trials
4802808|NCT02604602|PPH|pph
4802809|NCT02604589|Catheters, Indwelling|catheters, indwelling
4802810|NCT02604589|Infusion Pumps|infusion pumps
4802811|NCT02604589|Anesthesia, Local|anesthesia, local
4802812|NCT02604589|Analgesia, Patient-Controlled|analgesia, patient-controlled
4802813|NCT02604589|Bupivacaine|bupivacaine
4802814|NCT02604576|functional dyspepsia|functional dyspepsia
4802815|NCT02604524|Type 1 Diabetes Mellitus (T1DM)|type 1 diabetes mellitus (t1dm)
4802816|NCT02604524|Artificial Pancreas (AP)|artificial pancreas (ap)
4802817|NCT02604524|Sensor-Augmented Pump (SAP) Therapy|sensor-augmented pump (sap) therapy
4802818|NCT02604524|Closed Loop Control|closed loop control
4802819|NCT02604524|Insulin Pump|insulin pump
4802820|NCT02604524|Continuous Glucose Monitor (CGM)|continuous glucose monitor (cgm)
4802821|NCT02604511|Waldenstrom's Macroglobulinemia|waldenstrom's macroglobulinemia
4802822|NCT02604485|Hypoglycemia|hypoglycemia
4802823|NCT02604485|Congenital Hyperinsulinism|congenital hyperinsulinism
4802824|NCT02604472|Nasopharyngeal carcinoma|nasopharyngeal carcinoma
4802825|NCT02604472|induction chemotherapy|induction chemotherapy
4802826|NCT02604472|concurrent chemoradiotherapy|concurrent chemoradiotherapy
4802827|NCT02604446|Arthroplasty, Replacement, Knee|arthroplasty, replacement, knee
4802828|NCT02604446|Analgesics|analgesics
4802829|NCT02604446|Administration and dosage|administration and dosage
4802830|NCT02604446|Knee|knee
4802831|NCT02604446|Postoperational care|postoperational care
4802832|NCT02604446|Pain management|pain management
4802833|NCT02604433|ACE-536|ace-536
4802834|NCT02604433|Safety|safety
4802835|NCT02604433|Efficacy|efficacy
4802836|NCT02604433|Placebo|placebo
4802837|NCT02604433|Red Blood Cell Transfusions|red blood cell transfusions
4802838|NCT02604433|Beta -Thalassemia|beta -thalassemia
4802839|NCT02604394|Rheolytic Thrombectomy|rheolytic thrombectomy
4802840|NCT02604394|Percutaneous Coronary Intervention|percutaneous coronary intervention
4802841|NCT02604394|Angioplasty|angioplasty
4802842|NCT02604394|Cardiac Magnetic Resonance Imaging|cardiac magnetic resonance imaging
4802843|NCT02604394|Myocardial Salvage Index|myocardial salvage index
4802844|NCT02604394|STEMI, ST elevation Myocardial Infarction|stemi, st elevation myocardial infarction
4802845|NCT02604394|Corrected TIMI Frame Count, cTFC|corrected timi frame count, ctfc
4802846|NCT02604394|Index of microcirculatory resistance, thermodilution, IMR|index of microcirculatory resistance, thermodilution, imr
4802847|NCT02604381|Osteoarthritis|osteoarthritis
4802848|NCT02604381|Knee|knee
4802849|NCT02604381|Glucosamine Sulfate|glucosamine sulfate
4802850|NCT02604381|Ginkgo Biloba|ginkgo biloba
4802851|NCT02604381|WOMAC|womac
4802852|NCT02604381|Joint Health Wellness|joint health wellness
4802853|NCT02604381|Interleukin-1-beta|interleukin-1-beta
4802854|NCT02604368|hemoglobin SS|hemoglobin ss
4802855|NCT02604368|hemoglobin SC|hemoglobin sc
4802856|NCT02604368|hemoglobin S/β°-thalassemia|hemoglobin s/β°-thalassemia
4802857|NCT02604329|low level laser therapy|low level laser therapy
4802858|NCT02604329|oral mucositis|oral mucositis
4802859|NCT02604329|child|child
4802860|NCT02604316|Overweight and Obesity|overweight and obesity
4802861|NCT02604316|Appetite|appetite
4802862|NCT02604316|Gut hormones and obesity|gut hormones and obesity
4802863|NCT02604316|Arabinoxylan, Beta-Glucan|arabinoxylan, beta-glucan
4802864|NCT02604316|SmartPill|smartpill
4802865|NCT02604303|Abdominal Aortic Aneurysm|abdominal aortic aneurysm
4802866|NCT02604303|RhoA|rhoa
4802867|NCT02604303|Biomarker|biomarker
4802868|NCT02604290|Kinesio taping|kinesio taping
4802869|NCT02604290|Neuromuscular taping|neuromuscular taping
4802870|NCT02604290|Targeted treatment|targeted treatment
4802871|NCT02604290|Chronic low back pain|chronic low back pain
4802872|NCT02604290|Randomised controlled trial|randomised controlled trial
4802873|NCT02604277|Psychology|psychology
4802874|NCT02604238|Pulmonary Embolism at intermediate risk|pulmonary embolism at intermediate risk
4802875|NCT02604225|Anaethesiology|anaethesiology
4802876|NCT02604186|Spasticity|spasticity
4802877|NCT02604186|Botulinum Toxin|botulinum toxin
4802878|NCT02604186|Hereditary Spastic Paraplegia|hereditary spastic paraplegia
4802879|NCT02604134|silver nitrate|silver nitrate
4802880|NCT02604134|children|children
4802881|NCT02604134|dental caries|dental caries
4802882|NCT02604134|medical management|medical management
4802883|NCT02604134|quality of life|quality of life
4802884|NCT02604121|oral cavity|oral cavity
4802885|NCT02604121|cancerous and precancerous lesions|cancerous and precancerous lesions
4802886|NCT02604108|physical activity|physical activity
4802887|NCT02604108|healthy diet|healthy diet
4802888|NCT02604095|Acanthosis nigricans|acanthosis nigricans
4802889|NCT02604095|Obesity|obesity
4802890|NCT02604069|Breast reconstruction|breast reconstruction
4802891|NCT02604069|Breast cancer|breast cancer
4802892|NCT02604069|Microsurgery|microsurgery
4802893|NCT02604069|Continuous flap monitor|continuous flap monitor
4802894|NCT02604043|supraglottic pH|supraglottic ph
4802895|NCT02604017|HCV GT1|hcv gt1
4802896|NCT02604017|Non-cirrhotic|non-cirrhotic
4802897|NCT02604017|RBV Free|rbv free
4802898|NCT02604017|Without cirrhosis|without cirrhosis
4802899|NCT02604017|Chronic Hepatitis C|chronic hepatitis c
4802900|NCT02604017|Hepatitis C Genotype 1 (GT1)|hepatitis c genotype 1 (gt1)
4802901|NCT02604017|IFN free|ifn free
4802902|NCT02604017|Hepatitis C|hepatitis c
4802903|NCT02604017|Ribavirin Free|ribavirin free
4802904|NCT02604017|Interferon (IFN) Free|interferon (ifn) free
4802906|NCT02604017|Hepatitis C virus|hepatitis c virus
4802907|NCT02604017|DAA|daa
4802908|NCT02604004|lamivudine|lamivudine
4802909|NCT02604004|bioequivalence test|bioequivalence test
4802910|NCT02604004|pharmacokinetics|pharmacokinetics
4802911|NCT02604004|high-performance liquid chromatography|high-performance liquid chromatography
4802912|NCT02604004|3TC|3tc
4802913|NCT02604004|LC-MS/MS|lc-ms/ms
4802914|NCT02604004|mass spectrometry|mass spectrometry
4802915|NCT02603991|children and adolescents|children and adolescents
4802916|NCT02603991|Prospective cohort study|prospective cohort study
4802917|NCT02603991|vagus nerve stimulation|vagus nerve stimulation
4802918|NCT02603991|PINS|pins
4802919|NCT02603952|Influenza|influenza
4802920|NCT02603952|Influenza A|influenza a
4802921|NCT02603952|Flu|flu
4802922|NCT02603952|Flu A|flu a
4802923|NCT02603939|Pain|pain
4802924|NCT02603939|Magnetic resonance imaging|magnetic resonance imaging
4802925|NCT02603913|Pre-eclampsia|pre-eclampsia
4802926|NCT02603913|Pregnancy induced hypertension|pregnancy induced hypertension
4802927|NCT02603913|Preterm birth|preterm birth
4802928|NCT02603913|Intra-uterine growth restriction|intra-uterine growth restriction
4802929|NCT02603913|Oxidative stress|oxidative stress
4802930|NCT02603900|Adductor Canal Catheter|adductor canal catheter
4802931|NCT02603900|Arthroplasty, Replacement, Knee|arthroplasty, replacement, knee
4802932|NCT02603900|Local infiltration of analgesia|local infiltration of analgesia
4802933|NCT02603887|Smoldering Multiple Myeloma|smoldering multiple myeloma
4802934|NCT02603887|SMM|smm
4802935|NCT02603887|Intermediate or high-risk|intermediate or high-risk
4802936|NCT02603887|Pembrolizumab|pembrolizumab
4802937|NCT02603887|Keytruda|keytruda
4802938|NCT02603887|MK-3475|mk-3475
4802939|NCT02603887|SCH-900475|sch-900475
4802940|NCT02603874|Fluoroscopy|fluoroscopy
4802941|NCT02603874|Spinal Fusion|spinal fusion
4802942|NCT02603874|Wrong Level Surgery|wrong level surgery
4802943|NCT02603848|Inguinal surgery|inguinal surgery
4802944|NCT02603848|Hernia Repair|hernia repair
4802945|NCT02603848|Orchidopexy|orchidopexy
4802946|NCT02603848|Hydrocele|hydrocele
4802947|NCT02603848|Pediatric|pediatric
4802948|NCT02603848|Post-operative pain|post-operative pain
4802949|NCT02603848|Morphine sulfate|morphine sulfate
4802950|NCT02603848|Ibuprofen|ibuprofen
4802951|NCT02603835|SSO2 Therapy|sso2 therapy
4802952|NCT02603835|Acute myocardial infarction|acute myocardial infarction
4802953|NCT02603835|Anterior myocardial infarction|anterior myocardial infarction
4802954|NCT02603835|SuperSaturated oxygen delivery|supersaturated oxygen delivery
4802955|NCT02603835|Left main coronary artery|left main coronary artery
4802956|NCT02603835|Myocardial infarction|myocardial infarction
4802957|NCT02603835|Heart attack|heart attack
4802958|NCT02603835|Percutaneous coronary intervention|percutaneous coronary intervention
4802959|NCT02603835|Cardiac catheterization laboratory|cardiac catheterization laboratory
4802961|NCT02603835|Stent|stent
4802962|NCT02603835|Stenting|stenting
4802963|NCT02603835|Stents|stents
4802964|NCT02603835|Angioplasty|angioplasty
4802965|NCT02603835|LMCA|lmca
4802966|NCT02603835|Delivery of supersaturated oxygen (SSO2) therapy for the treatment of anterior acute myocardial infarction|delivery of supersaturated oxygen (sso2) therapy for the treatment of anterior acute myocardial infarction
4802967|NCT02603796|3-Dimensional|3-dimensional
4802968|NCT02603796|continuous positive airway pressure|continuous positive airway pressure
4802969|NCT02603796|nasal changes|nasal changes
4802970|NCT02603757|Vitamin D|vitamin d
4802971|NCT02603744|Premature ovarian failure adipose derived stromal cells intraovarian injection|premature ovarian failure adipose derived stromal cells intraovarian injection
4802972|NCT02603718|Stroke|stroke
4802973|NCT02603718|On-line EEG|on-line eeg
4802974|NCT02603718|BEI index|bei index
4802975|NCT02603718|Attention|attention
4802976|NCT02603718|Rehabilitation|rehabilitation
4802977|NCT02603705|chronic pain|chronic pain
4802978|NCT02603705|opioid|opioid
4802979|NCT02603705|oxycodone|oxycodone
4802980|NCT02603705|non cancer pain|non cancer pain
4802981|NCT02603705|moderate to severe|moderate to severe
4802982|NCT02603692|Newly diagnosed brain tumor|newly diagnosed brain tumor
4802983|NCT02603692|Progressive brain tumor|progressive brain tumor
4802984|NCT02603692|PROMIS|promis
4802985|NCT02603692|Quality of life|quality of life
4802986|NCT02603679|Cyclin-Dependent Kinase Inhibitor p16|cyclin-dependent kinase inhibitor p16
4802987|NCT02603666|cystic fibrosis|cystic fibrosis
4802988|NCT02603666|elastography|elastography
4802989|NCT02603666|liver biopsy|liver biopsy
4802990|NCT02603614|Chronic Heart Failure|chronic heart failure
4802991|NCT02603614|Renal Insufficiency|renal insufficiency
4802992|NCT02603614|Natriuretic Peptides|natriuretic peptides
4802993|NCT02603614|Cenderitide|cenderitide
4802994|NCT02603601|Randomized controlled trial|randomized controlled trial
4802995|NCT02603601|Mindfulness|mindfulness
4802996|NCT02603601|Obesity|obesity
4802997|NCT02603588|Acupuncture|acupuncture
4802998|NCT02603588|Sphenopalatine ganglion|sphenopalatine ganglion
4802999|NCT02603588|Nasal ventilation|nasal ventilation
4803000|NCT02603588|Neuropeptides|neuropeptides
4803001|NCT02603575|Caspofungin|caspofungin
4803002|NCT02603575|corticosteroids|corticosteroids
4803003|NCT02603575|Pneumocystis Pneumonia|pneumocystis pneumonia
4803004|NCT02603575|Immunocompromised|immunocompromised
4803005|NCT02603575|Non-HIV|non-hiv
4803006|NCT02603575|respiratory failure|respiratory failure
4803007|NCT02603562|FSHD|fshd
4803008|NCT02603536|Text Messaging|text messaging
4803009|NCT02603536|Harm Reduction|harm reduction
4803010|NCT02603523|accidental falls|accidental falls
4803011|NCT02603523|older people|older people
4803012|NCT02603523|dance|dance
4803013|NCT02603523|randomized controlled trial|randomized controlled trial
4803014|NCT02603497|ASP015K|asp015k
4803015|NCT02603497|impaired renal function|impaired renal function
4803016|NCT02603497|Pharmacokinetics|pharmacokinetics
4803017|NCT02603471|HIV+|hiv+
4803018|NCT02603471|Alcohol dependence|alcohol dependence
4803019|NCT02603471|Mobile Technology|mobile technology
4803020|NCT02603458|Schizophrenia|schizophrenia
4803021|NCT02603458|Naurex|naurex
4803022|NCT02603458|Intravenous Treatment|intravenous treatment
4803023|NCT02603458|NRX-1074|nrx-1074
4803024|NCT02603445|BCL201|bcl201
4803025|NCT02603445|idelalisib|idelalisib
4803026|NCT02603445|Follicular lymphoma|follicular lymphoma
4803027|NCT02603445|FL|fl
4803028|NCT02603445|mantle cell lymphoma|mantle cell lymphoma
4803029|NCT02603445|MCL|mcl
4803030|NCT02603432|Bladder cancer|bladder cancer
4803031|NCT02603432|Urologic neoplasms|urologic neoplasms
4803032|NCT02603432|urothelial carcinoma|urothelial carcinoma
4803033|NCT02603432|PD-L1|pd-l1
4803034|NCT02603432|programmed cell death protein|programmed cell death protein
4803035|NCT02603432|maintenance treatment|maintenance treatment
4803036|NCT02603419|classical Hodgkins Lymphoma (relapsed/refractory)|classical hodgkins lymphoma (relapsed/refractory)
4803037|NCT02603419|post-allogeneic HSCT|post-allogeneic hsct
4803038|NCT02603419|anti PD-L1|anti pd-l1
4803039|NCT02603419|Phase 1|phase 1
4803040|NCT02603419|PK|pk
4803041|NCT02603419|Receptor occupancy|receptor occupancy
4803042|NCT02603419|Immunophenotypic biomarkers|immunophenotypic biomarkers
4803043|NCT02603393|COPD, QVA149|copd, qva149
4803044|NCT02603380|Delirium|delirium
4803045|NCT02603380|Feasibility study|feasibility study
4803046|NCT02603380|software application|software application
4803047|NCT02603380|qualitative|qualitative
4803048|NCT02603328|Cerebral cavernous malformation|cerebral cavernous malformation
4803049|NCT02603328|Statins|statins
4803050|NCT02603328|MRI|mri
4803051|NCT02603328|Permeability|permeability
4803052|NCT02603328|Quantitative susceptibility mapping|quantitative susceptibility mapping
4803053|NCT02603302|rectal cancer|rectal cancer
4803054|NCT02603302|radiotherapy|radiotherapy
4803055|NCT02603302|escalated dose|escalated dose
4803056|NCT02603302|interval|interval
4803057|NCT02603276|hypercholesterolemia|hypercholesterolemia
4803058|NCT02603276|dietary supplements|dietary supplements
4803059|NCT02603276|red yeast rice|red yeast rice
4803060|NCT02603276|plant sterols|plant sterols
4803061|NCT02603263|social norms|social norms
4803062|NCT02603263|healthy eating|healthy eating
4803063|NCT02603263|vegetables|vegetables
4803064|NCT02603263|field study|field study
4803065|NCT02603250|Anemia|anemia
4803066|NCT02603250|Iron deficiency|iron deficiency
4803067|NCT02603250|noninvasive anemia screening|noninvasive anemia screening
4803068|NCT02603211|breast cancer|breast cancer
4803069|NCT02603198|third molar|third molar
4803070|NCT02603198|tooth extraction|tooth extraction
4803071|NCT02603198|impacted tooth|impacted tooth
4803072|NCT02603185|Phase 1, Healthy subjects|phase 1, healthy subjects
4803073|NCT02603172|GSK3039294|gsk3039294
4803074|NCT02603172|GSK2315698|gsk2315698
4803075|NCT02603172|systemic amyloidosis|systemic amyloidosis
4803076|NCT02603172|CPHPC|cphpc
4803077|NCT02603172|dose-escalation|dose-escalation
4803078|NCT02603159|Chemoradiotherapy|chemoradiotherapy
4803079|NCT02603159|Esophageal Squamous Cancer|esophageal squamous cancer
4803080|NCT02603159|Capecitabine|capecitabine
4803081|NCT02603146|RA prevention|ra prevention
4803082|NCT02603146|hydroxychloroquine (HCQ)|hydroxychloroquine (hcq)
4803083|NCT02603146|anti-CCP3|anti-ccp3
4803084|NCT02603133|healthcare|healthcare
4803085|NCT02603133|burnout|burnout
4803086|NCT02603133|resilience|resilience
4803087|NCT02603133|fatigue|fatigue
4803088|NCT02603133|NICU|nicu
4803089|NCT02603133|safety culture|safety culture
4803090|NCT02603133|quality of care|quality of care
4803091|NCT02603081|Meniere's|meniere's
4803092|NCT02603081|hearing loss|hearing loss
4803093|NCT02603081|vertigo|vertigo
4803094|NCT02603081|tinnitus|tinnitus
4803095|NCT02603081|ebselen|ebselen
4803096|NCT02603055|Safety|safety
4803097|NCT02603055|immunogenicity|immunogenicity
4803098|NCT02603055|Hepatitis E|hepatitis e
4803099|NCT02603029|skin rejuvenation|skin rejuvenation
4803100|NCT02603029|anti-ageing effects|anti-ageing effects
4803101|NCT02603029|minimal erythema dose|minimal erythema dose
4803102|NCT02603029|dermis structure|dermis structure
4803103|NCT02603029|physiological skin condition|physiological skin condition
4803104|NCT02603029|wrinkling|wrinkling
4803105|NCT02603016|Clinical Nutrition|clinical nutrition
4803106|NCT02603003|Circulating tumor cells(CTCs)|circulating tumor cells(ctcs)
4803107|NCT02603003|Traditional Chinese Medicine(TCM)|traditional chinese medicine(tcm)
4803108|NCT02603003|Myeloid-derived suppressor cells(MDSCs)|myeloid-derived suppressor cells(mdscs)
4803109|NCT02602990|Cerebral|cerebral
4803110|NCT02602990|Arteriovenous|arteriovenous
4803111|NCT02602990|Malformation|malformation
4803112|NCT02602990|Embolization|embolization
4803113|NCT02602990|Endovascular|endovascular
4803114|NCT02602977|inflammation|inflammation
4803115|NCT02602977|remote ischemic preconditioning|remote ischemic preconditioning
4803116|NCT02602938|aspirin|aspirin
4803117|NCT02602938|circulating tumor cells|circulating tumor cells
4803118|NCT02602938|metastatic breast cancer|metastatic breast cancer
4803119|NCT02602938|metastatic colorectal cancer|metastatic colorectal cancer
4803120|NCT02602899|PINS|pins
4803121|NCT02602899|Deep Brain Stimulator|deep brain stimulator
4803122|NCT02602899|Refractory Epilepsy|refractory epilepsy
4803123|NCT02602899|Anterior Thalamic Nucleus|anterior thalamic nucleus
4803124|NCT02602860|SV2A|sv2a
4803125|NCT02602860|Levetiracetam|levetiracetam
4803126|NCT02602860|Brivaracetam|brivaracetam
4803127|NCT02602860|PET|pet
4803128|NCT02602847|Liver transplantation|liver transplantation
4803129|NCT02602847|HBV|hbv
4803130|NCT02602847|cccDNA|cccdna
4803131|NCT02602834|exercise test|exercise test
4803132|NCT02602834|biological markers|biological markers
4803133|NCT02602808|acute pancreatitis|acute pancreatitis
4803134|NCT02602808|non-coding RNA|non-coding rna
4803135|NCT02602808|biological markers|biological markers
4803136|NCT02602808|receiver operating characteristic curve|receiver operating characteristic curve
4803137|NCT02602795|Opiate Dependence|opiate dependence
4803138|NCT02602795|Sexually Transmitted Diseases|sexually transmitted diseases
4803139|NCT02602795|HIV|hiv
4803140|NCT02602795|Extended release naltrexone|extended release naltrexone
4803141|NCT02602756|Choroid Melanoma|choroid melanoma
4803142|NCT02602743|sedation|sedation
4803143|NCT02602743|remifentanyl|remifentanyl
4803144|NCT02602743|pediatric patient|pediatric patient
4803145|NCT02602743|colonoscopy|colonoscopy
4803146|NCT02602730|Cigarette smoking|cigarette smoking
4803147|NCT02602730|Smoking, Tobacco|smoking, tobacco
4803148|NCT02602730|postpartum|postpartum
4803149|NCT02602730|internet|internet
4803150|NCT02602730|interactive|interactive
4803151|NCT02602730|coach|coach
4803152|NCT02602717|follicular origin|follicular origin
4803153|NCT02602691|Heart transplantation|heart transplantation
4803154|NCT02602691|AlloMap® gene expression profiling test|allomap® gene expression profiling test
4803155|NCT02602691|Medico-economic study|medico-economic study
4803156|NCT02602678|Children.|children.
4803157|NCT02602678|prone position|prone position
4803158|NCT02602678|acute viral bronchiolitis|acute viral bronchiolitis
4803159|NCT02602678|syncytial virus|syncytial virus
4803160|NCT02602678|work of breathing|work of breathing
4803161|NCT02602678|intrinsic PEEP|intrinsic peep
4803162|NCT02602665|catheter placement|catheter placement
4803163|NCT02602652|geometric mean titer|geometric mean titer
4803164|NCT02602652|seroprotection|seroprotection
4803165|NCT02602652|live attenuated chimeric JE vaccine|live attenuated chimeric je vaccine
4803166|NCT02602652|JE-CV|je-cv
4803167|NCT02602652|SA14-14-2 vaccine|sa14-14-2 vaccine
4803168|NCT02602626|Human Papillomavirus|human papillomavirus
4803169|NCT02602626|HPV|hpv
4803170|NCT02602626|Postpartum|postpartum
4803171|NCT02602587|acute myeloid leukemia|acute myeloid leukemia
4803172|NCT02602587|Dendrogenin A|dendrogenin a
4803173|NCT02602587|5,6-cholesterol epoxide|5,6-cholesterol epoxide
4803174|NCT02602587|6-oxo-cholestane-3beta|6-oxo-cholestane-3beta
4803175|NCT02602587|5alpha-diol|5alpha-diol
4803176|NCT02602587|cholesterol epoxide hydrolase|cholesterol epoxide hydrolase
4803177|NCT02602587|oxysterols|oxysterols
4803178|NCT02602574|Cholangiopancreatography, Endoscopic Retrograde|cholangiopancreatography, endoscopic retrograde
4803179|NCT02602574|Pancreatitis|pancreatitis
4803180|NCT02602574|Heat-Shock Proteins|heat-shock proteins
4803181|NCT02602574|Pentraxin 3 protein|pentraxin 3 protein
4803182|NCT02602574|C-Reactive Protein|c-reactive protein
4803183|NCT02602574|procalcitonin|procalcitonin
4803184|NCT02602574|Interleukin-1 beta|interleukin-1 beta
4803185|NCT02602574|Leukocytes, Mononuclear|leukocytes, mononuclear
4803186|NCT02602574|Killer Cells, Natural|killer cells, natural
4803187|NCT02602574|natural-killer group 2, member D receptor|natural-killer group 2, member d receptor
4803188|NCT02602561|HMB|hmb
4803189|NCT02602561|beta-hydroxy-beta-methylbutyrate|beta-hydroxy-beta-methylbutyrate
4803190|NCT02602561|ACL|acl
4803191|NCT02602561|surgery|surgery
4803192|NCT02602561|muscle mass|muscle mass
4803193|NCT02602548|Propionibacterium acnes|propionibacterium acnes
4803194|NCT02602548|shoulder surgery|shoulder surgery
4803195|NCT02602548|infection|infection
4803196|NCT02602496|Diet|diet
4803197|NCT02602496|Whole grain|whole grain
4803198|NCT02602496|Fruits|fruits
4803199|NCT02602496|Vegetables|vegetables
4803200|NCT02602496|Gut health|gut health
4803201|NCT02602496|Anti-inflammatory|anti-inflammatory
4803202|NCT02602483|temporomandibular|temporomandibular
4803203|NCT02602483|joint|joint
4803204|NCT02602483|pain|pain
4803205|NCT02602483|ibuprofen|ibuprofen
4803206|NCT02602483|magnesium|magnesium
4803207|NCT02602483|vitamin C|vitamin c
4803208|NCT02602457|Atrial Fibrillation|atrial fibrillation
4803209|NCT02602444|ticagrelor|ticagrelor
4803210|NCT02602444|STEMI|stemi
4803211|NCT02602444|NSTEMI|nstemi
4803212|NCT02602444|pharmacokinetics|pharmacokinetics
4803213|NCT02602444|pharmacodynamics|pharmacodynamics
4803214|NCT02602431|laser|laser
4803215|NCT02602431|third molar|third molar
4803216|NCT02602431|low laser|low laser
4803217|NCT02602431|inflammatory response|inflammatory response
4803218|NCT02602418|Human Immunodeficiency Virus (HIV)|human immunodeficiency virus (hiv)
4803219|NCT02602418|working memory training|working memory training
4803220|NCT02602418|brain function|brain function
4803221|NCT02602418|functional magnetic resonance imaging (fMRI)|functional magnetic resonance imaging (fmri)
4803222|NCT02602405|Outcome Assessment (Health Care)|outcome assessment (health care)
4803223|NCT02602405|Return to work|return to work
4803224|NCT02602405|Registries|registries
4803225|NCT02602405|Norway|norway
4803226|NCT02602392|Self management|self management
4803227|NCT02602392|Education|education
4803228|NCT02602392|Children|children
4803229|NCT02602392|Caregivers|caregivers
4803230|NCT02602392|Health Care Providers|health care providers
4803231|NCT02602379|Pain|pain
4803232|NCT02602379|Monitoring|monitoring
4803233|NCT02602379|Analgesia Nociception Index|analgesia nociception index
4803234|NCT02602379|NoL|nol
4803235|NCT02602379|Nociception Level|nociception level
4803236|NCT02602379|Remifentanil|remifentanil
4803237|NCT02602366|HIV|hiv
4803238|NCT02602366|DCE|dce
4803239|NCT02602366|MPT|mpt
4803240|NCT02602366|Microbicide|microbicide
4803241|NCT02602327|radioembolization|radioembolization
4803242|NCT02602327|Yttrium-90|yttrium-90
4803243|NCT02602327|90Y|90y
4803244|NCT02602327|Resin microspheres|resin microspheres
4803245|NCT02602327|Tas-102|tas-102
4803246|NCT02602327|Lonsurf|lonsurf
4803247|NCT02602327|SIR-Sphere|sir-sphere
4803248|NCT02602314|Chronic myeloid leukemia|chronic myeloid leukemia
4803249|NCT02602314|Nilotinib|nilotinib
4803250|NCT02602314|Imatinib|imatinib
4803251|NCT02602301|oxytocin|oxytocin
4803252|NCT02602223|Alveolar Ridge Augmentation|alveolar ridge augmentation
4803253|NCT02602223|Tooth Socket|tooth socket
4803254|NCT02602223|Guided Tissue Regeneration|guided tissue regeneration
4803255|NCT02602223|Membranes|membranes
4803256|NCT02602210|cirrhosis|cirrhosis
4803257|NCT02602210|liver|liver
4803258|NCT02602210|corticosteroids|corticosteroids
4803259|NCT02602210|hypotension|hypotension
4803260|NCT02602210|sepsis|sepsis
4803261|NCT02602210|cortisol|cortisol
4803262|NCT02602197|Paracetamol|paracetamol
4803263|NCT02602197|Dexketoprofen|dexketoprofen
4803264|NCT02602197|postoperative pain|postoperative pain
4803265|NCT02602197|septoplasty|septoplasty
4803266|NCT02602184|skin regeneration|skin regeneration
4803267|NCT02602184|re-epithelialization|re-epithelialization
4803268|NCT02602184|split thickness wounds|split thickness wounds
4803269|NCT02602184|Abdominoplasty|abdominoplasty
4803270|NCT02602158|breath test|breath test
4803271|NCT02602158|lipid emulsions|lipid emulsions
4803272|NCT02602158|MRI|mri
4803273|NCT02602158|gastric emptying|gastric emptying
4803274|NCT02602145|femoral|femoral
4803275|NCT02602145|popliteal|popliteal
4803276|NCT02602145|stent|stent
4803277|NCT02602145|modeling|modeling
4803278|NCT02602145|flexion|flexion
4803279|NCT02602132|INDWELLING URINARY CATHETER|indwelling urinary catheter
4803280|NCT02602132|CLAMPING|clamping
4803281|NCT02602132|REMOVAL|removal
4803282|NCT02602106|Aquatic activities|aquatic activities
4803283|NCT02602106|Aerobic exercise|aerobic exercise
4803284|NCT02602106|Resistance exercise|resistance exercise
4803285|NCT02602106|Pregnancy|pregnancy
4803286|NCT02602106|Maternal weight gain|maternal weight gain
4803287|NCT02602106|birthweight|birthweight
4803288|NCT02602093|Lumbar Disk Herniation|lumbar disk herniation
4803289|NCT02602093|Percutaneous Transforaminal Endoscopic Discectomy|percutaneous transforaminal endoscopic discectomy
4803290|NCT02602093|Micro Discectomy|micro discectomy
4803291|NCT02602093|Minimal Invasive Spine Surgery|minimal invasive spine surgery
4803292|NCT02602054|persistent ductus arteriosus|persistent ductus arteriosus
4803293|NCT02602054|preterm infants|preterm infants
4803294|NCT02602054|surgical treatment|surgical treatment
4803295|NCT02602054|pharmacological treatment|pharmacological treatment
4803296|NCT02602028|Familial Mediterranean Fever|familial mediterranean fever
4803297|NCT02602028|Colchicine|colchicine
4803298|NCT02602002|Remifentanil, Pharmacodynamic Pain assessments, Intravenous, South Korea|remifentanil, pharmacodynamic pain assessments, intravenous, south korea
4803299|NCT02601976|PegInterferon alpha-2a|peginterferon alpha-2a
4803300|NCT02601976|Ribavirin|ribavirin
4803301|NCT02601976|Hepatitis C Virus|hepatitis c virus
4803302|NCT02601976|Sustained Virological Response|sustained virological response
4803303|NCT02601976|End of Treatment Response|end of treatment response
4803304|NCT02601976|Unipeg|unipeg
4803305|NCT02601976|Ribazole|ribazole
4803306|NCT02601924|Anesthesia|anesthesia
4803307|NCT02601924|injection|injection
4803308|NCT02601924|pain|pain
4803309|NCT02601924|pressure massage|pressure massage
4803310|NCT02601924|topical gel|topical gel
4803311|NCT02601911|Failure|failure
4803312|NCT02601911|Injection|injection
4803313|NCT02601911|Ketorolac|ketorolac
4803314|NCT02601911|Premedication|premedication
4803315|NCT02601885|Relapsing-remitting|relapsing-remitting
4803316|NCT02601885|Secondary progressive|secondary progressive
4803317|NCT02601885|Relapsing forms|relapsing forms
4803318|NCT02601833|Caries|caries
4803319|NCT02601833|Cavity|cavity
4803320|NCT02601820|patient-reported outcomes|patient-reported outcomes
4803321|NCT02601820|observational|observational
4803323|NCT02601820|Hepatitis|hepatitis
4803324|NCT02601820|Hepatitis C|hepatitis c
4803325|NCT02601820|Chronic Liver Disease|chronic liver disease
4803326|NCT02601820|Liver Disease|liver disease
4803327|NCT02601820|Liver|liver
4803328|NCT02601820|Infectious Disease|infectious disease
4803329|NCT02601820|Hep C|hep c
4803330|NCT02601820|HepC|hepc
4803331|NCT02601820|PROs|pros
4803332|NCT02601807|Back|back
4803333|NCT02601807|Pain|pain
4803334|NCT02601807|PSWT|pswt
4803335|NCT02601807|ActiPatch|actipatch
4803336|NCT02601807|Pulsed shortwave therapy|pulsed shortwave therapy
4803337|NCT02601794|Breast Cancer|breast cancer
4803338|NCT02601794|mHealth|mhealth
4803339|NCT02601794|Mindfulness|mindfulness
4803340|NCT02601794|Complementary Therapies|complementary therapies
4803341|NCT02601781|Bioresorbable Vascular Scaffold (BVS)|bioresorbable vascular scaffold (bvs)
4803342|NCT02601781|STEMI|stemi
4803343|NCT02601781|Primary PCI|primary pci
4803344|NCT02601768|ASD II|asd ii
4803345|NCT02601768|transcatheter closure|transcatheter closure
4803346|NCT02601768|percutaneous closure|percutaneous closure
4803347|NCT02601768|3D TEE|3d tee
4803348|NCT02601768|balloon-sizing|balloon-sizing
4803349|NCT02601742|zinc|zinc
4803350|NCT02601742|Duration|duration
4803351|NCT02601729|Type 1 diabetes|type 1 diabetes
4803352|NCT02601729|real-time continuous glucose monitoring|real-time continuous glucose monitoring
4803353|NCT02601729|observational study|observational study
4803354|NCT02601729|insulin pump|insulin pump
4803355|NCT02601729|Belgium|belgium
4803356|NCT02601716|Plasmodium falciparum|plasmodium falciparum
4803357|NCT02601716|PfSPZ Vaccine|pfspz vaccine
4803358|NCT02601716|Sporozoites|sporozoites
4803359|NCT02601716|Controlled Human Malaria Infection|controlled human malaria infection
4803360|NCT02601690|Rye Grass|rye grass
4803361|NCT02601690|Ragweed|ragweed
4803362|NCT02601690|Cat|cat
4803363|NCT02601690|House Dust Mite|house dust mite
4803364|NCT02601677|Obsessive Compulsive Disorder|obsessive compulsive disorder
4803365|NCT02601677|Deep Brain Stimulation|deep brain stimulation
4803366|NCT02601677|Nucleus accumbens|nucleus accumbens
4803367|NCT02601651|Totally Extraperitoneal Inguinal Hernioplasty|totally extraperitoneal inguinal hernioplasty
4803368|NCT02601651|Lidocaine infusion|lidocaine infusion
4803369|NCT02601651|Postoperative opioid consumption|postoperative opioid consumption
4803370|NCT02601625|Tolerability|tolerability
4803371|NCT02601625|Anifrolumab|anifrolumab
4803372|NCT02601625|Subcutaneous injection|subcutaneous injection
4803373|NCT02601625|Intravenous infusion|intravenous infusion
4803374|NCT02601599|Smoking Cessation|smoking cessation
4803375|NCT02601599|Tobacco Use Cessation|tobacco use cessation
4803376|NCT02601599|Motivational Interviewing|motivational interviewing
4803377|NCT02601599|Students, Medical|students, medical
4803378|NCT02601599|Randomized Controlled Trial|randomized controlled trial
4803379|NCT02601560|Coronary Artery Disease|coronary artery disease
4803380|NCT02601560|CAD|cad
4803381|NCT02601547|Positron-Emission Tomography|positron-emission tomography
4803382|NCT02601547|chemotherapy-induced brain damage|chemotherapy-induced brain damage
4803383|NCT02601547|neuro-cognitive function alteration|neuro-cognitive function alteration
4803384|NCT02601534|sedentary behaviour|sedentary behaviour
4803385|NCT02601534|physical activity|physical activity
4803386|NCT02601508|deep NM block|deep nm block
4803387|NCT02601508|Surgeon's satisfaction|surgeon's satisfaction
4803388|NCT02601508|bridion|bridion
4803389|NCT02601482|Glycemic control|glycemic control
4803390|NCT02601482|exercise|exercise
4803391|NCT02601482|Interval Training|interval training
4803392|NCT02601456|Amputation, Traumatic|amputation, traumatic
4803393|NCT02601456|Biomechanics|biomechanics
4803394|NCT02601456|Asymmetry|asymmetry
4803395|NCT02601456|Amputee Running|amputee running
4803396|NCT02601456|Prolonged Effort|prolonged effort
4803397|NCT02601417|Cholangitis|cholangitis
4803398|NCT02601417|Bile culture|bile culture
4803399|NCT02601391|STEPPS-HI|stepps-hi
4803400|NCT02601391|personality disorder|personality disorder
4803401|NCT02601391|evaluation|evaluation
4803402|NCT02601391|forensic|forensic
4803403|NCT02601378|Uveal melanoma|uveal melanoma
4803404|NCT02601378|Metastatic uveal melanoma|metastatic uveal melanoma
4803405|NCT02601378|Phase I|phase i
4803406|NCT02601378|LXS196|lxs196
4803407|NCT02601378|PKC inhibitor|pkc inhibitor
4803408|NCT02601378|HDM201|hdm201
4803409|NCT02601378|HDM2 inhibitor|hdm2 inhibitor
4803410|NCT02601378|dose escalation|dose escalation
4803411|NCT02601339|spectroscopy, Near-Infrared|spectroscopy, near-infrared
4803412|NCT02601300|Ulcerative Colitis|ulcerative colitis
4803413|NCT02601300|GED-0301|ged-0301
4803414|NCT02601300|Mongersen|mongersen
4803415|NCT02601300|Efficacy|efficacy
4803416|NCT02601300|Safety|safety
4803417|NCT02601261|pregnant|pregnant
4803418|NCT02601261|gestational ages|gestational ages
4803419|NCT02601261|hospitalized|hospitalized
4803420|NCT02601261|problem of pregnancy|problem of pregnancy
4803421|NCT02601248|safety, PK|safety, pk
4803422|NCT02601235|nasal congestion|nasal congestion
4803423|NCT02601222|chronic eczema|chronic eczema
4803424|NCT02601222|efficacy and safety|efficacy and safety
4803425|NCT02601222|Runzao zhiyang capsule|runzao zhiyang capsule
4803426|NCT02601196|Leiomyoma|leiomyoma
4803427|NCT02601196|Infertility|infertility
4803428|NCT02601196|IVF|ivf
4803429|NCT02601196|Ulipristal acetate|ulipristal acetate
4803430|NCT02601183|brain temperture，thrombolysis，early diagnosis|brain temperture，thrombolysis，early diagnosis
4803431|NCT02601170|Platelet Rich Plasma|platelet rich plasma
4803432|NCT02601170|Hemophilia|hemophilia
4803433|NCT02601170|Hemophilic arthropathy|hemophilic arthropathy
4803434|NCT02601157|stent|stent
4803435|NCT02601157|polymer|polymer
4803436|NCT02601157|antiplatelet therapy|antiplatelet therapy
4803437|NCT02601157|clopidogrel|clopidogrel
4803438|NCT02601144|DBS|dbs
4803439|NCT02601144|VFS|vfs
4803440|NCT02601144|FOG|fog
4803441|NCT02601131|platelet count|platelet count
4803442|NCT02601131|platelet transfusion|platelet transfusion
4803443|NCT02601131|complement factors|complement factors
4803444|NCT02601131|endothelial markers|endothelial markers
4803445|NCT02601131|stem cell transplantation|stem cell transplantation
4803446|NCT02601105|gotu kola|gotu kola
4803447|NCT02601105|centella asiatica|centella asiatica
4803448|NCT02601092|Mini Gastric Bypass|mini gastric bypass
4803449|NCT02601092|Roux-en-Y Gastric Bypass|roux-en-y gastric bypass
4803450|NCT02601092|RCT|rct
4803451|NCT02601079|Biopsy|biopsy
4803452|NCT02601079|Diagnostics|diagnostics
4803453|NCT02601079|Genetic analysis|genetic analysis
4803454|NCT02601066|LMNA|lmna
4803455|NCT02601066|Sudden Death|sudden death
4803456|NCT02601066|Neuromuscular|neuromuscular
4803457|NCT02601040|Safety|safety
4803458|NCT02601040|Immunogenicity|immunogenicity
4803459|NCT02601040|Vaccine|vaccine
4803460|NCT02601040|Hepatitis A|hepatitis a
4803461|NCT02601014|Hormone-Resistant Prostate Cancer|hormone-resistant prostate cancer
4803462|NCT02601014|Prostate Carcinoma Metastatic in the Bone|prostate carcinoma metastatic in the bone
4803463|NCT02600988|Graft-Versus-Host-Disease|graft-versus-host-disease
4803464|NCT02600988|post-allogeneic transplant|post-allogeneic transplant
4803465|NCT02600988|haematopoietic progenitors|haematopoietic progenitors
4803466|NCT02600949|Pancreatic cancer|pancreatic cancer
4803467|NCT02600949|Colorectal Cancer|colorectal cancer
4803468|NCT02600949|Pancreatic ductal adenocarcinoma|pancreatic ductal adenocarcinoma
4803469|NCT02600949|PDA|pda
4803470|NCT02600949|CRC|crc
4803471|NCT02600949|Personalized peptide vaccine|personalized peptide vaccine
4803472|NCT02600949|Phone call|phone call
4803473|NCT02600949|Advanced/metastatic|advanced/metastatic
4803474|NCT02600936|venous outflow obstruction|venous outflow obstruction
4803475|NCT02600936|peripheral venous disease|peripheral venous disease
4803476|NCT02600936|vein stent|vein stent
4803477|NCT02600936|Wallstent|wallstent
4803478|NCT02600936|registry|registry
4803479|NCT02600936|May Thurner|may thurner
4803480|NCT02600923|palbociclib, ibrance, breast cancer|palbociclib, ibrance, breast cancer
4803481|NCT02600910|Manual Wheelchair|manual wheelchair
4803482|NCT02600910|Shoulder injury|shoulder injury
4803483|NCT02600910|Shoulder function|shoulder function
4803484|NCT02600910|rotator cuff|rotator cuff
4803485|NCT02600910|Tendinopathy|tendinopathy
4803486|NCT02600910|Spinal cord injury|spinal cord injury
4803487|NCT02600910|Shoulder pain|shoulder pain
4803488|NCT02600910|Shoulder impingement|shoulder impingement
4803489|NCT02600871|Abscess|abscess
4803490|NCT02600871|Antiseptic|antiseptic
4803491|NCT02600871|Provodine|provodine
4803492|NCT02600871|Povidone-Iodine|povidone-iodine
4803493|NCT02600819|end stage renal disease (ESRD)|end stage renal disease (esrd)
4803494|NCT02600819|hemodialysis (HD)|hemodialysis (hd)
4803495|NCT02600819|open-label|open-label
4803496|NCT02600819|HIV-1 Infection|hiv-1 infection
4803497|NCT02600806|Community-acquired pneumonia|community-acquired pneumonia
4803498|NCT02600806|Procalcitonin|procalcitonin
4803499|NCT02600806|Outpatients|outpatients
4803500|NCT02600806|Outcomes|outcomes
4803501|NCT02600806|Azithromycin|azithromycin
4803502|NCT02600806|Fluoroquinolones|fluoroquinolones
4803503|NCT02600780|Febuxostat|febuxostat
4803504|NCT02600780|Efficacy|efficacy
4803505|NCT02600780|Safety|safety
4803506|NCT02600780|Allopurinol|allopurinol
4803507|NCT02600780|Hyperuricemia|hyperuricemia
4803508|NCT02600780|Zurig|zurig
4803509|NCT02600780|Getz Pharma|getz pharma
4803510|NCT02600754|older adults, depressive symptoms, psychosocial treatment|older adults, depressive symptoms, psychosocial treatment
4803511|NCT02600741|Schizophrenia|schizophrenia
4803512|NCT02600741|Caregiver|caregiver
4803513|NCT02600741|Psycho-education and skills training|psycho-education and skills training
4803514|NCT02600741|Paliperidone Palmitate|paliperidone palmitate
4803515|NCT02600741|Oral Antipsychotic|oral antipsychotic
4803516|NCT02600728|Parkinson Disease|parkinson disease
4803517|NCT02600728|Gait|gait
4803518|NCT02600728|cues|cues
4803519|NCT02600728|memory|memory
4803520|NCT02600728|training|training
4803521|NCT02600702|Home base exercise|home base exercise
4803522|NCT02600689|Pulmonary rehab|pulmonary rehab
4803523|NCT02600689|Exergame|exergame
4803524|NCT02600689|Home-based|home-based
4803525|NCT02600637|stroke|stroke
4803526|NCT02600637|depression|depression
4803527|NCT02600637|anxiety|anxiety
4803528|NCT02600637|mindfulness|mindfulness
4803529|NCT02600637|meditation|meditation
4803530|NCT02600572|balance, postural|balance, postural
4803531|NCT02600572|postural equilibrium|postural equilibrium
4803532|NCT02600572|mental speed|mental speed
4803533|NCT02600572|isometric exercise|isometric exercise
4803534|NCT02600572|eccentric exercise|eccentric exercise
4803535|NCT02600559|Otitis media|otitis media
4803536|NCT02600559|Ear infection|ear infection
4803537|NCT02600559|Tympanostomy tubes|tympanostomy tubes
4803538|NCT02600533|minority group recruitment|minority group recruitment
4803539|NCT02600533|stages of implementation|stages of implementation
4803540|NCT02600533|clinical trials education|clinical trials education
4803541|NCT02600481|standard-pressure pneumoperitoneum|standard-pressure pneumoperitoneum
4803542|NCT02600481|prolonged pneumoperitoneum|prolonged pneumoperitoneum
4803543|NCT02600481|myocardial injuries|myocardial injuries
4803544|NCT02600481|troponin T(TnT)|troponin t(tnt)
4803545|NCT02600481|Trendelenburg position|trendelenburg position
4803546|NCT02600481|chest CT scan|chest ct scan
4803547|NCT02600481|low-pressure pneumoperitoneum|low-pressure pneumoperitoneum
4803548|NCT02600481|robot-assisted surgery|robot-assisted surgery
4803549|NCT02600442|Neoadjuvant Therapy|neoadjuvant therapy
4803550|NCT02600442|Chemotherapy|chemotherapy
4803551|NCT02600442|Positron-Emission Tomography|positron-emission tomography
4803552|NCT02600442|PET-CT|pet-ct
4803553|NCT02600442|FDG|fdg
4803554|NCT02600442|Fluorodeoxyglucose|fluorodeoxyglucose
4803555|NCT02600442|Diagnosis|diagnosis
4803556|NCT02600442|Prognosis|prognosis
4803557|NCT02600442|Pathological complete response|pathological complete response
4803558|NCT02600442|molecular biology|molecular biology
4803559|NCT02600442|proliferation genes|proliferation genes
4803560|NCT02600429|Neurotrophic Keratopathy|neurotrophic keratopathy
4803561|NCT02600429|NK|nk
4803562|NCT02600403|Visual Evoked Potentials|visual evoked potentials
4803563|NCT02600403|Optical Coherence Tomography|optical coherence tomography
4803564|NCT02600403|Visual Fields|visual fields
4803565|NCT02600390|Leg Ulcer|leg ulcer
4803566|NCT02600390|LU|lu
4803567|NCT02600390|SANGUINATE|sanguinate
4803568|NCT02600390|QOL|qol
4803569|NCT02600390|SCD|scd
4803570|NCT02600390|Sickle Cell Disease|sickle cell disease
4803571|NCT02600390|Sickle Cell|sickle cell
4803572|NCT02600390|Anemia|anemia
4803573|NCT02600390|Leg Wound|leg wound
4803574|NCT02600390|Leg|leg
4803575|NCT02600390|Skin Lesion|skin lesion
4803576|NCT02600364|Aneurysm|aneurysm
4803577|NCT02600364|intracerebral|intracerebral
4803578|NCT02600364|stroke|stroke
4803579|NCT02600364|p64|p64
4803580|NCT02600351|Hepatitis C Virus (HCV)|hepatitis c virus (hcv)
4803581|NCT02600351|Ledipasvir/Sofosbuvir|ledipasvir/sofosbuvir
4803582|NCT02600351|Ribavirin|ribavirin
4803583|NCT02600338|Systematic review and meta-analysis|systematic review and meta-analysis
4803584|NCT02600338|Evidence-based medicine (EBM)|evidence-based medicine (ebm)
4803585|NCT02600338|Evidence-based nutrition (EBN)|evidence-based nutrition (ebn)
4803586|NCT02600338|Clinical practice guidelines|clinical practice guidelines
4803587|NCT02600338|Clinical trials|clinical trials
4803588|NCT02600338|Legumes|legumes
4803589|NCT02600338|Beans, peas, chickpeas, lentils, soy, peanuts, lupins|beans, peas, chickpeas, lentils, soy, peanuts, lupins
4803590|NCT02600338|Cardiometabolic risk factors|cardiometabolic risk factors
4803591|NCT02600338|Blood pressure|blood pressure
4803592|NCT02600325|Acute Hepatitis C|acute hepatitis c
4803593|NCT02600325|Human Immunodeficiency virus|human immunodeficiency virus
4803594|NCT02600325|Grazoprevir|grazoprevir
4803595|NCT02600325|Elbasvir|elbasvir
4803596|NCT02600286|Physical medicine and rehabilitation|physical medicine and rehabilitation
4803597|NCT02600286|Neurology|neurology
4803598|NCT02600260|thrombophilia|thrombophilia
4803599|NCT02600260|thrombosis|thrombosis
4803600|NCT02600260|Pregnancy, High-Risk|pregnancy, high-risk
4803601|NCT02600260|venous thrombosis|venous thrombosis
4803602|NCT02600260|enoxaparin|enoxaparin
4803603|NCT02600260|risk assessment|risk assessment
4803604|NCT02600260|deep vein thrombosis|deep vein thrombosis
4803605|NCT02600260|pulmonary embolism|pulmonary embolism
4803606|NCT02600260|hospitalization|hospitalization
4803607|NCT02600247|Total knee arthroplasty|total knee arthroplasty
4803608|NCT02600247|Duloxetine|duloxetine
4803609|NCT02600221|ACOS|acos
4803610|NCT02600195|Intensive Care, Neonatal|intensive care, neonatal
4803611|NCT02600195|Nosocomial Infections|nosocomial infections
4803612|NCT02600195|Quality Improvement|quality improvement
4803613|NCT02600182|Thoracic surgery|thoracic surgery
4803614|NCT02600182|Non-invasive ventilation|non-invasive ventilation
4803615|NCT02600182|Physiotherapy|physiotherapy
4803616|NCT02600143|Melanoma|melanoma
4803617|NCT02600143|Colitis|colitis
4803618|NCT02600143|Ipilimumab|ipilimumab
4803619|NCT02600143|Nivolumab|nivolumab
4803620|NCT02600143|Pembrolizumab|pembrolizumab
4803621|NCT02600091|Anxiety|anxiety
4803622|NCT02600091|Depression|depression
4803623|NCT02600091|Type 1 Diabetes|type 1 diabetes
4803624|NCT02600091|Mindfulness-based Cognitive Therapy|mindfulness-based cognitive therapy
4803625|NCT02600091|Glycaemic control|glycaemic control
4803626|NCT02600078|hypoxia|hypoxia
4803627|NCT02600078|ataxia|ataxia
4803628|NCT02600013|incomplete motor SCI|incomplete motor sci
4803629|NCT02600013|robotic gait training|robotic gait training
4803630|NCT02600013|exoskeleton|exoskeleton
4803631|NCT02600013|rehabilitation tool|rehabilitation tool
4803632|NCT02600013|EKSO-GT|ekso-gt
4803633|NCT02599961|Glut 1 DS|glut 1 ds
4803634|NCT02599935|Nutritional status|nutritional status
4803635|NCT02599935|MNA|mna
4803636|NCT02599935|GSA|gsa
4803637|NCT02599909|Tumor Microenvironment|tumor microenvironment
4803638|NCT02599909|100 Trillion Microbial Cells|100 trillion microbial cells
4803639|NCT02599909|Liver Tumors|liver tumors
4803640|NCT02599909|Intestinal Microbiota|intestinal microbiota
4803641|NCT02599909|Immune Regulation|immune regulation
4803642|NCT02599896|Dose Escalation|dose escalation
4803643|NCT02599896|HIV Prevention|hiv prevention
4803644|NCT02599896|Broadly HIV-1 Neutralizing Activity|broadly hiv-1 neutralizing activity
4803645|NCT02599896|Open-Label|open-label
4803646|NCT02599896|Half-Life|half-life
4803647|NCT02599883|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
4803648|NCT02599883|Diagnostic Imaging|diagnostic imaging
4803649|NCT02599883|Disease Management|disease management
4803650|NCT02599883|Clinical Decision Support Systems|clinical decision support systems
4803651|NCT02599883|Cost-Utility Analysis|cost-utility analysis
4803652|NCT02599870|PGx|pgx
4803653|NCT02599870|pharmacogenetic testing|pharmacogenetic testing
4803654|NCT02599870|IDgenetix|idgenetix
4803655|NCT02599870|Pain Management|pain management
4803656|NCT02599870|AltheaDx|altheadx
4803657|NCT02599870|Post-Operative Pain Management|post-operative pain management
4803658|NCT02599844|acute kidney injury|acute kidney injury
4803659|NCT02599831|Electrical pudendal nerve stimulation|electrical pudendal nerve stimulation
4803660|NCT02599831|Pelvic floor muscle training|pelvic floor muscle training
4803661|NCT02599831|Transanal electrical stimulation|transanal electrical stimulation
4803662|NCT02599831|Post radical prostatectomy incontinence|post radical prostatectomy incontinence
4803663|NCT02599831|Comparative study|comparative study
4803664|NCT02599792|Safety and Pharmacokinetics|safety and pharmacokinetics
4803665|NCT02599779|Renal cell cancer|renal cell cancer
4803666|NCT02599779|SBRT|sbrt
4803667|NCT02599779|Pembrolizumab|pembrolizumab
4803668|NCT02599766|animal assisted intervention, brain injury, rehabilitation|animal assisted intervention, brain injury, rehabilitation
4803669|NCT02599740|Blood glucose|blood glucose
4803670|NCT02599727|balance, postural|balance, postural
4803671|NCT02599727|postural equilibrium|postural equilibrium
4803672|NCT02599727|heart rate|heart rate
4803673|NCT02599727|blood pressure|blood pressure
4803674|NCT02599727|pulse oxygenation|pulse oxygenation
4803675|NCT02599727|mental speed|mental speed
4803676|NCT02599714|AZD2014|azd2014
4803677|NCT02599714|Palbociclib|palbociclib
4803678|NCT02599714|Fulvestrant|fulvestrant
4803679|NCT02599714|Hormonal Therapy|hormonal therapy
4803680|NCT02599714|Estrogen Receptor Positive|estrogen receptor positive
4803681|NCT02599714|Breast Cancer|breast cancer
4803682|NCT02599701|Delta Sleep|delta sleep
4803683|NCT02599701|Growth Hormone|growth hormone
4803684|NCT02599701|IGF-1|igf-1
4803685|NCT02599675|Muscle|muscle
4803686|NCT02599675|Vitamin D|vitamin d
4803687|NCT02599675|Strength|strength
4803688|NCT02599675|Endurance|endurance
4803689|NCT02599675|Muscle fiber|muscle fiber
4803690|NCT02599662|Cancer|cancer
4803691|NCT02599662|Intraoperative Radiation Therapy - IORT|intraoperative radiation therapy - iort
4803692|NCT02599649|Myelodysplastic syndrome|myelodysplastic syndrome
4803693|NCT02599649|MDS|mds
4803694|NCT02599649|Low or intermediate-1 MDS|low or intermediate-1 mds
4803695|NCT02599649|High Risk MDS|high risk mds
4803696|NCT02599649|Lirilumab|lirilumab
4803697|NCT02599649|Nivolumab|nivolumab
4803698|NCT02599649|BMS-936558|bms-936558
4803699|NCT02599649|Opdivo|opdivo
4803700|NCT02599649|Azacitidine|azacitidine
4803701|NCT02599649|5-azacytidine|5-azacytidine
4803702|NCT02599649|5-aza|5-aza
4803703|NCT02599649|Vidaza|vidaza
4803704|NCT02599649|5-AZC|5-azc
4803705|NCT02599649|AZA-CR|aza-cr
4803706|NCT02599649|Ladakamycin|ladakamycin
4803707|NCT02599649|NSC-102816|nsc-102816
4803708|NCT02599649|Azacytidine|azacytidine
4803709|NCT02599623|Incarcerated|incarcerated
4803710|NCT02599623|Anesthesia|anesthesia
4803711|NCT02599623|Hernia|hernia
4803712|NCT02599610|labor, vaginal examination, transperineal ultrasound, pain, anxiety|labor, vaginal examination, transperineal ultrasound, pain, anxiety
4803713|NCT02599584|behaviour|behaviour
4803714|NCT02599558|EOE|eoe
4803715|NCT02599532|Apixaban|apixaban
4803716|NCT02599532|Pharmacokinetics|pharmacokinetics
4803717|NCT02599532|Pharmacodynamics|pharmacodynamics
4803718|NCT02599506|breast cancer|breast cancer
4803719|NCT02599506|fear of recurrence|fear of recurrence
4803720|NCT02599506|longitudinal study|longitudinal study
4803721|NCT02599506|radiation therapy|radiation therapy
4803722|NCT02599506|emotional concerns|emotional concerns
4803723|NCT02599506|trajectory|trajectory
4803724|NCT02599506|psychological constructs|psychological constructs
4803725|NCT02599506|diary keeping|diary keeping
4803726|NCT02599480|HFpEF|hfpef
4803727|NCT02599480|left ventricular hypertrophy|left ventricular hypertrophy
4803728|NCT02599480|cardiac remodeling,|cardiac remodeling,
4803729|NCT02599467|Nerve Pain|nerve pain
4803730|NCT02599467|Electromyography|electromyography
4803731|NCT02599467|Median Nerve|median nerve
4803732|NCT02599467|Breast Neoplasms|breast neoplasms
4803733|NCT02599415|psoriasis patients referred to receive TL01 NB-UVB therapy|psoriasis patients referred to receive tl01 nb-uvb therapy
4803734|NCT02599389|in-stent restenosis; drug-coated balloons; Excimer Laser, cost effectiveness study, quality of life|in-stent restenosis; drug-coated balloons; excimer laser, cost effectiveness study, quality of life
4803735|NCT02599350|Ventilation|ventilation
4803736|NCT02599350|Gas exchange|gas exchange
4803737|NCT02599350|V/Q ratio|v/q ratio
4803738|NCT02599350|Requirement for mechanical ventilation|requirement for mechanical ventilation
4803739|NCT02599337|bioequivalence|bioequivalence
4803740|NCT02599311|pelvic organ prolapse|pelvic organ prolapse
4803741|NCT02599298|sleep|sleep
4803742|NCT02599298|treatment|treatment
4803743|NCT02599259|Stroke|stroke
4803744|NCT02599259|Oral anticoagulants|oral anticoagulants
4803745|NCT02599259|NOAC|noac
4803746|NCT02599259|wireless monitoring|wireless monitoring
4803747|NCT02599259|Warfarin|warfarin
4803748|NCT02599259|Xarelto|xarelto
4803749|NCT02599259|compliance|compliance
4803750|NCT02599259|adherence|adherence
4803751|NCT02599259|monitoring|monitoring
4803752|NCT02599259|directly observed therapy|directly observed therapy
4803753|NCT02599259|DOT|dot
4803754|NCT02599259|mobile device|mobile device
4803755|NCT02599259|electronic monitoring|electronic monitoring
4803756|NCT02599259|artificial intelligence|artificial intelligence
4803757|NCT02599259|oral anticoagulation therapy|oral anticoagulation therapy
4803758|NCT02599259|adherence monitoring methods|adherence monitoring methods
4803759|NCT02599259|nonadherence|nonadherence
4803760|NCT02599259|non-adherence|non-adherence
4803761|NCT02599246|Home ventilator|home ventilator
4803762|NCT02599246|FiO2|fio2
4803763|NCT02599246|O2|o2
4803764|NCT02599246|NIV|niv
4803765|NCT02599246|COPD|copd
4803766|NCT02599233|pain trajectory|pain trajectory
4803767|NCT02599181|Perineural cathether|perineural cathether
4803768|NCT02599181|Catheter infection|catheter infection
4803769|NCT02599168|dexmedetomidine|dexmedetomidine
4803770|NCT02599168|propofol|propofol
4803771|NCT02599168|BIS|bis
4803772|NCT02599168|CLADS|clads
4803773|NCT02599155|crystalloid|crystalloid
4803774|NCT02599155|colloid|colloid
4803775|NCT02599155|children|children
4803776|NCT02599155|infant|infant
4803777|NCT02599155|cardiac surgery|cardiac surgery
4803778|NCT02599142|radiotherapy immobilisation|radiotherapy immobilisation
4803779|NCT02599142|open-face shells|open-face shells
4803780|NCT02599129|Alopecia areata|alopecia areata
4803781|NCT02599116|cytoreductive surgery|cytoreductive surgery
4803782|NCT02599116|hyperthermic intraperitoneal chemotherapy|hyperthermic intraperitoneal chemotherapy
4803783|NCT02599116|microbiome|microbiome
4803784|NCT02599090|Glioblastoma|glioblastoma
4803785|NCT02599090|Gliosarcoma|gliosarcoma
4803786|NCT02599090|Brain Cancer|brain cancer
4803787|NCT02599090|Sorafenib|sorafenib
4803788|NCT02599090|Temozolomide|temozolomide
4803789|NCT02599090|Radiation|radiation
4803790|NCT02599090|Radiotherapy|radiotherapy
4803791|NCT02599090|XRT|xrt
4803792|NCT02599077|oral contraceptives|oral contraceptives
4803793|NCT02599077|endometrioma|endometrioma
4803794|NCT02599077|dienogest|dienogest
4803795|NCT02599064|Age-related macular degeneration|age-related macular degeneration
4803796|NCT02599064|RXI-109|rxi-109
4803797|NCT02599064|NVAMD|nvamd
4803798|NCT02599064|Retinal scarring|retinal scarring
4803799|NCT02599064|Subretinal scarring|subretinal scarring
4803800|NCT02599064|Retinal fibrosis|retinal fibrosis
4803801|NCT02599064|Subretinal fibrosis|subretinal fibrosis
4803802|NCT02599064|Eye diseases|eye diseases
4803803|NCT02599038|NAFLD|nafld
4803804|NCT02599038|NASH|nash
4803805|NCT02599038|Serine|serine
4803806|NCT02599038|Glutathione|glutathione
4803807|NCT02599025|Cerebral palsy|cerebral palsy
4803808|NCT02599025|passive cycling|passive cycling
4803809|NCT02599025|autonomic control system|autonomic control system
4803810|NCT02598986|glycemic index, pita bread, phosphorus, potassium, magnesium|glycemic index, pita bread, phosphorus, potassium, magnesium
4803811|NCT02598973|Parkinson Disease|parkinson disease
4803812|NCT02598973|exercise|exercise
4803813|NCT02598947|posterior shoulder tightness|posterior shoulder tightness
4803814|NCT02598947|shoulder impingement syndrome|shoulder impingement syndrome
4803815|NCT02598947|Glenohumeral joint|glenohumeral joint
4803816|NCT02598947|exercise|exercise
4803817|NCT02598921|Assisted reproductive technology|assisted reproductive technology
4803818|NCT02598882|Elderly|elderly
4803819|NCT02598882|Videogame|videogame
4803820|NCT02598882|energy expenditure|energy expenditure
4803821|NCT02598882|electromyography|electromyography
4803822|NCT02598882|rehabilitation|rehabilitation
4803823|NCT02598869|Triamcinolone acetonide|triamcinolone acetonide
4803824|NCT02598856|Emergency Treatment|emergency treatment
4803825|NCT02598856|Morphine Derivates|morphine derivates
4803826|NCT02598856|Heroin|heroin
4803827|NCT02598856|Antidotes|antidotes
4803828|NCT02598856|Administration, Intravenous|administration, intravenous
4803829|NCT02598856|Pharmacology|pharmacology
4803830|NCT02598856|Naloxone|naloxone
4803831|NCT02598856|Healthy volunteers|healthy volunteers
4803832|NCT02598856|Administration, intramuscular|administration, intramuscular
4803833|NCT02598856|Administration, intranasal|administration, intranasal
4803834|NCT02598830|Cachexia|cachexia
4803835|NCT02598830|Vitamin D|vitamin d
4803836|NCT02598830|Muscle|muscle
4803837|NCT02598830|Strength training|strength training
4803838|NCT02598804|Physical activity level|physical activity level
4803839|NCT02598804|Knee osteoarthritis|knee osteoarthritis
4803840|NCT02598804|Randomized controlled trials|randomized controlled trials
4803841|NCT02598804|Alternate month design study|alternate month design study
4803842|NCT02598804|Self-management|self-management
4803843|NCT02598804|Self-care|self-care
4803844|NCT02598804|Education and exercise in knee osteoarthritis|education and exercise in knee osteoarthritis
4803845|NCT02598804|Education|education
4803846|NCT02598804|Non pharmacological treatment|non pharmacological treatment
4803847|NCT02598791|incretin hormones|incretin hormones
4803848|NCT02598791|GIP|gip
4803849|NCT02598791|GLP-1|glp-1
4803850|NCT02598765|Glaucoma|glaucoma
4803851|NCT02598765|Trabeculectomy|trabeculectomy
4803852|NCT02598765|Eye Disease|eye disease
4803853|NCT02598765|Intraocular Pressure|intraocular pressure
4803854|NCT02598765|Visual Acuity|visual acuity
4803855|NCT02598752|functional performance testing|functional performance testing
4803856|NCT02598752|exercise fitness testing|exercise fitness testing
4803857|NCT02598752|15-274|15-274
4803858|NCT02598739|Physical exercise|physical exercise
4803859|NCT02598739|Psoriatic arthritis|psoriatic arthritis
4803860|NCT02598739|Quality of life|quality of life
4803861|NCT02598700|total hip arthroplasty|total hip arthroplasty
4803862|NCT02598700|imaging|imaging
4803863|NCT02598700|arthritis|arthritis
4803864|NCT02598700|surgical technique|surgical technique
4803865|NCT02598674|acute kidney injury|acute kidney injury
4803866|NCT02598661|Myelodysplastic Syndromes|myelodysplastic syndromes
4803867|NCT02598661|Imetelstat|imetelstat
4803868|NCT02598648|FXR|fxr
4803869|NCT02598648|RIPK3|ripk3
4803870|NCT02598648|Neonates|neonates
4803871|NCT02598648|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
4803872|NCT02598648|Acute Lung Injury|acute lung injury
4803873|NCT02598635|Cholecalciferol|cholecalciferol
4803874|NCT02598635|peritoneal dialysis|peritoneal dialysis
4803875|NCT02598635|FGF23|fgf23
4803876|NCT02598635|Calcium|calcium
4803877|NCT02598635|Phosphorus|phosphorus
4803878|NCT02598609|Adverse event|adverse event
4803879|NCT02598609|Neonatal Intensive Care Unit|neonatal intensive care unit
4803880|NCT02598609|Catheter-related Bloodstream Infection (CRBSI) nos|catheter-related bloodstream infection (crbsi) nos
4803881|NCT02598609|Extravasation injury|extravasation injury
4803882|NCT02598609|Medication error|medication error
4803883|NCT02598609|Central venous catheter complication|central venous catheter complication
4803884|NCT02598609|Unprogrammed extubation|unprogrammed extubation
4803885|NCT02598596|Refractory gout|refractory gout
4803886|NCT02598596|Chronic gout|chronic gout
4803887|NCT02598583|Paroxysmal Nocturnal Hemoglobinuria|paroxysmal nocturnal hemoglobinuria
4803888|NCT02598583|PNH|pnh
4803889|NCT02598583|complement inhibitor|complement inhibitor
4803890|NCT02598570|Relapsed Lymphoma|relapsed lymphoma
4803891|NCT02598570|Phosphoinositide 3-kinase (PI3K) Inhibitor|phosphoinositide 3-kinase (pi3k) inhibitor
4803892|NCT02598570|Duvelisib|duvelisib
4803893|NCT02598570|Japanese|japanese
4803894|NCT02598570|Refractory Lymphoma|refractory lymphoma
4803895|NCT02598518|Integrating Combined Therapies|integrating combined therapies
4803896|NCT02598518|Alcohol Use Disorder|alcohol use disorder
4803897|NCT02598518|Mental Health Disorder|mental health disorder
4803898|NCT02598492|Mechanical Ventilator|mechanical ventilator
4803899|NCT02598479|Cancer|cancer
4803900|NCT02598479|Insulin Potentiation Low Dose Chemotherapy|insulin potentiation low dose chemotherapy
4803901|NCT02598479|IPT|ipt
4803902|NCT02598479|IPTLD|iptld
4803903|NCT02598479|Nutrition therapy|nutrition therapy
4803904|NCT02598427|Breast Cancer|breast cancer
4803905|NCT02598427|HER2 Positive|her2 positive
4803906|NCT02598427|HER2+|her2+
4803907|NCT02598427|Brain Metastases|brain metastases
4803908|NCT02598427|Metastatic Breast Cancer|metastatic breast cancer
4803909|NCT02598427|Intrathecal Treatment|intrathecal treatment
4803910|NCT02598427|Lumbar Puncture|lumbar puncture
4803911|NCT02598427|Pertuzumab|pertuzumab
4803912|NCT02598427|Trastuzumab|trastuzumab
4803913|NCT02598427|Advanced Breast Cancer|advanced breast cancer
4803914|NCT02598427|Duke University|duke university
4803915|NCT02598414|Colorectal Disease|colorectal disease
4803916|NCT02598414|Robotic Surgery|robotic surgery
4803917|NCT02598414|Indocyanine Green Fluorescence Imaging|indocyanine green fluorescence imaging
4803918|NCT02598414|Anastomotic Leak|anastomotic leak
4803919|NCT02598414|Short-term Outcomes|short-term outcomes
4803920|NCT02598388|Healthy|healthy
4803921|NCT02598388|Vaccine|vaccine
4803922|NCT02598388|Ebola viruses|ebola viruses
4803923|NCT02598388|Ebola virus disease (EVD)|ebola virus disease (evd)
4803924|NCT02598388|Filoviruses|filoviruses
4803925|NCT02598388|Hemorrhagic fever|hemorrhagic fever
4803926|NCT02598388|Monovalent vaccine|monovalent vaccine
4803927|NCT02598388|Human adenovirus serotype 26 (Ad26) expressing the Ebola virus Mayinga variant glycoprotein (Ad26.ZEBOV)|human adenovirus serotype 26 (ad26) expressing the ebola virus mayinga variant glycoprotein (ad26.zebov)
4803928|NCT02598388|Modified Vaccinia Virus Ankara - Bavarian Nordic (MVA-BN) Filo-vector|modified vaccinia virus ankara - bavarian nordic (mva-bn) filo-vector
4803929|NCT02598388|Safety|safety
4803930|NCT02598388|Immunogenicity|immunogenicity
4803931|NCT02598375|Early reached target enteral nutrition in PICU feeding intolerance IFABP|early reached target enteral nutrition in picu feeding intolerance ifabp
4803932|NCT02598362|ciprofloxacin|ciprofloxacin
4803933|NCT02598362|pharmacokinetics|pharmacokinetics
4803934|NCT02598362|excretion|excretion
4803935|NCT02598362|clearance|clearance
4803936|NCT02598362|infant|infant
4803937|NCT02598362|children|children
4803938|NCT02598362|adolescent|adolescent
4803939|NCT02598349|Unresectable|unresectable
4803940|NCT02598349|Borderline resectable|borderline resectable
4803941|NCT02598336|Structured Light Plethysmography|structured light plethysmography
4803942|NCT02598336|Spirometry|spirometry
4803943|NCT02598336|Pneumotachograph|pneumotachograph
4803944|NCT02598297|Ruxolitinib|ruxolitinib
4803945|NCT02598297|INC424|inc424
4803946|NCT02598297|early myelofibrosis|early myelofibrosis
4803947|NCT02598297|High molecular risk mutations|high molecular risk mutations
4803948|NCT02598297|HMR|hmr
4803949|NCT02598284|Preventive measures|preventive measures
4803950|NCT02598284|Quality Improvement|quality improvement
4803951|NCT02598271|Acute Kidney Injury|acute kidney injury
4803952|NCT02598271|Cardiac Surgery|cardiac surgery
4803953|NCT02598258|Sauna|sauna
4803954|NCT02598258|Cold water bath|cold water bath
4803955|NCT02598245|urinary incontinence, CESA, VASA, TOT, TVT|urinary incontinence, cesa, vasa, tot, tvt
4803956|NCT02598219|Sentinel node|sentinel node
4803957|NCT02598206|food effect|food effect
4803958|NCT02598206|healthy volunteers|healthy volunteers
4803959|NCT02598206|pharmacokinetics|pharmacokinetics
4803960|NCT02598206|CCR2i|ccr2i
4803961|NCT02598141|Protheses, nails, screws or plates|protheses, nails, screws or plates
4803962|NCT02598115|collaborative pharmaceutical care|collaborative pharmaceutical care
4803963|NCT02598089|Seasonal Influenza|seasonal influenza
4803964|NCT02598089|Trivalent Vaccine|trivalent vaccine
4803965|NCT02598089|Inactivated Vaccine|inactivated vaccine
4803966|NCT02598050|postoperative health outcomes|postoperative health outcomes
4803967|NCT02598050|older surgical patients|older surgical patients
4803968|NCT02598037|Obesity|obesity
4803969|NCT02598037|Polymorphism|polymorphism
4803970|NCT02598037|Hormones|hormones
4803971|NCT02597985|Frailty|frailty
4803972|NCT02597959|ergonomic risk factors|ergonomic risk factors
4803973|NCT02597959|allied health professionals|allied health professionals
4803974|NCT02597959|surgical care|surgical care
4803975|NCT02597881|natural history|natural history
4803976|NCT02597868|therapy|therapy
4803977|NCT02597868|Capecitabine|capecitabine
4803978|NCT02597868|breast cancer|breast cancer
4803979|NCT02597842|Postoperative nausea and vomiting|postoperative nausea and vomiting
4803980|NCT02597842|TEAS|teas
4803981|NCT02597829|Inflammatory Bowel Disease|inflammatory bowel disease
4803982|NCT02597829|Mucosal Healing|mucosal healing
4803983|NCT02597829|Certolizumab pegol|certolizumab pegol
4803984|NCT02597803|Dry Eye Syndrome|dry eye syndrome
4803985|NCT02597803|Dry Eye|dry eye
4803986|NCT02597803|DES|des
4803987|NCT02597790|endothelial function|endothelial function
4803988|NCT02597790|cardiovascular risk|cardiovascular risk
4803989|NCT02597790|HIV|hiv
4803990|NCT02597790|Hepatitis C|hepatitis c
4803991|NCT02597790|metabolic disease|metabolic disease
4803992|NCT02597790|inflammation|inflammation
4803993|NCT02597764|Diaphragmatic breathing (DB)|diaphragmatic breathing (db)
4803994|NCT02597764|Bladder and bowel disorders (BBD)|bladder and bowel disorders (bbd)
4803995|NCT02597764|Autonomic nervous system (ANS)|autonomic nervous system (ans)
4803996|NCT02597764|Heart rate variability (HRV)|heart rate variability (hrv)
4803997|NCT02597764|Deep breathing|deep breathing
4803998|NCT02597764|Randomized controlled trial (RCT)|randomized controlled trial (rct)
4803999|NCT02597751|DCD|dcd
4804000|NCT02597751|Neuroimaging|neuroimaging
4804001|NCT02597751|Rehabilitation|rehabilitation
4804002|NCT02597725|Urodynamics|urodynamics
4804003|NCT02597725|Late effects|late effects
4804004|NCT02597725|Urinary Incontinence|urinary incontinence
4804005|NCT02597712|acid reflux|acid reflux
4804006|NCT02597712|intragastric pH|intragastric ph
4804007|NCT02597712|gastrin|gastrin
4804008|NCT02597712|hypergastrinemia|hypergastrinemia
4804009|NCT02597699|Termination of pregnancy|termination of pregnancy
4804010|NCT02597699|Feticide|feticide
4804011|NCT02597699|Fetal pain|fetal pain
4804012|NCT02597699|Remifentanil Ultiva®|remifentanil ultiva®
4804013|NCT02597699|Fetal asystole|fetal asystole
4804014|NCT02597699|Fetopathologic analysis|fetopathologic analysis
4804015|NCT02597660|patellar tendinopathy|patellar tendinopathy
4804016|NCT02597660|somatropin|somatropin
4804017|NCT02597660|jumper's knee|jumper's knee
4804018|NCT02597647|immunology|immunology
4804019|NCT02597647|Microbiota|microbiota
4804020|NCT02597582|LigaSure|ligasure
4804021|NCT02597582|Neck dissection|neck dissection
4804022|NCT02597582|Operative duration|operative duration
4804023|NCT02597582|Postoperative drainage|postoperative drainage
4804024|NCT02597582|Postoperative pain|postoperative pain
4804025|NCT02597569|stroke|stroke
4804026|NCT02597569|Cognitive Orientation to daily Occupational Performance|cognitive orientation to daily occupational performance
4804027|NCT02597569|health services accessibility|health services accessibility
4804028|NCT02597569|cognitive impairment|cognitive impairment
4804029|NCT02597569|rehabilitation|rehabilitation
4804030|NCT02597569|integrated knowledge translation|integrated knowledge translation
4804130|NCT02596893|GED-0301|ged-0301
4804031|NCT02597569|interrupted time series|interrupted time series
4804032|NCT02597569|The CO-OP Approach|the co-op approach
4804033|NCT02597556|Albendazole|albendazole
4804034|NCT02597556|Ancylostoma duodenale|ancylostoma duodenale
4804035|NCT02597556|Ascariasis lumbricoides|ascariasis lumbricoides
4804036|NCT02597556|Coinfection|coinfection
4804037|NCT02597556|Diarrhea|diarrhea
4804038|NCT02597556|Helminths|helminths
4804039|NCT02597556|Necator americanus|necator americanus
4804040|NCT02597556|Microbiota|microbiota
4804041|NCT02597556|Trichuris trichiura|trichuris trichiura
4804042|NCT02597543|heart transplantation|heart transplantation
4804043|NCT02597543|cardiac MRI|cardiac mri
4804044|NCT02597543|graft rejection|graft rejection
4804045|NCT02597543|nonspecific allograft dysfunction|nonspecific allograft dysfunction
4804046|NCT02597543|allograft vasculopathy|allograft vasculopathy
4804047|NCT02597530|TEAS|teas
4804048|NCT02597530|anesthesia|anesthesia
4804049|NCT02597517|gastritis|gastritis
4804050|NCT02597517|chromoendoscopy|chromoendoscopy
4804051|NCT02597517|magnification|magnification
4804052|NCT02597517|Helicobacter pylori|helicobacter pylori
4804053|NCT02597517|Atrophic gastritis|atrophic gastritis
4804054|NCT02597491|Smoking,|smoking,
4804055|NCT02597491|Smoking cessation|smoking cessation
4804056|NCT02597491|Sequential, multiple assignment, randomized trials (SMART)|sequential, multiple assignment, randomized trials (smart)
4804057|NCT02597491|Lung cancer screening|lung cancer screening
4804058|NCT02597478|Advanced Cancers|advanced cancers
4804059|NCT02597478|Fentanyl Sublingual Spray|fentanyl sublingual spray
4804060|NCT02597478|Fentanyl SL Spray|fentanyl sl spray
4804061|NCT02597478|FSS|fss
4804062|NCT02597478|Questionnaires|questionnaires
4804063|NCT02597478|Surveys|surveys
4804064|NCT02597478|Mental Abilities Test|mental abilities test
4804065|NCT02597478|Phone Call|phone call
4804066|NCT02597478|Shuttle Walk Test|shuttle walk test
4804067|NCT02597452|breast lump|breast lump
4804068|NCT02597452|breast exam|breast exam
4804069|NCT02597452|breast cancer screening|breast cancer screening
4804070|NCT02597452|breast lump detection|breast lump detection
4804071|NCT02597439|Ultra-high risk|ultra-high risk
4804072|NCT02597439|UHR|uhr
4804073|NCT02597439|psychosis|psychosis
4804074|NCT02597426|Nasopharyngeal Carcinoma|nasopharyngeal carcinoma
4804075|NCT02597426|Intensity-Modulated Radiotherapy|intensity-modulated radiotherapy
4804076|NCT02597426|Post treatment|post treatment
4804077|NCT02597374|Electroencephalography|electroencephalography
4804078|NCT02597374|mu rhythm|mu rhythm
4804079|NCT02597374|Sensorimotor Cortex|sensorimotor cortex
4804080|NCT02597374|Unilateral Cerebral Palsy|unilateral cerebral palsy
4804082|NCT02597361|Ehlers-Danlos syndrome, vascular type|ehlers-danlos syndrome, vascular type
4804083|NCT02597361|Type 2 Angiotensin Receptor Blockers|type 2 angiotensin receptor blockers
4804084|NCT02597348|Liver|liver
4804085|NCT02597348|Metastasis|metastasis
4804086|NCT02597348|Colorectal cancer|colorectal cancer
4804087|NCT02597348|Liver transplantation|liver transplantation
4804088|NCT02597335|Glioma|glioma
4804089|NCT02597335|IDH1/IDH2 mutation|idh1/idh2 mutation
4804090|NCT02597335|Spectroscopy MRI|spectroscopy mri
4804091|NCT02597335|D-2-hydroxyglutarate|d-2-hydroxyglutarate
4804092|NCT02597335|Free circulating DNA|free circulating dna
4804093|NCT02597322|Axitinib|axitinib
4804094|NCT02597322|T2a Renal tumor|t2a renal tumor
4804095|NCT02597322|organ confined tumors|organ confined tumors
4804096|NCT02597322|nephron sparing surgery|nephron sparing surgery
4804097|NCT02597322|nephron sparing procedure|nephron sparing procedure
4804098|NCT02597322|radical nephrectomy|radical nephrectomy
4804099|NCT02597283|Bifurcation lesions|bifurcation lesions
4804100|NCT02597283|Percutaneous coronary intervention|percutaneous coronary intervention
4804101|NCT02597283|Randomized controlled trial|randomized controlled trial
4804102|NCT02597270|Hepatitis C virus|hepatitis c virus
4804103|NCT02597257|Lidocaine infusion therapy|lidocaine infusion therapy
4804104|NCT02597244|Lumbar foraminal stenosis|lumbar foraminal stenosis
4804105|NCT02597231|Delirium|delirium
4804106|NCT02597231|Melatonin|melatonin
4804107|NCT02597218|Hepatectomy|hepatectomy
4804108|NCT02597218|Prophylaxis|prophylaxis
4804109|NCT02597205|Medical adherence|medical adherence
4804110|NCT02597205|Lifestyle modification|lifestyle modification
4804111|NCT02597205|Mobile Health|mobile health
4804112|NCT02597205|Secondary Prevention|secondary prevention
4804113|NCT02597192|gingivitis|gingivitis
4804114|NCT02597192|gingival inflammation|gingival inflammation
4804115|NCT02597192|probiotics|probiotics
4804116|NCT02597192|Bacillus|bacillus
4804117|NCT02597075|Colorectal Cancer|colorectal cancer
4804118|NCT02597075|Metastatic Colorectal Cancer|metastatic colorectal cancer
4804119|NCT02597075|Physical Activity|physical activity
4804120|NCT02597075|Quality of life|quality of life
4804121|NCT02597036|Advanced, Angiopoietin|advanced, angiopoietin
4804122|NCT02596997|Adenovirus Brincidofovir|adenovirus brincidofovir
4804123|NCT02596984|Intensive Care Unit|intensive care unit
4804124|NCT02596984|Shock|shock
4804125|NCT02596984|Antifungal agent|antifungal agent
4804126|NCT02596984|Pharmacokinetics|pharmacokinetics
4804127|NCT02596984|Sepsis|sepsis
4804128|NCT02596932|Intrapartum|intrapartum
4804129|NCT02596893|Crohn's Disease|crohn's disease
4804131|NCT02596893|Mongersen|mongersen
4804132|NCT02596893|IBD|ibd
4804133|NCT02596893|Safety|safety
4804134|NCT02596893|Efficacy|efficacy
4804135|NCT02596880|Hepatitis C|hepatitis c
4804136|NCT02596880|Cirrhosis|cirrhosis
4804137|NCT02596880|Sofosbuvir|sofosbuvir
4804138|NCT02596880|Daclatasvir|daclatasvir
4804139|NCT02596880|Ribavirin|ribavirin
4804140|NCT02596867|B adrenergic pathway|b adrenergic pathway
4804141|NCT02596867|B Blocker|b blocker
4804142|NCT02596841|Lung diffusing capacity|lung diffusing capacity
4804143|NCT02596841|Idiopathic Interstitial Pneumonias|idiopathic interstitial pneumonias
4804144|NCT02596828|molecular targeted therapy|molecular targeted therapy
4804145|NCT02596828|protein kinase inhibitor|protein kinase inhibitor
4804146|NCT02596828|mTOR Inhibitor|mtor inhibitor
4804147|NCT02596828|cytostatic topoisomerase-I-inhibitor|cytostatic topoisomerase-i-inhibitor
4804148|NCT02596828|temozolomide|temozolomide
4804149|NCT02596828|irinotecan|irinotecan
4804150|NCT02596828|dasatinib|dasatinib
4804151|NCT02596828|rapamycin|rapamycin
4804152|NCT02596802|Fetoscopic Endoluminal Tracheal Occlusion|fetoscopic endoluminal tracheal occlusion
4804153|NCT02596802|Congenital Diaphragmatic Hernia|congenital diaphragmatic hernia
4804154|NCT02596763|Off-label prescription|off-label prescription
4804155|NCT02596763|Alcoholism|alcoholism
4804156|NCT02596763|Pharmacovigilance|pharmacovigilance
4804157|NCT02596763|Pharmacoepidemiology|pharmacoepidemiology
4804158|NCT02596763|Baclofen|baclofen
4804159|NCT02596737|health|health
4804160|NCT02596737|work|work
4804161|NCT02596737|lifestyle|lifestyle
4804162|NCT02596737|behavior|behavior
4804163|NCT02596737|management|management
4804164|NCT02596737|stress|stress
4804165|NCT02596737|physical activity|physical activity
4804166|NCT02596737|nutrition|nutrition
4804167|NCT02596737|mortality|mortality
4804168|NCT02596737|morbidity|morbidity
4804169|NCT02596737|public health|public health
4804170|NCT02596724|Breast Cancer|breast cancer
4804171|NCT02596724|Neoadjuvant therapy for breast cancer|neoadjuvant therapy for breast cancer
4804172|NCT02596711|Cancer Prevention|cancer prevention
4804173|NCT02596711|Tobacco Use Cessation|tobacco use cessation
4804174|NCT02596711|Nicotine Patch|nicotine patch
4804175|NCT02596711|NRT|nrt
4804176|NCT02596711|Questionnaires|questionnaires
4804177|NCT02596711|Surveys|surveys
4804178|NCT02596711|Carbon Monoxide Test|carbon monoxide test
4804179|NCT02596711|CO|co
4804180|NCT02596711|Health Education|health education
4804181|NCT02596711|Handouts|handouts
4804182|NCT02596711|Pamphlets|pamphlets
4804183|NCT02596711|Counseling sessions|counseling sessions
4804184|NCT02596698|Mood Disorder|mood disorder
4804185|NCT02596672|physical activity|physical activity
4804186|NCT02596672|older adults|older adults
4804187|NCT02596672|retirement homes|retirement homes
4804188|NCT02596672|walking|walking
4804189|NCT02596672|feasibility study|feasibility study
4804190|NCT02596659|lateral epicondylosis|lateral epicondylosis
4804191|NCT02596659|lateral epicondylitis|lateral epicondylitis
4804192|NCT02596659|shockwave|shockwave
4804193|NCT02596659|sonoelastography|sonoelastography
4804194|NCT02596659|tennis elbow|tennis elbow
4804195|NCT02596659|pain intensity|pain intensity
4804196|NCT02596659|grip strength|grip strength
4804197|NCT02596659|upper limb function|upper limb function
4804198|NCT02596659|stiffness of common extensor tendon|stiffness of common extensor tendon
4804199|NCT02596620|Helicobacter pylori|helicobacter pylori
4804200|NCT02596620|Proton pump inhibitor|proton pump inhibitor
4804201|NCT02596620|Eradication|eradication
4804202|NCT02596607|ischemic stroke, acute phase, thrombolysis, management times|ischemic stroke, acute phase, thrombolysis, management times
4804203|NCT02596594|IUGR|iugr
4804204|NCT02596594|severe IUGR|severe iugr
4804205|NCT02596594|brain sparing|brain sparing
4804206|NCT02596594|fetal nutrition|fetal nutrition
4804207|NCT02596594|Prolongation|prolongation
4804208|NCT02596594|pregnancy|pregnancy
4804209|NCT02596594|neonatal outcome|neonatal outcome
4804210|NCT02596581|periodontitis|periodontitis
4804211|NCT02596581|diabetes mellitus|diabetes mellitus
4804212|NCT02596581|chemerin|chemerin
4804213|NCT02596581|interleukin-6|interleukin-6
4804214|NCT02596503|young adults|young adults
4804215|NCT02596503|adolescents|adolescents
4804216|NCT02596490|Non-Small Cell Lung Cancer|non-small cell lung cancer
4804217|NCT02596490|NSCLC|nsclc
4804218|NCT02596490|Couples-based meditation program|couples-based meditation program
4804219|NCT02596490|Couples-based cancer-related discussion program|couples-based cancer-related discussion program
4804220|NCT02596490|Questionnaires|questionnaires
4804221|NCT02596490|Surveys|surveys
4804222|NCT02596490|Metastatic lung cancer|metastatic lung cancer
4804223|NCT02596490|Quality of life|quality of life
4804224|NCT02596490|QOL|qol
4804225|NCT02596477|Heart failure|heart failure
4804226|NCT02596412|children|children
4804227|NCT02596412|botulinum toxin|botulinum toxin
4804228|NCT02596412|augmented reality|augmented reality
4804229|NCT02596412|Pain|pain
4804230|NCT02596399|Healthy volunteers|healthy volunteers
4804231|NCT02596399|DSTA4637S|dsta4637s
4804232|NCT02596360|Antinociception|antinociception
4804328|NCT02595775|Colonoscopy|colonoscopy
4804233|NCT02596360|Freeze-induced hyperalgesia model|freeze-induced hyperalgesia model
4804234|NCT02596360|Dextromethorphan|dextromethorphan
4804235|NCT02596360|NMDA-receptors|nmda-receptors
4804236|NCT02596360|Pharmacogenetic|pharmacogenetic
4804237|NCT02596360|CYP3A4 gene|cyp3a4 gene
4804238|NCT02596360|MDR1 gene|mdr1 gene
4804239|NCT02596334|HIV-1 infected patient|hiv-1 infected patient
4804240|NCT02596334|monotherapy|monotherapy
4804241|NCT02596334|dolutegravir|dolutegravir
4804242|NCT02596321|House Dust Mite|house dust mite
4804243|NCT02596308|Plague vaccine|plague vaccine
4804244|NCT02596308|Immunogenicity|immunogenicity
4804245|NCT02596308|Safety|safety
4804246|NCT02596282|neonatal male circumcision|neonatal male circumcision
4804247|NCT02596282|Clinical officers vs Nurse midwives|clinical officers vs nurse midwives
4804248|NCT02596282|Rakai, Uganda|rakai, uganda
4804249|NCT02596282|acceptability and safety of neonatal male circumcision|acceptability and safety of neonatal male circumcision
4804250|NCT02596243|CIN2, CIN2/3, CIN3|cin2, cin2/3, cin3
4804251|NCT02596243|Cervical Intraepithelial Neoplasia|cervical intraepithelial neoplasia
4804252|NCT02596243|High-Risk HPV|high-risk hpv
4804253|NCT02596243|HPV infection|hpv infection
4804254|NCT02596243|precancer Diseases|precancer diseases
4804255|NCT02596243|Double Blind|double blind
4804256|NCT02596243|Safety/Efficacy|safety/efficacy
4804257|NCT02596217|ABBV-066|abbv-066
4804258|NCT02596217|BI 655066|bi 655066
4804259|NCT02596217|risankizumab|risankizumab
4804260|NCT02596165|validation|validation
4804261|NCT02596165|pulse wave analysis|pulse wave analysis
4804262|NCT02596165|blood pressure monitoring|blood pressure monitoring
4804263|NCT02596152|balance|balance
4804264|NCT02596152|strength|strength
4804265|NCT02596152|barriers towards exercise|barriers towards exercise
4804266|NCT02596152|quality of life|quality of life
4804267|NCT02596152|body dissatisfaction|body dissatisfaction
4804268|NCT02596152|executive functions|executive functions
4804269|NCT02596152|eating behavior|eating behavior
4804270|NCT02596152|fitness|fitness
4804271|NCT02596126|Polypill|polypill
4804272|NCT02596126|Prevention of Secondary Cardiovascular Disease|prevention of secondary cardiovascular disease
4804273|NCT02596126|Cardiovascular Disease|cardiovascular disease
4804274|NCT02596126|Myocardial Infarction|myocardial infarction
4804275|NCT02596126|Cardiovascular Combination Polypill AAR|cardiovascular combination polypill aar
4804276|NCT02596126|Cardiovascular Disease in the Elderly|cardiovascular disease in the elderly
4804277|NCT02596126|Adherence|adherence
4804278|NCT02596126|SECURE|secure
4804279|NCT02596126|Elderly|elderly
4804280|NCT02596126|Secondary Cardiovascular Disease|secondary cardiovascular disease
4804281|NCT02596126|Secondary Cardiovascular Prevention|secondary cardiovascular prevention
4804282|NCT02596126|Randomized Cardiovascular Trial|randomized cardiovascular trial
4804283|NCT02596126|Randomized Trial|randomized trial
4804284|NCT02596126|Cardiovascular Polypill|cardiovascular polypill
4804285|NCT02596113|colorectal cancer|colorectal cancer
4804286|NCT02596113|genes involved in carcinogenesis of the colon|genes involved in carcinogenesis of the colon
4804287|NCT02596113|screening colorectal cancer|screening colorectal cancer
4804288|NCT02596100|Bioequivalence|bioequivalence
4804289|NCT02596009|COPD|copd
4804290|NCT02596009|Cachexia due to chronic obstructive pulmonary disease|cachexia due to chronic obstructive pulmonary disease
4804291|NCT02596009|wasting syndrome|wasting syndrome
4804292|NCT02596009|Loss of weight|loss of weight
4804293|NCT02596009|muscle atrophy|muscle atrophy
4804294|NCT02596009|loss of body mass|loss of body mass
4804295|NCT02596009|signficant loss of appetite|signficant loss of appetite
4804296|NCT02596009|cachectic syndrome|cachectic syndrome
4804297|NCT02595983|FAP|fap
4804298|NCT02595983|Familial Amyloidotic Polyneuropathy|familial amyloidotic polyneuropathy
4804299|NCT02595983|ATTR Amyloidosis|attr amyloidosis
4804300|NCT02595983|Orthotopic Liver Transplant|orthotopic liver transplant
4804301|NCT02595983|RNAi therapeutic|rnai therapeutic
4804302|NCT02595970|Psoriasis|psoriasis
4804303|NCT02595970|Secukinumab|secukinumab
4804304|NCT02595970|Simplified Psoriasis Index|simplified psoriasis index
4804305|NCT02595970|CAIN457A|cain457a
4804306|NCT02595970|AIN457AFR01|ain457afr01
4804307|NCT02595970|AIN457A|ain457a
4804308|NCT02595957|Exome Sequencing|exome sequencing
4804309|NCT02595957|Incidental or Secondary Findings|incidental or secondary findings
4804310|NCT02595853|Upper GastroIntestinal bleeding, endoscopy, Hemospray|upper gastrointestinal bleeding, endoscopy, hemospray
4804311|NCT02595827|Pediatrics|pediatrics
4804312|NCT02595827|Epidemiology|epidemiology
4804313|NCT02595827|Fever|fever
4804314|NCT02595827|Democratic Republic of the Congo|democratic republic of the congo
4804315|NCT02595827|Randomized Controlled Trial|randomized controlled trial
4804316|NCT02595814|Registry|registry
4804317|NCT02595814|Heart failure|heart failure
4804318|NCT02595814|Hospitalized|hospitalized
4804319|NCT02595814|Global|global
4804320|NCT02595814|Morbidity|morbidity
4804321|NCT02595814|Mortality|mortality
4804322|NCT02595814|Quality of life|quality of life
4804323|NCT02595814|AHF|ahf
4804324|NCT02595775|endoscopy measures|endoscopy measures
4804325|NCT02595775|audit and feedback|audit and feedback
4804326|NCT02595775|quality improvement|quality improvement
4804327|NCT02595775|randomized controlled trial|randomized controlled trial
4804329|NCT02595710|Cryptogenic Chronic Hepatitis|cryptogenic chronic hepatitis
4804330|NCT02595710|Bartonellosis|bartonellosis
4804331|NCT02595684|Obesity|obesity
4804332|NCT02595684|Tadalfil|tadalfil
4804333|NCT02595684|Insulin secretion|insulin secretion
4804334|NCT02595684|Insulin sensitivity|insulin sensitivity
4804335|NCT02595671|Digital coaching|digital coaching
4804336|NCT02595671|Sustainable weight loss|sustainable weight loss
4804337|NCT02595671|Self-determination theory|self-determination theory
4804338|NCT02595671|Obesity|obesity
4804339|NCT02595671|Overweight|overweight
4804340|NCT02595671|Diet|diet
4804341|NCT02595671|Physical activity|physical activity
4804342|NCT02595645|colorectal adenoma|colorectal adenoma
4804343|NCT02595645|colorectal cancer|colorectal cancer
4804344|NCT02595645|next generation sequencing|next generation sequencing
4804345|NCT02595645|liquid biopsy|liquid biopsy
4804346|NCT02595645|screening colonoscopy|screening colonoscopy
4804347|NCT02595645|surveillance strategies|surveillance strategies
4804348|NCT02595619|AKI|aki
4804349|NCT02595619|Extracorporeal Carbon Dioxide Removal|extracorporeal carbon dioxide removal
4804350|NCT02595619|Renal Replacement Therapy|renal replacement therapy
4804351|NCT02595619|Mechanical Ventilation|mechanical ventilation
4804352|NCT02595606|dry eye syndromes|dry eye syndromes
4804353|NCT02595606|diabetes mellitus|diabetes mellitus
4804354|NCT02595593|Trauma|trauma
4804355|NCT02595593|Rib Plate|rib plate
4804356|NCT02595593|Rib Fixation|rib fixation
4804357|NCT02595580|Blood Glucose Self-Monitoring|blood glucose self-monitoring
4804358|NCT02595567|Liver disease|liver disease
4804359|NCT02595567|Pleural effusion|pleural effusion
4804360|NCT02595554|Cervical cancer, Stage IIB, Neoadjuvant chemotherapy|cervical cancer, stage iib, neoadjuvant chemotherapy
4804361|NCT02595541|pediatric|pediatric
4804362|NCT02595541|cardiac|cardiac
4804363|NCT02595541|sildenfil|sildenfil
4804364|NCT02595541|milrinone|milrinone
4804365|NCT02595541|pulmonary hypertension|pulmonary hypertension
4804366|NCT02595489|Leukodystrophy|leukodystrophy
4804367|NCT02595489|ABCD1|abcd1
4804368|NCT02595489|Demyelination|demyelination
4804369|NCT02595489|Inflammation|inflammation
4804370|NCT02595489|ALD|ald
4804371|NCT02595489|Vitamin D|vitamin d
4804372|NCT02595489|Oxidative Stress|oxidative stress
4804373|NCT02595489|X- linked|x- linked
4804374|NCT02595489|Adrenoleukodystrophy|adrenoleukodystrophy
4804375|NCT02595476|analgesia|analgesia
4804376|NCT02595476|pupillometry|pupillometry
4804377|NCT02595476|general anesthesia|general anesthesia
4804378|NCT02595450|Non-small cell lung cancer|non-small cell lung cancer
4804379|NCT02595437|dialysis|dialysis
4804380|NCT02595437|pediatric|pediatric
4804381|NCT02595437|chronic kidney disease|chronic kidney disease
4804382|NCT02595411|Children|children
4804383|NCT02595411|Rehabilitation|rehabilitation
4804384|NCT02595411|Upper Limb|upper limb
4804385|NCT02595411|Assessments|assessments
4804386|NCT02595411|Outcome Measures|outcome measures
4804387|NCT02595398|Uveitis|uveitis
4804388|NCT02595398|UME|ume
4804389|NCT02595398|Posterior Uveitis|posterior uveitis
4804390|NCT02595398|Anterior Uveitis|anterior uveitis
4804391|NCT02595398|Intermediate Uveitis|intermediate uveitis
4804392|NCT02595398|Panuveitis|panuveitis
4804393|NCT02595398|Non-infectious Uveitis|non-infectious uveitis
4804394|NCT02595398|Triamcinolone|triamcinolone
4804395|NCT02595398|Choroid|choroid
4804396|NCT02595398|Choroidal Injection|choroidal injection
4804397|NCT02595398|Suprachoroidal|suprachoroidal
4804398|NCT02595398|Microneedle|microneedle
4804399|NCT02595398|Microinjection|microinjection
4804400|NCT02595359|endophthalmitis|endophthalmitis
4804401|NCT02595359|antibiotic therapy|antibiotic therapy
4804402|NCT02595359|cataract surgery|cataract surgery
4804403|NCT02595359|prevention|prevention
4804404|NCT02595333|repeat cesarean section|repeat cesarean section
4804405|NCT02595333|pain|pain
4804406|NCT02595320|breast, gastrointestinal,capecitabine, cancer, metastatic|breast, gastrointestinal,capecitabine, cancer, metastatic
4804407|NCT02595307|Risk Recall|risk recall
4804408|NCT02595307|Pamphlet|pamphlet
4804409|NCT02595307|Brochure|brochure
4804410|NCT02595307|Patient satisfaction|patient satisfaction
4804411|NCT02595307|Informed Consent|informed consent
4804412|NCT02595281|Ovarian Carcinoma|ovarian carcinoma
4804413|NCT02595281|neoadjuvant|neoadjuvant
4804414|NCT02595281|ROMA|roma
4804415|NCT02595281|Ca125|ca125
4804416|NCT02595281|HE4|he4
4804417|NCT02595281|biomarker|biomarker
4804418|NCT02595268|Healthy|healthy
4804419|NCT02595268|Pitavastatin|pitavastatin
4804420|NCT02595268|JNJ-63623872|jnj-63623872
4804421|NCT02595255|chemotherapy/GnRH analogues/lymphoma/children/fertility|chemotherapy/gnrh analogues/lymphoma/children/fertility
4804422|NCT02595203|Bioavailability|bioavailability
4804423|NCT02595190|Sacral perineurial cysts(Tarlov Cysts)|sacral perineurial cysts(tarlov cysts)
4804424|NCT02595190|Resting state functional magnetic resonance imaging (rfMRI)|resting state functional magnetic resonance imaging (rfmri)
4804425|NCT02595190|VAS|vas
4804426|NCT02595190|Medicine conservative treatment|medicine conservative treatment
4804427|NCT02595190|Surgical treatment|surgical treatment
4804428|NCT02595177|multifocal IOL|multifocal iol
4804429|NCT02595177|monovision|monovision
4804430|NCT02595177|hybrid monovision|hybrid monovision
4804431|NCT02595177|spectacles independence|spectacles independence
4804432|NCT02595151|Probe-based confocal laser endomicroscopy|probe-based confocal laser endomicroscopy
4804433|NCT02595151|chronic atrophic antral gastritis|chronic atrophic antral gastritis
4804434|NCT02595151|microcirculatory dynamics|microcirculatory dynamics
4804435|NCT02595138|zoledronic acid|zoledronic acid
4804436|NCT02595138|triple-negative breast cancer|triple-negative breast cancer
4804437|NCT02595138|adjuvant treatment|adjuvant treatment
4804438|NCT02595125|intrauterine device|intrauterine device
4804439|NCT02595125|contraceptive method|contraceptive method
4804440|NCT02595125|direct technique|direct technique
4804441|NCT02595125|torpedo technique|torpedo technique
4804442|NCT02595125|verbal numeric scale|verbal numeric scale
4804443|NCT02595112|staphylococcal infections|staphylococcal infections
4804444|NCT02595112|nasal carriage|nasal carriage
4804445|NCT02595112|nasal cavity|nasal cavity
4804446|NCT02595112|Staphylococcus aureus|staphylococcus aureus
4804566|NCT02594332|mepolizumab|mepolizumab
4804447|NCT02595060|acute lung injury, molgramostim, GM-CSF, pneumonia, barrier restoration|acute lung injury, molgramostim, gm-csf, pneumonia, barrier restoration
4804448|NCT02595047|Self-regeneration, in vivo tissue prefabrication,|self-regeneration, in vivo tissue prefabrication,
4804449|NCT02595021|Total or subtotal colectomy|total or subtotal colectomy
4804450|NCT02595021|Ovarian cancer|ovarian cancer
4804451|NCT02595021|Complications|complications
4804452|NCT02595021|One-year disease-free survival|one-year disease-free survival
4804453|NCT02595021|Stage IIIc|stage iiic
4804454|NCT02595021|Stage IV|stage iv
4804455|NCT02594982|Delirium|delirium
4804456|NCT02594982|intensive care nursing|intensive care nursing
4804457|NCT02594982|Acute acquired brain injury|acute acquired brain injury
4804458|NCT02594982|neurointensive care|neurointensive care
4804459|NCT02594982|Intensive care delirium screening checklist|intensive care delirium screening checklist
4804460|NCT02594982|Confusion Assessment Method for the ICU|confusion assessment method for the icu
4804461|NCT02594969|atopic dermatitis|atopic dermatitis
4804462|NCT02594956|nasogastric decompression|nasogastric decompression
4804463|NCT02594943|Diagnostics|diagnostics
4804464|NCT02594943|Biopsy|biopsy
4804465|NCT02594943|Diffuse gastric cancer|diffuse gastric cancer
4804466|NCT02594930|synovial biopsy|synovial biopsy
4804467|NCT02594930|knee arthroplasty|knee arthroplasty
4804468|NCT02594930|infection|infection
4804469|NCT02594904|G6PD Deficiency|g6pd deficiency
4804470|NCT02594904|Neonatal Hyperbilirubinemia|neonatal hyperbilirubinemia
4804471|NCT02594904|Yinzhihuang Oral Liquid|yinzhihuang oral liquid
4804472|NCT02594904|Indirect Bilirubin|indirect bilirubin
4804473|NCT02594891|cholangitis|cholangitis
4804474|NCT02594891|endoscopic retrograde cholangiopancreatography|endoscopic retrograde cholangiopancreatography
4804475|NCT02594891|complication|complication
4804476|NCT02594878|Chronic non-bacterial osteomyelitis|chronic non-bacterial osteomyelitis
4804477|NCT02594878|Chronic recurrent multifocal osteomyelitis|chronic recurrent multifocal osteomyelitis
4804478|NCT02594878|Non- bacterial osteomyelitis|non- bacterial osteomyelitis
4804479|NCT02594878|SAPHO syndrome|sapho syndrome
4804480|NCT02594878|Whole body MRI|whole body mri
4804481|NCT02594878|Pamidronate|pamidronate
4804482|NCT02594878|Inflammatory bone disease|inflammatory bone disease
4804483|NCT02594878|Autoinflammatory disease|autoinflammatory disease
4804484|NCT02594865|Enteral Nutrition|enteral nutrition
4804485|NCT02594865|Continuous Glucose Monitoring|continuous glucose monitoring
4804486|NCT02594839|interstitial lung disease|interstitial lung disease
4804487|NCT02594839|idiopathic interstitial pneumonia|idiopathic interstitial pneumonia
4804488|NCT02594839|idiopathic pulmonary fibrosis|idiopathic pulmonary fibrosis
4804489|NCT02594839|stem cells|stem cells
4804490|NCT02594800|Atherosclerotic Intracranial Arterial Stenosis|atherosclerotic intracranial arterial stenosis
4804491|NCT02594800|Intensive Rosuvastatin Therapy|intensive rosuvastatin therapy
4804492|NCT02594800|Computed Tomography Perfusion (CTP)|computed tomography perfusion (ctp)
4804493|NCT02594735|Juvenile dermatomyositis|juvenile dermatomyositis
4804494|NCT02594735|inflammatory myopathies|inflammatory myopathies
4804495|NCT02594735|Orencia|orencia
4804496|NCT02594735|Abatacept|abatacept
4804497|NCT02594722|COPD|copd
4804498|NCT02594722|Functional Electrical Stimulation Cycling|functional electrical stimulation cycling
4804499|NCT02594722|Pulmonary Rehabilitation|pulmonary rehabilitation
4804500|NCT02594696|Major depression and Cancer|major depression and cancer
4804501|NCT02594696|Schizophrenia and Cancer|schizophrenia and cancer
4804502|NCT02594696|Bipolar disorder and Cancer|bipolar disorder and cancer
4804503|NCT02594696|Lung Cancer|lung cancer
4804504|NCT02594696|Breast Cancer|breast cancer
4804505|NCT02594696|Head and Neck cancer|head and neck cancer
4804506|NCT02594696|GI cancer|gi cancer
4804507|NCT02594696|Schizophrenia|schizophrenia
4804508|NCT02594696|Bipolar disorder|bipolar disorder
4804509|NCT02594670|acupoints|acupoints
4804510|NCT02594670|insomnia|insomnia
4804511|NCT02594670|acupuncture|acupuncture
4804512|NCT02594670|randomized controlled trial|randomized controlled trial
4804513|NCT02594657|Eccentric|eccentric
4804514|NCT02594657|Ergometer|ergometer
4804515|NCT02594657|Pedal rate|pedal rate
4804516|NCT02594657|Oxygen consumption|oxygen consumption
4804517|NCT02594657|Only health volunteers|only health volunteers
4804518|NCT02594631|Urethral stones|urethral stones
4804519|NCT02594631|Acute Cacular urinary retention|acute cacular urinary retention
4804520|NCT02594631|Extracorporeal Shock Wave Lithotripsy (ESWL)|extracorporeal shock wave lithotripsy (eswl)
4804521|NCT02594631|Visual lithotripsy|visual lithotripsy
4804522|NCT02594631|bladder stone|bladder stone
4804523|NCT02594592|Osteoporosis|osteoporosis
4804524|NCT02594592|Osteoporosis Self-Assessment Tool|osteoporosis self-assessment tool
4804525|NCT02594592|One-Minute Osteoporosis Risk Test|one-minute osteoporosis risk test
4804526|NCT02594592|Asians|asians
4804527|NCT02594566|Cytomegalovirus|cytomegalovirus
4804528|NCT02594566|Vaccine|vaccine
4804529|NCT02594566|Congenital Infection|congenital infection
4804530|NCT02594553|Antibiotics|antibiotics
4804531|NCT02594553|Children|children
4804532|NCT02594553|General Practitioner|general practitioner
4804533|NCT02594553|GP|gp
4804534|NCT02594553|After-hours care|after-hours care
4804535|NCT02594553|Out-of-hours care|out-of-hours care
4804536|NCT02594553|Booklet|booklet
4804537|NCT02594553|Primary Health Care|primary health care
4804538|NCT02594553|Child|child
4804539|NCT02594527|Older people|older people
4804540|NCT02594527|Physical activity|physical activity
4804541|NCT02594527|Hospital|hospital
4804542|NCT02594514|cardiovascular risk|cardiovascular risk
4804543|NCT02594514|metabolic profile|metabolic profile
4804544|NCT02594488|Myocardial infarction|myocardial infarction
4804545|NCT02594488|Autonomic nervous system|autonomic nervous system
4804546|NCT02594488|Risk stratification|risk stratification
4804547|NCT02594488|Implantable cardiac monitor|implantable cardiac monitor
4804548|NCT02594488|Sudden cardiac death|sudden cardiac death
4804549|NCT02594488|ECG|ecg
4804550|NCT02594475|endoscopic retrograde cholangiopancreatography, position|endoscopic retrograde cholangiopancreatography, position
4804551|NCT02594462|contraception|contraception
4804552|NCT02594462|Anemia, Sickle Cell|anemia, sickle cell
4804553|NCT02594449|Pharmacodynamic Study of BCS|pharmacodynamic study of bcs
4804554|NCT02594436|Actinic Keratosis|actinic keratosis
4804555|NCT02594436|topical|topical
4804556|NCT02594436|ingenol mebutate|ingenol mebutate
4804557|NCT02594436|Picato®|picato®
4804558|NCT02594384|Phase 1|phase 1
4804559|NCT02594384|Safety|safety
4804560|NCT02594384|Apilimod dimesylate|apilimod dimesylate
4804561|NCT02594384|Pharmacokinetics|pharmacokinetics
4804562|NCT02594384|Non-Hodgkin Lymphoma|non-hodgkin lymphoma
4804563|NCT02594384|Chronic lymphocytic leukemia|chronic lymphocytic leukemia
4804564|NCT02594358|Caffeine|caffeine
4804565|NCT02594332|eosinophilic asthma|eosinophilic asthma
4804567|NCT02594332|treatment|treatment
4804568|NCT02594306|drug addiction|drug addiction
4804569|NCT02594306|Heroin|heroin
4804570|NCT02594306|craving|craving
4804571|NCT02594306|event related potential|event related potential
4804572|NCT02594306|crystal methamphetamine|crystal methamphetamine
4804573|NCT02594267|PTCL|ptcl
4804574|NCT02594267|Peripheral T-Cell Lymphoma|peripheral t-cell lymphoma
4804575|NCT02594267|Folotyn|folotyn
4804576|NCT02594267|Pralatrexate|pralatrexate
4804577|NCT02594267|CHOP|chop
4804578|NCT02594241|Ventral hernia|ventral hernia
4804579|NCT02594241|Abdominal wall reconstruction|abdominal wall reconstruction
4804580|NCT02594241|Enhanced recovery after surgery|enhanced recovery after surgery
4804581|NCT02594241|Steroid|steroid
4804582|NCT02594215|AKT1|akt1
4804583|NCT02594215|Overgrowth|overgrowth
4804584|NCT02594202|Specimen Collection|specimen collection
4804585|NCT02594202|Carcinogenesis|carcinogenesis
4804586|NCT02594202|Prognostic Biomarkers|prognostic biomarkers
4804587|NCT02594202|Molecular Mechanims|molecular mechanims
4804588|NCT02594202|Cell Lines|cell lines
4804589|NCT02594189|Influenza A|influenza a
4804590|NCT02594189|H3N2|h3n2
4804591|NCT02594189|Challenge Model|challenge model
4804592|NCT02594189|Influenza|influenza
4804593|NCT02594189|Human Challenge|human challenge
4804594|NCT02594176|Osteoarthritis|osteoarthritis
4804595|NCT02594176|Pain|pain
4804596|NCT02594176|NSAID|nsaid
4804597|NCT02594176|Sequessome|sequessome
4804598|NCT02594137|Decompressive craniectomy|decompressive craniectomy
4804599|NCT02594137|Brain Edema|brain edema
4804600|NCT02594124|Spinal Muscular Atrophy|spinal muscular atrophy
4804601|NCT02594124|SMA|sma
4804602|NCT02594124|SMN|smn
4804603|NCT02594124|SMNRx|smnrx
4804604|NCT02594124|ISIS-SMNRx|isis-smnrx
4804605|NCT02594124|ISIS-SMN Rx|isis-smn rx
4804606|NCT02594124|ISIS 396443|isis 396443
4804607|NCT02594124|SHINE|shine
4804608|NCT02594124|IONIS-SMNRx|ionis-smnrx
4804609|NCT02594124|IONIS-SMN Rx|ionis-smn rx
4804610|NCT02594124|Spinraza|spinraza
4804611|NCT02594124|nusinersen|nusinersen
4804612|NCT02594111|inflammation|inflammation
4804613|NCT02594111|percutaneous coronary intervention|percutaneous coronary intervention
4804614|NCT02594111|coronary artery disease|coronary artery disease
4804615|NCT02594111|colchicine|colchicine
4804616|NCT02594098|Atopic dermatitis|atopic dermatitis
4804617|NCT02594098|extrinsic atopic dermatitis|extrinsic atopic dermatitis
4804618|NCT02594098|intrinsic atopic dermatitis|intrinsic atopic dermatitis
4804619|NCT02594059|endothelial function, idiopathic pulmonary fibrosis|endothelial function, idiopathic pulmonary fibrosis
4804620|NCT02594020|suspected caries|suspected caries
4804621|NCT02594020|initial enamel lesions|initial enamel lesions
4804622|NCT02594007|telehealth|telehealth
4804623|NCT02594007|heart failure|heart failure
4804624|NCT02593994|Onyx|onyx
4804625|NCT02593994|drug eluting stent|drug eluting stent
4804626|NCT02593994|Routine Clinical Practice|routine clinical practice
4804627|NCT02593994|Angioplasty, Transluminal, Percutaneous Coronary|angioplasty, transluminal, percutaneous coronary
4804628|NCT02593994|Coronary Artery Disease|coronary artery disease
4804629|NCT02593981|sleep|sleep
4804630|NCT02593981|fruit|fruit
4804631|NCT02593981|honey|honey
4804632|NCT02593981|geriatric|geriatric
4804633|NCT02593929|squamous cell carcinoma|squamous cell carcinoma
4804634|NCT02593929|head and neck cancer|head and neck cancer
4804635|NCT02593929|operable|operable
4804636|NCT02593903|Antibiotic Prophylaxis|antibiotic prophylaxis
4804637|NCT02593890|Breast Cancer|breast cancer
4804638|NCT02593890|Breast Surgery|breast surgery
4804639|NCT02593890|Mastectomy|mastectomy
4804640|NCT02593890|Lumpectomy|lumpectomy
4804641|NCT02593890|Post-operative|post-operative
4804642|NCT02593890|Bra|bra
4804643|NCT02593890|Lingerie|lingerie
4804644|NCT02593890|Body Image|body image
4804645|NCT02593890|Psycho-social|psycho-social
4804646|NCT02593890|Impact|impact
4804647|NCT02593877|Trauma|trauma
4804648|NCT02593877|Hemostasis|hemostasis
4804649|NCT02593877|Resuscitation|resuscitation
4804650|NCT02593877|Coagulopathy|coagulopathy
4804651|NCT02593877|Transfusion|transfusion
4804652|NCT02593851|Respiratory Syncytial Virus Infections|respiratory syncytial virus infections
4804653|NCT02593851|JNJ-53718678|jnj-53718678
4804654|NCT02593851|Placebo|placebo
4804655|NCT02593851|Infants|infants
4804656|NCT02593812|Learning|learning
4804657|NCT02593812|Practice|practice
4804658|NCT02593799|Liver cirrhosis|liver cirrhosis
4804659|NCT02593799|Esophageal and Gastric Varices|esophageal and gastric varices
4804660|NCT02593799|Endoscopy|endoscopy
4804661|NCT02593773|Interferon gamma|interferon gamma
4804662|NCT02593747|Allergy|allergy
4804663|NCT02593708|HER2+|her2+
4804664|NCT02593695|Anorexia Nervosa|anorexia nervosa
4804665|NCT02593695|Deep Brain Stimulation|deep brain stimulation
4804666|NCT02593695|Nucleus accumbens|nucleus accumbens
4804667|NCT02593656|protein ingestion|protein ingestion
4804668|NCT02593656|resistance exercise|resistance exercise
4804669|NCT02593656|interval exercise|interval exercise
4804670|NCT02593656|stretching exercise|stretching exercise
4804671|NCT02593656|endurance exercise|endurance exercise
4804672|NCT02593643|Major Depressive Disorder|major depressive disorder
4804673|NCT02593643|Bipolar Disorder|bipolar disorder
4804674|NCT02593643|Depression|depression
4804675|NCT02593643|Suicide|suicide
4804676|NCT02593643|Suicidal Ideation|suicidal ideation
4804677|NCT02593643|Ketamine|ketamine
4804678|NCT02593643|Midazolam|midazolam
4804679|NCT02593643|Inpatients|inpatients
4804680|NCT02593617|Energy Drinks|energy drinks
4804681|NCT02593617|Alcohol Drinking|alcohol drinking
4804682|NCT02593617|Substance Use|substance use
4804683|NCT02593604|Hidradenitis suppurativa|hidradenitis suppurativa
4804684|NCT02593604|Wide excision|wide excision
4804685|NCT02593604|Quality of Life|quality of life
4804686|NCT02593604|Sexual Function|sexual function
4804687|NCT02593539|APDS|apds
4804688|NCT02593539|Safety|safety
4804689|NCT02593539|Pharmacokinetics|pharmacokinetics
4804690|NCT02593539|GSK2269557|gsk2269557
4804691|NCT02593539|PASLI|pasli
4804692|NCT02593513|Embryo Transfer|embryo transfer
4804693|NCT02593513|Embryo Selection Criteria for Implantation|embryo selection criteria for implantation
4804694|NCT02593513|Assisted Reproductive Technology|assisted reproductive technology
4804695|NCT02593500|Bioequivalence, budesonide,|bioequivalence, budesonide,
4804696|NCT02593487|Coronary Artery Disease|coronary artery disease
4804697|NCT02593487|Hyperlipidemia|hyperlipidemia
4804698|NCT02593487|Rosuvastatin|rosuvastatin
4804699|NCT02593487|Lipoproteins|lipoproteins
4804700|NCT02593487|high-density lipoprotein|high-density lipoprotein
4804701|NCT02593487|HDL2|hdl2
4804702|NCT02593474|Adolescent|adolescent
4804703|NCT02593474|Youth|youth
4804704|NCT02593461|Embryo Transfer|embryo transfer
4804705|NCT02593461|Embryo Selection Criteria for Implantation|embryo selection criteria for implantation
4804706|NCT02593461|Assisted Reproductive Technology|assisted reproductive technology
4804707|NCT02593448|Cardiopulmonary Bypass|cardiopulmonary bypass
4804708|NCT02593448|Anoxia|anoxia
4804709|NCT02593435|BRCA1/2 gene mutation|brca1/2 gene mutation
4804710|NCT02593435|Breast Cancer|breast cancer
4804711|NCT02593435|Chinese high risk group|chinese high risk group
4804712|NCT02593422|ovarian cancer|ovarian cancer
4804713|NCT02593422|expressive writing|expressive writing
4804714|NCT02593422|writing interventions|writing interventions
4804715|NCT02593422|psychosocial support|psychosocial support
4804716|NCT02593409|HIV-1|hiv-1
4804717|NCT02593409|pre-exposure prophylaxis (PrEP)|pre-exposure prophylaxis (prep)
4804718|NCT02593409|immune response|immune response
4804719|NCT02593396|sexual dysfunctions|sexual dysfunctions
4804720|NCT02593396|erectile dysfunctions|erectile dysfunctions
4804721|NCT02593396|hypoactive sexual desire dysfunctions|hypoactive sexual desire dysfunctions
4804722|NCT02593383|safety|safety
4804723|NCT02593383|efficacy|efficacy
4804724|NCT02593370|Hip surgery anesthesia|hip surgery anesthesia
4804725|NCT02593370|Perioperative analgesia|perioperative analgesia
4804726|NCT02593357|endothelial function|endothelial function
4804727|NCT02593357|COPD|copd
4804728|NCT02593357|pulmonary function|pulmonary function
4804729|NCT02593344|asthma, endothelial function|asthma, endothelial function
4804730|NCT02593318|energy metabolism|energy metabolism
4804731|NCT02593318|oxaloacetate|oxaloacetate
4804732|NCT02593305|nitrate|nitrate
4804733|NCT02593305|blood flow|blood flow
4804734|NCT02593305|blood pressure|blood pressure
4804735|NCT02593305|vascular function|vascular function
4804736|NCT02593305|hypoxia|hypoxia
4804737|NCT02593292|Clinical pathway|clinical pathway
4804738|NCT02593292|Electronic Health Records|electronic health records
4804739|NCT02593292|Maternal Health Services & administration|maternal health services & administration
4804740|NCT02593292|Patient Access to Records|patient access to records
4804741|NCT02593292|Patient Satisfaction|patient satisfaction
4804742|NCT02593292|Prenatal Care/methods|prenatal care/methods
4804743|NCT02593279|Asthma|asthma
4804744|NCT02593279|phenotype|phenotype
4804745|NCT02593279|small|small
4804746|NCT02593279|airway|airway
4804747|NCT02593279|proximal|proximal
4804748|NCT02593279|dysfunction|dysfunction
4804749|NCT02593266|Prevention|prevention
4804750|NCT02593266|Family|family
4804751|NCT02593266|Intervention|intervention
4804752|NCT02593266|Depression|depression
4804753|NCT02593266|Children|children
4804754|NCT02593253|Quality Improvement|quality improvement
4804755|NCT02593253|Quality Indicators, Health Care|quality indicators, health care
4804756|NCT02593253|Hospital Medicine|hospital medicine
4804757|NCT02593240|Energy|energy
4804758|NCT02593240|Presenteeism|presenteeism
4804759|NCT02593240|Absenteeism|absenteeism
4804760|NCT02593240|Cardiometabolic health|cardiometabolic health
4804761|NCT02593240|Obesity|obesity
4804762|NCT02593240|Overweight|overweight
4804763|NCT02593240|Weight Loss|weight loss
4804764|NCT02593240|Quality of Life|quality of life
4804765|NCT02593240|Weight Control|weight control
4804766|NCT02593240|Eating Behavior|eating behavior
4804767|NCT02593240|Food Cravings|food cravings
4804768|NCT02593240|Hunger|hunger
4804769|NCT02593240|Worksite Wellness|worksite wellness
4804770|NCT02593227|TNBC|tnbc
4804771|NCT02593214|Condoms, Female|condoms, female
4804772|NCT02593214|Contraception, Barrier|contraception, barrier
4804773|NCT02593175|Triple-Negative Breast Cancer|triple-negative breast cancer
4804774|NCT02593175|TNBC|tnbc
4804775|NCT02593175|Panitumumab|panitumumab
4804776|NCT02593175|Vectibix|vectibix
4804777|NCT02593175|Paclitaxel|paclitaxel
4804778|NCT02593175|Taxol|taxol
4804779|NCT02593175|Carboplatin|carboplatin
4804780|NCT02593175|Paraplatin|paraplatin
4804781|NCT02593175|Biopsy|biopsy
4804782|NCT02593175|Fine-needle aspiration|fine-needle aspiration
4804783|NCT02593175|FNA|fna
4804784|NCT02593136|Vitamins|vitamins
4804785|NCT02593136|Public Health|public health
4804786|NCT02593136|Nutrition|nutrition
4804787|NCT02593123|Donor Type (Matched Related Donor or Matched Unrelated Donor)|donor type (matched related donor or matched unrelated donor)
4804788|NCT02593084|Resistance Training|resistance training
4804789|NCT02593084|Exercise|exercise
4804790|NCT02593084|Walking|walking
4804791|NCT02593084|Safety|safety
4804792|NCT02593084|Feasibility Studies|feasibility studies
4804793|NCT02593058|Anhedonia|anhedonia
4804794|NCT02593058|Apathy|apathy
4804795|NCT02593058|Negative symptoms|negative symptoms
4804796|NCT02593058|Anticipatory pleasure|anticipatory pleasure
4804797|NCT02593058|Savoring|savoring
4804798|NCT02593032|hemoglobin A1c protein, human > 7.5|hemoglobin a1c protein, human > 7.5
4804799|NCT02593006|Joint Diseases|joint diseases
4804800|NCT02593006|Juvenile Arthritis|juvenile arthritis
4804801|NCT02593006|treatment|treatment
4804802|NCT02593006|biologic therapy|biologic therapy
4804803|NCT02593006|comparative effectiveness|comparative effectiveness
4804804|NCT02592967|Carcinoma, Non-Small-Cell Lung|carcinoma, non-small-cell lung
4804805|NCT02592967|JNJ-64041757|jnj-64041757
4804806|NCT02592967|Listeria monocytogenes|listeria monocytogenes
4804807|NCT02592928|eHealth|ehealth
4804808|NCT02592928|Spirometry|spirometry
4804809|NCT02592928|Lung Function|lung function
4804810|NCT02592928|Primary Care|primary care
4804811|NCT02592928|Telehealth|telehealth
4804812|NCT02592928|Integrated Care|integrated care
4804813|NCT02592902|recurrent respiratory papillomatosis|recurrent respiratory papillomatosis
4804814|NCT02592902|extra oesophageal reflux|extra oesophageal reflux
4804815|NCT02592902|laryngeal cyst|laryngeal cyst
4804816|NCT02592902|phonosurgery|phonosurgery
4804817|NCT02592902|oesophageal impedance|oesophageal impedance
4804818|NCT02592889|MITRAL REGURGITATION|mitral regurgitation
4804819|NCT02592876|Antibodies, Monoclonal|antibodies, monoclonal
4804820|NCT02592876|Antibody-Drug Conjugate|antibody-drug conjugate
4804821|NCT02592876|Antigens, CD19|antigens, cd19
4804822|NCT02592876|Autologous Stem Cell Transplant|autologous stem cell transplant
4804823|NCT02592876|Drug Therapy|drug therapy
4804824|NCT02592876|Follicular Lymphoma Grade 3b|follicular lymphoma grade 3b
4805220|NCT02590575|Hypercapnic|hypercapnic
4804825|NCT02592876|Hematologic Diseases|hematologic diseases
4804826|NCT02592876|Immune System Diseases|immune system diseases
4804827|NCT02592876|Immunoproliferative Disorders|immunoproliferative disorders
4804828|NCT02592876|Immunotherapy|immunotherapy
4804829|NCT02592876|Lymphatic Diseases|lymphatic diseases
4804830|NCT02592876|Lymphoma|lymphoma
4804831|NCT02592876|Lymphoma, B-Cell|lymphoma, b-cell
4804832|NCT02592876|Lymphoma, Large B-Cell, Diffuse|lymphoma, large b-cell, diffuse
4804833|NCT02592876|Lymphoma, Non-Hodgkin|lymphoma, non-hodgkin
4804834|NCT02592876|Monomethylauristatin F|monomethylauristatin f
4804835|NCT02592876|Neoplasms|neoplasms
4804836|NCT02592876|Neoplasms by Histologic Type|neoplasms by histologic type
4804837|NCT02592876|Transformed Lymphoma / DLBCL|transformed lymphoma / dlbcl
4804838|NCT02592876|Rituximab|rituximab
4804839|NCT02592876|Ifosfamide|ifosfamide
4804840|NCT02592876|Carboplatin|carboplatin
4804841|NCT02592876|Etoposide|etoposide
4804842|NCT02592850|Osteopathic manipulative treatment|osteopathic manipulative treatment
4804843|NCT02592850|Frequent Episodic Tension-Type Headache|frequent episodic tension-type headache
4804844|NCT02592850|Randomized Controlled Trial|randomized controlled trial
4804845|NCT02592837|Endobronchial ultrasound|endobronchial ultrasound
4804846|NCT02592837|EBUS|ebus
4804847|NCT02592837|TBNA|tbna
4804848|NCT02592837|Mediastinal ymphadenopathy|mediastinal ymphadenopathy
4804849|NCT02592837|Hilar lymphadenopathy|hilar lymphadenopathy
4804850|NCT02592837|Lung cancer|lung cancer
4804851|NCT02592824|glutamate, heart failure, coronary artery bypass surgery|glutamate, heart failure, coronary artery bypass surgery
4804852|NCT02592811|Cholangiopancreatography|cholangiopancreatography
4804853|NCT02592811|therapeutic strategy|therapeutic strategy
4804854|NCT02592811|Endoscopic Retrograde|endoscopic retrograde
4804855|NCT02592772|menthol|menthol
4804856|NCT02592772|nicotine|nicotine
4804857|NCT02592772|reduced nicotine|reduced nicotine
4804858|NCT02592772|smoking|smoking
4804859|NCT02592772|cigarette|cigarette
4804860|NCT02592772|cigarettes|cigarettes
4804861|NCT02592772|men smoking|men smoking
4804862|NCT02592772|smoking research|smoking research
4804863|NCT02592772|nicotine dependence|nicotine dependence
4804864|NCT02592720|Acute Coronary Syndromes|acute coronary syndromes
4804865|NCT02592720|Fractional Flow Reserve|fractional flow reserve
4804866|NCT02592720|Percutaneous Coronary Intervention|percutaneous coronary intervention
4804867|NCT02592681|menstrual migraine|menstrual migraine
4804868|NCT02592681|acupuncture|acupuncture
4804869|NCT02592681|acupressure|acupressure
4804870|NCT02592655|tourniquet|tourniquet
4804871|NCT02592655|arterial|arterial
4804872|NCT02592655|pre-hospital|pre-hospital
4804873|NCT02592655|SOFTT-W|softt-w
4804874|NCT02592655|Battle Wrap|battle wrap
4804875|NCT02592655|windlass|windlass
4804876|NCT02592655|exsanguination|exsanguination
4804877|NCT02592655|hemorrhage|hemorrhage
4804878|NCT02592655|amputation|amputation
4804879|NCT02592642|lumbar spinal stenosis|lumbar spinal stenosis
4804880|NCT02592642|neurogenic claudication|neurogenic claudication
4804881|NCT02592642|non-operative|non-operative
4804882|NCT02592642|treatment|treatment
4804883|NCT02592642|outcomes|outcomes
4804884|NCT02592642|clinical trial|clinical trial
4804885|NCT02592629|subacromial injection|subacromial injection
4804886|NCT02592629|rotator cuff disease|rotator cuff disease
4804887|NCT02592629|steroid injection|steroid injection
4804888|NCT02592616|Exercise|exercise
4804889|NCT02592616|Appetite|appetite
4804890|NCT02592616|Energy intake|energy intake
4804891|NCT02592603|Serrated lesions|serrated lesions
4804892|NCT02592603|Surveillance|surveillance
4804893|NCT02592603|Colorectal cancer|colorectal cancer
4804894|NCT02592603|Endocuff|endocuff
4804895|NCT02592603|Sessile serrated adenoma|sessile serrated adenoma
4804896|NCT02592603|Colonoscopy|colonoscopy
4804897|NCT02592590|Exercise|exercise
4804898|NCT02592590|Physical Activity|physical activity
4804899|NCT02592590|Smartphone|smartphone
4804900|NCT02592590|Technology|technology
4804901|NCT02592577|Previously Treated|previously treated
4804902|NCT02592577|Cell Therapy|cell therapy
4804903|NCT02592577|T Cell Therapy|t cell therapy
4804904|NCT02592577|MAGE-A10|mage-a10
4804905|NCT02592577|Immuno-oncology|immuno-oncology
4804906|NCT02592577|T Cell Receptor|t cell receptor
4804907|NCT02592577|Metastatic|metastatic
4804908|NCT02592564|Magnetic Resonance Imaging|magnetic resonance imaging
4804909|NCT02592564|Cognitive Behavior Therapy|cognitive behavior therapy
4804910|NCT02592564|Telomerase|telomerase
4804911|NCT02592564|Telomere Length, Mean Leukocyte|telomere length, mean leukocyte
4804912|NCT02592538|Biliary duct carcinoma;|biliary duct carcinoma;
4804913|NCT02592538|radiofrequency ablation|radiofrequency ablation
4804914|NCT02592538|S-1|s-1
4804915|NCT02592512|Hypoxia|hypoxia
4804916|NCT02592512|hypercapnia|hypercapnia
4804917|NCT02592499|HM III|hm iii
4804918|NCT02592499|survival|survival
4804919|NCT02592499|LVAD|lvad
4804920|NCT02592486|quadrivalent influenza vaccine|quadrivalent influenza vaccine
4804921|NCT02592486|23-valent pneumococcal vaccine|23-valent pneumococcal vaccine
4804922|NCT02592486|immunogenicity|immunogenicity
4804923|NCT02592473|Prostate Artery Embolization (PAE)|prostate artery embolization (pae)
4805221|NCT02590549|Keratoconus|keratoconus
4804924|NCT02592473|Benign Prostatic Hyperplasia (BPH)|benign prostatic hyperplasia (bph)
4804925|NCT02592473|Lower Urinary Tract Symptoms (LUTS)|lower urinary tract symptoms (luts)
4804926|NCT02592473|BPH|bph
4804927|NCT02592473|PAE|pae
4804928|NCT02592473|LUTS|luts
4804929|NCT02592473|Prostatic Artery Embolization|prostatic artery embolization
4804930|NCT02592447|CML|cml
4804931|NCT02592447|chronic phase CML|chronic phase cml
4804932|NCT02592447|leukemia|leukemia
4804933|NCT02592434|Arthritis|arthritis
4804934|NCT02592434|Pediatric|pediatric
4804935|NCT02592434|Tofacitinib|tofacitinib
4804936|NCT02592434|Long-term|long-term
4804937|NCT02592434|JIA|jia
4804938|NCT02592434|polyarticular|polyarticular
4804939|NCT02592434|CP-690,550|cp-690,550
4804940|NCT02592434|Xeljanz|xeljanz
4804941|NCT02592395|pancreatic adenocarcinoma|pancreatic adenocarcinoma
4804942|NCT02592395|electrochemotherapy|electrochemotherapy
4804943|NCT02592395|electroporation|electroporation
4804944|NCT02592395|radiogenomics|radiogenomics
4804945|NCT02592395|imaging|imaging
4804946|NCT02592395|magnetic resonance spectroscopy|magnetic resonance spectroscopy
4804947|NCT02592356|Full-body dual-energy x-ray absorptiometry|full-body dual-energy x-ray absorptiometry
4804948|NCT02592356|DXA|dxa
4804949|NCT02592356|Body measurement|body measurement
4804950|NCT02592356|Weight of participant|weight of participant
4804951|NCT02592356|Questionnaires|questionnaires
4804952|NCT02592356|Surveys|surveys
4804953|NCT02592356|Chemotherapy|chemotherapy
4804954|NCT02592356|Advanced Cancers|advanced cancers
4804955|NCT02592356|Endocrine Tumor|endocrine tumor
4804956|NCT02592343|fecal microbiota transplantation|fecal microbiota transplantation
4804957|NCT02592343|lyophilized|lyophilized
4804958|NCT02592330|CALEC|calec
4804959|NCT02592330|Limbal Stem Cell Deficiency|limbal stem cell deficiency
4804960|NCT02592330|LSCD|lscd
4804961|NCT02592317|JNJ-56021927|jnj-56021927
4804962|NCT02592317|Prostatic Neoplasms, Castration-Resistant|prostatic neoplasms, castration-resistant
4804963|NCT02592291|Mobile health|mobile health
4804964|NCT02592291|Apps|apps
4804965|NCT02592291|Applications|applications
4804966|NCT02592291|Smart phone|smart phone
4804967|NCT02592291|mHealth|mhealth
4804968|NCT02592291|Chronic and Complex Conditions|chronic and complex conditions
4804969|NCT02592291|Self-Management|self-management
4804970|NCT02592291|Self-Care|self-care
4804971|NCT02592278|Dental Caries|dental caries
4804972|NCT02592278|Fluoride Varnish|fluoride varnish
4804973|NCT02592278|Preschool child|preschool child
4804974|NCT02592278|Prevention|prevention
4804975|NCT02592239|Functional brain MRI|functional brain mri
4804976|NCT02592239|functional dyspepsia|functional dyspepsia
4804977|NCT02592239|hedonic response|hedonic response
4804978|NCT02592200|Female|female
4804979|NCT02592200|Constipation|constipation
4804980|NCT02592200|Lactobacillus gasseri DSM 27123|lactobacillus gasseri dsm 27123
4804981|NCT02592200|Probiotics|probiotics
4804982|NCT02592187|Life-logging|life-logging
4804983|NCT02592187|Cognitive Training|cognitive training
4804984|NCT02592187|Mild Cognitive Impairment|mild cognitive impairment
4804985|NCT02592187|Memory|memory
4804986|NCT02592187|Information and communications technology (ICT) in healthcare|information and communications technology (ict) in healthcare
4804987|NCT02592187|Portable camera|portable camera
4804988|NCT02592135|Acute Cardiac Insufficiency|acute cardiac insufficiency
4804989|NCT02592135|Acute Heart Failure|acute heart failure
4804990|NCT02592122|Mechanical ventilation|mechanical ventilation
4804991|NCT02592122|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
4804992|NCT02592122|Airway resistance|airway resistance
4804993|NCT02592122|Bronchial dilation test|bronchial dilation test
4804994|NCT02592109|Complementary Feeding Recommendation|complementary feeding recommendation
4804995|NCT02592109|Linear Programming|linear programming
4804996|NCT02592109|Nutritional Status|nutritional status
4804997|NCT02592109|Omega-3 Fatty Acids|omega-3 fatty acids
4804998|NCT02592109|Malondialdehyde|malondialdehyde
4804999|NCT02592109|alpha-Tocopherol|alpha-tocopherol
4805000|NCT02592096|safety and bioavailability|safety and bioavailability
4805001|NCT02592083|Neoadjuvant Therapy|neoadjuvant therapy
4805002|NCT02592083|Cyclin-Dependent Kinase Inhibitor p16|cyclin-dependent kinase inhibitor p16
4805003|NCT02592044|pain|pain
4805004|NCT02592044|anxiety|anxiety
4805005|NCT02592044|Catheterization, Peripheral|catheterization, peripheral
4805006|NCT02592005|pollution|pollution
4805007|NCT02591979|Sleep Apnea Syndrome|sleep apnea syndrome
4805008|NCT02591979|Primary Health Care|primary health care
4805009|NCT02591940|cardiovascular modeling|cardiovascular modeling
4805010|NCT02591940|aortic coarctation|aortic coarctation
4805011|NCT02591940|aortic valve disease|aortic valve disease
4805012|NCT02591927|myocardial infarction|myocardial infarction
4805013|NCT02591927|glucose-insulin-potassium|glucose-insulin-potassium
4805014|NCT02591901|Spinal Cord Injuries|spinal cord injuries
4805015|NCT02591901|Multiple Sclerosis|multiple sclerosis
4805016|NCT02591901|Transverse Myelitis|transverse myelitis
4805017|NCT02591901|Neurogenic Bladder Dysfunction|neurogenic bladder dysfunction
4805018|NCT02591901|Feasibility Study|feasibility study
4805019|NCT02591901|Urinary Tract Infection|urinary tract infection
4805020|NCT02591875|Cardiac Catheter Ablation|cardiac catheter ablation
4805021|NCT02591875|Cardiac Arrhythmias|cardiac arrhythmias
4805022|NCT02591875|Atrial Flutter|atrial flutter
4805023|NCT02591836|LDL‐C|ldl‐c
4805024|NCT02591836|Lipid Regulator|lipid regulator
4805025|NCT02591797|pain|pain
4805026|NCT02591797|Infant Behavior|infant behavior
4805027|NCT02591797|Heart rate|heart rate
4805028|NCT02591797|Dental Anxiety|dental anxiety
4805029|NCT02591784|nimotuzumab esophageal radiotherapy|nimotuzumab esophageal radiotherapy
4805030|NCT02591771|Adrenaline|adrenaline
4805031|NCT02591771|Extra Corporeal Life Support|extra corporeal life support
4805032|NCT02591771|Inotropes|inotropes
4805033|NCT02591758|Hexo-Skin|hexo-skin
4805034|NCT02591758|Hexoskin|hexoskin
4805035|NCT02591758|NOVA-SKIN|nova-skin
4805036|NCT02591758|angina|angina
4805037|NCT02591758|biometric vest|biometric vest
4805038|NCT02591706|Single missing tooth|single missing tooth
4805039|NCT02591706|Implants|implants
4805040|NCT02591706|Peri-implant bone remodeling|peri-implant bone remodeling
4805041|NCT02591706|Bone thickness|bone thickness
4805042|NCT02591706|Thickness of soft tissue|thickness of soft tissue
4805043|NCT02591693|Family Caregivers|family caregivers
4805044|NCT02591693|Occupational Therapy|occupational therapy
4805045|NCT02591693|Activities of Daily Living|activities of daily living
4805046|NCT02591667|Colorectal cancer|colorectal cancer
4805047|NCT02591667|Peritoneal metastasis|peritoneal metastasis
4805048|NCT02591667|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
4805049|NCT02591667|5-Fluorouracil|5-fluorouracil
4805050|NCT02591667|Oxaliplatin|oxaliplatin
4805051|NCT02591667|Irinotecan|irinotecan
4805052|NCT02591667|Bevacizumab|bevacizumab
4805053|NCT02591667|Histopathological response|histopathological response
4805054|NCT02591654|FLT|flt
4805055|NCT02591654|Pembrolizumab|pembrolizumab
4805056|NCT02591654|Metastatic Melanoma|metastatic melanoma
4805057|NCT02591654|MK-3475|mk-3475
4805058|NCT02591641|pre-hospital transport|pre-hospital transport
4805059|NCT02591641|shear force|shear force
4805060|NCT02591641|tissue interface pressure|tissue interface pressure
4805061|NCT02591628|Hypertension|hypertension
4805062|NCT02591628|Thiazide diuretics|thiazide diuretics
4805063|NCT02591589|Hyperoxia|hyperoxia
4805064|NCT02591589|Delirium|delirium
4805065|NCT02591589|Normoxic|normoxic
4805066|NCT02591589|t-MoCA|t-moca
4805067|NCT02591576|Diabetes|diabetes
4805068|NCT02591576|ST-elevation myocardial infarction (STEMI)|st-elevation myocardial infarction (stemi)
4805069|NCT02591576|non-STEMI|non-stemi
4805070|NCT02591576|Excess mortality|excess mortality
4805071|NCT02591576|Relative survival|relative survival
4805072|NCT02591550|chronic cough|chronic cough
4805073|NCT02591550|cough reflex sensitivity|cough reflex sensitivity
4805074|NCT02591550|transient receptor potential vanilloid 1|transient receptor potential vanilloid 1
4805075|NCT02591550|transient receptor potential ankyrin 1|transient receptor potential ankyrin 1
4805076|NCT02591498|cognitive training|cognitive training
4805077|NCT02591485|PTSD prevention|ptsd prevention
4805078|NCT02591485|Acute stress disorder|acute stress disorder
4805079|NCT02591485|Attention training|attention training
4805080|NCT02591485|Cognitive bias modification|cognitive bias modification
4805081|NCT02591459|Autism|autism
4805082|NCT02591446|TMS|tms
4805083|NCT02591446|Autism Spectrum Disorders|autism spectrum disorders
4805084|NCT02591446|Plasticity|plasticity
4805085|NCT02591407|Continuous Epidural Analgesia|continuous epidural analgesia
4805086|NCT02591407|Transversus Abdominis Plane block|transversus abdominis plane block
4805087|NCT02591381|urinary stress incontinence|urinary stress incontinence
4805088|NCT02591355|Platelet Rich Plasma|platelet rich plasma
4805089|NCT02591355|Hair Loss|hair loss
4805090|NCT02591342|femoral neck fracture|femoral neck fracture
4805091|NCT02591342|hip arthroplasty|hip arthroplasty
4805092|NCT02591342|complication|complication
4805093|NCT02591342|periprosthetic femoral fracture|periprosthetic femoral fracture
4805094|NCT02591316|nutrition|nutrition
4805095|NCT02591316|physical activity|physical activity
4805096|NCT02591316|breast cancer survivor|breast cancer survivor
4805097|NCT02591316|cognition|cognition
4805098|NCT02591303|Insomnia|insomnia
4805099|NCT02591303|Stress|stress
4805100|NCT02591303|Real-life stressful events|real-life stressful events
4805101|NCT02591290|Meningitis|meningitis
4805102|NCT02591290|Meningococcal Meningitis|meningococcal meningitis
4805103|NCT02591290|Meningococcal Infections|meningococcal infections
4805104|NCT02591290|Menactra®|menactra®
4805105|NCT02591290|Meningococcal Vaccine|meningococcal vaccine
4805106|NCT02591277|Hepatitis C virus|hepatitis c virus
4805107|NCT02591277|observational|observational
4805108|NCT02591277|post-marketing|post-marketing
4805109|NCT02591277|ledipasvir/sofosbuvir|ledipasvir/sofosbuvir
4805110|NCT02591277|Japan|japan
4805111|NCT02591238|smoking|smoking
4805112|NCT02591238|melatonin|melatonin
4805113|NCT02591238|vascular injury|vascular injury
4805114|NCT02591225|left atrial thrombus size|left atrial thrombus size
4805115|NCT02591225|transesophageale echocardiography|transesophageale echocardiography
4805116|NCT02591225|silent cerebral embolism|silent cerebral embolism
4805117|NCT02591212|Bystanding behaviors|bystanding behaviors
4805118|NCT02591212|Campus|campus
4805119|NCT02591212|Prevention|prevention
4805120|NCT02591212|Sexual Assault|sexual assault
4805121|NCT02591212|CampusSave|campussave
4805122|NCT02591173|Autonomic|autonomic
4805123|NCT02591173|Hypertension|hypertension
4805124|NCT02591173|Renin-Angiotensin System|renin-angiotensin system
4805125|NCT02591134|weight loss|weight loss
4805126|NCT02591134|NNS|nns
4805127|NCT02591134|beverages|beverages
4805128|NCT02591134|diet|diet
4805129|NCT02591134|appetite|appetite
4805130|NCT02591134|satiety|satiety
4805131|NCT02591134|weight control|weight control
4805132|NCT02591108|train of four|train of four
4805133|NCT02591108|neuromuscular blockade|neuromuscular blockade
4805134|NCT02591108|surgery|surgery
4805135|NCT02591069|Vagus nerve stimulation|vagus nerve stimulation
4805136|NCT02591069|vegetative state|vegetative state
4805137|NCT02591069|minimally conscious state|minimally conscious state
4805138|NCT02591069|akinetic mutism|akinetic mutism
4805139|NCT02591069|consciousness|consciousness
4805140|NCT02591069|connectivity|connectivity
4805141|NCT02591043|Pelvic|pelvic
4805142|NCT02591043|Treatment Outcome|treatment outcome
4805143|NCT02591030|Bile Duct Cancer|bile duct cancer
4805144|NCT02591030|phase II/III|phase ii/iii
4805145|NCT02591030|Modified folfirinox|modified folfirinox
4805146|NCT02591030|Gemcis|gemcis
4805147|NCT02591004|Neuroprotection|neuroprotection
4805148|NCT02591004|calcium channel blockers|calcium channel blockers
4805149|NCT02591004|magnesium sulhate|magnesium sulhate
4805150|NCT02591004|Middle cerebral artery doppler|middle cerebral artery doppler
4805151|NCT02590978|gallstone pancreatitis|gallstone pancreatitis
4805152|NCT02590978|mild acute pancreatitis|mild acute pancreatitis
4805153|NCT02590978|adult|adult
4805154|NCT02590952|safety, PK|safety, pk
4805155|NCT02590926|Fractional Flow Reserve, Myocardial|fractional flow reserve, myocardial
4805156|NCT02590913|fructose|fructose
4805157|NCT02590913|metabolism|metabolism
4805158|NCT02590913|acute|acute
4805159|NCT02590900|pharmacokinetics|pharmacokinetics
4805160|NCT02590900|pregnancy|pregnancy
4805161|NCT02590900|oral contraceptives|oral contraceptives
4805162|NCT02590900|oestradiol|oestradiol
4805163|NCT02590874|Mild Cognitive Impairment|mild cognitive impairment
4805164|NCT02590874|Cognition|cognition
4805165|NCT02590874|Memory|memory
4805166|NCT02590874|Depression|depression
4805167|NCT02590874|Depressive disorder|depressive disorder
4805168|NCT02590874|Antidepressive agents|antidepressive agents
4805169|NCT02590874|Duloxetine|duloxetine
4805170|NCT02590874|Cymbalta|cymbalta
4805171|NCT02590874|Selective serotonin and norepinephrine uptake inhibitors|selective serotonin and norepinephrine uptake inhibitors
4805172|NCT02590861|Partial Dentures|partial dentures
4805173|NCT02590861|Dental Implants|dental implants
4805174|NCT02590861|Quality of Life|quality of life
4805175|NCT02590861|Partial Edentulism|partial edentulism
4805176|NCT02590848|Walnut intake|walnut intake
4805177|NCT02590848|Brain development|brain development
4805178|NCT02590848|Nutritional intervention|nutritional intervention
4805179|NCT02590848|Healthy adolescents|healthy adolescents
4805180|NCT02590835|Adult patients|adult patients
4805181|NCT02590835|Patient demand for orthodontic treatment|patient demand for orthodontic treatment
4805182|NCT02590822|Diabetes|diabetes
4805183|NCT02590822|T2DM|t2dm
4805184|NCT02590822|young adults|young adults
4805185|NCT02590822|heart|heart
4805186|NCT02590822|weight loss|weight loss
4805187|NCT02590822|MRI|mri
4805188|NCT02590822|exercise|exercise
4805189|NCT02590822|diastolic function|diastolic function
4805190|NCT02590809|Left ventricular obstruction|left ventricular obstruction
4805191|NCT02590796|Delirium|delirium
4805192|NCT02590796|Inattention|inattention
4805193|NCT02590796|Medical device|medical device
4805194|NCT02590796|Software application|software application
4805195|NCT02590796|Validation study|validation study
4805196|NCT02590796|Diagnosis|diagnosis
4805197|NCT02590796|Dementia|dementia
4805198|NCT02590783|treatment|treatment
4805199|NCT02590757|non-invasive ventilation|non-invasive ventilation
4805321|NCT02589925|subthalamic nucleus|subthalamic nucleus
4805200|NCT02590757|non-invasive neurally adjusted ventilatory assist|non-invasive neurally adjusted ventilatory assist
4805201|NCT02590757|nasal continuous positive airway pressure|nasal continuous positive airway pressure
4805202|NCT02590744|Emergence Agitation|emergence agitation
4805203|NCT02590744|eye patch|eye patch
4805204|NCT02590744|preschool children|preschool children
4805205|NCT02590653|STEMI|stemi
4805206|NCT02590653|myocardial strain|myocardial strain
4805207|NCT02590653|atorvastatin|atorvastatin
4805208|NCT02590627|Parasite clearance, Treatment failure|parasite clearance, treatment failure
4805209|NCT02590601|PPCM|ppcm
4805210|NCT02590601|Bromocriptine|bromocriptine
4805211|NCT02590601|Peripartum cardiomyopathy|peripartum cardiomyopathy
4805212|NCT02590588|IgM-associated AL amyloidosis|igm-associated al amyloidosis
4805213|NCT02590575|extracorporeal CO2 removal|extracorporeal co2 removal
4805214|NCT02590575|renal replacement therapy|renal replacement therapy
4805215|NCT02590575|Prismalung|prismalung
4805216|NCT02590575|ARDS|ards
4805217|NCT02590575|hypercapnia|hypercapnia
4805218|NCT02590575|Changes in the arterial pCO2 value|changes in the arterial pco2 value
4805219|NCT02590575|ventilated|ventilated
4805222|NCT02590549|riboflavin|riboflavin
4805223|NCT02590549|corneal collagen crosslinking|corneal collagen crosslinking
4805224|NCT02590549|intrasromal ring|intrasromal ring
4805225|NCT02590536|Sildenafil|sildenafil
4805226|NCT02590536|Fetal growth Restriction|fetal growth restriction
4805227|NCT02590536|Umbilical Artery Doppler|umbilical artery doppler
4805228|NCT02590510|Intrathecal chemotherapy|intrathecal chemotherapy
4805229|NCT02590471|Angioplasty with stenting of the superficial femoral artery|angioplasty with stenting of the superficial femoral artery
4805230|NCT02590471|Fasciotomy in Hunter's channel|fasciotomy in hunter's channel
4805231|NCT02590471|Breakage of stent|breakage of stent
4805232|NCT02590458|Breast Cancer|breast cancer
4805233|NCT02590458|Short Breast MRI Scan|short breast mri scan
4805234|NCT02590458|SBMRI|sbmri
4805235|NCT02590458|Routine MRI|routine mri
4805236|NCT02590458|High risk for breast cancer|high risk for breast cancer
4805237|NCT02590458|Screening|screening
4805238|NCT02590432|Immunogenicity|immunogenicity
4805239|NCT02590432|Irritable Bowel Syndrome with Constipation|irritable bowel syndrome with constipation
4805240|NCT02590432|Chronic Idiopathic Constipation|chronic idiopathic constipation
4805241|NCT02590432|Linaclotide|linaclotide
4805242|NCT02590432|Linzess|linzess
4805243|NCT02590406|Morbid Obesity|morbid obesity
4805244|NCT02590406|Bariatric Surgery|bariatric surgery
4805245|NCT02590406|Pre-Oxygenation|pre-oxygenation
4805246|NCT02590406|Anesthesia Induction|anesthesia induction
4805247|NCT02590406|Positive pressure ventilation|positive pressure ventilation
4805248|NCT02590406|Non hypoxic apnea time|non hypoxic apnea time
4805249|NCT02590406|Positive-Pressure Respiration|positive-pressure respiration
4805250|NCT02590406|Anesthesia, General|anesthesia, general
4805251|NCT02590393|Nicotine addiction|nicotine addiction
4805252|NCT02590393|Cigarette smoking|cigarette smoking
4805253|NCT02590393|E-cigarettes|e-cigarettes
4805254|NCT02590380|Adolescent|adolescent
4805255|NCT02590380|paediatric|paediatric
4805256|NCT02590380|pediatric|pediatric
4805257|NCT02590380|scoliosis|scoliosis
4805258|NCT02590380|spine deformity|spine deformity
4805259|NCT02590367|oxaliplatin-induced peripheral neuropathy|oxaliplatin-induced peripheral neuropathy
4805260|NCT02590367|HD6610 granule|hd6610 granule
4805261|NCT02590367|colorectal cancer|colorectal cancer
4805262|NCT02590354|Treatment interruption|treatment interruption
4805263|NCT02590354|functional cure|functional cure
4805264|NCT02590341|myocarditis|myocarditis
4805265|NCT02590341|children|children
4805266|NCT02590341|adolescents|adolescents
4805267|NCT02590341|registry|registry
4805268|NCT02590341|multi-center|multi-center
4805269|NCT02590341|pediatric|pediatric
4805270|NCT02590341|heart failure|heart failure
4805271|NCT02590341|inflammatory heart disease|inflammatory heart disease
4805272|NCT02590341|inflammatory cardiomyopathy|inflammatory cardiomyopathy
4805273|NCT02590328|Neonatal Screening|neonatal screening
4805274|NCT02590328|Severe Combined Immunodeficiency|severe combined immunodeficiency
4805275|NCT02590328|Immunologic Deficiency Syndromes|immunologic deficiency syndromes
4805276|NCT02590328|DNA Repair-Deficiency Disorders|dna repair-deficiency disorders
4805277|NCT02590328|T-cell Receptor Excision Circle|t-cell receptor excision circle
4805278|NCT02590315|BC|bc
4805279|NCT02590302|Clinical pathway|clinical pathway
4805280|NCT02590302|Mental Health|mental health
4805281|NCT02590302|Emergency Department|emergency department
4805282|NCT02590302|Paediatric|paediatric
4805283|NCT02590302|Risk assessment|risk assessment
4805284|NCT02590302|Service integration|service integration
4805285|NCT02590302|Transitions in care|transitions in care
4805286|NCT02590302|Implementation|implementation
4805287|NCT02590302|Scoring tools|scoring tools
4805288|NCT02590302|Clinical Pathway Evaluation|clinical pathway evaluation
4805289|NCT02590276|frontotemporal Dementia|frontotemporal dementia
4805290|NCT02590276|Amyotrophic lateral sclerosis|amyotrophic lateral sclerosis
4805291|NCT02590276|Biomarkers|biomarkers
4805292|NCT02590276|brain Imaging PET|brain imaging pet
4805293|NCT02590263|WHO grade III|who grade iii
4805294|NCT02590263|WHO grade IV|who grade iv
4805295|NCT02590263|Glioblastoma|glioblastoma
4805296|NCT02590237|Laryngoscopy|laryngoscopy
4805297|NCT02590237|Video Laryngoscopy|video laryngoscopy
4805298|NCT02590211|experimental study|experimental study
4805299|NCT02590211|cognitive mechanisms|cognitive mechanisms
4805300|NCT02590211|poker|poker
4805301|NCT02590211|cognitive remediation therapy|cognitive remediation therapy
4805302|NCT02590133|Refractory Nasopharyngeal Carcinoma, Endostar, 5-Fu|refractory nasopharyngeal carcinoma, endostar, 5-fu
4805303|NCT02590081|Normal saline|normal saline
4805304|NCT02590081|Destrose 5%|destrose 5%
4805305|NCT02590081|Blood pressure|blood pressure
4805306|NCT02590081|Interdialytic weight gain|interdialytic weight gain
4805307|NCT02590081|thirst level|thirst level
4805308|NCT02590081|End Stage Renal Failure|end stage renal failure
4805309|NCT02589990|health|health
4805310|NCT02589990|muscle strength|muscle strength
4805311|NCT02589990|exercise genomics|exercise genomics
4805312|NCT02589977|magnetic resonance imaging|magnetic resonance imaging
4805313|NCT02589977|positron-emission tomography|positron-emission tomography
4805314|NCT02589977|echocardiography|echocardiography
4805315|NCT02589977|myocardial blood flow|myocardial blood flow
4805316|NCT02589977|energy metabolism|energy metabolism
4805317|NCT02589964|probiotics|probiotics
4805318|NCT02589964|antibiotic associated diarrhea|antibiotic associated diarrhea
4805319|NCT02589964|clostridium difficile|clostridium difficile
4805320|NCT02589925|deep brain stimulation|deep brain stimulation
4805322|NCT02589925|Nucleus basalis Meynert|nucleus basalis meynert
4805323|NCT02589886|Self-help|self-help
4805324|NCT02589886|Education|education
4805325|NCT02589886|e-Health|e-health
4805326|NCT02589873|Lifestyle Intervention|lifestyle intervention
4805327|NCT02589873|Workplace|workplace
4805328|NCT02589873|Diabetes Prevention|diabetes prevention
4805329|NCT02589860|Stem Cell Transplantation|stem cell transplantation
4805330|NCT02589847|Clostridium difficile|clostridium difficile
4805331|NCT02589847|C diff|c diff
4805333|NCT02589847|CDAD|cdad
4805334|NCT02589847|Fecal transplant|fecal transplant
4805335|NCT02589847|Fecal Microbiota transplant|fecal microbiota transplant
4805336|NCT02589847|diarrhea|diarrhea
4805337|NCT02589847|FMT|fmt
4805338|NCT02589847|microbiota restoration therapy|microbiota restoration therapy
4805339|NCT02589847|microbiota suspension|microbiota suspension
4805340|NCT02589847|fecal bacteriotherapy|fecal bacteriotherapy
4805341|NCT02589847|C diff diarrhea|c diff diarrhea
4805342|NCT02589808|pre-operative|pre-operative
4805343|NCT02589808|transthoracic echocardiography|transthoracic echocardiography
4805344|NCT02589808|handheld|handheld
4805345|NCT02589795|safety|safety
4805346|NCT02589795|immunogenicity|immunogenicity
4805347|NCT02589795|HIV vaccine|hiv vaccine
4805348|NCT02589782|bedaquiline|bedaquiline
4805349|NCT02589782|Nitroimidazoles|nitroimidazoles
4805350|NCT02589782|diarylquinolines|diarylquinolines
4805351|NCT02589782|linezolid|linezolid
4805352|NCT02589782|clofazimine|clofazimine
4805353|NCT02589782|pretomanid|pretomanid
4805354|NCT02589782|moxifloxacin|moxifloxacin
4805355|NCT02589756|obesity|obesity
4805356|NCT02589756|persistent organic pollutants|persistent organic pollutants
4805357|NCT02589756|metabolic syndrome|metabolic syndrome
4805358|NCT02589743|clinical trial|clinical trial
4805359|NCT02589743|pit and fissure sealants|pit and fissure sealants
4805360|NCT02589743|tooth eruption|tooth eruption
4805361|NCT02589743|retention|retention
4805362|NCT02589743|adhesive system|adhesive system
4805363|NCT02589743|intermediary layer|intermediary layer
4805364|NCT02589730|Smartphone app|smartphone app
4805365|NCT02589730|diabetic management|diabetic management
4805366|NCT02589730|lifestyle behaviors|lifestyle behaviors
4805367|NCT02589730|medication management|medication management
4805368|NCT02589678|AIDS|aids
4805369|NCT02589678|Immunology|immunology
4805370|NCT02589678|Public Health|public health
4805371|NCT02589678|Female sex workers|female sex workers
4805372|NCT02589678|Single mothers|single mothers
4805373|NCT02589665|IL-23 antibody|il-23 antibody
4805374|NCT02589652|Pegylated interferon|pegylated interferon
4805375|NCT02589652|Entecavir|entecavir
4805376|NCT02589600|Bone loss|bone loss
4805377|NCT02589600|Frail Geriatric Women|frail geriatric women
4805378|NCT02589600|Nursing Home Patients|nursing home patients
4805379|NCT02589600|Long-term Care Patients|long-term care patients
4805380|NCT02589600|Osteoporosis|osteoporosis
4805381|NCT02589600|Osteoporotic Fractures|osteoporotic fractures
4805382|NCT02589561|hearing loss|hearing loss
4805383|NCT02589561|hearing aids|hearing aids
4805384|NCT02589548|Hodgkin Lymphoma|hodgkin lymphoma
4805385|NCT02589548|Hodgkin Disease|hodgkin disease
4805386|NCT02589509|Event-related potentials|event-related potentials
4805387|NCT02589509|Attention|attention
4805388|NCT02589509|Cognitive rehabilitation|cognitive rehabilitation
4805389|NCT02589509|Independent activities of daily living|independent activities of daily living
4805390|NCT02589470|cognitive rehabilitation|cognitive rehabilitation
4805391|NCT02589470|memory|memory
4805392|NCT02589470|epilepsy|epilepsy
4805393|NCT02589457|Chronic Hepatitis B virus, HIV-1 infection|chronic hepatitis b virus, hiv-1 infection
4805394|NCT02589457|Healthy Male Volunteer|healthy male volunteer
4805395|NCT02589457|Tenofovir Disoproxil Fumarate|tenofovir disoproxil fumarate
4805396|NCT02589444|Clinical Endocrinology|clinical endocrinology
4805397|NCT02589444|Immunology|immunology
4805398|NCT02589444|Inflammation|inflammation
4805399|NCT02589444|Microbiology|microbiology
4805400|NCT02589444|Respiratory Disorders|respiratory disorders
4805401|NCT02589444|Vitamins|vitamins
4805402|NCT02589431|hypothalamo pituitary adrenal axis|hypothalamo pituitary adrenal axis
4805403|NCT02589418|Manual acupuncture|manual acupuncture
4805404|NCT02589418|Experimental dental pain|experimental dental pain
4805405|NCT02589418|Psychophysics|psychophysics
4805406|NCT02589418|Autonomic nervous system|autonomic nervous system
4805407|NCT02589418|Subjective pain ratings|subjective pain ratings
4805408|NCT02589379|postoperative pancreatic fistula|postoperative pancreatic fistula
4805409|NCT02589379|soft and hard pancreas|soft and hard pancreas
4805410|NCT02589366|Lymphoseek|lymphoseek
4805411|NCT02589366|endometrial cancer|endometrial cancer
4805412|NCT02589366|sentinel lymph node|sentinel lymph node
4805413|NCT02589366|lymph node dissection|lymph node dissection
4805414|NCT02589275|TNX-102 SL|tnx-102 sl
4805415|NCT02589275|bedtime|bedtime
4805416|NCT02589275|sublingual|sublingual
4805417|NCT02589275|3-month|3-month
4805418|NCT02589275|long term safety|long term safety
4805419|NCT02589275|long term efficacy|long term efficacy
4805420|NCT02589275|Fibromyalgia|fibromyalgia
4805421|NCT02589236|Cystic Fibrosis|cystic fibrosis
4805422|NCT02589236|N91115|n91115
4805423|NCT02589236|Cavosonstat|cavosonstat
4805424|NCT02589223|multisensory stimulation|multisensory stimulation
4805425|NCT02589210|Diabetes Mellitus|diabetes mellitus
4805426|NCT02589210|Foot Disease|foot disease
4805427|NCT02589210|Foot Ulcer|foot ulcer
4805428|NCT02589197|osteoarthritis|osteoarthritis
4805429|NCT02589197|correction of functional deformity|correction of functional deformity
4805430|NCT02589197|procedures|procedures
4805431|NCT02589197|traumatic osteoarthritis|traumatic osteoarthritis
4805432|NCT02589197|degenerative osteoarthritis|degenerative osteoarthritis
4805433|NCT02589197|total knee arthroplasty|total knee arthroplasty
4805434|NCT02589197|Healthy Volunteers|healthy volunteers
4805435|NCT02589197|electromyography|electromyography
4805436|NCT02589197|Musculoskeletal Diseases|musculoskeletal diseases
4805437|NCT02589184|balance, postural|balance, postural
4805438|NCT02589184|postural equilibrium|postural equilibrium
4805439|NCT02589184|pain scale|pain scale
4805440|NCT02589184|range of motion|range of motion
4805441|NCT02589145|Blood And Marrow Transplantation|blood and marrow transplantation
4805442|NCT02589145|Diffuse large B-cell lymphoma|diffuse large b-cell lymphoma
4805443|NCT02589145|DLBCL|dlbcl
4805444|NCT02589145|Busulfan|busulfan
4805445|NCT02589145|Busulfex|busulfex
4805446|NCT02589145|Myleran|myleran
4805447|NCT02589145|Lenalidomide|lenalidomide
4805448|NCT02589145|CC-5013|cc-5013
4805449|NCT02589145|Revlimid|revlimid
4805450|NCT02589145|Vorinostat|vorinostat
4805451|NCT02589145|SAHA|saha
4805452|NCT02589145|Suberoylanilide Hydroxamic Acid|suberoylanilide hydroxamic acid
4805453|NCT02589145|MSK-390|msk-390
4805454|NCT02589145|Zolinza|zolinza
4805455|NCT02589145|Gemcitabine|gemcitabine
4805456|NCT02589145|Gemcitabine Hydrochloride|gemcitabine hydrochloride
4805457|NCT02589145|Gemzar|gemzar
4805458|NCT02589145|Melphalan|melphalan
4805459|NCT02589145|Alkeran|alkeran
4805460|NCT02589145|Rituximab|rituximab
4805461|NCT02589145|Rituxan|rituxan
4805462|NCT02589145|Dexamethasone|dexamethasone
4805463|NCT02589145|Decadron|decadron
4805464|NCT02589145|Glutamine|glutamine
4805465|NCT02589145|Enterex|enterex
4805466|NCT02589145|Glutapack-10|glutapack-10
4805467|NCT02589145|NutreStore|nutrestore
4805468|NCT02589145|Resource|resource
4805469|NCT02589145|GlutaSolve|glutasolve
4805470|NCT02589145|Sympt-X G.I.|sympt-x g.i.
4805471|NCT02589145|Symptx-X|symptx-x
4805472|NCT02589145|Pyridoxine|pyridoxine
4805473|NCT02589145|Enoxaparin|enoxaparin
4805474|NCT02589145|Lovenox Injection|lovenox injection
4805475|NCT02589145|Palifermin|palifermin
4805476|NCT02589145|Kepivance|kepivance
4805477|NCT02589119|cryptoglandular|cryptoglandular
4805478|NCT02589119|perianal fistula|perianal fistula
4805479|NCT02589119|cryptoglandular perianal fistulas|cryptoglandular perianal fistulas
4805480|NCT02589106|Anisotropic Textile Braces|anisotropic textile braces
4805481|NCT02589093|Analgesia|analgesia
4805482|NCT02589093|Monitoring|monitoring
4805483|NCT02589093|Analgesia Nociception Index|analgesia nociception index
4805484|NCT02589093|ANI|ani
4805485|NCT02589093|PhysioDoloris|physiodoloris
4805486|NCT02589093|Pain|pain
4805487|NCT02589041|intraneural sciatic block|intraneural sciatic block
4805488|NCT02589028|diabetes mellitus|diabetes mellitus
4805489|NCT02589028|incretin hormone|incretin hormone
4805490|NCT02589028|glucose level|glucose level
4805491|NCT02589028|GLP-1|glp-1
4805492|NCT02589028|GIP|gip
4805493|NCT02589028|premeal protein|premeal protein
4805494|NCT02589015|morbid obesity|morbid obesity
4805495|NCT02589015|neck circumference|neck circumference
4805496|NCT02589015|difficult mask ventilation|difficult mask ventilation
4805497|NCT02589015|difficult laryngoscopy|difficult laryngoscopy
4805498|NCT02589002|sucralose|sucralose
4805499|NCT02589002|insulin sensitivity|insulin sensitivity
4805500|NCT02589002|beta-cell response|beta-cell response
4805501|NCT02589002|appetite regulating hormone|appetite regulating hormone
4805502|NCT02588976|Activated clotting time|activated clotting time
4805503|NCT02588976|Sonoclot|sonoclot
4805504|NCT02588963|upper respiratory tract infections|upper respiratory tract infections
4805505|NCT02588963|lower respiratory tract infections|lower respiratory tract infections
4805506|NCT02588963|health promotion|health promotion
4805507|NCT02588963|respiratory physiotherapy|respiratory physiotherapy
4805508|NCT02588963|infant|infant
4805509|NCT02588937|Entecavir, EntecaBell ODT., Hepatitis B|entecavir, entecabell odt., hepatitis b
4805510|NCT02588924|Parkinson Disease|parkinson disease
4805511|NCT02588924|ENVIRONMENTAL AND OCCUPATIONAL EXPOSURE TO METALS|environmental and occupational exposure to metals
4805512|NCT02588911|Radiofrequency Catheter Ablation|radiofrequency catheter ablation
4805513|NCT02588911|Operative Surgical Procedure|operative surgical procedure
4805514|NCT02588911|Saphenous Vein|saphenous vein
4805515|NCT02588885|physical therapy|physical therapy
4805516|NCT02588885|psychotherapy|psychotherapy
4805517|NCT02588885|dysfunctional sexual behavior|dysfunctional sexual behavior
4805518|NCT02588885|pelvic pain|pelvic pain
4805519|NCT02588885|posttraumatic stress|posttraumatic stress
4805520|NCT02588885|PTSD|ptsd
4805521|NCT02588885|chronic pain|chronic pain
4805522|NCT02588872|platelet-rich plasma|platelet-rich plasma
4805523|NCT02588872|hyaluronic acid|hyaluronic acid
4805524|NCT02588859|T2DM, Diabetes|t2dm, diabetes
4805525|NCT02588846|Prostate|prostate
4805526|NCT02588846|Radiotherapy|radiotherapy
4805527|NCT02588846|IGRT|igrt
4805528|NCT02588846|VMAT|vmat
4805529|NCT02588846|Image-guided radiation therapy|image-guided radiation therapy
4805530|NCT02588846|Volumetric modulated arc therapy|volumetric modulated arc therapy
4805531|NCT02588846|Adaptive radiotherapy|adaptive radiotherapy
4805532|NCT02588820|HIV|hiv
4805533|NCT02588794|sepsis, acute kidney injury , CytoSorb|sepsis, acute kidney injury , cytosorb
4805534|NCT02588768|Low-level laser therapy|low-level laser therapy
4805535|NCT02588768|Light emitting diodes|light emitting diodes
4805536|NCT02588768|Rugby|rugby
4805537|NCT02588768|Field test|field test
4805538|NCT02588768|Photobiomodulation|photobiomodulation
4805539|NCT02588755|Chemoembolization|chemoembolization
4805540|NCT02588755|Therapeutic|therapeutic
4805541|NCT02588755|Tegafur|tegafur
4805542|NCT02588742|elderly ICU patients|elderly icu patients
4805543|NCT02588729|Gestational diabetes|gestational diabetes
4805544|NCT02588729|app|app
4805545|NCT02588729|RCT|rct
4805546|NCT02588729|diet|diet
4805547|NCT02588729|physical activity|physical activity
4805548|NCT02588716|Hepatectomy, Surgical Blood Loss, terlipressin|hepatectomy, surgical blood loss, terlipressin
4805549|NCT02588677|Amyotrophic Lateral Sclerosis (ALS) - masitinib|amyotrophic lateral sclerosis (als) - masitinib
4805550|NCT02588664|Early Supported Discharge|early supported discharge
4805551|NCT02588651|Lymphoma|lymphoma
4805552|NCT02588651|Leukemia|leukemia
4805553|NCT02588651|Brentuximab Vedotin|brentuximab vedotin
4805554|NCT02588638|NGS|ngs
4805555|NCT02588638|Quality of life|quality of life
4805556|NCT02588638|Diagnosis|diagnosis
4805557|NCT02588638|Rare disease|rare disease
4805558|NCT02588638|Next-generation sequencing|next-generation sequencing
4805559|NCT02588612|Previously Treated|previously treated
4805560|NCT02588612|Cell Therapy|cell therapy
4805561|NCT02588612|T Cell Therapy|t cell therapy
4805562|NCT02588612|NY-ESO-1|ny-eso-1
4805563|NCT02588612|Immuno-oncology|immuno-oncology
4805564|NCT02588612|T Cell Receptor|t cell receptor
4805565|NCT02588586|HIV|hiv
4805566|NCT02588586|3BNC117|3bnc117
4805567|NCT02588586|Broadly neutralizing antibody|broadly neutralizing antibody
4805568|NCT02588560|lymphoma, hepatitis C virus, chemotherapy|lymphoma, hepatitis c virus, chemotherapy
4805569|NCT02588547|Shivering|shivering
4805570|NCT02588547|Granisetron|granisetron
4805571|NCT02588547|Spinal|spinal
4805572|NCT02588547|Cesarean section|cesarean section
4805693|NCT02587624|atrial fibrillation|atrial fibrillation
4805573|NCT02588534|etanercept, healthy subject,open-label, randomized, auto-injection, bioequivalence, pharmacokinetic|etanercept, healthy subject,open-label, randomized, auto-injection, bioequivalence, pharmacokinetic
4805574|NCT02588508|perineal tear|perineal tear
4805575|NCT02588508|pain|pain
4805576|NCT02588508|pelvic floor|pelvic floor
4805577|NCT02588508|Labour|labour
4805578|NCT02588495|Ultrasound|ultrasound
4805579|NCT02588495|Gastric area|gastric area
4805580|NCT02588495|Accuracy|accuracy
4805581|NCT02588495|Aspirate|aspirate
4805582|NCT02588482|electroencephalography (EEG)|electroencephalography (eeg)
4805583|NCT02588482|mismatch negativity (MMN)|mismatch negativity (mmn)
4805584|NCT02588469|pediatric obesity|pediatric obesity
4805585|NCT02588469|obstructive sleep apnea|obstructive sleep apnea
4805586|NCT02588469|physical exercise|physical exercise
4805587|NCT02588469|compression socks|compression socks
4805588|NCT02588469|rostral fluid shift|rostral fluid shift
4805589|NCT02588391|premature birth; executive function; preschool|premature birth; executive function; preschool
4805590|NCT02588365|Attention Deficit Hyperactivity Disorder; executive function; preschool|attention deficit hyperactivity disorder; executive function; preschool
4805591|NCT02588339|Hematologic disorder|hematologic disorder
4805592|NCT02588339|allogeneic hematopoietic cell transplantation|allogeneic hematopoietic cell transplantation
4805593|NCT02588326|Bioequivalence|bioequivalence
4805594|NCT02588326|Suspension nasal spray|suspension nasal spray
4805595|NCT02588326|Mometasone furoate|mometasone furoate
4805596|NCT02588326|Pharmacokinetics|pharmacokinetics
4805597|NCT02588326|Particle size distribution|particle size distribution
4805598|NCT02588274|Chronic prostatitis|chronic prostatitis
4805599|NCT02588274|chronic pelvic pain syndrome|chronic pelvic pain syndrome
4805600|NCT02588274|acupuncture|acupuncture
4805601|NCT02588274|placebo needle|placebo needle
4805602|NCT02588274|randomized controlled trial|randomized controlled trial
4805603|NCT02588261|erlotinib|erlotinib
4805604|NCT02588261|EGFR mutation|egfr mutation
4805605|NCT02588261|naquotinib|naquotinib
4805606|NCT02588261|Non-small cell lung cancer (NSCLC)|non-small cell lung cancer (nsclc)
4805607|NCT02588261|ASP8273|asp8273
4805608|NCT02588261|gefitinib|gefitinib
4805609|NCT02588183|atrial fibrillation|atrial fibrillation
4805610|NCT02588183|catheter ablation|catheter ablation
4805611|NCT02588183|pulmonary vein|pulmonary vein
4805612|NCT02588183|cryoenergy|cryoenergy
4805613|NCT02588183|cryoablation|cryoablation
4805614|NCT02588183|ArcticFront|arcticfront
4805615|NCT02588157|Rapid sequence induction intubation|rapid sequence induction intubation
4805616|NCT02588157|McGrath X-Blade|mcgrath x-blade
4805617|NCT02588157|Glidescope|glidescope
4805618|NCT02588157|Macintosh|macintosh
4805619|NCT02588144|Parkinson's disease|parkinson's disease
4805620|NCT02588144|freezing of gait|freezing of gait
4805621|NCT02588144|deep brain stimulation|deep brain stimulation
4805622|NCT02588144|substantia nigra pars reticulata|substantia nigra pars reticulata
4805623|NCT02588144|subthalamic nucleus|subthalamic nucleus
4805624|NCT02588131|tremelimumab|tremelimumab
4805625|NCT02588131|anti-PD-L1 MEDI4736 (Durvalumab)|anti-pd-l1 medi4736 (durvalumab)
4805626|NCT02588131|malignant mesothelioma|malignant mesothelioma
4805627|NCT02588105|Phase I, open label study; safety and efficacy of AZD0156; ATM inhibitor|phase i, open label study; safety and efficacy of azd0156; atm inhibitor
4805628|NCT02588092|Camidanlumab tesirine|camidanlumab tesirine
4805629|NCT02588079|Dental Fear|dental fear
4805630|NCT02588079|Dental Phobia|dental phobia
4805631|NCT02588079|Internet based cognitive behavioral therapy|internet based cognitive behavioral therapy
4805632|NCT02588079|specific phobia|specific phobia
4805633|NCT02588079|children and adolescents anxiety|children and adolescents anxiety
4805634|NCT02588079|Self Efficacy|self efficacy
4805635|NCT02588040|Chronic Lateral Epicondylitis|chronic lateral epicondylitis
4805636|NCT02588040|Leukocyte- and Platelet-Rich Plasma|leukocyte- and platelet-rich plasma
4805637|NCT02588040|Recover-L-PRP|recover-l-prp
4805638|NCT02587988|Erectile dysfunction & Hypertension|erectile dysfunction & hypertension
4805639|NCT02587949|acute cerebrovascular stroke|acute cerebrovascular stroke
4805640|NCT02587936|Chronic|chronic
4805641|NCT02587936|Risk prediction model|risk prediction model
4805642|NCT02587936|Quality Improvement (QI)|quality improvement (qi)
4805643|NCT02587936|Pragmatic trial|pragmatic trial
4805644|NCT02587936|Cluster randomization|cluster randomization
4805645|NCT02587936|Collaborative care|collaborative care
4805646|NCT02587936|clinical informatics|clinical informatics
4805647|NCT02587936|Chronic kidney disease|chronic kidney disease
4805648|NCT02587936|hypertension|hypertension
4805649|NCT02587936|high BP|high bp
4805650|NCT02587936|diabetes|diabetes
4805651|NCT02587897|Ultrasonography|ultrasonography
4805652|NCT02587897|Nerve Conduction Velocity|nerve conduction velocity
4805653|NCT02587897|Ergonomics|ergonomics
4805654|NCT02587897|Work Related Injury|work related injury
4805655|NCT02587897|Cumulative Trauma Disorders|cumulative trauma disorders
4805656|NCT02587884|Recurrence|recurrence
4805657|NCT02587884|Microvascular Invasion|microvascular invasion
4805658|NCT02587884|Aspartate beta-hydroxylase|aspartate beta-hydroxylase
4805659|NCT02587858|NBIA|nbia
4805660|NCT02587858|PKAN|pkan
4805661|NCT02587858|brain iron|brain iron
4805662|NCT02587858|Neurodegeneration with Brain Iron Accumulation|neurodegeneration with brain iron accumulation
4805663|NCT02587858|Hallervorden Spatz Syndrome|hallervorden spatz syndrome
4805664|NCT02587858|Pantothenate Kinase Associated Neurodegeneration|pantothenate kinase associated neurodegeneration
4805665|NCT02587858|PLAN|plan
4805666|NCT02587858|INAD|inad
4805667|NCT02587858|PLA2G6-associated neurodegeneration|pla2g6-associated neurodegeneration
4805668|NCT02587858|BPAN|bpan
4805669|NCT02587858|Beta-propeller Protein-associated neurodegenration|beta-propeller protein-associated neurodegenration
4805670|NCT02587858|WDR45|wdr45
4805671|NCT02587858|PLA2G6|pla2g6
4805672|NCT02587845|total hip arthroplasty|total hip arthroplasty
4805673|NCT02587845|transexamic acid|transexamic acid
4805674|NCT02587832|cpap|cpap
4805675|NCT02587832|HHHFNC|hhhfnc
4805676|NCT02587832|RDS|rds
4805677|NCT02587832|ELBW|elbw
4805678|NCT02587806|RRMS|rrms
4805679|NCT02587793|Hepatocellular Carcinoma|hepatocellular carcinoma
4805680|NCT02587793|primary culture|primary culture
4805681|NCT02587793|fine-needle aspiration|fine-needle aspiration
4805682|NCT02587793|cancer-associated fibroblast|cancer-associated fibroblast
4805683|NCT02587741|type 2 diabetes mellitus|type 2 diabetes mellitus
4805684|NCT02587741|Diabetic Retinopathy|diabetic retinopathy
4805685|NCT02587741|glucose fluctuation|glucose fluctuation
4805686|NCT02587741|oxidative stress|oxidative stress
4805687|NCT02587741|Insulin|insulin
4805688|NCT02587741|Oral drugs|oral drugs
4805689|NCT02587728|Carpal Tunnel Syndrome|carpal tunnel syndrome
4805690|NCT02587728|Amyloidosis|amyloidosis
4805691|NCT02587715|RRMS|rrms
4805692|NCT02587702|Term Infants|term infants
4805694|NCT02587624|catheter ablation|catheter ablation
4805695|NCT02587624|remote magnetic navigation|remote magnetic navigation
4805696|NCT02587598|leukemia|leukemia
4805697|NCT02587598|myelodysplastic syndrome (MDS)|myelodysplastic syndrome (mds)
4805698|NCT02587598|myelodysplastic/myeloproliferative neoplasms (MDS/MPN)|myelodysplastic/myeloproliferative neoplasms (mds/mpn)
4805699|NCT02587598|myelofibrosis (MF)|myelofibrosis (mf)
4805700|NCT02587598|lymphoproliferative disorders|lymphoproliferative disorders
4805701|NCT02587598|acute myeloid leukemia (AML)|acute myeloid leukemia (aml)
4805702|NCT02587598|lymphomas|lymphomas
4805703|NCT02587598|multiple myeloma (MM)|multiple myeloma (mm)
4805704|NCT02587598|PIM kinases|pim kinases
4805705|NCT02587559|physical therapy|physical therapy
4805706|NCT02587546|laryngeal carcinoma|laryngeal carcinoma
4805707|NCT02587546|bilateral vocal cord paralysis|bilateral vocal cord paralysis
4805708|NCT02587546|laryngotracheal stenosis|laryngotracheal stenosis
4805709|NCT02587546|laser treatment|laser treatment
4805710|NCT02587546|decannulation|decannulation
4805711|NCT02587546|voice|voice
4805712|NCT02587546|swallowing|swallowing
4805713|NCT02587533|Baroreflex|baroreflex
4805714|NCT02587533|Chemoreflex|chemoreflex
4805715|NCT02587533|Autonomic nervous system|autonomic nervous system
4805716|NCT02587533|Sympathetic activity|sympathetic activity
4805717|NCT02587533|Muscle sympathetic nerve activity (MSNA)|muscle sympathetic nerve activity (msna)
4805718|NCT02587533|Microneurography|microneurography
4805719|NCT02587533|Electrical baroreflex stimulation|electrical baroreflex stimulation
4805720|NCT02587533|Resistant hypertension|resistant hypertension
4805721|NCT02587533|Device-based therapy|device-based therapy
4805722|NCT02587520|Tetanus|tetanus
4805723|NCT02587520|Diphtheria|diphtheria
4805724|NCT02587520|Pertussis|pertussis
4805725|NCT02587520|SP0173|sp0173
4805726|NCT02587520|Tdap vaccine|tdap vaccine
4805727|NCT02587481|Acute coronary syndrom|acute coronary syndrom
4805728|NCT02587481|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
4805729|NCT02587481|Myocardial infarction|myocardial infarction
4805730|NCT02587481|Blood based biomarkers|blood based biomarkers
4805731|NCT02587468|phenolics|phenolics
4805732|NCT02587468|absorption|absorption
4805733|NCT02587468|fruit & vegetable concentrate|fruit & vegetable concentrate
4805734|NCT02587468|Bioavailability of phenolic compounds|bioavailability of phenolic compounds
4805735|NCT02587455|Non-small cell carcinoma|non-small cell carcinoma
4805736|NCT02587442|Acute Radiation Syndrome|acute radiation syndrome
4805737|NCT02587442|ARS|ars
4805738|NCT02587442|Amifostine|amifostine
4805739|NCT02587442|Radio-protectants|radio-protectants
4805740|NCT02587416|Pharmacokinetics|pharmacokinetics
4805741|NCT02587416|Lipid Regulator|lipid regulator
4805742|NCT02587390|Pharmacokinetics|pharmacokinetics
4805743|NCT02587390|Lipid Regulator|lipid regulator
4805744|NCT02587364|Pharmacokinetics|pharmacokinetics
4805745|NCT02587364|Lipid Regulator|lipid regulator
4805746|NCT02587351|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
4805747|NCT02587351|COPD|copd
4805748|NCT02587351|Exacerbation|exacerbation
4805749|NCT02587351|Lung function|lung function
4805750|NCT02587351|Cardiac|cardiac
4805751|NCT02587351|Cardiovascular|cardiovascular
4805752|NCT02587351|Beta blockers|beta blockers
4805753|NCT02587351|Metoprolol succinate|metoprolol succinate
4805754|NCT02587351|Smoking|smoking
4805755|NCT02587338|Subjective Memory Impairment|subjective memory impairment
4805756|NCT02587338|tDCS|tdcs
4805757|NCT02587338|NIRS|nirs
4805758|NCT02587338|Cognitive Training|cognitive training
4805759|NCT02587338|Working Memory|working memory
4805760|NCT02587286|mHealth|mhealth
4805761|NCT02587286|Telemedicine|telemedicine
4805762|NCT02587286|Randomized Controlled Trial|randomized controlled trial
4805763|NCT02587286|Glucose control|glucose control
4805764|NCT02587273|Critical care|critical care
4805765|NCT02587273|Intensive Care|intensive care
4805766|NCT02587273|Fentanyl|fentanyl
4805767|NCT02587273|Pharmacokinetics|pharmacokinetics
4805768|NCT02587273|Multiple Organ Failure|multiple organ failure
4805769|NCT02587260|P2Y12 inhibitors|p2y12 inhibitors
4805770|NCT02587260|Acute Coronary Syndrome (ACS)|acute coronary syndrome (acs)
4805771|NCT02587260|Endothelial function|endothelial function
4805772|NCT02587260|Adenosine measurement in human subject|adenosine measurement in human subject
4805773|NCT02587260|Endopath|endopath
4805774|NCT02587234|motor recovery|motor recovery
4805775|NCT02587234|chronic|chronic
4805776|NCT02587234|human|human
4805777|NCT02587234|sensory|sensory
4805778|NCT02587234|afferent input|afferent input
4805779|NCT02587234|motor training|motor training
4805780|NCT02587208|circumcision|circumcision
4805781|NCT02587208|plastibell|plastibell
4805782|NCT02587208|infants|infants
4805783|NCT02587208|open sleeve|open sleeve
4805784|NCT02587195|Multiple Sclerosis|multiple sclerosis
4805785|NCT02587169|liposarcoma|liposarcoma
4805786|NCT02587169|leiomyosarcoma|leiomyosarcoma
4805787|NCT02587169|retroperitoneum|retroperitoneum
4805788|NCT02587169|chondrosarcoma|chondrosarcoma
4805789|NCT02587156|Required dietary protein|required dietary protein
4805790|NCT02587156|Amino acid|amino acid
4805791|NCT02587156|Splanchnic extraction|splanchnic extraction
4805792|NCT02587130|intractable pain|intractable pain
4805793|NCT02587130|pressure ulcer|pressure ulcer
4805794|NCT02587130|bed sore|bed sore
4805795|NCT02587130|palliative medicine|palliative medicine
4805796|NCT02587130|ketamine|ketamine
4805797|NCT02587130|pain management|pain management
4805798|NCT02587117|Antioxidant|antioxidant
4805799|NCT02587117|Lycopene|lycopene
4805800|NCT02587117|Prednisolone|prednisolone
4805801|NCT02587104|Diabetes Mellitus|diabetes mellitus
4805802|NCT02587104|Foot Diseases|foot diseases
4805803|NCT02587104|Foot Ulcer|foot ulcer
4805804|NCT02587078|Haemodynamic stabilization|haemodynamic stabilization
4805805|NCT02587052|biopsy-proven acute rejection|biopsy-proven acute rejection
4805806|NCT02587052|graft loss|graft loss
4805807|NCT02587052|graft survival|graft survival
4805808|NCT02587039|delirium|delirium
4805809|NCT02587039|heart|heart
4805810|NCT02587039|valve|valve
4805811|NCT02587039|graft|graft
4805812|NCT02587039|surgery|surgery
4805813|NCT02587039|coronary|coronary
4805814|NCT02587026|Biorepository|biorepository
4805815|NCT02587026|Precision Genomics|precision genomics
4805816|NCT02587000|adenomyosis|adenomyosis
4805817|NCT02587000|ulipristal acetate|ulipristal acetate
4805818|NCT02587000|sonography|sonography
4805819|NCT02587000|Magnetic resonance imaging [MRI]|magnetic resonance imaging [mri]
4805820|NCT02587000|Pictorial Blood-loss Assessment Chart [PBAC]|pictorial blood-loss assessment chart [pbac]
4805821|NCT02586987|Selumetinib|selumetinib
4805822|NCT02586987|Tremelimumab|tremelimumab
4805823|NCT02586987|MEDI4736|medi4736
4805824|NCT02586987|Safety|safety
4805825|NCT02586987|Tolerability|tolerability
4805826|NCT02586987|Pharmacokinetics|pharmacokinetics
4805827|NCT02586987|Patients with advanced solid tumours|patients with advanced solid tumours
4805828|NCT02586987|Disease progression|disease progression
4805829|NCT02586974|CO2 insufflation|co2 insufflation
4805830|NCT02586974|robot assisted radical prostatectomy|robot assisted radical prostatectomy
4805831|NCT02586974|laparoscopy|laparoscopy
4805832|NCT02586974|hypothermia|hypothermia
4805833|NCT02586974|cytokine response|cytokine response
4805834|NCT02586961|randomized prospective study|randomized prospective study
4805835|NCT02586961|complication rate|complication rate
4805836|NCT02586961|bronchiolitis|bronchiolitis
4805837|NCT02586961|children|children
4805838|NCT02586948|extracorporeal CO2 removal|extracorporeal co2 removal
4805840|NCT02586935|Autism|autism
4805841|NCT02586909|Alzheimer's disease|alzheimer's disease
4805842|NCT02586909|RVT-101|rvt-101
4805843|NCT02586909|donepezil|donepezil
4805844|NCT02586883|Dilation of the Bronchi|dilation of the bronchi
4805845|NCT02586883|Bronchial potential difference|bronchial potential difference
4805846|NCT02586883|Dilation of the Bronchi (DDB)|dilation of the bronchi (ddb)
4805847|NCT02586857|Glioblastoma Multiforme|glioblastoma multiforme
4805848|NCT02586857|GBM|gbm
4805849|NCT02586844|NET|net
4805850|NCT02586844|PanNET|pannet
4805851|NCT02586844|Molecular profiling|molecular profiling
4805852|NCT02586844|Transcriptome sequencing|transcriptome sequencing
4805853|NCT02586831|Diabetes Mellitus, Type 1|diabetes mellitus, type 1
4805854|NCT02586831|Hypoglycemia|hypoglycemia
4805855|NCT02586831|Autoimmune Diseases|autoimmune diseases
4805856|NCT02586831|Diabetes Mellitus|diabetes mellitus
4805857|NCT02586805|DX-2930|dx-2930
4805858|NCT02586805|Hereditary Angioedema|hereditary angioedema
4805859|NCT02586805|Dyax|dyax
4805860|NCT02586792|Influenza,Open-Label, Vaccine, Intramusclar, H7N7, H7N9, Non-adjuvanted, sub-study|influenza,open-label, vaccine, intramusclar, h7n7, h7n9, non-adjuvanted, sub-study
4805861|NCT02586779|Referral and consultation|referral and consultation
4805862|NCT02586779|emergency department|emergency department
4805863|NCT02586779|WhatsApp|whatsapp
4805864|NCT02586766|Youth Violence|youth violence
4805865|NCT02586727|Radiation Retinopathy|radiation retinopathy
4805866|NCT02586727|aflibercept|aflibercept
4805867|NCT02586688|child depression|child depression
4805868|NCT02586688|depression|depression
4805869|NCT02586688|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
4805870|NCT02586688|Adolescent Major Depressive Disorder|adolescent major depressive disorder
4805871|NCT02586688|TMS|tms
4805872|NCT02586688|adolescent depression|adolescent depression
4805873|NCT02586675|ER+ breast cancer|er+ breast cancer
4805874|NCT02586675|PR+ breast cancer|pr+ breast cancer
4805875|NCT02586675|hormone receptor positive|hormone receptor positive
4805876|NCT02586675|HER2- breast cancer|her2- breast cancer
4805877|NCT02586675|HER2 negative|her2 negative
4805878|NCT02586675|locally advanced|locally advanced
4805879|NCT02586675|metastatic|metastatic
4805880|NCT02586662|scapular dyskinesis|scapular dyskinesis
4805881|NCT02586662|kinematics|kinematics
4805882|NCT02586649|tiotropium bromide|tiotropium bromide
4805883|NCT02586636|Metformin|metformin
4805884|NCT02586636|OCT1|oct1
4805885|NCT02586610|Pembrolizumab|pembrolizumab
4805886|NCT02586610|Chemoradiation|chemoradiation
4805887|NCT02586610|Anti-PD-1 Antibody|anti-pd-1 antibody
4805888|NCT02586610|MK-3475|mk-3475
4805889|NCT02586597|Stroke|stroke
4805890|NCT02586597|PAS|pas
4805891|NCT02586597|TMS|tms
4805892|NCT02586597|cortical excitability|cortical excitability
4805893|NCT02586597|plasticity|plasticity
4805894|NCT02586584|Patient-Reported Outcome, Antiretroviral Therapy|patient-reported outcome, antiretroviral therapy
4805895|NCT02586571|Body Composition|body composition
4805896|NCT02586571|Breast Feeding|breast feeding
4805897|NCT02586571|Growth|growth
4805898|NCT02586571|Infant|infant
4805899|NCT02586571|Milk, Human|milk, human
4805900|NCT02586571|Nutritional Sciences|nutritional sciences
4805901|NCT02586571|Weaning|weaning
4805902|NCT02586532|Detection|detection
4805903|NCT02586532|Cancer|cancer
4805904|NCT02586532|Antibody|antibody
4805905|NCT02586532|Biopsy|biopsy
4805906|NCT02586532|Registry|registry
4805907|NCT02586519|wearable technology|wearable technology
4805908|NCT02586519|Orpyx|orpyx
4805909|NCT02586519|SurroSense Rx|surrosense rx
4805910|NCT02586519|smart insole|smart insole
4805911|NCT02586519|TCC|tcc
4805912|NCT02586519|total contact cast|total contact cast
4805913|NCT02586519|insole|insole
4805914|NCT02586519|removable cast walker|removable cast walker
4805915|NCT02586519|RCW|rcw
4805916|NCT02586506|correct use of inhaler|correct use of inhaler
4805917|NCT02586506|dose left|dose left
4805918|NCT02586506|ease of use|ease of use
4805919|NCT02586506|ELLIPTA|ellipta
4805920|NCT02586506|Asthma|asthma
4805921|NCT02586493|Placebo|placebo
4805922|NCT02586493|ELLIPTA inhaler|ellipta inhaler
4805923|NCT02586493|Correct use|correct use
4805924|NCT02586493|COPD|copd
4805925|NCT02586493|Ease of use|ease of use
4805926|NCT02586480|bradycardia|bradycardia
4805927|NCT02586454|Transmuscular quadratus lumborum block, total abdominal hysterectomy|transmuscular quadratus lumborum block, total abdominal hysterectomy
4805928|NCT02586441|Bispectral index (BIS)|bispectral index (bis)
4805929|NCT02586441|EEG|eeg
4805930|NCT02586441|Depth of anesthesia|depth of anesthesia
4805931|NCT02586415|endovascular|endovascular
4805932|NCT02586415|endovascular procedure|endovascular procedure
4805933|NCT02586415|Mechanical Thrombectomy|mechanical thrombectomy
4805934|NCT02586402|ESAs CKD|esas ckd
4805935|NCT02586363|Entecavir|entecavir
4805936|NCT02586363|Food effect|food effect
4805937|NCT02586363|Cavir Tab 0.5mg|cavir tab 0.5mg
4805938|NCT02586363|Baraclude Tab. 0.5mg|baraclude tab. 0.5mg
4805939|NCT02586285|S-Adenosyl Methionine|s-adenosyl methionine
4805940|NCT02586285|Recurrence|recurrence
4805941|NCT02586272|Embryo Transfer|embryo transfer
4805942|NCT02586272|assisted reproductive technology|assisted reproductive technology
4805943|NCT02586246|CDP870|cdp870
4805944|NCT02586246|Rheumatoid arthritis|rheumatoid arthritis
4805945|NCT02586246|Long-term|long-term
4805946|NCT02586207|Larynx|larynx
4805947|NCT02586207|Squamous Cell|squamous cell
4805948|NCT02586207|Oral cavity|oral cavity
4805949|NCT02586207|Oropharynx|oropharynx
4805950|NCT02586207|Hypopharynx|hypopharynx
4805951|NCT02586194|Impaired hepatic function|impaired hepatic function
4805952|NCT02586194|Pharmacokinetics|pharmacokinetics
4805954|NCT02586168|Insulin Resistance|insulin resistance
4805955|NCT02586168|Lipid Regulator|lipid regulator
4805956|NCT02586142|spasticity|spasticity
4805957|NCT02586142|claw toe|claw toe
4805958|NCT02586142|ultrasounds guidance|ultrasounds guidance
4805959|NCT02586142|botulinum toxin|botulinum toxin
4805960|NCT02586142|stretching exercise|stretching exercise
4805961|NCT02586090|Pediatric Obesity|pediatric obesity
4805962|NCT02586090|Lifestyle Intervention|lifestyle intervention
4805963|NCT02586090|Family-based Intervention|family-based intervention
4805964|NCT02586090|Motivational Interviewing|motivational interviewing
4805965|NCT02586064|posttraumatic stress disorder|posttraumatic stress disorder
4805966|NCT02586064|Veterans|veterans
4805967|NCT02586064|Psychotherapy|psychotherapy
4805968|NCT02586064|Randomized Controlled Trial|randomized controlled trial
4805969|NCT02585999|Hormonal contraception, hormone pharmacokinetics|hormonal contraception, hormone pharmacokinetics
4805970|NCT02585973|AZD1775|azd1775
4805971|NCT02585973|Cisplatin|cisplatin
4805972|NCT02585973|Head and Neck Squamous Cell Carcinoma|head and neck squamous cell carcinoma
4805973|NCT02585973|HNSCC|hnscc
4805974|NCT02585973|Chemoradiotherapy|chemoradiotherapy
4805975|NCT02585973|Radiotherapy|radiotherapy
4805976|NCT02585973|CRT|crt
4805977|NCT02585947|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
4805978|NCT02585947|Tenofovir|tenofovir
4805979|NCT02585934|Alzheimer's disease|alzheimer's disease
4805980|NCT02585934|RVT-101|rvt-101
4805981|NCT02585934|donepezil|donepezil
4805982|NCT02585934|intepirdine|intepirdine
4805983|NCT02585934|dementia|dementia
4805984|NCT02585921|Urban Health|urban health
4805985|NCT02585895|LDL-C Apheresis|ldl-c apheresis
4805986|NCT02585895|Hypercholesterolemia|hypercholesterolemia
4805987|NCT02585895|Elevated Cholesterol|elevated cholesterol
4805988|NCT02585895|High Cholesterol|high cholesterol
4805989|NCT02585895|PCSK9 mutations|pcsk9 mutations
4805990|NCT02585895|Severe Familial Hypercholesterolemia|severe familial hypercholesterolemia
4805991|NCT02585895|evolocumab|evolocumab
4805992|NCT02585895|Repatha|repatha
4805993|NCT02585869|Lipid Regulator|lipid regulator
4805994|NCT02585869|TG|tg
4805995|NCT02585856|Biliary duct carcinoma|biliary duct carcinoma
4805996|NCT02585856|Photodynamic therapy|photodynamic therapy
4805997|NCT02585843|Heart Failure|heart failure
4805998|NCT02585843|Mineralocorticoid receptor antagonists|mineralocorticoid receptor antagonists
4805999|NCT02585843|Loop diuretic resistance|loop diuretic resistance
4806000|NCT02585817|Cardiac Implantable Electronic Devices|cardiac implantable electronic devices
4806001|NCT02585804|FSGS, SGLT2, chronic kidney disease, GFR, proteinuria|fsgs, sglt2, chronic kidney disease, gfr, proteinuria
4806002|NCT02585791|electronic cigarette|electronic cigarette
4806003|NCT02585791|airway inflammation|airway inflammation
4806004|NCT02585791|nasal potential difference|nasal potential difference
4806005|NCT02585726|Varicose Veins|varicose veins
4806006|NCT02585726|Great Saphenous Vein|great saphenous vein
4806007|NCT02585726|Venous Insufficiency|venous insufficiency
4806008|NCT02585687|Liver Perfusion MRI, Hepatocellular carcinoma|liver perfusion mri, hepatocellular carcinoma
4806009|NCT02585622|Diabetic Kidney Disease|diabetic kidney disease
4806010|NCT02585622|Mesenchymal Stromal Cells (MSC)|mesenchymal stromal cells (msc)
4806011|NCT02585622|immune response|immune response
4806012|NCT02585622|allogeneic|allogeneic
4806013|NCT02585622|disease progression|disease progression
4806014|NCT02585609|Sleep|sleep
4806015|NCT02585583|Deep Brain|deep brain
4806016|NCT02585583|Essential tremor|essential tremor
4806017|NCT02585583|Parkinson Disease|parkinson disease
4806018|NCT02585583|Tremor|tremor
4806019|NCT02585583|Radiosurgery|radiosurgery
4806020|NCT02585583|Thalamotomy|thalamotomy
4806021|NCT02585583|deep brain stimulation|deep brain stimulation
4806022|NCT02585583|DBS|dbs
4806023|NCT02585583|intractable, drug resistant, invalidating tremor|intractable, drug resistant, invalidating tremor
4806024|NCT02585570|shoulder|shoulder
4806025|NCT02585570|phenylephrine|phenylephrine
4806026|NCT02585570|hypotension|hypotension
4806027|NCT02585544|genital prolapse|genital prolapse
4806028|NCT02585544|day-care management|day-care management
4806029|NCT02585544|vaginal route|vaginal route
4806030|NCT02585544|prosthetic reinforcement|prosthetic reinforcement
4806031|NCT02585531|Bronchiolitis|bronchiolitis
4806032|NCT02585531|Dexamethasone|dexamethasone
4806033|NCT02585531|Epinephrine|epinephrine
4806034|NCT02585531|Hypertonic saline|hypertonic saline
4806035|NCT02585427|Diabetes|diabetes
4806036|NCT02585427|Obesity|obesity
4806037|NCT02585427|metabolic disorders|metabolic disorders
4806038|NCT02585388|pretreated metastatic breast cancer|pretreated metastatic breast cancer
4806039|NCT02585362|palliative|palliative
4806040|NCT02585336|Sugar-Sweetened beverages|sugar-sweetened beverages
4806041|NCT02585336|Metabolic health|metabolic health
4806042|NCT02585336|Soft drinks|soft drinks
4806043|NCT02585323|Physical activity|physical activity
4806044|NCT02585323|Osteoarthritis|osteoarthritis
4806045|NCT02585323|Knee|knee
4806046|NCT02585323|Exercise|exercise
4806047|NCT02585323|Arthritis|arthritis
4806048|NCT02585310|PRBC transfusion|prbc transfusion
4806049|NCT02585310|CABGs|cabgs
4806050|NCT02585245|Hospital Nutrition screens|hospital nutrition screens
4806051|NCT02585232|Behavioral sciences|behavioral sciences
4806052|NCT02585232|Counseling|counseling
4806053|NCT02585232|Intervention Studies|intervention studies
4806054|NCT02585232|Cognitive Behavioral Therapy|cognitive behavioral therapy
4806055|NCT02585232|Telemedicine|telemedicine
4806056|NCT02585232|Mindfulness|mindfulness
4806057|NCT02585206|Mobile Phone|mobile phone
4806058|NCT02585206|Text Messaging|text messaging
4806059|NCT02585206|Internet|internet
4806060|NCT02585206|Tobacco Use|tobacco use
4806061|NCT02585180|Ventilator-associated pneumonia|ventilator-associated pneumonia
4806062|NCT02585180|Surveillance|surveillance
4806063|NCT02585180|Subglottic-secretions|subglottic-secretions
4806064|NCT02585180|Critically ill patients|critically ill patients
4806065|NCT02585180|Prevention|prevention
4806066|NCT02585167|VAAFT|vaaft
4806067|NCT02585167|anal fistula|anal fistula
4806068|NCT02585167|sphincter reconstruction|sphincter reconstruction
4806069|NCT02585154|Deep Brain Stimulation|deep brain stimulation
4806070|NCT02585128|Delirium|delirium
4806071|NCT02585128|Transcatheter Aortic Valve Implantation|transcatheter aortic valve implantation
4806072|NCT02585128|Elderly|elderly
4806073|NCT02585102|Vegetables|vegetables
4806074|NCT02585089|Hypertension|hypertension
4806075|NCT02585089|active biopeptide|active biopeptide
4806076|NCT02585089|cardiovascular pathophysiology|cardiovascular pathophysiology
4806077|NCT02585089|angiotensin converting enzyme inhibition|angiotensin converting enzyme inhibition
4806078|NCT02585089|cured-pork ham|cured-pork ham
4806079|NCT02585076|Stroke prevention|stroke prevention
4806080|NCT02585076|Risk assessment|risk assessment
4806081|NCT02585063|independent prescribing,|independent prescribing,
4806082|NCT02585063|optometrist|optometrist
4806083|NCT02585063|acute care|acute care
4806084|NCT02585050|do not attempt resuscitation|do not attempt resuscitation
4806085|NCT02585050|neurological outcome|neurological outcome
4806086|NCT02585050|live discharged ratio|live discharged ratio
4806087|NCT02585024|smoking|smoking
4806088|NCT02585024|cytisine|cytisine
4806089|NCT02585024|Pharmacokinetics|pharmacokinetics
4806090|NCT02585011|Hemiarthroplasty|hemiarthroplasty
4806091|NCT02585011|Anesthesia, Local|anesthesia, local
4806092|NCT02585011|Pain, Postoperative|pain, postoperative
4806093|NCT02584972|Postural control|postural control
4806094|NCT02584972|Gait|gait
4806095|NCT02584972|Children|children
4806096|NCT02584972|Autism Spectrum Disorder|autism spectrum disorder
4806097|NCT02584933|ALK|alk
4806098|NCT02584933|Malignancies|malignancies
4806099|NCT02584907|Critically ill|critically ill
4806100|NCT02584907|Diet|diet
4806101|NCT02584907|Blood glucose|blood glucose
4806102|NCT02584894|Stress Disorders, Post-Traumatic|stress disorders, post-traumatic
4806103|NCT02584894|trauma exposure|trauma exposure
4806104|NCT02584894|Repeated transcranial magnetic stimulation|repeated transcranial magnetic stimulation
4806105|NCT02584855|Spondyloarthritis|spondyloarthritis
4806106|NCT02584855|Spondylarthropathy|spondylarthropathy
4806107|NCT02584816|BRV-PV|brv-pv
4806108|NCT02584816|Rotavirus vaccine|rotavirus vaccine
4806109|NCT02584816|lot-to-lot consistency|lot-to-lot consistency
4806110|NCT02584816|interference with routine immunization|interference with routine immunization
4806111|NCT02584790|Nasopharyngeal carcinoma|nasopharyngeal carcinoma
4806112|NCT02584790|Narrow band imaging|narrow band imaging
4806113|NCT02584777|Post-essential thrombocythemia myelofibrosis|post-essential thrombocythemia myelofibrosis
4806114|NCT02584777|Post-Polycythemia Vera Myelofibrosis|post-polycythemia vera myelofibrosis
4806115|NCT02584738|Asthma|asthma
4806116|NCT02584738|Exacerbation|exacerbation
4806117|NCT02584738|Nebulization|nebulization
4806118|NCT02584738|Magnesium|magnesium
4806119|NCT02584738|Pediatric|pediatric
4806120|NCT02584725|Tranexamic Acid|tranexamic acid
4806121|NCT02584725|Total Joint Arthroplasty|total joint arthroplasty
4806122|NCT02584725|Intraoperative Blood Loss|intraoperative blood loss
4806123|NCT02584660|Rivaroxaban|rivaroxaban
4806124|NCT02584660|JNJ39039039|jnj39039039
4806125|NCT02584660|Pulmonary embolism|pulmonary embolism
4806126|NCT02584647|Unresectable|unresectable
4806127|NCT02584634|Non-Small Cell Lung Cancer|non-small cell lung cancer
4806128|NCT02584634|NSCLC|nsclc
4806129|NCT02584634|ALK|alk
4806130|NCT02584634|avelumab|avelumab
4806131|NCT02584634|crizotinib|crizotinib
4806132|NCT02584634|PF-06463922|pf-06463922
4806133|NCT02584595|Tachycardia|tachycardia
4806134|NCT02584595|Ventricular Tachycardia|ventricular tachycardia
4806135|NCT02584595|Cardiac Arrhythmias|cardiac arrhythmias
4806136|NCT02584595|Cardiovascular Diseases|cardiovascular diseases
4806137|NCT02584595|Heart Diseases|heart diseases
4806138|NCT02584582|Glucagon|glucagon
4806139|NCT02584582|Glukagon-like peptide-1 (GLP-1)|glukagon-like peptide-1 (glp-1)
4806140|NCT02584582|GLP-1 receptor agonist (GLP-1RA)|glp-1 receptor agonist (glp-1ra)
4806141|NCT02584582|Incretins|incretins
4806142|NCT02584569|Drug therapy|drug therapy
4806143|NCT02584530|ultrasound|ultrasound
4806144|NCT02584530|PICC line|picc line
4806145|NCT02584530|neonate|neonate
4806146|NCT02584517|Vasculitis|vasculitis
4806147|NCT02584517|Autoimmune disease|autoimmune disease
4806148|NCT02584517|Connective tissue disease|connective tissue disease
4806149|NCT02584517|Polymyalgia rheumatica|polymyalgia rheumatica
4806150|NCT02584517|Musculoskeletal Diseases|musculoskeletal diseases
4806151|NCT02584517|Immune disorder|immune disorder
4806152|NCT02584517|Rheumatic disease|rheumatic disease
4806153|NCT02584504|Non-statin LMT|non-statin lmt
4806154|NCT02584504|Low dose statin|low dose statin
4806155|NCT02584478|Dual receptor Tyrosine Kinase Inhibitor|dual receptor tyrosine kinase inhibitor
4806156|NCT02584478|Anti-angiogenic therapy|anti-angiogenic therapy
4806157|NCT02584478|Combination Therapy|combination therapy
4806158|NCT02584439|ivabradine|ivabradine
4806159|NCT02584439|heart rate|heart rate
4806160|NCT02584439|aging|aging
4806161|NCT02584439|visco-elasticity|visco-elasticity
4806162|NCT02584426|Cefazolin|cefazolin
4806163|NCT02584400|prostatic tumors|prostatic tumors
4806164|NCT02584400|[18F]HX4 Pet imaging|[18f]hx4 pet imaging
4806165|NCT02584400|hypoxia|hypoxia
4806166|NCT02584400|phase II trial|phase ii trial
4806167|NCT02584400|esophageal tumors|esophageal tumors
4806168|NCT02584400|rectal tumors|rectal tumors
4806169|NCT02584400|brain metastases|brain metastases
4806170|NCT02584400|primary brain tumors|primary brain tumors
4806171|NCT02584374|iliac vein compression|iliac vein compression
4806172|NCT02584361|Hearing loss|hearing loss
4806173|NCT02584361|Cochlear implant|cochlear implant
4806174|NCT02584348|ultrasound, antrum, pulmonary aspiration, emergency surgery|ultrasound, antrum, pulmonary aspiration, emergency surgery
4806175|NCT02584335|wound treatment|wound treatment
4806176|NCT02584335|lidocaine|lidocaine
4806177|NCT02584335|pain reduction|pain reduction
4806178|NCT02584335|local anesthetic|local anesthetic
4806179|NCT02584283|Liver Transplantation|liver transplantation
4806180|NCT02584283|Donation after Circulatory Death|donation after circulatory death
4806181|NCT02584283|Machine Perfusion|machine perfusion
4806182|NCT02584270|palatal drop prosthesis|palatal drop prosthesis
4806183|NCT02584231|Desmopressin|desmopressin
4806184|NCT02584231|Paediatrics|paediatrics
4806185|NCT02584231|urinary concentration test|urinary concentration test
4806186|NCT02584205|inspiratory muscle training|inspiratory muscle training
4806187|NCT02584205|obstructive sleep apnea|obstructive sleep apnea
4806188|NCT02584205|functional capacity|functional capacity
4806189|NCT02584179|mpMRI, significant cancer|mpmri, significant cancer
4806190|NCT02584166|Morbidity|morbidity
4806191|NCT02584166|Mortality|mortality
4806192|NCT02584166|conferences|conferences
4806193|NCT02584166|human science|human science
4806194|NCT02584153|Hernia|hernia
4806195|NCT02584153|Ventral|ventral
4806196|NCT02584153|Incisional|incisional
4806197|NCT02584153|Abdominal|abdominal
4806198|NCT02584153|Herniorrhaphy|herniorrhaphy
4806199|NCT02584153|Recurrence|recurrence
4806200|NCT02584153|laparotomy|laparotomy
4806201|NCT02584153|prevention|prevention
4806202|NCT02584140|PrEP|prep
4806203|NCT02584140|Pre-exposure Prophylaxis|pre-exposure prophylaxis
4806204|NCT02584140|HIV Prevention|hiv prevention
4806205|NCT02584127|Smoking|smoking
4806206|NCT02584127|cessation|cessation
4806207|NCT02584127|Internet program|internet program
4806208|NCT02584101|Acceptance and Commitment Therapy|acceptance and commitment therapy
4806209|NCT02584088|NovaSure|novasure
4806210|NCT02584088|Ablation|ablation
4806211|NCT02584088|Menorrhagia|menorrhagia
4806212|NCT02584088|Endometrium|endometrium
4806213|NCT02584049|Osteopathic treatment|osteopathic treatment
4806214|NCT02584049|Care-induced Pain|care-induced pain
4806215|NCT02584049|Pain|pain
4806216|NCT02584049|Elderly|elderly
4806217|NCT02584036|influenza|influenza
4806218|NCT02584036|vaccine|vaccine
4806219|NCT02584036|public health|public health
4806220|NCT02584036|preventable disease|preventable disease
4806221|NCT02584036|vaccine history|vaccine history
4806222|NCT02584036|point-of-care|point-of-care
4806223|NCT02584023|ultrasonography|ultrasonography
4806224|NCT02584023|infant|infant
4806225|NCT02584023|perioperative period|perioperative period
4806226|NCT02584023|general anesthesia|general anesthesia
4806227|NCT02584010|Postoperative scars|postoperative scars
4806228|NCT02584010|Cicatrix|cicatrix
4806229|NCT02584010|Cicatrization|cicatrization
4806230|NCT02583997|To suture or not to suture....|to suture or not to suture....
4806231|NCT02583997|Tooth extraction|tooth extraction
4806232|NCT02583997|Third molar|third molar
4806233|NCT02583971|Direct current cardioversion|direct current cardioversion
4806234|NCT02583971|Medical management|medical management
4806235|NCT02583971|Atrial fibrillation ablation|atrial fibrillation ablation
4806236|NCT02583945|acute kidney injury|acute kidney injury
4806237|NCT02583945|hemodynamic stabilisation|hemodynamic stabilisation
4806238|NCT02583945|nephrotoxic medication|nephrotoxic medication
4806239|NCT02583932|Randomized controlled trial|randomized controlled trial
4806240|NCT02583932|Psychological|psychological
4806241|NCT02583932|Meaning|meaning
4806242|NCT02583932|Existential|existential
4806243|NCT02583932|Quality of life|quality of life
4806244|NCT02583932|Intervention|intervention
4806245|NCT02583932|Cancer|cancer
4806246|NCT02583932|Advanced disease|advanced disease
4806247|NCT02583932|New diagnosis|new diagnosis
4806248|NCT02583880|nutritional status|nutritional status
4806249|NCT02583880|malnutrition|malnutrition
4806250|NCT02583880|energy intake|energy intake
4806251|NCT02583880|caloric deficit|caloric deficit
4806252|NCT02583880|ICU|icu
4806253|NCT02583880|hospital|hospital
4806254|NCT02583880|enteral nutrition|enteral nutrition
4806255|NCT02583880|parenteral nutrition|parenteral nutrition
4806256|NCT02583880|nutrition|nutrition
4806257|NCT02583854|Coronary angiography|coronary angiography
4806258|NCT02583854|Transradial|transradial
4806259|NCT02583854|Patient experience|patient experience
4806260|NCT02583854|VAS|vas
4806261|NCT02583854|Compression device|compression device
4806262|NCT02583802|MHD|mhd
4806263|NCT02583802|ear pills|ear pills
4806264|NCT02583802|Shengmai capsule|shengmai capsule
4806265|NCT02583802|Chinese medicine treatment|chinese medicine treatment
4806266|NCT02583776|continuous glucose monitoring (cgm)|continuous glucose monitoring (cgm)
4806267|NCT02583776|neonatal hypoglycemia|neonatal hypoglycemia
4806268|NCT02583776|very low birth weight infants (VLBWI)|very low birth weight infants (vlbwi)
4806269|NCT02583776|preterm infants|preterm infants
4806270|NCT02583763|pro-brain natriuretic peptide (1-76)|pro-brain natriuretic peptide (1-76)
4806271|NCT02583763|Insulin-Like Growth Factor Binding Proteins|insulin-like growth factor binding proteins
4806272|NCT02583763|Insulin-Like Growth Factor I|insulin-like growth factor i
4806273|NCT02583763|Echocardiography|echocardiography
4806274|NCT02583763|Velocity Vector Imaging|velocity vector imaging
4806275|NCT02583763|Heart Function Tests|heart function tests
4806276|NCT02583750|glucose metabolism|glucose metabolism
4806277|NCT02583750|sleep deprivation|sleep deprivation
4806278|NCT02583737|bone|bone
4806279|NCT02583737|maxillary sinus|maxillary sinus
4806280|NCT02583672|Gaucher Disease|gaucher disease
4806281|NCT02583659|Gastric cancer|gastric cancer
4806282|NCT02583659|First-line chemotherapy|first-line chemotherapy
4806283|NCT02583659|Biomarker|biomarker
4806284|NCT02583646|Obesity|obesity
4806285|NCT02583646|Puberty|puberty
4806286|NCT02583646|Ultrasound|ultrasound
4806287|NCT02583646|Pediatric|pediatric
4806288|NCT02583620|high myopia|high myopia
4806289|NCT02583568|breast cancer|breast cancer
4806290|NCT02583568|image-guided surgery|image-guided surgery
4806291|NCT02583555|Quality of Life|quality of life
4806292|NCT02583555|Health Care Utilization|health care utilization
4806293|NCT02583542|breast|breast
4806294|NCT02583542|lung|lung
4806295|NCT02583542|squamous|squamous
4806296|NCT02583542|KRAS|kras
4806297|NCT02583542|AZD|azd
4806298|NCT02583542|selumetinib|selumetinib
4806299|NCT02583529|Parkinson Disease|parkinson disease
4806300|NCT02583529|Neurogenic Overactive Bladder|neurogenic overactive bladder
4806301|NCT02583529|Posterior Tibial Nerve Electrostimulation|posterior tibial nerve electrostimulation
4806302|NCT02583503|Total knee arthroplasty|total knee arthroplasty
4806303|NCT02583503|Total knee replacement|total knee replacement
4806304|NCT02583503|TKA|tka
4806305|NCT02583503|TKR|tkr
4806306|NCT02583490|Electroconvulsive Therapy|electroconvulsive therapy
4806307|NCT02583490|Low Pulse Amplitude Focal Electroconvulsive Therapy|low pulse amplitude focal electroconvulsive therapy
4806308|NCT02583490|ECT|ect
4806309|NCT02583490|Depression|depression
4806310|NCT02583490|Suicidal Ideation|suicidal ideation
4806411|NCT02582853|sCD163|scd163
4806509|NCT02582385|Cytokines|cytokines
4806311|NCT02583477|Pancreatic Ductal Adenocarcinoma, PDAC, immunotherapy, PDL1, AZD5069, MEDI4736|pancreatic ductal adenocarcinoma, pdac, immunotherapy, pdl1, azd5069, medi4736
4806312|NCT02583438|Gut Microbiota|gut microbiota
4806313|NCT02583438|inflammatory marker|inflammatory marker
4806314|NCT02583438|Glucose and lipid metabolism|glucose and lipid metabolism
4806315|NCT02583399|Pediatric (Birth to less than 6 months of age)|pediatric (birth to less than 6 months of age)
4806316|NCT02583399|Pain|pain
4806317|NCT02583399|Fever|fever
4806318|NCT02583386|mobility|mobility
4806319|NCT02583386|falls|falls
4806320|NCT02583386|fall prevention|fall prevention
4806321|NCT02583386|gait and balance|gait and balance
4806322|NCT02583386|automatic fall detector|automatic fall detector
4806323|NCT02583373|Pneumonia|pneumonia
4806324|NCT02583373|Streptococcus pneumoniae|streptococcus pneumoniae
4806325|NCT02583373|Pneumolysin|pneumolysin
4806326|NCT02583360|Infant|infant
4806327|NCT02583360|Feeding difficulties|feeding difficulties
4806328|NCT02583360|Dysphagia|dysphagia
4806329|NCT02583334|acupuncture|acupuncture
4806330|NCT02583334|fibromyalgia|fibromyalgia
4806331|NCT02583334|rheumatism|rheumatism
4806332|NCT02583334|clinical trial|clinical trial
4806333|NCT02583321|chlorhexidine gluconate|chlorhexidine gluconate
4806334|NCT02583321|oral care|oral care
4806335|NCT02583321|mechanical ventilation|mechanical ventilation
4806336|NCT02583321|critically ill patients|critically ill patients
4806337|NCT02583321|tracheal secretions|tracheal secretions
4806338|NCT02583321|subglottic secretions|subglottic secretions
4806339|NCT02583308|Ventilator-associated pneumonia|ventilator-associated pneumonia
4806340|NCT02583308|Surveillance|surveillance
4806341|NCT02583308|Subglottic-secretions|subglottic-secretions
4806342|NCT02583308|Critically ill patients|critically ill patients
4806343|NCT02583308|Prevention|prevention
4806344|NCT02583295|Awareness|awareness
4806345|NCT02583295|Cardiac Surgery|cardiac surgery
4806346|NCT02583295|Maternal|maternal
4806347|NCT02583295|Pediatric|pediatric
4806348|NCT02583295|Sound|sound
4806349|NCT02583295|Music|music
4806350|NCT02583243|Opioid dependence|opioid dependence
4806351|NCT02583243|HIV/AIDS|hiv/aids
4806352|NCT02583243|Hepatitis C|hepatitis c
4806353|NCT02583243|Severe mental illness|severe mental illness
4806354|NCT02583243|Injection Drug Use|injection drug use
4806355|NCT02583230|Antidepressant Medication|antidepressant medication
4806356|NCT02583230|Adherence|adherence
4806357|NCT02583230|Mobile Smartphone Intervention|mobile smartphone intervention
4806358|NCT02583230|Telemedicine|telemedicine
4806359|NCT02583230|Primary Care|primary care
4806360|NCT02583217|Laryngeal mask|laryngeal mask
4806361|NCT02583217|Ketamine|ketamine
4806362|NCT02583217|Remifentanyl|remifentanyl
4806363|NCT02583165|advanced solid tumors|advanced solid tumors
4806364|NCT02583165|immunotherapy|immunotherapy
4806365|NCT02583165|immuno-oncology|immuno-oncology
4806366|NCT02583139|Children, Moderate and/or highly emetogenic chemotherapy|children, moderate and/or highly emetogenic chemotherapy
4806367|NCT02583126|Teenager|teenager
4806368|NCT02583126|moderate and/or highly emetogenic chemotherapy|moderate and/or highly emetogenic chemotherapy
4806369|NCT02583113|Total Knee Replacement|total knee replacement
4806370|NCT02583113|Unicompartment Knee Replacement|unicompartment knee replacement
4806371|NCT02583087|Barrett esophagus|barrett esophagus
4806372|NCT02583087|Esophageal adenocarcinoma|esophageal adenocarcinoma
4806373|NCT02583087|Endoscopic submucosal dissection|endoscopic submucosal dissection
4806374|NCT02583074|deep brain stimulation|deep brain stimulation
4806375|NCT02583074|Subthalamic Nucleus|subthalamic nucleus
4806376|NCT02583074|dystonia|dystonia
4806377|NCT02583035|cancer|cancer
4806378|NCT02583035|geriatric|geriatric
4806379|NCT02582996|Headache|headache
4806380|NCT02582996|Aura|aura
4806381|NCT02582996|Migraine|migraine
4806382|NCT02582996|Moderate to Severe|moderate to severe
4806383|NCT02582957|ARDS|ards
4806384|NCT02582957|Shock Lung|shock lung
4806385|NCT02582957|Acute Chest Syndrome|acute chest syndrome
4806386|NCT02582957|Respiratory Distress Syndrome, Adult|respiratory distress syndrome, adult
4806387|NCT02582957|Respiratory insufficiency|respiratory insufficiency
4806388|NCT02582957|Trauma|trauma
4806389|NCT02582918|Randomized Controlled Trial|randomized controlled trial
4806390|NCT02582918|Mass Screening|mass screening
4806391|NCT02582905|Alcohol Use Disorder|alcohol use disorder
4806392|NCT02582905|Bipolar Disorder|bipolar disorder
4806393|NCT02582905|Mood|mood
4806394|NCT02582905|Alcohol craving|alcohol craving
4806395|NCT02582905|Pregnenolone|pregnenolone
4806396|NCT02582905|Citicoline|citicoline
4806397|NCT02582879|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
4806398|NCT02582879|CLL|cll
4806399|NCT02582879|Small Lymphocytic Leukemia|small lymphocytic leukemia
4806400|NCT02582879|SLL|sll
4806401|NCT02582866|Lacosamide|lacosamide
4806402|NCT02582866|Vimpat|vimpat
4806403|NCT02582866|Epilepsy|epilepsy
4806404|NCT02582866|Partial onset seizures|partial onset seizures
4806405|NCT02582866|Tonic-clonic seizures|tonic-clonic seizures
4806406|NCT02582866|Monotherapy|monotherapy
4806407|NCT02582866|AED|aed
4806408|NCT02582853|GBS|gbs
4806409|NCT02582853|AIDP|aidp
4806410|NCT02582853|Spinal fluid|spinal fluid
4806412|NCT02582840|Japanese patients with type 1 diabetes with inadequate glycemic control on insulin|japanese patients with type 1 diabetes with inadequate glycemic control on insulin
4806413|NCT02582827|Advanced Solid Tumors|advanced solid tumors
4806414|NCT02582827|solid tumor|solid tumor
4806415|NCT02582827|lymphoma|lymphoma
4806416|NCT02582814|Japanese patients with type 1 diabetes with inadequate glycemic control on insulin|japanese patients with type 1 diabetes with inadequate glycemic control on insulin
4806417|NCT02582801|PET/CT|pet/ct
4806418|NCT02582801|Alfatide Ⅱ|alfatide ⅱ
4806419|NCT02582801|breast cancer|breast cancer
4806420|NCT02582762|Nail gel|nail gel
4806421|NCT02582762|Nail surface abnormality|nail surface abnormality
4806422|NCT02582762|Efficacy|efficacy
4806423|NCT02582749|Androgen Deprivation Therapy|androgen deprivation therapy
4806424|NCT02582749|Androgen Receptor Antagonist|androgen receptor antagonist
4806425|NCT02582749|Radium-223 Dichloride|radium-223 dichloride
4806426|NCT02582749|Placebo|placebo
4806427|NCT02582736|Antipsychotics|antipsychotics
4806428|NCT02582736|Drug side effects|drug side effects
4806429|NCT02582736|Psychosis|psychosis
4806430|NCT02582736|Hyperglycemic emergencies|hyperglycemic emergencies
4806431|NCT02582736|Diabetes|diabetes
4806432|NCT02582736|Epidemiology|epidemiology
4806433|NCT02582736|Database research|database research
4806434|NCT02582736|CNODES|cnodes
4806435|NCT02582697|Germ Cell|germ cell
4806436|NCT02582697|Intermediate and poor-risk metastatic germ cell tumours|intermediate and poor-risk metastatic germ cell tumours
4806437|NCT02582671|Real World Effectiveness|real world effectiveness
4806438|NCT02582658|Paritaprevir|paritaprevir
4806439|NCT02582658|Dasabuvir|dasabuvir
4806440|NCT02582658|Ombitasvir|ombitasvir
4806441|NCT02582658|Chronic Hepatitis C|chronic hepatitis c
4806442|NCT02582658|HCV|hcv
4806443|NCT02582645|impaction|impaction
4806444|NCT02582645|impacted canine|impacted canine
4806445|NCT02582645|palatally|palatally
4806446|NCT02582645|open window|open window
4806447|NCT02582645|closed window|closed window
4806448|NCT02582645|management|management
4806449|NCT02582632|Hepatitis C Virus|hepatitis c virus
4806450|NCT02582632|Interferon-Free|interferon-free
4806451|NCT02582632|Ribavirin-Free|ribavirin-free
4806452|NCT02582632|Hepatitis C|hepatitis c
4806453|NCT02582632|Hepatitis C Genotype 1b|hepatitis c genotype 1b
4806454|NCT02582619|Spinal Cord Injury and Employment|spinal cord injury and employment
4806455|NCT02582606|Insulin Resistance|insulin resistance
4806456|NCT02582606|Meal pattern|meal pattern
4806457|NCT02582606|Obese|obese
4806458|NCT02582593|Cognitive Aging|cognitive aging
4806459|NCT02582593|Neuromodulation|neuromodulation
4806460|NCT02582593|Low Level Light Therapy|low level light therapy
4806461|NCT02582593|Near Infrared Light|near infrared light
4806462|NCT02582593|Neurostimulation|neurostimulation
4806463|NCT02582580|pelvic floor|pelvic floor
4806464|NCT02582580|perineal trauma|perineal trauma
4806465|NCT02582580|physiotherapy|physiotherapy
4806466|NCT02582580|perineal integrity|perineal integrity
4806467|NCT02582567|Pregnant Women|pregnant women
4806468|NCT02582567|Quality of Life|quality of life
4806469|NCT02582567|Exercise|exercise
4806470|NCT02582567|Sleep|sleep
4806471|NCT02582567|Fetal Research|fetal research
4806472|NCT02582567|Diet, Mediterranean|diet, mediterranean
4806473|NCT02582567|Physical Fitness|physical fitness
4806474|NCT02582567|Oxidative stress|oxidative stress
4806475|NCT02582567|Inflammation|inflammation
4806476|NCT02582528|cognitive remediation|cognitive remediation
4806477|NCT02582528|cognition|cognition
4806478|NCT02582528|youth|youth
4806479|NCT02582528|mental health|mental health
4806480|NCT02582528|functional outcome|functional outcome
4806481|NCT02582515|d-cycloserine|d-cycloserine
4806482|NCT02582515|comprehensive behavioral intervention for tics|comprehensive behavioral intervention for tics
4806483|NCT02582515|habit reversal training|habit reversal training
4806484|NCT02582502|Hyperbaric Oxygen|hyperbaric oxygen
4806485|NCT02582502|HBOT|hbot
4806486|NCT02582502|Hyperbaric Chamber|hyperbaric chamber
4806487|NCT02582502|Pressurized Oxygen|pressurized oxygen
4806488|NCT02582489|Mesenchymal stem cells|mesenchymal stem cells
4806489|NCT02582489|Bone marrow aspirate concentrate|bone marrow aspirate concentrate
4806490|NCT02582476|Hypokalemic Periodic Paralysis|hypokalemic periodic paralysis
4806491|NCT02582476|Bumetanide|bumetanide
4806492|NCT02582476|Periodic Paralysis|periodic paralysis
4806493|NCT02582463|Risk Assessment|risk assessment
4806494|NCT02582463|Hospitals|hospitals
4806495|NCT02582463|Pharmacists|pharmacists
4806496|NCT02582463|Medication Systems|medication systems
4806497|NCT02582463|Patient Selection|patient selection
4806498|NCT02582463|Prognosis research|prognosis research
4806499|NCT02582450|Haemophilia|haemophilia
4806500|NCT02582450|Adherence of Treatment|adherence of treatment
4806501|NCT02582450|Knowledge of Illness|knowledge of illness
4806502|NCT02582450|Medical-patient Relationship|medical-patient relationship
4806503|NCT02582450|Illness Behavior|illness behavior
4806504|NCT02582450|Treatment Difficulties|treatment difficulties
4806505|NCT02582450|Veritas|veritas
4806506|NCT02582437|Minimum Alveolar Concentration|minimum alveolar concentration
4806507|NCT02582411|Healthy Subjects|healthy subjects
4806508|NCT02582385|Amyotrophic lateral sclerosis (ALS)|amyotrophic lateral sclerosis (als)
4806510|NCT02582385|Neuropathology|neuropathology
4806511|NCT02582359|Acute Myeloid Leukemia|acute myeloid leukemia
4806512|NCT02582346|MRI|mri
4806513|NCT02582346|Neurography|neurography
4806514|NCT02582346|Tractography|tractography
4806515|NCT02582346|Pelvic nerves|pelvic nerves
4806516|NCT02582203|Ceftaroline fosamil|ceftaroline fosamil
4806517|NCT02582203|Vancomycin|vancomycin
4806518|NCT02582203|Acute bacterial skin and skin structure infections|acute bacterial skin and skin structure infections
4806519|NCT02582203|Methicillin-resistant S. aureus|methicillin-resistant s. aureus
4806520|NCT02582190|electrical cardioversion|electrical cardioversion
4806521|NCT02582190|persistent atrial fibrillation|persistent atrial fibrillation
4806522|NCT02582177|Fungal infection|fungal infection
4806523|NCT02582177|Skin infection|skin infection
4806524|NCT02582177|Dermatophytoses|dermatophytoses
4806525|NCT02582164|Optical Coherence Tomography (OCT)|optical coherence tomography (oct)
4806526|NCT02582164|Swept Source OCT|swept source oct
4806527|NCT02582138|physical frailty|physical frailty
4806528|NCT02582138|sarcopenia|sarcopenia
4806529|NCT02582138|exercise|exercise
4806530|NCT02582138|nutrition|nutrition
4806531|NCT02582138|information and communications technology|information and communications technology
4806532|NCT02582125|ONO-4538|ono-4538
4806533|NCT02582125|Advanced non-small cell lung cancer|advanced non-small cell lung cancer
4806534|NCT02582047|influenza vaccine|influenza vaccine
4806535|NCT02582047|pneumococcal vaccine|pneumococcal vaccine
4806536|NCT02582047|simultaneous vaccination|simultaneous vaccination
4806537|NCT02582034|Optimized Dosimetry versus standard Dosimetry|optimized dosimetry versus standard dosimetry
4806538|NCT02582034|Internal Radiation Therapy|internal radiation therapy
4806539|NCT02582021|Microvascular Coronary Dysfunction (MCD)|microvascular coronary dysfunction (mcd)
4806540|NCT02582021|Magnetic resonance imaging (MRI)|magnetic resonance imaging (mri)
4806541|NCT02582021|Coronary angiography|coronary angiography
4806542|NCT02582021|Coronary Vascular Dysfunction (CVD)|coronary vascular dysfunction (cvd)
4806543|NCT02581995|Diabetic macular edema|diabetic macular edema
4806544|NCT02581995|Intravitreal injection|intravitreal injection
4806545|NCT02581982|Urothelial cancer|urothelial cancer
4806546|NCT02581982|Bladder cancer|bladder cancer
4806547|NCT02581982|Immunotherapy|immunotherapy
4806548|NCT02581982|Paclitaxel|paclitaxel
4806549|NCT02581969|Hemophilia A, Congenital|hemophilia a, congenital
4806550|NCT02581956|Immunology|immunology
4806551|NCT02581891|Neovascular age-related macular degeneration|neovascular age-related macular degeneration
4806552|NCT02581891|nAMD)|namd)
4806553|NCT02581878|Thorium-227|thorium-227
4806554|NCT02581878|BAY1862864 Injection|bay1862864 injection
4806555|NCT02581878|Safety|safety
4806556|NCT02581878|Pharmacokinetics|pharmacokinetics
4806557|NCT02581878|CD22|cd22
4806558|NCT02581878|Radioimmunotherapy|radioimmunotherapy
4806559|NCT02581839|eribulin|eribulin
4806560|NCT02581839|central nervous system|central nervous system
4806561|NCT02581839|CNS|cns
4806562|NCT02581839|Eribulin Mesylate|eribulin mesylate
4806563|NCT02581839|Halaven|halaven
4806564|NCT02581813|Bone health|bone health
4806565|NCT02581813|Body composition|body composition
4806566|NCT02581813|Dairy foods|dairy foods
4806567|NCT02581813|Exercise|exercise
4806568|NCT02581813|inflammation|inflammation
4806569|NCT02581813|nutrition intervention|nutrition intervention
4806570|NCT02581813|weight management|weight management
4806571|NCT02581774|induction|induction
4806572|NCT02581774|cesarean delivery|cesarean delivery
4806573|NCT02581761|Hemodynamically stable women >18 years old|hemodynamically stable women >18 years old
4806574|NCT02581761|with abnormal plateauing serum βHCG|with abnormal plateauing serum βhcg
4806575|NCT02581735|Haemophilia|haemophilia
4806576|NCT02581735|Adherence|adherence
4806577|NCT02581735|Prophylaxis treatment|prophylaxis treatment
4806578|NCT02581735|Quality of Life|quality of life
4806579|NCT02581735|Illness Behavior|illness behavior
4806580|NCT02581735|Veritas-Pro questionnaire|veritas-pro questionnaire
4806581|NCT02581735|uPatient|upatient
4806582|NCT02581722|PrePex, Male Circumcision, HIV Prevention, Adolescents|prepex, male circumcision, hiv prevention, adolescents
4806583|NCT02581709|Feasibility study|feasibility study
4806584|NCT02581709|Cognition|cognition
4806585|NCT02581709|Chemotherapy|chemotherapy
4806586|NCT02581709|Neoplasms|neoplasms
4806587|NCT02581670|oligometastatic breast cancer|oligometastatic breast cancer
4806588|NCT02581618|ischemic preconditioning|ischemic preconditioning
4806589|NCT02581618|myocardial injury|myocardial injury
4806590|NCT02581618|percutaneous coronary intervention|percutaneous coronary intervention
4806591|NCT02581592|Hepatic Impairment|hepatic impairment
4806592|NCT02581592|Hepatitis|hepatitis
4806593|NCT02581592|Liver Cirrhosis|liver cirrhosis
4806594|NCT02581579|Tuberculosis|tuberculosis
4806595|NCT02581579|Tregs|tregs
4806596|NCT02581579|Tolerance|tolerance
4806597|NCT02581579|Probiotic|probiotic
4806598|NCT02581579|Mycobacteria|mycobacteria
4806599|NCT02581540|Troponin|troponin
4806600|NCT02581540|High Sensitivity Troponin T|high sensitivity troponin t
4806601|NCT02581540|MACE|mace
4806602|NCT02581540|risk stratification|risk stratification
4806603|NCT02581540|suspected cardiac chest pain|suspected cardiac chest pain
4807516|NCT02576743|AVM|avm
4806604|NCT02581540|Acute Coronary Syndrome|acute coronary syndrome
4806605|NCT02581540|GRACE|grace
4806606|NCT02581540|TIMI|timi
4806607|NCT02581540|HEART|heart
4806608|NCT02581514|decision algorithm|decision algorithm
4806609|NCT02581501|Xeloda|xeloda
4806610|NCT02581501|Gemcitabine|gemcitabine
4806611|NCT02581501|Abraxane|abraxane
4806612|NCT02581501|Pancreatic Cancer|pancreatic cancer
4806613|NCT02581501|Metastatic Cancer|metastatic cancer
4806614|NCT02581501|Phase I|phase i
4806615|NCT02581501|5-FU|5-fu
4806616|NCT02581501|Capecitabine|capecitabine
4806617|NCT02581501|Gemzar|gemzar
4806618|NCT02581501|NAB-Paclitaxel|nab-paclitaxel
4806619|NCT02581501|Chemotherapy|chemotherapy
4806620|NCT02581488|Diabetes|diabetes
4806621|NCT02581488|diabetic foot ulcer|diabetic foot ulcer
4806622|NCT02581488|foot sore|foot sore
4806623|NCT02581488|type 2 diabetes|type 2 diabetes
4806624|NCT02581488|type 1 diabetes|type 1 diabetes
4806625|NCT02581488|neuropathy|neuropathy
4806626|NCT02581488|DFU|dfu
4806627|NCT02581475|Adenoma detection rate|adenoma detection rate
4806628|NCT02581475|Colonoscopy|colonoscopy
4806629|NCT02581475|Withdrawal time|withdrawal time
4806630|NCT02581449|omega-3 fatty acids|omega-3 fatty acids
4806631|NCT02581449|hemodialysis|hemodialysis
4806632|NCT02581449|oxidative stress|oxidative stress
4806633|NCT02581449|dyslipidemia|dyslipidemia
4806634|NCT02581436|Prediction test|prediction test
4806635|NCT02581436|genetic transcription profile|genetic transcription profile
4806636|NCT02581436|Transplant follow-up|transplant follow-up
4806637|NCT02581436|Chronic index|chronic index
4806638|NCT02581436|Graft Function|graft function
4806639|NCT02581410|Zostavax®|zostavax®
4806640|NCT02581410|≥ 65 years of age|≥ 65 years of age
4806641|NCT02581410|Herpes Zoster|herpes zoster
4806642|NCT02581410|Shingles|shingles
4806643|NCT02581410|Immunogenicity|immunogenicity
4806644|NCT02581410|Safety|safety
4806645|NCT02581397|cough|cough
4806646|NCT02581397|expectorant|expectorant
4806647|NCT02581397|upper respiratory tract infections|upper respiratory tract infections
4806648|NCT02581397|respiratory tract infections|respiratory tract infections
4806649|NCT02581397|antitussive agents|antitussive agents
4806650|NCT02581384|Ewing Sarcoma|ewing sarcoma
4806651|NCT02581384|Rhabdomyosarcoma|rhabdomyosarcoma
4806652|NCT02581384|Wilms Tumor|wilms tumor
4806653|NCT02581384|Rhabdomyosarcoma of Mediastinum|rhabdomyosarcoma of mediastinum
4806654|NCT02581384|Ewing's Sarcoma Metastatic|ewing's sarcoma metastatic
4806655|NCT02581384|Ewing Family of Tumors|ewing family of tumors
4806656|NCT02581384|Ewing's Tumor Metastatic|ewing's tumor metastatic
4806657|NCT02581384|Osteosarcoma, Metastatic|osteosarcoma, metastatic
4806658|NCT02581384|Osteosarcoma in Children|osteosarcoma in children
4806659|NCT02581384|Rhabdoid Tumor|rhabdoid tumor
4806660|NCT02581384|Lung Metastasis|lung metastasis
4806661|NCT02581384|Radiation for Children|radiation for children
4806662|NCT02581384|SBRT for children|sbrt for children
4806663|NCT02581384|Stereotactic Body Radiotherapy|stereotactic body radiotherapy
4806664|NCT02581384|Pulmonary Metastasis|pulmonary metastasis
4806665|NCT02581384|Lung Metastasis in Children|lung metastasis in children
4806666|NCT02581384|Pulmonary Metastasis in Children|pulmonary metastasis in children
4806667|NCT02581384|Comfort Care|comfort care
4806668|NCT02581384|Palliative Care|palliative care
4806669|NCT02581371|Cerebrolysin|cerebrolysin
4806670|NCT02581371|neuroplasticity|neuroplasticity
4806671|NCT02581371|upper limb|upper limb
4806672|NCT02581371|middle cerebral artery|middle cerebral artery
4806673|NCT02581371|NBS|nbs
4806674|NCT02581371|navigation brain stimulation|navigation brain stimulation
4806675|NCT02581371|paretic limb|paretic limb
4806676|NCT02581371|stroke|stroke
4806677|NCT02581371|ischemic stroke|ischemic stroke
4806678|NCT02581371|rehabilitation|rehabilitation
4806679|NCT02581371|Frenchay Arm Test|frenchay arm test
4806680|NCT02581371|NBS eXimia Nexstim|nbs eximia nexstim
4806681|NCT02581371|Barthel index|barthel index
4806682|NCT02581358|scoliosis|scoliosis
4806683|NCT02581358|spinal deformity|spinal deformity
4806684|NCT02581358|Cobb angle|cobb angle
4806685|NCT02581358|assessment|assessment
4806686|NCT02581358|ultrasound|ultrasound
4806687|NCT02581345|Moderate to severe chronic plaque psoriasis|moderate to severe chronic plaque psoriasis
4806688|NCT02581345|Psoriasis|psoriasis
4806689|NCT02581332|behavioral intervention|behavioral intervention
4806690|NCT02581254|Snare|snare
4806691|NCT02581254|Polypectomy|polypectomy
4806692|NCT02581241|QT interval prolongation|qt interval prolongation
4806693|NCT02581215|mFOLFIRINOX|mfolfirinox
4806694|NCT02581215|Ramucirumab|ramucirumab
4806695|NCT02581202|antiretroviral therapy|antiretroviral therapy
4806696|NCT02581189|Chronic Hepatitis C|chronic hepatitis c
4806697|NCT02581189|Effectiveness|effectiveness
4806698|NCT02581189|Influence of adherence|influence of adherence
4806699|NCT02581189|Genotype 1 or 4|genotype 1 or 4
4806700|NCT02581189|Patient reported outcomes|patient reported outcomes
4806701|NCT02581163|Effectiveness|effectiveness
4806702|NCT02581163|Influence of adherence|influence of adherence
4806703|NCT02581150|Outpatient hospitalization|outpatient hospitalization
4806704|NCT02581150|Randomized trial|randomized trial
4807517|NCT02576743|Aneurysm|aneurysm
4806705|NCT02581150|Peripheral arterial disease|peripheral arterial disease
4806706|NCT02581150|Endovascular treatment|endovascular treatment
4806707|NCT02581150|Health Economics|health economics
4806708|NCT02581124|JTZ-951|jtz-951
4806709|NCT02581124|Lapatinib|lapatinib
4806710|NCT02581124|Pharmacokinetics|pharmacokinetics
4806711|NCT02581085|Tocotrienol|tocotrienol
4806712|NCT02581085|Vitamin E|vitamin e
4806713|NCT02581059|Regorafenib|regorafenib
4806714|NCT02581059|American Ginseng|american ginseng
4806715|NCT02581059|Fatigue|fatigue
4806716|NCT02581020|Hepatitis C|hepatitis c
4806717|NCT02581020|Follow-up|follow-up
4806718|NCT02581020|Observation|observation
4806719|NCT02581020|Japanese|japanese
4806720|NCT02581007|CML|cml
4806721|NCT02581007|AML|aml
4806722|NCT02581007|MDS|mds
4806723|NCT02581007|ALL|all
4806724|NCT02581007|CLL/CPL|cll/cpl
4806725|NCT02581007|HD|hd
4806726|NCT02581007|NHL|nhl
4806727|NCT02581007|MPS|mps
4806728|NCT02581007|CMML|cmml
4806729|NCT02581007|MM|mm
4806730|NCT02580994|Extended Disease Small Cell Lung Cancer|extended disease small cell lung cancer
4806731|NCT02580994|phase II|phase ii
4806732|NCT02580994|randomized|randomized
4806733|NCT02580994|pembrolizumab|pembrolizumab
4806734|NCT02580994|cross-over|cross-over
4806735|NCT02580994|etoposide|etoposide
4806736|NCT02580994|cisplatin|cisplatin
4806737|NCT02580994|carboplatin|carboplatin
4806738|NCT02580994|rechallenge|rechallenge
4806739|NCT02580981|Cancer|cancer
4806740|NCT02580981|Oncology|oncology
4806741|NCT02580981|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
4806742|NCT02580981|ALL|all
4806743|NCT02580981|Genomics|genomics
4806744|NCT02580981|Genetics|genetics
4806745|NCT02580981|Sequencing|sequencing
4806746|NCT02580981|DNA|dna
4806747|NCT02580981|RNA|rna
4806748|NCT02580981|Ph-like|ph-like
4806749|NCT02580968|Electroacupuncture therapy|electroacupuncture therapy
4806750|NCT02580968|Migraine|migraine
4806751|NCT02580968|Acupuncture Therapy|acupuncture therapy
4806752|NCT02580929|Radiotherapy|radiotherapy
4806753|NCT02580929|General Surgery|general surgery
4806754|NCT02580916|non-melanoma skin cancer|non-melanoma skin cancer
4806755|NCT02580916|outcome assessment|outcome assessment
4806756|NCT02580916|quality of life|quality of life
4806757|NCT02580877|oral insulin|oral insulin
4806758|NCT02580838|Stroke|stroke
4806759|NCT02580838|Spasticity|spasticity
4806760|NCT02580838|OnabotulinumtoxinA|onabotulinumtoxina
4806761|NCT02580825|Childhood obesity|childhood obesity
4806762|NCT02580825|Ground reaction force|ground reaction force
4806763|NCT02580825|Knee pain|knee pain
4806764|NCT02580812|Perinatal listeriosis|perinatal listeriosis
4806765|NCT02580812|Neurological impairment|neurological impairment
4806766|NCT02580812|Sepsis|sepsis
4806767|NCT02580812|Prematurity|prematurity
4806768|NCT02580812|Neurotropism|neurotropism
4806769|NCT02580812|Listeria monocytogenes|listeria monocytogenes
4806770|NCT02580812|Intellectual Quotient|intellectual quotient
4806771|NCT02580773|Sickle cell disease|sickle cell disease
4806772|NCT02580773|Anemia|anemia
4806773|NCT02580773|Rare disease|rare disease
4806774|NCT02580773|Reanimation|reanimation
4806775|NCT02580773|Prophylactic anticoagulation|prophylactic anticoagulation
4806776|NCT02580760|Silicone|silicone
4806777|NCT02580760|Transgender|transgender
4806778|NCT02580760|Dermatology|dermatology
4806779|NCT02580760|Blood contamination|blood contamination
4806780|NCT02580760|Adverse event after injection|adverse event after injection
4806781|NCT02580734|burning mouth syndrome|burning mouth syndrome
4806782|NCT02580734|treatment|treatment
4806783|NCT02580734|oral chronic pain|oral chronic pain
4806784|NCT02580721|mucosal tissue thickness|mucosal tissue thickness
4806785|NCT02580721|dental implant|dental implant
4806786|NCT02580721|marginal bone loss|marginal bone loss
4806787|NCT02580721|soft tissue|soft tissue
4806788|NCT02580643|Autologous Protein Solution|autologous protein solution
4806789|NCT02580643|Osteoarthritis|osteoarthritis
4806790|NCT02580643|Intra-articular Injection|intra-articular injection
4806791|NCT02580630|Strength training, injection, glucocorticoid|strength training, injection, glucocorticoid
4806792|NCT02580565|sickle cell disease|sickle cell disease
4806793|NCT02580552|Cutaneous T-cell Lymphoma|cutaneous t-cell lymphoma
4806794|NCT02580552|CTCL|ctcl
4806795|NCT02580552|Mycosis Fungoides|mycosis fungoides
4806796|NCT02580552|Chronic lymphocytic leukemia|chronic lymphocytic leukemia
4806797|NCT02580552|CLL|cll
4806798|NCT02580552|Diffuse large B-cell lymphoma|diffuse large b-cell lymphoma
4806799|NCT02580552|DLBCL|dlbcl
4806800|NCT02580552|Adult T-cell leukemia/lymphoma|adult t-cell leukemia/lymphoma
4806801|NCT02580552|ATLL|atll
4806802|NCT02580539|Allogeneic Transplantation|allogeneic transplantation
4806803|NCT02580539|T cell|t cell
4806804|NCT02580539|Epstein-Barr Virus|epstein-barr virus
4806805|NCT02580513|Circadian Rhythm|circadian rhythm
4806806|NCT02580513|Circadian Misalignment|circadian misalignment
4806807|NCT02580513|Insulin Sensitivity|insulin sensitivity
4806808|NCT02580500|Epidural anesthesia|epidural anesthesia
4806809|NCT02580500|Spinal anesthesia|spinal anesthesia
4806810|NCT02580500|pilonidal dermoid sinus|pilonidal dermoid sinus
4806811|NCT02580487|acute appendicitis|acute appendicitis
4806812|NCT02580487|pain management|pain management
4806813|NCT02580487|analgesics|analgesics
4806814|NCT02580487|pediatric patients|pediatric patients
4806815|NCT02580487|laparoscopy|laparoscopy
4806816|NCT02580487|open surgery|open surgery
4806817|NCT02580461|family caregivers|family caregivers
4806818|NCT02580461|cancer|cancer
4806819|NCT02580461|exercise intervention|exercise intervention
4806820|NCT02580461|center based|center based
4806821|NCT02580448|Breast Cancer|breast cancer
4806822|NCT02580448|Breast|breast
4806823|NCT02580448|Advanced Breast Cancer|advanced breast cancer
4806824|NCT02580448|Metastatic Breast Cancer|metastatic breast cancer
4806825|NCT02580448|CYP17|cyp17
4806826|NCT02580448|Male Breast Cancer|male breast cancer
4806827|NCT02580448|Triple Negative Cancer|triple negative cancer
4806828|NCT02580448|ER+ Breast Cancer|er+ breast cancer
4806829|NCT02580435|multiple sclerosis|multiple sclerosis
4806830|NCT02580435|microbiome|microbiome
4806831|NCT02580435|prediction|prediction
4806832|NCT02580435|outcome|outcome
4806833|NCT02580422|Echocardiography|echocardiography
4806834|NCT02580409|health care utilization|health care utilization
4806835|NCT02580409|health care costs|health care costs
4806836|NCT02580383|Radiofrequency ablation|radiofrequency ablation
4806837|NCT02580383|RF-MB|rf-mb
4806838|NCT02580383|Lumbar RF|lumbar rf
4806839|NCT02580383|Facet joint syndrome|facet joint syndrome
4806840|NCT02580383|Multifidus twitching|multifidus twitching
4806841|NCT02580383|Sensory stimulation|sensory stimulation
4806842|NCT02580370|REALISE 1|realise 1
4806843|NCT02580357|Connective tissue graft|connective tissue graft
4806844|NCT02580357|Gingival recession|gingival recession
4806845|NCT02580357|Low level laser therapy|low level laser therapy
4806846|NCT02580305|SUVN-502|suvn-502
4806847|NCT02580305|5-HT6|5-ht6
4806848|NCT02580305|Phase 2|phase 2
4806849|NCT02580305|Cognition|cognition
4806850|NCT02580305|Donepezil|donepezil
4806851|NCT02580305|Memantine|memantine
4806852|NCT02580305|Alzheimer's Disease|alzheimer's disease
4806853|NCT02580279|Breast Neoplasms|breast neoplasms
4806854|NCT02580279|prevention & control|prevention & control
4806855|NCT02580279|Epigallocatechin gallate|epigallocatechin gallate
4806856|NCT02580279|Dermatitis|dermatitis
4806857|NCT02580266|Kidney|kidney
4806858|NCT02580266|Diabetes|diabetes
4806859|NCT02580240|septic shock|septic shock
4806860|NCT02580240|hydrocortisone|hydrocortisone
4806861|NCT02580240|mortality|mortality
4806862|NCT02580227|Tranexamic Acid|tranexamic acid
4806863|NCT02580227|Blood Transfusions|blood transfusions
4806864|NCT02580188|Neuromuscular blockade|neuromuscular blockade
4806865|NCT02580188|Sugammadex|sugammadex
4806866|NCT02580188|Laparoscopic surgery|laparoscopic surgery
4806867|NCT02580188|Intra abdominal pressure alarm|intra abdominal pressure alarm
4806868|NCT02580136|Esthesioneuroblastoma|esthesioneuroblastoma
4806869|NCT02580136|Tumor|tumor
4806870|NCT02580136|Skull Base Surgery|skull base surgery
4806871|NCT02580136|Sinonasal Cancer|sinonasal cancer
4806872|NCT02580110|no specific condition|no specific condition
4806873|NCT02580097|Arterial Spin Labeling|arterial spin labeling
4806874|NCT02580097|Ischemic stroke|ischemic stroke
4806875|NCT02580097|Collateral Circulation|collateral circulation
4806876|NCT02580097|Perfusion imaging|perfusion imaging
4806877|NCT02580084|atherosclerosis of the peripheral arteries|atherosclerosis of the peripheral arteries
4806878|NCT02580084|Aorta-femoral Bypass|aorta-femoral bypass
4806879|NCT02580084|Hybrid Intervention|hybrid intervention
4806880|NCT02580084|Iliac Arteries With Stenting and Plasty of the Common Femoral Artery|iliac arteries with stenting and plasty of the common femoral artery
4806881|NCT02580084|plastic arteries with lesions of the common femoral artery and deep femoral artery|plastic arteries with lesions of the common femoral artery and deep femoral artery
4806882|NCT02580071|Hematopoietic Stem Cell Transplant|hematopoietic stem cell transplant
4806883|NCT02580071|Chinese Herbal Medicine|chinese herbal medicine
4806884|NCT02580071|immune reconstitution|immune reconstitution
4806885|NCT02580071|clinical trial|clinical trial
4806886|NCT02580071|ALL|all
4806887|NCT02580071|AML|aml
4806888|NCT02580058|platinum resistant|platinum resistant
4806889|NCT02580058|platinum refractory|platinum refractory
4806890|NCT02580045|metastatic cancer|metastatic cancer
4806891|NCT02580045|lumbar puncture|lumbar puncture
4806892|NCT02580045|advanced cancer|advanced cancer
4806893|NCT02580045|brain metastases|brain metastases
4806894|NCT02580045|chemotherapy|chemotherapy
4806895|NCT02580045|endocrine therapy|endocrine therapy
4806896|NCT02580045|HER2 targeted therapy|her2 targeted therapy
4806897|NCT02580045|immune therapy|immune therapy
4806898|NCT02580045|anti-cancer therapy|anti-cancer therapy
4806899|NCT02580045|blood brain barrier|blood brain barrier
4806900|NCT02580045|pharmacokinetics|pharmacokinetics
4806901|NCT02580045|Duke University|duke university
4806902|NCT02580045|brain metastasis|brain metastasis
4806903|NCT02580019|Cellular therapy|cellular therapy
4806904|NCT02580019|Stroke|stroke
4806905|NCT02580019|Neuronal Plasticity|neuronal plasticity
4806906|NCT02580019|Recovery|recovery
4806907|NCT02580019|umbilical cord mesenchymal stem cells|umbilical cord mesenchymal stem cells
4806908|NCT02580019|Transplantation|transplantation
4806909|NCT02580019|Cardiovascular Diseases|cardiovascular diseases
4806910|NCT02580019|Ischemia|ischemia
4806911|NCT02580019|Brain Infarction|brain infarction
4806912|NCT02580019|Brain Ischemia|brain ischemia
4806913|NCT02580019|Cerebrovascular Disorders|cerebrovascular disorders
4806914|NCT02579993|Cornea|cornea
4806915|NCT02579993|Limbal stem cell|limbal stem cell
4806916|NCT02579967|Haploidentical|haploidentical
4806917|NCT02579967|Autoimmunity|autoimmunity
4806918|NCT02579967|Immune Dysregulation|immune dysregulation
4806919|NCT02579967|Congenital|congenital
4806920|NCT02579967|Opportunistic Infection|opportunistic infection
4806921|NCT02579941|Hyperfibrinolysis|hyperfibrinolysis
4806922|NCT02579941|Pregnant women at term|pregnant women at term
4806923|NCT02579941|Tranexamic acid|tranexamic acid
4806924|NCT02579928|Ketamine|ketamine
4806925|NCT02579928|Depression|depression
4806926|NCT02579928|Major Depressive Disorder|major depressive disorder
4806927|NCT02579928|Anxiety|anxiety
4806928|NCT02579928|School refusal|school refusal
4806929|NCT02579928|Suicide|suicide
4806930|NCT02579928|Generalized Anxiety|generalized anxiety
4806931|NCT02579928|Suicidal Ideation|suicidal ideation
4806932|NCT02579902|Irritable Bowel Syndrome|irritable bowel syndrome
4806933|NCT02579902|inflammation|inflammation
4806934|NCT02579902|oxidative stress|oxidative stress
4806935|NCT02579902|clinical signs|clinical signs
4806936|NCT02579902|vitamin D3|vitamin d3
4806937|NCT02579889|Closed Loop Stimulation|closed loop stimulation
4806938|NCT02579889|Atrial Fibrillation|atrial fibrillation
4806939|NCT02579889|Stroke|stroke
4806940|NCT02579889|Heart Failure|heart failure
4806941|NCT02579889|Pacemaker|pacemaker
4806942|NCT02579889|ICD|icd
4806943|NCT02579876|Milk Allergy|milk allergy
4806944|NCT02579876|Viaskin Milk|viaskin milk
4806945|NCT02579876|Epicutaneous ImmunoTherapy (EPIT)|epicutaneous immunotherapy (epit)
4806946|NCT02579876|Eosinophilic Esophagitis|eosinophilic esophagitis
4806947|NCT02579876|Milk-Induced Eosinophilic Esophagitis|milk-induced eosinophilic esophagitis
4806948|NCT02579863|PD1|pd1
4806949|NCT02579863|PD-1|pd-1
4806950|NCT02579863|PD-L1|pd-l1
4806951|NCT02579863|PDL1|pdl1
4806952|NCT02579850|COPD|copd
4806953|NCT02579850|COPD Exacerbation|copd exacerbation
4806954|NCT02579850|EXACT-PRO|exact-pro
4806955|NCT02579837|screening|screening
4806956|NCT02579824|Myeloma|myeloma
4806957|NCT02579824|Relapsed and/or Refractory|relapsed and/or refractory
4806958|NCT02579824|Multiple Myeloma|multiple myeloma
4806959|NCT02579824|MM|mm
4806960|NCT02579824|DS-3032b|ds-3032b
4806961|NCT02579811|Kidney|kidney
4806962|NCT02579811|Cancer|cancer
4806963|NCT02579811|Axitinib|axitinib
4806964|NCT02579811|Pd-1 inhibitor|pd-1 inhibitor
4806965|NCT02579811|Pd-L1 inhibitor|pd-l1 inhibitor
4806966|NCT02579798|Bariatric surgery|bariatric surgery
4806967|NCT02579798|Post-surgery hypoxemia|post-surgery hypoxemia
4806968|NCT02579798|Obesity|obesity
4806969|NCT02579785|Family Planning|family planning
4806970|NCT02579785|Abortion|abortion
4806971|NCT02579785|mHealth|mhealth
4806972|NCT02579785|Behaviour Change Communication|behaviour change communication
4806973|NCT02579785|Menstrual Regulation|menstrual regulation
4806974|NCT02579785|Postabortion|postabortion
4806975|NCT02579785|Bangladesh|bangladesh
4806976|NCT02579759|PXT3003|pxt3003
4806977|NCT02579746|hypertension|hypertension
4806978|NCT02579746|immigrant|immigrant
4806979|NCT02579746|dietary intervention|dietary intervention
4806980|NCT02579746|lifestyle modification|lifestyle modification
4806981|NCT02579720|Recurrent Grass Pollen Allergy|recurrent grass pollen allergy
4806982|NCT02579720|Pollinex® Quattro|pollinex® quattro
4806983|NCT02579707|Healthy Volunteers|healthy volunteers
4806984|NCT02579681|Cognition|cognition
4806985|NCT02579681|Tecfidera|tecfidera
4806986|NCT02579681|RRMS|rrms
4806987|NCT02579681|BG00012|bg00012
4806988|NCT02579642|Moderate to severe depression|moderate to severe depression
4806989|NCT02579642|Monopolar|monopolar
4806990|NCT02579642|Bipolar|bipolar
4806991|NCT02579642|Ketamine|ketamine
4806992|NCT02579642|ECT|ect
4806993|NCT02579642|Electroconvulsive therapy|electroconvulsive therapy
4806994|NCT02579642|NMDA|nmda
4806995|NCT02579629|Analgesia|analgesia
4806996|NCT02579629|Cesarean section|cesarean section
4806997|NCT02579629|Opiates|opiates
4806998|NCT02579616|Lenvatinib|lenvatinib
4806999|NCT02579616|E7080|e7080
4807000|NCT02579616|Unresectable biliary tract cancer|unresectable biliary tract cancer
4807001|NCT02579616|BTC|btc
4807002|NCT02579616|Gemcitabine-based combination chemotherapy|gemcitabine-based combination chemotherapy
4807003|NCT02579616|Lenvima|lenvima
4807004|NCT02579538|Total Knee Arthroplasty|total knee arthroplasty
4807005|NCT02579538|Thoracotomy|thoracotomy
4807006|NCT02579538|Mastectomy|mastectomy
4807007|NCT02579538|Video-Assisted Thoracoscopic Surgery (VATS)|video-assisted thoracoscopic surgery (vats)
4807008|NCT02579538|Persistent Pain|persistent pain
4807009|NCT02579538|Cognitive Flexibility|cognitive flexibility
4807010|NCT02579525|septic shock|septic shock
4807011|NCT02579525|tissue perfusion|tissue perfusion
4807012|NCT02579525|macrocirculatory|macrocirculatory
4807013|NCT02579525|mean arterial pressure|mean arterial pressure
4807014|NCT02579525|vasopressor use|vasopressor use
4807015|NCT02579525|days alive free of organ support|days alive free of organ support
4807016|NCT02579499|Coronary artery disease|coronary artery disease
4807017|NCT02579499|LDL choelsterol|ldl choelsterol
4807018|NCT02579499|Statin|statin
4807019|NCT02579473|Continuous dopaminergic stimulation|continuous dopaminergic stimulation
4807020|NCT02579460|Barrett's esophagus|barrett's esophagus
4807021|NCT02579460|Gastroesophageal Reflux Disease|gastroesophageal reflux disease
4807022|NCT02579434|CYP3A|cyp3a
4807023|NCT02579408|NAFLD|nafld
4807024|NCT02579408|LDLT|ldlt
4807025|NCT02579408|steatosis|steatosis
4807026|NCT02579408|CAP|cap
4807027|NCT02579408|transient elastography|transient elastography
4807028|NCT02579382|HBV|hbv
4807029|NCT02579382|Hepatitis|hepatitis
4807030|NCT02579382|Liver Disease|liver disease
4807031|NCT02579369|Epidermolysis Bullosa|epidermolysis bullosa
4807032|NCT02579369|stem cell|stem cell
4807033|NCT02579317|Baroreflex mechanism|baroreflex mechanism
4807034|NCT02579317|Alcohol Use Disorder|alcohol use disorder
4807035|NCT02579317|Substance Use Disorder|substance use disorder
4807036|NCT02579317|Heart Rate Variability|heart rate variability
4807037|NCT02579317|Breathing|breathing
4807038|NCT02579291|Stroke|stroke
4807039|NCT02579291|Dry needling|dry needling
4807040|NCT02579291|Spasticity|spasticity
4807041|NCT02579291|Motor function|motor function
4807042|NCT02579291|Stabilometry|stabilometry
4807043|NCT02579278|EMVI|emvi
4807044|NCT02579278|Extramural Venous Invasion|extramural venous invasion
4807045|NCT02579278|mrEMVI|mremvi
4807046|NCT02579278|Rectal Cancer|rectal cancer
4807047|NCT02579278|ctDNA|ctdna
4807048|NCT02579278|Neoplasm DNA|neoplasm dna
4807049|NCT02579278|MRI|mri
4807050|NCT02579265|Parenteral nutrition|parenteral nutrition
4807051|NCT02579265|Neonates|neonates
4807052|NCT02579265|Infants|infants
4807053|NCT02579265|Lipid emulsions|lipid emulsions
4807054|NCT02579265|Intravenous|intravenous
4807055|NCT02579252|vaccine|vaccine
4807056|NCT02579252|tau protein|tau protein
4807057|NCT02579252|active|active
4807058|NCT02579252|immunization|immunization
4807059|NCT02579252|KLH|klh
4807060|NCT02579252|immunotherapy|immunotherapy
4807061|NCT02579252|tau|tau
4807062|NCT02579239|LGMD2B|lgmd2b
4807063|NCT02579239|FSHD|fshd
4807064|NCT02579226|AZD2811|azd2811
4807065|NCT02579226|Advanced solid tumours|advanced solid tumours
4807066|NCT02579226|Small-cell lung cancer|small-cell lung cancer
4807067|NCT02579213|electronic nose|electronic nose
4807068|NCT02579213|abnormal fetal karyotype|abnormal fetal karyotype
4807069|NCT02579161|Percutaneous Nephrolithotomy|percutaneous nephrolithotomy
4807070|NCT02579161|Kidney Stones|kidney stones
4807071|NCT02579161|Antibiotics|antibiotics
4807072|NCT02579148|erectile dysfunction|erectile dysfunction
4807073|NCT02579148|stem cell|stem cell
4807074|NCT02579148|collagen scaffold|collagen scaffold
4807075|NCT02579135|Condoms|condoms
4807076|NCT02579135|Sexual Abstinence|sexual abstinence
4807077|NCT02579135|Sexual Communication|sexual communication
4807078|NCT02579122|Reviparin|reviparin
4807079|NCT02579122|Bridging|bridging
4807080|NCT02579122|Phenprocoumon|phenprocoumon
4807081|NCT02579096|Gout|gout
4807082|NCT02579096|Allopurinol|allopurinol
4807083|NCT02579096|Febuxostat|febuxostat
4807085|NCT02579070|Diabetic Foot|diabetic foot
4807086|NCT02579070|foot temperature|foot temperature
4807087|NCT02579070|diabetic foot ulcer|diabetic foot ulcer
4807088|NCT02579057|Congestive heart failure|congestive heart failure
4807089|NCT02579057|Furosemide|furosemide
4807090|NCT02579031|Percutaneous Coronary Intervention|percutaneous coronary intervention
4807091|NCT02579031|Stents|stents
4807092|NCT02579031|Drug-Eluting Stents|drug-eluting stents
4807093|NCT02579031|Coronary Artery Disease|coronary artery disease
4807094|NCT02579031|Acute Coronary Syndrome|acute coronary syndrome
4807095|NCT02579018|Anorexia Nervosa|anorexia nervosa
4807096|NCT02579018|Exercise|exercise
4807097|NCT02579018|Healthy Adults|healthy adults
4807098|NCT02579018|Physical Activity|physical activity
4807099|NCT02579005|Radiation|radiation
4807100|NCT02579005|Immune response|immune response
4807101|NCT02579005|Anti-tumor|anti-tumor
4807102|NCT02579005|Lung Cancer|lung cancer
4807103|NCT02578992|intubating stylet|intubating stylet
4807104|NCT02578992|head and neck position|head and neck position
4807105|NCT02578979|atrial fibrillation|atrial fibrillation
4807106|NCT02578979|ischemic stroke|ischemic stroke
4807107|NCT02578979|electrocardiogram|electrocardiogram
4807108|NCT02578979|holter|holter
4807109|NCT02578966|Early Childhood Caries|early childhood caries
4807110|NCT02578966|Randomized clinical trial|randomized clinical trial
4807111|NCT02578966|Motivational Interviewing|motivational interviewing
4807112|NCT02578953|Bioequivalence|bioequivalence
4807113|NCT02578953|Fasted state|fasted state
4807114|NCT02578953|Japanese male healthy subjects|japanese male healthy subjects
4807115|NCT02578953|Dutasteride|dutasteride
4807116|NCT02578914|allergic conjunctivitis|allergic conjunctivitis
4807117|NCT02578914|seasonal allergies|seasonal allergies
4807118|NCT02578914|ragweed allergy|ragweed allergy
4807119|NCT02578914|grass allergy|grass allergy
4807120|NCT02578914|tree allergy|tree allergy
4807121|NCT02578914|NS2|ns2
4807122|NCT02578914|Aldeyra|aldeyra
4807123|NCT02578901|Thrombocytopenia|thrombocytopenia
4807124|NCT02578901|Tranexamic Acid|tranexamic acid
4807125|NCT02578901|TXA|txa
4807126|NCT02578901|Chemotherapy induced thrombocytopenia|chemotherapy induced thrombocytopenia
4807127|NCT02578875|Sequence Technique|sequence technique
4807128|NCT02578875|Infectious Disease|infectious disease
4807129|NCT02578875|Pathogen Detection|pathogen detection
4807130|NCT02578875|Diagnostic|diagnostic
4807131|NCT02578836|Weight Loss|weight loss
4807132|NCT02578836|Overweight|overweight
4807133|NCT02578836|Endoscopic treatment for obesity|endoscopic treatment for obesity
4807134|NCT02578823|Targeted Temperature Management(TTM)|targeted temperature management(ttm)
4807135|NCT02578823|in-hospital cardiac arrest(IHCA)|in-hospital cardiac arrest(ihca)
4807136|NCT02578823|restoration of spontaneous circulation(ROSC)|restoration of spontaneous circulation(rosc)
4807137|NCT02578823|unconsciousness|unconsciousness
4807138|NCT02578823|brain injury|brain injury
4807139|NCT02578797|Castration-Resistant Prostate Cancer (CRPC)|castration-resistant prostate cancer (crpc)
4807140|NCT02578797|Prostatic Neoplasms|prostatic neoplasms
4807141|NCT02578797|Genital Diseases, Male|genital diseases, male
4807142|NCT02578797|Genital Neoplasms, Male|genital neoplasms, male
4807143|NCT02578797|Neoplasms|neoplasms
4807144|NCT02578797|Neoplasms by Site|neoplasms by site
4807145|NCT02578797|Prostatic Diseases|prostatic diseases
4807146|NCT02578797|Urogenital Neoplasms|urogenital neoplasms
4807147|NCT02578784|Dialysis|dialysis
4807148|NCT02578758|Transdiagnostic Internet-based Protocol|transdiagnostic internet-based protocol
4807149|NCT02578758|Positive affect regulation|positive affect regulation
4807150|NCT02578706|HIV|hiv
4807151|NCT02578706|Aspirin|aspirin
4807152|NCT02578706|Clopidogrel|clopidogrel
4807153|NCT02578706|Platelet|platelet
4807154|NCT02578706|Inflammation|inflammation
4807155|NCT02578706|Cardiovascular disease|cardiovascular disease
4807156|NCT02578706|Arachidonic acid|arachidonic acid
4807157|NCT02578706|Cyclooxygenase inhibitor|cyclooxygenase inhibitor
4807158|NCT02578706|ADP inhibitor|adp inhibitor
4807159|NCT02578706|Immune activation|immune activation
4807160|NCT02578706|Monocyte|monocyte
4807161|NCT02578706|Coagulation|coagulation
4807162|NCT02578706|Thrombogenicity|thrombogenicity
4807163|NCT02578680|PD1|pd1
4807164|NCT02578680|PD-1|pd-1
4807165|NCT02578680|PDL1|pdl1
4807166|NCT02578680|PD-L1|pd-l1
4807167|NCT02578680|Non-Small-Cell Lung Cancer|non-small-cell lung cancer
4807168|NCT02578641|Nasopharyngeal Carcinoma (NPC)|nasopharyngeal carcinoma (npc)
4807169|NCT02578641|NPC|npc
4807170|NCT02578641|immunotherapy|immunotherapy
4807171|NCT02578641|Nasopharyngeal Cancer|nasopharyngeal cancer
4807172|NCT02578641|Nose Cancer|nose cancer
4807173|NCT02578641|Cell therapy|cell therapy
4807174|NCT02578641|Head and Neck Cancer|head and neck cancer
4807175|NCT02578641|Cytotoxic T Lymphocytes|cytotoxic t lymphocytes
4807176|NCT02578641|chemotherapy|chemotherapy
4807177|NCT02578641|Epstein-Barr Virus|epstein-barr virus
4807178|NCT02578576|Diagnostic Techniques|diagnostic techniques
4807179|NCT02578576|Digestive System|digestive system
4807180|NCT02578550|Immunodeficiency Virus Type 1, Human|immunodeficiency virus type 1, human
4807181|NCT02578550|Darunavir|darunavir
4807182|NCT02578550|Cobicistat|cobicistat
4807183|NCT02578550|Emtricitabine|emtricitabine
4807184|NCT02578550|Tenofovir alafenamide|tenofovir alafenamide
4807185|NCT02578550|Healthy participants|healthy participants
4807186|NCT02578537|Ticagrelor|ticagrelor
4807187|NCT02578537|Pharmacokinetics|pharmacokinetics
4807188|NCT02578537|NSTE-ACS|nste-acs
4807189|NCT02578537|CKD|ckd
4807190|NCT02578524|cataract satisfaction|cataract satisfaction
4807191|NCT02578511|Acute Lymphoblastic Leukemia in Complete Remission|acute lymphoblastic leukemia in complete remission
4807192|NCT02578511|Lymphoblastic Lymphoma in Complete Remission|lymphoblastic lymphoma in complete remission
4807193|NCT02578511|Mixed Phenotype Acute Leukemia in Complete Remission|mixed phenotype acute leukemia in complete remission
4807194|NCT02578511|IXAZOMIB|ixazomib
4807195|NCT02578511|POMP/D|pomp/d
4807196|NCT02578511|Phase I|phase i
4807197|NCT02578511|Early Phase|early phase
4807198|NCT02578511|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
4807199|NCT02578511|Lymphoblastic Lymphoma|lymphoblastic lymphoma
4807200|NCT02578511|Mixed Phenotype Acute Leukemia|mixed phenotype acute leukemia
4807201|NCT02578511|ALL|all
4807202|NCT02578498|glucagon|glucagon
4807203|NCT02578498|Carbohydrate diet|carbohydrate diet
4807204|NCT02578472|Healthy|healthy
4807205|NCT02578472|JNJ-42847922|jnj-42847922
4807206|NCT02578472|zolpidem|zolpidem
4807207|NCT02578472|Placebo|placebo
4807208|NCT02578459|Cancer pain|cancer pain
4807209|NCT02578459|Intrathecal therapy|intrathecal therapy
4807210|NCT02578459|Pain|pain
4807211|NCT02578459|Pancreatic cancer|pancreatic cancer
4807212|NCT02578433|Mindful Self Compassion short form|mindful self compassion short form
4807213|NCT02578433|Progressive Muscle Relaxation|progressive muscle relaxation
4807214|NCT02578394|Gout|gout
4807215|NCT02578394|Kidney|kidney
4807216|NCT02578394|Depo-Medrone|depo-medrone
4807217|NCT02578394|Anakinra|anakinra
4807218|NCT02578381|pressure wire|pressure wire
4807219|NCT02578381|coronary angiogram|coronary angiogram
4807220|NCT02578381|validation|validation
4807221|NCT02578368|gastric cancer|gastric cancer
4807222|NCT02578368|perioperative|perioperative
4807223|NCT02578368|FLOT|flot
4807224|NCT02578368|limited metastatic|limited metastatic
4807225|NCT02578368|GEJ cancer|gej cancer
4807226|NCT02578355|Atherosclerosis|atherosclerosis
4807227|NCT02578355|Coronary Artery Disease|coronary artery disease
4807228|NCT02578355|Cardiovascular Disease|cardiovascular disease
4807229|NCT02578355|Coronary Computed Tomographic Angiography|coronary computed tomographic angiography
4807230|NCT02578355|CCTA|ccta
4807231|NCT02578355|Myocardial Infarction|myocardial infarction
4807232|NCT02578355|MI|mi
4807233|NCT02578355|OPeRA|opera
4807234|NCT02578329|Mediterranean diet|mediterranean diet
4807235|NCT02578329|blood fatty acid|blood fatty acid
4807236|NCT02578329|Coronary Artery Disease|coronary artery disease
4807237|NCT02578316|Advanced Solid Tumors|advanced solid tumors
4807238|NCT02578316|Lymphomas|lymphomas
4807239|NCT02578303|sleep apnea|sleep apnea
4807240|NCT02578303|phase-contrast MRI|phase-contrast mri
4807241|NCT02578303|cerebral blood flow|cerebral blood flow
4807242|NCT02578303|vascular risk factor|vascular risk factor
4807243|NCT02578303|dementia|dementia
4807244|NCT02578290|decision support systems|decision support systems
4807245|NCT02578290|clinical|clinical
4807246|NCT02578238|Korea|korea
4807247|NCT02578238|Humira|humira
4807248|NCT02578238|Pediatric Crohn's Disease|pediatric crohn's disease
4807249|NCT02578225|Heart|heart
4807250|NCT02578225|Chronic|chronic
4807251|NCT02578225|Failure|failure
4807252|NCT02578225|MI|mi
4807253|NCT02578225|real life|real life
4807254|NCT02578225|Turkey|turkey
4807255|NCT02578160|pain|pain
4807256|NCT02578160|infant behaviour|infant behaviour
4807257|NCT02578160|heart rate|heart rate
4807258|NCT02578160|dental anxiety|dental anxiety
4807259|NCT02578147|risky sexual behavior|risky sexual behavior
4807260|NCT02578147|early intervention|early intervention
4807261|NCT02578121|Relapsed|relapsed
4807262|NCT02578121|Response Rate|response rate
4807263|NCT02578121|Progression free|progression free
4807264|NCT02578082|Renal Impairment|renal impairment
4807265|NCT02578082|Renal Insufficiency|renal insufficiency
4807266|NCT02578069|Ischemic Stroke|ischemic stroke
4807267|NCT02578069|Intracranial Stenting|intracranial stenting
4807268|NCT02578056|pelvic organ prolapse|pelvic organ prolapse
4807269|NCT02578056|urinary incontinence|urinary incontinence
4807270|NCT02578017|Sickle Cell Disease|sickle cell disease
4807271|NCT02578017|Hydroxyurea|hydroxyurea
4807272|NCT02578017|Adherence|adherence
4807273|NCT02578004|Difficult|difficult
4807274|NCT02578004|environmental, microbial, immunological and genetic factors|environmental, microbial, immunological and genetic factors
4807275|NCT02578004|significantly different|significantly different
4807276|NCT02577965|ST segment Elevation Myocardial Infarction|st segment elevation myocardial infarction
4807277|NCT02577965|Optical Coherence Tomography|optical coherence tomography
4807278|NCT02577965|Percutaneous Coronary Intervention|percutaneous coronary intervention
4807279|NCT02577965|Thrombus histopathology|thrombus histopathology
4807280|NCT02577965|Gender differences|gender differences
4807281|NCT02577952|lipodystrophy|lipodystrophy
4807282|NCT02577952|lipodystrophy, congenital generalized|lipodystrophy, congenital generalized
4807283|NCT02577952|Berardinelli-Seip Congenital Lipodystrophy|berardinelli-seip congenital lipodystrophy
4807284|NCT02577952|Congenital generalized lipodystrophy|congenital generalized lipodystrophy
4807285|NCT02577952|generalized lipodystrophy|generalized lipodystrophy
4807286|NCT02577952|lipodystrophy, familial partial|lipodystrophy, familial partial
4807287|NCT02577952|partial lipodystrophy|partial lipodystrophy
4807288|NCT02577952|lipodystrophy, partial, acquired|lipodystrophy, partial, acquired
4807289|NCT02577952|acquired lipodystrophy|acquired lipodystrophy
4807290|NCT02577913|contraception|contraception
4807291|NCT02577913|contraceptive patch|contraceptive patch
4807292|NCT02577913|Levonorgestrel|levonorgestrel
4807293|NCT02577913|gestodene|gestodene
4807294|NCT02577913|safety|safety
4807295|NCT02577900|foot ulcer and honey and silver|foot ulcer and honey and silver
4807296|NCT02577861|limbal stem cells deficinecy, LSCD, ocular burn|limbal stem cells deficinecy, lscd, ocular burn
4807297|NCT02577848|Glucagon-like peptide-1|glucagon-like peptide-1
4807298|NCT02577848|Non-ST-segment elevation myocardial infarction|non-st-segment elevation myocardial infarction
4807299|NCT02577848|Left ventricular ejection fraction|left ventricular ejection fraction
4807300|NCT02577835|Hypertension|hypertension
4807301|NCT02577835|Arterial Stiffness|arterial stiffness
4807302|NCT02577835|Ambulatory blood pressure|ambulatory blood pressure
4807303|NCT02577796|radial artery spasm|radial artery spasm
4807304|NCT02577796|radial artery occlusion|radial artery occlusion
4807305|NCT02577796|radial access|radial access
4807306|NCT02577783|Doxorubicin Hydrochloride|doxorubicin hydrochloride
4807307|NCT02577770|Acupuncture|acupuncture
4807308|NCT02577770|caffeine|caffeine
4807309|NCT02577770|pain|pain
4807310|NCT02577757|Languages network|languages network
4807311|NCT02577757|Functional MRI|functional mri
4807312|NCT02577744|Electrical Impedance Tomography|electrical impedance tomography
4807313|NCT02577731|Trauma|trauma
4807314|NCT02577705|food insecurity|food insecurity
4807315|NCT02577705|adverse childhood experiences|adverse childhood experiences
4807316|NCT02577705|violence exposure|violence exposure
4807317|NCT02577705|trauma|trauma
4807318|NCT02577705|poverty|poverty
4807319|NCT02577705|TANF|tanf
4807320|NCT02577705|assets|assets
4807321|NCT02577705|depression|depression
4807322|NCT02577705|randomized control trial|randomized control trial
4807323|NCT02577679|Dentistry|dentistry
4807324|NCT02577653|balance, postural|balance, postural
4807325|NCT02577653|postural equilibrium|postural equilibrium
4807326|NCT02577614|Cardiopulmonary Bypass|cardiopulmonary bypass
4807327|NCT02577614|Aortic Valve Repair|aortic valve repair
4807328|NCT02577614|Coronary Re-Implantation|coronary re-implantation
4807329|NCT02577614|Deep Hypothermic Circulatory Arrest|deep hypothermic circulatory arrest
4807330|NCT02577614|Factor VIII Inhibitor Bypass Activity|factor viii inhibitor bypass activity
4807331|NCT02577614|Transfusion|transfusion
4807332|NCT02577601|Emergency contraception|emergency contraception
4807333|NCT02577601|Birth Control Pills|birth control pills
4807334|NCT02577588|p53 Antigen|p53 antigen
4807335|NCT02577588|T cell therapy|t cell therapy
4807336|NCT02577588|autologous|autologous
4807337|NCT02577588|Adoptive Cellular Immunotherapy|adoptive cellular immunotherapy
4807338|NCT02577575|Oxytocin|oxytocin
4807339|NCT02577575|Syntocinon|syntocinon
4807340|NCT02577575|Social Cognition|social cognition
4807341|NCT02577575|Schizophrenia|schizophrenia
4807342|NCT02577549|Knee Pain|knee pain
4807343|NCT02577549|Exercise|exercise
4807344|NCT02577549|Diet|diet
4807345|NCT02577549|Weight Loss|weight loss
4807346|NCT02577536|Pregnancy outcome|pregnancy outcome
4807347|NCT02577536|Neonatal outcome|neonatal outcome
4807348|NCT02577536|Birth weight|birth weight
4807349|NCT02577536|Weight gain|weight gain
4807350|NCT02577536|Physical disability|physical disability
4807351|NCT02577510|Lateral Femoral Cutaneous Nerve Block|lateral femoral cutaneous nerve block
4807352|NCT02577510|Meralgia Parasthetica|meralgia parasthetica
4807353|NCT02577510|nerve stimulator|nerve stimulator
4807354|NCT02577510|ultrasound|ultrasound
4807355|NCT02577484|Fractional Flow Reserve|fractional flow reserve
4807356|NCT02577484|Rapid Exchange|rapid exchange
4807357|NCT02577484|Catheter|catheter
4807358|NCT02577471|Constipation|constipation
4807359|NCT02577471|pregnancy|pregnancy
4807360|NCT02577471|delivery|delivery
4807361|NCT02577432|spinal anesthesia|spinal anesthesia
4807362|NCT02577419|breast milk|breast milk
4807363|NCT02577419|chylothorax|chylothorax
4807364|NCT02577419|infants|infants
4807365|NCT02577419|cardiac surgery|cardiac surgery
4807366|NCT02577419|modified fat breast milk|modified fat breast milk
4807367|NCT02577406|AG-221|ag-221
4807368|NCT02577406|CC-90007|cc-90007
4807369|NCT02577406|Efficacy|efficacy
4807370|NCT02577406|Safety|safety
4807371|NCT02577406|Leukemia|leukemia
4807372|NCT02577406|Acute myeloid meukemia|acute myeloid meukemia
4807373|NCT02577406|Isocitrate dehydrogenase 2 mutation|isocitrate dehydrogenase 2 mutation
4807374|NCT02577406|Enasidenib|enasidenib
4807375|NCT02577393|Lung Neoplasms|lung neoplasms
4807376|NCT02577393|esophagitis|esophagitis
4807377|NCT02577393|Prevention & Control|prevention & control
4807378|NCT02577393|Epigallocatechin Gallate|epigallocatechin gallate
4807379|NCT02577367|Hypothyroidism|hypothyroidism
4807380|NCT02577367|Tube Feeding|tube feeding
4807381|NCT02577341|Nimotuzumab, Chemoradiotherapy,Squamous Cell Lung Cancer|nimotuzumab, chemoradiotherapy,squamous cell lung cancer
4807382|NCT02577302|Chronic Tibial nerve stimulation|chronic tibial nerve stimulation
4807383|NCT02577302|Wireless PNS|wireless pns
4807384|NCT02577302|neuromodulation|neuromodulation
4807385|NCT02577289|simultaneous implantation|simultaneous implantation
4807386|NCT02577289|Dental implant|dental implant
4807387|NCT02577289|Open sinus Lifting|open sinus lifting
4807388|NCT02577289|PRF|prf
4807389|NCT02577289|platelet rich fibrin (PRF)|platelet rich fibrin (prf)
4807390|NCT02577276|stroke|stroke
4807391|NCT02577276|remote monitoring|remote monitoring
4807392|NCT02577276|hemiparesis|hemiparesis
4807393|NCT02577250|ketamine|ketamine
4807394|NCT02577250|stress disorders, post-traumatic|stress disorders, post-traumatic
4807395|NCT02577250|stress disorders, traumatic|stress disorders, traumatic
4807396|NCT02577250|anxiety disorders|anxiety disorders
4807397|NCT02577250|mental disorders|mental disorders
4807398|NCT02577250|adjuvants, anesthesia|adjuvants, anesthesia
4807399|NCT02577250|analgesics|analgesics
4807400|NCT02577250|anesthetics|anesthetics
4807401|NCT02577250|anesthetics, dissociative|anesthetics, dissociative
4807402|NCT02577250|anesthetics, general|anesthetics, general
4807403|NCT02577250|anesthetics, intravenous|anesthetics, intravenous
4807404|NCT02577250|excitatory amino acid agents|excitatory amino acid agents
4807405|NCT02577250|excitatory amino acid antagonists|excitatory amino acid antagonists
4807406|NCT02577250|hypnotics and sedatives|hypnotics and sedatives
4807407|NCT02577250|molecular mechanisms of pharmacological action|molecular mechanisms of pharmacological action
4807408|NCT02577250|neurotransmitter agents|neurotransmitter agents
4807409|NCT02577250|peripheral nervous system agents|peripheral nervous system agents
4807410|NCT02577250|pharmacologic actions|pharmacologic actions
4807411|NCT02577250|physiological effects of drugs|physiological effects of drugs
4807412|NCT02577250|psychotropic drugs|psychotropic drugs
4807413|NCT02577250|sensory system agents|sensory system agents
4807414|NCT02577250|central nervous system agents|central nervous system agents
4807415|NCT02577250|central nervous system depressants|central nervous system depressants
4807416|NCT02577250|depression|depression
4807417|NCT02577250|depressive disorder|depressive disorder
4807418|NCT02577250|depressive disorder, treatment-resistant|depressive disorder, treatment-resistant
4807419|NCT02577250|behavioral symptoms|behavioral symptoms
4807420|NCT02577250|mood disorders|mood disorders
4807421|NCT02577250|therapeutic uses|therapeutic uses
4807422|NCT02577237|caregiver|caregiver
4807423|NCT02577237|simulation|simulation
4807424|NCT02577224|Patient-led care|patient-led care
4807425|NCT02577224|Botulinum toxin|botulinum toxin
4807426|NCT02577224|Dystonia|dystonia
4807427|NCT02577224|Randomised controlled trial|randomised controlled trial
4807428|NCT02577224|Acceptability|acceptability
4807429|NCT02577211|Critically ill|critically ill
4807430|NCT02577211|Enteral nutrition|enteral nutrition
4807431|NCT02577172|Testicular cancer|testicular cancer
4807432|NCT02577172|Physical Exercise|physical exercise
4807433|NCT02577172|Chemotherapy|chemotherapy
4807434|NCT02577159|sodium-glucose cotransporter 2 inhibitor|sodium-glucose cotransporter 2 inhibitor
4807435|NCT02577159|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
4807436|NCT02577159|dyslipidemia|dyslipidemia
4807437|NCT02577159|remnants|remnants
4807438|NCT02577159|apolipoprotein B-48|apolipoprotein b-48
4807439|NCT02577146|stone|stone
4807440|NCT02577146|ureter|ureter
4807441|NCT02577146|ultrasound|ultrasound
4807442|NCT02577133|colic|colic
4807443|NCT02577133|probiotic|probiotic
4807444|NCT02577133|Lactobacillus reuteri|lactobacillus reuteri
4807445|NCT02577133|prevention|prevention
4807446|NCT02577120|Epiceram|epiceram
4807447|NCT02577120|Ceramiseal|ceramiseal
4807448|NCT02577107|Age-related macular degeneration,|age-related macular degeneration,
4807449|NCT02577107|ranibizumab,|ranibizumab,
4807450|NCT02577107|conbercept,|conbercept,
4807451|NCT02577107|plasma VEGF|plasma vegf
4807452|NCT02577107|PK|pk
4807453|NCT02577094|CD22 positive- lymphoblastic leukemia-RIT-Yttrium|cd22 positive- lymphoblastic leukemia-rit-yttrium
4807454|NCT02577055|Multiple leiomyoma|multiple leiomyoma
4807455|NCT02577055|Uterine Artery Embolization|uterine artery embolization
4807456|NCT02577055|Surgery|surgery
4807457|NCT02577055|childbearing age|childbearing age
4807458|NCT02577055|Fertility|fertility
4807459|NCT02577055|Noninferiority trial|noninferiority trial
4807460|NCT02577042|Raltegravir|raltegravir
4807461|NCT02577042|protease inhibitors|protease inhibitors
4807462|NCT02577042|darunavir|darunavir
4807463|NCT02577042|inflammation|inflammation
4807464|NCT02577042|statins|statins
4807465|NCT02577042|comorbidities|comorbidities
4807466|NCT02576990|PD1|pd1
4807467|NCT02576990|PD-1|pd-1
4807468|NCT02576990|PDL1|pdl1
4807469|NCT02576990|PD-L1|pd-l1
4807470|NCT02576977|PDL1|pdl1
4807471|NCT02576977|PD1|pd1
4807472|NCT02576977|Multiple Myeloma|multiple myeloma
4807473|NCT02576938|Atopic Eczema|atopic eczema
4807474|NCT02576912|Cannabis|cannabis
4807475|NCT02576912|Marijuana|marijuana
4807476|NCT02576912|THC|thc
4807477|NCT02576912|Pregnenolone|pregnenolone
4807478|NCT02576912|Psychotic Disorders|psychotic disorders
4807479|NCT02576912|PREG|preg
4807480|NCT02576899|smoking cessation|smoking cessation
4807481|NCT02576899|posttraumatic stress disorder|posttraumatic stress disorder
4807482|NCT02576899|tobacco|tobacco
4807483|NCT02576899|treatment|treatment
4807484|NCT02576899|smoking|smoking
4807485|NCT02576899|mindfulness|mindfulness
4807486|NCT02576899|acceptance|acceptance
4807487|NCT02576899|functioning|functioning
4807488|NCT02576886|supine|supine
4807489|NCT02576886|prone|prone
4807490|NCT02576886|myocardial perfusion imaging|myocardial perfusion imaging
4807491|NCT02576886|radiation exposure|radiation exposure
4807492|NCT02576886|pre-screening tool|pre-screening tool
4807493|NCT02576873|Survival|survival
4807494|NCT02576873|Hemodiafiltration|hemodiafiltration
4807495|NCT02576873|End-stage renal disease|end-stage renal disease
4807496|NCT02576873|Hemodialysis|hemodialysis
4807497|NCT02576821|Amnesia, Alzheimer, hippocampal sclerosis, fronto-temporal lobar degeneration|amnesia, alzheimer, hippocampal sclerosis, fronto-temporal lobar degeneration
4807498|NCT02576795|Haemophilia A|haemophilia a
4807499|NCT02576795|Gene Therapy|gene therapy
4807500|NCT02576795|Clotting Disorders|clotting disorders
4807501|NCT02576795|Blood Disorder|blood disorder
4807502|NCT02576782|regional anesthesia|regional anesthesia
4807503|NCT02576782|dexamethasone|dexamethasone
4807504|NCT02576782|bupivacaine|bupivacaine
4807505|NCT02576782|femoral|femoral
4807506|NCT02576782|sciatic|sciatic
4807507|NCT02576769|Basal cell carcinoma|basal cell carcinoma
4807508|NCT02576769|Pigmentation|pigmentation
4807509|NCT02576769|Melanocyte|melanocyte
4807510|NCT02576769|Melanin|melanin
4807511|NCT02576769|Skin cancer|skin cancer
4807512|NCT02576756|Risk on aspiration|risk on aspiration
4807513|NCT02576756|Postoperative|postoperative
4807514|NCT02576756|Difficult Intubation|difficult intubation
4807515|NCT02576743|Stroke|stroke
4807518|NCT02576717|MS|ms
4807519|NCT02576717|RMS|rms
4807520|NCT02576717|Multiple Sclerosis|multiple sclerosis
4807521|NCT02576717|Relapsing Multiple Sclerosis|relapsing multiple sclerosis
4807522|NCT02576691|cardiac arrest|cardiac arrest
4807523|NCT02576691|percutaneous coronary intervention|percutaneous coronary intervention
4807524|NCT02576691|cardiogenic shock|cardiogenic shock
4807525|NCT02576691|outcome|outcome
4807526|NCT02576678|Psoriasis|psoriasis
4807527|NCT02576678|Moderate to Severe Plaque Psoriasis|moderate to severe plaque psoriasis
4807528|NCT02576678|Plaque Psoriasis|plaque psoriasis
4807529|NCT02576678|CC-10004|cc-10004
4807530|NCT02576678|Apremilast|apremilast
4807531|NCT02576678|Pharmacokinetics|pharmacokinetics
4807532|NCT02576678|Open-label|open-label
4807533|NCT02576678|Safety|safety
4807534|NCT02576678|Pediatric|pediatric
4807535|NCT02576665|Anaplastic Astrocytoma, Glioblastoma|anaplastic astrocytoma, glioblastoma
4807536|NCT02576652|bone biopsy|bone biopsy
4807537|NCT02576652|tetracycline|tetracycline
4807538|NCT02576652|demeclocycline|demeclocycline
4807539|NCT02576652|total hip replacement|total hip replacement
4807540|NCT02576639|Alzheimer's Disease,|alzheimer's disease,
4807541|NCT02576639|Amyloid Beta,|amyloid beta,
4807542|NCT02576639|cerebrospinal fluid,|cerebrospinal fluid,
4807543|NCT02576639|beta secretase|beta secretase
4807544|NCT02576626|Nebulizer|nebulizer
4807545|NCT02576626|DPI|dpi
4807546|NCT02576626|COPD|copd
4807547|NCT02576626|indacaterol|indacaterol
4807548|NCT02576626|ipratropium|ipratropium
4807549|NCT02576626|glycopyrronium|glycopyrronium
4807550|NCT02576626|salbutamol|salbutamol
4807551|NCT02576626|Breezhaler|breezhaler
4807552|NCT02576626|Nebuliser|nebuliser
4807553|NCT02576626|Hyperinflation|hyperinflation
4807554|NCT02576626|Dyspnea|dyspnea
4807555|NCT02576626|SABA|saba
4807556|NCT02576626|short-acting muscarinic antagonists (SAMA)|short-acting muscarinic antagonists (sama)
4807557|NCT02576626|long-acting beta2-agonist (LABA)|long-acting beta2-agonist (laba)
4807558|NCT02576626|LAMA|lama
4807559|NCT02576626|FEV1|fev1
4807560|NCT02576574|Avelumab|avelumab
4807561|NCT02576574|MSB0010718C|msb0010718c
4807562|NCT02576574|Non-Small Cell Lung Cancer|non-small cell lung cancer
4807563|NCT02576561|human papillomavirus|human papillomavirus
4807564|NCT02576561|Cervical Intraepithelial Neoplasia|cervical intraepithelial neoplasia
4807565|NCT02576561|Cold Knife Conization|cold knife conization
4807566|NCT02576561|hysterectomy|hysterectomy
4807567|NCT02576561|Loop Electrosurgical Excision Procedure|loop electrosurgical excision procedure
4807568|NCT02576561|LEEP|leep
4807569|NCT02576561|HSIL|hsil
4807570|NCT02576561|High-Grade Squamous Intraepithelial Lesion|high-grade squamous intraepithelial lesion
4807571|NCT02576496|phase 1 clinical trial|phase 1 clinical trial
4807572|NCT02576496|multiple myeloma|multiple myeloma
4807573|NCT02576496|Hodgkin's lymphoma|hodgkin's lymphoma
4807574|NCT02576496|peripheral T-cell lymphoma|peripheral t-cell lymphoma
4807575|NCT02576496|non-Hodgkin's lymphoma|non-hodgkin's lymphoma
4807576|NCT02576470|swallowing|swallowing
4807577|NCT02576470|stroke|stroke
4807578|NCT02576470|dysphagia|dysphagia
4807579|NCT02576470|deglutition|deglutition
4807580|NCT02576431|NTRK Fusion Positive|ntrk fusion positive
4807581|NCT02576431|LOXO-101|loxo-101
4807582|NCT02576431|Loxo|loxo
4807583|NCT02576431|TRK|trk
4807584|NCT02576431|TRK Fusion|trk fusion
4807585|NCT02576431|NTRK1|ntrk1
4807586|NCT02576431|NTRK2|ntrk2
4807587|NCT02576431|NTRK3|ntrk3
4807588|NCT02576431|TRKA|trka
4807589|NCT02576431|TRKB|trkb
4807590|NCT02576431|TRKC|trkc
4807591|NCT02576431|ETV6|etv6
4807592|NCT02576431|NTRK|ntrk
4807593|NCT02576431|larotrectinib|larotrectinib
4807594|NCT02576431|fusion|fusion
4807595|NCT02576431|tumors|tumors
4807596|NCT02576431|CNS tumors|cns tumors
4807597|NCT02576431|solid tumors|solid tumors
4807598|NCT02576431|central nervous system tumors|central nervous system tumors
4807599|NCT02576431|solid CNS tumors|solid cns tumors
4807600|NCT02576431|primary CNS tumor|primary cns tumor
4807601|NCT02576431|Advanced CNS tumor|advanced cns tumor
4807602|NCT02576431|Metastatic CNS tumor|metastatic cns tumor
4807603|NCT02576431|NTRK1 fusion|ntrk1 fusion
4807604|NCT02576431|NTRK2 fusion|ntrk2 fusion
4807605|NCT02576431|NTRK3 fusion|ntrk3 fusion
4807606|NCT02576431|ETV6-NTRK3|etv6-ntrk3
4807607|NCT02576431|ETV6 fusion|etv6 fusion
4807608|NCT02576418|Partosure TTD test|partosure ttd test
4807609|NCT02576418|CL|cl
4807610|NCT02576418|ART|art
4807611|NCT02576418|SN|sn
4807612|NCT02576418|SP|sp
4807613|NCT02576418|PPV|ppv
4807614|NCT02576418|NPV|npv
4807615|NCT02576379|Helicopter Emergency Medical System|helicopter emergency medical system
4807616|NCT02576379|Mortality|mortality
4807617|NCT02576379|Labour market affiliation|labour market affiliation
4807618|NCT02576379|Modified Rankin Scale|modified rankin scale
4807619|NCT02576327|Lymphoma|lymphoma
4807620|NCT02576327|Aprepitant|aprepitant
4807621|NCT02576327|Chemotherapy-induced nausea and vomiting (CINV)|chemotherapy-induced nausea and vomiting (cinv)
4807622|NCT02576327|Autologous Hematopoietic Stem Cell Transplantation|autologous hematopoietic stem cell transplantation
4807623|NCT02576327|Hematological Malignancies|hematological malignancies
4807624|NCT02576301|AML|aml
4807625|NCT02576301|MDS|mds
4807626|NCT02576288|Sitagliptin|sitagliptin
4807627|NCT02576288|Brachial artery flow mediated dilation|brachial artery flow mediated dilation
4807628|NCT02576288|Carotid stiffness|carotid stiffness
4807629|NCT02576288|Pro-inflammatory|pro-inflammatory
4807630|NCT02576288|Pro-atherogenic|pro-atherogenic
4807631|NCT02576288|M1 macrophages|m1 macrophages
4807632|NCT02576275|Phase 3|phase 3
4807633|NCT02576275|iNHL|inhl
4807634|NCT02576275|Follicular Lymphoma|follicular lymphoma
4807635|NCT02576275|FL|fl
4807636|NCT02576275|PI3K|pi3k
4807637|NCT02576275|Small Lymphocytic Lymphoma|small lymphocytic lymphoma
4807638|NCT02576275|SLL|sll
4807639|NCT02576275|Marginal Zone Lymphoma|marginal zone lymphoma
4807640|NCT02576275|MZL|mzl
4807641|NCT02576249|osteoarthritis|osteoarthritis
4807642|NCT02576249|injection|injection
4807643|NCT02576249|steroid|steroid
4807644|NCT02576249|anesthetic|anesthetic
4807645|NCT02576236|Naïve patient|naïve patient
4807646|NCT02576236|Suspicion of H pylori infection|suspicion of h pylori infection
4807647|NCT02576236|Endoscopy|endoscopy
4807648|NCT02576236|Antibiotics therapeutic strategies|antibiotics therapeutic strategies
4807649|NCT02576236|Urea breath test|urea breath test
4807650|NCT02576223|Peripheral Nerve Blocks|peripheral nerve blocks
4807651|NCT02576197|mild to moderate|mild to moderate
4807652|NCT02576197|probiotic|probiotic
4807653|NCT02576184|Incisional hernia|incisional hernia
4807654|NCT02576184|Stoma|stoma
4807655|NCT02576184|rectal cancer|rectal cancer
4807656|NCT02576184|synthetic mesh|synthetic mesh
4807657|NCT02576184|biologic mesh|biologic mesh
4807658|NCT02576171|cognitive behavioral therapy;|cognitive behavioral therapy;
4807659|NCT02576171|guided self-help|guided self-help
4807660|NCT02576171|adolescent|adolescent
4807661|NCT02576067|Atherosclerotic cardiovascular disease|atherosclerotic cardiovascular disease
4807662|NCT02576067|Inflammation reduction|inflammation reduction
4807663|NCT02576041|driving simulator|driving simulator
4807664|NCT02576028|Total Hip Replacement|total hip replacement
4807665|NCT02576028|Manipulation Therapy|manipulation therapy
4807666|NCT02576002|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
4807667|NCT02575989|Trauma|trauma
4807668|NCT02575989|Prehospital|prehospital
4807669|NCT02575989|Hypothermia|hypothermia
4807670|NCT02575976|Rehabilitation|rehabilitation
4807671|NCT02575976|Coronary artery disease|coronary artery disease
4807672|NCT02575976|Patient Education|patient education
4807673|NCT02575976|Randomized Controlled Trial|randomized controlled trial
4807674|NCT02575976|Protocol|protocol
4807675|NCT02575937|low glycemic diet|low glycemic diet
4807676|NCT02575937|diabetes|diabetes
4807677|NCT02575924|media|media
4807678|NCT02575924|blastocyst|blastocyst
4807679|NCT02575924|male infertility|male infertility
4807680|NCT02575924|poor responders|poor responders
4807681|NCT02575924|pgs|pgs
4807682|NCT02575859|HIPEC|hipec
4807683|NCT02575859|peritoneal lavage|peritoneal lavage
4807684|NCT02575833|Angina|angina
4807685|NCT02575833|Stable Angina|stable angina
4807686|NCT02575833|Cardiovascular Disease|cardiovascular disease
4807687|NCT02575833|Exercise-induced Angina|exercise-induced angina
4807688|NCT02575807|Ovarian cancer|ovarian cancer
4807689|NCT02575807|Fallopian cancer|fallopian cancer
4807690|NCT02575807|Primary peritoneal cancer|primary peritoneal cancer
4807691|NCT02575755|Azithromycin|azithromycin
4807692|NCT02575755|Piperaquine|piperaquine
4807693|NCT02575755|IPTp|iptp
4807694|NCT02575755|Pharmacokinetics|pharmacokinetics
4807695|NCT02575755|Efficacy|efficacy
4807696|NCT02575729|carpal tunnel syndrome|carpal tunnel syndrome
4807697|NCT02575729|local steroid injection|local steroid injection
4807698|NCT02575729|sonography|sonography
4807699|NCT02575729|sonography-guided|sonography-guided
4807700|NCT02575716|McGrath®|mcgrath®
4807701|NCT02575716|Videolaryngoscope|videolaryngoscope
4807702|NCT02575716|intubating condition|intubating condition
4807703|NCT02575716|muscle relaxant|muscle relaxant
4807704|NCT02575716|intubation|intubation
4807705|NCT02575690|spirulina, placebo, obesity,antihypertensive treatment|spirulina, placebo, obesity,antihypertensive treatment
4807706|NCT02575677|labor pain|labor pain
4807707|NCT02575677|oxycodone|oxycodone
4807708|NCT02575664|Pain|pain
4807709|NCT02575664|Arthroplasty|arthroplasty
4807710|NCT02575664|Buprenorphine|buprenorphine
4807711|NCT02575651|PARP|parp
4807712|NCT02575651|Advanced Solid Malignancies|advanced solid malignancies
4807713|NCT02575651|Fluzoparib|fluzoparib
4807714|NCT02575651|Ovarian Cancer|ovarian cancer
4807715|NCT02575651|BRCA|brca
4807716|NCT02575625|Liver steatosis|liver steatosis
4807717|NCT02575625|Steatohepatitis|steatohepatitis
4807718|NCT02575625|Fibroscan|fibroscan
4807719|NCT02575599|Self-management|self-management
4807720|NCT02575599|web-based|web-based
4807721|NCT02575599|quantitative approach|quantitative approach
4807722|NCT02575586|Trigger Points|trigger points
4807723|NCT02575586|Dry needling|dry needling
4807724|NCT02575586|Torque|torque
4807725|NCT02575586|H-Reflex|h-reflex
4807726|NCT02575573|resuscitation decision|resuscitation decision
4807727|NCT02575560|Progression-Free Survival|progression-free survival
4807728|NCT02575547|Nutritional Status|nutritional status
4807729|NCT02575547|Locoregionally Advanced Nasopharyngeal Carcinoma|locoregionally advanced nasopharyngeal carcinoma
4807730|NCT02575534|anti-arrhythmic therapy|anti-arrhythmic therapy
4807731|NCT02575482|SUVN-D4010|suvn-d4010
4807732|NCT02575482|serotonin 4 (5-HT4) receptor|serotonin 4 (5-ht4) receptor
4807733|NCT02575482|first in human|first in human
4807734|NCT02575482|safety|safety
4807735|NCT02575482|pharmacokinetics|pharmacokinetics
4807736|NCT02575482|tolerability|tolerability
4807737|NCT02575482|single dose|single dose
4807738|NCT02575482|repeat dose|repeat dose
4807739|NCT02575417|advance care planning|advance care planning
4807740|NCT02575417|end-of-life care|end-of-life care
4807741|NCT02575417|health games|health games
4807742|NCT02575417|Family caregivers|family caregivers
4807743|NCT02575417|Advance directives|advance directives
4807744|NCT02575404|Metastatic|metastatic
4807745|NCT02575404|Keytruda|keytruda
4807746|NCT02575404|pembrolizumab|pembrolizumab
4807747|NCT02575404|GR-MD-02|gr-md-02
4807748|NCT02575404|Galactoarabino-rhamnogalacturonate|galactoarabino-rhamnogalacturonate
4807749|NCT02575404|Immunotherapy|immunotherapy
4807750|NCT02575391|L-Glutamine|l-glutamine
4807751|NCT02575391|chemotherapy|chemotherapy
4807752|NCT02575391|radiotherapy|radiotherapy
4807753|NCT02575391|therapeutic toxicity|therapeutic toxicity
4807754|NCT02575378|Metastatic Colorectal Cancer|metastatic colorectal cancer
4807755|NCT02575378|Maintenance Treatment|maintenance treatment
4807756|NCT02575378|Chinese Traditional Medicine|chinese traditional medicine
4807757|NCT02575378|Clinical Trial|clinical trial
4807758|NCT02575378|efficacy|efficacy
4807759|NCT02575378|safety|safety
4807760|NCT02575365|RRMS,|rrms,
4807761|NCT02575365|Cognition,|cognition,
4807762|NCT02575365|brain,|brain,
4807763|NCT02575365|Fingolimod,|fingolimod,
4807764|NCT02575365|Multiple Sclerosis,|multiple sclerosis,
4807765|NCT02575365|neurodegeneration,|neurodegeneration,
4807766|NCT02575365|Brain atrophy,|brain atrophy,
4807767|NCT02575365|gray matter atrophy,|gray matter atrophy,
4807768|NCT02575365|thalamic atrophy,|thalamic atrophy,
4807769|NCT02575365|biomarkers,|biomarkers,
4807770|NCT02575365|BICAMS Battery,|bicams battery,
4807771|NCT02575352|Bone Substitute|bone substitute
4807772|NCT02575352|Calcium Phosphate Cement|calcium phosphate cement
4807773|NCT02575352|GRAFTYS|graftys
4807774|NCT02575352|GRAFTYS®HBS|graftys®hbs
4807775|NCT02575352|GRAFTYS®QUICKSET|graftys®quickset
4807776|NCT02575352|Bone void filler|bone void filler
4807777|NCT02575352|Bone growth|bone growth
4807778|NCT02575352|Registry|registry
4807779|NCT02575352|Bone defect|bone defect
4807780|NCT02575352|Revision arthroplasty|revision arthroplasty
4807781|NCT02575352|Arthrodesis|arthrodesis
4807782|NCT02575339|MLN0128|mln0128
4807783|NCT02575339|Sapanisertib|sapanisertib
4807784|NCT02575339|TORC1/2 inhibitor|torc1/2 inhibitor
4807785|NCT02575339|INK128|ink128
4807786|NCT02575339|Nexavar|nexavar
4807787|NCT02575339|Sorafenib|sorafenib
4807788|NCT02575326|Asthma, Body Mass Idex, BMI, Overweight, Obesity|asthma, body mass idex, bmi, overweight, obesity
4807789|NCT02575313|L-Glutamine|l-glutamine
4807790|NCT02575313|chemotherapy|chemotherapy
4807791|NCT02575313|radiotherapy|radiotherapy
4807792|NCT02575313|therapeutic toxicity|therapeutic toxicity
4807793|NCT02575300|neuroendocrine tumors (NETs)|neuroendocrine tumors (nets)
4807794|NCT02575300|gastroenteropancreatic NETs|gastroenteropancreatic nets
4807795|NCT02575300|pancreatic NETs|pancreatic nets
4807796|NCT02575300|gastrointestinal (GI) tract NET|gastrointestinal (gi) tract net
4807797|NCT02575300|advanced carcinoid tumors|advanced carcinoid tumors
4807798|NCT02575274|Peri-implantitis|peri-implantitis
4807799|NCT02575274|Peri-implant disease|peri-implant disease
4807800|NCT02575274|Dental implants|dental implants
4807801|NCT02575274|Guided bone regeneration|guided bone regeneration
4807802|NCT02575261|CAR-T cell immunotherapy|car-t cell immunotherapy
4807803|NCT02575261|EphA2|epha2
4807804|NCT02575261|malignant glioma|malignant glioma
4807805|NCT02575248|dienogest|dienogest
4807806|NCT02575248|infertility|infertility
4807807|NCT02575248|endometriosis|endometriosis
4807808|NCT02575235|Sarcopenia|sarcopenia
4807809|NCT02575235|Cetylpyridinium chloride|cetylpyridinium chloride
4807810|NCT02575222|Immunotherapy|immunotherapy
4807811|NCT02575222|PD-1|pd-1
4807812|NCT02575222|anti-PD-1|anti-pd-1
4807813|NCT02575222|antibody|antibody
4807814|NCT02575222|Kidney Cancer|kidney cancer
4807815|NCT02575222|RCC|rcc
4807816|NCT02575222|non-metastatic|non-metastatic
4807817|NCT02575196|Cardiac arrest|cardiac arrest
4807818|NCT02575196|Cardiopulmonary Resuscitation|cardiopulmonary resuscitation
4807819|NCT02575196|CPR|cpr
4807820|NCT02575196|cerebral blood flow|cerebral blood flow
4807821|NCT02575196|cerebral perfusion|cerebral perfusion
4807822|NCT02575183|Waterpipe smoking|waterpipe smoking
4807823|NCT02575183|Nicotine dependence|nicotine dependence
4807824|NCT02575183|Smoking cessation|smoking cessation
4807825|NCT02575183|Varinecline, Chantix therapy|varinecline, chantix therapy
4807826|NCT02575183|Behavioral therapy|behavioral therapy
4807827|NCT02575170|amino acid|amino acid
4807828|NCT02575170|cesarean delivery|cesarean delivery
4807829|NCT02575170|hypothermia|hypothermia
4807830|NCT02575131|satiety|satiety
4807831|NCT02575131|overweight|overweight
4807832|NCT02575131|breakfast|breakfast
4807833|NCT02575131|ecological validity|ecological validity
4807834|NCT02575105|Bispectral Index Hydrocephalus|bispectral index hydrocephalus
4807835|NCT02575092|Hyperhomocysteinemia|hyperhomocysteinemia
4807836|NCT02575092|Coronary angiography|coronary angiography
4807837|NCT02575092|Percutaneous coronary intervention|percutaneous coronary intervention
4807838|NCT02575092|Hypertension|hypertension
4807839|NCT02575092|Contrast-induced nephropathy|contrast-induced nephropathy
4807840|NCT02575066|pazopanib|pazopanib
4807841|NCT02575066|radiotherapy|radiotherapy
4807842|NCT02575053|latex allergy|latex allergy
4807843|NCT02575053|latex hypersensitivity|latex hypersensitivity
4807844|NCT02575053|powder free latex surgical gloves|powder free latex surgical gloves
4807845|NCT02575053|latex safe protocol|latex safe protocol
4807846|NCT02575001|Type 1 diabetes|type 1 diabetes
4807847|NCT02575001|Children and adolescents|children and adolescents
4807848|NCT02575001|Stress|stress
4807849|NCT02575001|Genetic factors|genetic factors
4807850|NCT02575001|Psychological background|psychological background
4807851|NCT02574988|drug allergy|drug allergy
4807852|NCT02574988|drug hypersensitivity|drug hypersensitivity
4807853|NCT02574988|adverse drug reactions|adverse drug reactions
4807854|NCT02574988|severe cutaneous adverse reactions|severe cutaneous adverse reactions
4807855|NCT02574949|radiation|radiation
4807856|NCT02574949|fluoroscopy|fluoroscopy
4807857|NCT02574949|diagnostic|diagnostic
4807858|NCT02574936|karydakis modification|karydakis modification
4807859|NCT02574936|pilonidal sinus|pilonidal sinus
4807860|NCT02574936|complication|complication
4807861|NCT02574923|Cerebral Palsy|cerebral palsy
4807862|NCT02574923|Stem Cells|stem cells
4807863|NCT02574871|Stress|stress
4807864|NCT02574871|Chronic stress|chronic stress
4807865|NCT02574871|Perceived stress|perceived stress
4807866|NCT02574871|Psychological distress|psychological distress
4807867|NCT02574832|Pain|pain
4807868|NCT02574832|Surgery|surgery
4807869|NCT02574832|Pregnancy|pregnancy
4807870|NCT02574832|Anesthesia|anesthesia
4807871|NCT02574819|opioid-induced constipation|opioid-induced constipation
4807872|NCT02574806|BNP|bnp
4807873|NCT02574806|Reference values|reference values
4807874|NCT02574806|Newborn|newborn
4807875|NCT02574806|Ventricular function|ventricular function
4807876|NCT02574806|Stress|stress
4807877|NCT02574806|Pediatrics|pediatrics
4807878|NCT02574806|Biomarkers|biomarkers
4807879|NCT02574793|Glucose Fluctuation|glucose fluctuation
4807880|NCT02574793|GH-Secreting Adenoma|gh-secreting adenoma
4807881|NCT02574793|Cushing Syndrome|cushing syndrome
4807882|NCT02574780|lymphedema|lymphedema
4807883|NCT02574780|complex physical therapy|complex physical therapy
4807884|NCT02574780|muscle strength|muscle strength
4807885|NCT02574767|Weight gain, Fatty Acids, Omega-3|weight gain, fatty acids, omega-3
4807886|NCT02574754|warfarin|warfarin
4807887|NCT02574754|pharmacokinetics|pharmacokinetics
4807888|NCT02574754|bioequivalence|bioequivalence
4807889|NCT02574754|healthy volunteer|healthy volunteer
4807890|NCT02574728|Pediatrics|pediatrics
4807891|NCT02574728|Brain Tumors|brain tumors
4807892|NCT02574728|Neuroblastoma|neuroblastoma
4807893|NCT02574728|Osteosarcoma|osteosarcoma
4807894|NCT02574728|Ewing's Sarcoma|ewing's sarcoma
4807895|NCT02574728|Rhabdomyosarcoma|rhabdomyosarcoma
4807896|NCT02574728|Wilms Tumors|wilms tumors
4807897|NCT02574728|Soft Tissue Sarcomas|soft tissue sarcomas
4807898|NCT02574702|superficial surgical site infection|superficial surgical site infection
4807899|NCT02574702|loop ileostomy|loop ileostomy
4807900|NCT02574702|Ileostomy closure|ileostomy closure
4807901|NCT02574689|Physical Activity|physical activity
4807902|NCT02574689|Cancer Prevention|cancer prevention
4807903|NCT02574637|MEDI2070|medi2070
4807904|NCT02574637|inflammatory bowel disease|inflammatory bowel disease
4807905|NCT02574637|moderate to severe Crohn's Disease|moderate to severe crohn's disease
4807906|NCT02574637|IL-23|il-23
4807907|NCT02574598|PDL1|pdl1
4807908|NCT02574598|monoclonal antibody|monoclonal antibody
4807909|NCT02574585|Spinal cord injury|spinal cord injury
4807910|NCT02574585|Paraplegia|paraplegia
4807911|NCT02574585|Stem cells|stem cells
4807912|NCT02574585|Mesenchymal cells|mesenchymal cells
4807913|NCT02574572|Spinal cord injury|spinal cord injury
4807914|NCT02574572|Mesenchymal cells|mesenchymal cells
4807915|NCT02574572|Stem cells|stem cells
4807916|NCT02574559|Caregiver|caregiver
4807917|NCT02574559|Stress|stress
4807918|NCT02574559|Depression|depression
4807919|NCT02574559|Autism Spectrum Disorder|autism spectrum disorder
4807920|NCT02574559|Compassion Meditation|compassion meditation
4807921|NCT02574546|Mastectomy|mastectomy
4807922|NCT02574533|Immunotherapy|immunotherapy
4807923|NCT02574533|PD-1 inhibitor|pd-1 inhibitor
4807924|NCT02574533|Keytruda|keytruda
4807925|NCT02574533|checkpoint inhibitor|checkpoint inhibitor
4807926|NCT02574533|vaccine|vaccine
4807927|NCT02574533|FANG|fang
4807928|NCT02574533|Vigil|vigil
4807929|NCT02574520|Post-operative pain|post-operative pain
4807930|NCT02574520|opioid|opioid
4807931|NCT02574520|opioid reduction|opioid reduction
4807932|NCT02574520|laparoscopic cholecystectomy|laparoscopic cholecystectomy
4807933|NCT02574520|laparoscopic surgery|laparoscopic surgery
4807934|NCT02574520|bupivacaine|bupivacaine
4807935|NCT02574520|extended release|extended release
4807936|NCT02574520|locally acting analgesic|locally acting analgesic
4807937|NCT02574507|breast cancer|breast cancer
4807938|NCT02574507|weight management|weight management
4807939|NCT02574507|couples|couples
4807940|NCT02574507|symptom management|symptom management
4807941|NCT02574481|atherosclerosis|atherosclerosis
4807942|NCT02574481|Superficial Femoral Artery (SFA)|superficial femoral artery (sfa)
4807943|NCT02574481|Proximal Popliteal Artery (PPA)|proximal popliteal artery (ppa)
4807944|NCT02574481|lower extremities|lower extremities
4807945|NCT02574481|stenting|stenting
4807946|NCT02574481|paclitaxel|paclitaxel
4807947|NCT02574468|Dexamethasone|dexamethasone
4807948|NCT02574468|Direct pulp capping|direct pulp capping
4807949|NCT02574468|MTA|mta
4807950|NCT02574468|pulpotomy|pulpotomy
4807951|NCT02574442|cervical intraepithelial neoplasia grade 1|cervical intraepithelial neoplasia grade 1
4807952|NCT02574442|cervical intraepithelial neoplasia grade 2|cervical intraepithelial neoplasia grade 2
4807953|NCT02574442|cervical intraepithelial neoplasia grade 3|cervical intraepithelial neoplasia grade 3
4807954|NCT02574442|adenocarcinoma in situ|adenocarcinoma in situ
4807955|NCT02574429|Borderline Personality Disorder|borderline personality disorder
4807956|NCT02574429|Posttraumatic Stress Disorder|posttraumatic stress disorder
4807957|NCT02574429|Cognitive Processing Therapy|cognitive processing therapy
4807958|NCT02574429|Group Therapy|group therapy
4807959|NCT02574429|Comorbidity|comorbidity
4807960|NCT02574429|Dialectical Behavior Therapy|dialectical behavior therapy
4807961|NCT02574416|Health behaviour|health behaviour
4807962|NCT02574416|Health outcomes|health outcomes
4807963|NCT02574416|Diet quality|diet quality
4807964|NCT02574416|Physical function|physical function
4807965|NCT02574416|Lifestyle|lifestyle
4807966|NCT02574416|Older adults|older adults
4807967|NCT02574403|atypical hemolytic uremic syndrome (aHUS)|atypical hemolytic uremic syndrome (ahus)
4807968|NCT02574403|eculizumab discontinuation|eculizumab discontinuation
4807969|NCT02574390|ALS|als
4807970|NCT02574390|stem cell|stem cell
4807971|NCT02574390|biomarker|biomarker
4807972|NCT02574390|disease progression|disease progression
4807973|NCT02574364|abdomen CT|abdomen ct
4807974|NCT02574364|open appendicectomy|open appendicectomy
4807975|NCT02574312|Mechanical Axis Alignment|mechanical axis alignment
4807976|NCT02574312|Knee Arthroplasty, Total|knee arthroplasty, total
4807977|NCT02574299|dyslexia|dyslexia
4807978|NCT02574299|training|training
4807979|NCT02574299|auditory rehabilitation|auditory rehabilitation
4807980|NCT02574299|hearing loss|hearing loss
4807981|NCT02574299|evoked potentials|evoked potentials
4807982|NCT02574299|dichotic|dichotic
4807983|NCT02574299|plasticity|plasticity
4807984|NCT02574299|noise|noise
4807985|NCT02574247|Audiology|audiology
4807986|NCT02574247|Auditory Pathways|auditory pathways
4807987|NCT02574247|Auditory Perception|auditory perception
4807988|NCT02574247|Brain Stem|brain stem
4807989|NCT02574247|Cochlea|cochlea
4807990|NCT02574247|Ear, Inner|ear, inner
4807991|NCT02574247|Efferent Pathways|efferent pathways
4807992|NCT02574247|Hair Cells, Auditory, Outer|hair cells, auditory, outer
4807993|NCT02574247|Learning|learning
4807994|NCT02574247|Neurons, Efferent|neurons, efferent
4807995|NCT02574247|Speech Perception|speech perception
4807996|NCT02574234|Postoperative cognitive disorders POCD|postoperative cognitive disorders pocd
4807997|NCT02574234|inflammation|inflammation
4807998|NCT02574234|Surgery|surgery
4807999|NCT02574208|Adult outpatients|adult outpatients
4808000|NCT02574208|Paris, France|paris, france
4808001|NCT02574195|Diabetes Mellitus|diabetes mellitus
4808002|NCT02574195|microvascular complications|microvascular complications
4808003|NCT02574195|macrovascular complications|macrovascular complications
4808004|NCT02574195|epidemiology|epidemiology
4808005|NCT02574195|Russia|russia
4808006|NCT02574182|Mild Cognitive Impairment|mild cognitive impairment
4808007|NCT02574182|Magnetic Resonance Imaging|magnetic resonance imaging
4808008|NCT02574169|Alveolar Recruitment Maneuvers (ARM)|alveolar recruitment maneuvers (arm)
4808009|NCT02574169|Continuous Positive Airway Pressure (CPAP)|continuous positive airway pressure (cpap)
4808010|NCT02574169|Extended Sigh (eSigh)|extended sigh (esigh)
4808011|NCT02574143|Prognosis|prognosis
4808012|NCT02574143|Prospective Study|prospective study
4808013|NCT02574143|Quality of Life|quality of life
4808014|NCT02574143|Radiology|radiology
4808015|NCT02574143|Rehabilitation|rehabilitation
4808016|NCT02574143|Registry;|registry;
4808017|NCT02574143|Signs and Symptoms|signs and symptoms
4808018|NCT02574143|Therapy|therapy
4808019|NCT02574143|Bronchiectiasis|bronchiectiasis
4808020|NCT02574143|Diagnosis|diagnosis
4808021|NCT02574143|Epidemiology|epidemiology
4808022|NCT02574143|Etiology|etiology
4808023|NCT02574143|Longitudinal Study|longitudinal study
4808024|NCT02574143|Microbiology|microbiology
4808025|NCT02574104|Intensive Care Units, Neonatal|intensive care units, neonatal
4808026|NCT02574104|Patient simulation|patient simulation
4808027|NCT02574104|Interdisciplinary Communication|interdisciplinary communication
4808028|NCT02574104|Human factors|human factors
4808029|NCT02574104|Hazard Analysis and Critical Control Points|hazard analysis and critical control points
4808030|NCT02574091|EGFR inhibitor|egfr inhibitor
4808031|NCT02574091|topical agent|topical agent
4808032|NCT02574091|psoriasis|psoriasis
4808033|NCT02574091|phase 1|phase 1
4808034|NCT02574065|crying|crying
4808035|NCT02574065|colicky|colicky
4808036|NCT02574065|infants|infants
4808037|NCT02574065|Lactobacillus reuteri DSM 17938|lactobacillus reuteri dsm 17938
4808038|NCT02574052|Menu Labelling;|menu labelling;
4808039|NCT02574052|Nutrition Education;|nutrition education;
4808040|NCT02574052|dietary assessment tools;|dietary assessment tools;
4808041|NCT02574039|volunteers|volunteers
4808042|NCT02574039|oat|oat
4808043|NCT02574039|phenolic acid|phenolic acid
4808044|NCT02574039|bioavailability|bioavailability
4808045|NCT02574026|MEG|meg
4808046|NCT02574026|EEG|eeg
4808047|NCT02574026|MRI|mri
4808048|NCT02574026|Brain mapping|brain mapping
4808049|NCT02574026|functional imaging|functional imaging
4808050|NCT02574026|brain computer interface|brain computer interface
4808051|NCT02573974|undernutrition|undernutrition
4808052|NCT02573974|gastrointestinal cancer|gastrointestinal cancer
4808053|NCT02573974|skeletal muscle|skeletal muscle
4808054|NCT02573974|energy metabolism|energy metabolism
4808055|NCT02573948|People who inject drugs|people who inject drugs
4808056|NCT02573948|Vietnam|vietnam
4808057|NCT02573948|Community support groups|community support groups
4808058|NCT02573935|Multiple Myeloma|multiple myeloma
4808059|NCT02573935|Clarithromycin|clarithromycin
4808060|NCT02573935|Induction Chemotherapy|induction chemotherapy
4808061|NCT02573935|Transplantation, Autologous|transplantation, autologous
4808062|NCT02573922|constipation|constipation
4808063|NCT02573922|opioid|opioid
4808064|NCT02573922|Oxycodone|oxycodone
4808065|NCT02573922|Oxycodone-naloxone|oxycodone-naloxone
4808066|NCT02573922|spine surgery|spine surgery
4808067|NCT02573896|relapsed refractory neuroblastoma|relapsed refractory neuroblastoma
4808068|NCT02573883|Vulva|vulva
4808069|NCT02573883|Lichen Sclerosus|lichen sclerosus
4808070|NCT02573883|Fractionated Carbon Dioxide Laser|fractionated carbon dioxide laser
4808071|NCT02573883|Mona Lisa Laser|mona lisa laser
4808072|NCT02573883|Clobetasol Proprionate|clobetasol proprionate
4808073|NCT02573883|Vulvodynia|vulvodynia
4808074|NCT02573870|COPD|copd
4808075|NCT02573870|DPI|dpi
4808076|NCT02573870|Batefenterol|batefenterol
4808077|NCT02573870|Fluticasone Furoate|fluticasone furoate
4808078|NCT02573857|Induced blood stage malaria|induced blood stage malaria
4808079|NCT02573857|Transmission|transmission
4808080|NCT02573857|Gametocytemia|gametocytemia
4808081|NCT02573844|irritable bowel syndrome|irritable bowel syndrome
4808082|NCT02573844|abdominal pain|abdominal pain
4808083|NCT02573844|rome III criteria|rome iii criteria
4808084|NCT02573844|abdominal distension|abdominal distension
4808085|NCT02573844|consistency of stools|consistency of stools
4808086|NCT02573844|stool frequency|stool frequency
4808087|NCT02573844|meteorism|meteorism
4808088|NCT02573844|flatulence|flatulence
4808089|NCT02573844|abdominal discomfort|abdominal discomfort
4808090|NCT02573844|proklama|proklama
4808091|NCT02573844|probiotics|probiotics
4808092|NCT02573844|alga klamath|alga klamath
4808093|NCT02573844|aphanizomenon flos-aquae|aphanizomenon flos-aquae
4808094|NCT02573844|prebiotics|prebiotics
4808095|NCT02573844|colitis ulcerosa|colitis ulcerosa
4808097|NCT02573831|pain|pain
4808098|NCT02573831|oxycodone|oxycodone
4808099|NCT02573831|placenta|placenta
4808100|NCT02573818|sedation for EGD and colonoscopy procedures|sedation for egd and colonoscopy procedures
4808101|NCT02573805|nocturnal penile tumescence and rigidity|nocturnal penile tumescence and rigidity
4808102|NCT02573805|erectile dysfunction|erectile dysfunction
4808103|NCT02573805|Chinese males|chinese males
4808104|NCT02573792|First onset of optical neuritis|first onset of optical neuritis
4808105|NCT02573779|human milk|human milk
4808106|NCT02573779|enteral nutrition|enteral nutrition
4808107|NCT02573779|microbiome|microbiome
4808108|NCT02573779|Microbiota|microbiota
4808109|NCT02573766|Neurofeedback training|neurofeedback training
4808110|NCT02573766|EEG|eeg
4808111|NCT02573766|electroencephalograph|electroencephalograph
4808112|NCT02573766|Questionnaires|questionnaires
4808113|NCT02573766|Surveys|surveys
4808114|NCT02573766|Chemotherapy-Induced Peripheral Neuropathy|chemotherapy-induced peripheral neuropathy
4808115|NCT02573766|CIPN|cipn
4808116|NCT02573740|Mild Cognitive Impairment|mild cognitive impairment
4808117|NCT02573740|Alzheimer's Disease|alzheimer's disease
4808118|NCT02573714|Ketamine|ketamine
4808119|NCT02573714|Intranasal|intranasal
4808120|NCT02573714|Pain crisis|pain crisis
4808121|NCT02573714|Vasoocclusive Pain|vasoocclusive pain
4808122|NCT02573714|Sickle cell disease|sickle cell disease
4808123|NCT02573701|Schizophrenia|schizophrenia
4808124|NCT02573701|Adolescents|adolescents
4808125|NCT02573701|Treatment|treatment
4808126|NCT02573701|Guidelines|guidelines
4808127|NCT02573688|Obesity|obesity
4808128|NCT02573688|Metabolic Syndrome X|metabolic syndrome x
4808129|NCT02573688|Interdisciplinary Studies|interdisciplinary studies
4808130|NCT02573675|hemodialysis|hemodialysis
4808131|NCT02573675|peritoneal dialysis|peritoneal dialysis
4808132|NCT02573662|Metabolic complications|metabolic complications
4808133|NCT02573662|Type 2 diabetes|type 2 diabetes
4808134|NCT02573662|Sedentary lifestyle|sedentary lifestyle
4808135|NCT02573662|Low grade inflammation|low grade inflammation
4808136|NCT02573662|Lipid metabolism|lipid metabolism
4808137|NCT02573662|Glucose metabolism|glucose metabolism
4808138|NCT02573662|Bone metabolism|bone metabolism
4808139|NCT02573662|Physical inactivity|physical inactivity
4808140|NCT02573623|Immunology diagnosis test|immunology diagnosis test
4808141|NCT02573623|Children|children
4808142|NCT02573623|Zambia|zambia
4808143|NCT02573571|single nucleotide polymorphisms|single nucleotide polymorphisms
4808144|NCT02573571|cytokines|cytokines
4808145|NCT02573571|microbiome|microbiome
4808146|NCT02573545|liver|liver
4808147|NCT02573532|myocardial ischemia/diagnosis|myocardial ischemia/diagnosis
4808148|NCT02573532|myocardial ischemia/epidemiology|myocardial ischemia/epidemiology
4808149|NCT02573532|perioperative|perioperative
4808150|NCT02573532|perioperative complications/diagnosis|perioperative complications/diagnosis
4808151|NCT02573532|prognosis|prognosis
4808152|NCT02573519|11C Donepezil PET/CT scan|11c donepezil pet/ct scan
4808153|NCT02573519|3D-Transit|3d-transit
4808154|NCT02573519|Diabetes Mellitus|diabetes mellitus
4808155|NCT02573519|Gastrointestinal motility disorder|gastrointestinal motility disorder
4808156|NCT02573519|Diabetic autonomic neuropathy|diabetic autonomic neuropathy
4808157|NCT02573506|Non-small cell lung cancer|non-small cell lung cancer
4808158|NCT02573506|Split-course Chemoradiotherapy|split-course chemoradiotherapy
4808159|NCT02573506|Consolidation chemotherapy|consolidation chemotherapy
4808160|NCT02573480|youth violence, intervention, emergency medicine|youth violence, intervention, emergency medicine
4808161|NCT02573467|sporadic inclusion body myositis,|sporadic inclusion body myositis,
4808162|NCT02573467|muscle wasting,|muscle wasting,
4808163|NCT02573467|extension study,|extension study,
4808164|NCT02573467|BYM338,|bym338,
4808165|NCT02573467|bimagrumab,|bimagrumab,
4808166|NCT02573428|Autism Spectrum Disorder|autism spectrum disorder
4808167|NCT02573428|Eye Gaze|eye gaze
4808168|NCT02573428|Remote Eye Gaze Tracking|remote eye gaze tracking
4808169|NCT02573428|Autism|autism
4808170|NCT02573402|electric stimulation|electric stimulation
4808171|NCT02573402|urodynamic study|urodynamic study
4808172|NCT02573389|pancreatic fistula, pancreatectomy, endoscopic stenting, pancreatic stenting, distal pancreatectomy|pancreatic fistula, pancreatectomy, endoscopic stenting, pancreatic stenting, distal pancreatectomy
4808173|NCT02573376|HIV|hiv
4808174|NCT02573376|Hepatitis C|hepatitis c
4808175|NCT02573376|Drug Abuse|drug abuse
4808176|NCT02573376|Hepatitis C Virus|hepatitis c virus
4808177|NCT02573376|sofosbuvir|sofosbuvir
4808178|NCT02573376|ledipasvir|ledipasvir
4808179|NCT02573376|pharmacology|pharmacology
4808180|NCT02573376|pharmacokinetics|pharmacokinetics
4808181|NCT02573324|Newly Diagnosed Glioblastoma|newly diagnosed glioblastoma
4808182|NCT02573324|Epithelial Growth Factor Receptor (EGFR)|epithelial growth factor receptor (egfr)
4808183|NCT02573324|Temozolomide|temozolomide
4808184|NCT02573324|ABT-414|abt-414
4808185|NCT02573324|Radiology Therapy Oncology Group|radiology therapy oncology group
4808186|NCT02573324|Antibody Drug Conjugate|antibody drug conjugate
4808187|NCT02573324|Brain Tumor|brain tumor
4808188|NCT02573324|Brain Tumor Group|brain tumor group
4808189|NCT02573324|EGFRvIII|egfrviii
4808190|NCT02573324|EGFR Amplified|egfr amplified
4808191|NCT02573324|First Line Therapy|first line therapy
4808192|NCT02573324|Brain Cancer|brain cancer
4808193|NCT02573298|cryotherapy|cryotherapy
4808194|NCT02573298|power Doppler score|power doppler score
4808195|NCT02573298|synovial fluid cytokines|synovial fluid cytokines
4808196|NCT02573298|pain VAS|pain vas
4808197|NCT02573259|efficacy|efficacy
4808198|NCT02573259|safety|safety
4808199|NCT02573259|pharmacokinetics|pharmacokinetics
4808200|NCT02573259|pharmacodynamics|pharmacodynamics
4808201|NCT02573259|open label|open label
4808202|NCT02573259|dose response|dose response
4808203|NCT02573259|multiple ascending dose|multiple ascending dose
4808204|NCT02573259|immunogenicity|immunogenicity
4808205|NCT02573259|recommended phase 2 dose|recommended phase 2 dose
4808206|NCT02573259|subcutaneous|subcutaneous
4808207|NCT02573246|neurostimulation|neurostimulation
4808208|NCT02573246|cognitive restructuring|cognitive restructuring
4808209|NCT02573246|TMS|tms
4808210|NCT02573246|emotion regulation|emotion regulation
4808211|NCT02573246|MRI|mri
4808212|NCT02573246|Emotional Memory Task|emotional memory task
4808213|NCT02573246|Reappraisal|reappraisal
4808214|NCT02573246|Distraction|distraction
4808215|NCT02573194|Appetite|appetite
4808216|NCT02573194|Amino acids|amino acids
4808217|NCT02573194|Protein Source|protein source
4808218|NCT02573168|Pharmacogenomic|pharmacogenomic
4808219|NCT02573168|Pharmacogenomic Testing|pharmacogenomic testing
4808220|NCT02573168|Pharmacogenomics|pharmacogenomics
4808221|NCT02573168|Genetic Testing|genetic testing
4808222|NCT02573168|Genetics|genetics
4808223|NCT02573168|GeneSight|genesight
4808224|NCT02573168|Enhanced GeneSight|enhanced genesight
4808225|NCT02573168|Psychotropic|psychotropic
4808226|NCT02573155|Pharmacokinetics|pharmacokinetics
4808227|NCT02573155|Pharmacodynamics|pharmacodynamics
4808229|NCT02573155|Safety|safety
4808230|NCT02573155|Tolerability|tolerability
4808231|NCT02573155|mild persistent asthma|mild persistent asthma
4808232|NCT02573155|moderate to severe COPD|moderate to severe copd
4808233|NCT02573142|obesity|obesity
4808234|NCT02573142|treatment|treatment
4808235|NCT02573142|community|community
4808236|NCT02573142|integrated|integrated
4808237|NCT02573129|cardiovascular disease risk|cardiovascular disease risk
4808238|NCT02573129|Mediterranean diet|mediterranean diet
4808239|NCT02573129|red meat|red meat
4808240|NCT02573116|obstructive sleep apnea|obstructive sleep apnea
4808241|NCT02573116|endothelial dysfunction|endothelial dysfunction
4808242|NCT02573116|periodontitis|periodontitis
4808243|NCT02573090|Occlusal caries|occlusal caries
4808244|NCT02573090|Resin based fissure sealant|resin based fissure sealant
4808245|NCT02573090|Composite resin restoration|composite resin restoration
4808246|NCT02573090|Effectiveness|effectiveness
4808247|NCT02573090|Longevity|longevity
4808248|NCT02573077|Hyponatremia due to SIADH|hyponatremia due to siadh
4808249|NCT02573077|Cancer|cancer
4808250|NCT02573038|Aflibercept|aflibercept
4808251|NCT02573038|choroidal neovascularization|choroidal neovascularization
4808252|NCT02573038|angioid streaks|angioid streaks
4808253|NCT02573038|young patient|young patient
4808254|NCT02572999|Aged|aged
4808255|NCT02572999|Frail|frail
4808256|NCT02572999|Functional decline|functional decline
4808257|NCT02572999|Impairment|impairment
4808258|NCT02572999|valvular heart disease|valvular heart disease
4808259|NCT02572999|Cohort|cohort
4808260|NCT02572999|risk factors|risk factors
4808261|NCT02572947|Dolutegravir|dolutegravir
4808262|NCT02572947|HIV infection|hiv infection
4808263|NCT02572947|Anti-Retroviral Agents|anti-retroviral agents
4808264|NCT02572947|HIV Integrase Inhibitors|hiv integrase inhibitors
4808265|NCT02572947|Integrase Inhibitors|integrase inhibitors
4808266|NCT02572947|Pharmacologic Actions|pharmacologic actions
4808267|NCT02572947|Therapeutic Uses|therapeutic uses
4808268|NCT02572934|Testicular cancer|testicular cancer
4808269|NCT02572934|Survivorship|survivorship
4808270|NCT02572934|late adverse treatment effects|late adverse treatment effects
4808271|NCT02572921|Positive Psychotherapy|positive psychotherapy
4808272|NCT02572921|Depression|depression
4808273|NCT02572921|Happiness|happiness
4808274|NCT02572908|wheat, IBS, gluten, ATI|wheat, ibs, gluten, ati
4808275|NCT02572895|Cranberry|cranberry
4808276|NCT02572895|Proanthocyanidins|proanthocyanidins
4808277|NCT02572895|Urinary catabolites|urinary catabolites
4808278|NCT02572882|hemodialysis|hemodialysis
4808279|NCT02572882|p-inulin|p-inulin
4808280|NCT02572882|gut microbiome|gut microbiome
4808281|NCT02572869|Mandible Reconstruction|mandible reconstruction
4808282|NCT02572869|Fibula Osteomyocutaneous Free Flaps|fibula osteomyocutaneous free flaps
4808283|NCT02572869|Quality of Life|quality of life
4808284|NCT02572869|15-244|15-244
4808285|NCT02572856|Feasibility|feasibility
4808286|NCT02572856|continuous glucose monitor|continuous glucose monitor
4808287|NCT02572856|surgery|surgery
4808288|NCT02572843|NSCLC|nsclc
4808289|NCT02572843|lung cancer|lung cancer
4808290|NCT02572843|MEDI4736|medi4736
4808291|NCT02572843|non-small cell lung cancer|non-small cell lung cancer
4808292|NCT02572843|immunotherapy|immunotherapy
4808293|NCT02572843|anti-PD-L1|anti-pd-l1
4808294|NCT02572830|Reconsolidation|reconsolidation
4808295|NCT02572830|EMDR|emdr
4808296|NCT02572830|PTSD|ptsd
4808297|NCT02572817|Anti-Influenza Immune Plasma|anti-influenza immune plasma
4808298|NCT02572804|bladder cancer-cystectomy|bladder cancer-cystectomy
4808299|NCT02572804|rectus sheath catheter|rectus sheath catheter
4808300|NCT02572804|epidural|epidural
4808301|NCT02572713|Parkinson's Disease|parkinson's disease
4808302|NCT02572713|alpha-synuclein|alpha-synuclein
4808303|NCT02572713|biomarker|biomarker
4808304|NCT02572687|metastatic|metastatic
4808305|NCT02572687|advanced|advanced
4808306|NCT02572687|immuno-oncology|immuno-oncology
4808307|NCT02572687|vascular endothelial growth factor (VEGF)|vascular endothelial growth factor (vegf)
4808308|NCT02572687|angiogenesis|angiogenesis
4808309|NCT02572687|PD-1|pd-1
4808310|NCT02572687|PD-L1|pd-l1
4808311|NCT02572674|Bipolar disorder|bipolar disorder
4808312|NCT02572674|relapse risk factors|relapse risk factors
4808313|NCT02572674|prospective follow up|prospective follow up
4808314|NCT02572661|Radiotherapy, Sentinel Node Mapping, Spect|radiotherapy, sentinel node mapping, spect
4808315|NCT02572648|Cardiomyopathy|cardiomyopathy
4808316|NCT02572648|Magnetic Resonance Imaging (MRI)|magnetic resonance imaging (mri)
4808317|NCT02572635|Pneumococcal Infection|pneumococcal infection
4808318|NCT02572635|Phase I|phase i
4808319|NCT02572635|Immunogenicity|immunogenicity
4808320|NCT02572635|Safety|safety
4808321|NCT02572635|Vaccination|vaccination
4808322|NCT02572622|exercise|exercise
4808323|NCT02572622|deep friction massage|deep friction massage
4808324|NCT02572622|spinal decompression|spinal decompression
4808325|NCT02572622|non-surgical spinal decompression|non-surgical spinal decompression
4808326|NCT02572596|Hematopoietic Stem Cell Mobilization|hematopoietic stem cell mobilization
4808327|NCT02572596|Thrombopoietin|thrombopoietin
4808328|NCT02572583|Reconciling Exterior and Interior Therapy|reconciling exterior and interior therapy
4808329|NCT02572583|Influenza|influenza
4808330|NCT02572570|Adult dental care|adult dental care
4808331|NCT02572557|Spray Cryotherapy|spray cryotherapy
4808332|NCT02572544|young healthy adults|young healthy adults
4808333|NCT02572544|single pinhole glasses|single pinhole glasses
4808334|NCT02572544|multiple pinhole glasses|multiple pinhole glasses
4808335|NCT02572531|Lactobacillus reuteri|lactobacillus reuteri
4808336|NCT02572531|Wound Healing|wound healing
4808337|NCT02572531|Third Molar|third molar
4808338|NCT02572531|Postoperative Complications|postoperative complications
4808339|NCT02572518|immunity yellow fever vaccine|immunity yellow fever vaccine
4808340|NCT02572505|HIV-Discordant|hiv-discordant
4808341|NCT02572505|Preexposure Prophylaxis|preexposure prophylaxis
4808342|NCT02572492|Multiple Myeloma|multiple myeloma
4808343|NCT02572492|Recurrence|recurrence
4808344|NCT02572492|Carfilzomib|carfilzomib
4808345|NCT02572492|Salvage Therapy|salvage therapy
4808346|NCT02572492|Transplantation, Autologous|transplantation, autologous
4808347|NCT02572479|fatty acids, amyotrophic lateral sclerosis, nutrient status|fatty acids, amyotrophic lateral sclerosis, nutrient status
4808348|NCT02572466|high-sensitive troponin-I|high-sensitive troponin-i
4808349|NCT02572466|End-stage renal disease|end-stage renal disease
4808350|NCT02572466|hemodialysis|hemodialysis
4808351|NCT02572440|Aortic arch surgery; Blood conservation; aPRP|aortic arch surgery; blood conservation; aprp
4808352|NCT02572401|Human immunodeficiency virus|human immunodeficiency virus
4808353|NCT02572401|Sexually transmitted disease|sexually transmitted disease
4808354|NCT02572401|Behavioral intervention|behavioral intervention
4808355|NCT02572401|Randomized controlled trial|randomized controlled trial
4808356|NCT02572401|Text messages|text messages
4808357|NCT02572401|Social cognitive theory|social cognitive theory
4808358|NCT02572401|Theory of planned behavior|theory of planned behavior
4808359|NCT02572401|Sexual behavior|sexual behavior
4808360|NCT02572401|African Americans|african americans
4808361|NCT02572401|Men|men
4808362|NCT02572349|Healthy Subjects|healthy subjects
4808363|NCT02572310|total knee arthroplasty|total knee arthroplasty
4808364|NCT02572297|epilepsy|epilepsy
4808365|NCT02572297|SUDEP|sudep
4808366|NCT02572297|SpO2|spo2
4808367|NCT02572284|Stereotactic Body Radiation Therapy (SBRT)|stereotactic body radiation therapy (sbrt)
4808368|NCT02572284|High Risk Prostate Cancer|high risk prostate cancer
4808369|NCT02572284|Preoperative SBRT|preoperative sbrt
4808370|NCT02572284|Prostate Adenocarcinoma|prostate adenocarcinoma
4808371|NCT02572284|Prostatectomy|prostatectomy
4808372|NCT02572284|Quality of Life|quality of life
4808373|NCT02572271|Autologous augmentation|autologous augmentation
4808374|NCT02572271|Mastopexy|mastopexy
4808375|NCT02572271|Massive weight loss|massive weight loss
4808376|NCT02572245|Healthy Subjects|healthy subjects
4808377|NCT02572245|Device|device
4808378|NCT02572245|PK|pk
4808379|NCT02572245|Phase 1|phase 1
4808380|NCT02572245|Bioequivalence|bioequivalence
4808381|NCT02572245|Adalimumab|adalimumab
4808382|NCT02572245|Single Dose|single dose
4808383|NCT02572193|achalasia|achalasia
4808384|NCT02572193|surgery|surgery
4808385|NCT02572167|Monomethyl auristatin E|monomethyl auristatin e
4808386|NCT02572167|Antigens, CD30|antigens, cd30
4808387|NCT02572167|Antibody-Drug Conjugate|antibody-drug conjugate
4808388|NCT02572167|Antibodies, Monoclonal|antibodies, monoclonal
4808389|NCT02572167|Immunotherapy|immunotherapy
4808390|NCT02572167|Autologous stem cell transplant|autologous stem cell transplant
4808391|NCT02572115|After-Hours Care|after-hours care
4808392|NCT02572115|Primary Care|primary care
4808393|NCT02572115|Emergency Medical Services/utilization|emergency medical services/utilization
4808394|NCT02572115|Denmark|denmark
4808395|NCT02572115|Questionnaires|questionnaires
4808396|NCT02572115|Patient Satisfaction|patient satisfaction
4808397|NCT02572115|Patient feeling of safety|patient feeling of safety
4808398|NCT02572115|Triage/standards|triage/standards
4808399|NCT02572115|Referral and Consultation/statistics & numerical data|referral and consultation/statistics & numerical data
4808400|NCT02572115|Humans|humans
4808401|NCT02572115|Male|male
4808402|NCT02572115|Female|female
4808403|NCT02572115|Hotlines|hotlines
4808404|NCT02572115|telenursing|telenursing
4808405|NCT02572115|Night Care/utilization|night care/utilization
4808406|NCT02572115|postal service|postal service
4808407|NCT02572102|ECG|ecg
4808408|NCT02572102|Blood Pressure|blood pressure
4808409|NCT02572102|Energy Drinks|energy drinks
4808410|NCT02572102|Panax Ginseng|panax ginseng
4808411|NCT02572037|Premature ejaculation|premature ejaculation
4808412|NCT02572037|Dapoxetine|dapoxetine
4808413|NCT02572037|local anaesthetics|local anaesthetics
4808414|NCT02572037|nerve electrophysiology|nerve electrophysiology
4808415|NCT02572011|Lower limb amputation|lower limb amputation
4808416|NCT02572011|Transtibial|transtibial
4808417|NCT02572011|Balance|balance
4808418|NCT02572011|Postural Control|postural control
4808419|NCT02572011|Limits of Stability|limits of stability
4808420|NCT02572011|Rehabilitation|rehabilitation
4808421|NCT02572011|Home-based intervention|home-based intervention
4808422|NCT02572011|Nintendo Wii|nintendo wii
4808423|NCT02572011|Balance Board|balance board
4808718|NCT02570373|Healthy|healthy
4808424|NCT02571985|Zenith aortoiliac aneurysm|zenith aortoiliac aneurysm
4808425|NCT02571985|iliac aneurysm|iliac aneurysm
4808426|NCT02571985|branch|branch
4808427|NCT02571985|connections|connections
4808428|NCT02571985|endovascular graft|endovascular graft
4808429|NCT02571985|graft-iliac bifurcation|graft-iliac bifurcation
4808430|NCT02571985|Aneurysm|aneurysm
4808431|NCT02571985|Vascular Diseases|vascular diseases
4808432|NCT02571985|Cardiovascular Diseases|cardiovascular diseases
4808433|NCT02571972|dorzolamide-timolol|dorzolamide-timolol
4808434|NCT02571972|topical aqueous suppression|topical aqueous suppression
4808435|NCT02571972|neovascular age-related macular degeneration|neovascular age-related macular degeneration
4808436|NCT02571972|macular edema|macular edema
4808437|NCT02571972|intravitreal injection|intravitreal injection
4808438|NCT02571972|anti-vascular endothelial growth factor|anti-vascular endothelial growth factor
4808439|NCT02571959|Obesity|obesity
4808440|NCT02571959|Pharmacology|pharmacology
4808441|NCT02571959|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination
4808442|NCT02571933|Pediatrics|pediatrics
4808443|NCT02571933|Pain Scale|pain scale
4808444|NCT02571933|Faces Pain Scale - Revised|faces pain scale - revised
4808445|NCT02571933|Cameroon|cameroon
4808446|NCT02571920|cardiac surgery|cardiac surgery
4808447|NCT02571920|cardiac output|cardiac output
4808448|NCT02571907|Zenith aortoiliac aneurysm|zenith aortoiliac aneurysm
4808449|NCT02571907|Iliac aneurysm|iliac aneurysm
4808450|NCT02571907|Branch|branch
4808451|NCT02571907|Connections|connections
4808452|NCT02571907|Endovascular graft|endovascular graft
4808453|NCT02571907|Graft-iliac bifurcation|graft-iliac bifurcation
4808454|NCT02571907|Aneurysm|aneurysm
4808455|NCT02571907|Vascular Diseases|vascular diseases
4808456|NCT02571907|Cardiovascular Diseases|cardiovascular diseases
4808457|NCT02571881|constipation|constipation
4808458|NCT02571881|oxycodone|oxycodone
4808459|NCT02571881|caesarean section|caesarean section
4808460|NCT02571855|insomnia|insomnia
4808461|NCT02571855|Pharmacokinetics|pharmacokinetics
4808462|NCT02571855|Safety|safety
4808463|NCT02571855|Pharmacodynamics|pharmacodynamics
4808464|NCT02571855|Healthy|healthy
4808465|NCT02571842|Recurrent IgA nephropathy|recurrent iga nephropathy
4808466|NCT02571842|Rituximab|rituximab
4808467|NCT02571829|Liposarcoma|liposarcoma
4808468|NCT02571829|Soft tissue sarcoma|soft tissue sarcoma
4808469|NCT02571829|CDK4|cdk4
4808470|NCT02571829|CDK6|cdk6
4808471|NCT02571829|LEE011|lee011
4808472|NCT02571829|ribociclib|ribociclib
4808473|NCT02571816|ASP2215|asp2215
4808474|NCT02571816|Healthy|healthy
4808475|NCT02571816|Hepatic Impairment|hepatic impairment
4808476|NCT02571816|Mild Hepatic Impairment|mild hepatic impairment
4808477|NCT02571816|Moderate Hepatic Impairment|moderate hepatic impairment
4808478|NCT02571803|coronary artery disease|coronary artery disease
4808479|NCT02571803|atherosclerosis|atherosclerosis
4808480|NCT02571803|DASH diet|dash diet
4808481|NCT02571790|Patient with Generalized Anxiety Disorders|patient with generalized anxiety disorders
4808482|NCT02571777|Asthma|asthma
4808483|NCT02571725|Ovarian cancer|ovarian cancer
4808484|NCT02571725|Fallopian tube cancer|fallopian tube cancer
4808485|NCT02571725|Peritoneal cancer|peritoneal cancer
4808486|NCT02571725|PARP|parp
4808487|NCT02571725|BRCA|brca
4808488|NCT02571725|Immunotherapy|immunotherapy
4808489|NCT02571725|Olaparib|olaparib
4808490|NCT02571725|Tremelimumab|tremelimumab
4808491|NCT02571725|CTLA4|ctla4
4808492|NCT02571673|Survivorship|survivorship
4808493|NCT02571673|Quality of Life|quality of life
4808494|NCT02571673|HN-STAR web-based|hn-star web-based
4808495|NCT02571673|15-245|15-245
4808496|NCT02571660|vitamin d levels|vitamin d levels
4808497|NCT02571660|exacerbation of asthma|exacerbation of asthma
4808498|NCT02571660|asthma control|asthma control
4808499|NCT02571634|intranasal fentanyl|intranasal fentanyl
4808500|NCT02571634|conscious sedation|conscious sedation
4808501|NCT02571608|Type 2 diabetes mellitus, Metformin, peri-operative|type 2 diabetes mellitus, metformin, peri-operative
4808502|NCT02571595|HIV - Human Immunodeficiency Virus|hiv - human immunodeficiency virus
4808503|NCT02571595|digital cognitive behavioural therapy for insomnia (dCBT-I)|digital cognitive behavioural therapy for insomnia (dcbt-i)
4808504|NCT02571595|insomnia|insomnia
4808505|NCT02571595|cognitive Impairment|cognitive impairment
4808506|NCT02571595|concentration|concentration
4808507|NCT02571595|productivity|productivity
4808508|NCT02571582|Predictors of mortality|predictors of mortality
4808509|NCT02571543|Ibuprofen|ibuprofen
4808510|NCT02571543|IVF|ivf
4808511|NCT02571543|minimal stimulation|minimal stimulation
4808512|NCT02571543|modified natural-cycle|modified natural-cycle
4808513|NCT02571543|nonsteroidal anti-inflammatory drug (NSAID)|nonsteroidal anti-inflammatory drug (nsaid)
4808514|NCT02571543|Anti-Inflammatory Agents, Non-Steroidal/therapeutic use|anti-inflammatory agents, non-steroidal/therapeutic use
4808515|NCT02571543|Oocyte Retrieval|oocyte retrieval
4808516|NCT02571543|Ovarian Follicle/drug effects|ovarian follicle/drug effects
4808517|NCT02571517|Respiratory viral infection.|respiratory viral infection.
4808518|NCT02571517|Respiratory syncytial virus bronchiolitis|respiratory syncytial virus bronchiolitis
4808519|NCT02571517|METHYLPREDNISOLONE SODIUM SUCCINATE|methylprednisolone sodium succinate
4808520|NCT02571504|HIV - Human Immunodeficiency Virus|hiv - human immunodeficiency virus
4808521|NCT02571504|Memory|memory
4808522|NCT02571504|Concentration|concentration
4808523|NCT02571478|Military Couples|military couples
4808524|NCT02571478|Marriage|marriage
4808525|NCT02571478|Primary Care|primary care
4808526|NCT02571478|Marriage Intervention|marriage intervention
4808527|NCT02571478|Air Force|air force
4808528|NCT02571465|functional hemodynamic parameter|functional hemodynamic parameter
4808529|NCT02571465|passive leg raising|passive leg raising
4808530|NCT02571465|stroke volume variation|stroke volume variation
4808531|NCT02571465|pulse pressure variation|pulse pressure variation
4808532|NCT02571452|Veteran|veteran
4808533|NCT02571452|Insomnia|insomnia
4808534|NCT02571452|Primary Healthcare|primary healthcare
4808535|NCT02571439|TAP block, post-cesarean analgesia|tap block, post-cesarean analgesia
4808536|NCT02571413|animated cartoon-aided teaching|animated cartoon-aided teaching
4808537|NCT02571413|oral presentation|oral presentation
4808538|NCT02571413|allergic rhinitis|allergic rhinitis
4808539|NCT02571413|intranasal corticosteroid|intranasal corticosteroid
4808540|NCT02571413|how to use intranasal corticosteroid|how to use intranasal corticosteroid
4808541|NCT02571400|Risk|risk
4808542|NCT02571400|Opioid analgesics|opioid analgesics
4808543|NCT02571400|Opioid-related disorders|opioid-related disorders
4808544|NCT02571400|Surgery|surgery
4808545|NCT02571400|Post-operative care|post-operative care
4808546|NCT02571400|Post-operative period|post-operative period
4808547|NCT02571400|Post-operative complications|post-operative complications
4808548|NCT02571400|Opioid Use disorders|opioid use disorders
4808549|NCT02571400|Pain, post-operative|pain, post-operative
4808550|NCT02571400|Opiate Addiction|opiate addiction
4808551|NCT02571387|Motivation|motivation
4808552|NCT02571387|Impulsive eating|impulsive eating
4808553|NCT02571387|Mindfulness|mindfulness
4808554|NCT02571387|Self-help|self-help
4808555|NCT02571387|Physical activity|physical activity
4808556|NCT02571387|Weight-loss|weight-loss
4808557|NCT02571374|symbiotic|symbiotic
4808558|NCT02571374|colorectal cancer|colorectal cancer
4808559|NCT02571361|Acetaminophen|acetaminophen
4808560|NCT02571361|Ibuprofen|ibuprofen
4808561|NCT02571361|Arthroplasty, Replacement, Hip|arthroplasty, replacement, hip
4808562|NCT02571309|Self-management|self-management
4808563|NCT02571309|Asthma|asthma
4808564|NCT02571309|Patient education|patient education
4808565|NCT02571309|Health literacy|health literacy
4808566|NCT02571309|Health-related quality of life|health-related quality of life
4808567|NCT02571309|Asthma control|asthma control
4808568|NCT02571309|Adherence|adherence
4808569|NCT02571296|Preterm Birth|preterm birth
4808570|NCT02571296|Oral Micronized Progesterone|oral micronized progesterone
4808571|NCT02571283|Total Knee Arthroplasty|total knee arthroplasty
4808572|NCT02571283|Total Knee Replacement|total knee replacement
4808573|NCT02571283|Exparel|exparel
4808574|NCT02571283|Cocktail Injection|cocktail injection
4808575|NCT02571283|Pain Management|pain management
4808576|NCT02571270|Exercise|exercise
4808577|NCT02571270|quality of life|quality of life
4808578|NCT02571270|healthy|healthy
4808579|NCT02571270|cardiac remodeling|cardiac remodeling
4808580|NCT02571257|LDL-C|ldl-c
4808581|NCT02571257|Lipid Regulator|lipid regulator
4808582|NCT02571244|Tobacco Use Disorder|tobacco use disorder
4808583|NCT02571244|Hospitalized patients|hospitalized patients
4808584|NCT02571244|Text message|text message
4808585|NCT02571244|Motivational Interview|motivational interview
4808586|NCT02571244|Substance-Related Disorders|substance-related disorders
4808587|NCT02571244|Behaviors and Mental Disorders|behaviors and mental disorders
4808588|NCT02571218|atrial fibrillation|atrial fibrillation
4808589|NCT02571218|mapping|mapping
4808590|NCT02571218|substrate|substrate
4808591|NCT02571218|ablation|ablation
4808592|NCT02571205|testosterone|testosterone
4808593|NCT02571205|pubertal delay|pubertal delay
4808594|NCT02571192|ADME|adme
4808595|NCT02571179|Labor pain|labor pain
4808596|NCT02571179|Fentanyl|fentanyl
4808597|NCT02571179|Transmucosal|transmucosal
4808598|NCT02571153|Intravenous anesthesia|intravenous anesthesia
4808599|NCT02571153|Postoperative nausea vomiting|postoperative nausea vomiting
4808600|NCT02571153|Postoperative pain|postoperative pain
4808601|NCT02571153|Patient satisfaction|patient satisfaction
4808602|NCT02571153|Quality of health care|quality of health care
4808603|NCT02571153|Ketamine|ketamine
4808604|NCT02571114|Glycemic Responses|glycemic responses
4808605|NCT02571114|Metabolic Responses|metabolic responses
4808606|NCT02571114|Males|males
4808607|NCT02571114|Females|females
4808608|NCT02571101|Clomipramine|clomipramine
4808609|NCT02571101|Premature ejaculation|premature ejaculation
4808610|NCT02571101|CDFR0812|cdfr0812
4808611|NCT02571101|Sildenafil|sildenafil
4808612|NCT02571088|Sickle Cell Hemoglobin C Disease|sickle cell hemoglobin c disease
4808613|NCT02571088|Sports Training|sports training
4808614|NCT02571088|Hemoglobin S Disease|hemoglobin s disease
4808615|NCT02571088|Lactate|lactate
4808616|NCT02571075|auricular|auricular
4808617|NCT02571075|acupuncture|acupuncture
4808618|NCT02571075|pain|pain
4808619|NCT02571062|bioequivalence|bioequivalence
4808620|NCT02571036|Gastrointestinal stromal tumors (GIST)|gastrointestinal stromal tumors (gist)
4808621|NCT02571036|systemic mastocytosis (SM)|systemic mastocytosis (sm)
4808622|NCT02571036|PDGFR-alpha|pdgfr-alpha
4808623|NCT02571036|KIT|kit
4808624|NCT02571036|mast cell leukemia (MCL)|mast cell leukemia (mcl)
4808625|NCT02571036|mast cell disease (MCD)|mast cell disease (mcd)
4808626|NCT02571036|DCC-2618|dcc-2618
4808627|NCT02571036|melanoma|melanoma
4808628|NCT02571036|aggressive systemic mastocytosis (ASM)|aggressive systemic mastocytosis (asm)
4808629|NCT02571023|Skull Base Trauma|skull base trauma
4808630|NCT02571023|microscope surgery|microscope surgery
4808631|NCT02571023|neuroendoscope surgery|neuroendoscope surgery
4808632|NCT02571010|static mechanical allodynia|static mechanical allodynia
4808633|NCT02571010|somatosensory rehabilitation|somatosensory rehabilitation
4808634|NCT02571010|vibrotactile stimulation|vibrotactile stimulation
4808635|NCT02570997|Alzheimer's Disease|alzheimer's disease
4808636|NCT02570997|Mild Cognitive Impairment|mild cognitive impairment
4808637|NCT02570971|mannitol|mannitol
4808638|NCT02570971|treatment|treatment
4808639|NCT02570958|robotic surgery|robotic surgery
4808640|NCT02570958|indocyanine green|indocyanine green
4808641|NCT02570958|electromagnetic navigational bronchoscopy|electromagnetic navigational bronchoscopy
4808642|NCT02570932|Adult Autologous Bone Marrow Mesenchymal Cells Expanded|adult autologous bone marrow mesenchymal cells expanded
4808643|NCT02570932|chronic spinal cord injury (SCI)|chronic spinal cord injury (sci)
4808644|NCT02570919|Prostate cancer|prostate cancer
4808645|NCT02570919|IGRT|igrt
4808646|NCT02570919|Hypofractionation|hypofractionation
4808647|NCT02570919|Extreme|extreme
4808648|NCT02570919|Single Fraction|single fraction
4808649|NCT02570919|Urethral Sparing|urethral sparing
4808650|NCT02570919|MRI|mri
4808651|NCT02570893|Esophageal cancer;adjuvant therapy;chemotherapy;radiotherapy|esophageal cancer;adjuvant therapy;chemotherapy;radiotherapy
4808652|NCT02570867|glaucoma|glaucoma
4808653|NCT02570867|brain function|brain function
4808654|NCT02570867|fMRI|fmri
4808655|NCT02570854|Anemia|anemia
4808656|NCT02570841|Heat pain threshold|heat pain threshold
4808657|NCT02570841|Cold pain threshold|cold pain threshold
4808658|NCT02570841|Mechanical pain threshold|mechanical pain threshold
4808659|NCT02570841|High dose Capsaicin|high dose capsaicin
4808660|NCT02570828|healthy neonate, tachypnea, thermal imaging, pneumonia|healthy neonate, tachypnea, thermal imaging, pneumonia
4808661|NCT02570815|lung cancer|lung cancer
4808662|NCT02570815|segmentectomy|segmentectomy
4808663|NCT02570815|robotic surgery|robotic surgery
4808664|NCT02570815|near-infrared fluorescent|near-infrared fluorescent
4808665|NCT02570815|IC-GREEN|ic-green
4808666|NCT02570815|indocyanine green|indocyanine green
4808667|NCT02570815|early-stage lung cancer|early-stage lung cancer
4808668|NCT02570776|Helicobacter pylori|helicobacter pylori
4808669|NCT02570776|UBT|ubt
4808670|NCT02570776|Sensitivity|sensitivity
4808671|NCT02570776|specificity|specificity
4808672|NCT02570776|prevalence|prevalence
4808673|NCT02570763|neurostimulation|neurostimulation
4808674|NCT02570763|comorbidity|comorbidity
4808675|NCT02570763|tDCS|tdcs
4808676|NCT02570763|CBT|cbt
4808677|NCT02570763|anxiety|anxiety
4808678|NCT02570763|alcohol|alcohol
4808679|NCT02570685|Gratitude Intervention|gratitude intervention
4808680|NCT02570685|positive emotion|positive emotion
4808681|NCT02570685|friendships|friendships
4808682|NCT02570685|positive psychology|positive psychology
4808683|NCT02570685|life satisfaction|life satisfaction
4808684|NCT02570659|WAD|wad
4808685|NCT02570659|Whiplash|whiplash
4808686|NCT02570659|Information Video|information video
4808687|NCT02570633|Migraine|migraine
4808688|NCT02570633|Ginger|ginger
4808689|NCT02570633|Prophylactic treatment|prophylactic treatment
4808690|NCT02570594|Cognition|cognition
4808691|NCT02570594|Autobiographical|autobiographical
4808692|NCT02570594|memoryCognitive|memorycognitive
4808693|NCT02570594|remediation|remediation
4808694|NCT02570581|volonteeres|volonteeres
4808695|NCT02570568|Venepuncture|venepuncture
4808696|NCT02570568|Transillumination|transillumination
4808697|NCT02570555|driving|driving
4808698|NCT02570542|CD34+ Cell Dose|cd34+ cell dose
4808699|NCT02570542|Autologous Stem Cell Transplantation|autologous stem cell transplantation
4808700|NCT02570542|15-193|15-193
4808701|NCT02570529|Pancreatic cancer|pancreatic cancer
4808702|NCT02570529|Chemoradiotherapy|chemoradiotherapy
4808703|NCT02570529|Gastrointestinal toxicity|gastrointestinal toxicity
4808704|NCT02570529|Albis|albis
4808705|NCT02570516|Indigo carmine chromoendoscopy|indigo carmine chromoendoscopy
4808706|NCT02570516|Narrow band imaging|narrow band imaging
4808707|NCT02570516|Colonoscopy|colonoscopy
4808708|NCT02570490|fusidic acid|fusidic acid
4808709|NCT02570490|skin infection|skin infection
4808710|NCT02570451|cognitive impairment|cognitive impairment
4808711|NCT02570451|post surgical outcomes|post surgical outcomes
4808712|NCT02570451|elective joint replacement surgery|elective joint replacement surgery
4808713|NCT02570438|postoperative outcomes|postoperative outcomes
4808714|NCT02570438|older surgical patients|older surgical patients
4808715|NCT02570386|In-vitro fertilization|in-vitro fertilization
4808716|NCT02570386|frozen thawed embryo transfer|frozen thawed embryo transfer
4808717|NCT02570386|fresh embryo transfer|fresh embryo transfer
4808719|NCT02570373|Guselkumab|guselkumab
4808720|NCT02570347|Snake Envenomation|snake envenomation
4808721|NCT02570347|Antibiotic Prophylaxis|antibiotic prophylaxis
4808722|NCT02570347|Viperidae|viperidae
4808723|NCT02570334|early ART|early art
4808724|NCT02570334|neurocognitive evaluation|neurocognitive evaluation
4808725|NCT02570321|Cornea|cornea
4808726|NCT02570321|Ulcer|ulcer
4808727|NCT02570321|Infectious keratitis|infectious keratitis
4808728|NCT02570321|Bacterial|bacterial
4808729|NCT02570321|Fungal|fungal
4808730|NCT02570295|Army|army
4808731|NCT02570295|Sport|sport
4808732|NCT02570295|Physical Fitness|physical fitness
4808733|NCT02570295|Injuries|injuries
4808734|NCT02570295|Psychological Tests|psychological tests
4808735|NCT02570295|Attrition|attrition
4808736|NCT02570282|Female|female
4808737|NCT02570256|stroke|stroke
4808738|NCT02570256|upper extremity|upper extremity
4808739|NCT02570256|motor exploration|motor exploration
4808740|NCT02570256|error augmentation|error augmentation
4808741|NCT02570256|robotic rehabilitation|robotic rehabilitation
4808742|NCT02570243|heparin|heparin
4808743|NCT02570243|radial artery|radial artery
4808744|NCT02570230|Thoracotomy|thoracotomy
4808745|NCT02570230|Postoperative pain|postoperative pain
4808746|NCT02570230|Ketamine|ketamine
4808747|NCT02570217|NCPAP, High Flow Nasal Cannula, pretem infants, NICU|ncpap, high flow nasal cannula, pretem infants, nicu
4808748|NCT02570178|clinical trial|clinical trial
4808749|NCT02570178|accidental falls|accidental falls
4808750|NCT02570178|postural balance|postural balance
4808751|NCT02570178|elderly|elderly
4808752|NCT02570178|primary Health Care|primary health care
4808753|NCT02570165|efficacy|efficacy
4808754|NCT02570165|dry powder inhaler|dry powder inhaler
4808755|NCT02570165|vilanterol|vilanterol
4808756|NCT02570165|batefenterol|batefenterol
4808757|NCT02570152|Dengue|dengue
4808758|NCT02570152|Non-laboratory confirmed dengue (non-LCD)|non-laboratory confirmed dengue (non-lcd)
4808759|NCT02570152|Acute febrile illness (AFI)|acute febrile illness (afi)
4808760|NCT02570152|Laboratory confirmed dengue (LCD)|laboratory confirmed dengue (lcd)
4808761|NCT02570126|Immunogenicity|immunogenicity
4808762|NCT02570126|Varicella|varicella
4808763|NCT02570126|Safety|safety
4808764|NCT02570126|Human serum albumin|human serum albumin
4808765|NCT02570126|Healthy children|healthy children
4808766|NCT02570126|12 to 23 months|12 to 23 months
4808767|NCT02570100|Cancer Stem Cells|cancer stem cells
4808768|NCT02570087|Coronary ChronicTotal Occlusion|coronary chronictotal occlusion
4808769|NCT02570087|Coronary Angioplasty|coronary angioplasty
4808770|NCT02570087|Reduced Ejection Fraction|reduced ejection fraction
4808771|NCT02570061|recruitment|recruitment
4808772|NCT02570061|comprehension|comprehension
4808773|NCT02570061|satisfaction|satisfaction
4808774|NCT02570061|informed consent|informed consent
4808775|NCT02570061|telephone|telephone
4808776|NCT02570035|Mirabegron|mirabegron
4808777|NCT02570035|Overactive Bladder|overactive bladder
4808778|NCT02570035|Cardiovascular Disease|cardiovascular disease
4808779|NCT02570022|Pain control|pain control
4808780|NCT02570022|liposomal bupivacaine|liposomal bupivacaine
4808781|NCT02570022|exparel|exparel
4808782|NCT02570022|shoulder arthroplasty|shoulder arthroplasty
4808783|NCT02570009|couples|couples
4808784|NCT02570009|weight loss treatment|weight loss treatment
4808785|NCT02570009|home environment|home environment
4808786|NCT02569970|Epilepsy|epilepsy
4808787|NCT02569970|SUDEP|sudep
4808788|NCT02569970|fluoxetine|fluoxetine
4808789|NCT02569970|placebo|placebo
4808790|NCT02569970|SpO2|spo2
4808791|NCT02569918|Neuroplasticity|neuroplasticity
4808792|NCT02569918|Sensory Feedback|sensory feedback
4808793|NCT02569918|Transcutaneous electrical stimulation|transcutaneous electrical stimulation
4808794|NCT02569918|Robotic hand|robotic hand
4808795|NCT02569905|flurbiprofen|flurbiprofen
4808796|NCT02569905|Parecoxib sodium|parecoxib sodium
4808797|NCT02569905|Postoperative Shivering|postoperative shivering
4808798|NCT02569879|Boostrix™|boostrix™
4808799|NCT02569879|Bagota|bagota
4808800|NCT02569879|maternal vaccination|maternal vaccination
4808801|NCT02569879|Pertussis|pertussis
4808802|NCT02569879|Mortality|mortality
4808803|NCT02569879|Morbidity|morbidity
4808804|NCT02569866|plastic surgery|plastic surgery
4808805|NCT02569866|mammaplasty|mammaplasty
4808806|NCT02569866|wound infection|wound infection
4808807|NCT02569866|prophylaxis|prophylaxis
4808808|NCT02569827|Uncomplicated Dengue Fever|uncomplicated dengue fever
4808809|NCT02569827|Treatment|treatment
4808810|NCT02569827|Phase Ib/IIa|phase ib/iia
4808811|NCT02569827|single centre|single centre
4808812|NCT02569827|double-blind|double-blind
4808813|NCT02569827|placebo-controlled|placebo-controlled
4808814|NCT02569827|parallel-group dose ranging trial|parallel-group dose ranging trial
4808815|NCT02569827|Modipafant|modipafant
4808816|NCT02569827|Celgosivir|celgosivir
4808817|NCT02569788|re-irradiation|re-irradiation
4808818|NCT02569788|carbon ion radiotherapy|carbon ion radiotherapy
4808819|NCT02569775|Cerebral Palsy|cerebral palsy
4808820|NCT02569775|Stem Cells|stem cells
4808821|NCT02569762|Non-Nutritive Sweeteners|non-nutritive sweeteners
4809016|NCT02568709|Oxytocin|oxytocin
4808822|NCT02569762|Artificial Sweeteners|artificial sweeteners
4808823|NCT02569762|Glucose Metabolism|glucose metabolism
4808824|NCT02569762|Microbiota|microbiota
4808825|NCT02569762|Dysbiosis|dysbiosis
4808826|NCT02569671|Dental Implants, Single-Tooth|dental implants, single-tooth
4808827|NCT02569645|Rectal cancer|rectal cancer
4808828|NCT02569645|Rosuvastatin|rosuvastatin
4808829|NCT02569632|Meningococcal Vaccines|meningococcal vaccines
4808830|NCT02569632|Neisseria Meningitidis|neisseria meningitidis
4808831|NCT02569632|Factor H-binding Protein|factor h-binding protein
4808832|NCT02569619|Physical Activity|physical activity
4808833|NCT02569619|Mental Health|mental health
4808834|NCT02569619|Physical Exercise|physical exercise
4808835|NCT02569619|Mental disorder|mental disorder
4808836|NCT02569619|Promotion|promotion
4808837|NCT02569606|consumption of blood|consumption of blood
4808838|NCT02569606|consumption of coagulation products|consumption of coagulation products
4808839|NCT02569606|coagulation algorithm|coagulation algorithm
4808840|NCT02569606|trauma related transfusion|trauma related transfusion
4808841|NCT02569580|anti-lice treatment|anti-lice treatment
4808842|NCT02569567|Smart-Shear Wave(SSW)|smart-shear wave(ssw)
4808843|NCT02569567|Transient Elastography(TE)|transient elastography(te)
4808844|NCT02569567|Liver cirrhosis|liver cirrhosis
4808845|NCT02569554|PF-06463922|pf-06463922
4808846|NCT02569554|rabeprazole|rabeprazole
4808847|NCT02569554|proton pump inhibitor (PPI)|proton pump inhibitor (ppi)
4808848|NCT02569554|pharmacokinetics(PK)|pharmacokinetics(pk)
4808849|NCT02569554|food effect|food effect
4808850|NCT02569541|fusidic acid|fusidic acid
4808851|NCT02569541|prosthetic joint infections|prosthetic joint infections
4808852|NCT02569541|bone infections|bone infections
4808853|NCT02569541|osteomyelitis|osteomyelitis
4808854|NCT02569528|atrial fibrillation|atrial fibrillation
4808855|NCT02569528|anticoagulation|anticoagulation
4808856|NCT02569476|BGB-3111|bgb-3111
4808857|NCT02569476|Obinutuzumab|obinutuzumab
4808858|NCT02569476|B-cell|b-cell
4808859|NCT02569476|Lymphoma|lymphoma
4808860|NCT02569476|Leukemia|leukemia
4808861|NCT02569476|Therapeutic uses|therapeutic uses
4808862|NCT02569450|Surgery|surgery
4808863|NCT02569450|Performance|performance
4808864|NCT02569450|Outcome|outcome
4808865|NCT02569450|Control chart|control chart
4808866|NCT02569437|doxycycline|doxycycline
4808867|NCT02569437|oral methylprednisone|oral methylprednisone
4808868|NCT02569437|sinusitis with nasal polyps|sinusitis with nasal polyps
4808869|NCT02569424|PEEP level|peep level
4808870|NCT02569424|Trendelenburg position|trendelenburg position
4808871|NCT02569424|cross-sectional area of the jugular and subclavian veins|cross-sectional area of the jugular and subclavian veins
4808872|NCT02569424|central venous catheter|central venous catheter
4808873|NCT02569398|Alzheimer disease|alzheimer disease
4808874|NCT02569398|Atabecestat|atabecestat
4808875|NCT02569398|Dementia|dementia
4808876|NCT02569385|Weaning TTE|weaning tte
4808877|NCT02569385|patients in prolonged weaning|patients in prolonged weaning
4808878|NCT02569346|Triumeq|triumeq
4808879|NCT02569346|Pharmacokinetics|pharmacokinetics
4808880|NCT02569346|Crushing|crushing
4808881|NCT02569346|Drip feed|drip feed
4808882|NCT02569333|ulcerative colitis|ulcerative colitis
4808883|NCT02569333|inflammatory bowel disease|inflammatory bowel disease
4808884|NCT02569333|education|education
4808885|NCT02569333|patient-reported outcomes|patient-reported outcomes
4808886|NCT02569307|At Risk of Mental State|at risk of mental state
4808887|NCT02569307|Prodromal Phase|prodromal phase
4808888|NCT02569307|Psychosis|psychosis
4808889|NCT02569294|group interventions|group interventions
4808890|NCT02569294|emotional distress|emotional distress
4808891|NCT02569294|breast cancer|breast cancer
4808892|NCT02569294|yoga|yoga
4808893|NCT02569294|hypnosis|hypnosis
4808894|NCT02569294|cognitive-behavioral therapy|cognitive-behavioral therapy
4808895|NCT02569281|Subacromial pain syndrome|subacromial pain syndrome
4808896|NCT02569281|Eccentric exercise|eccentric exercise
4808897|NCT02569281|Pressure pain|pressure pain
4808898|NCT02569281|US-guided percutaneous electrolysis|us-guided percutaneous electrolysis
4808899|NCT02569268|Arteriosclerosis|arteriosclerosis
4808900|NCT02569268|Vascular function|vascular function
4808901|NCT02569268|Vascular disease early detection system|vascular disease early detection system
4808902|NCT02569229|children|children
4808903|NCT02569229|cystic fibrosis|cystic fibrosis
4808904|NCT02569229|glucose intolerance|glucose intolerance
4808905|NCT02569229|continuous glucose measurement|continuous glucose measurement
4808906|NCT02569216|Electrical Inhibition|electrical inhibition
4808907|NCT02569216|Preterm Birth|preterm birth
4808908|NCT02569216|Premature Birth|premature birth
4808909|NCT02569216|Preterm Labor|preterm labor
4808910|NCT02569216|Premature Labor|premature labor
4808911|NCT02569216|tocolytic|tocolytic
4808912|NCT02569216|uterus|uterus
4808913|NCT02569177|myocardial infarction|myocardial infarction
4808914|NCT02569177|cardiac surgery|cardiac surgery
4808915|NCT02569177|troponin|troponin
4808916|NCT02569177|heart-type fatty acid binding protein|heart-type fatty acid binding protein
4808917|NCT02569138|Balance|balance
4808918|NCT02569138|Footwear|footwear
4808919|NCT02569138|Shoes|shoes
4808920|NCT02569138|Falls|falls
4808921|NCT02569125|segmental overgrowth syndrome|segmental overgrowth syndrome
4808922|NCT02569099|stroke survivors|stroke survivors
4808923|NCT02569099|caregivers|caregivers
4808924|NCT02569099|burden of care|burden of care
4808925|NCT02569099|quality of life|quality of life
4808926|NCT02569099|function|function
4808927|NCT02569099|community reintegration|community reintegration
4808928|NCT02569099|caregiver training|caregiver training
4808929|NCT02569086|Sepsis|sepsis
4808930|NCT02569086|Therapeutic Drug Monitoring|therapeutic drug monitoring
4808931|NCT02569086|Beta-lactams|beta-lactams
4808932|NCT02569086|Pharmacokinetics|pharmacokinetics
4808933|NCT02569073|Functional Chest Pain|functional chest pain
4808934|NCT02569073|Non-Cardiac Chest Pain|non-cardiac chest pain
4808935|NCT02569073|Esophageal Hypersensitivity|esophageal hypersensitivity
4808936|NCT02569060|diabetes mellitus|diabetes mellitus
4808937|NCT02569060|community intervention|community intervention
4808938|NCT02569060|intervention|intervention
4808939|NCT02569060|randomized|randomized
4808940|NCT02569060|dietary intervention|dietary intervention
4808941|NCT02569060|self-management support|self-management support
4808942|NCT02569060|food bank|food bank
4808943|NCT02569047|Atraumatic Restorative Treatment|atraumatic restorative treatment
4808944|NCT02569047|Occlusoproximal|occlusoproximal
4808945|NCT02569047|Primary Teeth|primary teeth
4808946|NCT02569047|Glass Ionomer Cements|glass ionomer cements
4808947|NCT02569047|Hall Technique|hall technique
4808948|NCT02569021|Parkinsons Disease|parkinsons disease
4808949|NCT02569021|Essential Tremor|essential tremor
4808950|NCT02569021|DBS|dbs
4808951|NCT02569021|Depp Brain Stimulation|depp brain stimulation
4808952|NCT02569008|Fluid Challenge|fluid challenge
4808953|NCT02569008|Mean systemic filling pressure|mean systemic filling pressure
4808954|NCT02569008|Fluid therapy|fluid therapy
4808955|NCT02568995|postoperative pain|postoperative pain
4808956|NCT02568995|morphine|morphine
4808957|NCT02568995|total hip arthroplasty|total hip arthroplasty
4808958|NCT02568995|femoral nerve block|femoral nerve block
4808959|NCT02568982|Cushing's disease|cushing's disease
4808960|NCT02568982|Quality of life|quality of life
4808961|NCT02568982|Metabolic|metabolic
4808962|NCT02568982|patients with Cushing's disease|patients with cushing's disease
4808963|NCT02568982|cardiovascular|cardiovascular
4808964|NCT02568982|thromboembolic|thromboembolic
4808965|NCT02568982|bone complications|bone complications
4808966|NCT02568969|Cardiosurgery, lactate|cardiosurgery, lactate
4808967|NCT02568943|multiple myelome, MM, expanded treatment, panobinostat, bortezomib, dexamethasone, relapsed, refractory, LBH589|multiple myelome, mm, expanded treatment, panobinostat, bortezomib, dexamethasone, relapsed, refractory, lbh589
4808968|NCT02568930|quality of life heart failure mechanical support transplant|quality of life heart failure mechanical support transplant
4808969|NCT02568917|Dental Atraumatic Restorative Treatment|dental atraumatic restorative treatment
4808970|NCT02568917|Composite Resins|composite resins
4808971|NCT02568917|Primary Teeth|primary teeth
4808972|NCT02568917|Permanent Teeth|permanent teeth
4808973|NCT02568917|Clinical Effectiveness|clinical effectiveness
4808974|NCT02568917|Cost Analysis|cost analysis
4808975|NCT02568878|Depression|depression
4808976|NCT02568878|Anxiety|anxiety
4808977|NCT02568878|Methamphetamine dependence|methamphetamine dependence
4808978|NCT02568852|D-dimer|d-dimer
4808979|NCT02568852|Fibrinogen|fibrinogen
4808980|NCT02568852|Laparoscopic cholecystectomy|laparoscopic cholecystectomy
4808981|NCT02568839|Neoadjuvant therapy|neoadjuvant therapy
4808982|NCT02568826|Low Back Pain|low back pain
4808983|NCT02568826|Muscle relaxant|muscle relaxant
4808984|NCT02568813|epilepsy|epilepsy
4808985|NCT02568813|depression|depression
4808986|NCT02568813|mood disorder|mood disorder
4808987|NCT02568813|anxiety|anxiety
4808988|NCT02568813|cyclothymia|cyclothymia
4808989|NCT02568813|Behavioral neuropsychiatric features|behavioral neuropsychiatric features
4808990|NCT02568787|NAFLD|nafld
4808991|NCT02568787|cytokines|cytokines
4808992|NCT02568787|interleukin (IL)|interleukin (il)
4808993|NCT02568787|interferon (IFN)|interferon (ifn)
4808994|NCT02568787|liver function test (LFTS)|liver function test (lfts)
4808995|NCT02568787|nutrition|nutrition
4808996|NCT02568787|bran arabinoxylan compound (RBAC)|bran arabinoxylan compound (rbac)
4808997|NCT02568787|tumor necrosis factor -- type I receptor (TNF-RI)|tumor necrosis factor -- type i receptor (tnf-ri)
4808998|NCT02568787|TNF-RII (tumor necrosis factor -- type II receptor (TNF-RII)|tnf-rii (tumor necrosis factor -- type ii receptor (tnf-rii)
4808999|NCT02568774|Post-stroke|post-stroke
4809000|NCT02568761|Snoring|snoring
4809001|NCT02568761|Sleep apnea|sleep apnea
4809002|NCT02568761|Obstructive sleep apnea|obstructive sleep apnea
4809003|NCT02568761|Speech therapy|speech therapy
4809004|NCT02568761|Injection snoreplasty|injection snoreplasty
4809005|NCT02568761|Ethanol|ethanol
4809006|NCT02568761|Oropharyngeal exercises|oropharyngeal exercises
4809007|NCT02568735|Dexketoprofen|dexketoprofen
4809008|NCT02568735|Etoricoxib|etoricoxib
4809009|NCT02568735|hip arthroplasty|hip arthroplasty
4809010|NCT02568735|pain|pain
4809011|NCT02568722|Renal replacement therapy|renal replacement therapy
4809012|NCT02568722|Acute kidney injury|acute kidney injury
4809013|NCT02568722|Dialysis|dialysis
4809014|NCT02568722|Hemodialysis|hemodialysis
4809015|NCT02568722|Critical illness|critical illness
4809017|NCT02568709|Syntocinon|syntocinon
4809018|NCT02568709|Social Cognition|social cognition
4809019|NCT02568709|Schizophrenia|schizophrenia
4809020|NCT02568709|Magnetoencephalography (MEG)|magnetoencephalography (meg)
4809021|NCT02568696|kidney transplantation|kidney transplantation
4809022|NCT02568696|renal transplantation|renal transplantation
4809023|NCT02568696|fibrinolysis|fibrinolysis
4809024|NCT02568696|cell mediated rejection|cell mediated rejection
4809025|NCT02568696|coagulation|coagulation
4809026|NCT02568696|delayed graft function|delayed graft function
4809027|NCT02568696|Halloran criteria|halloran criteria
4809028|NCT02568696|graft rejection|graft rejection
4809029|NCT02568696|thrombin generation|thrombin generation
4809030|NCT02568696|fibrin generation|fibrin generation
4809031|NCT02568683|DLBCL|dlbcl
4809032|NCT02568683|Relapsed|relapsed
4809033|NCT02568683|Refractory|refractory
4809034|NCT02568644|Migraine|migraine
4809035|NCT02568644|Ginger|ginger
4809036|NCT02568644|Acute treatment|acute treatment
4809037|NCT02568631|Autistic Disorder|autistic disorder
4809038|NCT02568618|Military|military
4809039|NCT02568618|Genomics|genomics
4809040|NCT02568618|Pain|pain
4809041|NCT02568605|Dietary intervention|dietary intervention
4809042|NCT02568605|Prebiotic fibre|prebiotic fibre
4809043|NCT02568605|Weight loss|weight loss
4809044|NCT02568605|Gut microbiota|gut microbiota
4809045|NCT02568605|Obesity|obesity
4809046|NCT02568605|Liver fat|liver fat
4809047|NCT02568605|Hepatic fibrosis|hepatic fibrosis
4809048|NCT02568540|Hepatitis C|hepatitis c
4809049|NCT02568540|Smartphone|smartphone
4809050|NCT02568540|app|app
4809051|NCT02568540|Tracker|tracker
4809052|NCT02568540|C Tracker|c tracker
4809053|NCT02568527|LSCD|lscd
4809054|NCT02568527|SLET|slet
4809055|NCT02568527|Donor Human Amniotic Membrane (hAM)|donor human amniotic membrane (ham)
4809056|NCT02568527|PLGA|plga
4809057|NCT02568514|mhealth|mhealth
4809058|NCT02568514|text messaging|text messaging
4809059|NCT02568514|secure text messaging|secure text messaging
4809060|NCT02568514|communication|communication
4809061|NCT02568501|diabetes|diabetes
4809062|NCT02568501|adolescent|adolescent
4809063|NCT02568501|young adult|young adult
4809064|NCT02568501|behavioral economics|behavioral economics
4809065|NCT02568501|financial incentives|financial incentives
4809066|NCT02568501|social incentives|social incentives
4809067|NCT02568475|nursing home residents, decision aid, acute care transfers|nursing home residents, decision aid, acute care transfers
4809068|NCT02568462|Stents|stents
4809069|NCT02568462|Angioplasty|angioplasty
4809070|NCT02568462|Coronary Vessels|coronary vessels
4809071|NCT02568462|Coronary Artery Disease|coronary artery disease
4809072|NCT02568462|Angina Pectoris|angina pectoris
4809073|NCT02568462|Myocardial Ischemia|myocardial ischemia
4809074|NCT02568462|Myocardial Infarction|myocardial infarction
4809075|NCT02568462|Myocardial Revascularization|myocardial revascularization
4809076|NCT02568410|Mast Cells|mast cells
4809077|NCT02568410|Blood Platelets|blood platelets
4809078|NCT02568410|cardiac surgical procedures|cardiac surgical procedures
4809079|NCT02568371|biobank|biobank
4809080|NCT02568371|DNA|dna
4809081|NCT02568371|genetic|genetic
4809082|NCT02568371|young adults|young adults
4809083|NCT02568371|cohort study|cohort study
4809084|NCT02568345|Dose-Response Relationship|dose-response relationship
4809085|NCT02568345|Drug|drug
4809086|NCT02568345|Obesity|obesity
4809087|NCT02568345|Cyclodextrins|cyclodextrins
4809088|NCT02568267|Entrectinib|entrectinib
4809089|NCT02568267|RXDX-101|rxdx-101
4809090|NCT02568267|TrkA|trka
4809091|NCT02568267|TrkB|trkb
4809092|NCT02568267|TrkC|trkc
4809093|NCT02568267|NTRK1|ntrk1
4809094|NCT02568267|NTRK2|ntrk2
4809095|NCT02568267|NTRK3|ntrk3
4809096|NCT02568267|ROS1|ros1
4809097|NCT02568267|ALK|alk
4809098|NCT02568267|Trk Fusions|trk fusions
4809099|NCT02568267|NTRK Gene Rearrangements|ntrk gene rearrangements
4809100|NCT02568267|ROS1 Fusions|ros1 fusions
4809101|NCT02568267|ROS1 Gene Rearrangements|ros1 gene rearrangements
4809102|NCT02568267|ALK Fusions|alk fusions
4809103|NCT02568267|ALK Gene Rearrangements|alk gene rearrangements
4809104|NCT02568267|Basket study|basket study
4809105|NCT02568267|Non-small cell lung cancer|non-small cell lung cancer
4809106|NCT02568267|Colorectal cancer|colorectal cancer
4809107|NCT02568267|Salivary gland cancers|salivary gland cancers
4809108|NCT02568267|Primary brain tumors|primary brain tumors
4809109|NCT02568267|Melanoma|melanoma
4809110|NCT02568267|Sarcomas|sarcomas
4809111|NCT02568267|Papillary thyroid cancer|papillary thyroid cancer
4809112|NCT02568267|Renal cell cancer|renal cell cancer
4809113|NCT02568267|Pancreatic cancer|pancreatic cancer
4809114|NCT02568267|Breast cancer|breast cancer
4809115|NCT02568267|Cholangiocarcinoma|cholangiocarcinoma
4809116|NCT02568267|Head & Neck cancers|head & neck cancers
4809117|NCT02568267|Ovarian cancer|ovarian cancer
4809118|NCT02568267|Neuroendocrine tumors|neuroendocrine tumors
4809119|NCT02568267|Anaplastic Large Cell Lymphoma|anaplastic large cell lymphoma
4809120|NCT02568241|Interferon Alfa-2b|interferon alfa-2b
4809121|NCT02568241|Relapse|relapse
4809226|NCT02567643|CNS|cns
4809122|NCT02568241|Donor lymphocyte infusion|donor lymphocyte infusion
4809123|NCT02568228|Triacylglycerols|triacylglycerols
4809124|NCT02568228|Omega-3 fatty acids|omega-3 fatty acids
4809125|NCT02568228|Krill oil|krill oil
4809126|NCT02568228|Fish|fish
4809127|NCT02568228|Healthy Volunteers|healthy volunteers
4809128|NCT02568215|HIV-1 Infections|hiv-1 infections
4809129|NCT02568189|Sepsis|sepsis
4809130|NCT02568189|Gastroenteritis|gastroenteritis
4809131|NCT02568189|Dehydration|dehydration
4809132|NCT02568189|Ultrasound|ultrasound
4809133|NCT02568189|Ultrasonography|ultrasonography
4809134|NCT02568189|Inferior Vena Cava|inferior vena cava
4809135|NCT02568176|Healthy|healthy
4809136|NCT02568176|Pharmacokinetics|pharmacokinetics
4809137|NCT02568176|Esketamine|esketamine
4809138|NCT02568176|JNJ-54135419|jnj-54135419
4809139|NCT02568176|Midazolam|midazolam
4809140|NCT02568176|Bupropion|bupropion
4809141|NCT02568137|mobile health|mobile health
4809142|NCT02568137|Behavior change|behavior change
4809143|NCT02568137|Africa|africa
4809144|NCT02568124|Tranexamic acid|tranexamic acid
4809145|NCT02568124|Cyklokapron|cyklokapron
4809146|NCT02568124|Conservative management|conservative management
4809147|NCT02568124|Medical management|medical management
4809148|NCT02568111|erythema|erythema
4809149|NCT02568111|PLEGRIDY|plegridy
4809150|NCT02568111|injection site reaction (ISR)|injection site reaction (isr)
4809151|NCT02568111|MS|ms
4809152|NCT02568111|RRMS|rrms
4809153|NCT02568098|Drug combination|drug combination
4809154|NCT02568098|Ivermectin|ivermectin
4809155|NCT02568098|Primaquine|primaquine
4809156|NCT02568098|Dihydroartemisinin-Piperaquine|dihydroartemisinin-piperaquine
4809157|NCT02568098|Albendazole|albendazole
4809158|NCT02568098|Pharmacokinetics|pharmacokinetics
4809159|NCT02568098|Mosquito-Lethal Effect|mosquito-lethal effect
4809160|NCT02568098|Healthy adult subject|healthy adult subject
4809161|NCT02568072|exercise|exercise
4809162|NCT02568072|cardiac remodelling|cardiac remodelling
4809163|NCT02568072|left ventricular non-compaction cardiomyopathy|left ventricular non-compaction cardiomyopathy
4809164|NCT02568046|Metastatic Colorectal Cancer|metastatic colorectal cancer
4809165|NCT02567981|chronic undernutrition|chronic undernutrition
4809166|NCT02567981|anemia|anemia
4809167|NCT02567981|micronutrient supplement|micronutrient supplement
4809168|NCT02567955|HPV vaccines, interchangeable use|hpv vaccines, interchangeable use
4809169|NCT02567877|hypothyroidism|hypothyroidism
4809170|NCT02567877|deiodinase polymorphism|deiodinase polymorphism
4809171|NCT02567877|cognitive function|cognitive function
4809172|NCT02567877|thyroidectomy|thyroidectomy
4809173|NCT02567877|levothyroxine|levothyroxine
4809174|NCT02567851|Brentuximab Vedotin|brentuximab vedotin
4809175|NCT02567851|PET scans|pet scans
4809176|NCT02567851|Lymphoma|lymphoma
4809177|NCT02567825|ear infection|ear infection
4809178|NCT02567825|antibiotics|antibiotics
4809179|NCT02567825|infants|infants
4809180|NCT02567825|children|children
4809181|NCT02567825|pediatrics|pediatrics
4809182|NCT02567825|tympanostomy tubes|tympanostomy tubes
4809183|NCT02567799|Lung Neoplasms|lung neoplasms
4809184|NCT02567773|Itraconazole|itraconazole
4809185|NCT02567773|GSK2881078|gsk2881078
4809186|NCT02567773|CYP3A4|cyp3a4
4809187|NCT02567773|Selective Androgen Receptor Modulator|selective androgen receptor modulator
4809188|NCT02567773|Safety|safety
4809189|NCT02567773|Pharmacokinetics|pharmacokinetics
4809190|NCT02567773|Tolerability|tolerability
4809191|NCT02567760|MP1|mp1
4809192|NCT02567760|cognitive enhancing effect|cognitive enhancing effect
4809193|NCT02567760|menopausal women|menopausal women
4809194|NCT02567747|Colombia|colombia
4809195|NCT02567747|otitis|otitis
4809196|NCT02567747|Database|database
4809197|NCT02567747|pneumonia|pneumonia
4809198|NCT02567734|irreversible electroporation|irreversible electroporation
4809199|NCT02567734|ablation|ablation
4809200|NCT02567734|neoplasms|neoplasms
4809201|NCT02567734|cancer|cancer
4809202|NCT02567734|carcinoma|carcinoma
4809203|NCT02567734|NanoKnife|nanoknife
4809204|NCT02567734|Ablation Techniques|ablation techniques
4809205|NCT02567721|Post-authorisation safety study (PASS)|post-authorisation safety study (pass)
4809206|NCT02567721|Adverse Drug Reaction Reporting Systems|adverse drug reaction reporting systems
4809207|NCT02567721|Post marketing product surveillance|post marketing product surveillance
4809208|NCT02567721|European Medicines Agency (EMA)|european medicines agency (ema)
4809209|NCT02567721|Influenza Vaccine|influenza vaccine
4809210|NCT02567721|Computerized Medical Record System|computerized medical record system
4809211|NCT02567721|United Kingdom|united kingdom
4809212|NCT02567721|Primary Health Care|primary health care
4809213|NCT02567708|GSK2269557|gsk2269557
4809214|NCT02567708|Asthma|asthma
4809215|NCT02567708|Pharmacokinetics|pharmacokinetics
4809216|NCT02567708|Safety|safety
4809217|NCT02567708|Adults|adults
4809218|NCT02567708|DISKUS Dry Powder Inhaler|diskus dry powder inhaler
4809219|NCT02567708|Efficacy|efficacy
4809220|NCT02567682|anemia, sickle cell|anemia, sickle cell
4809221|NCT02567669|radiotherapy|radiotherapy
4809222|NCT02567656|CTCL|ctcl
4809223|NCT02567656|PTCL|ptcl
4809224|NCT02567656|RP6530|rp6530
4809225|NCT02567643|Brain|brain
4809227|NCT02567643|Metastases|metastases
4809228|NCT02567630|Cerebral Palsy|cerebral palsy
4809229|NCT02567630|physical|physical
4809230|NCT02567630|sensory|sensory
4809231|NCT02567630|motor impairments|motor impairments
4809232|NCT02567630|upper extremity|upper extremity
4809233|NCT02567630|Constraint-Induced Movement Therapy|constraint-induced movement therapy
4809234|NCT02567617|Polyphenols, Prostaglandin E2, hormonal contraceptives|polyphenols, prostaglandin e2, hormonal contraceptives
4809235|NCT02567591|pre liver transplantation patients|pre liver transplantation patients
4809236|NCT02567552|endometrial receptivity|endometrial receptivity
4809237|NCT02567552|endometrial predecidualization|endometrial predecidualization
4809238|NCT02567552|endometrial genomics|endometrial genomics
4809239|NCT02567552|endometrial receptivity array|endometrial receptivity array
4809240|NCT02567526|food and fluid intake|food and fluid intake
4809241|NCT02567526|nursing home residents|nursing home residents
4809242|NCT02567526|staffing|staffing
4809243|NCT02567513|food and fluid intake|food and fluid intake
4809244|NCT02567513|nursing homes|nursing homes
4809245|NCT02567500|emotional|emotional
4809246|NCT02567500|auditory hallucinations|auditory hallucinations
4809247|NCT02567500|non-psychotic children|non-psychotic children
4809248|NCT02567474|chronic lung disease|chronic lung disease
4809249|NCT02567461|dual antiplatelet therapy|dual antiplatelet therapy
4809250|NCT02567461|clopidogrel|clopidogrel
4809251|NCT02567461|aspirin|aspirin
4809252|NCT02567461|edoxaban|edoxaban
4809253|NCT02567448|Obstructive Sleep Apnea|obstructive sleep apnea
4809254|NCT02567448|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
4809255|NCT02567448|Overlap syndrome|overlap syndrome
4809256|NCT02567448|Pcrit|pcrit
4809257|NCT02567448|Critical closing pressure|critical closing pressure
4809258|NCT02567383|head and neck cancer|head and neck cancer
4809259|NCT02567383|hyperthermia, Thermotron RF-8|hyperthermia, thermotron rf-8
4809260|NCT02567383|radiotherapy|radiotherapy
4809261|NCT02567370|Schizophrenia or Schizoaffective Disorder|schizophrenia or schizoaffective disorder
4809262|NCT02567357|change triggered temper outbursts|change triggered temper outbursts
4809263|NCT02567357|parent training|parent training
4809264|NCT02567357|autism|autism
4809265|NCT02567357|intellectual disability|intellectual disability
4809266|NCT02567357|Prader-Willi syndrome|prader-willi syndrome
4809267|NCT02567357|Fragile X syndrome|fragile x syndrome
4809268|NCT02567357|web-based training|web-based training
4809269|NCT02567357|Down syndrome|down syndrome
4809270|NCT02567344|Cannabis|cannabis
4809271|NCT02567344|rTMS|rtms
4809272|NCT02567344|Craving|craving
4809273|NCT02567344|Decision making|decision making
4809274|NCT02567318|Pain|pain
4809275|NCT02567318|Secondary hyperalgesia|secondary hyperalgesia
4809276|NCT02567318|Healthy volunteers|healthy volunteers
4809277|NCT02567318|Magnetic Resonance Imaging|magnetic resonance imaging
4809278|NCT02567292|Digestive Disease and Disorders|digestive disease and disorders
4809279|NCT02567292|Neonatal|neonatal
4809280|NCT02567292|Pediatric Disorders|pediatric disorders
4809281|NCT02567253|Cytoreductive surgery|cytoreductive surgery
4809282|NCT02567253|(H)ipec|(h)ipec
4809283|NCT02567253|Ovarian cancer|ovarian cancer
4809284|NCT02567253|Cisplatin|cisplatin
4809285|NCT02567253|Peritoneal carcinomatosis|peritoneal carcinomatosis
4809286|NCT02567253|Pharmacokinetics|pharmacokinetics
4809287|NCT02567253|Pharmacodynamics|pharmacodynamics
4809288|NCT02567214|dyspnea|dyspnea
4809289|NCT02567214|exercise|exercise
4809290|NCT02567214|shuttle test|shuttle test
4809291|NCT02567214|long-acting β2-agonists|long-acting β2-agonists
4809292|NCT02567214|longacting muscarinic antagonist|longacting muscarinic antagonist
4809293|NCT02567214|indacaterol|indacaterol
4809294|NCT02567214|glycopyrronium|glycopyrronium
4809295|NCT02567214|tiotropium|tiotropium
4809296|NCT02567201|Voluntary attention|voluntary attention
4809297|NCT02567201|Electroencephalogram|electroencephalogram
4809298|NCT02567201|Brain-computer interface|brain-computer interface
4809299|NCT02567201|Disorders of consciousness|disorders of consciousness
4809300|NCT02567162|Intracerebral hemorrhage|intracerebral hemorrhage
4809301|NCT02567162|Hemorrhagic stroke|hemorrhagic stroke
4809302|NCT02567162|Intraparenchymal hemorrhage|intraparenchymal hemorrhage
4809303|NCT02567162|Cerebrovascular disease|cerebrovascular disease
4809304|NCT02567162|Stroke|stroke
4809305|NCT02567149|Wart|wart
4809306|NCT02567110|Mid-life Depression|mid-life depression
4809307|NCT02567110|Bipolar Disorder|bipolar disorder
4809308|NCT02567110|DSM-5 MDE|dsm-5 mde
4809309|NCT02567110|Inflammation|inflammation
4809310|NCT02567110|CNS Glutamate|cns glutamate
4809311|NCT02567084|Bone substitute|bone substitute
4809312|NCT02567084|benign bone cyst|benign bone cyst
4809313|NCT02567084|ceramic|ceramic
4809314|NCT02567084|remodelling|remodelling
4809315|NCT02567071|C-section|c-section
4809316|NCT02567071|Microbiota|microbiota
4809317|NCT02567058|Achilles tendon|achilles tendon
4809318|NCT02567045|Immunochemical fecal occult blood test|immunochemical fecal occult blood test
4809319|NCT02567045|Colonoscopy|colonoscopy
4809320|NCT02567045|Screening uptake|screening uptake
4809321|NCT02567045|Screening participation|screening participation
4809322|NCT02567045|Familiar risk|familiar risk
4809420|NCT02566499|Microwaves|microwaves
4809323|NCT02567045|Colorectal Cancer|colorectal cancer
4809324|NCT02567032|Oxytocin|oxytocin
4809325|NCT02567032|Syntocinon|syntocinon
4809326|NCT02567032|Social Cognition|social cognition
4809327|NCT02567032|Schizophrenia|schizophrenia
4809328|NCT02567032|Psychosis|psychosis
4809329|NCT02567032|Schizoaffective Disorder|schizoaffective disorder
4809330|NCT02567032|Schizophreniform Disorder|schizophreniform disorder
4809331|NCT02567032|Psychotic Disorders|psychotic disorders
4809332|NCT02567006|vaccines|vaccines
4809333|NCT02567006|reminders|reminders
4809334|NCT02567006|immunization timeliness|immunization timeliness
4809335|NCT02567006|vaccine coverage|vaccine coverage
4809336|NCT02566980|depression|depression
4809337|NCT02566980|mood disorder|mood disorder
4809338|NCT02566980|post-partum depression|post-partum depression
4809339|NCT02566980|suicidality|suicidality
4809340|NCT02566980|post-partum suicidality|post-partum suicidality
4809341|NCT02566980|perinatal depression|perinatal depression
4809342|NCT02566980|perinatal mood disorder|perinatal mood disorder
4809343|NCT02566980|inflammation|inflammation
4809344|NCT02566980|kynurenine pathway|kynurenine pathway
4809345|NCT02566980|glutamate|glutamate
4809346|NCT02566954|radiology|radiology
4809347|NCT02566954|3D measurement|3d measurement
4809348|NCT02566954|lower limb|lower limb
4809349|NCT02566941|critical illness polyneuropathy|critical illness polyneuropathy
4809350|NCT02566941|critical illness myopathy|critical illness myopathy
4809351|NCT02566941|neuromuscular electrical stimulation|neuromuscular electrical stimulation
4809352|NCT02566941|intensive care unit acquired weakness|intensive care unit acquired weakness
4809353|NCT02566941|prevention of critical illness polyneuropathy|prevention of critical illness polyneuropathy
4809354|NCT02566928|Methicillin-Resistant Staphylococcus aureus|methicillin-resistant staphylococcus aureus
4809355|NCT02566928|Recurrence|recurrence
4809356|NCT02566928|Practice Based Research Network|practice based research network
4809357|NCT02566928|Community Health Workers/Promotoras|community health workers/promotoras
4809358|NCT02566928|Decolonization and Decontamination|decolonization and decontamination
4809359|NCT02566928|Staphylococcal Skin Infections|staphylococcal skin infections
4809360|NCT02566928|Household Transmission|household transmission
4809361|NCT02566889|Pediatric Inflammatory Bowel Disease|pediatric inflammatory bowel disease
4809362|NCT02566889|Infliximab|infliximab
4809363|NCT02566889|Pediatric Participants|pediatric participants
4809364|NCT02566889|Pediatric Ulcerative Colitis|pediatric ulcerative colitis
4809365|NCT02566889|Pediatric Crohn's Disease|pediatric crohn's disease
4809366|NCT02566889|Dose Escalation|dose escalation
4809367|NCT02566876|Children|children
4809368|NCT02566876|Abdominal Pain|abdominal pain
4809369|NCT02566876|Functional Dyspepsia|functional dyspepsia
4809370|NCT02566876|Irritable Bowel Syndrome|irritable bowel syndrome
4809371|NCT02566876|Quality of Life|quality of life
4809372|NCT02566863|dexmedetomidine|dexmedetomidine
4809373|NCT02566863|heart rate|heart rate
4809374|NCT02566863|heart rate variability|heart rate variability
4809375|NCT02566837|ultrasound|ultrasound
4809376|NCT02566837|Electrical stimulation guidance|electrical stimulation guidance
4809377|NCT02566837|botulinum toxin|botulinum toxin
4809378|NCT02566772|Prostate Cancer|prostate cancer
4809379|NCT02566759|Drug therapy|drug therapy
4809380|NCT02566733|remifentanil|remifentanil
4809381|NCT02566720|amantadine|amantadine
4809382|NCT02566720|tractography|tractography
4809383|NCT02566720|mri|mri
4809384|NCT02566720|coma|coma
4809385|NCT02566720|abi|abi
4809386|NCT02566720|tbi|tbi
4809387|NCT02566720|traumatic brain injury|traumatic brain injury
4809388|NCT02566720|acquired brain injury|acquired brain injury
4809389|NCT02566668|Asthma|asthma
4809390|NCT02566668|Severe Asthma|severe asthma
4809391|NCT02566668|IL-10|il-10
4809392|NCT02566668|IL-27|il-27
4809393|NCT02566668|IL-13|il-13
4809394|NCT02566668|Epithelial Cells|epithelial cells
4809395|NCT02566668|T lymphocytes|t lymphocytes
4809396|NCT02566668|Interferon-g|interferon-g
4809397|NCT02566629|microbiota community|microbiota community
4809398|NCT02566629|IBS|ibs
4809399|NCT02566603|ITP|itp
4809400|NCT02566603|Thrombocytopenia|thrombocytopenia
4809401|NCT02566577|Chronic anemia|chronic anemia
4809402|NCT02566577|Cardiopulmonary testing|cardiopulmonary testing
4809403|NCT02566577|Transfusion-dependent anemia|transfusion-dependent anemia
4809404|NCT02566551|Prostatic artery embolization|prostatic artery embolization
4809405|NCT02566551|Transurethral resection of the prostate|transurethral resection of the prostate
4809406|NCT02566538|Cohort study|cohort study
4809407|NCT02566538|psychometric tests|psychometric tests
4809408|NCT02566538|cognitive function|cognitive function
4809409|NCT02566538|cardiovascular risk|cardiovascular risk
4809410|NCT02566538|prediction algorithm|prediction algorithm
4809411|NCT02566525|CytoSorb device|cytosorb device
4809412|NCT02566525|Plasma free hemoglobin|plasma free hemoglobin
4809413|NCT02566525|inflammation|inflammation
4809414|NCT02566525|extracorporeal bypass|extracorporeal bypass
4809415|NCT02566512|Tracheostomy|tracheostomy
4809416|NCT02566512|weaning|weaning
4809417|NCT02566512|respiratory failure|respiratory failure
4809418|NCT02566512|cough strength|cough strength
4809419|NCT02566499|Medical imaging|medical imaging
4809421|NCT02566473|Patient reported outcomes|patient reported outcomes
4809422|NCT02566473|Osteoarthritis|osteoarthritis
4809423|NCT02566473|Total joint replacement|total joint replacement
4809424|NCT02566460|Lactate clearance|lactate clearance
4809425|NCT02566460|systemic central venous oxygen saturation|systemic central venous oxygen saturation
4809426|NCT02566460|septic shock|septic shock
4809427|NCT02566460|haemodynamic therapy|haemodynamic therapy
4809428|NCT02566434|Dietary Supplements|dietary supplements
4809429|NCT02566395|Stem Cell Transplantation|stem cell transplantation
4809430|NCT02566395|Haploidentical Donors|haploidentical donors
4809431|NCT02566369|Efficacy|efficacy
4809432|NCT02566369|Safety|safety
4809433|NCT02566369|Acne vulgaris|acne vulgaris
4809434|NCT02566356|Oxytocin|oxytocin
4809435|NCT02566356|Syntocinon|syntocinon
4809436|NCT02566356|Social Cognition|social cognition
4809437|NCT02566356|Schizophrenia|schizophrenia
4809438|NCT02566356|Functional Magnetic Resonance Imaging (fMRI)|functional magnetic resonance imaging (fmri)
4809439|NCT02566343|Spirometry|spirometry
4809440|NCT02566343|Exercise Test|exercise test
4809441|NCT02566343|Blood Gas Analysis|blood gas analysis
4809442|NCT02566343|Respiratory Function Tests|respiratory function tests
4809443|NCT02566343|Diagnostic Techniques, Respiratory System|diagnostic techniques, respiratory system
4809444|NCT02566343|Surgical Procedures, Operative|surgical procedures, operative
4809445|NCT02566330|EndoBarrier|endobarrier
4809446|NCT02566330|Duodenojejunal Bypass Liner|duodenojejunal bypass liner
4809447|NCT02566291|laryngeal mask|laryngeal mask
4809448|NCT02566291|airway leakage|airway leakage
4809449|NCT02566291|airway morbidity|airway morbidity
4809450|NCT02566278|Obstructive Sleep Apnea|obstructive sleep apnea
4809451|NCT02566278|Pcrit|pcrit
4809452|NCT02566278|Upper airway collapsibility|upper airway collapsibility
4809453|NCT02566265|influenza|influenza
4809454|NCT02566265|multiple myeloma|multiple myeloma
4809455|NCT02566265|Waldenstrom's macroglobulinemia|waldenstrom's macroglobulinemia
4809456|NCT02566252|Safety|safety
4809457|NCT02566252|tolerability|tolerability
4809458|NCT02566239|aging|aging
4809459|NCT02566239|ORCATECH|orcatech
4809460|NCT02566239|Oregon Center for Aging & Technology|oregon center for aging & technology
4809461|NCT02566239|Life Lab|life lab
4809462|NCT02566239|Living Lab|living lab
4809463|NCT02566239|in-home assessment|in-home assessment
4809464|NCT02566239|technology and aging|technology and aging
4809465|NCT02566213|volunteers|volunteers
4809466|NCT02566200|Acute coronary syndrome|acute coronary syndrome
4809467|NCT02566200|Cardiology|cardiology
4809468|NCT02566174|Cancer Caregivers|cancer caregivers
4809469|NCT02566174|Cancer Patients|cancer patients
4809470|NCT02566174|Role Adjustment|role adjustment
4809471|NCT02566174|Mutuality|mutuality
4809472|NCT02566174|Well-Being|well-being
4809473|NCT02566161|Genetics|genetics
4809474|NCT02566161|Genomics|genomics
4809475|NCT02566148|Life-event survey|life-event survey
4809476|NCT02566148|observational survey among migrants in France|observational survey among migrants in france
4809477|NCT02566135|C-LMA|c-lma
4809478|NCT02566135|I-gel|i-gel
4809479|NCT02566135|ventilating bougie|ventilating bougie
4809480|NCT02566135|intubation|intubation
4809481|NCT02566096|major abdominal cancer|major abdominal cancer
4809482|NCT02566070|Enteral feeding|enteral feeding
4809483|NCT02566070|Continuous gastric feeding|continuous gastric feeding
4809484|NCT02566070|Bolus gastric feeding|bolus gastric feeding
4809485|NCT02566044|Cystic Fibrosis|cystic fibrosis
4809486|NCT02566031|COPD|copd
4809487|NCT02566031|open-label|open-label
4809488|NCT02566031|QVA149|qva149
4809489|NCT02566031|symptomatic|symptomatic
4809490|NCT02566031|tiotropium|tiotropium
4809491|NCT02566018|elderly|elderly
4809492|NCT02566005|Misoprostol|misoprostol
4809493|NCT02566005|Induction|induction
4809494|NCT02566005|Foley|foley
4809495|NCT02565992|Pembrolizumab|pembrolizumab
4809496|NCT02565992|Coxsackievirus A21|coxsackievirus a21
4809497|NCT02565992|melanoma|melanoma
4809498|NCT02565992|CAVATAK|cavatak
4809499|NCT02565992|CVA21|cva21
4809500|NCT02565992|checkpoint inhibitor|checkpoint inhibitor
4809501|NCT02565979|Resveratrol|resveratrol
4809502|NCT02565979|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
4809503|NCT02565979|Insulin Resistance|insulin resistance
4809504|NCT02565979|Metabolic Diseases|metabolic diseases
4809505|NCT02565979|Glucose Metabolism Disorders|glucose metabolism disorders
4809506|NCT02565953|Vascular access devices obstruction|vascular access devices obstruction
4809507|NCT02565927|Trachea|trachea
4809508|NCT02565927|Stent|stent
4809509|NCT02565927|Intraluminal brachytherapy|intraluminal brachytherapy
4809510|NCT02565888|Hepatitis C|hepatitis c
4809511|NCT02565888|HIV|hiv
4809512|NCT02565888|atazanavir|atazanavir
4809513|NCT02565888|ritonavir|ritonavir
4809514|NCT02565888|daclatasvir|daclatasvir
4809515|NCT02565888|cobicistat|cobicistat
4809516|NCT02565875|Efficiency, Organizational|efficiency, organizational
4809517|NCT02565875|Simulation|simulation
4809518|NCT02565875|Communication|communication
4809519|NCT02565875|Laparoscopy|laparoscopy
4809520|NCT02565875|Medical Education|medical education
4809521|NCT02565862|HCV|hcv
4809522|NCT02565862|Diabetes Mellitus|diabetes mellitus
4809523|NCT02565862|Daclatasvir|daclatasvir
4809524|NCT02565862|Metformin|metformin
4809525|NCT02565862|drug-drug interaction|drug-drug interaction
4809526|NCT02565862|pharmacokinetics|pharmacokinetics
4809527|NCT02565836|Vitamin K 1|vitamin k 1
4809528|NCT02565836|prothrombin complex concentrates|prothrombin complex concentrates
4809529|NCT02565836|warfarin|warfarin
4809530|NCT02565823|Exercise|exercise
4809531|NCT02565797|Decubitus Ulcer, Peri-operative, support surface, alternating pressure, neurosurgery|decubitus ulcer, peri-operative, support surface, alternating pressure, neurosurgery
4809532|NCT02565771|Childhood cancer|childhood cancer
4809533|NCT02565771|Cancer|cancer
4809534|NCT02565771|Sequels|sequels
4809535|NCT02565771|Surgery|surgery
4809536|NCT02565771|Complications|complications
4809537|NCT02565771|Chemotherapy|chemotherapy
4809538|NCT02565771|Radiotherapy|radiotherapy
4809539|NCT02565758|Cancer|cancer
4809540|NCT02565758|Advanced Solid Tumors|advanced solid tumors
4809541|NCT02565758|Neoplasm|neoplasm
4809542|NCT02565758|Undifferentiated pleomorphic sarcoma|undifferentiated pleomorphic sarcoma
4809543|NCT02565758|squamous cell carcinoma of the head and neck|squamous cell carcinoma of the head and neck
4809544|NCT02565758|carcinoma of the breast|carcinoma of the breast
4809545|NCT02565758|antibody drug conjugate|antibody drug conjugate
4809546|NCT02565745|Prevention|prevention
4809547|NCT02565745|Pressure ulcers|pressure ulcers
4809548|NCT02565745|Clinical trial|clinical trial
4809549|NCT02565745|Nursing|nursing
4809550|NCT02565706|Fruit, vegetables, income, WIC program, farmers' market|fruit, vegetables, income, wic program, farmers' market
4809551|NCT02565680|acute urticaria|acute urticaria
4809552|NCT02565680|glucocorticoids|glucocorticoids
4809553|NCT02565680|antihistamines|antihistamines
4809554|NCT02565680|prurit|prurit
4809555|NCT02565680|itch score|itch score
4809556|NCT02565680|rash|rash
4809557|NCT02565667|low rectal carcinoma|low rectal carcinoma
4809558|NCT02565667|anastomosis|anastomosis
4809559|NCT02565667|anterior rectal resection|anterior rectal resection
4809560|NCT02565654|Irritable bowel syndrome(IBS)|irritable bowel syndrome(ibs)
4809561|NCT02565654|Small intestinal bacterial overgrowth (SIBO)|small intestinal bacterial overgrowth (sibo)
4809562|NCT02565654|Rifaximin|rifaximin
4809563|NCT02565602|Calcium metabolism|calcium metabolism
4809564|NCT02565602|Osteoporosis|osteoporosis
4809565|NCT02565602|Postmenopausal women|postmenopausal women
4809566|NCT02565576|CFZ533, Myasthenia Gravis|cfz533, myasthenia gravis
4809567|NCT02565563|EMDR|emdr
4809568|NCT02565563|Mechanisms|mechanisms
4809569|NCT02565563|Eye Movement Desensitisation Reprocessing|eye movement desensitisation reprocessing
4809570|NCT02565550|Microbiota Community|microbiota community
4809571|NCT02565550|FODMAPs|fodmaps
4809572|NCT02565550|IBS|ibs
4809573|NCT02565524|schizophrenia|schizophrenia
4809574|NCT02565524|early dissociative disorder|early dissociative disorder
4809575|NCT02565524|genetic|genetic
4809576|NCT02565511|Randomization, Placebo controlled, Parallel-group, APOE4 Homozygotes, Preclinical Alzheimer's Disease (AD), Aβ lowering|randomization, placebo controlled, parallel-group, apoe4 homozygotes, preclinical alzheimer's disease (ad), aβ lowering
4809577|NCT02565498|Soft tissue sarcoma|soft tissue sarcoma
4809578|NCT02565498|Extremity|extremity
4809579|NCT02565498|Preoperative radiotherapy|preoperative radiotherapy
4809580|NCT02565498|Postoperative radiotherapy|postoperative radiotherapy
4809581|NCT02565485|pulse pressure|pulse pressure
4809582|NCT02565485|fetal heart rate|fetal heart rate
4809583|NCT02565485|epidural analgesia|epidural analgesia
4809584|NCT02565485|hypotension|hypotension
4809585|NCT02565485|preload|preload
4809586|NCT02565485|fluid bolus|fluid bolus
4809587|NCT02565485|central hypovolemia|central hypovolemia
4809588|NCT02565459|Mesenchymal stromal cells|mesenchymal stromal cells
4809589|NCT02565459|kidney transplantation|kidney transplantation
4809590|NCT02565459|tolerance|tolerance
4809591|NCT02565433|brain metastases|brain metastases
4809592|NCT02565433|Gamma Knife|gamma knife
4809593|NCT02565433|Radiosurgery|radiosurgery
4809594|NCT02565433|Quality of Life|quality of life
4809595|NCT02565355|Pediatric Gastroenterology|pediatric gastroenterology
4809596|NCT02565342|Clavicle|clavicle
4809597|NCT02565303|cesarean delivery|cesarean delivery
4809598|NCT02565303|ropivacaine|ropivacaine
4809599|NCT02565303|minimum effective dose|minimum effective dose
4809600|NCT02565303|dose-response relationship|dose-response relationship
4809601|NCT02565303|intrathecal|intrathecal
4809602|NCT02565303|intervertebral space|intervertebral space
4809603|NCT02565290|polyunsaturated fatty acid|polyunsaturated fatty acid
4809604|NCT02565290|fetal ductus arteriosus|fetal ductus arteriosus
4809605|NCT02565290|inflammation|inflammation
4809606|NCT02565251|sepsis|sepsis
4809607|NCT02565251|hemodynamic monitoring|hemodynamic monitoring
4809608|NCT02565251|septic shock|septic shock
4809609|NCT02565251|volemic resuscitation|volemic resuscitation
4809610|NCT02565251|fluid resuscitation|fluid resuscitation
4809611|NCT02565212|Montelukast|montelukast
4809612|NCT02565212|Sniffin' Sticks test|sniffin' sticks test
4809613|NCT02565212|allergic rhinitis|allergic rhinitis
4809614|NCT02565212|mometasone furoate|mometasone furoate
4809615|NCT02565199|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
4809616|NCT02565173|glaucoma|glaucoma
4810100|NCT02562352|eHealth|ehealth
4809617|NCT02565173|primary open-angle glaucoma|primary open-angle glaucoma
4809618|NCT02565173|ocular hypertension|ocular hypertension
4809619|NCT02565173|adenosine agonist|adenosine agonist
4809620|NCT02565173|eye drop|eye drop
4809621|NCT02565173|trabodenoson|trabodenoson
4809622|NCT02565173|trabecular meshwork|trabecular meshwork
4809623|NCT02565147|STEMI, infarct size, CMR, bivalirudin|stemi, infarct size, cmr, bivalirudin
4809624|NCT02565121|Olfactory perception|olfactory perception
4809625|NCT02565121|Adrenal cortex hormones|adrenal cortex hormones
4809626|NCT02565121|Steroids|steroids
4809627|NCT02565121|Education|education
4809628|NCT02565108|Cannabidiol|cannabidiol
4809629|NCT02565108|GWP42003-P|gwp42003-p
4809630|NCT02565108|Clobazam|clobazam
4809631|NCT02565108|Epidiolex|epidiolex
4809632|NCT02565108|CBD|cbd
4809633|NCT02565082|Hemostatic potential|hemostatic potential
4809634|NCT02565082|Sickle cell disease|sickle cell disease
4809635|NCT02565082|Thrombin generation test|thrombin generation test
4809636|NCT02565056|Acceptance and Commitment Therapy|acceptance and commitment therapy
4809637|NCT02565043|Negative Pressure Wound Therapy|negative pressure wound therapy
4809638|NCT02565030|Chronic thromboembolic Pulmonary Hypertension|chronic thromboembolic pulmonary hypertension
4809639|NCT02565030|Distal Chronic thromboembolic Pulmonary Hypertension|distal chronic thromboembolic pulmonary hypertension
4809640|NCT02565030|Proximal Chronic thromboembolic Pulmonary Hypertension|proximal chronic thromboembolic pulmonary hypertension
4809641|NCT02565030|Operable disease|operable disease
4809642|NCT02565030|In-operable disease|in-operable disease
4809643|NCT02565030|Pulmonary Endarterectomy|pulmonary endarterectomy
4809644|NCT02565030|PH specific targeted therapy|ph specific targeted therapy
4809645|NCT02565030|Phosphodiesterase type 5 Inhibitors|phosphodiesterase type 5 inhibitors
4809646|NCT02565030|Endothelin Receptor Antagonist|endothelin receptor antagonist
4809647|NCT02565030|Prostacyclin analogues|prostacyclin analogues
4809648|NCT02565030|Soluble Guanylate cyclase stimulator|soluble guanylate cyclase stimulator
4809649|NCT02565030|Sildenafil|sildenafil
4809650|NCT02565030|Tadalafil|tadalafil
4809651|NCT02565030|Bosentan|bosentan
4809652|NCT02565030|Ambrisentan|ambrisentan
4809653|NCT02565030|Macitentan|macitentan
4809654|NCT02565030|Iloprost|iloprost
4809655|NCT02565030|Riociguat|riociguat
4809656|NCT02565030|Idiopathic Pulmonary Arterial Hypertension|idiopathic pulmonary arterial hypertension
4809657|NCT02565017|IBM Watson|ibm watson
4809658|NCT02565017|Clinical Decision Support System|clinical decision support system
4809659|NCT02565017|Patient Preferences|patient preferences
4809660|NCT02565017|15-226|15-226
4809661|NCT02565004|Genetic|genetic
4809662|NCT02565004|Sample Collection|sample collection
4809663|NCT02564991|Alcoholism|alcoholism
4809664|NCT02564991|MRI|mri
4809665|NCT02564991|Structural MRI|structural mri
4809666|NCT02564991|Cerebellum|cerebellum
4809667|NCT02564978|Age-Related Macular Degeneration|age-related macular degeneration
4809668|NCT02564978|Age-Related Macular Degeneration (AMD)|age-related macular degeneration (amd)
4809669|NCT02564978|Geographic Atrophy|geographic atrophy
4809670|NCT02564978|Minocycline|minocycline
4809671|NCT02564978|Atrophic Macular Degeneration|atrophic macular degeneration
4809672|NCT02564965|Acute Necrotizing Pancreatitis|acute necrotizing pancreatitis
4809673|NCT02564965|Walled-Off Pancreatic Necrosis|walled-off pancreatic necrosis
4809674|NCT02564952|Cannabidiol|cannabidiol
4809675|NCT02564952|GWP42003-P|gwp42003-p
4809676|NCT02564952|Clobazam|clobazam
4809677|NCT02564952|Epidiolex|epidiolex
4809678|NCT02564939|prevention|prevention
4809679|NCT02564926|DM|dm
4809680|NCT02564913|tongue diagnosis|tongue diagnosis
4809681|NCT02564913|heart rate variability|heart rate variability
4809682|NCT02564913|nailfold videocapillaroscopy|nailfold videocapillaroscopy
4809683|NCT02564900|Advanced solid tumors|advanced solid tumors
4809684|NCT02564900|phase 1|phase 1
4809685|NCT02564900|oncology|oncology
4809686|NCT02564900|HER2|her2
4809687|NCT02564900|Antibody drug conjugate (ADC)|antibody drug conjugate (adc)
4809688|NCT02564887|dysphagia|dysphagia
4809689|NCT02564887|oral pharyngeal cancer|oral pharyngeal cancer
4809690|NCT02564887|Iowa Oral Performance Instrument (IOPI)|iowa oral performance instrument (iopi)
4809691|NCT02564887|IOPI|iopi
4809692|NCT02564861|pharmacokinetics|pharmacokinetics
4809693|NCT02564848|Clinical T1-2N0 ER+|clinical t1-2n0 er+
4809694|NCT02564848|Invasive breast cancer|invasive breast cancer
4809695|NCT02564848|estrogen-positive|estrogen-positive
4809696|NCT02564822|migraine disorders|migraine disorders
4809697|NCT02564822|cortical excitability|cortical excitability
4809698|NCT02564822|transcranial magnetic stimulation|transcranial magnetic stimulation
4809699|NCT02564822|electroencephalography|electroencephalography
4809700|NCT02564796|Erythropoetin|erythropoetin
4809701|NCT02564796|Cyanotic Heart Disease|cyanotic heart disease
4809702|NCT02564796|Transfusion|transfusion
4809703|NCT02564796|Congenital Heart Disease|congenital heart disease
4809704|NCT02564731|children|children
4809705|NCT02564731|prognosis|prognosis
4809706|NCT02564718|Pediatric|pediatric
4809707|NCT02564679|bariatric surgery|bariatric surgery
4809708|NCT02564679|sleeve gastrectomy|sleeve gastrectomy
4809709|NCT02564666|hepatocellular carcinoma|hepatocellular carcinoma
4809710|NCT02564666|sorafenib|sorafenib
4809711|NCT02564666|telephone counseling|telephone counseling
4809712|NCT02564640|videolaryngoscope|videolaryngoscope
4809713|NCT02564640|direct laryngoscope|direct laryngoscope
4809714|NCT02564640|hemodynamic changes|hemodynamic changes
4809715|NCT02564640|elderly patients|elderly patients
4809716|NCT02564601|intervention|intervention
4809717|NCT02564601|cognition|cognition
4809718|NCT02564601|aging|aging
4809719|NCT02564601|piano training|piano training
4809720|NCT02564601|computer brain training|computer brain training
4809721|NCT02564575|Ebolavirus|ebolavirus
4809722|NCT02564562|PF-06463922|pf-06463922
4809723|NCT02564562|[14C]PF-06463922|[14c]pf-06463922
4809724|NCT02564562|Human ADME|human adme
4809725|NCT02564562|Radiolabel|radiolabel
4809726|NCT02564562|Mass Balance|mass balance
4809727|NCT02564562|Pharmacokinetics|pharmacokinetics
4809728|NCT02564549|low risk prostate cancer|low risk prostate cancer
4809729|NCT02564523|Healthy|healthy
4809730|NCT02564523|Vaccine|vaccine
4809731|NCT02564523|Ebola viruses|ebola viruses
4809732|NCT02564523|Ebola virus disease (EVD)|ebola virus disease (evd)
4809733|NCT02564523|Filoviruses|filoviruses
4809734|NCT02564523|Hemorrhagic fever|hemorrhagic fever
4809735|NCT02564523|Monovalent vaccine|monovalent vaccine
4809736|NCT02564523|Human adenovirus serotype 26 (Ad26) expressing the Ebola virus Mayinga variant glycoprotein (Ad26.ZEBOV)|human adenovirus serotype 26 (ad26) expressing the ebola virus mayinga variant glycoprotein (ad26.zebov)
4809737|NCT02564523|Modified Vaccinia Virus Ankara - Bavarian Nordic (MVA-BN) Filo-vector|modified vaccinia virus ankara - bavarian nordic (mva-bn) filo-vector
4809738|NCT02564523|Safety|safety
4809739|NCT02564523|Immunogenicity|immunogenicity
4809740|NCT02564484|Cancer Therapy|cancer therapy
4809741|NCT02564484|Pharmacogenomics|pharmacogenomics
4809742|NCT02564484|Drug Response|drug response
4809743|NCT02564484|Genetic Variants|genetic variants
4809744|NCT02564484|Vincristine-Induced Neuropathy|vincristine-induced neuropathy
4809745|NCT02564484|Cancer Survivor|cancer survivor
4809746|NCT02564432|amputee|amputee
4809747|NCT02564354|Cystic Fibrosis|cystic fibrosis
4809748|NCT02564354|CF|cf
4809749|NCT02564354|ΔF508|δf508
4809750|NCT02564354|CFTR|cftr
4809751|NCT02564354|QR-010|qr-010
4809752|NCT02564354|antisense oligonucleotide|antisense oligonucleotide
4809753|NCT02564354|RNA therapy|rna therapy
4809754|NCT02564354|F508del|f508del
4809755|NCT02564354|NPD|npd
4809756|NCT02564354|nasal potential difference|nasal potential difference
4809757|NCT02564341|HIV Infection|hiv infection
4809758|NCT02564341|Pain|pain
4809759|NCT02564341|Collaborative Care|collaborative care
4809760|NCT02564341|Chronic Opioid Therapy|chronic opioid therapy
4809761|NCT02564341|Addiction|addiction
4809762|NCT02564341|Analgesics, Opioid|analgesics, opioid
4809763|NCT02564328|Stroke|stroke
4809764|NCT02564328|Bone Marrow Mesenchymal Stem Cell|bone marrow mesenchymal stem cell
4809765|NCT02564328|Transplantation|transplantation
4809766|NCT02564315|Smoking|smoking
4809767|NCT02564315|Cessation|cessation
4809768|NCT02564315|Tobacco|tobacco
4809769|NCT02564315|Relapse|relapse
4809770|NCT02564302|PVI|pvi
4809771|NCT02564302|Atrial Fibrillation|atrial fibrillation
4809772|NCT02564302|MUSE Headband|muse headband
4809773|NCT02564302|Mindfulness|mindfulness
4809774|NCT02564289|microvesicles, microparticles|microvesicles, microparticles
4809775|NCT02564289|Plethysmography|plethysmography
4809776|NCT02564289|Snus|snus
4809777|NCT02564289|Arterial Stiffness|arterial stiffness
4809778|NCT02564289|EPC|epc
4809779|NCT02564276|Indocyanine Green|indocyanine green
4809780|NCT02564276|Sentinel Lymph Node Biopsy|sentinel lymph node biopsy
4809781|NCT02564263|PD1|pd1
4809782|NCT02564263|PD-L1|pd-l1
4809783|NCT02564263|PDL1|pdl1
4809784|NCT02564263|Gene expression profiling (GEP)|gene expression profiling (gep)
4809785|NCT02564237|Group A streptococcal|group a streptococcal
4809786|NCT02564198|relapsed pediatric solid tumors|relapsed pediatric solid tumors
4809787|NCT02564198|unspecified childhood solid tumor|unspecified childhood solid tumor
4809788|NCT02564198|brain and central nervous system tumors|brain and central nervous system tumors
4809789|NCT02564159|malnutrition|malnutrition
4809790|NCT02564159|muscle ultrasound|muscle ultrasound
4809791|NCT02564159|intensive care unit|intensive care unit
4809792|NCT02564159|mechanical ventilation|mechanical ventilation
4809793|NCT02564159|albumin|albumin
4809794|NCT02564159|prealbumin|prealbumin
4809795|NCT02564159|nutrition|nutrition
4809796|NCT02564055|Vehicle-Controlled|vehicle-controlled
4809797|NCT02564055|GSK2894512|gsk2894512
4809798|NCT02564055|Double blind|double blind
4809799|NCT02564055|Dose-finding|dose-finding
4809800|NCT02564055|Atopic Dermatitis|atopic dermatitis
4809801|NCT02564042|Double blind|double blind
4809802|NCT02564042|Dose-finding|dose-finding
4809803|NCT02564042|Vehicle-Controlled|vehicle-controlled
4809804|NCT02564042|GSK2894512|gsk2894512
4809805|NCT02564042|Plaque Psoriasis|plaque psoriasis
4809806|NCT02563977|Breast reconstruction|breast reconstruction
4809807|NCT02563977|Deep inferior epigastric perforator flap|deep inferior epigastric perforator flap
4809808|NCT02563977|Abdominal wall morbidity|abdominal wall morbidity
4809809|NCT02563977|Plastic and reconstructive surgery|plastic and reconstructive surgery
4809810|NCT02563964|Myocardial infarction|myocardial infarction
4809811|NCT02563964|vulnerable plaque|vulnerable plaque
4809812|NCT02563964|Positron emission tomography (PET)|positron emission tomography (pet)
4809813|NCT02563964|Cardiac magnetic resonance imaging (CMR)|cardiac magnetic resonance imaging (cmr)
4809814|NCT02563964|Biomarkers|biomarkers
4809815|NCT02563951|Nausea|nausea
4809816|NCT02563951|Vomiting|vomiting
4809817|NCT02563951|Chemotherapy|chemotherapy
4809818|NCT02563951|Radiation therapy|radiation therapy
4809819|NCT02563925|Brain Irradiation|brain irradiation
4809820|NCT02563925|Tremelimumab|tremelimumab
4809821|NCT02563925|15-038|15-038
4809822|NCT02563912|Children|children
4809823|NCT02563912|resuscitation|resuscitation
4809824|NCT02563912|simulation|simulation
4809825|NCT02563912|medication error|medication error
4809826|NCT02563899|Primary Axillary Hyperhidrosis|primary axillary hyperhidrosis
4809827|NCT02563899|GSK573719|gsk573719
4809828|NCT02563899|Hyperhidrosis Disease Severity Scale (HDSS)|hyperhidrosis disease severity scale (hdss)
4809829|NCT02563899|Topical|topical
4809830|NCT02563899|PRO|pro
4809831|NCT02563899|Hyperhidrosis Symptom Severity Measure (HSSM)|hyperhidrosis symptom severity measure (hssm)
4809832|NCT02563899|Umeclidinium|umeclidinium
4809833|NCT02563821|Termination of pregancy|termination of pregancy
4809834|NCT02563821|Third trimester|third trimester
4809835|NCT02563821|Programmed intermittent epidural bolus|programmed intermittent epidural bolus
4809836|NCT02563821|Continuous epidural infusion|continuous epidural infusion
4809837|NCT02563821|Epidural analgesia|epidural analgesia
4809838|NCT02563821|Legally induced abortion|legally induced abortion
4809839|NCT02563795|Spinal anesthesia|spinal anesthesia
4809840|NCT02563795|Cesarean|cesarean
4809841|NCT02563795|Maternal hypotension|maternal hypotension
4809842|NCT02563769|Cocaine|cocaine
4809843|NCT02563769|Clavulanic Acid|clavulanic acid
4809844|NCT02563756|Medial gonarthritis, knee osteoarthritis,|medial gonarthritis, knee osteoarthritis,
4809845|NCT02563756|Muscle function, muscle mass, muscle atrophy|muscle function, muscle mass, muscle atrophy
4809846|NCT02563756|Total knee arthroplasty (TKA)|total knee arthroplasty (tka)
4809847|NCT02563756|Unicondylar knee arthroplasty (UKA)|unicondylar knee arthroplasty (uka)
4809848|NCT02563756|Total knee replacement (TKR)|total knee replacement (tkr)
4809849|NCT02563756|Unicondylar knee replacement (UKR)|unicondylar knee replacement (ukr)
4809850|NCT02563756|Health-related quality of life (HRQoL)|health-related quality of life (hrqol)
4809851|NCT02563756|Patient related outcome measurements (PROMs)|patient related outcome measurements (proms)
4809852|NCT02563743|Sick-leave|sick-leave
4809853|NCT02563743|Return to work|return to work
4809854|NCT02563743|Occupational health|occupational health
4809855|NCT02563743|Common mental disorder|common mental disorder
4809856|NCT02563743|Depression|depression
4809857|NCT02563743|Anxiety disorders|anxiety disorders
4809858|NCT02563743|Adjustment disorders|adjustment disorders
4809859|NCT02563743|Problem solving therapy|problem solving therapy
4809860|NCT02563743|Occupational Health Services|occupational health services
4809861|NCT02563743|Randomized controlled trial|randomized controlled trial
4809862|NCT02563743|Intervention studies|intervention studies
4809863|NCT02563743|Occupational stress|occupational stress
4809864|NCT02563730|Cryobiopsy|cryobiopsy
4809865|NCT02563730|lung biopsy|lung biopsy
4809866|NCT02563730|interstitial lung disease|interstitial lung disease
4809867|NCT02563717|Resuscitation|resuscitation
4809868|NCT02563717|Positive-Pressure Respiration|positive-pressure respiration
4809869|NCT02563717|Infant, Extremely Premature|infant, extremely premature
4809870|NCT02563717|Continuous Positive Airway Pressure|continuous positive airway pressure
4809871|NCT02563717|Intubation|intubation
4809872|NCT02563704|Artesunate|artesunate
4809873|NCT02563704|Quinine|quinine
4809874|NCT02563704|Efficacy|efficacy
4809875|NCT02563704|Malaria|malaria
4809876|NCT02563704|Children|children
4809877|NCT02563704|Cameroon|cameroon
4809878|NCT02563652|Abdomen/surgery|abdomen/surgery
4809879|NCT02563652|Biological markers|biological markers
4809880|NCT02563652|Length of stay|length of stay
4809881|NCT02563652|Postoperative care|postoperative care
4809882|NCT02563652|Anesthesia recovery period|anesthesia recovery period
4809883|NCT02563652|Prognosis|prognosis
4809884|NCT02563639|newly diagnosed|newly diagnosed
4809885|NCT02563639|paroxysmal|paroxysmal
4809886|NCT02563639|persistent|persistent
4809887|NCT02563626|coronary artery aneurysm|coronary artery aneurysm
4809888|NCT02563626|prognosis|prognosis
4809889|NCT02563626|outcomes|outcomes
4809890|NCT02563626|management|management
4809891|NCT02563626|incidence|incidence
4809892|NCT02563626|heart failure|heart failure
4809893|NCT02563626|acute coronary syndrome|acute coronary syndrome
4809894|NCT02563626|death|death
4809895|NCT02563613|community-based intervention|community-based intervention
4809896|NCT02563613|family holistic health|family holistic health
4809897|NCT02563613|positive psychology|positive psychology
4809898|NCT02563613|physical exercise|physical exercise
4809899|NCT02563613|healthy diet|healthy diet
4809900|NCT02563587|Laughter|laughter
4809901|NCT02563587|children|children
4809902|NCT02563587|postoperative|postoperative
4809903|NCT02563587|pain|pain
4809904|NCT02563587|anxiety|anxiety
4809905|NCT02563587|cortisol|cortisol
4809906|NCT02563574|Alcohol and brain function|alcohol and brain function
4809907|NCT02563574|HIV and brain function|hiv and brain function
4809908|NCT02563574|Motivational Interviewing|motivational interviewing
4809909|NCT02563561|Bladder Cancer|bladder cancer
4809910|NCT02563561|Non-muscle invasive bladder cancer|non-muscle invasive bladder cancer
4809911|NCT02563561|Apaziquone|apaziquone
4809912|NCT02563561|TURBT|turbt
4809913|NCT02563561|Stage Ta, G1-G2|stage ta, g1-g2
4809914|NCT02563522|non healing ulcers|non healing ulcers
4809915|NCT02563522|VM202|vm202
4809916|NCT02563522|Diabetic ulcers|diabetic ulcers
4809917|NCT02563522|foot ulcers|foot ulcers
4809918|NCT02563509|HIV|hiv
4809919|NCT02563509|cellular immunity therapy|cellular immunity therapy
4809920|NCT02563509|functional cure|functional cure
4809921|NCT02563496|pharmacokinetic|pharmacokinetic
4809922|NCT02563496|pediatric|pediatric
4809923|NCT02563496|Tafenoquine|tafenoquine
4809924|NCT02563496|Plasmodium vivax Malaria|plasmodium vivax malaria
4809925|NCT02563496|G6PD deficiency|g6pd deficiency
4809926|NCT02563483|caregivers|caregivers
4809927|NCT02563483|anxiety|anxiety
4809928|NCT02563483|depression|depression
4809929|NCT02563483|yoga|yoga
4809930|NCT02563483|meditation|meditation
4809931|NCT02563483|stress|stress
4809932|NCT02563457|diabetic patients|diabetic patients
4809933|NCT02563457|periodontal treatment|periodontal treatment
4809934|NCT02563457|glycaemic control|glycaemic control
4809935|NCT02563444|Diagnostic (Biopsy) or Therapeutic Procedure (Infiltration, Ablation)|diagnostic (biopsy) or therapeutic procedure (infiltration, ablation)
4809936|NCT02563431|shoulder pain|shoulder pain
4809937|NCT02563431|prevention program|prevention program
4809938|NCT02563418|video oculography|video oculography
4809939|NCT02563405|alpha receptor blocker|alpha receptor blocker
4809940|NCT02563405|uric acid|uric acid
4809941|NCT02563405|CCB|ccb
4809942|NCT02563405|blood pressure variability|blood pressure variability
4809943|NCT02563366|kidney transplantation|kidney transplantation
4809944|NCT02563366|mesenchymal stem cell therapy|mesenchymal stem cell therapy
4809945|NCT02563366|poor early graft function|poor early graft function
4809946|NCT02563366|delayed graft function|delayed graft function
4809947|NCT02563366|ischemia reperfusion injury|ischemia reperfusion injury
4809948|NCT02563366|donation after cardiac death|donation after cardiac death
4809949|NCT02563353|whole body vibration|whole body vibration
4809950|NCT02563353|PTH|pth
4809951|NCT02563340|kidney transplantation|kidney transplantation
4809952|NCT02563340|antibody-mediated rejection|antibody-mediated rejection
4809953|NCT02563340|mesenchymal stem cell therapy|mesenchymal stem cell therapy
4809954|NCT02563340|donor specific antibody|donor specific antibody
4809955|NCT02563340|acute rejection|acute rejection
4809956|NCT02563314|Noninvasive Ventilation|noninvasive ventilation
4809957|NCT02563314|Pulmonary Disease|pulmonary disease
4809958|NCT02563314|Chronic Obstructive|chronic obstructive
4809959|NCT02563314|Renal Doppler|renal doppler
4809960|NCT02563314|Oxygen|oxygen
4809961|NCT02563314|Hypercapnia|hypercapnia
4809962|NCT02563288|esmolol|esmolol
4809963|NCT02563288|dexmedetomidine|dexmedetomidine
4809964|NCT02563288|opioids|opioids
4809965|NCT02563197|Device study|device study
4809966|NCT02563197|Peak inspiratory flow rate|peak inspiratory flow rate
4809967|NCT02563197|Non-cystic fibrosis bronchiectasis|non-cystic fibrosis bronchiectasis
4809968|NCT02563197|T-326 Inhaler|t-326 inhaler
4809969|NCT02563171|visceral adipose-specific serpin|visceral adipose-specific serpin
4809970|NCT02563171|intelectin 1 (omentin)|intelectin 1 (omentin)
4809971|NCT02563171|Tumor Necrosis Factor-alpha|tumor necrosis factor-alpha
4809972|NCT02563158|liver resection|liver resection
4809973|NCT02563158|blood inflow control|blood inflow control
4809974|NCT02563158|ischemia-reperfusion injury|ischemia-reperfusion injury
4809975|NCT02563158|inflammatory response|inflammatory response
4809976|NCT02563158|randomized controlled trial|randomized controlled trial
4809977|NCT02563145|Real-time fMRI feedback|real-time fmri feedback
4809978|NCT02563132|colonoscopy|colonoscopy
4809979|NCT02563132|carbon dioxide|carbon dioxide
4809980|NCT02563132|inflammatory bowel disease|inflammatory bowel disease
4809981|NCT02563093|Influenza|influenza
4809982|NCT02563093|Fluzone® Quadrivalent, Influenza Vaccine|fluzone® quadrivalent, influenza vaccine
4809983|NCT02563093|Fluzone® Intradermal Quadrivalent, Influenza Vaccine|fluzone® intradermal quadrivalent, influenza vaccine
4809984|NCT02563093|Fluzone® High Dose, Influenza Vaccine|fluzone® high dose, influenza vaccine
4809985|NCT02563080|exocrine insufficiency|exocrine insufficiency
4809986|NCT02563080|acute pancreatitis|acute pancreatitis
4809987|NCT02563080|severe|severe
4809988|NCT02563080|moderately severe|moderately severe
4809989|NCT02563067|Asthma|asthma
4809990|NCT02563067|QAW039|qaw039
4809991|NCT02563028|Visual Evoked Potentials|visual evoked potentials
4809992|NCT02563028|Microdiscectomy|microdiscectomy
4809993|NCT02563028|SightSaver|sightsaver
4809994|NCT02563015|Infant|infant
4809995|NCT02563015|Vitamin D|vitamin d
4809996|NCT02563015|Deficiency|deficiency
4809997|NCT02563015|Lean Mass|lean mass
4809998|NCT02563002|PD1|pd1
4809999|NCT02563002|PDL1|pdl1
4810000|NCT02563002|PD-L1|pd-l1
4810001|NCT02562924|MEDIHONEY|medihoney
4810002|NCT02562924|Chronic Rhinosinusitis With Nasal Polyposis|chronic rhinosinusitis with nasal polyposis
4810003|NCT02562924|Functional Endoscopic Sinus Surgery|functional endoscopic sinus surgery
4810004|NCT02562911|cystic fibrosis|cystic fibrosis
4810005|NCT02562911|menstrual cycle|menstrual cycle
4810006|NCT02562911|puberty|puberty
4810007|NCT02562885|Benign epilepsy with centro-temporal spikes|benign epilepsy with centro-temporal spikes
4810008|NCT02562885|Continuous spike waves in slow wave sleep|continuous spike waves in slow wave sleep
4810009|NCT02562885|Electroencephalography|electroencephalography
4810010|NCT02562885|Sleep, slow wave|sleep, slow wave
4810011|NCT02562872|Controlled|controlled
4810012|NCT02562872|Human|human
4810013|NCT02562872|Malaria|malaria
4810014|NCT02562872|Infection|infection
4810015|NCT02562872|Healthy|healthy
4810016|NCT02562872|Volunteer|volunteer
4810017|NCT02562846|electroconvulsive therapy|electroconvulsive therapy
4810018|NCT02562846|response prediction|response prediction
4810019|NCT02562846|cognitive side effects|cognitive side effects
4810020|NCT02562833|Osteoarthritis|osteoarthritis
4810021|NCT02562833|Self-management|self-management
4810022|NCT02562833|Multi-Component Exercise|multi-component exercise
4810023|NCT02562807|Urinary Incontinence|urinary incontinence
4810024|NCT02562807|Urinary Incontinence, Stress|urinary incontinence, stress
4810025|NCT02562807|Lower Urinary Tract Symptoms|lower urinary tract symptoms
4810026|NCT02562794|refugee|refugee
4810027|NCT02562781|postoperative complications|postoperative complications
4810028|NCT02562781|postoperative cognitive dysfunction|postoperative cognitive dysfunction
4810029|NCT02562781|oxygen|oxygen
4810030|NCT02562755|Hepatocellular Carcinoma (HCC)|hepatocellular carcinoma (hcc)
4810031|NCT02562755|Pexastimogene Devacirepvec (Pexa-Vec)|pexastimogene devacirepvec (pexa-vec)
4810032|NCT02562755|Sorafenib|sorafenib
4810033|NCT02562755|GM-CSF therapy|gm-csf therapy
4810034|NCT02562755|Thymidine Kinase-Deactivated Vaccinia Virus|thymidine kinase-deactivated vaccinia virus
4810035|NCT02562755|Oncology|oncology
4810036|NCT02562755|Recombinant Vaccinia Virus|recombinant vaccinia virus
4810037|NCT02562755|Oncolytic Virus Therapy|oncolytic virus therapy
4810038|NCT02562755|Oncolytic virotherapy|oncolytic virotherapy
4810039|NCT02562742|Hepatitis C virus|hepatitis c virus
4810040|NCT02562742|observational|observational
4810041|NCT02562742|post-marketing|post-marketing
4810042|NCT02562742|sofosbuvir|sofosbuvir
4810043|NCT02562742|Infection|infection
4810044|NCT02562729|Cervical cancer; Nerve-sparing hysterectomy; simplified|cervical cancer; nerve-sparing hysterectomy; simplified
4810045|NCT02562690|Coronary Artery Disease|coronary artery disease
4810046|NCT02562690|Myocardial Ischemia|myocardial ischemia
4810047|NCT02562690|Arterial Occlusive Diseases|arterial occlusive diseases
4810048|NCT02562690|Coronary Thrombosis|coronary thrombosis
4810049|NCT02562651|STEMI, adverse LVR (left ventricular remodeling), MMPs, Doxycycline|stemi, adverse lvr (left ventricular remodeling), mmps, doxycycline
4810050|NCT02562638|NPO|npo
4810051|NCT02562638|NBM|nbm
4810052|NCT02562638|pre-procedure|pre-procedure
4810053|NCT02562638|cardiac|cardiac
4810054|NCT02562599|Induction Chemotherapy|induction chemotherapy
4810055|NCT02562599|Concurrent Chemoradiotherapy|concurrent chemoradiotherapy
4810056|NCT02562586|Suction|suction
4810057|NCT02562586|Arthroplasty|arthroplasty
4810058|NCT02562586|Replacement|replacement
4810059|NCT02562586|Hip|hip
4810060|NCT02562534|ECG|ecg
4810061|NCT02562534|MRI|mri
4810062|NCT02562534|rythm troubles|rythm troubles
4810063|NCT02562534|conductive troubles|conductive troubles
4810064|NCT02562534|ECG artifacts|ecg artifacts
4810065|NCT02562534|Database|database
4810066|NCT02562508|Human Papilloma Virus 16|human papilloma virus 16
4810067|NCT02562508|Human Papilloma Virus 18|human papilloma virus 18
4810068|NCT02562508|vaccine|vaccine
4810069|NCT02562508|adolescent girl|adolescent girl
4810070|NCT02562508|bridging trial|bridging trial
4810071|NCT02562508|non-inferiority|non-inferiority
4810072|NCT02562495|severe cerebral pathology|severe cerebral pathology
4810073|NCT02562495|Ultrasound|ultrasound
4810074|NCT02562495|thickness of the quadriceps|thickness of the quadriceps
4810075|NCT02562482|Antibody Response|antibody response
4810076|NCT02562482|Immune Response|immune response
4810077|NCT02562482|Healthy Volunteer|healthy volunteer
4810078|NCT02562482|Vaccine-Mediated Protection|vaccine-mediated protection
4810079|NCT02562482|Chikungunya Virus|chikungunya virus
4810080|NCT02562482|Vaccines, Virus-like Particles|vaccines, virus-like particles
4810081|NCT02562456|Dental Atraumatic Restorative Treatment|dental atraumatic restorative treatment
4810082|NCT02562456|Composite Resins|composite resins
4810083|NCT02562456|Primary Teeth|primary teeth
4810084|NCT02562456|Clinical Efficacy|clinical efficacy
4810085|NCT02562456|Cost Analysis|cost analysis
4810086|NCT02562443|Myelodysplastic Syndrome|myelodysplastic syndrome
4810087|NCT02562443|MDS|mds
4810088|NCT02562430|Placebo response|placebo response
4810089|NCT02562391|atrial fibrillation|atrial fibrillation
4810090|NCT02562391|ablation|ablation
4810091|NCT02562391|thoracoscopy|thoracoscopy
4810092|NCT02562391|left atrial appendage|left atrial appendage
4810093|NCT02562365|adjuvent chemotherapy|adjuvent chemotherapy
4810094|NCT02562365|ovarian cancer|ovarian cancer
4810095|NCT02562352|polypharmacy|polypharmacy
4810096|NCT02562352|multimorbidity|multimorbidity
4810097|NCT02562352|randomized controlled trial|randomized controlled trial
4810098|NCT02562352|drug discontinuation|drug discontinuation
4810099|NCT02562352|patient preference|patient preference
4810101|NCT02562274|Menopause|menopause
4810102|NCT02562274|Cognitive impairment|cognitive impairment
4810103|NCT02562274|Working memory|working memory
4810104|NCT02562274|Bone formation markers|bone formation markers
4810105|NCT02562274|Osteoporosis|osteoporosis
4810106|NCT02562261|sepsis|sepsis
4810107|NCT02562261|platelet|platelet
4810108|NCT02562261|platelet reactivity|platelet reactivity
4810109|NCT02562261|P2Y12|p2y12
4810110|NCT02562235|Pulmonary arterial hypertension|pulmonary arterial hypertension
4810111|NCT02562222|migraine disorders|migraine disorders
4810112|NCT02562222|transcranial direct current stimulation|transcranial direct current stimulation
4810113|NCT02562222|electric stimulation therapy|electric stimulation therapy
4810114|NCT02562222|pain|pain
4810115|NCT02562222|rehabilitation|rehabilitation
4810116|NCT02562209|Obesity|obesity
4810117|NCT02562209|Abdominal adiposity|abdominal adiposity
4810118|NCT02562209|High protein diet|high protein diet
4810119|NCT02562196|migraine disorders|migraine disorders
4810120|NCT02562196|transcranial direct current stimulation|transcranial direct current stimulation
4810121|NCT02562196|electric stimulation therapy|electric stimulation therapy
4810122|NCT02562196|pain|pain
4810123|NCT02562170|breast|breast
4810124|NCT02562170|reconstruction|reconstruction
4810125|NCT02562170|mesh|mesh
4810126|NCT02562170|acellular dermal matrix|acellular dermal matrix
4810127|NCT02562131|PET-MR|pet-mr
4810128|NCT02562131|recidive|recidive
4810129|NCT02562131|PET/MR imaging|pet/mr imaging
4810130|NCT02562131|18F-Fluciclovine|18f-fluciclovine
4810131|NCT02562131|radical treatment|radical treatment
4810132|NCT02562131|recurrence|recurrence
4810133|NCT02562105|Intensive care unit|intensive care unit
4810134|NCT02562105|Hematological malignancy|hematological malignancy
4810135|NCT02562105|Acute respiratory failure|acute respiratory failure
4810136|NCT02562105|Prognosis|prognosis
4810137|NCT02562105|Mechanical ventilation|mechanical ventilation
4810138|NCT02562092|AIDS|aids
4810139|NCT02562092|Health Promotion|health promotion
4810140|NCT02562079|T lymphocyte|t lymphocyte
4810141|NCT02562079|OX40/OX40L|ox40/ox40l
4810142|NCT02562040|Pediatrics|pediatrics
4810143|NCT02562040|Primary Snoring|primary snoring
4810144|NCT02562040|Adenotonsillectomy|adenotonsillectomy
4810145|NCT02562001|Spinal Cord Injuries|spinal cord injuries
4810146|NCT02562001|gait training|gait training
4810147|NCT02562001|robotic|robotic
4810148|NCT02562001|Lokomat|lokomat
4810149|NCT02562001|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
4810150|NCT02562001|transcranial direct-current stimulation|transcranial direct-current stimulation
4810151|NCT02562001|Electroencephalography|electroencephalography
4810152|NCT02562001|Functional near-infrared spectroscopy|functional near-infrared spectroscopy
4810153|NCT02561975|Double pulmonary diffusing capacity to carbon monoxyd (CO) associated to nitric oxide (NO)|double pulmonary diffusing capacity to carbon monoxyd (co) associated to nitric oxide (no)
4810154|NCT02561975|Evolution of membrane and capillar damages|evolution of membrane and capillar damages
4810155|NCT02561975|Early pronostic value of congenital heart disease|early pronostic value of congenital heart disease
4810156|NCT02561962|Multiple Myeloma|multiple myeloma
4810157|NCT02561962|Relapsed Multiple Myeloma|relapsed multiple myeloma
4810158|NCT02561962|Refractory Multiple Myeloma|refractory multiple myeloma
4810159|NCT02561949|Depression/therapy|depression/therapy
4810160|NCT02561949|Developing Countries|developing countries
4810161|NCT02561949|Interpersonal Relations|interpersonal relations
4810162|NCT02561949|Life Change Events|life change events
4810163|NCT02561949|Psychotherapy, group|psychotherapy, group
4810164|NCT02561949|Resilience, Psychological|resilience, psychological
4810165|NCT02561949|Sierra Leone|sierra leone
4810166|NCT02561949|Survivors/psychology|survivors/psychology
4810167|NCT02561949|Social Adjustment|social adjustment
4810168|NCT02561949|Social Behavior|social behavior
4810169|NCT02561949|War|war
4810170|NCT02561936|Healthy|healthy
4810171|NCT02561936|EUDRANT|eudrant
4810172|NCT02561936|Rilpivirine|rilpivirine
4810173|NCT02561923|Healthy|healthy
4810174|NCT02561923|Rivaroxaban|rivaroxaban
4810175|NCT02561923|XARELTO|xarelto
4810176|NCT02561910|Inguinal hernia repair|inguinal hernia repair
4810177|NCT02561910|laparoscopic inguinal hernia repair|laparoscopic inguinal hernia repair
4810178|NCT02561910|TAPP|tapp
4810179|NCT02561871|Ad26.RSV.FA2 (JNJ-61187165-AAA)|ad26.rsv.fa2 (jnj-61187165-aaa)
4810180|NCT02561871|Ad35.RSV.FA2 (JNJ-61187191-AAA)|ad35.rsv.fa2 (jnj-61187191-aaa)
4810181|NCT02561871|Healthy participants|healthy participants
4810182|NCT02561858|Renal Ammonium ;uric acid|renal ammonium ;uric acid
4810183|NCT02561845|Effectiveness of statins, on lipid goal attainment and lipid parameters in Percutaneous Coronary Intervention patients|effectiveness of statins, on lipid goal attainment and lipid parameters in percutaneous coronary intervention patients
4810184|NCT02561832|breast cancer|breast cancer
4810185|NCT02561819|Short Bowel Syndrome|short bowel syndrome
4810186|NCT02561819|Congenital Short Bowel Syndrome|congenital short bowel syndrome
4810187|NCT02561819|Body Composition|body composition
4810188|NCT02561819|Parenteral Nutrition|parenteral nutrition
4810189|NCT02561819|Intestinal Failure|intestinal failure
4810190|NCT02561780|Mental Health Knowledge|mental health knowledge
4810191|NCT02561780|Stigma|stigma
4810192|NCT02561780|Mental Health Literacy|mental health literacy
4810193|NCT02561767|kidney transplantation|kidney transplantation
4810194|NCT02561767|mesenchymal stem cell|mesenchymal stem cell
4810195|NCT02561767|donation after citizen's death|donation after citizen's death
4810196|NCT02561767|ischemia reperfusion injury|ischemia reperfusion injury
4810197|NCT02561767|renal function recovery|renal function recovery
4810198|NCT02561754|Diet|diet
4810199|NCT02561754|Obesity|obesity
4810200|NCT02561754|Adolescents|adolescents
4810201|NCT02561754|Intellectual and Developmental Disability|intellectual and developmental disability
4810202|NCT02561728|Helmet|helmet
4810203|NCT02561728|Hangar|hangar
4810204|NCT02561728|P-Pod|p-pod
4810205|NCT02561728|Plagiocephaly|plagiocephaly
4810206|NCT02561728|Surgery|surgery
4810207|NCT02561715|Parkinson's|parkinson's
4810208|NCT02561715|Anosognosia|anosognosia
4810210|NCT02561715|Deep Brain Surgery|deep brain surgery
4810211|NCT02561689|Occlusal caries|occlusal caries
4810212|NCT02561689|Resin fissure sealant|resin fissure sealant
4810213|NCT02561689|Longevity|longevity
4810214|NCT02561689|Effectiveness|effectiveness
4810215|NCT02561676|Mindfulness|mindfulness
4810216|NCT02561676|Spinal Cord Injury|spinal cord injury
4810217|NCT02561663|microcirculation|microcirculation
4810218|NCT02561663|blood pressure|blood pressure
4810219|NCT02561663|pulse wave analysis|pulse wave analysis
4810220|NCT02561663|pulse wave velocity|pulse wave velocity
4810221|NCT02561637|Case management|case management
4810222|NCT02561624|mHealth|mhealth
4810223|NCT02561624|Text message|text message
4810224|NCT02561611|Pedal Desk|pedal desk
4810225|NCT02561611|Workplace Intervention|workplace intervention
4810226|NCT02561611|Physical Activity|physical activity
4810227|NCT02561611|Energy Expenditure|energy expenditure
4810228|NCT02561546|concurrent|concurrent
4810229|NCT02561520|platelet rich plasma|platelet rich plasma
4810230|NCT02561520|platelet poor plasma|platelet poor plasma
4810231|NCT02561520|ocular GVHD|ocular gvhd
4810232|NCT02561455|Advanced solid tumors|advanced solid tumors
4810233|NCT02561455|Acute myeloid leukemia|acute myeloid leukemia
4810234|NCT02561455|gilteritinib|gilteritinib
4810235|NCT02561455|ASP2215|asp2215
4810236|NCT02561416|Fibromyalgia syndrome|fibromyalgia syndrome
4810237|NCT02561416|Mindfulness (MBSR)|mindfulness (mbsr)
4810238|NCT02561416|Neuroimaging|neuroimaging
4810239|NCT02561416|Cytokines|cytokines
4810240|NCT02561416|Randomized Controlled Trial|randomized controlled trial
4810241|NCT02561416|Cost-effectiveness|cost-effectiveness
4810242|NCT02561416|Psychoeducation (FibroQol)|psychoeducation (fibroqol)
4810243|NCT02561403|traumatic brain injury (TBI)|traumatic brain injury (tbi)
4810244|NCT02561403|aging|aging
4810245|NCT02561403|cognitive training|cognitive training
4810246|NCT02561403|Cognitive Aging|cognitive aging
4810247|NCT02561377|resistance training|resistance training
4810248|NCT02561377|Prediabetic state|prediabetic state
4810249|NCT02561377|Metabolomics|metabolomics
4810250|NCT02561364|Fetal Biophysical Profile|fetal biophysical profile
4810251|NCT02561351|bronchial asthma|bronchial asthma
4810252|NCT02561351|fractional exhaled nitric oxide (FeNO)|fractional exhaled nitric oxide (feno)
4810253|NCT02561351|asthma exacerbation|asthma exacerbation
4810254|NCT02561338|GKA,T2DM,HMS5552|gka,t2dm,hms5552
4810255|NCT02561325|Blood pressure|blood pressure
4810256|NCT02561325|Sodium Chloride|sodium chloride
4810257|NCT02561325|Sodium Bicarbonate|sodium bicarbonate
4810258|NCT02561299|Drug-coated Balloons|drug-coated balloons
4810259|NCT02561299|Calcified Lesions|calcified lesions
4810260|NCT02561299|Orbital Atherectomy|orbital atherectomy
4810261|NCT02561299|Below the Knee|below the knee
4810262|NCT02561299|Paclitaxel|paclitaxel
4810263|NCT02561299|Lutonix 014 Drug-coated Balloon|lutonix 014 drug-coated balloon
4810264|NCT02561286|Human immunodeficiency virus|human immunodeficiency virus
4810265|NCT02561286|Sexually transmitted disease|sexually transmitted disease
4810266|NCT02561286|Men who have sex with men|men who have sex with men
4810267|NCT02561286|African Americans|african americans
4810268|NCT02561286|Behavioral intervention|behavioral intervention
4810269|NCT02561286|Randomized controlled trial|randomized controlled trial
4810270|NCT02561286|Sexual behavior|sexual behavior
4810271|NCT02561286|Mediation analysis|mediation analysis
4810272|NCT02561286|Social cognitive theory|social cognitive theory
4810273|NCT02561286|Theory of planned behavior|theory of planned behavior
4810274|NCT02561247|Acute Kidney Injury|acute kidney injury
4810275|NCT02561247|Continuous Renal Replacement Therapy|continuous renal replacement therapy
4810276|NCT02561247|Blood Urea Nitrogen (BUN)|blood urea nitrogen (bun)
4810277|NCT02561247|Prismaflex|prismaflex
4810278|NCT02561247|Pediatric|pediatric
4810279|NCT02561221|primary care|primary care
4810280|NCT02561221|pragmatic trial|pragmatic trial
4810281|NCT02561221|weight loss|weight loss
4810282|NCT02561221|overweight|overweight
4810283|NCT02561221|diet|diet
4810284|NCT02561221|physical activity|physical activity
4810285|NCT02561221|PCORI|pcori
4810286|NCT02561208|Patient adherence|patient adherence
4810287|NCT02561208|Mobile Health|mobile health
4810288|NCT02561208|HPV DNA Tests|hpv dna tests
4810289|NCT02561208|Self-collected|self-collected
4810290|NCT02561195|Clostridium difficile, Vaccine.|clostridium difficile, vaccine.
4810291|NCT02561169|antiviral|antiviral
4810292|NCT02561169|oseltamivir|oseltamivir
4810293|NCT02561156|Drug therapy|drug therapy
4810294|NCT02561143|cachexia|cachexia
4810295|NCT02561143|nutrition supplementation|nutrition supplementation
4810296|NCT02561143|IAtta|iatta
4810297|NCT02561143|palliative care|palliative care
4810298|NCT02561143|quality of life|quality of life
4810299|NCT02561130|Diabetes|diabetes
4810300|NCT02561130|Insulin|insulin
4810301|NCT02561130|Glargine|glargine
4810302|NCT02561130|Metformin|metformin
4810303|NCT02561130|Forxiga|forxiga
4810304|NCT02561130|Diet|diet
4810305|NCT02561130|Exercise|exercise
4810306|NCT02561130|Lifestyle|lifestyle
4810307|NCT02561104|cataract|cataract
4810308|NCT02561104|phacoemulsification|phacoemulsification
4810309|NCT02561104|laser-assisted surgery|laser-assisted surgery
4810310|NCT02561104|femtosecond laser|femtosecond laser
4810311|NCT02561091|Deafness|deafness
4810312|NCT02561091|Hearing Loss, Sensorineural|hearing loss, sensorineural
4810313|NCT02561091|Ear Diseases|ear diseases
4810314|NCT02561091|Hearing Disorders|hearing disorders
4810315|NCT02561091|Otorhinolaryngologic Diseases|otorhinolaryngologic diseases
4810316|NCT02561091|Sensation Disorders|sensation disorders
4810317|NCT02561091|Signs and Symptoms|signs and symptoms
4810318|NCT02561091|Hearing and Speech impairment|hearing and speech impairment
4810319|NCT02561091|Hearing Loss, Unilateral|hearing loss, unilateral
4810320|NCT02561078|insulin pumps|insulin pumps
4810321|NCT02561078|concentrated insulin|concentrated insulin
4810322|NCT02561078|OmniPod|omnipod
4810323|NCT02561065|Health Lifestyle|health lifestyle
4810324|NCT02561065|Lifestyle Risk Reduction|lifestyle risk reduction
4810325|NCT02561065|Health Behavior|health behavior
4810326|NCT02561065|Sedentary Lifestyle|sedentary lifestyle
4810327|NCT02561065|Intervention Studies|intervention studies
4810328|NCT02561065|Cardiovascular risk in office workers|cardiovascular risk in office workers
4810329|NCT02561065|Motivational Interview|motivational interview
4810330|NCT02561065|Preventive health services|preventive health services
4810331|NCT02561065|Health education|health education
4810332|NCT02561065|Physical activity|physical activity
4810333|NCT02561065|Dietary behaviour intervention|dietary behaviour intervention
4810334|NCT02561065|Workplace|workplace
4810335|NCT02561026|Frozen plasma|frozen plasma
4810336|NCT02561026|INR|inr
4810337|NCT02561026|procedures|procedures
4810338|NCT02561000|Platelets|platelets
4810339|NCT02561000|Platelet Aggregation Inhibitors|platelet aggregation inhibitors
4810340|NCT02561000|Protease-Activated Receptor 1|protease-activated receptor 1
4810341|NCT02561000|Hemorrhage|hemorrhage
4810342|NCT02560961|Kinesio Taping|kinesio taping
4810343|NCT02560961|Soccer|soccer
4810344|NCT02560961|Hop Test|hop test
4810345|NCT02560961|Vertical Jump|vertical jump
4810346|NCT02560935|primary stroke prevention|primary stroke prevention
4810347|NCT02560935|hydroxyurea|hydroxyurea
4810348|NCT02560935|low income country|low income country
4810349|NCT02560935|sub-Saharan Africa|sub-saharan africa
4810350|NCT02560922|Osteoarthritis|osteoarthritis
4810351|NCT02560922|Knee Osteoarthritis|knee osteoarthritis
4810352|NCT02560922|Hip Osteoarthritis|hip osteoarthritis
4810353|NCT02560896|Family|family
4810354|NCT02560896|History|history
4810355|NCT02560896|Pancreas|pancreas
4810356|NCT02560896|Cancer|cancer
4810357|NCT02560896|Genetic|genetic
4810358|NCT02560883|Hairy Cell|hairy cell
4810359|NCT02560857|Quantiferon-Monitor|quantiferon-monitor
4810360|NCT02560857|organ rejection|organ rejection
4810361|NCT02560857|global immunity|global immunity
4810362|NCT02560831|Osteoarthritis|osteoarthritis
4810363|NCT02560831|Therapeutic exercises|therapeutic exercises
4810364|NCT02560831|Pain|pain
4810365|NCT02560831|Muscle strength|muscle strength
4810366|NCT02560831|Postural balance|postural balance
4810367|NCT02560818|splice profiles of messenger RNA|splice profiles of messenger rna
4810368|NCT02560779|TRC105|trc105
4810369|NCT02560779|CD105|cd105
4810370|NCT02560779|Endoglin|endoglin
4810371|NCT02560779|Angiogenesis inhibitor|angiogenesis inhibitor
4810372|NCT02560779|HCC|hcc
4810373|NCT02560779|TKI|tki
4810374|NCT02560779|Tyrosine Kinase Inhibitor|tyrosine kinase inhibitor
4810375|NCT02560779|Sorafenib|sorafenib
4810376|NCT02560779|Nexavar|nexavar
4810377|NCT02560766|Restless Leg Syndrome|restless leg syndrome
4810378|NCT02560766|RLS|rls
4810379|NCT02560727|Inflammatory Bowel Diseases|inflammatory bowel diseases
4810380|NCT02560727|Fecal Microbiota Transplantation|fecal microbiota transplantation
4810381|NCT02560727|transendoscopic enteral tubing|transendoscopic enteral tubing
4810382|NCT02560714|sacroiliac joint fusion|sacroiliac joint fusion
4810383|NCT02560714|SIJ Fusion|sij fusion
4810384|NCT02560714|SI Joint|si joint
4810385|NCT02560714|SIJ|sij
4810386|NCT02560701|high-deductible health plans|high-deductible health plans
4810387|NCT02560701|medication adherence|medication adherence
4810388|NCT02560688|drug interaction|drug interaction
4810389|NCT02560688|clopidogrel|clopidogrel
4810390|NCT02560688|healthy subjects|healthy subjects
4810391|NCT02560675|Whiplash Injury Pain|whiplash injury pain
4810392|NCT02560675|Chronic Pain|chronic pain
4810393|NCT02560675|TBI|tbi
4810394|NCT02560662|Breast cancer, physical exercise, recovery|breast cancer, physical exercise, recovery
4810395|NCT02560636|Muscle Invasive|muscle invasive
4810396|NCT02560636|Metastatic|metastatic
4810397|NCT02560636|Advanced|advanced
4810398|NCT02560623|Barrett's|barrett's
4810399|NCT02560623|esophagus|esophagus
4810400|NCT02560623|reflux|reflux
4810401|NCT02560623|esophageal adenocarcinoma|esophageal adenocarcinoma
4810402|NCT02560597|epilepsy|epilepsy
4810403|NCT02560597|epilepsia partialis continua|epilepsia partialis continua
4810404|NCT02560597|status epilepticus|status epilepticus
4810405|NCT02560597|treatment resistant|treatment resistant
4810406|NCT02560597|repetitive transcranial magnetic stimulation|repetitive transcranial magnetic stimulation
4810407|NCT02560584|Non-muscle invasive bladder cancer|non-muscle invasive bladder cancer
4810408|NCT02560584|NMIBC|nmibc
4810409|NCT02560584|Cysview|cysview
4810410|NCT02560558|Immunosuppression|immunosuppression
4810411|NCT02560558|Transplantation Immunology|transplantation immunology
4810412|NCT02560532|aneurysmal subarachnoid hemorrhage|aneurysmal subarachnoid hemorrhage
4810413|NCT02560532|cerebral vasospasm|cerebral vasospasm
4810414|NCT02560532|clazosentan|clazosentan
4810415|NCT02560519|human serum albumin solution|human serum albumin solution
4810416|NCT02560519|Cardiopulmonary Bypass|cardiopulmonary bypass
4810417|NCT02560493|BMIz|bmiz
4810418|NCT02560493|Exergaming|exergaming
4810419|NCT02560493|Cardiovascular Disease|cardiovascular disease
4810420|NCT02560480|groin pain, groin injury, magnetic resonance imaging|groin pain, groin injury, magnetic resonance imaging
4810421|NCT02560454|Cognitive Remediation|cognitive remediation
4810422|NCT02560454|Working Memory Training|working memory training
4810423|NCT02560454|Cognitive training|cognitive training
4810424|NCT02560428|Mixed Methods|mixed methods
4810425|NCT02560428|Cardiovascular Health|cardiovascular health
4810426|NCT02560428|Implementation Evaluation|implementation evaluation
4810427|NCT02560428|Cardiovascular Prevention Screening|cardiovascular prevention screening
4810428|NCT02560415|Autism Spectrum Disorder|autism spectrum disorder
4810429|NCT02560415|Serious Game|serious game
4810430|NCT02560415|Controlled trial|controlled trial
4810431|NCT02560415|Denver model|denver model
4810432|NCT02560402|Glomerular hyperfiltration|glomerular hyperfiltration
4810433|NCT02560402|Renal Resistive Index (RRI)|renal resistive index (rri)
4810434|NCT02560389|Posttraumatic Stress Disorder|posttraumatic stress disorder
4810435|NCT02560389|functional Magnetic Resonance Imaging|functional magnetic resonance imaging
4810436|NCT02560389|Levodopa (L-DOPA)|levodopa (l-dopa)
4810437|NCT02560389|Exposure Therapy|exposure therapy
4810438|NCT02560389|Fear Extinction|fear extinction
4810439|NCT02560376|PET/CT|pet/ct
4810440|NCT02560376|glucagon-like peptide-1 receptor (GLP-1R) imaging|glucagon-like peptide-1 receptor (glp-1r) imaging
4810441|NCT02560363|AZD9977|azd9977
4810442|NCT02560363|Safety|safety
4810443|NCT02560363|Tolerability|tolerability
4810444|NCT02560363|Pharmacokinetics|pharmacokinetics
4810445|NCT02560363|Food effect|food effect
4810446|NCT02560363|AZD9977 capsules|azd9977 capsules
4810447|NCT02560363|AZD9977 suspension|azd9977 suspension
4810448|NCT02560350|adipose-derived stem cells|adipose-derived stem cells
4810449|NCT02560350|small intestinal submucosa|small intestinal submucosa
4810450|NCT02560350|adipocyte-containing hypodermis|adipocyte-containing hypodermis
4810451|NCT02560337|Ovarian cancer|ovarian cancer
4810452|NCT02560337|Relapse|relapse
4810453|NCT02560337|Recurrence|recurrence
4810454|NCT02560337|Chemotherapy resistance|chemotherapy resistance
4810455|NCT02560324|Ramelteon|ramelteon
4810456|NCT02560324|Nicotine|nicotine
4810457|NCT02560324|Nicotine dependence|nicotine dependence
4810458|NCT02560324|Insomnia|insomnia
4810459|NCT02560324|Tobacco Dependence|tobacco dependence
4810460|NCT02560285|Risk assessment|risk assessment
4810461|NCT02560285|Mortality|mortality
4810462|NCT02560285|Morbidity|morbidity
4810463|NCT02560285|Risk factor|risk factor
4810464|NCT02560272|vaccine|vaccine
4810465|NCT02560272|haemophilus influenzae type b|haemophilus influenzae type b
4810466|NCT02560259|knee pain|knee pain
4810467|NCT02560246|Microbiome|microbiome
4810468|NCT02560233|Neurofeedback|neurofeedback
4810469|NCT02560233|Stress|stress
4810470|NCT02560233|fMRI|fmri
4810471|NCT02560233|Real-time fMRI Neurofeedback|real-time fmri neurofeedback
4810472|NCT02560233|Anterior cingulate cortex|anterior cingulate cortex
4810473|NCT02560233|Hypothalamic-pituitary-adrenal axis|hypothalamic-pituitary-adrenal axis
4810474|NCT02560233|Cortisol|cortisol
4810476|NCT02560233|Heart rate variability|heart rate variability
4810477|NCT02560233|Blood pressure|blood pressure
4810478|NCT02560233|Simultaneous EEG/fMRI|simultaneous eeg/fmri
4810479|NCT02560181|recurrent prostate cancer, HDR whole gland salvage|recurrent prostate cancer, hdr whole gland salvage
4810480|NCT02560168|Coronary artery disease|coronary artery disease
4810481|NCT02560168|iECG|iecg
4810482|NCT02560168|MyoVista|myovista
4810483|NCT02560168|Heart Test Labs|heart test labs
4810484|NCT02560168|Wavelet analysis|wavelet analysis
4810485|NCT02560168|Surface electrocardiogram|surface electrocardiogram
4810486|NCT02560155|Orthopedic surgery|orthopedic surgery
4810487|NCT02560155|Surgical site infection|surgical site infection
4810488|NCT02560155|Decolonization|decolonization
4810489|NCT02560155|Staphylococcus aureus|staphylococcus aureus
4810490|NCT02560129|recovery|recovery
4810491|NCT02560129|ICU|icu
4810492|NCT02560129|clinic|clinic
4810493|NCT02560129|survivor|survivor
4810494|NCT02560129|physical function|physical function
4810495|NCT02560116|Pulmonary artery systolic pressure|pulmonary artery systolic pressure
4810496|NCT02560116|Optison|optison
4810497|NCT02560090|Diabetes|diabetes
4810498|NCT02560077|cognitive|cognitive
4810499|NCT02560077|memory|memory
4810500|NCT02560077|physical fitness|physical fitness
4810501|NCT02560077|psychological fitness|psychological fitness
4810502|NCT02560077|elderly|elderly
4810503|NCT02560077|middle aged|middle aged
4810504|NCT02560051|Prostate Cancer|prostate cancer
4810505|NCT02560051|Advanced|advanced
4810506|NCT02560051|Local Failures|local failures
4810507|NCT02560038|Urothelial Cancer|urothelial cancer
4810508|NCT02560038|Bladder Cancer|bladder cancer
4810509|NCT02560038|Metastatic|metastatic
4810510|NCT02560025|Acute Myeloid Leukemia|acute myeloid leukemia
4810511|NCT02560012|Renal Cell Carcinoma|renal cell carcinoma
4810512|NCT02560012|RCC|rcc
4810513|NCT02560012|Personalized therapy|personalized therapy
4810514|NCT02560012|targeted inhibitors|targeted inhibitors
4810515|NCT02559999|Healthy Volunteers|healthy volunteers
4810516|NCT02559999|Pain|pain
4810517|NCT02559999|EEG|eeg
4810518|NCT02559973|Buprenorphine|buprenorphine
4810519|NCT02559973|opioid use disorder|opioid use disorder
4810520|NCT02559921|Recombinant Human Rabies Immunoglobin (rhRIG)|recombinant human rabies immunoglobin (rhrig)
4810521|NCT02559869|Biofluid|biofluid
4810522|NCT02559869|ALS|als
4810523|NCT02559869|MRI|mri
4810524|NCT02559869|PET|pet
4810525|NCT02559869|Imaging|imaging
4810526|NCT02559869|Biomarkers|biomarkers
4810527|NCT02559869|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
4810528|NCT02559869|TRACK ALS|track als
4810529|NCT02559869|pathology|pathology
4810530|NCT02559843|pomegranate|pomegranate
4810531|NCT02559843|diabetes|diabetes
4810532|NCT02559843|oxidative stress|oxidative stress
4810533|NCT02559817|Irritable Bowel Syndrome with Constipation in children|irritable bowel syndrome with constipation in children
4810534|NCT02559817|Linzess|linzess
4810535|NCT02559791|Reslizumab|reslizumab
4810536|NCT02559791|Eosinophils|eosinophils
4810537|NCT02559791|Asthma|asthma
4810538|NCT02559791|Airway inflammation|airway inflammation
4810539|NCT02559791|Prednisone|prednisone
4810540|NCT02559765|physiotherapy|physiotherapy
4810541|NCT02559765|progressive multiple sclerosis|progressive multiple sclerosis
4810542|NCT02559765|rehabilitation|rehabilitation
4810543|NCT02559765|rehabilitation services|rehabilitation services
4810544|NCT02559739|Stroke|stroke
4810545|NCT02559739|Ischemic Attack, Transient|ischemic attack, transient
4810546|NCT02559739|Cardiovascular Diseases|cardiovascular diseases
4810547|NCT02559739|Sleep Apnea Syndromes|sleep apnea syndromes
4810548|NCT02559739|Sleep Initiation and Maintenance Disorders|sleep initiation and maintenance disorders
4810549|NCT02559739|Insomnia|insomnia
4810550|NCT02559739|Restless Legs Syndrome|restless legs syndrome
4810551|NCT02559739|Sleep Deprivation|sleep deprivation
4810552|NCT02559726|Hypertrophic cardiomyopathy, hyper-synchronicity, outflow-tract obstruction, dual chamber pacing|hypertrophic cardiomyopathy, hyper-synchronicity, outflow-tract obstruction, dual chamber pacing
4810553|NCT02559713|Lactation|lactation
4810554|NCT02559713|Lactating Women|lactating women
4810555|NCT02559713|Vedolizumab|vedolizumab
4810556|NCT02559713|Colitis Ulcerative|colitis ulcerative
4810557|NCT02559713|Crohn Disease|crohn disease
4810558|NCT02559713|Crohn's|crohn's
4810559|NCT02559700|Healthy Ageing|healthy ageing
4810560|NCT02559687|Programmed Cell Death-1 (PD-1)|programmed cell death-1 (pd-1)
4810561|NCT02559687|PD1|pd1
4810562|NCT02559687|Programmed Cell Death-Ligand 1 (PD-L1)|programmed cell death-ligand 1 (pd-l1)
4810563|NCT02559687|Programmed Cell Death-Ligand 2 (PD-L2)|programmed cell death-ligand 2 (pd-l2)
4810564|NCT02559687|PDL1|pdl1
4810565|NCT02559687|PDL2|pdl2
4810566|NCT02559674|Pancreas|pancreas
4810567|NCT02559674|Pancreatic|pancreatic
4810568|NCT02559674|Cancer|cancer
4810569|NCT02559674|Advanced Pancreatic Cancer|advanced pancreatic cancer
4810570|NCT02559674|Immunotherapy|immunotherapy
4810571|NCT02559674|Immunotherapeutic|immunotherapeutic
4810572|NCT02559674|Interleukin-15|interleukin-15
4810573|NCT02559674|Gemcitabine|gemcitabine
4810574|NCT02559674|Nab-paclitaxel|nab-paclitaxel
4810575|NCT02559674|Solid Tumor|solid tumor
4810576|NCT02559674|Metastatic Disease|metastatic disease
4810577|NCT02559674|Combination Immunotherapy|combination immunotherapy
4810578|NCT02559583|Multiple Myeloma|multiple myeloma
4810579|NCT02559583|chronic lymphocytic leukemia|chronic lymphocytic leukemia
4810580|NCT02559583|Non-Hodgkin lymphoma|non-hodgkin lymphoma
4810581|NCT02559570|Functional constipation in children|functional constipation in children
4810582|NCT02559570|Linzess|linzess
4810583|NCT02559544|failed prior endocrine therapy|failed prior endocrine therapy
4810584|NCT02559518|Cerebellum|cerebellum
4810585|NCT02559518|Transcranial Direct Current Stimulation|transcranial direct current stimulation
4810586|NCT02559518|Repetitive Transcranial Magnetic Stimulation|repetitive transcranial magnetic stimulation
4810587|NCT02559518|Motor Learning|motor learning
4810588|NCT02559518|Serial Reaction Time Task|serial reaction time task
4810589|NCT02559518|HandwritingTask|handwritingtask
4810590|NCT02559505|natural influenza infection|natural influenza infection
4810591|NCT02559505|live attenuated influenza vaccination (LAIV)|live attenuated influenza vaccination (laiv)
4810592|NCT02559505|inactivated influenza vaccination (IIV)|inactivated influenza vaccination (iiv)
4810593|NCT02559505|infants|infants
4810594|NCT02559505|children|children
4810595|NCT02559466|pharmaco-resistant depressed patients|pharmaco-resistant depressed patients
4810596|NCT02559427|sleep apnea|sleep apnea
4810597|NCT02559427|Venous Insufficiency|venous insufficiency
4810598|NCT02559427|SPA treatment|spa treatment
4810599|NCT02559401|Eloquent cortex|eloquent cortex
4810600|NCT02559349|Stereotactic Body Radiotherapy|stereotactic body radiotherapy
4810601|NCT02559349|SBRT|sbrt
4810602|NCT02559336|Palliative Care|palliative care
4810603|NCT02559336|Cancer|cancer
4810604|NCT02559336|Health Services Research|health services research
4810605|NCT02559310|Pneumonia|pneumonia
4810606|NCT02559310|CABP|cabp
4810607|NCT02559310|CAP|cap
4810608|NCT02559310|Community acquired bacterial pneumonia|community acquired bacterial pneumonia
4810609|NCT02559297|Regulatory T cells|regulatory t cells
4810610|NCT02559297|Sevoflurane|sevoflurane
4810611|NCT02559297|Desflurane|desflurane
4810612|NCT02559297|Cytokines|cytokines
4810613|NCT02559297|Flow cytometry|flow cytometry
4810614|NCT02559297|Living Donor Kidney Transplant|living donor kidney transplant
4810615|NCT02559284|Saline Solution, Isotonic / Administration & dosage|saline solution, isotonic / administration & dosage
4810616|NCT02559284|Therapeutic Irrigation / methods|therapeutic irrigation / methods
4810617|NCT02559284|Postoperative Care / methods|postoperative care / methods
4810618|NCT02559284|Quality of life|quality of life
4810619|NCT02559180|Diabetes|diabetes
4810620|NCT02559180|Macular Edema|macular edema
4810621|NCT02559180|Diabetic Retinopathy|diabetic retinopathy
4810622|NCT02559141|haemodynamic optimization|haemodynamic optimization
4810623|NCT02559141|cardiac index|cardiac index
4810624|NCT02559141|non-invasive|non-invasive
4810625|NCT02559141|pulse pressure variation|pulse pressure variation
4810626|NCT02559128|Insulin Resistance|insulin resistance
4810627|NCT02559128|Chronic Heart Failure|chronic heart failure
4810628|NCT02559128|Type 2 Diabetes|type 2 diabetes
4810629|NCT02559128|Endothelial Dysfunction|endothelial dysfunction
4810630|NCT02559115|68Ga-RM2|68ga-rm2
4810631|NCT02559115|PET/CT scan|pet/ct scan
4810632|NCT02559115|Gastrin Releasing Peptide Receptor (GRPr)|gastrin releasing peptide receptor (grpr)
4810633|NCT02559115|14-146|14-146
4810634|NCT02559102|Dexmedetomidine sedation|dexmedetomidine sedation
4810635|NCT02559102|General anaesthesia|general anaesthesia
4810636|NCT02559102|Neurodevelopment|neurodevelopment
4810637|NCT02559102|Infants|infants
4810638|NCT02559102|Neonates|neonates
4810639|NCT02559076|Overweight|overweight
4810640|NCT02559076|Obesity|obesity
4810641|NCT02559076|Preschool children|preschool children
4810642|NCT02559076|United Arab Emirates|united arab emirates
4810643|NCT02559076|Dietary patterns|dietary patterns
4810644|NCT02559076|BMI z-scores|bmi z-scores
4810645|NCT02559063|cognitive training|cognitive training
4810646|NCT02559063|speed of processing|speed of processing
4810647|NCT02559063|neuroplasticity|neuroplasticity
4810648|NCT02559063|cognitive aging|cognitive aging
4810649|NCT02559037|acupuncture|acupuncture
4810650|NCT02559037|moxibustion|moxibustion
4810651|NCT02559037|intestinal microbiota|intestinal microbiota
4810652|NCT02559037|Mucosal immunity|mucosal immunity
4810653|NCT02559024|Metastatic colorectal cancer|metastatic colorectal cancer
4810654|NCT02559024|liver lesion|liver lesion
4810655|NCT02559024|anti-OX40 antibody|anti-ox40 antibody
4810656|NCT02559024|MEDI6469|medi6469
4810657|NCT02559024|Immunotherapy|immunotherapy
4810658|NCT02559011|Arrhythmias, Cardiac|arrhythmias, cardiac
4810659|NCT02559011|Transcatheter Aortic Valve implantation|transcatheter aortic valve implantation
4810660|NCT02559011|Aortic Valve Stenosis|aortic valve stenosis
4810661|NCT02558985|Pulmonary Compliance|pulmonary compliance
4810662|NCT02558985|Casting|casting
4810663|NCT02558972|Postural Tachycardia Syndrome (POTS)|postural tachycardia syndrome (pots)
4810664|NCT02558972|Vasovagal Syncope (VVS)|vasovagal syncope (vvs)
4810665|NCT02558972|Fainting|fainting
4810666|NCT02558972|Orthostatic Intolerance|orthostatic intolerance
4810667|NCT02558972|Droxidopa|droxidopa
4810668|NCT02558972|Northera|northera
4810669|NCT02558933|Fetal Alcohol Syndrome|fetal alcohol syndrome
4810670|NCT02558933|Prenatal exposure|prenatal exposure
4810671|NCT02558933|Biomarkers|biomarkers
4810672|NCT02558933|Oxidative stress|oxidative stress
4810673|NCT02558933|Epigallocatechin gallate|epigallocatechin gallate
4810674|NCT02558920|Systematic review and meta-analysis|systematic review and meta-analysis
4810675|NCT02558920|Evidence-based medicine (EBM)|evidence-based medicine (ebm)
4810676|NCT02558920|Evidence-based nutrition (EBN)|evidence-based nutrition (ebn)
4810677|NCT02558920|Clinical practice guidelines|clinical practice guidelines
4810678|NCT02558920|Clinical trials|clinical trials
4810679|NCT02558920|Dietary sugars|dietary sugars
4810680|NCT02558920|Fructose|fructose
4810681|NCT02558920|Sucrose|sucrose
4810682|NCT02558920|High fructose corn syrup|high fructose corn syrup
4810683|NCT02558920|Isocaloric|isocaloric
4810684|NCT02558920|Hypercaloric|hypercaloric
4810685|NCT02558920|Body weight|body weight
4810686|NCT02558920|Prospective cohort studies|prospective cohort studies
4810687|NCT02558907|geriatrics|geriatrics
4810688|NCT02558907|cancer|cancer
4810689|NCT02558907|MMS test|mms test
4810690|NCT02558907|MoCA test|moca test
4810691|NCT02558907|cognitive evaluation|cognitive evaluation
4810692|NCT02558894|Pancreatic Ductal Adenocarcinoma, PDAC|pancreatic ductal adenocarcinoma, pdac
4810693|NCT02558881|screening|screening
4810694|NCT02558881|colorectal cancer|colorectal cancer
4810695|NCT02558881|colon capsule|colon capsule
4810696|NCT02558881|virtual colonoscopy|virtual colonoscopy
4810697|NCT02558855|Thrust Joint Manipulation|thrust joint manipulation
4810698|NCT02558855|Non-thrust Joint Manipulation|non-thrust joint manipulation
4810699|NCT02558855|Transversus Abdominis|transversus abdominis
4810700|NCT02558829|Adult Growth Hormone Deficiency|adult growth hormone deficiency
4810701|NCT02558803|HPV Vaccinations|hpv vaccinations
4810702|NCT02558803|Quadrivalent Vaccine|quadrivalent vaccine
4810703|NCT02558790|Attention Deficit/Hyperactivity Disorder|attention deficit/hyperactivity disorder
4810704|NCT02558790|ADHD|adhd
4810705|NCT02558790|Attention Deficit Disorder|attention deficit disorder
4810706|NCT02558790|ADD|add
4810707|NCT02558790|Magnesium|magnesium
4810708|NCT02558777|Delirium|delirium
4810709|NCT02558777|Pilot Study|pilot study
4810710|NCT02558777|Nurse intervention|nurse intervention
4810711|NCT02558777|Hospitalization|hospitalization
4810712|NCT02558751|pneumococcal conjugate vaccine|pneumococcal conjugate vaccine
4810713|NCT02558751|aging HIV|aging hiv
4810714|NCT02558738|dermatitis and irritations at the outer ear canal|dermatitis and irritations at the outer ear canal
4810715|NCT02558738|prevention of subacute otitis externa|prevention of subacute otitis externa
4810716|NCT02558712|screening|screening
4810717|NCT02558712|tele-ophthalmology|tele-ophthalmology
4810718|NCT02558686|trigger points|trigger points
4810719|NCT02558686|disability|disability
4810720|NCT02558686|post-dry needling soreness|post-dry needling soreness
4810721|NCT02558686|eccentric exercise|eccentric exercise
4810722|NCT02558673|Trimethylamine-N-oxide|trimethylamine-n-oxide
4810723|NCT02558673|Biomarkers|biomarkers
4810724|NCT02558673|Production|production
4810725|NCT02558673|Metabolism|metabolism
4810726|NCT02558673|Gut microbiome|gut microbiome
4810727|NCT02558673|Healthy|healthy
4810728|NCT02558660|Supplemental Nutrition Incentive Program (SNAP)|supplemental nutrition incentive program (snap)
4810729|NCT02558660|economic incentive|economic incentive
4810730|NCT02558647|therapy|therapy
4810731|NCT02558647|CBT-I|cbt-i
4810732|NCT02558647|internet-based|internet-based
4810733|NCT02558647|online|online
4810734|NCT02558647|short-term benefits|short-term benefits
4810735|NCT02558647|medium-term outcomes|medium-term outcomes
4810736|NCT02558647|health resource use|health resource use
4810737|NCT02558647|sick leave|sick leave
4810738|NCT02558621|Robotic Spinal Fusion Surgery|robotic spinal fusion surgery
4810739|NCT02558608|Prime Spontaneous Pneumothorax|prime spontaneous pneumothorax
4810740|NCT02558608|recurrence|recurrence
4810741|NCT02558595|PKD|pkd
4810742|NCT02558595|Kidney disease|kidney disease
4810743|NCT02558595|Vitamin B3|vitamin b3
4810744|NCT02558582|Pulmonary arterial hypertension|pulmonary arterial hypertension
4810745|NCT02558582|Chronic thromboembolic pulmonary hypertension|chronic thromboembolic pulmonary hypertension
4810746|NCT02558582|Rehabilitation|rehabilitation
4810747|NCT02558582|Oxygen|oxygen
4810748|NCT02558569|fentanyl, scalp block|fentanyl, scalp block
4810749|NCT02558556|Laparoscopic cholecystectomy (LC)|laparoscopic cholecystectomy (lc)
4810750|NCT02558556|Indocyanine green (ICG)|indocyanine green (icg)
4810751|NCT02558556|Near-Infrared Fluorescence Imaging (NIRF)|near-infrared fluorescence imaging (nirf)
4810752|NCT02558556|Critical View of Safety (CVS)|critical view of safety (cvs)
4810753|NCT02558517|Systemic Lupus Erythematosus|systemic lupus erythematosus
4810754|NCT02558517|Corticosteroids|corticosteroids
4810755|NCT02558517|Chronic disease|chronic disease
4810756|NCT02558491|Type 1 Diabetes Mellitus (T1DM)|type 1 diabetes mellitus (t1dm)
4810757|NCT02558491|Artificial Pancreas Project (APP)|artificial pancreas project (app)
4810758|NCT02558491|Diabetes Assistant (DiAs)|diabetes assistant (dias)
4810759|NCT02558491|Insulin Pump|insulin pump
4810760|NCT02558491|Continuous Glucose Monitor|continuous glucose monitor
4810761|NCT02558491|Exercise|exercise
4810762|NCT02558491|Glucose Variability|glucose variability
4810763|NCT02558491|Decision Support System|decision support system
4810764|NCT02558491|Multiple Daily Injections (MDI)|multiple daily injections (mdi)
4810765|NCT02558478|Whole exome sequencing|whole exome sequencing
4810766|NCT02558465|Xarelto, rivaroxaban, VTE, PE, DVT, Japan, PMS, SDUI|xarelto, rivaroxaban, vte, pe, dvt, japan, pms, sdui
4810767|NCT02558452|elderly kidney transplant recipient|elderly kidney transplant recipient
4810768|NCT02558452|registry|registry
4810769|NCT02558452|tacrolimus once daily|tacrolimus once daily
4810770|NCT02558426|Chronic Venous Disease|chronic venous disease
4810771|NCT02558426|Estrogen receptors|estrogen receptors
4810772|NCT02558426|GPER|gper
4810773|NCT02558413|Viral Diseases|viral diseases
4810774|NCT02558413|Antiviral|antiviral
4810775|NCT02558413|Paramyxoviridae Infections|paramyxoviridae infections
4810776|NCT02558413|RSV|rsv
4810777|NCT02558413|Respiratory Syncytial Virus|respiratory syncytial virus
4810778|NCT02558413|Aviragen Therapeutics, Inc.|aviragen therapeutics, inc.
4810779|NCT02558413|Aviragen Therapeutics|aviragen therapeutics
4810780|NCT02558413|Aviragen|aviragen
4810781|NCT02558348|Dual receptor Tyrosine Kinase Inhibitor|dual receptor tyrosine kinase inhibitor
4810782|NCT02558348|Anti-angiogenic therapy|anti-angiogenic therapy
4810783|NCT02558257|Advanced Cancers|advanced cancers
4810784|NCT02558257|Survey|survey
4810785|NCT02558257|Questionnaire|questionnaire
4810786|NCT02558244|Childhood Cancer|childhood cancer
4810787|NCT02558244|Image-defined Risk Factors|image-defined risk factors
4810788|NCT02558244|Pediatric Oncology|pediatric oncology
4810789|NCT02558192|LGG|lgg
4810790|NCT02558192|Probiotics|probiotics
4810791|NCT02558192|nosocomial infection prevention|nosocomial infection prevention
4810792|NCT02558192|pediatrics|pediatrics
4810793|NCT02558166|Acute Kidney Injury (AKI)|acute kidney injury (aki)
4810794|NCT02558166|Renal Resistive Index (RRI)|renal resistive index (rri)
4810795|NCT02558153|drug eluting balloon|drug eluting balloon
4810796|NCT02558153|percutaneous balloon angioplasty|percutaneous balloon angioplasty
4810797|NCT02558127|asthma|asthma
4810798|NCT02558127|cystic fibrosis|cystic fibrosis
4810799|NCT02558101|Screening|screening
4810800|NCT02558101|Early detection|early detection
4810801|NCT02558101|Health inequality|health inequality
4810802|NCT02558101|Uptake|uptake
4810803|NCT02558088|salmeterol|salmeterol
4810804|NCT02558088|pharmacokinetics|pharmacokinetics
4810805|NCT02558088|doping|doping
4810806|NCT02558088|beta2-agonists|beta2-agonists
4810807|NCT02558088|long-acting beta2-agonists|long-acting beta2-agonists
4810808|NCT02558062|Ventilator Associated Pneumonia|ventilator associated pneumonia
4810809|NCT02558062|Distal lung|distal lung
4810810|NCT02558049|Patient decision aid|patient decision aid
4810811|NCT02558036|Head Neck Position Videolaryngoscopy|head neck position videolaryngoscopy
4810812|NCT02558023|PRE-ECLAMPSIA|pre-eclampsia
4810813|NCT02558023|URAPIDIL|urapidil
4810814|NCT02558023|NICARDIPINE|nicardipine
4810815|NCT02558010|Methadone|methadone
4810816|NCT02558010|Gabapentin|gabapentin
4810817|NCT02558010|Postoperative Pain|postoperative pain
4810818|NCT02558010|Posterior Spinal Fusion|posterior spinal fusion
4810819|NCT02558010|Pediatric|pediatric
4810820|NCT02557997|HIV reservoir|hiv reservoir
4810821|NCT02557997|HIV-1 DNA|hiv-1 dna
4810822|NCT02557997|Immune activation|immune activation
4810823|NCT02557997|Monocyte function|monocyte function
4810824|NCT02557997|Activation biomarkers|activation biomarkers
4810825|NCT02557984|Dopamine|dopamine
4810826|NCT02557984|Opioid|opioid
4810827|NCT02557984|Reward|reward
4810828|NCT02557958|COPD, pulmonary disease|copd, pulmonary disease
4810829|NCT02557932|PPI standard triple therapy|ppi standard triple therapy
4810830|NCT02557932|Bismuth quadruple therapy|bismuth quadruple therapy
4810831|NCT02557932|Helicobacter|helicobacter
4810832|NCT02557906|Acellular dermal matrix|acellular dermal matrix
4810833|NCT02557906|ADM|adm
4810834|NCT02557906|SurgiMend|surgimend
4810835|NCT02557906|Breast reconstruction|breast reconstruction
4810836|NCT02557906|Immediate breast reconstruction|immediate breast reconstruction
4810837|NCT02557906|Autologous reconstruction|autologous reconstruction
4810838|NCT02557906|Biological mesh|biological mesh
4810839|NCT02557867|dexmedetomidine|dexmedetomidine
4810840|NCT02557867|pharmacokinetic|pharmacokinetic
4810841|NCT02557867|obesity|obesity
4810842|NCT02557841|Cerebellum|cerebellum
4810843|NCT02557841|Transcranial Direct Current Stimulation|transcranial direct current stimulation
4810844|NCT02557841|Motor Learning|motor learning
4810845|NCT02557841|Serial Reaction Time Task|serial reaction time task
4810846|NCT02557841|Handwriting|handwriting
4810847|NCT02557815|Repetitive Transcranial Magnetic Stimulation|repetitive transcranial magnetic stimulation
4810848|NCT02557815|Emotion Regulation|emotion regulation
4810849|NCT02557815|Craving|craving
4810850|NCT02557789|Absolute bioavailability|absolute bioavailability
4810851|NCT02557789|Pharmacokinetics|pharmacokinetics
4810852|NCT02557776|BRCA1|brca1
4810853|NCT02557776|BRCA2|brca2
4810854|NCT02557776|hereditary breast cancer|hereditary breast cancer
4810855|NCT02557776|genetic counseling|genetic counseling
4810856|NCT02557763|Oxford UKA|oxford uka
4810857|NCT02557763|anterior knee pain|anterior knee pain
4810858|NCT02557763|lateral facet of patella|lateral facet of patella
4810859|NCT02557750|Childhood Cancer|childhood cancer
4810860|NCT02557750|Pediatric Oncology|pediatric oncology
4810861|NCT02557737|stroke|stroke
4810862|NCT02557737|upper extremity|upper extremity
4810863|NCT02557737|spasticity|spasticity
4810864|NCT02557737|botulinum toxin|botulinum toxin
4810865|NCT02557737|ultrasonography|ultrasonography
4810866|NCT02557737|electric stimulation|electric stimulation
4810867|NCT02557711|spasticity|spasticity
4810868|NCT02557711|stroke|stroke
4810869|NCT02557711|ultrasound elastography|ultrasound elastography
4810870|NCT02557711|acoustic radiation force impulse|acoustic radiation force impulse
4810871|NCT02557659|Low Profile|low profile
4810872|NCT02557659|Abdominal Aortic Aneurysms|abdominal aortic aneurysms
4810873|NCT02557659|Endovascular|endovascular
4810874|NCT02557594|Hepatitis B|hepatitis b
4810875|NCT02557568|nasal carriage|nasal carriage
4810876|NCT02557568|Staphylococcus aureus|staphylococcus aureus
4810877|NCT02557568|hemodialysis patients|hemodialysis patients
4810878|NCT02557542|Varicose Veins; One Stop Clinic|varicose veins; one stop clinic
4810879|NCT02557529|Head and Neck Cancer|head and neck cancer
4810880|NCT02557529|Concomitant chemoradiotherapy|concomitant chemoradiotherapy
4810881|NCT02557529|Exercise Training|exercise training
4810882|NCT02557529|Progressive Resistance Training|progressive resistance training
4810883|NCT02557529|Weight loss|weight loss
4810884|NCT02557529|Lean Body Mass|lean body mass
4810885|NCT02557529|Body Composition|body composition
4810886|NCT02557503|TACE; oxaliplatin; fluorouracil; liver cancer|tace; oxaliplatin; fluorouracil; liver cancer
4810887|NCT02557490|TACE; hepatic artery infusion; oxaliplatin; raltitrexed|tace; hepatic artery infusion; oxaliplatin; raltitrexed
4810888|NCT02557464|semantic memory|semantic memory
4810889|NCT02557464|eye movements|eye movements
4810890|NCT02557464|reading|reading
4810891|NCT02557438|Bone|bone
4810892|NCT02557438|Child Health|child health
4810893|NCT02557438|Nutrition|nutrition
4810894|NCT02557425|malaria|malaria
4810895|NCT02557425|infant|infant
4810896|NCT02557425|pregnancy|pregnancy
4810897|NCT02557425|prophylaxis|prophylaxis
4810898|NCT02557425|dihyroartemisinin-piperaquine|dihyroartemisinin-piperaquine
4810899|NCT02557425|sulfadoxine-pyrimethamine|sulfadoxine-pyrimethamine
4810900|NCT02557425|behavior|behavior
4810901|NCT02557425|neurodevelopment|neurodevelopment
4810902|NCT02557425|cognitive|cognitive
4810903|NCT02557399|Clindamycin|clindamycin
4810904|NCT02557399|Gel|gel
4810905|NCT02557399|Benzoyl Peroxide|benzoyl peroxide
4810906|NCT02557399|Acne Vulgaris|acne vulgaris
4810907|NCT02557386|Cruciate ligament surgery|cruciate ligament surgery
4810908|NCT02557386|Adductor canal|adductor canal
4810909|NCT02557386|Nerve block|nerve block
4810910|NCT02557373|rice bran|rice bran
4810911|NCT02557373|infants|infants
4810912|NCT02557373|stool metabolome and microbiome|stool metabolome and microbiome
4810913|NCT02557373|dietary intervention|dietary intervention
4810914|NCT02557360|liver injury|liver injury
4810915|NCT02557360|detoxification|detoxification
4810916|NCT02557360|S-adenosyl-L-methionine|s-adenosyl-l-methionine
4810917|NCT02557360|quality of life|quality of life
4810918|NCT02557334|Strawberry Powder|strawberry powder
4810919|NCT02557334|Cardiovascular Disease Risk Factors|cardiovascular disease risk factors
4810920|NCT02557269|Pollenosis|pollenosis
4810921|NCT02557269|Congestion|congestion
4810922|NCT02557269|Mucoadhesive Treatment|mucoadhesive treatment
4810923|NCT02557269|Nasal Decongestant|nasal decongestant
4810924|NCT02557269|Nasal Antihistamine|nasal antihistamine
4810925|NCT02557269|Nasal Corticosteroid|nasal corticosteroid
4810926|NCT02557256|Childhood Cancer|childhood cancer
4810927|NCT02557256|Abdominal Tumors|abdominal tumors
4810928|NCT02557256|Pelvic Tumors|pelvic tumors
4810929|NCT02557256|Pediatric Oncology|pediatric oncology
4810930|NCT02557243|Childhood Cancer|childhood cancer
4810931|NCT02557243|Soft Tissue Tumors|soft tissue tumors
4810932|NCT02557243|Bone Tumors|bone tumors
4810933|NCT02557243|Extremity Tumor|extremity tumor
4810934|NCT02557243|Pediatric Oncology|pediatric oncology
4810935|NCT02557230|Childhood Cancer|childhood cancer
4810936|NCT02557230|Genitourinary tumors|genitourinary tumors
4810937|NCT02557230|urogenital tumors|urogenital tumors
4810938|NCT02557230|Pediatric Oncology|pediatric oncology
4810939|NCT02557204|nasogastric tube insertion|nasogastric tube insertion
4810940|NCT02557204|Video laryngoscope|video laryngoscope
4810941|NCT02557204|success rate|success rate
4810942|NCT02557165|Muscle regeneration|muscle regeneration
4810943|NCT02557113|cement leakage|cement leakage
4810944|NCT02557113|cement augmentation|cement augmentation
4810945|NCT02557113|vertebral body fracture|vertebral body fracture
4810946|NCT02557113|vertebral cavity|vertebral cavity
4810947|NCT02557113|vertebroplasty|vertebroplasty
4810948|NCT02557048|Childhood Cancer|childhood cancer
4810949|NCT02557048|Head and Neck Tumors|head and neck tumors
4810950|NCT02557048|Pediatric Oncology|pediatric oncology
4810951|NCT02557022|Systematic review and meta-analysis|systematic review and meta-analysis
4810952|NCT02557022|Evidence-based medicine (EBM)|evidence-based medicine (ebm)
4810953|NCT02557022|Evidence-based nutrition (EBN)|evidence-based nutrition (ebn)
4810954|NCT02557022|Clinical practice guidelines|clinical practice guidelines
4810955|NCT02557022|Glycemic index|glycemic index
4810956|NCT02557022|Glycemic load|glycemic load
4810957|NCT02557022|Body weight|body weight
4810958|NCT02557022|Cardiovascular risk factors|cardiovascular risk factors
4810959|NCT02557022|Cardiovascular disease|cardiovascular disease
4810960|NCT02557009|Hemodynamics|hemodynamics
4810961|NCT02557009|Central Venous Pressure|central venous pressure
4810962|NCT02557009|Pulmonary Artery Pressure|pulmonary artery pressure
4810963|NCT02557009|Cardiac Output|cardiac output
4810964|NCT02556983|Appendicitis|appendicitis
4810965|NCT02556983|Tomography, X-Ray Computed|tomography, x-ray computed
4810966|NCT02556983|Receiver operating characteristic (ROC) Curve|receiver operating characteristic (roc) curve
4810967|NCT02556983|Computer Simulation|computer simulation
4810968|NCT02556944|Depth of focus|depth of focus
4810969|NCT02556931|immunosuppression|immunosuppression
4810970|NCT02556931|nonmyeloablative|nonmyeloablative
4810971|NCT02556931|non-myeloablative|non-myeloablative
4810972|NCT02556931|allogeneic|allogeneic
4810973|NCT02556931|tacrolimus|tacrolimus
4810974|NCT02556931|peripheral blood|peripheral blood
4810975|NCT02556931|cyclophosphamide|cyclophosphamide
4810976|NCT02556931|mycophenolate mofetil|mycophenolate mofetil
4810977|NCT02556918|Coronary artery bypass graft surgery (CABG)|coronary artery bypass graft surgery (cabg)
4810978|NCT02556918|Type 2 Diabetes|type 2 diabetes
4810979|NCT02556905|Multiple Myeloma|multiple myeloma
4810980|NCT02556905|Revlimid|revlimid
4810981|NCT02556905|Lenalidomide|lenalidomide
4810982|NCT02556905|Observational|observational
4810983|NCT02556905|Korea|korea
4810984|NCT02556905|Post Marketing Surveillance[PMS]|post marketing surveillance[pms]
4810985|NCT02556892|Lymphocytic Leukemia|lymphocytic leukemia
4810986|NCT02556892|Ibrutinib|ibrutinib
4810987|NCT02556892|PCI-32765|pci-32765
4810988|NCT02556892|JNJ-54179060|jnj-54179060
4810989|NCT02556879|Liver transplantation|liver transplantation
4810990|NCT02556879|Graft failure|graft failure
4810991|NCT02556879|Donor specific antibodies|donor specific antibodies
4810992|NCT02556853|Ultrasound|ultrasound
4810993|NCT02556853|Double lumen tube|double lumen tube
4810994|NCT02556840|Monogenic diabetes|monogenic diabetes
4810995|NCT02556840|maturity-onset diabetes of the young|maturity-onset diabetes of the young
4810996|NCT02556840|MODY|mody
4810997|NCT02556840|Pregnancy|pregnancy
4810998|NCT02556840|Gestational diabetes|gestational diabetes
4810999|NCT02556840|Glucokinase|glucokinase
4811000|NCT02556840|Insulin therapy during pregnancy|insulin therapy during pregnancy
4811001|NCT02556840|Evaluation of fetal growth by ultrasonography measurements|evaluation of fetal growth by ultrasonography measurements
4811002|NCT02556827|demodex|demodex
4811003|NCT02556827|oxidative stress|oxidative stress
4811004|NCT02556827|reflectance confocal microscopy|reflectance confocal microscopy
4811005|NCT02556814|ITP|itp
4811006|NCT02556814|Caffeic Acid|caffeic acid
4811007|NCT02556814|dexamethasone|dexamethasone
4811008|NCT02556801|Sublingual immunotherapy|sublingual immunotherapy
4811009|NCT02556801|Dose range finding|dose range finding
4811010|NCT02556801|Grass pollen|grass pollen
4811011|NCT02556801|Allergic rhinitis/rhinoconjunctivitis|allergic rhinitis/rhinoconjunctivitis
4811012|NCT02556801|Immunogenicity|immunogenicity
4811013|NCT02556788|Efficacy|efficacy
4811014|NCT02556788|Safety|safety
4811015|NCT02556788|Acne vulgaris|acne vulgaris
4811016|NCT02556762|Esophageal cancer|esophageal cancer
4811017|NCT02556762|Simultaneous modulated accelerated boost|simultaneous modulated accelerated boost
4811018|NCT02556762|Standard dose radiotherapy|standard dose radiotherapy
4811019|NCT02556762|Chemotherapy|chemotherapy
4811020|NCT02556762|Survival|survival
4811021|NCT02556749|Cranberries|cranberries
4811022|NCT02556749|blood pressure|blood pressure
4811023|NCT02556749|cholesterol|cholesterol
4811024|NCT02556749|SphygmoCor|sphygmocor
4811025|NCT02556736|gene therapy|gene therapy
4811026|NCT02556736|optogenetics|optogenetics
4811027|NCT02556736|channelrhodopsin|channelrhodopsin
4811028|NCT02556736|retina|retina
4811029|NCT02556736|retinitis pigmentosa|retinitis pigmentosa
4811030|NCT02556710|Osteoarthritis|osteoarthritis
4811031|NCT02556710|Osteoarthritis of the Knee|osteoarthritis of the knee
4811032|NCT02556684|Breast-Specific Gamma Imaging|breast-specific gamma imaging
4811033|NCT02556684|Locally Advanced Breast Cancer|locally advanced breast cancer
4811034|NCT02556684|Neoadjuvant Chemotherapy|neoadjuvant chemotherapy
4811035|NCT02556684|BSGI|bsgi
4811036|NCT02556658|Smartpilot View|smartpilot view
4811037|NCT02556658|Hip fracture surgery|hip fracture surgery
4811038|NCT02556658|Depth of anaesthesia|depth of anaesthesia
4811039|NCT02556658|Intraoperative hypotension|intraoperative hypotension
4811040|NCT02556658|Quality of anaesthesia|quality of anaesthesia
4811041|NCT02556645|Combat|combat
4811042|NCT02556645|Psychological Treatment|psychological treatment
4811043|NCT02556645|Military|military
4811044|NCT02556645|Psychotherapy|psychotherapy
4811045|NCT02556645|Trauma|trauma
4811046|NCT02556645|Posttraumatic Stress|posttraumatic stress
4811047|NCT02556645|Posttraumatic Stress Disorder|posttraumatic stress disorder
4811048|NCT02556619|Liver Cancer|liver cancer
4811049|NCT02556619|Randomized Control Trial|randomized control trial
4811050|NCT02556619|Palliative Care|palliative care
4811051|NCT02556619|Liver Cell Carcinoma|liver cell carcinoma
4811052|NCT02556619|Palliative Therapy|palliative therapy
4811053|NCT02556606|ketamine|ketamine
4811054|NCT02556606|depression|depression
4811055|NCT02556606|treatment resistant|treatment resistant
4811056|NCT02556606|treatment resistant depression|treatment resistant depression
4811057|NCT02556606|late life depression|late life depression
4811058|NCT02556606|depression in the elderly|depression in the elderly
4811059|NCT02556606|geriatric depression|geriatric depression
4811060|NCT02556593|Non-Small Cell Lung Cancer|non-small cell lung cancer
4811061|NCT02556593|IMRT|imrt
4811062|NCT02556593|erlotinib|erlotinib
4811063|NCT02556593|whole-brain radiotherapy|whole-brain radiotherapy
4811064|NCT02556580|albumin|albumin
4811065|NCT02556580|surgery|surgery
4811066|NCT02556580|inflammation|inflammation
4811067|NCT02556580|volume kinetics|volume kinetics
4811068|NCT02556567|Sleep patterns|sleep patterns
4811069|NCT02556567|Physical activity|physical activity
4811070|NCT02556567|Fitbit|fitbit
4811071|NCT02556515|CMC1|cmc1
4811072|NCT02556515|arthritis|arthritis
4811073|NCT02556515|degenerative arthritis|degenerative arthritis
4811074|NCT02556515|thumb|thumb
4811075|NCT02556515|interpositional arthroplasty|interpositional arthroplasty
4811076|NCT02556515|total joint replacement|total joint replacement
4811077|NCT02556489|immunological memory|immunological memory
4811078|NCT02556476|critical care|critical care
4811079|NCT02556476|intensive care|intensive care
4811080|NCT02556476|health related quality of life|health related quality of life
4811081|NCT02556476|cost benefit analysis|cost benefit analysis
4811082|NCT02556463|MEDI9197|medi9197
4811083|NCT02556463|TLR 7/8 Agonist|tlr 7/8 agonist
4811084|NCT02556463|Durvalumab|durvalumab
4811085|NCT02556463|MEDI4736|medi4736
4811086|NCT02556463|Imfinzi|imfinzi
4811087|NCT02556437|Subcutaneous immunoglobulin|subcutaneous immunoglobulin
4811088|NCT02556437|MMN|mmn
4811089|NCT02556424|Ophthalmology|ophthalmology
4811090|NCT02556424|Uveitic macular edema|uveitic macular edema
4811091|NCT02556424|Triamcinolone subconjunctival injection|triamcinolone subconjunctival injection
4811092|NCT02556424|Dexamethasone intraocular implant|dexamethasone intraocular implant
4811093|NCT02556372|AIH|aih
4811094|NCT02556372|JKB-122|jkb-122
4811095|NCT02556372|autoimmune|autoimmune
4811096|NCT02556372|hepatitis|hepatitis
4811097|NCT02556346|CD20|cd20
4811098|NCT02556346|immunotoxin|immunotoxin
4811099|NCT02556346|CLL|cll
4811100|NCT02556346|SLL|sll
4811101|NCT02556346|leukemia|leukemia
4811102|NCT02556346|lymphocytic lymphoma|lymphocytic lymphoma
4811103|NCT02556346|lymphocytic leukemia|lymphocytic leukemia
4811104|NCT02556346|MT-3724|mt-3724
4811105|NCT02556346|relapsed|relapsed
4811106|NCT02556346|refractory|refractory
4811107|NCT02556346|immunotherapy|immunotherapy
4811108|NCT02556346|cancer|cancer
4811109|NCT02556346|antibodies|antibodies
4811110|NCT02556346|safety|safety
4811111|NCT02556346|pharmacokinetics|pharmacokinetics
4811112|NCT02556333|TAF|taf
4811113|NCT02556333|F/TAF|f/taf
4811114|NCT02556333|antiretroviral therapy|antiretroviral therapy
4811115|NCT02556333|TDF|tdf
4811116|NCT02556333|directly observed therapy|directly observed therapy
4811117|NCT02556294|HIV risk behavior|hiv risk behavior
4811118|NCT02556268|Single-Dose, Open-Label, Non-Blinded, Non-Placebo-|single-dose, open-label, non-blinded, non-placebo-
4811119|NCT02556268|Controlled, Stratified Design|controlled, stratified design
4811120|NCT02556255|Peripheral Arterial Disease|peripheral arterial disease
4811121|NCT02556255|Peripheral Artery Disease|peripheral artery disease
4811122|NCT02556255|PAD|pad
4811123|NCT02556255|Atherosclerosis|atherosclerosis
4811124|NCT02556255|Arterial Occlusive Diseases|arterial occlusive diseases
4811125|NCT02556255|Peripheral Vascular Diseases|peripheral vascular diseases
4811126|NCT02556255|PVD|pvd
4811127|NCT02556242|vector control|vector control
4811128|NCT02556242|insecticide|insecticide
4811129|NCT02556229|Aflibercept|aflibercept
4811130|NCT02556229|inflammatory choroidal neovascularization|inflammatory choroidal neovascularization
4811131|NCT02556229|young patient|young patient
4811132|NCT02556216|bone biopsy; bone density|bone biopsy; bone density
4811133|NCT02556203|TAVR|tavr
4811134|NCT02556203|TAVI|tavi
4811135|NCT02556203|Transfemoral aortic valve implantation|transfemoral aortic valve implantation
4811136|NCT02556177|TBI|tbi
4811137|NCT02556177|MR|mr
4811138|NCT02556177|mTBI|mtbi
4811139|NCT02556177|NFL|nfl
4811140|NCT02556177|MRI|mri
4811141|NCT02556164|Electroacupuncture|electroacupuncture
4811142|NCT02556164|Body Worn Sensor|body worn sensor
4811143|NCT02556164|Gait|gait
4811144|NCT02556164|Balance|balance
4811145|NCT02556138|Intragastric Balloon|intragastric balloon
4811146|NCT02556138|ORBERA Intragastric Balloon|orbera intragastric balloon
4811147|NCT02556138|Weight Loss|weight loss
4811148|NCT02556138|BMI >35|bmi >35
4811149|NCT02556125|SCI|sci
4811150|NCT02556125|Respiratory impairment|respiratory impairment
4811151|NCT02556125|Diaphragm pacing|diaphragm pacing
4811152|NCT02556125|Diaphragm stimulation|diaphragm stimulation
4811153|NCT02556073|asthma control|asthma control
4811154|NCT02556073|adherence|adherence
4811155|NCT02556073|asthma self management plan|asthma self management plan
4811156|NCT02556073|airway inflammation|airway inflammation
4811157|NCT02556060|ketamine use disorder|ketamine use disorder
4811158|NCT02556060|lamotrigine|lamotrigine
4811159|NCT02556060|craving|craving
4811160|NCT02556008|Children|children
4811161|NCT02556008|Epilepsy|epilepsy
4811162|NCT02556008|Cannabidiol|cannabidiol
4811163|NCT02555995|AMD|amd
4811164|NCT02555995|OCT|oct
4811165|NCT02555982|Essential Head tremor|essential head tremor
4811166|NCT02555982|Botulinum toxin injections|botulinum toxin injections
4811167|NCT02555982|Quality of life|quality of life
4811168|NCT02555982|Embarrassment assessment|embarrassment assessment
4811169|NCT02555956|Macular grid|macular grid
4811170|NCT02555956|Subthreshold|subthreshold
4811171|NCT02555956|diabetic macular edema|diabetic macular edema
4811172|NCT02555956|decrease in visual acuity|decrease in visual acuity
4811173|NCT02555891|Prescriptions|prescriptions
4811174|NCT02555891|Epidemiology|epidemiology
4811175|NCT02555891|Health Administration Databases|health administration databases
4811176|NCT02555891|Elderly|elderly
4811177|NCT02555891|STOPP/START criteria|stopp/start criteria
4811178|NCT02555878|Cancer|cancer
4811179|NCT02555878|Rivaroxaban|rivaroxaban
4811180|NCT02555878|Venous thromboembolism|venous thromboembolism
4811181|NCT02555865|etiology|etiology
4811182|NCT02555865|children|children
4811183|NCT02555852|Proton Pump Inhibitors|proton pump inhibitors
4811184|NCT02555852|Pneumonia|pneumonia
4811185|NCT02555852|NSAIDs|nsaids
4811186|NCT02555852|Histamine H2 Antagonists|histamine h2 antagonists
4811187|NCT02555852|Drug safety|drug safety
4811188|NCT02555839|Relapsed Multiple Myeloma|relapsed multiple myeloma
4811189|NCT02555839|Refractory Multiple Myeloma|refractory multiple myeloma
4811190|NCT02555839|Pomalidomide|pomalidomide
4811191|NCT02555839|Imnovid|imnovid
4811192|NCT02555839|Non-interventional|non-interventional
4811193|NCT02555813|Metastatic Pancreatic Cancer|metastatic pancreatic cancer
4811194|NCT02555813|nab-Paclitaxel|nab-paclitaxel
4811195|NCT02555813|Gemcitabine|gemcitabine
4811196|NCT02555813|Non-interventional|non-interventional
4811197|NCT02555800|Laryngeal papillomatosis|laryngeal papillomatosis
4811198|NCT02555800|Cidofovir|cidofovir
4811199|NCT02555800|Bevacizumab|bevacizumab
4811324|NCT02554812|anti M-CSF|anti m-csf
4811200|NCT02555800|Recurrent respiratory papillomatosis|recurrent respiratory papillomatosis
4811201|NCT02555787|FK506E|fk506e
4811202|NCT02555787|Tacrolimus|tacrolimus
4811203|NCT02555787|Observational|observational
4811204|NCT02555787|Kidney transplantation|kidney transplantation
4811205|NCT02555787|Advagraf|advagraf
4811206|NCT02555774|subjective memory impairment|subjective memory impairment
4811207|NCT02555774|cognitive training|cognitive training
4811208|NCT02555735|pancreatic cancer|pancreatic cancer
4811209|NCT02555696|Metastatic Breast Cancer|metastatic breast cancer
4811210|NCT02555696|nab-paclitaxel|nab-paclitaxel
4811211|NCT02555696|Abraxane|abraxane
4811212|NCT02555683|Asthma|asthma
4811213|NCT02555683|QAW039|qaw039
4811214|NCT02555670|Muscles|muscles
4811215|NCT02555670|Intensive Care|intensive care
4811216|NCT02555670|Tomography, X-Ray Computed|tomography, x-ray computed
4811217|NCT02555670|Electric Impedance|electric impedance
4811218|NCT02555657|PD1|pd1
4811219|NCT02555657|PD-1|pd-1
4811220|NCT02555657|PDL1|pdl1
4811221|NCT02555657|PD-LI|pd-li
4811222|NCT02555644|cancer|cancer
4811223|NCT02555631|type 2 diabetes|type 2 diabetes
4811224|NCT02555631|prevention|prevention
4811225|NCT02555631|men|men
4811226|NCT02555618|Vaccine|vaccine
4811227|NCT02555605|children|children
4811228|NCT02555605|dexmedetomidine|dexmedetomidine
4811229|NCT02555605|magnetic resonance imaging scans|magnetic resonance imaging scans
4811230|NCT02555605|deep sedation|deep sedation
4811231|NCT02555605|adverse respiratory events|adverse respiratory events
4811232|NCT02555553|Cognitive behavioral therapy guided self-help|cognitive behavioral therapy guided self-help
4811233|NCT02555553|Mobile Mental Health|mobile mental health
4811234|NCT02555553|Binge Eating|binge eating
4811235|NCT02555553|Cognitive Behavioral Therapy|cognitive behavioral therapy
4811236|NCT02555553|Eating Disorder Treatment|eating disorder treatment
4811237|NCT02555553|Self-monitoring|self-monitoring
4811238|NCT02555553|Eating Disorders|eating disorders
4811239|NCT02555553|Ecological Momentary Intervention|ecological momentary intervention
4811240|NCT02555501|children|children
4811241|NCT02555501|cancer|cancer
4811242|NCT02555501|stomatitis|stomatitis
4811243|NCT02555501|clinical trial|clinical trial
4811244|NCT02555501|laser therapy, low-level|laser therapy, low-level
4811245|NCT02555501|methylene blue|methylene blue
4811246|NCT02555501|photochemotherapy|photochemotherapy
4811247|NCT02555475|Hepatitis C|hepatitis c
4811248|NCT02555475|primary care|primary care
4811249|NCT02555397|Prostate Cancer|prostate cancer
4811250|NCT02555397|Locally Recurrent|locally recurrent
4811251|NCT02555397|Gene Therapy|gene therapy
4811252|NCT02555397|IL-12|il-12
4811253|NCT02555397|Adenovirus|adenovirus
4811254|NCT02555371|Severe eosinophilic asthma|severe eosinophilic asthma
4811255|NCT02555371|mepolizumab|mepolizumab
4811256|NCT02555371|asthma exacerbation|asthma exacerbation
4811257|NCT02555358|Resectable advanced gastric cancer|resectable advanced gastric cancer
4811258|NCT02555345|classic asthma, cough variant asthma,eosinophilic bronchitis|classic asthma, cough variant asthma,eosinophilic bronchitis
4811259|NCT02555319|Pulmonary Valve|pulmonary valve
4811260|NCT02555319|Transcatheter Pulmonary Valve|transcatheter pulmonary valve
4811261|NCT02555319|Congenital Heart Disease|congenital heart disease
4811262|NCT02555306|Macular Degeneration|macular degeneration
4811263|NCT02555293|Liver resection|liver resection
4811264|NCT02555293|fibrosis|fibrosis
4811265|NCT02555293|inflammation|inflammation
4811266|NCT02555293|Rifaximin|rifaximin
4811267|NCT02555267|geriatric assessment|geriatric assessment
4811268|NCT02555267|diffuse large B-cell lymphoma|diffuse large b-cell lymphoma
4811269|NCT02555267|activity of daily living|activity of daily living
4811270|NCT02555267|instrumental activity of daily living|instrumental activity of daily living
4811271|NCT02555267|Charlson's comorbidity index|charlson's comorbidity index
4811272|NCT02555254|cardiac arrest|cardiac arrest
4811273|NCT02555254|targeted temperature management|targeted temperature management
4811274|NCT02555254|hypothermia induced|hypothermia induced
4811275|NCT02555254|shockable rhythm|shockable rhythm
4811276|NCT02555241|ASD, Children|asd, children
4811277|NCT02555228|simethicone|simethicone
4811278|NCT02555228|gastroscopy|gastroscopy
4811279|NCT02555228|McNalley score|mcnalley score
4811280|NCT02555215|Pediatrics|pediatrics
4811281|NCT02555202|dyspnea|dyspnea
4811282|NCT02555163|bladder cancer, laser|bladder cancer, laser
4811283|NCT02555137|chronic thromboembolic pulmonary hypertension|chronic thromboembolic pulmonary hypertension
4811284|NCT02555137|pulmonary embolism|pulmonary embolism
4811285|NCT02555137|pulmonary hypertension|pulmonary hypertension
4811286|NCT02555137|screening|screening
4811287|NCT02555137|echocardiography|echocardiography
4811288|NCT02555124|Healthy|healthy
4811289|NCT02555124|JNJ-42847922|jnj-42847922
4811290|NCT02555111|thrombosis|thrombosis
4811291|NCT02555072|Yellow Fever Vaccine, immunity evolution|yellow fever vaccine, immunity evolution
4811292|NCT02555059|Ciprofloxacin|ciprofloxacin
4811293|NCT02555059|Japan|japan
4811294|NCT02555059|Post-marketing surveillance|post-marketing surveillance
4811295|NCT02555046|Spectroscopy, Near-Infrared|spectroscopy, near-infrared
4811296|NCT02555046|Endovascular Procedures|endovascular procedures
4811297|NCT02555046|Local Anesthesia|local anesthesia
4811298|NCT02555046|General Anesthesia|general anesthesia
4811299|NCT02555033|Instability resistance training|instability resistance training
4811300|NCT02555033|unstable surface|unstable surface
4811301|NCT02555033|elderly people|elderly people
4811302|NCT02554994|ASPRA cohort|aspra cohort
4811303|NCT02554994|multifactorial intervention|multifactorial intervention
4811304|NCT02554994|Medicaid services|medicaid services
4811305|NCT02554994|Geriatric disorder|geriatric disorder
4811306|NCT02554994|Short Physical Performance Battery|short physical performance battery
4811307|NCT02554929|Social Anxiety Disorder|social anxiety disorder
4811308|NCT02554929|Selective Mutism|selective mutism
4811309|NCT02554929|CBT|cbt
4811310|NCT02554929|preschool anxiety disorders|preschool anxiety disorders
4811311|NCT02554916|Mobility decline|mobility decline
4811312|NCT02554903|LVAD|lvad
4811313|NCT02554890|Acute|acute
4811314|NCT02554890|Heart Failure|heart failure
4811315|NCT02554890|reduced ejection fraction|reduced ejection fraction
4811316|NCT02554890|NTproBNP|ntprobnp
4811317|NCT02554890|Heart failure with reduced ejection fraction (HFREF)|heart failure with reduced ejection fraction (hfref)
4811318|NCT02554838|Specific phobia|specific phobia
4811319|NCT02554838|Fear of Falling|fear of falling
4811320|NCT02554838|Life-space area|life-space area
4811321|NCT02554812|anti PD-L1|anti pd-l1
4811322|NCT02554812|anti 4-1BB|anti 4-1bb
4811323|NCT02554812|OX40 agonist|ox40 agonist
4811325|NCT02554812|Non-small cell lung cancer (NSCLC)|non-small cell lung cancer (nsclc)
4811326|NCT02554812|melanoma|melanoma
4811327|NCT02554812|squamous cell carcinoma of head and neck (SCCHN)|squamous cell carcinoma of head and neck (scchn)
4811328|NCT02554812|triple negative breast cancer (TNBC)|triple negative breast cancer (tnbc)
4811329|NCT02554812|gastric cancer|gastric cancer
4811330|NCT02554812|Small cell lung cancer (SCLC)|small cell lung cancer (sclc)
4811331|NCT02554812|bladder cancer|bladder cancer
4811332|NCT02554812|platinum resistant ovarian cancer|platinum resistant ovarian cancer
4811333|NCT02554812|TGCT/PVNS|tgct/pvns
4811334|NCT02554786|QMF149, Mometasone furoate (MF), asthma|qmf149, mometasone furoate (mf), asthma
4811335|NCT02554773|Hemophilia|hemophilia
4811336|NCT02554773|RNAi therapeutic|rnai therapeutic
4811337|NCT02554721|Healthy Volunteers|healthy volunteers
4811338|NCT02554708|Aneurysm|aneurysm
4811339|NCT02554708|bifurcation|bifurcation
4811340|NCT02554708|wide neck|wide neck
4811341|NCT02554708|pCONus|pconus
4811342|NCT02554708|intracerebral|intracerebral
4811343|NCT02554708|stroke|stroke
4811344|NCT02554695|adrenergic|adrenergic
4811345|NCT02554682|Adolescent Health|adolescent health
4811346|NCT02554682|Sexual Health|sexual health
4811347|NCT02554682|Parent-Teen Communication|parent-teen communication
4811348|NCT02554682|Teen Driving|teen driving
4811349|NCT02554682|Alcohol Prevention|alcohol prevention
4811350|NCT02554669|Blood glucose (indicated by interstitial glucose)|blood glucose (indicated by interstitial glucose)
4811351|NCT02554669|Markers of systemic inflammation|markers of systemic inflammation
4811352|NCT02554643|intermittent exercise|intermittent exercise
4811353|NCT02554643|continuous exercise|continuous exercise
4811354|NCT02554643|blood glucose|blood glucose
4811355|NCT02554643|intramyocellular lipids|intramyocellular lipids
4811356|NCT02554643|diabetes|diabetes
4811357|NCT02554643|gene expression|gene expression
4811358|NCT02554617|healthy people|healthy people
4811359|NCT02554617|fractional exhaled nitric oxide (FeNo)|fractional exhaled nitric oxide (feno)
4811360|NCT02554617|factors|factors
4811361|NCT02554604|HDL|hdl
4811362|NCT02554604|Preeclampsia|preeclampsia
4811363|NCT02554604|saliva|saliva
4811364|NCT02554578|mHealth|mhealth
4811365|NCT02554578|multidisciplinary team|multidisciplinary team
4811366|NCT02554578|immunosuppressive medication|immunosuppressive medication
4811367|NCT02554578|pharmaceutical care|pharmaceutical care
4811368|NCT02554578|adherence|adherence
4811369|NCT02554578|heart transplant|heart transplant
4811370|NCT02554578|recipients|recipients
4811371|NCT02554565|Patients with cervical cancer|patients with cervical cancer
4811372|NCT02554552|Osteoarthritis|osteoarthritis
4811373|NCT02554526|hemophilia A|hemophilia a
4811374|NCT02554526|inhibitor|inhibitor
4811375|NCT02554526|bypassing therapy|bypassing therapy
4811376|NCT02554526|factor VIII|factor viii
4811377|NCT02554513|Apraxia of Speech|apraxia of speech
4811378|NCT02554513|Treatment|treatment
4811379|NCT02554487|stroke|stroke
4811380|NCT02554487|sleep disordered breathing|sleep disordered breathing
4811381|NCT02554487|sleep apnea|sleep apnea
4811382|NCT02554487|infarct volume|infarct volume
4811383|NCT02554487|penumbra|penumbra
4811384|NCT02554474|Physical activity|physical activity
4811385|NCT02554474|Exercise|exercise
4811386|NCT02554474|Rheumatoid|rheumatoid
4811387|NCT02554474|Arthritis|arthritis
4811388|NCT02554474|Lupus|lupus
4811389|NCT02554474|SLE|sle
4811390|NCT02554448|Circulating Tumor Cells|circulating tumor cells
4811391|NCT02554448|rectal Neoplasms|rectal neoplasms
4811392|NCT02554448|neoadjuvant otherapy|neoadjuvant otherapy
4811393|NCT02554435|physical activity|physical activity
4811394|NCT02554435|activity monitor|activity monitor
4811395|NCT02554435|older adults|older adults
4811396|NCT02554435|5 A's counseling|5 a's counseling
4811397|NCT02554409|Fluzone Quadrivalent Intradermal Influenza Vaccine|fluzone quadrivalent intradermal influenza vaccine
4811398|NCT02554409|Pregnancy Registry|pregnancy registry
4811399|NCT02554409|Influenza|influenza
4811400|NCT02554396|ophthalmology|ophthalmology
4811401|NCT02554396|vision|vision
4811402|NCT02554396|ocular|ocular
4811403|NCT02554383|pediatrics|pediatrics
4811404|NCT02554383|antibiotics|antibiotics
4811405|NCT02554383|placebo|placebo
4811406|NCT02554344|CIN3|cin3
4811407|NCT02554344|Squamous CIN3|squamous cin3
4811408|NCT02554331|Gait|gait
4811409|NCT02554331|REM sleep behavior disorder|rem sleep behavior disorder
4811410|NCT02554331|Parkinson's disease|parkinson's disease
4811411|NCT02554331|Follow-up|follow-up
4811412|NCT02554318|Tempeh|tempeh
4811413|NCT02554318|Body weight|body weight
4811414|NCT02554318|Handgrip strength|handgrip strength
4811415|NCT02554318|6MWT|6mwt
4811416|NCT02554318|Supplementation|supplementation
4811417|NCT02554318|Wasting|wasting
4811418|NCT02554305|efficacy and safety of fusion Oxygenation System|efficacy and safety of fusion oxygenation system
4811419|NCT02554305|isolated Coronary Artery Bypass Grafting|isolated coronary artery bypass grafting
4811420|NCT02554305|Bypass Grafting|bypass grafting
4811421|NCT02554227|Spondylodiscitis|spondylodiscitis
4811422|NCT02554227|erosive osteochondrosis|erosive osteochondrosis
4811423|NCT02554227|infection|infection
4811424|NCT02554227|cytokine profiles|cytokine profiles
4811425|NCT02554227|lumbar spine|lumbar spine
4811426|NCT02554201|pudendal nerve modulation|pudendal nerve modulation
4811427|NCT02554201|transanal/transvaginal electrical stimulation|transanal/transvaginal electrical stimulation
4811428|NCT02554188|Dietary Intervention|dietary intervention
4811429|NCT02554188|Fasting-mimicking|fasting-mimicking
4811430|NCT02554188|Influenza Vaccines|influenza vaccines
4811431|NCT02554175|Propofol|propofol
4811432|NCT02554175|Schnider model|schnider model
4811433|NCT02554162|Satiety, appetite, wholegrain rye|satiety, appetite, wholegrain rye
4811434|NCT02554149|total hip|total hip
4811435|NCT02554149|stem version|stem version
4811436|NCT02554149|replacement|replacement
4811437|NCT02554149|hip|hip
4811438|NCT02554097|laparoscopic transcystic common bile duct exploration|laparoscopic transcystic common bile duct exploration
4811439|NCT02554097|laparoscopic common bile duct exploration|laparoscopic common bile duct exploration
4811440|NCT02554097|endoscopic sphincterotomy,|endoscopic sphincterotomy,
4811441|NCT02554097|cost-effective analysis|cost-effective analysis
4811442|NCT02554058|Spinal cord injury|spinal cord injury
4811443|NCT02554058|rehabilitation|rehabilitation
4811444|NCT02554058|cycling|cycling
4811445|NCT02554032|antegrade cerebral perfusion|antegrade cerebral perfusion
4811446|NCT02554032|innominate artery cannulation|innominate artery cannulation
4811447|NCT02554032|axillary artery cannulation|axillary artery cannulation
4811448|NCT02554032|aortic surgery|aortic surgery
4811449|NCT02554032|deep hypothermic circulatory arrest|deep hypothermic circulatory arrest
4811450|NCT02554019|SLE, Lupus|sle, lupus
4811451|NCT02554019|IL10, IL-10, BT063, BT-063|il10, il-10, bt063, bt-063
4811452|NCT02553993|Stroke|stroke
4811453|NCT02553993|Cognition|cognition
4811454|NCT02553993|Exergames|exergames
4811455|NCT02553993|Weight shifting|weight shifting
4811456|NCT02553993|Balance|balance
4811457|NCT02553993|Rehabilitation|rehabilitation
4811458|NCT02553980|Physical activity|physical activity
4811459|NCT02553980|Information technology|information technology
4811460|NCT02553980|Middle-aged|middle-aged
4811461|NCT02553980|Health promotion|health promotion
4811462|NCT02553967|functional Magnetic Resonance Imaging (fMRI)|functional magnetic resonance imaging (fmri)
4811463|NCT02553967|Breast reconstructive surgery|breast reconstructive surgery
4811464|NCT02553967|Breast Q questionnaire|breast q questionnaire
4811465|NCT02553954|Mechanisms of Senescence|mechanisms of senescence
4811466|NCT02553954|Senescence markers|senescence markers
4811467|NCT02553915|Omega-3|omega-3
4811468|NCT02553915|EPA|epa
4811469|NCT02553915|Depression|depression
4811470|NCT02553915|Overweight|overweight
4811471|NCT02553915|Inflammation|inflammation
4811472|NCT02553915|Eicosapentaenoic acid|eicosapentaenoic acid
4811473|NCT02553902|Positional therapy|positional therapy
4811474|NCT02553902|MAD|mad
4811475|NCT02553902|Oral appliance|oral appliance
4811476|NCT02553902|Sleep position trainer|sleep position trainer
4811477|NCT02553902|POSA|posa
4811478|NCT02553876|neurostimulation|neurostimulation
4811479|NCT02553876|dorsal root ganglion|dorsal root ganglion
4811480|NCT02553876|hand pain|hand pain
4811481|NCT02553876|upper limb pain|upper limb pain
4811482|NCT02553863|chemotherapy induced peripheral neuropathy|chemotherapy induced peripheral neuropathy
4811483|NCT02553863|acupuncture|acupuncture
4811484|NCT02553863|pain|pain
4811485|NCT02553863|cost-effectiveness|cost-effectiveness
4811486|NCT02553837|Healthy Volunteers|healthy volunteers
4811487|NCT02553824|binge eating|binge eating
4811488|NCT02553824|bulimia nervosa|bulimia nervosa
4811489|NCT02553824|binge eating disorder|binge eating disorder
4811490|NCT02553824|eating disorder treatment|eating disorder treatment
4811491|NCT02553811|carpal tunnel syndrome|carpal tunnel syndrome
4811492|NCT02553811|clinical examination|clinical examination
4811493|NCT02553811|diagnosis|diagnosis
4811494|NCT02553811|clinical trial|clinical trial
4811495|NCT02553811|median nerve compression|median nerve compression
4811496|NCT02553811|accuracy|accuracy
4811497|NCT02553811|ultrasonography|ultrasonography
4811498|NCT02553811|electromyography|electromyography
4811499|NCT02553811|electrodiagnostic testing|electrodiagnostic testing
4811500|NCT02553785|BioVentrix|bioventrix
4811501|NCT02553785|Revivent|revivent
4811502|NCT02553785|Revivent TC|revivent tc
4811503|NCT02553759|observed action|observed action
4811504|NCT02553759|range of motion|range of motion
4811505|NCT02553759|mirror neuron|mirror neuron
4811506|NCT02553746|Ultrasound|ultrasound
4811507|NCT02553746|Spinal anesthesia|spinal anesthesia
4811508|NCT02553746|Epidural anesthesia|epidural anesthesia
4811509|NCT02553733|Dietary nitrate supplementation|dietary nitrate supplementation
4811510|NCT02553733|Beetroot juice|beetroot juice
4811511|NCT02553720|Post thrombotic syndrome|post thrombotic syndrome
4811512|NCT02553720|Chronic venous insufficiency|chronic venous insufficiency
4811513|NCT02553694|OSA, Apnea|osa, apnea
4811514|NCT02553668|Proteomics|proteomics
4811515|NCT02553668|Oxygen|oxygen
4811516|NCT02553668|Pathways|pathways
4811517|NCT02553642|Tumor Mutation|tumor mutation
4811518|NCT02553642|Nivolumab|nivolumab
4811519|NCT02553642|Nivolumab plus Ipilimumab|nivolumab plus ipilimumab
4811520|NCT02553642|Predicted Neo-antigen Burden|predicted neo-antigen burden
4811521|NCT02553642|15-126|15-126
4811522|NCT02553590|Non Interventional Study|non interventional study
4811523|NCT02553590|NIS|nis
4811524|NCT02553590|sublingual immunotherapy|sublingual immunotherapy
4811525|NCT02553590|allergen|allergen
4811526|NCT02553590|tree|tree
4811527|NCT02553590|birch|birch
4811528|NCT02553590|alder|alder
4811529|NCT02553577|prenatal|prenatal
4811530|NCT02553577|cytokines|cytokines
4811531|NCT02553538|cancer screening|cancer screening
4811532|NCT02553538|patient navigation|patient navigation
4811533|NCT02553525|Deep Brain Stimulation|deep brain stimulation
4811534|NCT02553525|Movement Disorders|movement disorders
4811535|NCT02553525|Parkinson Disease|parkinson disease
4811536|NCT02553525|Essential Tremor|essential tremor
4811537|NCT02553525|Subthalamic Nucleus|subthalamic nucleus
4811538|NCT02553525|Globus Pallidus|globus pallidus
4811539|NCT02553525|Thalamus|thalamus
4811540|NCT02553525|Tremor|tremor
4811541|NCT02553525|Bradykinesia|bradykinesia
4811542|NCT02553525|Temporal Pattern|temporal pattern
4811543|NCT02553525|Electrical Stimulation|electrical stimulation
4811544|NCT02553525|Neuromodulation|neuromodulation
4811545|NCT02553525|PD|pd
4811546|NCT02553525|ET|et
4811547|NCT02553525|MS|ms
4811548|NCT02553525|STN|stn
4811549|NCT02553525|GPi|gpi
4811550|NCT02553525|DBS|dbs
4811551|NCT02553525|Nervous System Diseases|nervous system diseases
4811552|NCT02553525|Neurodegenerative Diseases|neurodegenerative diseases
4811553|NCT02553499|Solid tumor|solid tumor
4811554|NCT02553499|PD1|pd1
4811555|NCT02553499|PD-L1|pd-l1
4811556|NCT02553499|PDL1|pdl1
4811557|NCT02553486|adoption|adoption
4811558|NCT02553486|children|children
4811559|NCT02553486|quality of life|quality of life
4811560|NCT02553460|Infants|infants
4811561|NCT02553434|pigtail catheter|pigtail catheter
4811562|NCT02553434|small-bore catheter|small-bore catheter
4811563|NCT02553434|trauma|trauma
4811564|NCT02553434|hemothorax|hemothorax
4811565|NCT02553421|infiltration|infiltration
4811566|NCT02553421|extravasation|extravasation
4811567|NCT02553421|peripheral intravenous therapy|peripheral intravenous therapy
4811568|NCT02553356|Female Subjects|female subjects
4811569|NCT02553343|Influenza|influenza
4811570|NCT02553343|High-Dose Quadrivalent Influenza Vaccine|high-dose quadrivalent influenza vaccine
4811571|NCT02553343|High-Dose Trivalent Influenza Vaccine|high-dose trivalent influenza vaccine
4811572|NCT02553330|Hair loss|hair loss
4811573|NCT02553330|alopecia areata|alopecia areata
4811574|NCT02553330|alopecia totalis|alopecia totalis
4811681|NCT02552758|patient|patient
4811575|NCT02553330|alopecia universalis|alopecia universalis
4811576|NCT02553330|JAK inhibitors|jak inhibitors
4811577|NCT02553330|topical hair growth|topical hair growth
4811578|NCT02553278|abdominoplasty|abdominoplasty
4811579|NCT02553265|Familial dysautonomia (HSAN III)|familial dysautonomia (hsan iii)
4811580|NCT02553265|Norepinephrine|norepinephrine
4811581|NCT02553265|Sympathetic nervous system|sympathetic nervous system
4811582|NCT02553265|Autonomic nervous system|autonomic nervous system
4811583|NCT02553265|Blood pressure variability|blood pressure variability
4811584|NCT02553265|Hypertension|hypertension
4811585|NCT02553265|Carbidopa/Lodosyn|carbidopa/lodosyn
4811586|NCT02553265|Afferent baroreflex failure|afferent baroreflex failure
4811587|NCT02553265|Clinical trial|clinical trial
4811588|NCT02553252|post traumatic stress disorder (PTSD)|post traumatic stress disorder (ptsd)
4811589|NCT02553252|Sudarshan Kriya Yoga (SKY)|sudarshan kriya yoga (sky)
4811590|NCT02553239|Atrial Fibrillation|atrial fibrillation
4811591|NCT02553239|Paroxysmal|paroxysmal
4811592|NCT02553239|Cryoablation|cryoablation
4811593|NCT02553226|Active phase of labour|active phase of labour
4811594|NCT02553226|Discontinuation|discontinuation
4811595|NCT02553226|Caesarean section|caesarean section
4811596|NCT02553200|intubated patients|intubated patients
4811597|NCT02553200|secretion clearance|secretion clearance
4811598|NCT02553200|lung function|lung function
4811599|NCT02553200|breathing exercise|breathing exercise
4811600|NCT02553161|Depression|depression
4811601|NCT02553148|prevalence|prevalence
4811602|NCT02553148|epidemiology|epidemiology
4811603|NCT02553148|palliative care|palliative care
4811604|NCT02553148|pediatric|pediatric
4811605|NCT02553135|choroideremia, gene therapy|choroideremia, gene therapy
4811606|NCT02553122|Blood Loss|blood loss
4811607|NCT02553122|Tranexamic Acid|tranexamic acid
4811608|NCT02553122|Evicel|evicel
4811609|NCT02553109|small paraclinoid|small paraclinoid
4811610|NCT02553096|exacerbations|exacerbations
4811611|NCT02553096|self-management support|self-management support
4811612|NCT02553096|software application|software application
4811613|NCT02553031|Application of MR-PET|application of mr-pet
4811614|NCT02553005|Acupuncture|acupuncture
4811615|NCT02553005|Rheumatoid Arthritis|rheumatoid arthritis
4811616|NCT02553005|Quality of life|quality of life
4811617|NCT02553005|Hand Strength|hand strength
4811618|NCT02552979|atopic dermatitis|atopic dermatitis
4811619|NCT02552979|atopic patch test|atopic patch test
4811620|NCT02552927|PDA|pda
4811621|NCT02552927|Jaundice|jaundice
4811622|NCT02552927|Phototherapy|phototherapy
4811623|NCT02552914|Colli-Pee|colli-pee
4811624|NCT02552914|STI|sti
4811625|NCT02552914|first-void urine|first-void urine
4811626|NCT02552901|hepatic|hepatic
4811627|NCT02552901|liver|liver
4811628|NCT02552901|LFT|lft
4811629|NCT02552901|hepatic assessment|hepatic assessment
4811630|NCT02552901|ICG dye|icg dye
4811631|NCT02552901|indocyanine green dye|indocyanine green dye
4811632|NCT02552901|Diagnostic Green|diagnostic green
4811633|NCT02552901|Pulsion|pulsion
4811634|NCT02552901|Akorn|akorn
4811635|NCT02552901|Cardiox|cardiox
4811636|NCT02552901|anazen|anazen
4811637|NCT02552901|essence|essence
4811638|NCT02552901|dye detection monitor|dye detection monitor
4811639|NCT02552901|Earpads|earpads
4811640|NCT02552901|flow sensor|flow sensor
4811641|NCT02552901|scaphoid fossa|scaphoid fossa
4811642|NCT02552901|liver disease|liver disease
4811643|NCT02552901|acute hepatic failure|acute hepatic failure
4811644|NCT02552901|AHF|ahf
4811645|NCT02552901|NASH|nash
4811646|NCT02552901|hepatitis C|hepatitis c
4811647|NCT02552901|cirrhosis|cirrhosis
4811648|NCT02552901|MELD|meld
4811649|NCT02552901|pulse dye densitometry|pulse dye densitometry
4811650|NCT02552901|liver transplant|liver transplant
4811651|NCT02552901|fluorescence|fluorescence
4811652|NCT02552901|near infra-red|near infra-red
4811653|NCT02552901|serial blood draws|serial blood draws
4811654|NCT02552901|PDR|pdr
4811655|NCT02552901|plasma disappearance rate|plasma disappearance rate
4811656|NCT02552901|R15|r15
4811657|NCT02552901|k coefficient|k coefficient
4811658|NCT02552901|transcutaneously|transcutaneously
4811659|NCT02552901|liver donor|liver donor
4811660|NCT02552901|liver dysfunction|liver dysfunction
4811661|NCT02552901|Child-Pugh|child-pugh
4811662|NCT02552901|AST|ast
4811663|NCT02552901|ALT|alt
4811664|NCT02552901|GGT|ggt
4811665|NCT02552901|alk phos|alk phos
4811666|NCT02552901|prothrombin time|prothrombin time
4811667|NCT02552901|albumin|albumin
4811668|NCT02552901|serum ICG|serum icg
4811669|NCT02552901|liver function tests|liver function tests
4811670|NCT02552888|Endothelial Dysfunction|endothelial dysfunction
4811671|NCT02552888|Inflammation|inflammation
4811672|NCT02552875|Acceleromyography|acceleromyography
4811673|NCT02552875|staircase phenomenon|staircase phenomenon
4811674|NCT02552875|tetanic stimulation|tetanic stimulation
4811675|NCT02552797|Shared Decision Making|shared decision making
4811676|NCT02552797|CAMHS|camhs
4811677|NCT02552758|violence|violence
4811678|NCT02552758|PET|pet
4811679|NCT02552758|omega-3 fatty acid|omega-3 fatty acid
4811680|NCT02552758|schizophrenia|schizophrenia
4811682|NCT02552719|Injustice Experience|injustice experience
4811683|NCT02552719|Questionnaire|questionnaire
4811684|NCT02552719|Validation|validation
4811685|NCT02552719|German translation|german translation
4811686|NCT02552706|probiotics|probiotics
4811687|NCT02552706|preterm very low birth weight infants|preterm very low birth weight infants
4811688|NCT02552706|necrotizing enterocolitis|necrotizing enterocolitis
4811689|NCT02552706|gut microflora|gut microflora
4811690|NCT02552706|TLR|tlr
4811691|NCT02552706|NF-KB|nf-kb
4811692|NCT02552706|inflammatory factors|inflammatory factors
4811693|NCT02552693|Enhancing retention|enhancing retention
4811694|NCT02552680|Work-Related Musculoskeletal Disorders|work-related musculoskeletal disorders
4811695|NCT02552680|Quality of life|quality of life
4811696|NCT02552680|Health Education|health education
4811697|NCT02552667|Asthma|asthma
4811698|NCT02552667|Allergic rhinitis|allergic rhinitis
4811699|NCT02552628|Wilson's Disease|wilson's disease
4811700|NCT02552628|Deep Brain Stimulation|deep brain stimulation
4811701|NCT02552628|dystonia|dystonia
4811702|NCT02552615|scoliosis, verticality perception, body symmetry|scoliosis, verticality perception, body symmetry
4811703|NCT02552602|HIV|hiv
4811704|NCT02552602|Multivitamins|multivitamins
4811705|NCT02552589|clinical trial, phase III|clinical trial, phase iii
4811706|NCT02552589|plaque index|plaque index
4811707|NCT02552589|gingivitis index|gingivitis index
4811708|NCT02552589|fluoride|fluoride
4811709|NCT02552589|toothpaste|toothpaste
4811710|NCT02552550|squamous cell carcinoma of the oropharynx|squamous cell carcinoma of the oropharynx
4811711|NCT02552550|swallowing, speech|swallowing, speech
4811712|NCT02552550|quality of life|quality of life
4811713|NCT02552524|pathological gambling|pathological gambling
4811714|NCT02552524|rTMS|rtms
4811715|NCT02552524|cognitive tests|cognitive tests
4811716|NCT02552524|autonomic nervous system|autonomic nervous system
4811717|NCT02552524|craving|craving
4811718|NCT02552472|Asthma|asthma
4811719|NCT02552472|Inhaler Use|inhaler use
4811720|NCT02552472|Adherence|adherence
4811721|NCT02552472|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
4811722|NCT02552459|dexmedetomidine|dexmedetomidine
4811723|NCT02552459|patient controlled analgesia|patient controlled analgesia
4811724|NCT02552433|nutritional deficiencies|nutritional deficiencies
4811725|NCT02552433|plastic surgery|plastic surgery
4811726|NCT02552433|post-bariatric|post-bariatric
4811727|NCT02552433|protein|protein
4811728|NCT02552433|skin surplus|skin surplus
4811729|NCT02552420|infrared thermal imaging|infrared thermal imaging
4811730|NCT02552420|deep venous thrombosis|deep venous thrombosis
4811731|NCT02552407|thrombectomy|thrombectomy
4811732|NCT02552407|acute coronary syndromes|acute coronary syndromes
4811733|NCT02552407|percutaneous coronary intervention|percutaneous coronary intervention
4811734|NCT02552407|STEMI|stemi
4811735|NCT02552381|Cancer|cancer
4811736|NCT02552381|Thromboembolic event|thromboembolic event
4811737|NCT02552381|Fibrin Structure|fibrin structure
4811738|NCT02552381|LMWH|lmwh
4811739|NCT02552368|Stroke Rehabilitation|stroke rehabilitation
4811740|NCT02552368|BCI|bci
4811741|NCT02552368|Stroke|stroke
4811742|NCT02552368|Upper Extremity Rehabilitation|upper extremity rehabilitation
4811743|NCT02552368|paresis|paresis
4811744|NCT02552368|hemiparesis|hemiparesis
4811745|NCT02552329|mild cognitive impairment|mild cognitive impairment
4811746|NCT02552329|Tai Chi|tai chi
4811747|NCT02552329|cognitive functions|cognitive functions
4811748|NCT02552316|microbiome|microbiome
4811749|NCT02552316|bacteria|bacteria
4811750|NCT02552316|NB-UVB Phototherapy|nb-uvb phototherapy
4811751|NCT02552316|light therapy|light therapy
4811752|NCT02552277|Diabetic|diabetic
4811753|NCT02552277|PDA-002|pda-002
4811754|NCT02552277|Placenta-Derived Cells|placenta-derived cells
4811755|NCT02552277|Peripheral neuropathy|peripheral neuropathy
4811756|NCT02552277|Neuropathy|neuropathy
4811757|NCT02552277|Double-Blind|double-blind
4811758|NCT02552277|Safety|safety
4811759|NCT02552277|Efficacy|efficacy
4811760|NCT02552277|Human Placenta-derived Cells|human placenta-derived cells
4811761|NCT02552238|Lumason|lumason
4811762|NCT02552238|Dobutamine stress echo|dobutamine stress echo
4811763|NCT02552238|stress echo|stress echo
4811764|NCT02552238|coronary artery disease|coronary artery disease
4811765|NCT02552225|laryngeal sensory neuropathy, chronic laryngeal neuropathy|laryngeal sensory neuropathy, chronic laryngeal neuropathy
4811766|NCT02552212|Axial Spondyloarthritis|axial spondyloarthritis
4811767|NCT02552212|axSpA|axspa
4811768|NCT02552212|Ankylosing Spondylitis|ankylosing spondylitis
4811769|NCT02552212|Anti TNF-alpha|anti tnf-alpha
4811770|NCT02552212|Certolizumab Pegol|certolizumab pegol
4811771|NCT02552212|Nr-axSpA|nr-axspa
4811772|NCT02552212|Non-radiographic|non-radiographic
4811773|NCT02552212|Spondylarthropathies|spondylarthropathies
4811774|NCT02552212|Arthritis|arthritis
4811775|NCT02552212|Spinal Diseases|spinal diseases
4811776|NCT02552212|Immunosuppressive Agents|immunosuppressive agents
4811777|NCT02552160|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
4811778|NCT02552160|Fixed-dose Combination|fixed-dose combination
4811874|NCT02551679|Peripheral arterial disease|peripheral arterial disease
4812068|NCT02550327|resectable|resectable
4811779|NCT02552160|LAMA/LABA (Long Acting Beta2-Agonists / Long Acting Muscarinic Antagonists)|lama/laba (long acting beta2-agonists / long acting muscarinic antagonists)
4811780|NCT02552160|Inhaler|inhaler
4811781|NCT02552160|Aclidinium/Formoterol|aclidinium/formoterol
4811782|NCT02552160|Glycopyrronium/Indacaterol|glycopyrronium/indacaterol
4811783|NCT02552160|Umeclidinium/Vilanterol|umeclidinium/vilanterol
4811784|NCT02552147|Autism spectrum disorder|autism spectrum disorder
4811785|NCT02552147|Aggression|aggression
4811786|NCT02552147|Irritability|irritability
4811787|NCT02552147|Nicotine|nicotine
4811788|NCT02552147|Nicotinic acetylcholine receptor|nicotinic acetylcholine receptor
4811789|NCT02552147|Nicotinic agonist|nicotinic agonist
4811790|NCT02552147|Adult autism|adult autism
4811791|NCT02552134|Access to physical activity resources, community based exercise programme, sports-clubs, health resort,|access to physical activity resources, community based exercise programme, sports-clubs, health resort,
4811792|NCT02552121|ovary cancer|ovary cancer
4811793|NCT02552121|cervix cancer|cervix cancer
4811794|NCT02552121|endometrium cancer|endometrium cancer
4811795|NCT02552121|bladder cancer|bladder cancer
4811796|NCT02552121|prostate cancer (CRPC)|prostate cancer (crpc)
4811797|NCT02552121|esophagus cancer|esophagus cancer
4811798|NCT02552121|lung cancer (NSCLC)|lung cancer (nsclc)
4811799|NCT02552108|Cognitive-behavioural therapy|cognitive-behavioural therapy
4811800|NCT02552056|Child Adolescent Mental Integration PHC Traditional Healers|child adolescent mental integration phc traditional healers
4811801|NCT02552043|Cystic fibrosis|cystic fibrosis
4811802|NCT02552043|Exercise capacity|exercise capacity
4811803|NCT02552043|Interactive gaming console|interactive gaming console
4811804|NCT02552043|Pulmonary rehabilitation|pulmonary rehabilitation
4811805|NCT02552017|adenoma detection rate|adenoma detection rate
4811806|NCT02552017|Endocuff|endocuff
4811807|NCT02552017|Endocuff Vision|endocuff vision
4811808|NCT02552017|colonoscopy|colonoscopy
4811809|NCT02552017|bowel cancer screening|bowel cancer screening
4811810|NCT02552017|bowel cancer|bowel cancer
4811811|NCT02552004|pCLE|pcle
4811812|NCT02552004|Digestive surgery|digestive surgery
4811813|NCT02552004|Endocrine surgery|endocrine surgery
4811814|NCT02551991|Pancreatic cancer|pancreatic cancer
4811815|NCT02551991|MM-398|mm-398
4811816|NCT02551991|Metastatic pancreatic cancer|metastatic pancreatic cancer
4811817|NCT02551991|First line pancreatic cancer treatment|first line pancreatic cancer treatment
4811818|NCT02551978|obesity|obesity
4811819|NCT02551978|child|child
4811820|NCT02551978|primary prevention|primary prevention
4811821|NCT02551978|serious game|serious game
4811822|NCT02551978|nutrition|nutrition
4811823|NCT02551978|physical activity|physical activity
4811824|NCT02551978|psychosocial|psychosocial
4811825|NCT02551978|stress|stress
4811826|NCT02551978|knowledge|knowledge
4811827|NCT02551978|diet|diet
4811828|NCT02551965|Cancer|cancer
4811829|NCT02551965|Patient|patient
4811830|NCT02551965|Oncology|oncology
4811831|NCT02551965|Caregiver|caregiver
4811832|NCT02551952|Games|games
4811833|NCT02551952|Cognitive Tests|cognitive tests
4811834|NCT02551952|General Anesthesia|general anesthesia
4811835|NCT02551952|Surgery|surgery
4811836|NCT02551913|Psychological Theory|psychological theory
4811837|NCT02551913|adolescents|adolescents
4811838|NCT02551900|Type 2 Diabetes|type 2 diabetes
4811839|NCT02551900|Vascular Function|vascular function
4811840|NCT02551900|Water Exercise|water exercise
4811841|NCT02551900|Warm Water|warm water
4811842|NCT02551900|Cold Water|cold water
4811843|NCT02551887|HPV Vaccinations|hpv vaccinations
4811844|NCT02551887|Quadrivalent Vaccine|quadrivalent vaccine
4811845|NCT02551848|Movement disorders|movement disorders
4811846|NCT02551848|Botulinum toxin type A|botulinum toxin type a
4811847|NCT02551848|Kinematics|kinematics
4811848|NCT02551835|ODIN|odin
4811849|NCT02551835|Meta-analysis|meta-analysis
4811850|NCT02551835|Cholecalciferol|cholecalciferol
4811851|NCT02551835|25(OH)D|25(oh)d
4811852|NCT02551835|Subgroup effects|subgroup effects
4811853|NCT02551822|Urge Urinary Incontinence, sacral neuromodulation|urge urinary incontinence, sacral neuromodulation
4811854|NCT02551796|lenticule extraction|lenticule extraction
4811855|NCT02551796|laser in situ keratomileusis|laser in situ keratomileusis
4811856|NCT02551796|femtosecond laser-assisted laser in situ keratomileusis|femtosecond laser-assisted laser in situ keratomileusis
4811857|NCT02551796|tear|tear
4811858|NCT02551796|inflammatory mediators|inflammatory mediators
4811859|NCT02551783|urethral stricture|urethral stricture
4811860|NCT02551783|urethroplasty|urethroplasty
4811861|NCT02551783|buccal mucosa|buccal mucosa
4811862|NCT02551783|graft|graft
4811863|NCT02551757|Rehabilitation|rehabilitation
4811864|NCT02551757|Continuous Positive Airway Pressure|continuous positive airway pressure
4811865|NCT02551744|histamine-2 receptor antagonist|histamine-2 receptor antagonist
4811866|NCT02551744|proton pump inhibitor|proton pump inhibitor
4811867|NCT02551744|thienopyridine|thienopyridine
4811868|NCT02551744|clopidogrel|clopidogrel
4811869|NCT02551744|prevention|prevention
4811870|NCT02551679|Stem cells|stem cells
4811871|NCT02551679|Endothelial progenitor cells|endothelial progenitor cells
4811872|NCT02551679|Autologous cells|autologous cells
4811873|NCT02551679|Vascular disease|vascular disease
4812067|NCT02550340|ECG|ecg
4811875|NCT02551679|Regenerative medicine|regenerative medicine
4811876|NCT02551653|Idiopathic Pulmonary Arterial Hypertension|idiopathic pulmonary arterial hypertension
4811877|NCT02551653|Biodistribution|biodistribution
4811878|NCT02551653|Positron Emission Tomography|positron emission tomography
4811879|NCT02551653|[11C]-GSK2256098|[11c]-gsk2256098
4811880|NCT02551653|Healthy subjects|healthy subjects
4811881|NCT02551614|lipopolysaccharide|lipopolysaccharide
4811882|NCT02551614|COPD|copd
4811883|NCT02551614|neutrophil|neutrophil
4811884|NCT02551601|subfoveal choroidal thickness|subfoveal choroidal thickness
4811885|NCT02551601|optical coherence tomography|optical coherence tomography
4811886|NCT02551601|enhanced depth imaging|enhanced depth imaging
4811887|NCT02551588|fibrosis|fibrosis
4811888|NCT02551588|Magnetic resonance imaging|magnetic resonance imaging
4811889|NCT02551549|Subjects|subjects
4811890|NCT02551536|Allergic rhinitis|allergic rhinitis
4811891|NCT02551536|montelukast|montelukast
4811892|NCT02551536|fexofenadine|fexofenadine
4811893|NCT02551536|levocetrizine|levocetrizine
4811894|NCT02551510|Skin Adhesive|skin adhesive
4811895|NCT02551510|Suture|suture
4811896|NCT02551510|Port Incisions|port incisions
4811897|NCT02551497|volunteer drug interaction study|volunteer drug interaction study
4811898|NCT02551471|Locally advanced rectal cancer|locally advanced rectal cancer
4811899|NCT02551471|Fixed primary rectal cancer|fixed primary rectal cancer
4811900|NCT02551471|Pelvic recurrence|pelvic recurrence
4811901|NCT02551471|Benchmarking France Australia|benchmarking france australia
4811902|NCT02551432|pembrolizumab|pembrolizumab
4811903|NCT02551432|paclitaxel|paclitaxel
4811904|NCT02551419|mild cognitive impairment|mild cognitive impairment
4811905|NCT02551419|ketones|ketones
4811906|NCT02551419|medium chain triglycerides|medium chain triglycerides
4811907|NCT02551419|Positron emission tomography|positron emission tomography
4811908|NCT02551419|magnetic resonance imaging|magnetic resonance imaging
4811909|NCT02551419|cognition|cognition
4811910|NCT02551419|brain|brain
4811911|NCT02551419|neuroimaging|neuroimaging
4811912|NCT02551406|nocturnal hypoventilation|nocturnal hypoventilation
4811913|NCT02551406|capno-oxymetry|capno-oxymetry
4811914|NCT02551393|Older adults|older adults
4811915|NCT02551393|Home Blood Pressure Monitoring|home blood pressure monitoring
4811916|NCT02551367|letrozole|letrozole
4811917|NCT02551354|Labor, Obstetric|labor, obstetric
4811918|NCT02551354|pain|pain
4811919|NCT02551354|pupil diameter|pupil diameter
4811920|NCT02551354|Visual Analogic Scale (VAS)|visual analogic scale (vas)
4811921|NCT02551341|prostatectomy|prostatectomy
4811922|NCT02551341|robotic|robotic
4811923|NCT02551315|Intra-cortical pore volume|intra-cortical pore volume
4811924|NCT02551315|HR-pQCT|hr-pqct
4811925|NCT02551315|DXA|dxa
4811926|NCT02551315|bone mineral density|bone mineral density
4811927|NCT02551315|bone turnover markers|bone turnover markers
4811928|NCT02551315|urinary pentosidine|urinary pentosidine
4811929|NCT02551289|MRI|mri
4811930|NCT02551289|Gluten|gluten
4811931|NCT02551289|Imaging|imaging
4811932|NCT02551289|Enteropathy-Associated T-Cell Lymphoma|enteropathy-associated t-cell lymphoma
4811933|NCT02551263|Breast Cancer|breast cancer
4811934|NCT02551263|Eribulin|eribulin
4811935|NCT02551263|HER2-negative|her2-negative
4811936|NCT02551263|hormone-resistant|hormone-resistant
4811937|NCT02551263|inoperable|inoperable
4811938|NCT02551263|recurrent metastatic|recurrent metastatic
4811939|NCT02551250|hepatocellular carcinoma|hepatocellular carcinoma
4811940|NCT02551250|surveillance|surveillance
4811941|NCT02551250|liver cirrhosis|liver cirrhosis
4811942|NCT02551250|ultrasonography|ultrasonography
4811943|NCT02551250|magnetic resonance imaging|magnetic resonance imaging
4811944|NCT02551237|Elderly patient|elderly patient
4811945|NCT02551237|Radiotherapy|radiotherapy
4811946|NCT02551237|Radio chemotherapy|radio chemotherapy
4811947|NCT02551237|Neoadjuvant treatment|neoadjuvant treatment
4811948|NCT02551224|COPD|copd
4811949|NCT02551198|polyethylene glycol with ascorbic acid|polyethylene glycol with ascorbic acid
4811950|NCT02551198|oral sulfate solution|oral sulfate solution
4811951|NCT02551198|bowel preparation|bowel preparation
4811952|NCT02551159|programmed cell death ligand 1 (PD-L1), MEDI4736, Cytotoxic T-lymphocyte-associated antigen 4 {CTLA-4}, PFS, SCCHN|programmed cell death ligand 1 (pd-l1), medi4736, cytotoxic t-lymphocyte-associated antigen 4 {ctla-4}, pfs, scchn
4811953|NCT02551133|Dexamethasone|dexamethasone
4811954|NCT02551133|mastectomy|mastectomy
4811955|NCT02551133|persistent surgical pain|persistent surgical pain
4811956|NCT02551120|Idiopathic hypoparathyroidism|idiopathic hypoparathyroidism
4811957|NCT02551120|Autosomal dominant hypocalcaemia|autosomal dominant hypocalcaemia
4811958|NCT02551120|Pseudohypoparathyroidism|pseudohypoparathyroidism
4811959|NCT02551120|Quality of Life|quality of life
4811960|NCT02551120|Bone Mineral Density|bone mineral density
4811961|NCT02551120|Muscle strength|muscle strength
4811962|NCT02551120|Cardiovascular indices|cardiovascular indices
4811963|NCT02551055|Drug Therapy|drug therapy
4811964|NCT02551042|Digital Ulcers|digital ulcers
4811965|NCT02551042|Raynauds Phenomenon|raynauds phenomenon
4811966|NCT02551042|Factor XIII|factor xiii
4811967|NCT02551029|Magnetic Resonance Imaging|magnetic resonance imaging
4811968|NCT02551029|Brainstem|brainstem
4811969|NCT02551029|Solitary Nucleus|solitary nucleus
4811970|NCT02551029|Visceral Nervous System|visceral nervous system
4811971|NCT02551029|Transient Receptor Potential Channels|transient receptor potential channels
4811972|NCT02550977|Contraception|contraception
4811973|NCT02550977|Transdermal contraceptive patch|transdermal contraceptive patch
4811974|NCT02550977|Safety|safety
4811975|NCT02550977|Efficacy|efficacy
4811976|NCT02550977|Pharmacokinetic|pharmacokinetic
4811977|NCT02550964|Autoimmune Disease|autoimmune disease
4811978|NCT02550964|Rheumatoid Arthritis|rheumatoid arthritis
4811979|NCT02550964|Systemic Lupus Erythematosus|systemic lupus erythematosus
4811980|NCT02550964|Hydroxychloroquine(HCQ)|hydroxychloroquine(hcq)
4811981|NCT02550964|Chloroquine(CQ)|chloroquine(cq)
4811982|NCT02550964|Toxic Maculopathy|toxic maculopathy
4811983|NCT02550925|Cancer survivors|cancer survivors
4811984|NCT02550886|Work Burden|work burden
4811985|NCT02550886|Ambulatory Orthopedic Surgery|ambulatory orthopedic surgery
4811986|NCT02550886|Anesthesiology|anesthesiology
4811987|NCT02550886|Perioperative Care|perioperative care
4811988|NCT02550860|intravenous fat emulsions|intravenous fat emulsions
4811989|NCT02550860|parenteral nutrition|parenteral nutrition
4811990|NCT02550860|skin barrier function|skin barrier function
4811991|NCT02550860|essential fatty acids|essential fatty acids
4811992|NCT02550860|transepidermal water loss|transepidermal water loss
4811993|NCT02550847|MR/PET|mr/pet
4811994|NCT02550847|pancreatic cancer|pancreatic cancer
4811995|NCT02550834|Core stability|core stability
4811996|NCT02550834|Indoors curling exercises|indoors curling exercises
4811997|NCT02550834|Motivation|motivation
4811998|NCT02550821|Physical activity levels|physical activity levels
4811999|NCT02550821|Bronchiectasis|bronchiectasis
4812000|NCT02550782|perineural dexmedetomidine|perineural dexmedetomidine
4812001|NCT02550782|infraclavicular perineural catheter|infraclavicular perineural catheter
4812002|NCT02550782|postoperative analgesia|postoperative analgesia
4812003|NCT02550769|Transanal NOTES|transanal notes
4812004|NCT02550769|Transanal TME|transanal tme
4812005|NCT02550769|Laparoscopic Low Anterior Resection|laparoscopic low anterior resection
4812006|NCT02550769|Surgery|surgery
4812007|NCT02550743|Stage II|stage ii
4812008|NCT02550743|Stage III|stage iii
4812009|NCT02550743|Stage IV|stage iv
4812010|NCT02550743|metastatic|metastatic
4812011|NCT02550717|Low-dose Acetylsalicylic Acid,|low-dose acetylsalicylic acid,
4812012|NCT02550717|Bleeding,|bleeding,
4812013|NCT02550717|The Health Improvement Network (THIN),|the health improvement network (thin),
4812014|NCT02550717|Cardiovascular|cardiovascular
4812015|NCT02550717|Secondary prevention of cardiovascular events|secondary prevention of cardiovascular events
4812016|NCT02550704|Irritable Bowel syndrome|irritable bowel syndrome
4812017|NCT02550704|Intestinal permeability|intestinal permeability
4812018|NCT02550704|Visceral hypersensitivity|visceral hypersensitivity
4812019|NCT02550704|Low grade inflammation|low grade inflammation
4812020|NCT02550678|Untreated nBCC|untreated nbcc
4812021|NCT02550678|Low-Risk|low-risk
4812022|NCT02550665|Alzheimer's disease|alzheimer's disease
4812023|NCT02550665|donepezil|donepezil
4812024|NCT02550626|delirium|delirium
4812025|NCT02550626|alpha synucleinopathy|alpha synucleinopathy
4812026|NCT02550626|spine surgery|spine surgery
4812027|NCT02550613|MR/PET, hepatocellular carcinoma, HCC|mr/pet, hepatocellular carcinoma, hcc
4812028|NCT02550600|ARDS|ards
4812029|NCT02550600|Acute lung impairment|acute lung impairment
4812030|NCT02550600|Extracorporeal lung assist|extracorporeal lung assist
4812031|NCT02550600|ECMO|ecmo
4812032|NCT02550600|ECLA|ecla
4812033|NCT02550600|Murray-score|murray-score
4812034|NCT02550600|SOFA-score|sofa-score
4812035|NCT02550587|Patient Satisfaction|patient satisfaction
4812036|NCT02550587|anesthesia Care|anesthesia care
4812037|NCT02550561|Posterior tibial nerve stimulation|posterior tibial nerve stimulation
4812038|NCT02550561|PTNS|ptns
4812039|NCT02550561|IC|ic
4812040|NCT02550548|Incretins|incretins
4812041|NCT02550548|GLP-1|glp-1
4812042|NCT02550548|GIP|gip
4812043|NCT02550548|hyperglycemic clamp|hyperglycemic clamp
4812044|NCT02550535|Gene Therapy|gene therapy
4812045|NCT02550535|WT1 TCR|wt1 tcr
4812046|NCT02550535|Gene modified T cels|gene modified t cels
4812047|NCT02550522|without associated head injury|without associated head injury
4812048|NCT02550509|stroke|stroke
4812049|NCT02550509|Botulinum toxin|botulinum toxin
4812050|NCT02550509|Muscle alterations|muscle alterations
4812051|NCT02550483|Healthy volunteers|healthy volunteers
4812052|NCT02550444|Clonidine|clonidine
4812053|NCT02550444|Anesthesia, Obstetrical|anesthesia, obstetrical
4812054|NCT02550379|Social Anxiety|social anxiety
4812055|NCT02550379|Social Phobia|social phobia
4812056|NCT02550379|Depression|depression
4812057|NCT02550379|Emotion Recognition Training|emotion recognition training
4812058|NCT02550366|Cardiac MRI|cardiac mri
4812059|NCT02550366|Accelerate imaging|accelerate imaging
4812060|NCT02550366|coronary artery disease|coronary artery disease
4812061|NCT02550353|lenticule extraction|lenticule extraction
4812062|NCT02550353|femtosecond laser-assisted laser in situ keratomileusis|femtosecond laser-assisted laser in situ keratomileusis
4812063|NCT02550353|tear|tear
4812064|NCT02550353|inflammatory mediators|inflammatory mediators
4812065|NCT02550340|Arrhythmia|arrhythmia
4812066|NCT02550340|Alcohol|alcohol
4812069|NCT02550327|potentially resectable|potentially resectable
4812070|NCT02550327|Pancreatic adenocarcinoma|pancreatic adenocarcinoma
4812071|NCT02550327|PDAC|pdac
4812072|NCT02550301|mean platelet volume|mean platelet volume
4812073|NCT02550262|Epidural|epidural
4812074|NCT02550262|Labor analgesia|labor analgesia
4812075|NCT02550262|Programmed intermittent epidural bolus|programmed intermittent epidural bolus
4812076|NCT02550236|Children|children
4812077|NCT02550236|Obesity|obesity
4812078|NCT02550236|Pregnancy|pregnancy
4812079|NCT02550236|Growth|growth
4812080|NCT02550236|Lifestyle|lifestyle
4812081|NCT02550236|Metabolic and cardiovascular health|metabolic and cardiovascular health
4812082|NCT02550236|Birth|birth
4812083|NCT02550236|Development|development
4812084|NCT02550210|Breast Conserving Surgery|breast conserving surgery
4812085|NCT02550210|Breast Imaging|breast imaging
4812086|NCT02550210|Breast Diagnostics|breast diagnostics
4812087|NCT02550197|Influenza|influenza
4812088|NCT02550197|Quadrivalent influenza vaccine|quadrivalent influenza vaccine
4812089|NCT02550197|Trivalent influenza vaccine|trivalent influenza vaccine
4812090|NCT02550184|Patients with symptoms of acute respiratory problems|patients with symptoms of acute respiratory problems
4812091|NCT02550171|Biobank|biobank
4812092|NCT02550171|Genetics|genetics
4812094|NCT02550171|Cohort|cohort
4812095|NCT02550171|normal control|normal control
4812096|NCT02550158|Crohn's Disease|crohn's disease
4812097|NCT02550158|Ulcerative Colitis|ulcerative colitis
4812098|NCT02550158|Educational program|educational program
4812099|NCT02550158|Inflammatory Bowel Disease|inflammatory bowel disease
4812100|NCT02550158|Psycho-pedagogic score|psycho-pedagogic score
4812101|NCT02550158|IBD|ibd
4812102|NCT02550145|Hyperinsulinemic|hyperinsulinemic
4812103|NCT02550145|post-bariatric surgery|post-bariatric surgery
4812104|NCT02550132|electromyography|electromyography
4812105|NCT02550132|biomechanical phenomena|biomechanical phenomena
4812106|NCT02550132|dose-response relationship|dose-response relationship
4812107|NCT02550132|musculoskeletal manipulations|musculoskeletal manipulations
4812108|NCT02550132|spinal manipulation|spinal manipulation
4812109|NCT02550106|CHRONIC SPONTANEOUS URTICARIA, OMALIZUMAB, URTICARIA CONTROL TEST|chronic spontaneous urticaria, omalizumab, urticaria control test
4812110|NCT02550093|Volunteers|volunteers
4812111|NCT02550067|HIV infection|hiv infection
4812112|NCT02550067|DepoLevonorgestrel|depolevonorgestrel
4812113|NCT02550067|Contraception|contraception
4812114|NCT02550067|DMPA|dmpa
4812115|NCT02550067|Copper IUD|copper iud
4812116|NCT02550067|Levonorgestrel implant|levonorgestrel implant
4812117|NCT02550067|IUD|iud
4812118|NCT02550041|Bronchitis aspergillus|bronchitis aspergillus
4812119|NCT02550041|cystic fibrosis|cystic fibrosis
4812120|NCT02550028|Neonates|neonates
4812121|NCT02550028|Seizure|seizure
4812122|NCT02550015|Exercise training|exercise training
4812123|NCT02550015|Oxygen consumption|oxygen consumption
4812124|NCT02549989|LY3023414|ly3023414
4812125|NCT02549989|15-079|15-079
4812126|NCT02549989|Persistent Endometrial Cancer|persistent endometrial cancer
4812127|NCT02549976|Crohn's Disease|crohn's disease
4812128|NCT02549976|Digestive Damage|digestive damage
4812129|NCT02549976|Lemann Index|lemann index
4812130|NCT02549950|Accelerated orthodontic tooth movement (AOTM)|accelerated orthodontic tooth movement (aotm)
4812131|NCT02549950|Peizo-corticission|peizo-corticission
4812132|NCT02549924|Resveratrol|resveratrol
4812133|NCT02549924|Glycemic Variability|glycemic variability
4812134|NCT02549924|MAGE|mage
4812135|NCT02549911|chemotherapy|chemotherapy
4812136|NCT02549911|surgery|surgery
4812137|NCT02549911|Surgically-Created Resection Cavity|surgically-created resection cavity
4812138|NCT02549911|Adverse Reaction to Drug|adverse reaction to drug
4812139|NCT02549885|Migraine disorders|migraine disorders
4812140|NCT02549885|Muscle stretching exercises|muscle stretching exercises
4812141|NCT02549872|Dementia|dementia
4812142|NCT02549872|Validity|validity
4812143|NCT02549872|Mortality|mortality
4812144|NCT02549872|Electronic health records|electronic health records
4812145|NCT02549859|DBS|dbs
4812146|NCT02549859|Low frequency stimulation|low frequency stimulation
4812147|NCT02549859|Dysphagia|dysphagia
4812148|NCT02549859|Freezing of gait|freezing of gait
4812149|NCT02549833|low-grade glioma|low-grade glioma
4812150|NCT02549833|WHO grade II|who grade ii
4812151|NCT02549833|vaccine|vaccine
4812152|NCT02549833|immunotherapy|immunotherapy
4812153|NCT02549833|glioma|glioma
4812154|NCT02549820|Congenital Diaphragmatic Hernia|congenital diaphragmatic hernia
4812155|NCT02549820|Tracheal Occlusion|tracheal occlusion
4812156|NCT02549807|Vascular hemiplegia|vascular hemiplegia
4812157|NCT02549807|2D ultrasound|2d ultrasound
4812158|NCT02549807|Muscle elasticity|muscle elasticity
4812159|NCT02549807|Pennation angle|pennation angle
4812160|NCT02549794|low concentration contrast agent|low concentration contrast agent
4812161|NCT02549794|Low dose contrast agent|low dose contrast agent
4812162|NCT02549794|computed tomography|computed tomography
4812163|NCT02549781|pathological gambler|pathological gambler
4812164|NCT02549781|Go-Nogo test|go-nogo test
4812165|NCT02549768|Dexmedetomidine|dexmedetomidine
4812166|NCT02549768|Pituitary|pituitary
4812167|NCT02549768|Transsphenoidal|transsphenoidal
4812168|NCT02549768|Cortisol|cortisol
4812169|NCT02549742|Electrochemotherapy|electrochemotherapy
4812170|NCT02549742|head neck cancer|head neck cancer
4812171|NCT02549742|bleomycin|bleomycin
4812172|NCT02549716|Acetaminophen|acetaminophen
4812173|NCT02549716|interleukin-6|interleukin-6
4812174|NCT02549716|interleukin-1|interleukin-1
4812175|NCT02549716|thromboxane A2|thromboxane a2
4812176|NCT02549703|multiple sclerosis|multiple sclerosis
4812177|NCT02549703|progressive multiple sclerosis|progressive multiple sclerosis
4812178|NCT02549703|mitochondria|mitochondria
4812179|NCT02549703|neurodegeneration|neurodegeneration
4812180|NCT02549690|IVF, Testosterone gel, DHEA, poor responder.|ivf, testosterone gel, dhea, poor responder.
4812181|NCT02549664|Hypertrophic Cardiomyopathy (HCM)|hypertrophic cardiomyopathy (hcm)
4812182|NCT02549664|Long QT Syndrome (LQTS)|long qt syndrome (lqts)
4812183|NCT02549651|DLBCL|dlbcl
4812184|NCT02549651|MEDI4736|medi4736
4812185|NCT02549651|durvalumab|durvalumab
4812186|NCT02549651|tremelimumab|tremelimumab
4812187|NCT02549651|AZD9150|azd9150
4812188|NCT02549651|anti-PD-L1|anti-pd-l1
4812189|NCT02549651|anti-CTLA-4|anti-ctla-4
4812190|NCT02549651|immunotherapy|immunotherapy
4812191|NCT02549651|IMTC|imtc
4812192|NCT02549651|STAT3|stat3
4812193|NCT02549625|Single right ventricular failure|single right ventricular failure
4812194|NCT02549612|Conductive hearing loss|conductive hearing loss
4812195|NCT02549612|middle ear pressure equalization|middle ear pressure equalization
4812196|NCT02549612|middle ear effusion|middle ear effusion
4812197|NCT02549599|Digital and mobile health|digital and mobile health
4812198|NCT02549599|Sexual and reproductive health|sexual and reproductive health
4812199|NCT02549599|Adolescents and young adults|adolescents and young adults
4812200|NCT02549586|solid organ transplant|solid organ transplant
4812201|NCT02549586|immune tolerance|immune tolerance
4812202|NCT02549586|autologous stem cell transplant|autologous stem cell transplant
4812203|NCT02549586|blood and marrow transplant|blood and marrow transplant
4812204|NCT02549586|autoimmune disease|autoimmune disease
4812205|NCT02549573|Motor Symptoms|motor symptoms
4812206|NCT02549573|Parkinson's disease|parkinson's disease
4812207|NCT02549573|Apokyn|apokyn
4812208|NCT02549573|Apomorphine|apomorphine
4812209|NCT02549573|PD|pd
4812210|NCT02549560|tDCS|tdcs
4812211|NCT02549560|Cardiac Surgery|cardiac surgery
4812212|NCT02549547|anxiety|anxiety
4812213|NCT02549547|depression|depression
4812214|NCT02549547|exercise|exercise
4812215|NCT02549547|group|group
4812216|NCT02549547|group medical visit|group medical visit
4812217|NCT02549547|mood disorder|mood disorder
4812218|NCT02549547|physical activity|physical activity
4812219|NCT02549547|primary care|primary care
4812220|NCT02549534|Taxane|taxane
4812221|NCT02549534|Neuropathy|neuropathy
4812222|NCT02549534|Chemotherapy-Induced Peripheral Neuropathy (CIPN)|chemotherapy-induced peripheral neuropathy (cipn)
4812223|NCT02549534|Breast Cancer|breast cancer
4812224|NCT02549534|Local skin heating|local skin heating
4812225|NCT02549534|Axon reflex|axon reflex
4812226|NCT02549534|Axon flare|axon flare
4812227|NCT02549534|Total Neuropathy Score (TNS)|total neuropathy score (tns)
4812228|NCT02549534|Laser Doppler Flowmetry (LDF)|laser doppler flowmetry (ldf)
4812229|NCT02549534|Laser Speckle Contrast Imaging (LSCI)|laser speckle contrast imaging (lsci)
4812230|NCT02549534|Full-field laser perfusion imaging (FLPI)|full-field laser perfusion imaging (flpi)
4812231|NCT02549534|Paclitaxel|paclitaxel
4812232|NCT02549534|Taxol|taxol
4812233|NCT02549521|calcium|calcium
4812234|NCT02549521|magnesium|magnesium
4812235|NCT02549521|vitamin D|vitamin d
4812236|NCT02549521|bone turnover markers|bone turnover markers
4812237|NCT02549482|Central volume deficit|central volume deficit
4812238|NCT02549482|Head-up tilt|head-up tilt
4812239|NCT02549482|Systolic pressure variation|systolic pressure variation
4812240|NCT02549456|natural orifice surgery|natural orifice surgery
4812241|NCT02549456|natural orifice specimen extraction|natural orifice specimen extraction
4812242|NCT02549456|taTME|tatme
4812243|NCT02549443|Catabolic response|catabolic response
4812244|NCT02549443|Amino Acids|amino acids
4812245|NCT02549443|Insulin|insulin
4812246|NCT02549430|Advanced breast cancer|advanced breast cancer
4812247|NCT02549430|Postmenopausal|postmenopausal
4812248|NCT02549430|ER positive|er positive
4812249|NCT02549430|Her2 negative|her2 negative
4812250|NCT02549378|microcirculation|microcirculation
4812251|NCT02549378|confocal microscopy|confocal microscopy
4812252|NCT02549378|hypocapnia|hypocapnia
4812253|NCT02549326|Vitamin D|vitamin d
4812254|NCT02549313|brain lesion|brain lesion
4812255|NCT02549313|intracranial pressure|intracranial pressure
4812256|NCT02549313|cerebral perfusion pressure|cerebral perfusion pressure
4812257|NCT02549300|connective tissue massage|connective tissue massage
4812258|NCT02549300|adolescent tension-type headache|adolescent tension-type headache
4812259|NCT02549274|Cervicalgia|cervicalgia
4812260|NCT02549274|self-rehabilitation|self-rehabilitation
4812261|NCT02549274|physiotherapy|physiotherapy
4812262|NCT02549261|nimotuzumab|nimotuzumab
4812263|NCT02549261|non-small cell lung cancer|non-small cell lung cancer
4812264|NCT02549261|radiochemotherapy|radiochemotherapy
4812265|NCT02549261|stage IIIA/IIIB non-small cell lung cancer|stage iiia/iiib non-small cell lung cancer
4812266|NCT02549248|Interstitial Lung Diseases|interstitial lung diseases
4812267|NCT02549248|nanoparticles|nanoparticles
4812268|NCT02549248|lung|lung
4812269|NCT02549248|broncho-alveolar lavage|broncho-alveolar lavage
4812270|NCT02549248|bronchial washings|bronchial washings
4812271|NCT02549235|IVF|ivf
4812272|NCT02549235|Miscarriage|miscarriage
4812273|NCT02549235|Uterine septum|uterine septum
4812274|NCT02549222|pathogen reduction|pathogen reduction
4812275|NCT02549222|INTERCEPT|intercept
4812276|NCT02549222|platelet|platelet
4812277|NCT02549222|pulmonary|pulmonary
4812278|NCT02549222|ARDS|ards
4812279|NCT02549222|hematology|hematology
4812280|NCT02549222|oncology|oncology
4812281|NCT02549222|assisted ventilation|assisted ventilation
4812282|NCT02549222|transfusion of platelet components|transfusion of platelet components
4812283|NCT02549222|hematology-oncology patients|hematology-oncology patients
4812284|NCT02549209|Pembrolizumab|pembrolizumab
4812285|NCT02549209|Keytruda|keytruda
4812286|NCT02549209|Anti-Programmed [Cell] Death Protein 1 (PD-1) Antibody|anti-programmed [cell] death protein 1 (pd-1) antibody
4812287|NCT02549209|Carboplatin|carboplatin
4812288|NCT02549209|Paclitaxel|paclitaxel
4812289|NCT02549183|Spinal Cord Stimulation|spinal cord stimulation
4812290|NCT02549170|Autoimmune Diseases|autoimmune diseases
4812291|NCT02549170|Polyneuropathies|polyneuropathies
4812292|NCT02549170|Nervous System Diseases|nervous system diseases
4812293|NCT02549170|Peripheral Nervous System Diseases|peripheral nervous system diseases
4812294|NCT02549170|Polyradiculoneuropathy|polyradiculoneuropathy
4812295|NCT02549170|Autoimmune Diseases of the Nervous System|autoimmune diseases of the nervous system
4812296|NCT02549170|Immunoglobulins|immunoglobulins
4812297|NCT02549170|Immune System Diseases|immune system diseases
4812298|NCT02549170|Demyelinating Diseases|demyelinating diseases
4812299|NCT02549170|Polyradiculoneuropathy, Chronic Inflammatory Demyelinating|polyradiculoneuropathy, chronic inflammatory demyelinating
4812300|NCT02549170|Neuromuscular Diseases|neuromuscular diseases
4812301|NCT02549144|HDL biochemical composition and function|hdl biochemical composition and function
4812302|NCT02549105|EMLA CREAM|emla cream
4812303|NCT02549105|LIDOCAINE INFILTERATION|lidocaine infilteration
4812304|NCT02549105|PAIN RELIEF|pain relief
4812305|NCT02549092|levodopa-carbidopa intestinal gel|levodopa-carbidopa intestinal gel
4812306|NCT02549092|levodopa|levodopa
4812307|NCT02549092|carbidopa|carbidopa
4812308|NCT02549092|Advanced Parkinson's Disease|advanced parkinson's disease
4812309|NCT02549092|Non-Motor Symptom Scale NMSS|non-motor symptom scale nmss
4812310|NCT02549092|Parkinson's Disease Sleep Scale PDSS-2|parkinson's disease sleep scale pdss-2
4812311|NCT02549092|efficacy|efficacy
4812312|NCT02549066|cardiopulmonary bypass|cardiopulmonary bypass
4812313|NCT02549066|renal blood flow|renal blood flow
4812314|NCT02549066|renal function|renal function
4812315|NCT02549066|renal oxygenation|renal oxygenation
4812316|NCT02549001|Onychomycosis|onychomycosis
4812317|NCT02549001|Nail fungus|nail fungus
4812318|NCT02548975|Cardiac surgery|cardiac surgery
4812319|NCT02548975|Risk factors|risk factors
4812320|NCT02548975|Postoperative delirium|postoperative delirium
4812321|NCT02548962|Multiple Myeloma|multiple myeloma
4812322|NCT02548962|Bruton's Tyrosine Kinase|bruton's tyrosine kinase
4812323|NCT02548962|PCI-32765|pci-32765
4812324|NCT02548962|Pomalidomide|pomalidomide
4812325|NCT02548962|Dexamethasone|dexamethasone
4812326|NCT02548962|Relapsed Refractory Multiple Myeloma|relapsed refractory multiple myeloma
4812327|NCT02548962|Ibrutinib|ibrutinib
4812328|NCT02548936|Cholesterol, LDL|cholesterol, ldl
4812329|NCT02548936|Carotid Intima-Media Thickness|carotid intima-media thickness
4812330|NCT02548936|Atherosclerosis|atherosclerosis
4812331|NCT02548936|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination
4812332|NCT02548936|Lupus Erythematosus, Systemic|lupus erythematosus, systemic
4812333|NCT02548897|Parkinson's Disease with Freezing of Gait Symptoms|parkinson's disease with freezing of gait symptoms
4812334|NCT02548858|Perineorrhaphy|perineorrhaphy
4812335|NCT02548858|Pelvic organ prolapse|pelvic organ prolapse
4812336|NCT02548858|Vaginal or abdominal reconstruction|vaginal or abdominal reconstruction
4812337|NCT02548858|Body image|body image
4812338|NCT02548845|hyponatremia|hyponatremia
4812339|NCT02548845|SIADH|siadh
4812340|NCT02548845|Oncologic patients|oncologic patients
4812341|NCT02548832|Berberine|berberine
4812342|NCT02548832|Bezafibrate|bezafibrate
4812343|NCT02548806|Clonidine|clonidine
4812344|NCT02548793|Cardiac Arrest|cardiac arrest
4812346|NCT02548793|Family-centered Care|family-centered care
4812347|NCT02548793|Health Literacy|health literacy
4812348|NCT02548793|Health Education|health education
4812349|NCT02548793|Education Dissemination|education dissemination
4812350|NCT02548780|unresectable|unresectable
4812351|NCT02548767|High fructose corn syrup|high fructose corn syrup
4812352|NCT02548767|Sugar|sugar
4812353|NCT02548754|atrial fibrillation|atrial fibrillation
4812354|NCT02548754|neuromodulation|neuromodulation
4812355|NCT02548754|inflammation|inflammation
4812356|NCT02548741|Metformin|metformin
4812357|NCT02548741|diabetes|diabetes
4812358|NCT02548741|type 2 diabetes|type 2 diabetes
4812359|NCT02548741|diabetes complications|diabetes complications
4812360|NCT02548741|methylglyoxal|methylglyoxal
4812361|NCT02548741|Prediabetes|prediabetes
4812362|NCT02548728|Opioid Dependence|opioid dependence
4812363|NCT02548728|Opioid Withdrawal|opioid withdrawal
4812364|NCT02548728|Opioid|opioid
4812365|NCT02548728|Oxytocin|oxytocin
4812366|NCT02548728|OT (oxytocin)|ot (oxytocin)
4812367|NCT02548728|Intranasal administration|intranasal administration
4812368|NCT02548715|thyroxine|thyroxine
4812369|NCT02548715|Otolaryngology|otolaryngology
4812370|NCT02548702|Sport|sport
4812371|NCT02548702|type 2 diabetes|type 2 diabetes
4812372|NCT02548702|community intervention programme|community intervention programme
4812373|NCT02548702|Fit4life|fit4life
4812374|NCT02548702|Exercise|exercise
4812375|NCT02548689|alopecia|alopecia
4812376|NCT02548689|hair loss|hair loss
4812377|NCT02548663|amyotrophic lateral sclerosis|amyotrophic lateral sclerosis
4812378|NCT02548663|sport therapy|sport therapy
4812379|NCT02548663|osteopathic manual treatment|osteopathic manual treatment
4812380|NCT02548663|muscle oxidative metabolism|muscle oxidative metabolism
4812381|NCT02548650|myocardial infarction|myocardial infarction
4812382|NCT02548650|diabetes mellitus|diabetes mellitus
4812383|NCT02548650|vorapaxar|vorapaxar
4812384|NCT02548650|peripheral arterial disease|peripheral arterial disease
4812385|NCT02548585|MEDI0382, diabetes|medi0382, diabetes
4812386|NCT02548572|Transcorneal Electrical Stimulation|transcorneal electrical stimulation
4812387|NCT02548572|TES|tes
4812388|NCT02548572|Retinitis Pigmentosa|retinitis pigmentosa
4812389|NCT02548572|RP|rp
4812390|NCT02548416|Atelectasis|atelectasis
4812391|NCT02548416|Positive End-Expiratory Pressure|positive end-expiratory pressure
4812392|NCT02548416|Oxygenation|oxygenation
4812393|NCT02548416|Anaesthesia|anaesthesia
4812394|NCT02548416|Computed tomography|computed tomography
4812395|NCT02548403|Bowel preparation|bowel preparation
4812396|NCT02548403|Simethicone|simethicone
4812397|NCT02548403|Polyethylene glycol with ascorbic acid|polyethylene glycol with ascorbic acid
4812398|NCT02548390|Phase 1/1b|phase 1/1b
4812399|NCT02548390|open-label|open-label
4812400|NCT02548390|dose-escalation|dose-escalation
4812401|NCT02548390|pharmacokinetics|pharmacokinetics
4812402|NCT02548390|solid tumor|solid tumor
4812403|NCT02548390|metastatic cancer|metastatic cancer
4812404|NCT02548390|chemotherapy|chemotherapy
4812405|NCT02548390|nano formulation|nano formulation
4812406|NCT02548390|alkylator|alkylator
4812407|NCT02548377|Head and Neck Neoplasms|head and neck neoplasms
4812408|NCT02548377|Surgical Flaps|surgical flaps
4812409|NCT02548377|Ischemic Preconditioning|ischemic preconditioning
4812410|NCT02548377|Hemostasis|hemostasis
4812411|NCT02548377|Thrombosis|thrombosis
4812412|NCT02548377|Immune System|immune system
4812413|NCT02548377|Reperfusion Injury|reperfusion injury
4812414|NCT02548364|Vitamin D|vitamin d
4812415|NCT02548364|Myocardial Infarction|myocardial infarction
4812416|NCT02548364|Ventricular remodeling|ventricular remodeling
4812417|NCT02548364|Biomarkers|biomarkers
4812418|NCT02548351|Non Alcoholic Steatohepatitis, fatty liver disease, NASH|non alcoholic steatohepatitis, fatty liver disease, nash
4812419|NCT02548312|Readers' perceptions|readers' perceptions
4812420|NCT02548299|Diabetes|diabetes
4812421|NCT02548299|Cooking|cooking
4812422|NCT02548299|Nutrition|nutrition
4812423|NCT02548299|Lifestyle Medicine|lifestyle medicine
4812424|NCT02548286|Hypertension|hypertension
4812425|NCT02548286|Healthy male volunteer|healthy male volunteer
4812426|NCT02548286|Candesartan, Amlodipine|candesartan, amlodipine
4812427|NCT02548273|Corneal endothelium|corneal endothelium
4812428|NCT02548273|phacoemulsification|phacoemulsification
4812429|NCT02548247|Stool frequency|stool frequency
4812430|NCT02548247|Bowel motor function|bowel motor function
4812431|NCT02548247|Orafti® Inulin|orafti® inulin
4812432|NCT02548247|Dietary Fiber|dietary fiber
4812433|NCT02548234|Stroke|stroke
4812434|NCT02548234|Randomized control trial|randomized control trial
4812435|NCT02548234|Mirror therapy|mirror therapy
4812436|NCT02548234|Bilateral arm training|bilateral arm training
4812437|NCT02548234|Comparative efficacy research|comparative efficacy research
4812438|NCT02548234|Neurorehabilitation|neurorehabilitation
4812439|NCT02548221|Thoracentesis|thoracentesis
4812440|NCT02548221|Pleural Effusions|pleural effusions
4812441|NCT02548221|Transthoracic echocardiogram|transthoracic echocardiogram
4812442|NCT02548221|Lung volume measurements|lung volume measurements
4812443|NCT02548195|GEMOX|gemox
4812444|NCT02548195|intrahepatic cholangiocarcinoma|intrahepatic cholangiocarcinoma
4812445|NCT02548195|adjuvant therapy|adjuvant therapy
4812446|NCT02548195|oxaliplatin|oxaliplatin
4812447|NCT02548195|gemcitabine|gemcitabine
4812448|NCT02548195|capecitabine|capecitabine
4812449|NCT02548195|curative surgery|curative surgery
4812450|NCT02548169|Dendritic Cell Vaccine|dendritic cell vaccine
4812451|NCT02548169|FOLFIRINOX|folfirinox
4812452|NCT02548169|nab-paclitaxel|nab-paclitaxel
4812453|NCT02548169|gemcitabine|gemcitabine
4812454|NCT02548117|Testosterone therapy|testosterone therapy
4812455|NCT02548117|erythrocytosis|erythrocytosis
4812456|NCT02548117|finasteride|finasteride
4812457|NCT02548091|non invasive ventilation|non invasive ventilation
4812458|NCT02548091|reperfusion pulmonary edema|reperfusion pulmonary edema
4812459|NCT02548091|chronic thrombolic pulmonary hypertension|chronic thrombolic pulmonary hypertension
4812460|NCT02548091|pulmonary artery angioplasty|pulmonary artery angioplasty
4812461|NCT02548078|Protection against Ebola Zaire virus|protection against ebola zaire virus
4812462|NCT02548065|Fibromyalgia Syndrome|fibromyalgia syndrome
4812463|NCT02548065|Balneotherapy|balneotherapy
4812464|NCT02548065|Vetriolo Water|vetriolo water
4812465|NCT02548052|retinoic acid receptor-related orphan receptor (ROR) gamma inverse agonist|retinoic acid receptor-related orphan receptor (ror) gamma inverse agonist
4812466|NCT02548052|Plaque type psoriasis|plaque type psoriasis
4812467|NCT02548052|psoriasis plaque test|psoriasis plaque test
4812468|NCT02548052|Topical|topical
4812469|NCT02548052|GSK2981278|gsk2981278
4812470|NCT02548039|Anovulatory|anovulatory
4812471|NCT02548039|Clomiphene|clomiphene
4812472|NCT02548026|meal frequency|meal frequency
4812473|NCT02548026|eating frequency|eating frequency
4812474|NCT02548026|ingestive frequency|ingestive frequency
4812475|NCT02548026|positive energy balance|positive energy balance
4812476|NCT02548026|satiety|satiety
4812477|NCT02548026|appetite|appetite
4812478|NCT02548026|hunger|hunger
4812479|NCT02547987|breast cancer|breast cancer
4812480|NCT02547987|triple negative|triple negative
4812481|NCT02547987|TNBC|tnbc
4812482|NCT02547987|triple negative breast cancer|triple negative breast cancer
4812483|NCT02547974|Safety|safety
4812484|NCT02547974|Immunogenicity|immunogenicity
4812485|NCT02547974|Reactogenicity|reactogenicity
4812486|NCT02547961|breast cancer|breast cancer
4812487|NCT02547961|HER2|her2
4812488|NCT02547961|CAR-T cell|car-t cell
4812489|NCT02547948|CD19|cd19
4812490|NCT02547948|CAR T Cells|car t cells
4812491|NCT02547948|Lymphoma|lymphoma
4812492|NCT02547922|lupus, nephritis, randomized, placebo, anifrolumab, safety, efficacy, adult|lupus, nephritis, randomized, placebo, anifrolumab, safety, efficacy, adult
4812493|NCT02547896|codeine|codeine
4812494|NCT02547896|diclofenac|diclofenac
4812495|NCT02547896|impacted third molar tooth|impacted third molar tooth
4812496|NCT02547883|Statins|statins
4812497|NCT02547883|Elderly|elderly
4812498|NCT02547883|Mortality|mortality
4812499|NCT02547883|Quality of life|quality of life
4812500|NCT02547883|Randomized trial|randomized trial
4812501|NCT02547883|Cost effectiveness study|cost effectiveness study
4812502|NCT02547883|Primary care|primary care
4812503|NCT02547870|Rilpivirine|rilpivirine
4812504|NCT02547870|Healthy participants|healthy participants
4812505|NCT02547857|Pelvic ultrasound|pelvic ultrasound
4812506|NCT02547857|Transvaginal ultrasound|transvaginal ultrasound
4812507|NCT02547818|Early stage AD|early stage ad
4812508|NCT02547818|MCI|mci
4812509|NCT02547818|aMCI|amci
4812510|NCT02547818|prodromal|prodromal
4812511|NCT02547818|Memory loss|memory loss
4812512|NCT02547818|Memory problems|memory problems
4812513|NCT02547818|Aging|aging
4812514|NCT02547818|Early Alzheimer's Disease|early alzheimer's disease
4812515|NCT02547818|Early AD|early ad
4812516|NCT02547805|Urine Oxalate|urine oxalate
4812517|NCT02547805|Nephrolithiasis|nephrolithiasis
4812518|NCT02547805|Kidney Stones|kidney stones
4812519|NCT02547805|Hyperoxaluria|hyperoxaluria
4812520|NCT02547805|Enteric Hyperoxaluria|enteric hyperoxaluria
4812521|NCT02547805|Idiopathic Hyperoxaluria|idiopathic hyperoxaluria
4812522|NCT02547805|Urological Diseases|urological diseases
4812523|NCT02547805|Kidney Diseases|kidney diseases
4812524|NCT02547805|Supersaturation|supersaturation
4812525|NCT02547805|Dietary Oxalate|dietary oxalate
4812526|NCT02547792|Influenza B|influenza b
4812527|NCT02547779|crystalloid|crystalloid
4812528|NCT02547779|acute kidney injury|acute kidney injury
4812529|NCT02547766|Ventricular Assist Device|ventricular assist device
4812530|NCT02547766|Recovery of Function|recovery of function
4812531|NCT02547753|Tooth extraction|tooth extraction
4812532|NCT02547753|Antibiotic prophylaxis|antibiotic prophylaxis
4812533|NCT02547753|Postoperative complications|postoperative complications
4812534|NCT02547740|macula|macula
4812535|NCT02547740|visual fields|visual fields
4812536|NCT02547740|optical coherence tomography|optical coherence tomography
4812537|NCT02547740|glaucoma progression|glaucoma progression
4812538|NCT02547740|retinal ganglion cells|retinal ganglion cells
4812539|NCT02547727|rabies vaccination|rabies vaccination
4812540|NCT02547714|cyclosporine A|cyclosporine a
4812541|NCT02547610|MR/PET in the evaluation|mr/pet in the evaluation
4812542|NCT02547610|patients|patients
4812543|NCT02547597|Beta-blockers|beta-blockers
4812544|NCT02547597|Anti-anginal effect|anti-anginal effect
4812545|NCT02547597|Lipid metabolism|lipid metabolism
4812546|NCT02547597|Glucose metabolism|glucose metabolism
4812547|NCT02547571|Outpatient|outpatient
4812548|NCT02547558|Indacaterol|indacaterol
4812549|NCT02547558|Pulmonary gas exchange|pulmonary gas exchange
4812550|NCT02547558|Long-acting bronchodilators|long-acting bronchodilators
4812551|NCT02547532|COPD|copd
4812552|NCT02547532|alpha-1 antitrypsin deficiency|alpha-1 antitrypsin deficiency
4812553|NCT02547532|microbioma|microbioma
4812554|NCT02547519|Type 1 diabetes|type 1 diabetes
4812555|NCT02547519|T1D|t1d
4812556|NCT02547519|diabetes mellitus|diabetes mellitus
4812557|NCT02547519|oral insulin|oral insulin
4812558|NCT02547519|oral tolerance|oral tolerance
4812559|NCT02547519|autoantigen|autoantigen
4812560|NCT02547519|self tolerance|self tolerance
4812561|NCT02547519|prevention|prevention
4813057|NCT02544347|vaspin|vaspin
4812562|NCT02547519|at risk for developing type 1 diabetes|at risk for developing type 1 diabetes
4812563|NCT02547519|juvenile diabetes|juvenile diabetes
4812564|NCT02547506|cardiorespiratory fitness|cardiorespiratory fitness
4812565|NCT02547506|group exercise|group exercise
4812566|NCT02547493|Vaccination against Pneumococcal|vaccination against pneumococcal
4812567|NCT02547493|Naïve Abatacept patients|naïve abatacept patients
4812568|NCT02547480|liver|liver
4812569|NCT02547480|metastatic|metastatic
4812570|NCT02547467|mortality|mortality
4812571|NCT02547415|Pain, Chronic|pain, chronic
4812572|NCT02547415|children|children
4812573|NCT02547376|Telomeres|telomeres
4812574|NCT02547376|Telomerase|telomerase
4812575|NCT02547376|Alternative lengthening of Telomeres Mechanism|alternative lengthening of telomeres mechanism
4812576|NCT02547285|biomechanics of walking|biomechanics of walking
4812577|NCT02547285|footwear|footwear
4812578|NCT02547272|Intensive care|intensive care
4812579|NCT02547272|S Aureus|s aureus
4812580|NCT02547259|schizophrenia|schizophrenia
4812581|NCT02547259|memory|memory
4812582|NCT02547259|pain|pain
4812583|NCT02547246|bulimia|bulimia
4812584|NCT02547246|repetitive transcranial magnetic stimulation (rTMS)|repetitive transcranial magnetic stimulation (rtms)
4812585|NCT02547194|coronary artery bypass grafting|coronary artery bypass grafting
4812586|NCT02547194|saphenous vein|saphenous vein
4812587|NCT02547194|no-touch technique|no-touch technique
4812588|NCT02547181|Fracture|fracture
4812589|NCT02547181|Follow-up|follow-up
4812590|NCT02547181|metacarpal|metacarpal
4812591|NCT02547168|Atrial Fibrillation|atrial fibrillation
4812592|NCT02547168|Symptomatic Atrial Fibrillation|symptomatic atrial fibrillation
4812593|NCT02547168|Asymptomatic Atrial Fibrillation|asymptomatic atrial fibrillation
4812594|NCT02547168|Lung Resection|lung resection
4812595|NCT02547168|Ambulatory Cardiac Monitor|ambulatory cardiac monitor
4812596|NCT02547142|Prospective Pre-Post Evaluation|prospective pre-post evaluation
4812597|NCT02547142|Early Palliative care|early palliative care
4812598|NCT02547142|FACT-E questionnaire|fact-e questionnaire
4812599|NCT02547142|HADS questionnaire|hads questionnaire
4812600|NCT02547142|Patient Health Questionnaire-9 (PHQ-9)|patient health questionnaire-9 (phq-9)
4812601|NCT02547103|Chlorhexidine gluconate|chlorhexidine gluconate
4812602|NCT02547103|Mupirocin ointment|mupirocin ointment
4812603|NCT02547103|Normal saline|normal saline
4812604|NCT02547103|Peritonitis|peritonitis
4812605|NCT02547103|Peritoneal dialysis|peritoneal dialysis
4812606|NCT02547064|intubation|intubation
4812607|NCT02547064|stylet|stylet
4812608|NCT02547064|videolaryngoscope|videolaryngoscope
4812609|NCT02547038|Helicobacter pylori|helicobacter pylori
4812610|NCT02547038|Eradication rate|eradication rate
4812611|NCT02547025|Helicobacter pylori|helicobacter pylori
4812612|NCT02547025|third-line therapy|third-line therapy
4812613|NCT02547025|antibiotic susceptibility|antibiotic susceptibility
4812614|NCT02547025|Eradication|eradication
4812615|NCT02547012|Helicobacter pylori|helicobacter pylori
4812616|NCT02547012|Eradication rate|eradication rate
4812617|NCT02547012|Rescue treatment|rescue treatment
4812618|NCT02546999|Botulinum Toxins, Type A|botulinum toxins, type a
4812619|NCT02546999|Walking|walking
4812620|NCT02546986|CC-486|cc-486
4812621|NCT02546986|Azacitidine|azacitidine
4812622|NCT02546986|Oral azacitidine|oral azacitidine
4812623|NCT02546986|Methyltransferase inhibitor|methyltransferase inhibitor
4812624|NCT02546986|Hypomethylation|hypomethylation
4812625|NCT02546986|Hypomethylating agent|hypomethylating agent
4812626|NCT02546986|Epigenetic|epigenetic
4812627|NCT02546986|MK-3475|mk-3475
4812628|NCT02546986|Pembrolizumab|pembrolizumab
4812629|NCT02546986|Keytruda|keytruda
4812630|NCT02546986|PD-1|pd-1
4812631|NCT02546986|PD-L1|pd-l1
4812632|NCT02546986|ImmunotherapyAdvanced non-small cell lung cancer|immunotherapyadvanced non-small cell lung cancer
4812633|NCT02546986|Metastatic non-small cell lung cancer|metastatic non-small cell lung cancer
4812634|NCT02546986|Non-small cell lung cancer|non-small cell lung cancer
4812635|NCT02546986|NSCLC|nsclc
4812636|NCT02546986|Merck Pembrolizumab (Keynote-117)|merck pembrolizumab (keynote-117)
4812637|NCT02546960|Healthy|healthy
4812638|NCT02546960|JNJ-63871860|jnj-63871860
4812639|NCT02546960|ExPEC4V|expec4v
4812640|NCT02546947|Respiratory Distress Syndrome, Adult|respiratory distress syndrome, adult
4812641|NCT02546947|Neuromuscular Blocking Agents|neuromuscular blocking agents
4812642|NCT02546947|Atracurium|atracurium
4812643|NCT02546947|Mechanical ventilation|mechanical ventilation
4812644|NCT02546947|ARDS|ards
4812645|NCT02546947|partial pressure of oxygen(PaO2) /inspired oxygen (FiO2) < 200|partial pressure of oxygen(pao2) /inspired oxygen (fio2) < 200
4812646|NCT02546947|Positive End Expiratory Pressure (PEEP) > 5 since less than 48 hrs|positive end expiratory pressure (peep) > 5 since less than 48 hrs
4812647|NCT02546934|triple negative breast cancer|triple negative breast cancer
4812648|NCT02546934|fine line chemotherapy|fine line chemotherapy
4812649|NCT02546921|IgE antibody|ige antibody
4812650|NCT02546921|Folate receptor|folate receptor
4812651|NCT02546921|Cancer Immunotherapy|cancer immunotherapy
4812652|NCT02546921|First in class|first in class
4812653|NCT02546908|Prostatic Neoplasms|prostatic neoplasms
4812654|NCT02546908|Non-interventional|non-interventional
4812655|NCT02546908|Observational|observational
4813058|NCT02544347|omentin|omentin
4812656|NCT02546895|head and neck cancer patients|head and neck cancer patients
4812657|NCT02546895|clinical data|clinical data
4812658|NCT02546895|tissue collection|tissue collection
4812659|NCT02546895|prospective registration|prospective registration
4812660|NCT02546895|patients|patients
4812661|NCT02546882|stromal vascular fraction|stromal vascular fraction
4812662|NCT02546882|skin graft|skin graft
4812663|NCT02546843|rocuronium|rocuronium
4812664|NCT02546843|sugammadex|sugammadex
4812665|NCT02546843|pediatric anesthesia|pediatric anesthesia
4812666|NCT02546843|cisatracurium|cisatracurium
4812667|NCT02546843|surgical conditions|surgical conditions
4812668|NCT02546817|Treatment|treatment
4812669|NCT02546817|Tx|tx
4812670|NCT02546817|Prevent|prevent
4812671|NCT02546778|Radio frequency|radio frequency
4812672|NCT02546778|Female|female
4812673|NCT02546778|Humans|humans
4812674|NCT02546778|Esthetics|esthetics
4812675|NCT02546765|analgesics|analgesics
4812676|NCT02546765|cardiac surgery|cardiac surgery
4812677|NCT02546765|sedation|sedation
4812678|NCT02546739|Leukemia|leukemia
4812679|NCT02546739|Lymphoma|lymphoma
4812680|NCT02546739|CAR T|car t
4812681|NCT02546726|heat therapy|heat therapy
4812682|NCT02546726|steam-room|steam-room
4812683|NCT02546726|aerobic exercise|aerobic exercise
4812684|NCT02546726|hypertension|hypertension
4812685|NCT02546726|multiple behavior change|multiple behavior change
4812686|NCT02546726|lifestyle modification|lifestyle modification
4812687|NCT02546713|dental implants|dental implants
4812688|NCT02546687|Anastomotic Leak|anastomotic leak
4812689|NCT02546687|Esophagectomy Gastric Pull-up|esophagectomy gastric pull-up
4812690|NCT02546674|Chronic Myeloid Leukemia|chronic myeloid leukemia
4812691|NCT02546674|Nilotinib|nilotinib
4812692|NCT02546674|Molecular Response|molecular response
4812693|NCT02546674|MR4.5|mr4.5
4812694|NCT02546661|Durvalumab|durvalumab
4812695|NCT02546661|Olaparib|olaparib
4812696|NCT02546661|Vistusertib|vistusertib
4812697|NCT02546661|Muscle invasive bladder cancer|muscle invasive bladder cancer
4812698|NCT02546661|MIBC|mibc
4812699|NCT02546661|BISCAY|biscay
4812700|NCT02546661|MEDI4736|medi4736
4812701|NCT02546661|AZD4547|azd4547
4812702|NCT02546661|AZD2281|azd2281
4812703|NCT02546661|AZD1775|azd1775
4812704|NCT02546661|AZD2014|azd2014
4812705|NCT02546661|AZD9150|azd9150
4812706|NCT02546622|Factor|factor
4812707|NCT02546622|Coagulation|coagulation
4812708|NCT02546622|Inhibitor|inhibitor
4812709|NCT02546622|HTC|htc
4812710|NCT02546622|Bleeding|bleeding
4812711|NCT02546557|CABG|cabg
4812712|NCT02546557|Coronary Artery Bypass Grafting|coronary artery bypass grafting
4812713|NCT02546544|Linsitinib|linsitinib
4812714|NCT02546544|anti-IGF-1R/IR|anti-igf-1r/ir
4812715|NCT02546544|Ewing Sarcoma|ewing sarcoma
4812716|NCT02546544|dual IGF-1R/IR inhibition|dual igf-1r/ir inhibition
4812717|NCT02546544|Relapsed Ewing Sarcoma|relapsed ewing sarcoma
4812718|NCT02546544|Refractory Ewing Sarcoma|refractory ewing sarcoma
4812719|NCT02546544|Metastatic Ewing Sarcoma|metastatic ewing sarcoma
4812720|NCT02546518|Conductive hearing loss|conductive hearing loss
4812721|NCT02546518|Middle ear effusion|middle ear effusion
4812722|NCT02546518|Middle ear pressure equalization|middle ear pressure equalization
4812723|NCT02546505|Consumer behavior|consumer behavior
4812724|NCT02546505|Nutrition Labeling|nutrition labeling
4812725|NCT02546479|Mortality|mortality
4812726|NCT02546479|Radiation|radiation
4812727|NCT02546479|Spine deformities|spine deformities
4812728|NCT02546466|low back pain|low back pain
4812729|NCT02546466|functional taping|functional taping
4812730|NCT02546466|balance|balance
4812731|NCT02546466|posture|posture
4812732|NCT02546466|rehabilitation|rehabilitation
4812733|NCT02546466|psychosocial factors|psychosocial factors
4812734|NCT02546466|minimal intervention strategy|minimal intervention strategy
4812735|NCT02546453|high risk solid tumor pediatric, genetic alteration, Metastatic solid tumor pediatric|high risk solid tumor pediatric, genetic alteration, metastatic solid tumor pediatric
4812736|NCT02546414|Platelet count/spleen diameter ratio|platelet count/spleen diameter ratio
4812737|NCT02546414|China|china
4812738|NCT02546375|Bosutinib|bosutinib
4812739|NCT02546375|chronic myeloid leukaemia|chronic myeloid leukaemia
4812740|NCT02546375|retrospective|retrospective
4812741|NCT02546375|observational|observational
4812742|NCT02546349|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
4812743|NCT02546349|airway inflammation|airway inflammation
4812744|NCT02546349|eosinophilic airway inflammation|eosinophilic airway inflammation
4812745|NCT02546349|exhaled nitric oxide|exhaled nitric oxide
4812746|NCT02546336|Ultrasound Guidance|ultrasound guidance
4812747|NCT02546336|Cooled Radiofrequency|cooled radiofrequency
4812748|NCT02546336|Hip Denervation|hip denervation
4812749|NCT02546323|Rosuvastatin 20 mg treatment, Carotid Intima-Media Thickness, Chinese subjects, Subclinical atherosclerosis|rosuvastatin 20 mg treatment, carotid intima-media thickness, chinese subjects, subclinical atherosclerosis
4812750|NCT02546297|LAMA,ICS+LABA|lama,ics+laba
4812751|NCT02546284|CMML|cmml
4812752|NCT02546258|Fungal Nail|fungal nail
4812753|NCT02546232|locally advanced breast cancer|locally advanced breast cancer
4812754|NCT02546232|metastatic breast cancer|metastatic breast cancer
4812755|NCT02546219|eosinophilic esophagitis|eosinophilic esophagitis
4812756|NCT02546219|EoE|eoe
4812757|NCT02546219|integrins|integrins
4812758|NCT02546206|Bifidobacterium|bifidobacterium
4812759|NCT02546206|Gingivitis|gingivitis
4812760|NCT02546206|Gingival crevicular fluid|gingival crevicular fluid
4812761|NCT02546206|Interleukin-1beta|interleukin-1beta
4812762|NCT02546206|Probiotics|probiotics
4812763|NCT02546180|Patient education|patient education
4812764|NCT02546180|Preoperative anxiety|preoperative anxiety
4812765|NCT02546154|Iron|iron
4812766|NCT02546154|Anaemia|anaemia
4812767|NCT02546154|Anaemia, Iron-Deficiency|anaemia, iron-deficiency
4812768|NCT02546154|Kidney Diseases|kidney diseases
4812769|NCT02546154|Inflammatory Bowel Diseases|inflammatory bowel diseases
4812770|NCT02546154|Fatigue|fatigue
4812771|NCT02546076|Keloid|keloid
4812772|NCT02546076|Hypertrophic scars|hypertrophic scars
4812773|NCT02546076|Er-YAG Lasers|er-yag lasers
4812774|NCT02546050|Gut microbiota|gut microbiota
4812775|NCT02546050|metformin|metformin
4812776|NCT02546050|Metabolism|metabolism
4812777|NCT02546050|Metagenomics|metagenomics
4812778|NCT02546050|Metabolomics|metabolomics
4812779|NCT02546037|coagulation|coagulation
4812780|NCT02546037|haemodialysis|haemodialysis
4812781|NCT02546024|Major depressive disorder|major depressive disorder
4812782|NCT02546024|late-onset|late-onset
4812783|NCT02546024|treatment response|treatment response
4812784|NCT02546024|predictors|predictors
4812785|NCT02546024|moderators|moderators
4812786|NCT02545998|Telehealthcare|telehealthcare
4812787|NCT02545985|sirolimus|sirolimus
4812788|NCT02545985|coronary stent|coronary stent
4812789|NCT02545985|Prolim|prolim
4812790|NCT02545972|immunosuppression|immunosuppression
4812791|NCT02545959|Intrathecal Rituximab|intrathecal rituximab
4812792|NCT02545959|intrathecal chemotherapy|intrathecal chemotherapy
4812793|NCT02545959|cerebrospinal fluid|cerebrospinal fluid
4812794|NCT02545959|lumbar puncture|lumbar puncture
4812795|NCT02545959|Physiological Effects of Drugs|physiological effects of drugs
4812796|NCT02545959|Rituximab|rituximab
4812797|NCT02545946|traditional incision and drainage|traditional incision and drainage
4812798|NCT02545946|minimally invasive incision and drainage|minimally invasive incision and drainage
4812799|NCT02545946|vessel loop|vessel loop
4812800|NCT02545946|emergency department|emergency department
4812801|NCT02545946|pediatrics|pediatrics
4812802|NCT02545933|prasugrel|prasugrel
4812803|NCT02545933|ticagrelor|ticagrelor
4812804|NCT02545933|vorapaxar|vorapaxar
4812805|NCT02545920|haemodialysis|haemodialysis
4812806|NCT02545920|hypotension|hypotension
4812807|NCT02545907|Amyloidosis|amyloidosis
4812808|NCT02545907|AL Amyloidosis|al amyloidosis
4812809|NCT02545855|myAIRVO2|myairvo2
4812810|NCT02545855|high-flow nasal cannula therapy|high-flow nasal cannula therapy
4812811|NCT02545855|home oxygen therapy|home oxygen therapy
4812812|NCT02545855|HOT|hot
4812813|NCT02545790|coarctation of aorta|coarctation of aorta
4812814|NCT02545790|aortic stenosis|aortic stenosis
4812815|NCT02545790|biomarkers|biomarkers
4812816|NCT02545790|cardiac hypertrophy|cardiac hypertrophy
4812817|NCT02545777|Acute gouty arthritis|acute gouty arthritis
4812818|NCT02545777|tonifying spleen and descending the turbid|tonifying spleen and descending the turbid
4812819|NCT02545777|soaking|soaking
4812820|NCT02545777|wet wrapping|wet wrapping
4812821|NCT02545764|Gait Analysis|gait analysis
4812822|NCT02545764|Knee Adduction Moment|knee adduction moment
4812823|NCT02545764|Physiotherapy|physiotherapy
4812824|NCT02545764|Obesity|obesity
4812825|NCT02545751|Esophageal cancer|esophageal cancer
4812826|NCT02545751|Metastatic esophageal cancer|metastatic esophageal cancer
4812827|NCT02545751|Radiotherapy|radiotherapy
4812828|NCT02545751|Thymalfasin|thymalfasin
4812829|NCT02545751|ZADAXIN's®|zadaxin's®
4812830|NCT02545751|Stereotactic Body Radiation Therapy|stereotactic body radiation therapy
4812831|NCT02545725|Colorectal Cancer|colorectal cancer
4812832|NCT02545725|Quality of life|quality of life
4812833|NCT02545725|Questionnaires|questionnaires
4812834|NCT02545712|Ethanol|ethanol
4812835|NCT02545712|Propylene glycol|propylene glycol
4812836|NCT02545712|Benzyl alcohol|benzyl alcohol
4812837|NCT02545712|Acesulfam potassium|acesulfam potassium
4812838|NCT02545712|Aspartame|aspartame
4812839|NCT02545712|Glycerin|glycerin
4812840|NCT02545712|Sorbitol|sorbitol
4812841|NCT02545712|Methyl-p-hydroxybenzoate|methyl-p-hydroxybenzoate
4812842|NCT02545712|Propanyl-p-hydroxybenzoate|propanyl-p-hydroxybenzoate
4812843|NCT02545712|Patients|patients
4812844|NCT02545699|Adenoma|adenoma
4812845|NCT02545699|Polyp|polyp
4812846|NCT02545699|CRC|crc
4812847|NCT02545699|Colonoscopy|colonoscopy
4812848|NCT02545699|Detection Yield|detection yield
4812849|NCT02545673|Intervention Studies|intervention studies
4812850|NCT02545673|Access to Health Care|access to health care
4812851|NCT02545673|Social Stigma|social stigma
4812852|NCT02545673|Social Support|social support
4812853|NCT02545634|probiotic|probiotic
4812854|NCT02545634|ADHD|adhd
4812855|NCT02545634|anxiety|anxiety
4812856|NCT02545634|digestive health|digestive health
4812857|NCT02545634|children|children
4812858|NCT02545634|attention deficit|attention deficit
4812859|NCT02545634|gut brain axis|gut brain axis
4812860|NCT02545634|nutritional supplement|nutritional supplement
4812861|NCT02545634|microbiome|microbiome
4812862|NCT02545621|Receptor for advanced glycation end products (RAGE)|receptor for advanced glycation end products (rage)
4812863|NCT02545621|Acute respiratory distress syndrome (ARDS)|acute respiratory distress syndrome (ards)
4812864|NCT02545621|Monocyte/Macrophage activation|monocyte/macrophage activation
4812865|NCT02545621|Fluorescence-Activated Cell Sorting (FACS) analysis|fluorescence-activated cell sorting (facs) analysis
4812866|NCT02545621|Thioredoxin interacting protein (TXNIP)|thioredoxin interacting protein (txnip)
4812867|NCT02545621|NOD-like receptor family, pyrin domain containing 3 (NLRP3)|nod-like receptor family, pyrin domain containing 3 (nlrp3)
4812868|NCT02545621|Inflammasome|inflammasome
4812869|NCT02545595|General anaesthesia|general anaesthesia
4812870|NCT02545595|Curarization with rocuronium|curarization with rocuronium
4812871|NCT02545556|Liver Cancer|liver cancer
4812872|NCT02545556|HepaSphere|hepasphere
4812873|NCT02545556|cryosurgery|cryosurgery
4812874|NCT02545530|renal dialysis|renal dialysis
4812875|NCT02545530|hypertension|hypertension
4812876|NCT02545530|clonidine|clonidine
4812877|NCT02545504|Gastroesophageal junction (GEJ)|gastroesophageal junction (gej)
4812878|NCT02545504|Stomach cancer|stomach cancer
4812879|NCT02545491|CCD|ccd
4812880|NCT02545491|Child development|child development
4812881|NCT02545491|daycare|daycare
4812882|NCT02545491|caregiver|caregiver
4812883|NCT02545478|septic shock|septic shock
4812884|NCT02545478|infection|infection
4812885|NCT02545478|inflammation|inflammation
4812886|NCT02545478|pathologic process|pathologic process
4812887|NCT02545478|biomarkers|biomarkers
4812888|NCT02545465|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
4812889|NCT02545465|Inoperable Chronic Thromboembolic Pulmonary Hypertension|inoperable chronic thromboembolic pulmonary hypertension
4812890|NCT02545465|Persistent Chronic Thromboembolic Pulmonary Hypertension|persistent chronic thromboembolic pulmonary hypertension
4812891|NCT02545465|Recurrent Chronic Thromboembolic Pulmonary Hypertension|recurrent chronic thromboembolic pulmonary hypertension
4812892|NCT02545465|Switch of therapy|switch of therapy
4812893|NCT02545465|Titration phase|titration phase
4812894|NCT02545465|Retrospective chart review|retrospective chart review
4812895|NCT02545439|Alkermes|alkermes
4812896|NCT02545439|Samidorphan|samidorphan
4812897|NCT02545439|ALKS 5461|alks 5461
4812898|NCT02545439|Healthy Volunteer|healthy volunteer
4812899|NCT02545439|Pharmacokinetics|pharmacokinetics
4812900|NCT02545426|myocardial stunning|myocardial stunning
4812901|NCT02545426|dialysate calcium concentration|dialysate calcium concentration
4812902|NCT02545426|nutritional status|nutritional status
4812903|NCT02545426|hemodinamic|hemodinamic
4812904|NCT02545426|hemodialysis|hemodialysis
4812905|NCT02545374|chronic wound|chronic wound
4812906|NCT02545374|tablet|tablet
4812907|NCT02545374|telemedicine|telemedicine
4812908|NCT02545374|wounds consultation|wounds consultation
4812909|NCT02545374|Smartphone|smartphone
4812910|NCT02545296|In-vitro Diagnostics|in-vitro diagnostics
4812911|NCT02545296|paediatrics|paediatrics
4812912|NCT02545270|Surgery, Laparoscopic|surgery, laparoscopic
4812913|NCT02545270|surgical rating scale|surgical rating scale
4812914|NCT02545257|Aged people|aged people
4812915|NCT02545257|Home care|home care
4812916|NCT02545257|Drug related problems, DRPs|drug related problems, drps
4812917|NCT02545257|Coordinated medication management model|coordinated medication management model
4812918|NCT02545244|Gingivitis, Black Tea, Green Tea,Chlorhexidine, Biofilm,|gingivitis, black tea, green tea,chlorhexidine, biofilm,
4812919|NCT02545218|Perineum. Perineorraphy. Pelvic floor exercise.|perineum. perineorraphy. pelvic floor exercise.
4812920|NCT02545205|Rehabilitation|rehabilitation
4812921|NCT02545205|Robotics|robotics
4812922|NCT02545192|PTSD|ptsd
4812923|NCT02545166|Stroke|stroke
4812924|NCT02545166|Purines|purines
4812925|NCT02545166|SMARTChip|smartchip
4812926|NCT02545166|Ischaemia|ischaemia
4812927|NCT02545166|Carotid endarterectomy|carotid endarterectomy
4812928|NCT02545166|Biosensor|biosensor
4812929|NCT02545140|risk factors|risk factors
4812930|NCT02545140|screening|screening
4812931|NCT02545140|adolescents|adolescents
4812932|NCT02545127|inadequate milk production|inadequate milk production
4812933|NCT02545114|Hyponatremia|hyponatremia
4812934|NCT02545114|SIADH, stroke|siadh, stroke
4812935|NCT02545114|SAH; ICH|sah; ich
4812936|NCT02545114|AIS|ais
4812937|NCT02545101|Hyponatremia due to SIADH|hyponatremia due to siadh
4812938|NCT02545101|tolvaptan|tolvaptan
4812939|NCT02545088|Rehabilitation|rehabilitation
4812940|NCT02545088|Robotics|robotics
4812941|NCT02545049|Type 2 Diabetes|type 2 diabetes
4812942|NCT02545049|Kidney diseases|kidney diseases
4812943|NCT02545036|chronic kidney disease|chronic kidney disease
4812944|NCT02545036|Daycare|daycare
4813075|NCT02544256|Microcirculation|microcirculation
4812945|NCT02545036|Traditional Chinese Medicine(TCM)|traditional chinese medicine(tcm)
4812946|NCT02544984|prophylactic macrolides|prophylactic macrolides
4812947|NCT02544984|RSV|rsv
4812948|NCT02544984|chronic lung disease|chronic lung disease
4812949|NCT02544984|respiratory infections|respiratory infections
4812950|NCT02544958|Enlarged pores|enlarged pores
4812951|NCT02544958|Er:YAG laser|er:yag laser
4813354|NCT02542514|IOL|iol
4812952|NCT02544945|Radiotherapy|radiotherapy
4812953|NCT02544932|anticoagulant|anticoagulant
4812954|NCT02544932|atherosclerosis|atherosclerosis
4812955|NCT02544932|endothelium|endothelium
4812956|NCT02544919|SMOF|smof
4812957|NCT02544919|neurological complications|neurological complications
4812958|NCT02544919|neurotoxicity|neurotoxicity
4812959|NCT02544919|liver transplantation|liver transplantation
4812960|NCT02544919|Lipid emulsions|lipid emulsions
4812961|NCT02544906|recipients|recipients
4812962|NCT02544880|HNSCC|hnscc
4812963|NCT02544880|Head and Neck Squamous Cell Carcinoma|head and neck squamous cell carcinoma
4812964|NCT02544880|Tadalafil|tadalafil
4812965|NCT02544880|PDE5 Inhibition|pde5 inhibition
4812966|NCT02544880|Anti-MUC1 Vaccine|anti-muc1 vaccine
4812967|NCT02544880|Recurrent Head and Neck Squamous Cell Carcinoma|recurrent head and neck squamous cell carcinoma
4812968|NCT02544880|Recurrent HNSCC|recurrent hnscc
4812969|NCT02544880|Second primary site disease stage III|second primary site disease stage iii
4812970|NCT02544880|Second primary site disease stage IV|second primary site disease stage iv
4812971|NCT02544880|Anti-Influenza Vaccine|anti-influenza vaccine
4812972|NCT02544854|Pharmacokinetics, pharmacodynamics, propofol, pediatrics|pharmacokinetics, pharmacodynamics, propofol, pediatrics
4812973|NCT02544828|Osteoarthritis|osteoarthritis
4812974|NCT02544828|knee arthroplasty|knee arthroplasty
4812975|NCT02544828|iron|iron
4812976|NCT02544815|digoxin, eficacy, safety|digoxin, eficacy, safety
4812977|NCT02544776|pco|pco
4812978|NCT02544776|Amlodipine|amlodipine
4812979|NCT02544737|Esophageal cancer|esophageal cancer
4812980|NCT02544737|Metastatic esophageal cancer|metastatic esophageal cancer
4812981|NCT02544737|Apatinib|apatinib
4812982|NCT02544724|Relapsed|relapsed
4812983|NCT02544724|Refractory|refractory
4812984|NCT02544724|DLBCL|dlbcl
4812985|NCT02544724|Chemotherapy|chemotherapy
4812986|NCT02544711|Pelvis|pelvis
4812987|NCT02544711|Surgical resection|surgical resection
4812988|NCT02544711|Patient specific instrument|patient specific instrument
4812989|NCT02544698|vaccine|vaccine
4812990|NCT02544698|safety|safety
4812991|NCT02544685|Febrile neutropenia|febrile neutropenia
4812992|NCT02544685|Synbiotic|synbiotic
4812993|NCT02544685|Probiotic|probiotic
4812994|NCT02544685|Prebiotic|prebiotic
4812995|NCT02544685|Safety|safety
4812996|NCT02544685|Cancer|cancer
4812997|NCT02544685|Oncology|oncology
4812998|NCT02544685|Chemotherapy|chemotherapy
4812999|NCT02544685|Symbiotic|symbiotic
4813000|NCT02544659|Treatment|treatment
4813001|NCT02544659|Bisphosphonates|bisphosphonates
4813002|NCT02544659|Response rate|response rate
4813003|NCT02544646|trabeculectomy|trabeculectomy
4813004|NCT02544633|Mirati|mirati
4813005|NCT02544633|MGCD265|mgcd265
4813006|NCT02544633|MET|met
4813007|NCT02544633|NSCLC|nsclc
4813008|NCT02544607|Ketamine|ketamine
4813009|NCT02544607|Depression|depression
4813010|NCT02544607|Anxious Depression|anxious depression
4813011|NCT02544607|MRI|mri
4813012|NCT02544568|high fat|high fat
4813013|NCT02544568|high protein|high protein
4813014|NCT02544568|high carbohydrate|high carbohydrate
4813015|NCT02544568|insulin|insulin
4813016|NCT02544568|glucose|glucose
4813017|NCT02544555|Peripheral arterial disease|peripheral arterial disease
4813018|NCT02544555|Atherosclerosis|atherosclerosis
4813019|NCT02544555|Intraluminal approach|intraluminal approach
4813020|NCT02544555|Subintimal approach|subintimal approach
4813021|NCT02544542|Mild Hypothermia|mild hypothermia
4813022|NCT02544542|Hypoxic-Ischemic Encephalopathy|hypoxic-ischemic encephalopathy
4813023|NCT02544516|Schizophrenia|schizophrenia
4813024|NCT02544516|motor and sensory perceptions|motor and sensory perceptions
4813025|NCT02544490|Sepsis|sepsis
4813026|NCT02544490|MicroRNAs|micrornas
4813027|NCT02544490|Diagnosis|diagnosis
4813028|NCT02544490|Prognosis|prognosis
4813029|NCT02544464|osteoarthritis|osteoarthritis
4813030|NCT02544464|knee arthroplasty|knee arthroplasty
4813031|NCT02544464|iron|iron
4813032|NCT02544412|Mindfulness|mindfulness
4813033|NCT02544412|School Teachers|school teachers
4813034|NCT02544412|preservice teachers|preservice teachers
4813035|NCT02544412|teacher education|teacher education
4813036|NCT02544399|Bone microarchitecture|bone microarchitecture
4813037|NCT02544399|Playing golf|playing golf
4813038|NCT02544399|Walkers|walkers
4813039|NCT02544386|bone microarchitecture|bone microarchitecture
4813040|NCT02544386|hemiplegia|hemiplegia
4813041|NCT02544373|OSA|osa
4813042|NCT02544373|Obstructive Sleep Apnea|obstructive sleep apnea
4813043|NCT02544373|Cognition|cognition
4813044|NCT02544373|Cognitive Dysfunction|cognitive dysfunction
4813045|NCT02544373|Memory|memory
4813046|NCT02544373|Positive Aiway Pressure|positive aiway pressure
4813047|NCT02544373|CPAP|cpap
4813048|NCT02544373|MS|ms
4813049|NCT02544360|photoaging mobile apps|photoaging mobile apps
4813050|NCT02544360|adolescent smoking|adolescent smoking
4813051|NCT02544360|tobacco prevention|tobacco prevention
4813052|NCT02544360|school-based prevention|school-based prevention
4813053|NCT02544360|adolescent health|adolescent health
4813054|NCT02544360|school health|school health
4813055|NCT02544360|smoking|smoking
4813056|NCT02544360|tobacco|tobacco
4813059|NCT02544347|diabetes mellitus|diabetes mellitus
4813060|NCT02544347|chronic periodontitis|chronic periodontitis
4813061|NCT02544347|tumor-necrosis factor alfa|tumor-necrosis factor alfa
4813062|NCT02544347|gingival crevicular fluid|gingival crevicular fluid
4813063|NCT02544334|Rheumatoid arthritis|rheumatoid arthritis
4813064|NCT02544334|Metagenome|metagenome
4813065|NCT02544334|microbiome|microbiome
4813066|NCT02544308|Solitary, Bone|solitary, bone
4813067|NCT02544282|Analgesics|analgesics
4813068|NCT02544282|Opioid|opioid
4813069|NCT02544282|Mastectomy|mastectomy
4813070|NCT02544282|Segmental Mastectomy|segmental mastectomy
4813071|NCT02544282|Pecs II|pecs ii
4813072|NCT02544269|Lumbosacral plexus blockade|lumbosacral plexus blockade
4813073|NCT02544269|Continuous spinal anesthesia|continuous spinal anesthesia
4813074|NCT02544269|Hemodynamics|hemodynamics
4813076|NCT02544256|Mild Hypothermia, Induced|mild hypothermia, induced
4813077|NCT02544256|Subarachnoid Hemorrhage, Aneurysmal|subarachnoid hemorrhage, aneurysmal
4813078|NCT02544256|Aneurysmal Clipping|aneurysmal clipping
4813079|NCT02544256|Vasospasms|vasospasms
4813080|NCT02544230|granulocyte transfusions|granulocyte transfusions
4813081|NCT02544191|azoospermia nonobstructive|azoospermia nonobstructive
4813082|NCT02544191|male infertility|male infertility
4813083|NCT02544178|radiotherapy|radiotherapy
4813084|NCT02544178|neurocognitive defect|neurocognitive defect
4813085|NCT02544178|leukoencephalopathy|leukoencephalopathy
4813086|NCT02544165|smoking|smoking
4813087|NCT02544165|caffeine intake|caffeine intake
4813088|NCT02544165|haemodynamic parameters|haemodynamic parameters
4813089|NCT02544165|Advanced Glycation End Products (AGEs)|advanced glycation end products (ages)
4813090|NCT02544165|Non-invasive measurements devices|non-invasive measurements devices
4813091|NCT02544087|fire-heat syndrome|fire-heat syndrome
4813092|NCT02544087|blood stasis syndrome|blood stasis syndrome
4813093|NCT02544087|method of clearing heat|method of clearing heat
4813094|NCT02544087|method of promoting blood circulation|method of promoting blood circulation
4813095|NCT02544048|Immune|immune
4813096|NCT02544048|Parasitemia|parasitemia
4813097|NCT02544048|Menactra|menactra
4813098|NCT02544048|Polymerase Chain Reaction (PCR)|polymerase chain reaction (pcr)
4813099|NCT02544048|Coartem|coartem
4813100|NCT02544035|Childhood Growth and Development|childhood growth and development
4813101|NCT02544035|Development|development
4813102|NCT02544022|Pain Scale|pain scale
4813104|NCT02544022|Tool Validation|tool validation
4813105|NCT02544022|Cognitive Interviews|cognitive interviews
4813106|NCT02544009|Energy Expenditure|energy expenditure
4813107|NCT02544009|Obesity|obesity
4813108|NCT02544009|Behavioral Weight Loss Treatment|behavioral weight loss treatment
4813109|NCT02543996|Sample Collection|sample collection
4813110|NCT02543996|Laboratory Research Specimens|laboratory research specimens
4813111|NCT02543996|Biospecimen Procurement|biospecimen procurement
4813112|NCT02543996|Rare Diseases|rare diseases
4813113|NCT02543983|Neurobiology|neurobiology
4813114|NCT02543983|Suicide|suicide
4813115|NCT02543983|Ketamine|ketamine
4813116|NCT02543983|Major Depression Disorder|major depression disorder
4813117|NCT02543983|Biomarkers|biomarkers
4813118|NCT02543957|ERCP|ercp
4813119|NCT02543957|Cholangitis|cholangitis
4813120|NCT02543957|Bacteremia|bacteremia
4813121|NCT02543957|Antibiotics|antibiotics
4813122|NCT02543931|turmeric|turmeric
4813123|NCT02543931|curcumin|curcumin
4813124|NCT02543931|curcuminoids|curcuminoids
4813125|NCT02543931|arthritis|arthritis
4813126|NCT02543931|methotrexate|methotrexate
4813127|NCT02543892|Vaccine|vaccine
4813128|NCT02543879|AML|aml
4813129|NCT02543879|BET Inhibitor|bet inhibitor
4813130|NCT02543879|FT-1101|ft-1101
4813131|NCT02543879|Acute Leukemia|acute leukemia
4813132|NCT02543879|Myelodysplastic Syndrome|myelodysplastic syndrome
4813133|NCT02543879|NHL|nhl
4813134|NCT02543879|Non-Hodgkin Lymphoma|non-hodgkin lymphoma
4813135|NCT02543840|Quality Improvement|quality improvement
4813136|NCT02543840|Organization of Services|organization of services
4813137|NCT02543840|Implementation|implementation
4813138|NCT02543827|Vaccine|vaccine
4813139|NCT02543827|Recurrent Urinary Tract Infections (RUTI)|recurrent urinary tract infections (ruti)
4813140|NCT02543788|optic neuritis|optic neuritis
4813141|NCT02543788|vision|vision
4813142|NCT02543788|quality of life|quality of life
4813143|NCT02543788|pathophysiology|pathophysiology
4813144|NCT02543775|Cervical Cancer|cervical cancer
4813145|NCT02543775|Sentinel Lymph Node|sentinel lymph node
4813146|NCT02543775|Lymphadenectomy|lymphadenectomy
4813147|NCT02543762|Chromoendoscopy|chromoendoscopy
4813148|NCT02543762|Ulcerative Colitis|ulcerative colitis
4813149|NCT02543762|Crohn disease|crohn disease
4813150|NCT02543762|Colorectal Neoplasia|colorectal neoplasia
4813151|NCT02543749|CML|cml
4813152|NCT02543749|DC vaccine|dc vaccine
4813153|NCT02543723|medication adherence, telehealth strategies, nurse coaching|medication adherence, telehealth strategies, nurse coaching
4813154|NCT02543684|glycemic response|glycemic response
4813155|NCT02543684|diabetes|diabetes
4813156|NCT02543684|insulinemic response|insulinemic response
4813157|NCT02543684|mixed meals|mixed meals
4813158|NCT02543684|glycemic index|glycemic index
4813159|NCT02543671|vitamin D status|vitamin d status
4813453|NCT02541864|Eradication|eradication
4813160|NCT02543671|25-hydroxyvitamin D|25-hydroxyvitamin d
4813161|NCT02543671|cheese|cheese
4813162|NCT02543671|Randomized controlled trial|randomized controlled trial
4813163|NCT02543671|postmenopausal women|postmenopausal women
4813164|NCT02543671|enriched|enriched
4813165|NCT02543671|vitamin D3|vitamin d3
4813166|NCT02543658|Acute Pancreatitis|acute pancreatitis
4813167|NCT02543658|Intra-abdominal hypertension|intra-abdominal hypertension
4813168|NCT02543658|Abdominal compartment syndrome|abdominal compartment syndrome
4813169|NCT02543658|Curative Effect|curative effect
4813170|NCT02543658|Security|security
4813171|NCT02543658|Neostigmine|neostigmine
4813172|NCT02543632|heart failure|heart failure
4813173|NCT02543632|parachute|parachute
4813174|NCT02543632|partitioning device|partitioning device
4813175|NCT02543593|tDCS|tdcs
4813176|NCT02543580|mastectomy|mastectomy
4813177|NCT02543580|transcutaneous electrical acupoint stimulation|transcutaneous electrical acupoint stimulation
4813178|NCT02543580|acute pain|acute pain
4813179|NCT02543580|chronic pain|chronic pain
4813180|NCT02543567|Ebola viruses|ebola viruses
4813181|NCT02543567|Ebola virus disease (EVD)|ebola virus disease (evd)
4813182|NCT02543567|Filoviruses|filoviruses
4813183|NCT02543567|Monovalent vaccine|monovalent vaccine
4813184|NCT02543567|Safety|safety
4813185|NCT02543567|Immunogenicity|immunogenicity
4813186|NCT02543567|Ebola vaccine|ebola vaccine
4813187|NCT02543567|Human adenovirus serotype 26 (Ad26) expressing the Ebola virus Mayinga variant glycoprotein (Ad26.ZEBOV)|human adenovirus serotype 26 (ad26) expressing the ebola virus mayinga variant glycoprotein (ad26.zebov)
4813188|NCT02543567|Modified Vaccinia Virus Ankara ‐ Bavarian Nordic Filo‐vector (MVA‐BN Filo)|modified vaccinia virus ankara ‐ bavarian nordic filo‐vector (mva‐bn filo)
4813189|NCT02543567|Healthy participants|healthy participants
4813190|NCT02543541|Palliative Care|palliative care
4813191|NCT02543541|Supportive Care|supportive care
4813192|NCT02543541|Caregiver|caregiver
4813193|NCT02543541|Phase I|phase i
4813194|NCT02543515|following hysteroscopy|following hysteroscopy
4813195|NCT02543502|Periodontitis|periodontitis
4813196|NCT02543502|atherosclerosis|atherosclerosis
4813197|NCT02543502|Heart Disease|heart disease
4813198|NCT02543476|PD-L1 status, biomarkers, prevalence, SCCHN, overall survival|pd-l1 status, biomarkers, prevalence, scchn, overall survival
4813199|NCT02543450|Chronic stroke|chronic stroke
4813200|NCT02543450|Participation|participation
4813201|NCT02543450|Walking ability|walking ability
4813202|NCT02543385|S Ketamine|s ketamine
4813203|NCT02543385|Morphine|morphine
4813204|NCT02543385|Consumption|consumption
4813205|NCT02543372|concerned significant other|concerned significant other
4813206|NCT02543372|problem gambling|problem gambling
4813207|NCT02543372|internet-delivered cognitive-behavioral therapy|internet-delivered cognitive-behavioral therapy
4813208|NCT02543372|behavioral couples therapy|behavioral couples therapy
4813209|NCT02543359|Training|training
4813210|NCT02543359|Implementation|implementation
4813211|NCT02543359|Community-Based Mental Health Services|community-based mental health services
4813212|NCT02543359|Parent-Child Interaction Therapy|parent-child interaction therapy
4813213|NCT02543359|Children|children
4813214|NCT02543333|Acute Asthma,|acute asthma,
4813215|NCT02543320|Head and Neck Cancer|head and neck cancer
4813216|NCT02543320|LORETA|loreta
4813217|NCT02543320|Low Resolution Electromagnetic Tomography|low resolution electromagnetic tomography
4813218|NCT02543320|Pain|pain
4813219|NCT02543320|Radiotherapy|radiotherapy
4813220|NCT02543320|Electroencephalograph|electroencephalograph
4813222|NCT02543320|Questionnaires|questionnaires
4813223|NCT02543320|Surveys|surveys
4813224|NCT02543320|Neurofeedback training|neurofeedback training
4813225|NCT02543307|Hip Replacement|hip replacement
4813226|NCT02543307|Spinal Diseases|spinal diseases
4813227|NCT02543307|Rotator Cuff Reconstruction|rotator cuff reconstruction
4813228|NCT02543307|Nursing|nursing
4813229|NCT02543307|Nurse-led|nurse-led
4813230|NCT02543307|Pathways|pathways
4813231|NCT02543307|Patient Satisfaction|patient satisfaction
4813232|NCT02543307|Quality of Nursing Care|quality of nursing care
4813233|NCT02543294|Heart Failure|heart failure
4813234|NCT02543294|Echocardiogram|echocardiogram
4813235|NCT02543294|ECHO|echo
4813236|NCT02543294|Electrocardiogram|electrocardiogram
4813237|NCT02543294|ECG|ecg
4813238|NCT02543294|Questionnaire|questionnaire
4813239|NCT02543294|Survey|survey
4813240|NCT02543294|Telephone Follow-Up|telephone follow-up
4813241|NCT02543294|HF|hf
4813242|NCT02543294|Cancer treatment induced left ventricular dysfunction|cancer treatment induced left ventricular dysfunction
4813243|NCT02543294|CILVD|cilvd
4813244|NCT02543294|Left ventricular ejection fraction|left ventricular ejection fraction
4813245|NCT02543294|LVEF|lvef
4813246|NCT02543268|Ebola viruses|ebola viruses
4813247|NCT02543268|Ebola virus disease (EVD)|ebola virus disease (evd)
4813248|NCT02543268|Filoviruses|filoviruses
4813249|NCT02543268|Monovalent vaccine|monovalent vaccine
4813250|NCT02543268|Safety|safety
4813251|NCT02543268|Immunogenicity|immunogenicity
4813252|NCT02543268|Human adenovirus serotype 26 (Ad26) expressing the Ebola virus Mayinga variant glycoprotein (Ad26.ZEBOV)|human adenovirus serotype 26 (ad26) expressing the ebola virus mayinga variant glycoprotein (ad26.zebov)
4813352|NCT02542540|muscular strength|muscular strength
4813353|NCT02542514|PCNSL|pcnsl
4813253|NCT02543268|Modified Vaccinia Virus Ankara ‐ Bavarian Nordic Filo‐vector (MVA‐BN Filo)|modified vaccinia virus ankara ‐ bavarian nordic filo‐vector (mva‐bn filo)
4813254|NCT02543268|Healthy participants|healthy participants
4813255|NCT02543255|High risk|high risk
4813256|NCT02543242|Urinary Incontinence|urinary incontinence
4813257|NCT02543242|Stress Urinary Incontinence|stress urinary incontinence
4813258|NCT02543242|Urge Incontinence|urge incontinence
4813259|NCT02543242|Mixed Urinary Incontience|mixed urinary incontience
4813260|NCT02543242|Female Pelvic Health|female pelvic health
4813261|NCT02543216|fatty acids, FADS gene, genotype, diet|fatty acids, fads gene, genotype, diet
4813262|NCT02543203|Relaxation|relaxation
4813263|NCT02543190|Care Transition|care transition
4813264|NCT02543190|Readmission|readmission
4813265|NCT02543190|Rehospitalization|rehospitalization
4813266|NCT02543177|NSTEMI, CKD|nstemi, ckd
4813267|NCT02543164|Glycemic Index|glycemic index
4813268|NCT02543164|glycemic response|glycemic response
4813269|NCT02543151|Biliary stricture|biliary stricture
4813270|NCT02543151|Cholangioscopy|cholangioscopy
4813271|NCT02543151|Spyglass|spyglass
4813272|NCT02543151|Liver transplant|liver transplant
4813273|NCT02543125|very low birth weight|very low birth weight
4813274|NCT02543125|respiratory distress|respiratory distress
4813275|NCT02543125|NHFOV|nhfov
4813276|NCT02543125|NIPPV|nippv
4813277|NCT02543099|endothelial function|endothelial function
4813278|NCT02543099|policosanol|policosanol
4813279|NCT02543099|efficacy|efficacy
4813280|NCT02543099|safety|safety
4813281|NCT02543086|Phase 1, malaria, inoculum, P. falciparum, KAE609, Piperaquine|phase 1, malaria, inoculum, p. falciparum, kae609, piperaquine
4813282|NCT02543021|Colitis|colitis
4813283|NCT02543021|Dysplasia|dysplasia
4813284|NCT02543021|Chromoendoscopy|chromoendoscopy
4813285|NCT02543008|Asymptomatic individuals|asymptomatic individuals
4813286|NCT02542982|tDCS|tdcs
4813287|NCT02542982|motor recovery|motor recovery
4813288|NCT02542956|Tummy tuck (abdominoplasty)|tummy tuck (abdominoplasty)
4813289|NCT02542956|Breast Surgery|breast surgery
4813290|NCT02542930|Non-small cell lung cancer|non-small cell lung cancer
4813291|NCT02542930|Metastatic Non-small cell lung cancer|metastatic non-small cell lung cancer
4813292|NCT02542930|Radiotherapy|radiotherapy
4813293|NCT02542930|Thymalfasin|thymalfasin
4813294|NCT02542930|ZADAXIN's®|zadaxin's®
4813295|NCT02542891|e-health|e-health
4813296|NCT02542891|depressive disorder|depressive disorder
4813297|NCT02542891|cost-effectiveness|cost-effectiveness
4813298|NCT02542891|Cognitive behavioral treatment|cognitive behavioral treatment
4813299|NCT02542878|myofascial release|myofascial release
4813300|NCT02542878|back extensors endurance|back extensors endurance
4813301|NCT02542878|foam roller|foam roller
4813302|NCT02542878|sport|sport
4813303|NCT02542852|HIV-1|hiv-1
4813304|NCT02542839|Botulinum Toxin|botulinum toxin
4813305|NCT02542839|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
4813306|NCT02542826|Pulmonary Rehabilitation|pulmonary rehabilitation
4813307|NCT02542826|3-minute constant rate shuttle walk test|3-minute constant rate shuttle walk test
4813308|NCT02542826|3-minute constant rate step test|3-minute constant rate step test
4813309|NCT02542826|Dyspnea|dyspnea
4813310|NCT02542813|Pharmacokinetics|pharmacokinetics
4813311|NCT02542813|safety|safety
4813312|NCT02542813|tolerability|tolerability
4813313|NCT02542813|oxytocin|oxytocin
4813314|NCT02542787|MS|ms
4813315|NCT02542787|Spasticity|spasticity
4813316|NCT02542787|VSN16R|vsn16r
4813317|NCT02542774|Diabetes mellitus|diabetes mellitus
4813318|NCT02542774|Stroke|stroke
4813319|NCT02542774|Myocardial infarction|myocardial infarction
4813320|NCT02542774|Stable angina pectoris|stable angina pectoris
4813321|NCT02542774|Heart failure|heart failure
4813322|NCT02542774|Quality of care|quality of care
4813323|NCT02542748|norepinephrine|norepinephrine
4813324|NCT02542748|ephedrine|ephedrine
4813325|NCT02542722|lifestyle modification|lifestyle modification
4813326|NCT02542722|olive oil|olive oil
4813327|NCT02542722|Mediterranean diet|mediterranean diet
4813328|NCT02542683|congenital heart diseases|congenital heart diseases
4813329|NCT02542683|cognition|cognition
4813330|NCT02542683|adaptive behavior|adaptive behavior
4813331|NCT02542683|physical activity|physical activity
4813332|NCT02542683|neurodevelopment|neurodevelopment
4813333|NCT02542644|Fuchs' Endothelial Dystrophy, DMEK|fuchs' endothelial dystrophy, dmek
4813334|NCT02542618|Depression|depression
4813335|NCT02542618|Treatment|treatment
4813336|NCT02542618|IBSR|ibsr
4813337|NCT02542618|CBT|cbt
4813338|NCT02542605|Migraine|migraine
4813339|NCT02542605|Headache|headache
4813340|NCT02542605|Migraine Headache|migraine headache
4813341|NCT02542605|Headache, Migraine|headache, migraine
4813342|NCT02542605|Amgen|amgen
4813343|NCT02542592|Glucocorticoids|glucocorticoids
4813344|NCT02542592|Immune Signaling|immune signaling
4813345|NCT02542592|Recovery|recovery
4813346|NCT02542592|Hip arthroplasty, total|hip arthroplasty, total
4813347|NCT02542579|Helicobacter pylori|helicobacter pylori
4813348|NCT02542579|Dyspepsia|dyspepsia
4813349|NCT02542540|Osteogenesis Imperfecta|osteogenesis imperfecta
4813350|NCT02542540|physical exercise training|physical exercise training
4813351|NCT02542540|Wii|wii
4813355|NCT02542462|mechanisms for intussusception|mechanisms for intussusception
4813356|NCT02542462|rotavirus vaccine|rotavirus vaccine
4813357|NCT02542449|Green tea|green tea
4813358|NCT02542449|weight maintenance|weight maintenance
4813359|NCT02542449|obesity|obesity
4813360|NCT02542449|fat mass|fat mass
4813361|NCT02542384|abdominal surgery|abdominal surgery
4813362|NCT02542384|laparoscopy|laparoscopy
4813363|NCT02542384|Hysterectomy|hysterectomy
4813364|NCT02542384|Prostatectomy|prostatectomy
4813365|NCT02542384|Hemi-colectomy|hemi-colectomy
4813366|NCT02542384|Ventral Hernia repair|ventral hernia repair
4813367|NCT02542384|CR845|cr845
4813368|NCT02542384|analgesic|analgesic
4813369|NCT02542384|kappa opioid|kappa opioid
4813370|NCT02542384|partial bowel resection|partial bowel resection
4813371|NCT02542371|HIV|hiv
4813372|NCT02542371|Atherosclerosis|atherosclerosis
4813373|NCT02542371|Tilmanocept|tilmanocept
4813374|NCT02542345|Cardiac Multislice CT|cardiac multislice ct
4813375|NCT02542345|MRI coronarography|mri coronarography
4813376|NCT02542332|lung cancer screening|lung cancer screening
4813377|NCT02542332|statistical background|statistical background
4813378|NCT02542306|Blood loss|blood loss
4813379|NCT02542306|coagulopathy|coagulopathy
4813380|NCT02542306|fibrinogen concentrate|fibrinogen concentrate
4813381|NCT02542306|transfusion|transfusion
4813382|NCT02542293|NSCLC|nsclc
4813383|NCT02542293|PDL1|pdl1
4813384|NCT02542293|MEDI4736|medi4736
4813385|NCT02542293|Durvalumab|durvalumab
4813386|NCT02542293|Tremelimumab|tremelimumab
4813387|NCT02542293|OS|os
4813388|NCT02542267|Bare Metal Stent|bare metal stent
4813389|NCT02542267|In-Stent Restenosis|in-stent restenosis
4813390|NCT02542241|Open abdomen|open abdomen
4813391|NCT02542241|hypertonic saline solution|hypertonic saline solution
4813392|NCT02542241|intensive care|intensive care
4813393|NCT02542228|Immune Deficiency, antibody|immune deficiency, antibody
4813394|NCT02542228|Quality of Life survey|quality of life survey
4813395|NCT02542176|Metabolic Syndrome|metabolic syndrome
4813396|NCT02542176|Grape|grape
4813397|NCT02542176|HDL|hdl
4813398|NCT02542176|Lipoproteins|lipoproteins
4813399|NCT02542137|Small cell lung cancer|small cell lung cancer
4813400|NCT02542137|Metastatic small cell lung cancer|metastatic small cell lung cancer
4813401|NCT02542137|ZADAXIN|zadaxin
4813402|NCT02542137|radiotherapy|radiotherapy
4813403|NCT02542137|Thymalfasin|thymalfasin
4813404|NCT02542124|CTCL|ctcl
4813405|NCT02542124|Total Skin Electron Beam Therapy (TSEBT)|total skin electron beam therapy (tsebt)
4813406|NCT02542124|Mycosis fungoides|mycosis fungoides
4813407|NCT02542124|Sézary syndrome|sézary syndrome
4813408|NCT02542124|recombinant human Interleukin-12 (rHuIL-12)|recombinant human interleukin-12 (rhuil-12)
4813409|NCT02542124|T Cell|t cell
4813410|NCT02542111|diffuse large b-cell lymphoma|diffuse large b-cell lymphoma
4813411|NCT02542085|incisional hernia|incisional hernia
4813412|NCT02542085|laparoscopic repair|laparoscopic repair
4813413|NCT02542085|hybrid repair|hybrid repair
4813414|NCT02542085|seroma|seroma
4813415|NCT02542085|recurrent hernia|recurrent hernia
4813416|NCT02542033|postprandial glycemia; apple juice; sugar reduction; glucose oxidase|postprandial glycemia; apple juice; sugar reduction; glucose oxidase
4813417|NCT02542007|intracoronary stent|intracoronary stent
4813418|NCT02542007|drug eluting stent|drug eluting stent
4813419|NCT02542007|sirolimus|sirolimus
4813420|NCT02542007|endothelial progenitor cells|endothelial progenitor cells
4813421|NCT02541981|Heart transplant|heart transplant
4813422|NCT02541981|renal insufficiency|renal insufficiency
4813423|NCT02541955|Rheumatoid arthritis (RA)|rheumatoid arthritis (ra)
4813424|NCT02541955|Musculoskeletal ultrasound (MSUS)|musculoskeletal ultrasound (msus)
4813425|NCT02541929|Alzheimer's disease|alzheimer's disease
4813426|NCT02541929|Docosahexaenoic acid|docosahexaenoic acid
4813427|NCT02541929|brain health|brain health
4813428|NCT02541929|memory|memory
4813429|NCT02541929|fish oil|fish oil
4813430|NCT02541929|cognition|cognition
4813431|NCT02541929|DHA|dha
4813432|NCT02541929|omega 3 fatty acid|omega 3 fatty acid
4813433|NCT02541929|brain|brain
4813434|NCT02541916|Transplantation Tolerance|transplantation tolerance
4813435|NCT02541916|Immune Tolerance|immune tolerance
4813436|NCT02541916|Transplantation|transplantation
4813437|NCT02541916|Liver Transplantation|liver transplantation
4813438|NCT02541916|Biological Markers|biological markers
4813439|NCT02541916|Gene Expression|gene expression
4813440|NCT02541916|Immunosuppression|immunosuppression
4813441|NCT02541916|Immunology|immunology
4813442|NCT02541916|Multiplex Polymerase Chain Reaction|multiplex polymerase chain reaction
4813443|NCT02541916|Real-Time Polymerase Chain Reaction|real-time polymerase chain reaction
4813444|NCT02541903|Epidermal growth factor receptor (EGFR),|epidermal growth factor receptor (egfr),
4813445|NCT02541903|Human Papillomavirus (HPV)|human papillomavirus (hpv)
4813446|NCT02541903|Penile squamous cell carcinoma (PSCC)|penile squamous cell carcinoma (pscc)
4813447|NCT02541903|Gilotrif|gilotrif
4813448|NCT02541890|Rehabilitation|rehabilitation
4813449|NCT02541890|Return to Work|return to work
4813450|NCT02541864|Helicobacter pylori|helicobacter pylori
4813451|NCT02541864|Hybrid therapy|hybrid therapy
4813452|NCT02541864|Bismuth containing quadruple therapy|bismuth containing quadruple therapy
4813454|NCT02541838|Autonomic Neuropathy|autonomic neuropathy
4813455|NCT02541838|diabetes|diabetes
4813456|NCT02541838|balance control|balance control
4813457|NCT02541825|transjugular intrahepatic portosystemic shunt|transjugular intrahepatic portosystemic shunt
4813458|NCT02541812|Obsessive-Compulsive Disorder|obsessive-compulsive disorder
4813459|NCT02541812|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
4813460|NCT02541812|Error processing|error processing
4813461|NCT02541799|informed consent|informed consent
4813462|NCT02541799|telemedicine|telemedicine
4813463|NCT02541799|research methods|research methods
4813464|NCT02541786|dexlansoprazole MR|dexlansoprazole mr
4813465|NCT02541786|rabeprazole|rabeprazole
4813466|NCT02541786|Helicobacter pylori|helicobacter pylori
4813467|NCT02541786|triple therapy|triple therapy
4813468|NCT02541773|Chronic Heart Failure|chronic heart failure
4813469|NCT02541773|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
4813470|NCT02541773|Vascular Biomarker|vascular biomarker
4813472|NCT02541773|Extracellular Matrix|extracellular matrix
4813473|NCT02541773|Brain Natruetic Peptide|brain natruetic peptide
4813474|NCT02541773|Growth Degradation Factor-15|growth degradation factor-15
4813475|NCT02541773|Body Composition|body composition
4813476|NCT02541734|SPECT|spect
4813477|NCT02541734|radiopeptides|radiopeptides
4813478|NCT02541734|gelofusine|gelofusine
4813479|NCT02541734|Beta cell|beta cell
4813480|NCT02541695|Experimental challenge trial|experimental challenge trial
4813481|NCT02541669|Drug therapy|drug therapy
4813482|NCT02541656|Preload dependence indices|preload dependence indices
4813483|NCT02541656|pulse pressure variation|pulse pressure variation
4813484|NCT02541656|plethysmographic waveform of pulse oximetry variation|plethysmographic waveform of pulse oximetry variation
4813485|NCT02541656|stroke volume variation|stroke volume variation
4813486|NCT02541656|laparoscopy|laparoscopy
4813487|NCT02541656|pneumoperitoneum|pneumoperitoneum
4813488|NCT02541643|Relapsed/Refractory Multiple Myeloma|relapsed/refractory multiple myeloma
4813489|NCT02541630|Mindfulness|mindfulness
4813490|NCT02541591|post cardiac arrest|post cardiac arrest
4813491|NCT02541591|hemodynamics|hemodynamics
4813492|NCT02541578|stroke, acute; gait, complexity|stroke, acute; gait, complexity
4813493|NCT02541552|Knee arthroscopy|knee arthroscopy
4813494|NCT02541552|Quadriceps weakness|quadriceps weakness
4813495|NCT02541552|ropivacaine|ropivacaine
4813496|NCT02541552|saphenous nerve block|saphenous nerve block
4813497|NCT02541552|Adductor canal|adductor canal
4813498|NCT02541526|amphetamine type stimulant dependence|amphetamine type stimulant dependence
4813499|NCT02541526|mirtazepine|mirtazepine
4813500|NCT02541513|paliparidone|paliparidone
4813501|NCT02541513|amphetamine type stimulant dependence|amphetamine type stimulant dependence
4813502|NCT02541500|minocycline|minocycline
4813503|NCT02541500|amphetamine type stimulant dependence|amphetamine type stimulant dependence
4813504|NCT02541474|Controlled trial|controlled trial
4813505|NCT02541474|Matched|matched
4813506|NCT02541474|Before-After design|before-after design
4813507|NCT02541474|Prospective|prospective
4813508|NCT02541474|complex interventions|complex interventions
4813509|NCT02541461|Body composition measurement|body composition measurement
4813510|NCT02541461|Lipid profile|lipid profile
4813511|NCT02541461|Weight loss|weight loss
4813512|NCT02541461|Gastrectomy|gastrectomy
4813513|NCT02541435|Radiotherapy|radiotherapy
4813514|NCT02541435|Biological markers|biological markers
4813515|NCT02541435|Magnetic resonance imaging|magnetic resonance imaging
4813516|NCT02541435|Echocardiography|echocardiography
4813517|NCT02541435|Tomography, X-Ray Computed|tomography, x-ray computed
4813518|NCT02541435|Risk factors|risk factors
4813519|NCT02541435|Heart|heart
4813520|NCT02541435|Quality of Life|quality of life
4813521|NCT02541409|directly observed therapy|directly observed therapy
4813522|NCT02541409|sofosbuvir|sofosbuvir
4813523|NCT02541409|ribavirin|ribavirin
4813524|NCT02541409|pegylated interferon|pegylated interferon
4813525|NCT02541409|resource-limited setting|resource-limited setting
4813526|NCT02541396|Bunion|bunion
4813527|NCT02541396|Bunionectomy|bunionectomy
4813528|NCT02541383|Untreated Multiple Myeloma|untreated multiple myeloma
4813529|NCT02541383|daratumumab|daratumumab
4813530|NCT02541357|Colorectal Surgery|colorectal surgery
4813531|NCT02541331|IgE-dependent asthma|ige-dependent asthma
4813532|NCT02541318|peri-menopausal women|peri-menopausal women
4813533|NCT02541318|sleep disturbances|sleep disturbances
4813534|NCT02541318|Dao-in exercise|dao-in exercise
4813535|NCT02541318|body constitution|body constitution
4813536|NCT02541305|falls prevention|falls prevention
4813537|NCT02541305|proprioception|proprioception
4813538|NCT02541305|physical condition|physical condition
4813539|NCT02541266|Imaging|imaging
4813540|NCT02541266|Questionnaire|questionnaire
4813541|NCT02541240|resilience|resilience
4813542|NCT02541240|optimism|optimism
4813543|NCT02541240|stress|stress
4813544|NCT02541240|coping|coping
4813545|NCT02541240|curriculum|curriculum
4813546|NCT02541201|Plant sterols|plant sterols
4813547|NCT02541201|Low-Density Lipoprotein Cholesterol|low-density lipoprotein cholesterol
4813548|NCT02541201|Phytosterols|phytosterols
4813549|NCT02541188|Breast cancer|breast cancer
4813550|NCT02541175|Electrocardiography|electrocardiography
4813551|NCT02541175|Automation|automation
4813552|NCT02541175|Arrhythmias, Cardiac|arrhythmias, cardiac
4813553|NCT02541175|Atrial Fibrillation|atrial fibrillation
4813554|NCT02541175|Atrial Flutter|atrial flutter
4813555|NCT02541175|Atrial Premature Complexes|atrial premature complexes
4813556|NCT02541175|Esophagus|esophagus
4813557|NCT02541136|exercise|exercise
4813558|NCT02541136|resilience|resilience
4813559|NCT02541136|physiotherapy|physiotherapy
4813560|NCT02541136|fMRI|fmri
4813561|NCT02541123|Traumatic Brain Injury|traumatic brain injury
4813562|NCT02541123|Head Injury|head injury
4813563|NCT02541084|Age-related macular degeneration|age-related macular degeneration
4813564|NCT02541084|Caregiver burden|caregiver burden
4813565|NCT02541084|Anti-vascular endothelial growth factor (VEGF) therapy|anti-vascular endothelial growth factor (vegf) therapy
4813566|NCT02541058|Velocardiofacial Syndrome|velocardiofacial syndrome
4813567|NCT02541058|Shprintzen Syndrome|shprintzen syndrome
4813568|NCT02541058|Conotruncal Defects|conotruncal defects
4813569|NCT02541058|Chromosomal Abnormalities|chromosomal abnormalities
4813570|NCT02541058|22q, 22q.11.2|22q, 22q.11.2
4813571|NCT02541058|deletion|deletion
4813572|NCT02541058|duplication|duplication
4813573|NCT02541045|non-alcoholic steatohepatitis|non-alcoholic steatohepatitis
4813574|NCT02541045|metadoxine|metadoxine
4813575|NCT02541045|efficacy|efficacy
4813576|NCT02541045|therapy|therapy
4813577|NCT02541019|C23.888.821.712.700|c23.888.821.712.700
4813578|NCT02541006|FEV1|fev1
4813579|NCT02541006|FVC|fvc
4813580|NCT02541006|AUC 0-24|auc 0-24
4813581|NCT02541006|bronchodilator efficacy|bronchodilator efficacy
4813582|NCT02541006|tiotropium|tiotropium
4813583|NCT02540993|Type 2 Diabetes|type 2 diabetes
4813584|NCT02540993|Kidney diseases|kidney diseases
4813585|NCT02540967|Contrast enhancement in the following MR imaging|contrast enhancement in the following mr imaging
4813586|NCT02540967|Brain and spine|brain and spine
4813587|NCT02540967|Body and extremities|body and extremities
4813588|NCT02540967|Gadobutrol|gadobutrol
4813589|NCT02540954|Age-related macular degeneration (AMD)|age-related macular degeneration (amd)
4813590|NCT02540954|Eylea treatment|eylea treatment
4813591|NCT02540954|Treat and Extend|treat and extend
4813592|NCT02540954|Intravitreal|intravitreal
4813593|NCT02540902|Knee replacement|knee replacement
4813594|NCT02540902|Knee arthroplasty|knee arthroplasty
4813595|NCT02540902|All-polyethylene tibia|all-polyethylene tibia
4813596|NCT02540902|Bone density|bone density
4813597|NCT02540863|myofascial pain syndrome|myofascial pain syndrome
4813598|NCT02540863|exercise therapy|exercise therapy
4813599|NCT02540863|randomized controlled trial|randomized controlled trial
4813600|NCT02540850|septin 9|septin 9
4813601|NCT02540850|SEPT9|sept9
4813602|NCT02540850|colorectal cancer|colorectal cancer
4813603|NCT02540850|CRC|crc
4813604|NCT02540850|screening|screening
4813605|NCT02540850|methylation|methylation
4813606|NCT02540850|adenoma|adenoma
4813607|NCT02540850|polyps|polyps
4813608|NCT02540850|FIT|fit
4813609|NCT02540850|FOBT|fobt
4813610|NCT02540850|colonoscopy|colonoscopy
4813611|NCT02540824|Apatinib|apatinib
4813612|NCT02540824|RET|ret
4813613|NCT02540824|gene fusion|gene fusion
4813614|NCT02540824|Non-small Cell Lung Cancer|non-small cell lung cancer
4813615|NCT02540798|Anxiety|anxiety
4813616|NCT02540798|Urodynamics|urodynamics
4813617|NCT02540798|Symptom reproducibility|symptom reproducibility
4813618|NCT02540798|Lower urinary tract symptoms|lower urinary tract symptoms
4813619|NCT02540798|Women|women
4813620|NCT02540785|Refractive Surgical Procedures|refractive surgical procedures
4813621|NCT02540785|small-incision lenticule extraction|small-incision lenticule extraction
4813622|NCT02540785|lenticule extraction|lenticule extraction
4813623|NCT02540785|inflammatory mediators|inflammatory mediators
4813624|NCT02540772|Confabulations|confabulations
4813625|NCT02540772|Neuropsychological rehabilitation|neuropsychological rehabilitation
4813626|NCT02540772|Memory|memory
4813627|NCT02540759|Buglossoides arvensis|buglossoides arvensis
4813628|NCT02540759|vegetable oil|vegetable oil
4813629|NCT02540759|omega-3 fatty acids|omega-3 fatty acids
4813630|NCT02540759|participants|participants
4813631|NCT02540746|Emotional Dysregulation|emotional dysregulation
4813632|NCT02540746|Early Intervention|early intervention
4813633|NCT02540746|Youth Mental Health|youth mental health
4813634|NCT02540746|Staging|staging
4813635|NCT02540746|Motivational Enhancement|motivational enhancement
4813636|NCT02540746|Family Connections|family connections
4813637|NCT02540746|Family Skills Training|family skills training
4813638|NCT02540733|cerebral infarction|cerebral infarction
4813639|NCT02540733|diabetes|diabetes
4813640|NCT02540733|rehabilitation|rehabilitation
4813641|NCT02540733|MRI|mri
4813642|NCT02540681|Transtibial amputation|transtibial amputation
4813643|NCT02540681|Prosthetic fit|prosthetic fit
4813644|NCT02540681|Prosthetic alignment|prosthetic alignment
4813645|NCT02540655|Stem Cells|stem cells
4813646|NCT02540655|Adult Stem Cells|adult stem cells
4813647|NCT02540655|Spinocerebellar Ataxia|spinocerebellar ataxia
4813648|NCT02540655|Steminent|steminent
4813649|NCT02540629|Cardiopulmonary resuscitation|cardiopulmonary resuscitation
4813650|NCT02540629|Emergency Medicine|emergency medicine
4813651|NCT02540616|MdDS|mdds
4813652|NCT02540616|TES|tes
4813653|NCT02540616|TMS|tms
4813654|NCT02540590|microcirculation|microcirculation
4813655|NCT02540590|wound healing|wound healing
4813656|NCT02540590|tunnel technique|tunnel technique
4813657|NCT02540590|gingival recession|gingival recession
4813658|NCT02540590|Mucograft|mucograft
4813659|NCT02540590|laser speckle contrast analyzer|laser speckle contrast analyzer
4813660|NCT02540538|Adjuvants, immunologic|adjuvants, immunologic
4813661|NCT02540538|Interleukin-2|interleukin-2
4813662|NCT02540538|Hepatitis B vaccines|hepatitis b vaccines
4813663|NCT02540538|Non-responders|non-responders
4813664|NCT02540525|stress incontinence|stress incontinence
4813665|NCT02540525|transobturator sling|transobturator sling
4813666|NCT02540525|single-incision mini-sling|single-incision mini-sling
4813667|NCT02540499|lung cancer|lung cancer
4813668|NCT02540499|breath hold|breath hold
4813669|NCT02540499|radiotherapy|radiotherapy
4813670|NCT02540486|Type 2 diabetes|type 2 diabetes
4813671|NCT02540486|T2DM|t2dm
4813672|NCT02540473|Resilience|resilience
4813673|NCT02540447|Liver transplantation|liver transplantation
4813674|NCT02540447|Graft rinse|graft rinse
4813675|NCT02540447|Ischemia reperfusion injury|ischemia reperfusion injury
4813676|NCT02540434|Hypofibrinogenemia|hypofibrinogenemia
4813677|NCT02540434|ROTEM|rotem
4813678|NCT02540434|Cardiac Surgery|cardiac surgery
4813679|NCT02540434|Concentrated Fibrinogen|concentrated fibrinogen
4813680|NCT02540421|cervical intraepithelial neoplasia|cervical intraepithelial neoplasia
4813681|NCT02540421|human papillomavirus|human papillomavirus
4813682|NCT02540421|conization|conization
4813683|NCT02540408|Occupational COPD|occupational copd
4813684|NCT02540408|Pathophysiology|pathophysiology
4813685|NCT02540408|Exercise limitation|exercise limitation
4813686|NCT02540408|Pulmonary hyperinflation|pulmonary hyperinflation
4813687|NCT02540408|Arterial stiffness|arterial stiffness
4813688|NCT02540395|Kidney transplantation|kidney transplantation
4813689|NCT02540395|Immunosuppression|immunosuppression
4813690|NCT02540395|IFN-γ|ifn-γ
4813691|NCT02540382|TIPS|tips
4813692|NCT02540382|Hepatocellular Carcinoma|hepatocellular carcinoma
4813693|NCT02540382|Portasystemic Shunt|portasystemic shunt
4813694|NCT02540369|Diabetic macular edema|diabetic macular edema
4813819|NCT02539446|External focus|external focus
4813695|NCT02540369|Wet Age-related macular degeneration|wet age-related macular degeneration
4813696|NCT02540343|Translation|translation
4813697|NCT02540343|Validation|validation
4813698|NCT02540343|Orebro-G|orebro-g
4813699|NCT02540291|E7046|e7046
4813700|NCT02540291|Advanced malignancies|advanced malignancies
4813701|NCT02540291|malignancies|malignancies
4813702|NCT02540265|Bunion|bunion
4813703|NCT02540265|Bunionectomy|bunionectomy
4813704|NCT02540265|Pain|pain
4813705|NCT02540265|Analgesia|analgesia
4813706|NCT02540265|N1539|n1539
4813707|NCT02540252|Lower Limb Amputation|lower limb amputation
4813708|NCT02540252|Nutrition|nutrition
4813709|NCT02540252|Eating|eating
4813710|NCT02540252|Inflammation|inflammation
4813711|NCT02540252|Nursing|nursing
4813712|NCT02540226|Tranexamic Acid|tranexamic acid
4813713|NCT02540226|Total Knee Arthroplasty|total knee arthroplasty
4813714|NCT02540226|Total Knee Replacement|total knee replacement
4813715|NCT02540187|haemophilia|haemophilia
4813716|NCT02540187|TFPI|tfpi
4813717|NCT02540187|thrombin generation|thrombin generation
4813718|NCT02540187|hemorrhagic score|hemorrhagic score
4813719|NCT02540174|alcohol and tobacco consumption|alcohol and tobacco consumption
4813720|NCT02540174|addiction treatment|addiction treatment
4813721|NCT02540161|Sym004|sym004
4813722|NCT02540161|Glioblastoma|glioblastoma
4813723|NCT02540161|Desjardins|desjardins
4813724|NCT02540161|Pro00063483|pro00063483
4813725|NCT02540161|Symphogen|symphogen
4813726|NCT02540161|Duke Cancer Institute|duke cancer institute
4813727|NCT02540135|high grade glioma|high grade glioma
4813728|NCT02540135|glioblastoma multiforme|glioblastoma multiforme
4813729|NCT02540135|anaplastic astrocytoma|anaplastic astrocytoma
4813730|NCT02540135|flourescein|flourescein
4813731|NCT02540135|flourescence-guided surgery|flourescence-guided surgery
4813732|NCT02540135|intraoperative MRI|intraoperative mri
4813733|NCT02540135|iMRI|imri
4813734|NCT02540109|Stroke|stroke
4813735|NCT02540109|Anomia|anomia
4813736|NCT02540096|mental practice|mental practice
4813737|NCT02540096|motor imagery|motor imagery
4813738|NCT02540096|hemiparesis|hemiparesis
4813739|NCT02540096|stroke|stroke
4813740|NCT02540096|gait|gait
4813741|NCT02540096|mobility|mobility
4813742|NCT02540070|Adductor canal Block|adductor canal block
4813743|NCT02540070|ultrasound|ultrasound
4813744|NCT02540070|periarticular injections|periarticular injections
4813745|NCT02540070|Dexmedetomidine|dexmedetomidine
4813746|NCT02540018|DEB, drug-eluting balloon, Paclitaxel, peripheral artery disease|deb, drug-eluting balloon, paclitaxel, peripheral artery disease
4813747|NCT02539979|IV Paracetamol|iv paracetamol
4813748|NCT02539979|Radiofrequency Lesion/Ablation of medial branch nerve|radiofrequency lesion/ablation of medial branch nerve
4813749|NCT02539979|Preventative Pain Management|preventative pain management
4813750|NCT02539940|Below-the-knee|below-the-knee
4813751|NCT02539914|Virtual reality|virtual reality
4814335|NCT02536144|magnetic|magnetic
4813752|NCT02539914|Motor and cognitive rehabilitation|motor and cognitive rehabilitation
4813753|NCT02539914|Positive emotion stimuli|positive emotion stimuli
4813754|NCT02539901|cochlear implant|cochlear implant
4813755|NCT02539901|Developmental Psychology|developmental psychology
4813756|NCT02539901|cognitive development|cognitive development
4813757|NCT02539901|communicative development|communicative development
4813758|NCT02539901|perceptual development|perceptual development
4813759|NCT02539901|deaf child|deaf child
4813760|NCT02539875|Effectiveness of quit immediately (QI) and cut down to quit (CDTQ) interventions in achieving smoking abstinence|effectiveness of quit immediately (qi) and cut down to quit (cdtq) interventions in achieving smoking abstinence
4813761|NCT02539862|Insomnia|insomnia
4813762|NCT02539862|behavioral and cognitive therapies|behavioral and cognitive therapies
4813763|NCT02539836|children's obesity|children's obesity
4813764|NCT02539836|gut microbiome|gut microbiome
4813765|NCT02539836|body mass index|body mass index
4813766|NCT02539836|fruit and vegetable fermentation extraction|fruit and vegetable fermentation extraction
4813767|NCT02539836|dietary nutrition intervention|dietary nutrition intervention
4813768|NCT02539784|stimulation|stimulation
4813769|NCT02539771|vaso-occlusive crisis|vaso-occlusive crisis
4813770|NCT02539771|obstructive sleep apnea|obstructive sleep apnea
4813771|NCT02539771|priapism|priapism
4813772|NCT02539758|acute angle closure|acute angle closure
4813773|NCT02539758|ocular massage|ocular massage
4813774|NCT02539745|vitamin D|vitamin d
4813775|NCT02539745|primary open- angle glaucoma|primary open- angle glaucoma
4813776|NCT02539732|Weaning|weaning
4813777|NCT02539732|Spontaneous breathing trial|spontaneous breathing trial
4813778|NCT02539732|Neurally-adjusted ventilator assist|neurally-adjusted ventilator assist
4813779|NCT02539732|Electrical activity of the diaphragm|electrical activity of the diaphragm
4813780|NCT02539719|Platinum-Resistant|platinum-resistant
4813781|NCT02539719|Refractory|refractory
4813782|NCT02539680|Phosphate transporter|phosphate transporter
4813783|NCT02539680|CKD|ckd
4813784|NCT02539680|duodenal biopsies|duodenal biopsies
4813785|NCT02539602|High school|high school
4813786|NCT02539602|Longitudnal|longitudnal
4813787|NCT02539602|Sexual initiation|sexual initiation
4813788|NCT02539602|Contraception|contraception
4813789|NCT02539602|Adolescents|adolescents
4813790|NCT02539602|Pregnancy prevention|pregnancy prevention
4813791|NCT02539602|Sexual health|sexual health
4813792|NCT02539576|pharmacokinetics|pharmacokinetics
4813793|NCT02539576|Healthy subjects|healthy subjects
4813794|NCT02539576|Abacavir/dolutegravir/lamivudine|abacavir/dolutegravir/lamivudine
4813795|NCT02539576|Japanese|japanese
4813796|NCT02539576|Fixed-dose combination|fixed-dose combination
4813797|NCT02539576|safety|safety
4813798|NCT02539563|labor duration|labor duration
4813799|NCT02539550|PF-06266047|pf-06266047
4813800|NCT02539550|safety|safety
4813801|NCT02539550|tolerability|tolerability
4813802|NCT02539550|pharmacokinetics|pharmacokinetics
4813803|NCT02539550|first-in-human|first-in-human
4813804|NCT02539550|healthy volunteers|healthy volunteers
4813805|NCT02539550|PDE4|pde4
4813806|NCT02539550|phosphodiesterase-4|phosphodiesterase-4
4813807|NCT02539537|locally advanced pancreatic carcinoma|locally advanced pancreatic carcinoma
4813808|NCT02539537|FOLFIRINOX|folfirinox
4813809|NCT02539524|clinical impact|clinical impact
4813810|NCT02539524|anxiety|anxiety
4813811|NCT02539524|quality of life|quality of life
4813812|NCT02539524|Yoga|yoga
4813813|NCT02539498|Primary Hyperparathyroidism|primary hyperparathyroidism
4813814|NCT02539498|Parathyroid Hormone|parathyroid hormone
4813815|NCT02539498|High-Resolution peripheral Quantitative Computed Tomography|high-resolution peripheral quantitative computed tomography
4813816|NCT02539498|Bone densitometry|bone densitometry
4813817|NCT02539498|Bone microarchitecture|bone microarchitecture
4813818|NCT02539446|Aging|aging
4813820|NCT02539446|Internal focus|internal focus
4813821|NCT02539446|Attention|attention
4813822|NCT02539446|Posture balance|posture balance
4813823|NCT02539446|Parkinson's disease|parkinson's disease
4813824|NCT02539407|β-lactam antibiotics|β-lactam antibiotics
4813825|NCT02539407|Children|children
4813826|NCT02539407|Anti-infectives|anti-infectives
4813827|NCT02539407|Aminoglycosides, glycopeptides|aminoglycosides, glycopeptides
4813828|NCT02539407|Fluoroquinolone|fluoroquinolone
4813829|NCT02539407|Fungal|fungal
4813830|NCT02539407|Antiviral|antiviral
4813831|NCT02539394|Anterior Cervical Discectomy and Fusion|anterior cervical discectomy and fusion
4813832|NCT02539394|Dysphagia|dysphagia
4813833|NCT02539394|ACDF|acdf
4813834|NCT02539368|Infliximab|infliximab
4813835|NCT02539368|Observational|observational
4813836|NCT02539368|Follow-up|follow-up
4813837|NCT02539368|Safety|safety
4813838|NCT02539368|Effectiveness|effectiveness
4813839|NCT02539355|Insulin resistance|insulin resistance
4813840|NCT02539355|Diabetes|diabetes
4813841|NCT02539355|Cancer|cancer
4813842|NCT02539355|Obesity|obesity
4813843|NCT02539355|Inflammation|inflammation
4813844|NCT02539342|Oral Mucositis|oral mucositis
4813845|NCT02539342|Cancer|cancer
4813846|NCT02539342|Chemotherapy|chemotherapy
4813847|NCT02539329|neuropathy|neuropathy
4813848|NCT02539329|antibodies antiFGFR3|antibodies antifgfr3
4813849|NCT02539329|Biological diagnostic criteria|biological diagnostic criteria
4813850|NCT02539316|Parenteral Nutrition|parenteral nutrition
4813851|NCT02539290|Unexplained infertility|unexplained infertility
4813852|NCT02539290|Infertility|infertility
4813853|NCT02539290|Tubal flushing|tubal flushing
4813854|NCT02539290|Uterine flushing|uterine flushing
4813855|NCT02539290|Live birth|live birth
4813856|NCT02539290|Pregnancy|pregnancy
4813857|NCT02539290|Randomized controlled trial|randomized controlled trial
4813858|NCT02539290|Saline|saline
4813859|NCT02539290|Physiological saline|physiological saline
4813860|NCT02539264|All patients registered for A PSG|all patients registered for a psg
4813861|NCT02539264|polysomnography|polysomnography
4813862|NCT02539251|Early Child Development|early child development
4813863|NCT02539251|Ages and Stages Questionnaire _3|ages and stages questionnaire _3
4813864|NCT02539251|Validation|validation
4813865|NCT02539238|Medical Education|medical education
4813866|NCT02539238|cardiopulmonary resuscitation|cardiopulmonary resuscitation
4813867|NCT02539238|feedback|feedback
4813868|NCT02539238|cost-effectiveness analysis|cost-effectiveness analysis
4813869|NCT02539212|microwave|microwave
4813870|NCT02539212|radiofrequency|radiofrequency
4813871|NCT02539212|ablation|ablation
4813872|NCT02539160|coronary artery disease|coronary artery disease
4813873|NCT02539160|diabetes mellitus|diabetes mellitus
4813874|NCT02539160|chronic kidney disease|chronic kidney disease
4813875|NCT02539160|ticagrelor|ticagrelor
4813876|NCT02539147|lipopolysaccharide|lipopolysaccharide
4813877|NCT02539147|sepsis|sepsis
4813878|NCT02539147|caspase-4 and -5|caspase-4 and -5
4813879|NCT02539147|monocytes|monocytes
4813880|NCT02539147|IL-1β and IL-1α|il-1β and il-1α
4813881|NCT02539134|Drug therapy|drug therapy
4813882|NCT02539121|Labor|labor
4813883|NCT02539121|Acupuncture|acupuncture
4813884|NCT02539121|Postpartum hemorrhage|postpartum hemorrhage
4813885|NCT02539121|Placental expulsion time|placental expulsion time
4813886|NCT02539121|Postpartum blood loss|postpartum blood loss
4813887|NCT02539108|Influenza|influenza
4813888|NCT02539108|Influenza virus vaccine|influenza virus vaccine
4813889|NCT02539108|Fluzone® Quadrivalent Influenza Vaccine (No Preservative)|fluzone® quadrivalent influenza vaccine (no preservative)
4813890|NCT02539095|intra-articular injection|intra-articular injection
4813891|NCT02539095|intra-articular collagen injection|intra-articular collagen injection
4813892|NCT02539095|collagen|collagen
4813893|NCT02539095|knee joint pain|knee joint pain
4813894|NCT02539082|collagen|collagen
4813895|NCT02539082|collagen injection|collagen injection
4813896|NCT02539082|plantar fasciitis|plantar fasciitis
4813897|NCT02539069|cartilage defects|cartilage defects
4813898|NCT02539069|Chondron|chondron
4813899|NCT02539069|Autologous cultured Chondrocyte|autologous cultured chondrocyte
4813900|NCT02539069|arthroscopy|arthroscopy
4813901|NCT02539056|cartilage defects|cartilage defects
4813902|NCT02539056|Chondron|chondron
4813903|NCT02539056|Autologous cultured Chondrocyte|autologous cultured chondrocyte
4813904|NCT02539043|Lipolysis|lipolysis
4813905|NCT02539043|Subcutaneous Fat, Abdominal/metabolism|subcutaneous fat, abdominal/metabolism
4813906|NCT02539043|Subcutaneous Fat, Abdominal/ultrasonography|subcutaneous fat, abdominal/ultrasonography
4813907|NCT02539043|High-Intensity Focused Ultrasound Ablation/methods|high-intensity focused ultrasound ablation/methods
4813908|NCT02539043|Waist Circumference|waist circumference
4813909|NCT02539043|Pilot Projects|pilot projects
4813910|NCT02539043|Subcutaneous Fat|subcutaneous fat
4813911|NCT02539043|High-Intensity Focused Ultrasound Ablation|high-intensity focused ultrasound ablation
4813912|NCT02539043|Adiposity|adiposity
4813913|NCT02539030|Cartilage defect of knee|cartilage defect of knee
4813914|NCT02539030|microfracture|microfracture
4813915|NCT02539030|modified microfracture|modified microfracture
4813916|NCT02539030|collagen|collagen
4813917|NCT02539017|cellular immune therapy|cellular immune therapy
4813918|NCT02539017|triple negative breast cancer|triple negative breast cancer
4813919|NCT02539017|adjuvant therapy|adjuvant therapy
4813920|NCT02539004|kidney stones|kidney stones
4813921|NCT02539004|ureteral stones|ureteral stones
4813922|NCT02538991|Bulkamid|bulkamid
4813923|NCT02538991|Tension-Free Vaginal Tape|tension-free vaginal tape
4813924|NCT02538991|Women|women
4813925|NCT02538978|CLI|cli
4813926|NCT02538965|Lenalidomide|lenalidomide
4813927|NCT02538965|Revlimid|revlimid
4813928|NCT02538965|Pediatric|pediatric
4813929|NCT02538965|Relapsed or Refractory|relapsed or refractory
4813930|NCT02538965|Acute Myeloid Leukemia|acute myeloid leukemia
4813931|NCT02538965|Leukemia|leukemia
4813932|NCT02538952|GeneXpert|genexpert
4813933|NCT02538952|Tuberculosis|tuberculosis
4813934|NCT02538952|Human immunodeficiency virus|human immunodeficiency virus
4813935|NCT02538952|Diagnostic accuracy|diagnostic accuracy
4813936|NCT02538952|Impact|impact
4813937|NCT02538939|Calcific tendinitis, Shoulder, Needle lavage, Sodium thiosulfate|calcific tendinitis, shoulder, needle lavage, sodium thiosulfate
4813938|NCT02538913|Exercise|exercise
4813939|NCT02538913|Pelvic floor|pelvic floor
4813940|NCT02538913|Prehabilitation|prehabilitation
4813941|NCT02538913|Fecal incontinence|fecal incontinence
4813942|NCT02538913|Urinary incontinence|urinary incontinence
4813943|NCT02538913|Sexual dysfunction, physiological|sexual dysfunction, physiological
4814534|NCT02534363|Psychosis|psychosis
4813944|NCT02538900|peripheral arterial disease, peripheral artery disease, PAD, exercise|peripheral arterial disease, peripheral artery disease, pad, exercise
4813945|NCT02538822|aortic aneurysm|aortic aneurysm
4813946|NCT02538822|thoracic ascending aorta|thoracic ascending aorta
4813947|NCT02538822|ATA|ata
4813948|NCT02538822|dynamic imaging|dynamic imaging
4813949|NCT02538822|mechanical testing|mechanical testing
4813950|NCT02538796|Anorexia Nervosa|anorexia nervosa
4813951|NCT02538796|Cognition|cognition
4813952|NCT02538796|Conscious|conscious
4813953|NCT02538796|Non-Conscious|non-conscious
4813954|NCT02538705|Diabetic foot syndrome|diabetic foot syndrome
4813955|NCT02538705|Ulcers|ulcers
4813956|NCT02538679|transversus abdominis plane block|transversus abdominis plane block
4813957|NCT02538679|tap block|tap block
4813958|NCT02538679|regional anesthesia|regional anesthesia
4813959|NCT02538679|colorectal surgery|colorectal surgery
4813960|NCT02538653|glycemic & insulin response, SDS, cereal product, Nutrition|glycemic & insulin response, sds, cereal product, nutrition
4813961|NCT02538640|Nutrition, glycemic response, cereal products|nutrition, glycemic response, cereal products
4813962|NCT02538627|Heregulin-positive|heregulin-positive
4813963|NCT02538627|EGFR|egfr
4813964|NCT02538627|ErbB3|erbb3
4813965|NCT02538627|Phase I|phase i
4813966|NCT02538627|Oncology|oncology
4813967|NCT02538627|Cancer|cancer
4813968|NCT02538627|IGF-1|igf-1
4813969|NCT02538627|MEKinhibitor|mekinhibitor
4813970|NCT02538627|IGF-1R inhibitor|igf-1r inhibitor
4813971|NCT02538627|KRAS|kras
4813972|NCT02538627|NRAS|nras
4813973|NCT02538601|Post Traumatic Stress Disorder|post traumatic stress disorder
4813974|NCT02538601|PTSD|ptsd
4813975|NCT02538601|Cigarette Smoking|cigarette smoking
4813976|NCT02538601|Lower Respiratory Symptoms|lower respiratory symptoms
4813977|NCT02538601|Cognitive Behavioral Therapy|cognitive behavioral therapy
4813978|NCT02538601|CBT|cbt
4813979|NCT02538601|Transdiagnostic Treatments|transdiagnostic treatments
4813980|NCT02538601|World Trade Center|world trade center
4813981|NCT02538588|Healthy Volunteers|healthy volunteers
4813982|NCT02538575|Cystic Fibrosis|cystic fibrosis
4813983|NCT02538575|Adults|adults
4813984|NCT02538575|6-minute walk test|6-minute walk test
4813985|NCT02538497|NBO|nbo
4813986|NCT02538497|The Newborn Behavioral Observation|the newborn behavioral observation
4813987|NCT02538497|postpartum depression|postpartum depression
4813988|NCT02538497|postnatal depression|postnatal depression
4813989|NCT02538497|child development|child development
4813990|NCT02538497|parent-child interaction|parent-child interaction
4813991|NCT02538458|Saline Solution, Hypertonic (3 %)|saline solution, hypertonic (3 %)
4813992|NCT02538458|Infant|infant
4813993|NCT02538445|Schizophrenia|schizophrenia
4813994|NCT02538445|Memory|memory
4813995|NCT02538445|Cognition|cognition
4813996|NCT02538432|Disease Progression|disease progression
4813997|NCT02538432|Non-Responsive Disease|non-responsive disease
4813998|NCT02538432|Advanced Disease|advanced disease
4813999|NCT02538406|Adenoma|adenoma
4814000|NCT02538406|withdrawal time|withdrawal time
4814001|NCT02538406|Colonoscopy|colonoscopy
4814002|NCT02538380|Lung cancer|lung cancer
4814003|NCT02538380|Adrenal gland metastasis|adrenal gland metastasis
4814004|NCT02538354|Riboflavin (vitamin B2)|riboflavin (vitamin b2)
4814005|NCT02538354|Faecalibacterium prausnitzii|faecalibacterium prausnitzii
4814006|NCT02538328|laparoscopy|laparoscopy
4814007|NCT02538328|obesity|obesity
4814008|NCT02538328|harmonic scalpel|harmonic scalpel
4814009|NCT02538328|ligasure|ligasure
4814010|NCT02538315|[18F]FODPA, Parkinson's, PET/CT, Stem Cell transplantation|[18f]fodpa, parkinson's, pet/ct, stem cell transplantation
4814011|NCT02538302|Minirin|minirin
4814012|NCT02538302|Oxybutynin|oxybutynin
4814013|NCT02538302|Nocturnal enuresis|nocturnal enuresis
4814014|NCT02538289|Dyspnea|dyspnea
4814015|NCT02538289|Palliative Care|palliative care
4814016|NCT02538289|Heart Failure|heart failure
4814017|NCT02538289|Chronic Pulmonary Disease|chronic pulmonary disease
4814018|NCT02538289|Opioids|opioids
4814019|NCT02538276|carotid endarterectomy, carotid stenosis, carotid stenting|carotid endarterectomy, carotid stenosis, carotid stenting
4814020|NCT02538250|Oral nutritional supplement|oral nutritional supplement
4814021|NCT02538250|supplementation|supplementation
4814022|NCT02538250|adult patients|adult patients
4814023|NCT02538224|Periodontitis|periodontitis
4814024|NCT02538224|doxycycline/ketoprofen topical gel therapeutic|doxycycline/ketoprofen topical gel therapeutic
4814025|NCT02538198|lenalidomide (CC-5013)|lenalidomide (cc-5013)
4814026|NCT02538198|maintenance|maintenance
4814027|NCT02538198|15-129|15-129
4814028|NCT02538172|Cell-mediated immunity|cell-mediated immunity
4814029|NCT02538172|Antiviral prophylaxis|antiviral prophylaxis
4814030|NCT02538172|Transplantation|transplantation
4814031|NCT02538159|Non-tunneled Central venous catheter|non-tunneled central venous catheter
4814032|NCT02538159|Bacteraemia|bacteraemia
4814033|NCT02538159|Peripherally inserted central venous catheter|peripherally inserted central venous catheter
4814034|NCT02538146|pain|pain
4814035|NCT02538146|depression|depression
4814036|NCT02538146|cytokines|cytokines
4814037|NCT02538146|well-being|well-being
4814038|NCT02538133|99mTc-Exametazime (HMPAO)-Labeled Leukocytes|99mtc-exametazime (hmpao)-labeled leukocytes
4814137|NCT02537431|X-linked Hypophosphatemia|x-linked hypophosphatemia
4814039|NCT02538133|suspected subdiaphragmatic vascular prosthesis infection|suspected subdiaphragmatic vascular prosthesis infection
4814040|NCT02538133|diagnosis|diagnosis
4814041|NCT02538094|Cognitive Enhancement|cognitive enhancement
4814042|NCT02538094|tDCS|tdcs
4814043|NCT02538094|stimulation|stimulation
4814044|NCT02538094|MS|ms
4814045|NCT02538094|Multiple Sclerosis|multiple sclerosis
4814046|NCT02538094|Encephalitis|encephalitis
4814047|NCT02538081|schizophrenia|schizophrenia
4814048|NCT02538081|olanzapine|olanzapine
4814049|NCT02538081|risperidone|risperidone
4814050|NCT02538081|alpha 7 nicotinic receptors|alpha 7 nicotinic receptors
4814051|NCT02538081|cognition|cognition
4814052|NCT02538068|Purpose in Life|purpose in life
4814053|NCT02538068|Self-determination|self-determination
4814054|NCT02538068|Physical activity|physical activity
4814055|NCT02538068|Self-monitoring|self-monitoring
4814056|NCT02538068|Behavior change|behavior change
4814057|NCT02538055|Community Health Workers|community health workers
4814058|NCT02538055|Diabetes Mellitus|diabetes mellitus
4814059|NCT02538055|Chronic Pain|chronic pain
4814060|NCT02538029|Dual tasking|dual tasking
4814061|NCT02538016|Cystinuria|cystinuria
4814062|NCT02538016|Kidney Stones|kidney stones
4814063|NCT02537964|chlorhexidine|chlorhexidine
4814064|NCT02537951|autofluorescent flavoprotein imaging, capsaicin|autofluorescent flavoprotein imaging, capsaicin
4814065|NCT02537925|COX-2 inhibitors|cox-2 inhibitors
4814066|NCT02537925|radiosensitivity|radiosensitivity
4814067|NCT02537925|nasopharyngeal carcinoma|nasopharyngeal carcinoma
4814068|NCT02537912|peanut skin|peanut skin
4814069|NCT02537912|body fat|body fat
4814070|NCT02537912|blood glucose|blood glucose
4814071|NCT02537912|waistline|waistline
4814072|NCT02537912|body weight|body weight
4814073|NCT02537886|PCOR|pcor
4814074|NCT02537873|Cocaine Use Disorder|cocaine use disorder
4814075|NCT02537847|Sitafloxacin|sitafloxacin
4814076|NCT02537847|Extended-Spectrum ß-lactamase-producing Escherichia coli|extended-spectrum ß-lactamase-producing escherichia coli
4814077|NCT02537847|Treatment for Acute Pyelonephritis|treatment for acute pyelonephritis
4814078|NCT02537847|Ertapenem|ertapenem
4814079|NCT02537795|Deep Brain Stimulation|deep brain stimulation
4814080|NCT02537795|Anterior Capsulotomy|anterior capsulotomy
4814081|NCT02537782|Cardiac Resynchronisation Therapy|cardiac resynchronisation therapy
4814082|NCT02537782|Heart Failure|heart failure
4814083|NCT02537782|Left ventricular dyssynchrony|left ventricular dyssynchrony
4814084|NCT02537782|Echocardiography|echocardiography
4814085|NCT02537782|Apical rocking|apical rocking
4814086|NCT02537782|Septal flash|septal flash
4814087|NCT02537769|LVAD|lvad
4814088|NCT02537769|Tricuspid regurgitation|tricuspid regurgitation
4814089|NCT02537769|Heart failure|heart failure
4814090|NCT02537769|Transplant|transplant
4814091|NCT02537769|3D transesophageal echocardiography (TEE)|3d transesophageal echocardiography (tee)
4814092|NCT02537769|2D transesophageal echocardiography (TEE)|2d transesophageal echocardiography (tee)
4814093|NCT02537769|Mild|mild
4814094|NCT02537769|Moderate|moderate
4814095|NCT02537743|Patient Reported Outcomes|patient reported outcomes
4814096|NCT02537704|Obesity|obesity
4814097|NCT02537704|Translational|translational
4814098|NCT02537704|Diabetes Prevention Program|diabetes prevention program
4814099|NCT02537704|Group Lifestyle Balance Program|group lifestyle balance program
4814100|NCT02537652|Central blood pressure|central blood pressure
4814101|NCT02537652|Transient ischaemic attack|transient ischaemic attack
4814102|NCT02537639|Simulator in transesophageal echocardiography|simulator in transesophageal echocardiography
4814103|NCT02537613|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
4814104|NCT02537600|BRAF mutation|braf mutation
4814105|NCT02537600|Brain metastasis|brain metastasis
4814106|NCT02537600|Cobimetinib + Vemurafenib combination treatment|cobimetinib + vemurafenib combination treatment
4814107|NCT02537587|Blood glucose|blood glucose
4814108|NCT02537587|Blood insulin|blood insulin
4814109|NCT02537587|Humans|humans
4814110|NCT02537587|Postprandial|postprandial
4814111|NCT02537587|Carbohydrate|carbohydrate
4814112|NCT02537587|Protein|protein
4814113|NCT02537587|Resistant starch|resistant starch
4814114|NCT02537587|Sugar|sugar
4814115|NCT02537574|Alkermes|alkermes
4814116|NCT02537574|Buprenorphine|buprenorphine
4814117|NCT02537574|Naltrexone|naltrexone
4814118|NCT02537574|Vivitrol|vivitrol
4814119|NCT02537574|Opioid Use|opioid use
4814120|NCT02537574|Opiates|opiates
4814121|NCT02537574|Dependence|dependence
4814122|NCT02537574|Abuse|abuse
4814123|NCT02537574|Heroin|heroin
4814124|NCT02537574|Painkillers|painkillers
4814125|NCT02537574|Substance Abuse|substance abuse
4814126|NCT02537496|Alzheimer's Disease|alzheimer's disease
4814127|NCT02537496|Brain stimulation|brain stimulation
4814128|NCT02537496|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
4814129|NCT02537496|Neuroplasticity|neuroplasticity
4814130|NCT02537496|cognitive enhancement|cognitive enhancement
4814131|NCT02537496|TMS-EEG|tms-eeg
4814132|NCT02537496|rTMS|rtms
4814133|NCT02537496|PAS|pas
4814134|NCT02537431|KRN23|krn23
4814135|NCT02537431|Fibroblast growth factor 23 (FGF23)|fibroblast growth factor 23 (fgf23)
4814136|NCT02537431|XLH|xlh
4814239|NCT02536768|Counseling|counseling
4814138|NCT02537379|Hepatitis C virus|hepatitis c virus
4814139|NCT02537379|observational|observational
4814140|NCT02537379|post-marketing|post-marketing
4814141|NCT02537379|sofosbuvir|sofosbuvir
4814142|NCT02537353|Upper gastrointestinal bleeding|upper gastrointestinal bleeding
4814143|NCT02537353|Hemospray|hemospray
4814144|NCT02537353|Endoscopic hemostasis|endoscopic hemostasis
4814145|NCT02537340|PET/MR|pet/mr
4814146|NCT02537340|MRI|mri
4814147|NCT02537340|Rectal cancer|rectal cancer
4814148|NCT02537340|EMVI|emvi
4814149|NCT02537340|FDG|fdg
4814150|NCT02537327|Recurrent caries|recurrent caries
4814151|NCT02537327|Secondary caries|secondary caries
4814152|NCT02537327|Dental composite|dental composite
4814153|NCT02537327|Dental amalgam|dental amalgam
4814154|NCT02537314|Normal Body Weight|normal body weight
4814155|NCT02537301|Endoscopic Retrograde Cholangiopancreatography|endoscopic retrograde cholangiopancreatography
4814156|NCT02537301|social networking|social networking
4814157|NCT02537301|group chat|group chat
4814158|NCT02537288|VA106483|va106483
4814159|NCT02537288|fedovapagon|fedovapagon
4814160|NCT02537288|males|males
4814161|NCT02537288|females|females
4814162|NCT02537288|moxifloxacin|moxifloxacin
4814163|NCT02537288|TQT|tqt
4814164|NCT02537288|QT/QTC|qt/qtc
4814165|NCT02537288|ECG|ecg
4814166|NCT02537288|Nocturia|nocturia
4814167|NCT02537262|carbohydrate|carbohydrate
4814168|NCT02537262|quality of recovery(QOR) 40|quality of recovery(qor) 40
4814169|NCT02537262|enhanced recovery after surgery(ERAS)|enhanced recovery after surgery(eras)
4814170|NCT02537249|dexmedetomidine|dexmedetomidine
4814171|NCT02537249|quality of recovery|quality of recovery
4814172|NCT02537236|Omega-3 Fatty Acids|omega-3 fatty acids
4814173|NCT02537236|Therapeutic Lifestyle Changes|therapeutic lifestyle changes
4814174|NCT02537236|Human Immunodeficiency Virus|human immunodeficiency virus
4814175|NCT02537236|Cardiac Risk|cardiac risk
4814176|NCT02537236|Dyslipidemia|dyslipidemia
4814177|NCT02537171|Apatinib|apatinib
4814178|NCT02537171|Locally Advanced Gastric Cancer|locally advanced gastric cancer
4814179|NCT02537171|Metastatic Gastric Cancer|metastatic gastric cancer
4814180|NCT02537158|sorafenib|sorafenib
4814181|NCT02537158|transcatheter arterial chemoembolization|transcatheter arterial chemoembolization
4814182|NCT02537158|hepatocellular carcinoma|hepatocellular carcinoma
4814183|NCT02537158|microvascular invasion|microvascular invasion
4814184|NCT02537145|compliance|compliance
4814185|NCT02537145|do-it-yourself methodology|do-it-yourself methodology
4814186|NCT02537145|pilot|pilot
4814187|NCT02537145|human microbiome|human microbiome
4814188|NCT02537132|Non Invasive Ventilation (NIV)|non invasive ventilation (niv)
4814189|NCT02537132|Amyotrophic Lateral sclerosis (ALS)|amyotrophic lateral sclerosis (als)
4814190|NCT02537132|adaptation|adaptation
4814191|NCT02537132|home care|home care
4814192|NCT02537106|Brain Tumors|brain tumors
4814193|NCT02537106|Microcirculation|microcirculation
4814194|NCT02537106|Osmotherapy|osmotherapy
4814195|NCT02537106|Hypertonic NaCl|hypertonic nacl
4814196|NCT02537106|Natremia|natremia
4814197|NCT02537080|Postoperative cognitive dysfunction|postoperative cognitive dysfunction
4814198|NCT02537080|Nimodipin|nimodipin
4814199|NCT02537080|Anesthesia|anesthesia
4814200|NCT02537067|a partial cartilage defect of ankle|a partial cartilage defect of ankle
4814201|NCT02537067|Chondron|chondron
4814202|NCT02537067|Autologus Chondrocyte|autologus chondrocyte
4814203|NCT02537054|Choroidal neovascularization|choroidal neovascularization
4814204|NCT02537054|Angioid streaks|angioid streaks
4814205|NCT02537054|Pseudoxanthoma Elasticum|pseudoxanthoma elasticum
4814206|NCT02537054|vascular endothelial growth factor|vascular endothelial growth factor
4814207|NCT02537054|aflibercept|aflibercept
4814208|NCT02537028|MSC2364447C|msc2364447c
4814209|NCT02537028|Phase 1|phase 1
4814210|NCT02537028|BTK inhibitor|btk inhibitor
4814211|NCT02537028|Systemic Lupus Erythematosus|systemic lupus erythematosus
4814212|NCT02537028|M2951|m2951
4814213|NCT02537028|Lupus|lupus
4814214|NCT02537002|PF-05230907|pf-05230907
4814215|NCT02537002|Pharmacokinetics|pharmacokinetics
4814216|NCT02537002|Pharmacodynamic|pharmacodynamic
4814217|NCT02537002|Immunogenicity|immunogenicity
4814218|NCT02536989|peptic ulcer bleeding|peptic ulcer bleeding
4814219|NCT02536989|blood clot|blood clot
4814220|NCT02536989|dose|dose
4814221|NCT02536976|mirabegron|mirabegron
4814222|NCT02536950|bionic pancreas|bionic pancreas
4814223|NCT02536950|closed-loop control|closed-loop control
4814224|NCT02536950|artificial pancreas|artificial pancreas
4814225|NCT02536885|Postoperative cognitive dysfunction|postoperative cognitive dysfunction
4814226|NCT02536885|Blood pressure|blood pressure
4814227|NCT02536885|Anesthesia|anesthesia
4814228|NCT02536872|infection overactive bladder|infection overactive bladder
4814229|NCT02536846|Healthy volunteers|healthy volunteers
4814230|NCT02536846|antipsychotic drugs|antipsychotic drugs
4814231|NCT02536846|brain metabolism|brain metabolism
4814232|NCT02536833|OA|oa
4814233|NCT02536833|Samumed|samumed
4814234|NCT02536781|Anthocyanin|anthocyanin
4814235|NCT02536781|Inflammation|inflammation
4814236|NCT02536781|Orthodontic treatment|orthodontic treatment
4814237|NCT02536768|Medication adherence|medication adherence
4814238|NCT02536768|ART|art
4814240|NCT02536768|Adherence Guidelines for Chronic Diseases (HIV, TB and NCDs)|adherence guidelines for chronic diseases (hiv, tb and ncds)
4814241|NCT02536742|Breast Cancer|breast cancer
4814242|NCT02536742|Metastatic|metastatic
4814243|NCT02536742|HER2 negative|her2 negative
4814244|NCT02536742|Palbociclib|palbociclib
4814245|NCT02536716|Dental Implant|dental implant
4814246|NCT02536690|propofol|propofol
4814247|NCT02536690|midazolam|midazolam
4814248|NCT02536690|remifentanil|remifentanil
4814249|NCT02536690|combination|combination
4814250|NCT02536690|synergic|synergic
4814251|NCT02536690|pharmacodynamics|pharmacodynamics
4814252|NCT02536690|Loss of consciousness|loss of consciousness
4814253|NCT02536677|Acute Chest Pain|acute chest pain
4814254|NCT02536677|Acute Coronary Syndrome|acute coronary syndrome
4814255|NCT02536677|Evaluation and Management|evaluation and management
4814256|NCT02536677|Decision Aid|decision aid
4814257|NCT02536677|Healthcare Utilization|healthcare utilization
4814258|NCT02536651|validation studies, patient-reported outcome measures|validation studies, patient-reported outcome measures
4814259|NCT02536638|urine protein|urine protein
4814260|NCT02536638|pregnancy|pregnancy
4814261|NCT02536638|pyelonephritis|pyelonephritis
4814262|NCT02536638|kidney infection|kidney infection
4814263|NCT02536625|everolimus|everolimus
4814264|NCT02536625|NK|nk
4814265|NCT02536625|metastatic|metastatic
4814266|NCT02536612|Motivation|motivation
4814267|NCT02536612|Behavioral Economics|behavioral economics
4814268|NCT02536612|Conditional Economic Incentives|conditional economic incentives
4814269|NCT02536612|Conditional cash transfers|conditional cash transfers
4814270|NCT02536612|Contingency management|contingency management
4814271|NCT02536599|Febrile Neutropenia|febrile neutropenia
4814272|NCT02536599|Childhood Cancer|childhood cancer
4814273|NCT02536599|Pediatric Oncology|pediatric oncology
4814274|NCT02536599|Fever|fever
4814275|NCT02536599|Neutropenia|neutropenia
4814276|NCT02536573|Total hip replacement|total hip replacement
4814277|NCT02536560|intestinal microbiota|intestinal microbiota
4814278|NCT02536560|antibiotics|antibiotics
4814279|NCT02536560|infant|infant
4814280|NCT02536560|allergy|allergy
4814281|NCT02536547|Clinical pulmonary infection score|clinical pulmonary infection score
4814282|NCT02536547|sepsis|sepsis
4814283|NCT02536547|lung ultrasound|lung ultrasound
4814284|NCT02536547|ventilator-associated pneumonia|ventilator-associated pneumonia
4814285|NCT02536534|Pulmonary Arterial Hypertension (PAH)|pulmonary arterial hypertension (pah)
4814286|NCT02536534|Chronic Thromboembolic Pulmonary Hypertension (CTEPH)|chronic thromboembolic pulmonary hypertension (cteph)
4814287|NCT02536456|screening|screening
4814288|NCT02536456|counseling|counseling
4814289|NCT02536456|follow-up|follow-up
4814290|NCT02536456|cardiovascular disease|cardiovascular disease
4814291|NCT02536456|population-based project|population-based project
4814292|NCT02536456|China|china
4814293|NCT02536443|heart failure|heart failure
4814294|NCT02536443|prognosis|prognosis
4814295|NCT02536443|clinical characteristics|clinical characteristics
4814296|NCT02536430|Infra alveolar nerve block|infra alveolar nerve block
4814297|NCT02536430|Ketorolac|ketorolac
4814298|NCT02536430|Success rate|success rate
4814299|NCT02536417|Melatonin|melatonin
4814300|NCT02536417|Delirium prevention|delirium prevention
4814301|NCT02536417|End-of-life|end-of-life
4814302|NCT02536352|Fluoride Supplementation|fluoride supplementation
4814303|NCT02536352|Prenatal Vitamin|prenatal vitamin
4814304|NCT02536352|Pregnancy Nutrition|pregnancy nutrition
4814305|NCT02536352|Prenatal Nutrition|prenatal nutrition
4814306|NCT02536287|secondary hyperparathyroidism|secondary hyperparathyroidism
4814307|NCT02536287|total parathyroidectomy|total parathyroidectomy
4814308|NCT02536287|autotransplantation|autotransplantation
4814309|NCT02536287|morbidity|morbidity
4814310|NCT02536287|recurrence|recurrence
4814311|NCT02536287|postoperative hypocalcemia|postoperative hypocalcemia
4814312|NCT02536261|Prolactinoma|prolactinoma
4814313|NCT02536261|dopamine agonist|dopamine agonist
4814314|NCT02536261|withdrawal|withdrawal
4814315|NCT02536261|cavernous sinus|cavernous sinus
4814316|NCT02536248|sitagliptin|sitagliptin
4814317|NCT02536248|diabetes|diabetes
4814318|NCT02536248|inflammation|inflammation
4814319|NCT02536196|Cerebral protection, aortic stenosis, transcatheter aortic valve implantation, TAVI, TriGuard, Keystone Heart|cerebral protection, aortic stenosis, transcatheter aortic valve implantation, tavi, triguard, keystone heart
4814320|NCT02536183|Solid tumors|solid tumors
4814321|NCT02536183|relapsed pediatric solid tumors|relapsed pediatric solid tumors
4814322|NCT02536183|high intensity focused ultrasound|high intensity focused ultrasound
4814323|NCT02536183|Lyso-thermosensitive liposomal doxorubicin|lyso-thermosensitive liposomal doxorubicin
4814324|NCT02536183|ThermoDox|thermodox
4814325|NCT02536183|relapsed sarcoma|relapsed sarcoma
4814326|NCT02536183|Ewing Sarcoma family of tumors|ewing sarcoma family of tumors
4814327|NCT02536183|Osteosarcoma|osteosarcoma
4814328|NCT02536183|Neuroblastoma|neuroblastoma
4814329|NCT02536183|Wilms Tumor|wilms tumor
4814330|NCT02536183|Hepatic Tumor|hepatic tumor
4814331|NCT02536183|Germ Cell Tumors|germ cell tumors
4814332|NCT02536170|Arginine Therapy|arginine therapy
4814333|NCT02536157|Volar plate|volar plate
4814334|NCT02536144|colon capsule|colon capsule
4814336|NCT02536144|maneuverability|maneuverability
4814337|NCT02536144|colonoscopy|colonoscopy
4814338|NCT02536131|Psychosomatics|psychosomatics
4814339|NCT02536131|Gastroenterology|gastroenterology
4814340|NCT02536131|Psychoneuroimmunology|psychoneuroimmunology
4814341|NCT02536105|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
4814342|NCT02536105|ADHD|adhd
4814343|NCT02536053|[E04.100.814.603]|[e04.100.814.603]
4814344|NCT02536040|silver diamine fluoride|silver diamine fluoride
4814345|NCT02536040|diammine silver fluoride|diammine silver fluoride
4814346|NCT02536040|children|children
4814347|NCT02536027|continuous venovenous hemofiltration|continuous venovenous hemofiltration
4814348|NCT02536027|neutrophil gelatinase-associated lipocalin|neutrophil gelatinase-associated lipocalin
4814349|NCT02536027|sepsis|sepsis
4814350|NCT02536027|acute kidney injury|acute kidney injury
4814351|NCT02536014|Dexmedetomidine|dexmedetomidine
4814352|NCT02536014|pneumoperitoneum|pneumoperitoneum
4814353|NCT02536014|trendelenburg position|trendelenburg position
4814354|NCT02536014|QTc interval|qtc interval
4814355|NCT02536014|Tp-e interval|tp-e interval
4814356|NCT02536014|robotic prostatectomy|robotic prostatectomy
4814357|NCT02536001|Vaginal mesh|vaginal mesh
4814358|NCT02536001|Total vaginal length|total vaginal length
4814359|NCT02536001|Quality of life|quality of life
4814360|NCT02535988|Colorectal Cancer|colorectal cancer
4814361|NCT02535988|Metastatic Colorectal Cancer|metastatic colorectal cancer
4814362|NCT02535988|ZADAXIN|zadaxin
4814363|NCT02535988|Abscopal Effect|abscopal effect
4814364|NCT02535988|Radiotherapy|radiotherapy
4814365|NCT02535962|PFAPA|pfapa
4814366|NCT02535936|Cerebral Palsy|cerebral palsy
4814367|NCT02535923|Schizophrenia and Disorders with Psychotic Feature|schizophrenia and disorders with psychotic feature
4814368|NCT02535923|Mental Disorders|mental disorders
4814369|NCT02535923|Insomnia Disorder|insomnia disorder
4814370|NCT02535910|vitamin D3|vitamin d3
4814371|NCT02535910|25(OH)D3|25(oh)d3
4814372|NCT02535910|vitamin D status|vitamin d status
4814373|NCT02535910|risk factors of cardiovascular diease|risk factors of cardiovascular diease
4814374|NCT02535884|Huntington Disease|huntington disease
4814375|NCT02535884|DBS|dbs
4814376|NCT02535884|Chorea|chorea
4814377|NCT02535858|Anxiety|anxiety
4814378|NCT02535832|Rheumatoid Arthritis|rheumatoid arthritis
4814379|NCT02535819|Cataract surgery|cataract surgery
4814380|NCT02535806|Relapsed, Refractory|relapsed, refractory
4814381|NCT02535767|Primaquine|primaquine
4814382|NCT02535741|Knee Replacement|knee replacement
4814383|NCT02535741|Arthroplasty|arthroplasty
4814384|NCT02535728|Frail Elderly|frail elderly
4814385|NCT02535728|Cardiac Surgical Procedure|cardiac surgical procedure
4814386|NCT02535728|Risk Assessment|risk assessment
4814387|NCT02535728|Quality of Life|quality of life
4814388|NCT02535715|Oral Insulin|oral insulin
4814389|NCT02535702|fMRI|fmri
4814390|NCT02535702|EEG|eeg
4814391|NCT02535689|Anti-DNA Antibody|anti-dna antibody
4814392|NCT02535689|Tofacitinib|tofacitinib
4814393|NCT02535689|Lupus|lupus
4814394|NCT02535689|Safety|safety
4814395|NCT02535676|schizophrenia|schizophrenia
4814396|NCT02535676|transcranial stimulation|transcranial stimulation
4814397|NCT02535663|rhamnogalacturonan|rhamnogalacturonan
4814398|NCT02535663|Natural killer cell activity|natural killer cell activity
4814399|NCT02535663|interleukin-12|interleukin-12
4814400|NCT02535663|interferon-gamma|interferon-gamma
4814401|NCT02535663|immune function|immune function
4814402|NCT02535663|inflammatory|inflammatory
4814403|NCT02535572|Electroconvulsive Therapy|electroconvulsive therapy
4814404|NCT02535546|Chronic obstructive pulmonary disease (COPD)|chronic obstructive pulmonary disease (copd)
4814405|NCT02535546|Streptococcus pneumoniae|streptococcus pneumoniae
4814406|NCT02535546|Pneumonia|pneumonia
4814407|NCT02535546|Pneumococcal conjugate vaccine-13 (PCV-13)|pneumococcal conjugate vaccine-13 (pcv-13)
4814408|NCT02535546|Pneumococcal polysaccharide vaccine-23 (PPV-23)|pneumococcal polysaccharide vaccine-23 (ppv-23)
4814409|NCT02535546|Pneumococcal vaccine|pneumococcal vaccine
4814410|NCT02535533|Kidney cancer|kidney cancer
4814411|NCT02535533|Selenium (Se)|selenium (se)
4814412|NCT02535507|pyrotinib|pyrotinib
4814413|NCT02535507|HER2|her2
4814414|NCT02535507|Non-small Cell Lung Cancer|non-small cell lung cancer
4814415|NCT02535507|Phase II|phase ii
4814416|NCT02535481|epidermal graft|epidermal graft
4814417|NCT02535481|suction blister|suction blister
4814418|NCT02535481|blister graft|blister graft
4814419|NCT02535481|suction graft|suction graft
4814420|NCT02535481|Epidermis/su, tr [Surgery, Transplantation]|epidermis/su, tr [surgery, transplantation]
4814421|NCT02535390|cognitive remediation|cognitive remediation
4814422|NCT02535390|vocational outcomes|vocational outcomes
4814423|NCT02535377|Cryodamage|cryodamage
4814424|NCT02535377|microarrays|microarrays
4814425|NCT02535377|Insemination|insemination
4814426|NCT02535377|sperm|sperm
4814427|NCT02535364|acute lymphoblastic leukemia|acute lymphoblastic leukemia
4814428|NCT02535364|ALL|all
4814429|NCT02535364|chimeric antigen receptor|chimeric antigen receptor
4814430|NCT02535364|CAR|car
4814431|NCT02535364|CAR T cells|car t cells
4814432|NCT02535364|JCAR015|jcar015
4814433|NCT02535364|autologous T cell therapy|autologous t cell therapy
4814434|NCT02535364|cell therapy|cell therapy
4814435|NCT02535351|Clear cell Metastatic renal cell carcinoma|clear cell metastatic renal cell carcinoma
4814436|NCT02535351|Cytoreductive nephrectomy|cytoreductive nephrectomy
4814437|NCT02535351|First line treatment|first line treatment
4814438|NCT02535299|telomere-telomerase|telomere-telomerase
4814439|NCT02535299|Par-4|par-4
4814440|NCT02535299|GLP-1|glp-1
4814441|NCT02535299|metformin|metformin
4814442|NCT02535273|dexmedetomidine|dexmedetomidine
4814443|NCT02535273|prone position|prone position
4814444|NCT02535273|spine surgery|spine surgery
4814445|NCT02535273|Minimally invasive|minimally invasive
4814446|NCT02535273|local anesthesia|local anesthesia
4814447|NCT02535260|Pregnancy|pregnancy
4814448|NCT02535221|Premenopausal Patients|premenopausal patients
4814449|NCT02535221|Estrogen Receptor-Positive HER2 negative|estrogen receptor-positive her2 negative
4814450|NCT02535169|at risk for type 2 diabetes|at risk for type 2 diabetes
4814451|NCT02535169|currently has type 2 diabetes|currently has type 2 diabetes
4814452|NCT02535065|Low Profile|low profile
4814453|NCT02535065|Abdominal Aortic Aneurysms|abdominal aortic aneurysms
4814454|NCT02535065|Endovascular|endovascular
4814455|NCT02535039|Elderly|elderly
4814456|NCT02535039|cognitive retention disorder|cognitive retention disorder
4814457|NCT02535039|methylprednisolone|methylprednisolone
4814458|NCT02534974|Critical care|critical care
4814459|NCT02534974|Trauma patients|trauma patients
4814460|NCT02534961|Hepatocellular carcinoma|hepatocellular carcinoma
4814461|NCT02534961|Radiofrequency ablation|radiofrequency ablation
4814462|NCT02534961|Antibiotics|antibiotics
4814463|NCT02534948|mindfulness|mindfulness
4814464|NCT02534948|MABT|mabt
4814465|NCT02534948|social anxiety|social anxiety
4814466|NCT02534948|mindfulness and acceptance|mindfulness and acceptance
4814467|NCT02534948|group therapy|group therapy
4814468|NCT02534935|Phase 2 Immunogenicity|phase 2 immunogenicity
4814469|NCT02534935|Safety|safety
4814470|NCT02534935|Tolerability Study|tolerability study
4814471|NCT02534935|rLP2086 Vaccine|rlp2086 vaccine
4814472|NCT02534935|Healthy Toddlers|healthy toddlers
4814473|NCT02534935|Neisseria meningitidis|neisseria meningitidis
4814474|NCT02534935|Duration of Immunogenicity|duration of immunogenicity
4814475|NCT02534909|PNH|pnh
4814476|NCT02534870|Volunteer|volunteer
4814477|NCT02534857|randomized double blinded study|randomized double blinded study
4814478|NCT02534857|live birth rate|live birth rate
4814479|NCT02534857|IVF treatment|ivf treatment
4814480|NCT02534857|brief incubation of oocytes and sperm|brief incubation of oocytes and sperm
4814481|NCT02534844|Niemann-Pick Type C1 (NPC1) Disease|niemann-pick type c1 (npc1) disease
4814482|NCT02534844|neurologic disease|neurologic disease
4814483|NCT02534844|gross motor dysfunction|gross motor dysfunction
4814484|NCT02534844|fine motor dysfunction|fine motor dysfunction
4814485|NCT02534844|dysphagia|dysphagia
4814486|NCT02534844|swallowing problems|swallowing problems
4814487|NCT02534844|cognitive dysfunction|cognitive dysfunction
4814488|NCT02534844|gait abnormalities|gait abnormalities
4814489|NCT02534844|pediatrics|pediatrics
4814490|NCT02534727|Tuberculosis|tuberculosis
4814491|NCT02534727|Non-Tuberculous Mycobacterim|non-tuberculous mycobacterim
4814492|NCT02534727|Xpert/MDR-RIF|xpert/mdr-rif
4814493|NCT02534727|TDM|tdm
4814494|NCT02534701|stroke|stroke
4814495|NCT02534701|clot retrieval system|clot retrieval system
4814496|NCT02534701|recanalization|recanalization
4814497|NCT02534649|Molecular profiling|molecular profiling
4814498|NCT02534649|Genomic alteration|genomic alteration
4814499|NCT02534649|Advanced cancer|advanced cancer
4814500|NCT02534610|preemptive|preemptive
4814501|NCT02534610|postoperative pain|postoperative pain
4814502|NCT02534610|etoricoxib|etoricoxib
4814503|NCT02534584|acute kidney injury|acute kidney injury
4814504|NCT02534584|outcome|outcome
4814505|NCT02534584|mortality|mortality
4814506|NCT02534584|care-bundle|care-bundle
4814507|NCT02534558|MicroRNA-29|microrna-29
4814508|NCT02534558|shoulder stiffness|shoulder stiffness
4814509|NCT02534558|mir-29a|mir-29a
4814510|NCT02534545|Intracranial atherosclerotic stenosis|intracranial atherosclerotic stenosis
4814511|NCT02534545|ischemia|ischemia
4814512|NCT02534545|remote ischemic conditioning|remote ischemic conditioning
4814513|NCT02534545|stroke|stroke
4814514|NCT02534532|Atrial fibrillation screening|atrial fibrillation screening
4814515|NCT02534506|Advanced malignant tumors|advanced malignant tumors
4814516|NCT02534506|Metastatic malignant tumors|metastatic malignant tumors
4814517|NCT02534480|Amyloid|amyloid
4814518|NCT02534415|Antiinflammatory|antiinflammatory
4814519|NCT02534415|Gingiva|gingiva
4814520|NCT02534415|Hyaluronic acid|hyaluronic acid
4814521|NCT02534415|Palate|palate
4814522|NCT02534415|Transplants|transplants
4814523|NCT02534415|Wound healing|wound healing
4814524|NCT02534402|Biomarkers|biomarkers
4814525|NCT02534402|Genomics|genomics
4814526|NCT02534402|Prednisone|prednisone
4814527|NCT02534389|rectal cancer|rectal cancer
4814528|NCT02534389|inflammation|inflammation
4814529|NCT02534389|omega-3|omega-3
4814530|NCT02534389|fish oil|fish oil
4814531|NCT02534389|nutritional status|nutritional status
4814532|NCT02534376|prostatectomy, cholesterol, statin|prostatectomy, cholesterol, statin
4814533|NCT02534363|Cognition|cognition
4814535|NCT02534363|Antipsychotic Agents|antipsychotic agents
4814536|NCT02534363|Treatment|treatment
4814537|NCT02534363|Effectiveness|effectiveness
4814538|NCT02534363|Aripiprazole|aripiprazole
4814539|NCT02534363|Quetiapine|quetiapine
4814540|NCT02534363|Ziprasidone|ziprasidone
4814541|NCT02534363|Neurocognition|neurocognition
4814542|NCT02534350|Respiratory Syncytial Virus (RSV)|respiratory syncytial virus (rsv)
4814543|NCT02534350|Antiviral|antiviral
4814544|NCT02534350|Lung Transplant|lung transplant
4814545|NCT02534324|Hypertension|hypertension
4814546|NCT02534324|Emergency|emergency
4814547|NCT02534298|single sided deafness.|single sided deafness.
4814548|NCT02534298|Auditory plasticity|auditory plasticity
4814549|NCT02534298|Asymmetrical hearing loss|asymmetrical hearing loss
4814550|NCT02534298|Cochlear implants|cochlear implants
4814551|NCT02534298|Inter hemispheric asymmetry|inter hemispheric asymmetry
4814552|NCT02534298|Lateralization index|lateralization index
4814553|NCT02534298|Dichotic hearing|dichotic hearing
4814554|NCT02534285|Anesthesia, Inhalation|anesthesia, inhalation
4814555|NCT02534285|Hearing|hearing
4814556|NCT02534285|Noise, Occupational|noise, occupational
4814557|NCT02534246|Core tissue biopsy|core tissue biopsy
4814558|NCT02534246|Core needle biopsy|core needle biopsy
4814559|NCT02534246|EUS|eus
4814560|NCT02534246|Fine needle biopsy|fine needle biopsy
4814561|NCT02534246|Fine needle aspiration|fine needle aspiration
4814562|NCT02534233|barrett's esophagus with dysplasia|barrett's esophagus with dysplasia
4814563|NCT02534233|early esophageal cancer|early esophageal cancer
4814564|NCT02534220|Toothbrushing|toothbrushing
4814565|NCT02534220|Oral hygiene|oral hygiene
4814566|NCT02534220|Dental hygiene|dental hygiene
4814567|NCT02534194|Gestation|gestation
4814568|NCT02534194|Premature|premature
4814569|NCT02534194|Infants|infants
4814570|NCT02534181|Refeeding Syndrome|refeeding syndrome
4814571|NCT02534181|Cancer|cancer
4814572|NCT02534168|genetic polymorphisms|genetic polymorphisms
4814573|NCT02534155|MitraClip®|mitraclip®
4814574|NCT02534155|MR|mr
4814575|NCT02534155|DMR|dmr
4814576|NCT02534155|high-risk patients|high-risk patients
4814577|NCT02534155|mitral regurgitation|mitral regurgitation
4814578|NCT02534155|surgery|surgery
4814579|NCT02534155|intermediate risk patients|intermediate risk patients
4814580|NCT02534129|breast cancer|breast cancer
4814581|NCT02534129|radiation|radiation
4814582|NCT02534129|dermatitis|dermatitis
4814583|NCT02534116|abdominal reconstruction|abdominal reconstruction
4814584|NCT02534090|Premature|premature
4814585|NCT02534090|Preterm|preterm
4814586|NCT02534090|Necrotizing|necrotizing
4814587|NCT02534090|Enterocolitis|enterocolitis
4814588|NCT02534090|NIRS|nirs
4814589|NCT02534077|omegaven|omegaven
4814590|NCT02534077|cholestasis|cholestasis
4814591|NCT02534077|parenteral nutrition associated liver disease|parenteral nutrition associated liver disease
4814592|NCT02534064|Menopause|menopause
4814593|NCT02534064|Osteoporosis|osteoporosis
4814594|NCT02534064|Hip fractures|hip fractures
4814595|NCT02534064|vitamin D deficiency|vitamin d deficiency
4814596|NCT02534051|clinical care path|clinical care path
4814597|NCT02534051|care pathway|care pathway
4814598|NCT02534051|obesity|obesity
4814599|NCT02534051|pregnancy|pregnancy
4814600|NCT02534038|Disinhibition|disinhibition
4814601|NCT02533986|Berry|berry
4814602|NCT02533986|Inflammation|inflammation
4814603|NCT02533986|Cognition|cognition
4814604|NCT02533986|Polyphenols|polyphenols
4814605|NCT02533986|Appetite|appetite
4814606|NCT02533986|Glucose metabolism|glucose metabolism
4814607|NCT02533960|Registry of Acute Stroke Under Novel Oral Anticoagulants|registry of acute stroke under novel oral anticoagulants
4814608|NCT02533947|Allogeneic Stem Cell Transplantation|allogeneic stem cell transplantation
4814609|NCT02533947|Hematological Malignancies|hematological malignancies
4814610|NCT02533947|Exercise Intervention|exercise intervention
4814611|NCT02533947|Cognitive Function|cognitive function
4814612|NCT02533947|Fatigue|fatigue
4814613|NCT02533947|Randomized Controlled Trial|randomized controlled trial
4814614|NCT02533934|HIV|hiv
4814615|NCT02533934|Hepatitis C|hepatitis c
4814616|NCT02533934|Liver Disease|liver disease
4814617|NCT02533934|HCV Treatment|hcv treatment
4814618|NCT02533934|transplant|transplant
4814619|NCT02533921|Palliative Care|palliative care
4814620|NCT02533921|Parkinson's Disease|parkinson's disease
4814621|NCT02533869|low-dose computed tomography|low-dose computed tomography
4814622|NCT02533817|Fructose|fructose
4814623|NCT02533817|Insulin|insulin
4814624|NCT02533817|Postprandial lipemia|postprandial lipemia
4814625|NCT02533817|Ambulatory blood pressure|ambulatory blood pressure
4814626|NCT02533817|Ethnicity|ethnicity
4814627|NCT02533804|health|health
4814628|NCT02533804|wellness|wellness
4814629|NCT02533804|life expectancy|life expectancy
4814630|NCT02533804|quality of life|quality of life
4814631|NCT02533804|performance|performance
4814632|NCT02533804|religion|religion
4814633|NCT02533804|skin|skin
4814634|NCT02533804|cardiovascular|cardiovascular
4814635|NCT02533804|joints|joints
4814636|NCT02533804|bone|bone
4814637|NCT02533804|respiration|respiration
4814638|NCT02533804|pain|pain
4814639|NCT02533804|nervous system diseases|nervous system diseases
4814640|NCT02533804|oral health|oral health
4814641|NCT02533804|behavior|behavior
4814642|NCT02533804|child|child
4814643|NCT02533804|depression|depression
4814644|NCT02533804|mood|mood
4814645|NCT02533804|panic|panic
4814646|NCT02533804|sleep|sleep
4814647|NCT02533804|stress|stress
4814648|NCT02533804|nutrition|nutrition
4814649|NCT02533804|exercise|exercise
4814650|NCT02533804|life change events|life change events
4814651|NCT02533804|personality|personality
4814652|NCT02533804|employment|employment
4814653|NCT02533804|social networking|social networking
4814654|NCT02533804|time management|time management
4814655|NCT02533804|residence characteristics|residence characteristics
4814656|NCT02533791|Safety|safety
4814657|NCT02533791|immunogenicity|immunogenicity
4814658|NCT02533791|Ebola vaccine|ebola vaccine
4814659|NCT02533791|boosting|boosting
4814660|NCT02533765|Cisplatin-resistant|cisplatin-resistant
4814661|NCT02533765|Neoplasms, Germ Cell and Embryonal|neoplasms, germ cell and embryonal
4814662|NCT02533765|Salvage treatment|salvage treatment
4814663|NCT02533765|olaparib|olaparib
4814664|NCT02533752|Left Atrial Appendage Closure|left atrial appendage closure
4814665|NCT02533752|Watchman device|watchman device
4814666|NCT02533752|LAA Closure|laa closure
4814667|NCT02533726|Bed Sores|bed sores
4814668|NCT02533726|Bedsores|bedsores
4814669|NCT02533726|Decubitus Ulcer|decubitus ulcer
4814670|NCT02533726|Pressure Sore|pressure sore
4814671|NCT02533713|rehabilitation|rehabilitation
4814672|NCT02533713|bone strength|bone strength
4814673|NCT02533713|quality of life|quality of life
4814674|NCT02533687|prostate|prostate
4814675|NCT02533687|transurethral resection|transurethral resection
4814676|NCT02533687|bipolar|bipolar
4814677|NCT02533687|monopolar|monopolar
4814678|NCT02533661|Effectiveness|effectiveness
4814679|NCT02533661|Genes|genes
4814680|NCT02533661|Intervention|intervention
4814681|NCT02533661|Neurodevelopment|neurodevelopment
4814682|NCT02533661|Prematurity|prematurity
4814683|NCT02533661|Preschool Age|preschool age
4814684|NCT02533648|Type 2 diabetes mellitus, oxidative stress|type 2 diabetes mellitus, oxidative stress
4814685|NCT02533648|insulin sensitivity|insulin sensitivity
4814686|NCT02533648|insulin resistance|insulin resistance
4814687|NCT02533648|mitochondrial dysfunction|mitochondrial dysfunction
4814688|NCT02533648|skeletal muscle|skeletal muscle
4814689|NCT02533648|xanthine oxidase|xanthine oxidase
4814690|NCT02533648|allopurinol|allopurinol
4814691|NCT02533622|progressive mobility|progressive mobility
4814692|NCT02533583|pulse oximetry|pulse oximetry
4814693|NCT02533583|clinical assessment|clinical assessment
4814694|NCT02533583|neonate|neonate
4814695|NCT02533583|lung disease|lung disease
4814696|NCT02533570|Lupus|lupus
4814697|NCT02533557|brachial plexus block|brachial plexus block
4814698|NCT02533557|nerve stimulator|nerve stimulator
4814699|NCT02533557|ultrasound|ultrasound
4814700|NCT02533544|tenofovir disoproxil fumarate|tenofovir disoproxil fumarate
4814701|NCT02533505|Respiratory|respiratory
4814702|NCT02533505|COPD|copd
4814703|NCT02533505|O2 Consumption|o2 consumption
4814704|NCT02533492|total knee replacement|total knee replacement
4814705|NCT02533492|vicryl plus|vicryl plus
4814706|NCT02533492|surgical site infection|surgical site infection
4814707|NCT02533453|Type 2 Diabetes Mellitus, T2DM, GLP-1, GLP-1 Once weekly, Exenatide|type 2 diabetes mellitus, t2dm, glp-1, glp-1 once weekly, exenatide
4814708|NCT02533414|kidney stone|kidney stone
4814709|NCT02533414|retrograde intrarenal surgery|retrograde intrarenal surgery
4814710|NCT02533414|ureteral access sheath|ureteral access sheath
4814711|NCT02533414|kidney function|kidney function
4814712|NCT02533388|transcutaneous electrical acupoint stimulation|transcutaneous electrical acupoint stimulation
4814713|NCT02533388|stress response|stress response
4814714|NCT02533375|efficacy|efficacy
4814715|NCT02533375|safety|safety
4814716|NCT02533349|laryngopharyngeal reflux disease|laryngopharyngeal reflux disease
4814717|NCT02533349|prokinetics|prokinetics
4814718|NCT02533349|proton pump inhibitor|proton pump inhibitor
4814719|NCT02533336|Malaria control|malaria control
4814720|NCT02533336|Insecticide treated durable Wall Liners|insecticide treated durable wall liners
4814721|NCT02533336|Malaria incidence|malaria incidence
4814722|NCT02533336|Randomized Trial|randomized trial
4814723|NCT02533323|NK/T-cell lymphoma|nk/t-cell lymphoma
4814724|NCT02533323|induction chemotherapy|induction chemotherapy
4814725|NCT02533323|survival|survival
4814726|NCT02533310|Specific phobia|specific phobia
4814727|NCT02533310|Exposure therapy|exposure therapy
4814728|NCT02533310|Virtual reality|virtual reality
4814729|NCT02533310|Randomized controlled trial|randomized controlled trial
4814730|NCT02533297|standardization,|standardization,
4814731|NCT02533297|performance clinical skills|performance clinical skills
4814732|NCT02533297|nursing|nursing
4814733|NCT02533297|learning curve|learning curve
4814734|NCT02533271|rectal cancer|rectal cancer
4814735|NCT02533271|short-term radiotherapy|short-term radiotherapy
4814736|NCT02533271|neoadjuvant chemotherapy|neoadjuvant chemotherapy
4814737|NCT02533271|total mesorectal excision|total mesorectal excision
4814832|NCT02532699|gamma-aminobutyric acid|gamma-aminobutyric acid
4814738|NCT02533258|advanced renal cell carcinoma, disease progression, sunitinib, interferon alpha|advanced renal cell carcinoma, disease progression, sunitinib, interferon alpha
4814739|NCT02533245|Exercise Training|exercise training
4814740|NCT02533245|Quality of Life|quality of life
4814741|NCT02533245|Patient Reported Outcomes|patient reported outcomes
4814742|NCT02533245|Organ Transplantation|organ transplantation
4814743|NCT02533232|Schizophrenia|schizophrenia
4814744|NCT02533232|Anti-inflammatory|anti-inflammatory
4814745|NCT02533232|Clozapine|clozapine
4814746|NCT02533232|Minocycline|minocycline
4814747|NCT02533232|Psychosis NOS|psychosis nos
4814748|NCT02533219|Hyperinsulinemic hypoglycemia|hyperinsulinemic hypoglycemia
4814749|NCT02533219|PET/CT|pet/ct
4814750|NCT02533219|PET/MRI|pet/mri
4814751|NCT02533219|[18F]-DOPA|[18f]-dopa
4814752|NCT02533219|PET/MR|pet/mr
4814753|NCT02533219|Congenital Hyperinsulinism|congenital hyperinsulinism
4814754|NCT02533193|enhanced recovery after surgery protocal|enhanced recovery after surgery protocal
4814755|NCT02533193|laparoscopic hepatectomy|laparoscopic hepatectomy
4814756|NCT02533180|Liver allograft recipient|liver allograft recipient
4814757|NCT02533180|Immunosuppression withdrawal|immunosuppression withdrawal
4814758|NCT02533180|Calcineurin inhibitor (CNI) based immunosuppression|calcineurin inhibitor (cni) based immunosuppression
4814759|NCT02533180|Living Donor (of the Respective Liver Transplant Recipient)|living donor (of the respective liver transplant recipient)
4814760|NCT02533141|Investigation of the changes of flicker induced vasodilatation before, during and after withdrawal of therapy with simvastatin|investigation of the changes of flicker induced vasodilatation before, during and after withdrawal of therapy with simvastatin
4814761|NCT02533128|Intraoperative blood pressure|intraoperative blood pressure
4814762|NCT02533128|Triple low|triple low
4814763|NCT02533128|Anesthetic overdose|anesthetic overdose
4814764|NCT02533128|Major adverse cardiac events (MACE)|major adverse cardiac events (mace)
4814765|NCT02533128|Myocardial injury after noncardiac surgery (MINS)|myocardial injury after noncardiac surgery (mins)
4814766|NCT02533128|Perioperative risk stratification|perioperative risk stratification
4814767|NCT02533128|Brain-type natriuretic peptide (BNP)|brain-type natriuretic peptide (bnp)
4814768|NCT02533128|High-sensitivity cardiac Troponin I (hs-cTnI)|high-sensitivity cardiac troponin i (hs-ctni)
4814769|NCT02533115|VYXEOS|vyxeos
4814770|NCT02533102|Pharmacokinetics|pharmacokinetics
4814771|NCT02533102|E7050|e7050
4814772|NCT02533102|Healthy Subjects|healthy subjects
4814773|NCT02533050|obstructive sleep apnea|obstructive sleep apnea
4814774|NCT02533050|acute coronary event|acute coronary event
4814775|NCT02533050|cognitive functions|cognitive functions
4814776|NCT02533050|Continuous positive airway pressure night|continuous positive airway pressure night
4814777|NCT02533011|Sepsis|sepsis
4814778|NCT02533011|Heparin Binding Protein|heparin binding protein
4814779|NCT02532998|Pharmacodynamics|pharmacodynamics
4814780|NCT02532998|AZD9977|azd9977
4814781|NCT02532998|Safety|safety
4814782|NCT02532998|Tolerability|tolerability
4814783|NCT02532998|Pharmacokinetics|pharmacokinetics
4814784|NCT02532998|Eplerenone|eplerenone
4814785|NCT02532998|Fludrocortisone|fludrocortisone
4814786|NCT02532985|Gastrointestinal tolerability|gastrointestinal tolerability
4814787|NCT02532985|dietary fiber|dietary fiber
4814788|NCT02532985|clinical trial|clinical trial
4814789|NCT02532985|healthy subjects|healthy subjects
4814790|NCT02532933|Replacement, Knee|replacement, knee
4814791|NCT02532920|Natural history|natural history
4814792|NCT02532920|Atopic dermatitis|atopic dermatitis
4814793|NCT02532920|Atopic march|atopic march
4814794|NCT02532907|HCV|hcv
4814795|NCT02532894|endothelial dysfunction|endothelial dysfunction
4814796|NCT02532894|microvesicles|microvesicles
4814797|NCT02532894|endothelial progenitor cells|endothelial progenitor cells
4814798|NCT02532894|electronic cigarettes|electronic cigarettes
4814799|NCT02532842|Schizophrenia|schizophrenia
4814800|NCT02532842|Paliperidone palmitate|paliperidone palmitate
4814801|NCT02532816|stunting|stunting
4814802|NCT02532816|indonesia|indonesia
4814803|NCT02532803|Cancer|cancer
4814804|NCT02532803|Rectum|rectum
4814805|NCT02532803|Rectal Cancer|rectal cancer
4814806|NCT02532803|Polyps|polyps
4814807|NCT02532790|Mild proteinuria|mild proteinuria
4814808|NCT02532764|cystic fibrosis|cystic fibrosis
4814809|NCT02532764|ΔF508|δf508
4814810|NCT02532764|RNA therapies|rna therapies
4814811|NCT02532764|antisense oligonucleotide|antisense oligonucleotide
4814812|NCT02532764|CFTR|cftr
4814813|NCT02532764|F508del|f508del
4814814|NCT02532764|CF|cf
4814815|NCT02532764|RNA therapy|rna therapy
4814816|NCT02532738|efficacy of MSC|efficacy of msc
4814817|NCT02532738|refractory|refractory
4814818|NCT02532725|heat stress response|heat stress response
4814819|NCT02532725|cardiopulmonary exercise test|cardiopulmonary exercise test
4814820|NCT02532725|men|men
4814821|NCT02532725|middle aged|middle aged
4814822|NCT02532725|heat-shock response|heat-shock response
4814823|NCT02532712|EC-18|ec-18
4814824|NCT02532712|Hematology|hematology
4814825|NCT02532712|Cancer|cancer
4814826|NCT02532712|Neutropenia|neutropenia
4814827|NCT02532699|Antrodia cinnamomea mycelia|antrodia cinnamomea mycelia
4814828|NCT02532699|blood pressure|blood pressure
4814829|NCT02532699|adenosine|adenosine
4814830|NCT02532699|antrosterol|antrosterol
4814831|NCT02532699|clinical trial|clinical trial
4814833|NCT02532686|Treatment resistant|treatment resistant
4814834|NCT02532686|DAAOI|daaoi
4814835|NCT02532686|NMDA|nmda
4814836|NCT02532634|ramosetron|ramosetron
4814837|NCT02532634|palonosetron|palonosetron
4814838|NCT02532634|chemotherapy induced nausea and vomiting|chemotherapy induced nausea and vomiting
4814839|NCT02532582|nerve compression|nerve compression
4814840|NCT02532530|Aortic valve replacement with or without CABG|aortic valve replacement with or without cabg
4814841|NCT02532517|CODMAN ENTERPRISE® Vascular Reconstruction Device|codman enterprise® vascular reconstruction device
4814842|NCT02532517|Wide Neck, Intracranial, Saccular Aneurysms|wide neck, intracranial, saccular aneurysms
4814843|NCT02532517|Cerebral Aneurysms|cerebral aneurysms
4814844|NCT02532504|postnatal depression|postnatal depression
4814845|NCT02532504|Cognitive behaviour Therapy|cognitive behaviour therapy
4814846|NCT02532504|Traditional Birth Attendants|traditional birth attendants
4814847|NCT02532504|low income country|low income country
4814848|NCT02532491|Psychosis|psychosis
4814849|NCT02532491|Antipsychotic Agents|antipsychotic agents
4814850|NCT02532491|Treatment|treatment
4814851|NCT02532491|Effectiveness|effectiveness
4814852|NCT02532491|Aripiprazole|aripiprazole
4814853|NCT02532491|Risperidone|risperidone
4814854|NCT02532452|Epstein-Barr Virus (EBV)|epstein-barr virus (ebv)
4814855|NCT02532452|Adenovirus (ADV)|adenovirus (adv)
4814856|NCT02532452|Cytomegalovirus (CMV)|cytomegalovirus (cmv)
4814857|NCT02532452|T-Cells|t-cells
4814858|NCT02532452|Donor|donor
4814859|NCT02532452|BK virus (BKV)|bk virus (bkv)
4814860|NCT02532439|fracture osteoporosis|fracture osteoporosis
4814861|NCT02532439|bone microarchitecture|bone microarchitecture
4814862|NCT02532439|Inflammatory joint diseases|inflammatory joint diseases
4814863|NCT02532439|Bone fragility|bone fragility
4814864|NCT02532439|Rheumatoid Arthritis|rheumatoid arthritis
4814865|NCT02532439|Spondyloarthritis|spondyloarthritis
4814866|NCT02532439|Primary Hyperparathyroidism|primary hyperparathyroidism
4814867|NCT02532439|constitutional thinness|constitutional thinness
4814868|NCT02532439|anorexia nervosa|anorexia nervosa
4814869|NCT02532426|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
4814870|NCT02532426|Muscle biopsy|muscle biopsy
4814871|NCT02532426|Chronic hypoxia|chronic hypoxia
4814872|NCT02532426|OXYPHEN|oxyphen
4814873|NCT02532426|Oxydative phenotype|oxydative phenotype
4814874|NCT02532426|Exercise|exercise
4814875|NCT02532400|Breast Neoplasms|breast neoplasms
4814876|NCT02532400|Neoadjuvant Endocrine Therapy|neoadjuvant endocrine therapy
4814877|NCT02532400|Ovarian Function Suppression|ovarian function suppression
4814878|NCT02532400|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
4814879|NCT02532374|nicotine absorption|nicotine absorption
4814880|NCT02532374|nicotine containing product|nicotine containing product
4814881|NCT02532374|adult smoker|adult smoker
4814882|NCT02532374|Nicorette|nicorette
4814883|NCT02532374|nicotine delivery system|nicotine delivery system
4814884|NCT02532361|Sterilization|sterilization
4814885|NCT02532361|Hysteroscopic Device Placement|hysteroscopic device placement
4814886|NCT02532361|Tubal Ligation|tubal ligation
4814887|NCT02532348|Human Immunodeficiency Virus|human immunodeficiency virus
4814888|NCT02532348|HIV|hiv
4814889|NCT02532348|antiretroviral therapy|antiretroviral therapy
4814890|NCT02532348|platelets|platelets
4814891|NCT02532348|Immune activation|immune activation
4814892|NCT02532348|Inflammatory state|inflammatory state
4814893|NCT02532335|FXR|fxr
4814894|NCT02532335|bile acids|bile acids
4814895|NCT02532335|FGF19|fgf19
4814896|NCT02532335|C4|c4
4814897|NCT02532335|gut microbiota|gut microbiota
4814898|NCT02532335|Pharmacodynamics of FXR activation in the small bowel|pharmacodynamics of fxr activation in the small bowel
4814899|NCT02532309|Rosuvastatin|rosuvastatin
4814900|NCT02532309|Carotid Atherosclerosis plaque|carotid atherosclerosis plaque
4814901|NCT02532309|Crestor|crestor
4814902|NCT02532309|Rosuvastatin calcium|rosuvastatin calcium
4814903|NCT02532283|Influenza A virus|influenza a virus
4814904|NCT02532283|JNJ-63623872|jnj-63623872
4814905|NCT02532283|Oseltamivir|oseltamivir
4814906|NCT02532270|obstetric|obstetric
4814907|NCT02532270|anesthesia|anesthesia
4814908|NCT02532270|hypotension|hypotension
4814909|NCT02532270|arterial pressure|arterial pressure
4814910|NCT02532270|measurement techniques|measurement techniques
4814911|NCT02532257|Lymphoma|lymphoma
4814912|NCT02532257|Follicular Lymphoma|follicular lymphoma
4814913|NCT02532257|FL|fl
4814914|NCT02532257|Previously untreated|previously untreated
4814915|NCT02532257|Lenalidomide|lenalidomide
4814916|NCT02532257|CC-5013|cc-5013
4814917|NCT02532257|Revlimid|revlimid
4814918|NCT02532257|Rituximab|rituximab
4814919|NCT02532257|Rituxan|rituxan
4814920|NCT02532257|Ibrutinib|ibrutinib
4814921|NCT02532257|PCI-32765|pci-32765
4814922|NCT02532257|Imbruvica|imbruvica
4814923|NCT02532244|distal hereditary motor neuronopathy|distal hereditary motor neuronopathy
4814924|NCT02532231|Leukemia|leukemia
4814925|NCT02532231|Acute myeloid leukemia|acute myeloid leukemia
4814926|NCT02532231|AML|aml
4814927|NCT02532231|High risk for relapse|high risk for relapse
4814928|NCT02532231|Nivolumab|nivolumab
4814929|NCT02532231|BMS-936558|bms-936558
4814930|NCT02532231|Opdivo|opdivo
4814931|NCT02532192|Lymphoma|lymphoma
4814932|NCT02532192|Diffuse large B-cell lymphoma|diffuse large b-cell lymphoma
4814933|NCT02532192|DLBCL|dlbcl
4814934|NCT02532192|Relapsed|relapsed
4814935|NCT02532192|Refractory|refractory
4814936|NCT02532192|Belinostat|belinostat
4814937|NCT02532192|Rituximab|rituximab
4814938|NCT02532192|Rituxan|rituxan
4814939|NCT02532192|Cisplatin|cisplatin
4814940|NCT02532192|Platinol-AQ|platinol-aq
4814941|NCT02532192|Platinol|platinol
4814942|NCT02532192|CDDP|cddp
4814943|NCT02532192|Cytarabine|cytarabine
4814944|NCT02532192|Ara-C|ara-c
4814945|NCT02532192|Cytosar|cytosar
4814946|NCT02532192|DepoCyt|depocyt
4814947|NCT02532192|Cytosine arabinosine hydrochloride|cytosine arabinosine hydrochloride
4814948|NCT02532192|Dexamethasone|dexamethasone
4814949|NCT02532192|Decadron|decadron
4814950|NCT02532192|Ciprofloxacin|ciprofloxacin
4814951|NCT02532192|Ciprofloxacin hydrochloride|ciprofloxacin hydrochloride
4814952|NCT02532192|Cipro|cipro
4814953|NCT02532192|Fluconazole|fluconazole
4814954|NCT02532192|Diflucan|diflucan
4814955|NCT02532179|subcutaneous immunotherapy (SCIT)|subcutaneous immunotherapy (scit)
4814956|NCT02532179|glycerinated mouse allergenic extract|glycerinated mouse allergenic extract
4814957|NCT02532179|mouse specific IgE|mouse specific ige
4814958|NCT02532179|mouse specific IgG and IgG4|mouse specific igg and igg4
4814959|NCT02532179|mouse prick skin test wheal|mouse prick skin test wheal
4814960|NCT02532166|narrow band imaging|narrow band imaging
4814961|NCT02532166|Chromoendoscopy|chromoendoscopy
4814962|NCT02532166|Lugol|lugol
4814963|NCT02532153|Suicidal Ideation|suicidal ideation
4814964|NCT02532153|Suicide|suicide
4814965|NCT02532153|Suicidal Thoughts|suicidal thoughts
4814966|NCT02532153|Depression|depression
4814967|NCT02532153|Ketamine|ketamine
4814968|NCT02532127|Low-dose risk|low-dose risk
4814969|NCT02532075|COPD|copd
4814970|NCT02532075|Respiratory Muscle Warm Up|respiratory muscle warm up
4814971|NCT02532062|lung cancer risk|lung cancer risk
4814972|NCT02532062|cigarette smokers|cigarette smokers
4814973|NCT02532049|Malaria|malaria
4814974|NCT02532049|Vaccine|vaccine
4814975|NCT02532049|Immune Response|immune response
4814976|NCT02532036|MVA85A|mva85a
4814977|NCT02532036|Tuberculosis|tuberculosis
4814978|NCT02532036|Vaccine|vaccine
4814979|NCT02532036|Aerosol|aerosol
4814980|NCT02532023|omega 3 fatty acid|omega 3 fatty acid
4814981|NCT02532023|curcumin|curcumin
4814982|NCT02532023|COX-2|cox-2
4814983|NCT02532023|iNOs|inos
4814984|NCT02532023|VCAM-1|vcam-1
4814985|NCT02532023|ICAM-1|icam-1
4814986|NCT02532023|IL-1β|il-1β
4814987|NCT02532023|IL-6|il-6
4814988|NCT02532023|TNF-α|tnf-α
4814989|NCT02532023|hsCRP|hscrp
4814990|NCT02532023|migraine|migraine
4814991|NCT02531997|self-image|self-image
4814992|NCT02531997|sexual health|sexual health
4814993|NCT02531997|breast cancer|breast cancer
4814994|NCT02531997|gynecologic cancer|gynecologic cancer
4814995|NCT02531997|ovarian cancer|ovarian cancer
4814996|NCT02531997|cervical cancer|cervical cancer
4814997|NCT02531997|uterine cancer|uterine cancer
4814998|NCT02531997|mind body|mind body
4814999|NCT02531997|hypnotic relaxation therapy|hypnotic relaxation therapy
4815000|NCT02531997|hypnosis|hypnosis
4815001|NCT02531997|progressive muscle relaxation|progressive muscle relaxation
4815002|NCT02531971|Bioequivalence|bioequivalence
4815003|NCT02531971|Therapeutic Equivalency|therapeutic equivalency
4815004|NCT02531945|topography|topography
4815005|NCT02531945|cobb angle|cobb angle
4815006|NCT02531932|advanced triple negative breast cancer|advanced triple negative breast cancer
4815007|NCT02531919|tumor acidity|tumor acidity
4815008|NCT02531893|Irritability|irritability
4815009|NCT02531893|Disruptive Mood|disruptive mood
4815010|NCT02531893|Tantrums|tantrums
4815011|NCT02531893|Frustration|frustration
4815012|NCT02531893|Interpretation Bias|interpretation bias
4815013|NCT02531893|Emotional Judgment|emotional judgment
4815014|NCT02531893|Cognitive-Behavioral|cognitive-behavioral
4815015|NCT02531893|Exposure|exposure
4815016|NCT02531893|Research Psychotherapy|research psychotherapy
4815017|NCT02531880|MRI|mri
4815018|NCT02531880|Manganese Enhanced MRI|manganese enhanced mri
4815019|NCT02531880|Seizure Disorder|seizure disorder
4815020|NCT02531880|Seizures|seizures
4815021|NCT02531880|Epileptic Focus|epileptic focus
4815022|NCT02531867|HPP|hpp
4815023|NCT02531867|Bone Disease|bone disease
4815024|NCT02531867|Soft Bones|soft bones
4815025|NCT02531867|Low Alkaline Phosphatase|low alkaline phosphatase
4815026|NCT02531867|Genetic Metabolic Disorder|genetic metabolic disorder
4815027|NCT02531867|Alkaline Phosphatase|alkaline phosphatase
4815028|NCT02531867|Rickets|rickets
4815029|NCT02531867|Osteomalacia|osteomalacia
4815030|NCT02531815|safety|safety
4815031|NCT02531815|tolerability|tolerability
4815032|NCT02531815|pharmacokinetics|pharmacokinetics
4815033|NCT02531815|pharmacodynamics|pharmacodynamics
4815034|NCT02531815|Phase 1|phase 1
4815035|NCT02531815|first in human|first in human
4815036|NCT02531815|monoclonal antibody|monoclonal antibody
4815037|NCT02531815|tissue factor pathway inhibitor|tissue factor pathway inhibitor
4815038|NCT02531815|japanese|japanese
4815039|NCT02531802|ETEC diarrhea|etec diarrhea
4815040|NCT02531802|Escherichia Coli (ETEC)|escherichia coli (etec)
4815041|NCT02531776|Diabetes|diabetes
4815042|NCT02531776|Needle|needle
4815043|NCT02531776|Pen needle|pen needle
4815044|NCT02531763|mHealth|mhealth
4815045|NCT02531763|behavioral economics|behavioral economics
4815046|NCT02531763|social incentives|social incentives
4815047|NCT02531750|Metabolism|metabolism
4815048|NCT02531750|Bone metabolism|bone metabolism
4815049|NCT02531750|Glucose Metabolism|glucose metabolism
4815050|NCT02531750|Lipid metabolism|lipid metabolism
4815051|NCT02531750|Low grade inflamation|low grade inflamation
4815052|NCT02531724|acute kidney injury|acute kidney injury
4815053|NCT02531724|cardiac surgery|cardiac surgery
4815054|NCT02531724|renal blood flow|renal blood flow
4815055|NCT02531724|levosimendan|levosimendan
4815056|NCT02531711|Lumbosacral|lumbosacral
4815057|NCT02531711|radicular|radicular
4815058|NCT02531685|dmLT|dmlt
4815059|NCT02531685|Enteric|enteric
4815060|NCT02531685|Escherichia coli Infections|escherichia coli infections
4815061|NCT02531685|Shigella|shigella
4815062|NCT02531685|Toxin LTR192G/L211A|toxin ltr192g/l211a
4815063|NCT02531672|11C-choline|11c-choline
4815064|NCT02531672|Positron Emission Tomography|positron emission tomography
4815065|NCT02531672|15-117|15-117
4815066|NCT02531646|pulmonary nodule|pulmonary nodule
4815067|NCT02531633|Giant Cell Arteritis, Sirukumab, Prednisone|giant cell arteritis, sirukumab, prednisone
4815068|NCT02531620|prehabilitation|prehabilitation
4815069|NCT02531620|colorectal surgery|colorectal surgery
4815070|NCT02531555|chronic periodontitis|chronic periodontitis
4815071|NCT02531555|dental scaling|dental scaling
4815072|NCT02531555|gingival crevicular fluid|gingival crevicular fluid
4815073|NCT02531555|lasers|lasers
4815074|NCT02531555|periodontal pocket|periodontal pocket
4815075|NCT02531555|root planing|root planing
4815076|NCT02531516|Prostatic neoplasms|prostatic neoplasms
4815077|NCT02531516|Prostate Cancer|prostate cancer
4815078|NCT02531516|High-Risk prostate cancer|high-risk prostate cancer
4815079|NCT02531516|JNJ-56021927|jnj-56021927
4815080|NCT02531516|Apalutamide|apalutamide
4815081|NCT02531516|ATLAS|atlas
4815082|NCT02531516|Radiation|radiation
4815083|NCT02531516|Long-term hormone therapy|long-term hormone therapy
4815084|NCT02531516|Localized or locally advanced prostate cancer|localized or locally advanced prostate cancer
4815085|NCT02531516|Janssen|janssen
4815086|NCT02531503|Asthma remission|asthma remission
4815087|NCT02531503|Predicting factors|predicting factors
4815088|NCT02531503|Children|children
4815089|NCT02531464|family caregiver|family caregiver
4815090|NCT02531464|quality of life|quality of life
4815091|NCT02531464|supportive care|supportive care
4815092|NCT02531464|distress screening|distress screening
4815093|NCT02531464|needs assessment|needs assessment
4815094|NCT02531451|Muscle mass|muscle mass
4815095|NCT02531451|strength|strength
4815096|NCT02531451|NSAID|nsaid
4815097|NCT02531451|Ibuprofen|ibuprofen
4815098|NCT02531451|resistance exercise|resistance exercise
4815099|NCT02531425|TNBC|tnbc
4815100|NCT02531425|Triple Negative Breast Cancer|triple negative breast cancer
4815101|NCT02531412|Acute kidney injury|acute kidney injury
4815102|NCT02531412|Critically ill cancer patients|critically ill cancer patients
4815103|NCT02531412|Spironolactone|spironolactone
4815104|NCT02531399|flicker induced changes|flicker induced changes
4815105|NCT02531399|total volumetric retinal blood flow|total volumetric retinal blood flow
4815106|NCT02531308|diffuse large b-cell lymphoma (DLBCL),|diffuse large b-cell lymphoma (dlbcl),
4815107|NCT02531308|lymphoma|lymphoma
4815108|NCT02531282|Patient education as topic|patient education as topic
4815109|NCT02531282|Health promotion|health promotion
4815110|NCT02531282|Patient participation|patient participation
4815111|NCT02531282|Self efficacy|self efficacy
4815112|NCT02531256|Laryngeal Mask Airway|laryngeal mask airway
4815113|NCT02531243|prodrome|prodrome
4815114|NCT02531243|family therapy|family therapy
4815115|NCT02531243|clinical high risk|clinical high risk
4815116|NCT02531204|ASP1585|asp1585
4815117|NCT02531204|Bioequivalence|bioequivalence
4815118|NCT02531204|Pharmacodynamic|pharmacodynamic
4815119|NCT02531204|Phosphate binder|phosphate binder
4815120|NCT02531204|Bixalomer|bixalomer
4815121|NCT02531204|urinary phosphorus excretion|urinary phosphorus excretion
4815122|NCT02531191|ASP015K|asp015k
4815123|NCT02531191|JAK inhibitor|jak inhibitor
4815124|NCT02531191|bioequivalence study|bioequivalence study
4815125|NCT02531178|Rheumatoid Arthritis|rheumatoid arthritis
4815126|NCT02531139|Cerebrovascular Circulation|cerebrovascular circulation
4815127|NCT02531139|Anesthesia|anesthesia
4815128|NCT02531139|Blood pressure|blood pressure
4815129|NCT02531139|Peripheral Arterial Diseases|peripheral arterial diseases
4815130|NCT02531074|Mobile Applications|mobile applications
4815131|NCT02531061|Rheumatoid Arthritis|rheumatoid arthritis
4815132|NCT02531061|bDMARDs|bdmards
4815133|NCT02531061|biotherapy|biotherapy
4815134|NCT02531061|remission|remission
4815135|NCT02531061|erosion|erosion
4815136|NCT02531048|healthy volunteers|healthy volunteers
4815137|NCT02530957|Intubation|intubation
4815138|NCT02530957|Preoxygenation|preoxygenation
4815139|NCT02530957|Complications|complications
4815140|NCT02530957|Non invasive ventilation|non invasive ventilation
4815141|NCT02530957|High flow nasal cannula|high flow nasal cannula
4815142|NCT02530944|Lupus|lupus
4815143|NCT02530944|Systemic Lupus Erythematosus (SLE)|systemic lupus erythematosus (sle)
4815144|NCT02530944|genetic|genetic
4815145|NCT02530944|online|online
4815146|NCT02530944|genome wide association|genome wide association
4815147|NCT02530944|systemic lupus erythematosus|systemic lupus erythematosus
4815148|NCT02530944|genome wide association study (GWAS)|genome wide association study (gwas)
4815149|NCT02530918|DS-7080a Monoclonal Antibody|ds-7080a monoclonal antibody
4815150|NCT02530905|Duchenne muscular dystrophy|duchenne muscular dystrophy
4815151|NCT02530905|Exon Skipping|exon skipping
4815152|NCT02530892|embryo|embryo
4815153|NCT02530892|in vitro fertilization|in vitro fertilization
4815154|NCT02530892|IVF|ivf
4815155|NCT02530840|imbalanced diabetic patients|imbalanced diabetic patients
4815156|NCT02530840|HbA1c|hba1c
4815157|NCT02530840|peers|peers
4815158|NCT02530827|energy expenditure|energy expenditure
4815159|NCT02530827|doubly labeled water|doubly labeled water
4815160|NCT02530827|accelerometer|accelerometer
4815161|NCT02530827|HIV|hiv
4815162|NCT02530827|lipodystrophy syndrome.|lipodystrophy syndrome.
4815163|NCT02530814|organochlorine compounds|organochlorine compounds
4815164|NCT02530814|pesticides|pesticides
4815165|NCT02530788|Heart Failure|heart failure
4815166|NCT02530788|Cardiac Surgery|cardiac surgery
4815167|NCT02530788|Ventricular Assist Device|ventricular assist device
4815168|NCT02530788|Selenium|selenium
4815169|NCT02530762|Gastrointestinal tolerability|gastrointestinal tolerability
4815170|NCT02530762|dietary fiber|dietary fiber
4815171|NCT02530762|clinical trial|clinical trial
4815172|NCT02530762|healthy subjects|healthy subjects
4815173|NCT02530749|Surgery|surgery
4815174|NCT02530749|Frailty|frailty
4815175|NCT02530736|Gait speed|gait speed
4815176|NCT02530736|Pulmonary Rehabilitation|pulmonary rehabilitation
4815177|NCT02530723|power training|power training
4815178|NCT02530723|high-speed training|high-speed training
4815179|NCT02530723|high-velocity training|high-velocity training
4815180|NCT02530723|function|function
4815181|NCT02530723|older adults|older adults
4815182|NCT02530723|older women|older women
4815183|NCT02530697|Leishmaniasis|leishmaniasis
4815184|NCT02530697|Mucocutaneous|mucocutaneous
4815185|NCT02530697|Miltefosine|miltefosine
4815186|NCT02530697|Pentoxifylline|pentoxifylline
4815187|NCT02530671|multi-directional power toothbrush|multi-directional power toothbrush
4815188|NCT02530671|manual toothbrush|manual toothbrush
4815189|NCT02530658|Genetic Predisposition|genetic predisposition
4815190|NCT02530658|Pediatric|pediatric
4815191|NCT02530658|Genomic Analysis|genomic analysis
4815192|NCT02530658|Heritable Disease|heritable disease
4815193|NCT02530658|Cancer Risk|cancer risk
4815194|NCT02530658|Genetic Counseling|genetic counseling
4815195|NCT02530658|DNA|dna
4815196|NCT02530658|Clinical Genomics|clinical genomics
4815197|NCT02530658|Clinical Decision-Making|clinical decision-making
4815198|NCT02530658|Treatment Planning|treatment planning
4815199|NCT02530632|microperfusion|microperfusion
4815200|NCT02530632|temperature|temperature
4815201|NCT02530632|near-infrared spectroscopy|near-infrared spectroscopy
4815202|NCT02530632|anesthesia|anesthesia
4815203|NCT02530632|total intravenous anaesthesia|total intravenous anaesthesia
4815204|NCT02530580|GABA modulator|gaba modulator
4815205|NCT02530580|AZD7325|azd7325
4815206|NCT02530580|Object manipulation|object manipulation
4815207|NCT02530580|Cutaneous sensation|cutaneous sensation
4815208|NCT02530580|Manual dexterity|manual dexterity
4815209|NCT02530567|portal pressure|portal pressure
4815210|NCT02530567|portosystemic pressure gradient|portosystemic pressure gradient
4815211|NCT02530567|azygos blood flow|azygos blood flow
4815212|NCT02530554|Pilot Projects|pilot projects
4815213|NCT02530515|Leukemia|leukemia
4815214|NCT02530515|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
4815215|NCT02530515|CLL|cll
4815216|NCT02530515|T-cells|t-cells
4815217|NCT02530515|Immune cells|immune cells
4815218|NCT02530515|Rituximab|rituximab
4815219|NCT02530515|Rituxan|rituxan
4815220|NCT02530515|Cyclophosphamide|cyclophosphamide
4815221|NCT02530515|Cytoxan|cytoxan
4815222|NCT02530515|Neosar|neosar
4815223|NCT02530515|Fludarabine Phosphate|fludarabine phosphate
4815224|NCT02530515|Fludarabine|fludarabine
4815225|NCT02530515|Fludara|fludara
4815226|NCT02530515|Bendamustine|bendamustine
4815227|NCT02530515|Bendamustine Hydrochloride|bendamustine hydrochloride
4815228|NCT02530515|Bendamustine HCL|bendamustine hcl
4815229|NCT02530515|CEP-18083|cep-18083
4815230|NCT02530515|SDX-105|sdx-105
4815231|NCT02530515|Treanda|treanda
4815232|NCT02530515|Lenalidomide|lenalidomide
4815233|NCT02530515|CC-5013|cc-5013
4815234|NCT02530515|Revlimid|revlimid
4815235|NCT02530489|Breast Cancer|breast cancer
4815236|NCT02530489|Triple negative breast cancer|triple negative breast cancer
4815237|NCT02530489|TNBC|tnbc
4815238|NCT02530489|Invasive adenocarcinoma of the breast|invasive adenocarcinoma of the breast
4815239|NCT02530489|MPDL3280A|mpdl3280a
4815240|NCT02530489|Nab-paclitaxel|nab-paclitaxel
4815241|NCT02530489|Paclitaxel|paclitaxel
4815242|NCT02530489|Abraxane|abraxane
4815243|NCT02530489|ABI-007|abi-007
4815244|NCT02530476|Leukemia|leukemia
4815245|NCT02530476|Acute myeloid leukemia|acute myeloid leukemia
4815246|NCT02530476|AML|aml
4815247|NCT02530476|Relapsed/Refractory|relapsed/refractory
4815248|NCT02530476|FLT3-ITD mutation|flt3-itd mutation
4815249|NCT02530476|FLT3-mutated high-risk myelodysplastic syndrome|flt3-mutated high-risk myelodysplastic syndrome
4815250|NCT02530476|MDS|mds
4815251|NCT02530476|Chronic Myelomonocytic Leukemia|chronic myelomonocytic leukemia
4815252|NCT02530476|CMML|cmml
4815253|NCT02530476|Selinexor|selinexor
4815254|NCT02530476|KPT-330|kpt-330
4815255|NCT02530476|Sorafenib|sorafenib
4815256|NCT02530476|Nexavar|nexavar
4815257|NCT02530476|BAY 43-9006|bay 43-9006
4815258|NCT02530476|FLT3-inhibitor therapy|flt3-inhibitor therapy
4815259|NCT02530463|Leukemia|leukemia
4815260|NCT02530463|Myelodysplastic syndrome|myelodysplastic syndrome
4815261|NCT02530463|MDS|mds
4815262|NCT02530463|Nivolumab|nivolumab
4815263|NCT02530463|BMS-936558|bms-936558
4815264|NCT02530463|Opdivo|opdivo
4815265|NCT02530463|Ipilimumab|ipilimumab
4815266|NCT02530463|Yervoy|yervoy
4815267|NCT02530463|BMS-734016|bms-734016
4815268|NCT02530463|MDX010|mdx010
4815269|NCT02530463|5-azacitidine|5-azacitidine
4815270|NCT02530463|Azacitidine|azacitidine
4815271|NCT02530463|5-AZA|5-aza
4815272|NCT02530463|Vidaza|vidaza
4815273|NCT02530463|5-AZC|5-azc
4815274|NCT02530463|AZA-CR|aza-cr
4815275|NCT02530463|Ladakamycin|ladakamycin
4815276|NCT02530463|NSC-102816|nsc-102816
4815277|NCT02530463|Azacytidine|azacytidine
4815278|NCT02530450|children|children
4815279|NCT02530450|poor adherence|poor adherence
4815280|NCT02530450|continuous glucose monitoring|continuous glucose monitoring
4815281|NCT02530437|Esophageal Cancer|esophageal cancer
4815282|NCT02530437|Adenocarcinoma of the Esophagus|adenocarcinoma of the esophagus
4815283|NCT02530437|Adenocarcinoma of the Gastroesophageal Junction|adenocarcinoma of the gastroesophageal junction
4815284|NCT02530437|Chemoradiation|chemoradiation
4815285|NCT02530437|LY2940680|ly2940680
4815286|NCT02530437|Paclitaxel (Protein-Bound)|paclitaxel (protein-bound)
4815287|NCT02530437|Taxol|taxol
4815288|NCT02530437|Carboplatin|carboplatin
4815289|NCT02530437|Paraplatin|paraplatin
4815290|NCT02530437|Radiation therapy|radiation therapy
4815291|NCT02530437|XRT|xrt
4815292|NCT02530437|External beam|external beam
4815293|NCT02530437|Endoscopy|endoscopy
4815294|NCT02530424|HER2-positive|her2-positive
4815295|NCT02530424|ER-positive|er-positive
4815296|NCT02530424|invasive|invasive
4815297|NCT02530424|CDK4,6|cdk4,6
4815298|NCT02530424|Palbociclib|palbociclib
4815299|NCT02530424|neoadjuvant treatment|neoadjuvant treatment
4815300|NCT02530411|Hormone resistance|hormone resistance
4815301|NCT02530411|vandetanib|vandetanib
4815302|NCT02530411|fulvestrant|fulvestrant
4815303|NCT02530359|septic acute kidney injury|septic acute kidney injury
4815304|NCT02530359|pirfenidone|pirfenidone
4815305|NCT02530320|Palbociclib|palbociclib
4815306|NCT02530320|oligodendroglioma|oligodendroglioma
4815307|NCT02530320|oligoastrocytoma anaplastic|oligoastrocytoma anaplastic
4815308|NCT02530307|Stroke,|stroke,
4815309|NCT02530307|Rehabilitation|rehabilitation
4815310|NCT02530307|Ischemic|ischemic
4815311|NCT02530307|fMRI|fmri
4815312|NCT02530268|psoriatic arthritis|psoriatic arthritis
4815313|NCT02530268|spondyloarthritis|spondyloarthritis
4815314|NCT02530268|disease registry|disease registry
4815315|NCT02530255|retinal amyloid|retinal amyloid
4815316|NCT02530255|Retinal amyloid index|retinal amyloid index
4815317|NCT02530255|Alzheimer disease|alzheimer disease
4815318|NCT02530255|telomere attrition|telomere attrition
4815319|NCT02530255|telomere activation|telomere activation
4815320|NCT02530242|Sickle Cell Anemia|sickle cell anemia
4815321|NCT02530229|periprosthetic joint infection|periprosthetic joint infection
4815322|NCT02530229|septic arthritis|septic arthritis
4815323|NCT02530203|post-operative atrial fibrillation|post-operative atrial fibrillation
4815324|NCT02530203|spinal cord stimulation|spinal cord stimulation
4815325|NCT02530203|CABG|cabg
4815326|NCT02530177|Alopecia|alopecia
4815327|NCT02530177|Skin Aging|skin aging
4815328|NCT02530177|Nail Changes|nail changes
4815329|NCT02530177|Hair Changes|hair changes
4815330|NCT02530177|15-198|15-198
4815331|NCT02530164|tDCS|tdcs
4815332|NCT02530164|SSRI|ssri
4815333|NCT02530151|Hip arthroscopy|hip arthroscopy
4815334|NCT02530151|Intra-articular injection|intra-articular injection
4815335|NCT02530151|Morphine|morphine
4815336|NCT02530151|Clonidine|clonidine
4815337|NCT02530073|congenital diaphragmatic hernia|congenital diaphragmatic hernia
4815338|NCT02530073|FETO|feto
4815339|NCT02530073|tracheal occlusion|tracheal occlusion
4815340|NCT02530060|Healthy|healthy
4815341|NCT02530060|Rilpivirine|rilpivirine
4815342|NCT02530060|Tenofovir|tenofovir
4815343|NCT02530060|Emtricitabine|emtricitabine
4815344|NCT02530060|Tenofovir Disoproxil Fumarate|tenofovir disoproxil fumarate
4815345|NCT02530047|Ovarian cancer|ovarian cancer
4815346|NCT02530047|Epithelial ovarian cancer|epithelial ovarian cancer
4815347|NCT02530047|Mesenchymal Stem Cells Secreting Interferon Beta|mesenchymal stem cells secreting interferon beta
4815348|NCT02530047|MSC-INFb|msc-infb
4815349|NCT02530047|Questionnaires|questionnaires
4815350|NCT02530047|Surveys|surveys
4815351|NCT02530034|Leukemia|leukemia
4815352|NCT02530034|Advanced Hematologic Malignancies|advanced hematologic malignancies
4815353|NCT02530034|Myelodysplastic syndrome|myelodysplastic syndrome
4815354|NCT02530034|MDS|mds
4815355|NCT02530034|Chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
4815356|NCT02530034|CMML|cmml
4815357|NCT02530034|Acute myeloid leukemia|acute myeloid leukemia
4815358|NCT02530034|AML|aml
4815359|NCT02530034|Myelofibrosis|myelofibrosis
4815360|NCT02530034|Hu8F4|hu8f4
4815361|NCT02530021|Ischemic heart disease|ischemic heart disease
4815362|NCT02530021|Heart rate variability|heart rate variability
4815363|NCT02530021|Exercise Strss Test|exercise strss test
4815364|NCT02529956|Psoriasis|psoriasis
4815365|NCT02529956|UCB4940|ucb4940
4815366|NCT02529943|Spinal Stenosis|spinal stenosis
4815367|NCT02529943|Motor Evoked Potential|motor evoked potential
4815368|NCT02529930|HSIL|hsil
4815369|NCT02529930|CIN 2/3|cin 2/3
4815370|NCT02529930|Therapeutic DNA vaccine|therapeutic dna vaccine
4815371|NCT02529930|Human Papillomavirus|human papillomavirus
4815372|NCT02529930|Immunotherapy|immunotherapy
4815373|NCT02529891|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
4815374|NCT02529891|COPD|copd
4815375|NCT02529891|Volatile Organic Compounds|volatile organic compounds
4815376|NCT02529891|Exacerbation|exacerbation
4815377|NCT02529878|gastric caner|gastric caner
4815378|NCT02529878|Apatinib|apatinib
4815379|NCT02529878|S1|s1
4815380|NCT02529878|conversion therapy|conversion therapy
4815381|NCT02529878|metastatic gastric cancer|metastatic gastric cancer
4815382|NCT02529865|Cell Transplantation|cell transplantation
4815383|NCT02529852|Lymphoma|lymphoma
4815384|NCT02529852|Diffuse Large B Cell Lymphoma|diffuse large b cell lymphoma
4815385|NCT02529852|DLBCL|dlbcl
4815386|NCT02529852|Lenalidomide|lenalidomide
4815387|NCT02529852|CC-5013|cc-5013
4815388|NCT02529852|Revlimid|revlimid
4815389|NCT02529852|Obinutuzumab|obinutuzumab
4815390|NCT02529852|GA101|ga101
4815391|NCT02529852|Gazyva|gazyva
4815392|NCT02529852|Cyclophosphamide|cyclophosphamide
4815393|NCT02529852|Cytoxan|cytoxan
4815394|NCT02529852|Neosar|neosar
4815395|NCT02529852|Doxorubicin|doxorubicin
4815396|NCT02529852|Doxorubicin Hydrochloride|doxorubicin hydrochloride
4815397|NCT02529852|Adriamycin PFS|adriamycin pfs
4815398|NCT02529852|Adriamycin RDF|adriamycin rdf
4815399|NCT02529852|Adriamycin|adriamycin
4815400|NCT02529852|Rubex|rubex
4815401|NCT02529852|Vincristine|vincristine
4815402|NCT02529852|Prednisone|prednisone
4815403|NCT02529839|MS|ms
4815404|NCT02529839|BMT|bmt
4815405|NCT02529826|Cancer-affected prepubertal boys|cancer-affected prepubertal boys
4815406|NCT02529813|Leukemia|leukemia
4815407|NCT02529813|Lymphoma|lymphoma
4815408|NCT02529813|Advanced Lymphoid Malignancies|advanced lymphoid malignancies
4815409|NCT02529813|CD19+ lymphoid malignancy|cd19+ lymphoid malignancy
4815410|NCT02529813|Multiple myeloma|multiple myeloma
4815411|NCT02529813|MM|mm
4815412|NCT02529813|CD19-specific T cells|cd19-specific t cells
4815413|NCT02529813|Chimeric Antigen Receptor T cells|chimeric antigen receptor t cells
4815414|NCT02529813|CAR T cells|car t cells
4815415|NCT02529813|Autologous|autologous
4815416|NCT02529813|Allogeneic|allogeneic
4815417|NCT02529813|Fludarabine|fludarabine
4815418|NCT02529813|Fludarabine phosphate|fludarabine phosphate
4815419|NCT02529813|Cyclophosphamide|cyclophosphamide
4815420|NCT02529813|Cytoxan|cytoxan
4815421|NCT02529813|Neosar|neosar
4815422|NCT02529813|nonviral|nonviral
4815423|NCT02529813|non-viral|non-viral
4815424|NCT02529813|DNA plasmids|dna plasmids
4815425|NCT02529761|HCC|hcc
4815426|NCT02529761|sorafenib|sorafenib
4815427|NCT02529761|TACE|tace
4815428|NCT02529761|overall survival|overall survival
4815429|NCT02529696|accelerometer|accelerometer
4815430|NCT02529696|RASS|rass
4815431|NCT02529683|Nuvaring|nuvaring
4815432|NCT02529683|contraceptive vaginal ring|contraceptive vaginal ring
4815433|NCT02529683|Kenya|kenya
4815434|NCT02529683|adherence|adherence
4815435|NCT02529683|acceptability|acceptability
4815436|NCT02529683|immunological effects|immunological effects
4815437|NCT02529670|Low Level Laser Therapy|low level laser therapy
4815438|NCT02529670|Low Back Pain|low back pain
4815439|NCT02529670|Diagnosis|diagnosis
4815440|NCT02529670|Genetic|genetic
4815441|NCT02529670|Clinical trial|clinical trial
4815442|NCT02529657|Lower Level Laser Therapy (LLLT)|lower level laser therapy (lllt)
4815443|NCT02529657|inflammation|inflammation
4815444|NCT02529657|cytokines|cytokines
4815445|NCT02529657|wound healing|wound healing
4815446|NCT02529657|laminectomy|laminectomy
4815447|NCT02529657|clinical study|clinical study
4815448|NCT02529644|HIV Screening|hiv screening
4815449|NCT02529644|African American|african american
4815450|NCT02529644|Church|church
4815451|NCT02529631|Polyglucosamine|polyglucosamine
4815452|NCT02529631|L 112|l 112
4815453|NCT02529631|overweight,|overweight,
4815454|NCT02529631|obesity|obesity
4815455|NCT02529631|orlistat|orlistat
4815456|NCT02529631|weight reduction|weight reduction
4815457|NCT02529605|dietary supplement|dietary supplement
4815458|NCT02529605|pharmacokinetics|pharmacokinetics
4815459|NCT02529605|Healthy Volunteers|healthy volunteers
4815460|NCT02529592|Sickness behavior|sickness behavior
4815461|NCT02529592|Cytokines|cytokines
4815462|NCT02529592|Psychoneuroimmunology|psychoneuroimmunology
4815463|NCT02529579|adoptive Cellular Immunotherapy|adoptive cellular immunotherapy
4815464|NCT02529579|patient safety|patient safety
4815465|NCT02529579|therapeutic effect|therapeutic effect
4815466|NCT02529566|Lumbar Degenerative Disc Disease|lumbar degenerative disc disease
4815467|NCT02529566|Degenerative Spinal Conditions|degenerative spinal conditions
4815468|NCT02529566|Adjacent Segment Disease|adjacent segment disease
4815469|NCT02529566|Autologous Bone Marrow|autologous bone marrow
4815470|NCT02529566|Lower Back Pain|lower back pain
4815471|NCT02529566|Chronic Lower Back Pain|chronic lower back pain
4815472|NCT02529566|Stem Cells|stem cells
4815473|NCT02529566|Lumbar disk|lumbar disk
4815474|NCT02529566|Mesenchymal Stem Cells|mesenchymal stem cells
4815475|NCT02529566|Stabilization|stabilization
4815476|NCT02529566|CLBP|clbp
4815477|NCT02529566|Autograft|autograft
4815478|NCT02529566|Allograft|allograft
4815479|NCT02529566|Autograft versus Allograft|autograft versus allograft
4815480|NCT02529566|Facet Joint|facet joint
4815481|NCT02529566|Radicular Pain|radicular pain
4815482|NCT02529566|Adipose|adipose
4815483|NCT02529566|Disc Replacement|disc replacement
4815484|NCT02529566|Facet Joint Replacement|facet joint replacement
4815485|NCT02529553|bladder cancer|bladder cancer
4815486|NCT02529540|Myopia|myopia
4815487|NCT02529540|self-refraction|self-refraction
4815488|NCT02529540|glasses|glasses
4815489|NCT02529540|spectacles|spectacles
4815490|NCT02529514|Baclofen|baclofen
4815491|NCT02529514|Cardiac Surgery|cardiac surgery
4815492|NCT02529514|Polysomnography|polysomnography
4815493|NCT02529514|Intensive Care Units|intensive care units
4815494|NCT02529514|Sleep|sleep
4815495|NCT02529449|ASP1941|asp1941
4815496|NCT02529449|type 1 diabetes mellitus|type 1 diabetes mellitus
4815497|NCT02529449|SGLT2 inhibitor|sglt2 inhibitor
4815498|NCT02529436|overuse antidepressant|overuse antidepressant
4815499|NCT02529436|dementia|dementia
4815500|NCT02529423|food intake|food intake
4815501|NCT02529423|food-related behaviour|food-related behaviour
4815502|NCT02529423|obesity|obesity
4815503|NCT02529423|socioeconomic environment|socioeconomic environment
4815504|NCT02529423|depression|depression
4815505|NCT02529423|nutritional strategies|nutritional strategies
4815506|NCT02529397|Working Memory Training, Weight Loss,|working memory training, weight loss,
4815507|NCT02529384|Breast magnetic resonance imaging|breast magnetic resonance imaging
4815508|NCT02529384|Diffusion-weighted imaging|diffusion-weighted imaging
4815509|NCT02529384|Multiple b-value diffusion weighted imaging|multiple b-value diffusion weighted imaging
4815510|NCT02529358|Maintenance intervention|maintenance intervention
4815511|NCT02529358|Text messages|text messages
4815512|NCT02529358|Emotion Regulation|emotion regulation
4815513|NCT02529332|Endoscopic Sellar/Parasellar Tumor Resection|endoscopic sellar/parasellar tumor resection
4815514|NCT02529319|atrial fibrillation|atrial fibrillation
4815515|NCT02529319|ablation|ablation
4815517|NCT02529280|Latinas|latinas
4815518|NCT02529280|Breast Cancer|breast cancer
4815519|NCT02529280|Clinical Trials|clinical trials
4815520|NCT02529280|Participation|participation
4815521|NCT02529267|Cohort Studies|cohort studies
4815522|NCT02529267|intimate partner violence|intimate partner violence
4815523|NCT02529267|orthopaedic surgery|orthopaedic surgery
4815524|NCT02529267|epidemiology|epidemiology
4815525|NCT02529267|outcomes in fracture care|outcomes in fracture care
4815526|NCT02529254|post graduate surgical education|post graduate surgical education
4815527|NCT02529254|video coaching|video coaching
4815528|NCT02529254|Surgical education|surgical education
4815529|NCT02529254|coaching|coaching
4815530|NCT02529202|Dexmedetomidine|dexmedetomidine
4815531|NCT02529202|Neonate|neonate
4815532|NCT02529202|Pharmacokinetics|pharmacokinetics
4815533|NCT02529202|Therapeutic Hypothermia|therapeutic hypothermia
4815534|NCT02529202|Hypoxic-ischemic Encephalopathy|hypoxic-ischemic encephalopathy
4815535|NCT02529202|Adrenergic Agents|adrenergic agents
4815536|NCT02529202|Adrenergic Agonists|adrenergic agonists
4815537|NCT02529202|Analgesics|analgesics
4815538|NCT02529202|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists
4815539|NCT02529202|Central Nervous System Agents|central nervous system agents
4815540|NCT02529202|Central Nervous System Depressants|central nervous system depressants
4815541|NCT02529189|Stable Angina|stable angina
4815542|NCT02529189|Angioplasty|angioplasty
4815543|NCT02529189|Optical Coherence Tomography|optical coherence tomography
4815544|NCT02529189|Nitrate|nitrate
4815545|NCT02529176|telemetry|telemetry
4815546|NCT02529176|cardiac monitoring|cardiac monitoring
4815547|NCT02529163|Integrated Care Pathway|integrated care pathway
4815548|NCT02529163|Acute Psychotic Episode|acute psychotic episode
4815549|NCT02529163|Randomised Control Trial|randomised control trial
4815550|NCT02529124|Ageing|ageing
4815551|NCT02529124|Body Composition|body composition
4815552|NCT02529124|Nutrition|nutrition
4815553|NCT02529124|Physical Activity|physical activity
4815554|NCT02529111|Atrial Septal Defects (ASD)|atrial septal defects (asd)
4815555|NCT02529111|Percutaneous closure|percutaneous closure
4815556|NCT02529098|functional magnetic resonance imaging|functional magnetic resonance imaging
4815557|NCT02529098|Lens implantation|lens implantation
4815558|NCT02529098|pseudophakia|pseudophakia
4815559|NCT02529020|mouthguard|mouthguard
4815560|NCT02529020|ventilation|ventilation
4815561|NCT02529020|anaerobic power|anaerobic power
4815562|NCT02529020|ergogenic effects|ergogenic effects
4815563|NCT02529007|Colonoscopy|colonoscopy
4815564|NCT02529007|early cancer detection|early cancer detection
4815565|NCT02529007|cancer screening|cancer screening
4815566|NCT02528994|Dietary supplements|dietary supplements
4815567|NCT02528994|Metabolism|metabolism
4815568|NCT02528981|GBS|gbs
4815569|NCT02528981|Probiotics|probiotics
4815570|NCT02528981|Group B Streptococcal|group b streptococcal
4815571|NCT02528981|Pregnancy|pregnancy
4815572|NCT02528968|Pharmacokinetic dosing|pharmacokinetic dosing
4815573|NCT02528968|Haemophilia|haemophilia
4815574|NCT02528955|Head and neck cancer|head and neck cancer
4815575|NCT02528955|postoperative|postoperative
4815576|NCT02528955|radiotherapy|radiotherapy
4815577|NCT02528955|de-intensification|de-intensification
4815578|NCT02528942|Lung cancer|lung cancer
4815579|NCT02528942|Radiation therapy|radiation therapy
4815580|NCT02528942|4DCT-ventilation imaging|4dct-ventilation imaging
4815581|NCT02528890|group B streptococcus|group b streptococcus
4815582|NCT02528890|GBS|gbs
4815583|NCT02528864|biomarker|biomarker
4815584|NCT02528864|cancer metabolism|cancer metabolism
4815585|NCT02528864|chemical exchange saturation transfer|chemical exchange saturation transfer
4815586|NCT02528864|endometrial cancer|endometrial cancer
4815587|NCT02528864|diffusion-weighted imaging|diffusion-weighted imaging
4815588|NCT02528864|magnetic resonance spectroscopy|magnetic resonance spectroscopy
4815589|NCT02528864|uterine malignancy|uterine malignancy
4815590|NCT02528851|CPAP|cpap
4815591|NCT02528851|preterm|preterm
4815592|NCT02528851|cardiac output|cardiac output
4815593|NCT02528838|Myeloma|myeloma
4815594|NCT02528838|Non-interventional|non-interventional
4815595|NCT02528838|Observational|observational
4815596|NCT02528838|Lenalidomide|lenalidomide
4815597|NCT02528838|REVIEW|review
4815598|NCT02528838|Post-authorization|post-authorization
4815599|NCT02528838|Netherlands|netherlands
4815600|NCT02528786|Drug therapy|drug therapy
4815601|NCT02528734|pneumothorax|pneumothorax
4815602|NCT02528708|fibrinogen concentrate|fibrinogen concentrate
4815603|NCT02528708|coagulation|coagulation
4815604|NCT02528695|18F-FDG PET/CT|18f-fdg pet/ct
4815605|NCT02528695|Adipose tissue|adipose tissue
4815606|NCT02528695|type 2 diabetes|type 2 diabetes
4815607|NCT02528682|dendritic cells|dendritic cells
4815608|NCT02528682|PD-L1/L2 silencing|pd-l1/l2 silencing
4815609|NCT02528682|vaccination|vaccination
4815610|NCT02528682|stem cell transplantation|stem cell transplantation
4815611|NCT02528682|minor histocompatibility antigens|minor histocompatibility antigens
4815612|NCT02528669|accelerometer|accelerometer
4815613|NCT02528669|patient ambulation|patient ambulation
4815614|NCT02528656|Pectus Excavatum|pectus excavatum
4815615|NCT02528656|Pectus Carinatum|pectus carinatum
4815616|NCT02528656|Vacuum Bell|vacuum bell
4815617|NCT02528656|Dynamic compression system|dynamic compression system
4815618|NCT02528656|Hearth variability|hearth variability
4815619|NCT02528656|Autonomic Nervous System|autonomic nervous system
4815620|NCT02528643|MDV3100|mdv3100
4815621|NCT02528643|advanced hepatocellular carcinoma|advanced hepatocellular carcinoma
4815622|NCT02528643|enzalutamide|enzalutamide
4815623|NCT02528643|Xtandi|xtandi
4815624|NCT02528643|ASP9785|asp9785
4815625|NCT02528604|Catheter Ablation|catheter ablation
4815626|NCT02528604|Permanent pacemaker|permanent pacemaker
4815627|NCT02528604|AV node ablation|av node ablation
4815628|NCT02528604|Electrical Cardioversion|electrical cardioversion
4815629|NCT02528604|Implantable loop recorder|implantable loop recorder
4815630|NCT02528591|patient|patient
4815631|NCT02528591|renal transplant|renal transplant
4815632|NCT02528578|healthy volunteers|healthy volunteers
4815633|NCT02528539|Prevention|prevention
4815634|NCT02528539|lymphedema|lymphedema
4815635|NCT02528539|acupuncture|acupuncture
4815636|NCT02528539|self-management|self-management
4815637|NCT02528526|Hypoxia|hypoxia
4815638|NCT02528526|Pancreatic Neoplasms|pancreatic neoplasms
4815639|NCT02528526|Hepatocellular Cancer|hepatocellular cancer
4815640|NCT02528526|Cholangiocarcinoma|cholangiocarcinoma
4815641|NCT02528526|Colorectal Neoplasms|colorectal neoplasms
4815642|NCT02528526|Treatment|treatment
4815643|NCT02528513|sedation|sedation
4815644|NCT02528513|Midazolam|midazolam
4815645|NCT02528513|Propofol|propofol
4815646|NCT02528513|Dexmedetomidine|dexmedetomidine
4815647|NCT02528487|Pulmonary Rehabilitation|pulmonary rehabilitation
4815648|NCT02528487|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
4815649|NCT02528487|Psychiatric Disorders|psychiatric disorders
4815650|NCT02528461|Sofosbuvir|sofosbuvir
4815651|NCT02528461|Direct acting anti-viral treatment|direct acting anti-viral treatment
4815652|NCT02528461|liver cirrhosis|liver cirrhosis
4815653|NCT02528448|Vasoactive hormones|vasoactive hormones
4815654|NCT02528448|bio markers|bio markers
4815655|NCT02528448|salt regulation|salt regulation
4815656|NCT02528448|Renal variables|renal variables
4815657|NCT02528435|Methotrexate|methotrexate
4815658|NCT02528383|Postmenopausal Women on Aromatase Inhibitors|postmenopausal women on aromatase inhibitors
4815659|NCT02528383|Vagifem|vagifem
4815660|NCT02528370|COPD exacerbation|copd exacerbation
4815661|NCT02528370|Telemedicine|telemedicine
4815662|NCT02528370|Intervention Studies|intervention studies
4815663|NCT02528370|Patient Readmission|patient readmission
4815664|NCT02528357|mAb|mab
4815665|NCT02528357|GSK3174998|gsk3174998
4815666|NCT02528357|anticancer agent|anticancer agent
4815667|NCT02528357|checkpoint|checkpoint
4815668|NCT02528357|OX40|ox40
4815669|NCT02528357|Pembrolizumab|pembrolizumab
4815670|NCT02528357|MK-3475-167|mk-3475-167
4815671|NCT02528357|solid tumor|solid tumor
4815672|NCT02528357|immunotherapy|immunotherapy
4815673|NCT02528357|KEYNOTE-167|keynote-167
4815674|NCT02528357|monoclonal antibody|monoclonal antibody
4815675|NCT02528357|antitumor|antitumor
4815676|NCT02528344|High Intensity Interval Training|high intensity interval training
4815677|NCT02528331|Transcranial magnetic stimulation (TMS)|transcranial magnetic stimulation (tms)
4815678|NCT02528331|Cognitive behavioral therapy (CBT)|cognitive behavioral therapy (cbt)
4815679|NCT02528305|High-intensity Interval Training|high-intensity interval training
4815680|NCT02528292|Rheumatoid Arthritis|rheumatoid arthritis
4815681|NCT02528292|Anti-TNF|anti-tnf
4815682|NCT02528292|Ultrasound|ultrasound
4815683|NCT02528292|Synovial histomorphology|synovial histomorphology
4815684|NCT02528292|Ectopic Lymphoneogenesis|ectopic lymphoneogenesis
4815685|NCT02528279|Plasmodium ovale|plasmodium ovale
4815686|NCT02528279|relapse|relapse
4815687|NCT02528279|artemether-lumefantrine|artemether-lumefantrine
4815688|NCT02528279|mixed species malaria|mixed species malaria
4815689|NCT02528279|non-falciparum malaria|non-falciparum malaria
4815690|NCT02528253|Chronic low back pain|chronic low back pain
4815691|NCT02528253|Chronic pain|chronic pain
4815692|NCT02528240|platelets|platelets
4815693|NCT02528201|Ankylosing Spondylitis|ankylosing spondylitis
4815694|NCT02528201|Celecoxib|celecoxib
4815695|NCT02528201|Diclofenac|diclofenac
4815696|NCT02528162|gestational diabetes|gestational diabetes
4815697|NCT02528162|education|education
4815698|NCT02528149|Fibromuscular Dysplasia|fibromuscular dysplasia
4815699|NCT02528149|dysplastic renal artery aneurysm|dysplastic renal artery aneurysm
4815700|NCT02528149|renal artery aneurysms|renal artery aneurysms
4815701|NCT02528149|non atheromatous|non atheromatous
4815702|NCT02528149|dysplastic|dysplastic
4815703|NCT02528149|anatomopathologic|anatomopathologic
4815704|NCT02528149|genetic|genetic
4815705|NCT02528123|Small incision lenticule extraction (SMILE)|small incision lenticule extraction (smile)
4815706|NCT02528123|Femtosecond laser|femtosecond laser
4815707|NCT02528084|rotator cuff, shoulder, rehabilitation, yoga|rotator cuff, shoulder, rehabilitation, yoga
4815708|NCT02528071|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
4815709|NCT02528071|ALS|als
4815710|NCT02528071|Diaphragmatic Endurance Test|diaphragmatic endurance test
4815711|NCT02528058|Myopic traction maculopathy|myopic traction maculopathy
4815712|NCT02528045|Myopic traction maculopathy|myopic traction maculopathy
4815713|NCT02528032|Left ventricular dysfunction|left ventricular dysfunction
4815714|NCT02528032|Other cardiac dysrhythmias|other cardiac dysrhythmias
4815715|NCT02528006|Spasmodic Dysphonia|spasmodic dysphonia
4815716|NCT02528006|Type 2 Thyroplasty|type 2 thyroplasty
4815717|NCT02528006|Titanium Bridges|titanium bridges
4815718|NCT02528006|Operation|operation
4815719|NCT02527980|electronic cigarettes|electronic cigarettes
4815720|NCT02527980|nicotine dependence|nicotine dependence
4815721|NCT02527980|smoking|smoking
4815722|NCT02527980|tobacco use|tobacco use
4815723|NCT02527967|colorectal cancer|colorectal cancer
4815724|NCT02527967|enhanced recovery after surgery|enhanced recovery after surgery
4815725|NCT02527967|perioperative care|perioperative care
4815726|NCT02527967|fast-track surgery|fast-track surgery
4815727|NCT02527967|laparoscopy|laparoscopy
4815728|NCT02527967|minimally invasive surgery|minimally invasive surgery
4815729|NCT02527967|complications|complications
4815730|NCT02527954|Y-chromosome microdeletions|y-chromosome microdeletions
4815731|NCT02527954|aneuploidy|aneuploidy
4815732|NCT02527954|embryos|embryos
4815733|NCT02527954|spermatozoa|spermatozoa
4815734|NCT02527941|Genital immunology|genital immunology
4815735|NCT02527941|HIV susceptibility|hiv susceptibility
4815736|NCT02527941|Microbiome|microbiome
4815737|NCT02527941|Bacterial vaginosis|bacterial vaginosis
4815738|NCT02527941|Virus entry assay|virus entry assay
4815739|NCT02527928|pharmacoeconomics|pharmacoeconomics
4815740|NCT02527902|IGA Glomerulonephritis|iga glomerulonephritis
4815741|NCT02527902|Autonomic nervous system|autonomic nervous system
4815742|NCT02527902|ANS|ans
4815743|NCT02527889|Exercise|exercise
4815744|NCT02527889|blood flow velocity|blood flow velocity
4815745|NCT02527889|tissue oxygenation|tissue oxygenation
4815746|NCT02527889|BCRL|bcrl
4815747|NCT02527876|Exercise|exercise
4815748|NCT02527876|Smoking|smoking
4815749|NCT02527863|Tolvaptan|tolvaptan
4815750|NCT02527863|L-NMMA|l-nmma
4815751|NCT02527863|ADPKD|adpkd
4815752|NCT02527824|biliary tract neoplasm|biliary tract neoplasm
4815753|NCT02527824|oxaliplatin|oxaliplatin
4815754|NCT02527824|irinotecan|irinotecan
4815755|NCT02527824|S-1|s-1
4815756|NCT02527811|ulinastatin|ulinastatin
4815757|NCT02527811|CPB|cpb
4815758|NCT02527811|pediatric|pediatric
4815759|NCT02527785|stomach neoplasm|stomach neoplasm
4815760|NCT02527785|oxaliplatin|oxaliplatin
4815761|NCT02527785|irinotecan|irinotecan
4815762|NCT02527785|S-1|s-1
4815763|NCT02527720|Mindfulness|mindfulness
4815764|NCT02527720|Therapy|therapy
4815765|NCT02527720|Problem Drinking|problem drinking
4815766|NCT02527720|Breathing-based mindfulness training|breathing-based mindfulness training
4815767|NCT02527694|Emergency medical services|emergency medical services
4815768|NCT02527694|Resuscitation|resuscitation
4815769|NCT02527512|Scoliosis|scoliosis
4815770|NCT02527512|Spine fusion|spine fusion
4815771|NCT02527512|0.35% povidone-iodine|0.35% povidone-iodine
4815772|NCT02527486|COPD|copd
4815773|NCT02527486|Asthma|asthma
4815774|NCT02527486|ACOS|acos
4815775|NCT02527486|Bronchiectasis|bronchiectasis
4815776|NCT02527460|Inflammation|inflammation
4815777|NCT02527460|Cognitive Function|cognitive function
4815778|NCT02527460|HIV|hiv
4815779|NCT02527447|Measurable Residual Disease|measurable residual disease
4815780|NCT02527447|Relapsed/Refractory AML|relapsed/refractory aml
4815781|NCT02527447|Salvage Chemotherapy|salvage chemotherapy
4815782|NCT02527434|Urothelial bladder cancer, Triple-negative breast cancer, Pancreatic ductal adenocarcinoma, Advanced Solid Tumors, Tremelimumab, MEDI4736, ORR|urothelial bladder cancer, triple-negative breast cancer, pancreatic ductal adenocarcinoma, advanced solid tumors, tremelimumab, medi4736, orr
4815783|NCT02527395|Experimental pain|experimental pain
4815784|NCT02527395|Men|men
4815785|NCT02527369|Fat Reduction|fat reduction
4815786|NCT02527369|Lipolysis|lipolysis
4815787|NCT02527330|Myocardial iron deposition|myocardial iron deposition
4815788|NCT02527330|T2* imaging|t2* imaging
4815789|NCT02527330|heart failure|heart failure
4815790|NCT02527317|Early|early
4815791|NCT02527291|Cytomegalovirus|cytomegalovirus
4815792|NCT02527291|Interleukin|interleukin
4815793|NCT02527291|Polymerase Chain Reaction|polymerase chain reaction
4815794|NCT02527291|CMV antibodies|cmv antibodies
4815795|NCT02527252|Massage|massage
4815796|NCT02527252|Craniosacral|craniosacral
4815797|NCT02527252|Disability Evaluation|disability evaluation
4815798|NCT02527252|Randomized Controlled Trial|randomized controlled trial
4815799|NCT02527187|Immune System Diseases|immune system diseases
4815800|NCT02527187|Prick Test|prick test
4815801|NCT02527187|Betula verrucosa|betula verrucosa
4815802|NCT02527135|SMS|sms
4815803|NCT02527135|Text messages|text messages
4815804|NCT02527135|Young women|young women
4815805|NCT02527135|HIV|hiv
4815806|NCT02527122|Immune System Diseases|immune system diseases
4815807|NCT02527122|Prick Test|prick test
4815808|NCT02527122|Dermatophagoides pteronyssinus|dermatophagoides pteronyssinus
4815809|NCT02527122|Dermatophagoides farinae|dermatophagoides farinae
4815810|NCT02527096|dolutegravir(Tivicay®)|dolutegravir(tivicay®)
4815811|NCT02527096|lamivudine(Epivir®)|lamivudine(epivir®)
4815812|NCT02527096|HIV-1|hiv-1
4815813|NCT02527096|efficacy|efficacy
4815814|NCT02527096|safety|safety
4815815|NCT02527057|Diffusion-weighted magnetic resonance imaging|diffusion-weighted magnetic resonance imaging
4815816|NCT02527057|Preoperative concurrent chemoradiation|preoperative concurrent chemoradiation
4815817|NCT02527057|Response|response
4815818|NCT02527044|Coronary Artery Bypass|coronary artery bypass
4815819|NCT02527044|Flow Reserve|flow reserve
4815820|NCT02527031|Emergency Medical Services|emergency medical services
4815821|NCT02527031|Extracorporeal Membrane Oxygenation|extracorporeal membrane oxygenation
4815822|NCT02527018|OBGYN|obgyn
4815823|NCT02527018|Nexfin|nexfin
4815824|NCT02527018|Hypertensive|hypertensive
4815825|NCT02527018|Hemodynamic|hemodynamic
4815826|NCT02527005|IPT|ipt
4815827|NCT02527005|malaria|malaria
4815828|NCT02527005|pregnant|pregnant
4815829|NCT02527005|HIV positive|hiv positive
4815830|NCT02526979|OAB|oab
4815831|NCT02526979|overactive bladder|overactive bladder
4815832|NCT02526979|Myrbetric|myrbetric
4815833|NCT02526979|neurogenic detrusor overactivity|neurogenic detrusor overactivity
4815834|NCT02526979|Betanis|betanis
4815835|NCT02526979|Myrbetriq|myrbetriq
4815836|NCT02526979|NDO|ndo
4815837|NCT02526979|YM178|ym178
4815838|NCT02526979|mirabegron|mirabegron
4815839|NCT02526979|Betmiga|betmiga
4815840|NCT02526953|anal cancer|anal cancer
4815841|NCT02526953|chemoradiation|chemoradiation
4815842|NCT02526953|intensity-modulated radiotherapy|intensity-modulated radiotherapy
4815843|NCT02526953|paclitaxel|paclitaxel
4815844|NCT02526940|Human Immunodeficiency Virus|human immunodeficiency virus
4815845|NCT02526940|HIV|hiv
4815846|NCT02526940|HAART|haart
4815847|NCT02526940|Highly Active antiretroviral therapy|highly active antiretroviral therapy
4815848|NCT02526940|GALT|galt
4815849|NCT02526940|Gut Associated Lymphoid Tissue|gut associated lymphoid tissue
4815850|NCT02526940|reservoir|reservoir
4815851|NCT02526940|rectum|rectum
4815852|NCT02526927|Anorexia Nervosa|anorexia nervosa
4815853|NCT02526927|microarchitecture|microarchitecture
4815854|NCT02526927|prepubertal|prepubertal
4815855|NCT02526914|social cognition|social cognition
4815856|NCT02526914|oxytocin|oxytocin
4815857|NCT02526914|vasopressin|vasopressin
4815858|NCT02526914|decision making|decision making
4815859|NCT02526914|social decision making|social decision making
4815860|NCT02526914|economic games|economic games
4815861|NCT02526888|pharmacokinetic|pharmacokinetic
4815862|NCT02526888|interaction|interaction
4815863|NCT02526875|hypertension, Telmisartan/S-Amlodipine|hypertension, telmisartan/s-amlodipine
4815864|NCT02526862|noninvasive mechanical ventilation (NIVM)|noninvasive mechanical ventilation (nivm)
4815865|NCT02526862|continuous positive airway pressure (CPAP) ventilation|continuous positive airway pressure (cpap) ventilation
4815866|NCT02526862|bilevel positive airway pressure (BIPAP) ventilation|bilevel positive airway pressure (bipap) ventilation
4815867|NCT02526862|pressure ulcer (PU)|pressure ulcer (pu)
4815868|NCT02526862|nursing assessment|nursing assessment
4815869|NCT02526849|Fecal Microbiota Transplantation|fecal microbiota transplantation
4815870|NCT02526849|Slow Transit Constipation|slow transit constipation
4815871|NCT02526849|Randomized Controlled Trial|randomized controlled trial
4815872|NCT02526836|colon cancer mesocolic excision central ligation|colon cancer mesocolic excision central ligation
4815873|NCT02526810|glargine|glargine
4815874|NCT02526810|continuous subcutaneous insulin injection|continuous subcutaneous insulin injection
4815875|NCT02526810|blood glucose control|blood glucose control
4815876|NCT02526810|blood glucose fluctuation|blood glucose fluctuation
4815877|NCT02526810|Oxidative Stress|oxidative stress
4815878|NCT02526797|prostate biopsy|prostate biopsy
4815879|NCT02526797|prostate cancer|prostate cancer
4815880|NCT02526797|Magnetic resonance imaging|magnetic resonance imaging
4815881|NCT02526797|Neoplasm staging|neoplasm staging
4815882|NCT02526771|lymph node dissection|lymph node dissection
4815883|NCT02526758|Pulmonary disease|pulmonary disease
4815884|NCT02526758|chronic obstructive|chronic obstructive
4815885|NCT02526758|small airway|small airway
4815886|NCT02526745|vaccine|vaccine
4815887|NCT02526745|safety|safety
4815888|NCT02526745|immunogenicity|immunogenicity
4815889|NCT02526732|NASH|nash
4815890|NCT02526732|fatty Liver|fatty liver
4815891|NCT02526732|VO2 max|vo2 max
4815892|NCT02526732|M30 antigen|m30 antigen
4815893|NCT02526719|bilateral prophylactic mastectomies|bilateral prophylactic mastectomies
4815894|NCT02526719|immediate breast reconstruction|immediate breast reconstruction
4815895|NCT02526719|nipple sparing|nipple sparing
4815896|NCT02526719|BRCA1 Protein|brca1 protein
4815897|NCT02526706|Bleb filtration|bleb filtration
4815898|NCT02526706|VisionBlue|visionblue
4815899|NCT02526680|OrCam|orcam
4815900|NCT02526680|Low-vision device|low-vision device
4815901|NCT02526680|End-stage glaucoma|end-stage glaucoma
4815902|NCT02526641|Direct acting antiviral treatment|direct acting antiviral treatment
4815903|NCT02526641|sCD163|scd163
4815904|NCT02526641|Portal hypertension|portal hypertension
4815905|NCT02526641|Metabolic liver function|metabolic liver function
4815906|NCT02526641|Cirrhosis|cirrhosis
4815907|NCT02526628|Testosterone|testosterone
4815908|NCT02526628|Neurocognition|neurocognition
4815909|NCT02526615|rosiglitazone|rosiglitazone
4815910|NCT02526615|metformin|metformin
4815911|NCT02526615|muscle|muscle
4815912|NCT02526576|Facial Atrophy|facial atrophy
4815913|NCT02526576|Autologous|autologous
4815914|NCT02526576|Adult|adult
4815915|NCT02526576|Adipose Derived Stem Cells|adipose derived stem cells
4815916|NCT02526576|Stromal Vascular Fraction|stromal vascular fraction
4815917|NCT02526576|Collagenase|collagenase
4815918|NCT02526550|Live attenuated Japanese Encephalitis vaccine|live attenuated japanese encephalitis vaccine
4815919|NCT02526550|IMOJEV|imojev
4815920|NCT02526550|CD.JEVAX|cd.jevax
4815921|NCT02526550|Booster|booster
4815922|NCT02526550|Thai children|thai children
4815923|NCT02526550|Immunogenicity|immunogenicity
4815924|NCT02526550|Safety|safety
4815925|NCT02526550|Interchangeability|interchangeability
4815926|NCT02526550|Hepatitis A vaccine|hepatitis a vaccine
4815927|NCT02526550|Vaccination or Other Immunization Procedure|vaccination or other immunization procedure
4815928|NCT02526537|Gefitinib|gefitinib
4815929|NCT02526537|NSCLC|nsclc
4815930|NCT02526537|postoperative|postoperative
4815931|NCT02526537|stage Ib|stage ib
4815932|NCT02526537|Relapse Free Survival in 2 years|relapse free survival in 2 years
4815933|NCT02526485|heparin|heparin
4815934|NCT02526485|thrombocytopenia|thrombocytopenia
4815935|NCT02526485|genomics|genomics
4815936|NCT02526472|embryo transfer, in vitro fertilization|embryo transfer, in vitro fertilization
4815937|NCT02526446|Chinese|chinese
4815938|NCT02526446|caregiver stress|caregiver stress
4815939|NCT02526446|self-administered acupressure|self-administered acupressure
4815940|NCT02526433|depression|depression
4815941|NCT02526433|mental wellbeing|mental wellbeing
4815942|NCT02526433|motherhood|motherhood
4815943|NCT02526433|music|music
4815944|NCT02526433|alternative therapies|alternative therapies
4815945|NCT02526420|VRS-317|vrs-317
4815946|NCT02526420|Long Acting Growth Hormone|long acting growth hormone
4815947|NCT02526420|Versartis|versartis
4815948|NCT02526420|somavaratan|somavaratan
4815949|NCT02526420|Growth Hormone Deficiency|growth hormone deficiency
4816052|NCT02525705|Type III and IV|type iii and iv
4815950|NCT02526420|Adult Growth Hormone Deficiency|adult growth hormone deficiency
4815951|NCT02526420|AGHD|aghd
4815952|NCT02526420|Growth Hormone Replacement|growth hormone replacement
4815953|NCT02526420|Growth Hormone Replacement Therapy|growth hormone replacement therapy
4815954|NCT02526420|XTEN|xten
4815955|NCT02526407|postnatal depression|postnatal depression
4815956|NCT02526407|mental wellbeing|mental wellbeing
4815957|NCT02526407|baby blues|baby blues
4815958|NCT02526407|mothers|mothers
4815959|NCT02526407|music|music
4815960|NCT02526407|alternative therapies|alternative therapies
4815961|NCT02526355|Maternal depression|maternal depression
4815962|NCT02526355|Mobile phone based intervention|mobile phone based intervention
4815963|NCT02526355|Learning Through Play|learning through play
4815964|NCT02526355|CBT|cbt
4815965|NCT02526355|Intelligent Real Time Therapy|intelligent real time therapy
4815966|NCT02526316|cervical cancer|cervical cancer
4815967|NCT02526316|vulvar cancer|vulvar cancer
4815968|NCT02526316|vaginal cancer|vaginal cancer
4815969|NCT02526316|penile cancer|penile cancer
4815970|NCT02526316|anal cancer|anal cancer
4815971|NCT02526316|head and neck cancer|head and neck cancer
4815972|NCT02526277|RLS|rls
4815973|NCT02526264|stoma|stoma
4815974|NCT02526264|quality of life|quality of life
4815975|NCT02526251|IBD|ibd
4815976|NCT02526251|Fecal calprotectin|fecal calprotectin
4815977|NCT02526251|Microbiome|microbiome
4815978|NCT02526251|Dysbiosis|dysbiosis
4815979|NCT02526251|Disease activity|disease activity
4815980|NCT02526251|telemedicine|telemedicine
4815981|NCT02526238|transcranial magnetic stimulation|transcranial magnetic stimulation
4815982|NCT02526238|trunk rotation|trunk rotation
4815983|NCT02526225|acute ischemic stroke|acute ischemic stroke
4815984|NCT02526225|safety and effectiveness|safety and effectiveness
4815985|NCT02526225|Ginkgo diterpene lactone meglumine injection|ginkgo diterpene lactone meglumine injection
4815986|NCT02526212|opioid use disorder|opioid use disorder
4815987|NCT02526212|group counseling|group counseling
4815988|NCT02526212|office-based buprenorphine treatment|office-based buprenorphine treatment
4815989|NCT02526199|Local anesthetics|local anesthetics
4815990|NCT02526199|Perineural nerve blocks|perineural nerve blocks
4815991|NCT02526199|Perineurial Dexamethasone|perineurial dexamethasone
4815992|NCT02526160|KRN23|krn23
4815993|NCT02526160|Fibroblast growth factor 23 (FGF23)|fibroblast growth factor 23 (fgf23)
4815994|NCT02526160|XLH|xlh
4815995|NCT02526160|X-linked hypophosphatemia|x-linked hypophosphatemia
4815996|NCT02526160|burosumab|burosumab
4815997|NCT02526160|Crysvita|crysvita
4815998|NCT02526134|Laying of medical devices (radio opaque markers)|laying of medical devices (radio opaque markers)
4815999|NCT02526095|Esophagus|esophagus
4816000|NCT02526095|Surgery|surgery
4816001|NCT02526082|cardiovascular disease|cardiovascular disease
4816002|NCT02526082|frailty|frailty
4816003|NCT02526082|quality of life|quality of life
4816004|NCT02526082|mortality|mortality
4816005|NCT02526082|prevention|prevention
4816006|NCT02526030|psychosis|psychosis
4816007|NCT02526030|antipsychotic agents|antipsychotic agents
4816008|NCT02526030|treatment|treatment
4816009|NCT02526030|effectiveness|effectiveness
4816010|NCT02526004|Cystic Fibrosis|cystic fibrosis
4816011|NCT02526004|Microbiome|microbiome
4816012|NCT02526004|Stratified Antibacterial therapy|stratified antibacterial therapy
4816013|NCT02526004|Resistance|resistance
4816014|NCT02526004|Pathogen Host Interaction|pathogen host interaction
4816015|NCT02525991|schizophrenia|schizophrenia
4816016|NCT02525991|bipolar disorder|bipolar disorder
4816017|NCT02525978|Heart Rate|heart rate
4816018|NCT02525965|Wide resection margin|wide resection margin
4816019|NCT02525965|Recurrence|recurrence
4816020|NCT02525965|Early-stage hepatocellular carcinoma|early-stage hepatocellular carcinoma
4816021|NCT02525952|Carcinoma, Hepatocellular|carcinoma, hepatocellular
4816022|NCT02525952|Hepatectomy|hepatectomy
4816023|NCT02525952|Transarterial Chemoembolization|transarterial chemoembolization
4816024|NCT02525952|Scoring System|scoring system
4816025|NCT02525913|Breast|breast
4816026|NCT02525913|Mastectomy|mastectomy
4816027|NCT02525874|Tecfidera|tecfidera
4816028|NCT02525874|DMF|dmf
4816029|NCT02525874|dimethyl fumarate|dimethyl fumarate
4816030|NCT02525757|Lung Cancer|lung cancer
4816031|NCT02525757|Non-small cell lung cancer|non-small cell lung cancer
4816032|NCT02525757|NSCLC|nsclc
4816033|NCT02525757|Unresectable|unresectable
4816034|NCT02525757|MPDL3280A|mpdl3280a
4816035|NCT02525757|Carboplatin|carboplatin
4816036|NCT02525757|Paraplatin|paraplatin
4816037|NCT02525757|Paclitaxel|paclitaxel
4816038|NCT02525757|Taxol|taxol
4816039|NCT02525757|Radiation therapy|radiation therapy
4816040|NCT02525757|XRT|xrt
4816041|NCT02525731|HIV Infection|hiv infection
4816042|NCT02525731|Pain|pain
4816043|NCT02525731|Chronic Opioid Therapy|chronic opioid therapy
4816044|NCT02525731|Addiction|addiction
4816045|NCT02525731|Analgesics, Opioid|analgesics, opioid
4816046|NCT02525718|Breast Reconstruction|breast reconstruction
4816047|NCT02525718|Mastectomy|mastectomy
4816048|NCT02525705|infants|infants
4816049|NCT02525705|oesophageal atresia|oesophageal atresia
4816050|NCT02525705|dumping syndrome|dumping syndrome
4816051|NCT02525705|prevalence|prevalence
4816053|NCT02525705|Oral glucose tolerance test|oral glucose tolerance test
4816054|NCT02525705|early hyperglycemia|early hyperglycemia
4816055|NCT02525705|late hypoglycemia|late hypoglycemia
4816056|NCT02525653|Albumin-Bound|albumin-bound
4816057|NCT02525653|Paclitaxel|paclitaxel
4816058|NCT02525653|Gemcitabine|gemcitabine
4816059|NCT02525653|15-054|15-054
4816060|NCT02525640|Single sided hearing loss|single sided hearing loss
4816061|NCT02525640|Single sided deafness|single sided deafness
4816062|NCT02525640|Hearing loss music appreciation|hearing loss music appreciation
4816063|NCT02525536|Drug Therapy|drug therapy
4816064|NCT02525510|Mild Hypothermia|mild hypothermia
4816065|NCT02525510|Machine Perfusion|machine perfusion
4816066|NCT02525510|Kidney Transplantation|kidney transplantation
4816067|NCT02525497|Automated PD|automated pd
4816068|NCT02525497|Effectiveness|effectiveness
4816069|NCT02525497|Safety|safety
4816070|NCT02525497|Manipulability|manipulability
4816071|NCT02525458|antimicrobial|antimicrobial
4816072|NCT02525458|biofilms|biofilms
4816073|NCT02525458|acrylic resin|acrylic resin
4816074|NCT02525458|polymethyl methacrylate|polymethyl methacrylate
4816075|NCT02525458|confocal laser scanning microscopy|confocal laser scanning microscopy
4816076|NCT02525458|split-mouth design|split-mouth design
4816077|NCT02525458|quaternary ammonium methacryloxy silicate|quaternary ammonium methacryloxy silicate
4816078|NCT02525445|placebo effects|placebo effects
4816079|NCT02525445|communication|communication
4816080|NCT02525445|acupuncture therapy|acupuncture therapy
4816081|NCT02525445|relaxation|relaxation
4816082|NCT02525432|Mesenchymal Stromal Cells, Multipotent|mesenchymal stromal cells, multipotent
4816083|NCT02525432|Multipotent Mesenchymal Stromal Cells|multipotent mesenchymal stromal cells
4816084|NCT02525432|Stem Cells, Mesenchymal|stem cells, mesenchymal
4816085|NCT02525393|Rehabilitation|rehabilitation
4816086|NCT02525393|Non Invasive Brain Stimulation|non invasive brain stimulation
4816087|NCT02525380|Transarterial chemoembolization|transarterial chemoembolization
4816088|NCT02525380|Doxorubicin-Eluting-Bead Embolization|doxorubicin-eluting-bead embolization
4816089|NCT02525380|DC Bead TACE|dc bead tace
4816090|NCT02525380|Hepatocellular carcinoma|hepatocellular carcinoma
4816091|NCT02525367|Parkinson's disease|parkinson's disease
4816092|NCT02525367|Multiple Sclerosis|multiple sclerosis
4816093|NCT02525367|Depressed Elderly|depressed elderly
4816094|NCT02525367|Cognitive Dysfunction|cognitive dysfunction
4816095|NCT02525367|Online Cognitive Training|online cognitive training
4816096|NCT02525354|arachidonic aci|arachidonic aci
4816097|NCT02525354|adiposity|adiposity
4816099|NCT02525341|Yoga|yoga
4816100|NCT02525341|exercises|exercises
4816101|NCT02525341|knee osteoarthritis|knee osteoarthritis
4816102|NCT02525341|older adults|older adults
4816103|NCT02525328|Constitutional Thinness|constitutional thinness
4816104|NCT02525328|linkage study|linkage study
4816105|NCT02525328|genome wide scan (GWAS)|genome wide scan (gwas)
4816106|NCT02525315|Schizophrenia|schizophrenia
4816107|NCT02525315|auditory hallucinations|auditory hallucinations
4816108|NCT02525315|TMS|tms
4816109|NCT02525302|DMD|dmd
4816110|NCT02525302|neuromuscular|neuromuscular
4816111|NCT02525302|Duchenne|duchenne
4816112|NCT02525289|mobility|mobility
4816113|NCT02525289|coronary artery bypass|coronary artery bypass
4816114|NCT02525289|positioning|positioning
4816115|NCT02525289|body|body
4816116|NCT02525263|Neo-Kidney Augment|neo-kidney augment
4816117|NCT02525263|Type 2 Diabetes|type 2 diabetes
4816118|NCT02525263|Chronic Kidney Disease|chronic kidney disease
4816119|NCT02525263|Cell Therapy|cell therapy
4816120|NCT02525250|Acute myeloid leukemia or myelodysplasic syndrome|acute myeloid leukemia or myelodysplasic syndrome
4816121|NCT02525198|Mild cognitive impairment|mild cognitive impairment
4816122|NCT02525198|Subjective memory impairment|subjective memory impairment
4816123|NCT02525198|Dementia|dementia
4816124|NCT02525198|Flavonoids|flavonoids
4816125|NCT02525198|Fatty acids|fatty acids
4816126|NCT02525198|Cognition|cognition
4816127|NCT02525198|Gut microflora|gut microflora
4816128|NCT02525172|immune modulation therapy|immune modulation therapy
4816129|NCT02525172|acid α-glucosidase|acid α-glucosidase
4816130|NCT02525172|antibody|antibody
4816131|NCT02525159|3,3'-diindolylmethane|3,3'-diindolylmethane
4816132|NCT02525159|premenopause|premenopause
4816133|NCT02525159|2-hydroxyestrone|2-hydroxyestrone
4816134|NCT02525146|HIV|hiv
4816135|NCT02525146|Reengagement in HIV Care|reengagement in hiv care
4816136|NCT02525146|ARTAS|artas
4816137|NCT02525133|post operative pain|post operative pain
4816138|NCT02525133|hernioplasty|hernioplasty
4816139|NCT02525133|bupivacaine|bupivacaine
4816140|NCT02525120|Disc herniation|disc herniation
4816141|NCT02525120|Herniated disc|herniated disc
4816142|NCT02525120|Triojection|triojection
4816143|NCT02525120|Ozone|ozone
4816144|NCT02525120|Lumbar spine|lumbar spine
4816145|NCT02525120|Leg pain|leg pain
4816146|NCT02525107|Prevention of Vaso Occlusive Painful Crisis|prevention of vaso occlusive painful crisis
4816147|NCT02525094|Eczema|eczema
4816148|NCT02525081|Microvascular Angina|microvascular angina
4816149|NCT02525081|therapy|therapy
4816150|NCT02525068|enzalutamide|enzalutamide
4816151|NCT02525068|AZD5363|azd5363
4816152|NCT02525068|Prostate|prostate
4816153|NCT02525055|Flu|flu
4816154|NCT02525055|Influenza|influenza
4816155|NCT02525055|Human Viral Challenge Model|human viral challenge model
4816156|NCT02525055|Wild-Type|wild-type
4816157|NCT02525055|H3N2|h3n2
4816158|NCT02525055|H1N1|h1n1
4816159|NCT02525055|Universal Influenza Vaccine|universal influenza vaccine
4816160|NCT02525055|intra-seasonal vaccines|intra-seasonal vaccines
4816161|NCT02525055|antiviral|antiviral
4816162|NCT02525042|Ankylosing Spondylitis|ankylosing spondylitis
4816163|NCT02525042|Dendritic cells (DC)|dendritic cells (dc)
4816164|NCT02525042|RNA|rna
4816165|NCT02525042|Axial spondyloarthritis|axial spondyloarthritis
4816166|NCT02525042|Lod score|lod score
4816167|NCT02525042|Human leucocyte antigen (HLA-B27)|human leucocyte antigen (hla-b27)
4816168|NCT02525029|GVHD|gvhd
4816169|NCT02525016|Bariatric surgery, lidocaine, plasmatic concentration, MonoEthylGlycineXylidide (MEGx), safety|bariatric surgery, lidocaine, plasmatic concentration, monoethylglycinexylidide (megx), safety
4816170|NCT02525003|vitamin D|vitamin d
4816171|NCT02525003|Serum 25-hydroxyvitamin D|serum 25-hydroxyvitamin d
4816172|NCT02525003|vitamin D2|vitamin d2
4816173|NCT02525003|UV-irradiated yeast|uv-irradiated yeast
4816174|NCT02525003|serum 25-hydroxyvitamin D3|serum 25-hydroxyvitamin d3
4816175|NCT02525003|serum 25-hydroxyvitamin D2|serum 25-hydroxyvitamin d2
4816176|NCT02525003|randomized controlled trial|randomized controlled trial
4816177|NCT02525003|vitamin D3|vitamin d3
4816178|NCT02525003|bioavailability|bioavailability
4816179|NCT02524990|Medical abortion|medical abortion
4816180|NCT02524990|pregnancy tests|pregnancy tests
4816181|NCT02524964|left ventricular remodeling|left ventricular remodeling
4816182|NCT02524964|cardiac magnetic resonance imaging|cardiac magnetic resonance imaging
4816183|NCT02524964|acute myocardial infarction|acute myocardial infarction
4816184|NCT02524938|Dietary polyphenols|dietary polyphenols
4816185|NCT02524938|Protein glycation|protein glycation
4816186|NCT02524925|fast track surgery|fast track surgery
4816187|NCT02524925|eras program|eras program
4816188|NCT02524925|hepatectomy|hepatectomy
4816189|NCT02524925|pancreatectomy|pancreatectomy
4816190|NCT02524925|NPY|npy
4816191|NCT02524925|ACTH/Cortsiosol|acth/cortsiosol
4816192|NCT02524925|postoperative stress|postoperative stress
4816193|NCT02524899|Schizotypal Personality Disorder|schizotypal personality disorder
4816194|NCT02524899|SPD|spd
4816195|NCT02524899|cognitive remediation therapy|cognitive remediation therapy
4816196|NCT02524899|CRT|crt
4816197|NCT02524899|guanfacine|guanfacine
4816198|NCT02524899|cognitive impairment|cognitive impairment
4816199|NCT02524899|working memory|working memory
4816200|NCT02524899|pharmacological cognitive enhancing agent|pharmacological cognitive enhancing agent
4816201|NCT02524899|neuropsychological testing|neuropsychological testing
4816202|NCT02524899|schizophrenia spectrum disorders|schizophrenia spectrum disorders
4816203|NCT02524899|Personality Disorders|personality disorders
4816204|NCT02524886|Deep Brain Simulation|deep brain simulation
4816205|NCT02524886|Psychiatric|psychiatric
4816206|NCT02524886|Side-effects|side-effects
4816207|NCT02524860|Prostate Cancer|prostate cancer
4816208|NCT02524860|Biopsy|biopsy
4816209|NCT02524860|Focal Healthcare|focal healthcare
4816210|NCT02524860|Fusion Targeted Biopsy|fusion targeted biopsy
4816211|NCT02524860|High Risk Cancer|high risk cancer
4816212|NCT02524860|Imaging|imaging
4816213|NCT02524860|Diagnostic|diagnostic
4816214|NCT02524860|Ultrasound|ultrasound
4816215|NCT02524860|Multiparametric Magnetic Resonance Imaging (MP-MRI)|multiparametric magnetic resonance imaging (mp-mri)
4816216|NCT02524860|MRI-Ultrasound Fusion|mri-ultrasound fusion
4816217|NCT02524860|Focal-Fusion Bx|focal-fusion bx
4816218|NCT02524834|Thoracoabdominal lesions|thoracoabdominal lesions
4816219|NCT02524795|Omega 3, Cytokines, Adipokines, Systemic lupus erythematosus|omega 3, cytokines, adipokines, systemic lupus erythematosus
4816220|NCT02524782|MEDI-4166, diabetes|medi-4166, diabetes
4816221|NCT02524769|Urge Urinary Incontinence|urge urinary incontinence
4816222|NCT02524769|Urinary Incontinence|urinary incontinence
4816223|NCT02524756|nerve sparing radical hysterectomy|nerve sparing radical hysterectomy
4816224|NCT02524743|Rocuronium|rocuronium
4816225|NCT02524743|lidocaine|lidocaine
4816226|NCT02524743|acetaminophen,|acetaminophen,
4816227|NCT02524743|pain|pain
4816228|NCT02524743|injection|injection
4816229|NCT02524717|Hepatic Impairment|hepatic impairment
4816230|NCT02524717|JNJ-56021927|jnj-56021927
4816231|NCT02524704|Cystic fibrosis|cystic fibrosis
4816232|NCT02524704|Electrical Impedance Tomography|electrical impedance tomography
4816233|NCT02524626|Vagus nerve stimulation|vagus nerve stimulation
4816234|NCT02524626|Postoperative ileus|postoperative ileus
4816235|NCT02524561|mammographic density|mammographic density
4816236|NCT02524561|abnormal mammogram|abnormal mammogram
4816237|NCT02524561|biopsy|biopsy
4816238|NCT02524548|Aromatase inhibitors|aromatase inhibitors
4816239|NCT02524548|Reminder Systems|reminder systems
4816240|NCT02524522|Integrated Pulmonary Index|integrated pulmonary index
4816241|NCT02524522|automated protocol-driven weaning|automated protocol-driven weaning
4816242|NCT02524522|pulmonary recruitment maneuver|pulmonary recruitment maneuver
4816243|NCT02524509|Chonodron|chonodron
4816244|NCT02524509|Microfracture|microfracture
4816245|NCT02524509|autologous cultured chondrocyte|autologous cultured chondrocyte
4816246|NCT02524509|cartilage defect of knee|cartilage defect of knee
4816247|NCT02524444|Intermittent preventive therapy|intermittent preventive therapy
4816248|NCT02524444|malaria|malaria
4816249|NCT02524444|pregnant|pregnant
4816250|NCT02524444|HIV positive|hiv positive
4816251|NCT02524444|Prevention|prevention
4816252|NCT02524431|Mitochondria|mitochondria
4816253|NCT02524431|trabeculectomy|trabeculectomy
4816254|NCT02524431|trabecular meshwork|trabecular meshwork
4816255|NCT02524431|Glaucoma surgery|glaucoma surgery
4816256|NCT02524418|Main Pancreatic Duct|main pancreatic duct
4816257|NCT02524392|independent medical evaluation|independent medical evaluation
4816258|NCT02524392|sick leave|sick leave
4816259|NCT02524392|sickness absence|sickness absence
4816260|NCT02524392|physician primary care|physician primary care
4816261|NCT02524392|general practitioner|general practitioner
4816262|NCT02524392|family physician|family physician
4816263|NCT02524366|Stress Urinary Incontinence|stress urinary incontinence
4816264|NCT02524366|Artificial Urinary Sphincter|artificial urinary sphincter
4816265|NCT02524353|cardiac surgery|cardiac surgery
4816266|NCT02524340|JIA|jia
4816267|NCT02524340|Arthritis|arthritis
4816268|NCT02524340|pJIA|pjia
4816269|NCT02524340|PCATS|pcats
4816270|NCT02524301|anorexia nervosa|anorexia nervosa
4816271|NCT02524301|opioid receptors|opioid receptors
4816272|NCT02524301|Positron emission tomography (PET)|positron emission tomography (pet)
4816273|NCT02524301|diprenorphine|diprenorphine
4816274|NCT02524262|atrohpic gastritis|atrohpic gastritis
4816275|NCT02524262|acetaldehyde|acetaldehyde
4816276|NCT02524262|ethanol|ethanol
4816277|NCT02524262|L-cysteine|l-cysteine
4816278|NCT02524236|BPH, OAB, Botox, dose response|bph, oab, botox, dose response
4816279|NCT02524223|medically assisted procreation|medically assisted procreation
4816280|NCT02524210|volunteers|volunteers
4816281|NCT02524197|Hip|hip
4816282|NCT02524197|Knee|knee
4816283|NCT02524197|Arthritis|arthritis
4816284|NCT02524197|pain|pain
4816285|NCT02524197|CR845|cr845
4816286|NCT02524197|kappa opioid|kappa opioid
4816287|NCT02524171|crime|crime
4816288|NCT02524171|mental health|mental health
4816289|NCT02524171|substance abuse|substance abuse
4816290|NCT02524171|homelessness|homelessness
4816291|NCT02524171|Veterans|veterans
4816292|NCT02524158|Yoga|yoga
4816293|NCT02524158|Mind-Body Therapies|mind-body therapies
4816294|NCT02524158|Chronic Low Back Pain|chronic low back pain
4816295|NCT02524158|Military Veterans|military veterans
4816296|NCT02524158|VA patients|va patients
4816297|NCT02524080|Ambulance|ambulance
4816298|NCT02524080|Trust|trust
4816299|NCT02524080|Patients|patients
4816300|NCT02524080|Healthcare chain|healthcare chain
4816301|NCT02524054|Dyspnea|dyspnea
4816302|NCT02524054|Hospitalized patients|hospitalized patients
4816303|NCT02524054|Ambulatory outpatients|ambulatory outpatients
4816304|NCT02524054|Shortness of breath|shortness of breath
4816305|NCT02524054|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
4816306|NCT02524054|Pulmonary disease|pulmonary disease
4816307|NCT02524041|Hyperparathyroidism|hyperparathyroidism
4816308|NCT02524041|microarchitecture|microarchitecture
4816309|NCT02524041|periostin|periostin
4816310|NCT02524028|Atrial Fibrillation|atrial fibrillation
4816311|NCT02524028|fMRI|fmri
4816312|NCT02524015|stroke|stroke
4816313|NCT02524015|pusher syndrome|pusher syndrome
4816314|NCT02524015|contraversive pushing|contraversive pushing
4816315|NCT02524015|lateropulsion|lateropulsion
4816316|NCT02524015|rehabilitation|rehabilitation
4816317|NCT02524015|physical therapy|physical therapy
4816318|NCT02524002|Abnormal Labor|abnormal labor
4816319|NCT02524002|Prolonged Induction|prolonged induction
4816320|NCT02524002|Ketosis|ketosis
4816321|NCT02524002|Diet|diet
4816322|NCT02523989|arsenic|arsenic
4816323|NCT02523989|heavy metal|heavy metal
4816324|NCT02523976|Acute|acute
4816325|NCT02523976|Leukemia|leukemia
4816326|NCT02523976|Lymphoid|lymphoid
4816327|NCT02523976|Philadelphia chromosome|philadelphia chromosome
4816328|NCT02523976|dasatinib|dasatinib
4816329|NCT02523963|family work shop|family work shop
4816330|NCT02523937|Pulmonary Embolism|pulmonary embolism
4816331|NCT02523937|Deep Venous Thrombosis|deep venous thrombosis
4816332|NCT02523937|Soluble Fibrin|soluble fibrin
4816333|NCT02523937|D-Dimers|d-dimers
4816334|NCT02523937|Low and intermediate clinical probability|low and intermediate clinical probability
4816335|NCT02523911|Suprep|suprep
4816336|NCT02523911|Simethicone|simethicone
4816337|NCT02523911|Colorectal cancer screening|colorectal cancer screening
4816338|NCT02523911|Routine colonoscopy|routine colonoscopy
4816339|NCT02523911|sodium sulfate/potassium sulfate/magnesium sulfate|sodium sulfate/potassium sulfate/magnesium sulfate
4816340|NCT02523911|Bowel cleansing|bowel cleansing
4816341|NCT02523911|Mass screening|mass screening
4816342|NCT02523898|Clomiphene|clomiphene
4816343|NCT02523898|infertility|infertility
4816344|NCT02523898|insuline resistant|insuline resistant
4816345|NCT02523898|metformine|metformine
4816346|NCT02523898|PCOS|pcos
4816347|NCT02523885|Pneumonia, Bacterial [C01.252.620]|pneumonia, bacterial [c01.252.620]
4816348|NCT02523885|Bronchopneumonia [C08.381.677.127]|bronchopneumonia [c08.381.677.127]
4816349|NCT02523885|Pleuropneumonia [C08.730.610.473]|pleuropneumonia [c08.730.610.473]
4816350|NCT02523885|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal
4816351|NCT02523872|Fluid overload|fluid overload
4816352|NCT02523872|Acute respiratory failure|acute respiratory failure
4816353|NCT02523872|Acute respiratory distress syndrome|acute respiratory distress syndrome
4816354|NCT02523872|Medication administration|medication administration
4816355|NCT02523846|IV-Patient Controlled Analgesia (IV-PCA)|iv-patient controlled analgesia (iv-pca)
4816356|NCT02523846|background morphine infusion|background morphine infusion
4816357|NCT02523846|patient re-education|patient re-education
4816358|NCT02523781|preeclampsia|preeclampsia
4816359|NCT02523781|information pamphlet|information pamphlet
4816360|NCT02523781|patient education|patient education
4816361|NCT02523755|epidural analgesia for labor|epidural analgesia for labor
4816362|NCT02523755|respiratory function|respiratory function
4816363|NCT02523755|electrical impedance tomography|electrical impedance tomography
4816364|NCT02523729|lactation|lactation
4816365|NCT02523729|human milk|human milk
4816366|NCT02523729|maltz|maltz
4816367|NCT02523729|antioxidant|antioxidant
4816368|NCT02523716|Hypoxic conditioning|hypoxic conditioning
4816369|NCT02523716|Cardio pulmonary exercise testing|cardio pulmonary exercise testing
4816370|NCT02523651|Periodontal Diseases|periodontal diseases
4816371|NCT02523651|Bone Regeneration|bone regeneration
4816372|NCT02523651|Dental Pulp Stem Cell|dental pulp stem cell
4816373|NCT02523638|Pegylated-Proline-interferon alpha-2b (AOP2014)|pegylated-proline-interferon alpha-2b (aop2014)
4816374|NCT02523638|Polycythemia Vera|polycythemia vera
4816375|NCT02523638|PEN-PV|pen-pv
4816376|NCT02523638|PROUD-PV|proud-pv
4816377|NCT02523638|CONTINUATION-PV|continuation-pv
4816378|NCT02523638|AOP Orphan|aop orphan
4816379|NCT02523638|Polycythemia|polycythemia
4816380|NCT02523638|Hematologic Diseases|hematologic diseases
4816381|NCT02523638|Myeloproliferative Disorders|myeloproliferative disorders
4816382|NCT02523638|Bone Marrow Diseases|bone marrow diseases
4816383|NCT02523638|Interferon-alpha|interferon-alpha
4816384|NCT02523638|Peginterferon alfa-2b|peginterferon alfa-2b
4816385|NCT02523625|Ultrasound|ultrasound
4816386|NCT02523599|post operative pain|post operative pain
4816387|NCT02523599|hernioplasty|hernioplasty
4816388|NCT02523599|bupivacaine|bupivacaine
4816389|NCT02523586|oxygen concentration|oxygen concentration
4816390|NCT02523586|oxygen therapy|oxygen therapy
4816391|NCT02523586|oxygen delivery|oxygen delivery
4816392|NCT02523586|oxygen masks|oxygen masks
4816393|NCT02523560|Telerehabilitation|telerehabilitation
4816394|NCT02523560|Home Monitoring|home monitoring
4816395|NCT02523560|Heart Failure|heart failure
4816396|NCT02523547|entecavir|entecavir
4816397|NCT02523495|Molecular Targeted Therapy|molecular targeted therapy
4816398|NCT02523495|metastasis colorectal cancer|metastasis colorectal cancer
4816399|NCT02523495|biomarker|biomarker
4816400|NCT02523482|Prescriptions|prescriptions
4816401|NCT02523482|Epidemiology|epidemiology
4816402|NCT02523482|STOPP/START Criteria|stopp/start criteria
4816403|NCT02523482|Beers Criteria|beers criteria
4816404|NCT02523456|Early warning score|early warning score
4816405|NCT02523456|Cardiac arrest|cardiac arrest
4816406|NCT02523443|Epidural Analgesia|epidural analgesia
4816407|NCT02523443|Intravenous Patient Controlled|intravenous patient controlled
4816408|NCT02523443|15-148|15-148
4816409|NCT02523430|Nasopharyngeal Carcinoma|nasopharyngeal carcinoma
4816410|NCT02523430|HepaSphere|hepasphere
4816411|NCT02523417|Breast Cancer|breast cancer
4816412|NCT02523417|HepaSphere|hepasphere
4816413|NCT02523404|Lung Cancer|lung cancer
4816414|NCT02523404|HepaSphere|hepasphere
4816415|NCT02523378|Advanced Cancers|advanced cancers
4816416|NCT02523378|Recurrent|recurrent
4816417|NCT02523378|Locally advanced|locally advanced
4816418|NCT02523378|Metastatic|metastatic
4816419|NCT02523378|Edmonton Symptom Assessment Scale|edmonton symptom assessment scale
4816420|NCT02523378|ESAS|esas
4816421|NCT02523378|Survey|survey
4816422|NCT02523378|Interview|interview
4816423|NCT02523378|Symptom questionnaire|symptom questionnaire
4816424|NCT02523365|Cervical Carcinoma|cervical carcinoma
4816425|NCT02523365|HepaSphere|hepasphere
4816426|NCT02523326|Genomic DNA|genomic dna
4816427|NCT02523326|chronic periodontitis|chronic periodontitis
4816428|NCT02523326|saliva|saliva
4816429|NCT02523326|mouthwash|mouthwash
4816430|NCT02523326|PCR|pcr
4816431|NCT02523326|genotyping|genotyping
4816432|NCT02523326|sequencing|sequencing
4816433|NCT02523235|moderate pain|moderate pain
4816434|NCT02523235|severe pain|severe pain
4816435|NCT02523235|surgery|surgery
4816436|NCT02523235|postop analgesia|postop analgesia
4816437|NCT02523235|TKA|tka
4816438|NCT02523235|adductor catheter|adductor catheter
4816439|NCT02523235|poplital catheter|poplital catheter
4816440|NCT02523235|foot/ankle surgery|foot/ankle surgery
4816441|NCT02523222|dextrose gel|dextrose gel
4816442|NCT02523222|newborn hypoglycemia|newborn hypoglycemia
4816443|NCT02523222|late preterm infant|late preterm infant
4816444|NCT02523222|large for gestational age|large for gestational age
4816445|NCT02523222|small for gestational age|small for gestational age
4816446|NCT02523222|prophylactic|prophylactic
4816447|NCT02523222|neonatal hypoglycemia|neonatal hypoglycemia
4816448|NCT02523209|Osteoporosis|osteoporosis
4816449|NCT02523209|chronic kidney disease|chronic kidney disease
4816450|NCT02523209|kidney transplantation|kidney transplantation
4816451|NCT02523209|fracture risk|fracture risk
4816452|NCT02523196|Hepatic Venous Pressure Gradient (HVPG) testing|hepatic venous pressure gradient (hvpg) testing
4816453|NCT02523196|HepQuant-SHUNT|hepquant-shunt
4816454|NCT02523196|Liver Function|liver function
4816455|NCT02523183|Epilepsy|epilepsy
4816456|NCT02523183|Marijuana|marijuana
4816457|NCT02523144|Transthoracic echocardiography|transthoracic echocardiography
4816458|NCT02523144|echo|echo
4816459|NCT02523144|TTE|tte
4816460|NCT02523131|Type 1 diabetes|type 1 diabetes
4816461|NCT02523131|Closed-loop glucose control|closed-loop glucose control
4816462|NCT02523131|Artificial Pancreas|artificial pancreas
4816463|NCT02523131|Continuous subcutaneous insulin infusion|continuous subcutaneous insulin infusion
4816464|NCT02523131|Continuous glucose monitoring|continuous glucose monitoring
4816465|NCT02523131|threshold suspend|threshold suspend
4816466|NCT02523131|predictive low glucose suspend|predictive low glucose suspend
4816467|NCT02523092|sarcoidosis|sarcoidosis
4816468|NCT02523092|Acthar|acthar
4816469|NCT02523092|CXCL9|cxcl9
4816470|NCT02523092|chemokine ligand 9|chemokine ligand 9
4816471|NCT02523053|Hepatocellular Carcinoma|hepatocellular carcinoma
4816472|NCT02523053|Recurrence|recurrence
4816473|NCT02523053|Microvascular Invasion|microvascular invasion
4816474|NCT02523053|5-Fluorouracil|5-fluorouracil
4816475|NCT02523040|Langerhans cell histiocytosis (LCH)|langerhans cell histiocytosis (lch)
4816476|NCT02523040|Erdheim-Chester disease (ECD)|erdheim-chester disease (ecd)
4816477|NCT02523040|Histiocytic Sarcoma (HS)|histiocytic sarcoma (hs)
4816478|NCT02522988|cancer-related fatigue|cancer-related fatigue
4816479|NCT02522975|biosimilar epoetin|biosimilar epoetin
4816480|NCT02522975|efficacy|efficacy
4816481|NCT02522975|safety|safety
4816482|NCT02522975|immunogenicity|immunogenicity
4816483|NCT02522975|renal anaemia|renal anaemia
4816484|NCT02522962|physical therapy|physical therapy
4816485|NCT02522962|group-based|group-based
4816486|NCT02522962|core stability|core stability
4816487|NCT02522962|balance|balance
4816488|NCT02522962|movement quality|movement quality
4816489|NCT02522962|somatosensory stimulation|somatosensory stimulation
4816490|NCT02522962|coordination|coordination
4816491|NCT02522923|Physical Therapy Modalities|physical therapy modalities
4816492|NCT02522923|Primary Care|primary care
4816493|NCT02522923|Health Services Research|health services research
4816494|NCT02522884|Angioplasty|angioplasty
4816495|NCT02522884|Peripheral Artery Disease|peripheral artery disease
4816496|NCT02522884|PAD|pad
4816497|NCT02522884|Lesion|lesion
4816498|NCT02522884|Claudication|claudication
4816499|NCT02522858|premedication|premedication
4816500|NCT02522858|dexmedetomidine|dexmedetomidine
4816501|NCT02522858|anesthesia, spinal|anesthesia, spinal
4816502|NCT02522845|Varicose Veins|varicose veins
4816503|NCT02522845|Compression Stockings|compression stockings
4816504|NCT02522845|Laser Ablation|laser ablation
4816505|NCT02522845|Catheter Ablation, Radiofrequency|catheter ablation, radiofrequency
4816506|NCT02522819|Obstructive Sleep Apnea Syndrome|obstructive sleep apnea syndrome
4816507|NCT02522819|acute stroke|acute stroke
4816508|NCT02522819|apnea-hypopnea index (AHI)|apnea-hypopnea index (ahi)
4816509|NCT02522806|Endometrial biopsy|endometrial biopsy
4816510|NCT02522806|previous ovarian hyperstimulation cycle|previous ovarian hyperstimulation cycle
4816511|NCT02522806|first IVF|first ivf
4816512|NCT02522806|antagonist protocol|antagonist protocol
4816513|NCT02522806|clinical pregnancy rate|clinical pregnancy rate
4816514|NCT02522793|skin lesion|skin lesion
4816515|NCT02522728|Knee|knee
4816516|NCT02522728|Arthroplasty|arthroplasty
4816517|NCT02522728|Implant|implant
4816518|NCT02522689|kidney stone|kidney stone
4816519|NCT02522689|percutaneous nephrolithotripsy|percutaneous nephrolithotripsy
4816520|NCT02522689|ultra-mini PCNL|ultra-mini pcnl
4816521|NCT02522689|micro PCNL|micro pcnl
4816522|NCT02522676|kidney stone|kidney stone
4816523|NCT02522676|percutaneous nephrolithotripsy|percutaneous nephrolithotripsy
4816524|NCT02522676|retrograde intrarenal surgery|retrograde intrarenal surgery
4816525|NCT02522676|extracorporeal shock wave lithotripsy|extracorporeal shock wave lithotripsy
4816526|NCT02522676|mini PCNL|mini pcnl
4816527|NCT02522676|ultra-mini PCNL|ultra-mini pcnl
4816528|NCT02522676|micro PCNL|micro pcnl
4816529|NCT02522663|telephone support|telephone support
4816530|NCT02522663|discharge management|discharge management
4816531|NCT02522663|readmission|readmission
4816532|NCT02522663|aortic valve replacement|aortic valve replacement
4816533|NCT02522650|amiloride|amiloride
4816534|NCT02522650|proteinuric kidney disease|proteinuric kidney disease
4816535|NCT02522650|urokinase plasminogen activator receptor|urokinase plasminogen activator receptor
4816536|NCT02522650|proteinuria|proteinuria
4816537|NCT02522637|exercise|exercise
4816538|NCT02522637|training|training
4816539|NCT02522637|endurance|endurance
4816540|NCT02522624|Health insurance|health insurance
4816541|NCT02522624|Health services accessibility|health services accessibility
4816542|NCT02522624|Decision making|decision making
4816543|NCT02522624|Health literacy|health literacy
4816544|NCT02522611|Palliative Care|palliative care
4816545|NCT02522611|Adults|adults
4816546|NCT02522611|Cancer Pain|cancer pain
4816547|NCT02522611|Nerve Block|nerve block
4816548|NCT02522611|Quality of Life|quality of life
4816549|NCT02522585|expectant management|expectant management
4816550|NCT02522585|p16|p16
4816551|NCT02522585|immunohistochemistry|immunohistochemistry
4816552|NCT02522585|regression|regression
4816553|NCT02522585|progression|progression
4816554|NCT02522585|cervical intraepithelial neoplasia|cervical intraepithelial neoplasia
4816555|NCT02522572|Renal Transplantation|renal transplantation
4816556|NCT02522572|Desensitization|desensitization
4816557|NCT02522572|plerixafor|plerixafor
4816558|NCT02522572|bortezomib|bortezomib
4816559|NCT02522520|Undergoing chemotherapy|undergoing chemotherapy
4816560|NCT02522520|Exercise intervention|exercise intervention
4816561|NCT02522520|Health counselling|health counselling
4816562|NCT02522520|Symptom management|symptom management
4816563|NCT02522481|Lumason|lumason
4816564|NCT02522481|Dobutamine stress echo|dobutamine stress echo
4816565|NCT02522481|stress echo|stress echo
4816566|NCT02522481|coronary artery disease|coronary artery disease
4816567|NCT02522455|Flow-cycled pressure-support ventilation|flow-cycled pressure-support ventilation
4816568|NCT02522403|distal radius fracture|distal radius fracture
4816569|NCT02522403|laser acupuncture|laser acupuncture
4816570|NCT02522403|rehabilitation|rehabilitation
4816571|NCT02522390|data collection|data collection
4816572|NCT02522390|personal health services|personal health services
4816573|NCT02522390|personal health records|personal health records
4816574|NCT02522390|do-it-yourself|do-it-yourself
4816575|NCT02522390|nutrition researchers|nutrition researchers
4816576|NCT02522390|cohort studies|cohort studies
4816577|NCT02522390|databases, factual|databases, factual
4816578|NCT02522390|self-quantification methods|self-quantification methods
4816579|NCT02522377|Ketamine|ketamine
4816580|NCT02522377|Electroconvulsive Therapy|electroconvulsive therapy
4816581|NCT02522377|Major Depressive Disorder|major depressive disorder
4816709|NCT02521623|Breast Implant|breast implant
4816582|NCT02522377|Treatment Resistant Depression|treatment resistant depression
4816583|NCT02522377|electroconvulsive treatment|electroconvulsive treatment
4816584|NCT02522377|Severe depression|severe depression
4816585|NCT02522364|Postoperative atrial fibrillation|postoperative atrial fibrillation
4816586|NCT02522364|Dysfunction Following Cardiac Surgery|dysfunction following cardiac surgery
4816587|NCT02522312|Dry Eye|dry eye
4816588|NCT02522299|double-blind|double-blind
4816589|NCT02522299|PI3Kdelta|pi3kdelta
4816590|NCT02522299|GSK2269557|gsk2269557
4816591|NCT02522299|exacerbation|exacerbation
4816592|NCT02522299|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
4816593|NCT02522299|randomised|randomised
4816594|NCT02522299|placebo-controlled|placebo-controlled
4816595|NCT02522286|patient engagement|patient engagement
4816596|NCT02522286|physician's role|physician's role
4816597|NCT02522286|patient- centered care|patient- centered care
4816598|NCT02522286|communication|communication
4816599|NCT02522273|Obstetric|obstetric
4816600|NCT02522273|Midwifery|midwifery
4816601|NCT02522273|Fetal blood sample|fetal blood sample
4816602|NCT02522273|Lactate|lactate
4816603|NCT02522273|Handheld meter|handheld meter
4816604|NCT02522260|Breast cancer, chemotherapy, symptoms, optimal training|breast cancer, chemotherapy, symptoms, optimal training
4816605|NCT02522234|Neutropenia|neutropenia
4816606|NCT02522234|Chemotherapy|chemotherapy
4816607|NCT02522221|chronic anticoagulation|chronic anticoagulation
4816608|NCT02522221|vitamin K antagonist|vitamin k antagonist
4816609|NCT02522221|mechanical heart valve|mechanical heart valve
4816610|NCT02522221|CYP2C9|cyp2c9
4816611|NCT02522221|warfarin|warfarin
4816612|NCT02522221|tecarfarin|tecarfarin
4816613|NCT02522221|chronic kidney disease|chronic kidney disease
4816614|NCT02522195|shift work|shift work
4816615|NCT02522195|nutritional status|nutritional status
4816616|NCT02522195|nursing professionals|nursing professionals
4816617|NCT02522195|meal distribution|meal distribution
4816618|NCT02522195|food intake|food intake
4816619|NCT02522182|Cardiovascular Secondary Prevention|cardiovascular secondary prevention
4816620|NCT02522182|Nurse's Role|nurse's role
4816621|NCT02522143|self-harm|self-harm
4816622|NCT02522143|self-mutilation|self-mutilation
4816623|NCT02522143|cutting|cutting
4816624|NCT02522117|Kidney Transplantation|kidney transplantation
4816625|NCT02522117|Atorvastatin|atorvastatin
4816626|NCT02522117|Human Leukocyte Antigens|human leukocyte antigens
4816627|NCT02522117|Interleukin|interleukin
4816628|NCT02522104|Pharmacokinetics of Hydroxyurea|pharmacokinetics of hydroxyurea
4816629|NCT02522078|misoprostol|misoprostol
4816630|NCT02522078|abortion|abortion
4816631|NCT02522065|Hypokinesia|hypokinesia
4816632|NCT02522065|Patient Outcome Assessment|patient outcome assessment
4816633|NCT02522013|post-dural puncture headache|post-dural puncture headache
4816634|NCT02522013|Aminophylline|aminophylline
4816635|NCT02521948|MANTA|manta
4816636|NCT02521948|Arterial Closure Device|arterial closure device
4816637|NCT02521948|Large Bore Closure Device|large bore closure device
4816638|NCT02521909|Root Canal length|root canal length
4816639|NCT02521909|Electronic apex locator|electronic apex locator
4816640|NCT02521909|Endodontics|endodontics
4816641|NCT02521870|Skin Cancer|skin cancer
4816642|NCT02521870|Skin Tumors|skin tumors
4816643|NCT02521870|Head and Neck Squamous Cell Carcinoma|head and neck squamous cell carcinoma
4816644|NCT02521870|Cancer Immunotherapy|cancer immunotherapy
4816645|NCT02521857|Alkermes|alkermes
4816646|NCT02521857|Samidorphan|samidorphan
4816647|NCT02521857|ALKS 5461|alks 5461
4816648|NCT02521857|Healthy Volunteer|healthy volunteer
4816649|NCT02521857|Pharmacokinetics|pharmacokinetics
4816650|NCT02521844|solid tumors|solid tumors
4816651|NCT02521844|responsive to Wnt signalling regulation|responsive to wnt signalling regulation
4816652|NCT02521831|Circumcision|circumcision
4816653|NCT02521818|cognition|cognition
4816654|NCT02521818|dementia|dementia
4816655|NCT02521818|neuropsychological|neuropsychological
4816656|NCT02521818|elderly|elderly
4816657|NCT02521818|nutrition|nutrition
4816658|NCT02521818|diet|diet
4816659|NCT02521805|Appetite|appetite
4816660|NCT02521805|Protein|protein
4816661|NCT02521805|Protein quality|protein quality
4816662|NCT02521805|Dietary fibre|dietary fibre
4816663|NCT02521805|Satiety|satiety
4816664|NCT02521792|Open-label study|open-label study
4816665|NCT02521792|Clinical trial Phase 2|clinical trial phase 2
4816666|NCT02521792|Efficacy and safety|efficacy and safety
4816667|NCT02521792|Heterotopic ossification|heterotopic ossification
4816668|NCT02521792|Fibrodysplasia Ossificans Progressiva|fibrodysplasia ossificans progressiva
4816669|NCT02521792|Flare-up|flare-up
4816670|NCT02521792|Palovarotene|palovarotene
4816671|NCT02521792|Retinoic acid receptor agonist|retinoic acid receptor agonist
4816672|NCT02521792|Retinoic acid receptor gamma agonist|retinoic acid receptor gamma agonist
4816673|NCT02521792|Clementia|clementia
4816674|NCT02521792|Myositis Ossificans Progressiva|myositis ossificans progressiva
4816675|NCT02521792|Munchmeyer's Disease|munchmeyer's disease
4816676|NCT02521792|FOP|fop
4816677|NCT02521779|Inflammation|inflammation
4816678|NCT02521779|Endotoxemia|endotoxemia
4816679|NCT02521779|Lipopolysaccharide|lipopolysaccharide
4816680|NCT02521779|Diet|diet
4816681|NCT02521779|Fat|fat
4816682|NCT02521779|Postprandial|postprandial
4816683|NCT02521753|Polycystic ovary syndrome|polycystic ovary syndrome
4816684|NCT02521753|Obesity|obesity
4816685|NCT02521753|Metformin|metformin
4816686|NCT02521753|Magnesium|magnesium
4816687|NCT02521753|Polyunsaturated fatty acids|polyunsaturated fatty acids
4816688|NCT02521740|biological marker|biological marker
4816689|NCT02521740|frailty|frailty
4816690|NCT02521740|burden|burden
4816691|NCT02521740|nutrition|nutrition
4816692|NCT02521740|elderly|elderly
4816693|NCT02521714|Revlimid|revlimid
4816694|NCT02521714|lenalidomide|lenalidomide
4816695|NCT02521714|bioavailability|bioavailability
4816696|NCT02521714|healthy volunteers|healthy volunteers
4816697|NCT02521714|food effect|food effect
4816698|NCT02521714|pharmacokinetics|pharmacokinetics
4816699|NCT02521662|Electronic Cigarettes|electronic cigarettes
4816700|NCT02521662|Nicotine Patch|nicotine patch
4816701|NCT02521662|Smoking Cessation|smoking cessation
4816702|NCT02521649|Gastric Cancer|gastric cancer
4816703|NCT02521649|G17DT|g17dt
4816704|NCT02521649|PAS|pas
4816705|NCT02521649|Insegia|insegia
4816706|NCT02521649|Gastrimmune|gastrimmune
4816707|NCT02521623|Acelullar Dermal Matrix|acelullar dermal matrix
4816708|NCT02521623|Immediate Breast Reconstruction|immediate breast reconstruction
4816710|NCT02521584|Liver transplant recipient|liver transplant recipient
4816711|NCT02521558|Cognitive rehabilitation|cognitive rehabilitation
4816712|NCT02521558|Mobile electronic application|mobile electronic application
4816713|NCT02521558|Memory tasks|memory tasks
4816714|NCT02521545|Oral Remyelination|oral remyelination
4816715|NCT02521519|Facet induced pain|facet induced pain
4816716|NCT02521519|Myofascial pain|myofascial pain
4816717|NCT02521519|Trigger points|trigger points
4816718|NCT02521519|Low back pain|low back pain
4816719|NCT02521454|policing|policing
4816720|NCT02521454|resilience|resilience
4816721|NCT02521454|implicit bias|implicit bias
4816722|NCT02521454|violence|violence
4816723|NCT02521441|Neutropenia|neutropenia
4816724|NCT02521441|Myelotoxic Chemotherapy|myelotoxic chemotherapy
4816725|NCT02521441|G-CSF|g-csf
4816726|NCT02521363|Implantable Microdevice|implantable microdevice
4816727|NCT02521363|In Vivo Drug Sensitivity Testing|in vivo drug sensitivity testing
4816728|NCT02521363|HER2-Positive|her2-positive
4816729|NCT02521363|Triple Negative|triple negative
4816730|NCT02521363|15-127|15-127
4816731|NCT02521350|Acute Kidney Injury|acute kidney injury
4816732|NCT02521350|Surgery|surgery
4816733|NCT02521350|Perioperative care|perioperative care
4816734|NCT02521311|multiple sclerosis|multiple sclerosis
4816735|NCT02521311|eye pain|eye pain
4816736|NCT02521311|vision loss|vision loss
4816737|NCT02521259|anesthetic depth|anesthetic depth
4816738|NCT02521259|emergence agitation|emergence agitation
4816739|NCT02521220|L-citrulline|l-citrulline
4816740|NCT02521220|Endothelial dysfunction|endothelial dysfunction
4816741|NCT02521194|Advanced Cancers|advanced cancers
4816742|NCT02521194|Inpatient occupational therapy|inpatient occupational therapy
4816743|NCT02521194|Questionnaire|questionnaire
4816744|NCT02521194|Survey|survey
4816745|NCT02521168|euthyroid sick syndrome|euthyroid sick syndrome
4816746|NCT02521168|cardiopulmonary bypass|cardiopulmonary bypass
4816747|NCT02521168|congenital heart disease|congenital heart disease
4816748|NCT02521168|time to extubation|time to extubation
4816749|NCT02521155|Oral health literacy intervention|oral health literacy intervention
4816750|NCT02521155|oral hygiene behavior|oral hygiene behavior
4816751|NCT02521142|OCT Angiography|oct angiography
4816752|NCT02521116|retinal oxygenation|retinal oxygenation
4816753|NCT02521116|retinal vessel diameters|retinal vessel diameters
4816754|NCT02521116|Dynamic vessel analyzer (DVA)|dynamic vessel analyzer (dva)
4816755|NCT02521116|Oxymap T1|oxymap t1
4816756|NCT02521077|Ascorbic Acid|ascorbic acid
4816757|NCT02521077|Breast Neoplasms|breast neoplasms
4816758|NCT02521077|Fatigue|fatigue
4816759|NCT02521064|IBD|ibd
4816760|NCT02521064|enteral nutrition|enteral nutrition
4816761|NCT02521064|corticosteroids|corticosteroids
4816762|NCT02521051|Non-Small Cell Lung Cancer (NSCLC)|non-small cell lung cancer (nsclc)
4816763|NCT02521051|Anaplastic lymphoma kinase|anaplastic lymphoma kinase
4816764|NCT02521051|ALK|alk
4816765|NCT02521051|Brain metastases|brain metastases
4816766|NCT02521012|Depression|depression
4816767|NCT02521012|Depressive symptoms|depressive symptoms
4816768|NCT02521012|Vitamin D|vitamin d
4816769|NCT02521012|Intervention|intervention
4816770|NCT02520986|Sexually transmitted disease|sexually transmitted disease
4816771|NCT02520986|Genital Warts|genital warts
4816772|NCT02520986|Venereal Warts|venereal warts
4816773|NCT02520960|Catheter Ablation|catheter ablation
4816774|NCT02520960|Pulmonary Vein Isolation|pulmonary vein isolation
4816775|NCT02520960|Radiofrequency|radiofrequency
4816776|NCT02520947|desflurane|desflurane
4816777|NCT02520947|BIS|bis
4816778|NCT02520947|coronary artery bypass grafting surgery|coronary artery bypass grafting surgery
4816779|NCT02520934|Enzyme Replacement Therapy|enzyme replacement therapy
4816780|NCT02520934|Miglustat|miglustat
4816781|NCT02520934|Gaucher Disease|gaucher disease
4816782|NCT02520921|Diabetes mellitus|diabetes mellitus
4816783|NCT02520921|Acute coronary syndrome|acute coronary syndrome
4816784|NCT02520921|Coronary artery disease|coronary artery disease
4816785|NCT02520921|Aspirin|aspirin
4816786|NCT02520921|Secondary prevention|secondary prevention
4816787|NCT02520895|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
4816788|NCT02520895|Non-Hodgkin lymphoma|non-hodgkin lymphoma
4816789|NCT02520895|Follicular Lymphoma|follicular lymphoma
4816790|NCT02520895|Diffuse Large B Cell Lymphoma|diffuse large b cell lymphoma
4816791|NCT02520895|MALT Lymphoma|malt lymphoma
4816792|NCT02520895|T Cell Lymphoma|t cell lymphoma
4816793|NCT02520895|Immune Repertoire|immune repertoire
4816794|NCT02520895|Infection|infection
4816795|NCT02520895|relapse|relapse
4816796|NCT02520895|survival|survival
4816797|NCT02520895|treatment response|treatment response
4816798|NCT02520895|VJ rearrangement|vj rearrangement
4816799|NCT02520882|PET/CT|pet/ct
4816800|NCT02520882|Bombesin|bombesin
4816801|NCT02520882|gastrin-releasing peptide receptor|gastrin-releasing peptide receptor
4816802|NCT02520882|68Gallium labeling|68gallium labeling
4816803|NCT02520830|blueberry polyphenols|blueberry polyphenols
4816804|NCT02520830|Polyphenol metabolites|polyphenol metabolites
4816805|NCT02520830|endothelial function|endothelial function
4816806|NCT02520830|Molecular mechanisms of action|molecular mechanisms of action
4816807|NCT02520830|Vascular function|vascular function
4816808|NCT02520830|Healthy men|healthy men
4816809|NCT02520817|Antioxidants|antioxidants
4816810|NCT02520817|Zinc|zinc
4816811|NCT02520817|Truck drivers|truck drivers
4816812|NCT02520804|balanced salt solution|balanced salt solution
4816813|NCT02520765|Obesity Index, ICSI|obesity index, icsi
4816814|NCT02520752|cMET, INC280, caffeine, midazolam|cmet, inc280, caffeine, midazolam
4816815|NCT02520739|olive oil|olive oil
4816816|NCT02520739|phenolic compounds|phenolic compounds
4816817|NCT02520739|triterpenes|triterpenes
4816818|NCT02520739|oxidation and inflammation|oxidation and inflammation
4816819|NCT02520726|Posttraumatic stress disorder|posttraumatic stress disorder
4816820|NCT02520726|PTSD|ptsd
4816821|NCT02520726|Sertraline|sertraline
4816822|NCT02520726|Burns|burns
4816823|NCT02520713|Pediatric Solid Tumor|pediatric solid tumor
4816824|NCT02520648|Back pain|back pain
4816825|NCT02520648|Manual therapy|manual therapy
4816826|NCT02520635|prognosis|prognosis
4816827|NCT02520635|supra-early chemotherapy|supra-early chemotherapy
4816828|NCT02520609|Metabolomics|metabolomics
4816829|NCT02520609|Non-Alcoholic Steatohepatitis|non-alcoholic steatohepatitis
4816830|NCT02520609|Non-Alcoholic Fatty Liver Disease|non-alcoholic fatty liver disease
4816831|NCT02520609|Energy Expenditure|energy expenditure
4816832|NCT02520596|Raspberries|raspberries
4816833|NCT02520596|Anthocyanins|anthocyanins
4816834|NCT02520596|Ellagitannins|ellagitannins
4816835|NCT02520596|Metabolites|metabolites
4816836|NCT02520557|Epilepsy|epilepsy
4816837|NCT02520557|Genetic associations with severe Cutaneous Adverse Reactions|genetic associations with severe cutaneous adverse reactions
4816838|NCT02520492|intracranial pressure|intracranial pressure
4816839|NCT02520479|extranodal natural killer/T-cell lymphoma|extranodal natural killer/t-cell lymphoma
4816840|NCT02520479|nasal type|nasal type
4816841|NCT02520479|radiotherapy|radiotherapy
4816842|NCT02520479|chemotherapy|chemotherapy
4816843|NCT02520440|Citrulline|citrulline
4816844|NCT02520440|GIF|gif
4816845|NCT02520440|MOF|mof
4816846|NCT02520440|Calprotectina|calprotectina
4816847|NCT02520440|intraabdominal pressure|intraabdominal pressure
4816848|NCT02520427|Amgen|amgen
4816849|NCT02520427|Phase 1|phase 1
4816850|NCT02520427|Clinical Trial|clinical trial
4816851|NCT02520427|Oncology/Hematology|oncology/hematology
4816852|NCT02520427|Relapsed/Refractory AML|relapsed/refractory aml
4816853|NCT02520427|Immunotherapy|immunotherapy
4816854|NCT02520310|Mitral Regurgitation|mitral regurgitation
4816855|NCT02520310|mitral valve surgery|mitral valve surgery
4816856|NCT02520310|AVJ-514 Delivery System|avj-514 delivery system
4816857|NCT02520310|Symptomatic Heart Failure|symptomatic heart failure
4816858|NCT02520310|Heart Valve Disease|heart valve disease
4816859|NCT02520297|Pain|pain
4816860|NCT02520297|Long bone|long bone
4816861|NCT02520297|Fracture|fracture
4816862|NCT02520271|Mood Disorders|mood disorders
4816863|NCT02520271|Motivational Interview|motivational interview
4816864|NCT02520271|Behavioral Activation|behavioral activation
4816865|NCT02520258|artificial sweeteners|artificial sweeteners
4816866|NCT02520258|obesity|obesity
4816867|NCT02520258|diabetes|diabetes
4816868|NCT02520258|metabolic syndrome|metabolic syndrome
4816869|NCT02520258|aspartame|aspartame
4816870|NCT02520232|chronic exercise|chronic exercise
4816871|NCT02520232|genetic polymorphisms|genetic polymorphisms
4816872|NCT02520232|brain imagery|brain imagery
4816873|NCT02520232|executive functions|executive functions
4816874|NCT02520232|alzheimer's disease|alzheimer's disease
4816875|NCT02520219|Peripheral T-cell lymphomas,Endostar|peripheral t-cell lymphomas,endostar
4816876|NCT02520193|Early mobilisation|early mobilisation
4816877|NCT02520193|Invasive ventilation|invasive ventilation
4816878|NCT02520193|Ventilator free days|ventilator free days
4816879|NCT02520193|Intensive Care Unit|intensive care unit
4816880|NCT02520167|Gestational weight gain|gestational weight gain
4816881|NCT02520154|Ovarian Cancer|ovarian cancer
4816882|NCT02520154|Metastatic Ovarian Cancer|metastatic ovarian cancer
4816883|NCT02520154|High-grade epithelial non-mucinous ovarian cancer|high-grade epithelial non-mucinous ovarian cancer
4816884|NCT02520154|Advanced stage ovarian cancer|advanced stage ovarian cancer
4816885|NCT02520154|Carboplatin|carboplatin
4816886|NCT02520154|Paraplatin|paraplatin
4816887|NCT02520154|Paclitaxel|paclitaxel
4816888|NCT02520154|Taxol|taxol
4816889|NCT02520154|Pembrolizumab|pembrolizumab
4816890|NCT02520154|Keytruda|keytruda
4816891|NCT02520154|MK-3475|mk-3475
4816892|NCT02520154|SCH-900475|sch-900475
4816893|NCT02520141|Biliary cancer|biliary cancer
4816894|NCT02520141|Advanced biliary cancers|advanced biliary cancers
4816895|NCT02520141|Intrahepatic cholangiocarcinoma|intrahepatic cholangiocarcinoma
4816896|NCT02520141|Extrahepatic cholangiocarcinoma|extrahepatic cholangiocarcinoma
4816897|NCT02520141|Gallbladder cancer|gallbladder cancer
4816898|NCT02520141|Received prior chemotherapy|received prior chemotherapy
4816899|NCT02520141|Ramucirumab|ramucirumab
4816900|NCT02520141|IMC-1121B|imc-1121b
4816901|NCT02520128|Intensity Modulated Radiotherapy|intensity modulated radiotherapy
4816902|NCT02520128|Radiotherapy|radiotherapy
4816903|NCT02520089|platelet-rich plasma|platelet-rich plasma
4816904|NCT02520089|bone grafting|bone grafting
4816905|NCT02520089|pseudoarthrosis|pseudoarthrosis
4816906|NCT02520076|Islet Transplantation|islet transplantation
4816907|NCT02520063|hormone-receptor positive breast cancer|hormone-receptor positive breast cancer
4816908|NCT02520063|Her2 negative breast cancer|her2 negative breast cancer
4816909|NCT02520063|neoadjuvant|neoadjuvant
4816910|NCT02520063|everolimus|everolimus
4816911|NCT02520063|TRC105|trc105
4816912|NCT02520063|letrozole|letrozole
4816913|NCT02520050|Type 2 diabetes|type 2 diabetes
4816914|NCT02520050|Obesity|obesity
4816915|NCT02520050|Nutrition|nutrition
4816916|NCT02520050|Medical Nutrition Therapy|medical nutrition therapy
4816917|NCT02520037|Fluid responsiveness|fluid responsiveness
4816918|NCT02520037|Volume responsiveness|volume responsiveness
4816919|NCT02520037|Hemodynamics|hemodynamics
4816920|NCT02520024|self-directed care|self-directed care
4816921|NCT02520024|serious mental illness|serious mental illness
4816922|NCT02520011|Refractory AML|refractory aml
4816923|NCT02520011|Relapsed AML|relapsed aml
4816924|NCT02520011|AML|aml
4816925|NCT02520011|Newly diagnosed high-risk AML|newly diagnosed high-risk aml
4816926|NCT02519998|Biomarkers|biomarkers
4816927|NCT02519998|Electrocardiography|electrocardiography
4816928|NCT02519998|Balance|balance
4816929|NCT02519998|Neuropsychiatric assessment|neuropsychiatric assessment
4816930|NCT02519998|Cortisol|cortisol
4816931|NCT02519998|Calcitonin-gene-related peptide|calcitonin-gene-related peptide
4816932|NCT02519998|Electroencephalography|electroencephalography
4816933|NCT02519998|Optical coherence tomography|optical coherence tomography
4816934|NCT02519998|Von Frey Testing|von frey testing
4816935|NCT02519985|VHF digital ultrasound|vhf digital ultrasound
4816936|NCT02519985|Corneal thickness|corneal thickness
4816937|NCT02519985|Epithelial thickness|epithelial thickness
4816938|NCT02519985|Angle diameter|angle diameter
4816939|NCT02519985|Sulcus diameter|sulcus diameter
4816940|NCT02519985|Anterior chamber depth|anterior chamber depth
4818247|NCT02512198|Feedback|feedback
4816941|NCT02519985|Repeatability|repeatability
4816942|NCT02519985|Reproducibility|reproducibility
4816943|NCT02519972|Low dose CT screening|low dose ct screening
4816944|NCT02519972|Family history of lung cancer|family history of lung cancer
4816945|NCT02519946|Heart Transplantation|heart transplantation
4816946|NCT02519946|Tonometry|tonometry
4816947|NCT02519946|Exercise Test|exercise test
4816948|NCT02519946|Diet|diet
4816949|NCT02519946|Cardiovascular Physiology|cardiovascular physiology
4816950|NCT02519946|Telemedicine|telemedicine
4816951|NCT02519946|Pediatrics|pediatrics
4816952|NCT02519946|Health Behavior|health behavior
4816953|NCT02519946|Physical Fitness|physical fitness
4816954|NCT02519946|Exercise Movement Techniques|exercise movement techniques
4816955|NCT02519946|Adolescent Behavior|adolescent behavior
4816956|NCT02519946|Child Behavior|child behavior
4816957|NCT02519933|hemodialysis|hemodialysis
4816958|NCT02519933|vascular access|vascular access
4816959|NCT02519907|Nerve Stimulation|nerve stimulation
4816960|NCT02519907|Neuroplasticity|neuroplasticity
4816961|NCT02519907|Sensory Feedback|sensory feedback
4816962|NCT02519881|cartilage defect in ankle|cartilage defect in ankle
4816963|NCT02519881|microfracture|microfracture
4816964|NCT02519881|modified microfracture using collagen|modified microfracture using collagen
4816965|NCT02519881|collagen|collagen
4816966|NCT02519868|Neuromodulation|neuromodulation
4816967|NCT02519868|Local anaesthetics|local anaesthetics
4816968|NCT02519829|Suture|suture
4816969|NCT02519829|Skin staples|skin staples
4816970|NCT02519829|Vicryl|vicryl
4816971|NCT02519829|Monocryl|monocryl
4816972|NCT02519816|post stem cell transplantation|post stem cell transplantation
4816973|NCT02519816|Steroid refractory|steroid refractory
4816974|NCT02519816|dependent chronic|dependent chronic
4816975|NCT02519790|Pregnancy|pregnancy
4816976|NCT02519790|Depression|depression
4816977|NCT02519790|Anxiety|anxiety
4816978|NCT02519790|Mental Health|mental health
4816979|NCT02519790|Women|women
4816980|NCT02519777|HIV-Associated Neurocognitive Disorder|hiv-associated neurocognitive disorder
4816981|NCT02519764|volunteer runners who are participating in the 2015 Mont Blanc Ultra Trail|volunteer runners who are participating in the 2015 mont blanc ultra trail
4816982|NCT02519764|hydration protocol|hydration protocol
4816983|NCT02519764|natremia|natremia
4816984|NCT02519764|Volunteers|volunteers
4816985|NCT02519725|Family|family
4816986|NCT02519725|PTSD|ptsd
4816987|NCT02519725|Anxiety disorders|anxiety disorders
4816988|NCT02519725|Depression disorders|depression disorders
4816989|NCT02519725|Qualitative research|qualitative research
4816990|NCT02519712|Induction Chemotherapy|induction chemotherapy
4816991|NCT02519712|G-CSF-Mobilized Stem Cells|g-csf-mobilized stem cells
4816992|NCT02519712|Haploidentical Related Donors|haploidentical related donors
4816993|NCT02519712|15-141|15-141
4816994|NCT02519660|Ralydan|ralydan
4816995|NCT02519660|EMLA cream|emla cream
4816996|NCT02519660|Procedural pain|procedural pain
4816997|NCT02519660|Phlebotomy|phlebotomy
4816998|NCT02519660|Child|child
4816999|NCT02519634|Super-Mini Percutaneous Nephrolithotomy|super-mini percutaneous nephrolithotomy
4817000|NCT02519634|SMP|smp
4817001|NCT02519634|Retrograde Intrarenal Surgery|retrograde intrarenal surgery
4817002|NCT02519634|RIRS|rirs
4817003|NCT02519634|Randomized Controlled Trial|randomized controlled trial
4817004|NCT02519634|RCT|rct
4817005|NCT02519621|diabetic ulcer|diabetic ulcer
4817006|NCT02519621|pressure ulcer|pressure ulcer
4817007|NCT02519621|chronic or traumatic wound|chronic or traumatic wound
4817008|NCT02519621|sub-acute or dehisced wound|sub-acute or dehisced wound
4817009|NCT02519608|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
4817010|NCT02519608|stable coronary artery disease|stable coronary artery disease
4817011|NCT02519608|ticagrelor|ticagrelor
4817012|NCT02519608|clopidogrel|clopidogrel
4817013|NCT02519608|endothelial function|endothelial function
4817014|NCT02519608|inflammation|inflammation
4817015|NCT02519608|platelet reactivity|platelet reactivity
4817016|NCT02519595|Procedural sedation|procedural sedation
4817017|NCT02519595|ketamine|ketamine
4817018|NCT02519595|children|children
4817019|NCT02519582|Colorectal Cancer|colorectal cancer
4817020|NCT02519582|S100A4|s100a4
4817021|NCT02519556|Probiotics|probiotics
4817022|NCT02519556|Inflammation|inflammation
4817023|NCT02519556|Awareness|awareness
4817024|NCT02519556|Immune tolerance|immune tolerance
4817025|NCT02519543|insulin resistance|insulin resistance
4817026|NCT02519530|Positive Youth Development|positive youth development
4817027|NCT02519530|Teen Outreach|teen outreach
4817028|NCT02519530|Teen Pregnancy Prevention|teen pregnancy prevention
4817029|NCT02519504|Galactose-1-phosphate uridylyltransferase deficiency|galactose-1-phosphate uridylyltransferase deficiency
4817030|NCT02519504|Cognitive disorders|cognitive disorders
4817031|NCT02519478|football|football
4817032|NCT02519478|Training Techniques|training techniques
4817033|NCT02519478|education|education
4817034|NCT02519478|Athletic Injuries|athletic injuries
4817035|NCT02519478|Brain Concussion|brain concussion
4817036|NCT02519465|nasal cannula|nasal cannula
4817037|NCT02519465|Inhalation Devices|inhalation devices
4817038|NCT02519452|Multiple Myeloma|multiple myeloma
4819349|NCT02505620|OSAS|osas
4817039|NCT02519452|Daratumumab (JNJ-54767414)|daratumumab (jnj-54767414)
4817040|NCT02519452|Recombinant Human Hyaluronidase|recombinant human hyaluronidase
4817041|NCT02519439|Partial Onset Seizures|partial onset seizures
4817042|NCT02519439|complex partial seizures|complex partial seizures
4817043|NCT02519439|simple partial seizures|simple partial seizures
4817044|NCT02519439|anticonvulsant|anticonvulsant
4817045|NCT02519439|ganaxolone|ganaxolone
4817046|NCT02519439|neurosteroid|neurosteroid
4817047|NCT02519439|Marinus|marinus
4817048|NCT02519439|epilepsy|epilepsy
4817049|NCT02519426|Third molar|third molar
4817050|NCT02519426|Classification|classification
4817051|NCT02519426|Inferior alveolar nerve|inferior alveolar nerve
4817052|NCT02519426|Lingual nerve injuries|lingual nerve injuries
4817053|NCT02519426|Mandibular canal|mandibular canal
4817054|NCT02519413|lymphocyte|lymphocyte
4817055|NCT02519413|serious infections|serious infections
4817056|NCT02519413|opportunistic infections|opportunistic infections
4817057|NCT02519413|Relapsing Forms|relapsing forms
4817058|NCT02519400|amitriptyline|amitriptyline
4817059|NCT02519400|cyp2d6|cyp2d6
4817060|NCT02519400|cyp2c19|cyp2c19
4817061|NCT02519374|Fiber tolerability|fiber tolerability
4817062|NCT02519374|Children|children
4817063|NCT02519361|elderly|elderly
4817064|NCT02519361|immune response|immune response
4817065|NCT02519361|acute infection|acute infection
4817066|NCT02519348|Hepatocellular Carcinoma|hepatocellular carcinoma
4817067|NCT02519348|Immunotherapy|immunotherapy
4817068|NCT02519348|Antibodies, Monoclonal|antibodies, monoclonal
4817069|NCT02519348|Tremelimumab|tremelimumab
4817070|NCT02519348|MEDI4736|medi4736
4817071|NCT02519348|Durvalumab|durvalumab
4817072|NCT02519335|cardiopulmonary bypass|cardiopulmonary bypass
4817073|NCT02519335|ischemia reperfusion injury|ischemia reperfusion injury
4817074|NCT02519322|Melanoma|melanoma
4817075|NCT02519322|Oligometastatic melanoma|oligometastatic melanoma
4817076|NCT02519322|Resectable|resectable
4817077|NCT02519322|Nivolumab|nivolumab
4817078|NCT02519322|BMS-936558|bms-936558
4817079|NCT02519322|Opdivo|opdivo
4817080|NCT02519322|Ipilimumab|ipilimumab
4817081|NCT02519322|Yervoy|yervoy
4817082|NCT02519322|BMS-734016|bms-734016
4817083|NCT02519322|MDX010|mdx010
4817084|NCT02519283|AHF|ahf
4817085|NCT02519283|HF|hf
4817086|NCT02519283|ED|ed
4817088|NCT02519283|Emergency Department|emergency department
4817089|NCT02519283|Emergency Room|emergency room
4817090|NCT02519257|CAD|cad
4817091|NCT02519257|VHD|vhd
4817092|NCT02519257|Thy-1|thy-1
4817093|NCT02519244|Multiple Sclerosis|multiple sclerosis
4817094|NCT02519244|Ambulation|ambulation
4817095|NCT02519244|Rehabilitation|rehabilitation
4817096|NCT02519244|Wearable Robotic Devices|wearable robotic devices
4817097|NCT02519231|IUD|iud
4817098|NCT02519231|naproxen|naproxen
4817099|NCT02519231|bleeding|bleeding
4817100|NCT02519153|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors
4817101|NCT02519153|PDE5i|pde5i
4817102|NCT02519153|Sildinafil|sildinafil
4817103|NCT02519140|Gastric cancer|gastric cancer
4817104|NCT02519140|colon cancer|colon cancer
4817105|NCT02519140|EMR|emr
4817106|NCT02519140|biopsy|biopsy
4817107|NCT02519140|bariatric surgery|bariatric surgery
4817108|NCT02519114|M Myeloma|m myeloma
4817109|NCT02519114|KIR ligand mismatch|kir ligand mismatch
4817110|NCT02519114|Haploidentical|haploidentical
4817111|NCT02519088|Homologous Blood Transfusion|homologous blood transfusion
4817112|NCT02519088|Total Hip Replacement|total hip replacement
4817113|NCT02519088|Patient Blood Management|patient blood management
4817114|NCT02519075|Hepatocarcinoma|hepatocarcinoma
4817115|NCT02519075|TARE|tare
4817116|NCT02519075|response assessment|response assessment
4817117|NCT02519062|Carcinoma|carcinoma
4817118|NCT02519062|Non-Small-Cell Lung|non-small-cell lung
4817119|NCT02519062|FDG PET|fdg pet
4817120|NCT02519062|hypoxia markers|hypoxia markers
4817121|NCT02519062|immune markers|immune markers
4817122|NCT02519049|Mesothelioma|mesothelioma
4817123|NCT02519049|11C-methionine PET|11c-methionine pet
4817124|NCT02519049|talc pleurodesis|talc pleurodesis
4817125|NCT02519036|Huntington's Disease|huntington's disease
4817126|NCT02519036|HTTRx|httrx
4817127|NCT02519036|Early Manifest Huntington's Disease|early manifest huntington's disease
4817128|NCT02518997|Preterm Infants|preterm infants
4817129|NCT02518997|Bedside Reading aloud|bedside reading aloud
4817130|NCT02518997|Parental wellbeing|parental wellbeing
4817131|NCT02518997|Parental Bonding|parental bonding
4817132|NCT02518997|cardio-respiratory stability|cardio-respiratory stability
4817133|NCT02518945|Type 1 Diabetes|type 1 diabetes
4817134|NCT02518945|Liraglutide|liraglutide
4817135|NCT02518945|Dapagliflozin|dapagliflozin
4817136|NCT02518945|Triple Therapy|triple therapy
4817137|NCT02518919|Children|children
4817138|NCT02518919|Emergency Department|emergency department
4817139|NCT02518919|Sedation|sedation
4817140|NCT02518906|Psychotherapy|psychotherapy
4817141|NCT02518906|psychotherapy process|psychotherapy process
4817142|NCT02518906|therapeutic alliance|therapeutic alliance
4817143|NCT02518906|psychotherapeutic change|psychotherapeutic change
4817144|NCT02518906|psychophysiology|psychophysiology
4817145|NCT02518893|Military Personnel|military personnel
4817146|NCT02518893|Air Force Personnel|air force personnel
4817147|NCT02518893|Army Personnel|army personnel
4817148|NCT02518893|Navy Personnel|navy personnel
4817149|NCT02518893|Armed Forces Personnel|armed forces personnel
4817150|NCT02518893|Marines|marines
4817151|NCT02518893|Soldiers|soldiers
4817152|NCT02518893|Sailors|sailors
4817153|NCT02518893|Airmen|airmen
4817154|NCT02518893|Decision Making|decision making
4817155|NCT02518893|Research Subjects|research subjects
4817156|NCT02518893|Life Experiences|life experiences
4817157|NCT02518893|Patient Participation|patient participation
4817158|NCT02518893|Refusal to Participate|refusal to participate
4817159|NCT02518893|Healthcare Research|healthcare research
4817160|NCT02518893|Qualitative Research|qualitative research
4817161|NCT02518893|Interview|interview
4817162|NCT02518893|Interviews, Telephone|interviews, telephone
4817163|NCT02518893|Ethics, Research|ethics, research
4817164|NCT02518867|Cerebral palsy|cerebral palsy
4817165|NCT02518867|Transcranial magnetic stimulation|transcranial magnetic stimulation
4817166|NCT02518841|ThermaWedge TM|thermawedge tm
4817167|NCT02518841|stretches|stretches
4817168|NCT02518828|Acute Heart Failure|acute heart failure
4817169|NCT02518802|Gefitinib|gefitinib
4817170|NCT02518802|Pemetrexed|pemetrexed
4817171|NCT02518802|Synchronous therapy|synchronous therapy
4817172|NCT02518802|Adjuvent therapy|adjuvent therapy
4817173|NCT02518789|myoclonus|myoclonus
4817174|NCT02518789|Etomidate|etomidate
4817175|NCT02518789|Dexmedetomidine|dexmedetomidine
4817176|NCT02518750|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
4817177|NCT02518750|Salvage Regimen|salvage regimen
4817178|NCT02518750|Re-Induction Therapy|re-induction therapy
4817179|NCT02518750|Multi-agent chemotherapy|multi-agent chemotherapy
4817180|NCT02518737|Glucose-dependent Insulinotropic Polypeptide|glucose-dependent insulinotropic polypeptide
4817181|NCT02518737|Receptor Deficiency|receptor deficiency
4817182|NCT02518711|symptoms of ADHD|symptoms of adhd
4817183|NCT02518698|Castrated resistant prostate cancer|castrated resistant prostate cancer
4817184|NCT02518698|Patients with bone metastases|patients with bone metastases
4817185|NCT02518685|Obesity|obesity
4817186|NCT02518685|Weight loss|weight loss
4817187|NCT02518685|Device|device
4817188|NCT02518685|Non-surgical|non-surgical
4817189|NCT02518685|Endoscopic|endoscopic
4817190|NCT02518685|TransPyloric Shuttle|transpyloric shuttle
4817191|NCT02518685|TPS|tps
4817192|NCT02518659|hypomagnesemia|hypomagnesemia
4817193|NCT02518659|hypocalcemia|hypocalcemia
4817194|NCT02518659|inulin|inulin
4817195|NCT02518659|FOS|fos
4817196|NCT02518659|PPI|ppi
4817197|NCT02518659|proton-pump inhibitors|proton-pump inhibitors
4817198|NCT02518646|Delirium|delirium
4817199|NCT02518646|Intensive care unit|intensive care unit
4817200|NCT02518646|Adult|adult
4817201|NCT02518646|Clinical prediction|clinical prediction
4817202|NCT02518633|obesity|obesity
4817203|NCT02518633|hypoxia|hypoxia
4817204|NCT02518633|adipose tissue|adipose tissue
4817205|NCT02518607|Safety and Tolerability|safety and tolerability
4817206|NCT02518607|Male Volunteers|male volunteers
4817207|NCT02518594|women|women
4817208|NCT02518594|cervical length of less than 30 millimeters|cervical length of less than 30 millimeters
4817209|NCT02518594|carrying twins|carrying twins
4817210|NCT02518594|short cervix|short cervix
4817211|NCT02518516|Statins, HMG-CoA|statins, hmg-coa
4817212|NCT02518516|Acute kidney injury|acute kidney injury
4817213|NCT02518516|Kidney diseases|kidney diseases
4817214|NCT02518516|Renal failure|renal failure
4817215|NCT02518503|Diabetes Mellitus|diabetes mellitus
4817216|NCT02518503|Statins|statins
4817217|NCT02518503|HMG-CoA reductase inhibitors|hmg-coa reductase inhibitors
4817218|NCT02518477|breast cancer surgery|breast cancer surgery
4817219|NCT02518477|axillary lymph node dissection|axillary lymph node dissection
4817220|NCT02518477|resistance training|resistance training
4817221|NCT02518477|breast cancer related lymphedema|breast cancer related lymphedema
4817222|NCT02518464|headache|headache
4817223|NCT02518464|chronic|chronic
4817224|NCT02518464|migraine|migraine
4817225|NCT02518464|right to left shunt|right to left shunt
4817226|NCT02518451|antihypertensive|antihypertensive
4817227|NCT02518451|bioequivalence|bioequivalence
4817228|NCT02518451|formulation|formulation
4817229|NCT02518451|pharmakokinetic|pharmakokinetic
4817230|NCT02518451|valsartan|valsartan
4817231|NCT02518451|subjects|subjects
4817232|NCT02518451|Fasting conditions|fasting conditions
4817233|NCT02518438|Tramadol|tramadol
4817234|NCT02518438|Postoperative analgesia|postoperative analgesia
4817235|NCT02518438|Infiltration|infiltration
4817236|NCT02518438|Cesarean section|cesarean section
4817237|NCT02518412|Alzheimers disease|alzheimers disease
4817238|NCT02518412|Transcranial direct current stimulation (tDCS)|transcranial direct current stimulation (tdcs)
4817239|NCT02518412|Neuromodulation|neuromodulation
4817240|NCT02518412|Neuropsychology|neuropsychology
4817241|NCT02518399|Blood vessels|blood vessels
4817242|NCT02518399|Heat|heat
4817243|NCT02518399|Cardiovascular diseases|cardiovascular diseases
4817244|NCT02518386|emergency department|emergency department
4817245|NCT02518386|epidemiology|epidemiology
4817246|NCT02518386|prehospital care|prehospital care
4817247|NCT02518386|dispatch|dispatch
4817248|NCT02518386|acute self poisoning|acute self poisoning
4817249|NCT02518360|NON SPECIFIC LOW BACK PAIN|non specific low back pain
4817250|NCT02518360|OSTEOPATHY|osteopathy
4817251|NCT02518360|FOOT PRESSURE PLATFORM|foot pressure platform
4817252|NCT02518360|POSTURAL BALANCE|postural balance
4817253|NCT02518334|type two diabetes|type two diabetes
4817254|NCT02518334|glycemic control|glycemic control
4817255|NCT02518321|Toileting|toileting
4817256|NCT02518321|Technology-Assisted Toilets|technology-assisted toilets
4817257|NCT02518321|Rehabilitation|rehabilitation
4817258|NCT02518321|Assistive Devices|assistive devices
4817259|NCT02518321|Activities of Daily Living|activities of daily living
4817260|NCT02518282|high-sensitivity troponin T|high-sensitivity troponin t
4817261|NCT02518282|Acute myocardial infarction|acute myocardial infarction
4817262|NCT02518282|Heart valvular surgery|heart valvular surgery
4817263|NCT02518282|Cardiac surgery|cardiac surgery
4817264|NCT02518269|hip|hip
4817265|NCT02518269|arthroplasty|arthroplasty
4817266|NCT02518269|G7|g7
4817267|NCT02518269|EchoBimetric|echobimetric
4817268|NCT02518269|E1|e1
4817269|NCT02518269|ceramic|ceramic
4817270|NCT02518269|Arcom XL|arcom xl
4817271|NCT02518256|Neoplasms|neoplasms
4817272|NCT02518256|Glandular and Epithelial|glandular and epithelial
4817273|NCT02518256|Ovarian Neoplasms|ovarian neoplasms
4817274|NCT02518256|Ovarian cancer|ovarian cancer
4817275|NCT02518204|cognitive assessment|cognitive assessment
4817276|NCT02518204|neuropsychological assessment|neuropsychological assessment
4817277|NCT02518204|Brain Performance Test|brain performance test
4817278|NCT02518204|computerized assessment|computerized assessment
4817279|NCT02518191|GnRHa|gnrha
4817280|NCT02518191|ovarian function|ovarian function
4817281|NCT02518191|anti-mullerian hormone|anti-mullerian hormone
4817282|NCT02518178|NFC|nfc
4817283|NCT02518178|randomization|randomization
4817284|NCT02518178|RCT|rct
4817285|NCT02518178|mHealth|mhealth
4817286|NCT02518178|maternal and child health|maternal and child health
4817287|NCT02518165|Cognitive Domain: Speed|cognitive domain: speed
4817288|NCT02518165|Cognitive Domain: Reaction Time|cognitive domain: reaction time
4817289|NCT02518165|Cognitive Domain: Attention|cognitive domain: attention
4817290|NCT02518165|Cognitive Domain: Executive Function|cognitive domain: executive function
4817291|NCT02518165|Cognitive Domain Memory|cognitive domain memory
4817292|NCT02518165|Sleep Quality|sleep quality
4817293|NCT02518165|Sleep Efficiency|sleep efficiency
4817294|NCT02518139|Chronic Obstructive Pulmonary Disease, COPD|chronic obstructive pulmonary disease, copd
4817295|NCT02518126|LIF IUGR|lif iugr
4817296|NCT02518087|CPB|cpb
4817297|NCT02518087|oXiris®|oxiris®
4817298|NCT02518087|CS-AKI|cs-aki
4817299|NCT02518087|SIRS|sirs
4817300|NCT02518087|Cytokines|cytokines
4817301|NCT02518087|LPS|lps
4817302|NCT02518087|AKI|aki
4817303|NCT02518074|volunteers|volunteers
4817304|NCT02518061|Glioma; 11C-Methionine PET|glioma; 11c-methionine pet
4817305|NCT02518048|Psoriasis|psoriasis
4817306|NCT02518022|Type 1 Diabetes mellitus|type 1 diabetes mellitus
4817307|NCT02518022|Hypoglycemia|hypoglycemia
4817308|NCT02518022|continuous subcutaneous insulin infusion|continuous subcutaneous insulin infusion
4817309|NCT02518022|Alcohol|alcohol
4817310|NCT02518022|continuous glucose monitoring system|continuous glucose monitoring system
4817311|NCT02518022|Nutrition|nutrition
4817312|NCT02517983|chronic respiratory diseases phenotyping|chronic respiratory diseases phenotyping
4817313|NCT02517970|infant feeding|infant feeding
4817314|NCT02517970|breast-feeding|breast-feeding
4817315|NCT02517970|bottle-feeding|bottle-feeding
4817316|NCT02517970|feeding interactions|feeding interactions
4817317|NCT02517970|maternal feeding practices|maternal feeding practices
4817318|NCT02517957|Xiashi surgical|xiashi surgical
4817319|NCT02517944|Familial hypercholesterolemia|familial hypercholesterolemia
4817320|NCT02517918|Advanced solid tumor|advanced solid tumor
4817321|NCT02517918|Bone metastasis and advanced pretreated osteosarcoma|bone metastasis and advanced pretreated osteosarcoma
4817322|NCT02517918|Phase I trial|phase i trial
4817323|NCT02517918|Dose escalation and expansion cohort|dose escalation and expansion cohort
4817324|NCT02517918|Biomarkers study|biomarkers study
4817325|NCT02517879|ITNs|itns
4817326|NCT02517879|malaria prevention|malaria prevention
4817327|NCT02517866|Drug therapy|drug therapy
4817328|NCT02517827|common femoral artery|common femoral artery
4817329|NCT02517827|drug-coated balloon|drug-coated balloon
4817330|NCT02517827|surgical endarterectomy|surgical endarterectomy
4817331|NCT02517801|anthocyanins|anthocyanins
4817332|NCT02517801|Post-menopausal women|post-menopausal women
4817333|NCT02517801|endothelial function|endothelial function
4817334|NCT02517801|vascular function|vascular function
4817335|NCT02517775|polyphenols|polyphenols
4817336|NCT02517775|vascular function|vascular function
4817337|NCT02517775|endothelial function|endothelial function
4817338|NCT02517775|cranberry|cranberry
4817339|NCT02517775|healthy|healthy
4817340|NCT02517723|Borderline Personality Disorder|borderline personality disorder
4817341|NCT02517723|comorbid Posttraumatic Stress Disorder|comorbid posttraumatic stress disorder
4817342|NCT02517723|Narrative Exposure Therapy|narrative exposure therapy
4817343|NCT02517723|Dialectical-Behavioral Therapy|dialectical-behavioral therapy
4817344|NCT02517684|Crohn's disease|crohn's disease
4817345|NCT02517684|pediatric|pediatric
4817346|NCT02517684|infliximab|infliximab
4817347|NCT02517684|top-down|top-down
4817348|NCT02517684|TISKids|tiskids
4817349|NCT02517671|Fitness|fitness
4817350|NCT02517671|Run time|run time
4817351|NCT02517671|VO2max|vo2max
4817352|NCT02517671|VEGF|vegf
4817353|NCT02517671|Central blood pressure|central blood pressure
4817354|NCT02517671|Augmentation Index|augmentation index
4817355|NCT02517671|Pulse wave analysis|pulse wave analysis
4817356|NCT02517632|Physical activity|physical activity
4817357|NCT02517632|Cardiac rehabilitation|cardiac rehabilitation
4817358|NCT02517619|Iontophoresis|iontophoresis
4817359|NCT02517619|Ophthalmology|ophthalmology
4817360|NCT02517619|Non-Infectious Anterior Segment Uveitis|non-infectious anterior segment uveitis
4817361|NCT02517593|BCRAT|bcrat
4817362|NCT02517593|IBIS|ibis
4817364|NCT02517593|breast cancer|breast cancer
4817365|NCT02517593|Tyrer-Cuzick|tyrer-cuzick
4817366|NCT02517554|meet National Comprehensive Cancer Network® criteria for cancer genetic testing for breast, ovarian and colorectal cancers|meet national comprehensive cancer network® criteria for cancer genetic testing for breast, ovarian and colorectal cancers
4817367|NCT02517528|(HCV) Infection|(hcv) infection
4817368|NCT02517528|Compensated Cirrhosis|compensated cirrhosis
4817369|NCT02517515|HCV Infection|hcv infection
4817370|NCT02517515|Chronic Hepatitis C Virus|chronic hepatitis c virus
4817371|NCT02517515|Hepatitis C Virus (HCV) Genotype 1b|hepatitis c virus (hcv) genotype 1b
4817372|NCT02517502|DHA|dha
4817373|NCT02517502|Omega-3|omega-3
4817374|NCT02517502|neoadjuvant chemotherapy|neoadjuvant chemotherapy
4817375|NCT02517502|chemotherapy|chemotherapy
4817376|NCT02517502|breast cancer|breast cancer
4817377|NCT02517489|Community-Acquired Pneumonia (CAP)|community-acquired pneumonia (cap)
4817378|NCT02517489|Hydrocortisone|hydrocortisone
4817379|NCT02517489|Corticosteroids|corticosteroids
4817380|NCT02517463|Emergency contraception|emergency contraception
4817381|NCT02517463|ulipristal acetate|ulipristal acetate
4817382|NCT02517463|efficacy|efficacy
4817383|NCT02517450|Subjects|subjects
4817384|NCT02517411|COPD|copd
4817385|NCT02517411|physiotherapy|physiotherapy
4817386|NCT02517411|Stable disease|stable disease
4817387|NCT02517398|Solid tumor|solid tumor
4817388|NCT02517398|MSB0011359C (M7824)|msb0011359c (m7824)
4817389|NCT02517398|Metastatic or Locally Advanced Solid Tumors|metastatic or locally advanced solid tumors
4817390|NCT02517346|CPAP compliance|cpap compliance
4817391|NCT02517346|Telemonitoring|telemonitoring
4817392|NCT02517346|Standard management|standard management
4817393|NCT02517346|Cost effectiveness|cost effectiveness
4817394|NCT02517333|Motor skill proficiency|motor skill proficiency
4817395|NCT02517333|movement difficulties|movement difficulties
4817396|NCT02517333|Developmental Coordination Disorder (DCD)|developmental coordination disorder (dcd)
4817397|NCT02517333|Low physical fitness|low physical fitness
4817398|NCT02517320|Diabetic Nephropathy|diabetic nephropathy
4817399|NCT02517294|Nasotracheal intubation|nasotracheal intubation
4817400|NCT02517294|adenoid size|adenoid size
4817401|NCT02517294|epistaxis|epistaxis
4817402|NCT02517294|nasopharyngeal mucosal injury|nasopharyngeal mucosal injury
4817403|NCT02517255|ST segment elevation myocardial infarction|st segment elevation myocardial infarction
4817404|NCT02517255|Failed Thrombolysis|failed thrombolysis
4817405|NCT02517255|Rescue Percutaneous Coronary Intervention|rescue percutaneous coronary intervention
4817406|NCT02517255|Cardiac Magnetic Resonance Imaging|cardiac magnetic resonance imaging
4817407|NCT02517229|volunteers|volunteers
4817408|NCT02517216|volunteers|volunteers
4817409|NCT02517190|volunteers|volunteers
4817410|NCT02517177|volunteers|volunteers
4817411|NCT02517151|iron|iron
4817412|NCT02517151|fatigue|fatigue
4817413|NCT02517151|crohn's disease|crohn's disease
4817414|NCT02517151|ulcerative colitis|ulcerative colitis
4817415|NCT02517151|IBD|ibd
4817416|NCT02517138|volunteers|volunteers
4817417|NCT02517112|volunteers|volunteers
4817418|NCT02517099|Preschool|preschool
4817419|NCT02517099|Wheeze|wheeze
4817420|NCT02517099|Moderate|moderate
4817421|NCT02517099|Severe|severe
4817422|NCT02517086|blood circulation|blood circulation
4817423|NCT02517073|mechanical ventilation|mechanical ventilation
4817424|NCT02517073|epidemiology|epidemiology
4817425|NCT02517073|intensive care unit|intensive care unit
4817426|NCT02517073|national survey|national survey
4817427|NCT02517060|Social perceptions|social perceptions
4817428|NCT02517008|non-monetary incentive|non-monetary incentive
4817429|NCT02517008|institutional delivery|institutional delivery
4817430|NCT02516982|mHealth|mhealth
4817431|NCT02516982|Telemedicine|telemedicine
4817432|NCT02516982|Perinatal depression|perinatal depression
4817433|NCT02516982|Screening|screening
4817434|NCT02516982|Edinburgh Postnatal Depression Scale|edinburgh postnatal depression scale
4817435|NCT02516982|Whooley Questions|whooley questions
4817436|NCT02516982|Data collection|data collection
4817437|NCT02516982|Mood disorders|mood disorders
4817438|NCT02516982|Mental health|mental health
4817439|NCT02516982|Antenatal care|antenatal care
4817440|NCT02516982|Prenatal Care|prenatal care
4817441|NCT02516956|Breakfast|breakfast
4817442|NCT02516956|Food choices|food choices
4817443|NCT02516956|Lunch|lunch
4817444|NCT02516956|Eating habits|eating habits
4817445|NCT02516956|Appetite|appetite
4817446|NCT02516956|Neural activation|neural activation
4817447|NCT02516956|Attention|attention
4817448|NCT02516956|Glucose|glucose
4817449|NCT02516956|Insulin|insulin
4817450|NCT02516956|fMRI|fmri
4817451|NCT02516943|Arterial blood gas analysis|arterial blood gas analysis
4817452|NCT02516930|health promotion|health promotion
4817453|NCT02516930|crowdsourcing|crowdsourcing
4817454|NCT02516904|Subjects|subjects
4817455|NCT02516891|treatment|treatment
4817456|NCT02516891|stent|stent
4817457|NCT02516891|coronary bifurcations lesions|coronary bifurcations lesions
4817458|NCT02516878|acupuncture|acupuncture
4817459|NCT02516878|Chinese Medicine|chinese medicine
4817460|NCT02516878|obesity|obesity
4817461|NCT02516865|postpartum|postpartum
4817462|NCT02516865|physical activity|physical activity
4817463|NCT02516852|community development; poultry; animal-source food; stunting|community development; poultry; animal-source food; stunting
4817464|NCT02516839|Overweight|overweight
4817465|NCT02516839|Obesity|obesity
4817466|NCT02516839|Overeating|overeating
4817467|NCT02516839|Body Mass Index|body mass index
4817468|NCT02516839|Weight|weight
4817469|NCT02516839|Treatment|treatment
4817470|NCT02516839|Cravings|cravings
4817471|NCT02516839|Intervention|intervention
4817472|NCT02516839|Behavioral Treatment|behavioral treatment
4817473|NCT02516813|M3814|m3814
4817474|NCT02516813|Advanced solid tumors|advanced solid tumors
4817475|NCT02516813|DNA-PK Inhibitor|dna-pk inhibitor
4817476|NCT02516813|Radiotherapy|radiotherapy
4817477|NCT02516813|Chemotherapy|chemotherapy
4817478|NCT02516787|volunteers|volunteers
4817479|NCT02516761|Fibromyalgia|fibromyalgia
4817480|NCT02516748|optical diagnosis|optical diagnosis
4817481|NCT02516748|narrow band image|narrow band image
4817482|NCT02516644|Parkinson Disease|parkinson disease
4817483|NCT02516644|Mobility|mobility
4817484|NCT02516644|Balance|balance
4817485|NCT02516644|Virtual Reality|virtual reality
4817486|NCT02516644|treadmill training|treadmill training
4817487|NCT02516631|Labour, induced|labour, induced
4817488|NCT02516631|Misoprostol|misoprostol
4817489|NCT02516631|Pharmacokinetics|pharmacokinetics
4817490|NCT02516631|Cardiotocography|cardiotocography
4817491|NCT02516631|Safety|safety
4817492|NCT02516605|Primary Biliary Cirrhosis, PBC|primary biliary cirrhosis, pbc
4817493|NCT02516605|Primary Biliary Cholangitis|primary biliary cholangitis
4817494|NCT02516566|Positive end-expiratory pressure ventilation|positive end-expiratory pressure ventilation
4817495|NCT02516566|Optic nerve sheath diameter|optic nerve sheath diameter
4817496|NCT02516540|hereditary breast and ovarian cancer (HBOC)|hereditary breast and ovarian cancer (hboc)
4817497|NCT02516540|BRCA1/2 mutation carriers|brca1/2 mutation carriers
4817498|NCT02516540|Mediterranean diet|mediterranean diet
4817499|NCT02516540|Structured exercise training|structured exercise training
4817500|NCT02516540|prevention|prevention
4817501|NCT02516514|Blood culture|blood culture
4817502|NCT02516514|Bacteremia|bacteremia
4817503|NCT02516514|Single sampling|single sampling
4817504|NCT02516501|Ketogenic Diet|ketogenic diet
4817505|NCT02516501|Body composition|body composition
4817506|NCT02516501|Radiation therapy|radiation therapy
4817507|NCT02516436|Bunavail|bunavail
4817508|NCT02516436|Suboxone|suboxone
4817509|NCT02516436|Heroin|heroin
4817510|NCT02516436|Zubsolv|zubsolv
4817511|NCT02516436|Buprenorphine|buprenorphine
4817512|NCT02516436|Naloxone|naloxone
4817513|NCT02516436|Opioids|opioids
4817514|NCT02516436|Addiction|addiction
4817515|NCT02516436|Induction|induction
4817516|NCT02516397|body fat mass reduction|body fat mass reduction
4817517|NCT02516384|Fecal Microbiota Transplantation|fecal microbiota transplantation
4817518|NCT02516384|Ulcerative Colitis|ulcerative colitis
4817519|NCT02516345|Physical activity|physical activity
4817520|NCT02516345|Financial incentives|financial incentives
4817521|NCT02516345|Children|children
4817522|NCT02516345|Parents|parents
4817523|NCT02516345|RCT|rct
4817524|NCT02516345|Wireless pedometer|wireless pedometer
4817525|NCT02516306|Presbyopia|presbyopia
4817526|NCT02516306|Vision|vision
4817527|NCT02516306|UNR844|unr844
4817528|NCT02516280|Total knee replacement|total knee replacement
4817529|NCT02516280|Cold|cold
4817530|NCT02516280|Neurocryostimulation|neurocryostimulation
4817531|NCT02516280|CO2 cryotherapy|co2 cryotherapy
4817532|NCT02516280|mobility|mobility
4817533|NCT02516267|platelet aggregability|platelet aggregability
4817534|NCT02516267|acute coronary syndrome|acute coronary syndrome
4817535|NCT02516267|coronary artery bypass graft|coronary artery bypass graft
4817536|NCT02516254|vitamin D|vitamin d
4817537|NCT02516254|fortified bread|fortified bread
4817538|NCT02516254|efficacy|efficacy
4817539|NCT02516254|Vitamin D Deficiency|vitamin d deficiency
4817540|NCT02516241|Urothelial Cancer|urothelial cancer
4817541|NCT02516241|Phase III|phase iii
4817542|NCT02516189|Microcirculation|microcirculation
4817543|NCT02516189|Electromyography|electromyography
4817544|NCT02516189|Motor Activity|motor activity
4817545|NCT02516176|stroke|stroke
4817546|NCT02516176|cerebral vascular accident|cerebral vascular accident
4817547|NCT02516176|balance|balance
4817548|NCT02516176|treadmill|treadmill
4817549|NCT02516176|falls|falls
4817550|NCT02516176|hemiparesis|hemiparesis
4817551|NCT02516150|Type 1 Diabetes|type 1 diabetes
4817552|NCT02516150|Bionic Pancreas|bionic pancreas
4817553|NCT02516150|Artificial Pancreas|artificial pancreas
4817554|NCT02516150|Insulin|insulin
4817555|NCT02516150|Glucagon|glucagon
4817556|NCT02516150|Alcohol|alcohol
4817557|NCT02516150|Alcohol Clamp|alcohol clamp
4817558|NCT02516137|Dry needling|dry needling
4817559|NCT02516124|Autoimmune diseases|autoimmune diseases
4817560|NCT02516124|Systemic sclerosis|systemic sclerosis
4817561|NCT02516124|Autologous Hematopoietic stem cell transplant|autologous hematopoietic stem cell transplant
4817562|NCT02516072|remote ischemic preconditioning|remote ischemic preconditioning
4817563|NCT02516059|thoracic epidural analgesia|thoracic epidural analgesia
4817564|NCT02516059|oxycodone|oxycodone
4817565|NCT02516059|oral naloxone|oral naloxone
4817566|NCT02516059|radical cystectomy|radical cystectomy
4817567|NCT02516059|bowel function|bowel function
4817568|NCT02516059|pain|pain
4817569|NCT02516033|Atrial Fibrillation|atrial fibrillation
4817570|NCT02516033|Hybrid Ablation|hybrid ablation
4817571|NCT02516033|Efficacy|efficacy
4817572|NCT02516033|Risk Profile|risk profile
4817573|NCT02516033|Biomarkers|biomarkers
4817574|NCT02516020|IVF|ivf
4817575|NCT02516020|ICSI|icsi
4817576|NCT02516020|culture media|culture media
4817577|NCT02516020|sequential|sequential
4817578|NCT02515981|tobacco dependence|tobacco dependence
4817579|NCT02515981|smoking cessation|smoking cessation
4817580|NCT02515981|mental health|mental health
4817581|NCT02515981|cardiovascular disease|cardiovascular disease
4817582|NCT02515981|obesity|obesity
4817583|NCT02515955|Healthy|healthy
4817584|NCT02515955|JNJ-54175446|jnj-54175446
4817585|NCT02515929|Oligomeric Proanthocyanidins|oligomeric proanthocyanidins
4817586|NCT02515929|Periodontal Disease|periodontal disease
4817587|NCT02515903|Endoscopy|endoscopy
4817588|NCT02515903|Intracerebral hemorrhage|intracerebral hemorrhage
4817589|NCT02515903|surgery|surgery
4817590|NCT02515903|stereotactic aspiration|stereotactic aspiration
4817591|NCT02515903|Key-hole approach|key-hole approach
4817592|NCT02515903|Intracerebral hemorrhage surgical treatment|intracerebral hemorrhage surgical treatment
4817593|NCT02515903|Transparent endoscopic sheath|transparent endoscopic sheath
4817594|NCT02515903|Agitation-aspiration device|agitation-aspiration device
4817595|NCT02515890|midazolam|midazolam
4817596|NCT02515890|dexmedetomidine|dexmedetomidine
4817597|NCT02515890|memory|memory
4817598|NCT02515890|ketamine|ketamine
4817599|NCT02515864|Male and Female Volunteers|male and female volunteers
4817600|NCT02515786|Chronic respiratory failure|chronic respiratory failure
4817601|NCT02515786|Oxygen therapy|oxygen therapy
4817602|NCT02515786|Nasal catheter|nasal catheter
4817603|NCT02515786|Mucociliary clearance|mucociliary clearance
4817604|NCT02515747|Lipoprotein(a)|lipoprotein(a)
4817605|NCT02515747|coronary artery bypass grafting (CABG)|coronary artery bypass grafting (cabg)
4817606|NCT02515747|apo(a)|apo(a)
4817607|NCT02515747|prognosis|prognosis
4817608|NCT02515747|myocardial infarction|myocardial infarction
4817609|NCT02515747|cardiovascular death|cardiovascular death
4817610|NCT02515747|percutaneous coronary intervention (PCI)|percutaneous coronary intervention (pci)
4817611|NCT02515734|FOLFOXIRI|folfoxiri
4817612|NCT02515734|Bmab|bmab
4817613|NCT02515734|Cmab|cmab
4817614|NCT02515617|Ventilator-associated pneumonia|ventilator-associated pneumonia
4817615|NCT02515617|Subglottic-secretions drainage|subglottic-secretions drainage
4817616|NCT02515617|Critically ill patients|critically ill patients
4817617|NCT02515617|Cost-utility analysis|cost-utility analysis
4817618|NCT02515617|Prevention|prevention
4817619|NCT02515591|Healthy volunteer|healthy volunteer
4817620|NCT02515591|Respiratory|respiratory
4817621|NCT02515591|Bronchoalveolar lavage|bronchoalveolar lavage
4817622|NCT02515578|Primary Health Care|primary health care
4817623|NCT02515578|Cardiovascular Diseases|cardiovascular diseases
4817624|NCT02515578|Quality Improvement|quality improvement
4817625|NCT02515565|pneumonia|pneumonia
4817626|NCT02515565|Exacerbation|exacerbation
4817627|NCT02515565|physiotherapy|physiotherapy
4817628|NCT02515565|hospitalization|hospitalization
4817629|NCT02515539|Transcatheter Mitral Valve Replacement|transcatheter mitral valve replacement
4817630|NCT02515539|Mitral Regurgitation|mitral regurgitation
4817631|NCT02515539|Mitral Insufficiency|mitral insufficiency
4817632|NCT02515539|Transapical|transapical
4817633|NCT02515539|Transfemoral|transfemoral
4817634|NCT02515513|Pancreas|pancreas
4817635|NCT02515513|Pancreas Cancer|pancreas cancer
4817636|NCT02515513|Muscle Biopsy|muscle biopsy
4817637|NCT02515513|Cachexia|cachexia
4817638|NCT02515513|Muscle Cachexia|muscle cachexia
4817639|NCT02515500|cigarette reduction|cigarette reduction
4817640|NCT02515500|digital health|digital health
4817641|NCT02515500|mobile health|mobile health
4817642|NCT02515500|technology|technology
4817643|NCT02515500|Quitbit|quitbit
4817644|NCT02515500|mHealth|mhealth
4817645|NCT02515500|smoking cessation|smoking cessation
4817646|NCT02515500|quit smoking|quit smoking
4817647|NCT02515500|self-regulation|self-regulation
4817648|NCT02515487|Post-chemotherapy|post-chemotherapy
4817649|NCT02515487|cognitive impairment|cognitive impairment
4817650|NCT02515474|Cholangiopancreatography|cholangiopancreatography
4817651|NCT02515474|Endoscopic|endoscopic
4817652|NCT02515474|Common bile duct|common bile duct
4817653|NCT02515474|Complication|complication
4817654|NCT02515474|Recurrence|recurrence
4817655|NCT02515474|Laparoscopic|laparoscopic
4817656|NCT02515461|Diabetes mellitus|diabetes mellitus
4817657|NCT02515461|Low energy shockwave therapy|low energy shockwave therapy
4817658|NCT02515461|Chronic Renal Insufficiency|chronic renal insufficiency
4817659|NCT02515448|VAP|vap
4817660|NCT02515448|Critical care|critical care
4817661|NCT02515448|Pharmacokinetics|pharmacokinetics
4817662|NCT02515448|Gentamicin|gentamicin
4817663|NCT02515435|apatinib|apatinib
4817664|NCT02515435|NSCLC|nsclc
4817665|NCT02515435|safety|safety
4817666|NCT02515435|efficacy|efficacy
4817667|NCT02515422|Caesarean Section|caesarean section
4817668|NCT02515409|Obstructive Sleep Apnea Syndrome (OSAS)|obstructive sleep apnea syndrome (osas)
4817669|NCT02515409|Heated Humidified High Flow Nasal Cannula (HHHNC)|heated humidified high flow nasal cannula (hhhnc)
4817670|NCT02515409|Continues positive airway pressure (CPAP)|continues positive airway pressure (cpap)
4817671|NCT02515409|Children|children
4817672|NCT02515409|Non invasive ventilation|non invasive ventilation
4817673|NCT02515409|Treatment|treatment
4817674|NCT02515383|Adolescent Cancer|adolescent cancer
4817675|NCT02515383|MD Anderson Symptom Inventory (modified for adolescent use)|md anderson symptom inventory (modified for adolescent use)
4817676|NCT02515383|MDASI|mdasi
4817677|NCT02515383|Surveys|surveys
4817678|NCT02515383|Questionnaires|questionnaires
4817679|NCT02515383|Interviews|interviews
4817680|NCT02515383|Symptoms|symptoms
4817681|NCT02515370|Option B plus|option b plus
4817682|NCT02515370|HIV infected women|hiv infected women
4817683|NCT02515357|Sleep Disorders|sleep disorders
4817684|NCT02515357|Metabolic Syndrome|metabolic syndrome
4817685|NCT02515357|Mediterranean Diet|mediterranean diet
4817686|NCT02515357|Mediterranean Lifestyle|mediterranean lifestyle
4817687|NCT02515344|Patients|patients
4817688|NCT02515344|early detection of cancer|early detection of cancer
4817689|NCT02515344|patient compliance|patient compliance
4817690|NCT02515331|resistant hypertension|resistant hypertension
4817691|NCT02515318|COPD|copd
4817692|NCT02515318|Exacerbation|exacerbation
4817693|NCT02515318|Hospitalisation|hospitalisation
4817694|NCT02515318|Physiotherapy|physiotherapy
4817695|NCT02515292|IUGR (intrauterine growth restriction)|iugr (intrauterine growth restriction)
4817696|NCT02515292|IGF2 (insulin-like growth factor 2)|igf2 (insulin-like growth factor 2)
4817697|NCT02515292|morbidity|morbidity
4817698|NCT02515266|protein|protein
4817699|NCT02515266|growth|growth
4817700|NCT02515266|head circumference|head circumference
4817701|NCT02515253|Breast Pain|breast pain
4817702|NCT02515253|Mastalgia|mastalgia
4817703|NCT02515253|Bras|bras
4817704|NCT02515253|Breast Support|breast support
4817705|NCT02515227|peptide|peptide
4817706|NCT02515227|vaccine|vaccine
4817707|NCT02515227|Montanide ISA-51|montanide isa-51
4817708|NCT02515227|pembrolizumab|pembrolizumab
4817709|NCT02515227|PD-1|pd-1
4817710|NCT02515227|KEYTRUDA|keytruda
4817711|NCT02515214|bariatric surgery|bariatric surgery
4817712|NCT02515214|reproduction|reproduction
4817713|NCT02515175|HSV|hsv
4817714|NCT02515175|Herpes|herpes
4817715|NCT02515175|Genital Herpes|genital herpes
4817716|NCT02515175|Vaccine|vaccine
4817717|NCT02515162|conization|conization
4817718|NCT02515162|LLETZ|lletz
4817719|NCT02515162|cervical dysplasia|cervical dysplasia
4817720|NCT02515162|cervical intraepithelial neoplasia|cervical intraepithelial neoplasia
4817721|NCT02515162|Fischer cone biopsy excisor|fischer cone biopsy excisor
4817722|NCT02515162|loop electrosurgical excision procedure|loop electrosurgical excision procedure
4817723|NCT02515149|linkage to care|linkage to care
4817724|NCT02515149|point of care diagnostics|point of care diagnostics
4817725|NCT02515149|point of care CD4|point of care cd4
4817726|NCT02515149|HIV care cascade|hiv care cascade
4817727|NCT02515149|Kenya|kenya
4817728|NCT02515123|intensive care unit|intensive care unit
4817729|NCT02515123|malnutrition|malnutrition
4817730|NCT02515123|GI motility|gi motility
4817731|NCT02515123|nutritional intake|nutritional intake
4817732|NCT02515110|lumpectomy|lumpectomy
4817733|NCT02515110|mastectomy without reconstruction|mastectomy without reconstruction
4817734|NCT02515110|mastectomy with reconstruction|mastectomy with reconstruction
4817735|NCT02515110|Estrogen Receptor Negative|estrogen receptor negative
4817736|NCT02515110|Estrogen Receptor Positive|estrogen receptor positive
4817737|NCT02515110|HER2/Neu Negative|her2/neu negative
4817738|NCT02515110|HER2/Neu Positive|her2/neu positive
4817739|NCT02515110|Progesterone Receptor Negative|progesterone receptor negative
4817740|NCT02515110|Progesterone Receptor Positive|progesterone receptor positive
4817741|NCT02515110|Stage IA Breast Cancer|stage ia breast cancer
4817742|NCT02515110|Stage IB Breast Cancer|stage ib breast cancer
4817743|NCT02515110|Stage IIA Breast Cancer|stage iia breast cancer
4817744|NCT02515110|Stage IIB Breast Cancer|stage iib breast cancer
4820347|NCT02500576|Proleukin|proleukin
4817745|NCT02515110|Stage IIIA Breast Cancer|stage iiia breast cancer
4817746|NCT02515084|recurrence Thyroid cancer|recurrence thyroid cancer
4817747|NCT02515084|18F-FDG PET-CT|18f-fdg pet-ct
4817748|NCT02515084|diffusion-weighted Magnetic Resonance Imaging|diffusion-weighted magnetic resonance imaging
4817749|NCT02515045|Cataract|cataract
4817750|NCT02515045|Surgery|surgery
4817751|NCT02515045|Prophylaxis|prophylaxis
4817752|NCT02515019|Anaesthetics inhalation|anaesthetics inhalation
4817753|NCT02515019|Bispectral index|bispectral index
4817754|NCT02515019|Cardiopulmonary bypass|cardiopulmonary bypass
4817755|NCT02514993|Sternal fracture|sternal fracture
4817756|NCT02514993|Thoracic spine fracture|thoracic spine fracture
4817757|NCT02514993|Thoracic cage injury|thoracic cage injury
4817758|NCT02514967|SLE|sle
4817759|NCT02514967|Lupus|lupus
4817760|NCT02514967|Lupus Erythematosus, Systemic|lupus erythematosus, systemic
4817761|NCT02514967|Autoimmune Diseases|autoimmune diseases
4817762|NCT02514967|A-623|a-623
4817763|NCT02514967|Blisibimod|blisibimod
4817764|NCT02514967|Nephritis|nephritis
4817765|NCT02514902|Lateral Flow Device (LFD)|lateral flow device (lfd)
4817766|NCT02514902|Acute Stroke|acute stroke
4817767|NCT02514902|Traumatic Brain Injury (TBI)|traumatic brain injury (tbi)
4817768|NCT02514902|Point of Care (POC)|point of care (poc)
4817769|NCT02514902|Biomarker|biomarker
4817770|NCT02514824|recurrent merkel cell carcinoma|recurrent merkel cell carcinoma
4817771|NCT02514824|metastatic merkel cell carcinoma|metastatic merkel cell carcinoma
4817772|NCT02514798|COPD|copd
4817773|NCT02514798|HFNC|hfnc
4817774|NCT02514798|work of breathing|work of breathing
4817775|NCT02514746|Japanese Encephalitis Vaccines|japanese encephalitis vaccines
4817776|NCT02514746|Flavivirus Infections|flavivirus infections
4817777|NCT02514733|kidney|kidney
4817778|NCT02514733|transplant|transplant
4817779|NCT02514655|Tracheal intubation|tracheal intubation
4817780|NCT02514655|Cuff pressure|cuff pressure
4817781|NCT02514655|Ventilator-acquired pneumonia|ventilator-acquired pneumonia
4817782|NCT02514655|Intensive care unit|intensive care unit
4817783|NCT02514655|Tracheal injuries|tracheal injuries
4817784|NCT02514629|Hypogonadism|hypogonadism
4817785|NCT02514629|Obesity|obesity
4817786|NCT02514629|Erectile Dysfunction|erectile dysfunction
4817787|NCT02514629|Testosterone|testosterone
4817788|NCT02514629|Metformin|metformin
4817789|NCT02514629|Weight Loss|weight loss
4817790|NCT02514629|Insulin Resistance|insulin resistance
4817791|NCT02514616|Reflux|reflux
4817792|NCT02514616|Reflux disease|reflux disease
4817793|NCT02514616|Gastroesophageal reflux disease|gastroesophageal reflux disease
4817794|NCT02514616|Lower esophageal sphincter stimulation|lower esophageal sphincter stimulation
4817795|NCT02514603|Neoplasm metastasis|neoplasm metastasis
4817796|NCT02514603|Checkpoint Kinase 1|checkpoint kinase 1
4817797|NCT02514603|CHK1|chk1
4817798|NCT02514603|CHK1 inhibitor|chk1 inhibitor
4817799|NCT02514551|stomach cancer|stomach cancer
4817800|NCT02514512|Lung Cancer|lung cancer
4817801|NCT02514512|Stereotactic Ablative Radiotherapy (SABR)|stereotactic ablative radiotherapy (sabr)
4817802|NCT02514512|MLC Tracking|mlc tracking
4817803|NCT02514512|Radiotherapy|radiotherapy
4817804|NCT02514499|patients|patients
4817805|NCT02514460|stents|stents
4817806|NCT02514460|atherectomy|atherectomy
4817807|NCT02514460|femoral artery|femoral artery
4817808|NCT02514460|popliteal artery|popliteal artery
4817809|NCT02514447|SCLC|sclc
4817810|NCT02514421|pancreatic adenocarcinoma|pancreatic adenocarcinoma
4817811|NCT02514421|electrochemotherapy|electrochemotherapy
4817812|NCT02514421|electroporation|electroporation
4817813|NCT02514421|radiogenomics|radiogenomics
4817814|NCT02514421|imaging|imaging
4817815|NCT02514421|magnetic resonance spectroscopy|magnetic resonance spectroscopy
4817816|NCT02514395|linguistic validation|linguistic validation
4817817|NCT02514395|KOOS|koos
4817818|NCT02514395|Marathi translation|marathi translation
4817819|NCT02514356|behavioral economics|behavioral economics
4817820|NCT02514356|antiretroviral adherence|antiretroviral adherence
4817821|NCT02514356|SMS|sms
4817822|NCT02514356|mobile health (mHealth)|mobile health (mhealth)
4817823|NCT02514356|Adolescents|adolescents
4817824|NCT02514356|Uganda|uganda
4817825|NCT02514356|HIV|hiv
4817826|NCT02514343|radius fracture|radius fracture
4817827|NCT02514343|magnesium sulfate|magnesium sulfate
4817828|NCT02514343|rehabilitation|rehabilitation
4817829|NCT02514343|bupivacaine|bupivacaine
4817830|NCT02514330|Drop Jump|drop jump
4817831|NCT02514330|High Intensity Interval Training|high intensity interval training
4817832|NCT02514330|Muscle Fatigue|muscle fatigue
4817833|NCT02514330|Aerobic Performance|aerobic performance
4817834|NCT02514278|Organ preservation|organ preservation
4817835|NCT02514278|Local excision|local excision
4817836|NCT02514278|Radiochemotherapy|radiochemotherapy
4817837|NCT02514278|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
4817838|NCT02514278|Folfirinox|folfirinox
4817839|NCT02514278|Tumour response|tumour response
4817840|NCT02514265|pelvic pain, bladder pain|pelvic pain, bladder pain
4817841|NCT02514252|Advanced Cancers|advanced cancers
4817842|NCT02514252|Metastatic|metastatic
4817843|NCT02514252|Recurrent cancer|recurrent cancer
4817844|NCT02514252|Incurable cancer|incurable cancer
4817845|NCT02514252|Fentanyl sublingual spray|fentanyl sublingual spray
4817846|NCT02514252|FSS|fss
4817847|NCT02514252|Questionnaires|questionnaires
4817848|NCT02514252|Surveys|surveys
4817849|NCT02514252|Mental ability tests|mental ability tests
4817850|NCT02514252|Phone calls|phone calls
4817851|NCT02514252|Study diary|study diary
4817852|NCT02514252|Pain control|pain control
4817853|NCT02514226|microbiology|microbiology
4817854|NCT02514226|halitosis|halitosis
4817855|NCT02514213|PSA|psa
4817856|NCT02514187|Osteogenesis|osteogenesis
4817857|NCT02514161|Smokers|smokers
4817858|NCT02514161|Maximum Inspiratory Pressure|maximum inspiratory pressure
4817859|NCT02514148|patient education|patient education
4817860|NCT02514148|therapeutic exercise|therapeutic exercise
4817861|NCT02514148|manual therapy|manual therapy
4817862|NCT02514109|neuronopathy|neuronopathy
4817863|NCT02514109|antibodies|antibodies
4817864|NCT02514109|Clinical and biological diagnostic criteria|clinical and biological diagnostic criteria
4817865|NCT02514083|Ibrutinib|ibrutinib
4817866|NCT02514083|Fludarabine|fludarabine
4817867|NCT02514083|BTK Inhibitor|btk inhibitor
4817868|NCT02514083|T-Cell Modulation|t-cell modulation
4817869|NCT02514070|LDL-C|ldl-c
4817870|NCT02514070|Omega-3 Fatty Acid|omega-3 fatty acid
4817871|NCT02514070|PCSK9|pcsk9
4817872|NCT02514070|HDL-C|hdl-c
4817873|NCT02514018|Varicella-Zoster Virus|varicella-zoster virus
4817874|NCT02514018|Immune Activation|immune activation
4817875|NCT02514018|HIV Vaccine|hiv vaccine
4817876|NCT02514018|Mucosal Immunity|mucosal immunity
4817877|NCT02514005|Trigger points|trigger points
4817878|NCT02514005|Manual therapy|manual therapy
4817879|NCT02514005|Patellofemoral syndrome|patellofemoral syndrome
4817880|NCT02514005|Dry needling|dry needling
4817881|NCT02513992|ictal SPECT|ictal spect
4817882|NCT02513979|Angiotensin type II receptor (AT2R) antagonists|angiotensin type ii receptor (at2r) antagonists
4817883|NCT02513979|Acute postoperative pain|acute postoperative pain
4817884|NCT02513979|Chronic postoperative pain|chronic postoperative pain
4817885|NCT02513979|Abdominal surgery|abdominal surgery
4817886|NCT02513953|Endometriosis|endometriosis
4817887|NCT02513953|Mesosalpinx|mesosalpinx
4817888|NCT02513953|Broad Ligament|broad ligament
4817889|NCT02513953|Laparoscopy|laparoscopy
4817890|NCT02513940|Torsades de pointes|torsades de pointes
4817891|NCT02513940|Testosterone|testosterone
4817892|NCT02513940|Progesterone|progesterone
4817893|NCT02513940|Clinical trial|clinical trial
4817894|NCT02513940|Risk reduction|risk reduction
4817895|NCT02513940|Electrocardiography|electrocardiography
4817896|NCT02513927|Blood pressure variability|blood pressure variability
4817897|NCT02513927|CCB|ccb
4817898|NCT02513927|beta-receptor blockers|beta-receptor blockers
4817899|NCT02513927|heart rate|heart rate
4817900|NCT02513914|endovascular neurosurgery|endovascular neurosurgery
4817901|NCT02513901|Chidamide|chidamide
4817902|NCT02513901|Histone Deacetylase Inhibitor|histone deacetylase inhibitor
4817903|NCT02513901|HIV-1 Reservoir|hiv-1 reservoir
4817904|NCT02513901|Chronic HIV infections|chronic hiv infections
4817905|NCT02513901|Antiretroviral Therapy|antiretroviral therapy
4817906|NCT02513901|HIV Eradication|hiv eradication
4817907|NCT02513862|autologous platelet rich plasma|autologous platelet rich plasma
4817908|NCT02513862|deep hypothermic circulatory arrest|deep hypothermic circulatory arrest
4817909|NCT02513862|transfusion|transfusion
4817910|NCT02513849|esophagus|esophagus
4817911|NCT02513849|gastroscopy|gastroscopy
4817912|NCT02513849|tamoxifen|tamoxifen
4817913|NCT02513836|opioids|opioids
4817914|NCT02513823|blood pressure|blood pressure
4817915|NCT02513823|vitamin D|vitamin d
4817916|NCT02513784|Microbiome|microbiome
4817917|NCT02513784|Esophagus|esophagus
4817918|NCT02513784|Endoscopy|endoscopy
4817919|NCT02513784|Mouthwash|mouthwash
4817920|NCT02513771|Sitagliptin|sitagliptin
4817921|NCT02513771|Inflammation|inflammation
4817922|NCT02513771|Immune activation|immune activation
4817923|NCT02513771|Viral suppression|viral suppression
4817924|NCT02513771|HIV-1|hiv-1
4817925|NCT02513771|Immunology biomarkers|immunology biomarkers
4817926|NCT02513771|sCD14|scd14
4817927|NCT02513758|HIV patients|hiv patients
4817928|NCT02513758|Genital HIV penetration|genital hiv penetration
4817929|NCT02513745|cataract|cataract
4817930|NCT02513745|toric|toric
4817931|NCT02513745|phacoemulsification|phacoemulsification
4817932|NCT02513732|Drug Eluting Stent|drug eluting stent
4817933|NCT02513732|Coronary Stent|coronary stent
4817934|NCT02513732|Everolimus|everolimus
4817935|NCT02513732|Stent Thrombosis|stent thrombosis
4817936|NCT02513719|drug eluting stent|drug eluting stent
4817937|NCT02513719|stent|stent
4817938|NCT02513719|real world|real world
4817939|NCT02513693|Anesthesia|anesthesia
4817940|NCT02513693|Rocuronium|rocuronium
4817941|NCT02513693|Sugammadex|sugammadex
4817942|NCT02513693|Neostigmine|neostigmine
4817943|NCT02513693|TOF|tof
4817944|NCT02513693|Radical Prostatectomy|radical prostatectomy
4817945|NCT02513693|Robotic Surgery|robotic surgery
4817946|NCT02513693|Accelerometry|accelerometry
4817947|NCT02513680|Skin Aging|skin aging
4817948|NCT02513680|laser phototherapy|laser phototherapy
4817949|NCT02513680|Rejuvenation|rejuvenation
4817950|NCT02513680|Infrared Rays/therapeutic use|infrared rays/therapeutic use
4817951|NCT02513680|Female|female
4817952|NCT02513680|Humans|humans
4817953|NCT02513680|Esthetics|esthetics
4817954|NCT02513680|Phototherapy|phototherapy
4817955|NCT02513680|facial rejuvenation|facial rejuvenation
4817956|NCT02513654|tolerability|tolerability
4817957|NCT02513654|repeat dosing|repeat dosing
4817958|NCT02513654|safety|safety
4817959|NCT02513654|healthy Chinese subjects|healthy chinese subjects
4817960|NCT02513654|Pharmacokinetics|pharmacokinetics
4817961|NCT02513654|lamotrigine|lamotrigine
4817962|NCT02513628|Cardiac arrest|cardiac arrest
4817963|NCT02513628|neuroprognostication|neuroprognostication
4817964|NCT02513628|optic nerve sheath diameter|optic nerve sheath diameter
4817965|NCT02513628|outcome|outcome
4817966|NCT02513628|ultrasonography|ultrasonography
4817967|NCT02513615|Fibrosis|fibrosis
4817968|NCT02513615|Peritoneal Dialysis|peritoneal dialysis
4817969|NCT02513615|Epigenetics|epigenetics
4817970|NCT02513615|Peritoneal membrane injury|peritoneal membrane injury
4817971|NCT02513615|Glucose exposure|glucose exposure
4817972|NCT02513602|implantology|implantology
4817973|NCT02513602|kidney|kidney
4817974|NCT02513602|renal disease|renal disease
4817975|NCT02513602|edentulism|edentulism
4817976|NCT02513602|tooth loss|tooth loss
4817977|NCT02513589|Positron emission tomography|positron emission tomography
4817978|NCT02513589|Carotid plaque|carotid plaque
4817979|NCT02513589|Inflammation|inflammation
4817980|NCT02513589|Stroke|stroke
4817981|NCT02513576|Sternal instability|sternal instability
4817982|NCT02513576|physical therapy|physical therapy
4817983|NCT02513576|Respiratory muscle strength|respiratory muscle strength
4817984|NCT02513563|Squamous cell lung cancer|squamous cell lung cancer
4817985|NCT02513524|hypertension|hypertension
4817986|NCT02513524|adherence|adherence
4817987|NCT02513524|resistant hypertension|resistant hypertension
4817988|NCT02513524|blood pressure|blood pressure
4817989|NCT02513524|non-adherence|non-adherence
4817990|NCT02513511|difficult airway|difficult airway
4817991|NCT02513511|awake intubation|awake intubation
4817992|NCT02513485|Inflammation|inflammation
4817993|NCT02513485|Anhedonia|anhedonia
4817994|NCT02513485|Psychomotor retardation|psychomotor retardation
4817995|NCT02513472|Eribulin Mesylate|eribulin mesylate
4817996|NCT02513472|Pembrolizumab|pembrolizumab
4817997|NCT02513472|Metastatic Triple-Negative Breast Cancer|metastatic triple-negative breast cancer
4817998|NCT02513472|mTNBC|mtnbc
4817999|NCT02513459|ABBV-066|abbv-066
4818000|NCT02513459|BI 655066|bi 655066
4818001|NCT02513459|risankizumab|risankizumab
4818002|NCT02513433|Lumbar epidural anaesthesia|lumbar epidural anaesthesia
4818003|NCT02513420|levator ani avulsion|levator ani avulsion
4818004|NCT02513420|perineal muscle training|perineal muscle training
4818005|NCT02513420|pelvic floor ultrasound|pelvic floor ultrasound
4818006|NCT02513394|HR+/HER2- breast cancer|hr+/her2- breast cancer
4818007|NCT02513394|Palbociclib|palbociclib
4818008|NCT02513368|aesthetic|aesthetic
4818009|NCT02513368|connective tissue graft|connective tissue graft
4818010|NCT02513368|mucosa thickness|mucosa thickness
4818011|NCT02513355|Non-small cell lung cancer,Endostar|non-small cell lung cancer,endostar
4818012|NCT02513342|Endostar,Advanced lung squamous carcinoma|endostar,advanced lung squamous carcinoma
4818013|NCT02513329|Breast Cancer|breast cancer
4818014|NCT02513329|Anti-estrogens|anti-estrogens
4818015|NCT02513329|Hot Flushes|hot flushes
4818016|NCT02513329|Tamoxifen|tamoxifen
4818017|NCT02513329|Aromatase inhibitors|aromatase inhibitors
4818018|NCT02513329|Hot Flashes|hot flashes
4818019|NCT02513316|Microbleeds|microbleeds
4818020|NCT02513303|Dialysis|dialysis
4818021|NCT02513303|End Stage Renal Disease|end stage renal disease
4818022|NCT02513303|End Stage Kidney Disease|end stage kidney disease
4818023|NCT02513303|ESRD|esrd
4818024|NCT02513303|Chronic Kidney Failure|chronic kidney failure
4818025|NCT02513303|Chronic Renal Failure|chronic renal failure
4818026|NCT02513303|Chronic Kidney Disease|chronic kidney disease
4818027|NCT02513303|Hemodialysis|hemodialysis
4818028|NCT02513303|Vascular Access|vascular access
4818029|NCT02513303|Arteriovenous Fistula|arteriovenous fistula
4818030|NCT02513303|AV Fistula|av fistula
4818031|NCT02513303|AVF|avf
4818032|NCT02513303|Nephrology|nephrology
4818033|NCT02513303|Vascular Surgery|vascular surgery
4818034|NCT02513303|Dialysis Access|dialysis access
4818035|NCT02513290|quality of life|quality of life
4818036|NCT02513290|allergic rhinitis|allergic rhinitis
4818037|NCT02513290|bilastine|bilastine
4818038|NCT02513290|loratadine|loratadine
4818039|NCT02513290|clinical trial|clinical trial
4818040|NCT02513277|type 2 diabetes|type 2 diabetes
4818041|NCT02513277|impaired glucose regulation|impaired glucose regulation
4818042|NCT02513277|intellectual disability|intellectual disability
4818043|NCT02513277|learning disability|learning disability
4818044|NCT02513277|screening|screening
4818045|NCT02513277|prevention|prevention
4818046|NCT02513277|lifestyle education|lifestyle education
4818047|NCT02513264|Registry|registry
4818048|NCT02513264|Asthma|asthma
4818049|NCT02513264|Inner City Asthma Consortium (ICAC) study eligibility|inner city asthma consortium (icac) study eligibility
4818050|NCT02513212|Sensitivity|sensitivity
4818051|NCT02513199|Hepatocellular Carcinoma|hepatocellular carcinoma
4818052|NCT02513199|Trans-Arterial Chemoembolization|trans-arterial chemoembolization
4818053|NCT02513199|Stereotactic Body Radiation Therapy|stereotactic body radiation therapy
4818054|NCT02513199|HCC|hcc
4818055|NCT02513199|TACE|tace
4818056|NCT02513199|SBRT|sbrt
4818057|NCT02513173|low back pain|low back pain
4818058|NCT02513173|verbal instruction|verbal instruction
4818059|NCT02513173|lumbar multifidus|lumbar multifidus
4818060|NCT02513173|ultrasound imaging|ultrasound imaging
4818061|NCT02513173|Muscle thickness|muscle thickness
4818062|NCT02513134|IOL power calculations|iol power calculations
4818063|NCT02513134|Intraoperative|intraoperative
4818064|NCT02513134|OCT|oct
4818065|NCT02513134|Refractive outcome|refractive outcome
4818066|NCT02513134|Biometry|biometry
4818067|NCT02513121|NAFLD|nafld
4818068|NCT02513121|Steatohepatitis|steatohepatitis
4818069|NCT02513121|NASH|nash
4818070|NCT02513121|Liver|liver
4818071|NCT02513121|Diet|diet
4818072|NCT02513121|Pediatric|pediatric
4818073|NCT02513121|Adolescent|adolescent
4818074|NCT02513056|non-conditional pacemakers|non-conditional pacemakers
4818075|NCT02513056|implantable cardioverter defibrillator|implantable cardioverter defibrillator
4818076|NCT02513017|partially randomized clinical trial|partially randomized clinical trial
4818077|NCT02513017|cardiovascular disease|cardiovascular disease
4818078|NCT02513017|insomnia|insomnia
4818079|NCT02513017|preference|preference
4818080|NCT02513017|acceptability|acceptability
4818081|NCT02512978|myocardial infarction|myocardial infarction
4818082|NCT02512978|hypothyroidism|hypothyroidism
4818083|NCT02512978|levothyroxine|levothyroxine
4818084|NCT02512978|cardiac magnetic resonance imaging|cardiac magnetic resonance imaging
4818085|NCT02512978|myocardial perfusion/metabolism radionuclide imaging|myocardial perfusion/metabolism radionuclide imaging
4818086|NCT02512978|myocardial fibrosis|myocardial fibrosis
4818087|NCT02512978|myocardial perfusion/metabolism|myocardial perfusion/metabolism
4818088|NCT02512978|cardiac function|cardiac function
4818089|NCT02512952|Periodontal regeneration|periodontal regeneration
4818090|NCT02512952|Growth factors|growth factors
4818091|NCT02512939|tuberculosis|tuberculosis
4818092|NCT02512939|diagnostic test|diagnostic test
4818093|NCT02512926|Solid Tumors|solid tumors
4818094|NCT02512926|Leukemia|leukemia
4818095|NCT02512926|Relapsed|relapsed
4818096|NCT02512926|Refractory|refractory
4818097|NCT02512913|Smoking Cessation|smoking cessation
4818098|NCT02512913|Intervention|intervention
4818099|NCT02512913|Pregnancy|pregnancy
4818100|NCT02512913|Postnatal|postnatal
4818101|NCT02512900|Asthma|asthma
4818102|NCT02512887|Hypospadias|hypospadias
4818103|NCT02512887|Caudal Block|caudal block
4818104|NCT02512887|Dorsal Penile Block|dorsal penile block
4818105|NCT02512887|Anesthesia|anesthesia
4818106|NCT02512887|Complications|complications
4818107|NCT02512887|Post-operative|post-operative
4818108|NCT02512887|Urethrocutaneous Fistula|urethrocutaneous fistula
4818109|NCT02512887|Glans dehiscence|glans dehiscence
4818110|NCT02512861|Bupivacaine|bupivacaine
4818111|NCT02512861|Cardiac Surgery|cardiac surgery
4818112|NCT02512861|Pediatrics|pediatrics
4818113|NCT02512861|Nerve Block|nerve block
4818114|NCT02512848|postmenopause|postmenopause
4818115|NCT02512848|endometrial sampling|endometrial sampling
4818116|NCT02512848|vaginal bleeding|vaginal bleeding
4818117|NCT02512835|Primary health care|primary health care
4818118|NCT02512835|Public health|public health
4818119|NCT02512835|Medical Informatics|medical informatics
4818120|NCT02512835|Social Determinants of Health|social determinants of health
4818121|NCT02512822|radiofrequency|radiofrequency
4818122|NCT02512822|submental fat|submental fat
4818123|NCT02512822|fat reduction|fat reduction
4818124|NCT02512822|body contouring|body contouring
4818125|NCT02512796|Liver transplantation|liver transplantation
4818126|NCT02512796|Renal transplantation|renal transplantation
4818127|NCT02512796|Pancreas transplantation|pancreas transplantation
4818128|NCT02512783|Propofol|propofol
4818129|NCT02512783|Lidocaine|lidocaine
4818130|NCT02512783|Intravenous propofol|intravenous propofol
4818131|NCT02512757|Neoplasms, Lung|neoplasms, lung
4818132|NCT02512757|Pulmonary Neoplasms|pulmonary neoplasms
4818133|NCT02512757|Pulmonary Cancer|pulmonary cancer
4818134|NCT02512744|Tracheostomy|tracheostomy
4818135|NCT02512744|Decannulation|decannulation
4818136|NCT02512744|Adult airway management|adult airway management
4818137|NCT02512718|intravenous fat emulsions|intravenous fat emulsions
4818138|NCT02512718|fish oil lipid emulsion|fish oil lipid emulsion
4818139|NCT02512692|intrahepatic cholangiocarcinoma|intrahepatic cholangiocarcinoma
4818140|NCT02512692|cholangiocarcinoma|cholangiocarcinoma
4818141|NCT02512692|90Y TARE|90y tare
4818142|NCT02512692|radioembolization|radioembolization
4818143|NCT02512692|gemcitabine and cisplatin|gemcitabine and cisplatin
4818144|NCT02512679|Hematopoietic Stem Cell Transplantation Pediatrics,|hematopoietic stem cell transplantation pediatrics,
4818145|NCT02512679|stem cell transplantation|stem cell transplantation
4818146|NCT02512679|bone marrow transplantation|bone marrow transplantation
4818147|NCT02512679|Peripheral Blood Stem Cell Transplantation|peripheral blood stem cell transplantation
4820348|NCT02500576|TIL|til
4818148|NCT02512679|Allogeneic Transplantation|allogeneic transplantation
4818149|NCT02512679|pediatrics|pediatrics
4818150|NCT02512679|Combined Immune Deficiency|combined immune deficiency
4818151|NCT02512679|Chronic Granulomatous disease|chronic granulomatous disease
4818152|NCT02512666|Hematologic malignancy|hematologic malignancy
4818153|NCT02512653|Allergy to Cupressus pollen|allergy to cupressus pollen
4818154|NCT02512640|Pressure-controlled ventilation|pressure-controlled ventilation
4818155|NCT02512640|Volume-controlled ventilation|volume-controlled ventilation
4818156|NCT02512640|Laparoscopy|laparoscopy
4818157|NCT02512640|Oxidative stress|oxidative stress
4818158|NCT02512627|mild cognitive impairment|mild cognitive impairment
4818159|NCT02512627|exercise|exercise
4818160|NCT02512627|cognitive training|cognitive training
4818161|NCT02512575|AZD9567|azd9567
4818162|NCT02512575|Healthy subjects|healthy subjects
4818163|NCT02512575|Phase 1|phase 1
4818164|NCT02512575|placebo controlled|placebo controlled
4818165|NCT02512575|single ascending dose|single ascending dose
4818166|NCT02512575|Pharmacokinetics|pharmacokinetics
4818167|NCT02512575|Pharmacodynamics|pharmacodynamics
4818168|NCT02512575|Rheumatoid Arthritis|rheumatoid arthritis
4818169|NCT02512549|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
4818170|NCT02512549|rehabiltation|rehabiltation
4818171|NCT02512523|Type 2 diabetes mellitus|type 2 diabetes mellitus
4818172|NCT02512523|CGMS|cgms
4818173|NCT02512523|Teneligliptin|teneligliptin
4818174|NCT02512523|Sitagliptin|sitagliptin
4818175|NCT02512510|Chronic Obstructive Pulmonary Disease, COPD|chronic obstructive pulmonary disease, copd
4818176|NCT02512497|Cutaneous T-cell Lymphoma|cutaneous t-cell lymphoma
4818177|NCT02512497|CTCL|ctcl
4818178|NCT02512497|T-Prolymphocytic Leukemia|t-prolymphocytic leukemia
4818179|NCT02512497|T-PLL|t-pll
4818180|NCT02512497|T-Large Granulocytic Leukemia|t-large granulocytic leukemia
4818181|NCT02512497|T-LGL|t-lgl
4818182|NCT02512497|T-Lymphoblastic Leukemia/Lymphoma|t-lymphoblastic leukemia/lymphoma
4818183|NCT02512497|T-ALL|t-all
4818184|NCT02512497|Peripheral T-Cell Lymphoma|peripheral t-cell lymphoma
4818185|NCT02512497|PTCL|ptcl
4818186|NCT02512497|Allogeneic stem cell transplantation|allogeneic stem cell transplantation
4818187|NCT02512497|Romidepsin|romidepsin
4818188|NCT02512497|Istodax|istodax
4818189|NCT02512497|Depsipeptide|depsipeptide
4818190|NCT02512497|FK228|fk228
4818191|NCT02512497|Busulfan|busulfan
4818192|NCT02512497|Busulfex|busulfex
4818193|NCT02512497|Myleran|myleran
4818194|NCT02512497|Fludarabine|fludarabine
4818195|NCT02512497|Fludarabine phosphate|fludarabine phosphate
4818196|NCT02512497|Fludara|fludara
4818197|NCT02512484|tuberculosis|tuberculosis
4818198|NCT02512484|accident and emergency|accident and emergency
4818199|NCT02512471|minimum effective volume|minimum effective volume
4818200|NCT02512471|ropivacaine|ropivacaine
4818201|NCT02512471|ultrasound-guided supraclavicular block|ultrasound-guided supraclavicular block
4818202|NCT02512419|Physical Activity|physical activity
4818203|NCT02512419|Latinos|latinos
4818204|NCT02512419|Mexican American Men|mexican american men
4818205|NCT02512419|Spanish-Language|spanish-language
4818206|NCT02512419|Text-Message|text-message
4818207|NCT02512406|Tourette Syndrome|tourette syndrome
4818208|NCT02512406|Tics|tics
4818209|NCT02512341|Computer Aided Auscultation (CAA)|computer aided auscultation (caa)
4818210|NCT02512341|Electronic Stethoscope|electronic stethoscope
4818211|NCT02512341|Phonocardiography|phonocardiography
4818212|NCT02512341|Heart Auscultation|heart auscultation
4818213|NCT02512328|Colonoscopy|colonoscopy
4818214|NCT02512328|new media|new media
4818216|NCT02512328|colonoscopy preparation|colonoscopy preparation
4818217|NCT02512328|SPA|spa
4818218|NCT02512328|smartphone application|smartphone application
4818219|NCT02512315|Nasopharyngeal carcinoma|nasopharyngeal carcinoma
4818220|NCT02512315|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
4818221|NCT02512315|Concurrent chemoradiation|concurrent chemoradiation
4818222|NCT02512315|Distant metastasis|distant metastasis
4818223|NCT02512315|Survival|survival
4818224|NCT02512302|COPD|copd
4818225|NCT02512276|Medication Non-adherence|medication non-adherence
4818226|NCT02512276|Hyperlipidemia|hyperlipidemia
4818227|NCT02512276|Diabetes|diabetes
4818228|NCT02512276|Hypertension|hypertension
4818229|NCT02512237|HER2|her2
4818230|NCT02512237|breast cancer|breast cancer
4818231|NCT02512237|ADC|adc
4818232|NCT02512237|antibody drug conjugate|antibody drug conjugate
4818233|NCT02512237|elevated HER2 expression|elevated her2 expression
4818234|NCT02512224|parenteral nutrition|parenteral nutrition
4818235|NCT02512224|enteral nutrition|enteral nutrition
4818236|NCT02512211|Hemophilia|hemophilia
4818237|NCT02512211|Validation|validation
4818238|NCT02512211|Questionnaires|questionnaires
4818239|NCT02512211|Activities|activities
4818240|NCT02512211|Sport|sport
4818241|NCT02512211|Patients|patients
4818242|NCT02512198|Professional Practice|professional practice
4818243|NCT02512198|General Practitioners|general practitioners
4818244|NCT02512198|Inappropriate Prescribing|inappropriate prescribing
4818245|NCT02512198|Persuasive Communication|persuasive communication
4818246|NCT02512198|Information Theory|information theory
4818248|NCT02512185|Prostate cancer|prostate cancer
4818249|NCT02512185|Chemotherapy|chemotherapy
4818250|NCT02512185|mCRPC|mcrpc
4818251|NCT02512159|Diabetic foot ulcer|diabetic foot ulcer
4818252|NCT02512159|Foot care|foot care
4818253|NCT02512159|Wound management|wound management
4818254|NCT02512146|IBS|ibs
4818255|NCT02512146|Ionotropic glutamate receptors|ionotropic glutamate receptors
4818256|NCT02512133|MIGS|migs
4818257|NCT02512133|SLT|slt
4818258|NCT02512094|Barthel index|barthel index
4818259|NCT02512094|Hip fracture|hip fracture
4818260|NCT02512094|Validity|validity
4818261|NCT02512094|Reliability|reliability
4818262|NCT02512081|Sciatica|sciatica
4818263|NCT02512081|Patient Experience|patient experience
4818264|NCT02512081|Investigations|investigations
4818265|NCT02512081|Qualitative Research|qualitative research
4818266|NCT02512016|Pelvic floor|pelvic floor
4818267|NCT02511990|HIV|hiv
4818268|NCT02511990|10-1074|10-1074
4818269|NCT02511990|Monoclonal Antibody|monoclonal antibody
4818270|NCT02511977|Dental Prosthesis|dental prosthesis
4818271|NCT02511977|Implant-Supported|implant-supported
4818272|NCT02511964|Aerobic Exercise|aerobic exercise
4818273|NCT02511964|HIT,|hit,
4818274|NCT02511964|VO2Max|vo2max
4818275|NCT02511964|Performance|performance
4818276|NCT02511951|postoperative pancreatic fistula|postoperative pancreatic fistula
4818277|NCT02511951|postoperative hospital stay time|postoperative hospital stay time
4818278|NCT02511951|anastomosis time|anastomosis time
4818279|NCT02511951|reoperation rate|reoperation rate
4818280|NCT02511951|morbidity|morbidity
4818281|NCT02511951|pancreaticojejunostomy|pancreaticojejunostomy
4818282|NCT02511951|pancreaticoduodenectomy|pancreaticoduodenectomy
4818283|NCT02511938|childhood obesity|childhood obesity
4818284|NCT02511938|restaurant|restaurant
4818285|NCT02511938|away from home foods|away from home foods
4818286|NCT02511925|Critical care|critical care
4818287|NCT02511925|Feedback|feedback
4818288|NCT02511899|Microcirculation|microcirculation
4818289|NCT02511899|Endothelial function|endothelial function
4818290|NCT02511899|Metabolism|metabolism
4818291|NCT02511899|Cardiovascular Disease|cardiovascular disease
4818292|NCT02511899|human study|human study
4818293|NCT02511899|healthy subjects|healthy subjects
4818294|NCT02511899|Mangifera indica|mangifera indica
4818295|NCT02511899|Careless|careless
4818296|NCT02511886|Alcoholism|alcoholism
4818297|NCT02511886|Alcohol Abuse|alcohol abuse
4818298|NCT02511886|Alcohol Addiction|alcohol addiction
4818299|NCT02511886|Alcohol Dependence|alcohol dependence
4818300|NCT02511886|Alcohol Induced Disorders|alcohol induced disorders
4818301|NCT02511886|Alcoholic Intoxication|alcoholic intoxication
4818302|NCT02511873|Fycompa|fycompa
4818303|NCT02511873|Small Fiber Neuropathy|small fiber neuropathy
4818304|NCT02511873|SFN|sfn
4818305|NCT02511873|Neuropathy|neuropathy
4818306|NCT02511873|Pain|pain
4818307|NCT02511847|Breast Cancer|breast cancer
4818308|NCT02511847|EGFR|egfr
4818309|NCT02511847|Afatinib|afatinib
4818310|NCT02511847|Paclitaxel|paclitaxel
4818311|NCT02511847|Pathologic complete remission|pathologic complete remission
4818312|NCT02511808|Drinking|drinking
4818313|NCT02511808|Alcohol Problems|alcohol problems
4818314|NCT02511808|Alcoholism|alcoholism
4818315|NCT02511808|Reduced Drinking|reduced drinking
4818316|NCT02511808|Problematic Drinking|problematic drinking
4818317|NCT02511808|Non-Abstinence-based Drinking|non-abstinence-based drinking
4818318|NCT02511808|Controlled Drinking|controlled drinking
4818319|NCT02511808|Heavy Drinking|heavy drinking
4818320|NCT02511795|AZD1775|azd1775
4818321|NCT02511795|Olaparib|olaparib
4818322|NCT02511795|AZD1775 plus Olaparib|azd1775 plus olaparib
4818323|NCT02511795|Refractory Solid Tumours|refractory solid tumours
4818324|NCT02511795|Relapsed Small Cell Lung Cancer (SCLC)|relapsed small cell lung cancer (sclc)
4818325|NCT02511782|children|children
4818326|NCT02511782|bone marrow transplant|bone marrow transplant
4818327|NCT02511782|GVHD|gvhd
4818328|NCT02511756|Perfusion-computed tomography|perfusion-computed tomography
4818329|NCT02511730|Mammography|mammography
4818330|NCT02511704|Nicotine|nicotine
4818331|NCT02511704|Electronic cigarette|electronic cigarette
4818332|NCT02511704|Cigarette|cigarette
4818333|NCT02511639|Hormone receptor positive|hormone receptor positive
4818334|NCT02511639|HER2 negative|her2 negative
4818335|NCT02511626|endometriosis|endometriosis
4818336|NCT02511626|quality of life|quality of life
4818337|NCT02511626|professional activity|professional activity
4818338|NCT02511626|pain|pain
4818339|NCT02511626|infertility|infertility
4818340|NCT02511626|sexuality|sexuality
4818341|NCT02511626|partnership|partnership
4818342|NCT02511626|anxiety|anxiety
4818343|NCT02511626|depression|depression
4818344|NCT02511626|stress|stress
4818345|NCT02511626|childhood trauma|childhood trauma
4818346|NCT02511626|medical support|medical support
4818347|NCT02511626|dyspareunia|dyspareunia
4818348|NCT02511600|Lung Diseases|lung diseases
4818349|NCT02511600|Mesothelioma|mesothelioma
4818350|NCT02511600|Pleurectomy decortication|pleurectomy decortication
4818351|NCT02511600|Progel|progel
4818352|NCT02511600|Talcum powder|talcum powder
4818353|NCT02511600|Pain questionnaires|pain questionnaires
4818354|NCT02511600|Surveys|surveys
4818355|NCT02511600|Intraoperative air leaks|intraoperative air leaks
4818356|NCT02511600|IAL|ial
4818357|NCT02511574|progesterone|progesterone
4818358|NCT02511574|uterine cervix|uterine cervix
4818359|NCT02511574|cervical pessary|cervical pessary
4818360|NCT02511561|Otitis externa|otitis externa
4818361|NCT02511561|Swimmer's ear|swimmer's ear
4818362|NCT02511561|Ear infection|ear infection
4818363|NCT02511509|Schizophrenia|schizophrenia
4818364|NCT02511509|Electroconvulsive Therapy|electroconvulsive therapy
4818365|NCT02511509|Bifrontal ECT|bifrontal ect
4818366|NCT02511509|Bitemporal ECT|bitemporal ect
4818367|NCT02511509|Cognitive functions|cognitive functions
4818368|NCT02511509|Postictal delirium|postictal delirium
4818369|NCT02511483|COMT|comt
4818370|NCT02511483|Beta-blocker|beta-blocker
4818371|NCT02511483|Hemicolectomy|hemicolectomy
4818372|NCT02511470|Cardiopulmonary Resuscitation|cardiopulmonary resuscitation
4818373|NCT02511470|Pediatric simulation study|pediatric simulation study
4818374|NCT02511470|Metronome|metronome
4818375|NCT02511444|GBS|gbs
4818376|NCT02511444|GBS culture|gbs culture
4818377|NCT02511444|GBS PCR|gbs pcr
4818378|NCT02511444|GBS colonization|gbs colonization
4818379|NCT02511431|Delta Hepatitis|delta hepatitis
4818380|NCT02511431|Hepatitis D|hepatitis d
4818381|NCT02511431|Liver Disease|liver disease
4818382|NCT02511431|Hepatitis D Virus|hepatitis d virus
4818383|NCT02511431|Chronic Hepatitis|chronic hepatitis
4818384|NCT02511405|rGBM|rgbm
4818385|NCT02511405|Recurrent Glioblastoma|recurrent glioblastoma
4818386|NCT02511405|Recurrent GBM|recurrent gbm
4818387|NCT02511366|ileal brake|ileal brake
4818388|NCT02511353|malaria|malaria
4818389|NCT02511353|plasmodium|plasmodium
4818390|NCT02511353|dihydroartemisinin-piperaquine|dihydroartemisinin-piperaquine
4818391|NCT02511353|ivermectin|ivermectin
4818392|NCT02511327|Pertussis|pertussis
4818393|NCT02511327|Pregnancy|pregnancy
4818394|NCT02511327|Vaccination|vaccination
4818395|NCT02511327|Preterm|preterm
4818396|NCT02511327|Breast milk|breast milk
4818397|NCT02511327|Humoral immune response|humoral immune response
4818398|NCT02511327|Cellular immune response|cellular immune response
4818399|NCT02511327|Maternal antibodies|maternal antibodies
4818400|NCT02511314|Nursing homes|nursing homes
4818401|NCT02511314|quasi-experimental|quasi-experimental
4818402|NCT02511314|mixed methods|mixed methods
4818403|NCT02511314|parallel study|parallel study
4818404|NCT02511314|urinary incontinence|urinary incontinence
4818405|NCT02511288|hematologic test|hematologic test
4818406|NCT02511275|parenchymal clamping|parenchymal clamping
4818407|NCT02511275|microdialysis technique|microdialysis technique
4818408|NCT02511275|partial nephrectomy|partial nephrectomy
4818409|NCT02511249|neonatal arterial ischemic stroke|neonatal arterial ischemic stroke
4818410|NCT02511249|language development|language development
4818411|NCT02511249|global intellectual functioning|global intellectual functioning
4818412|NCT02511249|motor abilities|motor abilities
4818413|NCT02511197|PET|pet
4818414|NCT02511197|lung injury|lung injury
4818415|NCT02511197|integrin receptor|integrin receptor
4818416|NCT02511184|crizotinib|crizotinib
4818417|NCT02511184|pembrolizumab|pembrolizumab
4818418|NCT02511184|ALK-positive NSCLC|alk-positive nsclc
4818419|NCT02511184|Lung Cancer|lung cancer
4818420|NCT02511184|ALK-translocated NSCLC|alk-translocated nsclc
4818421|NCT02511184|Non Small Cell Lung Cancer|non small cell lung cancer
4818422|NCT02511158|Anterior Cruciate Ligament, Posterior Cruciate Ligament, Medial Collateral Ligament, Lateral Collateral Ligament|anterior cruciate ligament, posterior cruciate ligament, medial collateral ligament, lateral collateral ligament
4818423|NCT02511145|volunteers|volunteers
4818424|NCT02511132|Ewing's Sarcoma Family of Tumors, ESFT, Sarcoma|ewing's sarcoma family of tumors, esft, sarcoma
4818425|NCT02511132|Soft Tissue Sarcoma|soft tissue sarcoma
4818426|NCT02511106|Stage IB-IIA-IIIA Non-Small Cell Lung Cancer; EGFRm+; Ex19Del; L858R; AZD9291; Phase III, adjuvant chemotherapy; complete tumour resection; EGFR-TKI|stage ib-iia-iiia non-small cell lung cancer; egfrm+; ex19del; l858r; azd9291; phase iii, adjuvant chemotherapy; complete tumour resection; egfr-tki
4818427|NCT02511093|Hypertension|hypertension
4818428|NCT02511093|Team-based care|team-based care
4818429|NCT02511093|Collaboration|collaboration
4818430|NCT02511093|Healthcare professionals|healthcare professionals
4818431|NCT02511093|Healthcare services|healthcare services
4818432|NCT02511080|Spot-on; perioperative hypothermia.|spot-on; perioperative hypothermia.
4818433|NCT02511054|Immunogenicity|immunogenicity
4818434|NCT02511054|Liver Stage|liver stage
4818435|NCT02511054|Parasites|parasites
4818436|NCT02511054|Blood|blood
4818437|NCT02511054|Infection|infection
4818438|NCT02511041|CDG|cdg
4818439|NCT02511041|PGM3|pgm3
4818440|NCT02511041|Immune|immune
4818441|NCT02511028|MRI|mri
4818442|NCT02511028|Multiple Sclerosis|multiple sclerosis
4818443|NCT02511028|Healthy Volunteer|healthy volunteer
4818444|NCT02511015|Early Onset Parkinson's Disease|early onset parkinson's disease
4818445|NCT02511015|Cellular Quality Control Programs|cellular quality control programs
4818446|NCT02511015|Mitochondria|mitochondria
4818447|NCT02511015|Neuroinflammation|neuroinflammation
4818448|NCT02511015|Immunology|immunology
4818449|NCT02511002|Influenza|influenza
4818450|NCT02511002|Hemagglutinin (HA)|hemagglutinin (ha)
4818451|NCT02511002|Post Influenza Challenge|post influenza challenge
4818452|NCT02511002|Neuranimidase (NA)|neuranimidase (na)
4818453|NCT02511002|Influenza Illness|influenza illness
4818454|NCT02510989|Syndromic obesity|syndromic obesity
4818455|NCT02510989|Genes|genes
4818456|NCT02510989|Exome|exome
4818457|NCT02510963|Vertical infection transmission|vertical infection transmission
4818458|NCT02510963|Tenofovir|tenofovir
4818459|NCT02510937|pulmonary fibrosis|pulmonary fibrosis
4818460|NCT02510937|pharmacokinetic|pharmacokinetic
4818461|NCT02510937|pharmacodynamics|pharmacodynamics
4818462|NCT02510937|CC-90001|cc-90001
4818463|NCT02510937|Safety|safety
4818464|NCT02510924|Intubation|intubation
4818465|NCT02510924|Airtraq|airtraq
4818466|NCT02510924|General anesthesia|general anesthesia
4818467|NCT02510924|Difficult airway|difficult airway
4818468|NCT02510911|colectomy|colectomy
4818469|NCT02510911|laparoscopy|laparoscopy
4818470|NCT02510911|caffeine|caffeine
4818471|NCT02510885|neovascular age-related macular degeneration|neovascular age-related macular degeneration
4818472|NCT02510885|age-related macular degeneration|age-related macular degeneration
4818473|NCT02510885|diabetic retinopathy|diabetic retinopathy
4818474|NCT02510885|SD-OCT|sd-oct
4818475|NCT02510885|Angiography|angiography
4818476|NCT02510885|diabetic macular edema|diabetic macular edema
4818477|NCT02510846|Polyhandicap|polyhandicap
4818478|NCT02510846|Behavior disorders|behavior disorders
4818479|NCT02510846|Educative program|educative program
4818480|NCT02510846|Caregivers|caregivers
4818481|NCT02510846|Quality of life.|quality of life.
4818482|NCT02510833|Parkinson Disease|parkinson disease
4818483|NCT02510833|Physical Therapy Modalities|physical therapy modalities
4818484|NCT02510833|Quality of Life|quality of life
4818485|NCT02510833|Self Care|self care
4818486|NCT02510768|alba|alba
4818487|NCT02510664|Adolescence|adolescence
4818488|NCT02510664|Adherence|adherence
4818489|NCT02510651|: non-segmental vitiligo|: non-segmental vitiligo
4818490|NCT02510651|melanocyte-keratinocyte suspension|melanocyte-keratinocyte suspension
4818491|NCT02510651|cryoblebbing|cryoblebbing
4818492|NCT02510651|CO2 laser|co2 laser
4818493|NCT02510612|Dexmedetomidine|dexmedetomidine
4818494|NCT02510612|Diabetic|diabetic
4818495|NCT02510612|glycometabolism|glycometabolism
4818496|NCT02510612|sedation|sedation
4818497|NCT02510599|NASH|nash
4818498|NCT02510599|Liver disease|liver disease
4818499|NCT02510508|addiction|addiction
4818500|NCT02510508|substance abuse|substance abuse
4818501|NCT02510508|alcohol|alcohol
4818502|NCT02510508|drugs|drugs
4818503|NCT02510508|community reinforcement|community reinforcement
4818504|NCT02510508|family treatment|family treatment
4818505|NCT02510508|randomized control trial|randomized control trial
4818506|NCT02510495|Sphincterotomy|sphincterotomy
4818507|NCT02510495|Dilatation|dilatation
4818508|NCT02510495|Common bile duct|common bile duct
4818509|NCT02510495|Pancreatitis|pancreatitis
4818510|NCT02510482|cardiac biomarkers|cardiac biomarkers
4818511|NCT02510443|Permanent contraception method|permanent contraception method
4818512|NCT02510443|Contraceptive device|contraceptive device
4818513|NCT02510391|modular|modular
4818514|NCT02510391|anxiety|anxiety
4818515|NCT02510391|preschool|preschool
4818516|NCT02510391|exposure and response prevention|exposure and response prevention
4818517|NCT02510391|Cognitive behavioral therapy|cognitive behavioral therapy
4818518|NCT02510352|Rotator cuff tear|rotator cuff tear
4818519|NCT02510352|MRI|mri
4818520|NCT02510287|analgesia, epidural|analgesia, epidural
4818521|NCT02510287|labor pain|labor pain
4818522|NCT02510287|patient satisfaction|patient satisfaction
4818523|NCT02510274|ASP3325|asp3325
4818524|NCT02510274|pharmacokinetics|pharmacokinetics
4818525|NCT02510274|pharmacodynamics|pharmacodynamics
4818526|NCT02510274|Chronic Kidney Disease|chronic kidney disease
4818527|NCT02510274|Hyperphosphatemia|hyperphosphatemia
4818528|NCT02510261|RNAi therapeutic|rnai therapeutic
4818529|NCT02510261|FAP|fap
4818530|NCT02510261|Familial Amyloid Polyneuropathy|familial amyloid polyneuropathy
4818531|NCT02510261|TTR|ttr
4818532|NCT02510261|Transthyretin|transthyretin
4818533|NCT02510261|Amyloidosis|amyloidosis
4818534|NCT02510235|Dry Eye|dry eye
4818535|NCT02510222|child|child
4818536|NCT02510209|Teen pregnancy|teen pregnancy
4818537|NCT02510183|Acupressure|acupressure
4818538|NCT02510183|Perioperative Care|perioperative care
4818539|NCT02510183|Postoperative Nausea and Vomiting|postoperative nausea and vomiting
4818540|NCT02510183|Nursing Care Management|nursing care management
4818541|NCT02510170|Fetus|fetus
4818542|NCT02510170|Skull|skull
4818543|NCT02510170|ultrasonography|ultrasonography
4818544|NCT02510157|sugammadex|sugammadex
4818545|NCT02510157|dexamethasone|dexamethasone
4818546|NCT02510157|neuromuscular blockade|neuromuscular blockade
4818547|NCT02510118|ChangTai Keli|changtai keli
4818548|NCT02510118|Colon cancer|colon cancer
4818549|NCT02510105|Critical Care|critical care
4818550|NCT02510105|ARDS|ards
4818551|NCT02510105|Intrapulmonary Percussive Ventilation|intrapulmonary percussive ventilation
4818552|NCT02510105|VDR4|vdr4
4820349|NCT02500576|T-cells|t-cells
4818553|NCT02510105|Lung aeration|lung aeration
4818554|NCT02510105|CT scan|ct scan
4818555|NCT02510066|Pancreatic Cancer|pancreatic cancer
4818556|NCT02510066|Pain|pain
4818557|NCT02510066|Acupuncture|acupuncture
4818558|NCT02510040|Convergence Insufficiency|convergence insufficiency
4818559|NCT02510040|Divergence Insufficiency|divergence insufficiency
4818560|NCT02510040|Small-angle Hypertropia|small-angle hypertropia
4818561|NCT02510040|Strabismus|strabismus
4818562|NCT02510027|HPV testing|hpv testing
4818563|NCT02510027|Triage|triage
4818564|NCT02510027|Mexico|mexico
4818565|NCT02510027|Cervical cancer screening|cervical cancer screening
4818566|NCT02510001|RASMT CRC|rasmt crc
4818567|NCT02510001|RASWT/c-MET CRC|raswt/c-met crc
4818568|NCT02510001|Dose Escalation|dose escalation
4818569|NCT02510001|Histologically or cytologically confirmed|histologically or cytologically confirmed
4818570|NCT02510001|Dose Expansion|dose expansion
4818571|NCT02509988|Nutrition|nutrition
4818572|NCT02509988|Glucose metabolism|glucose metabolism
4818573|NCT02509988|Body composition|body composition
4818574|NCT02509975|embolization|embolization
4818575|NCT02509975|prostate|prostate
4818576|NCT02509962|Energy metabolism|energy metabolism
4818577|NCT02509962|Glucose tolerance|glucose tolerance
4818578|NCT02509962|Blood pressure|blood pressure
4818579|NCT02509962|Immunoregulation|immunoregulation
4818580|NCT02509923|Male Subjects|male subjects
4818581|NCT02509910|Major abdominal surgery|major abdominal surgery
4818582|NCT02509910|Goal directed therapy|goal directed therapy
4818583|NCT02509897|Hypoxia training|hypoxia training
4818584|NCT02509897|Activity energy expenditure|activity energy expenditure
4818585|NCT02509897|Immunoregulation|immunoregulation
4818586|NCT02509897|Energy Metabolism|energy metabolism
4818587|NCT02509897|Exercise|exercise
4818588|NCT02509884|Alveolar Echinococcosis (AE)|alveolar echinococcosis (ae)
4818589|NCT02509884|Echinococcus multilocularis|echinococcus multilocularis
4818590|NCT02509884|antiparasitic treatment|antiparasitic treatment
4818591|NCT02509884|surgery|surgery
4818592|NCT02509884|classification|classification
4818593|NCT02509884|staging|staging
4818594|NCT02509884|prospective cohort study|prospective cohort study
4818595|NCT02509871|Body composition|body composition
4818596|NCT02509858|Diabetes mellitus, thyroxine|diabetes mellitus, thyroxine
4818597|NCT02509832|Therapeutic Hypothermia (TH)|therapeutic hypothermia (th)
4818598|NCT02509832|Acute Myocardial Infarction (AMI)|acute myocardial infarction (ami)
4818599|NCT02509832|Percutaneous Coronary Intervention (PCI)|percutaneous coronary intervention (pci)
4818600|NCT02509819|rehabilitation|rehabilitation
4818601|NCT02509819|IDEO|ideo
4818602|NCT02509780|Vichy|vichy
4818603|NCT02509780|urine alkalization|urine alkalization
4818604|NCT02509767|Contraceptive Methods|contraceptive methods
4818605|NCT02509767|Female Contraception|female contraception
4818606|NCT02509767|Contraceptive satisfaction|contraceptive satisfaction
4818607|NCT02509767|Injectable contraception|injectable contraception
4818608|NCT02509767|Birth control|birth control
4818609|NCT02509754|atrial fibrillation|atrial fibrillation
4818610|NCT02509754|congestive heart failure|congestive heart failure
4818611|NCT02509754|catheter ablation|catheter ablation
4818612|NCT02509754|rate control|rate control
4818613|NCT02509754|left ventricular function|left ventricular function
4818614|NCT02509741|obesity|obesity
4818615|NCT02509741|nutrition|nutrition
4818616|NCT02509741|intervention|intervention
4818617|NCT02509741|food replacement|food replacement
4818618|NCT02509741|IOT|iot
4818619|NCT02509728|choline|choline
4818620|NCT02509728|docosahexaenoic acid|docosahexaenoic acid
4818621|NCT02509715|thyroidectomy|thyroidectomy
4818622|NCT02509715|nerve monitoring|nerve monitoring
4818623|NCT02509702|Mobile health|mobile health
4818624|NCT02509702|Screening|screening
4818625|NCT02509702|Early detection of cancer|early detection of cancer
4818626|NCT02509702|HPV|hpv
4818627|NCT02509702|SMS intervention|sms intervention
4818628|NCT02509702|RCT|rct
4818629|NCT02509702|Tanzania|tanzania
4818630|NCT02509689|mTBI|mtbi
4818631|NCT02509689|cognition disorders|cognition disorders
4818632|NCT02509689|post-concussive syndrome|post-concussive syndrome
4818633|NCT02509689|neuroplasticity|neuroplasticity
4818634|NCT02509689|EEG|eeg
4818635|NCT02509689|biofeedback|biofeedback
4818636|NCT02509689|stress disorder/post-traumatic|stress disorder/post-traumatic
4818637|NCT02509689|depression|depression
4818638|NCT02509676|dynamic stretching training|dynamic stretching training
4818639|NCT02509676|muscle tendon unit|muscle tendon unit
4818640|NCT02509676|ultrasound|ultrasound
4818641|NCT02509650|Exome sequencing|exome sequencing
4818642|NCT02509650|Skin disease|skin disease
4818643|NCT02509650|Familial lipomatosis|familial lipomatosis
4818644|NCT02509637|Respiratory System|respiratory system
4818645|NCT02509637|Physical Therapy Modalities|physical therapy modalities
4818646|NCT02509611|Yoga|yoga
4818647|NCT02509611|Parkinson's disease|parkinson's disease
4818648|NCT02509611|redox status|redox status
4818649|NCT02509611|motor function|motor function
4818650|NCT02509559|Receptors, Adrenergic|receptors, adrenergic
4818651|NCT02509559|Propranolol|propranolol
4818652|NCT02509533|Vacuum Assisted Closure|vacuum assisted closure
4818653|NCT02509520|Nutritional supplementation|nutritional supplementation
4818654|NCT02509520|Neuromuscular Electric Stimulation|neuromuscular electric stimulation
4818655|NCT02509520|ICU acquired weakness|icu acquired weakness
4818656|NCT02509520|Post ICU Syndrome|post icu syndrome
4818657|NCT02509520|sarcopenia|sarcopenia
4818658|NCT02509507|Liver tumours|liver tumours
4818659|NCT02509494|Vaccine|vaccine
4818660|NCT02509494|Ebola|ebola
4818661|NCT02509494|Ebola virus disease|ebola virus disease
4818662|NCT02509494|EVD|evd
4818663|NCT02509494|Hemorrhagic fever|hemorrhagic fever
4818664|NCT02509494|Sierra Leone|sierra leone
4818665|NCT02509494|Human adenovirus serotype 26 (Ad26) expressing the Ebola virus Mayinga variant glycoprotein (Ad26.ZEBOV)|human adenovirus serotype 26 (ad26) expressing the ebola virus mayinga variant glycoprotein (ad26.zebov)
4818666|NCT02509494|Safety|safety
4818667|NCT02509494|Immunogenicity|immunogenicity
4818668|NCT02509494|Modified Vaccinia Virus Ankara ‐ Bavarian Nordic Filo‐vector|modified vaccinia virus ankara ‐ bavarian nordic filo‐vector
4818669|NCT02509494|(MVA‐BN Filo)|(mva‐bn filo)
4818670|NCT02509481|malaria|malaria
4818671|NCT02509481|lymphatic filariasis|lymphatic filariasis
4818672|NCT02509481|mosquito|mosquito
4818673|NCT02509481|ivermectin|ivermectin
4818674|NCT02509481|mass drug administration|mass drug administration
4818675|NCT02509455|Balance control|balance control
4818676|NCT02509455|Body-mounted sensors|body-mounted sensors
4818677|NCT02509455|Balance Measures|balance measures
4818678|NCT02509442|mapping brain functions|mapping brain functions
4818679|NCT02509442|Direct electric stimulation (DES)|direct electric stimulation (des)
4818680|NCT02509442|potential evoked|potential evoked
4818681|NCT02509429|T1DM|t1dm
4818682|NCT02509429|Type 1 Diabetes|type 1 diabetes
4818683|NCT02509429|Artificial Pancreas|artificial pancreas
4818684|NCT02509429|DiAs platform|dias platform
4818685|NCT02509416|endoscopic ultrasound|endoscopic ultrasound
4818686|NCT02509416|endoscopic retrograde cholangiopancreatography|endoscopic retrograde cholangiopancreatography
4818687|NCT02509416|competency|competency
4818688|NCT02509403|Perineal hygiene|perineal hygiene
4818689|NCT02509403|Hygiene wipes|hygiene wipes
4818690|NCT02509403|Hygiene Towels|hygiene towels
4818691|NCT02509403|Safety|safety
4818692|NCT02509403|Essential oils|essential oils
4818693|NCT02509403|Natural Health Product|natural health product
4818694|NCT02509390|Fibrinogen level|fibrinogen level
4818695|NCT02509390|Hyperfibrinogenemia|hyperfibrinogenemia
4818696|NCT02509390|Trauma|trauma
4818697|NCT02509390|Thrombosis risk|thrombosis risk
4818698|NCT02509377|Fetal Surgery|fetal surgery
4818699|NCT02509377|Open Fetal Surgery|open fetal surgery
4818700|NCT02509377|Elevated BMI|elevated bmi
4818701|NCT02509377|Body Mass Index|body mass index
4818702|NCT02509377|Spina Bifida|spina bifida
4818703|NCT02509364|AE-IPF|ae-ipf
4818704|NCT02509312|Analgesia, Obstetrical|analgesia, obstetrical
4818705|NCT02509312|Blood Loss, Surgical|blood loss, surgical
4818706|NCT02509312|Analgesics, Opioid/administration & dosage|analgesics, opioid/administration & dosage
4818707|NCT02509312|Cyclooxygenase Inhibitors/administration & dosage|cyclooxygenase inhibitors/administration & dosage
4818708|NCT02509312|Cesarean Section|cesarean section
4818709|NCT02509312|Female|female
4818710|NCT02509312|Humans|humans
4818711|NCT02509312|Ketorolac/administration & dosage|ketorolac/administration & dosage
4818712|NCT02509312|Hydromorphone/administration & dosage|hydromorphone/administration & dosage
4818713|NCT02509312|Pain, Postoperative/drug therapy|pain, postoperative/drug therapy
4818714|NCT02509312|Pregnancy|pregnancy
4818715|NCT02509312|Morphine/administration & dosage|morphine/administration & dosage
4818716|NCT02509299|COPD|copd
4818717|NCT02509299|Quality of life|quality of life
4818718|NCT02509299|Perceived health status|perceived health status
4818719|NCT02509286|Esophageal neoplasms|esophageal neoplasms
4818720|NCT02509286|gastro-esophageal junction neoplasms|gastro-esophageal junction neoplasms
4818721|NCT02509286|adenocarcinoma|adenocarcinoma
4818722|NCT02509286|esophagectomy|esophagectomy
4818723|NCT02509286|surgery|surgery
4818724|NCT02509286|radiotherapy|radiotherapy
4818725|NCT02509286|chemotherapy|chemotherapy
4818726|NCT02509260|colorectal surgery|colorectal surgery
4818727|NCT02509247|sleep apnea|sleep apnea
4818728|NCT02509247|CPAP|cpap
4818729|NCT02509247|telemonitoring|telemonitoring
4818730|NCT02509247|telecare|telecare
4818731|NCT02509234|pediatric sarcomas|pediatric sarcomas
4818732|NCT02509234|Ewing sarcoma|ewing sarcoma
4818733|NCT02509234|rhabdomyosarcoma|rhabdomyosarcoma
4818734|NCT02509234|soft tissue sarcoma|soft tissue sarcoma
4818735|NCT02509208|iliac crest bone graft|iliac crest bone graft
4818736|NCT02509208|ICBG|icbg
4818737|NCT02509208|pelvic osteotomy|pelvic osteotomy
4818738|NCT02509208|spinal fusion|spinal fusion
4818739|NCT02509208|hemostasis|hemostasis
4818740|NCT02509208|haemostasis|haemostasis
4818741|NCT02509208|hemostatic|hemostatic
4818742|NCT02509208|haemostatic|haemostatic
4818743|NCT02509208|dextran|dextran
4818744|NCT02509208|SurgiClot|surgiclot
4818745|NCT02509208|cancellous bone bleeding|cancellous bone bleeding
4818746|NCT02509182|Hyperoxia|hyperoxia
4818747|NCT02509182|One-Lung Ventilation|one-lung ventilation
4818748|NCT02509182|Thoracic Surgery|thoracic surgery
4818749|NCT02509182|Anesthesiology|anesthesiology
4818750|NCT02509156|Cardiomyopathy|cardiomyopathy
4818751|NCT02509156|AIC|aic
4818752|NCT02509156|Anthracyclines|anthracyclines
4818753|NCT02509156|Chemotherapy|chemotherapy
4818754|NCT02509156|Allogeneic|allogeneic
4818755|NCT02509156|Mesenchymal stem cells|mesenchymal stem cells
4818756|NCT02509156|MSCs|mscs
4818757|NCT02509156|Cancer survivors|cancer survivors
4818758|NCT02509156|Breast Cancer|breast cancer
4818759|NCT02509156|Leukemia|leukemia
4818760|NCT02509156|Lymphoma|lymphoma
4818761|NCT02509156|Sarcoma|sarcoma
4818762|NCT02509143|Postoperative Nausea and Vomiting|postoperative nausea and vomiting
4818763|NCT02509143|Colorectal Neoplasms|colorectal neoplasms
4818764|NCT02509130|Severe Asthma|severe asthma
4818765|NCT02509130|Asthma|asthma
4818766|NCT02509130|Specialised Asthma Care|specialised asthma care
4818767|NCT02509130|Asthma Care|asthma care
4818768|NCT02509117|Alzheimer's disease|alzheimer's disease
4818769|NCT02509104|Bioavailability|bioavailability
4818770|NCT02509104|Dutasteride|dutasteride
4818771|NCT02509104|Healthy Male Subjects|healthy male subjects
4818772|NCT02509104|Fixed Dose Combination|fixed dose combination
4818773|NCT02509078|ARDS|ards
4818774|NCT02509078|neuromuscular blocker|neuromuscular blocker
4818775|NCT02509078|cisatracurium|cisatracurium
4818776|NCT02509065|bionic pancreas|bionic pancreas
4818777|NCT02509065|artificial pancreas|artificial pancreas
4818778|NCT02509065|insulin|insulin
4818779|NCT02509065|glucagon|glucagon
4818780|NCT02509065|continuous glucose monitor (CGM)|continuous glucose monitor (cgm)
4818781|NCT02509065|insulin pump|insulin pump
4818782|NCT02509065|outpatient|outpatient
4818783|NCT02509039|CC-122|cc-122
4818784|NCT02509039|Phase1|phase1
4818785|NCT02509039|solid tumor|solid tumor
4818786|NCT02509039|non-Hodgkin's lymphom|non-hodgkin's lymphom
4818787|NCT02509026|non-radiographic axial spondyloarthritis|non-radiographic axial spondyloarthritis
4818788|NCT02509013|chronic kidney disease|chronic kidney disease
4818789|NCT02509013|stable coronary heart disease|stable coronary heart disease
4818790|NCT02509013|prevalence|prevalence
4818791|NCT02508987|Obesity|obesity
4818792|NCT02508987|oxidative stress|oxidative stress
4818793|NCT02508987|antioxidants|antioxidants
4818794|NCT02508987|periodontal disease|periodontal disease
4818795|NCT02508961|Physical Activity|physical activity
4818796|NCT02508961|Exercise|exercise
4818797|NCT02508961|Physiotherapy|physiotherapy
4818798|NCT02508948|airway management|airway management
4818799|NCT02508948|critically ill|critically ill
4818800|NCT02508948|hemodynamic management|hemodynamic management
4818801|NCT02508948|intubation|intubation
4818802|NCT02508948|prospective study|prospective study
4818803|NCT02508948|risk factors|risk factors
4818804|NCT02508909|Videoassisted surgery|videoassisted surgery
4818805|NCT02508883|Cancer|cancer
4818806|NCT02508883|hemorrhage|hemorrhage
4818807|NCT02508883|endoscopy|endoscopy
4818808|NCT02508883|gastrointestinal hemorrhage|gastrointestinal hemorrhage
4818809|NCT02508857|pain, postoperative|pain, postoperative
4818810|NCT02508857|anesthesia adjuvants|anesthesia adjuvants
4818811|NCT02508857|magnesium sulfate|magnesium sulfate
4818812|NCT02508844|Probiotics|probiotics
4818813|NCT02508844|Vivomixx®|vivomixx®
4818814|NCT02508844|Microbiota|microbiota
4818815|NCT02508831|Bilateral amputation|bilateral amputation
4818816|NCT02508831|upper limb|upper limb
4818817|NCT02508831|allograft|allograft
4818818|NCT02508779|Diabetes|diabetes
4818819|NCT02508779|Blood Glucose Management|blood glucose management
4818820|NCT02508779|Preconception|preconception
4818821|NCT02508779|Hypoglycemia|hypoglycemia
4818822|NCT02508779|Women with diabetes|women with diabetes
4818823|NCT02508766|Postural Control|postural control
4818824|NCT02508766|Plantar Stimulation|plantar stimulation
4818825|NCT02508766|Volunteers|volunteers
4818826|NCT02508753|QT/QTc Intervals|qt/qtc intervals
4818827|NCT02508701|HPV|hpv
4818828|NCT02508701|Message Design|message design
4818829|NCT02508701|Adolescent Males|adolescent males
4818830|NCT02508688|hepatic hydrothorax|hepatic hydrothorax
4818831|NCT02508688|thoracoscopic surgery|thoracoscopic surgery
4818832|NCT02508688|diaphragmatic defect|diaphragmatic defect
4818833|NCT02508675|injury|injury
4818834|NCT02508675|risk factors|risk factors
4818835|NCT02508675|outcome|outcome
4818836|NCT02508675|costs|costs
4818837|NCT02508662|Advanced Cancers|advanced cancers
4818838|NCT02508662|Solid Tumors|solid tumors
4818839|NCT02508662|Genomic Mutations|genomic mutations
4818840|NCT02508662|FDA Approved Off-Label Chemotherapy|fda approved off-label chemotherapy
4818841|NCT02508662|Refractory|refractory
4818842|NCT02508623|Portal hypertension|portal hypertension
4818843|NCT02508623|liver cirrhosis|liver cirrhosis
4818844|NCT02508623|Rifaximin|rifaximin
4818845|NCT02508597|Smoking cessation intervention|smoking cessation intervention
4818846|NCT02508571|Infant, Premature|infant, premature
4818847|NCT02508571|Intervention Studies|intervention studies
4818848|NCT02508571|Bottle feeding|bottle feeding
4818849|NCT02508532|2L GIST|2l gist
4818850|NCT02508532|GIST second line|gist second line
4818851|NCT02508532|GIST gleevec|gist gleevec
4818852|NCT02508532|GIST imatinib|gist imatinib
4818853|NCT02508532|Second-line GIST clinical trial|second-line gist clinical trial
4818854|NCT02508532|BLU-285|blu-285
4818855|NCT02508532|BLU 285|blu 285
4818856|NCT02508532|BLUE-285|blue-285
4818857|NCT02508532|BLUE 285|blue 285
4818858|NCT02508532|Avapritinib|avapritinib
4818859|NCT02508532|GIST imatinib relapse|gist imatinib relapse
4818860|NCT02508532|GIST gleevec relapse|gist gleevec relapse
4818861|NCT02508532|GIST KIT|gist kit
4818862|NCT02508532|GIST relapse|gist relapse
4818863|NCT02508532|GIST refractory|gist refractory
4818864|NCT02508532|GIST imatinib intolerance|gist imatinib intolerance
4818865|NCT02508532|GIST TKI treatment|gist tki treatment
4818866|NCT02508532|GIST tyrosine kinase inhibitor treatment|gist tyrosine kinase inhibitor treatment
4818867|NCT02508532|GIST TKI|gist tki
4818868|NCT02508532|GIST tyrosine kinase inhibitor|gist tyrosine kinase inhibitor
4818869|NCT02508532|Advanced GIST|advanced gist
4818870|NCT02508532|GIST mutations|gist mutations
4818871|NCT02508532|GIST treatments|gist treatments
4818872|NCT02508532|Blueprint GIST|blueprint gist
4818873|NCT02508532|Relapsed GIST clinical trial|relapsed gist clinical trial
4818874|NCT02508532|Refractory GIST clinical trial|refractory gist clinical trial
4818875|NCT02508532|KIT-mutant GIST|kit-mutant gist
4818876|NCT02508532|cancer gist|cancer gist
4818877|NCT02508532|gastrointestinal stromal tumor|gastrointestinal stromal tumor
4818878|NCT02508532|gist cancer|gist cancer
4818879|NCT02508532|PDGFRA|pdgfra
4818880|NCT02508506|ALKS 5461|alks 5461
4818881|NCT02508506|Alkermes|alkermes
4818882|NCT02508506|Samidorphan|samidorphan
4818883|NCT02508506|Renal Impairment|renal impairment
4818884|NCT02508506|Pharmacokinetics|pharmacokinetics
4818885|NCT02508506|Buprenorphine|buprenorphine
4818886|NCT02508480|Stigma|stigma
4818887|NCT02508480|Community Integration|community integration
4818888|NCT02508467|Liver cancer|liver cancer
4818889|NCT02508467|FGF19 gene amplification|fgf19 gene amplification
4818890|NCT02508467|FGF19 overexpression|fgf19 overexpression
4818891|NCT02508467|FGF19 upregulation|fgf19 upregulation
4818892|NCT02508467|Cyclin D1 (CCND1) gene amplification|cyclin d1 (ccnd1) gene amplification
4818893|NCT02508467|Cyclin D1 (CCND1) copy number gain|cyclin d1 (ccnd1) copy number gain
4818894|NCT02508467|BLU-554|blu-554
4818895|NCT02508467|FGFR4|fgfr4
4818896|NCT02508467|Hepatocellular carcinoma|hepatocellular carcinoma
4818897|NCT02508467|Liver Disease|liver disease
4818898|NCT02508467|Liver Neoplasms|liver neoplasms
4818899|NCT02508454|Prevention|prevention
4818900|NCT02508454|Screening|screening
4818901|NCT02508454|Biobanking|biobanking
4818902|NCT02508441|Neoplasms|neoplasms
4818903|NCT02508441|Solid Tumors|solid tumors
4818904|NCT02508441|Advanced Malignancy|advanced malignancy
4818905|NCT02508441|Cancer|cancer
4818906|NCT02508428|Osteolysis|osteolysis
4818907|NCT02508428|Polyethylene|polyethylene
4818908|NCT02508428|Crosslinked Polyethylene|crosslinked polyethylene
4818909|NCT02508428|Total Hip Replacement|total hip replacement
4818910|NCT02508428|Marathon|marathon
4818911|NCT02508415|obesity|obesity
4818912|NCT02508415|periodontal disease|periodontal disease
4818913|NCT02508415|intervention|intervention
4818914|NCT02508389|squamous cell carcinoma of the head and neck|squamous cell carcinoma of the head and neck
4818915|NCT02508389|oral cavity|oral cavity
4818916|NCT02508389|oropharynx|oropharynx
4818917|NCT02508389|intensity-modulated radiation therapy|intensity-modulated radiation therapy
4818918|NCT02508389|chemotherapy|chemotherapy
4818919|NCT02508389|oral mucositis|oral mucositis
4818920|NCT02508389|superoxide dismutase|superoxide dismutase
4818921|NCT02508389|radioprotection|radioprotection
4818922|NCT02508376|adjuvants|adjuvants
4818923|NCT02508376|AP10-602|ap10-602
4818924|NCT02508376|GLA-SE|gla-se
4818925|NCT02508376|ID93|id93
4818926|NCT02508376|Tuberculosis|tuberculosis
4818927|NCT02508376|vaccine|vaccine
4818928|NCT02508363|Taxi drivers|taxi drivers
4818929|NCT02508363|Health care access|health care access
4818930|NCT02508363|15-163|15-163
4818931|NCT02508311|Tetraplegia|tetraplegia
4818932|NCT02508311|High Paraplegia|high paraplegia
4818933|NCT02508298|ICG|icg
4818934|NCT02508298|ARFI|arfi
4818935|NCT02508298|portal hypertension|portal hypertension
4818936|NCT02508298|cirrhosis|cirrhosis
4818937|NCT02508298|diagnostic study|diagnostic study
4818938|NCT02508272|Transcriptome profiling|transcriptome profiling
4818939|NCT02508259|mitochondria|mitochondria
4818940|NCT02508259|purinergic signaling|purinergic signaling
4818941|NCT02508259|cell danger response|cell danger response
4818942|NCT02508194|RSV|rsv
4818943|NCT02508194|Older adults|older adults
4818944|NCT02508194|MEDI7510|medi7510
4818945|NCT02508194|Vaccine|vaccine
4818946|NCT02508194|Efficacy|efficacy
4818947|NCT02508181|intra ocular pressure|intra ocular pressure
4818948|NCT02508181|I-gel|i-gel
4818949|NCT02508181|LMA Supreme|lma supreme
4818950|NCT02508181|strabismus surgery|strabismus surgery
4818951|NCT02508168|Drug therapy|drug therapy
4818952|NCT02508129|Insomnia|insomnia
4818953|NCT02508129|hypertension|hypertension
4818954|NCT02508129|blood pressure|blood pressure
4818955|NCT02508129|sleep|sleep
4818956|NCT02508129|behavioral treatment|behavioral treatment
4818957|NCT02508129|Cognitive Behavioral Treatment of Insomnia (CBTI)|cognitive behavioral treatment of insomnia (cbti)
4818958|NCT02508129|Brief Behavioral Treatment of Insomnia (BBTI)|brief behavioral treatment of insomnia (bbti)
4818959|NCT02508129|pragmatic trial|pragmatic trial
4818960|NCT02508129|internet|internet
4818961|NCT02508116|pharmacogenetics|pharmacogenetics
4818962|NCT02508116|clopidogrel|clopidogrel
4818963|NCT02508116|genotype|genotype
4818964|NCT02508103|Premenstrual Dysphoric Disorder|premenstrual dysphoric disorder
4818965|NCT02508103|Premenstrual Syndrome|premenstrual syndrome
4818966|NCT02508103|PMS|pms
4818967|NCT02508103|PMDD|pmdd
4818968|NCT02508038|alpha beta depleted|alpha beta depleted
4818969|NCT02508038|alphabeta|alphabeta
4818970|NCT02508038|TCR alpha beta depleted|tcr alpha beta depleted
4818971|NCT02508038|alpha beta|alpha beta
4818972|NCT02508038|haploidentical|haploidentical
4818973|NCT02508038|Zoledronate|zoledronate
4818974|NCT02508038|Zoledronic acid|zoledronic acid
4818975|NCT02508038|Pediatric cancers|pediatric cancers
4818976|NCT02508038|alfa beta|alfa beta
4818977|NCT02508038|αβ T cell depleted HSCT|αβ t cell depleted hsct
4818978|NCT02508038|alpha beta T cell and B cell depleted HSCT|alpha beta t cell and b cell depleted hsct
4818979|NCT02508038|haploidentical HSCT|haploidentical hsct
4818980|NCT02508025|disability evaluation|disability evaluation
4818981|NCT02508025|psychosocial factors|psychosocial factors
4818982|NCT02508012|anti-TNF|anti-tnf
4818983|NCT02508012|Immuno-monitoring|immuno-monitoring
4818984|NCT02508012|Anti-drug antibody (ADAb)|anti-drug antibody (adab)
4818985|NCT02508012|Inflammatory bowel disease (IBD)|inflammatory bowel disease (ibd)
4818986|NCT02508012|Crohn's disease|crohn's disease
4818987|NCT02508012|Ulcerative colitis|ulcerative colitis
4818988|NCT02507973|Mechanical Ventilation|mechanical ventilation
4818989|NCT02507973|Intracranial Pressure|intracranial pressure
4818990|NCT02507973|Airway Pressure Release Ventilation|airway pressure release ventilation
4818991|NCT02507934|Dry Eye|dry eye
4818992|NCT02507908|neuroendocrine tumors|neuroendocrine tumors
4818993|NCT02507908|5-hydroxyindolacetic acid|5-hydroxyindolacetic acid
4818994|NCT02507908|serotonin|serotonin
4818995|NCT02507908|isotope-dilution massa-spectrometer|isotope-dilution massa-spectrometer
4818996|NCT02507895|Stroke|stroke
4818997|NCT02507895|lower extremeties|lower extremeties
4818998|NCT02507895|Brain-computer interface|brain-computer interface
4818999|NCT02507895|Motor imagery|motor imagery
4819000|NCT02507895|Rehabilitation|rehabilitation
4819001|NCT02507895|TMS|tms
4819002|NCT02507843|Vitamin D|vitamin d
4819003|NCT02507817|LIF,Magnesium Sulphate|lif,magnesium sulphate
4819004|NCT02507791|Fitbit|fitbit
4819005|NCT02507791|Obesity|obesity
4819006|NCT02507791|Pediatrics|pediatrics
4819007|NCT02507778|Lung|lung
4819008|NCT02507778|Cancer|cancer
4819009|NCT02507778|Biomarkers|biomarkers
4819010|NCT02507778|Early detection|early detection
4819011|NCT02507778|Circulating tumor cell|circulating tumor cell
4819012|NCT02507765|SBRT|sbrt
4819013|NCT02507713|Amyotrophic lateral sclerosis|amyotrophic lateral sclerosis
4819014|NCT02507713|Ultrasonography|ultrasonography
4819015|NCT02507713|Motor neurons|motor neurons
4819016|NCT02507713|Neuromuscular diseases|neuromuscular diseases
4819017|NCT02507713|Fasciculation|fasciculation
4819018|NCT02507700|nerve block|nerve block
4819019|NCT02507674|appendicitis|appendicitis
4819020|NCT02507674|pediatric|pediatric
4819021|NCT02507674|ultrasound|ultrasound
4819022|NCT02507635|cytokines|cytokines
4819023|NCT02507635|persistent allergic rhinitis|persistent allergic rhinitis
4819024|NCT02507635|H1 antihistamines|h1 antihistamines
4819025|NCT02507583|Brain Tumor|brain tumor
4819026|NCT02507583|Glioma|glioma
4819027|NCT02507583|Newly Diagnosed|newly diagnosed
4819028|NCT02507557|Therapy, Fluid|therapy, fluid
4819029|NCT02507557|Digestive System Surgical Procedures|digestive system surgical procedures
4819030|NCT02507557|Postoperative Complications|postoperative complications
4819031|NCT02507544|Advanced Solid Malignancy|advanced solid malignancy
4819032|NCT02507544|Safety and Tolerability|safety and tolerability
4819033|NCT02507544|Tumor Response|tumor response
4819034|NCT02507544|Hematology|hematology
4819035|NCT02507544|Oncology|oncology
4819036|NCT02507518|lung cancer, PET, progression free survival|lung cancer, pet, progression free survival
4819037|NCT02507492|POMC, LEPR, PCSK1|pomc, lepr, pcsk1
4819038|NCT02507466|locomotion|locomotion
4819039|NCT02507453|volunteers|volunteers
4819040|NCT02507427|Prostate cancer, robot, nerve mapping and monitoring|prostate cancer, robot, nerve mapping and monitoring
4819041|NCT02507414|Mesenteric Traction Syndrome|mesenteric traction syndrome
4819042|NCT02507414|Upper gastrointestinal cancer surgery|upper gastrointestinal cancer surgery
4819043|NCT02507388|AMD|amd
4819044|NCT02507388|nAMD|namd
4819045|NCT02507388|wetAMD|wetamd
4819046|NCT02507388|Age-Related Macular Degeneration|age-related macular degeneration
4819047|NCT02507375|Non-Squamous|non-squamous
4819048|NCT02507362|keratoconus , corneal collagen cross-linking|keratoconus , corneal collagen cross-linking
4819049|NCT02507349|serious mental illness|serious mental illness
4819050|NCT02507349|mental health services research|mental health services research
4819051|NCT02507349|measurement-based care|measurement-based care
4819052|NCT02507349|shared decision making|shared decision making
4819053|NCT02507349|psychiatric medication management|psychiatric medication management
4819054|NCT02507349|community psychiatry|community psychiatry
4819055|NCT02507349|comparative effectiveness research|comparative effectiveness research
4819056|NCT02507349|mixed methods research|mixed methods research
4819057|NCT02507336|Mantle Cell Lymphoma (MCL)|mantle cell lymphoma (mcl)
4819058|NCT02507336|Non-Hodgkin's Lymphoma (NHL)|non-hodgkin's lymphoma (nhl)
4819059|NCT02507258|osteoarthritis|osteoarthritis
4819060|NCT02507258|avascular necrosis|avascular necrosis
4819061|NCT02507258|correction of functional deformity|correction of functional deformity
4819062|NCT02507258|painful hip dysplasia|painful hip dysplasia
4819063|NCT02507258|protrusio acetabuli|protrusio acetabuli
4819064|NCT02507258|rheumatoid arthritis|rheumatoid arthritis
4819065|NCT02507258|ankylosis|ankylosis
4819066|NCT02507245|GHD|ghd
4819067|NCT02507232|glioma|glioma
4819068|NCT02507232|temozolomide|temozolomide
4819069|NCT02507232|brain|brain
4819070|NCT02507232|NovoTTF-200A|novottf-200a
4819071|NCT02507232|cancer|cancer
4819072|NCT02507232|low-grade glioma|low-grade glioma
4819073|NCT02507206|schizotypal personality disorder|schizotypal personality disorder
4819074|NCT02507206|cognitive impairment|cognitive impairment
4819075|NCT02507206|working memory|working memory
4819076|NCT02507206|Dopamine Agonists|dopamine agonists
4819077|NCT02507206|Cognition Disorders|cognition disorders
4819078|NCT02507206|Personality Disorders|personality disorders
4819079|NCT02507206|Delirium|delirium
4819080|NCT02507206|Dementia|dementia
4819081|NCT02507206|Amnestic|amnestic
4819082|NCT02507206|Cognitive Disorders|cognitive disorders
4819083|NCT02507206|Mental Disorders|mental disorders
4819084|NCT02507206|Dihydrexidine|dihydrexidine
4819085|NCT02507206|Dopamine A|dopamine a
4819086|NCT02507180|Clinical Decision Rule|clinical decision rule
4819087|NCT02507180|Ultrasound|ultrasound
4819088|NCT02507180|Suspected Deep Vein Thrombosis|suspected deep vein thrombosis
4819089|NCT02507180|D-Dimer|d-dimer
4819090|NCT02507154|cetuximab|cetuximab
4819091|NCT02507154|NK cells|nk cells
4819092|NCT02507154|nasopharyngeal cancer|nasopharyngeal cancer
4819093|NCT02507154|head and neck squamous cell cancer|head and neck squamous cell cancer
4819094|NCT02507141|Reflectance Confocal Microscopy|reflectance confocal microscopy
4819095|NCT02507141|15-128|15-128
4819096|NCT02507050|Ivabradine|ivabradine
4819097|NCT02507050|Microvascular dysfunction|microvascular dysfunction
4819098|NCT02507050|PCI|pci
4819099|NCT02507050|Procedural related myocardial injury|procedural related myocardial injury
4819100|NCT02507050|IMR|imr
4819101|NCT02507050|Index of Microvascular Resistance|index of microvascular resistance
4819102|NCT02506998|Allergic rhinoconjunctivitis|allergic rhinoconjunctivitis
4819103|NCT02506998|Dialyzable Leukocyte Extracts|dialyzable leukocyte extracts
4819104|NCT02506985|Rivaroxaban|rivaroxaban
4819105|NCT02506985|CDT (Catheter directed thrombolysis)|cdt (catheter directed thrombolysis)
4819106|NCT02506985|PE (pulmonary embolism)|pe (pulmonary embolism)
4819107|NCT02506985|NETs|nets
4819108|NCT02506985|factor Xa|factor xa
4819109|NCT02506972|Blood glucose|blood glucose
4819110|NCT02506972|Humans|humans
4819111|NCT02506972|Postprandial|postprandial
4819112|NCT02506972|Sugar|sugar
4819113|NCT02506972|Carbohydrate|carbohydrate
4819114|NCT02506972|Oat beta-glucan|oat beta-glucan
4819115|NCT02506959|Multiple myeloma (MM)|multiple myeloma (mm)
4819116|NCT02506959|MM|mm
4819117|NCT02506959|Refractory|refractory
4819118|NCT02506959|Relapsed|relapsed
4819119|NCT02506959|Stem Cell Transplant|stem cell transplant
4819120|NCT02506959|Busulfan|busulfan
4819121|NCT02506959|Busulfex|busulfex
4819122|NCT02506959|Myleran|myleran
4819123|NCT02506959|Palifermin|palifermin
4819124|NCT02506959|Kepivance|kepivance
4819125|NCT02506959|Panobinostat|panobinostat
4819126|NCT02506959|LBH589B|lbh589b
4819127|NCT02506959|Gemcitabine|gemcitabine
4819128|NCT02506959|Gemcitabine Hydrochloride|gemcitabine hydrochloride
4819129|NCT02506959|Gemzar|gemzar
4819130|NCT02506959|Melphalan|melphalan
4819131|NCT02506959|Alkeran|alkeran
4819132|NCT02506959|Dexamethasone|dexamethasone
4819133|NCT02506959|Decadron|decadron
4819134|NCT02506959|Pyridoxine|pyridoxine
4819135|NCT02506959|Caphosol|caphosol
4819136|NCT02506959|Glutamine|glutamine
4819137|NCT02506959|Enterex|enterex
4819138|NCT02506959|Glutapak|glutapak
4819139|NCT02506959|NutreStore|nutrestore
4819140|NCT02506959|Resource|resource
4819141|NCT02506959|GlutaSolve|glutasolve
4819142|NCT02506959|Sympt-X|sympt-x
4819143|NCT02506946|Polycystic Ovary Syndrome|polycystic ovary syndrome
4819144|NCT02506946|Non-Alcoholic Fatty Liver Disease|non-alcoholic fatty liver disease
4819145|NCT02506946|Adolescents|adolescents
4819146|NCT02506946|Young Women|young women
4819147|NCT02506946|MRI|mri
4819148|NCT02506946|MRS|mrs
4819149|NCT02506946|DXA|dxa
4819150|NCT02506946|Hirsutism|hirsutism
4819151|NCT02506946|Amenorrhea|amenorrhea
4819152|NCT02506946|Metabolic syndrome|metabolic syndrome
4819153|NCT02506946|Dyslipidemia|dyslipidemia
4819154|NCT02506946|Percentage liver fat|percentage liver fat
4819155|NCT02506920|Postprandial lipemia|postprandial lipemia
4820857|NCT02497378|Bortezomib|bortezomib
4819156|NCT02506920|glycemic response|glycemic response
4819157|NCT02506881|darbepoetin alfa|darbepoetin alfa
4819158|NCT02506881|pharmacokinetics|pharmacokinetics
4819159|NCT02506881|pharmacodynamics|pharmacodynamics
4819160|NCT02506881|healthy volunteers|healthy volunteers
4819161|NCT02506868|darbepoetin alfa|darbepoetin alfa
4819162|NCT02506842|Pancreatic Cancer|pancreatic cancer
4819163|NCT02506842|Pancreatic Adenocarcinoma|pancreatic adenocarcinoma
4819164|NCT02506842|AG|ag
4819165|NCT02506842|OFF|off
4819166|NCT02506842|Second-Line Adjuvant Therapy|second-line adjuvant therapy
4819167|NCT02506829|Inpatients|inpatients
4819168|NCT02506790|Melatonin, metformin, toremifene|melatonin, metformin, toremifene
4819169|NCT02506777|Melatonin, metformin, chemotherapy|melatonin, metformin, chemotherapy
4819170|NCT02506738|telemonitoring|telemonitoring
4819171|NCT02506738|mHealth|mhealth
4819172|NCT02506738|functional status|functional status
4819173|NCT02506738|older people|older people
4819174|NCT02506725|prenatal care|prenatal care
4819175|NCT02506725|pregnancy|pregnancy
4819176|NCT02506725|prematurity|prematurity
4819177|NCT02506673|Audiovisual Aids|audiovisual aids
4819178|NCT02506673|Perioperative Period|perioperative period
4819179|NCT02506673|Anxiety|anxiety
4819180|NCT02506634|symptom|symptom
4819181|NCT02506608|Neuroplasticty, Sensory Feedback|neuroplasticty, sensory feedback
4819182|NCT02506556|Pi3K pathway|pi3k pathway
4819183|NCT02506543|Adolescent Health|adolescent health
4819184|NCT02506543|Ethiopia|ethiopia
4819185|NCT02506543|Sexual Violence|sexual violence
4819186|NCT02506530|lymphedema|lymphedema
4819187|NCT02506530|breast cancer|breast cancer
4819188|NCT02506517|HER pathway aberrations|her pathway aberrations
4819189|NCT02506439|Vitamin D|vitamin d
4819190|NCT02506439|Cholecalciferol|cholecalciferol
4819191|NCT02506439|Dose-response|dose-response
4819192|NCT02506439|Randomized Controlled Trial|randomized controlled trial
4819193|NCT02506439|Pregnancy|pregnancy
4819194|NCT02506439|Cord blood|cord blood
4819195|NCT02506439|Serum 25-hydroxyvitamin D|serum 25-hydroxyvitamin d
4819196|NCT02506439|Vitamin D Deficiency|vitamin d deficiency
4819197|NCT02506439|Nutrition|nutrition
4819198|NCT02506439|Dietary intervention study|dietary intervention study
4819199|NCT02506426|Chronic Sinusitis|chronic sinusitis
4819200|NCT02506426|Chronic Rhinosinusitis|chronic rhinosinusitis
4819201|NCT02506426|Endoscopic sinus surgery|endoscopic sinus surgery
4819202|NCT02506426|Septoplasty|septoplasty
4819203|NCT02506413|Maternal and Newborn Health|maternal and newborn health
4819204|NCT02506361|TOP2α|top2α
4819205|NCT02506361|anthracyclines|anthracyclines
4819206|NCT02506361|taxanes|taxanes
4819207|NCT02506361|non dose-dense chemotherapy|non dose-dense chemotherapy
4819208|NCT02506335|Liver disease|liver disease
4819209|NCT02506335|cardiomyopathy|cardiomyopathy
4819210|NCT02506335|congenital heart disease|congenital heart disease
4819211|NCT02506322|Bipolar I Disorder|bipolar i disorder
4819212|NCT02506322|Bipolar II Disorder|bipolar ii disorder
4819213|NCT02506322|Relapse Prevention|relapse prevention
4819214|NCT02506296|type 2 diabetes|type 2 diabetes
4819215|NCT02506296|endogenous insulin secretion|endogenous insulin secretion
4819216|NCT02506283|cryotherapy|cryotherapy
4819217|NCT02506283|recovery|recovery
4819218|NCT02506283|athletic performance|athletic performance
4819219|NCT02506283|maximum voluntary contraction|maximum voluntary contraction
4819220|NCT02506283|rated perceived exertion|rated perceived exertion
4819221|NCT02506283|delayed onset muscle soreness|delayed onset muscle soreness
4819222|NCT02506283|jump performance|jump performance
4819223|NCT02506244|Atrial Fibrillation|atrial fibrillation
4819224|NCT02506244|Wearable device|wearable device
4819225|NCT02506244|Wristband|wristband
4819226|NCT02506244|ECG Patch|ecg patch
4819227|NCT02506244|Strokes|strokes
4819228|NCT02506244|Asymptomatic|asymptomatic
4819229|NCT02506244|Heart Rhythm|heart rhythm
4819230|NCT02506244|Home Monitoring|home monitoring
4819231|NCT02506231|Allogeneic hematopoietic cell transplantation|allogeneic hematopoietic cell transplantation
4819232|NCT02506231|GVHD prophylaxis|gvhd prophylaxis
4819233|NCT02506231|Methotrexate|methotrexate
4819234|NCT02506231|Folinic acid|folinic acid
4819235|NCT02506231|Leucovorin|leucovorin
4819236|NCT02506231|Mucositis|mucositis
4819237|NCT02506192|Gulf War Illness|gulf war illness
4819238|NCT02506192|Chronic Inflammation|chronic inflammation
4819239|NCT02506192|Delayed-Release Prednisone|delayed-release prednisone
4819240|NCT02506192|Health-Related Quality of Life|health-related quality of life
4819241|NCT02506179|Real-life effect|real-life effect
4819242|NCT02506179|Adalimumab|adalimumab
4819243|NCT02506179|Patient reported outcomes (PRO)|patient reported outcomes (pro)
4819244|NCT02506179|Moderate to severe ulcerative colitis (UC)|moderate to severe ulcerative colitis (uc)
4819245|NCT02506179|Ulcerative colitis (UC)|ulcerative colitis (uc)
4819246|NCT02506166|sleep apnea|sleep apnea
4819247|NCT02506166|sleep disordered breathing|sleep disordered breathing
4819248|NCT02506166|sudden cardiac death|sudden cardiac death
4819249|NCT02506166|heart failure|heart failure
4819250|NCT02506166|ischemic cardiomyopathy|ischemic cardiomyopathy
4819251|NCT02506166|implantable cardioverter-defibrillator (ICD) therapy|implantable cardioverter-defibrillator (icd) therapy
4821664|NCT02493192|pethidine|pethidine
4819252|NCT02506166|cardiac resynchronization therapy (CRT)|cardiac resynchronization therapy (crt)
4819253|NCT02506166|risk stratification|risk stratification
4819254|NCT02506166|positive airway pressure therapy|positive airway pressure therapy
4819255|NCT02506166|SERVE-HF|serve-hf
4819256|NCT02506140|minor stroke|minor stroke
4819257|NCT02506140|transient ischemic attack|transient ischemic attack
4819258|NCT02506140|ticagrelor|ticagrelor
4819259|NCT02506140|clopidogrel|clopidogrel
4819260|NCT02506140|dual anti-platelet therapy|dual anti-platelet therapy
4819261|NCT02506140|platelet reactivity|platelet reactivity
4819262|NCT02506127|TBS, MDD, Sham-controlled, neuromodulation, TMS|tbs, mdd, sham-controlled, neuromodulation, tms
4819263|NCT02506114|prostate|prostate
4819264|NCT02506062|ischemic preconditioning|ischemic preconditioning
4819265|NCT02506062|Raynaud's Phenomenon|raynaud's phenomenon
4819266|NCT02506062|(RP)|(rp)
4819267|NCT02506036|Treatment|treatment
4819268|NCT02506036|Social-Cognitive Training|social-cognitive training
4819269|NCT02506036|Web-based|web-based
4819270|NCT02506036|Right Hemisphere Stroke|right hemisphere stroke
4819271|NCT02506036|Frontotemporal Dementia|frontotemporal dementia
4819272|NCT02506036|Right Sided Cerebral Hemisphere Cerebrovascular Accident|right sided cerebral hemisphere cerebrovascular accident
4819273|NCT02506023|Factor VIII antigen|factor viii antigen
4819274|NCT02506023|von Willebrand factor (vWF) antigen|von willebrand factor (vwf) antigen
4819275|NCT02506023|Mutation type|mutation type
4819276|NCT02506010|Hypoxia|hypoxia
4819277|NCT02505984|oxytocin, bonding|oxytocin, bonding
4819278|NCT02505984|child development|child development
4819279|NCT02505971|hemangioma, propranolol, nadolol|hemangioma, propranolol, nadolol
4819280|NCT02505958|insulin resistance, obesity, caloric intake|insulin resistance, obesity, caloric intake
4819281|NCT02505945|Esophageal Reflux|esophageal reflux
4819282|NCT02505945|Gastric Acid Reflux Disease|gastric acid reflux disease
4819283|NCT02505945|Heartburn|heartburn
4819284|NCT02505932|Shoulder instability|shoulder instability
4819285|NCT02505919|Lower Urinary Tract Symptoms (LUTS)|lower urinary tract symptoms (luts)
4819286|NCT02505906|Late toxicity|late toxicity
4819287|NCT02505906|Simultaneous integrated boost (SIB)|simultaneous integrated boost (sib)
4819288|NCT02505906|Radiotherapy|radiotherapy
4819289|NCT02505880|Hypnosis|hypnosis
4819290|NCT02505880|Pediatric surgery|pediatric surgery
4819291|NCT02505880|Anesthesia|anesthesia
4819292|NCT02505854|Obesity|obesity
4819293|NCT02505854|Probiotic|probiotic
4819294|NCT02505854|Symbiotic|symbiotic
4819295|NCT02505854|Weight loss|weight loss
4819296|NCT02505854|Gut microbiota|gut microbiota
4819297|NCT02505854|Bifidobacterium lactis|bifidobacterium lactis
4819298|NCT02505854|Fructooligosaccharide|fructooligosaccharide
4819299|NCT02505854|Blood sugar|blood sugar
4819300|NCT02505854|Lipemia|lipemia
4819301|NCT02505841|Appendectomy|appendectomy
4819302|NCT02505841|Laparoscopy|laparoscopy
4819303|NCT02505841|pediatric surgery|pediatric surgery
4819304|NCT02505828|Arthritis|arthritis
4819305|NCT02505828|septic|septic
4819306|NCT02505828|Juvenile idiopathic arthritis|juvenile idiopathic arthritis
4819307|NCT02505828|diagnosis|diagnosis
4819308|NCT02505828|proteomic|proteomic
4819309|NCT02505828|cytokine|cytokine
4819310|NCT02505828|monocytes|monocytes
4819311|NCT02505802|Stroke|stroke
4819312|NCT02505802|Botulinum Toxins|botulinum toxins
4819313|NCT02505802|Muscle Spasticity|muscle spasticity
4819314|NCT02505802|Gait|gait
4819315|NCT02505789|Epstein-Barr Virus|epstein-barr virus
4819316|NCT02505789|Post-transplant lymphoproliferative disease (PTLD)|post-transplant lymphoproliferative disease (ptld)
4819317|NCT02505789|Infection|infection
4819318|NCT02505789|Cell Transplants|cell transplants
4819319|NCT02505789|Herpesvirus 4, Human|herpesvirus 4, human
4819320|NCT02505711|Agriculture|agriculture
4819321|NCT02505711|Food|food
4819322|NCT02505711|Micronutrients|micronutrients
4819323|NCT02505711|Pregnancy|pregnancy
4819324|NCT02505711|Infants|infants
4819325|NCT02505711|Women's groups|women's groups
4819326|NCT02505711|Bangladesh|bangladesh
4819327|NCT02505698|Breast Imaging|breast imaging
4819328|NCT02505698|Mammography|mammography
4819329|NCT02505698|Anatomical Imaging|anatomical imaging
4819330|NCT02505685|Lung|lung
4819331|NCT02505685|Cancer|cancer
4819332|NCT02505685|Biomarkers|biomarkers
4819333|NCT02505685|PET-CT|pet-ct
4819334|NCT02505685|Early detection|early detection
4819335|NCT02505672|Vestibular function|vestibular function
4819336|NCT02505672|chemoradiotherapy|chemoradiotherapy
4819337|NCT02505659|Anterior cruciate ligament rupture|anterior cruciate ligament rupture
4819338|NCT02505659|Preoperative re-education|preoperative re-education
4819339|NCT02505659|Knee functional performance|knee functional performance
4819340|NCT02505659|Anterior cruciate ligament surgery|anterior cruciate ligament surgery
4819341|NCT02505659|Single-leg hop for distance test performance|single-leg hop for distance test performance
4819342|NCT02505646|circulatory failure|circulatory failure
4819343|NCT02505646|fluid responsiveness|fluid responsiveness
4819344|NCT02505646|abdominal compression|abdominal compression
4819345|NCT02505633|brachial plexus block|brachial plexus block
4819346|NCT02505633|nerve stimulator|nerve stimulator
4819347|NCT02505633|ultrasound|ultrasound
4819348|NCT02505620|Neurocognitive function|neurocognitive function
4819350|NCT02505594|Obstructive Sleep Apnea|obstructive sleep apnea
4819351|NCT02505594|Vasoreactivity|vasoreactivity
4819352|NCT02505594|Endothelial function|endothelial function
4819353|NCT02505594|Exercise|exercise
4819354|NCT02505581|Postoperative Wound Infection|postoperative wound infection
4819355|NCT02505581|Surgical Wound Infection|surgical wound infection
4819356|NCT02505581|Colorectal Surgery Infection Prophylaxis|colorectal surgery infection prophylaxis
4819357|NCT02505568|Behcet Disease|behcet disease
4819358|NCT02505568|Infliximab|infliximab
4819359|NCT02505568|Adult participants|adult participants
4819360|NCT02505555|feasibility|feasibility
4819361|NCT02505555|accuracy|accuracy
4819362|NCT02505555|tolerability|tolerability
4819363|NCT02505555|four dimensional hysterosalpingo-contrast sonography|four dimensional hysterosalpingo-contrast sonography
4819364|NCT02505542|Axial Spondyloarthritis|axial spondyloarthritis
4819365|NCT02505542|axSpA|axspa
4819366|NCT02505542|Ankylosing Spondylitis|ankylosing spondylitis
4819367|NCT02505542|Anti TNF-alpha|anti tnf-alpha
4819368|NCT02505542|Certolizumab Pegol|certolizumab pegol
4819369|NCT02505542|Remission|remission
4819370|NCT02505542|Spondylarthropathies|spondylarthropathies
4819371|NCT02505542|Arthritis|arthritis
4819372|NCT02505542|Spinal Diseases|spinal diseases
4819373|NCT02505542|Immunosuppressive Agents|immunosuppressive agents
4819374|NCT02505529|Aging|aging
4819375|NCT02505529|Muscle|muscle
4819376|NCT02505529|Weakness|weakness
4819377|NCT02505529|Sarcopenia|sarcopenia
4819378|NCT02505529|Dynapenia|dynapenia
4819379|NCT02505516|pathology|pathology
4819380|NCT02505503|Claudication|claudication
4819381|NCT02505503|Footwear|footwear
4819382|NCT02505503|Shoes|shoes
4819383|NCT02505503|Walking capacity|walking capacity
4819384|NCT02505503|Walking distance|walking distance
4819385|NCT02505490|Lunch|lunch
4819386|NCT02505490|Television|television
4819387|NCT02505490|Macaroni and Cheese|macaroni and cheese
4819388|NCT02505490|Salad tossed in dressing|salad tossed in dressing
4819389|NCT02505477|schiozphrenia|schiozphrenia
4819390|NCT02505477|cognition|cognition
4819391|NCT02505477|negative symptoms|negative symptoms
4819392|NCT02505477|glutamate|glutamate
4819393|NCT02505477|glutathione|glutathione
4819394|NCT02505477|N-acetylcysteine|n-acetylcysteine
4819395|NCT02505451|Metabolic syndrome|metabolic syndrome
4819396|NCT02505451|diabetes|diabetes
4819397|NCT02505451|myocardial function|myocardial function
4819398|NCT02505451|dobutamine|dobutamine
4819399|NCT02505399|Rotational Atherectomy|rotational atherectomy
4819400|NCT02505399|clopidogrel|clopidogrel
4819401|NCT02505399|thrombosis|thrombosis
4819402|NCT02505399|ticagrelor|ticagrelor
4819403|NCT02505386|Ertapenem|ertapenem
4819404|NCT02505386|Subcutaneously|subcutaneously
4819405|NCT02505386|Aged|aged
4819406|NCT02505386|Elderly|elderly
4819407|NCT02505386|Pharmacokinetics|pharmacokinetics
4819408|NCT02505373|Brief Therapy|brief therapy
4819409|NCT02505373|Attempted Suicide|attempted suicide
4819410|NCT02505373|Therapeutic Alliance|therapeutic alliance
4819411|NCT02505373|Suicidal Ideation|suicidal ideation
4819412|NCT02505373|Suicide|suicide
4819413|NCT02505373|ASSIP|assip
4819414|NCT02505321|insulin resistance|insulin resistance
4819415|NCT02505321|physiology|physiology
4819416|NCT02505321|genetics|genetics
4819417|NCT02505321|gene variants|gene variants
4819418|NCT02505321|pathogenesis|pathogenesis
4819419|NCT02505321|type 2 diabetes|type 2 diabetes
4819420|NCT02505321|fat|fat
4819421|NCT02505321|polygenic lipodystrophy|polygenic lipodystrophy
4819422|NCT02505308|insulin|insulin
4819423|NCT02505308|proinsulin|proinsulin
4819424|NCT02505308|genotype|genotype
4819425|NCT02505308|beta cells|beta cells
4819426|NCT02505308|physiology|physiology
4819427|NCT02505308|genetics|genetics
4819428|NCT02505308|pathogenesis|pathogenesis
4819429|NCT02505308|rare variants|rare variants
4819430|NCT02505308|type 2 diabetes|type 2 diabetes
4819431|NCT02505282|Orthostatic hypotension|orthostatic hypotension
4819432|NCT02505282|Vitamin K|vitamin k
4819433|NCT02505269|limited stage|limited stage
4819434|NCT02505269|Hodgkin's disease|hodgkin's disease
4819435|NCT02505269|non-bulky|non-bulky
4819436|NCT02505243|ribavirin|ribavirin
4819437|NCT02505243|direct-acting antivirals|direct-acting antivirals
4819438|NCT02505243|pharmacokinetics|pharmacokinetics
4819439|NCT02505243|therapeutic drug monitoring|therapeutic drug monitoring
4819440|NCT02505217|platelet reactivity, thrombin generation|platelet reactivity, thrombin generation
4819441|NCT02505204|clonidine|clonidine
4819442|NCT02505204|paravertebral block|paravertebral block
4819443|NCT02505204|hemodynamic stability|hemodynamic stability
4819444|NCT02505191|Pharmacokinetics|pharmacokinetics
4819445|NCT02505178|Depression|depression
4819446|NCT02505178|Depressive Disorder|depressive disorder
4819447|NCT02505178|Depressive Disorder, Major|depressive disorder, major
4819448|NCT02505178|Mental Disorders|mental disorders
4819449|NCT02505178|Mood Disorders|mood disorders
4819450|NCT02505178|Behavioural Symptoms|behavioural symptoms
4819451|NCT02505178|Problem Solving Therapy|problem solving therapy
4819452|NCT02505165|Intervention|intervention
4822267|NCT02488954|Probiotics|probiotics
4819453|NCT02505165|Illness Uncertainty|illness uncertainty
4819454|NCT02505165|Childhood Cancer|childhood cancer
4819455|NCT02505165|Solid Tumor|solid tumor
4819456|NCT02505165|Leukemia|leukemia
4819457|NCT02505165|Lymphoma|lymphoma
4819458|NCT02505165|Brain Tumor|brain tumor
4819459|NCT02505165|Randomized clinical trial|randomized clinical trial
4819460|NCT02505165|Parental uncertainty management intervention|parental uncertainty management intervention
4819461|NCT02505165|Parent|parent
4819462|NCT02505165|Oncology|oncology
4819463|NCT02505165|Pediatric|pediatric
4819464|NCT02505152|Hypertension, Portal|hypertension, portal
4819465|NCT02505152|Portal Vein, Cavernous Transformation Of|portal vein, cavernous transformation of
4819466|NCT02505152|Portosystemic shunt|portosystemic shunt
4819467|NCT02505152|Radiology, Interventional|radiology, interventional
4819468|NCT02505139|nasopharyngeal carcinoma|nasopharyngeal carcinoma
4819469|NCT02505139|distant metastasis|distant metastasis
4819470|NCT02505139|circulating tumor cells|circulating tumor cells
4819471|NCT02505139|outcome prediction|outcome prediction
4819472|NCT02505113|Portal Vein, Cavernous Transformation Of|portal vein, cavernous transformation of
4819473|NCT02505113|Hypertension, Portal|hypertension, portal
4819474|NCT02505100|threat of premature birth|threat of premature birth
4819475|NCT02505087|Selenoprotein N-related myopathy|selenoprotein n-related myopathy
4819476|NCT02505087|biomarkers|biomarkers
4819477|NCT02505087|washout|washout
4819478|NCT02505087|N-ACETYLCYSTEINE|n-acetylcysteine
4819479|NCT02505074|mitral valve|mitral valve
4819480|NCT02505074|tricuspid valve|tricuspid valve
4819481|NCT02505074|Melody valve|melody valve
4819482|NCT02505035|Palliative care|palliative care
4819483|NCT02505035|Pragmatic trial|pragmatic trial
4819484|NCT02505022|Cognition|cognition
4819485|NCT02505022|Early mental illness|early mental illness
4819486|NCT02505022|Role functioning|role functioning
4819487|NCT02505009|Therapeutic Uses|therapeutic uses
4819488|NCT02505009|Entecavir|entecavir
4819489|NCT02505009|Tenofovir|tenofovir
4819490|NCT02505009|Engerix-B|engerix-b
4819491|NCT02505009|DNA Virus Infections|dna virus infections
4819492|NCT02505009|Antiviral Agents|antiviral agents
4819493|NCT02505009|Vaccination|vaccination
4819494|NCT02504996|sciatalgia|sciatalgia
4819495|NCT02504996|emergency department|emergency department
4819496|NCT02504996|paracetamol|paracetamol
4819497|NCT02504996|morphine|morphine
4819498|NCT02504983|SNPs|snps
4819499|NCT02504970|Anesthesia|anesthesia
4819500|NCT02504970|Quality Improvement|quality improvement
4819501|NCT02504957|Photodynamic therapy|photodynamic therapy
4819502|NCT02504944|Retinopathy of prematurity|retinopathy of prematurity
4819503|NCT02504944|Propranolol|propranolol
4819504|NCT02504944|Newborn|newborn
4819505|NCT02504944|Eye Drops|eye drops
4819506|NCT02504944|Retinal angiogenesis|retinal angiogenesis
4819507|NCT02504944|Retinal neovascularization|retinal neovascularization
4819508|NCT02504931|PTSD|ptsd
4819509|NCT02504931|Alcohol|alcohol
4819510|NCT02504931|Dual Diagnosis|dual diagnosis
4819511|NCT02504931|Sertraline|sertraline
4819512|NCT02504931|SSRI|ssri
4819513|NCT02504918|Plasmodium Falciparum|plasmodium falciparum
4819514|NCT02504918|Regulatory|regulatory
4819515|NCT02504918|Chemoprevention|chemoprevention
4819516|NCT02504918|Coartem|coartem
4819517|NCT02504918|Parasitemia|parasitemia
4819518|NCT02504905|Parietal Lobe|parietal lobe
4819519|NCT02504905|Plasticity|plasticity
4819520|NCT02504905|Cerebellum|cerebellum
4819521|NCT02504905|Dystonia|dystonia
4819522|NCT02504905|Transcranial Magnetic Stimulation (TMS)|transcranial magnetic stimulation (tms)
4819523|NCT02504892|Overall Response Rate|overall response rate
4819524|NCT02504892|Hereditary Cancer Syndrome|hereditary cancer syndrome
4819525|NCT02504892|mTOR Therapy Naive|mtor therapy naive
4819526|NCT02504879|Osteosclerosis|osteosclerosis
4819527|NCT02504879|Hyperostosis|hyperostosis
4819528|NCT02504866|Aerobic Exercise Training|aerobic exercise training
4819529|NCT02504866|Balance|balance
4819530|NCT02504866|TBI|tbi
4819531|NCT02504853|Eosinophilic Esophagitis|eosinophilic esophagitis
4819532|NCT02504853|Loeys-Dietz Syndrome|loeys-dietz syndrome
4819533|NCT02504853|TGFbeta|tgfbeta
4819534|NCT02504840|Multiple Sclerosis|multiple sclerosis
4819535|NCT02504840|Clinically Isolated Syndrome|clinically isolated syndrome
4819536|NCT02504840|CNS Inflammatory Demyellnation|cns inflammatory demyellnation
4819537|NCT02504840|Radiologically Isolated Syndrome|radiologically isolated syndrome
4819538|NCT02504827|pharmacokinetics|pharmacokinetics
4819539|NCT02504827|ceftazidime/avibactam|ceftazidime/avibactam
4819540|NCT02504814|nasal high flow|nasal high flow
4819541|NCT02504801|primary lung cancer patients|primary lung cancer patients
4819542|NCT02504788|Whole Brain Radiotherapy (WBRT)|whole brain radiotherapy (wbrt)
4819543|NCT02504788|Neurocognitive Functions (NCFs)|neurocognitive functions (ncfs)
4819544|NCT02504788|Hippocampus|hippocampus
4819545|NCT02504788|Hippocampus Sparing during Whole Brain Radiotherapy (HS-WBRT)|hippocampus sparing during whole brain radiotherapy (hs-wbrt)
4819546|NCT02504749|GIT motility|git motility
4819547|NCT02504749|General anaesthesia|general anaesthesia
4819548|NCT02504749|spinal anaesthesia|spinal anaesthesia
4819549|NCT02504736|LDL cholesterol|ldl cholesterol
4819550|NCT02504736|A1c|a1c
4819551|NCT02504736|High risk South Asians|high risk south asians
4819552|NCT02504736|Colesevelam|colesevelam
4819553|NCT02504723|Gastric varices|gastric varices
4819554|NCT02504723|cyanoacrylate|cyanoacrylate
4819555|NCT02504723|carvedilol|carvedilol
4819556|NCT02504710|Musculoskeletal Manipulations|musculoskeletal manipulations
4819557|NCT02504710|Learning|learning
4819558|NCT02504710|Feedback|feedback
4819559|NCT02504710|Kinematics|kinematics
4819560|NCT02504710|Inertial Sensor|inertial sensor
4819561|NCT02504684|varicose veins|varicose veins
4819562|NCT02504684|endovenous laser treatment|endovenous laser treatment
4819563|NCT02504684|endovenous thermal ablation|endovenous thermal ablation
4819564|NCT02504684|saphenous vein|saphenous vein
4819565|NCT02504671|DMARD-IR|dmard-ir
4819566|NCT02504671|GSK3196165|gsk3196165
4819567|NCT02504671|Rheumatoid Arthritis|rheumatoid arthritis
4819568|NCT02504658|adolescents text messages eating exercise self-efficacy diabetes|adolescents text messages eating exercise self-efficacy diabetes
4819569|NCT02504632|platelet activation|platelet activation
4819570|NCT02504632|transcatheter aortic valve implantation|transcatheter aortic valve implantation
4819571|NCT02504593|Quality Assurance|quality assurance
4819572|NCT02504593|Monitoring & Evaluation|monitoring & evaluation
4819573|NCT02504593|Malaria rapid diagnostic test (RDT)|malaria rapid diagnostic test (rdt)
4819574|NCT02504593|Community-based malaria diagnosis|community-based malaria diagnosis
4819575|NCT02504593|Community health workers|community health workers
4819576|NCT02504567|Catheter Ablation|catheter ablation
4819577|NCT02504567|Radiofrequency|radiofrequency
4819578|NCT02504567|Laser|laser
4819579|NCT02504567|Atrial Fibrillation|atrial fibrillation
4819580|NCT02504554|children|children
4819581|NCT02504541|Hypogonadism|hypogonadism
4819582|NCT02504541|Testosterone enanthate|testosterone enanthate
4819583|NCT02504528|asthma|asthma
4819584|NCT02504528|allergy|allergy
4819585|NCT02504528|bronchial hyperresponsiveness|bronchial hyperresponsiveness
4819586|NCT02504528|provocation|provocation
4819587|NCT02504502|Whole Genome Sequencing|whole genome sequencing
4819588|NCT02504502|Laboratory Report|laboratory report
4819589|NCT02504502|Patient Centered|patient centered
4819590|NCT02504502|Communication of Results|communication of results
4819591|NCT02504502|Patient Provider Communication|patient provider communication
4819592|NCT02504476|Schizophrenia or Schizoaffective Disorder|schizophrenia or schizoaffective disorder
4819593|NCT02504463|Alkermes|alkermes
4819594|NCT02504463|Samidorphan|samidorphan
4819595|NCT02504463|ALKS 33|alks 33
4819596|NCT02504463|Healthy Volunteer|healthy volunteer
4819597|NCT02504463|Pharmacokinetics|pharmacokinetics
4819598|NCT02504450|Bipolar 1 disorder|bipolar 1 disorder
4819599|NCT02504450|schizophrenia|schizophrenia
4819600|NCT02504424|Tissue Expansion|tissue expansion
4819601|NCT02504424|Tissue Expander|tissue expander
4819602|NCT02504424|Breast Tissue Expansion|breast tissue expansion
4819603|NCT02504424|Breast Tissue Expander|breast tissue expander
4819604|NCT02504424|Breast Reconstruction|breast reconstruction
4819605|NCT02504424|2 Stage Breast Reconstruction|2 stage breast reconstruction
4819606|NCT02504372|NSCLC|nsclc
4819607|NCT02504372|PDL1|pdl1
4819608|NCT02504372|PD-L1|pd-l1
4819609|NCT02504372|PDL|pdl
4819610|NCT02504359|BEAM|beam
4819611|NCT02504359|allogeneic|allogeneic
4819612|NCT02504359|myeloma|myeloma
4819613|NCT02504359|ixazomib|ixazomib
4819614|NCT02504359|transplant|transplant
4819615|NCT02504359|plasma cell leukemia|plasma cell leukemia
4819616|NCT02504333|metastatic pancreatic adenocarcinoma|metastatic pancreatic adenocarcinoma
4819617|NCT02504333|Nab-paclitaxel|nab-paclitaxel
4819618|NCT02504333|Gemcitabine|gemcitabine
4819619|NCT02504333|modified FOLFOX|modified folfox
4819620|NCT02504320|Drug therapy|drug therapy
4819621|NCT02504255|Crohn disease|crohn disease
4819622|NCT02504255|inflammatory biomarkers|inflammatory biomarkers
4819623|NCT02504255|immunologic markers|immunologic markers
4819624|NCT02504255|calprotectin|calprotectin
4819625|NCT02504216|Rivaroxaban|rivaroxaban
4819626|NCT02504216|Xarelto|xarelto
4819627|NCT02504216|Aspirin|aspirin
4819628|NCT02504216|Acetylic salicylic acid|acetylic salicylic acid
4819629|NCT02504216|Anticoagulant|anticoagulant
4819630|NCT02504216|Peripheral artery disease|peripheral artery disease
4819631|NCT02504216|Peripheral arterial disease|peripheral arterial disease
4819632|NCT02504216|Revascularization|revascularization
4819633|NCT02504216|Acute limb ischemia|acute limb ischemia
4819634|NCT02504216|Amputation|amputation
4819635|NCT02504216|Cardiovascular events|cardiovascular events
4819636|NCT02504190|Lymphoma|lymphoma
4819637|NCT02504190|TEAM conditioning|team conditioning
4819638|NCT02504190|autologous stem cells transplantation|autologous stem cells transplantation
4819639|NCT02504164|midazolam|midazolam
4819640|NCT02504164|satisfaction|satisfaction
4819641|NCT02504164|endoscopic submucosal dissection|endoscopic submucosal dissection
4819642|NCT02504099|Chronic Hepatitis C Infection|chronic hepatitis c infection
4819643|NCT02504099|Early Stage Hepatocellular Carcinoma|early stage hepatocellular carcinoma
4819644|NCT02504073|Clinical Reasoning|clinical reasoning
4819645|NCT02504073|Physiotherapists|physiotherapists
4819646|NCT02504060|diarrhea|diarrhea
4819647|NCT02504060|abdominal pain|abdominal pain
4819648|NCT02504047|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
4819649|NCT02504034|Portal Vein, Cavernous Transformation Of|portal vein, cavernous transformation of
4819650|NCT02504034|Hypertension, Portal|hypertension, portal
4819651|NCT02504034|Radiology, Interventional|radiology, interventional
4819652|NCT02504034|Portalsystemic shunt|portalsystemic shunt
4819653|NCT02504008|bisphosphonate|bisphosphonate
4819654|NCT02504008|CRPS|crps
4819655|NCT02504008|RSD|rsd
4819656|NCT02504008|non-opioid|non-opioid
4819657|NCT02504008|CRPS-1|crps-1
4819658|NCT02504008|acute on chronic pain|acute on chronic pain
4819659|NCT02504008|chronic pain|chronic pain
4819660|NCT02504008|zoledronic acid|zoledronic acid
4819661|NCT02503969|Colorectal Cancer|colorectal cancer
4819662|NCT02503969|Mass Screening|mass screening
4819663|NCT02503969|Uptake|uptake
4819664|NCT02503969|Morbidity|morbidity
4819665|NCT02503969|Mental Health|mental health
4819666|NCT02503943|GLP-1|glp-1
4819667|NCT02503943|Masked hypertension|masked hypertension
4819668|NCT02503943|Lipid metabolism|lipid metabolism
4819669|NCT02503917|Imaging, Ultrasound|imaging, ultrasound
4819670|NCT02503917|Image-guided radiotherapy|image-guided radiotherapy
4819671|NCT02503917|Cancer|cancer
4819672|NCT02503904|Pharmacology|pharmacology
4819673|NCT02503904|Lidocaine|lidocaine
4819674|NCT02503904|Epinephrine|epinephrine
4819675|NCT02503904|Cefazolin|cefazolin
4819676|NCT02503904|Metronidazole|metronidazole
4819677|NCT02503904|Infection|infection
4819678|NCT02503904|prevention|prevention
4819679|NCT02503904|prophylaxis|prophylaxis
4819680|NCT02503904|SSI|ssi
4819681|NCT02503904|Surgery|surgery
4819682|NCT02503904|Complications|complications
4819683|NCT02503865|Metabolic syndrome|metabolic syndrome
4819684|NCT02503865|Diabetes mellitus,|diabetes mellitus,
4819685|NCT02503865|Hypertension|hypertension
4819686|NCT02503865|Overweight|overweight
4819687|NCT02503865|analimentary detoxication|analimentary detoxication
4819688|NCT02503852|Female Pattern Baldness|female pattern baldness
4819689|NCT02503852|Male Pattern Baldness|male pattern baldness
4819690|NCT02503852|Genetic Alopecia|genetic alopecia
4819691|NCT02503852|Androgenic Alopecia|androgenic alopecia
4819692|NCT02503852|Hair Loss|hair loss
4819693|NCT02503839|Host-modulating therapy|host-modulating therapy
4819694|NCT02503839|Vaccine|vaccine
4819695|NCT02503839|Cyclooxygenase inhibitors|cyclooxygenase inhibitors
4819696|NCT02503813|brain death|brain death
4819697|NCT02503813|apnea challenge test|apnea challenge test
4819698|NCT02503787|chronic pain|chronic pain
4819699|NCT02503787|intractable pain|intractable pain
4819700|NCT02503787|failed back surgery syndrome|failed back surgery syndrome
4819701|NCT02503774|Solid Tumors, MEDI9447, oleclumab, MEDI4736, durvalumab, CD73, PD-L1, EGFRm NSCLC, immunotherapy, pancreatic, colorectal|solid tumors, medi9447, oleclumab, medi4736, durvalumab, cd73, pd-l1, egfrm nsclc, immunotherapy, pancreatic, colorectal
4819702|NCT02503761|meropenem|meropenem
4819703|NCT02503761|infusion|infusion
4819704|NCT02503761|late-onset sepsis|late-onset sepsis
4819705|NCT02503761|newborn|newborn
4819706|NCT02503761|management|management
4819707|NCT02503735|CKD|ckd
4819708|NCT02503735|HCV|hcv
4819709|NCT02503696|Inflammatory Bowel Disease|inflammatory bowel disease
4819710|NCT02503696|Cancer|cancer
4819711|NCT02503696|Colorectal Cancer|colorectal cancer
4819712|NCT02503696|Neoplasm|neoplasm
4819713|NCT02503696|Colorectal Neoplasm|colorectal neoplasm
4819714|NCT02503696|Intestinal Neoplasms|intestinal neoplasms
4819715|NCT02503696|Gastrointestinal Neoplasms|gastrointestinal neoplasms
4819716|NCT02503696|Digestive System Neoplasms|digestive system neoplasms
4819717|NCT02503696|Neoplasms by Site|neoplasms by site
4819718|NCT02503696|Neoplasms|neoplasms
4819719|NCT02503696|Digestive System Diseases|digestive system diseases
4819720|NCT02503696|Gastrointestinal Diseases|gastrointestinal diseases
4819721|NCT02503696|Colonic Diseases|colonic diseases
4819722|NCT02503696|Intestinal Diseases|intestinal diseases
4819723|NCT02503696|Rectal Diseases|rectal diseases
4819724|NCT02503683|RNAi therapeutic|rnai therapeutic
4819725|NCT02503683|AAT|aat
4819726|NCT02503683|Alpha-1 Antitrypsin Deficiency|alpha-1 antitrypsin deficiency
4819727|NCT02503657|tipelukast|tipelukast
4819728|NCT02503657|IPF|ipf
4819729|NCT02503657|fibrosis|fibrosis
4819730|NCT02503657|Idiopathic Pulmonary Fibrosis|idiopathic pulmonary fibrosis
4819731|NCT02503644|diffuse cutaneous systemic sclerosis|diffuse cutaneous systemic sclerosis
4819732|NCT02503644|scleroderma|scleroderma
4819733|NCT02503644|IVA337|iva337
4819734|NCT02503644|dcSSc|dcssc
4819735|NCT02503631|Cancer|cancer
4819736|NCT02503631|Colorectal Cancer|colorectal cancer
4819737|NCT02503631|Neoplasm|neoplasm
4819738|NCT02503631|Colorectal Neoplasm|colorectal neoplasm
4819739|NCT02503631|Intestinal Neoplasms|intestinal neoplasms
4819740|NCT02503631|Gastrointestinal Neoplasms|gastrointestinal neoplasms
4819741|NCT02503631|Digestive System Neoplasms|digestive system neoplasms
4819742|NCT02503631|Neoplasms by Site|neoplasms by site
4819743|NCT02503631|Neoplasms|neoplasms
4819744|NCT02503631|Digestive System Diseases|digestive system diseases
4819745|NCT02503631|Gastrointestinal Diseases|gastrointestinal diseases
4819746|NCT02503631|Colonic Diseases|colonic diseases
4822268|NCT02488954|treatments|treatments
4819747|NCT02503631|Intestinal Diseases|intestinal diseases
4819748|NCT02503631|Rectal Diseases|rectal diseases
4819749|NCT02503605|Biosimilar|biosimilar
4819750|NCT02503605|ovarian stimulation|ovarian stimulation
4819751|NCT02503605|oocyte donor|oocyte donor
4819752|NCT02503579|Brain-derived neurotropic factor|brain-derived neurotropic factor
4819753|NCT02503579|Executive function|executive function
4819754|NCT02503566|CAV|cav
4819755|NCT02503566|OCT|oct
4819756|NCT02503566|heart rate|heart rate
4819757|NCT02503566|antibodies|antibodies
4819758|NCT02503553|option grid|option grid
4819759|NCT02503553|neurosurgery|neurosurgery
4819760|NCT02503553|cerebral aneurysm|cerebral aneurysm
4819761|NCT02503540|macular edema|macular edema
4819762|NCT02503540|rvo|rvo
4819763|NCT02503540|diabetic macular edema|diabetic macular edema
4819764|NCT02503527|Enteral nutrition|enteral nutrition
4819765|NCT02503527|Tube feeding|tube feeding
4819766|NCT02503527|Diet, carbohydrate-restricted|diet, carbohydrate-restricted
4819767|NCT02503527|Diabetes|diabetes
4819768|NCT02503527|Aneurysmal Subarachnoid Hemorrhage|aneurysmal subarachnoid hemorrhage
4819769|NCT02503527|Blood glucose|blood glucose
4819770|NCT02503527|Insulin|insulin
4819771|NCT02503501|Memory|memory
4819772|NCT02503501|Insulin glulisine|insulin glulisine
4819773|NCT02503501|Alzheimer's disease|alzheimer's disease
4819774|NCT02503501|Mild Cognitive Impairment|mild cognitive impairment
4819775|NCT02503501|Intranasal insulin|intranasal insulin
4819776|NCT02503501|Cognition Disorders|cognition disorders
4819777|NCT02503488|Appetitive Aggression|appetitive aggression
4819778|NCT02503462|HIV|hiv
4819779|NCT02503462|darunavir|darunavir
4819780|NCT02503462|ritonavir|ritonavir
4819781|NCT02503462|cobicistat|cobicistat
4819782|NCT02503462|CSF|csf
4819783|NCT02503462|pharmacokinetics|pharmacokinetics
4819784|NCT02503449|Pulmonary Cryptococcosis|pulmonary cryptococcosis
4819785|NCT02503436|Ovarian Cancer, Fallopian Tube Cancer, primary peritoneal cancer, BRCA1 Gene, BRCA2 Gene|ovarian cancer, fallopian tube cancer, primary peritoneal cancer, brca1 gene, brca2 gene
4819786|NCT02503423|cervical cancer|cervical cancer
4819787|NCT02503423|HNSCC|hnscc
4819788|NCT02503423|CTCL|ctcl
4819789|NCT02503423|PTCL|ptcl
4819790|NCT02503423|DLBCL|dlbcl
4819791|NCT02503410|back|back
4819792|NCT02503410|pain|pain
4819793|NCT02503345|Kidney Stones|kidney stones
4819794|NCT02503345|Nephrolithiasis|nephrolithiasis
4819795|NCT02503345|Urine Oxalate|urine oxalate
4819796|NCT02503345|Hyperoxaluria|hyperoxaluria
4819797|NCT02503345|Enteric Hyperoxaluria|enteric hyperoxaluria
4819798|NCT02503345|Idiopathic Hyperoxaluria|idiopathic hyperoxaluria
4819799|NCT02503345|Urological Diseases|urological diseases
4819800|NCT02503345|Kidney Diseases|kidney diseases
4819801|NCT02503345|Dietary Oxalate|dietary oxalate
4819802|NCT02503280|Cardiovascular|cardiovascular
4819803|NCT02503280|Secondary|secondary
4819804|NCT02503267|antithrombin III deficiency|antithrombin iii deficiency
4819805|NCT02503267|congenital heart diseases|congenital heart diseases
4819806|NCT02503254|Smoking|smoking
4819807|NCT02503254|Modified risk tobacco product|modified risk tobacco product
4819808|NCT02503254|Conventional cigarette|conventional cigarette
4819809|NCT02503254|Reduced exposure|reduced exposure
4819810|NCT02503254|Confinement|confinement
4819811|NCT02503254|Carbon Heated Tobacco Product|carbon heated tobacco product
4819812|NCT02503215|Hemodialysis|hemodialysis
4819813|NCT02503215|Obstructive sleep apnea|obstructive sleep apnea
4819814|NCT02503215|Compression stockings|compression stockings
4819815|NCT02503189|Dry eye syndromes|dry eye syndromes
4819816|NCT02503189|Corneal diseases|corneal diseases
4819817|NCT02503189|Conjunctival diseases|conjunctival diseases
4819818|NCT02503176|Dry eye syndromes|dry eye syndromes
4819819|NCT02503176|Corneal diseases|corneal diseases
4819820|NCT02503176|Conjunctival diseases|conjunctival diseases
4819821|NCT02503163|Dry eye syndromes|dry eye syndromes
4819822|NCT02503163|Corneal diseases|corneal diseases
4819823|NCT02503163|Conjunctival diseases|conjunctival diseases
4819824|NCT02503150|Colorectal Cancer|colorectal cancer
4819825|NCT02503150|Tumor Therapeutic Vaccine|tumor therapeutic vaccine
4819826|NCT02503150|Dendritic Cell|dendritic cell
4819827|NCT02503137|male pattern baldness|male pattern baldness
4819828|NCT02503137|SM04554|sm04554
4819829|NCT02503137|AGA|aga
4819830|NCT02503111|Men who have sex with men|men who have sex with men
4819831|NCT02503111|Human immunodeficiency virus|human immunodeficiency virus
4819832|NCT02503111|Human papillomavirus|human papillomavirus
4819833|NCT02503111|Anal intraepithelial neoplasia|anal intraepithelial neoplasia
4819834|NCT02503111|Squamous cell carcinoma|squamous cell carcinoma
4819835|NCT02503111|High-resolution anoscopy|high-resolution anoscopy
4819836|NCT02503111|Anal cancer|anal cancer
4819837|NCT02503111|High-risk oncogenic|high-risk oncogenic
4819838|NCT02503111|Intraepithelial lesion|intraepithelial lesion
4819839|NCT02503111|Low-risk non-oncogenic|low-risk non-oncogenic
4819840|NCT02503111|Dysplasia|dysplasia
4819841|NCT02503111|High-grade squamous intraepithelial lesion|high-grade squamous intraepithelial lesion
4819842|NCT02503111|Low-grade squamous intraepithelial lesion|low-grade squamous intraepithelial lesion
4819843|NCT02503111|Ablative therapy|ablative therapy
4819844|NCT02503111|Electrocautery|electrocautery
4819845|NCT02503111|Infrared coagulation|infrared coagulation
4819846|NCT02503111|Active surveillance|active surveillance
4819847|NCT02503098|Eating Disorders|eating disorders
4819848|NCT02503098|Cognitive Behavioral Therapy|cognitive behavioral therapy
4819849|NCT02503098|Mobile Phone|mobile phone
4819850|NCT02503098|Smartphone|smartphone
4819851|NCT02503098|App|app
4819852|NCT02503098|Binge Eating Disorder|binge eating disorder
4819853|NCT02503098|Bulimia Nervosa|bulimia nervosa
4819854|NCT02503098|Signal Detection Analysis|signal detection analysis
4819855|NCT02503085|Ibuprofen|ibuprofen
4819856|NCT02503072|ARV adherence|arv adherence
4819857|NCT02503020|Arachidonic acid|arachidonic acid
4819858|NCT02503020|Omega-6/omega-3 ratio|omega-6/omega-3 ratio
4819859|NCT02503020|Preterm infants nutrition|preterm infants nutrition
4819860|NCT02502981|CKD|ckd
4819861|NCT02502981|left ventricle|left ventricle
4819862|NCT02502981|aldosterone|aldosterone
4819863|NCT02502981|spironolactone|spironolactone
4819864|NCT02502955|Quality Control|quality control
4819865|NCT02502955|Cardiosurgery|cardiosurgery
4819866|NCT02502955|Cardiology|cardiology
4819867|NCT02502955|Vascular Surgery|vascular surgery
4819868|NCT02502955|ICU|icu
4819869|NCT02502942|Obstructive Sleep Apnea|obstructive sleep apnea
4819870|NCT02502942|Exercise|exercise
4819871|NCT02502942|Upper airway muscle|upper airway muscle
4819872|NCT02502929|Diabetes|diabetes
4819873|NCT02502929|Depression|depression
4819874|NCT02502929|Medication therapy management|medication therapy management
4819875|NCT02502929|Community health workers|community health workers
4819876|NCT02502929|Cambodian|cambodian
4819877|NCT02502929|Refugee|refugee
4819878|NCT02502929|Prevention|prevention
4819879|NCT02502890|asthma|asthma
4819880|NCT02502890|nested case-control study|nested case-control study
4819881|NCT02502890|difficult-to-control asthma|difficult-to-control asthma
4819882|NCT02502890|asthma exacerbations|asthma exacerbations
4819883|NCT02502890|cold symptoms|cold symptoms
4819884|NCT02502890|gene expression|gene expression
4819885|NCT02502838|overactive bladder|overactive bladder
4819886|NCT02502838|pelvic organ prolapse|pelvic organ prolapse
4819887|NCT02502838|TVT|tvt
4819888|NCT02502812|bioequivalence|bioequivalence
4819889|NCT02502812|SB224326|sb224326
4819890|NCT02502812|clopidogrel|clopidogrel
4819891|NCT02502812|Relative bioavailability|relative bioavailability
4819892|NCT02502786|Humanized Monoclonal Antibody 3F8 (Hu3F8)|humanized monoclonal antibody 3f8 (hu3f8)
4819893|NCT02502786|Granulocyte-Macrophage Colony Stimulating Factor (GM-CSF)|granulocyte-macrophage colony stimulating factor (gm-csf)
4819894|NCT02502786|15-096|15-096
4819895|NCT02502773|Goal-directed therapy|goal-directed therapy
4819896|NCT02502773|Fluid loading|fluid loading
4819897|NCT02502773|Abdominal surgery|abdominal surgery
4819898|NCT02502773|Postoperative morbidity|postoperative morbidity
4819899|NCT02502773|Postoperative mortality|postoperative mortality
4819900|NCT02502773|Individualized goal-directed fluid therapy|individualized goal-directed fluid therapy
4819901|NCT02502773|Elective or emergency abdominal surgery|elective or emergency abdominal surgery
4819902|NCT02502773|General Anesthesia|general anesthesia
4819903|NCT02502773|Moderate-to-high risk surgical patients|moderate-to-high risk surgical patients
4819904|NCT02502760|Postoperative Complications|postoperative complications
4819905|NCT02502760|Perioperative Care|perioperative care
4819906|NCT02502760|Colorectal Surgery|colorectal surgery
4819907|NCT02502760|Frail Elderly|frail elderly
4819908|NCT02502734|inhaled corticosteroids|inhaled corticosteroids
4819909|NCT02502734|pediatric subjects|pediatric subjects
4819910|NCT02502734|asthma|asthma
4819911|NCT02502734|fluticasone furoate|fluticasone furoate
4819912|NCT02502721|Male|male
4819913|NCT02502708|glioblastoma multiforme|glioblastoma multiforme
4819914|NCT02502708|glioma|glioma
4819915|NCT02502708|gliosarcoma|gliosarcoma
4819916|NCT02502708|malignant brain tumor|malignant brain tumor
4819917|NCT02502708|ependymoma|ependymoma
4819918|NCT02502708|medulloblastoma|medulloblastoma
4819919|NCT02502695|VATS Lobectomy and Segmentectomy for Lung Cancer|vats lobectomy and segmentectomy for lung cancer
4819920|NCT02502695|Lung Cancer|lung cancer
4819921|NCT02502682|Chlorhexidine bathing|chlorhexidine bathing
4819922|NCT02502669|acne|acne
4819923|NCT02502669|nodulocystic|nodulocystic
4819924|NCT02502669|finasteride|finasteride
4819925|NCT02502669|5 alpha reductase inhibitor|5 alpha reductase inhibitor
4819926|NCT02502656|RAS mutation|ras mutation
4819927|NCT02502656|DNA|dna
4819928|NCT02502656|Colorectal Cancer|colorectal cancer
4819929|NCT02502643|Safety and Efficacy|safety and efficacy
4819930|NCT02502643|Thoracic Surgery|thoracic surgery
4819931|NCT02502617|Psychopathology|psychopathology
4819932|NCT02502617|Cognition|cognition
4819933|NCT02502617|Depression|depression
4819934|NCT02502617|Nutrition|nutrition
4819935|NCT02502617|Cortisol|cortisol
4819936|NCT02502617|Anorexia nervosa|anorexia nervosa
4819937|NCT02502604|Cognitive Remediation|cognitive remediation
4819938|NCT02502604|Goal Management Training|goal management training
4819939|NCT02502604|Major Depressive Disorder|major depressive disorder
4819940|NCT02502604|Post-traumatic Stress Disorder|post-traumatic stress disorder
4819941|NCT02502604|Neuropsychological Functioning|neuropsychological functioning
4822865|NCT02485743|satiety|satiety
4819942|NCT02502578|Triglyceride Deposit Cardiomyovasculopathy|triglyceride deposit cardiomyovasculopathy
4819943|NCT02502552|Crohn's Disease|crohn's disease
4819944|NCT02502552|Ulcerative Colitis|ulcerative colitis
4819945|NCT02502552|Inflammatory Bowel Disease|inflammatory bowel disease
4819946|NCT02502552|anti-glycan antibodies|anti-glycan antibodies
4819947|NCT02502552|antibodies stability|antibodies stability
4819948|NCT02502552|mucosal healing|mucosal healing
4819949|NCT02502552|predictive markers|predictive markers
4819950|NCT02502539|Juvenile idiopathic arthritis|juvenile idiopathic arthritis
4819951|NCT02502539|Physical exercise|physical exercise
4819952|NCT02502539|Pro-anti-inflammatory balance|pro-anti-inflammatory balance
4819953|NCT02502539|Interleukins|interleukins
4819954|NCT02502539|miRNA|mirna
4819955|NCT02502539|Calgranulins|calgranulins
4819956|NCT02502487|Analgesia|analgesia
4819957|NCT02502487|Cystoscopy|cystoscopy
4819958|NCT02502487|Dorsal nerve of penis|dorsal nerve of penis
4819959|NCT02502487|Nerve block|nerve block
4819960|NCT02502487|Ropivacaine|ropivacaine
4819961|NCT02502474|staphylococcus aureus|staphylococcus aureus
4819962|NCT02502474|digestive carriage|digestive carriage
4819963|NCT02502474|mucosal colonization|mucosal colonization
4819964|NCT02502448|rotational thromboelastometry|rotational thromboelastometry
4819965|NCT02502448|cardiac surgery|cardiac surgery
4819966|NCT02502448|acute normovolemic hemodilution|acute normovolemic hemodilution
4819967|NCT02502422|Laryngeal mask airway|laryngeal mask airway
4819968|NCT02502409|Hemophilia B|hemophilia b
4819969|NCT02502409|Hemophilia B with Inhibitors|hemophilia b with inhibitors
4819970|NCT02502396|Cancer|cancer
4819971|NCT02502396|Deep-vein thrombosis of the lower and upper extremities|deep-vein thrombosis of the lower and upper extremities
4819972|NCT02502396|Pulmonary embolism|pulmonary embolism
4819973|NCT02502396|Non-valvular atrial fibrillation|non-valvular atrial fibrillation
4819974|NCT02502396|Chart review|chart review
4819975|NCT02502396|VTE|vte
4819976|NCT02502396|NVAF|nvaf
4819977|NCT02502396|Rivaroxaban|rivaroxaban
4819978|NCT02502383|Adolescent|adolescent
4819979|NCT02502383|Overweight|overweight
4819980|NCT02502383|Obesity|obesity
4819981|NCT02502383|Weight loss|weight loss
4819982|NCT02502383|Nutrition|nutrition
4819983|NCT02502383|Physical Activity|physical activity
4819984|NCT02502383|School-based|school-based
4819985|NCT02502383|Primary care|primary care
4819986|NCT02502383|Motivational Interviewing|motivational interviewing
4819987|NCT02502357|pain control|pain control
4819988|NCT02502357|healing statements|healing statements
4819989|NCT02502357|pelvic prolapse|pelvic prolapse
4819990|NCT02502344|insulin resistance|insulin resistance
4819991|NCT02502344|abnormal glucose tolerance|abnormal glucose tolerance
4819992|NCT02502344|DM prevention|dm prevention
4819993|NCT02502331|Oral Cholera Vaccine|oral cholera vaccine
4819994|NCT02502331|immunogenicity|immunogenicity
4819995|NCT02502331|safety|safety
4819996|NCT02502318|Proven or suspected lung cancer treated by lobectomy|proven or suspected lung cancer treated by lobectomy
4819997|NCT02502305|health literacy|health literacy
4819998|NCT02502305|attitude|attitude
4819999|NCT02502305|motivation|motivation
4820000|NCT02502292|Health Literacy|health literacy
4820001|NCT02502292|Health Ageing|health ageing
4820002|NCT02502292|Health Literacy Interventions|health literacy interventions
4820003|NCT02502292|IROHLA|irohla
4820004|NCT02502292|Photo Novel Study|photo novel study
4820006|NCT02502240|Latin American|latin american
4820007|NCT02502227|mindfulness|mindfulness
4820008|NCT02502227|psychological stress|psychological stress
4820009|NCT02502227|wellness programs|wellness programs
4820010|NCT02502227|cortisol|cortisol
4820011|NCT02502214|Preimplantation Genetic Diagnosis|preimplantation genetic diagnosis
4820012|NCT02502214|PGD|pgd
4820013|NCT02502214|Next-Generation Sequencing|next-generation sequencing
4820014|NCT02502214|NGS|ngs
4820015|NCT02502214|Single-Gene disorders|single-gene disorders
4820016|NCT02502214|Cystic Fibrosis|cystic fibrosis
4820017|NCT02502214|CFTR|cftr
4820018|NCT02502214|Single-cell analysis|single-cell analysis
4820019|NCT02502214|PCR|pcr
4820020|NCT02502214|SNP|snp
4820021|NCT02502214|Whole Genome Amplification|whole genome amplification
4820022|NCT02502201|six-minute walk|six-minute walk
4820023|NCT02502188|Healthy Subjects|healthy subjects
4820024|NCT02502188|Severe Plaque Psoriasis|severe plaque psoriasis
4820025|NCT02502188|Moderate|moderate
4820026|NCT02502188|Phase 1|phase 1
4820027|NCT02502188|Safety|safety
4820028|NCT02502188|Tolerability|tolerability
4820029|NCT02502188|CC-90005|cc-90005
4820030|NCT02502175|Opium tincture|opium tincture
4820031|NCT02502175|opium|opium
4820032|NCT02502175|methadone|methadone
4820033|NCT02502175|opioid dependence|opioid dependence
4820034|NCT02502175|opiate dependence|opiate dependence
4820035|NCT02502175|clinical trial|clinical trial
4820036|NCT02502175|Iran|iran
4820037|NCT02502149|rFVIIIFc|rfviiifc
4820038|NCT02502149|Eloctate|eloctate
4820039|NCT02502149|Hemophilia|hemophilia
4820040|NCT02502136|CO2 insufflation|co2 insufflation
4820041|NCT02502110|Atrial Fibrillation|atrial fibrillation
4820042|NCT02502110|statin|statin
4820043|NCT02502110|radiofrequency ablation|radiofrequency ablation
4820044|NCT02502006|Non-steroidal Anti-inflammatory Drugs|non-steroidal anti-inflammatory drugs
4820045|NCT02502006|Healthy volunteers|healthy volunteers
4820046|NCT02502006|Celecoxib|celecoxib
4820047|NCT02502006|Naproxen|naproxen
4820048|NCT02502006|Prostaglandin|prostaglandin
4820049|NCT02502006|Cyclooxygenase|cyclooxygenase
4820050|NCT02501980|Screening|screening
4820051|NCT02501980|Hepatocellular Cancer|hepatocellular cancer
4820052|NCT02501980|Biomarker|biomarker
4820053|NCT02501980|Mortality rate|mortality rate
4820054|NCT02501967|multiple chronic conditions|multiple chronic conditions
4820055|NCT02501941|Ketamine|ketamine
4820056|NCT02501941|Cortical Spreading Depolarization|cortical spreading depolarization
4820057|NCT02501941|Cortical Spreading Depression|cortical spreading depression
4820058|NCT02501928|neurogenic detrusor overactivity|neurogenic detrusor overactivity
4820059|NCT02501928|fesoterodine|fesoterodine
4820060|NCT02501928|Japan|japan
4820061|NCT02501915|Muscle|muscle
4820062|NCT02501902|Ibrance, palbociclib, Abraxane, nab-paclitaxel, pancreas,|ibrance, palbociclib, abraxane, nab-paclitaxel, pancreas,
4820063|NCT02501889|obesity|obesity
4820064|NCT02501889|overweight|overweight
4820065|NCT02501889|weight loss|weight loss
4820066|NCT02501889|satiety|satiety
4820067|NCT02501889|walnuts|walnuts
4820068|NCT02501889|gastrointestinal peptides|gastrointestinal peptides
4820069|NCT02501876|The risk of progession|the risk of progession
4820070|NCT02501876|patients|patients
4820071|NCT02501850|Lipoprotein (a)|lipoprotein (a)
4820072|NCT02501837|Healthy women|healthy women
4820073|NCT02501811|Heart Failure|heart failure
4820074|NCT02501811|Ischemia|ischemia
4820075|NCT02501811|Autologous Stem Cells|autologous stem cells
4820076|NCT02501811|LV dysfunction|lv dysfunction
4820077|NCT02501811|Mesenchymal Stem Cells|mesenchymal stem cells
4820078|NCT02501811|ckit Cardiac Stem Cells|ckit cardiac stem cells
4820079|NCT02501811|Combination Cell Therapy|combination cell therapy
4820080|NCT02501811|LV function|lv function
4820081|NCT02501811|Functional status|functional status
4820082|NCT02501798|ADHD|adhd
4820083|NCT02501798|Methylphenidate|methylphenidate
4820084|NCT02501798|Academic|academic
4820085|NCT02501798|Motivation|motivation
4820086|NCT02501785|Quality of Life|quality of life
4820087|NCT02501785|Patient care givers|patient care givers
4820088|NCT02501785|15-145|15-145
4820089|NCT02501785|Ambulatory Extended Recovery|ambulatory extended recovery
4820090|NCT02501746|Group medical care|group medical care
4820091|NCT02501746|Microfinance|microfinance
4820092|NCT02501746|Hypertension|hypertension
4820093|NCT02501746|Community-based intervention|community-based intervention
4820094|NCT02501746|Global health|global health
4820095|NCT02501733|Total Knee Replacement|total knee replacement
4820096|NCT02501733|Total Knee Arthroplasty|total knee arthroplasty
4820097|NCT02501720|burn|burn
4820098|NCT02501720|hand|hand
4820099|NCT02501720|flexion contracture|flexion contracture
4820100|NCT02501720|tourniquet|tourniquet
4820101|NCT02501720|tumescent technique|tumescent technique
4820102|NCT02501720|children|children
4820103|NCT02501707|echocardiography|echocardiography
4820104|NCT02501707|radiation-induced lung injury|radiation-induced lung injury
4820105|NCT02501707|prognostic|prognostic
4820106|NCT02501707|chemo radiotherapy|chemo radiotherapy
4820107|NCT02501707|non-small cell lung cancer|non-small cell lung cancer
4820108|NCT02501707|NSCLC|nsclc
4820109|NCT02501681|sublingual microcirculation|sublingual microcirculation
4820110|NCT02501681|cardiovascular surgery|cardiovascular surgery
4820111|NCT02501616|SGLT2 inhibitor|sglt2 inhibitor
4820112|NCT02501564|Osteoarthritis|osteoarthritis
4820113|NCT02501564|NAPROXEN SODIUM|naproxen sodium
4820114|NCT02501551|Malignant melanoma|malignant melanoma
4820115|NCT02501551|C-KIT mutation|c-kit mutation
4820116|NCT02501525|renal stone|renal stone
4820117|NCT02501525|retrograde intrarenal surgery|retrograde intrarenal surgery
4820118|NCT02501525|ureteral access sheath|ureteral access sheath
4820119|NCT02501525|pain|pain
4820120|NCT02501512|transesophageal signal|transesophageal signal
4820121|NCT02501512|swallowing|swallowing
4820122|NCT02501512|newborn|newborn
4820123|NCT02501486|adrenal insufficiency|adrenal insufficiency
4820124|NCT02501486|adverse drug reaction|adverse drug reaction
4820125|NCT02501486|corticosteroid|corticosteroid
4820126|NCT02501473|follicular lymphoma|follicular lymphoma
4820127|NCT02501473|fNHL|fnhl
4820128|NCT02501473|low-grade lymphoma|low-grade lymphoma
4820129|NCT02501473|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
4820130|NCT02501473|follicular NHL|follicular nhl
4820131|NCT02501473|Marginal Zone|marginal zone
4820132|NCT02501460|Adult cancer survivors|adult cancer survivors
4820133|NCT02501460|Exercise|exercise
4820134|NCT02501460|Dietary supplementation|dietary supplementation
4820135|NCT02501434|aneurysmal subarachnoid hemorrhage|aneurysmal subarachnoid hemorrhage
4820136|NCT02501434|unfractionated heparin|unfractionated heparin
4820137|NCT02501434|neurobehavioral manifestations|neurobehavioral manifestations
4820138|NCT02501434|delayed ischemic neurological deficits|delayed ischemic neurological deficits
4820139|NCT02501434|cerebral aneurysm|cerebral aneurysm
4820140|NCT02501434|coil embolization|coil embolization
4820141|NCT02501434|Montreal Cognitive Assessment|montreal cognitive assessment
4820142|NCT02501421|vaccine|vaccine
4820143|NCT02501421|influenza vector|influenza vector
4820144|NCT02501421|tuberculosis|tuberculosis
4820145|NCT02501382|Fasciitis|fasciitis
4820146|NCT02501382|Fasciitis, Necrotizing|fasciitis, necrotizing
4820147|NCT02501382|Soft tissue infections|soft tissue infections
4820148|NCT02501382|Fournier's gangrene|fournier's gangrene
4820149|NCT02501382|Immunopathogenesis|immunopathogenesis
4820150|NCT02501356|prebiotic|prebiotic
4820151|NCT02501356|dietary supplement|dietary supplement
4820152|NCT02501343|Glucose metabolism|glucose metabolism
4820153|NCT02501343|Potential renal acid load|potential renal acid load
4820154|NCT02501343|Postprandial glycemia|postprandial glycemia
4820155|NCT02501343|Body acid-base homeostasis|body acid-base homeostasis
4820156|NCT02501343|Sodium bicarbonate|sodium bicarbonate
4820157|NCT02501330|Drug use investigation in Japan|drug use investigation in japan
4820158|NCT02501317|urinary incontinence|urinary incontinence
4820159|NCT02501317|physical therapy|physical therapy
4820160|NCT02501317|rehabilitation|rehabilitation
4820161|NCT02501317|pelvic floor|pelvic floor
4820162|NCT02501317|perineum|perineum
4820163|NCT02501317|conservative treatment|conservative treatment
4820164|NCT02501265|Nicotine addiction|nicotine addiction
4820165|NCT02501265|Cigarette smoking|cigarette smoking
4820166|NCT02501265|Bupropion|bupropion
4820167|NCT02501265|Varenicline|varenicline
4820168|NCT02501265|Adaptive Approach|adaptive approach
4820169|NCT02501265|Nicotine Patch|nicotine patch
4820170|NCT02501265|Chantix|chantix
4820171|NCT02501252|Community|community
4820172|NCT02501252|Skilled birth attendance|skilled birth attendance
4820173|NCT02501252|Rural|rural
4820174|NCT02501252|Ethiopia|ethiopia
4820175|NCT02501226|Psychiatry|psychiatry
4820176|NCT02501226|Depression|depression
4820177|NCT02501226|Psychoeducation|psychoeducation
4820178|NCT02501226|Randomized controlled trial|randomized controlled trial
4820179|NCT02501226|Treatment adherence|treatment adherence
4820180|NCT02501226|Remission|remission
4820181|NCT02501213|Diuretic|diuretic
4820182|NCT02501213|Malignant ascites|malignant ascites
4820183|NCT02501200|Dyslipidemia|dyslipidemia
4820184|NCT02501200|CKD-391|ckd-391
4820185|NCT02501200|Atorvastatin|atorvastatin
4820186|NCT02501200|Ezetimibe|ezetimibe
4820187|NCT02501174|Geriatric oncology|geriatric oncology
4820188|NCT02501148|Embolic protection|embolic protection
4820189|NCT02501148|Carotid artery stenting|carotid artery stenting
4820190|NCT02501135|Femoral nerve blocks|femoral nerve blocks
4820191|NCT02501135|children|children
4820192|NCT02501135|knee and thigh surgery|knee and thigh surgery
4820193|NCT02501122|Quality|quality
4820194|NCT02501122|hospital care|hospital care
4820195|NCT02501122|adenotonsillectomy|adenotonsillectomy
4820196|NCT02501109|Aripiprazole|aripiprazole
4820197|NCT02501109|Oral Soluble Film|oral soluble film
4820198|NCT02501109|Schizophrenia|schizophrenia
4820199|NCT02501096|Lenvatinib|lenvatinib
4820200|NCT02501096|Lenvima|lenvima
4820201|NCT02501096|E7080|e7080
4820202|NCT02501096|Phase 1b/2|phase 1b/2
4820203|NCT02501096|Pembrolizumab|pembrolizumab
4820204|NCT02501096|Solid tumors|solid tumors
4820205|NCT02501083|cardiomyopathy|cardiomyopathy
4820206|NCT02501083|echocardiography|echocardiography
4820207|NCT02501083|prognosis|prognosis
4820208|NCT02501083|respiratory|respiratory
4820209|NCT02501083|home mechanical ventilation|home mechanical ventilation
4820210|NCT02501083|vital capacity|vital capacity
4820211|NCT02501083|maximal inspiratory pressure|maximal inspiratory pressure
4820212|NCT02501083|maximal expiratory pressure|maximal expiratory pressure
4820213|NCT02501070|Percutaneous Coronary Intervention|percutaneous coronary intervention
4820214|NCT02501070|Angioplasty|angioplasty
4820215|NCT02501070|Stent|stent
4820216|NCT02501070|Community Networks|community networks
4820217|NCT02501057|Human Immunodeficiency Virus|human immunodeficiency virus
4820218|NCT02501057|Unsafe Drinking|unsafe drinking
4820219|NCT02501057|Antiretroviral Therapy (ART)|antiretroviral therapy (art)
4820220|NCT02501031|Flaxseed|flaxseed
4820221|NCT02501031|Postmenopause|postmenopause
4820222|NCT02501031|Hormones|hormones
4820223|NCT02501031|Lignans|lignans
4820224|NCT02501031|No Evidence of Disease|no evidence of disease
4820225|NCT02501018|CLI|cli
4820226|NCT02500979|Type 1 Diabetes Mellitus; Pramlintide|type 1 diabetes mellitus; pramlintide
4820227|NCT02500966|Cervical Intraepithelial Neoplasia|cervical intraepithelial neoplasia
4820228|NCT02500966|stenosis|stenosis
4820229|NCT02500966|cervix|cervix
4820230|NCT02500966|medical device|medical device
4820231|NCT02500966|inventories|inventories
4820232|NCT02500966|Uterine Cervix|uterine cervix
4820233|NCT02500966|Intrauterine Devices|intrauterine devices
4820234|NCT02500966|intrauterine|intrauterine
4820235|NCT02500966|conization|conization
4820236|NCT02500966|loop electrosurgical excision|loop electrosurgical excision
4820237|NCT02500953|ASP3325|asp3325
4820238|NCT02500953|pharmacokinetics|pharmacokinetics
4820239|NCT02500953|pharmacodynamics|pharmacodynamics
4820240|NCT02500927|ASP8273|asp8273
4820241|NCT02500927|Non-Small Cell Lung Cancer|non-small cell lung cancer
4820242|NCT02500927|EGFR Tyrosine Kinase Inhibitor|egfr tyrosine kinase inhibitor
4820243|NCT02500927|EGFR Mutation|egfr mutation
4822866|NCT02485743|weight loss|weight loss
4820244|NCT02500914|small cell lung cancer|small cell lung cancer
4820245|NCT02500901|Enzalutamide|enzalutamide
4820246|NCT02500901|Niraparib|niraparib
4820247|NCT02500901|PARP-1 inhibitor|parp-1 inhibitor
4820248|NCT02500901|PARP-2 inhibitor|parp-2 inhibitor
4820249|NCT02500901|Castrate-Resistant Prostate Cancer|castrate-resistant prostate cancer
4820250|NCT02500888|OCD|ocd
4820251|NCT02500888|Neurosurgery|neurosurgery
4820252|NCT02500888|Radiosurgery|radiosurgery
4820253|NCT02500875|Negative-Pressure Wound Therapy|negative-pressure wound therapy
4820254|NCT02500875|Topical Negative Pressure Therapy|topical negative pressure therapy
4820255|NCT02500875|Sodium Hypochlorite|sodium hypochlorite
4820256|NCT02500862|Eye|eye
4820257|NCT02500862|Imaging|imaging
4820258|NCT02500849|Gene therapy|gene therapy
4820259|NCT02500849|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
4820260|NCT02500849|HIV Infections|hiv infections
4820261|NCT02500849|Retroviridae Infections|retroviridae infections
4820262|NCT02500849|RNA Virus Infections|rna virus infections
4820263|NCT02500849|Virus Diseases|virus diseases
4820264|NCT02500849|Sexually Transmitted Diseases, Viral|sexually transmitted diseases, viral
4820265|NCT02500849|Sexually Transmitted Diseases|sexually transmitted diseases
4820266|NCT02500849|Immunologic Deficiency Syndromes|immunologic deficiency syndromes
4820267|NCT02500849|Immune System Diseases|immune system diseases
4820268|NCT02500849|Busulfan|busulfan
4820269|NCT02500849|Pharmacologic Actions|pharmacologic actions
4820270|NCT02500836|Ear|ear
4820271|NCT02500836|Nose|nose
4820272|NCT02500836|Throat|throat
4820273|NCT02500823|Mitochondrial DNA copy number|mitochondrial dna copy number
4820274|NCT02500823|Peripheral blood cells|peripheral blood cells
4820275|NCT02500810|neurotoxicity|neurotoxicity
4820276|NCT02500810|chemotherapy|chemotherapy
4820277|NCT02500810|monosialoganglioside|monosialoganglioside
4820278|NCT02500810|prevention|prevention
4820279|NCT02500758|Surgical scrubbing|surgical scrubbing
4820280|NCT02500758|Chlorhexidine digluconate|chlorhexidine digluconate
4820281|NCT02500758|Parachlorometaxylenol|parachlorometaxylenol
4820282|NCT02500719|Posttraumatic Stress Disorder|posttraumatic stress disorder
4820283|NCT02500719|Neurofeedback|neurofeedback
4820284|NCT02500719|fMRI|fmri
4820285|NCT02500719|Skin Conductance Response|skin conductance response
4820286|NCT02500693|Lung Cancer, Screening, COPD|lung cancer, screening, copd
4820287|NCT02500680|Influenza|influenza
4820288|NCT02500680|Adjuvant|adjuvant
4820289|NCT02500667|N91115|n91115
4820290|NCT02500667|Rifampin|rifampin
4820291|NCT02500667|drug interaction|drug interaction
4820292|NCT02500667|Cavosonstat|cavosonstat
4820293|NCT02500654|Peri-implantitis|peri-implantitis
4820294|NCT02500654|Regenerative therapy|regenerative therapy
4820295|NCT02500654|Surgical therapy|surgical therapy
4820296|NCT02500654|Enamel matrix derivative|enamel matrix derivative
4820297|NCT02500654|Peri-implant microflora|peri-implant microflora
4820298|NCT02500654|Peri-implant fluid|peri-implant fluid
4820299|NCT02500641|Biological Markers|biological markers
4820300|NCT02500641|Cardiovascular disease|cardiovascular disease
4820301|NCT02500641|Humans|humans
4820302|NCT02500641|Pulse Wave Velocity|pulse wave velocity
4820303|NCT02500641|Cardiovascular risk factors|cardiovascular risk factors
4820304|NCT02500641|Allopurinol|allopurinol
4820305|NCT02500641|Pulse Wave Analysis|pulse wave analysis
4820306|NCT02500641|Thiazoles|thiazoles
4820307|NCT02500641|Inflammation|inflammation
4820308|NCT02500641|Uric acid|uric acid
4820309|NCT02500641|Febuxostat|febuxostat
4820310|NCT02500641|Oxidative stress|oxidative stress
4820311|NCT02500641|Tumor Necrosis Factor|tumor necrosis factor
4820312|NCT02500641|Arthritis|arthritis
4820313|NCT02500641|Hyperuricemia|hyperuricemia
4820314|NCT02500628|metformin|metformin
4820315|NCT02500628|mitochondria|mitochondria
4820316|NCT02500628|complex 1|complex 1
4820317|NCT02500628|fibromyalgia|fibromyalgia
4820318|NCT02500628|neurogenic pain|neurogenic pain
4820319|NCT02500628|diabetes|diabetes
4820320|NCT02500628|tardive dyskinesia|tardive dyskinesia
4820321|NCT02500628|heart rate variability|heart rate variability
4820322|NCT02500602|PTSD|ptsd
4820323|NCT02500602|alcohol use disorders|alcohol use disorders
4820324|NCT02500602|posttraumatic stress disorder|posttraumatic stress disorder
4820325|NCT02500602|AUD|aud
4820326|NCT02500602|Veteran|veteran
4820327|NCT02500602|substance use disorders|substance use disorders
4820328|NCT02500602|SUD|sud
4820329|NCT02500589|smoking|smoking
4820330|NCT02500589|tobacco|tobacco
4820331|NCT02500576|Melanoma|melanoma
4820332|NCT02500576|Metastatic|metastatic
4820333|NCT02500576|Cyclophosphamide|cyclophosphamide
4820334|NCT02500576|Cytoxan|cytoxan
4820335|NCT02500576|Neosar|neosar
4820336|NCT02500576|Mesna|mesna
4820337|NCT02500576|Mesnex|mesnex
4820338|NCT02500576|Fludarabine|fludarabine
4820339|NCT02500576|Fludarabine phosphate|fludarabine phosphate
4820340|NCT02500576|MK-3475|mk-3475
4820341|NCT02500576|Keytruda|keytruda
4820342|NCT02500576|Pembrolizumab|pembrolizumab
4820343|NCT02500576|SCH-900475|sch-900475
4820344|NCT02500576|IL-2|il-2
4820345|NCT02500576|Aldesleukin|aldesleukin
4820346|NCT02500576|Interleukin-2|interleukin-2
4820350|NCT02500576|Questionnaires|questionnaires
4820351|NCT02500576|Surveys|surveys
4820352|NCT02500576|Phone calls|phone calls
4820353|NCT02500550|Haploidentical stem cell transplantation|haploidentical stem cell transplantation
4820354|NCT02500550|Graft versus host disease|graft versus host disease
4820355|NCT02500550|Immune reconstitution|immune reconstitution
4820356|NCT02500550|Alloreactive T-cells|alloreactive t-cells
4820357|NCT02500550|Photodynamic treatment|photodynamic treatment
4820358|NCT02500550|Hematologic malignancy|hematologic malignancy
4820359|NCT02500550|Transplant-related mortality|transplant-related mortality
4820360|NCT02500485|SHR3824 SP2086 drug-drug interaction|shr3824 sp2086 drug-drug interaction
4820361|NCT02500472|Tobacco|tobacco
4820362|NCT02500472|Smoking|smoking
4820363|NCT02500459|Topotecan|topotecan
4820364|NCT02500459|Cleveland Multiport Catheter|cleveland multiport catheter
4820365|NCT02500459|Cancer|cancer
4820366|NCT02500433|Cerebral palsy|cerebral palsy
4820367|NCT02500433|child|child
4820368|NCT02500433|rehabilitation|rehabilitation
4820369|NCT02500433|video games|video games
4820370|NCT02500433|virtual reality.|virtual reality.
4820371|NCT02500420|Hypertrophic cardiomyopathy|hypertrophic cardiomyopathy
4820372|NCT02500420|Stress MRI|stress mri
4820373|NCT02500420|Cardiac MRI|cardiac mri
4820374|NCT02500420|Stress echocardiography|stress echocardiography
4820375|NCT02500420|T1 mapping|t1 mapping
4820376|NCT02500420|2D strain|2d strain
4820377|NCT02500394|renal replacement therapy|renal replacement therapy
4820378|NCT02500381|Duchenne muscular dystrophy|duchenne muscular dystrophy
4820379|NCT02500381|Exon Skipping|exon skipping
4820380|NCT02500381|DMD|dmd
4820381|NCT02500381|Exon 53|exon 53
4820382|NCT02500381|Exon 45|exon 45
4820383|NCT02500381|Ambulatory|ambulatory
4820384|NCT02500381|Pediatric|pediatric
4820385|NCT02500342|Thyroid Dysfunction|thyroid dysfunction
4820386|NCT02500342|Fatigue|fatigue
4820387|NCT02500342|Randomized Controlled Trial|randomized controlled trial
4820388|NCT02500342|Thyroxine|thyroxine
4820389|NCT02500342|Hypothyroidism|hypothyroidism
4820390|NCT02500316|Growth hormone deficiency (GHD)|growth hormone deficiency (ghd)
4820391|NCT02500316|r-hGH|r-hgh
4820392|NCT02500316|Long-acting|long-acting
4820393|NCT02500303|Amputation|amputation
4820394|NCT02500290|ACS|acs
4820395|NCT02500277|thoracoscopy|thoracoscopy
4820396|NCT02500277|pleuroscopy|pleuroscopy
4820397|NCT02500277|semirigid thoracoscopy|semirigid thoracoscopy
4820398|NCT02500277|flexible cryoprobe|flexible cryoprobe
4820399|NCT02500277|cryobiopsy|cryobiopsy
4820400|NCT02500277|pleural biopsy|pleural biopsy
4820401|NCT02500251|Transplantation|transplantation
4820402|NCT02500251|belimumab|belimumab
4820403|NCT02500251|Velcade|velcade
4820404|NCT02500225|Etomidate|etomidate
4820405|NCT02500225|Sevoflurane|sevoflurane
4820406|NCT02500199|HER2 positive|her2 positive
4820407|NCT02500173|radiotherapy|radiotherapy
4820408|NCT02500173|side effects|side effects
4820409|NCT02500147|Polycystic Ovary Syndrome|polycystic ovary syndrome
4820410|NCT02500147|Non-Alcoholic Fatty Liver Disease|non-alcoholic fatty liver disease
4820411|NCT02500147|Adolescents|adolescents
4820412|NCT02500147|Young Women|young women
4820413|NCT02500147|MRI|mri
4820414|NCT02500147|MRS|mrs
4820415|NCT02500147|DXA|dxa
4820416|NCT02500147|PNPLA3|pnpla3
4820417|NCT02500147|Metformin|metformin
4820418|NCT02500147|Randomized Clinical Trial|randomized clinical trial
4820419|NCT02500147|Placebo|placebo
4820420|NCT02500147|Hirsutism|hirsutism
4820421|NCT02500147|Acne|acne
4820422|NCT02500147|Amenorrhea|amenorrhea
4820423|NCT02500147|Metabolic Syndrome|metabolic syndrome
4820424|NCT02500147|Dyslipidemia|dyslipidemia
4820425|NCT02500147|Percentage liver fat|percentage liver fat
4820426|NCT02500121|Pembrolizumab|pembrolizumab
4820427|NCT02500121|PD-1 Inhibitor|pd-1 inhibitor
4820428|NCT02500108|Domperidone|domperidone
4820429|NCT02500108|Ventricular Tachyarrhythmia|ventricular tachyarrhythmia
4820430|NCT02500108|Sudden cardiac death|sudden cardiac death
4820431|NCT02500108|Pharmacotherapy|pharmacotherapy
4820432|NCT02500108|Adverse events|adverse events
4820433|NCT02500082|citrate transporter deficiency|citrate transporter deficiency
4820434|NCT02500082|SLC13A5 gene|slc13a5 gene
4820435|NCT02500082|citric acid cycle|citric acid cycle
4820436|NCT02500082|energy metabolism|energy metabolism
4820437|NCT02500056|Inguinal hernia|inguinal hernia
4820438|NCT02500056|Chronic pain|chronic pain
4820439|NCT02500056|Mesh|mesh
4820440|NCT02500056|Lichtenstein hernioplasty|lichtenstein hernioplasty
4820441|NCT02500043|Gastric Cancer|gastric cancer
4820442|NCT02500043|Metastatic Gastric Cancer|metastatic gastric cancer
4820443|NCT02499965|Topical Anesthetic|topical anesthetic
4820444|NCT02499965|Ethyl Chloride|ethyl chloride
4820445|NCT02499965|Pain Reduction|pain reduction
4820446|NCT02499965|IV cannulation|iv cannulation
4820447|NCT02499952|Pembrolizumab|pembrolizumab
4820448|NCT02499952|MK-3475|mk-3475
4820449|NCT02499952|PMNSGCT|pmnsgct
4820450|NCT02499952|PD-L1|pd-l1
4820451|NCT02499952|Non Seminomatous Germ Cell Tumors|non seminomatous germ cell tumors
4820452|NCT02499848|MRI Lesion|mri lesion
4820453|NCT02499848|transperineal injection|transperineal injection
4820454|NCT02499848|prostate biopsies|prostate biopsies
4820455|NCT02499822|Hypertension|hypertension
4820456|NCT02499822|Blood pressure variability|blood pressure variability
4820457|NCT02499822|Home systolic blood pressure|home systolic blood pressure
4820458|NCT02499822|Organ damage|organ damage
4820459|NCT02499822|Nifedipine GITS|nifedipine gits
4820460|NCT02499822|Ramipril|ramipril
4820461|NCT02499809|Vibration therapy|vibration therapy
4820462|NCT02499809|Recovery from exercise|recovery from exercise
4820463|NCT02499796|Invasive mechanical ventilation|invasive mechanical ventilation
4820464|NCT02499796|Humidifying devices|humidifying devices
4820465|NCT02499796|Respiratory mechanics|respiratory mechanics
4820466|NCT02499783|China|china
4820467|NCT02499783|Tumor necrosis factor (TNF)-alpha|tumor necrosis factor (tnf)-alpha
4820468|NCT02499783|Biologic|biologic
4820469|NCT02499770|Small Cell Lung Cancer|small cell lung cancer
4820470|NCT02499770|CDK 4/6 Inhibitor|cdk 4/6 inhibitor
4820471|NCT02499757|Perception|perception
4820472|NCT02499757|brain response|brain response
4820473|NCT02499757|nicotine|nicotine
4820474|NCT02499757|taste|taste
4820475|NCT02499744|NIPPV|nippv
4820476|NCT02499744|HHFNC|hhfnc
4820477|NCT02499744|RDS|rds
4820478|NCT02499744|neonate|neonate
4820479|NCT02499731|physical activity|physical activity
4820480|NCT02499731|nutrition|nutrition
4820481|NCT02499731|social network|social network
4820482|NCT02499718|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
4820483|NCT02499718|Non-invasive positive pressure ventilation|non-invasive positive pressure ventilation
4820484|NCT02499718|quality of life|quality of life
4820485|NCT02499718|long-term oxygen therapy|long-term oxygen therapy
4820486|NCT02499666|Exercise Capacity|exercise capacity
4820487|NCT02499666|Chronic Total Occlusion|chronic total occlusion
4820488|NCT02499653|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
4820489|NCT02499653|Non Invasive Ventilation (NIV)|non invasive ventilation (niv)
4820490|NCT02499653|Acceptance|acceptance
4820491|NCT02499653|Adherence|adherence
4820492|NCT02499653|Clinical Psychology|clinical psychology
4820493|NCT02499640|Recovery of function|recovery of function
4820494|NCT02499640|Autonomic nervous system|autonomic nervous system
4820495|NCT02499640|Heart rate variability|heart rate variability
4820496|NCT02499640|Cryotherapy|cryotherapy
4820497|NCT02499640|Immersion|immersion
4820498|NCT02499627|Lymphoma|lymphoma
4820499|NCT02499627|Hodgkin|hodgkin
4820500|NCT02499627|PTCL|ptcl
4820501|NCT02499627|CD30+|cd30+
4820502|NCT02499614|MET amplification|met amplification
4820503|NCT02499614|ROS1 translocation|ros1 translocation
4820504|NCT02499614|Crizotinib|crizotinib
4820505|NCT02499601|Heart Failure with Preserved Ejection Fraction (HFpEF)|heart failure with preserved ejection fraction (hfpef)
4820506|NCT02499601|Heart Failure (HF)|heart failure (hf)
4820507|NCT02499601|New York Heart Association functional Class (NYHA f. Cl)|new york heart association functional class (nyha f. cl)
4820508|NCT02499575|Exparel|exparel
4820509|NCT02499575|bupivacaine|bupivacaine
4820510|NCT02499575|Hallux valgus deformity|hallux valgus deformity
4820511|NCT02499575|bunionectomy|bunionectomy
4820512|NCT02499536|Atelectasis|atelectasis
4820513|NCT02499536|Postoperative|postoperative
4820514|NCT02499536|Lung ultrasound|lung ultrasound
4820515|NCT02499510|femoropopliteal disease|femoropopliteal disease
4820516|NCT02499510|restenosis|restenosis
4820517|NCT02499497|Prostate Cancer|prostate cancer
4820518|NCT02499432|Evidence Based Psychotherapy|evidence based psychotherapy
4820519|NCT02499432|Implementation|implementation
4820520|NCT02499432|PTSD|ptsd
4820521|NCT02499393|newborn|newborn
4820522|NCT02499393|therapeutic hypothermia|therapeutic hypothermia
4820523|NCT02499393|magnesium sulphate|magnesium sulphate
4820524|NCT02499380|RePneu|repneu
4820525|NCT02499380|Coil|coil
4820526|NCT02499380|LVRC|lvrc
4820527|NCT02499380|PneumRx|pneumrx
4820528|NCT02499367|triple negative|triple negative
4820529|NCT02499367|metastatic|metastatic
4820530|NCT02499341|Tramadol|tramadol
4820531|NCT02499341|Ketamine|ketamine
4820532|NCT02499341|Morphine|morphine
4820533|NCT02499328|Carcinoma of the Head and Neck|carcinoma of the head and neck
4820534|NCT02499276|mechanical ventilation|mechanical ventilation
4820535|NCT02499276|pressure support ventilation|pressure support ventilation
4820536|NCT02499276|NAVA|nava
4820537|NCT02499276|PAV|pav
4820538|NCT02499276|variable ventilation|variable ventilation
4820539|NCT02499276|patient ventilator asynchrony|patient ventilator asynchrony
4820540|NCT02499263|Adalimumab trough level|adalimumab trough level
4820541|NCT02499263|Fecal Calprotectin|fecal calprotectin
4820542|NCT02499263|Fecal microbiota|fecal microbiota
4820543|NCT02499250|refractory angina pectoris|refractory angina pectoris
4820544|NCT02499250|remote ischemic conditioning|remote ischemic conditioning
4820545|NCT02499250|life quality|life quality
4820546|NCT02499250|anxiety|anxiety
4820547|NCT02499250|depression|depression
4820548|NCT02499250|inflammation|inflammation
4820549|NCT02499237|osteoporosis|osteoporosis
4820550|NCT02499237|denosumab|denosumab
4820551|NCT02499237|zoledronic acid|zoledronic acid
4820552|NCT02499237|bone mineral density|bone mineral density
4820553|NCT02499237|bone markers|bone markers
4820554|NCT02499211|obesity|obesity
4820555|NCT02499211|health disparities|health disparities
4820556|NCT02499211|healthy food marketing|healthy food marketing
4820557|NCT02499211|food environments|food environments
4820558|NCT02499211|marketing environments|marketing environments
4820559|NCT02499211|food access|food access
4820560|NCT02499211|food purchase decision making|food purchase decision making
4820561|NCT02499198|Nornicotine|nornicotine
4820562|NCT02499198|Tobacco|tobacco
4820563|NCT02499198|N'-nitrosonornicotine|n'-nitrosonornicotine
4820564|NCT02499198|NNN|nnn
4820565|NCT02499185|Biomarker|biomarker
4820566|NCT02499185|Intra Abdominal Surgery|intra abdominal surgery
4820567|NCT02499185|AKI|aki
4820568|NCT02499172|Adverse pregnancy outcome|adverse pregnancy outcome
4820569|NCT02499159|Exparel|exparel
4820570|NCT02499159|Thoracoscopy|thoracoscopy
4820571|NCT02499159|Bupivicaine|bupivicaine
4820572|NCT02499159|Liposomal|liposomal
4820573|NCT02499146|Palbociclib|palbociclib
4820574|NCT02499146|PD-0332991|pd-0332991
4820575|NCT02499146|pharmacokinetics|pharmacokinetics
4820576|NCT02499146|breast cancer patients|breast cancer patients
4820577|NCT02499146|Chinese|chinese
4820578|NCT02499120|palbociclib, cetuximab, human papillomavirus, squamous cell carcinoma, head and neck cancer|palbociclib, cetuximab, human papillomavirus, squamous cell carcinoma, head and neck cancer
4820579|NCT02499107|food intake|food intake
4820580|NCT02499107|satiety|satiety
4820581|NCT02499107|blood glucose|blood glucose
4820582|NCT02499107|potato|potato
4820583|NCT02499107|insulin|insulin
4820584|NCT02499081|Relapsed|relapsed
4820585|NCT02499081|Refractory|refractory
4820586|NCT02499081|Proteasome Inhibitor|proteasome inhibitor
4820587|NCT02499055|anxiety|anxiety
4820588|NCT02499055|behaviour therapy|behaviour therapy
4820589|NCT02499055|computer assisted therapy|computer assisted therapy
4820590|NCT02499055|psychotherapy|psychotherapy
4820591|NCT02499042|post-resuscitation|post-resuscitation
4820592|NCT02499042|oxygen therapy|oxygen therapy
4820593|NCT02499042|out-of-hospital cardiac arrest|out-of-hospital cardiac arrest
4820594|NCT02499016|Appendicitis|appendicitis
4820595|NCT02499016|Appendectomy|appendectomy
4820596|NCT02499016|Single-incision|single-incision
4820597|NCT02499003|Diffuse large B-cell lymphoma|diffuse large b-cell lymphoma
4820598|NCT02499003|Follicular lymphoma|follicular lymphoma
4820599|NCT02499003|Transformed indolent lymphoma|transformed indolent lymphoma
4820600|NCT02498977|Liver|liver
4820601|NCT02498977|Transplant|transplant
4820602|NCT02498977|Immunosuppression|immunosuppression
4820603|NCT02498964|cardiac anesthesia simulation,NASA task load index|cardiac anesthesia simulation,nasa task load index
4820604|NCT02498938|Pulmonary disease,chronic obstructive,|pulmonary disease,chronic obstructive,
4820605|NCT02498938|generalized chronic periodontitis|generalized chronic periodontitis
4820606|NCT02498938|SERPINA1 gene polymorphism|serpina1 gene polymorphism
4820607|NCT02498912|T Cells|t cells
4820608|NCT02498912|Cyclophosphamide|cyclophosphamide
4820609|NCT02498912|MUC16ecto antigen|muc16ecto antigen
4820610|NCT02498912|Intraperitoneal Infusion|intraperitoneal infusion
4820611|NCT02498912|15-014|15-014
4820612|NCT02498899|Advanced Cancers|advanced cancers
4820613|NCT02498899|Video|video
4820614|NCT02498899|Questionnaires|questionnaires
4820615|NCT02498899|Surveys|surveys
4820616|NCT02498873|VO2Max|vo2max
4820617|NCT02498873|Physical Conditioning|physical conditioning
4820618|NCT02498873|Aerobic Exercise|aerobic exercise
4820619|NCT02498873|Performance|performance
4820620|NCT02498860|adenocarcinoma|adenocarcinoma
4820621|NCT02498860|lung|lung
4820622|NCT02498860|adjuvant chemotherapy|adjuvant chemotherapy
4820623|NCT02498860|pemetrexed|pemetrexed
4820624|NCT02498860|cisplatin|cisplatin
4820625|NCT02498860|surgery|surgery
4820626|NCT02498834|Communication|communication
4820627|NCT02498834|provider|provider
4820628|NCT02498834|caregiver|caregiver
4820629|NCT02498834|adolescent|adolescent
4820630|NCT02498821|PICC|picc
4820631|NCT02498821|central catheter|central catheter
4820632|NCT02498821|vascular access|vascular access
4820633|NCT02498808|Interferon lambda|interferon lambda
4820634|NCT02498808|Interleukin-29|interleukin-29
4820635|NCT02498808|Neutrophil|neutrophil
4820636|NCT02498795|Intratissue Percutaneous Electrolysis|intratissue percutaneous electrolysis
4820637|NCT02498795|Dry needling|dry needling
4820638|NCT02498795|Eccentric exercise|eccentric exercise
4820639|NCT02498795|Patella|patella
4820640|NCT02498782|Chagas Disease|chagas disease
4820641|NCT02498782|Dosage forms|dosage forms
4820642|NCT02498782|Regimens|regimens
4820643|NCT02498769|Cardiac Surgery|cardiac surgery
4820644|NCT02498769|Postoperative Complications|postoperative complications
4820645|NCT02498769|Autonomic Nerve Block|autonomic nerve block
4820646|NCT02498730|bipolar disorder|bipolar disorder
4820647|NCT02498730|VO2max|vo2max
4820648|NCT02498730|aerobic exercise|aerobic exercise
4820649|NCT02498691|endometriosis|endometriosis
4820650|NCT02498691|preterm delivery|preterm delivery
4820651|NCT02498691|caesarean|caesarean
4820652|NCT02498691|Pregnancy outcomes of women with or without endometriosis|pregnancy outcomes of women with or without endometriosis
4820653|NCT02498665|Wilms' Tumor 1|wilms' tumor 1
4820654|NCT02498665|Vaccine|vaccine
4820655|NCT02498665|Neoplasms|neoplasms
4820656|NCT02498639|balloon aortic valvuloplasty|balloon aortic valvuloplasty
4820657|NCT02498639|rapid ventricular pacing|rapid ventricular pacing
4820658|NCT02498639|outcome|outcome
4820659|NCT02498626|mixed venous saturation|mixed venous saturation
4820660|NCT02498626|open heart surgery|open heart surgery
4820661|NCT02498626|children|children
4820662|NCT02498600|Phase II Randomized Trial of Nivolumab with or without Ipilimumab in Patients with Persistent or Recurrent Epithelial Ovarian|phase ii randomized trial of nivolumab with or without ipilimumab in patients with persistent or recurrent epithelial ovarian
4820663|NCT02498600|Primary Peritoneal or Fallopian|primary peritoneal or fallopian
4820664|NCT02498600|Tube Cancer|tube cancer
4820665|NCT02498587|Severe Acute Respiratory Infection|severe acute respiratory infection
4820666|NCT02498496|COPD|copd
4820667|NCT02498496|AECOPD|aecopd
4820668|NCT02498496|Magnesium Sulfate|magnesium sulfate
4820669|NCT02498496|Acute exacerbation of COPD|acute exacerbation of copd
4820670|NCT02498496|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
4820671|NCT02498496|ED|ed
4820672|NCT02498496|ER|er
4820673|NCT02498496|Emergency Department|emergency department
4820674|NCT02498483|Infant|infant
4820675|NCT02498457|maintenance hemodialysis patients|maintenance hemodialysis patients
4820676|NCT02498457|coronary artery calcification|coronary artery calcification
4820677|NCT02498457|low calcium dialysate|low calcium dialysate
4820678|NCT02498457|effects|effects
4820679|NCT02498457|safety|safety
4820680|NCT02498444|Fontan|fontan
4820681|NCT02498444|Treprostinil|treprostinil
4820682|NCT02498444|Remodulin|remodulin
4820683|NCT02498444|Single ventricle|single ventricle
4820684|NCT02498431|irisin|irisin
4820685|NCT02498431|myocardial infarction|myocardial infarction
4820686|NCT02498431|coronary|coronary
4820687|NCT02498392|Major Depressive Disorder|major depressive disorder
4820688|NCT02498392|Depression|depression
4820689|NCT02498392|Anxiety symptoms|anxiety symptoms
4820690|NCT02498392|JNJ-42165279|jnj-42165279
4820691|NCT02498379|novel radiotracer|novel radiotracer
4820692|NCT02498379|biodistribution|biodistribution
4820693|NCT02498379|safety|safety
4820694|NCT02498340|G6PD|g6pd
4820695|NCT02498340|genotype|genotype
4820696|NCT02498340|phenotype|phenotype
4820697|NCT02498340|diet restriction|diet restriction
4820698|NCT02498327|Chronic|chronic
4820699|NCT02498314|Manual therapy|manual therapy
4820700|NCT02498314|Hip osteoarthritis|hip osteoarthritis
4820701|NCT02498314|Mobilization|mobilization
4820702|NCT02498301|travelers' diarrhea|travelers' diarrhea
4820703|NCT02498301|military|military
4820704|NCT02498301|enteric illness|enteric illness
4820705|NCT02498301|gastrointestinal|gastrointestinal
4820706|NCT02498288|capsule|capsule
4820707|NCT02498288|Isotretinoin|isotretinoin
4820708|NCT02498288|Bioequivalence|bioequivalence
4820709|NCT02498262|Severe Mobility and Manipulation Impairments|severe mobility and manipulation impairments
4820710|NCT02498249|Low-Level Laser Therapy|low-level laser therapy
4820711|NCT02498249|trapezius muscle|trapezius muscle
4820712|NCT02498249|neck pain|neck pain
4820713|NCT02498236|Psychosis|psychosis
4820714|NCT02498236|Schizophrenia|schizophrenia
4820715|NCT02498236|Oxytocin|oxytocin
4820716|NCT02498210|IVM|ivm
4820717|NCT02498210|HIPPO signaling|hippo signaling
4820718|NCT02498171|Labour analgesia|labour analgesia
4820719|NCT02498171|Intrathecal morphine|intrathecal morphine
4820720|NCT02498171|Bupivacaine|bupivacaine
4820721|NCT02498171|Fentanyl|fentanyl
4820722|NCT02498132|Mobile Technologies|mobile technologies
4820723|NCT02498119|Type 2 DM|type 2 dm
4820724|NCT02498119|lipid bodies|lipid bodies
4820725|NCT02498106|nutrition|nutrition
4820726|NCT02498106|aggression|aggression
4820727|NCT02498106|n-3 fatty acids|n-3 fatty acids
4820728|NCT02498106|psychiatry|psychiatry
4820729|NCT02498106|inpatients admitted >2 years|inpatients admitted >2 years
4820730|NCT02498093|Resistance training|resistance training
4820731|NCT02498093|Arthroplasty, Replacement, Hip|arthroplasty, replacement, hip
4820732|NCT02498093|Professional-Patient Relations|professional-patient relations
4820733|NCT02498093|Evidence-based practice|evidence-based practice
4820734|NCT02498080|Drug eluting balloons|drug eluting balloons
4820735|NCT02498080|Critical limb ischemia|critical limb ischemia
4820736|NCT02498080|Infra-popliteal arteries|infra-popliteal arteries
4820737|NCT02498080|Percutaneous transluminal angioplasty|percutaneous transluminal angioplasty
4820738|NCT02498041|Ultrathin Nasal Endoscopy|ultrathin nasal endoscopy
4820739|NCT02498041|Barrett's Esophagus|barrett's esophagus
4820740|NCT02498041|Transnasal Endoscopy|transnasal endoscopy
4820741|NCT02498028|cervical fusion|cervical fusion
4820742|NCT02498028|cervical arthroplasty|cervical arthroplasty
4820743|NCT02498028|cervicobrachial pain|cervicobrachial pain
4820744|NCT02498002|Diet|diet
4820745|NCT02498002|Fasting|fasting
4820746|NCT02498002|Intermittent Fasting|intermittent fasting
4820747|NCT02498002|Alternate-day Fasting|alternate-day fasting
4820748|NCT02498002|Physical Activity|physical activity
4820749|NCT02498002|Glucose|glucose
4820750|NCT02498002|Insulin|insulin
4820751|NCT02498002|Appetite|appetite
4820752|NCT02497989|Male circumcision|male circumcision
4820753|NCT02497989|Demand creation|demand creation
4820754|NCT02497976|Interstitial|interstitial
4820755|NCT02497976|Cystitis|cystitis
4820756|NCT02497976|Bladder|bladder
4820757|NCT02497976|Pain|pain
4820758|NCT02497950|HeartMate 3|heartmate 3
4820759|NCT02497950|LVAS|lvas
4820760|NCT02497950|LVAD|lvad
4820761|NCT02497950|Heart-assist devices|heart-assist devices
4820762|NCT02497950|Thoratec Corporation|thoratec corporation
4820763|NCT02497937|GSK2798745|gsk2798745
4820764|NCT02497937|TRPV4 Channel Blocker|trpv4 channel blocker
4820765|NCT02497937|Pharmacodynamics|pharmacodynamics
4820766|NCT02497937|Adults|adults
4820767|NCT02497937|Congestive Heart Failure|congestive heart failure
4820768|NCT02497911|Adductor Canal Catheter|adductor canal catheter
4820769|NCT02497911|Intraarticular Catheter|intraarticular catheter
4820770|NCT02497911|Arthroplasty, Replacement, Knee|arthroplasty, replacement, knee
4820771|NCT02497885|MERS|mers
4820772|NCT02497885|healthcare personnel|healthcare personnel
4820773|NCT02497859|Weight Reduction|weight reduction
4820774|NCT02497859|Weight Loss Diet|weight loss diet
4820775|NCT02497859|Satiety Response|satiety response
4820776|NCT02497859|Insulin|insulin
4820777|NCT02497859|Glucagon-Like Peptide 1|glucagon-like peptide 1
4820778|NCT02497859|PYY (3-36) peptide|pyy (3-36) peptide
4820779|NCT02497859|Ghrelin|ghrelin
4820780|NCT02497859|Glucose|glucose
4820781|NCT02497859|Eggs|eggs
4820782|NCT02497859|Protein|protein
4820783|NCT02497859|Energy Intake|energy intake
4820784|NCT02497859|Breakfast|breakfast
4820785|NCT02497846|Hyaluronic acid|hyaluronic acid
4820786|NCT02497846|MiconJet needle|miconjet needle
4820787|NCT02497807|Tourette syndrome|tourette syndrome
4820788|NCT02497807|Iron deficiency|iron deficiency
4820789|NCT02497794|chew gum|chew gum
4820790|NCT02497794|bowel movements|bowel movements
4820791|NCT02497794|cesarean section|cesarean section
4820792|NCT02497781|Complicated urinary tract infections (cUTIs)|complicated urinary tract infections (cutis)
4820793|NCT02497768|mastication|mastication
4820794|NCT02497768|pistachios|pistachios
4820795|NCT02497768|brazils|brazils
4820796|NCT02497768|participants|participants
4820797|NCT02497729|Endotracheal Intubation|endotracheal intubation
4820798|NCT02497729|Checklist|checklist
4820799|NCT02497729|Positioning|positioning
4820800|NCT02497690|Cochlear Implant|cochlear implant
4820801|NCT02497690|Hearing Aid|hearing aid
4820802|NCT02497690|Telemedicine|telemedicine
4820803|NCT02497677|parental sensitivity|parental sensitivity
4820804|NCT02497677|child attachment|child attachment
4820805|NCT02497664|Radiotherapy|radiotherapy
4820806|NCT02497664|Active Breathing Control Technique|active breathing control technique
4820807|NCT02497651|Smoking|smoking
4820808|NCT02497651|Diabetes|diabetes
4820809|NCT02497651|Incretin hormones|incretin hormones
4820810|NCT02497651|Glucose tolerance|glucose tolerance
4820811|NCT02497638|metformin|metformin
4820812|NCT02497638|atorvastatin|atorvastatin
4820813|NCT02497638|prostate-specific antigen|prostate-specific antigen
4820814|NCT02497638|biochemical recurrence|biochemical recurrence
4820815|NCT02497625|Low back pain|low back pain
4820816|NCT02497625|Empathy|empathy
4820817|NCT02497625|Subgroups|subgroups
4820818|NCT02497625|Minimal intervention|minimal intervention
4820819|NCT02497547|Atrophy|atrophy
4820820|NCT02497547|Pathological Conditions, Anatomical|pathological conditions, anatomical
4820821|NCT02497547|Oxytocin|oxytocin
4820822|NCT02497547|Oxytocics|oxytocics
4820823|NCT02497534|ataxia|ataxia
4820824|NCT02497534|neuromuscular|neuromuscular
4820825|NCT02497521|polycystic kidney disease|polycystic kidney disease
4820826|NCT02497521|autosomal dominant polycystic kidney disease|autosomal dominant polycystic kidney disease
4820827|NCT02497521|ADPKD|adpkd
4820828|NCT02497521|Tolvaptan|tolvaptan
4820829|NCT02497521|Jinarc|jinarc
4820830|NCT02497508|progressive disease after at least 1 course of chemotherapy|progressive disease after at least 1 course of chemotherapy
4820831|NCT02497495|Immersion|immersion
4820832|NCT02497495|Recovery of Function|recovery of function
4820833|NCT02497495|Lactate|lactate
4820834|NCT02497495|Creatine Kinase|creatine kinase
4820835|NCT02497495|Musculoskeletal Pain|musculoskeletal pain
4820836|NCT02497469|Drug Therapy|drug therapy
4820837|NCT02497456|HIV|hiv
4820838|NCT02497456|Counselling|counselling
4820839|NCT02497456|Care|care
4820840|NCT02497456|antiretroviral therapy|antiretroviral therapy
4820841|NCT02497456|linkage|linkage
4820842|NCT02497456|Uganda|uganda
4820843|NCT02497456|Africa|africa
4820844|NCT02497443|drug-resistant symptomatic epilepsy|drug-resistant symptomatic epilepsy
4820845|NCT02497443|seizure|seizure
4820846|NCT02497443|autologous mesenchymal stem cells|autologous mesenchymal stem cells
4820847|NCT02497443|safety|safety
4820848|NCT02497443|remission|remission
4820849|NCT02497443|electroencephalography|electroencephalography
4820850|NCT02497443|refractory symptomatic epilepsy|refractory symptomatic epilepsy
4820851|NCT02497443|autologous MSC|autologous msc
4820852|NCT02497443|efficacy|efficacy
4820853|NCT02497417|ARIES Clostridium difficile|aries clostridium difficile
4820854|NCT02497378|Multiple Myeloma|multiple myeloma
4820855|NCT02497378|Daratumumab|daratumumab
4820856|NCT02497378|JNJ-54767414|jnj-54767414
4820858|NCT02497378|Dexamethasone|dexamethasone
4820859|NCT02497365|keratits|keratits
4820860|NCT02497365|besifloxacin|besifloxacin
4820861|NCT02497339|Smoking cessation interventions|smoking cessation interventions
4820862|NCT02497339|mindfulness training|mindfulness training
4820863|NCT02497326|second degree burns|second degree burns
4820864|NCT02497326|heparin|heparin
4820865|NCT02497326|topical|topical
4820866|NCT02497300|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists
4820867|NCT02497300|Mineralocorticoid Effects|mineralocorticoid effects
4820868|NCT02497287|Treatment-resistant Depression|treatment-resistant depression
4820869|NCT02497287|Esketamine|esketamine
4820870|NCT02497287|Oral Antidepressant|oral antidepressant
4820871|NCT02497274|bariatric surgery|bariatric surgery
4820872|NCT02497274|taste perception|taste perception
4820873|NCT02497274|lipid receptors|lipid receptors
4820874|NCT02497261|Food Allergy|food allergy
4820875|NCT02497261|Peanut|peanut
4820876|NCT02497261|Sensitization|sensitization
4820877|NCT02497261|Child|child
4820878|NCT02497261|Double-blind placebo-controlled challenge|double-blind placebo-controlled challenge
4820879|NCT02497261|Prospective cohort|prospective cohort
4820880|NCT02497248|Atrial Fibrillation|atrial fibrillation
4820881|NCT02497248|Pulmonary Vein Ablation|pulmonary vein ablation
4820882|NCT02497248|Mitral stenosis|mitral stenosis
4820883|NCT02497248|Body surface mapping|body surface mapping
4820884|NCT02497235|Drug therapy, Positron Emission Tomography, Brain enzyme occupancy, Cholesterol 24S-hydroxylase, CH24H|drug therapy, positron emission tomography, brain enzyme occupancy, cholesterol 24s-hydroxylase, ch24h
4820885|NCT02497196|TPCS|tpcs
4820886|NCT02497196|tDCS|tdcs
4820887|NCT02497196|visceral pain|visceral pain
4820888|NCT02497196|pancreatitis|pancreatitis
4820889|NCT02497196|healthy subjects|healthy subjects
4820890|NCT02497196|pelvic pain|pelvic pain
4820891|NCT02497196|neuromodulation|neuromodulation
4820892|NCT02497196|non-invasive brain stimulation|non-invasive brain stimulation
4820893|NCT02497157|bevacizumab|bevacizumab
4820894|NCT02497157|oxaliplatin|oxaliplatin
4820895|NCT02497157|irinotecan|irinotecan
4820896|NCT02497157|hydrochloride hydrate|hydrochloride hydrate
4820897|NCT02497157|fluorouracil|fluorouracil
4820898|NCT02497157|levofolinate calcium|levofolinate calcium
4820899|NCT02497144|interstitial lung disease|interstitial lung disease
4820900|NCT02497144|neuromuscular electrical stimulation|neuromuscular electrical stimulation
4820901|NCT02497144|exercise capacity|exercise capacity
4820902|NCT02497144|quality of life|quality of life
4820903|NCT02497131|PTCL|ptcl
4820904|NCT02497131|CD30+|cd30+
4820905|NCT02497118|lung cancer Anti angiogenesis therapy survival|lung cancer anti angiogenesis therapy survival
4820906|NCT02497105|Epilepsy|epilepsy
4820907|NCT02497105|Intractable Seizures|intractable seizures
4820908|NCT02497105|Ketogenic Diet|ketogenic diet
4820909|NCT02497105|Biochemical Profiles|biochemical profiles
4820910|NCT02497079|Bronchoscopy|bronchoscopy
4820911|NCT02497079|Ultrasonography|ultrasonography
4820912|NCT02497079|Tuberculous lymphadenitis|tuberculous lymphadenitis
4820913|NCT02497079|Polymerase chain reaction|polymerase chain reaction
4820914|NCT02497079|Sensitivity and specificity|sensitivity and specificity
4820915|NCT02497066|topical|topical
4820916|NCT02497066|compound|compound
4820917|NCT02497066|pain|pain
4820918|NCT02497053|MPM|mpm
4820919|NCT02497040|anaesthesia|anaesthesia
4820920|NCT02497040|local anaesthesia|local anaesthesia
4820921|NCT02497040|hemodynamics|hemodynamics
4820922|NCT02497040|bupivacaine|bupivacaine
4820923|NCT02497040|levobupivacaine|levobupivacaine
4820924|NCT02497027|pharmacogenetic, pharmacogenomic, depressive, mental health|pharmacogenetic, pharmacogenomic, depressive, mental health
4820925|NCT02496988|Cytokine-Induced Killer Cells|cytokine-induced killer cells
4820926|NCT02496988|Milignant Gliomas|milignant gliomas
4820927|NCT02496988|Temozolomide|temozolomide
4820928|NCT02496962|sleep deprivation|sleep deprivation
4820929|NCT02496936|Energy Expenditure|energy expenditure
4820930|NCT02496936|Appetite|appetite
4820931|NCT02496936|Satiety|satiety
4820932|NCT02496923|prophylactic NHFO|prophylactic nhfo
4820933|NCT02496923|risk of developing postoperative pulmonary complications|risk of developing postoperative pulmonary complications
4820934|NCT02496923|reduces hospital length of stay|reduces hospital length of stay
4820935|NCT02496884|chronic kidney disease|chronic kidney disease
4820936|NCT02496884|. α2δ ligands|. α2δ ligands
4820937|NCT02496884|mirogabalin|mirogabalin
4820938|NCT02496884|pain relief|pain relief
4820939|NCT02496884|kidney metabolism|kidney metabolism
4820940|NCT02496858|Young Patient|young patient
4820941|NCT02496858|Genetic Characteristics|genetic characteristics
4820942|NCT02496832|Hypoxia|hypoxia
4820943|NCT02496832|18F-FAZA|18f-faza
4820944|NCT02496832|18F-Fluoroazomycin arabinoside|18f-fluoroazomycin arabinoside
4820945|NCT02496832|Positron emission tomography|positron emission tomography
4820946|NCT02496832|PET|pet
4820947|NCT02496832|Participating in study EMR200592-001|participating in study emr200592-001
4820948|NCT02496819|Children|children
4820949|NCT02496806|Polyphenols|polyphenols
4820950|NCT02496806|Absorption|absorption
4820951|NCT02496806|Metabolism|metabolism
4820952|NCT02496806|Phlorotannins|phlorotannins
4820953|NCT02496806|Seaweeds|seaweeds
4820954|NCT02496767|fast skeletal troponin activator|fast skeletal troponin activator
4820955|NCT02496767|tirasemtiv|tirasemtiv
4820956|NCT02496767|CK-2017357|ck-2017357
4820957|NCT02496767|double-blind|double-blind
4820958|NCT02496767|randomized|randomized
4820959|NCT02496767|placebo-controlled|placebo-controlled
4820960|NCT02496741|isocitrate dehydrogenase 1/2 mutation|isocitrate dehydrogenase 1/2 mutation
4820961|NCT02496741|metformin|metformin
4820962|NCT02496741|chloroquine|chloroquine
4820963|NCT02496728|Mobile Health|mobile health
4820964|NCT02496728|Smartphone|smartphone
4820965|NCT02496728|Cardiovascular health|cardiovascular health
4820966|NCT02496728|College students|college students
4820967|NCT02496728|Smoking|smoking
4820968|NCT02496728|Physical activity|physical activity
4820969|NCT02496728|Diet|diet
4820970|NCT02496728|BMI|bmi
4820971|NCT02496728|Blood pressure|blood pressure
4820972|NCT02496728|Cholesterol|cholesterol
4820973|NCT02496728|Glucose|glucose
4820974|NCT02496728|Text|text
4820975|NCT02496728|Facebook|facebook
4820976|NCT02496728|Instagram|instagram
4820977|NCT02496728|Push Notifications|push notifications
4820978|NCT02496728|Ecological Momentary Assessment|ecological momentary assessment
4820979|NCT02496702|exergaming|exergaming
4820980|NCT02496702|Senior Fitness Test|senior fitness test
4820981|NCT02496689|HPP|hpp
4820982|NCT02496689|Bone Disease|bone disease
4820983|NCT02496689|Soft Bones|soft bones
4820984|NCT02496689|Low Alkaline Phosphatase|low alkaline phosphatase
4820985|NCT02496689|genetic metabolic disorder|genetic metabolic disorder
4820986|NCT02496689|alkaline phosphatase|alkaline phosphatase
4820987|NCT02496689|rickets|rickets
4820988|NCT02496689|osteomalacia|osteomalacia
4820989|NCT02496676|Lymphoma|lymphoma
4820990|NCT02496676|Epstein-Barr Virus|epstein-barr virus
4820991|NCT02496676|Immunodeficiency|immunodeficiency
4820992|NCT02496676|MAGT1 Gene|magt1 gene
4820993|NCT02496676|Intracellular Magnesium|intracellular magnesium
4820994|NCT02496650|alcohol withdrawal state|alcohol withdrawal state
4820995|NCT02496650|dexmedetomidine|dexmedetomidine
4820996|NCT02496650|benzodiasepines|benzodiasepines
4820997|NCT02496650|intensive care|intensive care
4820999|NCT02496637|Eating Disorders|eating disorders
4821000|NCT02496637|Appetite regulation|appetite regulation
4821001|NCT02496637|Eating Regulation|eating regulation
4821002|NCT02496611|Obesity|obesity
4821003|NCT02496611|Pharmacotherapy|pharmacotherapy
4821004|NCT02496611|GLP-1|glp-1
4821005|NCT02496611|Children|children
4821006|NCT02496611|Exenatide|exenatide
4821007|NCT02496611|BYDUREON|bydureon
4821008|NCT02496611|Weight Loss|weight loss
4821009|NCT02496611|Maintenance|maintenance
4821010|NCT02496598|Reproductive Techniques, Assisted|reproductive techniques, assisted
4821011|NCT02496598|Ovarian Follicle|ovarian follicle
4821012|NCT02496585|Nintedanib (BIBF 1120)|nintedanib (bibf 1120)
4821013|NCT02496585|Prednisone|prednisone
4821014|NCT02496585|Radiation Pneumonitis|radiation pneumonitis
4821015|NCT02496572|Tuberculosis, multidrug resistant|tuberculosis, multidrug resistant
4821016|NCT02496572|Short-course regimen|short-course regimen
4821017|NCT02496572|Medecins sans Frontieres, MSF|medecins sans frontieres, msf
4821018|NCT02496572|Uzbekistan, Ministry of Health|uzbekistan, ministry of health
4821019|NCT02496559|C-reactive Protein|c-reactive protein
4821020|NCT02496559|Primary Health Care|primary health care
4821021|NCT02496559|Child Welfare|child welfare
4821022|NCT02496559|After-Hours Care|after-hours care
4821023|NCT02496559|Anti-Bacterial Agents|anti-bacterial agents
4821024|NCT02496559|Drug Prescriptions|drug prescriptions
4821025|NCT02496520|dendritic cell vaccination|dendritic cell vaccination
4821026|NCT02496520|sarcoma|sarcoma
4821027|NCT02496520|central nervous system tumor|central nervous system tumor
4821028|NCT02496520|childhood|childhood
4821029|NCT02496520|adolescent|adolescent
4821030|NCT02496520|immunotherapy|immunotherapy
4821031|NCT02496507|sitting|sitting
4821032|NCT02496507|intervention|intervention
4821033|NCT02496507|desks|desks
4821034|NCT02496507|workplace|workplace
4821035|NCT02496507|cardiovascular|cardiovascular
4821036|NCT02496507|metabolic|metabolic
4821037|NCT02496507|qualitative|qualitative
4821038|NCT02496507|randomised controlled trial|randomised controlled trial
4821039|NCT02496468|childhood asthma|childhood asthma
4821040|NCT02496468|preschool wheeze|preschool wheeze
4821041|NCT02496468|adult asthma|adult asthma
4821042|NCT02496468|transition|transition
4821043|NCT02496468|phenotype|phenotype
4821044|NCT02496468|endotype|endotype
4821045|NCT02496468|trajectory|trajectory
4821046|NCT02496455|NAV1.7 Voltage-Gated Sodium Channel|nav1.7 voltage-gated sodium channel
4821047|NCT02496455|pain, postoperative|pain, postoperative
4821048|NCT02496455|cesarean section|cesarean section
4821049|NCT02496442|Transurethral Resection of Prostate|transurethral resection of prostate
4821050|NCT02496442|Cystoscopy|cystoscopy
4821051|NCT02496442|PCNL|pcnl
4821052|NCT02496442|RERAS|reras
4821053|NCT02496442|Urethroscopy|urethroscopy
4821054|NCT02496403|buprenorphine-naloxone combination|buprenorphine-naloxone combination
4821055|NCT02496403|Suboxone|suboxone
4821056|NCT02496403|Buprenorphine|buprenorphine
4821057|NCT02496403|Substance Use|substance use
4821058|NCT02496403|Behavioral intervention|behavioral intervention
4821059|NCT02496403|Opioid partial agonist|opioid partial agonist
4821060|NCT02496403|medication assisted therapy|medication assisted therapy
4821061|NCT02496403|opioid addiction|opioid addiction
4821062|NCT02496390|Fecal Microbial Transplantation|fecal microbial transplantation
4821063|NCT02496390|Gut microbiome|gut microbiome
4821064|NCT02496390|Metabolic disorders|metabolic disorders
4821065|NCT02496390|Obesity|obesity
4821066|NCT02496377|Anaemia|anaemia
4821067|NCT02496377|Iron deficiency|iron deficiency
4821068|NCT02496377|Ferric carboxymaltose|ferric carboxymaltose
4821069|NCT02496377|Patient blood management|patient blood management
4821070|NCT02496377|Hip arthroplasty|hip arthroplasty
4821071|NCT02496377|Knee arthroplasty|knee arthroplasty
4821072|NCT02496364|Tranexamic Acid|tranexamic acid
4821073|NCT02496364|Scoliosis|scoliosis
4821074|NCT02496364|bleeding control|bleeding control
4821075|NCT02496351|transcutaneous electrical nerve stimulation|transcutaneous electrical nerve stimulation
4821076|NCT02496338|Menopause|menopause
4821077|NCT02496338|Quality of Life|quality of life
4821078|NCT02496338|Marital Satisfaction|marital satisfaction
4821079|NCT02496338|training|training
4821080|NCT02496325|Pudendal nerve block|pudendal nerve block
4821081|NCT02496325|Ultrasound guided|ultrasound guided
4821082|NCT02496325|Transperineal puncture|transperineal puncture
4821083|NCT02496325|Perineal surgery|perineal surgery
4821084|NCT02496325|children|children
4821085|NCT02496312|Apathy|apathy
4821086|NCT02496312|Goal-directed behavior|goal-directed behavior
4821087|NCT02496312|Quantitative evaluation|quantitative evaluation
4821088|NCT02496312|Sensor|sensor
4821089|NCT02496312|Ethogram|ethogram
4821090|NCT02496299|COMPARISSON|comparisson
4821091|NCT02496299|CAUDAL BLOCK|caudal block
4821092|NCT02496299|BUPIVACAINE|bupivacaine
4821093|NCT02496299|DEXAMETHASONE|dexamethasone
4821094|NCT02496286|Necessary paracentesis for symptom control|necessary paracentesis for symptom control
4821095|NCT02496273|Dendritic Cells|dendritic cells
4821096|NCT02496273|Cytotoxic T-Lymphocytes|cytotoxic t-lymphocytes
4821097|NCT02496273|Adeno-Associated Virus|adeno-associated virus
4821098|NCT02496260|Magnetic resonance imaging|magnetic resonance imaging
4821099|NCT02496260|Cardiac function|cardiac function
4821100|NCT02496260|Breast Cancer|breast cancer
4821101|NCT02496247|malnutrition|malnutrition
4821102|NCT02496247|undernutrition|undernutrition
4821103|NCT02496247|Z-score|z-score
4821104|NCT02496247|Guinea-Bissau|guinea-bissau
4821105|NCT02496247|food aid|food aid
4821106|NCT02496234|Coronary Artery Bypass Graft Surgery|coronary artery bypass graft surgery
4821107|NCT02496234|Acute kidney injury|acute kidney injury
4821108|NCT02496234|Renal failure|renal failure
4821109|NCT02496234|Biomarker|biomarker
4821110|NCT02496221|Cholecystokinin|cholecystokinin
4821111|NCT02496221|ultrasonography|ultrasonography
4821112|NCT02496221|Albiglutide|albiglutide
4821113|NCT02496221|Gallbladder ejection fraction|gallbladder ejection fraction
4821114|NCT02496169|PTCA|ptca
4821115|NCT02496169|stenosis|stenosis
4821116|NCT02496169|sirolimus|sirolimus
4821117|NCT02496169|stent|stent
4821118|NCT02496156|type 1 diabetes mellitus|type 1 diabetes mellitus
4821119|NCT02496156|adolescence|adolescence
4821120|NCT02496156|adherence|adherence
4821121|NCT02496156|insulin pump|insulin pump
4821122|NCT02496156|continuous subcutaneous insulin infusion|continuous subcutaneous insulin infusion
4821123|NCT02496156|continuous glucose monitor|continuous glucose monitor
4821124|NCT02496156|shared medical decision making|shared medical decision making
4821125|NCT02496143|Healthy Volunteers|healthy volunteers
4821126|NCT02496143|Phase I|phase i
4821127|NCT02496143|Placebo controlled|placebo controlled
4821128|NCT02496143|Single Ascending Dose|single ascending dose
4821129|NCT02496143|PK|pk
4821130|NCT02496143|Oral administration|oral administration
4821131|NCT02496143|Softgel|softgel
4821132|NCT02496130|minilaparotomy|minilaparotomy
4821133|NCT02496130|morcellation|morcellation
4821134|NCT02496130|laparoscopy|laparoscopy
4821135|NCT02496104|Preterm|preterm
4821136|NCT02496104|Infant|infant
4821137|NCT02496104|Habituation|habituation
4821138|NCT02496104|APIB|apib
4821139|NCT02496065|breast cancer|breast cancer
4821140|NCT02496065|BLZ-100|blz-100
4821141|NCT02496065|Tumor Paint|tumor paint
4821142|NCT02496065|breast tumors|breast tumors
4821143|NCT02496052|amnion graft|amnion graft
4821144|NCT02496052|New biological barrier system|new biological barrier system
4821145|NCT02496039|PBA|pba
4821146|NCT02496039|involuntary crying|involuntary crying
4821147|NCT02496039|involuntary laughing|involuntary laughing
4821148|NCT02496000|Diabetes Mellitus type 2|diabetes mellitus type 2
4821149|NCT02496000|Metformin|metformin
4821150|NCT02496000|oral insulin|oral insulin
4821151|NCT02495974|Xtandi|xtandi
4821152|NCT02495974|Enzalutamide|enzalutamide
4821153|NCT02495974|Prostate cancer|prostate cancer
4821154|NCT02495974|Metastatic castration resistant prostate cancer|metastatic castration resistant prostate cancer
4821155|NCT02495961|hyperlipidemias|hyperlipidemias
4821156|NCT02495961|hyperglycemia|hyperglycemia
4821157|NCT02495961|hypertension|hypertension
4821158|NCT02495961|leptin|leptin
4822970|NCT02485119|endometrial|endometrial
4821159|NCT02495961|hyperhomocysteinemia|hyperhomocysteinemia
4821160|NCT02495935|TES|tes
4821161|NCT02495935|Transcorneal Electrical Stimulation|transcorneal electrical stimulation
4821162|NCT02495935|Amblyopia|amblyopia
4821163|NCT02495909|paediatric schistosomiasis|paediatric schistosomiasis
4821164|NCT02495909|morbidity|morbidity
4821165|NCT02495909|immunology|immunology
4821166|NCT02495883|Essential Tremor|essential tremor
4821167|NCT02495883|Magnetic Resonance Imaging|magnetic resonance imaging
4821168|NCT02495883|Therapy|therapy
4821169|NCT02495883|Alcohol|alcohol
4821170|NCT02495883|Propranolol|propranolol
4821171|NCT02495844|UCB0942|ucb0942
4821172|NCT02495844|Treatment-resistant focal epilepsy|treatment-resistant focal epilepsy
4821173|NCT02495844|Partial seizures|partial seizures
4821174|NCT02495844|Seizure therapy|seizure therapy
4821175|NCT02495831|PK study|pk study
4821176|NCT02495818|Rotator cuff syndrome|rotator cuff syndrome
4821177|NCT02495818|supraspinatus tendonitis|supraspinatus tendonitis
4821178|NCT02495818|suprascapular nerve block|suprascapular nerve block
4821179|NCT02495818|ultrasound guided|ultrasound guided
4821180|NCT02495818|supraspinatus|supraspinatus
4821181|NCT02495805|a continuous proximal adductor canal block (ACB)|a continuous proximal adductor canal block (acb)
4821182|NCT02495805|continuous femoral nerve block (FNB)|continuous femoral nerve block (fnb)
4821183|NCT02495779|PrEP|prep
4821184|NCT02495779|HIV|hiv
4821185|NCT02495779|MSM|msm
4821186|NCT02495779|Men Having Sex With Men|men having sex with men
4821187|NCT02495779|Episodic PrEP|episodic prep
4821188|NCT02495779|Adherence|adherence
4821189|NCT02495779|Episodic HIV Risk|episodic hiv risk
4821190|NCT02495766|Multiple sclerosis|multiple sclerosis
4821191|NCT02495766|Bone marrow mesenchymal stromal cells|bone marrow mesenchymal stromal cells
4821192|NCT02495766|Stem cells|stem cells
4821193|NCT02495766|Nervous System Diseases|nervous system diseases
4821194|NCT02495766|Demyelinating Diseases|demyelinating diseases
4821195|NCT02495766|Autoimmune Diseases|autoimmune diseases
4821196|NCT02495753|cesarean section|cesarean section
4821197|NCT02495753|wound infection|wound infection
4821198|NCT02495753|vaginal cleansing|vaginal cleansing
4821199|NCT02495753|endometritis|endometritis
4821200|NCT02495727|Step-reduction model|step-reduction model
4821201|NCT02495727|Reduced activity|reduced activity
4821202|NCT02495727|Atrophy|atrophy
4821203|NCT02495727|Skeletal Muscle|skeletal muscle
4821204|NCT02495727|Sarcopenia|sarcopenia
4821205|NCT02495727|Dynapenia|dynapenia
4821206|NCT02495714|Exercise|exercise
4821207|NCT02495714|Diet|diet
4821208|NCT02495714|Learning|learning
4821209|NCT02495688|General Anesthesia|general anesthesia
4821210|NCT02495688|Regional Anesthesia|regional anesthesia
4821211|NCT02495662|Vascular access|vascular access
4821212|NCT02495662|Hemodialysis|hemodialysis
4821213|NCT02495662|Arteriovenous shunt|arteriovenous shunt
4821214|NCT02495662|Arteriovenous fistula|arteriovenous fistula
4821215|NCT02495662|Maturation|maturation
4821216|NCT02495662|Liposomal prednisolone|liposomal prednisolone
4821217|NCT02495662|PEG-liposomal prednisolone sodium phosphate|peg-liposomal prednisolone sodium phosphate
4821218|NCT02495662|Radio-cephalic|radio-cephalic
4821219|NCT02495662|Shunt|shunt
4821220|NCT02495610|NPH|nph
4821221|NCT02495610|Gait analysis|gait analysis
4821222|NCT02495610|neuropsychology|neuropsychology
4821223|NCT02495610|micturition diary|micturition diary
4821224|NCT02495610|MRI|mri
4821225|NCT02495597|bronchial inflammation|bronchial inflammation
4821226|NCT02495597|Bronchiolitis obliterans|bronchiolitis obliterans
4821227|NCT02495597|Sputum|sputum
4821228|NCT02495597|Blood|blood
4821229|NCT02495597|Inflammation|inflammation
4821230|NCT02495597|adaptive immune system|adaptive immune system
4821231|NCT02495597|innate immune system|innate immune system
4821232|NCT02495584|Vitamin D|vitamin d
4821233|NCT02495584|Fortified milk|fortified milk
4821234|NCT02495584|Supplementation|supplementation
4821235|NCT02495584|UV exposure|uv exposure
4821236|NCT02495584|Winter|winter
4821237|NCT02495584|Healthy adults|healthy adults
4821238|NCT02495584|Body Composition|body composition
4821239|NCT02495584|Muscle function|muscle function
4821240|NCT02495584|Blood pressure|blood pressure
4821241|NCT02495571|ALS and Dysphagia|als and dysphagia
4821242|NCT02495571|ALS and cough|als and cough
4821243|NCT02495571|cough reflex test|cough reflex test
4821244|NCT02495558|Cough Reflex test|cough reflex test
4821245|NCT02495558|Decannulation|decannulation
4821246|NCT02495545|spinal cord injury (SCI)|spinal cord injury (sci)
4821247|NCT02495532|Neoplasm Metastasis|neoplasm metastasis
4821248|NCT02495532|Colorectal Neoplasms|colorectal neoplasms
4821249|NCT02495532|Lymph Nodes|lymph nodes
4821250|NCT02495532|Lymph Node Revealing Solution|lymph node revealing solution
4821251|NCT02495506|Cardiac surgery|cardiac surgery
4821252|NCT02495506|bleeding|bleeding
4821253|NCT02495506|platelet transfusion|platelet transfusion
4821254|NCT02495480|disposable sheath|disposable sheath
4821255|NCT02495480|intubation|intubation
4821256|NCT02495480|colonoscopy|colonoscopy
4821257|NCT02495428|Bandage|bandage
4821258|NCT02495428|Treadmill|treadmill
4821259|NCT02495428|Lactate Acid|lactate acid
4821461|NCT02494362|Therapeutic gaming|therapeutic gaming
4821260|NCT02495389|urinary urgency incontinence|urinary urgency incontinence
4821261|NCT02495376|YACS|yacs
4821262|NCT02495376|cancer|cancer
4821263|NCT02495376|MBSR|mbsr
4821264|NCT02495311|adenomyosis|adenomyosis
4821265|NCT02495311|uterine myoma|uterine myoma
4821266|NCT02495311|lower urinary tract symptoms|lower urinary tract symptoms
4821267|NCT02495311|sexual dysfunction|sexual dysfunction
4821268|NCT02495311|gastrointestinal symptom|gastrointestinal symptom
4821269|NCT02495298|Fascial manipulation|fascial manipulation
4821270|NCT02495298|Carpal Tunnel Syndrome|carpal tunnel syndrome
4821271|NCT02495285|pediatric patients gelatine|pediatric patients gelatine
4821272|NCT02495272|Postpartum hemorrhage|postpartum hemorrhage
4821273|NCT02495272|Third stage of labour|third stage of labour
4821274|NCT02495272|Oxytocin|oxytocin
4821275|NCT02495272|Uterotonics|uterotonics
4821276|NCT02495272|Active management of third stage of labour|active management of third stage of labour
4821277|NCT02495259|Double-lumen endobronchial tube|double-lumen endobronchial tube
4821278|NCT02495259|Laryngoscopy|laryngoscopy
4821279|NCT02495259|intubating stylet|intubating stylet
4821280|NCT02495233|Erlotinib|erlotinib
4821281|NCT02495233|ASP2215|asp2215
4821282|NCT02495233|NSCLC|nsclc
4821283|NCT02495233|Non-Small-Cell Lung Cancer|non-small-cell lung cancer
4821284|NCT02495220|dexmedetomidine|dexmedetomidine
4821285|NCT02495220|subtenon anesthesia|subtenon anesthesia
4821286|NCT02495220|postoperative pain|postoperative pain
4821287|NCT02495220|pov|pov
4821288|NCT02495194|Promotion of psychological well-being|promotion of psychological well-being
4821289|NCT02495194|Horticultural therapy|horticultural therapy
4821290|NCT02495194|Randomized Controlled Trial|randomized controlled trial
4821291|NCT02495194|Gardening|gardening
4821292|NCT02495194|Elderly|elderly
4821293|NCT02495129|Primary Sjögren's syndrome|primary sjögren's syndrome
4821294|NCT02495129|Sicca syndrome|sicca syndrome
4821295|NCT02495129|Salivary glands|salivary glands
4821296|NCT02495129|Positron Emission Tomography|positron emission tomography
4821297|NCT02495129|B cell depletion|b cell depletion
4821298|NCT02495103|Dose-Escalation|dose-escalation
4821299|NCT02495103|Maximum Tolerated Dose|maximum tolerated dose
4821300|NCT02495103|Safety|safety
4821301|NCT02495103|Overall Response|overall response
4821302|NCT02495090|Hypospadias|hypospadias
4821303|NCT02495090|exome sequencing|exome sequencing
4821304|NCT02495090|genital malformation|genital malformation
4821305|NCT02495077|Kidney Transplantation|kidney transplantation
4821306|NCT02495077|infliximab|infliximab
4821307|NCT02495077|Tissue Donors|tissue donors
4821308|NCT02495077|Remicade|remicade
4821309|NCT02495077|Induction Therapy|induction therapy
4821310|NCT02495077|Deceased Donor Kidney Transplant Recipients|deceased donor kidney transplant recipients
4821311|NCT02495051|gastroesophageal reflux|gastroesophageal reflux
4821312|NCT02495051|barrett esophagus|barrett esophagus
4821313|NCT02495038|combination|combination
4821314|NCT02495038|rocuronium|rocuronium
4821315|NCT02495038|cisatracurium|cisatracurium
4821316|NCT02495038|neuromuscular blockade monitoring|neuromuscular blockade monitoring
4821317|NCT02495038|drug synergism|drug synergism
4821318|NCT02495012|efficacy|efficacy
4821319|NCT02495012|safety|safety
4821320|NCT02495012|STEMI|stemi
4821321|NCT02494999|pneumococcal conjugate vaccine|pneumococcal conjugate vaccine
4821322|NCT02494999|immunogenicity|immunogenicity
4821323|NCT02494999|safety|safety
4821324|NCT02494986|Human immunodeficiency virus type 1|human immunodeficiency virus type 1
4821325|NCT02494986|Rilpivirine|rilpivirine
4821326|NCT02494986|Roll-over study|roll-over study
4821327|NCT02494960|smoking cessation intervention|smoking cessation intervention
4821328|NCT02494947|Coronary Angiography|coronary angiography
4821329|NCT02494947|Exercise|exercise
4821330|NCT02494921|Metastatic|metastatic
4821331|NCT02494921|Castration-Resistant|castration-resistant
4821332|NCT02494908|Parkinson Disease|parkinson disease
4821333|NCT02494908|MRI|mri
4821334|NCT02494882|Ruxolitinib|ruxolitinib
4821335|NCT02494882|Dasatinib|dasatinib
4821336|NCT02494882|Dexamethasone|dexamethasone
4821337|NCT02494882|14-272|14-272
4821338|NCT02494869|Aerobic Training|aerobic training
4821339|NCT02494869|Exercise|exercise
4821340|NCT02494869|Gene Expression|gene expression
4821341|NCT02494869|15-093|15-093
4821342|NCT02494856|Naproxen|naproxen
4821343|NCT02494856|Lower third molar|lower third molar
4821344|NCT02494856|Oral Surgery|oral surgery
4821345|NCT02494856|Esomeprazole|esomeprazole
4821346|NCT02494830|Anesthetic Drugs|anesthetic drugs
4821347|NCT02494817|HIV prevention|hiv prevention
4821348|NCT02494817|Toolkit|toolkit
4821349|NCT02494817|Male couples|male couples
4821350|NCT02494817|Sexual agreements|sexual agreements
4821351|NCT02494804|Cytokine-Induced Killer Cells|cytokine-induced killer cells
4821352|NCT02494804|Milignant Gliomas|milignant gliomas
4821353|NCT02494804|Temozolomide|temozolomide
4821354|NCT02494778|Huntington's disease, pridopidine|huntington's disease, pridopidine
4821355|NCT02494765|I-gelTM|i-geltm
4821356|NCT02494765|Ambu® AuraOnceTM|ambu® auraoncetm
4821357|NCT02494765|supraglottic devices|supraglottic devices
4821358|NCT02494765|laryngeal mask effects on airway|laryngeal mask effects on airway
4821561|NCT02493855|Hepatitis C|hepatitis c
4821359|NCT02494765|3D magnetic resonance imaging|3d magnetic resonance imaging
4821360|NCT02494752|Contour deformities of face|contour deformities of face
4821361|NCT02494752|autologous fat grafting|autologous fat grafting
4821362|NCT02494752|Post traumatic facial contour defects|post traumatic facial contour defects
4821363|NCT02494739|antioxidant|antioxidant
4821364|NCT02494739|oxidative stress|oxidative stress
4821365|NCT02494739|inflammation|inflammation
4821366|NCT02494739|polyphenols|polyphenols
4821367|NCT02494739|yogurt|yogurt
4821368|NCT02494726|Ischemic stroke|ischemic stroke
4821369|NCT02494726|ICH stroke|ich stroke
4821370|NCT02494726|TEG|teg
4821371|NCT02494726|Thromboelastography|thromboelastography
4821372|NCT02494726|Stroke|stroke
4821373|NCT02494713|Advanced Prostate Cancer|advanced prostate cancer
4821374|NCT02494713|Neoadjuvant|neoadjuvant
4821375|NCT02494713|Hormone therapy|hormone therapy
4821376|NCT02494713|ADT|adt
4821377|NCT02494713|Androgen Deprivation Therapy|androgen deprivation therapy
4821378|NCT02494713|Chemotherapy|chemotherapy
4821379|NCT02494713|Radical Prostatectomy|radical prostatectomy
4821380|NCT02494700|Lymphoma|lymphoma
4821381|NCT02494700|Low grade B lymphocyte (B cell) lymphoma|low grade b lymphocyte (b cell) lymphoma
4821382|NCT02494700|Mantle cell lymphoma involving the ocular adnexa|mantle cell lymphoma involving the ocular adnexa
4821383|NCT02494700|Limited and advanced stage|limited and advanced stage
4821384|NCT02494700|Ocular adnexa|ocular adnexa
4821385|NCT02494700|Radiation therapy|radiation therapy
4821386|NCT02494700|XRT|xrt
4821387|NCT02494661|Public Health|public health
4821388|NCT02494661|Community|community
4821389|NCT02494661|Obesity|obesity
4821390|NCT02494661|Hispanic|hispanic
4821391|NCT02494661|Women|women
4821392|NCT02494661|Nutrition|nutrition
4821393|NCT02494661|Mindfulness and stress|mindfulness and stress
4821394|NCT02494661|Food shopping|food shopping
4821395|NCT02494648|Obstructive sleep apnea|obstructive sleep apnea
4821396|NCT02494648|Resistive inspiratory muscle training|resistive inspiratory muscle training
4821397|NCT02494648|Coronary artery disease|coronary artery disease
4821398|NCT02494648|Cardiac rehabilitation|cardiac rehabilitation
4821399|NCT02494583|Gastric carcinoma|gastric carcinoma
4821400|NCT02494583|Gastric cancer|gastric cancer
4821401|NCT02494583|Gastroesophageal junction cancer|gastroesophageal junction cancer
4821402|NCT02494583|Gastroesophageal junction carcinoma|gastroesophageal junction carcinoma
4821403|NCT02494583|PD1|pd1
4821404|NCT02494583|PD-1|pd-1
4821405|NCT02494583|PDL1|pdl1
4821406|NCT02494583|PD-L1|pd-l1
4821407|NCT02494544|knee implant|knee implant
4821408|NCT02494544|knee replacement|knee replacement
4821409|NCT02494544|total knee replacement|total knee replacement
4821410|NCT02494531|Alzheimer Disease|alzheimer disease
4821411|NCT02494531|PET|pet
4821412|NCT02494531|diagnosis|diagnosis
4821413|NCT02494531|MCI|mci
4821414|NCT02494531|illiterate|illiterate
4821415|NCT02494518|stroke|stroke
4821416|NCT02494518|aerobic exercise|aerobic exercise
4821417|NCT02494518|forced exercise|forced exercise
4821418|NCT02494518|repetitive task practice|repetitive task practice
4821419|NCT02494518|arm function|arm function
4821420|NCT02494518|upper extremity|upper extremity
4821421|NCT02494505|chronic inflammatory demyelinating polyradiculopathy|chronic inflammatory demyelinating polyradiculopathy
4821422|NCT02494505|intravenous immunoglobulin (IVIG)|intravenous immunoglobulin (ivig)
4821423|NCT02494505|withdrawal|withdrawal
4821424|NCT02494505|quality of life|quality of life
4821425|NCT02494505|Clinical trial|clinical trial
4821426|NCT02494505|cost|cost
4821427|NCT02494492|Uveitis|uveitis
4821428|NCT02494492|Lymphocyte cells|lymphocyte cells
4821429|NCT02494492|lymphocyte T regulator|lymphocyte t regulator
4821430|NCT02494492|vitreous haze|vitreous haze
4821431|NCT02494492|intravitreal injection|intravitreal injection
4821432|NCT02494479|Psoriasis|psoriasis
4821433|NCT02494479|Topical Psoriasis|topical psoriasis
4821434|NCT02494479|Mild Psoriasis|mild psoriasis
4821435|NCT02494479|Moderate Psoriasis|moderate psoriasis
4821436|NCT02494479|Active Psoriasis|active psoriasis
4821437|NCT02494479|Plaque Psoriasis|plaque psoriasis
4821438|NCT02494479|Skin Diseases|skin diseases
4821439|NCT02494466|Airway Resistance|airway resistance
4821440|NCT02494466|montelukast sodium|montelukast sodium
4821441|NCT02494466|laryngeal mask airway|laryngeal mask airway
4821442|NCT02494427|Crowns|crowns
4821443|NCT02494427|Inlays|inlays
4821444|NCT02494427|Onlays|onlays
4821445|NCT02494414|Cardiac arrest|cardiac arrest
4821446|NCT02494414|outcome|outcome
4821447|NCT02494414|neurological status|neurological status
4821448|NCT02494401|systemic sclerosis|systemic sclerosis
4821449|NCT02494401|ssc|ssc
4821450|NCT02494375|Sleep|sleep
4821451|NCT02494375|glycemic control|glycemic control
4821452|NCT02494375|type 1 diabetes|type 1 diabetes
4821453|NCT02494375|amylase|amylase
4821454|NCT02494375|body composition|body composition
4821455|NCT02494375|lean|lean
4821456|NCT02494375|overweight|overweight
4821457|NCT02494375|obese|obese
4821458|NCT02494362|Hand exercises|hand exercises
4821459|NCT02494362|Hand function|hand function
4821460|NCT02494362|Computer based exercises|computer based exercises
4821462|NCT02494349|α1-blockers|α1-blockers
4821463|NCT02494349|antimuscarinic agent|antimuscarinic agent
4821464|NCT02494323|Dual Channel Functional Electrical Stimulation|dual channel functional electrical stimulation
4821465|NCT02494323|dropfoot, balanced dorsiflexion|dropfoot, balanced dorsiflexion
4821466|NCT02494284|Coronary artery disease|coronary artery disease
4821467|NCT02494284|Dual antiplatelet platelet therapy|dual antiplatelet platelet therapy
4821468|NCT02494284|Drug eluting stent|drug eluting stent
4821469|NCT02494258|CC-486|cc-486
4821470|NCT02494258|Oral Azacitidine|oral azacitidine
4821471|NCT02494258|Solid tumors|solid tumors
4821472|NCT02494258|hematological disorders|hematological disorders
4821473|NCT02494258|rollover study|rollover study
4821474|NCT02494245|Rehabilitation|rehabilitation
4821475|NCT02494245|Intervention|intervention
4821476|NCT02494245|Walking|walking
4821477|NCT02494232|minor blunt thoracic trauma|minor blunt thoracic trauma
4821478|NCT02494232|physical examination|physical examination
4821479|NCT02494219|Group A streptococcal pharyngitis|group a streptococcal pharyngitis
4821480|NCT02494219|Rapid streptococcal test|rapid streptococcal test
4821481|NCT02494219|Throat swab culture|throat swab culture
4821482|NCT02494206|QBX258|qbx258
4821483|NCT02494206|human monoclonal antibodies|human monoclonal antibodies
4821484|NCT02494206|VAK694|vak694
4821485|NCT02494206|QAX576|qax576
4821486|NCT02494206|15-085|15-085
4821487|NCT02494180|fentanyl|fentanyl
4821488|NCT02494180|midazolam|midazolam
4821489|NCT02494180|pethidine|pethidine
4821490|NCT02494180|diazepam|diazepam
4821491|NCT02494167|Acute Myeloid Leukemia|acute myeloid leukemia
4821492|NCT02494167|Myelodysplastic Syndrome|myelodysplastic syndrome
4821493|NCT02494167|MultiTAA Specific T cells|multitaa specific t cells
4821494|NCT02494128|Child health service|child health service
4821495|NCT02494128|Family health|family health
4821496|NCT02494128|Nurse|nurse
4821497|NCT02494128|Education|education
4821498|NCT02494128|Parental group|parental group
4821499|NCT02494128|Group leadership|group leadership
4821500|NCT02494128|Health promotion|health promotion
4821501|NCT02494102|Obstructive Sleep Apnea|obstructive sleep apnea
4821502|NCT02494102|General Anesthesia|general anesthesia
4821503|NCT02494102|Modafinil|modafinil
4821504|NCT02494089|in situ simulation|in situ simulation
4821505|NCT02494089|in hospital cardiac arrest|in hospital cardiac arrest
4821506|NCT02494089|clinical audit|clinical audit
4821507|NCT02494089|education|education
4821508|NCT02494089|patient simulation|patient simulation
4821509|NCT02494063|cervical cancer|cervical cancer
4821510|NCT02494063|sentinel lymph node|sentinel lymph node
4821511|NCT02494063|lymphadenectomy|lymphadenectomy
4821512|NCT02494050|Depression|depression
4821513|NCT02494050|Bipolar Disorder|bipolar disorder
4821514|NCT02494050|Anhedonia|anhedonia
4821515|NCT02494050|Women|women
4821516|NCT02494024|PSP|psp
4821517|NCT02494024|C2N-8E12|c2n-8e12
4821518|NCT02494024|tauopathy|tauopathy
4821519|NCT02494024|Progressive Supranuclear Palsy|progressive supranuclear palsy
4821520|NCT02494024|Steele Richardson Olszewski Syndrome|steele richardson olszewski syndrome
4821521|NCT02494024|Humanized anti-tau antibody|humanized anti-tau antibody
4821522|NCT02494011|Colles' Fracture; CKCE; Russian current|colles' fracture; ckce; russian current
4821523|NCT02493998|Sanfilippo Syndrome Type B|sanfilippo syndrome type b
4821524|NCT02493985|Brain physiology|brain physiology
4821525|NCT02493985|Intracranial pressure|intracranial pressure
4821526|NCT02493985|Cognition|cognition
4821527|NCT02493985|Cerebrovascular|cerebrovascular
4821528|NCT02493985|Head down tilt|head down tilt
4821529|NCT02493985|Space flight|space flight
4821530|NCT02493972|ovarian cancer|ovarian cancer
4821531|NCT02493972|peritoneal carcinosis|peritoneal carcinosis
4821532|NCT02493972|manual exploration|manual exploration
4821533|NCT02493972|surgery|surgery
4821534|NCT02493972|GelPort|gelport
4821535|NCT02493959|PYY|pyy
4821536|NCT02493959|Degradation|degradation
4821537|NCT02493959|kinetics|kinetics
4821538|NCT02493959|men|men
4821539|NCT02493920|Respiratory Distress Syndrome, Newborn|respiratory distress syndrome, newborn
4821540|NCT02493920|Delivery Room|delivery room
4821541|NCT02493920|Resuscitation|resuscitation
4821542|NCT02493920|Premature birth|premature birth
4821543|NCT02493920|Infant, Newborn|infant, newborn
4821544|NCT02493920|Respiration Artificial|respiration artificial
4821545|NCT02493894|Bowel preparation|bowel preparation
4821546|NCT02493894|perioperative bleeding|perioperative bleeding
4821547|NCT02493894|lumbar fusion|lumbar fusion
4821548|NCT02493881|Motor function of the extralaryngeal branches|motor function of the extralaryngeal branches
4821549|NCT02493881|intraoperative neuromonitoring|intraoperative neuromonitoring
4821550|NCT02493881|recurrent laryngeal nerve|recurrent laryngeal nerve
4821551|NCT02493868|Treatment-resistant Depression|treatment-resistant depression
4821552|NCT02493868|Esketamine|esketamine
4821553|NCT02493868|Placebo|placebo
4821554|NCT02493868|Oral Antidepressant|oral antidepressant
4821555|NCT02493868|Relapse prevention|relapse prevention
4821556|NCT02493855|Treatment naive|treatment naive
4821557|NCT02493855|HCV|hcv
4821558|NCT02493855|Interferon free|interferon free
4821559|NCT02493855|Hepatitis C Genotype 1a|hepatitis c genotype 1a
4821560|NCT02493855|Chronic Hepatitis C|chronic hepatitis c
4821562|NCT02493842|Nerve Stimulation|nerve stimulation
4821563|NCT02493842|Neuroplasticity|neuroplasticity
4821564|NCT02493842|Sensory Feedback|sensory feedback
4821565|NCT02493790|cognitive dysfunction|cognitive dysfunction
4821566|NCT02493790|Activity of Daily Living|activity of daily living
4821567|NCT02493790|interference|interference
4821568|NCT02493790|rehabilitation|rehabilitation
4821569|NCT02493790|cognitive-motor dual task|cognitive-motor dual task
4821570|NCT02493751|Cancer, renal cell cancer, kidney disease, kidney neoplasms, axitinib|cancer, renal cell cancer, kidney disease, kidney neoplasms, axitinib
4821571|NCT02493673|Continuous Positive Airway Pressure|continuous positive airway pressure
4821572|NCT02493673|Stroke|stroke
4821573|NCT02493673|Cerebrovascular reactivity|cerebrovascular reactivity
4821574|NCT02493673|Brain oxygenation|brain oxygenation
4821575|NCT02493660|Massive Rotator Cuff Tear|massive rotator cuff tear
4821576|NCT02493660|Arthroscopy|arthroscopy
4821577|NCT02493660|Shoulder Joint|shoulder joint
4821578|NCT02493660|Rotator cuff partial repair|rotator cuff partial repair
4821579|NCT02493634|Magnetic Resonance spectroscopy|magnetic resonance spectroscopy
4821580|NCT02493634|Aortic Arch|aortic arch
4821581|NCT02493621|Pain, Postoperative|pain, postoperative
4821582|NCT02493621|Nerve Block|nerve block
4821583|NCT02493621|Anesthesia, Epidural|anesthesia, epidural
4821584|NCT02493582|CIK|cik
4821585|NCT02493582|Apatinib|apatinib
4821586|NCT02493582|Lung Adenocarcinoma|lung adenocarcinoma
4821587|NCT02493569|Breast cancer, hospital, epidemiology, diagnosis, treatment|breast cancer, hospital, epidemiology, diagnosis, treatment
4821588|NCT02493556|Phototherapy|phototherapy
4821589|NCT02493556|Plyometric exercise|plyometric exercise
4821590|NCT02493556|Muscle recovery|muscle recovery
4821591|NCT02493543|autoantibodies|autoantibodies
4821592|NCT02493530|MDS/MPN|mds/mpn
4821593|NCT02493504|Heparin|heparin
4821594|NCT02493491|dysphonia|dysphonia
4821595|NCT02493491|dysphagia|dysphagia
4821596|NCT02493491|neurogenic|neurogenic
4821597|NCT02493491|vocal fold augmentation|vocal fold augmentation
4821598|NCT02493491|VFA|vfa
4821599|NCT02493491|vocal fold insufficiency|vocal fold insufficiency
4821600|NCT02493491|Prolaryn|prolaryn
4821601|NCT02493491|Radiesse|radiesse
4821602|NCT02493491|Coaptite|coaptite
4821603|NCT02493491|voice|voice
4821604|NCT02493491|Parkinson's Disease|parkinson's disease
4821605|NCT02493491|Multiple Sclerosis|multiple sclerosis
4821606|NCT02493491|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
4821607|NCT02493491|ALS|als
4821608|NCT02493491|MS|ms
4821609|NCT02493491|calcium hydroxylapatite|calcium hydroxylapatite
4821610|NCT02493491|hyaluronic acid|hyaluronic acid
4821611|NCT02493478|Intubation|intubation
4821612|NCT02493478|Advanced airway intervention|advanced airway intervention
4821613|NCT02493478|Intensive care unit|intensive care unit
4821614|NCT02493465|everolimus|everolimus
4821615|NCT02493465|left ventricular hypertrophy|left ventricular hypertrophy
4821616|NCT02493439|Best Possible Self|best possible self
4821617|NCT02493439|Positive Psychology|positive psychology
4821618|NCT02493439|Romanian Immigrants|romanian immigrants
4821619|NCT02493439|Optimism|optimism
4821620|NCT02493439|Future Thinking|future thinking
4821621|NCT02493413|psychoneuroimmunology|psychoneuroimmunology
4821622|NCT02493413|stress|stress
4821623|NCT02493413|lymphocyte population|lymphocyte population
4821624|NCT02493413|personality type|personality type
4821625|NCT02493413|obesity|obesity
4821626|NCT02493413|heart rate variability|heart rate variability
4821627|NCT02493413|awareness|awareness
4821628|NCT02493400|Follow up|follow up
4821629|NCT02493400|Exercise|exercise
4821630|NCT02493400|Rehabilitation|rehabilitation
4821631|NCT02493387|Physiotherapist led group-based exercise|physiotherapist led group-based exercise
4821632|NCT02493387|Physical activity|physical activity
4821633|NCT02493387|Atrial fibrillation|atrial fibrillation
4821634|NCT02493348|Fibromyalgia|fibromyalgia
4821635|NCT02493348|Rhythmic Sensory Stimulation|rhythmic sensory stimulation
4821636|NCT02493348|Gamma Stimulation|gamma stimulation
4821638|NCT02493283|blood leucocytes|blood leucocytes
4821639|NCT02493283|pharmacokinetics|pharmacokinetics
4821640|NCT02493283|metabolism|metabolism
4821641|NCT02493270|smoking cessation|smoking cessation
4821642|NCT02493270|tobacco|tobacco
4821643|NCT02493270|dental|dental
4821644|NCT02493270|periodontal|periodontal
4821645|NCT02493257|nonallergic irritant rhinitis|nonallergic irritant rhinitis
4821646|NCT02493257|nasal congestion|nasal congestion
4821647|NCT02493257|rhinorrhea|rhinorrhea
4821648|NCT02493218|mindfulness|mindfulness
4821649|NCT02493218|intervention|intervention
4821650|NCT02493218|african american|african american
4821651|NCT02493218|youth|youth
4821652|NCT02493218|stress|stress
4821653|NCT02493218|poverty|poverty
4821654|NCT02493205|Implantable Cardiac Monitor|implantable cardiac monitor
4821655|NCT02493205|Stent|stent
4821656|NCT02493192|Parturition|parturition
4821657|NCT02493192|Humanizing Deliver|humanizing deliver
4821658|NCT02493192|Labor Pain|labor pain
4821659|NCT02493192|Natural Childbirth|natural childbirth
4821660|NCT02493192|Labor Onset|labor onset
4821661|NCT02493192|First Labor Stage|first labor stage
4821662|NCT02493192|Birth ball|birth ball
4821663|NCT02493192|meperidine|meperidine
4821665|NCT02493140|Weight management|weight management
4821666|NCT02493140|cashew apple extract|cashew apple extract
4821667|NCT02493140|overweight|overweight
4821668|NCT02493101|Periostin staining|periostin staining
4821669|NCT02493101|Urine periostin level|urine periostin level
4821670|NCT02493101|Lupus nephritis|lupus nephritis
4821671|NCT02493101|IgA nephropathy|iga nephropathy
4821672|NCT02493075|atrial fibrillation|atrial fibrillation
4821673|NCT02493075|Catheter Ablation|catheter ablation
4821674|NCT02493075|contact force|contact force
4821675|NCT02493075|Chinese-specific|chinese-specific
4821676|NCT02493062|Hysterotomy|hysterotomy
4821677|NCT02493062|Myelomeningocele|myelomeningocele
4821678|NCT02493062|Open fetal surgery|open fetal surgery
4821679|NCT02493062|Sonohysterogram|sonohysterogram
4821680|NCT02493049|Multiple Sclerosis|multiple sclerosis
4821681|NCT02493049|Domperidone|domperidone
4821682|NCT02493049|Relapsing-Remitting MS|relapsing-remitting ms
4821683|NCT02493049|Demyelinating disease|demyelinating disease
4821684|NCT02493049|Remyelination|remyelination
4821685|NCT02493023|Bronchoscopy|bronchoscopy
4821686|NCT02493023|Bronchoscopes|bronchoscopes
4821687|NCT02493010|Virtual Reality Exposure Therapy|virtual reality exposure therapy
4821688|NCT02493010|Computerized Cognitive Behavioral Therapy|computerized cognitive behavioral therapy
4821689|NCT02493010|Public Speaking|public speaking
4821690|NCT02493010|Social Phobia|social phobia
4821691|NCT02493010|Biofeedback|biofeedback
4821692|NCT02492997|body fat|body fat
4821693|NCT02492984|FVIII inhibitor|fviii inhibitor
4821694|NCT02492971|Assistive technology|assistive technology
4821695|NCT02492971|functional needs|functional needs
4821696|NCT02492971|system usability|system usability
4821697|NCT02492945|Tennis elbow|tennis elbow
4821698|NCT02492945|Polydeoxyribonucleotides|polydeoxyribonucleotides
4821699|NCT02492945|Prolotherapy|prolotherapy
4821700|NCT02492945|Randomized controlled trial|randomized controlled trial
4821701|NCT02492945|Visual analogue scale|visual analogue scale
4821702|NCT02492945|disability|disability
4821703|NCT02492945|ultrasonography|ultrasonography
4821704|NCT02492919|cardiac surgery|cardiac surgery
4821705|NCT02492919|risk factors|risk factors
4821706|NCT02492919|infection|infection
4821707|NCT02492880|stimulation|stimulation
4821708|NCT02492880|implantable|implantable
4821709|NCT02492880|pulse generator|pulse generator
4821710|NCT02492880|back pain|back pain
4821711|NCT02492880|chronic pain|chronic pain
4821712|NCT02492880|leg pain|leg pain
4821713|NCT02492854|Lower Extremity Bypass|lower extremity bypass
4821714|NCT02492854|Surgical Site Infection|surgical site infection
4821715|NCT02492854|Wound Dressing|wound dressing
4821716|NCT02492854|Negative Pressure Wound Dressing|negative pressure wound dressing
4821717|NCT02492841|dentin substitute|dentin substitute
4821718|NCT02492841|vital pulp therapy|vital pulp therapy
4821719|NCT02492841|Biodentine|biodentine
4821720|NCT02492841|caries|caries
4821721|NCT02492789|immunotherapy|immunotherapy
4821722|NCT02492789|solid tumor|solid tumor
4821723|NCT02492789|PD-1 blockade|pd-1 blockade
4821724|NCT02492776|Volunteers|volunteers
4821725|NCT02492737|acute myeloid leukemia|acute myeloid leukemia
4821726|NCT02492737|AML|aml
4821727|NCT02492737|myelodysplastic syndrome|myelodysplastic syndrome
4821728|NCT02492737|MDS|mds
4821729|NCT02492737|dual mutation|dual mutation
4821730|NCT02492737|MPN|mpn
4821731|NCT02492737|AITL|aitl
4821732|NCT02492737|hematologic malignancies|hematologic malignancies
4821733|NCT02492737|IDH1|idh1
4821734|NCT02492737|IDH2|idh2
4821735|NCT02492737|AG-881|ag-881
4821736|NCT02492724|cervical spine|cervical spine
4821737|NCT02492724|total disc replacement (cTDR)|total disc replacement (ctdr)
4821738|NCT02492724|degenerative disc disease|degenerative disc disease
4821739|NCT02492724|activ® C|activ® c
4821740|NCT02492724|clinical outcome|clinical outcome
4821741|NCT02492724|long-term results|long-term results
4821742|NCT02492724|NDI|ndi
4821743|NCT02492724|VAS|vas
4821744|NCT02492724|heterotopic ossification (HO)|heterotopic ossification (ho)
4821745|NCT02492724|range of motion (ROM)|range of motion (rom)
4821746|NCT02492724|adjacent segment degeneration|adjacent segment degeneration
4821747|NCT02492698|Probiotic|probiotic
4821748|NCT02492698|Weight loss|weight loss
4821749|NCT02492698|Lp-PLA2|lp-pla2
4821750|NCT02492685|Quantitative analysis|quantitative analysis
4821751|NCT02492685|contrast enhanced endoscopic ultrasonography|contrast enhanced endoscopic ultrasonography
4821752|NCT02492659|femtosecond laser|femtosecond laser
4821753|NCT02492633|Smoking cessation|smoking cessation
4821754|NCT02492633|Smoke-free housing|smoke-free housing
4821755|NCT02492633|Affordable housing|affordable housing
4821756|NCT02492633|Second-hand smoke|second-hand smoke
4821757|NCT02492633|Tobacco control|tobacco control
4821758|NCT02492620|ferric citrate|ferric citrate
4821759|NCT02492620|phosphate|phosphate
4821760|NCT02492620|kidney|kidney
4821761|NCT02492607|Women|women
4821762|NCT02492607|DCIS|dcis
4821763|NCT02492607|Active surveillance|active surveillance
4821764|NCT02492607|Standard treatment|standard treatment
4821765|NCT02492581|Selincro|selincro
4821766|NCT02492581|cohort|cohort
4821767|NCT02492581|real-life|real-life
4821768|NCT02492581|total alcohol consumption|total alcohol consumption
4821769|NCT02492581|heavy drinking days|heavy drinking days
4821770|NCT02492581|clinical global impression-severity|clinical global impression-severity
4821771|NCT02492581|EQ5D|eq5d
4821772|NCT02492581|AQoLS|aqols
4821773|NCT02492581|Sheehan disability scale|sheehan disability scale
4821774|NCT02492568|recurrent|recurrent
4821775|NCT02492568|NSCLC|nsclc
4821776|NCT02492568|pembrolizumab|pembrolizumab
4821777|NCT02492568|SBRT|sbrt
4821778|NCT02492555|IBD|ibd
4821779|NCT02492555|Telemedicine|telemedicine
4821780|NCT02492555|At-home monitoring|at-home monitoring
4821781|NCT02492555|Disease activity|disease activity
4821782|NCT02492555|fecal calprotectin|fecal calprotectin
4821783|NCT02492542|electrical stimulation|electrical stimulation
4821784|NCT02492542|urinary incontinence|urinary incontinence
4821785|NCT02492529|Alzheimer, Recognition Memory, Mild Cognitive Impairment, fMRI|alzheimer, recognition memory, mild cognitive impairment, fmri
4821786|NCT02492516|adipose tissue mesenchymal stem cell intravenous injection ALS|adipose tissue mesenchymal stem cell intravenous injection als
4821787|NCT02492503|recurrent or metastatic carcinoma cervix chemotherapy|recurrent or metastatic carcinoma cervix chemotherapy
4821788|NCT02492490|Kidney transplantation|kidney transplantation
4821789|NCT02492490|DCD|dcd
4821790|NCT02492490|Stromal Vascular Fraction|stromal vascular fraction
4821791|NCT02492490|MSC|msc
4821792|NCT02492451|intrauterine insemination|intrauterine insemination
4821793|NCT02492451|pregnancy rate|pregnancy rate
4821794|NCT02492451|endometrial injury|endometrial injury
4821795|NCT02492438|pneumococcal vaccination|pneumococcal vaccination
4821796|NCT02492438|dialysis|dialysis
4821797|NCT02492438|immune response|immune response
4821798|NCT02492425|Community Acquired Pneumonia|community acquired pneumonia
4821799|NCT02492425|Healthcare Associated Pneumonia|healthcare associated pneumonia
4821800|NCT02492399|hypertrophic cardiomyopathy|hypertrophic cardiomyopathy
4821801|NCT02492399|mitral valve|mitral valve
4821802|NCT02492399|SAM syndrome|sam syndrome
4821803|NCT02492386|bioabsorbable vascular scaffold|bioabsorbable vascular scaffold
4821804|NCT02492386|erectile dysfunction|erectile dysfunction
4821805|NCT02492373|Post inflammatory hyperpigmentation|post inflammatory hyperpigmentation
4821806|NCT02492373|topical high potency steroid|topical high potency steroid
4821807|NCT02492373|Qs NdYAG laser|qs ndyag laser
4821808|NCT02492360|Peripheral Neuropathies|peripheral neuropathies
4821809|NCT02492360|Testicular Cancer|testicular cancer
4821810|NCT02492360|Cisplatin|cisplatin
4821811|NCT02492360|Pharmacogenomics|pharmacogenomics
4821812|NCT02492308|kidney|kidney
4821813|NCT02492308|transplantation|transplantation
4821814|NCT02492308|MSC|msc
4821815|NCT02492217|Ankylosing Spondylitis|ankylosing spondylitis
4821816|NCT02492217|adalimumab|adalimumab
4821817|NCT02492217|TNF-alpha agents|tnf-alpha agents
4821818|NCT02492217|spondyloarthritis|spondyloarthritis
4821819|NCT02492217|biologic therapies|biologic therapies
4821820|NCT02492217|AS|as
4821821|NCT02492217|biomarkers|biomarkers
4821822|NCT02492217|efficacy prediction|efficacy prediction
4821823|NCT02492191|Smart Phones|smart phones
4821824|NCT02492191|Ambulatory Care|ambulatory care
4821825|NCT02492191|Outcome and Process Assessment|outcome and process assessment
4821826|NCT02492165|Japanese Encephalitis|japanese encephalitis
4821827|NCT02492165|Japanese encephalitis chimeric virus vaccine|japanese encephalitis chimeric virus vaccine
4821828|NCT02492165|IMOJEV®|imojev®
4821829|NCT02492165|Live attenuated vaccine|live attenuated vaccine
4821830|NCT02492152|women|women
4821831|NCT02492152|active labor|active labor
4821832|NCT02492126|Chronic Cough|chronic cough
4821833|NCT02492126|Gastroesophageal Reflux|gastroesophageal reflux
4821834|NCT02492126|Esophageal Motility|esophageal motility
4821835|NCT02492126|Cough Sensitivity|cough sensitivity
4821836|NCT02492113|Mechanical ventilation|mechanical ventilation
4821837|NCT02492113|Positive end-expiratory pressure|positive end-expiratory pressure
4821838|NCT02492113|Work of breathing|work of breathing
4821839|NCT02492113|Morbidly obese|morbidly obese
4821840|NCT02492100|Sexual Dysfunction Post-Bone Marrow Transplant|sexual dysfunction post-bone marrow transplant
4821841|NCT02492087|topical|topical
4821842|NCT02492087|tranexamic acid|tranexamic acid
4821843|NCT02492087|haemostasis|haemostasis
4821844|NCT02492087|caesarean section|caesarean section
4821845|NCT02492087|bleeding|bleeding
4821846|NCT02492087|postpartum hemorrhage|postpartum hemorrhage
4821847|NCT02492087|prophylactic|prophylactic
4821848|NCT02492074|delta-9-tetrahydrocannabinol|delta-9-tetrahydrocannabinol
4821849|NCT02492074|cannabidiol|cannabidiol
4821850|NCT02492074|COMT|comt
4821851|NCT02492061|couples' HCT married couples|couples' hct married couples
4821852|NCT02492061|Rakai|rakai
4821853|NCT02492061|Uganda|uganda
4821854|NCT02492035|Hypertension|hypertension
4821855|NCT02492035|lifestyle|lifestyle
4821856|NCT02492035|clinical trials|clinical trials
4821857|NCT02492035|primary care setting|primary care setting
4821858|NCT02491996|desire model|desire model
4821859|NCT02491983|metastatic breast cancer|metastatic breast cancer
4821860|NCT02491983|Endocrine receptors positive|endocrine receptors positive
4821861|NCT02491983|HER-2 negative|her-2 negative
4821862|NCT02491957|Energy Expenditure|energy expenditure
4821863|NCT02491957|Physical Endurance|physical endurance
4821864|NCT02491957|Muscle Stength|muscle stength
4821865|NCT02491957|Metabolism|metabolism
4821866|NCT02491931|Cardiac Surgical Procedures|cardiac surgical procedures
4821867|NCT02491931|Cardiovascular Surgical Procedures|cardiovascular surgical procedures
4821868|NCT02491931|Dietary Supplements|dietary supplements
4821869|NCT02491931|Glutamine|glutamine
4821870|NCT02491931|TROPONIN I|troponin i
4821871|NCT02491931|cardiopulmonary bypass|cardiopulmonary bypass
4821872|NCT02491879|mechanical low back pain|mechanical low back pain
4821873|NCT02491879|emergency department|emergency department
4821874|NCT02491879|ketoprofen|ketoprofen
4821875|NCT02491879|gel|gel
4821876|NCT02491840|gastric cancer|gastric cancer
4821877|NCT02491840|cardia cancer|cardia cancer
4821878|NCT02491827|optical biopsy|optical biopsy
4821879|NCT02491814|Dairy|dairy
4821880|NCT02491814|Breakfast cereal|breakfast cereal
4821881|NCT02491814|Postprandial Glycemia|postprandial glycemia
4821882|NCT02491814|Satiety|satiety
4821883|NCT02491814|Food Intake|food intake
4821884|NCT02491814|Milk|milk
4821885|NCT02491814|Yogurt|yogurt
4821887|NCT02491814|Almond|almond
4821888|NCT02491801|Dairy|dairy
4821889|NCT02491801|Milk|milk
4821890|NCT02491801|Yogurt|yogurt
4821891|NCT02491801|Cheese|cheese
4821892|NCT02491801|Postprandial glycaemia|postprandial glycaemia
4821893|NCT02491801|Satiety|satiety
4821894|NCT02491801|Food Intake|food intake
4821895|NCT02491801|Elderly|elderly
4821896|NCT02491801|Prevention and Treatment|prevention and treatment
4821897|NCT02491762|Serratus Anterior|serratus anterior
4821898|NCT02491762|Accessory Respiratory|accessory respiratory
4821899|NCT02491762|Tissue Expander|tissue expander
4821900|NCT02491762|Respiratory Function Tests|respiratory function tests
4821901|NCT02491749|Cardiac anesthesia|cardiac anesthesia
4821902|NCT02491749|ultra fast track|ultra fast track
4821903|NCT02491749|ICU stay|icu stay
4821904|NCT02491710|Surgical education|surgical education
4821905|NCT02491710|Laparoscopy|laparoscopy
4821906|NCT02491710|Laparoscopic suturing|laparoscopic suturing
4821907|NCT02491697|DC-CIK|dc-cik
4821908|NCT02491697|Breast cancer|breast cancer
4821909|NCT02491697|Capecitabine|capecitabine
4821910|NCT02491684|asthma|asthma
4821911|NCT02491684|Upper Respiratory Tract Infection|upper respiratory tract infection
4821912|NCT02491684|exacerbation|exacerbation
4821913|NCT02491684|Interferon|interferon
4821914|NCT02491684|efficacy|efficacy
4821915|NCT02491684|safety|safety
4821916|NCT02491684|prevention|prevention
4821917|NCT02491671|Prevention PAL Prolonged Air Leak (PAL)|prevention pal prolonged air leak (pal)
4821918|NCT02491671|Lung Resection|lung resection
4821919|NCT02491671|Thoracic Surgery|thoracic surgery
4821920|NCT02491671|Post-operative Thoracic Air Leak|post-operative thoracic air leak
4821921|NCT02491645|Autistic spectrum disorder|autistic spectrum disorder
4821922|NCT02491645|Sensory processing abnormalities|sensory processing abnormalities
4821923|NCT02491645|Sensory interventions|sensory interventions
4821924|NCT02491645|occupational therapy|occupational therapy
4821925|NCT02491632|Advanced Cancers|advanced cancers
4821926|NCT02491632|Dexamethasone|dexamethasone
4821927|NCT02491632|Decadron|decadron
4821928|NCT02491632|Exercise|exercise
4821929|NCT02491632|Physical activity|physical activity
4821930|NCT02491632|Questionnaires|questionnaires
4821931|NCT02491632|Surveys|surveys
4821932|NCT02491632|Physical activity tests|physical activity tests
4821933|NCT02491632|Phone calls|phone calls
4821934|NCT02491619|Angle class III|angle class iii
4821935|NCT02491619|tomography|tomography
4821936|NCT02491619|tooth inclination|tooth inclination
4821937|NCT02491619|bone thickness|bone thickness
4821938|NCT02491593|fecal occult blood|fecal occult blood
4821939|NCT02491554|Deep Brain Stimulation|deep brain stimulation
4821940|NCT02491554|Essential tremor|essential tremor
4821941|NCT02491554|DISTINCT|distinct
4821942|NCT02491554|MR-tractography guided DBS implantation|mr-tractography guided dbs implantation
4821943|NCT02491554|Conventional AC-PC based DBS implantation|conventional ac-pc based dbs implantation
4821944|NCT02491515|Osteoporosis|osteoporosis
4821945|NCT02491515|BMD|bmd
4821946|NCT02491515|denosumab|denosumab
4821947|NCT02491515|previous therapy|previous therapy
4821948|NCT02491489|Manual therapy|manual therapy
4821949|NCT02491476|Safety|safety
4821950|NCT02491476|Electrodes|electrodes
4821951|NCT02491476|Device|device
4821952|NCT02491476|StereoElectroencephalograph|stereoelectroencephalograph
4821953|NCT02491476|Epileptogenic zone|epileptogenic zone
4821954|NCT02491476|Fast ripples|fast ripples
4821955|NCT02491463|Reactogenicity|reactogenicity
4821956|NCT02491463|Safety|safety
4821957|NCT02491463|Respiratory syncytial virus (RSV)|respiratory syncytial virus (rsv)
4821958|NCT02491463|Vaccine|vaccine
4821959|NCT02491463|Immunogenicity|immunogenicity
4821960|NCT02491424|Osseointegration|osseointegration
4821961|NCT02491424|Direct skeletal attachment|direct skeletal attachment
4821962|NCT02491385|Thoracic epidural analgesia|thoracic epidural analgesia
4821963|NCT02491385|bowel function recovery|bowel function recovery
4821964|NCT02491333|polycystic ovary syndrome|polycystic ovary syndrome
4821965|NCT02491333|acupuncture|acupuncture
4821966|NCT02491333|insulin resistance|insulin resistance
4821967|NCT02491333|HOMA-IR|homa-ir
4821968|NCT02491333|metformin|metformin
4821969|NCT02491320|polycystic ovary syndrome|polycystic ovary syndrome
4821970|NCT02491320|acupuncture|acupuncture
4821971|NCT02491320|pre-treatment|pre-treatment
4821972|NCT02491320|Letrozole|letrozole
4821973|NCT02491320|Live Birth|live birth
4821974|NCT02491294|School|school
4821975|NCT02491294|Family|family
4821976|NCT02491294|Fruit and Vegetables|fruit and vegetables
4821977|NCT02491294|Cooking|cooking
4821978|NCT02491294|Physical Activity|physical activity
4821979|NCT02491281|Primary Osteoarthritis, Total Knee Replacement, cartilage|primary osteoarthritis, total knee replacement, cartilage
4821980|NCT02491242|HIV|hiv
4821981|NCT02491242|dolutegravir|dolutegravir
4821982|NCT02491242|intolerance|intolerance
4821983|NCT02491242|dual therapies|dual therapies
4821984|NCT02491229|non-alcoholic fatty liver disease (NAFLD)|non-alcoholic fatty liver disease (nafld)
4821985|NCT02491229|Obesity|obesity
4821986|NCT02491229|Hepafast|hepafast
4821987|NCT02491216|Frailty|frailty
4821988|NCT02491216|Frail elderly|frail elderly
4821989|NCT02491216|Acupressure|acupressure
4821990|NCT02491216|Pragmatic Randomised Controlled Trial|pragmatic randomised controlled trial
4821991|NCT02491203|Virtual reality|virtual reality
4821992|NCT02491203|telerehabilitation|telerehabilitation
4821993|NCT02491203|Stroke rehabilitation|stroke rehabilitation
4821994|NCT02491177|HIV Transmission|hiv transmission
4821995|NCT02491177|Prevention of Mother to Child Transmission|prevention of mother to child transmission
4821996|NCT02491177|Linkage to care|linkage to care
4821997|NCT02491177|Retention in care|retention in care
4821998|NCT02491177|Community Mentor Mothers|community mentor mothers
4821999|NCT02491177|Mobile phone text messaging|mobile phone text messaging
4822000|NCT02491177|Antiretroviral therapy adherence|antiretroviral therapy adherence
4822001|NCT02491177|Infant Health|infant health
4822002|NCT02491177|Maternal CD4/viral loads|maternal cd4/viral loads
4822003|NCT02491177|Early infant diagnosis|early infant diagnosis
4822004|NCT02491177|Acceptability of interventions|acceptability of interventions
4822005|NCT02491177|Vertical transmission|vertical transmission
4822006|NCT02491138|participants|participants
4822007|NCT02491086|intervention, nicotine replacement sampling, smoking cessation, smoking hotspots|intervention, nicotine replacement sampling, smoking cessation, smoking hotspots
4822008|NCT02491034|Depression|depression
4822009|NCT02491034|Hispanics|hispanics
4822010|NCT02491034|Stigma|stigma
4822011|NCT02491034|Barriers to Treatment|barriers to treatment
4822012|NCT02491008|Thyroid Dysfunction|thyroid dysfunction
4822013|NCT02491008|Bone mineral density|bone mineral density
4822014|NCT02491008|Osteoporosis|osteoporosis
4822015|NCT02491008|Fractures, Bone|fractures, bone
4822016|NCT02491008|Randomized Controlled Trial|randomized controlled trial
4822017|NCT02490995|children|children
4822018|NCT02490969|copeptin|copeptin
4822019|NCT02490969|rule out marker, emergency department, cheast pain unit|rule out marker, emergency department, cheast pain unit
4822020|NCT02490969|emergency department|emergency department
4822021|NCT02490969|chest pain unit|chest pain unit
4822022|NCT02490956|Diagnostic immunization with rabies vaccine|diagnostic immunization with rabies vaccine
4822023|NCT02490956|Primary immunodeficiency|primary immunodeficiency
4822024|NCT02490943|peginterferon beta-1a|peginterferon beta-1a
4822025|NCT02490943|MS (Multiple Sclerosis)|ms (multiple sclerosis)
4822026|NCT02490943|Injection Site Reaction Erythema|injection site reaction erythema
4822027|NCT02490930|lymphopenia|lymphopenia
4822028|NCT02490917|Female urinary incontinence|female urinary incontinence
4822029|NCT02490917|Sphincter deficiency|sphincter deficiency
4822030|NCT02490904|Kidney transplantation|kidney transplantation
4822031|NCT02490904|Eplerenone|eplerenone
4822032|NCT02490891|Lymphoma, angiogenesis, PET scan|lymphoma, angiogenesis, pet scan
4822033|NCT02490839|Helicobacter pylori|helicobacter pylori
4822034|NCT02490839|high dose dual therapy|high dose dual therapy
4822035|NCT02490839|bismuth-containing quadruple therapy|bismuth-containing quadruple therapy
4822036|NCT02490839|antibiotic resistance|antibiotic resistance
4822037|NCT02490826|Speech Sound Disorders|speech sound disorders
4822038|NCT02490826|Tabletop|tabletop
4822039|NCT02490826|Digital|digital
4822040|NCT02490813|Fish allergy|fish allergy
4822041|NCT02490813|shrimp allergy|shrimp allergy
4822042|NCT02490813|crab allergy|crab allergy
4822043|NCT02490813|traditional Chinese medicine|traditional chinese medicine
4822044|NCT02490761|Geriatrics|geriatrics
4822045|NCT02490761|Nutritional Status|nutritional status
4822046|NCT02490761|Hospitalisation|hospitalisation
4822047|NCT02490722|Patient education|patient education
4822048|NCT02490722|Empowerment|empowerment
4822049|NCT02490709|Rectal neoplasms|rectal neoplasms
4822050|NCT02490709|Colorectal neoplasms|colorectal neoplasms
4822051|NCT02490709|Local excision|local excision
4822052|NCT02490696|PET scan|pet scan
4822053|NCT02490696|FAZA|faza
4822054|NCT02490696|F-Miso|f-miso
4822055|NCT02490696|hypoxia|hypoxia
4822056|NCT02490696|lung cancer|lung cancer
4822057|NCT02490631|skin flora|skin flora
4822058|NCT02490605|Postural balance|postural balance
4822059|NCT02490605|Temporomandibular disorders|temporomandibular disorders
4822060|NCT02490605|Splints|splints
4822061|NCT02490579|video messaging|video messaging
4822062|NCT02490579|exercise|exercise
4822063|NCT02490579|diet|diet
4822064|NCT02490579|weight gain|weight gain
4822065|NCT02490579|pregnancy|pregnancy
4822066|NCT02490566|chronic condition|chronic condition
4822067|NCT02490566|telehealth|telehealth
4822068|NCT02490566|nutrition|nutrition
4822069|NCT02490566|exercise|exercise
4822070|NCT02490553|air pollution|air pollution
4822071|NCT02490553|epidemiological survey|epidemiological survey
4822072|NCT02490553|representative sample|representative sample
4822073|NCT02490540|opioids|opioids
4822074|NCT02490540|analgesia|analgesia
4822075|NCT02490540|pain|pain
4822076|NCT02490540|anesthesia|anesthesia
4822077|NCT02490527|myopathy|myopathy
4822078|NCT02490527|muscular weakness|muscular weakness
4822079|NCT02490527|cramping|cramping
4822080|NCT02490527|fatigue|fatigue
4822081|NCT02490488|ovarian cancer|ovarian cancer
4822082|NCT02490462|Cerebral Palsy|cerebral palsy
4822083|NCT02490462|Physical Therapy|physical therapy
4822084|NCT02490462|Family-centered Care|family-centered care
4822085|NCT02490384|Cervical cerclage|cervical cerclage
4822086|NCT02490345|gabapentin|gabapentin
4822087|NCT02490319|radiation pneumonitis|radiation pneumonitis
4822088|NCT02490319|lung cancer|lung cancer
4822089|NCT02490319|prediction models|prediction models
4822090|NCT02490319|genetic variants|genetic variants
4822091|NCT02490241|pregnant|pregnant
4822092|NCT02490241|female|female
4822093|NCT02490241|women|women
4822094|NCT02490241|lithium|lithium
4822095|NCT02490241|bipolar|bipolar
4822096|NCT02490228|female|female
4822097|NCT02490228|minimally invasive surgery|minimally invasive surgery
4822098|NCT02490150|Corifollitropin alfa|corifollitropin alfa
4822099|NCT02490150|Stimulation protocol|stimulation protocol
4822100|NCT02490124|Diabetes Type 1|diabetes type 1
4822101|NCT02490124|Vascular Function|vascular function
4822102|NCT02490098|Type 1 diabetes|type 1 diabetes
4822103|NCT02490098|Closed-loop system|closed-loop system
4822104|NCT02490098|Artificial pancreas|artificial pancreas
4822105|NCT02490098|Insulin|insulin
4822106|NCT02490098|Glucagon|glucagon
4822107|NCT02490098|Hypoglycemia|hypoglycemia
4822108|NCT02490098|Postprandial glucose|postprandial glucose
4822109|NCT02490085|Type 2 diabetes|type 2 diabetes
4822110|NCT02490085|Closed-loop strategy|closed-loop strategy
4822111|NCT02490085|Artificial pancreas|artificial pancreas
4822112|NCT02490085|Insulin|insulin
4822113|NCT02490085|Elderly|elderly
4822114|NCT02490085|Multiple daily injections|multiple daily injections
4822115|NCT02490085|Hypoglycemia|hypoglycemia
4822116|NCT02490046|D mannose|d mannose
4822117|NCT02490046|multiple sclerosis|multiple sclerosis
4822118|NCT02490046|recurrent urinary infections|recurrent urinary infections
4822119|NCT02490020|Renal transplantation|renal transplantation
4822120|NCT02490020|mesenchymal stem cell|mesenchymal stem cell
4822121|NCT02490020|Transplantation Rejection|transplantation rejection
4822122|NCT02490020|donation after cardiac death|donation after cardiac death
4822123|NCT02490007|Acellular pertussis vaccine|acellular pertussis vaccine
4822124|NCT02490007|whole cell pertussis vaccine|whole cell pertussis vaccine
4822125|NCT02490007|IgE-mediated food allergy|ige-mediated food allergy
4822126|NCT02489916|Metastatic Colorectal Cancer|metastatic colorectal cancer
4822127|NCT02489916|CM4307|cm4307
4822128|NCT02489916|Previously treated metastatic colorectal cancer|previously treated metastatic colorectal cancer
4822129|NCT02489903|Epigenetics|epigenetics
4822130|NCT02489903|resensitization|resensitization
4822131|NCT02489903|Platinum doublets|platinum doublets
4822132|NCT02489903|lung cancer|lung cancer
4822133|NCT02489903|Ovarian epithelial cancer|ovarian epithelial cancer
4822134|NCT02489877|multiple sclerosis|multiple sclerosis
4822135|NCT02489877|HERV-W virus|herv-w virus
4822136|NCT02489877|Herpesviridae family|herpesviridae family
4822137|NCT02489864|Terlipressin|terlipressin
4822138|NCT02489864|mean arterial pressure|mean arterial pressure
4822139|NCT02489864|type 2 HRS|type 2 hrs
4822140|NCT02489838|Liver Neoplasma|liver neoplasma
4822141|NCT02489838|Lung Radiation dose|lung radiation dose
4822142|NCT02489825|randomized controlled trial|randomized controlled trial
4822143|NCT02489825|vertebral fracture|vertebral fracture
4822144|NCT02489825|osteoporosis|osteoporosis
4822145|NCT02489825|vertebroplasty|vertebroplasty
4822146|NCT02489825|augmentation|augmentation
4822147|NCT02489812|children|children
4822148|NCT02489812|behavior|behavior
4822150|NCT02489812|dentistry|dentistry
4822151|NCT02489799|advance care planning|advance care planning
4822152|NCT02489773|Lucica|lucica
4822153|NCT02489773|glycated albumin|glycated albumin
4822154|NCT02489773|GA|ga
4822155|NCT02489773|fructosamine|fructosamine
4822156|NCT02489760|Etanercept|etanercept
4822157|NCT02489760|Adalimumab|adalimumab
4822158|NCT02489760|Ankylosing Spondylitis|ankylosing spondylitis
4822159|NCT02489760|Switch Study|switch study
4822160|NCT02489747|cognitive function|cognitive function
4822161|NCT02489747|CNT|cnt
4822162|NCT02489747|memory function|memory function
4822163|NCT02489747|Triticum aestivum L|triticum aestivum l
4822164|NCT02489747|wheat bran|wheat bran
4822165|NCT02489734|sevoflurane|sevoflurane
4822166|NCT02489734|emergence delirium|emergence delirium
4822167|NCT02489734|preschool|preschool
4822168|NCT02489721|peripherally inserted central venous catheter|peripherally inserted central venous catheter
4822169|NCT02489721|depp vein thrombosis|depp vein thrombosis
4822170|NCT02489721|related blood stream infections|related blood stream infections
4822171|NCT02489721|midline|midline
4822172|NCT02489708|Bronchiolitis|bronchiolitis
4822173|NCT02489708|Cough|cough
4822174|NCT02489708|Ear Infection|ear infection
4822175|NCT02489708|Respiratory Infection|respiratory infection
4822176|NCT02489708|Wheezing|wheezing
4822177|NCT02489708|Clinical Decision Support Systems|clinical decision support systems
4822178|NCT02489695|locally advanced or metastatic|locally advanced or metastatic
4822179|NCT02489656|Double loop ureteral stent|double loop ureteral stent
4822180|NCT02489656|USSQ|ussq
4822181|NCT02489656|Quality of life|quality of life
4822182|NCT02489656|Pain|pain
4822183|NCT02489604|neuroendocrine tumors|neuroendocrine tumors
4822184|NCT02489578|Community Acquired Pneumonia|community acquired pneumonia
4822185|NCT02489578|health care associated pneumonia|health care associated pneumonia
4822186|NCT02489565|Coronary Artery Disease|coronary artery disease
4822187|NCT02489565|stable|stable
4822188|NCT02489565|Telemedicine|telemedicine
4822189|NCT02489565|Patient Discharge|patient discharge
4822190|NCT02489539|Aortic aneurysm|aortic aneurysm
4822191|NCT02489539|Abdominal aorta|abdominal aorta
4822192|NCT02489539|Stent graft|stent graft
4822193|NCT02489539|Aneurysm|aneurysm
4822194|NCT02489539|Vascular Diseases|vascular diseases
4822195|NCT02489539|Cardiovascular Diseases|cardiovascular diseases
4822196|NCT02489500|AL Amyloidosis|al amyloidosis
4822197|NCT02489500|Stem Cell Transplantation|stem cell transplantation
4822198|NCT02489448|Breast Cancer|breast cancer
4822199|NCT02489383|Asthma|asthma
4822200|NCT02489383|Continuous Exercise Training|continuous exercise training
4822201|NCT02489383|interval Exercise Training|interval exercise training
4822202|NCT02489383|Clinical Control|clinical control
4822203|NCT02489383|Inflammation|inflammation
4822204|NCT02489370|home care|home care
4822205|NCT02489370|telecare|telecare
4822206|NCT02489370|telehealth|telehealth
4822207|NCT02489370|telemonitoring|telemonitoring
4822208|NCT02489370|chronic heart failure|chronic heart failure
4822209|NCT02489370|randomized controlled trial|randomized controlled trial
4822210|NCT02489370|Congestive Heart Failure|congestive heart failure
4822211|NCT02489370|telemedicine|telemedicine
4822212|NCT02489331|Dyslipidemias|dyslipidemias
4822213|NCT02489318|Prostate Cancer|prostate cancer
4822214|NCT02489318|JNJ-56021927|jnj-56021927
4822215|NCT02489318|Androgen Deprivation Therapy|androgen deprivation therapy
4822216|NCT02489318|ARN-509|arn-509
4822217|NCT02489318|Apalutamide|apalutamide
4822218|NCT02489318|TITAN|titan
4822219|NCT02489318|Metastatic Hormone-sensitive Prostate Cancer|metastatic hormone-sensitive prostate cancer
4822220|NCT02489305|Depressive Disorder, Major|depressive disorder, major
4822221|NCT02489305|Depression|depression
4822222|NCT02489305|Anti-Depressant|anti-depressant
4822223|NCT02489305|Observational|observational
4822224|NCT02489292|Urea Cycle Disorder|urea cycle disorder
4822225|NCT02489292|UCD|ucd
4822226|NCT02489292|cell therapy|cell therapy
4822227|NCT02489292|stem cell|stem cell
4822228|NCT02489279|Attention deficit hyperactivity disorder.|attention deficit hyperactivity disorder.
4822229|NCT02489279|Attention training|attention training
4822230|NCT02489279|Mobile devices|mobile devices
4822231|NCT02489279|Brain training|brain training
4822232|NCT02489266|Melanoma|melanoma
4822233|NCT02489266|Immunotherapy|immunotherapy
4822234|NCT02489227|PsO|pso
4822235|NCT02489214|donafenib|donafenib
4822236|NCT02489201|donafenib|donafenib
4822237|NCT02489188|gait asymmetry|gait asymmetry
4822238|NCT02489188|joint angles|joint angles
4822239|NCT02489175|Parastomal hernia|parastomal hernia
4822240|NCT02489175|prevention|prevention
4822241|NCT02489175|stomaplasty|stomaplasty
4822242|NCT02489175|ring|ring
4822243|NCT02489149|food insecurity|food insecurity
4822244|NCT02489136|spiritist passe|spiritist passe
4822245|NCT02489136|laying of hands|laying of hands
4822246|NCT02489136|newborn|newborn
4822247|NCT02489136|adult|adult
4822248|NCT02489136|conditions|conditions
4822249|NCT02489110|Alzheimer's Disease|alzheimer's disease
4822250|NCT02489110|Dementia|dementia
4822251|NCT02489110|caregiving|caregiving
4822252|NCT02489110|caregiver|caregiver
4822253|NCT02489110|coping|coping
4822254|NCT02489110|coping with caregiving|coping with caregiving
4822255|NCT02489110|stress|stress
4822256|NCT02489110|Hispanic caregiver|hispanic caregiver
4822257|NCT02489110|Latino caregiver|latino caregiver
4822258|NCT02489084|Head and Neck neoplasms|head and neck neoplasms
4822259|NCT02489084|Genome-wide association study|genome-wide association study
4822260|NCT02489084|Polymorphism, single nucleotide|polymorphism, single nucleotide
4822261|NCT02489084|Toxicity|toxicity
4822262|NCT02489019|Anesthesia|anesthesia
4822263|NCT02489019|Fentanyl|fentanyl
4822264|NCT02489019|Elderly|elderly
4822265|NCT02488980|Falciparum Parasitaemia, Malaria|falciparum parasitaemia, malaria
4822266|NCT02488954|Ulcerative colitis|ulcerative colitis
4822269|NCT02488954|Propionibacterium freudenreichii|propionibacterium freudenreichii
4822270|NCT02488941|Liver Function Tests|liver function tests
4822271|NCT02488941|Blood Coagulation|blood coagulation
4822272|NCT02488928|NSCLC|nsclc
4822273|NCT02488928|EBUS|ebus
4822274|NCT02488928|elastography|elastography
4822275|NCT02488928|predictive value|predictive value
4822276|NCT02488928|strain|strain
4822277|NCT02488915|Brain|brain
4822278|NCT02488915|Brain Clot|brain clot
4822279|NCT02488915|Brain Diseases|brain diseases
4822280|NCT02488915|Brain Infarction|brain infarction
4822281|NCT02488915|Cerebral Ischemia|cerebral ischemia
4822282|NCT02488915|Cerebrovascular Disorders|cerebrovascular disorders
4822283|NCT02488915|EmboTrap® Revascularization Device|embotrap® revascularization device
4822284|NCT02488915|EmboTrap|embotrap
4822285|NCT02488915|Ischemia|ischemia
4822286|NCT02488915|Ischemic|ischemic
4822287|NCT02488915|Ischemic Stroke|ischemic stroke
4822288|NCT02488915|Mechanical Thrombectomy|mechanical thrombectomy
4822289|NCT02488915|Neurovascular Intervention|neurovascular intervention
4822290|NCT02488915|Revascularization|revascularization
4822291|NCT02488915|Stent Retriever|stent retriever
4822292|NCT02488915|Stroke|stroke
4822293|NCT02488915|Vascular Diseases|vascular diseases
4822294|NCT02488915|Neuravi|neuravi
4822295|NCT02488889|Chantix|chantix
4822296|NCT02488876|Cardiac surgery|cardiac surgery
4822297|NCT02488876|Tissue sample database|tissue sample database
4822298|NCT02488876|Inflammatory responds|inflammatory responds
4822299|NCT02488863|Older adults|older adults
4822300|NCT02488863|Chronic Pain|chronic pain
4822301|NCT02488863|Musculoskeletal|musculoskeletal
4822302|NCT02488850|immune monitoring|immune monitoring
4822303|NCT02488850|T cell activation|t cell activation
4822304|NCT02488850|early stage|early stage
4822305|NCT02488837|Deep Brain Stimulation|deep brain stimulation
4822306|NCT02488824|Quadriplegia|quadriplegia
4822307|NCT02488824|Paraplegia|paraplegia
4822308|NCT02488824|Spinal Cord Injury|spinal cord injury
4822309|NCT02488824|Body Temperature Regulation|body temperature regulation
4822310|NCT02488824|Mild Cognitive Impairment|mild cognitive impairment
4822311|NCT02488785|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
4822312|NCT02488785|Telehealth|telehealth
4822313|NCT02488785|Hispanics|hispanics
4822314|NCT02488785|Latinos|latinos
4822315|NCT02488785|Self-Care|self-care
4822316|NCT02488785|Mobile Health|mobile health
4822317|NCT02488785|mHealth|mhealth
4822318|NCT02488772|sleep quality|sleep quality
4822319|NCT02488772|emergency department|emergency department
4822320|NCT02488733|type 2 diabetes mellitus|type 2 diabetes mellitus
4822321|NCT02488733|obesity|obesity
4822322|NCT02488733|laparoscopic sleeve gastrectomy|laparoscopic sleeve gastrectomy
4822323|NCT02488733|bariatric surgery|bariatric surgery
4822324|NCT02488733|metabolic surgery|metabolic surgery
4822325|NCT02488720|amyloid imaging|amyloid imaging
4822326|NCT02488720|biomarkers|biomarkers
4822327|NCT02488720|cognition|cognition
4822328|NCT02488720|longitudinal|longitudinal
4822329|NCT02488720|cognitive decline|cognitive decline
4822330|NCT02488720|observational|observational
4822331|NCT02488707|low rectal cancer|low rectal cancer
4822332|NCT02488707|minimally invasive colorectal surgery|minimally invasive colorectal surgery
4822333|NCT02488707|trans-anal endoscopic microsurgery|trans-anal endoscopic microsurgery
4822334|NCT02488707|TEM|tem
4822335|NCT02488707|intersphincteric resection|intersphincteric resection
4822336|NCT02488707|ISR|isr
4822337|NCT02488707|subtotal intersphincteric resection|subtotal intersphincteric resection
4822338|NCT02488707|total intersphincteric resection|total intersphincteric resection
4822339|NCT02488707|trans-anal trans-abdominal resection|trans-anal trans-abdominal resection
4822340|NCT02488707|laparoscopic intersphincteric resection|laparoscopic intersphincteric resection
4822341|NCT02488707|anal sphincter preservation|anal sphincter preservation
4822342|NCT02488707|total mesorectal excision|total mesorectal excision
4822343|NCT02488707|TME|tme
4822344|NCT02488707|TATA|tata
4822345|NCT02488707|laparoscopic total mesorectal excision|laparoscopic total mesorectal excision
4822346|NCT02488707|external sphincter preservation|external sphincter preservation
4822347|NCT02488707|Neoadjuvant chemo-radiotherapy for rectal cancer|neoadjuvant chemo-radiotherapy for rectal cancer
4822348|NCT02488707|fit patients for minimally invasive surgery|fit patients for minimally invasive surgery
4822349|NCT02488668|Transcutaneous Electrical Stimulation|transcutaneous electrical stimulation
4822350|NCT02488668|Neuroplasticity|neuroplasticity
4822351|NCT02488668|Sensory Feedback|sensory feedback
4822352|NCT02488642|Isosorbide dinitrate gel solution|isosorbide dinitrate gel solution
4822353|NCT02488642|late intrauterine death|late intrauterine death
4822354|NCT02488642|nitric oxide donors|nitric oxide donors
4822355|NCT02488629|Head and neck squamous cell carcinoma|head and neck squamous cell carcinoma
4822356|NCT02488616|Closed-loop system|closed-loop system
4822357|NCT02488616|Artificial pancreas|artificial pancreas
4822358|NCT02488616|Type 1 diabetes|type 1 diabetes
4822359|NCT02488616|Hypoglycemia|hypoglycemia
4822360|NCT02488616|Insulin|insulin
4822361|NCT02488603|Breast Neoplasms|breast neoplasms
4822362|NCT02488603|Tamoxifen|tamoxifen
4822363|NCT02488603|Decision Aids|decision aids
4822364|NCT02488564|HER-2 Positive Breast Cancer|her-2 positive breast cancer
4822365|NCT02488564|operable breast cancer|operable breast cancer
4822366|NCT02488564|locally advanced breast cancer|locally advanced breast cancer
4822367|NCT02488564|no prior therapy|no prior therapy
4822368|NCT02488564|pCR|pcr
4822369|NCT02488525|Acquired Von Willebrand|acquired von willebrand
4822370|NCT02488525|Gastro-intestinal bleeding|gastro-intestinal bleeding
4822371|NCT02488525|LVAD|lvad
4822372|NCT02488512|Relapsed/refractory diffuse large b cell|relapsed/refractory diffuse large b cell
4822373|NCT02488512|Relapsed/refractory mantle cell lymphomas|relapsed/refractory mantle cell lymphomas
4822374|NCT02488512|DLBCL|dlbcl
4822375|NCT02488512|MCL|mcl
4822376|NCT02488512|90Y-DOTATOC|90y-dotatoc
4822377|NCT02488512|SSR-positive tumour|ssr-positive tumour
4822378|NCT02488499|Disruptive Behaviour Disorder|disruptive behaviour disorder
4822379|NCT02488499|Psychosocial|psychosocial
4822380|NCT02488499|Group Treatment|group treatment
4822381|NCT02488473|Volunteers|volunteers
4822382|NCT02488460|Motor Activity|motor activity
4822383|NCT02488460|Cognition|cognition
4822384|NCT02488460|Academic Acheivement|academic acheivement
4822385|NCT02488460|Preadolescent Children|preadolescent children
4822386|NCT02488447|Allergy|allergy
4822387|NCT02488447|Allergic rhinoconjunctivitis|allergic rhinoconjunctivitis
4822388|NCT02488447|Immunotherapy|immunotherapy
4822389|NCT02488447|Life Quality|life quality
4822390|NCT02488447|Adherence|adherence
4822391|NCT02488434|ICSI|icsi
4822392|NCT02488434|sperm selection|sperm selection
4822393|NCT02488434|fertile chip|fertile chip
4822394|NCT02488434|ıcsı outcomes|ıcsı outcomes
4822395|NCT02488395|Parkinson's disease|parkinson's disease
4822396|NCT02488395|Non-motor symptoms|non-motor symptoms
4822397|NCT02488395|Visual deficits|visual deficits
4822398|NCT02488395|Superior colliculus|superior colliculus
4822399|NCT02488395|fMRI|fmri
4822400|NCT02488382|lymphoma|lymphoma
4822401|NCT02488382|multiple myeloma|multiple myeloma
4822402|NCT02488382|stem cell mobilization|stem cell mobilization
4822403|NCT02488382|autologous stem cell transplantation|autologous stem cell transplantation
4822404|NCT02488369|Children and adolescents|children and adolescents
4822405|NCT02488343|Multiple Sclerosis|multiple sclerosis
4822406|NCT02488343|Adherence|adherence
4822407|NCT02488343|Therapies|therapies
4822408|NCT02488343|Psychological Intervention|psychological intervention
4822409|NCT02488317|Chronic Kidney Disease|chronic kidney disease
4822410|NCT02488317|Hemodialysis|hemodialysis
4822411|NCT02488317|Peritoneal Dialysis|peritoneal dialysis
4822412|NCT02488304|HRCT|hrct
4822413|NCT02488304|High Resolution Computed Tomography scans|high resolution computed tomography scans
4822414|NCT02488304|Functional Respiratory Imaging|functional respiratory imaging
4822415|NCT02488304|FRI|fri
4822416|NCT02488304|Computed Tomography|computed tomography
4822417|NCT02488304|CT|ct
4822418|NCT02488304|Bronchiolitis Obliterans Syndrome|bronchiolitis obliterans syndrome
4822419|NCT02488304|BOS|bos
4822420|NCT02488304|Lung Transplant|lung transplant
4822421|NCT02488291|Epidural|epidural
4822422|NCT02488291|Analgesia labor|analgesia labor
4822423|NCT02488291|Perinatal|perinatal
4822424|NCT02488291|anesthesia|anesthesia
4822425|NCT02488278|Glucose blood measurements, glucometers ,audio communication|glucose blood measurements, glucometers ,audio communication
4822426|NCT02488265|Parkinson´s disease|parkinson´s disease
4822427|NCT02488265|Physicaltherapy|physicaltherapy
4822428|NCT02488265|Postural Balance|postural balance
4822429|NCT02488265|Gait|gait
4822430|NCT02488265|Rehabilitation|rehabilitation
4822431|NCT02488252|Chinese Medicine|chinese medicine
4822432|NCT02488252|ACEI|acei
4822433|NCT02488252|ARB|arb
4822434|NCT02488252|Pragmatic trial|pragmatic trial
4822435|NCT02488213|Nutritional Counseling|nutritional counseling
4822436|NCT02488213|Diet|diet
4822437|NCT02488187|Breast Cancer|breast cancer
4822438|NCT02488187|MRI|mri
4822439|NCT02488187|Mammogram|mammogram
4822440|NCT02488187|Whole Breast Sonogram|whole breast sonogram
4822441|NCT02488187|ABUS|abus
4822442|NCT02488161|Colorectal cancer|colorectal cancer
4822443|NCT02488161|Risk factors|risk factors
4822444|NCT02488161|Adverse events|adverse events
4822445|NCT02488161|Predictive models|predictive models
4822446|NCT02488122|Bone Mineral Density|bone mineral density
4822447|NCT02488122|Isometric Exercise|isometric exercise
4822448|NCT02488122|Bone Growth|bone growth
4822449|NCT02488109|anorexia nervosa|anorexia nervosa
4822450|NCT02488109|eating disorders|eating disorders
4822451|NCT02488109|refeeding|refeeding
4822452|NCT02488109|adolescent medicine|adolescent medicine
4822453|NCT02488109|nutritional rehabilitation|nutritional rehabilitation
4822454|NCT02488083|non-invasive|non-invasive
4822455|NCT02488031|SCA, dysmetria|sca, dysmetria
4822456|NCT02488018|Glycemic index|glycemic index
4822457|NCT02488018|honey|honey
4822458|NCT02488018|reference glucose|reference glucose
4822459|NCT02488005|Inflammatory Bowel Disease|inflammatory bowel disease
4822460|NCT02488005|Small Bowel|small bowel
4822461|NCT02488005|Crohn's Disease|crohn's disease
4822462|NCT02488005|Small Bowel Ultrasound|small bowel ultrasound
4822463|NCT02487966|tDCS|tdcs
4822464|NCT02487966|Mirror Therapy|mirror therapy
4822465|NCT02487966|Phantom Limb Pain|phantom limb pain
4822466|NCT02487966|Traumatic amputation|traumatic amputation
4822467|NCT02487953|Nicotine addiction|nicotine addiction
4822468|NCT02487953|Cigarette smoking|cigarette smoking
4822469|NCT02487953|Smoking cessation|smoking cessation
4822470|NCT02487953|Nicotine patches|nicotine patches
4822471|NCT02487953|E-cigarettes|e-cigarettes
4822472|NCT02487940|Recurrent implantation failure|recurrent implantation failure
4822473|NCT02487940|IVF|ivf
4822474|NCT02487940|ICSI|icsi
4822475|NCT02487940|Intralipid|intralipid
4822476|NCT02487914|Drug Delivery|drug delivery
4822477|NCT02487914|Iontophoresis|iontophoresis
4822478|NCT02487914|Lidocaine|lidocaine
4822479|NCT02487914|Pressure|pressure
4822480|NCT02487914|Tactile perception|tactile perception
4822481|NCT02487901|arthrodesiss|arthrodesiss
4822482|NCT02487901|cervical vertebra|cervical vertebra
4822483|NCT02487901|laminoplasty|laminoplasty
4822484|NCT02487888|Genetic Variation|genetic variation
4822485|NCT02487888|Genetic Polymorphism|genetic polymorphism
4822486|NCT02487888|Polymorphism, Single Nucleotide|polymorphism, single nucleotide
4822487|NCT02487888|Genetic Association Studies|genetic association studies
4822488|NCT02487888|Healthcare Utilization|healthcare utilization
4822489|NCT02487875|Sit-to-stand test|sit-to-stand test
4822490|NCT02487875|Muscle strength|muscle strength
4822491|NCT02487875|Pulmonary rehabilitation|pulmonary rehabilitation
4822492|NCT02487836|Laying of the biliary stent|laying of the biliary stent
4822493|NCT02487771|DHA|dha
4822494|NCT02487771|childhood development|childhood development
4822495|NCT02487745|Cocaine|cocaine
4822496|NCT02487745|Methadone|methadone
4822497|NCT02487745|Employment|employment
4822498|NCT02487745|Opioids|opioids
4822499|NCT02487732|Diabetic Patients With Non-ST Elevation|diabetic patients with non-st elevation
4822500|NCT02487719|Iron deficiecy|iron deficiecy
4822501|NCT02487719|pregnancy|pregnancy
4822502|NCT02487719|prenatal care|prenatal care
4822503|NCT02487706|Hemodialysis|hemodialysis
4822504|NCT02487706|HIV-infection|hiv-infection
4822505|NCT02487654|Paroxysmal atrial fibrillation|paroxysmal atrial fibrillation
4822506|NCT02487654|Pulmonary vein isolation|pulmonary vein isolation
4822507|NCT02487654|Ganglionic plexi|ganglionic plexi
4822508|NCT02487654|Radiofrequency|radiofrequency
4822509|NCT02487654|late gadolinium enhancement cardiac MR imaging|late gadolinium enhancement cardiac mr imaging
4822510|NCT02487654|High Frequency Stimulation|high frequency stimulation
4822511|NCT02487641|Ultrasound|ultrasound
4822512|NCT02487641|mid-trimester|mid-trimester
4822513|NCT02487641|Obesity|obesity
4822514|NCT02487641|pregnancy|pregnancy
4822515|NCT02487615|Glycaemia|glycaemia
4822516|NCT02487615|Subclinical Atherosclerosis|subclinical atherosclerosis
4822517|NCT02487615|Carotid Doppler Ultrasound|carotid doppler ultrasound
4822518|NCT02487615|Carotid Plaque|carotid plaque
4822519|NCT02487615|Intima Media Thickness|intima media thickness
4822520|NCT02487615|Ankle Brachial Index|ankle brachial index
4822521|NCT02487615|Exercise Stress Test|exercise stress test
4822522|NCT02487615|Coronary Calcium Score|coronary calcium score
4822523|NCT02487615|Insulinemia|insulinemia
4822524|NCT02487615|Leptin|leptin
4822525|NCT02487615|Inflammation|inflammation
4822526|NCT02487615|Resistin|resistin
4822527|NCT02487615|Tumor Necrosis Factor alpha|tumor necrosis factor alpha
4822528|NCT02487615|Phospholipase A2, Group VII|phospholipase a2, group vii
4822529|NCT02487615|Body Mass Index|body mass index
4822530|NCT02487615|Adipose Tissue Function|adipose tissue function
4822531|NCT02487615|Single Gene Polymorphism|single gene polymorphism
4822532|NCT02487589|Falls|falls
4822533|NCT02487589|Elderly|elderly
4822534|NCT02487589|e-Health|e-health
4822535|NCT02487589|Telemedicine|telemedicine
4822536|NCT02487563|Isolated thrombocytopenia|isolated thrombocytopenia
4822537|NCT02487563|decitabine|decitabine
4822538|NCT02487563|rhTPO|rhtpo
4822539|NCT02487550|Renal neoplasma|renal neoplasma
4822540|NCT02487550|CIK cells|cik cells
4822541|NCT02487537|incretin release|incretin release
4822542|NCT02487524|Neuropathic Pain|neuropathic pain
4822543|NCT02487524|Breast Cancer|breast cancer
4822544|NCT02487524|Post surgical|post surgical
4822545|NCT02487498|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
4822546|NCT02487472|France|france
4822547|NCT02487472|Post-herpetic neuralgia|post-herpetic neuralgia
4822548|NCT02487472|Herpes zoster|herpes zoster
4822549|NCT02487472|Economic burden of disease|economic burden of disease
4822550|NCT02487459|acute lymphoblastic leukemia|acute lymphoblastic leukemia
4822551|NCT02487459|acute myeloid leukemia|acute myeloid leukemia
4822552|NCT02487459|chronic myeloid leukemia|chronic myeloid leukemia
4822553|NCT02487459|myelodysplastic syndrome|myelodysplastic syndrome
4822554|NCT02487459|non-hodgkin lymphoma|non-hodgkin lymphoma
4822555|NCT02487459|hodgkin lymphoma|hodgkin lymphoma
4822556|NCT02487446|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
4822557|NCT02487433|food effect|food effect
4822558|NCT02487433|pharmacokinetics|pharmacokinetics
4822559|NCT02487433|healthy volunteers|healthy volunteers
4822560|NCT02487381|delta-9-tetrahydrocannabinol|delta-9-tetrahydrocannabinol
4822561|NCT02487381|cannabidiol|cannabidiol
4822562|NCT02487381|COMT|comt
4822563|NCT02487381|Volunteers|volunteers
4822564|NCT02487355|dexmedetomidine|dexmedetomidine
4822565|NCT02487355|magnesium sulphate|magnesium sulphate
4822566|NCT02487342|Dairy|dairy
4822567|NCT02487342|appetite|appetite
4822568|NCT02487342|feeding behaviour|feeding behaviour
4822569|NCT02487329|Direct pulp capping|direct pulp capping
4822570|NCT02487329|Er,Cr:YSGG laser|er,cr:ysgg laser
4822571|NCT02487329|Tricalcium silicate|tricalcium silicate
4822572|NCT02487316|Anaplastic Large Cell Lymphoma|anaplastic large cell lymphoma
4822573|NCT02487316|anaplastic lymphoma kinase rearrangement|anaplastic lymphoma kinase rearrangement
4822574|NCT02487316|crizotinib|crizotinib
4822575|NCT02487316|CHOP chemotherapy|chop chemotherapy
4822576|NCT02487303|Acetaminophen|acetaminophen
4822577|NCT02487303|Pain, Postoperative|pain, postoperative
4822578|NCT02487303|Analgesia, Obstetrical|analgesia, obstetrical
4822579|NCT02487303|Cesarean Section|cesarean section
4822580|NCT02487290|AAA|aaa
4822581|NCT02487290|Endoleak|endoleak
4822582|NCT02487277|Pancreatic|pancreatic
4822583|NCT02487251|Obesity|obesity
4822584|NCT02487251|Family Mealtimes|family mealtimes
4822585|NCT02487251|Prevention|prevention
4822586|NCT02487238|Microbiome|microbiome
4822587|NCT02487238|Microbiota|microbiota
4822588|NCT02487238|Fecal Microbial Transplant|fecal microbial transplant
4822589|NCT02487238|Fecal Microbiota Transplant|fecal microbiota transplant
4822590|NCT02487238|FMT|fmt
4822591|NCT02487238|Gastroenterology|gastroenterology
4822592|NCT02487238|IBD|ibd
4822593|NCT02487238|Inflammatory Bowel Disease|inflammatory bowel disease
4822594|NCT02487238|Ulcerative Colitis|ulcerative colitis
4822595|NCT02487238|UC|uc
4822596|NCT02487238|Inflammatory Bowel Disease Unclassified|inflammatory bowel disease unclassified
4822597|NCT02487238|IBD-U|ibd-u
4822598|NCT02487238|Rebiotix|rebiotix
4822599|NCT02487238|RBX2660|rbx2660
4822600|NCT02487238|Pediatrics|pediatrics
4822601|NCT02487238|McMaster Children's Hospital|mcmaster children's hospital
4822602|NCT02487238|Centre Hospitalier Universitaire Sainte-Justine|centre hospitalier universitaire sainte-justine
4822603|NCT02487238|Children's Hospital at London Health Sciences Centre|children's hospital at london health sciences centre
4822604|NCT02487212|fractional laser|fractional laser
4822605|NCT02487212|hypertrophic scar|hypertrophic scar
4822606|NCT02487212|topical corticosteroid|topical corticosteroid
4822607|NCT02487212|laser assisted delivery systems|laser assisted delivery systems
4822608|NCT02487199|hepatitis C infection|hepatitis c infection
4822609|NCT02487199|hepatitis C|hepatitis c
4822610|NCT02487199|severe kidney disease|severe kidney disease
4822611|NCT02487199|chronic kidney disease|chronic kidney disease
4822612|NCT02487199|Genotype 1a|genotype 1a
4822613|NCT02487199|Genotype 4|genotype 4
4822614|NCT02487199|treatment experienced|treatment experienced
4822615|NCT02487199|interferon|interferon
4822616|NCT02487199|IFN|ifn
4822617|NCT02487199|pegIFN|pegifn
4822618|NCT02487186|Chronic periodontitis|chronic periodontitis
4822619|NCT02487186|Local doxycycline|local doxycycline
4822620|NCT02487186|Ultrasonic debridement|ultrasonic debridement
4822621|NCT02487186|PLGA microspheres|plga microspheres
4822622|NCT02487186|Microbiologic assessment|microbiologic assessment
4822623|NCT02487147|Live Attenuated Influenza Vaccine (FluMist)|live attenuated influenza vaccine (flumist)
4822624|NCT02487147|Free Air Portable Air Powered Respirator|free air portable air powered respirator
4822625|NCT02487147|N95 Respirator|n95 respirator
4822626|NCT02487147|Personal Protective Equipment|personal protective equipment
4822627|NCT02487147|Viral Transmission|viral transmission
4822628|NCT02487121|weight loss|weight loss
4822629|NCT02487095|RB1 Inactivation|rb1 inactivation
4822630|NCT02487095|Kinase Inhibitor|kinase inhibitor
4822631|NCT02487095|DNA Damage Response Network|dna damage response network
4822632|NCT02487095|MYC And CCNE1 Activation|myc and ccne1 activation
4822633|NCT02487095|Defective ATM-p53 Signaling Pathway|defective atm-p53 signaling pathway
4822634|NCT02487082|Autism Spectrum Disorder|autism spectrum disorder
4822635|NCT02487082|Children|children
4822636|NCT02487082|Melatonin|melatonin
4822637|NCT02487082|Donepezil|donepezil
4822638|NCT02487082|Sleep disorder|sleep disorder
4822639|NCT02487056|Heart Failure|heart failure
4822640|NCT02487056|Diagnosis|diagnosis
4822641|NCT02487056|Management|management
4822642|NCT02487043|Caries prevention|caries prevention
4822643|NCT02487043|Early Childhood Caries|early childhood caries
4822644|NCT02487030|HCV genotype 4 (GT-4)|hcv genotype 4 (gt-4)
4822645|NCT02487030|HCV|hcv
4822646|NCT02487030|Sustained Virologic Response|sustained virologic response
4822647|NCT02487030|Direct Acting Antiviral|direct acting antiviral
4822648|NCT02487030|Combination Therapy|combination therapy
4822649|NCT02487030|GS-7977|gs-7977
4822650|NCT02487030|GS-5885|gs-5885
4822651|NCT02487030|Ribavirin|ribavirin
4822652|NCT02487030|Sofosbuvir|sofosbuvir
4822653|NCT02487030|ledipasvir|ledipasvir
4822654|NCT02487030|Hepatitis C|hepatitis c
4822655|NCT02487030|Hepatitis C, Chronic|hepatitis c, chronic
4822656|NCT02487030|Liver Diseases|liver diseases
4822657|NCT02487030|Virus Diseases|virus diseases
4822658|NCT02487030|Antiviral Agents|antiviral agents
4822659|NCT02486965|VAS|vas
4822660|NCT02486965|thermode test|thermode test
4822661|NCT02486965|training program|training program
4822662|NCT02486965|6MWT|6mwt
4822663|NCT02486913|Primary prevention|primary prevention
4822664|NCT02486913|National Health Service Health Check|national health service health check
4822665|NCT02486900|Craving|craving
4822666|NCT02486900|Cue Reactivity|cue reactivity
4822667|NCT02486900|Neurofeedback|neurofeedback
4822668|NCT02486887|telemonitoring|telemonitoring
4822669|NCT02486874|Human acellular dermal matrix, burns, wound healing|human acellular dermal matrix, burns, wound healing
4822670|NCT02486861|Tomography, Optical Coherence|tomography, optical coherence
4822671|NCT02486848|Hairloss|hairloss
4822672|NCT02486848|Female Pattern Hair Loss|female pattern hair loss
4822673|NCT02486848|Androgenetic Alopecia|androgenetic alopecia
4822674|NCT02486848|Minoxidil|minoxidil
4822675|NCT02486822|Labor scale|labor scale
4822676|NCT02486822|Partograph|partograph
4822677|NCT02486822|Spontaneous labor|spontaneous labor
4822678|NCT02486822|Primigravida|primigravida
4822679|NCT02486744|Acthar|acthar
4822680|NCT02486744|Dialysis|dialysis
4822681|NCT02486744|Kidney|kidney
4822682|NCT02486744|Non-Diabetic|non-diabetic
4822683|NCT02486731|Hormonal sensitivity|hormonal sensitivity
4822684|NCT02486731|bone growth|bone growth
4822685|NCT02486705|ptsd|ptsd
4822686|NCT02486705|family|family
4822687|NCT02486705|caregiver|caregiver
4822688|NCT02486705|burden|burden
4822689|NCT02486692|Mental Health|mental health
4822690|NCT02486692|PTSD|ptsd
4822691|NCT02486692|Stigma|stigma
4822692|NCT02486692|Peer Education|peer education
4822693|NCT02486692|Web Education|web education
4822694|NCT02486692|Self Help|self help
4822695|NCT02486653|tamsulosin|tamsulosin
4822696|NCT02486653|randomized controlled trials as topic|randomized controlled trials as topic
4822697|NCT02486653|double-blind method|double-blind method
4822698|NCT02486653|random allocation|random allocation
4822699|NCT02486653|placebos|placebos
4822700|NCT02486653|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists
4822701|NCT02486653|urinary retention|urinary retention
4822702|NCT02486653|urinary tract infections|urinary tract infections
4822703|NCT02486653|urinary catheters|urinary catheters
4822704|NCT02486653|catheter-related infections|catheter-related infections
4822705|NCT02486653|postoperative complications|postoperative complications
4822706|NCT02486640|RRMS, CIS|rrms, cis
4822707|NCT02486627|cUTI|cuti
4822708|NCT02486627|AP|ap
4822709|NCT02486627|ACHN-490|achn-490
4822710|NCT02486627|anti-infective|anti-infective
4822711|NCT02486627|anti-bacterial|anti-bacterial
4822712|NCT02486627|antibiotic|antibiotic
4822713|NCT02486627|anti-microbial|anti-microbial
4822714|NCT02486627|UTI|uti
4822715|NCT02486627|bacterial infection|bacterial infection
4822716|NCT02486627|Gram-negative|gram-negative
4822717|NCT02486588|Financial incentives|financial incentives
4822718|NCT02486588|Messaging|messaging
4822719|NCT02486575|Residents|residents
4822720|NCT02486575|Training|training
4822721|NCT02486575|simulation|simulation
4822722|NCT02486575|mentoring|mentoring
4822723|NCT02486575|proctor|proctor
4822724|NCT02486562|Multiple Sclerosis|multiple sclerosis
4822725|NCT02486562|MS|ms
4822726|NCT02486549|Pain|pain
4822727|NCT02486549|Anesthesia Recovery Period|anesthesia recovery period
4822728|NCT02486549|Brachial Plexus|brachial plexus
4822729|NCT02486536|capsule endoscopy|capsule endoscopy
4822730|NCT02486536|polyethylene glycol|polyethylene glycol
4822731|NCT02486536|bowel preparation solutions|bowel preparation solutions
4822732|NCT02486523|SAM, severe acute malnutrition|sam, severe acute malnutrition
4822733|NCT02486510|HIV-1|hiv-1
4822734|NCT02486510|CCR5 coreceptors|ccr5 coreceptors
4822735|NCT02486510|Maraviroc|maraviroc
4822736|NCT02486497|Pancreatic cancer|pancreatic cancer
4822737|NCT02486497|Adjuvant chemotherapy|adjuvant chemotherapy
4822738|NCT02486497|hENT1|hent1
4822739|NCT02486497|Gemcitabine|gemcitabine
4822740|NCT02486484|macular degeneration|macular degeneration
4822741|NCT02486484|diabetic retinopathy|diabetic retinopathy
4822742|NCT02486484|macular edema|macular edema
4822743|NCT02486484|retinal vein occlusion|retinal vein occlusion
4822744|NCT02486484|choroidal neovascularization|choroidal neovascularization
4822745|NCT02486471|cervical dysplasia|cervical dysplasia
4822746|NCT02486471|colposcopy|colposcopy
4822747|NCT02486471|haemostatic procedure|haemostatic procedure
4822748|NCT02486471|biopsy of the cervix uteri|biopsy of the cervix uteri
4822749|NCT02486458|Fluoride|fluoride
4822750|NCT02486458|Biofilm fluid|biofilm fluid
4822751|NCT02486458|Calcium fluoride|calcium fluoride
4822752|NCT02486458|Topical|topical
4822753|NCT02486445|Deep venous thrombosis|deep venous thrombosis
4822754|NCT02486445|Rivaroxaban|rivaroxaban
4822755|NCT02486406|Hepatitis C Virus|hepatitis c virus
4822756|NCT02486406|Hepatitis C Genotype 1|hepatitis c genotype 1
4822757|NCT02486406|Hepatitis C Genotype 4|hepatitis c genotype 4
4822758|NCT02486406|Pediatric|pediatric
4822759|NCT02486341|continuous glucose monitoring system|continuous glucose monitoring system
4822760|NCT02486341|basal insulin|basal insulin
4822761|NCT02486341|diabetes mellitus|diabetes mellitus
4822762|NCT02486341|elderly|elderly
4822763|NCT02486328|Cognitive dysfunction|cognitive dysfunction
4822764|NCT02486328|Colonoscopy|colonoscopy
4822765|NCT02486328|Sedation|sedation
4822766|NCT02486315|coronary bifurcation|coronary bifurcation
4822767|NCT02486315|coronary stent|coronary stent
4822768|NCT02486289|Mercury toxicity poisoning|mercury toxicity poisoning
4822769|NCT02486263|infant|infant
4822770|NCT02486263|esophagitis|esophagitis
4822771|NCT02486263|neonate|neonate
4822772|NCT02486263|GERD|gerd
4822773|NCT02486237|diabetes mellitus|diabetes mellitus
4822774|NCT02486237|complications|complications
4822775|NCT02486237|prevalence|prevalence
4822776|NCT02486224|deep sea mineral water|deep sea mineral water
4822777|NCT02486224|exercise recovery|exercise recovery
4822778|NCT02486224|hydration|hydration
4822779|NCT02486224|salivary osmolar concentration|salivary osmolar concentration
4822780|NCT02486224|urinary osmolar concentration|urinary osmolar concentration
4822781|NCT02486211|heart arrest|heart arrest
4822782|NCT02486211|resuscitation|resuscitation
4822783|NCT02486211|seizures|seizures
4822784|NCT02486211|hypothermia, induced|hypothermia, induced
4822785|NCT02486211|Amantadine|amantadine
4822786|NCT02486198|Gastrointestinal cancer|gastrointestinal cancer
4822787|NCT02486198|oxaliplatin|oxaliplatin
4822788|NCT02486198|neurotoxicity|neurotoxicity
4822789|NCT02486120|Genetic Counseling|genetic counseling
4822790|NCT02486120|Clinical Decision-Making|clinical decision-making
4822791|NCT02486107|cervical vertebra|cervical vertebra
4822792|NCT02486107|surgery|surgery
4822793|NCT02486107|tubular retractor|tubular retractor
4822794|NCT02486107|endoscope|endoscope
4822795|NCT02486094|Imaging, Magnetic Resonance|imaging, magnetic resonance
4822796|NCT02486094|Rectal Cancer|rectal cancer
4822797|NCT02486094|Apoptosis|apoptosis
4822798|NCT02486094|Proliferation|proliferation
4822799|NCT02486094|Cancer|cancer
4822800|NCT02486094|Tissue Study|tissue study
4822801|NCT02486081|Assistive device|assistive device
4822802|NCT02486081|the disabled|the disabled
4822803|NCT02486081|special education|special education
4822804|NCT02486081|movement analysis|movement analysis
4822805|NCT02486081|system development|system development
4822806|NCT02486055|Study safety of BPM31510 in healthy subjects|study safety of bpm31510 in healthy subjects
4822807|NCT02486042|ROP|rop
4822808|NCT02486042|Premature infant|premature infant
4822809|NCT02486016|Bioequivalence|bioequivalence
4822810|NCT02486016|Therapeutic Equivalency|therapeutic equivalency
4822811|NCT02485990|Fallopian Tube|fallopian tube
4822812|NCT02485990|Epithelial Ovarian|epithelial ovarian
4822813|NCT02485990|EOC|eoc
4822814|NCT02485977|Pulmonary hypertension|pulmonary hypertension
4822815|NCT02485977|Magnetic Resonance Imaging|magnetic resonance imaging
4822816|NCT02485964|Vaccine|vaccine
4822817|NCT02485951|deep anterior lamellar keratoplasty|deep anterior lamellar keratoplasty
4822818|NCT02485951|big-bubble technique|big-bubble technique
4822819|NCT02485951|peripheral air injection|peripheral air injection
4822820|NCT02485951|keratoconus|keratoconus
4822821|NCT02485938|Duchenne Muscular Dystrophy|duchenne muscular dystrophy
4822822|NCT02485938|Cardiomyopathy|cardiomyopathy
4822823|NCT02485925|Interventional|interventional
4822824|NCT02485925|Radiofrequency ablation|radiofrequency ablation
4822825|NCT02485925|Paroxysmal Atrial Fibrillation|paroxysmal atrial fibrillation
4822826|NCT02485925|Catheter ablation|catheter ablation
4822827|NCT02485912|Ebola|ebola
4822828|NCT02485912|vaccine|vaccine
4822829|NCT02485912|safety|safety
4822830|NCT02485912|immunogenicity|immunogenicity
4822831|NCT02485899|Late infantile Neuronal Ceroid Lipofuscinosis Type 2|late infantile neuronal ceroid lipofuscinosis type 2
4822832|NCT02485899|LINCL|lincl
4822833|NCT02485899|NCL2|ncl2
4822834|NCT02485899|CLN2|cln2
4822835|NCT02485899|Jansky-Bielschowsky disease|jansky-bielschowsky disease
4822836|NCT02485886|PET|pet
4822837|NCT02485886|interstitial pulmonary fibrosis (IPF)|interstitial pulmonary fibrosis (ipf)
4822838|NCT02485886|cysteine cathepsins|cysteine cathepsins
4822839|NCT02485886|macrophage|macrophage
4822840|NCT02485873|Non-valvular atrial fibrillation (NVAF)|non-valvular atrial fibrillation (nvaf)
4822841|NCT02485873|Pevention|pevention
4822842|NCT02485873|Stroke|stroke
4822843|NCT02485860|pilonidal cysts|pilonidal cysts
4822844|NCT02485860|Cavity wound|cavity wound
4822845|NCT02485860|long healing|long healing
4822846|NCT02485860|honey|honey
4822847|NCT02485847|Eye Diseases|eye diseases
4822848|NCT02485821|Estradiol|estradiol
4822849|NCT02485821|Misoprostol|misoprostol
4822850|NCT02485821|Induction of labor|induction of labor
4822851|NCT02485821|Cervical ripening|cervical ripening
4822852|NCT02485821|Bishop score|bishop score
4822853|NCT02485808|Lower Urinary Tract Symptoms|lower urinary tract symptoms
4822854|NCT02485808|Bladder Symptoms|bladder symptoms
4822855|NCT02485808|Overactive Bladder|overactive bladder
4822856|NCT02485808|Urinary Urgency|urinary urgency
4822857|NCT02485808|Lower Urinary Tract Dysfunction|lower urinary tract dysfunction
4822858|NCT02485795|Pain Management|pain management
4822859|NCT02485795|Genetic Variation|genetic variation
4822860|NCT02485795|Genetic Polymorphism|genetic polymorphism
4822861|NCT02485795|Polymorphism, Single Nucleotide Genetic Association Studies|polymorphism, single nucleotide genetic association studies
4822862|NCT02485795|Healthcare Utilization|healthcare utilization
4822863|NCT02485756|Drug interactions|drug interactions
4822864|NCT02485743|satiation|satiation
4822867|NCT02485743|maintained weight loss|maintained weight loss
4822868|NCT02485730|Prevention|prevention
4822869|NCT02485730|Cohort Analysis|cohort analysis
4822870|NCT02485730|Healthy Participants|healthy participants
4822871|NCT02485678|ambulatory toxicity management|ambulatory toxicity management
4822872|NCT02485678|adjuvant or neoadjuvant chemotherapy|adjuvant or neoadjuvant chemotherapy
4822873|NCT02485665|Prostate cancer|prostate cancer
4822874|NCT02485665|Robot-assisted laparoscopic surgery|robot-assisted laparoscopic surgery
4822875|NCT02485665|Radical prostatectomy|radical prostatectomy
4822876|NCT02485665|Post-prostatectomy incontinence|post-prostatectomy incontinence
4822877|NCT02485665|Pelvic floor muscle exercise|pelvic floor muscle exercise
4822878|NCT02485665|Extracorporeal biofeedback device|extracorporeal biofeedback device
4822879|NCT02485652|NSCLC|nsclc
4822880|NCT02485652|EGFR-TKI|egfr-tki
4822881|NCT02485652|non small cell lung cancer|non small cell lung cancer
4822882|NCT02485652|HM61713|hm61713
4822883|NCT02485652|T790M-positive|t790m-positive
4822884|NCT02485652|lung cancer|lung cancer
4822885|NCT02485652|Phase II|phase ii
4822886|NCT02485652|Olmutinib|olmutinib
4822887|NCT02485639|HA-specific plasmablasts|ha-specific plasmablasts
4822888|NCT02485639|humoral immunity|humoral immunity
4822889|NCT02485639|influenza|influenza
4822890|NCT02485639|memory B cells|memory b cells
4822891|NCT02485626|Anthracyclines|anthracyclines
4822892|NCT02485600|Cadence|cadence
4822893|NCT02485600|Duodopa|duodopa
4822894|NCT02485600|Advanced Parkinson's disease|advanced parkinson's disease
4822895|NCT02485600|LCIG|lcig
4822896|NCT02485600|Levodopa-carbidopa intestinal gel|levodopa-carbidopa intestinal gel
4822897|NCT02485600|Observational|observational
4822898|NCT02485587|Arousal Biofeedback|arousal biofeedback
4822899|NCT02485587|Electrodermal activity|electrodermal activity
4822900|NCT02485574|Bone bridging|bone bridging
4822901|NCT02485574|Arthrodesis|arthrodesis
4822902|NCT02485574|Lumbar|lumbar
4822903|NCT02485574|Cage|cage
4822904|NCT02485561|Colon cancer screening|colon cancer screening
4822905|NCT02485561|Colorectal cancer screening|colorectal cancer screening
4822906|NCT02485561|Colonoscopy|colonoscopy
4822907|NCT02485561|Sigmoidoscopy|sigmoidoscopy
4822908|NCT02485561|Stool blood test|stool blood test
4822909|NCT02485561|Narrative|narrative
4822910|NCT02485522|fecal incontinence|fecal incontinence
4822911|NCT02485522|diet|diet
4822912|NCT02485522|nutrition|nutrition
4822913|NCT02485522|metabolites|metabolites
4822914|NCT02485522|stool|stool
4822915|NCT02485522|FI|fi
4822916|NCT02485379|Prostate cancer|prostate cancer
4822917|NCT02485379|Multiparametric MRI|multiparametric mri
4822918|NCT02485379|Prostate biopsy|prostate biopsy
4822919|NCT02485379|Targeted biopsy|targeted biopsy
4822920|NCT02485379|Comparative study|comparative study
4822921|NCT02485366|Rejuvenated packed red blood cells|rejuvenated packed red blood cells
4822922|NCT02485353|Vosaroxin|vosaroxin
4822923|NCT02485353|Cytarabine|cytarabine
4822924|NCT02485353|Remission Induction|remission induction
4822925|NCT02485353|Safety|safety
4822926|NCT02485353|Progression-Free Survival|progression-free survival
4822927|NCT02485353|Mortality Rate|mortality rate
4822928|NCT02485353|Length of Stay|length of stay
4822929|NCT02485314|children|children
4822930|NCT02485314|disability|disability
4822931|NCT02485314|family|family
4822932|NCT02485314|participation|participation
4822933|NCT02485301|Protection against Ebola Zaire virus|protection against ebola zaire virus
4822934|NCT02485275|AIS|ais
4822935|NCT02485275|ICAS|icas
4822936|NCT02485275|CSVD|csvd
4822937|NCT02485262|Protease inhibitor treatment|protease inhibitor treatment
4822938|NCT02485249|Iontophoresis|iontophoresis
4822939|NCT02485249|Macular Edema|macular edema
4822940|NCT02485249|Ophthalmology|ophthalmology
4822941|NCT02485223|Multiple Sclerosis|multiple sclerosis
4822942|NCT02485223|MS|ms
4822943|NCT02485223|Diagnostic test|diagnostic test
4822944|NCT02485223|Central veins|central veins
4822945|NCT02485223|MRI|mri
4822946|NCT02485210|photodynamic therapy , Endodontic treatment|photodynamic therapy , endodontic treatment
4822947|NCT02485197|Muscle Metabolic Function|muscle metabolic function
4822948|NCT02485197|Vitamin D Status|vitamin d status
4822949|NCT02485197|25(OH)D|25(oh)d
4822950|NCT02485197|Older Adults|older adults
4822951|NCT02485158|Subjective Effects|subjective effects
4822952|NCT02485158|Alcohol|alcohol
4822953|NCT02485158|Amphetamine|amphetamine
4822954|NCT02485158|THC|thc
4822955|NCT02485158|Personality|personality
4822956|NCT02485145|Topical|topical
4822957|NCT02485145|Hand osteoarthritis|hand osteoarthritis
4822958|NCT02485132|Type 2 diabetes|type 2 diabetes
4822959|NCT02485132|Sulfonylurea|sulfonylurea
4822960|NCT02485132|Hypoglycemia|hypoglycemia
4822961|NCT02485132|Quality of life|quality of life
4822962|NCT02485119|BAY 94-9343|bay 94-9343
4822963|NCT02485119|Anetumab ravtansine|anetumab ravtansine
4822964|NCT02485119|ADC (Antibody Drug Conjugate)|adc (antibody drug conjugate)
4822965|NCT02485119|Phase I|phase i
4822966|NCT02485119|Japan|japan
4822967|NCT02485119|solid cancers|solid cancers
4822968|NCT02485119|Advanced, refractory solid tumors|advanced, refractory solid tumors
4822969|NCT02485119|mesothelin|mesothelin
4822971|NCT02485119|adenocarcinoma of lung|adenocarcinoma of lung
4822972|NCT02485119|gastrointestinal, ovarian, pancreatic, cholangio, mesothelioma and triple negative breast cancers|gastrointestinal, ovarian, pancreatic, cholangio, mesothelioma and triple negative breast cancers
4822973|NCT02485080|hepatitis C|hepatitis c
4822974|NCT02485080|liver transplantation|liver transplantation
4822975|NCT02485080|genotype 1|genotype 1
4822976|NCT02485067|Overactive Bladder|overactive bladder
4822977|NCT02485067|Tolterodine (Detrusitol)|tolterodine (detrusitol)
4822978|NCT02485067|Pilocarpine|pilocarpine
4822979|NCT02485041|Dapoxetine|dapoxetine
4822980|NCT02485041|Mirodenafil|mirodenafil
4822981|NCT02485041|DDI study|ddi study
4822982|NCT02485028|Dapoxetine|dapoxetine
4822983|NCT02485028|Mirodenafil|mirodenafil
4822984|NCT02485028|DDI study|ddi study
4822985|NCT02485015|CIK|cik
4822986|NCT02485015|gastric cancer|gastric cancer
4822987|NCT02485015|Apatinib|apatinib
4822988|NCT02485002|kidney|kidney
4822989|NCT02485002|kidney stone|kidney stone
4822990|NCT02485002|NGAL|ngal
4822991|NCT02485002|ureterorenoscopy|ureterorenoscopy
4822992|NCT02485002|intrarenal surgery|intrarenal surgery
4822993|NCT02485002|kidney function|kidney function
4822994|NCT02484976|Family Based Behavioral Treatment|family based behavioral treatment
4822995|NCT02484976|functional magnetic resonance imaging (fMRI)|functional magnetic resonance imaging (fmri)
4822996|NCT02484976|Childhood Obesity|childhood obesity
4822997|NCT02484976|Satiety|satiety
4822998|NCT02484976|BMI z-score|bmi z-score
4822999|NCT02484976|Impulsive|impulsive
4823000|NCT02484976|Non-obese controls|non-obese controls
4823001|NCT02484976|Visual food cues|visual food cues
4823002|NCT02484976|Leptin|leptin
4823003|NCT02484976|Hormones|hormones
4823004|NCT02484950|Mesenchymal stem cells|mesenchymal stem cells
4823005|NCT02484937|Pain management|pain management
4823006|NCT02484911|chemotherapy nausea vomiting|chemotherapy nausea vomiting
4823007|NCT02484885|Magnetic Resonance Imaging|magnetic resonance imaging
4823008|NCT02484885|Pulmonary Function|pulmonary function
4823009|NCT02484872|Inflammation|inflammation
4823010|NCT02484872|Glasgow score|glasgow score
4823011|NCT02484872|Intensive Care Unit|intensive care unit
4823012|NCT02484872|Emergency|emergency
4823013|NCT02484859|Drug: remifentanil|drug: remifentanil
4823014|NCT02484859|Drug: tramadol|drug: tramadol
4823015|NCT02484859|Drug: metoprolol|drug: metoprolol
4823016|NCT02484859|Functional endoscopic sinus surgery|functional endoscopic sinus surgery
4823017|NCT02484859|Controlled hypotension|controlled hypotension
4823018|NCT02484833|First line|first line
4823019|NCT02484833|metastatic colorectal cancer|metastatic colorectal cancer
4823020|NCT02484833|Cetuximab|cetuximab
4823021|NCT02484833|strategy study|strategy study
4823022|NCT02484820|Preterm Birth|preterm birth
4823023|NCT02484820|pessary|pessary
4823024|NCT02484820|threatened preterm labor|threatened preterm labor
4823025|NCT02484794|Eating Disorders|eating disorders
4823026|NCT02484794|Smartphone|smartphone
4823027|NCT02484794|App|app
4823028|NCT02484794|Mobile Health|mobile health
4823029|NCT02484794|Recovery Record|recovery record
4823030|NCT02484794|Cognitive Behavioural Therapy|cognitive behavioural therapy
4823031|NCT02484794|Outpatient Program|outpatient program
4823032|NCT02484794|Self Monitoring|self monitoring
4823033|NCT02484781|Gait disorder|gait disorder
4823034|NCT02484781|Resurfacing Hip Arthroplasty|resurfacing hip arthroplasty
4823035|NCT02484781|Total Hip Arthroplasty|total hip arthroplasty
4823036|NCT02484729|AZD9977|azd9977
4823037|NCT02484729|Safety|safety
4823038|NCT02484729|Tolerability|tolerability
4823039|NCT02484729|Pharmacokinetics|pharmacokinetics
4823040|NCT02484729|First-in-human|first-in-human
4823041|NCT02484729|Single Ascending Dose|single ascending dose
4823042|NCT02484729|Regional absorption|regional absorption
4823043|NCT02484729|Healthy male subjects|healthy male subjects
4823044|NCT02484716|Hemorrhagic Hereditary Telangiectasia (HHT)|hemorrhagic hereditary telangiectasia (hht)
4823045|NCT02484716|Antiangiogenic therapy|antiangiogenic therapy
4823046|NCT02484716|Timolol|timolol
4823047|NCT02484651|deep neuromuscular block|deep neuromuscular block
4823048|NCT02484651|sugammadex|sugammadex
4823049|NCT02484651|stability of anesthesia|stability of anesthesia
4823050|NCT02484651|suppression of EMG activity|suppression of emg activity
4823051|NCT02484651|PQRS|pqrs
4823052|NCT02484651|General Anesthesia|general anesthesia
4823053|NCT02484651|Quality of Recovery|quality of recovery
4823054|NCT02484625|snacking|snacking
4823055|NCT02484625|food intake|food intake
4823056|NCT02484625|satiety|satiety
4823057|NCT02484625|obesity|obesity
4823058|NCT02484625|type-2 diabetes|type-2 diabetes
4823059|NCT02484599|Eating Disorders|eating disorders
4823060|NCT02484599|Anorexia Nervosa|anorexia nervosa
4823061|NCT02484599|Attention bias|attention bias
4823062|NCT02484599|Attention bias modification|attention bias modification
4823063|NCT02484586|Presbyopia|presbyopia
4823064|NCT02484586|Refractive error|refractive error
4823065|NCT02484586|Contact lens|contact lens
4823066|NCT02484573|Cirrhosis|cirrhosis
4823067|NCT02484573|Variceal Bleeding|variceal bleeding
4823068|NCT02484573|Non-selective beta blocker|non-selective beta blocker
4823069|NCT02484573|Intestinal Permeability|intestinal permeability
4823070|NCT02484573|Gene expression|gene expression
4823071|NCT02484573|Bacterial translocation|bacterial translocation
4823072|NCT02484560|Duchenne Muscular Dystrophy|duchenne muscular dystrophy
4823073|NCT02484560|Neuromuscular Diseases|neuromuscular diseases
4823074|NCT02484560|Muscular Dystrophy|muscular dystrophy
4823075|NCT02484560|Genetic Diseases, X-linked|genetic diseases, x-linked
4823076|NCT02484560|Musculoskeletal Diseases|musculoskeletal diseases
4823077|NCT02484560|Nervous System Diseases|nervous system diseases
4823078|NCT02484547|Aducanumab|aducanumab
4823079|NCT02484547|BIIB037|biib037
4823080|NCT02484534|Coagulation Factor|coagulation factor
4823081|NCT02484534|cirrhosis|cirrhosis
4823082|NCT02484508|Guli capsule|guli capsule
4823083|NCT02484508|knee osteoarthritis|knee osteoarthritis
4823084|NCT02484508|Changing of WOMAC and VAS score|changing of womac and vas score
4823085|NCT02484495|Complementary feeding recommendation|complementary feeding recommendation
4823086|NCT02484495|Program evaluation|program evaluation
4823087|NCT02484495|Process and impact evaluation|process and impact evaluation
4823088|NCT02484456|Major Depression|major depression
4823089|NCT02484456|Glycine Receptor Antagonist|glycine receptor antagonist
4823090|NCT02484456|4-Chlorokyneurenine|4-chlorokyneurenine
4823091|NCT02484456|Treatment Resistant|treatment resistant
4823092|NCT02484456|Glutamatergic System|glutamatergic system
4823093|NCT02484417|Neutralizing Antibody|neutralizing antibody
4823094|NCT02484417|Viral Shedding|viral shedding
4823095|NCT02484417|Mucosal Immune Reponse|mucosal immune reponse
4823096|NCT02484417|Upper Respiratory Infection|upper respiratory infection
4823097|NCT02484404|Immune Checkpoint Inhibitor|immune checkpoint inhibitor
4823098|NCT02484404|PARP Inhibitor|parp inhibitor
4823099|NCT02484404|VEGFR Inhibitor|vegfr inhibitor
4823100|NCT02484378|ACS|acs
4823101|NCT02484378|IVUS|ivus
4823102|NCT02484378|HDL|hdl
4823103|NCT02484365|Hemoglobins|hemoglobins
4823104|NCT02484365|Monitoring, Outpatient|monitoring, outpatient
4823105|NCT02484365|Preoperative Period|preoperative period
4823106|NCT02484365|Pediatrics|pediatrics
4823107|NCT02484352|dosage of oxycodone during intubation|dosage of oxycodone during intubation
4823108|NCT02484326|ST-elevation myocardial infarction|st-elevation myocardial infarction
4823109|NCT02484326|Cardiac rupture|cardiac rupture
4823110|NCT02484326|Risk assessment|risk assessment
4823111|NCT02484300|loop gain|loop gain
4823112|NCT02484300|chemoreflex control|chemoreflex control
4823113|NCT02484300|melatonin|melatonin
4823114|NCT02484300|antioxidant|antioxidant
4823115|NCT02484300|obstructive sleep apnea|obstructive sleep apnea
4823116|NCT02484300|ventilatory control|ventilatory control
4823117|NCT02484274|iron-deficiency|iron-deficiency
4823118|NCT02484274|iron-deficiency anemia|iron-deficiency anemia
4823119|NCT02484274|infants and toddlers|infants and toddlers
4823120|NCT02484274|industrialised countries|industrialised countries
4823121|NCT02484274|population-based study|population-based study
4823122|NCT02484274|prevalence and risk factors|prevalence and risk factors
4823123|NCT02484274|screening strategies|screening strategies
4823124|NCT02484274|diagnosis markers|diagnosis markers
4823125|NCT02484274|primary prevention|primary prevention
4823126|NCT02484261|childhood leukemia|childhood leukemia
4823127|NCT02484261|relapsed leukemia|relapsed leukemia
4823128|NCT02484261|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
4823129|NCT02484248|pediatric|pediatric
4823130|NCT02484248|eosinophilia|eosinophilia
4823131|NCT02484248|duodenal|duodenal
4823132|NCT02484248|ketotifen|ketotifen
4823133|NCT02484248|functional dyspepsia|functional dyspepsia
4823134|NCT02484235|obesity|obesity
4823135|NCT02484235|exercise|exercise
4823136|NCT02484235|HIIT|hiit
4823137|NCT02484235|Vo2|vo2
4823138|NCT02484235|kinetics|kinetics
4823139|NCT02484222|adenotonsillectomy|adenotonsillectomy
4823140|NCT02484222|fentanyl|fentanyl
4823141|NCT02484209|diabetes|diabetes
4823142|NCT02484209|frailty|frailty
4823143|NCT02484209|aged|aged
4823144|NCT02484209|metformin|metformin
4823145|NCT02484209|sulphonylurea|sulphonylurea
4823146|NCT02484209|hypoglycaemia|hypoglycaemia
4823147|NCT02484183|bubble continuous positive airway pressure (CPAP)|bubble continuous positive airway pressure (cpap)
4823148|NCT02484183|pneumonia|pneumonia
4823149|NCT02484183|Human Immunodeficiency Virus (HIV)|human immunodeficiency virus (hiv)
4823150|NCT02484183|malnutrition|malnutrition
4823151|NCT02484183|Malawi|malawi
4823152|NCT02484183|Africa|africa
4823153|NCT02484183|Noninvasive Ventilation|noninvasive ventilation
4823154|NCT02484183|child|child
4823155|NCT02484183|pediatric|pediatric
4823156|NCT02484183|hypoxemia|hypoxemia
4823157|NCT02484170|Mannitol|mannitol
4823158|NCT02484170|cream|cream
4823159|NCT02484170|neuropathic pain|neuropathic pain
4823160|NCT02484157|Whole Blood Coagulation Time|whole blood coagulation time
4823161|NCT02484157|cardiac surgery|cardiac surgery
4823162|NCT02484144|information|information
4823163|NCT02484144|coronarography|coronarography
4823164|NCT02484144|understanding|understanding
4823165|NCT02484131|Osteoporosis|osteoporosis
4823166|NCT02484131|DXA Screening|dxa screening
4823167|NCT02484131|Women|women
4823168|NCT02484131|Breast Cancer|breast cancer
4823169|NCT02484131|Survivors|survivors
4823170|NCT02484131|Educational materials|educational materials
4823171|NCT02484131|Personal choices on delivery methods|personal choices on delivery methods
4823172|NCT02484092|Hemophilia B|hemophilia b
4823173|NCT02484092|Blood Coagulation Disorders|blood coagulation disorders
4823174|NCT02484092|Gene Therapy|gene therapy
4823175|NCT02484092|Gene Transfer|gene transfer
4823176|NCT02484092|Factor IX Deficiency|factor ix deficiency
4823177|NCT02484092|Factor IX Gene|factor ix gene
4823178|NCT02484092|Factor IX Protein|factor ix protein
4823179|NCT02484092|Vector|vector
4823180|NCT02484092|AAV|aav
4823181|NCT02484066|Virtual bronchoscopic navigation|virtual bronchoscopic navigation
4823182|NCT02484066|Endobronchial ultrasound|endobronchial ultrasound
4823183|NCT02484066|Guide Sheath|guide sheath
4823184|NCT02484066|Transbronchial biopsy|transbronchial biopsy
4823185|NCT02484066|Peripheral pulmonary lesions|peripheral pulmonary lesions
4823186|NCT02484053|adult and pediatric cancers|adult and pediatric cancers
4823187|NCT02484053|blood disorders|blood disorders
4823188|NCT02484053|lymphoma|lymphoma
4823189|NCT02484053|graft-versus-host-disease|graft-versus-host-disease
4823190|NCT02484053|diseases of the immune system|diseases of the immune system
4823191|NCT02484040|tumor response|tumor response
4823192|NCT02484040|toxicity|toxicity
4823193|NCT02484040|recurrence|recurrence
4823194|NCT02484040|chemoradiotherpy|chemoradiotherpy
4823195|NCT02484040|rectum|rectum
4823196|NCT02484027|acute ischemic stroke|acute ischemic stroke
4823197|NCT02484027|mRS|mrs
4823198|NCT02484027|rosuvastatin|rosuvastatin
4823199|NCT02484001|Eslicarbazepine acetate|eslicarbazepine acetate
4823200|NCT02484001|BIA 2-093|bia 2-093
4823201|NCT02484001|Epilepsy|epilepsy
4823202|NCT02483975|Fluticasone Furoate|fluticasone furoate
4823203|NCT02483975|Asthma|asthma
4823204|NCT02483975|HPA axis|hpa axis
4823205|NCT02483975|Children|children
4823206|NCT02483975|Inhaled corticosteroid|inhaled corticosteroid
4823207|NCT02483962|Chronic|chronic
4823208|NCT02483923|serratus anterior block|serratus anterior block
4823209|NCT02483923|ultrasound|ultrasound
4823210|NCT02483923|breast cancer|breast cancer
4823211|NCT02483923|postoperative pain|postoperative pain
4823212|NCT02483910|School-age children|school-age children
4823213|NCT02483910|Pediatrics|pediatrics
4823214|NCT02483910|Direct Instruction-Language for Learning|direct instruction-language for learning
4823215|NCT02483884|Bombesin|bombesin
4823216|NCT02483884|Gastrin-Releasing Peptide|gastrin-releasing peptide
4823217|NCT02483884|Prostatic Neoplasms|prostatic neoplasms
4823218|NCT02483884|Genital Diseases, Male|genital diseases, male
4823219|NCT02483884|Genital Neoplasms, Male|genital neoplasms, male
4823220|NCT02483884|Neoplasms|neoplasms
4823221|NCT02483884|Neoplasms by Site|neoplasms by site
4823222|NCT02483884|Urogenital Neoplasms|urogenital neoplasms
4823223|NCT02483884|Gastrointestinal Agents|gastrointestinal agents
4823224|NCT02483884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
4823225|NCT02483884|Neurotransmitter Agents|neurotransmitter agents
4823226|NCT02483884|Pharmacologic Actions|pharmacologic actions
4823227|NCT02483884|Physiological Effects of Drugs|physiological effects of drugs
4823228|NCT02483884|Therapeutic Uses|therapeutic uses
4823229|NCT02483871|Estrogen Receptor Positive|estrogen receptor positive
4823230|NCT02483858|oncology, solid tumors|oncology, solid tumors
4823231|NCT02483819|Elderly patient|elderly patient
4823232|NCT02483819|NICOM|nicom
4823233|NCT02483819|TURP|turp
4823234|NCT02483767|Premenopausal Breast Cancer|premenopausal breast cancer
4823235|NCT02483767|Preservation of Ovarian Function|preservation of ovarian function
4823236|NCT02483767|Gonadotropin-Releasing Hormone Agonist|gonadotropin-releasing hormone agonist
4823237|NCT02483728|Metal Allergy|metal allergy
4823238|NCT02483715|Helicobacter pylori|helicobacter pylori
4823239|NCT02483715|high dose dual therapy|high dose dual therapy
4823240|NCT02483715|bismuth-containing quadruple therapy|bismuth-containing quadruple therapy
4823241|NCT02483715|antibiotic resistance|antibiotic resistance
4823242|NCT02483702|Irradiated Blood|irradiated blood
4823243|NCT02483702|Non-Irradiated Blood|non-irradiated blood
4823244|NCT02483702|graft versus host disease|graft versus host disease
4823245|NCT02483702|TA-GVHD|ta-gvhd
4823246|NCT02483702|potassium|potassium
4823247|NCT02483702|Blood transfusion|blood transfusion
4823248|NCT02483689|Post Operative Pain|post operative pain
4823249|NCT02483689|Appendicitis|appendicitis
4823250|NCT02483689|Appendectomy|appendectomy
4823251|NCT02483689|Local Anesthetic|local anesthetic
4823252|NCT02483689|Saline|saline
4823253|NCT02483689|Pain Management|pain management
4823254|NCT02483689|Surgery|surgery
4823255|NCT02483689|Recovery|recovery
4823256|NCT02483676|Rehabilitation|rehabilitation
4823257|NCT02483676|Robotics|robotics
4823258|NCT02483676|Gait|gait
4823259|NCT02483663|Twins|twins
4823260|NCT02483663|Obesity|obesity
4823261|NCT02483663|Appetite|appetite
4823262|NCT02483637|spray cryotherapy|spray cryotherapy
4823263|NCT02483637|cryotherapy|cryotherapy
4823264|NCT02483637|chronic bronchitis|chronic bronchitis
4823265|NCT02483637|airflow restrictions|airflow restrictions
4823267|NCT02483611|Recovery|recovery
4823268|NCT02483611|Lidocaine|lidocaine
4823269|NCT02483611|Cisatracurium|cisatracurium
4823270|NCT02483611|Magnesium sulfate|magnesium sulfate
4823271|NCT02483611|Isotonic solution|isotonic solution
4823272|NCT02483598|buspirone|buspirone
4823273|NCT02483598|pharmacokinetics|pharmacokinetics
4823274|NCT02483598|Cytochrome P450 3A4|cytochrome p450 3a4
4823275|NCT02483585|Migraine|migraine
4823276|NCT02483585|Headache|headache
4823277|NCT02483585|Episodic|episodic
4823278|NCT02483585|Prevention|prevention
4823279|NCT02483585|Prophylaxis|prophylaxis
4823280|NCT02483559|Sleep|sleep
4823281|NCT02483559|Photoreceptor Cells, Vertebrate|photoreceptor cells, vertebrate
4823282|NCT02483559|Melatonin|melatonin
4823283|NCT02483546|Medical education|medical education
4823284|NCT02483546|simulation|simulation
4823285|NCT02483546|ACLS|acls
4823286|NCT02483520|Family caregiver|family caregiver
4823287|NCT02483507|Ultrasound guidance|ultrasound guidance
4823288|NCT02483507|Vascular access|vascular access
4823289|NCT02483507|Pediatric anesthesia|pediatric anesthesia
4823290|NCT02483494|Telemedicine|telemedicine
4823291|NCT02483494|Advanced Practice Nurse|advanced practice nurse
4823292|NCT02483481|sinusoidal obstruction syndrome|sinusoidal obstruction syndrome
4823293|NCT02483481|ultrasound elastography|ultrasound elastography
4823294|NCT02483481|bone marrow transplant|bone marrow transplant
4823295|NCT02483429|Vertigo|vertigo
4823296|NCT02483429|Dizziness|dizziness
4823297|NCT02483429|Unsteadiness|unsteadiness
4823298|NCT02483429|Stroke|stroke
4823299|NCT02483429|Vestibular neuritis|vestibular neuritis
4823300|NCT02483429|Benign paroxysmal positional vertigo|benign paroxysmal positional vertigo
4823301|NCT02483429|Vestibulo-ocular reflex|vestibulo-ocular reflex
4823302|NCT02483429|Video-oculography|video-oculography
4823303|NCT02483429|Emergency department|emergency department
4823304|NCT02483403|Magnetic Resonance Imaging|magnetic resonance imaging
4823305|NCT02483403|Pulmonary Function|pulmonary function
4823306|NCT02483403|Volunteers|volunteers
4823307|NCT02483390|palliative care|palliative care
4823308|NCT02483390|e-health|e-health
4823309|NCT02483390|e-therapy|e-therapy
4823310|NCT02483390|psychosocial services|psychosocial services
4823311|NCT02483377|Sign or Symptom|sign or symptom
4823312|NCT02483351|Blood Transfusion|blood transfusion
4823313|NCT02483338|Psychometric validity|psychometric validity
4823314|NCT02483338|Pain scale|pain scale
4823315|NCT02483338|Postoperative|postoperative
4823316|NCT02483338|Children|children
4823317|NCT02483312|Recurrent|recurrent
4823318|NCT02483299|response to therapy|response to therapy
4823319|NCT02483286|Osteoporosis|osteoporosis
4823320|NCT02483286|Fall|fall
4823321|NCT02483286|Fracture|fracture
4823322|NCT02483286|sarcopenia|sarcopenia
4823323|NCT02483286|Exercise|exercise
4823324|NCT02483273|Conjunctival microcirculation|conjunctival microcirculation
4823325|NCT02483273|Sublingual microcirculation|sublingual microcirculation
4823326|NCT02483273|Sidestream Dark Field (SDF) microscopy|sidestream dark field (sdf) microscopy
4823327|NCT02483247|Neoplasms|neoplasms
4823328|NCT02483195|Hair loss|hair loss
4823329|NCT02483195|Post Menopausal|post menopausal
4823330|NCT02483182|Herpes labialis, Cold sores, ZEP-3 ointment|herpes labialis, cold sores, zep-3 ointment
4823331|NCT02483169|ischemic stroke|ischemic stroke
4823332|NCT02483169|intracranial hemorrhage|intracranial hemorrhage
4823333|NCT02483169|cilostazol|cilostazol
4823334|NCT02483169|probucol|probucol
4823335|NCT02483169|intima media thickness|intima media thickness
4823336|NCT02483156|HCV|hcv
4823337|NCT02483156|Sofosbuvir|sofosbuvir
4823338|NCT02483156|Ribavirin|ribavirin
4823339|NCT02483143|contrast media|contrast media
4823340|NCT02483143|pulmonary embolism|pulmonary embolism
4823341|NCT02483143|N-acetylcysteine|n-acetylcysteine
4823342|NCT02483104|ABT-888|abt-888
4823343|NCT02483104|BRCA|brca
4823344|NCT02483104|Primary peritoneal cancer|primary peritoneal cancer
4823345|NCT02483104|carboplatin|carboplatin
4823346|NCT02483104|Fallopian tube|fallopian tube
4823347|NCT02483104|Poly (ADP-ribose) polymerase (PARP)|poly (adp-ribose) polymerase (parp)
4823348|NCT02483104|paclitaxel|paclitaxel
4823349|NCT02483104|Ovarian cancer|ovarian cancer
4823350|NCT02483104|veliparib|veliparib
4823351|NCT02483091|Knowledge translation|knowledge translation
4823352|NCT02483091|Clinical practice guidelines|clinical practice guidelines
4823353|NCT02483091|Multimodal care|multimodal care
4823354|NCT02483091|Brief Action Planning|brief action planning
4823355|NCT02483091|Feasibility outcomes|feasibility outcomes
4823356|NCT02483065|dementia|dementia
4823357|NCT02483065|hospital admission|hospital admission
4823358|NCT02483065|mortality|mortality
4823359|NCT02483065|health-related quality of life|health-related quality of life
4823360|NCT02483065|activities of daily living|activities of daily living
4823361|NCT02483052|lobectomy|lobectomy
4823362|NCT02483052|spray cryotherapy|spray cryotherapy
4823363|NCT02483052|lung cancer|lung cancer
4823364|NCT02483039|Acute kidney injury|acute kidney injury
4823365|NCT02483039|Chronic kidney disease|chronic kidney disease
4823366|NCT02483039|Quality improvement|quality improvement
4823367|NCT02483013|whitening dentifrices|whitening dentifrices
4823368|NCT02483013|color alteration|color alteration
4823369|NCT02483013|tooth sensitivity|tooth sensitivity
4823370|NCT02482987|dental|dental
4823371|NCT02482987|extraction|extraction
4823372|NCT02482987|socket preservation|socket preservation
4823373|NCT02482987|ridge preservation|ridge preservation
4823374|NCT02482987|implant site preparation|implant site preparation
4823375|NCT02482974|Liver transplantation|liver transplantation
4823376|NCT02482974|Everolimus|everolimus
4823377|NCT02482974|Sirolimus|sirolimus
4823378|NCT02482974|Treatment outcome|treatment outcome
4823379|NCT02482974|Safety|safety
4823380|NCT02482948|Debridement|debridement
4823381|NCT02482948|collagenase|collagenase
4823382|NCT02482948|leptospermum honey|leptospermum honey
4823383|NCT02482922|feasibility studies|feasibility studies
4823384|NCT02482922|intervention|intervention
4823385|NCT02482922|Pre-Hypertensive|pre-hypertensive
4823386|NCT02482922|Pre-Hyperlipidemia|pre-hyperlipidemia
4823387|NCT02482844|TAVI|tavi
4823388|NCT02482844|de novo and persistent LBBB|de novo and persistent lbbb
4823389|NCT02482844|electrophysiology|electrophysiology
4823390|NCT02482844|Holter|holter
4823391|NCT02482844|pacemaker|pacemaker
4823392|NCT02482831|Sciatic nerve block|sciatic nerve block
4823393|NCT02482831|block duration|block duration
4823394|NCT02482831|Semmes Weinstein monofilaments|semmes weinstein monofilaments
4823395|NCT02482831|fasting blood glucose|fasting blood glucose
4823396|NCT02482831|nerve block|nerve block
4823397|NCT02482831|sensory block duration|sensory block duration
4823398|NCT02482831|motor block duration|motor block duration
4823399|NCT02482818|chronic cough|chronic cough
4823400|NCT02482818|cough hypersensitivity|cough hypersensitivity
4823401|NCT02482818|Lyrica|lyrica
4823402|NCT02482818|Pregabalin|pregabalin
4823403|NCT02482818|cough reflex sensitivity|cough reflex sensitivity
4823404|NCT02482792|Musculoskeletal disorders|musculoskeletal disorders
4823405|NCT02482792|Psychosomatic|psychosomatic
4823406|NCT02482792|Pain|pain
4823407|NCT02482753|Chidamide|chidamide
4823408|NCT02482753|breast cancer|breast cancer
4823409|NCT02482753|exemestane|exemestane
4823410|NCT02482753|Estrogen Receptor|estrogen receptor
4823411|NCT02482740|Uterine Cervical Neoplasms|uterine cervical neoplasms
4823412|NCT02482740|antiestrogens|antiestrogens
4823413|NCT02482727|Blood Flow Restriction|blood flow restriction
4823414|NCT02482727|Occlusion training|occlusion training
4823415|NCT02482727|Distal radius fracture|distal radius fracture
4823416|NCT02482714|Quality of Life|quality of life
4823417|NCT02482714|Physical Activity|physical activity
4823418|NCT02482701|EMR|emr
4823419|NCT02482701|EAC|eac
4823420|NCT02482701|Barrett's Neoplasia|barrett's neoplasia
4823421|NCT02482701|Multiband Mucosectomy|multiband mucosectomy
4823422|NCT02482675|Dairy|dairy
4823423|NCT02482675|Milk|milk
4823424|NCT02482675|Glucose|glucose
4823425|NCT02482675|Postprandial|postprandial
4823426|NCT02482675|Hyperglycemia|hyperglycemia
4823427|NCT02482675|Prediabetes|prediabetes
4823428|NCT02482675|Blood glucose|blood glucose
4823429|NCT02482675|Oxidative stress|oxidative stress
4823430|NCT02482675|Vascular health|vascular health
4823431|NCT02482675|Vascular function|vascular function
4823432|NCT02482662|Diagnosis|diagnosis
4823433|NCT02482636|infant immunisations|infant immunisations
4823434|NCT02482636|vaccines|vaccines
4823435|NCT02482636|paediatric|paediatric
4823436|NCT02482636|pneumococcal|pneumococcal
4823437|NCT02482636|meningococcal|meningococcal
4823438|NCT02482623|Dementia|dementia
4823439|NCT02482623|neuropsychiatric symptoms|neuropsychiatric symptoms
4823440|NCT02482623|implementation science|implementation science
4823441|NCT02482623|depression|depression
4823442|NCT02482623|pain|pain
4823443|NCT02482610|Dairy|dairy
4823444|NCT02482610|Milk|milk
4823445|NCT02482610|Glucose|glucose
4823446|NCT02482610|Postprandial|postprandial
4823447|NCT02482610|Hyperglycemia|hyperglycemia
4823448|NCT02482610|Prediabetes|prediabetes
4823449|NCT02482610|Blood glucose|blood glucose
4823450|NCT02482610|Oxidative stress|oxidative stress
4823451|NCT02482610|Vascular health|vascular health
4823452|NCT02482610|Vascular function|vascular function
4823453|NCT02482571|Functional MRS|functional mrs
4823454|NCT02482571|Glutamate|glutamate
4823455|NCT02482558|Glycaemic Index|glycaemic index
4823456|NCT02482558|NAFLD|nafld
4823457|NCT02482558|Glycogen|glycogen
4823458|NCT02482558|Liver|liver
4823459|NCT02482558|Diet|diet
4823460|NCT02482532|Melanoma|melanoma
4823461|NCT02482532|metastatic|metastatic
4823462|NCT02482532|relapsed|relapsed
4823463|NCT02482532|refractory|refractory
4823464|NCT02482506|African American|african american
4823465|NCT02482506|Overweight|overweight
4823466|NCT02482506|Adults|adults
4823467|NCT02482480|SLEEP|sleep
4823468|NCT02482480|APNEA|apnea
4823469|NCT02482480|EXERCISE|exercise
4823470|NCT02482467|ovarian cyst|ovarian cyst
4823471|NCT02482467|prenatal diagnosis|prenatal diagnosis
4823472|NCT02482467|puberty|puberty
4823473|NCT02482454|radiofrequency ablation|radiofrequency ablation
4823474|NCT02482454|cytokine-induced killer cells|cytokine-induced killer cells
4823475|NCT02482454|cholangiocarcinoma|cholangiocarcinoma
4823476|NCT02482441|Advanced Solid Tumors and in Combination|advanced solid tumors and in combination
4823477|NCT02482441|FOLFIRI for Patients with Previously Treated Metastatic|folfiri for patients with previously treated metastatic
4823478|NCT02482441|Colorectal Cancer|colorectal cancer
4823479|NCT02482428|human papilloma virus (HPV), Genital Warts, Sexually transmitted disease (STD), viral disease|human papilloma virus (hpv), genital warts, sexually transmitted disease (std), viral disease
4823480|NCT02482415|Palliative Care|palliative care
4823481|NCT02482415|Randomized controlled trial|randomized controlled trial
4823482|NCT02482415|Family caregivers|family caregivers
4823483|NCT02482415|Intervention|intervention
4823484|NCT02482415|Family|family
4823485|NCT02482415|Intervention studies|intervention studies
4823486|NCT02482415|Home Care|home care
4823487|NCT02482311|AZD1775|azd1775
4823488|NCT02482311|Ovarian cancer (BRCA1/2 mutation)|ovarian cancer (brca1/2 mutation)
4823489|NCT02482311|Ovarian cancer (PARP-failure)|ovarian cancer (parp-failure)
4823490|NCT02482311|Triple negative breast cancer (TNBC)|triple negative breast cancer (tnbc)
4823491|NCT02482311|Small-cell lung cancer (SCLC)|small-cell lung cancer (sclc)
4823492|NCT02482311|Solid tumours|solid tumours
4823493|NCT02482298|Sickle cell disease|sickle cell disease
4823494|NCT02482298|Young adults|young adults
4823495|NCT02482298|Hestia2|hestia2
4823496|NCT02482298|Ticagrelor|ticagrelor
4823497|NCT02482233|electronic cigarette|electronic cigarette
4823498|NCT02482233|nicotine replacement therapy|nicotine replacement therapy
4823499|NCT02482233|smoking cessation|smoking cessation
4823500|NCT02482233|perioperative|perioperative
4823501|NCT02482194|Spinal cord injury|spinal cord injury
4823502|NCT02482194|mesenchymal stem cells|mesenchymal stem cells
4823503|NCT02482194|transplantation|transplantation
4823504|NCT02482181|diffusion weighted magnetic resonance imaging|diffusion weighted magnetic resonance imaging
4823505|NCT02482168|immunotherapy|immunotherapy
4823506|NCT02482168|CD40|cd40
4823507|NCT02482155|pharmacokinetics|pharmacokinetics
4823508|NCT02482155|MOMENTACT|momentact
4823509|NCT02482155|ibuprofen 400 mg|ibuprofen 400 mg
4823510|NCT02482155|oral|oral
4823511|NCT02482155|granules|granules
4823512|NCT02482142|phosphorus|phosphorus
4823513|NCT02482142|lean|lean
4823514|NCT02482142|obese|obese
4823515|NCT02482142|energy expenditure|energy expenditure
4823516|NCT02482129|Acute anterior uveitis|acute anterior uveitis
4823517|NCT02482129|LME636|lme636
4823518|NCT02482116|malaria|malaria
4823519|NCT02482116|pneumonia|pneumonia
4823520|NCT02482116|Nigeria|nigeria
4823521|NCT02482116|IMCI|imci
4823522|NCT02482116|diagnosis|diagnosis
4823523|NCT02482103|Therapy resistant hypertension|therapy resistant hypertension
4823524|NCT02482051|Carbapenem-resistant Enterobacteriaceae|carbapenem-resistant enterobacteriaceae
4823525|NCT02482051|Accelerate ID/AST|accelerate id/ast
4823526|NCT02482025|Medications|medications
4823527|NCT02482025|Hospitalization|hospitalization
4823528|NCT02482025|Electronic medical records|electronic medical records
4823529|NCT02482012|research|research
4823530|NCT02482012|vulnerable population|vulnerable population
4823531|NCT02482012|45 CFR 46.406|45 cfr 46.406
4823532|NCT02481999|Depth of anesthesia|depth of anesthesia
4823533|NCT02481973|PMS|pms
4823534|NCT02481973|Homoeopathy|homoeopathy
4823535|NCT02481973|Grant Bentley Method|grant bentley method
4823536|NCT02481934|Recurrent multiple myeloma|recurrent multiple myeloma
4823537|NCT02481934|NK cells|nk cells
4823538|NCT02481934|cell therapy|cell therapy
4823539|NCT02481934|NKAE|nkae
4823540|NCT02481934|Relapsed multiple myeloma|relapsed multiple myeloma
4823541|NCT02481921|heart failure|heart failure
4823542|NCT02481921|self-management|self-management
4823543|NCT02481921|group intervention|group intervention
4823544|NCT02481908|AECOPD|aecopd
4823545|NCT02481908|left ventricular dysfunction|left ventricular dysfunction
4823546|NCT02481908|valsalva maneuver|valsalva maneuver
4823547|NCT02481908|systolic time intervals|systolic time intervals
4823548|NCT02481895|cognition|cognition
4823549|NCT02481895|psychosocial functioning|psychosocial functioning
4823550|NCT02481869|Closed|closed
4823551|NCT02481869|unilateral|unilateral
4823552|NCT02481869|pilon|pilon
4823553|NCT02481843|Hyperoxia|hyperoxia
4823554|NCT02481843|Microcirculation|microcirculation
4823555|NCT02481843|Erythropoietin|erythropoietin
4823556|NCT02481843|Normobaric Oxygen Paradox|normobaric oxygen paradox
4823557|NCT02481804|diet|diet
4823558|NCT02481804|vitamin|vitamin
4823559|NCT02481778|Radiotherapy|radiotherapy
4823560|NCT02481778|Cardiac|cardiac
4823561|NCT02481778|Toxicity|toxicity
4823562|NCT02481752|Tobacco Use|tobacco use
4823563|NCT02481752|Nicotine Dependence|nicotine dependence
4823564|NCT02481739|endometriosis|endometriosis
4823565|NCT02481739|fertility|fertility
4823566|NCT02481739|endometriosis surgery|endometriosis surgery
4823567|NCT02481726|68Ga|68ga
4823568|NCT02481726|Alfatide II|alfatide ii
4823569|NCT02481726|RGD|rgd
4823570|NCT02481726|αvβ3|αvβ3
4823571|NCT02481726|PET/CT|pet/ct
4823572|NCT02481713|psychosis|psychosis
4823573|NCT02481713|adherence|adherence
4823574|NCT02481713|motivation|motivation
4823575|NCT02481674|Prodromal Stage|prodromal stage
4823576|NCT02481674|Early Manifest Stage|early manifest stage
4823577|NCT02481635|Blood Vessels|blood vessels
4823578|NCT02481635|Reconstructive Surgery|reconstructive surgery
4823579|NCT02481622|HIV infection|hiv infection
4823580|NCT02481622|vaginal tissues|vaginal tissues
4823581|NCT02481622|uterine tissues|uterine tissues
4823582|NCT02481609|Loss of Smell|loss of smell
4823583|NCT02481609|Olfaction|olfaction
4823584|NCT02481609|Hyposmia|hyposmia
4823585|NCT02481596|family|family
4823586|NCT02481596|support|support
4823587|NCT02481596|diet|diet
4823588|NCT02481596|exercise|exercise
4823589|NCT02481596|social|social
4823590|NCT02481583|levosulpiride|levosulpiride
4823591|NCT02481583|pharmacokinetics|pharmacokinetics
4823592|NCT02481583|adverse effects|adverse effects
4823593|NCT02481583|bioavailability|bioavailability
4823594|NCT02481570|Adolescent Idiopathic Scoliosis|adolescent idiopathic scoliosis
4823595|NCT02481570|Scoliosis surgery|scoliosis surgery
4823596|NCT02481570|Pharmacokinetic simulation|pharmacokinetic simulation
4823597|NCT02481518|Cisplatin nephrotoxicity|cisplatin nephrotoxicity
4823598|NCT02481518|Acute kidney injury|acute kidney injury
4823599|NCT02481492|Circumcision, Male|circumcision, male
4823600|NCT02481492|Shang Ring|shang ring
4823601|NCT02481492|Children|children
4823602|NCT02481492|Foreskin|foreskin
4823603|NCT02481466|Arterial plaque|arterial plaque
4823604|NCT02481466|Magnetic resonance imaging (MRI)|magnetic resonance imaging (mri)
4823605|NCT02481466|Portfolio diet|portfolio diet
4823606|NCT02481466|Dietary modification|dietary modification
4823607|NCT02481466|Dietary trials|dietary trials
4823608|NCT02481466|hypercholesterolemia|hypercholesterolemia
4823609|NCT02481466|diabetes|diabetes
4823610|NCT02481466|exercise|exercise
4823611|NCT02481466|cardiovascular disease risk|cardiovascular disease risk
4823612|NCT02481466|glycemic index (GI)|glycemic index (gi)
4823613|NCT02481466|Carotid Ultrasound|carotid ultrasound
4823614|NCT02481466|Dietary Approaches to Stop Hypertension (DASH) diet|dietary approaches to stop hypertension (dash) diet
4823615|NCT02481440|umbilical cord mesenchymal stem cells|umbilical cord mesenchymal stem cells
4823616|NCT02481440|spinal cord injury|spinal cord injury
4823617|NCT02481427|Total|total
4823618|NCT02481427|Unicondylar|unicondylar
4823619|NCT02481427|Osteoarthritis|osteoarthritis
4823620|NCT02481427|Arthroplasty|arthroplasty
4823621|NCT02481427|Replacement|replacement
4823622|NCT02481427|Knee|knee
4823623|NCT02481414|HSIL, CIN II/III|hsil, cin ii/iii
4823624|NCT02481401|cardiovascular health|cardiovascular health
4823625|NCT02481401|behavior change|behavior change
4823626|NCT02481401|community-based|community-based
4823627|NCT02481401|family-based|family-based
4823628|NCT02481401|prevention|prevention
4823629|NCT02481375|iron|iron
4823630|NCT02481375|ferritin|ferritin
4823631|NCT02481375|soluble transferrin receptor|soluble transferrin receptor
4823632|NCT02481375|hepcidin|hepcidin
4823633|NCT02481375|reticulocyte count|reticulocyte count
4823634|NCT02481375|hemoglobin|hemoglobin
4823635|NCT02481375|supplementation|supplementation
4823636|NCT02481349|Glioma|glioma
4823637|NCT02481349|Hatha yoga|hatha yoga
4823638|NCT02481349|Questionnaires|questionnaires
4823639|NCT02481349|Surveys|surveys
4823640|NCT02481336|Chemotherapy|chemotherapy
4823641|NCT02481336|Peripheral Neuropathy|peripheral neuropathy
4823642|NCT02481323|cerebral small vessel disease|cerebral small vessel disease
4823643|NCT02481323|cerebrovascular reactivity|cerebrovascular reactivity
4823644|NCT02481323|cilostazol|cilostazol
4823645|NCT02481323|isosorbide mononitrate|isosorbide mononitrate
4823646|NCT02481297|Leukemia|leukemia
4823647|NCT02481297|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
4823648|NCT02481297|CLL|cll
4823649|NCT02481297|Refractory/Relapsed|refractory/relapsed
4823650|NCT02481297|Untreated with high-risk molecular features|untreated with high-risk molecular features
4823651|NCT02481297|Small lymphocytic leukemia|small lymphocytic leukemia
4823652|NCT02481297|SLL|sll
4823653|NCT02481297|Lirilumab|lirilumab
4823654|NCT02481297|Rituximab|rituximab
4823655|NCT02481297|Rituxan|rituxan
4823656|NCT02481284|Breast reconstruction|breast reconstruction
4823657|NCT02481284|Deep inferior epigastric artery perforator flap|deep inferior epigastric artery perforator flap
4823658|NCT02481284|Skin perfusion|skin perfusion
4823659|NCT02481284|Plastic and reconstructive surgery|plastic and reconstructive surgery
4823660|NCT02481271|cholecystectomy|cholecystectomy
4823661|NCT02481258|Stenosis|stenosis
4823662|NCT02481258|Aortic Valve|aortic valve
4823663|NCT02481258|Aorta|aorta
4823664|NCT02481258|Calcified|calcified
4823665|NCT02481258|Calcific|calcific
4823666|NCT02481258|Calcification|calcification
4823667|NCT02481245|Bipolar Disorder|bipolar disorder
4823668|NCT02481245|Bezafibrate|bezafibrate
4823669|NCT02481245|Depressive Episode|depressive episode
4823670|NCT02481219|Polyps|polyps
4823671|NCT02481219|Capsule endoscopy|capsule endoscopy
4823672|NCT02481219|Bowel preparation regimen|bowel preparation regimen
4823673|NCT02481219|Average risk patients for colorectal cancer screening|average risk patients for colorectal cancer screening
4823674|NCT02481206|Ventricular Tachycardia|ventricular tachycardia
4823675|NCT02481193|Cisatracurium|cisatracurium
4823676|NCT02481193|Myalgia|myalgia
4823677|NCT02481193|Fasciculation|fasciculation
4823678|NCT02481193|Succinylcholine|succinylcholine
4823679|NCT02481167|Aged|aged
4823680|NCT02481167|Meibomian Glands|meibomian glands
4823681|NCT02481167|dry eye|dry eye
4823682|NCT02481167|Elderly|elderly
4823683|NCT02481154|Glioma|glioma
4823684|NCT02481154|IDH1|idh1
4823685|NCT02481154|IDH2|idh2
4823686|NCT02481154|Dual Mutation|dual mutation
4823687|NCT02481154|AG-881|ag-881
4823688|NCT02481128|lymphoscintigraphy|lymphoscintigraphy
4823689|NCT02481128|sentinel lymph node biopsy|sentinel lymph node biopsy
4823690|NCT02481076|malleolar fractures|malleolar fractures
4823691|NCT02481076|ORIF|orif
4823692|NCT02481076|compression|compression
4823693|NCT02481076|infection|infection
4823694|NCT02481076|wound dehisence|wound dehisence
4823695|NCT02481063|Eccentric|eccentric
4823696|NCT02481063|Running|running
4823697|NCT02481063|Muscle|muscle
4823698|NCT02481063|Tendon|tendon
4823699|NCT02481063|Ultrasound|ultrasound
4823700|NCT02481063|Thermography|thermography
4823701|NCT02481050|Eribulin Mesylate|eribulin mesylate
4823702|NCT02481050|Human Epidermal Growth Factor Receptor 2|human epidermal growth factor receptor 2
4823703|NCT02481050|Metastatic Breast Cancer|metastatic breast cancer
4823704|NCT02481050|HER2-Negative|her2-negative
4823705|NCT02481024|Qualitative|qualitative
4823706|NCT02481024|Care transition|care transition
4823707|NCT02481024|Medication|medication
4823708|NCT02481011|Fibrinolytic agents|fibrinolytic agents
4823709|NCT02481011|Adverse effects|adverse effects
4823710|NCT02481011|Registries|registries
4823711|NCT02481011|Incidence|incidence
4823712|NCT02481011|Risk assessment|risk assessment
4823713|NCT02480985|Pituitary Disorders|pituitary disorders
4823714|NCT02480985|Traumatic Brain Injury|traumatic brain injury
4823715|NCT02480985|Critical Care|critical care
4823716|NCT02480985|Outcome Research|outcome research
4823717|NCT02480985|Risk Factors|risk factors
4823718|NCT02480985|Patient Oriented Research|patient oriented research
4823719|NCT02480972|fibrosis|fibrosis
4823720|NCT02480972|cirrhosis|cirrhosis
4823721|NCT02480972|MRI|mri
4823722|NCT02480946|Rheumatoid Arthritis|rheumatoid arthritis
4823723|NCT02480946|Osteoclastogenesis inhibitor|osteoclastogenesis inhibitor
4823724|NCT02480946|Anti-Inflammatory Agent|anti-inflammatory agent
4823725|NCT02480946|Musculoskeletal Diseases|musculoskeletal diseases
4823726|NCT02480946|Joint Diseases|joint diseases
4823727|NCT02480920|Atrial fibrillation Drug Adherence|atrial fibrillation drug adherence
4823728|NCT02480920|New Oral Anticoagulants|new oral anticoagulants
4823729|NCT02480920|Drug Adherence|drug adherence
4823730|NCT02480907|eating disorders|eating disorders
4823731|NCT02480907|caregivers|caregivers
4823732|NCT02480907|parents|parents
4823733|NCT02480907|skills training|skills training
4823734|NCT02480907|workshops|workshops
4823735|NCT02480907|support|support
4823736|NCT02480907|internet|internet
4823737|NCT02480907|online|online
4823738|NCT02480907|family|family
4823739|NCT02480868|Primary or secondary osteoarthritis|primary or secondary osteoarthritis
4823740|NCT02480868|fusion of the ankle|fusion of the ankle
4823741|NCT02480855|work related stress|work related stress
4823742|NCT02480855|questionnaire|questionnaire
4823743|NCT02480855|early identification|early identification
4823744|NCT02480842|Breast Neoplasms|breast neoplasms
4823745|NCT02480842|Mammaplasty|mammaplasty
4823746|NCT02480842|Breast Implantation|breast implantation
4823747|NCT02480842|Range of Motion, Articular|range of motion, articular
4823748|NCT02480842|Shoulder Joint|shoulder joint
4823749|NCT02480842|Physical Therapy Modalities|physical therapy modalities
4823750|NCT02480803|Parkinson|parkinson
4823751|NCT02480803|Parkinson's Disease|parkinson's disease
4823752|NCT02480803|Deep Brain Stimulation|deep brain stimulation
4823753|NCT02480803|levodopa-carbidopa|levodopa-carbidopa
4823754|NCT02480803|Duodopa|duodopa
4823755|NCT02480803|continuous intrajejunal infusion|continuous intrajejunal infusion
4823756|NCT02480764|Drug therapy|drug therapy
4823757|NCT02480751|Chronic Renal Failure|chronic renal failure
4823758|NCT02480751|Prostaglandin|prostaglandin
4823759|NCT02480751|Prostacyclin|prostacyclin
4823760|NCT02480751|Glomerular Disease; Nephrosclerosis|glomerular disease; nephrosclerosis
4823761|NCT02480738|subjective cognitive impairment|subjective cognitive impairment
4823762|NCT02480725|CJD|cjd
4823763|NCT02480725|CSF|csf
4823764|NCT02480725|prion|prion
4823765|NCT02480725|thrombin|thrombin
4823766|NCT02480673|Metabolic Syndrome X|metabolic syndrome x
4823767|NCT02480673|Chia|chia
4823768|NCT02480673|Dyslipidemia|dyslipidemia
4823769|NCT02480660|Hospitalized|hospitalized
4823770|NCT02480660|adolescents|adolescents
4823771|NCT02480660|knowledge|knowledge
4823772|NCT02480660|transition|transition
4823773|NCT02480660|educational intervention|educational intervention
4823774|NCT02480634|zoledronic acid|zoledronic acid
4823775|NCT02480634|radiotherapy|radiotherapy
4823776|NCT02480595|Abdominal Aortic Aneurysm|abdominal aortic aneurysm
4823777|NCT02480595|AAA|aaa
4823778|NCT02480595|Endovascular|endovascular
4823779|NCT02480595|EVAR|evar
4823780|NCT02480595|Stent|stent
4823781|NCT02480595|Stent Graft|stent graft
4823782|NCT02480595|High Angle|high angle
4823783|NCT02480595|Tortuous|tortuous
4823882|NCT02479737|hemothorax|hemothorax
4823784|NCT02480556|blood loss; caesarean section ; manual placental separation|blood loss; caesarean section ; manual placental separation
4823785|NCT02480530|Medication Adherence|medication adherence
4823786|NCT02480530|Reciprocal Peer|reciprocal peer
4823787|NCT02480530|Telemonitoring|telemonitoring
4823788|NCT02480517|Hypertension|hypertension
4823789|NCT02480517|Renal Denervation|renal denervation
4823790|NCT02480478|Intrahepatic Cholestasis of Pregnancy|intrahepatic cholestasis of pregnancy
4823791|NCT02480439|Drug Therapy|drug therapy
4823792|NCT02480413|Broselow Tape|broselow tape
4823793|NCT02480413|Weight estimation|weight estimation
4823794|NCT02480413|Patient safety|patient safety
4823795|NCT02480400|MDD|mdd
4823796|NCT02480400|Escitalopram|escitalopram
4823797|NCT02480400|Placebo|placebo
4823798|NCT02480361|Acupuncture|acupuncture
4823799|NCT02480361|Gastric cancer|gastric cancer
4823800|NCT02480322|metabolic alterations|metabolic alterations
4823801|NCT02480257|intervention|intervention
4823802|NCT02480257|emotion regulation|emotion regulation
4823803|NCT02480257|fMRI|fmri
4823804|NCT02480257|mindfulness|mindfulness
4823805|NCT02480257|yoga-based movement|yoga-based movement
4823806|NCT02480231|Tension-Free Vaginal Tape|tension-free vaginal tape
4823807|NCT02480231|Suburethral Slings|suburethral slings
4823808|NCT02480231|Midurethral Slings|midurethral slings
4823809|NCT02480231|Mid-urethral sling|mid-urethral sling
4823810|NCT02480231|urinary retention|urinary retention
4823811|NCT02480218|cognition|cognition
4823812|NCT02480218|tamoxifen|tamoxifen
4823813|NCT02480218|aromatase inhibitors|aromatase inhibitors
4823814|NCT02480205|CPAP|cpap
4823815|NCT02480205|NIV|niv
4823816|NCT02480205|NIPPV|nippv
4823817|NCT02480205|Edi|edi
4823818|NCT02480192|Vasomotor|vasomotor
4823819|NCT02480192|Symptoms|symptoms
4823820|NCT02480179|functional MRI|functional mri
4823821|NCT02480179|appetite|appetite
4823822|NCT02480179|neurofeedback|neurofeedback
4823823|NCT02480166|hepatitis C, genotype 6|hepatitis c, genotype 6
4823824|NCT02480153|Phase 3|phase 3
4823825|NCT02480153|adalimumab|adalimumab
4823826|NCT02480153|rheumatoid arthritis|rheumatoid arthritis
4823827|NCT02480140|Self-regulation|self-regulation
4823828|NCT02480140|Constraint-induced movement therapy|constraint-induced movement therapy
4823829|NCT02480140|Stroke|stroke
4823830|NCT02480140|Functional recovery|functional recovery
4823831|NCT02480140|Randomized controlled trial|randomized controlled trial
4823832|NCT02480101|influenza vaccine pandemic|influenza vaccine pandemic
4823833|NCT02480075|Genetic Variation|genetic variation
4823834|NCT02480075|Genetic Polymorphism|genetic polymorphism
4823835|NCT02480075|Polymorphism, Single Nucleotide|polymorphism, single nucleotide
4823836|NCT02480075|Genetic Association Studies|genetic association studies
4823837|NCT02480062|Decision Support System|decision support system
4823838|NCT02480062|mHealth|mhealth
4823839|NCT02480062|Primary Health Care|primary health care
4823840|NCT02480062|Non-communicable diseases|non-communicable diseases
4823841|NCT02480036|IORT|iort
4823842|NCT02480036|Kyphoplasty|kyphoplasty
4823843|NCT02480036|Spine|spine
4823844|NCT02480036|Cancer|cancer
4823845|NCT02479997|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
4823846|NCT02479997|Indocyanine green (ICG)|indocyanine green (icg)
4823847|NCT02479997|Radioisotope (RI)|radioisotope (ri)
4823848|NCT02479997|Near infrared fluorescence camera|near infrared fluorescence camera
4823849|NCT02479984|staging laparoscopy|staging laparoscopy
4823850|NCT02479984|pancreatic cancer|pancreatic cancer
4823851|NCT02479984|biliary cancer|biliary cancer
4823852|NCT02479958|Photochemotherapy|photochemotherapy
4823853|NCT02479958|Bacteria|bacteria
4823854|NCT02479932|Extra-peritoneal cesarean|extra-peritoneal cesarean
4823855|NCT02479932|Intra-peritoneal cesarean|intra-peritoneal cesarean
4823856|NCT02479919|theta burst stimulation|theta burst stimulation
4823857|NCT02479919|Social Cognition|social cognition
4823858|NCT02479919|Schizophrenia|schizophrenia
4823859|NCT02479919|transcranial magnetic stimulation|transcranial magnetic stimulation
4823860|NCT02479906|Post-Traumatic Stress Disorder|post-traumatic stress disorder
4823861|NCT02479906|PTSD|ptsd
4823862|NCT02479906|dTMS|dtms
4823863|NCT02479893|cold snare polypectomy|cold snare polypectomy
4823864|NCT02479893|APC|apc
4823865|NCT02479893|hot snare polypectomy|hot snare polypectomy
4823866|NCT02479815|Complementary feeding recommendation|complementary feeding recommendation
4823867|NCT02479815|Program evaluation|program evaluation
4823868|NCT02479815|Process and impact evaluation|process and impact evaluation
4823869|NCT02479815|Micronutrient powder (MNP) safety|micronutrient powder (mnp) safety
4823870|NCT02479802|plasma exchange|plasma exchange
4823871|NCT02479802|albumin|albumin
4823872|NCT02479789|Intravenous Lidocaine|intravenous lidocaine
4823873|NCT02479789|Recurrent laryngeal nerve|recurrent laryngeal nerve
4823874|NCT02479789|Intra operative nerve monitoring|intra operative nerve monitoring
4823875|NCT02479789|Thyroidectomy|thyroidectomy
4823876|NCT02479763|Epidural waveform analysis|epidural waveform analysis
4823877|NCT02479763|Loss of resistance|loss of resistance
4823878|NCT02479737|Chest tube|chest tube
4823879|NCT02479737|chest drainage|chest drainage
4823880|NCT02479737|retained blood complications|retained blood complications
4823881|NCT02479737|chest tube clogging|chest tube clogging
4823883|NCT02479737|tamponade|tamponade
4823884|NCT02479737|heart surgery|heart surgery
4823885|NCT02479737|pleural effusion|pleural effusion
4823886|NCT02479737|intensive care|intensive care
4823887|NCT02479724|continuous, non-invasive|continuous, non-invasive
4823888|NCT02479711|glass ionomer|glass ionomer
4823889|NCT02479711|bulk fill composite|bulk fill composite
4823890|NCT02479698|Stem cell transplant|stem cell transplant
4823891|NCT02479698|Human Leukocyte Antigen|human leukocyte antigen
4823892|NCT02479698|HLA|hla
4823893|NCT02479698|BK specific CTL lines|bk specific ctl lines
4823894|NCT02479698|BK-CTLs|bk-ctls
4823895|NCT02479698|Hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
4823896|NCT02479698|HSCT|hsct
4823897|NCT02479698|BK Infection|bk infection
4823898|NCT02479698|Cytotoxic T lymphocytes|cytotoxic t lymphocytes
4823899|NCT02479698|CTLs|ctls
4823900|NCT02479698|Myeloablative|myeloablative
4823901|NCT02479698|Non-myeloablative|non-myeloablative
4823902|NCT02479698|Graft Versus Host Disease|graft versus host disease
4823903|NCT02479698|GVHD|gvhd
4823904|NCT02479672|breathing tube placement|breathing tube placement
4823905|NCT02479672|VideoTrac® laryngoscope|videotrac® laryngoscope
4823906|NCT02479672|direct laryngoscopy|direct laryngoscopy
4823907|NCT02479659|Immunizations|immunizations
4823908|NCT02479646|Pegfilgrastim|pegfilgrastim
4823909|NCT02479646|G-CSF|g-csf
4823910|NCT02479646|Pharmacokinetics|pharmacokinetics
4823911|NCT02479646|Pharmacodynamics|pharmacodynamics
4823912|NCT02479633|prognostic factors|prognostic factors
4823913|NCT02479607|Breast Cancer|breast cancer
4823914|NCT02479607|Cytostatic Agents|cytostatic agents
4823915|NCT02479607|Nursing|nursing
4823916|NCT02479607|Health Literacy|health literacy
4823917|NCT02479607|Quality of Life|quality of life
4823918|NCT02479607|Oncology Nursing|oncology nursing
4823919|NCT02479607|Self Care|self care
4823920|NCT02479607|Symptom Management|symptom management
4823921|NCT02479607|Participatory Care|participatory care
4823922|NCT02479607|Person-centered Care|person-centered care
4823923|NCT02479607|Information and Communication Technology|information and communication technology
4823924|NCT02479607|Patient-reported symptoms|patient-reported symptoms
4823925|NCT02479607|Mobile device|mobile device
4823926|NCT02479594|competence-feedback|competence-feedback
4823927|NCT02479581|Enhanced Recovery after Surgery|enhanced recovery after surgery
4823928|NCT02479568|Cardiovascular disease|cardiovascular disease
4823929|NCT02479568|biomarkers|biomarkers
4823930|NCT02479568|transcriptomics|transcriptomics
4823931|NCT02479568|orange juice|orange juice
4823932|NCT02479568|hesperidin|hesperidin
4823933|NCT02479568|systolic blood pressure|systolic blood pressure
4823934|NCT02479568|metabolomics|metabolomics
4823935|NCT02479568|cardiovascular risk factor|cardiovascular risk factor
4823936|NCT02479542|Negative-Pressure Wound Therapy|negative-pressure wound therapy
4823937|NCT02479542|Wound Healing|wound healing
4823938|NCT02479542|Global Health|global health
4823939|NCT02479542|Cameroon|cameroon
4823940|NCT02479516|Diabetes screening|diabetes screening
4823941|NCT02479516|Health Promotion|health promotion
4823942|NCT02479516|Low and Middle Income Countries|low and middle income countries
4823943|NCT02479516|CHAP|chap
4823944|NCT02479503|antibiotic prophylaxis heart transplantation|antibiotic prophylaxis heart transplantation
4823945|NCT02479490|metastatic renal cancer|metastatic renal cancer
4823946|NCT02479490|failure of VEGFR_TKI|failure of vegfr_tki
4823947|NCT02479490|prednisone|prednisone
4823948|NCT02479490|everolimus|everolimus
4823949|NCT02479477|Public Health|public health
4823950|NCT02479477|Nursing Staff, Hospital|nursing staff, hospital
4823951|NCT02479464|AssureRx|assurerx
4823952|NCT02479464|Algorithm|algorithm
4823953|NCT02479464|Major depressive disorder|major depressive disorder
4823954|NCT02479451|End stage renal disease|end stage renal disease
4823955|NCT02479451|Olfaction|olfaction
4823956|NCT02479451|Dialysis|dialysis
4823957|NCT02479451|Hemodialysis|hemodialysis
4823958|NCT02479451|Malnutrition|malnutrition
4823959|NCT02479425|pressure ulcer|pressure ulcer
4823960|NCT02479425|Positioning|positioning
4823961|NCT02479412|Mild to moderate asthma|mild to moderate asthma
4823962|NCT02479412|FEV1|fev1
4823963|NCT02479412|efficacy|efficacy
4823964|NCT02479412|safety|safety
4823965|NCT02479399|Suglat|suglat
4823966|NCT02479399|SGLT-2 inhibitor|sglt-2 inhibitor
4823967|NCT02479399|Ipragliflozin L-Proline|ipragliflozin l-proline
4823968|NCT02479399|ASP1941 long-term use|asp1941 long-term use
4823969|NCT02479347|General surgery|general surgery
4823970|NCT02479347|Postoperative|postoperative
4823971|NCT02479334|Spices|spices
4823972|NCT02479334|Functional food|functional food
4823973|NCT02479334|Cardiometabolic risk|cardiometabolic risk
4823974|NCT02479334|Metabolic syndrome|metabolic syndrome
4823975|NCT02479334|Inflammation|inflammation
4823976|NCT02479334|Peripheral blood mononuclear cell|peripheral blood mononuclear cell
4823977|NCT02479334|Acute|acute
4823978|NCT02479321|Perioperative Goal-Directed Hemodynamic Therapy|perioperative goal-directed hemodynamic therapy
4823979|NCT02479321|Fluid therapy|fluid therapy
4823980|NCT02479321|Aged|aged
4823981|NCT02479321|Perioperative complications|perioperative complications
4823982|NCT02479321|Survival|survival
4823983|NCT02479308|Alkermes|alkermes
4823984|NCT02479308|Samidorphan|samidorphan
4823985|NCT02479308|ALKS 5461|alks 5461
4823986|NCT02479308|QT/QTc|qt/qtc
4823987|NCT02479308|Buprenorphine|buprenorphine
4823988|NCT02479308|Pharmacodynamics|pharmacodynamics
4823989|NCT02479269|Brain Natriuretic Peptide|brain natriuretic peptide
4823990|NCT02479269|aerobic execise|aerobic execise
4823991|NCT02479269|C- Reactive Protein|c- reactive protein
4823992|NCT02479256|PCOS|pcos
4823993|NCT02479256|Induction of ovulation|induction of ovulation
4823994|NCT02479256|Clomiphene citrate|clomiphene citrate
4823995|NCT02479256|Tamoxifen|tamoxifen
4823996|NCT02479243|Arterial Spin Labeling|arterial spin labeling
4823998|NCT02479243|Atherosclerotic Stenosis|atherosclerotic stenosis
4823999|NCT02479243|Collateral Circulation|collateral circulation
4824000|NCT02479243|Ischemic stroke|ischemic stroke
4824001|NCT02479230|vaccine|vaccine
4824002|NCT02479230|breast cancer|breast cancer
4824003|NCT02479230|metastatic|metastatic
4824004|NCT02479204|safety|safety
4824005|NCT02479204|heart rate|heart rate
4824006|NCT02479204|pharmacokinetics|pharmacokinetics
4824007|NCT02479191|Abdominal|abdominal
4824008|NCT02479191|Aortic|aortic
4824009|NCT02479191|Aneurysm|aneurysm
4824010|NCT02479152|Mechanical CPR|mechanical cpr
4824011|NCT02479152|Hemodynamics|hemodynamics
4824012|NCT02479126|Interstitial Lung Disease|interstitial lung disease
4824013|NCT02479126|Idiopathic Pulmonary Fibrosis|idiopathic pulmonary fibrosis
4824014|NCT02479126|Electronic Health Records|electronic health records
4824015|NCT02479126|Computed Tomography|computed tomography
4824016|NCT02479126|Mortality|mortality
4824017|NCT02479126|Hospitalization|hospitalization
4824018|NCT02479126|Acute care visits|acute care visits
4824019|NCT02479126|Anti-inflammatory drug therapies|anti-inflammatory drug therapies
4824020|NCT02479113|GDM|gdm
4824021|NCT02479113|Maternal Hypertriglyceridaemia|maternal hypertriglyceridaemia
4824022|NCT02479100|Contrast Enhanced Spectral Mammography|contrast enhanced spectral mammography
4824023|NCT02479100|Breast|breast
4824024|NCT02479100|Cancer|cancer
4824025|NCT02479100|Diagnosis|diagnosis
4824026|NCT02479100|Patient management|patient management
4824027|NCT02479087|von Willebrand Factor|von willebrand factor
4824028|NCT02479087|Factor VIII|factor viii
4824029|NCT02479087|Hemorrhage|hemorrhage
4824030|NCT02479087|Immune Tolerance|immune tolerance
4824031|NCT02479087|Hemophilia A|hemophilia a
4824032|NCT02479074|Chronic|chronic
4824033|NCT02479061|Observationnal study|observationnal study
4824034|NCT02479061|Prevalence|prevalence
4824035|NCT02479061|Palliative care|palliative care
4824036|NCT02479061|Anti cancer center|anti cancer center
4824037|NCT02479048|satiety/appetite|satiety/appetite
4824038|NCT02479048|glycemic response|glycemic response
4824039|NCT02479048|cardiometabolic risk|cardiometabolic risk
4824040|NCT02479035|insulin sensitive|insulin sensitive
4824041|NCT02479035|insulin resistant|insulin resistant
4824042|NCT02479035|red raspberry|red raspberry
4824043|NCT02479035|polyphenols|polyphenols
4824044|NCT02479035|bioavailability|bioavailability
4824045|NCT02478996|perioperative|perioperative
4824046|NCT02478996|internet-based|internet-based
4824047|NCT02478996|exercise program|exercise program
4824048|NCT02478957|mastocytosis|mastocytosis
4824049|NCT02478957|cromolyn sodium|cromolyn sodium
4824050|NCT02478944|Inflammatory bowel disease|inflammatory bowel disease
4824051|NCT02478944|Manometry|manometry
4824052|NCT02478892|high risk|high risk
4824053|NCT02478892|specifically those with BRCA1/2 mutations|specifically those with brca1/2 mutations
4824054|NCT02478827|Cognitive Training|cognitive training
4824055|NCT02478827|Working Memory|working memory
4824056|NCT02478827|Processing Speed|processing speed
4824057|NCT02478788|ADHD|adhd
4824058|NCT02478775|obesity|obesity
4824059|NCT02478775|fertility|fertility
4824060|NCT02478775|infertility|infertility
4824061|NCT02478775|reproductive hormones|reproductive hormones
4824062|NCT02478762|Foetal glycated hemoglobin|foetal glycated hemoglobin
4824063|NCT02478762|Glycemic objectives treatment|glycemic objectives treatment
4824064|NCT02478736|postoperative delirium|postoperative delirium
4824065|NCT02478736|on-pump cardiac surgery|on-pump cardiac surgery
4824066|NCT02478736|cerebral oximetry|cerebral oximetry
4824067|NCT02478736|cerebral blood flow velosity|cerebral blood flow velosity
4824068|NCT02478723|requiring therapy|requiring therapy
4824069|NCT02478723|Teeth|teeth
4824070|NCT02478697|tobacco smoking behavior|tobacco smoking behavior
4824071|NCT02478697|employment|employment
4824072|NCT02478697|job-seeking|job-seeking
4824073|NCT02478697|tobacco cessation|tobacco cessation
4824074|NCT02478697|transtheoretical model|transtheoretical model
4824075|NCT02478697|behavior change|behavior change
4824076|NCT02478684|delayed cord clamping|delayed cord clamping
4824077|NCT02478684|premature infants|premature infants
4824078|NCT02478684|randomized study|randomized study
4824079|NCT02478684|hematocrit|hematocrit
4824080|NCT02478658|irisin|irisin
4824081|NCT02478658|resistance training|resistance training
4824082|NCT02478658|physical fitness|physical fitness
4824083|NCT02478658|Volunteers|volunteers
4824971|NCT02473497|cMET|cmet
4824084|NCT02478632|tenofovir disoproxil fumarate|tenofovir disoproxil fumarate
4824085|NCT02478632|dolutegravir plus rilpivirine|dolutegravir plus rilpivirine
4824086|NCT02478632|two-drug regimen|two-drug regimen
4824087|NCT02478632|bone mineral density|bone mineral density
4824088|NCT02478632|dual energy X-ray absorptiometry (DEXA)|dual energy x-ray absorptiometry (dexa)
4824089|NCT02478632|Human Immunodeficiency Virus-1|human immunodeficiency virus-1
4824090|NCT02478632|nucleoside reverse transcriptase inhibitor -sparing regimen|nucleoside reverse transcriptase inhibitor -sparing regimen
4824091|NCT02478632|integrase inhibitor|integrase inhibitor
4824092|NCT02478619|Obesity|obesity
4824093|NCT02478619|Respiratory Muscle Training|respiratory muscle training
4824094|NCT02478619|Bariatric Surgery|bariatric surgery
4824095|NCT02478619|Breathing exercises|breathing exercises
4824096|NCT02478619|Gastroplasty|gastroplasty
4824097|NCT02478606|Lower Extremity|lower extremity
4824098|NCT02478606|Muscle Stretching Exercises|muscle stretching exercises
4824099|NCT02478606|Muscle Strength|muscle strength
4824100|NCT02478606|Static Stretching|static stretching
4824101|NCT02478606|Proprioceptive Neuromuscular Facilitation (PNF) Stretching|proprioceptive neuromuscular facilitation (pnf) stretching
4824102|NCT02478606|Muscle Strength Dynamometer|muscle strength dynamometer
4824103|NCT02478593|Education|education
4824104|NCT02478593|Geriatric|geriatric
4824105|NCT02478593|Benzodiazepine|benzodiazepine
4824106|NCT02478593|Prevalence|prevalence
4824107|NCT02478580|Obstructive Sleep Apnea|obstructive sleep apnea
4824108|NCT02478580|Anesthesia Recovery Period|anesthesia recovery period
4824109|NCT02478554|Fetal growth restriction|fetal growth restriction
4824110|NCT02478554|macrosomia|macrosomia
4824111|NCT02478541|triglycerides|triglycerides
4824112|NCT02478541|glucose|glucose
4824113|NCT02478541|fructose|fructose
4824114|NCT02478541|fatty acids|fatty acids
4824115|NCT02478515|ranibizumab|ranibizumab
4824116|NCT02478515|PRN regimen|prn regimen
4824117|NCT02478515|macular edema|macular edema
4824118|NCT02478515|branch retinal vein occlusion|branch retinal vein occlusion
4824119|NCT02478502|testicular cancer|testicular cancer
4824120|NCT02478502|cisplatin resistancy|cisplatin resistancy
4824121|NCT02478489|alcohol|alcohol
4824122|NCT02478489|heavy drinking|heavy drinking
4824123|NCT02478489|naltrexone|naltrexone
4824124|NCT02478489|hospital|hospital
4824125|NCT02478489|alcohol use disorder|alcohol use disorder
4824126|NCT02478489|alcohol dependence|alcohol dependence
4824127|NCT02478489|comparative effectiveness|comparative effectiveness
4824128|NCT02478463|Cabotegravir|cabotegravir
4824129|NCT02478463|Pharmacokinetic|pharmacokinetic
4824130|NCT02478463|Healthy Adult Volunteers|healthy adult volunteers
4824131|NCT02478463|GSK1265744|gsk1265744
4824132|NCT02478437|Lumbar Facet Syndrome|lumbar facet syndrome
4824133|NCT02478411|muscle weakness|muscle weakness
4824134|NCT02478411|rehabilitation|rehabilitation
4824135|NCT02478411|intensive care|intensive care
4824136|NCT02478411|mechanical ventilation|mechanical ventilation
4824137|NCT02478411|cyclo ergometer|cyclo ergometer
4824138|NCT02478411|physiotherapy|physiotherapy
4824139|NCT02478385|Birth environment|birth environment
4824140|NCT02478385|oxytocin|oxytocin
4824141|NCT02478385|epidural|epidural
4824142|NCT02478385|analgesia|analgesia
4824143|NCT02478385|home-like|home-like
4824144|NCT02478372|local infiltration analgesia|local infiltration analgesia
4824145|NCT02478372|Epidural|epidural
4824146|NCT02478372|Enhanced Recovery|enhanced recovery
4824147|NCT02478372|Total Knee Arthroplasty|total knee arthroplasty
4824148|NCT02478333|Healthy|healthy
4824149|NCT02478333|ALS-008176|als-008176
4824150|NCT02478333|Japanese adult participants|japanese adult participants
4824151|NCT02478320|Advanced Cancers|advanced cancers
4824152|NCT02478320|CDKN2A-Deficient Advanced Solid Cancers|cdkn2a-deficient advanced solid cancers
4824153|NCT02478320|Advanced or metastatic cancer.|advanced or metastatic cancer.
4824154|NCT02478320|Ilorasertib|ilorasertib
4824155|NCT02478320|ABT-348|abt-348
4824156|NCT02478307|chronic low back pain|chronic low back pain
4824157|NCT02478307|mindfulness meditation|mindfulness meditation
4824158|NCT02478307|cognitive therapy|cognitive therapy
4824159|NCT02478307|mindfulness-based cognitive therapy|mindfulness-based cognitive therapy
4824160|NCT02478307|efficacy|efficacy
4824161|NCT02478307|mechanisms|mechanisms
4824162|NCT02478307|coping|coping
4824163|NCT02478294|Atrial Fibrillation|atrial fibrillation
4824164|NCT02478294|Stroke|stroke
4824165|NCT02478294|Systemic embolism|systemic embolism
4824166|NCT02478294|Left atrial appendage excision|left atrial appendage excision
4824167|NCT02478294|Warfarin|warfarin
4824168|NCT02478268|idiopathic pulmonary fibrosis|idiopathic pulmonary fibrosis
4824169|NCT02478268|xenon gas|xenon gas
4824170|NCT02478255|Radiation induced lung injury|radiation induced lung injury
4824171|NCT02478255|Xenon gas|xenon gas
4824172|NCT02478255|hyperpolarized|hyperpolarized
4824173|NCT02478229|Liver transplant|liver transplant
4824174|NCT02478229|Genotype 1 HCV infection|genotype 1 hcv infection
4824175|NCT02478229|Sofosbuvir (SOF)/ Ledipasvir (LDV)|sofosbuvir (sof)/ ledipasvir (ldv)
4824176|NCT02478229|Sustained virological response (SVR12 )|sustained virological response (svr12 )
4824177|NCT02478203|Airtraq|airtraq
4824178|NCT02478203|Glidescope|glidescope
4824179|NCT02478203|pediatric|pediatric
4824180|NCT02478203|face-to-face|face-to-face
4824181|NCT02478177|Anticoagulant|anticoagulant
4824182|NCT02478177|Stroke|stroke
4824183|NCT02478177|Ischemic Stroke|ischemic stroke
4824184|NCT02478177|Intracerebral hemorrhage|intracerebral hemorrhage
4824185|NCT02478151|Deceased donor liver transplant|deceased donor liver transplant
4824186|NCT02478151|Normothermic machine perfusion|normothermic machine perfusion
4824187|NCT02478125|metastatic castrate resistant prostate cancer|metastatic castrate resistant prostate cancer
4824188|NCT02478112|Intensity Modulated Radiotherapy|intensity modulated radiotherapy
4824189|NCT02478112|Balloon implant|balloon implant
4824190|NCT02478099|MPDL3280A|mpdl3280a
4824191|NCT02478099|cancer of the urinary tract|cancer of the urinary tract
4824192|NCT02478099|non small cell lung cancer|non small cell lung cancer
4824193|NCT02478099|triple negative breast cancer|triple negative breast cancer
4824194|NCT02478086|amino acids|amino acids
4824195|NCT02478086|renal function|renal function
4824196|NCT02478086|extreme premature|extreme premature
4824197|NCT02478060|Allergy|allergy
4824198|NCT02478060|Birch|birch
4824199|NCT02478060|Rhinitis|rhinitis
4824200|NCT02478060|Rhinoconjuntivitis|rhinoconjuntivitis
4824201|NCT02478060|SPIRE|spire
4824202|NCT02478060|Toleromune|toleromune
4824203|NCT02478047|to Evaluate the Effectiveness of Acupucnture in the Management of Chemotherapy-induced Nausea and Vomiting|to evaluate the effectiveness of acupucnture in the management of chemotherapy-induced nausea and vomiting
4824204|NCT02478021|effects of cortisol on cognition|effects of cortisol on cognition
4824205|NCT02478008|Transcatheter Mitral Valve Replacement|transcatheter mitral valve replacement
4824206|NCT02478008|Mitral Regurgitation|mitral regurgitation
4824207|NCT02478008|Mitral Insufficiency|mitral insufficiency
4824208|NCT02478008|Transapical|transapical
4824209|NCT02477995|Immunogenicity|immunogenicity
4824210|NCT02477995|Safety|safety
4824211|NCT02477995|DTaP Vaccine|dtap vaccine
4824212|NCT02477982|Propofol|propofol
4824213|NCT02477982|Cardiopulmonary Bypass|cardiopulmonary bypass
4824214|NCT02477982|Pharmacokinetics|pharmacokinetics
4824215|NCT02477982|Obesity|obesity
4824216|NCT02477956|vitamin D|vitamin d
4824217|NCT02477956|obesity|obesity
4824218|NCT02477956|bariatric surgery|bariatric surgery
4824219|NCT02477917|allergy|allergy
4824220|NCT02477917|SCIT|scit
4824221|NCT02477904|Autism|autism
4824222|NCT02477904|Autism Spectrum Disorder|autism spectrum disorder
4824223|NCT02477904|Ketogenic Diet|ketogenic diet
4824224|NCT02477904|Biochemical Profiles|biochemical profiles
4824225|NCT02477891|Multiple myeloma|multiple myeloma
4824226|NCT02477891|Daratumumab|daratumumab
4824227|NCT02477891|Early access|early access
4824228|NCT02477878|Adult leukemias and myelodysplasia|adult leukemias and myelodysplasia
4824229|NCT02477878|Adult lymphomas|adult lymphomas
4824230|NCT02477878|Adult multiple myeloma|adult multiple myeloma
4824231|NCT02477878|allogeneic stem cell transplant|allogeneic stem cell transplant
4824232|NCT02477878|donor lymphocyte infusion|donor lymphocyte infusion
4824233|NCT02477852|tuberculosis|tuberculosis
4824234|NCT02477852|spinal|spinal
4824235|NCT02477852|general|general
4824236|NCT02477852|operation|operation
4824237|NCT02477852|drug|drug
4824238|NCT02477852|therapy|therapy
4824239|NCT02477839|Epilepsy, children, partial-onset seizures, lacosamide, LCM, pediatric|epilepsy, children, partial-onset seizures, lacosamide, lcm, pediatric
4824240|NCT02477800|BIIB037|biib037
4824241|NCT02477800|Aducanumab|aducanumab
4824242|NCT02477787|HLA-haploidentical hematopoietic cell transplantation|hla-haploidentical hematopoietic cell transplantation
4824243|NCT02477787|natural killer cells|natural killer cells
4824244|NCT02477774|Anterolateral Thigh|anterolateral thigh
4824245|NCT02477670|Negative Symptoms|negative symptoms
4824246|NCT02477670|Schizophrenia|schizophrenia
4824247|NCT02477670|AVP-786|avp-786
4824248|NCT02477657|Adult patients with refractory malignant ascites secondary to GU or GI malignancy.|adult patients with refractory malignant ascites secondary to gu or gi malignancy.
4824249|NCT02477644|Advanced FIGO IIIB|advanced figo iiib
4824250|NCT02477644|IV high grade serious ovarian cancer|iv high grade serious ovarian cancer
4824251|NCT02477644|endometrioid ovarian cancer|endometrioid ovarian cancer
4824252|NCT02477644|standard first-line treatment|standard first-line treatment
4824253|NCT02477644|platinum-taxane chemotherapy|platinum-taxane chemotherapy
4824254|NCT02477644|bevacizumab|bevacizumab
4824255|NCT02477644|olaparib|olaparib
4824256|NCT02477644|placebo|placebo
4824257|NCT02477631|Myelodysplastic syndrome|myelodysplastic syndrome
4824258|NCT02477631|oxidative stress|oxidative stress
4824259|NCT02477631|labile plasma iron|labile plasma iron
4824260|NCT02477592|long standing persistent atrial fibrillation|long standing persistent atrial fibrillation
4824261|NCT02477592|novel approach|novel approach
4824262|NCT02477592|ablation|ablation
4824263|NCT02477566|pcos|pcos
4824264|NCT02477566|Long acting Triptorelin|long acting triptorelin
4824265|NCT02477566|Short acting Triptorelin|short acting triptorelin
4824266|NCT02477566|In Vitro Fertilization|in vitro fertilization
4824267|NCT02477553|decision aid|decision aid
4824268|NCT02477553|cancer screening|cancer screening
4824269|NCT02477553|colorectal neoplasm|colorectal neoplasm
4824270|NCT02477553|decision making|decision making
4824271|NCT02477553|risk communication|risk communication
4824272|NCT02477553|numeracy|numeracy
4824273|NCT02477553|health literacy|health literacy
4824274|NCT02477527|atripla|atripla
4824275|NCT02477527|stribild|stribild
4824276|NCT02477527|dreams|dreams
4824277|NCT02477501|Spinal anesthesia|spinal anesthesia
4824278|NCT02477501|cesarean|cesarean
4824279|NCT02477501|blood pressure|blood pressure
4824280|NCT02477501|Norepinephrine|norepinephrine
4824281|NCT02477501|Ephedrine|ephedrine
4824282|NCT02477488|Allopurinol|allopurinol
4824283|NCT02477488|Renal Dialysis|renal dialysis
4824284|NCT02477475|reflux esophagitis|reflux esophagitis
4824285|NCT02477475|Nexium|nexium
4824286|NCT02477449|safety|safety
4824287|NCT02477449|istaroxime|istaroxime
4824288|NCT02477423|Microbiome|microbiome
4824289|NCT02477423|Antibiotics|antibiotics
4824290|NCT02477410|porcine protein|porcine protein
4824291|NCT02477410|appetite|appetite
4824292|NCT02477410|muscle protein synthesis|muscle protein synthesis
4824293|NCT02477410|gastrointestinal hormones|gastrointestinal hormones
4824294|NCT02477397|Spiromax|spiromax
4824295|NCT02477397|Budesonide/formoterol|budesonide/formoterol
4824296|NCT02477397|COPD|copd
4824297|NCT02477397|exacerbations|exacerbations
4824298|NCT02477397|SMART|smart
4824299|NCT02477345|Cholestasis|cholestasis
4824300|NCT02477345|Parenteral Nutrition|parenteral nutrition
4824301|NCT02477345|Liver disease|liver disease
4824302|NCT02477332|QGE031|qge031
4824303|NCT02477332|omalizumab|omalizumab
4824304|NCT02477332|chronic|chronic
4824305|NCT02477332|spontaneous|spontaneous
4824306|NCT02477332|urticaria|urticaria
4824307|NCT02477332|adults|adults
4824308|NCT02477332|CSU|csu
4824309|NCT02477293|Hyeonggaeyeongyo-tang|hyeonggaeyeongyo-tang
4824310|NCT02477293|Chronic rhinitis|chronic rhinitis
4824311|NCT02477293|Pattern identification|pattern identification
4824312|NCT02477293|Korean medicine|korean medicine
4824313|NCT02477254|lupus|lupus
4824314|NCT02477241|overactive bladder syndrome|overactive bladder syndrome
4824315|NCT02477241|urgency urinary incontinence|urgency urinary incontinence
4824316|NCT02477241|fMRI|fmri
4824317|NCT02477241|urodynamics|urodynamics
4824318|NCT02477215|Multiple Myeloma|multiple myeloma
4824319|NCT02477202|Mirena® IUD's|mirena® iud's
4824320|NCT02477202|Women|women
4824321|NCT02477202|risk-reducing salpingo-oophorectomy|risk-reducing salpingo-oophorectomy
4824322|NCT02477202|risk-reducing salpingectomy|risk-reducing salpingectomy
4824323|NCT02477163|Nephropathy induced by drugs medicaments and biological substances|nephropathy induced by drugs medicaments and biological substances
4824324|NCT02477163|Other nephritis and nephropathy not specified as acute or chronic|other nephritis and nephropathy not specified as acute or chronic
4824325|NCT02477150|lupus|lupus
4824326|NCT02477137|Prostate Cancer|prostate cancer
4824327|NCT02477137|Nursing|nursing
4824328|NCT02477137|Health Literacy|health literacy
4824329|NCT02477137|Quality of Life|quality of life
4824330|NCT02477137|Radiotherapy|radiotherapy
4824331|NCT02477137|Oncology Nursing|oncology nursing
4824332|NCT02477137|Self Care|self care
4824333|NCT02477137|Symptom Management|symptom management
4824334|NCT02477137|Participatory Care|participatory care
4824335|NCT02477137|Person-centered Care|person-centered care
4824336|NCT02477137|Information and Communication Technology|information and communication technology
4824337|NCT02477137|Patient-reported symptoms|patient-reported symptoms
4824338|NCT02477137|Mobile device|mobile device
4824339|NCT02477111|Endovascular repair|endovascular repair
4824340|NCT02477098|rectus sheath block|rectus sheath block
4824341|NCT02477098|cytokines|cytokines
4824342|NCT02477098|sleep|sleep
4824343|NCT02477085|Labor|labor
4824344|NCT02477085|induction|induction
4824345|NCT02477085|delivery|delivery
4824346|NCT02477085|prostaglandins|prostaglandins
4824347|NCT02477085|oxytocin|oxytocin
4824348|NCT02477085|amniotomy|amniotomy
4824349|NCT02477085|balloon catheter|balloon catheter
4824350|NCT02477059|Hand OA|hand oa
4824351|NCT02477059|Tocilizumab|tocilizumab
4824352|NCT02477059|Osteoarthritis|osteoarthritis
4824353|NCT02477059|Interleukin-6|interleukin-6
4824354|NCT02477020|Drug Therapy|drug therapy
4824355|NCT02477007|Paediatric emergency|paediatric emergency
4824356|NCT02477007|pain|pain
4824357|NCT02477007|long-bones fractures|long-bones fractures
4824358|NCT02477007|morphine|morphine
4824359|NCT02477007|ibuprofen|ibuprofen
4824360|NCT02477007|paracetamol|paracetamol
4824361|NCT02477007|children|children
4824362|NCT02476994|Essential Fatty Acids (EFA)|essential fatty acids (efa)
4824363|NCT02476994|Parenteral Nutrition|parenteral nutrition
4824364|NCT02476994|Clinolipid/Clinoleic|clinolipid/clinoleic
4824365|NCT02476994|Parenteral Nutrition Associated Cholestasis (PNAC)|parenteral nutrition associated cholestasis (pnac)
4824366|NCT02476994|Parenteral Nutrition Associated Liver Disease (PNALD)|parenteral nutrition associated liver disease (pnald)
4824367|NCT02476994|Intestinal Failure Associated Liver Disease (IFALD)|intestinal failure associated liver disease (ifald)
4824368|NCT02476994|Phytosterols|phytosterols
4824369|NCT02476994|Intralipid|intralipid
4824370|NCT02476994|Infants/Preterm Infants|infants/preterm infants
4824371|NCT02476994|FADS1 and FADS2|fads1 and fads2
4824372|NCT02476994|Short Bowel Syndrome|short bowel syndrome
4824373|NCT02476994|Cancer Nutrition|cancer nutrition
4824374|NCT02476994|Olive Oil Emulsion|olive oil emulsion
4824375|NCT02476994|Soybean Oil Emulsion|soybean oil emulsion
4824376|NCT02476955|ARQ 092|arq 092
4824377|NCT02476955|Carboplatin|carboplatin
4824378|NCT02476955|Paclitaxel|paclitaxel
4824379|NCT02476955|AKT inhibitor in combination therapy|akt inhibitor in combination therapy
4824380|NCT02476955|Targeted therapy|targeted therapy
4824381|NCT02476955|Molecular therapy|molecular therapy
4824382|NCT02476955|Tyrosine kinase inhibitor (TKI)|tyrosine kinase inhibitor (tki)
4824383|NCT02476955|Receptor tyrosine kinase (RTK)|receptor tyrosine kinase (rtk)
4824384|NCT02476955|Biomarkers|biomarkers
4824385|NCT02476955|Phase 1 - Phase I|phase 1 - phase i
4824386|NCT02476955|Solid tumors|solid tumors
4824387|NCT02476955|Metastatic solid tumors|metastatic solid tumors
4824388|NCT02476955|Recurrent solid tumors|recurrent solid tumors
4824389|NCT02476955|Ovarian cancer|ovarian cancer
4824390|NCT02476955|Endometrial cancer|endometrial cancer
4824391|NCT02476955|Cervical cancer|cervical cancer
4824392|NCT02476955|Triple-negative breast cancer|triple-negative breast cancer
4824393|NCT02476955|AKT kinases|akt kinases
4824394|NCT02476955|AKT pathway|akt pathway
4824395|NCT02476955|AKT signaling|akt signaling
4824396|NCT02476955|AKT inhibitor|akt inhibitor
4824397|NCT02476955|AKT pan inhibitor|akt pan inhibitor
4824398|NCT02476955|Chemotherapy|chemotherapy
4824399|NCT02476955|PI3K/AKT/mTOR signaling pathway|pi3k/akt/mtor signaling pathway
4824400|NCT02476955|AKT1|akt1
4824401|NCT02476955|AKT2|akt2
4824402|NCT02476955|AKT3|akt3
4824403|NCT02476955|Phase I Clinical Trial|phase i clinical trial
4824404|NCT02476955|Clinical oncology|clinical oncology
4824405|NCT02476955|Tumor|tumor
4824406|NCT02476955|AKT1 inhibitor|akt1 inhibitor
4824407|NCT02476955|AKT2 inhibitor|akt2 inhibitor
4824408|NCT02476955|AKT3 inhibitor|akt3 inhibitor
4824409|NCT02476955|AKT1 mutation|akt1 mutation
4824410|NCT02476955|AKT2 mutation|akt2 mutation
4824411|NCT02476955|AKT3 mutation|akt3 mutation
4824412|NCT02476955|AKT1 amplification|akt1 amplification
4824413|NCT02476955|AKT2 amplification|akt2 amplification
4824414|NCT02476955|AKT3 amplification|akt3 amplification
4824415|NCT02476955|Anastrozole|anastrozole
4824416|NCT02476955|Estrogen receptor positive|estrogen receptor positive
4824417|NCT02476955|PIK3CA mutation|pik3ca mutation
4824418|NCT02476929|Electronic nose|electronic nose
4824419|NCT02476929|Nasal nitrous oxide|nasal nitrous oxide
4824420|NCT02476929|Allergic Rhinitis|allergic rhinitis
4824421|NCT02476929|Non-Allergic Rhinitis|non-allergic rhinitis
4824422|NCT02476929|Nasal polyps|nasal polyps
4824423|NCT02476916|Pyruvate Kinase Deficiency|pyruvate kinase deficiency
4824424|NCT02476916|Hemolytic anemia|hemolytic anemia
4824425|NCT02476916|Protein Kinase R (PKR)|protein kinase r (pkr)
4824426|NCT02476916|Drive PK|drive pk
4824427|NCT02476877|comorbidity|comorbidity
4824428|NCT02476877|epidemiology|epidemiology
4824429|NCT02476877|mental illness|mental illness
4824430|NCT02476877|drug abuse|drug abuse
4824431|NCT02476864|macitentan|macitentan
4824432|NCT02476864|biocomparison|biocomparison
4824433|NCT02476864|safety|safety
4824434|NCT02476851|Blood Donation|blood donation
4824435|NCT02476851|Whole Blood|whole blood
4824436|NCT02476838|hand injury|hand injury
4824437|NCT02476838|hand amputation|hand amputation
4824438|NCT02476838|hand amputee|hand amputee
4824439|NCT02476838|hand surgery|hand surgery
4824440|NCT02476825|volunteers|volunteers
4824441|NCT02476773|Hookworm Vaccine|hookworm vaccine
4824442|NCT02476773|Na-APR-1 (M74)/Alhydrogel® Hookworm Vaccine|na-apr-1 (m74)/alhydrogel® hookworm vaccine
4824443|NCT02476773|Na-GST-1/Alhydrogel® Hookworm Vaccine|na-gst-1/alhydrogel® hookworm vaccine
4824444|NCT02476760|Incretins|incretins
4824445|NCT02476760|Antidiabetic agents|antidiabetic agents
4824446|NCT02476760|Pancreatitis|pancreatitis
4824447|NCT02476747|Colonic polyp|colonic polyp
4824448|NCT02476734|REDIRECTED AUTOLOGOUS CART- 19 T-CELL IMMUNOTHERAPY|redirected autologous cart- 19 t-cell immunotherapy
4824449|NCT02476721|pulmonary embolism|pulmonary embolism
4824450|NCT02476721|emergency department|emergency department
4824451|NCT02476708|schizophrenia|schizophrenia
4824452|NCT02476708|schizoaffective disorder|schizoaffective disorder
4824453|NCT02476708|cognition|cognition
4824454|NCT02476708|curcumin|curcumin
4824455|NCT02476695|CHB|chb
4824456|NCT02476682|Sessile serrated polyps|sessile serrated polyps
4824457|NCT02476682|Advanced mucosal neoplasia|advanced mucosal neoplasia
4824458|NCT02476669|plasma EBV DNA|plasma ebv dna
4824459|NCT02476669|biomarker|biomarker
4824460|NCT02476669|intensity-modulated radiation therapy|intensity-modulated radiation therapy
4824461|NCT02476617|Treatment naive|treatment naive
4824462|NCT02476617|Interferon free|interferon free
4824463|NCT02476617|HCV|hcv
4824464|NCT02476617|Chronic Hepatitis C|chronic hepatitis c
4824465|NCT02476617|Hepatitis C Genotype 1a|hepatitis c genotype 1a
4824466|NCT02476617|Hepatitis C|hepatitis c
4824467|NCT02476617|pegylated-interferon (pegIFN)/ribavirin (RBV) experienced|pegylated-interferon (pegifn)/ribavirin (rbv) experienced
4824468|NCT02476604|prevention|prevention
4824469|NCT02476604|adult|adult
4824470|NCT02476604|student|student
4824471|NCT02476591|Resource utilization|resource utilization
4824472|NCT02476591|intensive care unit|intensive care unit
4824972|NCT02473497|crizotinib|crizotinib
4824473|NCT02476578|Hypocholesterolemia|hypocholesterolemia
4824474|NCT02476578|Frail Elderly|frail elderly
4824475|NCT02476578|Aged|aged
4824476|NCT02476578|Aged, 80 and over|aged, 80 and over
4824477|NCT02476578|Cholesterol|cholesterol
4824478|NCT02476578|Clinical Laboratory Information Systems|clinical laboratory information systems
4824479|NCT02476578|Hemoglobin A, Glycosylated|hemoglobin a, glycosylated
4824480|NCT02476578|diet therapy|diet therapy
4824481|NCT02476578|Anticholesteremic Agents|anticholesteremic agents
4824482|NCT02476578|Health Services for the Aged|health services for the aged
4824483|NCT02476578|Hypoglycemic Agents|hypoglycemic agents
4824484|NCT02476578|Hypoglycemia|hypoglycemia
4824485|NCT02476565|Intubation|intubation
4824486|NCT02476461|percutanepus needle fasciotomy|percutanepus needle fasciotomy
4824487|NCT02476461|xiapex|xiapex
4824488|NCT02476461|clostridium histolyticum|clostridium histolyticum
4824489|NCT02476448|ureteral jet|ureteral jet
4824490|NCT02476448|pelvic surgery|pelvic surgery
4824491|NCT02476448|cystoscopy|cystoscopy
4824492|NCT02476435|Depersonalization|depersonalization
4824493|NCT02476435|Derealization|derealization
4824494|NCT02476435|Embodiment|embodiment
4824495|NCT02476435|Emotional numbing|emotional numbing
4824496|NCT02476435|Transcranial magnetic stimulation|transcranial magnetic stimulation
4824497|NCT02476435|Angular gyrus|angular gyrus
4824498|NCT02476435|Temporo-parietal junction|temporo-parietal junction
4824499|NCT02476422|Diclofenac potassium|diclofenac potassium
4824500|NCT02476422|Post-operative dental pain|post-operative dental pain
4824501|NCT02476422|Moderate to severe pain|moderate to severe pain
4824502|NCT02476409|congestive heart failure|congestive heart failure
4824503|NCT02476409|tolvaptan|tolvaptan
4824504|NCT02476409|copeptin|copeptin
4824505|NCT02476331|Cognitive training|cognitive training
4824506|NCT02476331|Working memory|working memory
4824507|NCT02476331|Emotion regulation|emotion regulation
4824508|NCT02476266|resistance training|resistance training
4824509|NCT02476266|strength training|strength training
4824510|NCT02476266|balance|balance
4824511|NCT02476266|muscle strength|muscle strength
4824512|NCT02476253|acidosis|acidosis
4824513|NCT02476253|shock|shock
4824514|NCT02476253|sodium bicarbonate|sodium bicarbonate
4824515|NCT02476253|renal replacement therapy|renal replacement therapy
4824516|NCT02476240|Exercise|exercise
4824517|NCT02476240|Attention|attention
4824518|NCT02476227|atrial fibrillation|atrial fibrillation
4824519|NCT02476227|pulmonary vein isolation|pulmonary vein isolation
4824520|NCT02476227|RF ablation|rf ablation
4824521|NCT02476214|group prenatal care, group guidance|group prenatal care, group guidance
4824522|NCT02476201|Heart Failure|heart failure
4824523|NCT02476201|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
4824524|NCT02476201|Quadripolar Left Ventricular Lead|quadripolar left ventricular lead
4824525|NCT02476201|Multipoint Pacing|multipoint pacing
4824526|NCT02476201|Hemodynamic Response|hemodynamic response
4824527|NCT02476188|Neutrophil extracellular traps, stroke|neutrophil extracellular traps, stroke
4824528|NCT02476175|mirabegron|mirabegron
4824529|NCT02476175|antimuscarinics|antimuscarinics
4824530|NCT02476175|beta 3 agonist|beta 3 agonist
4824531|NCT02476175|overactive bladder|overactive bladder
4824532|NCT02476175|children|children
4824533|NCT02476162|Childhood Cancer Survivor|childhood cancer survivor
4824534|NCT02476162|Cancer Prevention and Control|cancer prevention and control
4824535|NCT02476162|Blood Pressure Monitoring|blood pressure monitoring
4824536|NCT02476162|Pre-Hypertension|pre-hypertension
4824537|NCT02476136|individual patient data meta-analysis|individual patient data meta-analysis
4824538|NCT02476136|anxiety disorder|anxiety disorder
4824539|NCT02476136|antidepressants|antidepressants
4824540|NCT02476136|selective serotonin reuptake inhibitors|selective serotonin reuptake inhibitors
4824541|NCT02476136|serotonin-norepinephrine reuptake inhibitors|serotonin-norepinephrine reuptake inhibitors
4824542|NCT02476110|Oral nutritive supplements|oral nutritive supplements
4824543|NCT02476110|Nutritional risk screening|nutritional risk screening
4824544|NCT02476110|Homecare|homecare
4824545|NCT02476097|esomeprazole randomized study|esomeprazole randomized study
4824546|NCT02476097|proton pump inhibitor|proton pump inhibitor
4824547|NCT02476097|gastric acid rebound|gastric acid rebound
4824548|NCT02476097|randomized study|randomized study
4824549|NCT02476097|esomeprazole|esomeprazole
4824550|NCT02476071|HIV prevention|hiv prevention
4824551|NCT02476071|Demand for voluntary male circumcision|demand for voluntary male circumcision
4824552|NCT02476058|Major Depressive Disorder|major depressive disorder
4824553|NCT02476058|JNJ-42847922|jnj-42847922
4824554|NCT02476058|Diphenhydramine|diphenhydramine
4824555|NCT02476058|Placebo|placebo
4824556|NCT02476045|metastatic colorectal cancer|metastatic colorectal cancer
4824557|NCT02476045|RAS wild-type|ras wild-type
4824558|NCT02476045|maintenance therapy|maintenance therapy
4824559|NCT02476045|panitumumab|panitumumab
4824560|NCT02476019|Obesity|obesity
4824561|NCT02476019|Energy Expenditure|energy expenditure
4824562|NCT02475993|Sickle Cell Disease|sickle cell disease
4824563|NCT02475980|Adolescent|adolescent
4824564|NCT02475980|Contraception|contraception
4824565|NCT02475980|Counseling|counseling
4824566|NCT02475967|E-Learning|e-learning
4825069|NCT02473042|NMBM|nmbm
4824567|NCT02475967|coronary artery disease|coronary artery disease
4824568|NCT02475967|telerehabilitation|telerehabilitation
4824569|NCT02475967|e-health|e-health
4824570|NCT02475954|Depression|depression
4824571|NCT02475954|Telehealth|telehealth
4824572|NCT02475954|Parkinson's Disease|parkinson's disease
4824573|NCT02475954|Veterans|veterans
4824574|NCT02475954|Care-partners|care-partners
4824575|NCT02475954|Cognitive-Behavioral Therapy|cognitive-behavioral therapy
4824576|NCT02475954|Caregiver|caregiver
4824577|NCT02475941|geriatric fractures|geriatric fractures
4824578|NCT02475915|Treatment interruption|treatment interruption
4824579|NCT02475915|Controlling HIV|controlling hiv
4824580|NCT02475902|prevention and control|prevention and control
4824581|NCT02475824|ERCP|ercp
4824582|NCT02475824|Sedation|sedation
4824583|NCT02475824|safety|safety
4824584|NCT02475811|3D ultrasonography|3d ultrasonography
4824585|NCT02475811|fetal Lung Volume|fetal lung volume
4824586|NCT02475811|neonatal respiratory function|neonatal respiratory function
4824587|NCT02475798|Zenith aortoiliac aneurysm|zenith aortoiliac aneurysm
4824588|NCT02475798|Iliac aneurysm|iliac aneurysm
4824589|NCT02475798|Branch|branch
4824590|NCT02475798|Connections|connections
4824591|NCT02475798|Endovascular graft|endovascular graft
4824592|NCT02475798|Graft-iliac bifurcation|graft-iliac bifurcation
4824593|NCT02475798|Aneurysm|aneurysm
4824594|NCT02475798|Vascular Diseases|vascular diseases
4824595|NCT02475798|Cardiovascular Diseases|cardiovascular diseases
4824596|NCT02475785|Forsus Fatigue Resistant Device|forsus fatigue resistant device
4824597|NCT02475785|Class II|class ii
4824598|NCT02475785|anchorage|anchorage
4824599|NCT02475785|FFRD|ffrd
4824600|NCT02475785|mini plates|mini plates
4824601|NCT02475785|fixed functional appliance|fixed functional appliance
4824602|NCT02475772|ovarian cancer|ovarian cancer
4824603|NCT02475772|recurrent|recurrent
4824604|NCT02475772|chemotherapy|chemotherapy
4824605|NCT02475772|intraperitoneal|intraperitoneal
4824606|NCT02475772|cisplatin|cisplatin
4824607|NCT02475772|doxorubicin|doxorubicin
4824608|NCT02475746|drug interaction, PF-06372865, itraconazole|drug interaction, pf-06372865, itraconazole
4824609|NCT02475707|leukemia|leukemia
4824610|NCT02475707|lymphoblastic|lymphoblastic
4824612|NCT02475707|multiTAA-specific T cells|multitaa-specific t cells
4824613|NCT02475707|HSCT|hsct
4824614|NCT02475590|Sleeve gastrectomy|sleeve gastrectomy
4824615|NCT02475590|Roux-en-Y gastric bypass|roux-en-y gastric bypass
4824616|NCT02475590|Excess weight loss|excess weight loss
4824617|NCT02475590|Quality of life|quality of life
4824618|NCT02475577|telemedicine|telemedicine
4824619|NCT02475577|heart failure|heart failure
4824620|NCT02475577|home blood pressure monitoring|home blood pressure monitoring
4824621|NCT02475564|resveratrol|resveratrol
4824622|NCT02475512|elderly|elderly
4824623|NCT02475512|long-term care|long-term care
4824624|NCT02475499|Incretins|incretins
4824625|NCT02475499|Antidiabetic agents|antidiabetic agents
4824626|NCT02475499|Pancreatic Cancer|pancreatic cancer
4824627|NCT02475486|Rheumatoid Arthritis|rheumatoid arthritis
4824628|NCT02475486|sympathetic nervous system|sympathetic nervous system
4824629|NCT02475486|SNA|sna
4824630|NCT02475486|fatigue|fatigue
4824631|NCT02475473|Volunteers|volunteers
4824632|NCT02475460|HeartMate 3|heartmate 3
4824633|NCT02475460|LVAS|lvas
4824634|NCT02475460|LVAD|lvad
4824635|NCT02475460|Heart-assist Devices|heart-assist devices
4824636|NCT02475460|Advanced|advanced
4824637|NCT02475460|Ventricular Dysfunction|ventricular dysfunction
4824638|NCT02475460|refractory left ventricular|refractory left ventricular
4824639|NCT02475460|Thoratec Corporation|thoratec corporation
4824640|NCT02475434|Human Milk|human milk
4824641|NCT02475434|Prematurity|prematurity
4824642|NCT02475434|Nutrition|nutrition
4824643|NCT02475421|Diabetes|diabetes
4824644|NCT02475421|Glucagon|glucagon
4824645|NCT02475421|Metabolic clearance rate of glucagon|metabolic clearance rate of glucagon
4824646|NCT02475408|Circulation, Collateral|circulation, collateral
4824647|NCT02475408|Coronary Artery Disease|coronary artery disease
4824648|NCT02475408|Internal Mammary-Coronary Artery Anastomosis|internal mammary-coronary artery anastomosis
4824649|NCT02475408|Ischemia|ischemia
4824650|NCT02475395|Male Fertility|male fertility
4824651|NCT02475395|Male Infertility|male infertility
4824652|NCT02475395|Fertility|fertility
4824653|NCT02475395|Sperm|sperm
4824654|NCT02475395|Sperm Concentration|sperm concentration
4824655|NCT02475369|pancreatic enzyme supplementation|pancreatic enzyme supplementation
4824656|NCT02475356|Mirena|mirena
4824657|NCT02475356|Heavy Menstrual Bleeding|heavy menstrual bleeding
4824658|NCT02475356|Dysmenorrhea|dysmenorrhea
4824659|NCT02475356|Japan|japan
4824660|NCT02475356|Post-marketing surveillance|post-marketing surveillance
4824661|NCT02475317|Volunteer|volunteer
4824662|NCT02475278|Drug therapy|drug therapy
4824663|NCT02475265|Anorexia Nervosa|anorexia nervosa
4824664|NCT02475265|Osteoporosis|osteoporosis
4824665|NCT02475265|Eating Disorder|eating disorder
4824666|NCT02475265|Disordered Eating|disordered eating
4824667|NCT02475265|Estrogen|estrogen
4824668|NCT02475265|Bone|bone
4824770|NCT02474680|personalized medicine|personalized medicine
4824669|NCT02475239|Benign Paroxysmal Positional Vertigo, Postural Restriction|benign paroxysmal positional vertigo, postural restriction
4824670|NCT02475226|Traumatic Brain Injury|traumatic brain injury
4824671|NCT02475226|Brain Damage|brain damage
4824672|NCT02475226|Mortality|mortality
4824673|NCT02475226|C10.228.140.199|c10.228.140.199
4824674|NCT02475213|Malanoma, Non small cell lung cancer, SCCHN|malanoma, non small cell lung cancer, scchn
4824675|NCT02475213|Other B7-H3 expressing cancers|other b7-h3 expressing cancers
4824676|NCT02475187|TEG|teg
4824677|NCT02475187|MEA|mea
4824678|NCT02475187|Thrombotic events|thrombotic events
4824679|NCT02475187|VTE|vte
4824680|NCT02475187|LMWH|lmwh
4824681|NCT02475187|Hip fractures|hip fractures
4824682|NCT02475161|Healthy|healthy
4824683|NCT02475161|Rabeprazole|rabeprazole
4824684|NCT02475161|JNJ-42847922|jnj-42847922
4824685|NCT02475148|JNJ-54175446|jnj-54175446
4824686|NCT02475148|Healthy|healthy
4824687|NCT02475135|Immunodeficiency Virus Type 1, Human|immunodeficiency virus type 1, human
4824688|NCT02475135|Immunodeficiency Virus Type 2, Human|immunodeficiency virus type 2, human
4824689|NCT02475135|Darunavir|darunavir
4824690|NCT02475135|Cobicistat|cobicistat
4824691|NCT02475135|Tenofovir Alafenamide|tenofovir alafenamide
4824692|NCT02475135|Emtricitabine|emtricitabine
4824693|NCT02475135|Elvitegravir|elvitegravir
4824694|NCT02475122|Measurement of azygos blood flow|measurement of azygos blood flow
4824695|NCT02475109|Proliferative Diabetic Retinopathy|proliferative diabetic retinopathy
4824696|NCT02475083|Stroke|stroke
4824697|NCT02475083|Virtual reality|virtual reality
4824698|NCT02475083|Balance|balance
4824699|NCT02475083|Falls|falls
4824700|NCT02475057|Prostate Cancer|prostate cancer
4824701|NCT02475057|Cardiovascular disease|cardiovascular disease
4824702|NCT02475057|Degarelix|degarelix
4824703|NCT02475044|post-concussion|post-concussion
4824704|NCT02475044|Cognitive-Behavioral Theray|cognitive-behavioral theray
4824705|NCT02475044|parenting|parenting
4824706|NCT02475031|transversus abdominis plane block|transversus abdominis plane block
4824707|NCT02475018|Shuhua Milk|shuhua milk
4824708|NCT02475018|plant sterol esters|plant sterol esters
4824709|NCT02475018|serum cholesterol|serum cholesterol
4824710|NCT02475018|human|human
4824711|NCT02475005|self management app|self management app
4824712|NCT02475005|headache|headache
4824713|NCT02475005|adolescent|adolescent
4824714|NCT02474992|HIV|hiv
4824715|NCT02474992|Social network|social network
4824716|NCT02474992|Social support|social support
4824717|NCT02474992|Disclosure|disclosure
4824718|NCT02474992|Stigma|stigma
4824719|NCT02474992|Kenya|kenya
4824720|NCT02474979|Pressure ulcer|pressure ulcer
4824721|NCT02474979|Prevention|prevention
4824722|NCT02474979|Pressure mapping|pressure mapping
4824723|NCT02474953|Curcumin|curcumin
4824724|NCT02474953|Pharmacokinetic|pharmacokinetic
4824725|NCT02474940|Multiple Sclerosis|multiple sclerosis
4824726|NCT02474940|Chronic Pain|chronic pain
4824727|NCT02474940|Chronic Fatigue|chronic fatigue
4824728|NCT02474940|Autoimmune Diseases|autoimmune diseases
4824729|NCT02474940|Autoimmune Diseases of the Nervous System|autoimmune diseases of the nervous system
4824730|NCT02474940|Central Nervous System Diseases|central nervous system diseases
4824731|NCT02474940|Demyelinating Autoimmune Diseases, CNS|demyelinating autoimmune diseases, cns
4824732|NCT02474940|Demyelinating Diseases|demyelinating diseases
4824733|NCT02474927|antibody-mediated rejection|antibody-mediated rejection
4824734|NCT02474927|lung transplant|lung transplant
4824735|NCT02474927|Carfilzomib|carfilzomib
4824736|NCT02474901|Shedding|shedding
4824737|NCT02474901|Immunogenicity|immunogenicity
4824738|NCT02474901|Safety|safety
4824739|NCT02474901|HIV infected|hiv infected
4824740|NCT02474901|Children|children
4824741|NCT02474901|Young adults|young adults
4824742|NCT02474875|Fibromyalgia|fibromyalgia
4824743|NCT02474875|Patient education|patient education
4824744|NCT02474875|Central sensitization|central sensitization
4824745|NCT02474836|Allergy|allergy
4824746|NCT02474810|central venous catheters|central venous catheters
4824747|NCT02474810|hemodialysis|hemodialysis
4824748|NCT02474810|thrombosis|thrombosis
4824749|NCT02474810|tissue plasminogen activator|tissue plasminogen activator
4824750|NCT02474797|Ultrasonography|ultrasonography
4824751|NCT02474797|Diaphragm|diaphragm
4824752|NCT02474797|Lung ultrasound|lung ultrasound
4824753|NCT02474797|Sepsis|sepsis
4824754|NCT02474797|Critical care|critical care
4824755|NCT02474797|Chest physiotherapy|chest physiotherapy
4824756|NCT02474745|second stage of labor|second stage of labor
4824757|NCT02474745|pushing techniques|pushing techniques
4824758|NCT02474719|nephrology|nephrology
4824759|NCT02474719|extra-renal purification|extra-renal purification
4824760|NCT02474719|peritoneal dialysis|peritoneal dialysis
4824761|NCT02474706|cefoxitin Patient safety|cefoxitin patient safety
4824762|NCT02474706|Infectious diseases|infectious diseases
4824763|NCT02474706|Extended-Spectrum β-lactamases E.coli|extended-spectrum β-lactamases e.coli
4824764|NCT02474706|Antibiotics|antibiotics
4824765|NCT02474680|depression|depression
4824766|NCT02474680|Major Depressive Disorder|major depressive disorder
4824767|NCT02474680|MDD|mdd
4824768|NCT02474680|mental health|mental health
4824769|NCT02474680|pharmacogenomics|pharmacogenomics
4824771|NCT02474680|precision medicine|precision medicine
4824772|NCT02474680|anti-depressants|anti-depressants
4824774|NCT02474667|Delayed Graft Function|delayed graft function
4824775|NCT02474667|Renal Transplantation|renal transplantation
4824776|NCT02474667|Deseased Donor Kidney|deseased donor kidney
4824777|NCT02474667|BB3|bb3
4824778|NCT02474667|Kidney Transplantation|kidney transplantation
4824779|NCT02474667|Acute Kidney Injury|acute kidney injury
4824780|NCT02474641|Breast cancer|breast cancer
4824781|NCT02474641|Hypofractionation with SIB|hypofractionation with sib
4824782|NCT02474641|Non-inferiority|non-inferiority
4824783|NCT02474641|adjuvant radiotherapy with simultaneous integrated boost|adjuvant radiotherapy with simultaneous integrated boost
4824784|NCT02474628|Physiological Phenomena|physiological phenomena
4824785|NCT02474615|Apicoectomy|apicoectomy
4824786|NCT02474615|Oral surgery|oral surgery
4824787|NCT02474615|Biocompatible materials|biocompatible materials
4824788|NCT02474615|Dental Cements|dental cements
4824789|NCT02474615|Translational Medical Research|translational medical research
4824790|NCT02474602|phototherapy|phototherapy
4824791|NCT02474602|strength training|strength training
4824792|NCT02474602|photobiostimulation|photobiostimulation
4824793|NCT02474602|muscle development|muscle development
4824794|NCT02474589|Treatment|treatment
4824795|NCT02474589|orthopoxvirus|orthopoxvirus
4824796|NCT02474589|smallpox|smallpox
4824797|NCT02474563|Multiple Myeloma|multiple myeloma
4824798|NCT02474563|Bortezomib|bortezomib
4824799|NCT02474563|Melphalan|melphalan
4824800|NCT02474563|Prednisone|prednisone
4824801|NCT02474550|diffuse large b cell lymphoma|diffuse large b cell lymphoma
4824802|NCT02474550|peg-filgrastim|peg-filgrastim
4824803|NCT02474550|febrile neutropenia|febrile neutropenia
4824804|NCT02474537|hepatic impairment,|hepatic impairment,
4824805|NCT02474537|INC280,|inc280,
4824806|NCT02474537|Oral cMET Inhibitor,|oral cmet inhibitor,
4824807|NCT02474537|Non-Cancer|non-cancer
4824808|NCT02474524|Psychosis|psychosis
4824809|NCT02474524|Schizophrenia|schizophrenia
4824810|NCT02474524|Self-management|self-management
4824811|NCT02474524|Recovery|recovery
4824812|NCT02474524|Tablet computer|tablet computer
4824813|NCT02474524|Digital health|digital health
4824814|NCT02474524|Internet|internet
4824815|NCT02474524|Online|online
4824816|NCT02474524|Peer support|peer support
4824817|NCT02474498|Regenerative therapy|regenerative therapy
4824818|NCT02474498|Randomized clinical trial (RCT)|randomized clinical trial (rct)
4824819|NCT02474498|Enamel matrix derivative|enamel matrix derivative
4824820|NCT02474498|Hydroxyapatite-beta tricalcium phosphate|hydroxyapatite-beta tricalcium phosphate
4824821|NCT02474498|Buccal furcation|buccal furcation
4824822|NCT02474485|bioresorbable vascular scaffold|bioresorbable vascular scaffold
4824823|NCT02474485|Absorb|absorb
4824824|NCT02474485|drug eluting balloon|drug eluting balloon
4824825|NCT02474485|percutaneous coronary intervention|percutaneous coronary intervention
4824826|NCT02474459|Deep Brain Stimulation|deep brain stimulation
4824827|NCT02474459|DBS|dbs
4824828|NCT02474459|STN|stn
4824829|NCT02474459|GPi|gpi
4824830|NCT02474459|Globus pallidus|globus pallidus
4824831|NCT02474459|Subthalamic nucleus|subthalamic nucleus
4824832|NCT02474459|Neuromodulation|neuromodulation
4824833|NCT02474407|Seizures|seizures
4824834|NCT02474407|Epilepsy|epilepsy
4824835|NCT02474355|NSCLC|nsclc
4824836|NCT02474355|EGFRm|egfrm
4824837|NCT02474355|T790M|t790m
4824838|NCT02474329|Parkinson's disease|parkinson's disease
4824839|NCT02474329|Ambulatory monitoring|ambulatory monitoring
4824840|NCT02474329|Disease progression|disease progression
4824841|NCT02474303|Truvada|truvada
4824842|NCT02474303|EMTRICITABINE/TENOFOVIR DISPROXIL FUMARATE|emtricitabine/tenofovir disproxil fumarate
4824843|NCT02474303|HIV PREEXPOSURE PROPHYLAXIS (PrEP)|hiv preexposure prophylaxis (prep)
4824844|NCT02474303|Female Sex Workers|female sex workers
4824845|NCT02474290|Acute Myeloid Leukemia|acute myeloid leukemia
4824846|NCT02474290|FLT3-ITD|flt3-itd
4824847|NCT02474290|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
4824848|NCT02474238|Iridotomy|iridotomy
4824849|NCT02474225|intraocular pressure|intraocular pressure
4824850|NCT02474225|intravitreal|intravitreal
4824851|NCT02474212|Venous thromboembolism|venous thromboembolism
4824852|NCT02474212|pulmonary embolism|pulmonary embolism
4824853|NCT02474212|thromboprophylaxis|thromboprophylaxis
4824854|NCT02474212|anticoagulant|anticoagulant
4824855|NCT02474212|anti-FXa|anti-fxa
4824856|NCT02474212|low-molecular weight heparin|low-molecular weight heparin
4824857|NCT02474212|enoxaparin|enoxaparin
4824858|NCT02474199|Regulatory T Cells ( Treg)|regulatory t cells ( treg)
4824859|NCT02474199|Donor Alloantigen Reactive Tregs (darTregs)|donor alloantigen reactive tregs (dartregs)
4824860|NCT02474199|Liver Transplant|liver transplant
4824861|NCT02474199|Alloantigen Reactive Tregs|alloantigen reactive tregs
4824862|NCT02474199|Calcineurin Inhibitors (CNI)|calcineurin inhibitors (cni)
4824863|NCT02474199|immunosuppressants (IS)|immunosuppressants (is)
4824864|NCT02474186|breast|breast
4824865|NCT02474186|cancer|cancer
4824866|NCT02474186|metastatic|metastatic
4824867|NCT02474186|breast cancer|breast cancer
4824868|NCT02474186|metastatic breast cancer|metastatic breast cancer
4824869|NCT02474186|radiation|radiation
4824870|NCT02474186|radiotherapy|radiotherapy
4824871|NCT02474186|radiation therapy|radiation therapy
4824872|NCT02474186|abscopal|abscopal
4824873|NCT02474186|abscopal effect|abscopal effect
4824874|NCT02474186|T-cell|t-cell
4824875|NCT02474186|GM-CSF|gm-csf
4824876|NCT02474186|anti-tumor|anti-tumor
4824877|NCT02474186|immune|immune
4824878|NCT02474186|immune response|immune response
4824879|NCT02474186|capecitabine|capecitabine
4824880|NCT02474186|xeloda|xeloda
4824881|NCT02474186|taxol|taxol
4824882|NCT02474186|paclitaxel|paclitaxel
4824883|NCT02474186|other solid metastatic tumor|other solid metastatic tumor
4824884|NCT02474108|atrial fibrillation|atrial fibrillation
4824885|NCT02474108|radiofrequency ablation|radiofrequency ablation
4824886|NCT02474108|prevention of AF|prevention of af
4824887|NCT02474108|mitral valve|mitral valve
4824888|NCT02474108|left atrium enlargement|left atrium enlargement
4824889|NCT02474108|cryoablation|cryoablation
4824890|NCT02474056|decreased blood volume vein volume flow ultrasound exam|decreased blood volume vein volume flow ultrasound exam
4824891|NCT02474043|Injection drug use|injection drug use
4824892|NCT02474017|Inhaler|inhaler
4824893|NCT02474017|Adolescent|adolescent
4824894|NCT02473978|During Labor|during labor
4824895|NCT02473978|Complicating Anesthesia or Other Sedation|complicating anesthesia or other sedation
4824896|NCT02473978|Cerebral|cerebral
4824897|NCT02473926|Physical Activity|physical activity
4824898|NCT02473926|Physical Function|physical function
4824899|NCT02473926|Physical Impairment|physical impairment
4824900|NCT02473926|Sedentary Lifestyle|sedentary lifestyle
4824901|NCT02473887|ondansetron|ondansetron
4824902|NCT02473887|palatability|palatability
4824903|NCT02473887|vomiting|vomiting
4824904|NCT02473861|exercise training|exercise training
4824905|NCT02473861|breast cancer|breast cancer
4824906|NCT02473861|taxane chemotherapy|taxane chemotherapy
4824907|NCT02473861|peripheral neuropathy|peripheral neuropathy
4824908|NCT02473861|fatigue|fatigue
4824909|NCT02473861|autonomic function|autonomic function
4824910|NCT02473835|T-lymphocyte|t-lymphocyte
4824911|NCT02473835|Adipose tissue|adipose tissue
4824912|NCT02473835|Inflammation|inflammation
4824913|NCT02473835|Calorie restriction|calorie restriction
4824914|NCT02473822|anterior cruciate ligament|anterior cruciate ligament
4824915|NCT02473822|Tape Locking Screw|tape locking screw
4824916|NCT02473822|LCA|lca
4824917|NCT02473822|joint trauma|joint trauma
4824918|NCT02473796|home based child care|home based child care
4824919|NCT02473770|Registry|registry
4824920|NCT02473770|Exposures|exposures
4824921|NCT02473770|Biological Specimens|biological specimens
4824922|NCT02473770|Occupational Health|occupational health
4824923|NCT02473757|Recombinant DNA Product|recombinant dna product
4824924|NCT02473757|Laboratory Evaluation|laboratory evaluation
4824925|NCT02473757|NIH Office of Biotechnology Activities|nih office of biotechnology activities
4824926|NCT02473757|Gamma-Retroviral Vectors|gamma-retroviral vectors
4824927|NCT02473744|lower limb edema|lower limb edema
4824928|NCT02473744|subcutaneous drainage|subcutaneous drainage
4824929|NCT02473744|bioelectrical impedance|bioelectrical impedance
4824930|NCT02473744|quality of life|quality of life
4824931|NCT02473731|CDX3379|cdx3379
4824932|NCT02473705|Geriatric|geriatric
4824933|NCT02473705|bicarbonate|bicarbonate
4824934|NCT02473705|omega polyunsaturated fatty acids|omega polyunsaturated fatty acids
4824935|NCT02473705|exercise capacity|exercise capacity
4824936|NCT02473679|First Responder|first responder
4824937|NCT02473679|BLS|bls
4824938|NCT02473679|AED|aed
4824939|NCT02473679|Resuscitation|resuscitation
4824940|NCT02473666|Patient Blood Management|patient blood management
4824941|NCT02473666|Red Blood Cells|red blood cells
4824942|NCT02473666|Platelet|platelet
4824943|NCT02473627|Pharmacokinetics|pharmacokinetics
4824944|NCT02473601|mivacurium chloramine|mivacurium chloramine
4824945|NCT02473601|patients with liver cirrhosis|patients with liver cirrhosis
4824946|NCT02473601|muscle relaxation effect|muscle relaxation effect
4824947|NCT02473575|Caffeine, running, performance|caffeine, running, performance
4824948|NCT02473562|Parkinson's disease|parkinson's disease
4824949|NCT02473562|Varenicline|varenicline
4824950|NCT02473562|Excessive daytime sleepiness|excessive daytime sleepiness
4824951|NCT02473549|motor|motor
4824952|NCT02473549|rehabilitation|rehabilitation
4824953|NCT02473549|transcranial direct current stimulation|transcranial direct current stimulation
4824954|NCT02473523|Fatigue|fatigue
4824955|NCT02473523|Pain Alleviation|pain alleviation
4824956|NCT02473523|Emotional Wellbeing|emotional wellbeing
4824957|NCT02473523|Physical Wellbeing|physical wellbeing
4824958|NCT02473523|Yoga|yoga
4824959|NCT02473510|Trivalent|trivalent
4824960|NCT02473510|Influenza|influenza
4824961|NCT02473510|FluMist Quadrivalent|flumist quadrivalent
4824962|NCT02473510|Vaccine|vaccine
4824963|NCT02473510|Prevention|prevention
4824964|NCT02473510|Healthy|healthy
4824965|NCT02473497|chromosomal rearrangement|chromosomal rearrangement
4824966|NCT02473497|activating mutation|activating mutation
4824967|NCT02473497|activating genetic alteration|activating genetic alteration
4824968|NCT02473497|genetic aberration|genetic aberration
4824969|NCT02473497|ALK|alk
4824970|NCT02473497|ROS1|ros1
4824973|NCT02473497|oral formulation|oral formulation
4824974|NCT02473484|High Grade Glioma|high grade glioma
4824975|NCT02473484|Proteomics|proteomics
4824976|NCT02473484|MALDI-MSI|maldi-msi
4824977|NCT02473471|Micro-Osteoperforation (MOPs)|micro-osteoperforation (mops)
4824978|NCT02473471|regional acceleratory phenomenon (RAP)|regional acceleratory phenomenon (rap)
4824979|NCT02473471|Malocculsion|malocculsion
4824980|NCT02473458|Licorice|licorice
4824981|NCT02473458|Glycyrrhizic acid|glycyrrhizic acid
4824982|NCT02473458|Ischemic Stroke|ischemic stroke
4824983|NCT02473458|Acute|acute
4824984|NCT02473445|Inherited mitochondrial disease|inherited mitochondrial disease
4824985|NCT02473445|Leigh Syndrome|leigh syndrome
4824986|NCT02473445|Leber's Hereditary Optic Neuropathy (LHON)|leber's hereditary optic neuropathy (lhon)
4824987|NCT02473445|Myoclonic epilepsy and ragged-red fibers (MERFF)|myoclonic epilepsy and ragged-red fibers (merff)
4824988|NCT02473445|Mitochondrial encephalomyopathy, lactic acidosis, and stroke-like syndrome (MELAS)|mitochondrial encephalomyopathy, lactic acidosis, and stroke-like syndrome (melas)
4824989|NCT02473445|Kearn-Sayre syndrome|kearn-sayre syndrome
4824990|NCT02473445|Polymerase gamma (POLG) -related disorders|polymerase gamma (polg) -related disorders
4824991|NCT02473445|Mitochondrial neurogastrointestinal encephalopathy syndrome (MNGIE)|mitochondrial neurogastrointestinal encephalopathy syndrome (mngie)
4824992|NCT02473432|respiratory muscle training|respiratory muscle training
4824993|NCT02473432|neuromuscular electrical stimulation|neuromuscular electrical stimulation
4824994|NCT02473432|oropharyngeal dysphagia|oropharyngeal dysphagia
4824995|NCT02473432|stroke|stroke
4824996|NCT02473432|rehabilitation|rehabilitation
4824997|NCT02473419|Medical food|medical food
4824998|NCT02473419|ADHD|adhd
4824999|NCT02473419|Vayarin|vayarin
4825000|NCT02473419|Fish Oil|fish oil
4825001|NCT02473406|Acute Pancreatitis, prevent,Necrotizing|acute pancreatitis, prevent,necrotizing
4825002|NCT02473380|glioma|glioma
4825003|NCT02473380|fluorescence spectroscopy|fluorescence spectroscopy
4825004|NCT02473341|Bovine Colostrum|bovine colostrum
4825005|NCT02473341|Corticosteriods|corticosteriods
4825006|NCT02473341|Endotoxin|endotoxin
4825007|NCT02473341|MELD|meld
4825008|NCT02473341|mDF|mdf
4825009|NCT02473328|dose reduction study|dose reduction study
4825010|NCT02473289|Depressive disorder, major|depressive disorder, major
4825011|NCT02473289|Sirukumab|sirukumab
4825012|NCT02473263|Severe septic syndrome|severe septic syndrome
4825013|NCT02473263|mobile intensive care unit|mobile intensive care unit
4825014|NCT02473263|strategy|strategy
4825015|NCT02473263|antibiotics|antibiotics
4825016|NCT02473263|hemodynamic optimization|hemodynamic optimization
4825017|NCT02473237|COPD|copd
4825018|NCT02473237|biomass|biomass
4825019|NCT02473224|challenge|challenge
4825020|NCT02473224|GII.2|gii.2
4825021|NCT02473224|HID50|hid50
4825022|NCT02473224|Norovirus|norovirus
4825023|NCT02473224|Snow Mountain filtrate|snow mountain filtrate
4825024|NCT02473198|Total Knee Arthroplasty|total knee arthroplasty
4825025|NCT02473198|Amide Local Anesthetic|amide local anesthetic
4825026|NCT02473172|Weaning from mechanical ventilation|weaning from mechanical ventilation
4825027|NCT02473159|Near-infrared fluorescence|near-infrared fluorescence
4825028|NCT02473159|Indocyanine green, ICG|indocyanine green, icg
4825029|NCT02473159|breast cancer|breast cancer
4825030|NCT02473146|AML|aml
4825031|NCT02473146|untreated|untreated
4825032|NCT02473146|60-80 years old|60-80 years old
4825033|NCT02473146|favorable and intermediate karyotype|favorable and intermediate karyotype
4825034|NCT02473133|radiotherapy|radiotherapy
4825035|NCT02473133|dose redistribution|dose redistribution
4825036|NCT02473133|boost|boost
4825037|NCT02473120|metastatic|metastatic
4825038|NCT02473120|ESR1|esr1
4825039|NCT02473120|aromatase inhibitor|aromatase inhibitor
4825040|NCT02473120|breast cancer|breast cancer
4825041|NCT02473107|Dental caries|dental caries
4825042|NCT02473107|Primary tooth|primary tooth
4825043|NCT02473107|Caries Detection|caries detection
4825044|NCT02473094|Metformin|metformin
4825045|NCT02473094|Rectal Cancer|rectal cancer
4825046|NCT02473094|Rectum|rectum
4825047|NCT02473094|Radiotherapy|radiotherapy
4825048|NCT02473094|Capecitabine|capecitabine
4825049|NCT02473094|Neoadjuvant|neoadjuvant
4825050|NCT02473094|Adenocarcinoma|adenocarcinoma
4825051|NCT02473094|Carcinoma|carcinoma
4825052|NCT02473081|Type 2 diabetes|type 2 diabetes
4825053|NCT02473081|Minimal psychological intervention|minimal psychological intervention
4825054|NCT02473081|Glycemic control|glycemic control
4825055|NCT02473081|Depressive symptoms|depressive symptoms
4825056|NCT02473081|Problem Area in Diabetes|problem area in diabetes
4825057|NCT02473081|Middle-aged and older adults|middle-aged and older adults
4825058|NCT02473081|HbA1c protein, human|hba1c protein, human
4825059|NCT02473068|CPAP|cpap
4825060|NCT02473055|kangaroo care|kangaroo care
4825061|NCT02473055|sleep|sleep
4825062|NCT02473055|heart rate|heart rate
4825063|NCT02473055|respiratory rate|respiratory rate
4825064|NCT02473055|preterm infant|preterm infant
4825065|NCT02473042|Post-operative nausea and vomiting|post-operative nausea and vomiting
4825066|NCT02473042|PONV|ponv
4825067|NCT02473042|Breast cancer|breast cancer
4825068|NCT02473042|Neuromuscular blockade monitor|neuromuscular blockade monitor
4825070|NCT02473042|Breast cancer surgery|breast cancer surgery
4825071|NCT02473042|Prophylactic anti-emetics|prophylactic anti-emetics
4825072|NCT02473042|Electrical stimulation|electrical stimulation
4825073|NCT02473042|Zofran|zofran
4825074|NCT02473042|Ondansetron|ondansetron
4825075|NCT02473042|Dexamethasone|dexamethasone
4825076|NCT02473042|Decadron|decadron
4825077|NCT02473042|Phenergan|phenergan
4825078|NCT02473042|Promethazine|promethazine
4825079|NCT02473042|Phenazine|phenazine
4825080|NCT02473042|Phencen|phencen
4825081|NCT02473042|Prometh|prometh
4825082|NCT02473042|Prorex|prorex
4825083|NCT02473042|V-Gan|v-gan
4825084|NCT02473042|Pepcid|pepcid
4825085|NCT02473042|Famotidine|famotidine
4825086|NCT02473042|Questionnaire|questionnaire
4825087|NCT02473042|Survey|survey
4825088|NCT02473016|Classical Trigeminal Neuralgia|classical trigeminal neuralgia
4825089|NCT02473003|Breast cancer|breast cancer
4825090|NCT02473003|prostate cancer|prostate cancer
4825091|NCT02473003|colorectal cancer|colorectal cancer
4825092|NCT02473003|fatigue|fatigue
4825093|NCT02473003|physical exercise|physical exercise
4825094|NCT02473003|randomised trial|randomised trial
4825095|NCT02473003|intervention|intervention
4825096|NCT02472990|DMD|dmd
4825097|NCT02472990|morphological predictive factors|morphological predictive factors
4825098|NCT02472990|Mechanical|mechanical
4825099|NCT02472938|Relapsing remitting Multiple Sclerosis|relapsing remitting multiple sclerosis
4825100|NCT02472912|Pharmacokinetics|pharmacokinetics
4825101|NCT02472912|Adalimumab|adalimumab
4825102|NCT02472912|Biosimilar Pharmaceuticals|biosimilar pharmaceuticals
4825103|NCT02472899|Geriatrics|geriatrics
4825104|NCT02472899|Neurocognitive Disorder|neurocognitive disorder
4825105|NCT02472899|Biomarkers|biomarkers
4825106|NCT02472899|Immunology|immunology
4825107|NCT02472886|HCV genotype 1|hcv genotype 1
4825108|NCT02472886|HCV|hcv
4825109|NCT02472886|Sustained Virologic Response|sustained virologic response
4825110|NCT02472886|Direct Acting Antiviral|direct acting antiviral
4825111|NCT02472886|Combination Therapy|combination therapy
4825112|NCT02472886|GS-7977|gs-7977
4825113|NCT02472886|GS-5885|gs-5885
4825114|NCT02472886|Ribavirin|ribavirin
4825115|NCT02472886|Sofosbuvir|sofosbuvir
4825116|NCT02472886|ledipasvir|ledipasvir
4825117|NCT02472886|Hepatitis C|hepatitis c
4825118|NCT02472886|Hepatitis C, Chronic|hepatitis c, chronic
4825119|NCT02472886|Liver Diseases|liver diseases
4825120|NCT02472886|Virus Diseases|virus diseases
4825121|NCT02472886|Antiviral Agents|antiviral agents
4825122|NCT02472886|HCV/HIV co-infection|hcv/hiv co-infection
4825123|NCT02472873|endometrioma|endometrioma
4825124|NCT02472873|endometriosis|endometriosis
4825125|NCT02472873|sclerotherapy|sclerotherapy
4825126|NCT02472873|ethanol|ethanol
4825127|NCT02472873|aspiration|aspiration
4825128|NCT02472873|laparoscopy|laparoscopy
4825129|NCT02472860|Autism Spectrum Disorder|autism spectrum disorder
4825130|NCT02472860|Neuroplasticity-based Cognitive Training|neuroplasticity-based cognitive training
4825131|NCT02472847|Marinol|marinol
4825132|NCT02472847|Dronabinol|dronabinol
4825133|NCT02472847|Fear extinction|fear extinction
4825134|NCT02472847|Healthy volunteers|healthy volunteers
4825135|NCT02472834|Carbamylation|carbamylation
4825136|NCT02472834|Albumin|albumin
4825137|NCT02472834|Protein structure|protein structure
4825138|NCT02472834|Kidney disease|kidney disease
4825139|NCT02472795|Systemic lupus erythematosus|systemic lupus erythematosus
4825140|NCT02472782|osteoporosis|osteoporosis
4825141|NCT02472782|quality of life|quality of life
4825142|NCT02472782|adherence|adherence
4825143|NCT02472782|treatment|treatment
4825144|NCT02472743|Phototherapy|phototherapy
4825145|NCT02472730|Colonoscopy|colonoscopy
4825146|NCT02472730|Training Techniques|training techniques
4825147|NCT02472730|Endoscopy, Gastrointestinal|endoscopy, gastrointestinal
4825148|NCT02472717|liraglutide, GLP-1 receptor agonists|liraglutide, glp-1 receptor agonists
4825149|NCT02472704|celiac disease|celiac disease
4825150|NCT02472704|lymphocytic enteritis|lymphocytic enteritis
4825151|NCT02472704|non-celiac gluten sensitivity|non-celiac gluten sensitivity
4825152|NCT02472704|double-blind gluten rechallenge|double-blind gluten rechallenge
4825153|NCT02472691|relapse after allogeneic transplantation|relapse after allogeneic transplantation
4825155|NCT02472691|AML|aml
4825156|NCT02472691|CMML|cmml
4825157|NCT02472691|DLI|dli
4825158|NCT02472691|Azacitidine|azacitidine
4825159|NCT02472691|Lenalidomide|lenalidomide
4825160|NCT02472691|C04.557.337.539.275|c04.557.337.539.275
4825161|NCT02472691|C15.378.190.625|c15.378.190.625
4825162|NCT02472691|C04.557.337.539.522|c04.557.337.539.522
4825163|NCT02472665|pediatric|pediatric
4825164|NCT02472665|plasma-derived FVIII concentrate|plasma-derived fviii concentrate
4825165|NCT02472613|Post－Stroke Depression|post－stroke depression
4825166|NCT02472613|Acupunture|acupunture
4825167|NCT02472613|Fluoxetine|fluoxetine
4825168|NCT02472613|RCT|rct
4825169|NCT02472600|extended spectrum beta-lactamase producing enterobacteriaceae|extended spectrum beta-lactamase producing enterobacteriaceae
4825170|NCT02472600|carbapenemase producing enterobacteriaceae|carbapenemase producing enterobacteriaceae
4825171|NCT02472600|multidrug resistant bacteria|multidrug resistant bacteria
4825672|NCT02469753|NSAIDs|nsaids
4825172|NCT02472574|Intracerebral Hemorrhage|intracerebral hemorrhage
4825173|NCT02472574|minimally invasive surgery|minimally invasive surgery
4825174|NCT02472574|recombinant tissue plasminogen activator|recombinant tissue plasminogen activator
4825175|NCT02472574|Dose-effect Relationship|dose-effect relationship
4825176|NCT02472561|Cardiology|cardiology
4825177|NCT02472561|Vascular|vascular
4825178|NCT02472561|Peripheral Artery Disease|peripheral artery disease
4825179|NCT02472561|Artery|artery
4825180|NCT02472561|Mobile Health|mobile health
4825181|NCT02472561|Exercise|exercise
4825182|NCT02472561|PAD|pad
4825183|NCT02472535|HoFH|hofh
4825184|NCT02472509|Ursodeoxycholic acid (UDCA)|ursodeoxycholic acid (udca)
4825185|NCT02472509|White blood cells (WBC)|white blood cells (wbc)
4825186|NCT02472509|Alanine Transaminase (ALT)|alanine transaminase (alt)
4825187|NCT02472509|Alkaline Phosphatase (ALP)|alkaline phosphatase (alp)
4825188|NCT02472509|Aspartate Aminotransferase (AST)|aspartate aminotransferase (ast)
4825189|NCT02472509|Gamma-Glutamyl Transpeptidase (GGT)|gamma-glutamyl transpeptidase (ggt)
4825190|NCT02472509|Lactate dehydrogenase (LDH)|lactate dehydrogenase (ldh)
4825191|NCT02472509|Low-Density Lipoprotein (LDL)|low-density lipoprotein (ldl)
4825192|NCT02472509|High-Density Lipoprotein (HDL)|high-density lipoprotein (hdl)
4825193|NCT02472509|Glucose-6-phosphate dehydrogenase (G6PD)|glucose-6-phosphate dehydrogenase (g6pd)
4825194|NCT02472509|Ultrasound (US)|ultrasound (us)
4825195|NCT02472470|rTMS|rtms
4825196|NCT02472470|Depression|depression
4825197|NCT02472470|Youth|youth
4825198|NCT02472470|TBS|tbs
4825199|NCT02472470|Brain Stimulation|brain stimulation
4825200|NCT02472470|Electrophysiology|electrophysiology
4825201|NCT02472470|Imaging|imaging
4825202|NCT02472431|ADRC|adrc
4825203|NCT02472431|Adipose-Derived Regenerative Cells|adipose-derived regenerative cells
4825204|NCT02472431|Fat Tissue|fat tissue
4825205|NCT02472431|Stem Cells|stem cells
4825206|NCT02472431|Erectile Dysfunction|erectile dysfunction
4825207|NCT02472431|Arteriogenic Impotence|arteriogenic impotence
4825208|NCT02472431|Venogenic Impotence|venogenic impotence
4825209|NCT02472431|Vasculogenic Impotence|vasculogenic impotence
4825210|NCT02472431|Male Impotence|male impotence
4825211|NCT02472431|Male Sexual Impotence|male sexual impotence
4825212|NCT02472392|EWINGS, SARCOMA|ewings, sarcoma
4825213|NCT02472379|Immune System|immune system
4825214|NCT02472379|Behavioral Sciences|behavioral sciences
4825215|NCT02472379|Women's Health|women's health
4825216|NCT02472379|Health Psychology|health psychology
4825217|NCT02472379|Writing|writing
4825218|NCT02472353|breast|breast
4825219|NCT02472353|cancer|cancer
4825220|NCT02472353|doxorubicin|doxorubicin
4825221|NCT02472353|metformin|metformin
4825222|NCT02472353|cardiotoxicity|cardiotoxicity
4825223|NCT02472353|ejection fraction|ejection fraction
4825224|NCT02472353|LVEF|lvef
4825225|NCT02472288|urinary retention|urinary retention
4825226|NCT02472288|poststroke|poststroke
4825227|NCT02472288|electroacupuncture|electroacupuncture
4825228|NCT02472288|randomized controlled trial|randomized controlled trial
4825229|NCT02472288|effectiveness|effectiveness
4825230|NCT02472288|safety|safety
4825231|NCT02472262|Environmental|environmental
4825232|NCT02472262|Enteric|enteric
4825233|NCT02472249|TACE|tace
4825234|NCT02472249|CT perfusion|ct perfusion
4825235|NCT02472249|Liver blood flow|liver blood flow
4825236|NCT02472236|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
4825237|NCT02472223|"Pink Eye"|"pink eye"
4825238|NCT02472197|Endometrial polyp|endometrial polyp
4825239|NCT02472197|Hysteroscopic resection|hysteroscopic resection
4825240|NCT02472197|Morcellation|morcellation
4825241|NCT02472184|Office hysteroscopy|office hysteroscopy
4825242|NCT02472184|Endometrial biopsy|endometrial biopsy
4825243|NCT02472184|Abnormal uterine bleeding|abnormal uterine bleeding
4825244|NCT02472184|Uterine fibroids|uterine fibroids
4825245|NCT02472171|n-3 polyunsaturated fatty acids|n-3 polyunsaturated fatty acids
4825246|NCT02472171|blueberries|blueberries
4825247|NCT02472158|Bandages|bandages
4825248|NCT02472158|Central Venous Catheters|central venous catheters
4825249|NCT02472158|Catheter-Related Infections|catheter-related infections
4825250|NCT02472145|Leukemia, myeloid, acute|leukemia, myeloid, acute
4825251|NCT02472145|DACOGEN|dacogen
4825252|NCT02472145|Decitabine|decitabine
4825253|NCT02472145|JNJ-56022473|jnj-56022473
4825254|NCT02472145|CLS362|cls362
4825255|NCT02472132|Central Venous Catheter|central venous catheter
4825256|NCT02472132|Point Of Care Ultra Sound|point of care ultra sound
4825257|NCT02472132|Sub Clavian Vein|sub clavian vein
4825258|NCT02472132|Internal Jugular Vein|internal jugular vein
4825259|NCT02472132|Trans Thoracic Echocardiography|trans thoracic echocardiography
4825260|NCT02472119|Celiac disease|celiac disease
4825261|NCT02472119|Gluten-free diet|gluten-free diet
4825262|NCT02472119|Wheat flour treatment|wheat flour treatment
4825263|NCT02472119|Microbial transglutaminase|microbial transglutaminase
4825264|NCT02472119|Lysine Ethyl Ester|lysine ethyl ester
4825265|NCT02472119|Celiac Disease Treatment|celiac disease treatment
4825266|NCT02472106|Aortic Valve|aortic valve
4825267|NCT02472106|TAVI|tavi
4825268|NCT02472106|Stenosis|stenosis
4825269|NCT02472093|Postural exercise|postural exercise
4825270|NCT02472093|Back pain|back pain
4825271|NCT02472093|Tender points|tender points
4825272|NCT02472093|Fibromyalgia|fibromyalgia
4825273|NCT02472093|Perceptive rehabilitation|perceptive rehabilitation
4825274|NCT02472067|Musculoskeletal Injury|musculoskeletal injury
4825275|NCT02472067|physical therapy|physical therapy
4825276|NCT02472067|psychological intervention|psychological intervention
4825277|NCT02472067|risk factors|risk factors
4825278|NCT02472054|hemophagocytic lymphohistiocytosis (HLH)|hemophagocytic lymphohistiocytosis (hlh)
4825279|NCT02472054|Alemtuzumab (CAMPATH®)|alemtuzumab (campath®)
4825280|NCT02472041|chest drain|chest drain
4825281|NCT02472028|Cerebrovascular Disorders|cerebrovascular disorders
4825282|NCT02472028|Stroke|stroke
4825283|NCT02472028|Antihypertensive Agents|antihypertensive agents
4825284|NCT02472028|Arterial Pressure|arterial pressure
4825285|NCT02472028|Memory Disorders|memory disorders
4825286|NCT02472015|neuropsychiatric symptoms|neuropsychiatric symptoms
4825287|NCT02472015|dementia|dementia
4825288|NCT02472015|telemedicine|telemedicine
4825289|NCT02472015|long-term care facilities|long-term care facilities
4825290|NCT02472002|Transplant coronary diseases|transplant coronary diseases
4825291|NCT02472002|Mesenchymal cell therapy|mesenchymal cell therapy
4825292|NCT02472002|Administration of CSM by NOGA system|administration of csm by noga system
4825293|NCT02472002|Coronary disease in heart transplant patients|coronary disease in heart transplant patients
4825294|NCT02471989|FODMAP|fodmap
4825295|NCT02471989|Diet|diet
4825296|NCT02471989|pH-impedance monitoring|ph-impedance monitoring
4825297|NCT02471976|Leonetti law|leonetti law
4825298|NCT02471976|palliative care|palliative care
4825299|NCT02471963|Empagliflozin|empagliflozin
4825300|NCT02471963|Diabetes mellitus|diabetes mellitus
4825301|NCT02471963|Macro- and Microcirculation|macro- and microcirculation
4825302|NCT02471963|Vascular Improvement|vascular improvement
4825303|NCT02471963|Endothelium function|endothelium function
4825304|NCT02471937|Streptococcus agalactiae|streptococcus agalactiae
4825305|NCT02471937|Group B Streptococcus|group b streptococcus
4825306|NCT02471937|Neonates|neonates
4825307|NCT02471937|colonization|colonization
4825308|NCT02471937|meningitis|meningitis
4825309|NCT02471937|Clonal Complex CC17|clonal complex cc17
4825310|NCT02471937|microbiota|microbiota
4825311|NCT02471937|next generation sequencing (NGS)|next generation sequencing (ngs)
4825312|NCT02471924|Pregnant women|pregnant women
4825313|NCT02471911|DLBCL|dlbcl
4825314|NCT02471911|Aggressive|aggressive
4825315|NCT02471911|Diffuse|diffuse
4825316|NCT02471911|Large|large
4825317|NCT02471885|remote ischaemic conditioning|remote ischaemic conditioning
4825318|NCT02471885|remote ischemic conditioning|remote ischemic conditioning
4825319|NCT02471885|cardio-oncology|cardio-oncology
4825320|NCT02471885|anthracycline|anthracycline
4825321|NCT02471885|troponin|troponin
4825322|NCT02471885|chemotherapy|chemotherapy
4825323|NCT02471885|myocardial reperfusion injury|myocardial reperfusion injury
4825324|NCT02471833|Hypertension|hypertension
4825325|NCT02471833|Prevention|prevention
4825326|NCT02471833|Family History|family history
4825327|NCT02471833|inflammation|inflammation
4825328|NCT02471833|blood brain barrier|blood brain barrier
4825329|NCT02471833|amyloid|amyloid
4825330|NCT02471820|Multiple Myeloma|multiple myeloma
4825331|NCT02471794|Type II Diabetes|type ii diabetes
4825332|NCT02471794|Personalized Health Planning|personalized health planning
4825333|NCT02471794|Shared Medical Appointments|shared medical appointments
4825334|NCT02471781|Aortic Aneurysm|aortic aneurysm
4825335|NCT02471781|Aneurysm|aneurysm
4825336|NCT02471781|Vascular Prosthesis|vascular prosthesis
4825337|NCT02471781|Vascular Disease|vascular disease
4825338|NCT02471781|Blood Vessel Prosthesis Implantation|blood vessel prosthesis implantation
4825339|NCT02471768|central pressure|central pressure
4825340|NCT02471768|Gensini score|gensini score
4825341|NCT02471768|pulsatility|pulsatility
4825342|NCT02471768|coronary artery disease|coronary artery disease
4825343|NCT02471755|electro-acupuncture|electro-acupuncture
4825344|NCT02471755|menopause|menopause
4825345|NCT02471755|menopausal transition symptoms|menopausal transition symptoms
4825346|NCT02471755|efficacy|efficacy
4825347|NCT02471755|RCT|rct
4825348|NCT02471755|placebo control|placebo control
4825349|NCT02471729|Cardio-Renal Syndrome|cardio-renal syndrome
4825350|NCT02471729|Chronic Heart Failure|chronic heart failure
4825351|NCT02471729|Renal Denervation|renal denervation
4825352|NCT02471729|Sympathetic activation|sympathetic activation
4825353|NCT02471729|Heart Failure|heart failure
4825354|NCT02471729|Cardiovascular Diseases|cardiovascular diseases
4825355|NCT02471729|Heart Diseases|heart diseases
4825356|NCT02471716|Diffuse Type Tenosynovial Giant Cell Tumor (dt-TGCT)|diffuse type tenosynovial giant cell tumor (dt-tgct)
4825357|NCT02471703|Total Hip Arthroplasty|total hip arthroplasty
4825358|NCT02471703|Total Hip Replacement|total hip replacement
4825359|NCT02471703|Inflammatory Joint Disease|inflammatory joint disease
4825360|NCT02471703|Non-Inflammatory Joint Disease|non-inflammatory joint disease
4825361|NCT02471690|Volunteers|volunteers
4825362|NCT02471677|Ovarian stimulation|ovarian stimulation
4825363|NCT02471677|corifollitropin alfa|corifollitropin alfa
4825364|NCT02471677|GnRH antagonist protocol|gnrh antagonist protocol
4825365|NCT02471677|high responders|high responders
4825366|NCT02471677|follitropin beta|follitropin beta
4825367|NCT02471664|Percutaneous mitral valve repair|percutaneous mitral valve repair
4825368|NCT02471664|Coronary sinus annuloplasty|coronary sinus annuloplasty
4825369|NCT02471664|Mitral loop cerclage|mitral loop cerclage
4825370|NCT02471625|Controls|controls
4825371|NCT02471599|IgA nephropathy|iga nephropathy
4825372|NCT02471599|tonsillitis|tonsillitis
4825373|NCT02471599|tonsil provocation test|tonsil provocation test
4825374|NCT02471599|Tonsillectomy|tonsillectomy
4825375|NCT02471573|IVF|ivf
4825376|NCT02471573|Freeze-all|freeze-all
4825377|NCT02471573|frozen embryo transfer|frozen embryo transfer
4825378|NCT02471573|fresh transfer|fresh transfer
4825379|NCT02471560|Microbiota|microbiota
4825380|NCT02471560|DMF|dmf
4825381|NCT02471560|Gastro intestinal|gastro intestinal
4825382|NCT02471560|MS|ms
4825383|NCT02471547|Recurrence|recurrence
4825384|NCT02471495|NMIBC|nmibc
4825385|NCT02471495|Non-Muscle-Invasive Bladder Cancer|non-muscle-invasive bladder cancer
4825386|NCT02471495|Nonmuscle Invasive Bladder Cancer|nonmuscle invasive bladder cancer
4825387|NCT02471495|BCG refractory|bcg refractory
4825388|NCT02471495|BCG failure|bcg failure
4825389|NCT02471495|Carcinoma in situ|carcinoma in situ
4825390|NCT02471495|CIS|cis
4825391|NCT02471482|Near Infra Red Spectrometry|near infra red spectrometry
4825392|NCT02471482|Cerebral oxygenation|cerebral oxygenation
4825393|NCT02471482|Mozart music|mozart music
4825394|NCT02471404|Diabetes Mellitus Type 2,|diabetes mellitus type 2,
4825395|NCT02471404|metformin,|metformin,
4825396|NCT02471404|saxagliptin,|saxagliptin,
4825397|NCT02471404|dapagliflozin,|dapagliflozin,
4825398|NCT02471404|glimepiride,|glimepiride,
4825399|NCT02471404|inadequate glycaemic control|inadequate glycaemic control
4825400|NCT02471378|Assay|assay
4825401|NCT02471378|Women|women
4825402|NCT02471378|Infected|infected
4825403|NCT02471378|Antibodies|antibodies
4825404|NCT02471365|Exposure Assessment|exposure assessment
4825405|NCT02471365|Questionnaire|questionnaire
4825406|NCT02471365|Product Use|product use
4825407|NCT02471365|Biomonitoring|biomonitoring
4825408|NCT02471352|Dermatologic Condition|dermatologic condition
4825409|NCT02471352|Skin Disease|skin disease
4825410|NCT02471352|Biospecimen|biospecimen
4825411|NCT02471352|Healthy Volunteers|healthy volunteers
4825412|NCT02471352|Merkel Cell Carcinoma|merkel cell carcinoma
4825413|NCT02471339|Psychological Intervention|psychological intervention
4825414|NCT02471339|Coping|coping
4825415|NCT02471339|Mindfulness|mindfulness
4825416|NCT02471339|Randomized|randomized
4825417|NCT02471326|HIV Neutralizing Antibodies|hiv neutralizing antibodies
4825418|NCT02471326|HIV Therapy|hiv therapy
4825419|NCT02471313|Cross-Sectional Imaging|cross-sectional imaging
4825420|NCT02471313|Chemoembolization|chemoembolization
4825421|NCT02471313|Radiation Therapy|radiation therapy
4825422|NCT02471313|Tumor Hypoxia|tumor hypoxia
4825423|NCT02471313|PET Imaging|pet imaging
4825424|NCT02471300|Asthma|asthma
4825425|NCT02471300|Inflammasome|inflammasome
4825426|NCT02471300|Fasting|fasting
4825427|NCT02471300|Airflow Obstruction|airflow obstruction
4825428|NCT02471287|Ocular Genetic Diseases|ocular genetic diseases
4825429|NCT02471287|GENETIC DISEASE|genetic disease
4825430|NCT02471144|pediatric, chronic severe plaque psoriasis, secukinumab, etanercept|pediatric, chronic severe plaque psoriasis, secukinumab, etanercept
4825431|NCT02471131|WATCHMAN|watchman
4825432|NCT02471131|Atrial Fibrillation|atrial fibrillation
4825433|NCT02471131|Hybrid Ablation|hybrid ablation
4825434|NCT02471131|Safety|safety
4825435|NCT02471131|Feasibility|feasibility
4825436|NCT02471131|Stroke Prevention|stroke prevention
4825437|NCT02471118|Inflammatory Type|inflammatory type
4825438|NCT02471092|satiety|satiety
4825439|NCT02471092|glycemia|glycemia
4825440|NCT02471092|milk protein|milk protein
4825441|NCT02471079|Radiation-induced health problems|radiation-induced health problems
4825442|NCT02471079|Cardiovascular events|cardiovascular events
4825443|NCT02471079|Lung toxicity|lung toxicity
4825444|NCT02471053|Exercise|exercise
4825445|NCT02471053|Quality of Life|quality of life
4825446|NCT02471053|Complementary Therapies|complementary therapies
4825447|NCT02471053|Neoadjuvant Therapy|neoadjuvant therapy
4825448|NCT02471053|Feasibility Studies|feasibility studies
4825449|NCT02471040|brain metabolism|brain metabolism
4825450|NCT02471040|cognitive function|cognitive function
4825451|NCT02471027|Locally advanced cervical cancer|locally advanced cervical cancer
4825452|NCT02471027|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
4825453|NCT02471027|Disease-free survival|disease-free survival
4825454|NCT02471027|Overall survival|overall survival
4825455|NCT02471014|Pneumovax23|pneumovax23
4825456|NCT02471014|Obesity|obesity
4825457|NCT02471001|concentration|concentration
4825458|NCT02471001|Isoflurane|isoflurane
4825459|NCT02471001|cardioprotective|cardioprotective
4825460|NCT02471001|cardioplegia|cardioplegia
4825461|NCT02471001|heart surgery|heart surgery
4825462|NCT02471001|Disorder|disorder
4825463|NCT02471001|Heart|heart
4825464|NCT02471001|Functional|functional
4825465|NCT02471001|Postoperative|postoperative
4825466|NCT02470949|body weight|body weight
4825467|NCT02470949|Hispanics|hispanics
4825468|NCT02470949|Energy Intake|energy intake
4825469|NCT02470949|Social Status|social status
4825470|NCT02470923|Smoking cessation|smoking cessation
4825471|NCT02470923|Nicotine|nicotine
4825472|NCT02470923|Spirometry|spirometry
4825473|NCT02470923|Internal medicine|internal medicine
4825474|NCT02470910|Prostate Cancer|prostate cancer
4825475|NCT02470910|Stage I-III prostate adenocarcinoma|stage i-iii prostate adenocarcinoma
4825476|NCT02470806|Venous leg ulcer|venous leg ulcer
4825477|NCT02470806|ulcer|ulcer
4825478|NCT02470806|venous stasis|venous stasis
4825479|NCT02470806|compression|compression
4825480|NCT02470806|diabetic foot ulcers|diabetic foot ulcers
4825481|NCT02470806|dfu|dfu
4825482|NCT02470806|vlu|vlu
4825483|NCT02470793|Corneal Endothelial Cell Loss|corneal endothelial cell loss
4825484|NCT02470793|Fuchs' Endothelial Dystrophy|fuchs' endothelial dystrophy
4825485|NCT02470793|Lamellar Keratoplasty|lamellar keratoplasty
4825486|NCT02470793|Descemet Stripping Endothelial Keratoplasty|descemet stripping endothelial keratoplasty
4825487|NCT02470793|Descemet Membrane Endothelial Keratoplasty|descemet membrane endothelial keratoplasty
4825488|NCT02470793|Minimal Surgical Procedure|minimal surgical procedure
4825489|NCT02470728|patient readmission|patient readmission
4825490|NCT02470728|pain relief units|pain relief units
4825491|NCT02470728|pain centers|pain centers
4825492|NCT02470728|multidisciplinary pain clinics|multidisciplinary pain clinics
4825493|NCT02470728|multidisciplinary pain centers|multidisciplinary pain centers
4825494|NCT02470728|pain clinics|pain clinics
4825495|NCT02470728|hospital readmission|hospital readmission
4825496|NCT02470728|emergencies|emergencies
4825497|NCT02470728|emergency medicine|emergency medicine
4825498|NCT02470728|critical care|critical care
4825499|NCT02470728|emergency treatment|emergency treatment
4825500|NCT02470728|opioid|opioid
4825501|NCT02470728|acute pain service|acute pain service
4825502|NCT02470715|genetic sequencing|genetic sequencing
4825503|NCT02470715|genome|genome
4825504|NCT02470715|cancer|cancer
4825505|NCT02470715|DNA|dna
4825506|NCT02470715|RNA|rna
4825507|NCT02470715|protein|protein
4825508|NCT02470715|metabolite|metabolite
4825509|NCT02470702|Volunteers|volunteers
4825510|NCT02470650|comparative effectiveness|comparative effectiveness
4825511|NCT02470598|Automated Peritoneal Dialysis|automated peritoneal dialysis
4825512|NCT02470598|Adapted APD (aAPD)|adapted apd (aapd)
4825513|NCT02470598|Hydration status|hydration status
4825514|NCT02470598|Residual Renal Function|residual renal function
4825515|NCT02470598|Ultrafiltration|ultrafiltration
4825516|NCT02470585|Veliparib|veliparib
4825517|NCT02470585|Carboplatin|carboplatin
4825518|NCT02470585|Paclitaxel|paclitaxel
4825519|NCT02470585|Overall Survival|overall survival
4825520|NCT02470585|ABT-888|abt-888
4825521|NCT02470585|Randomized|randomized
4825522|NCT02470585|Poly Adenosine Diphosphate (ADP) - Ribose Polymerase (PARP)|poly adenosine diphosphate (adp) - ribose polymerase (parp)
4825523|NCT02470585|Ovarian|ovarian
4825524|NCT02470585|BRCA|brca
4825525|NCT02470546|Hepatic encephalopathy|hepatic encephalopathy
4825526|NCT02470546|Metformin|metformin
4825527|NCT02470546|Liver cirrhosis|liver cirrhosis
4825528|NCT02470481|Psoriatic arthritis|psoriatic arthritis
4825529|NCT02470468|Immunotherapy|immunotherapy
4825530|NCT02470468|Metastatic|metastatic
4825531|NCT02470468|NSCLC|nsclc
4825532|NCT02470468|Biological|biological
4825533|NCT02470468|Lung Cancer|lung cancer
4825534|NCT02470468|Vaccine|vaccine
4825535|NCT02470455|Atorvastatin|atorvastatin
4825536|NCT02470455|Prediabetics|prediabetics
4825537|NCT02470455|HbA1c|hba1c
4825538|NCT02470416|duodenal|duodenal
4825539|NCT02470416|ampulla|ampulla
4825540|NCT02470403|dysglycemic, normoglycemic, prediabetes, type 2 diabetes mellitus|dysglycemic, normoglycemic, prediabetes, type 2 diabetes mellitus
4825541|NCT02470390|Volunteer|volunteer
4825542|NCT02470390|Pharmacokenetics (PK) (plasma and Cerebrospinal Fluid [CSF])|pharmacokenetics (pk) (plasma and cerebrospinal fluid [csf])
4825543|NCT02470377|MdDS|mdds
4825544|NCT02470377|TMS|tms
4825545|NCT02470377|fMRI|fmri
4825546|NCT02470377|EEG|eeg
4825547|NCT02470364|Myasthenia gravis|myasthenia gravis
4825548|NCT02470364|Quality of life|quality of life
4825549|NCT02470325|Cerebral palsy|cerebral palsy
4825550|NCT02470325|Genetic neurodegenerative diseases|genetic neurodegenerative diseases
4825551|NCT02470312|utility of MediGuide system|utility of mediguide system
4825552|NCT02470312|CRT|crt
4825553|NCT02470312|EP|ep
4825554|NCT02470299|ketorolac|ketorolac
4825555|NCT02470299|GTPase|gtpase
4825556|NCT02470299|cancer|cancer
4825557|NCT02470299|peritoneal|peritoneal
4825558|NCT02470299|fallopian|fallopian
4825559|NCT02470299|ovarian|ovarian
4825560|NCT02470273|Melanoma|melanoma
4825561|NCT02470260|Diabetes|diabetes
4825562|NCT02470260|Pre-diabetes|pre-diabetes
4825563|NCT02470260|Cognition|cognition
4825564|NCT02470260|Depressive symptoms|depressive symptoms
4825565|NCT02470247|Transcatheter Aortic Valve Implantation|transcatheter aortic valve implantation
4825566|NCT02470234|ADHD|adhd
4825567|NCT02470234|Children|children
4825568|NCT02470234|Pharmacokinetics|pharmacokinetics
4825569|NCT02470221|goal-directed fluid therapy|goal-directed fluid therapy
4825570|NCT02470221|intraoperative hemodynamics|intraoperative hemodynamics
4825571|NCT02470221|postoperative complications|postoperative complications
4825572|NCT02470208|Cytomegalovirus reactivation in stem cell transplant|cytomegalovirus reactivation in stem cell transplant
4825573|NCT02470182|sleep apnea|sleep apnea
4825574|NCT02470182|snoring|snoring
4825575|NCT02470156|community based participatory research|community based participatory research
4825576|NCT02470156|healthy eating|healthy eating
4825577|NCT02470156|physical activity|physical activity
4825578|NCT02470156|obesity|obesity
4825579|NCT02470143|Human-computer interaction|human-computer interaction
4825580|NCT02470143|Fear|fear
4825581|NCT02470143|Motivation|motivation
4825582|NCT02470143|Usability|usability
4825583|NCT02470130|simulation|simulation
4825584|NCT02470130|anxiety|anxiety
4825585|NCT02470130|debriefing|debriefing
4825586|NCT02470130|memorization|memorization
4825587|NCT02470104|children|children
4825588|NCT02470104|bone marrow transplant|bone marrow transplant
4825589|NCT02470104|autologous|autologous
4825590|NCT02470104|allogeneic|allogeneic
4825591|NCT02470104|breastmilk|breastmilk
4825592|NCT02470104|hematopoietic stem cell transplantation (HSCT)|hematopoietic stem cell transplantation (hsct)
4825593|NCT02470078|extubation|extubation
4825594|NCT02470065|NSCLC|nsclc
4825595|NCT02470065|Early stage|early stage
4825596|NCT02470065|Phase II|phase ii
4825597|NCT02470065|Randomized|randomized
4825598|NCT02470065|EGFR mutated|egfr mutated
4825599|NCT02470052|Endobronchial Valves|endobronchial valves
4825600|NCT02470052|Intrabronchial Valves|intrabronchial valves
4825601|NCT02470052|Bronchial Valve|bronchial valve
4825602|NCT02470052|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
4825603|NCT02470052|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
4825604|NCT02470052|Bronchoscopic Lung Volume Reduction|bronchoscopic lung volume reduction
4825605|NCT02470052|Emphysema|emphysema
4825606|NCT02470052|Pulmonary Emphysema|pulmonary emphysema
4825607|NCT02470052|Lung Diseases|lung diseases
4825608|NCT02470052|Respiratory Tract Disease|respiratory tract disease
4825609|NCT02470013|Malnutrition|malnutrition
4825610|NCT02470013|Geriatrics|geriatrics
4825611|NCT02470013|Enteral Nutrition|enteral nutrition
4825612|NCT02470000|myofascial pain|myofascial pain
4825613|NCT02470000|neck|neck
4825614|NCT02470000|laser|laser
4825615|NCT02470000|elastography|elastography
4825616|NCT02470000|shear wave velocity|shear wave velocity
4825617|NCT02470000|randomized control trial|randomized control trial
4825618|NCT02470000|Intravascular Laser Irradiation of Blood|intravascular laser irradiation of blood
4825619|NCT02469987|safety|safety
4825620|NCT02469987|tolerability|tolerability
4825621|NCT02469987|immunogenicity|immunogenicity
4825622|NCT02469987|MYL-1402O|myl-1402o
4825623|NCT02469987|PK|pk
4825624|NCT02469987|Avastin®|avastin®
4825625|NCT02469987|biosimilarity|biosimilarity
4825626|NCT02469987|male|male
4825627|NCT02469974|Myelofibrosis|myelofibrosis
4825628|NCT02469974|RUXOLITINIB|ruxolitinib
4825629|NCT02469974|Autologous stem cell transplant|autologous stem cell transplant
4825630|NCT02469948|spasticity|spasticity
4825631|NCT02469948|botulinum toxin|botulinum toxin
4825632|NCT02469948|ultrasonography guidance|ultrasonography guidance
4825633|NCT02469948|electric stimulation guidance|electric stimulation guidance
4825634|NCT02469948|stroke|stroke
4825635|NCT02469935|Validation|validation
4825636|NCT02469935|Surgeon-performed ultrasound|surgeon-performed ultrasound
4825637|NCT02469935|Gallstones|gallstones
4825638|NCT02469909|Decannulation|decannulation
4825639|NCT02469909|tracheostomy|tracheostomy
4825640|NCT02469896|ALS|als
4825641|NCT02469896|tocilizumab|tocilizumab
4825642|NCT02469896|biomarker|biomarker
4825643|NCT02469870|Parents of children who have autism|parents of children who have autism
4825644|NCT02469870|video-conferencing|video-conferencing
4825645|NCT02469870|Applied Behavior Analysis|applied behavior analysis
4825646|NCT02469870|Acceptance Commitment Training|acceptance commitment training
4825647|NCT02469870|optimism training|optimism training
4825648|NCT02469870|Positive Behavior Support|positive behavior support
4825649|NCT02469857|AB103|ab103
4825650|NCT02469857|Necrotizing fasciitis|necrotizing fasciitis
4825651|NCT02469818|pocus|pocus
4825652|NCT02469818|ultrasonography|ultrasonography
4825653|NCT02469818|glenohumeral dislocation|glenohumeral dislocation
4825654|NCT02469792|Anterior cruciate ligament|anterior cruciate ligament
4825655|NCT02469792|Ligament rupture|ligament rupture
4825656|NCT02469792|Intraarticular injection|intraarticular injection
4825657|NCT02469792|ADRC|adrc
4825658|NCT02469792|Adipose-derived regenerative cells|adipose-derived regenerative cells
4825659|NCT02469792|Adipose tissue|adipose tissue
4825660|NCT02469792|Stem cells|stem cells
4825661|NCT02469779|Tobacco Prevention|tobacco prevention
4825662|NCT02469779|ASPIRE Website|aspire website
4825663|NCT02469779|Surveys|surveys
4825664|NCT02469779|Questionnaires|questionnaires
4825665|NCT02469779|Focus Groups|focus groups
4825666|NCT02469779|Health Interactive Website|health interactive website
4825667|NCT02469766|ureteral stones|ureteral stones
4825668|NCT02469766|ureter|ureter
4825669|NCT02469766|ureteroscopy|ureteroscopy
4825670|NCT02469766|flexible|flexible
4825671|NCT02469766|SWL|swl
4825673|NCT02469753|Anti-TNF|anti-tnf
4825674|NCT02469753|syndesmophytes|syndesmophytes
4825675|NCT02469753|mSASSS|msasss
4825676|NCT02469740|Ticagrelor|ticagrelor
4825677|NCT02469740|Clopidogrel|clopidogrel
4825678|NCT02469740|Coronary Artery Disease|coronary artery disease
4825679|NCT02469740|Percutaneous Coronary Intervention|percutaneous coronary intervention
4825680|NCT02469740|Acute Coronary Syndrome|acute coronary syndrome
4825681|NCT02469714|Patient Navigator|patient navigator
4825682|NCT02469714|Integrated Care|integrated care
4825683|NCT02469714|Latino|latino
4825684|NCT02469714|Mental health and wellness|mental health and wellness
4825685|NCT02469714|Physical health and wellness|physical health and wellness
4825686|NCT02469688|cedar pollinosis|cedar pollinosis
4825687|NCT02469688|immunological response,|immunological response,
4825688|NCT02469688|ASP4070|asp4070
4825689|NCT02469688|vaccine|vaccine
4825690|NCT02469675|Spinal Cord Injuries|spinal cord injuries
4825691|NCT02469675|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
4825692|NCT02469675|Transcranial magnetic stimulation, single pulse|transcranial magnetic stimulation, single pulse
4825693|NCT02469675|non-invasive brain stimulation|non-invasive brain stimulation
4825694|NCT02469662|Total Elbow Arthroplasty|total elbow arthroplasty
4825695|NCT02469662|TEA|tea
4825696|NCT02469662|Elbow Arthroplasty|elbow arthroplasty
4825697|NCT02469662|Elbow Replacement|elbow replacement
4825698|NCT02469662|Advanced Rheumatoid Arthritis|advanced rheumatoid arthritis
4825699|NCT02469662|Post-Traumatic Arthritis|post-traumatic arthritis
4825700|NCT02469662|Degenerative Arthritis|degenerative arthritis
4825701|NCT02469662|Elbow Joint Destruction|elbow joint destruction
4825702|NCT02469662|Post-Traumatic Lesions or Bone Loss|post-traumatic lesions or bone loss
4825703|NCT02469662|Ankylosed Joints|ankylosed joints
4825704|NCT02469662|Acute Comminuted Articular Fracture|acute comminuted articular fracture
4825705|NCT02469662|significantly compromises daily living activities|significantly compromises daily living activities
4825706|NCT02469662|degree of joint or soft tissue damage precludes reliable osteosynthesis|degree of joint or soft tissue damage precludes reliable osteosynthesis
4825707|NCT02469662|precludes less radical procedures, including 13-C3 fractures of the distal humerus|precludes less radical procedures, including 13-c3 fractures of the distal humerus
4825708|NCT02469610|Post surgical pain|post surgical pain
4825709|NCT02469584|prolapse|prolapse
4825710|NCT02469584|anterior colporrhaphy|anterior colporrhaphy
4825711|NCT02469545|depression|depression
4825712|NCT02469545|microbiota-gut-brain axis|microbiota-gut-brain axis
4825713|NCT02469545|Lactobacillus Plantarum 299v|lactobacillus plantarum 299v
4825714|NCT02469545|probiotic|probiotic
4825715|NCT02469480|MCRC|mcrc
4825716|NCT02469480|iron substitution|iron substitution
4825717|NCT02469480|iron deficiency anemia|iron deficiency anemia
4825718|NCT02469467|phosphate binder|phosphate binder
4825719|NCT02469467|dialysis|dialysis
4825720|NCT02469454|etonogestrel-implant|etonogestrel-implant
4825721|NCT02469454|newborn|newborn
4825722|NCT02469454|growth|growth
4825723|NCT02469454|Child Development|child development
4825724|NCT02469441|coffee|coffee
4825725|NCT02469441|postoperative ileus|postoperative ileus
4825726|NCT02469441|colorectal surgery|colorectal surgery
4825727|NCT02469428|Controlled human exposure study|controlled human exposure study
4825728|NCT02469428|Ozone|ozone
4825729|NCT02469428|Inflammation|inflammation
4825730|NCT02469415|Leukemia|leukemia
4825731|NCT02469415|Myelodysplastic syndromes|myelodysplastic syndromes
4825732|NCT02469415|MDS|mds
4825733|NCT02469415|Lower-risk|lower-risk
4825734|NCT02469415|Pacritinib|pacritinib
4825735|NCT02469415|5-azacitidine|5-azacitidine
4825736|NCT02469415|Azacitidine|azacitidine
4825737|NCT02469415|5-azacytidine|5-azacytidine
4825738|NCT02469415|Vidaza|vidaza
4825739|NCT02469415|5-AZC|5-azc
4825740|NCT02469415|AZA-CR|aza-cr
4825741|NCT02469415|Ladakamycin|ladakamycin
4825742|NCT02469415|NSC-102816|nsc-102816
4825743|NCT02469415|Azacytidine|azacytidine
4825744|NCT02469415|Decitabine|decitabine
4825745|NCT02469415|Dacogen|dacogen
4825746|NCT02469402|reduced|reduced
4825747|NCT02469402|protein|protein
4825748|NCT02469402|formula|formula
4825749|NCT02469402|Alpha-lactalbumin|alpha-lactalbumin
4825750|NCT02469402|infant|infant
4825751|NCT02469389|Schizophrenia|schizophrenia
4825752|NCT02469389|Negative Symptoms|negative symptoms
4825753|NCT02469363|Macintosh laryngoscope|macintosh laryngoscope
4825754|NCT02469363|McCoy laryngoscope|mccoy laryngoscope
4825755|NCT02469363|C-Mac videolaryngoscope|c-mac videolaryngoscope
4825756|NCT02469363|McGrath videolaryngoscope|mcgrath videolaryngoscope
4825757|NCT02469363|Hemodynamic parameters|hemodynamic parameters
4825758|NCT02469350|Gait and balance disorders|gait and balance disorders
4825759|NCT02469350|serious game|serious game
4825760|NCT02469311|infection; arthroplasty; chlorhexidine; hip; knee|infection; arthroplasty; chlorhexidine; hip; knee
4825761|NCT02469298|acute, uncomplicated influenza|acute, uncomplicated influenza
4825762|NCT02469298|Danirixin|danirixin
4825763|NCT02469298|oseltamivir|oseltamivir
4825764|NCT02469285|Fatty acids|fatty acids
4825765|NCT02469285|Lipids|lipids
4825766|NCT02469285|Nitroso compounds|nitroso compounds
4825767|NCT02469285|Lipid metabolism|lipid metabolism
4825768|NCT02469285|Gut metabolism|gut metabolism
4825769|NCT02469259|oxytocin|oxytocin
4825770|NCT02469259|PTSD|ptsd
4825771|NCT02469259|Alcohol Use Disorder|alcohol use disorder
4825772|NCT02469259|social cognition|social cognition
4825773|NCT02469259|craving|craving
4825774|NCT02469259|fear-potentiated startle|fear-potentiated startle
4825775|NCT02469246|HIV|hiv
4825776|NCT02469246|HIV-1 Positive|hiv-1 positive
4825777|NCT02469246|Virologically-Suppressed|virologically-suppressed
4825778|NCT02469220|Diet|diet
4825779|NCT02469220|low FODMAP|low fodmap
4825780|NCT02469220|UC|uc
4825781|NCT02469220|IBS|ibs
4825782|NCT02469207|regenerative medicine|regenerative medicine
4825783|NCT02469207|stem cells|stem cells
4825784|NCT02469207|immunomodulatory|immunomodulatory
4825785|NCT02469207|induced pluripotent stem cells|induced pluripotent stem cells
4825786|NCT02469207|gut physiology|gut physiology
4825787|NCT02469129|positron emission tomography (PET) imaging|positron emission tomography (pet) imaging
4825788|NCT02469129|poly(ADP-ribose) polymerase 1 (PARP1)|poly(adp-ribose) polymerase 1 (parp1)
4825789|NCT02469129|[18F]FluorThanatrace ([18F]FTT)|[18f]fluorthanatrace ([18f]ftt)
4825790|NCT02469129|PARP1 inhibitors|parp1 inhibitors
4825791|NCT02469129|cancer treatments|cancer treatments
4825792|NCT02469103|capsule colonoscopy|capsule colonoscopy
4825793|NCT02469103|ulcerative colitis|ulcerative colitis
4825794|NCT02469077|Chronic Low Back Pain|chronic low back pain
4825795|NCT02469064|mechanical ventilation|mechanical ventilation
4825796|NCT02469064|respiratory muscle|respiratory muscle
4825797|NCT02469064|weaning|weaning
4825798|NCT02469064|training|training
4825799|NCT02469064|Intensive care|intensive care
4825800|NCT02469012|chronic hepatitis C|chronic hepatitis c
4825801|NCT02469012|antiviral treatment|antiviral treatment
4825802|NCT02469012|interferon-free|interferon-free
4825803|NCT02469012|neurocognitive performance|neurocognitive performance
4825804|NCT02469012|emotional state|emotional state
4825805|NCT02469012|quality of life|quality of life
4825806|NCT02468999|Intranasal insulin|intranasal insulin
4825807|NCT02468986|Rheumatoid Arthritis|rheumatoid arthritis
4825808|NCT02468973|health behavior|health behavior
4825809|NCT02468973|consultation|consultation
4825810|NCT02468973|undergraduate|undergraduate
4825811|NCT02468960|Coronary Artery Disease|coronary artery disease
4825812|NCT02468960|OPN NC|opn nc
4825813|NCT02468960|Angina|angina
4825814|NCT02468960|Stable|stable
4825815|NCT02468960|Unstable|unstable
4825816|NCT02468947|Neonatal sepsis|neonatal sepsis
4825817|NCT02468934|electrical stimulation|electrical stimulation
4825818|NCT02468934|neurostimulation|neurostimulation
4825819|NCT02468934|neuromodulation|neuromodulation
4825820|NCT02468934|TKA pain|tka pain
4825821|NCT02468934|pain following total knee replacement|pain following total knee replacement
4825822|NCT02468934|total knee arthroplasty|total knee arthroplasty
4825823|NCT02468921|Goitre|goitre
4825824|NCT02468921|thyroid disease|thyroid disease
4825825|NCT02468921|struma|struma
4825826|NCT02468895|Myositis|myositis
4825827|NCT02468895|Idiopathic inflammatory myopathy|idiopathic inflammatory myopathy
4825828|NCT02468895|Antibodies|antibodies
4825829|NCT02468895|Genetics|genetics
4825830|NCT02468895|Biomarkers|biomarkers
4825831|NCT02468882|Breast cancer|breast cancer
4825832|NCT02468882|Radiotherapy|radiotherapy
4825833|NCT02468882|Toxicity|toxicity
4825834|NCT02468882|Outcomes|outcomes
4825835|NCT02468882|Watercress|watercress
4825836|NCT02468869|Recall|recall
4825837|NCT02468869|Discharge communication|discharge communication
4825838|NCT02468869|Satisfaction|satisfaction
4825839|NCT02468869|Adherence|adherence
4825840|NCT02468869|Information structuring|information structuring
4825841|NCT02468869|Empathy skills|empathy skills
4825842|NCT02468843|Deep brain stimulation|deep brain stimulation
4825843|NCT02468843|DBS|dbs
4825844|NCT02468843|Dystonia|dystonia
4825845|NCT02468843|DYT1|dyt1
4825846|NCT02468830|mirabegron|mirabegron
4825847|NCT02468830|antimuscarinics|antimuscarinics
4825848|NCT02468830|beta 3 agonist|beta 3 agonist
4825849|NCT02468830|overactive bladder|overactive bladder
4825850|NCT02468830|children|children
4825851|NCT02468817|parathyroid hormone (PTH)|parathyroid hormone (pth)
4825852|NCT02468817|bone mineral density (BMD)|bone mineral density (bmd)
4825853|NCT02468804|Parkinson's|parkinson's
4825854|NCT02468804|Non-parkinsons|non-parkinsons
4825855|NCT02468791|Rheumatoid Arthritis|rheumatoid arthritis
4825856|NCT02468791|Autoimmune Diseases|autoimmune diseases
4825857|NCT02468791|Rituximab|rituximab
4825858|NCT02468791|Immune System Diseases|immune system diseases
4825859|NCT02468791|Joint Diseases|joint diseases
4825860|NCT02468791|Rheumatic Diseases|rheumatic diseases
4825861|NCT02468778|HeartMate PHP|heartmate php
4825862|NCT02468778|High Risk PCI|high risk pci
4825863|NCT02468778|Left Ventricular Dysfunction|left ventricular dysfunction
4825864|NCT02468778|Thoratec Corporation|thoratec corporation
4825865|NCT02468713|Omega-3|omega-3
4825866|NCT02468713|Blood lipid profiles|blood lipid profiles
4825867|NCT02468713|DHA|dha
4825868|NCT02468713|EPA|epa
4825869|NCT02468713|Triglyceride|triglyceride
4825870|NCT02468713|Glucose|glucose
4825871|NCT02468713|Insulin|insulin
4825872|NCT02468713|LDL|ldl
4825873|NCT02468713|TPN|tpn
4825874|NCT02468687|Relapsed/Refractory|relapsed/refractory
4825875|NCT02468674|Sarcopenia, muscle wasting, elderly, strength, physical|sarcopenia, muscle wasting, elderly, strength, physical
4825876|NCT02468674|function, lean body mass, gait speed|function, lean body mass, gait speed
4825877|NCT02468661|Non-Small Cell Lung Cancer|non-small cell lung cancer
4825878|NCT02468648|Oral Therapy|oral therapy
4825879|NCT02468648|Liver Biopsy|liver biopsy
4825880|NCT02468648|Chronic Hepatitis C|chronic hepatitis c
4825881|NCT02468635|Pulmonary rehabilitation|pulmonary rehabilitation
4825882|NCT02468635|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
4825883|NCT02468635|physical ability|physical ability
4825884|NCT02468635|pulmonary function|pulmonary function
4825885|NCT02468635|quality of daily life|quality of daily life
4825886|NCT02468596|Axonal excitability|axonal excitability
4825887|NCT02468596|Neuropathy|neuropathy
4825888|NCT02468596|QTRAC|qtrac
4825889|NCT02468596|anti-MAG|anti-mag
4825890|NCT02468596|Electrophysiology|electrophysiology
4825891|NCT02468583|Osteoarthritis|osteoarthritis
4825892|NCT02468583|Post-traumatic|post-traumatic
4825893|NCT02468583|Knee|knee
4825894|NCT02468583|Pain|pain
4825895|NCT02468583|Corticosteroid|corticosteroid
4825896|NCT02468583|Intra-articular|intra-articular
4825897|NCT02468583|Injection|injection
4825898|NCT02468570|PKU|pku
4825899|NCT02468570|PEG-PAL|peg-pal
4825900|NCT02468570|Pegvaliase|pegvaliase
4825901|NCT02468570|BMN 165|bmn 165
4825902|NCT02468570|rAv-PAL PEG|rav-pal peg
4825903|NCT02468570|PRISM 302|prism 302
4825904|NCT02468570|PRISM 303|prism 303
4825905|NCT02468570|BioMarin|biomarin
4825906|NCT02468570|165-302|165-302
4825907|NCT02468557|Relapsed/refractory pancreatic ductal adenocarcinoma|relapsed/refractory pancreatic ductal adenocarcinoma
4825908|NCT02468557|Previously untreated pancreatic ductal adenocarcinoma|previously untreated pancreatic ductal adenocarcinoma
4825909|NCT02468544|Engagement in care|engagement in care
4825910|NCT02468544|mHealth|mhealth
4825911|NCT02468531|Xenon|xenon
4825912|NCT02468531|Standford A acute aortic dissection|standford a acute aortic dissection
4825913|NCT02468505|Structured transition support program|structured transition support program
4825914|NCT02468505|Transition 'as usual'|transition 'as usual'
4825915|NCT02468492|Knee Osteoarthritis|knee osteoarthritis
4825916|NCT02468492|Platelet Rich Plasma|platelet rich plasma
4825917|NCT02468492|Mechanism of Action|mechanism of action
4825918|NCT02468492|Stem Cells|stem cells
4825919|NCT02468492|Synovial Fluid|synovial fluid
4825920|NCT02468479|Liver cirrhosis|liver cirrhosis
4825921|NCT02468466|suicide|suicide
4825922|NCT02468466|prevention|prevention
4825923|NCT02468453|velos|velos
4825924|NCT02468453|Vascular|vascular
4825925|NCT02468453|Rejuvenation|rejuvenation
4825926|NCT02468440|renal insufficiency|renal insufficiency
4825927|NCT02468440|kidney transplant|kidney transplant
4825928|NCT02468440|educational therapy|educational therapy
4825929|NCT02468414|Peritoneal Dialysis|peritoneal dialysis
4825930|NCT02468414|End Stage Renal Disease|end stage renal disease
4825931|NCT02468414|Anemia|anemia
4825932|NCT02468388|maltitol|maltitol
4825933|NCT02468388|xylitol|xylitol
4825934|NCT02468388|quantitative light-induced fluorescence|quantitative light-induced fluorescence
4825935|NCT02468388|saliva pH|saliva ph
4825936|NCT02468388|re-mineralization|re-mineralization
4825937|NCT02468388|dental caries|dental caries
4825938|NCT02468362|Intersphincteric resection|intersphincteric resection
4825939|NCT02468362|laparoscopic rectal rescetion|laparoscopic rectal rescetion
4825940|NCT02468362|total mesorectal excsison|total mesorectal excsison
4825941|NCT02468349|Acute Myocardial Infarction|acute myocardial infarction
4825942|NCT02468349|Telemedicine|telemedicine
4825943|NCT02468349|Readmissions|readmissions
4825944|NCT02468336|Physiology|physiology
4825945|NCT02468323|PONV|ponv
4825946|NCT02468323|Palonosetron|palonosetron
4825947|NCT02468323|Ondansetron|ondansetron
4825948|NCT02468323|Cesarean section|cesarean section
4825949|NCT02468310|Maternal mortality|maternal mortality
4825950|NCT02468310|Neonatal mortality|neonatal mortality
4825951|NCT02468310|Neonatal morbidity|neonatal morbidity
4825952|NCT02468310|Text messaging|text messaging
4825953|NCT02468310|Clinical decision making|clinical decision making
4825954|NCT02468310|Maternal Morbidity|maternal morbidity
4825955|NCT02468271|Clinimetrics|clinimetrics
4825956|NCT02468271|Lung function|lung function
4825957|NCT02468271|Lung clearance index|lung clearance index
4825958|NCT02468258|Assisted Reproduction|assisted reproduction
4825959|NCT02468245|Nursing intervention|nursing intervention
4825960|NCT02468245|compliance|compliance
4825961|NCT02468232|chronic heart failure|chronic heart failure
4825962|NCT02468232|cardiovascular death|cardiovascular death
4825963|NCT02468232|hospitalization|hospitalization
4825964|NCT02468232|outcome study|outcome study
4825965|NCT02468232|worsening heart failure|worsening heart failure
4825966|NCT02468232|NT-proBNP|nt-probnp
4825967|NCT02468232|NYHA|nyha
4825968|NCT02468232|KCCQ|kccq
4825969|NCT02468232|HF-rEF|hf-ref
4825970|NCT02468219|aortic stenosis|aortic stenosis
4825971|NCT02468219|aortic valve replacement|aortic valve replacement
4826071|NCT02467621|Pneumonia|pneumonia
4825972|NCT02468219|transcatheter aortic valve implantation|transcatheter aortic valve implantation
4825973|NCT02468219|frailty|frailty
4825974|NCT02468219|cardiac rehabilitation|cardiac rehabilitation
4825975|NCT02468193|Cushing's syndrome|cushing's syndrome
4825976|NCT02468193|osilodrostat|osilodrostat
4825977|NCT02468193|LCI699|lci699
4825978|NCT02468193|ectopic corticotropin syndrome|ectopic corticotropin syndrome
4825979|NCT02468193|adrenal adenoma|adrenal adenoma
4825980|NCT02468193|adrenal carcinoma|adrenal carcinoma
4825981|NCT02468193|ACTH-Independent Macronodular Adrenal Hyperplasia|acth-independent macronodular adrenal hyperplasia
4825982|NCT02468193|AIMAH|aimah
4825983|NCT02468193|Primary Pigmented Nodular Adrenal Dysplasia|primary pigmented nodular adrenal dysplasia
4825984|NCT02468193|PPNAD|ppnad
4825985|NCT02468128|Analgesic|analgesic
4825986|NCT02468128|Opioids|opioids
4825987|NCT02468128|Pain relief after surgery|pain relief after surgery
4825988|NCT02468128|Dinalbuphine|dinalbuphine
4825989|NCT02468128|Sebacoyl Dinalbuphine Ester|sebacoyl dinalbuphine ester
4825990|NCT02468128|SDE|sde
4825991|NCT02468128|SDN|sdn
4825992|NCT02468128|LT1001|lt1001
4825993|NCT02468102|Rivaroxaban|rivaroxaban
4825994|NCT02468102|Venous Thrombosis/Pulmonary Embolism|venous thrombosis/pulmonary embolism
4825995|NCT02468102|Stroke Prevention in Atrial Fibrillation|stroke prevention in atrial fibrillation
4825996|NCT02468102|Anticoagulants|anticoagulants
4825997|NCT02468102|Hematologic Agents|hematologic agents
4825998|NCT02468102|Therapeutic Uses|therapeutic uses
4825999|NCT02468102|Observational|observational
4826000|NCT02468102|Pulmonary Embolism|pulmonary embolism
4826001|NCT02468102|Venous Thrombosis|venous thrombosis
4826002|NCT02468102|Venous Thromboembolism|venous thromboembolism
4826003|NCT02468102|Intracranial Hemorrhages|intracranial hemorrhages
4826004|NCT02468102|Gastrointestinal Hemorrhage|gastrointestinal hemorrhage
4826005|NCT02468076|ERCP|ercp
4826006|NCT02468076|radiofrequency ablation|radiofrequency ablation
4826007|NCT02468076|obstructive jaundice|obstructive jaundice
4826008|NCT02468050|Anxiety|anxiety
4826009|NCT02468050|Depression|depression
4826010|NCT02468050|Exercise|exercise
4826011|NCT02468050|Breast Cancer|breast cancer
4826012|NCT02468050|Biopsy|biopsy
4826013|NCT02468050|Screening|screening
4826014|NCT02468050|Diagnosis|diagnosis
4826015|NCT02468037|iron|iron
4826016|NCT02468037|diabetes|diabetes
4826017|NCT02468037|phlebotomy|phlebotomy
4826018|NCT02467998|meaningful use|meaningful use
4826019|NCT02467998|electronic health records|electronic health records
4826020|NCT02467998|structured language|structured language
4826021|NCT02467998|NPWT|npwt
4826022|NCT02467998|PQRS|pqrs
4826023|NCT02467985|gynecological laparoscopic surgery|gynecological laparoscopic surgery
4826024|NCT02467972|Hunger and satiety|hunger and satiety
4826025|NCT02467972|Hormones gastrointestinal|hormones gastrointestinal
4826026|NCT02467972|Bowel movements|bowel movements
4826027|NCT02467959|emergency ultrasound|emergency ultrasound
4826028|NCT02467959|acute appendicitis|acute appendicitis
4826029|NCT02467959|bedside ultrasound|bedside ultrasound
4826030|NCT02467920|exenatide|exenatide
4826031|NCT02467920|glargine|glargine
4826032|NCT02467920|aspart 30|aspart 30
4826033|NCT02467894|Adherence|adherence
4826034|NCT02467894|Exercise|exercise
4826035|NCT02467881|Physical Activity|physical activity
4826036|NCT02467881|Sedentary|sedentary
4826037|NCT02467881|Lifestyle Intervention|lifestyle intervention
4826038|NCT02467868|Pegfilgrastim|pegfilgrastim
4826039|NCT02467868|Granulocyte Colony Stimulating Factor (G-CSF)|granulocyte colony stimulating factor (g-csf)
4826040|NCT02467868|Breast Cancer|breast cancer
4826041|NCT02467868|Neutropenia|neutropenia
4826042|NCT02467855|Drug therapy|drug therapy
4826043|NCT02467842|Influenza vaccine|influenza vaccine
4826044|NCT02467842|Quadrivalent|quadrivalent
4826045|NCT02467842|Inactivated cell culture-derived|inactivated cell culture-derived
4826046|NCT02467829|Cerebral Palsy|cerebral palsy
4826047|NCT02467829|Walking Aids|walking aids
4826048|NCT02467816|Secondary schools|secondary schools
4826049|NCT02467816|School lunch|school lunch
4826050|NCT02467816|Plate waste|plate waste
4826051|NCT02467803|humeral fracture|humeral fracture
4826052|NCT02467803|exercise|exercise
4826053|NCT02467803|musculoskeletal manipulations|musculoskeletal manipulations
4826054|NCT02467777|orthopaedics|orthopaedics
4826055|NCT02467777|post-operative warming|post-operative warming
4826056|NCT02467764|Knee|knee
4826057|NCT02467764|Knee osteoarthritis|knee osteoarthritis
4826058|NCT02467764|Knee replacement|knee replacement
4826059|NCT02467764|Hip|hip
4826060|NCT02467764|Hip osteoarthritis|hip osteoarthritis
4826061|NCT02467764|Hip replacement|hip replacement
4826062|NCT02467725|Preimplantation Embryo Development|preimplantation embryo development
4826063|NCT02467712|Fongal infection|fongal infection
4826064|NCT02467712|joint prosthesis|joint prosthesis
4826065|NCT02467712|prosthetic reconstruction|prosthetic reconstruction
4826066|NCT02467699|Knee|knee
4826067|NCT02467699|Knee osteoarthritis|knee osteoarthritis
4826068|NCT02467699|Knee replacement|knee replacement
4826069|NCT02467621|Stress ulcer prophylaxis|stress ulcer prophylaxis
4826070|NCT02467621|Proton pump inhibitor|proton pump inhibitor
4826072|NCT02467621|Clostridium difficile infection|clostridium difficile infection
4826073|NCT02467608|HUEXC030|huexc030
4826074|NCT02467608|Pulmonary Tuberculosis|pulmonary tuberculosis
4826075|NCT02467595|no muscle relaxant|no muscle relaxant
4826076|NCT02467595|rocuronium|rocuronium
4826077|NCT02467595|intubation condition|intubation condition
4826078|NCT02467595|tracheal intubation|tracheal intubation
4826079|NCT02467595|operating room time|operating room time
4826080|NCT02467595|low-dose rocuronium|low-dose rocuronium
4826081|NCT02467582|Aspirin|aspirin
4826082|NCT02467582|colon cancer|colon cancer
4826083|NCT02467582|stage II|stage ii
4826084|NCT02467582|stage III|stage iii
4826085|NCT02467582|PIK3CA|pik3ca
4826086|NCT02467582|double-blind|double-blind
4826087|NCT02467582|placebo|placebo
4826088|NCT02467582|Adjuvant Treatment|adjuvant treatment
4826089|NCT02467556|CRPS|crps
4826090|NCT02467556|intervention|intervention
4826091|NCT02467556|multimodal|multimodal
4826092|NCT02467543|Primary dysmenorrhea|primary dysmenorrhea
4826093|NCT02467543|Viburnum opulus 3X|viburnum opulus 3x
4826094|NCT02467543|Homoeopathic|homoeopathic
4826095|NCT02467530|end stage renal disease|end stage renal disease
4826096|NCT02467530|peritoneal dialysis (PD)|peritoneal dialysis (pd)
4826097|NCT02467530|advanced glycation end products|advanced glycation end products
4826098|NCT02467530|Gut Microbiota Inflammation|gut microbiota inflammation
4826099|NCT02467517|Neuropathic pain|neuropathic pain
4826100|NCT02467517|Ketamine|ketamine
4826101|NCT02467517|Magnesium sulfate|magnesium sulfate
4826102|NCT02467517|Quality of life|quality of life
4826103|NCT02467517|Anxiety and depression|anxiety and depression
4826104|NCT02467517|Mood and sleep|mood and sleep
4826105|NCT02467491|Exercise|exercise
4826106|NCT02467491|Technology|technology
4826107|NCT02467491|Aging|aging
4826108|NCT02467478|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
4826109|NCT02467478|Endothelial cells|endothelial cells
4826110|NCT02467478|Cellular biomarker|cellular biomarker
4826111|NCT02467478|endothelial dysfunction|endothelial dysfunction
4826112|NCT02467478|CD34+|cd34+
4826113|NCT02467478|Impaired renal function|impaired renal function
4826114|NCT02467465|Fasciosis plantar|fasciosis plantar
4826115|NCT02467465|physiotherapy|physiotherapy
4826116|NCT02467465|fascitis plantar|fascitis plantar
4826117|NCT02467465|dry needling|dry needling
4826118|NCT02467439|unaware intervention;|unaware intervention;
4826119|NCT02467439|contract sexual partner referral|contract sexual partner referral
4826120|NCT02467439|peer referral|peer referral
4826121|NCT02467426|Mesothelioma, malignant|mesothelioma, malignant
4826122|NCT02467426|Chemotherapy|chemotherapy
4826123|NCT02467413|Alzheimer's Disease|alzheimer's disease
4826124|NCT02467413|Vascular Dementia|vascular dementia
4826125|NCT02467400|bone formation|bone formation
4826126|NCT02467387|Non-ischemic Heart Failure|non-ischemic heart failure
4826127|NCT02467387|Stem Cells|stem cells
4826128|NCT02467374|OCD|ocd
4826129|NCT02467374|Neuroimaging|neuroimaging
4826130|NCT02467374|Fear Extinction|fear extinction
4826131|NCT02467374|Behavior Therapy|behavior therapy
4826132|NCT02467361|Neoplasms|neoplasms
4826133|NCT02467296|Sodium|sodium
4826134|NCT02467296|outcomes|outcomes
4826135|NCT02467283|chronic periodontitis|chronic periodontitis
4826136|NCT02467283|genetics|genetics
4826137|NCT02467283|microarray analysis|microarray analysis
4826138|NCT02467283|gingiva|gingiva
4826139|NCT02467283|genes|genes
4826140|NCT02467283|inflammation|inflammation
4826141|NCT02467270|Chronic Phase Chronic Myeloid Leukemia|chronic phase chronic myeloid leukemia
4826142|NCT02467270|Molecular Response|molecular response
4826143|NCT02467270|CML|cml
4826144|NCT02467270|Leukemia|leukemia
4826145|NCT02467270|Leukemia, Myeloid|leukemia, myeloid
4826146|NCT02467270|Leukemia, Myelogenous, Chronic, BCR-ABL Positive|leukemia, myelogenous, chronic, bcr-abl positive
4826147|NCT02467270|Neoplasms by Histologic Type|neoplasms by histologic type
4826148|NCT02467270|Neoplasms|neoplasms
4826149|NCT02467270|Myeloproliferative Disorders|myeloproliferative disorders
4826150|NCT02467270|Bone Marrow Diseases|bone marrow diseases
4826151|NCT02467270|Hematologic Diseases|hematologic diseases
4826152|NCT02467270|CP-CML|cp-cml
4826153|NCT02467244|Hypothyroidism|hypothyroidism
4826154|NCT02467244|Serum adiponectin|serum adiponectin
4826155|NCT02467244|hsCRP|hscrp
4826156|NCT02467244|Homeostatic Model Assessment (HOMA-IR)|homeostatic model assessment (homa-ir)
4826157|NCT02467244|Quantitative Insulin Sensitivity Check Index (QUICKI)|quantitative insulin sensitivity check index (quicki)
4826158|NCT02467244|Cardiovascular risk assessment scoring (Framingham scoring)|cardiovascular risk assessment scoring (framingham scoring)
4826159|NCT02467244|Levothyroxin|levothyroxin
4826160|NCT02467231|new diagnosis of cancer|new diagnosis of cancer
4826161|NCT02467231|chemotherapy|chemotherapy
4826162|NCT02467231|oncofertility|oncofertility
4826163|NCT02467231|alkylating agent|alkylating agent
4826164|NCT02467231|fertility preservation|fertility preservation
4826165|NCT02467231|fertility after cancer|fertility after cancer
4826166|NCT02467231|late effects|late effects
4826167|NCT02467218|Hyperbaric Oxygen Treatment|hyperbaric oxygen treatment
4826168|NCT02467218|Fibromyalgia|fibromyalgia
4826169|NCT02467218|Global Function|global function
4826170|NCT02467218|Sleep|sleep
4826171|NCT02467218|Chronic Pain|chronic pain
4826172|NCT02467218|Depression|depression
4826173|NCT02467218|Anxiety|anxiety
4826174|NCT02467205|Physical Activity|physical activity
4826175|NCT02467179|Arrhythmia|arrhythmia
4826176|NCT02467179|cavo-tricuspid isthmus|cavo-tricuspid isthmus
4826177|NCT02467179|atrial fibrillation|atrial fibrillation
4826178|NCT02467179|atrial fibrillation ablation|atrial fibrillation ablation
4826179|NCT02467166|esophagoscopy|esophagoscopy
4826180|NCT02467166|atrial fibrillation ablation|atrial fibrillation ablation
4826181|NCT02467166|radio frequency catheter ablation|radio frequency catheter ablation
4826182|NCT02467166|esophageal lesion|esophageal lesion
4826183|NCT02467166|arrhythmia|arrhythmia
4826184|NCT02467166|atrial fibrillation|atrial fibrillation
4826185|NCT02467166|AF|af
4826186|NCT02467166|esophageal damage|esophageal damage
4826187|NCT02467153|Sarcopenia|sarcopenia
4826188|NCT02467153|Older adult|older adult
4826189|NCT02467153|Vitamin D|vitamin d
4826190|NCT02467153|Physical activity|physical activity
4826191|NCT02467153|Muscle atrophy|muscle atrophy
4826192|NCT02467153|Muscle strength|muscle strength
4826193|NCT02467153|Physical function|physical function
4826194|NCT02467153|Frailty|frailty
4826195|NCT02467153|Osteoporosis|osteoporosis
4826196|NCT02467140|Inguinal hernia repair|inguinal hernia repair
4826197|NCT02467140|Hernia|hernia
4826198|NCT02467140|ProGrib self-fixating mesh|progrib self-fixating mesh
4826199|NCT02467140|Biological mesh|biological mesh
4826200|NCT02467140|Tack fixation|tack fixation
4826201|NCT02467101|cicatricial alopecia|cicatricial alopecia
4826202|NCT02467101|treatment|treatment
4826203|NCT02467101|placebo|placebo
4826204|NCT02467101|double-blind|double-blind
4826205|NCT02467088|PMS|pms
4826206|NCT02467088|Individualised homoeopathic treatment|individualised homoeopathic treatment
4826207|NCT02467088|Indian females|indian females
4826208|NCT02467075|CT, iodinated contrast, contrast-induced AKI, kidney injury|ct, iodinated contrast, contrast-induced aki, kidney injury
4826209|NCT02467062|4D flow|4d flow
4826210|NCT02467049|ECG|ecg
4826211|NCT02467049|Ultrasound|ultrasound
4826212|NCT02467049|Peripherally Inserted Central Catheters|peripherally inserted central catheters
4826213|NCT02467049|PICC|picc
4826214|NCT02467036|overweight children|overweight children
4826215|NCT02467036|overweight parents|overweight parents
4826216|NCT02467036|eating in the absence of hunger|eating in the absence of hunger
4826217|NCT02467036|families with overweight child|families with overweight child
4826218|NCT02467036|bmi|bmi
4826219|NCT02467036|body mass index|body mass index
4826220|NCT02467036|treatment|treatment
4826221|NCT02467036|behavioral treatment|behavioral treatment
4826222|NCT02467036|family based treatment|family based treatment
4826223|NCT02467036|experiments|experiments
4826224|NCT02467036|intervention|intervention
4826225|NCT02467036|psychophysiological response to food cues|psychophysiological response to food cues
4826226|NCT02467023|chronic critical illness|chronic critical illness
4826227|NCT02467023|strength training|strength training
4826228|NCT02467023|exercise|exercise
4826229|NCT02467023|sepsis|sepsis
4826230|NCT02467023|mechanical ventilation|mechanical ventilation
4826231|NCT02467010|Bortezomib|bortezomib
4826232|NCT02467010|cyclophosphamide|cyclophosphamide
4826233|NCT02467010|dexamethason|dexamethason
4826234|NCT02467010|multiple myeloma|multiple myeloma
4826235|NCT02466997|Vitiligo|vitiligo
4826236|NCT02466997|Tacrolimus|tacrolimus
4826237|NCT02466997|Face|face
4826238|NCT02466984|metoclopramide|metoclopramide
4826239|NCT02466984|subcutaneous route|subcutaneous route
4826240|NCT02466984|palliative care|palliative care
4826241|NCT02466984|pharmacology|pharmacology
4826242|NCT02466984|bioavailability|bioavailability
4826243|NCT02466984|nausea|nausea
4826244|NCT02466984|vomiting|vomiting
4826245|NCT02466958|depressed|depressed
4826246|NCT02466958|older adults|older adults
4826247|NCT02466958|antidepressants|antidepressants
4826248|NCT02466958|depression|depression
4826249|NCT02466958|MDD|mdd
4826250|NCT02466919|Helicobacter pylori|helicobacter pylori
4826251|NCT02466906|Stage III colon cancer|stage iii colon cancer
4826252|NCT02466906|rhGM-CSF|rhgm-csf
4826253|NCT02466906|Immunotherapy|immunotherapy
4826254|NCT02466906|Surgery|surgery
4826255|NCT02466906|Adjuvant chemotherapy|adjuvant chemotherapy
4826256|NCT02466880|Type 2|type 2
4826257|NCT02466880|NIDDM|niddm
4826258|NCT02466867|Ringworm|ringworm
4826259|NCT02466854|Bleeding|bleeding
4826260|NCT02466854|Acute Coronary Syndrome|acute coronary syndrome
4826261|NCT02466854|percutaneous coronary intervention|percutaneous coronary intervention
4826262|NCT02466854|1 year follow up|1 year follow up
4826263|NCT02466815|Healthy|healthy
4826264|NCT02466815|JNJ-42756493|jnj-42756493
4826265|NCT02466802|Advanced|advanced
4826266|NCT02466789|Bleeding Disorder, inherited|bleeding disorder, inherited
4826267|NCT02466789|Von Willebrands Disease|von willebrands disease
4826268|NCT02466789|Hematologic Test|hematologic test
4826269|NCT02466789|VWF|vwf
4826270|NCT02466789|VWD|vwd
4826271|NCT02466763|round window|round window
4826272|NCT02466763|cochlear implants|cochlear implants
4826273|NCT02466763|cochleostomy|cochleostomy
4826274|NCT02466737|axillary surgery|axillary surgery
4826275|NCT02466737|sentinel lymph node biopsy|sentinel lymph node biopsy
4826276|NCT02466711|gastric motility|gastric motility
4826277|NCT02466698|Colectomy|colectomy
4826278|NCT02466698|Surgical Procedures, Operative|surgical procedures, operative
4826279|NCT02466685|Bipolar|bipolar
4826280|NCT02466685|Depression|depression
4826281|NCT02466685|Cognition|cognition
4826282|NCT02466685|Cognitive|cognitive
4826283|NCT02466659|IXT|ixt
4826284|NCT02466646|Periodontal Debridement|periodontal debridement
4826285|NCT02466646|Gingival Crevicular Fluid|gingival crevicular fluid
4826286|NCT02466646|Aggressive Periodontitis|aggressive periodontitis
4826287|NCT02466646|Interleukin-1beta|interleukin-1beta
4826288|NCT02466646|Interleukin-17|interleukin-17
4826289|NCT02466620|Body Weight|body weight
4826290|NCT02466620|Resuscitation|resuscitation
4826291|NCT02466620|Pediatric weight estimation|pediatric weight estimation
4826292|NCT02466607|Retinal function|retinal function
4826293|NCT02466568|advanced|advanced
4826294|NCT02466568|metastatic|metastatic
4826295|NCT02466568|lung disease|lung disease
4826296|NCT02466568|adenocarcinoma|adenocarcinoma
4826297|NCT02466568|non-small cell lung cancer (NSCLC)|non-small cell lung cancer (nsclc)
4826298|NCT02466542|Esmolol|esmolol
4826299|NCT02466542|Pain|pain
4826300|NCT02466542|Anesthesia|anesthesia
4826301|NCT02466542|Analgesia|analgesia
4826302|NCT02466529|type 1 spinal muscular atrophy (SMA)|type 1 spinal muscular atrophy (sma)
4826303|NCT02466516|GS-4997|gs-4997
4826304|NCT02466516|Non-alcoholic fatty liver disease (NAFLD)|non-alcoholic fatty liver disease (nafld)
4826305|NCT02466516|Fibrosis|fibrosis
4826306|NCT02466516|Simtuzumab|simtuzumab
4826307|NCT02466477|Pharmacogenomic|pharmacogenomic
4826308|NCT02466477|Pharmacogenomic Testing|pharmacogenomic testing
4826309|NCT02466477|Pharmacogenomics|pharmacogenomics
4826310|NCT02466477|Genetic Testing|genetic testing
4826311|NCT02466477|Genetics|genetics
4826312|NCT02466477|Major Depressive Disorder|major depressive disorder
4826313|NCT02466477|GeneSight|genesight
4826314|NCT02466477|Enhanced GeneSight|enhanced genesight
4826315|NCT02466477|Psychotropic|psychotropic
4826316|NCT02466438|Antibiotics|antibiotics
4826317|NCT02466438|Piperacillin-tazobactam|piperacillin-tazobactam
4826318|NCT02466438|Resistant bacteria|resistant bacteria
4826319|NCT02466412|smoking|smoking
4826320|NCT02466412|nicotine absorption|nicotine absorption
4826321|NCT02466412|potential modified risk tobacco product|potential modified risk tobacco product
4826322|NCT02466412|cigarette|cigarette
4826323|NCT02466412|Carbon Heated Tobacco Product|carbon heated tobacco product
4826324|NCT02466373|clonidine|clonidine
4826325|NCT02466373|pharmacodynamics|pharmacodynamics
4826326|NCT02466373|pharmacokinetics|pharmacokinetics
4826327|NCT02466373|intensive care|intensive care
4826328|NCT02466373|delirium|delirium
4826329|NCT02466360|Non-specific chronic lower back pain|non-specific chronic lower back pain
4826330|NCT02466360|Physical activity|physical activity
4826331|NCT02466360|Self-exercises|self-exercises
4826332|NCT02466360|Brakes|brakes
4826333|NCT02466360|Levers|levers
4826334|NCT02466360|Adhesion|adhesion
4826335|NCT02466360|Self-care|self-care
4826336|NCT02466321|Inverse Reverse Shoulder|inverse reverse shoulder
4826337|NCT02466308|sustained acoustic medicine|sustained acoustic medicine
4826338|NCT02466308|therapeutic ultrasound|therapeutic ultrasound
4826339|NCT02466308|SAM|sam
4826340|NCT02466308|LITUS|litus
4826341|NCT02466269|Facial Nerve Injuries|facial nerve injuries
4826342|NCT02466256|Intraocular lens implantation|intraocular lens implantation
4826343|NCT02466243|JBT-101, lenabasum, dermatomyositis|jbt-101, lenabasum, dermatomyositis
4826344|NCT02466230|Magnetic stimulation of the brain|magnetic stimulation of the brain
4826345|NCT02466230|Antidepressant mechanisms|antidepressant mechanisms
4826346|NCT02466217|Auto-immune disease|auto-immune disease
4826347|NCT02466217|Auto-inflammatory disease|auto-inflammatory disease
4826348|NCT02466217|Omics|omics
4826349|NCT02466217|System biology|system biology
4826350|NCT02466191|nystagmus|nystagmus
4826351|NCT02466191|pharmacological trial|pharmacological trial
4826352|NCT02466191|multiple sclerosis|multiple sclerosis
4826353|NCT02466191|oscillopsia|oscillopsia
4826354|NCT02466165|cardiometabolic risk|cardiometabolic risk
4826355|NCT02466165|physical exercise|physical exercise
4826356|NCT02466152|PK|pk
4826357|NCT02466152|GSK2894512|gsk2894512
4826358|NCT02466152|Atopic Dermatitis|atopic dermatitis
4826359|NCT02466139|microbiology|microbiology
4826360|NCT02466139|c reactive protein|c reactive protein
4826361|NCT02466139|urgent cardiac surgery|urgent cardiac surgery
4826362|NCT02466126|Depression|depression
4826363|NCT02466126|brief Cognitive Behavioral Therapy (bCBT)|brief cognitive behavioral therapy (bcbt)
4826364|NCT02466126|Randomized Controlled Trial|randomized controlled trial
4826365|NCT02466074|Acetazolamide|acetazolamide
4826366|NCT02466074|Lesions|lesions
4826367|NCT02466074|Neurodegeneration|neurodegeneration
4826368|NCT02466074|Repair|repair
4826369|NCT02466061|BMI >= 30 kg/m2|bmi >= 30 kg/m2
4826370|NCT02466048|spinal fusion|spinal fusion
4826371|NCT02466048|bone graft|bone graft
4826372|NCT02466048|collagen|collagen
4826373|NCT02466009|Colorectal cancer|colorectal cancer
4826374|NCT02466009|metastatic colorectal cancer|metastatic colorectal cancer
4826375|NCT02466009|colorectal adenocarcinoma|colorectal adenocarcinoma
4826376|NCT02465996|barrier dysfunction|barrier dysfunction
4826377|NCT02465996|functional dyspepsia|functional dyspepsia
4826378|NCT02465996|Confocal Laser Endomicroscopic|confocal laser endomicroscopic
4826379|NCT02465996|therapeutic response|therapeutic response
4826380|NCT02465983|Pancreatic Cancer|pancreatic cancer
4826381|NCT02465983|CAR / CART|car / cart
4826382|NCT02465983|T cells|t cells
4826383|NCT02465983|Immunotherapy|immunotherapy
4826384|NCT02465983|Gene therapy|gene therapy
4826385|NCT02465983|Redirected T cells|redirected t cells
4826386|NCT02465983|Autologous T cells|autologous t cells
4826387|NCT02465970|Transcranial Direct Current Stimulation|transcranial direct current stimulation
4826388|NCT02465957|Merkel Cell Carcinoma|merkel cell carcinoma
4826389|NCT02465957|Neukoplast|neukoplast
4826390|NCT02465957|NK-92|nk-92
4826391|NCT02465957|Natural Killer Cell|natural killer cell
4826392|NCT02465957|MCC|mcc
4826393|NCT02465957|aNK|ank
4826394|NCT02465944|inflammation|inflammation
4826395|NCT02465931|Informed Consent|informed consent
4826396|NCT02465931|Fragile X Syndrome|fragile x syndrome
4826397|NCT02465931|Tablets|tablets
4826398|NCT02465931|Decisional Capacity|decisional capacity
4826399|NCT02465892|cancer|cancer
4826400|NCT02465892|stress|stress
4826401|NCT02465892|chronic pain|chronic pain
4826402|NCT02465892|anxiety|anxiety
4826403|NCT02465892|coping|coping
4826404|NCT02465892|balance|balance
4826405|NCT02465892|online course|online course
4826406|NCT02465892|psychosocial|psychosocial
4826407|NCT02465892|support|support
4826408|NCT02465892|tools|tools
4826409|NCT02465879|Psoriatic arthritis|psoriatic arthritis
4826410|NCT02465879|Ankylosing spondylitis|ankylosing spondylitis
4826411|NCT02465879|Rheumatoid arthritis|rheumatoid arthritis
4826412|NCT02465879|Seronegative|seronegative
4826413|NCT02465866|Plasma concentration|plasma concentration
4826414|NCT02465866|Time to plasma concentration|time to plasma concentration
4826415|NCT02465866|Elimination rate constant|elimination rate constant
4826416|NCT02465866|Elimination half life|elimination half life
4826417|NCT02465866|Area under the curve|area under the curve
4826418|NCT02465853|hemiplegic shoulder pain|hemiplegic shoulder pain
4826419|NCT02465853|quality of Life|quality of life
4826420|NCT02465853|stroke|stroke
4826421|NCT02465840|rehabilitation|rehabilitation
4826422|NCT02465840|functional MRI|functional mri
4826423|NCT02465814|Uterine fibroids|uterine fibroids
4826424|NCT02465814|Heavy Menstrual Bleeding|heavy menstrual bleeding
4826425|NCT02465788|Helos|helos
4826426|NCT02465788|Hair Removal|hair removal
4826427|NCT02465788|Hair Reduction|hair reduction
4826428|NCT02465775|non-invasive|non-invasive
4826429|NCT02465762|non-invasive|non-invasive
4826430|NCT02465749|Retinitis Pigmentosa|retinitis pigmentosa
4826431|NCT02465749|oxygen|oxygen
4826432|NCT02465749|blue light|blue light
4826433|NCT02465723|Intravoxel Incoherent Motion (IVIM)|intravoxel incoherent motion (ivim)
4826434|NCT02465723|Diffusion-weighted Magnetic Resonance|diffusion-weighted magnetic resonance
4826435|NCT02465723|Acid Sphingomyelinase/Ceramide Pathway Activation|acid sphingomyelinase/ceramide pathway activation
4826436|NCT02465723|15-104|15-104
4826437|NCT02465710|pelvic organ prolapse|pelvic organ prolapse
4826438|NCT02465710|pelvic floor reconstruction surgery|pelvic floor reconstruction surgery
4826439|NCT02465710|transvaginal mesh surgery|transvaginal mesh surgery
4826440|NCT02465710|Women|women
4826441|NCT02465710|Surgical treatment|surgical treatment
4826442|NCT02465697|Borderline Personality Disorder|borderline personality disorder
4826443|NCT02465697|Avoidant Personality Disorder|avoidant personality disorder
4826444|NCT02465697|Brain Imaging|brain imaging
4826445|NCT02465658|uterine prolapse|uterine prolapse
4826446|NCT02465658|cervical elongation|cervical elongation
4826447|NCT02465658|pelvic floor reconstruction surgery|pelvic floor reconstruction surgery
4826448|NCT02465541|Cancer Survivors|cancer survivors
4826449|NCT02465541|Yoga|yoga
4826450|NCT02465541|Endometrial Cancer|endometrial cancer
4826451|NCT02465528|ALK|alk
4826452|NCT02465528|NSCLC|nsclc
4826453|NCT02465528|hematological malignancy|hematological malignancy
4826454|NCT02465515|cardiovascular events /outcomes|cardiovascular events /outcomes
4826455|NCT02465515|Type 2 diabetes mellitus|type 2 diabetes mellitus
4826456|NCT02465515|albiglutide|albiglutide
4826457|NCT02465515|glucagon-like peptide-1 receptor agonist|glucagon-like peptide-1 receptor agonist
4826458|NCT02465502|Colorectal cancer|colorectal cancer
4826459|NCT02465502|Regorafenib|regorafenib
4826460|NCT02465489|deferiprone|deferiprone
4826461|NCT02465489|deferiprone extended release formulation|deferiprone extended release formulation
4826462|NCT02465489|pharmacokinetics|pharmacokinetics
4826463|NCT02465476|skin disease|skin disease
4826464|NCT02465476|telemedicine|telemedicine
4826465|NCT02465463|fecal microbiota transplant|fecal microbiota transplant
4826466|NCT02465463|probiotic|probiotic
4826467|NCT02465450|JBT-101, Lenabasum, Cystic Fibrosis|jbt-101, lenabasum, cystic fibrosis
4826468|NCT02465424|quality of life questionnaires|quality of life questionnaires
4826469|NCT02465398|Fracture shoulder arthroplasty|fracture shoulder arthroplasty
4826778|NCT02463864|exercise|exercise
4826470|NCT02465398|Three or four part fracture|three or four part fracture
4826471|NCT02465398|Hemiarthroplasty|hemiarthroplasty
4826472|NCT02465398|Multi-center|multi-center
4826473|NCT02465398|Europe|europe
4826474|NCT02465398|Non-controlled|non-controlled
4826475|NCT02465398|Anatomical reconstruction|anatomical reconstruction
4826476|NCT02465398|Proximal|proximal
4826477|NCT02465372|Physical Activity|physical activity
4826478|NCT02465372|Youth|youth
4826479|NCT02465372|School Health|school health
4826480|NCT02465346|acute stroke|acute stroke
4826481|NCT02465346|prehospital|prehospital
4826482|NCT02465346|treatment|treatment
4826483|NCT02465333|heel|heel
4826484|NCT02465333|atrophy|atrophy
4826485|NCT02465333|fat|fat
4826486|NCT02465333|adipose tissue|adipose tissue
4826487|NCT02465333|fat pad|fat pad
4826488|NCT02465307|Consciousness|consciousness
4826489|NCT02465307|Alertness|alertness
4826490|NCT02465307|Cognition|cognition
4826491|NCT02465307|Activity level|activity level
4826492|NCT02465307|Delirium|delirium
4826493|NCT02465307|Hyperactive delirium|hyperactive delirium
4826494|NCT02465307|Hypoactive delirium|hypoactive delirium
4826495|NCT02465307|Facial expression|facial expression
4826496|NCT02465307|Posture|posture
4826497|NCT02465307|Intensive care unit|intensive care unit
4826498|NCT02465294|Probiotics|probiotics
4826499|NCT02465294|Weight loss|weight loss
4826500|NCT02465294|Body composition|body composition
4826501|NCT02465255|Acute Abdominal Pain|acute abdominal pain
4826502|NCT02465255|Sublingual Analgesia|sublingual analgesia
4826503|NCT02465255|Children|children
4826504|NCT02465255|Ketorolac|ketorolac
4826505|NCT02465255|Tramadol|tramadol
4826506|NCT02465255|Paracetamol|paracetamol
4826507|NCT02465255|Analgesia|analgesia
4826508|NCT02465216|Tuberculosis|tuberculosis
4826509|NCT02465216|TB|tb
4826510|NCT02465216|Pulmonary|pulmonary
4826511|NCT02465216|Vaccine|vaccine
4826512|NCT02465216|Adjuvant|adjuvant
4826513|NCT02465203|Hepatitis C, chronic|hepatitis c, chronic
4826514|NCT02465190|Vaccine|vaccine
4826515|NCT02465190|Effectiveness|effectiveness
4826516|NCT02465190|Influenza|influenza
4826517|NCT02465177|Unhealthy alcohol use|unhealthy alcohol use
4826518|NCT02465177|ICU survivors|icu survivors
4826519|NCT02465177|Alcohol use disorder|alcohol use disorder
4826520|NCT02465177|SBIRT|sbirt
4826521|NCT02465177|Screening, brief intervention, and referral to treatment|screening, brief intervention, and referral to treatment
4826522|NCT02465034|Neural plasticity|neural plasticity
4826523|NCT02465034|Noninvasive brain stimulation|noninvasive brain stimulation
4826524|NCT02465034|Motor cortex|motor cortex
4826525|NCT02465021|Satiety|satiety
4826526|NCT02465021|Food intake|food intake
4826527|NCT02465021|Breakfast cereals/snacks|breakfast cereals/snacks
4826528|NCT02465021|Postprandial glycemia|postprandial glycemia
4826529|NCT02465008|postoperative|postoperative
4826530|NCT02465008|Patient-reported|patient-reported
4826531|NCT02464995|Asthma,|asthma,
4826532|NCT02464995|Asthma exacerbation|asthma exacerbation
4826533|NCT02464995|Bronchial thermoplasty|bronchial thermoplasty
4826789|NCT02463838|Care Coordination|care coordination
4826534|NCT02464969|VTE, thromboembolism, thrombosis, embolism, apixaban, Eliquis|vte, thromboembolism, thrombosis, embolism, apixaban, eliquis
4826535|NCT02464943|Aorta|aorta
4826536|NCT02464943|Thoracic|thoracic
4826537|NCT02464943|Aortic dissection|aortic dissection
4826538|NCT02464943|Type B|type b
4826539|NCT02464943|DeBakey type III|debakey type iii
4826540|NCT02464943|Endovascular|endovascular
4826541|NCT02464930|Blood|blood
4826542|NCT02464930|Cytology|cytology
4826543|NCT02464930|Esophagus|esophagus
4826544|NCT02464930|microRNA|microrna
4826545|NCT02464891|Atypical Hemolytic Uremic Syndrome|atypical hemolytic uremic syndrome
4826546|NCT02464891|CCX168|ccx168
4826547|NCT02464891|dialysis|dialysis
4826548|NCT02464891|C5aR antagonist|c5ar antagonist
4826549|NCT02464865|thiamine deficiency|thiamine deficiency
4826550|NCT02464865|obese children|obese children
4826551|NCT02464865|Thai|thai
4826552|NCT02464839|Fungal nails and feet infection|fungal nails and feet infection
4826553|NCT02464839|Onychomycosis|onychomycosis
4826554|NCT02464839|Hallux valgus|hallux valgus
4826555|NCT02464826|Onychomycosis|onychomycosis
4826556|NCT02464826|Chronic paronychia|chronic paronychia
4826557|NCT02464826|Treatment|treatment
4826558|NCT02464813|pregabalin|pregabalin
4826559|NCT02464813|idiopathic scoliosis|idiopathic scoliosis
4826560|NCT02464800|diabetic retinopathy|diabetic retinopathy
4826561|NCT02464787|antioxidants|antioxidants
4826562|NCT02464787|carotenoids|carotenoids
4826563|NCT02464787|diet|diet
4826564|NCT02464774|Breast Cancer|breast cancer
4826565|NCT02464774|Triple-Negative Breast Cancer|triple-negative breast cancer
4826566|NCT02464774|Breast-Conserving Therapy|breast-conserving therapy
4826567|NCT02464774|Mastectomy|mastectomy
4826568|NCT02464774|Recurrence|recurrence
4826569|NCT02464735|Sleep disruption|sleep disruption
4826570|NCT02464735|Spontaneous breathing trial|spontaneous breathing trial
4826571|NCT02464735|Weaning|weaning
4826572|NCT02464722|Remifentanil|remifentanil
4826573|NCT02464722|Dexmedetomidine|dexmedetomidine
4826574|NCT02464722|Endoscopic sinus surgery|endoscopic sinus surgery
4826575|NCT02464709|Actinic Keratosis|actinic keratosis
4826576|NCT02464709|Photodynamic Therapy|photodynamic therapy
4826577|NCT02464709|Natural Daylight|natural daylight
4826578|NCT02464696|Hematological Malignancies|hematological malignancies
4826579|NCT02464696|Hypoxemic Respiratory Failure|hypoxemic respiratory failure
4826580|NCT02464696|Blood cancer|blood cancer
4826581|NCT02464696|Non-invasive positive pressure ventilation|non-invasive positive pressure ventilation
4826582|NCT02464696|NIPPV|nippv
4826583|NCT02464696|High flow nasal cannula oxygen therapy|high flow nasal cannula oxygen therapy
4826584|NCT02464670|Ebola|ebola
4826585|NCT02464670|Vaccine|vaccine
4826586|NCT02464657|Leukemia|leukemia
4826587|NCT02464657|Acute myeloid leukemia|acute myeloid leukemia
4826588|NCT02464657|AML|aml
4826589|NCT02464657|Myelodysplastic Syndrome|myelodysplastic syndrome
4826590|NCT02464657|MDS|mds
4826591|NCT02464657|High-risk|high-risk
4826592|NCT02464657|Nivolumab|nivolumab
4826593|NCT02464657|BMS-936558|bms-936558
4826594|NCT02464657|Opdivo|opdivo
4826595|NCT02464657|Idarubicin|idarubicin
4826596|NCT02464657|Idamycin|idamycin
4826597|NCT02464657|Cytarabine|cytarabine
4826598|NCT02464657|Ara-C|ara-c
4826599|NCT02464657|Cytosar|cytosar
4826600|NCT02464657|DepoCyt|depocyt
4826601|NCT02464657|Cytosine Arabinosine Hydrochloride|cytosine arabinosine hydrochloride
4826602|NCT02464657|Solu-Medrol|solu-medrol
4826603|NCT02464657|Methylprednisolone|methylprednisolone
4826604|NCT02464657|Depo-Medrol|depo-medrol
4826605|NCT02464657|Medrol|medrol
4826606|NCT02464657|Dexamethasone|dexamethasone
4826607|NCT02464657|Decadron|decadron
4826608|NCT02464644|On-line Questionnaire|on-line questionnaire
4826609|NCT02464644|No travel|no travel
4826610|NCT02464644|Health|health
4826611|NCT02464644|Medicines|medicines
4826612|NCT02464644|Drugs|drugs
4826613|NCT02464644|Lifestyle|lifestyle
4826614|NCT02464644|Family|family
4826615|NCT02464644|Help for others|help for others
4826616|NCT02464644|Rare condition|rare condition
4826617|NCT02464644|General population|general population
4826618|NCT02464618|Colonoscopy|colonoscopy
4826619|NCT02464618|Upper endoscopy|upper endoscopy
4826620|NCT02464618|Adherence|adherence
4826621|NCT02464618|Disparities|disparities
4826622|NCT02464592|Cryoprobes|cryoprobes
4826623|NCT02464592|Transbronchial lung biopsy|transbronchial lung biopsy
4826624|NCT02464592|Cryobiopsy|cryobiopsy
4826625|NCT02464579|breastfeeding rate|breastfeeding rate
4826626|NCT02464579|preterm infant|preterm infant
4826627|NCT02464579|neonatal intensive care unit|neonatal intensive care unit
4826628|NCT02464553|Low Back Pain Pain|low back pain pain
4826629|NCT02464553|Periradicular therapy|periradicular therapy
4826630|NCT02464553|Spinal Stenosis with neurologic changes|spinal stenosis with neurologic changes
4826631|NCT02464540|laminate veneers|laminate veneers
4826632|NCT02464540|luting agent|luting agent
4826633|NCT02464527|Stimulus-stimulus pairing|stimulus-stimulus pairing
4826634|NCT02464514|Obesity|obesity
4826635|NCT02464514|Orexigen|orexigen
4826636|NCT02464514|Insulin|insulin
4826637|NCT02464514|Leptin|leptin
4826638|NCT02464514|Adiponectin|adiponectin
4826639|NCT02464514|Growth hormone replacement|growth hormone replacement
4826640|NCT02464501|PAD|pad
4826641|NCT02464501|COPPER-A|copper-a
4826642|NCT02464501|Peripheral Arterial Disease|peripheral arterial disease
4826643|NCT02464501|OPC|opc
4826644|NCT02464501|Occlusion Perfusion Catheter|occlusion perfusion catheter
4826645|NCT02464501|Paclitaxel|paclitaxel
4826646|NCT02464501|Pressana|pressana
4826647|NCT02464501|Precision Delivery System|precision delivery system
4826648|NCT02464488|Anticoagulants|anticoagulants
4826649|NCT02464488|Factor Xa Inhibitors|factor xa inhibitors
4826650|NCT02464488|Antithrombins|antithrombins
4826651|NCT02464488|Pharmacokinetics|pharmacokinetics
4826652|NCT02464488|Aged, 80 years and older|aged, 80 years and older
4826653|NCT02464475|osteopathic manipulative treatment|osteopathic manipulative treatment
4826654|NCT02464475|interoception|interoception
4826655|NCT02464462|serum calcidiol|serum calcidiol
4826656|NCT02464462|T2DM|t2dm
4826657|NCT02464462|vitamin D3 supplementation|vitamin d3 supplementation
4826658|NCT02464462|post-menopausal women|post-menopausal women
4826659|NCT02464462|ethnic diverse|ethnic diverse
4826660|NCT02464462|calcium supplementation|calcium supplementation
4826661|NCT02464449|Cognitive Behavioral Therapy|cognitive behavioral therapy
4826662|NCT02464449|Mobile Health Technology|mobile health technology
4826663|NCT02464449|Patient Care Management|patient care management
4826664|NCT02464436|RP|rp
4826665|NCT02464410|Opioid analgesics|opioid analgesics
4826666|NCT02464410|Primary care|primary care
4826667|NCT02464410|Veterans|veterans
4826668|NCT02464410|Motivational interviewing|motivational interviewing
4826669|NCT02464410|Cognitive behavioral therapy|cognitive behavioral therapy
4826670|NCT02464410|Self-efficacy|self-efficacy
4826671|NCT02464410|Behavioral symptoms|behavioral symptoms
4826672|NCT02464410|Injuries|injuries
4826673|NCT02464410|Opioid Safety|opioid safety
4826674|NCT02464397|Vascular healing of coronary stents in patients with acute coronary syndrome|vascular healing of coronary stents in patients with acute coronary syndrome
4826675|NCT02464384|ultrasound and cartilage biodegradation markers|ultrasound and cartilage biodegradation markers
4826676|NCT02464371|muscle weakness|muscle weakness
4826677|NCT02464371|microRNAs|micrornas
4826678|NCT02464371|septic shock|septic shock
4826679|NCT02464358|HPV|hpv
4826680|NCT02464345|BED|bed
4826681|NCT02464345|Binge Eating Disorer|binge eating disorer
4826682|NCT02464345|BN|bn
4826683|NCT02464345|Bulimia Nervosa|bulimia nervosa
4826684|NCT02464345|Obesity|obesity
4826685|NCT02464332|soft tissue sarcoma|soft tissue sarcoma
4826686|NCT02464332|BLZ-100|blz-100
4826687|NCT02464332|Tumor Paint|tumor paint
4826688|NCT02464306|recipients|recipients
4826689|NCT02464293|depression|depression
4826690|NCT02464293|anxiety|anxiety
4826691|NCT02464293|stress|stress
4826692|NCT02464280|Tomosynthesis|tomosynthesis
4826693|NCT02464280|osteosynthetic implant|osteosynthetic implant
4826694|NCT02464280|CT|ct
4826695|NCT02464280|monitoring|monitoring
4826696|NCT02464267|patient reported outcome instrument|patient reported outcome instrument
4826697|NCT02464254|Physical activity, positive affect, older adults, aging|physical activity, positive affect, older adults, aging
4826698|NCT02464228|PTCL|ptcl
4826699|NCT02464228|Lymphoma|lymphoma
4826700|NCT02464228|AITL|aitl
4826701|NCT02464215|gastric cancer|gastric cancer
4826702|NCT02464215|D2|d2
4826703|NCT02464215|laparoscopic|laparoscopic
4826704|NCT02464215|open|open
4826705|NCT02464215|surgery|surgery
4826706|NCT02464202|Tooth autotransplantation|tooth autotransplantation
4826707|NCT02464202|stereolithography tooth replica|stereolithography tooth replica
4826708|NCT02464202|CBCT|cbct
4826709|NCT02464202|Outcome|outcome
4826710|NCT02464176|Arthroplasty, Hip, Replacement|arthroplasty, hip, replacement
4826711|NCT02464176|Anesthesia, Local|anesthesia, local
4826712|NCT02464176|Anesthesia Conduction|anesthesia conduction
4826713|NCT02464176|Bupivacaine|bupivacaine
4826714|NCT02464176|Dexamethasone|dexamethasone
4826715|NCT02464176|Preanesthetic Medications|preanesthetic medications
4826716|NCT02464176|Nerve Block|nerve block
4826717|NCT02464176|Lumbar Plexus Block|lumbar plexus block
4826718|NCT02464176|Analgesia|analgesia
4826719|NCT02464176|Glucocorticoids|glucocorticoids
4826720|NCT02464176|Local Anesthetics|local anesthetics
4826721|NCT02464163|Influenza|influenza
4826722|NCT02464150|gluten|gluten
4826723|NCT02464150|antigen-specific T cells|antigen-specific t cells
4826724|NCT02464150|transcriptome|transcriptome
4826725|NCT02464098|Hematological Malignancies|hematological malignancies
4826726|NCT02464098|Solid Tumors|solid tumors
4826727|NCT02464098|Hematopoietic Stem Cell Transplantation (HSCT)|hematopoietic stem cell transplantation (hsct)
4826728|NCT02464098|Childhood Cancer|childhood cancer
4826729|NCT02464098|Polymerase Chain Reaction (PCR)|polymerase chain reaction (pcr)
4826730|NCT02464085|Stroke|stroke
4826731|NCT02464085|Upper limb|upper limb
4826732|NCT02464085|Neuroplastic change|neuroplastic change
4826733|NCT02464085|Longitudinal|longitudinal
4826734|NCT02464085|Function|function
4826735|NCT02464072|Parathyroidectomy|parathyroidectomy
4826736|NCT02464072|Renal Insufficiency, Chronic|renal insufficiency, chronic
4826737|NCT02464059|cathelicidin|cathelicidin
4826738|NCT02464059|vitamin D|vitamin d
4826739|NCT02464046|Insomnia|insomnia
4826740|NCT02464046|JNJ-42847922|jnj-42847922
4826741|NCT02464046|Placebo|placebo
4826742|NCT02464033|Diamyd|diamyd
4826743|NCT02464033|Diabetes|diabetes
4826744|NCT02464033|Juvenile Diabetes|juvenile diabetes
4826745|NCT02464033|Diabetes Type 1|diabetes type 1
4826746|NCT02464033|Type 1 Diabetes|type 1 diabetes
4826747|NCT02464033|Autoimmune Diabetes|autoimmune diabetes
4826748|NCT02464033|Insulin Dependent Diabetes|insulin dependent diabetes
4826749|NCT02464033|Type 1 Diabetes MellitusType 1 Diabetes Mellitus|type 1 diabetes mellitustype 1 diabetes mellitus
4826750|NCT02464033|rhGAD65|rhgad65
4826751|NCT02464033|GAD65|gad65
4826752|NCT02464033|GAD-Alum|gad-alum
4826753|NCT02464033|Diabetes Mellitus|diabetes mellitus
4826754|NCT02464033|Diabetes mellitus Type 1|diabetes mellitus type 1
4826755|NCT02464033|Glucose Metabolism Disorders|glucose metabolism disorders
4826756|NCT02464033|Metabolic Diseases|metabolic diseases
4826757|NCT02464033|Vitamin D|vitamin d
4826758|NCT02464033|Etanercept|etanercept
4826759|NCT02463955|flexible endoscopy|flexible endoscopy
4826760|NCT02463929|Diphenhydramine|diphenhydramine
4826761|NCT02463929|emergence agitation|emergence agitation
4826762|NCT02463929|pediatric anesthesia|pediatric anesthesia
4826763|NCT02463929|PAEDS|paeds
4826764|NCT02463929|Withdrawal|withdrawal
4826765|NCT02463903|Adaptation, Psychological|adaptation, psychological
4826766|NCT02463903|Heart Failure|heart failure
4826767|NCT02463903|Intervention Studies|intervention studies
4826768|NCT02463903|Quality of Life|quality of life
4826769|NCT02463903|Hospital Readmission|hospital readmission
4826770|NCT02463903|Depression|depression
4826771|NCT02463903|Anxiety|anxiety
4826772|NCT02463890|Sleep Apnea Syndromes|sleep apnea syndromes
4826773|NCT02463890|Sleep Apnea, Obstructives|sleep apnea, obstructives
4826774|NCT02463890|Training|training
4826775|NCT02463864|frailty|frailty
4826776|NCT02463864|older adult|older adult
4826777|NCT02463864|hospital|hospital
4826779|NCT02463864|randomised control trial|randomised control trial
4826780|NCT02463864|functional decline|functional decline
4826781|NCT02463851|Ablation|ablation
4826782|NCT02463851|Multi-electrode catheter PVAC|multi-electrode catheter pvac
4826783|NCT02463851|Single-tip catheter Contact Force|single-tip catheter contact force
4826784|NCT02463851|Holter|holter
4826785|NCT02463838|Medi-Cal|medi-cal
4826786|NCT02463838|Health Plan|health plan
4826787|NCT02463838|Frequent Users|frequent users
4826788|NCT02463838|Heavy users|heavy users
4826790|NCT02463838|Managed Care|managed care
4826791|NCT02463838|Case Management|case management
4826792|NCT02463838|Mental Health|mental health
4826793|NCT02463838|Substance Use|substance use
4826794|NCT02463838|Emergency Department|emergency department
4826795|NCT02463799|prostatic neoplasms|prostatic neoplasms
4826796|NCT02463799|castration-resistant|castration-resistant
4826797|NCT02463799|bone metastasis|bone metastasis
4826798|NCT02463799|radium-223|radium-223
4826799|NCT02463799|sipuleucel-T|sipuleucel-t
4826800|NCT02463773|ARDS, PEEP, Critical Care Ultrasound|ards, peep, critical care ultrasound
4826801|NCT02463747|Neutropenic fever|neutropenic fever
4826802|NCT02463747|extended infusion|extended infusion
4826803|NCT02463747|beta-lactam|beta-lactam
4826804|NCT02463747|empiric antibiotic treatment|empiric antibiotic treatment
4826805|NCT02463721|sbp|sbp
4826806|NCT02463721|culture|culture
4826807|NCT02463708|Care Giver|care giver
4826808|NCT02463708|Dementia|dementia
4826809|NCT02463695|partial vestibular deficit|partial vestibular deficit
4826810|NCT02463695|cortical vestibular evoked potential|cortical vestibular evoked potential
4826811|NCT02463682|Artificial Pancreas|artificial pancreas
4826812|NCT02463682|Diabetes Mellitus, Type 1|diabetes mellitus, type 1
4826813|NCT02463682|Autoimmune Diseases|autoimmune diseases
4826814|NCT02463682|Diabetes Mellitus|diabetes mellitus
4826815|NCT02463682|Endocrine System Diseases|endocrine system diseases
4826816|NCT02463682|Glucose Metabolism Disorders|glucose metabolism disorders
4826817|NCT02463682|Immune System Diseases|immune system diseases
4826818|NCT02463682|Metabolic Diseases|metabolic diseases
4826819|NCT02463669|Point-of-care ultrasound|point-of-care ultrasound
4826820|NCT02463630|basilar invagination|basilar invagination
4826821|NCT02463630|atlantoaxial dislocation|atlantoaxial dislocation
4826822|NCT02463630|surgery|surgery
4826823|NCT02463630|restoration technique|restoration technique
4826824|NCT02463591|Direct Thrombin Inhibitor|direct thrombin inhibitor
4826825|NCT02463591|Prothrombin Complex Concentrate|prothrombin complex concentrate
4826826|NCT02463591|Dabigatran Etexilate|dabigatran etexilate
4826827|NCT02463591|Beriplex|beriplex
4826828|NCT02463591|Shed Blood|shed blood
4826829|NCT02463591|Washed Blood|washed blood
4826830|NCT02463591|Fibrinopeptide A|fibrinopeptide a
4826831|NCT02463578|Pneumococcal infection|pneumococcal infection
4826832|NCT02463578|Invasive pneumococcal disease (IPD)|invasive pneumococcal disease (ipd)
4826833|NCT02463578|Pneumococcal vaccine|pneumococcal vaccine
4826834|NCT02463578|Vaccinology|vaccinology
4826835|NCT02463578|Immunocompromised|immunocompromised
4826836|NCT02463578|Auto-immune diseases|auto-immune diseases
4826837|NCT02463578|Systemic vasculitis|systemic vasculitis
4826838|NCT02463578|ANCA-associated vasculitis|anca-associated vasculitis
4826839|NCT02463565|nutritional assessment|nutritional assessment
4826840|NCT02463565|food survey|food survey
4826841|NCT02463565|hospitalized patients|hospitalized patients
4826842|NCT02463565|hospital food|hospital food
4826843|NCT02463539|Pneumococcal infection|pneumococcal infection
4826844|NCT02463539|Invasive pneumococcal disease (IPD)|invasive pneumococcal disease (ipd)
4826845|NCT02463539|Pneumococcal vaccine|pneumococcal vaccine
4826846|NCT02463539|Systemic vasculitis|systemic vasculitis
4826847|NCT02463539|ANCA-associated vasculitis|anca-associated vasculitis
4826848|NCT02463539|Vaccinology|vaccinology
4826849|NCT02463539|Immunocompromised|immunocompromised
4826850|NCT02463539|Auto-immune disease|auto-immune disease
4826851|NCT02463526|Shoulder Impingement Syndrome|shoulder impingement syndrome
4826852|NCT02463526|Mulligan's Mobilization with Movement|mulligan's mobilization with movement
4826853|NCT02463526|Physical Therapy|physical therapy
4826854|NCT02463513|Riboflavin|riboflavin
4826855|NCT02463513|Blood pressure|blood pressure
4826856|NCT02463513|MTHFR|mthfr
4826857|NCT02463513|Methylenetetrahydrofolate reductase|methylenetetrahydrofolate reductase
4826858|NCT02463448|Underactive Bladder|underactive bladder
4826859|NCT02463435|nutritional management|nutritional management
4826860|NCT02463435|olive oil|olive oil
4826861|NCT02463435|weight loss|weight loss
4826862|NCT02463435|body composition|body composition
4826863|NCT02463435|nutrigenomics|nutrigenomics
4826864|NCT02463435|polymorphisms|polymorphisms
4826865|NCT02463435|cardiovascular risk|cardiovascular risk
4826866|NCT02463435|sarcopenia|sarcopenia
4826867|NCT02463435|inflammation|inflammation
4826868|NCT02463435|food intake|food intake
4826869|NCT02463435|sedentary lifestyle|sedentary lifestyle
4826870|NCT02463435|patient adherence|patient adherence
4826871|NCT02463435|bone density|bone density
4826872|NCT02463396|MBCT|mbct
4826873|NCT02463396|Mindfulness|mindfulness
4826874|NCT02463396|ADHD|adhd
4826875|NCT02463383|PPAR-gamma|ppar-gamma
4826876|NCT02463383|estrogens|estrogens
4826877|NCT02463383|NSAIDS|nsaids
4826878|NCT02463383|polymorphism|polymorphism
4826879|NCT02463383|metabolomics|metabolomics
4826880|NCT02463357|Exercise, Aerobic|exercise, aerobic
4826881|NCT02463357|Cognitive Function|cognitive function
4826882|NCT02463344|Dry AMD|dry amd
4826883|NCT02463344|Geographic atrophy|geographic atrophy
4826884|NCT02463344|ASP7316|asp7316
4826885|NCT02463331|autoimmune hepatitis|autoimmune hepatitis
4826886|NCT02463331|chloroquine|chloroquine
4826887|NCT02463331|treatment|treatment
4826888|NCT02463318|Multiple sclerosis|multiple sclerosis
4826889|NCT02463318|SIRT1|sirt1
4826890|NCT02463318|MnSOD|mnsod
4826891|NCT02463318|Catalase|catalase
4826892|NCT02463318|Oxidative stress|oxidative stress
4826893|NCT02463318|Antioxidant enzyme|antioxidant enzyme
4826894|NCT02463305|Colitis, ulcerative|colitis, ulcerative
4826895|NCT02463305|Inflammatory bowel diseases|inflammatory bowel diseases
4826896|NCT02463292|quality of life|quality of life
4826897|NCT02463292|young adults|young adults
4826898|NCT02463292|congenital heart disease|congenital heart disease
4826899|NCT02463266|Primary Care|primary care
4826900|NCT02463266|Elderly|elderly
4826901|NCT02463266|Depression|depression
4826902|NCT02463253|Renal Biopsy|renal biopsy
4826903|NCT02463253|elevated serum creatinine|elevated serum creatinine
4826904|NCT02463253|proteinuria|proteinuria
4826905|NCT02463201|Sleep Apnea, Obstructive|sleep apnea, obstructive
4826906|NCT02463201|Pediatric Obesity|pediatric obesity
4826907|NCT02463188|Sleep|sleep
4826908|NCT02463188|Substance Use|substance use
4826909|NCT02463188|Adolescents|adolescents
4826910|NCT02463175|Fluid Therapy;|fluid therapy;
4826911|NCT02463175|Transesophageal Doppler|transesophageal doppler
4826912|NCT02463149|School health|school health
4826913|NCT02463136|Adolescence|adolescence
4826914|NCT02463136|Brain Development|brain development
4826915|NCT02463136|Neuroimaging|neuroimaging
4826916|NCT02463136|Neurofeedback|neurofeedback
4826917|NCT02463136|Anxiety|anxiety
4826918|NCT02463110|Acute Coronary Syndrome|acute coronary syndrome
4826919|NCT02463110|Depression|depression
4826920|NCT02463110|Coronary Artery Disease|coronary artery disease
4826921|NCT02463110|Myocardial Infarction|myocardial infarction
4826922|NCT02463110|Percutaneous Coronary Intervention|percutaneous coronary intervention
4826923|NCT02463019|hepatitis B virus|hepatitis b virus
4826924|NCT02463019|tenofovir|tenofovir
4826925|NCT02462967|Liver Cirrhosis|liver cirrhosis
4826926|NCT02462954|Contraception|contraception
4826927|NCT02462954|Vaginal Gel|vaginal gel
4826928|NCT02462954|Diaphragm|diaphragm
4826929|NCT02462941|Heart transplant|heart transplant
4826930|NCT02462941|Adenosine|adenosine
4826931|NCT02462941|Pediatrics|pediatrics
4826932|NCT02462863|Diabetes|diabetes
4826933|NCT02462863|fish oil|fish oil
4826934|NCT02462863|arginine|arginine
4826935|NCT02462863|hyperglycemia|hyperglycemia
4826936|NCT02462850|Pain|pain
4826937|NCT02462850|Nausea|nausea
4826938|NCT02462850|Vomiting|vomiting
4826939|NCT02462837|Ureteral Stents|ureteral stents
4826940|NCT02462837|Pain and Discomfort|pain and discomfort
4826941|NCT02462837|Bladder Storage Symptoms|bladder storage symptoms
4826942|NCT02462824|Peripheral Artery Disease|peripheral artery disease
4826943|NCT02462824|Peripheral Arterial Disease|peripheral arterial disease
4826944|NCT02462824|PAD|pad
4826945|NCT02462811|Pain|pain
4826946|NCT02462811|Nausea|nausea
4826947|NCT02462811|Vomiting|vomiting
4826948|NCT02462785|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
4826949|NCT02462785|Adolescents|adolescents
4826950|NCT02462785|Carbohydrate Counting|carbohydrate counting
4826951|NCT02462785|Glycemic Control|glycemic control
4826952|NCT02462785|Self-Management|self-management
4826953|NCT02462785|T1DM|t1dm
4826954|NCT02462772|Cabotegravir|cabotegravir
4826955|NCT02462772|safety|safety
4826956|NCT02462772|long-acting injectable|long-acting injectable
4826957|NCT02462772|HIV prevention|hiv prevention
4826958|NCT02462772|acceptability|acceptability
4826959|NCT02462759|EMBRACE|embrace
4826960|NCT02462759|Spinal Muscular Atrophy|spinal muscular atrophy
4826961|NCT02462759|SMA|sma
4826962|NCT02462746|Postpartum|postpartum
4826963|NCT02462746|Dietary Supplements|dietary supplements
4826964|NCT02462746|Breastfeeding Women|breastfeeding women
4826965|NCT02462733|Self-control|self-control
4826966|NCT02462733|Preschoolers|preschoolers
4826967|NCT02462733|Tools of the Mind|tools of the mind
4826968|NCT02462733|Playing to Learn|playing to learn
4826969|NCT02462681|ketamine|ketamine
4826970|NCT02462681|adjuvant|adjuvant
4826971|NCT02462681|paravertebral block|paravertebral block
4826972|NCT02462668|Bronchoscopy|bronchoscopy
4826973|NCT02462668|Intubation|intubation
4826974|NCT02462668|Noninvasive positive pressure ventilation|noninvasive positive pressure ventilation
4826975|NCT02462642|Brahmi, Cognition, Anxiety, Pharmacokinetics|brahmi, cognition, anxiety, pharmacokinetics
4826976|NCT02462629|central nervous system tumor|central nervous system tumor
4826977|NCT02462629|BLZ-100|blz-100
4826978|NCT02462629|pediatrics|pediatrics
4826979|NCT02462629|Tumor Paint|tumor paint
4826980|NCT02462629|brain cancer|brain cancer
4826981|NCT02462629|tozuleristide|tozuleristide
4826982|NCT02462616|risk analysis|risk analysis
4826983|NCT02462616|general Chinese population|general chinese population
4826984|NCT02462616|cardiovascular autonomic neuropathy|cardiovascular autonomic neuropathy
4826985|NCT02462603|Parkinson's Disease|parkinson's disease
4826986|NCT02462603|PD|pd
4826987|NCT02462603|EPI-589|epi-589
4826988|NCT02462603|EPI589|epi589
4826989|NCT02462590|Probiotics|probiotics
4826990|NCT02462590|Ventilator Associated Pneumonia|ventilator associated pneumonia
4826991|NCT02462590|Infections|infections
4826992|NCT02462590|C-Difficile|c-difficile
4826993|NCT02462590|Antibiotic-associated Diarrhea|antibiotic-associated diarrhea
4826994|NCT02462590|Diarrhea|diarrhea
4826995|NCT02462577|Local morphine|local morphine
4826996|NCT02462577|Postmastectomy pain|postmastectomy pain
4826997|NCT02462564|peritoneal surface malignancies|peritoneal surface malignancies
4826998|NCT02462564|Post operative cognitive dysfunction|post operative cognitive dysfunction
4826999|NCT02462551|Depression|depression
4827000|NCT02462551|Treatment Resistant Depression|treatment resistant depression
4827001|NCT02462525|relapsed multiple myeloma|relapsed multiple myeloma
4827002|NCT02462525|antibody drug conjugate|antibody drug conjugate
4827003|NCT02462525|refractory multiple myeloma|refractory multiple myeloma
4827004|NCT02462512|Elastography|elastography
4827005|NCT02462512|Thyroid nodule|thyroid nodule
4827006|NCT02462473|Schizophrenia|schizophrenia
4827007|NCT02462473|Schizoaffective Disorder|schizoaffective disorder
4827008|NCT02462473|Aripiprazole|aripiprazole
4827009|NCT02462473|Olanzapine|olanzapine
4827010|NCT02462473|Paliperidone|paliperidone
4827011|NCT02462473|Quetiapine|quetiapine
4827012|NCT02462473|Risperidone|risperidone
4827013|NCT02462473|Liquid Chromatography-Tandem Mass Spectrometry|liquid chromatography-tandem mass spectrometry
4827014|NCT02462460|Breast MRI|breast mri
4827015|NCT02462460|T1 weighted and diffusion weighted MR|t1 weighted and diffusion weighted mr
4827016|NCT02462460|screening pancreatic|screening pancreatic
4827017|NCT02462460|screening ovarian|screening ovarian
4827018|NCT02462460|15-120|15-120
4827019|NCT02462447|prostate|prostate
4827020|NCT02462447|cancer|cancer
4827021|NCT02462447|biopsy|biopsy
4827022|NCT02462447|PET|pet
4827023|NCT02462434|Pediatric palliative care|pediatric palliative care
4827024|NCT02462421|SGLT2|sglt2
4827025|NCT02462421|SLC5A2|slc5a2
4827026|NCT02462421|SLC5A4|slc5a4
4827027|NCT02462421|SLC5A9|slc5a9
4827028|NCT02462421|SLC2A9|slc2a9
4827029|NCT02462421|GLUT9|glut9
4827030|NCT02462421|SGLT3|sglt3
4827031|NCT02462421|SGLT4|sglt4
4827032|NCT02462421|pharmacogenomics|pharmacogenomics
4827033|NCT02462356|CVATS|cvats
4827034|NCT02462356|UVATS|uvats
4827035|NCT02462356|perioperative effect|perioperative effect
4827036|NCT02462356|ergonomic influence|ergonomic influence
4827037|NCT02462330|Mesenchymal stem cells|mesenchymal stem cells
4827038|NCT02462330|ischemic cardiomyopathy|ischemic cardiomyopathy
4827039|NCT02462330|NogaStar XP system catheter|nogastar xp system catheter
4827040|NCT02462317|Spasticity|spasticity
4827041|NCT02462317|Post stroke motor recovery|post stroke motor recovery
4827042|NCT02462317|Botulinum toxin|botulinum toxin
4827043|NCT02462317|Baclofen|baclofen
4827044|NCT02462317|Pharmacological modulation|pharmacological modulation
4827045|NCT02462304|Diabetic Macula Edema|diabetic macula edema
4827046|NCT02462304|End-Point-Management|end-point-management
4827047|NCT02462304|ranibizumab|ranibizumab
4827048|NCT02462304|bevacizumab|bevacizumab
4827049|NCT02462291|Neurological Disorders|neurological disorders
4827050|NCT02462291|Non Pharmacological Treatment|non pharmacological treatment
4827051|NCT02462291|Ecological Therapy|ecological therapy
4827052|NCT02462278|Fertility|fertility
4827053|NCT02462278|Continuous temperature monitor|continuous temperature monitor
4827054|NCT02462278|Basal Body Temperature|basal body temperature
4827055|NCT02462278|Natural family planning|natural family planning
4827056|NCT02462239|Muscle-invasive bladder cancer|muscle-invasive bladder cancer
4827057|NCT02462239|Bladder cancer|bladder cancer
4827058|NCT02462239|PET imaging|pet imaging
4827060|NCT02462213|Cardiac amyloidosis|cardiac amyloidosis
4827061|NCT02462213|Cardiac MRI|cardiac mri
4827062|NCT02462213|Infiltrative cardiomyopathies|infiltrative cardiomyopathies
4827063|NCT02462187|genital warts|genital warts
4827064|NCT02462187|perianal warts|perianal warts
4827065|NCT02462174|anesthesia|anesthesia
4827066|NCT02462174|analgesia|analgesia
4827067|NCT02462174|caudal|caudal
4827068|NCT02462174|ketamine|ketamine
4827069|NCT02462174|bupivacaine|bupivacaine
4827070|NCT02462148|Anesthesia|anesthesia
4827071|NCT02462148|Anesthesia, Conduction|anesthesia, conduction
4827072|NCT02462148|Anesthesia, Local|anesthesia, local
4827073|NCT02462148|Bupivacaine|bupivacaine
4827074|NCT02462148|Dexamethasone|dexamethasone
4827075|NCT02462148|Saphenous|saphenous
4827076|NCT02462148|Adductor Canal|adductor canal
4827077|NCT02462148|Nerve Block|nerve block
4827078|NCT02462148|Analgesia|analgesia
4827079|NCT02462148|Preanesthetic Medication|preanesthetic medication
4827080|NCT02462148|Perioperative Period|perioperative period
4827081|NCT02462148|Peripheral Nerve Block|peripheral nerve block
4827082|NCT02462135|Mild cognitive impairment|mild cognitive impairment
4827083|NCT02462135|Memory training|memory training
4827084|NCT02462135|Randomized controlled study|randomized controlled study
4827085|NCT02462044|Computed tomography|computed tomography
4827086|NCT02462044|Coronary CTA|coronary cta
4827087|NCT02462044|Contrast media|contrast media
4827088|NCT02462018|Cerebral Palsy|cerebral palsy
4827089|NCT02462018|Muscle Spasticity|muscle spasticity
4827090|NCT02462018|Orthoses|orthoses
4827091|NCT02462018|Functional Electrical Stimulation|functional electrical stimulation
4827092|NCT02462018|Prospective|prospective
4827093|NCT02461992|FVIII activity|fviii activity
4827094|NCT02461953|hemodialysis|hemodialysis
4827095|NCT02461953|hemoperfusion|hemoperfusion
4827096|NCT02461953|quality of life|quality of life
4827097|NCT02461940|Sexual behavior|sexual behavior
4827098|NCT02461940|condom use|condom use
4827099|NCT02461940|secondary abstinence|secondary abstinence
4827100|NCT02461914|Type 2 diabetes mellitus|type 2 diabetes mellitus
4827101|NCT02461901|clostridium difficile|clostridium difficile
4827102|NCT02461901|environment|environment
4827103|NCT02461901|contamination|contamination
4827104|NCT02461901|fidaxomicin|fidaxomicin
4827105|NCT02461888|Relapsed|relapsed
4827106|NCT02461888|Refractory|refractory
4827107|NCT02461888|Cyclophosphamide|cyclophosphamide
4827108|NCT02461888|Dexamethasone|dexamethasone
4827109|NCT02461875|OHSS|ohss
4827110|NCT02461875|Infertility|infertility
4827111|NCT02461875|Cabergoline|cabergoline
4827112|NCT02461875|GnRH antagonist|gnrh antagonist
4827113|NCT02461875|IVF-ET|ivf-et
4827114|NCT02461862|Contraception|contraception
4827115|NCT02461862|Contraception Behavior|contraception behavior
4827116|NCT02461862|Intra uterine device|intra uterine device
4827117|NCT02461862|Intra uterine System|intra uterine system
4827118|NCT02461862|IUD|iud
4827119|NCT02461862|IUS|ius
4827120|NCT02461862|Acute Pain|acute pain
4827121|NCT02461771|AMD|amd
4827122|NCT02461771|Wet AMD|wet amd
4827123|NCT02461771|Neovascular AMD|neovascular amd
4827124|NCT02461745|VIEKIRA PAK|viekira pak
4827125|NCT02461732|posttraumatic stress disorder|posttraumatic stress disorder
4827126|NCT02461732|PTSD|ptsd
4827127|NCT02461732|substance dependence|substance dependence
4827128|NCT02461732|substance use|substance use
4827129|NCT02461706|Drug resistant epilepsy|drug resistant epilepsy
4827130|NCT02461693|Vigilance|vigilance
4827131|NCT02461693|Mood|mood
4827132|NCT02461693|Randomized Controlled Trial|randomized controlled trial
4827133|NCT02461693|Probability|probability
4827134|NCT02461680|partial section of the flexor tendons|partial section of the flexor tendons
4827135|NCT02461667|alendronate, metformin|alendronate, metformin
4827136|NCT02461641|amniotic tissue|amniotic tissue
4827137|NCT02461641|diabetic foot ulcer|diabetic foot ulcer
4827138|NCT02461641|Affinity|affinity
4827139|NCT02461641|NuShield|nushield
4827140|NCT02461628|Malaria|malaria
4827141|NCT02461628|Antimalarial subsidy|antimalarial subsidy
4827142|NCT02461628|Malaria rapid diagnostic test (RDT)|malaria rapid diagnostic test (rdt)
4827143|NCT02461628|Public-private partnership|public-private partnership
4827144|NCT02461628|Community health workers|community health workers
4827145|NCT02461615|Pulmonary Surfactant|pulmonary surfactant
4827146|NCT02461615|Rare Lung Disease|rare lung disease
4827147|NCT02461615|Registry|registry
4827148|NCT02461602|Warfarin|warfarin
4827149|NCT02461576|HIV-1|hiv-1
4827150|NCT02461550|Irreversible Electroporation Ablation|irreversible electroporation ablation
4827151|NCT02461550|15-001|15-001
4827152|NCT02461498|Warfarin|warfarin
4827153|NCT02461485|adults|adults
4827154|NCT02461485|moderate constipation|moderate constipation
4827155|NCT02461472|risk factors|risk factors
4827156|NCT02461472|risk analysis|risk analysis
4827157|NCT02461472|diabetic cardiovascular autonomic neuropathy|diabetic cardiovascular autonomic neuropathy
4827158|NCT02461472|general Chinese population|general chinese population
4827159|NCT02461459|Tuberous Sclerosis Complex|tuberous sclerosis complex
4827160|NCT02461459|TSC|tsc
4827161|NCT02461459|Autism|autism
4827162|NCT02461459|ASD|asd
4827163|NCT02461459|Intellectual Disability|intellectual disability
4827164|NCT02461459|ID|id
4827165|NCT02461459|MRI|mri
4827166|NCT02461446|germline heterozygous PTEN mutations|germline heterozygous pten mutations
4827167|NCT02461446|MRI|mri
4827168|NCT02461446|10q23.3|10q23.3
4827169|NCT02461446|ASD|asd
4827170|NCT02461446|Autism|autism
4827171|NCT02461446|Macrocephaly|macrocephaly
4827172|NCT02461446|PTEN Hamartoma Tumor Syndrome|pten hamartoma tumor syndrome
4827173|NCT02461446|PTEN|pten
4827174|NCT02461433|Obesity|obesity
4827175|NCT02461433|Obese|obese
4827176|NCT02461433|surgical site infection|surgical site infection
4827177|NCT02461433|closed incisions|closed incisions
4827178|NCT02461433|negative pressure therapy|negative pressure therapy
4827179|NCT02461420|Phelan-McDermid Syndrome|phelan-mcdermid syndrome
4827180|NCT02461420|PMS|pms
4827181|NCT02461420|Genotype|genotype
4827182|NCT02461420|Phenotype|phenotype
4827183|NCT02461420|Natural History|natural history
4827184|NCT02461420|Mapping|mapping
4827185|NCT02461420|22q13 Deletion Syndrome|22q13 deletion syndrome
4827186|NCT02461420|SHANK3|shank3
4827187|NCT02461420|Autism Spectrum Disorder|autism spectrum disorder
4827188|NCT02461420|ASD|asd
4827189|NCT02461420|Intellectual Disability|intellectual disability
4827190|NCT02461420|ID|id
4827191|NCT02461381|Bayesian estimation, short-term heart rate variability, diabetic cardiovascular autonomic neuropathy, diagnostic performance|bayesian estimation, short-term heart rate variability, diabetic cardiovascular autonomic neuropathy, diagnostic performance
4827192|NCT02461381|Diagnostic performance|diagnostic performance
4827193|NCT02461381|short-term heart rate variability|short-term heart rate variability
4827194|NCT02461381|diabetic cardiovascular autonomic neuropathy|diabetic cardiovascular autonomic neuropathy
4827195|NCT02461381|DCAN|dcan
4827196|NCT02461342|Genetic|genetic
4827197|NCT02461342|environment|environment
4827198|NCT02461342|interaction analysis|interaction analysis
4827199|NCT02461342|cardiovascular autonomic neuropathy|cardiovascular autonomic neuropathy
4827200|NCT02461342|CAN|can
4827201|NCT02461329|Hip Replacement, Total|hip replacement, total
4827202|NCT02461329|Gelatine solution|gelatine solution
4827203|NCT02461329|Balanced Crystaloid Solution|balanced crystaloid solution
4827204|NCT02461329|Volume therapy|volume therapy
4827205|NCT02461329|Platelet aggregation|platelet aggregation
4827206|NCT02461303|Klinefelter|klinefelter
4827207|NCT02461303|Spermatogenesis|spermatogenesis
4827208|NCT02461303|Puberty|puberty
4827209|NCT02461303|Fertility|fertility
4827210|NCT02461277|postoperative care|postoperative care
4827211|NCT02461277|exercise test|exercise test
4827212|NCT02461277|early ambulation|early ambulation
4827213|NCT02461277|Fast-track|fast-track
4827214|NCT02461251|Thromboelastometry|thromboelastometry
4827215|NCT02461251|Obstetric Hemorrhage|obstetric hemorrhage
4827216|NCT02461251|Blood Component Transfusion|blood component transfusion
4827217|NCT02461212|HepaFat-Scan|hepafat-scan
4827218|NCT02461212|Liver Disease|liver disease
4827219|NCT02461212|Pediatrics|pediatrics
4827220|NCT02461199|Fecal microbiota transplantation|fecal microbiota transplantation
4827221|NCT02461199|Gut colonization|gut colonization
4827222|NCT02461199|Multidrug-resistant bacteria|multidrug-resistant bacteria
4827223|NCT02461199|Blood disorders|blood disorders
4827224|NCT02461199|Drug Resistance, Multiple|drug resistance, multiple
4827225|NCT02461199|Disease Eradication|disease eradication
4827226|NCT02461186|Arterolane-piperaquine|arterolane-piperaquine
4827227|NCT02461186|Dehydroartemisinin-piperaquine|dehydroartemisinin-piperaquine
4827228|NCT02461186|therapeutic efficacy|therapeutic efficacy
4827229|NCT02461186|Uncomplicated falciparum malaria|uncomplicated falciparum malaria
4827230|NCT02461186|Artemisinin-resistant|artemisinin-resistant
4827231|NCT02461160|Drug therapy|drug therapy
4827232|NCT02461134|GVHD|gvhd
4827233|NCT02461134|ponesimod|ponesimod
4827234|NCT02461121|Acute Myeloid Leukemia|acute myeloid leukemia
4827235|NCT02461121|microtransplantationHLA-mismatched microtransplantation|microtransplantationhla-mismatched microtransplantation
4827236|NCT02461121|nonmyeloablative stem cell transplantation|nonmyeloablative stem cell transplantation
4827237|NCT02461121|graft-versus-host disease|graft-versus-host disease
4827238|NCT02461108|Public policy|public policy
4827239|NCT02461108|Food choice|food choice
4827240|NCT02461108|Nutrition labeling|nutrition labeling
4827241|NCT02461108|Fat tax|fat tax
4827242|NCT02461108|Vegetable subsidy|vegetable subsidy
4827243|NCT02461108|Behavioral economics|behavioral economics
4827244|NCT02461108|Health behavior|health behavior
4827245|NCT02461069|dimethyl fumarate|dimethyl fumarate
4827246|NCT02461056|ibuprofen|ibuprofen
4827247|NCT02461056|hydromorphone|hydromorphone
4827248|NCT02461056|drug interactions|drug interactions
4827249|NCT02461043|esophageal cancer|esophageal cancer
4827250|NCT02461043|adjuvant chemotherapy|adjuvant chemotherapy
4827251|NCT02461043|esophageal surgery|esophageal surgery
4827252|NCT02461043|paclitaxel|paclitaxel
4827253|NCT02461030|Dentin hypersensitivity|dentin hypersensitivity
4827254|NCT02461030|Periodontal disease|periodontal disease
4827255|NCT02461030|Arginine|arginine
4827256|NCT02461017|intubation|intubation
4827257|NCT02461017|ventilation|ventilation
4827258|NCT02461017|airway|airway
4827259|NCT02461017|airleak|airleak
4827260|NCT02461004|Dyslipidemia|dyslipidemia
4827261|NCT02461004|CKD-391|ckd-391
4827262|NCT02461004|Atorvastatin|atorvastatin
4827263|NCT02461004|Ezetimibe|ezetimibe
4827264|NCT02460978|Dapagliflozin|dapagliflozin
4827265|NCT02460978|Efficacy|efficacy
4827266|NCT02460978|Safety|safety
4827267|NCT02460978|Add on to insulin|add on to insulin
4827268|NCT02460978|Oral Antidiabetic|oral antidiabetic
4827269|NCT02460978|Type 1 diabetes|type 1 diabetes
4827270|NCT02460952|Pulmonary Embolism;|pulmonary embolism;
4827271|NCT02460952|perioperative period;|perioperative period;
4827272|NCT02460952|general anesthesia|general anesthesia
4827273|NCT02460939|Pulmonary Vessel Disease|pulmonary vessel disease
4827274|NCT02460939|metabolism of small molecules|metabolism of small molecules
4827275|NCT02460926|Scaling and root planning|scaling and root planning
4827276|NCT02460926|C-reactive protein|c-reactive protein
4827277|NCT02460913|acupuncture|acupuncture
4827278|NCT02460913|morphine|morphine
4827279|NCT02460913|acute pain|acute pain
4827280|NCT02460887|nasopharyngeal carcinoma|nasopharyngeal carcinoma
4827281|NCT02460887|induction chemotherapy|induction chemotherapy
4827282|NCT02460874|Brain Metastases|brain metastases
4827283|NCT02460874|Stereotactic Radiosurgery|stereotactic radiosurgery
4827284|NCT02460874|Glyburide|glyburide
4827285|NCT02460861|Prostate Cancer|prostate cancer
4827286|NCT02460861|Molecular staging|molecular staging
4827287|NCT02460861|GSTP1|gstp1
4827288|NCT02460861|Surgical margins|surgical margins
4827289|NCT02460861|prostatovesiculectomy|prostatovesiculectomy
4827290|NCT02460848|Malnutrition|malnutrition
4827291|NCT02460848|Severe Acute Malnutrition|severe acute malnutrition
4827292|NCT02460848|Cash Transfer|cash transfer
4827293|NCT02460848|Democratic Republic of Congo|democratic republic of congo
4827294|NCT02460848|Cluster randomize trial|cluster randomize trial
4827295|NCT02460796|Parkinson's disease|parkinson's disease
4827296|NCT02460796|Quality of life|quality of life
4827297|NCT02460796|Gait velocity|gait velocity
4827298|NCT02460796|Capacity|capacity
4827299|NCT02460783|Biomarkers|biomarkers
4827300|NCT02460783|Diabetes|diabetes
4827301|NCT02460783|Obesity|obesity
4827302|NCT02460783|Dementia of the Alzheimer Type|dementia of the alzheimer type
4827303|NCT02460783|Functional Magnetic Resonance Imaging (fMRI)|functional magnetic resonance imaging (fmri)
4827304|NCT02460770|Left Ventricular Assist Device|left ventricular assist device
4827305|NCT02460770|stem cell therapy|stem cell therapy
4827306|NCT02460770|ischemic heart failure|ischemic heart failure
4827307|NCT02460757|glottic movement|glottic movement
4827308|NCT02460757|emphysema|emphysema
4827309|NCT02460757|copd|copd
4827310|NCT02460757|vocal cord|vocal cord
4827311|NCT02460744|Breast cancer|breast cancer
4827312|NCT02460744|hypofractionation|hypofractionation
4827313|NCT02460744|radiotherapy|radiotherapy
4827314|NCT02460731|PSP|psp
4827315|NCT02460731|Young Plasma|young plasma
4827316|NCT02460718|diabetes mellitus|diabetes mellitus
4827317|NCT02460718|peer support|peer support
4827318|NCT02460718|pragmatic clinical trial|pragmatic clinical trial
4827319|NCT02460666|depressed|depressed
4827320|NCT02460666|older adults|older adults
4827321|NCT02460666|Major Depressive Disorder|major depressive disorder
4827322|NCT02460666|Tai-Chi|tai-chi
4827323|NCT02460666|geriatric|geriatric
4827324|NCT02460653|High flow nasal cannula|high flow nasal cannula
4827325|NCT02460653|Oxygen therapy|oxygen therapy
4827326|NCT02460653|Ventilation|ventilation
4827327|NCT02460640|Minimally invasive surgery|minimally invasive surgery
4827328|NCT02460640|Partial nephrectomy|partial nephrectomy
4827329|NCT02460627|Arthroscopy|arthroscopy
4827330|NCT02460627|Meniscus|meniscus
4827331|NCT02460627|Lidocaine|lidocaine
4827332|NCT02460614|bronchiolitis|bronchiolitis
4827333|NCT02460614|respiratory physiotherapy|respiratory physiotherapy
4827334|NCT02460614|pediatrics|pediatrics
4827335|NCT02460614|rhinopharyngeal clearance|rhinopharyngeal clearance
4827336|NCT02460575|Safety|safety
4827337|NCT02460562|resin denture base|resin denture base
4827338|NCT02460549|therapeutic patient education|therapeutic patient education
4827339|NCT02460549|insulinoresistance|insulinoresistance
4827340|NCT02460549|empowerment|empowerment
4827341|NCT02460549|prostate cancer|prostate cancer
4827342|NCT02460549|oral endocrine therapy|oral endocrine therapy
4827343|NCT02460549|side effects|side effects
4827344|NCT02460536|attention bias modification treatment|attention bias modification treatment
4827345|NCT02460536|attention training|attention training
4827346|NCT02460536|anxiety disorders|anxiety disorders
4827347|NCT02460536|clinical trials|clinical trials
4827348|NCT02460471|Radiotherapy|radiotherapy
4827349|NCT02460471|Palliative Care|palliative care
4827350|NCT02460471|IMRT|imrt
4827351|NCT02460458|Factor VIII|factor viii
4827352|NCT02460458|Hemorrhage|hemorrhage
4827353|NCT02460458|von Willebrand Diseases|von willebrand diseases
4827354|NCT02460458|von Willebrand Factor|von willebrand factor
4827355|NCT02460445|Functional hyperandrogenism|functional hyperandrogenism
4827356|NCT02460445|Polycystic ovary syndrome|polycystic ovary syndrome
4827357|NCT02460445|Idiopathic hyperandrogenism|idiopathic hyperandrogenism
4827358|NCT02460445|Iron tissue depots|iron tissue depots
4827359|NCT02460445|Phlebotomy|phlebotomy
4827360|NCT02460445|Insulin resistance|insulin resistance
4827361|NCT02460445|Carbohydrate metabolism|carbohydrate metabolism
4827362|NCT02460445|Blood pressure|blood pressure
4827363|NCT02460445|Autonomic dysfunction|autonomic dysfunction
4827364|NCT02460445|Oxidative stress|oxidative stress
4827365|NCT02460445|Blood clotting tests|blood clotting tests
4827366|NCT02460445|Efficacy|efficacy
4827367|NCT02460445|Side effects|side effects
4827368|NCT02460445|Randomized clinical trial|randomized clinical trial
4827369|NCT02460432|Drug-eluting Biliary stent|drug-eluting biliary stent
4827370|NCT02460432|Covered metalic stent|covered metalic stent
4827371|NCT02460419|Nasopharyngeal carcinoma|nasopharyngeal carcinoma
4827372|NCT02460419|metastasis|metastasis
4827373|NCT02460419|capecitabine|capecitabine
4827374|NCT02460406|strength training|strength training
4827375|NCT02460406|virtual reality|virtual reality
4827376|NCT02460406|plyometric exercises|plyometric exercises
4827377|NCT02460406|cerebral palsy|cerebral palsy
4827378|NCT02460406|hemiplegic|hemiplegic
4827379|NCT02460393|tolerance|tolerance
4827380|NCT02460393|safety and pharmacokinetic characteristics|safety and pharmacokinetic characteristics
4827381|NCT02460367|Non-small Cell Lung Cancer|non-small cell lung cancer
4827382|NCT02460367|Vaccine Therapy|vaccine therapy
4827383|NCT02460367|Immunotherapy|immunotherapy
4827384|NCT02460367|Second line therapy|second line therapy
4827385|NCT02460367|Progressive|progressive
4827386|NCT02460367|Relapsed|relapsed
4827387|NCT02460367|IDO|ido
4827388|NCT02460367|IDO Inhibitor|ido inhibitor
4827389|NCT02460354|Congenital nephrogenic diabetes insipidus|congenital nephrogenic diabetes insipidus
4827390|NCT02460341|fMRI|fmri
4827391|NCT02460341|Brain function|brain function
4827392|NCT02460341|Sensory processing|sensory processing
4827393|NCT02460315|time of cholecystectomy after ERCP|time of cholecystectomy after ercp
4827394|NCT02460276|Mantle cell lymphoma|mantle cell lymphoma
4827395|NCT02460276|Relapsed mantle cell lymphoma|relapsed mantle cell lymphoma
4827396|NCT02460276|Lenalidomide|lenalidomide
4827397|NCT02460276|Rituximab|rituximab
4827398|NCT02460276|Ibrutinib|ibrutinib
4827399|NCT02460276|Response duration|response duration
4827400|NCT02460276|Complete remission rate|complete remission rate
4827401|NCT02460276|Quality of life|quality of life
4827402|NCT02460276|Overall survival|overall survival
4827403|NCT02460276|Safety|safety
4827404|NCT02460250|Tissue and Organ Harvesting|tissue and organ harvesting
4827405|NCT02460250|Liver graft|liver graft
4827406|NCT02460250|Brain Death|brain death
4827407|NCT02460250|FibroScan®|fibroscan®
4827408|NCT02460237|HPV|hpv
4827409|NCT02460224|Non-small cell lung cancer|non-small cell lung cancer
4827410|NCT02460224|Melanoma|melanoma
4827411|NCT02460224|Renal cancer|renal cancer
4827412|NCT02460224|Mesothelioma|mesothelioma
4827413|NCT02460224|Triple Negative Breast|triple negative breast
4827414|NCT02460224|TNBC|tnbc
4827415|NCT02460224|Renal|renal
4827416|NCT02460211|Cardiovascular Disease|cardiovascular disease
4827417|NCT02460211|Vitamin D|vitamin d
4827418|NCT02460211|Open Heart Surgery|open heart surgery
4827419|NCT02460198|PD1|pd1
4827420|NCT02460198|PD-1|pd-1
4827421|NCT02460198|PDL1|pdl1
4827422|NCT02460198|PD-L1|pd-l1
4827423|NCT02460198|MSI-H|msi-h
4827424|NCT02460198|MSI|msi
4827425|NCT02460172|bi lateral|bi lateral
4827426|NCT02460172|knee surgery|knee surgery
4827427|NCT02460172|arthroplasty|arthroplasty
4827428|NCT02460172|orthopedics|orthopedics
4827429|NCT02460081|PDA-002|pda-002
4827430|NCT02460081|Diabetic Foot Ulcer|diabetic foot ulcer
4827431|NCT02460081|Peripheral arterial disease|peripheral arterial disease
4827432|NCT02460081|Phase 2|phase 2
4827433|NCT02460081|Randomized|randomized
4827434|NCT02460068|melanoma brain metastases|melanoma brain metastases
4827435|NCT02460068|nivolumab|nivolumab
4827436|NCT02460068|ipilimumab|ipilimumab
4827437|NCT02460055|EGD Dysphagia|egd dysphagia
4827438|NCT02460055|ETT Intubation dysphagia|ett intubation dysphagia
4827439|NCT02459990|Hypertension malformation fetal mortality|hypertension malformation fetal mortality
4827440|NCT02459964|Advanced Cancers|advanced cancers
4827441|NCT02459964|Pain|pain
4827442|NCT02459964|Fentanyl nasal spray|fentanyl nasal spray
4827443|NCT02459964|Hydromorphone hydrochloride|hydromorphone hydrochloride
4827444|NCT02459964|Phone call|phone call
4827445|NCT02459964|Numeric Rating Scale|numeric rating scale
4827446|NCT02459964|NRS|nrs
4827447|NCT02459951|Muscle Spasticity|muscle spasticity
4827448|NCT02459951|Botox A|botox a
4827449|NCT02459951|Upper limb hemiplegia|upper limb hemiplegia
4827450|NCT02459912|Prostate|prostate
4827451|NCT02459912|Minimally|minimally
4827452|NCT02459912|Low-Risk|low-risk
4827453|NCT02459912|Invasive|invasive
4827454|NCT02459912|Cancer|cancer
4827455|NCT02459886|alpha synuclein|alpha synuclein
4827456|NCT02459886|PD|pd
4827457|NCT02459860|depression|depression
4827458|NCT02459860|randomized behavioral trial|randomized behavioral trial
4827459|NCT02459860|aged|aged
4827460|NCT02459860|Latinos|latinos
4827461|NCT02459860|Spanish-speaking|spanish-speaking
4827462|NCT02459860|chronic medical conditions|chronic medical conditions
4827463|NCT02459834|Allulose|allulose
4827464|NCT02459834|Fructose|fructose
4827465|NCT02459834|Dose Response|dose response
4827466|NCT02459834|Catalytic Dose|catalytic dose
4827467|NCT02459834|Carbohydrate metabolism|carbohydrate metabolism
4827468|NCT02459834|Randomized clinical trials|randomized clinical trials
4827469|NCT02459821|Multiple sclerosis|multiple sclerosis
4827470|NCT02459821|Gait rehabilitation|gait rehabilitation
4827471|NCT02459821|Quality of life|quality of life
4827472|NCT02459821|Stair climbing|stair climbing
4827473|NCT02459821|Robotic|robotic
4827474|NCT02459782|Ultrasound guided peribulbar anesthesia|ultrasound guided peribulbar anesthesia
4827475|NCT02459756|anthocyanins|anthocyanins
4827476|NCT02459756|bioavailability|bioavailability
4827477|NCT02459743|Hematological malignancies|hematological malignancies
4827478|NCT02459743|Next Generation Sequencing|next generation sequencing
4827479|NCT02459743|Genotype-phenotype correlations|genotype-phenotype correlations
4827480|NCT02459743|Prognosis|prognosis
4827481|NCT02459743|Diagnosis|diagnosis
4827482|NCT02459730|Dental caries|dental caries
4827483|NCT02459730|glass ionomer cement|glass ionomer cement
4827484|NCT02459730|ART|art
4827485|NCT02459704|Gingival Recession|gingival recession
4827486|NCT02459704|Semilunar flap|semilunar flap
4827487|NCT02459704|Enamel matrix derivative|enamel matrix derivative
4827488|NCT02459704|Periodontal regeneration|periodontal regeneration
4827489|NCT02459691|prediabetes|prediabetes
4827490|NCT02459691|metabolic syndrome|metabolic syndrome
4827491|NCT02459691|lifestyle|lifestyle
4827492|NCT02459691|behavior change|behavior change
4827493|NCT02459691|primary care|primary care
4827494|NCT02459691|latinos|latinos
4827495|NCT02459691|diet|diet
4827496|NCT02459691|physical activity|physical activity
4827497|NCT02459652|Borderline Resectable Pancreatic Cancer|borderline resectable pancreatic cancer
4827498|NCT02459639|Chronic Widespread Pain|chronic widespread pain
4827499|NCT02459639|Telomere length|telomere length
4827500|NCT02459639|Multimodal rehabilitation|multimodal rehabilitation
4827501|NCT02459639|Integrative care|integrative care
4827502|NCT02459639|Existential aspects|existential aspects
4827503|NCT02459613|Radionuclide imaging|radionuclide imaging
4827504|NCT02459613|Annexin|annexin
4827505|NCT02459600|Eye surgery|eye surgery
4827506|NCT02459600|Children|children
4827507|NCT02459587|Self-Injurious Behavior|self-injurious behavior
4827508|NCT02459587|suicide prevention|suicide prevention
4827509|NCT02459574|Heart Failure|heart failure
4827510|NCT02459561|Obesity|obesity
4827511|NCT02459561|Diabetes|diabetes
4827512|NCT02459561|Overweight|overweight
4827513|NCT02459561|Medical device|medical device
4827514|NCT02459561|Endobarrier|endobarrier
4827515|NCT02459561|Clinical trial|clinical trial
4827516|NCT02459561|Diet|diet
4827517|NCT02459561|Exercise|exercise
4827518|NCT02459561|Body weight|body weight
4827519|NCT02459561|Medical therapy|medical therapy
4827520|NCT02459561|Medicine|medicine
4827521|NCT02459561|Device|device
4827522|NCT02459561|Randomised|randomised
4827523|NCT02459561|Control|control
4827524|NCT02459561|Intervention|intervention
4827525|NCT02459561|EndoBarrier Medical device|endobarrier medical device
4827526|NCT02459548|OSA|osa
4827527|NCT02459548|CPAP treatment|cpap treatment
4827528|NCT02459548|Primary care|primary care
4827529|NCT02459548|Efficacy|efficacy
4827530|NCT02459535|incretin release|incretin release
4827531|NCT02459522|Bayesian estimation|bayesian estimation
4827532|NCT02459522|short-term heart rate variability|short-term heart rate variability
4827533|NCT02459522|cardiovascular autonomic neuropathy|cardiovascular autonomic neuropathy
4827534|NCT02459522|diagnostic performance|diagnostic performance
4827535|NCT02459509|Sedation|sedation
4827536|NCT02459509|dexmedetomidine|dexmedetomidine
4827537|NCT02459509|pediatric|pediatric
4827538|NCT02459509|preoperative period|preoperative period
4827539|NCT02459470|Fluid Responsiveness|fluid responsiveness
4827540|NCT02459470|Pulse Pressure Variation|pulse pressure variation
4827541|NCT02459470|Stroke Volume Variation|stroke volume variation
4827542|NCT02459457|esophageal squamous cell carcinoma|esophageal squamous cell carcinoma
4827543|NCT02459457|concurrent chemoradiotherapy|concurrent chemoradiotherapy
4827544|NCT02459457|paclitaxel|paclitaxel
4827545|NCT02459457|cisplatin|cisplatin
4827546|NCT02459457|carboplatin|carboplatin
4827547|NCT02459457|fluorouracil|fluorouracil
4827548|NCT02459444|Respiratory Muscles|respiratory muscles
4827549|NCT02459444|Muscle Weakness|muscle weakness
4827550|NCT02459444|Hospitalization|hospitalization
4827551|NCT02459444|Length of Stay|length of stay
4827552|NCT02459444|Mortality|mortality
4827553|NCT02459418|Afolia|afolia
4827554|NCT02459418|Follitropin|follitropin
4827555|NCT02459405|Colorectal surgery|colorectal surgery
4827556|NCT02459405|Near infrared|near infrared
4827557|NCT02459405|Indocyanine green|indocyanine green
4827558|NCT02459405|anastomotic leak|anastomotic leak
4827559|NCT02459405|Prevention of leak|prevention of leak
4827560|NCT02459392|Epiduroscopy,|epiduroscopy,
4827561|NCT02459392|Failed back surgery syndrome|failed back surgery syndrome
4827562|NCT02459392|Spinal Stenosis with neurologic changes|spinal stenosis with neurologic changes
4827563|NCT02459366|Thoracolumbar fascia|thoracolumbar fascia
4827564|NCT02459366|Mechanical properties|mechanical properties
4827565|NCT02459366|Low back pain|low back pain
4827566|NCT02459353|dapagliflozin|dapagliflozin
4827567|NCT02459353|glucose variability|glucose variability
4827568|NCT02459327|Infant behavior|infant behavior
4827569|NCT02459327|Child behavior|child behavior
4827570|NCT02459327|Parenting|parenting
4827571|NCT02459327|Child rearing|child rearing
4827572|NCT02459327|Depression|depression
4827573|NCT02459327|Personal satisfaction|personal satisfaction
4827574|NCT02459327|Randomized controlled trials|randomized controlled trials
4827575|NCT02459327|Intervention studies|intervention studies
4827576|NCT02459327|Behavioral symptoms|behavioral symptoms
4827577|NCT02459327|Social behavior|social behavior
4827578|NCT02459288|Acute coronary syndrome|acute coronary syndrome
4827579|NCT02459288|Chronic kidney disease|chronic kidney disease
4827580|NCT02459288|End-Stage Renal Disease|end-stage renal disease
4827581|NCT02459288|eGFR|egfr
4827582|NCT02459288|Ticagrelor|ticagrelor
4827583|NCT02459288|Clopidogrel|clopidogrel
4827584|NCT02459275|feeding protocol|feeding protocol
4827585|NCT02459275|enteral nutrition protocol|enteral nutrition protocol
4827586|NCT02459275|critically ill|critically ill
4827587|NCT02459275|surgical ICU|surgical icu
4827588|NCT02459275|enteral nutrition|enteral nutrition
4827687|NCT02458495|Internet|internet
4827589|NCT02459275|nutrition therapy|nutrition therapy
4827590|NCT02459223|Nutritional intervention|nutritional intervention
4827591|NCT02459223|iron deficiency anemia|iron deficiency anemia
4827592|NCT02459210|clinical high risk for psychosis|clinical high risk for psychosis
4827593|NCT02459210|psychosis prodrome|psychosis prodrome
4827594|NCT02459210|cognitive remediation|cognitive remediation
4827595|NCT02459210|psychosis prevention|psychosis prevention
4827596|NCT02459197|Pain|pain
4827597|NCT02459184|preventive medicine|preventive medicine
4827598|NCT02459184|social determinants of health|social determinants of health
4827599|NCT02459184|primary health care|primary health care
4827600|NCT02459184|poverty|poverty
4827601|NCT02459184|income|income
4827602|NCT02459184|health promotion|health promotion
4827603|NCT02459132|High-intensity interval training|high-intensity interval training
4827604|NCT02459132|VO2peak|vo2peak
4827605|NCT02459132|Brachial flow-mediated dilation|brachial flow-mediated dilation
4827606|NCT02459132|Carotid-femoral pulse wave velocity|carotid-femoral pulse wave velocity
4827607|NCT02459132|Carotid intima-media thickness|carotid intima-media thickness
4827608|NCT02459132|Carotid distensibility|carotid distensibility
4827609|NCT02459132|Respiratory sinus arrhythmia|respiratory sinus arrhythmia
4827610|NCT02459119|urothelial cancer|urothelial cancer
4827611|NCT02459119|Regorafenib|regorafenib
4827612|NCT02459106|micro-RNA|micro-rna
4827613|NCT02459106|insulin resistance|insulin resistance
4827614|NCT02459093|wound complications|wound complications
4827615|NCT02459080|Chronic Obstructive Pulmonary Disease, COPD|chronic obstructive pulmonary disease, copd
4827616|NCT02459054|Artificial Heart|artificial heart
4827617|NCT02459054|Biventricular Heart Failure|biventricular heart failure
4827618|NCT02459054|SynCardia|syncardia
4827619|NCT02459002|Advanced lung cancer|advanced lung cancer
4827620|NCT02459002|NSCLC|nsclc
4827621|NCT02459002|palliative care|palliative care
4827622|NCT02458989|Thyroidectomy|thyroidectomy
4827623|NCT02458989|Thyroid surgery|thyroid surgery
4827624|NCT02458989|Scalpel|scalpel
4827625|NCT02458989|Electrocautery|electrocautery
4827626|NCT02458976|Scar|scar
4827627|NCT02458976|Pulsed-dye laser|pulsed-dye laser
4827628|NCT02458976|PDL|pdl
4827629|NCT02458963|PCOS|pcos
4827630|NCT02458963|Clomiphene citrate resistant|clomiphene citrate resistant
4827631|NCT02458963|Gonadotropin|gonadotropin
4827632|NCT02458963|IVF|ivf
4827633|NCT02458950|Anorexia nervosa|anorexia nervosa
4827634|NCT02458950|Siriraj Hospital|siriraj hospital
4827635|NCT02458950|Thai|thai
4827636|NCT02458937|Leukemia|leukemia
4827637|NCT02458937|Hodgkin Disease|hodgkin disease
4827638|NCT02458937|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
4827639|NCT02458937|Sickle Cell Disease|sickle cell disease
4827640|NCT02458937|Hip Core Decompression|hip core decompression
4827641|NCT02458937|Function Outcomes|function outcomes
4827642|NCT02458885|myocardial infarction|myocardial infarction
4827643|NCT02458885|observational registry|observational registry
4827644|NCT02458885|mortality|mortality
4827645|NCT02458872|Clinical Alarms|clinical alarms
4827646|NCT02458872|Patient Safety|patient safety
4827647|NCT02458859|Chronic|chronic
4827648|NCT02458859|Subacute|subacute
4827649|NCT02458833|Obesity|obesity
4827650|NCT02458833|Nutrition|nutrition
4827651|NCT02458833|Home Food Preparation|home food preparation
4827652|NCT02458833|Home Food Environment|home food environment
4827653|NCT02458833|Peer Mentoring|peer mentoring
4827654|NCT02458833|Early Head Start|early head start
4827655|NCT02458833|Cooking|cooking
4827656|NCT02458833|Diet|diet
4827657|NCT02458820|Cardiopulmonary Resuscitation|cardiopulmonary resuscitation
4827658|NCT02458820|Return of Spontaneous Circulation|return of spontaneous circulation
4827659|NCT02458820|ROSC|rosc
4827660|NCT02458820|Electroencephalogram|electroencephalogram
4827661|NCT02458742|spinal anesthesia|spinal anesthesia
4827662|NCT02458742|intrathecal morphine|intrathecal morphine
4827663|NCT02458742|transurethral resection of prostate|transurethral resection of prostate
4827664|NCT02458742|postoperative pain|postoperative pain
4827665|NCT02458729|Tranexamic Acid|tranexamic acid
4827666|NCT02458729|Total Knee Arthroplasty|total knee arthroplasty
4827667|NCT02458729|Rivaroxaban|rivaroxaban
4827668|NCT02458703|workload|workload
4827669|NCT02458703|oxygen level|oxygen level
4827670|NCT02458703|oxygen consumption|oxygen consumption
4827671|NCT02458703|breathing reserve|breathing reserve
4827672|NCT02458703|ventilatory efficiency|ventilatory efficiency
4827673|NCT02458690|Primary Care|primary care
4827674|NCT02458690|Older Adults|older adults
4827675|NCT02458690|Antidepressant Medications|antidepressant medications
4827676|NCT02458690|Cognitive-Behavioral Therapy|cognitive-behavioral therapy
4827677|NCT02458690|Computer-Based Psychotherapy|computer-based psychotherapy
4827678|NCT02458612|cerebral palsy|cerebral palsy
4827679|NCT02458612|mirror therapy|mirror therapy
4827680|NCT02458612|strength training|strength training
4827681|NCT02458560|Transcatheter Aortic Valve Replacement|transcatheter aortic valve replacement
4827682|NCT02458560|Aortic Stenosis|aortic stenosis
4827683|NCT02458534|Simulated manikin|simulated manikin
4827684|NCT02458508|MC4R|mc4r
4827685|NCT02458508|chemotherapy|chemotherapy
4827686|NCT02458508|radiotherapy|radiotherapy
4827688|NCT02458495|Mobile Health|mobile health
4827689|NCT02458495|Hemoglobin A, Glycosylated|hemoglobin a, glycosylated
4827690|NCT02458495|Medication Adherence|medication adherence
4827691|NCT02458495|Psychological Theory|psychological theory
4827692|NCT02458482|Children|children
4827693|NCT02458482|Positive Airway Pressure|positive airway pressure
4827694|NCT02458482|Nebulizer|nebulizer
4827695|NCT02458482|Moderate|moderate
4827696|NCT02458482|Acute|acute
4827697|NCT02458482|AccuPAP|accupap
4827698|NCT02458417|Ablative laser|ablative laser
4827699|NCT02458417|Fractional laser|fractional laser
4827700|NCT02458417|Vitiligo|vitiligo
4827701|NCT02458417|Piebaldism|piebaldism
4827702|NCT02458417|Cell suspension grafting|cell suspension grafting
4827703|NCT02458391|Breast Cancer|breast cancer
4827704|NCT02458391|Lymphedema|lymphedema
4827705|NCT02458365|Violence|violence
4827706|NCT02458365|Bullying|bullying
4827707|NCT02458365|Social skills|social skills
4827708|NCT02458365|Prevention & control|prevention & control
4827709|NCT02458365|Adolescent|adolescent
4827710|NCT02458339|Brain tumor|brain tumor
4827711|NCT02458339|Malignant Fourth Ventricular Brain Tumors|malignant fourth ventricular brain tumors
4827712|NCT02458326|Migraine|migraine
4827713|NCT02458326|Fibromyalgia|fibromyalgia
4827714|NCT02458326|Aerobic exercise|aerobic exercise
4827715|NCT02458300|Bronchiolitis|bronchiolitis
4827716|NCT02458300|Chest|chest
4827717|NCT02458300|Physical therapy|physical therapy
4827718|NCT02458287|mixed dyslipidemia|mixed dyslipidemia
4827719|NCT02458248|Chronic Kidney Disease|chronic kidney disease
4827720|NCT02458248|Sodium Reduction|sodium reduction
4827721|NCT02458248|eGFR 30-60ml/min/1.73m2|egfr 30-60ml/min/1.73m2
4827722|NCT02458235|pediatric leukemia myelodysplastic syndrome azacitidine|pediatric leukemia myelodysplastic syndrome azacitidine
4827723|NCT02458209|PK, bococizumab, comparability, LDL-C|pk, bococizumab, comparability, ldl-c
4827724|NCT02458196|IgG4 related disease|igg4 related disease
4827725|NCT02458196|IgG4-RD|igg4-rd
4827726|NCT02458196|Response rate|response rate
4827727|NCT02458196|Relapse|relapse
4827728|NCT02458170|Rheumatoid arthritis|rheumatoid arthritis
4827729|NCT02458170|Synovial tissue|synovial tissue
4827730|NCT02458170|Joint destruction|joint destruction
4827731|NCT02458170|Inflammation|inflammation
4827732|NCT02458157|ICU|icu
4827733|NCT02458157|Intensive|intensive
4827734|NCT02458157|CRRT|crrt
4827735|NCT02458157|Fluid Removal|fluid removal
4827736|NCT02458157|AKI|aki
4827737|NCT02458157|Critical Care|critical care
4827738|NCT02458131|community-based participatory research|community-based participatory research
4827739|NCT02458131|adolescents|adolescents
4827740|NCT02458118|chronic|chronic
4827741|NCT02458118|pancreatitis|pancreatitis
4827742|NCT02458118|secretin|secretin
4827743|NCT02458118|Blood flow|blood flow
4827744|NCT02458105|Acceptance and commitment therapy|acceptance and commitment therapy
4827745|NCT02458105|Cognitive behavior therapy|cognitive behavior therapy
4827746|NCT02458053|African American|african american
4827747|NCT02458053|male|male
4827748|NCT02458053|couples|couples
4827749|NCT02458053|randomized control trial|randomized control trial
4827750|NCT02458014|Leukemia|leukemia
4827751|NCT02458014|B-cell Lineage Acute Lymphocytic Leukemia|b-cell lineage acute lymphocytic leukemia
4827752|NCT02458014|Positive minimal residual disease|positive minimal residual disease
4827753|NCT02458014|MRD|mrd
4827754|NCT02458014|Acute lymphocytic leukemia|acute lymphocytic leukemia
4827755|NCT02458014|ALL|all
4827756|NCT02458014|Blinatumomab|blinatumomab
4827757|NCT02458014|Blinacyto|blinacyto
4827758|NCT02458014|Phone calls|phone calls
4827759|NCT02457949|Social Assistance|social assistance
4827760|NCT02457949|Drug Use|drug use
4827761|NCT02457949|Drug-Related harm|drug-related harm
4827762|NCT02457923|mobile phone counselling|mobile phone counselling
4827763|NCT02457923|infant feeding|infant feeding
4827764|NCT02457923|nutrition|nutrition
4827765|NCT02457897|Brown Adipose Tissue|brown adipose tissue
4827766|NCT02457897|Liothyronine|liothyronine
4827767|NCT02457897|Insulin Receptors|insulin receptors
4827768|NCT02457884|Diabetic macular oedema|diabetic macular oedema
4827769|NCT02457884|Perceptual learning|perceptual learning
4827770|NCT02457884|Chinese|chinese
4827771|NCT02457884|Hong Kong|hong kong
4827772|NCT02457858|Type 1 Diabetes|type 1 diabetes
4827773|NCT02457858|Islet Transplant|islet transplant
4827774|NCT02457845|Brain Tumor, Recurrent|brain tumor, recurrent
4827775|NCT02457845|Glioma|glioma
4827776|NCT02457845|Glioblastoma|glioblastoma
4827777|NCT02457845|Gliosarcoma|gliosarcoma
4827778|NCT02457845|Anaplastic Astrocytoma|anaplastic astrocytoma
4827779|NCT02457845|Oligodendroglioma|oligodendroglioma
4827780|NCT02457845|Rhabdoid Tumor|rhabdoid tumor
4827781|NCT02457845|Cerebral Primitive Neuroectodermal Tumor|cerebral primitive neuroectodermal tumor
4827782|NCT02457845|PNET|pnet
4827783|NCT02457845|Ependymoma|ependymoma
4827784|NCT02457845|Germ Cell Tumor|germ cell tumor
4827785|NCT02457845|Choroid Plexus Carcinoma|choroid plexus carcinoma
4827786|NCT02457845|Oncolytic Virus Therapy|oncolytic virus therapy
4827787|NCT02457845|Virotherapy, Oncolytic|virotherapy, oncolytic
4827788|NCT02457845|Immunotherapy|immunotherapy
4827789|NCT02457845|Central Nervous System Agents|central nervous system agents
4827790|NCT02457845|Antineoplastic Agents|antineoplastic agents
4827791|NCT02457845|Neoplasms|neoplasms
4827792|NCT02457845|Pediatric|pediatric
4827793|NCT02457845|Pediatrics|pediatrics
4827794|NCT02457845|Embryonal Tumor|embryonal tumor
4827795|NCT02457845|Oncolytic|oncolytic
4827796|NCT02457845|Virus|virus
4827797|NCT02457845|HSV|hsv
4827798|NCT02457845|Herpes Virus|herpes virus
4827799|NCT02457832|Magnetic Resonance Imaging|magnetic resonance imaging
4827800|NCT02457832|Neurology|neurology
4827801|NCT02457832|Neurosciences|neurosciences
4827802|NCT02457832|Physical Medicine|physical medicine
4827803|NCT02457832|Parkinson Disease|parkinson disease
4827804|NCT02457832|Rehabilitation|rehabilitation
4827805|NCT02457806|Dental Anesthesia|dental anesthesia
4827806|NCT02457780|PTSD|ptsd
4827807|NCT02457780|Trauma|trauma
4827808|NCT02457780|World Trade Center|world trade center
4827809|NCT02457780|Respiratory|respiratory
4827810|NCT02457780|Mind-Body|mind-body
4827811|NCT02457741|Mechanical ventilation|mechanical ventilation
4827812|NCT02457741|PEEP|peep
4827813|NCT02457741|Respiratory mechanics|respiratory mechanics
4827814|NCT02457741|End-expiratory lung volume|end-expiratory lung volume
4827815|NCT02457689|Human Immunodeficiency Virus|human immunodeficiency virus
4827816|NCT02457689|Immunodeficiency Virus, Human|immunodeficiency virus, human
4827817|NCT02457676|Self-Regulation Training|self-regulation training
4827818|NCT02457676|Neuroimaging|neuroimaging
4827819|NCT02457676|Response Inhibition|response inhibition
4827820|NCT02457676|Behavioral Regulation|behavioral regulation
4827821|NCT02457676|Emotional Regulation|emotional regulation
4827822|NCT02457663|Burns|burns
4827823|NCT02457637|chronic liver disease|chronic liver disease
4827824|NCT02457637|acute liver injury|acute liver injury
4827825|NCT02457637|acute decompensation|acute decompensation
4827826|NCT02457637|multiple organ failures|multiple organ failures
4827827|NCT02457637|acute on chronic liver failure|acute on chronic liver failure
4827828|NCT02457624|gastric cancer|gastric cancer
4827829|NCT02457624|chronic atrophic gastritis|chronic atrophic gastritis
4827830|NCT02457624|intestinal metaplasia|intestinal metaplasia
4827831|NCT02457546|Fibrin sealant|fibrin sealant
4827832|NCT02457546|CSF leak|csf leak
4827833|NCT02457494|CALVIH|calvih
4827834|NCT02457494|Renal stone|renal stone
4827835|NCT02457494|HIV1|hiv1
4827836|NCT02457494|Renal colic|renal colic
4827837|NCT02457494|Atazanavir|atazanavir
4827838|NCT02457494|Crystalluria|crystalluria
4827839|NCT02457494|Chronic Kidney Disease|chronic kidney disease
4827840|NCT02457494|Calcium Oxalate|calcium oxalate
4827841|NCT02457481|Embryo Culture Techniques|embryo culture techniques
4827842|NCT02457481|Embryonic Development|embryonic development
4827843|NCT02457468|coflex|coflex
4827844|NCT02457468|interlaminar stabilization|interlaminar stabilization
4827845|NCT02457468|lumbar spinal stenosis|lumbar spinal stenosis
4827846|NCT02457468|neurogenic claudication|neurogenic claudication
4827847|NCT02457468|decompression|decompression
4827848|NCT02457455|inflight emergencies|inflight emergencies
4827849|NCT02457442|Anesthetics, Inhalation|anesthetics, inhalation
4827850|NCT02457442|Anesthetics, Intravenous|anesthetics, intravenous
4827851|NCT02457442|Analgesics, Opioid|analgesics, opioid
4827852|NCT02457429|Gastro-oesophageal reflux|gastro-oesophageal reflux
4827853|NCT02457429|Children|children
4827854|NCT02457429|Dx-pH Pharyngeal probe|dx-ph pharyngeal probe
4827855|NCT02457429|GORD|gord
4827856|NCT02457429|Trans-nasal catheter|trans-nasal catheter
4827857|NCT02457416|Peanut allergy|peanut allergy
4827858|NCT02457416|Oral immunotherapy|oral immunotherapy
4827859|NCT02457390|contrast enhanced laparoscopic ultrasound|contrast enhanced laparoscopic ultrasound
4827860|NCT02457390|CE-LUS|ce-lus
4827861|NCT02457390|LUS|lus
4827862|NCT02457390|robot assisted CRC resection|robot assisted crc resection
4827863|NCT02457377|recurrent abortion|recurrent abortion
4827864|NCT02457377|cerclage|cerclage
4827865|NCT02457377|laparoscopy|laparoscopy
4827866|NCT02457377|cervical imcompetence|cervical imcompetence
4827867|NCT02457364|non-operative management|non-operative management
4827868|NCT02457351|Phase 1|phase 1
4827869|NCT02457351|Advanced solid tumor|advanced solid tumor
4827870|NCT02457351|pan-CDK inhibitor|pan-cdk inhibitor
4827871|NCT02457351|Drug-drug Interaction|drug-drug interaction
4827872|NCT02457338|C-section|c-section
4827873|NCT02457338|Infants|infants
4827874|NCT02457338|Probiotic|probiotic
4827875|NCT02457338|B. infantis|b. infantis
4827876|NCT02457338|Microbiota|microbiota
4827877|NCT02457338|Gut|gut
4827878|NCT02457338|Breast milk|breast milk
4827879|NCT02457338|Vaginal|vaginal
4827880|NCT02457325|Articaine|articaine
4827881|NCT02457325|Lower third molar|lower third molar
4827882|NCT02457325|Oral Surgery|oral surgery
4827883|NCT02457299|Esophagectomy|esophagectomy
4827884|NCT02457299|Gastric Conduit|gastric conduit
4827885|NCT02457299|Esophageal Cancer|esophageal cancer
4827886|NCT02457273|PDNC(Poorly Differentiated Neuroendocrine Carcinomas)|pdnc(poorly differentiated neuroendocrine carcinomas)
4827887|NCT02457273|TLC-388 (Lipotecan®)|tlc-388 (lipotecan®)
4827888|NCT02457247|Drug therapy|drug therapy
4827889|NCT02457234|fruits and vegetables|fruits and vegetables
4827890|NCT02457234|cultural immersion|cultural immersion
4827891|NCT02457221|Tacrolimus|tacrolimus
4827892|NCT02457221|Cyclophosphamide|cyclophosphamide
4827893|NCT02457221|Prograf|prograf
4827894|NCT02457221|lupus nephritis|lupus nephritis
4827895|NCT02457208|pharmacokinetics|pharmacokinetics
4827896|NCT02457195|PONV|ponv
4827897|NCT02457195|anesthesia|anesthesia
4827898|NCT02457195|granisetron|granisetron
4827899|NCT02457156|Pancreatico-jejunostomy|pancreatico-jejunostomy
4827900|NCT02457156|Pancreato-duodenectomy|pancreato-duodenectomy
4827901|NCT02457156|Cattell-Warren anastomosis|cattell-warren anastomosis
4827902|NCT02457156|Blumgart anastomosis|blumgart anastomosis
4827903|NCT02457143|recall|recall
4827904|NCT02457143|income-related disparities|income-related disparities
4827905|NCT02457143|cancer screening|cancer screening
4827906|NCT02457117|CyberKnife|cyberknife
4827907|NCT02457117|Partial breast irradiation|partial breast irradiation
4827908|NCT02457117|accelerated partial breast irradiation|accelerated partial breast irradiation
4827909|NCT02457117|breast sbrt|breast sbrt
4827910|NCT02457091|multiple sclerosis|multiple sclerosis
4827911|NCT02457091|exercise|exercise
4827912|NCT02457091|home-based|home-based
4827913|NCT02457091|training|training
4827914|NCT02457091|fitness|fitness
4827915|NCT02457078|nutritional supplements|nutritional supplements
4827916|NCT02457078|lutein|lutein
4827917|NCT02457078|DHA|dha
4827918|NCT02457078|vitamin E|vitamin e
4827919|NCT02457078|infant brain development|infant brain development
4827920|NCT02457065|survivors|survivors
4827921|NCT02457065|family|family
4827922|NCT02457052|Medical device|medical device
4827923|NCT02457039|Chemo-brain|chemo-brain
4827924|NCT02457039|Drug-Related Side Effects and Adverse Reactions|drug-related side effects and adverse reactions
4827925|NCT02457039|Mild Cognitive Impairment|mild cognitive impairment
4827926|NCT02457039|Breast cancer|breast cancer
4827927|NCT02457026|neovascular age-related macular degeneration|neovascular age-related macular degeneration
4827928|NCT02457026|age-related macular degeneration|age-related macular degeneration
4827929|NCT02457026|verteporfin|verteporfin
4827930|NCT02457026|persistent disease activity|persistent disease activity
4827931|NCT02457026|photodynamic therapy|photodynamic therapy
4827932|NCT02457026|Aflibercept|aflibercept
4827933|NCT02457000|Sleep|sleep
4827934|NCT02457000|Skin|skin
4827935|NCT02457000|Circadian Rhythm|circadian rhythm
4827936|NCT02456961|Collagen crosslinking (CXL)|collagen crosslinking (cxl)
4827937|NCT02456961|Standard corneal crosslinking (CXL)|standard corneal crosslinking (cxl)
4827938|NCT02456961|Transepithelial CXL|transepithelial cxl
4827939|NCT02456961|Iontophoresis|iontophoresis
4827940|NCT02456961|Riboflavin|riboflavin
4827941|NCT02456948|treatment resistant depression|treatment resistant depression
4827942|NCT02456948|inflammation|inflammation
4827943|NCT02456948|microglia|microglia
4827944|NCT02456948|minocycline|minocycline
4827945|NCT02456922|Type 1 Diabetes|type 1 diabetes
4827946|NCT02456922|Type 2 Diabetes|type 2 diabetes
4827947|NCT02456922|Harmony 1|harmony 1
4827948|NCT02456896|Oxcarbazepine|oxcarbazepine
4827949|NCT02456896|Brain Derived Neurotrophic Factor|brain derived neurotrophic factor
4827950|NCT02456896|Bipolar disorder|bipolar disorder
4827951|NCT02456896|Neuroprotection|neuroprotection
4827952|NCT02456883|ASP2215|asp2215
4827953|NCT02456883|14C-labeled gilteritinib|14c-labeled gilteritinib
4827954|NCT02456883|Advanced Solid Tumors|advanced solid tumors
4827955|NCT02456883|Pharmacokinetics|pharmacokinetics
4827956|NCT02456883|gilteritinib|gilteritinib
4827957|NCT02456870|Adipose tissue|adipose tissue
4827958|NCT02456870|Overfeeding|overfeeding
4827959|NCT02456857|Breast cancer|breast cancer
4827960|NCT02456857|Triple-Negative Breast Cancer|triple-negative breast cancer
4827961|NCT02456857|TNBC|tnbc
4827962|NCT02456857|Tumors insensitive to standard neoadjuvant chemotherapy|tumors insensitive to standard neoadjuvant chemotherapy
4827963|NCT02456857|Temsirolimus|temsirolimus
4827964|NCT02456857|CCI-779|cci-779
4827965|NCT02456857|Torisel|torisel
4827966|NCT02456857|Liposomal Doxorubicin|liposomal doxorubicin
4827967|NCT02456857|Doxil|doxil
4827968|NCT02456857|Doxorubicin Hydrochloride (Liposomal)|doxorubicin hydrochloride (liposomal)
4827969|NCT02456857|Bevacizumab|bevacizumab
4827970|NCT02456857|Avastin|avastin
4827971|NCT02456857|Anti-VEGF Monoclonal Antibody|anti-vegf monoclonal antibody
4827972|NCT02456857|rhuMAb-VEGF|rhumab-vegf
4827973|NCT02456818|Colonization|colonization
4827974|NCT02456818|Multi-resistant gram negative bacteria|multi-resistant gram negative bacteria
4827975|NCT02456818|Infection control measures|infection control measures
4827976|NCT02456818|Hand hygiene program|hand hygiene program
4827977|NCT02456818|Contact precautions|contact precautions
4827978|NCT02456818|Immunocompromised host|immunocompromised host
4827979|NCT02456792|PCOS|pcos
4827980|NCT02456792|Clomiphene citrate resistant|clomiphene citrate resistant
4827981|NCT02456792|LOD|lod
4827982|NCT02456792|IVF|ivf
4827983|NCT02456779|pepsin|pepsin
4827984|NCT02456779|peptest|peptest
4827985|NCT02456779|GERD|gerd
4827986|NCT02456779|NERD|nerd
4827987|NCT02456779|diagnostic|diagnostic
4827988|NCT02456766|FibroTouch|fibrotouch
4827989|NCT02456766|acoustic attenuation parameter|acoustic attenuation parameter
4827990|NCT02456766|liver biopsy|liver biopsy
4827991|NCT02456766|hepatic steatosis|hepatic steatosis
4827992|NCT02456753|in labor|in labor
4827993|NCT02456753|Ultrasonography|ultrasonography
4827994|NCT02456753|clinical examination|clinical examination
4827995|NCT02456753|Prenatal|prenatal
4827996|NCT02456740|Migraine|migraine
4827997|NCT02456740|Headache|headache
4827998|NCT02456740|Prevention|prevention
4827999|NCT02456740|Prophylaxis|prophylaxis
4828000|NCT02456727|Acupuncture|acupuncture
4828001|NCT02456727|Group/Community Acupuncture|group/community acupuncture
4828002|NCT02456727|Individual Acupuncture|individual acupuncture
4828003|NCT02456727|Chronic Pain|chronic pain
4828004|NCT02456727|Underserved|underserved
4828005|NCT02456727|Urban Primary Care|urban primary care
4828006|NCT02456727|Osteoarthritis|osteoarthritis
4828007|NCT02456727|Back Pain|back pain
4828008|NCT02456727|Neck Pain|neck pain
4828009|NCT02456714|Cholangiocarcinoma|cholangiocarcinoma
4828010|NCT02456714|FOLFIRINOX|folfirinox
4828011|NCT02456714|Phase II study|phase ii study
4828012|NCT02456701|CDX3379|cdx3379
4828013|NCT02456675|Refractory Hodgkin lymphoma|refractory hodgkin lymphoma
4828014|NCT02456675|Relapsed Hodgkin Lymphoma|relapsed hodgkin lymphoma
4828015|NCT02456649|lumpectomy margins|lumpectomy margins
4828016|NCT02456636|Weight loss|weight loss
4828017|NCT02456636|Weight management|weight management
4828018|NCT02456636|Diabetes|diabetes
4828019|NCT02456636|Heart disease|heart disease
4828020|NCT02456597|Peripheral Nerve Blocks|peripheral nerve blocks
4828021|NCT02456584|depot medroxyprogesterone acetate (DMPA)|depot medroxyprogesterone acetate (dmpa)
4828022|NCT02456584|confidence interval (CI)|confidence interval (ci)
4828023|NCT02456584|Subcutaneous (sub-Q)|subcutaneous (sub-q)
4828024|NCT02456584|Intrauterine device (IUD)|intrauterine device (iud)
4828025|NCT02456584|Levonorgestrel (LNG)|levonorgestrel (lng)
4828026|NCT02456584|intrauterine system (IUS)|intrauterine system (ius)
4828027|NCT02456558|HIV infection|hiv infection
4828028|NCT02456558|antiretroviral drugs|antiretroviral drugs
4828029|NCT02456558|deferiprone|deferiprone
4828030|NCT02456558|pharmacokinetics|pharmacokinetics
4828031|NCT02456519|children|children
4828032|NCT02456519|surgery|surgery
4828033|NCT02456428|Incretins|incretins
4828034|NCT02456428|Antidiabetic Agents|antidiabetic agents
4828035|NCT02456428|Heart Failure|heart failure
4828036|NCT02456389|Probable cancer|probable cancer
4828037|NCT02456389|Proven cancer|proven cancer
4828038|NCT02456389|Elective cancer surgery|elective cancer surgery
4828039|NCT02456389|Postoperative death|postoperative death
4828040|NCT02456389|Postoperative complications|postoperative complications
4828041|NCT02456389|Healthcare utilization|healthcare utilization
4828042|NCT02456389|Quality of life|quality of life
4828043|NCT02456389|Adjuvant therapy|adjuvant therapy
4828044|NCT02456389|Disease-free survival|disease-free survival
4828045|NCT02456389|Overall survival|overall survival
4828046|NCT02456376|Sensor Fusion|sensor fusion
4828047|NCT02456376|Stochastic Resonance Stimulation|stochastic resonance stimulation
4828048|NCT02456376|Sensory deficits|sensory deficits
4828049|NCT02456376|Postural Control|postural control
4828050|NCT02456363|Adalimumab|adalimumab
4828051|NCT02456363|NSAIDs|nsaids
4828052|NCT02456363|safety|safety
4828053|NCT02456363|efficacy|efficacy
4828054|NCT02456337|Gingival Recession|gingival recession
4828055|NCT02456337|Coronally advanced flap|coronally advanced flap
4828056|NCT02456337|Periodontal regeneration|periodontal regeneration
4828057|NCT02456324|Fistula, Anorectal|fistula, anorectal
4828058|NCT02456311|VATS|vats
4828059|NCT02456311|Energy sealing|energy sealing
4828060|NCT02456298|Telehealth|telehealth
4828061|NCT02456298|Applied behavior analysis|applied behavior analysis
4828062|NCT02456272|Otosclerosis|otosclerosis
4828063|NCT02456272|Surgical treatment|surgical treatment
4828064|NCT02456272|Hearing aids|hearing aids
4828065|NCT02456259|internal jugular vein patency|internal jugular vein patency
4828066|NCT02456259|MICS|mics
4828067|NCT02456259|neck cannula|neck cannula
4828068|NCT02456259|Jugular veins|jugular veins
4828069|NCT02456246|Stereotactive Body Radiation Therapy (SBRT)|stereotactive body radiation therapy (sbrt)
4828070|NCT02456246|Lung Fibrosis|lung fibrosis
4828071|NCT02456246|FLT-PET|flt-pet
4828072|NCT02456246|NSCLC|nsclc
4828073|NCT02456233|rotor|rotor
4828074|NCT02456233|FIRM|firm
4828075|NCT02456233|paroxysmal atrial fibrillation|paroxysmal atrial fibrillation
4828076|NCT02456233|persistent atrial fibrillation|persistent atrial fibrillation
4828077|NCT02456233|atrial tachyarrhythmia|atrial tachyarrhythmia
4828078|NCT02456233|ablation|ablation
4828079|NCT02456233|contact mapping|contact mapping
4828080|NCT02456233|clinical trial|clinical trial
4828081|NCT02456233|signal processing|signal processing
4828082|NCT02456220|Herbst appliance|herbst appliance
4828083|NCT02456220|Computed tomography|computed tomography
4828084|NCT02456220|3D imaging|3d imaging
4828085|NCT02456220|Growth and development|growth and development
4828086|NCT02456220|Orthodontic Appliances, Functional|orthodontic appliances, functional
4828087|NCT02456168|Lupus|lupus
4828088|NCT02456168|SLE|sle
4828089|NCT02456155|bedside placement|bedside placement
4828090|NCT02456155|nasal jejunal tube|nasal jejunal tube
4828091|NCT02456155|ultrasound|ultrasound
4828092|NCT02456155|severe acute pancreatitis|severe acute pancreatitis
4828093|NCT02456155|endoscope|endoscope
4828094|NCT02456155|efficacy|efficacy
4828095|NCT02456155|safety|safety
4828096|NCT02456129|Clinical Trial, Phase I|clinical trial, phase i
4828097|NCT02456077|MCV4: Meningococcal Conjugate Vaccine|mcv4: meningococcal conjugate vaccine
4828098|NCT02456077|HPV: Human Papillomavirus|hpv: human papillomavirus
4828099|NCT02456051|Pancreatic Carcinoma|pancreatic carcinoma
4828100|NCT02456051|New-Onset Diabetes|new-onset diabetes
4828101|NCT02456051|Adrenomedullin|adrenomedullin
4828102|NCT02456051|Early Diagnosis|early diagnosis
4828103|NCT02456051|Biological Markers|biological markers
4828104|NCT02456012|peptic ulcer hemorrhage|peptic ulcer hemorrhage
4828105|NCT02456012|comorbidity|comorbidity
4828106|NCT02456012|clinical trial|clinical trial
4828107|NCT02455973|obesity|obesity
4828108|NCT02455973|overweight|overweight
4828109|NCT02455947|Burnout|burnout
4828110|NCT02455947|Teachers|teachers
4828111|NCT02455947|Meditation|meditation
4828112|NCT02455947|IBSR|ibsr
4828113|NCT02455947|"The Work"|"the work"
4828114|NCT02455947|Byron Katie|byron katie
4828115|NCT02455895|Blepharitis|blepharitis
4828116|NCT02455856|Healthy|healthy
4828117|NCT02455856|Itraconazole|itraconazole
4828118|NCT02455856|JNJ-42847922|jnj-42847922
4828119|NCT02455843|microwave ablation|microwave ablation
4828120|NCT02455843|chemotherapy|chemotherapy
4828121|NCT02455830|Neonatal encephalopathy|neonatal encephalopathy
4828122|NCT02455830|Hypoxic-ischemic encephalopathy|hypoxic-ischemic encephalopathy
4828123|NCT02455830|Newborn infants|newborn infants
4828124|NCT02455830|Cytokines|cytokines
4828125|NCT02455830|Trophic factors|trophic factors
4828126|NCT02455791|Breast Cancer|breast cancer
4828127|NCT02455791|Triple negative breast cancer|triple negative breast cancer
4828128|NCT02455791|HER2 amplified breast cancer|her2 amplified breast cancer
4828129|NCT02455791|Ultrasound-guided biopsy|ultrasound-guided biopsy
4828130|NCT02455791|Fine needle aspirate|fine needle aspirate
4828131|NCT02455791|FNA|fna
4828132|NCT02455791|Core biopsy|core biopsy
4828133|NCT02455752|LE-TME|le-tme
4828134|NCT02455752|Laparoscopic rectal resection|laparoscopic rectal resection
4828135|NCT02455752|Retroperitoneal resection|retroperitoneal resection
4828136|NCT02455739|intestinal function|intestinal function
4828137|NCT02455739|chewing gum|chewing gum
4828138|NCT02455726|Peripheral Arterial Disease|peripheral arterial disease
4828139|NCT02455726|Magnesium Oxide|magnesium oxide
4828140|NCT02455726|Pain|pain
4828141|NCT02455687|Bronchial asthma|bronchial asthma
4828142|NCT02455687|Magnesium Sulfate|magnesium sulfate
4828143|NCT02455687|Inhaled budesonide|inhaled budesonide
4828144|NCT02455674|weight estimation|weight estimation
4828145|NCT02455674|emergency|emergency
4828146|NCT02455674|child|child
4828147|NCT02455635|Office Hysteroscopy|office hysteroscopy
4828148|NCT02455635|tubal patency|tubal patency
4828149|NCT02455635|infertility|infertility
4828150|NCT02455635|Lower Abdominal Pain|lower abdominal pain
4828151|NCT02455609|dexmedetomidine|dexmedetomidine
4828152|NCT02455609|ketamine|ketamine
4828153|NCT02455609|postoperative pain|postoperative pain
4828154|NCT02455596|Novaferon|novaferon
4828155|NCT02455596|Recombinant anti-tumor and anti-virus protein for injection|recombinant anti-tumor and anti-virus protein for injection
4828156|NCT02455596|Carcinoid Tumor|carcinoid tumor
4828157|NCT02455596|Pancreatic Neuroendocrine Tumor|pancreatic neuroendocrine tumor
4828158|NCT02455583|HIV prevention|hiv prevention
4828159|NCT02455583|Sexual activity biomarker|sexual activity biomarker
4828160|NCT02455583|Youth|youth
4828161|NCT02455583|Adolescents|adolescents
4828162|NCT02455570|Endoscopic Ultrasound|endoscopic ultrasound
4828163|NCT02455570|Quality Management|quality management
4828164|NCT02455570|Education and training|education and training
4828165|NCT02455570|Safety|safety
4828166|NCT02455570|Learning curve|learning curve
4828167|NCT02455544|Urine congophilia|urine congophilia
4828168|NCT02455518|pain|pain
4828169|NCT02455505|Cancer Care and Bereavement|cancer care and bereavement
4828170|NCT02455505|Supportive Care|supportive care
4828171|NCT02455505|15-095|15-095
4828172|NCT02455492|Mortality|mortality
4828173|NCT02455492|Perioperative period|perioperative period
4828174|NCT02455492|Elective surgical procedures|elective surgical procedures
4828175|NCT02455479|cocaine vaccine|cocaine vaccine
4828176|NCT02455479|cocaine dependence|cocaine dependence
4828177|NCT02455479|Cocaine|cocaine
4828178|NCT02455440|esmolol|esmolol
4828179|NCT02455440|anesthetics|anesthetics
4828180|NCT02455427|transcranial direct current stimulation|transcranial direct current stimulation
4828181|NCT02455427|conventional physical therapy|conventional physical therapy
4828182|NCT02455401|Postoperative Vomiting|postoperative vomiting
4828183|NCT02455388|Nutrition|nutrition
4828184|NCT02455388|Obesity|obesity
4828185|NCT02455388|Pediatric|pediatric
4828186|NCT02455375|Puumala virus|puumala virus
4828187|NCT02455375|diagnostic|diagnostic
4828188|NCT02455375|France|france
4828189|NCT02455336|tetraplegia|tetraplegia
4828190|NCT02455336|paraplegia|paraplegia
4828191|NCT02455336|hypertriglyceridemia|hypertriglyceridemia
4828192|NCT02455336|hyperlipidemia|hyperlipidemia
4828193|NCT02455336|peroxisome proliferator-activated receptor alpha|peroxisome proliferator-activated receptor alpha
4828194|NCT02455323|Efficacy|efficacy
4828195|NCT02455323|Tension-type headache|tension-type headache
4828196|NCT02455323|Manual therapy|manual therapy
4828197|NCT02455284|MRI|mri
4828198|NCT02455284|Tractography|tractography
4828199|NCT02455284|white|white
4828200|NCT02455284|physiology|physiology
4828201|NCT02455284|analysis|analysis
4828202|NCT02455284|matter|matter
4828203|NCT02455284|tracts|tracts
4828204|NCT02455271|Insomnia|insomnia
4828205|NCT02455258|Inactivity|inactivity
4828206|NCT02455180|Critical Care|critical care
4828207|NCT02455167|HCV|hcv
4828208|NCT02455167|Hepatitis C|hepatitis c
4828209|NCT02455154|Chinese Traditional Medicine|chinese traditional medicine
4828210|NCT02455154|Osteoporosis|osteoporosis
4828211|NCT02455154|adjuvant endocrine therapy|adjuvant endocrine therapy
4828212|NCT02455154|early breast cancer|early breast cancer
4828213|NCT02455141|chemptherapy|chemptherapy
4828214|NCT02455141|triple negative|triple negative
4828215|NCT02455141|taxanes|taxanes
4828216|NCT02455141|carboplatin|carboplatin
4828217|NCT02455128|Anxiety|anxiety
4828218|NCT02455128|Fear|fear
4828219|NCT02455128|Colorectal Surgery|colorectal surgery
4828220|NCT02455128|Colorectal Neoplasms|colorectal neoplasms
4828221|NCT02455115|Acute kidney injury|acute kidney injury
4828222|NCT02455115|Liver transplantation|liver transplantation
4828223|NCT02455115|Postoperative care|postoperative care
4828224|NCT02455115|Glomerular filtration rate|glomerular filtration rate
4828225|NCT02455115|Renal blood flow|renal blood flow
4828226|NCT02455115|Vasopressor|vasopressor
4828227|NCT02455115|Norepinephrine|norepinephrine
4828228|NCT02455102|Prevention|prevention
4828229|NCT02455102|Anticoagulation|anticoagulation
4828230|NCT02455102|Electronic warning system|electronic warning system
4828231|NCT02455089|Flare|flare
4828232|NCT02455089|Therapeutic adjustments|therapeutic adjustments
4828233|NCT02455089|Biological Marker|biological marker
4828234|NCT02455089|Immunologic Marker|immunologic marker
4828235|NCT02455089|Prognosis|prognosis
4828236|NCT02455076|Hypoglycemia|hypoglycemia
4828237|NCT02455037|Concussion|concussion
4828238|NCT02455037|Contact sport|contact sport
4828239|NCT02455037|Collision sport|collision sport
4828240|NCT02455037|Neck strengthening|neck strengthening
4828241|NCT02455024|Leukemia|leukemia
4828242|NCT02455024|Leukemia, Myeloid|leukemia, myeloid
4828243|NCT02455024|Leukemia, Myelogenous, Chronic, BCR-ABL Positive|leukemia, myelogenous, chronic, bcr-abl positive
4828244|NCT02455024|ponatinib|ponatinib
4828245|NCT02455024|Pharmacologic Actions|pharmacologic actions
4828246|NCT02455024|Protein Kinase Inhibitors|protein kinase inhibitors
4828247|NCT02455024|Risk factor|risk factor
4828248|NCT02455024|Leukemia, Myelogenous, Chronic|leukemia, myelogenous, chronic
4828249|NCT02455024|CML|cml
4828250|NCT02455024|CP-CML|cp-cml
4828251|NCT02455024|Iclusig|iclusig
4828252|NCT02455024|AP24534|ap24534
4828253|NCT02455024|AP-CML|ap-cml
4828254|NCT02455024|BP-CML|bp-cml
4828255|NCT02455024|Ph+ALL|ph+all
4828256|NCT02454998|Unilateral complete cleft lip|unilateral complete cleft lip
4828257|NCT02454998|Alveolar bone graft|alveolar bone graft
4828258|NCT02454946|Blood Group Antigens|blood group antigens
4828259|NCT02454946|erectile dysfunction|erectile dysfunction
4828260|NCT02454933|Phase III Open Label Study; AZD9291 plus MEDI4736 versus AZD9291 Monotherapy; NSCLC After Previous EGFR TKI Therapy; T790M Mutation Positive Tumours.|phase iii open label study; azd9291 plus medi4736 versus azd9291 monotherapy; nsclc after previous egfr tki therapy; t790m mutation positive tumours.
4828261|NCT02454920|Strabismus|strabismus
4828262|NCT02454920|Optical Coherence Tomography|optical coherence tomography
4828263|NCT02454920|Extraocular muscles|extraocular muscles
4828264|NCT02454868|Remifentanil|remifentanil
4828265|NCT02454868|Intubation|intubation
4828266|NCT02454868|Children|children
4828267|NCT02454855|quality of life|quality of life
4828268|NCT02454855|melatonin|melatonin
4828269|NCT02454855|Elderly patient|elderly patient
4828270|NCT02454842|TH-4000|th-4000
4828271|NCT02454842|low-oxygen conditions|low-oxygen conditions
4828272|NCT02454842|hypoxia|hypoxia
4828273|NCT02454842|non-small cell lung cancer|non-small cell lung cancer
4828274|NCT02454842|NSCLC|nsclc
4828275|NCT02454842|squamous cell carcinoma|squamous cell carcinoma
4828276|NCT02454842|Tarloxotinib|tarloxotinib
4828277|NCT02454829|Ovarian cortex cryopreservation|ovarian cortex cryopreservation
4828278|NCT02454829|ovarian function|ovarian function
4828279|NCT02454790|Acute toxicity|acute toxicity
4828280|NCT02454790|Late toxicity|late toxicity
4828281|NCT02454790|Prediction models|prediction models
4828282|NCT02454738|pulmonary tuberculosis|pulmonary tuberculosis
4828283|NCT02454738|chest|chest
4828284|NCT02454738|ultralow dose computed tomography|ultralow dose computed tomography
4828285|NCT02454725|HIV Testing|hiv testing
4828286|NCT02454725|Latino|latino
4828287|NCT02454712|Prodrug|prodrug
4828288|NCT02454712|PF614|pf614
4828289|NCT02454712|oxycodone extended-release|oxycodone extended-release
4828290|NCT02454712|oral|oral
4828291|NCT02454699|antiviral|antiviral
4828292|NCT02454699|ascending dose|ascending dose
4828293|NCT02454699|Cytomegalovirus|cytomegalovirus
4828294|NCT02454699|food effect|food effect
4828295|NCT02454699|Herpesviridae|herpesviridae
4828296|NCT02454699|MBX-400|mbx-400
4828297|NCT02454686|Complications after hepatectomy|complications after hepatectomy
4828298|NCT02454673|Radiotherapy|radiotherapy
4828299|NCT02454673|Neoadjuvant therapy|neoadjuvant therapy
4828300|NCT02454673|Pharmacodynamics|pharmacodynamics
4828301|NCT02454673|Pharmacokinetics|pharmacokinetics
4828302|NCT02454673|Nonlinear Dynamics|nonlinear dynamics
4828303|NCT02454660|adherence|adherence
4828304|NCT02454660|hypertension|hypertension
4828305|NCT02454660|mobile technology|mobile technology
4828306|NCT02454660|intervention|intervention
4828307|NCT02454647|Radiotherapy|radiotherapy
4828308|NCT02454647|Neoadjuvant therapy|neoadjuvant therapy
4828309|NCT02454647|Induction chemotherapy|induction chemotherapy
4828310|NCT02454647|Concurrent chemoradiotherapy|concurrent chemoradiotherapy
4828311|NCT02454647|Preoperative factors|preoperative factors
4828312|NCT02454647|Dynamic factors|dynamic factors
4828313|NCT02454647|Prognostic Factor|prognostic factor
4828314|NCT02454634|IDH1R132H|idh1r132h
4828315|NCT02454634|peptide vaccine|peptide vaccine
4828316|NCT02454634|immunotherapy|immunotherapy
4828317|NCT02454634|IDH1R132H-mutated glioma|idh1r132h-mutated glioma
4828318|NCT02454556|Assisted reproduction technologies|assisted reproduction technologies
4828319|NCT02454556|Follicle stimulating hormone (FSH).|follicle stimulating hormone (fsh).
4828320|NCT02454543|metastatic|metastatic
4828321|NCT02454543|prostatectomy|prostatectomy
4828322|NCT02454543|androgen deprivation|androgen deprivation
4828323|NCT02454543|best systemic therapy|best systemic therapy
4828324|NCT02454504|Sugammadex|sugammadex
4828325|NCT02454504|Delayed Emergence from Anesthesia|delayed emergence from anesthesia
4828326|NCT02454504|Curare|curare
4828327|NCT02454504|Robotic Surgical Procedures|robotic surgical procedures
4828328|NCT02454491|percutaneous coronary interventions|percutaneous coronary interventions
4828329|NCT02454491|radial artery access|radial artery access
4828330|NCT02454491|access site complications|access site complications
4828331|NCT02454491|verapamil|verapamil
4828332|NCT02454491|heparin|heparin
4828333|NCT02454478|lenvatinib|lenvatinib
4828334|NCT02454478|Everolimus|everolimus
4828335|NCT02454478|Carcinoma|carcinoma
4828336|NCT02454478|Unresectable advanced renal cell carcinoma|unresectable advanced renal cell carcinoma
4828337|NCT02454478|Metastatic renal cell carcinoma|metastatic renal cell carcinoma
4828338|NCT02454452|Varicose Veins|varicose veins
4828339|NCT02454439|Heart Failure with reduced ejection fraction (<35%)|heart failure with reduced ejection fraction (<35%)
4828340|NCT02454439|Cardiac Resynchronisation Therapy|cardiac resynchronisation therapy
4828341|NCT02454439|Non specific intraventricular conduction|non specific intraventricular conduction
4828342|NCT02454439|Efficacy|efficacy
4828343|NCT02454439|Life expectancy expected to exceed one year with a good functional status|life expectancy expected to exceed one year with a good functional status
4828344|NCT02454439|QRS morphology : NICD according to the AHA/ACCF/HRS Recommendations (non-LBBB and non-RBBB):|qrs morphology : nicd according to the aha/accf/hrs recommendations (non-lbbb and non-rbbb):
4828345|NCT02454439|QRS duration > 130 ms|qrs duration > 130 ms
4828346|NCT02454426|Depression|depression
4828347|NCT02454426|Heart disease|heart disease
4828348|NCT02454413|dentures hygiene|dentures hygiene
4828349|NCT02454413|biofilm formation|biofilm formation
4828350|NCT02454413|oral health|oral health
4828351|NCT02454400|physical therapy|physical therapy
4828352|NCT02454400|lumbar spine surgery|lumbar spine surgery
4828353|NCT02454400|pre-surgical intervention|pre-surgical intervention
4828354|NCT02454400|RCT|rct
4828355|NCT02454374|Physiotherapy|physiotherapy
4828356|NCT02454374|Knee Loading|knee loading
4828357|NCT02454374|Randomised Controlled Trial|randomised controlled trial
4828358|NCT02454374|Pain|pain
4828359|NCT02454361|Safety|safety
4828360|NCT02454361|tolerability|tolerability
4828361|NCT02454361|pharmacokinetics|pharmacokinetics
4828362|NCT02454361|KBP-7072|kbp-7072
4828363|NCT02454348|septic shock|septic shock
4828364|NCT02454348|vasopressin|vasopressin
4828365|NCT02454348|norepinephrine|norepinephrine
4828366|NCT02454296|Laminaria|laminaria
4828367|NCT02454270|First-in-Human|first-in-human
4828368|NCT02454270|B-Cell Chronic Lymphocytic Leukemia|b-cell chronic lymphocytic leukemia
4828369|NCT02454270|Diffuse Large-Cell Lymphoma|diffuse large-cell lymphoma
4828370|NCT02454270|Follicular Lymphoma|follicular lymphoma
4828371|NCT02454270|Mantle-Cell Lymphoma|mantle-cell lymphoma
4828372|NCT02454270|Acute Lymphoid Leukemia|acute lymphoid leukemia
4828373|NCT02454270|Dose Escalation Study|dose escalation study
4828374|NCT02454270|Duvortuxizumab|duvortuxizumab
4828375|NCT02454231|EPC|epc
4828376|NCT02454231|CD34+|cd34+
4828377|NCT02454231|CD14+CD34low|cd14+cd34low
4828378|NCT02454218|Fibromyalgia|fibromyalgia
4828379|NCT02454218|Transcranial direct current stimulation|transcranial direct current stimulation
4828380|NCT02454192|Evidence-based intervention|evidence-based intervention
4828381|NCT02454192|Implementation|implementation
4828382|NCT02454192|Underserved communities|underserved communities
4828383|NCT02454127|nutrition|nutrition
4828384|NCT02454127|popular diets|popular diets
4828385|NCT02454127|weight loss|weight loss
4828386|NCT02454127|lifestyle|lifestyle
4828387|NCT02454127|counseling|counseling
4828388|NCT02454114|Pneumonia|pneumonia
4828389|NCT02454114|Community|community
4828390|NCT02454114|Hospital|hospital
4828391|NCT02454114|Respiratory|respiratory
4828392|NCT02454114|Infection|infection
4828393|NCT02454088|Volume|volume
4828394|NCT02454088|Hands|hands
4828395|NCT02454088|Filler|filler
4828396|NCT02454088|Radiesse|radiesse
4828397|NCT02454088|Calcium hydroxylapatite|calcium hydroxylapatite
4828398|NCT02454075|YF476|yf476
4828399|NCT02454075|netazepide|netazepide
4828400|NCT02454075|gastric carcinoids|gastric carcinoids
4828401|NCT02454075|Zollinger-Ellison syndrome|zollinger-ellison syndrome
4828402|NCT02454062|Phase I|phase i
4828403|NCT02454062|Solid Tumors|solid tumors
4828404|NCT02454062|Pharmacokinetics|pharmacokinetics
4828405|NCT02454062|Pharmacodynamics|pharmacodynamics
4828406|NCT02454062|MTD|mtd
4828407|NCT02454023|Stroke|stroke
4828408|NCT02454023|Transient ischemic attack|transient ischemic attack
4828409|NCT02454023|Obstructive sleep apnea|obstructive sleep apnea
4828410|NCT02454023|Portable sleep monitor|portable sleep monitor
4828411|NCT02454023|Screening|screening
4828412|NCT02453997|lupus nephritis|lupus nephritis
4828413|NCT02453997|mycophenolic acid|mycophenolic acid
4828414|NCT02453997|pharmacokinetics|pharmacokinetics
4828415|NCT02453997|pharmacogenomics|pharmacogenomics
4828416|NCT02453984|89Zr-MPLD3280A-PET|89zr-mpld3280a-pet
4828417|NCT02453984|triple-negative breast cancer|triple-negative breast cancer
4828418|NCT02453984|non small cell lung cancer|non small cell lung cancer
4828419|NCT02453984|cancer of the urinary tract|cancer of the urinary tract
4828420|NCT02453971|alcohol consumption|alcohol consumption
4828421|NCT02453971|binge drinking|binge drinking
4828422|NCT02453971|web-based personalized feedback program|web-based personalized feedback program
4828423|NCT02453971|students|students
4828424|NCT02453958|Injury|injury
4828425|NCT02453958|Brain|brain
4828426|NCT02453958|Traumatic Mild|traumatic mild
4828427|NCT02453958|Mild Traumatic Brain Injury|mild traumatic brain injury
4828428|NCT02453945|pain|pain
4828429|NCT02453945|comfort|comfort
4828430|NCT02453945|healing|healing
4828431|NCT02453945|quality of life|quality of life
4828432|NCT02453932|Vascular dementia|vascular dementia
4828433|NCT02453932|Tianzhi granule|tianzhi granule
4828434|NCT02453932|Herbal medicine|herbal medicine
4828435|NCT02453932|Randomized controlled trial|randomized controlled trial
4828436|NCT02453932|Three arms|three arms
4828437|NCT02453919|functional cardiac abnormality|functional cardiac abnormality
4828438|NCT02453919|morphologic cardiac abnormality|morphologic cardiac abnormality
4828439|NCT02453919|blood pressure abnormality|blood pressure abnormality
4828440|NCT02453893|Iloperidone|iloperidone
4828441|NCT02453893|Risperidone|risperidone
4828442|NCT02453893|PANSS|panss
4828443|NCT02453880|anxiety|anxiety
4828444|NCT02453880|depression|depression
4828445|NCT02453880|chronic illness|chronic illness
4828446|NCT02453880|teen|teen
4828447|NCT02453880|young adult|young adult
4828448|NCT02453867|kidney transplantation|kidney transplantation
4828449|NCT02453867|senior kidney transplant recipients|senior kidney transplant recipients
4828450|NCT02453867|tacrolimus once daily|tacrolimus once daily
4828451|NCT02453867|reduced immunosuppression|reduced immunosuppression
4828452|NCT02453867|recipients >65 years|recipients >65 years
4828453|NCT02453867|Senior|senior
4828454|NCT02453802|Tranexamic Acid|tranexamic acid
4828455|NCT02453802|Total Knee Arthroplasty|total knee arthroplasty
4828456|NCT02453802|Rivaroxaban|rivaroxaban
4828457|NCT02453789|alginate oligosaccharide|alginate oligosaccharide
4828458|NCT02453789|cystic fibrosis|cystic fibrosis
4828459|NCT02453789|Burkholderia|burkholderia
4828460|NCT02453789|aztreonam|aztreonam
4828461|NCT02453776|Crohns Disease|crohns disease
4828462|NCT02453776|Ulcerative Colitis|ulcerative colitis
4828463|NCT02453776|Infliximab|infliximab
4828464|NCT02453776|Sustained|sustained
4828465|NCT02453776|Remission|remission
4828466|NCT02453776|Inflammatory bowel disease|inflammatory bowel disease
4828467|NCT02453776|IBD|ibd
4828468|NCT02453763|Transcranial direct current stimulation|transcranial direct current stimulation
4828469|NCT02453763|Noninvasive brain stimulation|noninvasive brain stimulation
4828470|NCT02453763|Brain|brain
4828471|NCT02453763|Central Nervous System Diseases|central nervous system diseases
4828472|NCT02453763|Nervous System Diseases|nervous system diseases
4828473|NCT02453763|Parkinson disease|parkinson disease
4828474|NCT02453763|Stroke|stroke
4828475|NCT02453763|Epilepsy|epilepsy
4828476|NCT02453763|Depression|depression
4828477|NCT02453763|Schizophrenia|schizophrenia
4828478|NCT02453763|Brain imaging|brain imaging
4828479|NCT02453763|Electrical impedance tomography|electrical impedance tomography
4828480|NCT02453763|Magnetic resonance electrical impedance tomography|magnetic resonance electrical impedance tomography
4828481|NCT02453763|Diffusion tensor imaging|diffusion tensor imaging
4828482|NCT02453763|Functional magnetic imaging|functional magnetic imaging
4828483|NCT02453763|Rehabilitation|rehabilitation
4828484|NCT02453750|Congenital Diaphragmatic Hernia|congenital diaphragmatic hernia
4828485|NCT02453750|Airway Inflammation|airway inflammation
4828486|NCT02453750|Asthma|asthma
4828487|NCT02453750|Hypersaline|hypersaline
4828488|NCT02453750|Pediatrics|pediatrics
4828489|NCT02453737|Proton|proton
4828490|NCT02453737|Brachytherapy|brachytherapy
4828491|NCT02453737|Partial Breast Irradiation|partial breast irradiation
4828492|NCT02453737|3D Conformal Photon|3d conformal photon
4828493|NCT02453724|Ultrasonography|ultrasonography
4828494|NCT02453724|Lung|lung
4828495|NCT02453724|Hemorrhage|hemorrhage
4828496|NCT02453724|Point of care ultrasound|point of care ultrasound
4828497|NCT02453698|Stop task|stop task
4828498|NCT02453698|modulatory effect of MPH|modulatory effect of mph
4828499|NCT02453698|bottom-up and top-down|bottom-up and top-down
4828500|NCT02453698|cognitive processes|cognitive processes
4828501|NCT02453633|Appointment reminder|appointment reminder
4828502|NCT02453633|Attendance|attendance
4828503|NCT02453633|No-show|no-show
4828504|NCT02453594|PD1|pd1
4828505|NCT02453594|PD-1|pd-1
4828506|NCT02453594|PDL1|pdl1
4828507|NCT02453594|PD-L1|pd-l1
4828508|NCT02453542|hemophilia|hemophilia
4828509|NCT02453542|inhibitors|inhibitors
4828510|NCT02453542|thrombin|thrombin
4828511|NCT02453529|plasma concentration|plasma concentration
4828512|NCT02453529|pulmonary concentration|pulmonary concentration
4828513|NCT02453516|Serratus Block|serratus block
4828514|NCT02453516|Breast Surgery|breast surgery
4828515|NCT02453503|Lichen planus|lichen planus
4828516|NCT02453503|Mucoadhesive film|mucoadhesive film
4828517|NCT02453503|licorice|licorice
4828518|NCT02453490|Colorectal Cancer|colorectal cancer
4828519|NCT02453490|liver metastasis|liver metastasis
4828520|NCT02453490|neoadjuvant chemotherapy|neoadjuvant chemotherapy
4828521|NCT02453477|Beta thalassemia|beta thalassemia
4828522|NCT02453477|Gene therapy|gene therapy
4828523|NCT02453477|Lentiviral vector|lentiviral vector
4828524|NCT02453451|MitraClip|mitraclip
4828525|NCT02453451|atrial septal defect|atrial septal defect
4828526|NCT02453451|iatrogenic|iatrogenic
4828527|NCT02453425|renal blood flow|renal blood flow
4828528|NCT02453425|renal oxygenation|renal oxygenation
4828529|NCT02453425|glomerular filtration rate|glomerular filtration rate
4828530|NCT02453425|filtration fraction|filtration fraction
4828531|NCT02453425|blood pressure|blood pressure
4828532|NCT02453412|Arteriovenous fistulae (AVFs)|arteriovenous fistulae (avfs)
4828533|NCT02453412|Non-maturation|non-maturation
4828534|NCT02453412|Computational simulation|computational simulation
4828535|NCT02453386|Motor fluctuations|motor fluctuations
4828536|NCT02453386|Off time|off time
4828537|NCT02453386|On time|on time
4828538|NCT02453386|Dyskinesia|dyskinesia
4828539|NCT02453360|Anesthesia|anesthesia
4828540|NCT02453360|Analgesia|analgesia
4828541|NCT02453347|Stable chronic medical conditions|stable chronic medical conditions
4828542|NCT02453347|No current alcohol or substance abuse|no current alcohol or substance abuse
4828543|NCT02453347|Alpha Stim|alpha stim
4828544|NCT02453321|Continuous Femoral Nerve Block|continuous femoral nerve block
4828545|NCT02453321|Continuous Adductor Canal Block|continuous adductor canal block
4828546|NCT02453308|Artemisinin combination Therapies|artemisinin combination therapies
4828547|NCT02453295|Lymphedema|lymphedema
4828548|NCT02453295|Arm Disability|arm disability
4828549|NCT02453295|Cancer Survivorship|cancer survivorship
4828550|NCT02453295|Intervention|intervention
4828551|NCT02453282|NSCLC, PD-L1, MEDI4736, Tremelimumab, PFS, OS|nsclc, pd-l1, medi4736, tremelimumab, pfs, os
4828552|NCT02453269|Obesity|obesity
4828553|NCT02453269|Children|children
4828554|NCT02453269|Health Colective|health colective
4828555|NCT02453243|Suicide screening in the ED|suicide screening in the ed
4828556|NCT02453243|Safety Planning|safety planning
4828557|NCT02453217|severe mental illness|severe mental illness
4828558|NCT02453217|physical health screening|physical health screening
4828559|NCT02453217|randomised controlled trial|randomised controlled trial
4828560|NCT02453217|health behaviour change|health behaviour change
4828561|NCT02453178|physical activity|physical activity
4828562|NCT02453178|aging|aging
4828563|NCT02453178|cognition|cognition
4828564|NCT02453178|brain|brain
4828565|NCT02453178|exercise|exercise
4828566|NCT02453165|vaginal dehiscence|vaginal dehiscence
4828567|NCT02453152|myotubular myopathy|myotubular myopathy
4828568|NCT02453152|respiratory muscles|respiratory muscles
4828569|NCT02453152|natural history|natural history
4828570|NCT02453126|Eosinophilic Esophagitis|eosinophilic esophagitis
4828571|NCT02453126|Esophageal Stricture|esophageal stricture
4828572|NCT02453048|Pertussis|pertussis
4828573|NCT02453048|Colonization|colonization
4828574|NCT02453048|Vaccine|vaccine
4828575|NCT02453048|Immune response|immune response
4828576|NCT02453048|BPZE1|bpze1
4828577|NCT02453048|Infection|infection
4828578|NCT02453048|Bordetella pertussis|bordetella pertussis
4828579|NCT02453048|B. pertussis|b. pertussis
4828580|NCT02453048|respiratory Tract Infection|respiratory tract infection
4828581|NCT02453035|bioresorbable scaffold|bioresorbable scaffold
4828582|NCT02453035|CAD|cad
4828583|NCT02453022|Bioavailability|bioavailability
4828584|NCT02453022|Omeprazole|omeprazole
4828585|NCT02453022|Danirixin|danirixin
4828586|NCT02453022|Food Effect|food effect
4828587|NCT02453022|Pharmacokinetics|pharmacokinetics
4828588|NCT02452996|GNbAC1|gnbac1
4828589|NCT02452996|Multiple Sclerosis|multiple sclerosis
4828590|NCT02452996|Multiple Sclerosis Associated Retrovirus (MSRV)|multiple sclerosis associated retrovirus (msrv)
4828591|NCT02452996|MSRV-Envelope protein|msrv-envelope protein
4828592|NCT02452996|Monoclonal antibody|monoclonal antibody
4828593|NCT02452983|Anemia|anemia
4828594|NCT02452983|Leukemia|leukemia
4828595|NCT02452983|Hematologic diseases|hematologic diseases
4828596|NCT02452983|Cytopenias|cytopenias
4828597|NCT02452983|Bone marrow diseases|bone marrow diseases
4828598|NCT02452983|Preleukemia|preleukemia
4828599|NCT02452944|nerve stimulator, obturator nerve, ultrasound|nerve stimulator, obturator nerve, ultrasound
4828600|NCT02452918|skin infection|skin infection
4828601|NCT02452892|Depression|depression
4828602|NCT02452892|Major depression|major depression
4828603|NCT02452892|Low-field magnetic stimulation|low-field magnetic stimulation
4828604|NCT02452892|LFMS|lfms
4828605|NCT02452840|neovascular age-related macular degeneration|neovascular age-related macular degeneration
4828606|NCT02452840|anti-vascular endothelial growth factor|anti-vascular endothelial growth factor
4828607|NCT02452840|verteporfin|verteporfin
4828608|NCT02452840|photodynamic therapy|photodynamic therapy
4828609|NCT02452840|persistent disease activity|persistent disease activity
4828610|NCT02452710|Fatigue in Cancer Survivors|fatigue in cancer survivors
4828611|NCT02452697|Nonmyeloablative|nonmyeloablative
4828612|NCT02452697|Stem Cell|stem cell
4828613|NCT02452697|Transplant|transplant
4828614|NCT02452684|Insomnia|insomnia
4828615|NCT02452658|Fast food literacy|fast food literacy
4828616|NCT02452645|Food|food
4828617|NCT02452645|Nutrition|nutrition
4828618|NCT02452645|Physical Activity|physical activity
4828619|NCT02452645|Family|family
4828620|NCT02452645|Child Care|child care
4828621|NCT02452645|Home|home
4828622|NCT02452645|Environment|environment
4828623|NCT02452632|ASP1941|asp1941
4828624|NCT02452632|Type 2 diabetes mellitus|type 2 diabetes mellitus
4828625|NCT02452619|Hyperbaric oxygen therapy|hyperbaric oxygen therapy
4828626|NCT02452619|brain trauma|brain trauma
4828627|NCT02452619|cognitive impairment|cognitive impairment
4828628|NCT02452606|Stalevo|stalevo
4828629|NCT02452606|sleep disturbance|sleep disturbance
4828630|NCT02452606|central circadian clock|central circadian clock
4828631|NCT02452606|narcolepsy|narcolepsy
4828632|NCT02452593|incontinence; pelvic floor exercises; neuromodulation|incontinence; pelvic floor exercises; neuromodulation
4828633|NCT02452580|Kangaroo Mother Care|kangaroo mother care
4828634|NCT02452580|Neonatal Intensive Care Units|neonatal intensive care units
4828635|NCT02452580|Postnatal growth|postnatal growth
4828636|NCT02452541|Traumatic Brain Injury|traumatic brain injury
4828637|NCT02452541|Critically ill Patients|critically ill patients
4828638|NCT02452541|Death|death
4828639|NCT02452541|Head Injury|head injury
4828640|NCT02452541|TBI-Prognosis|tbi-prognosis
4828641|NCT02452541|Critical Care Medicine|critical care medicine
4828642|NCT02452541|Withdrawal of Life Sustaining Therapy|withdrawal of life sustaining therapy
4828643|NCT02452541|Prognosis|prognosis
4828644|NCT02452541|Prognostic Evaluation|prognostic evaluation
4828645|NCT02452541|Outcome Research|outcome research
4828646|NCT02452541|Mortality|mortality
4828647|NCT02452541|Decision-making|decision-making
4828648|NCT02452528|Hepatitis B Virus|hepatitis b virus
4828649|NCT02452528|Chronic Hepatitis B|chronic hepatitis b
4828650|NCT02452528|HBV|hbv
4828651|NCT02452502|stroke|stroke
4828652|NCT02452502|thrombolytic therapy|thrombolytic therapy
4828653|NCT02452502|atorvastatin|atorvastatin
4828654|NCT02452489|Different acupoints compatibility|different acupoints compatibility
4828655|NCT02452437|oxycodone|oxycodone
4828656|NCT02452437|hemodialysis|hemodialysis
4828657|NCT02452411|Internet|internet
4828658|NCT02452411|Adjustment disorders|adjustment disorders
4828659|NCT02452411|Homework assignments|homework assignments
4828660|NCT02452411|Cognitive-Behavioral treatment|cognitive-behavioral treatment
4828661|NCT02452411|Online therapy|online therapy
4828662|NCT02452411|Emotional Regulation|emotional regulation
4828663|NCT02452411|ICT's|ict's
4828664|NCT02452398|Hair removal|hair removal
4828665|NCT02452398|depilation|depilation
4828666|NCT02452398|epilation|epilation
4828667|NCT02452372|RNAi therapeutic|rnai therapeutic
4828668|NCT02452372|Porphyria|porphyria
4828669|NCT02452372|AIP|aip
4828670|NCT02452359|stretch marks|stretch marks
4828671|NCT02452346|MDS|mds
4828672|NCT02452333|Excisional breast biopsy|excisional breast biopsy
4828673|NCT02452333|Oncoplastic surgery|oncoplastic surgery
4828674|NCT02452333|Oncoplastic reconstruction|oncoplastic reconstruction
4828675|NCT02452333|Breast conserving surgery|breast conserving surgery
4828676|NCT02452333|Tezel method of breast volume measurement|tezel method of breast volume measurement
4828677|NCT02452320|bariatric|bariatric
4828678|NCT02452320|Post-operative nausea and vomiting|post-operative nausea and vomiting
4828679|NCT02452320|laparoscopic Sleeve gastrectomy|laparoscopic sleeve gastrectomy
4828680|NCT02452320|intravenous acetaminophen|intravenous acetaminophen
4828681|NCT02452294|Brain|brain
4828682|NCT02452281|Therapeutically Unresectable|therapeutically unresectable
4828683|NCT02452281|Stage III or Stage IV|stage iii or stage iv
4828684|NCT02452281|Malignant Melanoma|malignant melanoma
4828685|NCT02452281|Advanced Melanoma|advanced melanoma
4828686|NCT02452203|floating|floating
4828687|NCT02452203|interoception|interoception
4828688|NCT02452177|parenteral nutrition associated liver disease|parenteral nutrition associated liver disease
4828689|NCT02452177|vitamin D|vitamin d
4828690|NCT02452177|short bowel syndrome|short bowel syndrome
4828691|NCT02452177|farnesoid X receptor|farnesoid x receptor
4828692|NCT02452177|cholestasis|cholestasis
4828693|NCT02452164|otoscopy|otoscopy
4828694|NCT02452164|otitis media|otitis media
4828695|NCT02452164|cellphone|cellphone
4828696|NCT02452164|family|family
4828697|NCT02452151|Inflectra|inflectra
4828698|NCT02452151|Infliximab|infliximab
4828699|NCT02452151|Biosimilar|biosimilar
4828700|NCT02452099|DMSO|dmso
4828701|NCT02452099|cryopreservation|cryopreservation
4828702|NCT02452099|autologous transplantation|autologous transplantation
4828703|NCT02452099|hematopoietic stem cells|hematopoietic stem cells
4828704|NCT02452099|hematological malignancies|hematological malignancies
4828705|NCT02452073|low triiodothyronine syndrome|low triiodothyronine syndrome
4828706|NCT02452073|chronic radiation enteritis|chronic radiation enteritis
4828707|NCT02452073|triiodothyronine|triiodothyronine
4828708|NCT02452073|thyroxine|thyroxine
4828709|NCT02452073|thyroid stimulating hormone|thyroid stimulating hormone
4828710|NCT02452060|perioperative period|perioperative period
4828711|NCT02452060|pain|pain
4828712|NCT02452060|gastric bypass|gastric bypass
4828713|NCT02452008|metastatic castration-resistant prostate cancer|metastatic castration-resistant prostate cancer
4828714|NCT02452008|enzalutamide|enzalutamide
4828715|NCT02452008|LY2157299|ly2157299
4828716|NCT02452008|TGF-β receptor inhibitor|tgf-β receptor inhibitor
4828717|NCT02451943|leiomyosarcoma|leiomyosarcoma
4828718|NCT02451943|soft tissue sarcoma (STS)|soft tissue sarcoma (sts)
4828719|NCT02451943|advanced soft tissue sarcoma|advanced soft tissue sarcoma
4828720|NCT02451943|metastatic soft tissue sarcoma|metastatic soft tissue sarcoma
4828721|NCT02451943|liposarcoma|liposarcoma
4828722|NCT02451943|undifferentiated pleomorphic sarcoma|undifferentiated pleomorphic sarcoma
4828723|NCT02451943|doxorubicin|doxorubicin
4828724|NCT02451917|Glargine insulin|glargine insulin
4828725|NCT02451917|Chronic Kidney Disease|chronic kidney disease
4828726|NCT02451917|CGMS|cgms
4828727|NCT02451904|Pathogenesis|pathogenesis
4828728|NCT02451904|Microvascular function|microvascular function
4828729|NCT02451904|Metabolic dysregulation|metabolic dysregulation
4828730|NCT02451904|Metabolomics|metabolomics
4828731|NCT02451878|shyness|shyness
4828732|NCT02451878|internet|internet
4828733|NCT02451878|self-help|self-help
4828734|NCT02451878|psychology|psychology
4828735|NCT02451878|wellbeing|wellbeing
4828736|NCT02451839|Crohn Disease|crohn disease
4828737|NCT02451839|Arthritis, Rheumatoid|arthritis, rheumatoid
4828738|NCT02451839|Psoriasis|psoriasis
4828739|NCT02451839|Patient Outcome Assessment|patient outcome assessment
4828740|NCT02451839|Adalimumab|adalimumab
4828741|NCT02451839|Global Health|global health
4828742|NCT02451839|Quality of Life|quality of life
4828743|NCT02451826|ovulation inhibition|ovulation inhibition
4828744|NCT02451826|endometrial changes|endometrial changes
4828745|NCT02451826|bleeding patterns|bleeding patterns
4828746|NCT02451813|opening injection pressure|opening injection pressure
4828747|NCT02451813|femoral nerve block|femoral nerve block
4828748|NCT02451813|fascia iliaca|fascia iliaca
4828749|NCT02451813|ultrasound guided nerve block|ultrasound guided nerve block
4828750|NCT02451774|pediatric|pediatric
4828751|NCT02451774|apoptosis|apoptosis
4828752|NCT02451761|chromosomal rearrangement|chromosomal rearrangement
4828753|NCT02451761|next generation sequencing|next generation sequencing
4828754|NCT02451761|intellectual disability|intellectual disability
4828755|NCT02451761|multiple congenital anomalies|multiple congenital anomalies
4828756|NCT02451761|gene disruption|gene disruption
4828757|NCT02451735|female breast cancer|female breast cancer
4828758|NCT02451735|bilateral breast cancer|bilateral breast cancer
4828759|NCT02451735|triple negative breast cancer|triple negative breast cancer
4828760|NCT02451735|breast cancer diagnosis|breast cancer diagnosis
4828761|NCT02451735|BRCA 1|brca 1
4828762|NCT02451735|BRCA 2|brca 2
4828763|NCT02451735|psychoeducational intervention (PEI)|psychoeducational intervention (pei)
4828764|NCT02451735|genetic counseling|genetic counseling
4828765|NCT02451735|hereditary breast and ovarian cancer (HBOC)|hereditary breast and ovarian cancer (hboc)
4828766|NCT02451735|cancer education materials|cancer education materials
4828768|NCT02451631|Mobile Application|mobile application
4828769|NCT02451631|Diabetes management|diabetes management
4828770|NCT02451618|Perinatal Depression|perinatal depression
4828771|NCT02451605|surgery|surgery
4828772|NCT02451592|Fungemia|fungemia
4828773|NCT02451592|Hematologic malignancies|hematologic malignancies
4828774|NCT02451579|Actinic Keratoses|actinic keratoses
4828775|NCT02451579|Photodynamic Therapy|photodynamic therapy
4828776|NCT02451579|PDT|pdt
4828777|NCT02451579|Blue Light|blue light
4828778|NCT02451566|Abdominal|abdominal
4828779|NCT02451566|Aortic|aortic
4828780|NCT02451566|Aneurysm|aneurysm
4828781|NCT02451540|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
4828782|NCT02451540|dynamics hyperinflation|dynamics hyperinflation
4829376|NCT02448004|Healthy|healthy
4828783|NCT02451540|Computed Tomography scan|computed tomography scan
4828784|NCT02451540|CT scan|ct scan
4828785|NCT02451540|Functional Respiratory Imaging|functional respiratory imaging
4828786|NCT02451540|FRI|fri
4828787|NCT02451540|Roflumilast|roflumilast
4828788|NCT02451540|PRO|pro
4828789|NCT02451514|Antibody persistence|antibody persistence
4828790|NCT02451514|Young Adults|young adults
4828791|NCT02451514|Healthy Adolescents|healthy adolescents
4828792|NCT02451514|MenABCWY vaccine|menabcwy vaccine
4828793|NCT02451514|Booster response|booster response
4828794|NCT02451514|MenABCWY+OMV|menabcwy+omv
4828795|NCT02451475|Pregabalin|pregabalin
4828796|NCT02451475|Fibromyalgia|fibromyalgia
4828797|NCT02451462|hematopoietic stem cell transplant|hematopoietic stem cell transplant
4828798|NCT02451462|bone marrow transplant|bone marrow transplant
4828799|NCT02451449|Celiac disease|celiac disease
4828800|NCT02451449|Infertility|infertility
4828801|NCT02451449|Prevalence study|prevalence study
4828802|NCT02451436|Adolescents, sleep, media use, obesity, type 2 diabetes|adolescents, sleep, media use, obesity, type 2 diabetes
4828803|NCT02451423|Non-metastatic|non-metastatic
4828804|NCT02451423|Bladder|bladder
4828805|NCT02451410|Nutrition|nutrition
4828806|NCT02451410|Physical activity|physical activity
4828807|NCT02451410|Overweight|overweight
4828808|NCT02451410|Obesity|obesity
4828809|NCT02451410|Malnutrition|malnutrition
4828810|NCT02451371|Schizophrenia|schizophrenia
4828811|NCT02451371|Refractory auditory hallucination|refractory auditory hallucination
4828812|NCT02451371|tDCS|tdcs
4828813|NCT02451358|Influenza|influenza
4828814|NCT02451358|Quadrivalent Inactivated Influenza Vaccine (QIV)|quadrivalent inactivated influenza vaccine (qiv)
4828815|NCT02451345|Prostate cancer|prostate cancer
4828816|NCT02451345|Tranformative Impact Award|tranformative impact award
4828817|NCT02451345|Early stage|early stage
4828818|NCT02451345|Active Surveillance|active surveillance
4828819|NCT02451345|Decision aid|decision aid
4828820|NCT02451345|Coaching session|coaching session
4828821|NCT02451345|Personalized|personalized
4828822|NCT02451345|UCSF|ucsf
4828823|NCT02451345|validation|validation
4828824|NCT02451319|RIRS, holmium, 1-2 cm,stones,kidney|rirs, holmium, 1-2 cm,stones,kidney
4828825|NCT02451293|Depression|depression
4828826|NCT02451293|Acute Coronary Syndrome|acute coronary syndrome
4828827|NCT02451293|Anxiety|anxiety
4828828|NCT02451293|Sleep|sleep
4828829|NCT02451293|Circadian|circadian
4828830|NCT02451280|stroke rehabilitation|stroke rehabilitation
4828831|NCT02451280|robot-assisted therapy|robot-assisted therapy
4828832|NCT02451280|hybrid therapy|hybrid therapy
4828833|NCT02451267|neck pain|neck pain
4828834|NCT02451267|aerobic exercise|aerobic exercise
4828835|NCT02451267|cervical pain|cervical pain
4828836|NCT02451241|Acupuncture|acupuncture
4828837|NCT02451228|Pharmacokinetics|pharmacokinetics
4828838|NCT02451228|Pharmacodynamics|pharmacodynamics
4828839|NCT02451228|Preterm labor|preterm labor
4828840|NCT02451228|Preterm birth|preterm birth
4828841|NCT02451228|Estradiol|estradiol
4828842|NCT02451228|Indomethacin|indomethacin
4828843|NCT02451228|Pregnancy|pregnancy
4828844|NCT02451228|Short Cervix|short cervix
4828845|NCT02451228|CYP2C9 Genotype|cyp2c9 genotype
4828846|NCT02451202|"surgical conditions"|"surgical conditions"
4828847|NCT02451202|"deep neuromuscular blockade"|"deep neuromuscular blockade"
4828848|NCT02451202|"deep neuromuscular paralysis"|"deep neuromuscular paralysis"
4828849|NCT02451189|Obesity|obesity
4828850|NCT02451189|Weight maintenance|weight maintenance
4828851|NCT02451189|Appetite|appetite
4828852|NCT02451189|Energy intake|energy intake
4828853|NCT02451189|Dietary fibre|dietary fibre
4828854|NCT02451189|Short-chain fatty acids|short-chain fatty acids
4828855|NCT02451189|Fermentation|fermentation
4828856|NCT02451189|Overweight|overweight
4828857|NCT02451150|Drug therapy|drug therapy
4828858|NCT02451124|Barrett|barrett
4828859|NCT02451124|Cancer|cancer
4828860|NCT02451124|Screening|screening
4828861|NCT02451111|Rituximab|rituximab
4828862|NCT02451111|Ibrutinib|ibrutinib
4828863|NCT02451111|Follicular Lymphoma|follicular lymphoma
4828865|NCT02451085|surgery|surgery
4828866|NCT02451085|Replacement|replacement
4828867|NCT02451059|community resource|community resource
4828868|NCT02451059|well-child care visit|well-child care visit
4828869|NCT02451059|low-income|low-income
4828870|NCT02451046|Liver transplantation|liver transplantation
4828871|NCT02451046|Primary dysfunction|primary dysfunction
4828872|NCT02451033|Regenerative medicine|regenerative medicine
4828873|NCT02451020|healthy volunteers|healthy volunteers
4828874|NCT02451020|acclimatization|acclimatization
4828875|NCT02451020|sleep|sleep
4828876|NCT02451020|hypoxia|hypoxia
4828877|NCT02450994|airway disease|airway disease
4828878|NCT02450994|bronchitis|bronchitis
4828879|NCT02450994|emphysema|emphysema
4828880|NCT02450994|lung|lung
4828881|NCT02450994|treatment|treatment
4828882|NCT02450994|sleep|sleep
4828883|NCT02450968|airway disease|airway disease
4828884|NCT02450968|bronchitis|bronchitis
4828885|NCT02450968|emphysema|emphysema
4828886|NCT02450968|lung|lung
4828887|NCT02450968|treatment|treatment
4829879|NCT02444910|KDT501|kdt501
4828888|NCT02450955|Tension-type headache|tension-type headache
4828889|NCT02450955|manual therapy|manual therapy
4828890|NCT02450955|disability|disability
4828891|NCT02450955|spinal manipulation|spinal manipulation
4828892|NCT02450929|post operative|post operative
4828893|NCT02450929|pneumonia|pneumonia
4828894|NCT02450929|vascular|vascular
4828895|NCT02450929|orthopedic|orthopedic
4828896|NCT02450929|urologic|urologic
4828897|NCT02450929|neurologic|neurologic
4828898|NCT02450916|work-related injury|work-related injury
4828899|NCT02450916|occupational disease|occupational disease
4828900|NCT02450916|workers' compensation|workers' compensation
4828901|NCT02450916|psychological|psychological
4828902|NCT02450916|policy|policy
4828903|NCT02450903|Non-Small-Cell Lung Cancer, ALK, LDK378|non-small-cell lung cancer, alk, ldk378
4828904|NCT02450890|ORADUR®-Methylphenidate|oradur®-methylphenidate
4828905|NCT02450877|Children|children
4828906|NCT02450877|Young Adults|young adults
4828907|NCT02450877|Azacitidine|azacitidine
4828908|NCT02450877|Acute Myeloid Leukemia|acute myeloid leukemia
4828909|NCT02450877|Molecular Relapse|molecular relapse
4828910|NCT02450877|Vidaza|vidaza
4828911|NCT02450877|AZA-AML-004|aza-aml-004
4828912|NCT02450864|Stiffness of Shoulder, Not Elsewhere Classified|stiffness of shoulder, not elsewhere classified
4828913|NCT02450851|Rare Diseases|rare diseases
4828914|NCT02450851|Undiagnosed Disease|undiagnosed disease
4828915|NCT02450838|Dengue Vaccine|dengue vaccine
4828916|NCT02450812|mCRPC|mcrpc
4828917|NCT02450773|postpartum|postpartum
4828918|NCT02450773|preeclampsia|preeclampsia
4828919|NCT02450773|gestational hypertension|gestational hypertension
4828920|NCT02450747|Visual Acuity|visual acuity
4828921|NCT02450734|ultrasound-guided intermediate cervical plexus block|ultrasound-guided intermediate cervical plexus block
4828922|NCT02450721|atherosclerosis|atherosclerosis
4828923|NCT02450721|biomarkers|biomarkers
4828924|NCT02450721|carotid artery stenosis|carotid artery stenosis
4828925|NCT02450721|ischemic stroke.|ischemic stroke.
4828926|NCT02450708|Allogeneic Hematopoietic Cell Donors|allogeneic hematopoietic cell donors
4828927|NCT02450708|KIR and HLA Genotypes|kir and hla genotypes
4828928|NCT02450708|15-059|15-059
4828929|NCT02450695|rTMS|rtms
4828930|NCT02450695|treatment refractory|treatment refractory
4828931|NCT02450695|treatment resistant|treatment resistant
4828932|NCT02450695|SSRI|ssri
4828933|NCT02450695|clomipramine|clomipramine
4828934|NCT02450669|Intubation|intubation
4828935|NCT02450669|Extubation|extubation
4828936|NCT02450669|Weaning|weaning
4828937|NCT02450669|Mechanical ventilation|mechanical ventilation
4828938|NCT02450617|Complex PTSD|complex ptsd
4828939|NCT02450604|Prevalence Study|prevalence study
4828940|NCT02450604|Fabry's disease|fabry's disease
4828941|NCT02450604|Chronic pain|chronic pain
4828942|NCT02450591|Sensitizing EGFR Mutations|sensitizing egfr mutations
4828943|NCT02450591|Erlotinib|erlotinib
4828944|NCT02450591|Surgery|surgery
4828945|NCT02450591|Radiation Therapy|radiation therapy
4828946|NCT02450591|15-067|15-067
4828947|NCT02450552|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
4828948|NCT02450552|ALS|als
4828949|NCT02450552|Lou Gehrig|lou gehrig
4828950|NCT02450539|patient reported outcomes (PRO)|patient reported outcomes (pro)
4828951|NCT02450539|patient focused outcomes (PFO)|patient focused outcomes (pfo)
4828952|NCT02450539|biomarkers|biomarkers
4828953|NCT02450539|CDK 4 and 6|cdk 4 and 6
4828954|NCT02450513|adalimumab|adalimumab
4828955|NCT02450513|anti-TNF|anti-tnf
4828956|NCT02450513|pharmacokinetics|pharmacokinetics
4828957|NCT02450513|trough level|trough level
4828958|NCT02450513|immunogenicity|immunogenicity
4828959|NCT02450487|Piroxicam|piroxicam
4828960|NCT02450487|Pharmacogenetic|pharmacogenetic
4828961|NCT02450487|Lower Third molar|lower third molar
4828962|NCT02450448|Renal Neoplasms|renal neoplasms
4828963|NCT02450448|Circulating Tumor Cells|circulating tumor cells
4828964|NCT02450435|Prostatic Neoplasms|prostatic neoplasms
4828965|NCT02450435|Circulating TUmor Cells|circulating tumor cells
4828966|NCT02450422|Colorectal Neoplasms|colorectal neoplasms
4828967|NCT02450422|Circulating Tumor Cells|circulating tumor cells
4828968|NCT02450409|Total knee arthroplasty|total knee arthroplasty
4828969|NCT02450409|Midflexion instability|midflexion instability
4828970|NCT02450409|Gap technique|gap technique
4828971|NCT02450409|Anatomical alignment|anatomical alignment
4828972|NCT02450396|Rare diseases|rare diseases
4828973|NCT02450396|pregnancy|pregnancy
4828974|NCT02450396|pregnancy,|pregnancy,
4828975|NCT02450357|Breast Neoplasms|breast neoplasms
4828976|NCT02450357|Circulating Tumor Cells|circulating tumor cells
4828977|NCT02450279|Aerosol delivery|aerosol delivery
4828978|NCT02450279|Invasive mechanical ventilation|invasive mechanical ventilation
4828979|NCT02450279|Jet Nebulizer|jet nebulizer
4828980|NCT02450279|Vibrating-Mesh nebulizer|vibrating-mesh nebulizer
4828981|NCT02450266|Primary disease|primary disease
4828982|NCT02450266|multiparametric MRI|multiparametric mri
4828983|NCT02450266|targeted prostate biopsy|targeted prostate biopsy
4828984|NCT02450266|MRI/ultrasound fusion-guided prostate biopsy|mri/ultrasound fusion-guided prostate biopsy
4828985|NCT02450266|systematic transrectal ultrasound-guided prostate biopsy|systematic transrectal ultrasound-guided prostate biopsy
4828986|NCT02450253|Vascular cognitive impairment|vascular cognitive impairment
4828987|NCT02450240|Depression|depression
4828988|NCT02450240|Anxiety|anxiety
4828989|NCT02450240|Eating Disorders|eating disorders
4828990|NCT02450240|Substance Use|substance use
4828991|NCT02450240|Functional Magnetic Resonance Imaging|functional magnetic resonance imaging
4828992|NCT02450240|Genetics|genetics
4828993|NCT02450240|Behavior|behavior
4828994|NCT02450240|Mental Health|mental health
4828995|NCT02450214|Ketamine|ketamine
4828996|NCT02450214|Magnesium|magnesium
4828997|NCT02450214|Analgesia|analgesia
4828998|NCT02450214|Liposuction|liposuction
4828999|NCT02450214|Lipoabdominoplasty|lipoabdominoplasty
4829000|NCT02450214|Preemptive analgesia|preemptive analgesia
4829001|NCT02450188|Erectile Dysfunction|erectile dysfunction
4829002|NCT02450188|PDE5 inhibitors|pde5 inhibitors
4829003|NCT02450188|Cognitive-behavioral Sex Therapy|cognitive-behavioral sex therapy
4829004|NCT02450175|Platelet Activation|platelet activation
4829005|NCT02450175|metastasis|metastasis
4829006|NCT02450110|spinal cord stimulation|spinal cord stimulation
4829007|NCT02450110|heart failure|heart failure
4829008|NCT02450110|autonomic regulation|autonomic regulation
4829009|NCT02450110|BNP|bnp
4829010|NCT02450110|left ventricle systolic dysfunction|left ventricle systolic dysfunction
4829011|NCT02450071|Pre-hospital|pre-hospital
4829012|NCT02450071|Out-of-hospital|out-of-hospital
4829013|NCT02450071|Prehospital emergency care (MeSH)|prehospital emergency care (mesh)
4829014|NCT02450071|Emergency medical services (MeSH)|emergency medical services (mesh)
4829015|NCT02450071|Helicopter emergency medical service|helicopter emergency medical service
4829016|NCT02450071|Critical care (MeSH)|critical care (mesh)
4829017|NCT02450071|Airway management (MeSH)|airway management (mesh)
4829018|NCT02450071|Endotracheal intubation (MeSH)|endotracheal intubation (mesh)
4829019|NCT02450071|Difficult endotracheal intubation|difficult endotracheal intubation
4829020|NCT02450071|Complications (MeSH)|complications (mesh)
4829021|NCT02450071|Patient safety|patient safety
4829022|NCT02450058|early breast cancer|early breast cancer
4829023|NCT02450058|adjuvant chemotherapy|adjuvant chemotherapy
4829024|NCT02450058|FEC|fec
4829025|NCT02450058|paclitaxel|paclitaxel
4829026|NCT02449993|diagnostic study|diagnostic study
4829027|NCT02449993|analysis of estrogen receptor|analysis of estrogen receptor
4829028|NCT02449993|progesterone receptor|progesterone receptor
4829029|NCT02449993|Human epidermal growth factor receptor 2|human epidermal growth factor receptor 2
4829030|NCT02449993|Ki-67|ki-67
4829031|NCT02449980|Spontaneous Pneumothorax|spontaneous pneumothorax
4829032|NCT02449980|Video Assisted Thoracoscopic Surgery|video assisted thoracoscopic surgery
4829033|NCT02449980|Tube Thoracostomy|tube thoracostomy
4829034|NCT02449980|Pediatric Surgery|pediatric surgery
4829035|NCT02449967|Pancreatic Cancer|pancreatic cancer
4829036|NCT02449967|HepaSphere|hepasphere
4829037|NCT02449954|Stress and Immune Responses|stress and immune responses
4829038|NCT02449954|morphine|morphine
4829039|NCT02449954|tramadol|tramadol
4829040|NCT02449954|ketorolac|ketorolac
4829041|NCT02449941|Stomach Neoplasms|stomach neoplasms
4829042|NCT02449941|proton pump inhibitor|proton pump inhibitor
4829043|NCT02449941|endoscopic submucosal dissection|endoscopic submucosal dissection
4829044|NCT02449941|Helicobacter pylori|helicobacter pylori
4829045|NCT02449941|Gastritis, Atrophic|gastritis, atrophic
4829046|NCT02449928|Severe Sepsis with Septic Shock, Lactate|severe sepsis with septic shock, lactate
4829047|NCT02449915|sacrocolpopexy|sacrocolpopexy
4829048|NCT02449915|rectocele repair|rectocele repair
4829049|NCT02449902|VVA|vva
4829050|NCT02449902|Postmenopausal|postmenopausal
4829051|NCT02449902|Painful Sex|painful sex
4829052|NCT02449863|Lung ultrasound|lung ultrasound
4829053|NCT02449863|Mechanical ventilation|mechanical ventilation
4829054|NCT02449863|Respiratory distress syndrome|respiratory distress syndrome
4829055|NCT02449863|Transient tachypnea of the newborn|transient tachypnea of the newborn
4829056|NCT02449850|In-utero environment|in-utero environment
4829057|NCT02449850|Asthma|asthma
4829058|NCT02449850|Allergic diseases|allergic diseases
4829059|NCT02449850|Food allergy|food allergy
4829060|NCT02449850|Birth cohort study|birth cohort study
4829061|NCT02449850|Primary prevention|primary prevention
4829062|NCT02449850|Intervention study|intervention study
4829063|NCT02449850|Atopic dermatitis|atopic dermatitis
4829064|NCT02449850|Rhinitis|rhinitis
4829065|NCT02449850|Allergy|allergy
4829066|NCT02449850|Lung function|lung function
4829067|NCT02449850|Non-communicable diseases|non-communicable diseases
4829068|NCT02449850|Foetal growth|foetal growth
4829069|NCT02449850|Obesity|obesity
4829070|NCT02449850|Cardiovascular disease|cardiovascular disease
4829071|NCT02449850|Diabetes|diabetes
4829072|NCT02449850|Blood pressure|blood pressure
4829073|NCT02449850|Anthropometric|anthropometric
4829074|NCT02449850|Trans epidermic water loss|trans epidermic water loss
4829075|NCT02449824|neoadjuvant chemotherapy|neoadjuvant chemotherapy
4829076|NCT02449824|magnetic resonance imaging|magnetic resonance imaging
4829077|NCT02449798|Difficult IV access|difficult iv access
4829078|NCT02449798|AccuCath|accucath
4829079|NCT02449798|IV outcomes|iv outcomes
4829080|NCT02449798|patient satisfaction|patient satisfaction
4829081|NCT02449785|Cystic fibrosis|cystic fibrosis
4829082|NCT02449785|MRI|mri
4829083|NCT02449785|UTE|ute
4829084|NCT02449785|CT|ct
4829085|NCT02449785|Exacerbation|exacerbation
4829086|NCT02449785|Quality of life|quality of life
4829087|NCT02449785|Pulmonary function|pulmonary function
4829088|NCT02449772|N04.452.442.422.336|n04.452.442.422.336
4829089|NCT02449746|Schizophrenia|schizophrenia
4829090|NCT02449746|Psychosis|psychosis
4829091|NCT02449746|Mental Health|mental health
4829092|NCT02449746|Autoimmunity|autoimmunity
4829093|NCT02449746|Psychoneuroimmunology|psychoneuroimmunology
4829094|NCT02449733|voluntary counseling and testing (VCT)|voluntary counseling and testing (vct)
4829095|NCT02449733|couples voluntary counseling and testing (CVCT)|couples voluntary counseling and testing (cvct)
4829096|NCT02449733|pre-exposure prophylaxis (PrEP)|pre-exposure prophylaxis (prep)
4829097|NCT02449733|homosexuality|homosexuality
4829098|NCT02449733|male|male
4829099|NCT02449733|South Africa|south africa
4829100|NCT02449720|intraperitoneal|intraperitoneal
4829101|NCT02449720|ropivacaine|ropivacaine
4829102|NCT02449720|bowel resection|bowel resection
4829103|NCT02449720|local anaesthetic|local anaesthetic
4829104|NCT02449720|recovery|recovery
4829105|NCT02449681|squamous cell carcinoma|squamous cell carcinoma
4829106|NCT02449681|the head and neck|the head and neck
4829107|NCT02449681|skin|skin
4829108|NCT02449681|TH-4000|th-4000
4829109|NCT02449681|Hypoxia|hypoxia
4829110|NCT02449681|Tarloxotinib|tarloxotinib
4829111|NCT02449668|Acupuncture|acupuncture
4829112|NCT02449668|Shoulder pain|shoulder pain
4829113|NCT02449668|Impingement syndrome|impingement syndrome
4829114|NCT02449668|Rotator cuff tendinitis|rotator cuff tendinitis
4829115|NCT02449668|Traditional Chinese medicine (TCM)|traditional chinese medicine (tcm)
4829116|NCT02449642|luteinizing hormone pulsatility|luteinizing hormone pulsatility
4829117|NCT02449642|estradiol level|estradiol level
4829118|NCT02449642|progesterone level|progesterone level
4829119|NCT02449629|HIV|hiv
4829120|NCT02449629|Transgender|transgender
4829121|NCT02449629|HIV Continuum of Care|hiv continuum of care
4829122|NCT02449616|Sickle cell|sickle cell
4829123|NCT02449616|vaso-occlusive crisis|vaso-occlusive crisis
4829124|NCT02449603|Chinese population|chinese population
4829125|NCT02449590|Onion|onion
4829126|NCT02449590|Cardiovascular disease|cardiovascular disease
4829127|NCT02449590|metabolomics|metabolomics
4829128|NCT02449590|Gene expression|gene expression
4829129|NCT02449590|Biomarker|biomarker
4829130|NCT02449577|Metabolomics|metabolomics
4829131|NCT02449577|Beer|beer
4829132|NCT02449577|Biomarker|biomarker
4829133|NCT02449577|Glucose response|glucose response
4829134|NCT02449577|Insulin response|insulin response
4829135|NCT02449486|Requirement of postoperative pain medication|requirement of postoperative pain medication
4829136|NCT02449473|Asthma|asthma
4829137|NCT02449473|Reactive Airways|reactive airways
4829138|NCT02449473|Respiratory Tract Disease|respiratory tract disease
4829139|NCT02449473|Obstructive Tract Disease|obstructive tract disease
4829140|NCT02449473|Lung Diseases|lung diseases
4829141|NCT02449460|hypertension|hypertension
4829142|NCT02449460|epidemiology|epidemiology
4829143|NCT02449460|glucose|glucose
4829144|NCT02449460|body mass index|body mass index
4829145|NCT02449460|lipids|lipids
4829146|NCT02449460|smoking|smoking
4829147|NCT02449460|coronary artery disease|coronary artery disease
4829148|NCT02449460|arterial stiffness|arterial stiffness
4829149|NCT02449460|carotid ultrasound|carotid ultrasound
4829150|NCT02449447|Major Depressive Disorder (MDD)|major depressive disorder (mdd)
4829151|NCT02449447|Blended treatment|blended treatment
4829152|NCT02449447|Cognitive behavior Therapy (CBT)|cognitive behavior therapy (cbt)
4829153|NCT02449447|Face-to-face|face-to-face
4829154|NCT02449447|internet-based treatment|internet-based treatment
4829155|NCT02449421|trauma|trauma
4829156|NCT02449382|continuous venovenous hemofiltration|continuous venovenous hemofiltration
4829157|NCT02449382|conventional treatment|conventional treatment
4829158|NCT02449382|mortality|mortality
4829159|NCT02449382|acute severe hypernatremia|acute severe hypernatremia
4829160|NCT02449356|Prone position ventilation|prone position ventilation
4829161|NCT02449356|Endotracheal intubation|endotracheal intubation
4829162|NCT02449356|Displacement|displacement
4829163|NCT02449317|contrast induced acute kidney injury|contrast induced acute kidney injury
4829164|NCT02449317|bioimpedance|bioimpedance
4829165|NCT02449304|endometrial ablation, heavy menstrual bleeding, novosure|endometrial ablation, heavy menstrual bleeding, novosure
4829166|NCT02449278|advanced-stage DLBCL|advanced-stage dlbcl
4829167|NCT02449278|ISRT|isrt
4829168|NCT02449278|chemotherapy|chemotherapy
4829169|NCT02449265|limited-stage DLBCL|limited-stage dlbcl
4829170|NCT02449265|consolidation involved-site radiotherapy|consolidation involved-site radiotherapy
4829171|NCT02449265|Chemotherapy|chemotherapy
4829172|NCT02449252|limited stage FL|limited stage fl
4829173|NCT02449252|Involved-site Radiotherapy|involved-site radiotherapy
4829174|NCT02449252|Chemotherapy|chemotherapy
4829175|NCT02449239|Urinary Bladder Cancer|urinary bladder cancer
4829176|NCT02449239|Non-muscle invasive bladder cancer|non-muscle invasive bladder cancer
4829177|NCT02449239|Bladder Neoplasm|bladder neoplasm
4829880|NCT02444910|Diabetes|diabetes
4829178|NCT02449239|Bladder Tumor|bladder tumor
4829179|NCT02449239|CIS|cis
4829180|NCT02449239|Papillary bladder cancer|papillary bladder cancer
4829181|NCT02449239|High grade bladder cancer|high grade bladder cancer
4829182|NCT02449200|cervical radiculopathy|cervical radiculopathy
4829183|NCT02449200|exercise|exercise
4829184|NCT02449200|manual therapy|manual therapy
4829185|NCT02449200|tape|tape
4829186|NCT02449174|C. difficile|c. difficile
4829187|NCT02449174|Fecal Microbiota transplantation|fecal microbiota transplantation
4829188|NCT02449161|endometrial ablation|endometrial ablation
4829189|NCT02449148|energy restriction|energy restriction
4829190|NCT02449148|fasting|fasting
4829191|NCT02449148|intermittent fast|intermittent fast
4829192|NCT02449148|cancer prevention|cancer prevention
4829193|NCT02449148|subcutaneous fat tissue gene expression|subcutaneous fat tissue gene expression
4829194|NCT02449135|Pancreatic Cancer|pancreatic cancer
4829195|NCT02449135|Nano drug|nano drug
4829196|NCT02449122|Lung Cancer|lung cancer
4829197|NCT02449122|Nano drug|nano drug
4829198|NCT02449109|Liver Cancer|liver cancer
4829199|NCT02449109|Nano drug|nano drug
4829200|NCT02449083|MRI|mri
4829201|NCT02449083|Shunt|shunt
4829202|NCT02449083|COPD|copd
4829203|NCT02449083|Dynamic T2 Preparation Puls|dynamic t2 preparation puls
4829204|NCT02449083|new sequences|new sequences
4829205|NCT02449083|magnet resonance imaging|magnet resonance imaging
4829206|NCT02449083|ventricular septal defect|ventricular septal defect
4829207|NCT02449083|Atrial septal defect|atrial septal defect
4829208|NCT02449070|Nicorandil|nicorandil
4829209|NCT02449070|Cardiac MRI|cardiac mri
4829210|NCT02449044|Hyponatremia|hyponatremia
4829211|NCT02449018|COPD,|copd,
4829212|NCT02449018|chronic bronchitis,|chronic bronchitis,
4829213|NCT02449018|inflammation,|inflammation,
4829214|NCT02449018|airway,|airway,
4829215|NCT02449018|LCI,|lci,
4829216|NCT02449018|pulmonary function test,|pulmonary function test,
4829217|NCT02449018|lung function,|lung function,
4829218|NCT02449018|controlled clinical trial,|controlled clinical trial,
4829219|NCT02449018|randomized,|randomized,
4829220|NCT02449018|airflow,|airflow,
4829221|NCT02449018|smoker|smoker
4829222|NCT02449005|regeneration|regeneration
4829223|NCT02449005|stem cells|stem cells
4829224|NCT02449005|infrabony periodontal defect|infrabony periodontal defect
4829225|NCT02449005|fibrin glue|fibrin glue
4829226|NCT02449005|collagen fleece|collagen fleece
4829227|NCT02448992|Neurobehavioral Assessments|neurobehavioral assessments
4829228|NCT02448992|Neurocognitive Functions (NCF)|neurocognitive functions (ncf)
4829229|NCT02448992|Prophylactic Cranial Irradiation (PCI)|prophylactic cranial irradiation (pci)
4829230|NCT02448992|Hippocampus|hippocampus
4829231|NCT02448992|Hippocampal-Sparing PCI|hippocampal-sparing pci
4829232|NCT02448953|Without cervical lymph node involvement|without cervical lymph node involvement
4829233|NCT02448940|probiotics|probiotics
4829234|NCT02448940|Lactobacillus|lactobacillus
4829235|NCT02448940|obesity|obesity
4829236|NCT02448940|body composition|body composition
4829237|NCT02448927|transcatheter aortic valve implantation|transcatheter aortic valve implantation
4829238|NCT02448927|Balloon aortic valvuloplasty|balloon aortic valvuloplasty
4829239|NCT02448927|Aortic stenosis|aortic stenosis
4829240|NCT02448927|TAVI|tavi
4829241|NCT02448927|TAVR (transcatheter aortic valve replacement)|tavr (transcatheter aortic valve replacement)
4829242|NCT02448927|CoreValve|corevalve
4829243|NCT02448927|BAV|bav
4829244|NCT02448927|Evolut R|evolut r
4829245|NCT02448862|IV-PCA|iv-pca
4829246|NCT02448862|Elderly patients|elderly patients
4829247|NCT02448862|Yound adults|yound adults
4829248|NCT02448862|Side effect|side effect
4829249|NCT02448862|Postoperative pain|postoperative pain
4829250|NCT02448862|Postoperative nausea and vomiting|postoperative nausea and vomiting
4829251|NCT02448849|Autologous|autologous
4829252|NCT02448849|nonunion fracture|nonunion fracture
4829253|NCT02448849|bone marrow|bone marrow
4829254|NCT02448849|mesenchymal|mesenchymal
4829255|NCT02448849|stromal cell|stromal cell
4829256|NCT02448849|platelet lysate product|platelet lysate product
4829257|NCT02448823|HIV|hiv
4829258|NCT02448823|combined prevention|combined prevention
4829259|NCT02448823|demand generation|demand generation
4829260|NCT02448784|Donepezil Hydrochloride|donepezil hydrochloride
4829261|NCT02448784|ARICEPT|aricept
4829262|NCT02448784|Dementia|dementia
4829263|NCT02448784|Lewy bodies|lewy bodies
4829264|NCT02448784|Dementia with Lewy bodies|dementia with lewy bodies
4829265|NCT02448784|Post-marketing surveillance|post-marketing surveillance
4829266|NCT02448771|Unresectable locally advanced invasive breast cancer|unresectable locally advanced invasive breast cancer
4829267|NCT02448771|Metastatic invasive breast cancer|metastatic invasive breast cancer
4829268|NCT02448758|mutation|mutation
4829269|NCT02448732|ACM-1|acm-1
4829270|NCT02448732|intravitreal injection|intravitreal injection
4829271|NCT02448732|neovascularization|neovascularization
4829272|NCT02448706|hearing aid|hearing aid
4829273|NCT02448693|endoscopic mucosal resection|endoscopic mucosal resection
4829274|NCT02448693|piecemeal polypectomy scar|piecemeal polypectomy scar
4829275|NCT02448693|colorectal neoplasms|colorectal neoplasms
4829276|NCT02448693|Narrow Band Imaging|narrow band imaging
4829277|NCT02448693|chromoendoscopy|chromoendoscopy
4829278|NCT02448641|ischemic stroke|ischemic stroke
4829279|NCT02448641|chronic stroke|chronic stroke
4829280|NCT02448641|fixed motor deficits|fixed motor deficits
4829281|NCT02448628|Hypertension|hypertension
4829282|NCT02448628|moderate renal impairment|moderate renal impairment
4829283|NCT02448628|mineralocorticoid receptor antagonist|mineralocorticoid receptor antagonist
4829284|NCT02448628|CS-3150|cs-3150
4829285|NCT02448628|Japanese|japanese
4829286|NCT02448615|Kenya|kenya
4829287|NCT02448615|Cohort|cohort
4829288|NCT02448602|Different acupoints compatibility|different acupoints compatibility
4829289|NCT02448589|Advanced Solid Tumors|advanced solid tumors
4829290|NCT02448589|Dose Escalation|dose escalation
4829291|NCT02448589|Dose Expansion|dose expansion
4829292|NCT02448589|MTD|mtd
4829293|NCT02448589|TAS-119|tas-119
4829294|NCT02448589|Aurora A Kinase Inhibitor|aurora a kinase inhibitor
4829295|NCT02448576|phase 3 randomized controlled trial|phase 3 randomized controlled trial
4829296|NCT02448576|prophylactic cranial irradiation|prophylactic cranial irradiation
4829297|NCT02448576|triple negative breast cancer|triple negative breast cancer
4829298|NCT02448576|brain metastasis|brain metastasis
4829299|NCT02448576|advanced breast cancer|advanced breast cancer
4829300|NCT02448563|Pregnancy|pregnancy
4829301|NCT02448563|African American|african american
4829302|NCT02448563|Weight Management Program|weight management program
4829303|NCT02448563|Behavioral Modifications|behavioral modifications
4829304|NCT02448537|Metastatic Sarcoma|metastatic sarcoma
4829305|NCT02448537|Unresectable Sarcoma|unresectable sarcoma
4829306|NCT02448537|PM01183|pm01183
4829307|NCT02448524|Treatment|treatment
4829308|NCT02448524|patients|patients
4829309|NCT02448524|primary in situ CHD (de novo) lesions|primary in situ chd (de novo) lesions
4829310|NCT02448511|ozone gas|ozone gas
4829311|NCT02448511|ulcer|ulcer
4829312|NCT02448511|infected ulcer|infected ulcer
4829313|NCT02448433|Phototherapy|phototherapy
4829314|NCT02448433|Light|light
4829315|NCT02448433|Depression|depression
4829316|NCT02448433|Sleep and circadian disturbances|sleep and circadian disturbances
4829317|NCT02448433|Youth|youth
4829318|NCT02448407|Knee osteoarthritis|knee osteoarthritis
4829319|NCT02448407|Platelet-rich plasma|platelet-rich plasma
4829320|NCT02448407|Pain's treatment|pain's treatment
4829321|NCT02448394|community support workers|community support workers
4829322|NCT02448394|retention in care|retention in care
4829323|NCT02448381|CTCL|ctcl
4829324|NCT02448381|Mycosis fungoides|mycosis fungoides
4829325|NCT02448381|Hypericin|hypericin
4829326|NCT02448381|SGX301|sgx301
4829328|NCT02448355|OCT|oct
4829329|NCT02448342|Heart Failure|heart failure
4829330|NCT02448342|Remote Patient Monitoring|remote patient monitoring
4829331|NCT02448342|Non Invasive Lung Fluid Status Monitor|non invasive lung fluid status monitor
4829332|NCT02448290|gastric adenocarcinoma patients with low/high MEK signature,|gastric adenocarcinoma patients with low/high mek signature,
4829333|NCT02448277|Macintosh laryngoscope, Pentax, Glidescope|macintosh laryngoscope, pentax, glidescope
4829334|NCT02448264|kallikrein inhibitor|kallikrein inhibitor
4829335|NCT02448264|oral prophylaxis|oral prophylaxis
4829336|NCT02448264|BioCryst|biocryst
4829337|NCT02448264|first-in-human|first-in-human
4829338|NCT02448264|hereditary angioedema|hereditary angioedema
4829339|NCT02448238|Human Immunodeficiency Virus|human immunodeficiency virus
4829340|NCT02448238|probiotic|probiotic
4829341|NCT02448238|microbial translocation|microbial translocation
4829342|NCT02448238|immune activation|immune activation
4829343|NCT02448238|inflammation|inflammation
4829344|NCT02448238|VSL#3|vsl#3
4829345|NCT02448238|Mali|mali
4829346|NCT02448238|Africa|africa
4829347|NCT02448212|PET|pet
4829348|NCT02448212|Receptor Occupancy|receptor occupancy
4829349|NCT02448199|pain|pain
4829350|NCT02448199|Knee|knee
4829351|NCT02448147|Heart failure|heart failure
4829352|NCT02448147|Exercise|exercise
4829353|NCT02448147|Biomarkers|biomarkers
4829354|NCT02448147|Sympathetic Nervous System|sympathetic nervous system
4829355|NCT02448147|MicroRNA|microrna
4829356|NCT02448121|Cell therapy|cell therapy
4829357|NCT02448121|Sickle cell disease|sickle cell disease
4829358|NCT02448121|Hip Osteonecrosis|hip osteonecrosis
4829359|NCT02448121|Autologous implantation|autologous implantation
4829360|NCT02448121|Mesenchymal stromal cell|mesenchymal stromal cell
4829361|NCT02448121|Humeral Osteonecrosis|humeral osteonecrosis
4829362|NCT02448121|Knee Osteonecrosis|knee osteonecrosis
4829363|NCT02448121|Ankle Osteonecrosis|ankle osteonecrosis
4829364|NCT02448095|Chronic myeloid leukemia|chronic myeloid leukemia
4829365|NCT02448095|Philadelphia positive|philadelphia positive
4829366|NCT02448095|Compassionate use|compassionate use
4829367|NCT02448082|Dandruff|dandruff
4829368|NCT02448082|Pityriasis capitis|pityriasis capitis
4829369|NCT02448082|Ichthyol® Pale|ichthyol® pale
4829370|NCT02448082|Sodium shale oil sulponate 1%|sodium shale oil sulponate 1%
4829371|NCT02448043|brittleness|brittleness
4829372|NCT02448030|Metaboreflex|metaboreflex
4829373|NCT02448030|Variation of blood flow|variation of blood flow
4829374|NCT02448030|Functional electrical stimulation|functional electrical stimulation
4829375|NCT02448030|Isometric exercise.|isometric exercise.
4829377|NCT02448004|JNJ-63623872|jnj-63623872
4829378|NCT02448004|14C-JNJ-63623872|14c-jnj-63623872
4829379|NCT02447965|Rectus Sheath Blocks|rectus sheath blocks
4829380|NCT02447965|Abdominal Surgery|abdominal surgery
4829381|NCT02447952|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
4829382|NCT02447952|Biotelemetry|biotelemetry
4829383|NCT02447939|pharmacokinetics|pharmacokinetics
4829384|NCT02447939|trametinib|trametinib
4829385|NCT02447939|cutaneous melanoma|cutaneous melanoma
4829386|NCT02447939|dabrafenib|dabrafenib
4829387|NCT02447939|safety|safety
4829388|NCT02447926|leukapheresis|leukapheresis
4829389|NCT02447926|regulatory T cells|regulatory t cells
4829390|NCT02447926|liver transplantation|liver transplantation
4829391|NCT02447913|Family planning|family planning
4829392|NCT02447913|Voucher|voucher
4829393|NCT02447913|Immunisations|immunisations
4829394|NCT02447835|Metabolic Disorders|metabolic disorders
4829395|NCT02447809|microRNA|microrna
4829396|NCT02447809|Platelet|platelet
4829397|NCT02447809|Clopidogrel low response|clopidogrel low response
4829398|NCT02447796|(AVF)|(avf)
4829399|NCT02447796|surgery|surgery
4829400|NCT02447783|Flavanols|flavanols
4829401|NCT02447783|Cocoa flavanols|cocoa flavanols
4829402|NCT02447783|Blood pressure|blood pressure
4829403|NCT02447783|Platelet Function|platelet function
4829404|NCT02447770|Flavanols|flavanols
4829405|NCT02447770|Cocoa flavanols|cocoa flavanols
4829406|NCT02447770|Blood pressure|blood pressure
4829407|NCT02447770|Platelet Function|platelet function
4829408|NCT02447757|Remifentanil, delivery, childbirth, analgesia, parturition, confinement|remifentanil, delivery, childbirth, analgesia, parturition, confinement
4829409|NCT02447744|depression|depression
4829410|NCT02447744|anxiety|anxiety
4829411|NCT02447744|early life stress|early life stress
4829412|NCT02447731|respiratory insufficiency|respiratory insufficiency
4829413|NCT02447692|Proportional Assist Ventilation|proportional assist ventilation
4829414|NCT02447692|Pressure Support Ventilation|pressure support ventilation
4829415|NCT02447692|Weaning|weaning
4829416|NCT02447666|Azacitidine|azacitidine
4829417|NCT02447666|Myelodysplastic syndrome|myelodysplastic syndrome
4829418|NCT02447666|Juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
4829419|NCT02447666|Hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
4829420|NCT02447666|Vidaza|vidaza
4829421|NCT02447666|Hypomethylating agent|hypomethylating agent
4829422|NCT02447640|Volunteers|volunteers
4829423|NCT02447614|follow up|follow up
4829424|NCT02447614|Primary Snoring|primary snoring
4829425|NCT02447614|Obstructive Sleep Apnea Syndrome|obstructive sleep apnea syndrome
4829426|NCT02447588|intrauterine insemination|intrauterine insemination
4829427|NCT02447588|progesterone|progesterone
4829428|NCT02447549|IMRT|imrt
4829429|NCT02447549|IGRT|igrt
4829430|NCT02447549|Muscle invasive|muscle invasive
4829431|NCT02447549|Adaptive Radiotherapy|adaptive radiotherapy
4829432|NCT02447536|Immunization|immunization
4829433|NCT02447536|Morbidity|morbidity
4829434|NCT02447536|Mortality|mortality
4829436|NCT02447484|female sex workers|female sex workers
4829437|NCT02447484|HIV sexual risk reduction|hiv sexual risk reduction
4829438|NCT02447484|behavior maintenance|behavior maintenance
4829439|NCT02447484|text messaging|text messaging
4829440|NCT02447458|Drug therapy|drug therapy
4829441|NCT02447432|Invasive disease by Streptococcus pneumoniae (S. pneumoniae) (including sepsis, meningitis, pneumonia, bacteraemia and acute otitis media)|invasive disease by streptococcus pneumoniae (s. pneumoniae) (including sepsis, meningitis, pneumonia, bacteraemia and acute otitis media)
4829442|NCT02447432|Infants|infants
4829443|NCT02447432|Multidose|multidose
4829444|NCT02447432|Haemophilus influenzae|haemophilus influenzae
4829445|NCT02447432|Streptococcus pneumoniae|streptococcus pneumoniae
4829446|NCT02447432|Preservative|preservative
4829447|NCT02447432|Safety|safety
4829448|NCT02447432|Pneumonia|pneumonia
4829449|NCT02447432|Immunogenicity|immunogenicity
4829450|NCT02447432|Pneumococcal conjugate vaccine|pneumococcal conjugate vaccine
4829451|NCT02447432|Acute otitis media caused by non-typeable Haemophilus influenzae (NTHi).|acute otitis media caused by non-typeable haemophilus influenzae (nthi).
4829452|NCT02447432|Respiratory tract infections|respiratory tract infections
4829453|NCT02447367|α1-blockers|α1-blockers
4829454|NCT02447367|antimuscarinic agent|antimuscarinic agent
4829455|NCT02447315|Pilocarpine|pilocarpine
4829456|NCT02447289|Dental caries|dental caries
4829457|NCT02447289|Moderate sedation|moderate sedation
4829458|NCT02447263|Liver Cancer|liver cancer
4829459|NCT02447263|HepaSphere|hepasphere
4829460|NCT02447250|Bronchopulmonary dysplasia|bronchopulmonary dysplasia
4829461|NCT02447250|very low birth weight|very low birth weight
4829462|NCT02447250|albuterol|albuterol
4829463|NCT02447250|pulmonary function test|pulmonary function test
4829464|NCT02447237|liquid diet|liquid diet
4829465|NCT02447237|solid diet|solid diet
4829466|NCT02447224|appendicitis|appendicitis
4829467|NCT02447224|non operative management|non operative management
4829468|NCT02447224|appendectomy|appendectomy
4829469|NCT02447185|Lucentis|lucentis
4829470|NCT02447185|Ranibizumab|ranibizumab
4829471|NCT02447185|Triamcinolone Acetonide|triamcinolone acetonide
4829472|NCT02447185|Vitrectomy|vitrectomy
4829473|NCT02447185|PDR|pdr
4829474|NCT02447185|25-Gauge Vitrectomy|25-gauge vitrectomy
4829475|NCT02447159|Nigeria|nigeria
4829476|NCT02447159|Developing Countries|developing countries
4829477|NCT02447159|Hospitals, Maternity/Utilization|hospitals, maternity/utilization
4829478|NCT02447159|Hospitals/Economics|hospitals/economics
4829479|NCT02447159|HIV|hiv
4829480|NCT02447133|no known ocular pathology|no known ocular pathology
4829481|NCT02447120|Volunteers with Healthy Eyes|volunteers with healthy eyes
4829482|NCT02447107|Chronic Pain|chronic pain
4829483|NCT02447107|Technology|technology
4829484|NCT02447107|Mobile Phone Applications|mobile phone applications
4829485|NCT02447094|ischemic|ischemic
4829486|NCT02447094|tPA|tpa
4829487|NCT02447094|tele-medicine|tele-medicine
4829488|NCT02447094|robot|robot
4829489|NCT02447094|tele-stroke|tele-stroke
4829490|NCT02447042|sepsis|sepsis
4829491|NCT02447042|Fluids|fluids
4829492|NCT02447042|Mean systemic filling pressure|mean systemic filling pressure
4829493|NCT02447029|abortion|abortion
4829494|NCT02447029|pain management|pain management
4829495|NCT02447003|PD1|pd1
4829496|NCT02447003|PD-1|pd-1
4829497|NCT02447003|PDL1|pdl1
4829498|NCT02447003|PD-L1|pd-l1
4829499|NCT02446977|ischemic|ischemic
4829500|NCT02446977|stroke|stroke
4829501|NCT02446977|vitamin B2|vitamin b2
4829502|NCT02446938|mechanical ventilation|mechanical ventilation
4829503|NCT02446938|esophageal pressure|esophageal pressure
4829504|NCT02446938|catheter position|catheter position
4829505|NCT02446938|validation|validation
4829506|NCT02446912|Active Systemic Lupus Erythematosus|active systemic lupus erythematosus
4829507|NCT02446899|Active Systemic Lupus Erythematosus|active systemic lupus erythematosus
4829508|NCT02446886|Multiple Sclerosis|multiple sclerosis
4829509|NCT02446886|MS|ms
4829510|NCT02446886|RRMS|rrms
4829511|NCT02446886|SPMS|spms
4829512|NCT02446886|ACTH|acth
4829513|NCT02446873|children|children
4829514|NCT02446873|Ecuador|ecuador
4829515|NCT02446873|rural|rural
4829516|NCT02446873|poor|poor
4829517|NCT02446847|HIV|hiv
4829518|NCT02446847|3BNC117|3bnc117
4829519|NCT02446847|Broadly neutralizing antibody|broadly neutralizing antibody
4829520|NCT02446834|PCOS|pcos
4829521|NCT02446834|intensive lifestyle intervention|intensive lifestyle intervention
4829522|NCT02446834|IGT|igt
4829523|NCT02446834|drugs treatment|drugs treatment
4829524|NCT02446795|Renal cell carcinoma|renal cell carcinoma
4829525|NCT02446795|Isoquercetin|isoquercetin
4829526|NCT02446795|kidney cancer|kidney cancer
4829527|NCT02446795|sunitinib|sunitinib
4829528|NCT02446795|fatigue|fatigue
4829529|NCT02446782|thoracoscopy|thoracoscopy
4829530|NCT02446782|pleuroscopy|pleuroscopy
4829531|NCT02446782|antibiotic prophylaxis|antibiotic prophylaxis
4829532|NCT02446782|pleural effusion|pleural effusion
4829533|NCT02446756|Osteoarthritis|osteoarthritis
4829534|NCT02446756|MRI|mri
4829535|NCT02446756|Cartilage|cartilage
4829536|NCT02446756|Acupuncture|acupuncture
4829537|NCT02446743|Nervous System Diseases|nervous system diseases
4829538|NCT02446743|Meningitis|meningitis
4829539|NCT02446743|Central Nervous System Diseases|central nervous system diseases
4829540|NCT02446717|Hepatitis C|hepatitis c
4829541|NCT02446717|HCV Genotype 6|hcv genotype 6
4829542|NCT02446717|HCV GT1|hcv gt1
4829543|NCT02446717|Interferon (IFN) free|interferon (ifn) free
4829544|NCT02446717|HCV Genotype 5|hcv genotype 5
4829545|NCT02446717|HCV|hcv
4829546|NCT02446717|HCV GT4|hcv gt4
4829547|NCT02446717|HCV Genotype 4|hcv genotype 4
4829548|NCT02446717|Chronic Hepatitis C|chronic hepatitis c
4829549|NCT02446717|Chronic HCV|chronic hcv
4829550|NCT02446717|Hepatitis C Genotype 1|hepatitis c genotype 1
4829551|NCT02446717|HCV GT5|hcv gt5
4829552|NCT02446717|HCV Genotype 1|hcv genotype 1
4829553|NCT02446704|Small Cell Lung Cancer|small cell lung cancer
4829554|NCT02446704|SCLC|sclc
4829555|NCT02446678|Gastrointestinal bleeding|gastrointestinal bleeding
4829556|NCT02446678|emergency department|emergency department
4829557|NCT02446678|PillCam ESO2|pillcam eso2
4829558|NCT02446652|Advanced cervical cancer|advanced cervical cancer
4829559|NCT02446652|Epigenetic therapy|epigenetic therapy
4829560|NCT02446652|Randomized phase III|randomized phase iii
4829561|NCT02446626|Lyme Disease|lyme disease
4829562|NCT02446626|Ixodes scapularis|ixodes scapularis
4829563|NCT02446626|Borrelia Burgdorferi|borrelia burgdorferi
4829564|NCT02446626|Post treatment|post treatment
4829565|NCT02446626|Infection|infection
4829566|NCT02446613|Allergic Rhinitis|allergic rhinitis
4829567|NCT02446613|Nasal allergen challenge|nasal allergen challenge
4829568|NCT02446613|Allergic Asthma|allergic asthma
4829569|NCT02446613|Effect on Allergen Reactivity|effect on allergen reactivity
4829570|NCT02446587|endovascular therapy|endovascular therapy
4829571|NCT02446587|thrombectomy|thrombectomy
4829572|NCT02446587|selection|selection
4829573|NCT02446587|imaging|imaging
4829574|NCT02446587|perfusion|perfusion
4829575|NCT02446587|collaterals|collaterals
4829576|NCT02446587|ASPECTS|aspects
4829577|NCT02446574|chemoradiation|chemoradiation
4829578|NCT02446574|dose escalation|dose escalation
4829579|NCT02446561|Healthy Volunteer|healthy volunteer
4829580|NCT02446561|Pharmacokinetics|pharmacokinetics
4829581|NCT02446548|direct renin inhibitor|direct renin inhibitor
4829582|NCT02446548|kidney transplantation|kidney transplantation
4829583|NCT02446548|albuminuria|albuminuria
4829584|NCT02446496|Bioequivalence|bioequivalence
4829585|NCT02446496|film coated tablets|film coated tablets
4829586|NCT02446496|cefadroxil|cefadroxil
4829587|NCT02446483|Idiazole 20mg|idiazole 20mg
4829588|NCT02446483|PARIET 20 mg|pariet 20 mg
4829589|NCT02446483|Rabeprazole|rabeprazole
4829590|NCT02446483|bioequivalence|bioequivalence
4829591|NCT02446470|calcaneus|calcaneus
4829592|NCT02446470|fracture fixation, internal|fracture fixation, internal
4829593|NCT02446457|Lymphoma|lymphoma
4829594|NCT02446457|Follicular lymphoma|follicular lymphoma
4829595|NCT02446457|FL|fl
4829596|NCT02446457|Relapsed|relapsed
4829597|NCT02446457|Rituximab|rituximab
4829598|NCT02446457|Rituxan|rituxan
4829599|NCT02446457|Pembrolizumab|pembrolizumab
4829600|NCT02446457|Keytruda|keytruda
4829601|NCT02446457|MK-3475|mk-3475
4829602|NCT02446457|SCH-900475|sch-900475
4829603|NCT02446457|Lenalidomide|lenalidomide
4829604|NCT02446457|CC-5013|cc-5013
4829605|NCT02446457|Revlimid|revlimid
4829606|NCT02446457|Diffuse large B-cell lymphoma|diffuse large b-cell lymphoma
4829607|NCT02446457|DLBCL|dlbcl
4829608|NCT02446444|High risk|high risk
4829609|NCT02446444|clinically localised prostate cancer|clinically localised prostate cancer
4829610|NCT02446431|Metronomic Drug Therapy|metronomic drug therapy
4829611|NCT02446418|dry powder inahler|dry powder inahler
4829612|NCT02446418|vilanerol|vilanerol
4829613|NCT02446418|efficacy|efficacy
4829614|NCT02446418|safety|safety
4829615|NCT02446418|fluticasone furoate|fluticasone furoate
4829616|NCT02446418|quality of life|quality of life
4829617|NCT02446405|metastatic prostate cancer|metastatic prostate cancer
4829618|NCT02446405|prostate cancer|prostate cancer
4829619|NCT02446405|prostate cancer treatment|prostate cancer treatment
4829620|NCT02446405|enzalutamide|enzalutamide
4829621|NCT02446353|Male Volunteers|male volunteers
4829622|NCT02446340|ShK-186|shk-186
4829623|NCT02446340|dalazatide|dalazatide
4829624|NCT02446340|Kv1.3|kv1.3
4829625|NCT02446340|SHK|shk
4829626|NCT02446301|Nalbuphine|nalbuphine
4829627|NCT02446301|SDE|sde
4829628|NCT02446301|dinalbuphine|dinalbuphine
4829629|NCT02446301|SDN|sdn
4829630|NCT02446301|pain|pain
4829631|NCT02446301|LT1001|lt1001
4829632|NCT02446275|efficacy, manual therapy, migraine, quality of life|efficacy, manual therapy, migraine, quality of life
4829633|NCT02446262|Pain|pain
4829634|NCT02446262|Visual Analogue Pain Scale|visual analogue pain scale
4829635|NCT02446262|Placebo|placebo
4829636|NCT02446262|Affective Neuroscience|affective neuroscience
4829637|NCT02446262|Functional Magnetic Resonance Imaging (fMRI)|functional magnetic resonance imaging (fmri)
4829638|NCT02446249|Gene Therapy|gene therapy
4829639|NCT02446249|Xerostomia|xerostomia
4829640|NCT02446223|Actinic Keratosis AKs Chest Pre-Cancer|actinic keratosis aks chest pre-cancer
4829641|NCT02446210|SCI|sci
4829642|NCT02446210|Neural Control|neural control
4829643|NCT02446210|Bilateral Movement|bilateral movement
4829644|NCT02446210|TMS|tms
4829645|NCT02446184|urethral obstruction|urethral obstruction
4829646|NCT02446184|posterior urethral valves|posterior urethral valves
4829647|NCT02446184|lower urinary tract obstruction|lower urinary tract obstruction
4829648|NCT02446171|naloxegol tablet crushed|naloxegol tablet crushed
4829649|NCT02446171|naloxegol oral solution|naloxegol oral solution
4829650|NCT02446171|naloxegol whole tablet|naloxegol whole tablet
4829651|NCT02446171|relative bioavailability|relative bioavailability
4829652|NCT02446171|Phase I|phase i
4829653|NCT02446171|healthy subjects|healthy subjects
4829654|NCT02446106|Monosodium L-Glutamate (MSG)|monosodium l-glutamate (msg)
4829655|NCT02446106|Satiety|satiety
4829656|NCT02446106|Soups|soups
4829657|NCT02446106|Energy Intake|energy intake
4829658|NCT02446106|Snack Intake|snack intake
4829659|NCT02446093|pancreas|pancreas
4829660|NCT02446093|pancreatic adenocarcinoma|pancreatic adenocarcinoma
4829661|NCT02446093|GMCI|gmci
4829662|NCT02446093|AdV-tk|adv-tk
4829663|NCT02446093|aglatimagene besadenovec|aglatimagene besadenovec
4829664|NCT02446080|Constipation|constipation
4829665|NCT02446080|Probiotics|probiotics
4829666|NCT02446080|Women|women
4829667|NCT02446067|Transcranial Doppler (TCD) sonography|transcranial doppler (tcd) sonography
4829668|NCT02446067|rTMS|rtms
4829669|NCT02446067|Cerebral hemodynamics|cerebral hemodynamics
4829670|NCT02446054|T2DM, type II diabetes Mellitus, HbA1c|t2dm, type ii diabetes mellitus, hba1c
4829671|NCT02446041|COPD|copd
4829672|NCT02446041|Chronic Bronchitis|chronic bronchitis
4829673|NCT02446041|Pulmonary Emphysema|pulmonary emphysema
4829674|NCT02446002|Volunteer|volunteer
4829675|NCT02445989|HIV|hiv
4829676|NCT02445989|Contraceptive Vaginal Ring|contraceptive vaginal ring
4829677|NCT02445989|Bacterial Vaginosis|bacterial vaginosis
4829678|NCT02445976|mCRPC|mcrpc
4829679|NCT02445976|metastatic|metastatic
4829680|NCT02445976|castration-resistant prostate cancer|castration-resistant prostate cancer
4829681|NCT02445950|Coaching|coaching
4829682|NCT02445950|Well-being|well-being
4829683|NCT02445950|Digital Health|digital health
4829684|NCT02445950|Profiling|profiling
4829685|NCT02445950|Customer Satisfaction|customer satisfaction
4829686|NCT02445950|User Experience|user experience
4829687|NCT02445950|Occupational Health|occupational health
4829688|NCT02445950|Lifestyle|lifestyle
4829689|NCT02445950|Psychological Stress|psychological stress
4829690|NCT02445950|Cost-Effectiveness|cost-effectiveness
4829691|NCT02445950|Guideline Adherence|guideline adherence
4829692|NCT02445937|decision making for incapacitated patients|decision making for incapacitated patients
4829693|NCT02445937|intensive care|intensive care
4829694|NCT02445937|surrogate decision making|surrogate decision making
4829695|NCT02445937|patient centered care|patient centered care
4829696|NCT02445937|palliative care|palliative care
4829697|NCT02445924|genetic signature|genetic signature
4829698|NCT02445924|non-small cell lung cancer|non-small cell lung cancer
4829699|NCT02445924|micro RNA|micro rna
4829700|NCT02445898|Glucocorticoid|glucocorticoid
4829701|NCT02445898|Orthostatic Intolerance|orthostatic intolerance
4829702|NCT02445898|Heart Rate Variability|heart rate variability
4829703|NCT02445898|Hip arthroplasty, total|hip arthroplasty, total
4829704|NCT02445885|Myocardial infarction|myocardial infarction
4829705|NCT02445885|Late presenters|late presenters
4829706|NCT02445885|Primary percutaneous coronary intervention|primary percutaneous coronary intervention
4829707|NCT02445885|Reperfusion|reperfusion
4829708|NCT02445885|Angioplasty|angioplasty
4829709|NCT02445885|Duration of ischemia|duration of ischemia
4829710|NCT02445885|Cardiovascular magnetic resonance imaging|cardiovascular magnetic resonance imaging
4829711|NCT02445872|Nausea|nausea
4829712|NCT02445872|Vomiting|vomiting
4829713|NCT02445872|Chemotherapy-induced Nausea and Vomiting|chemotherapy-induced nausea and vomiting
4829714|NCT02445872|CINV|cinv
4829715|NCT02445872|Aprepitant|aprepitant
4829716|NCT02445872|Lung cancer|lung cancer
4829717|NCT02445859|Antibiotic|antibiotic
4829718|NCT02445859|prophylaxis|prophylaxis
4829719|NCT02445859|surgical site infection|surgical site infection
4829720|NCT02445833|Obesity|obesity
4829721|NCT02445833|Internet intervention|internet intervention
4829722|NCT02445833|Cardiovascular disease|cardiovascular disease
4829723|NCT02445833|Hypertension|hypertension
4829724|NCT02445833|Lifestyle intervention|lifestyle intervention
4829725|NCT02445833|Weight loss treatment|weight loss treatment
4829726|NCT02445755|Neonates|neonates
4829727|NCT02445755|Bilicare System|bilicare system
4829728|NCT02445742|Chronic Myeloblastic Leukaemia|chronic myeloblastic leukaemia
4829729|NCT02445729|Cesarean Section|cesarean section
4829730|NCT02445729|Wound Healing|wound healing
4829731|NCT02445677|TENS|tens
4829732|NCT02445677|chronic pain|chronic pain
4829733|NCT02445677|rehabilitation|rehabilitation
4829734|NCT02445664|Patient education|patient education
4829735|NCT02445664|Video intervention|video intervention
4829736|NCT02445651|Integrative Medicine|integrative medicine
4829737|NCT02445651|Alternative Medicine|alternative medicine
4829738|NCT02445651|Complementary Medicine|complementary medicine
4829739|NCT02445651|Parkinson's disease|parkinson's disease
4829740|NCT02445651|Neurodegenerative Diseases|neurodegenerative diseases
4829741|NCT02445651|Idiopathic Parkinson's disease|idiopathic parkinson's disease
4829742|NCT02445651|Single Photon Emission Computed Tomography (SPECT)|single photon emission computed tomography (spect)
4829743|NCT02445651|Central Nervous System Diseases|central nervous system diseases
4829744|NCT02445651|Movement Disorders|movement disorders
4829745|NCT02445651|Nervous System Diseases|nervous system diseases
4829746|NCT02445651|Brain Diseases|brain diseases
4829747|NCT02445651|Oral supplements|oral supplements
4829748|NCT02445651|N-acetyl cysteine|n-acetyl cysteine
4829749|NCT02445612|fundus flavimaculatus|fundus flavimaculatus
4829750|NCT02445612|ASP7316|asp7316
4829751|NCT02445612|SMD|smd
4829752|NCT02445612|long term follow-up|long term follow-up
4829753|NCT02445612|juvenile macular dystrophy|juvenile macular dystrophy
4829754|NCT02445599|thoracotomy|thoracotomy
4829755|NCT02445599|pain management|pain management
4829756|NCT02445599|analgesia|analgesia
4829757|NCT02445599|postoperative care|postoperative care
4829758|NCT02445599|premedication|premedication
4829759|NCT02445599|preventive|preventive
4829760|NCT02445573|stress urinary incontinence|stress urinary incontinence
4829761|NCT02445573|electroacupuncture|electroacupuncture
4829762|NCT02445573|efficacy|efficacy
4829763|NCT02445560|probiotics|probiotics
4829764|NCT02445560|prebiotics|prebiotics
4829765|NCT02445560|high protein diet|high protein diet
4829766|NCT02445560|microbiota|microbiota
4829767|NCT02445534|Cell Therapy|cell therapy
4829768|NCT02445456|Rectal cancer|rectal cancer
4829769|NCT02445456|Sentinel Lymph Node Biopsy|sentinel lymph node biopsy
4829770|NCT02445417|Perinatal depression|perinatal depression
4829771|NCT02445378|Aromatherapy|aromatherapy
4829772|NCT02445378|essential oils|essential oils
4829773|NCT02445378|Acute Leukemia|acute leukemia
4829774|NCT02445365|Ulcerative colitis|ulcerative colitis
4829775|NCT02445365|Remote ischemic conditioning|remote ischemic conditioning
4829776|NCT02445339|Alcohol Dependence|alcohol dependence
4829777|NCT02445339|Alcohol Use Disorder|alcohol use disorder
4829778|NCT02445339|Care Management|care management
4829779|NCT02445339|Case Management|case management
4829780|NCT02445339|Emergency Care Services|emergency care services
4829979|NCT02444403|HCV|hcv
4829781|NCT02445339|Emergency Department|emergency department
4829782|NCT02445339|Emergency Room|emergency room
4829783|NCT02445339|Extended-release naltrexone|extended-release naltrexone
4829784|NCT02445339|Frequent Users|frequent users
4829785|NCT02445339|Health Care Utilization|health care utilization
4829786|NCT02445339|Medical Management|medical management
4829787|NCT02445339|Naltrexone|naltrexone
4829788|NCT02445339|Population Health|population health
4829789|NCT02445339|Public Health|public health
4829790|NCT02445339|Vivitrol|vivitrol
4829791|NCT02445339|XR-NTX|xr-ntx
4829792|NCT02445339|XR-NTX+CM|xr-ntx+cm
4829793|NCT02445339|Alcoholism|alcoholism
4829794|NCT02445339|Alcohol-Related Disorders|alcohol-related disorders
4829795|NCT02445339|Central Nervous System Agents|central nervous system agents
4829796|NCT02445339|Chemically-Induced Disorders|chemically-induced disorders
4829797|NCT02445339|Clinical Trial|clinical trial
4829798|NCT02445339|Emergency Medicine|emergency medicine
4829799|NCT02445339|Mental Disorders|mental disorders
4829800|NCT02445339|Narcotic Antagonists|narcotic antagonists
4829801|NCT02445339|Peripheral Nervous System Agents|peripheral nervous system agents
4829802|NCT02445339|Pharmacologic Actions|pharmacologic actions
4829803|NCT02445339|Physiological Effects of Drugs|physiological effects of drugs
4829804|NCT02445339|Sensory System Agents|sensory system agents
4829805|NCT02445339|Substance-Related Disorders|substance-related disorders
4829806|NCT02445300|dressing|dressing
4829807|NCT02445300|TKA|tka
4829808|NCT02445261|MOBILE PHONE ON AND IN AND|mobile phone on and in and
4829809|NCT02445261|UMBILICAL ARTERY DOPPLER|umbilical artery doppler
4829810|NCT02445261|FETAL CARDIOTOCOGRAPHY|fetal cardiotocography
4829811|NCT02445261|GROWTH RESTRICTED FETUS|growth restricted fetus
4829812|NCT02445261|NORMAL GROWTH FETUS|normal growth fetus
4829813|NCT02445248|Diffuse large B-cell lymphoma,|diffuse large b-cell lymphoma,
4829814|NCT02445248|DLBCL,|dlbcl,
4829815|NCT02445248|Relapsed/refractory,|relapsed/refractory,
4829816|NCT02445248|CTL019|ctl019
4829817|NCT02445248|CART19|cart19
4829818|NCT02445248|CART|cart
4829819|NCT02445248|CAR T cells|car t cells
4829820|NCT02445248|Chimeric antigen receptor|chimeric antigen receptor
4829821|NCT02445235|pain|pain
4829822|NCT02445235|wound care|wound care
4829823|NCT02445235|fungal infections|fungal infections
4829824|NCT02445235|scars|scars
4829825|NCT02445235|chronic pain|chronic pain
4829826|NCT02445235|outcomes|outcomes
4829827|NCT02445235|PRO|pro
4829828|NCT02445209|HER2-negative gastric and GEJ adenocarcinoma|her2-negative gastric and gej adenocarcinoma
4829829|NCT02445209|first-line palliative chemotherapy|first-line palliative chemotherapy
4829830|NCT02445209|EOX|eox
4829831|NCT02445209|mDCF|mdcf
4829832|NCT02445209|efficacy|efficacy
4829833|NCT02445209|safety|safety
4829834|NCT02445170|Diabetes|diabetes
4829835|NCT02445170|amputation|amputation
4829836|NCT02445170|below-knee|below-knee
4829837|NCT02445170|transmetatarsal|transmetatarsal
4829838|NCT02445170|[M01.150.100]|[m01.150.100]
4829839|NCT02445170|[C19.246.099]|[c19.246.099]
4829840|NCT02445157|Gait speed|gait speed
4829841|NCT02445157|Functional outcome measure|functional outcome measure
4829842|NCT02445144|Inflammation|inflammation
4829843|NCT02445144|Blood Flow|blood flow
4829844|NCT02445144|Cognition|cognition
4829845|NCT02445131|CLL|cll
4829846|NCT02445118|adipose, allograft|adipose, allograft
4829847|NCT02445092|Intrauterine insemination|intrauterine insemination
4829848|NCT02445092|Insemination catheter prewashing|insemination catheter prewashing
4829849|NCT02445092|Pregnancy outcome|pregnancy outcome
4829850|NCT02445066|Vitamin D|vitamin d
4829851|NCT02445053|Cystic Fibrosis|cystic fibrosis
4829852|NCT02445040|High Frequency Oscillatory Ventilation|high frequency oscillatory ventilation
4829853|NCT02445040|Infant, Very Low Birth Weight|infant, very low birth weight
4829854|NCT02445040|Periventricular Leukomalacia|periventricular leukomalacia
4829855|NCT02445040|Intraventricular Hemorrhage|intraventricular hemorrhage
4829856|NCT02445040|multi-center study|multi-center study
4829857|NCT02445027|Primary Care|primary care
4829858|NCT02445027|Healthy|healthy
4829859|NCT02445014|Barrett's|barrett's
4829860|NCT02445014|GERD|gerd
4829861|NCT02445014|Capsule|capsule
4829862|NCT02445014|SECM|secm
4829863|NCT02444988|crystalloid|crystalloid
4829864|NCT02444988|acute kidney injury|acute kidney injury
4829865|NCT02444975|Urinary Tract Infections|urinary tract infections
4829866|NCT02444975|Water intake|water intake
4829867|NCT02444936|solid tumor|solid tumor
4829868|NCT02444936|chemotherapy|chemotherapy
4829869|NCT02444936|vaccine|vaccine
4829870|NCT02444923|Corneal rigid gas permeable contact lenses|corneal rigid gas permeable contact lenses
4829871|NCT02444923|Scleral rigid gas permeable contact lenses|scleral rigid gas permeable contact lenses
4829872|NCT02444923|Custom Scleral contact lenses|custom scleral contact lenses
4829873|NCT02444923|Irregular cornea|irregular cornea
4829874|NCT02444923|Keratoconus|keratoconus
4829875|NCT02444923|Pellucid marginal degeneration|pellucid marginal degeneration
4829876|NCT02444923|Post keratoplasty irregular cornea|post keratoplasty irregular cornea
4829877|NCT02444923|Post refractive surgery irregular cornea|post refractive surgery irregular cornea
4829878|NCT02444923|Traumatic irregular cornea|traumatic irregular cornea
4829881|NCT02444910|Diabetes Mellitus|diabetes mellitus
4829882|NCT02444910|Type 2|type 2
4829883|NCT02444910|KinDex|kindex
4829884|NCT02444897|Gastric cancer|gastric cancer
4829885|NCT02444897|epidural|epidural
4829886|NCT02444897|PCA|pca
4829887|NCT02444897|laparoscopy|laparoscopy
4829888|NCT02444871|IgM-enriched immunoglobulins|igm-enriched immunoglobulins
4829889|NCT02444871|endotoxin activity assay|endotoxin activity assay
4829890|NCT02444871|thrombelastometry|thrombelastometry
4829891|NCT02444871|aggregometry|aggregometry
4829892|NCT02444858|paraquat poisoning|paraquat poisoning
4829893|NCT02444858|lung injury|lung injury
4829894|NCT02444858|stem cell therapy|stem cell therapy
4829895|NCT02444858|human umbilical cord mesenchymal stem cell|human umbilical cord mesenchymal stem cell
4829896|NCT02444858|phase 1/2 clinical study|phase 1/2 clinical study
4829897|NCT02444858|allogeneic stem cell transplantation|allogeneic stem cell transplantation
4829898|NCT02444819|HM61713|hm61713
4829899|NCT02444819|Epidermal Growth Factor Receptor mutation positive NSCLC|epidermal growth factor receptor mutation positive nsclc
4829900|NCT02444819|olmutinib|olmutinib
4829901|NCT02444806|Sleep disordered breathing|sleep disordered breathing
4829902|NCT02444806|Domiciliary NIV|domiciliary niv
4829903|NCT02444741|Lung Cancer|lung cancer
4829904|NCT02444741|Non-small cell lung cancer|non-small cell lung cancer
4829905|NCT02444741|NSCLC|nsclc
4829906|NCT02444741|Metastatic|metastatic
4829907|NCT02444741|Pembrolizumab|pembrolizumab
4829908|NCT02444741|Keytruda|keytruda
4829909|NCT02444741|MK-3475|mk-3475
4829910|NCT02444741|SCH-900475|sch-900475
4829911|NCT02444741|Stereotactic body radiation therapy|stereotactic body radiation therapy
4829912|NCT02444741|SBRT|sbrt
4829913|NCT02444741|Wide-field radiation therapy|wide-field radiation therapy
4829914|NCT02444741|WFRT|wfrt
4829915|NCT02444741|Radiation therapy|radiation therapy
4829916|NCT02444741|XRT|xrt
4829917|NCT02444728|thrombocytopenia|thrombocytopenia
4829918|NCT02444728|systemic lupus erythematosus|systemic lupus erythematosus
4829919|NCT02444728|hydroxychloroquine|hydroxychloroquine
4829920|NCT02444728|cyclophosphamide|cyclophosphamide
4829921|NCT02444728|remission|remission
4829922|NCT02444715|Lifestyle coaching|lifestyle coaching
4829923|NCT02444715|Phone-based system|phone-based system
4829924|NCT02444715|CVD prevention|cvd prevention
4829925|NCT02444715|Patient-centered decision support|patient-centered decision support
4829926|NCT02444702|spinal stenosis, clinical predictors rules, MRI, fusion, low back pain|spinal stenosis, clinical predictors rules, mri, fusion, low back pain
4829927|NCT02444689|Blood pressure|blood pressure
4829928|NCT02444689|Cardiovascular disease|cardiovascular disease
4829929|NCT02444689|Children|children
4829930|NCT02444689|Adolescent|adolescent
4829931|NCT02444689|Pediatrics|pediatrics
4829932|NCT02444689|End-organ damage|end-organ damage
4829933|NCT02444650|Correlation|correlation
4829934|NCT02444650|pulse wave velocity measurement|pulse wave velocity measurement
4829935|NCT02444650|tonometry|tonometry
4829936|NCT02444624|necrotizing enterocolitis|necrotizing enterocolitis
4829937|NCT02444624|Clostridium|clostridium
4829938|NCT02444624|premature birth|premature birth
4829939|NCT02444611|neonates|neonates
4829940|NCT02444611|BCG|bcg
4829941|NCT02444611|Hepatitis B vaccine|hepatitis b vaccine
4829942|NCT02444611|vaccines|vaccines
4829943|NCT02444611|immunity|immunity
4829944|NCT02444611|immune response|immune response
4829945|NCT02444611|Bacille- Calmette-Guerin|bacille- calmette-guerin
4829946|NCT02444598|wounds|wounds
4829947|NCT02444598|negative-pressure wound therapy|negative-pressure wound therapy
4829948|NCT02444598|conflict|conflict
4829949|NCT02444598|gunshot wound|gunshot wound
4829950|NCT02444598|blast injuries|blast injuries
4829951|NCT02444598|civilian|civilian
4829952|NCT02444598|war|war
4829953|NCT02444559|Volunteers|volunteers
4829954|NCT02444533|Liposomal Bupivacaine|liposomal bupivacaine
4829955|NCT02444520|Medically unexplained symptoms|medically unexplained symptoms
4829956|NCT02444520|Primary care|primary care
4829957|NCT02444520|Cognitive behaviour therapy skills|cognitive behaviour therapy skills
4829958|NCT02444520|Cluster randomised controlled trial|cluster randomised controlled trial
4829959|NCT02444520|Feasibility|feasibility
4829960|NCT02444481|Mycotic Vaginitis|mycotic vaginitis
4829961|NCT02444455|cellular therapy|cellular therapy
4829962|NCT02444455|acute lung injury|acute lung injury
4829963|NCT02444455|acute respiratory distress snydrome|acute respiratory distress snydrome
4829964|NCT02444455|human umbilical cord mesenchymal stem cell|human umbilical cord mesenchymal stem cell
4829965|NCT02444455|phase 1/2 clinical study|phase 1/2 clinical study
4829966|NCT02444455|allogeneic stem cell transplantation|allogeneic stem cell transplantation
4829967|NCT02444455|ALI|ali
4829968|NCT02444455|ARDS|ards
4829969|NCT02444442|Renal denervation|renal denervation
4829970|NCT02444442|Blood pressure|blood pressure
4829971|NCT02444442|Cardiovascular risk|cardiovascular risk
4829972|NCT02444442|Target organ damage|target organ damage
4829973|NCT02444442|Sympathetic activity|sympathetic activity
4829974|NCT02444442|Non-compliance|non-compliance
4829975|NCT02444429|Screening renal biopsy|screening renal biopsy
4829976|NCT02444429|Immunosuppression|immunosuppression
4829977|NCT02444403|HIV|hiv
4829978|NCT02444403|Viral hepatitis|viral hepatitis
4829980|NCT02444403|Needle-stick injury|needle-stick injury
4829981|NCT02444403|Needle/syringes|needle/syringes
4829982|NCT02444403|Structural intervention|structural intervention
4829983|NCT02444403|Stepped wedge|stepped wedge
4829984|NCT02444403|Police|police
4829985|NCT02444403|Occupational safety|occupational safety
4829986|NCT02444403|Police Training|police training
4829987|NCT02444390|Failed non steroidal aromatases inhibitors|failed non steroidal aromatases inhibitors
4829988|NCT02444390|Eligible for everolimus+exemestane|eligible for everolimus+exemestane
4829989|NCT02444364|diabetes|diabetes
4829990|NCT02444364|bone loss|bone loss
4829991|NCT02444364|Bone Density|bone density
4829992|NCT02444325|group prenatal care|group prenatal care
4829993|NCT02444325|CenteringPregnancy|centeringpregnancy
4829994|NCT02444325|diabetes|diabetes
4829995|NCT02444312|Caregiving|caregiving
4829996|NCT02444312|Benefit Finding|benefit finding
4829997|NCT02444312|Writing Intervention|writing intervention
4829998|NCT02444273|liver diseases|liver diseases
4829999|NCT02444273|liver transplantation|liver transplantation
4830000|NCT02444273|preoperative care|preoperative care
4830001|NCT02444273|physical therapy|physical therapy
4830002|NCT02444260|Inguinal Hernia,|inguinal hernia,
4830003|NCT02444260|Local Anesthesia|local anesthesia
4830004|NCT02444260|Randomized Clinical trial|randomized clinical trial
4830005|NCT02444260|HERNIOPLASTY|hernioplasty
4830006|NCT02444221|Atrial Fibrillation|atrial fibrillation
4830007|NCT02444221|Rivaroxaban|rivaroxaban
4830008|NCT02444221|Stroke|stroke
4830009|NCT02444195|gynecologic cancer|gynecologic cancer
4830010|NCT02444195|guided imagery|guided imagery
4830011|NCT02444195|postoperative distress|postoperative distress
4830012|NCT02444195|perioperative distress|perioperative distress
4830013|NCT02444143|Kidney|kidney
4830014|NCT02444143|Immunosuppression|immunosuppression
4830015|NCT02444143|Transplant|transplant
4830016|NCT02444130|multifocality|multifocality
4830017|NCT02444130|monovision|monovision
4830018|NCT02444117|neurophysiology|neurophysiology
4830019|NCT02444104|Left Ventricular Assist Device|left ventricular assist device
4830020|NCT02444091|Chronic Fatigue Syndrome|chronic fatigue syndrome
4830021|NCT02444091|Myalgic Encephalomyelitis (ME)|myalgic encephalomyelitis (me)
4830022|NCT02444091|Cyclophosphamide|cyclophosphamide
4830023|NCT02444091|Immunomodulatory treatment|immunomodulatory treatment
4830024|NCT02444091|CFS|cfs
4830025|NCT02444078|Alzheimer Disease|alzheimer disease
4830026|NCT02444078|Dementia|dementia
4830027|NCT02444078|Physical activity|physical activity
4830028|NCT02444078|Functional ability|functional ability
4830029|NCT02444078|Disability|disability
4830030|NCT02444078|Functional limitation|functional limitation
4830031|NCT02444065|Cognitive behavior therapy|cognitive behavior therapy
4830032|NCT02444065|Motivational interviewing|motivational interviewing
4830033|NCT02444065|Bulimia nervosa|bulimia nervosa
4830034|NCT02444065|Rapid response|rapid response
4830035|NCT02444013|Contrast induced nephropathy|contrast induced nephropathy
4830036|NCT02444000|chemotherapy|chemotherapy
4830037|NCT02444000|PCV|pcv
4830038|NCT02444000|radiotherapy|radiotherapy
4830039|NCT02444000|post operative treatment|post operative treatment
4830040|NCT02444000|anaplastic gliomas|anaplastic gliomas
4830041|NCT02444000|1p/19q codeletion|1p/19q codeletion
4830042|NCT02444000|cognition|cognition
4830043|NCT02443987|Tension-Free Vaginal Tape|tension-free vaginal tape
4830044|NCT02443961|Bronchopulmonary dysplasia|bronchopulmonary dysplasia
4830045|NCT02443961|pulmonary hypertension|pulmonary hypertension
4830046|NCT02443961|stem cell therapy|stem cell therapy
4830047|NCT02443961|mesenchymal stem cells|mesenchymal stem cells
4830048|NCT02443961|very low weight preterm babies|very low weight preterm babies
4830049|NCT02443922|type 2 diabetes|type 2 diabetes
4830050|NCT02443922|beta cell function|beta cell function
4830051|NCT02443922|meal tolerance test (MTT)|meal tolerance test (mtt)
4830052|NCT02443922|maximal stimulation test (MaxStim)|maximal stimulation test (maxstim)
4830053|NCT02443922|method standardization|method standardization
4830054|NCT02443922|insulin secretion|insulin secretion
4830055|NCT02443922|prediabetes|prediabetes
4830056|NCT02443922|insulin sensitivity|insulin sensitivity
4830057|NCT02443922|glimepiride|glimepiride
4830058|NCT02443922|sitagliptin|sitagliptin
4830059|NCT02443922|metformin|metformin
4830060|NCT02443909|Holmium Laser|holmium laser
4830061|NCT02443909|Kidney Stones|kidney stones
4830062|NCT02443909|RIRS|rirs
4830063|NCT02443883|stomach cancer|stomach cancer
4830064|NCT02443844|BPH|bph
4830065|NCT02443844|bladder cancer|bladder cancer
4830066|NCT02443844|treatment|treatment
4830067|NCT02443844|recurrence|recurrence
4830068|NCT02443844|progression|progression
4830069|NCT02443831|high risk relapsed CD19+ hematological malignancies|high risk relapsed cd19+ hematological malignancies
4830070|NCT02443766|Integrative Medicine|integrative medicine
4830071|NCT02443766|Alternative Medicine|alternative medicine
4830072|NCT02443766|Complementary Medicine|complementary medicine
4830073|NCT02443766|Meditation Retreat|meditation retreat
4830074|NCT02443766|Ignatian Retreat|ignatian retreat
4830075|NCT02443766|Single Photon Emission Computed Tomography (SPECT)|single photon emission computed tomography (spect)
4830076|NCT02443766|Functional Magnetic Resonance Imaging (fMRI)|functional magnetic resonance imaging (fmri)
4830077|NCT02443766|Wellbeing|wellbeing
4830078|NCT02443766|General Health|general health
4830079|NCT02443740|First in human|first in human
4830080|NCT02443740|Single Ascending Dose Study|single ascending dose study
4830081|NCT02443740|Safety and Tolerability|safety and tolerability
4830082|NCT02443740|Pharmacokinetics|pharmacokinetics
4830083|NCT02443740|Plasma|plasma
4830084|NCT02443740|Cerebrospinal Fluid|cerebrospinal fluid
4830085|NCT02443714|Needle-Free Jet Injection|needle-free jet injection
4830086|NCT02443714|Insulin Lispro|insulin lispro
4830087|NCT02443714|pharmacokinetics|pharmacokinetics
4830088|NCT02443714|pharmacodynamics|pharmacodynamics
4830089|NCT02443636|Depression|depression
4830090|NCT02443636|Mental Health|mental health
4830091|NCT02443636|Registry|registry
4830092|NCT02443636|Reliability|reliability
4830093|NCT02443636|Post Traumatic Stress Disorder|post traumatic stress disorder
4830094|NCT02443636|Bipolar Disorder|bipolar disorder
4830095|NCT02443636|Mood disorder|mood disorder
4830096|NCT02443636|Suicide|suicide
4830097|NCT02443610|Postpartum Hemorrhage|postpartum hemorrhage
4830098|NCT02443610|Venous Thromboembolism|venous thromboembolism
4830099|NCT02443610|Pregnancy|pregnancy
4830100|NCT02443597|ultrasound|ultrasound
4830101|NCT02443597|trisomy screening|trisomy screening
4830102|NCT02443597|obesity|obesity
4830103|NCT02443584|depression|depression
4830104|NCT02443584|pharmacogenetics|pharmacogenetics
4830105|NCT02443584|pharmacogenomics|pharmacogenomics
4830106|NCT02443584|major depressive disorder|major depressive disorder
4830107|NCT02443584|genetics|genetics
4830108|NCT02443584|anti-depressants|anti-depressants
4830109|NCT02443571|observational study|observational study
4830110|NCT02443558|Robotics|robotics
4830111|NCT02443558|Cerebral cortex|cerebral cortex
4830112|NCT02443558|Brain waves|brain waves
4830113|NCT02443558|Electroencephalography|electroencephalography
4830114|NCT02443558|Rehabilitation|rehabilitation
4830115|NCT02443558|Brain-Computer Interfaces|brain-computer interfaces
4830116|NCT02443545|Iron overload|iron overload
4830117|NCT02443545|Sickle cell disease|sickle cell disease
4830118|NCT02443545|Deferiprone|deferiprone
4830119|NCT02443545|Ferriprox|ferriprox
4830120|NCT02443545|Iron chelation|iron chelation
4830121|NCT02443519|Mindfulness|mindfulness
4830122|NCT02443519|MBCT|mbct
4830123|NCT02443519|Cognitive Therapy|cognitive therapy
4830124|NCT02443519|Disability|disability
4830125|NCT02443428|Breast Cancer|breast cancer
4830126|NCT02443402|Non diabetic hyperglycemia|non diabetic hyperglycemia
4830127|NCT02443389|nephrotoxic|nephrotoxic
4830128|NCT02443389|Fluid overload|fluid overload
4830129|NCT02443389|Acute renal failure|acute renal failure
4830130|NCT02443389|Prematurity|prematurity
4830131|NCT02443389|Risk factors|risk factors
4830132|NCT02443389|Epidemiology|epidemiology
4830133|NCT02443324|immuno-oncology|immuno-oncology
4830134|NCT02443324|Vascular Endothelial Growth Factor (VEGF)|vascular endothelial growth factor (vegf)
4830135|NCT02443324|angiogenesis|angiogenesis
4830136|NCT02443324|PD-1|pd-1
4830137|NCT02443324|carcinoma of the bladder|carcinoma of the bladder
4830138|NCT02443324|carcinoma of the urethra|carcinoma of the urethra
4830139|NCT02443324|carcinoma of the ureter|carcinoma of the ureter
4830140|NCT02443324|carcinoma of the renal pelvis|carcinoma of the renal pelvis
4830141|NCT02443324|carcinoma of the biliary tract|carcinoma of the biliary tract
4830142|NCT02443298|ABBV-066|abbv-066
4830143|NCT02443298|BI 655066|bi 655066
4830144|NCT02443298|risankizumab|risankizumab
4830145|NCT02443259|NAPI|napi
4830146|NCT02443259|late preterm|late preterm
4830147|NCT02443207|Toothache|toothache
4830148|NCT02443207|Quality of life|quality of life
4830149|NCT02443207|Oral Health|oral health
4830150|NCT02443207|Children|children
4830151|NCT02443194|depression|depression
4830152|NCT02443194|glioblastoma|glioblastoma
4830153|NCT02443181|Essential tremor; closed-loop DBS|essential tremor; closed-loop dbs
4830154|NCT02443168|Pharmacokinetic|pharmacokinetic
4830155|NCT02443168|Healthy|healthy
4830156|NCT02443168|Male|male
4830157|NCT02443168|AG-221|ag-221
4830158|NCT02443168|[14C]|[14c]
4830159|NCT02443168|Single dose|single dose
4830160|NCT02443168|Oral|oral
4830161|NCT02443168|Intravenous|intravenous
4830162|NCT02443142|mild TBI|mild tbi
4830163|NCT02443142|concussion|concussion
4830164|NCT02443142|post-concussion syndrome|post-concussion syndrome
4830165|NCT02443103|pilot study|pilot study
4830166|NCT02443103|guanabenz acetate|guanabenz acetate
4830167|NCT02443090|secondary hypogonadism|secondary hypogonadism
4830168|NCT02443090|sexual dysfunction|sexual dysfunction
4830169|NCT02443090|erectile dysfunction|erectile dysfunction
4830170|NCT02443064|Pharmacokinetics/pharmacodynamics|pharmacokinetics/pharmacodynamics
4830171|NCT02443064|vancomycin|vancomycin
4830172|NCT02443064|blood stream infections|blood stream infections
4830173|NCT02443064|Chinese patients|chinese patients
4830174|NCT02443064|MRSA|mrsa
4830175|NCT02443038|patient fall|patient fall
4830176|NCT02443038|yoga|yoga
4830177|NCT02443038|balance|balance
4830178|NCT02443012|Diabetic Macular Edema|diabetic macular edema
4830179|NCT02443012|Nepafenac|nepafenac
4830180|NCT02443012|Laser therapy|laser therapy
4830181|NCT02443012|Clinically significant macular edema|clinically significant macular edema
4830182|NCT02443012|Adjunct Treatment|adjunct treatment
4830183|NCT02443012|Topical Nepafenac|topical nepafenac
4830184|NCT02442986|weaning failure|weaning failure
4830185|NCT02442986|polyneuropathy|polyneuropathy
4830186|NCT02442986|encephalopathy|encephalopathy
4830187|NCT02442986|sepsis|sepsis
4830188|NCT02442947|stress when dressed|stress when dressed
4830189|NCT02442947|protective garment|protective garment
4830190|NCT02442947|work clothes|work clothes
4830191|NCT02442934|Critical Care|critical care
4830192|NCT02442934|Critical Care Nursing|critical care nursing
4830193|NCT02442934|Discomfort|discomfort
4830194|NCT02442934|Sleep deprivation|sleep deprivation
4830195|NCT02442934|Noise|noise
4830196|NCT02442934|Thirst|thirst
4830197|NCT02442934|Pain|pain
4830198|NCT02442895|mature oocytes|mature oocytes
4830199|NCT02442895|antral follicles count|antral follicles count
4830200|NCT02442895|follicle stimulating hormone|follicle stimulating hormone
4830201|NCT02442895|antimullerian hormone|antimullerian hormone
4830202|NCT02442882|Brain Concussion|brain concussion
4830203|NCT02442882|Balance|balance
4830204|NCT02442882|Locomotion|locomotion
4830205|NCT02442882|Mild Traumatic Brain Injury|mild traumatic brain injury
4830206|NCT02442869|Suicide|suicide
4830207|NCT02442817|DPP-4 Inhibitor|dpp-4 inhibitor
4830208|NCT02442817|Linagliptin|linagliptin
4830209|NCT02442817|SDF1-α|sdf1-α
4830210|NCT02442804|Pomegranate|pomegranate
4830211|NCT02442804|Stroke|stroke
4830212|NCT02442804|Neuropsychology|neuropsychology
4830213|NCT02442791|Cardiac arrest|cardiac arrest
4830214|NCT02442791|GLP-1|glp-1
4830215|NCT02442791|Neuroprotection|neuroprotection
4830216|NCT02442752|Drug therapy|drug therapy
4830217|NCT02442739|Ketamine|ketamine
4830218|NCT02442739|Prevention of depression|prevention of depression
4830219|NCT02442726|Heat Injury|heat injury
4830220|NCT02442726|Humans|humans
4830221|NCT02442726|Laser Stimulation|laser stimulation
4830222|NCT02442726|Quantitative Sensory Testing|quantitative sensory testing
4830223|NCT02442726|Reaction Time|reaction time
4830224|NCT02442726|Secondary Hyperalgesia|secondary hyperalgesia
4830225|NCT02442726|Thermal Thresholds|thermal thresholds
4830226|NCT02442713|Polysomnograph|polysomnograph
4830227|NCT02442713|fluvoxamine|fluvoxamine
4830228|NCT02442700|HIV-infected patients with dyslipidemia and receiving atazanavir/ritonavir|hiv-infected patients with dyslipidemia and receiving atazanavir/ritonavir
4830229|NCT02442674|Hyponatremia|hyponatremia
4830230|NCT02442674|Euvolemic|euvolemic
4830231|NCT02442674|Hypervolemic|hypervolemic
4830232|NCT02442674|Serum sodium|serum sodium
4830233|NCT02442674|Dilutional hyponatremia|dilutional hyponatremia
4830234|NCT02442674|Electrolyte abnormality|electrolyte abnormality
4830235|NCT02442674|Electrolyte imbalance|electrolyte imbalance
4830236|NCT02442674|Metabolic disease|metabolic disease
4830237|NCT02442674|Water-Electrolyte Imbalance|water-electrolyte imbalance
4830238|NCT02442648|Renal Transplantation|renal transplantation
4830239|NCT02442648|Carfilzomib|carfilzomib
4830240|NCT02442648|Kyprolis|kyprolis
4830241|NCT02442648|Desensitization|desensitization
4830242|NCT02442622|de Quervain's disease|de quervain's disease
4830243|NCT02442622|de Quervain's tenosynovitis.|de quervain's tenosynovitis.
4830244|NCT02442622|ASTYM|astym
4830245|NCT02442622|de Quervain's treatment|de quervain's treatment
4830246|NCT02442609|internet|internet
4830247|NCT02442609|anesthesia|anesthesia
4830248|NCT02442609|information|information
4830249|NCT02442609|surgery|surgery
4830250|NCT02442609|question|question
4830251|NCT02442596|Abdominal sepsis|abdominal sepsis
4830252|NCT02442596|Sepsis|sepsis
4830253|NCT02442596|Septic shock|septic shock
4830254|NCT02442596|Epidemiology|epidemiology
4830255|NCT02442596|Etiology|etiology
4830256|NCT02442596|Microbiology|microbiology
4830257|NCT02442596|Abdomen|abdomen
4830258|NCT02442596|Intra-abdominal|intra-abdominal
4830259|NCT02442596|Infection|infection
4830260|NCT02442596|Gastrointestinal tract|gastrointestinal tract
4830261|NCT02442596|Perforation|perforation
4830262|NCT02442596|Peritonitis|peritonitis
4830263|NCT02442596|Pancreas|pancreas
4830264|NCT02442596|Biliary tract|biliary tract
4830265|NCT02442596|Megacolon|megacolon
4830266|NCT02442583|colorectal cancer|colorectal cancer
4830267|NCT02442583|survivor|survivor
4830268|NCT02442583|exercise|exercise
4830269|NCT02442583|physical activity|physical activity
4830270|NCT02442583|sedentary|sedentary
4830271|NCT02442570|alpha B-crystallin|alpha b-crystallin
4830272|NCT02442570|immune tolerance|immune tolerance
4830273|NCT02442557|alpha B-crystallin|alpha b-crystallin
4830274|NCT02442557|immune tolerance|immune tolerance
4830275|NCT02442518|placenta accreta|placenta accreta
4830276|NCT02442518|placenta previa|placenta previa
4830277|NCT02442518|ultrasound|ultrasound
4830278|NCT02442505|Atrial Fibrillation; Pacemaker; Device-detected|atrial fibrillation; pacemaker; device-detected
4830279|NCT02442492|sildenafil|sildenafil
4830280|NCT02442492|IUGR|iugr
4830281|NCT02442492|FGR|fgr
4830282|NCT02442492|STRIDER|strider
4830283|NCT02442479|exercise|exercise
4830284|NCT02442479|resistance training|resistance training
4830285|NCT02442479|muscle strength|muscle strength
4830286|NCT02442479|muscle hypertrophy|muscle hypertrophy
4830287|NCT02442440|anisodamine|anisodamine
4830288|NCT02442440|septic shock|septic shock
4830289|NCT02442427|Respiratory syncytial virus|respiratory syncytial virus
4830290|NCT02442427|Palivizumab|palivizumab
4830291|NCT02442427|Bronchiolitis|bronchiolitis
4830292|NCT02442427|Treatment|treatment
4830293|NCT02442414|Cancer|cancer
4830294|NCT02442414|Advanced Solid Tumors|advanced solid tumors
4830295|NCT02442414|EGFR|egfr
4830296|NCT02442414|HER2|her2
4830297|NCT02442414|HER3|her3
4830298|NCT02442414|HER4|her4
4830299|NCT02442414|ALK mutations|alk mutations
4830300|NCT02442414|irreversible tyrosine kinase inhibitor|irreversible tyrosine kinase inhibitor
4830301|NCT02442414|Metastatic Non Small Cell Lung Cancer|metastatic non small cell lung cancer
4830302|NCT02442414|Gastric Cancer|gastric cancer
4830303|NCT02442414|Colorectal Cancer|colorectal cancer
4830304|NCT02442388|pain|pain
4830305|NCT02442388|root canal therapy|root canal therapy
4830306|NCT02442388|endodontics|endodontics
4830307|NCT02442388|file|file
4830308|NCT02442375|head and neck cancer|head and neck cancer
4830309|NCT02442375|accelerated radiotherapy|accelerated radiotherapy
4830310|NCT02442375|dose reduction|dose reduction
4830311|NCT02442375|dose de-escalation|dose de-escalation
4830312|NCT02442375|elective lymph nodes|elective lymph nodes
4830313|NCT02442375|FDG-PET|fdg-pet
4830314|NCT02442349|Phase II, Open Label, Single-arm study, Safety and Efficacy of AZD9291, Asia Pacific, NSCLC with T790M mutation within the Epidermal Growth Factor Receptor Gene|phase ii, open label, single-arm study, safety and efficacy of azd9291, asia pacific, nsclc with t790m mutation within the epidermal growth factor receptor gene
4830315|NCT02442310|deferiprone|deferiprone
4830316|NCT02442310|deferiprone delayed release formulation|deferiprone delayed release formulation
4830317|NCT02442310|pharmacokinetics|pharmacokinetics
4830318|NCT02442297|Glioblastoma|glioblastoma
4830319|NCT02442297|T cells Expressing HER2-specific Chimeric Antigen Receptors|t cells expressing her2-specific chimeric antigen receptors
4830320|NCT02442297|HER2-specific T cells|her2-specific t cells
4830321|NCT02442297|intracranial injection|intracranial injection
4830322|NCT02442284|Chronic Hepatitis C|chronic hepatitis c
4830323|NCT02442284|Interferon-Free|interferon-free
4830324|NCT02442284|Hepatitis C Genotype 1|hepatitis c genotype 1
4830325|NCT02442284|Hepatitis C Virus|hepatitis c virus
4830326|NCT02442284|Hepatitis C|hepatitis c
4830327|NCT02442284|Cirrhosis|cirrhosis
4830328|NCT02442271|Chronic Hepatitis C|chronic hepatitis c
4830329|NCT02442271|Hepatitis C Treatment Naive|hepatitis c treatment naive
4830330|NCT02442271|Hepatitis C Genotype 1|hepatitis c genotype 1
4830331|NCT02442271|Hepatitis C Treatment Experienced|hepatitis c treatment experienced
4830332|NCT02442271|Hepatitis C Virus|hepatitis c virus
4830333|NCT02442258|Renal Impairment|renal impairment
4830334|NCT02442219|gluten|gluten
4830335|NCT02442219|Tetramer|tetramer
4830336|NCT02442206|QVA149, cardiac function, ventricular enddiastolic volume, hyperinflated COPD patients|qva149, cardiac function, ventricular enddiastolic volume, hyperinflated copd patients
4830337|NCT02442154|early tracheostomy|early tracheostomy
4830338|NCT02442154|severe head injury|severe head injury
4830339|NCT02442154|endotracheal intubation|endotracheal intubation
4830340|NCT02442141|Near-Infrared Spectroscopy|near-infrared spectroscopy
4830341|NCT02442141|Cerebral|cerebral
4830342|NCT02442141|Infants|infants
4830343|NCT02442141|Anesthesia|anesthesia
4830344|NCT02442141|Neurodevelopmental|neurodevelopmental
4830345|NCT02442128|Fentany|fentany
4830346|NCT02442128|intubation|intubation
4830347|NCT02442128|sevoflurane|sevoflurane
4830348|NCT02442128|children|children
4830349|NCT02442128|Propofol|propofol
4830350|NCT02442115|Autism|autism
4830351|NCT02442115|Autism Spectrum Disorder (ASD)|autism spectrum disorder (asd)
4830352|NCT02442115|Tummy Troubles|tummy troubles
4830353|NCT02442115|Constipation|constipation
4830354|NCT02442115|GI Disorders|gi disorders
4830355|NCT02442115|Gastrointestinal Disorders|gastrointestinal disorders
4830356|NCT02442115|Gastrointestinal|gastrointestinal
4830357|NCT02442115|Oxidative Stress|oxidative stress
4830358|NCT02442115|Stomach problems|stomach problems
4830359|NCT02442115|Behaviors|behaviors
4830360|NCT02442115|Autistic|autistic
4830361|NCT02442115|ASD|asd
4830362|NCT02442115|MET gene|met gene
4830363|NCT02442115|GID|gid
4830364|NCT02442115|Pediatric|pediatric
4830365|NCT02442115|Pediatric GI disorders|pediatric gi disorders
4830366|NCT02442115|Children with Autism|children with autism
4830367|NCT02442115|functional constipation|functional constipation
4830368|NCT02442102|deglutition disorders|deglutition disorders
4830369|NCT02442102|therapeutics|therapeutics
4830370|NCT02442102|rehabilitation|rehabilitation
4830371|NCT02442102|outcome assessment|outcome assessment
4830372|NCT02442102|intubation|intubation
4830373|NCT02442102|critical care|critical care
4830374|NCT02442102|larynx|larynx
4830375|NCT02442102|voice|voice
4830376|NCT02442089|mHealth|mhealth
4830377|NCT02442089|eHealth|ehealth
4830378|NCT02442089|Health Systems|health systems
4830379|NCT02442089|Health Technology|health technology
4830380|NCT02442089|No Show|no show
4830381|NCT02442089|Non-attendance|non-attendance
4830382|NCT02442089|Chile|chile
4830383|NCT02442089|Randomized controlled trial|randomized controlled trial
4830384|NCT02442089|Efficiency, Organizational|efficiency, organizational
4830385|NCT02442089|Pediatric Hospitals|pediatric hospitals
4830386|NCT02442089|Global Health|global health
4830387|NCT02442089|Referral and Consultation|referral and consultation
4830388|NCT02442089|Health Care Systems|health care systems
4830389|NCT02442089|Community Health Systems|community health systems
4830390|NCT02442089|Health Information Systems|health information systems
4830391|NCT02442089|Integrated Health Care Systems|integrated health care systems
4830392|NCT02442089|Community Medicine|community medicine
4830393|NCT02442076|Skin vibration|skin vibration
4830394|NCT02442076|Acupuncture needle vibration|acupuncture needle vibration
4830395|NCT02442050|CABG|cabg
4830396|NCT02442050|valve surgery|valve surgery
4830397|NCT02442050|cardioplegia|cardioplegia
4830398|NCT02442050|heart surgery|heart surgery
4830399|NCT02442050|cardiac surgery|cardiac surgery
4830400|NCT02442050|Cardio-Pulmonary Bypass|cardio-pulmonary bypass
4830401|NCT02442050|myocardial arrest|myocardial arrest
4830402|NCT02442050|coronary artery bypass graft|coronary artery bypass graft
4830403|NCT02442050|CPB|cpb
4830404|NCT02442037|cellular therapy|cellular therapy
4830405|NCT02442037|active ulcerative colitis|active ulcerative colitis
4830406|NCT02442037|phase 1/2 clinical study|phase 1/2 clinical study
4830407|NCT02442037|human umbilical cord mesenchymal stem cell|human umbilical cord mesenchymal stem cell
4830408|NCT02442037|allogeneic stem cell transplantation|allogeneic stem cell transplantation
4830409|NCT02442037|UC|uc
4830410|NCT02442024|diabetes mellitus|diabetes mellitus
4830411|NCT02442024|diet|diet
4830412|NCT02442024|nutrient sensing|nutrient sensing
4830413|NCT02442011|Hematology Biobank|hematology biobank
4830414|NCT02441998|Colorectal Cancer|colorectal cancer
4830415|NCT02441998|Diminutive Polyps|diminutive polyps
4830416|NCT02441998|Narrow Band Imaging|narrow band imaging
4830417|NCT02441998|Colonic Polyps|colonic polyps
4830418|NCT02441998|colonoscopy|colonoscopy
4830419|NCT02441998|diagnostic imaging|diagnostic imaging
4830420|NCT02441998|optical diagnosis|optical diagnosis
4830421|NCT02441985|Primary orthostatic tremor|primary orthostatic tremor
4830422|NCT02441946|cyclin-dependent kinase (CDK) 4/6 inhibitor|cyclin-dependent kinase (cdk) 4/6 inhibitor
4830423|NCT02441946|CDK 4 and 6 inhibitor|cdk 4 and 6 inhibitor
4830424|NCT02441907|Diabetic Macular Edema|diabetic macular edema
4830425|NCT02441907|Ocular Cytokines|ocular cytokines
4830426|NCT02441907|Triamcinolone Acetonide|triamcinolone acetonide
4830427|NCT02441881|Radiofrequency ablation|radiofrequency ablation
4830428|NCT02441881|varicose veins|varicose veins
4830429|NCT02441881|endothermal ablation|endothermal ablation
4830430|NCT02441881|RFITT|rfitt
4830431|NCT02441881|Venefit|venefit
4830432|NCT02441842|β-blocker|β-blocker
4830433|NCT02441842|ACE inhibitor|ace inhibitor
4830434|NCT02441842|Stress|stress
4830435|NCT02441842|Craniotomy|craniotomy
4830436|NCT02441842|Postop hypertension|postop hypertension
4830437|NCT02441842|neurosurgical patients|neurosurgical patients
4830438|NCT02441829|Renal Impairment|renal impairment
4830439|NCT02441816|wet AMD|wet amd
4830440|NCT02441816|neovascular AMD|neovascular amd
4830441|NCT02441803|Leukemia|leukemia
4830442|NCT02441803|Acute myeloid leukemia|acute myeloid leukemia
4830443|NCT02441803|AML|aml
4830444|NCT02441803|Refractory|refractory
4830445|NCT02441803|Allogeneic hematopoietic stem cell transplantation|allogeneic hematopoietic stem cell transplantation
4830446|NCT02441803|AHSCT|ahsct
4830447|NCT02441803|Busulfan|busulfan
4830448|NCT02441803|Busulfex|busulfex
4830449|NCT02441803|Myleran|myleran
4830450|NCT02441803|Fludarabine|fludarabine
4830451|NCT02441803|Fludarabine Phosphate|fludarabine phosphate
4830452|NCT02441803|Fludara|fludara
4830453|NCT02441803|Clofarabine|clofarabine
4830454|NCT02441803|Clofarex|clofarex
4830455|NCT02441803|Clolar|clolar
4830456|NCT02441803|Total body irradiation|total body irradiation
4830457|NCT02441803|TBI|tbi
4830458|NCT02441803|XRT|xrt
4830459|NCT02441803|Thymoglobulin|thymoglobulin
4830460|NCT02441803|ATG (Rabbit)|atg (rabbit)
4830461|NCT02441803|Rabbit antithymocyte Globulin|rabbit antithymocyte globulin
4830462|NCT02441803|Rabbit Antilymphocyte Globulin|rabbit antilymphocyte globulin
4830463|NCT02441803|Rabbit ATG|rabbit atg
4830464|NCT02441803|rATG|ratg
4830465|NCT02441803|Stem cell infusion|stem cell infusion
4830466|NCT02441803|Cyclophosphamide|cyclophosphamide
4830467|NCT02441803|Cytoxan|cytoxan
4830468|NCT02441803|Neosar|neosar
4830469|NCT02441803|Tacrolimus|tacrolimus
4830470|NCT02441803|Prograf|prograf
4830471|NCT02441803|Mycophenolate mofetil|mycophenolate mofetil
4830472|NCT02441803|MMF|mmf
4830473|NCT02441803|CellCept|cellcept
4830474|NCT02441803|Decitabine|decitabine
4830475|NCT02441803|Dacogen|dacogen
4830476|NCT02441803|Cytarabine|cytarabine
4830477|NCT02441803|Ara-C|ara-c
4830478|NCT02441803|Cytosar|cytosar
4830479|NCT02441803|DepoCyt|depocyt
4830480|NCT02441803|Cytosine Arabinosine Hydrochloride|cytosine arabinosine hydrochloride
4830481|NCT02441803|Idarubicin|idarubicin
4830482|NCT02441803|Idamycin|idamycin
4830483|NCT02441790|5th metacarpal|5th metacarpal
4830484|NCT02441790|EAROM|earom
4830485|NCT02441790|standard immobilization|standard immobilization
4830486|NCT02441790|Boxer's Fracture|boxer's fracture
4830487|NCT02441790|hand function|hand function
4830488|NCT02441790|DASH|dash
4830489|NCT02441790|trauma|trauma
4830490|NCT02441777|retinal imaging|retinal imaging
4830491|NCT02441777|optical imaging|optical imaging
4830492|NCT02441777|optical coherence tomography|optical coherence tomography
4830493|NCT02441777|polarization sensitive coherence tomography|polarization sensitive coherence tomography
4830494|NCT02441764|Halaven|halaven
4830495|NCT02441764|Eribulin Mesylate|eribulin mesylate
4830496|NCT02441764|locally advanced or metastatic breast cancer|locally advanced or metastatic breast cancer
4830497|NCT02441751|Electrocardiography|electrocardiography
4830498|NCT02441751|Hemorrhage|hemorrhage
4830499|NCT02441751|Monitoring, Intraoperative|monitoring, intraoperative
4830500|NCT02441738|Atrial Fibrillation|atrial fibrillation
4830501|NCT02441738|Hybrid Ablation|hybrid ablation
4830502|NCT02441738|Catheter Ablation|catheter ablation
4830503|NCT02441686|Multiple Myeloma|multiple myeloma
4830504|NCT02441673|Postanaesthetic shivering|postanaesthetic shivering
4830505|NCT02441673|Subarachnoid block|subarachnoid block
4830506|NCT02441673|Tramadol|tramadol
4830507|NCT02441673|Nefopam|nefopam
4830508|NCT02441621|fluid responsiveness|fluid responsiveness
4830509|NCT02441621|diastolic dysfunction|diastolic dysfunction
4830510|NCT02441621|left ventricular|left ventricular
4830511|NCT02441556|thrombectomy|thrombectomy
4830512|NCT02441556|rt-PA|rt-pa
4830513|NCT02441556|stroke|stroke
4830514|NCT02441556|endovascular treatment|endovascular treatment
4830515|NCT02441556|randomized|randomized
4830516|NCT02441530|vitamin D|vitamin d
4830517|NCT02441517|Xtandi|xtandi
4830518|NCT02441517|Metastatic Castration Resistant Prostate Cancer|metastatic castration resistant prostate cancer
4830519|NCT02441517|Metastatic|metastatic
4830520|NCT02441517|Prostate Cancer|prostate cancer
4830521|NCT02441517|Chemotherapy|chemotherapy
4830522|NCT02441517|Castration-resistant|castration-resistant
4830523|NCT02441517|Enzalutamide|enzalutamide
4830524|NCT02441504|Exercise training|exercise training
4830525|NCT02441504|microvascular rarefaction|microvascular rarefaction
4830526|NCT02441478|cooperative behavior, therapy adherence, fMRI|cooperative behavior, therapy adherence, fmri
4830527|NCT02441452|Nuss procedure|nuss procedure
4830528|NCT02441452|postoperative care|postoperative care
4830529|NCT02441452|early ambulation|early ambulation
4830530|NCT02441426|Cognitive development|cognitive development
4830531|NCT02441426|Diarrheal disease|diarrheal disease
4830532|NCT02441426|Enteric infections|enteric infections
4830533|NCT02441426|Malnutrition|malnutrition
4830534|NCT02441426|Vaccine Response|vaccine response
4830535|NCT02441426|Enteropathy|enteropathy
4830536|NCT02441426|Antibiotic use|antibiotic use
4830537|NCT02441426|Micronutrients|micronutrients
4830538|NCT02441426|Breast feeding|breast feeding
4830539|NCT02441426|Gut inflammation|gut inflammation
4830540|NCT02441413|HRCT|hrct
4830541|NCT02441413|High Resolution Computed Tomography scans|high resolution computed tomography scans
4830542|NCT02441413|Functional Respiratory Imaging|functional respiratory imaging
4830543|NCT02441413|FRI|fri
4830544|NCT02441413|Computed Tomography|computed tomography
4830545|NCT02441413|CT|ct
4830546|NCT02441413|Bronchiolitis Obliterans Syndrome|bronchiolitis obliterans syndrome
4830547|NCT02441413|BOS|bos
4830548|NCT02441413|Lung Transplant|lung transplant
4830549|NCT02441400|GERD|gerd
4830550|NCT02441400|LES Pressure|les pressure
4830551|NCT02441400|Electrical Stimulation|electrical stimulation
4830552|NCT02441387|depression|depression
4830553|NCT02441387|elderly|elderly
4830554|NCT02441387|remission|remission
4830555|NCT02441387|treatment response|treatment response
4830556|NCT02441387|predictors of response|predictors of response
4830557|NCT02441387|cognitive decline|cognitive decline
4830558|NCT02441387|structural neuroimage|structural neuroimage
4830559|NCT02441387|genetic polymorphism|genetic polymorphism
4830560|NCT02441387|psychoeducation|psychoeducation
4830561|NCT02441374|Stroke|stroke
4830562|NCT02441374|Hemiparesis|hemiparesis
4830563|NCT02441374|Upper limb|upper limb
4830564|NCT02441348|Voice Therapy|voice therapy
4830565|NCT02441348|Muscle Tension Dysphonia|muscle tension dysphonia
4830566|NCT02441348|Lesions|lesions
4830567|NCT02441309|Metastatic and/or Recurrent Osteosarcoma|metastatic and/or recurrent osteosarcoma
4830568|NCT02441283|Chronic hepatitis C|chronic hepatitis c
4830569|NCT02441283|Hepatitis C virus|hepatitis c virus
4830570|NCT02441283|Sustained virologic response|sustained virologic response
4830571|NCT02441283|Hepatitis C|hepatitis c
4830572|NCT02441283|Direct Acting Antiviral|direct acting antiviral
4830573|NCT02441257|Gastroesophageal Reflux|gastroesophageal reflux
4830574|NCT02441257|Laryngeal Mask Airway|laryngeal mask airway
4830575|NCT02441257|Control Ventilation|control ventilation
4830576|NCT02441257|Spontaneous Ventilation|spontaneous ventilation
4830577|NCT02441205|High Intensity Interval Training|high intensity interval training
4830578|NCT02441192|physical training|physical training
4830579|NCT02441192|aerobic training|aerobic training
4830580|NCT02441192|resistance training|resistance training
4830581|NCT02441179|acute intermittent hypoxia|acute intermittent hypoxia
4830582|NCT02441179|rehabilitation|rehabilitation
4830583|NCT02441179|spinal cord injury|spinal cord injury
4830584|NCT02441166|Bone marrow tryptase|bone marrow tryptase
4830585|NCT02441166|cutaneous mastocytosis|cutaneous mastocytosis
4830586|NCT02441140|Stage III Ovarian Cancer|stage iii ovarian cancer
4830587|NCT02441140|Stage IV Ovarian Cancer|stage iv ovarian cancer
4830588|NCT02441127|free gingival graft|free gingival graft
4830589|NCT02441127|diode laser|diode laser
4830590|NCT02441127|donor site|donor site
4830591|NCT02441127|mucogingival surgery|mucogingival surgery
4830592|NCT02441101|Cardiac Resynchronization therapy|cardiac resynchronization therapy
4830593|NCT02441075|patients|patients
4830594|NCT02441075|BMT|bmt
4830595|NCT02441075|cyclosporine|cyclosporine
4830596|NCT02441075|tacrolimus|tacrolimus
4830597|NCT02441075|HSCT|hsct
4830598|NCT02441049|Latino|latino
4830599|NCT02441049|Hispanic|hispanic
4830600|NCT02441049|Diet|diet
4830601|NCT02441049|Family health|family health
4830602|NCT02441049|Promotora|promotora
4830603|NCT02441049|Intervention|intervention
4830604|NCT02441036|Gene expression and protein production|gene expression and protein production
4830605|NCT02441023|type 2 diabetes mellitus|type 2 diabetes mellitus
4830606|NCT02441023|nutritional therapy|nutritional therapy
4830607|NCT02441023|health education|health education
4830608|NCT02441023|self-management|self-management
4830609|NCT02441023|multimedia|multimedia
4830610|NCT02440997|aromatherapy, peppermint|aromatherapy, peppermint
4830611|NCT02440984|enteric nervous system|enteric nervous system
4830612|NCT02440984|anorectal disorder|anorectal disorder
4830613|NCT02440984|barostat anorectal|barostat anorectal
4830614|NCT02440984|physiology|physiology
4830615|NCT02440984|spina bifida|spina bifida
4830616|NCT02440971|Adaptive Servo Ventilation|adaptive servo ventilation
4830617|NCT02440971|Acute decompensated heart failure|acute decompensated heart failure
4830618|NCT02440971|SleepMinder|sleepminder
4830619|NCT02440971|ApneaLink Plus|apnealink plus
4830620|NCT02440971|Sleep disordered breathing|sleep disordered breathing
4830621|NCT02440971|Natriuretic peptide|natriuretic peptide
4830622|NCT02440932|low Phenylalanine diet|low phenylalanine diet
4830623|NCT02440932|PKU supplements|pku supplements
4830624|NCT02440932|diet induced thermogenesis|diet induced thermogenesis
4830625|NCT02440932|appetite|appetite
4830626|NCT02440932|body weight|body weight
4830627|NCT02440919|Respiratory mechanics|respiratory mechanics
4830628|NCT02440919|Oxygenation|oxygenation
4830629|NCT02440919|Suction|suction
4830630|NCT02440919|Mechanical ventilation|mechanical ventilation
4830631|NCT02440919|Respiratory therapy|respiratory therapy
4830632|NCT02440919|Capnography|capnography
4830633|NCT02440919|Pulmonary Ventilation|pulmonary ventilation
4830634|NCT02440906|Asthma|asthma
4830635|NCT02440906|Cerebrovascular Disease|cerebrovascular disease
4830636|NCT02440906|Intracranial Injury|intracranial injury
4830637|NCT02440906|Neoplasms|neoplasms
4830638|NCT02440906|Heart Failure|heart failure
4830639|NCT02440906|HIV/AIDs|hiv/aids
4830640|NCT02440906|Hereditary and Degenerative Diseases of the Central Nervous System|hereditary and degenerative diseases of the central nervous system
4830641|NCT02440906|Disorders of the Peripheral Nervous System|disorders of the peripheral nervous system
4830642|NCT02440906|Rheumatoid Arthritis and Other Inflammatory Polyarthropathies|rheumatoid arthritis and other inflammatory polyarthropathies
4830643|NCT02440906|History of hepatitis C|history of hepatitis c
4830644|NCT02440906|Schizophrenia|schizophrenia
4830645|NCT02440906|Episodic Mood Disorders|episodic mood disorders
4830646|NCT02440906|Delusional Disorders|delusional disorders
4830647|NCT02440906|Other Non-Organic Psychoses|other non-organic psychoses
4830648|NCT02440906|Organic Psychotic Conditions|organic psychotic conditions
4830649|NCT02440906|Neurotic Disorders|neurotic disorders
4830650|NCT02440906|Other Non-Psychotic Mental Disorders|other non-psychotic mental disorders
4830651|NCT02440893|Corus CAD|corus cad
4830652|NCT02440893|ASGES|asges
4830653|NCT02440893|Age/Sex/Gene Expression Score|age/sex/gene expression score
4830654|NCT02440893|Gene Expression|gene expression
4830655|NCT02440893|GES|ges
4830656|NCT02440893|CAD|cad
4830657|NCT02440893|CVD|cvd
4830658|NCT02440893|CHD|chd
4830659|NCT02440893|Precision Medicine|precision medicine
4830660|NCT02440893|Coronary Artery Disease|coronary artery disease
4830661|NCT02440893|Angina Pectoris|angina pectoris
4830662|NCT02440893|Chest Pain|chest pain
4830663|NCT02440893|Cardiovascular Disease|cardiovascular disease
4830664|NCT02440893|Coronary Heart Disease|coronary heart disease
4830665|NCT02440893|Metformin|metformin
4830666|NCT02440867|theta burst stimulation|theta burst stimulation
4830667|NCT02440867|Social Cognition|social cognition
4830668|NCT02440867|MRSI|mrsi
4830669|NCT02440867|Schizophrenia|schizophrenia
4830670|NCT02440867|transcranial magnetic stimulation|transcranial magnetic stimulation
4830671|NCT02440841|VA106483|va106483
4830672|NCT02440841|fedovapagon|fedovapagon
4830673|NCT02440841|drug-drug interaction|drug-drug interaction
4830674|NCT02440841|DDI|ddi
4830675|NCT02440841|males|males
4830676|NCT02440841|rifampicin|rifampicin
4830677|NCT02440841|rifampin|rifampin
4830678|NCT02440841|itraconazole|itraconazole
4830679|NCT02440841|CYP3A4|cyp3a4
4830680|NCT02440841|pharmacokinetics|pharmacokinetics
4830681|NCT02440841|PK|pk
4830682|NCT02440815|Psychotherapy|psychotherapy
4830683|NCT02440815|Problem Solving Therapy (PST)|problem solving therapy (pst)
4830684|NCT02440815|Depression|depression
4830685|NCT02440815|Major Depression|major depression
4830686|NCT02440815|Major Depressive Disorder|major depressive disorder
4830687|NCT02440815|Late Life Depression|late life depression
4830688|NCT02440815|Multimodal imaging|multimodal imaging
4830689|NCT02440815|Magnetic Resonance Imaging (MRI)|magnetic resonance imaging (mri)
4830690|NCT02440815|Cerebral blood flow|cerebral blood flow
4830691|NCT02440815|Cortical atrophy|cortical atrophy
4830692|NCT02440815|White matter lesion|white matter lesion
4830693|NCT02440763|Natural History|natural history
4830694|NCT02440737|Newly diagnosed|newly diagnosed
4830695|NCT02440737|Cancer patient|cancer patient
4830696|NCT02440737|Caregiver|caregiver
4830697|NCT02440737|Support person|support person
4830698|NCT02440724|winged stents|winged stents
4830699|NCT02440724|Self-expandable Metal Stents(SEMS)|self-expandable metal stents(sems)
4830700|NCT02440724|partial covered|partial covered
4830701|NCT02440724|uncovered|uncovered
4830702|NCT02440724|endoscopic insertion|endoscopic insertion
4830704|NCT02440685|FL|fl
4830705|NCT02440685|MCL|mcl
4830706|NCT02440685|PTCL|ptcl
4830707|NCT02440685|MF|mf
4830708|NCT02440685|CLL|cll
4830709|NCT02440672|Osteoarthritis|osteoarthritis
4830710|NCT02440672|TKA|tka
4830711|NCT02440672|Degenerative Knee Disease|degenerative knee disease
4830712|NCT02440659|Chronic Kidney Disease|chronic kidney disease
4830713|NCT02440659|Hemodialysis|hemodialysis
4830714|NCT02440659|Peritoneal Dialysis|peritoneal dialysis
4830715|NCT02440646|Computed tomography angiography|computed tomography angiography
4830716|NCT02440646|Quantitative coronary angiography|quantitative coronary angiography
4830717|NCT02440646|Coronary artery disease|coronary artery disease
4830718|NCT02440646|Natural history of atherosclerosis|natural history of atherosclerosis
4830719|NCT02440646|Radiocontrast-induced thyroid dysfunction|radiocontrast-induced thyroid dysfunction
4830720|NCT02440646|Contrast-induced nephropathy|contrast-induced nephropathy
4830721|NCT02440646|Plaque burden|plaque burden
4830722|NCT02440646|Glagovian artery remodeling|glagovian artery remodeling
4830723|NCT02440646|Radiation dose|radiation dose
4830724|NCT02440646|SYNTAX score|syntax score
4830725|NCT02440646|Fractional flow reserve|fractional flow reserve
4830726|NCT02440620|Heart failure related to medical treatment of breast cancer|heart failure related to medical treatment of breast cancer
4830727|NCT02440607|Randomization|randomization
4830728|NCT02440607|cognitive aids types|cognitive aids types
4830729|NCT02440607|aids|aids
4830730|NCT02440594|Primary Care|primary care
4830731|NCT02440594|Depression|depression
4830732|NCT02440594|Elderly|elderly
4830733|NCT02440555|diabetes, capillary blood glucose, self-administered questionnaire|diabetes, capillary blood glucose, self-administered questionnaire
4830734|NCT02440542|Nerve block|nerve block
4830735|NCT02440542|Ankle|ankle
4830736|NCT02440542|Talus|talus
4830737|NCT02440542|Pain, Postoperative|pain, postoperative
4830738|NCT02440516|Standardized|standardized
4830739|NCT02440516|Physical therapy|physical therapy
4830740|NCT02440516|occupational therapy|occupational therapy
4830741|NCT02440516|quality of life|quality of life
4830742|NCT02440516|disability|disability
4830743|NCT02440516|activities of daily living|activities of daily living
4830744|NCT02440516|ambulatory therapy|ambulatory therapy
4830745|NCT02440516|multiple sclerosis|multiple sclerosis
4830746|NCT02440464|Multiple Myeloma|multiple myeloma
4830747|NCT02440464|Allogeneic Transplant|allogeneic transplant
4830748|NCT02440464|Maintenance Therapy|maintenance therapy
4830749|NCT02440464|Anti-Myeloma Agents|anti-myeloma agents
4830750|NCT02440464|Hematologic Disorders|hematologic disorders
4830751|NCT02440438|Clostridium difficile, recurrence, relapse, antibodies, immune response, prognosis|clostridium difficile, recurrence, relapse, antibodies, immune response, prognosis
4830752|NCT02440425|platinum resistant|platinum resistant
4830753|NCT02440425|recurrent|recurrent
4830754|NCT02440425|persistent|persistent
4830755|NCT02440425|epithelial|epithelial
4830756|NCT02440425|ovarian|ovarian
4830757|NCT02440425|fallopian tube|fallopian tube
4830758|NCT02440425|primary peritoneal|primary peritoneal
4830759|NCT02440425|carcinoma|carcinoma
4830760|NCT02440412|Massage|massage
4830761|NCT02440412|Stress|stress
4830762|NCT02440412|salivary cortisol|salivary cortisol
4830763|NCT02440360|chronic homelessness|chronic homelessness
4830764|NCT02440347|local anesthesia|local anesthesia
4830765|NCT02440347|articaine|articaine
4830766|NCT02440347|AMSA|amsa
4830767|NCT02440334|cryosurgery|cryosurgery
4830768|NCT02440334|ultrasonography|ultrasonography
4830769|NCT02440282|patients|patients
4830770|NCT02440256|Cost-effectiveness|cost-effectiveness
4830771|NCT02440256|Opioid substitution treatment|opioid substitution treatment
4830772|NCT02440256|Integrated care|integrated care
4830773|NCT02440256|HIV|hiv
4830774|NCT02440256|HAART|haart
4830775|NCT02440256|Testing|testing
4830776|NCT02440256|Linkage to care|linkage to care
4830777|NCT02440256|Treatment adherence|treatment adherence
4830778|NCT02440230|adjuvant endocrine therapy|adjuvant endocrine therapy
4830779|NCT02440230|safety|safety
4830780|NCT02440230|Exemestane|exemestane
4830781|NCT02440230|ovarian function suppression|ovarian function suppression
4830782|NCT02440230|anastrozole|anastrozole
4830783|NCT02440204|sevoflurane|sevoflurane
4830784|NCT02440204|remifentanil|remifentanil
4830785|NCT02440204|intubation without using muscle relaxants|intubation without using muscle relaxants
4830786|NCT02440178|leukemia|leukemia
4830787|NCT02440178|induction|induction
4830788|NCT02440178|prophylaxis|prophylaxis
4830789|NCT02440178|antifungal|antifungal
4830790|NCT02440178|micafungin|micafungin
4830791|NCT02440178|phase II|phase ii
4830792|NCT02440165|nutrition|nutrition
4830793|NCT02440165|nurse|nurse
4830794|NCT02440165|intervention|intervention
4830795|NCT02440165|malnutrition|malnutrition
4830796|NCT02440126|Multiple Sclerosis|multiple sclerosis
4830797|NCT02440126|immunological|immunological
4830798|NCT02440126|biomarkers|biomarkers
4830799|NCT02440126|observational|observational
4830800|NCT02440126|Relapsing|relapsing
4830801|NCT02440126|Remitting Multiple Sclerosis|remitting multiple sclerosis
4830802|NCT02440100|Phase 1|phase 1
4830803|NCT02440100|Multiple doses of PF-06648671|multiple doses of pf-06648671
4830804|NCT02440100|safety, tolerability, PK|safety, tolerability, pk
4830805|NCT02440100|plasma and CSF abeta|plasma and csf abeta
4830806|NCT02440100|drug interaction|drug interaction
4830807|NCT02440074|Lumbar pain|lumbar pain
4830808|NCT02440074|Mesenchymal Stem Cells|mesenchymal stem cells
4830809|NCT02440061|Ghrelin|ghrelin
4830810|NCT02440061|age, BMI, and gender matched controls|age, bmi, and gender matched controls
4830811|NCT02440048|extraction|extraction
4830812|NCT02440048|Bond Apatite|bond apatite
4830813|NCT02440035|Healthy Participants|healthy participants
4830814|NCT02440035|Ad35.RSV.FA2|ad35.rsv.fa2
4830815|NCT02440035|JNJ-61187191|jnj-61187191
4830816|NCT02439996|Kawasaki disease IVIG|kawasaki disease ivig
4830817|NCT02439970|kidney transplant allograft|kidney transplant allograft
4830818|NCT02439970|recipients|recipients
4830819|NCT02439944|Nicotine Patch|nicotine patch
4830820|NCT02439944|Nicotine Mouth Spray|nicotine mouth spray
4830821|NCT02439944|Smoking Cessation|smoking cessation
4830822|NCT02439944|Quit Smoking|quit smoking
4830823|NCT02439944|Abstinence|abstinence
4830824|NCT02439944|Dependence|dependence
4830825|NCT02439944|Nicotine|nicotine
4830827|NCT02439944|Transdermal Nicotine Replacement Therapy|transdermal nicotine replacement therapy
4830828|NCT02439944|Functional Magnetic Resonance Imaging|functional magnetic resonance imaging
4830829|NCT02439944|Neuroimaging|neuroimaging
4830830|NCT02439944|Cue Reactivity|cue reactivity
4830831|NCT02439944|Resting State|resting state
4830832|NCT02439944|BOLD fMRI|bold fmri
4830833|NCT02439905|inflammatory cytokine|inflammatory cytokine
4830834|NCT02439905|protective effect|protective effect
4830835|NCT02439905|Dexmedetomidine|dexmedetomidine
4830836|NCT02439905|Precedex|precedex
4830837|NCT02439905|one lung ventilation|one lung ventilation
4830838|NCT02439905|ischemia-reperfusion|ischemia-reperfusion
4830839|NCT02439892|Radiotherapy|radiotherapy
4830840|NCT02439892|Exercise|exercise
4830841|NCT02439892|Diet therapy|diet therapy
4830842|NCT02439892|Rehabilitation|rehabilitation
4830843|NCT02439892|Patient Compliance|patient compliance
4830844|NCT02439892|Feasibility Studies|feasibility studies
4830845|NCT02439892|Sample Size|sample size
4830846|NCT02439892|Patient satisfaction|patient satisfaction
4830847|NCT02439853|primary progressive aphasia|primary progressive aphasia
4830848|NCT02439853|progressive nonfluent aphasia|progressive nonfluent aphasia
4830849|NCT02439853|progressive aphasia|progressive aphasia
4830850|NCT02439853|frontotemporal dementia|frontotemporal dementia
4830851|NCT02439853|frontotemporal lobar degeneration|frontotemporal lobar degeneration
4830852|NCT02439827|Lifestyle|lifestyle
4830853|NCT02439827|Intervention|intervention
4830854|NCT02439827|Motor Activity|motor activity
4830855|NCT02439827|Mediating Variables|mediating variables
4830856|NCT02439827|Mental Health|mental health
4830857|NCT02439827|Obesity|obesity
4830858|NCT02439827|Adolescent Health|adolescent health
4830859|NCT02439827|School|school
4830860|NCT02439827|Health Promotion|health promotion
4830861|NCT02439827|Brazil|brazil
4830862|NCT02439801|PEEP|peep
4830863|NCT02439801|compliance|compliance
4830864|NCT02439801|peak airway pressures|peak airway pressures
4830865|NCT02439788|Neuroblastoma|neuroblastoma
4830866|NCT02439788|Natural Killer T Cells|natural killer t cells
4830867|NCT02439788|Gene Therapy|gene therapy
4830868|NCT02439788|Chimeric Antigen Receptor|chimeric antigen receptor
4830869|NCT02439775|Uncontrolled hypertension|uncontrolled hypertension
4830870|NCT02439775|Renal denervation|renal denervation
4830871|NCT02439762|Veterans|veterans
4830872|NCT02439762|Cognitive Behavioral Therapy|cognitive behavioral therapy
4830873|NCT02439749|Uncontrolled hypertension|uncontrolled hypertension
4830874|NCT02439749|Renal denervation|renal denervation
4830875|NCT02439736|Traumatic Brain Injury|traumatic brain injury
4830876|NCT02439736|Head Injury|head injury
4830877|NCT02439723|Regorafenib|regorafenib
4830878|NCT02439723|Lean body mass|lean body mass
4830879|NCT02439723|Proton pump inhibitors pharmacokinetics|proton pump inhibitors pharmacokinetics
4830880|NCT02439684|HbA1c|hba1c
4831583|NCT02435342|psoriasis|psoriasis
4830881|NCT02439684|Diagnostic accuracy|diagnostic accuracy
4830882|NCT02439684|Diabetes Mellitus|diabetes mellitus
4830883|NCT02439684|Chinese|chinese
4830884|NCT02439684|Impaired fasting glucose|impaired fasting glucose
4830885|NCT02439671|Transition Support Program for young adults|transition support program for young adults
4830886|NCT02439658|genetic research|genetic research
4830887|NCT02439645|genetic research|genetic research
4830888|NCT02439606|GlideRite|gliderite
4830889|NCT02439606|Stylet|stylet
4830890|NCT02439606|Parker|parker
4830891|NCT02439606|orotracheal|orotracheal
4830892|NCT02439606|intubation|intubation
4830893|NCT02439606|GlideScope|glidescope
4830894|NCT02439593|Pancreas|pancreas
4830895|NCT02439593|chemoradiotherapy|chemoradiotherapy
4830896|NCT02439593|hyperthermia|hyperthermia
4830897|NCT02439580|Patients|patients
4830898|NCT02439580|After Surgery|after surgery
4830899|NCT02439567|Cirrhosis|cirrhosis
4830900|NCT02439567|Chronic hepatitis C|chronic hepatitis c
4830901|NCT02439567|Clinically significant portal hypertension|clinically significant portal hypertension
4830902|NCT02439567|Portal hypertension|portal hypertension
4830903|NCT02439567|Elastography|elastography
4830904|NCT02439567|Antiviral therapy|antiviral therapy
4830905|NCT02439541|cellular therapy|cellular therapy
4830906|NCT02439541|Chronic ischemic heart disease|chronic ischemic heart disease
4830907|NCT02439541|phase 1/2 clinical study|phase 1/2 clinical study
4830908|NCT02439541|human umbilical cord mesenchymal stem cell|human umbilical cord mesenchymal stem cell
4830909|NCT02439541|ischemic heart disease|ischemic heart disease
4830910|NCT02439541|allogeneic stem cell transplantation|allogeneic stem cell transplantation
4830911|NCT02439528|pulmonary fibrosis|pulmonary fibrosis
4830912|NCT02439528|syndrome|syndrome
4830913|NCT02439528|genetic|genetic
4830914|NCT02439528|emphysema|emphysema
4830915|NCT02439515|post-acute stroke|post-acute stroke
4830916|NCT02439515|functional electrical stimulation|functional electrical stimulation
4830917|NCT02439515|biofeedback|biofeedback
4830918|NCT02439515|balance|balance
4830919|NCT02439515|cycling|cycling
4830920|NCT02439515|rehabilitation|rehabilitation
4830921|NCT02439515|gait|gait
4830922|NCT02439476|Multiple myeloma|multiple myeloma
4830923|NCT02439476|ASCT|asct
4830924|NCT02439476|plerixafor|plerixafor
4830925|NCT02439476|stem cell mobilization|stem cell mobilization
4830926|NCT02439476|Salvage ASCT using plerixafor-based stem cell mobilization in relapsed multiple myeloma|salvage asct using plerixafor-based stem cell mobilization in relapsed multiple myeloma
4830927|NCT02439450|lung|lung
4830928|NCT02439450|cancer|cancer
4830929|NCT02439450|gp96|gp96
4830930|NCT02439450|vaccine|vaccine
4830931|NCT02439450|immunotherapy|immunotherapy
4830932|NCT02439450|Heat Biologics|heat biologics
4830933|NCT02439450|Nivolumab|nivolumab
4830934|NCT02439450|checkpoint inhibitor|checkpoint inhibitor
4830935|NCT02439385|Curcumin|curcumin
4830936|NCT02439385|Avastin|avastin
4830937|NCT02439385|FOLFIRI|folfiri
4830938|NCT02439385|Colorectal cancer|colorectal cancer
4830939|NCT02439385|Unresectable metastasis|unresectable metastasis
4830940|NCT02439346|Advanced solid tumors|advanced solid tumors
4830941|NCT02439346|Docetaxel|docetaxel
4830942|NCT02439346|mitogen-activated protein (MAP) kinase-interacting serine / threonine-protein kinase 1, also known as Mnk1 (MKNK1 inhibitor)|mitogen-activated protein (map) kinase-interacting serine / threonine-protein kinase 1, also known as mnk1 (mknk1 inhibitor)
4830943|NCT02439346|Taxanes|taxanes
4830944|NCT02439346|Non-small cell lung cancer|non-small cell lung cancer
4830945|NCT02439333|Acute exacerbation of chronic obstructive pulmonary disease|acute exacerbation of chronic obstructive pulmonary disease
4830946|NCT02439333|Nasal high flow therapy|nasal high flow therapy
4830947|NCT02439333|Oxygen therapy|oxygen therapy
4830948|NCT02439307|Rifaximin|rifaximin
4830949|NCT02439307|Minimal hepatic encephalopathy|minimal hepatic encephalopathy
4830950|NCT02439294|Recent acute myocardial infarction|recent acute myocardial infarction
4830951|NCT02439294|Obstructive sleep apnée (syndrome)|obstructive sleep apnée (syndrome)
4830952|NCT02439294|Ventricular remodeling|ventricular remodeling
4830953|NCT02439294|Continuous Positive Airway Pressure|continuous positive airway pressure
4830954|NCT02439281|Ropivacaine|ropivacaine
4830955|NCT02439281|Anesthesia adjuncts|anesthesia adjuncts
4830956|NCT02439281|clonidine|clonidine
4830957|NCT02439281|laparoscopic appendectomy|laparoscopic appendectomy
4830958|NCT02439281|rectus sheath block|rectus sheath block
4830959|NCT02439242|stroke volume, haemodynamic, fluid resucitation|stroke volume, haemodynamic, fluid resucitation
4830960|NCT02439216|Muscular Dystrophies|muscular dystrophies
4830961|NCT02439216|Musculoskeletal Diseases|musculoskeletal diseases
4830962|NCT02439216|Nervous System Diseases|nervous system diseases
4830963|NCT02439216|Neuromuscular Diseases|neuromuscular diseases
4830964|NCT02439216|Duchenne muscular dystrophy|duchenne muscular dystrophy
4830965|NCT02439216|DMD|dmd
4830966|NCT02439216|dystrophin|dystrophin
4830967|NCT02439216|dystrophy|dystrophy
4830968|NCT02439216|Duchenne|duchenne
4830969|NCT02439203|Parkinson Disease|parkinson disease
4830970|NCT02439203|Levodopa Induced Dyskinesia (LID)|levodopa induced dyskinesia (lid)
4830971|NCT02439203|Dyskinesia|dyskinesia
4830972|NCT02439177|Blood glucose monitoring system|blood glucose monitoring system
4830973|NCT02439177|System Accuracy|system accuracy
4830974|NCT02439164|sedation|sedation
4830975|NCT02439164|eloquent area glioma|eloquent area glioma
4830976|NCT02439164|neurologic function|neurologic function
4830977|NCT02439151|Extracorporeal Membrane Oxygenation|extracorporeal membrane oxygenation
4830978|NCT02439138|Waldenstrom's Macroglobulinemia|waldenstrom's macroglobulinemia
4830979|NCT02439125|levodopa|levodopa
4830980|NCT02439125|dyskinesia|dyskinesia
4830981|NCT02439125|parkinsons disease|parkinsons disease
4830982|NCT02439125|PD|pd
4830983|NCT02439112|Exercise|exercise
4830984|NCT02439112|Physical Function|physical function
4830985|NCT02439112|Physical Activity|physical activity
4830986|NCT02439112|Quality of Life|quality of life
4830987|NCT02439112|Pain|pain
4830988|NCT02439112|Bone Disease|bone disease
4830989|NCT02439086|rectal cancer|rectal cancer
4830990|NCT02439086|neoadjuvant chemoradiotherapy|neoadjuvant chemoradiotherapy
4830991|NCT02439086|long course radiotherapy|long course radiotherapy
4830992|NCT02439086|response|response
4830993|NCT02439047|reconstructive surgery|reconstructive surgery
4830994|NCT02439047|abdominal surgery|abdominal surgery
4830995|NCT02439034|pain management|pain management
4830996|NCT02439034|brachytherapy|brachytherapy
4830997|NCT02439008|liver metastases of colorectal cancer|liver metastases of colorectal cancer
4830998|NCT02439008|metastases of melanoma or renal cancer|metastases of melanoma or renal cancer
4830999|NCT02438969|Alcohol|alcohol
4831000|NCT02438969|Alcohol Dependence|alcohol dependence
4831001|NCT02438969|Stress|stress
4831002|NCT02438969|Fear Conditioning|fear conditioning
4831003|NCT02438917|Hepatitis C|hepatitis c
4831004|NCT02438917|Cirrhosis|cirrhosis
4831005|NCT02438917|Biomarkers|biomarkers
4831006|NCT02438917|Fibrosis|fibrosis
4831007|NCT02438904|Blood And Marrow Transplantation|blood and marrow transplantation
4831008|NCT02438904|Stem cell transplantation|stem cell transplantation
4831009|NCT02438904|SCT|sct
4831010|NCT02438904|Poor graft function|poor graft function
4831011|NCT02438904|CD34+ cell infusion|cd34+ cell infusion
4831012|NCT02438865|Upper Tract Urothelial Carcinoma|upper tract urothelial carcinoma
4831013|NCT02438865|Intravesical Chemotherapy|intravesical chemotherapy
4831014|NCT02438865|Epirubicin|epirubicin
4831015|NCT02438865|Urothelial Carcinoma|urothelial carcinoma
4831016|NCT02438800|Postpartum Period|postpartum period
4831017|NCT02438787|Ankylosing Spondylitis|ankylosing spondylitis
4831018|NCT02438787|Ustekinumab|ustekinumab
4831019|NCT02438787|Golimumab|golimumab
4831020|NCT02438787|STELARA|stelara
4831021|NCT02438774|Post-harvest practices , complementary foods|post-harvest practices , complementary foods
4831022|NCT02438774|aflatoxins and fumonisins exposure,|aflatoxins and fumonisins exposure,
4831023|NCT02438774|Maize, breast milk|maize, breast milk
4831024|NCT02438774|child growth, Tanzania|child growth, tanzania
4831025|NCT02438761|Acute Myeloid Leukemia|acute myeloid leukemia
4831026|NCT02438761|Myelodysplastic Syndrome|myelodysplastic syndrome
4831027|NCT02438761|PIK/Akt/mTor|pik/akt/mtor
4831028|NCT02438748|Oxidized Phosphatidylcholines|oxidized phosphatidylcholines
4831029|NCT02438735|ovarian endometriomas|ovarian endometriomas
4831030|NCT02438735|AMH|amh
4831031|NCT02438735|ovarian reserve|ovarian reserve
4831032|NCT02438670|Artificial Pancreas|artificial pancreas
4831033|NCT02438670|Type 1 Diabetes|type 1 diabetes
4831034|NCT02438670|MPC|mpc
4831035|NCT02438670|PID|pid
4831036|NCT02438631|placenta|placenta
4831037|NCT02438631|placental passage|placental passage
4831038|NCT02438605|Nellix|nellix
4831039|NCT02438605|EVAS|evas
4831040|NCT02438605|EVAR|evar
4831041|NCT02438605|Dynamic CT|dynamic ct
4831042|NCT02438605|Dyna CT|dyna ct
4831043|NCT02438592|Continuum of care|continuum of care
4831044|NCT02438579|Hypertonic saline|hypertonic saline
4831045|NCT02438579|nasal irrigation|nasal irrigation
4831046|NCT02438579|gargling|gargling
4831047|NCT02438579|URTI|urti
4831048|NCT02438566|Tranexamic Acid|tranexamic acid
4831049|NCT02438566|Blood Loss|blood loss
4831050|NCT02438566|Total Hip Replacement|total hip replacement
4831051|NCT02438566|Bilateral Knee Replacement|bilateral knee replacement
4831052|NCT02438540|acupuncture|acupuncture
4831053|NCT02438540|obesity|obesity
4831054|NCT02438540|type 2 diabetic mellitus|type 2 diabetic mellitus
4831055|NCT02438540|insulin sensitivity|insulin sensitivity
4831056|NCT02438540|metformin|metformin
4831057|NCT02438540|inflammatory factor|inflammatory factor
4831058|NCT02438540|adipokines|adipokines
4831059|NCT02438540|lipid profile|lipid profile
4831060|NCT02438501|low-dose involved field radiotherapy|low-dose involved field radiotherapy
4831061|NCT02438501|recurrent|recurrent
4831062|NCT02438501|advanced|advanced
4831063|NCT02438501|follicular lymphoma|follicular lymphoma
4831064|NCT02438462|Pulmonary Embolism|pulmonary embolism
4831065|NCT02438462|Soluble Fibrin|soluble fibrin
4831066|NCT02438462|D-Dimers|d-dimers
4831067|NCT02438462|Clinical Probability Score|clinical probability score
4831068|NCT02438462|Imaging|imaging
4831069|NCT02438449|breast reconstruction|breast reconstruction
4831070|NCT02438449|mastectomy|mastectomy
4831071|NCT02438449|health-related quality of life|health-related quality of life
4831072|NCT02438449|Health Utilities Index|health utilities index
4831073|NCT02438449|HUI|hui
4831074|NCT02438449|prospective|prospective
4831584|NCT02435342|Kv1.3,|kv1.3,
4831075|NCT02438449|quality-adjusted life years|quality-adjusted life years
4831076|NCT02438449|QALY|qaly
4831077|NCT02438410|infliximab|infliximab
4831078|NCT02438410|remicade|remicade
4831079|NCT02438410|IBD|ibd
4831080|NCT02438410|Colitis, Ulcerative|colitis, ulcerative
4831081|NCT02438371|pregnancy|pregnancy
4831082|NCT02438371|preterm labor|preterm labor
4831083|NCT02438371|tocolysis|tocolysis
4831084|NCT02438293|rhinovirus|rhinovirus
4831085|NCT02438293|cardiac surgery|cardiac surgery
4831086|NCT02438293|paediatric|paediatric
4831087|NCT02438293|respiratory infection|respiratory infection
4831088|NCT02438293|children|children
4831089|NCT02438280|Orthodontic|orthodontic
4831090|NCT02438280|Orthodontic treatment|orthodontic treatment
4831091|NCT02438280|Accelerated orthodontics|accelerated orthodontics
4831092|NCT02438280|Vibration|vibration
4831093|NCT02438241|Pain Measurement|pain measurement
4831094|NCT02438241|Electric Stimulation|electric stimulation
4831095|NCT02438241|Spirometry|spirometry
4831096|NCT02438241|Manometry|manometry
4831097|NCT02438228|cardiac output|cardiac output
4831098|NCT02438228|transpulmonary thermodilution|transpulmonary thermodilution
4831099|NCT02438228|pulse contour analysis|pulse contour analysis
4831100|NCT02438228|G09.330.380.124|g09.330.380.124
4831101|NCT02438215|PD|pd
4831102|NCT02438215|Parkinson's Disease|parkinson's disease
4831103|NCT02438189|Type 1 Diabetes|type 1 diabetes
4831104|NCT02438189|Hypoglycemia|hypoglycemia
4831105|NCT02438189|Hyperglycemia|hyperglycemia
4831106|NCT02438189|Artificial Pancreas|artificial pancreas
4831107|NCT02438163|Theta Burst Stimulation|theta burst stimulation
4831108|NCT02438150|Disaster|disaster
4831109|NCT02438150|Training|training
4831110|NCT02438137|Obstructive Sleep Apnea|obstructive sleep apnea
4831111|NCT02438137|OSA|osa
4831112|NCT02438137|sleep apnea|sleep apnea
4831113|NCT02438137|snoring|snoring
4831114|NCT02438137|dimethyl fumarate|dimethyl fumarate
4831115|NCT02438137|CPAP|cpap
4831116|NCT02438137|continuous positive airway pressure|continuous positive airway pressure
4831117|NCT02438124|Parkinson's disease|parkinson's disease
4831118|NCT02438124|Rhythmic auditory stimulation|rhythmic auditory stimulation
4831119|NCT02438124|Gait|gait
4831120|NCT02438098|Rivaroxaban|rivaroxaban
4831121|NCT02438098|Obesity|obesity
4831122|NCT02438098|Bariatric surgery|bariatric surgery
4831123|NCT02438098|Pharmacokinetics|pharmacokinetics
4831124|NCT02438098|Pharmacodynamics|pharmacodynamics
4831125|NCT02438085|acute coronary syndromes|acute coronary syndromes
4831126|NCT02438085|outcome|outcome
4831127|NCT02438085|medical management|medical management
4831128|NCT02438085|comorbidities|comorbidities
4831129|NCT02438085|registry|registry
4831130|NCT02438072|antidepressive agent|antidepressive agent
4831131|NCT02438072|drug metabolism|drug metabolism
4831132|NCT02438072|CYP450|cyp450
4831133|NCT02438072|P-glycoprotein|p-glycoprotein
4831134|NCT02438072|Phenotypic study|phenotypic study
4831135|NCT02438059|Inequality in health|inequality in health
4831136|NCT02438059|workplace health promotion|workplace health promotion
4831137|NCT02438059|internet|internet
4831138|NCT02438059|mobile app|mobile app
4831139|NCT02438059|weight loss|weight loss
4831140|NCT02438059|intervention|intervention
4831141|NCT02438059|randomized controlled trial|randomized controlled trial
4831142|NCT02438046|Connective Tissue Grafts|connective tissue grafts
4831143|NCT02438046|Wound healing|wound healing
4831144|NCT02438046|Biomaterials|biomaterials
4831145|NCT02438046|Pain|pain
4831146|NCT02438046|Clinical Trials|clinical trials
4831147|NCT02438046|Mucogingival Surgery|mucogingival surgery
4831148|NCT02438033|Deep Brain Stimulation|deep brain stimulation
4831149|NCT02438033|Globus Pallidus|globus pallidus
4831150|NCT02438033|GPi|gpi
4831151|NCT02438033|PC+S|pc+s
4831152|NCT02438020|Acanthosis nigricans|acanthosis nigricans
4831153|NCT02438020|obesity|obesity
4831154|NCT02438020|children|children
4831155|NCT02438020|metformin|metformin
4831156|NCT02437942|Athletic injuries|athletic injuries
4831157|NCT02437942|chronic|chronic
4831158|NCT02437942|rehabilitation|rehabilitation
4831159|NCT02437942|diagnosis|diagnosis
4831160|NCT02437942|biomechanics|biomechanics
4831161|NCT02437916|Melanoma|melanoma
4831162|NCT02437916|Non-small Cell Lung Cancer (NSCLC)|non-small cell lung cancer (nsclc)
4831163|NCT02437916|Squamous Cell Carcinoma|squamous cell carcinoma
4831164|NCT02437916|Carcinoma|carcinoma
4831165|NCT02437916|Head and Neck|head and neck
4831166|NCT02437916|Transitional Cell Carinoma (TCC)|transitional cell carinoma (tcc)
4831167|NCT02437916|Bladder|bladder
4831168|NCT02437916|Colorectal|colorectal
4831169|NCT02437916|Colorectal Cancer (CRC)|colorectal cancer (crc)
4831170|NCT02437903|voluma temporal, facial, volume loss|voluma temporal, facial, volume loss
4831171|NCT02437877|Respiration|respiration
4831172|NCT02437877|Learning|learning
4831173|NCT02437877|Speech|speech
4831174|NCT02437877|Language and Hearing Sciences|language and hearing sciences
4831175|NCT02437799|Pulse oximeter|pulse oximeter
4831176|NCT02437799|Caesarean section|caesarean section
4831177|NCT02437799|hypotension|hypotension
4831178|NCT02437799|Spinal anaesthesia|spinal anaesthesia
4831179|NCT02437773|OCD|ocd
4831180|NCT02437747|clinical trial|clinical trial
4831181|NCT02437708|regenerative endodontics|regenerative endodontics
4831182|NCT02437708|platelet rich fibrin|platelet rich fibrin
4831183|NCT02437695|Robotic Surgical Procedures|robotic surgical procedures
4831184|NCT02437695|Trendelenburg Position|trendelenburg position
4831185|NCT02437682|Gastro-esophageal Reflux Disease|gastro-esophageal reflux disease
4831186|NCT02437682|Proton pump inhibitor|proton pump inhibitor
4831187|NCT02437669|Intranasal|intranasal
4831188|NCT02437669|Hydromorphone|hydromorphone
4831189|NCT02437669|Pediatric|pediatric
4831190|NCT02437669|Emergency department|emergency department
4831191|NCT02437656|Radiochemotherapy|radiochemotherapy
4831192|NCT02437656|Metformin|metformin
4831193|NCT02437656|Rectal cancer|rectal cancer
4831194|NCT02437617|Advanced cancers|advanced cancers
4831195|NCT02437617|Tumor tissue|tumor tissue
4831196|NCT02437617|Genomic profile test|genomic profile test
4831197|NCT02437617|Analysis of treatment outcomes|analysis of treatment outcomes
4831198|NCT02437617|Molecular profiling|molecular profiling
4831199|NCT02437617|Molecular alteration|molecular alteration
4831200|NCT02437591|ASP2819|asp2819
4831201|NCT02437591|PAR-101|par-101
4831202|NCT02437591|OPT-80|opt-80
4831203|NCT02437591|Inflammatory Bowel Disease (IBD)|inflammatory bowel disease (ibd)
4831204|NCT02437591|Clostridium difficile Infection (CDI)|clostridium difficile infection (cdi)
4831205|NCT02437591|fidaxomicin|fidaxomicin
4831206|NCT02437591|Dificlir|dificlir
4831207|NCT02437578|vitamin d|vitamin d
4831208|NCT02437578|fertility|fertility
4831209|NCT02437578|markers|markers
4831210|NCT02437578|endocrine disruption|endocrine disruption
4831211|NCT02437578|reproduction|reproduction
4831212|NCT02437552|Cardiac Surgery, Coronary Artery Bypass, Exercise Movement Techniques|cardiac surgery, coronary artery bypass, exercise movement techniques
4831213|NCT02437526|Cure|cure
4831214|NCT02437526|Analytic treatment interruption|analytic treatment interruption
4831215|NCT02437513|Dysphagia|dysphagia
4831216|NCT02437513|Aspiration|aspiration
4831217|NCT02437513|Laryngeal cancer|laryngeal cancer
4831218|NCT02437474|vegan diet|vegan diet
4831219|NCT02437474|lacto-ovo-vegetarian diet|lacto-ovo-vegetarian diet
4831220|NCT02437474|cancer|cancer
4831221|NCT02437474|tumor remission|tumor remission
4831222|NCT02437461|knee synovitis|knee synovitis
4831223|NCT02437461|triamcinolone hexacetonide|triamcinolone hexacetonide
4831224|NCT02437461|treatment response|treatment response
4831225|NCT02437448|Mass spectrometry|mass spectrometry
4831226|NCT02437448|Exhaled breath analysis|exhaled breath analysis
4831227|NCT02437435|assisted reproduction|assisted reproduction
4831228|NCT02437435|physical therapy|physical therapy
4831229|NCT02437435|manual therapy|manual therapy
4831230|NCT02437435|uterine artery|uterine artery
4831231|NCT02437435|Vascularization Index (VI)|vascularization index (vi)
4831232|NCT02437435|Doppler ultrasonography|doppler ultrasonography
4831233|NCT02437435|vocal|vocal
4831234|NCT02437409|Ischemic, Acute|ischemic, acute
4831235|NCT02437357|Psychotherapy, Group|psychotherapy, group
4831236|NCT02437357|Metacognition|metacognition
4831237|NCT02437357|Cognitive Bias|cognitive bias
4831238|NCT02437331|Advanced heart failure|advanced heart failure
4831239|NCT02437331|diseased experience|diseased experience
4831240|NCT02437318|HR+|hr+
4831241|NCT02437318|HER2-negative|her2-negative
4831242|NCT02437318|advanced breast cancer|advanced breast cancer
4831243|NCT02437318|alpelisib|alpelisib
4831244|NCT02437318|fulvestrant|fulvestrant
4831245|NCT02437318|PI3K|pi3k
4831246|NCT02437318|Phase III|phase iii
4831247|NCT02437318|ER+|er+
4831248|NCT02437318|PgR+|pgr+
4831249|NCT02437318|men|men
4831250|NCT02437318|postmenopausal|postmenopausal
4831251|NCT02437318|aromatase inhibitor|aromatase inhibitor
4831252|NCT02437318|neoplasms|neoplasms
4831253|NCT02437305|Melanoma|melanoma
4831254|NCT02437305|People of Color|people of color
4831255|NCT02437279|Palpable|palpable
4831256|NCT02437279|Stage III|stage iii
4831257|NCT02437279|Skin melanoma|skin melanoma
4831258|NCT02437279|Ipilimumab|ipilimumab
4831259|NCT02437279|Nivolumab|nivolumab
4831260|NCT02437279|Surgery|surgery
4831261|NCT02437253|Mucopolysaccharidosis|mucopolysaccharidosis
4831262|NCT02437253|Inflammation|inflammation
4831263|NCT02437253|Tumor necrosis factor - alpha inhibitor|tumor necrosis factor - alpha inhibitor
4831264|NCT02437240|Pilates-based exercise|pilates-based exercise
4831265|NCT02437240|respiratory mechanics|respiratory mechanics
4831266|NCT02437240|cardiopulmonary physical therapy|cardiopulmonary physical therapy
4831267|NCT02437240|sternotomy|sternotomy
4831268|NCT02437175|pelvic pain|pelvic pain
4831269|NCT02437175|quality of life|quality of life
4831270|NCT02437175|adenomyosis|adenomyosis
4831271|NCT02437162|Axial Spondyloarthritis|axial spondyloarthritis
4831272|NCT02437162|Ustekinumab|ustekinumab
4831273|NCT02437162|Golimumab|golimumab
4831274|NCT02437162|Stelara|stelara
4831275|NCT02437149|Texting and driving|texting and driving
4831276|NCT02437149|Teenager and driving|teenager and driving
4831277|NCT02437149|Distracted Driving Campaign|distracted driving campaign
4831278|NCT02437123|mHealth|mhealth
4831279|NCT02437123|Indigenous|indigenous
4831280|NCT02437123|HIV prevention|hiv prevention
4831281|NCT02437123|substance use|substance use
4831282|NCT02437110|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
4831283|NCT02437110|Virus|virus
4831284|NCT02437110|Antiretroviral Therapy|antiretroviral therapy
4831285|NCT02437071|Radiotherapy|radiotherapy
4831286|NCT02437071|Ablation|ablation
4831287|NCT02437071|Pembrolizumab|pembrolizumab
4831288|NCT02437071|15-069|15-069
4831289|NCT02437071|Metastatic Colorectal Cancer Patients|metastatic colorectal cancer patients
4831290|NCT02437032|GDF-9|gdf-9
4831291|NCT02437032|BMP-15|bmp-15
4831292|NCT02437032|Steroids|steroids
4831293|NCT02437032|Apoptosis rate|apoptosis rate
4831294|NCT02437032|Endocrinology|endocrinology
4831295|NCT02437019|PCI-32765|pci-32765
4831296|NCT02437019|Ibrutinib|ibrutinib
4831297|NCT02437019|Early access program|early access program
4831298|NCT02437019|Chronic lymphocytic leukemia|chronic lymphocytic leukemia
4831299|NCT02437019|Relapsed or refractory chronic lymphocytic leukemia|relapsed or refractory chronic lymphocytic leukemia
4831300|NCT02437006|stroke|stroke
4831301|NCT02437006|exercise capacity|exercise capacity
4831302|NCT02436993|Neoadjuvant Treatment|neoadjuvant treatment
4831303|NCT02436993|Carboplatin|carboplatin
4831304|NCT02436993|Paclitaxel|paclitaxel
4831305|NCT02436993|Pertuzumab|pertuzumab
4831306|NCT02436993|Trastuzumab|trastuzumab
4831307|NCT02436993|Bevacizumab|bevacizumab
4831308|NCT02436980|premedication|premedication
4831309|NCT02436980|ERCP|ercp
4831310|NCT02436980|midazolam|midazolam
4831311|NCT02436980|tramadol|tramadol
4831312|NCT02436980|cognitive|cognitive
4831313|NCT02436928|H7N9 Influenza|h7n9 influenza
4831314|NCT02436928|Avian influenza A|avian influenza a
4831315|NCT02436928|cell culture derived|cell culture derived
4831316|NCT02436915|Slow gait|slow gait
4831317|NCT02436915|Executive function|executive function
4831318|NCT02436915|Transcranial direct current stimulation|transcranial direct current stimulation
4831319|NCT02436876|Osteosynthesis|osteosynthesis
4831320|NCT02436876|Complications|complications
4831321|NCT02436876|Infection or Inflammation|infection or inflammation
4831322|NCT02436876|Orthopedic|orthopedic
4831323|NCT02436876|Device|device
4831324|NCT02436876|Fracture|fracture
4831325|NCT02436876|Osteomyelitis|osteomyelitis
4831326|NCT02436863|Laminectomy|laminectomy
4831327|NCT02436863|Laminoplasty|laminoplasty
4831328|NCT02436863|Internal fixation|internal fixation
4831329|NCT02436863|deformity|deformity
4831330|NCT02436850|Thoracentesis|thoracentesis
4831331|NCT02436850|Pocket Ultrasound Device|pocket ultrasound device
4831332|NCT02436850|Ultrasound|ultrasound
4831333|NCT02436850|Soroka University Medical Center|soroka university medical center
4831334|NCT02436850|Physical Examination|physical examination
4831335|NCT02436850|Ethical Committee|ethical committee
4831336|NCT02436824|topical patch|topical patch
4831337|NCT02436824|chronic low back pain|chronic low back pain
4831338|NCT02436811|Health literacy|health literacy
4831339|NCT02436811|Pregnant women|pregnant women
4831340|NCT02436811|Feeding behaviour|feeding behaviour
4831341|NCT02436811|Oral health|oral health
4831342|NCT02436811|Child|child
4831343|NCT02436798|QT prolongation|qt prolongation
4831344|NCT02436798|Genomic biomarkers|genomic biomarkers
4831345|NCT02436785|music therapy|music therapy
4831346|NCT02436785|pain management|pain management
4831347|NCT02436785|self efficacy|self efficacy
4831348|NCT02436785|patient education|patient education
4831349|NCT02436785|relaxation|relaxation
4831350|NCT02436746|Von Recklinghausen's disease|von recklinghausen's disease
4831351|NCT02436746|Bourneville's disease|bourneville's disease
4831352|NCT02436746|Cognitive variability|cognitive variability
4831353|NCT02436746|Loss of heterozygosity|loss of heterozygosity
4831354|NCT02436733|pleural mesothelioma|pleural mesothelioma
4831355|NCT02436733|phase II|phase ii
4831356|NCT02436733|randomized|randomized
4831357|NCT02436733|surgery|surgery
4831358|NCT02436733|chemotherapy|chemotherapy
4831359|NCT02436733|feasibility|feasibility
4831360|NCT02436694|Dexamethasone|dexamethasone
4831361|NCT02436694|Perineural|perineural
4831362|NCT02436655|aortic stenosis|aortic stenosis
4831363|NCT02436655|normal ejection fraction|normal ejection fraction
4831364|NCT02436655|asymptomatic|asymptomatic
4831365|NCT02436629|Red beetroot juice|red beetroot juice
4831366|NCT02436629|High intensity intermittent exercise|high intensity intermittent exercise
4831367|NCT02436629|Nitrite|nitrite
4831368|NCT02436629|Soccer|soccer
4831369|NCT02436616|EEG|eeg
4831370|NCT02436616|Preterm Infants|preterm infants
4831371|NCT02436616|Neonate|neonate
4831372|NCT02436616|wireless|wireless
4831373|NCT02436603|Irritable Bowel Syndrome|irritable bowel syndrome
4831374|NCT02436603|IBS|ibs
4831375|NCT02436603|Mind-Body Training|mind-body training
4831376|NCT02436603|Integrative Medicine|integrative medicine
4831377|NCT02436603|FODMAP|fodmap
4831378|NCT02436590|osteoarthritis|osteoarthritis
4831379|NCT02436590|knee|knee
4831380|NCT02436590|pulsed electromagnetic fields|pulsed electromagnetic fields
4831381|NCT02436590|PEMF|pemf
4831382|NCT02436577|ticagrelor orodispersible tablet|ticagrelor orodispersible tablet
4831383|NCT02436577|ticagrelor immediate-release tablet|ticagrelor immediate-release tablet
4831384|NCT02436577|bioequivalence|bioequivalence
4831385|NCT02436577|Phase I|phase i
4831386|NCT02436577|healthy Japanese subjects|healthy japanese subjects
4831387|NCT02436564|pancreas|pancreas
4831388|NCT02436564|stem cells|stem cells
4831389|NCT02436564|tumours|tumours
4831390|NCT02436564|in vitro models|in vitro models
4831391|NCT02436564|organoids|organoids
4831392|NCT02436564|cancer,|cancer,
4831393|NCT02436564|bile duct|bile duct
4831394|NCT02436564|liver|liver
4831395|NCT02436538|anti-Müllerian hormone (AMH)|anti-müllerian hormone (amh)
4831396|NCT02436538|Mullerian anomalies|mullerian anomalies
4831397|NCT02436538|ICSI|icsi
4831398|NCT02436447|Renal Impairment, Renal function, MTP-131, Bendavia™|renal impairment, renal function, mtp-131, bendavia™
4831399|NCT02436434|Pulsed radiofrequency, osteoarthritis|pulsed radiofrequency, osteoarthritis
4831400|NCT02436395|gastric cancer|gastric cancer
4831401|NCT02436395|gastrectomy|gastrectomy
4831402|NCT02436395|laparotomy|laparotomy
4831403|NCT02436395|SSIs|ssis
4831404|NCT02436395|povidone-iodine|povidone-iodine
4831405|NCT02436395|normal saline|normal saline
4831406|NCT02436369|diabetic patients|diabetic patients
4831407|NCT02436369|flaxseed|flaxseed
4831408|NCT02436369|lipid profile|lipid profile
4831409|NCT02436369|cardiovascular risc factors|cardiovascular risc factors
4831410|NCT02436343|left ventricular functions|left ventricular functions
4831411|NCT02436343|pregnancy|pregnancy
4831412|NCT02436343|obesity|obesity
4831413|NCT02436330|Exergaming, Weight management|exergaming, weight management
4831414|NCT02436317|Point Of Care Ultrasonography|point of care ultrasonography
4831415|NCT02436317|Soroka University Medical Center|soroka university medical center
4831416|NCT02436317|Heart Failure|heart failure
4831417|NCT02436317|cardiovascular|cardiovascular
4831418|NCT02436278|Gait speed|gait speed
4831419|NCT02436278|Mortality|mortality
4831420|NCT02436278|Morbidity|morbidity
4831421|NCT02436265|Neuraxial|neuraxial
4831422|NCT02436265|Caudal|caudal
4831423|NCT02436265|Block|block
4831424|NCT02436265|Anesthesia|anesthesia
4831425|NCT02436265|Dexamethasone|dexamethasone
4831426|NCT02436252|Myelodysplastic Syndrome|myelodysplastic syndrome
4831427|NCT02436252|MDS|mds
4831428|NCT02436226|PCOS|pcos
4831429|NCT02436226|Clomiphene citrate resistant|clomiphene citrate resistant
4831430|NCT02436226|HCG|hcg
4831431|NCT02436213|workload|workload
4831432|NCT02436213|oxygen level|oxygen level
4831433|NCT02436213|oxygen consumption|oxygen consumption
4831434|NCT02436213|breathing reserve|breathing reserve
4831435|NCT02436213|ventilatory efficiency|ventilatory efficiency
4831436|NCT02436200|Intermittent Claudication|intermittent claudication
4831437|NCT02436200|IC|ic
4831438|NCT02436200|Peripheral Arterial Disease|peripheral arterial disease
4831439|NCT02436200|Peripheral Vascular Disease|peripheral vascular disease
4831440|NCT02436200|Peripheral Arterial Occlusive Disease|peripheral arterial occlusive disease
4831441|NCT02436187|NSTEMI|nstemi
4831442|NCT02436187|excess mortality|excess mortality
4831443|NCT02436187|evidence-based care|evidence-based care
4831444|NCT02436187|MINAP|minap
4831445|NCT02436161|Heart Failure|heart failure
4831446|NCT02436161|Comorbidity|comorbidity
4831447|NCT02436161|Patient Care Management|patient care management
4831448|NCT02436161|Primary Health Care|primary health care
4831449|NCT02436161|Delivery of Health Care, Integrated|delivery of health care, integrated
4831450|NCT02436148|PEQ validation study, Finland|peq validation study, finland
4831451|NCT02436122|Prostate cancer|prostate cancer
4831452|NCT02436122|Preoperative|preoperative
4831453|NCT02436122|Glycemic control|glycemic control
4831454|NCT02436122|Hemoglobin A1c|hemoglobin a1c
4831455|NCT02436122|Pathologic outcomes|pathologic outcomes
4831456|NCT02436122|Oncological outcomes|oncological outcomes
4831457|NCT02436122|Treatment Outcome|treatment outcome
4831458|NCT02436122|Hemoglobin A1c Protein, Human|hemoglobin a1c protein, human
4831459|NCT02436096|Pain|pain
4831460|NCT02436096|Sleep|sleep
4831461|NCT02436070|Pediatrics|pediatrics
4831462|NCT02436070|Emergency Medicine|emergency medicine
4831463|NCT02436070|Text messaging|text messaging
4831464|NCT02436044|Hepatocellular Carcinoma|hepatocellular carcinoma
4831465|NCT02436044|Locally advanced stge|locally advanced stge
4831466|NCT02436044|HAIC|haic
4831467|NCT02436044|FOLFOX4|folfox4
4831468|NCT02436044|Locally advanced|locally advanced
4831469|NCT02436018|Sedation|sedation
4831470|NCT02436018|Low pulse oximetry|low pulse oximetry
4831471|NCT02436018|Upper gastrointestinal endoscopy|upper gastrointestinal endoscopy
4831472|NCT02436018|WEI NASAL JET|wei nasal jet
4831473|NCT02435979|wrist|wrist
4831474|NCT02435979|proximal strengthening|proximal strengthening
4831475|NCT02435979|hand therapy|hand therapy
4831476|NCT02435953|Hepatocellular Carcinoma,TACE,Chemoembolization, RFA,Intermediate-stage|hepatocellular carcinoma,tace,chemoembolization, rfa,intermediate-stage
4831477|NCT02435940|inherited retinal degenerative disease|inherited retinal degenerative disease
4831478|NCT02435940|retinitis pigmentosa|retinitis pigmentosa
4831479|NCT02435940|Usher|usher
4831480|NCT02435940|Leber|leber
4831481|NCT02435940|Bardet-Biedl|bardet-biedl
4831482|NCT02435940|Batten|batten
4831483|NCT02435940|Best|best
4831585|NCT02435342|autoimmune|autoimmune
4831484|NCT02435940|cone dystrophy|cone dystrophy
4831485|NCT02435940|cone-rod dystrophy|cone-rod dystrophy
4831486|NCT02435940|choroideremia|choroideremia
4831487|NCT02435940|congenital night blindness|congenital night blindness
4831488|NCT02435940|enhanced s-cone|enhanced s-cone
4831489|NCT02435940|cone monochromacy|cone monochromacy
4831490|NCT02435940|Goldmann-Favre|goldmann-favre
4831491|NCT02435940|Kearns-Sayre|kearns-sayre
4831492|NCT02435940|Refsum|refsum
4831493|NCT02435940|retinoschisis|retinoschisis
4831494|NCT02435940|rod-cone dystrophy|rod-cone dystrophy
4831495|NCT02435940|rod dystrophy|rod dystrophy
4831496|NCT02435940|rod monochromacy|rod monochromacy
4831497|NCT02435940|Sorsby pseudoinflammatory dystrophy|sorsby pseudoinflammatory dystrophy
4831498|NCT02435940|stargardt|stargardt
4831499|NCT02435940|achromatopsia|achromatopsia
4831500|NCT02435940|juvenile inherited macular degeneration|juvenile inherited macular degeneration
4831501|NCT02435940|cone dichromacy|cone dichromacy
4831502|NCT02435940|cone trichromacy|cone trichromacy
4831503|NCT02435940|Charcot-Marie-Tooth|charcot-marie-tooth
4831504|NCT02435940|albipunctate dystrophy|albipunctate dystrophy
4831505|NCT02435901|Reduced Intensity Conditioning Regimen|reduced intensity conditioning regimen
4831506|NCT02435888|Resting energy expenditure|resting energy expenditure
4831507|NCT02435888|Predictive equations|predictive equations
4831508|NCT02435888|Overweight|overweight
4831509|NCT02435875|hypertension|hypertension
4831510|NCT02435875|perioperative|perioperative
4831511|NCT02435875|baroreflex sensitivity|baroreflex sensitivity
4831512|NCT02435862|Vitreolysis of the Vitreous|vitreolysis of the vitreous
4831513|NCT02435849|Pediatric|pediatric
4831514|NCT02435849|ALL|all
4831515|NCT02435849|Cell therapy|cell therapy
4831516|NCT02435810|Neuroinflammation|neuroinflammation
4831517|NCT02435810|Infections|infections
4831518|NCT02435797|nicorandil|nicorandil
4831519|NCT02435797|primary percutaneous coronary intervention|primary percutaneous coronary intervention
4831520|NCT02435797|acute ST segment elevation myocardial infarction|acute st segment elevation myocardial infarction
4831521|NCT02435797|thrombus aspiration|thrombus aspiration
4831522|NCT02435784|2-COM|2-com
4831523|NCT02435745|Ehlers-Danlos Syndrome|ehlers-danlos syndrome
4831524|NCT02435745|Obstructive Sleep Apnea|obstructive sleep apnea
4831525|NCT02435745|Prevalence|prevalence
4831526|NCT02435745|Aortic Aneurysm|aortic aneurysm
4831527|NCT02435719|HCAIs|hcais
4831528|NCT02435719|Handgel|handgel
4831529|NCT02435719|Hospital|hospital
4831530|NCT02435719|Effectiveness|effectiveness
4831531|NCT02435706|Dental implants|dental implants
4831532|NCT02435706|surgical flap|surgical flap
4831533|NCT02435706|esthetics|esthetics
4831534|NCT02435706|alveolar process|alveolar process
4831535|NCT02435693|pharmaceutical care|pharmaceutical care
4831536|NCT02435680|MCS110; carboplatin; gemcitabine; TNBC; TAMs|mcs110; carboplatin; gemcitabine; tnbc; tams
4831537|NCT02435667|Resistance Training|resistance training
4831538|NCT02435667|Exercise|exercise
4831539|NCT02435667|Heart Failure preserved Ejection Fraction|heart failure preserved ejection fraction
4831540|NCT02435654|Genes Polymorphisms|genes polymorphisms
4831541|NCT02435654|Plasma Concentration|plasma concentration
4831542|NCT02435602|endoscopy, gastrointestinal|endoscopy, gastrointestinal
4831543|NCT02435602|cancer screening|cancer screening
4831544|NCT02435576|Acute toxicity|acute toxicity
4831545|NCT02435576|Late toxicity|late toxicity
4831546|NCT02435576|NTCP models|ntcp models
4831547|NCT02435563|Anti-HIV Agents|anti-hiv agents
4831548|NCT02435563|cardiovascular agents|cardiovascular agents
4831549|NCT02435563|drug interactions|drug interactions
4831550|NCT02435537|analgesia|analgesia
4831551|NCT02435537|intrathecal|intrathecal
4831552|NCT02435537|opioids|opioids
4831553|NCT02435537|morphine|morphine
4831554|NCT02435537|dexmedetomidine|dexmedetomidine
4831555|NCT02435524|Breast Feeding, Exclusive|breast feeding, exclusive
4831556|NCT02435524|Infant Nutrition|infant nutrition
4831557|NCT02435524|Burkina Faso|burkina faso
4831558|NCT02435511|agent-based modeling|agent-based modeling
4831559|NCT02435511|community resources|community resources
4831560|NCT02435511|simulation modeling|simulation modeling
4831561|NCT02435511|information intervention|information intervention
4831562|NCT02435511|clinic-to-community linkages|clinic-to-community linkages
4831563|NCT02435485|degerative lumbar spondylolisthesis|degerative lumbar spondylolisthesis
4831564|NCT02435485|rehabilitation|rehabilitation
4831565|NCT02435485|balance|balance
4831566|NCT02435472|Active Surveillance|active surveillance
4831567|NCT02435472|Exercise|exercise
4831568|NCT02435472|Prostate cancer|prostate cancer
4831569|NCT02435472|Life style|life style
4831570|NCT02435472|Survey|survey
4831571|NCT02435472|Personalized exercise|personalized exercise
4831572|NCT02435472|Exercise trainer|exercise trainer
4831573|NCT02435433|liver cancer|liver cancer
4831574|NCT02435420|Total Hip Arthroplasty|total hip arthroplasty
4831575|NCT02435420|EMPERION Modular Stem|emperion modular stem
4831576|NCT02435420|Survivorship|survivorship
4831577|NCT02435355|Sleep apnea|sleep apnea
4831578|NCT02435355|education|education
4831579|NCT02435355|compliance|compliance
4831580|NCT02435355|CPAP|cpap
4831581|NCT02435342|ShK-186|shk-186
4831582|NCT02435342|dalazatide|dalazatide
4831586|NCT02435316|Education|education
4831587|NCT02435290|prediction|prediction
4831588|NCT02435290|prescribing error|prescribing error
4831589|NCT02435290|risk factors|risk factors
4831590|NCT02435277|Diabetes|diabetes
4831591|NCT02435212|New formulation, deferasirox, chelation, iron overload, compliance, satisfaction, palatability, PRO, PK, safety, PK/PD, ICL670|new formulation, deferasirox, chelation, iron overload, compliance, satisfaction, palatability, pro, pk, safety, pk/pd, icl670
4831592|NCT02435186|p53 gene|p53 gene
4831593|NCT02435186|chemotherapy|chemotherapy
4831594|NCT02435186|recurrent|recurrent
4831595|NCT02435186|epithelial|epithelial
4831596|NCT02435186|ovarian cancer|ovarian cancer
4831597|NCT02435186|fallopian tube cancer|fallopian tube cancer
4831598|NCT02435186|primary peritoneal cancer|primary peritoneal cancer
4831599|NCT02435173|APDS PASLI PI3Kdelta|apds pasli pi3kdelta
4831600|NCT02435108|MET poisitivity is defined as at least half of tumor cells show weak, moderate or high staining|met poisitivity is defined as at least half of tumor cells show weak, moderate or high staining
4831601|NCT02435095|Schizophrenia|schizophrenia
4831602|NCT02435095|Maintenance treatment, Intermittent treatment|maintenance treatment, intermittent treatment
4831603|NCT02435095|Brain volume|brain volume
4831604|NCT02435095|Antipsychotics|antipsychotics
4831605|NCT02435082|Concussion|concussion
4831606|NCT02435082|Vascular Assessment|vascular assessment
4831607|NCT02435082|Vascular Regulation|vascular regulation
4831608|NCT02435082|mild Traumatic Brain Injury, mTBI|mild traumatic brain injury, mtbi
4831609|NCT02435082|Traumatic Brain Injury, TBI|traumatic brain injury, tbi
4831610|NCT02435082|Cerebrovascular Regulation|cerebrovascular regulation
4831611|NCT02435082|Cerebral Blood Flow|cerebral blood flow
4831612|NCT02435082|Cerebral Blood Flow Velocity, CBFV|cerebral blood flow velocity, cbfv
4831613|NCT02435082|Cerebral Blood Flow Velocity Variability|cerebral blood flow velocity variability
4831614|NCT02435082|Cerebrovascular Assessment|cerebrovascular assessment
4831615|NCT02435069|cecostomy|cecostomy
4831616|NCT02435069|appendicostomy|appendicostomy
4831617|NCT02435056|medication overuse headache|medication overuse headache
4831618|NCT02435056|health care system|health care system
4831619|NCT02435030|NP-C|np-c
4831620|NCT02435030|LSD|lsd
4831621|NCT02435030|lysosomal storage disorder|lysosomal storage disorder
4831622|NCT02435030|lysosomal storage disease|lysosomal storage disease
4831623|NCT02435030|NPC2|npc2
4831624|NCT02435030|NPC1|npc1
4831625|NCT02435030|Niemann-Pick Type C|niemann-pick type c
4831626|NCT02435030|Niemann-Pick,|niemann-pick,
4831627|NCT02435030|Arimoclomol|arimoclomol
4831628|NCT02435017|kidney disease|kidney disease
4831629|NCT02435017|recommended dietary allowances|recommended dietary allowances
4831630|NCT02435017|nutrition assessment|nutrition assessment
4831631|NCT02435017|food|food
4831632|NCT02435017|dietary proteins|dietary proteins
4831633|NCT02435017|Vitamin D|vitamin d
4831634|NCT02435017|dietary fats|dietary fats
4831635|NCT02435017|ethnology|ethnology
4831636|NCT02435017|Continental Population Groups|continental population groups
4831637|NCT02435017|Phosphorus, dietary|phosphorus, dietary
4831638|NCT02435017|Phosphorus/analysis|phosphorus/analysis
4831639|NCT02434991|trouble swallowing|trouble swallowing
4831640|NCT02434991|food sticking|food sticking
4831641|NCT02434991|Achalasia|achalasia
4831642|NCT02434965|Neonates|neonates
4831643|NCT02434965|hypoxic-ischemic encephalopathy|hypoxic-ischemic encephalopathy
4831644|NCT02434965|human placental-derived stem cells|human placental-derived stem cells
4831645|NCT02434965|autologous|autologous
4831646|NCT02434952|Malaria, Falciparum|malaria, falciparum
4831647|NCT02434952|G6PD deficiency|g6pd deficiency
4831648|NCT02434952|Primaquine|primaquine
4831649|NCT02434952|Asia|asia
4831650|NCT02434926|fetoscopy|fetoscopy
4831651|NCT02434926|fetal surgery|fetal surgery
4831652|NCT02434926|anesthetic complications|anesthetic complications
4831653|NCT02434913|Proximal interphalangeal joint deformity|proximal interphalangeal joint deformity
4831654|NCT02434913|Arthroplasty|arthroplasty
4831655|NCT02434822|Cholera|cholera
4831656|NCT02434822|Shanchol™|shanchol™
4831657|NCT02434822|Cholera Vaccine|cholera vaccine
4831658|NCT02434809|Respiratory Motion-Corrected Cone-Beam CT|respiratory motion-corrected cone-beam ct
4831659|NCT02434809|Radiation|radiation
4831660|NCT02434809|14-225|14-225
4831661|NCT02434796|Intimate Partner Violence|intimate partner violence
4831662|NCT02434796|Gender-Based Violence|gender-based violence
4831663|NCT02434796|Gender|gender
4831664|NCT02434796|HIV|hiv
4831665|NCT02434783|Blood circulation|blood circulation
4831666|NCT02434783|Blood vessels|blood vessels
4831667|NCT02434783|Mitochondria|mitochondria
4831668|NCT02434783|Muscle, skeletal|muscle, skeletal
4831669|NCT02434783|Legs|legs
4831670|NCT02434783|Energy metabolism|energy metabolism
4831671|NCT02434731|Procedural pain|procedural pain
4831672|NCT02434731|Phlebotomy|phlebotomy
4831673|NCT02434731|Intellectual Disability|intellectual disability
4831674|NCT02434731|Child|child
4831675|NCT02434731|Buzzy|buzzy
4831676|NCT02434705|Eosinophilic|eosinophilic
4831677|NCT02434692|Primary Open Angle Glaucoma|primary open angle glaucoma
4831678|NCT02434692|POAG|poag
4831679|NCT02434692|Glaucoma|glaucoma
4831680|NCT02434692|Cataract|cataract
4831681|NCT02434692|Surgery|surgery
4831682|NCT02434692|Ocular Pressure|ocular pressure
4831683|NCT02434679|antibiotics resistance integrons|antibiotics resistance integrons
4831684|NCT02434679|neonatology newborns|neonatology newborns
4831685|NCT02434679|digestive acquisition|digestive acquisition
4831686|NCT02434679|dynamic of the acquisition of integrons|dynamic of the acquisition of integrons
4831687|NCT02434627|Becker|becker
4831688|NCT02434627|Dystrophy|dystrophy
4831689|NCT02434601|Non-carious cervical lesions|non-carious cervical lesions
4831690|NCT02434601|Randomized clinical trial|randomized clinical trial
4831941|NCT02433158|Rivipansel|rivipansel
4831691|NCT02434601|Permanent dental restoration|permanent dental restoration
4831692|NCT02434601|Dentin|dentin
4831693|NCT02434601|Adhesion|adhesion
4831694|NCT02434601|Restoration|restoration
4831695|NCT02434601|Sensitivity|sensitivity
4831696|NCT02434601|Prophylaxis|prophylaxis
4831697|NCT02434601|Randomized|randomized
4831698|NCT02434575|Lower Urinary Tract Symptoms|lower urinary tract symptoms
4831699|NCT02434575|Prostatic artery embolisation|prostatic artery embolisation
4831700|NCT02434575|Transurethral resection of the prostate|transurethral resection of the prostate
4831701|NCT02434575|Benign prostatic hyperplasia|benign prostatic hyperplasia
4831702|NCT02434575|Benign prostatic enlargement|benign prostatic enlargement
4831703|NCT02434549|Randomized Controlled Trial|randomized controlled trial
4831704|NCT02434549|Placebo Controlled|placebo controlled
4831705|NCT02434549|Double Blinded|double blinded
4831706|NCT02434549|Botulinum Toxin Type A|botulinum toxin type a
4831707|NCT02434549|Adults|adults
4831708|NCT02434549|Pain|pain
4831709|NCT02434549|Spasticity|spasticity
4831710|NCT02434549|Cerebral Palsy, Spastic|cerebral palsy, spastic
4831711|NCT02434549|Dysport|dysport
4831712|NCT02434536|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
4831713|NCT02434536|Disease Exacerbation Clinical Prediction Rule|disease exacerbation clinical prediction rule
4831714|NCT02434536|Decision Analysis|decision analysis
4831715|NCT02434523|laryngeal sensory neuropathy|laryngeal sensory neuropathy
4831716|NCT02434510|Infection|infection
4831717|NCT02434510|Total Knee Arthroplasty|total knee arthroplasty
4831718|NCT02434510|Total Hip Arthroplasty|total hip arthroplasty
4831719|NCT02434510|Splash Basins|splash basins
4831720|NCT02434497|LDL-C|ldl-c
4831721|NCT02434497|HoFH|hofh
4831722|NCT02434497|Hyperlipidemia|hyperlipidemia
4831723|NCT02434484|Symbenda|symbenda
4831724|NCT02434484|Non-Hodgkin's lymphomas|non-hodgkin's lymphomas
4831725|NCT02434484|Chronic lymphocytic leukemia|chronic lymphocytic leukemia
4831726|NCT02434484|Multiple myeloma|multiple myeloma
4831727|NCT02434484|Bendamustine Hydrochloride|bendamustine hydrochloride
4831728|NCT02434458|fibromyalgia,|fibromyalgia,
4831729|NCT02434458|polyneuropathy|polyneuropathy
4831730|NCT02434458|small fiber neuropathy|small fiber neuropathy
4831731|NCT02434458|rheumatoid arthritis|rheumatoid arthritis
4831732|NCT02434458|sudomotor|sudomotor
4831733|NCT02434406|Anxiety|anxiety
4831734|NCT02434406|Anxiety disorders|anxiety disorders
4831735|NCT02434406|Mental health|mental health
4831736|NCT02434406|Postpartum period|postpartum period
4831737|NCT02434406|maternal welfare|maternal welfare
4831738|NCT02434406|internet|internet
4831739|NCT02434406|intervention studies|intervention studies
4831740|NCT02434406|feasibility studies|feasibility studies
4831741|NCT02434406|randomized controlled trial|randomized controlled trial
4831742|NCT02434406|patient acceptance of health care|patient acceptance of health care
4831743|NCT02434393|Depression|depression
4831744|NCT02434393|Late Life Depression|late life depression
4831745|NCT02434393|LLD|lld
4831746|NCT02434393|amyloid imaging|amyloid imaging
4831747|NCT02434393|biomarkers|biomarkers
4831748|NCT02434380|Vitamin D|vitamin d
4831749|NCT02434380|Bone mineral content|bone mineral content
4831750|NCT02434380|Knee-heel length|knee-heel length
4831751|NCT02434380|Middle East|middle east
4831752|NCT02434367|Cancer|cancer
4831753|NCT02434354|Clinical stage III (nodal and/or intransit disease) or resectable stage IV melanoma (MEL), with or without prior treatment|clinical stage iii (nodal and/or intransit disease) or resectable stage iv melanoma (mel), with or without prior treatment
4831754|NCT02434328|AMD|amd
4831755|NCT02434328|CNV|cnv
4831756|NCT02434328|IVT|ivt
4831757|NCT02434315|Diabetes Mellitus|diabetes mellitus
4831758|NCT02434315|Sensing Technology|sensing technology
4831759|NCT02434289|Older adults|older adults
4831760|NCT02434289|Dietary protein|dietary protein
4831761|NCT02434289|Resistance exercise|resistance exercise
4831762|NCT02434289|Feasibility study|feasibility study
4831763|NCT02434289|Physical functioning|physical functioning
4831764|NCT02434289|Real-life setting|real-life setting
4831765|NCT02434250|Open angle glaucoma|open angle glaucoma
4831766|NCT02434250|Ocular hypertension|ocular hypertension
4831767|NCT02434250|Cataract|cataract
4831768|NCT02434250|Selective Laser Trabeculoplasty|selective laser trabeculoplasty
4831769|NCT02434250|Eximer Laser Trabeculectomy|eximer laser trabeculectomy
4831770|NCT02434250|Phacoemulsification Cataract Extraction|phacoemulsification cataract extraction
4831771|NCT02434224|Music therapy|music therapy
4831772|NCT02434224|premature infant|premature infant
4831773|NCT02434224|brain development|brain development
4831774|NCT02434198|pulmonary rehabilitation|pulmonary rehabilitation
4831979|NCT02433002|CKD|ckd
4831775|NCT02434198|balance assessment|balance assessment
4831776|NCT02434198|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
4831777|NCT02434185|Musculoskeletal Physiological Phenomena|musculoskeletal physiological phenomena
4831778|NCT02434185|Postmenopause|postmenopause
4831779|NCT02434185|Muscle Strength|muscle strength
4831780|NCT02434185|Absorptiometry, Photon|absorptiometry, photon
4831781|NCT02434172|HIV|hiv
4831782|NCT02434172|Cryptococcus|cryptococcus
4831783|NCT02434172|Lateral Flow Assay|lateral flow assay
4831784|NCT02434172|sub-Saharan Africa|sub-saharan africa
4831785|NCT02434172|Screening|screening
4831786|NCT02434172|treatment|treatment
4831787|NCT02434172|cryptococcal meningitis|cryptococcal meningitis
4831788|NCT02434120|MRI|mri
4831789|NCT02434120|Orbital neoplasm|orbital neoplasm
4831790|NCT02434107|Sentinel Lymph Node Biopsy|sentinel lymph node biopsy
4831791|NCT02434107|Lymph Node Excision|lymph node excision
4831792|NCT02434094|Diabetes Assistant (DiAs)|diabetes assistant (dias)
4831793|NCT02434094|Continuous Glucose Monitor (CGM)|continuous glucose monitor (cgm)
4831794|NCT02434094|Insulin Pump|insulin pump
4831795|NCT02434094|Human Factors|human factors
4831796|NCT02434094|Focus Group|focus group
4831797|NCT02434094|Artificial Pancreas (AP)|artificial pancreas (ap)
4831798|NCT02434094|eDAPT (electronic Diabetes Artificial Pancreas Training)|edapt (electronic diabetes artificial pancreas training)
4831799|NCT02434081|NSCLC|nsclc
4831800|NCT02434081|IIIA/B|iiia/b
4831801|NCT02434068|kidney calculi|kidney calculi
4831802|NCT02434068|followup studies|followup studies
4831803|NCT02434042|probiotic|probiotic
4831804|NCT02434042|children|children
4831805|NCT02434042|gastrointestinal|gastrointestinal
4831806|NCT02434042|upper respiratory|upper respiratory
4831807|NCT02434016|Diaphragm|diaphragm
4831808|NCT02434016|Mechanical ventilation|mechanical ventilation
4831809|NCT02434003|3D reconstruction|3d reconstruction
4831810|NCT02434003|AIS|ais
4831811|NCT02434003|Computer models|computer models
4831812|NCT02434003|Spinal Deformity|spinal deformity
4831813|NCT02433990|Congenital Heart Disease|congenital heart disease
4831814|NCT02433990|Acquired Cardiovascular Disease|acquired cardiovascular disease
4831815|NCT02433977|Asthma|asthma
4831816|NCT02433977|Obesity|obesity
4831817|NCT02433977|conjugated linolenic acid|conjugated linolenic acid
4831818|NCT02433977|nitrate|nitrate
4831819|NCT02433977|nitrite|nitrite
4831820|NCT02433977|nutritional supplements|nutritional supplements
4831821|NCT02433964|laser|laser
4831822|NCT02433964|LED|led
4831823|NCT02433964|PRICE|price
4831824|NCT02433964|pain|pain
4831825|NCT02433964|edema|edema
4831826|NCT02433951|exercise tolerance|exercise tolerance
4831827|NCT02433925|resveratrol|resveratrol
4831828|NCT02433925|oxidative stress|oxidative stress
4831829|NCT02433925|inflammation|inflammation
4831830|NCT02433873|Microbiota|microbiota
4831831|NCT02433873|Body weight|body weight
4831832|NCT02433873|Digestive system|digestive system
4831833|NCT02433847|mosapride|mosapride
4831834|NCT02433821|Mechanical Neck Pain|mechanical neck pain
4831835|NCT02433821|Pain|pain
4831836|NCT02433821|Function|function
4831837|NCT02433821|Quality of life|quality of life
4831838|NCT02433821|Pilates|pilates
4831839|NCT02433795|Marginal zone B-cell lymphoma|marginal zone b-cell lymphoma
4831840|NCT02433795|bendamustine plus rituximab|bendamustine plus rituximab
4831841|NCT02433782|Haemophilia|haemophilia
4831842|NCT02433782|Arthropathy|arthropathy
4831843|NCT02433782|Pain|pain
4831844|NCT02433782|Range of motion|range of motion
4831845|NCT02433782|Miofascial techniques|miofascial techniques
4831846|NCT02433743|HIV/AIDS|hiv/aids
4831847|NCT02433743|RUTF|rutf
4831848|NCT02433743|fat free mass|fat free mass
4831849|NCT02433743|anemia|anemia
4831850|NCT02433743|zinc|zinc
4831851|NCT02433743|Senegal|senegal
4831852|NCT02433717|schizophrenia|schizophrenia
4831853|NCT02433717|schizoaffective disorder|schizoaffective disorder
4831854|NCT02433717|pharmacogenetics|pharmacogenetics
4831855|NCT02433717|pharmacokinetics|pharmacokinetics
4831856|NCT02433717|event-related potentials|event-related potentials
4831857|NCT02433717|paliperidone|paliperidone
4831858|NCT02433691|(An)aerobic exercise|(an)aerobic exercise
4831859|NCT02433691|memory training|memory training
4831860|NCT02433691|cognitive benefits|cognitive benefits
4831861|NCT02433652|Dengue Vaccine|dengue vaccine
4831862|NCT02433639|advanced biliary tract cancer, TH-302|advanced biliary tract cancer, th-302
4831863|NCT02433613|Pulmonary Vein Isolation|pulmonary vein isolation
4831864|NCT02433613|Phased Radiofrequency Ablation|phased radiofrequency ablation
4831865|NCT02433574|radiosurgery|radiosurgery
4831866|NCT02433574|Neoadjuvant Therapy|neoadjuvant therapy
4831867|NCT02433548|Analgesia|analgesia
4831868|NCT02433548|Emergency medicine|emergency medicine
4831869|NCT02433548|Anesthesia, Regional|anesthesia, regional
4831870|NCT02433535|severe asthma|severe asthma
4831871|NCT02433535|simvastatin|simvastatin
4831872|NCT02433535|allergic airway inflammation|allergic airway inflammation
4831873|NCT02433522|ANCA-associated vasculitides|anca-associated vasculitides
4831874|NCT02433522|Maintenance treatment|maintenance treatment
4831875|NCT02433522|Rituximab|rituximab
4831876|NCT02433522|Granulomatosis with polyangiitis|granulomatosis with polyangiitis
4831877|NCT02433522|Microscopic polyangiitis|microscopic polyangiitis
4831878|NCT02433509|acute ischemic stroke|acute ischemic stroke
4831879|NCT02433509|umbilical cord blood|umbilical cord blood
4831880|NCT02433496|Opioid|opioid
4831881|NCT02433483|Adolescent|adolescent
4831882|NCT02433483|Children|children
4831883|NCT02433483|Microtransplant|microtransplant
4831884|NCT02433483|Leukemia|leukemia
4831885|NCT02433457|Healthy Volunteers|healthy volunteers
4831886|NCT02433457|CC-292|cc-292
4831887|NCT02433457|Open-Label|open-label
4831888|NCT02433457|Bioavailability Pharmacokinetics|bioavailability pharmacokinetics
4831889|NCT02433457|Phase I|phase i
4831890|NCT02433444|Biosensing Techniques|biosensing techniques
4831891|NCT02433431|mindfulness|mindfulness
4831892|NCT02433431|psychological stress|psychological stress
4831893|NCT02433431|immune marker|immune marker
4831894|NCT02433431|wellness programs|wellness programs
4831895|NCT02433431|mobile applications|mobile applications
4831896|NCT02433431|cortisol|cortisol
4831897|NCT02433405|Serum Amyloid A|serum amyloid a
4831898|NCT02433405|Fetuin-A|fetuin-a
4831899|NCT02433405|gingival crevicular fluid|gingival crevicular fluid
4831900|NCT02433405|serum|serum
4831901|NCT02433405|periodontal diseases|periodontal diseases
4831902|NCT02433392|drug-eluting beads|drug-eluting beads
4831903|NCT02433392|irinotecan hydrochloride|irinotecan hydrochloride
4831904|NCT02433353|PTSD|ptsd
4831905|NCT02433353|posttraumatic stress disorder|posttraumatic stress disorder
4831906|NCT02433353|venlafaxine|venlafaxine
4831907|NCT02433353|EMDR|emdr
4831908|NCT02433353|eye movement desensitization reprocessing|eye movement desensitization reprocessing
4831909|NCT02433353|antidepressant|antidepressant
4831910|NCT02433353|psychotherapy|psychotherapy
4831911|NCT02433340|Tolerability|tolerability
4831912|NCT02433340|Methotrexate|methotrexate
4831913|NCT02433340|Safety|safety
4831914|NCT02433327|Paediatric Early Warning System|paediatric early warning system
4831915|NCT02433327|trigger tool|trigger tool
4831916|NCT02433327|screening tool|screening tool
4831917|NCT02433327|risk assessment|risk assessment
4831918|NCT02433327|early recognition|early recognition
4831919|NCT02433301|chemotherapy|chemotherapy
4831920|NCT02433301|GEJ cancer|gej cancer
4831921|NCT02433301|PET/MR-imaging|pet/mr-imaging
4831922|NCT02433288|smart phone-based|smart phone-based
4831923|NCT02433288|rosuvastatin|rosuvastatin
4831924|NCT02433288|duration of treatment|duration of treatment
4831925|NCT02433288|Treatment adherence|treatment adherence
4831926|NCT02433223|outreach nursing|outreach nursing
4831927|NCT02433223|respiratory nursing guidelines|respiratory nursing guidelines
4831928|NCT02433197|Testicular cancer|testicular cancer
4831929|NCT02433197|Germ cell cancer|germ cell cancer
4831930|NCT02433197|Physical exercise|physical exercise
4831931|NCT02433197|Cancer-related fatigue|cancer-related fatigue
4831932|NCT02433197|Chemotherapy|chemotherapy
4831933|NCT02433197|Clinical rules|clinical rules
4831934|NCT02433197|Metabolomics|metabolomics
4831935|NCT02433184|Etanercept|etanercept
4831936|NCT02433184|treat to target|treat to target
4831937|NCT02433184|Disease Modifying Antirheumatic Drugs (DMARDs)|disease modifying antirheumatic drugs (dmards)
4831938|NCT02433171|regrowth|regrowth
4831939|NCT02433171|radiosurgery|radiosurgery
4831940|NCT02433171|radiation necrosis|radiation necrosis
4831942|NCT02433158|GMI-1070|gmi-1070
4831943|NCT02433158|Selectin Inhibitor|selectin inhibitor
4831944|NCT02433158|SCD|scd
4831945|NCT02433158|VOC|voc
4831946|NCT02433145|ADHD in preschoolers|adhd in preschoolers
4831947|NCT02433145|neuropsychological functions|neuropsychological functions
4831948|NCT02433145|behavior inhibition|behavior inhibition
4831949|NCT02433145|family function and parenting|family function and parenting
4831950|NCT02433132|Cystic fibrosis|cystic fibrosis
4831951|NCT02433132|Adults|adults
4831952|NCT02433132|Atypical form|atypical form
4831953|NCT02433132|Nasal brushing|nasal brushing
4831954|NCT02433132|Epithelial cells|epithelial cells
4831955|NCT02433132|Ion transport|ion transport
4831956|NCT02433106|Balance|balance
4831957|NCT02433106|Exercise|exercise
4831958|NCT02433054|deep vein thrombosis|deep vein thrombosis
4831959|NCT02433054|chronic venous disease|chronic venous disease
4831960|NCT02433054|May-Thurner syndrome|may-thurner syndrome
4831961|NCT02433054|venous stent|venous stent
4831962|NCT02433041|Postoperative delirium|postoperative delirium
4831963|NCT02433041|Cortisol|cortisol
4831964|NCT02433041|NSE|nse
4831965|NCT02433041|S-100beta|s-100beta
4831966|NCT02433041|MMSE|mmse
4831967|NCT02433041|Nu-DESC|nu-desc
4831968|NCT02433041|ICDSC|icdsc
4831969|NCT02433041|DOS|dos
4831970|NCT02433041|Haloperidol|haloperidol
4831971|NCT02433041|Ketamine|ketamine
4831972|NCT02433041|Combination of Haloperidol and Ketamine|combination of haloperidol and ketamine
4831973|NCT02433041|Placebo|placebo
4831974|NCT02433041|Prevention of|prevention of
4831975|NCT02433028|MS key phases of disease evolution|ms key phases of disease evolution
4831976|NCT02433028|MS New Treatment Options|ms new treatment options
4831977|NCT02433015|Electronic Cigarette|electronic cigarette
4831978|NCT02433002|eGFR|egfr
4831980|NCT02433002|Cystatin|cystatin
4831981|NCT02433002|Creatinine|creatinine
4831982|NCT02433002|Albuminuria|albuminuria
4831983|NCT02432989|Exercise Therapy|exercise therapy
4831984|NCT02432989|Concussion Management|concussion management
4831985|NCT02432989|Concussion Recovery|concussion recovery
4831986|NCT02432976|Quality of Life|quality of life
4831987|NCT02432976|Cardiac Surgery|cardiac surgery
4831988|NCT02432976|Coronary Artery Bypass Graft Surgery|coronary artery bypass graft surgery
4831989|NCT02432976|Incretin mimetic|incretin mimetic
4831990|NCT02432976|Exenatide|exenatide
4831991|NCT02432937|Corever|corever
4831992|NCT02432937|hypertension|hypertension
4831993|NCT02432885|cardiac magnetic resonance|cardiac magnetic resonance
4831994|NCT02432885|myocardial fibrosis|myocardial fibrosis
4831995|NCT02432885|muscular dystrophies|muscular dystrophies
4831996|NCT02432820|Prostate Cancer|prostate cancer
4831997|NCT02432768|Anaplerotic diet|anaplerotic diet
4831998|NCT02432768|McArdle Disease|mcardle disease
4831999|NCT02432768|Glycogen Storage Disease|glycogen storage disease
4832000|NCT02432768|Triheptanoin|triheptanoin
4832001|NCT02432755|home-based rehabilitation|home-based rehabilitation
4832002|NCT02432755|stroke|stroke
4832003|NCT02432755|combination therapy|combination therapy
4832004|NCT02432755|client-centered approach|client-centered approach
4832005|NCT02432755|post-acute|post-acute
4832006|NCT02432742|hyaluronic acid, comparative study, NLF|hyaluronic acid, comparative study, nlf
4832007|NCT02432729|smoking cessation|smoking cessation
4832008|NCT02432729|smoking abstinence|smoking abstinence
4832009|NCT02432729|clinical, biological and functional changes|clinical, biological and functional changes
4832010|NCT02432729|one year|one year
4832011|NCT02432729|healthy smokers|healthy smokers
4832012|NCT02432729|quit smoking|quit smoking
4832013|NCT02432703|Social Anxiety Disorder|social anxiety disorder
4832014|NCT02432703|JNJ-42165279|jnj-42165279
4832015|NCT02432690|Neoplasms|neoplasms
4832016|NCT02432677|tDCS|tdcs
4832017|NCT02432677|Opioid|opioid
4832018|NCT02432677|Pain|pain
4832019|NCT02432677|Pain threshold|pain threshold
4832020|NCT02432651|oxidative stress|oxidative stress
4832021|NCT02432651|hops|hops
4832022|NCT02432651|xanthohumol|xanthohumol
4832023|NCT02432651|DNA damage|dna damage
4832024|NCT02432651|cancer|cancer
4832025|NCT02432625|Osteogenesis Imperfecta|osteogenesis imperfecta
4832026|NCT02432625|Collagen|collagen
4832027|NCT02432625|Brittle Bone Disorder|brittle bone disorder
4832028|NCT02432625|Rare Disease Clinical Research Network|rare disease clinical research network
4832029|NCT02432625|COL1A2|col1a2
4832030|NCT02432599|F18-choline|f18-choline
4832031|NCT02432586|T1DM|t1dm
4832032|NCT02432586|Diabetes|diabetes
4832033|NCT02432586|Child|child
4832034|NCT02432586|Toddler|toddler
4832035|NCT02432573|timing|timing
4832036|NCT02432560|Lymphangioleiomyomatosis|lymphangioleiomyomatosis
4832037|NCT02432560|LAM|lam
4832038|NCT02432560|rare lung|rare lung
4832039|NCT02432560|Rare Lung Disease|rare lung disease
4832040|NCT02432547|Diabetic|diabetic
4832041|NCT02432547|Macular Oedema|macular oedema
4832042|NCT02432547|Retinopathy|retinopathy
4832043|NCT02432521|stroke|stroke
4832044|NCT02432521|transcranial magnetic stimulation (TMS)|transcranial magnetic stimulation (tms)
4832045|NCT02432521|Electroencephalography (EEG)|electroencephalography (eeg)
4832046|NCT02432521|Cerebrovascular Accident|cerebrovascular accident
4832047|NCT02432521|Brain Vascular Accident|brain vascular accident
4832048|NCT02432508|acupuncture|acupuncture
4832049|NCT02432508|laser|laser
4832050|NCT02432508|uremic pruritus|uremic pruritus
4832051|NCT02432508|randomized clinical trial|randomized clinical trial
4832052|NCT02432482|Tobacco|tobacco
4832053|NCT02432482|Cigarette|cigarette
4832054|NCT02432482|HIV|hiv
4832055|NCT02432482|Treatment|treatment
4832056|NCT02432482|Mobile|mobile
4832057|NCT02432482|Smartphone|smartphone
4832058|NCT02432469|coronary artery bypass|coronary artery bypass
4832059|NCT02432469|medication adherence|medication adherence
4832060|NCT02432469|secondary prevention|secondary prevention
4832061|NCT02432469|mobile applications|mobile applications
4832062|NCT02432443|Motor Skills|motor skills
4832063|NCT02432443|Pre-literacy Skills|pre-literacy skills
4832064|NCT02432443|Early Intervention|early intervention
4832065|NCT02432430|N05.300.150.410|n05.300.150.410
4832066|NCT02432430|practice guideline|practice guideline
4832067|NCT02432430|D20.215.894.899.290.130|d20.215.894.899.290.130
4832068|NCT02432430|Health Knowledge, Attitudes, Practice|health knowledge, attitudes, practice
4832069|NCT02432417|Glioblastoma|glioblastoma
4832070|NCT02432417|Autophagy|autophagy
4832071|NCT02432417|EGFR|egfr
4832072|NCT02432417|EGFRvIII|egfrviii
4832073|NCT02432417|Chloroquine|chloroquine
4832074|NCT02432417|Radiotherapy|radiotherapy
4832075|NCT02432417|Temozolomide|temozolomide
4832076|NCT02432404|HSV-2|hsv-2
4832077|NCT02432404|Contraceptive Vaginal Ring|contraceptive vaginal ring
4832078|NCT02432365|Paclitaxel|paclitaxel
4832079|NCT02432365|Cisplatin|cisplatin
4832080|NCT02432365|Cervical cancer|cervical cancer
4832081|NCT02432365|Radical hysterectomy|radical hysterectomy
4832082|NCT02432365|Neoadjuvant|neoadjuvant
4832285|NCT02431416|children|children
4832083|NCT02432339|immune system|immune system
4832084|NCT02432339|RENIN-ANGIOTENSIN SYSTEM|renin-angiotensin system
4832085|NCT02432326|Neoplasms|neoplasms
4832086|NCT02432300|Traumatic Brain Injury|traumatic brain injury
4832087|NCT02432300|Alexithymia|alexithymia
4832088|NCT02432300|Emotions|emotions
4832089|NCT02432287|aging|aging
4832090|NCT02432287|metformin|metformin
4832091|NCT02432287|prediabetes|prediabetes
4832092|NCT02432274|E7080|e7080
4832093|NCT02432274|Lenvatinib|lenvatinib
4832094|NCT02432274|Solid malignancies|solid malignancies
4832095|NCT02432274|Osteosarcoma|osteosarcoma
4832096|NCT02432274|Differentiated Thyroid Cancer|differentiated thyroid cancer
4832097|NCT02432261|spermatogenesis|spermatogenesis
4832098|NCT02432261|androgen|androgen
4832099|NCT02432261|male contraception|male contraception
4832100|NCT02432248|DHEA|dhea
4832101|NCT02432248|live birth rate|live birth rate
4832102|NCT02432248|poor ovarian responder|poor ovarian responder
4832103|NCT02432235|Camidanlumab tesirine|camidanlumab tesirine
4832104|NCT02432196|Mitral Valve Repair|mitral valve repair
4832105|NCT02432196|Transapical|transapical
4832106|NCT02432196|artificial chordae|artificial chordae
4832107|NCT02432183|individual|individual
4832108|NCT02432144|MPS 7|mps 7
4832109|NCT02432144|Sly Syndrome|sly syndrome
4832110|NCT02432144|MPS VII|mps vii
4832111|NCT02432144|Enzyme Replacement Therapy|enzyme replacement therapy
4832112|NCT02432144|Rare Disease|rare disease
4832113|NCT02432144|Mucopolysaccharidosis Type 7|mucopolysaccharidosis type 7
4832114|NCT02432144|Lysosomal Storage Disease|lysosomal storage disease
4832115|NCT02432144|Metabolic Disorder|metabolic disorder
4832116|NCT02432092|Cardiomegaly|cardiomegaly
4832117|NCT02432092|Cardiovascular Diseases|cardiovascular diseases
4832118|NCT02432092|Heart Diseases|heart diseases
4832119|NCT02432092|Systolic dysfunction|systolic dysfunction
4832120|NCT02432092|Diastolic dysfunction|diastolic dysfunction
4832121|NCT02432092|Ventricular hypertrophy|ventricular hypertrophy
4832122|NCT02432092|Heart failure|heart failure
4832123|NCT02432079|Abnormalities, Multiple|abnormalities, multiple
4832124|NCT02432079|Asplenia|asplenia
4832125|NCT02432079|Bilary Atresia|bilary atresia
4832126|NCT02432079|Birth Defect|birth defect
4832127|NCT02432079|Cardiovascular Abnormalities|cardiovascular abnormalities
4832128|NCT02432079|Cardiovascular Diseases|cardiovascular diseases
4832129|NCT02432079|Congenital Abnormalities|congenital abnormalities
4832130|NCT02432079|Congenital Heart Disease|congenital heart disease
4832131|NCT02432079|Dextrocardia Syndrome|dextrocardia syndrome
4832132|NCT02432079|Disturbed Internal Organ Positioning|disturbed internal organ positioning
4832133|NCT02432079|Genetics|genetics
4832134|NCT02432079|Genetic Testing|genetic testing
4832135|NCT02432079|Heart Defects, Congenital|heart defects, congenital
4832136|NCT02432079|Heart Diseases|heart diseases
4832137|NCT02432079|Heterotaxy syndrome|heterotaxy syndrome
4832138|NCT02432079|Intestinal malrotation|intestinal malrotation
4832139|NCT02432079|Laterality|laterality
4832140|NCT02432079|Left Atrial Isomerism|left atrial isomerism
4832141|NCT02432079|Pediatrics|pediatrics
4832142|NCT02432079|Polysplenia|polysplenia
4832143|NCT02432079|Right Atrial Isomerism|right atrial isomerism
4832144|NCT02432079|Splenic Diseases|splenic diseases
4832145|NCT02432079|Cilia|cilia
4832146|NCT02432079|Situs inversus|situs inversus
4832147|NCT02432079|Dextrocardia|dextrocardia
4832148|NCT02432066|Smoking|smoking
4832149|NCT02432066|Smoking Cessation|smoking cessation
4832150|NCT02432053|FK506|fk506
4832151|NCT02432053|Advagraf|advagraf
4832152|NCT02432053|Tacrolimus|tacrolimus
4832153|NCT02432053|Transplantation|transplantation
4832154|NCT02432040|chronic plaque psoriasis|chronic plaque psoriasis
4832155|NCT02432040|psoriasis|psoriasis
4832156|NCT02432040|atorvastatin|atorvastatin
4832157|NCT02432040|psoriasis area and severity index|psoriasis area and severity index
4832158|NCT02432040|betamethasone valerate|betamethasone valerate
4832159|NCT02431988|Relapsed|relapsed
4832160|NCT02431988|refractory|refractory
4832161|NCT02431988|DLBCL|dlbcl
4832162|NCT02431975|HIV|hiv
4832163|NCT02431975|infant|infant
4832164|NCT02431975|antiretroviral therapy, highly active|antiretroviral therapy, highly active
4832165|NCT02431975|antiretroviral agents|antiretroviral agents
4832166|NCT02431962|Lung Cancer|lung cancer
4832167|NCT02431962|Screening|screening
4832168|NCT02431962|Computed Tomography|computed tomography
4832169|NCT02431949|Music|music
4832170|NCT02431949|Amusia|amusia
4832171|NCT02431936|Stress|stress
4832172|NCT02431936|Blood Pressure|blood pressure
4832173|NCT02431936|Salt Sensitivity|salt sensitivity
4832174|NCT02431936|Renin-Angiotensin-Aldosterone System|renin-angiotensin-aldosterone system
4832175|NCT02431936|Sympathetic Nervous System|sympathetic nervous system
4832176|NCT02431923|Sequelae|sequelae
4832177|NCT02431923|Seroprevalence|seroprevalence
4832178|NCT02431923|Household Contacts|household contacts
4832179|NCT02431910|Electromyography|electromyography
4832180|NCT02431910|Baropodometry|baropodometry
4832181|NCT02431910|Torque|torque
4832182|NCT02431897|Pelvic Organ Prolapse|pelvic organ prolapse
4832183|NCT02431897|Pelvic Floor Disorders|pelvic floor disorders
4832479|NCT02430363|MK-3475|mk-3475
4832184|NCT02431897|Therapy, Estrogen Replacement|therapy, estrogen replacement
4832185|NCT02431897|Estrogens, Conjugated|estrogens, conjugated
4832186|NCT02431871|Developmental dysplasia of the hip|developmental dysplasia of the hip
4832187|NCT02431871|Hip dysplasia|hip dysplasia
4832188|NCT02431871|Occlusal defect|occlusal defect
4832189|NCT02431858|Nerve block|nerve block
4832190|NCT02431858|Catheter|catheter
4832191|NCT02431858|Catheter over needle|catheter over needle
4832192|NCT02431858|Femoral Nerve|femoral nerve
4832193|NCT02431858|Anaesthesia|anaesthesia
4832194|NCT02431858|[E04.525.210.550]|[e04.525.210.550]
4832195|NCT02431858|[E02.148]|[e02.148]
4832196|NCT02431845|Obsessive-Compulsive Disorder|obsessive-compulsive disorder
4832197|NCT02431845|Pharmacogenetics|pharmacogenetics
4832198|NCT02431832|Elderly|elderly
4832199|NCT02431819|Peripheral Arterial Disease|peripheral arterial disease
4832200|NCT02431819|Progressive compressive stockings|progressive compressive stockings
4832201|NCT02431793|Opioids|opioids
4832202|NCT02431780|Neonatal Seizures|neonatal seizures
4832203|NCT02431780|Decision Support Algorithm|decision support algorithm
4832204|NCT02431780|EEG|eeg
4832205|NCT02431741|Presence of at least one exuding malignant (fungating) wound in need for antimicrobial treatment|presence of at least one exuding malignant (fungating) wound in need for antimicrobial treatment
4832206|NCT02431728|Melatonin|melatonin
4832207|NCT02431728|Post-acute withdrawal symptoms|post-acute withdrawal symptoms
4832208|NCT02431728|Anxiety|anxiety
4832209|NCT02431728|Depression|depression
4832210|NCT02431728|Insomnia|insomnia
4832211|NCT02431728|Stress|stress
4832212|NCT02431728|Substance withdrawal syndrome|substance withdrawal syndrome
4832213|NCT02431702|Paliperidone Palmitate|paliperidone palmitate
4832214|NCT02431702|Oral Antipsychotics|oral antipsychotics
4832215|NCT02431702|Schizophrenia|schizophrenia
4832216|NCT02431702|Psychotic Disorders|psychotic disorders
4832217|NCT02431702|Cognition in Schizophrenia|cognition in schizophrenia
4832218|NCT02431702|Brain intracortical myelin volume|brain intracortical myelin volume
4832219|NCT02431702|Personal and Social Performance|personal and social performance
4832220|NCT02431702|Disease Modification|disease modification
4832221|NCT02431663|refractory convulsive status epilepticus|refractory convulsive status epilepticus
4832222|NCT02431663|ketamine|ketamine
4832223|NCT02431663|conventional anesthetics|conventional anesthetics
4832224|NCT02431663|children|children
4832225|NCT02431650|Induced blood stage malaria|induced blood stage malaria
4832226|NCT02431650|Transmission|transmission
4832227|NCT02431650|Mosquito feeding|mosquito feeding
4832228|NCT02431650|OZ439|oz439
4832229|NCT02431650|Primaquine|primaquine
4832230|NCT02431650|Piperaquine|piperaquine
4832231|NCT02431650|Artefonomel|artefonomel
4832232|NCT02431637|Induced blood stage malaria|induced blood stage malaria
4832233|NCT02431637|Transmission|transmission
4832234|NCT02431637|Standard membrane feeding assay|standard membrane feeding assay
4832235|NCT02431624|Healthy Volunteer|healthy volunteer
4832236|NCT02431585|abdominal pain|abdominal pain
4832237|NCT02431585|gluten free diet|gluten free diet
4832238|NCT02431585|functional gastrointestinal disorders|functional gastrointestinal disorders
4832239|NCT02431572|Intracranial Tumors|intracranial tumors
4832240|NCT02431572|Glioblastoma|glioblastoma
4832241|NCT02431572|Melanoma|melanoma
4832242|NCT02431559|Ovarian Cancer|ovarian cancer
4832243|NCT02431559|Motolimod|motolimod
4832244|NCT02431559|Immunotherapy|immunotherapy
4832245|NCT02431559|PD-L1|pd-l1
4832246|NCT02431559|MEDI4736|medi4736
4832247|NCT02431559|Pegylated|pegylated
4832248|NCT02431559|Liposomal|liposomal
4832249|NCT02431559|Doxorubicin|doxorubicin
4832250|NCT02431559|PLD|pld
4832251|NCT02431559|TLR-8|tlr-8
4832252|NCT02431559|Durvalumab|durvalumab
4832253|NCT02431546|Cardiology|cardiology
4832254|NCT02431546|Vascular|vascular
4832255|NCT02431546|CAD|cad
4832256|NCT02431546|Duke|duke
4832257|NCT02431546|Cardiac Rehabilitation|cardiac rehabilitation
4832258|NCT02431546|Prevention|prevention
4832259|NCT02431546|CVD|cvd
4832260|NCT02431546|Mobile Health|mobile health
4832261|NCT02431546|Exercise|exercise
4832262|NCT02431533|IBS-D|ibs-d
4832263|NCT02431533|diarrhea predominant|diarrhea predominant
4832264|NCT02431520|Patient Compliance|patient compliance
4832265|NCT02431520|HPV-DNA probes|hpv-dna probes
4832266|NCT02431520|Papanicolaou test|papanicolaou test
4832267|NCT02431520|Cervical cancer|cervical cancer
4832268|NCT02431507|apnea|apnea
4832269|NCT02431507|sleep apnea|sleep apnea
4832270|NCT02431507|magnetic sleep apnea device|magnetic sleep apnea device
4832271|NCT02431507|hyoid bone|hyoid bone
4832272|NCT02431455|Bariatric Surgery|bariatric surgery
4832273|NCT02431455|obesity, morbid|obesity, morbid
4832274|NCT02431455|incentive spirometry|incentive spirometry
4832275|NCT02431442|Heterozygous|heterozygous
4832276|NCT02431442|MC4R deficiency|mc4r deficiency
4832277|NCT02431442|associated|associated
4832278|NCT02431429|leishmaniasis|leishmaniasis
4832279|NCT02431429|miltefosine|miltefosine
4832280|NCT02431429|spermiogram|spermiogram
4832281|NCT02431416|females|females
4832282|NCT02431416|ghrelin|ghrelin
4832283|NCT02431416|GnRH|gnrh
4832284|NCT02431416|randomized, controlled study|randomized, controlled study
4832286|NCT02431390|RAPAELⓇ Smart Glove digital treatment system|rapaelⓡ smart glove digital treatment system
4832287|NCT02431390|Rehabilitation|rehabilitation
4832288|NCT02431390|Stroke|stroke
4832289|NCT02431390|Upper limbs|upper limbs
4832290|NCT02431377|infant formula|infant formula
4832291|NCT02431364|KPT-335|kpt-335
4832292|NCT02431364|Verdinexor|verdinexor
4832293|NCT02431364|Karyopharm|karyopharm
4832294|NCT02431364|First-in-Human|first-in-human
4832295|NCT02431364|Adult Subjects|adult subjects
4832296|NCT02431351|KPT-330|kpt-330
4832297|NCT02431351|Karyopharm|karyopharm
4832298|NCT02431351|Selinexor|selinexor
4832299|NCT02431351|SIER|sier
4832300|NCT02431351|Myelodysplastic Syndrome (MDS)|myelodysplastic syndrome (mds)
4832301|NCT02431351|Erythropoietin (EPO)|erythropoietin (epo)
4832302|NCT02431351|Refractory|refractory
4832303|NCT02431338|Remote ischemic conditioning|remote ischemic conditioning
4832304|NCT02431338|Cost-effectiveness analysis|cost-effectiveness analysis
4832305|NCT02431325|HIV|hiv
4832306|NCT02431325|Atherosclerosis|atherosclerosis
4832307|NCT02431325|Microbial Translocation|microbial translocation
4832308|NCT02431325|Teduglutide|teduglutide
4832309|NCT02431325|Gastrointestinal Permeability|gastrointestinal permeability
4832310|NCT02431325|Inflammation|inflammation
4832311|NCT02431312|Chronic HBV|chronic hbv
4832312|NCT02431312|immunotherapy|immunotherapy
4832313|NCT02431312|DNA vaccine|dna vaccine
4832314|NCT02431312|electroporation|electroporation
4832315|NCT02431286|nausea and vomiting, postoperative|nausea and vomiting, postoperative
4832316|NCT02431286|emesis, postoperative|emesis, postoperative
4832317|NCT02431273|TDF|tdf
4832318|NCT02431273|FTC|ftc
4832319|NCT02431273|MVC|mvc
4832320|NCT02431273|TDF-FTC|tdf-ftc
4832321|NCT02431273|TDF-FTC-MVC|tdf-ftc-mvc
4832322|NCT02431273|IVR|ivr
4832323|NCT02431273|ARV|arv
4832324|NCT02431260|solid tumor|solid tumor
4832325|NCT02431260|lymphoma|lymphoma
4832326|NCT02431260|BET bromodomain inhibitor|bet bromodomain inhibitor
4832327|NCT02431260|BRD|brd
4832328|NCT02431260|Diffuse large B-cell lymphoma (DLBCL)|diffuse large b-cell lymphoma (dlbcl)
4832329|NCT02431260|Burkitt's lymphoma|burkitt's lymphoma
4832330|NCT02431260|c-MYC|c-myc
4832331|NCT02431260|colorectal cancer|colorectal cancer
4832332|NCT02431260|Non-small cell lung cancer|non-small cell lung cancer
4832333|NCT02431260|Pancreatic adenocarcinoma|pancreatic adenocarcinoma
4832334|NCT02431260|castration-resistant prostate cancer|castration-resistant prostate cancer
4832335|NCT02431260|breast cancer|breast cancer
4832336|NCT02431260|NUT midline carcinoma|nut midline carcinoma
4832337|NCT02431260|leukemia|leukemia
4832338|NCT02431260|acute myeloid leukemia (AML)|acute myeloid leukemia (aml)
4832339|NCT02431260|atypical chronic myeloid leukemia (aCML)|atypical chronic myeloid leukemia (acml)
4832340|NCT02431260|myelodysplastic syndrome (MDS)|myelodysplastic syndrome (mds)
4832341|NCT02431260|myeloproliferative neoplasms|myeloproliferative neoplasms
4832342|NCT02431260|myelofibrosis (MF)|myelofibrosis (mf)
4832343|NCT02431260|multiple myeloma (MM)|multiple myeloma (mm)
4832344|NCT02431260|CMML|cmml
4832345|NCT02431260|MDS/MPN-U|mds/mpn-u
4832346|NCT02431260|RARS-T|rars-t
4832347|NCT02431247|Immunodeficiency Virus Type 1, Human|immunodeficiency virus type 1, human
4832348|NCT02431247|Darunavir|darunavir
4832349|NCT02431247|Cobicistat|cobicistat
4832350|NCT02431247|Tenofovir Alafenamide|tenofovir alafenamide
4832351|NCT02431247|Emtricitabine|emtricitabine
4832352|NCT02431247|Tenofovir Disoproxil Fumarate|tenofovir disoproxil fumarate
4832353|NCT02431234|Type 2 diabetes|type 2 diabetes
4832354|NCT02431234|Arterial calcification|arterial calcification
4832355|NCT02431234|Mediacalcosis|mediacalcosis
4832356|NCT02431234|Calcium score|calcium score
4832357|NCT02431221|perhexiline|perhexiline
4832358|NCT02431221|HCM|hcm
4832359|NCT02431221|Hypertrophic Cardiomyopathy|hypertrophic cardiomyopathy
4832360|NCT02431221|CPEX|cpex
4832361|NCT02431195|obesity|obesity
4832362|NCT02431195|bariatric surgery|bariatric surgery
4832363|NCT02431195|physical activity|physical activity
4832364|NCT02431195|eating habits|eating habits
4832365|NCT02431156|presbyopia|presbyopia
4832366|NCT02431156|monovision|monovision
4832367|NCT02431156|activities of daily living,|activities of daily living,
4832368|NCT02431156|pseudophakic|pseudophakic
4832369|NCT02431130|Training Program|training program
4832370|NCT02431091|Optical Coherence Tomography|optical coherence tomography
4832371|NCT02431078|CTCs|ctcs
4832372|NCT02431078|ZEB1|zeb1
4832373|NCT02431078|gastric cancer|gastric cancer
4832374|NCT02431065|Rectus sheath block|rectus sheath block
4832375|NCT02431065|Single port laparoscopy|single port laparoscopy
4832376|NCT02431026|induced mild hypothermia|induced mild hypothermia
4832377|NCT02431026|cervical cooling collar|cervical cooling collar
4832378|NCT02431026|mri brain thermometry|mri brain thermometry
4832379|NCT02431026|MRI thermometry|mri thermometry
4832380|NCT02431026|rate-of-cooling|rate-of-cooling
4832381|NCT02431026|Excel Cryo Cooling Collar|excel cryo cooling collar
4832382|NCT02431013|Drug-drug interaction|drug-drug interaction
4832383|NCT02431013|Pharmacokinetics|pharmacokinetics
4832384|NCT02430961|Critical Care|critical care
4832385|NCT02430961|Palliative Care|palliative care
4832386|NCT02430948|Screening|screening
4832387|NCT02430948|Shared Decision Making|shared decision making
4832388|NCT02430935|Psychosis|psychosis
4832389|NCT02430935|Psychosis NOS|psychosis nos
4832390|NCT02430935|Schizophrenia|schizophrenia
4832391|NCT02430935|Schizoaffective Disorder|schizoaffective disorder
4832392|NCT02430935|Early Intervention|early intervention
4832393|NCT02430896|Neuropsychological|neuropsychological
4832394|NCT02430896|neuroimaging|neuroimaging
4832395|NCT02430896|genetic markers|genetic markers
4832396|NCT02430896|treatment response predictor|treatment response predictor
4832397|NCT02430883|pain, RIRS, kidney|pain, rirs, kidney
4832398|NCT02430870|Drug therapy|drug therapy
4832399|NCT02430844|acute kidney injury|acute kidney injury
4832400|NCT02430844|radiographic contrast|radiographic contrast
4832401|NCT02430844|critically ill|critically ill
4832402|NCT02430844|biomarker|biomarker
4832403|NCT02430818|ketamine|ketamine
4832404|NCT02430818|emergency medicine|emergency medicine
4832405|NCT02430818|orthopedics|orthopedics
4832406|NCT02430805|hypertension|hypertension
4832407|NCT02430805|microinflammation and oxidative stress|microinflammation and oxidative stress
4832408|NCT02430805|renal disease|renal disease
4832409|NCT02430805|heart failure|heart failure
4832410|NCT02430805|genetics markers|genetics markers
4832411|NCT02430805|genomics markers|genomics markers
4832412|NCT02430805|proteomics markers|proteomics markers
4832413|NCT02430792|Prostatic Neoplasms|prostatic neoplasms
4832414|NCT02430792|Exercise|exercise
4832415|NCT02430792|Football|football
4832416|NCT02430792|Quality of Life|quality of life
4832417|NCT02430779|irreversible electroporation|irreversible electroporation
4832418|NCT02430779|Unresectable Renal Pelvic and Ureteral Neoplasms|unresectable renal pelvic and ureteral neoplasms
4832419|NCT02430766|irreversible electroporation|irreversible electroporation
4832420|NCT02430766|Unresectable Lymph Node Metastases|unresectable lymph node metastases
4832421|NCT02430753|irreversible electroporation|irreversible electroporation
4832422|NCT02430753|Lung Neoplasms|lung neoplasms
4832423|NCT02430753|Respiratory Function Insufficiency|respiratory function insufficiency
4832424|NCT02430740|Fertilization in Vitro|fertilization in vitro
4832425|NCT02430740|antagonist protocol|antagonist protocol
4832426|NCT02430740|antral follicle count|antral follicle count
4832427|NCT02430740|Anti-Mullerian Hormone|anti-mullerian hormone
4832428|NCT02430740|Reproductive Techniques, Assisted|reproductive techniques, assisted
4832429|NCT02430714|Thyroid Cancer|thyroid cancer
4832430|NCT02430714|Lenvima|lenvima
4832431|NCT02430714|Post-marketing surveillance|post-marketing surveillance
4832432|NCT02430714|LEN01T|len01t
4832433|NCT02430714|All-Patient Investigation|all-patient investigation
4832434|NCT02430714|Lenvatinib Mesylate|lenvatinib mesylate
4832435|NCT02430701|irreversible electroporation|irreversible electroporation
4832436|NCT02430701|Unresectable Esophageal Neoplasms|unresectable esophageal neoplasms
4832437|NCT02430688|irreversible electroporation|irreversible electroporation
4832438|NCT02430688|Unresectable Extremities|unresectable extremities
4832439|NCT02430675|irreversible electroporation|irreversible electroporation
4832440|NCT02430675|Unresectable Laryngeal Neoplasms|unresectable laryngeal neoplasms
4832441|NCT02430662|irreversible electroporation|irreversible electroporation
4832442|NCT02430662|Unresectable Gallbladder Neoplasms|unresectable gallbladder neoplasms
4832443|NCT02430649|irreversible electroporation|irreversible electroporation
4832444|NCT02430649|Unresectable Prostatic Neoplasms|unresectable prostatic neoplasms
4832445|NCT02430636|irreversible electroporation|irreversible electroporation
4832446|NCT02430636|Unresectable Stomach Neoplasms|unresectable stomach neoplasms
4832447|NCT02430623|irreversible electroporation|irreversible electroporation
4832448|NCT02430623|Unresectable Urinary Neoplasms|unresectable urinary neoplasms
4832449|NCT02430610|irreversible electroporation|irreversible electroporation
4832450|NCT02430610|Unresectable Uterine Cervical Neoplasms|unresectable uterine cervical neoplasms
4832451|NCT02430597|irreversible electroporation|irreversible electroporation
4832452|NCT02430597|Hilus Pulmonary Neoplasms|hilus pulmonary neoplasms
4832453|NCT02430545|Glasdegib|glasdegib
4832454|NCT02430545|PF-04449913|pf-04449913
4832455|NCT02430545|Drug-drug interaction|drug-drug interaction
4832456|NCT02430545|CYP3A4 inducer|cyp3a4 inducer
4832457|NCT02430545|Pharmacokinetics|pharmacokinetics
4832458|NCT02430532|INSPIRE|inspire
4832459|NCT02430532|SPMS|spms
4832460|NCT02430532|Tecfidera|tecfidera
4832461|NCT02430532|BG00012|bg00012
4832462|NCT02430519|Chronic Periodontitis|chronic periodontitis
4832463|NCT02430519|Clinical Parameters|clinical parameters
4832464|NCT02430519|Furcation defects|furcation defects
4832465|NCT02430519|Radiographic bone fill|radiographic bone fill
4832466|NCT02430493|ACS|acs
4832467|NCT02430480|Multiparametric MRI|multiparametric mri
4832468|NCT02430480|Prostatectomy|prostatectomy
4832469|NCT02430480|Focal Prostate Cancer|focal prostate cancer
4832470|NCT02430480|Normal Testosterone|normal testosterone
4832471|NCT02430480|Non Metastatic|non metastatic
4832472|NCT02430454|ICU|icu
4832473|NCT02430454|decision making|decision making
4832474|NCT02430402|Climatotherapy|climatotherapy
4832475|NCT02430389|hemodynamic stability|hemodynamic stability
4832476|NCT02430389|remifentanil|remifentanil
4832477|NCT02430376|Non-Muscle Myosin|non-muscle myosin
4832478|NCT02430363|pembrolizumab|pembrolizumab
4832480|NCT02430363|Glioblastoma|glioblastoma
4832481|NCT02430363|Gliosarcoma|gliosarcoma
4832482|NCT02430363|Suppressor of the PI3K/Akt pathways|suppressor of the pi3k/akt pathways
4832483|NCT02430363|Pictilisib|pictilisib
4832484|NCT02430363|GDC-0941|gdc-0941
4832485|NCT02430363|BEZ235|bez235
4832486|NCT02430363|NVP-BEZ235|nvp-bez235
4832487|NCT02430363|Ipatasertib|ipatasertib
4832488|NCT02430363|GDC-0068|gdc-0068
4832489|NCT02430311|Chinese Patients|chinese patients
4832490|NCT02430285|biliary stone|biliary stone
4832491|NCT02430285|cholelithiasis|cholelithiasis
4832492|NCT02430285|pancreatitis|pancreatitis
4832493|NCT02430285|EUS|eus
4832494|NCT02430285|ERCP|ercp
4832495|NCT02430285|early|early
4832496|NCT02430285|choledocholithiasis|choledocholithiasis
4832497|NCT02430272|Child|child
4832498|NCT02430272|outpatient|outpatient
4832499|NCT02430272|premedication|premedication
4832500|NCT02430259|rifapentine|rifapentine
4832501|NCT02430259|isoniazid|isoniazid
4832502|NCT02430259|QuantiFERON Gold In-Tube|quantiferon gold in-tube
4832503|NCT02430259|tuberculin skin test|tuberculin skin test
4832504|NCT02430207|Pulmonary Embolism|pulmonary embolism
4832505|NCT02430207|Temporary Pacing|temporary pacing
4832506|NCT02430207|Femoral Vein|femoral vein
4832507|NCT02430207|Subclavian Vein|subclavian vein
4832508|NCT02430168|Stone|stone
4832509|NCT02430168|RIRs|rirs
4832510|NCT02430168|PCNL|pcnl
4832511|NCT02430168|Pain|pain
4832512|NCT02430155|condom-loaded Foley's catheter|condom-loaded foley's catheter
4832513|NCT02430155|Bakri balloon|bakri balloon
4832514|NCT02430155|primary atonic postpartum hemorrhage|primary atonic postpartum hemorrhage
4832515|NCT02430142|microcirculation|microcirculation
4832516|NCT02430142|oxygen uptake|oxygen uptake
4832517|NCT02430142|hypoxia|hypoxia
4832518|NCT02430142|adenosine|adenosine
4832519|NCT02430142|central venous saturation|central venous saturation
4832520|NCT02430142|hypoxanthine|hypoxanthine
4832521|NCT02430142|laserdoppler|laserdoppler
4832522|NCT02430103|Breast Cancer|breast cancer
4832523|NCT02430103|Preservation of Ovarian Reserve Function|preservation of ovarian reserve function
4832524|NCT02430090|regionel anesthesia|regionel anesthesia
4832525|NCT02430090|levobupivacaine|levobupivacaine
4832526|NCT02430090|ceserean section|ceserean section
4832527|NCT02430077|Hepatic Steatosis|hepatic steatosis
4832528|NCT02430051|sensory processing|sensory processing
4832529|NCT02430051|oral care|oral care
4832530|NCT02430051|electrodermal activity|electrodermal activity
4832531|NCT02430051|cooperation|cooperation
4832532|NCT02430051|anxiety|anxiety
4832533|NCT02430051|distress|distress
4832534|NCT02430051|stress|stress
4832535|NCT02430051|behavior|behavior
4832536|NCT02430051|occupational therapy|occupational therapy
4832537|NCT02430038|transperineal ultrasound|transperineal ultrasound
4832538|NCT02430038|labour|labour
4832539|NCT02430038|sonopartogram|sonopartogram
4832540|NCT02430038|prediction model|prediction model
4832541|NCT02430025|Cardiovascular Diseases|cardiovascular diseases
4832542|NCT02430025|Vascular Diseases|vascular diseases
4832543|NCT02430025|Acute Coronary Syndrome|acute coronary syndrome
4832544|NCT02430025|Chest Pain|chest pain
4832545|NCT02430025|Heart Diseases|heart diseases
4832546|NCT02430025|Myocardial Ischemia|myocardial ischemia
4832547|NCT02430025|Pathologic Processes|pathologic processes
4832548|NCT02430012|coronary artery bypass grafting|coronary artery bypass grafting
4832549|NCT02430012|quality improvement|quality improvement
4832550|NCT02430012|secondary preventions|secondary preventions
4832551|NCT02429986|Adaptive Servo-Ventilation|adaptive servo-ventilation
4832552|NCT02429986|Chronic Heart Failure|chronic heart failure
4832553|NCT02429986|Central Sleep Apnea Syndrome|central sleep apnea syndrome
4832554|NCT02429986|Central and Obstructive Sleep Apnea Syndrome|central and obstructive sleep apnea syndrome
4832555|NCT02429986|Complex Sleep Apnea Syndrome|complex sleep apnea syndrome
4832556|NCT02429986|Hunter-Cheyne-Stokes Breathing|hunter-cheyne-stokes breathing
4832557|NCT02429986|Periodic Breathing|periodic breathing
4832558|NCT02429973|Osteosarcoma|osteosarcoma
4832559|NCT02429960|Nociception|nociception
4832560|NCT02429960|Analgesia|analgesia
4832561|NCT02429960|Intraoperative|intraoperative
4832562|NCT02429960|Monitoring|monitoring
4832563|NCT02429947|Charcot Marie Tooth disease|charcot marie tooth disease
4832564|NCT02429947|CMT|cmt
4832565|NCT02429947|HMSN|hmsn
4832566|NCT02429947|HMN|hmn
4832567|NCT02429947|HSN|hsn
4832568|NCT02429934|Systemic Lupus Erythematosus (SLE)|systemic lupus erythematosus (sle)
4832569|NCT02429934|Abatacept (Orencia)|abatacept (orencia)
4832570|NCT02429934|Arthritis|arthritis
4832571|NCT02429921|dietary intervention|dietary intervention
4832572|NCT02429921|arsenic poisoning|arsenic poisoning
4832573|NCT02429921|high-Se lentils|high-se lentils
4832574|NCT02429895|Methotrexate|methotrexate
4832575|NCT02429895|Efficacy|efficacy
4832576|NCT02429895|Safety|safety
4832577|NCT02429882|Ankylosing Spondyloarthritis; non-radiographic axial spondyloarthritis|ankylosing spondyloarthritis; non-radiographic axial spondyloarthritis
4832578|NCT02429843|Non-squamous cell lung cancer|non-squamous cell lung cancer
4832579|NCT02429843|Non-squamous non-small cell lung cancer|non-squamous non-small cell lung cancer
4832580|NCT02429843|vascular endothelial growth factor (VEGF)|vascular endothelial growth factor (vegf)
4832581|NCT02429843|TRC105|trc105
4832582|NCT02429830|gastroesophageal reflux disease|gastroesophageal reflux disease
4832583|NCT02429830|GERD|gerd
4832584|NCT02429830|obesity|obesity
4832585|NCT02429830|LSG|lsg
4832586|NCT02429830|Laparoscopic Sleeve Gastrectomy|laparoscopic sleeve gastrectomy
4832587|NCT02429817|Pulmonary aerosol distribution|pulmonary aerosol distribution
4832588|NCT02429817|SPECT-CT analysis|spect-ct analysis
4832589|NCT02429817|High flow nasal cannula|high flow nasal cannula
4832590|NCT02429817|Vibrating-mesh nebulizer|vibrating-mesh nebulizer
4832591|NCT02429817|Jet nebulizer|jet nebulizer
4832592|NCT02429791|two-drug regimen|two-drug regimen
4832593|NCT02429791|virologically-suppressed|virologically-suppressed
4832594|NCT02429791|dolutegravir plus rilpivirine|dolutegravir plus rilpivirine
4832595|NCT02429791|integrase inhibitor|integrase inhibitor
4832596|NCT02429791|protease inhibitor|protease inhibitor
4832597|NCT02429791|NNRTI-sparing|nnrti-sparing
4832598|NCT02429791|non-nucleoside reverse transcriptase inhibitor|non-nucleoside reverse transcriptase inhibitor
4832599|NCT02429791|HIV|hiv
4832600|NCT02429791|nucleoside reverse transcriptase inhibitors|nucleoside reverse transcriptase inhibitors
4832601|NCT02429752|inspiratory muscle training|inspiratory muscle training
4832602|NCT02429752|low back pain|low back pain
4832603|NCT02429752|respiration|respiration
4832604|NCT02429752|breathing|breathing
4832605|NCT02429739|Working Memory Training, computerized|working memory training, computerized
4832606|NCT02429739|Dyslexia|dyslexia
4832607|NCT02429739|Reading fluency|reading fluency
4832608|NCT02429739|Reading comprehension|reading comprehension
4832609|NCT02429726|malignant pleural effusion, p53 gene therapy, cisplatin|malignant pleural effusion, p53 gene therapy, cisplatin
4832610|NCT02429713|tourniquet|tourniquet
4832611|NCT02429713|total knee arthroplasty|total knee arthroplasty
4832612|NCT02429713|blood loss|blood loss
4832613|NCT02429674|Depression|depression
4832614|NCT02429674|Adolescence|adolescence
4832615|NCT02429648|AF|af
4832616|NCT02429635|Exercise|exercise
4832617|NCT02429635|lifestyle diseases|lifestyle diseases
4832618|NCT02429635|well-being|well-being
4832619|NCT02429596|antiepileptic drugs|antiepileptic drugs
4832620|NCT02429596|generic substitution|generic substitution
4832621|NCT02429570|meclofenamate|meclofenamate
4832622|NCT02429570|15-068|15-068
4832623|NCT02429557|autonomic failure|autonomic failure
4832624|NCT02429557|orthostatic hypotension|orthostatic hypotension
4832625|NCT02429557|compression garments|compression garments
4832626|NCT02429557|treatment|treatment
4832627|NCT02429544|Breast cancer|breast cancer
4832628|NCT02429544|Stage IV breast cancer|stage iv breast cancer
4832629|NCT02429544|Metastatic|metastatic
4832630|NCT02429544|Residential group programs|residential group programs
4832631|NCT02429544|Questionnaires|questionnaires
4832632|NCT02429544|Surveys|surveys
4832633|NCT02429544|EEG|eeg
4832634|NCT02429544|Computer testing|computer testing
4832635|NCT02429544|Saliva test|saliva test
4832636|NCT02429544|Study diary|study diary
4832637|NCT02429544|Actigraph|actigraph
4832638|NCT02429531|Pneumovax 23|pneumovax 23
4832639|NCT02429531|Typhim Vi|typhim vi
4832640|NCT02429531|allohemagglutinins|allohemagglutinins
4832641|NCT02429518|leishmaniasis|leishmaniasis
4832642|NCT02429518|miltefosine|miltefosine
4832643|NCT02429518|EKG|ekg
4832644|NCT02429492|Pathophysiology|pathophysiology
4832645|NCT02429492|Spinal interneurons|spinal interneurons
4832646|NCT02429492|Electrophysiology|electrophysiology
4832647|NCT02429492|EMG|emg
4832648|NCT02429492|transcranial magnetic stimulation (TMS)|transcranial magnetic stimulation (tms)
4832649|NCT02429479|Advance Care Planning|advance care planning
4832650|NCT02429479|Living Will|living will
4832651|NCT02429479|Family Caregiver|family caregiver
4832652|NCT02429479|Advance Directive|advance directive
4832653|NCT02429479|Surrogate Decision Maker|surrogate decision maker
4832654|NCT02429479|Proxy|proxy
4832655|NCT02429479|Self-Efficacy|self-efficacy
4832656|NCT02429466|testicular germ cell tumor|testicular germ cell tumor
4832657|NCT02429466|ovarian germ cell tumor|ovarian germ cell tumor
4832658|NCT02429466|platinum refractory|platinum refractory
4832659|NCT02429466|cisplatin|cisplatin
4832660|NCT02429466|SGI110|sgi110
4832661|NCT02429466|Guadecitabine|guadecitabine
4832662|NCT02429453|Warfarin|warfarin
4832663|NCT02429453|Traumatic intracranial hemorrhage|traumatic intracranial hemorrhage
4832664|NCT02429453|prothrombin complex concentrate|prothrombin complex concentrate
4832665|NCT02429453|fresh frozen plasma|fresh frozen plasma
4832666|NCT02429453|Spontaneous intracranial hemorrhage|spontaneous intracranial hemorrhage
4832667|NCT02429427|Primary Breast Cancer|primary breast cancer
4832668|NCT02429427|Celecoxib|celecoxib
4832669|NCT02429414|Surgical Procedure|surgical procedure
4832670|NCT02429414|Fiberoptic bronchoscopy|fiberoptic bronchoscopy
4832671|NCT02429414|FOB|fob
4832672|NCT02429414|Non-Video Double Lumen Tube|non-video double lumen tube
4832673|NCT02429414|DLT|dlt
4832674|NCT02429414|Video Double Lumen Tube|video double lumen tube
4832675|NCT02429414|VDLT|vdlt
4832676|NCT02429401|binge drinking|binge drinking
4832677|NCT02429401|heavy drinking|heavy drinking
4832678|NCT02429388|Heart failure|heart failure
4832679|NCT02429388|Spironolactone|spironolactone
4832680|NCT02429388|Diuretics|diuretics
4832681|NCT02429375|Mocetinostat (MGCD0103)|mocetinostat (mgcd0103)
4832682|NCT02429375|Brentuximab Vedotin (SGN-35)|brentuximab vedotin (sgn-35)
4832683|NCT02429375|Relapsed|relapsed
4832684|NCT02429375|Refractory|refractory
4832685|NCT02429323|induction|induction
4832686|NCT02429323|pediatrics|pediatrics
4832687|NCT02429323|sevoflurane|sevoflurane
4832688|NCT02429323|intubation time|intubation time
4832689|NCT02429310|Intermittent Claudication|intermittent claudication
4832690|NCT02429310|IC|ic
4832691|NCT02429310|Peripheral Arterial Disease|peripheral arterial disease
4832692|NCT02429310|Peripheral Vascular Disease|peripheral vascular disease
4832693|NCT02429310|Peripheral Arterial Occlusive Disease|peripheral arterial occlusive disease
4832694|NCT02429310|Lower Limb Arterial Disease|lower limb arterial disease
4832695|NCT02429310|Supervised Exercise Therapy|supervised exercise therapy
4832696|NCT02429310|Supervised Exercise Programme|supervised exercise programme
4832697|NCT02429310|Exercise Therapy|exercise therapy
4832698|NCT02429297|Hypertension|hypertension
4832699|NCT02429297|Diabetes|diabetes
4832700|NCT02429297|mHealth|mhealth
4832701|NCT02429297|Interactive Voice Response|interactive voice response
4832702|NCT02429297|Bolivia|bolivia
4832703|NCT02429297|Chronic disease|chronic disease
4832704|NCT02429284|Chronic Thromboembolic Pulmonary Hypertension (CTEPH)|chronic thromboembolic pulmonary hypertension (cteph)
4832705|NCT02429284|Pulmonary Endarterectomy (PEA)|pulmonary endarterectomy (pea)
4832706|NCT02429284|Pulmonary Thromboendarterectomy (PTE)|pulmonary thromboendarterectomy (pte)
4832707|NCT02429284|Pulmonary Hypertension|pulmonary hypertension
4832708|NCT02429284|Balloon Pulmonary Angioplasty (BPA)|balloon pulmonary angioplasty (bpa)
4832709|NCT02429271|undergoing thrombolysis|undergoing thrombolysis
4832710|NCT02429245|Knee|knee
4832711|NCT02429245|Knee osteoarthritis|knee osteoarthritis
4832712|NCT02429245|Knee replacement|knee replacement
4832713|NCT02429232|Pioglitazone|pioglitazone
4832714|NCT02429232|Linagliptin|linagliptin
4832715|NCT02429232|Diabetes mellitus|diabetes mellitus
4832716|NCT02429232|Diabetic macular edema|diabetic macular edema
4832717|NCT02429232|Kidney|kidney
4832718|NCT02429154|spectroscopy, near-infrared|spectroscopy, near-infrared
4832719|NCT02429154|Infant|infant
4832720|NCT02429154|Anesthesia, general|anesthesia, general
4832721|NCT02429128|Polycystic Ovary Syndrome (PCOS)|polycystic ovary syndrome (pcos)
4832722|NCT02429115|peer mentoring|peer mentoring
4832723|NCT02429115|chronic kidney disease|chronic kidney disease
4832724|NCT02429115|quality of life|quality of life
4832725|NCT02429115|pcori|pcori
4832726|NCT02429115|caregiver burden|caregiver burden
4832727|NCT02429102|Phase 1|phase 1
4832728|NCT02429102|Healthy subjects|healthy subjects
4832729|NCT02429102|Pharmacokinetics of MT-8554|pharmacokinetics of mt-8554
4832730|NCT02429089|recurrent|recurrent
4832731|NCT02429089|metastatic|metastatic
4832732|NCT02429063|Solid Tumors|solid tumors
4832733|NCT02429050|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
4832734|NCT02429050|Dyspnea|dyspnea
4832735|NCT02429050|Breathlessness|breathlessness
4832736|NCT02429050|Morphine|morphine
4832737|NCT02429050|Opioid|opioid
4832738|NCT02429050|Symptom Management|symptom management
4832739|NCT02429037|p53|p53
4832740|NCT02429037|gene therapy|gene therapy
4832741|NCT02429037|head and neck cancer|head and neck cancer
4832742|NCT02429024|Diabetes Mellitus|diabetes mellitus
4832743|NCT02429024|A1c|a1c
4832744|NCT02429011|depression|depression
4832745|NCT02429011|MRI|mri
4832746|NCT02429011|treatment-resistant|treatment-resistant
4832747|NCT02429011|imaging|imaging
4832748|NCT02429011|ketamine|ketamine
4832749|NCT02428985|Riociguat|riociguat
4832750|NCT02428985|Adempas|adempas
4832751|NCT02428985|soluble guanylate cyclase (sGC) stimulator|soluble guanylate cyclase (sgc) stimulator
4832752|NCT02428985|Pulmonary arterial hypertension|pulmonary arterial hypertension
4832753|NCT02428985|Japan|japan
4832754|NCT02428985|Post-marketing surveillance|post-marketing surveillance
4832755|NCT02428972|brain tumor|brain tumor
4832756|NCT02428972|quality of life|quality of life
4832757|NCT02428972|cognition|cognition
4832758|NCT02428972|anesthetic technique|anesthetic technique
4832759|NCT02428959|Amyl Nitrite|amyl nitrite
4832760|NCT02428959|High Resolution Manometry|high resolution manometry
4832761|NCT02428946|Insulin Sensitivity|insulin sensitivity
4832762|NCT02428946|obesity|obesity
4832763|NCT02428946|dopamine|dopamine
4832764|NCT02428933|Brown Adipose Tissue|brown adipose tissue
4832765|NCT02428933|Obesity|obesity
4832766|NCT02428933|Insulin Sensitivity|insulin sensitivity
4832767|NCT02428933|Dopamine|dopamine
4832768|NCT02428920|cardiovascular health|cardiovascular health
4832769|NCT02428920|behavior change|behavior change
4832770|NCT02428920|community-based|community-based
4832771|NCT02428920|prevention|prevention
4832772|NCT02428907|simulation training|simulation training
4832773|NCT02428907|minimal sedation|minimal sedation
4832774|NCT02428907|colonoscopy|colonoscopy
4832775|NCT02428907|patient satisfaction|patient satisfaction
4832776|NCT02428907|teamwork|teamwork
4832777|NCT02428907|team training|team training
4832778|NCT02428907|patient safety|patient safety
4832779|NCT02428881|onabotulinumtoxin A|onabotulinumtoxin a
4832780|NCT02428868|hip fracture|hip fracture
4832781|NCT02428868|anemia|anemia
4832782|NCT02428868|blood transfusion|blood transfusion
4832783|NCT02428868|tranexamic acid|tranexamic acid
4832784|NCT02428868|intravenous iron|intravenous iron
4832785|NCT02428855|Cholangiocarcinoma|cholangiocarcinoma
4832786|NCT02428842|Cervical cancer|cervical cancer
4832787|NCT02428842|Tumor biopsies|tumor biopsies
4832788|NCT02428842|Standard treatment|standard treatment
4832789|NCT02428842|Molecular profile|molecular profile
4832790|NCT02428842|Next Generation Sequencing|next generation sequencing
4832791|NCT02428829|hip|hip
4832792|NCT02428829|replacement|replacement
4832793|NCT02428829|arthroplasty|arthroplasty
4832794|NCT02428829|total|total
4832795|NCT02428829|orthopaedic|orthopaedic
4832796|NCT02428829|rehabiliation|rehabiliation
4832797|NCT02428829|physiotherapy|physiotherapy
4832798|NCT02428829|therapy|therapy
4832799|NCT02428816|differential diagnosis|differential diagnosis
4832800|NCT02428816|multimodal MRI|multimodal mri
4832801|NCT02428816|Parkinson's Disease|parkinson's disease
4832802|NCT02428816|Multiple System Atrophy|multiple system atrophy
4832803|NCT02428803|Peritoneal Dialysis|peritoneal dialysis
4832804|NCT02428777|Hysteroscopy|hysteroscopy
4832805|NCT02428751|Lymphoma, Large B-Cell, Diffuse|lymphoma, large b-cell, diffuse
4832806|NCT02428751|liposomal doxorubicin|liposomal doxorubicin
4832807|NCT02428751|doxorubicin|doxorubicin
4832808|NCT02428751|event-free survival|event-free survival
4832809|NCT02428738|Influenza Vaccine|influenza vaccine
4832810|NCT02428738|Text Message|text message
4832811|NCT02428673|Osteopenia|osteopenia
4832812|NCT02428673|spinal muscular atrophy|spinal muscular atrophy
4832813|NCT02428673|cerebral palsy|cerebral palsy
4832814|NCT02428673|muscular dystrophy|muscular dystrophy
4832815|NCT02428673|spina bifida|spina bifida
4832816|NCT02428673|Rett Syndrome|rett syndrome
4832817|NCT02428660|Polypharmacy|polypharmacy
4832818|NCT02428660|Chronic conditions|chronic conditions
4832819|NCT02428660|Drug Therapy Problems|drug therapy problems
4832820|NCT02428660|Medication Therapy Management|medication therapy management
4832821|NCT02428660|Medication-Related Problems|medication-related problems
4832822|NCT02428660|CYP3A4|cyp3a4
4832823|NCT02428660|CYP3A5|cyp3a5
4832824|NCT02428660|Drug-drug interactions|drug-drug interactions
4832825|NCT02428660|Drug-gene interactions|drug-gene interactions
4832826|NCT02428660|Drug-drug-gene interactions|drug-drug-gene interactions
4832827|NCT02428660|Adverse Drug Reactions|adverse drug reactions
4832828|NCT02428660|Activities of Daily Living|activities of daily living
4832829|NCT02428647|growth|growth
4832830|NCT02428647|plasma zinc concentration|plasma zinc concentration
4832831|NCT02428634|Cardiovascular health promotion|cardiovascular health promotion
4832832|NCT02428634|Children|children
4832833|NCT02428634|School intervention|school intervention
4832834|NCT02428621|early orthodontic treatment|early orthodontic treatment
4832835|NCT02428621|activator|activator
4832836|NCT02428621|removable appliance|removable appliance
4832837|NCT02428621|Twicare®|twicare®
4832838|NCT02428621|Herbst appliance|herbst appliance
4832839|NCT02428608|Glabellar Lines|glabellar lines
4832840|NCT02428608|Botulinum toxin, Type A|botulinum toxin, type a
4832841|NCT02428582|endovascular treatment|endovascular treatment
4832842|NCT02428582|arterial occlusive disease|arterial occlusive disease
4832843|NCT02428582|bare metal stent|bare metal stent
4832844|NCT02428582|polytetrafluoroethylene covered stent|polytetrafluoroethylene covered stent
4832845|NCT02428569|shared decision making|shared decision making
4832846|NCT02428569|patient education|patient education
4832847|NCT02428569|decision aids|decision aids
4832848|NCT02428556|Decision making|decision making
4832849|NCT02428543|FLT3-ITD patients in first complete remission|flt3-itd patients in first complete remission
4832850|NCT02428517|acute lymphoblastic leukemia|acute lymphoblastic leukemia
4832851|NCT02428517|allogeneic hematopoietic stem cell transplantation|allogeneic hematopoietic stem cell transplantation
4832852|NCT02428517|alternative hematopoietic stem cell donor|alternative hematopoietic stem cell donor
4832853|NCT02428517|busulfan|busulfan
4832854|NCT02428517|antithymocyte globulin|antithymocyte globulin
4832855|NCT02428504|Questionnaire|questionnaire
4832856|NCT02428491|Diphtheria|diphtheria
4832857|NCT02428491|Tetanus|tetanus
4832858|NCT02428491|Pertussis|pertussis
4832859|NCT02428491|Poliomyelitis|poliomyelitis
4832860|NCT02428491|Hepatitis B|hepatitis b
4832861|NCT02428491|Haemophilus Influenzae Type b|haemophilus influenzae type b
4832862|NCT02428491|DTaP-IPV-Hep B-PRP-T Combined Vaccine (Hexaxim®)|dtap-ipv-hep b-prp-t combined vaccine (hexaxim®)
4832863|NCT02428465|Purposeful Parenting|purposeful parenting
4832864|NCT02428465|Parenting stress|parenting stress
4832865|NCT02428465|Social-emotional and linguistic (SEL) skills|social-emotional and linguistic (sel) skills
4832866|NCT02428452|autism|autism
4832867|NCT02428452|Autism SPectrum Disorder|autism spectrum disorder
4832868|NCT02428452|early intervention|early intervention
4832869|NCT02428452|infant|infant
4832870|NCT02428452|toddler|toddler
4832871|NCT02428452|early identification|early identification
4832872|NCT02428452|pivotal response training (PRT)|pivotal response training (prt)
4832873|NCT02428452|control group|control group
4832874|NCT02428452|treatment group|treatment group
4832875|NCT02428452|at risk|at risk
4832876|NCT02428452|social communication|social communication
4832877|NCT02428452|positive affect|positive affect
4832878|NCT02428452|smiling|smiling
4832879|NCT02428439|genetic markers|genetic markers
4832880|NCT02428439|predictors|predictors
4832881|NCT02428439|Antidepressive Agents|antidepressive agents
4832882|NCT02428439|Suicidal Ideation|suicidal ideation
4832883|NCT02428439|Adolescent|adolescent
4832884|NCT02428426|Mucosal Microbiome|mucosal microbiome
4832885|NCT02428426|gastric intestinal metaplasia|gastric intestinal metaplasia
4832886|NCT02428426|duodenum|duodenum
4832887|NCT02428413|Waste Anesthetic Gas (WAG)|waste anesthetic gas (wag)
4832888|NCT02428387|caregivers|caregivers
4832889|NCT02428387|intervention|intervention
4832890|NCT02428387|health related quality of life|health related quality of life
4832891|NCT02428387|dementia|dementia
4832892|NCT02428374|MRI|mri
4832893|NCT02428374|Ventricular function, left|ventricular function, left
4832894|NCT02428309|Tregs|tregs
4832895|NCT02428296|Clinical Trial|clinical trial
4832896|NCT02428296|Congenital Malformations|congenital malformations
4832897|NCT02428296|Overgrowth|overgrowth
4832898|NCT02428296|Pilot Drug Treatment Trial|pilot drug treatment trial
4832899|NCT02428257|hip fracture|hip fracture
4832900|NCT02428257|elderly|elderly
4832901|NCT02428257|continous spinal anesthesia|continous spinal anesthesia
4832902|NCT02428257|hypobaric bupivacaine|hypobaric bupivacaine
4832903|NCT02428257|isobaric bupivacaine|isobaric bupivacaine
4832904|NCT02428257|hypotension|hypotension
4832905|NCT02428244|Smoking|smoking
4832906|NCT02428244|Cessation|cessation
4832907|NCT02428244|Trauma|trauma
4832908|NCT02428244|Fracture|fracture
4832909|NCT02428244|Complications|complications
4832910|NCT02428218|Randomized|randomized
4832911|NCT02428218|Ages 10-17|ages 10-17
4832912|NCT02428218|Pediatrics|pediatrics
4832913|NCT02428218|Placebo controlled|placebo controlled
4832914|NCT02428218|Relapse-Remitting|relapse-remitting
4832915|NCT02428218|Multiple Sclerosis|multiple sclerosis
4832916|NCT02428218|Safety|safety
4832917|NCT02428218|Efficacy|efficacy
4832918|NCT02428218|BG00012|bg00012
4832919|NCT02428179|Surgical site infection|surgical site infection
4832920|NCT02428179|Intraoperative briefings|intraoperative briefings
4832921|NCT02428179|Mortality|mortality
4832922|NCT02428179|Wound closure|wound closure
4832923|NCT02428179|Surgical procedure|surgical procedure
4832924|NCT02428166|crosslinking|crosslinking
4832925|NCT02428166|keratoconus|keratoconus
4832926|NCT02428166|keratometry|keratometry
4832927|NCT02428166|pachymetry|pachymetry
4832928|NCT02428166|pentacam|pentacam
4832929|NCT02428153|static stretching|static stretching
4832930|NCT02428153|dynamic stretching|dynamic stretching
4832931|NCT02428153|muscle-tendon unit|muscle-tendon unit
4832932|NCT02428153|ultrasound|ultrasound
4832933|NCT02428153|Subjects|subjects
4832934|NCT02428140|ischemic stroke|ischemic stroke
4832935|NCT02428140|atrial fibrillation|atrial fibrillation
4832936|NCT02428140|etiologic investigations|etiologic investigations
4832937|NCT02428140|secondary prevention|secondary prevention
4832938|NCT02428140|anticoagulation|anticoagulation
4832939|NCT02428140|arrhythmias|arrhythmias
4832940|NCT02428140|embolic stroke, undetermined etiology|embolic stroke, undetermined etiology
4832941|NCT02428140|implantable loop recorder|implantable loop recorder
4832942|NCT02428140|external loop recorder|external loop recorder
4832943|NCT02428062|Post-operative complications|post-operative complications
4832944|NCT02428062|Mild cognitive impairment|mild cognitive impairment
4832945|NCT02428062|Delirium|delirium
4832946|NCT02428036|TBI-1401(HF10)|tbi-1401(hf10)
4832947|NCT02428036|HF10|hf10
4832948|NCT02428036|HSV-1|hsv-1
4832949|NCT02428036|Oncolytic virus|oncolytic virus
4832950|NCT02428036|Oncolytic virotherapy|oncolytic virotherapy
4832951|NCT02428036|Phase I|phase i
4832952|NCT02428036|Melanoma|melanoma
4832953|NCT02428036|Intratumoral administration|intratumoral administration
4832954|NCT02428023|Thalassemia|thalassemia
4832955|NCT02428023|trait|trait
4832956|NCT02428023|coronary|coronary
4832957|NCT02428023|stroke|stroke
4832958|NCT02427997|Virtual Reality|virtual reality
4832959|NCT02427997|Treadmill|treadmill
4832960|NCT02427997|Multiple Sclerosis|multiple sclerosis
4832961|NCT02427984|Internal Left Hip Prosthesis|internal left hip prosthesis
4832962|NCT02427984|Internal Right Hip Prosthesis|internal right hip prosthesis
4832963|NCT02427958|Drug Therapy|drug therapy
4832964|NCT02427945|Information provision|information provision
4832965|NCT02427932|Pharmacokinetics (PK)|pharmacokinetics (pk)
4832966|NCT02427932|Pharmacodynamics (PD)|pharmacodynamics (pd)
4832967|NCT02427919|G-CSF|g-csf
4832968|NCT02427919|G-CSF receptor|g-csf receptor
4832969|NCT02427919|AML|aml
4832970|NCT02427919|refractory AML|refractory aml
4832971|NCT02427919|Neutropenic fever|neutropenic fever
4832972|NCT02427919|salvage chemotherapy|salvage chemotherapy
4832973|NCT02427906|cirrhosis|cirrhosis
4832974|NCT02427906|gut microbiota|gut microbiota
4832975|NCT02427906|transjugular portosystemic shunt|transjugular portosystemic shunt
4832976|NCT02427906|hepatic encephalopathy|hepatic encephalopathy
4832977|NCT02427893|immunotherapy|immunotherapy
4832978|NCT02427893|Vemurafenib|vemurafenib
4832979|NCT02427893|Cobimetinib|cobimetinib
4832980|NCT02427880|Edema|edema
4832981|NCT02427880|Nephrotic syndrome|nephrotic syndrome
4832982|NCT02427880|Acetazolamide|acetazolamide
4832983|NCT02427880|Furosemide|furosemide
4832984|NCT02427867|remote ischemic preconditioning|remote ischemic preconditioning
4832985|NCT02427867|non cardiac surgery|non cardiac surgery
4832986|NCT02427867|myocardial ischemia|myocardial ischemia
4832987|NCT02427854|Major delivery complications|major delivery complications
4832988|NCT02427854|Perineal injuries|perineal injuries
4832989|NCT02427854|episiotomy|episiotomy
4832990|NCT02427789|Physical exercise|physical exercise
4832991|NCT02427789|Biomarkers|biomarkers
4832992|NCT02427789|Neuroprotection|neuroprotection
4832993|NCT02427789|ergospirometry|ergospirometry
4832994|NCT02427789|Major Depressive Disorder|major depressive disorder
4832995|NCT02427763|Removable Orthodontic Appliance;|removable orthodontic appliance;
4832996|NCT02427763|malocclusion|malocclusion
4832997|NCT02427763|Streptococcus mutans|streptococcus mutans
4832998|NCT02427763|Lactobacillus|lactobacillus
4832999|NCT02427763|Epithelium|epithelium
4833000|NCT02427737|Magnetic Resonance Imaging|magnetic resonance imaging
4833001|NCT02427737|Patient satisfaction|patient satisfaction
4833002|NCT02427737|Diagnostic Imaging|diagnostic imaging
4833003|NCT02427711|Reduction of blood loss for revisions of knee arthroplasty|reduction of blood loss for revisions of knee arthroplasty
4833004|NCT02427711|blood transfusions|blood transfusions
4833005|NCT02427711|Readmission|readmission
4833006|NCT02427711|Bipolar sealer|bipolar sealer
4833007|NCT02427672|antisocial behavior|antisocial behavior
4833008|NCT02427672|aggression|aggression
4833009|NCT02427672|transcranial direct current stimulation|transcranial direct current stimulation
4833010|NCT02427672|dorsolateral prefrontal cortex|dorsolateral prefrontal cortex
4833011|NCT02427672|associated risk factors|associated risk factors
4833012|NCT02427659|VRD|vrd
4833013|NCT02427659|Virtual Reality as Distraction during Procedure|virtual reality as distraction during procedure
4833014|NCT02427659|Burn Wound Care|burn wound care
4833015|NCT02427646|Kinematics|kinematics
4833016|NCT02427646|Botulinum toxin type A|botulinum toxin type a
4833017|NCT02427633|recovery position|recovery position
4833018|NCT02427633|comatose|comatose
4833019|NCT02427633|resource limited|resource limited
4833020|NCT02427620|Lymphoma|lymphoma
4833021|NCT02427620|Mantle cell lymphoma|mantle cell lymphoma
4833022|NCT02427620|MCL|mcl
4833023|NCT02427620|B-lymphocyte antigen|b-lymphocyte antigen
4833024|NCT02427620|CD20|cd20
4833025|NCT02427620|Ibrutinib|ibrutinib
4833026|NCT02427620|PCI-32765|pci-32765
4833027|NCT02427620|Imbruvica|imbruvica
4833028|NCT02427620|Rituximab|rituximab
4833029|NCT02427620|Rituxan|rituxan
4833030|NCT02427620|Cyclophosphamide|cyclophosphamide
4833031|NCT02427620|Cytoxan|cytoxan
4833032|NCT02427620|Neosar|neosar
4833033|NCT02427620|Vincristine|vincristine
4833034|NCT02427620|Mesna|mesna
4833035|NCT02427620|Mesnex|mesnex
4833036|NCT02427620|Dexamethasone|dexamethasone
4833037|NCT02427620|Decadron|decadron
4833038|NCT02427620|Doxorubicin|doxorubicin
4833039|NCT02427620|Doxorubicin hydrochloride|doxorubicin hydrochloride
4833040|NCT02427620|Adriamycin PFS|adriamycin pfs
4833041|NCT02427620|Adriamycin RDF|adriamycin rdf
4833042|NCT02427620|Adriamycin|adriamycin
4833043|NCT02427620|Rubex|rubex
4833044|NCT02427620|G-CSF|g-csf
4833045|NCT02427620|Filgrastim|filgrastim
4833046|NCT02427620|Neupogen|neupogen
4833047|NCT02427620|Methotrexate|methotrexate
4833048|NCT02427620|Cytarabine|cytarabine
4833049|NCT02427620|Ara-C|ara-c
4833050|NCT02427620|Cytosar|cytosar
4833051|NCT02427620|DepoCyt|depocyt
4833052|NCT02427620|Cytosine arabinosine hydrochloride|cytosine arabinosine hydrochloride
4833053|NCT02427620|Citrovorum|citrovorum
4833054|NCT02427620|Leucovorin|leucovorin
4833055|NCT02427620|Wellcovorin|wellcovorin
4833056|NCT02427607|Epilepsy|epilepsy
4833057|NCT02427607|Perampanel|perampanel
4833058|NCT02427594|Kidney Diseases|kidney diseases
4833059|NCT02427594|Renal Insufficiency, Chronic|renal insufficiency, chronic
4833060|NCT02427594|Dietary nonvolatile acid load|dietary nonvolatile acid load
4833061|NCT02427594|Blood pressure|blood pressure
4833062|NCT02427594|Urine net acid excretion|urine net acid excretion
4833063|NCT02427568|Anxiety|anxiety
4833064|NCT02427568|MDMA|mdma
4833065|NCT02427568|Life-threatening illness|life-threatening illness
4833066|NCT02427568|psychotherapy|psychotherapy
4833067|NCT02427542|Randomized Controlled Trial|randomized controlled trial
4833068|NCT02427529|hcg|hcg
4833069|NCT02427503|asthma|asthma
4833070|NCT02427503|sinonasal polyposis|sinonasal polyposis
4833071|NCT02427503|eosinophilic bronchial inflammation|eosinophilic bronchial inflammation
4833072|NCT02427503|endoscopic sinus surgery|endoscopic sinus surgery
4833073|NCT02427490|Palliative Care|palliative care
4833074|NCT02427490|Caregivers|caregivers
4833075|NCT02427490|Medical Oncology|medical oncology
4833076|NCT02427464|diabetic|diabetic
4833077|NCT02427464|neuropathy|neuropathy
4833078|NCT02427464|shooting pain|shooting pain
4833079|NCT02427464|burning pain|burning pain
4833080|NCT02427464|pins and needles pain|pins and needles pain
4833081|NCT02427464|foot pain|foot pain
4833082|NCT02427464|ViroMed|viromed
4833083|NCT02427438|video|video
4833084|NCT02427438|handout|handout
4833085|NCT02427438|home program|home program
4833086|NCT02427438|stabilization|stabilization
4833087|NCT02427438|strengthening|strengthening
4833088|NCT02427438|core|core
4833089|NCT02427425|Transcutaneous Electric Nerve Stimulation|transcutaneous electric nerve stimulation
4833090|NCT02427425|Pain|pain
4833091|NCT02427412|Tranexamic Acid|tranexamic acid
4833092|NCT02427412|Knee Arthroplasty|knee arthroplasty
4833093|NCT02427412|Blood loss|blood loss
4833094|NCT02427412|Blood transfusion|blood transfusion
4833095|NCT02427412|Thrombolic complication|thrombolic complication
4833096|NCT02427412|Total blood loss 24 h after ended surgery.|total blood loss 24 h after ended surgery.
4833097|NCT02427412|Total blood loss 2 days after ended surgery.|total blood loss 2 days after ended surgery.
4833098|NCT02427386|Endometriosis|endometriosis
4833099|NCT02427386|Pelvic pain|pelvic pain
4833100|NCT02427386|Homeopathy|homeopathy
4833101|NCT02427386|RCT|rct
4833102|NCT02427373|bioavailability|bioavailability
4833103|NCT02427373|fish oil|fish oil
4833104|NCT02427373|krill oil|krill oil
4833105|NCT02427360|Retrospective Studies|retrospective studies
4833106|NCT02427360|Clinical Efficacy|clinical efficacy
4833107|NCT02427321|Cystoscopy|cystoscopy
4833108|NCT02427321|Bladder cancer|bladder cancer
4833109|NCT02427321|Bladder imaging|bladder imaging
4833110|NCT02427308|leishmaniasis|leishmaniasis
4833111|NCT02427308|miltefosine|miltefosine
4833112|NCT02427308|pregnancy|pregnancy
4833113|NCT02427269|Barrett's Esophagus|barrett's esophagus
4833114|NCT02427269|Esophageal Cancer|esophageal cancer
4833115|NCT02427269|Intramucosal Adenocarcinoma|intramucosal adenocarcinoma
4833116|NCT02427230|Pelvic Floor Muscle Training|pelvic floor muscle training
4833117|NCT02427230|Neuromuscular Electrical Stimulation|neuromuscular electrical stimulation
4833118|NCT02427230|Urinary Incontinence|urinary incontinence
4833119|NCT02427230|Spinal Cord Injury|spinal cord injury
4833120|NCT02427204|Hepatitis C infection|hepatitis c infection
4833121|NCT02427204|Hepatitis C treatment|hepatitis c treatment
4833122|NCT02427191|Chronic plantar fasciitis|chronic plantar fasciitis
4833123|NCT02427191|Heel pain|heel pain
4833124|NCT02427178|Allogeneic Hematopoietic Stem Cell Transplantation|allogeneic hematopoietic stem cell transplantation
4833125|NCT02427178|MNGIE|mngie
4833126|NCT02427178|Stem Cell transplant|stem cell transplant
4833127|NCT02427113|TMD|tmd
4833128|NCT02427113|Music Medicine|music medicine
4833129|NCT02427113|Vibroacousitc Therapy|vibroacousitc therapy
4833130|NCT02427100|Homeless|homeless
4833131|NCT02427100|Randomized Controlled Trial|randomized controlled trial
4833132|NCT02427100|Diet|diet
4833133|NCT02427100|Physical Activity|physical activity
4833134|NCT02427087|Nonalcoholic fatty liver|nonalcoholic fatty liver
4833135|NCT02427087|Physical activity|physical activity
4833136|NCT02427087|NAFLD|nafld
4833137|NCT02427087|Anthropometry|anthropometry
4833138|NCT02427087|Body Composition|body composition
4833139|NCT02427048|Clinical Practice Guidelines|clinical practice guidelines
4833140|NCT02427022|evidence based practices, critical time intervention|evidence based practices, critical time intervention
4833141|NCT02426944|atrial fibrillation|atrial fibrillation
4833142|NCT02426944|cardioembolic event|cardioembolic event
4833143|NCT02426944|stroke|stroke
4833144|NCT02426944|left atrial appendage closure|left atrial appendage closure
4833145|NCT02426944|novel anticoagulants|novel anticoagulants
4833146|NCT02426931|retrograde intrarenal surgery|retrograde intrarenal surgery
4833147|NCT02426931|flexible ureteroscopy|flexible ureteroscopy
4833148|NCT02426931|renal calculi|renal calculi
4833149|NCT02426892|Solid Tumors|solid tumors
4833150|NCT02426892|HPV-16 Positive Incurable Solid Tumors|hpv-16 positive incurable solid tumors
4833151|NCT02426892|ISA101|isa101
4833152|NCT02426892|HPV-16 vaccination|hpv-16 vaccination
4833153|NCT02426892|Nivolumab|nivolumab
4833154|NCT02426892|BMS-936558|bms-936558
4833155|NCT02426892|Opdivo|opdivo
4833156|NCT02426879|three-field lymphadenectomy|three-field lymphadenectomy
4833157|NCT02426879|cervical metastases|cervical metastases
4833158|NCT02426879|esophagectomy|esophagectomy
4833159|NCT02426853|Cancer Prevention|cancer prevention
4833160|NCT02426853|Sun protection|sun protection
4833161|NCT02426853|Photograph|photograph
4833162|NCT02426853|UV photograph|uv photograph
4833163|NCT02426853|Ultraviolet|ultraviolet
4833164|NCT02426853|Pamphlets|pamphlets
4833165|NCT02426853|Handouts|handouts
4833166|NCT02426853|Questionnaires|questionnaires
4833167|NCT02426853|Surveys|surveys
4833168|NCT02426853|Skin cancer risk behaviors|skin cancer risk behaviors
4833169|NCT02426840|Adverse bone health|adverse bone health
4833170|NCT02426840|Bone demineralization|bone demineralization
4833171|NCT02426840|HIV-infection|hiv-infection
4833172|NCT02426840|Children|children
4833173|NCT02426840|Adolescents|adolescents
4833174|NCT02426840|Calcium|calcium
4833175|NCT02426840|Vitamin D|vitamin d
4833176|NCT02426840|Supplementation|supplementation
4833177|NCT02426814|Patient Compliance|patient compliance
4833178|NCT02426814|Mobile Applications|mobile applications
4833179|NCT02426801|Patient Compliance|patient compliance
4833180|NCT02426801|Mobile Applications|mobile applications
4833181|NCT02426801|Medication Adherence|medication adherence
4833182|NCT02426788|medically unexplained|medically unexplained
4833183|NCT02426788|fibromyalgia|fibromyalgia
4833184|NCT02426788|postural orthostatic tachycardia syndrome (PoTs)|postural orthostatic tachycardia syndrome (pots)
4833185|NCT02426788|non-cardiac chest pain|non-cardiac chest pain
4833186|NCT02426788|CFS|cfs
4833187|NCT02426788|irritable bowel syndrome (IBS)|irritable bowel syndrome (ibs)
4833188|NCT02426788|functional neurological|functional neurological
4833189|NCT02426788|chronic pain|chronic pain
4833190|NCT02426788|hyperventilation|hyperventilation
4833191|NCT02426788|unexplained cough|unexplained cough
4833192|NCT02426762|skin sealant|skin sealant
4833193|NCT02426762|laparoscopic surgery|laparoscopic surgery
4833194|NCT02426762|surgical site infection|surgical site infection
4833195|NCT02426762|wound healing|wound healing
4833196|NCT02426736|Shoulder Joint|shoulder joint
4833197|NCT02426736|Arthroscopy|arthroscopy
4833198|NCT02426736|Ambulatory surgical procedures|ambulatory surgical procedures
4833199|NCT02426736|Pain, Postoperative|pain, postoperative
4833200|NCT02426736|Brachial Plexus Block|brachial plexus block
4833201|NCT02426736|Corticosteroid|corticosteroid
4833202|NCT02426736|Dexamethasone|dexamethasone
4833203|NCT02426736|Bupivacaine|bupivacaine
4833204|NCT02426736|Perineural|perineural
4833205|NCT02426710|ablation, atrial flutter, intracardiac echocardiography|ablation, atrial flutter, intracardiac echocardiography
4833206|NCT02426697|bone metastasis, radiotherapy, pain, prevention|bone metastasis, radiotherapy, pain, prevention
4833207|NCT02426684|End Stage Renal Disease|end stage renal disease
4833208|NCT02426684|Kidney Transplant|kidney transplant
4833209|NCT02426684|Desensitization|desensitization
4833210|NCT02426684|Highly Sensitized|highly sensitized
4833211|NCT02426684|Antibodies|antibodies
4833212|NCT02426671|neuromodulation|neuromodulation
4833213|NCT02426671|Minimum Masking Level|minimum masking level
4833214|NCT02426645|Biomarkers|biomarkers
4833215|NCT02426645|Sepsis|sepsis
4833216|NCT02426645|Multi organ dysfunction|multi organ dysfunction
4833217|NCT02426645|Immunomonitoring|immunomonitoring
4833218|NCT02426645|CEUS|ceus
4833219|NCT02426632|Healthy|healthy
4833220|NCT02426632|JNJ-53718678|jnj-53718678
4833221|NCT02426606|Lentils|lentils
4833222|NCT02426606|Post-prandial|post-prandial
4833223|NCT02426606|Glycemic response|glycemic response
4833224|NCT02426606|Insulin response|insulin response
4833225|NCT02426606|Diabetes|diabetes
4833226|NCT02426606|Mixed meal|mixed meal
4833227|NCT02426606|Glycemia|glycemia
4833228|NCT02426606|Slowly digestible starch|slowly digestible starch
4833229|NCT02426606|Post-prandial glycemia|post-prandial glycemia
4833230|NCT02426593|CHF|chf
4833231|NCT02426593|Heart Failure|heart failure
4833232|NCT02426567|Crohn's Disease|crohn's disease
4833233|NCT02426567|Exclusive Enteral Nutrition|exclusive enteral nutrition
4833234|NCT02426567|Dietary Treatment|dietary treatment
4833235|NCT02426567|Gut microbiota|gut microbiota
4833236|NCT02426541|Diabetes Mellitus|diabetes mellitus
4833237|NCT02426541|Dapagliflozin|dapagliflozin
4833238|NCT02426541|Placebo|placebo
4833239|NCT02426541|Insulin resistance|insulin resistance
4833240|NCT02426541|Insulin sensitivity|insulin sensitivity
4833241|NCT02426476|heart rate variability|heart rate variability
4833242|NCT02426476|biofeedback|biofeedback
4833243|NCT02426476|chronic pain|chronic pain
4833244|NCT02426476|Veterans|veterans
4833245|NCT02426463|Neonatal intensive care|neonatal intensive care
4833246|NCT02426463|need for intratracheal intubation|need for intratracheal intubation
4833247|NCT02426437|Acute Exacerbation of COPD (AECOPD)|acute exacerbation of copd (aecopd)
4833248|NCT02426437|COPD|copd
4833249|NCT02426437|Emphysema|emphysema
4833250|NCT02426437|Chronic Bronchitis|chronic bronchitis
4833251|NCT02426424|c-PAP|c-pap
4833252|NCT02426398|EEG|eeg
4833253|NCT02426372|Ulcerative Colitis|ulcerative colitis
4833254|NCT02426372|Inflammatory Bowel Disease|inflammatory bowel disease
4833255|NCT02426346|Adolescent; Adolescent obesity; Community-based; Overweight|adolescent; adolescent obesity; community-based; overweight
4833256|NCT02426307|Thrombosis|thrombosis
4833257|NCT02426307|Cardiovascular disease|cardiovascular disease
4833258|NCT02426307|Oral anticoagulation|oral anticoagulation
4833259|NCT02426307|bioprosthesis|bioprosthesis
4833260|NCT02426307|Multidetector Computed Tomography|multidetector computed tomography
4833261|NCT02426268|cardiac surgery|cardiac surgery
4833262|NCT02426268|cerebral oximetry|cerebral oximetry
4833263|NCT02426268|lower extremity oximetry|lower extremity oximetry
4833264|NCT02426255|Severe trauma|severe trauma
4833265|NCT02426255|traumatic Brain injury|traumatic brain injury
4833266|NCT02426255|Hemorrhage|hemorrhage
4833267|NCT02426242|brain-injury|brain-injury
4833268|NCT02426242|extubation|extubation
4833269|NCT02426229|SSc|ssc
4833270|NCT02426229|systemic sclerosis|systemic sclerosis
4833271|NCT02426229|cutaneous systemic sclerosis|cutaneous systemic sclerosis
4833272|NCT02426216|prostate cancer|prostate cancer
4833273|NCT02426216|chemoprevention|chemoprevention
4833274|NCT02426216|biomarker|biomarker
4833275|NCT02426203|Echocardiography|echocardiography
4833276|NCT02426177|postpartum hypertension|postpartum hypertension
4833372|NCT02425553|Reflux|reflux
4833277|NCT02426177|labetalol in postpartum hypertension|labetalol in postpartum hypertension
4833278|NCT02426177|nifedipine in postpartum hypertension|nifedipine in postpartum hypertension
4833279|NCT02426125|carcinoma of the bladder|carcinoma of the bladder
4833280|NCT02426125|carcinoma of the urethra|carcinoma of the urethra
4833281|NCT02426125|carcinoma the of ureter|carcinoma the of ureter
4833282|NCT02426125|carcinoma of the renal pelvis|carcinoma of the renal pelvis
4833283|NCT02426125|transitional cell carcinoma|transitional cell carcinoma
4833284|NCT02426125|transitional cell tumor|transitional cell tumor
4833285|NCT02426125|RANGE|range
4833286|NCT02426125|bladder cancer|bladder cancer
4833287|NCT02426099|Resistant hypertension|resistant hypertension
4833288|NCT02426099|diabetes mellitus|diabetes mellitus
4833289|NCT02426099|Spironolactone|spironolactone
4833290|NCT02426099|African|african
4833291|NCT02426086|Myelofibrosis|myelofibrosis
4833292|NCT02426086|JNJ-63935937|jnj-63935937
4833293|NCT02426086|Imetelstat|imetelstat
4833294|NCT02426073|Inflammaging|inflammaging
4833295|NCT02426047|seizures|seizures
4833296|NCT02426047|epilepsy|epilepsy
4833297|NCT02426047|catamenial|catamenial
4833298|NCT02426047|ketogenic diet|ketogenic diet
4833299|NCT02426047|modified Atkins diet|modified atkins diet
4833300|NCT02426047|intractable epilepsy|intractable epilepsy
4833301|NCT02426047|medically refractory epilepsy|medically refractory epilepsy
4833302|NCT02426047|adult|adult
4833303|NCT02426047|medium chain triglyceride|medium chain triglyceride
4833304|NCT02426034|Advanced|advanced
4833305|NCT02426034|Metastatic|metastatic
4833306|NCT02425995|ACL|acl
4833307|NCT02425995|Hidden lesions of the medial meniscus|hidden lesions of the medial meniscus
4833308|NCT02425995|Chronic knee instability|chronic knee instability
4833309|NCT02425995|Intercondylar and posteromedial arthroscopy|intercondylar and posteromedial arthroscopy
4833310|NCT02425995|Arthroscopic Posteromedial and Intercondylar portal|arthroscopic posteromedial and intercondylar portal
4833311|NCT02425995|Diagnosis capacity of hidden lesions of the medial meniscus|diagnosis capacity of hidden lesions of the medial meniscus
4833312|NCT02425982|Tennis Elbow|tennis elbow
4833313|NCT02425982|Lateral elbow pain|lateral elbow pain
4833314|NCT02425982|Latera epicondylitis|latera epicondylitis
4833315|NCT02425930|gastric cancer|gastric cancer
4833316|NCT02425930|complement system|complement system
4833317|NCT02425930|overal survival|overal survival
4833318|NCT02425904|Langerhans Cell Histiocytosis|langerhans cell histiocytosis
4833319|NCT02425865|UC, IBD|uc, ibd
4833320|NCT02425839|shear wave elastography|shear wave elastography
4833321|NCT02425839|surface electromyogram|surface electromyogram
4833322|NCT02425839|masseter|masseter
4833323|NCT02425826|Parapsoriasis|parapsoriasis
4833324|NCT02425826|Plaque Psoriasis|plaque psoriasis
4833325|NCT02425826|CC-10004|cc-10004
4833326|NCT02425826|Apremilast|apremilast
4833327|NCT02425826|Moderate Plaque Psoriasis|moderate plaque psoriasis
4833328|NCT02425826|Safety|safety
4833329|NCT02425787|Loss of a child|loss of a child
4833330|NCT02425787|Grief|grief
4833331|NCT02425774|Prucalopride|prucalopride
4833332|NCT02425774|Vagus Nerve Stimulation|vagus nerve stimulation
4833333|NCT02425774|Postoperative Ileus|postoperative ileus
4833334|NCT02425761|Cerebrospinal Fluid Shunts|cerebrospinal fluid shunts
4833335|NCT02425761|Randomized Controlled Trial|randomized controlled trial
4833336|NCT02425748|γδ T Cell, non small lung cancer, Without EGFR Mutation|γδ t cell, non small lung cancer, without egfr mutation
4833337|NCT02425735|Immunotherapy, γδ T Cell, heptocellular liver cancer|immunotherapy, γδ t cell, heptocellular liver cancer
4833338|NCT02425722|ASP0456|asp0456
4833339|NCT02425722|linaclotide|linaclotide
4833340|NCT02425722|chronic constipation|chronic constipation
4833341|NCT02425696|right-to-left shunt|right-to-left shunt
4833342|NCT02425696|contrast-enhanced transcranial Doppler|contrast-enhanced transcranial doppler
4833343|NCT02425696|migraine|migraine
4833344|NCT02425696|silent cerebral infarction|silent cerebral infarction
4833345|NCT02425683|Colon Cancer|colon cancer
4833346|NCT02425683|Rectal Cancer|rectal cancer
4833347|NCT02425683|Colorectal Cancer|colorectal cancer
4833348|NCT02425683|Stage IIIC Colorectal Cancer|stage iiic colorectal cancer
4833349|NCT02425670|Brain attack|brain attack
4833350|NCT02425670|stroke|stroke
4833351|NCT02425670|Ischemic stroke|ischemic stroke
4833352|NCT02425670|stem cell therapy|stem cell therapy
4833353|NCT02425657|Education|education
4833354|NCT02425657|Training|training
4833355|NCT02425657|Fast track|fast track
4833356|NCT02425657|Colonoscopy|colonoscopy
4833357|NCT02425644|relapsing multiple sclerosis|relapsing multiple sclerosis
4833358|NCT02425631|SI joint fusion|si joint fusion
4833359|NCT02425631|SI joint pain|si joint pain
4833360|NCT02425631|SI joint|si joint
4833361|NCT02425631|SI joint treatment|si joint treatment
4833362|NCT02425631|SI joint disease|si joint disease
4833363|NCT02425631|Sacroiliac joint|sacroiliac joint
4833364|NCT02425631|Simmetry|simmetry
4833365|NCT02425566|autonomic nervous system|autonomic nervous system
4833366|NCT02425566|hypertension|hypertension
4833367|NCT02425566|ganglionic blocker|ganglionic blocker
4833368|NCT02425566|trimethaphan|trimethaphan
4833369|NCT02425566|splanchnic circulation|splanchnic circulation
4833370|NCT02425566|capacitance|capacitance
4833371|NCT02425553|Diet|diet
4833373|NCT02425553|Dyspepsia|dyspepsia
4833374|NCT02425553|Symptoms|symptoms
4833375|NCT02425553|Alcohol|alcohol
4833376|NCT02425540|Pelvic MRI|pelvic mri
4833377|NCT02425527|Brain Injuries|brain injuries
4833378|NCT02425527|Traumatic Brain Injury|traumatic brain injury
4833379|NCT02425527|Video Games|video games
4833380|NCT02425514|Anterior cervical discectomy and fusion|anterior cervical discectomy and fusion
4833381|NCT02425514|NovoMax|novomax
4833382|NCT02425514|Bioactive Glass-ceramic Intervertebral Spacer|bioactive glass-ceramic intervertebral spacer
4833383|NCT02425501|Aflibercept|aflibercept
4833384|NCT02425501|anti-VEGF|anti-vegf
4833385|NCT02425488|Nursing|nursing
4833386|NCT02425488|Outcome and Process Assessment|outcome and process assessment
4833387|NCT02425488|Cardiac Resynchronization Therapy Devices|cardiac resynchronization therapy devices
4833388|NCT02425488|Heart Failure|heart failure
4833389|NCT02425488|Education|education
4833390|NCT02425475|Dermoscopy|dermoscopy
4833391|NCT02425449|succinylcholine|succinylcholine
4833392|NCT02425449|depolarizing muscle relaxants|depolarizing muscle relaxants
4833393|NCT02425449|pharmacologic effects|pharmacologic effects
4833394|NCT02425410|Diabetes Mellitus|diabetes mellitus
4833395|NCT02425410|Insulin-Dependent|insulin-dependent
4833396|NCT02425410|Virus Diseases|virus diseases
4833397|NCT02425410|Questionnaires|questionnaires
4833398|NCT02425410|Risk assessment|risk assessment
4833399|NCT02425410|Genome-Wide Association Study|genome-wide association study
4833400|NCT02425397|Ototoxicity|ototoxicity
4833401|NCT02425397|platinum derivatives|platinum derivatives
4833402|NCT02425397|paediatrics|paediatrics
4833403|NCT02425397|oncology|oncology
4833404|NCT02425397|clinical research|clinical research
4833405|NCT02425384|adolescent|adolescent
4833406|NCT02425384|physical activity|physical activity
4833407|NCT02425384|accelerometer|accelerometer
4833408|NCT02425358|cell therapy|cell therapy
4833409|NCT02425358|BMC|bmc
4833410|NCT02425358|timing|timing
4833411|NCT02425345|Physical Activity|physical activity
4833412|NCT02425345|National Institute of Aging Go4Life|national institute of aging go4life
4833413|NCT02425345|Postmenopausal Women|postmenopausal women
4833414|NCT02425345|Balance|balance
4833415|NCT02425345|Strength|strength
4833416|NCT02425345|Exercise|exercise
4833417|NCT02425345|Cardiovascular Disease|cardiovascular disease
4833418|NCT02425345|Stroke|stroke
4833419|NCT02425345|Mortality|mortality
4833420|NCT02425345|Myocardial Infarction|myocardial infarction
4833421|NCT02425345|Falls|falls
4833422|NCT02425345|Venous Thromboembolic Event|venous thromboembolic event
4833423|NCT02425345|Peripheral Artery Disease|peripheral artery disease
4833424|NCT02425345|Physical Function|physical function
4833425|NCT02425345|Mobility|mobility
4833426|NCT02425345|Coronary Artery Bypass Graft (CABG)|coronary artery bypass graft (cabg)
4833427|NCT02425345|Percutaneous Coronary Intervention (PCI)|percutaneous coronary intervention (pci)
4833428|NCT02425345|Hip Fractures|hip fractures
4833429|NCT02425345|Cardiovascular Mortality|cardiovascular mortality
4833430|NCT02425332|Spinal Cord Injury|spinal cord injury
4833431|NCT02425332|adaptive control|adaptive control
4833432|NCT02425332|assessment|assessment
4833433|NCT02425332|assist-as-needed|assist-as-needed
4833434|NCT02425332|walking ability|walking ability
4833435|NCT02425332|Lokomat|lokomat
4833436|NCT02425306|peptide|peptide
4833437|NCT02425306|vaccine|vaccine
4833438|NCT02425306|adjuvant|adjuvant
4833439|NCT02425306|polyICLC|polyiclc
4833440|NCT02425306|cyclophosphamide|cyclophosphamide
4833441|NCT02425306|Montanide ISA-51|montanide isa-51
4833442|NCT02425267|Telerehabilitation|telerehabilitation
4833443|NCT02425241|Vaccine|vaccine
4833444|NCT02425241|DNA|dna
4833445|NCT02425241|HIV-1|hiv-1
4833446|NCT02425241|Serum amyloid P component (SAP)|serum amyloid p component (sap)
4833447|NCT02425241|Clinical trial|clinical trial
4833448|NCT02425241|Vaccination|vaccination
4833449|NCT02425241|Prophylaxis|prophylaxis
4833450|NCT02425241|Adult male|adult male
4833451|NCT02425228|targeted biopsy|targeted biopsy
4833452|NCT02425228|conventional biopsy|conventional biopsy
4833453|NCT02425228|cognitive biopsy|cognitive biopsy
4833454|NCT02425215|Hyperbaric Oxygen Treatment|hyperbaric oxygen treatment
4833455|NCT02425215|Late radiation injury|late radiation injury
4833456|NCT02425215|Adult|adult
4833457|NCT02425215|Malignancy|malignancy
4833458|NCT02425215|Quality of Life|quality of life
4833459|NCT02425215|Chronic Pain|chronic pain
4833460|NCT02425202|pediatric|pediatric
4833461|NCT02425202|obstructive sleep apnea|obstructive sleep apnea
4833462|NCT02425202|tonsillectomy|tonsillectomy
4833463|NCT02425202|analgesia|analgesia
4833464|NCT02425176|botulinum toxin|botulinum toxin
4833465|NCT02425176|sialorrhoea|sialorrhoea
4833466|NCT02425176|drooling|drooling
4833467|NCT02425163|Prostate Cancer|prostate cancer
4833468|NCT02425163|Shear Wave Elastography|shear wave elastography
4833469|NCT02425163|Prostate|prostate
4833470|NCT02425163|Prostate Biopsy|prostate biopsy
4833471|NCT02425150|Keratoconus|keratoconus
4833472|NCT02425150|Corneal crosslinking|corneal crosslinking
4833473|NCT02425150|Corneal biomechanics|corneal biomechanics
4833474|NCT02425150|Corneal densitometry|corneal densitometry
4833681|NCT02423915|Rapamune|rapamune
4833475|NCT02425150|Scheimpflug photography|scheimpflug photography
4833476|NCT02425111|Drug therapy|drug therapy
4833477|NCT02425098|Drug therapy|drug therapy
4833478|NCT02425085|retinectomy|retinectomy
4833479|NCT02425085|endodiathermy|endodiathermy
4833480|NCT02425085|inferior|inferior
4833481|NCT02425085|retinal redetachment|retinal redetachment
4833482|NCT02425072|Cancer|cancer
4833483|NCT02425072|Brain|brain
4833484|NCT02425072|Lung|lung
4833485|NCT02425072|Small-cell|small-cell
4833486|NCT02425059|irreversible electroporation|irreversible electroporation
4833487|NCT02425059|Unresectable Rectal Neoplasms|unresectable rectal neoplasms
4833488|NCT02425046|family|family
4833489|NCT02425033|POEM|poem
4833490|NCT02425033|Minimally invasive surgery|minimally invasive surgery
4833491|NCT02425033|Achalasia|achalasia
4833492|NCT02425033|Spastic esophageal disorders|spastic esophageal disorders
4833493|NCT02425020|Supplement|supplement
4833494|NCT02425020|performance|performance
4833495|NCT02425020|whey|whey
4833496|NCT02425020|meat|meat
4833497|NCT02425020|protein|protein
4833498|NCT02424994|Morbidity|morbidity
4833499|NCT02424994|Mortality|mortality
4833500|NCT02424994|Health care utilization|health care utilization
4833501|NCT02424994|Cohort|cohort
4833502|NCT02424994|Epidemiology|epidemiology
4833503|NCT02424994|Cardiovascular diseases|cardiovascular diseases
4833504|NCT02424968|Healthy Stem Cell Donor|healthy stem cell donor
4833505|NCT02424955|Liver cancer|liver cancer
4833506|NCT02424955|Hepatocellular Carcinoma|hepatocellular carcinoma
4833507|NCT02424955|Liver imaging|liver imaging
4833508|NCT02424955|Stereotactic Ablative Radiotherapy|stereotactic ablative radiotherapy
4833509|NCT02424955|SABR|sabr
4833510|NCT02424929|Deep Brain Stimulation|deep brain stimulation
4833511|NCT02424916|Onco-dermatology|onco-dermatology
4833512|NCT02424916|Adoptive transfer|adoptive transfer
4833513|NCT02424916|Immunotherapy|immunotherapy
4833514|NCT02424903|infection|infection
4833515|NCT02424903|prosthesis|prosthesis
4833516|NCT02424903|hip|hip
4833517|NCT02424903|knee|knee
4833518|NCT02424903|shoulder|shoulder
4833519|NCT02424877|rheumatoid arthritis|rheumatoid arthritis
4833520|NCT02424877|drug treatment|drug treatment
4833521|NCT02424877|compliance|compliance
4833522|NCT02424877|outcome|outcome
4833523|NCT02424864|4D PET-CT|4d pet-ct
4833524|NCT02424851|myeloma|myeloma
4833525|NCT02424851|multiple myeloma|multiple myeloma
4833526|NCT02424851|chronic kidney disease|chronic kidney disease
4833527|NCT02424851|renal failure|renal failure
4833528|NCT02424851|bortezomib|bortezomib
4833529|NCT02424851|Velcade|velcade
4833530|NCT02424851|thalidomide|thalidomide
4833531|NCT02424851|bendamustine|bendamustine
4833532|NCT02424851|dexamethasone|dexamethasone
4833533|NCT02424851|serum free light chains|serum free light chains
4833534|NCT02424851|proteosomal inhibition|proteosomal inhibition
4833535|NCT02424851|immunomodulatory|immunomodulatory
4833536|NCT02424825|diet|diet
4833537|NCT02424825|cooking|cooking
4833538|NCT02424825|multiple sclerosis|multiple sclerosis
4833539|NCT02424825|fatigue|fatigue
4833540|NCT02424812|handwashing|handwashing
4833541|NCT02424812|behavior|behavior
4833542|NCT02424799|Urticaria|urticaria
4833543|NCT02424799|SYK Inhibitor|syk inhibitor
4833544|NCT02424786|Adherence|adherence
4833545|NCT02424786|Polypharmacy|polypharmacy
4833546|NCT02424786|Elderly|elderly
4833547|NCT02424786|Chronic kidney disease|chronic kidney disease
4833548|NCT02424734|Late-onset Sepsis|late-onset sepsis
4833549|NCT02424708|Reduced Glutathione|reduced glutathione
4833550|NCT02424708|Intranasal|intranasal
4833551|NCT02424708|(in)GSH|(in)gsh
4833552|NCT02424708|Parkinson's Disease|parkinson's disease
4833553|NCT02424708|Glutathione|glutathione
4833554|NCT02424708|Uptake|uptake
4833555|NCT02424708|central nervous system|central nervous system
4833556|NCT02424695|Cortical arousal intensity|cortical arousal intensity
4833557|NCT02424695|RLS|rls
4833558|NCT02424695|Heart rate|heart rate
4833559|NCT02424695|Blood pressure|blood pressure
4833560|NCT02424695|PLMs|plms
4833561|NCT02424630|sono-guided interscalene brachial plexus block|sono-guided interscalene brachial plexus block
4833562|NCT02424630|arthroscopy-guided suprascapular nerve block|arthroscopy-guided suprascapular nerve block
4833563|NCT02424630|arthroscopic rotator cuff repair|arthroscopic rotator cuff repair
4833564|NCT02424630|postoperative pain|postoperative pain
4833565|NCT02424591|Anesthesia Recovery Period|anesthesia recovery period
4833566|NCT02424591|Spinal Fusion|spinal fusion
4833567|NCT02424552|severe asthma|severe asthma
4833568|NCT02424552|vitamin D|vitamin d
4833569|NCT02424552|treatment|treatment
4833570|NCT02424539|Seasonal|seasonal
4833571|NCT02424539|Fluticasone Furoate|fluticasone furoate
4833572|NCT02424539|Perennial|perennial
4833573|NCT02424539|Allergic Rhinitis|allergic rhinitis
4833574|NCT02424539|Nasal Spray|nasal spray
4833575|NCT02424526|cerebral palsy|cerebral palsy
4833576|NCT02424526|treadmill training|treadmill training
4833577|NCT02424526|walking|walking
4833578|NCT02424487|Initial pressure|initial pressure
4833579|NCT02424487|changes of intracuff pressure|changes of intracuff pressure
4833682|NCT02423915|G-CSF|g-csf
4833580|NCT02424487|infants and children|infants and children
4833581|NCT02424474|cell free fetal DNA|cell free fetal dna
4833582|NCT02424474|general population|general population
4833583|NCT02424474|screening|screening
4833584|NCT02424474|trisomy 21|trisomy 21
4833585|NCT02424474|IVF|ivf
4833586|NCT02424435|Friedreich Ataxia|friedreich ataxia
4833587|NCT02424435|FRDA|frda
4833588|NCT02424422|Corrective Orthodontics|corrective orthodontics
4833589|NCT02424422|CBCT|cbct
4833590|NCT02424422|Rapid Maxillary Expansion|rapid maxillary expansion
4833591|NCT02424422|Cone Beam Computed Tomography|cone beam computed tomography
4833592|NCT02424422|Hyrax Expansion|hyrax expansion
4833593|NCT02424422|Craniofacial Sutures|craniofacial sutures
4833594|NCT02424409|Asthma|asthma
4833595|NCT02424409|Relapse|relapse
4833596|NCT02424409|Therapeutic counselling|therapeutic counselling
4833597|NCT02424409|Protocol of care|protocol of care
4833598|NCT02424396|Interleukin 2, IL2|interleukin 2, il2
4833599|NCT02424396|Relapsing Remitting Multiple Sclerosis|relapsing remitting multiple sclerosis
4833600|NCT02424396|Autoimmune diseases|autoimmune diseases
4833601|NCT02424396|Regulatory T cells, Tregs|regulatory t cells, tregs
4833602|NCT02424370|Aortic stenosis|aortic stenosis
4833603|NCT02424370|TAVR|tavr
4833604|NCT02424370|Frailty|frailty
4833605|NCT02424370|Elderly|elderly
4833606|NCT02424357|Adjustable strabismus surgery|adjustable strabismus surgery
4833607|NCT02424357|suture contamination|suture contamination
4833608|NCT02424357|5%povidone iodine|5%povidone iodine
4833609|NCT02424344|COPD|copd
4833610|NCT02424331|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
4833611|NCT02424331|Respiratory mechanics|respiratory mechanics
4833612|NCT02424331|Plethysmography|plethysmography
4833613|NCT02424331|Diaphragm|diaphragm
4833614|NCT02424331|Respiratory muscles|respiratory muscles
4833615|NCT02424331|Breathing exercises|breathing exercises
4833616|NCT02424292|Breast cancer|breast cancer
4833617|NCT02424292|Physcial activity/exercise|physcial activity/exercise
4833618|NCT02424292|anti-hormonal treatment|anti-hormonal treatment
4833619|NCT02424279|pancreatic cancer|pancreatic cancer
4833620|NCT02424279|pain|pain
4833621|NCT02424279|splanchnicectomy|splanchnicectomy
4833622|NCT02424266|Tear film|tear film
4833623|NCT02424266|Imaging|imaging
4833624|NCT02424266|Tomogrophy|tomogrophy
4833625|NCT02424266|dry eye|dry eye
4833626|NCT02424201|uterine atony|uterine atony
4833627|NCT02424175|Fecal Transplant|fecal transplant
4833628|NCT02424175|Primary Sclerosing Cholangitis|primary sclerosing cholangitis
4833629|NCT02424175|Fecal Microbiota Transplantation|fecal microbiota transplantation
4833630|NCT02424110|bipolar radiofrequency ablation|bipolar radiofrequency ablation
4833631|NCT02424110|argon beam coagulator|argon beam coagulator
4833632|NCT02424097|Prevention|prevention
4833633|NCT02424071|melatonin's|melatonin's
4833634|NCT02424071|quality of recovery|quality of recovery
4833635|NCT02424032|Neck pain|neck pain
4833636|NCT02424032|stabilization exercise|stabilization exercise
4833637|NCT02424032|connective tissue massage|connective tissue massage
4833638|NCT02424006|keratoplasty|keratoplasty
4833639|NCT02424006|bioengineered cornea|bioengineered cornea
4833640|NCT02424006|donor cornea|donor cornea
4833641|NCT02423993|Type 1 diabetes mellitus|type 1 diabetes mellitus
4833642|NCT02423993|Continuous subcutaneous insulin infusion|continuous subcutaneous insulin infusion
4833643|NCT02423993|Quality of life|quality of life
4833644|NCT02423993|Therapeutic education|therapeutic education
4833645|NCT02423993|Insulin pump|insulin pump
4833646|NCT02423941|Liver Transplantation|liver transplantation
4833647|NCT02423941|Retrograde Reperfusion|retrograde reperfusion
4833648|NCT02423941|Graft dysfunction|graft dysfunction
4833649|NCT02423941|Randomized study|randomized study
4833650|NCT02423928|immunotherapy|immunotherapy
4833651|NCT02423928|cryoablation|cryoablation
4833652|NCT02423928|prostate cancer|prostate cancer
4833653|NCT02423928|dendritic cell|dendritic cell
4833654|NCT02423915|Leukemia|leukemia
4833655|NCT02423915|Lymphoma|lymphoma
4833656|NCT02423915|Advanced hematologic malignancies|advanced hematologic malignancies
4833657|NCT02423915|Graft versus host disease|graft versus host disease
4833658|NCT02423915|GVHD|gvhd
4833659|NCT02423915|Fucosylated umbilical cord blood Regulatory T cells|fucosylated umbilical cord blood regulatory t cells
4833660|NCT02423915|CB|cb
4833661|NCT02423915|Tregs|tregs
4833662|NCT02423915|T cells|t cells
4833663|NCT02423915|Cord blood transplant|cord blood transplant
4833664|NCT02423915|Total body radiation|total body radiation
4833665|NCT02423915|TBI|tbi
4833666|NCT02423915|Radiation therapy|radiation therapy
4833667|NCT02423915|XRT|xrt
4833668|NCT02423915|Rituximab|rituximab
4833669|NCT02423915|Rituxan|rituxan
4833670|NCT02423915|Fludarabine|fludarabine
4833671|NCT02423915|Fludarabine phosphate|fludarabine phosphate
4833672|NCT02423915|Fludara|fludara
4833673|NCT02423915|Cyclophosphamide|cyclophosphamide
4833674|NCT02423915|Cytoxan|cytoxan
4833675|NCT02423915|Neosar|neosar
4833676|NCT02423915|Mycophenolate|mycophenolate
4833677|NCT02423915|Mycophenolate mofetil|mycophenolate mofetil
4833678|NCT02423915|MMF|mmf
4833679|NCT02423915|CellCept|cellcept
4833680|NCT02423915|Sirolimus|sirolimus
4833683|NCT02423915|Filgrastim|filgrastim
4833684|NCT02423915|Neupogen|neupogen
4833685|NCT02423889|Hypofractionated radiotherapy|hypofractionated radiotherapy
4833686|NCT02423889|SBRT|sbrt
4833687|NCT02423863|Cancer|cancer
4833688|NCT02423863|Immunotherapy|immunotherapy
4833689|NCT02423863|Intratumoral Injection|intratumoral injection
4833690|NCT02423863|Multicenter Study|multicenter study
4833691|NCT02423863|Autovaccination|autovaccination
4833692|NCT02423863|Solid Tumors|solid tumors
4833693|NCT02423850|Diabetic foot ulcers|diabetic foot ulcers
4833694|NCT02423850|Leg ulcers|leg ulcers
4833695|NCT02423850|Ulcer healing|ulcer healing
4833696|NCT02423850|Ulcer measurement|ulcer measurement
4833697|NCT02423850|Ulcer area|ulcer area
4833698|NCT02423850|Ulcer volume|ulcer volume
4833699|NCT02423850|3D measurement|3d measurement
4833700|NCT02423837|follicular lymphoma|follicular lymphoma
4833701|NCT02423837|bendamustine|bendamustine
4833702|NCT02423837|rituximab|rituximab
4833703|NCT02423798|Diabetes|diabetes
4833704|NCT02423798|Glucose sensor|glucose sensor
4833705|NCT02423798|Sensor accuracy and performance|sensor accuracy and performance
4833706|NCT02423798|CGM|cgm
4833707|NCT02423759|Chemoprevention|chemoprevention
4833708|NCT02423733|depression|depression
4833709|NCT02423733|dysthymia|dysthymia
4833710|NCT02423733|cognitive behavioural therapy|cognitive behavioural therapy
4833711|NCT02423733|CBT|cbt
4833712|NCT02423733|problem-solving therapy|problem-solving therapy
4833713|NCT02423733|PST|pst
4833714|NCT02423733|waitlist|waitlist
4833715|NCT02423733|secondary mental health care|secondary mental health care
4833716|NCT02423733|mental health|mental health
4833717|NCT02423733|e-therapy|e-therapy
4833718|NCT02423733|computerized therapy|computerized therapy
4833719|NCT02423668|cataract surgery|cataract surgery
4833720|NCT02423668|biometry|biometry
4833721|NCT02423668|second eye refinement|second eye refinement
4833722|NCT02423668|effective lens position|effective lens position
4833723|NCT02423642|Acute Kidney Injury Requiring Continuous Renal Replacement Therapy|acute kidney injury requiring continuous renal replacement therapy
4833724|NCT02423616|MIP|mip
4833725|NCT02423616|Hand Grip|hand grip
4833726|NCT02423616|Correlation|correlation
4833727|NCT02423616|Inspiratory Pressure|inspiratory pressure
4833728|NCT02423616|Hand Grip Force|hand grip force
4833729|NCT02423603|Triple Negative Breast Cancer|triple negative breast cancer
4833730|NCT02423603|Metastatic|metastatic
4833731|NCT02423603|AKT Inhibitor|akt inhibitor
4833732|NCT02423603|Advanced|advanced
4833733|NCT02423603|AZD5363|azd5363
4833734|NCT02423603|Paclitaxel|paclitaxel
4833735|NCT02423603|PAKT|pakt
4833736|NCT02423590|Squamous|squamous
4833737|NCT02423590|Lung|lung
4833738|NCT02423590|Apatorsen|apatorsen
4833739|NCT02423577|antiviral|antiviral
4833740|NCT02423577|influenza|influenza
4833741|NCT02423577|challenge|challenge
4833742|NCT02423564|Probiotic|probiotic
4833743|NCT02423564|Digesta-Lac|digesta-lac
4833744|NCT02423564|Occasional Constipation|occasional constipation
4833745|NCT02423564|Constipation|constipation
4833746|NCT02423551|Gut microbiota|gut microbiota
4833747|NCT02423551|Intestinal permeability|intestinal permeability
4833748|NCT02423551|Gut barrier integrity|gut barrier integrity
4833749|NCT02423525|glioblastoma|glioblastoma
4833750|NCT02423525|astrocytoma|astrocytoma
4833751|NCT02423525|oligodendroglioma|oligodendroglioma
4833752|NCT02423525|mixed oligoastrocytoma|mixed oligoastrocytoma
4833753|NCT02423525|low grade gliomas|low grade gliomas
4833754|NCT02423525|brain metastases|brain metastases
4833755|NCT02423525|meningiomas|meningiomas
4833756|NCT02423525|leptomeningeal metastases|leptomeningeal metastases
4833757|NCT02423512|Inflammatory Bowel Diseases|inflammatory bowel diseases
4833758|NCT02423512|Vedolizumab|vedolizumab
4833759|NCT02423512|Ulcerative Colitis|ulcerative colitis
4833760|NCT02423512|Crohn's Disease|crohn's disease
4833761|NCT02423512|MADCAM1|madcam1
4833762|NCT02423512|integrin alpha4beta7|integrin alpha4beta7
4833763|NCT02423499|Autism Spectrum Disorder|autism spectrum disorder
4833764|NCT02423499|Bipolar Disorder|bipolar disorder
4833765|NCT02423499|Emotions|emotions
4833766|NCT02423460|Ulcerative Colitis|ulcerative colitis
4833767|NCT02423460|Healthy Controls|healthy controls
4833768|NCT02423460|Crohn's Disease|crohn's disease
4833769|NCT02423434|Corneal Confocal Microscopy|corneal confocal microscopy
4833770|NCT02423434|Diabetes Mellitus|diabetes mellitus
4833771|NCT02423434|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
4833772|NCT02423434|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
4833773|NCT02423434|Diabetic Neuropathy|diabetic neuropathy
4833774|NCT02423434|Diabetes Complications|diabetes complications
4833775|NCT02423382|silicone oil|silicone oil
4833776|NCT02423382|retinal saturation|retinal saturation
4833777|NCT02423382|retinal blood flow|retinal blood flow
4833778|NCT02423382|retinal detachment|retinal detachment
4833779|NCT02423369|S-100B protein|s-100b protein
4833780|NCT02423369|Neuron-specific Enolase|neuron-specific enolase
4833781|NCT02423356|breast cancer|breast cancer
4833782|NCT02423356|sarcoma|sarcoma
4833783|NCT02423356|lymphoma|lymphoma
4833784|NCT02423356|echocardiography|echocardiography
4833785|NCT02423356|cardiotoxicity|cardiotoxicity
4833786|NCT02423356|pharmacogenetics|pharmacogenetics
4833787|NCT02423356|doxorubicin|doxorubicin
4833788|NCT02423356|chemotherapy|chemotherapy
4833789|NCT02423291|PMLBCL|pmlbcl
4833790|NCT02423291|Brentuximab Vedotin|brentuximab vedotin
4833791|NCT02423291|CD30-positive|cd30-positive
4833792|NCT02423291|Mediastinal Lymphoma|mediastinal lymphoma
4833793|NCT02423278|gastrectomy|gastrectomy
4833794|NCT02423278|lymphadenectomy|lymphadenectomy
4833795|NCT02423278|gastric cancer|gastric cancer
4833796|NCT02423278|adjuvant chemotherapy|adjuvant chemotherapy
4833797|NCT02423278|overall survival|overall survival
4833798|NCT02423265|Chronic total coronary occlusions|chronic total coronary occlusions
4833799|NCT02423265|Ranolazine|ranolazine
4833800|NCT02423252|Critical illness|critical illness
4833801|NCT02423252|Intervention|intervention
4833802|NCT02423252|RCT|rct
4833803|NCT02423252|Relaxation|relaxation
4833804|NCT02423252|Guided imagery|guided imagery
4833805|NCT02423252|Touch/Massage|touch/massage
4833806|NCT02423252|Music listening|music listening
4833807|NCT02423252|Neuropeptides|neuropeptides
4833808|NCT02423252|Inflammatory molecules|inflammatory molecules
4833809|NCT02423252|Post-traumatic stress|post-traumatic stress
4833810|NCT02423252|Critical care nurse|critical care nurse
4833811|NCT02423252|Psychocognitive nursing intervention|psychocognitive nursing intervention
4833812|NCT02423252|Interpersonal support|interpersonal support
4833813|NCT02423213|OCT|oct
4833814|NCT02423213|image-guided surgery|image-guided surgery
4833815|NCT02423213|ophthalmic surgery|ophthalmic surgery
4833816|NCT02423187|Stomach ulcer|stomach ulcer
4833817|NCT02423187|Duodenal ulcer|duodenal ulcer
4833818|NCT02423187|Rabeprazole|rabeprazole
4833819|NCT02423187|Recurrence|recurrence
4833820|NCT02423161|OCT|oct
4833821|NCT02423161|image-guided surgery|image-guided surgery
4833822|NCT02423161|vitreoretinal surgery|vitreoretinal surgery
4833823|NCT02423161|corneal surgery|corneal surgery
4833824|NCT02423148|Lung Cancer|lung cancer
4833825|NCT02423096|biomarker|biomarker
4833826|NCT02423096|neuroendocrine|neuroendocrine
4833827|NCT02423096|metabolite|metabolite
4833828|NCT02423096|cognitive functioning|cognitive functioning
4833829|NCT02423096|clinical symptoms|clinical symptoms
4833830|NCT02423096|schizophrenia|schizophrenia
4833831|NCT02423083|Neuroprotection|neuroprotection
4833832|NCT02423083|Multiple Sclerosis|multiple sclerosis
4833833|NCT02423083|Clinical Trial|clinical trial
4833834|NCT02423083|Safety and Tolerability|safety and tolerability
4833835|NCT02423070|Cell-free DNA|cell-free dna
4833836|NCT02423070|Acute Rejection|acute rejection
4833837|NCT02423070|Thoracic Organ Transplantation|thoracic organ transplantation
4833838|NCT02423070|Non-Invasive Testing|non-invasive testing
4833839|NCT02423070|Chronic Rejection|chronic rejection
4833840|NCT02423057|Pharmacodynamics|pharmacodynamics
4833841|NCT02423057|DNA Methylation|dna methylation
4833842|NCT02423057|Pharmacokinetics|pharmacokinetics
4833843|NCT02423057|Nucleoside Analogue|nucleoside analogue
4833844|NCT02423057|Epigenetics|epigenetics
4833845|NCT02423044|Anxiety|anxiety
4833846|NCT02423044|fMRI|fmri
4833847|NCT02423044|Virtual Reality|virtual reality
4833848|NCT02423044|Shock Threat|shock threat
4833849|NCT02423044|Healthy Volunteer|healthy volunteer
4833850|NCT02423031|Physiological Measures|physiological measures
4833851|NCT02423031|Emotional Context|emotional context
4833852|NCT02423031|Pediatric|pediatric
4833853|NCT02423031|Distresss Screening|distresss screening
4833854|NCT02423005|Stress urinary incontinence|stress urinary incontinence
4833855|NCT02423005|Neurotech Vital Compact|neurotech vital compact
4833856|NCT02423005|1h Provacative Pad Test|1h provacative pad test
4833857|NCT02423005|Neuroelectrical Muscle Stimulation (NEMS)|neuroelectrical muscle stimulation (nems)
4833858|NCT02422992|Iron metabolism|iron metabolism
4833859|NCT02422992|MRI|mri
4833860|NCT02422992|risk factors|risk factors
4833861|NCT02422992|haptoglobin phenotype|haptoglobin phenotype
4833862|NCT02422953|Stunting|stunting
4833863|NCT02422953|Wasting|wasting
4833864|NCT02422953|Underweight|underweight
4833865|NCT02422927|C-Reactive Protein|c-reactive protein
4833866|NCT02422927|Endothelial Microparticles|endothelial microparticles
4833867|NCT02422927|Endothelium|endothelium
4833868|NCT02422927|Nutraceutical|nutraceutical
4833869|NCT02422927|Cholesterol|cholesterol
4833870|NCT02422888|ST elevation myocardial infarction|st elevation myocardial infarction
4833871|NCT02422888|Percutaneous coronary intervention|percutaneous coronary intervention
4833872|NCT02422888|Endothelial function|endothelial function
4833873|NCT02422888|Ticagrelor|ticagrelor
4833874|NCT02422888|Prasugrel|prasugrel
4833875|NCT02422875|Sjögren's Syndrome|sjögren's syndrome
4833876|NCT02422875|Scleroderma|scleroderma
4833877|NCT02422875|Myositis|myositis
4833878|NCT02422875|Juvenile Idiopathic Arthritis|juvenile idiopathic arthritis
4833879|NCT02422875|Rheumatoid Arthritis|rheumatoid arthritis
4833880|NCT02422875|Inflammatory Arthritis|inflammatory arthritis
4833881|NCT02422875|Undifferentiated Connective Tissue Disease|undifferentiated connective tissue disease
4833882|NCT02422875|Idiopathic thrombocytopenic purpura|idiopathic thrombocytopenic purpura
4833883|NCT02422875|Graft vs Host Disease|graft vs host disease
4833884|NCT02422875|Autoimmune Lymphoproliferative Syndrome|autoimmune lymphoproliferative syndrome
4833885|NCT02422875|Immunoglobulin G4 (IgG4)-related disease|immunoglobulin g4 (igg4)-related disease
4833886|NCT02422875|Hepatitis C|hepatitis c
4833887|NCT02422875|Epstein Barr Virus (infectious mononucleosis - EBV)|epstein barr virus (infectious mononucleosis - ebv)
4833888|NCT02422875|Sepsis|sepsis
4833889|NCT02422875|Guillain-Barre syndrome|guillain-barre syndrome
4833890|NCT02422875|Mycoplasma pneumoniae|mycoplasma pneumoniae
4833891|NCT02422875|Human Immunodeficiency Virus|human immunodeficiency virus
4833892|NCT02422862|Physiotherapy|physiotherapy
4833893|NCT02422862|Manual Therapy|manual therapy
4833894|NCT02422849|Patient admission|patient admission
4833895|NCT02422836|photodamage|photodamage
4833896|NCT02422836|fine lines|fine lines
4833897|NCT02422836|wrinkles|wrinkles
4833898|NCT02422836|dyschromia|dyschromia
4833899|NCT02422823|anesthesia|anesthesia
4833900|NCT02422823|volumes|volumes
4833901|NCT02422823|articaine|articaine
4833902|NCT02422823|Inferior alveolar nerve block|inferior alveolar nerve block
4833903|NCT02422797|HIV|hiv
4833904|NCT02422797|NNRTI-sparing|nnrti-sparing
4833905|NCT02422797|two-drug regimen|two-drug regimen
4833906|NCT02422797|nucleoside reverse transcriptase inhibitors|nucleoside reverse transcriptase inhibitors
4833907|NCT02422797|protease inhibitor|protease inhibitor
4833908|NCT02422797|integrase inhibitor|integrase inhibitor
4833909|NCT02422797|non-nucleoside reverse transcriptase inhibitor|non-nucleoside reverse transcriptase inhibitor
4833910|NCT02422797|dolutegravir plus rilpivirine|dolutegravir plus rilpivirine
4833911|NCT02422797|virologically-suppressed|virologically-suppressed
4833912|NCT02422784|Vitamin D insufficient|vitamin d insufficient
4833913|NCT02422784|rooibos tea|rooibos tea
4833914|NCT02422784|calcium|calcium
4833915|NCT02422758|hypothermia|hypothermia
4833916|NCT02422758|perioperative nursing|perioperative nursing
4833917|NCT02422758|prewarming|prewarming
4833918|NCT02422758|prevention and control|prevention and control
4833919|NCT02422745|Cocoa extract multivitamins cardiovascular disease cancer|cocoa extract multivitamins cardiovascular disease cancer
4833920|NCT02422732|NF1|nf1
4833921|NCT02422732|Children|children
4833922|NCT02422732|Reading disability|reading disability
4833923|NCT02422732|Morphological and functional MRI|morphological and functional mri
4833924|NCT02422732|Genetic analysis|genetic analysis
4833925|NCT02422719|Chronic myeloid leukemia|chronic myeloid leukemia
4833926|NCT02422719|Intolerance|intolerance
4833927|NCT02422719|Resitance|resitance
4833928|NCT02422719|Radotinib|radotinib
4833929|NCT02422693|hydrotherapy|hydrotherapy
4833930|NCT02422693|aquatic|aquatic
4833931|NCT02422680|Quality assurance|quality assurance
4833932|NCT02422680|Caecum intubation rate|caecum intubation rate
4833933|NCT02422680|Patient satisfaction|patient satisfaction
4833934|NCT02422667|Orthopedics|orthopedics
4833935|NCT02422667|Outcome Assessment|outcome assessment
4833936|NCT02422628|EGFR inhibitor|egfr inhibitor
4833937|NCT02422628|EGFR mutation|egfr mutation
4833938|NCT02422628|EGFR|egfr
4833939|NCT02422628|adenocarcinoma|adenocarcinoma
4833940|NCT02422628|EGFR TKI|egfr tki
4833941|NCT02422628|treatment|treatment
4833942|NCT02422628|Non small cell|non small cell
4833943|NCT02422615|HR-positive|hr-positive
4833944|NCT02422615|HER2-negative|her2-negative
4833945|NCT02422615|Advanced breast cancer|advanced breast cancer
4833946|NCT02422615|LEE011|lee011
4833947|NCT02422615|ribociclib|ribociclib
4833948|NCT02422615|fulvestrant|fulvestrant
4833949|NCT02422615|faslodex|faslodex
4833950|NCT02422615|CDK|cdk
4833951|NCT02422615|CDK4|cdk4
4833952|NCT02422615|CDK6|cdk6
4833953|NCT02422615|CDK4/6|cdk4/6
4833954|NCT02422615|CDK4/6 inhibitor|cdk4/6 inhibitor
4833955|NCT02422615|Phase III|phase iii
4833956|NCT02422615|ER-positive|er-positive
4833957|NCT02422615|PR-positive|pr-positive
4833958|NCT02422615|Postmenopausal|postmenopausal
4833959|NCT02422615|Men|men
4833960|NCT02422602|Patients|patients
4833961|NCT02422602|treated by Rivaroxaban|treated by rivaroxaban
4833962|NCT02422589|ALK-positive advanced tumors,|alk-positive advanced tumors,
4833963|NCT02422589|midazolam,|midazolam,
4833964|NCT02422589|warfarin,|warfarin,
4833965|NCT02422589|ceritinib,|ceritinib,
4833966|NCT02422589|ALK,|alk,
4833967|NCT02422589|CYP3A-4,|cyp3a-4,
4833968|NCT02422589|Drug drug intereaction|drug drug intereaction
4833969|NCT02422563|neoadjuvant chemotherapy|neoadjuvant chemotherapy
4833970|NCT02422563|FIGO IB2, FIGO IIB|figo ib2, figo iib
4833971|NCT02422563|chemo-radiation|chemo-radiation
4833972|NCT02422563|dose dense chemotherapy|dose dense chemotherapy
4833973|NCT02422563|cisplatin|cisplatin
4833974|NCT02422563|paclitaxel|paclitaxel
4833975|NCT02422563|carboplatin|carboplatin
4833976|NCT02422563|ifosfamide|ifosfamide
4833977|NCT02422550|MRI|mri
4833978|NCT02422550|15-073|15-073
4833979|NCT02422550|participants undergoing radiation therapy|participants undergoing radiation therapy
4833980|NCT02422524|Hepatic|hepatic
4833981|NCT02422524|impairment|impairment
4833982|NCT02422524|PA-824|pa-824
4833983|NCT02422524|Pharmacokinetics|pharmacokinetics
4833984|NCT02422524|Safety|safety
4833985|NCT02422524|Tuberculosis|tuberculosis
4833986|NCT02422511|Genome Sequencing|genome sequencing
4833987|NCT02422511|Exome Sequencing|exome sequencing
4833988|NCT02422511|Newborn Screening|newborn screening
4833989|NCT02422511|Childhood Onset Genetic Conditions|childhood onset genetic conditions
4833990|NCT02422498|Treated with Concurrent Cisplatin|treated with concurrent cisplatin
4833991|NCT02422498|Treated with Radiation Therapy|treated with radiation therapy
4833992|NCT02422498|Homologous Recombination Repair Status|homologous recombination repair status
4833993|NCT02422498|Biomarker of Response|biomarker of response
4833994|NCT02422498|15-032|15-032
4833995|NCT02422498|Patients|patients
4833996|NCT02422485|Salsalate|salsalate
4833997|NCT02422446|Endothelial function|endothelial function
4833998|NCT02422446|Eicosapentaenoic acid|eicosapentaenoic acid
4833999|NCT02422446|Triglycerides|triglycerides
4834000|NCT02422433|EGD|egd
4834001|NCT02422433|OFDI|ofdi
4834002|NCT02422433|Barrett's Esophagus|barrett's esophagus
4834003|NCT02422433|Imaging|imaging
4834004|NCT02422420|Diabetes Prevention|diabetes prevention
4834005|NCT02422420|Financial Incentives|financial incentives
4834006|NCT02422420|Medicaid|medicaid
4834007|NCT02422420|Motivation|motivation
4834008|NCT02422381|NSCLC|nsclc
4834009|NCT02422381|lung cancer|lung cancer
4834010|NCT02422381|Gemzar|gemzar
4834011|NCT02422381|Pembrolizumab|pembrolizumab
4834012|NCT02422381|Anti-PD-1|anti-pd-1
4834013|NCT02422381|Immunotherapy|immunotherapy
4834014|NCT02422368|Graves' ophthalmopathy|graves' ophthalmopathy
4834015|NCT02422368|Antioxidant|antioxidant
4834016|NCT02422368|Activity|activity
4834017|NCT02422368|Severity|severity
4834018|NCT02422355|hip|hip
4834019|NCT02422355|femoral neck|femoral neck
4834020|NCT02422355|Garden classification|garden classification
4834021|NCT02422355|healing|healing
4834022|NCT02422355|cut-out|cut-out
4834023|NCT02422355|iatrogenic fracture|iatrogenic fracture
4834024|NCT02422355|implant|implant
4834025|NCT02422355|rotational stability|rotational stability
4834026|NCT02422355|minimal invasive|minimal invasive
4834027|NCT02422329|Advanced Cancers|advanced cancers
4834028|NCT02422329|Constipation|constipation
4834029|NCT02422329|Recurrent cancer|recurrent cancer
4834030|NCT02422329|Locally advanced cancer|locally advanced cancer
4834031|NCT02422329|Metastatic cancer|metastatic cancer
4834032|NCT02422329|Video|video
4834033|NCT02422329|Fact sheet|fact sheet
4834034|NCT02422329|Questionnaires|questionnaires
4834035|NCT02422329|Surveys|surveys
4834036|NCT02422303|Depression|depression
4834037|NCT02422303|Gynecoligical surgery|gynecoligical surgery
4834038|NCT02422303|Ketamine|ketamine
4834039|NCT02422290|Obsessive Compulsive Disorder|obsessive compulsive disorder
4834040|NCT02422290|Ketamine|ketamine
4834041|NCT02422290|Glutamate|glutamate
4834042|NCT02422290|OCD treatment|ocd treatment
4834043|NCT02422290|OCD medication|ocd medication
4834044|NCT02422277|Cystoprostatectomy|cystoprostatectomy
4834045|NCT02422277|Sexual function|sexual function
4834046|NCT02422277|Phosphodiestrase 5 inhibitors|phosphodiestrase 5 inhibitors
4834047|NCT02422277|Low intensity extracorporeal shock wave therapy|low intensity extracorporeal shock wave therapy
4834048|NCT02422277|Erectile dysfunction|erectile dysfunction
4834049|NCT02422277|Penile rehabilitation|penile rehabilitation
4834050|NCT02422212|metabolism|metabolism
4834051|NCT02422212|Diet Induced Thermogenesis|diet induced thermogenesis
4834052|NCT02422212|weight regain|weight regain
4834053|NCT02422212|energy expenditure|energy expenditure
4834054|NCT02422212|bariatric|bariatric
4834055|NCT02422186|Depressive Disorder, Treatment-Resistant|depressive disorder, treatment-resistant
4834056|NCT02422186|Esketamine|esketamine
4834057|NCT02422186|Oral Antidepressant|oral antidepressant
4834058|NCT02422186|Elderly Participants|elderly participants
4834059|NCT02422134|Pregnancy|pregnancy
4834060|NCT02422134|implantation|implantation
4834061|NCT02422134|Cytokine|cytokine
4834062|NCT02422108|RANKL|rankl
4834063|NCT02422082|Osteopenia|osteopenia
4834064|NCT02422082|Lactobacillus reuteri|lactobacillus reuteri
4834065|NCT02422082|Volumetric bone mineral density|volumetric bone mineral density
4834066|NCT02422056|Cleft Palate|cleft palate
4834067|NCT02422056|Hemorrhage|hemorrhage
4834068|NCT02422056|Palatoplasty|palatoplasty
4834069|NCT02422043|adolescence|adolescence
4834070|NCT02422030|Male Volunteers|male volunteers
4834071|NCT02422017|Leg ulcer|leg ulcer
4834072|NCT02422017|wound|wound
4834073|NCT02422017|topical timolol|topical timolol
4834074|NCT02422004|Rehabilitation|rehabilitation
4834075|NCT02422004|Weight-bearing|weight-bearing
4834076|NCT02422004|Range of motion|range of motion
4834077|NCT02421978|Cognitive dysfunction|cognitive dysfunction
4834078|NCT02421978|Inflammation|inflammation
4834079|NCT02421978|Fatigue|fatigue
4834080|NCT02421978|Decreased motivation|decreased motivation
4834081|NCT02421965|Schizophrenia|schizophrenia
4834082|NCT02421965|Schizoaffective Disorder|schizoaffective disorder
4834083|NCT02421965|Bipolar Disorder|bipolar disorder
4834084|NCT02421965|Major Depressive Disorder|major depressive disorder
4834085|NCT02421965|Mobile Application|mobile application
4834086|NCT02421965|Smartphone|smartphone
4834087|NCT02421965|SMI|smi
4834088|NCT02421965|Illness Self-Management|illness self-management
4834089|NCT02421965|EHealth|ehealth
4834090|NCT02421965|E-Health|e-health
4834091|NCT02421965|Health Technology|health technology
4834092|NCT02421965|mHealth|mhealth
4834093|NCT02421965|m-Health|m-health
4834094|NCT02421939|ASP2215|asp2215
4834095|NCT02421939|Relapsed Acute Myeloid Leukemia|relapsed acute myeloid leukemia
4834096|NCT02421939|FLT3 Mutation|flt3 mutation
4834097|NCT02421939|gilteritinib|gilteritinib
4834098|NCT02421939|Refractory Acute Myeloid Leukemia|refractory acute myeloid leukemia
4834099|NCT02421939|Acute Myeloid Leukemia (AML)|acute myeloid leukemia (aml)
4834100|NCT02421874|Patient care team|patient care team
4834101|NCT02421874|Care management|care management
4834102|NCT02421874|Electronic health records|electronic health records
4834103|NCT02421861|anxiety|anxiety
4834104|NCT02421861|intensive care unit|intensive care unit
4834105|NCT02421861|critical care|critical care
4834106|NCT02421848|Body composition|body composition
4834107|NCT02421848|Sarcopenia|sarcopenia
4834108|NCT02421848|Cirrhotic with Ascites|cirrhotic with ascites
4834109|NCT02421796|n Non-Celiac Wheat Sensitivity|n non-celiac wheat sensitivity
4834110|NCT02421796|Malnutrition|malnutrition
4834111|NCT02421796|Celiac disease|celiac disease
4834112|NCT02421796|Irritable Bowel Syndrome|irritable bowel syndrome
4834113|NCT02421783|Non-celiac wheat sensitivity|non-celiac wheat sensitivity
4834114|NCT02421783|Multiple food allergy|multiple food allergy
4834115|NCT02421783|Body mass index|body mass index
4834116|NCT02421783|Osteoporosis|osteoporosis
4834117|NCT02421757|Transcutaneous Magnetic Stimulation|transcutaneous magnetic stimulation
4834118|NCT02421757|placebo|placebo
4834119|NCT02421744|rehabilitation|rehabilitation
4834120|NCT02421744|Multiple Sclerosis|multiple sclerosis
4834121|NCT02421744|mobility|mobility
4834122|NCT02421744|gait|gait
4834123|NCT02421744|task-oriented training|task-oriented training
4834124|NCT02421731|Rehabilitation|rehabilitation
4834125|NCT02421731|Gait|gait
4834126|NCT02421718|Acute toxicity|acute toxicity
4834127|NCT02421718|Late toxicity|late toxicity
4834128|NCT02421718|Prediction models|prediction models
4834129|NCT02421679|PTSD|ptsd
4834130|NCT02421679|Military-related PTSD and other related conditions|military-related ptsd and other related conditions
4834131|NCT02421679|open-label extension|open-label extension
4834132|NCT02421653|Micronutrient powders|micronutrient powders
4834134|NCT02421653|Weaning|weaning
4834135|NCT02421653|Home fortification|home fortification
4834136|NCT02421653|Iodine|iodine
4834137|NCT02421653|Iodine deficiency|iodine deficiency
4834138|NCT02421653|Iodine Deficiency Disorder|iodine deficiency disorder
4834139|NCT02421653|IDD|idd
4834140|NCT02421653|Infant|infant
4834141|NCT02421653|Growth|growth
4834142|NCT02421653|Iodised oil|iodised oil
4834143|NCT02421627|moxibustion|moxibustion
4834144|NCT02421627|irritable bowel syndrome|irritable bowel syndrome
4834145|NCT02421627|Magnetic Resonance Imaging|magnetic resonance imaging
4834146|NCT02421614|acute respiratory failure|acute respiratory failure
4834147|NCT02421614|lung|lung
4834148|NCT02421614|enteral feeding|enteral feeding
4834149|NCT02421614|feeding composition|feeding composition
4834150|NCT02421614|olive|olive
4834151|NCT02421614|high fat|high fat
4834152|NCT02421549|Remote Monitoring|remote monitoring
4834153|NCT02421549|Remote Care|remote care
4834154|NCT02421549|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
4834155|NCT02421549|Pacemaker|pacemaker
4834156|NCT02421549|Implantable Cardioverter Defibrillator|implantable cardioverter defibrillator
4834157|NCT02421523|Exercise|exercise
4834158|NCT02421523|Strength training|strength training
4834159|NCT02421510|High level of sugar (glucose) in the blood|high level of sugar (glucose) in the blood
4834160|NCT02421484|Phase I clinical trial|phase i clinical trial
4834161|NCT02421484|stem cell|stem cell
4834162|NCT02421484|mesenchymal stromal cell|mesenchymal stromal cell
4834163|NCT02421484|mesenchymal stem cell|mesenchymal stem cell
4834164|NCT02421471|Actinic Keratosis|actinic keratosis
4834165|NCT02421471|topical treatment|topical treatment
4834166|NCT02421471|ingenol mebutate|ingenol mebutate
4834167|NCT02421432|trananal TME|trananal tme
4834168|NCT02421432|safety|safety
4834169|NCT02421432|efficacy|efficacy
4834170|NCT02421432|difficult cases|difficult cases
4834171|NCT02421419|flexor tendon entrapment|flexor tendon entrapment
4834172|NCT02421419|snapping finger|snapping finger
4834173|NCT02421419|trigger digits|trigger digits
4834174|NCT02421419|trigger thumb|trigger thumb
4834175|NCT02421393|Bone quality|bone quality
4834176|NCT02421393|Bone strength|bone strength
4834177|NCT02421393|Fractures|fractures
4834178|NCT02421393|Muscle strength|muscle strength
4834179|NCT02421393|Gait and balance|gait and balance
4834180|NCT02421393|Musculo-skeletal symptoms|musculo-skeletal symptoms
4834181|NCT02421393|Falls|falls
4834182|NCT02421380|Hyperpolarized Pyruvate|hyperpolarized pyruvate
4834183|NCT02421380|MRI|mri
4834184|NCT02421380|14-205|14-205
4834185|NCT02421354|Myeloproliferative Diseases|myeloproliferative diseases
4834186|NCT02421354|Post-Essential Thrombocythemia Myelofibrosis|post-essential thrombocythemia myelofibrosis
4834187|NCT02421354|Post-Polycythemia Vera Myelofibrosis|post-polycythemia vera myelofibrosis
4834188|NCT02421354|MF|mf
4834189|NCT02421354|Nivolumab|nivolumab
4834190|NCT02421354|BMS-936558|bms-936558
4834191|NCT02421354|Questionnaire|questionnaire
4834192|NCT02421354|Survey|survey
4834193|NCT02421354|Phone call|phone call
4834194|NCT02421341|Heart, Cardiovascular|heart, cardiovascular
4834195|NCT02421341|Pulmonary|pulmonary
4834196|NCT02421341|Skeletal Muscle|skeletal muscle
4834197|NCT02421341|Exercise|exercise
4834198|NCT02421315|OCD|ocd
4834199|NCT02421315|Functional Magnetic Resonance Imaging (fMRI)|functional magnetic resonance imaging (fmri)
4834200|NCT02421315|Magnetic Resonance Imaging (MRI)|magnetic resonance imaging (mri)
4834201|NCT02421289|CYP2B6 polymorphism|cyp2b6 polymorphism
4834202|NCT02421289|efavirenz|efavirenz
4834203|NCT02421289|Thai|thai
4834204|NCT02421289|HIV-infected patient|hiv-infected patient
4834205|NCT02421289|pharmacogenomic|pharmacogenomic
4834206|NCT02421263|Psilocybin|psilocybin
4834207|NCT02421263|Pharmacologic Actions|pharmacologic actions
4834208|NCT02421263|Psychotropic Drugs|psychotropic drugs
4834209|NCT02421224|Smoking Cessation|smoking cessation
4834210|NCT02421224|Incentives|incentives
4834211|NCT02421224|Health Behavior|health behavior
4834212|NCT02421224|Smoking|smoking
4834213|NCT02421224|Work-site|work-site
4834214|NCT02421211|Hepatitis C, Chronic|hepatitis c, chronic
4834215|NCT02421211|Simeprevir|simeprevir
4834216|NCT02421211|Ledipasvir|ledipasvir
4834217|NCT02421211|Sofosbuvir|sofosbuvir
4834218|NCT02421198|Intervention Studies|intervention studies
4834219|NCT02421185|Carcinoma, Hepatocellular|carcinoma, hepatocellular
4834220|NCT02421185|JNJ 42756493|jnj 42756493
4834221|NCT02421185|a pan-Fibroblast Growth Factor Receptor Tyrosine Kinase Inhibitor|a pan-fibroblast growth factor receptor tyrosine kinase inhibitor
4834222|NCT02421172|Hidradenitis Suppurativa|hidradenitis suppurativa
4834223|NCT02421159|HIV/AIDS|hiv/aids
4834224|NCT02421159|vulnerable populations|vulnerable populations
4834225|NCT02421159|heterosexuals at high risk|heterosexuals at high risk
4834226|NCT02421159|peer-driven intervention|peer-driven intervention
4834227|NCT02421159|tailored intervention|tailored intervention
4834228|NCT02421159|African-American|african-american
4834229|NCT02421159|Latino/Hispanic|latino/hispanic
4834230|NCT02421159|Seek, test, treat, and retain (STTR)|seek, test, treat, and retain (sttr)
4834231|NCT02421159|Brooklyn|brooklyn
4834232|NCT02421133|Care transition program|care transition program
4834233|NCT02421133|Patient readmission|patient readmission
4834234|NCT02421133|Transition Nurse|transition nurse
4834235|NCT02421133|Stepped wedge|stepped wedge
4834237|NCT02421081|CD34|cd34
4834238|NCT02421081|CD133|cd133
4834239|NCT02421081|CD309|cd309
4834240|NCT02421081|Radial Artery|radial artery
4834241|NCT02421081|Ulnar Artery|ulnar artery
4834242|NCT02421081|Lymphoid Cell|lymphoid cell
4834243|NCT02421081|blood levels|blood levels
4834244|NCT02421081|endothelial progenitor cells|endothelial progenitor cells
4834245|NCT02421081|stem cells|stem cells
4834246|NCT02421068|Paracetamol|paracetamol
4834247|NCT02421068|Fentanyl|fentanyl
4834248|NCT02421068|Phenobarbital|phenobarbital
4834249|NCT02421068|Doxapram|doxapram
4834250|NCT02421068|Midazolam|midazolam
4834251|NCT02421068|Sildenafil|sildenafil
4834252|NCT02421068|Levetiracetam|levetiracetam
4834253|NCT02421068|Pharmacokinetics|pharmacokinetics
4834254|NCT02421068|Pharmacology|pharmacology
4834255|NCT02421068|Fluconazole|fluconazole
4834256|NCT02421068|Ibuprofen|ibuprofen
4834257|NCT02421055|Bariatric Surgery|bariatric surgery
4834258|NCT02421055|Gastric Bypass|gastric bypass
4834259|NCT02421055|Sleeve Gastrectomy|sleeve gastrectomy
4834260|NCT02421055|Gastroplasty|gastroplasty
4834261|NCT02421042|Hepatic Impairment|hepatic impairment
4834262|NCT02421042|Hepatic Function|hepatic function
4834263|NCT02421029|gadolinium|gadolinium
4834264|NCT02421029|calcium disodium ethylenediaminetetraacetic acid (EDTA)|calcium disodium ethylenediaminetetraacetic acid (edta)
4834265|NCT02421029|heavy metal toxicity|heavy metal toxicity
4834266|NCT02421016|De novo stenosis|de novo stenosis
4834267|NCT02421016|bioresorbable polymer coating|bioresorbable polymer coating
4834268|NCT02421016|bioresorbable polymer backbone|bioresorbable polymer backbone
4834269|NCT02421003|heart surgery blood|heart surgery blood
4834270|NCT02420990|ADHD|adhd
4834271|NCT02420990|Adolescents|adolescents
4834272|NCT02420990|Substance Use Disorders|substance use disorders
4834273|NCT02420977|radiotracer|radiotracer
4834274|NCT02420964|injectable|injectable
4834275|NCT02420964|teaching methods|teaching methods
4834276|NCT02420951|Knee|knee
4834277|NCT02420951|Arthroplasty|arthroplasty
4834278|NCT02420951|Bupivacaine|bupivacaine
4834279|NCT02420951|Anesthetics, Local|anesthetics, local
4834280|NCT02420938|Leukemia|leukemia
4834281|NCT02420938|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
4834282|NCT02420938|CLL|cll
4834283|NCT02420938|Small Lymphocytic Lymphoma|small lymphocytic lymphoma
4834284|NCT02420938|SLL|sll
4834285|NCT02420938|Refractory/relapsed|refractory/relapsed
4834286|NCT02420938|High-risk molecular features|high-risk molecular features
4834287|NCT02420938|Rituximab|rituximab
4834288|NCT02420938|Rituxan|rituxan
4834289|NCT02420938|Urelumab|urelumab
4834290|NCT02420925|Gastroparesis|gastroparesis
4834291|NCT02420925|Celiac Plexus Block|celiac plexus block
4834292|NCT02420912|Leukemia|leukemia
4834293|NCT02420912|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
4834294|NCT02420912|CLL|cll
4834295|NCT02420912|Relapsed|relapsed
4834296|NCT02420912|Refractory|refractory
4834297|NCT02420912|High-risk|high-risk
4834298|NCT02420912|Untreated|untreated
4834299|NCT02420912|Nivolumab|nivolumab
4834300|NCT02420912|BMS-936558|bms-936558
4834301|NCT02420912|Opdivo|opdivo
4834302|NCT02420912|Ibrutinib|ibrutinib
4834303|NCT02420912|PCI-32765|pci-32765
4834304|NCT02420912|Imbruvica|imbruvica
4834305|NCT02420899|IVUS|ivus
4834306|NCT02420899|ACS|acs
4834307|NCT02420886|In Vitro culture of human embryos|in vitro culture of human embryos
4834308|NCT02420873|Leukemia|leukemia
4834309|NCT02420873|Hematological malignancy|hematological malignancy
4834310|NCT02420873|Myelofibrosis|myelofibrosis
4834311|NCT02420873|MF|mf
4834312|NCT02420873|Blastic plasmacytoid dendritic cell neoplasm|blastic plasmacytoid dendritic cell neoplasm
4834313|NCT02420873|BPDCN|bpdcn
4834314|NCT02420873|CD56 tumor marker|cd56 tumor marker
4834315|NCT02420873|Acute myeloid leukemia|acute myeloid leukemia
4834316|NCT02420873|AML|aml
4834317|NCT02420873|Natural-killer leukemia|natural-killer leukemia
4834318|NCT02420873|Acute lymphoblastic leukemia|acute lymphoblastic leukemia
4834319|NCT02420873|ALL|all
4834320|NCT02420873|CD56 expressing hematological malignancy|cd56 expressing hematological malignancy
4834321|NCT02420873|IMGN901|imgn901
4834322|NCT02420873|Lorvotuzumab mertansine|lorvotuzumab mertansine
4834323|NCT02420860|Myeloma|myeloma
4834324|NCT02420860|Multiple myeloma|multiple myeloma
4834325|NCT02420860|MM|mm
4834326|NCT02420860|Post autologous stem cell transplantation|post autologous stem cell transplantation
4834327|NCT02420860|ASCT|asct
4834328|NCT02420860|Elotuzumab|elotuzumab
4834329|NCT02420860|Lenalidomide|lenalidomide
4834330|NCT02420860|CC-5013|cc-5013
4834331|NCT02420860|Revlimid|revlimid
4834332|NCT02420860|Dexamethasone|dexamethasone
4834333|NCT02420860|Decadron|decadron
4834334|NCT02420860|Diphenhydramine|diphenhydramine
4834335|NCT02420860|Benadryl|benadryl
4834336|NCT02420860|Ranitidine|ranitidine
4834337|NCT02420860|Ranitidine hydrochloride|ranitidine hydrochloride
4834338|NCT02420860|Zantac|zantac
4834339|NCT02420860|Symptom questionnaire|symptom questionnaire
4834340|NCT02420860|Survey|survey
4834341|NCT02420847|Bladder cancer|bladder cancer
4834342|NCT02420847|Urothelial cancer|urothelial cancer
4834343|NCT02420847|Transitional cell carcinoma of the urothelium|transitional cell carcinoma of the urothelium
4834344|NCT02420847|Metastatic|metastatic
4834345|NCT02420847|Locally unresectable|locally unresectable
4834346|NCT02420847|Ixazomib|ixazomib
4834347|NCT02420847|Gemcitabine|gemcitabine
4834348|NCT02420847|Gemcitabine hydrochloride|gemcitabine hydrochloride
4834349|NCT02420847|Gemzar|gemzar
4834350|NCT02420847|Doxorubicin|doxorubicin
4834351|NCT02420847|Doxorubicin hydrochloride|doxorubicin hydrochloride
4834352|NCT02420847|Adriamycin PFS|adriamycin pfs
4834353|NCT02420847|Adriamycin RDF|adriamycin rdf
4834354|NCT02420847|Adriamycin|adriamycin
4834355|NCT02420847|Rubex|rubex
4834356|NCT02420808|CAD|cad
4834357|NCT02420808|STEMI|stemi
4834358|NCT02420808|non STEMI|non stemi
4834359|NCT02420808|Unstable angina|unstable angina
4834360|NCT02420808|Greece|greece
4834361|NCT02420795|Lymphoma|lymphoma
4834362|NCT02420795|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
4834363|NCT02420795|Relapsed/Refractory|relapsed/refractory
4834364|NCT02420795|NHL|nhl
4834365|NCT02420795|Mantle cell lymphoma|mantle cell lymphoma
4834366|NCT02420795|MCL|mcl
4834367|NCT02420795|Diffuse large B-cell lymphoma|diffuse large b-cell lymphoma
4834368|NCT02420795|DLBCL|dlbcl
4834369|NCT02420795|Transformed large cell lymphoma|transformed large cell lymphoma
4834370|NCT02420795|TLCL|tlcl
4834371|NCT02420795|ONC201|onc201
4834372|NCT02420795|Phone call|phone call
4834373|NCT02420782|Pharmacokinetics|pharmacokinetics
4834374|NCT02420782|ASP6282|asp6282
4834375|NCT02420782|Pharmacodynamics|pharmacodynamics
4834376|NCT02420782|Drug-drug interaction|drug-drug interaction
4834377|NCT02420782|Midazolam|midazolam
4834378|NCT02420782|Safety and tolerability|safety and tolerability
4834379|NCT02420782|Healthy volunteers|healthy volunteers
4834380|NCT02420782|Itraconazole|itraconazole
4834381|NCT02420769|CA 125|ca 125
4834382|NCT02420769|Progesterone|progesterone
4834383|NCT02420769|Doppler|doppler
4834384|NCT02420769|Corpus Luteum|corpus luteum
4834385|NCT02420743|PTD|ptd
4834386|NCT02420717|Leukemia|leukemia
4834387|NCT02420717|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
4834388|NCT02420717|ALL|all
4834389|NCT02420717|Philadelphia Chromosome (Ph)-Like|philadelphia chromosome (ph)-like
4834390|NCT02420717|Relapsed|relapsed
4834391|NCT02420717|Refractory|refractory
4834392|NCT02420717|6-mercaptopurine|6-mercaptopurine
4834393|NCT02420717|Mercaptopurine|mercaptopurine
4834394|NCT02420717|6-MP|6-mp
4834395|NCT02420717|Purinethol|purinethol
4834396|NCT02420717|Ruxolitinib|ruxolitinib
4834397|NCT02420717|Jakafi|jakafi
4834398|NCT02420717|INCB018424|incb018424
4834399|NCT02420717|INC424|inc424
4834400|NCT02420717|Dasatinib|dasatinib
4834401|NCT02420717|BMS-354825|bms-354825
4834402|NCT02420717|Sprycel|sprycel
4834403|NCT02420717|Rituximab|rituximab
4834404|NCT02420717|Rituxan|rituxan
4834405|NCT02420717|G-CSF|g-csf
4834406|NCT02420717|Filgrastim|filgrastim
4834407|NCT02420717|Neupogen|neupogen
4834408|NCT02420717|Pegfilgrastim|pegfilgrastim
4834409|NCT02420717|Neulasta|neulasta
4834410|NCT02420717|PEG-G-CSF|peg-g-csf
4834411|NCT02420717|Methotrexate|methotrexate
4834412|NCT02420717|Cytarabine|cytarabine
4834413|NCT02420717|Ara-C|ara-c
4834414|NCT02420717|Cytosar|cytosar
4834415|NCT02420717|DepoCyt|depocyt
4834416|NCT02420717|Cytosine|cytosine
4834417|NCT02420717|Arabinosine Hydrochloride|arabinosine hydrochloride
4834418|NCT02420717|Cyclophosphamide|cyclophosphamide
4834419|NCT02420717|Cytoxan|cytoxan
4834420|NCT02420717|Neosar|neosar
4834421|NCT02420717|Mesna|mesna
4834422|NCT02420717|Mesnex|mesnex
4834423|NCT02420717|Doxorubicin|doxorubicin
4834424|NCT02420717|Doxorubucin hydrochloride|doxorubucin hydrochloride
4834425|NCT02420717|Adriamycin PFS|adriamycin pfs
4834426|NCT02420717|Adriamycin RDF|adriamycin rdf
4834427|NCT02420717|Adriamycin|adriamycin
4834428|NCT02420717|Rubex|rubex
4834429|NCT02420717|Vincristine|vincristine
4834430|NCT02420717|Dexamethasone|dexamethasone
4834431|NCT02420717|Decadron|decadron
4834432|NCT02420717|Solumedrol|solumedrol
4834433|NCT02420717|Methylprednisolone|methylprednisolone
4834434|NCT02420717|Depo-medrol|depo-medrol
4834435|NCT02420717|Medrol|medrol
4834436|NCT02420717|Solu-medrol|solu-medrol
4834437|NCT02420717|Prednisone|prednisone
4834438|NCT02420717|Leucovorin|leucovorin
4834439|NCT02420717|Citrovorum|citrovorum
4834440|NCT02420717|Wellcovorin|wellcovorin
4834441|NCT02420704|IVF|ivf
4834442|NCT02420704|endometrial thickness|endometrial thickness
4834443|NCT02420704|cleavage stage embryo|cleavage stage embryo
4834444|NCT02420704|blastocyst stage embryo|blastocyst stage embryo
4834445|NCT02420704|Ongoing pregnancy rate|ongoing pregnancy rate
4834446|NCT02420691|Gastrointestinal cancer|gastrointestinal cancer
4834447|NCT02420691|Foregut neuroendocrine tumors|foregut neuroendocrine tumors
4834448|NCT02420691|NET|net
4834449|NCT02420691|Thymic|thymic
4834450|NCT02420691|Bronchopulmonary|bronchopulmonary
4834451|NCT02420691|Gastric|gastric
4834452|NCT02420691|Duodenal|duodenal
4834453|NCT02420691|Pancreatic|pancreatic
4834454|NCT02420691|LEE011|lee011
4834455|NCT02420665|Cervical Cancer|cervical cancer
4834456|NCT02420665|Cervical Dysplasia|cervical dysplasia
4834457|NCT02420665|Abnormal Pap test|abnormal pap test
4834458|NCT02420665|Positive human papillomavirus test|positive human papillomavirus test
4834459|NCT02420665|HPV|hpv
4834460|NCT02420665|Visual inspection with acetic acid|visual inspection with acetic acid
4834461|NCT02420665|VIA|via
4834462|NCT02420665|Colposcopy|colposcopy
4834463|NCT02420665|Proflavine|proflavine
4834464|NCT02420665|Acetic acid|acetic acid
4834465|NCT02420665|High-Resolution Microendoscopy|high-resolution microendoscopy
4834466|NCT02420665|HRME|hrme
4834467|NCT02420665|Phone call|phone call
4834468|NCT02420613|Diffuse Intrinsic Pontine Glioma|diffuse intrinsic pontine glioma
4834469|NCT02420613|DIPG|dipg
4834470|NCT02420613|Newly Diagnosed|newly diagnosed
4834471|NCT02420613|Progressive|progressive
4834472|NCT02420613|Pediatrics|pediatrics
4834473|NCT02420613|Vorinostat|vorinostat
4834474|NCT02420613|SAHA|saha
4834475|NCT02420613|Suberoylanilide Hydroxamic Acid|suberoylanilide hydroxamic acid
4834476|NCT02420613|MSK-390|msk-390
4834477|NCT02420613|Zolinza|zolinza
4834478|NCT02420613|Temsirolimus|temsirolimus
4834479|NCT02420613|CCI-779|cci-779
4834480|NCT02420613|Torisel|torisel
4834481|NCT02420613|Radiation therapy|radiation therapy
4834482|NCT02420613|XRT|xrt
4834483|NCT02420600|Circulating tumor cells|circulating tumor cells
4834484|NCT02420600|Head and neck cancer|head and neck cancer
4834485|NCT02420600|PD-1|pd-1
4834486|NCT02420600|natural killer cells|natural killer cells
4834487|NCT02420600|cytotoxic T lymphocytes|cytotoxic t lymphocytes
4834488|NCT02420587|Prostate Cancer|prostate cancer
4834489|NCT02420587|Adenocarcinoma of the prostate|adenocarcinoma of the prostate
4834490|NCT02420587|Castration resistant prostate cancer metastatic to bone|castration resistant prostate cancer metastatic to bone
4834491|NCT02420587|mCRPC|mcrpc
4834492|NCT02420587|AMG 208|amg 208
4834493|NCT02420587|Questionnaire|questionnaire
4834494|NCT02420587|Survey|survey
4834495|NCT02420561|Depression|depression
4834496|NCT02420561|Substance-Related Disorders|substance-related disorders
4834497|NCT02420561|Mental Health|mental health
4834498|NCT02420535|Dementia|dementia
4834499|NCT02420535|Alzheimer's Disease|alzheimer's disease
4834500|NCT02420535|Caregivers|caregivers
4834501|NCT02420535|Behavioral|behavioral
4834502|NCT02420535|Caregiver burden|caregiver burden
4834503|NCT02420496|Parental nutrition|parental nutrition
4834504|NCT02420496|associated|associated
4834505|NCT02420470|diabetes|diabetes
4834506|NCT02420470|neural and vessel alteration|neural and vessel alteration
4834507|NCT02420470|prodromal stage|prodromal stage
4834508|NCT02420457|Fitness devices|fitness devices
4834609|NCT02419859|Insulin pumps|insulin pumps
4834509|NCT02420418|Tobacco use disorder and bipolar disorders|tobacco use disorder and bipolar disorders
4834510|NCT02420418|N-acetylcysteine|n-acetylcysteine
4834511|NCT02420418|Oxidative stress|oxidative stress
4834512|NCT02420418|inflammation|inflammation
4834513|NCT02420405|Gene testing|gene testing
4834514|NCT02420405|Endobronchial ultrasound (EBUS)|endobronchial ultrasound (ebus)
4834515|NCT02420405|Next-generation sequencing (NGS)|next-generation sequencing (ngs)
4834516|NCT02420405|Small biopsies|small biopsies
4834517|NCT02420379|DMD|dmd
4834518|NCT02420379|Duchenne muscular dystrophy|duchenne muscular dystrophy
4834519|NCT02420379|eteplirsen|eteplirsen
4834520|NCT02420379|Dystrophin|dystrophin
4834521|NCT02420379|exon 51|exon 51
4834522|NCT02420353|muscle atrophy|muscle atrophy
4834523|NCT02420353|growth hormone|growth hormone
4834524|NCT02420353|ACL tear|acl tear
4834525|NCT02420340|Serious Mental Illness|serious mental illness
4834526|NCT02420340|Psychosocial Rehabilitation|psychosocial rehabilitation
4834527|NCT02420327|nicotine|nicotine
4834528|NCT02420327|galantamine|galantamine
4834529|NCT02420327|attention|attention
4834530|NCT02420327|cognition|cognition
4834531|NCT02420327|non-smoker|non-smoker
4834532|NCT02420314|Ascorbate|ascorbate
4834533|NCT02420314|Ascorbic acid|ascorbic acid
4834534|NCT02420314|Vitamin C|vitamin c
4834535|NCT02420314|NSCLC|nsclc
4834536|NCT02420314|Non Small Cell Lung Cancer|non small cell lung cancer
4834537|NCT02420314|carboplatin|carboplatin
4834538|NCT02420314|paclitaxel|paclitaxel
4834539|NCT02420288|Pregnancy|pregnancy
4834540|NCT02420288|Fetoplacental growth|fetoplacental growth
4834541|NCT02420288|Physical exercise|physical exercise
4834542|NCT02420288|Pregnant|pregnant
4834543|NCT02420288|Placental development|placental development
4834544|NCT02420288|Active pregnancy|active pregnancy
4834545|NCT02420275|brain injury|brain injury
4834546|NCT02420275|blue enriched withe bright light therapy|blue enriched withe bright light therapy
4834547|NCT02420275|sequel fatigue|sequel fatigue
4834548|NCT02420236|Exercise therapy|exercise therapy
4834549|NCT02420236|Resistance training|resistance training
4834550|NCT02420236|Multidisciplinary treatment|multidisciplinary treatment
4834551|NCT02420223|Recipients|recipients
4834552|NCT02420197|Exercise therapy|exercise therapy
4834553|NCT02420197|Resistance training|resistance training
4834554|NCT02420197|Multidisciplinary treatment|multidisciplinary treatment
4834555|NCT02420171|In Vitro|in vitro
4834556|NCT02420171|embryo quality|embryo quality
4834557|NCT02420171|Intracytoplasmic sperm injection|intracytoplasmic sperm injection
4834558|NCT02420158|Irritable Bowel Syndrome|irritable bowel syndrome
4834559|NCT02420158|Vagal nerve stimulation|vagal nerve stimulation
4834560|NCT02420158|Quality of life|quality of life
4834561|NCT02420119|Iron Therapy|iron therapy
4834562|NCT02420119|serum phosphates|serum phosphates
4834563|NCT02420119|vitamin D|vitamin d
4834564|NCT02420106|cervical dystonia|cervical dystonia
4834565|NCT02420106|neck pain|neck pain
4834566|NCT02420106|OMM|omm
4834567|NCT02420106|spasmodic torticollis|spasmodic torticollis
4834568|NCT02420067|von Hippel-Lindau disease|von hippel-lindau disease
4834569|NCT02420067|Endolymphatic sac tumors|endolymphatic sac tumors
4834570|NCT02420067|Audiological examination|audiological examination
4834571|NCT02420067|MRI|mri
4834572|NCT02420067|Surveillance|surveillance
4834573|NCT02420054|intermittent fasting|intermittent fasting
4834574|NCT02420054|alternate day fasting|alternate day fasting
4834575|NCT02420054|diabetes mellitus|diabetes mellitus
4834576|NCT02420054|non-alcoholic fatty liver disease|non-alcoholic fatty liver disease
4834577|NCT02420054|insulin sensitivity|insulin sensitivity
4834578|NCT02420041|Sacroiliac Joint Injection|sacroiliac joint injection
4834579|NCT02420041|Fluoroscopy|fluoroscopy
4834580|NCT02420041|Ultrasound|ultrasound
4834581|NCT02419989|Nontuberculous Mycobacteria|nontuberculous mycobacteria
4834582|NCT02419963|microbiome|microbiome
4834583|NCT02419963|biomarkers|biomarkers
4834584|NCT02419963|Vitamin D|vitamin d
4834585|NCT02419963|Serotonin|serotonin
4834586|NCT02419950|inguinal hernia|inguinal hernia
4834587|NCT02419950|TEP|tep
4834588|NCT02419950|chronic pain|chronic pain
4834589|NCT02419950|male sex|male sex
4834590|NCT02419950|mesh fixation|mesh fixation
4834591|NCT02419950|quality of life|quality of life
4834592|NCT02419950|national register|national register
4834593|NCT02419911|gastrointestinal|gastrointestinal
4834594|NCT02419911|gynecologic|gynecologic
4834595|NCT02419911|urologic|urologic
4834596|NCT02419911|bariatric|bariatric
4834597|NCT02419911|laparoscopic surgery|laparoscopic surgery
4834598|NCT02419898|Feasibility|feasibility
4834599|NCT02419885|finger amputation|finger amputation
4834600|NCT02419885|composite graft|composite graft
4834601|NCT02419885|adipo-fascia flap|adipo-fascia flap
4834602|NCT02419859|Diabetes Mellitus|diabetes mellitus
4834603|NCT02419859|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
4834604|NCT02419859|Glucose Metabolism Disorders|glucose metabolism disorders
4834605|NCT02419859|Metabolic Diseases|metabolic diseases
4834606|NCT02419859|Endocrine System Diseases|endocrine system diseases
4834607|NCT02419859|Insulin|insulin
4834608|NCT02419859|Continuous subcutaneous insulin infusion (CSII)|continuous subcutaneous insulin infusion (csii)
4834610|NCT02419846|Informed Decision Making|informed decision making
4834611|NCT02419846|Prostate|prostate
4834612|NCT02419846|Cancer|cancer
4834613|NCT02419833|non-STEMI|non-stemi
4834614|NCT02419833|immediate|immediate
4834615|NCT02419833|delayed|delayed
4834616|NCT02419833|PCI|pci
4834617|NCT02419807|Near Infrared Fluorescence Imaging|near infrared fluorescence imaging
4834618|NCT02419807|Indocyanine Green|indocyanine green
4834619|NCT02419807|axillary lymph node mapping|axillary lymph node mapping
4834620|NCT02419807|Mastectomy, Segmental|mastectomy, segmental
4834621|NCT02419807|Sentinel Lymph Node Biopsy|sentinel lymph node biopsy
4834622|NCT02419807|Lumpectomy|lumpectomy
4834623|NCT02419768|Long-range autocorrelations|long-range autocorrelations
4834624|NCT02419768|Variability|variability
4834625|NCT02419768|Physical Exercise|physical exercise
4834626|NCT02419768|Parkinson's Disease|parkinson's disease
4834627|NCT02419768|ICF|icf
4834628|NCT02419755|Infant leukemia|infant leukemia
4834629|NCT02419755|ALL|all
4834630|NCT02419755|AML|aml
4834631|NCT02419755|Biphenotypic leukemia|biphenotypic leukemia
4834632|NCT02419755|Pediatric|pediatric
4834633|NCT02419729|Vulvovaginal atrophy|vulvovaginal atrophy
4834634|NCT02419729|Menopause|menopause
4834635|NCT02419729|Fractional CO2 laser|fractional co2 laser
4834636|NCT02419729|Estrogen cream|estrogen cream
4834637|NCT02419716|colorectal cancer|colorectal cancer
4834638|NCT02419716|Colorectal cancer screening|colorectal cancer screening
4834639|NCT02419677|radiofrequency ablation|radiofrequency ablation
4834640|NCT02419677|cytokine-induced killer cells|cytokine-induced killer cells
4834641|NCT02419677|colorectal cancer iver metastases|colorectal cancer iver metastases
4834642|NCT02419664|pituitary|pituitary
4834643|NCT02419664|pituitary adenomas|pituitary adenomas
4834644|NCT02419664|Ga-PET|ga-pet
4834645|NCT02419664|Acromegaly|acromegaly
4834646|NCT02419664|TSHomas|tshomas
4834647|NCT02419664|Cushing|cushing
4834648|NCT02419651|out patient hysteroscopy|out patient hysteroscopy
4834649|NCT02419638|relapsing-remitting MS|relapsing-remitting ms
4834650|NCT02419638|lesions|lesions
4834651|NCT02419638|treatment|treatment
4834652|NCT02419573|cardiac arrest|cardiac arrest
4834653|NCT02419573|cardiopulmonary resuscitation|cardiopulmonary resuscitation
4834654|NCT02419573|laryngeal tube|laryngeal tube
4834655|NCT02419573|endotracheal intubation|endotracheal intubation
4834656|NCT02419573|non-traumatic Out of Hospital Cardiac Arrest (OOHCA)|non-traumatic out of hospital cardiac arrest (oohca)
4834657|NCT02419560|Relapsed|relapsed
4834658|NCT02419560|Laboratory biomarker research|laboratory biomarker research
4834659|NCT02419560|Pharmacologic study|pharmacologic study
4834660|NCT02419560|Bruton's tyrosine kinase inhibitor|bruton's tyrosine kinase inhibitor
4834661|NCT02419560|BCL-2 inhibitor|bcl-2 inhibitor
4834662|NCT02419547|Ventricular tachycardia|ventricular tachycardia
4834663|NCT02419547|ventricular tachycardia ablation|ventricular tachycardia ablation
4834664|NCT02419547|effects of anesthesia on VT induction|effects of anesthesia on vt induction
4834665|NCT02419547|programed stimulation|programed stimulation
4834666|NCT02419534|Pediatric, fissure in ano|pediatric, fissure in ano
4834667|NCT02419495|Advanced cancers|advanced cancers
4834668|NCT02419495|Malignant neoplasms|malignant neoplasms
4834669|NCT02419495|Paclitaxel|paclitaxel
4834670|NCT02419495|Taxol|taxol
4834671|NCT02419495|Eribulin|eribulin
4834672|NCT02419495|E7389|e7389
4834673|NCT02419495|Doxorubicin|doxorubicin
4834674|NCT02419495|Doxorubicin Hydrochloride|doxorubicin hydrochloride
4834675|NCT02419495|Adriamycin PFS|adriamycin pfs
4834676|NCT02419495|Adriamycin RDF|adriamycin rdf
4834677|NCT02419495|Adriamycin|adriamycin
4834678|NCT02419495|Rubex|rubex
4834679|NCT02419495|Cyclophosphamide|cyclophosphamide
4834680|NCT02419495|Cytoxan|cytoxan
4834681|NCT02419495|Neosar|neosar
4834682|NCT02419495|Pemetrexed|pemetrexed
4834683|NCT02419495|LY231514|ly231514
4834684|NCT02419495|Alimta|alimta
4834685|NCT02419495|MTA|mta
4834686|NCT02419495|Multitargeted Antifolate|multitargeted antifolate
4834687|NCT02419495|NSC-698037|nsc-698037
4834688|NCT02419495|Topotecan|topotecan
4834689|NCT02419495|Hycamtin|hycamtin
4834690|NCT02419495|Selinexor|selinexor
4834691|NCT02419495|KPT-330|kpt-330
4834692|NCT02419495|Carboplatin|carboplatin
4834693|NCT02419495|Paraplatin|paraplatin
4834694|NCT02419495|Irinotecan|irinotecan
4834695|NCT02419495|CPT-11|cpt-11
4834696|NCT02419495|Camptosar|camptosar
4834697|NCT02419495|5-FU|5-fu
4834698|NCT02419495|Fluorouracil|fluorouracil
4834699|NCT02419495|5-Fluorouracil|5-fluorouracil
4834700|NCT02419495|Adrucil|adrucil
4834701|NCT02419495|Efudex|efudex
4834702|NCT02419495|Capecitabine|capecitabine
4834703|NCT02419495|Xeloda|xeloda
4834704|NCT02419495|Oxaliplatin|oxaliplatin
4834705|NCT02419495|Eloxatin|eloxatin
4834706|NCT02419495|Olaparib|olaparib
4834707|NCT02419495|Lynparza|lynparza
4834708|NCT02419495|Pembrolizumab|pembrolizumab
4834709|NCT02419495|Keytruda|keytruda
4834710|NCT02419495|MK-3475|mk-3475
4834711|NCT02419495|SCH-900475|sch-900475
4834712|NCT02419495|Nivolumab|nivolumab
4834713|NCT02419495|BMS-936558|bms-936558
4834714|NCT02419495|Opdivo|opdivo
4835121|NCT02417389|fractures|fractures
4834715|NCT02419482|Exercise therapy|exercise therapy
4834716|NCT02419482|Reproductive Physiological Processes|reproductive physiological processes
4834717|NCT02419482|Fertility|fertility
4834718|NCT02419469|Leukemia|leukemia
4834719|NCT02419469|Precursor-B acute lymphoblastic leukemia|precursor-b acute lymphoblastic leukemia
4834720|NCT02419469|ALL|all
4834721|NCT02419469|Lymphoblastic lymphoma|lymphoblastic lymphoma
4834722|NCT02419469|LL|ll
4834723|NCT02419469|Lymphoma|lymphoma
4834724|NCT02419469|Cytarabine|cytarabine
4834725|NCT02419469|Ara-C|ara-c
4834726|NCT02419469|Cytosar|cytosar
4834727|NCT02419469|DepoCyt|depocyt
4834728|NCT02419469|Cytosine Arabinosine Hydrochloride|cytosine arabinosine hydrochloride
4834729|NCT02419469|Daunorubicin|daunorubicin
4834730|NCT02419469|Daunorubicin Hydrochloride|daunorubicin hydrochloride
4834731|NCT02419469|Cerubidine|cerubidine
4834732|NCT02419469|Daunomycin|daunomycin
4834733|NCT02419469|DNR|dnr
4834734|NCT02419469|Vincristine|vincristine
4834735|NCT02419469|Prednisone|prednisone
4834736|NCT02419469|PEG asparaginase|peg asparaginase
4834737|NCT02419469|Pegaspargase|pegaspargase
4834738|NCT02419469|Oncaspar|oncaspar
4834739|NCT02419469|Polyethylene glycol conjugated lasparaginase-H|polyethylene glycol conjugated lasparaginase-h
4834740|NCT02419469|Ofatumumab|ofatumumab
4834741|NCT02419469|Arzerra|arzerra
4834742|NCT02419469|Rituximab|rituximab
4834743|NCT02419469|Rituxan|rituxan
4834744|NCT02419469|Methotrexate|methotrexate
4834745|NCT02419469|Cyclophosphamide|cyclophosphamide
4834746|NCT02419469|Cytoxan|cytoxan
4834747|NCT02419469|Neosar|neosar
4834748|NCT02419469|Mercaptopurine|mercaptopurine
4834749|NCT02419469|6-mercaptopurine|6-mercaptopurine
4834750|NCT02419469|Purinethol|purinethol
4834751|NCT02419469|6-MP|6-mp
4834752|NCT02419469|Doxorubicin|doxorubicin
4834753|NCT02419469|Doxorubicin hydrochloride|doxorubicin hydrochloride
4834754|NCT02419469|Adriamycin PFS|adriamycin pfs
4834755|NCT02419469|Adriamycin RDF|adriamycin rdf
4834756|NCT02419469|Adriamycin|adriamycin
4834757|NCT02419469|Rubex|rubex
4834758|NCT02419469|Dexamethasone|dexamethasone
4834759|NCT02419469|Decadron|decadron
4834760|NCT02419469|Thioguanine|thioguanine
4834761|NCT02419469|6-thioguanine|6-thioguanine
4834762|NCT02419443|inguinal hernia repair, chronic pain|inguinal hernia repair, chronic pain
4834763|NCT02419430|well-being|well-being
4834764|NCT02419430|stress|stress
4834765|NCT02419430|resilience|resilience
4834766|NCT02419430|self-compassion|self-compassion
4834767|NCT02419391|RSV Vaccines|rsv vaccines
4834768|NCT02419391|Respiratory Syncytial Virus Vaccines|respiratory syncytial virus vaccines
4834769|NCT02419365|Primary Ciliary Dyskinesia (PCD)|primary ciliary dyskinesia (pcd)
4834770|NCT02419352|Cognitive function|cognitive function
4834771|NCT02419326|couples|couples
4834772|NCT02419326|relationships|relationships
4834773|NCT02419326|binge eating|binge eating
4834774|NCT02419326|eating disorder|eating disorder
4834775|NCT02419326|couple therapy|couple therapy
4834776|NCT02419313|Tremor|tremor
4834777|NCT02419313|Parkinson|parkinson
4834778|NCT02419313|botulinum|botulinum
4834779|NCT02419313|Xeomin|xeomin
4834780|NCT02419287|ALK|alk
4834781|NCT02419287|crizotinib|crizotinib
4834782|NCT02419274|asthma|asthma
4834783|NCT02419274|phenotype|phenotype
4834784|NCT02419274|childhood|childhood
4834785|NCT02419274|adulthood|adulthood
4834786|NCT02419261|knee surgery|knee surgery
4834787|NCT02419261|anterior cruciate ligament surgery|anterior cruciate ligament surgery
4834788|NCT02419261|nerve block|nerve block
4834789|NCT02419235|Refractory hypertension|refractory hypertension
4834790|NCT02419235|Homoeopathy|homoeopathy
4834791|NCT02419235|Homoeopathic complex|homoeopathic complex
4834792|NCT02419235|Amylenum nitrosum 6cH|amylenum nitrosum 6ch
4834793|NCT02419235|Crataegus oxyacantha 6cH|crataegus oxyacantha 6ch
4834794|NCT02419235|Natrum muriaticum 6cH|natrum muriaticum 6ch
4834795|NCT02419235|Scutellaria lateriflora 6cH|scutellaria lateriflora 6ch
4834796|NCT02419209|Low sexual desire|low sexual desire
4834797|NCT02419209|Perimenopause|perimenopause
4834798|NCT02419209|Homeopathy|homeopathy
4834799|NCT02419209|Hypoactive Sexual Desire Disorder|hypoactive sexual desire disorder
4834800|NCT02419183|Mild Cognitive Impairment|mild cognitive impairment
4834801|NCT02419183|Self-Administered Memory Screening Test With Automated Reporting (SAMSTAR)|self-administered memory screening test with automated reporting (samstar)
4834802|NCT02419183|Rey Auditory Verbal Learning Test (RAVLT)|rey auditory verbal learning test (ravlt)
4834803|NCT02419183|Word List Recall (WLR)|word list recall (wlr)
4834804|NCT02419157|Cervical lesions|cervical lesions
4834805|NCT02419157|Clinical trial|clinical trial
4834806|NCT02419157|Self-etch adhesive|self-etch adhesive
4834807|NCT02419144|older adults;|older adults;
4834808|NCT02419144|oral hygiene;|oral hygiene;
4834809|NCT02419144|adapted motivational interviewing|adapted motivational interviewing
4834810|NCT02419118|Myeloma|myeloma
4834811|NCT02419118|monoclonal antibody|monoclonal antibody
4834812|NCT02419118|Daratumumab|daratumumab
4834813|NCT02419105|Falls|falls
4834814|NCT02419105|hypogonadal men|hypogonadal men
4834815|NCT02419105|Seniors|seniors
4834816|NCT02419105|Testosterone|testosterone
4834817|NCT02419105|Colecalciferol|colecalciferol
4834818|NCT02419092|Inflammation|inflammation
4834819|NCT02419092|Insulin resistance|insulin resistance
4834820|NCT02419092|Bariatric surgery|bariatric surgery
4834821|NCT02419053|Surgical safety checklist|surgical safety checklist
4834822|NCT02419053|perioperative complications|perioperative complications
4834823|NCT02419053|pediatric|pediatric
4834824|NCT02419040|shoulder pain|shoulder pain
4834825|NCT02419040|rotator cuff|rotator cuff
4834826|NCT02419040|calcific tendonitis|calcific tendonitis
4834827|NCT02419040|barbotage|barbotage
4834828|NCT02419027|GI Flora|gi flora
4834829|NCT02419014|cranial electrotherapy|cranial electrotherapy
4834830|NCT02419014|cranial electrical stimulation|cranial electrical stimulation
4834831|NCT02419014|restless legs syndrome|restless legs syndrome
4834832|NCT02418962|PfSPZ Vaccine|pfspz vaccine
4834833|NCT02418949|hand|hand
4834834|NCT02418949|rehabilitation|rehabilitation
4834835|NCT02418949|active movement training|active movement training
4834836|NCT02418949|passive cyclical stretching|passive cyclical stretching
4834837|NCT02418936|Waardenburg syndrome|waardenburg syndrome
4834838|NCT02418936|Large vestibular aqueduct syndrome|large vestibular aqueduct syndrome
4834839|NCT02418936|Diagnosis|diagnosis
4834840|NCT02418936|copy number variation|copy number variation
4834841|NCT02418936|Multiplex polymerase chain reaction|multiplex polymerase chain reaction
4834842|NCT02418910|bipolar|bipolar
4834843|NCT02418910|self assessment|self assessment
4834844|NCT02418910|prospective randomized trial|prospective randomized trial
4834845|NCT02418897|Fatigue|fatigue
4834846|NCT02418897|multiple sclerosis|multiple sclerosis
4834847|NCT02418897|neuromuscular junction|neuromuscular junction
4834848|NCT02418897|SFEMG|sfemg
4834849|NCT02418871|cataract|cataract
4834850|NCT02418871|presbyopia|presbyopia
4834851|NCT02418858|Essential tremor|essential tremor
4834852|NCT02418858|DBS|dbs
4834853|NCT02418832|Azoospermia|azoospermia
4834854|NCT02418832|Rete Testis|rete testis
4834855|NCT02418832|TEFNA|tefna
4834856|NCT02418806|Family Caregivers|family caregivers
4834857|NCT02418806|Psychotherapy Group|psychotherapy group
4834858|NCT02418793|Hemophilia|hemophilia
4834859|NCT02418793|Factor VII|factor vii
4834860|NCT02418793|Factor VIIa|factor viia
4834861|NCT02418793|Inhibitors|inhibitors
4834862|NCT02418793|Long Acting|long acting
4834863|NCT02418728|obesity|obesity
4834864|NCT02418728|adipose tissue lipolysis|adipose tissue lipolysis
4834865|NCT02418728|lipolysis|lipolysis
4834866|NCT02418728|microdialysis|microdialysis
4834867|NCT02418728|atrial natriuretic peptide|atrial natriuretic peptide
4834868|NCT02418702|depression|depression
4834869|NCT02418702|suicide|suicide
4834870|NCT02418702|ketamine|ketamine
4834871|NCT02418702|rapid intravenous bolus|rapid intravenous bolus
4834872|NCT02418702|sub-anesthetic dose|sub-anesthetic dose
4834873|NCT02418702|double-blind placebo control|double-blind placebo control
4834874|NCT02418676|Human insulin|human insulin
4834875|NCT02418676|Hydroxypropyl-beta-cyclodextrin|hydroxypropyl-beta-cyclodextrin
4834876|NCT02418676|Pressure Ulcer|pressure ulcer
4834877|NCT02418676|Wound Healing|wound healing
4834878|NCT02418676|Gel|gel
4834879|NCT02418663|fluid responsiveness|fluid responsiveness
4834880|NCT02418663|enhanced recovery program|enhanced recovery program
4834881|NCT02418650|volunteers|volunteers
4834882|NCT02418637|worksite|worksite
4834883|NCT02418637|screen|screen
4834884|NCT02418637|migrant|migrant
4834885|NCT02418637|agricultural|agricultural
4834886|NCT02418637|worker|worker
4834887|NCT02418637|hypertension|hypertension
4834888|NCT02418637|Hyperlipidemia|hyperlipidemia
4834889|NCT02418637|diabetes|diabetes
4834890|NCT02418637|feasibility|feasibility
4834891|NCT02418624|breast cancer 1, early onset (BRCA1)|breast cancer 1, early onset (brca1)
4834892|NCT02418624|breast cancer 2, early onset (BRCA2)|breast cancer 2, early onset (brca2)
4834893|NCT02418624|homologous recombination deficiency|homologous recombination deficiency
4834894|NCT02418624|carboplatin|carboplatin
4834895|NCT02418624|olaparib|olaparib
4834896|NCT02418598|Adeno-associated virus|adeno-associated virus
4834897|NCT02418598|Aromatic L-amino acid decarboxylase|aromatic l-amino acid decarboxylase
4834898|NCT02418598|AAV-hAADC-2|aav-haadc-2
4834899|NCT02418598|AAV-2|aav-2
4834900|NCT02418598|Gene Therapy|gene therapy
4834901|NCT02418598|Gene Transfer|gene transfer
4834902|NCT02418598|Parkinson Disease|parkinson disease
4834903|NCT02418598|Basal Ganglia Disease|basal ganglia disease
4834904|NCT02418598|Brain Disease|brain disease
4834905|NCT02418585|Treatment-resistant Depression|treatment-resistant depression
4834906|NCT02418585|Esketamine|esketamine
4834907|NCT02418585|Placebo|placebo
4834908|NCT02418585|Oral Antidepressant|oral antidepressant
4834909|NCT02418559|Healthy|healthy
4834910|NCT02418559|JNJ-63623872|jnj-63623872
4834911|NCT02418559|Japanese Adult Participants|japanese adult participants
4834912|NCT02418533|infertility|infertility
4834913|NCT02418533|in vitro fertilization|in vitro fertilization
4834914|NCT02418533|fertility|fertility
4834915|NCT02418533|preimplantation genetic screening|preimplantation genetic screening
4834916|NCT02418533|embryo|embryo
4834917|NCT02418533|PGS|pgs
4834918|NCT02418533|Eeva|eeva
4834919|NCT02418533|IVF|ivf
4834920|NCT02418481|γδ T Cell|γδ t cell
4834921|NCT02418481|breast cancer|breast cancer
4834922|NCT02418481|her2-|her2-
4834923|NCT02418481|er-|er-
4834924|NCT02418481|pr-|pr-
4834925|NCT02418468|COPD, FEV1, indacaterol|copd, fev1, indacaterol
4834926|NCT02418455|MPS 7|mps 7
4834927|NCT02418455|Sly Syndrome|sly syndrome
4834928|NCT02418455|MPS VII|mps vii
4834929|NCT02418455|Enzyme Replacement Therapy|enzyme replacement therapy
4834930|NCT02418455|Rare Disease|rare disease
4834931|NCT02418455|Mucopolysaccharidosis type 7|mucopolysaccharidosis type 7
4834932|NCT02418455|Lysosomal Storage Disease|lysosomal storage disease
4834933|NCT02418455|Metabolic Disorder|metabolic disorder
4834934|NCT02418442|Systemic Arthritis|systemic arthritis
4834935|NCT02418442|Oligoarthritis|oligoarthritis
4834936|NCT02418442|Polyarthritis (Rheumatoid Factor Negative)|polyarthritis (rheumatoid factor negative)
4834937|NCT02418442|Polyarthritis (Rheumatoid Factor Positive)|polyarthritis (rheumatoid factor positive)
4834938|NCT02418442|Psoriatic Arthritis|psoriatic arthritis
4834939|NCT02418442|Enthesitis Related Arthritis (ERA)|enthesitis related arthritis (era)
4834940|NCT02418442|Undifferianted Arthritis|undifferianted arthritis
4834941|NCT02418442|CARRA Consensus Treatment Plans|carra consensus treatment plans
4834942|NCT02418442|FROST|frost
4834943|NCT02418429|fat oxidation|fat oxidation
4834944|NCT02418429|hunger|hunger
4834945|NCT02418429|resistant starch|resistant starch
4834946|NCT02418429|whey protein|whey protein
4834947|NCT02418377|Obesity|obesity
4834948|NCT02418377|Genetics|genetics
4834949|NCT02418377|Whole exome sequencing|whole exome sequencing
4834950|NCT02418377|Children|children
4834951|NCT02418351|RRMS|rrms
4834952|NCT02418325|RRMS|rrms
4834953|NCT02418312|histamine-2 receptor antagonist|histamine-2 receptor antagonist
4834954|NCT02418312|peptic ulcer|peptic ulcer
4834955|NCT02418312|thienopyridine|thienopyridine
4834956|NCT02418312|prevention|prevention
4834957|NCT02418299|urinary incontinence|urinary incontinence
4834958|NCT02418299|Er:YAG laser|er:yag laser
4834959|NCT02418286|Low Back Pain|low back pain
4834960|NCT02418286|Korean Rehabilitation Clinic|korean rehabilitation clinic
4834961|NCT02418286|Patient Registry|patient registry
4834962|NCT02418273|denosumab|denosumab
4834963|NCT02418273|pediatric|pediatric
4834964|NCT02418273|rheumatology|rheumatology
4834965|NCT02418273|osteoporosis|osteoporosis
4834966|NCT02418273|glucocorticoid|glucocorticoid
4834967|NCT02418260|Humerus|humerus
4834968|NCT02418260|shaft|shaft
4834969|NCT02418260|diaphyseal|diaphyseal
4834970|NCT02418260|fractures|fractures
4834971|NCT02418247|radioactive iodine therapy|radioactive iodine therapy
4834972|NCT02418247|ablation|ablation
4834973|NCT02418247|thyroid cancer|thyroid cancer
4834974|NCT02418234|Non-small Cell Lung Cancer|non-small cell lung cancer
4834975|NCT02418234|circulating tumor DNA|circulating tumor dna
4834976|NCT02418234|T790M|t790m
4834977|NCT02418234|amplification refractory mutation system|amplification refractory mutation system
4834978|NCT02418234|digital droplet PCR|digital droplet pcr
4834979|NCT02418221|histamine, biogenic amines, diamine oxidase|histamine, biogenic amines, diamine oxidase
4834980|NCT02418195|Depression|depression
4834981|NCT02418195|Ketamine|ketamine
4834982|NCT02418195|Suicide Attempt|suicide attempt
4834983|NCT02418195|Suicidal Ideation|suicidal ideation
4834984|NCT02418195|Suicidality|suicidality
4834985|NCT02418182|Analgesic|analgesic
4834986|NCT02418182|Pain Control|pain control
4834987|NCT02418182|IVF|ivf
4834988|NCT02418182|Tylenol|tylenol
4834989|NCT02418182|Acetaminophen|acetaminophen
4834990|NCT02418182|Egg Retrieval|egg retrieval
4834991|NCT02418182|iv vitro Fertilization|iv vitro fertilization
4834992|NCT02418117|Stereolitographic guide|stereolitographic guide
4834993|NCT02418117|flapless surgery|flapless surgery
4834994|NCT02418117|dental implants|dental implants
4834995|NCT02418091|patients with moderate DKD and uncontrolled HTN|patients with moderate dkd and uncontrolled htn
4834996|NCT02418065|Physical exercises|physical exercises
4834997|NCT02418065|Oral nutritional supplementation|oral nutritional supplementation
4834998|NCT02418065|Multimodal|multimodal
4834999|NCT02418065|Hemodialysis|hemodialysis
4835000|NCT02418065|Protein-Energy Wasting|protein-energy wasting
4835001|NCT02418052|esophageal cancer|esophageal cancer
4835002|NCT02418052|minimally invasive esophagectomy|minimally invasive esophagectomy
4835003|NCT02418052|anastomotic leak|anastomotic leak
4835004|NCT02418052|neck flexion|neck flexion
4835005|NCT02418039|Minimal hepatic encephalopathy|minimal hepatic encephalopathy
4835006|NCT02418039|Nutrition|nutrition
4835007|NCT02418013|Frailty|frailty
4835008|NCT02418013|Umbilical cord blood|umbilical cord blood
4835009|NCT02418013|Plasma|plasma
4835010|NCT02418013|Randomized trial|randomized trial
4835011|NCT02418013|Double-blinded trial|double-blinded trial
4835012|NCT02418013|Placebo-controlled trial|placebo-controlled trial
4835013|NCT02417974|Prevention|prevention
4835014|NCT02417974|Recurrence|recurrence
4835015|NCT02417974|Fecal Microbiota Therapy|fecal microbiota therapy
4835016|NCT02417961|Asthma,|asthma,
4835017|NCT02417961|Bronchial Diseases,|bronchial diseases,
4835018|NCT02417961|Respiratory Tract Diseases,|respiratory tract diseases,
4835019|NCT02417961|Lung Diseases,|lung diseases,
4835222|NCT02416921|Obesity|obesity
4835020|NCT02417961|Obstructive Lung Diseases,|obstructive lung diseases,
4835021|NCT02417961|Benralizumab|benralizumab
4835022|NCT02417909|Obesity|obesity
4835023|NCT02417909|quality of life|quality of life
4835024|NCT02417909|teenagers|teenagers
4835025|NCT02417909|psychological impact|psychological impact
4835026|NCT02417896|Acute kidney injury|acute kidney injury
4835027|NCT02417896|Spironolactone|spironolactone
4835028|NCT02417883|Furosemide|furosemide
4835029|NCT02417883|Interstitial Fibrosis|interstitial fibrosis
4835030|NCT02417870|Transplantation|transplantation
4835031|NCT02417870|interleukin-2|interleukin-2
4835032|NCT02417870|IL-2|il-2
4835033|NCT02417870|Kidney|kidney
4835034|NCT02417870|Renal|renal
4835035|NCT02417857|Single İncision Laparoscopic Surgery|single incision laparoscopic surgery
4835036|NCT02417857|Conventional Laparoscopic Surgery|conventional laparoscopic surgery
4835037|NCT02417792|psoriasis|psoriasis
4835038|NCT02417792|microbiota|microbiota
4835039|NCT02417766|Genetic Testing|genetic testing
4835040|NCT02417766|Secondary Findings|secondary findings
4835041|NCT02417766|Immune-Mediated Disorders|immune-mediated disorders
4835042|NCT02417766|Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcal in|pediatric autoimmune neuropsychiatric disorders associated with streptococcal in
4835043|NCT02417766|Whole Exome Sequencing|whole exome sequencing
4835044|NCT02417753|PARACENTESIS|paracentesis
4835045|NCT02417753|STAT3 Antisense Oligonucleotide|stat3 antisense oligonucleotide
4835046|NCT02417753|Ascites|ascites
4835047|NCT02417753|AZD9150|azd9150
4835048|NCT02417753|Surgical Resection|surgical resection
4835049|NCT02417740|Portal Hypertension|portal hypertension
4835050|NCT02417740|Portal Fibrosis|portal fibrosis
4835051|NCT02417740|Liver Disease|liver disease
4835052|NCT02417740|Varices|varices
4835053|NCT02417740|Splenomegaly|splenomegaly
4835054|NCT02417727|MEMORY TESTING|memory testing
4835055|NCT02417727|Biomarkers|biomarkers
4835056|NCT02417727|Learning|learning
4835057|NCT02417714|Computed Tomography|computed tomography
4835058|NCT02417714|Radiation Reduction|radiation reduction
4835059|NCT02417714|Iterative Reconstruction|iterative reconstruction
4835060|NCT02417688|carotid atherosclerosis, PET imaging agent|carotid atherosclerosis, pet imaging agent
4835061|NCT02417675|Option B+|option b+
4835062|NCT02417675|Adherence Club|adherence club
4835063|NCT02417675|Postpartum|postpartum
4835064|NCT02417675|Breastfeeding|breastfeeding
4835065|NCT02417675|Mother-to-child transmission|mother-to-child transmission
4835066|NCT02417662|NSCLC|nsclc
4835067|NCT02417662|Stereotactic Ablative Radiotherapy|stereotactic ablative radiotherapy
4835068|NCT02417662|Radiotherapy|radiotherapy
4835069|NCT02417662|Randomised|randomised
4835070|NCT02417662|Controlled|controlled
4835071|NCT02417662|Oligometastatic|oligometastatic
4835072|NCT02417610|Polynucleotide|polynucleotide
4835073|NCT02417610|Hyaluronic acid|hyaluronic acid
4835074|NCT02417610|Intra articular injection|intra articular injection
4835075|NCT02417597|hepatitis E|hepatitis e
4835076|NCT02417571|Chronic kidney disease|chronic kidney disease
4835077|NCT02417571|Blood pressure|blood pressure
4835078|NCT02417571|ambulatory blood pressure|ambulatory blood pressure
4835079|NCT02417571|glomerular filtration rate|glomerular filtration rate
4835080|NCT02417519|Coffee|coffee
4835081|NCT02417519|Chlorogenic acid|chlorogenic acid
4835082|NCT02417519|Insulin|insulin
4835083|NCT02417519|Appetite|appetite
4835084|NCT02417519|Metabolomics|metabolomics
4835085|NCT02417506|Acute pain|acute pain
4835086|NCT02417506|Herbal|herbal
4835087|NCT02417506|VAS|vas
4835088|NCT02417506|Stop watch|stop watch
4835089|NCT02417493|Food allergy|food allergy
4835090|NCT02417493|self-management|self-management
4835091|NCT02417493|epinephrine self-injection|epinephrine self-injection
4835092|NCT02417493|ntervention|ntervention
4835093|NCT02417493|adolescents|adolescents
4835094|NCT02417467|Electronic cigarette|electronic cigarette
4835095|NCT02417467|E-cigarette|e-cigarette
4835096|NCT02417467|Smoking cessation|smoking cessation
4835097|NCT02417454|probiotic|probiotic
4835098|NCT02417454|stress|stress
4835099|NCT02417454|emotion psychophysiology|emotion psychophysiology
4835100|NCT02417454|brain-body-gut interactions|brain-body-gut interactions
4835101|NCT02417441|TiLE|tile
4835102|NCT02417441|Embryo Assessment|embryo assessment
4835103|NCT02417441|Pregnancy|pregnancy
4835104|NCT02417441|Implantation|implantation
4835105|NCT02417441|Fertilization|fertilization
4835106|NCT02417428|Muscle function|muscle function
4835107|NCT02417428|Functional capacity|functional capacity
4835108|NCT02417415|Supine hypertension|supine hypertension
4835109|NCT02417415|Autonomic failure|autonomic failure
4835110|NCT02417415|Heat intolerance|heat intolerance
4835111|NCT02417415|Orthostatic hypotension|orthostatic hypotension
4835112|NCT02417415|Heat stress|heat stress
4835113|NCT02417402|back pain|back pain
4835114|NCT02417402|low back pain|low back pain
4835115|NCT02417402|chronic low back pain|chronic low back pain
4835116|NCT02417389|primary hyperparathyroidism|primary hyperparathyroidism
4835117|NCT02417389|hypercalcemia|hypercalcemia
4835118|NCT02417389|osteoporosis|osteoporosis
4835119|NCT02417389|bone turnover|bone turnover
4835120|NCT02417389|bone mineral density|bone mineral density
4835122|NCT02417376|Coronary heart disease|coronary heart disease
4835123|NCT02417376|Periodontitis|periodontitis
4835124|NCT02417376|C-reactive protein|c-reactive protein
4835125|NCT02417376|Blood pressure|blood pressure
4835126|NCT02417363|biomarkers|biomarkers
4835127|NCT02417363|renal disease|renal disease
4835128|NCT02417363|periodontitis|periodontitis
4835129|NCT02417324|medulloblastoma|medulloblastoma
4835130|NCT02417324|ependymoma|ependymoma
4835131|NCT02417324|pineoblastoma|pineoblastoma
4835132|NCT02417324|CNS-PNET|cns-pnet
4835133|NCT02417311|Engineered Heart Tissue (EHT)|engineered heart tissue (eht)
4835134|NCT02417311|human induced pluripotent stem cells (hiPSC)|human induced pluripotent stem cells (hipsc)
4835135|NCT02417298|ketamine|ketamine
4835136|NCT02417298|pain|pain
4835137|NCT02417298|sickle cell disorder|sickle cell disorder
4835138|NCT02417285|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
4835139|NCT02417285|Diffused Large B-Cell Lymphoma|diffused large b-cell lymphoma
4835140|NCT02417285|Phase 1B|phase 1b
4835141|NCT02417285|Open-Label|open-label
4835142|NCT02417285|Safety and Efficacy|safety and efficacy
4835143|NCT02417285|CC-122|cc-122
4835144|NCT02417285|Obinutuzumab|obinutuzumab
4835145|NCT02417285|GA101|ga101
4835146|NCT02417285|Relapsed|relapsed
4835147|NCT02417285|Refractory|refractory
4835148|NCT02417272|Total Disc Replacement|total disc replacement
4835149|NCT02417272|Anterior Cervical Decompression and Fusion|anterior cervical decompression and fusion
4835150|NCT02417259|Spectroscopy, Near-Infrared|spectroscopy, near-infrared
4835151|NCT02417246|pharmacokinetics|pharmacokinetics
4835152|NCT02417246|pharmacodynamics|pharmacodynamics
4835153|NCT02417246|pharmacogenetics|pharmacogenetics
4835154|NCT02417233|HIV-positive|hiv-positive
4835155|NCT02417233|adherence|adherence
4835156|NCT02417233|engagement to care|engagement to care
4835157|NCT02417233|mobile Health (mHealth)|mobile health (mhealth)
4835158|NCT02417233|SMS|sms
4835159|NCT02417233|peer navigation|peer navigation
4835160|NCT02417233|retention|retention
4835161|NCT02417207|hepatitis B immune globulin (HBIG)|hepatitis b immune globulin (hbig)
4835162|NCT02417207|liver transplantation|liver transplantation
4835163|NCT02417207|hepatitis B|hepatitis b
4835164|NCT02417207|entecavir|entecavir
4835165|NCT02417194|Renal cell carcinoma|renal cell carcinoma
4835166|NCT02417194|hemoglobin A1c protein|hemoglobin a1c protein
4835167|NCT02417194|Pathologic outcomes|pathologic outcomes
4835168|NCT02417194|Oncological outcomes|oncological outcomes
4835169|NCT02417194|Nephrectomy|nephrectomy
4835170|NCT02417181|Physician assistants|physician assistants
4835171|NCT02417181|Out-of-hours medical care|out-of-hours medical care
4835172|NCT02417181|Primary healthcare|primary healthcare
4835173|NCT02417181|Emergency Medical Services|emergency medical services
4835174|NCT02417155|Autonomic Nerve System|autonomic nerve system
4835175|NCT02417155|Epinephrin|epinephrin
4835176|NCT02417155|Hyperventilation|hyperventilation
4835177|NCT02417155|Hypoventilation|hypoventilation
4835178|NCT02417064|Treatment-resistant Depression|treatment-resistant depression
4835179|NCT02417064|Esketamine|esketamine
4835180|NCT02417064|Placebo|placebo
4835181|NCT02417064|Oral Antidepressant|oral antidepressant
4835182|NCT02417051|Psychological Resilience|psychological resilience
4835183|NCT02417051|Perceived Stress|perceived stress
4835184|NCT02417051|Psychological Stress|psychological stress
4835185|NCT02417051|Disaster Worker|disaster worker
4835186|NCT02417051|Superstorm Sandy|superstorm sandy
4835187|NCT02417051|Mental Health|mental health
4835188|NCT02417051|Prevention|prevention
4835189|NCT02417038|Postoperative Respiratory Monitoring|postoperative respiratory monitoring
4835190|NCT02417038|Neuraxial Opioid Administration for Cesarean Delivery|neuraxial opioid administration for cesarean delivery
4835191|NCT02417025|Military|military
4835192|NCT02417025|Health Service Delivery|health service delivery
4835193|NCT02417025|Telepsychology|telepsychology
4835194|NCT02417025|Prolonged Exposure|prolonged exposure
4835195|NCT02417025|Off-duty Activity of Military Personnel|off-duty activity of military personnel
4835196|NCT02417012|lifestyle|lifestyle
4835197|NCT02417012|exercise|exercise
4835198|NCT02417012|physical activity|physical activity
4835199|NCT02417012|diet|diet
4835200|NCT02417012|glycemic control|glycemic control
4835201|NCT02417012|hba1c|hba1c
4835202|NCT02417012|glucose lowering drugs|glucose lowering drugs
4835203|NCT02416999|glioma|glioma
4835204|NCT02416999|high-grade glioma|high-grade glioma
4835205|NCT02416960|female infertility|female infertility
4835206|NCT02416960|glycemic index|glycemic index
4835207|NCT02416960|leptin|leptin
4835208|NCT02416960|ghrelin|ghrelin
4835209|NCT02416960|overweight|overweight
4835210|NCT02416960|obesity|obesity
4835211|NCT02416960|in vitro fertilization|in vitro fertilization
4835212|NCT02416947|Soluble Corn Fiber|soluble corn fiber
4835213|NCT02416947|Osteoporosis|osteoporosis
4835214|NCT02416947|Bone Loss|bone loss
4835215|NCT02416921|Facebook|facebook
4835216|NCT02416921|Weight Gain Prevention|weight gain prevention
4835217|NCT02416921|Women's Health|women's health
4835218|NCT02416921|Online|online
4835219|NCT02416921|Weight Gain|weight gain
4835220|NCT02416921|Weight Loss|weight loss
4835221|NCT02416921|Female Contraception|female contraception
4835223|NCT02416921|Body Weight|body weight
4835224|NCT02416921|Internet|internet
4835225|NCT02416882|active|active
4835226|NCT02416882|not active|not active
4835227|NCT02416882|normal body weight|normal body weight
4835228|NCT02416869|Dexamethasone|dexamethasone
4835229|NCT02416869|Lower third molar surgery|lower third molar surgery
4835230|NCT02416856|Aphasia|aphasia
4835231|NCT02416856|Brain|brain
4835232|NCT02416856|Stimulation|stimulation
4835233|NCT02416856|Communication|communication
4835234|NCT02416856|Stroke|stroke
4835235|NCT02416856|Speech Disorders|speech disorders
4835236|NCT02416856|Communications Disorders|communications disorders
4835237|NCT02416856|Neurobehavioral Manifestations|neurobehavioral manifestations
4835238|NCT02416856|Neurologic Manifestations|neurologic manifestations
4835239|NCT02416856|Nervous System Diseases|nervous system diseases
4835240|NCT02416856|Signs and Symptoms|signs and symptoms
4835241|NCT02416843|Adipose tissue|adipose tissue
4835242|NCT02416843|metabolism|metabolism
4835243|NCT02416843|inflammation|inflammation
4835244|NCT02416843|post-prandial|post-prandial
4835245|NCT02416843|human|human
4835246|NCT02416830|embolization|embolization
4835247|NCT02416830|visceral Aneurysms|visceral aneurysms
4835248|NCT02416830|Prospective Registry|prospective registry
4835249|NCT02416817|Thrombelastography|thrombelastography
4835250|NCT02416817|Massive Transfusion|massive transfusion
4835251|NCT02416817|Major Trauma|major trauma
4835252|NCT02416817|Blood products|blood products
4835253|NCT02416817|Thromboelastometry|thromboelastometry
4835254|NCT02416804|buprenorphine|buprenorphine
4835255|NCT02416804|transdermal system|transdermal system
4835256|NCT02416804|Pain, postoperative|pain, postoperative
4835257|NCT02416804|Quality of life|quality of life
4835258|NCT02416804|Spinal stenosis|spinal stenosis
4835259|NCT02416804|Posterior lumbar fusion|posterior lumbar fusion
4835260|NCT02416791|robotic therapy|robotic therapy
4835261|NCT02416791|transcranial direct current stimulation|transcranial direct current stimulation
4835262|NCT02416778|COPD|copd
4835263|NCT02416778|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
4835264|NCT02416778|Iron deficiency|iron deficiency
4835265|NCT02416778|6 Minute-Walking-Test|6 minute-walking-test
4835266|NCT02416765|Closed-loop strategy|closed-loop strategy
4835267|NCT02416765|Artificial pancreas|artificial pancreas
4835268|NCT02416765|Postprandial glucose|postprandial glucose
4835269|NCT02416765|Insulin|insulin
4835270|NCT02416765|Glucagon|glucagon
4835271|NCT02416765|Hypoglycemia|hypoglycemia
4835272|NCT02416765|Type 1 diabetes|type 1 diabetes
4835273|NCT02416752|remifentanil|remifentanil
4835274|NCT02416752|head and neck surgery|head and neck surgery
4835275|NCT02416752|recovery pofile|recovery pofile
4835276|NCT02416752|Opioid induced hyperalgesia|opioid induced hyperalgesia
4835277|NCT02416752|post operative pain|post operative pain
4835278|NCT02416739|EGFR mutated lung cancer|egfr mutated lung cancer
4835279|NCT02416726|Gene testing|gene testing
4835280|NCT02416726|Next-generation sequecing|next-generation sequecing
4835281|NCT02416726|Primary tumor|primary tumor
4835282|NCT02416726|Metastatic lymph node|metastatic lymph node
4835283|NCT02416726|Peripheral blood|peripheral blood
4835284|NCT02416713|Driving|driving
4835285|NCT02416713|Teens|teens
4835286|NCT02416713|Texting|texting
4835287|NCT02416713|Cellphone|cellphone
4835288|NCT02416713|DriveID|driveid
4835289|NCT02416713|Motor vehicle accident|motor vehicle accident
4835290|NCT02416700|Dental prosthesis|dental prosthesis
4835291|NCT02416700|Patients|patients
4835292|NCT02416700|Osseointegrated implants|osseointegrated implants
4835293|NCT02416674|abdominal wall|abdominal wall
4835294|NCT02416674|vascularized composite allotransplantation|vascularized composite allotransplantation
4835295|NCT02416661|Gaucher Disease type 1|gaucher disease type 1
4835296|NCT02416661|Lymphatic Diseases|lymphatic diseases
4835297|NCT02416661|Lipid Metabolism, Inborn Errors|lipid metabolism, inborn errors
4835298|NCT02416661|Lipid Metabolism Disorders|lipid metabolism disorders
4835299|NCT02416661|Lipidoses|lipidoses
4835300|NCT02416648|Adult HIV patients|adult hiv patients
4835301|NCT02416648|Knowledge|knowledge
4835302|NCT02416648|Attitudes|attitudes
4835303|NCT02416648|Sexual behaviors|sexual behaviors
4835304|NCT02416635|Liver Neoplasms|liver neoplasms
4835305|NCT02416635|Circulating Tumor Cells|circulating tumor cells
4835306|NCT02416622|XLRS|xlrs
4835307|NCT02416622|maculoschisis|maculoschisis
4835308|NCT02416622|retinal degeneration|retinal degeneration
4835309|NCT02416622|RS1|rs1
4835310|NCT02416622|adeno-associated virus|adeno-associated virus
4835311|NCT02416622|gene therapy|gene therapy
4835312|NCT02416622|AAV|aav
4835313|NCT02416609|Locally advanced pancreatic cancer|locally advanced pancreatic cancer
4835314|NCT02416609|Stereotactic Body Radiotherapy|stereotactic body radiotherapy
4835315|NCT02416609|Chemopotentiator|chemopotentiator
4835316|NCT02416609|Low dose radiotherapy|low dose radiotherapy
4835317|NCT02416609|Hyper-Radiosensitivity|hyper-radiosensitivity
4835318|NCT02416596|ICSI|icsi
4835319|NCT02416596|IVF|ivf
4835320|NCT02416596|hysteroscopy|hysteroscopy
4835321|NCT02416596|Supervision|supervision
4835322|NCT02416596|In-vitro Fertilization|in-vitro fertilization
4835619|NCT02414932|ketamine|ketamine
4835323|NCT02416583|membrane sweeping|membrane sweeping
4835324|NCT02416583|dinoprostone|dinoprostone
4835325|NCT02416583|nulliparas|nulliparas
4835326|NCT02416583|labor induction|labor induction
4835327|NCT02416570|Clarithromycin|clarithromycin
4835328|NCT02416544|Overweight|overweight
4835329|NCT02416544|Obesity|obesity
4835330|NCT02416544|Caloric Restriction|caloric restriction
4835331|NCT02416544|Diet, Reducing|diet, reducing
4835332|NCT02416544|Diet, Sodium-Restricted|diet, sodium-restricted
4835333|NCT02416544|Body Weight Changes|body weight changes
4835334|NCT02416544|Energy intake|energy intake
4835335|NCT02416544|Feeding Behavior|feeding behavior
4835336|NCT02416531|Vulvar lichen sclerosus|vulvar lichen sclerosus
4835337|NCT02416531|Photodynamic therapy|photodynamic therapy
4835338|NCT02416531|Low-level laser therapy|low-level laser therapy
4835339|NCT02416531|Clobetasol propionate|clobetasol propionate
4835340|NCT02416518|Cancer|cancer
4835341|NCT02416518|Malignancy|malignancy
4835342|NCT02416518|Genomic|genomic
4835343|NCT02416518|Molecular|molecular
4835344|NCT02416479|medication adherence|medication adherence
4835345|NCT02416479|outcomes|outcomes
4835346|NCT02416479|intervention|intervention
4835347|NCT02416479|randomized controlled trial|randomized controlled trial
4835348|NCT02416466|Colorectal cancer|colorectal cancer
4835349|NCT02416466|Liver metastases|liver metastases
4835350|NCT02416466|Breast cancer|breast cancer
4835351|NCT02416466|Gastric cancer|gastric cancer
4835352|NCT02416466|Pancreas cancer|pancreas cancer
4835353|NCT02416466|Carcinoembryonic antigen|carcinoembryonic antigen
4835354|NCT02416466|CAR-T|car-t
4835355|NCT02416466|Immunotherapy|immunotherapy
4835356|NCT02416453|Healthy|healthy
4835357|NCT02416453|Ebola viruses|ebola viruses
4835358|NCT02416453|Ebola Viral Disease (EVD)|ebola viral disease (evd)
4835359|NCT02416453|Filoviruses|filoviruses
4835360|NCT02416453|Monovalent vaccine|monovalent vaccine
4835361|NCT02416453|Human adenovirus serotype 26 (Ad26) expressing the Ebola virus Mayinga variant glycoprotein (Ad26.ZEBOV)|human adenovirus serotype 26 (ad26) expressing the ebola virus mayinga variant glycoprotein (ad26.zebov)
4835362|NCT02416453|Modified Vaccinia Virus Ankara - Bavarian Nordic Filo-vector (MVA-BN Filo)|modified vaccinia virus ankara - bavarian nordic filo-vector (mva-bn filo)
4835363|NCT02416453|Safety|safety
4835364|NCT02416453|Immunogenicity|immunogenicity
4835365|NCT02416440|South African|south african
4835366|NCT02416440|urban African|urban african
4835367|NCT02416440|diabetes|diabetes
4835368|NCT02416440|prevalence|prevalence
4835369|NCT02416440|risk factors|risk factors
4835370|NCT02416440|genetics|genetics
4835371|NCT02416427|Atorvastatin|atorvastatin
4835372|NCT02416427|TAZ|taz
4835373|NCT02416427|Hippo pathway|hippo pathway
4835374|NCT02416427|ki67|ki67
4835375|NCT02416401|healthy|healthy
4835376|NCT02416401|aging|aging
4835377|NCT02416401|cognition|cognition
4835378|NCT02416401|age-related cognitive decline|age-related cognitive decline
4835379|NCT02416362|Postural Balance|postural balance
4835380|NCT02416362|Electromyography|electromyography
4835381|NCT02416362|Torque|torque
4835382|NCT02416349|Stroke|stroke
4835383|NCT02416349|Stretching|stretching
4835384|NCT02416349|Respiratory muscle|respiratory muscle
4835385|NCT02416349|Ventilatory pattern|ventilatory pattern
4835386|NCT02416349|Optoelectronic plethysmography|optoelectronic plethysmography
4835387|NCT02416336|sentinel lymph node|sentinel lymph node
4835388|NCT02416336|lymphoscintigraphy|lymphoscintigraphy
4835389|NCT02416336|intraoperative gamma camera|intraoperative gamma camera
4835390|NCT02416310|TEAS|teas
4835391|NCT02416310|cesarean section|cesarean section
4835392|NCT02416310|gastrointestinal function|gastrointestinal function
4835393|NCT02416297|malocclusion|malocclusion
4835394|NCT02416297|accelerated tooth movement|accelerated tooth movement
4835395|NCT02416297|Tomography|tomography
4835396|NCT02416297|Extraction|extraction
4835397|NCT02416258|Psoriasis|psoriasis
4835398|NCT02416232|melanoma|melanoma
4835399|NCT02416232|dabrafenib|dabrafenib
4835400|NCT02416232|trametinib|trametinib
4835401|NCT02416232|BRAF V600E/K mutation|braf v600e/k mutation
4835402|NCT02416219|Cricoid cartilage, cricoid pressure, obstetric|cricoid cartilage, cricoid pressure, obstetric
4835403|NCT02416206|Multiple myeloma|multiple myeloma
4835404|NCT02416206|hematopoietic stem cell transplant|hematopoietic stem cell transplant
4835405|NCT02416193|Diabetes|diabetes
4835406|NCT02416193|Cognition|cognition
4835407|NCT02416193|Functioning|functioning
4835408|NCT02416180|EVOHALER|evohaler
4835409|NCT02416180|Asthma|asthma
4835410|NCT02416180|SERETIDE|seretide
4835411|NCT02416180|DISKUS Inhaler|diskus inhaler
4835412|NCT02416180|MDI|mdi
4835413|NCT02416154|interferon-epsilon|interferon-epsilon
4835414|NCT02416154|female reproductive tract|female reproductive tract
4835415|NCT02416154|neopterin|neopterin
4835416|NCT02416154|menstrual cycle|menstrual cycle
4835417|NCT02416115|PONV|ponv
4835418|NCT02416115|ramosetron|ramosetron
4835419|NCT02416115|naloxone|naloxone
4835420|NCT02416089|Tampostat|tampostat
4835421|NCT02416089|Tamponade|tamponade
4835422|NCT02416089|Postpartum hemorrhage|postpartum hemorrhage
4835423|NCT02416076|Ulthera® System|ulthera® system
4835424|NCT02416076|Ultherapy®|ultherapy®
4835425|NCT02416076|Ulthera, Inc.|ulthera, inc.
4835426|NCT02416050|Cocaine|cocaine
4835427|NCT02416050|Dependence|dependence
4835428|NCT02416050|Abstinence|abstinence
4835429|NCT02416050|Prediction|prediction
4835430|NCT02416050|Model|model
4835431|NCT02416050|Humans|humans
4835432|NCT02416050|MRI|mri
4835433|NCT02416050|Cognitive|cognitive
4835434|NCT02416050|Impulsivity|impulsivity
4835435|NCT02416050|Craving|craving
4835436|NCT02416037|ARDS|ards
4835437|NCT02416037|prone position|prone position
4835438|NCT02416037|PEEP|peep
4835439|NCT02416037|mechanical ventilation|mechanical ventilation
4835440|NCT02416024|angiotensin converting enzyme inhibitor|angiotensin converting enzyme inhibitor
4835441|NCT02416024|anesthesia|anesthesia
4835442|NCT02416011|e-cigarette|e-cigarette
4835443|NCT02416011|nicotine dependence|nicotine dependence
4835444|NCT02415998|TEE|tee
4835445|NCT02415985|pharmacokinetics of rifabutin|pharmacokinetics of rifabutin
4835446|NCT02415985|HIV/TB co-infection|hiv/tb co-infection
4835447|NCT02415985|resource limited setting|resource limited setting
4835448|NCT02415985|AUC|auc
4835449|NCT02415985|Cmax|cmax
4835450|NCT02415985|Cmin|cmin
4835451|NCT02415985|Ctrough|ctrough
4835452|NCT02415972|ultrasound imaging|ultrasound imaging
4835453|NCT02415972|acute ischemic stroke|acute ischemic stroke
4835454|NCT02415972|cerebral perfusion measurement in acute ischemic stroke|cerebral perfusion measurement in acute ischemic stroke
4835455|NCT02415959|Exocrine Pancreatic Insufficiency|exocrine pancreatic insufficiency
4835456|NCT02415946|regenerative medicine|regenerative medicine
4835457|NCT02415946|bone substitutes|bone substitutes
4835458|NCT02415946|sinus floor augmentation|sinus floor augmentation
4835459|NCT02415933|Burkina Faso|burkina faso
4835460|NCT02415933|West Africa|west africa
4835461|NCT02415933|Children|children
4835462|NCT02415933|Child Abuse|child abuse
4835463|NCT02415933|Child Mental Health|child mental health
4835464|NCT02415933|Economic Empowerment|economic empowerment
4835465|NCT02415933|Women's Empowerment|women's empowerment
4835466|NCT02415933|Domestic Violence|domestic violence
4835467|NCT02415933|Child and Family Well-being|child and family well-being
4835468|NCT02415933|Child Separation|child separation
4835469|NCT02415933|Child Labor|child labor
4835470|NCT02415933|Child Maltreatment|child maltreatment
4835471|NCT02415920|Investigating oxytocin's effects|investigating oxytocin's effects
4835472|NCT02415920|human communication|human communication
4835473|NCT02415881|Panitumumab|panitumumab
4835474|NCT02415881|Optical Imaging|optical imaging
4835475|NCT02415868|Vaginal Microbiota|vaginal microbiota
4835476|NCT02415842|Supra-seasonal influenza vaccine|supra-seasonal influenza vaccine
4835477|NCT02415842|Pandemic|pandemic
4835478|NCT02415842|Exploratory|exploratory
4835479|NCT02415842|Protein epitopes|protein epitopes
4835480|NCT02415842|Laboratory evaluation|laboratory evaluation
4835481|NCT02415842|Retrospective|retrospective
4835482|NCT02415829|Neoajuvant chemotherapy|neoajuvant chemotherapy
4835483|NCT02415816|Pediatric|pediatric
4835484|NCT02415816|Whole body DWI MRI|whole body dwi mri
4835485|NCT02415803|low-dose ticagrelor|low-dose ticagrelor
4835486|NCT02415803|clopidogrel|clopidogrel
4835487|NCT02415803|Chinese patients with NSTE-ACS|chinese patients with nste-acs
4835488|NCT02415803|platelet reactivity|platelet reactivity
4835489|NCT02415803|inhibition of platelet aggregation|inhibition of platelet aggregation
4835490|NCT02415790|E2027|e2027
4835613|NCT02414984|Golimumab|golimumab
4835491|NCT02415790|Healthy Adult and Elderly Subjects|healthy adult and elderly subjects
4835492|NCT02415790|Pharmacokinetics/Pharmacodynamics|pharmacokinetics/pharmacodynamics
4835493|NCT02415738|Near infrared spectroscopy|near infrared spectroscopy
4835494|NCT02415738|Cerebral oxygenation|cerebral oxygenation
4835495|NCT02415738|Acute respiratory distress syndrom|acute respiratory distress syndrom
4835496|NCT02415738|Prone positioning|prone positioning
4835497|NCT02415712|Pharmacotherapy|pharmacotherapy
4835498|NCT02415686|Dravet syndrome|dravet syndrome
4835499|NCT02415686|Sudden Unexpected Death in Epilepsy (SUDEP)|sudden unexpected death in epilepsy (sudep)
4835500|NCT02415686|Arrhythmias|arrhythmias
4835501|NCT02415673|Orthodontics|orthodontics
4835502|NCT02415673|Nitinol|nitinol
4835503|NCT02415660|trigger point dry needling|trigger point dry needling
4835504|NCT02415660|thoracic spine manipulation|thoracic spine manipulation
4835505|NCT02415660|deep cervical extensor muscle|deep cervical extensor muscle
4835506|NCT02415660|deep cervical flexor muscle|deep cervical flexor muscle
4835507|NCT02415660|shear wave elastography|shear wave elastography
4835508|NCT02415647|children|children
4835509|NCT02415647|mental health|mental health
4835510|NCT02415647|family genetic study|family genetic study
4835511|NCT02415621|metastatic|metastatic
4835512|NCT02415621|castration resistant|castration resistant
4835513|NCT02415621|abiraterone therapy|abiraterone therapy
4835514|NCT02415582|Hypertension|hypertension
4835515|NCT02415582|Bloodpressure|bloodpressure
4835516|NCT02415582|Post-exercise hypotension|post-exercise hypotension
4835517|NCT02415582|Combined exercise|combined exercise
4835518|NCT02415582|Aerobic exercise|aerobic exercise
4835519|NCT02415582|Resistance exercise|resistance exercise
4835520|NCT02415582|Aging|aging
4835521|NCT02415582|Elderly|elderly
4836214|NCT02411422|manikins|manikins
4835522|NCT02415582|Ambulatory blood pressure monitoring|ambulatory blood pressure monitoring
4835523|NCT02415569|bowel cleansing|bowel cleansing
4835524|NCT02415569|bisacodyl|bisacodyl
4835525|NCT02415569|polyethyleneglycol|polyethyleneglycol
4835526|NCT02415569|colonoscopy|colonoscopy
4835527|NCT02415569|the bristol stool form scale|the bristol stool form scale
4835528|NCT02415556|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
4835529|NCT02415556|Intranasal Insulin|intranasal insulin
4835530|NCT02415556|Placebo|placebo
4835531|NCT02415556|Memory|memory
4835532|NCT02415556|Gait|gait
4835533|NCT02415556|Non diabetic older controls|non diabetic older controls
4835534|NCT02415517|Cognitive training|cognitive training
4835535|NCT02415517|Cognitive impairment|cognitive impairment
4835536|NCT02415517|Heart failure|heart failure
4835537|NCT02415517|Cognition|cognition
4835538|NCT02415504|Care transition|care transition
4835539|NCT02415504|Behavioural and psychological symptoms of dementia|behavioural and psychological symptoms of dementia
4835540|NCT02415504|BPSD|bpsd
4835541|NCT02415504|Dementia|dementia
4835542|NCT02415504|Persons with dementia|persons with dementia
4835543|NCT02415504|Discharge processes|discharge processes
4835544|NCT02415491|TGA|tga
4835545|NCT02415491|ASO|aso
4835546|NCT02415491|magnetic resonance imaging (MRI)|magnetic resonance imaging (mri)
4835547|NCT02415491|young adulthood|young adulthood
4835548|NCT02415478|Chronic obstructive pulmonary disease (COPD)|chronic obstructive pulmonary disease (copd)
4835549|NCT02415478|endoscopic lung volume reduction|endoscopic lung volume reduction
4835550|NCT02415478|Endobronchial valve|endobronchial valve
4835551|NCT02415478|physical capacity|physical capacity
4835552|NCT02415478|quality of life|quality of life
4835553|NCT02415465|Knee|knee
4835554|NCT02415465|Replacement|replacement
4835555|NCT02415452|relationship|relationship
4835556|NCT02415452|retinal artery lesions|retinal artery lesions
4835557|NCT02415452|long-term outcomes|long-term outcomes
4835558|NCT02415439|Safety|safety
4835559|NCT02415439|tolerability|tolerability
4835560|NCT02415439|pharmacokinetics|pharmacokinetics
4835561|NCT02415439|adult|adult
4835562|NCT02415439|volunteers|volunteers
4835563|NCT02415413|Smoldering multiple myeloma|smoldering multiple myeloma
4835564|NCT02415413|Carfilzomib|carfilzomib
4835565|NCT02415413|Lenalidomide|lenalidomide
4835566|NCT02415413|Melphalan|melphalan
4835567|NCT02415413|Dexamethasone|dexamethasone
4835568|NCT02415413|Autologous stem cell transplantation|autologous stem cell transplantation
4835569|NCT02415361|Parents|parents
4835570|NCT02415361|Follow-Up Studies|follow-up studies
4835571|NCT02415309|Melatonin|melatonin
4835572|NCT02415309|Lumbar medial branch block (LMBB)|lumbar medial branch block (lmbb)
4835573|NCT02415309|Anxiety|anxiety
4835574|NCT02415309|Interventional Pain|interventional pain
4835575|NCT02415309|Pain Procedure|pain procedure
4835576|NCT02415296|gambling disorder|gambling disorder
4835577|NCT02415296|screening model|screening model
4835578|NCT02415296|online gambling|online gambling
4835579|NCT02415296|clinical validation|clinical validation
4835580|NCT02415257|Vestibular schwannoma|vestibular schwannoma
4835581|NCT02415257|acoustic neuroma|acoustic neuroma
4835582|NCT02415257|cerebellopontine angle tumour|cerebellopontine angle tumour
4835583|NCT02415257|gentamicin|gentamicin
4835584|NCT02415257|rehabilitation|rehabilitation
4835585|NCT02415257|postural balance|postural balance
4835586|NCT02415244|ultrasound|ultrasound
4835587|NCT02415231|humor laughter C reactive protein|humor laughter c reactive protein
4835588|NCT02415205|Pain and stress assessment in premature infants|pain and stress assessment in premature infants
4835589|NCT02415192|safety data|safety data
4835590|NCT02415192|hypertension therapy|hypertension therapy
4835591|NCT02415179|Newly diagnosed asthma|newly diagnosed asthma
4835592|NCT02415179|peripheral airway function|peripheral airway function
4835593|NCT02415127|Interferon gamma|interferon gamma
4835594|NCT02415114|Coenzyme Q10|coenzyme q10
4835595|NCT02415114|Resveratrol|resveratrol
4835596|NCT02415114|Statin|statin
4835597|NCT02415101|Adenocarcinoma|adenocarcinoma
4835598|NCT02415101|Squamous cell carcinoma|squamous cell carcinoma
4835599|NCT02415101|Gastroesophageal Junction|gastroesophageal junction
4835600|NCT02415088|Nerve block|nerve block
4835601|NCT02415075|Return to work, state of subjective health, medical rehabilitation, motivational interviewing|return to work, state of subjective health, medical rehabilitation, motivational interviewing
4835602|NCT02415062|Parkinson's disease|parkinson's disease
4835603|NCT02415062|dementia|dementia
4835604|NCT02415036|HCC|hcc
4835605|NCT02415036|ICC|icc
4835606|NCT02415036|Percutaneous hepatic perfusion|percutaneous hepatic perfusion
4835607|NCT02414997|RIPC (remote ischemic preconditioning)|ripc (remote ischemic preconditioning)
4835608|NCT02414997|primary hypertension stage I|primary hypertension stage i
4835609|NCT02414997|vascular function|vascular function
4835610|NCT02414997|microRNA-126|microrna-126
4835611|NCT02414997|microRNA-34a|microrna-34a
4835612|NCT02414984|Rheumatoid Arthritis|rheumatoid arthritis
4835614|NCT02414984|Observational|observational
4835615|NCT02414984|Compliance|compliance
4835616|NCT02414971|cancer related fatigue|cancer related fatigue
4835617|NCT02414971|prostate cancer|prostate cancer
4835618|NCT02414971|mitochondria|mitochondria
4835620|NCT02414932|electroconvulsive therapy|electroconvulsive therapy
4835621|NCT02414932|glutamate|glutamate
4835622|NCT02414906|Goal Directed Therapy|goal directed therapy
4835623|NCT02414906|Acute Kidney Injury|acute kidney injury
4835624|NCT02414880|Sugammadex|sugammadex
4835625|NCT02414880|Neostigmine|neostigmine
4835626|NCT02414880|Rocuronium|rocuronium
4835627|NCT02414880|Cirrhosis|cirrhosis
4835628|NCT02414880|Liver resection|liver resection
4835629|NCT02414880|Neuromuscular|neuromuscular
4835630|NCT02414841|radiocephalic|radiocephalic
4835631|NCT02414841|arteriovenous fistula|arteriovenous fistula
4835632|NCT02414841|AVF|avf
4835633|NCT02414841|hemodialysis|hemodialysis
4835634|NCT02414841|PRT-201|prt-201
4835635|NCT02414841|vonapanitase|vonapanitase
4835636|NCT02414841|vascular access|vascular access
4835637|NCT02414841|kidney|kidney
4835638|NCT02414841|renal|renal
4835639|NCT02414841|PATENCY-2|patency-2
4835640|NCT02414841|secondary patency|secondary patency
4835641|NCT02414841|fistula abandonment|fistula abandonment
4835642|NCT02414841|use for hemodialysis|use for hemodialysis
4835643|NCT02414789|erythema migrans|erythema migrans
4835644|NCT02414789|Lyme|lyme
4835645|NCT02414789|early diagnosis|early diagnosis
4835646|NCT02414789|skin biomarkers|skin biomarkers
4835647|NCT02414789|proteomics diagnostic|proteomics diagnostic
4835648|NCT02414789|mass spectrometry|mass spectrometry
4835649|NCT02414750|Vemurafenib/cobimetinib (GDC-0973)|vemurafenib/cobimetinib (gdc-0973)
4835650|NCT02414750|Melanoma|melanoma
4835651|NCT02414750|Positron Emission Tomography|positron emission tomography
4835652|NCT02414750|Tumor Characteristics|tumor characteristics
4835653|NCT02414750|Response monitoring|response monitoring
4835654|NCT02414750|Resistance prediction|resistance prediction
4835655|NCT02414750|molecular targeted therapy|molecular targeted therapy
4835656|NCT02414711|Depression|depression
4835657|NCT02414711|Primary care|primary care
4835658|NCT02414711|General Practitioners|general practitioners
4835659|NCT02414685|poor-prognosis germ cell cancer, paclitaxel, ifosfamid and cisplatin regimen, tumor marker decline|poor-prognosis germ cell cancer, paclitaxel, ifosfamid and cisplatin regimen, tumor marker decline
4835660|NCT02414672|psychosocial intervention|psychosocial intervention
4835661|NCT02414672|advanced lung cancer|advanced lung cancer
4835662|NCT02414672|caregivers|caregivers
4835663|NCT02414672|self-care|self-care
4835664|NCT02414633|Psoriatic Arthritis|psoriatic arthritis
4835665|NCT02414620|Efficacy|efficacy
4835666|NCT02414620|Dental Vibe Unit|dental vibe unit
4835667|NCT02414620|Reduction|reduction
4835668|NCT02414620|Elimination|elimination
4835669|NCT02414620|Dental Anesthetic Injection|dental anesthetic injection
4835670|NCT02414607|Elderberry juice|elderberry juice
4835671|NCT02414607|Alzheimer's|alzheimer's
4835672|NCT02414607|Inflammation|inflammation
4835673|NCT02414555|Fluid Management|fluid management
4835674|NCT02414516|HDAC|hdac
4835675|NCT02414516|Epigenetic|epigenetic
4835676|NCT02414516|Histone|histone
4835677|NCT02414516|Acetylation|acetylation
4835678|NCT02414503|oxytocin|oxytocin
4835679|NCT02414503|social cognition|social cognition
4835680|NCT02414490|CIDP|cidp
4835681|NCT02414477|tobacco toxicants|tobacco toxicants
4835682|NCT02414477|smokeless tobacco|smokeless tobacco
4835683|NCT02414477|nitrosamines|nitrosamines
4835684|NCT02414477|tobacco specific nitrosamines (TSNAs)|tobacco specific nitrosamines (tsnas)
4835685|NCT02414464|tooth bleaching|tooth bleaching
4835686|NCT02414464|adolescent|adolescent
4835687|NCT02414464|clinical trial|clinical trial
4835688|NCT02414451|Propranolol|propranolol
4835689|NCT02414425|Fecal Incontinence|fecal incontinence
4835690|NCT02414425|Botulinum Toxin A|botulinum toxin a
4835691|NCT02414425|Rectal injection|rectal injection
4835692|NCT02414412|Ulmus macrocarpa water extract|ulmus macrocarpa water extract
4835693|NCT02414412|immunity|immunity
4835694|NCT02414399|post-discharge mortality|post-discharge mortality
4835695|NCT02414399|morbidity and mortality prevention|morbidity and mortality prevention
4835696|NCT02414399|azithromycin|azithromycin
4835697|NCT02414399|linear growth|linear growth
4835698|NCT02414386|Vitamin D|vitamin d
4835699|NCT02414386|Continuous Renal Replacement Therapy|continuous renal replacement therapy
4835700|NCT02414386|Multi Organ Failure|multi organ failure
4835701|NCT02414386|Acute Kidney Injury|acute kidney injury
4835702|NCT02414386|Critical Care|critical care
4835703|NCT02414386|Citrate anticoagulation|citrate anticoagulation
4835704|NCT02414373|urination|urination
4835705|NCT02414373|analgesia, epidural|analgesia, epidural
4835706|NCT02414373|local anesthetics|local anesthetics
4835707|NCT02414360|Review Literature as Topic|review literature as topic
4835708|NCT02414347|Dementia|dementia
4835709|NCT02414347|Tauopathies|tauopathies
4835710|NCT02414347|Brain Diseases|brain diseases
4835711|NCT02414347|Central Nervous System Diseases|central nervous system diseases
4835712|NCT02414347|Mild Cognitive Impairment|mild cognitive impairment
4835713|NCT02414347|Nervous System Diseases|nervous system diseases
4835714|NCT02414347|Neurodegenerative Disease|neurodegenerative disease
4835715|NCT02414334|Oligometastases|oligometastases
4835716|NCT02414334|Stereotactic ablative radiotherapy (SABR)|stereotactic ablative radiotherapy (sabr)
4835717|NCT02414334|Metastatic tumours|metastatic tumours
4835718|NCT02414308|Erectile dysfunction, Peyronie's disease, stem cell|erectile dysfunction, peyronie's disease, stem cell
4835719|NCT02414295|Stem cell|stem cell
4835720|NCT02414295|Kleinfelter syndrome|kleinfelter syndrome
4835721|NCT02414295|Azoospermia|azoospermia
4835722|NCT02414295|Sterility|sterility
4835723|NCT02414295|Infertility|infertility
4835724|NCT02414282|Dementia|dementia
4835725|NCT02414282|Brain Diseases|brain diseases
4835726|NCT02414282|mild cognitive impairment|mild cognitive impairment
4835727|NCT02414282|Central Nervous System Diseases|central nervous system diseases
4835728|NCT02414282|Neurodegenerative Disease|neurodegenerative disease
4835729|NCT02414269|modified T cells|modified t cells
4835730|NCT02414269|cyclophosphamide|cyclophosphamide
4835731|NCT02414269|CAR T cells|car t cells
4835732|NCT02414269|15-007|15-007
4835733|NCT02414269|CAR|car
4835734|NCT02414269|immunotherapy|immunotherapy
4835735|NCT02414256|breast surgery|breast surgery
4835736|NCT02414230|fronto-temporal dementia|fronto-temporal dementia
4835737|NCT02414230|Tauopathies|tauopathies
4835738|NCT02414230|Nervous System Diseases|nervous system diseases
4835739|NCT02414230|Neurodegenerative Diseases|neurodegenerative diseases
4835740|NCT02414217|numeracy|numeracy
4835741|NCT02414217|health literacy|health literacy
4835742|NCT02414204|Arteriovenous Fistulas (AVFS)|arteriovenous fistulas (avfs)
4835743|NCT02414204|Hemodialysis Fistula Maturation (HFM)|hemodialysis fistula maturation (hfm)
4835744|NCT02414204|Flow-Mediated Dilation (FMD)|flow-mediated dilation (fmd)
4835745|NCT02414204|Nitroglycerin-Mediated (NMD)|nitroglycerin-mediated (nmd)
4835746|NCT02414204|Venous Plethysmography (VP)|venous plethysmography (vp)
4835747|NCT02414191|Feedback|feedback
4835748|NCT02414191|Temperature management|temperature management
4835749|NCT02414191|Anesthesia|anesthesia
4835750|NCT02414178|Dementia|dementia
4835751|NCT02414178|Brain Diseases|brain diseases
4835752|NCT02414178|Central Nervous System Diseases|central nervous system diseases
4835753|NCT02414178|Mild Cognitive Impairment|mild cognitive impairment
4835754|NCT02414178|nervous system diseases|nervous system diseases
4835755|NCT02414178|Neurodegenerative Disease|neurodegenerative disease
4835756|NCT02414165|Recurrence|recurrence
4835757|NCT02414139|Non Small Cell Lung|non small cell lung
4835758|NCT02414139|Non Small Cell Lung Cancer|non small cell lung cancer
4835759|NCT02414139|Non-small cell lung cancer|non-small cell lung cancer
4835760|NCT02414139|NSCLC|nsclc
4835761|NCT02414139|INC280|inc280
4835762|NCT02414139|EGFR wild-type (wt)|egfr wild-type (wt)
4835763|NCT02414139|advanced non-small cell lung cancer|advanced non-small cell lung cancer
4835764|NCT02414139|advanced/metastatic disease|advanced/metastatic disease
4835765|NCT02414139|Non-small cell lung carcinoma (NSCLC)|non-small cell lung carcinoma (nsclc)
4835766|NCT02414139|treatment of lung cancer after first metastasis|treatment of lung cancer after first metastasis
4835767|NCT02414139|lung cancer|lung cancer
4835768|NCT02414139|lung adenocarcinoma|lung adenocarcinoma
4835769|NCT02414139|Non small cell lung carcinoma|non small cell lung carcinoma
4835770|NCT02414139|MET exon 14 deletion|met exon 14 deletion
4835771|NCT02414139|MET exon 14 skipping|met exon 14 skipping
4835772|NCT02414139|MET exon 14 mutation|met exon 14 mutation
4835773|NCT02414139|MET mutation|met mutation
4835774|NCT02414139|MET amplification|met amplification
4835775|NCT02414139|MET inhibitor|met inhibitor
4835776|NCT02414139|MET dysregulation|met dysregulation
4835777|NCT02414139|MET activation|met activation
4835778|NCT02414139|MET signaling|met signaling
4835779|NCT02414139|MET pathway|met pathway
4835780|NCT02414139|met|met
4835781|NCT02414139|cMET|cmet
4835782|NCT02414126|Heart failure|heart failure
4835783|NCT02414126|child|child
4835784|NCT02414126|work of breathing|work of breathing
4835785|NCT02414126|cardiac function|cardiac function
4835786|NCT02414126|sleep|sleep
4835787|NCT02414126|polysomnography|polysomnography
4835788|NCT02414126|CPAP|cpap
4835789|NCT02414087|flat foot|flat foot
4835790|NCT02414087|therapeutic effect|therapeutic effect
4835791|NCT02414087|insoles|insoles
4835792|NCT02414087|children|children
4835793|NCT02414061|Postprandial glycemia|postprandial glycemia
4835794|NCT02414061|metabolic health measures|metabolic health measures
4835795|NCT02414048|Hypoxia|hypoxia
4835796|NCT02414048|Head and neck cancer|head and neck cancer
4835797|NCT02414035|atrial fibrillation|atrial fibrillation
4835798|NCT02414035|anticoagulation|anticoagulation
4835799|NCT02414035|Dabigatran|dabigatran
4835800|NCT02413996|Virtual Reality Therapy|virtual reality therapy
4835801|NCT02413996|Rehabilitation|rehabilitation
4835802|NCT02413996|Total Knee Replacement|total knee replacement
4835803|NCT02413996|Knee Arthroplasty|knee arthroplasty
4835804|NCT02413996|Exercise|exercise
4835805|NCT02413996|Arthritis|arthritis
4835806|NCT02413996|Rheumatic Disease|rheumatic disease
4835807|NCT02413970|OSA|osa
4835808|NCT02413970|Neurostimulation|neurostimulation
4835809|NCT02413970|Hypoglossal nerve|hypoglossal nerve
4835810|NCT02413970|Tongue|tongue
4835811|NCT02413970|Upper airway stimulation|upper airway stimulation
4835812|NCT02413970|Surgery|surgery
4835813|NCT02413957|Elderly Patients|elderly patients
4835814|NCT02413957|Medication Safety|medication safety
4835815|NCT02413957|Pharmaceutical Care|pharmaceutical care
4835816|NCT02413957|Medication Reconciliation|medication reconciliation
4835817|NCT02413931|tuberculosis|tuberculosis
4835818|NCT02413931|MDR-TB|mdr-tb
4835819|NCT02413918|mixed episode|mixed episode
4835820|NCT02413866|body composition|body composition
4835821|NCT02413866|anthropometry|anthropometry
4835822|NCT02413840|COPD|copd
4835823|NCT02413840|Baduanjin qigong|baduanjin qigong
4835824|NCT02413840|depression|depression
4835825|NCT02413840|anxiety|anxiety
4835826|NCT02413827|Yervoy™, CDX-1401|yervoy™, cdx-1401
4835827|NCT02413801|Psoriasis|psoriasis
4835828|NCT02413801|PDUS|pdus
4835829|NCT02413788|adolescent idiopathic scoliosis|adolescent idiopathic scoliosis
4835830|NCT02413788|inflammatory markers|inflammatory markers
4835831|NCT02413788|exercise|exercise
4835832|NCT02413749|Psoriatic Arthritis|psoriatic arthritis
4835833|NCT02413723|intubation|intubation
4835834|NCT02413723|critical care|critical care
4835835|NCT02413723|laryngoscope|laryngoscope
4835836|NCT02413723|videolaryngoscope|videolaryngoscope
4835837|NCT02413723|intratracheal|intratracheal
4835838|NCT02413658|Phenytoin|phenytoin
4835839|NCT02413658|Skin graft donor site|skin graft donor site
4835840|NCT02413658|Clean surgical site|clean surgical site
4835841|NCT02413658|Wound model|wound model
4835842|NCT02413632|HIV-positive MSM (men who have sex with men)|hiv-positive msm (men who have sex with men)
4835843|NCT02413632|asymptomatic sexually transmitted infections|asymptomatic sexually transmitted infections
4835844|NCT02413632|screening|screening
4835845|NCT02413606|follow up care|follow up care
4835846|NCT02413606|satisfaction with care|satisfaction with care
4835847|NCT02413593|HCV genotype 3 (GT-3)|hcv genotype 3 (gt-3)
4835848|NCT02413593|HCV|hcv
4835849|NCT02413593|Sustained Virologic Response|sustained virologic response
4835850|NCT02413593|Direct Acting Antiviral|direct acting antiviral
4835851|NCT02413593|GS-7977|gs-7977
4835852|NCT02413593|GS-5885|gs-5885
4835853|NCT02413593|Ribavirin|ribavirin
4835854|NCT02413593|Sofosbuvir|sofosbuvir
4835855|NCT02413593|Ledipasvir|ledipasvir
4835856|NCT02413593|Hepatitis C|hepatitis c
4835857|NCT02413593|Hepatitis C, Chronic|hepatitis c, chronic
4835858|NCT02413554|acetylcholinesterase inhibitors|acetylcholinesterase inhibitors
4835859|NCT02413554|rivastigmine patch|rivastigmine patch
4835860|NCT02413554|post-operational delirium|post-operational delirium
4835861|NCT02413528|Patient Compliance|patient compliance
4835862|NCT02413528|Mobile Applications|mobile applications
4835863|NCT02413489|Lymphoma, Mantle-Cell|lymphoma, mantle-cell
4835864|NCT02413489|Lymphoma, Large B-Cell, Diffuse|lymphoma, large b-cell, diffuse
4835865|NCT02413489|Lymphoma, Follicular|lymphoma, follicular
4835866|NCT02413489|Daratumumab|daratumumab
4835867|NCT02413476|robotic-assisted gastrectomy|robotic-assisted gastrectomy
4835868|NCT02413476|laparoscopic-assisted gastrectomy|laparoscopic-assisted gastrectomy
4835869|NCT02413476|gastric cancer|gastric cancer
4835870|NCT02413450|induced Pluripotent Stem Cells (iPSC)|induced pluripotent stem cells (ipsc)
4835871|NCT02413450|Channelopathies|channelopathies
4835872|NCT02413450|Catecholaminergic|catecholaminergic
4835873|NCT02413450|Arrhythmogenic|arrhythmogenic
4835874|NCT02413437|contrast-enhanced ultrasound|contrast-enhanced ultrasound
4835875|NCT02413437|biopsy|biopsy
4835876|NCT02413424|sucralose|sucralose
4835877|NCT02413411|Arthroplasty|arthroplasty
4835878|NCT02413411|Osteoarthritis|osteoarthritis
4835879|NCT02413411|Replacement|replacement
4835880|NCT02413411|Intervention|intervention
4835881|NCT02413385|lifestyle intervention|lifestyle intervention
4835882|NCT02413385|physical activity|physical activity
4835883|NCT02413385|exercise|exercise
4835884|NCT02413385|eHealth|ehealth
4835885|NCT02413385|technology|technology
4835886|NCT02413385|coaching|coaching
4835887|NCT02413385|healthy eating|healthy eating
4835888|NCT02413372|First Line Therapy|first line therapy
4835889|NCT02413372|NASH|nash
4835890|NCT02413333|Contact lens solution|contact lens solution
4835891|NCT02413320|TNBC, breast cancer, neoadjuvant, carboplatin, docetaxel, paclitaxel, doxorubicin, cyclophosphamide|tnbc, breast cancer, neoadjuvant, carboplatin, docetaxel, paclitaxel, doxorubicin, cyclophosphamide
4835892|NCT02413307|Compassion Focused Therapy|compassion focused therapy
4835893|NCT02413281|Healthy Volunteer|healthy volunteer
4835894|NCT02413281|Abuse Liability|abuse liability
4835895|NCT02413281|ALKS 5461|alks 5461
4835896|NCT02413281|Alkermes|alkermes
4835897|NCT02413255|Drug therapy|drug therapy
4835898|NCT02413242|S. aureus|s. aureus
4835899|NCT02413242|P. aeruginosa|p. aeruginosa
4835900|NCT02413242|Colonization|colonization
4835901|NCT02413242|Pneumonia|pneumonia
4835902|NCT02413242|ICU|icu
4835903|NCT02413216|Tic Disorder|tic disorder
4835904|NCT02413216|Tourette|tourette
4835905|NCT02413216|Motor tic|motor tic
4835906|NCT02413216|Vocal tic|vocal tic
4835907|NCT02413216|Habit reversal training|habit reversal training
4835908|NCT02413216|CBIT|cbit
4835909|NCT02413216|TicHelper|tichelper
4835910|NCT02413216|Behavior Therapy|behavior therapy
4835911|NCT02413203|lipidomics|lipidomics
4835912|NCT02413203|ex vivo human whole blood assay|ex vivo human whole blood assay
4835913|NCT02413203|celecoxib|celecoxib
4835914|NCT02413203|selective COX-2 inhibitor|selective cox-2 inhibitor
4835915|NCT02413164|Schizophrenia|schizophrenia
4835916|NCT02413164|Mental Health|mental health
4835917|NCT02413164|Physical Therapy|physical therapy
4835918|NCT02413164|Quality of life|quality of life
4835919|NCT02413164|Stigma|stigma
4835920|NCT02413164|Positive and negative symptoms|positive and negative symptoms
4835921|NCT02413164|Physical fitness|physical fitness
4835922|NCT02413164|Physical activity|physical activity
4835923|NCT02413151|Exercise training|exercise training
4835924|NCT02413151|Cardiac resynchronization therapy|cardiac resynchronization therapy
4835925|NCT02413151|Autonomic nervous system modulation|autonomic nervous system modulation
4835926|NCT02413151|Chronic Heart failure|chronic heart failure
4835927|NCT02413138|GHD|ghd
4835928|NCT02413112|Aging|aging
4835929|NCT02413112|Sarcopenia|sarcopenia
4835930|NCT02413112|Resistance training|resistance training
4835931|NCT02413112|Strength|strength
4835932|NCT02413112|Muscle mass|muscle mass
4835933|NCT02413086|diabetic foot ulcer|diabetic foot ulcer
4835934|NCT02413086|early-stage amputation|early-stage amputation
4835935|NCT02413086|external therapy of herbs chitosan|external therapy of herbs chitosan
4835936|NCT02413086|wound surface healing|wound surface healing
4835937|NCT02413073|whole body vibration|whole body vibration
4835938|NCT02413073|kidney disease|kidney disease
4835939|NCT02413034|antibiotic|antibiotic
4835940|NCT02413021|Acute Myeloid Leukemia|acute myeloid leukemia
4835941|NCT02413021|Acute Lymphoid Leukemia|acute lymphoid leukemia
4835942|NCT02413021|deferasirox|deferasirox
4835943|NCT02412995|sea buckthorn|sea buckthorn
4835944|NCT02412995|strawberry|strawberry
4835945|NCT02412995|glucose response|glucose response
4835946|NCT02412995|satiety|satiety
4835947|NCT02412995|metabolomics|metabolomics
4835948|NCT02412995|intake biomarker|intake biomarker
4835949|NCT02412956|mHealth|mhealth
4835950|NCT02412904|follicular stimulating hormone|follicular stimulating hormone
4835951|NCT02412904|human menopausal gonadotrophin|human menopausal gonadotrophin
4835952|NCT02412904|Recombinant follicular stimulating hormone (rFSH)|recombinant follicular stimulating hormone (rfsh)
4835953|NCT02412904|Gonadotrophin releasing hormone (GnRH) antagonists|gonadotrophin releasing hormone (gnrh) antagonists
4835954|NCT02412904|GnRH agonist|gnrh agonist
4835955|NCT02412904|in vitro fertilization|in vitro fertilization
4835956|NCT02412904|controled ovarian stimulation|controled ovarian stimulation
4835957|NCT02412904|number of mature oocytes|number of mature oocytes
4835958|NCT02412891|introduction of urinary catheter|introduction of urinary catheter
4835959|NCT02412865|mhealth|mhealth
4835960|NCT02412852|neuropathy|neuropathy
4835961|NCT02412826|pancreatitis|pancreatitis
4835962|NCT02412826|acoustic|acoustic
4835963|NCT02412826|sensor|sensor
4835964|NCT02412813|hypersensitivity|hypersensitivity
4835965|NCT02412813|metal sensitivity|metal sensitivity
4835966|NCT02412813|arthroplasty|arthroplasty
4835967|NCT02412813|implant-related hypersensitivity|implant-related hypersensitivity
4835968|NCT02412813|metal-on-metal implants|metal-on-metal implants
4835969|NCT02412813|knee revision|knee revision
4835970|NCT02412800|Extravascular lung water|extravascular lung water
4835971|NCT02412800|Pulmonary vascualr permeability index|pulmonary vascualr permeability index
4835972|NCT02412800|Liver transplantation|liver transplantation
4835973|NCT02412774|diet beverages|diet beverages
4835974|NCT02412774|water|water
4835975|NCT02412774|diabetes|diabetes
4835976|NCT02412774|weight loss|weight loss
4835977|NCT02412774|insulin sensitivity|insulin sensitivity
4835978|NCT02412761|Anti-hypertensive medications|anti-hypertensive medications
4835979|NCT02412761|Pediatrics|pediatrics
4835980|NCT02412761|N-of-1 trial|n-of-1 trial
4835981|NCT02412748|Non-Resident|non-resident
4835982|NCT02412748|Fathers|fathers
4835983|NCT02412748|African American|african american
4835984|NCT02412735|Chronic Lumbar Back Pain|chronic lumbar back pain
4835985|NCT02412735|Low back pain|low back pain
4835986|NCT02412735|Back pain|back pain
4835987|NCT02412735|Degenerative Disc Disease|degenerative disc disease
4835988|NCT02412735|Injection of Degenerated Lumbar Disc|injection of degenerated lumbar disc
4835989|NCT02412735|Intervertebral Disc Degeneration|intervertebral disc degeneration
4835990|NCT02412735|Bone Diseases|bone diseases
4835991|NCT02412735|Musculoskeletal Diseases|musculoskeletal diseases
4835992|NCT02412735|Nervous System Diseases|nervous system diseases
4835993|NCT02412735|Neurologic Manifestations|neurologic manifestations
4835994|NCT02412735|Pain|pain
4835995|NCT02412735|Spinal Diseases|spinal diseases
4835996|NCT02412735|Stem Cells|stem cells
4835997|NCT02412735|Adult Stem Cells|adult stem cells
4835998|NCT02412735|Allogeneic Mesenchymal Precursor cells (MPCs)|allogeneic mesenchymal precursor cells (mpcs)
4835999|NCT02412735|Mesoblast|mesoblast
4836000|NCT02412735|Hyaluronic Acid|hyaluronic acid
4836001|NCT02412735|Pharmaceutical Solutions|pharmaceutical solutions
4836002|NCT02412735|Adjuvants, Immunologic|adjuvants, immunologic
4836003|NCT02412735|Immunologic Factors|immunologic factors
4836004|NCT02412735|Pharmacologic Actions|pharmacologic actions
4836005|NCT02412735|Protective Agents|protective agents
4836006|NCT02412735|rexlemestrocel-L|rexlemestrocel-l
4836007|NCT02412735|Viscosupplements|viscosupplements
4836008|NCT02412722|Drug therapy|drug therapy
4836009|NCT02412709|Long QT Syndrome|long qt syndrome
4836010|NCT02412709|LQTS|lqts
4836011|NCT02412709|genetic testing|genetic testing
4836012|NCT02412709|ECG|ecg
4836013|NCT02412709|saliva testing|saliva testing
4836014|NCT02412696|placental morphology|placental morphology
4836015|NCT02412696|CPAP|cpap
4836016|NCT02412696|placental secretory function|placental secretory function
4836017|NCT02412592|HBeAg positive|hbeag positive
4836018|NCT02412592|interferon|interferon
4836019|NCT02412592|peginterferon|peginterferon
4836020|NCT02412592|HBeAg seroconversion|hbeag seroconversion
4836021|NCT02412592|sustained viral response|sustained viral response
4836022|NCT02412592|relapse|relapse
4836023|NCT02412579|HCC|hcc
4836024|NCT02412579|Liver Cancer|liver cancer
4836025|NCT02412566|cholestasis|cholestasis
4836026|NCT02412566|growth failure|growth failure
4836027|NCT02412566|intravenous fat emulsion|intravenous fat emulsion
4836028|NCT02412566|SMOF|smof
4836029|NCT02412514|polio|polio
4836030|NCT02412514|inactivated poliovirus vaccine|inactivated poliovirus vaccine
4836031|NCT02412514|oral poliovirus vaccine|oral poliovirus vaccine
4836032|NCT02412514|IPV|ipv
4836033|NCT02412514|OPV|opv
4836034|NCT02412462|Phase I|phase i
4836035|NCT02412462|Clusterin|clusterin
4836036|NCT02412462|Epithelial-to-Mesenchymal Transition (EMT)|epithelial-to-mesenchymal transition (emt)
4836037|NCT02412462|Circulating Tumor Cells (CTC)|circulating tumor cells (ctc)
4836038|NCT02412462|EMT and Stem Cell Biomarkers|emt and stem cell biomarkers
4836039|NCT02412462|Pharmacokinetics|pharmacokinetics
4836040|NCT02412449|Pharmacokinetics|pharmacokinetics
4836041|NCT02412449|Anemia|anemia
4836042|NCT02412449|Chronic kidney disease|chronic kidney disease
4836043|NCT02412449|CKD|ckd
4836044|NCT02412449|Renal impairment|renal impairment
4836045|NCT02412449|Chronic renal insufficiency|chronic renal insufficiency
4836046|NCT02412449|Ferrous sulfate|ferrous sulfate
4836047|NCT02412449|Iron|iron
4836048|NCT02412449|End stage renal disease|end stage renal disease
4836049|NCT02412449|Dialysis|dialysis
4836050|NCT02412449|Oral anemia treatment|oral anemia treatment
4836051|NCT02412449|Bioavailability|bioavailability
4836052|NCT02412449|Erythropoietin|erythropoietin
4836053|NCT02412449|Hypoxia-inducible factor|hypoxia-inducible factor
4836054|NCT02412449|Volunteers|volunteers
4836055|NCT02412410|laborist|laborist
4836056|NCT02412410|efficacy|efficacy
4836057|NCT02412410|sleep|sleep
4836058|NCT02412410|fatigue|fatigue
4836059|NCT02412410|SAFTE|safte
4836060|NCT02412410|cognition|cognition
4836061|NCT02412397|Shoulder|shoulder
4836062|NCT02412384|Lung Neoplasms|lung neoplasms
4836063|NCT02412384|Circulating Tumor Cells|circulating tumor cells
4836064|NCT02412371|veliparib|veliparib
4836065|NCT02412371|PARP inhibitor|parp inhibitor
4836066|NCT02412371|ABT-888|abt-888
4836067|NCT02412371|first line|first line
4836068|NCT02412371|previously untreated|previously untreated
4836069|NCT02412371|stage III|stage iii
4836070|NCT02412371|non-small cell lung cancer|non-small cell lung cancer
4836071|NCT02412371|radiotherapy|radiotherapy
4836072|NCT02412371|paclitaxel|paclitaxel
4836073|NCT02412371|carboplatin|carboplatin
4836074|NCT02412358|toothbrushing|toothbrushing
4836075|NCT02412358|plaque control|plaque control
4836076|NCT02412358|gingivitis|gingivitis
4836077|NCT02412345|Erectile Dysfunction|erectile dysfunction
4836078|NCT02412345|Shockwave therapy|shockwave therapy
4836079|NCT02412345|Renal Transplant|renal transplant
4836080|NCT02412345|Male|male
4836081|NCT02412345|Renal Transplant Recipients|renal transplant recipients
4836082|NCT02412332|advanced COPD (stage III)|advanced copd (stage iii)
4836083|NCT02412332|Adult stem cells|adult stem cells
4836084|NCT02412332|Cell therapy|cell therapy
4836085|NCT02412319|HBeAg positive chronic hepatitis B|hbeag positive chronic hepatitis b
4836086|NCT02412319|HBeAg serum conversion rate|hbeag serum conversion rate
4836087|NCT02412319|HBeAg serum disappearance rate|hbeag serum disappearance rate
4836088|NCT02412319|HBeAg and HBsAg titer|hbeag and hbsag titer
4836089|NCT02412306|Amgen|amgen
4836090|NCT02412293|Perinatal|perinatal
4836091|NCT02412293|neonatal|neonatal
4836092|NCT02412293|newborn|newborn
4836093|NCT02412293|mortality|mortality
4836094|NCT02412189|Anesthesia|anesthesia
4836095|NCT02412189|Blood pressure|blood pressure
4836096|NCT02412189|Plasma volume|plasma volume
4836097|NCT02412189|Vasopressor agents|vasopressor agents
4836098|NCT02412189|Continuous noninvasive hemoglobin measurement|continuous noninvasive hemoglobin measurement
4836099|NCT02412189|Coronary artery bypass|coronary artery bypass
4836100|NCT02412176|pacemaker|pacemaker
4836101|NCT02412176|dyssynchrony|dyssynchrony
4836102|NCT02412176|apical pacing|apical pacing
4836103|NCT02412176|mid-septum|mid-septum
4836104|NCT02412098|Hepatic Impairment|hepatic impairment
4836105|NCT02412085|golimumab|golimumab
4836106|NCT02412085|ulcerative colitis|ulcerative colitis
4836107|NCT02412085|steroid-dependent|steroid-dependent
4836108|NCT02412072|Endometrial hyperplasia|endometrial hyperplasia
4836109|NCT02412072|Progesterone|progesterone
4836110|NCT02412072|LNG-IUS|lng-ius
4836111|NCT02412072|dilatation & curettage|dilatation & curettage
4836112|NCT02412072|endometrial aspiration sampling|endometrial aspiration sampling
4836113|NCT02412046|Pressure ulcer|pressure ulcer
4836114|NCT02412046|Interface pressure|interface pressure
4836115|NCT02412046|Pressure mapping device|pressure mapping device
4836116|NCT02412046|Ischemia reperfusion|ischemia reperfusion
4836117|NCT02412046|Monitoring|monitoring
4836118|NCT02412046|Microvascularization|microvascularization
4836119|NCT02412033|vaginal misoprostol|vaginal misoprostol
4836120|NCT02412007|spastic diplegia;cerebral palsy;activity based therapy|spastic diplegia;cerebral palsy;activity based therapy
4836121|NCT02411981|Lung Clearance Index|lung clearance index
4836122|NCT02411981|Non cystic fibrosis Bronchiectasis|non cystic fibrosis bronchiectasis
4836123|NCT02411981|Multiple Breath Nitrogen Washout|multiple breath nitrogen washout
4836124|NCT02411968|Cryosurgery|cryosurgery
4836125|NCT02411968|Carcinoma, renal cell|carcinoma, renal cell
4836126|NCT02411968|Diagnostic Imaging|diagnostic imaging
4836127|NCT02411968|Diagnostic techniques, urological|diagnostic techniques, urological
4836128|NCT02411968|Radionuclide imaging|radionuclide imaging
4836129|NCT02411968|Follow up|follow up
4836130|NCT02411903|Clopidogrel-drug interactions|clopidogrel-drug interactions
4836131|NCT02411890|postoperative pain|postoperative pain
4836132|NCT02411890|femoral nerve block|femoral nerve block
4836133|NCT02411890|adductor canal block|adductor canal block
4836134|NCT02411890|anterior cruciate ligament reconstruction|anterior cruciate ligament reconstruction
4836135|NCT02411877|Acute ischemic stroke|acute ischemic stroke
4836136|NCT02411877|Mild hypothermia|mild hypothermia
4836137|NCT02411877|Stroke|stroke
4836138|NCT02411877|Hypothermia|hypothermia
4836139|NCT02411877|Cerebral infarction|cerebral infarction
4836140|NCT02411877|Ischemia|ischemia
4836141|NCT02411877|Cerebrovascular disorder|cerebrovascular disorder
4836142|NCT02411877|Brain disease|brain disease
4836143|NCT02411877|Central nervous system disease|central nervous system disease
4836144|NCT02411877|Nervous system disease|nervous system disease
4836145|NCT02411877|Vascular disease|vascular disease
4836146|NCT02411877|Cardiovascular disease|cardiovascular disease
4836147|NCT02411877|Brain infarction|brain infarction
4836148|NCT02411877|Brain ischemia|brain ischemia
4836149|NCT02411877|Pathologic process|pathologic process
4836150|NCT02411877|Body temperature change|body temperature change
4836151|NCT02411877|Signs and symptoms|signs and symptoms
4836152|NCT02411864|IVIM|ivim
4836153|NCT02411864|brain|brain
4836154|NCT02411864|diffusion-weighted imaging|diffusion-weighted imaging
4836155|NCT02411851|Actinic Keratoses|actinic keratoses
4836156|NCT02411838|Multiple sclerosis|multiple sclerosis
4836157|NCT02411838|calorie restriction|calorie restriction
4836158|NCT02411838|adipokines|adipokines
4836159|NCT02411812|Orthodontic Appliances, Functional|orthodontic appliances, functional
4836160|NCT02411812|Herbst Appliance|herbst appliance
4836161|NCT02411812|Malocclusion, Angle Class II|malocclusion, angle class ii
4836162|NCT02411760|MRI|mri
4836163|NCT02411747|Medical|medical
4836164|NCT02411747|Urology|urology
4836165|NCT02411747|Randomized Controlled Trial|randomized controlled trial
4836166|NCT02411747|Endoscopy|endoscopy
4836167|NCT02411747|Cystoscopy|cystoscopy
4836168|NCT02411721|Anxiety|anxiety
4836169|NCT02411721|Dog Intervention|dog intervention
4836170|NCT02411721|MRI|mri
4836171|NCT02411721|Children|children
4836172|NCT02411695|Adolescent|adolescent
4836173|NCT02411695|Otsuka,|otsuka,
4836174|NCT02411695|Brexpiprazole|brexpiprazole
4836175|NCT02411669|Patient centred care|patient centred care
4836176|NCT02411656|Breast cancer|breast cancer
4836177|NCT02411656|Metastatic inflammatory breast cancer|metastatic inflammatory breast cancer
4836178|NCT02411656|MIBC|mibc
4836179|NCT02411656|IBC|ibc
4836180|NCT02411656|Breast carcinoma|breast carcinoma
4836181|NCT02411656|Metastatic|metastatic
4836182|NCT02411656|MK-3475|mk-3475
4836183|NCT02411656|Keytruda|keytruda
4836184|NCT02411656|Pembrolizumab|pembrolizumab
4836185|NCT02411656|SCH-900475|sch-900475
4836186|NCT02411630|PrEP|prep
4836187|NCT02411630|HIV Prevention|hiv prevention
4836188|NCT02411578|T1D|t1d
4836189|NCT02411578|Type 1 diabetes|type 1 diabetes
4836190|NCT02411578|Mini-dose glucagon|mini-dose glucagon
4836191|NCT02411578|adults|adults
4836192|NCT02411578|non-severe hypoglycemia|non-severe hypoglycemia
4836193|NCT02411565|epithelial|epithelial
4836194|NCT02411565|ovarian|ovarian
4836195|NCT02411565|fallopian tube|fallopian tube
4836196|NCT02411565|primary peritoneal carcinoma|primary peritoneal carcinoma
4836197|NCT02411565|peritoneal|peritoneal
4836198|NCT02411565|ovary|ovary
4836199|NCT02411539|HIV|hiv
4836200|NCT02411539|VRC01|vrc01
4836201|NCT02411500|Healthy|healthy
4836202|NCT02411500|Male|male
4836203|NCT02411500|Pharmacokinetics|pharmacokinetics
4836204|NCT02411474|stem cell transplantation (SCT)|stem cell transplantation (sct)
4836205|NCT02411461|Pediatric obesity|pediatric obesity
4836206|NCT02411461|pseudohypoparathyroidism|pseudohypoparathyroidism
4836207|NCT02411461|Albright Hereditary Osteodystrophy|albright hereditary osteodystrophy
4836208|NCT02411435|rifampin|rifampin
4836209|NCT02411435|drug interaction|drug interaction
4836210|NCT02411435|pharmacokinetics|pharmacokinetics
4836211|NCT02411435|cabotegravir|cabotegravir
4836212|NCT02411422|intubation|intubation
4836213|NCT02411422|cardiopulmonary resuscitation|cardiopulmonary resuscitation
4836215|NCT02411409|Health Information Technology (HIT)|health information technology (hit)
4836216|NCT02411409|self-care|self-care
4836217|NCT02411383|Diaphragm pacing|diaphragm pacing
4836218|NCT02411383|Respiratory assistance|respiratory assistance
4836219|NCT02411383|Lung transplant|lung transplant
4836220|NCT02411357|Contraception|contraception
4836221|NCT02411357|Unintended pregnancy|unintended pregnancy
4836222|NCT02411357|HIV risk|hiv risk
4836223|NCT02411357|Sexually transmitted infections|sexually transmitted infections
4836224|NCT02411357|Women|women
4836225|NCT02411357|Pregnancy|pregnancy
4836226|NCT02411357|Neonatal health|neonatal health
4836227|NCT02411357|Drug use|drug use
4836228|NCT02411357|Drug treatment|drug treatment
4836229|NCT02411357|Opioids|opioids
4836230|NCT02411344|HER2+/HR+|her2+/hr+
4836231|NCT02411344|breast cancer|breast cancer
4836232|NCT02411331|Lock Solution|lock solution
4836233|NCT02411331|Catheter related blood stream infections|catheter related blood stream infections
4836234|NCT02411331|Central venous catheter infection|central venous catheter infection
4836235|NCT02411331|Intravenous Drug Delivery Systems|intravenous drug delivery systems
4836236|NCT02411331|Coagulase-negative staphylococci infection|coagulase-negative staphylococci infection
4836237|NCT02411331|Ethanol lock solution|ethanol lock solution
4836362|NCT02410720|Adherence|adherence
4836238|NCT02411331|Vancomycin lock solution|vancomycin lock solution
4836239|NCT02411279|Heart failure|heart failure
4836240|NCT02411279|telemonitoring|telemonitoring
4836241|NCT02411279|intrusive sensors|intrusive sensors
4836242|NCT02411279|intrusive devices|intrusive devices
4836243|NCT02411279|Heart failure stage II|heart failure stage ii
4836244|NCT02411279|Heart failure stage III|heart failure stage iii
4836245|NCT02411279|heart disease|heart disease
4836246|NCT02411253|IL2|il2
4836247|NCT02411253|Interleukin 2|interleukin 2
4836248|NCT02411253|IL-2|il-2
4836249|NCT02411253|Auto-immune disease|auto-immune disease
4836250|NCT02411253|Insulin|insulin
4836251|NCT02411253|Diabetes|diabetes
4836252|NCT02411253|Regulatory T cells|regulatory t cells
4836253|NCT02411253|Treg|treg
4836254|NCT02411253|Immunoregulation|immunoregulation
4836255|NCT02411253|Immune tolerance|immune tolerance
4836256|NCT02411253|Immunotherapy|immunotherapy
4836257|NCT02411240|Air filtration|air filtration
4836258|NCT02411240|cardiovascular health|cardiovascular health
4836259|NCT02411240|cognition|cognition
4836260|NCT02411240|particulate matter|particulate matter
4836261|NCT02411240|mitochondrial DNA|mitochondrial dna
4836262|NCT02411227|Neuropsychologic Testing|neuropsychologic testing
4836263|NCT02411227|Neurocognitive|neurocognitive
4836264|NCT02411227|Virtual Reality|virtual reality
4836265|NCT02411227|Rehabilitation|rehabilitation
4836266|NCT02411227|Driving|driving
4836267|NCT02411175|Constipation|constipation
4836268|NCT02411175|Homeopathy|homeopathy
4836269|NCT02411162|atopic dermatitis|atopic dermatitis
4836270|NCT02411162|FLIM|flim
4836271|NCT02411162|chronic plaque psoriasis|chronic plaque psoriasis
4836272|NCT02411162|healthy volunteers|healthy volunteers
4836273|NCT02411162|GSK2894512|gsk2894512
4836274|NCT02411162|Skin residency|skin residency
4836275|NCT02411149|Adductor Canal Block|adductor canal block
4836276|NCT02411149|Total Knee Arthroplasty|total knee arthroplasty
4836277|NCT02411123|PGx|pgx
4836278|NCT02411123|pharmacogenetics|pharmacogenetics
4836279|NCT02411123|depression|depression
4836280|NCT02411123|anxiety|anxiety
4836281|NCT02411123|Neuropsychiatric diseases|neuropsychiatric diseases
4836282|NCT02411123|IDgenetix|idgenetix
4836283|NCT02411123|AltheaDx|altheadx
4836284|NCT02411097|Deep venous thromboembolism|deep venous thromboembolism
4836285|NCT02411097|Femoral nerve block|femoral nerve block
4836286|NCT02411097|Total knee arthroplasty|total knee arthroplasty
4836287|NCT02411084|Graft vs Host Disease|graft vs host disease
4836288|NCT02411084|Immune System Diseases|immune system diseases
4836289|NCT02411084|Dipeptidyl Peptidase 4|dipeptidyl peptidase 4
4836290|NCT02411084|CD4-Positive T-Lymphocytes|cd4-positive t-lymphocytes
4836291|NCT02411084|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
4836292|NCT02411071|HIV-1|hiv-1
4836293|NCT02411071|antiretroviral treatment|antiretroviral treatment
4836294|NCT02411071|low viral load|low viral load
4836295|NCT02411071|low-level viremia|low-level viremia
4836296|NCT02411058|information|information
4836297|NCT02411058|incentives|incentives
4836298|NCT02411045|Indirect incentives|indirect incentives
4836299|NCT02411045|Exercise more|exercise more
4836300|NCT02411019|Phase 2 follow up|phase 2 follow up
4836301|NCT02411019|Cervical Intraepithelial Neoplasia|cervical intraepithelial neoplasia
4836302|NCT02411019|Adult|adult
4836303|NCT02411019|Safety|safety
4836304|NCT02411019|Efficacy|efficacy
4836305|NCT02410941|Randomized controlled trial|randomized controlled trial
4836306|NCT02410941|Practice management|practice management
4836307|NCT02410941|tomography, x-ray computed/adverse effects|tomography, x-ray computed/adverse effects
4836308|NCT02410941|Clinical decision support|clinical decision support
4836309|NCT02410941|Computerized clinical decision support|computerized clinical decision support
4836310|NCT02410941|Decision support systems, clinical|decision support systems, clinical
4836311|NCT02410941|Health Expenditures|health expenditures
4836312|NCT02410941|Physician's practice patterns|physician's practice patterns
4836313|NCT02410941|Unnecessary Procedures/economics|unnecessary procedures/economics
4836314|NCT02410941|Physician's Practice Patterns/economics|physician's practice patterns/economics
4836315|NCT02410941|Diffusion of innovation|diffusion of innovation
4836316|NCT02410941|Decision Support Models|decision support models
4836317|NCT02410941|Clinical Prediction Rules|clinical prediction rules
4836318|NCT02410915|Rehabilitation|rehabilitation
4836319|NCT02410915|Robotics|robotics
4836320|NCT02410902|Autism|autism
4836321|NCT02410876|Bladder|bladder
4836322|NCT02410876|neurogenic lower urinary tract dysfunction|neurogenic lower urinary tract dysfunction
4836323|NCT02410876|benign prostatic obstruction|benign prostatic obstruction
4836324|NCT02410863|Stage III or IV with BRAF V600E/K mutation|stage iii or iv with braf v600e/k mutation
4836325|NCT02410850|Oral Appliance|oral appliance
4836326|NCT02410850|objective adherence|objective adherence
4836327|NCT02410850|cardiovascular events|cardiovascular events
4836328|NCT02410850|cardiovascular mortality|cardiovascular mortality
4836329|NCT02410850|cerebrovascular mortality|cerebrovascular mortality
4836330|NCT02410850|cost effectiveness|cost effectiveness
4836331|NCT02410837|lung lesion|lung lesion
4836332|NCT02410837|biopsy|biopsy
4836333|NCT02410837|bronchoscopy|bronchoscopy
4836334|NCT02410811|Sickle Cell Disease (SCD)|sickle cell disease (scd)
4836335|NCT02410811|Cardiac Magnetic Resonance Imaging (CMR)|cardiac magnetic resonance imaging (cmr)
4836336|NCT02410811|Cardiomyopathy|cardiomyopathy
4836337|NCT02410811|Pulmonary Hypertension|pulmonary hypertension
4836338|NCT02410785|obesity,|obesity,
4836339|NCT02410785|body weight,|body weight,
4836340|NCT02410785|overweight,|overweight,
4836341|NCT02410785|weight loss,|weight loss,
4836342|NCT02410785|polyglucosamine,|polyglucosamine,
4836343|NCT02410785|L112|l112
4836344|NCT02410785|caloric restriction|caloric restriction
4836345|NCT02410785|physical activity|physical activity
4836346|NCT02410746|pain|pain
4836347|NCT02410746|surgery|surgery
4836348|NCT02410733|melanoma|melanoma
4836349|NCT02410733|Lipo-MERIT|lipo-merit
4836350|NCT02410733|cancer vaccine|cancer vaccine
4836351|NCT02410733|RB_0003-01|rb_0003-01
4836352|NCT02410733|BioNTech|biontech
4836353|NCT02410733|BioNTech RNA Pharmaceuticals|biontech rna pharmaceuticals
4836354|NCT02410733|BioNTech RNA|biontech rna
4836355|NCT02410733|RNA|rna
4836356|NCT02410720|Colonoscopy Preparation|colonoscopy preparation
4836357|NCT02410720|Polyethylene Glycols|polyethylene glycols
4836358|NCT02410720|Mobile application|mobile application
4836359|NCT02410720|Software|software
4836360|NCT02410720|Compliance|compliance
4836361|NCT02410720|Patient Compliance|patient compliance
4836363|NCT02410707|procedural sedation|procedural sedation
4836364|NCT02410707|procedural pain|procedural pain
4836365|NCT02410707|procedural anxiolysis|procedural anxiolysis
4836366|NCT02410655|Uterine atony|uterine atony
4836367|NCT02410655|Postpartum hemorrhage|postpartum hemorrhage
4836368|NCT02410655|Vaginal delivery|vaginal delivery
4836369|NCT02410655|Uterotonic|uterotonic
4836370|NCT02410655|Oxytocin|oxytocin
4836371|NCT02410655|Bolus|bolus
4836372|NCT02410655|Evidence-based|evidence-based
4836373|NCT02410655|Protocol|protocol
4836374|NCT02410642|cardiopulmonary bypass|cardiopulmonary bypass
4836375|NCT02410629|Stroke|stroke
4836376|NCT02410616|Psychotherapy|psychotherapy
4836377|NCT02410616|Comparative Effectiveness Research|comparative effectiveness research
4836378|NCT02410616|Randomized Controlled Trial|randomized controlled trial
4836379|NCT02410616|Secondary Care|secondary care
4836380|NCT02410603|Chemotherapy|chemotherapy
4836381|NCT02410577|89Zr-J591|89zr-j591
4836382|NCT02410577|15-002|15-002
4836383|NCT02410564|insomnia|insomnia
4836384|NCT02410564|Sleep|sleep
4836385|NCT02410564|CBT-I intervention|cbt-i intervention
4836386|NCT02410564|SHUTi|shuti
4836387|NCT02410551|Myeloproliferative Diseases|myeloproliferative diseases
4836388|NCT02410551|Myeloproliferative Neoplasms|myeloproliferative neoplasms
4836389|NCT02410551|MPN|mpn
4836390|NCT02410551|Myelofibrosis|myelofibrosis
4836391|NCT02410551|Polycythemia vera|polycythemia vera
4836392|NCT02410551|PV|pv
4836393|NCT02410551|Essential thrombocythemia|essential thrombocythemia
4836394|NCT02410551|Allogeneic stem cell transplantation|allogeneic stem cell transplantation
4836395|NCT02410551|Allo TP|allo tp
4836396|NCT02410551|Pacritinib|pacritinib
4836397|NCT02410551|Busulfan|busulfan
4836398|NCT02410551|Busulfex|busulfex
4836399|NCT02410551|Myleran|myleran
4836400|NCT02410551|Questionnaires|questionnaires
4836401|NCT02410551|Surveys|surveys
4836402|NCT02410551|Phone calls|phone calls
4836403|NCT02410525|hyperlipidemia|hyperlipidemia
4836404|NCT02410525|positron emission tomography|positron emission tomography
4836405|NCT02410499|Drug therapy|drug therapy
4836406|NCT02410473|Congenital Heart Disease|congenital heart disease
4836407|NCT02410473|Point-of-care coagulation monitoring|point-of-care coagulation monitoring
4836408|NCT02410447|Shock waves|shock waves
4836409|NCT02410434|Stigma|stigma
4836410|NCT02410434|lesbian|lesbian
4836411|NCT02410434|gay|gay
4836412|NCT02410434|bisexual|bisexual
4836413|NCT02410434|transgender|transgender
4836414|NCT02410421|Individualized Medicine|individualized medicine
4836415|NCT02410421|Functional Neuroimaging|functional neuroimaging
4836416|NCT02410421|Robotic Proceedure|robotic proceedure
4836417|NCT02410421|Transcranial Magnetic Stimulation, Repetitive|transcranial magnetic stimulation, repetitive
4836418|NCT02410421|Transcranial Direct Current Stimulation Monocentric|transcranial direct current stimulation monocentric
4836419|NCT02410421|Compariative Cross-Over 3 Arms Study Randomized, Single-Blind Method|compariative cross-over 3 arms study randomized, single-blind method
4836420|NCT02410408|Patient Safety|patient safety
4836421|NCT02410408|App|app
4836422|NCT02410408|Root Cause Analysis|root cause analysis
4836423|NCT02410408|Patient Safety Certification|patient safety certification
4836424|NCT02410382|cancer|cancer
4836425|NCT02410382|radiation therapy|radiation therapy
4836426|NCT02410382|chemotherapy|chemotherapy
4836427|NCT02410382|dexamethasone|dexamethasone
4836428|NCT02410382|corticosteroids|corticosteroids
4836429|NCT02410343|long acting growth hormone|long acting growth hormone
4836430|NCT02410330|Therapeutic ultrasound|therapeutic ultrasound
4836431|NCT02410330|Angiographic recanalization rate|angiographic recanalization rate
4836432|NCT02410330|Salvagability index|salvagability index
4836433|NCT02410330|Sonothrombolysis|sonothrombolysis
4836434|NCT02410317|Postoperative pain|postoperative pain
4836435|NCT02410317|Postoperative morphine consumption|postoperative morphine consumption
4836436|NCT02410317|Emergency cesarean delivery|emergency cesarean delivery
4836437|NCT02410317|Ropivacaine|ropivacaine
4836438|NCT02410317|Local anesthetic wound 48-hours infusion|local anesthetic wound 48-hours infusion
4836439|NCT02410317|Emergency cesarean section|emergency cesarean section
4836440|NCT02410304|Rheumatoid arthritis / ultrasonography / synovitis|rheumatoid arthritis / ultrasonography / synovitis
4836441|NCT02410265|guided self-help|guided self-help
4836442|NCT02410265|student mental health|student mental health
4836443|NCT02410265|task shifting|task shifting
4836444|NCT02410265|prevention|prevention
4836445|NCT02410252|continuous temperature monitoring|continuous temperature monitoring
4836446|NCT02410252|patient self-management|patient self-management
4836447|NCT02410252|iThermonitor|ithermonitor
4836448|NCT02410252|Home monitoring|home monitoring
4836449|NCT02410239|Cerebral Adrenoleukodystrophy|cerebral adrenoleukodystrophy
4836450|NCT02410239|cALD|cald
4836451|NCT02410200|Pediatrics|pediatrics
4836452|NCT02410187|stereotactic body radiotherapy|stereotactic body radiotherapy
4836453|NCT02410174|Renal Cell Carcinoma|renal cell carcinoma
4836454|NCT02410174|RCC|rcc
4836455|NCT02410174|Stereotactic Body Radiotherapy|stereotactic body radiotherapy
4836456|NCT02410174|SBRT|sbrt
4836457|NCT02410161|ketone|ketone
4836458|NCT02410161|α-linolenic acid|α-linolenic acid
4836459|NCT02410161|flaxseed|flaxseed
4836460|NCT02410161|aging|aging
4836461|NCT02410161|β-hydroxybutyrate|β-hydroxybutyrate
4836462|NCT02410161|acetoacetate|acetoacetate
4836463|NCT02410161|omega-3 fatty acids|omega-3 fatty acids
4836464|NCT02410161|ketogenesis|ketogenesis
4836465|NCT02410148|open-angle glaucoma|open-angle glaucoma
4836466|NCT02410148|papilledema|papilledema
4836467|NCT02410148|non-invasive ICP|non-invasive icp
4836468|NCT02410148|Intracranial pressure|intracranial pressure
4836469|NCT02410135|Lower Urinary Tract Symptoms|lower urinary tract symptoms
4836470|NCT02410135|Sleep Disturbance|sleep disturbance
4836471|NCT02410096|exercise-induced asthma|exercise-induced asthma
4836472|NCT02410096|cold chamber|cold chamber
4836473|NCT02410096|exercise challenge|exercise challenge
4836474|NCT02410096|cold air challenge|cold air challenge
4836475|NCT02410096|oil supplementation|oil supplementation
4836476|NCT02410096|middle-chain and Polyunsaturated Fatty Acids|middle-chain and polyunsaturated fatty acids
4836477|NCT02410070|Distal radial fracture|distal radial fracture
4836478|NCT02410070|pronator quadratus|pronator quadratus
4836479|NCT02410070|mini-approach|mini-approach
4836480|NCT02410070|volar plating|volar plating
4836481|NCT02410070|open reduction and internal fixation|open reduction and internal fixation
4836482|NCT02410057|growth|growth
4836483|NCT02410057|formula|formula
4836484|NCT02410057|protein|protein
4836485|NCT02410057|alpha-lactalbumin|alpha-lactalbumin
4836486|NCT02410057|amino acids|amino acids
4836487|NCT02410044|Patient Reported Outcomes|patient reported outcomes
4836488|NCT02409992|Children with ODD and low prosocial emotions|children with odd and low prosocial emotions
4836489|NCT02409979|colonoscopy|colonoscopy
4836490|NCT02409979|carbon dioxide|carbon dioxide
4836491|NCT02409979|water exchange|water exchange
4836492|NCT02409979|discomfort|discomfort
4836493|NCT02409979|colonoscopy pain|colonoscopy pain
4836494|NCT02409966|periodontitis|periodontitis
4836495|NCT02409966|therapeutics|therapeutics
4836496|NCT02409966|quality of life|quality of life
4836497|NCT02409966|fear|fear
4836498|NCT02409966|anxiety|anxiety
4836499|NCT02409966|pain|pain
4836500|NCT02409953|volunteers|volunteers
4836501|NCT02409927|Medium-chain triglycerides|medium-chain triglycerides
4836502|NCT02409927|Metabolism|metabolism
4836503|NCT02409927|Ketones|ketones
4836504|NCT02409927|Lipids|lipids
4836505|NCT02409927|Emulsification|emulsification
4836506|NCT02409914|Insulin Resistance|insulin resistance
4836507|NCT02409914|Brain metabolism|brain metabolism
4836508|NCT02409914|PET|pet
4836509|NCT02409914|MRI|mri
4836510|NCT02409901|Physical Activity|physical activity
4836511|NCT02409901|Exercise Rehabilitation|exercise rehabilitation
4836512|NCT02409901|Kidney Function|kidney function
4836513|NCT02409901|Employment|employment
4836514|NCT02409901|Kidney Transplant|kidney transplant
4836515|NCT02409875|early intervention|early intervention
4836516|NCT02409875|obesity|obesity
4836517|NCT02409875|body weight|body weight
4836518|NCT02409875|body mass index|body mass index
4836519|NCT02409875|overnutrition|overnutrition
4836520|NCT02409875|early promoters, genetic|early promoters, genetic
4836521|NCT02409862|oxytocin|oxytocin
4836522|NCT02409862|socioemotional functioning|socioemotional functioning
4836523|NCT02409862|aging|aging
4836524|NCT02409849|Octreotide LAR|octreotide lar
4836525|NCT02409849|Neuroendocrine carcinomas|neuroendocrine carcinomas
4836526|NCT02409849|unresectable or metastatic|unresectable or metastatic
4836527|NCT02409849|Disease-free survival|disease-free survival
4836528|NCT02409823|adverse drug reactions|adverse drug reactions
4836529|NCT02409823|adherence to treatment|adherence to treatment
4836530|NCT02409823|quality of life|quality of life
4836531|NCT02409823|clinical status|clinical status
4836532|NCT02409784|Brain metabolism|brain metabolism
4836533|NCT02409784|Ketones|ketones
4836534|NCT02409784|Ketogenic diet|ketogenic diet
4836535|NCT02409784|TEP scan|tep scan
4836536|NCT02409758|Voice disorders|voice disorders
4836537|NCT02409758|Hoarseness|hoarseness
4836538|NCT02409758|Therapy|therapy
4836539|NCT02409745|endometrial scratch|endometrial scratch
4836540|NCT02409745|IVF|ivf
4836541|NCT02409745|randomized controlled study|randomized controlled study
4836542|NCT02409745|Prospective controlled trial|prospective controlled trial
4836543|NCT02409745|Different time to perform endometrial scratch|different time to perform endometrial scratch
4836544|NCT02409745|In vitro fertilization|in vitro fertilization
4836545|NCT02409745|embryo transfer|embryo transfer
4836546|NCT02409732|Actinic cheilitis|actinic cheilitis
4836547|NCT02409732|Photodynamic therapy|photodynamic therapy
4836548|NCT02409732|Levulan|levulan
4836549|NCT02409732|Blue light|blue light
4836550|NCT02409719|Arthritis, Degenerative|arthritis, degenerative
4836551|NCT02409719|Recovery of function|recovery of function
4836552|NCT02409706|Paediatric|paediatric
4836553|NCT02409706|Critical care|critical care
4836554|NCT02409706|Micronutrients|micronutrients
4836555|NCT02409680|Preterm birth|preterm birth
4836556|NCT02409680|Low dose aspirin|low dose aspirin
4836557|NCT02409667|plaque, psoriasis|plaque, psoriasis
4836558|NCT02409641|IOL|iol
4836559|NCT02409628|Non-melanoma Skin Cancer|non-melanoma skin cancer
4836560|NCT02409628|Basal Cell Carcinoma|basal cell carcinoma
4836561|NCT02409628|Squamous Cell Carcinoma|squamous cell carcinoma
4836562|NCT02409628|Surgical excision|surgical excision
4836563|NCT02409628|EktoTherix|ektotherix
4836564|NCT02409628|Secondary intention healing|secondary intention healing
4836565|NCT02409628|Acute wound repair|acute wound repair
4836566|NCT02409628|Tissue repair scaffold|tissue repair scaffold
4836567|NCT02409628|Regenerative medicine scaffold|regenerative medicine scaffold
4836568|NCT02409628|Electrospun scaffold|electrospun scaffold
4836569|NCT02409615|Complementary therapies|complementary therapies
4836570|NCT02409615|Hypnosis|hypnosis
4836571|NCT02409615|Healing Touch|healing touch
4836572|NCT02409602|Ultrasonography, Doppler, Color|ultrasonography, doppler, color
4836573|NCT02409602|Postpartum hemorrhage|postpartum hemorrhage
4836574|NCT02409602|Bilateral iliac artery ligation|bilateral iliac artery ligation
4836575|NCT02409602|Dorsal clitoral artery|dorsal clitoral artery
4836576|NCT02409576|EWS|ews
4836577|NCT02409576|OS|os
4836578|NCT02409576|RMS|rms
4836579|NCT02409550|Allergic Rhinitis|allergic rhinitis
4836580|NCT02409550|Asthma|asthma
4836581|NCT02409550|Children|children
4836582|NCT02409550|Control|control
4836583|NCT02409537|Asymptomatic hypercholesterolemia,|asymptomatic hypercholesterolemia,
4836584|NCT02409537|cardiovascular risk,|cardiovascular risk,
4836585|NCT02409537|total antioxidant capacity|total antioxidant capacity
4836586|NCT02409537|red wine polyphenol content|red wine polyphenol content
4836587|NCT02409537|vitamin E.|vitamin e.
4836588|NCT02409537|resveratrol|resveratrol
4836589|NCT02409511|Type 1 Diabetic|type 1 diabetic
4836590|NCT02409511|Type 2 Diabetic|type 2 diabetic
4836591|NCT02409511|Hypertension|hypertension
4836592|NCT02409511|Renal Injury|renal injury
4836593|NCT02409511|Diabetic retinopathy|diabetic retinopathy
4836594|NCT02409498|pudendal nerve block|pudendal nerve block
4836595|NCT02409498|vaginal reconstructive surgery|vaginal reconstructive surgery
4836596|NCT02409485|self-management|self-management
4836597|NCT02409485|head and neck cancer|head and neck cancer
4836598|NCT02409485|psychosocial intervention|psychosocial intervention
4836599|NCT02409485|couples|couples
4836600|NCT02409472|randomized clinical trial|randomized clinical trial
4836601|NCT02409433|lacosamide|lacosamide
4836602|NCT02409433|phenytoin|phenytoin
4836603|NCT02409394|Subjects|subjects
4836604|NCT02409303|Autism Spectrum Disorder|autism spectrum disorder
4836605|NCT02409303|Screening|screening
4836606|NCT02409303|Preventive intervention|preventive intervention
4836607|NCT02409303|Risk|risk
4836608|NCT02409277|Self-Management|self-management
4836609|NCT02409277|Asthma|asthma
4836610|NCT02409264|Insomnia|insomnia
4836611|NCT02409264|Females|females
4836612|NCT02409264|Homeopathy|homeopathy
4836613|NCT02409251|Antinuclear antibody (ANA)|antinuclear antibody (ana)
4836614|NCT02409251|Overuse|overuse
4836615|NCT02409251|Rheumatologists|rheumatologists
4836616|NCT02409251|Quality of care|quality of care
4836617|NCT02409238|Mild Cognitive Impairment|mild cognitive impairment
4836618|NCT02409238|Insulin Resistance|insulin resistance
4836619|NCT02409238|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
4836620|NCT02409225|remote monitoring|remote monitoring
4836621|NCT02409225|ICD|icd
4836622|NCT02409225|CRT-D|crt-d
4836623|NCT02409199|Gastric Carcinoma|gastric carcinoma
4836624|NCT02409199|apatinib|apatinib
4836625|NCT02409173|Metabolic syndrome|metabolic syndrome
4836626|NCT02409173|Sleep disorders|sleep disorders
4836627|NCT02409173|Bariatric Surgery|bariatric surgery
4836628|NCT02409173|Noninvasive ventilation|noninvasive ventilation
4836629|NCT02409173|Inflammation|inflammation
4836630|NCT02409173|Quality of life|quality of life
4836631|NCT02409160|Severe Obesity|severe obesity
4836632|NCT02409160|Sleep Disorders|sleep disorders
4836633|NCT02409160|Bariatric Surgery|bariatric surgery
4836634|NCT02409160|Inflammation|inflammation
4836635|NCT02409160|Quality of Life|quality of life
4836636|NCT02409134|Bone Marrow Transplantation|bone marrow transplantation
4836637|NCT02409134|Hematologic Malignancies|hematologic malignancies
4836638|NCT02409134|Adults|adults
4836639|NCT02409134|Cognition|cognition
4836640|NCT02409121|hematopoietic cell transplantation|hematopoietic cell transplantation
4836641|NCT02409121|caregivers|caregivers
4836642|NCT02409121|health information technology|health information technology
4836643|NCT02409121|patient-centered care|patient-centered care
4836644|NCT02409069|Transcutaneous vagus nerve stimulation|transcutaneous vagus nerve stimulation
4836645|NCT02409069|P300|p300
4836646|NCT02409069|Memory task|memory task
4836647|NCT02409056|intervention|intervention
4836648|NCT02409056|translation|translation
4836649|NCT02409056|workplace|workplace
4836650|NCT02409056|CVD|cvd
4836651|NCT02409056|CDSMP|cdsmp
4836652|NCT02409043|Stroke|stroke
4836653|NCT02409043|Ischemic stroke|ischemic stroke
4836654|NCT02409043|Hemorrhagic stroke|hemorrhagic stroke
4836655|NCT02409043|Biomarkers|biomarkers
4836656|NCT02409043|Angiotensins|angiotensins
4836657|NCT02409017|insulin drip|insulin drip
4836658|NCT02409017|labor|labor
4836659|NCT02409004|Drug-drug interaction|drug-drug interaction
4836660|NCT02408991|Chronic lower limb ischemia|chronic lower limb ischemia
4836661|NCT02408991|Art-Assist Device|art-assist device
4836662|NCT02408991|Neupogen|neupogen
4836663|NCT02408926|Pertussis|pertussis
4836664|NCT02408926|Pregnancy|pregnancy
4836665|NCT02408926|Humoral immune response|humoral immune response
4836666|NCT02408926|Functionality|functionality
4836667|NCT02408926|Vaccination|vaccination
4836668|NCT02408913|Immunity|immunity
4836669|NCT02408913|Ebola Virus|ebola virus
4836670|NCT02408913|Ebola Hemorrhagic Fever|ebola hemorrhagic fever
4836671|NCT02408913|Healthy|healthy
4836672|NCT02408913|Filovirus|filovirus
4836673|NCT02408900|Spasticity|spasticity
4836674|NCT02408900|Primary Lateral Sclerosis|primary lateral sclerosis
4836675|NCT02408900|Elastography|elastography
4836676|NCT02408900|Ultrasound|ultrasound
4836677|NCT02408887|Thyroidectomy|thyroidectomy
4836678|NCT02408887|Serum Thyroglobulin|serum thyroglobulin
4836679|NCT02408887|Quality of Life|quality of life
4836680|NCT02408887|Central Neck Lymph Node Metastasis|central neck lymph node metastasis
4836681|NCT02408887|Central Neck Lymph Node Dissection|central neck lymph node dissection
4836682|NCT02408874|Nanoparticles|nanoparticles
4836683|NCT02408874|Inflammatory Response|inflammatory response
4836684|NCT02408874|Silver|silver
4836685|NCT02408874|Lung Function|lung function
4836686|NCT02408874|Lung Microbiome|lung microbiome
4836687|NCT02408835|negative pressure wound therapy|negative pressure wound therapy
4836688|NCT02408835|lymphadenectomy|lymphadenectomy
4836689|NCT02408835|wound healing|wound healing
4836690|NCT02408809|Orthopaedic Smoking Cessation Discussion|orthopaedic smoking cessation discussion
4836691|NCT02408809|Smoking Cessation|smoking cessation
4836692|NCT02408809|Randomized Controlled Trial|randomized controlled trial
4836693|NCT02408796|Acute otitis media with tympanostomy tubes|acute otitis media with tympanostomy tubes
4836694|NCT02408757|ultrasound|ultrasound
4836695|NCT02408757|cerebral perfusion|cerebral perfusion
4836696|NCT02408757|cerebrospinal fluid drainage|cerebrospinal fluid drainage
4836697|NCT02408744|nephroprotection|nephroprotection
4836698|NCT02408744|pirfenidone|pirfenidone
4836699|NCT02408744|polymorphisms|polymorphisms
4836700|NCT02408718|Mobility|mobility
4836701|NCT02408718|walking aids|walking aids
4836702|NCT02408718|falls|falls
4836703|NCT02408718|gait and balance|gait and balance
4836704|NCT02408705|Endogenous Glucose Production|endogenous glucose production
4836705|NCT02408705|Hypoglycemic clamp|hypoglycemic clamp
4836706|NCT02408705|Tracer to Tracee Technique|tracer to tracee technique
4836707|NCT02408705|Type 1 diabetes mellitus|type 1 diabetes mellitus
4836708|NCT02408692|Emergency contraception|emergency contraception
4836709|NCT02408692|Obese BMI|obese bmi
4836710|NCT02408692|Normal BMI|normal bmi
4836711|NCT02408679|Vitamin D|vitamin d
4836712|NCT02408679|Vitamin D Deficiency|vitamin d deficiency
4836713|NCT02408679|Vitamin D Insufficiency|vitamin d insufficiency
4836714|NCT02408679|Healthy adults|healthy adults
4836715|NCT02408679|Predictive questionnaire|predictive questionnaire
4836716|NCT02408640|Internet-Based|internet-based
4836717|NCT02408640|Treatment|treatment
4836718|NCT02408549|Lacosamide|lacosamide
4836719|NCT02408549|Vimpat|vimpat
4836720|NCT02408549|Epilepsy|epilepsy
4836721|NCT02408549|Children|children
4836722|NCT02408549|Primary Generalized Tonic Clonic seizures|primary generalized tonic clonic seizures
4836723|NCT02408549|Idiopathic Generalized Epilepsy|idiopathic generalized epilepsy
4836724|NCT02408549|Adults|adults
4836725|NCT02408536|chemotherapy|chemotherapy
4836726|NCT02408536|hormone therapy|hormone therapy
4836727|NCT02408536|borderline|borderline
4836728|NCT02408536|low-grade|low-grade
4836729|NCT02408536|serous ovarian cancer|serous ovarian cancer
4836730|NCT02408523|Lacosamide|lacosamide
4836731|NCT02408523|Vimpat|vimpat
4836732|NCT02408523|Epilepsy|epilepsy
4836733|NCT02408523|Children|children
4836734|NCT02408523|Primary Generalized Tonic Clonic seizures|primary generalized tonic clonic seizures
4836735|NCT02408523|Idiopathic Generalized Epilepsy|idiopathic generalized epilepsy
4836736|NCT02408523|Adults|adults
4836737|NCT02408510|Volunteers|volunteers
4836738|NCT02408471|Arthritis|arthritis
4836739|NCT02408471|Rheumatoid Arthritis|rheumatoid arthritis
4836740|NCT02408471|Systemic Lupus Erythematosus|systemic lupus erythematosus
4836741|NCT02408471|Osteoarthritis|osteoarthritis
4836742|NCT02408471|Autoimmune Diseases|autoimmune diseases
4836743|NCT02408471|Connective Tissue Diseases|connective tissue diseases
4836744|NCT02408471|Immune System Diseases|immune system diseases
4836745|NCT02408471|Joint Diseases|joint diseases
4836746|NCT02408471|Musculoskeletal Diseases|musculoskeletal diseases
4836747|NCT02408471|Rheumatic Diseases|rheumatic diseases
4836748|NCT02408445|body composition|body composition
4836749|NCT02408445|Klinefelter syndrome|klinefelter syndrome
4836750|NCT02408445|XXY|xxy
4836751|NCT02408445|sex chromosome variation|sex chromosome variation
4836752|NCT02408445|sex chromsome aneuploidy|sex chromsome aneuploidy
4836753|NCT02408432|Blood And Marrow Transplantation|blood and marrow transplantation
4836754|NCT02408432|Left ventricular dysfunction|left ventricular dysfunction
4836755|NCT02408432|LV|lv
4836756|NCT02408432|Heart failure secondary to chemotherapy with anthracyclines|heart failure secondary to chemotherapy with anthracyclines
4836757|NCT02408432|Allogeneic human mesenchymal stem cells|allogeneic human mesenchymal stem cells
4836758|NCT02408432|hMSCs|hmscs
4836759|NCT02408432|Standard of care drugs for heart failure|standard of care drugs for heart failure
4836760|NCT02408406|TNM Finding v7|tnm finding v7
4836761|NCT02408393|Surgery|surgery
4836762|NCT02408393|Paravertebral block|paravertebral block
4836763|NCT02408393|Chronic pain|chronic pain
4836764|NCT02408380|biomarker|biomarker
4836765|NCT02408380|disease progression|disease progression
4836766|NCT02408367|Training|training
4836767|NCT02408367|Cognition|cognition
4836768|NCT02408367|Multiple Sclerosis|multiple sclerosis
4836769|NCT02408341|Propofol, Induction anesthesia, Doppler tissue imaging|propofol, induction anesthesia, doppler tissue imaging
4836770|NCT02408315|induction of labor|induction of labor
4836771|NCT02408315|safety|safety
4836772|NCT02408315|pharmacokinetic|pharmacokinetic
4836773|NCT02408315|misoprostol|misoprostol
4836774|NCT02408250|algorithm|algorithm
4836775|NCT02408250|critical illness|critical illness
4836776|NCT02408250|early exercise|early exercise
4836777|NCT02408250|feasibility|feasibility
4836778|NCT02408250|intensive care unit|intensive care unit
4836779|NCT02408250|physical therapy|physical therapy
4836780|NCT02408237|Transcranial direct current stimulation (tDCS)|transcranial direct current stimulation (tdcs)
4836781|NCT02408237|tDCS for domiciliary use|tdcs for domiciliary use
4836782|NCT02408237|Healthy Participants|healthy participants
4836783|NCT02408224|ACS|acs
4836784|NCT02408185|infections|infections
4836785|NCT02408185|multidrug resistant Gram negative bacteria (MDR-GNB)|multidrug resistant gram negative bacteria (mdr-gnb)
4836786|NCT02408185|Skin infections|skin infections
4836787|NCT02408185|Pneumonia|pneumonia
4836788|NCT02408185|Bacteriemia|bacteriemia
4836789|NCT02408185|Nosocomial infections|nosocomial infections
4836790|NCT02408172|hypertension|hypertension
4836791|NCT02408172|Sleep apnea syndrome|sleep apnea syndrome
4836792|NCT02408172|Amlodipine|amlodipine
4836793|NCT02408172|metoprolol|metoprolol
4836794|NCT02408159|Live, attenuated virus varicella-zoster vaccine|live, attenuated virus varicella-zoster vaccine
4836795|NCT02408159|Zostavax|zostavax
4836796|NCT02408159|herpes zoster|herpes zoster
4836797|NCT02408159|shingles|shingles
4836798|NCT02408133|Breast Cancer|breast cancer
4836799|NCT02408133|elderly|elderly
4836800|NCT02408133|quality of life|quality of life
4836801|NCT02408133|exercise|exercise
4836802|NCT02408120|Hyperglycemia|hyperglycemia
4836803|NCT02408120|Hypoglycemia|hypoglycemia
4836804|NCT02408107|Physical activity|physical activity
4836805|NCT02408107|Randomized controlled trial|randomized controlled trial
4836806|NCT02408094|Rheumatoid Arthritis|rheumatoid arthritis
4836912|NCT02407561|adenocarcinoma|adenocarcinoma
4836807|NCT02408094|Heat-dampness and blood stasis syndrome|heat-dampness and blood stasis syndrome
4836808|NCT02408094|Protein markers|protein markers
4836809|NCT02408081|Depression|depression
4836810|NCT02408081|Family functioning|family functioning
4836811|NCT02408081|Family Focused Nursing|family focused nursing
4836812|NCT02408081|Quality of life|quality of life
4836813|NCT02408068|subjects|subjects
4836814|NCT02408029|Focus|focus
4836815|NCT02408029|Testing Performance|testing performance
4836816|NCT02408029|CORA Hemostasis System|cora hemostasis system
4836817|NCT02408003|Transesophageal|transesophageal
4836818|NCT02408003|Echocardiography|echocardiography
4836819|NCT02408003|Milrinone|milrinone
4836820|NCT02408003|Levosimendan|levosimendan
4836821|NCT02408003|Strain|strain
4836822|NCT02408003|Deformation|deformation
4836823|NCT02408003|Diastole|diastole
4836824|NCT02408003|Afterload|afterload
4836825|NCT02408003|Preload|preload
4836826|NCT02408003|Systole|systole
4836827|NCT02407964|Drug-Induced Liver Injury|drug-induced liver injury
4836828|NCT02407964|DILI|dili
4836829|NCT02407938|dysphagia|dysphagia
4836830|NCT02407938|reflux symptoms|reflux symptoms
4836831|NCT02407938|retrosternal pain|retrosternal pain
4836832|NCT02407925|Optical diagnosis|optical diagnosis
4836833|NCT02407899|LADA|lada
4836834|NCT02407899|saxagliptin|saxagliptin
4836835|NCT02407899|vitamin D3|vitamin d3
4836836|NCT02407899|C-Peptide|c-peptide
4836837|NCT02407873|aged of 75 years or more|aged of 75 years or more
4836838|NCT02407860|breast feeding|breast feeding
4836839|NCT02407860|sucking|sucking
4836840|NCT02407860|dysfunction|dysfunction
4836841|NCT02407860|Latch assessment tool|latch assessment tool
4836842|NCT02407860|visual analogic scale|visual analogic scale
4836843|NCT02407860|infant physiology|infant physiology
4836844|NCT02407847|Nurse practitioners|nurse practitioners
4836845|NCT02407847|Primary healthcare|primary healthcare
4836846|NCT02407847|Emergency Medical Services|emergency medical services
4836847|NCT02407847|Substitution of care|substitution of care
4836848|NCT02407834|Biofilms|biofilms
4836849|NCT02407834|Dentures|dentures
4836850|NCT02407834|Denture Cleansers|denture cleansers
4836851|NCT02407834|Castor Oil|castor oil
4836852|NCT02407834|Stomatitis|stomatitis
4836853|NCT02407821|Controlled Clinical Trials, Randomized|controlled clinical trials, randomized
4836854|NCT02407821|Kidney Failure|kidney failure
4836855|NCT02407821|Renal Insufficiency, Chronic|renal insufficiency, chronic
4836856|NCT02407821|Dialysis, Renal|dialysis, renal
4836857|NCT02407821|Peritoneal Dialysis|peritoneal dialysis
4836858|NCT02407821|Hemodialysis|hemodialysis
4836859|NCT02407821|Depressive Symptoms|depressive symptoms
4836860|NCT02407821|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors
4836861|NCT02407821|Antidepressants|antidepressants
4836862|NCT02407821|Escitalopram|escitalopram
4836863|NCT02407795|stereotactic radiotherapy|stereotactic radiotherapy
4836864|NCT02407795|pain reduction|pain reduction
4836865|NCT02407795|quality of life|quality of life
4836866|NCT02407782|Scabies|scabies
4836867|NCT02407782|children|children
4836868|NCT02407782|cluster|cluster
4836869|NCT02407782|permethrin|permethrin
4836870|NCT02407782|Ivermectin|ivermectin
4836871|NCT02407769|Liver transplantation|liver transplantation
4836872|NCT02407769|Liver cirrhosis|liver cirrhosis
4836873|NCT02407769|Branched chain amino acids|branched chain amino acids
4836874|NCT02407769|Late evening supplementation|late evening supplementation
4836875|NCT02407769|Nutritional status|nutritional status
4836876|NCT02407756|Eczema|eczema
4836877|NCT02407743|postoperative pain|postoperative pain
4836878|NCT02407743|surgery|surgery
4836879|NCT02407743|pain resolution|pain resolution
4836880|NCT02407743|pain intensity|pain intensity
4836881|NCT02407743|persistent postsurgical pain|persistent postsurgical pain
4836882|NCT02407743|pain-related genes|pain-related genes
4836883|NCT02407743|analgesic|analgesic
4836884|NCT02407704|Exercise|exercise
4836885|NCT02407704|Physical activity|physical activity
4836886|NCT02407704|GABA|gaba
4836887|NCT02407704|Venlafaxine|venlafaxine
4836888|NCT02407704|fMRI|fmri
4836889|NCT02407704|Spectroscopy|spectroscopy
4836890|NCT02407704|Reward system|reward system
4836891|NCT02407704|BDNF|bdnf
4836892|NCT02407704|Sleep|sleep
4836893|NCT02407704|Cognitive function|cognitive function
4836894|NCT02407704|Biomarkers|biomarkers
4836895|NCT02407704|Aerobic exercise|aerobic exercise
4836896|NCT02407665|Tai Chi|tai chi
4836897|NCT02407665|fMRI|fmri
4836898|NCT02407639|insufflation|insufflation
4836899|NCT02407639|abdominal pain|abdominal pain
4836900|NCT02407626|ischemia|ischemia
4836901|NCT02407626|cardiac surgery|cardiac surgery
4836902|NCT02407626|volatile anesthetic|volatile anesthetic
4836903|NCT02407626|total intravenous anesthesia|total intravenous anesthesia
4836904|NCT02407613|breast cancer|breast cancer
4836905|NCT02407613|MR-HIFU|mr-hifu
4836906|NCT02407613|ablation|ablation
4836907|NCT02407613|non-invasive treatment|non-invasive treatment
4836908|NCT02407600|EMEND for Injection|emend for injection
4836909|NCT02407600|5HT-3|5ht-3
4836910|NCT02407600|Fosaprepitant|fosaprepitant
4836911|NCT02407561|rectal|rectal
4836913|NCT02407561|DecisionDx|decisiondx
4836914|NCT02407548|cholesterol efflux|cholesterol efflux
4836915|NCT02407548|dyslipidemia|dyslipidemia
4836916|NCT02407522|Metabolic Syndrome|metabolic syndrome
4836917|NCT02407522|black rice|black rice
4836918|NCT02407483|Laparoscopy|laparoscopy
4836919|NCT02407483|Training Programs|training programs
4836920|NCT02407470|Severe Aplastic Anemia (SAA), Hematopoietic Stem Cells, HSC Transplantation|severe aplastic anemia (saa), hematopoietic stem cells, hsc transplantation
4836921|NCT02407470|ATG, Mesenchymal Stem Cells, Transdifferentiation,|atg, mesenchymal stem cells, transdifferentiation,
4836922|NCT02407444|Proximal hip fracture|proximal hip fracture
4836923|NCT02407444|Elderly patients|elderly patients
4836924|NCT02407444|Physiotherapy|physiotherapy
4836925|NCT02407444|Leg cycling ergometer|leg cycling ergometer
4836926|NCT02407418|spinal manipulation|spinal manipulation
4836927|NCT02407418|muscle strength dynamometer|muscle strength dynamometer
4836928|NCT02407418|muscle strength|muscle strength
4836929|NCT02407379|Laser|laser
4836930|NCT02407379|periodontitis|periodontitis
4836931|NCT02407379|scaling root planing|scaling root planing
4836932|NCT02407379|bacteria|bacteria
4836933|NCT02407379|PMN|pmn
4836934|NCT02407366|Inoperable stage III non-small cell lung cancer|inoperable stage iii non-small cell lung cancer
4836935|NCT02407366|EGFR mutation|egfr mutation
4836936|NCT02407366|Icotinib|icotinib
4836937|NCT02407366|Radiotherapy|radiotherapy
4836938|NCT02407366|Chemoradiotherapy|chemoradiotherapy
4836939|NCT02407353|Phase 1|phase 1
4836940|NCT02407353|Double blind|double blind
4836941|NCT02407353|Placebo-Controlled|placebo-controlled
4836942|NCT02407353|Parallel Design|parallel design
4836943|NCT02407353|CSF Aβ Concentrations|csf aβ concentrations
4836944|NCT02407353|PF-06648671|pf-06648671
4836945|NCT02407340|Alcohol Withdrawal Delirium|alcohol withdrawal delirium
4836946|NCT02407327|Circulating tumour cells in Advanced Non Small Cell Lung Cancer|circulating tumour cells in advanced non small cell lung cancer
4836947|NCT02407314|Peripheral Arterial Disease|peripheral arterial disease
4836948|NCT02407314|Optical Coherence Tomography|optical coherence tomography
4836949|NCT02407314|Ticagrelor|ticagrelor
4836950|NCT02407314|Aspirin|aspirin
4836951|NCT02407314|Claudication|claudication
4836952|NCT02407314|Clopidogrel|clopidogrel
4836953|NCT02407288|OCD|ocd
4836954|NCT02407262|asthma|asthma
4836955|NCT02407262|black seed|black seed
4836956|NCT02407262|Nigella sativa|nigella sativa
4836957|NCT02407262|supplementation|supplementation
4836958|NCT02407236|Ustekinumab|ustekinumab
4836959|NCT02407236|Inflammatory Bowel Diseases (IBD)|inflammatory bowel diseases (ibd)
4836960|NCT02407236|Colitis, Ulcerative|colitis, ulcerative
4836961|NCT02407223|Nonradiographic Axial Spondylitis, Ankylosing|nonradiographic axial spondylitis, ankylosing
4836962|NCT02407223|Ustekinumab|ustekinumab
4836963|NCT02407210|Azilsartan，Olmesartan Medoxomil|azilsartan，olmesartan medoxomil
4836964|NCT02407197|T1 mapping|t1 mapping
4836965|NCT02407197|CMR|cmr
4836966|NCT02407197|Outcome|outcome
4836967|NCT02407197|multicenter|multicenter
4836968|NCT02407184|Microbiota|microbiota
4836969|NCT02407184|Microbiome|microbiome
4836970|NCT02407145|retropubic|retropubic
4836971|NCT02407145|midurethral sling|midurethral sling
4836972|NCT02407145|polyvinylidene fluoride|polyvinylidene fluoride
4836973|NCT02407119|H. pylori eradication|h. pylori eradication
4836974|NCT02407119|Atrophy|atrophy
4836975|NCT02407119|Intestinal metaplasia|intestinal metaplasia
4836976|NCT02407119|Endoscopic resection|endoscopic resection
4836977|NCT02407119|Stomach neoplasm|stomach neoplasm
4836978|NCT02407106|BLIS K12|blis k12
4836979|NCT02407106|streptococcus|streptococcus
4836980|NCT02407093|Body Composition|body composition
4836981|NCT02407093|Military|military
4836982|NCT02407093|High-Intensity Functional Training|high-intensity functional training
4836983|NCT02407093|Army Physical Fitness|army physical fitness
4836984|NCT02407093|CrossFit|crossfit
4836985|NCT02407002|Nitroglycerin|nitroglycerin
4836986|NCT02407002|Safety|safety
4836987|NCT02406976|Exercise|exercise
4836988|NCT02406976|Morbidity Obesity|morbidity obesity
4836989|NCT02406963|telemedicine|telemedicine
4836990|NCT02406950|Sitagliptin|sitagliptin
4836991|NCT02406950|Endothelium|endothelium
4837117|NCT02406027|Alzheimer's Disease|alzheimer's disease
4836992|NCT02406950|Ischemia-Reperfusion Injury|ischemia-reperfusion injury
4836993|NCT02406950|human|human
4836994|NCT02406924|pin|pin
4836995|NCT02406924|particulated graft|particulated graft
4836996|NCT02406924|bone augmentation|bone augmentation
4836997|NCT02406924|vertical augmentation|vertical augmentation
4836998|NCT02406924|horizontal augmentation|horizontal augmentation
4836999|NCT02406911|platelet|platelet
4837000|NCT02406911|ticagrelor|ticagrelor
4837001|NCT02406911|clopidogrel|clopidogrel
4837002|NCT02406911|end stage renal disease|end stage renal disease
4837003|NCT02406911|hemodialysis|hemodialysis
4837004|NCT02406859|Spinal Cord Injury|spinal cord injury
4837005|NCT02406859|Constipation|constipation
4837006|NCT02406859|Fecal Incontinence|fecal incontinence
4837007|NCT02406859|Neurogenic Bowel|neurogenic bowel
4837008|NCT02406859|Bowel Biofeedback|bowel biofeedback
4837009|NCT02406859|Manometry|manometry
4837010|NCT02406846|Pancreatic Neoplasms|pancreatic neoplasms
4837011|NCT02406846|Circulating Tumor Cells|circulating tumor cells
4837012|NCT02406833|glaucoma|glaucoma
4837013|NCT02406833|trabeculectomy|trabeculectomy
4837014|NCT02406807|chronic low back pain|chronic low back pain
4837015|NCT02406807|HVLA manipulation|hvla manipulation
4837016|NCT02406794|Breast cancer|breast cancer
4837017|NCT02406794|Hormonal therapy|hormonal therapy
4837018|NCT02406794|Aromatase inhibitors|aromatase inhibitors
4837019|NCT02406794|Estrogen deprivation|estrogen deprivation
4837020|NCT02406794|Myalgia|myalgia
4837021|NCT02406794|Arthralgia|arthralgia
4837022|NCT02406794|Carpal tunnel syndrome|carpal tunnel syndrome
4837023|NCT02406794|Pressure pain threshold|pressure pain threshold
4837024|NCT02406794|Neuromuscular taping|neuromuscular taping
4837025|NCT02406794|Kinesio taping|kinesio taping
4837026|NCT02406781|Efficacy of MK 3475 with Metronomic Cyclophosphamide|efficacy of mk 3475 with metronomic cyclophosphamide
4837027|NCT02406781|Advanced Sarcomas|advanced sarcomas
4837028|NCT02406781|Leiomyosarcoma|leiomyosarcoma
4837029|NCT02406781|Undifferentiated Sarcoma|undifferentiated sarcoma
4837030|NCT02406781|Other Sarcoma|other sarcoma
4837031|NCT02406781|GIST|gist
4837032|NCT02406781|Osteosarcoma|osteosarcoma
4837033|NCT02406768|normal controls|normal controls
4837034|NCT02406742|CC-122|cc-122
4837035|NCT02406742|Pharmacokinetics|pharmacokinetics
4837036|NCT02406742|Safety|safety
4837037|NCT02406742|Ibrutinib|ibrutinib
4837038|NCT02406742|Obinutuzumab|obinutuzumab
4837039|NCT02406742|GA101|ga101
4837040|NCT02406742|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
4837041|NCT02406742|Small Lymphocytic Lymphoma|small lymphocytic lymphoma
4837042|NCT02406703|local anesthesia|local anesthesia
4837043|NCT02406703|regional anesthetic|regional anesthetic
4837044|NCT02406690|Endometrial Insufficiency|endometrial insufficiency
4837045|NCT02406690|Endometrial Receptivity|endometrial receptivity
4837046|NCT02406677|Acute Coronary Syndromes, ACS, Myocardial Infarction, STEMI, NSTEMI, MI, Co-Payments, Copay, Cost Sharing|acute coronary syndromes, acs, myocardial infarction, stemi, nstemi, mi, co-payments, copay, cost sharing
4837047|NCT02406638|3D Pelvic floor USG|3d pelvic floor usg
4837048|NCT02406638|Mid-Urethral Sling|mid-urethral sling
4837049|NCT02406638|TVT|tvt
4837050|NCT02406638|TVT-O|tvt-o
4837051|NCT02406638|TVT-S|tvt-s
4837052|NCT02406612|Vascular Closure Device|vascular closure device
4837053|NCT02406612|Femoral Artery Closure|femoral artery closure
4837054|NCT02406573|Sensitivity|sensitivity
4837055|NCT02406547|Serrated lesion|serrated lesion
4837056|NCT02406547|sessile serrated adenoma|sessile serrated adenoma
4837057|NCT02406547|Narrow Band Imaging|narrow band imaging
4837058|NCT02406547|Colonoscopy|colonoscopy
4837059|NCT02406547|colorectal neoplasms|colorectal neoplasms
4837060|NCT02406521|Metastatic renal cell carcinoma|metastatic renal cell carcinoma
4837061|NCT02406521|mRCC|mrcc
4837062|NCT02406482|sex work, Kazakhstan, microfinance, drug use|sex work, kazakhstan, microfinance, drug use
4837063|NCT02406443|Type 2 Diabetes, DPP-4 inhibitors, renal sodium excretion|type 2 diabetes, dpp-4 inhibitors, renal sodium excretion
4837064|NCT02406339|Physical Therapy|physical therapy
4837065|NCT02406339|Rehabilitation|rehabilitation
4837066|NCT02406339|Neuromuscular Electrical Stimulation|neuromuscular electrical stimulation
4837067|NCT02406339|Muscle Strength|muscle strength
4837068|NCT02406300|Hip Fracture|hip fracture
4837069|NCT02406300|Regional Anesthesia|regional anesthesia
4837070|NCT02406300|Peripheral Nerve Blocks|peripheral nerve blocks
4837071|NCT02406300|Post-operative Mortality|post-operative mortality
4837072|NCT02406300|Cognitive Dysfunction|cognitive dysfunction
4837073|NCT02406300|Quality of Life|quality of life
4837074|NCT02406274|Mammography|mammography
4837075|NCT02406274|Contrast Enhanced Spectral Mammography|contrast enhanced spectral mammography
4837076|NCT02406274|Palpable Breast Abnormalities|palpable breast abnormalities
4837077|NCT02406274|15-053|15-053
4837078|NCT02406248|NSTEMI|nstemi
4837079|NCT02406222|Relapsed|relapsed
4837080|NCT02406222|Refractory|refractory
4837081|NCT02406222|Pomalidomide|pomalidomide
4837082|NCT02406222|Dexamethasone|dexamethasone
4837083|NCT02406222|Cyclophosphamide|cyclophosphamide
4837084|NCT02406209|uveitis|uveitis
4837085|NCT02406209|acute uveitis|acute uveitis
4837086|NCT02406209|anterior uveitis|anterior uveitis
4837087|NCT02406209|NS2|ns2
4837088|NCT02406209|Aldeyra|aldeyra
4837089|NCT02406209|prednisolone acetate|prednisolone acetate
4837090|NCT02406157|diabetic macular edema|diabetic macular edema
4837091|NCT02406157|micropulse|micropulse
4837092|NCT02406157|laser|laser
4837093|NCT02406157|subthreshold|subthreshold
4837094|NCT02406144|Multiple Myeloma|multiple myeloma
4837095|NCT02406131|Peripheral Vascular Diseases|peripheral vascular diseases
4837096|NCT02406131|Ischemic Preconditioning|ischemic preconditioning
4837097|NCT02406131|Inflammation|inflammation
4837098|NCT02406131|Angioplasty|angioplasty
4837099|NCT02406131|Restenosis|restenosis
4837100|NCT02406131|RCT|rct
4837101|NCT02406118|transanal TME quality|transanal tme quality
4837102|NCT02406118|CRM|crm
4837103|NCT02406105|tremor|tremor
4837104|NCT02406105|Parkinson disease|parkinson disease
4837105|NCT02406105|functional radioablation|functional radioablation
4837106|NCT02406105|Cyber Knife radiosurgery|cyber knife radiosurgery
4837107|NCT02406079|tracheotomy|tracheotomy
4837108|NCT02406079|procalcitonin|procalcitonin
4837109|NCT02406079|sepsis|sepsis
4837110|NCT02406053|lung cancer|lung cancer
4837111|NCT02406053|antioxidants|antioxidants
4837112|NCT02406053|oxidative damage|oxidative damage
4837113|NCT02406040|Protein synthesis|protein synthesis
4837114|NCT02406040|Protein breakdown|protein breakdown
4837115|NCT02406040|Muscle|muscle
4837116|NCT02406040|Energy restriction|energy restriction
4837118|NCT02406027|JNJ-54861911|jnj-54861911
4837119|NCT02406027|Placebo|placebo
4837120|NCT02406001|peri-implantitis|peri-implantitis
4837121|NCT02406001|osseous defects|osseous defects
4837122|NCT02406001|implant surface decontamination|implant surface decontamination
4837123|NCT02406001|bone grafting|bone grafting
4837124|NCT02406001|surgical therapy|surgical therapy
4837125|NCT02406001|porous titanium granules|porous titanium granules
4837126|NCT02406001|reconstruction|reconstruction
4837127|NCT02405988|Emergency Treatment|emergency treatment
4837128|NCT02405988|Morphine Derivates|morphine derivates
4837129|NCT02405988|Heroin|heroin
4837130|NCT02405988|Antidotes|antidotes
4837131|NCT02405988|Administration, Intravenous|administration, intravenous
4837132|NCT02405988|Pharmacology|pharmacology
4837133|NCT02405988|Naloxone|naloxone
4837134|NCT02405988|Healthy volunteers|healthy volunteers
4837135|NCT02405962|Acceptance and Commitment Therapy|acceptance and commitment therapy
4837136|NCT02405962|Childhood asthma|childhood asthma
4837137|NCT02405962|Randomized controlled trial|randomized controlled trial
4837138|NCT02405962|Training parents|training parents
4837139|NCT02405910|advanced|advanced
4837140|NCT02405910|non-squamous|non-squamous
4837141|NCT02405910|first line therapy|first line therapy
4837142|NCT02405897|flexible bronchoscopy|flexible bronchoscopy
4837143|NCT02405897|transbronchial lung biopsy|transbronchial lung biopsy
4837144|NCT02405897|forceps|forceps
4837145|NCT02405884|Glaucoma|glaucoma
4837146|NCT02405884|Renal Insufficiency, Chronic|renal insufficiency, chronic
4837147|NCT02405884|Low Tension Glaucoma|low tension glaucoma
4837148|NCT02405884|Ocular Hypertension|ocular hypertension
4837149|NCT02405858|Metastatic Castration-Resistant Prostate Cancer|metastatic castration-resistant prostate cancer
4837150|NCT02405858|Abiraterone Acetate|abiraterone acetate
4837151|NCT02405858|ZYTIGA|zytiga
4837152|NCT02405858|Prednisolone|prednisolone
4837153|NCT02405845|Atherosclerosis|atherosclerosis
4837154|NCT02405845|Internal Carotid Artery|internal carotid artery
4837155|NCT02405845|Free-floating thrombus|free-floating thrombus
4837156|NCT02405845|Ulcerated plaque|ulcerated plaque
4837157|NCT02405845|FFT|fft
4837158|NCT02405819|Cancer|cancer
4837159|NCT02405819|Oncology|oncology
4837160|NCT02405819|Survivorship|survivorship
4837161|NCT02405819|Care|care
4837162|NCT02405819|Plan|plan
4837163|NCT02405780|Rheumatoid|rheumatoid
4837164|NCT02405780|Arthritis|arthritis
4837165|NCT02405767|Diabetic foot ulcer|diabetic foot ulcer
4837166|NCT02405754|Corus CAD|corus cad
4837167|NCT02405754|Personalized Medicine|personalized medicine
4837168|NCT02405754|CAD|cad
4837169|NCT02405754|ASGES|asges
4837170|NCT02405754|Age/Sex/Gene Expression Score|age/sex/gene expression score
4837171|NCT02405754|GES|ges
4837172|NCT02405754|CVD|cvd
4837173|NCT02405754|CHD|chd
4837174|NCT02405754|Precision Medicine|precision medicine
4837175|NCT02405754|Clinical Utility|clinical utility
4837176|NCT02405754|Gene Expression|gene expression
4837177|NCT02405754|Coronary Heart Disease|coronary heart disease
4837178|NCT02405754|Cardiovascular Disease|cardiovascular disease
4837179|NCT02405754|Chest Pain|chest pain
4837180|NCT02405754|Coronary Artery Disease|coronary artery disease
4837181|NCT02405754|Angina Pectoris|angina pectoris
4837182|NCT02405754|exercise stress testing|exercise stress testing
4837183|NCT02405754|CT angiography|ct angiography
4837184|NCT02405754|invasive cardiac angiography|invasive cardiac angiography
4837185|NCT02405754|African-American patient|african-american patient
4837186|NCT02405754|ICA|ica
4837187|NCT02405754|CTA|cta
4837188|NCT02405728|PICC|picc
4837189|NCT02405728|BLOODSTREAM INFECTIONS|bloodstream infections
4837190|NCT02405728|VASCULAR ACCESS|vascular access
4837191|NCT02405728|DEEP VEIN THROMBOSIS|deep vein thrombosis
4837192|NCT02405728|CICC|cicc
4837193|NCT02405702|Infection|infection
4837194|NCT02405702|Knee|knee
4837195|NCT02405702|knee replacement|knee replacement
4837196|NCT02405676|Lymphoma|lymphoma
4837197|NCT02405676|non-Hodgkin|non-hodgkin
4837198|NCT02405676|B-lymphocytes|b-lymphocytes
4837199|NCT02405676|Child|child
4837200|NCT02405676|Multicenter study|multicenter study
4837201|NCT02405663|blood loss|blood loss
4837202|NCT02405663|caesarean section|caesarean section
4837203|NCT02405663|placental delivery|placental delivery
4837204|NCT02405650|CKD, chronic kidney disease, CRIC|ckd, chronic kidney disease, cric
4837205|NCT02405637|Feeding intolerance|feeding intolerance
4837206|NCT02405637|Simulated amniotic fluid|simulated amniotic fluid
4837207|NCT02405637|Necrotizing enterocolitis|necrotizing enterocolitis
4837208|NCT02405585|Pancreatic Cancer|pancreatic cancer
4837209|NCT02405585|Immunotherapy|immunotherapy
4837210|NCT02405585|Vaccine Therapy|vaccine therapy
4837211|NCT02405572|formula-fed|formula-fed
4837212|NCT02405572|infants|infants
4837213|NCT02405546|Nasal intubation|nasal intubation
4837214|NCT02405546|Counterclockwise rotation|counterclockwise rotation
4837215|NCT02405533|AHCC|ahcc
4837216|NCT02405533|nutritional supplement|nutritional supplement
4837217|NCT02405533|HPV|hpv
4837218|NCT02405520|human papillomavirus vaccine|human papillomavirus vaccine
4837219|NCT02405520|condylomata acuminata|condylomata acuminata
4837220|NCT02405507|Gastrointestinal Discomfort|gastrointestinal discomfort
4837221|NCT02405507|Wheat germ|wheat germ
4837222|NCT02405507|Constipation|constipation
4837223|NCT02405507|Glycaemic Index|glycaemic index
4837224|NCT02405507|Blood Cholesterol Level|blood cholesterol level
4837225|NCT02405507|Glycaemic Response|glycaemic response
4837226|NCT02405507|Cholesterol|cholesterol
4837227|NCT02405507|PAC-SYM|pac-sym
4837228|NCT02405507|Gut Microbiota|gut microbiota
4837229|NCT02405468|blood microbiota|blood microbiota
4837230|NCT02405468|coronary disease|coronary disease
4837231|NCT02405468|myocardial infarction|myocardial infarction
4837232|NCT02405455|cervical insufficiency|cervical insufficiency
4837233|NCT02405455|cervical cerclage|cervical cerclage
4837234|NCT02405455|cervical pessary|cervical pessary
4837235|NCT02405416|Hepatocellular Carcinoma|hepatocellular carcinoma
4837236|NCT02405416|Blood Loss|blood loss
4837237|NCT02405416|Haemorrhage|haemorrhage
4837238|NCT02405416|Vascular Control|vascular control
4837239|NCT02405403|amyotrophic lateral sclerosis disease|amyotrophic lateral sclerosis disease
4837240|NCT02405403|PET|pet
4837241|NCT02405403|microglial activation|microglial activation
4837242|NCT02405390|Storz C-Mac®|storz c-mac®
4837243|NCT02405390|Pediatric Airway|pediatric airway
4837244|NCT02405390|Cervical Spine Injury|cervical spine injury
4837245|NCT02405390|Trauma Airway Management|trauma airway management
4837246|NCT02405377|contrast-induced nephropathy|contrast-induced nephropathy
4837247|NCT02405377|hydration|hydration
4837248|NCT02405377|Percutaneous coronary intervention|percutaneous coronary intervention
4837249|NCT02405364|Multiple Myeloma|multiple myeloma
4837250|NCT02405364|Carfilzomib|carfilzomib
4837251|NCT02405364|Lenalidomide|lenalidomide
4837252|NCT02405364|Dexamethasone|dexamethasone
4837253|NCT02405364|Patient up to 65 years|patient up to 65 years
4837254|NCT02405364|initial management|initial management
4837255|NCT02405351|Telemedicine, Stroke, Working Memory, Cognitive Training|telemedicine, stroke, working memory, cognitive training
4837256|NCT02405338|AML|aml
4837257|NCT02405325|physical activity|physical activity
4837258|NCT02405325|multilevel|multilevel
4837259|NCT02405325|cost-effectiveness|cost-effectiveness
4837260|NCT02405325|older adults|older adults
4837261|NCT02405312|communication|communication
4837262|NCT02405312|palliative care|palliative care
4837263|NCT02405312|death|death
4837264|NCT02405299|child|child
4837265|NCT02405299|disorders inhibition|disorders inhibition
4837266|NCT02405299|neuropsychology|neuropsychology
4837267|NCT02405299|rehabilitation|rehabilitation
4837268|NCT02405299|ADHD|adhd
4837269|NCT02405299|assessment of neurocognitive rehabilitations in ADHD in children|assessment of neurocognitive rehabilitations in adhd in children
4837270|NCT02405273|Lung Cancer|lung cancer
4837271|NCT02405273|Surgery|surgery
4837272|NCT02405273|COPD|copd
4837273|NCT02405273|Rehabilitation|rehabilitation
4837274|NCT02405247|NSCLC|nsclc
4837275|NCT02405247|T790M|t790m
4837276|NCT02405247|EGFR|egfr
4837277|NCT02405247|TKI|tki
4837278|NCT02405247|Resistance|resistance
4837279|NCT02405247|Non Small Cell Lung Cancer|non small cell lung cancer
4837280|NCT02405247|AZD9291|azd9291
4837281|NCT02405234|Radial Head Arthroplasty|radial head arthroplasty
4837282|NCT02405221|HPV|hpv
4837283|NCT02405221|HPV16|hpv16
4837284|NCT02405221|Cervical Cancer|cervical cancer
4837285|NCT02405221|TA-CIN|ta-cin
4837286|NCT02405221|Vaccine|vaccine
4837287|NCT02405221|Adjuvant|adjuvant
4837288|NCT02405221|Nickles FaderPI|nickles faderpi
4837289|NCT02405182|Magnetic Resonance Imaging|magnetic resonance imaging
4837290|NCT02405182|MRI|mri
4837291|NCT02405182|Biomarker|biomarker
4837292|NCT02405169|Implantology|implantology
4837293|NCT02405169|oral surgery|oral surgery
4837294|NCT02405169|bone level changes|bone level changes
4837295|NCT02405169|marginal bone level|marginal bone level
4837296|NCT02405156|Letrozole|letrozole
4837297|NCT02405156|misoprostol|misoprostol
4837298|NCT02405156|second trimester miscarriage|second trimester miscarriage
4837299|NCT02405143|Controlled clinical trial|controlled clinical trial
4837300|NCT02405143|Electric Stimulation Therapy|electric stimulation therapy
4837301|NCT02405117|Bipolar Disorder|bipolar disorder
4837302|NCT02405117|Behavior Therapy|behavior therapy
4837303|NCT02405117|Technology Assisted|technology assisted
4837304|NCT02405117|Mobile Phone|mobile phone
4837305|NCT02405117|Smartphone|smartphone
4837306|NCT02405104|osteoarthritis|osteoarthritis
4837307|NCT02405104|hip|hip
4837308|NCT02405104|knee|knee
4837309|NCT02405104|total hip arthroplasty|total hip arthroplasty
4837310|NCT02405104|total knee arthroplasty|total knee arthroplasty
4837311|NCT02405104|post operative pain management|post operative pain management
4837312|NCT02405078|Lymphoma|lymphoma
4837615|NCT02403505|genotyping|genotyping
4837313|NCT02405078|Diffuse Large B-cell Lymphoma|diffuse large b-cell lymphoma
4837314|NCT02405078|DLBCL|dlbcl
4837315|NCT02405078|Relapsed/Refractory|relapsed/refractory
4837316|NCT02405078|Fluorodeoxyglucose-positron emission tomography/computed tomography|fluorodeoxyglucose-positron emission tomography/computed tomography
4837317|NCT02405078|FDG-PET/CT|fdg-pet/ct
4837318|NCT02405078|18F-Fluorodeoxyglucose|18f-fluorodeoxyglucose
4837319|NCT02405078|Blood draws|blood draws
4837320|NCT02405078|Chemotherapy|chemotherapy
4837321|NCT02405039|DED|ded
4837322|NCT02405039|Disease|disease
4837323|NCT02405013|Africa|africa
4837324|NCT02405013|Hepatitis C|hepatitis c
4837325|NCT02405013|HIV|hiv
4837326|NCT02405013|Antiviral treatment|antiviral treatment
4837327|NCT02405013|Adults|adults
4837328|NCT02405013|HCV genotype 1|hcv genotype 1
4837329|NCT02405013|HCV genotype 2|hcv genotype 2
4837330|NCT02405013|HCV genotype 4|hcv genotype 4
4837331|NCT02404974|physical activity|physical activity
4837332|NCT02404948|coronary artery disease|coronary artery disease
4837333|NCT02404948|diagnosis|diagnosis
4837334|NCT02404948|non-invasive|non-invasive
4837335|NCT02404935|Metastatic colorectal cancer|metastatic colorectal cancer
4837336|NCT02404935|cetuximab|cetuximab
4837337|NCT02404935|maintenance|maintenance
4837338|NCT02404922|Safety/Efficacy Study|safety/efficacy study
4837339|NCT02404922|Randomized|randomized
4837340|NCT02404922|Double Blind|double blind
4837341|NCT02404883|Cancer|cancer
4837342|NCT02404883|decisional conflict|decisional conflict
4837343|NCT02404883|online|online
4837344|NCT02404883|decision-aid tool|decision-aid tool
4837345|NCT02404870|Diabetes|diabetes
4837346|NCT02404870|Phosphate|phosphate
4837347|NCT02404870|Fibroblast Growth Factor 23 (FGF23)|fibroblast growth factor 23 (fgf23)
4837348|NCT02404870|Vitamin D|vitamin d
4837349|NCT02404870|PTH|pth
4837350|NCT02404857|Post stroke|post stroke
4837351|NCT02404857|BCI|bci
4837352|NCT02404857|Reeducation|reeducation
4837353|NCT02404857|Hand movement|hand movement
4837354|NCT02404831|Physiotherapy|physiotherapy
4837355|NCT02404831|Pulmonary Rehabilitation|pulmonary rehabilitation
4837356|NCT02404831|Exercise|exercise
4837357|NCT02404831|Telerehab|telerehab
4837358|NCT02404818|Radiation|radiation
4837359|NCT02404818|Cardiac|cardiac
4837360|NCT02404818|Hodgkin's lymphoma|hodgkin's lymphoma
4837361|NCT02404805|dolutegravir|dolutegravir
4837362|NCT02404805|simeprevir|simeprevir
4837363|NCT02404805|HIV|hiv
4837364|NCT02404805|HCV|hcv
4837365|NCT02404792|Frail Elderly|frail elderly
4837366|NCT02404792|IGF-1|igf-1
4837367|NCT02404779|ICU|icu
4837368|NCT02404779|Deep sedation|deep sedation
4837369|NCT02404779|Mechanical ventilation|mechanical ventilation
4837370|NCT02404779|Traumatic brain injury|traumatic brain injury
4837371|NCT02404779|Intracranial hypertension|intracranial hypertension
4837372|NCT02404779|Cisatracurium|cisatracurium
4837373|NCT02404779|Neuromuscular Blocking Agent|neuromuscular blocking agent
4837497|NCT02404142|NMBA|nmba
4837374|NCT02404779|Randomization versus placebo|randomization versus placebo
4837375|NCT02404766|manual therapy|manual therapy
4837376|NCT02404766|cervical|cervical
4837377|NCT02404766|range of movement|range of movement
4837378|NCT02404753|Locally advanced gastric cancer|locally advanced gastric cancer
4837379|NCT02404753|Laparoscopic distal D2 gastrectomy|laparoscopic distal d2 gastrectomy
4837380|NCT02404753|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
4837381|NCT02404740|VP shunted|vp shunted
4837382|NCT02404740|Normal intracranial pathology|normal intracranial pathology
4837383|NCT02404740|patients|patients
4837384|NCT02404727|Osteoarthritis, Hip|osteoarthritis, hip
4837385|NCT02404727|acetabular fixation|acetabular fixation
4837386|NCT02404727|dual mobility cup|dual mobility cup
4837387|NCT02404727|Radiostereometric Analysis|radiostereometric analysis
4837388|NCT02404727|Dual-Energy Radiographic Absorptiometry|dual-energy radiographic absorptiometry
4837389|NCT02404727|Accelerometry|accelerometry
4837390|NCT02404727|total hip arthroplasty|total hip arthroplasty
4837391|NCT02404727|intra-prosthetic dislocation|intra-prosthetic dislocation
4837392|NCT02404662|Alcohol use disorder|alcohol use disorder
4837393|NCT02404662|Depression|depression
4837394|NCT02404662|Mood disorders|mood disorders
4837395|NCT02404662|Bipolar disorder|bipolar disorder
4837396|NCT02404662|Supportive text messages|supportive text messages
4837397|NCT02404623|Vitamin D|vitamin d
4837398|NCT02404623|Respiratory Morbidity|respiratory morbidity
4837399|NCT02404623|prematurity|prematurity
4837400|NCT02404610|propofol|propofol
4837401|NCT02404610|moderate procedural sedation|moderate procedural sedation
4837402|NCT02404610|deep procedural sedation|deep procedural sedation
4837403|NCT02404610|memory|memory
4837404|NCT02404610|emergency department|emergency department
4837405|NCT02404597|Cardiac output|cardiac output
4837406|NCT02404597|Low blood pressure|low blood pressure
4837407|NCT02404597|Total Body Surface Area (TBSA)|total body surface area (tbsa)
4837408|NCT02404584|Metastatic kidney cancer|metastatic kidney cancer
4837409|NCT02404545|Hernia|hernia
4837410|NCT02404545|Mesh|mesh
4837411|NCT02404545|Ileal conduit|ileal conduit
4837412|NCT02404532|OPC-14597 Digital|opc-14597 digital
4837413|NCT02404532|Aripiprazole|aripiprazole
4837414|NCT02404532|Medical Information Device #1 System (MIND1)|medical information device #1 system (mind1)
4837415|NCT02404532|Ingestible Event Marker|ingestible event marker
4837416|NCT02404519|Vitamin K|vitamin k
4837417|NCT02404519|Menaquinone-7|menaquinone-7
4837418|NCT02404519|Matrix Gla Protein|matrix gla protein
4837419|NCT02404519|Vascular stiffness|vascular stiffness
4837420|NCT02404506|Eribulin|eribulin
4837421|NCT02404506|Breast Cancer|breast cancer
4837422|NCT02404506|Elderly Patient|elderly patient
4837423|NCT02404506|Phase II Trial|phase ii trial
4837424|NCT02404506|HER2-neg|her2-neg
4837425|NCT02404506|adenocarcinoma|adenocarcinoma
4837426|NCT02404493|Atopic Dermatitis|atopic dermatitis
4837427|NCT02404441|Phase I/II, PDR001, Checkpoint inhibitor, PD-1, PD-L1|phase i/ii, pdr001, checkpoint inhibitor, pd-1, pd-l1
4837428|NCT02404428|active surveillance|active surveillance
4837429|NCT02404428|MRI|mri
4837430|NCT02404428|diet|diet
4837431|NCT02404415|catheter ablation|catheter ablation
4837432|NCT02404415|genomics|genomics
4837433|NCT02404402|Traumatic Brain Injury|traumatic brain injury
4837434|NCT02404402|Light Emitting Diodes|light emitting diodes
4837435|NCT02404402|Cognition|cognition
4837436|NCT02404402|Neuromodulation|neuromodulation
4837437|NCT02404402|PTSD|ptsd
4837438|NCT02404402|Neurorehabilitation|neurorehabilitation
4837439|NCT02404402|Veterans|veterans
4837440|NCT02404402|Sleep|sleep
4837441|NCT02404389|Actinic keratosis, patients, topical, lesion count, clearance rate|actinic keratosis, patients, topical, lesion count, clearance rate
4837442|NCT02404376|STEMI|stemi
4837443|NCT02404376|Reperfusion Injury|reperfusion injury
4837444|NCT02404376|Myocardial Infarction|myocardial infarction
4837445|NCT02404376|Myocardial Ischemia|myocardial ischemia
4837446|NCT02404376|Remote Ischemic Conditioning|remote ischemic conditioning
4837447|NCT02404376|Exenatide|exenatide
4837448|NCT02404376|Glucagon-Like Peptide-1 (GLP-1)|glucagon-like peptide-1 (glp-1)
4837449|NCT02404376|Acute Coronary Syndrome|acute coronary syndrome
4837450|NCT02404376|Cardioprotection|cardioprotection
4837451|NCT02404363|Clopidogrel|clopidogrel
4837452|NCT02404363|Pancreatic Cancer|pancreatic cancer
4837453|NCT02404363|Efficacy|efficacy
4837454|NCT02404363|Chemotherapy|chemotherapy
4837455|NCT02404363|Microparticles|microparticles
4837456|NCT02404363|Disease free survival|disease free survival
4837457|NCT02404363|First line chemotherapy|first line chemotherapy
4837458|NCT02404350|Psoriatic Arthritis, Arthritis, Psoriatic, Psoriatic Arthropathy|psoriatic arthritis, arthritis, psoriatic, psoriatic arthropathy
4837459|NCT02404311|HIV|hiv
4837460|NCT02404311|AIDS|aids
4837461|NCT02404311|Vaccine|vaccine
4837462|NCT02404298|Transcriptome analysis|transcriptome analysis
4837463|NCT02404298|peripheral blood|peripheral blood
4837464|NCT02404298|chronic inflammatory demyelinating polyradiculoneuropathy|chronic inflammatory demyelinating polyradiculoneuropathy
4837465|NCT02404298|auto immune diseases|auto immune diseases
4837466|NCT02404298|IVIg|ivig
4837467|NCT02404272|Neonate|neonate
4837468|NCT02404272|oral feeding disorder|oral feeding disorder
4837469|NCT02404272|full oral feeding|full oral feeding
4837470|NCT02404272|training|training
4837471|NCT02404272|quality of health care|quality of health care
4837472|NCT02404259|pharmacokinetics|pharmacokinetics
4837473|NCT02404259|TDF|tdf
4837474|NCT02404259|HIV-infected children|hiv-infected children
4837475|NCT02404259|Thai|thai
4837476|NCT02404259|non-nucleoside reverse transcriptase inhibitor (NNRTI)|non-nucleoside reverse transcriptase inhibitor (nnrti)
4837477|NCT02404259|ritonavir-boosted protease inhibitor (bPI)|ritonavir-boosted protease inhibitor (bpi)
4837478|NCT02404259|less than eighteen years old|less than eighteen years old
4837479|NCT02404246|Bipolar|bipolar
4837480|NCT02404246|Peers|peers
4837481|NCT02404246|DBSA|dbsa
4837482|NCT02404220|Syk inhibitor|syk inhibitor
4837483|NCT02404220|Blood malignancy|blood malignancy
4837484|NCT02404220|Leukemia|leukemia
4837485|NCT02404207|Prevention|prevention
4837486|NCT02404194|schizophrenia|schizophrenia
4837487|NCT02404194|psychosis|psychosis
4837488|NCT02404194|at risk|at risk
4837489|NCT02404194|prodrome|prodrome
4837490|NCT02404194|attenuated psychosis syndrome|attenuated psychosis syndrome
4837491|NCT02404181|Validation Studies|validation studies
4837492|NCT02404181|EEG|eeg
4837493|NCT02404142|Trachel intubation|trachel intubation
4837494|NCT02404142|IDS score|ids score
4837495|NCT02404142|Videoaryngoscopy|videoaryngoscopy
4837496|NCT02404142|Glidescope® Titanium®|glidescope® titanium®
4837498|NCT02404142|Curare (Atracurium)|curare (atracurium)
4837499|NCT02404129|Fall|fall
4837500|NCT02404129|Turn 180 test|turn 180 test
4837501|NCT02404129|elderly|elderly
4837502|NCT02404129|balance|balance
4837503|NCT02404090|Obesity|obesity
4837504|NCT02404090|Weight Loss|weight loss
4837505|NCT02404090|Knee Osteoarthritis|knee osteoarthritis
4837506|NCT02404090|Subchondral Mineralization|subchondral mineralization
4837507|NCT02404077|Patients|patients
4837508|NCT02404077|undergoing|undergoing
4837509|NCT02404077|ICU|icu
4837510|NCT02404051|Breast cancer|breast cancer
4837511|NCT02404051|HER2Negative|her2negative
4837512|NCT02404051|hormone receptor positive (HR+)|hormone receptor positive (hr+)
4837513|NCT02404051|Metastatic|metastatic
4837616|NCT02403505|Oncology|oncology
4837514|NCT02404051|Locally Advanced|locally advanced
4837515|NCT02404051|fulvestrant|fulvestrant
4837516|NCT02404051|everolimus|everolimus
4837517|NCT02404051|exemestane|exemestane
4837518|NCT02404038|choice|choice
4837519|NCT02404038|young women|young women
4837520|NCT02404038|adolescent girls|adolescent girls
4837521|NCT02404038|preference|preference
4837522|NCT02404025|Eltrombopag|eltrombopag
4837523|NCT02404025|rabbit anti-thymocyte globulin|rabbit anti-thymocyte globulin
4837524|NCT02404025|additive effect|additive effect
4837525|NCT02404025|cyclosporine A|cyclosporine a
4837526|NCT02404012|iron deficiency|iron deficiency
4837527|NCT02404012|sleeve gastrectomy|sleeve gastrectomy
4837528|NCT02404012|gastric bypass|gastric bypass
4837529|NCT02404012|bariatric surgery|bariatric surgery
4837530|NCT02403973|Patient hotel|patient hotel
4837531|NCT02403973|Patient Satisfaction|patient satisfaction
4837532|NCT02403973|Perioperative care|perioperative care
4837533|NCT02403973|IN2005E|in2005e
4837534|NCT02403947|Multiple Sclerosis|multiple sclerosis
4837535|NCT02403947|Bone-marrow|bone-marrow
4837536|NCT02403947|Stem cells|stem cells
4837537|NCT02403947|Cell therapy|cell therapy
4837538|NCT02403934|Airway Management|airway management
4837539|NCT02403934|deep sedation|deep sedation
4837540|NCT02403934|Jaw elevation device|jaw elevation device
4837541|NCT02403921|biomarker|biomarker
4837542|NCT02403908|radiofrequency denervation, pulmonary hypertension|radiofrequency denervation, pulmonary hypertension
4837543|NCT02403882|behavioral economics|behavioral economics
4837544|NCT02403882|food pantry|food pantry
4837545|NCT02403882|food choice|food choice
4837546|NCT02403869|Metastatic breast cancer|metastatic breast cancer
4837547|NCT02403869|Monotherapy|monotherapy
4837548|NCT02403869|chemotherapy|chemotherapy
4837549|NCT02403869|second line|second line
4837550|NCT02403869|treatment|treatment
4837551|NCT02403869|Her 2 negative|her 2 negative
4837552|NCT02403856|calcifying tendinitis|calcifying tendinitis
4837553|NCT02403856|Needle lavage|needle lavage
4837554|NCT02403856|Shoulder|shoulder
4837555|NCT02403856|Corticosteroid injection|corticosteroid injection
4837556|NCT02403856|Ultrasound-guided|ultrasound-guided
4837557|NCT02403817|Video Games|video games
4837558|NCT02403804|Dietary supplements|dietary supplements
4837559|NCT02403804|serum choline|serum choline
4837560|NCT02403804|women|women
4837561|NCT02403791|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
4837562|NCT02403778|Melanoma|melanoma
4837563|NCT02403778|Malignant Melanoma|malignant melanoma
4837564|NCT02403752|dementia|dementia
4837565|NCT02403752|Alzheimer's disease|alzheimer's disease
4837566|NCT02403752|exercise|exercise
4837567|NCT02403739|Growth|growth
4837568|NCT02403700|bone remodeling|bone remodeling
4837569|NCT02403700|bone resorption|bone resorption
4837570|NCT02403700|three-dimensional imaging|three-dimensional imaging
4837571|NCT02403700|clinical trial|clinical trial
4837572|NCT02403700|dental implant|dental implant
4837573|NCT02403700|maxilla|maxilla
4837574|NCT02403700|bone healing|bone healing
4837575|NCT02403635|HSV|hsv
4837576|NCT02403635|Herpes|herpes
4837577|NCT02403635|volunteers|volunteers
4837578|NCT02403635|drug-drug interaction|drug-drug interaction
4837579|NCT02403609|cognitive assessment|cognitive assessment
4837580|NCT02403609|Brain Performance Test|brain performance test
4837581|NCT02403609|Lumosity|lumosity
4837582|NCT02403609|test-retest reliability|test-retest reliability
4837583|NCT02403609|computerized assessment|computerized assessment
4837584|NCT02403596|Hip replacement|hip replacement
4837585|NCT02403596|rivaroxaban|rivaroxaban
4837586|NCT02403596|exacyl|exacyl
4837587|NCT02403596|blood loss|blood loss
4837588|NCT02403583|HIV Transmission|hiv transmission
4837589|NCT02403583|Prevention of Mother to Child Transmission|prevention of mother to child transmission
4837590|NCT02403583|Serodiscordancy|serodiscordancy
4837591|NCT02403583|Home-based testing|home-based testing
4837592|NCT02403583|Home-based counseling|home-based counseling
4837593|NCT02403583|Linkage to care|linkage to care
4837594|NCT02403583|Couples HIV Testing and Counseling|couples hiv testing and counseling
4837595|NCT02403583|Acceptance of repeat HIV testing during pregnancy|acceptance of repeat hiv testing during pregnancy
4837596|NCT02403583|Retention in care|retention in care
4837597|NCT02403570|Multiple Sclerosis, MRI, rotating frame|multiple sclerosis, mri, rotating frame
4837598|NCT02403544|Clinical Trial, Phase I|clinical trial, phase i
4837599|NCT02403544|Concurrent Chemoradiation|concurrent chemoradiation
4837600|NCT02403544|Oxaliplatin|oxaliplatin
4837601|NCT02403544|Capecitabine|capecitabine
4837602|NCT02403544|Carcinoma, Hepatocellular|carcinoma, hepatocellular
4837603|NCT02403531|Esophageal cancer|esophageal cancer
4837604|NCT02403531|Chemoradiotherapy|chemoradiotherapy
4837605|NCT02403531|induction chemotherapy|induction chemotherapy
4837606|NCT02403505|Prostate Cancer|prostate cancer
4837607|NCT02403505|SNP|snp
4837608|NCT02403505|Single Nucleotide Polymorphism|single nucleotide polymorphism
4837609|NCT02403505|Genetics|genetics
4837610|NCT02403505|Pharmacogenomic|pharmacogenomic
4837611|NCT02403505|Pharmacogenetic|pharmacogenetic
4837612|NCT02403505|gene|gene
4837613|NCT02403505|genome|genome
4837614|NCT02403505|genotype|genotype
4837617|NCT02403505|Chemotherapy|chemotherapy
4837618|NCT02403505|Personalize|personalize
4837619|NCT02403505|Individualize|individualize
4837620|NCT02403492|Children|children
4837621|NCT02403492|Obesity|obesity
4837622|NCT02403492|Cardiovascular|cardiovascular
4837623|NCT02403492|Sleep|sleep
4837624|NCT02403492|Apnea|apnea
4837625|NCT02403492|Obstructive|obstructive
4837626|NCT02403466|Medical errors|medical errors
4837627|NCT02403466|Communication|communication
4837628|NCT02403466|Resident sign-out|resident sign-out
4837629|NCT02403453|Radiculopathy|radiculopathy
4837630|NCT02403453|Myelopathy|myelopathy
4837631|NCT02403453|Spondylosis|spondylosis
4837632|NCT02403453|Herniated Nucleus Pulposus|herniated nucleus pulposus
4837633|NCT02403453|C3-C7|c3-c7
4837634|NCT02403453|Osteophytes|osteophytes
4837635|NCT02403453|Neurological deficit|neurological deficit
4837636|NCT02403427|Bolus calculator|bolus calculator
4837637|NCT02403427|Insulin pump|insulin pump
4837638|NCT02403427|basal-bolus insulin therapy|basal-bolus insulin therapy
4837639|NCT02403401|Pregnancy prevention|pregnancy prevention
4837640|NCT02403388|Patient safety|patient safety
4837641|NCT02403388|Primary care|primary care
4837642|NCT02403388|Incident reporting|incident reporting
4837643|NCT02403388|Pluridisciplinary care offices|pluridisciplinary care offices
4837644|NCT02403388|Risk management|risk management
4837645|NCT02403388|Assessment|assessment
4837646|NCT02403310|adverse-risk AML|adverse-risk aml
4837647|NCT02403310|poor-risk karyotype|poor-risk karyotype
4837648|NCT02403310|cytogenetic abnormality|cytogenetic abnormality
4837649|NCT02403310|poor-risk mutations|poor-risk mutations
4837650|NCT02403310|antecedent hematologic disorder|antecedent hematologic disorder
4837651|NCT02403310|treatment related AML|treatment related aml
4837652|NCT02403297|Bleeding gums|bleeding gums
4837653|NCT02403297|Gum inflammation|gum inflammation
4837654|NCT02403297|Saliva|saliva
4837655|NCT02403284|insulin resistance|insulin resistance
4837656|NCT02403284|lipid metabolism|lipid metabolism
4837657|NCT02403284|glucose metabolism|glucose metabolism
4837658|NCT02403284|high fat diets|high fat diets
4837659|NCT02403271|Pharmacyclics|pharmacyclics
4837660|NCT02403271|PCYC|pcyc
4837661|NCT02403271|Ibrutinib|ibrutinib
4837662|NCT02403271|Durvalumab (MEDI4736)|durvalumab (medi4736)
4837663|NCT02403271|Relapsed Refractory Solid Tumor|relapsed refractory solid tumor
4837664|NCT02403271|Non-Small Cell Lung Cancer|non-small cell lung cancer
4837665|NCT02403271|NSCLC|nsclc
4837666|NCT02403271|Squamous|squamous
4837667|NCT02403271|Squamous NSCLC|squamous nsclc
4837668|NCT02403271|Squamous Non-Small Cell Lung Cancer|squamous non-small cell lung cancer
4837669|NCT02403271|Immunotherapy|immunotherapy
4837670|NCT02403271|IMBRUVICA®|imbruvica®
4837671|NCT02403271|Tumor Immunotherapy|tumor immunotherapy
4837672|NCT02403271|Anti-PD-L1|anti-pd-l1
4837673|NCT02403271|Lung Cancer|lung cancer
4837674|NCT02403271|Breast Cancer|breast cancer
4837675|NCT02403271|Triple Negative|triple negative
4837676|NCT02403271|HER2 Positive|her2 positive
4837677|NCT02403271|HER2 + Breast Cancer|her2 + breast cancer
4837678|NCT02403271|Pancreatic Cancer|pancreatic cancer
4837679|NCT02403258|acupuncture|acupuncture
4837680|NCT02403258|plum-blossom needle|plum-blossom needle
4837681|NCT02403258|tourette syndrome|tourette syndrome
4837682|NCT02403258|randomized controlled trial|randomized controlled trial
4837683|NCT02403245|Social interactions|social interactions
4837684|NCT02403245|Dementia|dementia
4837685|NCT02403245|Social stimulation|social stimulation
4837686|NCT02403245|Direct observation|direct observation
4837687|NCT02403232|Autologous adipose-derived stem cells|autologous adipose-derived stem cells
4837688|NCT02403219|Dry eye|dry eye
4837689|NCT02403219|Botulinum toxin A|botulinum toxin a
4837690|NCT02403219|Orbicularis muscle of the eye|orbicularis muscle of the eye
4837691|NCT02403193|Adenosine A2a receptor antagonist|adenosine a2a receptor antagonist
4837692|NCT02403193|NSCLC|nsclc
4837693|NCT02403193|PBF-509|pbf-509
4837694|NCT02403193|Immunotherapy|immunotherapy
4837695|NCT02403193|adenosine|adenosine
4837696|NCT02403193|PDR001|pdr001
4837697|NCT02403193|immune checkpoint inhibitors|immune checkpoint inhibitors
4837698|NCT02403193|Programmed Death-1 (PD-1) receptor|programmed death-1 (pd-1) receptor
4837699|NCT02403193|Adenosine A2a receptor (A2AR)|adenosine a2a receptor (a2ar)
4837700|NCT02403180|Visual Performance|visual performance
4837701|NCT02403154|Anterior pelvic ring|anterior pelvic ring
4837702|NCT02403154|Internal fixation|internal fixation
4837703|NCT02403154|External fixation|external fixation
4837704|NCT02403154|Orthopaedic|orthopaedic
4837705|NCT02403154|Orthopedic|orthopedic
4837706|NCT02403154|pubic rami|pubic rami
4837707|NCT02403128|362.17|362.17
4837708|NCT02403102|Magnetic Resonance Imaging|magnetic resonance imaging
4837709|NCT02403102|Myeloma|myeloma
4837710|NCT02403102|Autograft|autograft
4837711|NCT02403089|MAIT (Mucosal-Associated Invariant T) cells|mait (mucosal-associated invariant t) cells
4837712|NCT02403089|Gut microbiota|gut microbiota
4837713|NCT02403089|Preterm birth|preterm birth
4837714|NCT02403089|Hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
4837715|NCT02403089|Microbial infections|microbial infections
4837716|NCT02403050|Neoplasm Staging|neoplasm staging
4837717|NCT02403050|Radiotherapy|radiotherapy
4837718|NCT02403050|Fiducial Markers|fiducial markers
4837719|NCT02403037|Breast Neoplasms|breast neoplasms
4837720|NCT02403037|Auricular Therapy|auricular therapy
4837721|NCT02403037|Acupressure|acupressure
4837722|NCT02403037|Chemotherapy|chemotherapy
4837723|NCT02403037|Nausea|nausea
4837724|NCT02403037|Vomiting|vomiting
4837725|NCT02403024|Colon cancer|colon cancer
4837726|NCT02403024|rectal cancer|rectal cancer
4837727|NCT02403024|exercise|exercise
4837728|NCT02403024|physical activity|physical activity
4837729|NCT02403024|metabolic health|metabolic health
4837730|NCT02403011|Congenital Muscular Torticollis|congenital muscular torticollis
4837731|NCT02403011|Manual Therapy|manual therapy
4837732|NCT02403011|Infant|infant
4837733|NCT02402998|Primacy immune thrombocytopenia|primacy immune thrombocytopenia
4837734|NCT02402998|Adults|adults
4837735|NCT02402998|Eltrombopag|eltrombopag
4837736|NCT02402998|Long-term remission|long-term remission
4837737|NCT02402985|nutritional support|nutritional support
4837738|NCT02402985|diet therapy|diet therapy
4837739|NCT02402985|protein diet|protein diet
4837740|NCT02402985|isocaloric diet|isocaloric diet
4837741|NCT02402972|adjuvant chemotherapy|adjuvant chemotherapy
4837742|NCT02402972|intraportal chemotherapy|intraportal chemotherapy
4837743|NCT02402972|prevention|prevention
4837744|NCT02402959|Insomnia|insomnia
4837745|NCT02402959|Traditional Chinese Medicine|traditional chinese medicine
4837746|NCT02402959|herbal medicine|herbal medicine
4837747|NCT02402959|cohort study|cohort study
4837748|NCT02402959|individualized treatment|individualized treatment
4837749|NCT02402959|TCM pattern differentiation|tcm pattern differentiation
4837750|NCT02402920|Lung Cancer|lung cancer
4837751|NCT02402920|Small Cell Lung Cancer|small cell lung cancer
4837752|NCT02402920|SCLC|sclc
4837753|NCT02402920|Limited-Stage Small-Cell Lung Cancer|limited-stage small-cell lung cancer
4837754|NCT02402920|LS-SCLC|ls-sclc
4837755|NCT02402920|Extensive-Stage Small-Cell Lung Cancer|extensive-stage small-cell lung cancer
4837756|NCT02402920|ES-SCLC|es-sclc
4837757|NCT02402920|MK-3475|mk-3475
4837758|NCT02402920|Keytruda|keytruda
4837759|NCT02402920|Pembrolizumab|pembrolizumab
4837760|NCT02402920|SCH-900475|sch-900475
4837761|NCT02402920|Etoposide|etoposide
4837762|NCT02402920|VePesid|vepesid
4837763|NCT02402920|Cisplatin|cisplatin
4837764|NCT02402920|Platinol-AQ|platinol-aq
4837765|NCT02402920|Platinol|platinol
4837766|NCT02402920|CDDP|cddp
4837767|NCT02402920|Carboplatin|carboplatin
4837768|NCT02402920|Radiation therapy|radiation therapy
4837769|NCT02402920|XRT|xrt
4837770|NCT02402907|cesarean section|cesarean section
4837771|NCT02402907|chlorhexidine gluconate|chlorhexidine gluconate
4837772|NCT02402907|CHG|chg
4837773|NCT02402907|surgical site infection|surgical site infection
4837774|NCT02402907|obstetrics|obstetrics
4837775|NCT02402907|infection prevention|infection prevention
4837776|NCT02402907|pregnancy|pregnancy
4837777|NCT02402881|venous thromboembolism|venous thromboembolism
4837778|NCT02402881|deep venous thrombosis|deep venous thrombosis
4837779|NCT02402881|pulmonary embolism|pulmonary embolism
4837780|NCT02402881|blood clots|blood clots
4837781|NCT02402855|Couverture Maladie Universelle|couverture maladie universelle
4837782|NCT02402855|Couverture Maladie Universelle-Complémentaire|couverture maladie universelle-complémentaire
4837783|NCT02402855|free health care|free health care
4837784|NCT02402842|gastrointestinal oncology|gastrointestinal oncology
4837785|NCT02402842|immunology|immunology
4837786|NCT02402842|taxane|taxane
4837787|NCT02402764|Triple Negative Breast Cancer (TNBC)|triple negative breast cancer (tnbc)
4837788|NCT02402764|Breast - Female|breast - female
4837789|NCT02402764|Breast - Male|breast - male
4837790|NCT02402764|Metastatic Triple Negative Breast Cancer|metastatic triple negative breast cancer
4837791|NCT02402764|Receptor Tyrosine-protein Kinase erbB-2 (HER2) Negative|receptor tyrosine-protein kinase erbb-2 (her2) negative
4837792|NCT02402764|Erythroblastosis virus oncogene B (erbB)|erythroblastosis virus oncogene b (erbb)
4837793|NCT02402751|Volunteers|volunteers
4837794|NCT02402725|Relapsed Multiple Myeloma|relapsed multiple myeloma
4837795|NCT02402699|HBV|hbv
4837796|NCT02402699|HBC|hbc
4837797|NCT02402647|Hoarding|hoarding
4837798|NCT02402647|Compulsive Hoarding|compulsive hoarding
4837799|NCT02402595|Drug-drug interaction|drug-drug interaction
4837800|NCT02402595|Healthy Volunteers|healthy volunteers
4837801|NCT02402595|Pharmacokinetics|pharmacokinetics
4837802|NCT02402595|deuterated dextromethorphan|deuterated dextromethorphan
4837803|NCT02402595|dextromethorphan|dextromethorphan
4837804|NCT02402595|dextromethorphan with quinidine|dextromethorphan with quinidine
4837805|NCT02402595|deuterated dextromethorphan with quinidine|deuterated dextromethorphan with quinidine
4837806|NCT02402595|itraconazole|itraconazole
4837807|NCT02402582|Family-Centered Empowerment Model|family-centered empowerment model
4837808|NCT02402582|Quality of life|quality of life
4837809|NCT02402582|Perceived stress|perceived stress
4837810|NCT02402582|Anxiety|anxiety
4837811|NCT02402582|Myocardial infarction|myocardial infarction
4837812|NCT02402582|Clinical trial|clinical trial
4837813|NCT02402582|Iran|iran
4837814|NCT02402543|preemptive analgesia|preemptive analgesia
4838105|NCT02400684|laparoscopy|laparoscopy
4837815|NCT02402543|anorectal surgery|anorectal surgery
4837816|NCT02402543|gabapentin|gabapentin
4837817|NCT02402543|neurontin|neurontin
4837818|NCT02402543|ketamine|ketamine
4837819|NCT02402543|acetaminophen|acetaminophen
4837820|NCT02402543|tylenol|tylenol
4837821|NCT02402543|postoperative pain|postoperative pain
4837822|NCT02402543|postoperative narcotic usage|postoperative narcotic usage
4837823|NCT02402543|dexamethasone|dexamethasone
4837824|NCT02402543|decadron|decadron
4837825|NCT02402530|Neridronic Acid|neridronic acid
4837826|NCT02402530|Neridronate|neridronate
4837827|NCT02402530|CRPS|crps
4837828|NCT02402530|RSD|rsd
4837829|NCT02402517|Diabetes Prevention|diabetes prevention
4837830|NCT02402517|Obesity Prevention|obesity prevention
4837831|NCT02402491|Dual Antiplatelet Treatment|dual antiplatelet treatment
4837832|NCT02402491|In-Stent Restenosis|in-stent restenosis
4837833|NCT02402478|Clinical Cohort|clinical cohort
4837834|NCT02402478|Electronic Health Records|electronic health records
4837835|NCT02402478|Prognosis|prognosis
4837836|NCT02402478|Stable Coronary Artery Disease|stable coronary artery disease
4837837|NCT02402439|Type 1 diabetes|type 1 diabetes
4837838|NCT02402439|diabetes mellitus|diabetes mellitus
4837839|NCT02402439|pancreatic islet transplant|pancreatic islet transplant
4837840|NCT02402439|beta cell replacement|beta cell replacement
4837841|NCT02402426|Brain Health|brain health
4837842|NCT02402426|Brain Research|brain research
4837843|NCT02402426|Alzheimer's Disease|alzheimer's disease
4837844|NCT02402426|Neurodegenerative Disease|neurodegenerative disease
4837845|NCT02402426|Parkinson's Disease|parkinson's disease
4837846|NCT02402426|Dementia|dementia
4837847|NCT02402426|Stroke|stroke
4837848|NCT02402426|PTSD|ptsd
4837849|NCT02402426|Multiple Sclerosis|multiple sclerosis
4837850|NCT02402400|NSTEMI|nstemi
4837851|NCT02402361|Neuropathic pain|neuropathic pain
4837852|NCT02402361|Diabetic Neuropathy|diabetic neuropathy
4837853|NCT02402348|head and neck squamous cell carcinoma|head and neck squamous cell carcinoma
4837854|NCT02402309|Sjögren-Larsson Syndrome|sjögren-larsson syndrome
4837855|NCT02402309|SLS|sls
4837856|NCT02402309|Ichthyosis|ichthyosis
4837857|NCT02402309|FALDH Deficiency|faldh deficiency
4837858|NCT02402309|Neuro-ichthyosis|neuro-ichthyosis
4837859|NCT02402309|Fatty Alcohol:NAD+ Oxidoreductase Deficiency|fatty alcohol:nad+ oxidoreductase deficiency
4837860|NCT02402309|Fatty Aldehyde Dehydrogenase Deficiency Disease|fatty aldehyde dehydrogenase deficiency disease
4837861|NCT02402309|Congenital Icthyosis Mental Retardation Spasticity Syndrome|congenital icthyosis mental retardation spasticity syndrome
4837862|NCT02402309|Spastic Neurologic Disorder|spastic neurologic disorder
4837863|NCT02402309|Oligophrenia|oligophrenia
4837864|NCT02402283|Bioequivalency|bioequivalency
4837865|NCT02402283|two metronidazole-containing products|two metronidazole-containing products
4837866|NCT02402270|Colonoscopy|colonoscopy
4837867|NCT02402270|Preparation|preparation
4837868|NCT02402257|Central Venous Catheter|central venous catheter
4837869|NCT02402257|Simulation-based Mastery Learning|simulation-based mastery learning
4837870|NCT02402257|Medical Education|medical education
4837871|NCT02402257|Patient Outcomes|patient outcomes
4837872|NCT02402257|Bloodstream Infection Due to Central Venous Catheter|bloodstream infection due to central venous catheter
4837873|NCT02402257|Pneumothorax|pneumothorax
4837874|NCT02402257|Inadvertent Arterial Puncture|inadvertent arterial puncture
4837875|NCT02402205|Implementation; TF-CBT; adjudicated youth; RTF; trauma|implementation; tf-cbt; adjudicated youth; rtf; trauma
4837876|NCT02402192|corifollitropin alfa|corifollitropin alfa
4837877|NCT02402192|recombinant FSH|recombinant fsh
4837878|NCT02402192|HP-hMG|hp-hmg
4837879|NCT02402192|time-lapse|time-lapse
4837880|NCT02402192|kinetics of development|kinetics of development
4837881|NCT02402179|protein quality|protein quality
4837882|NCT02402153|evaluation of subcutaneous EEG recording|evaluation of subcutaneous eeg recording
4837883|NCT02402140|tacrolimus blood concentration|tacrolimus blood concentration
4837884|NCT02402140|pharmaceutical intervention|pharmaceutical intervention
4837885|NCT02402140|intrasubject variability|intrasubject variability
4837886|NCT02402127|Contact lenses|contact lenses
4837887|NCT02402127|Lubricity|lubricity
4837888|NCT02402101|tDCS|tdcs
4837889|NCT02402101|Dopamine|dopamine
4837890|NCT02402101|PET|pet
4837891|NCT02402088|stress|stress
4837892|NCT02402088|food cues|food cues
4837893|NCT02402088|obesity|obesity
4837894|NCT02402075|muscle motor evoked potentials|muscle motor evoked potentials
4837895|NCT02402075|spinal motor evoked potentials|spinal motor evoked potentials
4837896|NCT02402075|D-wave|d-wave
4837897|NCT02402075|brain tumor surgery|brain tumor surgery
4837898|NCT02402075|intraoperative neuromonitoring|intraoperative neuromonitoring
4837899|NCT02402062|pNET|pnet
4837900|NCT02401997|sperm|sperm
4837901|NCT02401997|oxidative stress|oxidative stress
4837902|NCT02401997|sexual abstinence|sexual abstinence
4837903|NCT02401971|Thalidomide|thalidomide
4837904|NCT02401971|Irinotecan|irinotecan
4837905|NCT02401971|Second Line|second line
4837906|NCT02401945|Macular Degeneration|macular degeneration
4837907|NCT02401919|Nursing|nursing
4837908|NCT02401919|Hospital|hospital
4837909|NCT02401919|Communication|communication
4837910|NCT02401919|Patient Participation|patient participation
4838207|NCT02400203|hemp|hemp
4837911|NCT02401919|Individualised Care|individualised care
4837912|NCT02401893|aging|aging
4837913|NCT02401893|influenza vaccine|influenza vaccine
4837914|NCT02401893|immune responses|immune responses
4837915|NCT02401867|transgender|transgender
4837916|NCT02401867|female-to-male|female-to-male
4837917|NCT02401867|cervical cancer|cervical cancer
4837918|NCT02401867|HPV|hpv
4837919|NCT02401867|sexual health|sexual health
4837920|NCT02401854|atrial fibrillation|atrial fibrillation
4837921|NCT02401854|hypertension|hypertension
4837922|NCT02401854|risk factors|risk factors
4837923|NCT02401854|primary care|primary care
4837924|NCT02401854|elderly|elderly
4837925|NCT02401815|Gastrointestinal Stromal Tumors|gastrointestinal stromal tumors
4837926|NCT02401815|KIT|kit
4837927|NCT02401815|Biomarkers|biomarkers
4837928|NCT02401815|PLX9486|plx9486
4837929|NCT02401815|PLX3397|plx3397
4837930|NCT02401815|Sunitinib|sunitinib
4837931|NCT02401802|Colonoscopy|colonoscopy
4837932|NCT02401802|Diet|diet
4837933|NCT02401802|Polyethylene glycols|polyethylene glycols
4837934|NCT02401802|Efficacy|efficacy
4837935|NCT02401802|Personal satisfaction|personal satisfaction
4837936|NCT02401802|Colorectal cancer screening|colorectal cancer screening
4837937|NCT02401789|oral surgery|oral surgery
4837938|NCT02401789|Implantology|implantology
4837939|NCT02401776|heart rate|heart rate
4837940|NCT02401776|blood pressure|blood pressure
4837941|NCT02401776|caffeine|caffeine
4837942|NCT02401776|energy drink|energy drink
4837943|NCT02401763|biomarker|biomarker
4837944|NCT02401737|Hepatitis B|hepatitis b
4837945|NCT02401724|Hemispatial neglect|hemispatial neglect
4837946|NCT02401724|Transcranial direct current stimulation|transcranial direct current stimulation
4837947|NCT02401724|Rehabilitation|rehabilitation
4837948|NCT02401698|Stroke|stroke
4837949|NCT02401698|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
4837950|NCT02401698|Neuronal Plasticity|neuronal plasticity
4837951|NCT02401698|Rehabilitation|rehabilitation
4837952|NCT02401685|breast cancer|breast cancer
4837953|NCT02401685|sentinel lymph node biopsy|sentinel lymph node biopsy
4837954|NCT02401685|axillary lymph node clearance|axillary lymph node clearance
4837955|NCT02401685|axillary lymph node dissection|axillary lymph node dissection
4837956|NCT02401685|macrometastases|macrometastases
4837957|NCT02401685|axillary radiotherapy|axillary radiotherapy
4837958|NCT02401685|POSNOC|posnoc
4837959|NCT02401672|TMS|tms
4837960|NCT02401672|nicotine dependence|nicotine dependence
4837961|NCT02401672|smoking cessation|smoking cessation
4837962|NCT02401659|remote monitoring|remote monitoring
4837963|NCT02401659|satisfaction|satisfaction
4837964|NCT02401659|telemonitoring|telemonitoring
4837965|NCT02401659|quality of life|quality of life
4837966|NCT02401633|Cardio-Pulmonary-Resuscitation|cardio-pulmonary-resuscitation
4837967|NCT02401633|Advanced Cardiac Life Support|advanced cardiac life support
4837968|NCT02401633|Compression-Only CPR|compression-only cpr
4837969|NCT02401633|Chest compression CPR|chest compression cpr
4837970|NCT02401620|AR: arthritis rheumatoid|ar: arthritis rheumatoid
4837971|NCT02401620|DMARDs: Disease-modifying antirheumatic drugs|dmards: disease-modifying antirheumatic drugs
4837972|NCT02401620|ACR. American College of Rheumatology|acr. american college of rheumatology
4837973|NCT02401620|EULAR: European League against rheumatology|eular: european league against rheumatology
4837974|NCT02401607|stress|stress
4837975|NCT02401607|emergency physicians|emergency physicians
4837976|NCT02401607|health care workers|health care workers
4837977|NCT02401607|biomarkers|biomarkers
4837978|NCT02401607|questionnaires|questionnaires
4837979|NCT02401607|anxiety|anxiety
4837980|NCT02401607|depression|depression
4837981|NCT02401607|burn-out|burn-out
4837982|NCT02401594|Non-major orthopaedic surgery|non-major orthopaedic surgery
4837983|NCT02401594|deep vein thrombosis|deep vein thrombosis
4837984|NCT02401542|Urothelial Cell Carcinoma|urothelial cell carcinoma
4837985|NCT02401542|UCC|ucc
4837986|NCT02401542|bladder cancer|bladder cancer
4837987|NCT02401542|B-701|b-701
4837988|NCT02401542|FGFR3|fgfr3
4837989|NCT02401542|invasive bladder cancer|invasive bladder cancer
4837990|NCT02401542|targeted therapy|targeted therapy
4837991|NCT02401542|Transitional Cell Carcinoma|transitional cell carcinoma
4837992|NCT02401542|TCC|tcc
4837993|NCT02401542|Phase 2|phase 2
4837994|NCT02401542|second line therapy|second line therapy
4837995|NCT02401542|monoclonal antibody|monoclonal antibody
4837996|NCT02401542|docetaxel|docetaxel
4837997|NCT02401542|combination therapy|combination therapy
4837998|NCT02401542|Phase 1|phase 1
4837999|NCT02401529|Dexamethasone|dexamethasone
4838000|NCT02401529|Prednisolone|prednisolone
4838001|NCT02401529|Tonsillectomy Nausea|tonsillectomy nausea
4838002|NCT02401529|Pain, Postoperative|pain, postoperative
4838003|NCT02401529|Postoperative Nausea and Vomiting|postoperative nausea and vomiting
4838004|NCT02401529|Randomized controlled trial|randomized controlled trial
4838005|NCT02401529|Post-tonsillectomy pain|post-tonsillectomy pain
4838006|NCT02401529|delayed feeding|delayed feeding
4838007|NCT02401516|Postural Reprogramming Insole|postural reprogramming insole
4838008|NCT02401516|Blood Pressure|blood pressure
4838009|NCT02401516|Posture|posture
4838010|NCT02401516|Quality Of Life|quality of life
4838208|NCT02400203|fatty acids|fatty acids
4838011|NCT02401516|General Functional Capacity|general functional capacity
4838012|NCT02401516|Respiratory Muscles Strength|respiratory muscles strength
4838013|NCT02401516|Flexibility|flexibility
4838014|NCT02401516|Arterial Systemic Hypertension|arterial systemic hypertension
4838015|NCT02401503|CLL|cll
4838016|NCT02401477|helicobacter pylori|helicobacter pylori
4838017|NCT02401477|ilaprazole|ilaprazole
4838018|NCT02401477|eradication|eradication
4838019|NCT02401477|dual therapy|dual therapy
4838020|NCT02401477|high dose therapy|high dose therapy
4838021|NCT02401425|Letrozole|letrozole
4838022|NCT02401425|Misoprostol|misoprostol
4838023|NCT02401425|First-Trimester|first-trimester
4838024|NCT02401425|Pretreatment|pretreatment
4838025|NCT02401386|Fibromyalgia; Eight Brocades; Baduanjin; Qigong; Pain severity|fibromyalgia; eight brocades; baduanjin; qigong; pain severity
4838026|NCT02401373|Vaccines|vaccines
4838027|NCT02401373|Ebola Virus Disease|ebola virus disease
4838028|NCT02401347|PALB2 mutation|palb2 mutation
4838029|NCT02401347|BRIP1 mutation|brip1 mutation
4838030|NCT02401347|BARD1 mutation|bard1 mutation
4838031|NCT02401347|Rad51c mutation|rad51c mutation
4838032|NCT02401347|PTEN mutation|pten mutation
4838033|NCT02401347|CHEK2 mutation|chek2 mutation
4838034|NCT02401347|ATM mutation|atm mutation
4838035|NCT02401347|NBN mutation|nbn mutation
4838036|NCT02401347|Rad51d mutation|rad51d mutation
4838037|NCT02401347|Rad50 mutation|rad50 mutation
4838038|NCT02401347|MRE11 mutation|mre11 mutation
4838039|NCT02401347|FANC mutation|fanc mutation
4838040|NCT02401347|HRD assay score|hrd assay score
4838041|NCT02401347|ATR mutation|atr mutation
4838042|NCT02401295|Relapsed multiple myeloma|relapsed multiple myeloma
4838043|NCT02401256|Efavirenz|efavirenz
4838044|NCT02401256|metabolism|metabolism
4838045|NCT02401256|pharmacokinetics changes|pharmacokinetics changes
4838046|NCT02401230|Human Immunodeficiency Virus|human immunodeficiency virus
4838047|NCT02401230|Acquired Immune Deficiency Syndrome Virus|acquired immune deficiency syndrome virus
4838048|NCT02401230|Pre-exposure Prophylaxis|pre-exposure prophylaxis
4838049|NCT02401204|Bacterial transmission|bacterial transmission
4838050|NCT02401204|Surveillance|surveillance
4838051|NCT02401204|Neonatal|neonatal
4838052|NCT02401204|Drug Resistance|drug resistance
4838053|NCT02401178|FLG-FADS genes variations-LCPUFA-atopic dermatitis|flg-fads genes variations-lcpufa-atopic dermatitis
4838054|NCT02401165|GADD34|gadd34
4838055|NCT02401165|Unfolded Protein Response|unfolded protein response
4838056|NCT02401165|Anti-citrullinated protein antibodies|anti-citrullinated protein antibodies
4838057|NCT02401100|Rectal Neoplasms|rectal neoplasms
4838058|NCT02401061|ITP|itp
4838059|NCT02401061|Thrombocytopenia|thrombocytopenia
4838060|NCT02401035|candidate for acid suppression therapy|candidate for acid suppression therapy
4838061|NCT02401035|presumptive diagnosis of GERD|presumptive diagnosis of gerd
4838062|NCT02401035|clinical diagnosis of suspected GERD|clinical diagnosis of suspected gerd
4838063|NCT02401035|symptomatic GERD|symptomatic gerd
4838064|NCT02401035|endoscopically proven GERD|endoscopically proven gerd
4838065|NCT02401022|smoking|smoking
4838066|NCT02401022|smoking cessation|smoking cessation
4838067|NCT02401022|cigarette|cigarette
4838068|NCT02400996|Endocrine Pancreas|endocrine pancreas
4838069|NCT02400996|Pancreatic Endocrine Neoplasm|pancreatic endocrine neoplasm
4838070|NCT02400983|ACAP, Automatic Algorithm|acap, automatic algorithm
4838071|NCT02400970|Polymerase Chain Reaction|polymerase chain reaction
4838072|NCT02400970|fertility preservation|fertility preservation
4838073|NCT02400957|silver nanoparticles|silver nanoparticles
4838074|NCT02400957|demineralization|demineralization
4838075|NCT02400957|brackets|brackets
4838076|NCT02400944|MSK Tobacco Cessation Program|msk tobacco cessation program
4838077|NCT02400944|smoking exposure|smoking exposure
4838078|NCT02400944|15-047|15-047
4838079|NCT02400905|PAD|pad
4838080|NCT02400905|PVD|pvd
4838081|NCT02400905|SFA stent|sfa stent
4838082|NCT02400879|bispectral index|bispectral index
4838083|NCT02400879|cardiac surgery|cardiac surgery
4838084|NCT02400879|recovery|recovery
4838085|NCT02400879|remifentanil|remifentanil
4838086|NCT02400866|cancer patients receiving moderately emetogenic chemotherapy|cancer patients receiving moderately emetogenic chemotherapy
4838087|NCT02400827|Polymerase Chain Reaction|polymerase chain reaction
4838088|NCT02400827|fertility preservation|fertility preservation
4838089|NCT02400801|endometriosis|endometriosis
4838090|NCT02400801|infertility|infertility
4838091|NCT02400801|assisted reproductive technology|assisted reproductive technology
4838092|NCT02400775|Pharmacotherapy|pharmacotherapy
4838093|NCT02400749|moderate to severe non-pustular palmo-plantar psoriasis|moderate to severe non-pustular palmo-plantar psoriasis
4838094|NCT02400736|Individual Placement and Support|individual placement and support
4838095|NCT02400736|Supported Employment|supported employment
4838096|NCT02400736|Employment|employment
4838097|NCT02400736|Vocational Rehabilitation|vocational rehabilitation
4838098|NCT02400736|Veterans|veterans
4838099|NCT02400736|Patient Aligned Care Team|patient aligned care team
4838100|NCT02400723|behavioral intervention|behavioral intervention
4838101|NCT02400723|relaxation|relaxation
4838102|NCT02400723|Veterans|veterans
4838103|NCT02400723|geriatric|geriatric
4838104|NCT02400684|AFSr classification|afsr classification
4838106|NCT02400658|breast cancer|breast cancer
4838107|NCT02400658|early-stage|early-stage
4838108|NCT02400658|IORT|iort
4838109|NCT02400658|brachytherapy|brachytherapy
4838110|NCT02400645|laparoscopic hysterectomy|laparoscopic hysterectomy
4838111|NCT02400645|robotic assisted hysterectomy|robotic assisted hysterectomy
4838112|NCT02400632|drug-eluting balloon|drug-eluting balloon
4838113|NCT02400632|in-stent restenosis|in-stent restenosis
4838114|NCT02400619|shockwaves|shockwaves
4838115|NCT02400619|Physiotherapy|physiotherapy
4838116|NCT02400619|Botulinum toxin|botulinum toxin
4838117|NCT02400606|constructing VPs|constructing vps
4838118|NCT02400606|knowledge and skills transfer|knowledge and skills transfer
4838119|NCT02400580|Laparoscopic Hysterectomy|laparoscopic hysterectomy
4838120|NCT02400580|IV acetaminophen|iv acetaminophen
4838121|NCT02400580|Postoperative pain control|postoperative pain control
4838122|NCT02400580|Surgery|surgery
4838123|NCT02400567|Luminal|luminal
4838124|NCT02400567|Post menopausal|post menopausal
4838125|NCT02400567|Breast conservation|breast conservation
4838126|NCT02400567|Neoadjuvant|neoadjuvant
4838127|NCT02400554|Indian, North American|indian, north american
4838128|NCT02400554|Oklahoma|oklahoma
4838129|NCT02400554|Female|female
4838130|NCT02400554|health promotion|health promotion
4838131|NCT02400541|Anorexia nervosa|anorexia nervosa
4838132|NCT02400541|Cognitive remediation therapy|cognitive remediation therapy
4838133|NCT02400515|Exercise|exercise
4838134|NCT02400515|Exercise Therapy|exercise therapy
4838135|NCT02400515|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
4838136|NCT02400502|Schizophrenia|schizophrenia
4838137|NCT02400502|Treatment|treatment
4838138|NCT02400502|Meditation|meditation
4838139|NCT02400502|Mindfulness|mindfulness
4838140|NCT02400502|Stress reactivity|stress reactivity
4838141|NCT02400502|First Episode Psychosis|first episode psychosis
4838142|NCT02400502|Coping|coping
4838143|NCT02400489|Heart Valve Replacement Surgery|heart valve replacement surgery
4838144|NCT02400489|Perimount|perimount
4838145|NCT02400489|Edwards|edwards
4838146|NCT02400476|HER2 +|her2 +
4838147|NCT02400476|Breast Cancer|breast cancer
4838148|NCT02400476|Neratinib|neratinib
4838149|NCT02400476|Nerlynx|nerlynx
4838150|NCT02400476|Loperamide|loperamide
4838151|NCT02400476|Colestipol|colestipol
4838152|NCT02400476|Budesonide|budesonide
4838153|NCT02400450|Pre-diabetes|pre-diabetes
4838154|NCT02400450|prediabetes|prediabetes
4838155|NCT02400450|glycated hemoglobin|glycated hemoglobin
4838156|NCT02400450|hemoglobin A1c|hemoglobin a1c
4838157|NCT02400450|LDL cholesterol|ldl cholesterol
4838158|NCT02400450|Cholesterol|cholesterol
4838159|NCT02400450|metabolic function|metabolic function
4838160|NCT02400450|vascular function|vascular function
4838161|NCT02400450|functional food|functional food
4838162|NCT02400437|Waldenstrom's Macroglobulinemia|waldenstrom's macroglobulinemia
4838163|NCT02400424|Stereotactic lung radiation therapy|stereotactic lung radiation therapy
4838164|NCT02400424|Radiochemotherapy|radiochemotherapy
4838165|NCT02400424|Unresectable stage III Non-Small Cell lung Carcinoma|unresectable stage iii non-small cell lung carcinoma
4838166|NCT02400424|Peripheral primary tumor|peripheral primary tumor
4838167|NCT02400411|Carbohydrate|carbohydrate
4838168|NCT02400411|Glycemic response|glycemic response
4838169|NCT02400411|insulin|insulin
4838170|NCT02400411|whole grain|whole grain
4838171|NCT02400411|meal|meal
4838172|NCT02400359|fMRI|fmri
4838173|NCT02400359|Magnetic Resonance Imaging|magnetic resonance imaging
4838174|NCT02400359|endocrinology|endocrinology
4838175|NCT02400359|MRI|mri
4838176|NCT02400359|obesity|obesity
4838177|NCT02400359|weight loss|weight loss
4838178|NCT02400359|lorcaserin|lorcaserin
4838179|NCT02400333|ticagrelor orodispersible tablet|ticagrelor orodispersible tablet
4838180|NCT02400333|ticagrelor immediate-release tablet|ticagrelor immediate-release tablet
4838181|NCT02400333|relative bioavailability|relative bioavailability
4838182|NCT02400333|Phase I|phase i
4838183|NCT02400333|healthy subjects|healthy subjects
4838184|NCT02400307|Phase 1|phase 1
4838185|NCT02400307|Renally Impaired|renally impaired
4838186|NCT02400294|Critical care|critical care
4838187|NCT02400294|Mechanical ventilation|mechanical ventilation
4838188|NCT02400294|Ventilator associated pneumonia|ventilator associated pneumonia
4838189|NCT02400294|Oral care|oral care
4838190|NCT02400268|Enterobacteriaceae|enterobacteriaceae
4838191|NCT02400268|Bloodstream|bloodstream
4838192|NCT02400268|Bacteremia|bacteremia
4838193|NCT02400268|Recurrence|recurrence
4838194|NCT02400268|Reinfection|reinfection
4838195|NCT02400229|coronary artery disease|coronary artery disease
4838196|NCT02400229|stable chest pain|stable chest pain
4838197|NCT02400229|intermediate pretest probability|intermediate pretest probability
4838198|NCT02400229|pragmatic randomised controlled trial|pragmatic randomised controlled trial
4838199|NCT02400229|coronary computed tomography|coronary computed tomography
4838200|NCT02400229|angiography|angiography
4838201|NCT02400229|invasive coronary angiography|invasive coronary angiography
4838202|NCT02400216|Chronic Hepatitis C|chronic hepatitis c
4838203|NCT02400216|Cirrhosis|cirrhosis
4838204|NCT02400216|Liver Biopsy|liver biopsy
4838205|NCT02400216|Microbiome|microbiome
4838206|NCT02400203|hemp oil,|hemp oil,
4838209|NCT02400203|omega-6|omega-6
4838210|NCT02400203|omega-3|omega-3
4838211|NCT02400203|blood pressure|blood pressure
4838212|NCT02400203|blood lipids|blood lipids
4838213|NCT02400190|radiation|radiation
4838214|NCT02400190|lumpectomy|lumpectomy
4838215|NCT02400190|favorable biology|favorable biology
4838216|NCT02400190|omission|omission
4838217|NCT02400125|Patient Registry|patient registry
4838218|NCT02400125|Coronary Artery Bypass|coronary artery bypass
4838219|NCT02400125|Cardiac Valve Annuloplasty|cardiac valve annuloplasty
4838220|NCT02400112|Vancomycin|vancomycin
4838221|NCT02400086|neuroligical or neuromuscular diseases|neuroligical or neuromuscular diseases
4838222|NCT02400086|bacterial respiratory tract flora|bacterial respiratory tract flora
4838223|NCT02400086|long term tracheostomy|long term tracheostomy
4838224|NCT02400047|Paediatric surgery|paediatric surgery
4838225|NCT02400034|midurethral sling|midurethral sling
4838226|NCT02400034|Voiding trial|voiding trial
4838227|NCT02400034|stress urinary incontinence|stress urinary incontinence
4838228|NCT02399995|Quality of Life|quality of life
4838229|NCT02399995|Hepatectomy|hepatectomy
4838230|NCT02399995|15-057|15-057
4838231|NCT02399982|Smartphone Application|smartphone application
4838232|NCT02399982|mobile mental health|mobile mental health
4838233|NCT02399982|Binge Eating|binge eating
4838234|NCT02399982|Cognitive behavioral therapy|cognitive behavioral therapy
4838235|NCT02399982|Eating Disorder treatment|eating disorder treatment
4838236|NCT02399982|Cognitive behavioral therapy guided self-help|cognitive behavioral therapy guided self-help
4838237|NCT02399982|self-monitoring|self-monitoring
4838238|NCT02399982|eating disorders|eating disorders
4838239|NCT02399982|ecological momentary intervention|ecological momentary intervention
4838240|NCT02399969|Low back pain|low back pain
4838241|NCT02399969|Acupuncture therapy|acupuncture therapy
4838242|NCT02399969|Acupuncture, ear|acupuncture, ear
4838243|NCT02399956|Lactation|lactation
4838244|NCT02399956|Pediatric malignancies|pediatric malignancies
4838245|NCT02399956|Cancer survivor|cancer survivor
4838246|NCT02399917|Leukemia|leukemia
4838247|NCT02399917|Acute Myeloid Leukemia|acute myeloid leukemia
4838248|NCT02399917|Refractory|refractory
4838249|NCT02399917|Relapsed|relapsed
4838250|NCT02399917|AML|aml
4838251|NCT02399917|Myelodysplastic Syndrome (MDS).|myelodysplastic syndrome (mds).
4838252|NCT02399917|MDS|mds
4838253|NCT02399917|High-risk|high-risk
4838254|NCT02399917|5-azacytidine|5-azacytidine
4838255|NCT02399917|Azacitidine|azacitidine
4838256|NCT02399917|5-aza|5-aza
4838257|NCT02399917|Vidaza|vidaza
4838258|NCT02399917|5-AZC|5-azc
4838259|NCT02399917|AZA-CR|aza-cr
4838260|NCT02399917|Ladakamycin|ladakamycin
4838261|NCT02399917|NSC-102816|nsc-102816
4838262|NCT02399917|Azacytidine|azacytidine
4838263|NCT02399917|Lirilumab|lirilumab
4838264|NCT02399917|Phone call|phone call
4838265|NCT02399891|Remodeling|remodeling
4838266|NCT02399891|Prognosis|prognosis
4838267|NCT02399891|Incidence|incidence
4838268|NCT02399891|Quality Assurance|quality assurance
4838269|NCT02399891|Ejection Fraction|ejection fraction
4838270|NCT02399891|Sudden Death|sudden death
4838271|NCT02399800|pancreatitis, chronic|pancreatitis, chronic
4838272|NCT02399800|endosonography|endosonography
4838273|NCT02399761|AADC deficiency, newborn screening|aadc deficiency, newborn screening
4838274|NCT02399735|NK cells|nk cells
4838275|NCT02399735|Liver Transplantation|liver transplantation
4838276|NCT02399735|Hepatocellular Carcinoma Recurrence|hepatocellular carcinoma recurrence
4838277|NCT02399722|Negative Pressure Wound Therapy, polymeric membrane dressing, wounds|negative pressure wound therapy, polymeric membrane dressing, wounds
4838278|NCT02399670|Total hip arthroplasty|total hip arthroplasty
4838279|NCT02399670|degenerative joint disease|degenerative joint disease
4838280|NCT02399670|Femoral offset|femoral offset
4838281|NCT02399670|Patient reported outcome|patient reported outcome
4838282|NCT02399657|diabetes mellitus|diabetes mellitus
4838283|NCT02399657|macular edema|macular edema
4838284|NCT02399657|hard exudate|hard exudate
4838285|NCT02399657|intravitreal injections|intravitreal injections
4838286|NCT02399657|dexamethasone|dexamethasone
4838287|NCT02399657|implant|implant
4838288|NCT02399644|pain|pain
4838289|NCT02399644|rehabilitation|rehabilitation
4838290|NCT02399644|exercise|exercise
4838291|NCT02399644|psychological|psychological
4838292|NCT02399644|intervention|intervention
4838293|NCT02399631|Perioperative treatment|perioperative treatment
4838294|NCT02399631|Laparoscopic surgery|laparoscopic surgery
4838295|NCT02399618|Clostridium difficile Infection|clostridium difficile infection
4838296|NCT02399618|Fecal Microbiota Transplantation|fecal microbiota transplantation
4838297|NCT02399618|Freeze-dried|freeze-dried
4838298|NCT02399618|Acid-resistant Capsules|acid-resistant capsules
4838299|NCT02399592|Platinum resistant|platinum resistant
4838300|NCT02399579|cat allergy|cat allergy
4838301|NCT02399579|symptom score|symptom score
4838302|NCT02399566|erlotinib|erlotinib
4838303|NCT02399566|pemetrexed|pemetrexed
4838304|NCT02399566|maintenance therapy|maintenance therapy
4838305|NCT02399527|Vascular Anomalies|vascular anomalies
4838306|NCT02399527|Lymphatic Anomalies|lymphatic anomalies
4838307|NCT02399527|Lymphatic Malformation|lymphatic malformation
4838308|NCT02399514|Sleep|sleep
4838309|NCT02399514|emphysema|emphysema
4838310|NCT02399514|coils|coils
4838311|NCT02399514|lung volume reduction|lung volume reduction
4838312|NCT02399501|2D ultrasound|2d ultrasound
4838313|NCT02399501|3D ultrasound|3d ultrasound
4838314|NCT02399501|sonohysterography|sonohysterography
4838315|NCT02399501|hysteroscopy|hysteroscopy
4838316|NCT02399501|Uterine factor of infertility|uterine factor of infertility
4838317|NCT02399475|Levothyroxine|levothyroxine
4838318|NCT02399475|Liothyronine|liothyronine
4838319|NCT02399475|Thyrotropin Releasing Hormone|thyrotropin releasing hormone
4838320|NCT02399475|Aging|aging
4838321|NCT02399475|Hypothyroidism|hypothyroidism
4838322|NCT02399475|Thyroid diseases|thyroid diseases
4838323|NCT02399449|iron|iron
4838324|NCT02399449|pharmacokinetics|pharmacokinetics
4838325|NCT02399436|Community-Based Participatory Research|community-based participatory research
4838326|NCT02399436|Community-Institutional Relations|community-institutional relations
4838327|NCT02399423|diabetes|diabetes
4838328|NCT02399423|metabolism|metabolism
4838329|NCT02399423|cardiovascular disease|cardiovascular disease
4838330|NCT02399423|weight gain|weight gain
4838331|NCT02399423|weight loss|weight loss
4838332|NCT02399423|european|european
4838333|NCT02399423|south asian|south asian
4838334|NCT02399423|obesity|obesity
4838335|NCT02399410|cytoreductive surgery|cytoreductive surgery
4838336|NCT02399410|hipec|hipec
4838337|NCT02399410|perioperative chemotherapy|perioperative chemotherapy
4838338|NCT02399410|peritoneal carcinomatosis|peritoneal carcinomatosis
4838339|NCT02399410|bevacizumab|bevacizumab
4838340|NCT02399410|colorectal surgery|colorectal surgery
4838341|NCT02399384|Cardiac Magnetic Resonance (CMR)|cardiac magnetic resonance (cmr)
4838342|NCT02399358|Drug induced Hyponatremia|drug induced hyponatremia
4838343|NCT02399358|Cyclophosphamide|cyclophosphamide
4838344|NCT02399358|Hyponatremia|hyponatremia
4838345|NCT02399358|Cyclophosphamide induced Hyponatremia|cyclophosphamide induced hyponatremia
4838346|NCT02399345|Treatment naive|treatment naive
4838347|NCT02399345|Hepatitis C Genotype 1|hepatitis c genotype 1
4838348|NCT02399319|anterior pelvic ring|anterior pelvic ring
4838349|NCT02399319|symphysis disruption|symphysis disruption
4838350|NCT02399293|Cognitive training|cognitive training
4838351|NCT02399293|Cognitive rehabilitation|cognitive rehabilitation
4838352|NCT02399293|Acquired brain injury|acquired brain injury
4838353|NCT02399293|N-back|n-back
4838354|NCT02399293|Visual Search|visual search
4838355|NCT02399293|Cognitive transfer|cognitive transfer
4838356|NCT02399280|Meal pattern|meal pattern
4838357|NCT02399280|weight loss|weight loss
4838358|NCT02399280|high caloric intake|high caloric intake
4838359|NCT02399280|Dinner|dinner
4838360|NCT02399280|Lunch|lunch
4838361|NCT02399267|mechanical ventilation|mechanical ventilation
4838362|NCT02399267|weaning|weaning
4838363|NCT02399267|critically ill|critically ill
4838364|NCT02399267|spontaneous breathing trial|spontaneous breathing trial
4838365|NCT02399267|screening|screening
4838366|NCT02399267|invasive ventilation|invasive ventilation
4838367|NCT02399267|SBT technique|sbt technique
4838368|NCT02399254|Pulmonary Rehabilitation|pulmonary rehabilitation
4838369|NCT02399228|radiation therapy|radiation therapy
4838370|NCT02399228|chemotherapy|chemotherapy
4838371|NCT02399228|head and neck cancer|head and neck cancer
4838372|NCT02399202|Renal impairment, osilodrostat, LCI699|renal impairment, osilodrostat, lci699
4838373|NCT02399189|Primary central nervous system lymphoma|primary central nervous system lymphoma
4838374|NCT02399189|rituximab|rituximab
4838375|NCT02399189|Methotrexate and Temozolomide|methotrexate and temozolomide
4838376|NCT02399189|autologous stem cell transplantation|autologous stem cell transplantation
4838377|NCT02399189|Carmustine and thiotepa|carmustine and thiotepa
4838378|NCT02399176|Osteoporosis|osteoporosis
4838379|NCT02399176|Yoga|yoga
4838380|NCT02399150|acute abdomen|acute abdomen
4838381|NCT02399150|Pain|pain
4838382|NCT02399150|stress biomarker|stress biomarker
4838383|NCT02399137|Pancreatic Cancer|pancreatic cancer
4838384|NCT02399137|Front-line Pancreatic Cancer|front-line pancreatic cancer
4838385|NCT02399137|Metastatic Pancreatic Cancer|metastatic pancreatic cancer
4838386|NCT02399137|Gemcitabine|gemcitabine
4838387|NCT02399137|Nab-paclitaxel|nab-paclitaxel
4838388|NCT02399137|Abraxane|abraxane
4838389|NCT02399137|Free IGF-1|free igf-1
4838390|NCT02399137|Heregulin|heregulin
4838391|NCT02399124|RCC|rcc
4838392|NCT02399124|Renal Cell Carcinoma|renal cell carcinoma
4838393|NCT02399124|Kidney tumors|kidney tumors
4838394|NCT02399111|Prevena Incision Management System (PIMS)|prevena incision management system (pims)
4838395|NCT02399111|Surgical Site Infection (SSI)|surgical site infection (ssi)
4838396|NCT02399085|DLBCL|dlbcl
4838397|NCT02399085|CD19|cd19
4838398|NCT02399085|monoclonal antibody|monoclonal antibody
4838399|NCT02399085|MOR00208|mor00208
4838400|NCT02399085|MOR208|mor208
4838401|NCT02399085|lenalidomide|lenalidomide
4838402|NCT02399059|recurrence|recurrence
4838403|NCT02399033|Xihuang Capsules|xihuang capsules
4838404|NCT02399033|hepatocellular carcinoma|hepatocellular carcinoma
4838405|NCT02399033|Recurrence|recurrence
4838406|NCT02399033|hepatectomy|hepatectomy
4838407|NCT02398994|Clinical Trials Unit|clinical trials unit
4838408|NCT02398994|Pediatric|pediatric
4838409|NCT02398968|Iron|iron
4838410|NCT02398968|RURTIs|rurtis
4838411|NCT02398968|CARIFS|carifs
4838412|NCT02398968|children|children
4838413|NCT02398955|Drug-Eluting Stents|drug-eluting stents
4838414|NCT02398955|Coronary Artery Disease|coronary artery disease
4838415|NCT02398955|Sirolimus|sirolimus
4838416|NCT02398955|Absorbable Implants|absorbable implants
4838417|NCT02398903|Morbid obesity|morbid obesity
4838418|NCT02398903|bariatric surgery|bariatric surgery
4838419|NCT02398903|sleeve gastrectomy|sleeve gastrectomy
4838420|NCT02398903|Roux-en-Y gastric bypass|roux-en-y gastric bypass
4838421|NCT02398903|hormonal contraception|hormonal contraception
4838422|NCT02398903|combined oral contraceptive|combined oral contraceptive
4838423|NCT02398903|progestin contraceptive desogestrel|progestin contraceptive desogestrel
4838424|NCT02398903|pharmacokinetics|pharmacokinetics
4838425|NCT02398825|Chronic myeloid leukemia|chronic myeloid leukemia
4838426|NCT02398825|Chronic phase|chronic phase
4838427|NCT02398825|Adults|adults
4838428|NCT02398825|Ponatinib|ponatinib
4838429|NCT02398825|Imatinib resistant|imatinib resistant
4838430|NCT02398760|Low Back Pain|low back pain
4838431|NCT02398760|Clinical Instability|clinical instability
4838432|NCT02398760|Motor Control Exercises|motor control exercises
4838433|NCT02398760|Clinical Tests|clinical tests
4838434|NCT02398734|sonolysis|sonolysis
4838435|NCT02398734|carotid endarterectomy|carotid endarterectomy
4838436|NCT02398734|stroke prevention|stroke prevention
4838437|NCT02398734|brain infarction|brain infarction
4838438|NCT02398721|FNAC|fnac
4838439|NCT02398721|Small Incidental Thyroid Nodules|small incidental thyroid nodules
4838440|NCT02398708|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
4838441|NCT02398708|Graft versus Host Disease|graft versus host disease
4838442|NCT02398695|Plaque|plaque
4838443|NCT02398695|Saliva|saliva
4838444|NCT02398695|Caries|caries
4838445|NCT02398682|electronic alerts|electronic alerts
4838446|NCT02398682|acute kidney injury|acute kidney injury
4838447|NCT02398682|NHS|nhs
4838448|NCT02398682|mortality|mortality
4838449|NCT02398669|Obesity|obesity
4838450|NCT02398669|Lorcaserin hydrochloride|lorcaserin hydrochloride
4838451|NCT02398669|APD356|apd356
4838452|NCT02398669|Pediatric|pediatric
4838453|NCT02398669|Pharmacokinetics|pharmacokinetics
4838454|NCT02398656|Minor Ischemic Stroke|minor ischemic stroke
4838455|NCT02398643|Acute Exacerbation of COPD|acute exacerbation of copd
4838456|NCT02398643|COPD|copd
4838457|NCT02398643|Emphysema|emphysema
4838458|NCT02398643|Chronic Bronchitis|chronic bronchitis
4838459|NCT02398630|Histerosalpingography|histerosalpingography
4838460|NCT02398630|MRI|mri
4838461|NCT02398630|Magnetic Resonance Imaging|magnetic resonance imaging
4838462|NCT02398630|HSG|hsg
4838463|NCT02398630|Diagnostico Maipu|diagnostico maipu
4838464|NCT02398630|Imaging|imaging
4838465|NCT02398630|Carrascosa Patricia|carrascosa patricia
4838466|NCT02398617|Heart Failure|heart failure
4838467|NCT02398617|End of Life Care|end of life care
4838468|NCT02398617|Decision Making|decision making
4838469|NCT02398604|Pediatrics|pediatrics
4838470|NCT02398604|HLHS|hlhs
4838471|NCT02398591|Healthy|healthy
4838472|NCT02398591|JNJ 53718678|jnj 53718678
4838473|NCT02398552|metastatic renal cell carcinoma|metastatic renal cell carcinoma
4838474|NCT02398552|sunitinib|sunitinib
4838475|NCT02398552|schedule 2weeks on/1 week off|schedule 2weeks on/1 week off
4838476|NCT02398526|Observational study|observational study
4838477|NCT02398526|Bone metastases|bone metastases
4838478|NCT02398526|Hormone Refractory Prostatic Cancer|hormone refractory prostatic cancer
4838479|NCT02398526|Xofigo|xofigo
4838480|NCT02398526|Radium-223|radium-223
4838481|NCT02398500|First-in-human|first-in-human
4838482|NCT02398500|anti-VEGF|anti-vegf
4838483|NCT02398500|neovascular AMD (nvAMD)|neovascular amd (nvamd)
4838484|NCT02398435|Auto-inflammatory disease|auto-inflammatory disease
4838485|NCT02398435|Still's disease|still's disease
4838486|NCT02398435|Arthritis Rheumatoid|arthritis rheumatoid
4838487|NCT02398435|IL-18|il-18
4838488|NCT02398435|interleukin-18|interleukin-18
4838489|NCT02398435|IL-18 binding protein|il-18 binding protein
4838490|NCT02398422|Autonomic nervous system|autonomic nervous system
4838491|NCT02398422|Auditory processing disorder|auditory processing disorder
4838492|NCT02398422|Social behavior|social behavior
4838493|NCT02398409|stroke|stroke
4838494|NCT02398409|Injury, Brain, Traumatic|injury, brain, traumatic
4838495|NCT02398409|Family Caregivers|family caregivers
4838496|NCT02398409|TBI (Traumatic Brain Injury)|tbi (traumatic brain injury)
4838497|NCT02398409|Informal Caregivers|informal caregivers
4838498|NCT02398370|ED|ed
4838499|NCT02398357|anticoagulation|anticoagulation
4838628|NCT02397720|Leukemia|leukemia
4838500|NCT02398357|Zelen-designed randomized controlled trial|zelen-designed randomized controlled trial
4838501|NCT02398331|Spinal cord injuries|spinal cord injuries
4838502|NCT02398331|Sexual function|sexual function
4838503|NCT02398331|Sexual response|sexual response
4838504|NCT02398331|Sexuality|sexuality
4838505|NCT02398331|Women|women
4838506|NCT02398318|neurosurgery|neurosurgery
4838507|NCT02398318|deep brain stimulation|deep brain stimulation
4838508|NCT02398318|exposure response prevention|exposure response prevention
4838509|NCT02398305|Cardiac catheterisation|cardiac catheterisation
4838510|NCT02398305|Radial access|radial access
4838511|NCT02398305|Compression|compression
4838512|NCT02398305|Terumo TR Band|terumo tr band
4838513|NCT02398305|radial artery|radial artery
4838514|NCT02398305|diagnostic|diagnostic
4838515|NCT02398279|schizophrenia|schizophrenia
4838516|NCT02398279|L-Arginine|l-arginine
4838517|NCT02398279|nitric oxide|nitric oxide
4838518|NCT02398279|drug augmentation|drug augmentation
4838519|NCT02398253|weight maintenance|weight maintenance
4838520|NCT02398253|cognitive behavior therapy|cognitive behavior therapy
4838521|NCT02398253|successful weight loss|successful weight loss
4838522|NCT02398227|Battered Women|battered women
4838523|NCT02398227|Trauma|trauma
4838524|NCT02398227|Domestic Violence|domestic violence
4838525|NCT02398214|Sleep|sleep
4838526|NCT02398214|Infants|infants
4838527|NCT02398214|Toddlers|toddlers
4838528|NCT02398214|Behavioral intervention|behavioral intervention
4838529|NCT02398175|Pediatric polytrauma|pediatric polytrauma
4838530|NCT02398175|thoracic injuries|thoracic injuries
4838531|NCT02398162|Scrub Typhus in Pediatric|scrub typhus in pediatric
4838532|NCT02398162|Immunology|immunology
4838533|NCT02398136|intervention|intervention
4838534|NCT02398136|ketamine|ketamine
4838535|NCT02398136|PTSD|ptsd
4838536|NCT02398136|treatment|treatment
4838537|NCT02398136|posttraumatic stress disorder|posttraumatic stress disorder
4838538|NCT02398123|Transversus Abdominis Plane|transversus abdominis plane
4838539|NCT02398123|caudal block|caudal block
4838540|NCT02398123|postoperative pain|postoperative pain
4838541|NCT02398123|children|children
4838542|NCT02398084|mastication|mastication
4838543|NCT02398084|cashews|cashews
4838544|NCT02398084|walnuts|walnuts
4838545|NCT02398084|participants|participants
4838546|NCT02398071|Positive Expiratory Pressure|positive expiratory pressure
4838547|NCT02398071|Exercise Recovery|exercise recovery
4838548|NCT02398071|COPD|copd
4838549|NCT02398058|trabectedin|trabectedin
4838550|NCT02398058|olaparib|olaparib
4838551|NCT02398058|sarcoma|sarcoma
4838552|NCT02398058|bone tumor|bone tumor
4838553|NCT02398045|Obsessive-compulsive disorder|obsessive-compulsive disorder
4838554|NCT02398045|cognitive behavioural therapy|cognitive behavioural therapy
4838555|NCT02398045|computerised|computerised
4838556|NCT02398032|sleep apnea|sleep apnea
4838557|NCT02398032|hypertension|hypertension
4838558|NCT02398032|mechanosensitivity|mechanosensitivity
4838559|NCT02398032|chemosensitivity|chemosensitivity
4838560|NCT02398032|adhesion factors|adhesion factors
4838561|NCT02398019|CPB|cpb
4838562|NCT02398019|oXiris®|oxiris®
4838563|NCT02398019|SIRS|sirs
4838564|NCT02398019|AKI|aki
4838565|NCT02398019|Cytokines|cytokines
4838566|NCT02398019|CSA-AKI|csa-aki
4838567|NCT02398006|Clavicle [mh]|clavicle [mh]
4838568|NCT02398006|Fracture Healing [mh]|fracture healing [mh]
4838569|NCT02398006|Fractures, Bone [mh]|fractures, bone [mh]
4838570|NCT02398006|Treatment outcome [mh]|treatment outcome [mh]
4838571|NCT02398006|Conservative treatment [tw]|conservative treatment [tw]
4838572|NCT02397980|Caregivers|caregivers
4838573|NCT02397967|NF1|nf1
4838574|NCT02397967|children|children
4838575|NCT02397967|reading disabilities|reading disabilities
4838576|NCT02397954|idiopathic polypoidal choroidal vasculopathy|idiopathic polypoidal choroidal vasculopathy
4838577|NCT02397954|IPCV|ipcv
4838578|NCT02397954|Zimura®|zimura®
4838579|NCT02397954|Avastin®|avastin®
4838580|NCT02397954|Eylea®|eylea®
4838581|NCT02397954|Lucentis®|lucentis®
4838582|NCT02397928|Malignant Pleural Mesothelioma|malignant pleural mesothelioma
4838583|NCT02397928|Treatment|treatment
4838584|NCT02397928|Minimal toxicity|minimal toxicity
4838585|NCT02397928|TTFields|ttfields
4838586|NCT02397928|Tumor Treating Fields|tumor treating fields
4838587|NCT02397928|Novocure|novocure
4838588|NCT02397928|Pemetrexed|pemetrexed
4838589|NCT02397928|Carboplatin|carboplatin
4838590|NCT02397928|Cisplatin|cisplatin
4838591|NCT02397915|Nasal Spray|nasal spray
4838592|NCT02397915|Fluticasone Furoate|fluticasone furoate
4838593|NCT02397915|Attributes|attributes
4838594|NCT02397915|Single Dose|single dose
4838595|NCT02397915|Allergic Rhinitis|allergic rhinitis
4838596|NCT02397915|Mometasone Furoate|mometasone furoate
4838597|NCT02397915|Questionnaire|questionnaire
4838598|NCT02397915|Preference|preference
4838599|NCT02397889|posttraumatic stress disorder|posttraumatic stress disorder
4838600|NCT02397889|PTSD|ptsd
4838601|NCT02397889|ketamine|ketamine
4838602|NCT02397889|trauma|trauma
4838603|NCT02397889|treatment|treatment
4838604|NCT02397889|New York|new york
4838605|NCT02397889|NYC|nyc
4838606|NCT02397876|Food Allergy|food allergy
4838607|NCT02397876|Cows Milk Allergy|cows milk allergy
4838608|NCT02397850|depression, chronic, psychotherapy, telephone, feasibility|depression, chronic, psychotherapy, telephone, feasibility
4838609|NCT02397837|Bipolar Disorder|bipolar disorder
4838610|NCT02397837|Cognition|cognition
4838611|NCT02397785|chronic pelvic pain|chronic pelvic pain
4838612|NCT02397785|electrical stimulation|electrical stimulation
4838613|NCT02397785|pelvic floor rehabilitation|pelvic floor rehabilitation
4838614|NCT02397785|neuromodulation|neuromodulation
4838615|NCT02397772|Soil-transmitted helminths|soil-transmitted helminths
4838616|NCT02397772|Intestinal Nematodes|intestinal nematodes
4838617|NCT02397772|Hookworm|hookworm
4838618|NCT02397772|Ascaris|ascaris
4838619|NCT02397772|Mass Treatment|mass treatment
4838620|NCT02397772|Kenya|kenya
4838621|NCT02397746|osteoarthritis|osteoarthritis
4838622|NCT02397746|avascular necrosis|avascular necrosis
4838623|NCT02397746|ankylosis|ankylosis
4838624|NCT02397746|protrusio acetabuli|protrusio acetabuli
4838625|NCT02397746|rheumatoid arthritis|rheumatoid arthritis
4838626|NCT02397746|correction of functional deformity|correction of functional deformity
4838627|NCT02397746|revision procedures|revision procedures
4838629|NCT02397720|Acute myeloid leukemia|acute myeloid leukemia
4838630|NCT02397720|AML|aml
4838631|NCT02397720|Refractory/ relapsed|refractory/ relapsed
4838632|NCT02397720|5-azacytidine|5-azacytidine
4838633|NCT02397720|Azacitidine|azacitidine
4838634|NCT02397720|5-aza|5-aza
4838635|NCT02397720|Vidaza|vidaza
4838636|NCT02397720|5-AZC|5-azc
4838637|NCT02397720|AZA-CR|aza-cr
4838638|NCT02397720|Ladakamycin|ladakamycin
4838639|NCT02397720|NSC-102816|nsc-102816
4838640|NCT02397720|Azacytidine|azacytidine
4838641|NCT02397720|Nivolumab|nivolumab
4838642|NCT02397720|BMS-936558|bms-936558
4838643|NCT02397720|Phone calls|phone calls
4838644|NCT02397694|Adult|adult
4838645|NCT02397694|HIV|hiv
4838646|NCT02397694|naive|naive
4838647|NCT02397655|stroke|stroke
4838648|NCT02397655|ischemia|ischemia
4838649|NCT02397655|atherosclerosis|atherosclerosis
4838650|NCT02397655|ultrasonography|ultrasonography
4838651|NCT02397590|Fimasartan|fimasartan
4838652|NCT02397564|scar|scar
4838653|NCT02397564|ICD-10 CM:L90.5|icd-10 cm:l90.5
4838654|NCT02397538|Fimasartan|fimasartan
4838655|NCT02397447|Momordica Charantia|momordica charantia
4838656|NCT02397447|Insulin secretion|insulin secretion
4838657|NCT02397447|Insulin sensitivity|insulin sensitivity
4838658|NCT02397434|assessment of QOL (EORTC QLQ-C30)|assessment of qol (eortc qlq-c30)
4838659|NCT02397421|Heart failure|heart failure
4838660|NCT02397421|Diabetes|diabetes
4838661|NCT02397421|Left ventricular remodelling|left ventricular remodelling
4838662|NCT02397421|SGLT-2 inhibitors|sglt-2 inhibitors
4838663|NCT02397395|Renal Impairment|renal impairment
4838664|NCT02397395|End-stage Renal Disease|end-stage renal disease
4838665|NCT02397395|Simeprevir|simeprevir
4838666|NCT02397395|Daclatasvir|daclatasvir
4838667|NCT02397382|Psoriasis|psoriasis
4838668|NCT02397382|Guselkumab|guselkumab
4838669|NCT02397382|Cytochromes P450|cytochromes p450
4838670|NCT02397369|Education and evaluate post intervention KAP|education and evaluate post intervention kap
4838671|NCT02397356|ketamine|ketamine
4838672|NCT02397343|Reduction of secondary hyperalgesia and/-or local inflammation|reduction of secondary hyperalgesia and/-or local inflammation
4838673|NCT02397304|Intra-muscular triglyceride use|intra-muscular triglyceride use
4838674|NCT02397291|Pregnancy|pregnancy
4838675|NCT02397291|IUGR|iugr
4838676|NCT02397265|Type 1 diabetes|type 1 diabetes
4838677|NCT02397265|Hypoglycaemia|hypoglycaemia
4838678|NCT02397265|Closed loop insulin pump|closed loop insulin pump
4838679|NCT02397265|Artificial pancreas|artificial pancreas
4838680|NCT02397265|Exercise|exercise
4838681|NCT02397265|Mixed meals|mixed meals
4838682|NCT02397265|Bihormonal pump|bihormonal pump
4838683|NCT02397252|Human Papillomavirus|human papillomavirus
4838684|NCT02397252|Screening|screening
4838685|NCT02397252|Self-collection test|self-collection test
4838686|NCT02397252|Pap test|pap test
4838687|NCT02397226|Radiofrequency ablation|radiofrequency ablation
4838688|NCT02397226|Plethysmography|plethysmography
4838689|NCT02397226|Duplex ultrasound|duplex ultrasound
4838690|NCT02397226|High ligation/stripping|high ligation/stripping
4838691|NCT02397213|Ciclosporin|ciclosporin
4838692|NCT02397213|Acute Kidney injury|acute kidney injury
4838693|NCT02397213|Cardiac surgery|cardiac surgery
4838694|NCT02397213|Ischemia|ischemia
4838695|NCT02397213|Safety|safety
4838696|NCT02397213|Cystatin C|cystatin c
4838697|NCT02397200|Growth|growth
4838698|NCT02397200|low weight|low weight
4838699|NCT02397200|low height|low height
4838700|NCT02397200|Nutritional Supplementation|nutritional supplementation
4838701|NCT02397174|Polycystic Ovary syndrome|polycystic ovary syndrome
4838702|NCT02397174|hypocaloric diet|hypocaloric diet
4838703|NCT02397174|Ovarian Cysts|ovarian cysts
4838704|NCT02397174|Ovarian Diseases|ovarian diseases
4838705|NCT02397174|Obesity|obesity
4838706|NCT02397174|Mediterranean Diet|mediterranean diet
4838707|NCT02397135|genomic markers|genomic markers
4838708|NCT02397083|Endometrial Cancer|endometrial cancer
4838709|NCT02397083|Endometrial hyperplasia|endometrial hyperplasia
4838710|NCT02397083|Intrauterine device|intrauterine device
4838711|NCT02397083|IUD|iud
4838712|NCT02397083|Levonorgestrel intrauterine device|levonorgestrel intrauterine device
4838713|NCT02397083|LIUD|liud
4838714|NCT02397083|Mirena|mirena
4838715|NCT02397083|Everolimus|everolimus
4838716|NCT02397083|Afinitor|afinitor
4838717|NCT02397083|Zortress|zortress
4838718|NCT02397083|RAD001|rad001
4838719|NCT02397083|Questionnaires|questionnaires
4838720|NCT02397083|Survey|survey
4838721|NCT02397083|Quality of life|quality of life
4838722|NCT02397083|QOL|qol
4838723|NCT02397070|Jaw exercise|jaw exercise
4838724|NCT02397070|Occlusal splint|occlusal splint
4838725|NCT02397070|Treatment|treatment
4838726|NCT02397070|Muscular pain|muscular pain
4838727|NCT02397070|Mandibular movement|mandibular movement
4838728|NCT02397044|Implants, stability, loading|implants, stability, loading
4838729|NCT02397031|borderline personality disorder|borderline personality disorder
4838730|NCT02397031|mindfulness|mindfulness
4838731|NCT02397018|stroke|stroke
4838732|NCT02397018|cord blood|cord blood
4838733|NCT02397018|umbilical cord blood|umbilical cord blood
4838734|NCT02397018|hematopoietic stem cells|hematopoietic stem cells
4838735|NCT02397018|acute ischemic stroke|acute ischemic stroke
4838736|NCT02396992|Oropharyngeal Dysphagia|oropharyngeal dysphagia
4838737|NCT02396992|Aspiration pneumonia|aspiration pneumonia
4838738|NCT02396992|Malnutrition|malnutrition
4838739|NCT02396992|Oral Health|oral health
4838740|NCT02396992|Bacterial colonization|bacterial colonization
4838741|NCT02396992|Aging|aging
4838742|NCT02396940|3D|3d
4838743|NCT02396940|Three-dimensional|three-dimensional
4838744|NCT02396940|Laparoscopy|laparoscopy
4838745|NCT02396940|Inguinal hernia repair|inguinal hernia repair
4838746|NCT02396927|3D|3d
4838747|NCT02396927|Three-dimensional|three-dimensional
4838748|NCT02396927|laparoscopy|laparoscopy
4838749|NCT02396927|cholecystectomy|cholecystectomy
4838750|NCT02396901|early goal direct therapy|early goal direct therapy
4838751|NCT02396901|preventive strategies|preventive strategies
4838752|NCT02396901|cardiac surgery|cardiac surgery
4838753|NCT02396888|Blood vessel|blood vessel
4838754|NCT02396888|Fibroplasia|fibroplasia
4838755|NCT02396888|Wound healing|wound healing
4838756|NCT02396888|Insulin|insulin
4838757|NCT02396836|Hand hygiene|hand hygiene
4838758|NCT02396836|Hand decontamination|hand decontamination
4838759|NCT02396836|Microbial load|microbial load
4838760|NCT02396836|Hand coverage|hand coverage
4838761|NCT02396836|Glove juice technique|glove juice technique
4838762|NCT02396836|Ayliffe technique|ayliffe technique
4838763|NCT02396836|6 step technique|6 step technique
4838764|NCT02396823|Blood pressure regulation|blood pressure regulation
4838765|NCT02396823|Respiratory Muscle Training|respiratory muscle training
4838766|NCT02396797|Sick leave|sick leave
4838767|NCT02396797|Mental Health|mental health
4838768|NCT02396797|Coping|coping
4838769|NCT02396797|Social Support|social support
4838770|NCT02396797|Subjective Health Complaints|subjective health complaints
4838771|NCT02396784|child overweight|child overweight
4838772|NCT02396784|child obesity|child obesity
4838773|NCT02396784|prevention|prevention
4838774|NCT02396784|targeted intervention|targeted intervention
4838775|NCT02396784|development of overweight|development of overweight
4838776|NCT02396771|Uterine|uterine
4838777|NCT02396771|Massage|massage
4838778|NCT02396771|Compression|compression
4838779|NCT02396732|Aspirin|aspirin
4838780|NCT02396732|Enoxaparin|enoxaparin
4838781|NCT02396732|Thromboprophylaxis|thromboprophylaxis
4838782|NCT02396732|Trauma|trauma
4838783|NCT02396732|Venous thromboembolism|venous thromboembolism
4838784|NCT02396693|Newborn|newborn
4838785|NCT02396693|non invasive ventilation|non invasive ventilation
4838786|NCT02396680|Ragweed Allergy|ragweed allergy
4838787|NCT02396680|Rhinoconjunctivitis|rhinoconjunctivitis
4838788|NCT02396680|Immunotherapy|immunotherapy
4838789|NCT02396680|Ragweed-SPIRE|ragweed-spire
4838790|NCT02396641|Best Supportive Care|best supportive care
4838791|NCT02396628|Graft-versus-Host Disease (GvHD)|graft-versus-host disease (gvhd)
4838792|NCT02396628|resistance to therapy|resistance to therapy
4838793|NCT02396628|allogeneic stem cell transplantation|allogeneic stem cell transplantation
4838794|NCT02396628|Ruxolitinib|ruxolitinib
4838795|NCT02396615|Ad libitum energy intake|ad libitum energy intake
4838796|NCT02396615|Appetite|appetite
4838797|NCT02396589|stroke rehabilitation|stroke rehabilitation
4838798|NCT02396589|barriers to independence|barriers to independence
4838799|NCT02396589|environmental support|environmental support
4838800|NCT02396550|Expectations|expectations
4838801|NCT02396537|Children|children
4838802|NCT02396537|Midazolam|midazolam
4838803|NCT02396537|Lidocaine|lidocaine
4838804|NCT02396537|Intranasal|intranasal
4838805|NCT02396524|Chronic Disease|chronic disease
4838806|NCT02396524|Lifestyle Intervention|lifestyle intervention
4838807|NCT02396524|Health Promotion|health promotion
4838808|NCT02396524|Sport Mentorship|sport mentorship
4838809|NCT02396524|Men|men
4838810|NCT02396524|Health Technology|health technology
4838811|NCT02396524|Prevention|prevention
4838812|NCT02396524|Exercise|exercise
4838813|NCT02396524|Diet|diet
4838814|NCT02396472|social support|social support
4838815|NCT02396459|Triac|triac
4838816|NCT02396459|MCT8|mct8
4838817|NCT02396459|Allan-Herndon-Dudley Syndrome|allan-herndon-dudley syndrome
4838818|NCT02396433|Halaven|halaven
4838819|NCT02396433|BRCA|brca
4838820|NCT02396433|E7449|e7449
4838821|NCT02396420|BPH|bph
4838822|NCT02396420|prostatic hyperplasia|prostatic hyperplasia
4838823|NCT02396420|enlarged prostate|enlarged prostate
4838824|NCT02396420|benign prostatic hypertrophy|benign prostatic hypertrophy
4838825|NCT02396407|Chlorine water treatment|chlorine water treatment
4838826|NCT02396407|Point-of-use water treatment|point-of-use water treatment
4838827|NCT02396407|Household water treatment with safe storage|household water treatment with safe storage
4838828|NCT02396407|Handwashing with soap|handwashing with soap
4838829|NCT02396407|Hand hygiene|hand hygiene
4838830|NCT02396407|Latrines|latrines
4838831|NCT02396407|Child potties|child potties
4838832|NCT02396407|Intestinal parasitic infection|intestinal parasitic infection
4838833|NCT02396407|Soil-transmitted helminths|soil-transmitted helminths
4838834|NCT02396407|Water|water
4838835|NCT02396407|Sanitation|sanitation
4838836|NCT02396407|Handwashing|handwashing
4838837|NCT02396407|Diarrhea|diarrhea
4838838|NCT02396407|Herd immunity|herd immunity
4838839|NCT02396407|Helminths|helminths
4838840|NCT02396394|HIV|hiv
4838841|NCT02396394|ART Adherence|art adherence
4838842|NCT02396394|Retention in Care|retention in care
4838843|NCT02396394|Pregnant Women|pregnant women
4838844|NCT02396394|Postpartum Women|postpartum women
4838845|NCT02396381|Candidate modified risk tobacco product|candidate modified risk tobacco product
4838846|NCT02396381|Conventional cigarette|conventional cigarette
4838847|NCT02396381|Exposure response|exposure response
4838848|NCT02396381|Smoking|smoking
4838849|NCT02396381|Tobacco Heating System|tobacco heating system
4838850|NCT02396368|Prostate cancer|prostate cancer
4838851|NCT02396368|Bone metastatic Castration-Resistant Prostate Cancer|bone metastatic castration-resistant prostate cancer
4838852|NCT02396368|Radium 223|radium 223
4838853|NCT02396368|Tasquinimod|tasquinimod
4838854|NCT02396355|flow cytometry|flow cytometry
4838855|NCT02396342|Hemophilia B, gene therapy|hemophilia b, gene therapy
4838856|NCT02396303|General: To compare Carbetocin and Oxytocin for the control of PPH.|general: to compare carbetocin and oxytocin for the control of pph.
4838857|NCT02396290|acne scar|acne scar
4838858|NCT02396290|fractional carbon dioxide laser|fractional carbon dioxide laser
4838859|NCT02396290|platelet rich plasma|platelet rich plasma
4838860|NCT02396264|Mediterranean Diet|mediterranean diet
4838861|NCT02396264|Ovarian Cysts|ovarian cysts
4838862|NCT02396264|Treatment|treatment
4838863|NCT02396264|Ovarian Diseases|ovarian diseases
4838864|NCT02396264|normocaloric diet|normocaloric diet
4838865|NCT02396225|voriconazole|voriconazole
4838866|NCT02396225|inhalation|inhalation
4838867|NCT02396225|aerosol|aerosol
4838868|NCT02396225|epithelial lining fluid|epithelial lining fluid
4838869|NCT02396225|concentration|concentration
4838870|NCT02396225|pharmacokinetic|pharmacokinetic
4838871|NCT02396199|Abdominal aortic aneurysm|abdominal aortic aneurysm
4838872|NCT02396199|Endovascular|endovascular
4838873|NCT02396199|Juxtarenal|juxtarenal
4838874|NCT02396199|Pararenal|pararenal
4838875|NCT02396199|Fenestrated|fenestrated
4838876|NCT02396173|disability|disability
4838877|NCT02396173|vocational|vocational
4838878|NCT02396173|rehabilitation|rehabilitation
4838879|NCT02396173|prediction|prediction
4838880|NCT02396160|overactive bladder|overactive bladder
4838881|NCT02396160|urinary incontinence|urinary incontinence
4838882|NCT02396160|nocturia|nocturia
4838883|NCT02396160|urinary frequency|urinary frequency
4838884|NCT02396147|Drug therapy|drug therapy
4838885|NCT02396095|female|female
4838886|NCT02396095|cancer|cancer
4838887|NCT02396082|care coordination|care coordination
4838888|NCT02396082|quality of life|quality of life
4838889|NCT02396082|community-based|community-based
4838890|NCT02396082|care quality|care quality
4838891|NCT02396082|Long term care placement|long term care placement
4838892|NCT02396082|memory care|memory care
4838893|NCT02396082|Neuropsychiatric behaviors|neuropsychiatric behaviors
4838894|NCT02396056|Guided Bone Regeneration|guided bone regeneration
4838895|NCT02396056|Gingival Mesenchymal Stem Cells|gingival mesenchymal stem cells
4838896|NCT02395991|gadoxetic acid|gadoxetic acid
4838897|NCT02395991|transient dyspnea|transient dyspnea
4838898|NCT02395965|Osteopathic manipulative medicine|osteopathic manipulative medicine
4838899|NCT02395965|Osteopathic manipulative treatment|osteopathic manipulative treatment
4838900|NCT02395952|cornea|cornea
4838901|NCT02395952|epithelial defect|epithelial defect
4838902|NCT02395952|amniotic membrane|amniotic membrane
4838903|NCT02395939|Cryobiopsy|cryobiopsy
4838904|NCT02395939|Radial EBUS|radial ebus
4838905|NCT02395939|Guide Sheath|guide sheath
4838906|NCT02395939|Peripheral pulmonary lesions|peripheral pulmonary lesions
4838907|NCT02395887|Spinal stenosis|spinal stenosis
4838908|NCT02395887|Spinal decompression|spinal decompression
4838909|NCT02395887|Postural balance|postural balance
4838910|NCT02395887|Neurogenic claudication|neurogenic claudication
4838911|NCT02395848|recurrent|recurrent
4838912|NCT02395848|infection|infection
4838913|NCT02395835|body mass index|body mass index
4838914|NCT02395835|methylation|methylation
4838915|NCT02395835|PPAR gamma|ppar gamma
4838916|NCT02395835|pregnancy|pregnancy
4838917|NCT02395822|AML|aml
4838918|NCT02395822|Relapsed|relapsed
4838919|NCT02395822|Refractory|refractory
4838920|NCT02395796|epidural|epidural
4838921|NCT02395796|labor analgesia|labor analgesia
4838922|NCT02395796|pressure monitoring|pressure monitoring
4838923|NCT02395783|Preterm infants|preterm infants
4838924|NCT02395783|diagnosis of cerebral white matter injury|diagnosis of cerebral white matter injury
4838925|NCT02395770|Shoulder|shoulder
4838926|NCT02395770|Rotator cuff|rotator cuff
4838927|NCT02395770|Rehabilitation|rehabilitation
4838928|NCT02395770|Motor control|motor control
4838929|NCT02395757|Age Related Macular Degeneration (AMD)|age related macular degeneration (amd)
4838930|NCT02395757|Microperimetry|microperimetry
4838931|NCT02395757|Diagnostic|diagnostic
4838932|NCT02395731|dual eligible|dual eligible
4838933|NCT02395731|care coordination|care coordination
4838934|NCT02395731|community-based|community-based
4838935|NCT02395731|care quality|care quality
4838936|NCT02395731|care needs|care needs
4838937|NCT02395731|health services|health services
4838938|NCT02395731|care management|care management
4838939|NCT02395731|low income|low income
4838940|NCT02395731|Neuropsychiatric behaviors|neuropsychiatric behaviors
4838941|NCT02395718|elderly|elderly
4838942|NCT02395718|quick diagnostic unit|quick diagnostic unit
4838943|NCT02395718|short stay unit|short stay unit
4838944|NCT02395718|randomised controlled trial|randomised controlled trial
4838945|NCT02395679|Dendritic cell-based immunotherapy|dendritic cell-based immunotherapy
4838946|NCT02395666|Neuroblastoma in remission|neuroblastoma in remission
4838947|NCT02395666|Relapsed Neuroblastoma|relapsed neuroblastoma
4838948|NCT02395666|Refractory Neuroblastoma|refractory neuroblastoma
4838949|NCT02395653|Pediatric|pediatric
4838950|NCT02395653|Postoperative|postoperative
4838951|NCT02395653|Pain Management|pain management
4838952|NCT02395627|Hormone Therapy Resistant|hormone therapy resistant
4838953|NCT02395627|Estrogen Receptor-Positive|estrogen receptor-positive
4838954|NCT02395627|Estrogen Receptor-Negative|estrogen receptor-negative
4838955|NCT02395614|tissue expander|tissue expander
4838956|NCT02395614|breast reconstruction|breast reconstruction
4838957|NCT02395601|B-Cell Lymphoma|b-cell lymphoma
4838958|NCT02395601|EZH2 Inhibitor|ezh2 inhibitor
4838959|NCT02395601|Phase 1|phase 1
4838960|NCT02395497|Penile Transplant|penile transplant
4838961|NCT02395497|Vascularized Composite Allotransplantation (VCA)|vascularized composite allotransplantation (vca)
4838962|NCT02395497|Composite Tissue Allotransplantation (CTA)|composite tissue allotransplantation (cta)
4838963|NCT02395497|Penis|penis
4838964|NCT02395497|Amputation|amputation
4838965|NCT02395497|Immunosuppression|immunosuppression
4838966|NCT02395497|Composite Tissue|composite tissue
4838967|NCT02395497|Male|male
4838968|NCT02395497|Humans|humans
4838969|NCT02395497|Allotransplantation|allotransplantation
4838970|NCT02395458|Sequential therapy|sequential therapy
4838971|NCT02395458|Triple therapy|triple therapy
4838972|NCT02395458|Eradication|eradication
4838973|NCT02395393|Acute rejection|acute rejection
4838974|NCT02395393|Chronic rejection|chronic rejection
4838975|NCT02395393|Confocal microscopy|confocal microscopy
4838976|NCT02395380|CRP|crp
4838977|NCT02395380|Postoperative complication|postoperative complication
4838978|NCT02395380|Length of stay|length of stay
4838979|NCT02395367|Prognosis|prognosis
4838980|NCT02395367|Risk Factors|risk factors
4838981|NCT02395354|Endoscopic treatment|endoscopic treatment
4838982|NCT02395354|Stenosis|stenosis
4838983|NCT02395354|Crohn's Disease|crohn's disease
4838984|NCT02395354|balloon dilatation|balloon dilatation
4838985|NCT02395354|self-expanding metallic stent|self-expanding metallic stent
4838986|NCT02395354|chronic transmural inflammation|chronic transmural inflammation
4838987|NCT02395354|steady narrowing of the intestinal lumen|steady narrowing of the intestinal lumen
4838988|NCT02395341|reproductive hormones|reproductive hormones
4838989|NCT02395341|cancer survivors|cancer survivors
4838990|NCT02395341|endocrine function|endocrine function
4838991|NCT02395341|antral follicle counts|antral follicle counts
4838992|NCT02395341|female infertility due to diminished ovarian reserve|female infertility due to diminished ovarian reserve
4838993|NCT02395341|perimenopause|perimenopause
4838994|NCT02395341|premature menopause|premature menopause
4838995|NCT02395328|Orphans and vulnerable children (OVC)|orphans and vulnerable children (ovc)
4838996|NCT02395328|Home visiting intervention|home visiting intervention
4838997|NCT02395328|South Africa|south africa
4838998|NCT02395328|Program evaluation|program evaluation
4838999|NCT02395315|Diabetes Mellitus|diabetes mellitus
4839000|NCT02395315|Osseointegration|osseointegration
4839001|NCT02395315|Bone vascularity|bone vascularity
4839002|NCT02395315|Primary implant stability|primary implant stability
4839003|NCT02395289|Cognitive-Based Compassion Training (CBCT)|cognitive-based compassion training (cbct)
4839004|NCT02395289|HIV-related clinical outcomes|hiv-related clinical outcomes
4839005|NCT02395289|Stress and stress-related psychological adjustment|stress and stress-related psychological adjustment
4839006|NCT02395289|Stress-related inflammatory biomarkers|stress-related inflammatory biomarkers
4839007|NCT02395276|Congenital Heart Defects|congenital heart defects
4839008|NCT02395276|Hypoxic Ischemic Brain Injury|hypoxic ischemic brain injury
4839009|NCT02395276|Hypothermia Therapy|hypothermia therapy
4839010|NCT02395276|Pediatrics|pediatrics
4839011|NCT02395237|Fed Conditions|fed conditions
4839012|NCT02395224|Follow-up studies|follow-up studies
4839013|NCT02395224|Prognosis|prognosis
4839014|NCT02395224|Palliative care|palliative care
4839015|NCT02395224|Chemotherapy, adjuvant|chemotherapy, adjuvant
4839016|NCT02395224|Cost-benefit analysis|cost-benefit analysis
4839017|NCT02395224|Population|population
4839018|NCT02395224|Antineoplastic agents/Adverse effects|antineoplastic agents/adverse effects
4839019|NCT02395224|Terminal care|terminal care
4839020|NCT02395224|Medical futility|medical futility
4839021|NCT02395224|Survival rate|survival rate
4839022|NCT02395224|Norway|norway
4839023|NCT02395198|hepatitis c virus|hepatitis c virus
4839024|NCT02395198|opioid substitution treatment|opioid substitution treatment
4839025|NCT02395172|avelumab|avelumab
4839026|NCT02395172|MSB0010718C|msb0010718c
4839027|NCT02395172|Non-Small Cell Lung Cancer|non-small cell lung cancer
4839028|NCT02395172|Anti-PD-L1|anti-pd-l1
4839029|NCT02395159|vascular surgery patients|vascular surgery patients
4839030|NCT02395159|wound management|wound management
4839031|NCT02395133|Eczema|eczema
4839032|NCT02395120|Dental Care|dental care
4839033|NCT02395120|Caregiver Illness Perception|caregiver illness perception
4839034|NCT02395120|Common Sense Model of Self-Regulation|common sense model of self-regulation
4839035|NCT02395120|Dental Access|dental access
4839036|NCT02395120|Referral letter|referral letter
4839037|NCT02395120|Dental Caries|dental caries
4839038|NCT02395107|Aortic Valve Stenosis|aortic valve stenosis
4839039|NCT02395107|Functional Capacity|functional capacity
4839040|NCT02395107|Cardiomyopathies|cardiomyopathies
4839041|NCT02395107|Endomyocardial Fibrosis|endomyocardial fibrosis
4839042|NCT02395107|Cardiovascular Diseases|cardiovascular diseases
4839043|NCT02395107|Heart Diseases|heart diseases
4839044|NCT02395107|Heart Valve Diseases|heart valve diseases
4839045|NCT02395107|Atrial Fibrillation|atrial fibrillation
4839046|NCT02395107|Hypertrophy|hypertrophy
4839047|NCT02395107|Hypertrophy, Left Ventricular|hypertrophy, left ventricular
4839048|NCT02395107|Diastology|diastology
4839049|NCT02395081|pregnancy|pregnancy
4839050|NCT02395081|Mongolia|mongolia
4839051|NCT02395081|Vitamin D|vitamin d
4839052|NCT02395081|preeclampsia|preeclampsia
4839053|NCT02395068|Pharmacokinetics|pharmacokinetics
4839054|NCT02395068|Nimotuzumab|nimotuzumab
4839055|NCT02395068|Safety|safety
4839056|NCT02395068|Effcacy|effcacy
4839057|NCT02395068|Irinotecan|irinotecan
4839058|NCT02395029|PD|pd
4839059|NCT02395003|Obesity|obesity
4839060|NCT02395003|Pediatric|pediatric
4839061|NCT02394977|CPR|cpr
4839062|NCT02394977|Cardio first angle|cardio first angle
4839063|NCT02394977|Clinical trial|clinical trial
4839064|NCT02394951|chemotherapy|chemotherapy
4839065|NCT02394938|Music therapy|music therapy
4839066|NCT02394912|vena cava filter|vena cava filter
4839067|NCT02394899|SCD|scd
4839068|NCT02394899|early childhood intervention|early childhood intervention
4839069|NCT02394899|parental stress|parental stress
4839070|NCT02394899|neurocognition|neurocognition
4839071|NCT02394873|Deep Second-Degree Burn Wound|deep second-degree burn wound
4839072|NCT02394847|propofol|propofol
4839073|NCT02394847|electroconvulsive therapy|electroconvulsive therapy
4839074|NCT02394847|anesthesia|anesthesia
4839075|NCT02394834|Metastatic colorectal cancer, Panitumumab, mFOLFOX6, Bevacizumab|metastatic colorectal cancer, panitumumab, mfolfox6, bevacizumab
4839076|NCT02394795|Metastatic colorectal cancer, Panitumumab, mFOLFOX6, Bevacizumab|metastatic colorectal cancer, panitumumab, mfolfox6, bevacizumab
4839077|NCT02394782|Multiple sclerosis, relapsing-remitting|multiple sclerosis, relapsing-remitting
4839078|NCT02394782|Rebif|rebif
4839079|NCT02394782|Interferon beta-1a|interferon beta-1a
4839080|NCT02394782|RebiSmart®2.0|rebismart®2.0
4839081|NCT02394782|MSdialog™|msdialog™
4839082|NCT02394769|Colorectal Cancer|colorectal cancer
4839083|NCT02394743|Glomerular Filtration Rate|glomerular filtration rate
4839084|NCT02394730|HIV, d-dimer, hs-CRP, activated T-lymphocytes|hiv, d-dimer, hs-crp, activated t-lymphocytes
4839085|NCT02394704|Rumination|rumination
4839086|NCT02394704|Sensory processing|sensory processing
4839087|NCT02394704|Non-pharmacological intervention|non-pharmacological intervention
4839088|NCT02394704|Depression|depression
4839089|NCT02394704|Anxiety|anxiety
4839090|NCT02394704|PTSD|ptsd
4839091|NCT02394665|Glioblastoma|glioblastoma
4839092|NCT02394665|Gliosarcoma|gliosarcoma
4839093|NCT02394665|GBM|gbm
4839094|NCT02394626|Recurrent glioblastoma|recurrent glioblastoma
4839095|NCT02394626|Surgery|surgery
4839096|NCT02394626|Complete resection of enhancing tumor|complete resection of enhancing tumor
4839097|NCT02394626|Survival|survival
4839098|NCT02394626|Quality of life|quality of life
4839099|NCT02394613|Glaucoma|glaucoma
4839100|NCT02394613|DARC|darc
4839101|NCT02394613|Diagnosis|diagnosis
4839102|NCT02394600|rhinitis|rhinitis
4839103|NCT02394600|allergy|allergy
4839104|NCT02394587|mindfulness|mindfulness
4839105|NCT02394587|MBSR|mbsr
4839106|NCT02394587|SCD|scd
4839107|NCT02394587|experimental|experimental
4839108|NCT02394548|Locally advanced, inoperable non-small cell lung carcinoma|locally advanced, inoperable non-small cell lung carcinoma
4839109|NCT02394548|Limited stage small cell lung carcinoma|limited stage small cell lung carcinoma
4839110|NCT02394548|Acute esophagitis|acute esophagitis
4839211|NCT02394132|Radiotherapy|radiotherapy
4839111|NCT02394548|Intensity-modulated radiation therapy|intensity-modulated radiation therapy
4839112|NCT02394535|Pancreatic Cancer|pancreatic cancer
4839113|NCT02394535|Adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
4839114|NCT02394535|Locally Advanced Pancreatic Cancer|locally advanced pancreatic cancer
4839115|NCT02394535|Abraxane|abraxane
4839116|NCT02394535|Nab-Paclitaxel|nab-paclitaxel
4839117|NCT02394535|Paclitaxel (Protein-Bound)|paclitaxel (protein-bound)
4839118|NCT02394535|ABI-007|abi-007
4839119|NCT02394535|Radiation therapy|radiation therapy
4839120|NCT02394535|XRT|xrt
4839121|NCT02394535|Capecitabine|capecitabine
4839122|NCT02394535|Xeloda|xeloda
4839123|NCT02394535|Questionnaires|questionnaires
4839124|NCT02394535|Surveys|surveys
4839125|NCT02394522|Malaria|malaria
4839126|NCT02394522|Spatial Repellents|spatial repellents
4839127|NCT02394522|Plasmodium|plasmodium
4839128|NCT02394509|Epilepsy Memory Problems|epilepsy memory problems
4839129|NCT02394509|Self-Management|self-management
4839130|NCT02394496|Fulvestrant|fulvestrant
4839131|NCT02394496|Lapatinib|lapatinib
4839132|NCT02394496|Aromatase Inhibitor|aromatase inhibitor
4839133|NCT02394496|metastatic breast cancer|metastatic breast cancer
4839134|NCT02394483|Single ascending dose|single ascending dose
4839135|NCT02394483|double blind|double blind
4839136|NCT02394470|congestion|congestion
4839137|NCT02394470|total body water|total body water
4839138|NCT02394470|bioimpedentiometry|bioimpedentiometry
4839139|NCT02394470|lung ultrasound|lung ultrasound
4839140|NCT02394470|diuretics|diuretics
4839141|NCT02394470|dyspnea|dyspnea
4839142|NCT02394470|pulmonary B lines|pulmonary b lines
4839143|NCT02394470|deuterium|deuterium
4839144|NCT02394457|Postdural puncture headache|postdural puncture headache
4839145|NCT02394457|Epidural Blood Patch|epidural blood patch
4839146|NCT02394457|Cosyntropin|cosyntropin
4839147|NCT02394457|PDPH|pdph
4839148|NCT02394457|Regional anesthesia|regional anesthesia
4839149|NCT02394457|Lumbar puncture|lumbar puncture
4839150|NCT02394457|ACTH|acth
4839151|NCT02394457|Tetracosactin|tetracosactin
4839152|NCT02394444|Intervention program|intervention program
4839153|NCT02394444|Parenting stress|parenting stress
4839154|NCT02394444|Parental mental health|parental mental health
4839155|NCT02394444|Preterm infant's development|preterm infant's development
4839156|NCT02394431|Sickle Cell Disease|sickle cell disease
4839157|NCT02394431|Echocardiography|echocardiography
4839158|NCT02394431|Speckle tracking|speckle tracking
4839159|NCT02394392|Medication satisfaction|medication satisfaction
4839160|NCT02394392|Quality of life|quality of life
4839161|NCT02394392|Drug compliance|drug compliance
4839162|NCT02394366|Skin oxygenation|skin oxygenation
4839163|NCT02394366|peripheral perfusion|peripheral perfusion
4839164|NCT02394353|bariatrics|bariatrics
4839165|NCT02394353|transient elastography|transient elastography
4839166|NCT02394314|MEDI0382, diabetes|medi0382, diabetes
4839167|NCT02394301|Efficacy of Novel Drug Combinations for Relief of Psoriasis|efficacy of novel drug combinations for relief of psoriasis
4839168|NCT02394288|Cardiac Troponin|cardiac troponin
4839169|NCT02394288|Perioperative Period|perioperative period
4839170|NCT02394288|surgery|surgery
4839171|NCT02394262|Biological Markers|biological markers
4839172|NCT02394262|Multidetector Computed Tomography|multidetector computed tomography
4839173|NCT02394249|Insulin Resistance|insulin resistance
4839174|NCT02394249|Cognition|cognition
4839175|NCT02394249|Affect|affect
4839176|NCT02394249|Insulin|insulin
4839177|NCT02394249|Lipids|lipids
4839178|NCT02394236|exercise training|exercise training
4839179|NCT02394223|Cancer|cancer
4839180|NCT02394223|Prostate|prostate
4839181|NCT02394223|PSA|psa
4839182|NCT02394223|Biopsies|biopsies
4839183|NCT02394223|FFOCT procedure|ffoct procedure
4839184|NCT02394210|Multiple myeloma asymptomatic relapse symptomatic relapse|multiple myeloma asymptomatic relapse symptomatic relapse
4839185|NCT02394210|IMW Consensus Panel|imw consensus panel
4839186|NCT02394210|anti-MM therapy|anti-mm therapy
4839187|NCT02394197|Plasmodium vivax|plasmodium vivax
4839188|NCT02394197|Mexico|mexico
4839189|NCT02394197|treatment|treatment
4839190|NCT02394197|chloroquine|chloroquine
4839191|NCT02394197|primaquine|primaquine
4839192|NCT02394197|14-day treatment (T14)|14-day treatment (t14)
4839193|NCT02394197|intermittent single doses (ISD)|intermittent single doses (isd)
4839194|NCT02394184|transcatheter aortic valve replacement|transcatheter aortic valve replacement
4839195|NCT02394171|Physical Activity|physical activity
4839196|NCT02394171|Social Cohesion|social cohesion
4839197|NCT02394171|Intervention Development|intervention development
4839198|NCT02394171|Ethnic Minorities|ethnic minorities
4839199|NCT02394171|Nutrition|nutrition
4839200|NCT02394158|Recurrent Gestational Diabetes Mellitus|recurrent gestational diabetes mellitus
4839201|NCT02394158|Prevention|prevention
4839202|NCT02394158|Metformin|metformin
4839203|NCT02394145|platelet|platelet
4839204|NCT02394145|ticagrelor|ticagrelor
4839205|NCT02394145|clopidogrel|clopidogrel
4839206|NCT02394145|end stage renal disease|end stage renal disease
4839207|NCT02394145|hemodialysis|hemodialysis
4839208|NCT02394145|genetics|genetics
4839209|NCT02394132|Lentigo maligna|lentigo maligna
4839210|NCT02394132|Imiquimod|imiquimod
4839212|NCT02394054|vasopressin|vasopressin
4839213|NCT02394054|intranasal administration|intranasal administration
4839214|NCT02394054|healthy sample|healthy sample
4839215|NCT02394041|acupuncture|acupuncture
4839216|NCT02394041|cervical dystocia|cervical dystocia
4839217|NCT02394041|caesarean section|caesarean section
4839218|NCT02394041|obstetric labor|obstetric labor
4839219|NCT02394041|randomized controlled trial|randomized controlled trial
4839220|NCT02394015|Platinum-sensitive Recurrent Ovarian Cancer|platinum-sensitive recurrent ovarian cancer
4839221|NCT02394002|EEG, burst-suppression, N20, SEP, median nerve, facilitation|eeg, burst-suppression, n20, sep, median nerve, facilitation
4839222|NCT02393911|vestibulitis|vestibulitis
4839223|NCT02393911|microbiome|microbiome
4839224|NCT02393872|Prevention|prevention
4839225|NCT02393859|ALL|all
4839226|NCT02393859|High-risk first relapse B-precursor ALL|high-risk first relapse b-precursor all
4839227|NCT02393859|Precursor Cell Lymphoblastic Leukemia|precursor cell lymphoblastic leukemia
4839228|NCT02393859|Neoplasms|neoplasms
4839229|NCT02393859|Lymphoproliferative Disorders|lymphoproliferative disorders
4839230|NCT02393859|Immunoproliferative Disorders|immunoproliferative disorders
4839231|NCT02393859|Antibodies, Bispecific|antibodies, bispecific
4839232|NCT02393846|ankle sprain|ankle sprain
4839233|NCT02393846|topical ketoprofen|topical ketoprofen
4839234|NCT02393846|non-steroidal anti-inflammatory drug|non-steroidal anti-inflammatory drug
4839235|NCT02393846|emergency department|emergency department
4839236|NCT02393833|Vascular endothelial growth factor (VEGF)|vascular endothelial growth factor (vegf)
4839237|NCT02393833|Vascular cell adhesion molecule-1 (VCAM-1)|vascular cell adhesion molecule-1 (vcam-1)
4839238|NCT02393833|HER2-ECD|her2-ecd
4839239|NCT02393807|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
4839240|NCT02393794|BRCA1|brca1
4839241|NCT02393794|BRCA2|brca2
4839242|NCT02393794|TNBC|tnbc
4839243|NCT02393781|severe sepsis|severe sepsis
4839244|NCT02393781|septic shock|septic shock
4839245|NCT02393781|adrenomedullin|adrenomedullin
4839246|NCT02393781|organ dysfunction|organ dysfunction
4839247|NCT02393703|exosomes|exosomes
4839248|NCT02393703|15-015|15-015
4839249|NCT02393664|Thoracoscopy|thoracoscopy
4839250|NCT02393664|Recovery|recovery
4839251|NCT02393664|Tracheal intubation|tracheal intubation
4839252|NCT02393638|Endoscopic Sphincterotomy|endoscopic sphincterotomy
4839253|NCT02393625|NSCLC, ALK-positive|nsclc, alk-positive
4839254|NCT02393586|Tuberculosis|tuberculosis
4839255|NCT02393586|Whole blood Bactericidal Activity|whole blood bactericidal activity
4839256|NCT02393586|WBA|wba
4839257|NCT02393586|Faropenem|faropenem
4839258|NCT02393573|Insulin Resistance|insulin resistance
4839259|NCT02393573|Protein balance|protein balance
4839260|NCT02393573|Surgery|surgery
4839261|NCT02393573|Post operative complications|post operative complications
4839262|NCT02393573|metformin|metformin
4839263|NCT02393573|Pre-diabetes|pre-diabetes
4839264|NCT02393573|Fasting blood glucose|fasting blood glucose
4839265|NCT02393547|obesity|obesity
4839266|NCT02393534|Primary Care|primary care
4839267|NCT02393534|Health Services Research|health services research
4839268|NCT02393534|Telemedicine|telemedicine
4839269|NCT02393521|Vibration|vibration
4839270|NCT02393521|Pressure Pain Threshold|pressure pain threshold
4839271|NCT02393521|Trigger Points|trigger points
4839272|NCT02393521|Neck Pain|neck pain
4839273|NCT02393508|transfusion, red blood cell|transfusion, red blood cell
4839274|NCT02393508|transfusion reaction|transfusion reaction
4839275|NCT02393508|quality of life|quality of life
4839276|NCT02393443|oxytocin|oxytocin
4839277|NCT02393443|healthy sample|healthy sample
4839278|NCT02393443|intranasal administration|intranasal administration
4839279|NCT02393443|learning|learning
4839280|NCT02393417|Verruca vulgaris|verruca vulgaris
4839281|NCT02393417|Common Warts|common warts
4839282|NCT02393378|Drug Therapy|drug therapy
4839283|NCT02393365|Hepatitis C|hepatitis c
4839284|NCT02393365|HCV|hcv
4839285|NCT02393365|screening|screening
4839286|NCT02393352|Body Composition|body composition
4839287|NCT02393352|Autonomic Nervous System|autonomic nervous system
4839288|NCT02393352|Oxygen|oxygen
4839289|NCT02393352|Randomized Controlled Trial|randomized controlled trial
4839290|NCT02393300|tranexamic acid|tranexamic acid
4839291|NCT02393300|blood loss|blood loss
4839292|NCT02393300|topical administration|topical administration
4839293|NCT02393300|intravenous administration|intravenous administration
4839294|NCT02393248|alterations in FGF or FGFR|alterations in fgf or fgfr
4839295|NCT02393248|squamous non-small cell lung cancer|squamous non-small cell lung cancer
4839296|NCT02393248|gastric cancer|gastric cancer
4839297|NCT02393248|urothelial cancer|urothelial cancer
4839298|NCT02393248|endometrial cancer|endometrial cancer
4839299|NCT02393248|multiple myeloma|multiple myeloma
4839300|NCT02393248|MPN|mpn
4839301|NCT02393235|unexplained infertility|unexplained infertility
4839302|NCT02393235|tubal infertility|tubal infertility
4839303|NCT02393235|pulsatility index|pulsatility index
4839304|NCT02393235|resistance index|resistance index
4839305|NCT02393235|fertile women|fertile women
4839306|NCT02393222|Dialysis|dialysis
4839307|NCT02393222|Cerebrovascular disease|cerebrovascular disease
4839308|NCT02393222|ESRD|esrd
4839309|NCT02393209|Drug therapy|drug therapy
4839310|NCT02393196|colloid preloading|colloid preloading
4839311|NCT02393196|colloid coloading|colloid coloading
4839312|NCT02393183|Antioxidant|antioxidant
4839313|NCT02393183|Graves' ophthalmopathy|graves' ophthalmopathy
4839314|NCT02393183|Thyroid eye disease|thyroid eye disease
4839315|NCT02393183|Severity score|severity score
4839316|NCT02393183|Activity score|activity score
4839317|NCT02393183|Quality of life|quality of life
4839318|NCT02393144|Labor analysis|labor analysis
4839319|NCT02393144|Transperineal ultrasound imaging|transperineal ultrasound imaging
4839320|NCT02393144|Labor curve|labor curve
4839321|NCT02393131|Brain Metastases|brain metastases
4839322|NCT02393131|Whole Brain Radiotherapy|whole brain radiotherapy
4839323|NCT02393131|Neurocognitive function|neurocognitive function
4839324|NCT02393118|Assistive technology|assistive technology
4839325|NCT02393118|Non-surgical visual prosthetic|non-surgical visual prosthetic
4839326|NCT02393118|sensory substitution|sensory substitution
4839327|NCT02393118|BrainPort|brainport
4839328|NCT02393118|Blindness|blindness
4839329|NCT02393118|Assistive device|assistive device
4839330|NCT02393105|Breast Cancer|breast cancer
4839331|NCT02393079|Traumatic Brain Injury|traumatic brain injury
4839332|NCT02393079|Cognitive|cognitive
4839333|NCT02393053|Gingival Recession|gingival recession
4839334|NCT02393053|Case-Control Studies|case-control studies
4839335|NCT02393053|Adipose Tissue|adipose tissue
4839336|NCT02393040|Alopecia|alopecia
4839337|NCT02393040|Androgenetic Alopecia|androgenetic alopecia
4839338|NCT02393040|Alopecia, Male Pattern|alopecia, male pattern
4839339|NCT02393040|Hair loss|hair loss
4839340|NCT02393040|Platelet-Rich Plasma|platelet-rich plasma
4839341|NCT02393040|Alopecia, Female Pattern|alopecia, female pattern
4839342|NCT02393040|placebo|placebo
4839343|NCT02393040|double-blind|double-blind
4839344|NCT02393014|65 years old or older|65 years old or older
4839345|NCT02393014|hospitalized in|hospitalized in
4839346|NCT02393014|geriatrics|geriatrics
4839347|NCT02393001|skin cancer|skin cancer
4839348|NCT02393001|suspicious lesion|suspicious lesion
4839349|NCT02393001|skin biopsy|skin biopsy
4839350|NCT02393001|noninvasive|noninvasive
4839351|NCT02393001|screening|screening
4839352|NCT02392962|proprioception|proprioception
4839353|NCT02392962|countermovement jump|countermovement jump
4839354|NCT02392962|postural balance|postural balance
4839355|NCT02392949|Spine|spine
4839356|NCT02392949|mobilization|mobilization
4839357|NCT02392936|according to the definition of the Comité Technique des Infections Nosocomiales et Liées aux Soins (2007)|according to the definition of the comité technique des infections nosocomiales et liées aux soins (2007)
4839358|NCT02392923|health related quality of life|health related quality of life
4839359|NCT02392910|Iron Sucrose|iron sucrose
4839360|NCT02392910|Mortality|mortality
4839361|NCT02392910|Hospitalization|hospitalization
4839362|NCT02392897|meal frequency|meal frequency
4839363|NCT02392897|eating frequency|eating frequency
4839364|NCT02392897|ingestive frequency|ingestive frequency
4839365|NCT02392897|Positive energy balance|positive energy balance
4839366|NCT02392897|Satiation|satiation
4839367|NCT02392884|Human Immunodeficiency Virus|human immunodeficiency virus
4839368|NCT02392884|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
4839369|NCT02392884|Cognitive Rehabilitation|cognitive rehabilitation
4839370|NCT02392884|Minority Health|minority health
4839371|NCT02392884|Vulnerable Populations|vulnerable populations
4839372|NCT02392884|Underserved, Patients|underserved, patients
4839373|NCT02392884|Medication Adherence|medication adherence
4839374|NCT02392884|Medication Compliance|medication compliance
4839375|NCT02392884|Medication Non-compliance|medication non-compliance
4839376|NCT02392884|Medication Persistence|medication persistence
4839377|NCT02392884|Medication Non-Adherence|medication non-adherence
4839378|NCT02392871|Metastatic melanoma|metastatic melanoma
4839379|NCT02392871|Palliative radiotherapy|palliative radiotherapy
4839380|NCT02392845|Drug combination|drug combination
4839381|NCT02392845|Accelerated chemotherapy|accelerated chemotherapy
4839382|NCT02392845|Mathematical model|mathematical model
4839383|NCT02392845|Hematotoxicity|hematotoxicity
4839384|NCT02392845|Individualized dosage|individualized dosage
4839385|NCT02392832|long-lasting microbial larvicide|long-lasting microbial larvicide
4839386|NCT02392832|intervention|intervention
4839387|NCT02392832|cluster randomised controlled trial|cluster randomised controlled trial
4839388|NCT02392832|Anopheles mosquito|anopheles mosquito
4839389|NCT02392806|Continuous positive airway pressure|continuous positive airway pressure
4839390|NCT02392806|CPAP|cpap
4839391|NCT02392806|Bubble CPAP|bubble cpap
4839392|NCT02392806|Extubation failure|extubation failure
4839393|NCT02392806|Preterm infant|preterm infant
4839394|NCT02392767|L-Arginine|l-arginine
4839395|NCT02392767|Pycnogenol|pycnogenol
4839396|NCT02392767|vitamin K2|vitamin k2
4839397|NCT02392767|vitamin B|vitamin b
4839398|NCT02392767|endothelial function|endothelial function
4839399|NCT02392767|hypertension|hypertension
4839400|NCT02392767|Homocystein >10|homocystein >10
4839401|NCT02392754|Screening|screening
4839402|NCT02392754|Atrial Fibrillation|atrial fibrillation
4839404|NCT02392754|Primary care|primary care
4839405|NCT02392741|Physical Activity|physical activity
4839406|NCT02392741|Microcirculation|microcirculation
4839407|NCT02392741|Pregnancy Outcome|pregnancy outcome
4839408|NCT02392741|Obesity|obesity
4839409|NCT02392741|Pregnancy|pregnancy
4839410|NCT02392715|Inspiratory muscle training|inspiratory muscle training
4839411|NCT02392715|General exercise training|general exercise training
4839412|NCT02392715|pulmonary rehabilitation|pulmonary rehabilitation
4839413|NCT02392715|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
4839414|NCT02392702|Subjects|subjects
4839415|NCT02392702|Safety/Efficacy Study|safety/efficacy study
4839416|NCT02392702|Randomized|randomized
4839417|NCT02392702|Open Label|open label
4839418|NCT02392689|procalcitonin|procalcitonin
4839419|NCT02392689|biomarker|biomarker
4839420|NCT02392689|antibiotic therapy|antibiotic therapy
4839421|NCT02392689|emergency department|emergency department
4839422|NCT02392689|cardiology|cardiology
4839423|NCT02392689|in vitro diagnostics|in vitro diagnostics
4839424|NCT02392676|Ovarian cancer|ovarian cancer
4839425|NCT02392676|Platinum|platinum
4839426|NCT02392676|Somatic BRCA mutation|somatic brca mutation
4839427|NCT02392676|Homologous recombination repair|homologous recombination repair
4839428|NCT02392663|Sputum clearance|sputum clearance
4839429|NCT02392663|Cough severity|cough severity
4839430|NCT02392663|Hypertonic saline|hypertonic saline
4839431|NCT02392663|Acid hyaluronic|acid hyaluronic
4839432|NCT02392663|Tolerability|tolerability
4839433|NCT02392637|Biliary Tract Cancer|biliary tract cancer
4839434|NCT02392637|Intrahepatic cholangiocarcinoma|intrahepatic cholangiocarcinoma
4839435|NCT02392637|Extrahepatic cholangiocarcinoma,|extrahepatic cholangiocarcinoma,
4839436|NCT02392637|Gallbladder cancer|gallbladder cancer
4839437|NCT02392637|Metastatic|metastatic
4839438|NCT02392637|Unresectable|unresectable
4839439|NCT02392637|Abraxane|abraxane
4839440|NCT02392637|Nab-Paclitaxel|nab-paclitaxel
4839441|NCT02392637|Paclitaxel (Protein-Bound)|paclitaxel (protein-bound)
4839442|NCT02392637|ABI-007|abi-007
4839443|NCT02392637|Cisplatin|cisplatin
4839444|NCT02392637|Platinol-AQ|platinol-aq
4839445|NCT02392637|Platinol|platinol
4839446|NCT02392637|CDDP|cddp
4839447|NCT02392637|Gemcitabine|gemcitabine
4839448|NCT02392637|Gemcitabine Hydrochloride|gemcitabine hydrochloride
4839449|NCT02392637|Gemzar|gemzar
4839450|NCT02392637|Phone calls|phone calls
4839451|NCT02392611|Estrogen Receptor Positive Breast Cancer|estrogen receptor positive breast cancer
4839452|NCT02392585|Leiomyoma of uterus|leiomyoma of uterus
4839453|NCT02392585|Hemostasis, Surgical|hemostasis, surgical
4839454|NCT02392585|Prevention of Surgical Blood Loss|prevention of surgical blood loss
4839455|NCT02392585|mechanical uterine tourniquet|mechanical uterine tourniquet
4839456|NCT02392572|Leukemia|leukemia
4839457|NCT02392572|Acute myelogenous leukemia|acute myelogenous leukemia
4839458|NCT02392572|AML|aml
4839459|NCT02392572|Myelodysplastic syndrome|myelodysplastic syndrome
4839460|NCT02392572|MDS|mds
4839461|NCT02392572|Acute lymphoblastic leukemia|acute lymphoblastic leukemia
4839462|NCT02392572|ALL|all
4839463|NCT02392572|Relapsed|relapsed
4839464|NCT02392572|Refractory|refractory
4839465|NCT02392572|ONC201|onc201
4839466|NCT02392572|Cytarabine|cytarabine
4839467|NCT02392572|Ara-C|ara-c
4839468|NCT02392572|Cytosar|cytosar
4839469|NCT02392572|DepoCyt|depocyt
4839470|NCT02392572|Cytosine Arabinosine Hydrochloride|cytosine arabinosine hydrochloride
4839471|NCT02392559|Hypercholesterolemia|hypercholesterolemia
4839472|NCT02392559|Elevated Cholesterol|elevated cholesterol
4839473|NCT02392559|High Cholesterol|high cholesterol
4839474|NCT02392559|Heterozygous Familial Hypercholesterolemia|heterozygous familial hypercholesterolemia
4839475|NCT02392559|PCSK9 mutations|pcsk9 mutations
4839476|NCT02392559|Paediatric|paediatric
4839477|NCT02392559|pediatric|pediatric
4839478|NCT02392559|Childhood Familial Hypercholesterolemia|childhood familial hypercholesterolemia
4839479|NCT02392533|ultrasound|ultrasound
4839480|NCT02392520|severe OHSS|severe ohss
4839481|NCT02392520|antagonist administration|antagonist administration
4839482|NCT02392520|conventional treatment|conventional treatment
4839483|NCT02392442|Bronchoalveolar Lavage|bronchoalveolar lavage
4839484|NCT02392442|Bronchoscopy|bronchoscopy
4839485|NCT02392442|Endotoxin Instillation|endotoxin instillation
4839486|NCT02392442|Immunophenotype|immunophenotype
4839487|NCT02392442|miRNA|mirna
4839488|NCT02392390|Topical Dynamic Phototherapy|topical dynamic phototherapy
4839489|NCT02392390|Microbiota|microbiota
4839490|NCT02392351|Hypertension|hypertension
4839491|NCT02392351|Renal Denervation|renal denervation
4839492|NCT02392338|Atrial fibrillation|atrial fibrillation
4839493|NCT02392338|Ablation|ablation
4839494|NCT02392338|Hybrid|hybrid
4839495|NCT02392312|kidney transplant|kidney transplant
4839496|NCT02392312|ATG-F|atg-f
4839497|NCT02392286|Corticosteroid|corticosteroid
4839498|NCT02392273|migraine|migraine
4839499|NCT02392273|cluster headache|cluster headache
4839500|NCT02392273|primary headache|primary headache
4839501|NCT02392273|Ausanil|ausanil
4839502|NCT02392273|capsicum annuum|capsicum annuum
4839503|NCT02392221|Crohn's disease (CD)|crohn's disease (cd)
4839504|NCT02392221|Pediatric|pediatric
4839505|NCT02392221|Inflammatory Bowel Disease|inflammatory bowel disease
4839506|NCT02392208|telavancin|telavancin
4839507|NCT02392208|end-stage renal disease|end-stage renal disease
4839508|NCT02392208|ESRD|esrd
4839509|NCT02392208|pharmacokinetics|pharmacokinetics
4839510|NCT02392208|hemodialysis|hemodialysis
4839511|NCT02392208|chronic kidney disease|chronic kidney disease
4839512|NCT02392208|CKD|ckd
4839513|NCT02392208|dialysis|dialysis
4839514|NCT02392208|Vibativ|vibativ
4839515|NCT02392195|Plagiocephaly|plagiocephaly
4839516|NCT02392182|lung|lung
4839517|NCT02392169|neuroendocrine|neuroendocrine
4839518|NCT02392169|ADHD|adhd
4839519|NCT02392169|heredity|heredity
4839520|NCT02392169|cognitive function|cognitive function
4839521|NCT02392143|colorectal cancer screening|colorectal cancer screening
4839522|NCT02392104|International Normalized Ratio|international normalized ratio
4839523|NCT02392104|Warfarin|warfarin
4839524|NCT02392078|Procedural Success|procedural success
4839525|NCT02392078|Progression|progression
4839526|NCT02392078|Quality of Life|quality of life
4839527|NCT02392052|caregivers|caregivers
4839528|NCT02392039|Lymphoma|lymphoma
4839529|NCT02392039|Diffuse Large B-cell Lymphoma|diffuse large b-cell lymphoma
4839530|NCT02392039|Mantle Cell Lymphoma|mantle cell lymphoma
4839531|NCT02392039|Grade 3B Follicular Lymphoma|grade 3b follicular lymphoma
4839532|NCT02392039|Burkitt Lymphoma|burkitt lymphoma
4839533|NCT02392039|Peripheral T cell Lymphoma NOS|peripheral t cell lymphoma nos
4839534|NCT02392039|NK/T cell Lymphoma|nk/t cell lymphoma
4839535|NCT02392039|Transformed Lymphoma|transformed lymphoma
4839536|NCT02392039|Aggressive lymphoma|aggressive lymphoma
4839537|NCT02392039|Bone pain|bone pain
4839538|NCT02392039|Pegfilgrastim|pegfilgrastim
4839539|NCT02392039|Neulasta|neulasta
4839540|NCT02392039|PEG-G-CSF|peg-g-csf
4839541|NCT02392039|Loratadine|loratadine
4839542|NCT02392039|Placebo|placebo
4839543|NCT02392039|Sugar pill|sugar pill
4839544|NCT02392039|Questionnaires|questionnaires
4839545|NCT02392039|Surveys|surveys
4839546|NCT02392013|older adult falls|older adult falls
4839547|NCT02392013|home hazards|home hazards
4839548|NCT02392013|home barriers|home barriers
4839549|NCT02392000|chronic insomnia|chronic insomnia
4839550|NCT02392000|Veterans Health|veterans health
4839551|NCT02391974|Hyaluronic acid|hyaluronic acid
4839552|NCT02391974|Periodontal pockets|periodontal pockets
4839553|NCT02391974|Periodontitis|periodontitis
4839554|NCT02391948|Cerebral palsy|cerebral palsy
4839555|NCT02391948|Gross motor delay|gross motor delay
4839556|NCT02391935|Chronic Effect of Ultraviolet Radiation on Normal Skin (Photo-aging)|chronic effect of ultraviolet radiation on normal skin (photo-aging)
4839557|NCT02391922|out of hospital cardiac arrest|out of hospital cardiac arrest
4839558|NCT02391922|first aid|first aid
4839559|NCT02391909|Vaccine|vaccine
4839560|NCT02391883|clopidogrel therapy|clopidogrel therapy
4839561|NCT02391883|platelet aggregation inhibitor|platelet aggregation inhibitor
4839562|NCT02391883|adverse event|adverse event
4839563|NCT02391870|depression|depression
4839564|NCT02391870|mindfulness|mindfulness
4839565|NCT02391870|pregnancy|pregnancy
4839566|NCT02391870|prevention|prevention
4839567|NCT02391870|cognitive behavioral therapy|cognitive behavioral therapy
4839568|NCT02391857|cardiopulmonary resuscitation|cardiopulmonary resuscitation
4839569|NCT02391857|Gastric emptying|gastric emptying
4839570|NCT02391844|Knee|knee
4839571|NCT02391844|Post-Operative Pain|post-operative pain
4839572|NCT02391844|Xartemis|xartemis
4839573|NCT02391831|SMA|sma
4839574|NCT02391831|Spinal Muscular Atrophy|spinal muscular atrophy
4839575|NCT02391831|Neuromuscular disease|neuromuscular disease
4839576|NCT02391818|balance|balance
4839577|NCT02391818|quality of life|quality of life
4839578|NCT02391818|chemotherapy|chemotherapy
4839579|NCT02391818|neuropathy|neuropathy
4839580|NCT02391818|cancer|cancer
4839581|NCT02391779|High normal blood pressure|high normal blood pressure
4839582|NCT02391779|Stage I|stage i
4839583|NCT02391766|Self-management|self-management
4839584|NCT02391766|Caregiving|caregiving
4839585|NCT02391766|Quality of life|quality of life
4839586|NCT02391766|Empowerment|empowerment
4839587|NCT02391753|levator avulsion|levator avulsion
4839588|NCT02391753|transperineal ultrasound|transperineal ultrasound
4839589|NCT02391753|levator hiatus|levator hiatus
4839590|NCT02391727|SYN004|syn004
4839591|NCT02391727|cetuximab|cetuximab
4839592|NCT02391714|pain assessment|pain assessment
4839593|NCT02391714|patient satisfaction|patient satisfaction
4839594|NCT02391714|Visual Analog Scale|visual analog scale
4839595|NCT02391714|contraceptive devices|contraceptive devices
4839596|NCT02391714|nulliparity|nulliparity
4839597|NCT02391662|Metastatic Pancreatic Adenocarcinoma|metastatic pancreatic adenocarcinoma
4839598|NCT02391662|Elderly|elderly
4839599|NCT02391662|Nab-paclitaxel|nab-paclitaxel
4839600|NCT02391662|Gemcitabine|gemcitabine
4839601|NCT02391649|schizophrenia|schizophrenia
4839602|NCT02391649|bibliotherapy program|bibliotherapy program
4839603|NCT02391649|problem-solving|problem-solving
4839604|NCT02391649|family caregivers|family caregivers
4839605|NCT02391649|randomized controlled trial|randomized controlled trial
4839606|NCT02391636|Postpartum Hemorrhage|postpartum hemorrhage
4839607|NCT02391636|carbetocin|carbetocin
4839608|NCT02391636|oxytocin|oxytocin
4839609|NCT02391623|Multiple Ascending Dose|multiple ascending dose
4839610|NCT02391623|Healthy Subjects|healthy subjects
4839611|NCT02391623|Hyperlipidemia|hyperlipidemia
4839612|NCT02391623|Lipid Metabolism Disorders|lipid metabolism disorders
4839613|NCT02391623|Metabolic Diseases|metabolic diseases
4839614|NCT02391610|birth cohort study|birth cohort study
4839615|NCT02391610|environmental exposures|environmental exposures
4839616|NCT02391610|birth defects|birth defects
4839617|NCT02391610|pregnant outcomes|pregnant outcomes
4839618|NCT02391610|children development|children development
4839619|NCT02391545|Follicular Lymphoma|follicular lymphoma
4839620|NCT02391545|Previously Untreated|previously untreated
4839621|NCT02391519|Pregnancy|pregnancy
4839622|NCT02391519|High altitude|high altitude
4839623|NCT02391519|vasoreactivity|vasoreactivity
4839624|NCT02391519|myometrial arteries|myometrial arteries
4839625|NCT02391506|First CMC joint|first cmc joint
4839626|NCT02391506|Osteoarthritis|osteoarthritis
4839627|NCT02391506|Cartilage Replacement|cartilage replacement
4839628|NCT02391506|First CMC Joint Osteoarthritis|first cmc joint osteoarthritis
4839629|NCT02391506|Damaged Articular Surface|damaged articular surface
4839630|NCT02391493|bilinguals|bilinguals
4839631|NCT02391493|language control|language control
4839632|NCT02391493|executive functions|executive functions
4839633|NCT02391493|functional MRI|functional mri
4839634|NCT02391493|stimulation mapping|stimulation mapping
4839635|NCT02391493|brain tumors|brain tumors
4839636|NCT02391480|Cancer|cancer
4839637|NCT02391480|Bromodomain Inhibitor|bromodomain inhibitor
4839638|NCT02391480|Advanced Cancer|advanced cancer
4839639|NCT02391454|Neoplasms|neoplasms
4839640|NCT02391454|Cell Phones|cell phones
4839641|NCT02391454|Motor Activity|motor activity
4839642|NCT02391454|Feasibility|feasibility
4839643|NCT02391441|Pulmonary|pulmonary
4839644|NCT02391441|Arterial|arterial
4839645|NCT02391441|Hypertension|hypertension
4839646|NCT02391441|Lung|lung
4839647|NCT02391441|Transplantation|transplantation
4839648|NCT02391441|MRI|mri
4839649|NCT02391428|ADHD|adhd
4839650|NCT02391428|omega3|omega3
4839651|NCT02391402|Brain injury|brain injury
4839652|NCT02391402|TBI|tbi
4839653|NCT02391402|PTSD|ptsd
4839654|NCT02391402|Polytrauma|polytrauma
4839655|NCT02391389|preterm infant|preterm infant
4839656|NCT02391376|superficial heat|superficial heat
4839657|NCT02391376|hot pack|hot pack
4839658|NCT02391376|thermotherapy|thermotherapy
4839659|NCT02391376|physiotherapy|physiotherapy
4839660|NCT02391376|Schober Test|schober test
4839661|NCT02391363|anxiety|anxiety
4839662|NCT02391363|worry|worry
4839663|NCT02391337|Atrial fibrillation|atrial fibrillation
4839664|NCT02391337|Quality of life|quality of life
4839665|NCT02391337|Left ventricular ejection fraction|left ventricular ejection fraction
4839666|NCT02391337|Diastolic function|diastolic function
4839667|NCT02391337|Echocardiography|echocardiography
4839668|NCT02391337|Beta-blockers|beta-blockers
4839669|NCT02391337|Digoxin|digoxin
4839670|NCT02391311|tDCS|tdcs
4839671|NCT02391311|Cognitive remediation therapy|cognitive remediation therapy
4839672|NCT02391298|Multiple Sclerosis|multiple sclerosis
4839673|NCT02391298|stress|stress
4839674|NCT02391298|meditation|meditation
4839675|NCT02391298|attention|attention
4839676|NCT02391272|recombinant human thrombopoietin|recombinant human thrombopoietin
4839677|NCT02391272|immune thrombocytopenia|immune thrombocytopenia
4839678|NCT02391272|pregnancy|pregnancy
4839679|NCT02391246|central nervous system tumours|central nervous system tumours
4839680|NCT02391246|[18F]-fluorodeoxyglucose|[18f]-fluorodeoxyglucose
4839681|NCT02391233|Effectiveness intervention|effectiveness intervention
4839682|NCT02391233|Cost-effectiveness intervention|cost-effectiveness intervention
4839683|NCT02391233|HIV prevention|hiv prevention
4839684|NCT02391233|Sexually transmitted infections prevention|sexually transmitted infections prevention
4839685|NCT02391233|Multimedia evidence-based intervention|multimedia evidence-based intervention
4839686|NCT02391233|Drug-users|drug-users
4839687|NCT02391233|Black/African-American women|black/african-american women
4839688|NCT02391233|Probation|probation
4839689|NCT02391233|HIV testing|hiv testing
4839690|NCT02391194|AVB-620|avb-620
4839691|NCT02391194|stage I|stage i
4839692|NCT02391194|newly diagnosed|newly diagnosed
4839693|NCT02391194|breast cancer|breast cancer
4839694|NCT02391194|stage II|stage ii
4839695|NCT02391194|stage III|stage iii
4839696|NCT02391194|ductal carcinoma in situ|ductal carcinoma in situ
4839697|NCT02391181|Bioequivalence|bioequivalence
4839698|NCT02391181|Iron Status|iron status
4839699|NCT02391155|follicular flushing|follicular flushing
4839700|NCT02391155|IVF|ivf
4839701|NCT02391155|poor responders|poor responders
4839702|NCT02391155|oocyte retrival|oocyte retrival
4839703|NCT02391142|heart failure|heart failure
4839704|NCT02391142|cardiac sympathetic nerve block|cardiac sympathetic nerve block
4839705|NCT02391142|sympathetic nervous system|sympathetic nervous system
4839706|NCT02391090|asthma|asthma
4839707|NCT02391090|hypoxia|hypoxia
4839708|NCT02391090|forced exhaled nitric oxide|forced exhaled nitric oxide
4839709|NCT02391090|inflammation|inflammation
4839710|NCT02391077|PrePex|prepex
4839711|NCT02391077|Male Circumcision|male circumcision
4839712|NCT02391077|Bacterial Load|bacterial load
4839713|NCT02391064|cognition|cognition
4839714|NCT02391064|brief computerized cognitive assessment|brief computerized cognitive assessment
4839715|NCT02391064|impairment prediction|impairment prediction
4839716|NCT02391051|prostate cancer|prostate cancer
4839717|NCT02391051|focal brachytherapy|focal brachytherapy
4839718|NCT02391051|PSA|psa
4839719|NCT02391051|Biological marker|biological marker
4839720|NCT02391038|MLN0264|mln0264
4839721|NCT02391038|Advanced gastrointestinal carcinoma|advanced gastrointestinal carcinoma
4839722|NCT02391025|Metastatic|metastatic
4839723|NCT02391025|Prostate Cancer|prostate cancer
4839724|NCT02391025|Castrate Resistant|castrate resistant
4839725|NCT02391012|Ulcerative colitis|ulcerative colitis
4839726|NCT02391012|Crohns disease|crohns disease
4839727|NCT02391012|Microbial transplantation|microbial transplantation
4839728|NCT02390986|Cancer|cancer
4839729|NCT02390986|Malignant Neoplasm|malignant neoplasm
4839730|NCT02390986|Anti-cancer drug|anti-cancer drug
4839731|NCT02390947|Colorectal Cancer|colorectal cancer
4839732|NCT02390947|Famitinib|famitinib
4839733|NCT02390934|Radium 223|radium 223
4839734|NCT02390934|bone metastases|bone metastases
4839735|NCT02390908|alcohol use|alcohol use
4839736|NCT02390908|hazardous drinking|hazardous drinking
4839737|NCT02390908|behavioral intervention|behavioral intervention
4839738|NCT02390908|ART adherence|art adherence
4839739|NCT02390908|viral load|viral load
4839740|NCT02390908|CD4|cd4
4839741|NCT02390895|Minimally-invasive endoscopic repair|minimally-invasive endoscopic repair
4839742|NCT02390895|fetal surgery|fetal surgery
4839743|NCT02390895|outcome|outcome
4839744|NCT02390895|Foetus|foetus
4839745|NCT02390869|relapse|relapse
4839746|NCT02390869|progression|progression
4839747|NCT02390804|postoperative pain|postoperative pain
4839748|NCT02390804|hysterectomy|hysterectomy
4839749|NCT02390804|single-port access laparoscopy|single-port access laparoscopy
4839750|NCT02390804|multi-port access laparoscopy|multi-port access laparoscopy
4839751|NCT02390804|TLH|tlh
4839752|NCT02390778|secondary traumatic stress|secondary traumatic stress
4839753|NCT02390778|vicarious trauma|vicarious trauma
4839754|NCT02390778|secondary distress|secondary distress
4839755|NCT02390765|Stress Response|stress response
4839756|NCT02390765|Binge Eating|binge eating
4839757|NCT02390765|Eating Behavior|eating behavior
4839758|NCT02390765|Obesity|obesity
4839759|NCT02390765|Disordered Eating|disordered eating
4839760|NCT02390752|Maximum Tolerated Dose|maximum tolerated dose
4839761|NCT02390752|Dose Escalation|dose escalation
4839762|NCT02390752|Acute Lymphocytic Leukemia|acute lymphocytic leukemia
4839763|NCT02390752|Acute Myelogenous Leukemia|acute myelogenous leukemia
4839764|NCT02390739|Immunotherapy|immunotherapy
4839765|NCT02390739|Gene Therapy|gene therapy
4839766|NCT02390739|Metastatic Cancer|metastatic cancer
4839767|NCT02390713|hepatectomy|hepatectomy
4839768|NCT02390713|post-operative liver failure|post-operative liver failure
4839769|NCT02390713|portal vein|portal vein
4839770|NCT02390713|portal flow|portal flow
4839771|NCT02390713|portal pressure|portal pressure
4839772|NCT02390713|modulation|modulation
4839773|NCT02390713|surgical device|surgical device
4839774|NCT02390700|Rheumatoid Arthritis|rheumatoid arthritis
4839775|NCT02390700|Observational|observational
4839776|NCT02390700|Golimumab|golimumab
4839777|NCT02390700|SIMPONI|simponi
4839778|NCT02390700|Intravenous Infusion|intravenous infusion
4839779|NCT02390661|seroma|seroma
4839780|NCT02390661|accelerated partial breast irradiation (APBI)|accelerated partial breast irradiation (apbi)
4839781|NCT02390661|breast lumpectomy|breast lumpectomy
4839782|NCT02390661|breast cancer|breast cancer
4839783|NCT02390635|Leukemia|leukemia
4839784|NCT02390635|Acute myeloid leukemia|acute myeloid leukemia
4839785|NCT02390635|AML|aml
4839786|NCT02390635|Acute promyelocytic leukemia|acute promyelocytic leukemia
4839787|NCT02390635|APL|apl
4839788|NCT02390635|Extramedullary leukemia|extramedullary leukemia
4839789|NCT02390635|EML|eml
4839790|NCT02390635|Whole body magnetic resonance imaging|whole body magnetic resonance imaging
4839791|NCT02390635|MRI|mri
4839792|NCT02390635|Positron emission tomography/ computed tomography|positron emission tomography/ computed tomography
4839793|NCT02390635|PET/CT|pet/ct
4839794|NCT02390635|18F-FDG|18f-fdg
4839795|NCT02390635|Gadolinium contrast agent|gadolinium contrast agent
4839796|NCT02390609|Healthy|healthy
4839797|NCT02390609|Ibrutinib|ibrutinib
4839798|NCT02390609|Bioavailability|bioavailability
4839799|NCT02390596|Kawasaki disease|kawasaki disease
4839800|NCT02390596|anti Interleukin 1 treatment|anti interleukin 1 treatment
4839801|NCT02390596|anakinra|anakinra
4839802|NCT02390596|resistance to IVIg|resistance to ivig
4839803|NCT02390596|coronary aneurysms|coronary aneurysms
4839804|NCT02390596|phase II trial|phase ii trial
4839805|NCT02390583|Internet dependence|internet dependence
4839806|NCT02390583|Sleep disorders|sleep disorders
4839807|NCT02390583|pathological gambling|pathological gambling
4839808|NCT02390570|Patient Capacity|patient capacity
4839809|NCT02390544|children|children
4839810|NCT02390544|bone marrow transplant|bone marrow transplant
4839811|NCT02390544|pharmacokinetics|pharmacokinetics
4839812|NCT02390531|Retinopathy of Prematurity|retinopathy of prematurity
4839813|NCT02390531|Bevacizumab|bevacizumab
4839814|NCT02390531|ROP|rop
4839815|NCT02390505|vitamin C|vitamin c
4839816|NCT02390505|CRPS|crps
4839817|NCT02390505|Upper limb surgery|upper limb surgery
4839818|NCT02390479|Sclerostin|sclerostin
4839819|NCT02390479|OPG|opg
4839820|NCT02390479|RANKL|rankl
4839821|NCT02390453|mild cognitive impairment|mild cognitive impairment
4839822|NCT02390453|randomized controlled trial|randomized controlled trial
4839823|NCT02390453|cognitive training|cognitive training
4839824|NCT02390453|exercise training|exercise training
4839825|NCT02390453|cognition|cognition
4839826|NCT02390453|physical performance|physical performance
4839827|NCT02390453|disability|disability
4839828|NCT02390453|mood|mood
4839829|NCT02390440|Pain management|pain management
4839830|NCT02390440|Exparel|exparel
4839831|NCT02390440|Rib fracture|rib fracture
4839832|NCT02390427|Metastatic Breast Cancer|metastatic breast cancer
4839833|NCT02390427|Advanced Breast Cancer|advanced breast cancer
4839834|NCT02390427|Recurrent Breast Cancer|recurrent breast cancer
4839835|NCT02390414|Myelodysplastic syndromes (MDS)|myelodysplastic syndromes (mds)
4839836|NCT02390388|pudendal block|pudendal block
4839837|NCT02390388|Hypospadias|hypospadias
4839838|NCT02390388|caudal block|caudal block
4839839|NCT02390388|child|child
4839840|NCT02390388|analgesia|analgesia
4839841|NCT02390336|Osteoarthritis of the hip|osteoarthritis of the hip
4839842|NCT02390336|Pain|pain
4839843|NCT02390336|Range of Motion|range of motion
4839844|NCT02390336|Physical Function|physical function
4839845|NCT02390336|Manual Therapy|manual therapy
4839846|NCT02390310|male circumcision|male circumcision
4839847|NCT02390310|Shang Ring|shang ring
4839848|NCT02390310|male circumcision device|male circumcision device
4839849|NCT02390310|prevention|prevention
4839850|NCT02390310|voluntary medical male circumcision (VMMC)|voluntary medical male circumcision (vmmc)
4839851|NCT02390284|RGCD|rgcd
4839852|NCT02390284|Glaucoma Suspect|glaucoma suspect
4839853|NCT02390232|gut microbiota|gut microbiota
4839854|NCT02390232|Non Alcoholic Steato Hepatitis|non alcoholic steato hepatitis
4839855|NCT02390232|Steatohepatitis|steatohepatitis
4839856|NCT02390232|Escherichia coli|escherichia coli
4839857|NCT02390232|colibactin|colibactin
4839858|NCT02390206|Stroke|stroke
4839859|NCT02390206|Spasticity|spasticity
4839860|NCT02390206|Botulinum Toxin type A|botulinum toxin type a
4839861|NCT02390206|Dysport|dysport
4839862|NCT02390193|Chronic kidney disease|chronic kidney disease
4839863|NCT02390193|Dialysis|dialysis
4839864|NCT02390193|Sleep|sleep
4839865|NCT02390193|Pulmonary function|pulmonary function
4839866|NCT02390193|Polysomnography|polysomnography
4839867|NCT02390193|Upper airway|upper airway
4839868|NCT02390128|iodine|iodine
4839869|NCT02390128|thyroid|thyroid
4839870|NCT02390128|TSH|tsh
4839871|NCT02390128|pregnancy|pregnancy
4839872|NCT02390128|nutrition|nutrition
4839873|NCT02390128|diet|diet
4839874|NCT02390102|Anemia|anemia
4839875|NCT02390102|Severe aortic stenosis|severe aortic stenosis
4839876|NCT02390102|Red blood cell transfusion|red blood cell transfusion
4839877|NCT02390102|Erythropoietin|erythropoietin
4839878|NCT02390089|Dysphagia|dysphagia
4839879|NCT02390089|Cough|cough
4839880|NCT02390089|Aspiration pneumonia|aspiration pneumonia
4839881|NCT02390024|Mechanical Ventilation|mechanical ventilation
4839882|NCT02390024|Asynchronies|asynchronies
4839883|NCT02390024|Cognition|cognition
4839884|NCT02390011|Advanced Solid Tumor|advanced solid tumor
4839885|NCT02389998|Functional Pain|functional pain
4839886|NCT02389998|Abdominal Pain|abdominal pain
4839887|NCT02389998|Irritable Bowel Syndrome|irritable bowel syndrome
4839888|NCT02389998|IBS|ibs
4839889|NCT02389998|Functional Dyspepsia|functional dyspepsia
4839890|NCT02389998|FGID|fgid
4839891|NCT02389998|Functional Gastrointestinal Disorders|functional gastrointestinal disorders
4839892|NCT02389959|HHT|hht
4839893|NCT02389959|Hereditary Hemorrhagic Telangiectasia|hereditary hemorrhagic telangiectasia
4839894|NCT02389959|epistaxis|epistaxis
4839895|NCT02389959|nose bleeds|nose bleeds
4839896|NCT02389959|nasal bleeding|nasal bleeding
4839897|NCT02389959|Avastin|avastin
4839898|NCT02389959|bevacizumab|bevacizumab
4839899|NCT02389946|Drug eluting coronary stents|drug eluting coronary stents
4839900|NCT02389946|Sirolimus|sirolimus
4839901|NCT02389946|Bioabsorbable polymer|bioabsorbable polymer
4839902|NCT02389946|DES|des
4839903|NCT02389933|Multiple Patient Program, LCZ696, heart failure, heart failure with reduced ejection fraction, HF-rEF|multiple patient program, lcz696, heart failure, heart failure with reduced ejection fraction, hf-ref
4839904|NCT02389894|Embolic Protection Device|embolic protection device
4839905|NCT02389894|Stroke|stroke
4839906|NCT02389894|Brain Infarction|brain infarction
4839907|NCT02389894|atheroma|atheroma
4839908|NCT02389894|Aortic Valve Replacement|aortic valve replacement
4839909|NCT02389881|Drug therapy|drug therapy
4839910|NCT02389868|Lovastatin|lovastatin
4839911|NCT02389868|Proteome|proteome
4839912|NCT02389868|Blood platelets|blood platelets
4839913|NCT02389855|Progression|progression
4839914|NCT02389855|Quality of Life|quality of life
4839915|NCT02389816|Drug therapy|drug therapy
4839916|NCT02389790|Crohn's Disease|crohn's disease
4839917|NCT02389764|Breast cancer|breast cancer
4839918|NCT02389764|Metastatic inflammatory breast cancer|metastatic inflammatory breast cancer
4839919|NCT02389764|MIBC|mibc
4839920|NCT02389764|HER2-negative|her2-negative
4839921|NCT02389764|Breast carcinoma|breast carcinoma
4839922|NCT02389764|BIBF 1120|bibf 1120
4839923|NCT02389764|Nintedanib|nintedanib
4839924|NCT02389764|Phone call|phone call
4839925|NCT02389751|Esophageal Cancer|esophageal cancer
4839926|NCT02389751|Esophageal carcinoma|esophageal carcinoma
4839927|NCT02389751|Adenocarcinoma or squamous cell carcinoma of the gastroesophageal junction|adenocarcinoma or squamous cell carcinoma of the gastroesophageal junction
4839928|NCT02389751|Adenocarcinoma or squamous cell carcinoma of the cervical esophagus|adenocarcinoma or squamous cell carcinoma of the cervical esophagus
4839929|NCT02389751|Adenocarcinoma or squamous cell carcinoma of thoracic esophagus|adenocarcinoma or squamous cell carcinoma of thoracic esophagus
4839930|NCT02389751|Ganetespib|ganetespib
4839931|NCT02389751|Carboplatin|carboplatin
4839932|NCT02389751|Paraplatin|paraplatin
4839933|NCT02389751|Paclitaxel|paclitaxel
4839934|NCT02389751|Taxol|taxol
4839935|NCT02389725|peripheral intravenous access|peripheral intravenous access
4839936|NCT02389725|tourniquet techniques|tourniquet techniques
4839937|NCT02389712|Bipolar Disorder|bipolar disorder
4839938|NCT02389712|Mayo Clinic|mayo clinic
4839939|NCT02389699|Intermediate and high grade ductal carcinoma in situ （DCIS）|intermediate and high grade ductal carcinoma in situ （dcis）
4839940|NCT02389686|Ductal carcinoma in situ （DCIS）|ductal carcinoma in situ （dcis）
4839941|NCT02389686|Nipple-sparing mastectomy (NSM)|nipple-sparing mastectomy (nsm)
4839942|NCT02389686|Intraoperative radiotherapy (IORT)|intraoperative radiotherapy (iort)
4839943|NCT02389686|INTRABEAM|intrabeam
4839944|NCT02389673|Intermediate and high grade ductal carcinoma in situ （DCIS）|intermediate and high grade ductal carcinoma in situ （dcis）
4839945|NCT02389660|Depression, Blended Cognitive Behavioural Therapy, Internet intervention|depression, blended cognitive behavioural therapy, internet intervention
4839946|NCT02389621|Elective invasive procedures|elective invasive procedures
4839947|NCT02389608|Transcranial direct current stimulation|transcranial direct current stimulation
4839948|NCT02389608|functional electrical stimulation|functional electrical stimulation
4839949|NCT02389608|hemiparesis|hemiparesis
4839950|NCT02389608|electromyography|electromyography
4839951|NCT02389608|balance|balance
4839952|NCT02389595|HIV|hiv
4839953|NCT02389595|vaccine|vaccine
4839954|NCT02389595|T cell|t cell
4839955|NCT02389582|platelet function; dabigatran;enoxaparin|platelet function; dabigatran;enoxaparin
4839956|NCT02389569|Biomaterial|biomaterial
4839957|NCT02389569|Dental caries|dental caries
4839958|NCT02389569|Composite|composite
4839959|NCT02389543|KPT-330|kpt-330
4839960|NCT02389543|Selinexor|selinexor
4839961|NCT02389543|Multiple Myeloma|multiple myeloma
4839962|NCT02389543|Relapsed/refractory|relapsed/refractory
4839963|NCT02389543|Lenalidomide|lenalidomide
4839964|NCT02389543|Dexamethasone|dexamethasone
4839965|NCT02389543|Karyopharm|karyopharm
4839966|NCT02389530|glioma|glioma
4839967|NCT02389530|neoplasms|neoplasms
4839968|NCT02389504|Exertion|exertion
4839969|NCT02389504|Efficacy of Treatment|efficacy of treatment
4839970|NCT02389491|high density formula|high density formula
4839971|NCT02389491|heart defects|heart defects
4839972|NCT02389491|infant|infant
4839973|NCT02389478|oropharyngeal|oropharyngeal
4839974|NCT02389478|breastmilk|breastmilk
4839975|NCT02389478|colostrum|colostrum
4839976|NCT02389478|human milk|human milk
4839977|NCT02389478|premature infant|premature infant
4839978|NCT02389465|Depression|depression
4839979|NCT02389465|Geriatric|geriatric
4839980|NCT02389465|Inflammation|inflammation
4839981|NCT02389426|Multiple Sclerosis|multiple sclerosis
4839982|NCT02389426|Cerebral hemodynamics|cerebral hemodynamics
4839983|NCT02389426|Cerebral hypoperfusion|cerebral hypoperfusion
4839984|NCT02389426|Cerebral circulation|cerebral circulation
4839985|NCT02389413|PQ912|pq912
4839986|NCT02389413|Glutaminy Cyclase (QC)|glutaminy cyclase (qc)
4839987|NCT02389413|QC - Inhibitor|qc - inhibitor
4839988|NCT02389400|adult with Langerhans cell histiocytosis|adult with langerhans cell histiocytosis
4839989|NCT02389400|newly diagnosed|newly diagnosed
4839990|NCT02389400|methotrexate|methotrexate
4839991|NCT02389400|cytosine arabinoside|cytosine arabinoside
4839992|NCT02389387|Dialysis Facilities|dialysis facilities
4839993|NCT02389387|African Americans|african americans
4839994|NCT02389387|Racial Disparity|racial disparity
4839995|NCT02389387|Kidney Transplantation|kidney transplantation
4839996|NCT02389387|Community-based Participatory Research|community-based participatory research
4839997|NCT02389387|Coalition|coalition
4839998|NCT02389348|Induced blood stage malaria|induced blood stage malaria
4839999|NCT02389335|type 1diabetes|type 1diabetes
4840000|NCT02389335|IFN γ|ifn γ
4840001|NCT02389335|IL-2|il-2
4840002|NCT02389335|TNF α|tnf α
4840003|NCT02389322|ESAT6|esat6
4840004|NCT02389322|CFP10|cfp10
4840005|NCT02389322|skin test|skin test
4840006|NCT02389322|diagnostic test|diagnostic test
4840007|NCT02389309|Solid tumors|solid tumors
4840008|NCT02389309|Advanced tumors|advanced tumors
4840009|NCT02389309|Temsirolimus|temsirolimus
4840010|NCT02389309|CCI-779|cci-779
4840011|NCT02389309|Torisel|torisel
4840012|NCT02389309|Dasatinib|dasatinib
4840013|NCT02389309|BMS-354825|bms-354825
4840014|NCT02389309|Sprycel|sprycel
4840015|NCT02389309|Cyclophosphamide|cyclophosphamide
4840016|NCT02389309|Cytoxan|cytoxan
4840017|NCT02389309|Neosar|neosar
4840018|NCT02389283|Rheumatoid arthritis|rheumatoid arthritis
4840019|NCT02389283|ultrasound joint count|ultrasound joint count
4840020|NCT02389270|Neurotrophins|neurotrophins
4840021|NCT02389270|Nerve Growth Factor|nerve growth factor
4840022|NCT02389270|Brain-Derived Neurotrophic Factor|brain-derived neurotrophic factor
4840023|NCT02389270|Urinary Biomarkers|urinary biomarkers
4840024|NCT02389270|Children|children
4840025|NCT02389257|volunteers|volunteers
4840026|NCT02389231|interleukine 2|interleukine 2
4840027|NCT02389231|warm autoimmune hemolytic anemia|warm autoimmune hemolytic anemia
4840028|NCT02389231|CD8 regulatory T cells|cd8 regulatory t cells
4840029|NCT02389218|atrial fibrillation|atrial fibrillation
4840030|NCT02389218|cryoablation|cryoablation
4840031|NCT02389218|catheter ablation|catheter ablation
4840032|NCT02389192|Ebola|ebola
4840033|NCT02389192|Mono-clonal Antibody|mono-clonal antibody
4840034|NCT02389179|Vitamin D Deficiency|vitamin d deficiency
4840035|NCT02389153|secondary prevention coronary heart disease|secondary prevention coronary heart disease
4840036|NCT02389153|myocardial infarction|myocardial infarction
4840037|NCT02389153|cardiovascular risk factors|cardiovascular risk factors
4840038|NCT02389153|collaborative care|collaborative care
4840039|NCT02389153|quality of life|quality of life
4840040|NCT02389153|patients´ satisfaction with treatment|patients´ satisfaction with treatment
4840041|NCT02389140|Blood flow|blood flow
4840042|NCT02389140|Glucose|glucose
4840043|NCT02389140|lactic acid|lactic acid
4840044|NCT02389127|Cirrhosis|cirrhosis
4840045|NCT02389127|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
4840046|NCT02389127|Glycosylated hemoglobin A1c|glycosylated hemoglobin a1c
4840047|NCT02389127|Glucose|glucose
4840048|NCT02389101|Lymphoma|lymphoma
4840049|NCT02389101|68Ga-DOTANOC PET/CT|68ga-dotanoc pet/ct
4840050|NCT02389101|Somatostatin receptor|somatostatin receptor
4840052|NCT02389101|Diffusion weighted imaging|diffusion weighted imaging
4840053|NCT02389101|Early treatment response|early treatment response
4840054|NCT02389088|Granulosa Cell|granulosa cell
4840055|NCT02389088|Androgens|androgens
4840056|NCT02389088|FSH|fsh
4840057|NCT02389088|Ovary|ovary
4840058|NCT02389075|intraepithelial lymphocytes (IEL)|intraepithelial lymphocytes (iel)
4840059|NCT02389075|microbiome|microbiome
4840060|NCT02389075|colon mucosa|colon mucosa
4840061|NCT02389049|Primary Ciliary Dyskinesia|primary ciliary dyskinesia
4840062|NCT02389049|Kartagener Syndrome|kartagener syndrome
4840063|NCT02389023|surgical site infection|surgical site infection
4840064|NCT02389023|infrainguinal bypass|infrainguinal bypass
4840065|NCT02389023|incisional wound vacuum assisted closure|incisional wound vacuum assisted closure
4840066|NCT02389023|Prevena|prevena
4840067|NCT02389010|Umbilical Cord Blood|umbilical cord blood
4840068|NCT02389010|Diabetic Foot|diabetic foot
4840069|NCT02389010|Ulcer|ulcer
4840070|NCT02389010|Cost|cost
4840071|NCT02389010|Effectiveness|effectiveness
4840072|NCT02389010|Safety|safety
4840073|NCT02389010|Platelet Gel|platelet gel
4840074|NCT02389010|Cord Blood Platelet Gel|cord blood platelet gel
4840075|NCT02389010|Adverse Event|adverse event
4840076|NCT02388997|mild asthma|mild asthma
4840077|NCT02388997|young adults|young adults
4840078|NCT02388997|rhinovirus|rhinovirus
4840079|NCT02388971|Drug therapy|drug therapy
4840080|NCT02388919|anlotinib|anlotinib
4840081|NCT02388919|Cancer|cancer
4840082|NCT02388919|NSCLC|nsclc
4840083|NCT02388919|Non-small Cell Lung Cancer|non-small cell lung cancer
4840084|NCT02388880|ITPR|itpr
4840085|NCT02388880|CPP|cpp
4840086|NCT02388880|TBI|tbi
4840087|NCT02388880|traumatic brain injury|traumatic brain injury
4840088|NCT02388880|cerebral perfusion pressure|cerebral perfusion pressure
4840089|NCT02388880|intrathoracic pressure regulator|intrathoracic pressure regulator
4840090|NCT02388841|Pulmonary embolism, Computed tomographic pulmonary|pulmonary embolism, computed tomographic pulmonary
4840091|NCT02388815|Diabetes Mellitus|diabetes mellitus
4840092|NCT02388815|Sensing Technology|sensing technology
4840093|NCT02388802|Infertility|infertility
4840094|NCT02388802|Transplant|transplant
4840095|NCT02388802|IVF|ivf
4840096|NCT02388802|Hysterectomy|hysterectomy
4840097|NCT02388802|Absolute uterine infertility|absolute uterine infertility
4840098|NCT02388789|sensory receptors|sensory receptors
4840099|NCT02388789|balance control|balance control
4840100|NCT02388789|gait|gait
4840101|NCT02388789|temperature|temperature
4840102|NCT02388776|ROTEM|rotem
4840103|NCT02388776|Fibrinogen|fibrinogen
4840104|NCT02388763|Contact lenses|contact lenses
4840105|NCT02388750|nausea|nausea
4840106|NCT02388750|vomiting|vomiting
4840107|NCT02388750|radiation|radiation
4840108|NCT02388750|anti-emetic drug|anti-emetic drug
4840109|NCT02388737|Drug therapy|drug therapy
4840110|NCT02388724|Drug therapy|drug therapy
4840111|NCT02388711|Dementia|dementia
4840112|NCT02388711|Transitional Care|transitional care
4840113|NCT02388711|Caregiver|caregiver
4840114|NCT02388698|HPV DNA|hpv dna
4840115|NCT02388698|PET-CT|pet-ct
4840116|NCT02388698|Recurrent cervical cancer|recurrent cervical cancer
4840117|NCT02388698|chemoradiation|chemoradiation
4840118|NCT02388685|peripheral arterial disease|peripheral arterial disease
4840119|NCT02388685|exercise|exercise
4840120|NCT02388685|perfusion|perfusion
4840121|NCT02388685|energetics|energetics
4840122|NCT02388685|magnetic resonance imaging|magnetic resonance imaging
4840123|NCT02388685|magnetic resonance spectroscopy|magnetic resonance spectroscopy
4840124|NCT02388659|MRS Biomarkers|mrs biomarkers
4840125|NCT02388581|Helicobactor pylori, Hp|helicobactor pylori, hp
4840126|NCT02388581|mucosa-associated lymphoid tissue-type lymphoma, MALToma|mucosa-associated lymphoid tissue-type lymphoma, maltoma
4840127|NCT02388542|cardiovascular disease|cardiovascular disease
4840128|NCT02388542|education|education
4840129|NCT02388542|peer mentor|peer mentor
4840130|NCT02388529|Heart Failure|heart failure
4840131|NCT02388529|Bendavia™|bendavia™
4840132|NCT02388529|MTP-131|mtp-131
4840133|NCT02388516|Bangladesh|bangladesh
4840134|NCT02388516|Vitamin D|vitamin d
4840135|NCT02388516|Acute Respiratory Infections|acute respiratory infections
4840136|NCT02388516|Infancy|infancy
4840137|NCT02388516|Pregnancy|pregnancy
4840138|NCT02388503|Blood glucose|blood glucose
4840139|NCT02388490|Brentuximabvedotin|brentuximabvedotin
4840141|NCT02388490|Lymphoma|lymphoma
4840142|NCT02388477|rotator cuff repair|rotator cuff repair
4840143|NCT02388477|Doxycycline|doxycycline
4840144|NCT02388464|Congestive Heart Failure|congestive heart failure
4840145|NCT02388464|Bendavia™|bendavia™
4840146|NCT02388464|MTP-131|mtp-131
4840147|NCT02388451|Mild Cognitive Impairment|mild cognitive impairment
4840148|NCT02388438|demineralized bone matrix|demineralized bone matrix
4840149|NCT02388412|Positron emission tomography|positron emission tomography
4840150|NCT02388412|Tissue background ratio|tissue background ratio
4840151|NCT02388412|Optical coherence tomography|optical coherence tomography
4840152|NCT02388412|Thin cap fibroous atheroma|thin cap fibroous atheroma
4840153|NCT02388412|Vulnerability|vulnerability
4840154|NCT02388412|Acute coronary syndrome|acute coronary syndrome
4840155|NCT02388399|Optical coherence tomography|optical coherence tomography
4840156|NCT02388399|Axial Plaque Stress|axial plaque stress
4840157|NCT02388399|Wall Shear Stress|wall shear stress
4840158|NCT02388399|Vulnerability|vulnerability
4840159|NCT02388386|Telemedicine|telemedicine
4840160|NCT02388386|Mobile Health|mobile health
4840161|NCT02388360|Prostaglandin analogs|prostaglandin analogs
4840162|NCT02388360|Corneal biomechanics|corneal biomechanics
4840163|NCT02388360|Corneal Hysteresis|corneal hysteresis
4840164|NCT02388360|Glaucoma, Open-Angle|glaucoma, open-angle
4840165|NCT02388334|Caregivers|caregivers
4840166|NCT02388334|Quality of life|quality of life
4840167|NCT02388334|Quality of care|quality of care
4840168|NCT02388321|Analgesia|analgesia
4840169|NCT02388321|pediatrics|pediatrics
4840170|NCT02388321|pain management|pain management
4840171|NCT02388308|Prostate cancer|prostate cancer
4840172|NCT02388308|Image-guided radiotherapy|image-guided radiotherapy
4840173|NCT02388308|Ultrasound guidance|ultrasound guidance
4840174|NCT02388295|Multiple System Atrophy (MSA), PET imaging, myeloperoxidase (MPO) inhibitor|multiple system atrophy (msa), pet imaging, myeloperoxidase (mpo) inhibitor
4840175|NCT02388282|dynamic intrinsic PEEP|dynamic intrinsic peep
4840176|NCT02388282|diaphragm echography|diaphragm echography
4840177|NCT02388282|respiratory mechanics|respiratory mechanics
4840178|NCT02388256|colon|colon
4840179|NCT02388256|colorectal|colorectal
4840180|NCT02388256|cancer|cancer
4840181|NCT02388256|neoplasm|neoplasm
4840182|NCT02388243|Brief intervention|brief intervention
4840183|NCT02388243|Low and middle income countries (LMIC)|low and middle income countries (lmic)
4840184|NCT02388243|eLearning|elearning
4840185|NCT02388243|Screening|screening
4840186|NCT02388243|Capacity Building|capacity building
4840187|NCT02388243|Primary Health Care|primary health care
4840188|NCT02388243|Education, Medical|education, medical
4840189|NCT02388243|Education, Nursing|education, nursing
4840190|NCT02388243|Education, Professional|education, professional
4840191|NCT02388243|Community Health Workers|community health workers
4840192|NCT02388230|Breast cancer|breast cancer
4840193|NCT02388230|Elastography|elastography
4840194|NCT02388230|Ultrasound imaging|ultrasound imaging
4840195|NCT02388230|Quantification of toxicity|quantification of toxicity
4840196|NCT02388230|Side-effects|side-effects
4840197|NCT02388217|chronic pain|chronic pain
4840198|NCT02388217|cannabis|cannabis
4840199|NCT02388217|Approved for cannabis treatment by Israeli ministry of health|approved for cannabis treatment by israeli ministry of health
4840200|NCT02388217|Unrelieved chronic pain|unrelieved chronic pain
4840201|NCT02388204|Gait|gait
4840202|NCT02388204|Locomotion|locomotion
4840203|NCT02388204|Freezing|freezing
4840204|NCT02388191|Contraception|contraception
4840205|NCT02388191|Naproxen|naproxen
4840206|NCT02388191|Intrauterine devices|intrauterine devices
4840207|NCT02388191|Pain Control|pain control
4840208|NCT02388165|Staphylococcal Vaccine|staphylococcal vaccine
4840209|NCT02388165|Post-operative Surgical Site Infection|post-operative surgical site infection
4840210|NCT02388165|Spinal Surgery|spinal surgery
4840211|NCT02388165|MRSA|mrsa
4840212|NCT02388165|Staphylococcus aureus|staphylococcus aureus
4840213|NCT02388139|acute myocardial infarction|acute myocardial infarction
4840214|NCT02388139|renal artery stenosis|renal artery stenosis
4840215|NCT02388113|Exercise therapy|exercise therapy
4840216|NCT02388113|Time factors|time factors
4840217|NCT02388074|Lung Cancer|lung cancer
4840218|NCT02388074|Porphyrin|porphyrin
4840219|NCT02388074|Fluorescence|fluorescence
4840220|NCT02388074|Diagnostic|diagnostic
4840221|NCT02388074|Sputum Cytology|sputum cytology
4840222|NCT02388074|Early Detection|early detection
4840223|NCT02388048|Leukemia|leukemia
4840224|NCT02388048|Chronic|chronic
4840225|NCT02388048|High-risk|high-risk
4840226|NCT02388048|ofatumumab|ofatumumab
4840227|NCT02388048|ibrutinib|ibrutinib
4840228|NCT02388048|Lymphoblastic|lymphoblastic
4840229|NCT02388035|profiles changes|profiles changes
4840230|NCT02388035|microorganisms|microorganisms
4840231|NCT02388035|cefotaxime|cefotaxime
4840232|NCT02388035|SBP|sbp
4840233|NCT02388035|Egyptian|egyptian
4840234|NCT02388035|effective antibiotics|effective antibiotics
4840235|NCT02388009|bioconjugate vaccine|bioconjugate vaccine
4840236|NCT02388009|safety|safety
4840237|NCT02388009|immunogenicity|immunogenicity
4840238|NCT02388009|shigellosis|shigellosis
4840239|NCT02387970|Dental implants|dental implants
4840240|NCT02387970|Partial edentulism|partial edentulism
4840241|NCT02387970|Immediate/delayed provisionalization|immediate/delayed provisionalization
4840242|NCT02387957|Wet AMD|wet amd
4840243|NCT02387957|subfoveal choroidal neovascularization|subfoveal choroidal neovascularization
4840244|NCT02387957|Fovista®|fovista®
4840245|NCT02387957|Avastin®|avastin®
4840246|NCT02387957|Lucentis®|lucentis®
4840247|NCT02387957|Eylea®|eylea®
4840248|NCT02387944|Children|children
4840249|NCT02387944|Cyanotic congenital heart defect|cyanotic congenital heart defect
4840250|NCT02387944|Cardiopulmonary Bypass|cardiopulmonary bypass
4840251|NCT02387944|Thromboelastometry|thromboelastometry
4840252|NCT02387944|Platelet Function Tests|platelet function tests
4840253|NCT02387931|Adolescent|adolescent
4840254|NCT02387931|Endometriosis|endometriosis
4840255|NCT02387931|Diet|diet
4840256|NCT02387931|Nutrition|nutrition
4840257|NCT02387931|Pain|pain
4840258|NCT02387918|Tonsillectomy|tonsillectomy
4840259|NCT02387918|postoperative vomiting (POV)|postoperative vomiting (pov)
4840260|NCT02387918|Dexamethasone|dexamethasone
4840261|NCT02387918|Acupuncture|acupuncture
4840262|NCT02387905|Stereotactic spinal radiosurgery|stereotactic spinal radiosurgery
4840263|NCT02387905|Spinal Cord Diseases|spinal cord diseases
4840264|NCT02387905|Vertebral body compression fracture|vertebral body compression fracture
4840265|NCT02387905|SSRS|ssrs
4840266|NCT02387905|Brief Pain Inventory|brief pain inventory
4840267|NCT02387905|MD Anderson Symptom Inventory - Spine Tumor|md anderson symptom inventory - spine tumor
4840268|NCT02387905|MDASI-SP|mdasi-sp
4840269|NCT02387905|Questionnaires|questionnaires
4840270|NCT02387905|Survey|survey
4840271|NCT02387879|Multiple Myeloma|multiple myeloma
4840272|NCT02387879|PASS|pass
4840273|NCT02387879|Observational|observational
4840274|NCT02387879|Non-interventional|non-interventional
4840275|NCT02387879|Relapse|relapse
4840276|NCT02387879|Refractory|refractory
4840277|NCT02387879|CC-5013|cc-5013
4840278|NCT02387879|Lenalidomide|lenalidomide
4840279|NCT02387879|Turkey|turkey
4840280|NCT02387866|Pharmacokinetic|pharmacokinetic
4840281|NCT02387866|Healthy Volunteers|healthy volunteers
4840282|NCT02387866|Male|male
4840283|NCT02387866|Japanese|japanese
4840284|NCT02387866|Caucasian|caucasian
4840285|NCT02387866|AG-221|ag-221
4840286|NCT02387840|Brain|brain
4840287|NCT02387840|Cancer|cancer
4840288|NCT02387840|Neurofibromatosis type 1|neurofibromatosis type 1
4840289|NCT02387840|NF1|nf1
4840290|NCT02387840|Magnetic resonance fingerprinting|magnetic resonance fingerprinting
4840291|NCT02387840|MRF|mrf
4840292|NCT02387827|long bout physical activity|long bout physical activity
4840293|NCT02387827|short bout physical activity|short bout physical activity
4840294|NCT02387827|Caloric Restriction|caloric restriction
4840295|NCT02387775|esophageal cooling device|esophageal cooling device
4840296|NCT02387775|post cardiac arrest|post cardiac arrest
4840297|NCT02387775|targetted temperature management|targetted temperature management
4840298|NCT02387775|therapeutic hypothermia|therapeutic hypothermia
4840299|NCT02387775|cooling|cooling
4840300|NCT02387775|rewarming|rewarming
4840301|NCT02387762|Acalabrutinib|acalabrutinib
4840302|NCT02387749|diabetic peripheral neuropathy|diabetic peripheral neuropathy
4840303|NCT02387749|mesenchymal stem cells|mesenchymal stem cells
4840304|NCT02387736|BPD|bpd
4840305|NCT02387736|DBT|dbt
4840306|NCT02387736|Dialectical Behaviour Therapy|dialectical behaviour therapy
4840307|NCT02387736|Borderline Personality Disorder|borderline personality disorder
4840308|NCT02387736|Suicide|suicide
4840309|NCT02387736|Non-suicidal self injury|non-suicidal self injury
4840310|NCT02387736|NSSI|nssi
4840311|NCT02387736|Randomized Control trials|randomized control trials
4840312|NCT02387736|treatment|treatment
4840313|NCT02387710|arousal threshold|arousal threshold
4840314|NCT02387710|phenotype|phenotype
4840315|NCT02387710|tiagabine|tiagabine
4840316|NCT02387710|slow wave sleep|slow wave sleep
4840317|NCT02387684|chronic hepatitis B|chronic hepatitis b
4840318|NCT02387684|interferon|interferon
4840319|NCT02387684|peginterferon|peginterferon
4840320|NCT02387684|HBsAg loss|hbsag loss
4840321|NCT02387658|peripheral arterial disease|peripheral arterial disease
4840322|NCT02387658|claudication|claudication
4840323|NCT02387658|translesional pressure gradient|translesional pressure gradient
4840324|NCT02387658|pressure wire|pressure wire
4840325|NCT02387658|six minute walk|six minute walk
4840326|NCT02387658|superficial femoral artery|superficial femoral artery
4840327|NCT02387658|pressure gradient|pressure gradient
4840328|NCT02387658|endovascular|endovascular
4840329|NCT02387645|Endometrium|endometrium
4840330|NCT02387645|Endometrial Neoplasms|endometrial neoplasms
4840331|NCT02387645|Early detection|early detection
4840332|NCT02387645|Carcinoma of Endometrium|carcinoma of endometrium
4840333|NCT02387645|Gynaecological Cancer|gynaecological cancer
4840334|NCT02387606|Respiratory Syncytial Virus Infections|respiratory syncytial virus infections
4840335|NCT02387606|Placebo|placebo
4840336|NCT02387606|Antiviral activity|antiviral activity
4840337|NCT02387606|JNJ-53718678|jnj-53718678
4840338|NCT02387593|Adenoma|adenoma
4840339|NCT02387593|Colonoscopy|colonoscopy
4840340|NCT02387593|Screening|screening
4840341|NCT02387580|Malaria|malaria
4840342|NCT02387580|Bioavailability|bioavailability
4840343|NCT02387580|Formulation|formulation
4840344|NCT02387541|Postoperative cognitive dysfunction|postoperative cognitive dysfunction
4840345|NCT02387528|MIndfulness|mindfulness
4840346|NCT02387528|Primary Health Care|primary health care
4840347|NCT02387463|chronic hepatitis B|chronic hepatitis b
4840348|NCT02387463|antiviral therapy|antiviral therapy
4840349|NCT02387463|peginterferon|peginterferon
4840350|NCT02387463|HBeAg seroconversion|hbeag seroconversion
4840351|NCT02387463|HBsAg loss|hbsag loss
4840352|NCT02387450|Claudication|claudication
4840353|NCT02387450|Maximal walking distance|maximal walking distance
4840354|NCT02387450|Morbi-mortality|morbi-mortality
4840355|NCT02387437|ARDS|ards
4840356|NCT02387437|EIT|eit
4840357|NCT02387437|recruitment maneuvers|recruitment maneuvers
4840358|NCT02387424|depression|depression
4840359|NCT02387424|mindfulness|mindfulness
4840360|NCT02387424|pregnancy|pregnancy
4840361|NCT02387424|prevention|prevention
4840362|NCT02387424|cognitive behavioral therapy|cognitive behavioral therapy
4840363|NCT02387411|heart failure|heart failure
4840364|NCT02387411|aerobic exercise|aerobic exercise
4840365|NCT02387411|strength training|strength training
4840366|NCT02387411|cardiopulmonary rehabilitation|cardiopulmonary rehabilitation
4840367|NCT02387411|high-intensity exercise training|high-intensity exercise training
4840368|NCT02387333|Radical cystectomy|radical cystectomy
4840369|NCT02387333|Urinary diversion|urinary diversion
4840370|NCT02387333|Ileal conduit|ileal conduit
4840371|NCT02387333|Parastomal hernia|parastomal hernia
4840372|NCT02387333|Prophylactic mesh|prophylactic mesh
4840373|NCT02387333|Mesh stoma reinforcement technique|mesh stoma reinforcement technique
4840374|NCT02387320|Anxiety|anxiety
4840375|NCT02387320|Pain|pain
4840376|NCT02387320|Nausea|nausea
4840377|NCT02387320|Fatigue|fatigue
4840378|NCT02387320|Sleep Disturbance|sleep disturbance
4840379|NCT02387320|Breast Cancer|breast cancer
4840380|NCT02387320|Surgery|surgery
4840381|NCT02387294|immunogenicity|immunogenicity
4840382|NCT02387294|reduced dos|reduced dos
4840383|NCT02387294|Phase III|phase iii
4840384|NCT02387294|tolerability|tolerability
4840385|NCT02387294|safety|safety
4840386|NCT02387281|Freezing of gait|freezing of gait
4840387|NCT02387242|Tuberculosis|tuberculosis
4840388|NCT02387242|Whole blood Bactericidal Activity|whole blood bactericidal activity
4840389|NCT02387242|WBA|wba
4840390|NCT02387242|Rifampicin|rifampicin
4840391|NCT02387229|Atrial Fibrillation|atrial fibrillation
4840393|NCT02387229|Neurocognitive decline|neurocognitive decline
4840394|NCT02387229|Rivaroxaban|rivaroxaban
4840395|NCT02387229|Acetylsalicylic acid|acetylsalicylic acid
4840396|NCT02387229|Anticoagulation|anticoagulation
4840397|NCT02387216|NSCLC|nsclc
4840398|NCT02387216|Non-Small Cell Lung Cancer|non-small cell lung cancer
4840399|NCT02387216|heregulin|heregulin
4840400|NCT02387216|ErbB3|erbb3
4840401|NCT02387216|docetaxel|docetaxel
4840402|NCT02387203|Pseudomyxoma Peritonei|pseudomyxoma peritonei
4840403|NCT02387203|Appendiceal cancer|appendiceal cancer
4840404|NCT02387203|CRS/HIPEC|crs/hipec
4840405|NCT02387203|PMP|pmp
4840406|NCT02387190|Heart Failure|heart failure
4840407|NCT02387190|Lung function test|lung function test
4840408|NCT02387190|Telenursing|telenursing
4840409|NCT02387190|Morbidity|morbidity
4840410|NCT02387190|Mortality|mortality
4840411|NCT02387190|Quality of life|quality of life
4840412|NCT02387164|Type 1 diabetes|type 1 diabetes
4840413|NCT02387164|Islet autoantibodies|islet autoantibodies
4840414|NCT02387164|glutamate decarboxylase autoantibodies (GADA)|glutamate decarboxylase autoantibodies (gada)
4840415|NCT02387164|Immune tolerance|immune tolerance
4840416|NCT02387164|Prediabetes|prediabetes
4840417|NCT02387164|Glucose tolerance|glucose tolerance
4840418|NCT02387164|glutamate decarboxylase|glutamate decarboxylase
4840419|NCT02387164|Prevention|prevention
4840420|NCT02387164|Children|children
4840421|NCT02387151|Mesenchymal Stromal Cells|mesenchymal stromal cells
4840422|NCT02387151|Rejection|rejection
4840423|NCT02387112|End stage heart disease|end stage heart disease
4840424|NCT02387112|Ventricular assist device|ventricular assist device
4840425|NCT02387099|Stage IIIB|stage iiib
4840426|NCT02387099|Stage IV|stage iv
4840427|NCT02387099|Recurrent|recurrent
4840428|NCT02387099|Metastatic|metastatic
4840429|NCT02387086|gefitinib|gefitinib
4840430|NCT02387086|thalidomide|thalidomide
4840431|NCT02387086|NSCLC|nsclc
4840432|NCT02387086|EGFR mutation|egfr mutation
4840433|NCT02387073|outcome assessment|outcome assessment
4840434|NCT02387073|self-reported|self-reported
4840435|NCT02387073|patient|patient
4840436|NCT02387073|clinical outcome|clinical outcome
4840437|NCT02387060|Anesthesia|anesthesia
4840438|NCT02387060|Spinal and Epidural|spinal and epidural
4840439|NCT02387060|Adverse Effect|adverse effect
4840440|NCT02387060|Complications|complications
4840441|NCT02387034|Osteoarthritis|osteoarthritis
4840442|NCT02387034|Sedentary|sedentary
4840443|NCT02387034|Physical activity|physical activity
4840444|NCT02387034|Health related quality of life|health related quality of life
4840445|NCT02387021|analgesia|analgesia
4840446|NCT02387021|nerve block|nerve block
4840447|NCT02387021|Total knee replacement|total knee replacement
4840448|NCT02386995|depth of anesthesia monitors|depth of anesthesia monitors
4840449|NCT02386995|deep brain stimulation|deep brain stimulation
4840450|NCT02386969|Neuropathic Pain|neuropathic pain
4840451|NCT02386969|repetitive transcranial magnetic stimulation (rTMS)|repetitive transcranial magnetic stimulation (rtms)
4840452|NCT02386956|manual therapy|manual therapy
4840453|NCT02386956|muscle chains|muscle chains
4840454|NCT02386956|Dynamic stretching|dynamic stretching
4840455|NCT02386956|Active stretching|active stretching
4840456|NCT02386930|Cognitive behavior therapy|cognitive behavior therapy
4840457|NCT02386930|Lifestyle modification|lifestyle modification
4840458|NCT02386930|HbA1c|hba1c
4840459|NCT02386930|Carbohydrates|carbohydrates
4840460|NCT02386891|food intake|food intake
4840461|NCT02386891|indoor thermal environment|indoor thermal environment
4840462|NCT02386878|Orphans and vulnerable children (OVC)|orphans and vulnerable children (ovc)
4840463|NCT02386878|Program Evaluation|program evaluation
4840464|NCT02386878|HIV Prevention|hiv prevention
4840465|NCT02386878|Psychosocial Wellbeing|psychosocial wellbeing
4840466|NCT02386878|Adolescents|adolescents
4840467|NCT02386852|Ginseng|ginseng
4840468|NCT02386852|Ginkgo Biloba|ginkgo biloba
4840469|NCT02386852|cardiovascular reactivity|cardiovascular reactivity
4840470|NCT02386852|cognition|cognition
4840471|NCT02386826|INC280|inc280
4840472|NCT02386826|c-MET Inhibitors|c-met inhibitors
4840473|NCT02386826|bevacizumab|bevacizumab
4840474|NCT02386826|Avastin|avastin
4840475|NCT02386826|C-Met proto-oncogene|c-met proto-oncogene
4840476|NCT02386800|primary myelofibrosis|primary myelofibrosis
4840477|NCT02386800|chronic idiopathic myelofibrosis,|chronic idiopathic myelofibrosis,
4840478|NCT02386800|post polycythemia vera myelofibrosis,|post polycythemia vera myelofibrosis,
4840479|NCT02386800|post essential thrombocythaemia myelofibrosis.|post essential thrombocythaemia myelofibrosis.
4840480|NCT02386787|Ultrasonography|ultrasonography
4840481|NCT02386787|Non-elective surgery|non-elective surgery
4840482|NCT02386787|Anesthesia|anesthesia
4840483|NCT02386774|In vivo confocal microscopy|in vivo confocal microscopy
4840484|NCT02386774|corneal disease|corneal disease
4840485|NCT02386774|Blepharitis|blepharitis
4840486|NCT02386774|Lacrimal Apparatus Diseases|lacrimal apparatus diseases
4840487|NCT02386774|Microscopy, Confocal|microscopy, confocal
4840488|NCT02386748|Cesarean section|cesarean section
4840489|NCT02386748|Chewing gums|chewing gums
4840490|NCT02386748|Intestinal motility|intestinal motility
4840491|NCT02386735|Corticosteroid treatment|corticosteroid treatment
4840492|NCT02386735|COPD|copd
4840493|NCT02386735|Primary Health Care|primary health care
4840494|NCT02386735|Randomized controlled trial|randomized controlled trial
4840495|NCT02386722|Adherence of inhaled medication|adherence of inhaled medication
4840496|NCT02386722|pharmaceutical care intervention|pharmaceutical care intervention
4840497|NCT02386683|Protective mechanical ventilation|protective mechanical ventilation
4840498|NCT02386683|ventilator-induced lung injury|ventilator-induced lung injury
4840499|NCT02386683|neurosurgery|neurosurgery
4840500|NCT02386657|Sickle Cell Disease|sickle cell disease
4840501|NCT02386657|Vaso-occlusive crisis|vaso-occlusive crisis
4840502|NCT02386657|Emergency management|emergency management
4840503|NCT02386631|gait|gait
4840504|NCT02386631|orthotics|orthotics
4840505|NCT02386631|kinetics|kinetics
4840506|NCT02386631|hallux valgus|hallux valgus
4840507|NCT02386631|bunions|bunions
4840508|NCT02386618|colorectal cancer|colorectal cancer
4840509|NCT02386618|laterally spreading tumors|laterally spreading tumors
4840510|NCT02386618|endoscopic mucosal resestion|endoscopic mucosal resestion
4840511|NCT02386618|local residual neoplasia|local residual neoplasia
4840512|NCT02386605|recovery|recovery
4840513|NCT02386605|rehabilitation|rehabilitation
4840514|NCT02386553|NURTURE|nurture
4840515|NCT02386540|Community Health Workers|community health workers
4840516|NCT02386540|Community Health Workers: utilization|community health workers: utilization
4840517|NCT02386540|Emergency Service|emergency service
4840518|NCT02386540|Primary Health Care/utilization|primary health care/utilization
4840519|NCT02386540|Health Services Accessibility|health services accessibility
4840520|NCT02386514|sexually transmitted infection|sexually transmitted infection
4840521|NCT02386514|gonorrhea|gonorrhea
4840522|NCT02386514|chlamydia|chlamydia
4840523|NCT02386514|presumptive therapy|presumptive therapy
4840524|NCT02386462|laryngeal mask airway|laryngeal mask airway
4840525|NCT02386462|circulatory reflexes|circulatory reflexes
4840526|NCT02386436|GSK2330811|gsk2330811
4840527|NCT02386436|Dose Escalation|dose escalation
4840528|NCT02386436|Safety|safety
4840529|NCT02386436|First Time in Human|first time in human
4840530|NCT02386436|Pharmacodynamics|pharmacodynamics
4840531|NCT02386436|Pharmacokinetics|pharmacokinetics
4840533|NCT02386423|Willis-Ekbom|willis-ekbom
4840534|NCT02386384|pregnancy failure|pregnancy failure
4840535|NCT02386358|Chronic Chagas Disease|chronic chagas disease
4840536|NCT02386358|Randomized Clinical Trial double blind|randomized clinical trial double blind
4840537|NCT02386358|Benznidazole vs Placebo|benznidazole vs placebo
4840538|NCT02386358|Adult patients|adult patients
4840539|NCT02386345|FIRM procedure|firm procedure
4840540|NCT02386319|Melatonin|melatonin
4840541|NCT02386319|Analgesic|analgesic
4840542|NCT02386319|Surgery|surgery
4840543|NCT02386319|Pharmacokinetic|pharmacokinetic
4840544|NCT02386280|Primary Prevention|primary prevention
4840545|NCT02386280|Substance-Related Disorders|substance-related disorders
4840546|NCT02386280|Family|family
4840547|NCT02386254|premorbid|premorbid
4840548|NCT02386254|scoring system|scoring system
4840549|NCT02386254|ECOG|ecog
4840550|NCT02386254|ICU|icu
4840551|NCT02386254|morbidity|morbidity
4840552|NCT02386254|mortality|mortality
4840553|NCT02386241|brain tumor|brain tumor
4840554|NCT02386228|miRNA|mirna
4840555|NCT02386228|posthemorrhagic hydrocephalus (PHH)|posthemorrhagic hydrocephalus (phh)
4840556|NCT02386215|HIV self-testing|hiv self-testing
4840557|NCT02386215|randomized controlled trial|randomized controlled trial
4840558|NCT02386215|Kenya|kenya
4840559|NCT02386189|Continuity of Patient Care|continuity of patient care
4840560|NCT02386189|Health Records, Personal|health records, personal
4840561|NCT02386189|Veterans|veterans
4840562|NCT02386189|Patient Participation|patient participation
4840563|NCT02386189|Chronic Disease|chronic disease
4840564|NCT02386137|MR-HIFU|mr-hifu
4840565|NCT02386137|HIFU|hifu
4840566|NCT02386137|Fibroid treatment|fibroid treatment
4840567|NCT02386137|MR Perfusion|mr perfusion
4840568|NCT02386137|CEUS perfusion|ceus perfusion
4840569|NCT02386137|Diffusion weighted imaging|diffusion weighted imaging
4840570|NCT02386137|ARFI|arfi
4840571|NCT02386137|Fibroid stiffness|fibroid stiffness
4840572|NCT02386124|frailty|frailty
4840573|NCT02386124|elderly|elderly
4840574|NCT02386124|acute coronary syndrome|acute coronary syndrome
4840575|NCT02386124|acute heart failure|acute heart failure
4840576|NCT02386124|arrhythmias|arrhythmias
4840577|NCT02386111|Sutent|sutent
4840578|NCT02386085|Osteopathic Manipulative Medicine|osteopathic manipulative medicine
4840579|NCT02386085|Osteopathic Manipulation|osteopathic manipulation
4840580|NCT02386085|adverse effects|adverse effects
4840581|NCT02386085|side effects|side effects
4840582|NCT02386085|undesirable effects|undesirable effects
4840583|NCT02386072|Betanis®|betanis®
4840584|NCT02386072|Myrbetriq®|myrbetriq®
4840585|NCT02386072|Quality of Life|quality of life
4840586|NCT02386072|Antimuscarinics|antimuscarinics
4840587|NCT02386072|Betmiga®|betmiga®
4840588|NCT02386072|Overactive Bladder|overactive bladder
4840589|NCT02386072|Observational|observational
4840590|NCT02386059|ondansetron|ondansetron
4840591|NCT02386059|dexamethasone|dexamethasone
4840592|NCT02386059|vitrectomy|vitrectomy
4840593|NCT02386059|local anesthesia|local anesthesia
4840594|NCT02386046|Caffeine use|caffeine use
4840595|NCT02386046|Normative data|normative data
4840596|NCT02385968|Modic|modic
4840597|NCT02385968|Microbiology|microbiology
4840598|NCT02385968|Immunology|immunology
4840599|NCT02385942|u-health|u-health
4840600|NCT02385942|chronic wound management|chronic wound management
4840601|NCT02385942|pressure ulcer|pressure ulcer
4840602|NCT02385929|Head and Neck Cancer|head and neck cancer
4840603|NCT02385929|Intervention|intervention
4840604|NCT02385929|Rehabilitation|rehabilitation
4840605|NCT02385929|Late Effects|late effects
4840606|NCT02385929|Dysphagia|dysphagia
4840607|NCT02385916|EstroSense|estrosense
4840608|NCT02385916|estrogen|estrogen
4840609|NCT02385903|Flammacerium|flammacerium
4840610|NCT02385903|Ischemic wound|ischemic wound
4840611|NCT02385903|Lower limb|lower limb
4840612|NCT02385903|Arteriopathy|arteriopathy
4840613|NCT02385903|Amputation|amputation
4840614|NCT02385903|Dressing|dressing
4840615|NCT02385838|Nutrition labelling|nutrition labelling
4840616|NCT02385838|Front-of-pack nutrition labels|front-of-pack nutrition labels
4840617|NCT02385838|Purchasing intentions|purchasing intentions
4840618|NCT02385838|Nutritional quality|nutritional quality
4840717|NCT02385487|Respiratory Insufficiency|respiratory insufficiency
4840619|NCT02385838|Randomized controlled trial (RCT)|randomized controlled trial (rct)
4840620|NCT02385812|Lung Cancer|lung cancer
4840621|NCT02385812|Mesothelioma|mesothelioma
4840622|NCT02385812|Asbestos|asbestos
4840623|NCT02385812|Screening|screening
4840624|NCT02385799|Autism Spectrum Disorder|autism spectrum disorder
4840625|NCT02385799|Behavior|behavior
4840626|NCT02385799|sertraline|sertraline
4840627|NCT02385799|treatment|treatment
4840628|NCT02385786|mindfulness-based cognitive therapy|mindfulness-based cognitive therapy
4840629|NCT02385786|depression|depression
4840630|NCT02385786|treatment|treatment
4840631|NCT02385786|mindfulness meditation|mindfulness meditation
4840632|NCT02385786|psychotherapy|psychotherapy
4840633|NCT02385773|colostrum|colostrum
4840634|NCT02385773|Immunoglobulin Y (IgY)|immunoglobulin y (igy)
4840635|NCT02385760|Facial Acne|facial acne
4840636|NCT02385747|perimenopausal bleeding|perimenopausal bleeding
4840637|NCT02385747|postmenopausal bleeding|postmenopausal bleeding
4840638|NCT02385747|hysteroscopy|hysteroscopy
4840639|NCT02385747|Steroid receptors|steroid receptors
4840640|NCT02385734|Multiple gingival recession|multiple gingival recession
4840641|NCT02385734|Concentrated growth factor|concentrated growth factor
4840642|NCT02385734|Coronally advanced flap|coronally advanced flap
4840643|NCT02385695|Disc Degeneration Disease|disc degeneration disease
4840644|NCT02385695|DDD|ddd
4840645|NCT02385695|multilevel lumbar Disc Degeneration Disease|multilevel lumbar disc degeneration disease
4840646|NCT02385669|vaccine|vaccine
4840647|NCT02385669|peptide|peptide
4840648|NCT02385669|ipilimumab|ipilimumab
4840649|NCT02385669|Yervoy|yervoy
4840650|NCT02385669|Montanide ISA-51|montanide isa-51
4840651|NCT02385643|alcohol dependence|alcohol dependence
4840652|NCT02385643|abstinence|abstinence
4840653|NCT02385643|relapse prevention|relapse prevention
4840654|NCT02385643|mobile support system|mobile support system
4840655|NCT02385630|Longitudinal Studies|longitudinal studies
4840656|NCT02385630|Esophagectomy|esophagectomy
4840657|NCT02385630|Gastrectomy|gastrectomy
4840658|NCT02385630|Hunger|hunger
4840659|NCT02385630|Appetite|appetite
4840660|NCT02385630|Glucagon-like Peptide 1|glucagon-like peptide 1
4840661|NCT02385630|Peptide YY|peptide yy
4840662|NCT02385630|Ghrelin|ghrelin
4840663|NCT02385630|Satiety Response|satiety response
4840664|NCT02385630|Feeding Behavior|feeding behavior
4840665|NCT02385630|Meals|meals
4840666|NCT02385630|Postprandial Period|postprandial period
4840667|NCT02385617|Glucagon-Like Peptide 1|glucagon-like peptide 1
4840668|NCT02385617|Peptide YY|peptide yy
4840669|NCT02385617|Ghrelin|ghrelin
4840670|NCT02385617|Satiety Response|satiety response
4840671|NCT02385617|Appetite|appetite
4840672|NCT02385617|Hunger|hunger
4840673|NCT02385617|Somatostatin|somatostatin
4840674|NCT02385617|Octreotide|octreotide
4840675|NCT02385617|Anastomosis, Roux-en-Y|anastomosis, roux-en-y
4840676|NCT02385617|Digestive System Surgical Procedures|digestive system surgical procedures
4840677|NCT02385617|Pharmacologic Actions|pharmacologic actions
4840678|NCT02385617|Physiological Effects of Drugs|physiological effects of drugs
4840679|NCT02385617|Endocrine System Diseases|endocrine system diseases
4840680|NCT02385617|Enteroendocrine Cells|enteroendocrine cells
4840681|NCT02385617|Gastrointestinal Agents|gastrointestinal agents
4840682|NCT02385604|Positron-Emission Tomography|positron-emission tomography
4840683|NCT02385604|Neoadjuvant Therapy|neoadjuvant therapy
4840684|NCT02385604|Chemoradiotherapy|chemoradiotherapy
4840685|NCT02385604|Esophagectomy|esophagectomy
4840686|NCT02385604|Response Evaluation Criteria in Solid Tumors|response evaluation criteria in solid tumors
4840687|NCT02385604|Treatment Outcome|treatment outcome
4840688|NCT02385604|Survival|survival
4840689|NCT02385604|Recurrence|recurrence
4840690|NCT02385604|Disease-Free Survival|disease-free survival
4840691|NCT02385604|Progression-Free Survival|progression-free survival
4840692|NCT02385604|Prognosis|prognosis
4840693|NCT02385604|Neoplasm Grading|neoplasm grading
4840694|NCT02385604|Adenocarcinoma|adenocarcinoma
4840695|NCT02385604|Squamous Cell Carcinoma|squamous cell carcinoma
4840696|NCT02385604|Neoplasm Metastasis|neoplasm metastasis
4840697|NCT02385591|physical activity|physical activity
4840698|NCT02385591|Latinos|latinos
4840699|NCT02385591|overweight|overweight
4840700|NCT02385591|SMS|sms
4840701|NCT02385591|mHealth|mhealth
4840702|NCT02385578|VS (vessel plus surface) classification system|vs (vessel plus surface) classification system
4840703|NCT02385578|Magnified endoscopy with narrow band imaging (ME-NBI)|magnified endoscopy with narrow band imaging (me-nbi)
4840704|NCT02385578|the rate of detection|the rate of detection
4840705|NCT02385552|colonoscopy|colonoscopy
4840706|NCT02385552|quality improvement|quality improvement
4840707|NCT02385552|adenoma detection rate|adenoma detection rate
4840708|NCT02385526|Vagus Nerve Stimulation|vagus nerve stimulation
4840709|NCT02385526|ASCEND|ascend
4840710|NCT02385526|VNS Titration to Improve Tolerance and Accelerate Adaptation|vns titration to improve tolerance and accelerate adaptation
4840711|NCT02385513|Immunogenicity|immunogenicity
4840712|NCT02385487|Myocardial Infarction|myocardial infarction
4840713|NCT02385487|Inflammation|inflammation
4840714|NCT02385487|Critical Illness|critical illness
4840715|NCT02385487|Necrosis|necrosis
4840716|NCT02385487|Sepsis|sepsis
4840718|NCT02385487|Myocardial Ischemia|myocardial ischemia
4840719|NCT02385487|Cardiovascular Diseases|cardiovascular diseases
4840720|NCT02385487|Heart Diseases|heart diseases
4840721|NCT02385487|Vascular Diseases|vascular diseases
4840722|NCT02385474|silver diamine fluoride|silver diamine fluoride
4840723|NCT02385474|randomized clinical trial|randomized clinical trial
4840724|NCT02385474|caries|caries
4840725|NCT02385474|children|children
4840726|NCT02385474|fluoride|fluoride
4840727|NCT02385448|dienogest|dienogest
4840728|NCT02385448|combined oral contraceptive pills|combined oral contraceptive pills
4840729|NCT02385448|endometriosis|endometriosis
4840730|NCT02385435|caudal block|caudal block
4840731|NCT02385422|secondary prophylaxis|secondary prophylaxis
4840732|NCT02385422|Propranolol|propranolol
4840733|NCT02385422|Carvedilol|carvedilol
4840734|NCT02385422|comparative effectiveness research|comparative effectiveness research
4840735|NCT02385409|Patient Blood Management|patient blood management
4840736|NCT02385409|Preoperative anemia|preoperative anemia
4840737|NCT02385409|Hip replacement|hip replacement
4840738|NCT02385409|Knee replacement|knee replacement
4840739|NCT02385396|Polycystic Ovary Syndrome|polycystic ovary syndrome
4840740|NCT02385396|Infertility|infertility
4840741|NCT02385396|Myo-inositol|myo-inositol
4840742|NCT02385396|Intracytoplasmic sperm injection|intracytoplasmic sperm injection
4840743|NCT02385383|Patient Blood Management|patient blood management
4840744|NCT02385383|Preoperative anemia|preoperative anemia
4840745|NCT02385383|IV Iron|iv iron
4840746|NCT02385357|Muscle function|muscle function
4840747|NCT02385357|Anaerobic power|anaerobic power
4840748|NCT02385357|Muscle damage|muscle damage
4840749|NCT02385331|Neutrophils|neutrophils
4840750|NCT02385331|necroptosis|necroptosis
4840751|NCT02385331|apoptosis|apoptosis
4840752|NCT02385305|Pressure support ventilation|pressure support ventilation
4840753|NCT02385305|respiratory drive|respiratory drive
4840754|NCT02385305|Physiology|physiology
4840755|NCT02385279|CAD|cad
4840756|NCT02385279|ACS|acs
4840757|NCT02385279|All comers|all comers
4840758|NCT02385279|PCI|pci
4840759|NCT02385266|Interstitial cystitis with Painful Bladder Syndrome|interstitial cystitis with painful bladder syndrome
4840760|NCT02385266|Urological Chronic Pelvic Pain Syndrome|urological chronic pelvic pain syndrome
4840761|NCT02385253|Training|training
4840762|NCT02385253|Primary Health Care|primary health care
4840763|NCT02385253|Skin Cancer|skin cancer
4840764|NCT02385253|Primary Care Physicians|primary care physicians
4840765|NCT02385253|Surveillance|surveillance
4840766|NCT02385253|Education|education
4840767|NCT02385214|Malignant|malignant
4840768|NCT02385214|Melanoma|melanoma
4840769|NCT02385214|Cancer|cancer
4840770|NCT02385214|Surgery|surgery
4840771|NCT02385188|Extramammary Paget's disease|extramammary paget's disease
4840772|NCT02385188|Vulva|vulva
4840773|NCT02385188|Genital, female|genital, female
4840774|NCT02385188|imiquimod|imiquimod
4840775|NCT02385175|Eustachian tube|eustachian tube
4840776|NCT02385175|test accuracy|test accuracy
4840777|NCT02385175|clinical test|clinical test
4840778|NCT02385175|questionnaire|questionnaire
4840779|NCT02385162|Mucolipidoses|mucolipidoses
4840780|NCT02385162|Metabolic Diseases|metabolic diseases
4840781|NCT02385162|Lysosomal Storage Diseases|lysosomal storage diseases
4840782|NCT02385149|resilience|resilience
4840783|NCT02385149|challenge test|challenge test
4840784|NCT02385149|whole grain wheat|whole grain wheat
4840785|NCT02385149|metabolic flexibility|metabolic flexibility
4840786|NCT02385149|cardio-metabolic|cardio-metabolic
4840787|NCT02385149|liver and adipose tissue|liver and adipose tissue
4840788|NCT02385136|NSCLC|nsclc
4840789|NCT02385136|Radiotherpy|radiotherpy
4840790|NCT02385136|Temozolomide|temozolomide
4840791|NCT02385123|ex-vivo|ex-vivo
4840792|NCT02385123|Influenza|influenza
4840793|NCT02385123|plasmablasts|plasmablasts
4840794|NCT02385110|Leukemia|leukemia
4840795|NCT02385110|Hemophagocytic lymphohistiocytosis|hemophagocytic lymphohistiocytosis
4840796|NCT02385110|HLH|hlh
4840797|NCT02385110|Alemtuzumab|alemtuzumab
4840798|NCT02385110|CAMPATH-1H|campath-1h
4840799|NCT02385110|Campath|campath
4840800|NCT02385110|Etoposide|etoposide
4840801|NCT02385110|VePesid|vepesid
4840802|NCT02385110|Dexamethasone|dexamethasone
4840803|NCT02385110|Decadron|decadron
4840804|NCT02385110|Methotrexate|methotrexate
4840805|NCT02385110|Phone call|phone call
4840806|NCT02385071|Healthy|healthy
4840807|NCT02385071|Simeprevir|simeprevir
4840808|NCT02385071|Bioavailability|bioavailability
4840809|NCT02385058|Helminthiasis|helminthiasis
4840810|NCT02385058|Amoebiasis|amoebiasis
4840811|NCT02385058|Mebendazole|mebendazole
4840812|NCT02385058|Quinfamide|quinfamide
4840813|NCT02385058|Mexican population|mexican population
4840814|NCT02385019|Allogeneic hematopoietic stem cell transplantation|allogeneic hematopoietic stem cell transplantation
4840815|NCT02385019|Graft vs host disease|graft vs host disease
4840816|NCT02385019|Regulatory T cells|regulatory t cells
4840817|NCT02385006|Thromboelastography|thromboelastography
4840818|NCT02385006|simulatneous pancreas-kidney transplantation|simulatneous pancreas-kidney transplantation
4840819|NCT02384993|Alzheimer's Disease|alzheimer's disease
4840820|NCT02384993|Dementia|dementia
4840821|NCT02384993|aerobic exercise|aerobic exercise
4840822|NCT02384993|physical activity|physical activity
4840823|NCT02384993|exercise|exercise
4840824|NCT02384993|neuroimaging|neuroimaging
4840825|NCT02384980|Intermittent Claudication|intermittent claudication
4840826|NCT02384980|Functional Electrical Stimulation|functional electrical stimulation
4840827|NCT02384954|Lymphoma|lymphoma
4840828|NCT02384954|indolent B Cell|indolent b cell
4840829|NCT02384954|non-Hodgkin Lymphoma|non-hodgkin lymphoma
4840830|NCT02384954|Cancer|cancer
4840831|NCT02384954|Immunotherapy|immunotherapy
4840832|NCT02384954|Relapsed|relapsed
4840833|NCT02384954|Refractory|refractory
4840834|NCT02384954|Rituximab|rituximab
4840835|NCT02384954|Interleukin-15|interleukin-15
4840836|NCT02384954|Absolute Lymphocyte Count|absolute lymphocyte count
4840837|NCT02384954|White Blood Cell|white blood cell
4840838|NCT02384954|Follicular Lymphoma|follicular lymphoma
4840839|NCT02384954|Marginal Zone Lymphoma|marginal zone lymphoma
4840840|NCT02384954|Small Lymphocytic Lymphoma|small lymphocytic lymphoma
4840841|NCT02384954|Lymphoplasmacytic Lymphoma|lymphoplasmacytic lymphoma
4840842|NCT02384954|anti-CD20|anti-cd20
4840843|NCT02384928|Acupuncture|acupuncture
4840844|NCT02384928|Pharmacopuncture|pharmacopuncture
4840845|NCT02384928|Usual Care|usual care
4840846|NCT02384902|glycemic index|glycemic index
4840847|NCT02384902|diabetic nephropathy|diabetic nephropathy
4840848|NCT02384902|low glycemic load|low glycemic load
4840849|NCT02384902|inflammation|inflammation
4840850|NCT02384876|pediatric|pediatric
4840851|NCT02384876|intraoperative arterial hypotension|intraoperative arterial hypotension
4840852|NCT02384876|ephedrine|ephedrine
4840853|NCT02384876|general anesthesia|general anesthesia
4840854|NCT02384863|Chest Pain|chest pain
4840855|NCT02384863|Acute Coronary Syndrome|acute coronary syndrome
4840856|NCT02384863|Cardiac|cardiac
4840857|NCT02384863|Emergency Department|emergency department
4840858|NCT02384863|Cardiac Testing|cardiac testing
4840859|NCT02384863|Healthcare Utilization|healthcare utilization
4840860|NCT02384863|Patient Centered Outcomes|patient centered outcomes
4840861|NCT02384863|Shared Decision Making|shared decision making
4840862|NCT02384863|Unnecessary hospital admissions|unnecessary hospital admissions
4840863|NCT02384863|Decision Aid|decision aid
4840864|NCT02384850|metastatic|metastatic
4840865|NCT02384837|national Cather Lad|national cather lad
4840866|NCT02384837|Interventional Imaging Training Base|interventional imaging training base
4840867|NCT02384811|Esophageal squamous cell carcinoma|esophageal squamous cell carcinoma
4840868|NCT02384811|postoperative radiotherapy|postoperative radiotherapy
4840869|NCT02384759|cancer, colorectal,|cancer, colorectal,
4840870|NCT02384746|metastatic breast cancer|metastatic breast cancer
4840871|NCT02384746|ER-positive|er-positive
4840872|NCT02384746|HER2-negative|her2-negative
4840873|NCT02384746|Fulvestrant|fulvestrant
4840874|NCT02384746|MLN9708|mln9708
4840875|NCT02384733|Radiation induced morbidity, recurrence|radiation induced morbidity, recurrence
4840876|NCT02384694|cardiorespiratory fitness|cardiorespiratory fitness
4840877|NCT02384694|weight|weight
4840878|NCT02384694|quality of life|quality of life
4840879|NCT02384694|depression|depression
4840880|NCT02384694|menopausal symptoms|menopausal symptoms
4840881|NCT02384694|exercise barriers|exercise barriers
4840882|NCT02384694|executive functions|executive functions
4840883|NCT02384681|Speech intelligibility|speech intelligibility
4840884|NCT02384681|Short-term memory|short-term memory
4840885|NCT02384681|Working memory|working memory
4840886|NCT02384681|Perceived mental task load|perceived mental task load
4840887|NCT02384668|Cholecalciferol|cholecalciferol
4840888|NCT02384668|Vitamin D3|vitamin d3
4840889|NCT02384668|Arterial stiffness|arterial stiffness
4840890|NCT02384668|Quality of Life|quality of life
4840891|NCT02384668|Bone density and geometry|bone density and geometry
4840892|NCT02384668|Muscle strength and balance|muscle strength and balance
4840893|NCT02384655|Preterms|preterms
4840894|NCT02384655|Breastfeeding|breastfeeding
4840895|NCT02384655|Lactation|lactation
4840896|NCT02384655|Macronutrients|macronutrients
4840897|NCT02384642|Adolescent Health|adolescent health
4840898|NCT02384642|Democratic Republic of Congo|democratic republic of congo
4840899|NCT02384642|Sexual Violence|sexual violence
4840900|NCT02384616|Lung Volume Measurements|lung volume measurements
4840901|NCT02384616|airway resistance|airway resistance
4840902|NCT02384616|general anesthesia|general anesthesia
4840903|NCT02384564|Laryngoscopy|laryngoscopy
4840904|NCT02384564|Video Laryngoscopy|video laryngoscopy
4840905|NCT02384564|Tracheal intubation|tracheal intubation
4840906|NCT02384551|GERD|gerd
4840907|NCT02384551|diet|diet
4840908|NCT02384551|carbohydrate|carbohydrate
4840909|NCT02384551|obesity|obesity
4840910|NCT02384538|Osteoarthritis|osteoarthritis
4840911|NCT02384538|Joint diseases|joint diseases
4840912|NCT02384538|Musculoskeletal diseases|musculoskeletal diseases
4840913|NCT02384538|Rheumatic diseases|rheumatic diseases
4840914|NCT02384538|Arthritis|arthritis
4840915|NCT02384538|Osteoarthritis, Hand|osteoarthritis, hand
4840916|NCT02384525|Septic AKI|septic aki
4840917|NCT02384525|CRRT|crrt
4840918|NCT02384525|BIA|bia
4840919|NCT02384512|Parkinson's disease|parkinson's disease
4840920|NCT02384512|akinesia|akinesia
4840921|NCT02384512|Azilect®|azilect®
4840922|NCT02384512|Rasagiline|rasagiline
4840923|NCT02384512|Combination therapy with L-dopa|combination therapy with l-dopa
4840924|NCT02384512|Wearing-off Questionnaire-32|wearing-off questionnaire-32
4840925|NCT02384512|Quality of life|quality of life
4840926|NCT02384512|Daily practice|daily practice
4840927|NCT02384460|Simplex|simplex
4840928|NCT02384460|Recessive Dystrophic|recessive dystrophic
4840929|NCT02384460|Junctional non-Herlitz|junctional non-herlitz
4840930|NCT02384460|Epidermolysis Bullosa|epidermolysis bullosa
4840931|NCT02384447|above knee amputation|above knee amputation
4840932|NCT02384447|sciatic nerve|sciatic nerve
4840933|NCT02384447|ultrasonography|ultrasonography
4840934|NCT02384447|histology|histology
4840935|NCT02384408|menopause|menopause
4840936|NCT02384408|drospirenone|drospirenone
4840937|NCT02384408|tibolone|tibolone
4840938|NCT02384408|Bcl-2|bcl-2
4840939|NCT02384408|steroid receptors|steroid receptors
4840940|NCT02384395|Dolutegravir|dolutegravir
4840941|NCT02384395|Abacavir|abacavir
4840942|NCT02384395|Lamivudine|lamivudine
4840943|NCT02384395|acute HIV infection|acute hiv infection
4840944|NCT02384395|human leukocyte antigen|human leukocyte antigen
4840945|NCT02384395|latent HIV reservoir|latent hiv reservoir
4840946|NCT02384395|integrase-based regimen|integrase-based regimen
4840947|NCT02384395|viremia|viremia
4840948|NCT02384395|antiretroviral therapy|antiretroviral therapy
4840949|NCT02384395|fixed dose combination|fixed dose combination
4840950|NCT02384382|Cancer of the Prostate|cancer of the prostate
4840951|NCT02384356|Non-communicable diseases|non-communicable diseases
4840952|NCT02384356|Chronic disease|chronic disease
4840953|NCT02384356|Mobile health|mobile health
4840954|NCT02384356|Diabetes Mellitus|diabetes mellitus
4840955|NCT02384356|Hypertension|hypertension
4840956|NCT02384356|Bolivia|bolivia
4840957|NCT02384356|Longitudinal survey|longitudinal survey
4840958|NCT02384356|Health indicators|health indicators
4840959|NCT02384356|Primary care|primary care
4840960|NCT02384356|Ambulatory care|ambulatory care
4840961|NCT02384343|Dexmedetomidine|dexmedetomidine
4840962|NCT02384343|Cesarean section|cesarean section
4840963|NCT02384343|Anesthesia, Spinal|anesthesia, spinal
4840964|NCT02384343|Anesthesia, Epidural|anesthesia, epidural
4840965|NCT02384304|randomized controlled trial|randomized controlled trial
4840966|NCT02384304|alcohol|alcohol
4840967|NCT02384304|internet|internet
4840968|NCT02384304|internet based therapy|internet based therapy
4840969|NCT02384304|cognitive behavior therapy|cognitive behavior therapy
4840970|NCT02384278|alcohol use disorder|alcohol use disorder
4840971|NCT02384278|internet|internet
4840972|NCT02384278|cognitive behavior therapy|cognitive behavior therapy
4840973|NCT02384278|relapse prevention|relapse prevention
4840974|NCT02384265|Diabetes|diabetes
4840975|NCT02384265|Disparities|disparities
4840976|NCT02384265|Behavioral|behavioral
4840977|NCT02384265|Text messaging|text messaging
4840978|NCT02384265|Social networks|social networks
4840979|NCT02384265|African American|african american
4840980|NCT02384265|Female|female
4840981|NCT02384252|obese cardiomyopathy|obese cardiomyopathy
4840982|NCT02384252|mitochondria|mitochondria
4840983|NCT02384252|contractile dysfunction|contractile dysfunction
4840984|NCT02384226|mobile application|mobile application
4840985|NCT02384226|postpartum|postpartum
4840986|NCT02384226|weight loss|weight loss
4840987|NCT02384187|Gabapentin|gabapentin
4840988|NCT02384187|PONV|ponv
4840989|NCT02384187|Adenotonsillectomy|adenotonsillectomy
4840990|NCT02384187|Pediatrics|pediatrics
4840991|NCT02384174|Aging|aging
4840992|NCT02384174|Resistant starch|resistant starch
4840993|NCT02384174|Dietary fibre|dietary fibre
4840994|NCT02384174|Immune system|immune system
4840995|NCT02384174|Bacteria|bacteria
4840996|NCT02384174|older subjects|older subjects
4840997|NCT02384122|Angiodysplasias|angiodysplasias
4840998|NCT02384122|Sandostatin LAR|sandostatin lar
4840999|NCT02384122|Gastrointestinal|gastrointestinal
4841000|NCT02384122|Somatostatin|somatostatin
4841001|NCT02384122|Octreotide|octreotide
4841002|NCT02384096|stimulation|stimulation
4841003|NCT02384096|implantable|implantable
4841004|NCT02384096|pulse generator|pulse generator
4841005|NCT02384096|back pain|back pain
4841006|NCT02384096|chronic pain|chronic pain
4841007|NCT02384096|leg pain|leg pain
4841008|NCT02384083|Multiple Myeloma|multiple myeloma
4841009|NCT02384083|Pethema|pethema
4841010|NCT02384083|Filanesib|filanesib
4841011|NCT02384083|Pomalidomide|pomalidomide
4841012|NCT02384044|Sensitivity|sensitivity
4841013|NCT02383979|Phantom limb pain|phantom limb pain
4841014|NCT02383979|Mirror therapy|mirror therapy
4841015|NCT02383979|Elective amputation|elective amputation
4841016|NCT02383979|Residual limb pain|residual limb pain
4841017|NCT02383979|Functional MRI|functional mri
4841018|NCT02383953|twins|twins
4841019|NCT02383953|IBD|ibd
4841020|NCT02383953|UC|uc
4841021|NCT02383953|CD|cd
4841022|NCT02383875|nutrition economics|nutrition economics
4841023|NCT02383875|food expenditure|food expenditure
4841024|NCT02383875|nutritional quality|nutritional quality
4841025|NCT02383875|low income|low income
4841026|NCT02383862|Sleep|sleep
4841027|NCT02383862|Pain|pain
4841028|NCT02383862|Anxiety|anxiety
4841029|NCT02383862|Depression|depression
4841030|NCT02383862|Fatigue|fatigue
4841031|NCT02383862|PROMIS|promis
4841032|NCT02383862|primary care|primary care
4841033|NCT02383836|Patent Foramen Ovale|patent foramen ovale
4841034|NCT02383823|glucose, cholesterol, estrogen, gender, age|glucose, cholesterol, estrogen, gender, age
4841035|NCT02383810|Chemotherapy Induced Diarrhea (CID)|chemotherapy induced diarrhea (cid)
4841036|NCT02383771|Ticagrelor|ticagrelor
4841037|NCT02383771|Aspirin|aspirin
4841038|NCT02383771|Peri-operative treatment|peri-operative treatment
4841039|NCT02383758|Behavioral Symptoms|behavioral symptoms
4841040|NCT02383758|Child Development Disorders, Pervasive|child development disorders, pervasive
4841041|NCT02383758|Bowel Incontinence|bowel incontinence
4841042|NCT02383758|Constipation|constipation
4841043|NCT02383745|Acute EEG|acute eeg
4841044|NCT02383745|status epilepticus|status epilepticus
4841045|NCT02383745|seizure|seizure
4841046|NCT02383706|Sleep Apnea, Obstructive|sleep apnea, obstructive
4841047|NCT02383706|Pregnancy|pregnancy
4841048|NCT02383706|Obesity, Morbid|obesity, morbid
4841049|NCT02383706|Complications, pregnancy|complications, pregnancy
4841050|NCT02383693|depression|depression
4841051|NCT02383693|Repetitive Transcranial Magnetic Stimulation|repetitive transcranial magnetic stimulation
4841052|NCT02383693|tolerability|tolerability
4841053|NCT02383693|efficiency|efficiency
4841054|NCT02383693|TMS|tms
4841055|NCT02383693|refractory|refractory
4841056|NCT02383680|Methotrexate therapy|methotrexate therapy
4841057|NCT02383654|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
4841058|NCT02383654|Autologous Adipose-Tissue Derived Stem Cells (ADSCs)|autologous adipose-tissue derived stem cells (adscs)
4841059|NCT02383641|Wolman disease|wolman disease
4841060|NCT02383641|Biomarker|biomarker
4841061|NCT02383628|ICG Dye|icg dye
4841062|NCT02383628|endoscopic neurosurgery|endoscopic neurosurgery
4841063|NCT02383628|tissue perfusion|tissue perfusion
4841064|NCT02383602|6,000 Thai MSM and TG from study sites in Bangkok, Chiang Mai, Chonburi and Songkhla|6,000 thai msm and tg from study sites in bangkok, chiang mai, chonburi and songkhla
4841065|NCT02383550|Multiple Sclerosis|multiple sclerosis
4841066|NCT02383550|Cognition|cognition
4841067|NCT02383498|Overall Response Rate|overall response rate
4841068|NCT02383498|Immune Activation|immune activation
4841069|NCT02383498|Tumor Infiltrating Lymphocytes|tumor infiltrating lymphocytes
4841070|NCT02383498|T Cell Response|t cell response
4841071|NCT02383498|Cross-Over|cross-over
4841072|NCT02383485|arterial stiffness|arterial stiffness
4841073|NCT02383472|Concussion|concussion
4841074|NCT02383472|Mild Traumatic Brain Injury|mild traumatic brain injury
4841075|NCT02383472|MTBI|mtbi
4841076|NCT02383472|LED|led
4841077|NCT02383472|Light Emitting Diode|light emitting diode
4841078|NCT02383472|Headache|headache
4841079|NCT02383472|Brain Concussion|brain concussion
4841080|NCT02383446|Echeclon|echeclon
4841081|NCT02383446|Elan|elan
4841082|NCT02383446|TTA|tta
4841083|NCT02383446|Transtibial Amputee|transtibial amputee
4841084|NCT02383394|second trimesteric pregnancy loss|second trimesteric pregnancy loss
4841085|NCT02383368|Pharmacokinetics|pharmacokinetics
4841086|NCT02383368|ASP4132|asp4132
4841087|NCT02383368|Lymphoma|lymphoma
4841088|NCT02383368|Refractory Solid Tumors|refractory solid tumors
4841089|NCT02383355|Persistent immune activation|persistent immune activation
4841090|NCT02383355|Platelet hyperreactivity|platelet hyperreactivity
4841091|NCT02383342|Pain Processing|pain processing
4841092|NCT02383342|Genetic Factors|genetic factors
4841093|NCT02383342|Biomarkers|biomarkers
4841094|NCT02383329|malnutrition|malnutrition
4841095|NCT02383329|Underweight|underweight
4841096|NCT02383329|Oral Nutrition Supplements|oral nutrition supplements
4841097|NCT02383329|Children|children
4841098|NCT02383316|Insulin sensitivity|insulin sensitivity
4841099|NCT02383316|Metabolism|metabolism
4841100|NCT02383316|Noonan syndrome|noonan syndrome
4841101|NCT02383316|Shp2|shp2
4841102|NCT02383303|savings|savings
4841103|NCT02383303|assets|assets
4841104|NCT02383303|material hardship|material hardship
4841105|NCT02383303|poverty|poverty
4841106|NCT02383303|Individual Development Account|individual development account
4841107|NCT02383264|feeding intolerance|feeding intolerance
4841108|NCT02383264|preterm infants|preterm infants
4841109|NCT02383264|near infrared spectroscopy|near infrared spectroscopy
4841110|NCT02383238|Dapagliflozin|dapagliflozin
4841111|NCT02383238|diabetes mellitus|diabetes mellitus
4841112|NCT02383238|vascular|vascular
4841113|NCT02383225|American Indian|american indian
4841114|NCT02383225|Adolescent|adolescent
4841115|NCT02383225|Prevention|prevention
4841116|NCT02383212|Advanced cancerous growth|advanced cancerous growth
4841117|NCT02383173|end of life|end of life
4841118|NCT02383173|palliative care|palliative care
4841119|NCT02383173|implementation|implementation
4841120|NCT02383160|low-intensity pulsed ultrasound|low-intensity pulsed ultrasound
4841121|NCT02383160|nonunion|nonunion
4841122|NCT02383160|scaphoid|scaphoid
4841123|NCT02383147|Adult|adult
4841124|NCT02383147|Aged|aged
4841125|NCT02383147|Alpha Rhythm|alpha rhythm
4841126|NCT02383147|Auditory Cortex|auditory cortex
4841127|NCT02383147|Chronic|chronic
4841128|NCT02383147|Electroencephalography|electroencephalography
4841129|NCT02383147|Female|female
4841130|NCT02383147|Humans|humans
4841131|NCT02383147|Male|male
4841132|NCT02383147|Neurofeedback|neurofeedback
4841133|NCT02383147|Prospective Studies|prospective studies
4841134|NCT02383147|Questionnaires|questionnaires
4841135|NCT02383147|Tinnitus|tinnitus
4841136|NCT02383147|Treatment Outcome|treatment outcome
4841137|NCT02383095|Schizophrenia|schizophrenia
4841138|NCT02383095|Art-therapy|art-therapy
4841139|NCT02383095|Visual organization|visual organization
4841140|NCT02383069|Pulmonary rehabilitation|pulmonary rehabilitation
4841141|NCT02383069|Asthma|asthma
4841142|NCT02383069|Children|children
4841143|NCT02383069|Teenager|teenager
4841144|NCT02383069|Physical capacity|physical capacity
4841145|NCT02383056|wound|wound
4841146|NCT02383056|secondary intention healing|secondary intention healing
4841147|NCT02383056|lower extremity|lower extremity
4841148|NCT02383030|Breast cancer|breast cancer
4841149|NCT02383030|Metastatic|metastatic
4841150|NCT02383030|HER2 negative|her2 negative
4841151|NCT02383030|postmenopausal|postmenopausal
4841152|NCT02383030|maintenance therapy|maintenance therapy
4841153|NCT02383030|fulvestrant|fulvestrant
4841154|NCT02383017|Multi-ingredient performance supplement, High Intensity Interval Training, Concurrent training|multi-ingredient performance supplement, high intensity interval training, concurrent training
4841155|NCT02383004|myringotomy tubes|myringotomy tubes
4841156|NCT02383004|acupuncture|acupuncture
4841157|NCT02383004|emergence delirium|emergence delirium
4841158|NCT02383004|pediatrics|pediatrics
4841159|NCT02383004|general anesthesia|general anesthesia
4841160|NCT02382991|Moderately active amputees|moderately active amputees
4841161|NCT02382991|C-leg Compact|c-leg compact
4841162|NCT02382991|Knee prosthesis|knee prosthesis
4841163|NCT02382991|Kenevo|kenevo
4841164|NCT02382991|Microprocessor controlled knee|microprocessor controlled knee
4841165|NCT02382991|Amputation|amputation
4841166|NCT02382991|3C60|3c60
4841167|NCT02382991|TGUG|tgug
4841168|NCT02382991|LCI|lci
4841169|NCT02382991|QUEST|quest
4841170|NCT02382991|SF-36|sf-36
4841171|NCT02382952|Abdominal surgery|abdominal surgery
4841172|NCT02382952|Pelvic surgery|pelvic surgery
4841173|NCT02382952|Stoma takedown|stoma takedown
4841174|NCT02382952|Bowel resection|bowel resection
4841175|NCT02382952|Lysis of abdominal adhesions|lysis of abdominal adhesions
4841176|NCT02382926|capacitive electrocardiography|capacitive electrocardiography
4841177|NCT02382926|Eulerian Magnification Method|eulerian magnification method
4841178|NCT02382900|quadrivalent|quadrivalent
4841179|NCT02382900|vaccine|vaccine
4841180|NCT02382887|intubation|intubation
4841181|NCT02382887|difficult airway|difficult airway
4841182|NCT02382887|fiberscopy|fiberscopy
4841183|NCT02382887|Airtraq|airtraq
4841184|NCT02382887|general anesthesia|general anesthesia
4841185|NCT02382874|Idiopathic nephrotic syndrome|idiopathic nephrotic syndrome
4841186|NCT02382874|adipose derived mesenchymal stromal cell|adipose derived mesenchymal stromal cell
4841187|NCT02382874|Focal segmental glomerulosclerosis|focal segmental glomerulosclerosis
4841188|NCT02382861|Neurally adjusted ventilatory assist|neurally adjusted ventilatory assist
4841189|NCT02382861|Weaning|weaning
4841190|NCT02382861|Mechanical ventilation|mechanical ventilation
4841191|NCT02382861|Extubation|extubation
4841192|NCT02382848|Eating Disorders|eating disorders
4841193|NCT02382848|Bulimia Nervosa|bulimia nervosa
4841194|NCT02382848|Nightmares|nightmares
4841195|NCT02382848|Post Traumatic Stress Disorder|post traumatic stress disorder
4841196|NCT02382835|metal-on-metal|metal-on-metal
4841197|NCT02382809|Alveolar osteitis|alveolar osteitis
4841198|NCT02382809|Third molar|third molar
4841199|NCT02382809|Dry socket|dry socket
4841200|NCT02382809|Mouthwash|mouthwash
4841201|NCT02382809|third molar extraction|third molar extraction
4841202|NCT02382783|Rheumatoid Arthritis|rheumatoid arthritis
4841203|NCT02382783|Disease Activity|disease activity
4841204|NCT02382783|Flare|flare
4841205|NCT02382783|Management of Flares|management of flares
4841206|NCT02382783|Pfizer|pfizer
4841207|NCT02382744|Saphenous Nerve|saphenous nerve
4841208|NCT02382744|Nerve Block|nerve block
4841209|NCT02382744|Ultrasound guided|ultrasound guided
4841210|NCT02382744|Neurostimulation|neurostimulation
4841211|NCT02382744|Regional Anesthesia|regional anesthesia
4841212|NCT02382744|Ropivacaine|ropivacaine
4841213|NCT02382744|Foot Surgery|foot surgery
4841214|NCT02382744|Nerve Stimulation|nerve stimulation
4841215|NCT02382744|Ankle Surgery|ankle surgery
4841216|NCT02382718|fish allergy|fish allergy
4841217|NCT02382718|parvalbumin|parvalbumin
4841218|NCT02382718|immunotherapy|immunotherapy
4841219|NCT02382718|mCyp c 1|mcyp c 1
4841220|NCT02382705|capsule endoscopy|capsule endoscopy
4841221|NCT02382705|battery life|battery life
4841222|NCT02382705|completion rate|completion rate
4841223|NCT02382705|diagnostic yield|diagnostic yield
4841224|NCT02382640|Drug therapy|drug therapy
4841225|NCT02382614|Endobronchial Valve|endobronchial valve
4841226|NCT02382614|Minimally Invasive|minimally invasive
4841227|NCT02382614|Intrabronchial Valves|intrabronchial valves
4841228|NCT02382614|Digital Thoracic Drainage System|digital thoracic drainage system
4841229|NCT02382614|Spiration Valve System|spiration valve system
4841230|NCT02382614|Prolonged Air Leak|prolonged air leak
4841231|NCT02382614|Persistent Air Leak|persistent air leak
4841232|NCT02382601|Pregnancy|pregnancy
4841233|NCT02382601|IUGR|iugr
4841234|NCT02382601|Small for gestational age|small for gestational age
4841235|NCT02382562|Depression|depression
4841236|NCT02382562|Asthma|asthma
4841237|NCT02382562|Urticaria|urticaria
4841238|NCT02382549|vaccine|vaccine
4841239|NCT02382549|peptide|peptide
4841240|NCT02382549|dabrafenib|dabrafenib
4841241|NCT02382549|trametinib|trametinib
4841242|NCT02382549|Montanide ISA-51|montanide isa-51
4841243|NCT02382549|MEKINIST|mekinist
4841244|NCT02382549|Tafinlar|tafinlar
4841245|NCT02382536|Diabetes|diabetes
4841246|NCT02382536|Insulin therapy|insulin therapy
4841247|NCT02382536|insulin pump|insulin pump
4841248|NCT02382536|Infusion sets|infusion sets
4841249|NCT02382523|acthar|acthar
4841250|NCT02382523|proteinuria|proteinuria
4841251|NCT02382523|IgA nephropathy|iga nephropathy
4841252|NCT02382484|Hypertension Resistant to Conventional Therapy|hypertension resistant to conventional therapy
4841253|NCT02382471|atherosclerotic|atherosclerotic
4841254|NCT02382471|BDNF|bdnf
4841255|NCT02382471|Follistatin|follistatin
4841256|NCT02382471|Irisin|irisin
4841257|NCT02382432|Anesthesia|anesthesia
4841258|NCT02382432|dexmedetomidine|dexmedetomidine
4841259|NCT02382432|pethidine|pethidine
4841260|NCT02382432|shivering|shivering
4841261|NCT02382432|spinal|spinal
4841262|NCT02382406|MK-3475|mk-3475
4841263|NCT02382406|Pembrolizumab|pembrolizumab
4841264|NCT02382406|Carboplatin|carboplatin
4841265|NCT02382406|Nab-paclitaxel|nab-paclitaxel
4841266|NCT02382393|cognitive assessment|cognitive assessment
4841267|NCT02382393|Brain Performance Test|brain performance test
4841268|NCT02382393|Lumosity|lumosity
4841269|NCT02382393|concurrent validity|concurrent validity
4841270|NCT02382393|computerized assessment|computerized assessment
4841271|NCT02382380|Magnetic Resonance Imaging|magnetic resonance imaging
4841272|NCT02382380|Contrast Agent|contrast agent
4841273|NCT02382380|Gadoterate|gadoterate
4841274|NCT02382341|ACL|acl
4841275|NCT02382341|BIOSURE|biosure
4841276|NCT02382341|HEALICOIL|healicoil
4841277|NCT02382341|PEEK|peek
4841278|NCT02382341|In-Growth|in-growth
4841279|NCT02382315|fear of cancer recurrence|fear of cancer recurrence
4841280|NCT02382315|psychosocial intervention|psychosocial intervention
4841281|NCT02382315|randomized controlled clinical trial|randomized controlled clinical trial
4841282|NCT02382302|U-health|u-health
4841283|NCT02382302|chronic wound management|chronic wound management
4841284|NCT02382289|Radiofrequency|radiofrequency
4841285|NCT02382289|monopolar|monopolar
4841286|NCT02382289|bipolar|bipolar
4841287|NCT02382289|Sacroiliac Joint Arthropathy|sacroiliac joint arthropathy
4841288|NCT02382289|three different modalities|three different modalities
4841289|NCT02382263|Advanced pancreatic cancer|advanced pancreatic cancer
4841290|NCT02382263|Fragile|fragile
4841291|NCT02382263|Nab-paclitaxel|nab-paclitaxel
4841292|NCT02382237|denutrition in Head and Neck cancer or oesophageal cancer|denutrition in head and neck cancer or oesophageal cancer
4841293|NCT02382224|generalized anxiety disorder|generalized anxiety disorder
4841294|NCT02382224|anxiety|anxiety
4841295|NCT02382224|worry exposure|worry exposure
4841296|NCT02382224|treatment|treatment
4841297|NCT02382211|CMV|cmv
4841298|NCT02382198|droooling, sialorrhea, parkinson's disease, parkinsons|droooling, sialorrhea, parkinson's disease, parkinsons
4841299|NCT02382185|Cardiac output|cardiac output
4841300|NCT02382120|carbon dioxide|carbon dioxide
4841301|NCT02382120|cardiac output|cardiac output
4841302|NCT02382120|ventilation|ventilation
4841303|NCT02382120|thermodilution|thermodilution
4841304|NCT02382107|TB|tb
4841305|NCT02382107|Tuberculosis|tuberculosis
4841306|NCT02382107|Diagnostic study|diagnostic study
4841307|NCT02382094|curative intention|curative intention
4841308|NCT02382094|radiation Therapy|radiation therapy
4841309|NCT02382094|health related quality of life|health related quality of life
4841310|NCT02382055|Eating Disorders|eating disorders
4841311|NCT02382055|Psychotherapy|psychotherapy
4841312|NCT02382055|Anorexia Nervosa|anorexia nervosa
4841313|NCT02382055|Treatment|treatment
4841314|NCT02382042|Rural Health|rural health
4841315|NCT02382042|Veterans|veterans
4841316|NCT02382042|Substance Abuse|substance abuse
4841317|NCT02382003|Anxiety|anxiety
4841318|NCT02382003|Cognitive bias|cognitive bias
4841319|NCT02382003|Telemedicine|telemedicine
4841320|NCT02381990|Prostate|prostate
4841321|NCT02381990|PSA|psa
4841322|NCT02381990|FUSION|fusion
4841323|NCT02381990|Ultrasound|ultrasound
4841324|NCT02381990|MRI|mri
4841325|NCT02381990|Cancer|cancer
4841326|NCT02381990|Cryotherapy|cryotherapy
4841327|NCT02381990|Outcomes|outcomes
4841328|NCT02381990|Recurrence|recurrence
4841329|NCT02381990|QOL, Quality of Life|qol, quality of life
4841330|NCT02381990|Urinary function|urinary function
4841331|NCT02381990|Sexual Function|sexual function
4841332|NCT02381964|cerebral blood flow|cerebral blood flow
4841333|NCT02381964|cognitive function|cognitive function
4841334|NCT02381964|vitamins|vitamins
4841335|NCT02381964|energy expenditure|energy expenditure
4841336|NCT02381964|NIRS|nirs
4841337|NCT02381964|Indirect calorimetry|indirect calorimetry
4841338|NCT02381938|inactivity|inactivity
4841339|NCT02381938|behavior change|behavior change
4841340|NCT02381938|worksite wellness|worksite wellness
4841341|NCT02381938|child care|child care
4841342|NCT02381925|CT|ct
4841343|NCT02381925|Scintigraphy|scintigraphy
4841344|NCT02381925|Ultrasound|ultrasound
4841345|NCT02381899|chronic lymphocytic leukemia|chronic lymphocytic leukemia
4841346|NCT02381899|bendamustine|bendamustine
4841347|NCT02381899|rituximab|rituximab
4841348|NCT02381886|IDHR132 mutations|idhr132 mutations
4841349|NCT02381886|IDH305|idh305
4841350|NCT02381886|IDH|idh
4841351|NCT02381886|IDH1|idh1
4841352|NCT02381886|AML|aml
4841353|NCT02381886|Acute Myeloid Leukemia|acute myeloid leukemia
4841354|NCT02381886|Leukemia|leukemia
4841355|NCT02381886|Myeloid|myeloid
4841356|NCT02381886|Acute|acute
4841357|NCT02381886|MDS|mds
4841358|NCT02381886|Myelodysplastic Syndrome|myelodysplastic syndrome
4841359|NCT02381886|Glioma|glioma
4841360|NCT02381886|Oligodendroglioma|oligodendroglioma
4841361|NCT02381886|Astrocytoma|astrocytoma
4841362|NCT02381886|Glioblastoma|glioblastoma
4841363|NCT02381886|Cholangiocarcinoma|cholangiocarcinoma
4841364|NCT02381886|Solid Tumors|solid tumors
4841365|NCT02381873|Arthroplasty|arthroplasty
4841366|NCT02381873|Replacement|replacement
4841367|NCT02381873|Knee|knee
4841368|NCT02381873|Osteoarthritis|osteoarthritis
4841369|NCT02381847|gastric cancer|gastric cancer
4841370|NCT02381847|intraperitoneal chemoperfusion|intraperitoneal chemoperfusion
4841371|NCT02381834|Urine Specimen Collection|urine specimen collection
4841372|NCT02381834|Infant|infant
4841373|NCT02381834|Neonate|neonate
4841374|NCT02381834|Bacterial Infection|bacterial infection
4841375|NCT02381821|junctional zone|junctional zone
4841376|NCT02381821|Implantation|implantation
4841377|NCT02381821|Intracytoplasmic sperm injection|intracytoplasmic sperm injection
4841378|NCT02381717|ultrasound|ultrasound
4841379|NCT02381717|bupivacaine|bupivacaine
4841380|NCT02381717|femoral nerve block|femoral nerve block
4841381|NCT02381717|pain reduction|pain reduction
4841382|NCT02381678|Heart Valve Replacement|heart valve replacement
4841383|NCT02381678|Perimount 2900|perimount 2900
4841384|NCT02381678|China|china
4841385|NCT02381678|Perimount 6900P|perimount 6900p
4841386|NCT02381626|HEPA filter|hepa filter
4841387|NCT02381626|14-247|14-247
4841388|NCT02381613|Fish|fish
4841389|NCT02381613|Herring|herring
4841390|NCT02381613|Meat|meat
4841391|NCT02381613|Beef|beef
4841392|NCT02381600|vitamin D|vitamin d
4841393|NCT02381600|aging|aging
4841394|NCT02381600|cognitive function|cognitive function
4841395|NCT02381600|depression|depression
4841396|NCT02381600|executive function|executive function
4841397|NCT02381574|Lumbar Total Disk Replacement|lumbar total disk replacement
4841398|NCT02381522|remote ischemic preconditioning|remote ischemic preconditioning
4841399|NCT02381509|inferior vena cava filters|inferior vena cava filters
4841400|NCT02381496|ACT-453859|act-453859
4841401|NCT02381496|ACT-463036|act-463036
4841402|NCT02381496|Setipiprant|setipiprant
4841403|NCT02381496|Tolerability|tolerability
4841404|NCT02381496|safety|safety
4841405|NCT02381496|pharmacodynamics|pharmacodynamics
4841406|NCT02381496|pharmacokinetics|pharmacokinetics
4841407|NCT02381457|Microdeletion Syndrome|microdeletion syndrome
4841408|NCT02381457|Aneuploidy|aneuploidy
4841409|NCT02381457|22q|22q
4841410|NCT02381457|Non-Invasive Prenatal Screening|non-invasive prenatal screening
4841411|NCT02381457|DiGeorge Syndrome|digeorge syndrome
4841412|NCT02381444|Advanced Parkinson's Disease|advanced parkinson's disease
4841413|NCT02381444|Levodopa Carbidopa Intestinal Gel|levodopa carbidopa intestinal gel
4841414|NCT02381444|Observational Study|observational study
4841415|NCT02381444|Quality of life|quality of life
4841416|NCT02381444|Jejunal Percutaneous Endoscopic Gastrostomy|jejunal percutaneous endoscopic gastrostomy
4841417|NCT02381431|imaging|imaging
4841418|NCT02381431|diagnostic|diagnostic
4841419|NCT02381431|pediatrics|pediatrics
4841420|NCT02381418|Influenza|influenza
4841421|NCT02381418|Vaccine|vaccine
4841422|NCT02381418|Committee for Medicinal Products for Human Use (CHMP) criteria|committee for medicinal products for human use (chmp) criteria
4841423|NCT02381392|emergency medicine|emergency medicine
4841424|NCT02381392|infrared|infrared
4841425|NCT02381392|intravenous|intravenous
4841426|NCT02381379|CML|cml
4841427|NCT02381379|peginterferon|peginterferon
4841428|NCT02381379|stop|stop
4841429|NCT02381379|BCR-ABL|bcr-abl
4841430|NCT02381366|Mesenchymal Stem Cells|mesenchymal stem cells
4841431|NCT02381366|Human Umbilical Cord Blood|human umbilical cord blood
4841432|NCT02381366|Premature Infants|premature infants
4841433|NCT02381366|Bronchopulmonary Dysplasia|bronchopulmonary dysplasia
4841434|NCT02381366|Chronic Lung Disease|chronic lung disease
4841435|NCT02381366|Cell Therapy|cell therapy
4841436|NCT02381353|Enucleation|enucleation
4841437|NCT02381353|Evisceration|evisceration
4841438|NCT02381353|Exparel|exparel
4841439|NCT02381353|bupivacaine|bupivacaine
4841440|NCT02381340|Obesity|obesity
4841441|NCT02381340|Bariatric surgery|bariatric surgery
4841442|NCT02381340|Gastric plication|gastric plication
4841443|NCT02381340|Minimal invasive surgery|minimal invasive surgery
4841444|NCT02381340|gastrointestinal hormones|gastrointestinal hormones
4841445|NCT02381340|food-reward|food-reward
4841446|NCT02381340|satiety|satiety
4841447|NCT02381340|microbiota|microbiota
4841448|NCT02381327|Speed of eating|speed of eating
4841449|NCT02381327|body weight|body weight
4841450|NCT02381327|food intake|food intake
4841451|NCT02381314|Other B7-H3 expressing cancers|other b7-h3 expressing cancers
4841452|NCT02381301|Biological Markers|biological markers
4841453|NCT02381301|Multidetector Computed Tomography|multidetector computed tomography
4841454|NCT02381288|Drug therapy|drug therapy
4841455|NCT02381262|Fitbit|fitbit
4841456|NCT02381249|Esophagectomy|esophagectomy
4841457|NCT02381249|Gastrectomy|gastrectomy
4841458|NCT02381249|Octreotide|octreotide
4841459|NCT02381249|Somatostatin|somatostatin
4841460|NCT02381249|Appetite|appetite
4841461|NCT02381249|Hunger|hunger
4841462|NCT02381249|Glucagon-Like Peptide 1|glucagon-like peptide 1
4841463|NCT02381249|Peptide YY|peptide yy
4841464|NCT02381249|Reinforcement|reinforcement
4841465|NCT02381249|Reward|reward
4841466|NCT02381249|Psychological Phenomena and Processes|psychological phenomena and processes
4841467|NCT02381249|Gastrointestinal Agents|gastrointestinal agents
4841468|NCT02381249|Nutritional Status|nutritional status
4841469|NCT02381249|Pancreaticoduodenectomy|pancreaticoduodenectomy
4841470|NCT02381249|Whipple Procedure|whipple procedure
4841471|NCT02381210|Congo Red Dot Test|congo red dot test
4841472|NCT02381197|Congo Red Dot Test|congo red dot test
4841473|NCT02381171|myofacial pain|myofacial pain
4841474|NCT02381171|neuromodulation|neuromodulation
4841475|NCT02381171|repetitive transcranial magnetic stimulation|repetitive transcranial magnetic stimulation
4841476|NCT02381171|electroacupuncture|electroacupuncture
4841477|NCT02381158|Wheezing|wheezing
4841478|NCT02381158|Children|children
4841479|NCT02381145|Polyphenols|polyphenols
4841480|NCT02381145|Resveratrol|resveratrol
4841481|NCT02381145|Epigallocatechin-gallate|epigallocatechin-gallate
4841482|NCT02381145|Insulin sensitivity|insulin sensitivity
4841483|NCT02381145|mitochondrial function|mitochondrial function
4841484|NCT02381145|lipid oxidation|lipid oxidation
4841485|NCT02381145|tissue lipolysis|tissue lipolysis
4841486|NCT02381119|dietary services|dietary services
4841487|NCT02381119|personalized advice|personalized advice
4841488|NCT02381119|biological markers|biological markers
4841489|NCT02381106|arterial contractility|arterial contractility
4841490|NCT02381106|Uterine contractility|uterine contractility
4841491|NCT02381080|B-Cell Chronic Lymphocytic Leukemia|b-cell chronic lymphocytic leukemia
4841492|NCT02381080|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
4841493|NCT02381080|Small Lymphocytic Lymphoma|small lymphocytic lymphoma
4841494|NCT02381080|Marginal Zone Lymphoma|marginal zone lymphoma
4841495|NCT02381080|Mantle Cell Lymphoma|mantle cell lymphoma
4841496|NCT02381080|Follicular Lymphoma|follicular lymphoma
4841497|NCT02381080|Waldenstrom's Macroglobulinemia|waldenstrom's macroglobulinemia
4841498|NCT02381080|Ibrutinib|ibrutinib
4841499|NCT02381080|IMBRUVICA|imbruvica
4841500|NCT02381080|PCI-32765|pci-32765
4841501|NCT02381080|JNJ-54179060|jnj-54179060
4841502|NCT02381067|Cervical Fusion|cervical fusion
4841503|NCT02381067|NuCel|nucel
4841504|NCT02381067|Amniotic Allograft|amniotic allograft
4841505|NCT02381067|Prospective|prospective
4841506|NCT02381054|Patient reported outcomes|patient reported outcomes
4841507|NCT02381041|Rhinoplasty|rhinoplasty
4841508|NCT02381041|Topical Vasonconstrictor|topical vasonconstrictor
4841509|NCT02381041|Cocaine|cocaine
4841510|NCT02381041|Adrenaline|adrenaline
4841511|NCT02381028|Atopic eczema|atopic eczema
4841512|NCT02381028|Human milk|human milk
4841513|NCT02381028|Topical treatment|topical treatment
4841514|NCT02381028|Children|children
4841515|NCT02381015|Genetic testing|genetic testing
4841516|NCT02381015|Genomic testing|genomic testing
4841517|NCT02381015|Chemoprevention|chemoprevention
4841518|NCT02381015|Prostate Specific Antigen|prostate specific antigen
4841519|NCT02381015|Prostate Cancer|prostate cancer
4841520|NCT02381015|Predictive Genetic Testing|predictive genetic testing
4841521|NCT02381015|Genetic Counseling|genetic counseling
4841522|NCT02381015|Prostate-Specific Antigen|prostate-specific antigen
4841523|NCT02381002|Serum ferritin, physical exercise, Diet|serum ferritin, physical exercise, diet
4841524|NCT02380989|Ayurveda|ayurveda
4841525|NCT02380989|Acute pain|acute pain
4841526|NCT02380989|Sports Injury|sports injury
4841527|NCT02380963|Soy|soy
4841528|NCT02380963|Obesity|obesity
4841529|NCT02380963|Weight Loss|weight loss
4841530|NCT02380963|Muscle|muscle
4841531|NCT02380963|Cardiovascular Disease|cardiovascular disease
4841532|NCT02380963|Colorado Diet|colorado diet
4841533|NCT02380937|real-time MRI|real-time mri
4841534|NCT02380937|electrophysiology study|electrophysiology study
4841535|NCT02380937|atrial flutter|atrial flutter
4841536|NCT02380937|ablation|ablation
4841537|NCT02380937|active tracking|active tracking
4841538|NCT02380924|subjects|subjects
4841539|NCT02380911|Dyslipidemia|dyslipidemia
4841540|NCT02380911|Global cardiovascular risk|global cardiovascular risk
4841541|NCT02380911|Statins|statins
4841542|NCT02380911|Educational interventions|educational interventions
4841543|NCT02380885|severe mental illness|severe mental illness
4841544|NCT02380885|social cognition|social cognition
4841545|NCT02380885|intervention|intervention
4841546|NCT02380872|Gingival recession|gingival recession
4841547|NCT02380872|fibrin|fibrin
4841548|NCT02380872|connective tissue|connective tissue
4841549|NCT02380872|gingival crevicular fluid|gingival crevicular fluid
4841550|NCT02380872|matrix metalloproteinase|matrix metalloproteinase
4841551|NCT02380872|cytokine|cytokine
4841552|NCT02380859|problems of gait and balance|problems of gait and balance
4841553|NCT02380820|Mattress|mattress
4841554|NCT02380820|Preventing bed sores|preventing bed sores
4841555|NCT02380820|Skin pressure|skin pressure
4841556|NCT02380807|Paraspinal Muscles|paraspinal muscles
4841557|NCT02380807|Trigger Points|trigger points
4841558|NCT02380807|Randomized Controlled Trial|randomized controlled trial
4841559|NCT02380807|Mobility Limitation|mobility limitation
4841560|NCT02380794|Danshen Gegen Capsule|danshen gegen capsule
4841561|NCT02380768|Supraglottic airway|supraglottic airway
4841562|NCT02380768|Laryngeal mask airway|laryngeal mask airway
4841563|NCT02380768|Children|children
4841564|NCT02380755|Flow-mediated dilatation|flow-mediated dilatation
4841565|NCT02380755|Clomiphene citrate|clomiphene citrate
4841566|NCT02380755|sICAM-1|sicam-1
4841567|NCT02380755|sVCAM-1|svcam-1
4841568|NCT02380755|sE- Selectin|se- selectin
4841569|NCT02380755|Endothelial function|endothelial function
4841570|NCT02380755|Cardiovascular risk|cardiovascular risk
4841571|NCT02380755|Endocrine System Diseases|endocrine system diseases
4841572|NCT02380755|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators
4841573|NCT02380755|Estrogen Receptor Modulators|estrogen receptor modulators
4841574|NCT02380755|Infertility, Male|infertility, male
4841575|NCT02380755|Endothelial Progenitor Cells|endothelial progenitor cells
4841576|NCT02380755|Obesity|obesity
4841577|NCT02380755|Testosterone|testosterone
4841578|NCT02380742|Pessary|pessary
4841579|NCT02380742|Pain|pain
4841580|NCT02380742|EMLA|emla
4841581|NCT02380742|lidocaine|lidocaine
4841582|NCT02380742|prilocaine|prilocaine
4841583|NCT02380729|Health care delivery|health care delivery
4841584|NCT02380729|Human Phenotype Ontology|human phenotype ontology
4841585|NCT02380729|Mutation prioritization|mutation prioritization
4841586|NCT02380729|Next Generation Sequencing|next generation sequencing
4841587|NCT02380729|Mutation detection|mutation detection
4841588|NCT02380729|Bioinformatic analysis|bioinformatic analysis
4841589|NCT02380729|Quality of life|quality of life
4841590|NCT02380703|aggression|aggression
4841591|NCT02380703|dementia|dementia
4841592|NCT02380703|Alzheimer's disease|alzheimer's disease
4841593|NCT02380703|pain|pain
4841594|NCT02380703|depression|depression
4841595|NCT02380703|caregiver|caregiver
4841596|NCT02380703|behavioral health|behavioral health
4841597|NCT02380703|counseling|counseling
4841598|NCT02380690|self-management|self-management
4841599|NCT02380690|peer support|peer support
4841600|NCT02380690|social support|social support
4841601|NCT02380664|swimmers|swimmers
4841602|NCT02380664|adolescent swimmers|adolescent swimmers
4841603|NCT02380664|whole-body vibration|whole-body vibration
4841604|NCT02380664|bone and bones|bone and bones
4841605|NCT02380664|body composition|body composition
4841606|NCT02380625|Ebola|ebola
4841607|NCT02380625|EVD|evd
4841608|NCT02380625|Adaptive design|adaptive design
4841609|NCT02380625|therapeutics|therapeutics
4841610|NCT02380612|Second Degree Burn Injuries|second degree burn injuries
4841611|NCT02380599|Spinal Manipulation|spinal manipulation
4841612|NCT02380599|Mobilization|mobilization
4841613|NCT02380599|Autonomic Nervous System|autonomic nervous system
4841614|NCT02380573|methylene blue|methylene blue
4841615|NCT02380573|fMRI|fmri
4841616|NCT02380560|myometrial thickness|myometrial thickness
4841617|NCT02380560|Preterm premature rupture of membranes|preterm premature rupture of membranes
4841618|NCT02380560|Preterm Labour|preterm labour
4841619|NCT02380547|Sonography|sonography
4841620|NCT02380547|Diaphragmatic function|diaphragmatic function
4841621|NCT02380547|Non invasive ventilation|non invasive ventilation
4841622|NCT02380547|Critical care patients|critical care patients
4841623|NCT02380547|Extubation after 24 hours of invasive ventilation|extubation after 24 hours of invasive ventilation
4841624|NCT02380534|High level of Lp(a)|high level of lp(a)
4841625|NCT02380521|Exenatide once weekly|exenatide once weekly
4841626|NCT02380521|T2DM|t2dm
4841627|NCT02380521|IMT|imt
4841628|NCT02380521|Atherogenic lipoproteins|atherogenic lipoproteins
4841629|NCT02380508|BCG study|bcg study
4841630|NCT02380495|Adolescents|adolescents
4841631|NCT02380495|Respiratory Pathology|respiratory pathology
4841632|NCT02380482|Traumatic brain injury|traumatic brain injury
4841633|NCT02380482|Myocardial dysfunction|myocardial dysfunction
4841634|NCT02380482|Transthoracic echocardiography|transthoracic echocardiography
4841635|NCT02380482|Speckle tracking|speckle tracking
4841636|NCT02380469|Caregivers|caregivers
4841637|NCT02380469|Cancer|cancer
4841638|NCT02380469|Information|information
4841639|NCT02380469|Intervention|intervention
4841640|NCT02380469|Randomised trial|randomised trial
4841641|NCT02380443|colorectal cancer|colorectal cancer
4841642|NCT02380443|KRAS mutant|kras mutant
4841643|NCT02380443|BRAF mutant|braf mutant
4841644|NCT02380443|metastatic|metastatic
4841645|NCT02380443|liver metastasis|liver metastasis
4841646|NCT02380443|AlloStim®|allostim®
4841647|NCT02380443|cryoablation|cryoablation
4841648|NCT02380443|cancer vaccine|cancer vaccine
4841649|NCT02380443|immunotherapy|immunotherapy
4841650|NCT02380430|Ambulatory surgery|ambulatory surgery
4841651|NCT02380430|Pain management|pain management
4841652|NCT02380430|Nausea and vomiting management|nausea and vomiting management
4841653|NCT02380430|Questionnaire|questionnaire
4841654|NCT02380430|Survey|survey
4841655|NCT02380430|Management|management
4841656|NCT02380404|Edentulous maxilla|edentulous maxilla
4841657|NCT02380391|Platelet reactivity|platelet reactivity
4841658|NCT02380391|Acute coronary syndrome|acute coronary syndrome
4841659|NCT02380391|Antiplatelet treatment|antiplatelet treatment
4841660|NCT02380391|Antiretroviral treatment|antiretroviral treatment
4841661|NCT02380391|HIV|hiv
4841662|NCT02380365|lung transplantation|lung transplantation
4841663|NCT02380365|electrocardiography|electrocardiography
4841664|NCT02380365|macrolides|macrolides
4841665|NCT02380365|QTc interval|qtc interval
4841666|NCT02380365|arrhythmia|arrhythmia
4841667|NCT02380352|antibiotic stewardship|antibiotic stewardship
4841668|NCT02380352|non-inferiority|non-inferiority
4841669|NCT02380352|randomized controlled trial|randomized controlled trial
4841670|NCT02380313|Metastatic Castration-Resistant Prostate Cancer|metastatic castration-resistant prostate cancer
4841671|NCT02380313|Enzalutamide|enzalutamide
4841672|NCT02380313|Abiraterone|abiraterone
4841673|NCT02380313|Dose-Finding|dose-finding
4841674|NCT02380313|Afuresertib|afuresertib
4841675|NCT02380287|interleukin-17|interleukin-17
4841676|NCT02380287|maximum tolerated dose|maximum tolerated dose
4841677|NCT02380287|novel monoclonal antibody|novel monoclonal antibody
4841678|NCT02380274|Prostate Cancer|prostate cancer
4841679|NCT02380274|Castration-resistant Prostate Cancer|castration-resistant prostate cancer
4841680|NCT02380274|Metastatic Prostate Cancer|metastatic prostate cancer
4841681|NCT02380222|Systemic mastocytosis|systemic mastocytosis
4841682|NCT02380222|Patient-reported outcome (PRO)|patient-reported outcome (pro)
4841683|NCT02380209|breast cancer|breast cancer
4841684|NCT02380209|CEST MRI|cest mri
4841685|NCT02380183|anesthesia|anesthesia
4841686|NCT02380183|nerve block|nerve block
4841687|NCT02380183|needle guidance|needle guidance
4841688|NCT02380170|sepsis|sepsis
4841689|NCT02380170|urinary tract infection|urinary tract infection
4841690|NCT02380170|resistance|resistance
4841691|NCT02380170|pathogens|pathogens
4841692|NCT02380170|mortality|mortality
4841693|NCT02380170|health economics|health economics
4841694|NCT02380157|Blood pressure|blood pressure
4841695|NCT02380157|Potassium, Dietary|potassium, dietary
4841696|NCT02380157|Renin-angiotensin-aldosterone system|renin-angiotensin-aldosterone system
4841697|NCT02380157|Sympathetic nervous system|sympathetic nervous system
4841698|NCT02380144|carotenoid|carotenoid
4841699|NCT02380144|bioavailability|bioavailability
4841700|NCT02380144|beta-cryptoxanthin|beta-cryptoxanthin
4841701|NCT02380144|flavonoid|flavonoid
4841702|NCT02380144|hesperidin|hesperidin
4841703|NCT02380144|narirutin|narirutin
4841704|NCT02380144|randomized cross-over|randomized cross-over
4841705|NCT02380144|Pharmacokinetics|pharmacokinetics
4841706|NCT02380144|micronutrients|micronutrients
4841707|NCT02380144|Oranges/Orange Juice|oranges/orange juice
4841708|NCT02380131|XELOX|xelox
4841709|NCT02380131|Herceptin|herceptin
4841710|NCT02380131|Potentially Resectable Gastric Cancer|potentially resectable gastric cancer
4841711|NCT02380118|emergency|emergency
4841712|NCT02380118|emergency medicine|emergency medicine
4841713|NCT02380118|sedation|sedation
4841714|NCT02380118|acute agitation|acute agitation
4841715|NCT02380092|Knee|knee
4841716|NCT02380092|Post-Market Surveillance|post-market surveillance
4841717|NCT02380092|Legion|legion
4841718|NCT02380092|Verilast|verilast
4841719|NCT02380092|Degenerative Joint Disease|degenerative joint disease
4841720|NCT02380079|Homozygous Sickle Cell Disease S/Beta 0 Thalassemia|homozygous sickle cell disease s/beta 0 thalassemia
4841721|NCT02380053|Beta-blocker|beta-blocker
4841722|NCT02380053|Cardiopulmonary exercise testing|cardiopulmonary exercise testing
4841723|NCT02380027|Prostate biopsy|prostate biopsy
4841724|NCT02380027|MRI|mri
4841725|NCT02380027|transrectal|transrectal
4841726|NCT02380027|Detection|detection
4841727|NCT02380001|Postoperative pain|postoperative pain
4841728|NCT02380001|Dexketoprofen trometamol|dexketoprofen trometamol
4841729|NCT02380001|third molar surgery|third molar surgery
4841730|NCT02379962|biobanking|biobanking
4841731|NCT02379962|research participation|research participation
4841732|NCT02379962|China|china
4841733|NCT02379949|virtual reality exposure therapy|virtual reality exposure therapy
4841734|NCT02379949|social phobia|social phobia
4841735|NCT02379949|social anxiety disorder|social anxiety disorder
4841736|NCT02379949|cognitive behavioral therapy|cognitive behavioral therapy
4841737|NCT02379936|Classification|classification
4841738|NCT02379936|HIE|hie
4841739|NCT02379936|Infections|infections
4841740|NCT02379936|Lactate dehydrogenase|lactate dehydrogenase
4841741|NCT02379936|Intensive Care|intensive care
4841742|NCT02379884|Mechanical ventilation|mechanical ventilation
4841743|NCT02379884|Elderly|elderly
4841744|NCT02379884|Mortality|mortality
4841745|NCT02379884|Health services|health services
4841746|NCT02379871|Thoracic Spinal Manipulation, Autonomic Nervous System|thoracic spinal manipulation, autonomic nervous system
4841747|NCT02379858|GI Tract Recovery|gi tract recovery
4841748|NCT02379858|Hospital Discharge|hospital discharge
4841749|NCT02379832|preeclampsia|preeclampsia
4841750|NCT02379832|preterm birth|preterm birth
4841751|NCT02379832|pregnancy|pregnancy
4841752|NCT02379832|placenta|placenta
4841753|NCT02379832|intra-uterine growth restriction|intra-uterine growth restriction
4841754|NCT02379832|fetal growth restriction|fetal growth restriction
4841755|NCT02379832|ultrasound|ultrasound
4841756|NCT02379832|doppler|doppler
4841757|NCT02379832|biomarkers|biomarkers
4841758|NCT02379832|serum|serum
4841759|NCT02379832|PAPP-A|papp-a
4841760|NCT02379832|PlGF|plgf
4841761|NCT02379832|sFlt-1|sflt-1
4841762|NCT02379832|endoglin|endoglin
4841763|NCT02379793|LEO 80185 gel|leo 80185 gel
4841764|NCT02379793|calcipotriol|calcipotriol
4841765|NCT02379793|betamethasone|betamethasone
4841766|NCT02379754|vestibular schwannoma|vestibular schwannoma
4841767|NCT02379754|acoustic neuroma|acoustic neuroma
4841768|NCT02379754|cerebellopontine angle tumour|cerebellopontine angle tumour
4841769|NCT02379754|gentamicin|gentamicin
4841770|NCT02379754|rehabilitation|rehabilitation
4841771|NCT02379754|postural balance|postural balance
4841772|NCT02379741|Antibodies|antibodies
4841773|NCT02379741|Antibodies, Monoclonal|antibodies, monoclonal
4841774|NCT02379741|Antineoplastic agent|antineoplastic agent
4841775|NCT02379741|Physiological effects of drugs|physiological effects of drugs
4841776|NCT02379741|Therapeutic uses|therapeutic uses
4841777|NCT02379741|Clinical Trial, Phase I|clinical trial, phase i
4841778|NCT02379741|Immunotherapy, Active|immunotherapy, active
4841779|NCT02379741|CD40 Antigen|cd40 antigen
4841780|NCT02379741|Immunologic Factors|immunologic factors
4841781|NCT02379741|Injections, Intralesional|injections, intralesional
4841782|NCT02379728|positional therapy|positional therapy
4841783|NCT02379728|tennis ball technique|tennis ball technique
4841784|NCT02379728|sleep pregnancy|sleep pregnancy
4841785|NCT02379728|supine position|supine position
4841786|NCT02379728|supine|supine
4841787|NCT02379728|sleep position|sleep position
4841788|NCT02379728|low birth weight|low birth weight
4841789|NCT02379728|stillbirth|stillbirth
4841790|NCT02379728|intrauterine growth restriction|intrauterine growth restriction
4841791|NCT02379715|Remifentanil|remifentanil
4841792|NCT02379715|smooth induction|smooth induction
4841793|NCT02379715|desflurane|desflurane
4841794|NCT02379689|psychosocial state|psychosocial state
4841795|NCT02379637|N-acetylcysteine|n-acetylcysteine
4841796|NCT02379637|adults|adults
4841797|NCT02379637|cough and cold|cough and cold
4841798|NCT02379572|5-ALA|5-ala
4841799|NCT02379572|Intraoperative MRI|intraoperative mri
4841800|NCT02379572|Extent of resection|extent of resection
4841801|NCT02379559|prostate cancer|prostate cancer
4841802|NCT02379559|African-American|african-american
4841803|NCT02379559|Metabolic Syndrome|metabolic syndrome
4841804|NCT02379559|Exercise|exercise
4841805|NCT02379559|Men's Health|men's health
4841806|NCT02379546|reflex, oculocardiac|reflex, oculocardiac
4841807|NCT02379546|monitoring, intraoperative|monitoring, intraoperative
4841808|NCT02379520|recurrent cancer|recurrent cancer
4841809|NCT02379520|refractory cancer|refractory cancer
4841810|NCT02379520|virus specific T-cells|virus specific t-cells
4841811|NCT02379520|gene therapy|gene therapy
4841812|NCT02379520|HPV|hpv
4841813|NCT02379507|mild to moderate|mild to moderate
4841814|NCT02379468|Diabetic|diabetic
4841815|NCT02379468|Foot|foot
4841816|NCT02379468|Ulcer|ulcer
4841817|NCT02379455|Polypharmacy|polypharmacy
4841818|NCT02379455|Geriatrics|geriatrics
4841819|NCT02379455|Elderly|elderly
4841820|NCT02379455|Drug review|drug review
4841821|NCT02379442|Graft-Versus-Host Disease|graft-versus-host disease
4841822|NCT02379442|Corticosteroids|corticosteroids
4841823|NCT02379442|Mesenchymal Stromal Cell|mesenchymal stromal cell
4841824|NCT02379442|Adoptive Cellular Therapy|adoptive cellular therapy
4841825|NCT02379429|Specimen Collection|specimen collection
4841826|NCT02379429|Urine|urine
4841827|NCT02379429|Blood|blood
4841828|NCT02379429|Saliva|saliva
4841829|NCT02379416|Drug Efflux|drug efflux
4841830|NCT02379416|Taxanes|taxanes
4841831|NCT02379416|Combination|combination
4841832|NCT02379416|Bcr-Abl Kinase Inhibitors|bcr-abl kinase inhibitors
4841833|NCT02379416|Neoplasms|neoplasms
4841834|NCT02379403|Flavonoid|flavonoid
4841835|NCT02379403|Vascular|vascular
4841836|NCT02379403|Biomarkers|biomarkers
4841837|NCT02379403|Arterial Stiffness|arterial stiffness
4841838|NCT02379403|Nutrigenomics|nutrigenomics
4841839|NCT02379364|Physiotherapy|physiotherapy
4841840|NCT02379364|Patellofemoral Pain Syndrome|patellofemoral pain syndrome
4841841|NCT02379364|Manual therapy|manual therapy
4841842|NCT02379351|Non-stress Test|non-stress test
4841843|NCT02379351|Fetal Monitoring|fetal monitoring
4841844|NCT02379351|Telemedicine|telemedicine
4841845|NCT02379338|Dopamine D3 receptor|dopamine d3 receptor
4841846|NCT02379312|Foams|foams
4841847|NCT02379312|Satiety|satiety
4841848|NCT02379312|Appetite|appetite
4841849|NCT02379247|HER-2 Negative|her-2 negative
4841850|NCT02379247|Metastatic Breast Cancer|metastatic breast cancer
4841851|NCT02379234|CVVH|cvvh
4841852|NCT02379234|Renal replacement therapy|renal replacement therapy
4841853|NCT02379234|High fidelity simulation|high fidelity simulation
4841854|NCT02379234|Nurse training|nurse training
4841855|NCT02379208|Visual Field Tests|visual field tests
4841856|NCT02379208|Ocular Hypertension|ocular hypertension
4841857|NCT02379208|Glaucoma, Open-Angle|glaucoma, open-angle
4841858|NCT02379208|Quality of Life|quality of life
4841859|NCT02379208|Glaucoma progression|glaucoma progression
4841860|NCT02379208|Early glaucoma|early glaucoma
4841861|NCT02379208|Frequency Doubling Technology (FDT)|frequency doubling technology (fdt)
4841862|NCT02379208|RareBit|rarebit
4841863|NCT02379208|Octopus 900 perimetry|octopus 900 perimetry
4841864|NCT02379182|dysphagia|dysphagia
4841865|NCT02379182|VitalStim|vitalstim
4841866|NCT02379182|electrical stimulation|electrical stimulation
4841867|NCT02379169|macular pigment optical density, age related macular degeneration, dry eye, vision|macular pigment optical density, age related macular degeneration, dry eye, vision
4841868|NCT02379156|Quadriplegia|quadriplegia
4841869|NCT02379156|Spinal Cord Injury|spinal cord injury
4841870|NCT02379156|Body Temperature Regulation|body temperature regulation
4841871|NCT02379156|Mild Cognitive Impairment|mild cognitive impairment
4841872|NCT02379143|SWD, EPA, SAFE PRACTICE|swd, epa, safe practice
4841873|NCT02379130|Premature|premature
4841874|NCT02379130|Family Nurture Intervention|family nurture intervention
4841875|NCT02379091|Drug therapy|drug therapy
4841876|NCT02379078|Shared decision-making|shared decision-making
4841877|NCT02379078|Priority setting|priority setting
4841878|NCT02379078|Patient decision aid|patient decision aid
4841879|NCT02379078|Interprofessional care|interprofessional care
4841880|NCT02379078|Diabetes mellitus|diabetes mellitus
4841881|NCT02379078|Patient education|patient education
4841882|NCT02379078|Medical informatics|medical informatics
4841883|NCT02379078|Toolkit development|toolkit development
4841884|NCT02379078|Study protocol|study protocol
4841885|NCT02379078|User-centred design|user-centred design
4841886|NCT02379078|Qualitative methods|qualitative methods
4841887|NCT02379013|Fatigue|fatigue
4841888|NCT02379013|functional MRI|functional mri
4841889|NCT02378987|cerebral palsy|cerebral palsy
4841890|NCT02378987|language|language
4841891|NCT02378987|acoustic|acoustic
4841892|NCT02378987|motor speech|motor speech
4841893|NCT02378987|follow-up|follow-up
4841894|NCT02378974|Cerebral Infarction|cerebral infarction
4841895|NCT02378974|Mesenchymal Stem Cells|mesenchymal stem cells
4841896|NCT02378974|Stroke|stroke
4841897|NCT02378948|Esophagectomy|esophagectomy
4841898|NCT02378948|Nutrition|nutrition
4841899|NCT02378948|Oral feeding|oral feeding
4841900|NCT02378948|Enteral feeding|enteral feeding
4841901|NCT02378948|Pulmonary complications|pulmonary complications
4841902|NCT02378948|Anastomotic leakage|anastomotic leakage
4841903|NCT02378948|Quality of life|quality of life
4841904|NCT02378896|Cognitive Behavioral Therapy|cognitive behavioral therapy
4841905|NCT02378883|Apollo|apollo
4841906|NCT02378883|Onyx|onyx
4841907|NCT02378883|arteriovenous malformation|arteriovenous malformation
4841908|NCT02378883|AVM|avm
4841909|NCT02378883|Onyx™ Liquid Embolic System|onyx™ liquid embolic system
4841910|NCT02378883|Apollo™ Onyx™ Delivery Micro Catheter|apollo™ onyx™ delivery micro catheter
4841911|NCT02378883|Brain Diseases|brain diseases
4841912|NCT02378870|CRPC|crpc
4841913|NCT02378857|Univentricular heart defect|univentricular heart defect
4841914|NCT02378857|Fontan circulation|fontan circulation
4841915|NCT02378831|diagnosing sleep|diagnosing sleep
4841916|NCT02378818|Schizophrenia|schizophrenia
4841917|NCT02378818|Negative symptoms|negative symptoms
4841918|NCT02378818|Lack of motivation|lack of motivation
4841919|NCT02378818|Cognitive characterization|cognitive characterization
4841920|NCT02378818|Computational psychiatry|computational psychiatry
4841921|NCT02378818|Depression|depression
4841922|NCT02378805|Alport syndrome|alport syndrome
4841923|NCT02378805|thin basement membrane disease|thin basement membrane disease
4841924|NCT02378805|familial benign hematuria|familial benign hematuria
4841925|NCT02378792|PINS VNS Refractory Epilepsy|pins vns refractory epilepsy
4841926|NCT02378779|Premature ejaculation|premature ejaculation
4841927|NCT02378779|general practice|general practice
4841928|NCT02378779|sexual dysfunction|sexual dysfunction
4841929|NCT02378766|tailored web-based intervention|tailored web-based intervention
4841930|NCT02378766|health behavior|health behavior
4841931|NCT02378766|hiv comorbidities|hiv comorbidities
4841932|NCT02378766|online trial|online trial
4841933|NCT02378753|Ebola|ebola
4841934|NCT02378753|Sierra Leone|sierra leone
4841935|NCT02378753|vaccine|vaccine
4841936|NCT02378753|rVSVΔG-ZEBOV|rvsvδg-zebov
4841937|NCT02378740|Anesthesia|anesthesia
4841938|NCT02378740|Cervical Fusion|cervical fusion
4842144|NCT02377713|single dose|single dose
4841939|NCT02378740|Quality of Recovery|quality of recovery
4841940|NCT02378740|Ketamine Infusion|ketamine infusion
4841941|NCT02378714|Smoking Cessation|smoking cessation
4841942|NCT02378714|Major Depressive Disorder|major depressive disorder
4841943|NCT02378714|Nicotine Dependence|nicotine dependence
4841944|NCT02378714|Varenicline|varenicline
4841945|NCT02378714|Behavioral Activation Therapy|behavioral activation therapy
4841946|NCT02378714|Cigarette Smoking|cigarette smoking
4841947|NCT02378701|Leukemia|leukemia
4841948|NCT02378701|Myelodysplastic syndrome|myelodysplastic syndrome
4841950|NCT02378701|Low- or intermediate-1-risk|low- or intermediate-1-risk
4841951|NCT02378701|Chronic Myelomonocytic Leukemia -1|chronic myelomonocytic leukemia -1
4841952|NCT02378701|CMML-1|cmml-1
4841953|NCT02378701|Quality of Life in Myelodysplasia Scale|quality of life in myelodysplasia scale
4841954|NCT02378701|QUALMS-1|qualms-1
4841955|NCT02378701|Anemia Subset of FACT|anemia subset of fact
4841956|NCT02378701|FACT-An|fact-an
4841957|NCT02378701|Questionnaires|questionnaires
4841958|NCT02378701|Surveys|surveys
4841959|NCT02378688|Crohn's Disease|crohn's disease
4841960|NCT02378675|Adipocytokines|adipocytokines
4841961|NCT02378662|Peritoneal Dialysis|peritoneal dialysis
4841962|NCT02378662|End Stage Renal Disease|end stage renal disease
4841963|NCT02378662|Anemia|anemia
4841964|NCT02378649|Pulmonary Hypertension|pulmonary hypertension
4841965|NCT02378623|paradoxical embolism|paradoxical embolism
4841966|NCT02378623|lead thrombus|lead thrombus
4841967|NCT02378623|ICD|icd
4841968|NCT02378623|Pacemaker|pacemaker
4841969|NCT02378623|Cognitive decline|cognitive decline
4841970|NCT02378623|Stroke|stroke
4841971|NCT02378623|TIA|tia
4841972|NCT02378597|Resiliency burnout stress|resiliency burnout stress
4841973|NCT02378571|Medication adherence|medication adherence
4841974|NCT02378571|Hospital readmissions|hospital readmissions
4841975|NCT02378558|Breast Surgery|breast surgery
4841976|NCT02378545|Sepsis|sepsis
4841977|NCT02378545|Hyperoxia|hyperoxia
4841978|NCT02378545|Sepsis Six|sepsis six
4841979|NCT02378545|Oxygen delivery|oxygen delivery
4841980|NCT02378532|Glioblastoma|glioblastoma
4841981|NCT02378532|Chloroquine|chloroquine
4841982|NCT02378532|Autophagy|autophagy
4841983|NCT02378532|EGFRvIII|egfrviii
4841984|NCT02378532|Radiotherapy|radiotherapy
4841985|NCT02378532|Temozolomide|temozolomide
4841986|NCT02378519|Low back pain,|low back pain,
4841987|NCT02378519|neck pain,|neck pain,
4841988|NCT02378519|chronic pain|chronic pain
4841989|NCT02378519|SSED|ssed
4841990|NCT02378519|Pilot project|pilot project
4841991|NCT02378519|interactive web-based self-help programme|interactive web-based self-help programme
4841992|NCT02378519|CBT-coaching|cbt-coaching
4841993|NCT02378519|physiotherapy|physiotherapy
4841994|NCT02378493|Antibiogramme|antibiogramme
4841995|NCT02378493|Antibiofilmogramme|antibiofilmogramme
4841996|NCT02378467|Cystic Fibrosis|cystic fibrosis
4841997|NCT02378467|Hypertonic Saline|hypertonic saline
4841998|NCT02378467|Inhaled Saline|inhaled saline
4841999|NCT02378467|Digestive System Diseases|digestive system diseases
4842000|NCT02378467|Genetic Diseases, Inborn|genetic diseases, inborn
4842001|NCT02378467|Lung Diseases|lung diseases
4842002|NCT02378467|Pancreatic Diseases|pancreatic diseases
4842003|NCT02378467|Pathologic Processes|pathologic processes
4842004|NCT02378467|Respiratory Tract Diseases|respiratory tract diseases
4842005|NCT02378454|Lung Clearance Index|lung clearance index
4842006|NCT02378454|Cystic Fibrosis|cystic fibrosis
4842007|NCT02378454|Multiple Breath Nitrogen Washout|multiple breath nitrogen washout
4842008|NCT02378441|volunteers|volunteers
4842009|NCT02378428|Neuroblastoma|neuroblastoma
4842010|NCT02378415|Depression|depression
4842011|NCT02378402|Creatine|creatine
4842012|NCT02378402|heart failure|heart failure
4842013|NCT02378402|lipid|lipid
4842014|NCT02378402|MRS|mrs
4842015|NCT02378402|myocardium|myocardium
4842016|NCT02378324|Attendance|attendance
4842017|NCT02378324|Screening without fee|screening without fee
4842018|NCT02378311|Bike|bike
4842019|NCT02378311|Bicycle|bicycle
4842020|NCT02378311|Scooter|scooter
4842021|NCT02378311|Handlebar|handlebar
4842022|NCT02378285|recent lateral humeral epicondylitis|recent lateral humeral epicondylitis
4842023|NCT02378285|platelet-rich plasma|platelet-rich plasma
4842024|NCT02378285|infiltration|infiltration
4842025|NCT02378285|tennis elbow|tennis elbow
4842026|NCT02378285|ultrasonography|ultrasonography
4842027|NCT02378272|Care Manager|care manager
4842028|NCT02378272|Primary Care|primary care
4842029|NCT02378272|Depressive symptoms|depressive symptoms
4842030|NCT02378272|quality of life|quality of life
4842031|NCT02378272|return to work|return to work
4842032|NCT02378246|Iodine|iodine
4842033|NCT02378246|Double-Blind Method|double-blind method
4842034|NCT02378246|Randomized Controlled Tria|randomized controlled tria
4842035|NCT02378246|Cognitive Development|cognitive development
4842036|NCT02378233|Iodine|iodine
4842037|NCT02378233|Double-Blind Method|double-blind method
4842038|NCT02378233|Randomized Controlled Trial|randomized controlled trial
4842039|NCT02378220|Home Care Agencies|home care agencies
4842040|NCT02378220|Home Health Care Agencies|home health care agencies
4842041|NCT02378220|Home Health Care Nursing|home health care nursing
4842042|NCT02378220|Home Health Nurses|home health nurses
4842043|NCT02378220|CYP 2D6|cyp 2d6
4842044|NCT02378220|CYP 2C9|cyp 2c9
4842045|NCT02378220|CYP 2C19|cyp 2c19
4842046|NCT02378220|CYP 3A4|cyp 3a4
4842047|NCT02378220|CYP 3A5|cyp 3a5
4842048|NCT02378194|in stage 3 or 4 steps|in stage 3 or 4 steps
4842049|NCT02378168|postconditioning|postconditioning
4842050|NCT02378168|six month follow up|six month follow up
4842051|NCT02378168|cardiac event|cardiac event
4842052|NCT02378168|non-cardiac event|non-cardiac event
4842053|NCT02378155|cardioversion|cardioversion
4842054|NCT02378155|atrial fibrillation|atrial fibrillation
4842055|NCT02378129|Dentin Sensitivity|dentin sensitivity
4842056|NCT02378129|Dentin Desensitizing Agents|dentin desensitizing agents
4842057|NCT02378129|Glass Ionomer Cements|glass ionomer cements
4842058|NCT02378129|Randomized Controlled Trial|randomized controlled trial
4842059|NCT02378103|Aortic Dissection|aortic dissection
4842060|NCT02378103|Chinese XinJiang Province|chinese xinjiang province
4842061|NCT02378077|Obesity|obesity
4842062|NCT02378077|Insulin Resistance|insulin resistance
4842063|NCT02378064|Fluorodeoxyglucose F18|fluorodeoxyglucose f18
4842064|NCT02378064|Positron-Emission Tomography and Computed Tomography|positron-emission tomography and computed tomography
4842065|NCT02378064|Plaque, Atherosclerotic|plaque, atherosclerotic
4842066|NCT02378064|Renin-Angiotensin System|renin-angiotensin system
4842067|NCT02378038|PNT2258|pnt2258
4842068|NCT02378038|Richter's Transformation|richter's transformation
4842069|NCT02378038|NHL|nhl
4842070|NCT02378038|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
4842071|NCT02378038|Lymphoma|lymphoma
4842072|NCT02378038|DLBCL|dlbcl
4842073|NCT02378038|Diffuse Large B-cell Lymphoma|diffuse large b-cell lymphoma
4842074|NCT02378038|Lymphoma, Large B-cell, Diffuse|lymphoma, large b-cell, diffuse
4842075|NCT02378038|Lymphoma, Non-Hodgkin|lymphoma, non-hodgkin
4842076|NCT02378038|Lymphoma, B-cell|lymphoma, b-cell
4842077|NCT02378025|Chronic Pain|chronic pain
4842078|NCT02378025|Veterans|veterans
4842079|NCT02378025|Gulf War Illness|gulf war illness
4842080|NCT02377973|growth,|growth,
4842081|NCT02377973|infancy,|infancy,
4842082|NCT02377973|children,|children,
4842083|NCT02377973|diet,|diet,
4842084|NCT02377973|breastfeeding|breastfeeding
4842085|NCT02377973|complementary feeding|complementary feeding
4842086|NCT02377973|early life programming|early life programming
4842087|NCT02377973|tracking|tracking
4842088|NCT02377973|physical activity|physical activity
4842089|NCT02377960|SMS|sms
4842090|NCT02377960|text message|text message
4842091|NCT02377960|mHealth|mhealth
4842092|NCT02377960|IMB|imb
4842093|NCT02377947|Lactulose Retention Enema|lactulose retention enema
4842094|NCT02377947|Hepatic Encephalopathy, Grade 3 or 4 West Haven Criteria|hepatic encephalopathy, grade 3 or 4 west haven criteria
4842095|NCT02377947|The Retro Study|the retro study
4842096|NCT02377934|Pulmonary Hypertension|pulmonary hypertension
4842097|NCT02377934|Cardiac MRT|cardiac mrt
4842098|NCT02377934|Radiotherapy|radiotherapy
4842099|NCT02377921|GNE Myopathy|gne myopathy
4842100|NCT02377921|GNEM|gnem
4842101|NCT02377921|HIBM|hibm
4842102|NCT02377921|Nonaka|nonaka
4842103|NCT02377921|Hereditary Inclusion Body Myopathy|hereditary inclusion body myopathy
4842104|NCT02377921|DMRV|dmrv
4842105|NCT02377882|Intra-operative neuromonitoring|intra-operative neuromonitoring
4842106|NCT02377882|Neuromuscular blocking agent|neuromuscular blocking agent
4842107|NCT02377882|Rocuronium|rocuronium
4842108|NCT02377882|Thyroid surgery|thyroid surgery
4842109|NCT02377856|acute hepatitis C|acute hepatitis c
4842110|NCT02377856|treatment|treatment
4842111|NCT02377856|SVR|svr
4842112|NCT02377843|vaccine|vaccine
4842113|NCT02377843|physician training|physician training
4842114|NCT02377843|adolescent health|adolescent health
4842115|NCT02377817|positional therapy|positional therapy
4842116|NCT02377817|tennis ball technique|tennis ball technique
4842117|NCT02377817|sleep in pregnancy|sleep in pregnancy
4842118|NCT02377817|supine|supine
4842119|NCT02377817|polysomnography|polysomnography
4842120|NCT02377817|sleep position|sleep position
4842121|NCT02377817|supine position|supine position
4842122|NCT02377804|dry needling|dry needling
4842123|NCT02377804|spasticity|spasticity
4842124|NCT02377804|pain|pain
4842125|NCT02377791|tacrolimus|tacrolimus
4842126|NCT02377791|Cytochrome P-450 CYP3A|cytochrome p-450 cyp3a
4842127|NCT02377791|Kidney transplant|kidney transplant
4842128|NCT02377791|FK506|fk506
4842129|NCT02377791|Prograf|prograf
4842130|NCT02377791|Rejection|rejection
4842131|NCT02377791|Gene Polymorphism|gene polymorphism
4842132|NCT02377765|Neuromodulation|neuromodulation
4842133|NCT02377765|Detrusor overactivity|detrusor overactivity
4842134|NCT02377765|Urinary urgency|urinary urgency
4842135|NCT02377765|Urgency urinary incontinence|urgency urinary incontinence
4842136|NCT02377726|Randomized Controlled Trial|randomized controlled trial
4842137|NCT02377726|Alcohol|alcohol
4842138|NCT02377726|Internet|internet
4842139|NCT02377726|Internet based therapy|internet based therapy
4842140|NCT02377726|Cognitive behavioral therapy|cognitive behavioral therapy
4842141|NCT02377713|KHK6640|khk6640
4842142|NCT02377713|Phase 1|phase 1
4842143|NCT02377713|Japanese|japanese
4842145|NCT02377713|Alzheimer's disease|alzheimer's disease
4842146|NCT02377687|Emergency surgery|emergency surgery
4842147|NCT02377687|HRQoL|hrqol
4842148|NCT02377687|Elderly|elderly
4842149|NCT02377648|Cardiac Allograft Vasculopathy|cardiac allograft vasculopathy
4842150|NCT02377648|Heart Transplant|heart transplant
4842151|NCT02377648|Bioresorbable Vascular Scaffold|bioresorbable vascular scaffold
4842152|NCT02377635|Arsenic|arsenic
4842153|NCT02377635|Arsenicosis|arsenicosis
4842154|NCT02377609|Dry Blood Spot (DBS)|dry blood spot (dbs)
4842155|NCT02377609|Validation|validation
4842156|NCT02377609|Tacrolimus|tacrolimus
4842157|NCT02377609|Bioanalytical assay method cross-validation|bioanalytical assay method cross-validation
4842158|NCT02377596|Feeding|feeding
4842159|NCT02377596|difficulties|difficulties
4842160|NCT02377596|disorders|disorders
4842161|NCT02377596|childhood|childhood
4842162|NCT02377596|eating|eating
4842163|NCT02377557|Dermatologic Agent|dermatologic agent
4842164|NCT02377531|early glucose screen, perinatal outcome|early glucose screen, perinatal outcome
4842165|NCT02377505|Treatment-Resistant Schizophrenia|treatment-resistant schizophrenia
4842166|NCT02377505|Deep Brain Stimulation|deep brain stimulation
4842167|NCT02377466|Spontaneous Preterm Labor|spontaneous preterm labor
4842168|NCT02377466|GSK221149|gsk221149
4842169|NCT02377466|Retosiban|retosiban
4842170|NCT02377453|stroke|stroke
4842171|NCT02377453|participation|participation
4842172|NCT02377453|brain imaging|brain imaging
4842173|NCT02377453|biomechanical|biomechanical
4842174|NCT02377440|ACE inhibitor|ace inhibitor
4842175|NCT02377427|pharmacokinetics|pharmacokinetics
4842176|NCT02377427|pediatric|pediatric
4842177|NCT02377427|Mepolizumab|mepolizumab
4842178|NCT02377427|subcutaneous|subcutaneous
4842179|NCT02377427|eosinophilic asthma|eosinophilic asthma
4842180|NCT02377427|pharmacodynamics|pharmacodynamics
4842181|NCT02377414|Preterm labor|preterm labor
4842182|NCT02377414|Retosiban|retosiban
4842183|NCT02377414|Pharmacokinetics|pharmacokinetics
4842184|NCT02377414|Safety|safety
4842185|NCT02377414|Infusion|infusion
4842186|NCT02377414|GSK2847065|gsk2847065
4842187|NCT02377401|healthy volunteer|healthy volunteer
4842188|NCT02377401|Zanamivir|zanamivir
4842189|NCT02377401|pharmacokinetics|pharmacokinetics
4842190|NCT02377401|intravenous|intravenous
4842191|NCT02377388|diabetes mellitus|diabetes mellitus
4842192|NCT02377388|platelet function testing|platelet function testing
4842193|NCT02377388|acute coronary syndromes|acute coronary syndromes
4842194|NCT02377388|saxagliptin|saxagliptin
4842195|NCT02377388|sitagliptin|sitagliptin
4842196|NCT02377388|dpp-4 inhibitors|dpp-4 inhibitors
4842197|NCT02377375|Deep Brain Stimulation|deep brain stimulation
4842198|NCT02377375|OCD|ocd
4842199|NCT02377336|GS-6615|gs-6615
4842200|NCT02377336|coronary heart disease|coronary heart disease
4842201|NCT02377336|angina pectoris|angina pectoris
4842202|NCT02377336|late sodium current|late sodium current
4842203|NCT02377336|myocardial ischemia|myocardial ischemia
4842204|NCT02377336|coronary artery disease|coronary artery disease
4842205|NCT02377336|chronic stable angina|chronic stable angina
4842206|NCT02377323|Multiple Sclerosis|multiple sclerosis
4842207|NCT02377323|Patient-reported outcomes|patient-reported outcomes
4842208|NCT02377323|Employment status|employment status
4842209|NCT02377323|Quality of Life|quality of life
4842210|NCT02377323|Cognition|cognition
4842211|NCT02377323|Rebif|rebif
4842212|NCT02377297|dental atraumatic restorative treatment|dental atraumatic restorative treatment
4842213|NCT02377297|primary tooth|primary tooth
4842214|NCT02377297|occlusal restoration|occlusal restoration
4842215|NCT02377297|glass-ionomer cement|glass-ionomer cement
4842216|NCT02377271|Bosentan|bosentan
4842217|NCT02377245|Juvenile|juvenile
4842218|NCT02377245|Inflammatory|inflammatory
4842219|NCT02377245|Rheumatism|rheumatism
4842220|NCT02377245|Pediatric-Onset inflammatory diseases|pediatric-onset inflammatory diseases
4842221|NCT02377206|PET|pet
4842222|NCT02377206|[18F]DPA-714|[18f]dpa-714
4842223|NCT02377206|cognitive decline|cognitive decline
4842224|NCT02377193|kidney transplant|kidney transplant
4842225|NCT02377193|luminex method|luminex method
4842226|NCT02377193|simulect ATG|simulect atg
4842227|NCT02377193|immunosuppression|immunosuppression
4842228|NCT02377180|musculoskeletal pain|musculoskeletal pain
4842229|NCT02377180|regional anesthesia|regional anesthesia
4842230|NCT02377180|diagnostic nerve block|diagnostic nerve block
4842231|NCT02377180|intramuscular capsaicin|intramuscular capsaicin
4842232|NCT02377180|referred pain|referred pain
4842233|NCT02377180|hyperalgesia|hyperalgesia
4842234|NCT02377180|experimental pain|experimental pain
4842235|NCT02377180|central hypersensitivity|central hypersensitivity
4842236|NCT02377180|human experimental pain|human experimental pain
4842237|NCT02377154|keratometry|keratometry
4842238|NCT02377154|verion|verion
4842239|NCT02377154|iol|iol
4842240|NCT02377154|intraocular lens|intraocular lens
4842241|NCT02377154|iolmaster|iolmaster
4842242|NCT02377154|lenstar|lenstar
4842243|NCT02377154|pentacam|pentacam
4842244|NCT02377154|IOL calculation|iol calculation
4842245|NCT02377154|VERION Image Guided System|verion image guided system
4842246|NCT02377141|Oesophageal Variceal Bleed|oesophageal variceal bleed
4842247|NCT02377141|TIPSS|tipss
4842248|NCT02377141|Endoscopic Variceal Band Ligation|endoscopic variceal band ligation
4842249|NCT02377141|Decompensated Liver Disease|decompensated liver disease
4842250|NCT02377128|Study|study
4842251|NCT02377128|focus|focus
4842252|NCT02377128|ovarian|ovarian
4842253|NCT02377128|reserve|reserve
4842254|NCT02377115|Postoperative delirium|postoperative delirium
4842255|NCT02377115|Postoperative cognitive decline|postoperative cognitive decline
4842256|NCT02377115|Postoperative cognitive dysfunction|postoperative cognitive dysfunction
4842257|NCT02377115|Risk assessment|risk assessment
4842258|NCT02377115|Tablet computer|tablet computer
4842259|NCT02377115|Clinical screening tool|clinical screening tool
4842260|NCT02377089|Trigeminal Nerve Stimulation|trigeminal nerve stimulation
4842261|NCT02377089|Post-Traumatic Stress Disorder|post-traumatic stress disorder
4842262|NCT02377063|colonic flora|colonic flora
4842263|NCT02377063|microbiomes|microbiomes
4842264|NCT02377050|Nutritional support|nutritional support
4842265|NCT02377037|Sitting|sitting
4842266|NCT02377037|Standing|standing
4842267|NCT02377037|Transitions|transitions
4842268|NCT02376998|Thoracic Aorta|thoracic aorta
4842269|NCT02376998|Trauma|trauma
4842270|NCT02376998|Endovascular|endovascular
4842271|NCT02376959|Anxiety|anxiety
4842272|NCT02376959|Complementary Therapies|complementary therapies
4842273|NCT02376959|energy therapies|energy therapies
4842274|NCT02376933|vertebral bodies|vertebral bodies
4842275|NCT02376933|vertebral fracture|vertebral fracture
4842276|NCT02376933|vertebral augmentation|vertebral augmentation
4842277|NCT02376933|radiotherapy|radiotherapy
4842278|NCT02376933|vertebroplasty|vertebroplasty
4842279|NCT02376933|kyphoplasty|kyphoplasty
4842280|NCT02376920|occular melanoma|occular melanoma
4842281|NCT02376920|melanoma of eye|melanoma of eye
4842282|NCT02376920|DecisionDx-UM|decisiondx-um
4842283|NCT02376907|distal malignant biliary obstruction|distal malignant biliary obstruction
4842284|NCT02376907|endoscopic retrograde cholangiopancreatography|endoscopic retrograde cholangiopancreatography
4842285|NCT02376907|endoscopic ultrasound|endoscopic ultrasound
4842286|NCT02376907|gastric outlet obstruction|gastric outlet obstruction
4842287|NCT02376907|stent|stent
4842288|NCT02376881|Erythropoietin -Methanol - Optic Neuropathy|erythropoietin -methanol - optic neuropathy
4842289|NCT02376855|Health Services Accessibility|health services accessibility
4842290|NCT02376842|severe sepsis infection|severe sepsis infection
4842291|NCT02376829|Orthodontic|orthodontic
4842292|NCT02376829|Orthodontic Treatment|orthodontic treatment
4842293|NCT02376829|Clear Aligners|clear aligners
4842294|NCT02376829|Malocclusion|malocclusion
4842295|NCT02376816|DMD|dmd
4842296|NCT02376816|muscular dystrophy|muscular dystrophy
4842297|NCT02376816|dystrophin|dystrophin
4842298|NCT02376803|Randomized controlled trial|randomized controlled trial
4842299|NCT02376803|Warfarin|warfarin
4842300|NCT02376803|Time in therapeutic range|time in therapeutic range
4842301|NCT02376803|Bleeding|bleeding
4842302|NCT02376803|Thromboembolic|thromboembolic
4842303|NCT02376803|Hemorrhage|hemorrhage
4842304|NCT02376803|Anticoagulant|anticoagulant
4842305|NCT02376803|TTR|ttr
4842306|NCT02376803|Chronobiology|chronobiology
4842307|NCT02376803|Chronotherapeutic|chronotherapeutic
4842308|NCT02376803|Coumadin|coumadin
4842309|NCT02376803|INR|inr
4842310|NCT02376803|International normalized ratio|international normalized ratio
4842311|NCT02376803|RCT|rct
4842312|NCT02376790|Psoriatic Arthritis|psoriatic arthritis
4842313|NCT02376790|Arthritis, Psoriasis|arthritis, psoriasis
4842314|NCT02376790|Etanercept|etanercept
4842315|NCT02376790|Enbrel|enbrel
4842316|NCT02376790|Methotrexate|methotrexate
4842317|NCT02376790|Minimal Disease Activity|minimal disease activity
4842318|NCT02376777|Anticoagulants|anticoagulants
4842319|NCT02376777|Antithrombins|antithrombins
4842320|NCT02376777|Atrial Fibrillation|atrial fibrillation
4842321|NCT02376777|Intracranial haemorrhage|intracranial haemorrhage
4842322|NCT02376777|Gastrointestinal haemorrhage|gastrointestinal haemorrhage
4842323|NCT02376777|Myocardial infarction|myocardial infarction
4842324|NCT02376777|Stroke|stroke
4842325|NCT02376777|Venous thrombosis|venous thrombosis
4842326|NCT02376777|Primary care|primary care
4842327|NCT02376751|Cholesteryl Ester Storage Disease|cholesteryl ester storage disease
4842328|NCT02376751|Acid lipase disease|acid lipase disease
4842329|NCT02376751|Cholesterol ester hydrolase deficiency|cholesterol ester hydrolase deficiency
4842330|NCT02376751|LIPA Deficiency|lipa deficiency
4842331|NCT02376751|Wolman disease|wolman disease
4842332|NCT02376751|Lysosomal Storage Disease|lysosomal storage disease
4842333|NCT02376725|Goniosynechialysis|goniosynechialysis
4842334|NCT02376712|Acute Kidney Injury|acute kidney injury
4842335|NCT02376712|Differential diagnosis|differential diagnosis
4842336|NCT02376712|Urinary indices|urinary indices
4842337|NCT02376712|Renal Blood Flow|renal blood flow
4842338|NCT02376712|Transesophageal Echocardiography|transesophageal echocardiography
4842339|NCT02376699|CD40 Antigen|cd40 antigen
4842340|NCT02376699|Drug Therapy|drug therapy
4842341|NCT02376699|Follicular Lymphoma|follicular lymphoma
4842342|NCT02376699|Hodgkin Disease|hodgkin disease
4842343|NCT02376699|Immunotherapy|immunotherapy
4842344|NCT02376699|Indolent Lymphoma|indolent lymphoma
4842345|NCT02376699|Lymphoma|lymphoma
4842346|NCT02376699|Lymphoma, B-Cell|lymphoma, b-cell
4842347|NCT02376699|Lymphoma, Large B-Cell, Diffuse|lymphoma, large b-cell, diffuse
4842348|NCT02376699|Lymphoma, Non-Hodgkin|lymphoma, non-hodgkin
4842349|NCT02376699|Monoclonal Antibody|monoclonal antibody
4842350|NCT02376699|Neoplasms|neoplasms
4842351|NCT02376699|Neoplasm Metastasis|neoplasm metastasis
4842352|NCT02376699|Solid tumor|solid tumor
4842353|NCT02376686|sleep Quality|sleep quality
4842354|NCT02376686|Depression|depression
4842355|NCT02376686|Music|music
4842356|NCT02376686|quality of life|quality of life
4842357|NCT02376673|Pediatric Health Literacy|pediatric health literacy
4842358|NCT02376673|Home Literacy Orientation|home literacy orientation
4842359|NCT02376673|safe sleep|safe sleep
4842360|NCT02376647|Patients|patients
4842361|NCT02376647|ARDS diagnosis|ards diagnosis
4842362|NCT02376621|omega-3 based dietary supplements|omega-3 based dietary supplements
4842363|NCT02376621|Bioavailability|bioavailability
4842364|NCT02376595|Rocuronium|rocuronium
4842365|NCT02376595|Pharmacokinetics|pharmacokinetics
4842366|NCT02376595|Pharmacodynamics|pharmacodynamics
4842367|NCT02376582|HIV/AIDS vaccine|hiv/aids vaccine
4842368|NCT02376582|helminth infection|helminth infection
4842369|NCT02376582|Impact of co-infection|impact of co-infection
4842370|NCT02376556|Dry eye syndrome|dry eye syndrome
4842371|NCT02376556|Blepharoplasty|blepharoplasty
4842372|NCT02376556|Muller muscle resection surgery|muller muscle resection surgery
4842373|NCT02376517|Health Behavior|health behavior
4842374|NCT02376517|Melanin Index|melanin index
4842375|NCT02376517|Spectrophotometry|spectrophotometry
4842376|NCT02376517|Sun Protective Clothing|sun protective clothing
4842377|NCT02376517|Education|education
4842378|NCT02376517|Primary Prevention|primary prevention
4842379|NCT02376439|siblings|siblings
4842380|NCT02376439|overweight|overweight
4842381|NCT02376439|adolescent|adolescent
4842382|NCT02376426|Healthy|healthy
4842383|NCT02376426|Ebola viruses|ebola viruses
4842384|NCT02376426|Ebola Viral Disease (EVD)|ebola viral disease (evd)
4842385|NCT02376426|Filoviruses|filoviruses
4842386|NCT02376426|Monovalent vaccine|monovalent vaccine
4842387|NCT02376426|Human adenovirus serotype 26 (Ad26) expressing the Ebola virus Mayinga variant glycoprotein (Ad26.ZEBOV)|human adenovirus serotype 26 (ad26) expressing the ebola virus mayinga variant glycoprotein (ad26.zebov)
4842388|NCT02376426|Modified Vaccinia Virus Ankara - Bavarian Nordic (MVA-BN) Filo-vector|modified vaccinia virus ankara - bavarian nordic (mva-bn) filo-vector
4842389|NCT02376426|Safety|safety
4842390|NCT02376426|Immunogenicity|immunogenicity
4842391|NCT02376413|Morbidity|morbidity
4842392|NCT02376413|The Breast Cancer Treatment Outcome Scale|the breast cancer treatment outcome scale
4842393|NCT02376413|Disease free survival|disease free survival
4842394|NCT02376413|Positivity cavity margin rate|positivity cavity margin rate
4842395|NCT02376413|Harvard/NSABP/RTOG breast cosmesis grading scale|harvard/nsabp/rtog breast cosmesis grading scale
4842396|NCT02376400|Healthy|healthy
4842397|NCT02376400|Ebola viruses|ebola viruses
4842398|NCT02376400|Ebola Viral Disease (EVD)|ebola viral disease (evd)
4842399|NCT02376400|Filoviruses|filoviruses
4842400|NCT02376400|Monovalent vaccine|monovalent vaccine
4842401|NCT02376400|Human adenovirus serotype 26 (Ad26) expressing the Ebola virus Mayinga variant glycoprotein (Ad26.ZEBOV)|human adenovirus serotype 26 (ad26) expressing the ebola virus mayinga variant glycoprotein (ad26.zebov)
4842402|NCT02376400|Modified Vaccinia Virus Ankara - Bavarian Nordic Filo-vector (MVA-BN Filo)|modified vaccinia virus ankara - bavarian nordic filo-vector (mva-bn filo)
4842403|NCT02376400|Safety|safety
4842404|NCT02376400|Immunogenicity|immunogenicity
4842405|NCT02376374|transmission|transmission
4842406|NCT02376374|vaccine|vaccine
4842407|NCT02376361|Surveillance|surveillance
4842408|NCT02376348|VMMC|vmmc
4842409|NCT02376348|Adult males|adult males
4842410|NCT02376348|HIV Prevention|hiv prevention
4842411|NCT02376348|Africa|africa
4842412|NCT02376335|Fatigue|fatigue
4842413|NCT02376335|Primary Biliary Cirrhosis|primary biliary cirrhosis
4842414|NCT02376335|Rituximab|rituximab
4842415|NCT02376335|PBC-40|pbc-40
4842416|NCT02376296|metastatic prostate cancer|metastatic prostate cancer
4842417|NCT02376296|castrate resistant prostate cancer|castrate resistant prostate cancer
4842418|NCT02376296|CRPC|crpc
4842419|NCT02376296|hormone sensitive prostate cancer|hormone sensitive prostate cancer
4842420|NCT02376283|STEMI|stemi
4842421|NCT02376283|NSTEMI|nstemi
4842422|NCT02376283|PPCI|ppci
4842423|NCT02376244|High intensity Interval Exercise training|high intensity interval exercise training
4842424|NCT02376244|Cardiac rehabilitation|cardiac rehabilitation
4842425|NCT02376244|cardiac revascularisation|cardiac revascularisation
4842426|NCT02376244|Percutaneous coronary interventions|percutaneous coronary interventions
4842427|NCT02376244|Cardiac surgery|cardiac surgery
4842428|NCT02376231|EOC Epithelial ovarian cancer|eoc epithelial ovarian cancer
4842429|NCT02376231|Surgery|surgery
4842430|NCT02376231|nil macroscopic residual disease|nil macroscopic residual disease
4842431|NCT02376231|Stage 3/4 Epithelial Ovarian Cancer requiring surgery|stage 3/4 epithelial ovarian cancer requiring surgery
4842432|NCT02376205|Anterior Cervical Discectomy and Fusion|anterior cervical discectomy and fusion
4842433|NCT02376205|Dysphagia|dysphagia
4842434|NCT02376192|Microcirculation|microcirculation
4842537|NCT02375490|Preschool Child|preschool child
4842435|NCT02376192|Sidestream Dark Field (SDF) Imaging|sidestream dark field (sdf) imaging
4842436|NCT02376192|Spinal Anesthesia|spinal anesthesia
4842437|NCT02376192|Phenylephrine|phenylephrine
4842438|NCT02376166|Prostate Cancer|prostate cancer
4842439|NCT02376140|micronutrient deficiency|micronutrient deficiency
4842440|NCT02376140|24-H recall|24-h recall
4842441|NCT02376140|West Africa|west africa
4842442|NCT02376140|Food consumption|food consumption
4842443|NCT02376127|Dynamic Contrast-Enhanced Perfusion|dynamic contrast-enhanced perfusion
4842444|NCT02376127|14-203|14-203
4842445|NCT02376114|ocular blood flow|ocular blood flow
4842446|NCT02376114|ginkgo biloba|ginkgo biloba
4842447|NCT02376114|glaucoma|glaucoma
4842448|NCT02376114|vasospasm|vasospasm
4842449|NCT02376062|Continuing Medical Education|continuing medical education
4842450|NCT02376062|Chronic Diseases|chronic diseases
4842451|NCT02376062|Nepal|nepal
4842452|NCT02376062|Implementation Research|implementation research
4842453|NCT02376049|Atopic Dermatitis|atopic dermatitis
4842454|NCT02376049|Eczema|eczema
4842455|NCT02376049|AD|ad
4842456|NCT02376036|Normal healthy volunteer|normal healthy volunteer
4842457|NCT02376023|Cervical Cancer|cervical cancer
4842458|NCT02376023|Women|women
4842459|NCT02376023|Latina|latina
4842460|NCT02376023|Chile|chile
4842461|NCT02376023|Text Message|text message
4842462|NCT02376023|Technology|technology
4842463|NCT02376023|Screening|screening
4842464|NCT02376023|Cancer Prevention|cancer prevention
4842465|NCT02376023|Health Disparities|health disparities
4842466|NCT02376023|Mobile Health|mobile health
4842467|NCT02376010|atherosclerosis|atherosclerosis
4842468|NCT02376010|coronary artery disease|coronary artery disease
4842469|NCT02376010|cardiac CT|cardiac ct
4842470|NCT02376010|computed tomographic angiography|computed tomographic angiography
4842471|NCT02375971|intravitreal ranibizumab|intravitreal ranibizumab
4842472|NCT02375971|laser ablation therapy|laser ablation therapy
4842473|NCT02375971|retinopathy of prematurity|retinopathy of prematurity
4842474|NCT02375971|preterm infants|preterm infants
4842475|NCT02375971|RAINBOW|rainbow
4842476|NCT02375958|PCA062, Triple Negative Breast Cancer, Head & Neck Cancer, Esophageal Cancer, pCAD, pcadherin, solid-tumors|pca062, triple negative breast cancer, head & neck cancer, esophageal cancer, pcad, pcadherin, solid-tumors
4842477|NCT02375945|lymphedema|lymphedema
4842478|NCT02375945|post operative compression treatment|post operative compression treatment
4842479|NCT02375945|compression therapy|compression therapy
4842480|NCT02375945|adjustable fulcro wraps|adjustable fulcro wraps
4842481|NCT02375945|edema|edema
4842482|NCT02375932|Electronic Medical Records|electronic medical records
4842483|NCT02375932|Primary Health Care|primary health care
4842484|NCT02375932|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
4842485|NCT02375919|PERC rule|perc rule
4842486|NCT02375919|emergency department|emergency department
4842487|NCT02375919|pulmonary embolism|pulmonary embolism
4842488|NCT02375906|HDV, hepatitis delta|hdv, hepatitis delta
4842489|NCT02375893|Coronary disease|coronary disease
4842490|NCT02375893|Bile acids|bile acids
4842491|NCT02375893|Gut microbiota|gut microbiota
4842492|NCT02375893|Risk factors|risk factors
4842493|NCT02375893|Atherosclerosis|atherosclerosis
4842494|NCT02375854|preterm|preterm
4842495|NCT02375854|acute kidney injury|acute kidney injury
4842496|NCT02375854|biomarkers|biomarkers
4842497|NCT02375854|chronic kidney disease|chronic kidney disease
4842498|NCT02375841|Communication|communication
4842499|NCT02375841|Physicians|physicians
4842500|NCT02375841|Patients|patients
4842501|NCT02375841|Caregivers|caregivers
4842502|NCT02375841|15-034|15-034
4842503|NCT02375828|Acceptability|acceptability
4842504|NCT02375828|Phase 3|phase 3
4842505|NCT02375828|Neonatal diabetes|neonatal diabetes
4842506|NCT02375815|statin|statin
4842507|NCT02375815|decision aid|decision aid
4842508|NCT02375802|Stem cells|stem cells
4842509|NCT02375789|Migraine Headache|migraine headache
4842510|NCT02375789|Cooling|cooling
4842511|NCT02375789|Intranasal|intranasal
4842512|NCT02375789|Rhinochill|rhinochill
4842513|NCT02375724|COPD|copd
4842514|NCT02375711|Chronic renal disease|chronic renal disease
4842515|NCT02375711|Hepatitis B vaccine|hepatitis b vaccine
4842516|NCT02375711|Biological Aging|biological aging
4842517|NCT02375685|Uveitis|uveitis
4842518|NCT02375685|Non-infectious Uveitis|non-infectious uveitis
4842519|NCT02375685|Intermediate Uveitis|intermediate uveitis
4842520|NCT02375685|Posterior Uveitis|posterior uveitis
4842521|NCT02375685|Behçet's disease uveitis|behçet's disease uveitis
4842522|NCT02375672|Pembrolizumab|pembrolizumab
4842523|NCT02375672|MK-3475|mk-3475
4842524|NCT02375607|Pain management|pain management
4842525|NCT02375581|Radiotherapy|radiotherapy
4842526|NCT02375581|Icotinib|icotinib
4842527|NCT02375568|mesenchymal stem cells|mesenchymal stem cells
4842528|NCT02375555|Multiple Myeloma|multiple myeloma
4842529|NCT02375516|Drug abuse|drug abuse
4842530|NCT02375503|Calcium|calcium
4842531|NCT02375503|Vitamin D|vitamin d
4842532|NCT02375503|Parathyroid Hormone|parathyroid hormone
4842533|NCT02375503|Bone|bone
4842534|NCT02375503|Microarchitecture|microarchitecture
4842535|NCT02375490|Exercise|exercise
4842536|NCT02375490|Eating Behavior|eating behavior
4842538|NCT02375490|Early Childcare Center|early childcare center
4842539|NCT02375490|Obesity|obesity
4842540|NCT02375490|Physical Literacy|physical literacy
4842541|NCT02375477|Clostridium difficile|clostridium difficile
4842542|NCT02375477|C. difficile|c. difficile
4842543|NCT02375477|adherence|adherence
4842544|NCT02375464|neuroendocrine tumor|neuroendocrine tumor
4842545|NCT02375464|carcinoid tumor|carcinoid tumor
4842546|NCT02375438|nutrition|nutrition
4842547|NCT02375438|mitochondrial cytopathy|mitochondrial cytopathy
4842548|NCT02375438|malnutrition|malnutrition
4842549|NCT02375438|energy intake|energy intake
4842550|NCT02375438|nutritional risk|nutritional risk
4842551|NCT02375425|BV, HSV|bv, hsv
4842552|NCT02375425|contraceptive|contraceptive
4842553|NCT02375425|ex vivo challenge model|ex vivo challenge model
4842554|NCT02375412|heart rate variability|heart rate variability
4842555|NCT02375412|post-operative outcome|post-operative outcome
4842556|NCT02375373|Gut Microbiota|gut microbiota
4842557|NCT02375347|Gut Microbiota|gut microbiota
4842558|NCT02375321|OSA|osa
4842559|NCT02375321|Depression|depression
4842560|NCT02375321|Quality of Life|quality of life
4842561|NCT02375321|CPAP|cpap
4842562|NCT02375308|Hypnotherapy; Cognitive Behavioral Therapy; Efficacy|hypnotherapy; cognitive behavioral therapy; efficacy
4842563|NCT02375295|struvite|struvite
4842564|NCT02375295|infection|infection
4842565|NCT02375295|stones|stones
4842566|NCT02375295|calculi|calculi
4842567|NCT02375295|antibiotics|antibiotics
4842568|NCT02375282|ambulation|ambulation
4842569|NCT02375282|cardiac rehabilitation|cardiac rehabilitation
4842570|NCT02375269|Visceral Surgery|visceral surgery
4842571|NCT02375269|Comprehensive Complication Index|comprehensive complication index
4842572|NCT02375269|Patient undergoing abdominal surgery|patient undergoing abdominal surgery
4842573|NCT02375230|Neonatal Resuscitation|neonatal resuscitation
4842574|NCT02375230|Respiratory Function Tests|respiratory function tests
4842575|NCT02375230|Neonatal Simulation|neonatal simulation
4842576|NCT02375230|Resuscitation Teaching|resuscitation teaching
4842577|NCT02375178|anti-infective agents|anti-infective agents
4842578|NCT02375178|local/therapeutic use|local/therapeutic use
4842579|NCT02375178|chlorhexidine|chlorhexidine
4842580|NCT02375178|dental desinfectants|dental desinfectants
4842581|NCT02375178|polyhexamethylene biguanide|polyhexamethylene biguanide
4842582|NCT02375178|mouthrinse|mouthrinse
4842583|NCT02375152|neurosurgery|neurosurgery
4842584|NCT02375152|capsulotomy|capsulotomy
4842585|NCT02375113|Obesity prevention|obesity prevention
4842586|NCT02375113|Soy supplementation|soy supplementation
4842587|NCT02375074|Supported Employment|supported employment
4842588|NCT02375074|Vocational Rehabilitation|vocational rehabilitation
4842589|NCT02375074|Youth|youth
4842590|NCT02375074|Sick leave|sick leave
4842591|NCT02375074|Disability|disability
4842592|NCT02375074|Coping|coping
4842593|NCT02375074|Work|work
4842594|NCT02375074|Occupational|occupational
4842595|NCT02375074|Labor market participation|labor market participation
4842596|NCT02375074|Randomized Controlled Trial|randomized controlled trial
4842597|NCT02375061|Best Possible Self|best possible self
4842598|NCT02375061|Positive Psychology|positive psychology
4842599|NCT02375061|Optimism|optimism
4842600|NCT02375061|Positive Technologies|positive technologies
4842601|NCT02375061|Future thinking|future thinking
4842602|NCT02375061|Pain Catastrophizing|pain catastrophizing
4842603|NCT02374983|Gamma Knife Radiosurgery|gamma knife radiosurgery
4842604|NCT02374983|Radiation Dosimetry|radiation dosimetry
4842605|NCT02374957|leg pain|leg pain
4842606|NCT02374957|claudication|claudication
4842607|NCT02374931|desmoid|desmoid
4842608|NCT02374931|FES-PET|fes-pet
4842609|NCT02374931|aggressive fibromatosis|aggressive fibromatosis
4842610|NCT02374918|Mild traumatic brain injury|mild traumatic brain injury
4842611|NCT02374918|Concussion|concussion
4842612|NCT02374918|Sleep problems|sleep problems
4842613|NCT02374918|Brain imaging|brain imaging
4842614|NCT02374918|fMRI|fmri
4842615|NCT02374905|drinksmeter|drinksmeter
4842616|NCT02374905|alcohol counselling|alcohol counselling
4842617|NCT02374892|Intervention|intervention
4842618|NCT02374892|Congenital Heart Disease|congenital heart disease
4842619|NCT02374892|Adolescent|adolescent
4842620|NCT02374892|Education|education
4842621|NCT02374892|Self-management|self-management
4842622|NCT02374866|Obesity|obesity
4842623|NCT02374866|Morbid Obesity|morbid obesity
4842624|NCT02374866|Therapeutic education|therapeutic education
4842625|NCT02374840|Pharmacogenomics|pharmacogenomics
4842626|NCT02374840|Adverse Drug Reactions|adverse drug reactions
4842627|NCT02374840|Pharmacogenetics|pharmacogenetics
4842628|NCT02374827|complete salpingectomy|complete salpingectomy
4842629|NCT02374827|standard tubal ligation|standard tubal ligation
4842630|NCT02374827|cesarean delivery|cesarean delivery
4842631|NCT02374827|feasibility|feasibility
4842632|NCT02374827|safety|safety
4842633|NCT02374827|partial salpingectomy|partial salpingectomy
4842634|NCT02374801|CRT-D device|crt-d device
4842635|NCT02374801|Severe HF (NYHA Class III or ambulatory IV)|severe hf (nyha class iii or ambulatory iv)
4842636|NCT02374801|Stable, optimal drug regimen|stable, optimal drug regimen
4842637|NCT02374801|Sinus rhythm|sinus rhythm
4842638|NCT02374801|Heart Failure|heart failure
4842639|NCT02374775|axial plaque stress|axial plaque stress
4842640|NCT02374775|pressure|pressure
4842641|NCT02374775|pressure gradient|pressure gradient
4842642|NCT02374775|coronary plaque|coronary plaque
4842643|NCT02374775|plaque rupture|plaque rupture
4842644|NCT02374775|acute coronary syndrome|acute coronary syndrome
4842645|NCT02374775|acute myocardial infarction|acute myocardial infarction
4842646|NCT02374775|computational fluid dynamics|computational fluid dynamics
4842647|NCT02374775|coronary computed tomography angiography|coronary computed tomography angiography
4842648|NCT02374775|wall shear stress|wall shear stress
4842649|NCT02374762|Arteriovenous Fistula|arteriovenous fistula
4842650|NCT02374762|Hemodialysis|hemodialysis
4842651|NCT02374762|Vascular Access|vascular access
4842652|NCT02374749|Axial Spondyloarthritis|axial spondyloarthritis
4842653|NCT02374749|Education|education
4842654|NCT02374749|Co-morbidities|co-morbidities
4842655|NCT02374749|Nurse|nurse
4842656|NCT02374736|recipients|recipients
4842657|NCT02374736|Subclinical Antibody-mediated rejection (ABMR)|subclinical antibody-mediated rejection (abmr)
4842658|NCT02374736|Intravenous immunoglobulins (IVIg)|intravenous immunoglobulins (ivig)
4842659|NCT02374736|Donor-specific antibodies (DSA)|donor-specific antibodies (dsa)
4842660|NCT02374723|improve|improve
4842661|NCT02374723|vision|vision
4842662|NCT02374697|Second opinion|second opinion
4842663|NCT02374684|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal
4842664|NCT02374671|Near Vision|near vision
4842665|NCT02374671|Reading Vision|reading vision
4842666|NCT02374671|Reading Glasses|reading glasses
4842667|NCT02374671|Reading|reading
4842668|NCT02374671|Readers|readers
4842669|NCT02374671|Presbyopic|presbyopic
4842670|NCT02374619|eccentric exercise|eccentric exercise
4842671|NCT02374619|pro-oxidants|pro-oxidants
4842672|NCT02374619|free radicals|free radicals
4842673|NCT02374619|adults|adults
4842674|NCT02374619|children|children
4842675|NCT02374606|outcomes measures|outcomes measures
4842676|NCT02374606|strength measurement|strength measurement
4842677|NCT02374606|disease progression|disease progression
4842678|NCT02374567|geriatric psychiatry|geriatric psychiatry
4842679|NCT02374567|pharmacovigilance|pharmacovigilance
4842680|NCT02374554|Respiratory Rate|respiratory rate
4842681|NCT02374554|Structured Light Plethysmography|structured light plethysmography
4842682|NCT02374554|Capnography|capnography
4842683|NCT02374541|Patient Navigation|patient navigation
4842684|NCT02374541|Health Disparities|health disparities
4842685|NCT02374541|Coordination of Services|coordination of services
4842686|NCT02374541|Early Intervention (Education)|early intervention (education)
4842687|NCT02374541|Health Services Accessibility|health services accessibility
4842688|NCT02374541|Patient Advocacy|patient advocacy
4842689|NCT02374528|Negative pressure wound therapy|negative pressure wound therapy
4842690|NCT02374528|wound|wound
4842691|NCT02374528|split-thickness skin grafting|split-thickness skin grafting
4842692|NCT02374502|Spondylarthropathies|spondylarthropathies
4842693|NCT02374502|Motor Activity|motor activity
4842694|NCT02374502|Physical Therapists|physical therapists
4842695|NCT02374502|Accelerometry|accelerometry
4842696|NCT02374476|VT|vt
4842697|NCT02374476|Refractory VT|refractory vt
4842698|NCT02374476|VT Storm|vt storm
4842699|NCT02374476|Ventricular Fibrillation|ventricular fibrillation
4842700|NCT02374476|V Fib|v fib
4842701|NCT02374476|VF|vf
4842702|NCT02374463|Balance|balance
4842703|NCT02374463|Fall Risk|fall risk
4842704|NCT02374463|Older Adults|older adults
4842705|NCT02374463|Tai Chi|tai chi
4842706|NCT02374463|Multimodal Balance Intervention|multimodal balance intervention
4842707|NCT02374450|Malaria|malaria
4842708|NCT02374450|Surveillance study|surveillance study
4842709|NCT02374450|Adverse Events of Specific Interest (AESI)|adverse events of specific interest (aesi)
4842710|NCT02374450|Children|children
4842711|NCT02374450|Infants|infants
4842712|NCT02374450|Adverse events (AE) leading to hospitalisation or death|adverse events (ae) leading to hospitalisation or death
4842713|NCT02374450|Meningitis|meningitis
4842714|NCT02374450|Epidemiology|epidemiology
4842715|NCT02374450|Africa|africa
4842716|NCT02374398|Tranexamic Acid|tranexamic acid
4842717|NCT02374398|Blood Loss|blood loss
4842718|NCT02374398|Aquamantys System|aquamantys system
4842719|NCT02374398|TKA|tka
4842720|NCT02374372|hemodialysis|hemodialysis
4842721|NCT02374372|beta microglobulin|beta microglobulin
4842722|NCT02374372|amyloidosis|amyloidosis
4842723|NCT02374307|Falls|falls
4842724|NCT02374307|home-care services|home-care services
4842725|NCT02374307|older people|older people
4842726|NCT02374307|falls-prevention|falls-prevention
4842727|NCT02374281|Newborn|newborn
4842728|NCT02374281|Neonatal Screening|neonatal screening
4842729|NCT02374281|Autonomic Nervous System|autonomic nervous system
4842730|NCT02374281|Pain|pain
4842731|NCT02374281|non-nutritive sucking|non-nutritive sucking
4842732|NCT02374281|sucrose administration|sucrose administration
4842733|NCT02374281|nociceptive action|nociceptive action
4842734|NCT02374281|Electro acoustical characteristics of crying|electro acoustical characteristics of crying
4842735|NCT02374255|Advanced cancer|advanced cancer
4842736|NCT02374255|goals of care|goals of care
4842737|NCT02374255|quality of care|quality of care
4842738|NCT02374255|end of life discussions|end of life discussions
4842739|NCT02374242|Brain|brain
4842740|NCT02374242|Metastases|metastases
4842741|NCT02374242|Immunotherapy|immunotherapy
4842742|NCT02374242|Intracranial response|intracranial response
4842743|NCT02374242|Nivolumab|nivolumab
4842744|NCT02374242|Ipilimumab|ipilimumab
4842745|NCT02374242|Biomarkers|biomarkers
4842746|NCT02374242|Immune related response criteria|immune related response criteria
4842747|NCT02374229|pulmonary hypertension|pulmonary hypertension
4842748|NCT02374229|pulmonary artery denervation|pulmonary artery denervation
4842749|NCT02374229|mitral valve disease|mitral valve disease
4842750|NCT02374216|Dental Implants|dental implants
4842751|NCT02374216|Periodontal Bone Loss|periodontal bone loss
4842752|NCT02374216|Implant-Supported Dental Prosthesis|implant-supported dental prosthesis
4842753|NCT02374216|Dental Prosthesis Failure|dental prosthesis failure
4842754|NCT02374203|Critical Illness|critical illness
4842755|NCT02374203|Mechanical ventilator|mechanical ventilator
4842756|NCT02374203|Indirect Calorimetry|indirect calorimetry
4842757|NCT02374164|Drug therapy|drug therapy
4842758|NCT02374151|intrauterine pressure catheter|intrauterine pressure catheter
4842759|NCT02374151|electrohysterography|electrohysterography
4842760|NCT02374138|psychosocial stress|psychosocial stress
4842761|NCT02374099|Breast Cancer|breast cancer
4842762|NCT02374099|Her2 -|her2 -
4842763|NCT02374099|ER+|er+
4842764|NCT02374099|CC-486 (ORAL AZACITIDINE)|cc-486 (oral azacitidine)
4842765|NCT02374099|Metastatic Breast Cancer|metastatic breast cancer
4842766|NCT02374099|Oralazacitidine|oralazacitidine
4842767|NCT02374099|Fulvestrant|fulvestrant
4842768|NCT02374099|Epigenetics|epigenetics
4842769|NCT02374021|rheumatoid arthritis|rheumatoid arthritis
4842770|NCT02374008|Peripheral nerve block|peripheral nerve block
4842771|NCT02374008|Total knee Arthroplasty|total knee arthroplasty
4842772|NCT02374008|Dexamethasone|dexamethasone
4842773|NCT02373995|Graves|graves
4842774|NCT02373995|Orbithopaty|orbithopaty
4842775|NCT02373995|euthyroidism|euthyroidism
4842776|NCT02373995|microbiome|microbiome
4842777|NCT02373943|vitamin A|vitamin a
4842778|NCT02373943|human|human
4842779|NCT02373943|bioavailability|bioavailability
4842780|NCT02373943|fortified maize|fortified maize
4842781|NCT02373943|cross-over|cross-over
4842782|NCT02373943|beta-carotene|beta-carotene
4842783|NCT02373930|Dolutegravir|dolutegravir
4842784|NCT02373930|safety|safety
4842785|NCT02373930|Rilpivirine|rilpivirine
4842786|NCT02373930|fixed dose combination|fixed dose combination
4842787|NCT02373930|relative bioavailability|relative bioavailability
4842788|NCT02373865|Diabetes mellitus type 2|diabetes mellitus type 2
4842789|NCT02373865|nocturnal hypoglycemia|nocturnal hypoglycemia
4842790|NCT02373865|metformin monotherapy|metformin monotherapy
4842791|NCT02373800|Induced|induced
4842792|NCT02373800|pre-term labor|pre-term labor
4842793|NCT02373787|Resorbable|resorbable
4842794|NCT02373787|Collagen membrane|collagen membrane
4842795|NCT02373787|NobelReplace CC|nobelreplace cc
4842796|NCT02373774|infant|infant
4842797|NCT02373774|lumbar puncture|lumbar puncture
4842798|NCT02373774|patient safety|patient safety
4842799|NCT02373774|ultrasound|ultrasound
4842800|NCT02373735|stroke volume variation|stroke volume variation
4842801|NCT02373735|radical cystectomy|radical cystectomy
4842802|NCT02373735|blood loss|blood loss
4842803|NCT02373735|postoperative complications|postoperative complications
4842804|NCT02373696|Pain|pain
4842805|NCT02373696|Caesarean section|caesarean section
4842806|NCT02373670|Positive deviance|positive deviance
4842807|NCT02373670|Peer mentors|peer mentors
4842808|NCT02373657|trachoma|trachoma
4842809|NCT02373657|soil transmitted helminths|soil transmitted helminths
4842810|NCT02373657|water|water
4842811|NCT02373657|hand washing|hand washing
4842812|NCT02373592|Diabetic Neuropathies|diabetic neuropathies
4842813|NCT02373592|Thermometry|thermometry
4842814|NCT02373592|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
4842815|NCT02373592|Foot Ulcer|foot ulcer
4842816|NCT02373592|Telemedicine|telemedicine
4842817|NCT02373579|omega-3 fatty acids|omega-3 fatty acids
4842818|NCT02373579|methotrexate|methotrexate
4842819|NCT02373579|hepatotoxicity|hepatotoxicity
4842820|NCT02373566|burns|burns
4842821|NCT02373566|dermal substitute|dermal substitute
4842822|NCT02373566|scar quality|scar quality
4842823|NCT02373566|reconstruction|reconstruction
4842824|NCT02373566|wound healing|wound healing
4842825|NCT02373566|wound closure|wound closure
4842826|NCT02373553|posture|posture
4842827|NCT02373553|postural|postural
4842828|NCT02373553|kinetics|kinetics
4842829|NCT02373540|spinal cord stimulation|spinal cord stimulation
4842830|NCT02373540|chronic pain|chronic pain
4842831|NCT02373540|failed back surgery syndrome|failed back surgery syndrome
4842832|NCT02373501|caesarean delivery|caesarean delivery
4842833|NCT02373501|uterine incision repair|uterine incision repair
4842834|NCT02373488|Constipation|constipation
4842835|NCT02373488|connective tissue manipulation|connective tissue manipulation
4842836|NCT02373488|abdominal massage|abdominal massage
4842837|NCT02373488|bowel movements|bowel movements
4842838|NCT02373488|quality of life|quality of life
4842839|NCT02373475|spine surgery|spine surgery
4842840|NCT02373475|prone position|prone position
4842841|NCT02373475|intraoperative lung protective strategies|intraoperative lung protective strategies
4842842|NCT02373475|postoperative pulmonary complications|postoperative pulmonary complications
4842843|NCT02373449|Ketamine|ketamine
4842844|NCT02373449|fMRI|fmri
4842845|NCT02373449|refractory neuropathic pain|refractory neuropathic pain
4842846|NCT02373436|Upper Extremity|upper extremity
4842847|NCT02373436|Rehabilitation|rehabilitation
4842848|NCT02373397|Wound healing|wound healing
4842849|NCT02373397|nerve regeneration|nerve regeneration
4842850|NCT02373397|re-epithelialization|re-epithelialization
4842851|NCT02373397|corneal epithelium|corneal epithelium
4842852|NCT02373397|laser corneal surgery|laser corneal surgery
4842853|NCT02373384|Radiolucent renal stones|radiolucent renal stones
4842854|NCT02373384|Oral dissolution therapy|oral dissolution therapy
4842855|NCT02373384|Systemic chemolysis|systemic chemolysis
4842856|NCT02373384|Renal uric acid stones|renal uric acid stones
4842857|NCT02373384|Alkalinization|alkalinization
4842858|NCT02373358|Complex trauma|complex trauma
4842859|NCT02373358|Yoga|yoga
4842860|NCT02373345|psychological factors|psychological factors
4842861|NCT02373345|functional disability|functional disability
4842862|NCT02373345|pain thresholds|pain thresholds
4842863|NCT02373345|tolerance thresholds|tolerance thresholds
4842864|NCT02373345|motor adaptations|motor adaptations
4842865|NCT02373345|natural course|natural course
4842866|NCT02373332|platelets|platelets
4842867|NCT02373332|12-lipoxygenase|12-lipoxygenase
4842868|NCT02373332|fatty acids|fatty acids
4842869|NCT02373332|DGLA|dgla
4842870|NCT02373332|DHA|dha
4842871|NCT02373332|EPA|epa
4842872|NCT02373332|12-LOX|12-lox
4842873|NCT02373319|Cardiovascular risk|cardiovascular risk
4842874|NCT02373319|Cholesterol|cholesterol
4842875|NCT02373319|Hypertension|hypertension
4842876|NCT02373319|Diabetes|diabetes
4842877|NCT02373319|Smoking|smoking
4842878|NCT02373319|Preventive Medicine|preventive medicine
4842879|NCT02373319|Epidemiology|epidemiology
4842880|NCT02373319|Public Health|public health
4842881|NCT02373319|Diet|diet
4842882|NCT02373319|Physical Activity|physical activity
4842883|NCT02373306|Risk stratification|risk stratification
4842884|NCT02373306|ICD intervention|icd intervention
4842885|NCT02373306|occurrence during one-year follow-up after NIPS|occurrence during one-year follow-up after nips
4842886|NCT02373293|Acute pancreatitis|acute pancreatitis
4842887|NCT02373280|Helicobacter pylori|helicobacter pylori
4842888|NCT02373280|tailored therapy|tailored therapy
4842889|NCT02373280|eradication|eradication
4842890|NCT02373241|Anemia, Sickle Cell|anemia, sickle cell
4842891|NCT02373241|Sickle Cell Disease|sickle cell disease
4842892|NCT02373241|Kidney Disease|kidney disease
4842893|NCT02373241|Hypertension|hypertension
4842894|NCT02373241|Proteinuria|proteinuria
4842895|NCT02373241|Losartan|losartan
4842896|NCT02373241|Antihypertensive Agents|antihypertensive agents
4842897|NCT02373241|Blood Pressure|blood pressure
4842898|NCT02373111|Anti-aging|anti-aging
4842899|NCT02373111|Isoflavones|isoflavones
4842900|NCT02373111|Astaxanthine|astaxanthine
4842901|NCT02373111|Skin aging|skin aging
4842902|NCT02373098|Fingolimod,cytokine,chemokine,RRMS|fingolimod,cytokine,chemokine,rrms
4842903|NCT02373085|Asymptomatic Bacteriuria|asymptomatic bacteriuria
4842904|NCT02373085|Kidney transplant recipients|kidney transplant recipients
4842905|NCT02373085|Pyelonephritis|pyelonephritis
4842906|NCT02373072|Pakinson's Disease, Movement Disorders|pakinson's disease, movement disorders
4842907|NCT02373033|Folate|folate
4842908|NCT02373033|folic acid|folic acid
4842909|NCT02373033|intervention trial|intervention trial
4842910|NCT02373033|folate status|folate status
4842911|NCT02373033|women in childbearing age|women in childbearing age
4842912|NCT02373033|food folate|food folate
4842913|NCT02372994|chronic disease|chronic disease
4842914|NCT02372994|continuity of patient care|continuity of patient care
4842915|NCT02372994|patient engagement|patient engagement
4842916|NCT02372994|cost effectiveness analysis|cost effectiveness analysis
4842917|NCT02372994|user-centred design|user-centred design
4842918|NCT02372994|Interdisciplinary Health Team|interdisciplinary health team
4842919|NCT02372994|Medical Informatics|medical informatics
4842920|NCT02372994|Patient-centred care|patient-centred care
4842921|NCT02372942|efficacy|efficacy
4842922|NCT02372942|prevention|prevention
4842923|NCT02372890|Otorhinolaryngeal Neoplasms|otorhinolaryngeal neoplasms
4842924|NCT02372890|Cancer of Head and Neck|cancer of head and neck
4842925|NCT02372890|Head and Neck Squamous Cell Carcinoma|head and neck squamous cell carcinoma
4842926|NCT02372890|Positron Emission Tomography|positron emission tomography
4842927|NCT02372890|PET/CT|pet/ct
4842928|NCT02372890|FDG|fdg
4842929|NCT02372877|Sickle Cell Disease|sickle cell disease
4842930|NCT02372877|Hemoglobin (Hb) S Disease|hemoglobin (hb) s disease
4842931|NCT02372877|Hb S Disease|hb s disease
4842932|NCT02372877|Congenital Hemolytic Anemia|congenital hemolytic anemia
4842933|NCT02372864|Ovariectomy|ovariectomy
4842934|NCT02372864|Mindfulness|mindfulness
4842935|NCT02372864|Postmenopause|postmenopause
4842936|NCT02372864|Hot Flashes|hot flashes
4842937|NCT02372851|Arsenic|arsenic
4843135|NCT02371772|Self Care|self care
4842938|NCT02372851|Household water treatment|household water treatment
4842939|NCT02372851|Point of use water treatment|point of use water treatment
4842940|NCT02372851|Water Quality|water quality
4842941|NCT02372851|Total Urinary Arsenic|total urinary arsenic
4842942|NCT02372851|West Bengal|west bengal
4842943|NCT02372851|Thermotolerant coliforms|thermotolerant coliforms
4842944|NCT02372851|Compliance|compliance
4842945|NCT02372851|Diarrhoea|diarrhoea
4842946|NCT02372825|Free iliac crest transfer|free iliac crest transfer
4842947|NCT02372825|Bone reconstruction|bone reconstruction
4842948|NCT02372825|Ankle reconstruction|ankle reconstruction
4842949|NCT02372825|Heel reconstruction|heel reconstruction
4842950|NCT02372812|effect of dexamethasone|effect of dexamethasone
4842951|NCT02372812|general surgery|general surgery
4842952|NCT02372812|post operative|post operative
4842953|NCT02372786|7% lidocaine / 7% tetracaine cream|7% lidocaine / 7% tetracaine cream
4842954|NCT02372786|2,5% lidocaine / 2,5% prilocaine cream|2,5% lidocaine / 2,5% prilocaine cream
4842955|NCT02372773|Frontotemporal Dementia|frontotemporal dementia
4842956|NCT02372773|MAPT|mapt
4842957|NCT02372773|PGRN|pgrn
4842958|NCT02372773|C9ORF72|c9orf72
4842959|NCT02372760|Bronchoscopic anesthesia lidocaine|bronchoscopic anesthesia lidocaine
4842960|NCT02372760|Spray Catheter|spray catheter
4842961|NCT02372760|brochoalveolar lavage|brochoalveolar lavage
4842962|NCT02372747|Totally laparoscopic gastrectomy|totally laparoscopic gastrectomy
4842963|NCT02372747|laparoscopic distal gastrectomy|laparoscopic distal gastrectomy
4842964|NCT02372747|Intracorporeal anastomosis|intracorporeal anastomosis
4842965|NCT02372747|Delta-Shaped Anastomosis|delta-shaped anastomosis
4842966|NCT02372747|Billroth II Anastomosis|billroth ii anastomosis
4842967|NCT02372747|Gastric cancer|gastric cancer
4842968|NCT02372721|acute kidney injury|acute kidney injury
4842969|NCT02372656|Simvastatin, Metformin, Chronic periodontitis|simvastatin, metformin, chronic periodontitis
4842970|NCT02372643|clitoris|clitoris
4842971|NCT02372643|sexuality|sexuality
4842972|NCT02372643|vascularization|vascularization
4842973|NCT02372643|doppler|doppler
4842974|NCT02372643|ultrasound|ultrasound
4842975|NCT02372643|reference|reference
4842976|NCT02372643|female|female
4842977|NCT02372643|Pilot Projects|pilot projects
4842978|NCT02372643|Vagina/ultrasonography|vagina/ultrasonography
4842979|NCT02372643|Urethra/ultrasonography|urethra/ultrasonography
4842980|NCT02372643|Regional Blood Flow/physiology|regional blood flow/physiology
4842981|NCT02372643|Arteries/ultrasonography|arteries/ultrasonography
4842982|NCT02372643|Clitoris/ultrasonography|clitoris/ultrasonography
4842983|NCT02372643|Reference values|reference values
4842984|NCT02372643|Clitoris/blood supply|clitoris/blood supply
4842985|NCT02372617|cerebral palsy|cerebral palsy
4842986|NCT02372617|hip|hip
4842987|NCT02372617|luxation|luxation
4842988|NCT02372617|subluxation|subluxation
4842989|NCT02372604|Chronic spontaneous urticaria|chronic spontaneous urticaria
4842990|NCT02372604|Levocetirizine|levocetirizine
4842991|NCT02372604|H1-antihistamine|h1-antihistamine
4842992|NCT02372604|Fourfold dosage|fourfold dosage
4842993|NCT02372604|Efficacy|efficacy
4842994|NCT02372604|Tolerance|tolerance
4842995|NCT02372604|UAS7 (Urticaria activity score)|uas7 (urticaria activity score)
4842996|NCT02372604|resistant|resistant
4842997|NCT02372591|Quantitative Sensory Testing|quantitative sensory testing
4842998|NCT02372591|Hydromorphone|hydromorphone
4842999|NCT02372591|Buprenorphine|buprenorphine
4843000|NCT02372578|Painful diabetic peripheral neuropathy (PDPN)|painful diabetic peripheral neuropathy (pdpn)
4843001|NCT02372578|ASP3662|asp3662
4843002|NCT02372565|African American|african american
4843003|NCT02372565|Women|women
4843004|NCT02372565|Physical Activity|physical activity
4843005|NCT02372565|Social Media|social media
4843006|NCT02372565|Exercise|exercise
4843007|NCT02372565|Facebook|facebook
4843008|NCT02372565|Text message|text message
4843009|NCT02372539|dexamethasone|dexamethasone
4843010|NCT02372526|Glucagon-like Peptide-1|glucagon-like peptide-1
4843011|NCT02372526|Glucose-dependent insulinotropic peptide|glucose-dependent insulinotropic peptide
4843012|NCT02372526|Glucagon|glucagon
4843013|NCT02372526|Peptide YY 3-36|peptide yy 3-36
4843014|NCT02372526|Ghrelin|ghrelin
4843015|NCT02372526|Body Weight|body weight
4843016|NCT02372526|Obesity|obesity
4843017|NCT02372526|Overnutrition|overnutrition
4843018|NCT02372526|Overweight|overweight
4843019|NCT02372526|Gastrointestinal Agents|gastrointestinal agents
4843020|NCT02372526|GLP-1 secretagogue|glp-1 secretagogue
4843021|NCT02372513|Cholesteryl Ester Storage Disease|cholesteryl ester storage disease
4843022|NCT02372513|Children|children
4843023|NCT02372513|Liver disease|liver disease
4843024|NCT02372474|POF|pof
4843025|NCT02372474|ESS|ess
4843026|NCT02372474|stem cell therapy|stem cell therapy
4843027|NCT02372461|Amoxicillin|amoxicillin
4843028|NCT02372461|Placebo|placebo
4843029|NCT02372435|PJI|pji
4843030|NCT02372422|Twins|twins
4843031|NCT02372422|Twin gestation|twin gestation
4843032|NCT02372422|Preterm birth|preterm birth
4843033|NCT02372422|Prevention|prevention
4843034|NCT02372396|PTSD|ptsd
4843035|NCT02372396|Psychotherapy|psychotherapy
4843036|NCT02372396|OEF/OIF|oef/oif
4843037|NCT02372396|Veterans|veterans
4843038|NCT02372383|Cystic Fibrosis|cystic fibrosis
4843039|NCT02372383|Pharmacokinetics|pharmacokinetics
4843040|NCT02372383|Pharmacodynamics|pharmacodynamics
4843041|NCT02372383|Nontuberculous Mycobacteria|nontuberculous mycobacteria
4843042|NCT02372383|Treatment|treatment
4843043|NCT02372357|chemotherapy|chemotherapy
4843044|NCT02372357|stem cell transplantation|stem cell transplantation
4843045|NCT02372344|the effect of food timing on PK|the effect of food timing on pk
4843046|NCT02372344|the effect of food timing on Safety and Tolerability|the effect of food timing on safety and tolerability
4843047|NCT02372344|AZD0585|azd0585
4843048|NCT02372344|Japanese|japanese
4843049|NCT02372331|pancreaticoduodenectomy|pancreaticoduodenectomy
4843050|NCT02372331|ERAS|eras
4843051|NCT02372331|Whipple's operation|whipple's operation
4843052|NCT02372331|Fast track|fast track
4843053|NCT02372318|opiod receptor modulator nalmefene|opiod receptor modulator nalmefene
4843054|NCT02372318|cue-reactivity|cue-reactivity
4843055|NCT02372318|fMRI|fmri
4843056|NCT02372318|resting-state networks|resting-state networks
4843057|NCT02372292|cardiorenal syndrome, decompensated heart failure, renal resistivity index, venous impedance index, kidney failure|cardiorenal syndrome, decompensated heart failure, renal resistivity index, venous impedance index, kidney failure
4843058|NCT02372279|Embryo development|embryo development
4843059|NCT02372279|Implantation|implantation
4843060|NCT02372279|In vitro fertilization|in vitro fertilization
4843061|NCT02372266|Infant, Newborn|infant, newborn
4843062|NCT02372266|hospital discharge|hospital discharge
4843063|NCT02372266|Early newborn discharge|early newborn discharge
4843064|NCT02372266|Newborn length of stay|newborn length of stay
4843065|NCT02372266|Maternity length of stay|maternity length of stay
4843066|NCT02372253|verapamil|verapamil
4843067|NCT02372253|type 1 diabetes|type 1 diabetes
4843068|NCT02372253|diabetes|diabetes
4843069|NCT02372253|beta cells|beta cells
4843070|NCT02372253|beta cell function|beta cell function
4843071|NCT02372253|insulin|insulin
4843072|NCT02372214|Endovascular Procedures|endovascular procedures
4843073|NCT02372214|3D printing|3d printing
4843074|NCT02372214|Simulation|simulation
4843075|NCT02372214|Training|training
4843076|NCT02372214|Learning curve|learning curve
4843077|NCT02372214|Education|education
4843078|NCT02372201|irritable bowel disease|irritable bowel disease
4843079|NCT02372201|microbiota|microbiota
4843080|NCT02372201|hydro colon therapy|hydro colon therapy
4843081|NCT02372201|food intolerance|food intolerance
4843082|NCT02372175|Dengue|dengue
4843083|NCT02372162|Hepatocellular Carcinoma|hepatocellular carcinoma
4843084|NCT02372162|Molecular Diagnostics|molecular diagnostics
4843085|NCT02372162|Sorafenib|sorafenib
4843086|NCT02372162|Therapeutic chemoembolization|therapeutic chemoembolization
4843087|NCT02372162|Next-generation sequencing|next-generation sequencing
4843088|NCT02372162|Sequence analysis, DNA|sequence analysis, dna
4843089|NCT02372162|Sequence analysis, RNA|sequence analysis, rna
4843090|NCT02372162|Metabolomics|metabolomics
4843091|NCT02372123|Dysmenorrhea|dysmenorrhea
4843092|NCT02372123|Primary dysmenorrhea|primary dysmenorrhea
4843093|NCT02372123|physiotherapy|physiotherapy
4843094|NCT02372123|massage|massage
4843095|NCT02372123|connective tissue massage|connective tissue massage
4843096|NCT02372123|connective tissue manipulation|connective tissue manipulation
4843097|NCT02372084|Hepatic impairment,|hepatic impairment,
4843098|NCT02372084|osilodrostat,|osilodrostat,
4843099|NCT02372084|LCI699|lci699
4843100|NCT02372032|Herniation|herniation
4843101|NCT02372032|Discectomy|discectomy
4843102|NCT02372032|Ozone|ozone
4843103|NCT02372019|Social Anxiety Disorder|social anxiety disorder
4843104|NCT02372019|Social Phobia|social phobia
4843105|NCT02372019|Reconsolidation|reconsolidation
4843106|NCT02372019|Cognitive Bias Modification|cognitive bias modification
4843107|NCT02372019|Interpretation Bias|interpretation bias
4843108|NCT02371980|Drug therapy|drug therapy
4843109|NCT02371928|Shoulder|shoulder
4843110|NCT02371928|Instability|instability
4843111|NCT02371928|Neuromuscular|neuromuscular
4843112|NCT02371928|Physiotherapy|physiotherapy
4843113|NCT02371928|Exercise|exercise
4843114|NCT02371928|Dislocation|dislocation
4843115|NCT02371928|Recurrence|recurrence
4843116|NCT02371915|Rural access|rural access
4843117|NCT02371915|Telehealth|telehealth
4843118|NCT02371902|Elbow pain|elbow pain
4843119|NCT02371902|lateral epicondylitis|lateral epicondylitis
4843120|NCT02371902|conservative treatment|conservative treatment
4843121|NCT02371902|shock wave treatment|shock wave treatment
4843122|NCT02371902|therapeutic ultrasound|therapeutic ultrasound
4843123|NCT02371850|Bioequivalence|bioequivalence
4843124|NCT02371850|Therapeutic Equivalency|therapeutic equivalency
4843125|NCT02371824|Magnetic Resonance Imaging|magnetic resonance imaging
4843126|NCT02371824|Bone Marrow|bone marrow
4843127|NCT02371824|Hip|hip
4843128|NCT02371824|Lumbar Vertebrae|lumbar vertebrae
4843129|NCT02371785|Peripheral Arterial Disease|peripheral arterial disease
4843130|NCT02371785|Critical Limb Ischemia|critical limb ischemia
4843131|NCT02371785|Claudication|claudication
4843132|NCT02371785|Percutaneous Vascular Intervention|percutaneous vascular intervention
4843133|NCT02371785|Peripheral Vascular Intervention|peripheral vascular intervention
4843134|NCT02371772|Warfarin|warfarin
4843136|NCT02371772|Conventional care|conventional care
4843137|NCT02371733|pulmonary arterial hypertension|pulmonary arterial hypertension
4843138|NCT02371733|aerobic exercise training|aerobic exercise training
4843139|NCT02371733|upper extremity|upper extremity
4843140|NCT02371733|exercise capacity|exercise capacity
4843141|NCT02371694|Lipid|lipid
4843142|NCT02371694|Carbohydrate counting|carbohydrate counting
4843143|NCT02371694|Adolescent|adolescent
4843144|NCT02371694|Continuous glucose monitoring|continuous glucose monitoring
4843145|NCT02371694|Insulin requirements|insulin requirements
4843146|NCT02371681|HR2E/RIPE|hr2e/ripe
4843147|NCT02371681|South Africa|south africa
4843148|NCT02371681|Time to Positivity/TTP|time to positivity/ttp
4843149|NCT02371681|FDG-PET/CT|fdg-pet/ct
4843150|NCT02371668|Influenza A|influenza a
4843151|NCT02371668|H1N1|h1n1
4843152|NCT02371668|Challenge Model|challenge model
4843153|NCT02371668|Human Immunoglobulin and H1N1|human immunoglobulin and h1n1
4843154|NCT02371668|Efficacy and Safety in H1N1|efficacy and safety in h1n1
4843155|NCT02371655|Bowel cleansing|bowel cleansing
4843156|NCT02371655|CTcolonography|ctcolonography
4843157|NCT02371655|Bowel preparation|bowel preparation
4843158|NCT02371655|Faecal and fluid tagging|faecal and fluid tagging
4843159|NCT02371642|Echocardiography|echocardiography
4843160|NCT02371629|Anticholinergic|anticholinergic
4843161|NCT02371629|Antimuscarinic|antimuscarinic
4843162|NCT02371629|Chronic Obstructive Airway Disease|chronic obstructive airway disease
4843163|NCT02371629|Chronic Obstructive Lung Disease|chronic obstructive lung disease
4843164|NCT02371629|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
4843165|NCT02371629|COPD|copd
4843166|NCT02371629|LAMA|lama
4843167|NCT02371629|Lung Disease|lung disease
4843168|NCT02371629|Lung Diseases, Obstructive|lung diseases, obstructive
4843169|NCT02371629|Lung Function|lung function
4843170|NCT02371629|Muscarinic receptor antagonist|muscarinic receptor antagonist
4843171|NCT02371629|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
4843172|NCT02371629|Respiratory Tract Diseases|respiratory tract diseases
4843173|NCT02371603|Prolyl hydroxylase inhibitor|prolyl hydroxylase inhibitor
4843174|NCT02371603|GSK1278863|gsk1278863
4843175|NCT02371603|Anemia|anemia
4843176|NCT02371603|Drug interaction|drug interaction
4843177|NCT02371590|cancer|cancer
4843178|NCT02371590|lenalidomide|lenalidomide
4843179|NCT02371590|obinutuzumab|obinutuzumab
4843180|NCT02371590|CLL|cll
4843181|NCT02371577|Revlimid|revlimid
4843182|NCT02371551|Diffusion Magnetic Resonance Imaging|diffusion magnetic resonance imaging
4843183|NCT02371551|Medical Sonography|medical sonography
4843184|NCT02371551|Computed Tomography, X-Ray|computed tomography, x-ray
4843185|NCT02371538|stem cell transplant|stem cell transplant
4843186|NCT02371538|human breastmilk|human breastmilk
4843187|NCT02371525|adherence|adherence
4843188|NCT02371525|prevention|prevention
4843189|NCT02371512|Mitral Valve Insufficiency|mitral valve insufficiency
4843190|NCT02371499|Irritable Bowel Syndrome|irritable bowel syndrome
4843191|NCT02371499|Lactobacillus casei dg|lactobacillus casei dg
4843192|NCT02371499|microbiota|microbiota
4843193|NCT02371486|cesarean section defect|cesarean section defect
4843194|NCT02371486|implantation|implantation
4843195|NCT02371486|ivf|ivf
4843196|NCT02371473|Acetazolamide|acetazolamide
4843197|NCT02371473|Central Sleep Apnea|central sleep apnea
4843198|NCT02371473|Opium Abuse|opium abuse
4843199|NCT02371460|Neonatal Prematurity|neonatal prematurity
4843200|NCT02371460|Omega-3 Fatty Acids|omega-3 fatty acids
4843201|NCT02371460|Breastfeeding|breastfeeding
4843202|NCT02371447|bladder cancer|bladder cancer
4843203|NCT02371447|recurrent non-muscle invasive bladder cancer|recurrent non-muscle invasive bladder cancer
4843204|NCT02371447|VPM1002BC|vpm1002bc
4843205|NCT02371447|BCG therapy|bcg therapy
4843206|NCT02371369|PLX3397|plx3397
4843207|NCT02371369|Pexidartinib|pexidartinib
4843208|NCT02371369|Colony Stimulating Factor 1 Receptor (CSF-1R) inhibitor|colony stimulating factor 1 receptor (csf-1r) inhibitor
4843209|NCT02371330|Thrombocytopenia|thrombocytopenia
4843210|NCT02371330|Neonate|neonate
4843211|NCT02371330|PFA-100|pfa-100
4843212|NCT02371330|Neo-BAT|neo-bat
4843213|NCT02371330|Hemorrhage|hemorrhage
4843214|NCT02371317|Randomized clinical trial|randomized clinical trial
4843215|NCT02371317|Early medical intervention|early medical intervention
4843216|NCT02371317|Intervention studies|intervention studies
4843217|NCT02371317|Blood pressure|blood pressure
4843218|NCT02371317|Stress Management|stress management
4843219|NCT02371304|local therapy|local therapy
4843220|NCT02371304|adjuvant chemoradiotherapy|adjuvant chemoradiotherapy
4843221|NCT02371304|rectal preserving|rectal preserving
4843222|NCT02371291|Memory Flexibility|memory flexibility
4843223|NCT02371278|Leucine|leucine
4843224|NCT02371278|Protein|protein
4843225|NCT02371278|Diet|diet
4843226|NCT02371278|Muscle protein synthesis|muscle protein synthesis
4843227|NCT02371265|HIV|hiv
4843228|NCT02371265|Mozambique|mozambique
4843229|NCT02371265|antenatal care|antenatal care
4843230|NCT02371265|adherence|adherence
4843231|NCT02371265|retention|retention
4843232|NCT02371265|pregnancy|pregnancy
4843233|NCT02371265|HIV-positive mothers retained in ART after 90 days|hiv-positive mothers retained in art after 90 days
4843234|NCT02371252|Osteoporosis|osteoporosis
4843235|NCT02371252|Bisphosphonates|bisphosphonates
4843236|NCT02371252|Alendronate|alendronate
4843237|NCT02371252|Bone mineral density|bone mineral density
4843238|NCT02371252|Bone markers|bone markers
4843239|NCT02371239|Glucose regulation|glucose regulation
4843240|NCT02371239|Glucose|glucose
4843241|NCT02371239|Lipids|lipids
4843242|NCT02371226|MPS I|mps i
4843243|NCT02371213|Social Networking|social networking
4843244|NCT02371213|Mobile phone|mobile phone
4843245|NCT02371213|Antenatal Care|antenatal care
4843246|NCT02371213|Health education|health education
4843247|NCT02371213|Maternal outcome|maternal outcome
4843248|NCT02371213|Neonatal outcome|neonatal outcome
4843249|NCT02371174|HER2-Negative Inoperable or Recurrent Breast Cancer|her2-negative inoperable or recurrent breast cancer
4843250|NCT02371174|Japan|japan
4843251|NCT02371174|Eribulin Mesylate|eribulin mesylate
4843252|NCT02371135|Gut Microbiome|gut microbiome
4843253|NCT02371135|15-016|15-016
4843254|NCT02371083|Pelvic organ prolapse managed by vaginal pessary|pelvic organ prolapse managed by vaginal pessary
4843255|NCT02370979|Dolutegravir|dolutegravir
4843256|NCT02370979|Proviral HIV-1 DNA|proviral hiv-1 dna
4843257|NCT02370979|Reservoir|reservoir
4843258|NCT02370953|Toric IOL alignment|toric iol alignment
4843259|NCT02370953|VERION digital marker|verion digital marker
4843260|NCT02370953|Manual ink-marking|manual ink-marking
4843261|NCT02370953|Randomized controlled trial|randomized controlled trial
4843262|NCT02370940|Iron bioavailability|iron bioavailability
4843263|NCT02370940|phytate|phytate
4843264|NCT02370940|serum iron curve|serum iron curve
4843265|NCT02370940|hepcidin|hepcidin
4843266|NCT02370940|iron status|iron status
4843267|NCT02370914|Concussion|concussion
4843268|NCT02370888|Lenalidomide|lenalidomide
4843269|NCT02370888|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
4843270|NCT02370888|Peripheral Blood Stem Cell Transplantation|peripheral blood stem cell transplantation
4843271|NCT02370862|Spinal Cord Injury|spinal cord injury
4843272|NCT02370862|Neurogenic Bowel|neurogenic bowel
4843273|NCT02370862|Bowel Evacuation|bowel evacuation
4843274|NCT02370862|Gut Motility|gut motility
4843275|NCT02370849|nimotuzumab|nimotuzumab
4843276|NCT02370849|gastric adenocarcinoma|gastric adenocarcinoma
4843277|NCT02370849|Cisplatin|cisplatin
4843278|NCT02370849|S-1|s-1
4843279|NCT02370849|epidermal growth factor receptor|epidermal growth factor receptor
4843280|NCT02370836|distress|distress
4843281|NCT02370823|Osteoarthritis|osteoarthritis
4843282|NCT02370823|Knee|knee
4843283|NCT02370810|tinnitus treatment, internet-intervention, CBT|tinnitus treatment, internet-intervention, cbt
4843284|NCT02370797|IOERT|ioert
4843285|NCT02370797|Radiation|radiation
4843286|NCT02370797|Single fraction|single fraction
4843287|NCT02370797|Lumpectomy|lumpectomy
4843288|NCT02370797|Radiation therapy|radiation therapy
4843289|NCT02370797|Avera|avera
4843290|NCT02370784|early diffuse scleroderma|early diffuse scleroderma
4843291|NCT02370784|Raynaud|raynaud
4843292|NCT02370758|Quantiferon-CMV|quantiferon-cmv
4843293|NCT02370758|Quantiferon-Monitor|quantiferon-monitor
4843294|NCT02370758|Solid Organ Transplants|solid organ transplants
4843295|NCT02370758|CMV Disease|cmv disease
4843296|NCT02370745|Incretin|incretin
4843297|NCT02370745|GLP-1|glp-1
4843298|NCT02370745|Skeletal muscle metabolism|skeletal muscle metabolism
4843299|NCT02370745|Microvascular recruitment|microvascular recruitment
4843300|NCT02370745|Amino Acids|amino acids
4843301|NCT02370745|Microvascular blood flow|microvascular blood flow
4843302|NCT02370732|Alcohol|alcohol
4843303|NCT02370732|Bariatric Surgery|bariatric surgery
4843304|NCT02370732|Roux en Y Gastric bypass|roux en y gastric bypass
4843305|NCT02370732|Alcohol impairment|alcohol impairment
4843306|NCT02370732|Alcohol reinforcement|alcohol reinforcement
4843307|NCT02370732|Alcohol pharmacokinetics|alcohol pharmacokinetics
4843308|NCT02370719|Diabetes mellitus|diabetes mellitus
4843309|NCT02370719|Randomized controlled trial|randomized controlled trial
4843310|NCT02370719|Primary care|primary care
4843311|NCT02370719|Physical activity|physical activity
4843312|NCT02370719|Lifestyle|lifestyle
4843313|NCT02370719|Blood glucose|blood glucose
4843314|NCT02370719|Mobile health|mobile health
4843315|NCT02370719|Hb A1c|hb a1c
4843316|NCT02370719|Self-management|self-management
4843317|NCT02370706|PIM447|pim447
4843318|NCT02370706|LGH447|lgh447
4843319|NCT02370706|PIM inhibitor|pim inhibitor
4843320|NCT02370706|LEE011|lee011
4843321|NCT02370706|CDK 4/6 inhibitor|cdk 4/6 inhibitor
4843322|NCT02370706|ruxolitinib|ruxolitinib
4843323|NCT02370706|INC424|inc424
4843324|NCT02370706|Jakavi®|jakavi®
4843325|NCT02370706|Jakafi®|jakafi®
4843326|NCT02370706|INCB18424|incb18424
4843327|NCT02370706|JAK inhibitor|jak inhibitor
4843328|NCT02370706|myelofibrosis|myelofibrosis
4843329|NCT02370706|PMF|pmf
4843330|NCT02370706|PPV-MF|ppv-mf
4843331|NCT02370706|PET-MF|pet-mf
4843332|NCT02370693|mycophenolate|mycophenolate
4843333|NCT02370693|lung scarring|lung scarring
4843334|NCT02370680|Antiplatelet|antiplatelet
4843335|NCT02370680|Antiplatelet therapy|antiplatelet therapy
4843336|NCT02370680|platelet turnover|platelet turnover
4843337|NCT02370680|high platelet turnover|high platelet turnover
4843338|NCT02370680|platelet aggregation|platelet aggregation
4843339|NCT02370680|cardiovascular disease|cardiovascular disease
4843340|NCT02370680|coronary artery disease|coronary artery disease
4843341|NCT02370680|diabetes mellitus|diabetes mellitus
4843342|NCT02370667|Exercise|exercise
4843343|NCT02370667|Magnetic Resonance Imaging|magnetic resonance imaging
4843344|NCT02370654|COPD|copd
4843345|NCT02370654|Tai chi|tai chi
4843346|NCT02370654|Pulmonary rehabilitation|pulmonary rehabilitation
4843347|NCT02370641|urolithin A|urolithin a
4843348|NCT02370641|microflora|microflora
4843349|NCT02370628|percutaneous vertebroplasty|percutaneous vertebroplasty
4843350|NCT02370628|facet block|facet block
4843351|NCT02370602|Drug therapy|drug therapy
4843352|NCT02370589|Ebola|ebola
4843353|NCT02370537|omega-3 carboxylic acid|omega-3 carboxylic acid
4843354|NCT02370498|Gastric cancer|gastric cancer
4843355|NCT02370498|Gastroesophageal junction cancer|gastroesophageal junction cancer
4843356|NCT02370498|PD1|pd1
4843357|NCT02370498|PD-1|pd-1
4843358|NCT02370498|PDL1|pdl1
4843359|NCT02370498|PD-L1|pd-l1
4843360|NCT02370472|Ultrasound|ultrasound
4843361|NCT02370472|Image|image
4843362|NCT02370472|Learning Tool|learning tool
4843363|NCT02370472|Ultrasound Guide Procedures|ultrasound guide procedures
4843364|NCT02370472|Simulated Setting|simulated setting
4843365|NCT02370459|Papillomavirus Vaccines|papillomavirus vaccines
4843366|NCT02370459|Immunization|immunization
4843367|NCT02370459|Quality Improvement|quality improvement
4843368|NCT02370459|Adolescent Health Services|adolescent health services
4843369|NCT02370446|Medication Log|medication log
4843370|NCT02370446|15-008|15-008
4843371|NCT02370433|Spinal Cord Injury|spinal cord injury
4843372|NCT02370433|Neurogenic Bowel|neurogenic bowel
4843373|NCT02370433|Bowel Evacuation|bowel evacuation
4843374|NCT02370420|Platelet-rich plasma|platelet-rich plasma
4843375|NCT02370420|Osteoarthritis|osteoarthritis
4843376|NCT02370407|surgical education|surgical education
4843377|NCT02370407|minimally invasive surgical procedures|minimally invasive surgical procedures
4843378|NCT02370407|laparoscopic simulation|laparoscopic simulation
4843379|NCT02370407|robotic simulation|robotic simulation
4843380|NCT02370407|medical education|medical education
4843381|NCT02370394|Intimate Partner Violence|intimate partner violence
4843382|NCT02370394|Perinatal Women|perinatal women
4843383|NCT02370394|Mental Health|mental health
4843384|NCT02370316|metacognition|metacognition
4843385|NCT02370316|MRI|mri
4843386|NCT02370316|Psychotherapy|psychotherapy
4843387|NCT02370251|Fat Emulsions, Intravenous|fat emulsions, intravenous
4843388|NCT02370251|Parenteral-Nutrition-Associated Liver Disease|parenteral-nutrition-associated liver disease
4843389|NCT02370251|Cholestasis|cholestasis
4843390|NCT02370251|Omegaven|omegaven
4843391|NCT02370251|Fish Oil|fish oil
4843392|NCT02370238|Triple negative metastatic breast cancer|triple negative metastatic breast cancer
4843393|NCT02370238|Cancer Stem Cells|cancer stem cells
4843394|NCT02370225|sjogren's syndrome|sjogren's syndrome
4843395|NCT02370225|aerobic exercise|aerobic exercise
4843396|NCT02370225|fatigue|fatigue
4843397|NCT02370212|Creatine|creatine
4843398|NCT02370212|interval training|interval training
4843399|NCT02370212|effects on performance|effects on performance
4843400|NCT02370173|PTSD|ptsd
4843401|NCT02370173|Stress|stress
4843402|NCT02370173|Sleep Problems|sleep problems
4843403|NCT02370173|Brain imaging|brain imaging
4843404|NCT02370173|fMRI|fmri
4843405|NCT02370147|smoking reduction intervention|smoking reduction intervention
4843406|NCT02370147|no intention to quit|no intention to quit
4843407|NCT02370147|randomized controlled trial|randomized controlled trial
4843408|NCT02370147|telephone follow-up intervention|telephone follow-up intervention
4843409|NCT02370121|Gymnema Sylvestre|gymnema sylvestre
4843410|NCT02370121|Insulin Secretion|insulin secretion
4843411|NCT02370121|Insulin Sensitivity|insulin sensitivity
4843412|NCT02370121|Central Obesity|central obesity
4843413|NCT02370108|electrical muscle stimulation|electrical muscle stimulation
4843414|NCT02370108|parkinson's disease|parkinson's disease
4843415|NCT02370108|rest tremor|rest tremor
4843416|NCT02370108|tremor reduction|tremor reduction
4843417|NCT02370095|ARDS|ards
4843418|NCT02370095|Acute Lung Injury|acute lung injury
4843419|NCT02370095|Acute Respiratory Failure|acute respiratory failure
4843420|NCT02370082|lumpectomy|lumpectomy
4843421|NCT02370082|breast conserving surgery|breast conserving surgery
4843422|NCT02370030|sepsis|sepsis
4843423|NCT02370030|citrulline|citrulline
4843424|NCT02370030|endothelial|endothelial
4843425|NCT02370030|toxemia|toxemia
4843426|NCT02370030|endothelial determination of progression|endothelial determination of progression
4843427|NCT02370030|with vs without citrulline|with vs without citrulline
4843428|NCT02370017|Autologous Ex vivo-expanded NK cell enriched lymphocytes|autologous ex vivo-expanded nk cell enriched lymphocytes
4843429|NCT02370004|Asthma|asthma
4843430|NCT02370004|RFST|rfst
4843431|NCT02370004|Bronchial Diseases|bronchial diseases
4843432|NCT02370004|Respiratory Tract Diseases|respiratory tract diseases
4843433|NCT02370004|Lung Diseases, Obstructive|lung diseases, obstructive
4843434|NCT02370004|Lung Diseases|lung diseases
4843435|NCT02369991|latissimus dorsi flap|latissimus dorsi flap
4843436|NCT02369991|bone transport|bone transport
4843437|NCT02369991|bone reconstruction|bone reconstruction
4843438|NCT02369991|tibia|tibia
4843439|NCT02369991|tibial fracture|tibial fracture
4843440|NCT02369978|Trypanocidal therapy|trypanocidal therapy
4843441|NCT02369978|Benznidazole|benznidazole
4843442|NCT02369978|Nifurtimox|nifurtimox
4843443|NCT02369978|Polymerase chain reaction|polymerase chain reaction
4843444|NCT02369978|Randomized trial|randomized trial
4843445|NCT02369965|HIV-1|hiv-1
4843446|NCT02369965|AIDS|aids
4843447|NCT02369965|Albuvirtide|albuvirtide
4843448|NCT02369965|Treatment-experienced|treatment-experienced
4843449|NCT02369965|Fusion inhibitor|fusion inhibitor
4843450|NCT02369939|anal carcinoma|anal carcinoma
4843451|NCT02369939|hyperthermia|hyperthermia
4843452|NCT02369939|radiotherapy|radiotherapy
4843453|NCT02369939|chemotherapy|chemotherapy
4843454|NCT02369939|radiochemotherapy|radiochemotherapy
4843455|NCT02369926|multiple sclerosis|multiple sclerosis
4843456|NCT02369926|telemedicine|telemedicine
4843457|NCT02369926|remote monitoring|remote monitoring
4843458|NCT02369926|lisinopril|lisinopril
4843459|NCT02369900|Esmolol|esmolol
4843460|NCT02369900|Septic Shock|septic shock
4843461|NCT02369900|Hypotension|hypotension
4843462|NCT02369900|Tachycardia|tachycardia
4843463|NCT02369887|MSM/TG who agree to start PrEP|msm/tg who agree to start prep
4843464|NCT02369874|Head and Neck cancer; MEDI4736; Tremelimumab|head and neck cancer; medi4736; tremelimumab
4843465|NCT02369822|Vitamin C|vitamin c
4843466|NCT02369822|convulsions status|convulsions status
4843467|NCT02369822|EEG|eeg
4843468|NCT02369822|children|children
4843469|NCT02369809|Ischemia|ischemia
4843470|NCT02369796|Drug therapy|drug therapy
4843471|NCT02369770|Acute Stroke|acute stroke
4843472|NCT02369770|Robotic therapy|robotic therapy
4843473|NCT02369770|Ankle impairment|ankle impairment
4843474|NCT02369744|Ureteral calculus|ureteral calculus
4843475|NCT02369744|Ureterolithiasis|ureterolithiasis
4843476|NCT02369744|Ureteral stone|ureteral stone
4843477|NCT02369744|Kidney stone|kidney stone
4843478|NCT02369744|Medical expulsive therapy|medical expulsive therapy
4843479|NCT02369744|tamsulosin|tamsulosin
4843480|NCT02369744|silodosin|silodosin
4843481|NCT02369744|rapaflo|rapaflo
4843482|NCT02369744|flomax|flomax
4843483|NCT02369679|upper limb|upper limb
4843484|NCT02369679|lymphedema|lymphedema
4843485|NCT02369666|Inflammation|inflammation
4843486|NCT02369666|Lycopene|lycopene
4843487|NCT02369666|Exercise|exercise
4843488|NCT02369653|Anticoagulation|anticoagulation
4843489|NCT02369614|rTMS - repetitive transcranial magnetic stimulation|rtms - repetitive transcranial magnetic stimulation
4843490|NCT02369614|CAPS - Clinician Administered PTSD Scale|caps - clinician administered ptsd scale
4843491|NCT02369601|amniorrhexis|amniorrhexis
4843492|NCT02369601|Ruptured membranes|ruptured membranes
4843493|NCT02369601|Alfa-fetoprotein|alfa-fetoprotein
4843494|NCT02369562|Dental implants|dental implants
4843495|NCT02369562|Periodontal Bone Loss|periodontal bone loss
4843496|NCT02369549|Chronic Kidney Disease (CKD)|chronic kidney disease (ckd)
4843497|NCT02369549|Micro-particle curcumin|micro-particle curcumin
4843498|NCT02369549|Albuminuria|albuminuria
4843499|NCT02369536|NAFLD|nafld
4843500|NCT02369536|nutraceutical mixture|nutraceutical mixture
4843501|NCT02369523|Primary Total Knee Arthroplasty|primary total knee arthroplasty
4843502|NCT02369510|spinal anesthesia|spinal anesthesia
4843503|NCT02369510|epinephrine|epinephrine
4843504|NCT02369510|bupivacaine|bupivacaine
4843505|NCT02369510|repeat cesarean|repeat cesarean
4843506|NCT02369484|Stage IIIb/ IV NSCLC harbouring HER2 exon 20 mutations|stage iiib/ iv nsclc harbouring her2 exon 20 mutations
4843507|NCT02369471|Cannabidivarin|cannabidivarin
4843508|NCT02369471|CBDV|cbdv
4843509|NCT02369471|GWP42006|gwp42006
4843510|NCT02369432|Drug carriers|drug carriers
4843511|NCT02369432|Polymeric microparticles|polymeric microparticles
4843512|NCT02369432|Preferential accumulation in inflamed skin|preferential accumulation in inflamed skin
4843513|NCT02369432|Atopic dermatitis|atopic dermatitis
4843514|NCT02369432|Pilosebaceous follicles|pilosebaceous follicles
4843515|NCT02369432|Selective drug delivery|selective drug delivery
4843516|NCT02369432|Drug reservoir|drug reservoir
4843517|NCT02369419|frailty|frailty
4843518|NCT02369419|Heart failure|heart failure
4843519|NCT02369419|cardiac resynchronization therapy|cardiac resynchronization therapy
4843520|NCT02369406|Botswana|botswana
4843521|NCT02369406|Immunology|immunology
4843522|NCT02369406|Antiretroviral Therapy|antiretroviral therapy
4843523|NCT02369393|Internet based treatment|internet based treatment
4843524|NCT02369393|Depression|depression
4843525|NCT02369393|Efficacy|efficacy
4843526|NCT02369393|Cost-effectiveness|cost-effectiveness
4843527|NCT02369393|Behavioral Activation|behavioral activation
4843528|NCT02369393|Self-applied|self-applied
4843529|NCT02369393|Ecological Momentary Assessment|ecological momentary assessment
4843530|NCT02369393|Physical Activity|physical activity
4843531|NCT02369367|Malignant Gliomas|malignant gliomas
4843532|NCT02369367|Glioblastoma Multiforme|glioblastoma multiforme
4843533|NCT02369367|Gliosarcoma|gliosarcoma
4843534|NCT02369367|Anaplastic Astrocytoma|anaplastic astrocytoma
4843535|NCT02369367|Anaplastic Oligodendroglioma|anaplastic oligodendroglioma
4843536|NCT02369367|Anaplastic Oligoastrocytoma|anaplastic oligoastrocytoma
4843537|NCT02369367|Camptosar|camptosar
4843538|NCT02369367|Irinotecan|irinotecan
4843539|NCT02369367|CPT-11|cpt-11
4843540|NCT02369367|Lenalidomide|lenalidomide
4843541|NCT02369367|Revlimid|revlimid
4843542|NCT02369367|CC-5013|cc-5013
4843543|NCT02369354|Kidney Transplant|kidney transplant
4843544|NCT02369354|African Americans|african americans
4843545|NCT02369341|Southern Hemisphere influenza vaccine|southern hemisphere influenza vaccine
4843546|NCT02369341|Elderly|elderly
4843547|NCT02369341|Seasonal flu|seasonal flu
4843548|NCT02369341|Fluarix Tetra|fluarix tetra
4843549|NCT02369341|Adults|adults
4843550|NCT02369341|Immunogenicity|immunogenicity
4843551|NCT02369341|Reactogenicity|reactogenicity
4843552|NCT02369341|Influenza|influenza
4843553|NCT02369315|child development|child development
4843554|NCT02369315|music training|music training
4843555|NCT02369315|self-regulation|self-regulation
4843556|NCT02369315|exposure to violence|exposure to violence
4843557|NCT02369276|neck dissection surgery|neck dissection surgery
4843558|NCT02369276|shoulder disability|shoulder disability
4843559|NCT02369276|musculoskeletal ultrasonography|musculoskeletal ultrasonography
4843560|NCT02369263|Deep Vein Thrombosis|deep vein thrombosis
4843562|NCT02369263|Leg Swelling|leg swelling
4843563|NCT02369263|Leg Pain|leg pain
4843564|NCT02369263|Blood Clot|blood clot
4843565|NCT02369250|regeneration|regeneration
4843566|NCT02369250|surgical therapy|surgical therapy
4843567|NCT02369250|furcation defect|furcation defect
4843568|NCT02369211|acetaminophen|acetaminophen
4843569|NCT02369172|Herpes|herpes
4843570|NCT02369172|volunteers|volunteers
4843571|NCT02369172|drug-drug interaction|drug-drug interaction
4843572|NCT02369120|patient education|patient education
4843573|NCT02369120|pain cognitions|pain cognitions
4843574|NCT02369107|acupuncture|acupuncture
4843575|NCT02369107|chemotherapy-induced nausea and vomiting|chemotherapy-induced nausea and vomiting
4843576|NCT02369094|Frailty|frailty
4843577|NCT02369094|Frail elderly|frail elderly
4843578|NCT02369094|Acupressure|acupressure
4843579|NCT02369094|Pragmatic Randomised Controlled Trial|pragmatic randomised controlled trial
4843580|NCT02369081|Hypertension|hypertension
4843581|NCT02369055|Rehabilitation|rehabilitation
4843582|NCT02369029|Phase I|phase i
4843583|NCT02369029|Dose escalation|dose escalation
4843584|NCT02369029|NUT-midline carcinoma|nut-midline carcinoma
4843585|NCT02369029|Acute Leucemia|acute leucemia
4843586|NCT02369029|Lymphoma|lymphoma
4843587|NCT02369029|Melanoma|melanoma
4843588|NCT02369029|Myeloma|myeloma
4843589|NCT02369029|HCC|hcc
4843590|NCT02369029|NSCLC|nsclc
4843591|NCT02369016|indolent Non-Hodgkin lymphoma|indolent non-hodgkin lymphoma
4843592|NCT02369016|rituximab-refractory|rituximab-refractory
4843593|NCT02369003|Deep Brain Stimulation|deep brain stimulation
4843594|NCT02369003|Schwann Cells|schwann cells
4843595|NCT02368990|NSCLC|nsclc
4843596|NCT02368990|T790M|t790m
4843597|NCT02368990|EGFR|egfr
4843598|NCT02368990|TKI Resistance|tki resistance
4843599|NCT02368990|Non Small Cell Lung Cancer|non small cell lung cancer
4843600|NCT02368990|AZD9291|azd9291
4843601|NCT02368990|Clovis|clovis
4843602|NCT02368977|Colonoscopy|colonoscopy
4843603|NCT02368977|Polyps|polyps
4843604|NCT02368977|Adenomas|adenomas
4843605|NCT02368964|double triggering|double triggering
4843606|NCT02368964|Oocyte maturation|oocyte maturation
4843607|NCT02368964|GNRH Agonist|gnrh agonist
4843608|NCT02368964|hCG|hcg
4843609|NCT02368964|IVF treatment|ivf treatment
4843610|NCT02368964|immature oocytes|immature oocytes
4843611|NCT02368951|Phase 1|phase 1
4843612|NCT02368951|Solid Tumors|solid tumors
4843613|NCT02368951|FGFR2|fgfr2
4843614|NCT02368951|Antibody drug conjugate|antibody drug conjugate
4843615|NCT02368938|Cardiovascular risk factors|cardiovascular risk factors
4843616|NCT02368938|Prospective study|prospective study
4843617|NCT02368938|Mortality|mortality
4843618|NCT02368938|Cardiovascular events|cardiovascular events
4843619|NCT02368938|Asymptomatic target organ damage|asymptomatic target organ damage
4843620|NCT02368938|elderly Chinese|elderly chinese
4843621|NCT02368925|Rhytids|rhytids
4843622|NCT02368925|Skin Laxity|skin laxity
4843623|NCT02368912|Phase 1|phase 1
4843624|NCT02368912|ASP1707|asp1707
4843625|NCT02368912|Dose escalation|dose escalation
4843626|NCT02368912|Food effect|food effect
4843627|NCT02368912|Maximum tolerated dose (MTD)|maximum tolerated dose (mtd)
4843628|NCT02368912|Healthy subjects|healthy subjects
4843629|NCT02368912|Single ascending dose|single ascending dose
4843630|NCT02368912|Multiple ascending dose|multiple ascending dose
4843631|NCT02368899|technology|technology
4843632|NCT02368899|information science|information science
4843633|NCT02368899|health care|health care
4843634|NCT02368873|prevention|prevention
4843635|NCT02368847|Aged|aged
4843636|NCT02368847|Psychiatric Hospitals|psychiatric hospitals
4843637|NCT02368821|cytotrophoblast|cytotrophoblast
4843638|NCT02368821|syncytiotrophoblast|syncytiotrophoblast
4843639|NCT02368821|placentas|placentas
4843640|NCT02368821|intrauterine growth restriction|intrauterine growth restriction
4843641|NCT02368821|preeclampsia|preeclampsia
4843642|NCT02368821|placenta accrete|placenta accrete
4843643|NCT02368808|orphans and vulnerable children|orphans and vulnerable children
4843644|NCT02368808|South Africa|south africa
4843645|NCT02368808|peer support group|peer support group
4843646|NCT02368795|Endoscopic Retrograde Cholangiopancreatography|endoscopic retrograde cholangiopancreatography
4843647|NCT02368795|Pancreatic duct stenting|pancreatic duct stenting
4843648|NCT02368795|Post-ERCP pancreatitis|post-ercp pancreatitis
4843649|NCT02368782|transient evoked otoacoustic emissions|transient evoked otoacoustic emissions
4843650|NCT02368782|distortion product otoacoustic emissions|distortion product otoacoustic emissions
4843651|NCT02368782|ketamine|ketamine
4843652|NCT02368782|propofol|propofol
4843653|NCT02368782|child|child
4843654|NCT02368756|dme|dme
4843655|NCT02368704|Endoplasmic Reticulum|endoplasmic reticulum
4843656|NCT02368678|Halitosis|halitosis
4843657|NCT02368678|Sulfur compounds|sulfur compounds
4843658|NCT02368678|Periodontitis|periodontitis
4843659|NCT02368678|Periodontal treatment|periodontal treatment
4843660|NCT02368600|lifestyle intervention|lifestyle intervention
4843661|NCT02368600|gestational diabetes mellitus|gestational diabetes mellitus
4843662|NCT02368600|Chinese|chinese
4843663|NCT02368600|prevention|prevention
4843664|NCT02368587|intracoronary infusion|intracoronary infusion
4843665|NCT02368587|intravenous infusion|intravenous infusion
4843666|NCT02368587|Wharton's jelly-derived mesenchymal stem cells|wharton's jelly-derived mesenchymal stem cells
4843667|NCT02368587|ischemic Cardiomyopathy|ischemic cardiomyopathy
4843668|NCT02368587|heart function|heart function
4843669|NCT02368548|Pharmaceutical care|pharmaceutical care
4843670|NCT02368548|Emergency Service|emergency service
4843671|NCT02368535|teamwork|teamwork
4843672|NCT02368509|sensory test|sensory test
4843673|NCT02368509|olfaction|olfaction
4843674|NCT02368509|gustation|gustation
4843675|NCT02368509|taste|taste
4843676|NCT02368509|cancer|cancer
4843677|NCT02368496|Long-term parenteral nutrition|long-term parenteral nutrition
4843678|NCT02368496|HR-pQCT|hr-pqct
4843679|NCT02368496|DXA|dxa
4843680|NCT02368496|Bone trophicity|bone trophicity
4843681|NCT02368457|Mandibular osteoradionecrosis|mandibular osteoradionecrosis
4843682|NCT02368457|Tocopherol|tocopherol
4843683|NCT02368457|pentoxifylline|pentoxifylline
4843684|NCT02368457|vitamine E|vitamine e
4843685|NCT02368457|wounds and injuries|wounds and injuries
4843686|NCT02368457|antioxidants|antioxidants
4843687|NCT02368457|free radical scavengers|free radical scavengers
4843688|NCT02368457|radiation-protective agents|radiation-protective agents
4843689|NCT02368457|vasodilatadors agents|vasodilatadors agents
4843690|NCT02368457|osteonecrosis|osteonecrosis
4843691|NCT02368457|mandible|mandible
4843692|NCT02368457|extraoral fistula|extraoral fistula
4843693|NCT02368457|exposed bone|exposed bone
4843694|NCT02368457|necrotic bone|necrotic bone
4843695|NCT02368457|head and neck radiotherapy|head and neck radiotherapy
4843696|NCT02368444|Posttraumatic Stress|posttraumatic stress
4843697|NCT02368444|Sleep|sleep
4843698|NCT02368431|Alcohol Use Disorder|alcohol use disorder
4843699|NCT02368431|Alcoholism|alcoholism
4843700|NCT02368431|Alcohol Dependence|alcohol dependence
4843701|NCT02368431|Zonisamide|zonisamide
4843702|NCT02368431|Alcoholic Intoxication|alcoholic intoxication
4843703|NCT02368431|Drinking Behaviors|drinking behaviors
4843704|NCT02368431|Anticonvulsants|anticonvulsants
4843705|NCT02368418|Cardiovascular disease|cardiovascular disease
4843706|NCT02368418|Rural health|rural health
4843707|NCT02368418|China|china
4843708|NCT02368418|Cohort study|cohort study
4843709|NCT02368392|in-hospital cardiac arrest|in-hospital cardiac arrest
4843710|NCT02368392|quality of life after cardiac arrest|quality of life after cardiac arrest
4843711|NCT02368392|survival after cardiac arrest|survival after cardiac arrest
4843712|NCT02368392|resources for cardiac arrest|resources for cardiac arrest
4843713|NCT02368379|Metyrapone|metyrapone
4843714|NCT02368379|ACTH stimulation test|acth stimulation test
4843715|NCT02368314|Deep vein thrombosis|deep vein thrombosis
4843716|NCT02368314|Prophylaxis|prophylaxis
4843717|NCT02368314|Sodium enoxaparin|sodium enoxaparin
4843718|NCT02368288|chronic hepatitic B|chronic hepatitic b
4843719|NCT02368288|peginterferon|peginterferon
4843720|NCT02368288|HBsAg|hbsag
4843721|NCT02368288|entecavir|entecavir
4843722|NCT02368262|Cerebral Palsy|cerebral palsy
4843723|NCT02368262|Risk factors|risk factors
4843724|NCT02368262|Child|child
4843725|NCT02368262|urinary incontinence|urinary incontinence
4843726|NCT02368236|Early Detection of Cancer|early detection of cancer
4843727|NCT02368236|Intervention Studies|intervention studies
4843728|NCT02368236|Randomized Controlled Trial|randomized controlled trial
4843729|NCT02368236|Colorectal Neoplasms|colorectal neoplasms
4843730|NCT02368236|Colonic Neoplasms|colonic neoplasms
4843731|NCT02368223|Children|children
4843732|NCT02368223|Rehabilitation|rehabilitation
4843733|NCT02368223|Telerehabilitation|telerehabilitation
4843734|NCT02368223|Upper limb therapy|upper limb therapy
4843735|NCT02368197|dialysis fistula|dialysis fistula
4843736|NCT02368197|cephalic arch stenosis|cephalic arch stenosis
4843737|NCT02368197|balloon angioplasty|balloon angioplasty
4843840|NCT02367690|DFU|dfu
4843738|NCT02368197|drug eluting balloon|drug eluting balloon
4843739|NCT02368184|noninvasive physiologic monitoring|noninvasive physiologic monitoring
4843740|NCT02368184|acute decompensated heart failure (ADHF)|acute decompensated heart failure (adhf)
4843741|NCT02368158|myocard infarction|myocard infarction
4843742|NCT02368158|arrhythmia|arrhythmia
4843743|NCT02368158|fitness of driving|fitness of driving
4843744|NCT02368145|stroke|stroke
4843745|NCT02368145|acute stroke|acute stroke
4843746|NCT02368145|post stroke depression|post stroke depression
4843747|NCT02368132|Caregivers|caregivers
4843748|NCT02368132|Dementia|dementia
4843749|NCT02368106|patient registry|patient registry
4843750|NCT02368106|radiation oncology|radiation oncology
4843751|NCT02368106|technology assessment|technology assessment
4843752|NCT02368093|Rheumatoid arthritis|rheumatoid arthritis
4843753|NCT02368080|Lung Clearance Index|lung clearance index
4843754|NCT02368080|Cystic Fibrosis|cystic fibrosis
4843755|NCT02368080|Multiple Breath Nitrogen Washout|multiple breath nitrogen washout
4843756|NCT02368054|Epinephrine|epinephrine
4843757|NCT02368054|Bupivacaine|bupivacaine
4843758|NCT02368054|Stroke Volume|stroke volume
4843759|NCT02368054|Cardiac Output|cardiac output
4843760|NCT02368054|Heart Rate|heart rate
4843761|NCT02368054|Hemodynamics|hemodynamics
4843762|NCT02368054|Total Peripheral Resistance|total peripheral resistance
4843763|NCT02368054|Blood Pressure|blood pressure
4843764|NCT02368054|Paracervical block|paracervical block
4843765|NCT02368054|LiDCO|lidco
4843766|NCT02368054|Adrenaline|adrenaline
4843767|NCT02368054|Conization|conization
4843768|NCT02368054|PulsCO|pulsco
4843769|NCT02368028|Plaque|plaque
4843770|NCT02368028|Saliva|saliva
4843771|NCT02368028|Dental Caries|dental caries
4843772|NCT02368015|Penetration|penetration
4843773|NCT02368015|Cefazolin|cefazolin
4843774|NCT02368015|Hepatic cyst|hepatic cyst
4843775|NCT02368002|obesity|obesity
4843776|NCT02368002|diet, reducing|diet, reducing
4843777|NCT02367989|Glucose response|glucose response
4843778|NCT02367989|Insulin response|insulin response
4843779|NCT02367989|Satiety|satiety
4843780|NCT02367963|Peer education|peer education
4843781|NCT02367963|Comprehensive health intervention|comprehensive health intervention
4843782|NCT02367963|Lifestyle|lifestyle
4843783|NCT02367963|Adult|adult
4843784|NCT02367963|Mid age|mid age
4843785|NCT02367963|Male|male
4843786|NCT02367963|Female|female
4843787|NCT02367963|Human|human
4843788|NCT02367963|Clinical trial|clinical trial
4843789|NCT02367963|Prevention and control|prevention and control
4843790|NCT02367963|Cardiovascular Disease|cardiovascular disease
4843791|NCT02367963|Behavior|behavior
4843792|NCT02367963|Risk Factors|risk factors
4843793|NCT02367963|Healthy lifestyle|healthy lifestyle
4843794|NCT02367963|Healthy people program|healthy people program
4843795|NCT02367963|Peer-group|peer-group
4843796|NCT02367937|Phase I drug-drug interaction|phase i drug-drug interaction
4843797|NCT02367898|Cognitive Training|cognitive training
4843798|NCT02367898|Lumosity|lumosity
4843799|NCT02367898|Crossword Puzzles|crossword puzzles
4843800|NCT02367885|Prevention|prevention
4843801|NCT02367872|Drug therapy|drug therapy
4843802|NCT02367859|ameloblastoma|ameloblastoma
4843803|NCT02367859|BRAF|braf
4843804|NCT02367859|odontogenic cancer|odontogenic cancer
4843805|NCT02367859|adamantinoma|adamantinoma
4843806|NCT02367846|Calcium Tracer|calcium tracer
4843807|NCT02367846|Oral Contraceptives|oral contraceptives
4843808|NCT02367846|Contraceptive Vaginal Ring|contraceptive vaginal ring
4843809|NCT02367846|Impact of contraceptives on bone health using 41Ca|impact of contraceptives on bone health using 41ca
4843810|NCT02367833|Insulin-like growth factor-1|insulin-like growth factor-1
4843811|NCT02367833|Combined oral contraceptive|combined oral contraceptive
4843812|NCT02367833|Contraceptive Vaginal Ring|contraceptive vaginal ring
4843813|NCT02367833|Transdermal Contraceptive|transdermal contraceptive
4843814|NCT02367807|HIV prevention|hiv prevention
4843815|NCT02367807|PrEP|prep
4843816|NCT02367807|young men who have sex with men|young men who have sex with men
4843817|NCT02367807|Truvada|truvada
4843818|NCT02367768|trauma blue|trauma blue
4843819|NCT02367768|major trauma|major trauma
4843820|NCT02367768|cohort study|cohort study
4843821|NCT02367768|prognostic factor|prognostic factor
4843822|NCT02367768|Healing Time|healing time
4843823|NCT02367768|Post Operative|post operative
4843824|NCT02367755|cardiopulmonary resuscitation|cardiopulmonary resuscitation
4843825|NCT02367755|cardiac arrest|cardiac arrest
4843826|NCT02367755|therapeutic hypothermia|therapeutic hypothermia
4843827|NCT02367755|propofol|propofol
4843828|NCT02367755|lorazepam|lorazepam
4843829|NCT02367755|cerebral perfusion|cerebral perfusion
4843830|NCT02367755|electroencephalography|electroencephalography
4843831|NCT02367742|Diet|diet
4843832|NCT02367742|Physical Activity|physical activity
4843833|NCT02367742|NAFLD|nafld
4843834|NCT02367703|Mini-laparoscopy|mini-laparoscopy
4843835|NCT02367703|hysterectomy|hysterectomy
4843836|NCT02367703|Benign uterine diseases|benign uterine diseases
4843837|NCT02367703|Operative time|operative time
4843838|NCT02367690|Diabetes|diabetes
4843839|NCT02367690|Foot Ulcers|foot ulcers
4843841|NCT02367690|KPT-330|kpt-330
4843842|NCT02367690|Selinexor|selinexor
4843843|NCT02367690|Karyopharm|karyopharm
4843844|NCT02367677|Photo|photo
4843845|NCT02367664|Japanese encephalitis|japanese encephalitis
4843846|NCT02367664|immunogenicity|immunogenicity
4843847|NCT02367664|safety|safety
4843848|NCT02367664|vaccine|vaccine
4843849|NCT02367651|Soft tissue sarcoma|soft tissue sarcoma
4843850|NCT02367651|Pazopanib|pazopanib
4843851|NCT02367651|Tyrosine kinase inhibitor|tyrosine kinase inhibitor
4843852|NCT02367599|PrEP|prep
4843853|NCT02367599|Pre exposure Prophylaxis|pre exposure prophylaxis
4843854|NCT02367599|Truvada|truvada
4843855|NCT02367599|CCTG|cctg
4843856|NCT02367599|595|595
4843857|NCT02367599|Vitamin D|vitamin d
4843858|NCT02367599|Bone mineral density|bone mineral density
4843859|NCT02367521|TBI Depression|tbi depression
4843860|NCT02367521|co-morbid psychiatric symptoms|co-morbid psychiatric symptoms
4843861|NCT02367508|advance care planning|advance care planning
4843862|NCT02367508|coping skills|coping skills
4843863|NCT02367508|mindfulness|mindfulness
4843864|NCT02367508|meditation|meditation
4843865|NCT02367508|cancer|cancer
4843866|NCT02367508|adult|adult
4843867|NCT02367508|caregivers|caregivers
4843868|NCT02367508|oncology providers|oncology providers
4843869|NCT02367508|advance directives|advance directives
4843870|NCT02367508|anxiety|anxiety
4843871|NCT02367508|depression|depression
4843872|NCT02367508|quality of life|quality of life
4843873|NCT02367508|pilot project|pilot project
4843874|NCT02367495|Coronary Restenosis|coronary restenosis
4843875|NCT02367495|restenosis|restenosis
4843876|NCT02367495|paclitaxel-coated balloon|paclitaxel-coated balloon
4843877|NCT02367495|drug-eluting stent|drug-eluting stent
4843878|NCT02367495|drug-coated balloon|drug-coated balloon
4843879|NCT02367495|coronary angiography|coronary angiography
4843880|NCT02367482|rGBM|rgbm
4843881|NCT02367482|Recurrent GBM|recurrent gbm
4843882|NCT02367482|Recurrent Glioblastoma|recurrent glioblastoma
4843883|NCT02367469|recurrent brain tumors|recurrent brain tumors
4843884|NCT02367469|brain tumors|brain tumors
4843885|NCT02367469|Newly diagnosed brain tumors|newly diagnosed brain tumors
4843886|NCT02367456|MDS|mds
4843887|NCT02367456|AML|aml
4843888|NCT02367443|radiotherapy|radiotherapy
4843889|NCT02367443|therapeutic use|therapeutic use
4843890|NCT02367443|Radiation|radiation
4843891|NCT02367443|non-small cell lung cancer|non-small cell lung cancer
4843892|NCT02367443|chemotherapy|chemotherapy
4843893|NCT02367417|Revision|revision
4843894|NCT02367417|Knee Joint|knee joint
4843895|NCT02367417|PMCF|pmcf
4843896|NCT02367417|Endo-Modell SL|endo-modell sl
4843897|NCT02367378|Minimally invasive surgery|minimally invasive surgery
4843898|NCT02367365|Neovascular Age-Related Macular Degeneration|neovascular age-related macular degeneration
4843899|NCT02367365|anti-vascular endothelial growth factor|anti-vascular endothelial growth factor
4843900|NCT02367365|neovascular lesion morphology|neovascular lesion morphology
4843901|NCT02367365|indocyanine green angiography|indocyanine green angiography
4843902|NCT02367365|persistent disease activity|persistent disease activity
4843903|NCT02367352|Drug therapy|drug therapy
4843904|NCT02367352|dose escalation|dose escalation
4843905|NCT02367352|dose expansion|dose expansion
4843906|NCT02367339|Critical Care|critical care
4843907|NCT02367339|Nursing staff|nursing staff
4843908|NCT02367339|Medical staff|medical staff
4843909|NCT02367339|Extended-spectrum betalactamase|extended-spectrum betalactamase
4843910|NCT02367339|Digestive tract colonization|digestive tract colonization
4843911|NCT02367339|Cross-contamination|cross-contamination
4843912|NCT02367326|score|score
4843913|NCT02367326|inflammatory bowel disease|inflammatory bowel disease
4843914|NCT02367326|crohn's disease|crohn's disease
4843915|NCT02367326|ulcerative colitis|ulcerative colitis
4843916|NCT02367326|clinical response|clinical response
4843917|NCT02367326|thiopurines|thiopurines
4843918|NCT02367313|Symptomatic Human Rhinovirus Infection|symptomatic human rhinovirus infection
4843919|NCT02367313|Moderate to Severe Asthma|moderate to severe asthma
4843920|NCT02367313|Antiviral|antiviral
4843921|NCT02367313|Cold|cold
4843922|NCT02367313|Aviragen Therapeutics, Inc.|aviragen therapeutics, inc.
4843923|NCT02367313|Aviragen Therapeutics|aviragen therapeutics
4843924|NCT02367313|Aviragen|aviragen
4843925|NCT02367287|Diet|diet
4843926|NCT02367287|Phenotype|phenotype
4843927|NCT02367287|Immunology|immunology
4843928|NCT02367287|Microbiota|microbiota
4843929|NCT02367287|Metabolomics|metabolomics
4843930|NCT02367287|Physical activity|physical activity
4843931|NCT02367287|Neuroendocrine system|neuroendocrine system
4843932|NCT02367287|Nutritional Physiological Phenomena|nutritional physiological phenomena
4843933|NCT02367248|Brain hemorrhage|brain hemorrhage
4843934|NCT02367248|Cerebral Hemorrhage|cerebral hemorrhage
4843935|NCT02367248|Deferoxamine|deferoxamine
4843936|NCT02367248|Xingnaojing injection|xingnaojing injection
4843937|NCT02367248|Hematoma edema|hematoma edema
4843938|NCT02367235|robotic|robotic
4843939|NCT02367235|sacrocolpopexy|sacrocolpopexy
4843940|NCT02367235|Colpassist|colpassist
4843941|NCT02367235|vaginal positioning device|vaginal positioning device
4843942|NCT02367209|FD MRI|fd mri
4843943|NCT02367209|COPD|copd
4843944|NCT02367209|SPECT/CT|spect/ct
4843945|NCT02367209|DCE MRI|dce mri
4843946|NCT02367196|CC-90002|cc-90002
4843947|NCT02367196|Monoclonal|monoclonal
4843948|NCT02367196|Antibody|antibody
4843949|NCT02367196|CD47|cd47
4843950|NCT02367196|Advanced|advanced
4843951|NCT02367196|Solid Cancers|solid cancers
4843952|NCT02367196|Hematologic Cancers|hematologic cancers
4843953|NCT02367183|Crohn's Disease|crohn's disease
4843954|NCT02367183|Active Crohn's Disease|active crohn's disease
4843955|NCT02367183|GED-0301|ged-0301
4843956|NCT02367183|Endoscopic|endoscopic
4843957|NCT02367183|Double-Blind|double-blind
4843958|NCT02367183|IBD|ibd
4843959|NCT02367183|Mongersen|mongersen
4843960|NCT02367170|respiratory dysfunction|respiratory dysfunction
4843961|NCT02367170|chronic critical illness|chronic critical illness
4843962|NCT02367170|diaphragm weakness|diaphragm weakness
4843963|NCT02367170|sepsis|sepsis
4843964|NCT02367170|ventilator dependance|ventilator dependance
4843965|NCT02367118|chronic rhinosinusitis without nasal polyps prednisone|chronic rhinosinusitis without nasal polyps prednisone
4843966|NCT02367105|Obesity|obesity
4843967|NCT02367105|Hypogonadism|hypogonadism
4843968|NCT02367105|Frailty|frailty
4843969|NCT02367092|Liver Transplantation|liver transplantation
4843970|NCT02367066|patients|patients
4843971|NCT02367066|glycaemic control on metformin|glycaemic control on metformin
4843972|NCT02367040|Clinical trial, Phase III|clinical trial, phase iii
4843973|NCT02367040|Phosphatidylinositol-3-kinase|phosphatidylinositol-3-kinase
4843974|NCT02367040|Non-Hodgkin's lymphoma|non-hodgkin's lymphoma
4843975|NCT02367040|Indolent B-cell non-Hodgkin's lymphoma|indolent b-cell non-hodgkin's lymphoma
4843976|NCT02367027|Biological Availability|biological availability
4843977|NCT02367027|Relative Bioavailability Trial|relative bioavailability trial
4843978|NCT02367014|Mitochondrial Myopathy|mitochondrial myopathy
4843979|NCT02367014|Primary Mitochondrial Disease|primary mitochondrial disease
4843980|NCT02367014|Bendavia™|bendavia™
4843981|NCT02367014|elamipretide|elamipretide
4843982|NCT02367001|general practitioner|general practitioner
4843983|NCT02367001|screening|screening
4843984|NCT02367001|participation|participation
4843985|NCT02367001|organized screening|organized screening
4843986|NCT02366988|Chronic pancreatitis|chronic pancreatitis
4843987|NCT02366988|Clinical Trial|clinical trial
4843988|NCT02366988|Bile stricture|bile stricture
4843989|NCT02366988|Endoscopy|endoscopy
4843990|NCT02366988|Surgery|surgery
4843991|NCT02366975|BPH/LUTS|bph/luts
4843992|NCT02366975|TRT|trt
4843993|NCT02366975|Metabolic Syndrome|metabolic syndrome
4843994|NCT02366962|Influenza|influenza
4843995|NCT02366962|Vaccine|vaccine
4843996|NCT02366962|ASP7374|asp7374
4843997|NCT02366949|Phase 1|phase 1
4843998|NCT02366949|Solid tumors|solid tumors
4843999|NCT02366949|Breast cancer|breast cancer
4844000|NCT02366949|Paclitaxel|paclitaxel
4844001|NCT02366949|MPS-1 inhibitor|mps-1 inhibitor
4844002|NCT02366949|Oncology|oncology
4844003|NCT02366884|malignant|malignant
4844004|NCT02366884|atavistic chemotherapy|atavistic chemotherapy
4844005|NCT02366884|cancer|cancer
4844006|NCT02366858|19 gauge|19 gauge
4844007|NCT02366858|22 gauge|22 gauge
4844008|NCT02366858|core tissue|core tissue
4844009|NCT02366806|Breast Cancer|breast cancer
4844010|NCT02366806|AJCC Stage 1, 2, 3|ajcc stage 1, 2, 3
4844011|NCT02366806|Educational Design|educational design
4844012|NCT02366806|Radiation Therapy Treatment|radiation therapy treatment
4844013|NCT02366793|accessory mobilization, nerve mobilization.|accessory mobilization, nerve mobilization.
4844014|NCT02366780|Lactation|lactation
4844015|NCT02366780|Breastmilk|breastmilk
4844016|NCT02366780|Macronutrients|macronutrients
4844017|NCT02366767|Insulin Infusion Systems|insulin infusion systems
4844018|NCT02366767|Continuous Glucose Monitors|continuous glucose monitors
4844019|NCT02366754|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
4844020|NCT02366741|SCLC|sclc
4844021|NCT02366741|Neuro-cognitive function|neuro-cognitive function
4844022|NCT02366741|PCI|pci
4844023|NCT02366741|Hippocampal sparing|hippocampal sparing
4844024|NCT02366676|Recurrent cystitis|recurrent cystitis
4844025|NCT02366676|hyaluronic acid|hyaluronic acid
4844026|NCT02366676|chondroitin sulphate|chondroitin sulphate
4844027|NCT02366663|Non-Hodgkin's lymphoma|non-hodgkin's lymphoma
4844028|NCT02366663|autologous stem cell transplantation|autologous stem cell transplantation
4844029|NCT02366663|radioimmunotherapy|radioimmunotherapy
4844030|NCT02366663|Zevalin|zevalin
4844031|NCT02366663|Lymphoma|lymphoma
4844032|NCT02366663|Lymphoma, Large B-Cell, Diffuse|lymphoma, large b-cell, diffuse
4844033|NCT02366663|Lymphoma, Non-Hodgkin|lymphoma, non-hodgkin
4844034|NCT02366663|Immune System Diseases|immune system diseases
4844035|NCT02366663|Immunoproliferative Disorders|immunoproliferative disorders
4844036|NCT02366663|Lymphatic Diseases|lymphatic diseases
4844037|NCT02366663|Lymphoma, B-Cell|lymphoma, b-cell
4844038|NCT02366663|Lymphoproliferative Disorders|lymphoproliferative disorders
4844039|NCT02366663|Neoplasms|neoplasms
4844040|NCT02366663|Neoplasms by Histologic Type|neoplasms by histologic type
4844041|NCT02366663|Antibodies, Monoclonal|antibodies, monoclonal
4844042|NCT02366663|Immunologic Factors|immunologic factors
4844043|NCT02366663|Pharmacologic Actions|pharmacologic actions
4844044|NCT02366663|Physiological Effects of Drugs|physiological effects of drugs
4844045|NCT02366637|COPD|copd
4844046|NCT02366637|Sputum|sputum
4844047|NCT02366546|Adoptive cell transfer|adoptive cell transfer
4844048|NCT02366546|Cell therapy|cell therapy
4844049|NCT02366546|Immunotherapy|immunotherapy
4844050|NCT02366546|NY-ESO-1|ny-eso-1
4844051|NCT02366546|Esophageal cancer|esophageal cancer
4844052|NCT02366546|Melanoma|melanoma
4844053|NCT02366546|Head and neck cancer|head and neck cancer
4844054|NCT02366546|Ovarian cancer|ovarian cancer
4844055|NCT02366546|Synovial sarcoma|synovial sarcoma
4844056|NCT02366546|TCR gene therapy|tcr gene therapy
4844057|NCT02366533|Linkage to care|linkage to care
4844058|NCT02366533|HIV|hiv
4844059|NCT02366533|Efficacy of linkage to care program|efficacy of linkage to care program
4844060|NCT02366520|Child|child
4844061|NCT02366520|Child Behavior|child behavior
4844062|NCT02366520|Dental Anxiety/prevention & control|dental anxiety/prevention & control
4844063|NCT02366520|Dental Anxiety/psychology|dental anxiety/psychology
4844064|NCT02366520|Cooperative Behavior|cooperative behavior
4844065|NCT02366520|Dental Care/psychology*|dental care/psychology*
4844066|NCT02366520|Humans|humans
4844067|NCT02366520|Videotape Recording|videotape recording
4844068|NCT02366507|hypotension|hypotension
4844069|NCT02366507|doppler|doppler
4844070|NCT02366507|shock|shock
4844071|NCT02366494|prostate cancer|prostate cancer
4844072|NCT02366494|treatment response|treatment response
4844073|NCT02366494|androgen deprivation therapy|androgen deprivation therapy
4844074|NCT02366481|Vitamin K|vitamin k
4844075|NCT02366481|Vitamin K2|vitamin k2
4844076|NCT02366481|Menaquinone-7|menaquinone-7
4844077|NCT02366481|Osteocalcin|osteocalcin
4844078|NCT02366481|Adults|adults
4844079|NCT02366481|Obesity|obesity
4844080|NCT02366481|Insulin resistance|insulin resistance
4844081|NCT02366481|Insulin sensitivity|insulin sensitivity
4844082|NCT02366481|Beta-cell function|beta-cell function
4844083|NCT02366481|Prediabetes|prediabetes
4844084|NCT02366468|Diabetic macular edema|diabetic macular edema
4844085|NCT02366468|Visual impairment|visual impairment
4844086|NCT02366442|dual/multitasking|dual/multitasking
4844087|NCT02366442|Executive function|executive function
4844088|NCT02366442|Affective function|affective function
4844089|NCT02366442|Balance|balance
4844090|NCT02366416|Exercise, Physical|exercise, physical
4844091|NCT02366403|PTSD|ptsd
4844092|NCT02366403|Meditation|meditation
4844093|NCT02366403|Yoga|yoga
4844094|NCT02366403|Cognitive Therapy|cognitive therapy
4844095|NCT02366390|Psychoeducative|psychoeducative
4844096|NCT02366390|HADS|hads
4844097|NCT02366390|COPD|copd
4844098|NCT02366390|dyspnea|dyspnea
4844099|NCT02366364|NRX-1074|nrx-1074
4844100|NCT02366364|NMDA Receptor Modulator|nmda receptor modulator
4844101|NCT02366364|Major Depressive Disorder|major depressive disorder
4844102|NCT02366364|Glycine Site Modulator|glycine site modulator
4844103|NCT02366312|Keratocystic odontogenic tumor|keratocystic odontogenic tumor
4844104|NCT02366312|KCOT|kcot
4844105|NCT02366273|Diabetes|diabetes
4844106|NCT02366273|Psoriasis|psoriasis
4844107|NCT02366273|Inflammation|inflammation
4844108|NCT02366273|Insulin-resistance|insulin-resistance
4844109|NCT02366247|Polyethylene Glycol Thymosin alpha1|polyethylene glycol thymosin alpha1
4844110|NCT02366247|Adefovir|adefovir
4844111|NCT02366247|Hepatitis B e Antigens positive|hepatitis b e antigens positive
4844112|NCT02366208|Polyethylene Glycol Thymosin alpha1|polyethylene glycol thymosin alpha1
4844113|NCT02366208|Adefovir|adefovir
4844114|NCT02366208|Hepatitis B e Antigens positive|hepatitis b e antigens positive
4844115|NCT02366195|T-VEC|t-vec
4844116|NCT02366195|CD8+ cell density|cd8+ cell density
4844117|NCT02366195|objective response rate|objective response rate
4844118|NCT02366195|unresected|unresected
4844119|NCT02366195|Melanoma|melanoma
4844120|NCT02366130|Breast cancer|breast cancer
4844121|NCT02366130|Hormone-positive bone-dominant metastatic breast cancer|hormone-positive bone-dominant metastatic breast cancer
4844122|NCT02366130|Ra-223 dichloride|ra-223 dichloride
4844123|NCT02366130|Xofigo|xofigo
4844124|NCT02366130|Radium-223 chloride|radium-223 chloride
4844125|NCT02366130|Radium-223 dichloride|radium-223 dichloride
4844126|NCT02366130|Alpharadin|alpharadin
4844127|NCT02366130|Denosumab|denosumab
4844128|NCT02366130|AMG 162|amg 162
4844129|NCT02366130|Prolia|prolia
4844130|NCT02366130|Hormone therapy|hormone therapy
4844131|NCT02366117|Quirc|quirc
4844132|NCT02366117|Quality Indiciator in Rehabilitative Care|quality indiciator in rehabilitative care
4844133|NCT02366104|Cardiovascular Diseases|cardiovascular diseases
4844134|NCT02366104|Aged|aged
4844135|NCT02366104|Primary Prevention|primary prevention
4844136|NCT02366052|Histologically confirmed NASH|histologically confirmed nash
4844137|NCT02366052|Hepatocyte Injury determined by M30 antigen|hepatocyte injury determined by m30 antigen
4844138|NCT02366026|HIV|hiv
4844139|NCT02366013|HIV|hiv
4844140|NCT02366013|HIV Prevention|hiv prevention
4844141|NCT02366013|HIV Vaccine|hiv vaccine
4844142|NCT02366013|Healthy|healthy
4844143|NCT02366000|Parent-child communication|parent-child communication
4844144|NCT02366000|Health risk behaviors|health risk behaviors
4844145|NCT02366000|Randomized controlled trial|randomized controlled trial
4844146|NCT02365987|interesterified|interesterified
4844147|NCT02365987|postprandial|postprandial
4844148|NCT02365974|arterial stiffness|arterial stiffness
4844149|NCT02365974|resistant hypertension|resistant hypertension
4844150|NCT02365974|sympathetic system|sympathetic system
4844151|NCT02365974|blood pressure|blood pressure
4844152|NCT02365974|transcutaneous electrical nerve stimulation|transcutaneous electrical nerve stimulation
4844153|NCT02365961|Hip Arthroscopy|hip arthroscopy
4844154|NCT02365948|Pharmacokinetics|pharmacokinetics
4844155|NCT02365948|Certolizumab Pegol|certolizumab pegol
4844156|NCT02365948|Healthy Chinese subjects|healthy chinese subjects
4844157|NCT02365935|adjuvant chemotherapy|adjuvant chemotherapy
4844158|NCT02365922|FTLD, PSP, CBD, PPA, FTD, FTD-ALS, CBS, ALS, svPPA, nfvPPA, oPSP|ftld, psp, cbd, ppa, ftd, ftd-als, cbs, als, svppa, nfvppa, opsp
4844159|NCT02365883|Prostate Cancer|prostate cancer
4844160|NCT02365883|Transrectal Imaging|transrectal imaging
4844161|NCT02365870|Anxiety Disorders|anxiety disorders
4844162|NCT02365870|Parkinson Disease|parkinson disease
4844163|NCT02365870|rotigotine|rotigotine
4844164|NCT02365857|spinal anesthesia|spinal anesthesia
4844165|NCT02365857|caesarian section|caesarian section
4844166|NCT02365857|Dexmedetomidine|dexmedetomidine
4844167|NCT02365844|Narrow Band Imaging|narrow band imaging
4844168|NCT02365844|oropharyngeal carcinoma|oropharyngeal carcinoma
4844169|NCT02365831|MBC|mbc
4844170|NCT02365831|breast|breast
4844171|NCT02365831|metastatic|metastatic
4844172|NCT02365831|cancer|cancer
4844173|NCT02365831|HER2|her2
4844174|NCT02365818|Bladder Cancer|bladder cancer
4844175|NCT02365805|BRCA 1 levels|brca 1 levels
4844176|NCT02365805|HER2 Negative|her2 negative
4844177|NCT02365792|Clinical Decision Support|clinical decision support
4844178|NCT02365792|Clinical Practice Guidelines|clinical practice guidelines
4844179|NCT02365792|Emergency Medical Services|emergency medical services
4844180|NCT02365779|salpingectomy|salpingectomy
4844181|NCT02365779|optical biopsy|optical biopsy
4844182|NCT02365779|Cellvizio®|cellvizio®
4844183|NCT02365766|MK-3475|mk-3475
4844184|NCT02365766|Gemcitabine|gemcitabine
4844185|NCT02365766|Cisplatin|cisplatin
4844186|NCT02365766|Pembrolizumab|pembrolizumab
4844187|NCT02365766|Neoadjuvant Bladder Cancer|neoadjuvant bladder cancer
4844188|NCT02365753|lower transverse cesarean delivery|lower transverse cesarean delivery
4844189|NCT02365753|Pregnant women|pregnant women
4844190|NCT02365740|Type 1 Diabetes mellitus|type 1 diabetes mellitus
4844191|NCT02365740|Gastric Emptying|gastric emptying
4844192|NCT02365740|Insulin Infusion Pump|insulin infusion pump
4844193|NCT02365701|Functional Dyspepsia|functional dyspepsia
4844194|NCT02365688|Open Abdominal Surgical Procedure|open abdominal surgical procedure
4844195|NCT02365675|Pemphigus|pemphigus
4844196|NCT02365675|Pemphigoid|pemphigoid
4844197|NCT02365675|Wound Healing|wound healing
4844198|NCT02365675|Itch|itch
4844199|NCT02365675|Pain|pain
4844200|NCT02365675|Wound dressing|wound dressing
4844201|NCT02365675|Topical treatment|topical treatment
4844202|NCT02365662|Oncology|oncology
4844203|NCT02365662|Cancer|cancer
4844204|NCT02365662|Solid Tumor types likely to exhibit elevated levels of Epidermal Growth Factor Receptor|solid tumor types likely to exhibit elevated levels of epidermal growth factor receptor
4844205|NCT02365662|Solid Tumors|solid tumors
4844206|NCT02365649|Crohn's Disease|crohn's disease
4844207|NCT02365623|Pulmonary Multi-Drug Resistant Tuberculosis (MDR-TB)|pulmonary multi-drug resistant tuberculosis (mdr-tb)
4844208|NCT02365623|TMC207|tmc207
4844209|NCT02365623|Bedaquiline|bedaquiline
4844210|NCT02365610|Cannabidivarin|cannabidivarin
4844211|NCT02365610|CBDV|cbdv
4844212|NCT02365610|GWP42006|gwp42006
4844213|NCT02365597|Urothelial Cancer|urothelial cancer
4844214|NCT02365597|JNJ-42756493|jnj-42756493
4844215|NCT02365597|Tyrosine Kinase Inhibitor|tyrosine kinase inhibitor
4844216|NCT02365532|drug-induced long QT syndrome|drug-induced long qt syndrome
4844217|NCT02365532|DILQTS|dilqts
4844218|NCT02365532|prolonged QT|prolonged qt
4844219|NCT02365519|LME636|lme636
4844220|NCT02365519|dry eye disease|dry eye disease
4844221|NCT02365519|efficacy|efficacy
4844222|NCT02365519|ocular discomfort|ocular discomfort
4844223|NCT02365506|Congenital Long QT Syndrome|congenital long qt syndrome
4844224|NCT02365506|LQTS|lqts
4844225|NCT02365506|Long QT2 Syndrome|long qt2 syndrome
4844226|NCT02365506|LQT2|lqt2
4844227|NCT02365506|Sudden Cardiac Death|sudden cardiac death
4844228|NCT02365493|Methicillin-Resistant Staphylococcus aureus (MRSA)|methicillin-resistant staphylococcus aureus (mrsa)
4844229|NCT02365467|TEVAR|tevar
4844230|NCT02365467|Thoracic Aneurysm|thoracic aneurysm
4844231|NCT02365467|Endovascular Aortic Repair|endovascular aortic repair
4844232|NCT02365467|Type B Dissection|type b dissection
4844233|NCT02365454|TAA|taa
4844234|NCT02365441|GIST|gist
4844235|NCT02365441|Advanced|advanced
4844236|NCT02365428|Maternal welfare|maternal welfare
4844237|NCT02365402|chronic hepatitis B|chronic hepatitis b
4844238|NCT02365402|peginterferon|peginterferon
4844239|NCT02365402|sustained viral response|sustained viral response
4844240|NCT02365402|entecavir|entecavir
4844241|NCT02365402|HBeAg|hbeag
4844242|NCT02365337|Vitamin D|vitamin d
4844243|NCT02365337|time lapse monitoring|time lapse monitoring
4844244|NCT02365337|embryo|embryo
4844245|NCT02365324|culinary skills|culinary skills
4844246|NCT02365324|menu planning|menu planning
4844247|NCT02365324|grocery shopping|grocery shopping
4844248|NCT02365324|children|children
4844249|NCT02365324|healthy eating|healthy eating
4844250|NCT02365324|physical activity|physical activity
4844251|NCT02365272|pharmacokinetics|pharmacokinetics
4844252|NCT02365272|aminoglycosides|aminoglycosides
4844253|NCT02365246|atopic dermatitis|atopic dermatitis
4844254|NCT02365246|immunoadsorption|immunoadsorption
4844255|NCT02365233|Type II Diabetes|type ii diabetes
4844256|NCT02365233|Nonalcoholic fatty liver|nonalcoholic fatty liver
4844257|NCT02365194|Ventral Hernia|ventral hernia
4844258|NCT02365194|Prehabilitation|prehabilitation
4844259|NCT02365181|Shoulder arthroplasty|shoulder arthroplasty
4844260|NCT02365168|Fish allergy|fish allergy
4844261|NCT02365155|Frailty|frailty
4844262|NCT02365155|Heart failure|heart failure
4844263|NCT02365155|Physical activity|physical activity
4844264|NCT02365155|Cognitive state|cognitive state
4844265|NCT02365142|Knee Osteoarthritis|knee osteoarthritis
4844266|NCT02365142|Mesenchimal stem cell|mesenchimal stem cell
4844267|NCT02365142|Osteoarthritis|osteoarthritis
4844268|NCT02365129|BRITE adipose tissue|brite adipose tissue
4844269|NCT02365129|physical activity|physical activity
4844270|NCT02365129|Thermogenesis|thermogenesis
4844271|NCT02365129|Body Temperature Regulation|body temperature regulation
4844272|NCT02365129|Energy Metabolism|energy metabolism
4844273|NCT02365116|Peer Mentorship|peer mentorship
4844274|NCT02365116|Psychiatric Hospitalization|psychiatric hospitalization
4844275|NCT02365116|Suicide Risk|suicide risk
4844276|NCT02365103|Anemia, Iron-Deficiency|anemia, iron-deficiency
4844277|NCT02365103|Iron, Bioavailability|iron, bioavailability
4844278|NCT02365103|Hepcidins|hepcidins
4844279|NCT02365103|Intestinal, Absorption|intestinal, absorption
4844280|NCT02365103|Isotope Labeling, Stable|isotope labeling, stable
4844281|NCT02365077|Adverse Effect of Glucocorticoids|adverse effect of glucocorticoids
4844282|NCT02365077|Femur Head Necrosis|femur head necrosis
4844283|NCT02365077|Susceptibility|susceptibility
4844284|NCT02365077|GWAS|gwas
4844285|NCT02365025|Sleep patterns|sleep patterns
4844286|NCT02365025|Electronic Media Exposure|electronic media exposure
4844287|NCT02365025|Parental Intervention|parental intervention
4844288|NCT02364934|rocuronium|rocuronium
4844289|NCT02364934|sex|sex
4844290|NCT02364934|elderly|elderly
4844291|NCT02364934|Close-loop infusion system|close-loop infusion system
4844292|NCT02364921|venous ulcer|venous ulcer
4844293|NCT02364921|wound healing|wound healing
4844294|NCT02364921|compression bandages|compression bandages
4844295|NCT02364908|systemic lupus erythematosus|systemic lupus erythematosus
4844296|NCT02364908|antimalarials|antimalarials
4844297|NCT02364908|therapeutic education|therapeutic education
4844298|NCT02364908|Coping questionnaire|coping questionnaire
4844299|NCT02364908|MASRI questionnaire|masri questionnaire
4844300|NCT02364908|morisky medication adherence scale|morisky medication adherence scale
4844301|NCT02364908|lupus Quality Of Life|lupus quality of life
4844302|NCT02364908|internal medicine|internal medicine
4844303|NCT02364895|Mailed invitation|mailed invitation
4844304|NCT02364895|Fecal Occult Blood Test|fecal occult blood test
4844305|NCT02364895|Screening|screening
4844306|NCT02364869|P-cresyl sulfate|p-cresyl sulfate
4844307|NCT02364869|Indoxyl sulfate|indoxyl sulfate
4844308|NCT02364869|Intestine|intestine
4844309|NCT02364869|Endothelial function|endothelial function
4844310|NCT02364856|Autonomic Nervous System|autonomic nervous system
4844311|NCT02364856|Cerebral Palsy|cerebral palsy
4844312|NCT02364856|Pain|pain
4844313|NCT02364856|Children|children
4844314|NCT02364843|Threonine|threonine
4844315|NCT02364843|enteral feedings|enteral feedings
4844316|NCT02364843|infants|infants
4844317|NCT02364843|amino acid|amino acid
4844318|NCT02364843|requirements|requirements
4844319|NCT02364830|Pimpinella anisum L.|pimpinella anisum l.
4844320|NCT02364830|Peppermint oil|peppermint oil
4844321|NCT02364830|Irritable Bowel Syndrome|irritable bowel syndrome
4844322|NCT02364817|Attention Deficit Disorder with Hyperactivity|attention deficit disorder with hyperactivity
4844323|NCT02364817|Alcohol Dependence|alcohol dependence
4844324|NCT02364817|Adults|adults
4844325|NCT02364817|Treatment outcome|treatment outcome
4844326|NCT02364817|Mental Health|mental health
4844327|NCT02364791|pulmonary resection|pulmonary resection
4844328|NCT02364791|chest tube|chest tube
4844329|NCT02364791|segmentectomy|segmentectomy
4844330|NCT02364791|lobectomy|lobectomy
4844331|NCT02364778|CAD|cad
4844332|NCT02364765|Maxillofacial Orthognathic Surgery|maxillofacial orthognathic surgery
4844333|NCT02364765|Hemoglobin|hemoglobin
4844334|NCT02364765|Red Blood Cells|red blood cells
4844335|NCT02364765|Hematocrit|hematocrit
4844336|NCT02364765|Blood Platelets|blood platelets
4844337|NCT02364765|Body Weight|body weight
4844338|NCT02364765|Operative Time|operative time
4844339|NCT02364765|Age Groups|age groups
4844340|NCT02364765|Gender|gender
4844341|NCT02364726|Acupuncture|acupuncture
4844342|NCT02364726|Paclitaxel|paclitaxel
4844343|NCT02364726|15-011|15-011
4844344|NCT02364700|stroke, robotics, hand rehabilitation|stroke, robotics, hand rehabilitation
4844345|NCT02364674|HRCT|hrct
4844346|NCT02364674|High Resolution Computed Tomography scans|high resolution computed tomography scans
4844347|NCT02364674|Functional Respiratory Imaging|functional respiratory imaging
4844348|NCT02364674|FRI|fri
4844349|NCT02364674|Computed Tomography|computed tomography
4844350|NCT02364674|CT|ct
4844351|NCT02364674|Bronchiolitis Obliterans|bronchiolitis obliterans
4844352|NCT02364674|BOS|bos
4844353|NCT02364674|Lung Transplant|lung transplant
4844354|NCT02364661|Hepatitis B virus|hepatitis b virus
4844355|NCT02364661|Metabolovirus|metabolovirus
4844356|NCT02364648|Endothelium, vascular|endothelium, vascular
4844357|NCT02364648|MitoQ|mitoq
4844358|NCT02364648|Mitochondria|mitochondria
4844359|NCT02364648|Oxidative Stress|oxidative stress
4844360|NCT02364648|Chronic Renal Insufficiency|chronic renal insufficiency
4844361|NCT02364648|Cardiovascular Disease|cardiovascular disease
4844362|NCT02364635|Phase I pharmacokinetics and safety study|phase i pharmacokinetics and safety study
4844363|NCT02364622|flexible intubating stylet|flexible intubating stylet
4844364|NCT02364622|double-lumen endobronchial tube|double-lumen endobronchial tube
4844365|NCT02364596|Staphylococcus aureus vaccine|staphylococcus aureus vaccine
4844366|NCT02364596|Staphylococcal infection|staphylococcal infection
4844367|NCT02364570|CVD|cvd
4844368|NCT02364570|Hyperglycemia|hyperglycemia
4844369|NCT02364570|Postprandial|postprandial
4844370|NCT02364570|Vascular Function|vascular function
4844371|NCT02364531|Prostatic Neoplasms|prostatic neoplasms
4844372|NCT02364531|Prostate Cancer|prostate cancer
4844373|NCT02364531|Metastatic|metastatic
4844374|NCT02364531|Observational|observational
4844375|NCT02364531|Abiraterone Acetate|abiraterone acetate
4844376|NCT02364531|ZYTIGA|zytiga
4844377|NCT02364518|Snoring|snoring
4844378|NCT02364518|snoreplasy|snoreplasy
4844379|NCT02364518|Tranquill|tranquill
4844380|NCT02364518|Sutures|sutures
4844381|NCT02364505|caregivers|caregivers
4844382|NCT02364492|[C04.588.180]|[c04.588.180]
4844383|NCT02364440|skin laxity|skin laxity
4844384|NCT02364440|Ultherapy™ System|ultherapy™ system
4844385|NCT02364440|rhytids|rhytids
4844386|NCT02364427|Pulse wave velocity|pulse wave velocity
4844387|NCT02364427|Arterial stiffness|arterial stiffness
4844388|NCT02364427|AKI|aki
4844389|NCT02364401|Atrial Fibrillation|atrial fibrillation
4844390|NCT02364401|Catheter ablation|catheter ablation
4844391|NCT02364388|breast imaging diagnosis|breast imaging diagnosis
4844392|NCT02364388|breast ultrasound|breast ultrasound
4844393|NCT02364388|Imagio|imagio
4844394|NCT02364388|Seno Medical Instruments, Inc.|seno medical instruments, inc.
4844395|NCT02364388|Seno|seno
4844396|NCT02364388|opto-acoustics|opto-acoustics
4844397|NCT02364388|OA|oa
4844398|NCT02364336|Chronic Hepatitis B|chronic hepatitis b
4844399|NCT02364310|Hypertension|hypertension
4844400|NCT02364310|baroreceptor stimulation|baroreceptor stimulation
4844401|NCT02364310|Hypertension resistant|hypertension resistant
4844402|NCT02364297|Bleeding gastric varices|bleeding gastric varices
4844403|NCT02364297|Transjugular intrahepatic portosystemic shunt (TIPS)|transjugular intrahepatic portosystemic shunt (tips)
4844404|NCT02364297|Injection of adhesives|injection of adhesives
4844405|NCT02364271|High-sensitive troponin|high-sensitive troponin
4844406|NCT02364271|Coronary Artery Calcium Score|coronary artery calcium score
4844407|NCT02364271|TIMI score|timi score
4844408|NCT02364271|Heart-type fatty acid binding protein|heart-type fatty acid binding protein
4844409|NCT02364271|Major adverse cardiac event|major adverse cardiac event
4844410|NCT02364271|HEART score|heart score
4844411|NCT02364245|Cerebral Palsy.|cerebral palsy.
4844412|NCT02364245|Upper Extremity|upper extremity
4844413|NCT02364245|Kinect|kinect
4844414|NCT02364245|Virtual reality|virtual reality
4844415|NCT02364219|prewarming|prewarming
4844416|NCT02364219|perioperative hypothermia|perioperative hypothermia
4844417|NCT02364219|microdialysis|microdialysis
4844418|NCT02364219|tissue oxygen saturation|tissue oxygen saturation
4844419|NCT02364219|cytoreductive surgery|cytoreductive surgery
4844420|NCT02364206|newly diagnosed glioblastoma|newly diagnosed glioblastoma
4844421|NCT02364206|p38 MAPK inhibitor|p38 mapk inhibitor
4844422|NCT02364206|temozolomide|temozolomide
4844423|NCT02364206|radiotherapy|radiotherapy
4844424|NCT02364193|Intrathoracic blood volume|intrathoracic blood volume
4844425|NCT02364193|Extravascular lung water|extravascular lung water
4844426|NCT02364154|biomarker|biomarker
4844427|NCT02364154|screening|screening
4844428|NCT02364154|coloscopy|coloscopy
4844429|NCT02364141|stroke|stroke
4844430|NCT02364141|upper extremity|upper extremity
4844431|NCT02364141|motor learning|motor learning
4844432|NCT02364141|rehabilitation|rehabilitation
4844433|NCT02364115|Spinal metastases|spinal metastases
4844434|NCT02364115|Spinal metastatic disease|spinal metastatic disease
4844435|NCT02364115|Stereotactic Body Radiotherapy|stereotactic body radiotherapy
4844436|NCT02364115|Response|response
4844437|NCT02364115|Bone metastases|bone metastases
4844438|NCT02364089|Adrenal Incidentaloma|adrenal incidentaloma
4844439|NCT02364089|Subclinical Cushing's syndrome|subclinical cushing's syndrome
4844440|NCT02364089|Hypertension|hypertension
4844441|NCT02364089|Cardiovascular Risk Factors|cardiovascular risk factors
4844442|NCT02364089|Metabolic Syndrome|metabolic syndrome
4844443|NCT02364089|Surgery of adrenal tumor|surgery of adrenal tumor
4844444|NCT02364076|Pembrolizumab|pembrolizumab
4844445|NCT02364076|Epacadostat|epacadostat
4844446|NCT02364063|Urinary incontinence|urinary incontinence
4844447|NCT02364063|cerebral palsy|cerebral palsy
4844448|NCT02364063|urotherapy|urotherapy
4844450|NCT02364037|intrauterine device|intrauterine device
4844451|NCT02364037|subdermal implant|subdermal implant
4844452|NCT02364037|contraceptive counseling|contraceptive counseling
4844453|NCT02364024|Colon and rectum carcinoma|colon and rectum carcinoma
4844454|NCT02364024|Immune response|immune response
4844455|NCT02364024|Biomarker|biomarker
4844456|NCT02364024|Prognosis|prognosis
4844457|NCT02364011|Biomechanics|biomechanics
4844458|NCT02364011|Primary Total Knee Arthroplasty|primary total knee arthroplasty
4844459|NCT02364011|TKA Bearings|tka bearings
4844460|NCT02364011|Osteoarthritis|osteoarthritis
4844461|NCT02364011|Total Knee Replacement|total knee replacement
4844462|NCT02363998|detoxification|detoxification
4844463|NCT02363998|agonist taper|agonist taper
4844464|NCT02363998|methadone step down|methadone step down
4844465|NCT02363998|buprenorphine step down|buprenorphine step down
4844466|NCT02363998|opioid withdrawal syndrome|opioid withdrawal syndrome
4844467|NCT02363959|Hyperbaric Oxygen|hyperbaric oxygen
4844468|NCT02363959|Lung Transplantation|lung transplantation
4844469|NCT02363959|Central Airway Stenosis|central airway stenosis
4844470|NCT02363959|Airway Exudative Plaques|airway exudative plaques
4844471|NCT02363959|Hyperbaric Oxygen Therapy|hyperbaric oxygen therapy
4844472|NCT02363959|Post-Lung Transplantation|post-lung transplantation
4844473|NCT02363959|Airway Ischemia|airway ischemia
4844474|NCT02363959|Endobronchial Biopsy|endobronchial biopsy
4844475|NCT02363959|Bronchoscopy|bronchoscopy
4844476|NCT02363946|alpha-1 antitrypsin|alpha-1 antitrypsin
4844477|NCT02363946|AATD|aatd
4844478|NCT02363933|Perampanel|perampanel
4844479|NCT02363933|Seizures|seizures
4844480|NCT02363920|COPD patients|copd patients
4844481|NCT02363907|diabetes mellitus|diabetes mellitus
4844482|NCT02363907|pediatric|pediatric
4844483|NCT02363907|continuous glucose monitoring system|continuous glucose monitoring system
4844484|NCT02363907|CGM|cgm
4844485|NCT02363855|Neoplasm Metastasis|neoplasm metastasis
4844486|NCT02363855|Metastatic castration-resistant prostate cancer|metastatic castration-resistant prostate cancer
4844487|NCT02363855|Castration-resistant prostate cancer (CRPC)|castration-resistant prostate cancer (crpc)
4844488|NCT02363842|Pressure Ulcer|pressure ulcer
4844489|NCT02363842|Skin IQ MCM coverlet|skin iq mcm coverlet
4844490|NCT02363842|Pressure redistribution surfaces|pressure redistribution surfaces
4844491|NCT02363829|clinical stages IIA, IIB, IIIA, IIIB, IVA|clinical stages iia, iib, iiia, iiib, iva
4844492|NCT02363829|invasive carcinoma|invasive carcinoma
4844493|NCT02363829|uterine cervix|uterine cervix
4844494|NCT02363790|Ventral Hernia|ventral hernia
4844495|NCT02363790|Laparoscopic|laparoscopic
4844496|NCT02363764|respiratory sampling|respiratory sampling
4844497|NCT02363751|Bellini|bellini
4844498|NCT02363751|Metastatic|metastatic
4844499|NCT02363751|Chemotherapy|chemotherapy
4844500|NCT02363751|Bevacizumab|bevacizumab
4844501|NCT02363738|Bipolar Disorder|bipolar disorder
4844502|NCT02363738|Bipolar Depression|bipolar depression
4844503|NCT02363738|Inflammation|inflammation
4844504|NCT02363738|Bipolar|bipolar
4844505|NCT02363725|Acute myocardial infarction|acute myocardial infarction
4844506|NCT02363725|Inflammation|inflammation
4844507|NCT02363725|CRP|crp
4844508|NCT02363725|Colchicine|colchicine
4844509|NCT02363712|Osteoarthritis, knee|osteoarthritis, knee
4844510|NCT02363712|therapy|therapy
4844511|NCT02363712|shoe|shoe
4844512|NCT02363712|Randomized Controlled Trial|randomized controlled trial
4844513|NCT02363699|cholelithiasis|cholelithiasis
4844514|NCT02363699|Cytokines|cytokines
4844515|NCT02363699|under general anesthesia|under general anesthesia
4844516|NCT02363673|Autism Spectrum Disorder|autism spectrum disorder
4844517|NCT02363673|Children|children
4844518|NCT02363673|Homoeopathy|homoeopathy
4844519|NCT02363660|HIV-uninfected|hiv-uninfected
4844520|NCT02363647|medullary thyroid cancer|medullary thyroid cancer
4844521|NCT02363647|thyroid cancer|thyroid cancer
4844522|NCT02363647|personalized therapy|personalized therapy
4844523|NCT02363647|personalized chemotherapy|personalized chemotherapy
4844524|NCT02363647|individualized treatment|individualized treatment
4844525|NCT02363647|colon cancer|colon cancer
4844526|NCT02363647|colorectal cancer|colorectal cancer
4844527|NCT02363634|magnesium status|magnesium status
4844528|NCT02363634|sleep quality|sleep quality
4844529|NCT02363608|Canine-Assisted|canine-assisted
4844530|NCT02363608|15-010|15-010
4844531|NCT02363608|post surgery patients|post surgery patients
4844532|NCT02363595|Genomic Predictors|genomic predictors
4844533|NCT02363595|14-277|14-277
4844534|NCT02363569|post coital bleeding|post coital bleeding
4844535|NCT02363569|vaginal bleeding|vaginal bleeding
4844536|NCT02363556|Cervical Dilation|cervical dilation
4844537|NCT02363556|Dilation and Evacuation|dilation and evacuation
4844538|NCT02363556|Misoprostol|misoprostol
4844539|NCT02363556|Misoprostol-Dilapan|misoprostol-dilapan
4844540|NCT02363556|Abortion|abortion
4844541|NCT02363530|cataract surgery|cataract surgery
4844542|NCT02363530|cornea protect|cornea protect
4844543|NCT02363530|xerophthalmia|xerophthalmia
4844544|NCT02363530|Corneal clarity|corneal clarity
4844545|NCT02363517|Hepatitis|hepatitis
4844546|NCT02363517|Viral|viral
4844547|NCT02363517|Non-A|non-a
4844548|NCT02363517|Non-B|non-b
4844549|NCT02363517|Parenterally-Transmitted|parenterally-transmitted
4844550|NCT02363504|Magnetic Resonance Imaging|magnetic resonance imaging
4844551|NCT02363504|Noradrenaline|noradrenaline
4844552|NCT02363504|locus coeruleus|locus coeruleus
4844553|NCT02363504|memory|memory
4844554|NCT02363465|skin thickness|skin thickness
4844555|NCT02363465|high-frequency ultrasound|high-frequency ultrasound
4844556|NCT02363452|Aicardi-Goutières syndrome|aicardi-goutières syndrome
4844557|NCT02363452|Reverse transcriptase inhibitors|reverse transcriptase inhibitors
4844558|NCT02363452|open single study|open single study
4844559|NCT02363452|interferon signature|interferon signature
4844560|NCT02363426|intravaginal culture|intravaginal culture
4844561|NCT02363426|in vitro fertilization|in vitro fertilization
4844562|NCT02363426|blastocyst|blastocyst
4844563|NCT02363426|pregnancy|pregnancy
4844564|NCT02363413|NIV|niv
4844565|NCT02363413|Overlap Syndrom|overlap syndrom
4844566|NCT02363413|home|home
4844567|NCT02363413|hospital|hospital
4844568|NCT02363400|Nasopharyngeal carcinoma (NPC)|nasopharyngeal carcinoma (npc)
4844569|NCT02363400|Epstein-Barr virus (EBV)|epstein-barr virus (ebv)
4844570|NCT02363400|radiotherapy (RT)|radiotherapy (rt)
4844571|NCT02363400|Plasma EBV DNA(pEBV DNA)|plasma ebv dna(pebv dna)
4844572|NCT02363400|Adjuvant Chemotherapy|adjuvant chemotherapy
4844573|NCT02363387|HIV|hiv
4844574|NCT02363387|antiretroviral medications|antiretroviral medications
4844575|NCT02363387|incentives|incentives
4844576|NCT02363374|Rectal cancer stage II|rectal cancer stage ii
4844577|NCT02363374|Rectal cancer stage III|rectal cancer stage iii
4844578|NCT02363374|Multimodality treatment of locally advanced rectal cancer|multimodality treatment of locally advanced rectal cancer
4844579|NCT02363348|L arginine|l arginine
4844580|NCT02363348|Preeclampsia|preeclampsia
4844581|NCT02363335|GLP-1|glp-1
4844582|NCT02363335|Phosphodiesterase Inhibitor|phosphodiesterase inhibitor
4844583|NCT02363335|GLP|glp
4844584|NCT02363322|Medical Countermeasures|medical countermeasures
4844585|NCT02363322|VHF|vhf
4844586|NCT02363322|EVD|evd
4844587|NCT02363309|13C|13c
4844588|NCT02363309|Stable Isotopes|stable isotopes
4844589|NCT02363309|Acetate|acetate
4844590|NCT02363309|Breath Tests|breath tests
4844591|NCT02363309|Palmitate|palmitate
4844592|NCT02363296|Brain Cooling - Selected|brain cooling - selected
4844593|NCT02363296|Brain Cooling Helmet|brain cooling helmet
4844594|NCT02363296|Repetitive TMS (rTMS)|repetitive tms (rtms)
4844595|NCT02363270|Analgesia|analgesia
4844596|NCT02363270|ketamine|ketamine
4844597|NCT02363257|Smoke free bus policy|smoke free bus policy
4844598|NCT02363257|BEST commuters|best commuters
4844599|NCT02363257|BEST employee|best employee
4844600|NCT02363244|Pap,HPVDNA|pap,hpvdna
4844601|NCT02363218|Liver Neoplasms|liver neoplasms
4844602|NCT02363218|Stereotactic Body Radiotherapy|stereotactic body radiotherapy
4844603|NCT02363218|CyberKnife|cyberknife
4844604|NCT02363192|Pharmacy|pharmacy
4844605|NCT02363179|Emergency Service, Hospital|emergency service, hospital
4844606|NCT02363140|Musculoskeletal System|musculoskeletal system
4844607|NCT02363127|Reproductive Techniques|reproductive techniques
4844608|NCT02363127|Infertility|infertility
4844609|NCT02363127|Reproductive Techniques Assisted|reproductive techniques assisted
4844610|NCT02363088|cervical screening|cervical screening
4844611|NCT02363088|uptake|uptake
4844612|NCT02363088|SMS messages|sms messages
4844613|NCT02363088|text messages|text messages
4844614|NCT02363088|reminder|reminder
4844615|NCT02363075|dexamfetamine sulphate|dexamfetamine sulphate
4844616|NCT02363075|severe asthenia|severe asthenia
4844617|NCT02363075|glioma|glioma
4844618|NCT02363075|MFI-20|mfi-20
4844619|NCT02363075|double-blind|double-blind
4844620|NCT02363075|stabilisation phase|stabilisation phase
4844621|NCT02363062|frontotemporal lobar degeneration|frontotemporal lobar degeneration
4844622|NCT02363062|genes|genes
4844623|NCT02363062|whole exome sequencing|whole exome sequencing
4844624|NCT02363049|Colectomy|colectomy
4844625|NCT02363049|primary tumor resection|primary tumor resection
4844626|NCT02363049|Asymptomatic primary colon cancer|asymptomatic primary colon cancer
4844627|NCT02363049|Unresectable synchronous liver metastasis|unresectable synchronous liver metastasis
4844628|NCT02363049|TNM Staging Primary Tumor (T)|tnm staging primary tumor (t)
4844629|NCT02363049|Unresectable|unresectable
4844630|NCT02363023|Ventilator associated pneumonia|ventilator associated pneumonia
4844631|NCT02363023|Bronchoalveolar lavage|bronchoalveolar lavage
4844632|NCT02363010|Obesity|obesity
4844633|NCT02363010|Weight loss|weight loss
4844634|NCT02363010|Overweight|overweight
4844635|NCT02362997|Classical Hodgkin Lymphoma (cHL)|classical hodgkin lymphoma (chl)
4844636|NCT02362997|Diffuse Large B Cell Lymphoma (DLBCL)|diffuse large b cell lymphoma (dlbcl)
4844637|NCT02362997|Peripheral T-cell lymphoma (PTCL)|peripheral t-cell lymphoma (ptcl)
4844638|NCT02362984|DLBS1033|dlbs1033
4844639|NCT02362984|acute ischemic stroke|acute ischemic stroke
4844640|NCT02362984|MRS|mrs
4844641|NCT02362984|mNIHSS|mnihss
4844642|NCT02362919|Influenza vaccination|influenza vaccination
4844643|NCT02362919|Elderly individuals|elderly individuals
4844644|NCT02362919|Prospective cohort study|prospective cohort study
4844645|NCT02362919|response|response
4844646|NCT02362906|pneumonia|pneumonia
4844647|NCT02362906|pediatrics|pediatrics
4844648|NCT02362893|Hypertension|hypertension
4844649|NCT02362893|Adherence|adherence
4844650|NCT02362893|Direct Observed Therapy (DOT)|direct observed therapy (dot)
4844651|NCT02362893|RCT|rct
4844652|NCT02362854|dental implant|dental implant
4844653|NCT02362854|laser|laser
4844654|NCT02362854|diode laser|diode laser
4844655|NCT02362854|peri-implantitis|peri-implantitis
4844656|NCT02362854|bacterial count|bacterial count
4844657|NCT02362828|Post-Dural Puncture Headache|post-dural puncture headache
4844658|NCT02362828|Blood Patch, epidural|blood patch, epidural
4844659|NCT02362828|Obstetrics|obstetrics
4844660|NCT02362828|European Society of Anaesthesiology (ESA)|european society of anaesthesiology (esa)
4844661|NCT02362828|epidemiology|epidemiology
4844662|NCT02362828|Accidental Dural Puncture (ADP)|accidental dural puncture (adp)
4844663|NCT02362828|Anaesthesia|anaesthesia
4844664|NCT02362828|childbirth complication|childbirth complication
4844665|NCT02362828|epidural analgesia|epidural analgesia
4844666|NCT02362828|postdural puncture headache|postdural puncture headache
4844667|NCT02362828|prophylactic epidural blood patch|prophylactic epidural blood patch
4844668|NCT02362828|epidural|epidural
4844669|NCT02362776|NMR spectroscopy|nmr spectroscopy
4844670|NCT02362776|metabolic changes|metabolic changes
4844671|NCT02362776|blood plasma|blood plasma
4844672|NCT02362776|biomarker|biomarker
4844673|NCT02362776|cancer|cancer
4844674|NCT02362750|comparative effectiveness|comparative effectiveness
4844675|NCT02362750|survivorship|survivorship
4844676|NCT02362750|Patient-Centered Outcomes Research|patient-centered outcomes research
4844677|NCT02362685|Metabolic myopathies|metabolic myopathies
4844678|NCT02362685|Exercise testing|exercise testing
4844679|NCT02362685|Blood sample|blood sample
4844680|NCT02362685|Muscle biopsy|muscle biopsy
4844681|NCT02362685|Genetic analysis|genetic analysis
4844682|NCT02362685|Cycloergometer|cycloergometer
4844683|NCT02362685|Grip-test|grip-test
4844684|NCT02362685|Exercise physiology|exercise physiology
4844685|NCT02362685|Muscle physiology|muscle physiology
4844686|NCT02362659|non-valvular|non-valvular
4844687|NCT02362659|atrial fibrillation|atrial fibrillation
4844688|NCT02362659|percutaneous coronary intervention|percutaneous coronary intervention
4844689|NCT02362646|Heart Failure|heart failure
4844690|NCT02362646|Left Ventricular Assist Device|left ventricular assist device
4844691|NCT02362646|Heart Transplantation|heart transplantation
4844692|NCT02362646|Cardiomyopathy, Destination Therapy|cardiomyopathy, destination therapy
4844693|NCT02362646|Cell Therapy|cell therapy
4844694|NCT02362646|Bridge to Transplant|bridge to transplant
4844695|NCT02362620|Castration Resistant Prostate Cancer, Biomarkers, Taxanes|castration resistant prostate cancer, biomarkers, taxanes
4844696|NCT02362594|PD-1|pd-1
4844697|NCT02362594|PD1|pd1
4844698|NCT02362594|Programmed Cell Death-1|programmed cell death-1
4844699|NCT02362594|Programmed Cell Death 1|programmed cell death 1
4844700|NCT02362594|Programmed Cell Death-Ligand 1 (PD-L1)|programmed cell death-ligand 1 (pd-l1)
4844701|NCT02362594|Programmed Cell Death-Ligand 2 (PD-L2)|programmed cell death-ligand 2 (pd-l2)
4844702|NCT02362594|PDL1|pdl1
4844703|NCT02362594|PDL2|pdl2
4844704|NCT02362581|Prophylaxis treatment|prophylaxis treatment
4844705|NCT02362581|On demand treatment|on demand treatment
4844706|NCT02362581|Severe hemophilia A|severe hemophilia a
4844707|NCT02362581|Moderate hemophilia A|moderate hemophilia a
4844708|NCT02362568|Intubation; Difficult|intubation; difficult
4844709|NCT02362555|Ossification of nuchal ligament|ossification of nuchal ligament
4844710|NCT02362490|chronic hepatitis B|chronic hepatitis b
4844711|NCT02362490|interferon|interferon
4844712|NCT02362490|Nucleotide analogues|nucleotide analogues
4844713|NCT02362490|HBsAg|hbsag
4844714|NCT02362464|Multi-epitope|multi-epitope
4844715|NCT02362464|Tarp Peptide|tarp peptide
4844716|NCT02362464|Dendritic Cell Vaccine|dendritic cell vaccine
4844717|NCT02362464|D0 Prostate Cancer|d0 prostate cancer
4844718|NCT02362451|Dendritic Cell Vaccine|dendritic cell vaccine
4844719|NCT02362451|Multi Epitope Tarp Peptide|multi epitope tarp peptide
4844720|NCT02362451|Autolougous Dendritic Cell|autolougous dendritic cell
4844721|NCT02362451|D0 Prostate Cancer|d0 prostate cancer
4844722|NCT02362451|Vaccine Therapy|vaccine therapy
4844723|NCT02362438|Intrathecal|intrathecal
4844724|NCT02362438|AAVp Mediated Gene Transfer|aavp mediated gene transfer
4844725|NCT02362438|Phase 1|phase 1
4844726|NCT02362438|Safety Study|safety study
4844727|NCT02362438|Giant Axonal Neuropathy|giant axonal neuropathy
4844728|NCT02362425|Neuromuscular Disease|neuromuscular disease
4844729|NCT02362425|Clinical Trial|clinical trial
4844730|NCT02362425|Ryanodine Receptor Type 1|ryanodine receptor type 1
4844731|NCT02362425|Myopathy|myopathy
4844732|NCT02362412|major depressive episodes|major depressive episodes
4844733|NCT02362412|FK949E|fk949e
4844734|NCT02362412|quetiapine|quetiapine
4844735|NCT02362412|bipolar depression|bipolar depression
4844736|NCT02362412|bipolar disorder|bipolar disorder
4844737|NCT02362373|epilepsy|epilepsy
4844738|NCT02362373|contraception|contraception
4844739|NCT02362373|drug interaction|drug interaction
4844740|NCT02362360|Ostomy|ostomy
4844741|NCT02362334|dual Sheimpflug analyzer|dual sheimpflug analyzer
4844742|NCT02362334|intraocular lens power|intraocular lens power
4844743|NCT02362334|optical low-coherence reflectometry|optical low-coherence reflectometry
4844744|NCT02362321|[C10.228.140.300.535.450.400.120]|[c10.228.140.300.535.450.400.120]
4844745|NCT02362295|palliative care|palliative care
4844746|NCT02362295|vulnerable population|vulnerable population
4844747|NCT02362295|qualitative research|qualitative research
4844748|NCT02362282|stroke|stroke
4844749|NCT02362282|walking|walking
4844750|NCT02362282|cognition|cognition
4844751|NCT02362282|rehabilitation|rehabilitation
4844752|NCT02362256|Opioid detoxification|opioid detoxification
4844753|NCT02362256|Opioid antagonist induction|opioid antagonist induction
4844754|NCT02362256|Conscious sedation|conscious sedation
4844755|NCT02362243|low back pain|low back pain
4844756|NCT02362243|low back injury|low back injury
4844757|NCT02362243|firefighter|firefighter
4844758|NCT02362243|prevention|prevention
4844759|NCT02362243|physical fitness|physical fitness
4844760|NCT02362243|exercise training|exercise training
4844761|NCT02362243|worksite|worksite
4844762|NCT02362243|web-based|web-based
4844763|NCT02362165|multiple myeloma|multiple myeloma
4844764|NCT02362165|cyclophosphamide|cyclophosphamide
4844765|NCT02362165|bortezomib|bortezomib
4844766|NCT02362165|doxorubicin|doxorubicin
4844767|NCT02362165|peripheral neuropathy|peripheral neuropathy
4844768|NCT02362152|Actinic keratosis|actinic keratosis
4844769|NCT02362152|Solar keratosis|solar keratosis
4844770|NCT02362152|Field treatment|field treatment
4844771|NCT02362152|Ingenol mebutate|ingenol mebutate
4844772|NCT02362152|Picato|picato
4844773|NCT02362126|Endoscopic full thickness resection|endoscopic full thickness resection
4844774|NCT02362126|EFTR|eftr
4844775|NCT02362126|FTRD|ftrd
4844776|NCT02362126|OTSC|otsc
4844777|NCT02362087|pain|pain
4844778|NCT02362061|junctional zone|junctional zone
4844779|NCT02362061|implantation|implantation
4844780|NCT02362061|three D ultraosund|three d ultraosund
4844781|NCT02362061|Assisted Reproductive Technology|assisted reproductive technology
4844782|NCT02362061|Pregnancy|pregnancy
4844783|NCT02362035|Bruton tyrosine kinase inhibitor|bruton tyrosine kinase inhibitor
4844784|NCT02362035|Btk|btk
4844785|NCT02362035|B-Cell Malignancies|b-cell malignancies
4844786|NCT02362035|Mantle Cell|mantle cell
4844787|NCT02362035|Multiple Myeloma|multiple myeloma
4844788|NCT02362035|CLL|cll
4844789|NCT02362035|SLL|sll
4844790|NCT02362035|DLBCL|dlbcl
4844791|NCT02362035|Follicular|follicular
4844792|NCT02362035|Waldenstrom|waldenstrom
4844793|NCT02362035|Burkitt lymphoma|burkitt lymphoma
4844794|NCT02362035|marginal zone lymphomas|marginal zone lymphomas
4844795|NCT02362035|hairy cell leukemia|hairy cell leukemia
4844796|NCT02362035|B cell acute lymphoid leukemia|b cell acute lymphoid leukemia
4844797|NCT02362035|Acalabrutinib|acalabrutinib
4844798|NCT02362035|ACP-196|acp-196
4844799|NCT02362009|Myomas|myomas
4844800|NCT02362009|Leiomyomas|leiomyomas
4844801|NCT02362009|Fibromas|fibromas
4844802|NCT02361970|sepsis|sepsis
4844803|NCT02361970|gamma delta T cells|gamma delta t cells
4844804|NCT02361970|immunosuppression|immunosuppression
4844805|NCT02361944|oxygen|oxygen
4844806|NCT02361944|hyperoxia|hyperoxia
4844807|NCT02361944|reactive oxygen species|reactive oxygen species
4844808|NCT02361944|oxidative stress|oxidative stress
4844809|NCT02361944|oxidative damage|oxidative damage
4844810|NCT02361944|endothelial function|endothelial function
4844811|NCT02361944|vascular reactivity|vascular reactivity
4844812|NCT02361944|mitochondrial function|mitochondrial function
4844813|NCT02361944|surgery|surgery
4844814|NCT02361944|anesthesia|anesthesia
4844815|NCT02361944|kidney injury|kidney injury
4844816|NCT02361944|renal failure|renal failure
4844817|NCT02361944|delirium|delirium
4844818|NCT02361944|myocardial injury|myocardial injury
4844819|NCT02361944|arrythmia|arrythmia
4844820|NCT02361931|accelerating healing|accelerating healing
4844821|NCT02361931|diabetic chronic wounds|diabetic chronic wounds
4844822|NCT02361931|diabetic patients|diabetic patients
4844823|NCT02361931|diabetic chronic ulcers|diabetic chronic ulcers
4844824|NCT02361931|Wagner grade II|wagner grade ii
4844825|NCT02361931|infection|infection
4844826|NCT02361931|necrosis|necrosis
4844827|NCT02361931|erythema|erythema
4844828|NCT02361931|mild drainage|mild drainage
4844829|NCT02361905|fibroid|fibroid
4844830|NCT02361905|cellular leiomyomas|cellular leiomyomas
4844831|NCT02361905|GnRH analogue|gnrh analogue
4844832|NCT02361905|ulipristal acetate|ulipristal acetate
4844833|NCT02361892|ovarian reserve|ovarian reserve
4844834|NCT02361892|infertility|infertility
4844835|NCT02361892|leiomyomas|leiomyomas
4844836|NCT02361892|ulipristal acetate|ulipristal acetate
4844837|NCT02361879|fibroids|fibroids
4844838|NCT02361879|gnrh analogue|gnrh analogue
4844839|NCT02361879|ulipristal acetate|ulipristal acetate
4844840|NCT02361879|hysteroscopy|hysteroscopy
4844841|NCT02361840|Troponin I|troponin i
4844842|NCT02361840|Pediatric shock|pediatric shock
4844843|NCT02361827|Vitamin D|vitamin d
4844844|NCT02361827|IVF outcome|ivf outcome
4844845|NCT02361814|flexor tendon|flexor tendon
4844846|NCT02361814|finger|finger
4844847|NCT02361814|amniotic membrane|amniotic membrane
4844848|NCT02361814|allograft|allograft
4844849|NCT02361814|tendon injury|tendon injury
4844850|NCT02361801|cardiac surgery|cardiac surgery
4844851|NCT02361801|dobutamine|dobutamine
4844852|NCT02361788|neonatal hyperbilirubinemia|neonatal hyperbilirubinemia
4844853|NCT02361788|etiology|etiology
4844854|NCT02361788|incidence|incidence
4844855|NCT02361788|risk factors|risk factors
4844856|NCT02361762|Executive Function|executive function
4844857|NCT02361762|Theory of Mind|theory of mind
4844858|NCT02361762|Individual Differences|individual differences
4844859|NCT02361762|Social Skills|social skills
4844860|NCT02361762|Executive Control|executive control
4844861|NCT02361710|Vitamin D|vitamin d
4844862|NCT02361710|pregnancy rate|pregnancy rate
4844863|NCT02361710|eFET|efet
4844864|NCT02361697|pediatric multiple sclerosis|pediatric multiple sclerosis
4844865|NCT02361697|clinically isolated syndrome in children|clinically isolated syndrome in children
4844866|NCT02361697|biomarker|biomarker
4844867|NCT02361697|magnetic resonance imaging|magnetic resonance imaging
4844868|NCT02361697|diffusion weighted imaging|diffusion weighted imaging
4844869|NCT02361684|cost-effectiveness|cost-effectiveness
4844870|NCT02361684|blended treatment|blended treatment
4844871|NCT02361684|Internet based treatment|internet based treatment
4844872|NCT02361684|Efficacy|efficacy
4844873|NCT02361684|Depression|depression
4844874|NCT02361684|cognitive behavioural therapy|cognitive behavioural therapy
4844875|NCT02361645|nonsteroidal antiinflammatory drugs|nonsteroidal antiinflammatory drugs
4844876|NCT02361645|prostaglandin E2|prostaglandin e2
4844877|NCT02361645|vitrectomy|vitrectomy
4844878|NCT02361606|adolescents|adolescents
4844879|NCT02361606|cognitive behavioral internet intervention|cognitive behavioral internet intervention
4844880|NCT02361593|endoscopic sclerotherapy, esophageal varices, transparent cap|endoscopic sclerotherapy, esophageal varices, transparent cap
4844881|NCT02361567|Post Operative Pain|post operative pain
4844882|NCT02361567|Addiction|addiction
4844883|NCT02361528|Septic shock|septic shock
4844884|NCT02361528|Severe sepsis|severe sepsis
4844885|NCT02361528|GM-CSF|gm-csf
4844886|NCT02361528|Immunosuppression|immunosuppression
4844887|NCT02361528|Hospital-acquired infections|hospital-acquired infections
4844888|NCT02361528|ICU-acquired infections|icu-acquired infections
4844889|NCT02361528|HLA-DR|hla-dr
4844890|NCT02361528|Monocytes|monocytes
4844891|NCT02361515|Prostate|prostate
4844892|NCT02361515|Hypofractionated radiotherapy|hypofractionated radiotherapy
4844893|NCT02361515|Stereotactic irradiation|stereotactic irradiation
4844894|NCT02361515|Spacer|spacer
4844895|NCT02361515|Rectal and bladder toxicities|rectal and bladder toxicities
4844896|NCT02361476|Anaesthesia|anaesthesia
4844897|NCT02361476|Children|children
4844898|NCT02361476|Clonidine|clonidine
4844899|NCT02361476|Sevoflurane|sevoflurane
4844900|NCT02361476|Postoperative agitation|postoperative agitation
4844901|NCT02361476|Prevention|prevention
4844902|NCT02361476|Pharmacokinetics|pharmacokinetics
4844903|NCT02361476|Safety|safety
4844904|NCT02361463|Laparoscopy;|laparoscopy;
4844905|NCT02361463|Training;|training;
4844906|NCT02361463|Three-Dimensional|three-dimensional
4844907|NCT02361450|Faecal incontinence|faecal incontinence
4844908|NCT02361450|Spina Bifida|spina bifida
4844909|NCT02361450|Enema|enema
4844910|NCT02361450|Constipation|constipation
4844911|NCT02361450|Myelomeningocele|myelomeningocele
4844912|NCT02361450|Human|human
4844913|NCT02361437|diabetes type II|diabetes type ii
4844914|NCT02361437|diabetic ulcers|diabetic ulcers
4844915|NCT02361424|PXT00864|pxt00864
4844916|NCT02361424|mild AD|mild ad
4844917|NCT02361424|phase 2a|phase 2a
4844918|NCT02361359|Arthroplasty|arthroplasty
4844919|NCT02361346|CD20|cd20
4844920|NCT02361346|immunotoxin|immunotoxin
4844921|NCT02361346|NHL|nhl
4844922|NCT02361346|non-Hodgkin's lymphoma|non-hodgkin's lymphoma
4844923|NCT02361346|lymphoma|lymphoma
4844924|NCT02361346|cancer|cancer
4844925|NCT02361346|antibodies|antibodies
4844926|NCT02361346|immunotherapy|immunotherapy
4844927|NCT02361346|safety|safety
4844928|NCT02361346|pharmacokinetics|pharmacokinetics
4844929|NCT02361346|maximum tolerated dose|maximum tolerated dose
4844930|NCT02361346|MT-3724|mt-3724
4844931|NCT02361346|relapsed|relapsed
4844932|NCT02361346|refractory|refractory
4844933|NCT02361346|leukemia|leukemia
4844934|NCT02361346|CLL|cll
4844935|NCT02361346|SLL|sll
4844936|NCT02361320|Pancreatic cancer|pancreatic cancer
4844937|NCT02361320|Pancreatic ductal adenocarcinoma|pancreatic ductal adenocarcinoma
4844938|NCT02361320|PDAC|pdac
4844939|NCT02361320|Computed tomography|computed tomography
4844940|NCT02361320|CT|ct
4844941|NCT02361320|Questionnaire|questionnaire
4844942|NCT02361320|Survey|survey
4844943|NCT02361268|end-stage renal disease|end-stage renal disease
4844944|NCT02361268|hemodialysis|hemodialysis
4844945|NCT02361268|yoga|yoga
4844946|NCT02361268|mind-body medicine|mind-body medicine
4844947|NCT02361268|meditation|meditation
4844948|NCT02361242|PXT00864|pxt00864
4844949|NCT02361242|mild AD|mild ad
4844950|NCT02361242|phase 2a|phase 2a
4844951|NCT02361138|SHR3824 Type 2 diabetes mellitus SGLT2|shr3824 type 2 diabetes mellitus sglt2
4844952|NCT02361125|Fatigue|fatigue
4844953|NCT02361125|Cancer related fatigue|cancer related fatigue
4844954|NCT02361125|Methylphenidate|methylphenidate
4844955|NCT02361125|Methylphenidate Hydrochloride|methylphenidate hydrochloride
4844956|NCT02361125|Ritalin|ritalin
4844957|NCT02361125|Concerta|concerta
4844958|NCT02361125|Fatigue evaluations|fatigue evaluations
4844959|NCT02361086|castration-resistant prostate cancer|castration-resistant prostate cancer
4844960|NCT02361086|CYP17|cyp17
4844961|NCT02361086|P450c17a|p450c17a
4844962|NCT02361086|lyase|lyase
4844963|NCT02361073|Stress-induced cardiomyopathy|stress-induced cardiomyopathy
4844964|NCT02361073|ERP|erp
4844965|NCT02361034|Safety and pharmacokinetics of drug in healthy volunteers|safety and pharmacokinetics of drug in healthy volunteers
4844966|NCT02361021|Critical Care|critical care
4844967|NCT02361021|Non invasive ventilation|non invasive ventilation
4844968|NCT02361021|Electrical impedance tomography|electrical impedance tomography
4844969|NCT02361021|End expiratory lung volume|end expiratory lung volume
4844970|NCT02361021|Lung ultrasound score|lung ultrasound score
4844971|NCT02361008|Infundibular Ventricular Septal Defect|infundibular ventricular septal defect
4844972|NCT02361008|occlusion|occlusion
4844973|NCT02361008|TEE-guided|tee-guided
4844974|NCT02361008|asymmetric occluder|asymmetric occluder
4844975|NCT02361008|surgical repair|surgical repair
4844976|NCT02360982|Delirium|delirium
4844977|NCT02360982|regional anesthesia|regional anesthesia
4844978|NCT02360982|general anesthesia|general anesthesia
4844979|NCT02360969|strabismus|strabismus
4844980|NCT02360969|surgical procedure|surgical procedure
4844981|NCT02360969|anesthesia|anesthesia
4844982|NCT02360969|squint|squint
4844983|NCT02360969|child|child
4844984|NCT02360956|Olmesartan medoxomil|olmesartan medoxomil
4844985|NCT02360956|Epicardial adipose tissue|epicardial adipose tissue
4844986|NCT02360956|Multidetector Computed Tomography|multidetector computed tomography
4844987|NCT02360943|elderly patients|elderly patients
4844988|NCT02360943|Pulmonary embolism|pulmonary embolism
4844989|NCT02360943|Anticoagulant treatments|anticoagulant treatments
4844990|NCT02360930|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
4844991|NCT02360930|Pharmacokinetics|pharmacokinetics
4844992|NCT02360930|Vincristine|vincristine
4844993|NCT02360917|Cognitive Dysfunction|cognitive dysfunction
4844994|NCT02360917|Cancer Survivorship|cancer survivorship
4844995|NCT02360891|multimodal biomarkers|multimodal biomarkers
4844996|NCT02360891|prognosis|prognosis
4844997|NCT02360891|endophenotypes|endophenotypes
4844998|NCT02360878|DJBS|djbs
4844999|NCT02360878|Duodenal-jejunal bypass sleeve|duodenal-jejunal bypass sleeve
4845000|NCT02360878|Duodenal-jejunal bypass liner|duodenal-jejunal bypass liner
4845001|NCT02360878|Endobarrier|endobarrier
4845002|NCT02360878|Obesity|obesity
4845003|NCT02360878|Type 2 diabetes|type 2 diabetes
4845004|NCT02360878|Incretin hormones|incretin hormones
4845005|NCT02360878|Postprandial glucose metabolism|postprandial glucose metabolism
4845006|NCT02360813|Cognitive remediation therapy|cognitive remediation therapy
4845007|NCT02360813|Psychiatric rehabilitation|psychiatric rehabilitation
4845008|NCT02360813|Forensic mental health|forensic mental health
4845009|NCT02360813|Forensic psychiatry|forensic psychiatry
4845010|NCT02360813|Clinical psychology|clinical psychology
4845011|NCT02360813|Randomized controlled trial|randomized controlled trial
4845012|NCT02360813|Principle driven intervention|principle driven intervention
4845013|NCT02360813|Psychological Intervention|psychological intervention
4845014|NCT02360813|Cognitive enhancement|cognitive enhancement
4845015|NCT02360800|Bleeding|bleeding
4845016|NCT02360800|Heart Surgery|heart surgery
4845017|NCT02360800|Reoperation|reoperation
4845018|NCT02360787|Almonds|almonds
4845019|NCT02360787|Energy restriction|energy restriction
4845020|NCT02360787|Obesity|obesity
4845021|NCT02360787|Body weight|body weight
4845022|NCT02360787|Body fat|body fat
4845023|NCT02360787|Blood pressure|blood pressure
4845024|NCT02360787|Cognitive function|cognitive function
4845025|NCT02360774|Canagliflozin|canagliflozin
4845026|NCT02360774|Obesity|obesity
4845027|NCT02360774|Weight Loss|weight loss
4845028|NCT02360774|Body Weight|body weight
4845029|NCT02360774|Body Weight Changes|body weight changes
4845030|NCT02360774|Overweight|overweight
4845031|NCT02360774|Sodium-glucose transporter subtype 2 inhibitor|sodium-glucose transporter subtype 2 inhibitor
4845032|NCT02360761|Lung cancer;Elderly;Sublobar resection;Lobectomy|lung cancer;elderly;sublobar resection;lobectomy
4845033|NCT02360696|Duodenal Eosinophilia|duodenal eosinophilia
4845034|NCT02360696|Functional Dyspepsia|functional dyspepsia
4845035|NCT02360696|Mucosal Eosinophilia|mucosal eosinophilia
4845036|NCT02360683|Subthalamic neurostimulation|subthalamic neurostimulation
4845037|NCT02360657|Alzheimer's Disease|alzheimer's disease
4845038|NCT02360657|Alzheimer Dementia|alzheimer dementia
4845039|NCT02360657|JNJ-54861911|jnj-54861911
4845040|NCT02360657|Beta Secretase Inhibitor|beta secretase inhibitor
4845041|NCT02360631|smoking|smoking
4845042|NCT02360631|quit smoking|quit smoking
4845043|NCT02360631|smoking treatment|smoking treatment
4845044|NCT02360618|Bladder Cancer|bladder cancer
4845045|NCT02360618|Metformin|metformin
4845046|NCT02360618|Simvastatin|simvastatin
4845047|NCT02360618|Combination Therapy|combination therapy
4845048|NCT02360605|colorectal cancer screening|colorectal cancer screening
4845049|NCT02360605|low literacy|low literacy
4845050|NCT02360605|community clinics|community clinics
4845051|NCT02360605|Fecal Immunochemical Test|fecal immunochemical test
4845052|NCT02360579|Autologous Adoptive Cell Transfer|autologous adoptive cell transfer
4845053|NCT02360579|Autologous Adoptive Cell Therapy|autologous adoptive cell therapy
4845054|NCT02360579|Cellular Immuno-therapy|cellular immuno-therapy
4845055|NCT02360579|Cell Therapy|cell therapy
4845056|NCT02360579|Tumor Infiltrating Lymphocytes|tumor infiltrating lymphocytes
4845057|NCT02360579|TIL|til
4845058|NCT02360579|LN-144|ln-144
4845059|NCT02360579|IL-2|il-2
4845060|NCT02360579|Melanoma|melanoma
4845061|NCT02360579|Lifileucel|lifileucel
4845062|NCT02360566|Psychosis|psychosis
4845063|NCT02360566|Schizophrenia|schizophrenia
4845064|NCT02360566|Participatory Video|participatory video
4845065|NCT02360566|Narrative|narrative
4845066|NCT02360540|Pulmonary Embolism|pulmonary embolism
4845067|NCT02360540|Diagnostic strategy|diagnostic strategy
4845068|NCT02360540|Exclusion|exclusion
4845069|NCT02360540|Clinical probability|clinical probability
4845070|NCT02360540|Implicit Judgment (Gestalt)|implicit judgment (gestalt)
4845071|NCT02360540|PERC|perc
4845072|NCT02360501|nasopharyngeal carcinoma|nasopharyngeal carcinoma
4845073|NCT02360501|induction chemotherapy|induction chemotherapy
4845074|NCT02360501|docetaxel|docetaxel
4845075|NCT02360501|xeloda|xeloda
4845076|NCT02360475|Vaccine|vaccine
4845077|NCT02360475|Immunogenicity|immunogenicity
4845078|NCT02360475|Safety|safety
4845079|NCT02360475|Respiratory syncytial virus (RSV)|respiratory syncytial virus (rsv)
4845080|NCT02360475|Reactogenicity|reactogenicity
4845081|NCT02360462|Transcranial Direct Current Stimulation|transcranial direct current stimulation
4845082|NCT02360462|tDCS|tdcs
4845083|NCT02360462|Hallux Valgus|hallux valgus
4845084|NCT02360462|Chronic Pain|chronic pain
4845085|NCT02360449|Pivotal Response Treatment|pivotal response treatment
4845086|NCT02360449|Applied Behavior Analysis|applied behavior analysis
4845087|NCT02360449|Peer Initiation|peer initiation
4845088|NCT02360449|Social Skills Group|social skills group
4845089|NCT02360436|Rett|rett
4845090|NCT02360436|MeCP2|mecp2
4845091|NCT02360436|Glutathione|glutathione
4845092|NCT02360436|Cysteine|cysteine
4845093|NCT02360436|ROS|ros
4845094|NCT02360384|wireless motility capsule|wireless motility capsule
4845095|NCT02360332|Autism|autism
4845096|NCT02360332|transition to adulthood|transition to adulthood
4845097|NCT02360332|employment|employment
4845098|NCT02360332|High School Seniors|high school seniors
4845099|NCT02360319|First episode or recent onset|first episode or recent onset
4845100|NCT02360293|Exercise|exercise
4845101|NCT02360293|App-mediated|app-mediated
4845102|NCT02360293|Veterans|veterans
4845103|NCT02360280|Depressive Disorder, Treatment-Resistant|depressive disorder, treatment-resistant
4845104|NCT02360267|Bipolar Disorder|bipolar disorder
4845105|NCT02360267|Pediatric|pediatric
4845106|NCT02360267|Offspring|offspring
4845107|NCT02360267|Depression|depression
4845108|NCT02360267|Mania|mania
4845109|NCT02360267|Children of parents who suffer from Bipolar disorder|children of parents who suffer from bipolar disorder
4845110|NCT02360228|tACS|tacs
4845111|NCT02360228|tDCS|tdcs
4845112|NCT02360228|sham|sham
4845113|NCT02360228|auditory hallucinations|auditory hallucinations
4845114|NCT02360228|Schizophrenia|schizophrenia
4845115|NCT02360228|Schizoaffective Disorder|schizoaffective disorder
4845116|NCT02360176|single port surgery|single port surgery
4845117|NCT02360176|bariatric surgery|bariatric surgery
4845118|NCT02360176|sleeve gastrectomy|sleeve gastrectomy
4845119|NCT02360176|randomise prospective study|randomise prospective study
4845120|NCT02360176|complication rate|complication rate
4845121|NCT02360150|cardiac angiography|cardiac angiography
4845122|NCT02360150|cardiac MRI|cardiac mri
4845123|NCT02360137|carotids|carotids
4845124|NCT02360137|plaque|plaque
4845125|NCT02360137|characteristics|characteristics
4845126|NCT02360137|stroke|stroke
4845127|NCT02360111|GVHD Prophylaxis|gvhd prophylaxis
4845128|NCT02360111|Cyclophosphamide|cyclophosphamide
4845129|NCT02360111|Renal Insufficiency|renal insufficiency
4845130|NCT02360111|Hematopoietic Stem Cell Transplant|hematopoietic stem cell transplant
4845131|NCT02360111|14-273|14-273
4845132|NCT02360098|Emergence from Anesthesia|emergence from anesthesia
4845133|NCT02360098|Anterior temporal lobectomy|anterior temporal lobectomy
4845134|NCT02360098|Amygdalohippocampectomy|amygdalohippocampectomy
4845135|NCT02360098|Anesthesia|anesthesia
4845136|NCT02360085|Cervical Myelopathy|cervical myelopathy
4845137|NCT02360085|Hypotension|hypotension
4845138|NCT02360072|child|child
4845139|NCT02360072|allergic rhinitis|allergic rhinitis
4845140|NCT02360072|asthma|asthma
4845141|NCT02360072|nitric oxide|nitric oxide
4845243|NCT02359461|Pulsatile cuts|pulsatile cuts
4845142|NCT02360072|bronchial hyper-responsiveness|bronchial hyper-responsiveness
4845143|NCT02360059|Breast cancer|breast cancer
4845144|NCT02360059|Neuropathy|neuropathy
4845145|NCT02360059|Paclitaxel|paclitaxel
4845146|NCT02360059|Metformin|metformin
4845147|NCT02360059|Metformin ER|metformin er
4845148|NCT02360059|Placebo|placebo
4845149|NCT02360059|Sugar pill|sugar pill
4845150|NCT02360059|Questionnaires|questionnaires
4845151|NCT02360059|Sensory tests|sensory tests
4845152|NCT02360059|Fine-motor tests|fine-motor tests
4845153|NCT02360059|Surveys|surveys
4845154|NCT02360020|coronary stent|coronary stent
4845155|NCT02360020|outcome|outcome
4845156|NCT02360007|opioids|opioids
4845157|NCT02360007|buprenorphine|buprenorphine
4845158|NCT02360007|interim treatment|interim treatment
4845159|NCT02360007|opioid dependence|opioid dependence
4845160|NCT02359994|hemostasis|hemostasis
4845161|NCT02359981|Weight loss, Fitness|weight loss, fitness
4845162|NCT02359968|resectable esophageal|resectable esophageal
4845163|NCT02359968|junctional cancer|junctional cancer
4845164|NCT02359968|FOLFOX|folfox
4845165|NCT02359968|paclitaxel-carboplatin|paclitaxel-carboplatin
4845166|NCT02359942|Helicobacter pylori infection|helicobacter pylori infection
4845167|NCT02359942|Eradication|eradication
4845168|NCT02359942|Urea breath test|urea breath test
4845169|NCT02359929|graft versus host disease|graft versus host disease
4845170|NCT02359929|GVHD|gvhd
4845171|NCT02359890|Interventional|interventional
4845172|NCT02359890|Radiofrequency ablation|radiofrequency ablation
4845173|NCT02359890|Paroxysmal Atrial Fibrillation|paroxysmal atrial fibrillation
4845174|NCT02359877|pegylated interferon beta|pegylated interferon beta
4845175|NCT02359877|Volunteers|volunteers
4845176|NCT02359864|radiation treatment|radiation treatment
4845177|NCT02359838|Hematologic Malignancy|hematologic malignancy
4845178|NCT02359838|Geriatric Assessment|geriatric assessment
4845179|NCT02359838|Geriatric Oncology|geriatric oncology
4845180|NCT02359838|Frailty|frailty
4845181|NCT02359812|Stroke|stroke
4845182|NCT02359812|Upper extremity|upper extremity
4845183|NCT02359812|Rehabilitation|rehabilitation
4845184|NCT02359812|Robot|robot
4845185|NCT02359812|Hemiplegia|hemiplegia
4845186|NCT02359812|Spasticity|spasticity
4845187|NCT02359812|Arm|arm
4845188|NCT02359812|Hand|hand
4845189|NCT02359799|Cerebral palsy|cerebral palsy
4845190|NCT02359799|Ankle Impairments|ankle impairments
4845191|NCT02359799|Robotic rehabilitation|robotic rehabilitation
4845192|NCT02359773|Magnetocardiography|magnetocardiography
4845193|NCT02359773|Myocardial Infarction|myocardial infarction
4845194|NCT02359773|Non-ischaemic chest pain|non-ischaemic chest pain
4845195|NCT02359760|Rapid orthodontics|rapid orthodontics
4845196|NCT02359760|accelerated orthodontics|accelerated orthodontics
4845197|NCT02359760|Piezocision|piezocision
4845198|NCT02359760|flapless corticotomies|flapless corticotomies
4845199|NCT02359760|minimaly invasive|minimaly invasive
4845200|NCT02359747|free gDNA|free gdna
4845201|NCT02359747|culture media|culture media
4845202|NCT02359734|Patient safety|patient safety
4845203|NCT02359734|Medication errors|medication errors
4845204|NCT02359734|Smart infusion pump|smart infusion pump
4845205|NCT02359721|Colony forming units Antimicrobial agents|colony forming units antimicrobial agents
4845206|NCT02359721|Microbial colonization|microbial colonization
4845207|NCT02359695|Poor ovarian response|poor ovarian response
4845208|NCT02359695|IVF|ivf
4845209|NCT02359695|Growth hormone|growth hormone
4845210|NCT02359643|Kawasaki disease|kawasaki disease
4845211|NCT02359617|continuous glucose sensor|continuous glucose sensor
4845212|NCT02359617|subcutaneous insulin infusion|subcutaneous insulin infusion
4845213|NCT02359617|closed-loop glucose control|closed-loop glucose control
4845214|NCT02359617|type 1 diabetes|type 1 diabetes
4845215|NCT02359604|infant|infant
4845216|NCT02359604|ppi|ppi
4845217|NCT02359604|proton pump inhibitor|proton pump inhibitor
4845218|NCT02359604|microbiome|microbiome
4845219|NCT02359604|Microbiota|microbiota
4845220|NCT02359578|lymphatic system|lymphatic system
4845221|NCT02359578|occlusion pressure|occlusion pressure
4845222|NCT02359578|Indocyanine Green|indocyanine green
4845223|NCT02359526|Chronic Diabetic Macular Edema|chronic diabetic macular edema
4845224|NCT02359526|Iluvien|iluvien
4845225|NCT02359526|Intra-vitreal injections|intra-vitreal injections
4845226|NCT02359526|Pilot study|pilot study
4845227|NCT02359513|bulimia|bulimia
4845228|NCT02359513|serotoninergic brain activity|serotoninergic brain activity
4845229|NCT02359513|fluoxetine|fluoxetine
4845230|NCT02359513|serotoninergic antidepressant|serotoninergic antidepressant
4845231|NCT02359513|brain serotonin profile|brain serotonin profile
4845232|NCT02359513|positon emission tomography|positon emission tomography
4845233|NCT02359500|68Ga- DOTATOC|68ga- dotatoc
4845234|NCT02359500|Diagnosis|diagnosis
4845235|NCT02359500|Somatostatin Receptor-Positive Neuroendocrine Tumors|somatostatin receptor-positive neuroendocrine tumors
4845236|NCT02359487|Namibia|namibia
4845237|NCT02359487|Alcohol|alcohol
4845238|NCT02359487|HIV|hiv
4845239|NCT02359487|Sexual risk|sexual risk
4845240|NCT02359474|high-risk soft tissue sarcoma|high-risk soft tissue sarcoma
4845241|NCT02359474|trabectedin|trabectedin
4845242|NCT02359461|Vascular function|vascular function
4845244|NCT02359461|Type 2 diabetes|type 2 diabetes
4845245|NCT02359461|Endothelium|endothelium
4845246|NCT02359461|Cardiovascular risk|cardiovascular risk
4845247|NCT02359461|Vasomotricity|vasomotricity
4845248|NCT02359461|FMD (Flow Mediated Dilatation)|fmd (flow mediated dilatation)
4845249|NCT02359435|Helicobacter pylori|helicobacter pylori
4845250|NCT02359435|Proton pump inhibitor|proton pump inhibitor
4845251|NCT02359435|Eradication|eradication
4845252|NCT02359396|Randomized open-label study|randomized open-label study
4845253|NCT02359396|Chinese Herbal|chinese herbal
4845254|NCT02359396|Constipation/drug therapy|constipation/drug therapy
4845255|NCT02359383|pleural disease|pleural disease
4845256|NCT02359383|infecTion|infection
4845257|NCT02359383|chest physiotherapy|chest physiotherapy
4845258|NCT02359370|Laryngoscopy|laryngoscopy
4845259|NCT02359370|Tracheal Intubation|tracheal intubation
4845260|NCT02359370|Lidocaine|lidocaine
4845261|NCT02359370|Magnesium Sulphate|magnesium sulphate
4845262|NCT02359370|Cardiovascular Physiological Phenomena|cardiovascular physiological phenomena
4845263|NCT02359331|Helicobacter pylori|helicobacter pylori
4845264|NCT02359331|resistance|resistance
4845265|NCT02359331|rescue therapy|rescue therapy
4845266|NCT02359318|White spot lesion|white spot lesion
4845267|NCT02359318|Resin Infiltration|resin infiltration
4845268|NCT02359318|Icon|icon
4845269|NCT02359318|Debonding|debonding
4845270|NCT02359318|Enamel damages|enamel damages
4845271|NCT02359318|Enamel|enamel
4845272|NCT02359318|Orthodontics|orthodontics
4845273|NCT02359266|Mood|mood
4845274|NCT02359266|Vitamin D deficiency|vitamin d deficiency
4845275|NCT02359266|Adjuvant treatment|adjuvant treatment
4845276|NCT02359253|Stroke|stroke
4845277|NCT02359253|Spasticity|spasticity
4845278|NCT02359253|Arm|arm
4845279|NCT02359253|Hand|hand
4845280|NCT02359253|Robotic therapy|robotic therapy
4845281|NCT02359227|Chronic Heart Failure|chronic heart failure
4845282|NCT02359227|Natriuretic Peptides|natriuretic peptides
4845283|NCT02359227|Cenderitide|cenderitide
4845284|NCT02359214|Vitamin D|vitamin d
4845285|NCT02359214|Cardiovascular disease|cardiovascular disease
4845286|NCT02359214|Diabetes|diabetes
4845287|NCT02359214|Obesity|obesity
4845288|NCT02359214|Cardiometabolic|cardiometabolic
4845289|NCT02359214|Bone disease|bone disease
4845290|NCT02359201|Nicotine replacement therapy|nicotine replacement therapy
4845291|NCT02359201|craving|craving
4845292|NCT02359201|Healthy moderately dependant smokers|healthy moderately dependant smokers
4845293|NCT02359188|Vagus Nerve Stimulation|vagus nerve stimulation
4845294|NCT02359175|Pain|pain
4845295|NCT02359175|Pain Measurement|pain measurement
4845296|NCT02359175|VAS|vas
4845297|NCT02359175|Visual Analog Pain Scale|visual analog pain scale
4845298|NCT02359175|Analgesics|analgesics
4845299|NCT02359175|Opioid|opioid
4845300|NCT02359175|Epidural analgesia|epidural analgesia
4845301|NCT02359175|VATS|vats
4845302|NCT02359175|Video-assisted Thoracic Surgery|video-assisted thoracic surgery
4845303|NCT02359175|Lobectomy|lobectomy
4845304|NCT02359175|Wedge Resection|wedge resection
4845305|NCT02359175|Segmental Resection|segmental resection
4845306|NCT02359175|Cytokins|cytokins
4845307|NCT02359175|Immune cells|immune cells
4845308|NCT02359162|NK/T-cell lymphoma|nk/t-cell lymphoma
4845309|NCT02359162|induction chemotherapy|induction chemotherapy
4845310|NCT02359162|survival|survival
4845311|NCT02359149|Intravitreal injections|intravitreal injections
4845312|NCT02359149|Nurses|nurses
4845313|NCT02359149|Physicians|physicians
4845314|NCT02359136|Arthroplasty, Replacement, Hip|arthroplasty, replacement, hip
4845315|NCT02359136|Anesthesia, Local|anesthesia, local
4845316|NCT02359136|Ropivacaine|ropivacaine
4845317|NCT02359136|Randomized controlled trial|randomized controlled trial
4845318|NCT02359110|laparoscopy|laparoscopy
4845319|NCT02359110|postoperative pain|postoperative pain
4845320|NCT02359110|gynecology|gynecology
4845321|NCT02359110|gabapentin|gabapentin
4845322|NCT02359071|handoff|handoff
4845323|NCT02359071|signoff|signoff
4845324|NCT02359071|handover|handover
4845325|NCT02359071|sign-out|sign-out
4845326|NCT02359071|shift change|shift change
4845327|NCT02359071|Emergency Department|emergency department
4845328|NCT02359045|Omega-3-carboxylic acids,|omega-3-carboxylic acids,
4845329|NCT02359045|Phase I,|phase i,
4845330|NCT02359045|Healthy Subjects,|healthy subjects,
4845331|NCT02359045|Pharmacokinetics,|pharmacokinetics,
4845332|NCT02359045|Relative bioavailability|relative bioavailability
4845333|NCT02359032|Healthy subjects|healthy subjects
4845334|NCT02359032|Pharmacokinetics of ASP6858|pharmacokinetics of asp6858
4845335|NCT02359032|ASP6858|asp6858
4845336|NCT02359032|Pharmacodynamics of ASP6858|pharmacodynamics of asp6858
4845337|NCT02359006|Analgesia|analgesia
4845338|NCT02359006|pain analgesia|pain analgesia
4845339|NCT02359006|methadone|methadone
4845340|NCT02359006|opiates|opiates
4845341|NCT02358993|Urinary Tract Infections|urinary tract infections
4845342|NCT02358993|Catheter-Related Infections|catheter-related infections
4845343|NCT02358993|Pelvic Reconstructive Surgery|pelvic reconstructive surgery
4845344|NCT02358993|Urogynecology|urogynecology
4845345|NCT02358993|Urinary catheterization|urinary catheterization
4845445|NCT02358499|fungi|fungi
4845346|NCT02358993|Post-operative Infections|post-operative infections
4845347|NCT02358993|Methenamine hippurate|methenamine hippurate
4845348|NCT02358980|Multiple Myeloma|multiple myeloma
4845349|NCT02358980|Cast Nephropathy|cast nephropathy
4845350|NCT02358980|Acute kidney injury|acute kidney injury
4845351|NCT02358980|KIDNEY THERAPY|kidney therapy
4845353|NCT02358967|ESRD|esrd
4845354|NCT02358967|dyslipidemia|dyslipidemia
4845355|NCT02358967|oxidative stress|oxidative stress
4845356|NCT02358967|inflammation|inflammation
4845357|NCT02358967|Hemodialysis|hemodialysis
4845358|NCT02358967|CKD|ckd
4845359|NCT02358954|quantitative sensory testing|quantitative sensory testing
4845360|NCT02358954|contact heat evoked potentials|contact heat evoked potentials
4845361|NCT02358954|vection stimulation|vection stimulation
4845362|NCT02358954|3D-turntable|3d-turntable
4845363|NCT02358954|Volunteers|volunteers
4845364|NCT02358941|ADHD, neurofeedback, computerized cognitive training, school|adhd, neurofeedback, computerized cognitive training, school
4845365|NCT02358928|NAFLD|nafld
4845366|NCT02358928|Metabolic syndrome|metabolic syndrome
4845367|NCT02358928|Hepatic Magnetic Resonance Spectroscopy|hepatic magnetic resonance spectroscopy
4845368|NCT02358928|Obesity|obesity
4845369|NCT02358902|Transcranial Direct Current Stimulation|transcranial direct current stimulation
4845370|NCT02358902|Exercise|exercise
4845371|NCT02358902|Fibromyalgia|fibromyalgia
4845372|NCT02358876|Parkinson's disease|parkinson's disease
4845373|NCT02358876|Deep brain stimulation|deep brain stimulation
4845374|NCT02358876|Bradykinesia|bradykinesia
4845375|NCT02358850|Tonsillectomy|tonsillectomy
4845376|NCT02358850|Adenoidectomy|adenoidectomy
4845377|NCT02358837|elastosonography|elastosonography
4845378|NCT02358837|comparing conventional sonography with ductosonography|comparing conventional sonography with ductosonography
4845379|NCT02358824|Hypertension|hypertension
4845380|NCT02358824|CKD-828|ckd-828
4845381|NCT02358824|Telmisartan|telmisartan
4845382|NCT02358824|S-amlodipine|s-amlodipine
4845383|NCT02358824|Pharmacokinetic|pharmacokinetic
4845384|NCT02358811|Obstructive Sleep Apnea|obstructive sleep apnea
4845385|NCT02358811|Voxel-Based Morphometry|voxel-based morphometry
4845386|NCT02358811|Polysomnography|polysomnography
4845387|NCT02358811|Magnetic resonance imaging|magnetic resonance imaging
4845388|NCT02358798|Time evolution of respiratory function|time evolution of respiratory function
4845389|NCT02358798|Longitudinal multicenter monitoring of large cohorts|longitudinal multicenter monitoring of large cohorts
4845390|NCT02358798|Preschool aged children|preschool aged children
4845391|NCT02358798|Detection of cystic fibrosis in neonatal period|detection of cystic fibrosis in neonatal period
4845392|NCT02358772|stroke|stroke
4845393|NCT02358772|thrombolysis|thrombolysis
4845394|NCT02358772|STEMO|stemo
4845395|NCT02358759|Abnormal zygote fertilization|abnormal zygote fertilization
4845396|NCT02358759|3PNs correction|3pns correction
4845397|NCT02358759|Giant oocyte management|giant oocyte management
4845398|NCT02358759|triploidy fertilization|triploidy fertilization
4845399|NCT02358759|Maternal nucleus removal|maternal nucleus removal
4845400|NCT02358746|epicardial catheter ablation|epicardial catheter ablation
4845401|NCT02358733|POR|por
4845402|NCT02358733|IMSI|imsi
4845403|NCT02358720|bone metastases|bone metastases
4845404|NCT02358707|ibuprofen phonophoresis|ibuprofen phonophoresis
4845405|NCT02358707|High performance liquid chromatography|high performance liquid chromatography
4845406|NCT02358694|IBS|ibs
4845407|NCT02358694|IBS-D|ibs-d
4845408|NCT02358694|SBI|sbi
4845409|NCT02358681|Intranasal|intranasal
4845410|NCT02358681|Ketorolac|ketorolac
4845411|NCT02358681|Pediatric|pediatric
4845412|NCT02358681|Migraine|migraine
4845413|NCT02358681|Headache|headache
4845414|NCT02358655|Oral anticoagulant|oral anticoagulant
4845415|NCT02358655|Knowledge translation|knowledge translation
4845416|NCT02358655|Emergency department|emergency department
4845417|NCT02358642|Rate of Pneumonia|rate of pneumonia
4845418|NCT02358642|Mortality rate|mortality rate
4845419|NCT02358603|Chronotropic Incompetence|chronotropic incompetence
4845420|NCT02358603|Heart Failure|heart failure
4845421|NCT02358564|IBS|ibs
4845422|NCT02358564|Irritable Bowel Syndrome|irritable bowel syndrome
4845423|NCT02358564|Visceral Hypersensitivity|visceral hypersensitivity
4845424|NCT02358564|Permeability|permeability
4845425|NCT02358564|Small Bowel|small bowel
4845426|NCT02358564|Lactulose|lactulose
4845427|NCT02358564|Mannitol|mannitol
4845428|NCT02358551|Pacemaker|pacemaker
4845429|NCT02358551|Axillary Vein|axillary vein
4845430|NCT02358551|Subclavian vein|subclavian vein
4845431|NCT02358551|Clinical Study|clinical study
4845432|NCT02358551|Cardiovascular implantable electronic devices|cardiovascular implantable electronic devices
4845433|NCT02358538|PCDH19|pcdh19
4845434|NCT02358538|ganaxolone|ganaxolone
4845435|NCT02358538|neurosteroid|neurosteroid
4845436|NCT02358538|CDKL5|cdkl5
4845437|NCT02358538|LGS|lgs
4845438|NCT02358538|CSWS|csws
4845439|NCT02358512|Intensive Care|intensive care
4845440|NCT02358512|Recovery of Function|recovery of function
4845441|NCT02358512|Survivors|survivors
4845442|NCT02358512|Outcome Assessment (Health Care)|outcome assessment (health care)
4845443|NCT02358512|Medical Economics|medical economics
4845444|NCT02358499|triazoles|triazoles
4845446|NCT02358499|transplantation, hematopoietic stem cell|transplantation, hematopoietic stem cell
4845447|NCT02358499|leukemia|leukemia
4845448|NCT02358499|pediatrics|pediatrics
4845449|NCT02358499|pharmacokinetics|pharmacokinetics
4845450|NCT02358499|bone marrow failure syndrome|bone marrow failure syndrome
4845451|NCT02358486|Functional Dyspepsia|functional dyspepsia
4845452|NCT02358486|Acupuncture|acupuncture
4845453|NCT02358486|Functional MRI|functional mri
4845454|NCT02358473|Nonsmall Cell Lung Cancer|nonsmall cell lung cancer
4845455|NCT02358473|NSCLC|nsclc
4845456|NCT02358473|Non-Small-Cell Lung Carcinoma|non-small-cell lung carcinoma
4845457|NCT02358473|Carcinoma, Non-Small Cell Lung|carcinoma, non-small cell lung
4845458|NCT02358473|KW-0761|kw-0761
4845459|NCT02358473|Mogamulizumab|mogamulizumab
4845460|NCT02358460|neonatal|neonatal
4845461|NCT02358460|respiratory|respiratory
4845462|NCT02358460|mechanical ventilation|mechanical ventilation
4845463|NCT02358447|total knee arthroplasty|total knee arthroplasty
4845464|NCT02358447|total knee prothesis|total knee prothesis
4845465|NCT02358447|Spectrometry, X-Ray Emission|spectrometry, x-ray emission
4845466|NCT02358447|SPECT/CT|spect/ct
4845467|NCT02358447|measurement of TKA component position|measurement of tka component position
4845468|NCT02358434|Implant|implant
4845469|NCT02358421|Rotterdam's diagnostic criteria of PCOS|rotterdam's diagnostic criteria of pcos
4845470|NCT02358421|Risk of OHSS|risk of ohss
4845471|NCT02358356|midgut|midgut
4845472|NCT02358356|pancreatic|pancreatic
4845473|NCT02358356|neuroendocrine|neuroendocrine
4845474|NCT02358356|advanced|advanced
4845475|NCT02358356|unresectable low|unresectable low
4845476|NCT02358356|intermediate grade|intermediate grade
4845477|NCT02358356|mNETs|mnets
4845478|NCT02358356|pNETs|pnets
4845479|NCT02358343|Comorbid Depression|comorbid depression
4845480|NCT02358343|Major Depressive Disorder|major depressive disorder
4845481|NCT02358343|Dysthymia|dysthymia
4845482|NCT02358343|Cognitive Behavioral therapy (CBT)|cognitive behavioral therapy (cbt)
4845483|NCT02358343|Sertraline|sertraline
4845484|NCT02358343|Engagement Interview|engagement interview
4845485|NCT02358343|End Stage Renal Disease (ESRD)|end stage renal disease (esrd)
4845486|NCT02358343|Hemodialysis|hemodialysis
4845487|NCT02358317|Autism|autism
4845488|NCT02358317|Postural Stability|postural stability
4845489|NCT02358317|Exergaming|exergaming
4845490|NCT02358317|White Matter|white matter
4845491|NCT02358252|Heart Rate Variability|heart rate variability
4845492|NCT02358252|orthostatic hypotension|orthostatic hypotension
4845493|NCT02358252|stroke|stroke
4845494|NCT02358252|integrated intelligent biosensor system|integrated intelligent biosensor system
4845495|NCT02358239|dizziness and vertigo|dizziness and vertigo
4845496|NCT02358239|emergency department (ED)|emergency department (ed)
4845497|NCT02358239|clinical trial|clinical trial
4845498|NCT02358239|acupuncture|acupuncture
4845499|NCT02358226|Substance-Related Disorders|substance-related disorders
4845500|NCT02358226|Human Immunodeficiency Virus|human immunodeficiency virus
4845501|NCT02358226|Alcoholism|alcoholism
4845502|NCT02358226|South Africa|south africa
4845503|NCT02358226|Men|men
4845504|NCT02358226|Soccer|soccer
4845505|NCT02358226|Vocational Training|vocational training
4845506|NCT02358213|reproductibility|reproductibility
4845507|NCT02358174|Hemorrhoids|hemorrhoids
4845508|NCT02358174|MMP|mmp
4845509|NCT02358174|NGAL|ngal
4845510|NCT02358174|Matrix Metalloproteinases|matrix metalloproteinases
4845511|NCT02358161|Pancreatic cancer|pancreatic cancer
4845512|NCT02358161|LDE225|lde225
4845513|NCT02358161|Gemcitabine|gemcitabine
4845514|NCT02358161|nab paclitaxel|nab paclitaxel
4845515|NCT02358148|Acute Coronary Syndrome|acute coronary syndrome
4845516|NCT02358148|Chest Pain|chest pain
4845517|NCT02358148|ACS|acs
4845518|NCT02358148|Risk Stratification Score|risk stratification score
4845519|NCT02358148|HEART Score|heart score
4845520|NCT02358148|Modified TIMI|modified timi
4845521|NCT02358148|Coronary Artery Disease|coronary artery disease
4845522|NCT02358148|Risk Factors|risk factors
4845523|NCT02358148|Myocardial Infarction|myocardial infarction
4845524|NCT02358135|Pragmatic|pragmatic
4845525|NCT02358135|Equivalency|equivalency
4845526|NCT02358135|Teledermatology|teledermatology
4845527|NCT02358109|Cost-Benefit Analysis, Exercise,Women,Diseases/Prevention|cost-benefit analysis, exercise,women,diseases/prevention
4845528|NCT02358096|Chronic Kidney Disease|chronic kidney disease
4845529|NCT02358096|Type 2 Diabetes|type 2 diabetes
4845530|NCT02358096|ASP8232|asp8232
4845531|NCT02358070|Hepatocellular Carcinoma|hepatocellular carcinoma
4845532|NCT02358057|Deep sedation|deep sedation
4845533|NCT02358057|Dexmedetomidine|dexmedetomidine
4845534|NCT02358057|Emergency Service, Hospital|emergency service, hospital
4845535|NCT02358031|Programmed Cell Death Receptor 1 (PD-1)|programmed cell death receptor 1 (pd-1)
4845536|NCT02358031|Programmed Cell Death Receptor Ligand 1 (PD-L1)|programmed cell death receptor ligand 1 (pd-l1)
4845537|NCT02358031|Programmed Cell Death Receptor Ligand 2 (PD-L2)|programmed cell death receptor ligand 2 (pd-l2)
4845538|NCT02358031|PD1|pd1
4845539|NCT02358031|PD-1|pd-1
4845540|NCT02358031|PDL1|pdl1
4845541|NCT02358031|PD-L1|pd-l1
4845542|NCT02358031|PDL2|pdl2
4845543|NCT02358018|68Ga-DOTATOC|68ga-dotatoc
4845544|NCT02358018|PET/CT scan|pet/ct scan
4845545|NCT02358018|14-226|14-226
4845546|NCT02357992|Lung cancer|lung cancer
4845547|NCT02357992|Non-small cell lung cancer|non-small cell lung cancer
4845548|NCT02357992|NSCLC|nsclc
4845549|NCT02357992|Squamous cell carcinoma|squamous cell carcinoma
4845550|NCT02357992|Adenocarcinoma with or without BAC features|adenocarcinoma with or without bac features
4845551|NCT02357992|Large cell carcinoma with or without neuroendocrine features|large cell carcinoma with or without neuroendocrine features
4845552|NCT02357992|Neuroendocrine carcinoma|neuroendocrine carcinoma
4845553|NCT02357992|Bronchioloalveolar cell carcinoma|bronchioloalveolar cell carcinoma
4845554|NCT02357992|Stereotactic radiotherapy (SRT)|stereotactic radiotherapy (srt)
4845555|NCT02357992|SRT|srt
4845556|NCT02357992|Stereotactic ablative radiotherapy|stereotactic ablative radiotherapy
4845557|NCT02357992|SABR|sabr
4845558|NCT02357992|Radiation therapy|radiation therapy
4845559|NCT02357992|XRT|xrt
4845560|NCT02357979|caries|caries
4845561|NCT02357979|prevention|prevention
4845562|NCT02357979|laser|laser
4845563|NCT02357979|fluoride|fluoride
4845564|NCT02357966|Staph|staph
4845565|NCT02357966|antibody|antibody
4845566|NCT02357940|Eczema|eczema
4845567|NCT02357940|Skin Irritation|skin irritation
4845568|NCT02357927|fears of recurrence|fears of recurrence
4845569|NCT02357927|cancer|cancer
4845570|NCT02357927|brief intervention|brief intervention
4845571|NCT02357927|telephone counseling|telephone counseling
4845572|NCT02357927|following primary cancer treatment|following primary cancer treatment
4845573|NCT02357914|Ultrasound|ultrasound
4845574|NCT02357914|Shoulder|shoulder
4845575|NCT02357914|Spinal Cord Injury|spinal cord injury
4845576|NCT02357914|Fluoroscopy|fluoroscopy
4845577|NCT02357888|Nicotine replacement therapy|nicotine replacement therapy
4845578|NCT02357888|craving|craving
4845579|NCT02357862|Cardiovascular Diseases|cardiovascular diseases
4845580|NCT02357862|Heart Valve Diseases|heart valve diseases
4845581|NCT02357862|Mitral Valve Annuloplasty|mitral valve annuloplasty
4845582|NCT02357862|Tricuspid Valve Insufficiency|tricuspid valve insufficiency
4845583|NCT02357823|Pneumococcal vaccine|pneumococcal vaccine
4845584|NCT02357823|HIV infection|hiv infection
4845585|NCT02357823|13-valent Pneumococcal Conjugate Vaccine|13-valent pneumococcal conjugate vaccine
4845586|NCT02357823|23-valent Pneumococcal Polysaccharide Vaccine|23-valent pneumococcal polysaccharide vaccine
4845587|NCT02357784|Sacral Neuromodulation|sacral neuromodulation
4845589|NCT02357784|Dual Incontinence|dual incontinence
4845590|NCT02357784|Current Perception Threshold Testing|current perception threshold testing
4845591|NCT02357784|CPT Testing|cpt testing
4845592|NCT02357784|Fecal Incontinence|fecal incontinence
4845593|NCT02357784|Urinary Incontinence|urinary incontinence
4845594|NCT02357784|Afferent Nerve Sensation|afferent nerve sensation
4845595|NCT02357784|InterStim|interstim
4845596|NCT02357771|misalignment of the two dental arches|misalignment of the two dental arches
4845597|NCT02357771|mal-align teeth|mal-align teeth
4845598|NCT02357758|Antibiotic Prophylaxis|antibiotic prophylaxis
4845599|NCT02357758|Urinary Microbiota|urinary microbiota
4845600|NCT02357745|neopterin|neopterin
4845601|NCT02357745|plasma|plasma
4845602|NCT02357745|urine|urine
4845603|NCT02357745|saliva|saliva
4845604|NCT02357745|menopause|menopause
4845605|NCT02357745|periodontitis|periodontitis
4845606|NCT02357732|Metastatic Melanoma|metastatic melanoma
4845607|NCT02357719|Sleep Apnea Syndromes|sleep apnea syndromes
4845608|NCT02357719|Polysomnography|polysomnography
4845609|NCT02357719|Holter ECG|holter ecg
4845610|NCT02357719|Thoracic impedance|thoracic impedance
4845611|NCT02357719|Heart rate variability|heart rate variability
4845612|NCT02357719|Nasal flow|nasal flow
4845613|NCT02357693|nausea, postoperative|nausea, postoperative
4845614|NCT02357693|postoperative nausea|postoperative nausea
4845615|NCT02357693|postoperative vomiting|postoperative vomiting
4845616|NCT02357693|vomiting, postoperative|vomiting, postoperative
4845617|NCT02357641|acute coronary disease, echographic strain analysis, cut off|acute coronary disease, echographic strain analysis, cut off
4845618|NCT02357602|Participants|participants
4845619|NCT02357602|HIV-1 negative|hiv-1 negative
4845620|NCT02357589|3D|3d
4845621|NCT02357589|laparoscopy|laparoscopy
4845622|NCT02357589|cholecystectomy|cholecystectomy
4845623|NCT02357563|fibroid|fibroid
4845624|NCT02357563|GnRH analogue|gnrh analogue
4845625|NCT02357563|ulipristal acetate|ulipristal acetate
4845626|NCT02357537|Telemedicine|telemedicine
4845627|NCT02357524|Effects on coagulation tests in healthy volunteers|effects on coagulation tests in healthy volunteers
4845628|NCT02357511|sensitivity|sensitivity
4845629|NCT02357511|specificity|specificity
4845630|NCT02357511|novel blood pressure monitor|novel blood pressure monitor
4845631|NCT02357511|Saturation|saturation
4845632|NCT02357498|pituitary|pituitary
4845633|NCT02357498|adenoma|adenoma
4845634|NCT02357498|transsphenoidal surgery|transsphenoidal surgery
4845635|NCT02357485|ADSC|adsc
4845636|NCT02357485|osteoarthritis|osteoarthritis
4845637|NCT02357485|knee|knee
4845638|NCT02357485|adipose|adipose
4845639|NCT02357472|Reproductive aging|reproductive aging
4845640|NCT02357472|DHEA|dhea
4845641|NCT02357472|poor ovarian responder|poor ovarian responder
4845642|NCT02357459|osteoarthritis|osteoarthritis
4845643|NCT02357459|knee|knee
4845644|NCT02357459|pain|pain
4845645|NCT02357459|corticosteroid|corticosteroid
4845646|NCT02357459|intra-articular|intra-articular
4845647|NCT02357459|injection|injection
4845648|NCT02357420|Diabetes Mellitus|diabetes mellitus
4845649|NCT02357420|Delayed Gastric Emptying|delayed gastric emptying
4845650|NCT02357420|Vomiting|vomiting
4845651|NCT02357420|Gastroparesis|gastroparesis
4845652|NCT02357420|Gastrointestinal Motility Disorder|gastrointestinal motility disorder
4845653|NCT02357407|fluoroquinolones|fluoroquinolones
4845654|NCT02357407|pharmacokinetic|pharmacokinetic
4845655|NCT02357407|infections|infections
4845656|NCT02357368|HIV-negative|hiv-negative
4845657|NCT02357329|fat taste|fat taste
4845658|NCT02357329|food preference|food preference
4845659|NCT02357329|consumption|consumption
4845660|NCT02357329|free fatty acids|free fatty acids
4845661|NCT02357316|Taste responses of healthy individuals|taste responses of healthy individuals
4845662|NCT02357303|Randomized controlled trial|randomized controlled trial
4845663|NCT02357303|Endoscopy|endoscopy
4845664|NCT02357303|Gastric mucosa|gastric mucosa
4845665|NCT02357303|Simethicone|simethicone
4845666|NCT02357303|Acetylcysteine|acetylcysteine
4845667|NCT02357290|mania|mania
4845668|NCT02357290|temper tantrum|temper tantrum
4845669|NCT02357290|irritability|irritability
4845670|NCT02357290|mood|mood
4845671|NCT02357290|bipolar|bipolar
4845672|NCT02357277|Osteoporosis|osteoporosis
4845673|NCT02357277|Glucocorticoids|glucocorticoids
4845674|NCT02357277|Postmenopausal|postmenopausal
4845675|NCT02357238|Uveitis|uveitis
4845676|NCT02357238|Infectious|infectious
4845677|NCT02357225|Pompe disease|pompe disease
4845678|NCT02357225|Pyridostigmine|pyridostigmine
4845679|NCT02357212|Non-St elevation acute coronary syndrome|non-st elevation acute coronary syndrome
4845680|NCT02357199|Mouth Diseases|mouth diseases
4845681|NCT02357199|Renal Insufficiency, Chronic|renal insufficiency, chronic
4845682|NCT02357199|Intervention Studies|intervention studies
4845683|NCT02357186|Mild head injury - clinical decision rule - Child|mild head injury - clinical decision rule - child
4845684|NCT02357173|smoking|smoking
4845685|NCT02357173|nicotine|nicotine
4845686|NCT02357173|tobacco products|tobacco products
4845687|NCT02357173|electronic cigarette|electronic cigarette
4845688|NCT02357147|Amatuximab|amatuximab
4845689|NCT02357147|Pemetrexed|pemetrexed
4845690|NCT02357147|Cisplatin|cisplatin
4845691|NCT02357147|Unresectable Malignant Pleural Mesothelioma|unresectable malignant pleural mesothelioma
4845692|NCT02357147|ARTEMIS|artemis
4845693|NCT02357134|Advanced cancers|advanced cancers
4845694|NCT02357134|Primary or secondary lung involvement|primary or secondary lung involvement
4845695|NCT02357134|Dyspnea|dyspnea
4845696|NCT02357134|Difficulty breathing|difficulty breathing
4845697|NCT02357134|Stationary cycle test|stationary cycle test
4845698|NCT02357134|Questionnaires|questionnaires
4845699|NCT02357134|Surveys|surveys
4845700|NCT02357134|High flow oxygen|high flow oxygen
4845701|NCT02357134|High flow air|high flow air
4845702|NCT02357134|Low flow oxygen|low flow oxygen
4845703|NCT02357134|Low flow air|low flow air
4845704|NCT02357108|Supportive Care|supportive care
4845705|NCT02357108|treatment options|treatment options
4845706|NCT02357108|doctor's compassion|doctor's compassion
4845707|NCT02357095|Caesarean Scar Pregnancy|caesarean scar pregnancy
4845708|NCT02357095|uterine artery chemo-embolization|uterine artery chemo-embolization
4845709|NCT02357095|treatment|treatment
4845710|NCT02357030|Gulf War Illness|gulf war illness
4845711|NCT02357030|nutrients|nutrients
4845712|NCT02357030|methylphenidate|methylphenidate
4845713|NCT02357030|mitochondria|mitochondria
4845714|NCT02356991|Famitinib|famitinib
4845715|NCT02356991|Phase II|phase ii
4845716|NCT02356991|NSCLC|nsclc
4845717|NCT02356978|Rare disease|rare disease
4845718|NCT02356978|Crigler-Najjar disease|crigler-najjar disease
4845719|NCT02356978|Paediatric|paediatric
4845720|NCT02356978|Experimental device|experimental device
4845721|NCT02356965|Third molar extraction|third molar extraction
4845722|NCT02356965|Wisdom tooth extraction|wisdom tooth extraction
4845723|NCT02356952|Metabolic Syndrome X|metabolic syndrome x
4845724|NCT02356952|Low Glycemic Index Mediterranean Diet|low glycemic index mediterranean diet
4845725|NCT02356952|Low Glycemic Index Diet|low glycemic index diet
4845726|NCT02356952|Randomized Clinical Trial|randomized clinical trial
4845727|NCT02356926|Adverse events|adverse events
4845728|NCT02356926|Medical errors|medical errors
4845729|NCT02356926|Emergency department|emergency department
4845730|NCT02356926|Cross checking|cross checking
4845731|NCT02356900|interval training|interval training
4845732|NCT02356900|hyperbaric oxygen|hyperbaric oxygen
4845733|NCT02356900|VO2 max|vo2 max
4845734|NCT02356900|altitude|altitude
4845735|NCT02356900|exercise performance|exercise performance
4845736|NCT02356900|mitochondrial oxidative capacity|mitochondrial oxidative capacity
4845737|NCT02356900|mitochondrial biogenesis|mitochondrial biogenesis
4845738|NCT02356861|treatment|treatment
4845739|NCT02356861|photobiomodulation|photobiomodulation
4845740|NCT02356861|Veterans|veterans
4845741|NCT02356861|brain-injury|brain-injury
4845742|NCT02356861|TBI|tbi
4845743|NCT02356861|PTSD|ptsd
4845744|NCT02356848|self-care|self-care
4845745|NCT02356848|self-monitoring|self-monitoring
4845746|NCT02356848|secondary prevention|secondary prevention
4845747|NCT02356848|foot ulcer|foot ulcer
4845748|NCT02356809|Gene therapy, plasmid, vegf, systemic scleroderma,secondary raynaud's phenomenon|gene therapy, plasmid, vegf, systemic scleroderma,secondary raynaud's phenomenon
4845749|NCT02356757|self-care|self-care
4845750|NCT02356757|self-monitoring|self-monitoring
4845751|NCT02356757|medication adherence|medication adherence
4845752|NCT02356757|diet|diet
4845753|NCT02356757|physical activity|physical activity
4845754|NCT02356757|primary prevention|primary prevention
4845755|NCT02356744|Maternal outcome|maternal outcome
4845756|NCT02356744|Fetal outcome|fetal outcome
4845757|NCT02356744|bariatric surgery|bariatric surgery
4845758|NCT02356744|Third Trimester|third trimester
4845759|NCT02356731|seizures,|seizures,
4845760|NCT02356731|quality of life|quality of life
4845761|NCT02356640|Celiac plexus neurolysis|celiac plexus neurolysis
4845762|NCT02356640|Celiac ganglion neurolysis|celiac ganglion neurolysis
4845763|NCT02356640|Pancreatic cancer|pancreatic cancer
4845764|NCT02356627|Occupational therapy|occupational therapy
4845765|NCT02356627|Adaptive intervention|adaptive intervention
4845766|NCT02356627|Home-based|home-based
4845767|NCT02356627|Assistive Technology|assistive technology
4845768|NCT02356627|Home modification|home modification
4845769|NCT02356627|Clinical effectiveness|clinical effectiveness
4845770|NCT02356627|Cost-effectiveness|cost-effectiveness
4845771|NCT02356627|Cost-utility|cost-utility
4845772|NCT02356614|Lap Band|lap band
4845773|NCT02356601|MRI|mri
4845774|NCT02356601|Lumbar spine|lumbar spine
4845775|NCT02356601|Ultrasound|ultrasound
4845776|NCT02356575|surgery|surgery
4845777|NCT02356575|chemotherapy|chemotherapy
4845778|NCT02356575|radiation|radiation
4845779|NCT02356575|Acupuncture|acupuncture
4845780|NCT02356575|16-947|16-947
4845781|NCT02356562|Hepatitis C|hepatitis c
4845782|NCT02356562|Interferon-Free|interferon-free
4845783|NCT02356562|Treatment Experienced|treatment experienced
4845784|NCT02356562|Chronic Hepatitis C|chronic hepatitis c
4845785|NCT02356562|Hepatitis C Virus|hepatitis c virus
4845786|NCT02356510|myocardial infarction|myocardial infarction
4845787|NCT02356510|TIMI flow|timi flow
4845788|NCT02356510|culprit lesion|culprit lesion
4845789|NCT02356510|culprit vessel|culprit vessel
4845790|NCT02356497|Bone metastases|bone metastases
4845791|NCT02356497|Metastatic bone disease|metastatic bone disease
4845792|NCT02356497|Multi-trial facility|multi-trial facility
4845793|NCT02356458|Mantle cell lymphoma|mantle cell lymphoma
4845794|NCT02356458|Relapsed|relapsed
4845795|NCT02356458|Refractory|refractory
4845796|NCT02356458|Cancer|cancer
4845797|NCT02356458|Lymphoma|lymphoma
4845798|NCT02356458|Ibrutinib Imbruvica|ibrutinib imbruvica
4845799|NCT02356458|Bortezomib Velcade|bortezomib velcade
4845800|NCT02356432|non-valvular atrial fibrillation|non-valvular atrial fibrillation
4845801|NCT02356432|cerebral microbleeds|cerebral microbleeds
4845802|NCT02356432|warfarin|warfarin
4845803|NCT02356432|NOACs|noacs
4845804|NCT02356432|acute ischemic stroke|acute ischemic stroke
4845805|NCT02356406|Radiosurgery|radiosurgery
4845806|NCT02356406|Celiac Plexus|celiac plexus
4845807|NCT02356406|Pain|pain
4845808|NCT02356406|Quality of Life|quality of life
4845809|NCT02356393|Desalinated Sea Water|desalinated sea water
4845810|NCT02356393|Magnesium|magnesium
4845811|NCT02356393|Drinking Water|drinking water
4845812|NCT02356367|telemonitoring|telemonitoring
4845813|NCT02356367|Adaptive servo-ventilation|adaptive servo-ventilation
4845814|NCT02356354|molecular factors|molecular factors
4845815|NCT02356354|cutaneous innervation|cutaneous innervation
4845816|NCT02356354|skin biopsy|skin biopsy
4845817|NCT02356354|post-burn scar|post-burn scar
4845818|NCT02356315|Brain|brain
4845819|NCT02356315|Brain Stem|brain stem
4845820|NCT02356315|Spinal Cord|spinal cord
4845821|NCT02356315|Neurophysiology|neurophysiology
4845822|NCT02356315|Magnetic Resonance Imaging|magnetic resonance imaging
4845823|NCT02356289|Hypertrophic Cardiomyopathy|hypertrophic cardiomyopathy
4845824|NCT02356276|locally advanced gastric cancer|locally advanced gastric cancer
4845825|NCT02356276|Hyperthermic Intraperitoneal Chemotherapy|hyperthermic intraperitoneal chemotherapy
4845826|NCT02356276|radical gastrectomy with D2 lymphadenectomy|radical gastrectomy with d2 lymphadenectomy
4845827|NCT02356263|stressful events|stressful events
4845828|NCT02356263|psychological stress|psychological stress
4845829|NCT02356263|life experiences|life experiences
4845830|NCT02356250|liver biopsy f 4|liver biopsy f 4
4845831|NCT02356237|Episiotomy|episiotomy
4845832|NCT02356237|Obstetric Anal Sphincter Injury|obstetric anal sphincter injury
4845833|NCT02356224|SHR3824 Type 2 diabetes mellitus SGLT2|shr3824 type 2 diabetes mellitus sglt2
4845834|NCT02356211|falls|falls
4845835|NCT02356185|Alcohol Drinking|alcohol drinking
4845836|NCT02356185|Injecting drug|injecting drug
4845837|NCT02356185|Antiretroviral therapy|antiretroviral therapy
4845838|NCT02356185|sub-Saharan Africa|sub-saharan africa
4845839|NCT02356172|Quality of Life|quality of life
4845840|NCT02356172|Depression|depression
4845841|NCT02356172|Kallmann Syndrome|kallmann syndrome
4845938|NCT02355561|JNJ-54861911|jnj-54861911
4845842|NCT02356172|Hypogonadotropic Hypogonadism|hypogonadotropic hypogonadism
4845843|NCT02356159|Hematopoietic Stem Cell Transplant|hematopoietic stem cell transplant
4845844|NCT02356159|Lymphoma|lymphoma
4845845|NCT02356159|Leukemia|leukemia
4845846|NCT02356159|Unrelated Donors|unrelated donors
4845847|NCT02356146|Kidney transplantation|kidney transplantation
4845848|NCT02356146|genotype|genotype
4845849|NCT02356146|tacrolimus|tacrolimus
4845850|NCT02356146|CYP3A5|cyp3a5
4845851|NCT02356133|Near-Infrared Spectroscopy|near-infrared spectroscopy
4845852|NCT02356094|glaucoma|glaucoma
4845853|NCT02356094|primary open angle glaucoma|primary open angle glaucoma
4845854|NCT02356094|cornea|cornea
4845855|NCT02356068|liver transplantation, rotem, bleeding, transfusion|liver transplantation, rotem, bleeding, transfusion
4845856|NCT02356055|activities of daily living|activities of daily living
4845857|NCT02356055|massed practice|massed practice
4845858|NCT02356055|occupational therapy|occupational therapy
4845859|NCT02356029|Cardiopulmonary Arrest|cardiopulmonary arrest
4845860|NCT02356029|Emergency Medical Services|emergency medical services
4845861|NCT02356029|Medical Futility|medical futility
4845862|NCT02356029|Decision Making|decision making
4845863|NCT02356029|Emotional Stress|emotional stress
4845864|NCT02356029|Burnout, Professional|burnout, professional
4845865|NCT02356016|Sarcopenic Obesity|sarcopenic obesity
4845866|NCT02356016|community dwelling elderly women|community dwelling elderly women
4845867|NCT02356016|electromyostimulation|electromyostimulation
4845868|NCT02356016|exercise|exercise
4845869|NCT02356016|dietary supplements|dietary supplements
4845870|NCT02356003|Tourette Syndrome|tourette syndrome
4845871|NCT02356003|Children|children
4845872|NCT02356003|Tics|tics
4845873|NCT02355977|Chronic periodontitis|chronic periodontitis
4845874|NCT02355977|Minocycline|minocycline
4845875|NCT02355977|Surface and root planning|surface and root planning
4845876|NCT02355977|Pocket depth|pocket depth
4845877|NCT02355977|Sulcus bleeding index|sulcus bleeding index
4845878|NCT02355977|Prevotella intermedia|prevotella intermedia
4845879|NCT02355912|Transfemoral|transfemoral
4845880|NCT02355873|heparin-coated|heparin-coated
4845881|NCT02355873|surface-treated polyacrylonitrile membrane hemofilter|surface-treated polyacrylonitrile membrane hemofilter
4845882|NCT02355873|critical ill|critical ill
4845883|NCT02355873|acute kidney injury|acute kidney injury
4845884|NCT02355873|chronic kidney disease|chronic kidney disease
4845885|NCT02355873|continuous renal replacement therapy|continuous renal replacement therapy
4845886|NCT02355834|Fecal Incontinence (FI)|fecal incontinence (fi)
4845887|NCT02355834|Inflammatory bowel disease (IBD)|inflammatory bowel disease (ibd)
4845888|NCT02355834|bowel control|bowel control
4845889|NCT02355834|Chronic diarrhoea|chronic diarrhoea
4845890|NCT02355834|rectal inflammation|rectal inflammation
4845891|NCT02355821|cellular aging|cellular aging
4845892|NCT02355821|vascular aging|vascular aging
4845893|NCT02355821|bone metabolism|bone metabolism
4845894|NCT02355821|collagen type 1 C-telopeptide|collagen type 1 c-telopeptide
4845895|NCT02355821|nuclear factor kappa-B ligand (RANKL)|nuclear factor kappa-b ligand (rankl)
4845896|NCT02355821|pulse wave velocity|pulse wave velocity
4845897|NCT02355821|telomerase activity|telomerase activity
4845898|NCT02355795|weight change|weight change
4845899|NCT02355795|diet|diet
4845900|NCT02355795|dietary fat|dietary fat
4845901|NCT02355795|feeding design|feeding design
4845902|NCT02355782|TMA, aHUS, TTP, stem cell transplant-associated TMA|tma, ahus, ttp, stem cell transplant-associated tma
4845903|NCT02355769|heart failure|heart failure
4845904|NCT02355769|renal failure|renal failure
4845905|NCT02355769|prognosis|prognosis
4845906|NCT02355769|impedance cardiography|impedance cardiography
4845907|NCT02355717|children, bone|children, bone
4845908|NCT02355717|Simple obesity|simple obesity
4845909|NCT02355717|cardiovascular disease|cardiovascular disease
4845910|NCT02355717|osteoporosis|osteoporosis
4845911|NCT02355717|diabetes|diabetes
4845912|NCT02355704|Kidney Transplantation|kidney transplantation
4845913|NCT02355704|Atorvastatin|atorvastatin
4845914|NCT02355704|C-Reactive Protein|c-reactive protein
4845915|NCT02355704|Biopsy|biopsy
4845916|NCT02355704|Interleukin|interleukin
4845917|NCT02355652|Total knee arthroplasty|total knee arthroplasty
4845918|NCT02355652|IKS Score|iks score
4845919|NCT02355652|cemented, uncemented|cemented, uncemented
4845920|NCT02355626|Anxiety|anxiety
4845921|NCT02355626|level of anxiety|level of anxiety
4845922|NCT02355626|delirium|delirium
4845923|NCT02355626|agitation|agitation
4845924|NCT02355626|tools for measuring anxiety|tools for measuring anxiety
4845925|NCT02355626|neuroendocrine system|neuroendocrine system
4845926|NCT02355613|Radiosurgery, brain, metastases|radiosurgery, brain, metastases
4845927|NCT02355600|Oocyte|oocyte
4845928|NCT02355600|Tamoxifen|tamoxifen
4845929|NCT02355600|Fertility preservation|fertility preservation
4845930|NCT02355587|melanoma|melanoma
4845931|NCT02355587|cutaneous melanoma|cutaneous melanoma
4845932|NCT02355587|DecisionDx-Melanoma|decisiondx-melanoma
4845933|NCT02355574|melanoma|melanoma
4845934|NCT02355574|cutaneous melanoma|cutaneous melanoma
4845935|NCT02355574|DecisionDx-Melanoma|decisiondx-melanoma
4845936|NCT02355561|Bioavailability|bioavailability
4845937|NCT02355561|Healthy Participants|healthy participants
4845939|NCT02355561|Food Effect|food effect
4845940|NCT02355535|refractory|refractory
4845941|NCT02355535|intolerant|intolerant
4845942|NCT02355535|solid tumors|solid tumors
4845943|NCT02355535|lymphoma|lymphoma
4845944|NCT02355522|saline infusion sonohysterography|saline infusion sonohysterography
4845945|NCT02355509|Acarbose|acarbose
4845946|NCT02355509|Postprandial lipemia|postprandial lipemia
4845947|NCT02355509|Cardiovascular risk|cardiovascular risk
4845948|NCT02355496|Cost Control|cost control
4845949|NCT02355496|Data Display|data display
4845950|NCT02355496|Diagnostic Tests, Routine|diagnostic tests, routine
4845951|NCT02355496|Physician's Practice Patterns|physician's practice patterns
4845952|NCT02355470|Sexual assault|sexual assault
4845953|NCT02355470|Alcohol consumption|alcohol consumption
4845954|NCT02355470|Intimate partner violence|intimate partner violence
4845955|NCT02355457|troponin|troponin
4845956|NCT02355457|myocardial infarction|myocardial infarction
4845957|NCT02355457|acs|acs
4845958|NCT02355457|AMI|ami
4845959|NCT02355457|biomarker|biomarker
4845960|NCT02355457|BACC|bacc
4845961|NCT02355457|high-sensitivity|high-sensitivity
4845962|NCT02355431|EGFR|egfr
4845963|NCT02355431|mutation|mutation
4845964|NCT02355405|lung ultrasound|lung ultrasound
4845965|NCT02355405|atelectasis|atelectasis
4845966|NCT02355405|thoracic computed Tomography|thoracic computed tomography
4845967|NCT02355379|Adjuvant chemotherapy in colonic adenocarcinoma in elderly|adjuvant chemotherapy in colonic adenocarcinoma in elderly
4845968|NCT02355366|Offspring|offspring
4845969|NCT02355366|significant mood symptoms|significant mood symptoms
4845970|NCT02355353|DWI-MRI|dwi-mri
4845971|NCT02355353|resectable liver metastases|resectable liver metastases
4845972|NCT02355340|Bone mineral density|bone mineral density
4845973|NCT02355340|Childhood cancer survivors|childhood cancer survivors
4845974|NCT02355314|ICU patients|icu patients
4845975|NCT02355314|Doppler-based renal|doppler-based renal
4845976|NCT02355301|ICF, impairment, activity, satisfaction, quality of care|icf, impairment, activity, satisfaction, quality of care
4845977|NCT02355288|Coronary Artery Disease|coronary artery disease
4845978|NCT02355288|Diabetes Mellitus|diabetes mellitus
4845979|NCT02355288|Minimally Invasive Cardiac Surgery|minimally invasive cardiac surgery
4845980|NCT02355288|Percutaneous Coronary Intervention|percutaneous coronary intervention
4845981|NCT02355275|Home Exercise|home exercise
4845982|NCT02355275|Resistance Exercise|resistance exercise
4845983|NCT02355262|Insurance Coverage|insurance coverage
4845984|NCT02355262|Insurance Continuity|insurance continuity
4845985|NCT02355249|traditional three incisions|traditional three incisions
4845986|NCT02355249|minimally invasive thoracol-laparoscopic esophagectomy|minimally invasive thoracol-laparoscopic esophagectomy
4845987|NCT02355249|MIE|mie
4845988|NCT02355249|esophageal cancer|esophageal cancer
4845989|NCT02355236|Naxozol|naxozol
4845990|NCT02355236|LDQ|ldq
4845991|NCT02355236|GSRS|gsrs
4845992|NCT02355236|Osteoarthritis|osteoarthritis
4845993|NCT02355236|Gastroprotective|gastroprotective
4845994|NCT02355223|Tuberculosis|tuberculosis
4845995|NCT02355223|Infection Control|infection control
4845996|NCT02355223|Transmission|transmission
4845997|NCT02355197|antioxidants|antioxidants
4845998|NCT02355197|Gestational diabetes mellitus|gestational diabetes mellitus
4845999|NCT02355197|oxidative stress|oxidative stress
4846000|NCT02355158|pain|pain
4846001|NCT02355158|diabetic neuropathy|diabetic neuropathy
4846002|NCT02355158|pain in feet|pain in feet
4846003|NCT02355145|type 2 diabetes, add-on diabetes therapy, rationale|type 2 diabetes, add-on diabetes therapy, rationale
4846004|NCT02355132|Medicaid|medicaid
4846005|NCT02355132|public insurance|public insurance
4846006|NCT02355132|cardiovascular disease|cardiovascular disease
4846007|NCT02355132|prevention|prevention
4846008|NCT02355132|community health centers|community health centers
4846009|NCT02355132|electronic health records|electronic health records
4846010|NCT02355132|cancer prevention|cancer prevention
4846011|NCT02355080|HIV|hiv
4846012|NCT02355080|HCV|hcv
4846013|NCT02355067|parenting|parenting
4846014|NCT02355067|postpartum depression|postpartum depression
4846015|NCT02355067|mothers|mothers
4846016|NCT02355067|infants|infants
4846017|NCT02355067|depression|depression
4846018|NCT02355054|Recurrent|recurrent
4846019|NCT02355041|diet|diet
4846020|NCT02355041|body weight|body weight
4846021|NCT02355041|eating|eating
4846022|NCT02355041|meal replacement|meal replacement
4846023|NCT02355028|LHA510|lha510
4846024|NCT02355028|PoC|poc
4846025|NCT02355028|Age-related macular degeneration|age-related macular degeneration
4846026|NCT02354976|omega-3 carboxylic acid|omega-3 carboxylic acid
4846027|NCT02354963|Poor ovarian response|poor ovarian response
4846028|NCT02354963|Salvador/Warts/Hippo pathway|salvador/warts/hippo pathway
4846029|NCT02354963|Follicular activation|follicular activation
4846030|NCT02354963|Poor ovarian reserve|poor ovarian reserve
4846031|NCT02354950|GSK1265744|gsk1265744
4846032|NCT02354950|healthy controls|healthy controls
4846033|NCT02354950|pharmacokinetic|pharmacokinetic
4846034|NCT02354950|Hepatic Impairment|hepatic impairment
4846035|NCT02354937|Pharmacokinetics|pharmacokinetics
4846036|NCT02354937|GSK1265744|gsk1265744
4846139|NCT02354404|Ebola virus|ebola virus
4846037|NCT02354937|Severe Renal Impairment|severe renal impairment
4846038|NCT02354911|Immunomodulation|immunomodulation
4846039|NCT02354872|Nicotine|nicotine
4846040|NCT02354859|Cystic Fibrosis|cystic fibrosis
4846041|NCT02354859|Gallium Nitrate|gallium nitrate
4846042|NCT02354859|IV Gallium|iv gallium
4846043|NCT02354859|Pseudomonas aeruginosa|pseudomonas aeruginosa
4846044|NCT02354833|Hypotension|hypotension
4846045|NCT02354833|Cesarean Delivery|cesarean delivery
4846046|NCT02354833|Phenylephrine|phenylephrine
4846047|NCT02354833|Spinal Anesthesia|spinal anesthesia
4846048|NCT02354833|Norepinephrine|norepinephrine
4846049|NCT02354807|BAT activation|bat activation
4846050|NCT02354807|quantitative PET imaging|quantitative pet imaging
4846051|NCT02354807|Mirabegron effect on BAT|mirabegron effect on bat
4846052|NCT02354794|arginine|arginine
4846053|NCT02354794|supplementation|supplementation
4846054|NCT02354794|metabolic syndrome|metabolic syndrome
4846055|NCT02354794|endothelial function|endothelial function
4846056|NCT02354781|DMD|dmd
4846057|NCT02354781|muscular dystrophy|muscular dystrophy
4846058|NCT02354781|Follistatin|follistatin
4846059|NCT02354742|Echocardiography|echocardiography
4846060|NCT02354742|EGDT|egdt
4846061|NCT02354742|Sepsis|sepsis
4846062|NCT02354716|esophagus|esophagus
4846063|NCT02354716|upper GI|upper gi
4846064|NCT02354716|endoscopy|endoscopy
4846065|NCT02354716|endoFLIP|endoflip
4846066|NCT02354716|functional luminal imaging|functional luminal imaging
4846067|NCT02354716|esophageal stricture|esophageal stricture
4846068|NCT02354716|narrow esophagus|narrow esophagus
4846069|NCT02354716|narrow caliber esophagus|narrow caliber esophagus
4846070|NCT02354716|esophageal narrowing|esophageal narrowing
4846071|NCT02354716|eosinophilic esophagitis|eosinophilic esophagitis
4846072|NCT02354716|Zenkers diverticulum|zenkers diverticulum
4846073|NCT02354716|Schatzki ring|schatzki ring
4846074|NCT02354703|alcoholism, treatment, serotonin transporter|alcoholism, treatment, serotonin transporter
4846075|NCT02354677|Bronchial epithelium|bronchial epithelium
4846076|NCT02354677|COPD|copd
4846077|NCT02354677|Repair|repair
4846078|NCT02354677|Remodelling|remodelling
4846079|NCT02354677|Club Cells|club cells
4846080|NCT02354664|respiratory test|respiratory test
4846081|NCT02354664|respiratory muscle endurance|respiratory muscle endurance
4846082|NCT02354664|spirometry|spirometry
4846083|NCT02354651|Pompe disease|pompe disease
4846084|NCT02354651|mechanical ventilation|mechanical ventilation
4846085|NCT02354651|diaphragm pacing|diaphragm pacing
4846086|NCT02354638|Perceptions|perceptions
4846087|NCT02354638|Education and evaluate post intervention KAP|education and evaluate post intervention kap
4846088|NCT02354625|Schwann cells|schwann cells
4846089|NCT02354599|Randomized, double-blind, placebo-controlled, single-dose subcutaneous administration study|randomized, double-blind, placebo-controlled, single-dose subcutaneous administration study
4846090|NCT02354586|gBRCAmut|gbrcamut
4846091|NCT02354586|BRCA|brca
4846092|NCT02354586|PARP inhibitor|parp inhibitor
4846094|NCT02354586|Ovarian cancer|ovarian cancer
4846095|NCT02354586|Serous Epithelial|serous epithelial
4846096|NCT02354586|Fallopian Tube|fallopian tube
4846097|NCT02354586|Primary Peritoneal|primary peritoneal
4846098|NCT02354560|Erythromycin|erythromycin
4846099|NCT02354560|Familial Adenomatous Polyposis (FAP)|familial adenomatous polyposis (fap)
4846100|NCT02354560|APC gene|apc gene
4846101|NCT02354560|nonsense mutations|nonsense mutations
4846102|NCT02354534|cervical dysplasia|cervical dysplasia
4846103|NCT02354534|HPV|hpv
4846104|NCT02354534|Treatment|treatment
4846105|NCT02354534|preinvasive|preinvasive
4846106|NCT02354534|cervix|cervix
4846107|NCT02354534|vaginal suppository|vaginal suppository
4846108|NCT02354534|Johns Hopkins|johns hopkins
4846109|NCT02354534|Cornelia Trimble|cornelia trimble
4846110|NCT02354534|abnormal pap|abnormal pap
4846111|NCT02354534|CIN|cin
4846112|NCT02354521|Protein|protein
4846113|NCT02354521|Mechanical ventilation|mechanical ventilation
4846114|NCT02354521|Children|children
4846115|NCT02354521|Outcomes|outcomes
4846116|NCT02354508|acromegaly|acromegaly
4846117|NCT02354508|GH|gh
4846118|NCT02354508|IGF-1|igf-1
4846119|NCT02354508|pasireotide LAR|pasireotide lar
4846120|NCT02354495|Indirect calorimetry|indirect calorimetry
4846121|NCT02354495|Protein|protein
4846122|NCT02354495|Mechanical ventilation|mechanical ventilation
4846123|NCT02354495|Respiratory failure|respiratory failure
4846124|NCT02354469|TBI|tbi
4846125|NCT02354469|Mild Traumatic Brain Injury|mild traumatic brain injury
4846126|NCT02354469|Post-Concussion Syndrome|post-concussion syndrome
4846127|NCT02354469|Recovery of Function|recovery of function
4846128|NCT02354469|Motor Activity|motor activity
4846129|NCT02354469|Diffusion Tensor Imaging|diffusion tensor imaging
4846130|NCT02354469|Neural Injury|neural injury
4846131|NCT02354469|Biomarkers|biomarkers
4846132|NCT02354456|atrial fibrillation|atrial fibrillation
4846133|NCT02354456|epidemiology|epidemiology
4846134|NCT02354456|antiocaogulation|antiocaogulation
4846135|NCT02354430|pregnancy|pregnancy
4846136|NCT02354430|low back pain|low back pain
4846137|NCT02354430|sick leave,|sick leave,
4846138|NCT02354430|motor activity|motor activity
4846140|NCT02354404|Filoviridae Infections|filoviridae infections
4846141|NCT02354404|Hemorrhagic Fever, Ebola|hemorrhagic fever, ebola
4846142|NCT02354404|Viral Diseases|viral diseases
4846143|NCT02354404|Hemorrhagic Fevers, Viral|hemorrhagic fevers, viral
4846144|NCT02354365|PEEP adjustment|peep adjustment
4846145|NCT02354365|Tidal Volume|tidal volume
4846146|NCT02354365|Driving Pressure|driving pressure
4846147|NCT02354365|Compliance|compliance
4846148|NCT02354339|Metabolic Syndrome|metabolic syndrome
4846149|NCT02354339|Irvingia gabonensis|irvingia gabonensis
4846150|NCT02354339|African mango|african mango
4846151|NCT02354339|Insulin resistance|insulin resistance
4846152|NCT02354313|MANTLE CELL LYMPHOMA (MCL)|mantle cell lymphoma (mcl)
4846153|NCT02354313|Lenalidomide (Len)|lenalidomide (len)
4846154|NCT02354313|Rituximab|rituximab
4846155|NCT02354313|ASCT|asct
4846156|NCT02354313|Revlimid|revlimid
4846157|NCT02354313|High dose chemotherapy|high dose chemotherapy
4846158|NCT02354313|transplant|transplant
4846159|NCT02354261|Basal Cell Carcinoma Nevus Syndrome|basal cell carcinoma nevus syndrome
4846160|NCT02354261|BCCNS|bccns
4846161|NCT02354261|BCC|bcc
4846162|NCT02354261|itraconazole|itraconazole
4846163|NCT02354261|basal cell carcinoma|basal cell carcinoma
4846164|NCT02354261|locally advanced basal cell carcinoma|locally advanced basal cell carcinoma
4846165|NCT02354248|TST|tst
4846166|NCT02354248|TMS|tms
4846167|NCT02354248|Stroke patients|stroke patients
4846168|NCT02354248|EMG|emg
4846169|NCT02354235|MT-2412|mt-2412
4846170|NCT02354235|MP-513|mp-513
4846171|NCT02354235|TA-7284|ta-7284
4846172|NCT02354235|Teneligliptin|teneligliptin
4846173|NCT02354235|Canagliflozin|canagliflozin
4846174|NCT02354222|MT-2412|mt-2412
4846175|NCT02354222|MP-513|mp-513
4846176|NCT02354222|TA-7284|ta-7284
4846177|NCT02354222|Teneligliptin|teneligliptin
4846178|NCT02354222|Canagliflozin|canagliflozin
4846179|NCT02354183|Commitment strategies|commitment strategies
4846180|NCT02354183|Motivation|motivation
4846181|NCT02354183|DBT skills|dbt skills
4846182|NCT02354183|Self-harm|self-harm
4846183|NCT02354183|Brief intervention|brief intervention
4846184|NCT02354170|Central Serous Chorioretinopathy, CSC|central serous chorioretinopathy, csc
4846185|NCT02354157|children dietary pattern|children dietary pattern
4846186|NCT02354157|control rules|control rules
4846187|NCT02354157|instrumental learning|instrumental learning
4846188|NCT02354157|food reinforcement|food reinforcement
4846189|NCT02354144|Human papillomavirus|human papillomavirus
4846190|NCT02354144|Carrageenan|carrageenan
4846191|NCT02354144|Microbicide|microbicide
4846192|NCT02354144|Anal HPV infection|anal hpv infection
4846193|NCT02354131|Ovarian cancer|ovarian cancer
4846194|NCT02354131|Niraparib|niraparib
4846195|NCT02354131|Bevacizumab|bevacizumab
4846197|NCT02354131|Phase 2 randomized|phase 2 randomized
4846198|NCT02354105|Axial Spondyloarthritis|axial spondyloarthritis
4846199|NCT02354105|Radiographic Axial Spondyloarthritis|radiographic axial spondyloarthritis
4846200|NCT02354105|Non-radiographic Axial Spondyloarthritis|non-radiographic axial spondyloarthritis
4846201|NCT02354105|Ankylosing spondylitis|ankylosing spondylitis
4846202|NCT02354105|Diagnosis|diagnosis
4846203|NCT02354105|Cimzia|cimzia
4846204|NCT02354105|CZP|czp
4846205|NCT02354105|Certolizumab Pegol|certolizumab pegol
4846206|NCT02354105|CDP870|cdp870
4846207|NCT02354092|cervical dilation|cervical dilation
4846208|NCT02354092|pain|pain
4846209|NCT02354092|paracervical block|paracervical block
4846210|NCT02354092|osmotic dilators|osmotic dilators
4846211|NCT02354079|Low LDL-C|low ldl-c
4846212|NCT02354079|Target Identification|target identification
4846213|NCT02354079|Genetic|genetic
4846214|NCT02354079|Endocrinology|endocrinology
4846215|NCT02354079|Cardiovascular Disease|cardiovascular disease
4846216|NCT02354066|Hallux valgus surgery|hallux valgus surgery
4846217|NCT02354066|forefoot surgery|forefoot surgery
4846218|NCT02354066|brake response time|brake response time
4846219|NCT02354066|foot orthoses|foot orthoses
4846220|NCT02354053|HIV|hiv
4846221|NCT02354053|Triumeq|triumeq
4846222|NCT02354053|vulnerable populations|vulnerable populations
4846223|NCT02354040|Stroke, Myocardial Infarction, Adherence, Health Literacy, Implementation, Developing Country|stroke, myocardial infarction, adherence, health literacy, implementation, developing country
4846224|NCT02354027|SHR3824 metformin drug-drug interaction|shr3824 metformin drug-drug interaction
4846225|NCT02354014|Multidrug-Resistant Tuberculosis|multidrug-resistant tuberculosis
4846226|NCT02354014|Bedaquiline|bedaquiline
4846227|NCT02354014|TMC207|tmc207
4846228|NCT02354001|schizophrenia|schizophrenia
4846229|NCT02354001|mental illness|mental illness
4846230|NCT02354001|serm|serm
4846231|NCT02354001|raloxifene|raloxifene
4846232|NCT02354001|clinical trial|clinical trial
4846233|NCT02353988|AR-positive|ar-positive
4846234|NCT02353988|Androgen Antagonists|androgen antagonists
4846235|NCT02353988|Bicalutamide|bicalutamide
4846236|NCT02353988|TNBC|tnbc
4846237|NCT02353988|metastatic|metastatic
4846238|NCT02353975|SHR3824|shr3824
4846239|NCT02353975|food effect|food effect
4846240|NCT02353975|mass|mass
4846241|NCT02353975|balance|balance
4846242|NCT02353975|Phase I|phase i
4846243|NCT02353962|neglect|neglect
4846244|NCT02353962|exergames|exergames
4846245|NCT02353949|Mild cognitive impairment|mild cognitive impairment
4846246|NCT02353949|Alzheimer|alzheimer
4846247|NCT02353949|PET|pet
4846248|NCT02353949|Amyloid|amyloid
4846249|NCT02353949|Frontotemporal|frontotemporal
4846250|NCT02353871|Moderate to Severe|moderate to severe
4846251|NCT02353858|Rectal Cancer|rectal cancer
4846252|NCT02353858|Hyperthermia|hyperthermia
4846253|NCT02353858|Radiochemotherapy|radiochemotherapy
4846254|NCT02353858|Chemoradiotherapy|chemoradiotherapy
4846255|NCT02353858|Deep regional hyperthermia|deep regional hyperthermia
4846256|NCT02353858|pathologic complete response|pathologic complete response
4846257|NCT02353858|Regression Grade|regression grade
4846258|NCT02353858|Locally advanced rectal cancer|locally advanced rectal cancer
4846259|NCT02353858|complete response|complete response
4846260|NCT02353806|Amlodipine besylate|amlodipine besylate
4846261|NCT02353806|Breast milk|breast milk
4846262|NCT02353806|Pharmacokinetics|pharmacokinetics
4846263|NCT02353806|Chronic hypertension|chronic hypertension
4846264|NCT02353806|Pregnancy|pregnancy
4846265|NCT02353793|Hypothermia|hypothermia
4846266|NCT02353793|(Poly) Trauma|(poly) trauma
4846267|NCT02353793|Emergency Room|emergency room
4846268|NCT02353793|Warming Blanket|warming blanket
4846269|NCT02353780|Rheumatoid arthritis|rheumatoid arthritis
4846270|NCT02353780|TNF inhibitors|tnf inhibitors
4846271|NCT02353702|Diaphragmatic function|diaphragmatic function
4846272|NCT02353702|sniff-test|sniff-test
4846273|NCT02353702|pulmonary complications|pulmonary complications
4846274|NCT02353702|upper abdominal surgery|upper abdominal surgery
4846275|NCT02353663|Rheumatic heart disease|rheumatic heart disease
4846276|NCT02353663|Rheumatic fever|rheumatic fever
4846277|NCT02353663|Mitral regurgitation|mitral regurgitation
4846278|NCT02353663|Aortic regurgitation|aortic regurgitation
4846279|NCT02353663|Mitral stenosis|mitral stenosis
4846280|NCT02353650|Q10|q10
4846281|NCT02353650|ubiquinol|ubiquinol
4846282|NCT02353611|tooth|tooth
4846283|NCT02353611|bleaching|bleaching
4846284|NCT02353585|vitamin K-antagonist|vitamin k-antagonist
4846285|NCT02353585|novel oral anticoagulants|novel oral anticoagulants
4846286|NCT02353585|apixaban|apixaban
4846287|NCT02353585|dabigatran|dabigatran
4846288|NCT02353585|rivaroxaban|rivaroxaban
4846289|NCT02353585|edoxaban|edoxaban
4846290|NCT02353585|direct oral anticoagulants|direct oral anticoagulants
4846291|NCT02353559|acute leukemia|acute leukemia
4846292|NCT02353559|traumatic stress|traumatic stress
4846293|NCT02353559|quality of life|quality of life
4846294|NCT02353559|symptom burden|symptom burden
4846295|NCT02353559|psychosocial oncology|psychosocial oncology
4846296|NCT02353559|palliative care|palliative care
4846297|NCT02353559|intervention|intervention
4846298|NCT02353559|hematological malignancies|hematological malignancies
4846299|NCT02353559|supportive care|supportive care
4846300|NCT02353546|affective symptoms|affective symptoms
4846301|NCT02353546|cancer|cancer
4846302|NCT02353546|depression|depression
4846303|NCT02353546|palliative care|palliative care
4846304|NCT02353546|pilot trial|pilot trial
4846305|NCT02353546|psychotherapy|psychotherapy
4846306|NCT02353533|adenoma|adenoma
4846307|NCT02353533|EMR|emr
4846308|NCT02353533|FTRD|ftrd
4846309|NCT02353533|non- lifting|non- lifting
4846310|NCT02353533|colon|colon
4846311|NCT02353442|Pain|pain
4846312|NCT02353442|Rotator cuff|rotator cuff
4846313|NCT02353442|Stretching|stretching
4846314|NCT02353442|Mobilization|mobilization
4846315|NCT02353442|Scapula|scapula
4846316|NCT02353442|Posterior capsule|posterior capsule
4846317|NCT02353416|Mediterranean Diet|mediterranean diet
4846318|NCT02353416|Low-Glycemic Index|low-glycemic index
4846319|NCT02353416|AGEs|ages
4846320|NCT02353403|Fructo-oligosaccharides|fructo-oligosaccharides
4846321|NCT02353403|Sugar-reduced foods|sugar-reduced foods
4846322|NCT02353403|Postprandial glucose response|postprandial glucose response
4846323|NCT02353390|presyncope|presyncope
4846324|NCT02353390|syncope|syncope
4846325|NCT02353390|adolescent|adolescent
4846326|NCT02353390|young adult|young adult
4846327|NCT02353390|immunization|immunization
4846328|NCT02353390|vaccination|vaccination
4846329|NCT02353390|water consumption|water consumption
4846330|NCT02353364|Advanced maternal age|advanced maternal age
4846331|NCT02353364|Aneuploidy|aneuploidy
4846332|NCT02353325|Iron deficiency|iron deficiency
4846333|NCT02353325|Iron fortification|iron fortification
4846334|NCT02353325|Iron encapsulation|iron encapsulation
4846335|NCT02353312|Diastolic|diastolic
4846336|NCT02353312|Biopterin|biopterin
4846337|NCT02353312|Therapeutic Use|therapeutic use
4846338|NCT02353312|Drug Therapy|drug therapy
4846339|NCT02353312|Quality of Life|quality of life
4846340|NCT02353299|Cognition|cognition
4846341|NCT02353299|Balance|balance
4846342|NCT02353286|Biodegradable stents, ERCP|biodegradable stents, ercp
4846343|NCT02353273|WH-1,Diabetic Foot,Ulcer|wh-1,diabetic foot,ulcer
4846344|NCT02353234|Phenolics|phenolics
4846345|NCT02353234|Aleurone|aleurone
4846346|NCT02353234|Bioavailability|bioavailability
4846347|NCT02353234|Pharmacokinetics|pharmacokinetics
4846348|NCT02353221|Early arthritis|early arthritis
4846349|NCT02353221|undiferentiated arthritis|undiferentiated arthritis
4846350|NCT02353182|abdominal|abdominal
4846351|NCT02353182|lower extremity|lower extremity
4846352|NCT02353169|changes in myocardial repolarization in healthy children|changes in myocardial repolarization in healthy children
4846353|NCT02353156|Hemorrhoidectomy|hemorrhoidectomy
4846354|NCT02353156|postoperative pain|postoperative pain
4846355|NCT02353156|Sitz bath|sitz bath
4846356|NCT02353156|Electronic bidet|electronic bidet
4846357|NCT02353143|Acute Myeloid Leukemia|acute myeloid leukemia
4846358|NCT02353143|AML|aml
4846359|NCT02353143|Relapsed|relapsed
4846360|NCT02353143|Refractory|refractory
4846361|NCT02353143|MEN1112|men1112
4846362|NCT02353143|Monoclonal antibody|monoclonal antibody
4846363|NCT02353130|autism spectrum disorders|autism spectrum disorders
4846364|NCT02353130|memantine|memantine
4846365|NCT02353130|cortical metrics|cortical metrics
4846366|NCT02353130|sensory testing|sensory testing
4846367|NCT02353078|Eosinophilic Esophagitis (EOE)|eosinophilic esophagitis (eoe)
4846368|NCT02353065|Colles' Fracture|colles' fracture
4846369|NCT02353065|ultrasonography|ultrasonography
4846370|NCT02353052|morphology standards|morphology standards
4846371|NCT02353013|protein intake|protein intake
4846372|NCT02353013|body composition|body composition
4846373|NCT02352974|Diamyd|diamyd
4846374|NCT02352974|Diabetes|diabetes
4846375|NCT02352974|Juvenile Diabetes|juvenile diabetes
4846376|NCT02352974|Diabetes Type 1|diabetes type 1
4846377|NCT02352974|Type 1 Diabetes|type 1 diabetes
4846378|NCT02352974|Autoimmune Diabetes|autoimmune diabetes
4846379|NCT02352974|Insulin Dependent Diabetes|insulin dependent diabetes
4846380|NCT02352974|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
4846381|NCT02352974|rhGAD65|rhgad65
4846382|NCT02352974|GAD65|gad65
4846383|NCT02352974|GAD-Alum|gad-alum
4846384|NCT02352974|Diabetes Mellitus|diabetes mellitus
4846385|NCT02352974|Diabetes mellitus Type 1|diabetes mellitus type 1
4846386|NCT02352974|Glucose Metabolism Disorders|glucose metabolism disorders
4846387|NCT02352974|Metabolic Diseases|metabolic diseases
4846388|NCT02352974|Vitamin D|vitamin d
4846389|NCT02352961|Unrecognised condition|unrecognised condition
4846390|NCT02352922|Laparoscopy|laparoscopy
4846391|NCT02352922|Robotic Surgical Procedures|robotic surgical procedures
4846392|NCT02352922|Hysterectomy|hysterectomy
4846393|NCT02352922|Anesthetics, Local|anesthetics, local
4846394|NCT02352922|Bupivacaine|bupivacaine
4846395|NCT02352922|Pain, Postoperative|pain, postoperative
4846396|NCT02352896|Leigh syndrome|leigh syndrome
4846397|NCT02352896|Mitochondrial disorders|mitochondrial disorders
4846398|NCT02352896|EPI743|epi743
4846399|NCT02352896|Vincerinone|vincerinone
4846400|NCT02352870|Feasibility study|feasibility study
4846401|NCT02352870|Randomised controlled trial|randomised controlled trial
4846402|NCT02352870|Cognitive behavioural therapy|cognitive behavioural therapy
4846403|NCT02352870|Psychological distress|psychological distress
4846404|NCT02352870|Cognitive illness representations|cognitive illness representations
4846405|NCT02352870|Common sense model|common sense model
4846406|NCT02352857|Fructo-oligosaccharides|fructo-oligosaccharides
4846407|NCT02352857|Sugar-reduced foods|sugar-reduced foods
4846408|NCT02352857|Postprandial glucose response|postprandial glucose response
4846409|NCT02352805|Extracorporeal circulation, ventricular assist device|extracorporeal circulation, ventricular assist device
4846410|NCT02352792|Local control|local control
4846411|NCT02352779|Cancer Survivor|cancer survivor
4846412|NCT02352766|Thyroid cancer|thyroid cancer
4846413|NCT02352766|Thyroid nodules|thyroid nodules
4846414|NCT02352766|Palpable nodules|palpable nodules
4846415|NCT02352766|FNA|fna
4846416|NCT02352753|Amgen, OI, Bone|amgen, oi, bone
4846417|NCT02352740|arginine|arginine
4846418|NCT02352740|supplementation|supplementation
4846419|NCT02352740|metabolic syndrome|metabolic syndrome
4846420|NCT02352740|nitric oxide|nitric oxide
4846421|NCT02352727|Nocturnal hypokinesia|nocturnal hypokinesia
4846422|NCT02352727|Accelerometers|accelerometers
4846423|NCT02352714|Adolescents|adolescents
4846424|NCT02352714|Women's Health|women's health
4846425|NCT02352714|Contraception|contraception
4846426|NCT02352714|Reproduction|reproduction
4846427|NCT02352714|Comparative Effectiveness Research|comparative effectiveness research
4846428|NCT02352714|Pregnancy Prevention|pregnancy prevention
4846429|NCT02352714|Intrauterine Device|intrauterine device
4846430|NCT02352701|helicobacter pylori|helicobacter pylori
4846431|NCT02352701|ilaprazole|ilaprazole
4846432|NCT02352701|eradication|eradication
4846433|NCT02352701|triple therapy|triple therapy
4846434|NCT02352688|elderly|elderly
4846435|NCT02352688|enhanced recovery after surgery|enhanced recovery after surgery
4846436|NCT02352662|Congenital Heart Disease|congenital heart disease
4846437|NCT02352662|Point-of-care coagulation monitoring|point-of-care coagulation monitoring
4846438|NCT02352662|Rotaional Thromboelastometry|rotaional thromboelastometry
4846439|NCT02352649|Peripheral nerve injury|peripheral nerve injury
4846440|NCT02352649|Neurotmesis|neurotmesis
4846441|NCT02352649|Gene therapy|gene therapy
4846442|NCT02352649|Plasmid|plasmid
4846443|NCT02352649|Nerve regeneration therapy|nerve regeneration therapy
4846444|NCT02352610|carpometacarpal joints|carpometacarpal joints
4846445|NCT02352597|PCOS|pcos
4846446|NCT02352597|Phytoestrogens|phytoestrogens
4846447|NCT02352597|ovulation induction|ovulation induction
4846448|NCT02352584|QIV|qiv
4846449|NCT02352584|Quadrivalent Influenza Vaccine|quadrivalent influenza vaccine
4846450|NCT02352584|Influenza vaccine|influenza vaccine
4846451|NCT02352584|Vaccination|vaccination
4846452|NCT02352558|Multiple Myeloma|multiple myeloma
4846453|NCT02352558|Lymphoma|lymphoma
4846454|NCT02352558|Acute Myeloid Leukemia|acute myeloid leukemia
4846455|NCT02352558|Myelo-Dysplastic Syndrome|myelo-dysplastic syndrome
4846456|NCT02352558|Chronic Myeloid Leukemia|chronic myeloid leukemia
4846457|NCT02352558|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
4846458|NCT02352532|Dry Needling|dry needling
4846459|NCT02352532|Shear Wave Elastography|shear wave elastography
4846460|NCT02352532|Ultrasound|ultrasound
4846461|NCT02352493|PNH|pnh
4846462|NCT02352493|RNAi therapeutic|rnai therapeutic
4846463|NCT02352480|Non Healing Wound|non healing wound
4846464|NCT02352467|Non Healing Wound|non healing wound
4846465|NCT02352454|Non Healing Wound|non healing wound
4846466|NCT02352428|Skin Cancer|skin cancer
4846467|NCT02352428|Secondary Prevention|secondary prevention
4846468|NCT02352428|Population Screening|population screening
4846469|NCT02352402|CABG|cabg
4846470|NCT02352402|Ticagrelor|ticagrelor
4846471|NCT02352402|Graft|graft
4846472|NCT02352402|Patency|patency
4846473|NCT02352389|Childhood|childhood
4846474|NCT02352389|Cancer|cancer
4846475|NCT02352389|Genetic mutations|genetic mutations
4846476|NCT02352376|Noninvasive ventilation|noninvasive ventilation
4846477|NCT02352376|Heart rate variability|heart rate variability
4846478|NCT02352376|Thoracic surgery|thoracic surgery
4846479|NCT02352363|Parkinson's Disease|parkinson's disease
4846480|NCT02352363|Motor fluctuations|motor fluctuations
4846481|NCT02352363|levodopa|levodopa
4846482|NCT02352363|inhaled drugs|inhaled drugs
4846483|NCT02352363|OFF episodes|off episodes
4846484|NCT02352350|Pre-Hospital Cardiac Arrest|pre-hospital cardiac arrest
4846485|NCT02352350|Blood Lactate Level|blood lactate level
4846486|NCT02352350|Neurological Injury|neurological injury
4846487|NCT02352337|cancer|cancer
4846488|NCT02352337|pancreatic cancer|pancreatic cancer
4846489|NCT02352337|metastatic pancreatic cancer|metastatic pancreatic cancer
4846490|NCT02352324|cardiac output|cardiac output
4846491|NCT02352324|coronary artery bypass grafting|coronary artery bypass grafting
4846492|NCT02352324|minimally invasive hemodynamic monitoring|minimally invasive hemodynamic monitoring
4846493|NCT02352324|fluid responsiveness|fluid responsiveness
4846494|NCT02352272|sleep extension|sleep extension
4846495|NCT02352272|attention|attention
4846496|NCT02352272|physical performance|physical performance
4846497|NCT02352259|Liver metastases of colorectal cancer Electrochemotherapy|liver metastases of colorectal cancer electrochemotherapy
4846498|NCT02352259|Bleomycin|bleomycin
4846499|NCT02352259|Electrochemotherapy|electrochemotherapy
4846500|NCT02352246|intermittent sprinting|intermittent sprinting
4846501|NCT02352246|abdominal fat mass|abdominal fat mass
4846502|NCT02352246|type 2 diabetes|type 2 diabetes
4846503|NCT02352246|postmenopausal women|postmenopausal women
4846504|NCT02352233|retroview colonoscope|retroview colonoscope
4846505|NCT02352233|retroflexion colonoscopy|retroflexion colonoscopy
4846506|NCT02352233|colonoscopy|colonoscopy
4846507|NCT02352207|Neonatal respiratory distress|neonatal respiratory distress
4846508|NCT02352207|prenatal lung malformation|prenatal lung malformation
4846509|NCT02352207|KRAS mutation|kras mutation
4846510|NCT02352207|pregnant woman|pregnant woman
4846511|NCT02352194|Multiple Sclerosis, Physical therapy, Physical capacity, Fatigue|multiple sclerosis, physical therapy, physical capacity, fatigue
4846512|NCT02352181|Cirrhosis, transplantation, transfusion, Rotem®|cirrhosis, transplantation, transfusion, rotem®
4846513|NCT02352168|allergic rhinitis；airway inflammation；hyperreactivity|allergic rhinitis；airway inflammation；hyperreactivity
4846514|NCT02352155|haemostasis|haemostasis
4846515|NCT02352142|Separation stress|separation stress
4846516|NCT02352142|Family Nurture|family nurture
4846517|NCT02352142|Maternal Confidence|maternal confidence
4846518|NCT02352142|Maternal Competence|maternal competence
4846519|NCT02352142|Calming Cycle|calming cycle
4846520|NCT02352142|Kangaroo Care|kangaroo care
4846521|NCT02352142|Infant Neurodevelopment|infant neurodevelopment
4846522|NCT02352142|Infant Psychological Development|infant psychological development
4846523|NCT02352142|Post-partum depression|post-partum depression
4846524|NCT02352142|Mother-infant Co-regulation|mother-infant co-regulation
4846525|NCT02352116|Postoperative Experience|postoperative experience
4846526|NCT02352116|Postoperative Behavioral Changes|postoperative behavioral changes
4846527|NCT02352116|Maladaptive Behavioral Changes|maladaptive behavioral changes
4846528|NCT02352103|prostate cancer|prostate cancer
4846529|NCT02352103|Urinary continence|urinary continence
4846530|NCT02352103|robotic assisted radical prostatectomy|robotic assisted radical prostatectomy
4846531|NCT02352103|Vattikuti Urology Institute (VIP) radical prostatectomy|vattikuti urology institute (vip) radical prostatectomy
4846532|NCT02352103|Retzius sparing radical prostatectomy|retzius sparing radical prostatectomy
4846533|NCT02352090|Contraception, oral|contraception, oral
4846534|NCT02352090|Ethinyl Estradiol|ethinyl estradiol
4846535|NCT02352090|Estradiol Valerate|estradiol valerate
4846536|NCT02352090|Dienogest|dienogest
4846537|NCT02352090|Insulin resistance|insulin resistance
4846538|NCT02352090|Chronic inflammation|chronic inflammation
4846539|NCT02352090|Coagulation|coagulation
4846540|NCT02352051|attention deficit-hyperactivity disorder (ADHD).|attention deficit-hyperactivity disorder (adhd).
4846541|NCT02352051|executive functions|executive functions
4846542|NCT02352038|malocclusion|malocclusion
4846543|NCT02352038|low-level laser therapy|low-level laser therapy
4846544|NCT02352025|S-equol|s-equol
4846545|NCT02352025|breast cancer|breast cancer
4846546|NCT02352025|triple negative|triple negative
4846547|NCT02352012|Interventional Treatment|interventional treatment
4846548|NCT02352012|Refractory Pneumothorax|refractory pneumothorax
4846549|NCT02352012|Bronchoscope|bronchoscope
4846550|NCT02351999|Atrial fibrillation|atrial fibrillation
4846551|NCT02351999|Transseptal puncture|transseptal puncture
4846552|NCT02351999|Atrial fibrillation ablation|atrial fibrillation ablation
4846553|NCT02351986|subacromial impingement|subacromial impingement
4846554|NCT02351986|physical therapy|physical therapy
4846555|NCT02351986|cryotherapy|cryotherapy
4846556|NCT02351960|Drug therapy|drug therapy
4846557|NCT02351960|GERD|gerd
4846558|NCT02351960|Dexlansoprazole|dexlansoprazole
4846559|NCT02351947|stroke|stroke
4846560|NCT02351947|Cerebrovascular accident|cerebrovascular accident
4846561|NCT02351947|rehabilitation|rehabilitation
4846562|NCT02351947|motor learning|motor learning
4846563|NCT02351947|fMRI|fmri
4846564|NCT02351947|plasticity|plasticity
4846565|NCT02351934|colorectal surgery|colorectal surgery
4846566|NCT02351934|volume status|volume status
4846567|NCT02351921|transcranial magnetic stimulation|transcranial magnetic stimulation
4846568|NCT02351921|spinal cord injury|spinal cord injury
4846569|NCT02351921|motor cortex|motor cortex
4846570|NCT02351921|somatosensory cortex|somatosensory cortex
4846571|NCT02351895|infection control|infection control
4846572|NCT02351895|Prevention of hospital acquired infection|prevention of hospital acquired infection
4846573|NCT02351856|laminopathy|laminopathy
4846574|NCT02351856|ARRY-797|arry-797
4846575|NCT02351804|US-guided peripheral nerve block|us-guided peripheral nerve block
4846576|NCT02351804|Anesthetics, Local|anesthetics, local
4846577|NCT02351804|duration|duration
4846578|NCT02351804|Sensation|sensation
4846579|NCT02351804|adductor canal block|adductor canal block
4846580|NCT02351804|lower limb|lower limb
4846581|NCT02351804|Adjuvants, Anesthesia|adjuvants, anesthesia
4846582|NCT02351778|Developing Countries|developing countries
4846583|NCT02351778|Quality of Life|quality of life
4846584|NCT02351778|Mixed Methods|mixed methods
4846585|NCT02351778|Validation|validation
4846586|NCT02351778|Caregiver Burden|caregiver burden
4846587|NCT02351726|aortic valve replacement|aortic valve replacement
4846588|NCT02351726|aortic stenosis|aortic stenosis
4846589|NCT02351726|aortic steno-insufficiency|aortic steno-insufficiency
4846590|NCT02351713|primary prevention|primary prevention
4846591|NCT02351687|Moderate Acute Malnutrition|moderate acute malnutrition
4846592|NCT02351674|Heart Rate|heart rate
4846593|NCT02351674|Percutaneous coronary intervention|percutaneous coronary intervention
4846594|NCT02351674|outcome|outcome
4846595|NCT02351648|readmission|readmission
4846596|NCT02351648|care transition|care transition
4846597|NCT02351635|Calprotectin|calprotectin
4846598|NCT02351635|Diagnosis|diagnosis
4846599|NCT02351609|smoking cessation|smoking cessation
4846600|NCT02351609|patient navigation|patient navigation
4846601|NCT02351609|financial incentives|financial incentives
4846602|NCT02351609|health disparities|health disparities
4846603|NCT02351596|Core Stability|core stability
4846604|NCT02351596|Balance|balance
4846605|NCT02351596|Core Control|core control
4846606|NCT02351505|Small Cell Lung Cancer|small cell lung cancer
4846607|NCT02351492|Bile duct obstruction|bile duct obstruction
4846608|NCT02351492|intraoperative cholangiography|intraoperative cholangiography
4846609|NCT02351492|MRCP|mrcp
4846610|NCT02351479|hula|hula
4846611|NCT02351479|breast cancer|breast cancer
4846612|NCT02351479|female|female
4846613|NCT02351479|hawaii|hawaii
4846614|NCT02351479|physical activity|physical activity
4846615|NCT02351479|cervical cancer|cervical cancer
4846616|NCT02351479|ovarian cancer|ovarian cancer
4846617|NCT02351479|endometrial cancer|endometrial cancer
4846618|NCT02351466|Brain Growth and Development|brain growth and development
4846619|NCT02351466|Cognition|cognition
4846620|NCT02351466|Children|children
4846621|NCT02351466|Continuous Glucose Monitoring|continuous glucose monitoring
4846622|NCT02351466|MRI|mri
4846623|NCT02351466|Functional MRI|functional mri
4846624|NCT02351440|duloxetine|duloxetine
4846625|NCT02351414|Osteoarthritis|osteoarthritis
4846626|NCT02351414|Ankylosis|ankylosis
4846627|NCT02351414|Revision procedures|revision procedures
4846628|NCT02351414|Correction of functional deformity|correction of functional deformity
4846629|NCT02351414|Rheumatoid arthritis|rheumatoid arthritis
4846630|NCT02351414|Arthritis|arthritis
4846631|NCT02351388|Alzheimer's disease|alzheimer's disease
4846632|NCT02351388|Depressive symptoms|depressive symptoms
4846633|NCT02351388|Neuropsychiatric symptoms|neuropsychiatric symptoms
4846634|NCT02351388|Behavioral and Psychological Symptoms of Dementia|behavioral and psychological symptoms of dementia
4846635|NCT02351388|Neuromodulation|neuromodulation
4846636|NCT02351388|Transcranial Direct Current Stimulation|transcranial direct current stimulation
4846637|NCT02351375|microbiota|microbiota
4846638|NCT02351375|small intestine|small intestine
4846639|NCT02351375|diet|diet
4846640|NCT02351375|feces|feces
4846641|NCT02351362|Retention|retention
4846642|NCT02351362|Attrition|attrition
4846643|NCT02351362|Incentive|incentive
4846644|NCT02351362|Pregnant women|pregnant women
4846645|NCT02351349|frailty|frailty
4846646|NCT02351349|CKD|ckd
4846647|NCT02351349|Physical Therapy Modalities|physical therapy modalities
4846648|NCT02351349|Elder Nutritional Physiological Phenomena|elder nutritional physiological phenomena
4846649|NCT02351336|Threatened preterm birth|threatened preterm birth
4846650|NCT02351336|Fetal adrenal gland volume|fetal adrenal gland volume
4846651|NCT02351336|Fetal zone enlargement|fetal zone enlargement
4846652|NCT02351336|Prediction of preterm birth|prediction of preterm birth
4846653|NCT02351297|High protein diet|high protein diet
4846654|NCT02351297|Microbiota|microbiota
4846655|NCT02351297|Rectal biopsies|rectal biopsies
4846656|NCT02351297|Metabolomics|metabolomics
4846657|NCT02351297|Bacterial metabolites|bacterial metabolites
4846658|NCT02351297|volunteers|volunteers
4846659|NCT02351284|HIV, vitamin D, osteoporosis|hiv, vitamin d, osteoporosis
4846660|NCT02351258|Pediatrics|pediatrics
4846661|NCT02351258|Medical Oncology|medical oncology
4846662|NCT02351258|Catheters|catheters
4846663|NCT02351258|Infection|infection
4846664|NCT02351206|X-Rays|x-rays
4846665|NCT02351206|Magnetic Resonance Imaging|magnetic resonance imaging
4846666|NCT02351206|Sensitivity and Specificity|sensitivity and specificity
4846667|NCT02351180|Chronic lung allograft dysfunction|chronic lung allograft dysfunction
4846668|NCT02351180|Community-acquired respiratory viral infection|community-acquired respiratory viral infection
4846669|NCT02351167|Smoking cessation|smoking cessation
4846670|NCT02351167|Counseling|counseling
4846671|NCT02351167|Genetics and Genomics|genetics and genomics
4846672|NCT02351141|Noble Gas MRI|noble gas mri
4846673|NCT02351141|Pulmonary Function|pulmonary function
4846674|NCT02351141|Quality of Life Questionnaires|quality of life questionnaires
4846675|NCT02351128|lanreotide|lanreotide
4846676|NCT02351102|Congenital CMV|congenital cmv
4846677|NCT02351102|Congenital Cytomegalovirus|congenital cytomegalovirus
4846678|NCT02351063|Heart failure|heart failure
4846679|NCT02351063|BNP|bnp
4846680|NCT02351063|home testing|home testing
4846681|NCT02351063|remote monitoring|remote monitoring
4846682|NCT02351050|sonolysis, brain infarction, coronary angioplasty|sonolysis, brain infarction, coronary angioplasty
4846683|NCT02351037|Acute Myeloid Leukemia|acute myeloid leukemia
4846684|NCT02351037|AML|aml
4846685|NCT02351037|Ibrutinib|ibrutinib
4846686|NCT02351037|Cytarabine|cytarabine
4846687|NCT02351037|LD-AraC|ld-arac
4846688|NCT02351037|Azacitidine|azacitidine
4846689|NCT02350985|Migraine|migraine
4846690|NCT02350985|Migrainous Vertigo|migrainous vertigo
4846691|NCT02350985|Headache Disorders|headache disorders
4846692|NCT02350985|Central Nervous System Origin Vertigo|central nervous system origin vertigo
4846693|NCT02350985|Paroxysmal Vertigo|paroxysmal vertigo
4846694|NCT02350985|Adrenergic beta-Antagonist|adrenergic beta-antagonist
4846695|NCT02350985|Vasodilator Agent|vasodilator agent
4846696|NCT02350985|Anti Arrhythmia Agent|anti arrhythmia agent
4846697|NCT02350985|Serotonin Uptake Inhibitor|serotonin uptake inhibitor
4846698|NCT02350985|Antidepressive Agent|antidepressive agent
4846699|NCT02350985|Propranolol|propranolol
4846700|NCT02350985|Venlafaxine|venlafaxine
4846701|NCT02350959|Plaque|plaque
4846702|NCT02350959|coronary computed tomography angiography|coronary computed tomography angiography
4846703|NCT02350933|tracheal damages|tracheal damages
4846704|NCT02350920|IBD|ibd
4846705|NCT02350920|Crohn's disease|crohn's disease
4846706|NCT02350920|ulcerative colitis|ulcerative colitis
4846707|NCT02350920|ACT|act
4846708|NCT02350907|antimicrobial resistance|antimicrobial resistance
4846709|NCT02350907|point-of-care testing|point-of-care testing
4846710|NCT02350907|Neisseria gonorrhoeae|neisseria gonorrhoeae
4846711|NCT02350868|without Standard Treatment|without standard treatment
4846712|NCT02350855|Nutrition intervention|nutrition intervention
4846713|NCT02350855|Palliative care|palliative care
4846714|NCT02350855|Public Health|public health
4846715|NCT02350855|Quality of life|quality of life
4846716|NCT02350855|Tailored food formula|tailored food formula
4846717|NCT02350855|Body weight|body weight
4846718|NCT02350842|non-Left Bundle Branch Block morphology|non-left bundle branch block morphology
4846719|NCT02350842|Triple-site biventricular pacing|triple-site biventricular pacing
4846720|NCT02350842|cardiac resynchronization therapy|cardiac resynchronization therapy
4846721|NCT02350803|distraction osteogenesis|distraction osteogenesis
4846722|NCT02350803|mini plate|mini plate
4846723|NCT02350803|Lefort 1 osteotomy|lefort 1 osteotomy
4846724|NCT02350790|Robotics|robotics
4846725|NCT02350790|Laparoscopy|laparoscopy
4846726|NCT02350790|Endometriosis|endometriosis
4846727|NCT02350790|Argon|argon
4846728|NCT02350790|Gynecology|gynecology
4846729|NCT02350777|T-cell Depleted Hematopoietic Stem Cell|t-cell depleted hematopoietic stem cell
4846730|NCT02350777|Allogeneic Hematopoietic Stem Cell Transplantation|allogeneic hematopoietic stem cell transplantation
4846731|NCT02350777|CliniMACS Cell Selection System|clinimacs cell selection system
4846732|NCT02350777|14-228|14-228
4846733|NCT02350777|HSCT|hsct
4846734|NCT02350764|Nivolumab|nivolumab
4846735|NCT02350764|Lung|lung
4846736|NCT02350764|ipilimumab|ipilimumab
4846737|NCT02350764|NSCLC|nsclc
4846738|NCT02350764|14-137|14-137
4846739|NCT02350751|Influenza, Flu, Flu A, Influenza A|influenza, flu, flu a, influenza a
4846740|NCT02350738|Mild cognitive impairment|mild cognitive impairment
4846741|NCT02350738|Dementia|dementia
4846742|NCT02350738|Cognitive training|cognitive training
4846743|NCT02350738|Cognitive rehabilitation|cognitive rehabilitation
4846744|NCT02350738|Cognitive therapy|cognitive therapy
4846745|NCT02350725|Chronic Fluid Overload|chronic fluid overload
4846746|NCT02350712|Recurrent or metastatic squamous cell carcinoma of the head and neck|recurrent or metastatic squamous cell carcinoma of the head and neck
4846747|NCT02350712|SCCHN|scchn
4846748|NCT02350647|Rotator cuff|rotator cuff
4846749|NCT02350647|Ossification|ossification
4846750|NCT02350647|Suture anchors|suture anchors
4846751|NCT02350621|cervical foraminal stenosis minimal invasive foraminotomy|cervical foraminal stenosis minimal invasive foraminotomy
4846752|NCT02350582|breast cancer|breast cancer
4846753|NCT02350582|telerehabilitation|telerehabilitation
4846754|NCT02350582|strength|strength
4846755|NCT02350582|fatigue|fatigue
4846756|NCT02350582|quality of life|quality of life
4846757|NCT02350569|liver transplant|liver transplant
4846758|NCT02350569|hepatitis C|hepatitis c
4846759|NCT02350569|Gilead|gilead
4846760|NCT02350569|Communicable Diseases|communicable diseases
4846761|NCT02350569|Infection|infection
4846762|NCT02350569|Liver Diseases|liver diseases
4846763|NCT02350569|RNA Virus Infections|rna virus infections
4846764|NCT02350543|Aspirin usage|aspirin usage
4846765|NCT02350543|Transurethral resection of bladder tumor (TURBT)|transurethral resection of bladder tumor (turbt)
4846766|NCT02350530|Colorectal cancer|colorectal cancer
4846767|NCT02350530|Metastatic colorectal cancer|metastatic colorectal cancer
4846768|NCT02350530|Liver metastases|liver metastases
4846769|NCT02350530|Liver resection|liver resection
4846770|NCT02350530|Liver ablation|liver ablation
4846771|NCT02350530|Conversion therapy|conversion therapy
4846772|NCT02350530|FOLFOXIRI|folfoxiri
4846773|NCT02350530|Oxaliplatin|oxaliplatin
4846774|NCT02350530|Irinotecan|irinotecan
4846775|NCT02350530|Fluorouracil|fluorouracil
4846776|NCT02350530|Bevacizumab|bevacizumab
4846777|NCT02350530|RAS mutation|ras mutation
4846778|NCT02350491|Pregnancy|pregnancy
4846779|NCT02350491|miRNA|mirna
4846780|NCT02350491|Rheumatoid Arthritis (RA)|rheumatoid arthritis (ra)
4846781|NCT02350491|Systemic Lupus Erythematosus (SLE)|systemic lupus erythematosus (sle)
4846782|NCT02350465|sarcopenia|sarcopenia
4846783|NCT02350465|aging|aging
4846784|NCT02350465|myosteatosis|myosteatosis
4846785|NCT02350465|exercise|exercise
4846786|NCT02350465|screening|screening
4846787|NCT02350452|laparoscopic surgery|laparoscopic surgery
4846788|NCT02350452|diode laser|diode laser
4846789|NCT02350452|AMH|amh
4846790|NCT02350452|AFC|afc
4846791|NCT02350439|Coronary artery disease|coronary artery disease
4846792|NCT02350439|Fractional floe reserve|fractional floe reserve
4846793|NCT02350400|Drug eluting beads|drug eluting beads
4846794|NCT02350400|Irinotecan|irinotecan
4846795|NCT02350400|Pharmacogenetics|pharmacogenetics
4846796|NCT02350400|Pharmacokinetics|pharmacokinetics
4846797|NCT02350374|diabetes|diabetes
4846798|NCT02350374|children|children
4846799|NCT02350361|endostar|endostar
4846800|NCT02350361|angiogenesis|angiogenesis
4846801|NCT02350361|EGFR-TKI|egfr-tki
4846802|NCT02350361|lung caner|lung caner
4846803|NCT02350348|neonates|neonates
4846804|NCT02350348|infants|infants
4846805|NCT02350348|anaesthesia|anaesthesia
4846806|NCT02350348|mortality|mortality
4846807|NCT02350348|adverse effects|adverse effects
4846808|NCT02350348|Epidemiological Study|epidemiological study
4846809|NCT02350348|European Society of Anaesthesiology|european society of anaesthesiology
4846810|NCT02350335|aneurysm|aneurysm
4846811|NCT02350335|nicotine replacement therapy|nicotine replacement therapy
4846812|NCT02350335|cerebral vasospasm|cerebral vasospasm
4846813|NCT02350335|outcome|outcome
4846814|NCT02350322|Diet|diet
4846815|NCT02350322|concentration|concentration
4846816|NCT02350322|seafood|seafood
4846817|NCT02350322|youths|youths
4846818|NCT02350322|Norway|norway
4846819|NCT02350322|Nutrient status in blood|nutrient status in blood
4846820|NCT02350322|Inflammatory markers|inflammatory markers
4846821|NCT02350309|Insomnia Disorder|insomnia disorder
4846822|NCT02350309|E2006|e2006
4846823|NCT02350309|Multiple Sleep Latency Test|multiple sleep latency test
4846824|NCT02350296|headache|headache
4846825|NCT02350296|dental pain|dental pain
4846826|NCT02350296|neuralgia|neuralgia
4846827|NCT02350296|dysmenorrhoea|dysmenorrhoea
4846828|NCT02350296|muscular and osteoarticular pain|muscular and osteoarticular pain
4846829|NCT02350283|Acute Ischemic Stroke|acute ischemic stroke
4846830|NCT02350283|Endovascular therapy|endovascular therapy
4846831|NCT02350283|Solitaire|solitaire
4846832|NCT02350283|Standard Medical Management|standard medical management
4846833|NCT02350270|cognitively healthy individuals|cognitively healthy individuals
4846834|NCT02350257|cognitive behavior therapy|cognitive behavior therapy
4846835|NCT02350257|child|child
4846836|NCT02350257|randomized controlled trial|randomized controlled trial
4846837|NCT02350257|internet|internet
4846838|NCT02350244|musculoskeletal diseases|musculoskeletal diseases
4846839|NCT02350244|eyestrain|eyestrain
4846840|NCT02350244|occupational diseases|occupational diseases
4846841|NCT02350244|computer work|computer work
4846842|NCT02350244|muscle stretching exercise|muscle stretching exercise
4846843|NCT02350244|computer software application|computer software application
4846844|NCT02350244|MSDs|msds
4846845|NCT02350231|preterm birth|preterm birth
4846846|NCT02350231|Twin pregnancy|twin pregnancy
4846847|NCT02350231|progesterone|progesterone
4846848|NCT02350218|Transplantation|transplantation
4846849|NCT02350218|Living donor|living donor
4846850|NCT02350218|Eglandin|eglandin
4846851|NCT02350218|Alprostadil|alprostadil
4846852|NCT02350205|Burn wounds|burn wounds
4846853|NCT02350205|Burns|burns
4846854|NCT02350205|Skin substitute|skin substitute
4846855|NCT02350192|ehealth|ehealth
4846856|NCT02350192|intervention|intervention
4846857|NCT02350192|effectiveness|effectiveness
4846858|NCT02350192|randomized controlled trial|randomized controlled trial
4846859|NCT02350166|colorectal cancer|colorectal cancer
4846860|NCT02350166|hepatectomy|hepatectomy
4846861|NCT02350166|laparoscopic surgery|laparoscopic surgery
4846862|NCT02350166|laparotomy|laparotomy
4846863|NCT02350166|complications|complications
4846864|NCT02350153|Mortality|mortality
4846865|NCT02350153|Morbidity|morbidity
4846866|NCT02350153|Incidence|incidence
4846867|NCT02350153|Prevalence|prevalence
4846868|NCT02350140|HIV|hiv
4846869|NCT02350140|Prevention of mother-to-child HIV transmission|prevention of mother-to-child hiv transmission
4846870|NCT02350140|PMTCT|pmtct
4846871|NCT02350140|mobile health (mHealth)|mobile health (mhealth)
4846872|NCT02350140|mobile phone|mobile phone
4846873|NCT02350140|text messaging|text messaging
4846874|NCT02350140|short message services (SMS)|short message services (sms)
4846875|NCT02350127|dementia|dementia
4846876|NCT02350127|clinical trial|clinical trial
4846877|NCT02350127|behavioral intervention|behavioral intervention
4846878|NCT02350127|exercise|exercise
4846879|NCT02350127|complementary and alternative medicine|complementary and alternative medicine
4846880|NCT02350127|cognition|cognition
4846881|NCT02350127|function|function
4846882|NCT02350127|quality of life|quality of life
4846883|NCT02350114|Heart failure|heart failure
4846884|NCT02350114|6 Minute Walk Test|6 minute walk test
4846885|NCT02350088|fast-track surgery|fast-track surgery
4846886|NCT02350075|short implants|short implants
4846887|NCT02350075|sinus floor elevation|sinus floor elevation
4846888|NCT02350075|randomized controlled trial|randomized controlled trial
4846889|NCT02350036|Preeclampsia|preeclampsia
4846890|NCT02350036|placental protein 13|placental protein 13
4846891|NCT02350036|Uterine artery doppler|uterine artery doppler
4846892|NCT02350023|alopecia areata|alopecia areata
4846893|NCT02350023|betamethasone|betamethasone
4846894|NCT02350023|latanoprost|latanoprost
4846895|NCT02350023|topical steroid|topical steroid
4846896|NCT02350023|prostaglandin|prostaglandin
4846897|NCT02350010|Etiology|etiology
4846898|NCT02350010|Prognostic risk factors|prognostic risk factors
4846899|NCT02350010|Intracerebral Hemorrhage|intracerebral hemorrhage
4846900|NCT02350010|non-invasive imaging|non-invasive imaging
4846901|NCT02350010|CT angiography|ct angiography
4846902|NCT02349997|central sleep apnea|central sleep apnea
4846903|NCT02349997|Cheyne-Stokes respiration|cheyne-stokes respiration
4846904|NCT02349997|obstructive sleep apnea|obstructive sleep apnea
4846905|NCT02349997|chronic heart failure|chronic heart failure
4846906|NCT02349997|fluid shift|fluid shift
4846907|NCT02349919|postinfectious cough, postviral cough|postinfectious cough, postviral cough
4846908|NCT02349906|non-malignant diseases, allogeneic stem cell transplantation|non-malignant diseases, allogeneic stem cell transplantation
4846909|NCT02349854|pruritus|pruritus
4846910|NCT02349854|itch|itch
4846911|NCT02349854|skin|skin
4846912|NCT02349854|scalp|scalp
4846913|NCT02349854|seborrheic dermatitis|seborrheic dermatitis
4846914|NCT02349828|antiviral|antiviral
4846915|NCT02349828|herpes simplex virus|herpes simplex virus
4846916|NCT02349828|herpes|herpes
4846917|NCT02349828|burn patients|burn patients
4846918|NCT02349828|HSV|hsv
4846919|NCT02349828|acyclovir|acyclovir
4846920|NCT02349815|Drug Utilization Study|drug utilization study
4846921|NCT02349802|Auto-injector Device, device-related injection, Auto-injector|auto-injector device, device-related injection, auto-injector
4846922|NCT02349789|Gait|gait
4846923|NCT02349789|Cerebellum|cerebellum
4846924|NCT02349789|Non invasive electrical stimulation|non invasive electrical stimulation
4846925|NCT02349789|tDCS|tdcs
4846926|NCT02349789|TMS|tms
4846927|NCT02349789|Balance|balance
4846928|NCT02349763|Dexamethasone|dexamethasone
4846929|NCT02349763|Hypersensitivity reaction|hypersensitivity reaction
4846930|NCT02349763|Paclitaxel|paclitaxel
4846931|NCT02349750|Endometrial Scratch Injury|endometrial scratch injury
4846932|NCT02349750|Unexplained infertility|unexplained infertility
4846933|NCT02349750|intrauterine insemenation|intrauterine insemenation
4846934|NCT02349750|ovulation induction|ovulation induction
4846935|NCT02349737|Bioelectrical Impedance Analysis|bioelectrical impedance analysis
4846936|NCT02349737|Body composition|body composition
4846937|NCT02349737|ICD|icd
4846938|NCT02349724|CEA|cea
4846939|NCT02349724|CAR T|car t
4846940|NCT02349711|probiotic|probiotic
4846942|NCT02349711|immune|immune
4846943|NCT02349698|CAR T|car t
4846944|NCT02349698|Leukemia|leukemia
4846945|NCT02349698|Lymphoma|lymphoma
4846946|NCT02349685|Helicobacter pylori|helicobacter pylori
4846947|NCT02349685|Personalized therapy|personalized therapy
4846948|NCT02349685|antimicrobial susceptibility|antimicrobial susceptibility
4846949|NCT02349685|rescue therapy|rescue therapy
4846950|NCT02349685|culture|culture
4846951|NCT02349672|HIE|hie
4846952|NCT02349672|Neonates|neonates
4846953|NCT02349633|EGFRm - Epidermal Growth Factor Receptor Mutation|egfrm - epidermal growth factor receptor mutation
4846954|NCT02349633|Advanced EGFRm (del19 or L858R +/- T790M NSCLC|advanced egfrm (del19 or l858r +/- t790m nsclc
4846955|NCT02349581|Anesthetics, Local|anesthetics, local
4846956|NCT02349581|Mastectomy|mastectomy
4846957|NCT02349581|Neuralgia|neuralgia
4846958|NCT02349581|Nerve block|nerve block
4846959|NCT02349542|Liposomal Bupivacaine|liposomal bupivacaine
4846960|NCT02349542|Simultaneous Bilateral Total Knee Arthroplasty|simultaneous bilateral total knee arthroplasty
4846961|NCT02349542|Safety|safety
4846962|NCT02349529|Epilepsy|epilepsy
4846963|NCT02349529|psychosocial|psychosocial
4846964|NCT02349503|Adrenocortical function|adrenocortical function
4846965|NCT02349503|Adrenal hyperplasia, Congenital|adrenal hyperplasia, congenital
4846966|NCT02349503|21-hydroxylase deficiency|21-hydroxylase deficiency
4846967|NCT02349503|Adrenogenital Syndrome|adrenogenital syndrome
4846968|NCT02349503|Adolescents|adolescents
4846969|NCT02349503|Female|female
4846970|NCT02349503|Hyperplasia|hyperplasia
4846971|NCT02349503|Adrenal Gland Diseases|adrenal gland diseases
4846972|NCT02349503|Congenital Abnormalities|congenital abnormalities
4846973|NCT02349503|Adrenocortical Hyperfunction|adrenocortical hyperfunction
4846974|NCT02349503|Disorders of Sex Development|disorders of sex development
4846975|NCT02349503|Endocrine System Diseases|endocrine system diseases
4846976|NCT02349503|Genetic Diseases, Inborn|genetic diseases, inborn
4846977|NCT02349503|Gonadal Disorders|gonadal disorders
4846978|NCT02349503|Metabolic Diseases|metabolic diseases
4846979|NCT02349503|Metabolism, Inborn Errors|metabolism, inborn errors
4846980|NCT02349503|Pathologic Processes|pathologic processes
4846981|NCT02349503|Steroid Metabolism, Inborn Errors|steroid metabolism, inborn errors
4846982|NCT02349503|Urogenital Abnormalities|urogenital abnormalities
4846983|NCT02349503|Corticotropin Releasing Factor|corticotropin releasing factor
4846984|NCT02349490|gastrointestinal hemorrhage|gastrointestinal hemorrhage
4846985|NCT02349490|endoscopy|endoscopy
4846986|NCT02349490|hemostasis|hemostasis
4846987|NCT02349451|Safety|safety
4846988|NCT02349451|Efficacy|efficacy
4846989|NCT02349451|Methotrexate|methotrexate
4846990|NCT02349373|Overuse injury|overuse injury
4846991|NCT02349373|Running related injury|running related injury
4846992|NCT02349373|Running pattern|running pattern
4846993|NCT02349360|safety|safety
4846994|NCT02349360|tolerability|tolerability
4846995|NCT02349321|physical or sexual intimate partner violence|physical or sexual intimate partner violence
4846996|NCT02349321|adolescents|adolescents
4846997|NCT02349321|primary prevention|primary prevention
4846998|NCT02349321|randomised controlled trial|randomised controlled trial
4846999|NCT02349321|school|school
4847000|NCT02349321|South Africa|south africa
4847001|NCT02349321|parenting|parenting
4847002|NCT02349282|muscle strength|muscle strength
4847003|NCT02349282|physical performance|physical performance
4847004|NCT02349282|vitamin D3|vitamin d3
4847005|NCT02349282|Cholecalciferol|cholecalciferol
4847006|NCT02349282|Calcifediol|calcifediol
4847007|NCT02349269|Atrial fibrillation|atrial fibrillation
4847008|NCT02349269|CABG|cabg
4847009|NCT02349269|Stroke|stroke
4847010|NCT02349256|MUS|mus
4847011|NCT02349256|British South Asians|british south asians
4847012|NCT02349256|Somatic Symptoms|somatic symptoms
4847013|NCT02349256|Qualitative interviews|qualitative interviews
4847014|NCT02349243|obese|obese
4847015|NCT02349243|weight loss|weight loss
4847016|NCT02349243|entacapone|entacapone
4847017|NCT02349217|Breast cancer|breast cancer
4847018|NCT02349217|Breast cancer survivors|breast cancer survivors
4847019|NCT02349217|Breast cancer partners|breast cancer partners
4847020|NCT02349217|Mindfulness-Based Relationship Enhancement|mindfulness-based relationship enhancement
4847021|NCT02349217|MBRE|mbre
4847022|NCT02349217|Standard of care|standard of care
4847023|NCT02349217|Pain Assessment|pain assessment
4847024|NCT02349217|Questionnaires|questionnaires
4847025|NCT02349217|Surveys|surveys
4847026|NCT02349217|Neurocognitive Tests|neurocognitive tests
4847027|NCT02349217|Cortisol Tests|cortisol tests
4847028|NCT02349217|Saliva tests|saliva tests
4847029|NCT02349217|Interviews|interviews
4847030|NCT02349217|Meditation|meditation
4847031|NCT02349217|Yoga|yoga
4847032|NCT02349217|Self-help materials|self-help materials
4847033|NCT02349204|Simulator|simulator
4847034|NCT02349204|Music|music
4847035|NCT02349204|Mozart Effect|mozart effect
4847036|NCT02349191|Alzheimers|alzheimers
4847037|NCT02349191|dementia|dementia
4847038|NCT02349191|omental transposition|omental transposition
4847039|NCT02349191|neurological|neurological
4847040|NCT02349152|Cardiopulmonary bypass|cardiopulmonary bypass
4847041|NCT02349152|Heart surgery|heart surgery
4847042|NCT02349126|Hepatitis B|hepatitis b
4847043|NCT02349126|HBV infection|hbv infection
4847044|NCT02349126|Hepatitis B Surface Antigen|hepatitis b surface antigen
4847045|NCT02349113|estrogen, aging|estrogen, aging
4847046|NCT02349087|EEG|eeg
4847047|NCT02349087|cardiac arrest|cardiac arrest
4847048|NCT02349087|resuscitation|resuscitation
4847049|NCT02349087|seizures|seizures
4847050|NCT02349061|Systemic Lupus Erythematosus|systemic lupus erythematosus
4847051|NCT02349061|Ustekinumab|ustekinumab
4847052|NCT02349048|Hepatitis C virus|hepatitis c virus
4847053|NCT02349048|Hepatitis C virus genotype 1|hepatitis c virus genotype 1
4847054|NCT02349048|Chronic Hepatitis C Virus Genotype 1 Infection|chronic hepatitis c virus genotype 1 infection
4847055|NCT02349048|Liver fibrosis|liver fibrosis
4847056|NCT02349048|Cirrhosis|cirrhosis
4847057|NCT02349048|Simeprevir|simeprevir
4847058|NCT02349048|Daclatasvir|daclatasvir
4847059|NCT02349048|Sofosbuvir|sofosbuvir
4847060|NCT02349035|Transradial amputee|transradial amputee
4847061|NCT02349022|[89Zr]Df-IAB2M|[89zr]df-iab2m
4847062|NCT02349022|Prostate cancer|prostate cancer
4847063|NCT02349022|PET scan|pet scan
4847064|NCT02349009|systemic sclerosis|systemic sclerosis
4847065|NCT02349009|scleroderma|scleroderma
4847066|NCT02348970|mandibular advancement devices ONIRIS®|mandibular advancement devices oniris®
4847067|NCT02348970|obstructive sleep apnea and hypopneas|obstructive sleep apnea and hypopneas
4847068|NCT02348957|Chronic myeloid leukemia|chronic myeloid leukemia
4847069|NCT02348957|Dasatinib|dasatinib
4847070|NCT02348957|Any line|any line
4847071|NCT02348957|Chronic phase|chronic phase
4847072|NCT02348944|Biological markers|biological markers
4847073|NCT02348944|Cartilage|cartilage
4847074|NCT02348840|Midwives|midwives
4847075|NCT02348840|Pregnant Women|pregnant women
4847076|NCT02348827|Unipolar depression|unipolar depression
4847077|NCT02348827|Family Therapies|family therapies
4847078|NCT02348827|Psychoeducation|psychoeducation
4847079|NCT02348827|Family psychoeducation|family psychoeducation
4847080|NCT02348814|NAFLD, NASH|nafld, nash
4847081|NCT02348788|Vivax|vivax
4847082|NCT02348788|Malaria|malaria
4847083|NCT02348788|artemether-lumefantrine|artemether-lumefantrine
4847084|NCT02348788|chloroquine|chloroquine
4847085|NCT02348788|RCT|rct
4847086|NCT02348749|18F-MFBG Imaging|18f-mfbg imaging
4847087|NCT02348749|14-138|14-138
4847088|NCT02348749|PET/MR|pet/mr
4847089|NCT02348749|PET/CT scan|pet/ct scan
4847090|NCT02348736|airway|airway
4847091|NCT02348736|videolaryngoscope|videolaryngoscope
4847092|NCT02348697|Cartilage Defect in the Knee|cartilage defect in the knee
4847093|NCT02348697|MACT|mact
4847094|NCT02348684|Breast Cancer|breast cancer
4847095|NCT02348658|Pharmacological therapy|pharmacological therapy
4847096|NCT02348645|Pilot projects|pilot projects
4847097|NCT02348645|Feasibility studies|feasibility studies
4847098|NCT02348645|Intervention studies|intervention studies
4847099|NCT02348645|Orthopedics|orthopedics
4847100|NCT02348645|Orthopedic Procedures|orthopedic procedures
4847101|NCT02348645|Neurosurgical Procedures|neurosurgical procedures
4847102|NCT02348645|Neurosurgery|neurosurgery
4847103|NCT02348645|Spine|spine
4847104|NCT02348645|Spinal Fusion|spinal fusion
4847105|NCT02348645|Spondylodesis|spondylodesis
4847106|NCT02348645|Spondylosyndesis|spondylosyndesis
4847107|NCT02348645|Laminectomy|laminectomy
4847108|NCT02348645|Foraminotomy|foraminotomy
4847109|NCT02348645|Decompression, surgical|decompression, surgical
4847110|NCT02348645|Low Back Pain|low back pain
4847111|NCT02348645|Quality of Life|quality of life
4847112|NCT02348580|teaching|teaching
4847113|NCT02348580|education|education
4847114|NCT02348580|active learning|active learning
4847115|NCT02348580|time on task|time on task
4847116|NCT02348580|financial education|financial education
4847117|NCT02348580|social education|social education
4847118|NCT02348580|rights based education|rights based education
4847119|NCT02348580|primary school|primary school
4847120|NCT02348580|life-skills|life-skills
4847121|NCT02348567|Health care, accreditation, unannounced survey, cluster randomized controlled trial, quality improvement, organisational development|health care, accreditation, unannounced survey, cluster randomized controlled trial, quality improvement, organisational development
4847122|NCT02348554|obesity|obesity
4847123|NCT02348554|energy expenditure|energy expenditure
4847124|NCT02348554|daily living physical activity|daily living physical activity
4847125|NCT02348554|smartphone|smartphone
4847126|NCT02348554|accelerometry|accelerometry
4847127|NCT02348554|prediction algorithm|prediction algorithm
4847128|NCT02348528|Multiple Myeloma|multiple myeloma
4847129|NCT02348528|Relapsed|relapsed
4847130|NCT02348528|Refractory|refractory
4847131|NCT02348528|Lenalidomide|lenalidomide
4847132|NCT02348528|Dexamethasone|dexamethasone
4847133|NCT02348528|open-label|open-label
4847134|NCT02348528|CC-5013-MM-021|cc-5013-mm-021
4847135|NCT02348502|HBsAg loss|hbsag loss
4847136|NCT02348502|interferon|interferon
4847137|NCT02348502|HBV reaction|hbv reaction
4847138|NCT02348502|Hepatitis B|hepatitis b
4847139|NCT02348489|AML|aml
4847140|NCT02348489|Acute Myeloid Leukemia|acute myeloid leukemia
4847141|NCT02348489|SGI-110|sgi-110
4847142|NCT02348489|DNA Hypomethylating Agen|dna hypomethylating agen
4847143|NCT02348437|Pronator quadratus|pronator quadratus
4847144|NCT02348437|Distal radius fracture|distal radius fracture
4847145|NCT02348437|Repair|repair
4847146|NCT02348437|Volar plating|volar plating
4847147|NCT02348437|PRWE|prwe
4847148|NCT02348424|genitourinary|genitourinary
4847149|NCT02348424|Neisseriaceae|neisseriaceae
4847150|NCT02348424|pharyngeal|pharyngeal
4847151|NCT02348424|Solithromycin|solithromycin
4847152|NCT02348411|Medication-refractory|medication-refractory
4847153|NCT02348398|Cervical Cancer|cervical cancer
4847154|NCT02348398|Recurrent cervical cancer|recurrent cervical cancer
4847155|NCT02348398|Squamous cervical cancer|squamous cervical cancer
4847156|NCT02348398|Adenocarcinoma of the cervix|adenocarcinoma of the cervix
4847157|NCT02348398|Adenosquamous cervical cancer|adenosquamous cervical cancer
4847158|NCT02348398|Persistent cervical cancer|persistent cervical cancer
4847159|NCT02348398|Pazopanib|pazopanib
4847160|NCT02348398|GW786034|gw786034
4847161|NCT02348398|Topotecan|topotecan
4847162|NCT02348398|Hycamtin|hycamtin
4847163|NCT02348385|amphetamine|amphetamine
4847164|NCT02348385|cigarette smokers|cigarette smokers
4847165|NCT02348359|Vascular Endothelial Growth Factor (VEGF)|vascular endothelial growth factor (vegf)
4847166|NCT02348359|Platelet Derived Growth Factor (PDGF)|platelet derived growth factor (pdgf)
4847167|NCT02348359|AMD|amd
4847168|NCT02348346|self-disinfecting surfaces|self-disinfecting surfaces
4847169|NCT02348346|titanium dioxide|titanium dioxide
4847170|NCT02348281|triple negative breast cancer|triple negative breast cancer
4847171|NCT02348281|androgen receptor|androgen receptor
4847172|NCT02348281|bicalutamide|bicalutamide
4847173|NCT02348268|Neck Pain|neck pain
4847174|NCT02348268|Myofascial release|myofascial release
4847175|NCT02348268|Manual therapy|manual therapy
4847176|NCT02348242|Intensive care|intensive care
4847177|NCT02348242|corneal damage|corneal damage
4847178|NCT02348242|prevention|prevention
4847179|NCT02348242|nursing protocol|nursing protocol
4847180|NCT02348229|Enhanced recovery after surgery|enhanced recovery after surgery
4847181|NCT02348229|laparoscopic gastrectomy|laparoscopic gastrectomy
4847182|NCT02348229|advanced gastric cancer|advanced gastric cancer
4847183|NCT02348229|C-reactive,visceral proteins|c-reactive,visceral proteins
4847184|NCT02348177|Human immunideficiency virus|human immunideficiency virus
4847185|NCT02348177|Tuberculosis|tuberculosis
4847186|NCT02348177|superboosting|superboosting
4847187|NCT02348177|lopinavir/ritonavir 1:1|lopinavir/ritonavir 1:1
4847188|NCT02348177|Pediatric TB/HIV co-infection|pediatric tb/hiv co-infection
4847189|NCT02348164|Carotenoids|carotenoids
4847190|NCT02348164|absorption|absorption
4847191|NCT02348164|citrus|citrus
4847192|NCT02348151|COPD|copd
4847193|NCT02348151|SWTi|swti
4847194|NCT02348151|Treadmill|treadmill
4847195|NCT02348138|Isometric Handgrip|isometric handgrip
4847196|NCT02348112|stress urinary incontinence|stress urinary incontinence
4847197|NCT02348112|Altis 522|altis 522
4847198|NCT02348112|urinary incontinence|urinary incontinence
4847199|NCT02348099|Diabetes|diabetes
4847200|NCT02348099|Lipohypertrophy|lipohypertrophy
4847201|NCT02348099|Ultrasound|ultrasound
4847202|NCT02348073|Epilepsy|epilepsy
4847203|NCT02348073|Attention Deficit Disorders|attention deficit disorders
4847204|NCT02348073|VAYARIN|vayarin
4847205|NCT02348073|Children|children
4847206|NCT02348073|Polyunsaturated n-3 fatty acid supplementation|polyunsaturated n-3 fatty acid supplementation
4847207|NCT02348034|Surgical Site Infection (SSI)|surgical site infection (ssi)
4847208|NCT02348034|Negative Pressure Wound Therapy (NPWT)|negative pressure wound therapy (npwt)
4847209|NCT02348008|MK-3475|mk-3475
4847210|NCT02348008|Pembrolizumab|pembrolizumab
4847211|NCT02348008|Bevacizumab|bevacizumab
4847212|NCT02347995|Exercise|exercise
4847213|NCT02347995|Protein|protein
4847214|NCT02347995|Nutrition|nutrition
4847215|NCT02347995|Stroke|stroke
4847216|NCT02347982|Turkey|turkey
4847217|NCT02347982|Epidemiologic|epidemiologic
4847218|NCT02347969|antioxidant|antioxidant
4847219|NCT02347969|skin radiance|skin radiance
4847220|NCT02347969|skin elasticity|skin elasticity
4847221|NCT02347969|skin firmness|skin firmness
4847222|NCT02347969|skin hydration|skin hydration
4847223|NCT02347956|robot surgery|robot surgery
4847224|NCT02347956|reduced port|reduced port
4847225|NCT02347956|single-site|single-site
4847226|NCT02347956|safety|safety
4847227|NCT02347956|feasibility|feasibility
4847228|NCT02347930|acute kidney injury|acute kidney injury
4847229|NCT02347930|ultrasound technology|ultrasound technology
4847230|NCT02347904|Esophageal cancer|esophageal cancer
4847231|NCT02347904|Adjuvant treatment|adjuvant treatment
4847233|NCT02347904|Oxaliplatin|oxaliplatin
4847234|NCT02347904|Feasibility|feasibility
4847235|NCT02347891|Inflammatory Myositis|inflammatory myositis
4847236|NCT02347891|Dermatomyositis|dermatomyositis
4847237|NCT02347891|Polymyositis|polymyositis
4847238|NCT02347891|Muscle Pain|muscle pain
4847239|NCT02347891|Myositis|myositis
4847240|NCT02347891|Refractory myositis|refractory myositis
4847241|NCT02347878|leukemia|leukemia
4847242|NCT02347878|lymphoma|lymphoma
4847243|NCT02347878|lumbar puncture|lumbar puncture
4847244|NCT02347878|intrathecal treatment|intrathecal treatment
4847245|NCT02347878|post-lumbar puncture headache|post-lumbar puncture headache
4847246|NCT02347865|osteoporosis post menopausal women|osteoporosis post menopausal women
4847247|NCT02347826|coned wires, wire lift,|coned wires, wire lift,
4847248|NCT02347826|patient|patient
4847249|NCT02347826|discomfort|discomfort
4847250|NCT02347813|squamous cell carcinoma|squamous cell carcinoma
4847251|NCT02347813|pioglitazone|pioglitazone
4847252|NCT02347813|PPARgamma|ppargamma
4847253|NCT02347813|skin cancer|skin cancer
4847254|NCT02347774|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
4847255|NCT02347774|COPD|copd
4847256|NCT02347761|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
4847257|NCT02347748|Pain|pain
4847258|NCT02347748|Anesthesia Recovery Period|anesthesia recovery period
4847259|NCT02347748|Postoperative Period|postoperative period
4847260|NCT02347748|Adaptation, Psychological|adaptation, psychological
4847261|NCT02347748|Relaxation|relaxation
4847262|NCT02347748|Stress, Psychological|stress, psychological
4847263|NCT02347735|Colorectal carcinoma|colorectal carcinoma
4847264|NCT02347735|Anastomotic leakage|anastomotic leakage
4847265|NCT02347735|Markers|markers
4847266|NCT02347735|Diagnosis|diagnosis
4847267|NCT02347722|biomarkers|biomarkers
4847268|NCT02347722|diagnosis|diagnosis
4847269|NCT02347722|etiology of heart failure|etiology of heart failure
4847270|NCT02347709|Diabetic Foot Ulcer|diabetic foot ulcer
4847271|NCT02347709|DFU|dfu
4847272|NCT02347709|Type 2 Diabetes|type 2 diabetes
4847273|NCT02347709|Neuropathy|neuropathy
4847274|NCT02347696|Diet|diet
4847275|NCT02347696|Physical Activity|physical activity
4847276|NCT02347696|Trial|trial
4847277|NCT02347696|Lipidomics|lipidomics
4847278|NCT02347696|Occidental Diseases|occidental diseases
4847279|NCT02347657|Homozygous for the F508del CFTR Mutation|homozygous for the f508del cftr mutation
4847280|NCT02347566|COPD|copd
4847281|NCT02347566|Physical Activity|physical activity
4847282|NCT02347566|Accelerometer|accelerometer
4847283|NCT02347540|Heart Failure|heart failure
4847284|NCT02347540|Diastolic Dysfunction|diastolic dysfunction
4847285|NCT02347540|Pre-Eclampsia|pre-eclampsia
4847286|NCT02347540|Endothelial dysfunction|endothelial dysfunction
4847287|NCT02347540|Biological Markers|biological markers
4847288|NCT02347540|MicroRNAs|micrornas
4847289|NCT02347540|Circulating cells|circulating cells
4847290|NCT02347488|ETT Holder, bite guard, airway, endotracheal tube|ett holder, bite guard, airway, endotracheal tube
4847291|NCT02347462|BiPAP|bipap
4847292|NCT02347449|Early-stage Breast cancer, node positive|early-stage breast cancer, node positive
4847293|NCT02347449|Prognosis|prognosis
4847294|NCT02347449|Oncotype Dx|oncotype dx
4847295|NCT02347436|Transurethral Resection of Prostate|transurethral resection of prostate
4847296|NCT02347423|Poliomyelitis immunization|poliomyelitis immunization
4847297|NCT02347423|primary series|primary series
4847298|NCT02347371|Heart transplant|heart transplant
4847299|NCT02347371|Cardiac allograft vasculopathy|cardiac allograft vasculopathy
4847300|NCT02347371|Chronic rejection|chronic rejection
4847301|NCT02347371|Immunosuppressant therapy|immunosuppressant therapy
4847302|NCT02347345|HCV, injection drug use|hcv, injection drug use
4847303|NCT02347280|clostridium difficile|clostridium difficile
4847304|NCT02347280|colitis|colitis
4847305|NCT02347280|colon|colon
4847306|NCT02347267|Beverages sweetened caloric, no caloric|beverages sweetened caloric, no caloric
4847307|NCT02347267|Weight|weight
4847308|NCT02347267|Fat percentage|fat percentage
4847309|NCT02347267|Body Composition|body composition
4847310|NCT02347267|Blood pressure|blood pressure
4847311|NCT02347267|Sugar|sugar
4847312|NCT02347267|Sodium|sodium
4847313|NCT02347267|Dietary intake|dietary intake
4847314|NCT02347228|OB318|ob318
4847315|NCT02347228|Advanced Solid Malignancies|advanced solid malignancies
4847316|NCT02347228|Antrodia cinnamomea|antrodia cinnamomea
4847317|NCT02347228|Antrodia camphorata|antrodia camphorata
4847318|NCT02347202|Counseling|counseling
4847319|NCT02347163|triple neg|triple neg
4847320|NCT02347163|breast cancer|breast cancer
4847321|NCT02347163|zoledronate|zoledronate
4847322|NCT02347163|mevalonate pathway|mevalonate pathway
4847323|NCT02347124|smoking cessation|smoking cessation
4847324|NCT02347124|oral health care|oral health care
4847325|NCT02347124|tobacco quitlines|tobacco quitlines
4847326|NCT02347098|plaque|plaque
4847327|NCT02347098|LDL|ldl
4847328|NCT02347098|statin|statin
4847329|NCT02347098|endothelial|endothelial
4847330|NCT02347098|apheresis|apheresis
4847331|NCT02347098|acute coronary artery syndrome|acute coronary artery syndrome
4847332|NCT02347033|Sertraline|sertraline
4847333|NCT02347033|Selective Serotonin Reuptake Inhibitor (SSRI)|selective serotonin reuptake inhibitor (ssri)
4847334|NCT02347033|Cognitive Behavioural Therapy (CBT)|cognitive behavioural therapy (cbt)
4847335|NCT02347033|Increasing Access to Psychological Therapies (IAPT)|increasing access to psychological therapies (iapt)
4847336|NCT02347020|Obesity|obesity
4847337|NCT02347020|Metabolic Disorders|metabolic disorders
4847338|NCT02347007|Obesity|obesity
4847339|NCT02347007|Overweight|overweight
4847340|NCT02347007|Body Weight|body weight
4847341|NCT02347007|Cardiovascular Diseases|cardiovascular diseases
4847342|NCT02347007|Cholesterol|cholesterol
4847343|NCT02347007|Almonds|almonds
4847344|NCT02347007|Visceral Adiposity|visceral adiposity
4847345|NCT02347007|Quality of Life|quality of life
4847346|NCT02347007|Hispanic Americans|hispanic americans
4847347|NCT02347007|African Continental Ancestry Group|african continental ancestry group
4847348|NCT02347007|Metabolic Syndrome X|metabolic syndrome x
4847349|NCT02346994|Body Weight|body weight
4847350|NCT02346994|Obesity in Adolescence|obesity in adolescence
4847351|NCT02346994|Obesity in Childhood|obesity in childhood
4847352|NCT02346994|Childhood Onset Obesity|childhood onset obesity
4847353|NCT02346994|Childhood Obesity|childhood obesity
4847354|NCT02346994|Child Obesity|child obesity
4847355|NCT02346994|Adolescent Obesity|adolescent obesity
4847356|NCT02346994|Teenagers|teenagers
4847357|NCT02346994|Teens|teens
4847358|NCT02346994|Youth|youth
4847359|NCT02346994|Adolescents|adolescents
4847360|NCT02346994|Adolescence|adolescence
4847361|NCT02346968|Kidney Transplantation|kidney transplantation
4847362|NCT02346968|Delayed Graft Function|delayed graft function
4847363|NCT02346968|C-terminal fragment of agrin|c-terminal fragment of agrin
4847364|NCT02346968|Dialysis|dialysis
4847365|NCT02346955|Cancer|cancer
4847366|NCT02346955|Oncology|oncology
4847367|NCT02346955|cCAM Biotherapeutics Ltd|ccam biotherapeutics ltd
4847368|NCT02346955|Immunomodulatory therapy|immunomodulatory therapy
4847369|NCT02346955|CM-24|cm-24
4847370|NCT02346955|Carcinoembryonic Antigen-related Cell Adhesion Molecule 1 (CEACAM1)|carcinoembryonic antigen-related cell adhesion molecule 1 (ceacam1)
4847371|NCT02346955|NSCLC (adenocarcinoma)|nsclc (adenocarcinoma)
4847372|NCT02346955|Uveal|uveal
4847373|NCT02346955|Acral|acral
4847374|NCT02346955|Mucosal|mucosal
4847375|NCT02346955|Cutaneous|cutaneous
4847376|NCT02346955|Colorectal|colorectal
4847377|NCT02346955|Gastric|gastric
4847378|NCT02346955|Ovarian|ovarian
4847379|NCT02346955|Bladder|bladder
4847380|NCT02346955|MK-6018-001|mk-6018-001
4847381|NCT02346929|Hematoma block|hematoma block
4847382|NCT02346929|distal radius fracture reduction|distal radius fracture reduction
4847383|NCT02346929|ultrasound|ultrasound
4847384|NCT02346929|ultrasound guided hematoma block|ultrasound guided hematoma block
4847385|NCT02346929|traditional hematoma block for analgesia|traditional hematoma block for analgesia
4847386|NCT02346929|bupivacaine|bupivacaine
4847387|NCT02346929|pain reduction|pain reduction
4847388|NCT02346929|wrist fracture|wrist fracture
4847389|NCT02346890|Volunteer|volunteer
4847390|NCT02346877|Enbrel|enbrel
4847391|NCT02346877|Rheumatoid Arthritis|rheumatoid arthritis
4847392|NCT02346864|head elevated position|head elevated position
4847393|NCT02346864|preterm|preterm
4847394|NCT02346864|three-stair-position|three-stair-position
4847395|NCT02346838|Prediabetes, prebiotics, metabolic endotoxemia|prediabetes, prebiotics, metabolic endotoxemia
4847396|NCT02346825|P-CIMT|p-cimt
4847397|NCT02346825|Pediatric Constraint Induced Movement Therapy|pediatric constraint induced movement therapy
4847398|NCT02346825|Hemiparesis|hemiparesis
4847399|NCT02346825|Cerebral Palsy|cerebral palsy
4847400|NCT02346825|Infants|infants
4847401|NCT02346825|Toddlers|toddlers
4847402|NCT02346825|Children|children
4847403|NCT02346786|Drinking Water|drinking water
4847404|NCT02346786|Mineral water|mineral water
4847405|NCT02346786|Sports|sports
4847406|NCT02346786|Accident prevention|accident prevention
4847407|NCT02346747|Stage III|stage iii
4847408|NCT02346747|Stage IV|stage iv
4847409|NCT02346747|Ovarian Cancer|ovarian cancer
4847410|NCT02346747|Maintenance|maintenance
4847411|NCT02346747|Immunotherapy|immunotherapy
4847412|NCT02346747|primary peritoneal cancer|primary peritoneal cancer
4847413|NCT02346747|fallopian tube cancer|fallopian tube cancer
4847414|NCT02346747|endometrioid ovarian cancer|endometrioid ovarian cancer
4847415|NCT02346747|high-grade serous ovarian cancer|high-grade serous ovarian cancer
4847416|NCT02346734|Multiple Sclerosis|multiple sclerosis
4847417|NCT02346734|Telerehablitation|telerehablitation
4847418|NCT02346721|Sofosbuvir|sofosbuvir
4847419|NCT02346721|SOF/GS-5816|sof/gs-5816
4847420|NCT02346721|GS-5816|gs-5816
4847421|NCT02346721|Hepatitis C|hepatitis c
4847422|NCT02346721|HCV|hcv
4847423|NCT02346721|Cirrhosis|cirrhosis
4847424|NCT02346721|Velpatasvir|velpatasvir
4847425|NCT02346708|Parkinson's|parkinson's
4847426|NCT02346708|TMS|tms
4847427|NCT02346708|Kluger|kluger
4847428|NCT02346695|LV deformation|lv deformation
4847429|NCT02346695|Endothelial glycocalyx|endothelial glycocalyx
4847430|NCT02346695|Coronary flow reserve|coronary flow reserve
4847431|NCT02346682|major depression disorder|major depression disorder
4847432|NCT02346682|biochemistry|biochemistry
4847433|NCT02346682|TCM diagnosis|tcm diagnosis
4847434|NCT02346682|Neurological|neurological
4847435|NCT02346682|metabonomics|metabonomics
4847436|NCT02346682|neuroimaging|neuroimaging
4847437|NCT02346669|Microbiota|microbiota
4847438|NCT02346669|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
4847439|NCT02346669|Obesity|obesity
4847440|NCT02346617|CMV|cmv
4847441|NCT02346617|T cell therapy|t cell therapy
4847442|NCT02346604|exercise|exercise
4847443|NCT02346591|Positive psychology|positive psychology
4847444|NCT02346591|Wellbeing|wellbeing
4847445|NCT02346591|Stress reduction|stress reduction
4847446|NCT02346591|Relaxation|relaxation
4847447|NCT02346591|Gratitude|gratitude
4847448|NCT02346591|Mobile app|mobile app
4847449|NCT02346591|Intervention|intervention
4847450|NCT02346591|Altruism|altruism
4847451|NCT02346591|Psychological well-being|psychological well-being
4847452|NCT02346591|Social well-being|social well-being
4847453|NCT02346591|Physical well-being|physical well-being
4847454|NCT02346591|Workplace engagement|workplace engagement
4847455|NCT02346552|laparoscopic Cholecystectomy|laparoscopic cholecystectomy
4847456|NCT02346552|laparoscope holder|laparoscope holder
4847457|NCT02346552|Nissen fundoplication|nissen fundoplication
4847458|NCT02346552|paraesophageal hernia|paraesophageal hernia
4847459|NCT02346552|sleeve surgery|sleeve surgery
4847460|NCT02346539|Nicotine|nicotine
4847461|NCT02346539|Depression|depression
4847462|NCT02346526|Prostate Cancer|prostate cancer
4847463|NCT02346526|Castration-resistant prostate cancer|castration-resistant prostate cancer
4847464|NCT02346526|Castration-resistant prostate cancer metastatic to bone|castration-resistant prostate cancer metastatic to bone
4847465|NCT02346513|Hip Replacement Arthroplasty|hip replacement arthroplasty
4847466|NCT02346513|Ceramic on Metal Articulation|ceramic on metal articulation
4847467|NCT02346513|Serum level of Cobalt and Chromium|serum level of cobalt and chromium
4847468|NCT02346500|Benign Prostatic Hyperplasia|benign prostatic hyperplasia
4847469|NCT02346500|Lower urinary tract symptoms|lower urinary tract symptoms
4847470|NCT02346500|Photoselective laser vaporization of the prostate|photoselective laser vaporization of the prostate
4847471|NCT02346500|Transrectal Ultrasound|transrectal ultrasound
4847472|NCT02346487|children|children
4847473|NCT02346474|Subcutaneous Fat|subcutaneous fat
4847474|NCT02346474|Visceral Fat|visceral fat
4847475|NCT02346461|Hereditary Inclusion Body Myopathy (HIBM)|hereditary inclusion body myopathy (hibm)
4847476|NCT02346461|Sialic Acid|sialic acid
4847477|NCT02346461|GNE Myopathy|gne myopathy
4847478|NCT02346461|N-Acetyl-D-mannosamine (ManNAc)|n-acetyl-d-mannosamine (mannac)
4847479|NCT02346461|GNE Gene|gne gene
4847480|NCT02346448|endoscopic sphincterotomy|endoscopic sphincterotomy
4847481|NCT02346448|balloon dilation|balloon dilation
4847482|NCT02346448|adverse events|adverse events
4847483|NCT02346448|pancreatitis|pancreatitis
4847484|NCT02346448|bleeding|bleeding
4847485|NCT02346435|small renal mass|small renal mass
4847486|NCT02346435|active surveillance|active surveillance
4847487|NCT02346422|Heart Failure|heart failure
4847488|NCT02346422|Cardiomyopathies|cardiomyopathies
4847489|NCT02346422|Heart Diseases|heart diseases
4847490|NCT02346422|Cardiovascular Diseases|cardiovascular diseases
4847491|NCT02346422|Cardiomegaly|cardiomegaly
4847492|NCT02346422|Gene Therapy|gene therapy
4847493|NCT02346396|neuropathic pain|neuropathic pain
4847494|NCT02346396|neurostimulation|neurostimulation
4847495|NCT02346396|ambulatory use|ambulatory use
4847496|NCT02346396|tDCS|tdcs
4847497|NCT02346383|back pain|back pain
4847498|NCT02346383|neuromodulation|neuromodulation
4847499|NCT02346383|spinal peripheral neuromodulation|spinal peripheral neuromodulation
4847500|NCT02346383|spinal cord stimulation|spinal cord stimulation
4847501|NCT02346383|postlaminectomy pain syndrome|postlaminectomy pain syndrome
4847502|NCT02346370|Recurrent, previously treated, locally advanced or metastatic NSCLC (non small cell lung cancer)|recurrent, previously treated, locally advanced or metastatic nsclc (non small cell lung cancer)
4847503|NCT02346357|hip arthroscopy|hip arthroscopy
4847504|NCT02346357|analgesia|analgesia
4847505|NCT02346344|type 2 diabetes|type 2 diabetes
4847506|NCT02346344|beta cell function|beta cell function
4847507|NCT02346344|meal tolerance test|meal tolerance test
4847508|NCT02346344|maximum stimulation test|maximum stimulation test
4847509|NCT02346344|method standardization|method standardization
4847510|NCT02346344|insulin secretion|insulin secretion
4847511|NCT02346344|prediabetes|prediabetes
4847512|NCT02346344|insulin sensitivity|insulin sensitivity
4847513|NCT02346318|Radiotherapy|radiotherapy
4847514|NCT02346318|Adverse Effect|adverse effect
4847515|NCT02346318|Dermatitis or Eczema|dermatitis or eczema
4847516|NCT02346292|COPD|copd
4847517|NCT02346292|Spirometry|spirometry
4847518|NCT02346292|severe and very severe COPD|severe and very severe copd
4847519|NCT02346292|COPD exacerbations|copd exacerbations
4847520|NCT02346292|therapy schemes|therapy schemes
4847521|NCT02346292|therapy changes|therapy changes
4847522|NCT02346279|Multiple Sclerosis|multiple sclerosis
4847523|NCT02346279|Rehabilitation|rehabilitation
4847524|NCT02346279|Questionnaire|questionnaire
4847525|NCT02346279|Patient-Reported Outcome|patient-reported outcome
4847526|NCT02346279|Responsiveness|responsiveness
4847527|NCT02346279|Minimal Important Clinical Difference|minimal important clinical difference
4847528|NCT02346266|Stroke|stroke
4847529|NCT02346266|Stroke Prevention|stroke prevention
4847530|NCT02346266|Children|children
4847531|NCT02346266|Education|education
4847532|NCT02346240|Certolizumab Pegol|certolizumab pegol
4847533|NCT02346240|Cimzia|cimzia
4847534|NCT02346240|Psoriasis|psoriasis
4847535|NCT02346227|Human Papillomavirus|human papillomavirus
4847536|NCT02346227|Uterine cervix|uterine cervix
4847537|NCT02346227|Infection|infection
4847538|NCT02346227|Antiviral Drug|antiviral drug
4847539|NCT02346227|Therapeutic use|therapeutic use
4847540|NCT02346214|Gestational Age|gestational age
4847541|NCT02346214|Anterior Lens Capsule Vascularity|anterior lens capsule vascularity
4847542|NCT02346214|Preterm|preterm
4847543|NCT02346214|Method-comparison|method-comparison
4847544|NCT02346188|blood lead, iron, zinc, child, cognition, behavior, Mexico|blood lead, iron, zinc, child, cognition, behavior, mexico
4847545|NCT02346175|SHR3824 Type 2 diabetes mellitus SGLT2|shr3824 type 2 diabetes mellitus sglt2
4847546|NCT02346162|Pre-pregnancy|pre-pregnancy
4847547|NCT02346162|Weight management|weight management
4847548|NCT02346136|Tai Chi|tai chi
4847549|NCT02346136|Cluster randomized controlled trial|cluster randomized controlled trial
4847550|NCT02346136|Intervention|intervention
4847551|NCT02346136|Elderly|elderly
4847552|NCT02346136|Mobility|mobility
4847553|NCT02346136|Health care utilization|health care utilization
4847554|NCT02346123|Chagas disease|chagas disease
4847555|NCT02346123|Polymorphisms|polymorphisms
4847556|NCT02346123|Biomarkers|biomarkers
4847557|NCT02346097|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
4847558|NCT02346097|Heart Failure|heart failure
4847559|NCT02346097|Ejection Fraction|ejection fraction
4847560|NCT02346097|Narrow|narrow
4847561|NCT02346097|Pacemaker|pacemaker
4847562|NCT02346097|Electrophysiology|electrophysiology
4847563|NCT02346097|Electrical activation mapping|electrical activation mapping
4847564|NCT02346097|Coronary Sinus|coronary sinus
4847565|NCT02346097|Mapping|mapping
4847566|NCT02346097|QRS|qrs
4847567|NCT02346097|QRS width|qrs width
4847568|NCT02346097|Pacing Interval|pacing interval
4847569|NCT02346097|Left Ventricular Lead|left ventricular lead
4847570|NCT02346097|Cardiac CT|cardiac ct
4847571|NCT02346097|Echocardiography|echocardiography
4847572|NCT02346097|Myocardial Scintigraphy|myocardial scintigraphy
4847573|NCT02346097|6 Minutes Walk Test|6 minutes walk test
4847574|NCT02346097|Imaging|imaging
4847575|NCT02346097|Left ventricular ejection fraction|left ventricular ejection fraction
4847576|NCT02346097|Epicardial veins|epicardial veins
4847577|NCT02346097|Resynchronization|resynchronization
4847578|NCT02346097|ImagingCRT|imagingcrt
4847579|NCT02346097|Optimal electrical resynchronization|optimal electrical resynchronization
4847580|NCT02346097|Cardiac computed tomography|cardiac computed tomography
4847581|NCT02346071|Bodily distress syndrome|bodily distress syndrome
4847582|NCT02346071|Medically unexplained symptoms|medically unexplained symptoms
4847583|NCT02346071|Functional somatic symptoms|functional somatic symptoms
4847584|NCT02346071|Functional somatic syndromes|functional somatic syndromes
4847585|NCT02346071|Treatment|treatment
4847586|NCT02346071|Acceptance and Commitment Therapy|acceptance and commitment therapy
4847587|NCT02346045|hypertension|hypertension
4847588|NCT02346032|second line|second line
4847589|NCT02346006|Exercise|exercise
4847590|NCT02346006|Visual Acuity|visual acuity
4847591|NCT02346006|Blood Vessels|blood vessels
4847592|NCT02346006|Retina|retina
4847593|NCT02346006|Choroid|choroid
4847594|NCT02345993|formoterol/beclomethasone in asthmatic crisis|formoterol/beclomethasone in asthmatic crisis
4847595|NCT02345993|asthmatic crisis treatment|asthmatic crisis treatment
4847596|NCT02345967|diabetes mellitus requiring insulin|diabetes mellitus requiring insulin
4847597|NCT02345954|Uterus Prolapse|uterus prolapse
4847598|NCT02345954|Laparoscopic Sacropexy|laparoscopic sacropexy
4847599|NCT02345954|Laparoscopic Hysteropexy|laparoscopic hysteropexy
4847600|NCT02345928|Safety|safety
4847601|NCT02345928|Efficacy|efficacy
4847602|NCT02345928|CNTO 7160|cnto 7160
4847603|NCT02345928|Healthy|healthy
4847604|NCT02345928|Asthma|asthma
4847605|NCT02345928|Atopic Dermatitis|atopic dermatitis
4847606|NCT02345876|Dyslexia, Medial olivocochlear system, Maturation, Auditory Processing|dyslexia, medial olivocochlear system, maturation, auditory processing
4847607|NCT02345863|CLL|cll
4847608|NCT02345850|Acute Leukemia|acute leukemia
4847609|NCT02345850|Myelodysplasia|myelodysplasia
4847610|NCT02345850|GVHD Prophylaxis|gvhd prophylaxis
4847611|NCT02345850|Chronic GVHD|chronic gvhd
4847612|NCT02345824|CDK4/6 Inhibitor|cdk4/6 inhibitor
4847613|NCT02345824|LEE011|lee011
4847614|NCT02345824|Recurrent Glioblastoma|recurrent glioblastoma
4847615|NCT02345824|Anaplastic Glioma|anaplastic glioma
4847616|NCT02345824|Ribociclib|ribociclib
4847617|NCT02345759|CKD patients|ckd patients
4847618|NCT02345759|protein-restricted diets|protein-restricted diets
4847619|NCT02345759|compliance|compliance
4847620|NCT02345759|psychological aspects|psychological aspects
4847621|NCT02345707|Cabotegravir|cabotegravir
4847622|NCT02345707|Human Immunodeficiency Virus|human immunodeficiency virus
4847623|NCT02345707|Bioavailability|bioavailability
4847624|NCT02345707|Pharmacokinetics|pharmacokinetics
4847625|NCT02345694|Obstructive Sleep Apnea Syndrome|obstructive sleep apnea syndrome
4847626|NCT02345694|Gait|gait
4847627|NCT02345694|Posture|posture
4847628|NCT02345694|Continuous Positive Airway Pressure|continuous positive airway pressure
4847629|NCT02345681|furosemide|furosemide
4847630|NCT02345681|under strict conditions|under strict conditions
4847631|NCT02345681|normalize|normalize
4847632|NCT02345681|ICU patients|icu patients
4847633|NCT02345681|fluid balance|fluid balance
4847634|NCT02345668|Transdiagnostic Internet-based Protocol|transdiagnostic internet-based protocol
4847635|NCT02345668|Treatment as Usual (TAU)|treatment as usual (tau)
4847636|NCT02345655|Substances consumption|substances consumption
4847637|NCT02345655|Opiate|opiate
4847638|NCT02345655|Family practice|family practice
4847639|NCT02345629|Refractory cancer pain|refractory cancer pain
4847640|NCT02345629|Cordotomy|cordotomy
4847641|NCT02345629|Sharpness pain sensory testing|sharpness pain sensory testing
4847642|NCT02345629|Heat pain sensory testing|heat pain sensory testing
4847643|NCT02345629|Symptom questionnaire|symptom questionnaire
4847644|NCT02345629|Advanced cancers|advanced cancers
4847645|NCT02345629|Pain|pain
4847646|NCT02345616|Cardiac surgery|cardiac surgery
4847647|NCT02345616|Pulmonary hypertension|pulmonary hypertension
4847648|NCT02345616|Nitric oxide|nitric oxide
4847649|NCT02345616|Induction anesthesia|induction anesthesia
4847650|NCT02345577|Kidney transplantation|kidney transplantation
4847651|NCT02345577|Stochastic whole body vibration therapy|stochastic whole body vibration therapy
4847652|NCT02345577|Muscle strength|muscle strength
4847653|NCT02345577|Intramuscular lipid content|intramuscular lipid content
4847654|NCT02345577|Intramyocellular lipid content|intramyocellular lipid content
4847655|NCT02345577|Short Physical Performance Battery Test|short physical performance battery test
4847656|NCT02345577|Prospective, randomised , double blind,placebo-controlled trial|prospective, randomised , double blind,placebo-controlled trial
4847657|NCT02345577|Physical Therapy Modalities|physical therapy modalities
4847658|NCT02345551|Exercise|exercise
4847659|NCT02345551|Sleep|sleep
4847660|NCT02345551|Telemedicine|telemedicine
4847661|NCT02345551|Behavior|behavior
4847662|NCT02345551|Shift work|shift work
4847663|NCT02345512|Falls|falls
4847664|NCT02345499|Radical cystectomy|radical cystectomy
4847665|NCT02345499|Laparoscopy|laparoscopy
4847666|NCT02345486|Pilot Projects|pilot projects
4847667|NCT02345486|Plasmalyte A|plasmalyte a
4847668|NCT02345486|Ringer's lactate|ringer's lactate
4847669|NCT02345486|Sodium Chloride|sodium chloride
4847670|NCT02345486|Critical Care|critical care
4847671|NCT02345486|"Resuscitation"|"resuscitation"
4847672|NCT02345473|Bladder cancer|bladder cancer
4847673|NCT02345473|Circulating cancer cells|circulating cancer cells
4847674|NCT02345421|LAL D|lal d
4847675|NCT02345421|CESD|cesd
4847676|NCT02345421|NASH|nash
4847677|NCT02345421|NAFLD|nafld
4847678|NCT02345421|Wilson's|wilson's
4847679|NCT02345421|Niemann Pick|niemann pick
4847680|NCT02345421|Familial Hypercholesterolemia|familial hypercholesterolemia
4847681|NCT02345395|Brain Aneurysm|brain aneurysm
4847682|NCT02345395|Pterional Craniotomy|pterional craniotomy
4847683|NCT02345395|MiniPterional Craniotomy|minipterional craniotomy
4847684|NCT02345395|Transpalpebral Approach|transpalpebral approach
4847685|NCT02345395|Unruptured Brain Aneurysm|unruptured brain aneurysm
4847686|NCT02345382|Advanced acute leukemia|advanced acute leukemia
4847687|NCT02345356|Pharmacogenomics|pharmacogenomics
4847688|NCT02345356|Warfarin|warfarin
4847689|NCT02345356|Caribbean Hispanics|caribbean hispanics
4847690|NCT02345356|Polymorphisms|polymorphisms
4847691|NCT02345356|Dosing Algorithm|dosing algorithm
4847692|NCT02345278|Immunotherapy|immunotherapy
4847693|NCT02345278|Allergic rhinitis/rhinoconjunctivitis|allergic rhinitis/rhinoconjunctivitis
4847694|NCT02345252|HIV|hiv
4847695|NCT02345226|HIV|hiv
4847696|NCT02345213|DLB|dlb
4847697|NCT02345213|Dementia with Lewy bodies|dementia with lewy bodies
4847698|NCT02345213|Lewy Body Disease|lewy body disease
4847699|NCT02345213|Dementia|dementia
4847700|NCT02345213|E2020|e2020
4847701|NCT02345213|Donepezil|donepezil
4847702|NCT02345213|Aricept|aricept
4847703|NCT02345200|dystrophy|dystrophy
4847704|NCT02345200|body composition|body composition
4847705|NCT02345200|malnutrition|malnutrition
4847706|NCT02345174|zirconium|zirconium
4847707|NCT02345174|oncology|oncology
4847708|NCT02345174|mAb|mab
4847709|NCT02345174|receptor occupancy|receptor occupancy
4847710|NCT02345174|dose|dose
4847711|NCT02345174|PET|pet
4847712|NCT02345174|HER3|her3
4847713|NCT02345174|89-Zr|89-zr
4847714|NCT02345174|biodistribution|biodistribution
4847715|NCT02345174|tumours|tumours
4847716|NCT02345161|Triple Therapy|triple therapy
4847717|NCT02345161|Formoterol|formoterol
4847718|NCT02345161|Respiratory|respiratory
4847719|NCT02345161|COPD|copd
4847720|NCT02345161|Budesonide|budesonide
4847721|NCT02345161|Vilanterol|vilanterol
4847722|NCT02345161|Fluticasone Furoate|fluticasone furoate
4847723|NCT02345161|Umeclidinium|umeclidinium
4847724|NCT02345161|Lung Function|lung function
4847725|NCT02345148|Healthy|healthy
4847726|NCT02345148|Esketamine|esketamine
4847727|NCT02345148|JNJ-54135419|jnj-54135419
4847728|NCT02345122|At-risk Drinking|at-risk drinking
4847729|NCT02345122|Depression|depression
4847730|NCT02345122|Anxiety|anxiety
4847731|NCT02345122|Alcohol Drinking|alcohol drinking
4847732|NCT02345109|weight|weight
4847733|NCT02345109|total body water|total body water
4847734|NCT02345109|body fat|body fat
4847735|NCT02345109|muscle mass|muscle mass
4847736|NCT02345109|bone mass|bone mass
4847737|NCT02345109|BMI|bmi
4847738|NCT02345109|visceral fat|visceral fat
4847739|NCT02345109|calories|calories
4847740|NCT02345083|Frailty|frailty
4847741|NCT02345083|Pre-frailty|pre-frailty
4847742|NCT02345083|Fit|fit
4847743|NCT02345083|Robust|robust
4847744|NCT02345083|Elderly|elderly
4847745|NCT02345083|Sociodemography status|sociodemography status
4847746|NCT02345083|Functional status|functional status
4847747|NCT02345083|Cognitive status|cognitive status
4847748|NCT02345083|Nutrition status|nutrition status
4847749|NCT02345083|Comorbidity|comorbidity
4847750|NCT02345083|Polypharmacy|polypharmacy
4847751|NCT02345083|Mortality|mortality
4847752|NCT02345083|Depression status|depression status
4847753|NCT02345083|Health-related quality of life|health-related quality of life
4847754|NCT02345083|Fall incidence|fall incidence
4847755|NCT02345083|Hospitality|hospitality
4847756|NCT02345057|Diabetic Nephropathy|diabetic nephropathy
4847757|NCT02345057|mineralocorticoid receptor antagonist|mineralocorticoid receptor antagonist
4847758|NCT02345057|CS-3150|cs-3150
4847759|NCT02345057|Japanese|japanese
4847760|NCT02345044|Essential hypertension|essential hypertension
4847761|NCT02345044|mineralocorticoid receptor antagonist|mineralocorticoid receptor antagonist
4847762|NCT02345044|CS-3150|cs-3150
4847763|NCT02345044|Japanese|japanese
4847764|NCT02345031|hearing loss|hearing loss
4847765|NCT02345031|speech-in-noise|speech-in-noise
4847766|NCT02345018|Mechano-chemical ablation|mechano-chemical ablation
4847767|NCT02345018|Treatment large varicose veins|treatment large varicose veins
4847768|NCT02345018|Below-knee and branches|below-knee and branches
4847769|NCT02345018|Endovenous|endovenous
4847770|NCT02345005|Vascular diseases|vascular diseases
4847771|NCT02345005|Aneurysm|aneurysm
4847772|NCT02345005|Treatment Efficacy|treatment efficacy
4847773|NCT02345005|Medical device|medical device
4847774|NCT02345005|Population Register|population register
4847775|NCT02344979|NSCLC|nsclc
4847776|NCT02344979|Chemotherapy|chemotherapy
4847777|NCT02344979|thrombocytopenia|thrombocytopenia
4847778|NCT02344979|rhTPO|rhtpo
4847779|NCT02344940|operable|operable
4847780|NCT02344940|premenopausal|premenopausal
4847781|NCT02344940|endocrine therapy|endocrine therapy
4847782|NCT02344940|safety|safety
4847783|NCT02344940|tamoxifen|tamoxifen
4847784|NCT02344940|toremifene|toremifene
4847785|NCT02344927|Cancer|cancer
4847786|NCT02344927|End-of-life care|end-of-life care
4847787|NCT02344927|Clinically-assisted hydration|clinically-assisted hydration
4847788|NCT02344914|dental support|dental support
4847789|NCT02344914|second stage of labor|second stage of labor
4847790|NCT02344901|non-valvular atrial fibrillation|non-valvular atrial fibrillation
4847791|NCT02344901|stroke prevention|stroke prevention
4847792|NCT02344901|novel oral anticoagulants|novel oral anticoagulants
4847793|NCT02344901|warfarin|warfarin
4847794|NCT02344888|PCOS|pcos
4847795|NCT02344888|Clomiphene citrate resistant|clomiphene citrate resistant
4847796|NCT02344888|Prednisolone|prednisolone
4847797|NCT02344823|cirrhosis|cirrhosis
4847798|NCT02344823|erectile dysfunction|erectile dysfunction
4847799|NCT02344823|portal hypertension|portal hypertension
4847800|NCT02344797|Perioperative|perioperative
4847801|NCT02344797|Postoperative Complications/prevention & control|postoperative complications/prevention & control
4847802|NCT02344784|ADD|add
4847803|NCT02344784|ADHD|adhd
4847804|NCT02344784|PPI|ppi
4847805|NCT02344771|Endothelial dysfunction|endothelial dysfunction
4847806|NCT02344771|General Surgery|general surgery
4847807|NCT02344771|Perioperative Care|perioperative care
4847808|NCT02344745|Lavender|lavender
4847809|NCT02344745|Aromatherapy|aromatherapy
4847810|NCT02344745|Urodynamics|urodynamics
4847811|NCT02344732|epithelium, cornea, diabetes, vitrectomy, oxygen|epithelium, cornea, diabetes, vitrectomy, oxygen
4847812|NCT02344719|cirrhosis|cirrhosis
4847813|NCT02344719|portal hypertension|portal hypertension
4847814|NCT02344719|taurin|taurin
4847815|NCT02344706|Emergency Care, Prehospital|emergency care, prehospital
4847816|NCT02344706|Coma|coma
4847817|NCT02344706|Electroencephalography|electroencephalography
4847818|NCT02344693|Electroencephalography|electroencephalography
4847819|NCT02344654|Fluorescence|fluorescence
4847820|NCT02344654|Cholangiography|cholangiography
4847821|NCT02344654|Indocyanine Green|indocyanine green
4847822|NCT02344654|Cholecystectomy, Laparoscopic|cholecystectomy, laparoscopic
4847823|NCT02344615|nerve stimulator|nerve stimulator
4847824|NCT02344615|ultrasound|ultrasound
4847825|NCT02344602|Diabetic Nephropathy|diabetic nephropathy
4847826|NCT02344602|Diabetes Mellitus|diabetes mellitus
4847827|NCT02344602|Diabetes Complications|diabetes complications
4847828|NCT02344602|Uric Acid|uric acid
4847829|NCT02344602|Febuxostat|febuxostat
4847830|NCT02344602|Uloric|uloric
4847831|NCT02344602|Glomerular Filtration Rate|glomerular filtration rate
4847832|NCT02344602|Kidney Disease|kidney disease
4847833|NCT02344602|Vascular Disease|vascular disease
4847834|NCT02344602|Cardiovascular Diseases|cardiovascular diseases
4847835|NCT02344602|Endothelial Function|endothelial function
4847836|NCT02344602|Arterial Stiffness|arterial stiffness
4847937|NCT02343978|CC|cc
4847837|NCT02344602|Pharmacologic Actions|pharmacologic actions
4847838|NCT02344602|Gout Suppressants|gout suppressants
4847839|NCT02344602|Therapeutic Uses|therapeutic uses
4847840|NCT02344602|Free Radical Scavengers|free radical scavengers
4847841|NCT02344602|Antioxidants|antioxidants
4847842|NCT02344602|Protective Agents|protective agents
4847843|NCT02344602|Physiological Effects of Drugs|physiological effects of drugs
4847844|NCT02344602|Angiotensin II Infusion|angiotensin ii infusion
4847845|NCT02344602|Flow-mediated Dilation|flow-mediated dilation
4847846|NCT02344602|Flow-mediated Constriction|flow-mediated constriction
4847847|NCT02344602|Nitroglycerin|nitroglycerin
4847848|NCT02344602|Hyperglycemia|hyperglycemia
4847849|NCT02344602|Renin-angiotensin-aldosterone System|renin-angiotensin-aldosterone system
4847850|NCT02344602|Nitric Oxide|nitric oxide
4847851|NCT02344602|cGMP|cgmp
4847852|NCT02344602|Oxidative Stress|oxidative stress
4847853|NCT02344602|Renal Haemodynamic Function|renal haemodynamic function
4847854|NCT02344602|Inulin Clearance|inulin clearance
4847855|NCT02344602|PAH Clearance|pah clearance
4847856|NCT02344602|Skin Biopsy|skin biopsy
4847857|NCT02344602|T1R mRNA Expression|t1r mrna expression
4847858|NCT02344602|Cytokines|cytokines
4847859|NCT02344602|Chemokines|chemokines
4847861|NCT02344589|Adductor Canal Block|adductor canal block
4847862|NCT02344589|Peripheral Nerve Block|peripheral nerve block
4847863|NCT02344576|heart failure|heart failure
4847864|NCT02344576|heart-assist devices|heart-assist devices
4847865|NCT02344576|decision making|decision making
4847866|NCT02344576|decision support techniques|decision support techniques
4847867|NCT02344576|hospice care|hospice care
4847868|NCT02344576|palliative care|palliative care
4847869|NCT02344576|caregivers|caregivers
4847870|NCT02344563|volunteers|volunteers
4847871|NCT02344550|metastatic breast cancer|metastatic breast cancer
4847872|NCT02344550|HER2 negative|her2 negative
4847873|NCT02344550|hormone-receptor positive|hormone-receptor positive
4847874|NCT02344537|Lyme DIsease|lyme disease
4847875|NCT02344537|Kundalini Yoga|kundalini yoga
4847876|NCT02344498|Liver cirrhosis|liver cirrhosis
4847877|NCT02344498|Antiviral agents|antiviral agents
4847878|NCT02344498|Liver diseases|liver diseases
4847879|NCT02344472|MBC|mbc
4847880|NCT02344472|HER2|her2
4847881|NCT02344472|CTC|ctc
4847882|NCT02344472|endocrine therapy|endocrine therapy
4847883|NCT02344472|Pertuzumab|pertuzumab
4847884|NCT02344472|Trastuzumab|trastuzumab
4847885|NCT02344472|HER2 therapy|her2 therapy
4847886|NCT02344446|physical therapy intervention|physical therapy intervention
4847887|NCT02344433|Family health history|family health history
4847888|NCT02344433|Genetic literacy|genetic literacy
4847889|NCT02344433|Health literacy|health literacy
4847890|NCT02344433|Relational agent|relational agent
4847891|NCT02344433|Common chronic conditions|common chronic conditions
4847892|NCT02344420|Heart Failure|heart failure
4847893|NCT02344420|CRT|crt
4847894|NCT02344407|Zaire Ebola Virus Disease|zaire ebola virus disease
4847895|NCT02344394|Atrial Fibrillation|atrial fibrillation
4847896|NCT02344394|Anti-Arrhythmia Agents|anti-arrhythmia agents
4847897|NCT02344394|Catheter Ablation|catheter ablation
4847898|NCT02344394|surgical hybrid ablation|surgical hybrid ablation
4847899|NCT02344368|Sucrose|sucrose
4847900|NCT02344368|Anesthesia|anesthesia
4847901|NCT02344368|Blood specimen collection|blood specimen collection
4847902|NCT02344368|Injections, Intravenous|injections, intravenous
4847903|NCT02344355|Ascorbic Acid|ascorbic acid
4847904|NCT02344355|temozolomide|temozolomide
4847905|NCT02344355|radiation|radiation
4847906|NCT02344342|telemonitoring|telemonitoring
4847907|NCT02344290|HIV|hiv
4847908|NCT02344290|Cardiovascular Disease|cardiovascular disease
4847909|NCT02344290|Myocardial Infarction|myocardial infarction
4847910|NCT02344290|Inflammation|inflammation
4847911|NCT02344290|Statin|statin
4847912|NCT02344290|Computerized Tomography|computerized tomography
4847913|NCT02344290|Cholesterol|cholesterol
4847914|NCT02344277|Subcutaneaous Implantable Cardiac Defibrillator|subcutaneaous implantable cardiac defibrillator
4847915|NCT02344277|Brugada syndrome|brugada syndrome
4847916|NCT02344277|Effectiveness|effectiveness
4847917|NCT02344277|Safety|safety
4847918|NCT02344264|US guided nerve block|us guided nerve block
4847919|NCT02344264|Total hip Arthroplasty|total hip arthroplasty
4847920|NCT02344264|NCFL|ncfl
4847921|NCT02344264|nervus cutaneous femoralis lateralis|nervus cutaneous femoralis lateralis
4847922|NCT02344251|Drug study|drug study
4847923|NCT02344251|Medication compliance|medication compliance
4847924|NCT02344238|Medication compliance|medication compliance
4847925|NCT02344238|Technology|technology
4847926|NCT02344238|Drug study|drug study
4847927|NCT02344186|diabetes, endoplasmic reticulum stress, obesity, GLP1 analogs|diabetes, endoplasmic reticulum stress, obesity, glp1 analogs
4847928|NCT02344160|Total Hip Arthroplasty|total hip arthroplasty
4847929|NCT02344160|THA|tha
4847930|NCT02344095|recurrent, persistent|recurrent, persistent
4847931|NCT02344069|Fibrinogen|fibrinogen
4847932|NCT02344056|Having Lunch|having lunch
4847933|NCT02344056|Skipping Lunch|skipping lunch
4847934|NCT02344030|airway|airway
4847935|NCT02344030|videolaryngoscope|videolaryngoscope
4847936|NCT02343978|Chronic Constipation|chronic constipation
4847938|NCT02343965|Touch-massage|touch-massage
4847939|NCT02343965|anxiety|anxiety
4847940|NCT02343965|leukemia|leukemia
4847941|NCT02343965|haematology|haematology
4847942|NCT02343965|cancerology|cancerology
4847943|NCT02343965|supportive care|supportive care
4847944|NCT02343965|complementary therapy|complementary therapy
4847945|NCT02343952|Pembrolizumab|pembrolizumab
4847946|NCT02343952|MK-3475|mk-3475
4847947|NCT02343874|Alcohol consumption|alcohol consumption
4847948|NCT02343874|Primary health care|primary health care
4847949|NCT02343874|health care costs|health care costs
4847950|NCT02343874|health service utilization|health service utilization
4847951|NCT02343861|Behavioral Research|behavioral research
4847952|NCT02343861|Emollients|emollients
4847953|NCT02343822|PRP|prp
4847954|NCT02343822|Platelet Rich Plasma|platelet rich plasma
4847955|NCT02343822|Lateral Epicondylitis|lateral epicondylitis
4847956|NCT02343822|Lateral Epicondylopathy|lateral epicondylopathy
4847957|NCT02343822|Lateral Epicondylosis|lateral epicondylosis
4847958|NCT02343822|Chronic Lateral Epicondylitis|chronic lateral epicondylitis
4847959|NCT02343822|PRPLE|prple
4847960|NCT02343822|Multiple PRP Injections|multiple prp injections
4847961|NCT02343822|Multiple PRP|multiple prp
4847962|NCT02343822|Platelet-Rich Plasma|platelet-rich plasma
4847963|NCT02343822|Tennis Elbow|tennis elbow
4847964|NCT02343822|Double Blinded Randomized Controlled|double blinded randomized controlled
4847965|NCT02343822|Multiple vs Single PRP injections|multiple vs single prp injections
4847966|NCT02343822|prp tennis elbow|prp tennis elbow
4847967|NCT02343809|Physiotherapy|physiotherapy
4847968|NCT02343809|Lateral epicondylitis|lateral epicondylitis
4847969|NCT02343809|Manual therapy|manual therapy
4847970|NCT02343796|Fiberglass reinforced resins|fiberglass reinforced resins
4847971|NCT02343783|Atopic Dermatitis|atopic dermatitis
4847972|NCT02343783|Asthma|asthma
4847973|NCT02343783|Healthy|healthy
4847974|NCT02343783|Skin Blisters|skin blisters
4847975|NCT02343783|Adult Participants|adult participants
4847976|NCT02343744|Generalized Pustular Psoriasis|generalized pustular psoriasis
4847977|NCT02343744|Erythrodermic Psoriasis|erythrodermic psoriasis
4847978|NCT02343744|Guselkumab|guselkumab
4847979|NCT02343744|CNTO1959|cnto1959
4847980|NCT02343731|microbiome|microbiome
4847981|NCT02343731|hygiene hypothesis|hygiene hypothesis
4847982|NCT02343731|human-animal interaction|human-animal interaction
4847983|NCT02343731|microbiota|microbiota
4847984|NCT02343731|connections between human-canine microbiome|connections between human-canine microbiome
4847985|NCT02343653|Malnutrition|malnutrition
4847986|NCT02343653|Muscle mass|muscle mass
4847987|NCT02343653|Nutrition|nutrition
4847988|NCT02343640|Baseball|baseball
4847989|NCT02343640|Ulnar collateral ligament|ulnar collateral ligament
4847990|NCT02343614|Intermediate risk|intermediate risk
4847991|NCT02343614|Cox-2 inhibitors|cox-2 inhibitors
4847992|NCT02343588|Chinese multi-centered school based obesity intervention|chinese multi-centered school based obesity intervention
4847993|NCT02343575|Hyperactive delirium|hyperactive delirium
4847994|NCT02343575|Mixed delirium|mixed delirium
4847995|NCT02343575|Anti-psychotic|anti-psychotic
4847996|NCT02343575|Haldol|haldol
4847997|NCT02343575|Valproic Acid|valproic acid
4847998|NCT02343536|Phase 1|phase 1
4847999|NCT02343536|Oral Azacitidine (CC-486)|oral azacitidine (cc-486)
4848000|NCT02343536|R-CHOP|r-chop
4848001|NCT02343536|Diffuse Large B-cell Lymphoma|diffuse large b-cell lymphoma
4848002|NCT02343536|Grade 3B Follicular Lymphoma|grade 3b follicular lymphoma
4848003|NCT02343536|Follicular Lymphoma|follicular lymphoma
4848004|NCT02343536|Transformed Lymphoma|transformed lymphoma
4848005|NCT02343523|Wearable device|wearable device
4848006|NCT02343523|Wrist-watch|wrist-watch
4848007|NCT02343523|Longitudinal monitoring|longitudinal monitoring
4848008|NCT02343523|Congestive Heart Failure|congestive heart failure
4848009|NCT02343510|Fallopian tubal cancer, high grade serous , ovarian cancer|fallopian tubal cancer, high grade serous , ovarian cancer
4848010|NCT02343484|pulsed radiofrequency|pulsed radiofrequency
4848011|NCT02343484|gelified ethanol|gelified ethanol
4848012|NCT02343471|Whey proteins|whey proteins
4848013|NCT02343471|Postprandial lipemia|postprandial lipemia
4848014|NCT02343471|Pre-meal|pre-meal
4848015|NCT02343471|Type 2 diabetes|type 2 diabetes
4848016|NCT02343458|COPD|copd
4848017|NCT02343432|Anesthesia|anesthesia
4848018|NCT02343432|Adverse Effect|adverse effect
4848019|NCT02343432|Spinal|spinal
4848020|NCT02343432|Epidural|epidural
4848021|NCT02343419|Bronchial Hyperreactivity|bronchial hyperreactivity
4848022|NCT02343419|Bronchial Provocation Tests|bronchial provocation tests
4848023|NCT02343419|Methacholine Chloride|methacholine chloride
4848024|NCT02343419|Respiratory Function Tests|respiratory function tests
4848025|NCT02343419|Spirometry|spirometry
4848026|NCT02343419|Airway Resistance|airway resistance
4848027|NCT02343419|Plethysmography|plethysmography
4848028|NCT02343406|Glioblastoma Multiforme|glioblastoma multiforme
4848029|NCT02343406|Epithelial Growth Factor vIII mutation|epithelial growth factor viii mutation
4848030|NCT02343406|Temozolomide|temozolomide
4848031|NCT02343406|Lomustine|lomustine
4848032|NCT02343406|ABT-414|abt-414
4848033|NCT02343406|European Organization for Research and Treatment of Cancer|european organization for research and treatment of cancer
4848034|NCT02343406|recurrent glioblastoma|recurrent glioblastoma
4848035|NCT02343406|Epithelial Growth Factor|epithelial growth factor
4848036|NCT02343406|Brain Tumor|brain tumor
4848037|NCT02343406|Brain Tumor Group|brain tumor group
4848038|NCT02343406|Antibody Drug Conjugate|antibody drug conjugate
4848039|NCT02343406|EORTC|eortc
4848040|NCT02343406|Pediatric High Grade Gliomas|pediatric high grade gliomas
4848041|NCT02343406|Pediatric diffuse Intrinsic Pontine Glioma|pediatric diffuse intrinsic pontine glioma
4848042|NCT02343406|Pediatric WHO grade III glioma|pediatric who grade iii glioma
4848043|NCT02343406|Pediatric WHO grade IV glioma|pediatric who grade iv glioma
4848044|NCT02343406|EGFR amplification|egfr amplification
4848045|NCT02343406|Children|children
4848046|NCT02343393|Endothelial Dysfunction|endothelial dysfunction
4848047|NCT02343393|Biomarkers|biomarkers
4848048|NCT02343393|Hydralazine-Isosorbide Dinitrate|hydralazine-isosorbide dinitrate
4848049|NCT02343380|diet-induced thermogenesis|diet-induced thermogenesis
4848050|NCT02343380|glucose|glucose
4848051|NCT02343380|respiratory quotient|respiratory quotient
4848052|NCT02343367|Hispanic|hispanic
4848053|NCT02343367|overweight|overweight
4848054|NCT02343367|families|families
4848055|NCT02343367|pediatric|pediatric
4848056|NCT02343367|primary care|primary care
4848057|NCT02343354|behavioural|behavioural
4848058|NCT02343354|diabetes prevention|diabetes prevention
4848059|NCT02343354|physical activity|physical activity
4848060|NCT02343354|healthy eating|healthy eating
4848061|NCT02343354|gestational diabetes|gestational diabetes
4848062|NCT02343341|early childhood education|early childhood education
4848063|NCT02343341|cardiovascular health|cardiovascular health
4848064|NCT02343341|behavior change|behavior change
4848065|NCT02343341|community-based|community-based
4848066|NCT02343341|family-based|family-based
4848067|NCT02343341|prevention|prevention
4848068|NCT02343315|low back pain|low back pain
4848069|NCT02343315|home exercises|home exercises
4848070|NCT02343315|chronic pain|chronic pain
4848071|NCT02343315|supervised exercise|supervised exercise
4848072|NCT02343315|core stability exercises|core stability exercises
4848073|NCT02343315|spinal stabilization exercises|spinal stabilization exercises
4848074|NCT02343302|Pancreatic Fistula|pancreatic fistula
4848075|NCT02343289|Healthy|healthy
4848076|NCT02343289|Pharmacokinetics|pharmacokinetics
4848077|NCT02343289|Esketamine|esketamine
4848078|NCT02343289|JNJ-54135419|jnj-54135419
4848079|NCT02343276|Radial Spasm|radial spasm
4848080|NCT02343263|Tonsillectomy|tonsillectomy
4848081|NCT02343263|Adenotonsillectomy|adenotonsillectomy
4848082|NCT02343263|Pain|pain
4848083|NCT02343263|Hemorrhage|hemorrhage
4848084|NCT02343237|Fibromyalgia syndrome|fibromyalgia syndrome
4848085|NCT02343237|pain|pain
4848086|NCT02343237|quality of life|quality of life
4848087|NCT02343237|osteopathic treatment|osteopathic treatment
4848088|NCT02343211|Paraneoplastic Neurological Syndromes|paraneoplastic neurological syndromes
4848089|NCT02343211|Onconeural antibodies|onconeural antibodies
4848090|NCT02343211|Cancer|cancer
4848091|NCT02343185|diaphragm|diaphragm
4848092|NCT02343185|osteopathic treatment|osteopathic treatment
4848093|NCT02343185|myofascial release|myofascial release
4848094|NCT02343172|Liposarcoma,|liposarcoma,
4848095|NCT02343172|MDM2 inhibition,|mdm2 inhibition,
4848096|NCT02343172|cdk4 inhibition,|cdk4 inhibition,
4848097|NCT02343172|HDM201,|hdm201,
4848098|NCT02343172|LEE011|lee011
4848099|NCT02343133|Radiation countermeasure|radiation countermeasure
4848100|NCT02343133|radiomitigation|radiomitigation
4848101|NCT02343107|Obesity|obesity
4848102|NCT02343107|Type 2 diabetes|type 2 diabetes
4848103|NCT02343107|Metabolic syndrome|metabolic syndrome
4848104|NCT02343107|e-coaching|e-coaching
4848105|NCT02343107|Telehealth|telehealth
4848106|NCT02343094|Proteinuria|proteinuria
4848107|NCT02343094|Lipocalin 2|lipocalin 2
4848108|NCT02343094|Neutrophil gelatinase associated lipocalin|neutrophil gelatinase associated lipocalin
4848109|NCT02343094|ELISA|elisa
4848110|NCT02343081|brain neoplasm|brain neoplasm
4848111|NCT02343081|bioequivalence|bioequivalence
4848112|NCT02343081|temozolomide|temozolomide
4848113|NCT02343042|Selinexor|selinexor
4848114|NCT02343042|KCP-330|kcp-330
4848115|NCT02343042|STOMP|stomp
4848116|NCT02343042|Multiple Myeloma|multiple myeloma
4848117|NCT02343042|Relapsed/Refractory|relapsed/refractory
4848118|NCT02343042|Dexamethasone|dexamethasone
4848119|NCT02343042|Pomalidomide|pomalidomide
4848120|NCT02343042|Bortezomib|bortezomib
4848121|NCT02343042|Karyopharm|karyopharm
4848122|NCT02343042|Lenalidomide|lenalidomide
4848123|NCT02343042|Daratumumab|daratumumab
4848124|NCT02343042|Newly Diagnosed|newly diagnosed
4848125|NCT02343042|Carfilzomib|carfilzomib
4848126|NCT02343029|Aerobic Exercise Training|aerobic exercise training
4848127|NCT02343029|prevention|prevention
4848128|NCT02343029|magnetic resonance spectroscopic imaging|magnetic resonance spectroscopic imaging
4848129|NCT02343029|psychometric tests|psychometric tests
4848130|NCT02343029|cognition|cognition
4848131|NCT02343029|dementia|dementia
4848132|NCT02343029|cognitive impairment|cognitive impairment
4848133|NCT02343003|cooled radiofrequency ablation|cooled radiofrequency ablation
4848134|NCT02343003|knee pain|knee pain
4848135|NCT02343003|osteoarthritis|osteoarthritis
4848136|NCT02343003|pain management|pain management
4848137|NCT02342990|working memory training|working memory training
4848138|NCT02342990|home-based training|home-based training
4848139|NCT02342990|periventricular leukomalacia|periventricular leukomalacia
4848140|NCT02342990|bilateral cerebral palsy|bilateral cerebral palsy
4848141|NCT02342990|neuropsychological profile|neuropsychological profile
4848142|NCT02342990|high density EEG|high density eeg
4848143|NCT02342990|slow waves activities|slow waves activities
4848144|NCT02342977|total hip arthroplasty|total hip arthroplasty
4848145|NCT02342964|Cystic fibrosis|cystic fibrosis
4848146|NCT02342964|hepatic fibrosis|hepatic fibrosis
4848147|NCT02342964|hepatic cirrhosis|hepatic cirrhosis
4848148|NCT02342964|non-invasive methods of measurement|non-invasive methods of measurement
4848149|NCT02342964|hepatic elasticity|hepatic elasticity
4848150|NCT02342951|Cystic fibrosis,|cystic fibrosis,
4848151|NCT02342951|lung clearance index,|lung clearance index,
4848152|NCT02342951|pulmonary function|pulmonary function
4848153|NCT02342938|Epilepsy surgery|epilepsy surgery
4848154|NCT02342938|High frequency activity|high frequency activity
4848155|NCT02342938|icEEG|iceeg
4848156|NCT02342938|fMRI|fmri
4848157|NCT02342938|MEG|meg
4848158|NCT02342886|Tuberculosis|tuberculosis
4848159|NCT02342886|Multi Drug-Resistant Tuberculosis|multi drug-resistant tuberculosis
4848160|NCT02342886|Drug-sensitive Tuberculosis|drug-sensitive tuberculosis
4848161|NCT02342886|PA-824|pa-824
4848162|NCT02342886|Moxifloxacin|moxifloxacin
4848163|NCT02342886|Pyrazinamide|pyrazinamide
4848164|NCT02342886|Rifampicin|rifampicin
4848165|NCT02342886|Isoniazid|isoniazid
4848166|NCT02342886|Ethambutol|ethambutol
4848167|NCT02342886|HRZE|hrze
4848168|NCT02342886|HR|hr
4848169|NCT02342886|Pretomanid|pretomanid
4848170|NCT02342886|NC-006|nc-006
4848171|NCT02342886|STAND|stand
4848172|NCT02342873|ultrasound|ultrasound
4848173|NCT02342873|nerve stimulator|nerve stimulator
4848174|NCT02342860|Water|water
4848175|NCT02342860|sanitation|sanitation
4848176|NCT02342860|hygiene access in school|hygiene access in school
4848177|NCT02342756|ARDS, HFOV|ards, hfov
4848178|NCT02342691|Safety and efficacy of BLXA4|safety and efficacy of blxa4
4848179|NCT02342665|Non Hodgkin's Lymphomas|non hodgkin's lymphomas
4848180|NCT02342626|Prostate|prostate
4848181|NCT02342626|Cancer|cancer
4848182|NCT02342626|Adenocarcinoma|adenocarcinoma
4848183|NCT02342587|Lapatinib|lapatinib
4848184|NCT02342561|Infection|infection
4848185|NCT02342561|Drape|drape
4848186|NCT02342561|Ioban|ioban
4848187|NCT02342561|Arthroplasty|arthroplasty
4848188|NCT02342561|Knee|knee
4848189|NCT02342561|Cylinder Sampling|cylinder sampling
4848190|NCT02342561|Bacteria|bacteria
4848191|NCT02342548|Huntington; chorea; total motor score; CAG repeat: total functional capacity; motor cognitive and behavioral symptoms|huntington; chorea; total motor score; cag repeat: total functional capacity; motor cognitive and behavioral symptoms
4848192|NCT02342522|Cardioprotection|cardioprotection
4848193|NCT02342522|STEMI|stemi
4848194|NCT02342522|PPCI|ppci
4848195|NCT02342522|Myocardial reperfusion injury|myocardial reperfusion injury
4848196|NCT02342522|Myocardial infarct size|myocardial infarct size
4848197|NCT02342522|ST-elevation myocardial infarction|st-elevation myocardial infarction
4848198|NCT02342522|Remote Ischaemic Conditioning|remote ischaemic conditioning
4848199|NCT02342522|Cardiovascular mortality|cardiovascular mortality
4848200|NCT02342509|et Control|et control
4848201|NCT02342509|inhalational sedation|inhalational sedation
4848202|NCT02342509|conserve volatile anesthetics|conserve volatile anesthetics
4848203|NCT02342470|prevention|prevention
4848204|NCT02342470|Recurrent peptic ulcer|recurrent peptic ulcer
4848205|NCT02342444|Trauma|trauma
4848206|NCT02342444|Surgery|surgery
4848207|NCT02342444|Enoxaparin|enoxaparin
4848208|NCT02342444|DVTs|dvts
4848209|NCT02342444|Thromboembolic events|thromboembolic events
4848210|NCT02342431|Thermoregulation|thermoregulation
4848211|NCT02342431|Pediatric Anesthesia|pediatric anesthesia
4848212|NCT02342431|Cardiac Catheterization|cardiac catheterization
4848213|NCT02342405|Oxidative stress|oxidative stress
4848214|NCT02342405|Nitrogen oxide|nitrogen oxide
4848215|NCT02342405|Reactive oxygen species|reactive oxygen species
4848216|NCT02342392|pterygium|pterygium
4848217|NCT02342392|ranibizumab|ranibizumab
4848218|NCT02342392|anti-VEGF|anti-vegf
4848219|NCT02342392|recurrence|recurrence
4848220|NCT02342392|vascularity|vascularity
4848221|NCT02342392|size|size
4848222|NCT02342366|Sodium Oxybate, Altruism, Neurostreroids, Liquid Ecstasy|sodium oxybate, altruism, neurostreroids, liquid ecstasy
4848223|NCT02342340|Beans, Lentils, Bioavailability, Phytochemical Absorption|beans, lentils, bioavailability, phytochemical absorption
4848224|NCT02342288|Intraoperative ocular pressure|intraoperative ocular pressure
4848225|NCT02342275|Infantile hemangioma|infantile hemangioma
4848226|NCT02342275|Propranolol|propranolol
4848227|NCT02342275|Atenolol|atenolol
4848228|NCT02342275|Efficacy|efficacy
4848229|NCT02342275|Safety|safety
4848230|NCT02342249|Influenza A|influenza a
4848231|NCT02342236|Biological Markers|biological markers
4848232|NCT02342223|human immunodeficiency virus|human immunodeficiency virus
4848233|NCT02342223|facial lipoatrophy|facial lipoatrophy
4848234|NCT02342223|facial lipodystrophy|facial lipodystrophy
4848235|NCT02342223|hyaluronic acid|hyaluronic acid
4848236|NCT02342223|dermal filler|dermal filler
4848237|NCT02342223|filler agent|filler agent
4848238|NCT02342210|Mindfulness|mindfulness
4848239|NCT02342210|Group Therapy|group therapy
4848240|NCT02342197|Low responders|low responders
4848241|NCT02342197|Minidose long protocol|minidose long protocol
4848242|NCT02342197|Microdose flare protocol|microdose flare protocol
4848243|NCT02342197|Oocyte yield|oocyte yield
4848244|NCT02342171|Ebola Viral Disease|ebola viral disease
4848245|NCT02342171|Convalescent Plasma|convalescent plasma
4848246|NCT02342171|Developing Countries|developing countries
4848247|NCT02342145|beta-Thalassemia major|beta-thalassemia major
4848248|NCT02342119|kidney transplantation|kidney transplantation
4848249|NCT02342119|race disparities|race disparities
4848250|NCT02342119|living donor kidney transplantation|living donor kidney transplantation
4848251|NCT02342119|transplant evaluation|transplant evaluation
4848252|NCT02342093|Ambulatory Blood Pressure Monitoring|ambulatory blood pressure monitoring
4848253|NCT02342093|Drospirenone|drospirenone
4848254|NCT02342093|Oral contraceptive|oral contraceptive
4848255|NCT02342080|Rehabilitation|rehabilitation
4848256|NCT02342080|Walking|walking
4848257|NCT02342080|Robotics|robotics
4848258|NCT02342080|Neuronal Plasticity|neuronal plasticity
4848259|NCT02342054|Cancer|cancer
4848260|NCT02342054|Prostate Cancer|prostate cancer
4848261|NCT02342054|Brachytherapy|brachytherapy
4848262|NCT02342054|Dose escalation|dose escalation
4848263|NCT02342054|High Dose Rate|high dose rate
4848264|NCT02342054|MRI-TRUS fusion|mri-trus fusion
4848265|NCT02342054|Detection of DILs by MRI|detection of dils by mri
4848266|NCT02342054|SINGLE FRACTION|single fraction
4848267|NCT02342041|SUVN-G3031|suvn-g3031
4848268|NCT02342041|histamine 3 (H3) receptor inverse agonist|histamine 3 (h3) receptor inverse agonist
4848269|NCT02342041|first in human|first in human
4848270|NCT02342041|safety|safety
4848271|NCT02342041|pharmacokinetics|pharmacokinetics
4848272|NCT02342041|tolerability|tolerability
4848273|NCT02342041|single dose|single dose
4848274|NCT02342041|repeat dose|repeat dose
4848275|NCT02342028|sleep apnea|sleep apnea
4848276|NCT02342028|intermittent hypoxia|intermittent hypoxia
4848277|NCT02342028|regulatory T cell|regulatory t cell
4848278|NCT02342028|autoimmunity|autoimmunity
4848279|NCT02342002|mifepristone|mifepristone
4848280|NCT02342002|misoprostol|misoprostol
4848281|NCT02342002|obstetrics|obstetrics
4848282|NCT02342002|reproductive health|reproductive health
4848283|NCT02342002|pregnancy|pregnancy
4848284|NCT02342002|abortion|abortion
4848285|NCT02342002|missed abortion|missed abortion
4848286|NCT02341989|Chemotherapy, adjuvant|chemotherapy, adjuvant
4848287|NCT02341989|Recurrence|recurrence
4848288|NCT02341989|Carboplatin|carboplatin
4848289|NCT02341989|Bleomycin|bleomycin
4848290|NCT02341989|Etoposide|etoposide
4848291|NCT02341989|Cisplatin|cisplatin
4848292|NCT02341976|whole body vibration|whole body vibration
4848293|NCT02341976|pelvic floor muscle|pelvic floor muscle
4848294|NCT02341976|urinary incontinence|urinary incontinence
4848295|NCT02341976|Urinary sphincter|urinary sphincter
4848296|NCT02341950|videogame|videogame
4848297|NCT02341950|health|health
4848298|NCT02341950|behavior|behavior
4848299|NCT02341950|mobile|mobile
4848300|NCT02341950|spinal|spinal
4848301|NCT02341950|cord|cord
4848302|NCT02341950|dysfunction|dysfunction
4848303|NCT02341911|triple negative breast cancer|triple negative breast cancer
4848304|NCT02341911|fine line chemotherapy|fine line chemotherapy
4848305|NCT02341898|nursing home care|nursing home care
4848306|NCT02341898|physical restraints|physical restraints
4848307|NCT02341898|dementia|dementia
4848308|NCT02341898|implementation research|implementation research
4848309|NCT02341898|cluster-randomized controlled trial|cluster-randomized controlled trial
4848310|NCT02341885|Kidney|kidney
4848311|NCT02341885|Renal replacement|renal replacement
4848312|NCT02341885|Acute kidney injury|acute kidney injury
4848313|NCT02341885|chronic kidney disease|chronic kidney disease
4848314|NCT02341885|Epidemiology|epidemiology
4848315|NCT02341885|Prevalence|prevalence
4848316|NCT02341872|White spot lesions|white spot lesions
4848317|NCT02341872|remineralization|remineralization
4848318|NCT02341872|QLF|qlf
4848319|NCT02341872|antibacterial|antibacterial
4848320|NCT02341846|cancer pain|cancer pain
4848321|NCT02341833|Anesthetic preconditioning|anesthetic preconditioning
4848322|NCT02341833|Sevoflurane|sevoflurane
4848323|NCT02341833|Liver transplantation|liver transplantation
4848324|NCT02341833|brain-death donors|brain-death donors
4848325|NCT02341820|breast cancer|breast cancer
4848326|NCT02341820|breast conserving surgery|breast conserving surgery
4848327|NCT02341820|cosmesis|cosmesis
4848328|NCT02341807|Choroideremia|choroideremia
4848329|NCT02341807|AAV|aav
4848330|NCT02341807|Gene therapy|gene therapy
4848331|NCT02341807|CHM|chm
4848332|NCT02341807|Adeno-associated virus|adeno-associated virus
4848333|NCT02341807|Adeno-associated viral vector|adeno-associated viral vector
4848334|NCT02341794|intracranial arterial disease|intracranial arterial disease
4848335|NCT02341794|dyslipidemia|dyslipidemia
4848336|NCT02341794|rosuvastatin|rosuvastatin
4848337|NCT02341781|MANTLE CELL LYMPHOMA|mantle cell lymphoma
4848338|NCT02341781|Multicenter|multicenter
4848339|NCT02341781|Observational|observational
4848340|NCT02341781|Lenalidomide (Revlimid®)|lenalidomide (revlimid®)
4848341|NCT02341781|Relapsed or progressed|relapsed or progressed
4848342|NCT02341781|Ibrutinib|ibrutinib
4848343|NCT02341768|clinical and device functional information|clinical and device functional information
4848344|NCT02341768|"real world ICD patient population"|"real world icd patient population"
4848345|NCT02341742|Physical activity|physical activity
4848346|NCT02341742|Bone health|bone health
4848347|NCT02341742|Pediatrics|pediatrics
4848348|NCT02341742|Bone|bone
4848349|NCT02341729|semi-urgent CABG|semi-urgent cabg
4848350|NCT02341729|reanimation|reanimation
4848351|NCT02341729|ticagrelor|ticagrelor
4848352|NCT02341729|crushed tablet|crushed tablet
4848353|NCT02341716|intermittent claudication|intermittent claudication
4848354|NCT02341716|exercise therapy|exercise therapy
4848355|NCT02341716|physiotherapy|physiotherapy
4848356|NCT02341690|Type 2 diabetes|type 2 diabetes
4848357|NCT02341690|Interval Walking Training|interval walking training
4848358|NCT02341690|Motivation|motivation
4848359|NCT02341677|Prostatic Neoplasms|prostatic neoplasms
4848360|NCT02341677|Diagnostic Techniques and Procedures|diagnostic techniques and procedures
4848361|NCT02341677|Magnetic Resonance Imaging|magnetic resonance imaging
4848362|NCT02341677|Ultrasonography|ultrasonography
4848363|NCT02341677|Biopsy|biopsy
4848364|NCT02341677|Image Fusion|image fusion
4848365|NCT02341664|Mobile Tablet Device|mobile tablet device
4848366|NCT02341664|Outpatient Clinic|outpatient clinic
4848367|NCT02341664|Tobacco|tobacco
4848368|NCT02341664|Health|health
4848369|NCT02341664|Barriers|barriers
4848370|NCT02341664|Prevention|prevention
4848371|NCT02341664|Prescribing Practices|prescribing practices
4848372|NCT02341664|Informed Consent|informed consent
4848373|NCT02341664|Statin|statin
4848374|NCT02341664|Lipid Panel|lipid panel
4848375|NCT02341664|Low Density Lipoprotein-C|low density lipoprotein-c
4848376|NCT02341664|Blood Draw|blood draw
4848377|NCT02341664|ACC/AHA Guidelines|acc/aha guidelines
4848378|NCT02341664|Adult Treatment Panel Guidelines (ATPIII)|adult treatment panel guidelines (atpiii)
4848379|NCT02341664|Atherosclerotic Cardiovascular Disease (ASCVD)|atherosclerotic cardiovascular disease (ascvd)
4848380|NCT02341664|Cholesterol-lowering therapies|cholesterol-lowering therapies
4848381|NCT02341664|Cholesterol Management|cholesterol management
4848382|NCT02341664|Cardiovascular Risk|cardiovascular risk
4848383|NCT02341664|10-year CVD Risk|10-year cvd risk
4848384|NCT02341664|Labs|labs
4848385|NCT02341664|Coronary revascularization|coronary revascularization
4848386|NCT02341664|Arterial revascularization|arterial revascularization
4848387|NCT02341664|Imaging|imaging
4848388|NCT02341651|High blood pressure|high blood pressure
4848389|NCT02341651|Cardiovascular diseases|cardiovascular diseases
4848390|NCT02341651|Antihypertensive agents|antihypertensive agents
4848391|NCT02341651|Pharmacological treatment|pharmacological treatment
4848392|NCT02341651|Non-pharmacological treatment|non-pharmacological treatment
4848393|NCT02341651|Community health care workers|community health care workers
4848394|NCT02341651|Treatment algorithm|treatment algorithm
4848395|NCT02341651|Public and private healthcare providers|public and private healthcare providers
4848396|NCT02341651|Strategy|strategy
4848397|NCT02341651|Referral loops|referral loops
4848398|NCT02341651|Intervention|intervention
4848399|NCT02341612|exercise-induced muscle damage|exercise-induced muscle damage
4848400|NCT02341612|skeletal muscle injury recovery|skeletal muscle injury recovery
4848401|NCT02341612|cryotherapy|cryotherapy
4848402|NCT02341612|recovery of function|recovery of function
4848403|NCT02341612|rehabilitation|rehabilitation
4848404|NCT02341586|Malaria|malaria
4848405|NCT02341586|Cambodia|cambodia
4848406|NCT02341586|Iron|iron
4848407|NCT02341586|Childbearing Age|childbearing age
4848408|NCT02341586|Women|women
4848409|NCT02341586|Home Fortification|home fortification
4848410|NCT02341573|Traditional Chinese Medicine|traditional chinese medicine
4848411|NCT02341573|Randomized Controlled Trial|randomized controlled trial
4848412|NCT02341560|NAION|naion
4848413|NCT02341495|Azacitidine|azacitidine
4848414|NCT02341495|Vidaza|vidaza
4848415|NCT02341495|Deferasirox|deferasirox
4848416|NCT02341495|Exjade|exjade
4848417|NCT02341495|Cholecalciferol|cholecalciferol
4848418|NCT02341495|Vitamin D|vitamin d
4848419|NCT02341482|Itraconazole|itraconazole
4848420|NCT02341482|Healthy Volunteers|healthy volunteers
4848421|NCT02341482|Drug-drug interaction|drug-drug interaction
4848422|NCT02341482|PF-04958242|pf-04958242
4848423|NCT02341469|Burkina Faso|burkina faso
4848424|NCT02341469|cluster randomised|cluster randomised
4848425|NCT02341469|stepped-wedge|stepped-wedge
4848426|NCT02341469|IMCI|imci
4848427|NCT02341443|bilateral double mandibular fractures|bilateral double mandibular fractures
4848428|NCT02341443|rigid fixation|rigid fixation
4848429|NCT02341443|no-rigid fixation|no-rigid fixation
4848430|NCT02341443|jaw|jaw
4848431|NCT02341430|hernia|hernia
4848432|NCT02341430|synthetic mesh|synthetic mesh
4848535|NCT02340793|Weight loss|weight loss
4848433|NCT02341417|Chronic Kidney Disease, Dialysis, Secondary Hyperparathyroidism, Pediatric|chronic kidney disease, dialysis, secondary hyperparathyroidism, pediatric
4848434|NCT02341391|chondrocyte cells|chondrocyte cells
4848435|NCT02341391|Osteoarthritis|osteoarthritis
4848436|NCT02341391|gene therapy|gene therapy
4848437|NCT02341378|chondrocyte cells|chondrocyte cells
4848438|NCT02341378|Osteoarthritis|osteoarthritis
4848439|NCT02341378|gene therapy|gene therapy
4848440|NCT02341365|Egg donation|egg donation
4848441|NCT02341365|vitaminD|vitamind
4848442|NCT02341365|ovarian reserve|ovarian reserve
4848443|NCT02341365|ovarian stimulation|ovarian stimulation
4848444|NCT02341326|Lung|lung
4848445|NCT02341326|COPD|copd
4848446|NCT02341326|smoking|smoking
4848447|NCT02341326|Non-smoker|non-smoker
4848448|NCT02341313|Hypoglycaemia|hypoglycaemia
4848449|NCT02341300|Pregnancy|pregnancy
4848450|NCT02341300|Cast-Iron pots|cast-iron pots
4848451|NCT02341300|Iron-deficiency anemia|iron-deficiency anemia
4848452|NCT02341274|Tacrolimus|tacrolimus
4848453|NCT02341274|Drug Formulation|drug formulation
4848454|NCT02341274|Absorption|absorption
4848455|NCT02341274|Bioavailability|bioavailability
4848456|NCT02341274|Healthy Volunteer|healthy volunteer
4848457|NCT02341248|Enteral Nutrition|enteral nutrition
4848458|NCT02341248|Pediatrics|pediatrics
4848459|NCT02341248|Microbiota|microbiota
4848460|NCT02341248|Metabolomics|metabolomics
4848461|NCT02341235|video game|video game
4848462|NCT02341235|narrative|narrative
4848463|NCT02341235|story|story
4848464|NCT02341235|survivorship|survivorship
4848465|NCT02341235|cancer survivor|cancer survivor
4848466|NCT02341235|mhealth|mhealth
4848467|NCT02341235|physical activity|physical activity
4848468|NCT02341235|women|women
4848469|NCT02341235|women's health|women's health
4848470|NCT02341222|hernia prosthetic surgery|hernia prosthetic surgery
4848471|NCT02341222|incisional hernia prosthesis|incisional hernia prosthesis
4848472|NCT02341222|prosthesis mesh fixation|prosthesis mesh fixation
4848473|NCT02341222|prosthesis mesh biocompatibility|prosthesis mesh biocompatibility
4848474|NCT02341209|CTCL|ctcl
4848475|NCT02341209|Sezary Syndrome (SS)|sezary syndrome (ss)
4848476|NCT02341209|Mycosis Fungoides (MF)|mycosis fungoides (mf)
4848477|NCT02341209|Cutaneous T-cell Lymphoma|cutaneous t-cell lymphoma
4848478|NCT02341209|MF|mf
4848479|NCT02341209|SS|ss
4848480|NCT02341131|Schizophrenia|schizophrenia
4848481|NCT02341131|Cognitive Remediation|cognitive remediation
4848482|NCT02341131|BDNF|bdnf
4848483|NCT02341118|BRCA1/2 Mutational Status|brca1/2 mutational status
4848484|NCT02341092|Traumatic brain injury|traumatic brain injury
4848485|NCT02341079|Total Knee Arthroplasty|total knee arthroplasty
4848486|NCT02341079|Osteoarthritis|osteoarthritis
4848487|NCT02341079|Femoral Nerve Blockade|femoral nerve blockade
4848488|NCT02341079|Liposomal Bupivacaine|liposomal bupivacaine
4848489|NCT02341066|Cardiovascular risk score|cardiovascular risk score
4848490|NCT02341066|Framingham risk score 2-year|framingham risk score 2-year
4848491|NCT02341066|Endothelial dysfunction|endothelial dysfunction
4848492|NCT02341066|EndoPAT|endopat
4848493|NCT02341066|Rheumatoid arthritis|rheumatoid arthritis
4848494|NCT02341053|SMA|sma
4848495|NCT02341053|Neuromuscular disability|neuromuscular disability
4848496|NCT02341040|wheat allergy|wheat allergy
4848497|NCT02341040|food allergy|food allergy
4848498|NCT02341040|pediatric|pediatric
4848499|NCT02341027|Immediate postpartum contraception|immediate postpartum contraception
4848500|NCT02341027|Contraceptive implants|contraceptive implants
4848501|NCT02341027|Breastfeeding|breastfeeding
4848502|NCT02341027|Jadelle|jadelle
4848503|NCT02341027|Lactation|lactation
4848504|NCT02341027|Levonorgestrel|levonorgestrel
4848505|NCT02341014|Carfilzomib|carfilzomib
4848506|NCT02341014|Romidepsin|romidepsin
4848507|NCT02341014|Lenalidomide|lenalidomide
4848508|NCT02341014|Lymphomas|lymphomas
4848509|NCT02341014|14-179|14-179
4848510|NCT02341001|Bariatric surgery|bariatric surgery
4848511|NCT02341001|Sleeve gastrectomy|sleeve gastrectomy
4848512|NCT02341001|Text messaging|text messaging
4848513|NCT02341001|Weight loss|weight loss
4848514|NCT02341001|BAROS|baros
4848515|NCT02341001|Follow-up care|follow-up care
4848516|NCT02340975|Gastric Adenocarcinoma|gastric adenocarcinoma
4848517|NCT02340975|Gastroesophageal Junction Adenocarcinoma|gastroesophageal junction adenocarcinoma
4848518|NCT02340975|Immunotherapy|immunotherapy
4848519|NCT02340975|Antibodies, Monoclonal|antibodies, monoclonal
4848520|NCT02340975|Tremelimumab|tremelimumab
4848521|NCT02340975|MEDI4736|medi4736
4848522|NCT02340923|DMD|dmd
4848523|NCT02340923|Duchenne Muscular Dystrophy|duchenne muscular dystrophy
4848524|NCT02340923|EIM|eim
4848525|NCT02340910|spasticity|spasticity
4848526|NCT02340910|whole body vibration|whole body vibration
4848527|NCT02340910|walking|walking
4848528|NCT02340871|Neurogenetics|neurogenetics
4848529|NCT02340871|genetic testing|genetic testing
4848530|NCT02340845|breast,colon, ovary, uterus, cervix, lung|breast,colon, ovary, uterus, cervix, lung
4848531|NCT02340845|Treatments|treatments
4848532|NCT02340806|epidural bolus|epidural bolus
4848533|NCT02340806|pain management|pain management
4848534|NCT02340806|labor analgesia|labor analgesia
4848536|NCT02340767|Suspicious Occlusal Caries|suspicious occlusal caries
4848537|NCT02340754|mindfulness|mindfulness
4848538|NCT02340754|meditation|meditation
4848539|NCT02340754|stress, psychological|stress, psychological
4848540|NCT02340754|quality of life|quality of life
4848541|NCT02340754|randomized controlled trial|randomized controlled trial
4848542|NCT02340741|carbon dioxide|carbon dioxide
4848543|NCT02340741|postoperative cerebrovascular complications|postoperative cerebrovascular complications
4848544|NCT02340741|air embolism|air embolism
4848545|NCT02340728|Stent Placement|stent placement
4848546|NCT02340728|Biliary Obstruction|biliary obstruction
4848547|NCT02340728|14-260|14-260
4848548|NCT02340715|Anal canal|anal canal
4848549|NCT02340715|Brain|brain
4848550|NCT02340715|Breast|breast
4848551|NCT02340715|Cervix|cervix
4848552|NCT02340715|Esophagus|esophagus
4848553|NCT02340715|Gynecology|gynecology
4848554|NCT02340715|Head and Neck|head and neck
4848555|NCT02340715|Lung|lung
4848556|NCT02340715|Pancreas|pancreas
4848557|NCT02340715|Primary liver or liver metastases|primary liver or liver metastases
4848558|NCT02340715|Prostate cancer|prostate cancer
4848559|NCT02340715|Sarcoma|sarcoma
4848560|NCT02340702|COPD and heart failure|copd and heart failure
4848561|NCT02340689|PH|ph
4848562|NCT02340689|PH type 1|ph type 1
4848563|NCT02340689|Primary Hyperoxaluria|primary hyperoxaluria
4848564|NCT02340689|Hyperoxaluria|hyperoxaluria
4848565|NCT02340689|Primary Oxalosis|primary oxalosis
4848566|NCT02340689|PH type 2|ph type 2
4848567|NCT02340689|PH type 3|ph type 3
4848568|NCT02340689|Genetic testing for PH|genetic testing for ph
4848569|NCT02340689|Genetic testing for Primary Hyperoxaluria|genetic testing for primary hyperoxaluria
4848570|NCT02340689|Hereditary study for PH|hereditary study for ph
4848571|NCT02340689|Hereditary study for Primary Hyperoxaluria|hereditary study for primary hyperoxaluria
4848572|NCT02340689|AGXT|agxt
4848573|NCT02340689|GRHPR|grhpr
4848574|NCT02340689|HOGA1|hoga1
4848575|NCT02340676|chronic graft-versus-host-disease|chronic graft-versus-host-disease
4848576|NCT02340663|dental orthotic|dental orthotic
4848577|NCT02340663|bite splint|bite splint
4848578|NCT02340663|oral parafunction|oral parafunction
4848579|NCT02340663|clenching|clenching
4848580|NCT02340663|grinding|grinding
4848581|NCT02340650|suspicious bladder lesion, normal bladder tissue|suspicious bladder lesion, normal bladder tissue
4848582|NCT02340585|Next Generation Neuroform Stent System|next generation neuroform stent system
4848583|NCT02340585|Wide Neck, Intracranial, Saccular Aneurysms|wide neck, intracranial, saccular aneurysms
4848584|NCT02340585|Cerebral Aneurysms|cerebral aneurysms
4848585|NCT02340572|Healthy Subjects|healthy subjects
4848586|NCT02340559|meta-cognition|meta-cognition
4848587|NCT02340559|positive symptoms|positive symptoms
4848588|NCT02340559|early phases|early phases
4848589|NCT02340559|schizophrenia|schizophrenia
4848590|NCT02340533|adenomyosis|adenomyosis
4848591|NCT02340481|Diarrhea|diarrhea
4848592|NCT02340481|Flatulence|flatulence
4848593|NCT02340481|Abdominal discomfort|abdominal discomfort
4848594|NCT02340481|Loperamide hydrochloride|loperamide hydrochloride
4848595|NCT02340481|Simethicone|simethicone
4848596|NCT02340481|Placebo|placebo
4848597|NCT02340442|arteriovenous ratio|arteriovenous ratio
4848598|NCT02340442|retinal flicker stimulation|retinal flicker stimulation
4848599|NCT02340442|Dynamic vessel analyzer|dynamic vessel analyzer
4848600|NCT02340416|orthopedic surgeries|orthopedic surgeries
4848601|NCT02340416|general anesthesia|general anesthesia
4848602|NCT02340403|Neuropathy|neuropathy
4848603|NCT02340403|Oxaliplatin|oxaliplatin
4848604|NCT02340403|Insula|insula
4848605|NCT02340403|choline|choline
4848606|NCT02340390|G7 Acetabular System|g7 acetabular system
4848607|NCT02340377|core body temperature|core body temperature
4848608|NCT02340377|whole-body hyperthermia|whole-body hyperthermia
4848609|NCT02340377|rectal body temperature|rectal body temperature
4848610|NCT02340364|Hospital Readmissions|hospital readmissions
4848611|NCT02340364|Patient Navigation|patient navigation
4848612|NCT02340351|acupuncture|acupuncture
4848613|NCT02340351|auricular acupuncture|auricular acupuncture
4848614|NCT02340351|NADA|nada
4848615|NCT02340351|anxiety|anxiety
4848616|NCT02340351|depression|depression
4848617|NCT02340299|High Frequency Oscillation Ventilation|high frequency oscillation ventilation
4848618|NCT02340299|Nasal Continuous Positive Airway Pressure|nasal continuous positive airway pressure
4848619|NCT02340299|Airway Extubation|airway extubation
4848620|NCT02340299|Prematurity|prematurity
4848621|NCT02340273|tendinopathy|tendinopathy
4848622|NCT02340273|ultrasound|ultrasound
4848623|NCT02340273|pain|pain
4848624|NCT02340273|heat|heat
4848625|NCT02340273|strength|strength
4848626|NCT02340273|LITUS|litus
4848627|NCT02340273|long duration|long duration
4848628|NCT02340273|therapeutic ultrasound|therapeutic ultrasound
4848629|NCT02340273|tendonopathy|tendonopathy
4848630|NCT02340260|Exercise|exercise
4848631|NCT02340260|Risk factors|risk factors
4848632|NCT02340260|Exercise therapy|exercise therapy
4848633|NCT02340260|Hemoglobin A, Glycosylated|hemoglobin a, glycosylated
4848634|NCT02340208|Non-Small Cell Lung Cancer|non-small cell lung cancer
4848635|NCT02340208|Neoplasms|neoplasms
4848636|NCT02340208|Immunoconjugate|immunoconjugate
4848637|NCT02340208|Tumor microenvironment alkalinization|tumor microenvironment alkalinization
4848638|NCT02340195|Kidney impairment|kidney impairment
4848639|NCT02340182|gut flora|gut flora
4848640|NCT02340182|antibiotics|antibiotics
4848641|NCT02340182|systemic immune response|systemic immune response
4848642|NCT02340182|Volunteers|volunteers
4848643|NCT02340091|facial nasolabial fold wrinkles|facial nasolabial fold wrinkles
4848644|NCT02340078|the facial nasolabial fold|the facial nasolabial fold
4848645|NCT02340065|colonoscopy|colonoscopy
4848646|NCT02340065|adenoma detection rate|adenoma detection rate
4848647|NCT02340065|Endocuff-assisted colonoscopy|endocuff-assisted colonoscopy
4848648|NCT02340052|postoperative pain treatment|postoperative pain treatment
4848649|NCT02340039|Polyphenol|polyphenol
4848650|NCT02340039|Fruit|fruit
4848651|NCT02340039|Metabolic|metabolic
4848652|NCT02340026|Delay in motor skill development|delay in motor skill development
4848653|NCT02340000|acute sinusitis|acute sinusitis
4848654|NCT02340000|amoxicillin/clavulanate|amoxicillin/clavulanate
4848655|NCT02340000|adults|adults
4848656|NCT02340000|outcomes|outcomes
4848657|NCT02339961|Systemic Sclerosis|systemic sclerosis
4848658|NCT02339961|Pulmonary hypertension|pulmonary hypertension
4848659|NCT02339961|Lung Doppler Signals|lung doppler signals
4848660|NCT02339948|Locally confined|locally confined
4848661|NCT02339935|Autism Spectrum Disorder|autism spectrum disorder
4848662|NCT02339935|Autism|autism
4848663|NCT02339909|Screening|screening
4848664|NCT02339909|Incentives|incentives
4848665|NCT02339896|rabies|rabies
4848666|NCT02339896|modified TRC intradermal rabies vaccine|modified trc intradermal rabies vaccine
4848667|NCT02339896|SPEEDA|speeda
4848668|NCT02339883|Physiological Measures|physiological measures
4848669|NCT02339883|MRI|mri
4848670|NCT02339883|Magnetic Resonance Imaging (MRI)|magnetic resonance imaging (mri)
4848671|NCT02339883|Cognitive Testing|cognitive testing
4848672|NCT02339857|coronary artery bypass grafting|coronary artery bypass grafting
4848673|NCT02339857|saphenous vein|saphenous vein
4848674|NCT02339857|grafts|grafts
4848675|NCT02339844|glutamate|glutamate
4848676|NCT02339844|dopamine|dopamine
4848677|NCT02339844|cognition|cognition
4848678|NCT02339844|cortical thickness|cortical thickness
4848679|NCT02339844|ppi|ppi
4848680|NCT02339844|p50|p50
4848681|NCT02339831|Knee|knee
4848682|NCT02339831|Arthroplasty|arthroplasty
4848683|NCT02339831|CPM|cpm
4848684|NCT02339831|Camoped|camoped
4848685|NCT02339831|Active vs Passive Motion Device|active vs passive motion device
4848686|NCT02339805|Minimal residual disease, NGS, NHL, DNA sequencing|minimal residual disease, ngs, nhl, dna sequencing
4848687|NCT02339792|COMPREHENSIVE GERIATRIC ASSESSMENT (CGA)|comprehensive geriatric assessment (cga)
4848688|NCT02339792|MEDICATION APPROPRIATENESS PRESCRIBING|medication appropriateness prescribing
4848689|NCT02339792|DRUG INTERACTIONS|drug interactions
4848690|NCT02339792|E-LEARNING|e-learning
4848691|NCT02339779|fat grafting|fat grafting
4848692|NCT02339779|fat injection|fat injection
4848693|NCT02339779|lipoaspirate|lipoaspirate
4848694|NCT02339779|fat transfer|fat transfer
4848695|NCT02339779|lipofilling|lipofilling
4848696|NCT02339779|liposculpturing|liposculpturing
4848697|NCT02339779|lipoinjection|lipoinjection
4848698|NCT02339779|lipotransfer|lipotransfer
4848699|NCT02339779|breast reconstruction|breast reconstruction
4848700|NCT02339766|Cesarean|cesarean
4848701|NCT02339766|Quadratus Lumborum Block|quadratus lumborum block
4848702|NCT02339766|Analgesia|analgesia
4848703|NCT02339766|Ultrasonography|ultrasonography
4848704|NCT02339727|Omega-3|omega-3
4848705|NCT02339727|Omega-6|omega-6
4848706|NCT02339714|allergic rhinitis|allergic rhinitis
4848707|NCT02339714|acupuncture|acupuncture
4848708|NCT02339714|moxibustion|moxibustion
4848709|NCT02339714|efficacy|efficacy
4848710|NCT02339714|safety|safety
4848711|NCT02339649|sepsis|sepsis
4848712|NCT02339649|septic shock|septic shock
4848713|NCT02339649|ICU|icu
4848714|NCT02339649|long-term outcome|long-term outcome
4848715|NCT02339649|neurocognitive|neurocognitive
4848716|NCT02339649|inflammatory|inflammatory
4848717|NCT02339649|MRI|mri
4848718|NCT02339649|EEG|eeg
4848719|NCT02339649|brain imaging|brain imaging
4848720|NCT02339649|serum biomarkers|serum biomarkers
4848721|NCT02339649|CSF|csf
4848722|NCT02339636|subclinical, enthesitis, synovitis|subclinical, enthesitis, synovitis
4848723|NCT02339623|Threatened preterm birth - fetal adrenal gland volume|threatened preterm birth - fetal adrenal gland volume
4848724|NCT02339610|Osteoarthritis|osteoarthritis
4848725|NCT02339610|Post-traumatic Arthritis|post-traumatic arthritis
4848726|NCT02339584|OAG|oag
4848727|NCT02339584|OHT|oht
4848728|NCT02339532|HER2-positive|her2-positive
4848729|NCT02339532|non-metastatic|non-metastatic
4848730|NCT02339532|TOP2A|top2a
4848731|NCT02339519|Laryngeal Masks|laryngeal masks
4848732|NCT02339506|stress|stress
4848733|NCT02339506|ACTH|acth
4848734|NCT02339506|cosyntropin|cosyntropin
4848735|NCT02339506|baroreflex sensitivity|baroreflex sensitivity
4848736|NCT02339506|cardiovagal|cardiovagal
4848737|NCT02339480|Massage therapy|massage therapy
4848738|NCT02339480|Simple obesity|simple obesity
4848739|NCT02339480|Energy metabolism|energy metabolism
4848740|NCT02339480|Mechanism|mechanism
4848741|NCT02339467|decreased outdoor walking ability|decreased outdoor walking ability
4848742|NCT02339467|Older adult|older adult
4848743|NCT02339454|Cardiac Shock wave therapy|cardiac shock wave therapy
4848744|NCT02339454|stable angina|stable angina
4848745|NCT02339454|exercise tolerance|exercise tolerance
4848746|NCT02339441|Systemic sclerosis|systemic sclerosis
4848747|NCT02339428|Colonoscopy|colonoscopy
4848748|NCT02339428|diagnostic|diagnostic
4848749|NCT02339428|diclophenac|diclophenac
4848750|NCT02339428|randomized controlled trial|randomized controlled trial
4848751|NCT02339402|Cystic fibrosis, Myotonic dystrophy, Noonan, Huntingtons|cystic fibrosis, myotonic dystrophy, noonan, huntingtons
4848752|NCT02339363|mindfulness|mindfulness
4848753|NCT02339363|adolescents|adolescents
4848754|NCT02339363|working memory|working memory
4848755|NCT02339363|stress|stress
4848756|NCT02339363|anxiety|anxiety
4848757|NCT02339311|The study focus is on lifestyle changes and patient activation in diabetic patients by regular monthly visit by the CHRs|the study focus is on lifestyle changes and patient activation in diabetic patients by regular monthly visit by the chrs
4848758|NCT02339298|Music Therapy|music therapy
4848759|NCT02339285|tACS|tacs
4848760|NCT02339285|Major Depressive Disorder|major depressive disorder
4848761|NCT02339285|MDD|mdd
4848762|NCT02339285|mood symptoms|mood symptoms
4848763|NCT02339285|sham|sham
4848764|NCT02339272|meiosis|meiosis
4848765|NCT02339272|synapsis|synapsis
4848766|NCT02339272|recombination|recombination
4848767|NCT02339272|sperm aneuploidy|sperm aneuploidy
4848768|NCT02339259|Rickettsial disease|rickettsial disease
4848769|NCT02339259|Febrile|febrile
4848770|NCT02339259|Murine typhus|murine typhus
4848771|NCT02339259|Scrub typhus|scrub typhus
4848772|NCT02339259|Diagnostic test|diagnostic test
4848773|NCT02339259|Clinical features|clinical features
4848774|NCT02339233|Epidural Stimulation|epidural stimulation
4848775|NCT02339220|Constraint-Induced Movement Therapy|constraint-induced movement therapy
4848776|NCT02339220|Physical Therapy|physical therapy
4848777|NCT02339220|Rehabilitation|rehabilitation
4848778|NCT02339220|Occupational Therapy|occupational therapy
4848779|NCT02339220|Fitness Training|fitness training
4848780|NCT02339220|Recovery of Function|recovery of function
4848781|NCT02339220|Neuroplasticity|neuroplasticity
4848782|NCT02339220|Exercise Therapy|exercise therapy
4848783|NCT02339220|Brain Injuries|brain injuries
4848784|NCT02339220|Traumatic Brain Injury|traumatic brain injury
4848785|NCT02339220|Physical Therapy Modalities|physical therapy modalities
4848786|NCT02339220|Neuroimaging|neuroimaging
4848787|NCT02339194|complete denture|complete denture
4848788|NCT02339194|quality of life|quality of life
4848789|NCT02339194|patient satisfaction|patient satisfaction
4848790|NCT02339155|Anthrax Vaccine Adsorbed|anthrax vaccine adsorbed
4848791|NCT02339155|Raxibacumab|raxibacumab
4848792|NCT02339155|Immunogenicity|immunogenicity
4848793|NCT02339103|arteriovenous anastomoses|arteriovenous anastomoses
4848794|NCT02339103|accidental hypothermia|accidental hypothermia
4848795|NCT02339103|rewarming|rewarming
4848796|NCT02339090|VRS-317|vrs-317
4848797|NCT02339090|Growth Hormone Deficiency|growth hormone deficiency
4848798|NCT02339090|Long Acting Recombinant Growth Hormone|long acting recombinant growth hormone
4848799|NCT02339090|Long Acting Growth Hormone|long acting growth hormone
4848800|NCT02339090|Pediatric Growth Hormone Deficiency|pediatric growth hormone deficiency
4848801|NCT02339090|Growth Hormone Replacement Therapy|growth hormone replacement therapy
4848802|NCT02339090|Versartis|versartis
4848803|NCT02339090|Xten|xten
4848804|NCT02339090|Human Growth Hormone|human growth hormone
4848805|NCT02339090|somavaratan|somavaratan
4848806|NCT02339090|growth failure|growth failure
4848807|NCT02339077|Group B Streptococcus, stillborn|group b streptococcus, stillborn
4848808|NCT02339064|Parkinson's disease,|parkinson's disease,
4848809|NCT02339064|apomorphine|apomorphine
4848810|NCT02339064|Apokyn|apokyn
4848811|NCT02339064|dopamine agonist|dopamine agonist
4848812|NCT02339064|levodopa|levodopa
4848813|NCT02339064|advanced|advanced
4848814|NCT02339064|PD|pd
4848815|NCT02339064|carbidopa|carbidopa
4848816|NCT02339064|pramipexole|pramipexole
4848817|NCT02339064|ropinirole|ropinirole
4848818|NCT02339064|rotigotine|rotigotine
4848819|NCT02339064|MAO-B inhibitors|mao-b inhibitors
4848820|NCT02339064|COMT inhibitors|comt inhibitors
4848821|NCT02339064|off|off
4848822|NCT02339064|dyskinesia|dyskinesia
4848823|NCT02339051|Basic Science|basic science
4848824|NCT02339038|Community Based Research|community based research
4848825|NCT02339038|Hepatitis C Virus and Human Immunodeficiency Virus|hepatitis c virus and human immunodeficiency virus
4848826|NCT02339038|Ledipasvir/Sofosbuvir|ledipasvir/sofosbuvir
4848827|NCT02339038|Fixed Dose Combination|fixed dose combination
4848828|NCT02339038|Sustained Viral Response|sustained viral response
4848829|NCT02339025|Cohort|cohort
4848830|NCT02339025|Participation|participation
4848831|NCT02339025|Biobank|biobank
4848832|NCT02339012|Genome Wide Association|genome wide association
4848833|NCT02339012|Biomarkers|biomarkers
4848834|NCT02339012|Methylation|methylation
4848835|NCT02339012|Phenotype|phenotype
4848836|NCT02339012|Cytometry|cytometry
4848837|NCT02338999|Autoimmunity Pathogenesis|autoimmunity pathogenesis
4848838|NCT02338999|Arteriosclerosis|arteriosclerosis
4848839|NCT02338999|Adult|adult
4848840|NCT02338986|High Titer Antibodies|high titer antibodies
4848841|NCT02338986|Convalescent Volunteers|convalescent volunteers
4848842|NCT02338986|Apheresis|apheresis
4848843|NCT02338986|Males|males
4848844|NCT02338986|Quantitative IgG|quantitative igg
4848845|NCT02338973|Macular Edema|macular edema
4848846|NCT02338973|Rod-Cone Dystrophy|rod-cone dystrophy
4848847|NCT02338973|Inherited Retinal Degeneration|inherited retinal degeneration
4848848|NCT02338973|Enhanced S-Cone Syndrom|enhanced s-cone syndrom
4848849|NCT02338973|Interferon Gamma|interferon gamma
4848850|NCT02338960|HSDD Female|hsdd female
4848851|NCT02338960|Sexual Desire Disorder|sexual desire disorder
4848852|NCT02338960|decreased desire|decreased desire
4848853|NCT02338960|female sexual dysfunction|female sexual dysfunction
4848854|NCT02338947|Frailty|frailty
4848855|NCT02338947|Cardiopulmonary Bypass|cardiopulmonary bypass
4848856|NCT02338947|Coronary artery bypass surgery|coronary artery bypass surgery
4848857|NCT02338947|Mortality|mortality
4848858|NCT02338947|Morbidity|morbidity
4848859|NCT02338921|triple combination therapy|triple combination therapy
4848860|NCT02338921|sitagliptin|sitagliptin
4848861|NCT02338921|dapagliflozin|dapagliflozin
4848862|NCT02338921|lobeglitazone|lobeglitazone
4848863|NCT02338908|dry needling|dry needling
4848864|NCT02338908|trigger point|trigger point
4848865|NCT02338908|eccentric exercise|eccentric exercise
4848866|NCT02338895|acute kidney injury, oliguria,renal ultrasound|acute kidney injury, oliguria,renal ultrasound
4848867|NCT02338882|Lenses|lenses
4848868|NCT02338882|Intraocular|intraocular
4848869|NCT02338856|Obesity|obesity
4848870|NCT02338830|Twins|twins
4848871|NCT02338830|Preterm labor|preterm labor
4848872|NCT02338830|Progesterone|progesterone
4848873|NCT02338830|Short cervix|short cervix
4848874|NCT02338804|mix vaccine, breast neoplasms, immunotherapy|mix vaccine, breast neoplasms, immunotherapy
4848875|NCT02338778|mix vaccine, liver neoplasms, immunotherapy|mix vaccine, liver neoplasms, immunotherapy
4848876|NCT02338752|mix vaccine, pancreatic neoplasms, immunotherapy|mix vaccine, pancreatic neoplasms, immunotherapy
4848877|NCT02338739|Retention|retention
4848878|NCT02338739|Lost to follow up|lost to follow up
4848879|NCT02338739|Adaptive strategies|adaptive strategies
4848880|NCT02338739|Dynamic regime|dynamic regime
4848881|NCT02338739|Sequentially randomized trial|sequentially randomized trial
4848882|NCT02338739|Sequential multiple assignment randomized trial|sequential multiple assignment randomized trial
4848883|NCT02338739|Engagement in care|engagement in care
4848884|NCT02338739|Kenya|kenya
4848885|NCT02338726|urinary incontinence|urinary incontinence
4848886|NCT02338726|pelvic floor|pelvic floor
4848887|NCT02338726|quality of life|quality of life
4848888|NCT02338726|elderly women|elderly women
4848889|NCT02338713|Drug therapy|drug therapy
4848890|NCT02338700|mix vaccine, prostate carcinoma, immunotherapy|mix vaccine, prostate carcinoma, immunotherapy
4848891|NCT02338687|Calcium|calcium
4848892|NCT02338687|Dietary supplements|dietary supplements
4848893|NCT02338687|Hypertension, Pregnancy-Induced|hypertension, pregnancy-induced
4848894|NCT02338687|Pre-Eclampsia|pre-eclampsia
4848895|NCT02338687|Nutritional education|nutritional education
4848896|NCT02338687|Diet therapy|diet therapy
4848897|NCT02338687|Diet records|diet records
4848898|NCT02338687|Hospitalization|hospitalization
4848899|NCT02338687|Maternal mortality|maternal mortality
4848900|NCT02338635|ER stress|er stress
4848901|NCT02338635|Peritoneal Dialysis|peritoneal dialysis
4848902|NCT02338622|olaparib|olaparib
4848903|NCT02338622|AZD5363|azd5363
4848904|NCT02338622|intrapatient dose escalation|intrapatient dose escalation
4848905|NCT02338622|advanced solid tumours|advanced solid tumours
4848906|NCT02338609|TSC-associated SEGA,|tsc-associated sega,
4848907|NCT02338609|height,|height,
4848908|NCT02338609|weight,|weight,
4848909|NCT02338609|Tanner Stage,|tanner stage,
4848910|NCT02338609|growth development,|growth development,
4848911|NCT02338609|everolimus,|everolimus,
4848912|NCT02338609|RAD001|rad001
4848913|NCT02338557|MRP, MIRROR THERAPY, STROKE|mrp, mirror therapy, stroke
4848914|NCT02338518|gastric cancer|gastric cancer
4848915|NCT02338518|neoadjuvant chemotherapy|neoadjuvant chemotherapy
4848916|NCT02338518|efficacy|efficacy
4848917|NCT02338518|safety|safety
4848918|NCT02338505|Robotic Surgery|robotic surgery
4848919|NCT02338505|Telelap-ALFX|telelap-alfx
4848920|NCT02338505|Gynecological disease|gynecological disease
4848921|NCT02338453|Social Anxiety|social anxiety
4848922|NCT02338453|Attention Modification|attention modification
4848923|NCT02338453|Dot-Probe|dot-probe
4848924|NCT02338453|GCBT|gcbt
4848925|NCT02338362|Corticosteroids|corticosteroids
4848926|NCT02338362|Bronchodilator Agents|bronchodilator agents
4848927|NCT02338362|Intraocular Pressure|intraocular pressure
4848928|NCT02338323|Hyperuricemia|hyperuricemia
4848929|NCT02338323|Renal Function|renal function
4848930|NCT02338323|Chronic kidney disease|chronic kidney disease
4848931|NCT02338323|Febuxostat|febuxostat
4848932|NCT02338323|Benzbromarone|benzbromarone
4848933|NCT02338297|Hepatocellular Carcinoma|hepatocellular carcinoma
4848934|NCT02338297|Arterioportal shunts|arterioportal shunts
4848935|NCT02338297|Transarterial Chemoembolization|transarterial chemoembolization
4848936|NCT02338297|Ethanol|ethanol
4848937|NCT02338297|Gelfoam|gelfoam
4848938|NCT02338297|Polyvinyl Alcohol Foam Embolization Particles (PVA)|polyvinyl alcohol foam embolization particles (pva)
4848939|NCT02338284|increased intracranial pressure|increased intracranial pressure
4848940|NCT02338284|optic nerve sheath diameter|optic nerve sheath diameter
4848941|NCT02338271|Low back pain|low back pain
4848942|NCT02338271|Mesenchymal stromal stem cell|mesenchymal stromal stem cell
4848943|NCT02338271|Hyaluronic acid|hyaluronic acid
4848944|NCT02338219|postpartum pelvic floor|postpartum pelvic floor
4848945|NCT02338206|infertility|infertility
4848946|NCT02338193|GDM|gdm
4848947|NCT02338193|T2DM|t2dm
4848948|NCT02338193|prediabetes|prediabetes
4848949|NCT02338180|dental caries|dental caries
4848950|NCT02338180|risk assessment|risk assessment
4848951|NCT02338180|approximal sealant|approximal sealant
4848952|NCT02338180|permanent molar|permanent molar
4848953|NCT02338180|preventive dentistry|preventive dentistry
4848954|NCT02338180|adolescent|adolescent
4848955|NCT02338154|Aortic Valve Replacement|aortic valve replacement
4848956|NCT02338154|Aortic Stenosis|aortic stenosis
4848957|NCT02338154|EDWARDS INTUITY|edwards intuity
4848958|NCT02338141|cervical cancer|cervical cancer
4848959|NCT02338141|colposcopy|colposcopy
4848960|NCT02338141|human papillomavirus|human papillomavirus
4848961|NCT02338141|human immunodeficiency virus|human immunodeficiency virus
4848962|NCT02338128|peritoneal dialysis|peritoneal dialysis
4848963|NCT02338128|hyperuricemia|hyperuricemia
4848964|NCT02338128|cardiovascular|cardiovascular
4848965|NCT02338128|Febuxostat|febuxostat
4848966|NCT02338089|Uterine contraction|uterine contraction
4848967|NCT02338089|Oxytocin desensitization|oxytocin desensitization
4848968|NCT02338063|Adolescent Risk Behavior|adolescent risk behavior
4848969|NCT02338063|Emotion Regulation|emotion regulation
4848970|NCT02338063|Health Promotion|health promotion
4848971|NCT02338063|Intervention|intervention
4848972|NCT02338063|Mental Health|mental health
4848973|NCT02338050|ALL|all
4848974|NCT02338050|Moxetumomab Pasudotox|moxetumomab pasudotox
4848975|NCT02338050|Moxe|moxe
4848976|NCT02338050|CAT-8015, HA22|cat-8015, ha22
4848977|NCT02338024|Enrollment in HIV care|enrollment in hiv care
4848978|NCT02338024|Recently detected HIV-positive|recently detected hiv-positive
4848979|NCT02338024|specialized health care clinics|specialized health care clinics
4848980|NCT02338024|Ukraine|ukraine
4848981|NCT02337998|Neurology|neurology
4848982|NCT02337998|Sports Medicine|sports medicine
4848983|NCT02337972|diabetic macular edema|diabetic macular edema
4848984|NCT02337972|Intravitreal injection|intravitreal injection
4848985|NCT02337972|conjunctival flora|conjunctival flora
4848986|NCT02337959|Healthy Volunteers|healthy volunteers
4848987|NCT02337946|Metastatic colorectal cancer, Panitumumab, mFOLFOX6, First-line|metastatic colorectal cancer, panitumumab, mfolfox6, first-line
4848988|NCT02337933|Metabolic Syndrome|metabolic syndrome
4848989|NCT02337933|Central Obesity|central obesity
4848990|NCT02337933|Insulin Sensitivity|insulin sensitivity
4848991|NCT02337933|Ursolic Acid|ursolic acid
4848992|NCT02337933|Triterpenoid|triterpenoid
4848993|NCT02337894|Protein kinetics|protein kinetics
4848994|NCT02337894|liver steatosis|liver steatosis
4848995|NCT02337868|dose-ranging,double blind,female,healthy,HydroVax,male,Placebo-Controlled,Vaccine,West Nile Virus|dose-ranging,double blind,female,healthy,hydrovax,male,placebo-controlled,vaccine,west nile virus
4848996|NCT02337855|Intestinal|intestinal
4848997|NCT02337855|Pichia pastoris|pichia pastoris
4848998|NCT02337855|S. mansoni|s. mansoni
4848999|NCT02337855|Schistosomiasis|schistosomiasis
4849000|NCT02337855|Sm-TSP-2/Alhydrogel|sm-tsp-2/alhydrogel
4849001|NCT02337855|Sm-TSP-2/Alhydrogel/GLA-AF|sm-tsp-2/alhydrogel/gla-af
4849002|NCT02337855|vaccine|vaccine
4849003|NCT02337842|NoV, CIN-1, GII4. Norovirus, challenge, FUT-2 gene, HBGA-blocking Ab|nov, cin-1, gii4. norovirus, challenge, fut-2 gene, hbga-blocking ab
4849004|NCT02337829|CLL|cll
4849005|NCT02337829|SLL|sll
4849006|NCT02337829|Btk|btk
4849007|NCT02337829|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
4849008|NCT02337829|Small Lymphocytic Lymphoma|small lymphocytic lymphoma
4849009|NCT02337829|Leukemia|leukemia
4849010|NCT02337829|Lymphoma|lymphoma
4849011|NCT02337829|Lymphocytic|lymphocytic
4849012|NCT02337829|ACP-196|acp-196
4849013|NCT02337829|acalabrutinib|acalabrutinib
4849014|NCT02337816|Endometriosis|endometriosis
4849015|NCT02337816|Metabolomics|metabolomics
4849016|NCT02337803|Physical Activity|physical activity
4849017|NCT02337790|Hypertension|hypertension
4849018|NCT02337790|Heart Failure|heart failure
4849019|NCT02337790|Fluids|fluids
4849020|NCT02337777|Magnetic Resonance Imaging|magnetic resonance imaging
4849021|NCT02337777|Magnetic Resonance Angiography|magnetic resonance angiography
4849022|NCT02337777|Diffusion Tensor Imaging|diffusion tensor imaging
4849023|NCT02337777|IDEAL|ideal
4849024|NCT02337777|T2* mapping|t2* mapping
4849025|NCT02337777|Magnetic ResonanceCine|magnetic resonancecine
4849026|NCT02337777|BOLD|bold
4849027|NCT02337777|phase contrast|phase contrast
4849028|NCT02337777|diffusion-weighted imaging|diffusion-weighted imaging
4849029|NCT02337777|Functional Magnetic Resonance Imaging|functional magnetic resonance imaging
4849030|NCT02337712|Small cell lung cancer|small cell lung cancer
4849031|NCT02337712|Radiotherapy|radiotherapy
4849032|NCT02337712|Dose fractionation|dose fractionation
4849033|NCT02337686|Keytruda|keytruda
4849034|NCT02337686|pembrolizumab|pembrolizumab
4849035|NCT02337686|immune effector function|immune effector function
4849036|NCT02337686|pembrolizumab monotherapy|pembrolizumab monotherapy
4849037|NCT02337686|ex vivo T-cell-specific cytokines profiling|ex vivo t-cell-specific cytokines profiling
4849038|NCT02337686|immune effector Tcell:Treg ratio|immune effector tcell:treg ratio
4849039|NCT02337686|immunological changes|immunological changes
4849040|NCT02337686|immune response|immune response
4849041|NCT02337673|Postoperative Pulmonary Complication|postoperative pulmonary complication
4849042|NCT02337673|Electrical Impedance Tomography|electrical impedance tomography
4849043|NCT02337673|Splenectomy|splenectomy
4849044|NCT02337673|Gastric surgery|gastric surgery
4849045|NCT02337673|Gastrectomy|gastrectomy
4849046|NCT02337673|Pancreatic surgery|pancreatic surgery
4849047|NCT02337673|Pancreatectomy|pancreatectomy
4849048|NCT02337673|Liver surgery|liver surgery
4849049|NCT02337673|Hemihepatectomy|hemihepatectomy
4849050|NCT02337673|Cholecystectomy|cholecystectomy
4849051|NCT02337673|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
4849052|NCT02337673|Hypoxemia|hypoxemia
4849053|NCT02337673|Atelectasis|atelectasis
4849054|NCT02337673|Pulmonary obstruction|pulmonary obstruction
4849055|NCT02337673|Pneumonia|pneumonia
4849056|NCT02337673|Pneumothorax|pneumothorax
4849057|NCT02337673|Pleural effusion|pleural effusion
4849058|NCT02337673|Pulmonary edema|pulmonary edema
4849059|NCT02337621|sunken chest|sunken chest
4849060|NCT02337621|caved-in chest|caved-in chest
4849061|NCT02337621|chest deformity|chest deformity
4849062|NCT02337621|sunken sternum|sunken sternum
4849063|NCT02337608|moderate to severe ulcerative colitis|moderate to severe ulcerative colitis
4849064|NCT02337608|GLPG1205|glpg1205
4849065|NCT02337595|CD45RA-depletion|cd45ra-depletion
4849066|NCT02337595|TCR-alpha/beta depletion|tcr-alpha/beta depletion
4849067|NCT02337595|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
4849068|NCT02337595|immune reconstitution|immune reconstitution
4849069|NCT02337595|Graft Enhancement, Immunologic|graft enhancement, immunologic
4849070|NCT02337595|Immunocompromized Host|immunocompromized host
4849071|NCT02337491|Recurrent|recurrent
4849072|NCT02337452|Hereditary cancer-causing mutation|hereditary cancer-causing mutation
4849073|NCT02337452|Gene mutation|gene mutation
4849074|NCT02337452|Family member with genetic mutation|family member with genetic mutation
4849075|NCT02337452|Questionnaire|questionnaire
4849076|NCT02337452|Surveys|surveys
4849077|NCT02337452|Registry|registry
4849078|NCT02337452|Database|database
4849079|NCT02337452|Communication|communication
4849080|NCT02337413|Constipation|constipation
4849081|NCT02337374|Urodynamics|urodynamics
4849082|NCT02337374|Midurethral sling|midurethral sling
4849083|NCT02337374|Transobturator tape (TOT)|transobturator tape (tot)
4849084|NCT02337374|Tension free vaginal tape (TVT)|tension free vaginal tape (tvt)
4849085|NCT02337361|risky alcohol use|risky alcohol use
4849086|NCT02337361|pregnancy|pregnancy
4849087|NCT02337348|coronary stents|coronary stents
4849088|NCT02337335|Hemodialyisis|hemodialyisis
4849089|NCT02337335|Predictive Model|predictive model
4849090|NCT02337335|ESAs|esas
4849091|NCT02337335|patients|patients
4849092|NCT02337322|Acquired Immune Deficiency Syndrome Virus|acquired immune deficiency syndrome virus
4849094|NCT02337322|HIV-1|hiv-1
4849095|NCT02337322|Antiretroviral treatment|antiretroviral treatment
4849096|NCT02337322|HIV Advanced Disease|hiv advanced disease
4849097|NCT02337322|AIDS|aids
4849098|NCT02337322|Dolutegravir|dolutegravir
4849099|NCT02337322|Darunavir|darunavir
4849100|NCT02337296|Motivational Interviewing|motivational interviewing
4849101|NCT02337296|Cognitive Behavioral Therapy|cognitive behavioral therapy
4849102|NCT02337296|Cancer|cancer
4849103|NCT02337296|Oral Agents|oral agents
4849104|NCT02337296|Adherence|adherence
4849105|NCT02337270|Tuberculosis|tuberculosis
4849106|NCT02337270|Vaccine|vaccine
4849107|NCT02337270|Aerosol|aerosol
4849108|NCT02337270|Adenovirus|adenovirus
4849109|NCT02337270|Immunogenicity|immunogenicity
4849110|NCT02337244|Osteoarthritis|osteoarthritis
4849111|NCT02337244|Rheumatoid arthritis|rheumatoid arthritis
4849112|NCT02337244|Traumatic arthritis|traumatic arthritis
4849113|NCT02337244|Polyarthritis|polyarthritis
4849114|NCT02337244|Total knee arthroplasty|total knee arthroplasty
4849115|NCT02337192|Orthodontic, Photochemoterapy|orthodontic, photochemoterapy
4849116|NCT02337166|alveolar bone loss|alveolar bone loss
4849117|NCT02337166|periodontal attachment loss|periodontal attachment loss
4849118|NCT02337153|Orthodontique Bone Stretching|orthodontique bone stretching
4849119|NCT02337140|TAVI|tavi
4849120|NCT02337140|complete AV-block|complete av-block
4849121|NCT02337140|HV-interval|hv-interval
4849122|NCT02337140|permanent pacemaker|permanent pacemaker
4849123|NCT02337140|valve implantation|valve implantation
4849124|NCT02337140|severe|severe
4849125|NCT02337140|conduction|conduction
4849126|NCT02337140|disorders|disorders
4849127|NCT02337114|Acceptance and Commitment Therapy|acceptance and commitment therapy
4849128|NCT02337101|Brain concussion|brain concussion
4849231|NCT02336542|CFP10|cfp10
4849129|NCT02337101|Mild Traumatic Brain Injury|mild traumatic brain injury
4849130|NCT02337101|Post-concussion symptoms|post-concussion symptoms
4849131|NCT02337101|Therapy|therapy
4849132|NCT02337101|Randomised controlled trial|randomised controlled trial
4849133|NCT02337101|Cognitive assessment|cognitive assessment
4849134|NCT02337088|delayed cord clamping|delayed cord clamping
4849135|NCT02337075|condition|condition
4849136|NCT02337075|preventing|preventing
4849137|NCT02337075|physical activity|physical activity
4849138|NCT02337049|Preeclampsia. Cardiovascular Disease (CVD) Risk.|preeclampsia. cardiovascular disease (cvd) risk.
4849139|NCT02337036|Liver transplantation|liver transplantation
4849140|NCT02337036|Child|child
4849141|NCT02337036|Tacrolimus|tacrolimus
4849142|NCT02337036|Pharmacokinetic|pharmacokinetic
4849143|NCT02337023|Brain scintigraphy|brain scintigraphy
4849144|NCT02336997|skin regeneration|skin regeneration
4849145|NCT02336997|mechanical stretch|mechanical stretch
4849146|NCT02336984|Ductal carcinoma in situ (DCIS)|ductal carcinoma in situ (dcis)
4849147|NCT02336958|cervical plexus|cervical plexus
4849148|NCT02336958|regional anesthesia|regional anesthesia
4849149|NCT02336958|ultrasound|ultrasound
4849150|NCT02336958|carotid surgery|carotid surgery
4849151|NCT02336932|vitamin d|vitamin d
4849152|NCT02336932|free hormone|free hormone
4849153|NCT02336932|surgical stress|surgical stress
4849154|NCT02336919|discharge|discharge
4849155|NCT02336919|mHealth|mhealth
4849156|NCT02336919|telehealth|telehealth
4849157|NCT02336919|text messaging|text messaging
4849158|NCT02336906|Lower urinary tract dysfunction|lower urinary tract dysfunction
4849159|NCT02336906|constipation|constipation
4849160|NCT02336893|Communication Barriers|communication barriers
4849161|NCT02336893|Total Communication Methods|total communication methods
4849162|NCT02336893|Quality Improvement|quality improvement
4849163|NCT02336893|Quality of Health Care|quality of health care
4849164|NCT02336893|Critical Care|critical care
4849165|NCT02336867|Complex anal fistula, clip,|complex anal fistula, clip,
4849166|NCT02336854|pharmacokinetics|pharmacokinetics
4849167|NCT02336841|Guided Self-Help|guided self-help
4849168|NCT02336841|Peer Mentoring|peer mentoring
4849169|NCT02336841|Anorexia Nervosa|anorexia nervosa
4849170|NCT02336841|Eating Disorders|eating disorders
4849171|NCT02336828|MEWS|mews
4849172|NCT02336828|deteriorate|deteriorate
4849173|NCT02336828|oncology|oncology
4849174|NCT02336828|ICU|icu
4849175|NCT02336828|predicting outcomes|predicting outcomes
4849176|NCT02336828|MEWS in predicting outcomes in oncology patients|mews in predicting outcomes in oncology patients
4849177|NCT02336815|Multiple myeloma|multiple myeloma
4849178|NCT02336815|Karyopharm|karyopharm
4849179|NCT02336815|KPT-330|kpt-330
4849180|NCT02336815|Selinexor|selinexor
4849181|NCT02336815|Refractory|refractory
4849182|NCT02336815|Bortezomib|bortezomib
4849183|NCT02336815|Carfilzomib|carfilzomib
4849184|NCT02336815|Lenalidomide|lenalidomide
4849185|NCT02336815|Pomalidomide|pomalidomide
4849186|NCT02336815|Dexamethasone|dexamethasone
4849187|NCT02336815|STORM|storm
4849188|NCT02336815|Daratumumab|daratumumab
4849189|NCT02336802|Anxiety|anxiety
4849190|NCT02336802|Fear|fear
4849191|NCT02336802|Avoidance|avoidance
4849192|NCT02336776|Chronic Kidney Disease|chronic kidney disease
4849193|NCT02336776|Electrical Stimulation|electrical stimulation
4849194|NCT02336737|breast cancer|breast cancer
4849195|NCT02336737|sentinel lymph node biopsy|sentinel lymph node biopsy
4849196|NCT02336724|gastrointestinal stromal tumor|gastrointestinal stromal tumor
4849197|NCT02336724|famitinib|famitinib
4849198|NCT02336698|Osteoarthritis|osteoarthritis
4849199|NCT02336698|Pain|pain
4849200|NCT02336698|Fulranumab|fulranumab
4849201|NCT02336698|JNJ-42160443|jnj-42160443
4849202|NCT02336698|Monotherapy|monotherapy
4849203|NCT02336698|Hip|hip
4849204|NCT02336698|Knee|knee
4849205|NCT02336698|Joint replacement surgery|joint replacement surgery
4849206|NCT02336685|Osteoarthritis|osteoarthritis
4849207|NCT02336685|Pain|pain
4849208|NCT02336685|Fulranumab|fulranumab
4849209|NCT02336685|JNJ-42160443|jnj-42160443
4849210|NCT02336685|Adjunctive therapy|adjunctive therapy
4849211|NCT02336685|Opioid|opioid
4849212|NCT02336685|Hip|hip
4849213|NCT02336685|Knee|knee
4849214|NCT02336685|Joint replacement surgery|joint replacement surgery
4849215|NCT02336672|Pancreatic adenocarcinoma|pancreatic adenocarcinoma
4849216|NCT02336672|Cryothermoablation|cryothermoablation
4849217|NCT02336633|Huntington disease|huntington disease
4849218|NCT02336633|Neurodegenerative disease|neurodegenerative disease
4849219|NCT02336633|Volumetric MRI|volumetric mri
4849220|NCT02336633|31P MR spectroscopy|31p mr spectroscopy
4849221|NCT02336633|metabolism|metabolism
4849222|NCT02336633|Caudate atrophy|caudate atrophy
4849223|NCT02336620|Severe sepsis, Balanced Salt Solution, Normal Saline|severe sepsis, balanced salt solution, normal saline
4849224|NCT02336581|Acceptance and Commitment Therapy|acceptance and commitment therapy
4849225|NCT02336581|Mindfulness|mindfulness
4849226|NCT02336581|Inpatients|inpatients
4849227|NCT02336581|Psychiatric Hospitalization|psychiatric hospitalization
4849228|NCT02336568|PTSD, Oxytocin|ptsd, oxytocin
4849229|NCT02336542|diagnosis of Tuberculosis|diagnosis of tuberculosis
4849230|NCT02336542|ESAT6|esat6
4849232|NCT02336542|skin test|skin test
4849233|NCT02336542|diagnostic test|diagnostic test
4849234|NCT02336529|postoperative|postoperative
4849235|NCT02336477|non-dystrophic myotonias|non-dystrophic myotonias
4849236|NCT02336477|paramyotonia congenita|paramyotonia congenita
4849237|NCT02336477|myotonia congenita|myotonia congenita
4849238|NCT02336477|Mexiletine|mexiletine
4849239|NCT02336477|Randomized clinical trial|randomized clinical trial
4849240|NCT02336451|ALK-positive|alk-positive
4849241|NCT02336451|NSCLC|nsclc
4849242|NCT02336451|brain metastasis|brain metastasis
4849243|NCT02336451|metastatic to the brain and/or to leptomeninges.|metastatic to the brain and/or to leptomeninges.
4849244|NCT02336425|Asthma|asthma
4849245|NCT02336412|Medication adherence|medication adherence
4849246|NCT02336399|HBsAg loss, interferon, HBV reaction|hbsag loss, interferon, hbv reaction
4849247|NCT02336386|Bortezomib|bortezomib
4849248|NCT02336373|Hemoglobin SC disease|hemoglobin sc disease
4849249|NCT02336373|hydroxyurea|hydroxyurea
4849250|NCT02336373|quality of life|quality of life
4849251|NCT02336373|viscosity|viscosity
4849252|NCT02336373|red cell density|red cell density
4849253|NCT02336347|Pharmacokinetics|pharmacokinetics
4849254|NCT02336347|Healthy Volunteers|healthy volunteers
4849255|NCT02336347|deuterated dextromethorphan|deuterated dextromethorphan
4849256|NCT02336347|deuterated dextromethorphan with quinidine|deuterated dextromethorphan with quinidine
4849257|NCT02336282|Adult survivor of acute lymphoblastic leukemia|adult survivor of acute lymphoblastic leukemia
4849258|NCT02336282|Executive dysfunction|executive dysfunction
4849259|NCT02336282|Transcranial direct current stimulation|transcranial direct current stimulation
4849260|NCT02336282|Cancer prevention and control|cancer prevention and control
4849261|NCT02336269|Pharmacogenomics|pharmacogenomics
4849262|NCT02336256|inguinal hernia repair|inguinal hernia repair
4849263|NCT02336256|totally extraperitoneal (TEP)|totally extraperitoneal (tep)
4849264|NCT02336256|single incision laparoscopic surgery (SILS)|single incision laparoscopic surgery (sils)
4849265|NCT02336256|plasma total antioxidant status|plasma total antioxidant status
4849266|NCT02336243|docosahexaenoic acid|docosahexaenoic acid
4849267|NCT02336243|premature birth|premature birth
4849268|NCT02336243|placentation disorders|placentation disorders
4849269|NCT02336243|preeclampsia|preeclampsia
4849270|NCT02336243|fetal growth|fetal growth
4849271|NCT02336230|GVHD|gvhd
4849272|NCT02336191|living donor liver transplantation|living donor liver transplantation
4849273|NCT02336191|graft function|graft function
4849274|NCT02336191|thromboelastometry|thromboelastometry
4849275|NCT02336165|Glioblastoma|glioblastoma
4849276|NCT02336165|Immunotherapy|immunotherapy
4849277|NCT02336165|T Cell|t cell
4849278|NCT02336165|PD-L1|pd-l1
4849279|NCT02336165|MEDI4736|medi4736
4849280|NCT02336165|Radiation|radiation
4849281|NCT02336165|Radiotherapy|radiotherapy
4849282|NCT02336165|GBM|gbm
4849283|NCT02336100|Diagnostic technique and procedure|diagnostic technique and procedure
4849284|NCT02336074|HIV|hiv
4849285|NCT02336074|Vaccine|vaccine
4849286|NCT02336074|Cure|cure
4849287|NCT02336074|Early Intervention|early intervention
4849288|NCT02336074|Infection|infection
4849289|NCT02336074|Primary infection|primary infection
4849290|NCT02336074|Reservoir|reservoir
4849291|NCT02336074|Vorinostat|vorinostat
4849292|NCT02336074|HDAC|hdac
4849293|NCT02336022|general anesthesia|general anesthesia
4849294|NCT02336009|wrist arthritis|wrist arthritis
4849295|NCT02336009|total wrist arthroplasty|total wrist arthroplasty
4849296|NCT02335970|Pain|pain
4849297|NCT02335970|Range of motion|range of motion
4849298|NCT02335970|Quality of life|quality of life
4849299|NCT02335944|non small cell lung cancer,|non small cell lung cancer,
4849300|NCT02335944|NSCLC,|nsclc,
4849301|NCT02335944|EGF816,|egf816,
4849302|NCT02335944|INC280,|inc280,
4849303|NCT02335944|tyrosine kinase inhibitor,|tyrosine kinase inhibitor,
4849304|NCT02335944|c-MET|c-met
4849305|NCT02335918|Opdivo®|opdivo®
4849306|NCT02335866|Platelet rich fibrin|platelet rich fibrin
4849307|NCT02335866|Gingival Recession|gingival recession
4849308|NCT02335853|urinary bladder|urinary bladder
4849309|NCT02335853|nerve growth factor|nerve growth factor
4849310|NCT02335853|overactive bladder|overactive bladder
4849311|NCT02335827|irreversible electroporation|irreversible electroporation
4849312|NCT02335827|renal tumor|renal tumor
4849313|NCT02335801|heart failure|heart failure
4849314|NCT02335801|growth hormone|growth hormone
4849315|NCT02335801|testosterone|testosterone
4849316|NCT02335801|insulin resistance|insulin resistance
4849317|NCT02335801|thyroid hormones|thyroid hormones
4849318|NCT02335801|survival|survival
4849319|NCT02335788|Therapeutic|therapeutic
4849320|NCT02335788|Embolization|embolization
4849321|NCT02335736|infertility|infertility
4849322|NCT02335684|Heart-assist devices|heart-assist devices
4849323|NCT02335684|exercise capacity|exercise capacity
4849324|NCT02335671|Early Stage Breast Cancer|early stage breast cancer
4849325|NCT02335671|Breast Conserving Surgery|breast conserving surgery
4849326|NCT02335671|Breast Cancer Stage I|breast cancer stage i
4849327|NCT02335671|Breast Cancer Stage II|breast cancer stage ii
4849328|NCT02335645|ACL reconstruction|acl reconstruction
4849329|NCT02335645|Running Mechanics|running mechanics
4849330|NCT02335645|Physical Therapy|physical therapy
4849331|NCT02335645|Knee|knee
4849332|NCT02335645|Video Analysis|video analysis
4849333|NCT02335645|Body Weight Supported Treadmill|body weight supported treadmill
4849334|NCT02335632|Hepatitis|hepatitis
4849335|NCT02335632|Probiotics|probiotics
4849336|NCT02335632|Lipopolysaccharides|lipopolysaccharides
4849337|NCT02335632|Cytokines|cytokines
4849338|NCT02335632|Alcoholics|alcoholics
4849339|NCT02335593|Hemodialysis patients|hemodialysis patients
4849340|NCT02335593|Zinc|zinc
4849341|NCT02335593|Anemia|anemia
4849342|NCT02335593|Oxidative stress|oxidative stress
4849343|NCT02335580|Prognosis|prognosis
4849344|NCT02335554|Subthreshold|subthreshold
4849345|NCT02335554|Employees|employees
4849346|NCT02335554|Internet|internet
4849347|NCT02335554|Mobile|mobile
4849348|NCT02335554|cognitive-behavioral|cognitive-behavioral
4849349|NCT02335515|Gastroretentive System|gastroretentive system
4849350|NCT02335515|Gastric Retention Time (GRT)|gastric retention time (grt)
4849351|NCT02335515|capsule|capsule
4849352|NCT02335515|Soctec|soctec
4849353|NCT02335515|Gastroenterology|gastroenterology
4849354|NCT02335476|optical coherence tomography|optical coherence tomography
4849355|NCT02335463|optical coherence tomography|optical coherence tomography
4849356|NCT02335450|exercise|exercise
4849357|NCT02335450|motivational interviewing|motivational interviewing
4849358|NCT02335424|P-D1|p-d1
4849359|NCT02335424|PD-1|pd-1
4849360|NCT02335424|PD1|pd1
4849361|NCT02335424|P-DL1|p-dl1
4849362|NCT02335424|PD-L1|pd-l1
4849363|NCT02335424|PDL-1|pdl-1
4849364|NCT02335424|PDL1|pdl1
4849365|NCT02335424|Bladder cancer|bladder cancer
4849366|NCT02335411|Gastric cancer|gastric cancer
4849367|NCT02335411|Gastroesophageal junction cancer|gastroesophageal junction cancer
4849368|NCT02335411|PD1|pd1
4849369|NCT02335411|PD-1|pd-1
4849370|NCT02335411|PDL1|pdl1
4849371|NCT02335411|PD-L1|pd-l1
4849372|NCT02335398|methadone|methadone
4849373|NCT02335398|chronic pain|chronic pain
4849374|NCT02335398|noncancer pain|noncancer pain
4849375|NCT02335398|cancer pain|cancer pain
4849376|NCT02335398|QTc prolongation|qtc prolongation
4849377|NCT02335372|Cervical cancer|cervical cancer
4849378|NCT02335372|Cervical neoplasia|cervical neoplasia
4849379|NCT02335372|Cervical cancer screening|cervical cancer screening
4849380|NCT02335372|Colposcopy|colposcopy
4849381|NCT02335372|Wide-field white light imaging|wide-field white light imaging
4849382|NCT02335372|Wide-field fluorescence imaging|wide-field fluorescence imaging
4849383|NCT02335372|Acetic acid|acetic acid
4849384|NCT02335372|Proflavine solution|proflavine solution
4849385|NCT02335333|Delayed Graft Function|delayed graft function
4849386|NCT02335333|Slow Graft Function|slow graft function
4849387|NCT02335333|Renal Transplant|renal transplant
4849388|NCT02335333|Extended Criteria Donor|extended criteria donor
4849389|NCT02335333|Biomarker of Aging|biomarker of aging
4849390|NCT02335333|Kidney Transplant|kidney transplant
4849391|NCT02335320|VHC|vhc
4849392|NCT02335320|IL28-B|il28-b
4849393|NCT02335320|point of care|point of care
4849394|NCT02335307|Pain|pain
4849395|NCT02335307|CYP2D6|cyp2d6
4849396|NCT02335294|Pain|pain
4849397|NCT02335294|abdominoplasty|abdominoplasty
4849398|NCT02335294|PCA|pca
4849399|NCT02335281|Standardized Fecal Microbiota Transplantation|standardized fecal microbiota transplantation
4849400|NCT02335281|Inflammatory Bowel Disease|inflammatory bowel disease
4849401|NCT02335281|Ulcerative Colitis|ulcerative colitis
4849402|NCT02335281|Crohn's Disease|crohn's disease
4849403|NCT02335268|MDS classified as IPSS low/int-1|mds classified as ipss low/int-1
4849404|NCT02335242|Sildenafil|sildenafil
4849405|NCT02335242|Magnetic Resonance Imaging|magnetic resonance imaging
4849406|NCT02335242|Dermatology|dermatology
4849407|NCT02335242|Pediatrics|pediatrics
4849408|NCT02335190|Sacroiliac joint|sacroiliac joint
4849409|NCT02335190|Radiofrequency ablation|radiofrequency ablation
4849410|NCT02335190|Ultrasound|ultrasound
4849411|NCT02335177|Falls|falls
4849412|NCT02335177|Elderly|elderly
4849413|NCT02335177|Physical activities|physical activities
4849414|NCT02335177|Technologies for autonomy|technologies for autonomy
4849415|NCT02335177|Impact of intervention|impact of intervention
4849416|NCT02335177|autonomy|autonomy
4849417|NCT02335177|physical activity program|physical activity program
4849418|NCT02335151|Circulating Tumor Cells|circulating tumor cells
4849419|NCT02335151|Anesthesia and immunity|anesthesia and immunity
4849420|NCT02335151|Cell Search System|cell search system
4849421|NCT02335138|HIV|hiv
4849422|NCT02335138|MSM|msm
4849423|NCT02335138|Couples|couples
4849424|NCT02335138|Home Testing|home testing
4849425|NCT02335138|Sexual Agreements|sexual agreements
4849426|NCT02335112|irreversible electroporation|irreversible electroporation
4849427|NCT02335112|Unresectable Head and Neck Neoplasms|unresectable head and neck neoplasms
4849428|NCT02335099|hemodialysis|hemodialysis
4849429|NCT02335099|vascular access|vascular access
4849430|NCT02335099|vascular access patency|vascular access patency
4849431|NCT02335099|ticagrelor|ticagrelor
4849432|NCT02335099|brilinta|brilinta
4849433|NCT02335073|Prognosis|prognosis
4849434|NCT02335060|cannabis|cannabis
4849435|NCT02335060|Marijuana|marijuana
4849436|NCT02335060|THC|thc
4849437|NCT02335060|N-acetylcysteine|n-acetylcysteine
4849438|NCT02335060|Psychotic Disorders|psychotic disorders
4849439|NCT02335047|reliability|reliability
4849440|NCT02335047|clinical test|clinical test
4849441|NCT02335047|physical therapy|physical therapy
4849442|NCT02335034|Osteoarthritis|osteoarthritis
4849443|NCT02335034|Knee|knee
4849444|NCT02335034|Education|education
4849445|NCT02335034|Quality of life|quality of life
4849446|NCT02335034|Treatment outcome|treatment outcome
4849447|NCT02335034|Musculoskeletal pain|musculoskeletal pain
4849448|NCT02334995|solitery rectal ulcer|solitery rectal ulcer
4849449|NCT02334995|biofeedback|biofeedback
4849450|NCT02334995|dissynergy|dissynergy
4849451|NCT02334982|Drug therapy|drug therapy
4849452|NCT02334969|ischemic stroke；Naoxintong Capsule|ischemic stroke；naoxintong capsule
4849453|NCT02334956|MRI|mri
4849454|NCT02334956|Executive Deficits|executive deficits
4849455|NCT02334943|Immune Activation|immune activation
4849456|NCT02334943|HIV-1 infected subjects|hiv-1 infected subjects
4849457|NCT02334943|Undetectable viral load|undetectable viral load
4849458|NCT02334943|Causes of Immune Activation in HIV-1 infected patients|causes of immune activation in hiv-1 infected patients
4849459|NCT02334943|Forms of Immune Activation|forms of immune activation
4849460|NCT02334943|Emergent non-AIDS related comorbidities|emergent non-aids related comorbidities
4849461|NCT02334930|propranolol|propranolol
4849462|NCT02334930|betablocker|betablocker
4849463|NCT02334930|angiogenesis|angiogenesis
4849464|NCT02334917|Suture Comparison|suture comparison
4849465|NCT02334891|congestive heart failure|congestive heart failure
4849466|NCT02334891|heart failure, diastolic|heart failure, diastolic
4849467|NCT02334891|heart failure, systolic|heart failure, systolic
4849468|NCT02334891|elderly frail|elderly frail
4849469|NCT02334891|guideline adherence|guideline adherence
4849470|NCT02334878|Stem Cells|stem cells
4849471|NCT02334878|Mesenchymal|mesenchymal
4849472|NCT02334826|multivessel coronary artery disease|multivessel coronary artery disease
4849473|NCT02334826|revascularization|revascularization
4849474|NCT02334826|bioresorbable vascular scaffold|bioresorbable vascular scaffold
4849475|NCT02334826|percutaneous coronary intervention|percutaneous coronary intervention
4849476|NCT02334826|coronary artery bypass grafting|coronary artery bypass grafting
4849477|NCT02334800|Palbociclib, PD-0332991, Hepatic Impairment|palbociclib, pd-0332991, hepatic impairment
4849478|NCT02334761|Biopsy|biopsy
4849479|NCT02334748|Juvenile Rheumatoid arthritis (JRA) chronic|juvenile rheumatoid arthritis (jra) chronic
4849480|NCT02334748|systemic inflammatory disorder|systemic inflammatory disorder
4849481|NCT02334748|painful joints|painful joints
4849482|NCT02334748|inflammation of the synovial membrane|inflammation of the synovial membrane
4849483|NCT02334748|auto-immune rheumatoid disease|auto-immune rheumatoid disease
4849484|NCT02334748|reactive rheumatoid arthritis|reactive rheumatoid arthritis
4849485|NCT02334748|Systemic Juvenile Rheumatoid arthritis (SJRA)|systemic juvenile rheumatoid arthritis (sjra)
4849486|NCT02334748|Hereditary Periodic Fevers|hereditary periodic fevers
4849487|NCT02334748|Hereditary periodic fever syndrome(HPFS)|hereditary periodic fever syndrome(hpfs)
4849488|NCT02334748|Familial Mediterranean fever syndrome(FMFS)|familial mediterranean fever syndrome(fmfs)
4849489|NCT02334748|Hyperimmunoglobulinemia D|hyperimmunoglobulinemia d
4849490|NCT02334748|Tumor necrosis factor (TNF) receptor-associated periodic syndrome (TRAPS)|tumor necrosis factor (tnf) receptor-associated periodic syndrome (traps)
4849491|NCT02334748|Muckle-Wells syndrome (MWS)|muckle-wells syndrome (mws)
4849492|NCT02334748|Familial cold auto inflammatory syndrome|familial cold auto inflammatory syndrome
4849493|NCT02334735|Melanoma|melanoma
4849494|NCT02334735|Immunotherapy|immunotherapy
4849495|NCT02334735|DC Vaccine|dc vaccine
4849496|NCT02334735|Adjuvant Therapy|adjuvant therapy
4849497|NCT02334735|Immunogenicity|immunogenicity
4849498|NCT02334696|Vascular Access|vascular access
4849499|NCT02334683|Comparison|comparison
4849500|NCT02334683|Botulinum toxin treatments|botulinum toxin treatments
4849501|NCT02334683|Ultrasound|ultrasound
4849502|NCT02334683|Electrophysiologic|electrophysiologic
4849503|NCT02334683|Spasticity|spasticity
4849504|NCT02334683|Focal dystonia|focal dystonia
4849505|NCT02334670|cryptococcal meningitis|cryptococcal meningitis
4849506|NCT02334670|HIV|hiv
4849507|NCT02334670|AIDS|aids
4849508|NCT02334670|Fluconazole|fluconazole
4849509|NCT02334657|non-aneurysmal|non-aneurysmal
4849510|NCT02334644|Treatment|treatment
4849511|NCT02334644|Natural Health Product|natural health product
4849512|NCT02334644|Anxiety|anxiety
4849513|NCT02334592|the effect of tanning|the effect of tanning
4849514|NCT02334592|vitamin D production|vitamin d production
4849515|NCT02334579|Radiation|radiation
4849516|NCT02334579|Stereotactic Radiosurgery|stereotactic radiosurgery
4849517|NCT02334579|Radiotherapy|radiotherapy
4849518|NCT02334579|Prostate Tumor|prostate tumor
4849519|NCT02334579|Prostate Surgery|prostate surgery
4849520|NCT02334579|CyberKnife|cyberknife
4849521|NCT02334566|PTSD|ptsd
4849522|NCT02334566|Refugee children mental health|refugee children mental health
4849523|NCT02334566|community health care|community health care
4849524|NCT02334553|COPD|copd
4849525|NCT02334553|Chronic bronchitis|chronic bronchitis
4849526|NCT02334553|Cystic fibrosis|cystic fibrosis
4849827|NCT02332785|Data review|data review
4849527|NCT02334553|Bronchoconstriction|bronchoconstriction
4849528|NCT02334553|Perfluorocarbons|perfluorocarbons
4849529|NCT02334553|Carbon dioxide|carbon dioxide
4849530|NCT02334527|metastatic urothelial carcinoma (UC)|metastatic urothelial carcinoma (uc)
4849531|NCT02334527|LCCC 1406|lccc 1406
4849532|NCT02334527|Lineberger|lineberger
4849533|NCT02334527|palbociclib|palbociclib
4849534|NCT02334514|Influenza|influenza
4849535|NCT02334514|Viral shedding|viral shedding
4849536|NCT02334514|oseltamivir|oseltamivir
4849537|NCT02334514|Polymerase Chain Reaction|polymerase chain reaction
4849538|NCT02334501|Healthy Volunteers|healthy volunteers
4849539|NCT02334462|Assays|assays
4849540|NCT02334462|Antibody|antibody
4849541|NCT02334462|Reactogenicity|reactogenicity
4849542|NCT02334462|Mosquito|mosquito
4849543|NCT02334462|Responses|responses
4849544|NCT02334449|healthy volunteers|healthy volunteers
4849545|NCT02334410|fractures|fractures
4849546|NCT02334410|immobilisation|immobilisation
4849547|NCT02334410|paraplegia|paraplegia
4849548|NCT02334410|tetraplegia|tetraplegia
4849549|NCT02334397|Prenatal Exercise|prenatal exercise
4849550|NCT02334397|Prenatal Education|prenatal education
4849551|NCT02334397|Pregnancy|pregnancy
4849552|NCT02334397|Exercise and Birth Outcomes|exercise and birth outcomes
4849553|NCT02334397|Education and Birth Outcomes|education and birth outcomes
4849554|NCT02334397|Maternal Quality of Life|maternal quality of life
4849555|NCT02334397|Birth Satisfaction|birth satisfaction
4849556|NCT02334371|Magnetic Resonance Imaging|magnetic resonance imaging
4849557|NCT02334371|Positron-Emission Tomography|positron-emission tomography
4849558|NCT02334332|Caregiver|caregiver
4849559|NCT02334293|Omegaven|omegaven
4849560|NCT02334293|parenteral nutrition|parenteral nutrition
4849561|NCT02334293|liver disease|liver disease
4849562|NCT02334293|liver injury|liver injury
4849563|NCT02334280|Community mental health|community mental health
4849564|NCT02334280|Health coach|health coach
4849565|NCT02334280|Weight loss|weight loss
4849566|NCT02334280|Fitness|fitness
4849567|NCT02334280|Serious mental illness|serious mental illness
4849568|NCT02334280|Health promotion|health promotion
4849569|NCT02334254|safety|safety
4849570|NCT02334254|rivaroxaban|rivaroxaban
4849571|NCT02334254|ticagrel|ticagrel
4849572|NCT02334254|triple antithrombotic regimen|triple antithrombotic regimen
4849573|NCT02334254|undergoing PCI|undergoing pci
4849574|NCT02334241|Sorbact|sorbact
4849575|NCT02334241|Best local Cares|best local cares
4849576|NCT02334241|DFU|dfu
4849577|NCT02334202|Adolescent|adolescent
4849578|NCT02334202|Obesity/Psychology|obesity/psychology
4849579|NCT02334202|Loss of Control Eating|loss of control eating
4849580|NCT02334202|Child|child
4849581|NCT02334202|Female|female
4849582|NCT02334202|Follow-Up Studies|follow-up studies
4849583|NCT02334202|Health Behavior|health behavior
4849584|NCT02334202|Health Education|health education
4849585|NCT02334202|Humans|humans
4849586|NCT02334202|Intervention Studies|intervention studies
4849587|NCT02334202|Prospective Studies|prospective studies
4849588|NCT02334202|Psychotherapy|psychotherapy
4849589|NCT02334202|Risk Factors|risk factors
4849590|NCT02334202|Weight Loss|weight loss
4849591|NCT02334202|Weight Gain|weight gain
4849592|NCT02334202|Military|military
4849593|NCT02334163|Hepatic Encephalopathy|hepatic encephalopathy
4849594|NCT02334163|Nitazoxanide|nitazoxanide
4849595|NCT02334163|Serum ammonia|serum ammonia
4849596|NCT02334150|combined spinal-epidural analgesia|combined spinal-epidural analgesia
4849597|NCT02334150|pelvic floor muscle|pelvic floor muscle
4849598|NCT02334150|postpartum electrophysiological function|postpartum electrophysiological function
4849599|NCT02334111|Parenting Support for Mothers in Recovery|parenting support for mothers in recovery
4849600|NCT02334111|Neonatal Abstinence Syndrome|neonatal abstinence syndrome
4849601|NCT02334111|Social Determinants of Health|social determinants of health
4849602|NCT02334111|Child Development|child development
4849603|NCT02334111|Child Abuse|child abuse
4849604|NCT02334111|Child Neglect|child neglect
4849605|NCT02334111|Primary Care|primary care
4849606|NCT02334098|Aggression|aggression
4849607|NCT02334098|Omega-3 supplementation|omega-3 supplementation
4849608|NCT02334098|Neurocognition|neurocognition
4849609|NCT02334098|Attention|attention
4849610|NCT02334098|Antisocial|antisocial
4849611|NCT02334059|opioid sparing|opioid sparing
4849612|NCT02334059|ketamine|ketamine
4849613|NCT02334059|obese|obese
4849614|NCT02334059|magnesium|magnesium
4849615|NCT02334046|tracheal extubation|tracheal extubation
4849616|NCT02334046|remifentanil|remifentanil
4849617|NCT02334033|hypertension|hypertension
4849618|NCT02334033|blood pressure|blood pressure
4849619|NCT02334033|cystatin C|cystatin c
4849620|NCT02334033|real-life|real-life
4849621|NCT02334033|kidney|kidney
4849622|NCT02334020|Mental illness|mental illness
4849623|NCT02334020|training|training
4849624|NCT02334020|support|support
4849625|NCT02334020|Mental Health|mental health
4849626|NCT02334007|venous thromboembolism prophylaxis|venous thromboembolism prophylaxis
4849627|NCT02334007|deep vein thrombosis|deep vein thrombosis
4849628|NCT02334007|pulmonary embolism|pulmonary embolism
4849629|NCT02334007|lung resection|lung resection
4849630|NCT02334007|low molecular weight heparin|low molecular weight heparin
4849631|NCT02333968|Cancer pain|cancer pain
4849632|NCT02333968|Self-management|self-management
4849633|NCT02333968|Randomized controlled trial|randomized controlled trial
4849634|NCT02333942|Aging|aging
4849635|NCT02333942|Diagnostic Equipment|diagnostic equipment
4849636|NCT02333929|rivaroxaban|rivaroxaban
4849637|NCT02333929|NOAC|noac
4849638|NCT02333929|anti-Xa activity|anti-xa activity
4849639|NCT02333929|method comparison|method comparison
4849640|NCT02333929|LCMS|lcms
4849641|NCT02333903|Obesity|obesity
4849642|NCT02333903|Sleeve gastrectomy|sleeve gastrectomy
4849643|NCT02333903|Personalized physical activity program|personalized physical activity program
4849644|NCT02333903|Body Composition|body composition
4849645|NCT02333903|Fat mass|fat mass
4849646|NCT02333903|Lean mass|lean mass
4849647|NCT02333890|breast|breast
4849648|NCT02333851|Type 2 diabetes mellitus treatment|type 2 diabetes mellitus treatment
4849649|NCT02333851|Hospitalized patients|hospitalized patients
4849650|NCT02333838|Cord Cell Transplantation|cord cell transplantation
4849651|NCT02333838|High risk myeloid malignancies|high risk myeloid malignancies
4849652|NCT02333799|Tuberculosis|tuberculosis
4849653|NCT02333799|MDR-TB|mdr-tb
4849654|NCT02333799|XDR-TB|xdr-tb
4849655|NCT02333799|Multi-drug resistant|multi-drug resistant
4849656|NCT02333799|Extensively drug resistant|extensively drug resistant
4849657|NCT02333799|Bedaquiline|bedaquiline
4849658|NCT02333799|PA-824|pa-824
4849659|NCT02333799|Linezolid|linezolid
4849660|NCT02333799|TB|tb
4849661|NCT02333799|Pretomanid|pretomanid
4849662|NCT02333799|TMC-207|tmc-207
4849663|NCT02333799|NiX-TB|nix-tb
4849664|NCT02333773|irreversible electroporation|irreversible electroporation
4849665|NCT02333773|Portal venous tumor emboli|portal venous tumor emboli
4849666|NCT02333734|Type 2 diabetes|type 2 diabetes
4849667|NCT02333734|Interval training|interval training
4849668|NCT02333734|Insulin resistance|insulin resistance
4849669|NCT02333734|fat metabolism|fat metabolism
4849670|NCT02333721|Stomach Neoplasms|stomach neoplasms
4849671|NCT02333721|Laparoscopy|laparoscopy
4849672|NCT02333695|SCI, Spinal Cord Injury, Stroke|sci, spinal cord injury, stroke
4849673|NCT02333669|Lung fluid absorption disorders|lung fluid absorption disorders
4849674|NCT02333669|Neonatal respiratory distress syndrome|neonatal respiratory distress syndrome
4849675|NCT02333669|Single nucleotide polymorphism|single nucleotide polymorphism
4849676|NCT02333669|SCNN1A|scnn1a
4849677|NCT02333630|asthma|asthma
4849678|NCT02333617|Manual Therapy|manual therapy
4849679|NCT02333617|Physical Therapy|physical therapy
4849680|NCT02333617|Dry Needling|dry needling
4849681|NCT02333617|Gluteus Medius|gluteus medius
4849682|NCT02333604|cancer|cancer
4849683|NCT02333604|cancer survivorship|cancer survivorship
4849684|NCT02333604|psychosocial needs|psychosocial needs
4849685|NCT02333604|cancer experience|cancer experience
4849686|NCT02333604|metastatic breast cancer|metastatic breast cancer
4849687|NCT02333604|multiple myeloma|multiple myeloma
4849688|NCT02333604|chronic myeloid leukemia|chronic myeloid leukemia
4849689|NCT02333604|breast cancer|breast cancer
4849690|NCT02333604|Prostate|prostate
4849691|NCT02333604|Colon|colon
4849692|NCT02333604|Kidney|kidney
4849693|NCT02333604|Lung|lung
4849694|NCT02333604|Melanoma|melanoma
4849695|NCT02333604|Caregiver|caregiver
4849696|NCT02333604|gastric cancer|gastric cancer
4849697|NCT02333604|stomach cancer|stomach cancer
4849698|NCT02333604|chronic lymphocytic leukemia|chronic lymphocytic leukemia
4849699|NCT02333552|Frailty|frailty
4849700|NCT02333552|Pre-frailty|pre-frailty
4849701|NCT02333552|Fit|fit
4849702|NCT02333552|Robust|robust
4849703|NCT02333552|Elderly|elderly
4849704|NCT02333552|Sociodemography status|sociodemography status
4849705|NCT02333552|Functional status|functional status
4849706|NCT02333552|Cognitive status|cognitive status
4849707|NCT02333552|Nutrition status|nutrition status
4849708|NCT02333552|Comorbidity|comorbidity
4849709|NCT02333552|Mortality|mortality
4849710|NCT02333552|Depression status|depression status
4849711|NCT02333526|ulcerative colitis|ulcerative colitis
4849712|NCT02333526|Clostidium difficile-associated colitis|clostidium difficile-associated colitis
4849713|NCT02333526|Syndecan-1|syndecan-1
4849714|NCT02333526|biomarker|biomarker
4849715|NCT02333474|mix vaccine, lung neoplasms, immunotherapy|mix vaccine, lung neoplasms, immunotherapy
4849716|NCT02333435|Prostatectomy|prostatectomy
4849717|NCT02333435|Omega-3 fatty acids|omega-3 fatty acids
4849718|NCT02333435|Quality of life|quality of life
4849719|NCT02333435|inflammation|inflammation
4849720|NCT02333435|cellular proliferation|cellular proliferation
4849721|NCT02333422|NIRS Neurofeedback|nirs neurofeedback
4849722|NCT02333422|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
4849723|NCT02333422|Near Infrared Spectroscopy|near infrared spectroscopy
4849724|NCT02333422|ADHD|adhd
4849725|NCT02333409|Cancer of pancreas|cancer of pancreas
4849726|NCT02333409|Acupuncture|acupuncture
4849727|NCT02333409|Pain|pain
4849728|NCT02333396|Navigator|navigator
4849729|NCT02333396|Intervention Study|intervention study
4849730|NCT02333396|Randomized Controlled Trial|randomized controlled trial
4849731|NCT02333396|Pediatric Intensive Care Unit|pediatric intensive care unit
4849732|NCT02333396|Decision Making|decision making
4849733|NCT02333383|Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) score|bath ankylosing spondylitis disease activity index (basdai) score
4849734|NCT02333383|EAMs|eams
4849735|NCT02333383|Adalimumab|adalimumab
4849736|NCT02333370|Advanced breast cancer|advanced breast cancer
4849737|NCT02333370|Hormone receptor positive|hormone receptor positive
4849738|NCT02333370|HER2-negative|her2-negative
4849739|NCT02333370|LEE011,|lee011,
4849740|NCT02333370|Letrozole|letrozole
4849741|NCT02333370|Tamoxifen|tamoxifen
4849742|NCT02333370|Fulvestrant|fulvestrant
4849743|NCT02333370|Postmenopausal Asian women|postmenopausal asian women
4849744|NCT02333370|Pre and Postmenopausal Japanese women|pre and postmenopausal japanese women
4849745|NCT02333344|prosthetic fixation|prosthetic fixation
4849746|NCT02333331|Sarcopenia, muscle wasting, elderly, strength, physical function, muscle, gait speed|sarcopenia, muscle wasting, elderly, strength, physical function, muscle, gait speed
4849747|NCT02333305|Ataxia with Oculomotor Apraxia type 1|ataxia with oculomotor apraxia type 1
4849748|NCT02333305|CoQ10|coq10
4849749|NCT02333305|hypoalbuminemia|hypoalbuminemia
4849750|NCT02333266|Candida bloodstream infection|candida bloodstream infection
4849751|NCT02333266|Detection fungal cells|detection fungal cells
4849752|NCT02333266|Fiber-Optic Surface Plasmon Resonance (FO-SPR)|fiber-optic surface plasmon resonance (fo-spr)
4849753|NCT02333253|poor responders|poor responders
4849754|NCT02333253|GnRH antagonist|gnrh antagonist
4849755|NCT02333253|Conventional protocol|conventional protocol
4849756|NCT02333240|Pregnancy|pregnancy
4849757|NCT02333240|Postnatal Care|postnatal care
4849758|NCT02333240|Blood Pressure Monitoring, Home|blood pressure monitoring, home
4849759|NCT02333240|Self Care|self care
4849760|NCT02333240|Pregnancy Complications, Cardiovascular|pregnancy complications, cardiovascular
4849761|NCT02333240|Qualitative Research|qualitative research
4849762|NCT02333240|Antihypertensive Agents|antihypertensive agents
4849763|NCT02333214|Virtual Reality Therapy|virtual reality therapy
4849764|NCT02333214|Video Game|video game
4849765|NCT02333214|Physical Exercise|physical exercise
4849766|NCT02333214|Aged|aged
4849767|NCT02333214|Frailty|frailty
4849768|NCT02333201|Deglutition Disorders|deglutition disorders
4849769|NCT02333201|Dysphagia|dysphagia
4849770|NCT02333201|Mechanical Ventilation|mechanical ventilation
4849771|NCT02333201|Sepsis|sepsis
4849772|NCT02333175|Parkinson's disease, Late stage|parkinson's disease, late stage
4849773|NCT02333149|Melatonin|melatonin
4849774|NCT02333071|HSDD|hsdd
4849775|NCT02333071|Female Sexual Desire Disorder|female sexual desire disorder
4849776|NCT02333058|ALL|all
4849777|NCT02333058|AML|aml
4849778|NCT02333058|MDS|mds
4849779|NCT02333058|JMML|jmml
4849780|NCT02333045|HIV-negative|hiv-negative
4849781|NCT02333045|Women|women
4849782|NCT02333045|At-risk|at-risk
4849783|NCT02333019|risk|risk
4849784|NCT02333006|Anosognosia|anosognosia
4849785|NCT02332993|FPP (Fermented Papaya Preparation)|fpp (fermented papaya preparation)
4849786|NCT02332993|Negative Pressure Therapy|negative pressure therapy
4849787|NCT02332993|Wound Vac|wound vac
4849788|NCT02332993|Wound|wound
4849789|NCT02332993|Type II Diabetic|type ii diabetic
4849790|NCT02332954|Depression|depression
4849791|NCT02332954|Major Depressive Disorder|major depressive disorder
4849792|NCT02332954|Cognition|cognition
4849793|NCT02332954|Cognitive symptoms|cognitive symptoms
4849794|NCT02332954|vortioxetine|vortioxetine
4849795|NCT02332954|real life|real life
4849796|NCT02332954|naturalistic|naturalistic
4849797|NCT02332915|apraxia|apraxia
4849798|NCT02332915|aphasia|aphasia
4849799|NCT02332915|rehabilitation|rehabilitation
4849800|NCT02332915|efficacy|efficacy
4849801|NCT02332915|intensity|intensity
4849802|NCT02332902|Neurofibroma|neurofibroma
4849803|NCT02332902|NF-1|nf-1
4849804|NCT02332902|Everolimus|everolimus
4849805|NCT02332902|mTOR inhibitor|mtor inhibitor
4849806|NCT02332863|Pancreatic cancer|pancreatic cancer
4849807|NCT02332863|Image guided radiation therapy|image guided radiation therapy
4849808|NCT02332863|Fiducial marker placement|fiducial marker placement
4849809|NCT02332863|Endoscopic ultrasound|endoscopic ultrasound
4849810|NCT02332850|Relapsed|relapsed
4849811|NCT02332850|Refractory|refractory
4849812|NCT02332837|informed consent, public led trials, shared decision making,|informed consent, public led trials, shared decision making,
4849813|NCT02332824|Pharmacological therapy|pharmacological therapy
4849814|NCT02332798|Multiple ascending doses|multiple ascending doses
4849815|NCT02332798|safety|safety
4849816|NCT02332798|tolerability|tolerability
4849817|NCT02332798|pharmacokinetics|pharmacokinetics
4849818|NCT02332798|cognitive impairment associated with schizophrenia (CIAS)|cognitive impairment associated with schizophrenia (cias)
4849819|NCT02332785|Colon Serrated Polyps|colon serrated polyps
4849820|NCT02332785|Serrated polyp|serrated polyp
4849821|NCT02332785|Hyperplastic polyps above sigmoid colon|hyperplastic polyps above sigmoid colon
4849822|NCT02332785|Sessile serrated adenoma|sessile serrated adenoma
4849823|NCT02332785|Traditional serrated adenoma|traditional serrated adenoma
4849824|NCT02332785|Colonoscopy|colonoscopy
4849825|NCT02332785|Endoscopy|endoscopy
4849826|NCT02332785|Data collection|data collection
4849828|NCT02332772|Colon Polyps|colon polyps
4849829|NCT02332772|Large polyps|large polyps
4849830|NCT02332772|Flat lesions|flat lesions
4849831|NCT02332772|Endoscopy|endoscopy
4849832|NCT02332772|Colonoscopic resection|colonoscopic resection
4849833|NCT02332772|Colonoscopy|colonoscopy
4849834|NCT02332772|Data review|data review
4849835|NCT02332772|Data collection|data collection
4849837|NCT02332668|PD-1|pd-1
4849838|NCT02332668|PDL1|pdl1
4849839|NCT02332668|PD-L1|pd-l1
4849840|NCT02332668|cHL|chl
4849841|NCT02332668|MSI-H|msi-h
4849842|NCT02332655|Sturge-Weber syndrome|sturge-weber syndrome
4849843|NCT02332655|SWS|sws
4849844|NCT02332655|Drug resistant epilepsy|drug resistant epilepsy
4849845|NCT02332629|Glucocorticoid|glucocorticoid
4849846|NCT02332629|Endothelial barrier|endothelial barrier
4849847|NCT02332629|Glycocalyx|glycocalyx
4849848|NCT02332629|Knee arthroplasty, total|knee arthroplasty, total
4849849|NCT02332616|Glucocorticoid|glucocorticoid
4849850|NCT02332616|Complement activation|complement activation
4849851|NCT02332616|Knee arthroplasty, total|knee arthroplasty, total
4849852|NCT02332603|Glucocorticoid|glucocorticoid
4849853|NCT02332603|Glucose homeostasis|glucose homeostasis
4849854|NCT02332603|Knee arthroplasty, total|knee arthroplasty, total
4849855|NCT02332603|Hip arthroplasty, total|hip arthroplasty, total
4849856|NCT02332564|Circulation, Collateral|circulation, collateral
4849857|NCT02332564|Coronary Artery Disease|coronary artery disease
4849858|NCT02332564|Internal Mammary-Coronary Artery Anastomosis|internal mammary-coronary artery anastomosis
4849859|NCT02332564|Ischemia|ischemia
4849860|NCT02332538|LASER|laser
4849861|NCT02332538|PROSTATE|prostate
4849862|NCT02332538|BIPOLAR|bipolar
4849863|NCT02332538|HYPERPLASIA|hyperplasia
4849864|NCT02332538|VAPORIZATION|vaporization
4849865|NCT02332525|Oral Vibrational Stimulation|oral vibrational stimulation
4849866|NCT02332525|Cognitive Function|cognitive function
4849867|NCT02332525|Mild Cognitive Impairment|mild cognitive impairment
4849868|NCT02332525|cognitive normal elderly|cognitive normal elderly
4849869|NCT02332512|Non-squamous non-small cell lung cancer|non-squamous non-small cell lung cancer
4849870|NCT02332512|Wild-type EGFR|wild-type egfr
4849871|NCT02332512|3rd/4th line treatment|3rd/4th line treatment
4849872|NCT02332512|apatinib|apatinib
4849873|NCT02332499|Anlotinib|anlotinib
4849874|NCT02332499|Metastatic Colorectal Cancer （mCRC）|metastatic colorectal cancer （mcrc）
4849875|NCT02332499|ALTER0703|alter0703
4849876|NCT02332447|Tonic-clonic seizures|tonic-clonic seizures
4849877|NCT02332447|Naloxone|naloxone
4849878|NCT02332447|SUDEP|sudep
4849879|NCT02332421|canine retraction|canine retraction
4849880|NCT02332421|acceleration of tooth movement|acceleration of tooth movement
4849881|NCT02332421|dentoalveolar distraction osteogenesis|dentoalveolar distraction osteogenesis
4849882|NCT02332408|vertebral hemangioma|vertebral hemangioma
4849883|NCT02332408|conventional radiotherapy|conventional radiotherapy
4849884|NCT02332408|Cyber Knife radiotherapy|cyber knife radiotherapy
4849885|NCT02332408|randomized trial|randomized trial
4849886|NCT02332408|radioablation|radioablation
4849887|NCT02332395|pain|pain
4849888|NCT02332395|pain catastrophizing|pain catastrophizing
4849889|NCT02332395|cesarean section|cesarean section
4849890|NCT02332369|Cataract|cataract
4849891|NCT02332356|Crohn Disease|crohn disease
4849892|NCT02332356|Inflammatory Bowel Diseases|inflammatory bowel diseases
4849893|NCT02332356|Disease Attributes|disease attributes
4849894|NCT02332343|Retina|retina
4849895|NCT02332343|Retinal pigment epithelium|retinal pigment epithelium
4849896|NCT02332317|Advanced cancer|advanced cancer
4849897|NCT02332317|Early integration|early integration
4849898|NCT02332317|Palliative rehabilitation|palliative rehabilitation
4849899|NCT02332304|Respiratory Distress Syndrome, Newborn|respiratory distress syndrome, newborn
4849900|NCT02332291|Depression|depression
4849901|NCT02332291|Geriatrics|geriatrics
4849902|NCT02332291|Elderly|elderly
4849903|NCT02332291|MRI|mri
4849904|NCT02332291|Antidepressants|antidepressants
4849905|NCT02332278|Cesarean section|cesarean section
4849906|NCT02332278|Early feeding|early feeding
4849907|NCT02332265|Food Security|food security
4849908|NCT02332265|Microfinance|microfinance
4849909|NCT02332265|Village Savings and Loans|village savings and loans
4849910|NCT02332265|HIV|hiv
4849911|NCT02332265|Quasi-experimental design|quasi-experimental design
4849912|NCT02332265|Malawi|malawi
4849913|NCT02332265|Structural intervention|structural intervention
4849914|NCT02332252|Surgical Wound Infection|surgical wound infection
4849915|NCT02332252|Electrocautery|electrocautery
4849916|NCT02332252|Scalpel|scalpel
4849917|NCT02332239|depression|depression
4849918|NCT02332239|violence|violence
4849919|NCT02332239|emergency department|emergency department
4849920|NCT02332239|mhealth|mhealth
4849921|NCT02332239|text message|text message
4849922|NCT02332213|Volatile organic compounds|volatile organic compounds
4849923|NCT02332213|Nanosensor technology|nanosensor technology
4849924|NCT02332213|GC-MS|gc-ms
4849925|NCT02332213|Breath-testing|breath-testing
4849926|NCT02332213|Digestive cancer|digestive cancer
4849927|NCT02332213|Precancerous lesions|precancerous lesions
4849928|NCT02332213|Colorectal cancer|colorectal cancer
4849929|NCT02332213|Adenoma|adenoma
4849930|NCT02332213|Gastric cancer|gastric cancer
4849931|NCT02332213|Atrophic gastritis|atrophic gastritis
4849932|NCT02332213|OLGIM|olgim
4849933|NCT02332200|Spondylolysis|spondylolysis
4849934|NCT02332200|Spondylolisthesis|spondylolisthesis
4849935|NCT02332200|Low Back Pain|low back pain
4849936|NCT02332174|pharmacokinetics|pharmacokinetics
4849937|NCT02332174|food effect|food effect
4849938|NCT02332174|sex effect|sex effect
4849939|NCT02332174|tolerability|tolerability
4849940|NCT02332135|microwave ablation|microwave ablation
4849941|NCT02332135|maintenance hemodialysis|maintenance hemodialysis
4849942|NCT02332135|mild-to-moderate Secondary Hyperparathyroidism|mild-to-moderate secondary hyperparathyroidism
4849943|NCT02332122|COPD|copd
4849944|NCT02332122|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
4849945|NCT02332122|Aspergillus fumigatus|aspergillus fumigatus
4849946|NCT02332122|Bronchiectasis|bronchiectasis
4849947|NCT02332122|Sensitization|sensitization
4849948|NCT02332122|Vitamin D|vitamin d
4849949|NCT02332109|Fuchs endothelial dystrophy|fuchs endothelial dystrophy
4849950|NCT02332109|oedema|oedema
4849951|NCT02332109|sodium chloride|sodium chloride
4849952|NCT02332109|hyaluronan|hyaluronan
4849953|NCT02332109|sodium hyaluronate|sodium hyaluronate
4849954|NCT02332070|acute kidney injury|acute kidney injury
4849955|NCT02332070|coronary angiography|coronary angiography
4849956|NCT02332070|cardiac surgery|cardiac surgery
4849957|NCT02332070|adverse events|adverse events
4849958|NCT02332070|iodinated contrast|iodinated contrast
4849959|NCT02332070|Thoracic Surgery|thoracic surgery
4849960|NCT02332057|IUD,Diclofenac , Lidocaine|iud,diclofenac , lidocaine
4849961|NCT02332031|Sorafenib, levothyroxine, drug interaction, pharmacokinetics, healthy volunteer|sorafenib, levothyroxine, drug interaction, pharmacokinetics, healthy volunteer
4849962|NCT02331992|Continuous Positive Airway Pressure|continuous positive airway pressure
4849964|NCT02331966|GROWTH FACTORS RECEPTORS|growth factors receptors
4849965|NCT02331966|RECURRENCES|recurrences
4849966|NCT02331953|spine surgery|spine surgery
4849967|NCT02331953|cerebral oximetry|cerebral oximetry
4849968|NCT02331953|postoperative delirium|postoperative delirium
4849969|NCT02331940|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
4849970|NCT02331940|sleeping oxygen saturation|sleeping oxygen saturation
4849971|NCT02331940|sleep quality|sleep quality
4849972|NCT02331927|colorectal cancer|colorectal cancer
4849973|NCT02331927|marker-driven|marker-driven
4849974|NCT02331927|bevacizumab|bevacizumab
4849975|NCT02331927|aflibercept|aflibercept
4849976|NCT02331927|cytokines|cytokines
4849977|NCT02331927|angiogenic factors|angiogenic factors
4849978|NCT02331927|CAF|caf
4849979|NCT02331914|GIST|gist
4849980|NCT02331914|Bio-databank|bio-databank
4849981|NCT02331862|urinary tract infection|urinary tract infection
4849982|NCT02331862|methylprednisolone|methylprednisolone
4849983|NCT02331849|Eosinophilic esophagitis (EoE)|eosinophilic esophagitis (eoe)
4849984|NCT02331849|GERD|gerd
4849985|NCT02331849|esophageal motility|esophageal motility
4849986|NCT02331836|adenoma detection rate|adenoma detection rate
4849987|NCT02331836|polyp detection rate|polyp detection rate
4849988|NCT02331836|withdrawal time|withdrawal time
4849989|NCT02331836|coecal and ileum intubation rate|coecal and ileum intubation rate
4849990|NCT02331797|endoscope|endoscope
4849991|NCT02331797|microscope|microscope
4849992|NCT02331797|transcanal|transcanal
4849993|NCT02331719|intracerebral hemorrhage|intracerebral hemorrhage
4849994|NCT02331719|subcortical intracerebral hemorrhage|subcortical intracerebral hemorrhage
4849995|NCT02331719|ICH|ich
4849996|NCT02331719|parafascicular minimally invasive subcortical access|parafascicular minimally invasive subcortical access
4849997|NCT02331693|EGFR|egfr
4849998|NCT02331693|CAR T cells|car t cells
4849999|NCT02331693|glioma|glioma
4850000|NCT02331680|Undergoing Hemodialysis|undergoing hemodialysis
4850001|NCT02331680|Undergoing Hemodiafiltration|undergoing hemodiafiltration
4850002|NCT02331667|Diet|diet
4850003|NCT02331667|Vitamin-D|vitamin-d
4850004|NCT02331667|Meat|meat
4850005|NCT02331667|Fatty fish|fatty fish
4850006|NCT02331667|Iodine|iodine
4850007|NCT02331667|fatty acid|fatty acid
4850008|NCT02331667|Intervention study|intervention study
4850009|NCT02331667|Wechsler Preschool and Primary Scale of Intelligence|wechsler preschool and primary scale of intelligence
4850010|NCT02331667|Strengths and Difficulties Questionnaire|strengths and difficulties questionnaire
4850011|NCT02331667|Nine hole peg test|nine hole peg test
4850012|NCT02331654|Chronic pain|chronic pain
4850013|NCT02331654|Direct Current Stimulation|direct current stimulation
4850014|NCT02331641|hepatectomy|hepatectomy
4850015|NCT02331641|hepatic resection|hepatic resection
4850016|NCT02331628|TBI Traumatic Brain Injury|tbi traumatic brain injury
4850017|NCT02331628|HO Heterotopic Ossification|ho heterotopic ossification
4850018|NCT02331628|NHO Neurogenic Heterotopic Ossification|nho neurogenic heterotopic ossification
4850019|NCT02331628|ESWT Extracorporeal Shock Wave Therapy|eswt extracorporeal shock wave therapy
4850020|NCT02331615|Traumatic Brain Injury|traumatic brain injury
4850021|NCT02331615|Executive function difficulties|executive function difficulties
4850022|NCT02331615|Transcranial direct current stimulation|transcranial direct current stimulation
4850023|NCT02331602|atrial fibrillation|atrial fibrillation
4850024|NCT02331602|anticoagulation|anticoagulation
4850025|NCT02331602|inflammation|inflammation
4850026|NCT02331589|Fatigue|fatigue
4850027|NCT02331589|Panax ginseng|panax ginseng
4850028|NCT02331589|Chronic hepatitis|chronic hepatitis
4850029|NCT02331589|Non-alcoholic Fatty Liver Disease|non-alcoholic fatty liver disease
4850030|NCT02331589|Adiponectin|adiponectin
4850031|NCT02331563|dexmedetomidine|dexmedetomidine
4850032|NCT02331550|Low-Grade Squamous Intraepithelial Lesions|low-grade squamous intraepithelial lesions
4850033|NCT02331524|exercise|exercise
4850034|NCT02331524|daily activity|daily activity
4850035|NCT02331485|Prevention of wound infection and wound complication|prevention of wound infection and wound complication
4850036|NCT02331472|interstitial cystitis|interstitial cystitis
4850037|NCT02331472|biomarker|biomarker
4850038|NCT02331459|mood|mood
4850039|NCT02331459|cognitive state|cognitive state
4850040|NCT02331459|physical activity|physical activity
4850041|NCT02331459|frailty|frailty
4850042|NCT02331394|Chinese herbs|chinese herbs
4850043|NCT02331394|lung cancer|lung cancer
4850044|NCT02331394|quality of life|quality of life
4850045|NCT02331368|Multiple Myeloma|multiple myeloma
4850046|NCT02331368|Anti-PD-1|anti-pd-1
4850047|NCT02331368|Pembrolizumab|pembrolizumab
4850048|NCT02331368|Post-transplant|post-transplant
4850049|NCT02331368|Maintenance|maintenance
4850050|NCT02331355|amputation, hand, forearm, arm, traumatic, transplantation|amputation, hand, forearm, arm, traumatic, transplantation
4850051|NCT02331342|Agreement of NICOM and Innocor|agreement of nicom and innocor
4850052|NCT02331329|Accuracy of NICOM|accuracy of nicom
4850053|NCT02331329|precision of NICOM|precision of nicom
4850054|NCT02331316|obesity|obesity
4850055|NCT02331316|diet|diet
4850056|NCT02331316|weight|weight
4850057|NCT02331316|hunger|hunger
4850058|NCT02331316|public led trial|public led trial
4850059|NCT02331264|Cardiac Toxicity|cardiac toxicity
4850060|NCT02331264|Metal on Metal Hip Implants|metal on metal hip implants
4850061|NCT02331186|Obesity|obesity
4850062|NCT02331186|Bariatric surgery|bariatric surgery
4850063|NCT02331186|Urinary incontinence|urinary incontinence
4850064|NCT02331186|Pelvic floor|pelvic floor
4850065|NCT02331173|XLRS|xlrs
4850066|NCT02331173|RS1|rs1
4850067|NCT02331173|maculoschisis|maculoschisis
4850068|NCT02331160|Pregnancy|pregnancy
4850069|NCT02331160|Breech Presentation|breech presentation
4850070|NCT02331160|Version, fetal|version, fetal
4850071|NCT02331160|Musculoskeletal Manipulations|musculoskeletal manipulations
4850072|NCT02331160|Medicine, Traditional|medicine, traditional
4850073|NCT02331134|Tissue|tissue
4850074|NCT02331134|Hematopoietic Stem Cell|hematopoietic stem cell
4850075|NCT02331134|Melanoma|melanoma
4850076|NCT02331134|Squamous Head and Neck Cancer|squamous head and neck cancer
4850077|NCT02331121|children|children
4850078|NCT02331121|parents|parents
4850079|NCT02331121|internet|internet
4850080|NCT02331121|video|video
4850081|NCT02331121|training|training
4850082|NCT02331121|interactive|interactive
4850083|NCT02331082|Infant Mortality|infant mortality
4850084|NCT02331082|Under-two mortality|under-two mortality
4850085|NCT02331082|Maternal Mortality|maternal mortality
4850086|NCT02331082|Implementation Research|implementation research
4850087|NCT02331082|Health Systems Strengthening|health systems strengthening
4850088|NCT02331082|Chronic Disease Management|chronic disease management
4850089|NCT02331082|Commuity Health Workers|commuity health workers
4850090|NCT02331069|radial neuropathy|radial neuropathy
4850091|NCT02331056|Stroke volume variation|stroke volume variation
4850092|NCT02331056|fluid responsiveness|fluid responsiveness
4850093|NCT02331056|One-lung ventilation|one-lung ventilation
4850094|NCT02331056|thoracotomy|thoracotomy
4850095|NCT02331030|brachio-axillary|brachio-axillary
4850096|NCT02331030|brachio-basilic|brachio-basilic
4850097|NCT02331030|interfascial plane block|interfascial plane block
4850098|NCT02331030|Pecs II block|pecs ii block
4850099|NCT02331030|supraclavicular brachial plexus block|supraclavicular brachial plexus block
4850100|NCT02331017|Bimodal|bimodal
4850101|NCT02331017|Cochlear Implant|cochlear implant
4850102|NCT02331017|Hearing aid|hearing aid
4850103|NCT02331017|Auditory Perception|auditory perception
4850104|NCT02331004|Frail Elderly|frail elderly
4850105|NCT02331004|Motor Skills|motor skills
4850106|NCT02331004|Upper Extremity|upper extremity
4850107|NCT02330991|glioblastoma|glioblastoma
4850108|NCT02330991|relapse|relapse
4850109|NCT02330991|Temozolomide|temozolomide
4850110|NCT02330991|glioblastoma at first relapse|glioblastoma at first relapse
4850111|NCT02330965|clinical research|clinical research
4850112|NCT02330965|mechanistic studies|mechanistic studies
4850113|NCT02330965|blood draw|blood draw
4850114|NCT02330965|CSF by lumbar puncture (optional)|csf by lumbar puncture (optional)
4850115|NCT02330952|Double-blind method|double-blind method
4850116|NCT02330952|Randomized Controlled trials|randomized controlled trials
4850117|NCT02330939|Postprandial glycemia|postprandial glycemia
4850118|NCT02330939|Momounsaturated fatty acids|momounsaturated fatty acids
4850119|NCT02330939|Saturated fatty acids|saturated fatty acids
4850120|NCT02330939|Glycemic index|glycemic index
4850121|NCT02330939|Glycemic load|glycemic load
4850122|NCT02330939|Sensor augmented pump system|sensor augmented pump system
4850123|NCT02330926|Combined modality treatment|combined modality treatment
4850124|NCT02330926|Diet therapy|diet therapy
4850125|NCT02330926|Exercise therapy|exercise therapy
4850126|NCT02330926|Ibuprofen|ibuprofen
4850127|NCT02330926|Dietary supplements|dietary supplements
4850128|NCT02330913|total gastrectomy|total gastrectomy
4850129|NCT02330913|intracorporeal|intracorporeal
4850130|NCT02330913|totally laparoscopic|totally laparoscopic
4850131|NCT02330913|esophagojejunostomy|esophagojejunostomy
4850132|NCT02330913|anastomosis|anastomosis
4850133|NCT02330900|Implantable cardioverter defibrillator|implantable cardioverter defibrillator
4850134|NCT02330900|Electromagnetic interference|electromagnetic interference
4850135|NCT02330900|Cell phone|cell phone
4850136|NCT02330887|Maternal Mortality|maternal mortality
4850137|NCT02330887|Institutional Birth Rate|institutional birth rate
4850138|NCT02330887|Neonatal Mortality Rate|neonatal mortality rate
4850139|NCT02330887|Preterm Birth|preterm birth
4850140|NCT02330887|Stillbirth|stillbirth
4850141|NCT02330887|Infant, Small for Gestational Age|infant, small for gestational age
4850142|NCT02330887|Nepal|nepal
4850143|NCT02330887|Implementation Research|implementation research
4850144|NCT02330887|Global Health|global health
4850145|NCT02330874|Risk|risk
4850146|NCT02330874|score|score
4850147|NCT02330874|readmission|readmission
4850148|NCT02330874|ICU|icu
4850149|NCT02330861|Coronary Circulation|coronary circulation
4850150|NCT02330848|Obesity|obesity
4850151|NCT02330848|Walnuts|walnuts
4850152|NCT02330848|Endothelial Function|endothelial function
4850153|NCT02330848|Adults at risk|adults at risk
4850154|NCT02330835|school|school
4850155|NCT02330835|bus|bus
4850156|NCT02330835|school bus|school bus
4850157|NCT02330835|driver|driver
4850158|NCT02330835|training|training
4850159|NCT02330835|behavior|behavior
4850160|NCT02330835|management|management
4850161|NCT02330835|interactive|interactive
4850162|NCT02330835|computer|computer
4850163|NCT02330809|headache|headache
4850164|NCT02330809|hunger intensity|hunger intensity
4850165|NCT02330809|public led online trial|public led online trial
4850166|NCT02330809|water intake|water intake
4850167|NCT02330783|Metastatic Renal Cell Carcinoma|metastatic renal cell carcinoma
4850168|NCT02330783|Third-line treatment|third-line treatment
4850169|NCT02330783|Sorafenib|sorafenib
4850170|NCT02330783|Bevacizumab|bevacizumab
4850171|NCT02330770|GnRHa trigger|gnrha trigger
4850172|NCT02330770|Luteal phase support|luteal phase support
4850173|NCT02330770|OHSS|ohss
4850174|NCT02330757|Frozen-thawed embryo transfer|frozen-thawed embryo transfer
4850175|NCT02330757|FET protocols|fet protocols
4850176|NCT02330705|Intrauterine insemination|intrauterine insemination
4850177|NCT02330705|IUI|iui
4850178|NCT02330705|HCG|hcg
4850179|NCT02330679|Major Depression, Neuroimaging, Desvenlafaxine, Machine learning|major depression, neuroimaging, desvenlafaxine, machine learning
4850180|NCT02330653|Colitis|colitis
4850181|NCT02330653|Fecal Microbiota Transplant|fecal microbiota transplant
4850182|NCT02330653|Ulcerative colitis|ulcerative colitis
4850183|NCT02330653|inflammatory bowel disease|inflammatory bowel disease
4850184|NCT02330640|CABG|cabg
4850185|NCT02330640|antiplatelet therapy|antiplatelet therapy
4850186|NCT02330640|ticagrelor|ticagrelor
4850187|NCT02330614|personality|personality
4850188|NCT02330614|bleaching|bleaching
4850189|NCT02330588|Obesity|obesity
4850190|NCT02330588|Prevention|prevention
4850191|NCT02330588|Pediatric|pediatric
4850192|NCT02330588|Parents|parents
4850193|NCT02330588|Primary Care|primary care
4850194|NCT02330588|eHealth|ehealth
4850195|NCT02330588|Internet|internet
4850196|NCT02330562|Marizomib|marizomib
4850197|NCT02330562|Bevacizumab|bevacizumab
4850198|NCT02330562|Avastin|avastin
4850199|NCT02330562|Grade IV malignant glioma|grade iv malignant glioma
4850200|NCT02330562|proteasome inhibitor|proteasome inhibitor
4850201|NCT02330562|glioblastoma|glioblastoma
4850202|NCT02330562|brain tumor|brain tumor
4850203|NCT02330562|malignant glioma|malignant glioma
4850204|NCT02330562|brain cancer|brain cancer
4850205|NCT02330562|gliosarcoma|gliosarcoma
4850206|NCT02330562|BEV|bev
4850207|NCT02330536|Circulatory and Respiratory Physiological Phenomena|circulatory and respiratory physiological phenomena
4850208|NCT02330536|Thoracoscopy|thoracoscopy
4850209|NCT02330510|Alzheimer's Disease|alzheimer's disease
4850210|NCT02330510|White Matter Hyperintensities|white matter hyperintensities
4850211|NCT02330510|Vascular Cognitive Impairment|vascular cognitive impairment
4850212|NCT02330510|Amyloid Imaging|amyloid imaging
4850213|NCT02330510|Transient Ischemic Attack|transient ischemic attack
4850214|NCT02330484|Community management， incentives, Medication Adherence|community management， incentives, medication adherence
4850215|NCT02330471|conization|conization
4850216|NCT02330471|LLETZ|lletz
4850217|NCT02330471|cervical dysplasia|cervical dysplasia
4850218|NCT02330471|cervical intraepithelial neoplasia|cervical intraepithelial neoplasia
4850219|NCT02330458|Inflammatory Bowel Disease|inflammatory bowel disease
4850220|NCT02330458|Crohn's disease|crohn's disease
4850221|NCT02330458|Pediatric IBD|pediatric ibd
4850222|NCT02330458|small bowel ultrasound|small bowel ultrasound
4850223|NCT02330458|infliximab|infliximab
4850224|NCT02330419|Naltrexone|naltrexone
4850225|NCT02330406|Dipeptidyl-Peptidase 4 Inhibitors|dipeptidyl-peptidase 4 inhibitors
4850226|NCT02330406|LDL Cholesterol|ldl cholesterol
4850227|NCT02330406|Glycosylated Hemoglobin|glycosylated hemoglobin
4850228|NCT02330406|Diabetes Mellitus|diabetes mellitus
4850229|NCT02330406|Coronary Disease|coronary disease
4850230|NCT02330380|psoriasis, comparative effects, inflammation|psoriasis, comparative effects, inflammation
4850231|NCT02330354|preschool|preschool
4850232|NCT02330354|behavior change|behavior change
4850233|NCT02330354|social marketing|social marketing
4850234|NCT02330354|child care providers|child care providers
4850235|NCT02330354|nutrition|nutrition
4850236|NCT02330354|child care centers|child care centers
4850237|NCT02330354|physical activity|physical activity
4850238|NCT02330341|Glucose Intolerance|glucose intolerance
4850239|NCT02330341|Artemisia dracunculus|artemisia dracunculus
4850240|NCT02330341|Insulin|insulin
4850241|NCT02330328|Chest Pain|chest pain
4850242|NCT02330328|Telemetry|telemetry
4850243|NCT02330315|transcranial direct current stimulation|transcranial direct current stimulation
4850244|NCT02330315|transcranial ultrasound|transcranial ultrasound
4850245|NCT02330315|non-invasive brain stimulation|non-invasive brain stimulation
4850246|NCT02330250|Systemic Lupus Erythematosus|systemic lupus erythematosus
4850247|NCT02330250|Pharmaceutical care|pharmaceutical care
4850248|NCT02330250|Pharmaceutical services|pharmaceutical services
4850249|NCT02330250|Medication adherence|medication adherence
4850250|NCT02330224|Blood pressure|blood pressure
4850251|NCT02330224|Lipids|lipids
4850252|NCT02330224|Cardiovascular|cardiovascular
4850253|NCT02330224|Health services|health services
4850254|NCT02330224|Hypertension|hypertension
4850255|NCT02330211|Colitis|colitis
4850256|NCT02330211|Fecal Microbiota Transplant|fecal microbiota transplant
4850257|NCT02330211|Crohn's Disease|crohn's disease
4850258|NCT02330211|inflammatory bowel disease|inflammatory bowel disease
4850259|NCT02330198|self-reported outcome instrument|self-reported outcome instrument
4850260|NCT02330185|spinal anesthesia|spinal anesthesia
4850261|NCT02330185|ultrasonography|ultrasonography
4850262|NCT02330185|anatomical landmark|anatomical landmark
4850263|NCT02330159|Pilonidal|pilonidal
4850264|NCT02330159|Quality of Life|quality of life
4850265|NCT02330133|mid-life women|mid-life women
4850266|NCT02330133|unintended pregnancy|unintended pregnancy
4850267|NCT02330133|STI/HIV prevention|sti/hiv prevention
4850268|NCT02330133|intervention|intervention
4850269|NCT02330133|interactive|interactive
4850270|NCT02330133|CD-ROM|cd-rom
4850271|NCT02330133|multimedia|multimedia
4850272|NCT02330133|video|video
4850273|NCT02330120|peak airway pressure|peak airway pressure
4850274|NCT02330120|airway resistance|airway resistance
4850275|NCT02330120|sedation|sedation
4850276|NCT02330120|intensive care|intensive care
4850277|NCT02330094|aSAH|asah
4850278|NCT02330094|SAH|sah
4850279|NCT02330081|pathogen reduction technology|pathogen reduction technology
4850280|NCT02330081|whole blood|whole blood
4850281|NCT02330081|Platelets|platelets
4850282|NCT02330081|Mirasol|mirasol
4850283|NCT02330042|Diabetes|diabetes
4850284|NCT02330042|OCT|oct
4850285|NCT02330042|Angiography|angiography
4850286|NCT02330042|Diabetic retinopathy|diabetic retinopathy
4850287|NCT02330029|Irritable bowel syndrome,|irritable bowel syndrome,
4850288|NCT02330029|Pinaverium|pinaverium
4850289|NCT02330029|Herbal medication for IBS,|herbal medication for ibs,
4850290|NCT02330029|Tong Xie Yao Fang (Formula for pain and diarrhea)|tong xie yao fang (formula for pain and diarrhea)
4850291|NCT02330003|Influenza|influenza
4850292|NCT02330003|Influenza vaccine|influenza vaccine
4850293|NCT02330003|Split influenza vaccine|split influenza vaccine
4850294|NCT02330003|Seasonal influenza vaccine|seasonal influenza vaccine
4850295|NCT02329990|phosphorus intake|phosphorus intake
4850296|NCT02329977|duodenal-biliary reflux|duodenal-biliary reflux
4850297|NCT02329964|Rocuronium|rocuronium
4850298|NCT02329964|Sugammadex|sugammadex
4850299|NCT02329964|Succinylcholine|succinylcholine
4850300|NCT02329964|Cisatracurium|cisatracurium
4850301|NCT02329964|Neostigmine|neostigmine
4850302|NCT02329964|acceleromyography (TOF-Watch®)|acceleromyography (tof-watch®)
4850303|NCT02329912|postoperative ileus|postoperative ileus
4850304|NCT02329912|SmartPill|smartpill
4850305|NCT02329912|gastrointestinal transit|gastrointestinal transit
4850306|NCT02329912|prokinetic drugs|prokinetic drugs
4850307|NCT02329886|chronic diseases|chronic diseases
4850308|NCT02329886|risk factors|risk factors
4850309|NCT02329886|health outcomes|health outcomes
4850310|NCT02329873|Acute exacerbation of chronic obstructive pulmonary disease|acute exacerbation of chronic obstructive pulmonary disease
4850311|NCT02329873|Older adults|older adults
4850312|NCT02329873|Respiratory rehabilitation exercise|respiratory rehabilitation exercise
4850313|NCT02329847|Hematologic Neoplasms|hematologic neoplasms
4850314|NCT02329847|JNJ54179060|jnj54179060
4850315|NCT02329847|Ibrutinib|ibrutinib
4850316|NCT02329847|Nivolumab|nivolumab
4850317|NCT02329821|lactate|lactate
4850318|NCT02329821|hartmann solution|hartmann solution
4850319|NCT02329821|hepatocellular carcinoma|hepatocellular carcinoma
4850320|NCT02329808|TDM|tdm
4850321|NCT02329808|dried blood spot|dried blood spot
4850426|NCT02329015|stress|stress
4850322|NCT02329808|immunosuppressive|immunosuppressive
4850323|NCT02329808|antifungal|antifungal
4850324|NCT02329769|Duchenne muscular dystrophy|duchenne muscular dystrophy
4850325|NCT02329769|DMD|dmd
4850326|NCT02329769|BioMarin|biomarin
4850327|NCT02329769|PRO044|pro044
4850328|NCT02329756|Tranexamic Acid|tranexamic acid
4850329|NCT02329730|diagnosis of Tuberculosis (TB)|diagnosis of tuberculosis (tb)
4850330|NCT02329730|ESAT6|esat6
4850331|NCT02329730|CFP10|cfp10
4850332|NCT02329730|Phase IIa Clinical Trial|phase iia clinical trial
4850333|NCT02329704|IUI/AIH|iui/aih
4850334|NCT02329704|Semen preparation|semen preparation
4850335|NCT02329704|Semen processing|semen processing
4850336|NCT02329704|ICSI/IVF|icsi/ivf
4850337|NCT02329704|ART|art
4850338|NCT02329704|Density Gradient|density gradient
4850339|NCT02329704|Swimming down|swimming down
4850340|NCT02329704|hyaluronan affinity testing|hyaluronan affinity testing
4850341|NCT02329704|Sperm vitality testin|sperm vitality testin
4850342|NCT02329691|safety climate|safety climate
4850343|NCT02329691|surgery|surgery
4850344|NCT02329678|Apicomarginal defects|apicomarginal defects
4850345|NCT02329678|clinical study/trial|clinical study/trial
4850346|NCT02329678|collagen membrane|collagen membrane
4850347|NCT02329678|guided tissue regeneration|guided tissue regeneration
4850348|NCT02329678|endodontic microsurgery|endodontic microsurgery
4850349|NCT02329652|Neuroprosthesis|neuroprosthesis
4850350|NCT02329652|Functional Electrical Stimulation|functional electrical stimulation
4850351|NCT02329639|bevacizumab|bevacizumab
4850352|NCT02329639|paclitaxel|paclitaxel
4850353|NCT02329639|pharmacogenetics|pharmacogenetics
4850354|NCT02329639|breast cancer|breast cancer
4850355|NCT02329561|Pharmacokinetics|pharmacokinetics
4850356|NCT02329561|Opioid|opioid
4850357|NCT02329561|Geriatric|geriatric
4850358|NCT02329561|Pharmacodynamics|pharmacodynamics
4850359|NCT02329548|Alizarin|alizarin
4850360|NCT02329548|Orthostatic|orthostatic
4850361|NCT02329548|POTS|pots
4850362|NCT02329548|Tilt table testing|tilt table testing
4850363|NCT02329548|Syncope|syncope
4850364|NCT02329548|Anxiety|anxiety
4850365|NCT02329522|Haemodynamics|haemodynamics
4850366|NCT02329522|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
4850367|NCT02329522|Ultrasonic Cardiac Output Monitor|ultrasonic cardiac output monitor
4850368|NCT02329522|severity|severity
4850369|NCT02329509|operative procedures|operative procedures
4850370|NCT02329483|Infertility|infertility
4850371|NCT02329483|Ovulation induction|ovulation induction
4850372|NCT02329483|Low-dose step-up protocol|low-dose step-up protocol
4850373|NCT02329483|Ovarian high responder|ovarian high responder
4850374|NCT02329483|Androgens|androgens
4850375|NCT02329483|Androstenedione|androstenedione
4850376|NCT02329483|Testosterone|testosterone
4850377|NCT02329483|rhFSH|rhfsh
4850378|NCT02329457|double-blind, randomized, intradermal, VZVv, HSCT|double-blind, randomized, intradermal, vzvv, hsct
4850379|NCT02329431|child mental health, mental health services, Latino families|child mental health, mental health services, latino families
4850380|NCT02329340|child safety|child safety
4850381|NCT02329340|injury|injury
4850382|NCT02329340|prevention|prevention
4850383|NCT02329340|computer|computer
4850384|NCT02329340|internet|internet
4850385|NCT02329327|Factor Xa Inhibitors|factor xa inhibitors
4850386|NCT02329327|Major|major
4850387|NCT02329327|Bleeding|bleeding
4850388|NCT02329327|Anticoagulant|anticoagulant
4850389|NCT02329301|malaria|malaria
4850390|NCT02329301|malaria, falciparum|malaria, falciparum
4850391|NCT02329301|antimalarials|antimalarials
4850392|NCT02329262|exercise|exercise
4850393|NCT02329262|mentors|mentors
4850394|NCT02329262|health education|health education
4850395|NCT02329262|obesity|obesity
4850396|NCT02329249|smoking cessation|smoking cessation
4850397|NCT02329249|coach-supported|coach-supported
4850398|NCT02329249|tobacco use cessation|tobacco use cessation
4850399|NCT02329249|online|online
4850400|NCT02329249|internet-based|internet-based
4850401|NCT02329249|tailored|tailored
4850402|NCT02329223|Chronic spontaneous uriticaria|chronic spontaneous uriticaria
4850403|NCT02329223|Omalizumab|omalizumab
4850404|NCT02329197|Infertility|infertility
4850405|NCT02329197|Invitro fertilization|invitro fertilization
4850406|NCT02329145|renal denervation|renal denervation
4850407|NCT02329132|diabetic macular edema|diabetic macular edema
4850408|NCT02329132|VEGF|vegf
4850409|NCT02329132|ranibizumab|ranibizumab
4850410|NCT02329132|oxygen consumption|oxygen consumption
4850411|NCT02329054|Ebola Virus Disease|ebola virus disease
4850412|NCT02329054|Antivirals|antivirals
4850413|NCT02329054|Mortality|mortality
4850414|NCT02329054|Viral load|viral load
4850415|NCT02329054|Proof-of-concept|proof-of-concept
4850416|NCT02329054|Phase II trial|phase ii trial
4850417|NCT02329054|Guinea|guinea
4850418|NCT02329054|Adults|adults
4850419|NCT02329054|Children|children
4850420|NCT02329041|videolaryngoscope|videolaryngoscope
4850421|NCT02329041|double-lumen tube|double-lumen tube
4850422|NCT02329041|intubation|intubation
4850423|NCT02329028|Emergency Care, Prehospital|emergency care, prehospital
4850424|NCT02329028|Electroencephalography|electroencephalography
4850425|NCT02329028|Coma|coma
4850427|NCT02329015|alternative|alternative
4850428|NCT02329015|complementary|complementary
4850429|NCT02329015|self-regulation|self-regulation
4850430|NCT02329002|Retinoblastoma|retinoblastoma
4850431|NCT02329002|Second primary tumor|second primary tumor
4850432|NCT02329002|Screening|screening
4850433|NCT02329002|Magnetic resonance imaging|magnetic resonance imaging
4850434|NCT02328989|prematurity|prematurity
4850435|NCT02328989|short cervix|short cervix
4850436|NCT02328989|twin pregnancy|twin pregnancy
4850437|NCT02328989|pessary|pessary
4850438|NCT02328963|Cytomegalovirus infection and disease|cytomegalovirus infection and disease
4850439|NCT02328963|CMV-seropositive recipients|cmv-seropositive recipients
4850440|NCT02328963|Everolimus|everolimus
4850441|NCT02328963|preemptive strategy|preemptive strategy
4850442|NCT02328963|mTOR inhibitor|mtor inhibitor
4850443|NCT02328898|Polymer free stent|polymer free stent
4850444|NCT02328898|percutaneous coronary intervention|percutaneous coronary intervention
4850445|NCT02328885|high-risk acute leukemia|high-risk acute leukemia
4850446|NCT02328885|graft versus leukemia|graft versus leukemia
4850447|NCT02328885|DLI|dli
4850448|NCT02328885|UCBT|ucbt
4850449|NCT02328872|screening|screening
4850450|NCT02328872|cervical screening|cervical screening
4850451|NCT02328872|Human Papillomavirus (HPV)|human papillomavirus (hpv)
4850452|NCT02328872|cancer prevention|cancer prevention
4850453|NCT02328859|Gait|gait
4850454|NCT02328859|Rehabilitation|rehabilitation
4850455|NCT02328859|Virtual Reality|virtual reality
4850456|NCT02328833|Depression|depression
4850457|NCT02328833|Clinical Practice Guideline|clinical practice guideline
4850458|NCT02328833|Implementation|implementation
4850459|NCT02328833|Primary Care|primary care
4850460|NCT02328833|Computerized Guideline|computerized guideline
4850461|NCT02328820|Fractional Flow Reserve, Myocardial|fractional flow reserve, myocardial
4850462|NCT02328820|Coronary Flow Reserve|coronary flow reserve
4850463|NCT02328807|adenocarcinoma|adenocarcinoma
4850464|NCT02328807|prostate|prostate
4850465|NCT02328807|ENCAGE™|encage™
4850466|NCT02328807|focal bipolar radiofrequency ablation|focal bipolar radiofrequency ablation
4850467|NCT02328807|radiofrequency ablation (RFA)|radiofrequency ablation (rfa)
4850468|NCT02328807|radiotherapy|radiotherapy
4850469|NCT02328794|smoking cessation|smoking cessation
4850470|NCT02328794|behavioral economics|behavioral economics
4850471|NCT02328794|e-cigarettes|e-cigarettes
4850472|NCT02328794|NRT|nrt
4850473|NCT02328781|vertebral artery stenosis|vertebral artery stenosis
4850474|NCT02328781|drug-eluting stent|drug-eluting stent
4850475|NCT02328703|Reiki|reiki
4850476|NCT02328703|Neuropathic Pain|neuropathic pain
4850477|NCT02328703|Military Service Members|military service members
4850478|NCT02328703|Extermity Trauma|extermity trauma
4850479|NCT02328690|binaural beat technology|binaural beat technology
4850480|NCT02328690|sound technology|sound technology
4850481|NCT02328690|cardiovascular stress response|cardiovascular stress response
4850482|NCT02328690|military|military
4850483|NCT02328690|music|music
4850484|NCT02328690|anxiety|anxiety
4850485|NCT02328690|stress|stress
4850486|NCT02328677|Colorectal cancer|colorectal cancer
4850487|NCT02328677|rectosigmoid|rectosigmoid
4850488|NCT02328677|rectum|rectum
4850489|NCT02328677|colon|colon
4850490|NCT02328664|Endoscopic resection|endoscopic resection
4850491|NCT02328664|Pathology|pathology
4850492|NCT02328664|Rescue surgery|rescue surgery
4850493|NCT02328651|Mild and Moderate Severe Patients With hand_foot-mouth Disease|mild and moderate severe patients with hand_foot-mouth disease
4850494|NCT02328638|ASD|asd
4850495|NCT02328625|Scleroderma|scleroderma
4850496|NCT02328625|Device|device
4850497|NCT02328625|ADRCs|adrcs
4850498|NCT02328625|adipose derived regenerative cells|adipose derived regenerative cells
4850499|NCT02328625|hand|hand
4850500|NCT02328547|fecal microbiota transplantation|fecal microbiota transplantation
4850501|NCT02328547|diarrhea-predominant|diarrhea-predominant
4850502|NCT02328534|ICSI/IVF|icsi/ivf
4850503|NCT02328534|Semen processing|semen processing
4850504|NCT02328534|Semen preparation|semen preparation
4850505|NCT02328534|Swim down|swim down
4850506|NCT02328534|Density gradient|density gradient
4850507|NCT02328534|Silica solution|silica solution
4850508|NCT02328521|Neointima|neointima
4850509|NCT02328521|Tomography, Optical Coherence|tomography, optical coherence
4850510|NCT02328521|drug-eluting stents|drug-eluting stents
4850511|NCT02328521|Nicorandil|nicorandil
4850512|NCT02328508|hyperbaric oxygen therapy|hyperbaric oxygen therapy
4850513|NCT02328508|diabetic foot ulcer|diabetic foot ulcer
4850514|NCT02328508|wound healing|wound healing
4850515|NCT02328508|inflammation|inflammation
4850516|NCT02328508|glycemic control|glycemic control
4850517|NCT02328508|amputation|amputation
4850518|NCT02328508|bacterial infection|bacterial infection
4850519|NCT02328508|quality of life|quality of life
4850520|NCT02328495|Misoprostol, Office hysteroscopy ,Pain|misoprostol, office hysteroscopy ,pain
4850521|NCT02328469|aseptic meningitis|aseptic meningitis
4850522|NCT02328469|tick-borne encephalitis|tick-borne encephalitis
4850523|NCT02328469|Lyme neuroborreliosis|lyme neuroborreliosis
4850524|NCT02328469|inflammation|inflammation
4850525|NCT02328469|outcome|outcome
4850526|NCT02328443|CYP3A|cyp3a
4850527|NCT02328443|Metabolomics|metabolomics
4850528|NCT02328404|Vitamin D|vitamin d
4850529|NCT02328404|deficiency|deficiency
4850530|NCT02328404|hypovitaminosis D|hypovitaminosis d
4850531|NCT02328404|Biodal|biodal
4850532|NCT02328404|25 hydroxy Vitamin D|25 hydroxy vitamin d
4850533|NCT02328404|25hydroxyvitamin D|25hydroxyvitamin d
4850534|NCT02328404|25(OH)D|25(oh)d
4850535|NCT02328404|PCOS|pcos
4850536|NCT02328404|insulin resistance|insulin resistance
4850537|NCT02328404|BMI|bmi
4850538|NCT02328404|chromium levels|chromium levels
4850539|NCT02328404|vitamin D 3|vitamin d 3
4850540|NCT02328404|cholecalciferol|cholecalciferol
4850541|NCT02328404|50,000 IU|50,000 iu
4850542|NCT02328365|Colorectal Cancer|colorectal cancer
4850543|NCT02328365|Comorbidity|comorbidity
4850544|NCT02328365|Perioperative Care|perioperative care
4850545|NCT02328365|Surgery|surgery
4850546|NCT02328352|Buckypaper (BP) of Multi-Walled Carbon Nanotubes (MWCNTs)|buckypaper (bp) of multi-walled carbon nanotubes (mwcnts)
4850547|NCT02328352|surgical hernia prosthesis|surgical hernia prosthesis
4850548|NCT02328352|abdominal wall defects surgery|abdominal wall defects surgery
4850549|NCT02328352|prosthesis adhesion|prosthesis adhesion
4850550|NCT02328352|disaster preparation and recovery hernia|disaster preparation and recovery hernia
4850551|NCT02328352|Abdominal Wall Disaster Surgery|abdominal wall disaster surgery
4850552|NCT02328352|Fixation of prosthetic materials in general surgery|fixation of prosthetic materials in general surgery
4850553|NCT02328326|Diabetes|diabetes
4850554|NCT02328326|diabetes self-management|diabetes self-management
4850555|NCT02328326|patient activation|patient activation
4850556|NCT02328326|social support|social support
4850557|NCT02328313|Cancer|cancer
4850558|NCT02328313|Breast Cancer|breast cancer
4850559|NCT02328313|Geriatric|geriatric
4850560|NCT02328313|Advance Age|advance age
4850561|NCT02328313|Exercise|exercise
4850562|NCT02328313|Physical Activity|physical activity
4850563|NCT02328313|Genetic Marker|genetic marker
4850564|NCT02328313|p16|p16
4850565|NCT02328313|Chemotherapy|chemotherapy
4850566|NCT02328313|Breast Cancer Treatment|breast cancer treatment
4850567|NCT02328287|Spinal Fusion|spinal fusion
4850568|NCT02328287|Revision Surgery|revision surgery
4850569|NCT02328287|Pseudarthrosis|pseudarthrosis
4850570|NCT02328287|Cell Therapy|cell therapy
4850571|NCT02328287|Bone Graft|bone graft
4850572|NCT02328235|skeletal muscle, metabolism, physiology|skeletal muscle, metabolism, physiology
4850573|NCT02328222|Early steroid withdrawal|early steroid withdrawal
4850574|NCT02328222|Acute allograft rejection|acute allograft rejection
4850575|NCT02328222|Mycophenolate|mycophenolate
4850576|NCT02328222|Tacrolimus|tacrolimus
4850577|NCT02328222|Basiliximab|basiliximab
4850578|NCT02328196|Outcome and Process Assessment (Health Care)|outcome and process assessment (health care)
4850579|NCT02328196|Rasch analysis|rasch analysis
4850580|NCT02328196|Meal time performance|meal time performance
4850581|NCT02328183|polymyxin B|polymyxin b
4850582|NCT02328183|carbapenem resistant bacteria|carbapenem resistant bacteria
4850583|NCT02328170|immunoglobulin E, food hypersensitivities, child, allergens|immunoglobulin e, food hypersensitivities, child, allergens
4850584|NCT02328144|Hemorrhoidectomy|hemorrhoidectomy
4850585|NCT02328144|Postoperative pain|postoperative pain
4850586|NCT02328144|Metronidazole|metronidazole
4850587|NCT02328118|Lucentis|lucentis
4850588|NCT02328118|Ranibizumab|ranibizumab
4850589|NCT02328118|Triamcinolone Acetonide|triamcinolone acetonide
4850590|NCT02328118|Vitrectomy|vitrectomy
4850591|NCT02328118|PDR|pdr
4850592|NCT02328079|Facial Palsy (acute), Acyclovir, Prednisolone|facial palsy (acute), acyclovir, prednisolone
4850593|NCT02328066|NBI|nbi
4850594|NCT02328066|NICE classification|nice classification
4850595|NCT02328066|deep submucosal invasion|deep submucosal invasion
4850596|NCT02328066|Colonic Polyps [C23.300.825.411.235]|colonic polyps [c23.300.825.411.235]
4850597|NCT02328066|Colonoscopy [E01.370.372.250.250.200]|colonoscopy [e01.370.372.250.250.200]
4850598|NCT02328053|fungal keratitis|fungal keratitis
4850599|NCT02328053|collagen cross linking|collagen cross linking
4850600|NCT02328040|Diabetes Mellitus, Type 1|diabetes mellitus, type 1
4850601|NCT02328040|Closed loop|closed loop
4850602|NCT02328040|Artificial Pancreas|artificial pancreas
4850603|NCT02328040|Insulin|insulin
4850604|NCT02328040|Sitagliptin|sitagliptin
4850605|NCT02328040|Januvia|januvia
4850606|NCT02328014|Bruton tyrosine kinase inhibitor|bruton tyrosine kinase inhibitor
4850607|NCT02328014|Btk|btk
4850608|NCT02328014|B-Cell Malignancies|b-cell malignancies
4850609|NCT02328014|Mantle Cell|mantle cell
4850610|NCT02328014|Multiple Myeloma|multiple myeloma
4850611|NCT02328014|CLL|cll
4850612|NCT02328014|SLL|sll
4850613|NCT02328014|DLBCL|dlbcl
4850614|NCT02328014|Folicular|folicular
4850615|NCT02328014|Waldenstrom|waldenstrom
4850616|NCT02328014|B-All|b-all
4850617|NCT02327988|cryotherapy|cryotherapy
4850618|NCT02327988|laser therapy|laser therapy
4850619|NCT02327988|eccentric exercise|eccentric exercise
4850620|NCT02327988|delayed onset muscle soreness|delayed onset muscle soreness
4850621|NCT02327988|muscle damage|muscle damage
4850622|NCT02327988|dynamometry|dynamometry
4850623|NCT02327988|electromyography|electromyography
4850624|NCT02327923|Laparoscopic cholecystectomy|laparoscopic cholecystectomy
4850625|NCT02327923|lidocaine infusion|lidocaine infusion
4850626|NCT02327923|Esmolol infusion|esmolol infusion
4850627|NCT02327923|Postoperative opioid consumption|postoperative opioid consumption
4850628|NCT02327923|Multimodal analgesia|multimodal analgesia
4850629|NCT02327910|Elderly patients，|elderly patients，
4850630|NCT02327910|General anesthesia，|general anesthesia，
4850631|NCT02327910|Transcutaneous partial pressure of carbon dioxide(TcPCO2)，|transcutaneous partial pressure of carbon dioxide(tcpco2)，
4850632|NCT02327910|Train-of-four(TOF)，|train-of-four(tof)，
4850633|NCT02327910|Extubation|extubation
4850634|NCT02327910|，Respiratory events|，respiratory events
4850635|NCT02327897|Atopic Asthma|atopic asthma
4850636|NCT02327897|Exposures|exposures
4850637|NCT02327897|Disease Progression|disease progression
4850638|NCT02327884|Genetics|genetics
4850639|NCT02327884|Dry Mouth|dry mouth
4850640|NCT02327884|Sjogren's Syndrome|sjogren's syndrome
4850641|NCT02327884|Gland Dysfuntion|gland dysfuntion
4850642|NCT02327884|Induced Pluripotent Stem Cell (iPS) Cell Lines|induced pluripotent stem cell (ips) cell lines
4850643|NCT02327871|Therapeutic hypothermia|therapeutic hypothermia
4850644|NCT02327871|patients|patients
4850645|NCT02327871|Safety, Efficacy|safety, efficacy
4850646|NCT02327845|natural history, biomarkers, phenotype, genotype|natural history, biomarkers, phenotype, genotype
4850647|NCT02327832|Confirmation|confirmation
4850648|NCT02327832|safety|safety
4850649|NCT02327793|Perfusion|perfusion
4850650|NCT02327793|Blood pressure|blood pressure
4850651|NCT02327767|Active Assistance|active assistance
4850652|NCT02327767|Resonance|resonance
4850653|NCT02327767|Stroke|stroke
4850654|NCT02327767|Arm Rehabilitation|arm rehabilitation
4850655|NCT02327741|Dual antiplatelet therapy|dual antiplatelet therapy
4850656|NCT02327741|clopidogrel|clopidogrel
4850657|NCT02327741|percutaneous coronary intervention|percutaneous coronary intervention
4850658|NCT02327728|blepharospasm|blepharospasm
4850659|NCT02327728|botulinum A|botulinum a
4850660|NCT02327728|injection pattern|injection pattern
4850661|NCT02327728|tear|tear
4850662|NCT02327715|Hepatitis B virus|hepatitis b virus
4850663|NCT02327715|Emtricitabine|emtricitabine
4850664|NCT02327715|Pregnancy|pregnancy
4850665|NCT02327715|Vertical transmission|vertical transmission
4850666|NCT02327702|Hepatitis B, chronic|hepatitis b, chronic
4850667|NCT02327702|Emtricitabine|emtricitabine
4850668|NCT02327702|Pregnancy|pregnancy
4850669|NCT02327689|Hepatitis B virus|hepatitis b virus
4850670|NCT02327689|Cirrhosis|cirrhosis
4850671|NCT02327689|Emtricitabine|emtricitabine
4850672|NCT02327689|Adefovir dipivoxil|adefovir dipivoxil
4850673|NCT02327676|Hepatitis B, chronic|hepatitis b, chronic
4850674|NCT02327676|Emtricitabine|emtricitabine
4850675|NCT02327676|Child|child
4850676|NCT02327663|Hepatitis B, chronic|hepatitis b, chronic
4850677|NCT02327663|Emtricitabine|emtricitabine
4850678|NCT02327663|Adefovir dipivixil|adefovir dipivixil
4850679|NCT02327663|HBeAg|hbeag
4850680|NCT02327637|Preterm Premature Rupture of the Membranes|preterm premature rupture of the membranes
4850681|NCT02327637|Bedrest|bedrest
4850682|NCT02327637|Physical Activity|physical activity
4850683|NCT02327585|Executive function training|executive function training
4850684|NCT02327585|child|child
4850685|NCT02327559|childbirth|childbirth
4850686|NCT02327559|mindfulness|mindfulness
4850687|NCT02327559|fear of labor|fear of labor
4850688|NCT02327559|labor pain|labor pain
4850689|NCT02327559|coping|coping
4850690|NCT02327559|self-efficacy|self-efficacy
4850691|NCT02327559|childbirth satisfaction|childbirth satisfaction
4850692|NCT02327559|depression|depression
4850693|NCT02327546|Pharmacokinetics|pharmacokinetics
4850694|NCT02327546|Anemia|anemia
4850695|NCT02327546|Chronic kidney disease|chronic kidney disease
4850696|NCT02327546|CKD|ckd
4850697|NCT02327546|Chronic renal insufficiency|chronic renal insufficiency
4850698|NCT02327546|Renal impairment|renal impairment
4850699|NCT02327546|Ferrous sulfate|ferrous sulfate
4850700|NCT02327546|Iron|iron
4850701|NCT02327546|Drug-drug interaction|drug-drug interaction
4850702|NCT02327546|End stage renal disease|end stage renal disease
4850703|NCT02327546|Dialysis|dialysis
4850704|NCT02327546|Erythropoietin|erythropoietin
4850705|NCT02327546|Oral anemia treatment|oral anemia treatment
4850706|NCT02327546|Hypoxia-induciable factor|hypoxia-induciable factor
4850708|NCT02327546|Hypoxia-induciable factor prolyl-hydroxylase inhibitor|hypoxia-induciable factor prolyl-hydroxylase inhibitor
4850709|NCT02327546|HIF-PHI|hif-phi
4850710|NCT02327533|generalized aggressive periodontitis|generalized aggressive periodontitis
4850711|NCT02327533|microarray analysis|microarray analysis
4850712|NCT02327520|Clostridium difficile infection|clostridium difficile infection
4850713|NCT02327520|burden|burden
4850714|NCT02327520|nationwide study|nationwide study
4850715|NCT02327520|South East Asia|south east asia
4850716|NCT02327520|Thailand|thailand
4850717|NCT02327520|Epidemiology|epidemiology
4850718|NCT02327520|Outcome Assessment (Health Care) [N04.761.559.590]|outcome assessment (health care) [n04.761.559.590]
4850719|NCT02327507|children|children
4850720|NCT02327507|fluoridated toothpaste|fluoridated toothpaste
4850721|NCT02327507|health education|health education
4850722|NCT02327507|Medicaid|medicaid
4850823|NCT02326935|Myelitis|myelitis
4850723|NCT02327494|Neuromuscular blockade|neuromuscular blockade
4850724|NCT02327494|Laparoscopy|laparoscopy
4850725|NCT02327494|Oxygen measurements|oxygen measurements
4850726|NCT02327481|Stomach Neoplasms Laparoscopy|stomach neoplasms laparoscopy
4850727|NCT02327442|chemokine receptor|chemokine receptor
4850728|NCT02327442|galium|galium
4850729|NCT02327442|dosimetry|dosimetry
4850730|NCT02327442|glioma|glioma
4850731|NCT02327403|Proteinuria|proteinuria
4850732|NCT02327403|Kidney transplantation|kidney transplantation
4850733|NCT02327403|Allograft dysfunction|allograft dysfunction
4850734|NCT02327403|B7-1|b7-1
4850735|NCT02327403|Belatacept|belatacept
4850736|NCT02327377|Irritable bowel syndrome|irritable bowel syndrome
4850737|NCT02327377|Intervention studies|intervention studies
4850738|NCT02327377|Visceral pain|visceral pain
4850739|NCT02327377|Chronic pain|chronic pain
4850740|NCT02327377|Abdominal pain|abdominal pain
4850741|NCT02327377|Dyspepsia|dyspepsia
4850742|NCT02327377|Nausea|nausea
4850743|NCT02327377|Nociception|nociception
4850744|NCT02327377|Parents|parents
4850745|NCT02327377|Coping behavior|coping behavior
4850746|NCT02327377|Anxiety|anxiety
4850747|NCT02327377|Depression|depression
4850748|NCT02327377|Catastrophization|catastrophization
4850749|NCT02327377|Reinforcement (psychology)|reinforcement (psychology)
4850750|NCT02327377|Self efficacy|self efficacy
4850751|NCT02327377|Health services overutilization|health services overutilization
4850752|NCT02327377|Questionnaires|questionnaires
4850753|NCT02327377|Self report|self report
4850754|NCT02327377|Health surveys|health surveys
4850755|NCT02327377|Prospective studies|prospective studies
4850756|NCT02327377|Adolescent health|adolescent health
4850757|NCT02327377|Mental health services|mental health services
4850758|NCT02327377|Health services accessibility|health services accessibility
4850759|NCT02327377|Health diaries|health diaries
4850760|NCT02327377|National Institute of Child Health & Human Development (US.)|national institute of child health & human development (us.)
4850761|NCT02327377|Telemedicine|telemedicine
4850762|NCT02327377|E-Health|e-health
4850763|NCT02327377|Web-based intervention|web-based intervention
4850764|NCT02327377|Parenting education|parenting education
4850765|NCT02327325|Low Back Pain|low back pain
4850766|NCT02327325|Exercise|exercise
4850767|NCT02327325|Cognitive Behavioral Therapy|cognitive behavioral therapy
4850768|NCT02327325|Aged|aged
4850769|NCT02327299|Iron deficiency|iron deficiency
4850770|NCT02327299|Iron fortification|iron fortification
4850771|NCT02327286|Diabetes Mellitus|diabetes mellitus
4850772|NCT02327286|Gestational diabetes|gestational diabetes
4850773|NCT02327273|subjects|subjects
4850774|NCT02327221|Crohn Disease|crohn disease
4850775|NCT02327221|Cell therapy|cell therapy
4850776|NCT02327221|Regulatory T lymphocytes|regulatory t lymphocytes
4850777|NCT02327221|Treg|treg
4850778|NCT02327221|Autologous|autologous
4850779|NCT02327221|Antigen specific T regulatory lymphocytes|antigen specific t regulatory lymphocytes
4850780|NCT02327208|Military Training|military training
4850781|NCT02327208|Whey Protein|whey protein
4850782|NCT02327208|Body Composition|body composition
4850783|NCT02327182|MT-4666|mt-4666
4850784|NCT02327182|α7 nicotinic acetylcholine receptor agonist|α7 nicotinic acetylcholine receptor agonist
4850785|NCT02327182|Alzheimer's Disease|alzheimer's disease
4850786|NCT02327182|Cognitive function|cognitive function
4850787|NCT02327182|Dementia|dementia
4850788|NCT02327182|Central Nervous System Agents|central nervous system agents
4850789|NCT02327169|Drug therapy|drug therapy
4850790|NCT02327156|Dexmedetomidine|dexmedetomidine
4850791|NCT02327104|mindfulness|mindfulness
4850792|NCT02327104|tobacco dependence|tobacco dependence
4850793|NCT02327104|relapse prevention|relapse prevention
4850794|NCT02327091|Alfacalcidol|alfacalcidol
4850795|NCT02327091|Falls|falls
4850796|NCT02327091|Handgrip|handgrip
4850797|NCT02327091|Muscle strength|muscle strength
4850798|NCT02327091|Sarcopenia|sarcopenia
4850799|NCT02327065|EUS|eus
4850800|NCT02327065|FNA|fna
4850801|NCT02327065|FNB|fnb
4850802|NCT02327052|Chagas disease|chagas disease
4850803|NCT02327052|longitudinal global strain|longitudinal global strain
4850804|NCT02327052|speckle tracking|speckle tracking
4850805|NCT02327026|Out-of-hospital cardiac arrest|out-of-hospital cardiac arrest
4850806|NCT02327026|Bag-valve-mask ventilation|bag-valve-mask ventilation
4850807|NCT02327026|Tracheal intubation|tracheal intubation
4850808|NCT02326961|osteoarthritis|osteoarthritis
4850809|NCT02326961|knee|knee
4850810|NCT02326961|adipose derived regenerative cells|adipose derived regenerative cells
4850811|NCT02326961|ADRC|adrc
4850812|NCT02326961|Celution|celution
4850813|NCT02326961|arthritis|arthritis
4850814|NCT02326948|Gallbladder cancer|gallbladder cancer
4850815|NCT02326948|Case-control study|case-control study
4850816|NCT02326948|Risk factor|risk factor
4850817|NCT02326948|Alcohol consumption|alcohol consumption
4850818|NCT02326948|Polypoid lesions of gallbladder|polypoid lesions of gallbladder
4850819|NCT02326948|Biliary stone|biliary stone
4850820|NCT02326935|MS|ms
4850821|NCT02326935|Multiple Sclerosis, Relapsing-Remitting|multiple sclerosis, relapsing-remitting
4850822|NCT02326935|Multiple Sclerosis, Chronic Progressive|multiple sclerosis, chronic progressive
4850824|NCT02326922|Dysfunctional uterine bleeding|dysfunctional uterine bleeding
4850825|NCT02326922|Metraplant-E|metraplant-e
4850826|NCT02326922|Levonorgestrel-releasing intrauterine device|levonorgestrel-releasing intrauterine device
4850827|NCT02326922|Endometrial decidualization|endometrial decidualization
4850828|NCT02326909|Upper Urinary Tract|upper urinary tract
4850829|NCT02326909|Optical Coherence Tomography|optical coherence tomography
4850830|NCT02326909|Transitional Cell Carcinoma|transitional cell carcinoma
4850831|NCT02326909|Urothelial Cell Carcinoma|urothelial cell carcinoma
4850832|NCT02326909|Diagnostic accuracy|diagnostic accuracy
4850833|NCT02326896|intubation|intubation
4850834|NCT02326896|intensive care unit|intensive care unit
4850835|NCT02326896|MACOCHA Score|macocha score
4850836|NCT02326870|laparoscopic Cholecystectomy|laparoscopic cholecystectomy
4850837|NCT02326870|laparoscope holder|laparoscope holder
4850838|NCT02326870|gynecological laparoscopy procedures|gynecological laparoscopy procedures
4850839|NCT02326870|fundoplication surgery|fundoplication surgery
4850840|NCT02326870|laparoscopic adnexal surgery|laparoscopic adnexal surgery
4850841|NCT02326870|excision of endometriosis lesion|excision of endometriosis lesion
4850842|NCT02326870|diagnostic laparoscopy procedures|diagnostic laparoscopy procedures
4850843|NCT02326870|right hemicolectomy|right hemicolectomy
4850844|NCT02326870|Diaphragmatic hernia|diaphragmatic hernia
4850845|NCT02326857|Distribution of Molecular Profiles in Latin American Women|distribution of molecular profiles in latin american women
4850846|NCT02326857|AJCC 7 Clinical Stage II to III|ajcc 7 clinical stage ii to iii
4850847|NCT02326857|Breast Cancer Observational Study|breast cancer observational study
4850848|NCT02326857|Prospective Cohort|prospective cohort
4850849|NCT02326857|Epidemiological, Histological, and Clinical Data|epidemiological, histological, and clinical data
4850850|NCT02326844|Germline BRCA1/2 Mutations (gBRCAm)|germline brca1/2 mutations (gbrcam)
4850851|NCT02326844|DNA Damaging Agents|dna damaging agents
4850852|NCT02326844|FOX03a, 53BP1 and RAD51|fox03a, 53bp1 and rad51
4850853|NCT02326818|Dystonia|dystonia
4850854|NCT02326818|Botulinum Toxin|botulinum toxin
4850855|NCT02326818|Musician's Dystonia|musician's dystonia
4850856|NCT02326818|Spasticity|spasticity
4850857|NCT02326792|Exercise|exercise
4850858|NCT02326792|Training|training
4850859|NCT02326792|Low back Pain|low back pain
4850860|NCT02326792|Physical Therapy|physical therapy
4850861|NCT02326779|esophageal cancer|esophageal cancer
4850862|NCT02326779|aspirin|aspirin
4850863|NCT02326779|survival|survival
4850864|NCT02326740|Pyoderma Gangrenosum|pyoderma gangrenosum
4850865|NCT02326740|Classic Pyoderma Gangrenosum|classic pyoderma gangrenosum
4850866|NCT02326727|Epidural Analgesia|epidural analgesia
4850867|NCT02326727|Natural Killer Cells|natural killer cells
4850868|NCT02326675|Etoposide|etoposide
4850869|NCT02326675|Cryotherapy|cryotherapy
4850870|NCT02326662|spinal cord injury|spinal cord injury
4850871|NCT02326662|neural stem cells|neural stem cells
4850872|NCT02326662|paraplegia|paraplegia
4850873|NCT02326662|transplantation|transplantation
4850874|NCT02326649|cardiac output|cardiac output
4850875|NCT02326610|Small for gestational age (SGA)|small for gestational age (sga)
4850876|NCT02326610|Human growth hormone (hGH)|human growth hormone (hgh)
4850877|NCT02326597|Hydroxyurea|hydroxyurea
4850878|NCT02326597|Bone marrow transplant|bone marrow transplant
4850879|NCT02326597|Chronic blood transfusion|chronic blood transfusion
4850880|NCT02326597|Treatment options for sickle cell disease|treatment options for sickle cell disease
4850881|NCT02326597|Decision making|decision making
4850882|NCT02326584|Acute Myeloid Leukemia|acute myeloid leukemia
4850883|NCT02326584|Antibody-Drug Conjugate|antibody-drug conjugate
4850884|NCT02326584|CD33 Antigen|cd33 antigen
4850885|NCT02326584|Drug Therapy|drug therapy
4850886|NCT02326584|Acute Myelogenous Leukemia|acute myelogenous leukemia
4850887|NCT02326571|EEG|eeg
4850888|NCT02326571|Cortical Spreading Depression|cortical spreading depression
4850889|NCT02326571|Cerebral Hemorrhage|cerebral hemorrhage
4850890|NCT02326571|miRNA|mirna
4850891|NCT02326571|Reactivity in EEG|reactivity in eeg
4850892|NCT02326571|Multimodal monitoring|multimodal monitoring
4850893|NCT02326558|zero ischemia|zero ischemia
4850894|NCT02326558|microwave|microwave
4850895|NCT02326558|ablation|ablation
4850896|NCT02326558|enucleation|enucleation
4850897|NCT02326558|renal cell carcinoma|renal cell carcinoma
4850898|NCT02326545|Video Games|video games
4850899|NCT02326545|Child|child
4850900|NCT02326545|Adolescent|adolescent
4850901|NCT02326532|Rheumatoid Arthritis|rheumatoid arthritis
4850902|NCT02326532|Veterans|veterans
4850903|NCT02326506|Extracorporeal Membrane Oxygenation|extracorporeal membrane oxygenation
4850904|NCT02326506|Cardiopulmonary Bypass|cardiopulmonary bypass
4850905|NCT02326493|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
4850906|NCT02326493|LV lead position|lv lead position
4850907|NCT02326493|Device programming|device programming
4850908|NCT02326493|Optimization|optimization
4850909|NCT02326493|Vectorcardiography|vectorcardiography
4850910|NCT02326480|Childhood Obesity|childhood obesity
4850911|NCT02326480|Genetics|genetics
4850912|NCT02326467|chlorhexidine|chlorhexidine
4850913|NCT02326467|safety|safety
4850914|NCT02326467|bath|bath
4850915|NCT02326467|rash|rash
4850916|NCT02326467|infant|infant
4850917|NCT02326441|advanced malignancies|advanced malignancies
4850918|NCT02326441|refractory therapies|refractory therapies
4850919|NCT02326441|phase 1|phase 1
4850920|NCT02326428|Stroke|stroke
4850921|NCT02326428|Cerebrovascular Accident|cerebrovascular accident
4850922|NCT02326428|Brain ischemia|brain ischemia
4850923|NCT02326428|Intravenous thrombolysis|intravenous thrombolysis
4850924|NCT02326428|Stroke thrombectomy|stroke thrombectomy
4850925|NCT02326428|Stent-retriever|stent-retriever
4850926|NCT02326415|Acute Appendicitis|acute appendicitis
4850927|NCT02326415|Appendectomy|appendectomy
4850928|NCT02326415|Fast-Track|fast-track
4850929|NCT02326415|Clinical Pathway|clinical pathway
4850930|NCT02326402|Circulatory support|circulatory support
4850931|NCT02326402|Extracorporeal circulatory support|extracorporeal circulatory support
4850932|NCT02326402|Extracorporeal bypass|extracorporeal bypass
4850933|NCT02326389|Cognitive functioning|cognitive functioning
4850934|NCT02326363|substance abuse|substance abuse
4850935|NCT02326363|Mental Health Disorders|mental health disorders
4850936|NCT02326350|Acute Respiratory Distress syndrome|acute respiratory distress syndrome
4850937|NCT02326350|Aspirin|aspirin
4850938|NCT02326298|Certolizumab Pegol|certolizumab pegol
4850939|NCT02326298|Cimzia|cimzia
4850940|NCT02326298|Psoriasis|psoriasis
4850941|NCT02326285|induction therapy|induction therapy
4850942|NCT02326285|NSCLC|nsclc
4850943|NCT02326285|Non-small Cell Lung Cancer|non-small cell lung cancer
4850944|NCT02326285|curative surgery|curative surgery
4850945|NCT02326272|Certolizumab Pegol|certolizumab pegol
4850946|NCT02326272|Cimzia|cimzia
4850947|NCT02326272|Psoriasis|psoriasis
4850948|NCT02326259|Diabetic Retinopathy|diabetic retinopathy
4850949|NCT02326259|Disease Progression|disease progression
4850950|NCT02326246|MRI|mri
4850951|NCT02326246|active surveillance|active surveillance
4850952|NCT02326207|Infant, Newborn|infant, newborn
4850953|NCT02326207|Neonatal intensive care unit|neonatal intensive care unit
4850954|NCT02326207|Ventilator circuit|ventilator circuit
4850955|NCT02326194|Safety,immunogenicity,Ebola|safety,immunogenicity,ebola
4850956|NCT02326181|respiratory muscle training|respiratory muscle training
4850957|NCT02326181|respiratory muscle strength|respiratory muscle strength
4850958|NCT02326181|respiratory endurance test|respiratory endurance test
4850959|NCT02326181|6-minute walking test|6-minute walking test
4850960|NCT02326142|Premature Obstetric Labor|premature obstetric labor
4850961|NCT02326142|Premature Birth|premature birth
4850962|NCT02326103|alcoholic|alcoholic
4850963|NCT02326103|hepatitis|hepatitis
4850964|NCT02326103|cirrhosis|cirrhosis
4850965|NCT02326103|cholesterol metabolites|cholesterol metabolites
4850966|NCT02326103|ciprofloxacin|ciprofloxacin
4850967|NCT02326077|sonopartogram|sonopartogram
4850968|NCT02326077|transperineal ultrasound|transperineal ultrasound
4850969|NCT02326077|intrapartum ultrasound|intrapartum ultrasound
4850970|NCT02326077|labor|labor
4850971|NCT02326077|delivery|delivery
4850972|NCT02326077|partogram|partogram
4850973|NCT02326077|ultrasound|ultrasound
4850974|NCT02326051|Antiphospholipid syndrome|antiphospholipid syndrome
4850975|NCT02326051|APS|aps
4850976|NCT02326051|LMWH|lmwh
4850977|NCT02326038|Memory|memory
4850978|NCT02326038|Attention|attention
4850979|NCT02326038|MCI|mci
4850980|NCT02326038|Ritalin|ritalin
4850981|NCT02325999|Endoscopic Submucosal Dissection|endoscopic submucosal dissection
4850982|NCT02325999|Laparoscopic Regional Lymph node Dissection|laparoscopic regional lymph node dissection
4850983|NCT02325999|early gastric cancer|early gastric cancer
4850984|NCT02325999|Disease-free survival|disease-free survival
4850985|NCT02325986|radiotherapy|radiotherapy
4850986|NCT02325986|esophageal carcinoma|esophageal carcinoma
4850987|NCT02325986|chemotherapy|chemotherapy
4850988|NCT02325973|STEMI|stemi
4850989|NCT02325973|IMR|imr
4850990|NCT02325973|FFR|ffr
4850991|NCT02325973|microcirculatory|microcirculatory
4850992|NCT02325960|exenatide|exenatide
4850993|NCT02325960|insulin glargine|insulin glargine
4850994|NCT02325947|Post stroke hand paresis brain injury|post stroke hand paresis brain injury
4850995|NCT02325934|Stribild|stribild
4850996|NCT02325934|pharmacokinetics|pharmacokinetics
4850997|NCT02325934|Crushing|crushing
4850998|NCT02325934|Drip feed|drip feed
4850999|NCT02325921|Magnetic Resonance Imaging|magnetic resonance imaging
4851000|NCT02325921|Diffusion Weighted MRI|diffusion weighted mri
4851001|NCT02325921|Diffusion Tensor Imaging|diffusion tensor imaging
4851002|NCT02325908|Hemodialysis|hemodialysis
4851003|NCT02325908|Estimated Dry Weight|estimated dry weight
4851004|NCT02325895|Osteoporosis|osteoporosis
4851005|NCT02325895|Dried plum|dried plum
4851006|NCT02325895|functional food|functional food
4851007|NCT02325869|Acute Coronary Syndrome, Coronary Occlusion, catheter|acute coronary syndrome, coronary occlusion, catheter
4851008|NCT02325856|Hemodialysis|hemodialysis
4851009|NCT02325856|Body Composition Monitor|body composition monitor
4851010|NCT02325830|Functional mitral regurgitation|functional mitral regurgitation
4851011|NCT02325830|Secondary mitral regurgitation|secondary mitral regurgitation
4851012|NCT02325830|Percutaneous mitral repair|percutaneous mitral repair
4851013|NCT02325817|Bifurcation Lesions|bifurcation lesions
4851014|NCT02325817|drug eluting balloon|drug eluting balloon
4851015|NCT02325817|paclitaxel|paclitaxel
4851016|NCT02325817|drug coated balloon|drug coated balloon
4851017|NCT02325804|overweight and obesity|overweight and obesity
4851018|NCT02325804|adipose tissue|adipose tissue
4851019|NCT02325804|weight loss program|weight loss program
4851020|NCT02325804|low-calorie diet|low-calorie diet
4851021|NCT02325804|circuit-based exercise|circuit-based exercise
4851022|NCT02325804|metabolic cardiovascular syndrome|metabolic cardiovascular syndrome
4851023|NCT02325765|congential cardiac surgery|congential cardiac surgery
4851024|NCT02325765|nuclearsome|nuclearsome
4851025|NCT02325765|systemic inflammation response syndrome|systemic inflammation response syndrome
4851026|NCT02325752|readmission|readmission
4851027|NCT02325752|chronic diseases|chronic diseases
4851028|NCT02325739|FGF401, PDR001, PD-1, FGFR4, FGF19, HCC|fgf401, pdr001, pd-1, fgfr4, fgf19, hcc
4851029|NCT02325726|Cardiac surgery|cardiac surgery
4851030|NCT02325726|Extracorporeal circulation|extracorporeal circulation
4851031|NCT02325726|Renal failure|renal failure
4851032|NCT02325713|ODT-PZQ|odt-pzq
4851033|NCT02325713|Bio-availability|bio-availability
4851034|NCT02325713|Praziquantel|praziquantel
4851035|NCT02325713|Cysticide|cysticide
4851036|NCT02325713|Pharmacokinetics|pharmacokinetics
4851037|NCT02325687|Obstructive Sleep Apnea|obstructive sleep apnea
4851038|NCT02325687|Arthroplasty, Replacement, Knee|arthroplasty, replacement, knee
4851039|NCT02325687|Cerebrospinal Fluid|cerebrospinal fluid
4851040|NCT02325687|Inflammation|inflammation
4851041|NCT02325687|TNF-alpha|tnf-alpha
4851042|NCT02325687|Interleukin-6 (IL-6)|interleukin-6 (il-6)
4851043|NCT02325687|Interleukin-8 (IL-8)|interleukin-8 (il-8)
4851044|NCT02325687|Interleukin-10 (IL-10)|interleukin-10 (il-10)
4851045|NCT02325687|Cytokines|cytokines
4851046|NCT02325687|Neurotrophins|neurotrophins
4851047|NCT02325687|BDNF|bdnf
4851048|NCT02325687|Beta-NGF|beta-ngf
4851049|NCT02325687|Proteomic Analysis|proteomic analysis
4851050|NCT02325674|Lipodystrophy|lipodystrophy
4851051|NCT02325674|Metreleptin Registry|metreleptin registry
4851052|NCT02325635|Adenoma Detection|adenoma detection
4851053|NCT02325635|Adenoma Prediction|adenoma prediction
4851054|NCT02325596|Chronic rhinosinusitis|chronic rhinosinusitis
4851055|NCT02325596|microRNA|microrna
4851056|NCT02325596|dendritic cell|dendritic cell
4851057|NCT02325596|helper T cell|helper t cell
4851058|NCT02325583|Intraoral 30% glucose, newborn, MRI|intraoral 30% glucose, newborn, mri
4851059|NCT02325544|dissociative seizures,|dissociative seizures,
4851060|NCT02325544|psychogenic nonepileptic seizures|psychogenic nonepileptic seizures
4851061|NCT02325531|implementation strategies|implementation strategies
4851062|NCT02325531|diabetes mellitus|diabetes mellitus
4851063|NCT02325531|cardiovascular disease|cardiovascular disease
4851064|NCT02325531|community health centers|community health centers
4851065|NCT02325531|quality improvement|quality improvement
4851066|NCT02325531|translational medical research|translational medical research
4851067|NCT02325518|Open-angle glaucoma (OAG)|open-angle glaucoma (oag)
4851068|NCT02325518|Ocular hypertension (OHT)|ocular hypertension (oht)
4851069|NCT02325518|AZORGA®|azorga®
4851070|NCT02325518|COSOPT®|cosopt®
4851071|NCT02325492|bariatric surgery|bariatric surgery
4851072|NCT02325492|NASH|nash
4851073|NCT02325492|ARAMCHOL|aramchol
4851074|NCT02325479|Low Molecular Weight (LMWH) Heparin ICSI Enaoxaprin sodium|low molecular weight (lmwh) heparin icsi enaoxaprin sodium
4851075|NCT02325466|Peripheral Artery Disease|peripheral artery disease
4851076|NCT02325466|Type 2 Diabetes|type 2 diabetes
4851077|NCT02325466|Blood Viscosity|blood viscosity
4851078|NCT02325466|Ticagrelor|ticagrelor
4851079|NCT02325466|Aspirin|aspirin
4851080|NCT02325453|Robotic Surgery|robotic surgery
4851081|NCT02325453|Laparoscopic Surgery|laparoscopic surgery
4851082|NCT02325453|Minimally Invasive Surgery|minimally invasive surgery
4851083|NCT02325453|Robotic Gastrectomy|robotic gastrectomy
4851084|NCT02325453|Laparoscopic Gastrectomy|laparoscopic gastrectomy
4851085|NCT02325453|Open Gastrectomy|open gastrectomy
4851086|NCT02325453|Gastric Surgery|gastric surgery
4851087|NCT02325440|RRMS (relapsing remitting multiple sclerosis)|rrms (relapsing remitting multiple sclerosis)
4851088|NCT02325440|Cluster of differentiation 49d (CD49d)|cluster of differentiation 49d (cd49d)
4851089|NCT02325440|immune function|immune function
4851090|NCT02325440|disease activity|disease activity
4851091|NCT02325427|stroke|stroke
4851092|NCT02325427|rehabilitation|rehabilitation
4851093|NCT02325427|upper limb|upper limb
4851094|NCT02325427|TMS|tms
4851095|NCT02325427|tDCS|tdcs
4851096|NCT02325414|Osteoporosis|osteoporosis
4851097|NCT02325414|Spinal Cord Injury|spinal cord injury
4851098|NCT02325414|Bone Diseases|bone diseases
4851099|NCT02325414|Metabolic Bone Diseases|metabolic bone diseases
4851100|NCT02325414|Musculoskeletal Diseases|musculoskeletal diseases
4851101|NCT02325414|Spinal Cord Diseases|spinal cord diseases
4851102|NCT02325414|Central Nervous System Diseases|central nervous system diseases
4851103|NCT02325414|Nervous System Diseases|nervous system diseases
4851104|NCT02325414|Nervous System|nervous system
4851105|NCT02325414|Wounds and Injuries|wounds and injuries
4851106|NCT02325414|Bone Density Conservation Agents|bone density conservation agents
4851107|NCT02325414|Physiological Effects of Drugs|physiological effects of drugs
4851108|NCT02325414|Pharmacologic Actions|pharmacologic actions
4851109|NCT02325414|Department of Defense|department of defense
4851110|NCT02325388|pressure ulcer|pressure ulcer
4851111|NCT02325388|decubitus ulcer|decubitus ulcer
4851112|NCT02325388|bed sore|bed sore
4851113|NCT02325388|continuous pressure mapping|continuous pressure mapping
4851114|NCT02325388|interface pressure imaging|interface pressure imaging
4851115|NCT02325375|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
4851116|NCT02325375|spinal fluid|spinal fluid
4851117|NCT02325375|CD163|cd163
4851118|NCT02325362|Cystic fibrosis|cystic fibrosis
4851119|NCT02325362|CFTR|cftr
4851120|NCT02325362|F508del mutation|f508del mutation
4851121|NCT02325362|Miglustat|miglustat
4851122|NCT02325362|Total Chloride Secretion|total chloride secretion
4851123|NCT02325362|Nasal Potential Difference|nasal potential difference
4851124|NCT02325349|Angiogenesis|angiogenesis
4851125|NCT02325349|Integrins|integrins
4851126|NCT02325349|RGD PET/CT|rgd pet/ct
4851127|NCT02325349|FDG PET/CT|fdg pet/ct
4851128|NCT02325349|Predictive value|predictive value
4851129|NCT02325349|Therapeutic response|therapeutic response
4851130|NCT02325349|Efficacy|efficacy
4851131|NCT02325349|Tolerability|tolerability
4851132|NCT02325336|Medication Errors|medication errors
4851133|NCT02325336|nurses|nurses
4851134|NCT02325336|hospital|hospital
4851135|NCT02325323|stomach cancer|stomach cancer
4851136|NCT02325323|gastric intestinal metaplasia|gastric intestinal metaplasia
4851137|NCT02325323|prospective cohort|prospective cohort
4851138|NCT02325323|low grade dysplasia|low grade dysplasia
4851139|NCT02325323|high grade dysplasia|high grade dysplasia
4851140|NCT02325323|prognosis factor|prognosis factor
4851141|NCT02325323|gastric cancer risks|gastric cancer risks
4851142|NCT02325310|Vaccine strain excretion in breast milk|vaccine strain excretion in breast milk
4851143|NCT02325310|Postpartum vaccination|postpartum vaccination
4851144|NCT02325310|Breastfeeding women|breastfeeding women
4851145|NCT02325310|Measles-mumps-rubella vaccine|measles-mumps-rubella vaccine
4851146|NCT02325310|Breast milk|breast milk
4851147|NCT02325310|Vaccinology|vaccinology
4851148|NCT02325297|Intensive care unit|intensive care unit
4851149|NCT02325258|Sepsis diagnosis|sepsis diagnosis
4851150|NCT02325258|Sepsis drug therapy|sepsis drug therapy
4851151|NCT02325258|Sepsis outcome|sepsis outcome
4851152|NCT02325245|Frailty|frailty
4851153|NCT02325245|Pre-frailty|pre-frailty
4851154|NCT02325245|Metformin|metformin
4851155|NCT02325245|Elderly|elderly
4851156|NCT02325245|Quality of life|quality of life
4851157|NCT02325245|Handgrip|handgrip
4851158|NCT02325245|Gait speed|gait speed
4851159|NCT02325245|Myostatin|myostatin
4851160|NCT02325219|Psoriasis|psoriasis
4851161|NCT02325219|CNTO 1959|cnto 1959
4851162|NCT02325219|Guselkumab|guselkumab
4851163|NCT02325219|Placebo|placebo
4851164|NCT02325180|ACT|act
4851165|NCT02325180|Plasmodium falciparum|plasmodium falciparum
4851166|NCT02325180|malaria|malaria
4851167|NCT02325180|efficacy|efficacy
4851168|NCT02325180|Indonesia|indonesia
4851169|NCT02325167|informal caregivers|informal caregivers
4851170|NCT02325167|mental stress|mental stress
4851171|NCT02325167|quality of life|quality of life
4851172|NCT02325167|psychotherapeutic intervention|psychotherapeutic intervention
4851173|NCT02325128|social anxiety|social anxiety
4851174|NCT02325128|exposure therapy|exposure therapy
4851175|NCT02325128|extinction|extinction
4851176|NCT02325128|sleep-dependent memory consolidation|sleep-dependent memory consolidation
4851177|NCT02325115|well-being, mental health, schizophrenia, quality of life|well-being, mental health, schizophrenia, quality of life
4851178|NCT02325089|Elderly|elderly
4851179|NCT02325089|Obstructive Sleep Apnea|obstructive sleep apnea
4851180|NCT02325089|Mandibular advancement oral appliance|mandibular advancement oral appliance
4851181|NCT02325089|Hypertension|hypertension
4851182|NCT02325089|Cardiovascular disease|cardiovascular disease
4851183|NCT02325089|Quality of life|quality of life
4851184|NCT02325076|Airway Management|airway management
4851185|NCT02325076|intubation|intubation
4851186|NCT02325076|pulmonary function test|pulmonary function test
4851187|NCT02325050|Healthy|healthy
4851188|NCT02325050|Ebola viruses|ebola viruses
4851189|NCT02325050|Ebola Viral Disease (EVD)|ebola viral disease (evd)
4851190|NCT02325050|Filoviruses|filoviruses
4851191|NCT02325050|monovalent vaccine|monovalent vaccine
4851192|NCT02325050|Human adenovirus serotype 26 (Ad26) expressing the Ebola virus Mayinga variant glycoprotein (Ad26.ZEBOV)|human adenovirus serotype 26 (ad26) expressing the ebola virus mayinga variant glycoprotein (ad26.zebov)
4851193|NCT02325050|Modified Vaccinia Virus Ankara - Bavarian Nordic (MVA-BN) Filo-vector|modified vaccinia virus ankara - bavarian nordic (mva-bn) filo-vector
4851194|NCT02325050|Safety|safety
4851195|NCT02325050|Immunogenicity|immunogenicity
4851196|NCT02325024|Sativex|sativex
4851197|NCT02325024|GW-1000-02|gw-1000-02
4851198|NCT02325024|Nabiximols|nabiximols
4851199|NCT02325024|Pharmacokinetics|pharmacokinetics
4851200|NCT02325024|Renal Insufficiency|renal insufficiency
4851201|NCT02325024|Chronic Kidney Failure|chronic kidney failure
4851202|NCT02325011|Sativex|sativex
4851203|NCT02325011|GW-1000-02|gw-1000-02
4851204|NCT02325011|Nabiximols|nabiximols
4851205|NCT02325011|Fluconazole|fluconazole
4851206|NCT02325011|Pharmacokinetics|pharmacokinetics
4851500|NCT02323360|SBRT|sbrt
4851207|NCT02325011|Drug-drug interaction|drug-drug interaction
4851208|NCT02324998|Radical Prostatectomy|radical prostatectomy
4851209|NCT02324998|Prostate Cancer|prostate cancer
4851210|NCT02324998|PARP inhibition|parp inhibition
4851211|NCT02324998|Olaparib|olaparib
4851212|NCT02324998|Degarelix|degarelix
4851213|NCT02324998|Neoadjuvant|neoadjuvant
4851214|NCT02324998|Pharmacodynamics|pharmacodynamics
4851215|NCT02324998|Pharmacokinetics|pharmacokinetics
4851216|NCT02324998|Biomarkers|biomarkers
4851217|NCT02324985|muscle soreness|muscle soreness
4851218|NCT02324972|Atopic dermatitis|atopic dermatitis
4851219|NCT02324972|Eczema|eczema
4851220|NCT02324972|AD|ad
4851221|NCT02324972|AQX-1125|aqx-1125
4851222|NCT02324972|SHIP1|ship1
4851223|NCT02324946|Sleep Apnea Syndromes|sleep apnea syndromes
4851224|NCT02324946|Perioperative Period|perioperative period
4851225|NCT02324946|Mass Screening|mass screening
4851226|NCT02324920|Syncope|syncope
4851227|NCT02324920|Closed Loop Stimulation|closed loop stimulation
4851228|NCT02324920|CLS|cls
4851229|NCT02324894|screening|screening
4851230|NCT02324894|MRI|mri
4851231|NCT02324881|smartphone|smartphone
4851232|NCT02324881|application|application
4851233|NCT02324881|pain management|pain management
4851234|NCT02324868|Bandages|bandages
4851235|NCT02324868|Catheter|catheter
4851236|NCT02324855|Autogenic drainage|autogenic drainage
4851237|NCT02324855|Positive expiratory pressure|positive expiratory pressure
4851238|NCT02324855|Airway clearance technique|airway clearance technique
4851239|NCT02324855|Quality of life|quality of life
4851240|NCT02324855|Exacerbations|exacerbations
4851241|NCT02324855|Chest physiotherapy|chest physiotherapy
4851242|NCT02324829|Total joint replacement|total joint replacement
4851243|NCT02324829|Physiotherapy|physiotherapy
4851244|NCT02324829|Kalman filtering|kalman filtering
4851245|NCT02324829|Kinematic modeling|kinematic modeling
4851246|NCT02324829|Hidden Markov model|hidden markov model
4851247|NCT02324829|Motion segmentation|motion segmentation
4851248|NCT02324790|OSA, Oral Pressure Therapy (OPT)|osa, oral pressure therapy (opt)
4851249|NCT02324764|transradial coronary angiography|transradial coronary angiography
4851250|NCT02324764|radial artery occlusion|radial artery occlusion
4851251|NCT02324764|coronary heart disease|coronary heart disease
4851252|NCT02324764|Glidesheath Slender|glidesheath slender
4851253|NCT02324738|Mefloquine/Dihydroartemisinin-piperaquine|mefloquine/dihydroartemisinin-piperaquine
4851254|NCT02324738|drug interaction|drug interaction
4851255|NCT02324725|naltrexone|naltrexone
4851256|NCT02324725|neuroimaging|neuroimaging
4851257|NCT02324725|heroin|heroin
4851258|NCT02324725|addiction|addiction
4851259|NCT02324725|dependence|dependence
4851260|NCT02324725|opioid|opioid
4851261|NCT02324725|Vivitrol®|vivitrol®
4851262|NCT02324725|functional magnetic resonance imaging|functional magnetic resonance imaging
4851263|NCT02324699|Vedolizumab|vedolizumab
4851264|NCT02324699|Corticosteroids|corticosteroids
4851265|NCT02324699|Prednisone|prednisone
4851266|NCT02324699|Crohn's disease|crohn's disease
4851267|NCT02324686|Warfarin|warfarin
4851268|NCT02324686|International Normalized Ratio|international normalized ratio
4851269|NCT02324686|Vitamin K|vitamin k
4851270|NCT02324673|Treatment-resistant seizures|treatment-resistant seizures
4851271|NCT02324660|screening procedure|screening procedure
4851272|NCT02324660|peak expiratory flow|peak expiratory flow
4851273|NCT02324660|respiratory health screening questionnaire|respiratory health screening questionnaire
4851274|NCT02324647|Urinary steroid profiling|urinary steroid profiling
4851275|NCT02324647|Adrenal incidentaloma|adrenal incidentaloma
4851276|NCT02324647|Adrenocortical carcinoma|adrenocortical carcinoma
4851277|NCT02324647|cost-effectiveness|cost-effectiveness
4851278|NCT02324621|protocol specific|protocol specific
4851279|NCT02324595|Ovarian Cancer|ovarian cancer
4851280|NCT02324595|Laparoscopy|laparoscopy
4851281|NCT02324595|Neoadjuvant Chemotherapy|neoadjuvant chemotherapy
4851282|NCT02324595|Robotic|robotic
4851283|NCT02324595|Interval Debulking Surgery|interval debulking surgery
4851284|NCT02324582|Urinary Bladder Neoplasms|urinary bladder neoplasms
4851285|NCT02324582|Mycobacterium bovis|mycobacterium bovis
4851286|NCT02324582|Programmed Cell Death 1 Receptor|programmed cell death 1 receptor
4851287|NCT02324582|pembrolizumab|pembrolizumab
4851288|NCT02324569|Pharmacological therapy|pharmacological therapy
4851289|NCT02324556|Rectal Cancer|rectal cancer
4851290|NCT02324556|Surgery|surgery
4851291|NCT02324556|Laparoscopy|laparoscopy
4851292|NCT02324517|response to various potential therapies as managed by lab assays|response to various potential therapies as managed by lab assays
4851293|NCT02324504|Peripherally Inserted Central Catheter (PICC)|peripherally inserted central catheter (picc)
4851294|NCT02324504|Electrocardiographic guidance|electrocardiographic guidance
4851295|NCT02324504|Reposition|reposition
4851296|NCT02324478|autonomic nervous system|autonomic nervous system
4851297|NCT02324478|heart rate variability|heart rate variability
4851298|NCT02324478|laparoscopic surgery|laparoscopic surgery
4851299|NCT02324478|general anesthesia|general anesthesia
4851300|NCT02324478|photoplethysmography|photoplethysmography
4851301|NCT02324439|ovarian cancer|ovarian cancer
4851302|NCT02324439|flaxseed|flaxseed
4851303|NCT02324439|dietary supplement|dietary supplement
4851304|NCT02324439|organic dietary supplement|organic dietary supplement
4851305|NCT02324439|recurrence|recurrence
4851306|NCT02324426|Parkinson's Disease|parkinson's disease
4851307|NCT02324426|Reduced Glutathione|reduced glutathione
4851308|NCT02324426|CNS|cns
4851309|NCT02324426|Glutathione|glutathione
4851310|NCT02324426|Uptake|uptake
4851311|NCT02324426|Intranasal|intranasal
4851312|NCT02324426|(in)GSH|(in)gsh
4851313|NCT02324387|Breast Cancer|breast cancer
4851314|NCT02324387|Molecular breast imaging|molecular breast imaging
4851315|NCT02324387|MBI|mbi
4851316|NCT02324387|Tc99m sestamibi|tc99m sestamibi
4851317|NCT02324387|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
4851318|NCT02324387|NAC|nac
4851319|NCT02324374|colon cancer|colon cancer
4851320|NCT02324361|Pediatric|pediatric
4851321|NCT02324361|Obesity|obesity
4851322|NCT02324361|Intervention|intervention
4851323|NCT02324361|Information and Communication Technologies|information and communication technologies
4851324|NCT02324361|Social Media|social media
4851325|NCT02324361|Text Messaging|text messaging
4851326|NCT02324361|Mobile Health|mobile health
4851327|NCT02324335|Oral Mucositis|oral mucositis
4851328|NCT02324335|Brilacidin|brilacidin
4851329|NCT02324335|Chemoradiation|chemoradiation
4851330|NCT02324322|Device: Robotic Exoskeleton|device: robotic exoskeleton
4851331|NCT02324296|small cell lung cancer|small cell lung cancer
4851332|NCT02324296|extended disease|extended disease
4851333|NCT02324296|limited disease|limited disease
4851334|NCT02324296|chemotherapy|chemotherapy
4851335|NCT02324296|cisplatin|cisplatin
4851336|NCT02324296|etoposide|etoposide
4851337|NCT02324296|ifosfamide|ifosfamide
4851338|NCT02324283|one-lung ventilation, oxygenation|one-lung ventilation, oxygenation
4851339|NCT02324270|Pain due to ankle sprain|pain due to ankle sprain
4851340|NCT02324244|Cytomegalovirus|cytomegalovirus
4851341|NCT02324244|critical patient|critical patient
4851342|NCT02324244|ICU|icu
4851343|NCT02324244|immunocompetent|immunocompetent
4851344|NCT02324244|clinical suspicion|clinical suspicion
4851345|NCT02324244|risk factors|risk factors
4851346|NCT02324218|Diabetes mellitus|diabetes mellitus
4851347|NCT02324218|Hepatitis B|hepatitis b
4851348|NCT02324218|Incidence|incidence
4851349|NCT02324192|Ultrasonography|ultrasonography
4851350|NCT02324192|clinical|clinical
4851351|NCT02324192|hand|hand
4851352|NCT02324166|cefazolin|cefazolin
4851353|NCT02324166|lidocaine|lidocaine
4851354|NCT02324153|Post-operative Delirium|post-operative delirium
4851355|NCT02324114|Cancer|cancer
4851356|NCT02324075|sanitation, toilet, urban, behavior change|sanitation, toilet, urban, behavior change
4851357|NCT02324062|Cancer Genetics|cancer genetics
4851358|NCT02324062|Multi-gene cancer panel testing|multi-gene cancer panel testing
4851359|NCT02324049|MPS IIIB|mps iiib
4851360|NCT02324049|Mucopolysaccharidosis|mucopolysaccharidosis
4851361|NCT02324049|Mucopolysaccharidosis type IIIB|mucopolysaccharidosis type iiib
4851362|NCT02324049|Sanfilippo Syndrome|sanfilippo syndrome
4851363|NCT02324049|Metabolism, Inborn Errors|metabolism, inborn errors
4851364|NCT02324049|Metabolic Diseases|metabolic diseases
4851365|NCT02324049|Genetic Diseases, Inborn|genetic diseases, inborn
4851366|NCT02324049|Carbohydrate Metabolism, Inborn Errors|carbohydrate metabolism, inborn errors
4851367|NCT02324049|Connective Tissue Diseases|connective tissue diseases
4851368|NCT02324049|Lysosomal Storage Diseases|lysosomal storage diseases
4851369|NCT02324049|Mucinoses|mucinoses
4851370|NCT02324049|Mucopolysaccharidoses|mucopolysaccharidoses
4851371|NCT02324049|Pathologic Processes|pathologic processes
4851372|NCT02324023|ultrasound|ultrasound
4851373|NCT02324023|perfusion|perfusion
4851374|NCT02324023|endoscopic|endoscopic
4851375|NCT02324010|gastric emptying|gastric emptying
4851376|NCT02324010|glycemia|glycemia
4851377|NCT02324010|appetite|appetite
4851378|NCT02324010|incretin hormones|incretin hormones
4851379|NCT02323997|HPV|hpv
4851380|NCT02323997|cervical cancer|cervical cancer
4851381|NCT02323997|human papillomavirus|human papillomavirus
4851382|NCT02323997|cervical pre-cancer|cervical pre-cancer
4851383|NCT02323997|cervical neoplasia|cervical neoplasia
4851384|NCT02323945|acute intermittent hypoxia|acute intermittent hypoxia
4851385|NCT02323945|incomplete spinal cord injury|incomplete spinal cord injury
4851386|NCT02323945|strength|strength
4851387|NCT02323945|walking|walking
4851388|NCT02323945|breathing|breathing
4851389|NCT02323919|myocardial infarction|myocardial infarction
4851390|NCT02323919|coronary artery bypass graft (CABG)|coronary artery bypass graft (cabg)
4851391|NCT02323919|angioplasty|angioplasty
4851392|NCT02323919|exercise|exercise
4851393|NCT02323919|cardiac patient|cardiac patient
4851394|NCT02323919|physical activity|physical activity
4851395|NCT02323906|Hepatocellular|hepatocellular
4851396|NCT02323906|Carcinoma|carcinoma
4851397|NCT02323906|Phase 1|phase 1
4851398|NCT02323906|CC-122|cc-122
4851399|NCT02323906|Sorafenib,|sorafenib,
4851400|NCT02323906|Nexavar|nexavar
4851401|NCT02323906|Unresectable Hepatocellular Carcinoma|unresectable hepatocellular carcinoma
4851402|NCT02323906|Unresectable HCCAdvanced,|unresectable hccadvanced,
4851403|NCT02323906|Hepatocellular Carcinoma|hepatocellular carcinoma
4851404|NCT02323906|liver cancer|liver cancer
4851501|NCT02323360|TACE|tace
4851405|NCT02323893|Positron Emission Tomography|positron emission tomography
4851406|NCT02323893|Cancer Immunotherapy|cancer immunotherapy
4851407|NCT02323867|Transplant|transplant
4851408|NCT02323867|Alternative Donor|alternative donor
4851409|NCT02323854|primary, recurrent, metastatic lung tumor, ablation|primary, recurrent, metastatic lung tumor, ablation
4851410|NCT02323841|cervical cancer|cervical cancer
4851411|NCT02323841|neoadjuvant chemotherapy|neoadjuvant chemotherapy
4851412|NCT02323841|Adverse Effects|adverse effects
4851413|NCT02323815|child acute malnutrition prevention|child acute malnutrition prevention
4851414|NCT02323815|behavior change communication|behavior change communication
4851415|NCT02323815|lipid-based nutrient supplement|lipid-based nutrient supplement
4851416|NCT02323815|screening coverage|screening coverage
4851417|NCT02323763|Magnetic Resonance Imaging|magnetic resonance imaging
4851418|NCT02323763|Bipolar Disorder|bipolar disorder
4851419|NCT02323763|Suicidal Ideation|suicidal ideation
4851420|NCT02323698|acute intermittent hypoxia|acute intermittent hypoxia
4851421|NCT02323698|incomplete spinal cord injury|incomplete spinal cord injury
4851422|NCT02323685|DCI|dci
4851423|NCT02323685|Delayed Cerebral Ischemia|delayed cerebral ischemia
4851424|NCT02323685|SAH|sah
4851425|NCT02323685|Subarachnoid Hemorrhage|subarachnoid hemorrhage
4851426|NCT02323685|Aneurysmal Subarachnoid Hemorrhage|aneurysmal subarachnoid hemorrhage
4851427|NCT02323685|Cerebral Ischemia|cerebral ischemia
4851428|NCT02323685|Brain Ischemia|brain ischemia
4851429|NCT02323659|Mycosis Fungoides|mycosis fungoides
4851430|NCT02323659|Cutaneous T-Cell Lymphoma|cutaneous t-cell lymphoma
4851431|NCT02323659|Interferon|interferon
4851432|NCT02323659|Methotrexate|methotrexate
4851433|NCT02323646|uterine fibroids|uterine fibroids
4851434|NCT02323646|leiomyoma|leiomyoma
4851435|NCT02323646|fibroid tumor|fibroid tumor
4851436|NCT02323646|fibroma|fibroma
4851437|NCT02323633|Pediatric Attention Deficit Hyperactivity Disorder|pediatric attention deficit hyperactivity disorder
4851438|NCT02323620|Acute myocardial Infarction|acute myocardial infarction
4851439|NCT02323620|bone marrow|bone marrow
4851440|NCT02323620|stem cells|stem cells
4851441|NCT02323620|cardiovascular disease|cardiovascular disease
4851442|NCT02323620|mortality|mortality
4851443|NCT02323581|Thoracoabdominal|thoracoabdominal
4851444|NCT02323581|Aneurysm|aneurysm
4851445|NCT02323581|Endovascular|endovascular
4851446|NCT02323581|Stent-Graft|stent-graft
4851447|NCT02323568|ovarian cancer|ovarian cancer
4851448|NCT02323568|quality of life|quality of life
4851449|NCT02323568|remission more than 3 years|remission more than 3 years
4851450|NCT02323555|Cancer|cancer
4851451|NCT02323555|chemotherapy|chemotherapy
4851452|NCT02323555|Targeted therapy|targeted therapy
4851453|NCT02323555|Day Hospital|day hospital
4851454|NCT02323542|Starch|starch
4851455|NCT02323542|cereal products|cereal products
4851456|NCT02323542|glucose kinetics|glucose kinetics
4851457|NCT02323542|blood glucose|blood glucose
4851458|NCT02323542|blood insulin|blood insulin
4851459|NCT02323529|Orfadin|orfadin
4851460|NCT02323529|Nitisinone|nitisinone
4851461|NCT02323529|NTBC|ntbc
4851462|NCT02323503|CRT-D|crt-d
4851463|NCT02323503|replacement|replacement
4851464|NCT02323503|primary prevention|primary prevention
4851465|NCT02323503|ventricular tachyarrhythmias|ventricular tachyarrhythmias
4851466|NCT02323490|meniscus repair|meniscus repair
4851467|NCT02323490|bone marrow stimulation|bone marrow stimulation
4851468|NCT02323477|cellular therapy|cellular therapy
4851469|NCT02323477|chronic ischemic heart disease|chronic ischemic heart disease
4851470|NCT02323477|phase 1/2 clinical study|phase 1/2 clinical study
4851471|NCT02323477|human umbilical cord multipotent stem cell|human umbilical cord multipotent stem cell
4851472|NCT02323477|human umbilical cord mesenchymal stem cell|human umbilical cord mesenchymal stem cell
4851473|NCT02323477|ischemic heart disease|ischemic heart disease
4851474|NCT02323477|bone marrow mononuclear cell|bone marrow mononuclear cell
4851475|NCT02323477|allogeneic stem cell transplantation|allogeneic stem cell transplantation
4851476|NCT02323438|biomarkers of tobacco exposure|biomarkers of tobacco exposure
4851477|NCT02323438|exposure|exposure
4851478|NCT02323438|tobacco|tobacco
4851479|NCT02323438|nicotine|nicotine
4851480|NCT02323438|nicotine gum|nicotine gum
4851481|NCT02323438|electronic cigarette|electronic cigarette
4851482|NCT02323438|e-cig|e-cig
4851483|NCT02323425|stroke|stroke
4851484|NCT02323425|Remote ischemic postconditioning|remote ischemic postconditioning
4851485|NCT02323425|symptomatic atherosclerotic intracranial arterial stenosis|symptomatic atherosclerotic intracranial arterial stenosis
4851486|NCT02323412|Low back pain|low back pain
4851487|NCT02323412|Chronic|chronic
4851488|NCT02323412|Modic Changes|modic changes
4851489|NCT02323412|MRI|mri
4851490|NCT02323412|epigenetics|epigenetics
4851491|NCT02323412|antibiotics|antibiotics
4851492|NCT02323412|randomized placebo controlled trial|randomized placebo controlled trial
4851493|NCT02323386|Dynamic RSA|dynamic rsa
4851494|NCT02323386|Knee|knee
4851495|NCT02323386|Total Knee Arthroplasty|total knee arthroplasty
4851496|NCT02323386|Kinematic Analysis|kinematic analysis
4851497|NCT02323373|Arthroplasty, Replacement, Knee|arthroplasty, replacement, knee
4851498|NCT02323373|Tranexamic Acid|tranexamic acid
4851499|NCT02323373|Drug Administration Routes|drug administration routes
4851502|NCT02323360|TAE|tae
4851503|NCT02323321|heart transplant|heart transplant
4851504|NCT02323321|heart preservation|heart preservation
4851505|NCT02323321|beating heart transplant|beating heart transplant
4851506|NCT02323295|Malignant bone tumors|malignant bone tumors
4851507|NCT02323282|Dose-response relationship|dose-response relationship
4851508|NCT02323282|Drug|drug
4851509|NCT02323256|cochlear implant|cochlear implant
4851510|NCT02323256|deafness|deafness
4851511|NCT02323256|audiometry|audiometry
4851512|NCT02323256|speech perception|speech perception
4851513|NCT02323256|severe to profound deafness restored with cochlear implantation|severe to profound deafness restored with cochlear implantation
4851514|NCT02323243|Detrusor striated sphincter dyssynergia|detrusor striated sphincter dyssynergia
4851515|NCT02323243|Temporary urethral stent|temporary urethral stent
4851516|NCT02323217|Imidazoline Receptor 2|imidazoline receptor 2
4851517|NCT02323217|(4,5-dihydro-1H-imidazol-2-yl)-1-methyl-1H-indole|(4,5-dihydro-1h-imidazol-2-yl)-1-methyl-1h-indole
4851518|NCT02323217|BU99008|bu99008
4851519|NCT02323217|Radionuclide Imaging|radionuclide imaging
4851520|NCT02323217|Molecular Imaging|molecular imaging
4851521|NCT02323217|Healthy Volunteers|healthy volunteers
4851522|NCT02323217|Alzheimer Disease|alzheimer disease
4851523|NCT02323204|posttraumatic stress|posttraumatic stress
4851524|NCT02323178|Chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
4851525|NCT02323178|thrombocytopenia|thrombocytopenia
4851526|NCT02323178|eltrombopag|eltrombopag
4851527|NCT02323152|women|women
4851528|NCT02323152|high risk|high risk
4851529|NCT02323139|High risk MDS|high risk mds
4851530|NCT02323139|Azacitidine|azacitidine
4851531|NCT02323139|LDE255|lde255
4851532|NCT02323126|Non small cell lung cancer,|non small cell lung cancer,
4851533|NCT02323126|NSCLC,|nsclc,
4851534|NCT02323126|EGFR-mutated,|egfr-mutated,
4851535|NCT02323126|EGF816,|egf816,
4851536|NCT02323126|INC280,|inc280,
4851537|NCT02323126|Nivolumab,|nivolumab,
4851538|NCT02323126|EGFR-T790M NSCLC,|egfr-t790m nsclc,
4851539|NCT02323126|EGFR wild-type (wt),|egfr wild-type (wt),
4851540|NCT02323126|cMET positive NSCLC,|cmet positive nsclc,
4851541|NCT02323126|cMET negative NSCLC|cmet negative nsclc
4851542|NCT02323113|Drug therapy|drug therapy
4851543|NCT02323100|cystic fibrosis|cystic fibrosis
4851544|NCT02323100|corrector|corrector
4851545|NCT02323100|glycerol phenylbutyrate|glycerol phenylbutyrate
4851546|NCT02323100|nasal potential difference|nasal potential difference
4851547|NCT02323087|Antibiotic resistance|antibiotic resistance
4851548|NCT02323087|Point of care tests|point of care tests
4851549|NCT02323087|Primary Health Care|primary health care
4851550|NCT02323022|AML|aml
4851551|NCT02323022|cladribine|cladribine
4851552|NCT02323022|induction therapy|induction therapy
4851553|NCT02323009|Transpulmonary pressure|transpulmonary pressure
4851554|NCT02323009|Esophageal balloon|esophageal balloon
4851555|NCT02323009|Esophageal pressure monitoring device|esophageal pressure monitoring device
4851556|NCT02323009|Cstat|cstat
4851557|NCT02323009|Static effective compliance|static effective compliance
4851558|NCT02323009|Ventilator weaning|ventilator weaning
4851559|NCT02323009|Morbidly Obese Ventilator Dependent Tracheotomized Patients|morbidly obese ventilator dependent tracheotomized patients
4851560|NCT02322983|Cerebral Palsy|cerebral palsy
4851561|NCT02322983|Dental Care|dental care
4851562|NCT02322983|Conscious Sedation|conscious sedation
4851563|NCT02322983|Autonomic Nervous System|autonomic nervous system
4851564|NCT02322983|Nitrous Oxide|nitrous oxide
4851565|NCT02322970|intracranial hypertension|intracranial hypertension
4851566|NCT02322970|tcd|tcd
4851567|NCT02322970|non invasive|non invasive
4851568|NCT02322970|ICP|icp
4851569|NCT02322944|acute myocardial infarction|acute myocardial infarction
4851570|NCT02322944|quality improvement|quality improvement
4851571|NCT02322944|reperfusion therapy|reperfusion therapy
4851572|NCT02322905|informal caregivers|informal caregivers
4851573|NCT02322905|caregiving|caregiving
4851574|NCT02322905|psychotherapy for caregivers|psychotherapy for caregivers
4851575|NCT02322905|cancer|cancer
4851576|NCT02322905|emotion regulation|emotion regulation
4851577|NCT02322905|distress|distress
4851578|NCT02322905|inflammation|inflammation
4851579|NCT02322892|Thiamine|thiamine
4851580|NCT02322892|Vitamin B1|vitamin b1
4851581|NCT02322892|Coronary artery bypass grafting|coronary artery bypass grafting
4851582|NCT02322892|Cardiac surgery|cardiac surgery
4851583|NCT02322892|Lactate|lactate
4851584|NCT02322892|Pyruvate dehydrogenase|pyruvate dehydrogenase
4851585|NCT02322879|Acetaminophen|acetaminophen
4851586|NCT02322879|Propylene glycol|propylene glycol
4851587|NCT02322866|acne|acne
4851588|NCT02322853|Metastatic breast cancer|metastatic breast cancer
4851589|NCT02322853|p38 map kinase|p38 map kinase
4851590|NCT02322853|tamoxifen|tamoxifen
4851591|NCT02322853|LY2228820|ly2228820
4851592|NCT02322853|Postmenopausal woman with advanced or metastatic breast cancer progressing on aromatase inhibitors (AI)|postmenopausal woman with advanced or metastatic breast cancer progressing on aromatase inhibitors (ai)
4851593|NCT02322827|hiv/aids|hiv/aids
4851594|NCT02322788|Inhalation, Pharmacodynamic, Patients,|inhalation, pharmacodynamic, patients,
4851595|NCT02322775|Asthma, Bronchial Diseases, Respiratory Tract Diseases, Lung Diseases, Obstructive Lung Diseases,|asthma, bronchial diseases, respiratory tract diseases, lung diseases, obstructive lung diseases,
4851596|NCT02322762|Type 2 diabetes mellitus|type 2 diabetes mellitus
4851597|NCT02322762|Anti-diabetic management patterns|anti-diabetic management patterns
4851598|NCT02322749|bioequivalence|bioequivalence
4851599|NCT02322749|bioavailability|bioavailability
4851600|NCT02322749|pharmacokinetics|pharmacokinetics
4851601|NCT02322749|Phase I|phase i
4851602|NCT02322749|AZD6244|azd6244
4851603|NCT02322749|cancer|cancer
4851604|NCT02322736|Metastatic Colorectal Cancer, wild type RAS, Panitumumab, Vectibix, Greece|metastatic colorectal cancer, wild type ras, panitumumab, vectibix, greece
4851605|NCT02322723|Adalimumab|adalimumab
4851606|NCT02322723|real life|real life
4851607|NCT02322723|RA|ra
4851608|NCT02322723|Humira|humira
4851609|NCT02322723|Rheumatoid Arthritis|rheumatoid arthritis
4851610|NCT02322723|effectiveness|effectiveness
4851611|NCT02322710|non-inferiority|non-inferiority
4851612|NCT02322710|randomized|randomized
4851613|NCT02322710|TulleGras|tullegras
4851614|NCT02322710|Urgotul|urgotul
4851615|NCT02322710|healing|healing
4851616|NCT02322710|surgical acute wounds|surgical acute wounds
4851617|NCT02322710|pain|pain
4851618|NCT02322697|Carnitine|carnitine
4851619|NCT02322697|hemodialysis|hemodialysis
4851620|NCT02322697|fatty acid|fatty acid
4851621|NCT02322697|imaging|imaging
4851622|NCT02322697|heart|heart
4851623|NCT02322684|Bougie|bougie
4851624|NCT02322684|Air-Q|air-q
4851625|NCT02322684|Insertion|insertion
4851626|NCT02322671|chewable tablet|chewable tablet
4851627|NCT02322671|montelukast sodium|montelukast sodium
4851628|NCT02322671|healthy adult subjects|healthy adult subjects
4851629|NCT02322671|relative bioavailability|relative bioavailability
4851630|NCT02322671|GW483100|gw483100
4851631|NCT02322593|Gastric Cancer|gastric cancer
4851632|NCT02322593|Gastrointestinal Diseases|gastrointestinal diseases
4851633|NCT02322593|Gastrointestinal Neoplasms|gastrointestinal neoplasms
4851634|NCT02322593|First Line Treatment|first line treatment
4851635|NCT02322593|Antineoplastic Agents|antineoplastic agents
4851636|NCT02322580|anti-TNF|anti-tnf
4851637|NCT02322580|therapeutic drug monitoring|therapeutic drug monitoring
4851638|NCT02322580|immunogenicity|immunogenicity
4851639|NCT02322554|electronic health records|electronic health records
4851640|NCT02322554|Qualified Clinical Data Registry|qualified clinical data registry
4851641|NCT02322554|PQRS|pqrs
4851642|NCT02322554|quality reporting|quality reporting
4851643|NCT02322554|cellular based products|cellular based products
4851644|NCT02322554|bioengieered skin|bioengieered skin
4851645|NCT02322554|USWR|uswr
4851646|NCT02322528|Non-invasive instruments|non-invasive instruments
4851647|NCT02322528|Environment|environment
4851648|NCT02322528|Wavefront|wavefront
4851649|NCT02322528|Placido Disk|placido disk
4851650|NCT02322528|Ellipsometer|ellipsometer
4851651|NCT02322528|Thermal Imaging|thermal imaging
4851652|NCT02322515|Knee|knee
4851653|NCT02322515|Proprioception|proprioception
4851654|NCT02322515|Electromyography|electromyography
4851655|NCT02322515|Taping|taping
4851656|NCT02322502|laryngeal mask airway|laryngeal mask airway
4851657|NCT02322502|desflurane|desflurane
4851658|NCT02322502|sevoflurane|sevoflurane
4851659|NCT02322502|propofol|propofol
4851660|NCT02322489|microcurent|microcurent
4851661|NCT02322489|pain|pain
4851662|NCT02322489|flexibility|flexibility
4851663|NCT02322463|patients who were admitted to the pediatric ED|patients who were admitted to the pediatric ed
4851664|NCT02322411|Stroke|stroke
4851665|NCT02322411|Deglutition|deglutition
4851666|NCT02322411|Deglutition disorders|deglutition disorders
4851667|NCT02322411|Resistance training|resistance training
4851668|NCT02322385|Autosomal Dominant Polycystic Kidney Disease|autosomal dominant polycystic kidney disease
4851669|NCT02322385|PKD 1 gene|pkd 1 gene
4851670|NCT02322385|PKD 2 gene|pkd 2 gene
4851671|NCT02322385|Truncational mutation|truncational mutation
4851672|NCT02322385|Hypomorphic mutation|hypomorphic mutation
4851673|NCT02322372|femoral blockade|femoral blockade
4851674|NCT02322372|bupivacaine|bupivacaine
4851675|NCT02322346|posttonsillectomy pain|posttonsillectomy pain
4851676|NCT02322346|levobupivacaine|levobupivacaine
4851677|NCT02322320|Multiple Myeloma|multiple myeloma
4851678|NCT02322320|Lenalidomide|lenalidomide
4851679|NCT02322320|Maintenance Therapy|maintenance therapy
4851680|NCT02322320|Progression|progression
4851681|NCT02322320|Long-term|long-term
4851682|NCT02322320|Anti-Myeloma Agents|anti-myeloma agents
4851683|NCT02322320|Hematologic Disorders|hematologic disorders
4851684|NCT02322307|Inflammatory Bowel Disease|inflammatory bowel disease
4851685|NCT02322307|Crohn's Disease|crohn's disease
4851686|NCT02322307|Ulcerative Colitis|ulcerative colitis
4851687|NCT02322307|Colitis|colitis
4851688|NCT02322307|PRO|pro
4851689|NCT02322307|Patient-centric|patient-centric
4851690|NCT02322307|HealthPROMISE|healthpromise
4851691|NCT02322294|Protein|protein
4851692|NCT02322294|mung bean|mung bean
4851693|NCT02322294|glucose|glucose
4851694|NCT02322294|triglycerides|triglycerides
4851695|NCT02322294|insulin|insulin
4851696|NCT02322294|body weight,|body weight,
4851697|NCT02322294|DXA scan|dxa scan
4851698|NCT02322281|cancer|cancer
4851699|NCT02322281|metastatic|metastatic
4851700|NCT02322281|locally advanced|locally advanced
4851701|NCT02322281|lung|lung
4851702|NCT02322281|non-small cell lung cancer|non-small cell lung cancer
4851703|NCT02322281|NSCLC|nsclc
4851704|NCT02322281|epidermal growth factor receptor|epidermal growth factor receptor
4851705|NCT02322281|EGFR|egfr
4851706|NCT02322281|T790M|t790m
4851707|NCT02322281|CO-1686|co-1686
4851708|NCT02322281|unresectable|unresectable
4851709|NCT02322281|recurrent|recurrent
4851710|NCT02322281|EGFR-directed therapy|egfr-directed therapy
4851711|NCT02322281|irreversible EGFR inhibitor|irreversible egfr inhibitor
4851712|NCT02322281|TIGER|tiger
4851713|NCT02322281|Rociletinib|rociletinib
4851714|NCT02322268|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
4851715|NCT02322268|Cosmos Caudatus|cosmos caudatus
4851716|NCT02322268|Ulam Raja|ulam raja
4851717|NCT02322268|Metabolomic profiling|metabolomic profiling
4851718|NCT02322268|antioxidant|antioxidant
4851719|NCT02322255|Natural History Study|natural history study
4851720|NCT02322255|Non-interventional Study|non-interventional study
4851721|NCT02322255|Observational Study|observational study
4851722|NCT02322255|Heterotopic ossification|heterotopic ossification
4851723|NCT02322255|Fibrodysplasia Ossificans Progressiva|fibrodysplasia ossificans progressiva
4851724|NCT02322255|FOP disease progression|fop disease progression
4851725|NCT02322255|FOP flare-up progression|fop flare-up progression
4851726|NCT02322255|Clementia|clementia
4851727|NCT02322255|Myositosis Ossificans Progressiva|myositosis ossificans progressiva
4851728|NCT02322255|Munchmeyer's Disease|munchmeyer's disease
4851729|NCT02322255|FOP|fop
4851730|NCT02322255|Palovarotene|palovarotene
4851731|NCT02322229|VMT|vmt
4851732|NCT02322229|sVMA|svma
4851733|NCT02322229|vitrectomy|vitrectomy
4851734|NCT02322229|ocriplasmin|ocriplasmin
4851735|NCT02322216|Allergies|allergies
4851736|NCT02322216|Ocular|ocular
4851737|NCT02322203|Niacin|niacin
4851738|NCT02322203|Cholesterol|cholesterol
4851739|NCT02322203|High-Density Lipoprotein|high-density lipoprotein
4851740|NCT02322203|Low-Density Lipoprotein|low-density lipoprotein
4851741|NCT02322203|Lipoproteins|lipoproteins
4851742|NCT02322190|Steroid Failure|steroid failure
4851743|NCT02322190|Immunomodulation|immunomodulation
4851744|NCT02322190|Corticosteroid Therapy|corticosteroid therapy
4851745|NCT02322177|Inborn Error of Metabolism|inborn error of metabolism
4851746|NCT02322177|Pregnancy|pregnancy
4851747|NCT02322177|Amino acid disorder|amino acid disorder
4851748|NCT02322177|Fatty acid oxidation disorder|fatty acid oxidation disorder
4851749|NCT02322177|Organic Acidemia|organic acidemia
4851750|NCT02322164|Skin|skin
4851751|NCT02322164|TEMPERATURE|temperature
4851752|NCT02322164|Placebo|placebo
4851753|NCT02322151|Filgrastim|filgrastim
4851754|NCT02322151|Neupogen|neupogen
4851755|NCT02322151|Transplant|transplant
4851756|NCT02322151|Breast Feeding|breast feeding
4851757|NCT02322151|Concentration|concentration
4851758|NCT02322125|walking|walking
4851759|NCT02322125|locomotion|locomotion
4851760|NCT02322125|rehabilitation|rehabilitation
4851761|NCT02322112|Dietary Fiber|dietary fiber
4851762|NCT02322112|Gastrointestinal Microbiome|gastrointestinal microbiome
4851763|NCT02322112|Overweight and Obesity|overweight and obesity
4851764|NCT02322112|Personalized Nutrition|personalized nutrition
4851765|NCT02322112|Inflammation|inflammation
4851766|NCT02322112|Metabolism|metabolism
4851767|NCT02322099|human immunodeficiency virus|human immunodeficiency virus
4851768|NCT02322099|bone diseases|bone diseases
4851769|NCT02322099|osteopenia|osteopenia
4851770|NCT02322099|osteoporosis|osteoporosis
4851771|NCT02322099|fracture|fracture
4851772|NCT02322099|bone turnover|bone turnover
4851773|NCT02322099|alendronate|alendronate
4851774|NCT02322099|antiretroviral|antiretroviral
4851775|NCT02322060|IVA, ovary tissue grafting, POI|iva, ovary tissue grafting, poi
4851776|NCT02322034|chronic heart failure|chronic heart failure
4851777|NCT02322034|multiple neurohormonal axis disequilibrium|multiple neurohormonal axis disequilibrium
4851778|NCT02322034|growth hormone deficiency|growth hormone deficiency
4851779|NCT02322034|Insulin-like growth factor-1 (IGF-1)|insulin-like growth factor-1 (igf-1)
4851780|NCT02322034|metabolic deficiency syndrome|metabolic deficiency syndrome
4851781|NCT02322034|interval training|interval training
4851782|NCT02322021|E2609|e2609
4851783|NCT02322021|Mild Cognitive Impairment|mild cognitive impairment
4851784|NCT02322021|Mild to Moderate Dementia|mild to moderate dementia
4851785|NCT02322021|Alzheimer's Disease|alzheimer's disease
4851786|NCT02322021|Prodromal Alzheimer's Disease|prodromal alzheimer's disease
4851787|NCT02321982|Mohs surgery|mohs surgery
4851788|NCT02321982|Preoperative consultation|preoperative consultation
4851789|NCT02321969|Chemoprevention|chemoprevention
4851790|NCT02321969|Colorectal adenomatous polyp|colorectal adenomatous polyp
4851791|NCT02321969|Green tea extract|green tea extract
4851792|NCT02321956|ASA class 1,2|asa class 1,2
4851793|NCT02321956|age 1-6 years|age 1-6 years
4851794|NCT02321956|General anesthesia with ETT|general anesthesia with ett
4851795|NCT02321930|Rheumatoid Arthritis|rheumatoid arthritis
4851796|NCT02321930|Musculoskeletal Ultrasound|musculoskeletal ultrasound
4851797|NCT02321930|Tofacitinib|tofacitinib
4851798|NCT02321930|biomarker|biomarker
4851799|NCT02321904|Confocal microscopy|confocal microscopy
4851800|NCT02321904|Cornea|cornea
4851801|NCT02321904|Neuropathy|neuropathy
4851802|NCT02321904|Detection|detection
4851803|NCT02321904|Diabetes|diabetes
4851804|NCT02321839|neovascular age-related macular degeneration|neovascular age-related macular degeneration
4851805|NCT02321839|Ranibizumab|ranibizumab
4851806|NCT02321839|Treat and extend|treat and extend
4851807|NCT02321813|quality of life|quality of life
4851808|NCT02321813|colorectal cancer|colorectal cancer
4851809|NCT02321813|definitive RCT|definitive rct
4851810|NCT02321813|complex intervention|complex intervention
4851811|NCT02321800|S-649266|s-649266
4851812|NCT02321800|complicated urinary tract infection|complicated urinary tract infection
4851813|NCT02321800|cefiderocol|cefiderocol
4851814|NCT02321800|acute uncomplicated pyelonephritis|acute uncomplicated pyelonephritis
4851815|NCT02321800|Gram-negative pathogens|gram-negative pathogens
4851816|NCT02321800|imipenem/cilastatin|imipenem/cilastatin
4851817|NCT02321787|Anesthesia, Caudal|anesthesia, caudal
4851818|NCT02321787|Ultrasonography|ultrasonography
4851819|NCT02321774|Stress|stress
4851820|NCT02321774|Virtual Reality|virtual reality
4851821|NCT02321774|Wearable Sensor|wearable sensor
4851822|NCT02321774|Wellness|wellness
4851823|NCT02321761|Amantadine hydrochloride|amantadine hydrochloride
4851824|NCT02321761|Rehabilitation|rehabilitation
4851825|NCT02321761|Acquired Brain Injury|acquired brain injury
4851826|NCT02321761|TBI|tbi
4851827|NCT02321748|HSV|hsv
4851828|NCT02321748|Herpes|herpes
4851829|NCT02321748|volunteers|volunteers
4851830|NCT02321748|drug-drug interaction|drug-drug interaction
4851831|NCT02321735|Long-Term Survivor|long-term survivor
4851832|NCT02321735|Genomic|genomic
4851833|NCT02321735|Survivorship|survivorship
4851834|NCT02321735|Quality of Life|quality of life
4851835|NCT02321722|Colonoscopy|colonoscopy
4851836|NCT02321696|physiotherapy|physiotherapy
4851837|NCT02321696|manual therapy|manual therapy
4851838|NCT02321696|acupuncture|acupuncture
4851839|NCT02321696|eccentric exercise|eccentric exercise
4851840|NCT02321670|operative technique|operative technique
4851841|NCT02321644|CC-90001|cc-90001
4851842|NCT02321644|PHARMACOKINETICS|pharmacokinetics
4851843|NCT02321644|PHARMACODYNAMICS|pharmacodynamics
4851844|NCT02321644|HEALTHY SUBJECTS|healthy subjects
4851845|NCT02321644|SINGLE DOSE|single dose
4851846|NCT02321644|MULTIPLE DOSE|multiple dose
4851847|NCT02321644|PUNCH BIOPSY|punch biopsy
4851848|NCT02321631|Malnourished|malnourished
4851849|NCT02321631|Head and Neck Cancer|head and neck cancer
4851850|NCT02321631|Surgery|surgery
4851851|NCT02321618|Hypertension|hypertension
4851852|NCT02321618|High Blood Pressure|high blood pressure
4851853|NCT02321618|African American men|african american men
4851854|NCT02321618|Black men|black men
4851855|NCT02321618|barbershop|barbershop
4851856|NCT02321605|Best Possible Self|best possible self
4851857|NCT02321605|Positive Psychology|positive psychology
4851858|NCT02321605|Optimism|optimism
4851859|NCT02321605|Positive Technology|positive technology
4851860|NCT02321605|Future Thinking|future thinking
4851861|NCT02321592|Hodgkin Lymphoma|hodgkin lymphoma
4851862|NCT02321592|AFM13|afm13
4851863|NCT02321592|Natural Killer Cells|natural killer cells
4851864|NCT02321553|metabolic syndrome|metabolic syndrome
4851865|NCT02321553|glucose|glucose
4851866|NCT02321553|cholesterol|cholesterol
4851867|NCT02321553|brown rice|brown rice
4851868|NCT02321553|inflammation|inflammation
4851869|NCT02321553|oxidative stress|oxidative stress
4851870|NCT02321540|Lung Cancer|lung cancer
4851871|NCT02321540|Non-small cell lung cancer|non-small cell lung cancer
4851872|NCT02321540|NSCLC|nsclc
4851873|NCT02321540|Epidermal growth factor receptor mutations|epidermal growth factor receptor mutations
4851874|NCT02321540|EGFR|egfr
4851875|NCT02321540|Recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
4851876|NCT02321540|Ibrutinib|ibrutinib
4851877|NCT02321540|PCI-32765|pci-32765
4851878|NCT02321540|Imbruvica|imbruvica
4851879|NCT02321527|Breast Cancer|breast cancer
4851880|NCT02321527|Microbubble contrast-enhanced ultrasound|microbubble contrast-enhanced ultrasound
4851881|NCT02321527|CEUS|ceus
4851882|NCT02321527|Sentinel lymph nodes|sentinel lymph nodes
4851883|NCT02321527|SLN|sln
4851884|NCT02321527|Perflutren Protein-Type A Microspheres Injectable Suspension|perflutren protein-type a microspheres injectable suspension
4851885|NCT02321527|OPTISON™|optison™
4851886|NCT02321527|Ultrasound|ultrasound
4851887|NCT02321527|Breast biopsy|breast biopsy
4851888|NCT02321527|Radioactive seed|radioactive seed
4851889|NCT02321527|Phone call|phone call
4851890|NCT02321527|Fine needle aspiration|fine needle aspiration
4851891|NCT02321527|FNA|fna
4851892|NCT02321501|Head and Neck Cancer|head and neck cancer
4851893|NCT02321501|Lung Cancer|lung cancer
4851894|NCT02321501|Non small cell lung|non small cell lung
4851895|NCT02321501|NSCLC|nsclc
4851896|NCT02321501|Metastatic|metastatic
4851897|NCT02321501|Locally advanced|locally advanced
4851898|NCT02321501|Metastatic solid tumors|metastatic solid tumors
4851899|NCT02321501|Anaplastic lymphoma kinase|anaplastic lymphoma kinase
4851900|NCT02321501|ALK|alk
4851901|NCT02321501|Ceritinib|ceritinib
4851902|NCT02321501|LDK378|ldk378
4851903|NCT02321501|Zykadia|zykadia
4851904|NCT02321501|Everolimus|everolimus
4851905|NCT02321501|Afinitor|afinitor
4851906|NCT02321501|Zortress|zortress
4851907|NCT02321501|RAD001|rad001
4851908|NCT02321501|Pharmacokinetic|pharmacokinetic
4851909|NCT02321501|PK|pk
4851910|NCT02321501|Biomarker testing|biomarker testing
4851911|NCT02321475|Psycho-emotional symptoms|psycho-emotional symptoms
4851912|NCT02321462|preparation|preparation
4851913|NCT02321423|Nail Dystrophy|nail dystrophy
4851914|NCT02321423|Plantar Keratoderma|plantar keratoderma
4851915|NCT02321423|Palmar Keratoderma|palmar keratoderma
4851916|NCT02321423|Leukokeratosis|leukokeratosis
4851917|NCT02321423|Cysts|cysts
4851918|NCT02321423|Pain|pain
4851919|NCT02321423|KRT17|krt17
4851920|NCT02321423|KRT16|krt16
4851921|NCT02321423|KRT6A|krt6a
4851922|NCT02321423|KRT6B|krt6b
4851923|NCT02321423|KRT6C|krt6c
4851924|NCT02321397|oxycodone naloxone combination|oxycodone naloxone combination
4851925|NCT02321397|severe chronic and non-malignant pain|severe chronic and non-malignant pain
4851926|NCT02321397|Malignant and non-malignant pain that requires around-the clock opioid therapy|malignant and non-malignant pain that requires around-the clock opioid therapy
4851927|NCT02321358|Behavior Change|behavior change
4851928|NCT02321358|Objectively Measured Physical Activity|objectively measured physical activity
4851929|NCT02321358|Survivorship|survivorship
4851930|NCT02321345|Allogeneic Stem Cell Transplant|allogeneic stem cell transplant
4851931|NCT02321345|Hematological Malignancies|hematological malignancies
4851932|NCT02321345|Palliative Care|palliative care
4851933|NCT02321345|Supportive care|supportive care
4851934|NCT02321332|Palmar hyperhidrosis|palmar hyperhidrosis
4851935|NCT02321332|Endoscopic thoracic sympathectomy|endoscopic thoracic sympathectomy
4851936|NCT02321319|chronic pain|chronic pain
4851937|NCT02321319|pediatric|pediatric
4851938|NCT02321293|curcumin|curcumin
4851939|NCT02321293|lung cancer|lung cancer
4851940|NCT02321293|TKI|tki
4851941|NCT02321267|AMD|amd
4851942|NCT02321267|PCV|pcv
4851943|NCT02321267|RAP|rap
4851944|NCT02321267|RVO|rvo
4851945|NCT02321267|DME|dme
4851946|NCT02321267|ERM|erm
4851947|NCT02321267|MH|mh
4851948|NCT02321267|mCNV|mcnv
4851949|NCT02321254|Stroke|stroke
4851950|NCT02321254|Upper limb|upper limb
4851951|NCT02321254|Robotics|robotics
4851952|NCT02321254|Electromyography|electromyography
4851953|NCT02321254|Rehabilitation|rehabilitation
4851954|NCT02321241|Wet-AMD|wet-amd
4851955|NCT02321241|Refractory patients to ranibizumab|refractory patients to ranibizumab
4851956|NCT02321241|Real life|real life
4851957|NCT02321241|Switch|switch
4851958|NCT02321241|Aflibercept|aflibercept
4851959|NCT02321228|Salpingectomy|salpingectomy
4851960|NCT02321228|Delayed oophorectomy|delayed oophorectomy
4851961|NCT02321228|Salpingo-oophorectomy|salpingo-oophorectomy
4851962|NCT02321228|Quality of life|quality of life
4851963|NCT02321228|Ovarian cancer|ovarian cancer
4851964|NCT02321228|BRCA|brca
4851965|NCT02321215|AECOPD|aecopd
4851966|NCT02321215|COPD|copd
4851967|NCT02321215|education|education
4851968|NCT02321202|omega-3|omega-3
4851969|NCT02321202|Progression|progression
4851970|NCT02321202|parenteral nutrition|parenteral nutrition
4851971|NCT02321150|Pterygium|pterygium
4851972|NCT02321150|Pterygiums|pterygiums
4851973|NCT02321150|Pterygia|pterygia
4851974|NCT02321150|Graft|graft
4851975|NCT02321150|Autograft|autograft
4851976|NCT02321150|Excision|excision
4851977|NCT02321150|Surgery|surgery
4851978|NCT02321150|Eye|eye
4851979|NCT02321150|electrocautery|electrocautery
4851980|NCT02321150|polyglactin|polyglactin
4851981|NCT02321124|Constipation|constipation
4851982|NCT02321124|connective tissue manipulation|connective tissue manipulation
4851983|NCT02321124|conservative therapy|conservative therapy
4851984|NCT02321124|massage|massage
4851985|NCT02321124|randomized controlled trial|randomized controlled trial
4851986|NCT02321111|Insulin signaling and glucose disposal in muscle|insulin signaling and glucose disposal in muscle
4851987|NCT02321111|Hepatic insulin sensitivity|hepatic insulin sensitivity
4851988|NCT02321111|TLR4 signaling and inflammatory gene expression|tlr4 signaling and inflammatory gene expression
4851989|NCT02321111|Plasma cytokine concentration|plasma cytokine concentration
4851990|NCT02321111|Intramyocellular diacylglycerol and ceramide content|intramyocellular diacylglycerol and ceramide content
4851991|NCT02321098|Onychomycosis|onychomycosis
4851992|NCT02321098|antifungal|antifungal
4851993|NCT02321072|oxygen|oxygen
4851994|NCT02321072|hypoxia|hypoxia
4851995|NCT02321072|hyperoxia|hyperoxia
4851996|NCT02321072|critical care|critical care
4851997|NCT02321072|intensive care|intensive care
4851998|NCT02321059|incisional hernia|incisional hernia
4851999|NCT02321059|hernia|hernia
4852000|NCT02321059|abdominal wall strength|abdominal wall strength
4852001|NCT02321059|validation|validation
4852002|NCT02321059|physical activity|physical activity
4852003|NCT02321046|Non-Small Cell Lung Cancer, NSCLC, Epidermal growth factor receptor, EGFR|non-small cell lung cancer, nsclc, epidermal growth factor receptor, egfr
4852004|NCT02321033|glycemic index|glycemic index
4852005|NCT02321033|inactivity|inactivity
4852006|NCT02321033|insulin sensitivity|insulin sensitivity
4852007|NCT02321033|metabolic flexibility|metabolic flexibility
4852008|NCT02321033|arterial stiffness|arterial stiffness
4852009|NCT02321033|young men|young men
4852010|NCT02320994|stroke|stroke
4852011|NCT02320994|aftercare|aftercare
4852012|NCT02320981|GERD|gerd
4852013|NCT02320981|EGD|egd
4852014|NCT02320981|pH testing|ph testing
4852015|NCT02320981|eosinophilic esophagitis|eosinophilic esophagitis
4852016|NCT02320981|impedance testing|impedance testing
4852017|NCT02320955|autologous bone flap|autologous bone flap
4852018|NCT02320955|decompressive craniectomy|decompressive craniectomy
4852019|NCT02320955|malignant brain swelling|malignant brain swelling
4852020|NCT02320955|patient specific implant|patient specific implant
4852021|NCT02320955|bone resorption|bone resorption
4852022|NCT02320955|aseptic bone necrosis|aseptic bone necrosis
4852023|NCT02320942|Bone Marrow Transplantation|bone marrow transplantation
4852024|NCT02320942|Exercise|exercise
4852025|NCT02320942|Rehabilitation|rehabilitation
4852026|NCT02320942|Cancer|cancer
4852027|NCT02320929|irrigation|irrigation
4852028|NCT02320929|tenosynovitis|tenosynovitis
4852029|NCT02320929|purulent|purulent
4852030|NCT02320929|closed-catheter|closed-catheter
4852031|NCT02320929|flexor tendon|flexor tendon
4852032|NCT02320903|Criminal Justice|criminal justice
4852033|NCT02320903|Juvenile Delinquency|juvenile delinquency
4852034|NCT02320890|transcranial direct current stimulation|transcranial direct current stimulation
4852035|NCT02320890|tDCS|tdcs
4852036|NCT02320890|Mild Cognitive Impairment|mild cognitive impairment
4852037|NCT02320890|MCI|mci
4852038|NCT02320864|muscle strength|muscle strength
4852039|NCT02320864|muscle weakness|muscle weakness
4852040|NCT02320864|hospitalization|hospitalization
4852041|NCT02320864|surgery|surgery
4852042|NCT02320864|total knee replacement|total knee replacement
4852043|NCT02320851|Somatoform disorder|somatoform disorder
4852044|NCT02320851|Functional vertigo/dizziness|functional vertigo/dizziness
4852045|NCT02320851|Chronic subjective dizziness|chronic subjective dizziness
4852046|NCT02320838|Transcutaneous Electric Nerve Stimulation|transcutaneous electric nerve stimulation
4852047|NCT02320838|Electric Stimulation Therapy|electric stimulation therapy
4852048|NCT02320838|Unmodulated Alternating Currents|unmodulated alternating currents
4852049|NCT02320838|Neural Conduction|neural conduction
4852050|NCT02320838|Pain Threshold|pain threshold
4852051|NCT02320825|Stereotactic Radiosurgery (SRS)|stereotactic radiosurgery (srs)
4852052|NCT02320825|Single-Fraction|single-fraction
4852053|NCT02320825|Hypofractionated|hypofractionated
4852054|NCT02320825|Spinal surgery|spinal surgery
4852055|NCT02320825|14-233|14-233
4852056|NCT02320799|interpersonal psychotherapy|interpersonal psychotherapy
4852057|NCT02320799|HIV|hiv
4852058|NCT02320799|women|women
4852059|NCT02320799|gender based violence|gender based violence
4852060|NCT02320799|mental health|mental health
4852061|NCT02320799|africa|africa
4852062|NCT02320799|kenya|kenya
4852063|NCT02320799|global mental health|global mental health
4852064|NCT02320799|HIV treatment adherence|hiv treatment adherence
4852065|NCT02320786|Power mobility|power mobility
4852066|NCT02320786|Wheelchair skills training|wheelchair skills training
4852067|NCT02320786|Spinal Cord Injury|spinal cord injury
4852068|NCT02320773|Overactive Bladder|overactive bladder
4852069|NCT02320773|Quality of Life|quality of life
4852070|NCT02320773|Betanis®|betanis®
4852071|NCT02320773|Betmiga®|betmiga®
4852072|NCT02320773|Observational|observational
4852073|NCT02320773|Myrbetriq®|myrbetriq®
4852074|NCT02320747|Volunteers|volunteers
4852075|NCT02320734|surgical rating scale|surgical rating scale
4852076|NCT02320734|neuromuscular relaxation|neuromuscular relaxation
4852077|NCT02320734|Anaesthesia|anaesthesia
4852078|NCT02320734|minimally invasive esophagectomy|minimally invasive esophagectomy
4852079|NCT02320708|Molar,third; Teeth,wisdom; Pain, Postoperative; Dental Surgery; Third molar extraction|molar,third; teeth,wisdom; pain, postoperative; dental surgery; third molar extraction
4852080|NCT02320643|Partially absorbable mesh|partially absorbable mesh
4852081|NCT02320617|Lung Neoplasms|lung neoplasms
4852082|NCT02320617|diffusion weighted MRI|diffusion weighted mri
4852083|NCT02320617|ADC value|adc value
4852084|NCT02320617|treatment effect|treatment effect
4852085|NCT02320604|Liposomal amphotericin B|liposomal amphotericin b
4852086|NCT02320604|AmBisome|ambisome
4852087|NCT02320604|Pharmacokinetics|pharmacokinetics
4852089|NCT02320604|Bariatric surgery|bariatric surgery
4852090|NCT02320578|Neoadjuvant Chemoptherapy|neoadjuvant chemoptherapy
4852091|NCT02320578|Laparoscopy 3D|laparoscopy 3d
4852092|NCT02320578|Cervical cancer|cervical cancer
4852093|NCT02320565|Endometrial Cancer|endometrial cancer
4852094|NCT02320565|Laparoscopy 3D|laparoscopy 3d
4852095|NCT02320552|Nutritional assessment|nutritional assessment
4852096|NCT02320539|MicroRNA|microrna
4852097|NCT02320539|Cerebrospinal fluid|cerebrospinal fluid
4852098|NCT02320526|Exercise|exercise
4852099|NCT02320526|Training|training
4852100|NCT02320526|Interval training|interval training
4852101|NCT02320526|Systemic inflammation|systemic inflammation
4852102|NCT02320526|Glucose disposal|glucose disposal
4852103|NCT02320526|Insulin sensitivity|insulin sensitivity
4852209|NCT02319759|Guselkumab|guselkumab
4852104|NCT02320526|Glucose effectiveness|glucose effectiveness
4852105|NCT02320513|Exercise|exercise
4852106|NCT02320461|diabetes mellitus|diabetes mellitus
4852107|NCT02320461|cardiovascular diseases|cardiovascular diseases
4852108|NCT02320461|cohort studies|cohort studies
4852109|NCT02320461|hypertension|hypertension
4852110|NCT02320461|obesity|obesity
4852111|NCT02320461|smoking|smoking
4852112|NCT02320461|social class|social class
4852113|NCT02320422|liver transplant|liver transplant
4852114|NCT02320422|medication adherence|medication adherence
4852115|NCT02320422|intervention|intervention
4852116|NCT02320409|Subjects|subjects
4852117|NCT02320383|CLL|cll
4852118|NCT02320357|Platelet activation|platelet activation
4852119|NCT02320357|CD40 ligand|cd40 ligand
4852120|NCT02320357|CD154|cd154
4852121|NCT02320357|Interferon alpha|interferon alpha
4852122|NCT02320357|clopidogrel|clopidogrel
4852123|NCT02320318|Irritable Bowel Syndrome|irritable bowel syndrome
4852124|NCT02320318|Colon, irritable|colon, irritable
4852125|NCT02320318|Bowel disease|bowel disease
4852126|NCT02320318|Diarrhea|diarrhea
4852127|NCT02320279|Fetal Heart Rate|fetal heart rate
4852128|NCT02320279|Fetal EKG|fetal ekg
4852129|NCT02320279|FHR tracing|fhr tracing
4852130|NCT02320279|fetal R-waves|fetal r-waves
4852131|NCT02320266|Deep Brain Stimulation Surgery|deep brain stimulation surgery
4852132|NCT02320253|Diabetes|diabetes
4852133|NCT02320253|Obesity|obesity
4852134|NCT02320253|Primary Care|primary care
4852135|NCT02320253|Lifestyle Intervention|lifestyle intervention
4852136|NCT02320240|antidepressants|antidepressants
4852137|NCT02320240|acute kidney injury|acute kidney injury
4852138|NCT02320240|SNRI|snri
4852139|NCT02320240|renal failure|renal failure
4852140|NCT02320240|duloxetine|duloxetine
4852141|NCT02320240|CNODES|cnodes
4852142|NCT02320188|modification of treatment planned|modification of treatment planned
4852143|NCT02320188|Exercise|exercise
4852144|NCT02320175|family centered rounds|family centered rounds
4852145|NCT02320175|patient safety|patient safety
4852146|NCT02320175|errors|errors
4852147|NCT02320175|adverse events|adverse events
4852148|NCT02320175|concordance|concordance
4852149|NCT02320175|patient experience|patient experience
4852150|NCT02320149|acne|acne
4852151|NCT02320123|Terminal Care|terminal care
4852152|NCT02320123|Decision Making|decision making
4852153|NCT02320123|Communication|communication
4852154|NCT02320110|Irisin|irisin
4852155|NCT02320110|Adiponectin|adiponectin
4852156|NCT02320110|Leptin|leptin
4852157|NCT02320110|Insulin resistance|insulin resistance
4852158|NCT02320110|Body Mass Index|body mass index
4852159|NCT02320110|Obesity|obesity
4852160|NCT02320110|Metabolic Syndrome|metabolic syndrome
4852161|NCT02320110|Lipid Profile|lipid profile
4852162|NCT02320110|Diabetes Mellitus|diabetes mellitus
4852163|NCT02320084|HT-1|ht-1
4852164|NCT02320084|Hereditary Tyrosinemia, Type I|hereditary tyrosinemia, type i
4852165|NCT02320084|hypertyrosinemia type 1|hypertyrosinemia type 1
4852166|NCT02320084|Orfadin|orfadin
4852167|NCT02320084|Long term safety|long term safety
4852168|NCT02320084|Hereditary Tyrosinemia Type 1|hereditary tyrosinemia type 1
4852169|NCT02320032|Alkermes|alkermes
4852170|NCT02320032|Schizophrenia|schizophrenia
4852171|NCT02320032|Aripiprazole|aripiprazole
4852172|NCT02320032|Aripiprazole lauroxil|aripiprazole lauroxil
4852173|NCT02320032|ALKS 9072|alks 9072
4852174|NCT02320006|hydrotubation|hydrotubation
4852175|NCT02320006|incomplete fallopian tube obstructive infertility|incomplete fallopian tube obstructive infertility
4852176|NCT02320006|Acupuncture|acupuncture
4852177|NCT02319993|Suan-Zao-Ren Tang|suan-zao-ren tang
4852178|NCT02319993|Tian-wang-bu-xin-dan|tian-wang-bu-xin-dan
4852179|NCT02319993|Traditional Chinese Medicine|traditional chinese medicine
4852180|NCT02319993|Herbs|herbs
4852181|NCT02319993|Quality of life|quality of life
4852182|NCT02319967|community health worker|community health worker
4852183|NCT02319967|emergency|emergency
4852184|NCT02319967|asthma|asthma
4852185|NCT02319941|Inhibition of Platelet Reactivity|inhibition of platelet reactivity
4852186|NCT02319941|ticagrelor|ticagrelor
4852187|NCT02319941|clopidogrel|clopidogrel
4852188|NCT02319941|Pharmacodynamics|pharmacodynamics
4852189|NCT02319941|Pharmacokinetics|pharmacokinetics
4852190|NCT02319915|tranexamic acid|tranexamic acid
4852191|NCT02319915|knee prosthesis|knee prosthesis
4852192|NCT02319915|pharmacokinetic profile|pharmacokinetic profile
4852193|NCT02319863|hepatocellular carcinoma|hepatocellular carcinoma
4852194|NCT02319863|prognosis|prognosis
4852195|NCT02319850|sarcopenia|sarcopenia
4852196|NCT02319850|screening|screening
4852197|NCT02319850|geriatrics|geriatrics
4852198|NCT02319850|muscle|muscle
4852199|NCT02319850|aging|aging
4852200|NCT02319850|ultrasound|ultrasound
4852201|NCT02319798|Crohn's disease|crohn's disease
4852202|NCT02319798|ulcerative colitis|ulcerative colitis
4852203|NCT02319798|Inflammatory bowel disease|inflammatory bowel disease
4852204|NCT02319798|IBD|ibd
4852205|NCT02319772|Healthy volunteers|healthy volunteers
4852206|NCT02319772|Ebola virus|ebola virus
4852207|NCT02319772|Filovirus|filovirus
4852208|NCT02319759|Psoriatic Arthritis|psoriatic arthritis
4852210|NCT02319759|Ustekinumab|ustekinumab
4852211|NCT02319759|Placebo|placebo
4852212|NCT02319694|Basal Ganglia|basal ganglia
4852213|NCT02319694|Behavior|behavior
4852214|NCT02319694|Behavioral|behavioral
4852215|NCT02319694|Brain|brain
4852216|NCT02319694|Cognitive|cognitive
4852217|NCT02319694|Computer Simulation|computer simulation
4852218|NCT02319694|Cues|cues
4852219|NCT02319694|Data|data
4852220|NCT02319694|Deep Brain Stimulation|deep brain stimulation
4852221|NCT02319694|Disease|disease
4852222|NCT02319681|Caregivers|caregivers
4852223|NCT02319681|Anxiety|anxiety
4852224|NCT02319681|Depression|depression
4852225|NCT02319655|Epiretinal membrane|epiretinal membrane
4852226|NCT02319655|Macular pucker|macular pucker
4852227|NCT02319655|Membrane peeling|membrane peeling
4852228|NCT02319655|pars plana vitrectomy|pars plana vitrectomy
4852229|NCT02319655|Air|air
4852230|NCT02319655|balanced salt solution|balanced salt solution
4852231|NCT02319655|Intraoperative OCT|intraoperative oct
4852232|NCT02319655|Hyporeflectivity|hyporeflectivity
4852233|NCT02319655|Retina|retina
4852234|NCT02319642|Rheumatoid Arthritis|rheumatoid arthritis
4852235|NCT02319642|TNFα antagonist|tnfα antagonist
4852236|NCT02319642|Certolizumab pegol|certolizumab pegol
4852237|NCT02319642|Chinese patients|chinese patients
4852238|NCT02319642|Open-label|open-label
4852239|NCT02319629|Morbid obesity,|morbid obesity,
4852240|NCT02319629|Cholelithiasis|cholelithiasis
4852241|NCT02319629|Bariatric surgery|bariatric surgery
4852242|NCT02319629|Ursodiol|ursodiol
4852243|NCT02319577|NSCLC|nsclc
4852244|NCT02319577|EGFR|egfr
4852245|NCT02319577|vinorelbine|vinorelbine
4852246|NCT02319577|gefitinib|gefitinib
4852247|NCT02319564|Wheeze|wheeze
4852248|NCT02319564|Asthma|asthma
4852249|NCT02319564|Randomized Trial|randomized trial
4852250|NCT02319564|Pre-school aged children|pre-school aged children
4852251|NCT02319538|Chronic thyroiditis|chronic thyroiditis
4852252|NCT02319538|Total thyroidectomy|total thyroidectomy
4852253|NCT02319538|Anti-TPO|anti-tpo
4852254|NCT02319538|PROMs|proms
4852255|NCT02319538|SF36|sf36
4852256|NCT02319538|Fatigue questionnaire|fatigue questionnaire
4852257|NCT02319538|Fatigue|fatigue
4852258|NCT02319538|Autoimmune symptoms|autoimmune symptoms
4852259|NCT02319538|HADs|hads
4852260|NCT02319538|FSS|fss
4852261|NCT02319538|fVAS|fvas
4852262|NCT02319525|lupus nephritis|lupus nephritis
4852263|NCT02319525|lupus|lupus
4852264|NCT02319525|decision-making|decision-making
4852265|NCT02319525|minorities|minorities
4852266|NCT02319525|immunosuppressive medications|immunosuppressive medications
4852267|NCT02319525|decision-aid|decision-aid
4852268|NCT02319525|treatment|treatment
4852269|NCT02319525|Decision conflict|decision conflict
4852270|NCT02319525|SLE|sle
4852271|NCT02319486|Retinoblastoma|retinoblastoma
4852272|NCT02319486|carboplatin|carboplatin
4852273|NCT02319473|system of care|system of care
4852274|NCT02319473|acute myocardial infarction|acute myocardial infarction
4852275|NCT02319473|registry|registry
4852276|NCT02319473|Primary PCI|primary pci
4852277|NCT02319473|Fibrinolytic therapy|fibrinolytic therapy
4852278|NCT02319460|Vitamin K Reversal Antagonist Therapy of Acute Major Bleeding|vitamin k reversal antagonist therapy of acute major bleeding
4852279|NCT02319460|Warfarin Reversal|warfarin reversal
4852280|NCT02319447|Living Donation|living donation
4852281|NCT02319447|Kidney Transplantation|kidney transplantation
4852282|NCT02319421|Alarm fatigue|alarm fatigue
4852283|NCT02319395|Parkinson's Disease|parkinson's disease
4852284|NCT02319395|Behaviour addiction|behaviour addiction
4852285|NCT02319395|Dopamine agonist|dopamine agonist
4852286|NCT02319395|Genetic.|genetic.
4852287|NCT02319382|Parkinson Disease|parkinson disease
4852288|NCT02319382|[18F]DPA-714|[18f]dpa-714
4852289|NCT02319382|Positron emission tomography (PET)|positron emission tomography (pet)
4852290|NCT02319382|Neuroinflammation|neuroinflammation
4852291|NCT02319369|High Risk Myelodysplastic Syndrome|high risk myelodysplastic syndrome
4852292|NCT02319343|Glucocorticoid|glucocorticoid
4852293|NCT02319343|Quadriceps muscle function|quadriceps muscle function
4852294|NCT02319343|Knee arthroplasty, total|knee arthroplasty, total
4852295|NCT02319330|HIV|hiv
4852296|NCT02319330|Adherence|adherence
4852297|NCT02319330|Mental health|mental health
4852298|NCT02319330|Depression|depression
4852299|NCT02319330|Women|women
4852300|NCT02319330|Mobile phone technology|mobile phone technology
4852301|NCT02319330|eHealth|ehealth
4852302|NCT02319330|India|india
4852303|NCT02319304|Pelvic Radiotherapy|pelvic radiotherapy
4852304|NCT02319304|Rectal Adenocarcinoma|rectal adenocarcinoma
4852305|NCT02319265|sepsis|sepsis
4852306|NCT02319265|antioxidant|antioxidant
4852307|NCT02319265|melatonin|melatonin
4852308|NCT02319265|inflammation|inflammation
4852309|NCT02319239|Prostate neoplasms|prostate neoplasms
4852310|NCT02319239|Urogenital neoplasms|urogenital neoplasms
4852311|NCT02319239|Genital neoplasms, male|genital neoplasms, male
4852312|NCT02319239|Radiation therapy|radiation therapy
4852313|NCT02319239|PSA|psa
4852314|NCT02319239|DW-MRI, diffusion weighted MRI|dw-mri, diffusion weighted mri
4852315|NCT02319239|Intra-fractional movement|intra-fractional movement
4852316|NCT02319239|Hypofractionated radiotherapy|hypofractionated radiotherapy
4852317|NCT02319239|Stereotactic|stereotactic
4852318|NCT02319239|Toxicity due to radiotherapy|toxicity due to radiotherapy
4852319|NCT02319239|Quality of life|quality of life
4852320|NCT02319213|Intra-abdominal pressure,|intra-abdominal pressure,
4852321|NCT02319213|intraocular pressure,|intraocular pressure,
4852322|NCT02319213|abdominal hypertension,|abdominal hypertension,
4852323|NCT02319213|laparoscopy,|laparoscopy,
4852324|NCT02319213|critical care|critical care
4852325|NCT02319200|Chemoprevention|chemoprevention
4852326|NCT02319200|Decompensation of cirrhosis|decompensation of cirrhosis
4852327|NCT02319200|Hepatocellular Carcinoma|hepatocellular carcinoma
4852328|NCT02319200|Death|death
4852329|NCT02319200|Efficacy|efficacy
4852330|NCT02319200|Safety|safety
4852331|NCT02319187|Esophageal Neoplasms|esophageal neoplasms
4852332|NCT02319161|intravenous regional anesthesia|intravenous regional anesthesia
4852333|NCT02319135|Acute Myeloid Leukemia|acute myeloid leukemia
4852334|NCT02319122|Cerebral Palsy|cerebral palsy
4852335|NCT02319122|Muscle structure|muscle structure
4852336|NCT02319122|Strength training|strength training
4852337|NCT02319096|Whole body vibration therapy|whole body vibration therapy
4852338|NCT02319096|pelvic floor muscle training|pelvic floor muscle training
4852339|NCT02319096|stress urinary incontinence|stress urinary incontinence
4852340|NCT02319083|CABG|cabg
4852341|NCT02319083|Coronary artery bypass surgery|coronary artery bypass surgery
4852342|NCT02319083|Coronary artery bypass grafting|coronary artery bypass grafting
4852343|NCT02319083|Coronary surgery|coronary surgery
4852344|NCT02319083|Myocardial infarction|myocardial infarction
4852345|NCT02319083|Coronary artery disease|coronary artery disease
4852346|NCT02319083|Off-pump|off-pump
4852347|NCT02319083|EuroSCORE|euroscore
4852348|NCT02319070|Cost|cost
4852349|NCT02319070|Clinical Outcomes|clinical outcomes
4852350|NCT02319070|Quality of Life|quality of life
4852351|NCT02319070|On Demand Treatment|on demand treatment
4852352|NCT02319070|Secondary Prophylaxis|secondary prophylaxis
4852353|NCT02319057|Healthy volunteer study|healthy volunteer study
4852354|NCT02319044|Head and neck cancer; SCCHN|head and neck cancer; scchn
4852355|NCT02319005|Cardiomyopathy|cardiomyopathy
4852356|NCT02319005|Heart Failure|heart failure
4852357|NCT02319005|FAC|fac
4852358|NCT02319005|Amyloid|amyloid
4852359|NCT02319005|Transthyretin|transthyretin
4852360|NCT02319005|TTR|ttr
4852361|NCT02319005|RNAi therapeutic|rnai therapeutic
4852362|NCT02318953|Telemedicine|telemedicine
4852363|NCT02318953|Ambulatory Surgical Procedures|ambulatory surgical procedures
4852364|NCT02318953|Postoperative Care|postoperative care
4852365|NCT02318953|Cost Effectiveness|cost effectiveness
4852366|NCT02318953|Mobile Applications|mobile applications
4852367|NCT02318953|Health Services Research|health services research
4852368|NCT02318953|Breast Reconstruction|breast reconstruction
4852369|NCT02318940|ultrasound guided|ultrasound guided
4852370|NCT02318940|femoral vein|femoral vein
4852371|NCT02318940|central venous catheter|central venous catheter
4852372|NCT02318940|pediatric|pediatric
4852373|NCT02318927|Deep Brain Stimulation|deep brain stimulation
4852374|NCT02318914|Pyoderma Gangrenosum|pyoderma gangrenosum
4852375|NCT02318914|Classic Pyoderma Gangrenosum|classic pyoderma gangrenosum
4852376|NCT02318888|Small bowel obstruction, Surgery, Colorectal cancer|small bowel obstruction, surgery, colorectal cancer
4852377|NCT02318875|Inflammation|inflammation
4852378|NCT02318875|swell|swell
4852379|NCT02318875|pain|pain
4852380|NCT02318875|functional impairment|functional impairment
4852381|NCT02318875|stiffness|stiffness
4852382|NCT02318862|reflux|reflux
4852383|NCT02318862|GERD|gerd
4852384|NCT02318862|EGD|egd
4852385|NCT02318862|pH testing|ph testing
4852386|NCT02318849|designated organ donor, college students|designated organ donor, college students
4852387|NCT02318836|hepatic, hepatic impairment, lofexidine|hepatic, hepatic impairment, lofexidine
4852388|NCT02318823|social neuroscience|social neuroscience
4852389|NCT02318823|emotion|emotion
4852390|NCT02318823|face recognition|face recognition
4852391|NCT02318823|empathy|empathy
4852392|NCT02318823|beer|beer
4852393|NCT02318823|alcohol|alcohol
4852394|NCT02318823|social cognition|social cognition
4852395|NCT02318810|Muscle relaxants|muscle relaxants
4852396|NCT02318797|Chronic disease|chronic disease
4852397|NCT02318797|Mental Health|mental health
4852398|NCT02318797|Behavioral Health|behavioral health
4852399|NCT02318797|Community mental health centers|community mental health centers
4852400|NCT02318797|Intervention studies|intervention studies
4852401|NCT02318797|Mixed methods|mixed methods
4852402|NCT02318797|Qualitative research|qualitative research
4852403|NCT02318784|neuroendocrine malignancies|neuroendocrine malignancies
4852404|NCT02318784|pancreatic neuroendocrine tumors (PNETs)|pancreatic neuroendocrine tumors (pnets)
4852405|NCT02318784|gastrointestinal (GI) carcinoids|gastrointestinal (gi) carcinoids
4852406|NCT02318784|carfilzomib|carfilzomib
4852407|NCT02318784|Kyprolis|kyprolis
4852408|NCT02318784|proteasome inhibitors|proteasome inhibitors
4852409|NCT02318758|This is a healthy volunteer study.|this is a healthy volunteer study.
4852410|NCT02318745|Family Therapy|family therapy
4852411|NCT02318745|Substance abuse prevention|substance abuse prevention
4852412|NCT02318745|Minority|minority
4852413|NCT02318745|randomized trials|randomized trials
4852414|NCT02318745|outcome research|outcome research
4852415|NCT02318745|adolescent treatment|adolescent treatment
4852416|NCT02318732|violence|violence
4852417|NCT02318719|Post-Herpetic Neuralgia|post-herpetic neuralgia
4852418|NCT02318719|Developmental Phase III|developmental phase iii
4852419|NCT02318706|Diabetic Peripheral Neuropathic Pain|diabetic peripheral neuropathic pain
4852420|NCT02318641|oxygen consumption|oxygen consumption
4852421|NCT02318641|retinal oximetry|retinal oximetry
4852422|NCT02318628|Cardio ankle vascular index|cardio ankle vascular index
4852423|NCT02318628|CAVI|cavi
4852424|NCT02318628|pulse wave velocity|pulse wave velocity
4852425|NCT02318628|PWV|pwv
4852426|NCT02318628|Non invasive arterial structure assessment|non invasive arterial structure assessment
4852427|NCT02318615|Breast Neoplasm|breast neoplasm
4852428|NCT02318615|Lymphedema|lymphedema
4852429|NCT02318615|Autologous flap|autologous flap
4852430|NCT02318615|lattismus dorsi flap|lattismus dorsi flap
4852431|NCT02318602|Lennox-Gastaut syndrome|lennox-gastaut syndrome
4852432|NCT02318602|Dravet syndrome|dravet syndrome
4852433|NCT02318602|Treatment-resistant seizures|treatment-resistant seizures
4852434|NCT02318576|Multiple Sclerosis|multiple sclerosis
4852435|NCT02318563|Treatment-resistant seizures|treatment-resistant seizures
4852436|NCT02318537|Treatment-resistant seizures|treatment-resistant seizures
4852437|NCT02318472|Microdialysis|microdialysis
4852438|NCT02318472|Patient related outcome|patient related outcome
4852439|NCT02318472|Heel rise test|heel rise test
4852440|NCT02318472|Immobilization|immobilization
4852441|NCT02318446|Anti-epileptic drugs|anti-epileptic drugs
4852442|NCT02318446|Folic acid|folic acid
4852443|NCT02318446|Homocysteine|homocysteine
4852444|NCT02318433|DRF|drf
4852445|NCT02318433|PTOA|ptoa
4852446|NCT02318433|dexamethasone|dexamethasone
4852447|NCT02318420|Obstetrics|obstetrics
4852448|NCT02318420|Partogram|partogram
4852449|NCT02318420|ePartogram|epartogram
4852450|NCT02318420|eHealth|ehealth
4852451|NCT02318420|Low-income|low-income
4852452|NCT02318420|Quality of care|quality of care
4852453|NCT02318420|Perinatal death|perinatal death
4852454|NCT02318420|Maternal death|maternal death
4852455|NCT02318420|Cesarean section|cesarean section
4852456|NCT02318420|Health information technology|health information technology
4852457|NCT02318394|advanced solid tumors; immunotherapy; OX40; immuno-oncology|advanced solid tumors; immunotherapy; ox40; immuno-oncology
4852458|NCT02318381|suprascapular nerve|suprascapular nerve
4852459|NCT02318381|rotator cuff tear|rotator cuff tear
4852460|NCT02318381|suprascapular neuropathy|suprascapular neuropathy
4852461|NCT02318381|superior transverse scapular ligament|superior transverse scapular ligament
4852462|NCT02318355|hemodilution|hemodilution
4852463|NCT02318355|hemorrhage|hemorrhage
4852464|NCT02318355|trauma|trauma
4852465|NCT02318355|lactate|lactate
4852466|NCT02318355|base deficit|base deficit
4852467|NCT02318355|randomized control trial|randomized control trial
4852468|NCT02318329|FGFR2b, FGFR2, FGFR, bladder neoplasms, esophageal cancer|fgfr2b, fgfr2, fgfr, bladder neoplasms, esophageal cancer
4852469|NCT02318316|Exhaled breath condensate|exhaled breath condensate
4852470|NCT02318316|allogeneic stem cell transplantation|allogeneic stem cell transplantation
4852471|NCT02318316|pulmonary complications|pulmonary complications
4852472|NCT02318290|Analgesia|analgesia
4852473|NCT02318290|Critical Care|critical care
4852474|NCT02318290|Hypnotics and Sedatives|hypnotics and sedatives
4852475|NCT02318251|Power, rate of force development|power, rate of force development
4852476|NCT02318251|involuntary|involuntary
4852477|NCT02318251|reflexive|reflexive
4852478|NCT02318238|evaluation|evaluation
4852479|NCT02318238|exercise tolerance|exercise tolerance
4852480|NCT02318238|healthy children|healthy children
4852481|NCT02318238|6MWT|6mwt
4852482|NCT02318225|Misoprostol|misoprostol
4852483|NCT02318225|Office hysteroscopy|office hysteroscopy
4852484|NCT02318225|Pain|pain
4852485|NCT02318212|Cervical dilatation|cervical dilatation
4852486|NCT02318199|emergence agitation|emergence agitation
4852487|NCT02318199|intracranial surgery|intracranial surgery
4852488|NCT02318199|general anesthesia|general anesthesia
4852489|NCT02318199|incidence|incidence
4852490|NCT02318199|risk factor|risk factor
4852491|NCT02318186|pharmacokinetic analysis|pharmacokinetic analysis
4852492|NCT02318186|remodulin|remodulin
4852493|NCT02318186|trepostinil|trepostinil
4852494|NCT02318186|pulmonary arterial hypertension|pulmonary arterial hypertension
4852495|NCT02318173|Cervical dilatation|cervical dilatation
4852496|NCT02318160|Autoimmune Thyroiditis|autoimmune thyroiditis
4852497|NCT02318160|Oxidative Status|oxidative status
4852498|NCT02318160|Children|children
4852499|NCT02318147|Severe acute pancreatitis|severe acute pancreatitis
4852500|NCT02318147|Fecal Microbiota Transplantation|fecal microbiota transplantation
4852501|NCT02318147|Bacterial Translocation|bacterial translocation
4852502|NCT02318147|Infectious Complications|infectious complications
4852503|NCT02318134|Severe acute pancreatitis|severe acute pancreatitis
4852504|NCT02318134|Fecal Microbiota Transplantation|fecal microbiota transplantation
4852505|NCT02318134|Intestinal barrier dysfunction|intestinal barrier dysfunction
4852506|NCT02318134|Intestinal flora|intestinal flora
4852507|NCT02318121|Labor, prolonged labor, augmentation of labor|labor, prolonged labor, augmentation of labor
4852508|NCT02318108|Organizational Innovation|organizational innovation
4852509|NCT02318108|Primary Health Care|primary health care
4852510|NCT02318095|Cancer of the pancreas|cancer of the pancreas
4852511|NCT02318082|Chronic versus Graft Host Disease|chronic versus graft host disease
4852512|NCT02318069|immune response|immune response
4852513|NCT02318069|TBE-vaccine|tbe-vaccine
4852514|NCT02318069|elderly|elderly
4852515|NCT02318069|additional doses|additional doses
4852516|NCT02318056|hand|hand
4852517|NCT02318056|burns|burns
4852518|NCT02318056|thermal|thermal
4852519|NCT02318056|dressing|dressing
4852520|NCT02318056|Aquacel®|aquacel®
4852521|NCT02318056|Mepilex® Transfer Ag|mepilex® transfer ag
4852522|NCT02318056|Xeroform®|xeroform®
4852523|NCT02318056|Bacitracin®|bacitracin®
4852524|NCT02318056|partial thickness|partial thickness
4852525|NCT02318056|epithelialization|epithelialization
4852526|NCT02318056|wound healing|wound healing
4852527|NCT02318056|scar|scar
4852528|NCT02318056|scarring|scarring
4852529|NCT02318043|adenosine monophosphate|adenosine monophosphate
4852530|NCT02318043|histamine|histamine
4852531|NCT02318043|bronchial provocation test|bronchial provocation test
4852532|NCT02318043|asthma symptom score|asthma symptom score
4852533|NCT02318043|asthma control|asthma control
4852534|NCT02318030|Transplant|transplant
4852535|NCT02318030|Adaptive Immunity|adaptive immunity
4852537|NCT02318030|Medication Adherence|medication adherence
4852538|NCT02318030|Tacrolimus|tacrolimus
4852539|NCT02318030|PTLD|ptld
4852540|NCT02318017|adhd|adhd
4852541|NCT02318017|global network|global network
4852542|NCT02318017|eeg|eeg
4852543|NCT02318004|telemonitoring|telemonitoring
4852544|NCT02317991|gastroesophageal adenocarcinoma|gastroesophageal adenocarcinoma
4852545|NCT02317991|nab-paclitaxel|nab-paclitaxel
4852546|NCT02317991|Abraxane|abraxane
4852547|NCT02317991|ramucirumab|ramucirumab
4852548|NCT02317991|Cyramza|cyramza
4852549|NCT02317991|GE junction|ge junction
4852550|NCT02317913|Kawasaki disease|kawasaki disease
4852551|NCT02317913|Epidemiology|epidemiology
4852552|NCT02317913|Incidence|incidence
4852553|NCT02317913|Coronary arterial lesions|coronary arterial lesions
4852554|NCT02317913|Shanghai|shanghai
4852555|NCT02317887|Gene Transfer|gene transfer
4852556|NCT02317887|X-Linked|x-linked
4852557|NCT02317887|Retinoschisis|retinoschisis
4852558|NCT02317887|AAV Vector|aav vector
4852559|NCT02317848|Diagnosis|diagnosis
4852560|NCT02317848|prognostic marker|prognostic marker
4852561|NCT02317848|polygraphy|polygraphy
4852562|NCT02317848|echocardiography|echocardiography
4852563|NCT02317848|ECG|ecg
4852564|NCT02317809|Healthy|healthy
4852565|NCT02317809|Pergoveris|pergoveris
4852566|NCT02317809|Bioequivalence|bioequivalence
4852567|NCT02317809|Infertility|infertility
4852568|NCT02317770|lidocaine, esophago-gastro-duodenoscopy|lidocaine, esophago-gastro-duodenoscopy
4852569|NCT02317757|elderly cancer patients, chemotherapy toxicity|elderly cancer patients, chemotherapy toxicity
4852570|NCT02317731|bowel preparation|bowel preparation
4852571|NCT02317718|serum vitamin D levels|serum vitamin d levels
4852572|NCT02317718|IVF|ivf
4852573|NCT02317718|ovarian reserve|ovarian reserve
4852574|NCT02317718|25 OHD3|25 ohd3
4852575|NCT02317718|pregnancy outcome|pregnancy outcome
4852576|NCT02317666|polypharmacy|polypharmacy
4852577|NCT02317666|drug burden index|drug burden index
4852578|NCT02317666|aged|aged
4852579|NCT02317666|medication review|medication review
4852580|NCT02317666|cholinergic agents|cholinergic agents
4852581|NCT02317640|Testosterone|testosterone
4852582|NCT02317640|Electrical Stimulation|electrical stimulation
4852583|NCT02317640|Stand Training|stand training
4852584|NCT02317614|Incentives|incentives
4852585|NCT02317614|Smartphone|smartphone
4852586|NCT02317614|Mobile intervention|mobile intervention
4852587|NCT02317614|eDOT|edot
4852588|NCT02317614|Adherence reinforcement|adherence reinforcement
4852589|NCT02317614|Drug users|drug users
4852590|NCT02317588|Oxylipins|oxylipins
4852591|NCT02317588|Flax oil|flax oil
4852592|NCT02317588|Fish oil|fish oil
4852593|NCT02317562|Peripheral neuropathy|peripheral neuropathy
4852594|NCT02317562|Disimmune disease|disimmune disease
4852595|NCT02317562|Neurology chronic disease|neurology chronic disease
4852596|NCT02317562|Rare disease|rare disease
4852597|NCT02317549|sepsis|sepsis
4852598|NCT02317549|septic shock|septic shock
4852599|NCT02317549|vasodilatory shock|vasodilatory shock
4852600|NCT02317549|circulatory shock|circulatory shock
4852601|NCT02317549|Systemic Inflammatory Response Syndrome|systemic inflammatory response syndrome
4852602|NCT02317549|SIRS|sirs
4852603|NCT02317549|infection|infection
4852604|NCT02317549|toxemia|toxemia
4852605|NCT02317549|gut barrier breakdown|gut barrier breakdown
4852606|NCT02317549|autodigestion|autodigestion
4852607|NCT02317549|multiorgan failure|multiorgan failure
4852608|NCT02317549|MOF|mof
4852609|NCT02317549|multiorgain dysfunction syndrome|multiorgain dysfunction syndrome
4852610|NCT02317549|MODS|mods
4852611|NCT02317549|hyperlactatemia|hyperlactatemia
4852612|NCT02317549|tissue hypoxia|tissue hypoxia
4852613|NCT02317536|Muscle function|muscle function
4852614|NCT02317536|L-Carnitine|l-carnitine
4852615|NCT02317536|Carnipure|carnipure
4852616|NCT02317536|DXA|dxa
4852617|NCT02317536|anabolism|anabolism
4852618|NCT02317536|6 minute walk|6 minute walk
4852619|NCT02317536|dynamometry|dynamometry
4852620|NCT02317536|muscle biopsy|muscle biopsy
4852621|NCT02317523|Dementia|dementia
4852622|NCT02317523|Caregiver|caregiver
4852623|NCT02317523|Cardiovascular Disease|cardiovascular disease
4852624|NCT02317523|Stress|stress
4852625|NCT02317523|Depression|depression
4852626|NCT02317523|Anxiety|anxiety
4852627|NCT02317523|Heart Disease|heart disease
4852628|NCT02317523|Carer|carer
4852629|NCT02317523|Care Giver|care giver
4852630|NCT02317523|Caregiving|caregiving
4852631|NCT02317523|Psychotherapy|psychotherapy
4852632|NCT02317523|Therapy|therapy
4852633|NCT02317523|Behavioral Activation|behavioral activation
4852634|NCT02317523|Education|education
4852635|NCT02317523|Intervention|intervention
4852636|NCT02317523|CBT|cbt
4852637|NCT02317523|Cognitive-Behavior Therapy|cognitive-behavior therapy
4852638|NCT02317510|Combined anesthesia|combined anesthesia
4852639|NCT02317510|General anesthesia|general anesthesia
4852640|NCT02317510|Laparoscopic cholecystectomy|laparoscopic cholecystectomy
4852641|NCT02317497|Neurocritical care|neurocritical care
4852642|NCT02317497|Severe Stroke|severe stroke
4852643|NCT02317497|Ischemic stroke|ischemic stroke
4852644|NCT02317497|Intracerebral hemorrhage|intracerebral hemorrhage
4852645|NCT02317497|Subarachnoid hemorrhage|subarachnoid hemorrhage
4852646|NCT02317497|Sedation|sedation
4852647|NCT02317497|RASS|rass
4852648|NCT02317497|BIS|bis
4852649|NCT02317445|helicobacter pylori|helicobacter pylori
4852650|NCT02317445|eradication therapy|eradication therapy
4852651|NCT02317445|major adverse cardiac events|major adverse cardiac events
4852652|NCT02317445|long-term outcome|long-term outcome
4852653|NCT02317445|To explore the significance of Hp eradication therapy in preventing major adverse cardiac events (MACE) and upper gastrointestinal bleeding (UGIB).|to explore the significance of hp eradication therapy in preventing major adverse cardiac events (mace) and upper gastrointestinal bleeding (ugib).
4852654|NCT02317432|Depression|depression
4852655|NCT02317432|Anxiety|anxiety
4852656|NCT02317432|Disability|disability
4852657|NCT02317432|Ethnic Minority|ethnic minority
4852658|NCT02317432|Elders|elders
4852659|NCT02317419|Solid Cancers|solid cancers
4852660|NCT02317393|Nuclear medicine|nuclear medicine
4852661|NCT02317393|Positron emission tomography|positron emission tomography
4852662|NCT02317393|avb3 integrin expression|avb3 integrin expression
4852663|NCT02317380|Self-Affirmation|self-affirmation
4852664|NCT02317380|Weight Loss|weight loss
4852665|NCT02317380|Self vs. Other|self vs. other
4852666|NCT02317380|Cancer Risk and Prevention|cancer risk and prevention
4852667|NCT02317367|Construct Validity|construct validity
4852668|NCT02317367|Self-Affirmation|self-affirmation
4852669|NCT02317367|Alcohol Consumption|alcohol consumption
4852670|NCT02317367|Breast Cancer|breast cancer
4852671|NCT02317354|X-Linked|x-linked
4852672|NCT02317354|Retinoschisis|retinoschisis
4852673|NCT02317341|Fatigue|fatigue
4852674|NCT02317341|Ketamine|ketamine
4852675|NCT02317341|Cancer|cancer
4852676|NCT02317328|Retinal Images|retinal images
4852677|NCT02317328|Adaptive Optics|adaptive optics
4852678|NCT02317263|MS|ms
4852679|NCT02317250|Alzheimer's disease|alzheimer's disease
4852680|NCT02317250|Alzheimer disease|alzheimer disease
4852681|NCT02317250|MDC|mdc
4852682|NCT02317250|Mild Decline in Cognition|mild decline in cognition
4852683|NCT02317250|MCI|mci
4852684|NCT02317250|Dementia|dementia
4852685|NCT02317250|PET|pet
4852686|NCT02317250|FDG-PET|fdg-pet
4852687|NCT02317250|FDG|fdg
4852688|NCT02317250|amyloid|amyloid
4852689|NCT02317250|amyloid imaging|amyloid imaging
4852690|NCT02317250|CMS|cms
4852691|NCT02317250|Coverage with Evidence Development|coverage with evidence development
4852692|NCT02317250|CED|ced
4852693|NCT02317250|MCI-ID|mci-id
4852694|NCT02317224|3-Hole approach|3-hole approach
4852695|NCT02317224|extended thymectomy|extended thymectomy
4852696|NCT02317224|myasthenia gravis|myasthenia gravis
4852697|NCT02317224|safety|safety
4852698|NCT02317224|effectiveness|effectiveness
4852699|NCT02317198|Elderly|elderly
4852700|NCT02317198|P2Y12 inhibitors|p2y12 inhibitors
4852701|NCT02317198|clopidogrel|clopidogrel
4852702|NCT02317198|ticagrelor|ticagrelor
4852703|NCT02317172|Saliva substitute|saliva substitute
4852704|NCT02317172|Edible gel|edible gel
4852705|NCT02317172|Xerostomia|xerostomia
4852706|NCT02317172|Diabetes Mellitus|diabetes mellitus
4852707|NCT02317172|Hypertension|hypertension
4852708|NCT02317133|Tregs|tregs
4852709|NCT02317133|bacterial translocation|bacterial translocation
4852710|NCT02317133|cytokines|cytokines
4852711|NCT02317107|Gait|gait
4852712|NCT02317107|Mild Traumatic Brain Injury|mild traumatic brain injury
4852713|NCT02317107|Post-Concussion Syndrome|post-concussion syndrome
4852714|NCT02317107|Recovery of Function|recovery of function
4852715|NCT02317107|Locomotion|locomotion
4852716|NCT02317107|Motor Activity|motor activity
4852717|NCT02317068|sick sinus syndrome|sick sinus syndrome
4852718|NCT02317068|paroxysmal atrial fibrillation|paroxysmal atrial fibrillation
4852719|NCT02317068|atrial pacing|atrial pacing
4852720|NCT02317068|high atrial base rate pacing|high atrial base rate pacing
4852721|NCT02317055|MRI|mri
4852722|NCT02317055|Oxygenation|oxygenation
4852723|NCT02317055|nirs|nirs
4852724|NCT02317029|Cardioversion|cardioversion
4852725|NCT02317029|Cardiac Arrythmias|cardiac arrythmias
4852726|NCT02317029|Myocardial Injury|myocardial injury
4852727|NCT02317029|Defibrillators|defibrillators
4852728|NCT02317029|Biomarkers|biomarkers
4852729|NCT02317016|oncology|oncology
4852730|NCT02317016|cancer|cancer
4852731|NCT02317016|non small cell lung cancer|non small cell lung cancer
4852732|NCT02317016|anticancer drug|anticancer drug
4852733|NCT02317016|pharmacokinetics|pharmacokinetics
4852734|NCT02317016|AZD9291|azd9291
4852735|NCT02317016|rosuvastatin|rosuvastatin
4852736|NCT02317016|EGFR genes|egfr genes
4852737|NCT02317003|physical exercise|physical exercise
4852738|NCT02317003|sedentarity|sedentarity
4852739|NCT02317003|general practice|general practice
4852740|NCT02317003|family medicine|family medicine
4852741|NCT02317003|pedometer|pedometer
4852742|NCT02316977|Reproducibility of Results|reproducibility of results
4852743|NCT02316964|AML|aml
4852744|NCT02316964|acute myeloid leukemia|acute myeloid leukemia
4852745|NCT02316964|decitabine|decitabine
4852746|NCT02316951|Postoperative|postoperative
4852747|NCT02316951|Pain|pain
4852748|NCT02316951|Symptoms|symptoms
4852749|NCT02316951|Video recording|video recording
4852750|NCT02316951|Orthopedic surgery|orthopedic surgery
4852751|NCT02316938|kidney transplant, renal transplant, biopsy, biopsies, donor specific antibodies|kidney transplant, renal transplant, biopsy, biopsies, donor specific antibodies
4852752|NCT02316912|allergy|allergy
4852753|NCT02316899|ASP0456|asp0456
4852754|NCT02316899|constipation|constipation
4852755|NCT02316899|linaclotide|linaclotide
4852756|NCT02316899|irritable bowel syndrome (IBS)|irritable bowel syndrome (ibs)
4852757|NCT02316886|coronary intervention|coronary intervention
4852758|NCT02316886|Vulnerable Plaque|vulnerable plaque
4852759|NCT02316886|Insignificant Stenosis|insignificant stenosis
4852760|NCT02316886|Bioresorbable Vascular Scaffold|bioresorbable vascular scaffold
4852761|NCT02316886|Everolimus Eluting stent|everolimus eluting stent
4852762|NCT02316873|music training, rhythm|music training, rhythm
4852763|NCT02316847|Cluster Seizures|cluster seizures
4852764|NCT02316847|Seizures|seizures
4852765|NCT02316847|Clusters|clusters
4852766|NCT02316847|Acute repetitive seizures|acute repetitive seizures
4852767|NCT02316834|Fallopian Tube Cancer|fallopian tube cancer
4852768|NCT02316834|Ovarian Cancer|ovarian cancer
4852769|NCT02316834|Peritoneal Cancer|peritoneal cancer
4852770|NCT02316834|BMN 673|bmn 673
4852771|NCT02316834|Talazoparib tosylate|talazoparib tosylate
4852772|NCT02316821|Diabetes Mellitus|diabetes mellitus
4852773|NCT02316821|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
4852774|NCT02316821|Diabetic Nephropathies|diabetic nephropathies
4852775|NCT02316821|Kidney Diseases|kidney diseases
4852776|NCT02316821|Renal Insufficiency, Chronic|renal insufficiency, chronic
4852777|NCT02316821|Diabetes Complications|diabetes complications
4852778|NCT02316821|Endocrine System Diseases|endocrine system diseases
4852779|NCT02316821|Glucose Metabolism Disorders|glucose metabolism disorders
4852780|NCT02316821|Metabolic Diseases|metabolic diseases
4852781|NCT02316821|Renal Insufficiency|renal insufficiency
4852782|NCT02316821|Urologic Diseases|urologic diseases
4852783|NCT02316821|bardoxolone methyl|bardoxolone methyl
4852784|NCT02316756|Phase 1, Single-Dose Escalation, Double Blind, Placebo-Controlled, Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, PF-06648671, Plasma Abeta|phase 1, single-dose escalation, double blind, placebo-controlled, safety, tolerability, pharmacokinetics, pharmacodynamics, pf-06648671, plasma abeta
4852785|NCT02316691|Graves Disease|graves disease
4852786|NCT02316691|Rituximab|rituximab
4852787|NCT02316678|Patient Preference|patient preference
4852788|NCT02316665|Type 1 diabetes|type 1 diabetes
4852789|NCT02316665|Sleep apnea syndrome|sleep apnea syndrome
4852790|NCT02316665|Nocturnal glycemia|nocturnal glycemia
4852791|NCT02316665|Continuous glucose monitoring system|continuous glucose monitoring system
4852792|NCT02316665|Continuous positive airway pressure|continuous positive airway pressure
4852793|NCT02316665|Sleep habits|sleep habits
4852794|NCT02316639|Neuromuscular Training|neuromuscular training
4852795|NCT02316639|Skeletally Immature|skeletally immature
4852796|NCT02316639|Knee Rehabilitation|knee rehabilitation
4852797|NCT02316600|elderly|elderly
4852798|NCT02316600|Robust volunteers for the first phase;|robust volunteers for the first phase;
4852799|NCT02316600|tele-monitoring|tele-monitoring
4852800|NCT02316600|self-management|self-management
4852801|NCT02316600|Patient 65 and over|patient 65 and over
4852802|NCT02316600|Presenting a frailty syndrome for the second phase|presenting a frailty syndrome for the second phase
4852803|NCT02316587|Computerized Tomography|computerized tomography
4852804|NCT02316587|Magnetic Resonance Imaging|magnetic resonance imaging
4852805|NCT02316587|Echocardiography|echocardiography
4852806|NCT02316587|Right Heart Catheterization|right heart catheterization
4852807|NCT02316574|Alcohol dependence|alcohol dependence
4852808|NCT02316574|Cognitive Behavioral Therapy|cognitive behavioral therapy
4852809|NCT02316574|Functional neuroimaging|functional neuroimaging
4852810|NCT02316535|colorectal cancer|colorectal cancer
4852811|NCT02316535|stage II/III|stage ii/iii
4852812|NCT02316535|elderly|elderly
4852813|NCT02316535|adjuvant chemotherapy|adjuvant chemotherapy
4852814|NCT02316535|capecitabine|capecitabine
4852815|NCT02316535|non-inferiority|non-inferiority
4852816|NCT02316496|Cancer|cancer
4852817|NCT02316496|Colorectal|colorectal
4852818|NCT02316496|Metastatic|metastatic
4852819|NCT02316496|Thrid-line|thrid-line
4852820|NCT02316496|Irinotecan|irinotecan
4852821|NCT02316496|Cetuximab|cetuximab
4852822|NCT02316470|Clostridium difficile|clostridium difficile
4852823|NCT02316470|Valneva|valneva
4852824|NCT02316470|Phase 2|phase 2
4852825|NCT02316470|Healthy adults|healthy adults
4852826|NCT02316457|TNBC|tnbc
4852827|NCT02316457|Breast Cancer|breast cancer
4852828|NCT02316457|Warehouse|warehouse
4852829|NCT02316457|Mutanome|mutanome
4852830|NCT02316457|RNA|rna
4852831|NCT02316457|Vaccine|vaccine
4852832|NCT02316444|Hepatitis B vaccine HIV infection|hepatitis b vaccine hiv infection
4852833|NCT02316418|Hairstetics™ anchoring system|hairstetics™ anchoring system
4852834|NCT02316418|hair extensions|hair extensions
4852835|NCT02316392|Helium|helium
4852836|NCT02316392|MRI|mri
4852837|NCT02316392|Lung transplantation|lung transplantation
4852838|NCT02316379|Respiratory|respiratory
4852839|NCT02316314|Friedreich's Ataxia|friedreich's ataxia
4852840|NCT02316314|Cardiomyopathy|cardiomyopathy
4852841|NCT02316301|Misoprostol, pain, office hysteroscopy|misoprostol, pain, office hysteroscopy
4852842|NCT02316249|pelvic organ prolapse|pelvic organ prolapse
4852843|NCT02316249|Atrophy of Vagina|atrophy of vagina
4852844|NCT02316249|Gellhorn pessary|gellhorn pessary
4852845|NCT02316249|Ring with support pessary|ring with support pessary
4852846|NCT02316249|Estrace cream|estrace cream
4852847|NCT02316249|vaginitis with pessary|vaginitis with pessary
4852848|NCT02316249|vaginal ulceration with pessary|vaginal ulceration with pessary
4852849|NCT02316249|vaginal erosion with pessary|vaginal erosion with pessary
4852850|NCT02316249|pessary complications|pessary complications
4852851|NCT02316249|vaginal bleeding with pessary|vaginal bleeding with pessary
4852852|NCT02316223|asthma|asthma
4852853|NCT02316223|high-risk|high-risk
4852854|NCT02316223|adult|adult
4852855|NCT02316223|elderly|elderly
4852856|NCT02316223|care coordination|care coordination
4852857|NCT02316223|community health worker|community health worker
4852858|NCT02316223|electronic medical record|electronic medical record
4852859|NCT02316197|DNA-PK Inhibitor|dna-pk inhibitor
4852860|NCT02316197|Advanced solid tumors|advanced solid tumors
4852861|NCT02316197|Chronic lymphocytic Leukemia|chronic lymphocytic leukemia
4852862|NCT02316197|Phase I, first-in-human|phase i, first-in-human
4852863|NCT02316197|Dose escalation|dose escalation
4852864|NCT02316197|Dose expansion|dose expansion
4852865|NCT02316197|Safety profile|safety profile
4852866|NCT02316197|Tolerability|tolerability
4852867|NCT02316197|PK|pk
4852868|NCT02316197|Antitumor activity|antitumor activity
4852869|NCT02316197|Maximum tolerated dose|maximum tolerated dose
4852870|NCT02316197|M3814|m3814
4852871|NCT02316184|Alcohol|alcohol
4852872|NCT02316158|Burden|burden
4852873|NCT02316158|Mental illness|mental illness
4852874|NCT02316158|Stress|stress
4852875|NCT02316158|Social support|social support
4852876|NCT02316145|ADHD|adhd
4852877|NCT02316145|Autism spectrum condition|autism spectrum condition
4852878|NCT02316145|Tourette's disorder|tourette's disorder
4852879|NCT02316145|Internet-based|internet-based
4852880|NCT02316145|chat|chat
4852881|NCT02316145|coach|coach
4852882|NCT02316119|bleeding risk, acute coronary syndrome, platelet agregation,|bleeding risk, acute coronary syndrome, platelet agregation,
4852883|NCT02316106|Smoldering multiple myeloma (SMM)|smoldering multiple myeloma (smm)
4852884|NCT02316106|Daratumumab|daratumumab
4852885|NCT02316080|dental bleaching|dental bleaching
4852886|NCT02316080|dentin sensitivity|dentin sensitivity
4852887|NCT02316080|biomaterials|biomaterials
4852888|NCT02316067|Spinal cord|spinal cord
4852889|NCT02316067|Wounds and Injuries|wounds and injuries
4852890|NCT02316067|Rehabilitation|rehabilitation
4852891|NCT02316054|type 2 diabetes mellitus|type 2 diabetes mellitus
4852892|NCT02316054|coronary microvascular disease|coronary microvascular disease
4852893|NCT02316054|coronary artery disease|coronary artery disease
4852894|NCT02316054|myocardial perfusion imaging|myocardial perfusion imaging
4852895|NCT02316054|prognosis|prognosis
4852896|NCT02316054|atherosclerosis|atherosclerosis
4852897|NCT02316054|myocardial ischemia|myocardial ischemia
4852898|NCT02316054|coronary heart disease|coronary heart disease
4852899|NCT02316041|Femtosecond laser|femtosecond laser
4852900|NCT02316041|Small incision lenticule extraction (SMILE)|small incision lenticule extraction (smile)
4852901|NCT02316028|decitabine|decitabine
4852902|NCT02316028|colorectal cancer|colorectal cancer
4852903|NCT02316028|hepatic arterial infusion|hepatic arterial infusion
4852904|NCT02316015|Child, Hospitalized|child, hospitalized
4852905|NCT02316015|Nutritional status|nutritional status
4852906|NCT02315976|chronic stable angina pectoris|chronic stable angina pectoris
4852907|NCT02315976|propatyl nitrate|propatyl nitrate
4852908|NCT02315976|Seattle Angina Questionnaire|seattle angina questionnaire
4852909|NCT02315911|Tonsillectomy|tonsillectomy
4852910|NCT02315911|Adenoidectomy|adenoidectomy
4852911|NCT02315911|Adenoidpharyngoplasty|adenoidpharyngoplasty
4852912|NCT02315911|OSA|osa
4852913|NCT02315898|children, congenital heart disease, metabolomics|children, congenital heart disease, metabolomics
4852914|NCT02315885|healthy volunteers|healthy volunteers
4852915|NCT02315885|social drinkers|social drinkers
4852916|NCT02315885|alcohol|alcohol
4852917|NCT02315872|Multiple Sclerosis|multiple sclerosis
4852918|NCT02315872|Acthar Gel|acthar gel
4852919|NCT02315872|ACTH|acth
4852920|NCT02315872|Fatigue|fatigue
4852921|NCT02315859|suction work|suction work
4852922|NCT02315833|Migraine|migraine
4852923|NCT02315833|Aura|aura
4852924|NCT02315820|Macrosomia|macrosomia
4852925|NCT02315820|Induction of labor|induction of labor
4852926|NCT02315820|Expectant management|expectant management
4852927|NCT02315820|Shoulder dystocia|shoulder dystocia
4852928|NCT02315794|aesthetic outcome|aesthetic outcome
4852929|NCT02315794|titanium abutment|titanium abutment
4852930|NCT02315794|zirconia abutment|zirconia abutment
4852931|NCT02315768|CLL|cll
4852932|NCT02315768|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
4852933|NCT02315768|Ibrutinib|ibrutinib
4852934|NCT02315768|Obinutuzumab|obinutuzumab
4852935|NCT02315768|Cancer|cancer
4852936|NCT02315755|Metastatic renal cell carcinoma, targeted molecular therapy|metastatic renal cell carcinoma, targeted molecular therapy
4852937|NCT02315716|Multiple Myeloma|multiple myeloma
4852938|NCT02315716|Carfilzomib|carfilzomib
4852939|NCT02315703|Healthy|healthy
4852940|NCT02315703|Acquired Immuno-Deficiency Syndrome|acquired immuno-deficiency syndrome
4852941|NCT02315703|Acquired Immunodeficiency Syndrome Virus|acquired immunodeficiency syndrome virus
4852942|NCT02315703|adenovirus serotype 26|adenovirus serotype 26
4852943|NCT02315703|Ad26.Mos.HIV|ad26.mos.hiv
4852944|NCT02315703|Modified Vaccinia Ankara|modified vaccinia ankara
4852945|NCT02315703|Glycoprotein|glycoprotein
4852946|NCT02315703|Adjuvant|adjuvant
4852947|NCT02315703|Vaccine|vaccine
4852948|NCT02315703|Placebo|placebo
4852949|NCT02315690|malaria, Swaziland, reactive case detection, focal mass drug administration|malaria, swaziland, reactive case detection, focal mass drug administration
4852950|NCT02315677|Epistaxis|epistaxis
4852951|NCT02315677|Nasal Intubation|nasal intubation
4852952|NCT02315677|Maxillofacial surgery|maxillofacial surgery
4852953|NCT02315664|Physical activity|physical activity
4852954|NCT02315664|Exercise|exercise
4852955|NCT02315664|Osteoarthritis|osteoarthritis
4852956|NCT02315664|Knee|knee
4852957|NCT02315664|Arthritis|arthritis
4852958|NCT02315638|Adeno-associated viral vectors|adeno-associated viral vectors
4852959|NCT02315638|Adeno-associated virus|adeno-associated virus
4852960|NCT02315638|AAV|aav
4852961|NCT02315638|AAV8|aav8
4852962|NCT02315638|ddRNAi|ddrnai
4852963|NCT02315638|shRNA|shrna
4852964|NCT02315638|RNAi|rnai
4852965|NCT02315638|Hepatitis|hepatitis
4852966|NCT02315638|Chronic Hepatitis C|chronic hepatitis c
4852967|NCT02315638|HCV|hcv
4852968|NCT02315638|CHC|chc
4852969|NCT02315638|Genotype 1|genotype 1
4852970|NCT02315625|MEN1|men1
4852971|NCT02315625|VHL|vhl
4852972|NCT02315625|Neoplasm|neoplasm
4852973|NCT02315625|NF1|nf1
4852974|NCT02315625|mTOR|mtor
4852975|NCT02315612|CD-22 Expressing Tumor|cd-22 expressing tumor
4852976|NCT02315612|Chimeric Antigen Receptor|chimeric antigen receptor
4852977|NCT02315612|Adoptive Immunotherapy|adoptive immunotherapy
4852978|NCT02315612|ALL|all
4852979|NCT02315612|Lymphoma|lymphoma
4852980|NCT02315599|Replication Competent Retrovirus (RCR)|replication competent retrovirus (rcr)
4852981|NCT02315599|Replication Competent Lentivirus (RCL)|replication competent lentivirus (rcl)
4852982|NCT02315599|T Cell Persistence|t cell persistence
4852983|NCT02315586|Idiopathic Pulmonary Fibrosis|idiopathic pulmonary fibrosis
4852984|NCT02315586|Apoliprotein A-1|apoliprotein a-1
4852985|NCT02315573|Carpal Tunnel Syndrome|carpal tunnel syndrome
4852986|NCT02315573|Anesthetics, Local|anesthetics, local
4852987|NCT02315573|Pain Perception|pain perception
4852988|NCT02315573|Pain Measurement|pain measurement
4852989|NCT02315573|Analgesia|analgesia
4852990|NCT02315573|Lidocaine|lidocaine
4852991|NCT02315573|Bupivacaine|bupivacaine
4852992|NCT02315560|bedwetting|bedwetting
4852993|NCT02315547|Microbiota|microbiota
4852994|NCT02315547|Airway infection|airway infection
4852995|NCT02315547|Bronchiectasis|bronchiectasis
4852996|NCT02315547|Airway inflammation|airway inflammation
4852997|NCT02315547|Oxidative stress|oxidative stress
4852998|NCT02315547|Matrix metalloproteinase|matrix metalloproteinase
4852999|NCT02315534|GBM|gbm
4853000|NCT02315534|Malignant Glioma|malignant glioma
4853001|NCT02315521|lower urinary tract obstruction|lower urinary tract obstruction
4853002|NCT02315521|posterior urethral valves|posterior urethral valves
4853003|NCT02315521|urethral atresia|urethral atresia
4853004|NCT02315521|Prune Belly Syndrome|prune belly syndrome
4853005|NCT02315521|Megalo-urethra|megalo-urethra
4853006|NCT02315521|Fetal renal function|fetal renal function
4853007|NCT02315521|Prenatal Diagnosis|prenatal diagnosis
4853008|NCT02315521|Ultrasound|ultrasound
4853009|NCT02315482|autonomic nervous system|autonomic nervous system
4853010|NCT02315482|heart rate variability|heart rate variability
4853011|NCT02315482|prostatectomy|prostatectomy
4853012|NCT02315482|steep trendelenburg|steep trendelenburg
4853013|NCT02315482|pneumoperitoneum|pneumoperitoneum
4853014|NCT02315482|Intervention Affecting Autonomic Nervous System|intervention affecting autonomic nervous system
4853015|NCT02315456|capsulorhexis|capsulorhexis
4853016|NCT02315456|IOL centration|iol centration
4853017|NCT02315443|Stroke|stroke
4853018|NCT02315443|Ischemia|ischemia
4853019|NCT02315443|Prehospital|prehospital
4853020|NCT02315443|NA-1|na-1
4853021|NCT02315443|Modified Rankin Scale|modified rankin scale
4853022|NCT02315443|Haemorrhagic stroke|haemorrhagic stroke
4853023|NCT02315443|Transient ischemic attack|transient ischemic attack
4853024|NCT02315417|Pyoderma Gangrenosum|pyoderma gangrenosum
4853025|NCT02315417|Classic Pyoderma Gangrenosum|classic pyoderma gangrenosum
4853026|NCT02315404|Obscure gastrointestinal bleeding|obscure gastrointestinal bleeding
4853027|NCT02315404|Overt gastrointestinal bleeding|overt gastrointestinal bleeding
4853028|NCT02315404|Occult gastrointestinal bleeding|occult gastrointestinal bleeding
4853029|NCT02315404|Enteroscopy|enteroscopy
4853030|NCT02315378|Anxiety, Acute Trauma|anxiety, acute trauma
4853031|NCT02315352|Healthy|healthy
4853032|NCT02315352|L-PZQ|l-pzq
4853033|NCT02315352|PZQ|pzq
4853034|NCT02315352|MSC2499550A|msc2499550a
4853035|NCT02315352|Praziquantel|praziquantel
4853036|NCT02315326|Ibrutinib,|ibrutinib,
4853037|NCT02315326|Imbruvica™|imbruvica™
4853038|NCT02315326|Bruton's Tyrosine Kinase (BTK) Inhibitor|bruton's tyrosine kinase (btk) inhibitor
4853039|NCT02315326|HD-MTX|hd-mtx
4853040|NCT02315326|14-184|14-184
4853041|NCT02315300|ECG, CGM, Hypoglycaemia, Sudden Cardiac Death|ecg, cgm, hypoglycaemia, sudden cardiac death
4853042|NCT02315287|Triple combination|triple combination
4853043|NCT02315287|Metformin|metformin
4853044|NCT02315287|Sitagliptin|sitagliptin
4853045|NCT02315287|Pioglitazone|pioglitazone
4853046|NCT02315287|Lobeglitazone|lobeglitazone
4853047|NCT02315274|Type 1 diabetes|type 1 diabetes
4853048|NCT02315274|Pregnancy|pregnancy
4853049|NCT02315274|Glycemic variability|glycemic variability
4853050|NCT02315274|Between visit contact|between visit contact
4853051|NCT02315261|Epidural analgesia|epidural analgesia
4853052|NCT02315261|Pain score|pain score
4853053|NCT02315248|bone density|bone density
4853054|NCT02315222|Nutriomics|nutriomics
4853055|NCT02315222|Dietary supplements|dietary supplements
4853056|NCT02315222|Scaling and root planing|scaling and root planing
4853057|NCT02315222|full mouth disinfection|full mouth disinfection
4853058|NCT02315209|Inguinal Hernia, Quality of Life, Mesh|inguinal hernia, quality of life, mesh
4853059|NCT02315183|Post cardiac surgery|post cardiac surgery
4853060|NCT02315170|diabetic retinopathy|diabetic retinopathy
4853061|NCT02315170|age-related macular edema|age-related macular edema
4853062|NCT02315157|Partial Response|partial response
4853063|NCT02315144|COPD|copd
4853064|NCT02315144|bronchodilation|bronchodilation
4853065|NCT02315092|Diabetic Foot Ulcers|diabetic foot ulcers
4853066|NCT02315092|Bacteria|bacteria
4853067|NCT02315092|Fluorescence|fluorescence
4853068|NCT02315079|Ocular Inflammation|ocular inflammation
4853069|NCT02315079|Matrix Metalloproteinase 9|matrix metalloproteinase 9
4853070|NCT02315066|Immunotherapy|immunotherapy
4853071|NCT02315066|PF-04518600|pf-04518600
4853072|NCT02315066|PF-05082566|pf-05082566
4853073|NCT02315066|solid tumors|solid tumors
4853074|NCT02315066|tumors|tumors
4853075|NCT02315066|neoplasm metastasis|neoplasm metastasis
4853076|NCT02315066|Phase 1|phase 1
4853077|NCT02315066|hepatocellular carcinoma|hepatocellular carcinoma
4853078|NCT02315066|HCC|hcc
4853079|NCT02315066|liver cancer|liver cancer
4853080|NCT02315066|ocular melanoma|ocular melanoma
4853081|NCT02315066|melanoma|melanoma
4853082|NCT02315066|clear cell renal cell carcinoma|clear cell renal cell carcinoma
4853083|NCT02315066|RCC|rcc
4853084|NCT02315066|kidney cancer|kidney cancer
4853085|NCT02315066|head and neck squamous cell carcinoma|head and neck squamous cell carcinoma
4853086|NCT02315066|HNSCC|hnscc
4853087|NCT02315066|head and neck cancer|head and neck cancer
4853088|NCT02315066|cervical cancer|cervical cancer
4853089|NCT02315066|cancer of the cervix|cancer of the cervix
4853090|NCT02315066|gastric cancer|gastric cancer
4853091|NCT02315066|stomach cancer|stomach cancer
4853092|NCT02315066|non small cell lung cancer|non small cell lung cancer
4853093|NCT02315066|NSCLC|nsclc
4853094|NCT02315066|lung cancer|lung cancer
4853095|NCT02315066|urothelial bladder carcinoma|urothelial bladder carcinoma
4853096|NCT02315066|bladder cancer|bladder cancer
4853097|NCT02315066|OX40|ox40
4853098|NCT02315066|4-1BB|4-1bb
4853099|NCT02315053|NSCLC|nsclc
4853100|NCT02315053|CCRT|ccrt
4853101|NCT02315053|FDG PET/CT|fdg pet/ct
4853102|NCT02315040|Intrauterine insemination (IUI)|intrauterine insemination (iui)
4853103|NCT02315040|Insemination method|insemination method
4853104|NCT02315040|Slow release insemination (SRI)|slow release insemination (sri)
4853105|NCT02315040|EVIE|evie
4853106|NCT02315040|Pregnancy rate|pregnancy rate
4853107|NCT02315001|Liraglutide|liraglutide
4853108|NCT02315001|GLP-1|glp-1
4853109|NCT02315001|Ischaemic heart disease|ischaemic heart disease
4853110|NCT02315001|Coronary heart disease|coronary heart disease
4853111|NCT02315001|Chronic stable angina|chronic stable angina
4853112|NCT02314988|Tranexamic acid|tranexamic acid
4853113|NCT02314988|Antifibrinolytic|antifibrinolytic
4853114|NCT02314988|Perioperative blood loss|perioperative blood loss
4853115|NCT02314988|Postoperative drain output|postoperative drain output
4853116|NCT02314988|Allogenic transfusion|allogenic transfusion
4853117|NCT02314949|T-regulatory cells|t-regulatory cells
4853118|NCT02314949|Tolerogenic protocol|tolerogenic protocol
4853119|NCT02314949|immunomodulation|immunomodulation
4853120|NCT02314936|Constipation|constipation
4853121|NCT02314936|Polydextrose|polydextrose
4853122|NCT02314936|Dietary Fiber|dietary fiber
4853123|NCT02314936|Fiber|fiber
4853124|NCT02314936|Colonic Transit Time|colonic transit time
4853125|NCT02314936|PAC-SYM|pac-sym
4853126|NCT02314910|Innervation|innervation
4853127|NCT02314910|Jaw Bone|jaw bone
4853128|NCT02314910|Implants|implants
4853129|NCT02314910|Stereognostic|stereognostic
4853130|NCT02314910|Osseoperception|osseoperception
4853131|NCT02314871|perioperative analgesia|perioperative analgesia
4853132|NCT02314871|minimal residual disease|minimal residual disease
4853133|NCT02314871|cancer recurrence|cancer recurrence
4853134|NCT02314871|epidural|epidural
4853135|NCT02314871|morphine|morphine
4853136|NCT02314871|piritramide|piritramide
4853137|NCT02314871|colon|colon
4853138|NCT02314871|cancer|cancer
4853139|NCT02314871|circulating cancer cells|circulating cancer cells
4853140|NCT02314871|colon cancer surgery|colon cancer surgery
4853141|NCT02314845|Pulmonary Atelectasis|pulmonary atelectasis
4853142|NCT02314845|Pulmonary Ventilation|pulmonary ventilation
4853143|NCT02314845|Anesthesia, General|anesthesia, general
4853144|NCT02314845|Electric Impedance|electric impedance
4853145|NCT02314845|Tomography, Spiral Computed|tomography, spiral computed
4853146|NCT02314845|Intraoperative Period|intraoperative period
4853147|NCT02314832|femoral nerve block|femoral nerve block
4853148|NCT02314832|adductor canal block|adductor canal block
4853149|NCT02314832|tinetti score|tinetti score
4853150|NCT02314832|2- Results to time to up and go (TUG ) test|2- results to time to up and go (tug ) test
4853151|NCT02314832|3- Results to Tinetti test|3- results to tinetti test
4853152|NCT02314832|4- Ambulation distance|4- ambulation distance
4853153|NCT02314832|5- Pain scores at rest and with movement|5- pain scores at rest and with movement
4853154|NCT02314819|colorectal cancer|colorectal cancer
4853155|NCT02314793|Pharmacokinetics|pharmacokinetics
4853156|NCT02314793|ASP2205|asp2205
4853157|NCT02314741|poem|poem
4853158|NCT02314741|per oral endoscopic myotomy|per oral endoscopic myotomy
4853159|NCT02314741|achalasia|achalasia
4853160|NCT02314728|Bishop Score|bishop score
4853161|NCT02314728|Induction of Labor|induction of labor
4853162|NCT02314728|Cervical Ripening|cervical ripening
4853163|NCT02314728|Unfavorable Cervix|unfavorable cervix
4853164|NCT02314728|Mode of Delivery|mode of delivery
4853165|NCT02314728|C-Section|c-section
4853166|NCT02314728|Cesarean Section|cesarean section
4853167|NCT02314715|Osteoarthritis Knee|osteoarthritis knee
4853168|NCT02314702|Osteoarthritis|osteoarthritis
4853169|NCT02314702|Avascular necrosis|avascular necrosis
4853170|NCT02314702|Ankylosis|ankylosis
4853171|NCT02314702|Protrusio acetabuli|protrusio acetabuli
4853172|NCT02314702|Painful hip dysplasia|painful hip dysplasia
4853173|NCT02314702|Rheumatoid arthritis|rheumatoid arthritis
4853174|NCT02314702|Correction of functional deformity|correction of functional deformity
4853175|NCT02314702|Revision procedures|revision procedures
4853176|NCT02314663|hypercholesterolaemia|hypercholesterolaemia
4853177|NCT02314663|medication adherence|medication adherence
4853178|NCT02314663|primary health care|primary health care
4853179|NCT02314637|DPP-IV inhibitor|dpp-iv inhibitor
4853180|NCT02314611|osteoarthritis|osteoarthritis
4853181|NCT02314611|avascular necrosis|avascular necrosis
4853182|NCT02314611|ankylosis|ankylosis
4853183|NCT02314611|protrusio acetabuli|protrusio acetabuli
4853184|NCT02314611|painful hip dysplasia|painful hip dysplasia
4853185|NCT02314611|rheumatoid arthritis|rheumatoid arthritis
4853186|NCT02314611|correction of functional deformity|correction of functional deformity
4853187|NCT02314611|revision procedures|revision procedures
4853188|NCT02314572|Multifocal Intraocular Lens|multifocal intraocular lens
4853189|NCT02314572|Binocular Trifocality|binocular trifocality
4853190|NCT02314572|Cataract Surgery|cataract surgery
4853191|NCT02314572|Spectacle Independence|spectacle independence
4853192|NCT02314572|Intermediate Vision|intermediate vision
4853193|NCT02314572|Photopic Vision|photopic vision
4853194|NCT02314572|Mesopic Vision|mesopic vision
4853195|NCT02314572|Scotopic Vision|scotopic vision
4853196|NCT02314572|Binocular Vision|binocular vision
4853197|NCT02314559|propofol|propofol
4853198|NCT02314559|colonoscopy|colonoscopy
4853199|NCT02314507|Gua sha|gua sha
4853200|NCT02314481|NSCLC|nsclc
4853201|NCT02314481|Clonal dominance|clonal dominance
4853202|NCT02314481|Clonal evolution|clonal evolution
4853203|NCT02314481|Intratumour heterogeneity|intratumour heterogeneity
4853204|NCT02314481|Genomic instability|genomic instability
4853205|NCT02314481|Drug resistance|drug resistance
4853206|NCT02314481|Immunotherapy|immunotherapy
4853207|NCT02314481|PDL1|pdl1
4853208|NCT02314481|BRAF V600|braf v600
4853210|NCT02314481|RET|ret
4853211|NCT02314481|HER2 amplification|her2 amplification
4853212|NCT02314481|MPDL3280A|mpdl3280a
4853213|NCT02314481|Vemurafenib|vemurafenib
4853214|NCT02314481|Alectinib|alectinib
4853215|NCT02314481|T-DM1|t-dm1
4853216|NCT02314481|Trastuzumab emtansine|trastuzumab emtansine
4853217|NCT02314481|TRACERX|tracerx
4853218|NCT02314455|Eosinophilic Esophagitis|eosinophilic esophagitis
4853219|NCT02314455|EoE|eoe
4853220|NCT02314455|dysphagia|dysphagia
4853221|NCT02314442|LDL-C|ldl-c
4853222|NCT02314442|RNAi therapeutic|rnai therapeutic
4853223|NCT02314416|wounds, stem cells, collagen matrix, maturation|wounds, stem cells, collagen matrix, maturation
4853224|NCT02314403|ESRD|esrd
4853225|NCT02314390|Depression|depression
4853226|NCT02314390|Mindfulness|mindfulness
4853227|NCT02314390|MBCT|mbct
4853228|NCT02314364|Non-small cell lung cancer|non-small cell lung cancer
4853229|NCT02314364|Metastatic|metastatic
4853230|NCT02314364|EGFR|egfr
4853231|NCT02314364|ALK|alk
4853232|NCT02314364|ROS1|ros1
4853233|NCT02314364|Stereotactic Body Radiation Therapy|stereotactic body radiation therapy
4853234|NCT02314351|migraine disorders|migraine disorders
4853235|NCT02314351|migraine with aura|migraine with aura
4853236|NCT02314351|migraine without aura|migraine without aura
4853237|NCT02314351|pain management|pain management
4853238|NCT02314351|emergency department|emergency department
4853239|NCT02314325|Factor VIII deficiency|factor viii deficiency
4853240|NCT02314325|Arthropathy|arthropathy
4853241|NCT02314325|MRI|mri
4853242|NCT02314325|XRay|xray
4853243|NCT02314325|Joint|joint
4853244|NCT02314325|HJHS|hjhs
4853245|NCT02314312|Kidney transplantation|kidney transplantation
4853246|NCT02314312|ECD|ecd
4853247|NCT02314299|Macular edema|macular edema
4853248|NCT02314299|Macular degeneration|macular degeneration
4853249|NCT02314299|MTP-131|mtp-131
4853250|NCT02314299|Ocuvia™|ocuvia™
4853251|NCT02314286|Rosuvastatin|rosuvastatin
4853252|NCT02314286|severe preeclampsia|severe preeclampsia
4853253|NCT02314286|48 hours following delivery|48 hours following delivery
4853254|NCT02314260|labour induction|labour induction
4853255|NCT02314260|cervical length|cervical length
4853256|NCT02314260|trans-vaginal assessment of cervical length|trans-vaginal assessment of cervical length
4853257|NCT02314260|Bishop score|bishop score
4853258|NCT02314247|PTCL|ptcl
4853259|NCT02314247|CTCL|ctcl
4853260|NCT02314247|Peripheral T-cell Lymphoma|peripheral t-cell lymphoma
4853261|NCT02314247|Cutaneous T-cell Lymphoma|cutaneous t-cell lymphoma
4853262|NCT02314247|Karyopharm|karyopharm
4853263|NCT02314247|KPT-330|kpt-330
4853264|NCT02314247|Selinexor|selinexor
4853265|NCT02314221|Exoskeletal-assisted walking|exoskeletal-assisted walking
4853266|NCT02314208|spastic paraplegia|spastic paraplegia
4853267|NCT02314208|metabolism|metabolism
4853268|NCT02314208|oxysterols|oxysterols
4853269|NCT02314208|neurogenetics|neurogenetics
4853270|NCT02314195|Obsessive Compulsive Disorder|obsessive compulsive disorder
4853271|NCT02314195|Music Therapy/methods|music therapy/methods
4853272|NCT02314195|Combined Modality Therapy|combined modality therapy
4853273|NCT02314195|Anxiety Disorders/therapy|anxiety disorders/therapy
4853274|NCT02314182|Rectal adenocarcinoma|rectal adenocarcinoma
4853275|NCT02314182|unresectable|unresectable
4853276|NCT02314182|surgery|surgery
4853277|NCT02314182|chemotherapy|chemotherapy
4853278|NCT02314143|dabrafenib|dabrafenib
4853279|NCT02314143|MEK|mek
4853280|NCT02314143|trametinib|trametinib
4853281|NCT02314143|BRAF|braf
4853282|NCT02314143|melanoma|melanoma
4853283|NCT02314143|Oncology|oncology
4853284|NCT02314104|Surgical procedures, Minimally invasive|surgical procedures, minimally invasive
4853285|NCT02314104|Nerve block|nerve block
4853286|NCT02314104|Anesthetics, Local|anesthetics, local
4853287|NCT02314078|Caesarean section|caesarean section
4853288|NCT02314078|Emergency|emergency
4853289|NCT02314078|Anaesthesia|anaesthesia
4853290|NCT02314065|Severe health anxiety|severe health anxiety
4853291|NCT02314065|Somatic symptom disorder|somatic symptom disorder
4853292|NCT02314065|Illness anxiety disorder|illness anxiety disorder
4853293|NCT02314065|Cognitive behavioral therapy|cognitive behavioral therapy
4853294|NCT02314065|Internet|internet
4853295|NCT02314065|Exposure|exposure
4853296|NCT02314013|uncomplicated diverticulitis, economic cost, hospital stay|uncomplicated diverticulitis, economic cost, hospital stay
4853297|NCT02313974|Lupus Nephritis Treatment|lupus nephritis treatment
4853298|NCT02313974|Renal Biopsy in Lupus|renal biopsy in lupus
4853299|NCT02313974|Lupus Flare|lupus flare
4853300|NCT02313961|ST elevation myocardial infarction|st elevation myocardial infarction
4853301|NCT02313961|Reperfusion injury|reperfusion injury
4853302|NCT02313961|Remote ischaemic conditioning|remote ischaemic conditioning
4853303|NCT02313909|Rivaroxaban|rivaroxaban
4853304|NCT02313909|Xarelto|xarelto
4853305|NCT02313909|Aspirin|aspirin
4853306|NCT02313909|ASA|asa
4853307|NCT02313909|Oral Anticoagulant|oral anticoagulant
4853308|NCT02313909|Blood Thinner|blood thinner
4853309|NCT02313909|Stroke|stroke
4853310|NCT02313909|Ischemic Stroke|ischemic stroke
4853311|NCT02313909|Cryptogenic Stroke|cryptogenic stroke
4853407|NCT02313220|Dapagliflozin|dapagliflozin
4853312|NCT02313909|Embolic stroke of undetermined source|embolic stroke of undetermined source
4853313|NCT02313909|ESUS|esus
4853314|NCT02313909|Transient Ischemic Attack|transient ischemic attack
4853315|NCT02313909|Thromboembolism|thromboembolism
4853316|NCT02313909|Cerebrovascular Disease|cerebrovascular disease
4853317|NCT02313883|periodontitis|periodontitis
4853318|NCT02313883|taurolidine (PerioSept(r))|taurolidine (periosept(r))
4853319|NCT02313883|scaling and root planing|scaling and root planing
4853320|NCT02313870|Bullous pemphigoid|bullous pemphigoid
4853321|NCT02313870|superpotent topical steroids|superpotent topical steroids
4853322|NCT02313870|methotrexate|methotrexate
4853323|NCT02313870|safety|safety
4853324|NCT02313857|Viralym-C|viralym-c
4853325|NCT02313857|Viral infections post HSCT|viral infections post hsct
4853326|NCT02313857|Virus-specific T cells|virus-specific t cells
4853327|NCT02313844|BK virus|bk virus
4853328|NCT02313844|Virus specific T cells|virus specific t cells
4853329|NCT02313844|Viral infections|viral infections
4853330|NCT02313831|autonomic nervous system|autonomic nervous system
4853331|NCT02313831|ventilatory anaerobic threshold|ventilatory anaerobic threshold
4853332|NCT02313831|oxygen consumption|oxygen consumption
4853333|NCT02313831|metabolic profile|metabolic profile
4853334|NCT02313831|exercise training|exercise training
4853335|NCT02313831|expiratory flow limitation|expiratory flow limitation
4853336|NCT02313818|Posttraumatic Stress Disorder|posttraumatic stress disorder
4853337|NCT02313818|Cognitive Processing Therapy|cognitive processing therapy
4853338|NCT02313818|Active Duty Military|active duty military
4853339|NCT02313805|Insulin initiation|insulin initiation
4853340|NCT02313805|Insulin checklist|insulin checklist
4853341|NCT02313792|Hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
4853342|NCT02313792|Palifermin|palifermin
4853343|NCT02313740|Influenza|influenza
4853344|NCT02313740|Influenza Vaccines|influenza vaccines
4853345|NCT02313714|heart failure, heart transplant, electrical stimulation|heart failure, heart transplant, electrical stimulation
4853346|NCT02313688|adenocarcinomas of esophagogastric junction|adenocarcinomas of esophagogastric junction
4853347|NCT02313688|resection margin|resection margin
4853348|NCT02313688|length|length
4853349|NCT02313688|prognosis|prognosis
4853350|NCT02313675|carpal tunnel syndrome|carpal tunnel syndrome
4853351|NCT02313675|opioid analgesics|opioid analgesics
4853352|NCT02313675|postoperative pain|postoperative pain
4853353|NCT02313675|IV tylenol|iv tylenol
4853354|NCT02313675|IV toradol|iv toradol
4853355|NCT02313649|liver|liver
4853356|NCT02313649|fibrosis|fibrosis
4853357|NCT02313649|elastography|elastography
4853358|NCT02313649|ShearWave Elastography|shearwave elastography
4853359|NCT02313649|ultrasound|ultrasound
4853360|NCT02313610|Retreatment Pulmonary Tuberculosis, Qinbudan,|retreatment pulmonary tuberculosis, qinbudan,
4853361|NCT02313584|dabigatran|dabigatran
4853362|NCT02313571|Epidural Analgesia|epidural analgesia
4853363|NCT02313571|Pain|pain
4853364|NCT02313558|dentifrice|dentifrice
4853365|NCT02313558|gingivitis|gingivitis
4853366|NCT02313558|dental plaque|dental plaque
4853367|NCT02313519|Infections|infections
4853368|NCT02313519|anastomotic leakage|anastomotic leakage
4853369|NCT02313506|Physical activity|physical activity
4853370|NCT02313506|Exercise|exercise
4853371|NCT02313506|Osteoarthritis|osteoarthritis
4853372|NCT02313506|Knee|knee
4853373|NCT02313506|Arthritis|arthritis
4853374|NCT02313441|remote ischemic preconditioning|remote ischemic preconditioning
4853375|NCT02313428|Diabetic Foot Ulcer|diabetic foot ulcer
4853376|NCT02313428|Topical Oxygen Therapy|topical oxygen therapy
4853377|NCT02313428|Medicaid Recipients|medicaid recipients
4853378|NCT02313428|Standard of Care|standard of care
4853379|NCT02313428|Diabetic Wounds|diabetic wounds
4853380|NCT02313363|Health care systems|health care systems
4853381|NCT02313363|Mobile applications|mobile applications
4853382|NCT02313363|Self-care|self-care
4853383|NCT02313363|Diabetes mellitus|diabetes mellitus
4853384|NCT02313363|Smartphone|smartphone
4853385|NCT02313350|Sciatica,|sciatica,
4853386|NCT02313350|herniated disc,|herniated disc,
4853387|NCT02313350|chemonucleolysis.|chemonucleolysis.
4853388|NCT02313337|Administration route|administration route
4853389|NCT02313337|Preanesthetic medication|preanesthetic medication
4853390|NCT02313337|Sedation|sedation
4853391|NCT02313324|Coccydynia|coccydynia
4853392|NCT02313324|Extracorporeal shock wave therapy|extracorporeal shock wave therapy
4853393|NCT02313324|Disability|disability
4853394|NCT02313311|Cleavage pattern, timing parameter, time-lapse|cleavage pattern, timing parameter, time-lapse
4853395|NCT02313272|neoplasms|neoplasms
4853396|NCT02313272|high-grade glioma|high-grade glioma
4853397|NCT02313272|recurrent glioma|recurrent glioma
4853398|NCT02313272|glioma|glioma
4853399|NCT02313272|Hypofractionated Stereotactic Irradiation (HFSRT)|hypofractionated stereotactic irradiation (hfsrt)
4853400|NCT02313272|Bevacizumab|bevacizumab
4853401|NCT02313272|Pembrolizumab|pembrolizumab
4853402|NCT02313272|recurrent high-grade glioma|recurrent high-grade glioma
4853403|NCT02313272|Grade III malignant glioma|grade iii malignant glioma
4853404|NCT02313272|Grade IV malignant glioma|grade iv malignant glioma
4853405|NCT02313272|brain and nervous system|brain and nervous system
4853406|NCT02313220|Obesity|obesity
4853408|NCT02313220|Exenatide|exenatide
4853409|NCT02313220|Combination treatment|combination treatment
4853410|NCT02313220|Type 2 diabetes|type 2 diabetes
4853411|NCT02313181|breastfeeding|breastfeeding
4853412|NCT02313181|lactation|lactation
4853413|NCT02313181|newborn|newborn
4853414|NCT02313168|difficult airway; prediction, FRONT score.|difficult airway; prediction, front score.
4853415|NCT02313155|Prevention|prevention
4853416|NCT02313129|Infertility|infertility
4853417|NCT02313129|Rheumatoid Arthritis|rheumatoid arthritis
4853418|NCT02313116|Lumpectomy|lumpectomy
4853419|NCT02313116|Breast cancer|breast cancer
4853420|NCT02313116|Optical coherence tomography|optical coherence tomography
4853421|NCT02313116|Tumor margin|tumor margin
4853422|NCT02313116|Imaging|imaging
4853423|NCT02313103|ESRD|esrd
4853424|NCT02313103|End Stage Renal Disease|end stage renal disease
4853425|NCT02313103|Normal Healthy Volunteers|normal healthy volunteers
4853426|NCT02313103|Renally Impaired|renally impaired
4853427|NCT02313077|Healthy|healthy
4853428|NCT02313077|Ebola viruses|ebola viruses
4853429|NCT02313077|Ebola Viral Disease (EVD)|ebola viral disease (evd)
4853430|NCT02313077|Filoviruses|filoviruses
4853431|NCT02313077|monovalent vaccine|monovalent vaccine
4853432|NCT02313077|Human adenovirus serotype 26 (Ad26) expressing the Ebola virus Mayinga variant glycoprotein (Ad26.ZEBOV)|human adenovirus serotype 26 (ad26) expressing the ebola virus mayinga variant glycoprotein (ad26.zebov)
4853433|NCT02313077|Modified Vaccinia Virus Ankara - Bavarian Nordic (MVA-BN) Filo-vector|modified vaccinia virus ankara - bavarian nordic (mva-bn) filo-vector
4853434|NCT02313077|Safety|safety
4853435|NCT02313077|Immunogenicity|immunogenicity
4853436|NCT02313051|metastatic breast cancer, everolimus|metastatic breast cancer, everolimus
4853437|NCT02313038|Coronary heart disease|coronary heart disease
4853438|NCT02313038|Percutaneous Coronary Intervention|percutaneous coronary intervention
4853439|NCT02313038|Drug Eluting Stents|drug eluting stents
4853440|NCT02313012|Maximum Tolerated Dose|maximum tolerated dose
4853441|NCT02313012|Solid Tumors|solid tumors
4853442|NCT02313012|Locally Advanced Tumors|locally advanced tumors
4853443|NCT02313012|Metastatic Solid Tumors|metastatic solid tumors
4853444|NCT02313012|Relapsed or refractory, BRAFV600 or RAS-mutated solid tumors|relapsed or refractory, brafv600 or ras-mutated solid tumors
4853445|NCT02313012|Melanoma|melanoma
4853446|NCT02313012|Colorectal Carcinomas Papillary|colorectal carcinomas papillary
4853447|NCT02313012|Thyroid carcinomas|thyroid carcinomas
4853448|NCT02313012|Pancreatic ductal Adenocarcinomas|pancreatic ductal adenocarcinomas
4853449|NCT02313012|Non -small cell lung cancer [NSCLC]|non -small cell lung cancer [nsclc]
4853450|NCT02312999|laparotomy|laparotomy
4853451|NCT02312999|plasma-Lyte|plasma-lyte
4853452|NCT02312999|volulyte|volulyte
4853453|NCT02312999|close loop|close loop
4853454|NCT02312999|abdominal surgery|abdominal surgery
4853455|NCT02312986|infection|infection
4853456|NCT02312986|colonization|colonization
4853457|NCT02312986|antibiotic resistance|antibiotic resistance
4853458|NCT02312973|Chronic kidney disease|chronic kidney disease
4853459|NCT02312973|Pharmacokinetics|pharmacokinetics
4853460|NCT02312973|Hemodialysis|hemodialysis
4853461|NCT02312973|Peritoneal dialysis|peritoneal dialysis
4853462|NCT02312973|Erythropoietin|erythropoietin
4853463|NCT02312934|Chemo brain|chemo brain
4853464|NCT02312934|Chemotherapy-related cognitive impairment|chemotherapy-related cognitive impairment
4853465|NCT02312934|CRCI|crci
4853466|NCT02312934|Breast cancer|breast cancer
4853467|NCT02312934|Chemo fog|chemo fog
4853468|NCT02312934|Nicotine|nicotine
4853469|NCT02312934|Transdermal nicotine|transdermal nicotine
4853470|NCT02312921|managed healthcare|managed healthcare
4853471|NCT02312921|child|child
4853472|NCT02312921|dental care|dental care
4853473|NCT02312908|REM Sleep Behavior Disorder|rem sleep behavior disorder
4853474|NCT02312908|Parkinson Disease|parkinson disease
4853475|NCT02312908|Placebos|placebos
4853476|NCT02312908|Randomized Controlled Trial|randomized controlled trial
4853477|NCT02312908|Double-Blind Method|double-blind method
4853478|NCT02312908|Clinical Trial|clinical trial
4853479|NCT02312869|Mechanical Ventilation|mechanical ventilation
4853480|NCT02312869|Burn patients|burn patients
4853481|NCT02312843|Mild Cognitive Impairment|mild cognitive impairment
4853482|NCT02312843|Cognitive disorders|cognitive disorders
4853483|NCT02312843|Prediabetes|prediabetes
4853484|NCT02312843|Exercise|exercise
4853485|NCT02312817|Carcinoma, Hepatocellular|carcinoma, hepatocellular
4853486|NCT02312817|Liver Neoplasms|liver neoplasms
4853487|NCT02312817|Liver Disease|liver disease
4853488|NCT02312817|Early Detection of Cancer|early detection of cancer
4853489|NCT02312817|Comparative Effectiveness Research|comparative effectiveness research
4853490|NCT02312791|Radiation|radiation
4853491|NCT02312791|Prognosis|prognosis
4853492|NCT02312791|Palliative Care|palliative care
4853493|NCT02312778|non-specific low back pain|non-specific low back pain
4853494|NCT02312778|center of pressure|center of pressure
4853495|NCT02312778|spinal lumbar manipulation|spinal lumbar manipulation
4853496|NCT02312778|high velocity and low amplitude manipulation|high velocity and low amplitude manipulation
4853497|NCT02312778|postural control|postural control
4853498|NCT02312752|Intra-epidermal stimulation in healthy control subjects|intra-epidermal stimulation in healthy control subjects
4853499|NCT02312739|pain assessment|pain assessment
4853500|NCT02312739|pain measurement|pain measurement
4853501|NCT02312739|patient satisfaction|patient satisfaction
4853502|NCT02312739|anxiety|anxiety
4853503|NCT02312739|analgesia and anesthesia|analgesia and anesthesia
4853504|NCT02312739|female sterilization|female sterilization
4853505|NCT02312726|mixed methods|mixed methods
4853506|NCT02312726|visual analog scale|visual analog scale
4853507|NCT02312726|verbal rating score|verbal rating score
4853508|NCT02312726|pain assessment|pain assessment
4853509|NCT02312726|patient satisfaction|patient satisfaction
4853510|NCT02312726|contraceptive devices|contraceptive devices
4853511|NCT02312726|postpartum|postpartum
4853512|NCT02312713|Osteoarthritis|osteoarthritis
4853513|NCT02312713|Knee Osteoarthritis|knee osteoarthritis
4853514|NCT02312700|empowerment|empowerment
4853515|NCT02312700|communication|communication
4853516|NCT02312700|shared decision making|shared decision making
4853517|NCT02312687|XLH|xlh
4853518|NCT02312687|FGF23|fgf23
4853519|NCT02312687|KRN23|krn23
4853520|NCT02312674|pancreatic carcinoma|pancreatic carcinoma
4853521|NCT02312674|hepatocellular carcinoma|hepatocellular carcinoma
4853522|NCT02312674|palliative therapy|palliative therapy
4853523|NCT02312674|oral nutritional supplements|oral nutritional supplements
4853524|NCT02312674|quality of life|quality of life
4853525|NCT02312674|nutritional status|nutritional status
4853526|NCT02312661|ovarian cancer|ovarian cancer
4853527|NCT02312661|metformin|metformin
4853528|NCT02312661|carboplatin|carboplatin
4853529|NCT02312661|paclitaxel|paclitaxel
4853530|NCT02312648|Functional Capacity|functional capacity
4853531|NCT02312648|Physical Exertion|physical exertion
4853532|NCT02312648|Patient Care|patient care
4853533|NCT02312648|Early mobilization|early mobilization
4853534|NCT02312635|cognitive rehabilitation, traumatic brain injury|cognitive rehabilitation, traumatic brain injury
4853535|NCT02312596|non-healing wound|non-healing wound
4853536|NCT02312596|diabetic foot ulcer|diabetic foot ulcer
4853537|NCT02312596|platelet rich plasma|platelet rich plasma
4853538|NCT02312583|depression|depression
4853539|NCT02312583|cognitive-behavior intervention|cognitive-behavior intervention
4853540|NCT02312570|non-healing wounds|non-healing wounds
4853541|NCT02312570|pressure ulcer|pressure ulcer
4853542|NCT02312570|platelet rich plasma|platelet rich plasma
4853543|NCT02312531|HBV|hbv
4853544|NCT02312531|Intrauterine infection|intrauterine infection
4853545|NCT02312531|hepatitis B immunoglobulin|hepatitis b immunoglobulin
4853546|NCT02312531|immune barrier|immune barrier
4853547|NCT02312531|virus replication|virus replication
4853548|NCT02312531|placenta|placenta
4853549|NCT02312518|non-healing wounds|non-healing wounds
4853550|NCT02312518|venous stasis|venous stasis
4853551|NCT02312518|ulcer|ulcer
4853552|NCT02312518|platelet rich plasma|platelet rich plasma
4853553|NCT02312505|cardiac output monitoring|cardiac output monitoring
4853554|NCT02312505|semi-invasive pulse contour analysis|semi-invasive pulse contour analysis
4853555|NCT02312505|transpulmonary thermodilution|transpulmonary thermodilution
4853556|NCT02312492|fatty acid kinetics|fatty acid kinetics
4853557|NCT02312440|tranexamic acid|tranexamic acid
4853558|NCT02312440|blood loss|blood loss
4853559|NCT02312440|topical administration|topical administration
4853560|NCT02312440|intravenous administration|intravenous administration
4853561|NCT02312401|MRI|mri
4853562|NCT02312401|14-172|14-172
4853563|NCT02312388|central venous catheters|central venous catheters
4853564|NCT02312362|HFDS|hfds
4853565|NCT02312362|ab interno|ab interno
4853566|NCT02312362|MIGS|migs
4853567|NCT02312362|surgery|surgery
4853568|NCT02312349|Celiac Disease|celiac disease
4853569|NCT02312349|Gluten free elaborated food|gluten free elaborated food
4853570|NCT02312336|ST Elevation Myocardial Infarction|st elevation myocardial infarction
4853571|NCT02312336|Transcoronary Cooling|transcoronary cooling
4853572|NCT02312258|Ixazomib|ixazomib
4853573|NCT02312258|Newly diagnosed|newly diagnosed
4853574|NCT02312219|HIV|hiv
4853575|NCT02312219|Inflammation|inflammation
4853576|NCT02312219|Atherosclerosis|atherosclerosis
4853577|NCT02312219|Positron-Emission Tomography|positron-emission tomography
4853578|NCT02312219|Imaging|imaging
4853579|NCT02312219|fluorodeoxyglucose|fluorodeoxyglucose
4853580|NCT02312193|hypertension|hypertension
4853581|NCT02312193|myogenic tone|myogenic tone
4853582|NCT02312167|endomicroscopy|endomicroscopy
4853583|NCT02312167|optical biopsy|optical biopsy
4853584|NCT02312167|exploratory surgery|exploratory surgery
4853585|NCT02312167|resection surgery|resection surgery
4853586|NCT02312167|robot-assisted|robot-assisted
4853587|NCT02312167|peritoneum carcinosis|peritoneum carcinosis
4853588|NCT02312167|inflammatory|inflammatory
4853589|NCT02312167|rectum cancer|rectum cancer
4853590|NCT02312167|liver cancer|liver cancer
4853591|NCT02312167|ovarian cancer|ovarian cancer
4853592|NCT02312167|digestive cancer|digestive cancer
4853593|NCT02312167|pancreas cancer|pancreas cancer
4853594|NCT02312167|duodenum cancer|duodenum cancer
4853595|NCT02312128|distal radius fractures|distal radius fractures
4853596|NCT02312128|early mobilization|early mobilization
4853597|NCT02312128|postoperative treatment|postoperative treatment
4853598|NCT02312128|outcome|outcome
4853599|NCT02312115|Renal transplant|renal transplant
4853600|NCT02312115|Kidney transplant|kidney transplant
4853601|NCT02312115|DGF|dgf
4853602|NCT02312102|myelodysplastic syndrome|myelodysplastic syndrome
4853603|NCT02312102|acute myeloid leukemia|acute myeloid leukemia
4853604|NCT02312102|allogeneic stem cell transplantation|allogeneic stem cell transplantation
4853605|NCT02312089|Luteal phase support, ICSI, GnRHa|luteal phase support, icsi, gnrha
4853606|NCT02312076|Luteal phase support, ICSI, GnRHa|luteal phase support, icsi, gnrha
4853607|NCT02312063|DPP-4 inhibitor|dpp-4 inhibitor
4853608|NCT02312063|sulfonylurea|sulfonylurea
4853609|NCT02312037|Relapsed CD33 AML|relapsed cd33 aml
4853610|NCT02312037|Refractory CD33 AML|refractory cd33 aml
4853611|NCT02312037|Relapsed CD33 APL|relapsed cd33 apl
4853612|NCT02312037|Refractory CD33 APL|refractory cd33 apl
4853613|NCT02312037|Relapsed CD33 MDS|relapsed cd33 mds
4853614|NCT02312037|Refractory CD33 MDS|refractory cd33 mds
4853615|NCT02312024|CytoSorb adsorber|cytosorb adsorber
4853616|NCT02312024|sepsis|sepsis
4853617|NCT02312024|cytokines|cytokines
4853618|NCT02312024|hemofiltration|hemofiltration
4853619|NCT02312024|hemadsorption|hemadsorption
4853620|NCT02312024|inflammation|inflammation
4853621|NCT02312011|Myotonic Dystrophy|myotonic dystrophy
4853622|NCT02312011|DM1|dm1
4853623|NCT02312011|Adult onset|adult onset
4853624|NCT02312011|Neuromuscular Disease|neuromuscular disease
4853625|NCT02312011|DMPKRx|dmpkrx
4853626|NCT02311998|Leukemia|leukemia
4853627|NCT02311998|CD22-positive Philadelphia-Chromosome Positive Acute Lymphoblastic Leukemia|cd22-positive philadelphia-chromosome positive acute lymphoblastic leukemia
4853628|NCT02311998|ALL|all
4853629|NCT02311998|Chronic Myeloid Leukemia Lymphoid Blast Phase|chronic myeloid leukemia lymphoid blast phase
4853630|NCT02311998|CML|cml
4853631|NCT02311998|Bosutinib|bosutinib
4853632|NCT02311998|SKI-606|ski-606
4853633|NCT02311998|Inotuzumab Ozogamicin|inotuzumab ozogamicin
4853634|NCT02311998|CMC-544|cmc-544
4853635|NCT02311998|Phone Call|phone call
4853636|NCT02311985|Liver cirrhosis|liver cirrhosis
4853637|NCT02311985|Blood coagulation|blood coagulation
4853638|NCT02311985|Thromboelastography|thromboelastography
4853639|NCT02311985|Blood transfusion|blood transfusion
4853640|NCT02311985|Catheterization, central venous|catheterization, central venous
4853641|NCT02311959|Breast|breast
4853642|NCT02311959|Invasive carcinoma|invasive carcinoma
4853643|NCT02311959|In situ carcinoma|in situ carcinoma
4853644|NCT02311959|Mastectomy|mastectomy
4853645|NCT02311959|Nipple areola|nipple areola
4853646|NCT02311959|Reconstruction|reconstruction
4853647|NCT02311959|Local recurrence|local recurrence
4853648|NCT02311946|Palbociclib, Rabeprazole, Proton Pump Inhibitor, Drug Interaction Study, DDI|palbociclib, rabeprazole, proton pump inhibitor, drug interaction study, ddi
4853649|NCT02311829|Quality of life, PNES, Epilepsy,|quality of life, pnes, epilepsy,
4853650|NCT02311816|Bacterial infection, empiric antibiotic therapy|bacterial infection, empiric antibiotic therapy
4853651|NCT02311790|cis-C16:1n7 supplement|cis-c16:1n7 supplement
4853652|NCT02311790|trans-C16:1n7 supplement|trans-c16:1n7 supplement
4853653|NCT02311790|palmitoleic acid supplement|palmitoleic acid supplement
4853654|NCT02311751|Autism Spectrum Disorder|autism spectrum disorder
4853655|NCT02311751|Executive Function|executive function
4853656|NCT02311751|rTMS (Repetitive Transcranial Magnetic Stimulation)|rtms (repetitive transcranial magnetic stimulation)
4853657|NCT02311751|MRI (Magnetic Resonance Imaging)|mri (magnetic resonance imaging)
4853658|NCT02311751|Healthy Subjects|healthy subjects
4853659|NCT02311738|Exercise and Genes in Obese (EGO)|exercise and genes in obese (ego)
4853660|NCT02311725|narrative communication|narrative communication
4853661|NCT02311725|depression|depression
4853662|NCT02311725|antidepressant augmentation|antidepressant augmentation
4853663|NCT02311725|primary care|primary care
4853664|NCT02311712|Esophageal cancer|esophageal cancer
4853665|NCT02311712|Early detection|early detection
4853666|NCT02311712|Cytological examination|cytological examination
4853667|NCT02311699|Gender|gender
4853668|NCT02311699|Physical Violence|physical violence
4853669|NCT02311699|Sexual Violence|sexual violence
4853670|NCT02311699|HIV|hiv
4853671|NCT02311699|AIDS|aids
4853672|NCT02311699|Prevention|prevention
4853673|NCT02311699|Community Intervention|community intervention
4853674|NCT02311699|Ethiopia|ethiopia
4853675|NCT02311699|Intimate Partner Violence|intimate partner violence
4853676|NCT02311686|Ethanol|ethanol
4853677|NCT02311686|Fatty acid ethyl esters|fatty acid ethyl esters
4853678|NCT02311686|Ethyl glucoronide|ethyl glucoronide
4853679|NCT02311686|Ethyl sulphate|ethyl sulphate
4853680|NCT02311686|Pharmacokinetics|pharmacokinetics
4853681|NCT02311673|Prader-Willi Syndrome|prader-willi syndrome
4853682|NCT02311673|obesity|obesity
4853683|NCT02311673|hyperphagia|hyperphagia
4853684|NCT02311647|Tamoxifen|tamoxifen
4853685|NCT02311647|Uterine cavity|uterine cavity
4853686|NCT02311647|endometrium|endometrium
4853687|NCT02311634|Electrical pudendal nerve stimulation|electrical pudendal nerve stimulation
4853688|NCT02311634|Transvaginal electrical stimulation|transvaginal electrical stimulation
4853689|NCT02311634|Urge urinary incontinence|urge urinary incontinence
4853690|NCT02311634|Comparative study|comparative study
4853691|NCT02311621|CAR T cell|car t cell
4853692|NCT02311621|pediatric|pediatric
4853693|NCT02311621|young adults|young adults
4853995|NCT02309983|fiber|fiber
4853694|NCT02311608|acute variceal hemorrhage|acute variceal hemorrhage
4853695|NCT02311608|terlipressin|terlipressin
4853696|NCT02311608|somatostatin|somatostatin
4853697|NCT02311608|octreotide|octreotide
4853698|NCT02311608|comparative effectiveness research|comparative effectiveness research
4853699|NCT02311595|gastric cancer|gastric cancer
4853700|NCT02311595|laparoscope|laparoscope
4853701|NCT02311569|JAK2|jak2
4853702|NCT02311569|Mirabegron|mirabegron
4853703|NCT02311569|Primary myelofibrosis|primary myelofibrosis
4853704|NCT02311569|beta-3-mimetic drugs|beta-3-mimetic drugs
4853705|NCT02311569|Myeloproliferative neoplasm|myeloproliferative neoplasm
4853706|NCT02311569|Essential thrombocythemia|essential thrombocythemia
4853707|NCT02311569|Polycythemia vera|polycythemia vera
4853708|NCT02311569|Betmiga|betmiga
4853709|NCT02311569|JAK2-V617F|jak2-v617f
4853710|NCT02311543|Axillary Lymph Node Dissection (ALND)|axillary lymph node dissection (alnd)
4853711|NCT02311543|Breast Cancer|breast cancer
4853712|NCT02311543|TachoSil®|tachosil®
4853713|NCT02311543|Lymphatic Drainage|lymphatic drainage
4853714|NCT02311543|Surgical Sealing Patch|surgical sealing patch
4853715|NCT02311491|nano crystalline|nano crystalline
4853716|NCT02311491|archwire|archwire
4853717|NCT02311465|Palliative Care|palliative care
4853718|NCT02311439|Locally advanced pancreatic cancer|locally advanced pancreatic cancer
4853719|NCT02311439|Chemotherapy|chemotherapy
4853720|NCT02311439|Radiotherapy|radiotherapy
4853721|NCT02311426|Rehabilitation; Functional outcome|rehabilitation; functional outcome
4853722|NCT02311413|Allergic rhinoconjunctivitis|allergic rhinoconjunctivitis
4853723|NCT02311400|Emotion|emotion
4853724|NCT02311400|Self-Affirmation|self-affirmation
4853725|NCT02311400|Alcohol Consumption|alcohol consumption
4853726|NCT02311387|Incidence|incidence
4853727|NCT02311387|Prevalence|prevalence
4853728|NCT02311387|Human|human
4853729|NCT02311387|Mastomys|mastomys
4853730|NCT02311387|Serosurvey|serosurvey
4853731|NCT02311374|Human Brain|human brain
4853732|NCT02311374|Sleep|sleep
4853733|NCT02311374|EEG|eeg
4853734|NCT02311374|Magnetic Resonance Imaging (MRI)|magnetic resonance imaging (mri)
4853735|NCT02311374|Apparent Diffusion Coefficient|apparent diffusion coefficient
4853736|NCT02311361|Anti-PDL1|anti-pdl1
4853737|NCT02311361|Anti-CTLA4|anti-ctla4
4853738|NCT02311361|Streostatic Body Radiation Therapy (SBRT)|streostatic body radiation therapy (sbrt)
4853739|NCT02311361|Monoclonal Antibody|monoclonal antibody
4853740|NCT02311361|Antitumor Immunity|antitumor immunity
4853741|NCT02311348|Biopsy|biopsy
4853742|NCT02311348|Pain|pain
4853743|NCT02311335|Hypertriglyceridemia|hypertriglyceridemia
4853744|NCT02311335|Atherosclerosis|atherosclerosis
4853745|NCT02311335|Genectic Variants|genectic variants
4853746|NCT02311335|Hyperalphalipoproteinemia|hyperalphalipoproteinemia
4853747|NCT02311335|Dyslipidemia|dyslipidemia
4853748|NCT02311322|Growth Disorder|growth disorder
4853749|NCT02311322|Growth|growth
4853750|NCT02311322|Exome Sequencing|exome sequencing
4853751|NCT02311244|All-cause mortality|all-cause mortality
4853752|NCT02311244|Cardiovascular mortality|cardiovascular mortality
4853753|NCT02311244|Myocardial infarction|myocardial infarction
4853754|NCT02311244|Stroke|stroke
4853755|NCT02311244|Dialysis|dialysis
4853756|NCT02311218|oral, microbiota, lactobacillus reuteri,|oral, microbiota, lactobacillus reuteri,
4853757|NCT02311205|Transarterial Chemoembolization (TACE)|transarterial chemoembolization (tace)
4853758|NCT02311205|Hepatocellular carcinoma (HCC)|hepatocellular carcinoma (hcc)
4853759|NCT02311205|Metastasis|metastasis
4853760|NCT02311205|Sorafenib|sorafenib
4853761|NCT02311192|Vitreous Haze|vitreous haze
4853762|NCT02311192|Ocular ultrasound|ocular ultrasound
4853763|NCT02311192|B scan|b scan
4853764|NCT02311192|Uveitis|uveitis
4853765|NCT02311179|Prosthesis fixation|prosthesis fixation
4853766|NCT02311179|hip arthroplasty|hip arthroplasty
4853767|NCT02311166|Hip dysplasia|hip dysplasia
4853768|NCT02311166|Soft tissue|soft tissue
4853769|NCT02311166|Hip|hip
4853770|NCT02311166|Self-report|self-report
4853771|NCT02311166|Physical activity|physical activity
4853772|NCT02311140|cystic fibrosis|cystic fibrosis
4853773|NCT02311140|nasal lavage|nasal lavage
4853774|NCT02311140|inflammation|inflammation
4853775|NCT02311140|Interleukin (IL)-6|interleukin (il)-6
4853776|NCT02311140|IL-8|il-8
4853777|NCT02311140|pulmonary function|pulmonary function
4853778|NCT02311127|Peripherally Inserted Central Catheters|peripherally inserted central catheters
4853779|NCT02311127|Securement device|securement device
4853780|NCT02311114|Program Evaluation|program evaluation
4853781|NCT02311114|Telehomecare|telehomecare
4853782|NCT02311114|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
4853783|NCT02311114|Heart Failure|heart failure
4853784|NCT02311114|LHINs|lhins
4853785|NCT02311114|Local Health Integrative Network|local health integrative network
4853786|NCT02311114|OTN|otn
4853787|NCT02311114|Ontario Telemedicine Network|ontario telemedicine network
4853788|NCT02311101|bladder cancer|bladder cancer
4853789|NCT02311101|mitomycin|mitomycin
4853790|NCT02311101|BCG|bcg
4853791|NCT02311101|intravesical|intravesical
4853792|NCT02311101|non-muscle invasive|non-muscle invasive
4853889|NCT02310399|Auditory Brainstem Implant|auditory brainstem implant
4853793|NCT02311062|training, soccer, eccentric, lengthening, unstable, squatting|training, soccer, eccentric, lengthening, unstable, squatting
4853794|NCT02311036|Post Acute Care(PAC)|post acute care(pac)
4853795|NCT02311036|Cerebrovascular diseases|cerebrovascular diseases
4853796|NCT02311010|transplant|transplant
4853797|NCT02311010|immunosuppressive drug|immunosuppressive drug
4853798|NCT02310984|Early breast cancer|early breast cancer
4853799|NCT02310984|Lumpectomy|lumpectomy
4853800|NCT02310984|Breast conserving surgery|breast conserving surgery
4853801|NCT02310984|Radiotherapy|radiotherapy
4853802|NCT02310984|Cosmesis|cosmesis
4853803|NCT02310971|Adenocarcinoma, resected|adenocarcinoma, resected
4853804|NCT02310958|Lapraroscopic surgical procedure|lapraroscopic surgical procedure
4853805|NCT02310958|infant|infant
4853806|NCT02310958|complications|complications
4853807|NCT02310958|inguinal hernia|inguinal hernia
4853808|NCT02310958|hernia recurrence|hernia recurrence
4853809|NCT02310945|pain|pain
4853810|NCT02310945|central nervous system sensitization|central nervous system sensitization
4853811|NCT02310945|physiotherapy|physiotherapy
4853812|NCT02310932|mental health|mental health
4853813|NCT02310932|cardiovascular disease|cardiovascular disease
4853814|NCT02310932|diabetes|diabetes
4853815|NCT02310932|hypertension|hypertension
4853816|NCT02310932|high blood pressure|high blood pressure
4853817|NCT02310919|Infertility|infertility
4853818|NCT02310919|In vitro fertilization|in vitro fertilization
4853819|NCT02310919|IVF|ivf
4853820|NCT02310906|Duchenne muscular dystrophy|duchenne muscular dystrophy
4853821|NCT02310906|Exon Skipping|exon skipping
4853822|NCT02310906|DMD|dmd
4853823|NCT02310906|Exon 53|exon 53
4853824|NCT02310906|Ambulatory|ambulatory
4853825|NCT02310906|Pediatric|pediatric
4853826|NCT02310867|hand transplantation, amputation|hand transplantation, amputation
4853827|NCT02310854|anterior cruciate ligament rupture|anterior cruciate ligament rupture
4853828|NCT02310854|autograft|autograft
4853829|NCT02310854|reconstruction|reconstruction
4853830|NCT02310854|orthopedic surgery|orthopedic surgery
4853831|NCT02310854|dynamic intraligament stabilization|dynamic intraligament stabilization
4853832|NCT02310828|Cluster headache|cluster headache
4853833|NCT02310828|Migrainous neuralgia|migrainous neuralgia
4853834|NCT02310828|Horton's headache|horton's headache
4853835|NCT02310828|Histaminic cephalalgia|histaminic cephalalgia
4853836|NCT02310802|IVF|ivf
4853837|NCT02310802|ICSI|icsi
4853838|NCT02310763|Duchenne Muscular Dystrophy, myostatin|duchenne muscular dystrophy, myostatin
4853839|NCT02310737|cesarean section|cesarean section
4853840|NCT02310737|facial incision|facial incision
4853841|NCT02310737|postoperative pain|postoperative pain
4853842|NCT02310724|youth onset type 2 diabetes|youth onset type 2 diabetes
4853843|NCT02310724|insulin sensitivity|insulin sensitivity
4853844|NCT02310724|beta cell function|beta cell function
4853845|NCT02310724|macrovascular comorbidities|macrovascular comorbidities
4853846|NCT02310724|microvascular comorbidities|microvascular comorbidities
4853847|NCT02310711|Breast|breast
4853848|NCT02310711|Mastectomy|mastectomy
4853849|NCT02310711|Lumpectomy|lumpectomy
4853850|NCT02310711|Breast Therapy|breast therapy
4853851|NCT02310698|Ultrasound|ultrasound
4853852|NCT02310698|Enhanced Mammography|enhanced mammography
4853853|NCT02310698|14-240|14-240
4853854|NCT02310685|Cardivascular risks (hypertension, sedentary, overweight)|cardivascular risks (hypertension, sedentary, overweight)
4853855|NCT02310685|Cardiovascular age|cardiovascular age
4853856|NCT02310685|E-health wellness program|e-health wellness program
4853857|NCT02310685|Prevention|prevention
4853858|NCT02310685|Community pharmacists|community pharmacists
4853859|NCT02310685|Lifestyle change|lifestyle change
4853860|NCT02310685|Cardiometabolic age|cardiometabolic age
4853861|NCT02310672|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
4853862|NCT02310633|TBI|tbi
4853863|NCT02310633|memory disorder|memory disorder
4853864|NCT02310633|injury, brain, traumatic|injury, brain, traumatic
4853865|NCT02310633|rehabilitation|rehabilitation
4853866|NCT02310607|Post-partum women|post-partum women
4853867|NCT02310581|Bunionectomy|bunionectomy
4853868|NCT02310568|PF 06372865|pf 06372865
4853869|NCT02310568|generalized anxiety disorder|generalized anxiety disorder
4853870|NCT02310568|outpatient|outpatient
4853871|NCT02310568|safety|safety
4853872|NCT02310568|efficacy|efficacy
4853873|NCT02310568|suboptimal response|suboptimal response
4853874|NCT02310555|Metabolic surgery|metabolic surgery
4853875|NCT02310529|Maternal depression|maternal depression
4853876|NCT02310529|Interpersonal Psycotherapy|interpersonal psycotherapy
4853877|NCT02310503|Mohs Surgery|mohs surgery
4853878|NCT02310490|Nasolabial Folds|nasolabial folds
4853879|NCT02310477|regorafenib, cohort, metastatic colorectal cancer|regorafenib, cohort, metastatic colorectal cancer
4853880|NCT02310438|Music therapy|music therapy
4853881|NCT02310438|stroke|stroke
4853882|NCT02310438|hemiparesis|hemiparesis
4853883|NCT02310438|neurologic music therapy|neurologic music therapy
4853884|NCT02310412|INTERCEPT|intercept
4853885|NCT02310412|platelet|platelet
4853886|NCT02310412|pathogen inactivation|pathogen inactivation
4853887|NCT02310412|platelet components stored|platelet components stored
4853888|NCT02310412|therapeutic efficacy|therapeutic efficacy
4853890|NCT02310399|Deafness|deafness
4853891|NCT02310399|Hearing Loss|hearing loss
4853892|NCT02310399|ABI|abi
4853893|NCT02310386|Fibromyalgia|fibromyalgia
4853894|NCT02310386|Electromagnetic field therapy|electromagnetic field therapy
4853895|NCT02310386|Randomized controlled trial|randomized controlled trial
4853896|NCT02310373|Nicotine-free hookah|nicotine-free hookah
4853897|NCT02310373|Waterpipe|waterpipe
4853898|NCT02310373|Smoking|smoking
4853899|NCT02310373|Sympathetic|sympathetic
4853900|NCT02310321|Acute Myeloid Leukemia|acute myeloid leukemia
4853901|NCT02310321|Cytarabine|cytarabine
4853902|NCT02310321|Idarubicin|idarubicin
4853903|NCT02310321|ASP2215|asp2215
4853904|NCT02310308|Xylitol|xylitol
4853905|NCT02310308|Magnolia|magnolia
4853906|NCT02310308|chewing gum|chewing gum
4853907|NCT02310295|Diabetic retinopathy|diabetic retinopathy
4853908|NCT02310295|Macular edema|macular edema
4853909|NCT02310295|Anti-VEGF|anti-vegf
4853910|NCT02310295|Triamcinolone|triamcinolone
4853911|NCT02310282|Telemedicine|telemedicine
4853912|NCT02310282|Emergency medicine|emergency medicine
4853913|NCT02310282|Stroke|stroke
4853914|NCT02310282|Stroke syndromes|stroke syndromes
4853915|NCT02310269|Cushing's disease,|cushing's disease,
4853916|NCT02310269|pasireotide s.c.|pasireotide s.c.
4853917|NCT02310269|Signifor|signifor
4853918|NCT02310256|Mitochondria, muscle|mitochondria, muscle
4853919|NCT02310256|Exercise|exercise
4853920|NCT02310256|Blood Flow Velocity|blood flow velocity
4853921|NCT02310243|Acute myeloid leukemia|acute myeloid leukemia
4853922|NCT02310243|Acute lymphoblastic leukemia|acute lymphoblastic leukemia
4853923|NCT02310243|MLL-rearranged leukemia|mll-rearranged leukemia
4853924|NCT02310243|Palbociclib (PD-0332991-00)|palbociclib (pd-0332991-00)
4853925|NCT02310230|Endoscopy, Upper|endoscopy, upper
4853926|NCT02310230|Minute Ventilation|minute ventilation
4853927|NCT02310230|Tidal Volume|tidal volume
4853928|NCT02310230|Respiratory Rate|respiratory rate
4853929|NCT02310217|Hypertension|hypertension
4853930|NCT02310217|Cognitive impairment|cognitive impairment
4853931|NCT02310217|Biomarkers|biomarkers
4853932|NCT02310191|ischemic stroke|ischemic stroke
4853933|NCT02310191|carotid stenting|carotid stenting
4853934|NCT02310191|MRI diffusion weighted imaging|mri diffusion weighted imaging
4853935|NCT02310191|Laboratory marker|laboratory marker
4853936|NCT02310178|weight loss|weight loss
4853937|NCT02310178|sleeve gastrectomy|sleeve gastrectomy
4853938|NCT02310178|gastric bypass|gastric bypass
4853939|NCT02310178|gastric banding|gastric banding
4853940|NCT02310178|bariatric procedures|bariatric procedures
4853941|NCT02310178|cohort|cohort
4853942|NCT02310178|morbid obesity|morbid obesity
4853943|NCT02310178|medical and economical impact|medical and economical impact
4853944|NCT02310178|severe obesity|severe obesity
4853945|NCT02310165|Paracentesis|paracentesis
4853946|NCT02310165|Ascites|ascites
4853947|NCT02310152|Child|child
4853948|NCT02310152|Adolescent|adolescent
4853949|NCT02310152|Parents|parents
4853950|NCT02310152|Cognitive Therapy|cognitive therapy
4853951|NCT02310152|Cognitive Behavior Therapy|cognitive behavior therapy
4853952|NCT02310152|Anxiety|anxiety
4853953|NCT02310113|NIRS|nirs
4853954|NCT02310113|transfusion|transfusion
4853955|NCT02310113|RBC|rbc
4853956|NCT02310087|male infertility|male infertility
4853957|NCT02310087|spermatogenesis|spermatogenesis
4853958|NCT02310087|antioxidants|antioxidants
4853959|NCT02310087|DNA damage|dna damage
4853960|NCT02310087|mitochondrial membrane potential|mitochondrial membrane potential
4853961|NCT02310087|apoptosis|apoptosis
4853962|NCT02310061|Dialysis|dialysis
4853963|NCT02310061|ESRD|esrd
4853964|NCT02310061|lung congestion|lung congestion
4853965|NCT02310061|heart failure|heart failure
4853966|NCT02310061|LW-US|lw-us
4853967|NCT02310009|Exercise|exercise
4853968|NCT02310009|IL-1RA|il-1ra
4853969|NCT02310009|Beta-cell function|beta-cell function
4853970|NCT02310009|Type 2 Diabetes|type 2 diabetes
4853971|NCT02309996|Randomized Controlled Trial|randomized controlled trial
4853972|NCT02309996|Intervention Studies|intervention studies
4853973|NCT02309996|Inservice Training|inservice training
4853974|NCT02309996|Personnel Management|personnel management
4853975|NCT02309996|Work place|work place
4853976|NCT02309996|Work accommodation|work accommodation
4853977|NCT02309996|Job modification|job modification
4853978|NCT02309996|Supervision|supervision
4853979|NCT02309996|Administration|administration
4853980|NCT02309996|Return to Work|return to work
4853981|NCT02309996|Industrial Psychology|industrial psychology
4853982|NCT02309996|Human Engineering|human engineering
4853983|NCT02309996|Risk Management|risk management
4853984|NCT02309996|Organization and Administration|organization and administration
4853985|NCT02309996|Work Disability|work disability
4853986|NCT02309996|Occupational Diseases|occupational diseases
4853987|NCT02309996|Occupational Injury|occupational injury
4853988|NCT02309996|Occupational Health|occupational health
4853989|NCT02309996|Occupational Exposure|occupational exposure
4853990|NCT02309996|Sick Leave|sick leave
4853991|NCT02309996|Absenteeism|absenteeism
4853992|NCT02309996|Employee Health|employee health
4853993|NCT02309983|bone turnover|bone turnover
4853994|NCT02309983|muscle atrophy|muscle atrophy
4853996|NCT02309957|Knee Cartilage Repair, Osteochondral Defects, BioMatrix CRD|knee cartilage repair, osteochondral defects, biomatrix crd
4853997|NCT02309944|Wound Healing|wound healing
4853998|NCT02309944|Obesity|obesity
4853999|NCT02309944|Gynecologic Surgery|gynecologic surgery
4854000|NCT02309944|Gynecologic Neoplasms|gynecologic neoplasms
4854001|NCT02309944|Surgical Complications|surgical complications
4854002|NCT02309931|Right hemicolectomy|right hemicolectomy
4854003|NCT02309931|Side-to-side anastomosis|side-to-side anastomosis
4854004|NCT02309931|Orocecal time|orocecal time
4854005|NCT02309931|Antipersitaltic|antipersitaltic
4854006|NCT02309931|Isoperistaltic|isoperistaltic
4854007|NCT02309931|Laparoscopic colectomy|laparoscopic colectomy
4854008|NCT02309931|Right laparoscopic hemicolectomy|right laparoscopic hemicolectomy
4854009|NCT02309918|acute HCV Genotype 1 Infection|acute hcv genotype 1 infection
4854010|NCT02309918|HCV RNA|hcv rna
4854011|NCT02309918|LDV/SOF FDC|ldv/sof fdc
4854012|NCT02309905|inmates|inmates
4854013|NCT02309905|skin lesion|skin lesion
4854014|NCT02309905|telemedicine|telemedicine
4854015|NCT02309892|Non-Small Cell Lung Cancer|non-small cell lung cancer
4854016|NCT02309892|Neoplasms|neoplasms
4854017|NCT02309892|Immunoconjugate|immunoconjugate
4854018|NCT02309892|Tumor microenvironment alkalinization|tumor microenvironment alkalinization
4854019|NCT02309879|Intravenous lidocaine|intravenous lidocaine
4854020|NCT02309879|Magnesium sulphate|magnesium sulphate
4854021|NCT02309879|Mastectomy|mastectomy
4854022|NCT02309879|Pain|pain
4854023|NCT02309827|Inflammatory bowel disease|inflammatory bowel disease
4854024|NCT02309723|Alzheimer's Disease|alzheimer's disease
4854025|NCT02309723|Mild Cognitive Impairment|mild cognitive impairment
4854026|NCT02309723|Neuroimaging|neuroimaging
4854027|NCT02309723|Diagnostic Tool|diagnostic tool
4854028|NCT02309697|Development|development
4854029|NCT02309697|Assessments|assessments
4854030|NCT02309697|Premature birth|premature birth
4854031|NCT02309684|Diabetic Foot Ulcer (DFU)|diabetic foot ulcer (dfu)
4854032|NCT02309684|Venous Leg Ulcer (VLU)|venous leg ulcer (vlu)
4854033|NCT02309658|cervix neoplasm|cervix neoplasm
4854034|NCT02309658|hENT1 protein, human|hent1 protein, human
4854035|NCT02309658|Chemotherapy|chemotherapy
4854036|NCT02309645|fibrin sealant|fibrin sealant
4854037|NCT02309645|CSF leak|csf leak
4854038|NCT02309619|esophageal cancer|esophageal cancer
4854039|NCT02309619|esophagectomy|esophagectomy
4854040|NCT02309619|quality of life|quality of life
4854041|NCT02309593|osteoarthritis|osteoarthritis
4854042|NCT02309593|avascular necrosis|avascular necrosis
4854043|NCT02309593|ankylosis|ankylosis
4854044|NCT02309593|protrusio acetabuli|protrusio acetabuli
4854045|NCT02309593|painful hip dysplasia|painful hip dysplasia
4854046|NCT02309593|rheumatoid arthritis|rheumatoid arthritis
4854047|NCT02309593|correction of functional deformity|correction of functional deformity
4854048|NCT02309593|revision procedures|revision procedures
4854049|NCT02309580|Ibrutinib|ibrutinib
4854050|NCT02309580|14-227|14-227
4854051|NCT02309567|Anti-p53 antibody|anti-p53 antibody
4854052|NCT02309567|PET/CT|pet/ct
4854053|NCT02309567|Lung Cancer|lung cancer
4854054|NCT02309567|FDG|fdg
4854055|NCT02309554|Contraception|contraception
4854056|NCT02309554|Post coital test|post coital test
4854057|NCT02309554|Vaginal|vaginal
4854058|NCT02309554|Diaphragm|diaphragm
4854059|NCT02309541|middle ear implant|middle ear implant
4854060|NCT02309541|feedback manager|feedback manager
4854061|NCT02309541|Sound quality|sound quality
4854062|NCT02309502|diabetic retinopathy|diabetic retinopathy
4854063|NCT02309502|retina|retina
4854064|NCT02309502|Laser|laser
4854065|NCT02309502|Pascal|pascal
4854066|NCT02309489|Family Planning Services|family planning services
4854067|NCT02309489|Maternal Health Services|maternal health services
4854068|NCT02309489|Breast Feeding|breast feeding
4854069|NCT02309489|Contraception|contraception
4854070|NCT02309489|Postnatal care|postnatal care
4854071|NCT02309489|Postpartum contraception|postpartum contraception
4854072|NCT02309489|Exclusive breastfeeding|exclusive breastfeeding
4854073|NCT02309489|Postpartum Period|postpartum period
4854074|NCT02309476|diffuse diabetic macular oedema|diffuse diabetic macular oedema
4854075|NCT02309476|Pascal|pascal
4854076|NCT02309476|Laser|laser
4854077|NCT02309476|DMO|dmo
4854078|NCT02309437|Nasopharyngeal carcinoma|nasopharyngeal carcinoma
4854079|NCT02309437|Pain|pain
4854080|NCT02309437|Oxycodone|oxycodone
4854081|NCT02309437|Opioids|opioids
4854082|NCT02309437|Radiation mucositis|radiation mucositis
4854083|NCT02309411|Pediatric|pediatric
4854084|NCT02309385|uveitis|uveitis
4854085|NCT02309385|acute uveitis|acute uveitis
4854086|NCT02309385|anterior uveitis|anterior uveitis
4854087|NCT02309385|dexamethasone sodium phosphate|dexamethasone sodium phosphate
4854088|NCT02309385|non-infectious uveitis|non-infectious uveitis
4854089|NCT02309385|DSP-Visulex|dsp-visulex
4854090|NCT02309385|Aciont|aciont
4854091|NCT02309346|clindamycin|clindamycin
4854092|NCT02309346|septic abortion|septic abortion
4854093|NCT02309307|safety and performance|safety and performance
4854094|NCT02309294|Patch Test|patch test
4854095|NCT02309281|Eylea|eylea
4854096|NCT02309268|left atrial appendage closure|left atrial appendage closure
4855287|NCT02302573|sonovue|sonovue
4854097|NCT02309255|Secondary coronary prevention|secondary coronary prevention
4854098|NCT02309255|Psychosocial factors|psychosocial factors
4854099|NCT02309255|Cardiac rehabilitation|cardiac rehabilitation
4854100|NCT02309229|sputum colour|sputum colour
4854101|NCT02309229|cystic fibrosis|cystic fibrosis
4854102|NCT02309229|pollution|pollution
4854103|NCT02309190|Transpulmonary pressure - morbid obesity|transpulmonary pressure - morbid obesity
4854104|NCT02309177|Pancreatic Cancer|pancreatic cancer
4854105|NCT02309177|Breast Cancer|breast cancer
4854106|NCT02309177|Metastatic Breast Cancer|metastatic breast cancer
4854107|NCT02309177|nab-Paclitaxel|nab-paclitaxel
4854108|NCT02309177|Gemcitabine|gemcitabine
4854109|NCT02309177|Carboplatin|carboplatin
4854110|NCT02309177|Non-Small Cell Lung Cancer|non-small cell lung cancer
4854111|NCT02309177|Lung Cancer|lung cancer
4854112|NCT02309177|mBC|mbc
4854113|NCT02309177|NSCLC|nsclc
4854114|NCT02309177|Triple-negative Breast Cancer|triple-negative breast cancer
4854115|NCT02309177|Hormone Receptor Positive|hormone receptor positive
4854116|NCT02309177|ER+|er+
4854117|NCT02309177|PR+|pr+
4854118|NCT02309177|TNBC|tnbc
4854119|NCT02309177|Nivolumab|nivolumab
4854120|NCT02309177|PD-1|pd-1
4854121|NCT02309177|Check-point Inhibitor/s|check-point inhibitor/s
4854122|NCT02309177|Immune Check-point Inhibitor/s|immune check-point inhibitor/s
4854123|NCT02309177|Anti-PD-1|anti-pd-1
4854124|NCT02309177|BMS-936558|bms-936558
4854125|NCT02309125|immediate gradual loading|immediate gradual loading
4854126|NCT02309099|Acoustic Neuroma|acoustic neuroma
4854127|NCT02309099|Vestibular Schwannoma|vestibular schwannoma
4854128|NCT02309099|Meniere's Disease|meniere's disease
4854129|NCT02309060|narrative communication|narrative communication
4854130|NCT02309060|depression|depression
4854131|NCT02309060|primary care|primary care
4854132|NCT02309060|treatment development|treatment development
4854133|NCT02309034|Overweight|overweight
4854134|NCT02309034|Obesity|obesity
4854135|NCT02309034|Cardiometabolic risk factors|cardiometabolic risk factors
4854136|NCT02309034|Adolescents|adolescents
4854137|NCT02309034|Exercise|exercise
4854138|NCT02309021|craving|craving
4854139|NCT02309008|Pharmacokinetics|pharmacokinetics
4854140|NCT02308995|Endometriosis|endometriosis
4854141|NCT02308995|Laparoscopy|laparoscopy
4854142|NCT02308995|Barbed sutures|barbed sutures
4854143|NCT02308982|encephalitis|encephalitis
4854144|NCT02308982|meningoencephalitis|meningoencephalitis
4854145|NCT02308982|encephalomyelitis|encephalomyelitis
4854146|NCT02308982|brain inflammation|brain inflammation
4854147|NCT02308982|intravenous immunoglobulin|intravenous immunoglobulin
4854148|NCT02308982|randomised controlled trial|randomised controlled trial
4854149|NCT02308982|Central Nervous System Diseases|central nervous system diseases
4854150|NCT02308982|Central Nervous System Infection|central nervous system infection
4854151|NCT02308969|altered state of consciousness|altered state of consciousness
4854152|NCT02308969|functional magnetic resonance imaging (fMRI)|functional magnetic resonance imaging (fmri)
4854153|NCT02308969|hallucination|hallucination
4854154|NCT02308969|model psychosis|model psychosis
4854155|NCT02308969|serotonin receptor|serotonin receptor
4854156|NCT02308969|LSD|lsd
4854157|NCT02308956|task sharing|task sharing
4854158|NCT02308956|task shifting|task shifting
4854159|NCT02308956|community mental health care|community mental health care
4854160|NCT02308956|primary care|primary care
4854161|NCT02308956|Developing country|developing country
4854162|NCT02308956|Sub-Saharan Africa|sub-saharan africa
4854163|NCT02308956|non-inferiority trial|non-inferiority trial
4854164|NCT02308917|IBD|ibd
4854165|NCT02308917|Crohn's|crohn's
4854166|NCT02308917|Ulcerative|ulcerative
4854167|NCT02308917|Colitis|colitis
4854168|NCT02308904|Infertility|infertility
4854169|NCT02308904|Thalassemia|thalassemia
4854170|NCT02308904|Iron overload|iron overload
4854171|NCT02308904|Pituitary Iron Load|pituitary iron load
4854172|NCT02308904|Oxidative Stress|oxidative stress
4854173|NCT02308904|REPRODUCTIVE CAPACITY AND ASSOCIATION TO IRON BURDEN AND CHELATION PATTERNS IN THALASSEMIA MAJOR PATIENTS|reproductive capacity and association to iron burden and chelation patterns in thalassemia major patients
4854174|NCT02308891|pancreatitis|pancreatitis
4854175|NCT02308891|ERCP|ercp
4854176|NCT02308878|Opioid abuse|opioid abuse
4854177|NCT02308878|Cognitive Therapy|cognitive therapy
4854178|NCT02308878|Executive Function|executive function
4854179|NCT02308878|Mobile Health|mobile health
4854180|NCT02308878|Rehabilitation|rehabilitation
4854181|NCT02308865|Early palliative care|early palliative care
4854182|NCT02308865|Lung cancer|lung cancer
4854183|NCT02308865|Quality of life|quality of life
4854184|NCT02308852|bi-manual , motor skill learning , stroke , chronic patients,neuro-rehabilitative robot|bi-manual , motor skill learning , stroke , chronic patients,neuro-rehabilitative robot
4854185|NCT02308839|Aneurysm|aneurysm
4854186|NCT02308839|Aorta|aorta
4854187|NCT02308839|Abdominal|abdominal
4854188|NCT02308800|diabetic foot ulcer|diabetic foot ulcer
4854189|NCT02308787|platelet depletion|platelet depletion
4854190|NCT02308787|apheresis|apheresis
4854191|NCT02308774|osteomyelitis, diabetic foot infection|osteomyelitis, diabetic foot infection
4854192|NCT02308735|gestation|gestation
4854193|NCT02308735|diabetes|diabetes
4854194|NCT02308735|ethanol|ethanol
4854195|NCT02308722|Borderline resectable|borderline resectable
4854196|NCT02308709|Radiotherapy|radiotherapy
4854197|NCT02308709|Pulmonary Functional Imaging|pulmonary functional imaging
4854198|NCT02308709|Computed Tomography (CT)|computed tomography (ct)
4854199|NCT02308709|Image Registration|image registration
4854200|NCT02308709|Functional Image-guided Radiotherapy|functional image-guided radiotherapy
4854201|NCT02308696|Older Adults|older adults
4854202|NCT02308696|Aging in Place|aging in place
4854203|NCT02308683|hscrp|hscrp
4854204|NCT02308683|hgba1c|hgba1c
4854205|NCT02308683|diabetes mellitus|diabetes mellitus
4854206|NCT02308644|Diabetic Retinopathy|diabetic retinopathy
4854207|NCT02308644|intravitreal bevacizumab|intravitreal bevacizumab
4854208|NCT02308644|Contrast Sensitivity|contrast sensitivity
4854209|NCT02308631|Endoscopic, Colostomy, Colopexy|endoscopic, colostomy, colopexy
4854210|NCT02308618|Achilles tendon rupture|achilles tendon rupture
4854211|NCT02308618|Rehabilitation|rehabilitation
4854212|NCT02308618|Immobilization|immobilization
4854213|NCT02308618|Muscle architecture|muscle architecture
4854214|NCT02308618|Functionality|functionality
4854215|NCT02308618|Neuromuscular parameters|neuromuscular parameters
4854216|NCT02308618|Weight-Bearing|weight-bearing
4854217|NCT02308605|SMARTCap|smartcap
4854218|NCT02308592|Pregnancy|pregnancy
4854219|NCT02308592|Depression|depression
4854220|NCT02308592|Antidepressant Use|antidepressant use
4854221|NCT02308592|Decision Aid|decision aid
4854222|NCT02308566|Intracranial Embolism|intracranial embolism
4854223|NCT02308566|Ultrasonography, Doppler, Transcranial|ultrasonography, doppler, transcranial
4854224|NCT02308553|BRAF V600 wildtype|braf v600 wildtype
4854225|NCT02308553|cutaneous malignant melanoma|cutaneous malignant melanoma
4854226|NCT02308553|nintedanib|nintedanib
4854227|NCT02308553|paclitaxel|paclitaxel
4854228|NCT02308553|kinase inhibitor|kinase inhibitor
4854229|NCT02308527|Children|children
4854230|NCT02308527|Young adults|young adults
4854231|NCT02308514|cryostimulation|cryostimulation
4854232|NCT02308488|prone IMRT to breast, level III & Supraclavicular|prone imrt to breast, level iii & supraclavicular
4854233|NCT02308488|acute toxicity of prone IMRT to breast, level III & SCV|acute toxicity of prone imrt to breast, level iii & scv
4854234|NCT02308462|children of mentally ill parents|children of mentally ill parents
4854235|NCT02308462|family intervention|family intervention
4854236|NCT02308462|randomized controlled trial|randomized controlled trial
4854237|NCT02308410|Tourniquet|tourniquet
4854238|NCT02308410|Postoperative outcome|postoperative outcome
4854239|NCT02308410|Total knee arthroplasty|total knee arthroplasty
4854240|NCT02308397|non coeliac gluten sensitivity|non coeliac gluten sensitivity
4854241|NCT02308397|gluten|gluten
4854242|NCT02308397|bread|bread
4854243|NCT02308384|iFOBT|ifobt
4854244|NCT02308384|FIT|fit
4854245|NCT02308384|general practice|general practice
4854246|NCT02308384|early diagnosis|early diagnosis
4854247|NCT02308371|critically ill pediatric patients|critically ill pediatric patients
4854248|NCT02308371|fluid resuscitation|fluid resuscitation
4854249|NCT02308358|Osteochondral Defect|osteochondral defect
4854250|NCT02308358|Femoral condyle osteochondral defect|femoral condyle osteochondral defect
4854251|NCT02308319|Hepatocellular carcinoma, Recurrence|hepatocellular carcinoma, recurrence
4854252|NCT02308306|Chronic pain|chronic pain
4854253|NCT02308306|Opioid analgesics|opioid analgesics
4854254|NCT02308306|Prediction study|prediction study
4854255|NCT02308306|Pharmaco-EEG|pharmaco-eeg
4854256|NCT02308293|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
4854257|NCT02308293|Hypoglycemia unawareness|hypoglycemia unawareness
4854258|NCT02308293|Lactate|lactate
4854259|NCT02308293|high intensity interval exercise|high intensity interval exercise
4854260|NCT02308293|MRS|mrs
4854261|NCT02308280|High-risk myeloma|high-risk myeloma
4854262|NCT02308280|Non myeloablative allogeneic transplantation|non myeloablative allogeneic transplantation
4854263|NCT02308280|Bortezomib|bortezomib
4854264|NCT02308267|Cystic Fibrosis|cystic fibrosis
4854265|NCT02308267|Mucosal immunity|mucosal immunity
4854266|NCT02308254|Blood pressure|blood pressure
4854267|NCT02308254|Gastric emptying|gastric emptying
4854268|NCT02308254|Glycemia|glycemia
4854269|NCT02308254|Appetite|appetite
4854270|NCT02308254|Incretin Hormones|incretin hormones
4854271|NCT02308254|Superior mesenteric artery blood low|superior mesenteric artery blood low
4854272|NCT02308241|Ribavirin|ribavirin
4854273|NCT02308241|Human Papillomavirus (HPV)|human papillomavirus (hpv)
4854274|NCT02308241|Recurrent/Metastatic (R/M)|recurrent/metastatic (r/m)
4854275|NCT02308241|14-211|14-211
4854276|NCT02308228|Aging|aging
4854277|NCT02308228|Hypertrophy|hypertrophy
4854278|NCT02308228|Metformin|metformin
4854279|NCT02308228|Strength|strength
4854280|NCT02308228|Muscle|muscle
4854281|NCT02308215|Retina|retina
4854282|NCT02308215|AMD|amd
4854283|NCT02308215|OCT|oct
4854284|NCT02308202|PTSD|ptsd
4854285|NCT02308202|treatment|treatment
4854286|NCT02308202|virtual reality|virtual reality
4854287|NCT02308202|doxazosin|doxazosin
4854288|NCT02308189|Exercise|exercise
4854289|NCT02308163|Rheumatoid Arthritis|rheumatoid arthritis
4854290|NCT02308163|ASP015K|asp015k
4854291|NCT02308150|transcatheter aortic valve replacement|transcatheter aortic valve replacement
4854292|NCT02308150|asian pacific|asian pacific
4854293|NCT02308150|asian|asian
4854294|NCT02308111|Primary Biliary Cirrhosis|primary biliary cirrhosis
4854295|NCT02308111|PBC|pbc
4854296|NCT02308111|Cirrhosis|cirrhosis
4854297|NCT02308111|Liver|liver
4854298|NCT02308085|Premenopausal|premenopausal
4854299|NCT02308085|endocrine responsive|endocrine responsive
4854300|NCT02308085|Breast|breast
4854301|NCT02308085|Pregnancy|pregnancy
4854302|NCT02308072|Squamous Cell Carcinoma|squamous cell carcinoma
4854303|NCT02308072|Head and Neck Cancer|head and neck cancer
4854304|NCT02308072|Locally Advanced|locally advanced
4854305|NCT02308072|Olaparib|olaparib
4854306|NCT02308072|Cisplatin|cisplatin
4854307|NCT02308072|IMRT|imrt
4854308|NCT02308072|Chemoradiotherapy|chemoradiotherapy
4854309|NCT02308072|PARP|parp
4854310|NCT02308072|HNSCC|hnscc
4854311|NCT02307994|infertility|infertility
4854312|NCT02307942|Randomized Clinical Trials|randomized clinical trials
4854313|NCT02307942|gastric banding|gastric banding
4854314|NCT02307942|calorie restriction|calorie restriction
4854315|NCT02307942|SPPB|sppb
4854316|NCT02307942|physical performance|physical performance
4854317|NCT02307942|elderly|elderly
4854318|NCT02307916|tympanic membrane perforation|tympanic membrane perforation
4854319|NCT02307916|ear drum|ear drum
4854320|NCT02307916|hole|hole
4854321|NCT02307903|end-stage renal failure (ESRF)|end-stage renal failure (esrf)
4854322|NCT02307890|Liver Transplantation|liver transplantation
4854323|NCT02307864|Healthy|healthy
4854324|NCT02307864|QT interval|qt interval
4854325|NCT02307864|QTc interval|qtc interval
4854326|NCT02307864|Electrocardiogram|electrocardiogram
4854327|NCT02307864|Tramadol hydrochloride|tramadol hydrochloride
4854328|NCT02307864|Moxifloxacin|moxifloxacin
4854329|NCT02307864|Placebo|placebo
4854458|NCT02307435|cryopreservation|cryopreservation
4854330|NCT02307838|Multiple Sclerosis, MS, RRMS, relapsing forms of multiple sclerosis, fingolimod, FTY720, Gilenya|multiple sclerosis, ms, rrms, relapsing forms of multiple sclerosis, fingolimod, fty720, gilenya
4854331|NCT02307825|Azithromycin|azithromycin
4854332|NCT02307825|Endoscopic sinus surgery|endoscopic sinus surgery
4854334|NCT02307799|spirometry|spirometry
4854335|NCT02307799|cohort study|cohort study
4854336|NCT02307799|case-control study|case-control study
4854337|NCT02307799|prevalence|prevalence
4854338|NCT02307773|Upper Gastrointestinal Endoscopy|upper gastrointestinal endoscopy
4854339|NCT02307773|Pharyngeal Anesthesia|pharyngeal anesthesia
4854340|NCT02307773|Lidocaine|lidocaine
4854341|NCT02307773|Belching|belching
4854342|NCT02307773|Retching|retching
4854343|NCT02307773|Tolerance|tolerance
4854344|NCT02307747|infection in ICU|infection in icu
4854345|NCT02307734|Lay Health Workers|lay health workers
4854346|NCT02307734|Chinese|chinese
4854347|NCT02307734|Vietnamese|vietnamese
4854348|NCT02307734|Tobacco Use|tobacco use
4854349|NCT02307734|Intervention|intervention
4854350|NCT02307734|Behavior Change|behavior change
4854351|NCT02307734|Social Networks|social networks
4854352|NCT02307734|Asians|asians
4854353|NCT02307721|Emergency Treatment|emergency treatment
4854354|NCT02307721|Morphine Derivates|morphine derivates
4854355|NCT02307721|Heroin|heroin
4854356|NCT02307721|Antidotes|antidotes
4854357|NCT02307721|Administration, Intranasal|administration, intranasal
4854358|NCT02307721|Pharmacology|pharmacology
4854359|NCT02307721|Naloxone|naloxone
4854360|NCT02307721|Healthy volunteers|healthy volunteers
4854361|NCT02307695|Saxagliptin|saxagliptin
4854362|NCT02307695|Type 1 Diabetes|type 1 diabetes
4854363|NCT02307695|Glycemic variability|glycemic variability
4854364|NCT02307695|C-Peptide|c-peptide
4854365|NCT02307682|AMD|amd
4854366|NCT02307682|CNV|cnv
4854367|NCT02307682|IVT|ivt
4854368|NCT02307643|Systemic lupus erythematosus|systemic lupus erythematosus
4854369|NCT02307630|124I-Humanized 3F8|124i-humanized 3f8
4854370|NCT02307630|PET Imaging|pet imaging
4854371|NCT02307630|13-147|13-147
4854372|NCT02307617|Major depressive disorder|major depressive disorder
4854373|NCT02307617|MDD|mdd
4854374|NCT02307617|healthy control|healthy control
4854375|NCT02307617|selective serotonin reuptake inhibitor|selective serotonin reuptake inhibitor
4854376|NCT02307617|SSRI|ssri
4854377|NCT02307617|depression|depression
4854378|NCT02307617|transcranial magnetic stimulation|transcranial magnetic stimulation
4854379|NCT02307617|TMS|tms
4854380|NCT02307617|magnetic resonance spectroscopy|magnetic resonance spectroscopy
4854381|NCT02307617|MRS|mrs
4854382|NCT02307617|adolescent|adolescent
4854383|NCT02307617|mild MDD|mild mdd
4854384|NCT02307617|mild depression|mild depression
4854385|NCT02307617|cortical excitability|cortical excitability
4854386|NCT02307617|cortical inhibition|cortical inhibition
4854387|NCT02307617|cortical silent period|cortical silent period
4854388|NCT02307617|motor threshold|motor threshold
4854389|NCT02307617|intracortical facilitation|intracortical facilitation
4854390|NCT02307617|intracortical inhibition|intracortical inhibition
4854391|NCT02307617|motor cortex|motor cortex
4854392|NCT02307617|dorsolateral prefrontal cortex|dorsolateral prefrontal cortex
4854393|NCT02307617|DLPFC|dlpfc
4854394|NCT02307617|thumb twitch|thumb twitch
4855288|NCT02302547|HIV-DNA|hiv-dna
4854395|NCT02307617|gamma aminobutyric acid|gamma aminobutyric acid
4854396|NCT02307617|GABA|gaba
4854397|NCT02307617|glutamate|glutamate
4854398|NCT02307617|single pulse|single pulse
4854399|NCT02307617|paired pulse|paired pulse
4854400|NCT02307604|Brain tumor|brain tumor
4854401|NCT02307604|Biomarkers|biomarkers
4854402|NCT02307604|Screening|screening
4854403|NCT02307578|Perampanel|perampanel
4854404|NCT02307578|Fycompa|fycompa
4854405|NCT02307578|Primary Generalized Tonic-Clonic Seizures|primary generalized tonic-clonic seizures
4854406|NCT02307578|E2007-G000-332|e2007-g000-332
4854407|NCT02307578|E2007|e2007
4854408|NCT02307565|Midodrine|midodrine
4854409|NCT02307565|Blood pressure|blood pressure
4854410|NCT02307565|Orthostatic hypotension|orthostatic hypotension
4854411|NCT02307565|Spinal Cord Injury|spinal cord injury
4854412|NCT02307565|Sympathetic vascular control|sympathetic vascular control
4854413|NCT02307565|Cerebral blood flow velocity|cerebral blood flow velocity
4854414|NCT02307565|Cognition function tasks|cognition function tasks
4854415|NCT02307565|Quality of Life|quality of life
4854416|NCT02307565|MRI|mri
4854417|NCT02307565|fMRI|fmri
4854418|NCT02307552|Imaging|imaging
4854419|NCT02307552|ultrasound|ultrasound
4854420|NCT02307552|prostate|prostate
4854421|NCT02307552|cancer|cancer
4854422|NCT02307552|diagnostic tool|diagnostic tool
4854423|NCT02307552|catheter|catheter
4854424|NCT02307552|urethra|urethra
4854425|NCT02307552|digital rectal exam|digital rectal exam
4854426|NCT02307526|Hypotension, Postural|hypotension, postural
4854427|NCT02307513|APREMILAST (CC-10004)|apremilast (cc-10004)
4854428|NCT02307513|CC-10004|cc-10004
4854429|NCT02307513|Efficacy|efficacy
4854430|NCT02307513|Safety|safety
4854431|NCT02307513|Phase 3|phase 3
4854432|NCT02307513|Behçet's Disease|behçet's disease
4854433|NCT02307487|TC-3 Gel|tc-3 gel
4854434|NCT02307487|MMC|mmc
4854435|NCT02307487|NMIBC|nmibc
4854436|NCT02307487|Non Muscle Invasive Bladder Cancer|non muscle invasive bladder cancer
4854437|NCT02307487|Hydrogel Reverse thermal gelation|hydrogel reverse thermal gelation
4854438|NCT02307487|Drug retention|drug retention
4854439|NCT02307487|Urinary Bladder Neoplasms|urinary bladder neoplasms
4854440|NCT02307487|Urologic Neoplasms|urologic neoplasms
4854441|NCT02307487|Urinary Bladder Diseases|urinary bladder diseases
4854442|NCT02307487|Urologic Diseases|urologic diseases
4854443|NCT02307474|Kidney|kidney
4854444|NCT02307474|Renal Cell Carcinoma|renal cell carcinoma
4854445|NCT02307474|Cancer|cancer
4854446|NCT02307474|Pilot|pilot
4854447|NCT02307474|Pazopanib|pazopanib
4854448|NCT02307474|stereotactic body radiation therapy|stereotactic body radiation therapy
4854449|NCT02307474|SBRT|sbrt
4854450|NCT02307461|Phase 1|phase 1
4854451|NCT02307461|Bioequivalence|bioequivalence
4854452|NCT02307461|Pharmacokinetics|pharmacokinetics
4854453|NCT02307461|Food|food
4854454|NCT02307461|Healthy Adult|healthy adult
4854455|NCT02307435|non union fracture|non union fracture
4854456|NCT02307435|bone defect|bone defect
4854457|NCT02307435|mesenchymal stem cell|mesenchymal stem cell
4854459|NCT02307383|SDD (Selective Digestive Decolonization)|sdd (selective digestive decolonization)
4854460|NCT02307383|OXA 48|oxa 48
4854461|NCT02307383|carbapenemase|carbapenemase
4854462|NCT02307383|probiotics|probiotics
4854463|NCT02307331|Total Hip Replacement|total hip replacement
4854464|NCT02307318|Radial Artery|radial artery
4854465|NCT02307318|Hemostasis|hemostasis
4854466|NCT02307318|Angiography|angiography
4854467|NCT02307292|Superficial femoral artery|superficial femoral artery
4854468|NCT02307292|Self Expanding Stent System|self expanding stent system
4854469|NCT02307253|EUS-guided biopsy, EUS-FNB|eus-guided biopsy, eus-fnb
4854470|NCT02307240|TNBC|tnbc
4854471|NCT02307240|HGSOC|hgsoc
4854472|NCT02307240|NMC|nmc
4854473|NCT02307188|Atrial Fibrillation|atrial fibrillation
4854474|NCT02307188|Atrial Flutter|atrial flutter
4854475|NCT02307188|Multipolar Catheter|multipolar catheter
4854476|NCT02307188|Atrial Arrhythmia|atrial arrhythmia
4854477|NCT02307162|COPD|copd
4854478|NCT02307149|melanoma|melanoma
4854479|NCT02307149|ipilimumab|ipilimumab
4854480|NCT02307149|coxsackievirus A21|coxsackievirus a21
4854481|NCT02307149|CAVATAK|cavatak
4854482|NCT02307149|CVA21|cva21
4854483|NCT02307149|checkpoint inhibitors|checkpoint inhibitors
4854484|NCT02307136|intensive care units|intensive care units
4854485|NCT02307136|emergency department|emergency department
4854486|NCT02307123|Prehospital emergency care (MeSH)|prehospital emergency care (mesh)
4854487|NCT02307123|Emergency medical services (MeSH)|emergency medical services (mesh)
4854488|NCT02307123|Helicopter emergency medical service, Critical care (MeSH)|helicopter emergency medical service, critical care (mesh)
4854489|NCT02307123|Airway management (MeSH)|airway management (mesh)
4854490|NCT02307123|Endotracheal intubation (MeSH)|endotracheal intubation (mesh)
4854491|NCT02307123|Patient outcome|patient outcome
4854492|NCT02307110|Diabetes Mellitus 1|diabetes mellitus 1
4854493|NCT02307110|long-term intensified insulin therapy|long-term intensified insulin therapy
4854494|NCT02307110|diabetic retinopathy|diabetic retinopathy
4854495|NCT02307110|diabetic macular edema|diabetic macular edema
4854496|NCT02307097|Randomised Controlled Trial|randomised controlled trial
4854497|NCT02307097|Cognitive-Behavioural Bibliotherapy|cognitive-behavioural bibliotherapy
4854498|NCT02307097|Social Anxiety Disorder|social anxiety disorder
4854499|NCT02307097|Cognitive-Behavioural Therapy|cognitive-behavioural therapy
4854500|NCT02307097|IAPT|iapt
4854501|NCT02307084|surgical site infection|surgical site infection
4854502|NCT02307084|long saphenous vein|long saphenous vein
4854503|NCT02307084|coronary artery bypass grafting|coronary artery bypass grafting
4854504|NCT02307058|Prostate Cancer|prostate cancer
4854505|NCT02307045|Arterial stiffness|arterial stiffness
4854506|NCT02307045|Endothelial Glycocalyx|endothelial glycocalyx
4854507|NCT02307032|Atrial Fibrillation Relapses Prediction|atrial fibrillation relapses prediction
4854508|NCT02307032|P wave Signal Averaged ECG|p wave signal averaged ecg
4854509|NCT02307032|P wave Wavelets|p wave wavelets
4854510|NCT02307032|Strain|strain
4854511|NCT02307032|Tissue Doppler Imaging|tissue doppler imaging
4854512|NCT02307019|Caregivers|caregivers
4854513|NCT02307019|Apraxias|apraxias
4854514|NCT02307019|Stroke|stroke
4854515|NCT02307019|Cerebral Stroke|cerebral stroke
4854516|NCT02307019|Rehabilitation|rehabilitation
4854517|NCT02307019|Pragmatic Clinical Trials as Topic|pragmatic clinical trials as topic
4854518|NCT02306993|Sickle Cell Disease (SCD)|sickle cell disease (scd)
4854519|NCT02306993|Sickle Cell Trait (SCT)|sickle cell trait (sct)
4854520|NCT02306967|oral cancer|oral cancer
4854521|NCT02306967|oral dysplasia|oral dysplasia
4854522|NCT02306954|Kidney Cancer|kidney cancer
4854523|NCT02306954|High Dose IL-2|high dose il-2
4854524|NCT02306954|SBRT|sbrt
4854525|NCT02306928|Septic shock|septic shock
4854526|NCT02306928|Intensive care unit|intensive care unit
4854527|NCT02306928|Therapeutic drug monitoring|therapeutic drug monitoring
4854528|NCT02306928|Pharmacokinetics|pharmacokinetics
4854529|NCT02306928|Critically ill|critically ill
4854530|NCT02306915|Lipegfilgrastim, Lonquex, Japanese Bridging|lipegfilgrastim, lonquex, japanese bridging
4854531|NCT02306863|Parkinson's Disease|parkinson's disease
4854532|NCT02306863|whole-body vibration|whole-body vibration
4854533|NCT02306863|WBV|wbv
4854534|NCT02306850|immunotherapy|immunotherapy
4854535|NCT02306850|PD-1 inhibitor|pd-1 inhibitor
4854536|NCT02306850|programmed death 1 inhibitor|programmed death 1 inhibitor
4854537|NCT02306850|neoadjuvant|neoadjuvant
4854538|NCT02306850|pembrolizumab|pembrolizumab
4854539|NCT02306850|MK-3475|mk-3475
4854540|NCT02306837|lymphoma, consolidation chemotherapy, auto-HSCT|lymphoma, consolidation chemotherapy, auto-hsct
4854541|NCT02306759|analgesia|analgesia
4854542|NCT02306759|ketamine|ketamine
4854543|NCT02306759|pain|pain
4854544|NCT02306746|Enteral nutrition|enteral nutrition
4854545|NCT02306746|randomised control trial|randomised control trial
4854546|NCT02306746|Critical care|critical care
4854547|NCT02306746|Outcome|outcome
4854548|NCT02306733|Post partum hemorrhage|post partum hemorrhage
4854549|NCT02306733|Ergometrine|ergometrine
4854550|NCT02306733|Oxytocin|oxytocin
4854551|NCT02306733|Obstetrics|obstetrics
4854552|NCT02306694|hemophilia|hemophilia
4854553|NCT02306694|bone disease|bone disease
4854554|NCT02306694|clinical study|clinical study
4854555|NCT02306694|biomarkers|biomarkers
4854556|NCT02306668|Dry eye|dry eye
4854557|NCT02306655|Coital incontinence|coital incontinence
4854558|NCT02306655|Incidence|incidence
4854559|NCT02306655|quality of life|quality of life
4854560|NCT02306629|Systemic Lupus Erythematosus|systemic lupus erythematosus
4854561|NCT02306590|amyotrophic lateral sclerosis|amyotrophic lateral sclerosis
4854562|NCT02306590|survival time|survival time
4854563|NCT02306590|ALS Functional Rating Scale|als functional rating scale
4854564|NCT02306590|quality of life|quality of life
4854565|NCT02306590|survival|survival
4854566|NCT02306577|STRIBILD|stribild
4854567|NCT02306577|HIV|hiv
4854568|NCT02306577|Illicit dgug user|illicit dgug user
4854569|NCT02306564|ICSI|icsi
4854570|NCT02306564|cabergoline|cabergoline
4854571|NCT02306564|Subendometrial vascularity|subendometrial vascularity
4854572|NCT02306551|Offspring|offspring
4854573|NCT02306551|Attachment|attachment
4854574|NCT02306551|Risk development|risk development
4854575|NCT02306551|Resilience|resilience
4854576|NCT02306538|edema|edema
4854577|NCT02306538|inflammation|inflammation
4854578|NCT02306538|scar|scar
4854579|NCT02306538|ejection fraction|ejection fraction
4854580|NCT02306538|volumes|volumes
4854581|NCT02306512|Melanoma In Situ|melanoma in situ
4854582|NCT02306512|Lentigo Maligna|lentigo maligna
4854583|NCT02306512|Confocal Microscopy|confocal microscopy
4854584|NCT02306512|Direct Immunofluorescence|direct immunofluorescence
4854585|NCT02306499|VARICOCELE-AZOOSPERMIA-ICSI|varicocele-azoospermia-icsi
4854586|NCT02306460|Neurobehavioral Manifestations|neurobehavioral manifestations
4854587|NCT02306460|POCD|pocd
4854588|NCT02306460|Atrial Fibrillation|atrial fibrillation
4854589|NCT02306460|Anti-Arrhythmia|anti-arrhythmia
4854590|NCT02306460|Atrial Appendage Closure|atrial appendage closure
4854591|NCT02306434|childbirth fear|childbirth fear
4854592|NCT02306434|Internet CBT|internet cbt
4854593|NCT02306434|counselling|counselling
4854594|NCT02306434|antenatal care|antenatal care
4854595|NCT02306434|postnatal care|postnatal care
4854596|NCT02306434|childbirth|childbirth
4854597|NCT02306434|Cognitive behavioural therapy|cognitive behavioural therapy
4854598|NCT02306421|RPH with the simplified Milligan-Morgan surgery|rph with the simplified milligan-morgan surgery
4854599|NCT02306421|mixed hemorrhoids|mixed hemorrhoids
4854600|NCT02306421|the effectiveness and safety|the effectiveness and safety
4854601|NCT02306421|A multi center clinical trial|a multi center clinical trial
4854602|NCT02306395|endometrial local injury|endometrial local injury
4854603|NCT02306395|repeated implatation failure|repeated implatation failure
4854604|NCT02306395|embyo transfer|embyo transfer
4854605|NCT02306382|endoanal ultrasonography|endoanal ultrasonography
4854606|NCT02306382|drainage|drainage
4854607|NCT02306382|perianal abscess|perianal abscess
4854608|NCT02306382|fistulas|fistulas
4854609|NCT02306382|incontience|incontience
4854610|NCT02306369|ICBT|icbt
4854611|NCT02306369|IBS|ibs
4854612|NCT02306369|FGID|fgid
4854613|NCT02306369|functional abdominal pain|functional abdominal pain
4854614|NCT02306369|Adolescents|adolescents
4854615|NCT02306369|Children|children
4854616|NCT02306369|Treatment|treatment
4854617|NCT02306369|CBT|cbt
4854618|NCT02306369|Exposure|exposure
4854619|NCT02306369|Cognitive Behavior Therapy|cognitive behavior therapy
4854620|NCT02306369|Internet|internet
4854621|NCT02306369|Computerized|computerized
4854622|NCT02306369|Abdominal Pain|abdominal pain
4854623|NCT02306369|Functional Pain|functional pain
4854624|NCT02306369|Functional Disorders|functional disorders
4854625|NCT02306343|rapid acting insulin|rapid acting insulin
4854626|NCT02306343|insulin injection|insulin injection
4854627|NCT02306343|insulin delivery|insulin delivery
4854628|NCT02306343|local heating|local heating
4854629|NCT02306343|experimental device|experimental device
4854630|NCT02306343|pre and post meal glucose level|pre and post meal glucose level
4854631|NCT02306330|Malditof|malditof
4854632|NCT02306330|Malditof MS|malditof ms
4854633|NCT02306330|matrix-assisted laser desorption ionization-time|matrix-assisted laser desorption ionization-time
4854634|NCT02306330|identifying pathogens|identifying pathogens
4854635|NCT02306330|randomized diagnostic trial|randomized diagnostic trial
4854636|NCT02306304|Abdominal aortic aneurysm|abdominal aortic aneurysm
4854637|NCT02306304|Abdominal aortic aneurism|abdominal aortic aneurism
4854638|NCT02306304|AAA|aaa
4854639|NCT02306304|Screening|screening
4854640|NCT02306304|duplex ultra sound|duplex ultra sound
4854641|NCT02306304|Israeli Arab men|israeli arab men
4854642|NCT02306304|family physician|family physician
4854643|NCT02306291|AML|aml
4854644|NCT02306291|Acute myeloid leukemia|acute myeloid leukemia
4854645|NCT02306291|E-selectin|e-selectin
4854646|NCT02306291|relapse refractory|relapse refractory
4854647|NCT02306291|elderly newly diagnosed|elderly newly diagnosed
4854648|NCT02306291|induction|induction
4854649|NCT02306278|gabapentin|gabapentin
4854650|NCT02306278|postoperative pain|postoperative pain
4854651|NCT02306278|vomiting|vomiting
4854652|NCT02306278|nausea|nausea
4854653|NCT02306252|Cancer|cancer
4854654|NCT02306252|Older Adult|older adult
4854655|NCT02306252|Geriatric|geriatric
4854656|NCT02306252|Function|function
4854657|NCT02306252|Functional Deficit|functional deficit
4854658|NCT02306252|Occupational Therapy|occupational therapy
4854659|NCT02306252|Physical Therapy|physical therapy
4854660|NCT02306252|Supportive Care|supportive care
4854661|NCT02306252|Oncology|oncology
4854662|NCT02306252|physiology|physiology
4854663|NCT02306252|Geriatric Assessment|geriatric assessment
4854664|NCT02306252|Health Services for the Aged|health services for the aged
4854665|NCT02306252|Physical Therapy Specialty|physical therapy specialty
4854666|NCT02306226|TAVI|tavi
4854667|NCT02306226|Aortic stenosis|aortic stenosis
4854668|NCT02306226|Transcatheter aortic valve replacement|transcatheter aortic valve replacement
4854669|NCT02306226|Transcatheter aortic valve implantation|transcatheter aortic valve implantation
4854670|NCT02306226|Transfemoral access|transfemoral access
4854671|NCT02306200|Aorta|aorta
4854672|NCT02306200|Aortic Disease|aortic disease
4854673|NCT02306200|Abdominal Aortic Aneurysm (AAA)|abdominal aortic aneurysm (aaa)
4854674|NCT02306200|Thoracic Aortic Aneurysm (TAA)|thoracic aortic aneurysm (taa)
4854675|NCT02306200|Bicuspid Aortic Valve (BAV)|bicuspid aortic valve (bav)
4854676|NCT02306200|Aortic Dissection|aortic dissection
4854677|NCT02306187|The changes of bone mineral density and bone turnover markers|the changes of bone mineral density and bone turnover markers
4854678|NCT02306174|Hoarding|hoarding
4854679|NCT02306135|Cancer|cancer
4854680|NCT02306135|Tumor|tumor
4854681|NCT02306135|Everolimus|everolimus
4854682|NCT02306135|mTOR|mtor
4854683|NCT02306135|Temsirolimus|temsirolimus
4854684|NCT02306135|Sirolimus|sirolimus
4854685|NCT02306135|Rapamycin|rapamycin
4854686|NCT02306122|medication adherence|medication adherence
4854687|NCT02306122|choice architecture|choice architecture
4854688|NCT02306122|pharmacy home|pharmacy home
4854689|NCT02306109|Motor Rehabilitation Treatment|motor rehabilitation treatment
4854690|NCT02306109|Intensive versus standard|intensive versus standard
4854691|NCT02306109|Motor Disability|motor disability
4854692|NCT02306096|prognostic and predictive biomarkers|prognostic and predictive biomarkers
4854693|NCT02306096|RNA-sequencing|rna-sequencing
4854694|NCT02306096|pathological complete response|pathological complete response
4855290|NCT02302547|NRTI|nrti
4854695|NCT02306096|minimal residual disease|minimal residual disease
4854696|NCT02306096|molecular subtype|molecular subtype
4854697|NCT02306096|gene expression profiling|gene expression profiling
4854698|NCT02306096|mutation screening|mutation screening
4854699|NCT02306096|BRCA|brca
4854700|NCT02306096|translational research|translational research
4854701|NCT02306096|genomics|genomics
4854702|NCT02306096|transcriptomics|transcriptomics
4854703|NCT02306096|proteomics|proteomics
4854704|NCT02306096|metabolomics|metabolomics
4854705|NCT02306096|liquid biopsy|liquid biopsy
4854706|NCT02306096|circulating tumor cells|circulating tumor cells
4854707|NCT02306096|circulating tumor DNA|circulating tumor dna
4854708|NCT02306044|Bleeding|bleeding
4854709|NCT02306044|Platelet indices|platelet indices
4854710|NCT02306044|Platelet aggregometry|platelet aggregometry
4854711|NCT02306044|Bleeding questionnaire|bleeding questionnaire
4854712|NCT02306031|diclofenac|diclofenac
4854713|NCT02306031|macular thickness|macular thickness
4854714|NCT02306031|phacoemulsification|phacoemulsification
4854715|NCT02306031|OCT(Optical coherence tomography )|oct(optical coherence tomography )
4854716|NCT02306031|diabetic|diabetic
4854717|NCT02306018|liver transplantation|liver transplantation
4854718|NCT02306018|cardiac output|cardiac output
4854719|NCT02306005|diabetes mellitus type 1, insulin therapy, lipoproteins, HDL|diabetes mellitus type 1, insulin therapy, lipoproteins, hdl
4854720|NCT02305966|advanced arthritis|advanced arthritis
4854721|NCT02305966|shoulder|shoulder
4854722|NCT02305953|Psoriasis|psoriasis
4854723|NCT02305953|Vascular Inflammation|vascular inflammation
4854724|NCT02305953|Coronary Atherosclerosis|coronary atherosclerosis
4854725|NCT02305953|Ascending aorta|ascending aorta
4854726|NCT02305953|PET scan|pet scan
4854727|NCT02305953|Cytokine|cytokine
4854728|NCT02305953|Chemokine|chemokine
4854729|NCT02305927|Vitamin D|vitamin d
4854730|NCT02305927|Pregnant women|pregnant women
4854731|NCT02305914|acute pancreatitis|acute pancreatitis
4854732|NCT02305914|chronic pancreatitis|chronic pancreatitis
4854733|NCT02305914|pancreatic cancer|pancreatic cancer
4854734|NCT02305914|pancreatic disease-associated portal hypertension|pancreatic disease-associated portal hypertension
4854735|NCT02305914|autoimmune pancreatitis|autoimmune pancreatitis
4854736|NCT02305914|PaO2/FiO2＜200|pao2/fio2＜200
4854737|NCT02305914|diabetes mellitus|diabetes mellitus
4854738|NCT02305914|blood lipid|blood lipid
4854739|NCT02305914|local complications|local complications
4854740|NCT02305914|quality of life|quality of life
4854741|NCT02305862|Coronary Arteriosclerosis|coronary arteriosclerosis
4854742|NCT02305862|Carotid Atherosclerotic Plaque|carotid atherosclerotic plaque
4854743|NCT02305862|Rosuvastatin|rosuvastatin
4854744|NCT02305849|ASP015K|asp015k
4854745|NCT02305849|Rheumatoid Arthritis|rheumatoid arthritis
4854746|NCT02305836|Electroacupuncture|electroacupuncture
4854747|NCT02305836|Donepezil|donepezil
4854748|NCT02305836|Alzheimer's disease|alzheimer's disease
4854749|NCT02305836|Randomized controlled trial|randomized controlled trial
4854750|NCT02305823|psychosis|psychosis
4854751|NCT02305823|antipsychotic agents|antipsychotic agents
4854752|NCT02305823|treatment|treatment
4854753|NCT02305823|effectiveness|effectiveness
4854754|NCT02305784|Cystic fibrosis|cystic fibrosis
4854755|NCT02305784|Pulmonary exacerbation|pulmonary exacerbation
4854756|NCT02305784|inflammation|inflammation
4854757|NCT02305784|Chitinase|chitinase
4854758|NCT02305784|cytokine|cytokine
4854759|NCT02305784|Cystic fibrosis related diabetes|cystic fibrosis related diabetes
4854760|NCT02305758|PARP inhibitor|parp inhibitor
4854761|NCT02305758|veliparib|veliparib
4854762|NCT02305758|metastatic colorectal cancer|metastatic colorectal cancer
4854763|NCT02305758|ABT-888|abt-888
4854764|NCT02305758|first line|first line
4854765|NCT02305758|previously untreated|previously untreated
4854766|NCT02305758|colorectal cancer|colorectal cancer
4854767|NCT02305758|colon cancer|colon cancer
4854768|NCT02305758|rectal cancer|rectal cancer
4854769|NCT02305758|FOLFIRI|folfiri
4854770|NCT02305758|fluorouracil|fluorouracil
4854771|NCT02305758|5-FU|5-fu
4854772|NCT02305758|leucovorin|leucovorin
4854773|NCT02305758|irinotecan|irinotecan
4854774|NCT02305732|Chikungunya virus|chikungunya virus
4854775|NCT02305732|CHIKV|chikv
4854776|NCT02305732|Dengue virus|dengue virus
4854777|NCT02305732|DENV|denv
4854778|NCT02305732|pathogen inactivation|pathogen inactivation
4854779|NCT02305732|platelets|platelets
4854780|NCT02305732|Puerto Rico|puerto rico
4854781|NCT02305706|insertion|insertion
4854782|NCT02305706|patient comfort|patient comfort
4854783|NCT02305667|Laryngoscope|laryngoscope
4854784|NCT02305667|Macintosh|macintosh
4854785|NCT02305667|Glidescope®|glidescope®
4854786|NCT02305667|King Vision™|king vision™
4854787|NCT02305667|Airtraq®|airtraq®
4854788|NCT02305667|intubation|intubation
4854789|NCT02305667|double lumen tube|double lumen tube
4854790|NCT02305654|Penis cancer|penis cancer
4854791|NCT02305654|Chemotherapy|chemotherapy
4854792|NCT02305654|Chemoradiotherapy|chemoradiotherapy
4854793|NCT02305654|Surgery|surgery
4854794|NCT02305654|Phase III|phase iii
4854795|NCT02305602|extracellular matrix|extracellular matrix
4854796|NCT02305589|postoperative delirium|postoperative delirium
4854797|NCT02305589|sugammadex|sugammadex
4854798|NCT02305589|cholinesterase inhibitor|cholinesterase inhibitor
4854799|NCT02305589|hip fracture surgery|hip fracture surgery
4854800|NCT02305550|Nitric Oxide|nitric oxide
4854801|NCT02305524|endotracheal intubation|endotracheal intubation
4854802|NCT02305511|Catheterization|catheterization
4854803|NCT02305511|Peripheral|peripheral
4854804|NCT02305498|Yoga|yoga
4854805|NCT02305498|14-059|14-059
4854806|NCT02305485|NeoVas|neovas
4854807|NCT02305485|Bioresorbable Coronary Scaffold|bioresorbable coronary scaffold
4854808|NCT02305485|Sirolimus|sirolimus
4854809|NCT02305485|Randomized Controlled Trial|randomized controlled trial
4854810|NCT02305472|NeoVas|neovas
4854811|NCT02305472|Bioresorbable Coronary Scaffold|bioresorbable coronary scaffold
4854812|NCT02305472|Sirolimus|sirolimus
4854813|NCT02305472|Registry Trial|registry trial
4854814|NCT02305459|SIRT|sirt
4854815|NCT02305459|microcatheter|microcatheter
4854816|NCT02305459|primary liver tumor|primary liver tumor
4854817|NCT02305459|secondary liver tumor|secondary liver tumor
4854818|NCT02305459|radioembolisation|radioembolisation
4854819|NCT02305459|QLQ-C30|qlq-c30
4854820|NCT02305459|CIRSE|cirse
4854821|NCT02305433|elderly|elderly
4854822|NCT02305433|functional-based physiotherapy|functional-based physiotherapy
4854823|NCT02305433|frailty syndrome|frailty syndrome
4854824|NCT02305433|osteoporotic hip fractures|osteoporotic hip fractures
4854825|NCT02305433|home-based physiotherapy|home-based physiotherapy
4854826|NCT02305433|home-dwelling|home-dwelling
4854827|NCT02305433|intervention|intervention
4854828|NCT02305433|randomised controlled trial|randomised controlled trial
4854829|NCT02305433|costs of social and health care|costs of social and health care
4854830|NCT02305433|quality of life|quality of life
4854831|NCT02305433|physical functioning|physical functioning
4854832|NCT02305433|mobility|mobility
4854833|NCT02305433|nutrition|nutrition
4854834|NCT02305394|ketamine|ketamine
4854835|NCT02305394|Electroconvulsive Therapy|electroconvulsive therapy
4854836|NCT02305394|Cognitive Function|cognitive function
4854837|NCT02305342|Uncomplicated UTI|uncomplicated uti
4854838|NCT02305342|Enoxacin|enoxacin
4854839|NCT02305303|Quality of life|quality of life
4854840|NCT02305303|post-traumatic stress disorder|post-traumatic stress disorder
4854841|NCT02305303|trauma|trauma
4854842|NCT02305238|Eylea,|eylea,
4854843|NCT02305238|Aflibercept|aflibercept
4854844|NCT02305238|Treat and Extend regimen|treat and extend regimen
4854845|NCT02305238|Age-related macular degeneration|age-related macular degeneration
4854846|NCT02305212|Working Memory|working memory
4854847|NCT02305199|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
4854848|NCT02305199|Hartmann's solution|hartmann's solution
4854849|NCT02305186|Immunotherapy|immunotherapy
4854850|NCT02305186|Neoadjuvant|neoadjuvant
4854851|NCT02305186|Resectable|resectable
4854852|NCT02305186|Borderline resectable|borderline resectable
4854853|NCT02305173|dexamethasone|dexamethasone
4854854|NCT02305173|pulmonary function|pulmonary function
4854855|NCT02305173|spirometry|spirometry
4854856|NCT02305173|mastectomy|mastectomy
4854857|NCT02305160|Respiratory distress syndrome|respiratory distress syndrome
4854858|NCT02305160|Pulmonary surfactant|pulmonary surfactant
4854859|NCT02305160|Mortality|mortality
4854860|NCT02305160|Prematurity|prematurity
4854861|NCT02305147|Parkinson Disease|parkinson disease
4854862|NCT02305147|Biomarkers|biomarkers
4854863|NCT02305147|Prognostic factors|prognostic factors
4854864|NCT02305147|Prodromal features|prodromal features
4854865|NCT02305147|Disease progression|disease progression
4854866|NCT02305134|Tipepidine, GIRK|tipepidine, girk
4854867|NCT02305121|Trochanteric fracture|trochanteric fracture
4854868|NCT02305121|Nail|nail
4854869|NCT02305121|Fracture reduction|fracture reduction
4854870|NCT02305121|Antirotation|antirotation
4854871|NCT02305121|trochanteric area with diaphyseal extension|trochanteric area with diaphyseal extension
4854872|NCT02305121|trochanteric area with femoral shaft|trochanteric area with femoral shaft
4854873|NCT02305043|non-interventional|non-interventional
4854874|NCT02305043|advanced gastric cancer|advanced gastric cancer
4854875|NCT02305043|Trastuzumab|trastuzumab
4854876|NCT02305043|HER2|her2
4854877|NCT02304991|Peanut|peanut
4854878|NCT02304991|Food Allergy|food allergy
4854879|NCT02304978|colorectal cancer|colorectal cancer
4854880|NCT02304978|Tissular factor|tissular factor
4854881|NCT02304978|TF|tf
4854882|NCT02304965|LVAD|lvad
4854883|NCT02304952|Lateral epicondylalgia|lateral epicondylalgia
4854884|NCT02304952|Pain|pain
4854885|NCT02304952|Function|function
4854886|NCT02304952|Physiotherapy|physiotherapy
4854887|NCT02304952|Quality of Life|quality of life
4854888|NCT02304939|Norepinephrine|norepinephrine
4854889|NCT02304939|Intensive Care|intensive care
4854890|NCT02304939|Changeovers|changeovers
4854891|NCT02304939|Smart pumps|smart pumps
4854892|NCT02304939|Quick change|quick change
4854893|NCT02304939|Double pumping|double pumping
4854894|NCT02304939|Shock|shock
4854895|NCT02304926|Dyslipidemia|dyslipidemia
4854896|NCT02304926|Simvastatin|simvastatin
4854897|NCT02304926|Ezetimibe|ezetimibe
4854898|NCT02304926|Lipid profile|lipid profile
4854899|NCT02304926|Inflammation|inflammation
4854900|NCT02304926|Oxidative stress|oxidative stress
4854901|NCT02304926|Endothelial function|endothelial function
4854902|NCT02304900|cataract|cataract
4854903|NCT02304887|Osteoporosis|osteoporosis
4854904|NCT02304887|Bone mineral densisty|bone mineral densisty
4854905|NCT02304887|Renal function|renal function
4854906|NCT02304887|CKD-MBD|ckd-mbd
4854907|NCT02304874|Ferritins|ferritins
4854908|NCT02304874|Iron Overload|iron overload
4854909|NCT02304874|Metabolic Syndrome|metabolic syndrome
4854910|NCT02304874|Venesection therapy|venesection therapy
4854911|NCT02304874|Volunteers|volunteers
4854912|NCT02304861|cataract|cataract
4854913|NCT02304861|viscoelastic (OVD) technology|viscoelastic (ovd) technology
4854914|NCT02304861|endothelial cell count|endothelial cell count
4854915|NCT02304861|endothelial cell pattern|endothelial cell pattern
4854916|NCT02304861|central corneal edema|central corneal edema
4854917|NCT02304848|Parkinson's Disease|parkinson's disease
4854918|NCT02304848|DBS|dbs
4854919|NCT02304848|Deep Brain Stimulation|deep brain stimulation
4854920|NCT02304848|Subthalamic Nucleus|subthalamic nucleus
4854921|NCT02304822|kidney stones|kidney stones
4854922|NCT02304822|retrograde intrarenal surgery|retrograde intrarenal surgery
4854923|NCT02304822|ciprofloxacin|ciprofloxacin
4854924|NCT02304822|prophylaxis|prophylaxis
4854925|NCT02304822|systemic inflammatory response syndrome|systemic inflammatory response syndrome
4854926|NCT02304809|metastatic or unresectable locally advanced malignancies.|metastatic or unresectable locally advanced malignancies.
4854927|NCT02304809|genomic alterations|genomic alterations
4854928|NCT02304809|biological vemurafenib targets BRAF|biological vemurafenib targets braf
4854929|NCT02304809|genomic.|genomic.
4854930|NCT02304796|Anxiety Disorders|anxiety disorders
4854931|NCT02304796|Group Psychotherapy|group psychotherapy
4854932|NCT02304796|Cognitive-Behavioral Therapy|cognitive-behavioral therapy
4854933|NCT02304796|Dance/Movement Therapy|dance/movement therapy
4854934|NCT02304796|CBT|cbt
4854935|NCT02304796|DMT|dmt
4854936|NCT02304796|Unified Protocol|unified protocol
4854937|NCT02304783|Renal colic, Piroxicam|renal colic, piroxicam
4854938|NCT02304757|differentiated thyroid cancer|differentiated thyroid cancer
4854939|NCT02304757|bone mineral density|bone mineral density
4854940|NCT02304757|thyroid stimulating hormone suppression|thyroid stimulating hormone suppression
4854941|NCT02304731|Physical Exercise, Atmospheric Pollution, Cognition.|physical exercise, atmospheric pollution, cognition.
4854942|NCT02304718|GDM|gdm
4854943|NCT02304718|pregnancy outcome|pregnancy outcome
4854944|NCT02304718|obesity|obesity
4854945|NCT02304718|exercise|exercise
4854946|NCT02304718|overweight|overweight
4854947|NCT02304640|fatigue|fatigue
4854948|NCT02304640|chemotherapy|chemotherapy
4854949|NCT02304640|breast cancer|breast cancer
4854950|NCT02304640|supportive care|supportive care
4854951|NCT02304640|Singapore|singapore
4854952|NCT02304523|Colonoscopy preparation|colonoscopy preparation
4854953|NCT02304523|Bowel cleansing|bowel cleansing
4854954|NCT02304523|Colon cleansing|colon cleansing
4854955|NCT02304523|Colonoscopy|colonoscopy
4854956|NCT02304523|CDFR0612|cdfr0612
4854957|NCT02304523|CDFR0613|cdfr0613
4854958|NCT02304510|Prevalence|prevalence
4854959|NCT02304510|Menorrhagia|menorrhagia
4854960|NCT02304497|Diabetes mellitus|diabetes mellitus
4854961|NCT02304497|Platelet rich fibrin|platelet rich fibrin
4854962|NCT02304497|growth factor|growth factor
4854963|NCT02304445|Radiotherapy|radiotherapy
4854964|NCT02304445|Chemoembolization|chemoembolization
4854965|NCT02304432|D-cycloserine|d-cycloserine
4854966|NCT02304432|Glycine|glycine
4854967|NCT02304432|Psychosis|psychosis
4854968|NCT02304432|Mutation|mutation
4854969|NCT02304432|GABA|gaba
4854970|NCT02304406|prevalence of ALK rearrangement, NSCLC, MENA|prevalence of alk rearrangement, nsclc, mena
4854971|NCT02304367|TIO|tio
4854972|NCT02304367|ENS|ens
4854973|NCT02304367|FGF23|fgf23
4854974|NCT02304367|KRN23|krn23
4854975|NCT02304354|rheumatoid arthritis|rheumatoid arthritis
4854976|NCT02304354|T lymphocytes|t lymphocytes
4854977|NCT02304354|rituximab|rituximab
4854978|NCT02304341|critical illness|critical illness
4854979|NCT02304341|disease progression|disease progression
4854980|NCT02304341|child|child
4854981|NCT02304341|severity of illness index|severity of illness index
4854982|NCT02304341|monitoring|monitoring
4854983|NCT02304328|SAH|sah
4854984|NCT02304328|WFNS|wfns
4854985|NCT02304328|hWFNS|hwfns
4854986|NCT02304328|grading|grading
4854987|NCT02304315|HBV-related liver transplantation|hbv-related liver transplantation
4854988|NCT02304315|Hepatitis B Immuno Globulin|hepatitis b immuno globulin
4854989|NCT02304302|Memantine|memantine
4854990|NCT02304302|Episodic Memory|episodic memory
4854991|NCT02304302|CVLT|cvlt
4854992|NCT02304302|Hippocampus dependent memory|hippocampus dependent memory
4854993|NCT02304302|Short-term memory|short-term memory
4854994|NCT02304263|tenofovir|tenofovir
4854995|NCT02304263|aging|aging
4854996|NCT02304263|renal function|renal function
4854997|NCT02304263|HIV|hiv
4854998|NCT02304263|frailty|frailty
4854999|NCT02304237|Premature Birth|premature birth
4855000|NCT02304237|progesterone|progesterone
4855001|NCT02304224|sepsis|sepsis
4855002|NCT02304224|melatonin|melatonin
4855003|NCT02304224|Human Leukocyte Antigen-DR|human leukocyte antigen-dr
4855004|NCT02304224|outcome|outcome
4855005|NCT02304211|Microdosing|microdosing
4855006|NCT02304211|Phase 0|phase 0
4855007|NCT02304211|Exploratory Investigational New Drug (IND)|exploratory investigational new drug (ind)
4855008|NCT02304211|Intra-Arterial|intra-arterial
4855009|NCT02304211|PET Imaging|pet imaging
4855010|NCT02304185|Healthy|healthy
4855011|NCT02304185|Acquired Immuno-Deficiency Syndrome|acquired immuno-deficiency syndrome
4855012|NCT02304185|Acquired Immunodeficiency Syndrome Virus|acquired immunodeficiency syndrome virus
4855013|NCT02304185|Glycoprotein|glycoprotein
4855014|NCT02304185|Adjuvant|adjuvant
4855015|NCT02304185|Vaccine|vaccine
4855016|NCT02304185|Placebo|placebo
4855017|NCT02304172|Thyroidectomy|thyroidectomy
4855018|NCT02304172|Thunderbeat|thunderbeat
4855019|NCT02304159|HCV|hcv
4855020|NCT02304159|Genotype 3|genotype 3
4855021|NCT02304159|Treatment naive|treatment naive
4855022|NCT02304159|Treatment experienced|treatment experienced
4855023|NCT02304146|Foam|foam
4855024|NCT02304146|UGFS|ugfs
4855025|NCT02304146|Stripping|stripping
4855026|NCT02304146|Incompetence|incompetence
4855027|NCT02304120|proprioception|proprioception
4855028|NCT02304120|postural control|postural control
4855029|NCT02304120|sensorimotor training|sensorimotor training
4855030|NCT02304120|uncontrolled manifold|uncontrolled manifold
4855031|NCT02304029|epilepsy|epilepsy
4855032|NCT02304029|seizures|seizures
4855033|NCT02304003|Shoulder tendinopathy|shoulder tendinopathy
4855034|NCT02304003|Subacromial impingement syndrome|subacromial impingement syndrome
4855035|NCT02304003|Rotator cuff tendinopathy|rotator cuff tendinopathy
4855036|NCT02304003|Supraspinatus tendinopathy|supraspinatus tendinopathy
4855037|NCT02303964|Trauma|trauma
4855038|NCT02303964|Hemorrhage|hemorrhage
4855039|NCT02303964|Plasma|plasma
4855040|NCT02303964|Shock|shock
4855041|NCT02303964|Polytrauma|polytrauma
4855042|NCT02303912|relapsed epithelial ovarian cancer,|relapsed epithelial ovarian cancer,
4855043|NCT02303912|relapsed fallopian tube cancer|relapsed fallopian tube cancer
4855044|NCT02303912|relapsed primary peritoneal cancer.|relapsed primary peritoneal cancer.
4855045|NCT02303860|Healthy volunteer study|healthy volunteer study
4855046|NCT02303808|Hyperosmolar agents|hyperosmolar agents
4855047|NCT02303808|Hypertonic saline|hypertonic saline
4855048|NCT02303808|Airway clearance techniques|airway clearance techniques
4855049|NCT02303808|Positive Expiratory Pressure|positive expiratory pressure
4855050|NCT02303808|Autogenic drainage|autogenic drainage
4855051|NCT02303795|bioprosthetic mitral valve|bioprosthetic mitral valve
4855052|NCT02303795|valvular heart disease|valvular heart disease
4855053|NCT02303795|anticoagulant agents|anticoagulant agents
4855054|NCT02303795|NOACs|noacs
4855055|NCT02303795|rivaroxaban|rivaroxaban
4855056|NCT02303795|warfarin|warfarin
4855057|NCT02303769|Lower Urinary Track Syndrome|lower urinary track syndrome
4855058|NCT02303769|Harnal|harnal
4855059|NCT02303769|Tamsulosin HCL 0.4mg|tamsulosin hcl 0.4mg
4855060|NCT02303743|Bowel preparation; colonoscopy; Smartphone application|bowel preparation; colonoscopy; smartphone application
4855061|NCT02303730|Diabetes|diabetes
4855062|NCT02303730|Non-alcoholic Fatty Liver Disease|non-alcoholic fatty liver disease
4855063|NCT02303717|Left main|left main
4855064|NCT02303717|PCI|pci
4855065|NCT02303717|DES|des
4855066|NCT02303704|Multiperfusion set|multiperfusion set
4855067|NCT02303704|Myocardial protection|myocardial protection
4855068|NCT02303704|Coronary Artery Bypass Grafting|coronary artery bypass grafting
4855069|NCT02303691|anxiety|anxiety
4855070|NCT02303691|attention bias modification|attention bias modification
4855071|NCT02303691|computer|computer
4855072|NCT02303678|D2C7|d2c7
4855073|NCT02303678|Randazzo|randazzo
4855074|NCT02303678|Bigner|bigner
4855075|NCT02303678|Pro00053325|pro00053325
4855076|NCT02303678|recurrent malignant glioma|recurrent malignant glioma
4855077|NCT02303665|TCM multi-channel therapy|tcm multi-channel therapy
4855078|NCT02303665|ART failure|art failure
4855079|NCT02303639|implantable cardioverter defibrillator|implantable cardioverter defibrillator
4855080|NCT02303639|antiarrhythmic medication|antiarrhythmic medication
4855081|NCT02303639|catheter ablation|catheter ablation
4855082|NCT02303626|BCX4161|bcx4161
4855083|NCT02303626|Prophylaxis|prophylaxis
4855084|NCT02303626|Prevention|prevention
4855085|NCT02303626|HAE|hae
4855086|NCT02303626|Hereditary Angioedema|hereditary angioedema
4855087|NCT02303600|Sub-acute cough|sub-acute cough
4855088|NCT02303587|Severe mycoplasma pneumoniae|severe mycoplasma pneumoniae
4855089|NCT02303587|pneumonia|pneumonia
4855090|NCT02303587|children|children
4855091|NCT02303574|AZD7986, Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, Food Effect, First-in-human, Single Ascending Dose, Multiple Ascending Dose, Healthy Subjects|azd7986, safety, tolerability, pharmacokinetics, pharmacodynamics, food effect, first-in-human, single ascending dose, multiple ascending dose, healthy subjects
4855092|NCT02303548|Sodium Bicarbonate|sodium bicarbonate
4855093|NCT02303535|Congenital heart disease|congenital heart disease
4855094|NCT02303535|European Paediatric Cardiac Code Short List|european paediatric cardiac code short list
4855594|NCT02301078|collagenase|collagenase
4855095|NCT02303535|Specific Procedure Definitions|specific procedure definitions
4855096|NCT02303535|OPCS|opcs
4855097|NCT02303535|paediatric|paediatric
4855098|NCT02303535|pediatric|pediatric
4855099|NCT02303522|ALL, pediatric, leukemia, childhood, lymphoblastic, lymphoma, acute, Precursor Cell|all, pediatric, leukemia, childhood, lymphoblastic, lymphoma, acute, precursor cell
4855100|NCT02303509|Healthy Subjects|healthy subjects
4855101|NCT02303509|Mild to moderate Psoriasis|mild to moderate psoriasis
4855102|NCT02303509|Subjects|subjects
4855103|NCT02303496|platelet rich plasma|platelet rich plasma
4855104|NCT02303470|Exercise|exercise
4855105|NCT02303457|CO2 laser surgery|co2 laser surgery
4855106|NCT02303457|open surgery|open surgery
4855107|NCT02303457|multicenter prospective|multicenter prospective
4855108|NCT02303457|randomized|randomized
4855109|NCT02303457|controlled clinical studies|controlled clinical studies
4855110|NCT02303457|T1N0 squamous cell carcinoma of glottis with anterior commissure involved|t1n0 squamous cell carcinoma of glottis with anterior commissure involved
4855111|NCT02303444|Progressive radioactive iodine refractory differentiated thyroid carcinoma|progressive radioactive iodine refractory differentiated thyroid carcinoma
4855112|NCT02303431|Pediatric|pediatric
4855113|NCT02303431|Pharmacokinetics (PK)|pharmacokinetics (pk)
4855114|NCT02303431|Pharmacodynamics (PDy)|pharmacodynamics (pdy)
4855115|NCT02303431|Anticoagulant|anticoagulant
4855116|NCT02303431|Safety|safety
4855117|NCT02303418|Obstetrics|obstetrics
4855118|NCT02303405|Glucose Control|glucose control
4855119|NCT02303405|Inflammation|inflammation
4855120|NCT02303379|Training Protocol|training protocol
4855121|NCT02303379|Cardiac Rehabilitation|cardiac rehabilitation
4855122|NCT02303379|High-Intensity Interval Training|high-intensity interval training
4855123|NCT02303379|Continuous Training|continuous training
4855124|NCT02303379|Pyramid Training|pyramid training
4855125|NCT02303379|Physical Performance|physical performance
4855126|NCT02303353|Breast cancer|breast cancer
4855127|NCT02303353|Ovarian cancer|ovarian cancer
4855128|NCT02303353|Lung cancer|lung cancer
4855129|NCT02303353|Colon cancer|colon cancer
4855130|NCT02303353|Gastric cancer|gastric cancer
4855131|NCT02303353|Pancreatic cancer|pancreatic cancer
4855132|NCT02303353|Rectum cancer|rectum cancer
4855133|NCT02303353|Plasmacytoma|plasmacytoma
4855134|NCT02303340|Cone Beam Computed Tomography|cone beam computed tomography
4855135|NCT02303340|Para Thyroid Hormone|para thyroid hormone
4855136|NCT02303340|Dual Energy X-ray Absorptiometry|dual energy x-ray absorptiometry
4855137|NCT02303340|Digital Imaging and Communication in Medicine|digital imaging and communication in medicine
4855138|NCT02303275|Heart Failure|heart failure
4855139|NCT02303275|Congestive Heart Failure|congestive heart failure
4855140|NCT02303275|Lifestyle Change|lifestyle change
4855141|NCT02303236|Exercise|exercise
4855142|NCT02303197|head and neck cancer|head and neck cancer
4855143|NCT02303197|chemoradiotherapy|chemoradiotherapy
4855144|NCT02303197|radioactive stomatitis|radioactive stomatitis
4855145|NCT02303184|RVO|rvo
4855146|NCT02303184|ME|me
4855147|NCT02303184|Central Subfield Thickness|central subfield thickness
4855148|NCT02303184|OCT|oct
4855149|NCT02303184|optical coherence tomography|optical coherence tomography
4855150|NCT02303184|cystoid macular edema|cystoid macular edema
4855151|NCT02303184|subretinal fluid|subretinal fluid
4855152|NCT02303184|Eylea|eylea
4855153|NCT02303184|aflibercept|aflibercept
4855154|NCT02303184|anti-VEGF|anti-vegf
4855155|NCT02303171|Antiphospholipid syndrome|antiphospholipid syndrome
4855156|NCT02303171|APS|aps
4855157|NCT02303171|Warfarin|warfarin
4855158|NCT02303158|Alzheimer's Disease|alzheimer's disease
4855159|NCT02303158|Biomarkers|biomarkers
4855160|NCT02303158|Depression|depression
4855161|NCT02303158|dementia|dementia
4855162|NCT02303158|cerebrospinal fluid|cerebrospinal fluid
4855163|NCT02303158|neuropsychological|neuropsychological
4855164|NCT02303145|Breast Cancer, Survivors|breast cancer, survivors
4855165|NCT02303119|LNH|lnh
4855166|NCT02303119|CD20+|cd20+
4855167|NCT02303119|follicular|follicular
4855168|NCT02303106|AUC exposure to lamotrigine|auc exposure to lamotrigine
4855169|NCT02303080|whey protein microgels|whey protein microgels
4855170|NCT02303080|thermogenesis|thermogenesis
4855171|NCT02303067|Cardiac|cardiac
4855172|NCT02303067|Computed Tomography|computed tomography
4855173|NCT02303067|Coronary Artery Disease|coronary artery disease
4855174|NCT02303054|Prostate Cancer|prostate cancer
4855175|NCT02303054|Focal Ablation|focal ablation
4855176|NCT02303054|MRI-US Fusion Biopsy|mri-us fusion biopsy
4855177|NCT02303054|Focal Therapy|focal therapy
4855178|NCT02303028|Pediatric|pediatric
4855179|NCT02303028|CNS Tumor|cns tumor
4855180|NCT02303028|Solid Tumour|solid tumour
4855181|NCT02303015|Germ cell cancer|germ cell cancer
4855182|NCT02303015|Late toxicity|late toxicity
4855183|NCT02303015|Renal impairment|renal impairment
4855184|NCT02303015|Cardiovascular disease|cardiovascular disease
4855185|NCT02302963|Diabetes Mellitus, Type 1 (T1DM)|diabetes mellitus, type 1 (t1dm)
4855186|NCT02302963|Diabetes Assistant (DiAs)|diabetes assistant (dias)
4855187|NCT02302963|Artificial Pancreas (AP) System|artificial pancreas (ap) system
4855188|NCT02302963|Closed-Loop Control (CLC)|closed-loop control (clc)
4855289|NCT02302547|dual therapy|dual therapy
4855189|NCT02302963|Unified Safety System (USS) Virginia|unified safety system (uss) virginia
4855190|NCT02302963|Sensor Augmented Pump (SAP)|sensor augmented pump (sap)
4855191|NCT02302963|Low Blood Glucose Index (LBGI)|low blood glucose index (lbgi)
4855192|NCT02302963|Continuous Glucose Monitor (CGM)|continuous glucose monitor (cgm)
4855193|NCT02302963|inControl Diabetes Management Platform|incontrol diabetes management platform
4855194|NCT02302950|HIV infection|hiv infection
4855195|NCT02302950|raltegravir use|raltegravir use
4855196|NCT02302950|women|women
4855197|NCT02302937|Inguinal Hernia|inguinal hernia
4855198|NCT02302937|Primary|primary
4855199|NCT02302937|laparoscopic surgery|laparoscopic surgery
4855200|NCT02302937|single port surgery|single port surgery
4855201|NCT02302911|Early intervention|early intervention
4855202|NCT02302898|Roux-en-Y Gastric Bypass Surgery|roux-en-y gastric bypass surgery
4855203|NCT02302898|Weight Regain|weight regain
4855204|NCT02302885|cancer-free 18-60 year old men and women|cancer-free 18-60 year old men and women
4855205|NCT02302859|Cancer Prevention|cancer prevention
4855206|NCT02302859|Tobacco Use Cessation|tobacco use cessation
4855207|NCT02302859|HIV-positive|hiv-positive
4855208|NCT02302859|Nicotine patch|nicotine patch
4855209|NCT02302859|NRT|nrt
4855210|NCT02302859|Questionnaire|questionnaire
4855211|NCT02302859|Survey|survey
4855212|NCT02302859|Smartphone|smartphone
4855213|NCT02302859|Counseling|counseling
4855214|NCT02302859|Saliva test|saliva test
4855215|NCT02302859|Saliva cotinine test|saliva cotinine test
4855216|NCT02302859|Nicotine replacement therapy|nicotine replacement therapy
4855217|NCT02302859|Smoking abstinence|smoking abstinence
4855218|NCT02302859|Aids|aids
4855219|NCT02302846|Leukemia|leukemia
4855220|NCT02302846|Acute myeloid leukemia|acute myeloid leukemia
4855221|NCT02302846|AML|aml
4855222|NCT02302846|High-risk myelodysplastic syndrome|high-risk myelodysplastic syndrome
4855223|NCT02302846|MDS|mds
4855224|NCT02302846|Ixazomib|ixazomib
4855225|NCT02302846|MLN9708|mln9708
4855226|NCT02302833|Neuroendocrine tumors|neuroendocrine tumors
4855227|NCT02302833|Pheochromocytomas|pheochromocytomas
4855228|NCT02302833|Paragangliomas|paragangliomas
4855229|NCT02302833|Unresectable|unresectable
4855230|NCT02302833|Metastatic|metastatic
4855231|NCT02302833|Cabozantinib|cabozantinib
4855232|NCT02302833|XL-184|xl-184
4855233|NCT02302833|XL184|xl184
4855234|NCT02302833|Questionnaire|questionnaire
4855235|NCT02302833|Survey|survey
4855236|NCT02302820|Advance Care Planning|advance care planning
4855237|NCT02302820|Nurse Care Coordination|nurse care coordination
4855238|NCT02302820|Comparative Effectiveness|comparative effectiveness
4855239|NCT02302820|Advance Directive|advance directive
4855240|NCT02302820|Decision Aides|decision aides
4855241|NCT02302781|Reasons for Dropout|reasons for dropout
4855242|NCT02302781|Subfertility|subfertility
4855243|NCT02302781|IVF|ivf
4855244|NCT02302781|NON IVF|non ivf
4855245|NCT02302742|Triple Negative Breast Cancer|triple negative breast cancer
4855246|NCT02302742|TNBC|tnbc
4855247|NCT02302742|Hereditary Breast and Ovarian Cancer|hereditary breast and ovarian cancer
4855248|NCT02302742|HBOC|hboc
4855249|NCT02302742|Prospective Registry|prospective registry
4855250|NCT02302729|Micronutrient intervention|micronutrient intervention
4855251|NCT02302729|Responsive feeding intervention|responsive feeding intervention
4855252|NCT02302729|School readiness intervention|school readiness intervention
4855253|NCT02302677|bile acids|bile acids
4855254|NCT02302677|sleeve gastrectomy|sleeve gastrectomy
4855255|NCT02302677|obesity|obesity
4855256|NCT02302677|GLP-1|glp-1
4855257|NCT02302677|FGF-19|fgf-19
4855258|NCT02302664|Achilles|achilles
4855259|NCT02302664|Platelet Rich Plasma|platelet rich plasma
4855260|NCT02302664|Patient reported outcome measure|patient reported outcome measure
4855261|NCT02302664|Orthopaedic trauma|orthopaedic trauma
4855262|NCT02302664|Musculoskeletal|musculoskeletal
4855263|NCT02302664|Tendon|tendon
4855264|NCT02302664|Sports Injury|sports injury
4855265|NCT02302664|Heel-Rise Endurance Test|heel-rise endurance test
4855266|NCT02302651|high intensity focused ultrasound|high intensity focused ultrasound
4855267|NCT02302651|osteoid osteoma|osteoid osteoma
4855268|NCT02302651|bone tumor|bone tumor
4855269|NCT02302638|single-step media|single-step media
4855270|NCT02302638|embryo development|embryo development
4855271|NCT02302638|blastocyst formation|blastocyst formation
4855272|NCT02302638|embryo utilization|embryo utilization
4855273|NCT02302625|Cognitive behavior therapy|cognitive behavior therapy
4855274|NCT02302612|chronic conditions|chronic conditions
4855275|NCT02302612|complex patients|complex patients
4855276|NCT02302612|engagement|engagement
4855277|NCT02302612|activation|activation
4855278|NCT02302586|Thoracic paravertebral block|thoracic paravertebral block
4855279|NCT02302586|Patient controlled analgesia|patient controlled analgesia
4855280|NCT02302586|Video Assisted Thoracoscopic Surgery|video assisted thoracoscopic surgery
4855281|NCT02302586|Postoperative acute pain|postoperative acute pain
4855282|NCT02302586|Chronic pain|chronic pain
4855283|NCT02302573|placenta accreta|placenta accreta
4855284|NCT02302573|contrast-enhanced unltrasound|contrast-enhanced unltrasound
4855285|NCT02302573|pregnancy|pregnancy
4855286|NCT02302573|MRI|mri
4855291|NCT02302547|virological control|virological control
4855292|NCT02302547|truvada®|truvada®
4855293|NCT02302534|scoliosis|scoliosis
4855294|NCT02302534|MRI (Magnetic Resonance Imaging)|mri (magnetic resonance imaging)
4855295|NCT02302521|MRI|mri
4855296|NCT02302508|pharmacokinetics|pharmacokinetics
4855297|NCT02302508|drug metabolism|drug metabolism
4855298|NCT02302508|platelet reactivity|platelet reactivity
4855299|NCT02302508|carboxylesterase|carboxylesterase
4855300|NCT02302508|cytochromes p450|cytochromes p450
4855301|NCT02302508|type 2 diabetes|type 2 diabetes
4855302|NCT02302508|active metabolite|active metabolite
4855303|NCT02302495|Carfilzomib weekly|carfilzomib weekly
4855304|NCT02302495|and Melphalan and Prednisone|and melphalan and prednisone
4855305|NCT02302482|Alzheimer's disease or related disorders|alzheimer's disease or related disorders
4855306|NCT02302482|Functional autonomy level|functional autonomy level
4855307|NCT02302482|Cognitive function|cognitive function
4855308|NCT02302482|Predictive factors|predictive factors
4855309|NCT02302469|Lenalidomide|lenalidomide
4855310|NCT02302469|Hematology|hematology
4855311|NCT02302469|Waldenstrom Macroglobulinemia|waldenstrom macroglobulinemia
4855312|NCT02302456|Immediate postpartum hemorrhage|immediate postpartum hemorrhage
4855313|NCT02302456|tranexamic acid|tranexamic acid
4855314|NCT02302456|prevention|prevention
4855315|NCT02302430|Cohesion|cohesion
4855316|NCT02302430|Oxytocin|oxytocin
4855317|NCT02302430|ROTC|rotc
4855318|NCT02302430|Virtual-reality|virtual-reality
4855319|NCT02302417|Asthma|asthma
4855320|NCT02302417|Asthma-COPD Overlap Syndrome|asthma-copd overlap syndrome
4855321|NCT02302417|Clinical Questionnaire|clinical questionnaire
4855322|NCT02302417|COPD|copd
4855323|NCT02302417|ACOS|acos
4855324|NCT02302404|FTIH|ftih
4855325|NCT02302404|pharmacodynamics|pharmacodynamics
4855326|NCT02302404|pharmacokinetics|pharmacokinetics
4855327|NCT02302404|GSK2982772|gsk2982772
4855328|NCT02302404|safety|safety
4855329|NCT02302404|Repeat dose|repeat dose
4855330|NCT02302404|tolerability|tolerability
4855331|NCT02302378|Hypotension|hypotension
4855332|NCT02302378|Anesthesia, Spinal [E03.155.086.331]|anesthesia, spinal [e03.155.086.331]
4855333|NCT02302365|white blood cell depletion|white blood cell depletion
4855334|NCT02302365|apheresis|apheresis
4855335|NCT02302352|Probiotics|probiotics
4855336|NCT02302352|Immune system|immune system
4855337|NCT02302339|Advanced melanoma|advanced melanoma
4855338|NCT02302339|Unresectable melanoma|unresectable melanoma
4855339|NCT02302339|Metastatic melanoma|metastatic melanoma
4855340|NCT02302339|Targeted Treatment for melanoma|targeted treatment for melanoma
4855341|NCT02302339|GPNMB|gpnmb
4855342|NCT02302339|CDX-011|cdx-011
4855343|NCT02302339|Glembatumumab vedotin|glembatumumab vedotin
4855344|NCT02302339|Antibody-drug-conjugate|antibody-drug-conjugate
4855345|NCT02302339|Skin neoplasm|skin neoplasm
4855346|NCT02302339|Varlilumab|varlilumab
4855347|NCT02302339|CDX-1127|cdx-1127
4855348|NCT02302326|reticulum endoplasmic stress|reticulum endoplasmic stress
4855349|NCT02302326|Polycystic Ovary Syndrome|polycystic ovary syndrome
4855350|NCT02302326|mitochondrial function|mitochondrial function
4855351|NCT02302326|insulin resistance|insulin resistance
4855352|NCT02302326|inflammation|inflammation
4855353|NCT02302326|myoinositol|myoinositol
4855354|NCT02302326|metformin|metformin
4855355|NCT02302326|oxidative stress|oxidative stress
4855356|NCT02302313|healthy volunteers|healthy volunteers
4855357|NCT02302313|critical awareness|critical awareness
4855358|NCT02302313|hypnosis|hypnosis
4855359|NCT02302313|Analgesia Nociception Index|analgesia nociception index
4855360|NCT02302313|numerical verbal scale|numerical verbal scale
4855361|NCT02302313|Determine the validity of the index (ANI)|determine the validity of the index (ani)
4855362|NCT02302313|nociception in critical awareness|nociception in critical awareness
4855363|NCT02302300|Cardiac surgery|cardiac surgery
4855364|NCT02302300|Preventive non-invasive ventilation|preventive non-invasive ventilation
4855365|NCT02302287|Chronic kidney disease|chronic kidney disease
4855366|NCT02302287|mediterranean diet|mediterranean diet
4855367|NCT02302287|low-protein diet|low-protein diet
4855368|NCT02302287|ketoacids|ketoacids
4855369|NCT02302287|intestinal microbiota|intestinal microbiota
4855370|NCT02302274|Brugada Syndrome|brugada syndrome
4855371|NCT02302274|ARVC|arvc
4855372|NCT02302274|flecainide|flecainide
4855373|NCT02302274|ST elevation|st elevation
4855374|NCT02302261|Pulsus paradoxus|pulsus paradoxus
4855375|NCT02302235|Glioblastoma multigorme|glioblastoma multigorme
4855376|NCT02302235|Ketogenic Diet|ketogenic diet
4855377|NCT02302235|radiotherapy|radiotherapy
4855378|NCT02302235|chemotherapy|chemotherapy
4855379|NCT02302235|safety|safety
4855380|NCT02302235|efficiency|efficiency
4855381|NCT02302209|oxytocin|oxytocin
4855382|NCT02302209|schizophrenia|schizophrenia
4855383|NCT02302209|autism spectrum disorder|autism spectrum disorder
4855384|NCT02302183|Hypoxemic, Respiratory distress, infant|hypoxemic, respiratory distress, infant
4855385|NCT02302157|Cervical spinal cord injury|cervical spinal cord injury
4855386|NCT02302157|AST-OPC1|ast-opc1
4855387|NCT02302157|SCiStar|scistar
4855388|NCT02302157|OPC1|opc1
4855389|NCT02302157|Neural cell|neural cell
4855390|NCT02302157|Trauma spinal cord|trauma spinal cord
4855391|NCT02302157|stemcell transplant|stemcell transplant
4855392|NCT02302157|Cervical spine injury|cervical spine injury
4855393|NCT02302157|Paralysis|paralysis
4855394|NCT02302157|Quadriplegia|quadriplegia
4855395|NCT02302157|Tetraplegia|tetraplegia
4855396|NCT02302157|Spine injury|spine injury
4855397|NCT02302157|oligodendrocyte progenitor cell|oligodendrocyte progenitor cell
4855398|NCT02302157|Subacute spinal cord injury|subacute spinal cord injury
4855399|NCT02302144|Postural Instability (falling)|postural instability (falling)
4855400|NCT02302144|Gait Disturbances (e.g., freezing)|gait disturbances (e.g., freezing)
4855401|NCT02302144|Bradykinesia (slowness of movement), rigidity|bradykinesia (slowness of movement), rigidity
4855402|NCT02302118|esophageal carcinoma|esophageal carcinoma
4855403|NCT02302118|kardia carcinoma|kardia carcinoma
4855404|NCT02302092|Drug Therapy|drug therapy
4855405|NCT02302079|ASP8232|asp8232
4855406|NCT02302079|Diabetes Mellitus|diabetes mellitus
4855407|NCT02302079|ranibizumab|ranibizumab
4855408|NCT02302079|Diabetic Macular Edema|diabetic macular edema
4855409|NCT02302066|Drug therapy|drug therapy
4855410|NCT02302053|Hair thinning, hair loss, alopecia, women, oral supplement|hair thinning, hair loss, alopecia, women, oral supplement
4855411|NCT02302040|Adolescent|adolescent
4855412|NCT02302027|withdrawal therapy|withdrawal therapy
4855413|NCT02302027|oxygen therapy|oxygen therapy
4855414|NCT02302001|Breast augmentation|breast augmentation
4855415|NCT02302001|Breast implants|breast implants
4855416|NCT02302001|Silicone implants|silicone implants
4855417|NCT02302001|Breast surgery|breast surgery
4855418|NCT02301975|Adult|adult
4855419|NCT02301975|asthma|asthma
4855420|NCT02301975|Fluticasone Propionate|fluticasone propionate
4855421|NCT02301975|Adolescents|adolescents
4855422|NCT02301975|Salmeterol|salmeterol
4855423|NCT02301975|Vilanterol|vilanterol
4855424|NCT02301975|ELLIPTA|ellipta
4855425|NCT02301975|ACCUHALER/DISKUS|accuhaler/diskus
4855426|NCT02301975|Non-inferior|non-inferior
4855427|NCT02301975|Fluticasone Furoate|fluticasone furoate
4855428|NCT02301962|panitumumab|panitumumab
4855429|NCT02301962|previously treated|previously treated
4855430|NCT02301962|metastatic colorectal cancer|metastatic colorectal cancer
4855431|NCT02301962|fully human antibody|fully human antibody
4855432|NCT02301962|wild-type KRAS and wild-type NRAS|wild-type kras and wild-type nras
4855433|NCT02301949|gastrointestinal bleeding|gastrointestinal bleeding
4855434|NCT02301949|vascular malformation|vascular malformation
4855435|NCT02301949|thalidomide retreatment|thalidomide retreatment
4855436|NCT02301936|Sickle Cell Disease|sickle cell disease
4855437|NCT02301936|Gilead|gilead
4855438|NCT02301936|Hepatitis C|hepatitis c
4855439|NCT02301923|Continuous Positive Airway Pressure|continuous positive airway pressure
4855440|NCT02301910|Myocardial Infarction|myocardial infarction
4855441|NCT02301910|Fibrinolysis|fibrinolysis
4855442|NCT02301910|Fortelyzin|fortelyzin
4855443|NCT02301871|MNP|mnp
4855444|NCT02301871|MET|met
4855445|NCT02301871|Soft tissue mobilization|soft tissue mobilization
4855446|NCT02301871|DNF|dnf
4855447|NCT02301871|Static Stretching|static stretching
4855448|NCT02301858|molecular pathology|molecular pathology
4855449|NCT02301858|functional genomics|functional genomics
4855450|NCT02301858|lung cancer|lung cancer
4855451|NCT02301858|primary tumor|primary tumor
4855452|NCT02301858|metastases|metastases
4855453|NCT02301845|Respiration, artificial|respiration, artificial
4855454|NCT02301832|acute compartment swelling (ACS)|acute compartment swelling (acs)
4855455|NCT02301832|near-infrared spectroscopy (NIRS)|near-infrared spectroscopy (nirs)
4855456|NCT02301767|MRI|mri
4855457|NCT02301767|Risk Factor|risk factor
4855458|NCT02301767|background Parenchymal Enhancement|background parenchymal enhancement
4855459|NCT02301767|(IMAGINE) Study|(imagine) study
4855460|NCT02301741|chronic low back pain|chronic low back pain
4855461|NCT02301728|breast milk|breast milk
4855462|NCT02301728|short chain fatty acids|short chain fatty acids
4855463|NCT02301728|maternal diet|maternal diet
4855464|NCT02301715|Intranasal oxytocin|intranasal oxytocin
4855465|NCT02301715|Emotion regulation|emotion regulation
4855466|NCT02301715|Attachment|attachment
4855467|NCT02301702|Maternal Immunization|maternal immunization
4855468|NCT02301702|Tdap|tdap
4855469|NCT02301702|Td|td
4855470|NCT02301702|Pertussis|pertussis
4855471|NCT02301689|Heart failure|heart failure
4855472|NCT02301689|Chronic heart failure|chronic heart failure
4855473|NCT02301689|Sleep disordered breathing|sleep disordered breathing
4855474|NCT02301689|Sleep apnea|sleep apnea
4855475|NCT02301689|Positive Airway Pressure|positive airway pressure
4855476|NCT02301676|Geriatrics; Cognitive impairment; Interviews, Telephone|geriatrics; cognitive impairment; interviews, telephone
4855477|NCT02301650|Hepatitis B virus|hepatitis b virus
4855478|NCT02301650|pregnancy|pregnancy
4855479|NCT02301650|nucleoside (acid) analogs|nucleoside (acid) analogs
4855480|NCT02301650|children|children
4855481|NCT02301650|safety|safety
4855482|NCT02301624|gMG|gmg
4855483|NCT02301624|Myasthenia Gravis|myasthenia gravis
4855484|NCT02301624|safety|safety
4855485|NCT02301624|efficacy|efficacy
4855486|NCT02301598|femtosecond laser|femtosecond laser
4855487|NCT02301598|anterior lamellar keratoplasty|anterior lamellar keratoplasty
4855488|NCT02301598|atomic-force microscopy|atomic-force microscopy
4855489|NCT02301585|shock, septic|shock, septic
4855490|NCT02301585|hemodynamics|hemodynamics
4855491|NCT02301585|algorithms|algorithms
4855492|NCT02301533|HIV infection|hiv infection
4855493|NCT02301533|antiretroviral therapy|antiretroviral therapy
4855494|NCT02301533|adherence|adherence
4855495|NCT02301533|men who have sex with men|men who have sex with men
4855496|NCT02301520|Vitamin D|vitamin d
4855497|NCT02301520|Iodine|iodine
4855498|NCT02301520|Lead|lead
4855499|NCT02301520|Thyroid function|thyroid function
4855500|NCT02301520|point-of-care test|point-of-care test
4855501|NCT02301494|CTCL|ctcl
4855502|NCT02301494|Mycosis Fungoides|mycosis fungoides
4855503|NCT02301494|Cutaneous T-cell Lymphoma|cutaneous t-cell lymphoma
4855504|NCT02301494|MF|mf
4855505|NCT02301494|topical therapy|topical therapy
4855506|NCT02301494|early stage|early stage
4855507|NCT02301455|hypertension treatment|hypertension treatment
4855508|NCT02301455|stroke prevention|stroke prevention
4855509|NCT02301403|smoking|smoking
4855510|NCT02301403|cessation|cessation
4855511|NCT02301403|tobacco|tobacco
4855512|NCT02301390|INTERVENE|intervene
4855513|NCT02301390|Ventricular tachycardia|ventricular tachycardia
4855514|NCT02301390|India|india
4855515|NCT02301364|Buparlisib (BKM120)|buparlisib (bkm120)
4855516|NCT02301364|14-177|14-177
4855517|NCT02301338|Videoconferencing|videoconferencing
4855518|NCT02301338|Following Surgery|following surgery
4855519|NCT02301338|14-213|14-213
4855520|NCT02301299|stroke|stroke
4855521|NCT02301299|barriers|barriers
4855522|NCT02301299|community|community
4855523|NCT02301286|Acetylsalicylic acid|acetylsalicylic acid
4855524|NCT02301286|Colon cancer|colon cancer
4855525|NCT02301286|Survival|survival
4855526|NCT02301273|Intensive care unit|intensive care unit
4855527|NCT02301273|Physiotherapy|physiotherapy
4855528|NCT02301273|Upright position|upright position
4855529|NCT02301273|Exercise|exercise
4855530|NCT02301273|Long term follow up of ICU survivors|long term follow up of icu survivors
4855531|NCT02301260|Processing Speed|processing speed
4855532|NCT02301260|Intervention|intervention
4855533|NCT02301260|Multiple Sclerosis|multiple sclerosis
4855534|NCT02301260|Cognition|cognition
4855535|NCT02301247|Multiple Sclerosis, Progressive|multiple sclerosis, progressive
4855536|NCT02301247|cognition|cognition
4855537|NCT02301247|memory|memory
4855538|NCT02301247|treatment|treatment
4855539|NCT02301234|Osteoarthritis|osteoarthritis
4855540|NCT02301234|Pain|pain
4855541|NCT02301234|Fulranumab|fulranumab
4855542|NCT02301234|JNJ-42160443|jnj-42160443
4855543|NCT02301234|Adjunctive therapy|adjunctive therapy
4855544|NCT02301234|Celecoxib|celecoxib
4855545|NCT02301234|Hip|hip
4855546|NCT02301234|Knee|knee
4855547|NCT02301234|Joint replacement surgery|joint replacement surgery
4855548|NCT02301221|Fecal Microbiota Transplantation|fecal microbiota transplantation
4855549|NCT02301221|Slow Transit Constipation|slow transit constipation
4855550|NCT02301221|Colonic motility|colonic motility
4855551|NCT02301195|Therapeutic Horseback Riding|therapeutic horseback riding
4855552|NCT02301169|Pain|pain
4855553|NCT02301143|Pancreatic Neoplasms|pancreatic neoplasms
4855554|NCT02301143|Pancreatic Cancer|pancreatic cancer
4855555|NCT02301143|Locally advanced pacriatic cancer|locally advanced pacriatic cancer
4855556|NCT02301143|nab-Paclitaxel|nab-paclitaxel
4855557|NCT02301143|Abraxane|abraxane
4855558|NCT02301143|Gemcitabine|gemcitabine
4855559|NCT02301143|ABI-007|abi-007
4855560|NCT02301130|advanced solid tumors|advanced solid tumors
4855561|NCT02301130|solid tumors|solid tumors
4855562|NCT02301130|mogamulizumab|mogamulizumab
4855563|NCT02301130|MEDI4736 (Durvalumab)|medi4736 (durvalumab)
4855564|NCT02301130|Tremelimumab|tremelimumab
4855565|NCT02301130|POTELIGEO®|poteligeo®
4855566|NCT02301130|KW-0761|kw-0761
4855567|NCT02301117|Renal|renal
4855568|NCT02301117|Kidney Diseases|kidney diseases
4855569|NCT02301117|Urologic Diseases|urologic diseases
4855570|NCT02301117|Renal Insufficiency|renal insufficiency
4855571|NCT02301117|Renal Impairment|renal impairment
4855572|NCT02301117|Pharmacokinetics|pharmacokinetics
4855573|NCT02301117|Advance Solid Tumor|advance solid tumor
4855574|NCT02301117|Creatinine Clearance|creatinine clearance
4855575|NCT02301117|Kidney Neoplasms|kidney neoplasms
4855576|NCT02301117|Renal Tumor|renal tumor
4855577|NCT02301117|Kidney|kidney
4855578|NCT02301117|Urology|urology
4855579|NCT02301117|Pharmacologic Action|pharmacologic action
4855580|NCT02301104|Liver Neoplasms|liver neoplasms
4855581|NCT02301104|Hepatic|hepatic
4855582|NCT02301104|TAS-102|tas-102
4855583|NCT02301104|mCRC|mcrc
4855584|NCT02301104|Liver Impairment|liver impairment
4855585|NCT02301104|Pharmacologic Actions|pharmacologic actions
4855586|NCT02301104|Liver Diseases|liver diseases
4855587|NCT02301104|Liver|liver
4855589|NCT02301104|Advanced Solid Tumor|advanced solid tumor
4855590|NCT02301104|Pharmacokinetics|pharmacokinetics
4855591|NCT02301091|HCC PVTT TACE RFA|hcc pvtt tace rfa
4855592|NCT02301078|Dupuytren disease|dupuytren disease
4855593|NCT02301078|needle aponeurotomy|needle aponeurotomy
4855595|NCT02301065|Viral|viral
4855596|NCT02301065|Infection|infection
4855597|NCT02301065|Allogeneic Stem Cell Transplant|allogeneic stem cell transplant
4855598|NCT02301052|hemorrhoids|hemorrhoids
4855599|NCT02301052|Allium Ampeloprasum|allium ampeloprasum
4855600|NCT02301052|herbal medicine|herbal medicine
4855601|NCT02301052|traditional persian medicine|traditional persian medicine
4855602|NCT02301000|Clostridium difficile|clostridium difficile
4855603|NCT02301000|Intestinal microbiota therapy|intestinal microbiota therapy
4855604|NCT02300987|Teratoma,|teratoma,
4855605|NCT02300987|Germ Cell tumor,|germ cell tumor,
4855606|NCT02300987|incurable teratoma,|incurable teratoma,
4855607|NCT02300987|CDK4/6,|cdk4/6,
4855608|NCT02300987|LEE011|lee011
4855609|NCT02300948|Pregnancy|pregnancy
4855610|NCT02300948|Perinatal Vitamins|perinatal vitamins
4855611|NCT02300948|folate|folate
4855612|NCT02300935|trametinib|trametinib
4855613|NCT02300935|nab-paclitaxel|nab-paclitaxel
4855614|NCT02300935|Mekinist|mekinist
4855615|NCT02300935|Abraxane|abraxane
4855616|NCT02300935|unresectable|unresectable
4855617|NCT02300935|metastatic|metastatic
4855618|NCT02300896|exercise|exercise
4855619|NCT02300896|physical fitness|physical fitness
4855620|NCT02300896|geriatrics|geriatrics
4855621|NCT02300870|Acute rejection, myocardial blood flow|acute rejection, myocardial blood flow
4855622|NCT02300831|NSCLC|nsclc
4855623|NCT02300831|Lung Cancer|lung cancer
4855624|NCT02300831|SELECT-1|select-1
4855625|NCT02300831|SELECT-2|select-2
4855626|NCT02300831|selumetinib|selumetinib
4855627|NCT02300831|biomarker|biomarker
4855628|NCT02300831|NIS|nis
4855629|NCT02300831|Observational study|observational study
4855630|NCT02300831|Disease registry|disease registry
4855631|NCT02300831|Clinical Outcomes|clinical outcomes
4855632|NCT02300818|Hipertension ocular, Glaucoma, Magnetotherapy, seawater|hipertension ocular, glaucoma, magnetotherapy, seawater
4855633|NCT02300805|Endometrial volume , VOCAL , Endometrial , Metrorrhagia|endometrial volume , vocal , endometrial , metrorrhagia
4855634|NCT02300792|honey, hepatitis A|honey, hepatitis a
4855635|NCT02300779|Colonoscopy|colonoscopy
4855636|NCT02300779|Diabetes Mellitus|diabetes mellitus
4855637|NCT02300779|Diet|diet
4855638|NCT02300779|Polyethylene glycols|polyethylene glycols
4855639|NCT02300779|Efficacy|efficacy
4855640|NCT02300779|Personal satisfaction|personal satisfaction
4855641|NCT02300766|Cerebellar Mutism Syndrome|cerebellar mutism syndrome
4855642|NCT02300766|Posterior Fossa Tumor|posterior fossa tumor
4855643|NCT02300766|Pediatric cancer|pediatric cancer
4855644|NCT02300766|Neurosurgical techniques|neurosurgical techniques
4855645|NCT02300727|Mucositis|mucositis
4855646|NCT02300727|Neoplasms|neoplasms
4855647|NCT02300727|CANCER|cancer
4855648|NCT02300727|Curcumin|curcumin
4855649|NCT02300727|Drug Therapy|drug therapy
4855650|NCT02300727|ANTINEOPLASTIC AGENTS|antineoplastic agents
4855651|NCT02300675|therapeutic patient education|therapeutic patient education
4855652|NCT02300675|patient adherence|patient adherence
4855653|NCT02300675|empowerment|empowerment
4855654|NCT02300675|breast cancer|breast cancer
4855655|NCT02300675|oral adjuvant endocrine therapy|oral adjuvant endocrine therapy
4855656|NCT02300675|side effects|side effects
4855657|NCT02300636|Knee joint|knee joint
4855658|NCT02300636|Muscle strength|muscle strength
4855659|NCT02300636|anterior cruciate ligament|anterior cruciate ligament
4855660|NCT02300610|Ureteral Diseases|ureteral diseases
4855661|NCT02300610|Urinary Bladder Diseases|urinary bladder diseases
4855662|NCT02300610|Transitional Cell Carcinoma|transitional cell carcinoma
4855663|NCT02300610|Bladder|bladder
4855664|NCT02300610|Carcinoma|carcinoma
4855665|NCT02300610|Renal|renal
4855666|NCT02300610|Pelvis|pelvis
4855667|NCT02300610|Ureter|ureter
4855668|NCT02300610|Urethra|urethra
4855669|NCT02300597|ADHD|adhd
4855670|NCT02300597|Autism Spectrum Disorders|autism spectrum disorders
4855671|NCT02300597|controlled|controlled
4855672|NCT02300597|Internet based|internet based
4855673|NCT02300597|coaching|coaching
4855674|NCT02300558|Type 3 long QT syndrome (LQT3)|type 3 long qt syndrome (lqt3)
4855675|NCT02300558|Long QT syndrome|long qt syndrome
4855676|NCT02300558|Congenital long QT|congenital long qt
4855677|NCT02300558|Sudden cardiac death|sudden cardiac death
4855678|NCT02300532|Malignant Glioma|malignant glioma
4855679|NCT02300532|Glioblastoma Multiforme|glioblastoma multiforme
4855680|NCT02300519|Haemophilia|haemophilia
4855681|NCT02300519|numerical models|numerical models
4855682|NCT02300519|thrombin generation|thrombin generation
4855683|NCT02300519|volunteers|volunteers
4855684|NCT02300519|endogenous thrombin potential|endogenous thrombin potential
4855685|NCT02300506|Malignant Glioma|malignant glioma
4855686|NCT02300506|Glioblastoma multiforme|glioblastoma multiforme
4855687|NCT02300493|among college students|among college students
4855688|NCT02300480|pain|pain
4855689|NCT02300480|calot's triangle|calot's triangle
4855690|NCT02300480|local block|local block
4855691|NCT02300480|analgesia|analgesia
4855692|NCT02300480|patient controlled intravenous analgesia|patient controlled intravenous analgesia
4855693|NCT02300454|in-stent restenosis|in-stent restenosis
4855694|NCT02300454|percutaneous coronary intervention|percutaneous coronary intervention
4855695|NCT02300454|balloon|balloon
4855696|NCT02300428|iron deficiency|iron deficiency
4855697|NCT02300389|high risk prostate cancer radiotherapy hypofractionation|high risk prostate cancer radiotherapy hypofractionation
4855698|NCT02300376|GFR|gfr
4855699|NCT02300376|Bayesian model|bayesian model
4855700|NCT02300376|plasma clearance|plasma clearance
4855701|NCT02300376|Calcium edetate de sodium|calcium edetate de sodium
4855702|NCT02300376|Inulin|inulin
4855703|NCT02300337|laryngeal tube|laryngeal tube
4855704|NCT02300337|cuff pressure|cuff pressure
4855705|NCT02300337|leakage|leakage
4855706|NCT02300337|laryngeal mask|laryngeal mask
4855707|NCT02300324|bioavailability|bioavailability
4855708|NCT02300324|Beneforte|beneforte
4855709|NCT02300324|sulforaphane|sulforaphane
4855710|NCT02300272|Practice-related learning|practice-related learning
4855711|NCT02300272|Sleep|sleep
4855712|NCT02300272|Pain|pain
4855713|NCT02300272|Circadian Rhythm|circadian rhythm
4855714|NCT02300272|Older Adults|older adults
4855715|NCT02300246|alveolar socket preservation|alveolar socket preservation
4855716|NCT02300246|tooth extraction|tooth extraction
4855717|NCT02300246|platelet concentrates|platelet concentrates
4855718|NCT02300246|growth factors|growth factors
4855719|NCT02300207|Electroacupuncture|electroacupuncture
4855720|NCT02300207|Cardiovascular function|cardiovascular function
4855721|NCT02300207|Orthostatic tolerance|orthostatic tolerance
4855722|NCT02300207|Head-down bed rest|head-down bed rest
4855723|NCT02300194|Pain management|pain management
4855724|NCT02300168|bariatric surgery; neuromuscular blockade|bariatric surgery; neuromuscular blockade
4855725|NCT02300155|Pregnancy|pregnancy
4855726|NCT02300155|Morning Sickness|morning sickness
4855727|NCT02300155|nausea and vomiting|nausea and vomiting
4855728|NCT02300155|hyperemesis gravidarum|hyperemesis gravidarum
4855729|NCT02300155|perinatal vitamins|perinatal vitamins
4855730|NCT02300142|HSV|hsv
4855731|NCT02300142|Herpes|herpes
4855732|NCT02300142|genital infection|genital infection
4855733|NCT02300142|vaccine|vaccine
4855734|NCT02300090|COPD, Exacerbation, respiratory disease, lung disease, breathlessness, dyspnoea, sputum, wheezing, cough|copd, exacerbation, respiratory disease, lung disease, breathlessness, dyspnoea, sputum, wheezing, cough
4855735|NCT02300077|fentanyl, morphine|fentanyl, morphine
4855736|NCT02300077|methadone|methadone
4855737|NCT02300051|Compulsive sexual behavior|compulsive sexual behavior
4855738|NCT02300051|Intervention|intervention
4855739|NCT02300051|Short term psychodynamic group psychotherapy|short term psychodynamic group psychotherapy
4855740|NCT02300051|Sexual addiction|sexual addiction
4855741|NCT02300051|Hypersexual behavior|hypersexual behavior
4855742|NCT02300012|Anterior cruciate ligament|anterior cruciate ligament
4855743|NCT02300012|Performance based investigations|performance based investigations
4855744|NCT02299973|irritable bowel syndrome|irritable bowel syndrome
4855745|NCT02299973|fecal microbiota transplantation|fecal microbiota transplantation
4855746|NCT02299973|bloating|bloating
4855747|NCT02299960|EndoPAT|endopat
4855748|NCT02299960|NICOM|nicom
4855749|NCT02299960|circulating endothelial cells|circulating endothelial cells
4855750|NCT02299908|Hernia, Inguinal|hernia, inguinal
4855751|NCT02299908|Herniorrhaphy|herniorrhaphy
4855752|NCT02299908|Abdominal Wall|abdominal wall
4855753|NCT02299908|Analgesia|analgesia
4855754|NCT02299908|Pain, Postoperative|pain, postoperative
4855755|NCT02299895|setting approach|setting approach
4855756|NCT02299895|health promotion|health promotion
4855757|NCT02299895|organization|organization
4855758|NCT02299895|implementation research|implementation research
4855759|NCT02299895|qualitative study|qualitative study
4855760|NCT02299895|comparison|comparison
4855761|NCT02299882|Posterior spine surgery|posterior spine surgery
4855762|NCT02299882|infection|infection
4855763|NCT02299882|vancomycin|vancomycin
4855764|NCT02299882|surgical wound infection|surgical wound infection
4855765|NCT02299856|Magnetic Resonance Imaging|magnetic resonance imaging
4855766|NCT02299856|Diagnostic Imaging|diagnostic imaging
4855767|NCT02299843|RFA|rfa
4855768|NCT02299843|ALPPS|alpps
4855769|NCT02299843|hepatectomy|hepatectomy
4855770|NCT02299843|morbidity and mortality|morbidity and mortality
4855771|NCT02299830|neoplasm|neoplasm
4855772|NCT02299830|central airway|central airway
4855773|NCT02299830|obstruction|obstruction
4855774|NCT02299791|clinic-level interventions|clinic-level interventions
4855775|NCT02299791|quality improvement|quality improvement
4855776|NCT02299791|translational medical research|translational medical research
4855777|NCT02299791|community health centers|community health centers
4855778|NCT02299765|Advanced Non-small Cell Lung Cancer (NSCLC)|advanced non-small cell lung cancer (nsclc)
4855779|NCT02299765|EGFR Mutation|egfr mutation
4855780|NCT02299765|gefitinib|gefitinib
4855781|NCT02299765|chemotherapy|chemotherapy
4855782|NCT02299739|Herbal Medicine|herbal medicine
4855783|NCT02299739|Complementary Therapies|complementary therapies
4855784|NCT02299739|Liver Function Tests|liver function tests
4855785|NCT02299739|Risk Factors|risk factors
4855786|NCT02299726|acute heart failure|acute heart failure
4855787|NCT02299726|MRA|mra
4855788|NCT02299726|emergency department|emergency department
4855789|NCT02299713|acupuncture|acupuncture
4855790|NCT02299713|knee pain|knee pain
4855791|NCT02299700|Janssen Autism Knowledge Engine|janssen autism knowledge engine
4855792|NCT02299700|Autism Spectrum Disorder|autism spectrum disorder
4855793|NCT02299661|Hypoxia inducible factor prolyl hydroxylase inhibitor.|hypoxia inducible factor prolyl hydroxylase inhibitor.
4855794|NCT02299661|Erythropoietin stimulating agent|erythropoietin stimulating agent
4855795|NCT02299661|Chronic renal disease|chronic renal disease
4855796|NCT02299661|renal anemia|renal anemia
4855797|NCT02299635|PF-03084014|pf-03084014
4855798|NCT02299635|Notch Alterations|notch alterations
4855799|NCT02299609|C14.280.647.500|c14.280.647.500
4855800|NCT02299596|Colorectal neoplasm|colorectal neoplasm
4855801|NCT02299596|Physical activity|physical activity
4855802|NCT02299583|prevention|prevention
4855803|NCT02299583|early intervention|early intervention
4855804|NCT02299583|trauma-informed practice|trauma-informed practice
4855805|NCT02299570|Clostridium difficile|clostridium difficile
4855806|NCT02299570|C diff|c diff
4855807|NCT02299570|CDI|cdi
4855808|NCT02299570|CDAD|cdad
4855809|NCT02299570|Fecal transplant|fecal transplant
4855810|NCT02299570|Fecal Microbiota Transplant|fecal microbiota transplant
4855811|NCT02299570|Diarrhea|diarrhea
4855812|NCT02299570|FMT|fmt
4855813|NCT02299570|Microbiota restoration therapy|microbiota restoration therapy
4855814|NCT02299570|Microbiota suspension|microbiota suspension
4855815|NCT02299570|Fecal bacteriotherapy|fecal bacteriotherapy
4855816|NCT02299570|C diff diarrhea|c diff diarrhea
4855817|NCT02299505|LDK378|ldk378
4855818|NCT02299505|ceritinib|ceritinib
4855819|NCT02299505|Alk+|alk+
4855820|NCT02299505|Alk positive|alk positive
4855821|NCT02299505|NSCLC|nsclc
4855822|NCT02299505|lung Cancer|lung cancer
4855823|NCT02299492|Mental Health Services|mental health services
4855824|NCT02299479|insulin pump|insulin pump
4855825|NCT02299479|continuous glucose monitor|continuous glucose monitor
4855826|NCT02299479|activity monitor|activity monitor
4855827|NCT02299466|parenteral nutrition|parenteral nutrition
4855828|NCT02299466|complications|complications
4855829|NCT02299466|indications|indications
4855830|NCT02299466|long-term administration|long-term administration
4855831|NCT02299466|HTPN|htpn
4855832|NCT02299453|Telemedicine|telemedicine
4855833|NCT02299453|Interpersonal Psychotherapy (IPT)|interpersonal psychotherapy (ipt)
4855834|NCT02299440|treatment of acute suicidal ideation|treatment of acute suicidal ideation
4855835|NCT02299440|ketamine|ketamine
4855836|NCT02299440|low-dose ketamine|low-dose ketamine
4855837|NCT02299414|Pregnancy|pregnancy
4855838|NCT02299414|Chronic hypertension|chronic hypertension
4855839|NCT02299401|Medical abortion|medical abortion
4855840|NCT02299401|Induced abortion|induced abortion
4855841|NCT02299401|Pregnancy test|pregnancy test
4855842|NCT02299401|Semi-quantitative pregnancy test|semi-quantitative pregnancy test
4855843|NCT02299388|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
4855844|NCT02299388|Hypertension|hypertension
4855845|NCT02299388|ambulatory blood pressure monitoring|ambulatory blood pressure monitoring
4855846|NCT02299388|Endothelial Dysfunction|endothelial dysfunction
4855847|NCT02299388|Pulse pressure|pulse pressure
4855848|NCT02299388|Renin-angiotensin system|renin-angiotensin system
4855849|NCT02299388|heart rate variability|heart rate variability
4855850|NCT02299375|Phase II clinical study|phase ii clinical study
4855851|NCT02299375|losmapimod|losmapimod
4855852|NCT02299375|exacerbations|exacerbations
4855853|NCT02299375|COPD|copd
4855854|NCT02299375|eosinophil sub-group|eosinophil sub-group
4855855|NCT02299362|Early Onset Scoliosis|early onset scoliosis
4855856|NCT02299362|EOS|eos
4855857|NCT02299362|Pulmonary function|pulmonary function
4855858|NCT02299362|Infantile Idiopathic Scoliosis|infantile idiopathic scoliosis
4855859|NCT02299362|MCGR|mcgr
4855860|NCT02299362|Magnetically controlled growing rods|magnetically controlled growing rods
4855861|NCT02299362|Growing rods|growing rods
4855862|NCT02299362|Growth friendly spine surgery|growth friendly spine surgery
4855863|NCT02299362|Cast|cast
4855864|NCT02299310|Chronic kidney disease, Anti-hypertensive drugs|chronic kidney disease, anti-hypertensive drugs
4855865|NCT02299297|Alopecia Areata|alopecia areata
4855866|NCT02299284|Spastic|spastic
4855867|NCT02299284|Hemiplegia|hemiplegia
4855868|NCT02299245|telomere|telomere
4855869|NCT02299245|telomerase|telomerase
4855870|NCT02299245|statin|statin
4855871|NCT02299245|percutaneous coronary intervention|percutaneous coronary intervention
4855872|NCT02299245|acute coronary syndrome|acute coronary syndrome
4855873|NCT02299232|dexmedetomidine|dexmedetomidine
4855874|NCT02299232|sedation|sedation
4855875|NCT02299232|MRI|mri
4855876|NCT02299219|Adolescent|adolescent
4855877|NCT02299219|Internet Self-Management|internet self-management
4855878|NCT02299219|Managing Cancer|managing cancer
4855879|NCT02299193|cognitive behavioral therapy for insomnia|cognitive behavioral therapy for insomnia
4855880|NCT02299193|sleep hygiene|sleep hygiene
4855881|NCT02299180|Advanced care planning|advanced care planning
4855882|NCT02299180|End of life care|end of life care
4855883|NCT02299167|Perianal surgery|perianal surgery
4855884|NCT02299167|hyperbaric bupivacaine|hyperbaric bupivacaine
4855885|NCT02299167|saddle block|saddle block
4855886|NCT02299115|Vigabatrin|vigabatrin
4855887|NCT02299115|Prednisolone|prednisolone
4855888|NCT02299102|Aspiration Procedures|aspiration procedures
4855889|NCT02299102|Bone Marrow|bone marrow
4855890|NCT02299102|To compare powered ported bone marrow aspiration procedures to manual standard bone marrow aspiration procedures|to compare powered ported bone marrow aspiration procedures to manual standard bone marrow aspiration procedures
4855891|NCT02299089|acromegaly|acromegaly
4855892|NCT02299089|neuroendocrine tumour (NET)|neuroendocrine tumour (net)
4855893|NCT02299089|carcinoid syndrome|carcinoid syndrome
4855894|NCT02299089|octreotide|octreotide
4855895|NCT02299089|Sandostatin LAR|sandostatin lar
4855896|NCT02299076|Tobacco smoking cessation|tobacco smoking cessation
4855897|NCT02299076|Motivation|motivation
4855898|NCT02299063|Mitochondria|mitochondria
4855899|NCT02299063|Dexmedetomidine|dexmedetomidine
4855900|NCT02299063|Heart Defects, Congenital|heart defects, congenital
4855901|NCT02299050|Type 2 Diabetes|type 2 diabetes
4855902|NCT02299050|T2DM|t2dm
4855903|NCT02299050|Cycloset|cycloset
4855904|NCT02299050|Glycemic Control|glycemic control
4855905|NCT02299050|GLP-1|glp-1
4855906|NCT02299024|opioids|opioids
4855907|NCT02299024|health literacy|health literacy
4855908|NCT02299011|Biomatrix drug eluting stent|biomatrix drug eluting stent
4855909|NCT02299011|Orsiro drug eluting stent|orsiro drug eluting stent
4855910|NCT02299011|Coronary artery disease|coronary artery disease
4855911|NCT02298985|curcumin; schizophrenia; neuroprotection|curcumin; schizophrenia; neuroprotection
4855912|NCT02298946|Anti-PD1 Therapy|anti-pd1 therapy
4855913|NCT02298946|Anti-Tumor Immunity|anti-tumor immunity
4855914|NCT02298946|Liver Metastatic|liver metastatic
4855915|NCT02298946|B7-DC Fc Fushion Protein|b7-dc fc fushion protein
4855916|NCT02298933|Complement Inhibition|complement inhibition
4855917|NCT02298933|Platelet Refractoriness|platelet refractoriness
4855918|NCT02298933|Eculizumab|eculizumab
4855919|NCT02298907|colorectal cancer|colorectal cancer
4855920|NCT02298907|surgery|surgery
4855921|NCT02298907|cardiopulmonary exercise testing|cardiopulmonary exercise testing
4855922|NCT02298907|perioperative|perioperative
4855923|NCT02298907|fitness|fitness
4855924|NCT02298894|Low Density Lipoprotein (LDL)|low density lipoprotein (ldl)
4855925|NCT02298894|Lipoprotein|lipoprotein
4855926|NCT02298894|Nuclear Magnetic Resonance (NMR)|nuclear magnetic resonance (nmr)
4855927|NCT02298894|Vertical Auto Profile (VAP)|vertical auto profile (vap)
4855928|NCT02298894|Ion mobility|ion mobility
4855929|NCT02298894|Apoliproprotein B (ApoB)|apoliproprotein b (apob)
4855930|NCT02298881|Dry Eye|dry eye
4855931|NCT02298881|Microbiome|microbiome
4855932|NCT02298855|Gynaecological cancer|gynaecological cancer
4855933|NCT02298855|Nurse-led care|nurse-led care
4855934|NCT02298855|Aftercare|aftercare
4855935|NCT02298855|Patient self-management|patient self-management
4855936|NCT02298855|Quality of life|quality of life
4855937|NCT02298855|Relapse free interval|relapse free interval
4855938|NCT02298855|Watch and wait|watch and wait
4855939|NCT02298842|Healthy Adults|healthy adults
4855940|NCT02298829|curvature|curvature
4855941|NCT02298829|bend|bend
4855942|NCT02298816|Monoclonal gammopathy of undetermined significance (MGUS)|monoclonal gammopathy of undetermined significance (mgus)
4855943|NCT02298816|Smoldering multiple myeloma (SMM)|smoldering multiple myeloma (smm)
4855944|NCT02298816|Multiple myeloma (MM)|multiple myeloma (mm)
4855945|NCT02298816|Waldenstroms Macroglobulinemia (WM)|waldenstroms macroglobulinemia (wm)
4855946|NCT02298816|Monoclonal B-cell lymphocytosis (MBL)|monoclonal b-cell lymphocytosis (mbl)
4855947|NCT02298816|Chronic lymphocytic leukemia (CLL)|chronic lymphocytic leukemia (cll)
4855948|NCT02298816|B-Cell Non-Hodgkin lymphoma (NHL)|b-cell non-hodgkin lymphoma (nhl)
4855949|NCT02298816|B-Cell Hematologic Malignancies|b-cell hematologic malignancies
4855950|NCT02298816|immunization|immunization
4855951|NCT02298816|Vaccination|vaccination
4855952|NCT02298816|Influenza, Human|influenza, human
4855953|NCT02298816|Pneumonia|pneumonia
4855954|NCT02298790|Dietary Habits|dietary habits
4855955|NCT02298790|Circadian|circadian
4855956|NCT02298790|Metabolism|metabolism
4855957|NCT02298790|Feeding Behavior|feeding behavior
4855958|NCT02298738|Atrial fibrillation, hypertension, vitamin D|atrial fibrillation, hypertension, vitamin d
4855959|NCT02298725|Insulin Resistance|insulin resistance
4855960|NCT02298725|Obesity|obesity
4855961|NCT02298725|US Dietary Guidelines|us dietary guidelines
4855962|NCT02298712|Iduronidase|iduronidase
4855963|NCT02298712|Lysosomal Storage Diseases|lysosomal storage diseases
4855964|NCT02298712|Genetic Diseases, Inborn|genetic diseases, inborn
4855965|NCT02298712|Biomarker|biomarker
4855966|NCT02298712|Hurler-Scheie Syndrome|hurler-scheie syndrome
4855967|NCT02298712|MPS I|mps i
4855968|NCT02298699|Sly Disease|sly disease
4855969|NCT02298699|Biomarker|biomarker
4855970|NCT02298686|Sanfilippo Disease Type A-B-C-D|sanfilippo disease type a-b-c-d
4855971|NCT02298686|Biomarker|biomarker
4855972|NCT02298673|Mucolipidosis Disorder type I,II,III, IV|mucolipidosis disorder type i,ii,iii, iv
4855973|NCT02298673|Biomarker|biomarker
4855974|NCT02298660|Autonomic Dysreflexia|autonomic dysreflexia
4855975|NCT02298660|Spinal Cord Injury|spinal cord injury
4855976|NCT02298660|OnabotulinumtoxinA|onabotulinumtoxina
4855977|NCT02298660|Neurogenic detrusor overactivity|neurogenic detrusor overactivity
4855978|NCT02298660|Urodynamics|urodynamics
4855979|NCT02298660|Cardiovascular|cardiovascular
4855980|NCT02298660|Quality of life|quality of life
4855981|NCT02298660|Blood pressure|blood pressure
4855982|NCT02298660|Twenty-four hour ambulatory blood pressure monitoring|twenty-four hour ambulatory blood pressure monitoring
4855983|NCT02298647|Gangliosidosis|gangliosidosis
4855984|NCT02298647|Biomarker|biomarker
4855985|NCT02298634|Lysosomal Storage Diseases|lysosomal storage diseases
4855986|NCT02298634|Lipogranulomatosis|lipogranulomatosis
4855987|NCT02298608|Renal mass|renal mass
4855988|NCT02298608|Kidney cancer|kidney cancer
4855989|NCT02298608|Irreversibel Electroporation|irreversibel electroporation
4855990|NCT02298608|Ablation|ablation
4855991|NCT02298608|Safety|safety
4855992|NCT02298608|Efficacy|efficacy
4855993|NCT02298608|IRE|ire
4855994|NCT02298595|Carcinoma|carcinoma
4855995|NCT02298595|Squamous|squamous
4855996|NCT02298595|Oropharyngeal|oropharyngeal
4855997|NCT02298595|HPV|hpv
4855998|NCT02298595|Resectable|resectable
4855999|NCT02298582|safety|safety
4856000|NCT02298582|procedural pain|procedural pain
4856001|NCT02298582|intranasal fentanyl|intranasal fentanyl
4856002|NCT02298582|elderly|elderly
4856003|NCT02298569|patient discharge|patient discharge
4856004|NCT02298569|hospital readmission|hospital readmission
4856005|NCT02298569|postnatal care|postnatal care
4856006|NCT02298569|Home Care Services|home care services
4856007|NCT02298569|Cost-Benefit Analysis|cost-benefit analysis
4856008|NCT02298569|Personal satisfaction|personal satisfaction
4856009|NCT02298569|Community Care Networks|community care networks
4856010|NCT02298556|Hypertension|hypertension
4856011|NCT02298556|Diabetes Mellitus|diabetes mellitus
4856012|NCT02298556|ACE Inhibitors|ace inhibitors
4856013|NCT02298556|Calcium Channel Blockers|calcium channel blockers
4856014|NCT02298517|Morbid obesity|morbid obesity
4856015|NCT02298517|bariatric surgery|bariatric surgery
4856016|NCT02298517|Respiratory muscle endurance|respiratory muscle endurance
4856017|NCT02298517|Respiratory muscle strength|respiratory muscle strength
4856018|NCT02298517|spirometry|spirometry
4856019|NCT02298517|physiotherapy|physiotherapy
4856020|NCT02298478|Self-help|self-help
4856021|NCT02298478|Computer-aided Treatment|computer-aided treatment
4856022|NCT02298478|Internet|internet
4856023|NCT02298478|Flying phobia|flying phobia
4856024|NCT02298478|minimal contact therapies|minimal contact therapies
4856025|NCT02298478|Cognitive-Behavioural Treatment|cognitive-behavioural treatment
4856026|NCT02298478|Waiting list control group|waiting list control group
4856027|NCT02298465|ESWL|eswl
4856028|NCT02298465|distal ureteric stone|distal ureteric stone
4856029|NCT02298465|transgluteal|transgluteal
4856030|NCT02298465|supine ESWL|supine eswl
4856031|NCT02298439|NAFLD|nafld
4856032|NCT02298426|Body Constitution Classification|body constitution classification
4856033|NCT02298426|Health Management|health management
4856034|NCT02298426|Obese Population|obese population
4856035|NCT02298374|Rehabilitation|rehabilitation
4856036|NCT02298374|Evaluation studies|evaluation studies
4856037|NCT02298374|Home care services|home care services
4856038|NCT02298361|Adolescent|adolescent
4856039|NCT02298361|Child|child
4856040|NCT02298361|Child Health Services/organization & administration*|child health services/organization & administration*
4856041|NCT02298361|Child, Preschool|child, preschool
4856042|NCT02298361|Cohort Studies|cohort studies
4856043|NCT02298361|Community Health Centers/organization & administration|community health centers/organization & administration
4856044|NCT02298361|Community Health Centers/standards|community health centers/standards
4856045|NCT02298361|Electronic Health Records|electronic health records
4856046|NCT02298361|Feasibility Studies|feasibility studies
4856047|NCT02298361|Female|female
4856048|NCT02298361|Health Services Accessibility/economics|health services accessibility/economics
4856049|NCT02298361|Humans|humans
4856050|NCT02298361|Infant|infant
4856051|NCT02298361|Infant, Newborn|infant, newborn
4856052|NCT02298361|Insurance Coverage|insurance coverage
4856053|NCT02298361|Insurance Coverage/statistics & numerical data|insurance coverage/statistics & numerical data
4856054|NCT02298361|Insurance Coverage/trends|insurance coverage/trends
4856055|NCT02298361|Insurance, Health|insurance, health
4856056|NCT02298361|Insurance, Health/legislation & jurisprudence|insurance, health/legislation & jurisprudence
4856057|NCT02298361|Insurance, Health/statistics & numerical data|insurance, health/statistics & numerical data
4856058|NCT02298361|Insurance, Health/trends|insurance, health/trends
4856059|NCT02298361|Logistic Models|logistic models
4856060|NCT02298361|Longitudinal Studies|longitudinal studies
4856061|NCT02298361|Male|male
4856062|NCT02298361|Medicaid|medicaid
4856063|NCT02298361|Medicaid/statistics & numerical data|medicaid/statistics & numerical data
4856064|NCT02298361|Medicaid/trends|medicaid/trends
4856065|NCT02298361|Medicaid/utilization|medicaid/utilization
4856066|NCT02298361|Medically Uninsured|medically uninsured
4856067|NCT02298361|Medicare/statistics & numerical data|medicare/statistics & numerical data
4856068|NCT02298361|Medicare/trends|medicare/trends
4856069|NCT02298361|Medicare/utilization|medicare/utilization
4856070|NCT02298361|Multivariate Analysis|multivariate analysis
4856071|NCT02298361|Oregon|oregon
4856072|NCT02298361|Patient Protection and Affordable Care Act|patient protection and affordable care act
4856073|NCT02298361|Patient-Centered Care|patient-centered care
4856074|NCT02298361|Pediatrics/legislation & jurisprudence|pediatrics/legislation & jurisprudence
4856460|NCT02295904|perineum|perineum
4856075|NCT02298361|Pediatrics/standards|pediatrics/standards
4856076|NCT02298361|Population Surveillance/methods|population surveillance/methods
4856077|NCT02298361|Primary Health Care/economics|primary health care/economics
4856078|NCT02298361|Quality Assurance, Health Care/legislation & jurisprudence|quality assurance, health care/legislation & jurisprudence
4856079|NCT02298361|Quality Assurance, Health Care/methods|quality assurance, health care/methods
4856080|NCT02298361|Quality Indicators, Health Care|quality indicators, health care
4856081|NCT02298361|Retrospective Studies|retrospective studies
4856082|NCT02298361|Socioeconomic Factors|socioeconomic factors
4856083|NCT02298361|United States|united states
4856084|NCT02298361|Young Adult|young adult
4856085|NCT02298348|Neuroblastoma|neuroblastoma
4856086|NCT02298348|NANT|nant
4856087|NCT02298348|Sorafenib|sorafenib
4856088|NCT02298348|Relapse|relapse
4856089|NCT02298335|Prednisone|prednisone
4856090|NCT02298335|idiopathic nephrotic syndrome|idiopathic nephrotic syndrome
4856091|NCT02298335|prospective|prospective
4856092|NCT02298309|TB|tb
4856093|NCT02298309|HIV|hiv
4856094|NCT02298309|Test and Treat|test and treat
4856095|NCT02298309|Linkage|linkage
4856096|NCT02298283|Hodgkin lymphoma|hodgkin lymphoma
4856097|NCT02298283|HL|hl
4856098|NCT02298283|brentuximab vedotin|brentuximab vedotin
4856099|NCT02298270|Neurofibromatosis|neurofibromatosis
4856100|NCT02298270|NF I|nf i
4856101|NCT02298270|NF 2|nf 2
4856102|NCT02298270|Schwannomatosis|schwannomatosis
4856103|NCT02298270|Stress Management|stress management
4856104|NCT02298270|Resiliency|resiliency
4856105|NCT02298270|Skype|skype
4856106|NCT02298244|Pulmonary Hypertension|pulmonary hypertension
4856107|NCT02298244|Atrial Fibrillation|atrial fibrillation
4856108|NCT02298244|Pulmonary Arterial Denervation|pulmonary arterial denervation
4856109|NCT02298244|Safety|safety
4856110|NCT02298244|Pulmonary Arterial GP Ablation|pulmonary arterial gp ablation
4856111|NCT02298231|Traumatic Brain Injury|traumatic brain injury
4856112|NCT02298231|Balance|balance
4856113|NCT02298231|TBI|tbi
4856114|NCT02298231|Veterans|veterans
4856115|NCT02298231|Virtual Reality|virtual reality
4856116|NCT02298179|Antibodies|antibodies
4856117|NCT02298179|Respiratory syncytial virus|respiratory syncytial virus
4856118|NCT02298179|Safety|safety
4856119|NCT02298179|Healthy adults|healthy adults
4856120|NCT02298179|Immunogenicity|immunogenicity
4856121|NCT02298166|Acute myeloid leukemia|acute myeloid leukemia
4856122|NCT02298166|FLT3 mutations|flt3 mutations
4856123|NCT02298166|Crenolanib|crenolanib
4856124|NCT02298166|Relapsed|relapsed
4856125|NCT02298166|Refractory|refractory
4856126|NCT02298140|SMS reminders|sms reminders
4856127|NCT02298140|Provider's compliance|provider's compliance
4856128|NCT02298140|malaria|malaria
4856129|NCT02298127|smoking cessation|smoking cessation
4856130|NCT02298127|auricular acupressure|auricular acupressure
4856131|NCT02298127|primary care settings|primary care settings
4856132|NCT02298127|randomized controlled trial|randomized controlled trial
4856133|NCT02298114|electrical stimulation|electrical stimulation
4856134|NCT02298114|intensive care unit|intensive care unit
4856135|NCT02298114|muscular atrophy|muscular atrophy
4856136|NCT02298101|Aerosol delivery|aerosol delivery
4856137|NCT02298101|Lung deposition|lung deposition
4856138|NCT02298101|SPECT|spect
4856139|NCT02298101|subjects|subjects
4856140|NCT02298075|Immune thrombocytopenia|immune thrombocytopenia
4856141|NCT02298075|Primary|primary
4856142|NCT02298075|Thrombopoietin receptor agonist|thrombopoietin receptor agonist
4856143|NCT02298062|Kawasaki disease coronary artery lesion, IVIG- resistant, Infliximab|kawasaki disease coronary artery lesion, ivig- resistant, infliximab
4856144|NCT02298049|fMRI|fmri
4856145|NCT02298049|reward|reward
4856146|NCT02298049|satiation|satiation
4856147|NCT02298036|Health Anxiety|health anxiety
4856148|NCT02298036|Urgent Care|urgent care
4856149|NCT02298036|Medically Unexplained|medically unexplained
4856150|NCT02298023|adipose derived mesenchymal stem cell|adipose derived mesenchymal stem cell
4856151|NCT02298023|allogeneic stem cell|allogeneic stem cell
4856152|NCT02298023|Rotator cuff tear|rotator cuff tear
4856153|NCT02297997|sarcopenia|sarcopenia
4856154|NCT02297997|cetylpyridinium chloride|cetylpyridinium chloride
4856155|NCT02297984|Neuroglobin|neuroglobin
4856156|NCT02297984|HIF-α|hif-α
4856157|NCT02297984|Acute ischemic stroke|acute ischemic stroke
4856158|NCT02297984|Prognosis|prognosis
4856159|NCT02297932|Exercise|exercise
4856160|NCT02297919|Web-based education, Adolescent, Obesity|web-based education, adolescent, obesity
4856161|NCT02297906|Intranasal|intranasal
4856162|NCT02297906|Ketorolac|ketorolac
4856163|NCT02297906|Pharmacokinetics|pharmacokinetics
4856164|NCT02297906|Pediatric|pediatric
4856165|NCT02297880|low calorie sweetener satiety, intake, hunger|low calorie sweetener satiety, intake, hunger
4856166|NCT02297815|antibiotic use|antibiotic use
4856167|NCT02297815|effectiveness|effectiveness
4856168|NCT02297815|acute respiratory infections|acute respiratory infections
4856169|NCT02297815|pediatrics|pediatrics
4856170|NCT02297776|cardiac arrest|cardiac arrest
4856171|NCT02297776|biomarker|biomarker
4856172|NCT02297776|microRNA|microrna
4856173|NCT02297776|circRNA|circrna
4856174|NCT02297776|NSE|nse
4856175|NCT02297776|CPC|cpc
4856176|NCT02297750|The focus of the study is double-wire technique versus single wire technique in patients undergoing ERCP with biliary cannulation as the primary objective.|the focus of the study is double-wire technique versus single wire technique in patients undergoing ercp with biliary cannulation as the primary objective.
4856177|NCT02297737|Tai Chi|tai chi
4856178|NCT02297698|Breast cancer, NeuVax|breast cancer, neuvax
4856179|NCT02297685|Transcutaneous electrical nerve stimulation (TENS)|transcutaneous electrical nerve stimulation (tens)
4856180|NCT02297685|Interferential currents therapy|interferential currents therapy
4856181|NCT02297685|Therapeutic exercises|therapeutic exercises
4856182|NCT02297685|Low back pain|low back pain
4856183|NCT02297685|Rehabilitation|rehabilitation
4856184|NCT02297672|breast cancer|breast cancer
4856185|NCT02297672|brachytherapy|brachytherapy
4856186|NCT02297672|partial breast radiotherapy|partial breast radiotherapy
4856187|NCT02297672|palladium 103|palladium 103
4856188|NCT02297659|damage control|damage control
4856189|NCT02297659|resuscitation|resuscitation
4856190|NCT02297659|laparotomy|laparotomy
4856191|NCT02297646|Prevention|prevention
4856192|NCT02297646|Exercise|exercise
4856193|NCT02297646|Health|health
4856194|NCT02297646|Endurance|endurance
4856195|NCT02297633|COPD|copd
4856196|NCT02297633|reactive oxygen metabolites|reactive oxygen metabolites
4856197|NCT02297620|SGLT-2 inhibitor|sglt-2 inhibitor
4856198|NCT02297620|Elderly patients|elderly patients
4856199|NCT02297620|ASP1941|asp1941
4856200|NCT02297607|Esophageal Cancer|esophageal cancer
4856201|NCT02297607|Esophagectomy|esophagectomy
4856202|NCT02297581|Geriatrics [MeSH]|geriatrics [mesh]
4856203|NCT02297581|Osteoporotic fractures [MeSH]|osteoporotic fractures [mesh]
4856204|NCT02297581|Hip fractures [MeSH]|hip fractures [mesh]
4856205|NCT02297581|Cost benefit analysis [MeSH]|cost benefit analysis [mesh]
4856206|NCT02297581|Quality of life [MeSH]|quality of life [mesh]
4856207|NCT02297581|Mortality [MeSH]|mortality [mesh]
4856208|NCT02297581|Complications|complications
4856209|NCT02297568|Breast-fed infant|breast-fed infant
4856210|NCT02297568|vitamin D supplementation|vitamin d supplementation
4856211|NCT02297568|Lactation|lactation
4856212|NCT02297555|Obesity|obesity
4856213|NCT02297555|Metabolic Syndrome|metabolic syndrome
4856214|NCT02297555|ENDOBARRIER®|endobarrier®
4856215|NCT02297542|Influenza Vaccine|influenza vaccine
4856216|NCT02297529|unresected, Melanoma, expanded access, EU|unresected, melanoma, expanded access, eu
4856217|NCT02297490|Environmental Exposure Chamber|environmental exposure chamber
4856218|NCT02297490|Specific Immunotherapy|specific immunotherapy
4856219|NCT02297490|SIT|sit
4856220|NCT02297490|SCIT|scit
4856221|NCT02297464|Risk|risk
4856222|NCT02297438|breast cancer|breast cancer
4856223|NCT02297438|postmenopausal women|postmenopausal women
4856224|NCT02297438|estrogen-receptor positive|estrogen-receptor positive
4856225|NCT02297438|HER2 negative|her2 negative
4856226|NCT02297438|locoregionally recurrent|locoregionally recurrent
4856227|NCT02297438|metastatic|metastatic
4856228|NCT02297425|NSCLC, Non-Small Cell Lung Cancer, EGFRm, Epidermal Grown Factor Receptor mutation|nsclc, non-small cell lung cancer, egfrm, epidermal grown factor receptor mutation
4856229|NCT02297399|Colonoscopy|colonoscopy
4856230|NCT02297399|Diabetes Mellitus|diabetes mellitus
4856231|NCT02297399|Polyethylene glycols|polyethylene glycols
4856232|NCT02297399|Ascorbate|ascorbate
4856233|NCT02297399|Personal satisfaction|personal satisfaction
4856234|NCT02297386|[18F] Dihydro-testosterone|[18f] dihydro-testosterone
4856235|NCT02297386|PET Scan|pet scan
4856236|NCT02297386|MRI|mri
4856237|NCT02297386|14-185|14-185
4856238|NCT02297360|Hair loss, hair thinning, women, marine protein supplement|hair loss, hair thinning, women, marine protein supplement
4856239|NCT02297334|CytoSorb(TM)|cytosorb(tm)
4856240|NCT02297334|cytokines|cytokines
4856241|NCT02297334|inflammation|inflammation
4856242|NCT02297334|cardiac surgery|cardiac surgery
4856243|NCT02297334|extracorporeal bypass|extracorporeal bypass
4856244|NCT02297321|tattoos|tattoos
4856245|NCT02297321|laser|laser
4856246|NCT02297321|whitening|whitening
4856247|NCT02297321|patch|patch
4856248|NCT02297295|Sequelae of; Amputation, Traumatic, Limb, Lower|sequelae of; amputation, traumatic, limb, lower
4856249|NCT02297282|Depression|depression
4856250|NCT02297282|Behavioural Activation|behavioural activation
4856251|NCT02297269|Deep vein thrombosis|deep vein thrombosis
4856252|NCT02297269|Surgery|surgery
4856253|NCT02297269|gastrointestinal malignancy|gastrointestinal malignancy
4856254|NCT02297230|Locally Advanced Breast Cancer|locally advanced breast cancer
4856255|NCT02297191|volunteer|volunteer
4856256|NCT02297191|pilot study|pilot study
4856257|NCT02297191|adults|adults
4856258|NCT02297165|anorexic|anorexic
4856259|NCT02297165|olfactory stimulation|olfactory stimulation
4856260|NCT02297165|autobiographical memories recovery|autobiographical memories recovery
4856261|NCT02297152|Premature ejaculation treatment|premature ejaculation treatment
4856262|NCT02297152|Sexual dysfunction|sexual dysfunction
4856263|NCT02297152|Intravaginal Ejaculatory Latency time|intravaginal ejaculatory latency time
4856264|NCT02297152|Masturbation aid|masturbation aid
4856265|NCT02297152|Ejaculatory disorders|ejaculatory disorders
4856266|NCT02297113|patients|patients
4856267|NCT02297113|departement|departement
4856364|NCT02296307|Early Detection of Cancer*|early detection of cancer*
4856268|NCT02297113|requiring Rapid Sequence Intubation (RSI)|requiring rapid sequence intubation (rsi)
4856269|NCT02297100|women|women
4856270|NCT02297100|interstitial cystitis|interstitial cystitis
4856271|NCT02297100|bladder pain syndrome|bladder pain syndrome
4856272|NCT02297100|botox|botox
4856273|NCT02297100|onabotulinum toxin A|onabotulinum toxin a
4856274|NCT02297074|Bread|bread
4856275|NCT02297074|Glycemic index|glycemic index
4856276|NCT02297074|Glycemic load|glycemic load
4856277|NCT02297074|Insulinemic index|insulinemic index
4856278|NCT02297074|Satiety|satiety
4856279|NCT02297074|Gastrointestinal hormones|gastrointestinal hormones
4856280|NCT02297061|Hip fracture|hip fracture
4856281|NCT02297061|Thrombelastography|thrombelastography
4856282|NCT02297061|Blood loss|blood loss
4856283|NCT02297048|Potassium intake|potassium intake
4856284|NCT02297048|Progesterone|progesterone
4856285|NCT02297048|steroidogenesis|steroidogenesis
4856286|NCT02297048|RU486|ru486
4856287|NCT02297048|Synachtene test|synachtene test
4856288|NCT02297022|Deep Brain Stimulation|deep brain stimulation
4856289|NCT02297022|obesity|obesity
4856290|NCT02297022|Prader-Willi syndrome|prader-willi syndrome
4856291|NCT02296996|BRAF V600|braf v600
4856292|NCT02296996|Rechallenge|rechallenge
4856293|NCT02296996|Combination|combination
4856294|NCT02296996|Dabrafenib|dabrafenib
4856295|NCT02296996|Trametinib|trametinib
4856296|NCT02296944|Childrens|childrens
4856297|NCT02296944|tempanoplasty|tempanoplasty
4856298|NCT02296944|tympanic membrane perforation|tympanic membrane perforation
4856299|NCT02296944|retrospective|retrospective
4856300|NCT02296944|cohort|cohort
4856301|NCT02296918|CLL|cll
4856302|NCT02296918|SLL|sll
4856303|NCT02296918|PLL|pll
4856304|NCT02296918|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
4856305|NCT02296918|Small Lymphocytic Lymphoma|small lymphocytic lymphoma
4856306|NCT02296918|Prolymphocytic Leukemia|prolymphocytic leukemia
4856307|NCT02296918|ACP-196|acp-196
4856308|NCT02296918|acalabrutinib|acalabrutinib
4856309|NCT02296918|obinutuzumab|obinutuzumab
4856310|NCT02296918|rituximab|rituximab
4856311|NCT02296918|venetoclax|venetoclax
4856312|NCT02296905|Hepatic Impairment|hepatic impairment
4856313|NCT02296905|Hepatitis C Virus Infection|hepatitis c virus infection
4856314|NCT02296892|Remimazolam, midazolam, bronchoscopy, procedural sedation|remimazolam, midazolam, bronchoscopy, procedural sedation
4856315|NCT02296853|Severe Hepatic Impairment|severe hepatic impairment
4856316|NCT02296840|analgesia|analgesia
4856317|NCT02296840|non-steroidal anti-inflammatory drugs|non-steroidal anti-inflammatory drugs
4856318|NCT02296840|narcotic-containing pain medication|narcotic-containing pain medication
4856319|NCT02296788|Gut Microbiota|gut microbiota
4856320|NCT02296775|Rheumatoid arthritis|rheumatoid arthritis
4856321|NCT02296775|Rituximab|rituximab
4856322|NCT02296775|Pharmacokinetics|pharmacokinetics
4856323|NCT02296736|computerised tomography (CT) scan|computerised tomography (ct) scan
4856324|NCT02296736|diagnostic accuracy|diagnostic accuracy
4856445|NCT02295956|Questionnaires|questionnaires
4856325|NCT02296736|Pancreatic head malignancy|pancreatic head malignancy
4856326|NCT02296710|mitral valve|mitral valve
4856327|NCT02296710|valve surgery|valve surgery
4856328|NCT02296710|echocardiography|echocardiography
4856329|NCT02296697|Pressure Ulcer|pressure ulcer
4856330|NCT02296697|Low Level Laser Therapy|low level laser therapy
4856331|NCT02296697|Dressings|dressings
4856332|NCT02296632|Telemedicine|telemedicine
4856333|NCT02296632|Patient Reported Outcomes|patient reported outcomes
4856334|NCT02296593|lactate|lactate
4856335|NCT02296593|continuous lactate monitoring|continuous lactate monitoring
4856336|NCT02296593|continuous blood glucose monitoring|continuous blood glucose monitoring
4856337|NCT02296593|EIRUS|eirus
4856338|NCT02296593|blood glucose|blood glucose
4856339|NCT02296593|cardiac surgery|cardiac surgery
4856340|NCT02296593|central veinous catheter|central veinous catheter
4856341|NCT02296593|microdialysis|microdialysis
4856342|NCT02296554|SLAP Repair|slap repair
4856343|NCT02296554|Biceps Tenodesis|biceps tenodesis
4856344|NCT02296528|Feeding Tube Dependent|feeding tube dependent
4856345|NCT02296502|DSM Diagnosis|dsm diagnosis
4856346|NCT02296450|Quality of Life (QoL)|quality of life (qol)
4856347|NCT02296450|Assessment|assessment
4856348|NCT02296450|14-236|14-236
4856349|NCT02296450|Patients and Survivors|patients and survivors
4856350|NCT02296424|Juvenile Rheumatoid arthritis (JRA) chronic|juvenile rheumatoid arthritis (jra) chronic
4856351|NCT02296424|systemic inflammatory disorder|systemic inflammatory disorder
4856352|NCT02296424|painful joints|painful joints
4856353|NCT02296424|inflammation of the synovial membrane|inflammation of the synovial membrane
4856354|NCT02296424|auto-immune rheumatoid disease|auto-immune rheumatoid disease
4856355|NCT02296424|reactive rheumatoid arthritis|reactive rheumatoid arthritis
4856356|NCT02296424|Systemic Juvenile Rheumatoid arthritis (SJRA)|systemic juvenile rheumatoid arthritis (sjra)
4856357|NCT02296411|Asthma, Anticholinergics|asthma, anticholinergics
4856358|NCT02296385|volunteers|volunteers
4856359|NCT02296333|Acetaminophen, ondansetron|acetaminophen, ondansetron
4856360|NCT02296307|Aged|aged
4856361|NCT02296307|Algorithms|algorithms
4856362|NCT02296307|CA-125 Antigen/blood*|ca-125 antigen/blood*
4856363|NCT02296307|Chi-Square Distribution|chi-square distribution
4856365|NCT02296307|Feasibility Studies|feasibility studies
4856366|NCT02296307|Female|female
4856367|NCT02296307|Humans|humans
4856368|NCT02296307|Logistic Models|logistic models
4856369|NCT02296307|Mass Screening/methods*|mass screening/methods*
4856370|NCT02296307|Middle Aged|middle aged
4856371|NCT02296307|Neoplasm Grading|neoplasm grading
4856372|NCT02296307|Neoplasm Invasiveness|neoplasm invasiveness
4856373|NCT02296307|Neoplasm Staging|neoplasm staging
4856374|NCT02296307|Ovarian Neoplasms/diagnosis*|ovarian neoplasms/diagnosis*
4856375|NCT02296307|Ovarian Neoplasms/epidemiology|ovarian neoplasms/epidemiology
4856376|NCT02296307|Ovarian Neoplasms/immunology|ovarian neoplasms/immunology
4856377|NCT02296307|Ovarian Neoplasms/ultrasonography|ovarian neoplasms/ultrasonography
4856378|NCT02296307|Pilot Projects|pilot projects
4856379|NCT02296307|Predictive Value of Tests|predictive value of tests
4856380|NCT02296307|Prevalence|prevalence
4856381|NCT02296307|Prognosis|prognosis
4856382|NCT02296307|Prospective Studies|prospective studies
4856383|NCT02296307|Quebec/epidemiology|quebec/epidemiology
4856384|NCT02296307|Tumor Burden|tumor burden
4856385|NCT02296294|Bioimpedance Spectroscopy, Body Composition Monitor, Fluid Therapy|bioimpedance spectroscopy, body composition monitor, fluid therapy
4856386|NCT02296268|stroke|stroke
4856387|NCT02296268|aerobic exercise|aerobic exercise
4856388|NCT02296268|screening|screening
4856389|NCT02296268|prescription|prescription
4856390|NCT02296255|cervical cancer screening|cervical cancer screening
4856391|NCT02296255|young women vaccination|young women vaccination
4856392|NCT02296255|impact of HPV vaccination on screening|impact of hpv vaccination on screening
4856393|NCT02296216|have been treated or not treated by Gamma Knife Radiosurgery|have been treated or not treated by gamma knife radiosurgery
4856394|NCT02296203|cetuximab rechallenge|cetuximab rechallenge
4856395|NCT02296177|evidence-based intervention|evidence-based intervention
4856396|NCT02296177|mammography|mammography
4856397|NCT02296177|underserved population|underserved population
4856398|NCT02296164|PROVe|prove
4856399|NCT02296164|CTCL|ctcl
4856400|NCT02296164|Mechlorethamine|mechlorethamine
4856401|NCT02296164|Cutaneous T-cell lymphoma|cutaneous t-cell lymphoma
4856402|NCT02296164|Mycosis fungoides cutaneous T-cell lymphoma|mycosis fungoides cutaneous t-cell lymphoma
4856403|NCT02296164|Valchlor|valchlor
4856404|NCT02296164|Dermatology|dermatology
4856405|NCT02296164|MF-CTCL|mf-ctcl
4856406|NCT02296164|Mycosis Fungoides|mycosis fungoides
4856407|NCT02296164|Oncology|oncology
4856408|NCT02296125|Advanced Non-Small Cell Lung Cancer; EGFRm+; AZD9291; TKI; Phase III|advanced non-small cell lung cancer; egfrm+; azd9291; tki; phase iii
4856409|NCT02296099|retropubic suburethral sling|retropubic suburethral sling
4856410|NCT02296099|stress urinary incontinence|stress urinary incontinence
4856411|NCT02296099|liposomal bupivacaine|liposomal bupivacaine
4856412|NCT02296086|Geriatrics [MeSH]|geriatrics [mesh]
4856413|NCT02296086|Hip fractures [MeSH]|hip fractures [mesh]
4856414|NCT02296086|China [MeSH]|china [mesh]
4856415|NCT02296086|Early ambulation [MeSH]|early ambulation [mesh]
4856416|NCT02296086|Immobilization [MeSH]|immobilization [mesh]
4856417|NCT02296073|Pediatric intensive care unit|pediatric intensive care unit
4856418|NCT02296073|Sedation|sedation
4856419|NCT02296073|Dexmedetomidine|dexmedetomidine
4856420|NCT02296073|mechanical ventilation|mechanical ventilation
4856421|NCT02296047|COPD, central drive, bronchodilators|copd, central drive, bronchodilators
4856422|NCT02296021|helicobacter pylori|helicobacter pylori
4856423|NCT02296021|berberine-containing quadruple therapy|berberine-containing quadruple therapy
4856424|NCT02296021|bismuth-containing quadruple therapy|bismuth-containing quadruple therapy
4856425|NCT02296008|high resolution manometry|high resolution manometry
4856426|NCT02296008|children|children
4856427|NCT02296008|congenital anorectal disorder|congenital anorectal disorder
4856428|NCT02296008|surgery|surgery
4856429|NCT02295995|Aged|aged
4856430|NCT02295995|Exercise|exercise
4856431|NCT02295995|Veterans|veterans
4856432|NCT02295995|Adherence|adherence
4856433|NCT02295995|Clinical Trials, Randomized|clinical trials, randomized
4856434|NCT02295982|Laparoscopic nephrectomy|laparoscopic nephrectomy
4856435|NCT02295982|one day surgery|one day surgery
4856436|NCT02295969|Rhinitis|rhinitis
4856437|NCT02295969|Conjunctivitis|conjunctivitis
4856438|NCT02295969|Grass pollen|grass pollen
4856439|NCT02295969|Sublingual tablet|sublingual tablet
4856440|NCT02295969|Allergen immunotherapy|allergen immunotherapy
4856441|NCT02295969|Safety|safety
4856442|NCT02295956|Pancreatic Cancer|pancreatic cancer
4856443|NCT02295956|Pancreatic adenocarcinoma|pancreatic adenocarcinoma
4856444|NCT02295956|Preoperative therapy|preoperative therapy
4856446|NCT02295956|Surveys|surveys
4856447|NCT02295956|Exercises|exercises
4856448|NCT02295956|Stretching|stretching
4856449|NCT02295956|Walking|walking
4856450|NCT02295956|Nutrition counseling|nutrition counseling
4856451|NCT02295956|Resistance exercise bands|resistance exercise bands
4856452|NCT02295956|Phone calls|phone calls
4856453|NCT02295956|Booklet|booklet
4856454|NCT02295956|Pamphlet|pamphlet
4856455|NCT02295930|colorectal cancer,|colorectal cancer,
4856456|NCT02295930|bevacizumab|bevacizumab
4856457|NCT02295930|cetuximab|cetuximab
4856458|NCT02295930|folfoxiri|folfoxiri
4856459|NCT02295930|kras wild type|kras wild type
4856461|NCT02295904|videoanalysis|videoanalysis
4856462|NCT02295865|Psoriasis|psoriasis
4856463|NCT02295865|Toreforant|toreforant
4856464|NCT02295865|JNJ-38518168|jnj-38518168
4856465|NCT02295852|Low-sodium calcium enriched diet|low-sodium calcium enriched diet
4856466|NCT02295852|Low-sodium diet|low-sodium diet
4856467|NCT02295852|Glucose and lipid metabolims|glucose and lipid metabolims
4856468|NCT02295839|Sleep|sleep
4856469|NCT02295839|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
4856470|NCT02295839|Fatigue|fatigue
4856471|NCT02295839|Sleep hygiene|sleep hygiene
4856472|NCT02295839|Relaxation|relaxation
4856473|NCT02295839|RCT|rct
4856474|NCT02295800|HIV|hiv
4856475|NCT02295800|PMTCT|pmtct
4856476|NCT02295800|Antenatal Care|antenatal care
4856477|NCT02295787|Depression|depression
4856478|NCT02295787|Suicide|suicide
4856479|NCT02295787|Suicidal Ideation|suicidal ideation
4856480|NCT02295787|Ketamine|ketamine
4856481|NCT02295787|Late-Life|late-life
4856482|NCT02295761|motor activity|motor activity
4856483|NCT02295761|obesity|obesity
4856484|NCT02295761|overweight|overweight
4856485|NCT02295761|intervention study|intervention study
4856486|NCT02295761|health promotion|health promotion
4856487|NCT02295761|lifestyle counseling|lifestyle counseling
4856488|NCT02295761|adherence|adherence
4856489|NCT02295735|Skin, safety, wounds, intensive care|skin, safety, wounds, intensive care
4856490|NCT02295722|eligible for high-dose therapy and stem cell transplantation|eligible for high-dose therapy and stem cell transplantation
4856491|NCT02295709|ultrasound|ultrasound
4856492|NCT02295709|cervical Transformational Epidural Steroid Injection|cervical transformational epidural steroid injection
4856493|NCT02295696|Adults, dialogue tools, outpatient clinic visits|adults, dialogue tools, outpatient clinic visits
4856494|NCT02295644|Therapeutic ultrasound|therapeutic ultrasound
4856495|NCT02295592|hemorrhoids|hemorrhoids
4856496|NCT02295592|The recurrence rate|the recurrence rate
4856497|NCT02295592|PPH|pph
4856498|NCT02295592|TSTstarr+|tststarr+
4856499|NCT02295566|Nitric Oxide|nitric oxide
4856500|NCT02295566|Pseudomonas Aeruginosa|pseudomonas aeruginosa
4856501|NCT02295566|Biofilm|biofilm
4856502|NCT02295553|Ketamine|ketamine
4856503|NCT02295553|Propofol|propofol
4856504|NCT02295553|Children|children
4856505|NCT02295553|Pediatrics|pediatrics
4856506|NCT02295553|Upper endoscopy|upper endoscopy
4856507|NCT02295514|Sepsis|sepsis
4856508|NCT02295514|Septic shock|septic shock
4856509|NCT02295501|Pathogen inactivation|pathogen inactivation
4856510|NCT02295501|ebola|ebola
4856511|NCT02295501|convalescent plasma|convalescent plasma
4856512|NCT02295501|EBOV|ebov
4856513|NCT02295501|amotosalen|amotosalen
4856514|NCT02295501|Provide access to the potential therapeutic benefit of EBOV convalescent plasma containing antibodies to EBOV.|provide access to the potential therapeutic benefit of ebov convalescent plasma containing antibodies to ebov.
4856515|NCT02295488|hymenoptera puncture|hymenoptera puncture
4856516|NCT02295462|nursing homes|nursing homes
4856517|NCT02295462|person-centered care|person-centered care
4856518|NCT02295462|inappropriate prescriptions|inappropriate prescriptions
4856519|NCT02295462|cluster-randomised controlled trial|cluster-randomised controlled trial
4856520|NCT02295462|antipsychotic drugs|antipsychotic drugs
4856521|NCT02295449|Prostate cancer|prostate cancer
4856522|NCT02295449|Contrast-enhanced ultrasound|contrast-enhanced ultrasound
4856523|NCT02295436|minodronic acid|minodronic acid
4856524|NCT02295436|pharmacokinetics|pharmacokinetics
4856525|NCT02295436|tolerability|tolerability
4856526|NCT02295436|food|food
4856527|NCT02295436|age|age
4856528|NCT02295436|Chinese subjects|chinese subjects
4856529|NCT02295410|Assessment, PTSD, Veterans|assessment, ptsd, veterans
4856530|NCT02295397|Food provocation|food provocation
4856531|NCT02295397|Matrix effect|matrix effect
4856532|NCT02295397|ED05|ed05
4856533|NCT02295397|Allergy|allergy
4856534|NCT02295397|Proton Pump Inhibitor|proton pump inhibitor
4856535|NCT02295384|Polypharmacy|polypharmacy
4856536|NCT02295384|Medication Therapy Management|medication therapy management
4856537|NCT02295371|Drug therapy|drug therapy
4856538|NCT02295371|Patient safety|patient safety
4856539|NCT02295371|Polydrug therapy|polydrug therapy
4856540|NCT02295319|Discharge|discharge
4856541|NCT02295319|Acute Admission Unit|acute admission unit
4856542|NCT02295319|Randomized Controlled Trial|randomized controlled trial
4856543|NCT02295306|OSA, polysomnography, ExSpiron monitor|osa, polysomnography, exspiron monitor
4856544|NCT02295293|Rhus|rhus
4856545|NCT02295293|Cholesterol|cholesterol
4856546|NCT02295293|Triglycerides|triglycerides
4856547|NCT02295293|Lipids|lipids
4856548|NCT02295293|Medicine, Traditional|medicine, traditional
4856549|NCT02295293|Herbal medicine|herbal medicine
4856550|NCT02295280|headache|headache
4856551|NCT02295267|Food allergy|food allergy
4856552|NCT02295267|Walnut|walnut
4856553|NCT02295267|Components|components
4856554|NCT02295267|Allergens|allergens
4856555|NCT02295241|Sarcopenia, muscles, aging|sarcopenia, muscles, aging
4856556|NCT02295228|Vitamin D, Vitamin D deficiency, Hip Arthroplasty|vitamin d, vitamin d deficiency, hip arthroplasty
4856557|NCT02295215|chagas disease|chagas disease
4856558|NCT02295215|exercise|exercise
4856559|NCT02295215|baroreflex sensitivity|baroreflex sensitivity
4856560|NCT02295163|Stellate ganglion block|stellate ganglion block
4856561|NCT02295163|hot flushes|hot flushes
4856562|NCT02295163|androgen deprivation therapy|androgen deprivation therapy
4856563|NCT02295163|prostate cancer|prostate cancer
4856564|NCT02295150|Nadroparin|nadroparin
4856565|NCT02295150|Anti-Xa activity|anti-xa activity
4856566|NCT02295124|Nausea|nausea
4856567|NCT02295111|electro-acupuncture|electro-acupuncture
4856568|NCT02295111|chronic pelvic pain|chronic pelvic pain
4856569|NCT02295111|patient practitioner interactions|patient practitioner interactions
4856570|NCT02295111|TCM health consultation|tcm health consultation
4856571|NCT02295111|meridian balanced method acupuncture|meridian balanced method acupuncture
4856572|NCT02295085|Cohort, Prospective, Biospecimens|cohort, prospective, biospecimens
4856573|NCT02295072|Exercise-based Randomized Controlled Trial|exercise-based randomized controlled trial
4856574|NCT02295072|Brain structure|brain structure
4856575|NCT02295072|Brain function|brain function
4856576|NCT02295072|Cognitive function|cognitive function
4856577|NCT02295072|Physical fitness|physical fitness
4856578|NCT02295072|Body Mass Index|body mass index
4856579|NCT02295072|Cardiovascular disease risk factors|cardiovascular disease risk factors
4856580|NCT02295072|Mental health|mental health
4856581|NCT02295072|Stress|stress
4856582|NCT02295072|Neurology|neurology
4856583|NCT02295072|Obesity|obesity
4856584|NCT02295072|brain|brain
4856585|NCT02295072|risk factors|risk factors
4856586|NCT02295072|bone|bone
4856587|NCT02295072|bones|bones
4856588|NCT02295072|body composition|body composition
4856589|NCT02295059|Breast cancer|breast cancer
4856590|NCT02295059|ERPR negative|erpr negative
4856591|NCT02295059|HER-2/neu overexpression positive or negative|her-2/neu overexpression positive or negative
4856592|NCT02295033|Boost versus no boost irradiation of early breast cancer|boost versus no boost irradiation of early breast cancer
4856593|NCT02294955|catheter ablation|catheter ablation
4856594|NCT02294955|atrial fibrillation|atrial fibrillation
4856595|NCT02294942|RNTA06|rnta06
4856596|NCT02294942|RANCAD|rancad
4856597|NCT02294929|catheter ablation|catheter ablation
4856598|NCT02294929|cryoballoon|cryoballoon
4856599|NCT02294903|Focal radiofrequency ablation|focal radiofrequency ablation
4856600|NCT02294903|Prostate cancer|prostate cancer
4856601|NCT02294903|Encage|encage
4856602|NCT02294864|focus: pulsed radiofrequency (E02.779.468.599)|focus: pulsed radiofrequency (e02.779.468.599)
4856603|NCT02294825|deep endometriosis;|deep endometriosis;
4856604|NCT02294825|colorectal endometriosis|colorectal endometriosis
4856605|NCT02294825|surgery|surgery
4856606|NCT02294825|medical treatment|medical treatment
4856607|NCT02294825|fertility|fertility
4856608|NCT02294812|Hearing Loss|hearing loss
4856609|NCT02294812|Speech Perception|speech perception
4856610|NCT02294812|Cognitive Training|cognitive training
4856611|NCT02294812|Cognitive Fitness|cognitive fitness
4856612|NCT02294812|Memory, Short-Term|memory, short-term
4856613|NCT02294799|Temporomandibular Joint Disorders|temporomandibular joint disorders
4856614|NCT02294799|Magnetic Ressonance Imaging|magnetic ressonance imaging
4856615|NCT02294799|Complementary Therapy|complementary therapy
4856616|NCT02294799|Physical Therapy Modalities.|physical therapy modalities.
4856617|NCT02294786|Randomised|randomised
4856618|NCT02294786|Octreotide|octreotide
4856619|NCT02294786|Diarrhoea|diarrhoea
4856620|NCT02294786|Phase II|phase ii
4856621|NCT02294786|Capecitabine|capecitabine
4856622|NCT02294786|Quality of life|quality of life
4856623|NCT02294786|Metastatic breast cancer|metastatic breast cancer
4856624|NCT02294786|HER2|her2
4856625|NCT02294786|Lapatinib|lapatinib
4856626|NCT02294786|Diarrhoea diary|diarrhoea diary
4856627|NCT02294773|Infertility|infertility
4856628|NCT02294773|Intrauterine insemination|intrauterine insemination
4856629|NCT02294773|Luteinizing hormone surge|luteinizing hormone surge
4856630|NCT02294760|Irritable Bowel Syndrome|irritable bowel syndrome
4856631|NCT02294760|Sacral Nerve Stimulation|sacral nerve stimulation
4856632|NCT02294760|Symptoms|symptoms
4856633|NCT02294760|Quality of Life|quality of life
4856634|NCT02294734|functional respiratory capacity|functional respiratory capacity
4856635|NCT02294734|High-resolution computed tomography|high-resolution computed tomography
4856636|NCT02294734|GSK2269557|gsk2269557
4856637|NCT02294734|acute exacerbation of COPD|acute exacerbation of copd
4856638|NCT02294734|lung capacity|lung capacity
4856639|NCT02294708|macula-off retinal detachment|macula-off retinal detachment
4856640|NCT02294708|scleral buckle|scleral buckle
4856641|NCT02294708|persistent sub-foveal fluid|persistent sub-foveal fluid
4856642|NCT02294708|postoperative postures|postoperative postures
4856643|NCT02294708|optical coherence tomography (OCT)|optical coherence tomography (oct)
4856644|NCT02294695|Empiric antibiotic therapy|empiric antibiotic therapy
4856645|NCT02294682|uncomplicated urogenital gonorrhea|uncomplicated urogenital gonorrhea
4856646|NCT02294682|Bacterial Type II Topoisomerase Inhibitors (BTI)|bacterial type ii topoisomerase inhibitors (bti)
4856647|NCT02294682|antibiotics|antibiotics
4856648|NCT02294682|GSK2140944|gsk2140944
4856649|NCT02294682|N. gonorrhoeae|n. gonorrhoeae
4856650|NCT02294656|CYSTOID MACULAR EDEMA|cystoid macular edema
4856651|NCT02294643|sarpogrelate|sarpogrelate
4856652|NCT02294591|Bipolar Disorder|bipolar disorder
4856653|NCT02294591|Depression|depression
4856654|NCT02294591|Acetylcystein|acetylcystein
4856655|NCT02294591|Oxidative Stress|oxidative stress
4856656|NCT02294591|Urine|urine
4856657|NCT02294578|Biomarkers|biomarkers
4856658|NCT02294578|saliva|saliva
4856659|NCT02294578|mRNA|mrna
4856660|NCT02294565|Sentinel Lymph Node Biopsy|sentinel lymph node biopsy
4856661|NCT02294565|Breast Cancer|breast cancer
4856662|NCT02294565|Lymphatic Mapping|lymphatic mapping
4856663|NCT02294552|Cyclophosphamide|cyclophosphamide
4856664|NCT02294552|Leukemia|leukemia
4856665|NCT02294552|Lymphoma|lymphoma
4856666|NCT02294552|Myelodysplastic Syndromes|myelodysplastic syndromes
4856667|NCT02294552|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
4856668|NCT02294552|Immunosuppressive Agents|immunosuppressive agents
4856669|NCT02294552|Immune System Diseases|immune system diseases
4856670|NCT02294552|Busulfan|busulfan
4856671|NCT02294552|Fludarabine|fludarabine
4856672|NCT02294552|Tacrolimus|tacrolimus
4856673|NCT02294552|Mycophenolate mofetil|mycophenolate mofetil
4856674|NCT02294552|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating
4856675|NCT02294552|Myeloablative Agonists|myeloablative agonists
4856676|NCT02294552|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
4856677|NCT02294552|Allogeneic|allogeneic
4856678|NCT02294526|Diet|diet
4856679|NCT02294526|Sardine|sardine
4856680|NCT02294526|Type 2 diabetes|type 2 diabetes
4856681|NCT02294513|Alzheimer disease|alzheimer disease
4856682|NCT02294513|Dementia|dementia
4856683|NCT02294513|Hearing loss|hearing loss
4856684|NCT02294513|Correction of hearing impairment|correction of hearing impairment
4856685|NCT02294513|Hearing aids|hearing aids
4856686|NCT02294513|Communication|communication
4856687|NCT02294513|Family caregivers|family caregivers
4856688|NCT02294513|Third-party disability|third-party disability
4856689|NCT02294500|ovarian function|ovarian function
4856690|NCT02294500|female|female
4856691|NCT02294500|Genital Function|genital function
4856692|NCT02294487|influenza|influenza
4856693|NCT02294487|pneumococcal|pneumococcal
4856694|NCT02294487|pneumonia|pneumonia
4856695|NCT02294487|vaccine|vaccine
4856696|NCT02294487|immunization|immunization
4856697|NCT02294487|#CAImmun|#caimmun
4856698|NCT02294487|Immuno-oncology|immuno-oncology
4856699|NCT02294487|supportive care|supportive care
4856700|NCT02294487|vaccination|vaccination
4856701|NCT02294487|meningococcal|meningococcal
4856702|NCT02294487|HIB|hib
4856703|NCT02294461|Enzalutamide|enzalutamide
4856704|NCT02294461|Androgen receptor|androgen receptor
4856705|NCT02294461|Prostate cancer|prostate cancer
4856706|NCT02294461|Xtandi|xtandi
4856707|NCT02294448|Cervical radiculopathy|cervical radiculopathy
4856708|NCT02294448|Neck pain|neck pain
4856709|NCT02294448|Qishe pill|qishe pill
4856710|NCT02294448|raditional Chinese medicine|raditional chinese medicine
4856711|NCT02294448|healthy Chinese subject|healthy chinese subject
4856712|NCT02294448|Population Pharmacokinetics|population pharmacokinetics
4856713|NCT02294448|Personalized Medicine|personalized medicine
4856714|NCT02294448|Individualized Medicine|individualized medicine
4856715|NCT02294435|Thoracoabdominal Aneurysms|thoracoabdominal aneurysms
4856716|NCT02294435|Endovascular|endovascular
4856717|NCT02294435|Ps-ide|ps-ide
4856718|NCT02294435|Early Feasibility|early feasibility
4856719|NCT02294435|Aneurysm|aneurysm
4856720|NCT02294435|Aortic Aneurysm, Thoracic|aortic aneurysm, thoracic
4856721|NCT02294435|Aortic Aneurysm|aortic aneurysm
4856722|NCT02294435|Aortic Diseases|aortic diseases
4856723|NCT02294435|Cardiovascular Diseases|cardiovascular diseases
4856724|NCT02294435|Vascular Diseases|vascular diseases
4856725|NCT02294435|Pararenal aneurysm|pararenal aneurysm
4856726|NCT02294435|Juxtarenal aneurysm|juxtarenal aneurysm
4856727|NCT02294435|Aortic dissection|aortic dissection
4856728|NCT02294435|Short neck infrarenal aneurysm|short neck infrarenal aneurysm
4856729|NCT02294435|Type 4 thoracoabdominal|type 4 thoracoabdominal
4856730|NCT02294435|TAAA|taaa
4856731|NCT02294422|Loss of resistance|loss of resistance
4856732|NCT02294422|Pilot balloon|pilot balloon
4856733|NCT02294422|Cuff pressure|cuff pressure
4856734|NCT02294422|Endotracheal tube|endotracheal tube
4856735|NCT02294409|social anxiety|social anxiety
4856736|NCT02294409|psychosis|psychosis
4856737|NCT02294409|CBT|cbt
4856738|NCT02294409|randomized|randomized
4856739|NCT02294409|CRT|crt
4856740|NCT02294396|Anticholinergic|anticholinergic
4856741|NCT02294396|Overactive Bladder (OAB)|overactive bladder (oab)
4856742|NCT02294396|Mirabegron|mirabegron
4856743|NCT02294396|YM178|ym178
4856744|NCT02294383|Pelvic Floor Biomechanics|pelvic floor biomechanics
4856745|NCT02294383|Tissue Elasticity|tissue elasticity
4856746|NCT02294383|Tactile Imaging|tactile imaging
4856747|NCT02294370|type 2 diabetes|type 2 diabetes
4856748|NCT02294370|continuous glucose monitoring|continuous glucose monitoring
4856749|NCT02294357|carfilzomib|carfilzomib
4856750|NCT02294357|proteasome inhibitor|proteasome inhibitor
4856751|NCT02294357|multiple myeloma|multiple myeloma
4856752|NCT02294357|relapsed/refractory|relapsed/refractory
4856753|NCT02294344|double filtration plasmapheresis|double filtration plasmapheresis
4856754|NCT02294344|ANCA-Associated Vasculitis|anca-associated vasculitis
4856755|NCT02294305|Depression|depression
4856756|NCT02294305|Social Anxiety|social anxiety
4856757|NCT02294305|Social Phobia|social phobia
4856758|NCT02294305|Major Depression|major depression
4856759|NCT02294305|Vortioxetine|vortioxetine
4856760|NCT02294279|cough, wheeze, dyspnoea|cough, wheeze, dyspnoea
4856761|NCT02294240|Pregnant, malnourished, energy dense biscuits, low birth weight|pregnant, malnourished, energy dense biscuits, low birth weight
4856762|NCT02294227|AIN457|ain457
4856763|NCT02294227|psoriatic arthritis|psoriatic arthritis
4856764|NCT02294227|chronic inflammatory disease|chronic inflammatory disease
4856765|NCT02294227|loading regimen|loading regimen
4856766|NCT02294227|secukinumab|secukinumab
4856767|NCT02294227|self-injection|self-injection
4856768|NCT02294214|malaria|malaria
4856769|NCT02294214|Spatial Repellents|spatial repellents
4856770|NCT02294214|Plasmodium|plasmodium
4856771|NCT02294201|Malaria|malaria
4856772|NCT02294201|Spatial Repellents|spatial repellents
4856773|NCT02294201|Plasmodium|plasmodium
4856774|NCT02294188|Malaria|malaria
4856775|NCT02294188|Spatial Repellents|spatial repellents
4856776|NCT02294188|Plasmodium|plasmodium
4856777|NCT02294175|larva|larva
4856778|NCT02294175|debridement|debridement
4856779|NCT02294175|lower extremity or diabetic foot ulcer|lower extremity or diabetic foot ulcer
4856780|NCT02294175|biofilm|biofilm
4856781|NCT02294175|infection|infection
4856782|NCT02294175|chronic wound|chronic wound
4856783|NCT02294149|chemotherapy|chemotherapy
4856784|NCT02294149|Omega 3|omega 3
4856785|NCT02294136|HIV|hiv
4856786|NCT02294136|HCV|hcv
4856787|NCT02294136|Adherence|adherence
4856788|NCT02294136|Psychiatric|psychiatric
4856789|NCT02294136|Behavioral|behavioral
4856790|NCT02294136|Intervention|intervention
4856791|NCT02294110|failure|failure
4856792|NCT02294110|spinal anesthesia|spinal anesthesia
4856793|NCT02294071|acetaminophen|acetaminophen
4856794|NCT02294071|ibuprofen|ibuprofen
4856795|NCT02294058|MS|ms
4856796|NCT02294058|RMS|rms
4856797|NCT02294058|Multiple Sclerosis|multiple sclerosis
4856798|NCT02294058|Relapsing Multiple Sclerosis|relapsing multiple sclerosis
4856799|NCT02294045|Knee|knee
4856800|NCT02294045|Healthy|healthy
4856801|NCT02294045|arthroscopy|arthroscopy
4856802|NCT02294045|MRI|mri
4856803|NCT02294045|amplification|amplification
4856804|NCT02294045|sounds|sounds
4856805|NCT02294045|pre-operative|pre-operative
4856806|NCT02294045|analyzing|analyzing
4856807|NCT02294032|Bcells|bcells
4856808|NCT02294032|kidney allograft dysfunction|kidney allograft dysfunction
4856809|NCT02294032|antibody mediated rejection|antibody mediated rejection
4856810|NCT02294019|ibuprofen 400 mg|ibuprofen 400 mg
4856811|NCT02294019|actual use|actual use
4856812|NCT02294019|compliance|compliance
4856813|NCT02294006|pancreatic|pancreatic
4856814|NCT02294006|neuroendocrine|neuroendocrine
4856815|NCT02294006|everolimus|everolimus
4856816|NCT02294006|metformin|metformin
4856817|NCT02294006|octreotide|octreotide
4856818|NCT02293941|liver inflammation|liver inflammation
4856819|NCT02293928|Hybrid coronary revascularization|hybrid coronary revascularization
4856820|NCT02293928|Antiplatelet therapy|antiplatelet therapy
4856821|NCT02293928|Aspirin|aspirin
4856822|NCT02293928|Clopidogrel|clopidogrel
4856823|NCT02293889|Knee osteoarthritis|knee osteoarthritis
4856824|NCT02293889|Pain|pain
4856825|NCT02293889|Vitamin D|vitamin d
4856826|NCT02293889|Physical activity|physical activity
4856827|NCT02293889|Pilot study|pilot study
4856828|NCT02293889|Qualitative Interview|qualitative interview
4856829|NCT02293889|Obesity|obesity
4856830|NCT02293889|Older adults|older adults
4856831|NCT02293876|Corneal Diseases|corneal diseases
4856832|NCT02293876|Corneal Ulcer|corneal ulcer
4856833|NCT02293876|Nursing Diagnosis|nursing diagnosis
4856834|NCT02293876|Intensive Care Units|intensive care units
4856835|NCT02293876|Nursing|nursing
4856836|NCT02293876|Randomized Clinical Trial|randomized clinical trial
4856837|NCT02293837|interleukin-6 (IL-6) receptor inhibitor|interleukin-6 (il-6) receptor inhibitor
4856838|NCT02293824|Infant, Premature|infant, premature
4856839|NCT02293824|Caffeine|caffeine
4856840|NCT02293824|Pharmacokinetics|pharmacokinetics
4856841|NCT02293824|Metabolism|metabolism
4856842|NCT02293772|Bedrest|bedrest
4856843|NCT02293772|Appetite|appetite
4856844|NCT02293759|BPH- LASER- PROSTATE- BLEEDING TENDENCY|bph- laser- prostate- bleeding tendency
4856845|NCT02293746|Obstructive Sleep Apnea|obstructive sleep apnea
4856847|NCT02293746|neurostimulation|neurostimulation
4856848|NCT02293746|hypoglossal nerve|hypoglossal nerve
4856849|NCT02293746|tongue|tongue
4856850|NCT02293746|upper airway stimulation|upper airway stimulation
4856851|NCT02293746|surgery|surgery
4856852|NCT02293733|Retrospective|retrospective
4856853|NCT02293733|EGFR|egfr
4856854|NCT02293733|mutation|mutation
4856855|NCT02293733|TKI|tki
4856856|NCT02293733|NSCLC|nsclc
4856857|NCT02293707|Castration-resistant prostate cancer|castration-resistant prostate cancer
4856858|NCT02293707|Therapeutic vaccine|therapeutic vaccine
4856859|NCT02293707|Telomerase vaccine|telomerase vaccine
4856860|NCT02293694|DMPA-SC: depo medroxyprogesterone acetate sub-cutaneous|dmpa-sc: depo medroxyprogesterone acetate sub-cutaneous
4856959|NCT02293252|Home Telemonitoring|home telemonitoring
4856861|NCT02293694|DMPA-IM: depo medroxyprogesterone acetate intramuscular|dmpa-im: depo medroxyprogesterone acetate intramuscular
4856862|NCT02293681|Spondylitis, Ankylosing|spondylitis, ankylosing
4856863|NCT02293681|Infliximab|infliximab
4856864|NCT02293681|Non-steroidal anti-inflammatory drugs|non-steroidal anti-inflammatory drugs
4856865|NCT02293681|Disease-modifying anti-rheumatic drugs|disease-modifying anti-rheumatic drugs
4856866|NCT02293668|poor responders|poor responders
4856867|NCT02293655|ADHD|adhd
4856868|NCT02293655|inattention|inattention
4856869|NCT02293655|hyperactivity|hyperactivity
4856870|NCT02293655|methylphenidate|methylphenidate
4856871|NCT02293642|primary cancers of the breast|primary cancers of the breast
4856872|NCT02293642|primary cancers of the kidney|primary cancers of the kidney
4856873|NCT02293642|primary cancers of the lung|primary cancers of the lung
4856874|NCT02293642|primary cancers of the prostate|primary cancers of the prostate
4856875|NCT02293629|Subjects|subjects
4856876|NCT02293616|ICU|icu
4856877|NCT02293616|Respiratory Failure|respiratory failure
4856878|NCT02293616|Weakness|weakness
4856879|NCT02293616|Nitrate supplementation|nitrate supplementation
4856880|NCT02293603|cardiomyopathy|cardiomyopathy
4856881|NCT02293603|cardiosphere-derived stem cells|cardiosphere-derived stem cells
4856882|NCT02293603|intracoronary infusion|intracoronary infusion
4856883|NCT02293603|adult stem cells|adult stem cells
4856884|NCT02293603|heart disease|heart disease
4856885|NCT02293603|ventricular dysfunction|ventricular dysfunction
4856886|NCT02293603|pathological processes|pathological processes
4856887|NCT02293603|cardiovascular diseases|cardiovascular diseases
4856888|NCT02293603|heart failure|heart failure
4856889|NCT02293590|Certolizumab pegol|certolizumab pegol
4856890|NCT02293590|DMARD|dmard
4856891|NCT02293590|Joint injection|joint injection
4856892|NCT02293590|Glucocorticoids|glucocorticoids
4856893|NCT02293564|Erosive Osteoarthritis|erosive osteoarthritis
4856894|NCT02293564|Osteoarthritis|osteoarthritis
4856895|NCT02293564|Osteoarthritis of the Hand|osteoarthritis of the hand
4856896|NCT02293538|Symptoms of Contact Lens Related Discomfort|symptoms of contact lens related discomfort
4856897|NCT02293512|Tinnitus|tinnitus
4856898|NCT02293512|Coping|coping
4856899|NCT02293512|Psychoeducational intervention|psychoeducational intervention
4856900|NCT02293499|asthma|asthma
4856901|NCT02293499|adolescent|adolescent
4856902|NCT02293499|intervention|intervention
4856903|NCT02293486|Antioxidants|antioxidants
4856904|NCT02293486|Protein Carbonylation|protein carbonylation
4856905|NCT02293486|Malondialdehyde|malondialdehyde
4856906|NCT02293486|Punicaceae|punicaceae
4856907|NCT02293486|Athletic Performance|athletic performance
4856908|NCT02293460|Peripheral neuropathy|peripheral neuropathy
4856909|NCT02293460|Disimmune disease|disimmune disease
4856910|NCT02293460|Neurology Chronic disease|neurology chronic disease
4856911|NCT02293460|Rare disease|rare disease
4856912|NCT02293447|Uterine|uterine
4856913|NCT02293447|Fibroid|fibroid
4856914|NCT02293447|Embolization|embolization
4856915|NCT02293447|Leiomyoma|leiomyoma
4856916|NCT02293447|Lidocaine|lidocaine
4856917|NCT02293447|Pain|pain
4856918|NCT02293434|Malnutrition|malnutrition
4856919|NCT02293434|Status Nutritional Weight|status nutritional weight
4856920|NCT02293434|Pediatric intensive care|pediatric intensive care
4856921|NCT02293408|MPS IIIB|mps iiib
4856922|NCT02293408|Mucopolysaccharidosis|mucopolysaccharidosis
4856923|NCT02293408|Mucopolysaccharidosis type IIIB|mucopolysaccharidosis type iiib
4856924|NCT02293408|Sanfilippo Syndrome|sanfilippo syndrome
4856925|NCT02293395|Acute Coronary Syndrome|acute coronary syndrome
4856926|NCT02293395|Myocardial infarction|myocardial infarction
4856927|NCT02293395|Unstable angina|unstable angina
4856928|NCT02293395|Acetylsalicylic acid|acetylsalicylic acid
4856929|NCT02293395|Rivaroxaban|rivaroxaban
4856930|NCT02293395|JNJ-39039039|jnj-39039039
4856931|NCT02293395|Bay 59-7939|bay 59-7939
4856932|NCT02293395|Xarelto|xarelto
4856933|NCT02293395|Clopidogrel|clopidogrel
4856934|NCT02293395|Ticagrelor|ticagrelor
4856935|NCT02293395|Plavix|plavix
4856936|NCT02293395|Brilinta|brilinta
4856937|NCT02293395|Effient|effient
4856938|NCT02293382|MPS IIIB|mps iiib
4856939|NCT02293382|Mucopolysaccharodosis III|mucopolysaccharodosis iii
4856940|NCT02293382|Mucopolysaccharidosis type IIIB|mucopolysaccharidosis type iiib
4856941|NCT02293382|Sanfilippo Syndrome|sanfilippo syndrome
4856942|NCT02293343|histamine profile|histamine profile
4856943|NCT02293343|IgE Antibodies|ige antibodies
4856944|NCT02293330|continuous versus intermittent bolus sciatic nerve block|continuous versus intermittent bolus sciatic nerve block
4856945|NCT02293317|Influenza Prime universal vaccine M-001 Multimeric|influenza prime universal vaccine m-001 multimeric
4856946|NCT02293291|Gulf war illness|gulf war illness
4856947|NCT02293278|MVPA|mvpa
4856948|NCT02293278|sedentary behaviour|sedentary behaviour
4856949|NCT02293278|PA intervention|pa intervention
4856950|NCT02293278|preschool|preschool
4856951|NCT02293278|gross motor|gross motor
4856952|NCT02293278|anthropometrics|anthropometrics
4856953|NCT02293278|day care|day care
4856954|NCT02293265|mepolizumab|mepolizumab
4856955|NCT02293265|omalizumab|omalizumab
4856956|NCT02293265|SB-240563|sb-240563
4856957|NCT02293265|Severe Asthma|severe asthma
4856958|NCT02293265|reslizumab|reslizumab
4856960|NCT02293239|whole-body electromyostimulation|whole-body electromyostimulation
4856961|NCT02293239|cachexia|cachexia
4856962|NCT02293239|cancer|cancer
4856963|NCT02293239|skeletal muscle mass|skeletal muscle mass
4856964|NCT02293239|nutrition|nutrition
4856965|NCT02293213|Category D|category d
4856966|NCT02293213|Category X|category x
4856967|NCT02293213|Electronic Medical Records|electronic medical records
4856968|NCT02293213|Long Acting Reversible Contraception|long acting reversible contraception
4856969|NCT02293187|vitamin D|vitamin d
4856970|NCT02293187|muscle performance|muscle performance
4856971|NCT02293187|falls|falls
4856972|NCT02293161|Interleukin-7 Receptor α|interleukin-7 receptor α
4856973|NCT02293161|monoclonal antibody|monoclonal antibody
4856974|NCT02293148|Prolyl hydroxylase inhibitor|prolyl hydroxylase inhibitor
4856975|NCT02293148|GSK1278863|gsk1278863
4856976|NCT02293148|Anemia|anemia
4856977|NCT02293148|QTc|qtc
4856978|NCT02293148|erythropoiesis stimulating agent|erythropoiesis stimulating agent
4856979|NCT02293135|Type 2 diabetes ; endothelium stimulation|type 2 diabetes ; endothelium stimulation
4856980|NCT02293122|Agreement|agreement
4856981|NCT02293122|Repeatability|repeatability
4856982|NCT02293122|Reproducibility|reproducibility
4856983|NCT02293096|Genotype|genotype
4856984|NCT02293096|CYP2D6|cyp2d6
4856985|NCT02293096|ADRB1|adrb1
4856986|NCT02293057|Adolescent|adolescent
4856987|NCT02293057|Juvenile Justice|juvenile justice
4856988|NCT02293057|Drug Use|drug use
4856989|NCT02293057|Marijuana|marijuana
4856990|NCT02293057|Gender Responsive|gender responsive
4856991|NCT02293057|Girls|girls
4856992|NCT02293057|HIV|hiv
4856993|NCT02293057|Sexual Risk|sexual risk
4856994|NCT02293044|Sensitivity|sensitivity
4856995|NCT02293031|maxillofacial bone defects|maxillofacial bone defects
4856996|NCT02293031|alveolar ridge atrophy|alveolar ridge atrophy
4856997|NCT02293031|gene-activated matrix|gene-activated matrix
4856998|NCT02293031|VEGF gene|vegf gene
4856999|NCT02293031|DNA plasmid|dna plasmid
4857000|NCT02293031|bone gene therapy|bone gene therapy
4857001|NCT02293005|Lung Cancer|lung cancer
4857002|NCT02293005|Mesothelioma|mesothelioma
4857003|NCT02293005|Unresectable malignant pleural mesothelioma|unresectable malignant pleural mesothelioma
4857004|NCT02293005|MPM|mpm
4857005|NCT02293005|Alisertib|alisertib
4857006|NCT02293005|MLN8237|mln8237
4857007|NCT02292992|Electrical impedance tomography|electrical impedance tomography
4857008|NCT02292992|Nasal Pillow Continuous Positive Airway Pressure(CPAP)|nasal pillow continuous positive airway pressure(cpap)
4857009|NCT02292992|High Flow Nasal Cannula|high flow nasal cannula
4857010|NCT02292992|extubation|extubation
4857011|NCT02292979|HL|hl
4857012|NCT02292966|Hepatitis C|hepatitis c
4857013|NCT02292966|Hepatitis|hepatitis
4857014|NCT02292966|Asunaprevir|asunaprevir
4857015|NCT02292966|Daclatasvir|daclatasvir
4857016|NCT02292966|Beclabuvir|beclabuvir
4857017|NCT02292966|Neurocognitive function|neurocognitive function
4857018|NCT02292966|Brain metabolites|brain metabolites
4857019|NCT02292966|Direct acting antiviral therapy|direct acting antiviral therapy
4857020|NCT02292953|ICSI|icsi
4857021|NCT02292953|Ovum Pickup|ovum pickup
4857022|NCT02292953|Embryo Transfer|embryo transfer
4857023|NCT02292940|patient outcome assessment|patient outcome assessment
4857024|NCT02292940|electronic health records|electronic health records
4857025|NCT02292888|Doppler VTI TEE SV volume responsiveness|doppler vti tee sv volume responsiveness
4857026|NCT02292875|Grass Allergy|grass allergy
4857027|NCT02292875|Rhinoconjunctivitis|rhinoconjunctivitis
4857028|NCT02292875|Environmental Exposure Unit|environmental exposure unit
4857029|NCT02292875|Immunotherapy|immunotherapy
4857030|NCT02292875|ToleroMune Grass|toleromune grass
4857031|NCT02292849|Depression|depression
4857032|NCT02292823|STEMI|stemi
4857033|NCT02292823|heart attack|heart attack
4857034|NCT02292823|stent|stent
4857035|NCT02292823|Bare Metal Stent|bare metal stent
4857036|NCT02292823|myocardial infarction|myocardial infarction
4857037|NCT02292823|PCI|pci
4857038|NCT02292784|infants|infants
4857039|NCT02292784|retosiban|retosiban
4857040|NCT02292784|Preterm Labor|preterm labor
4857041|NCT02292784|long-term safety follow-up|long-term safety follow-up
4857042|NCT02292771|Spontaneous Preterm Labor|spontaneous preterm labor
4857043|NCT02292771|retosiban|retosiban
4857044|NCT02292771|GSK221149|gsk221149
4857045|NCT02292771|atosiban|atosiban
4857046|NCT02292745|locally advanced pancreatic cancer|locally advanced pancreatic cancer
4857047|NCT02292745|chemotherapy|chemotherapy
4857048|NCT02292745|stereotactic radiotherapy|stereotactic radiotherapy
4857049|NCT02292732|Pharmacokinetics|pharmacokinetics
4857050|NCT02292732|Solid Tumors|solid tumors
4857051|NCT02292732|Safety|safety
4857052|NCT02292732|Trametinib|trametinib
4857053|NCT02292732|MEK Inhibitor|mek inhibitor
4857054|NCT02292732|Combined Oral Contraceptive|combined oral contraceptive
4857055|NCT02292732|Trametinib's Metabolite M5|trametinib's metabolite m5
4857056|NCT02292732|Norethindrone|norethindrone
4857057|NCT02292732|Ethinyl Estradiol|ethinyl estradiol
4857058|NCT02292719|Hepatitis C Virus|hepatitis c virus
4857059|NCT02292719|Genotype 2|genotype 2
4857060|NCT02292719|Chronic Hepatitis C|chronic hepatitis c
4857061|NCT02292719|Genotype 3|genotype 3
4857062|NCT02292719|Non-cirrhotic|non-cirrhotic
4857063|NCT02292719|Cirrhotic|cirrhotic
4857064|NCT02292706|HCV Cirrhosis registry|hcv cirrhosis registry
4857065|NCT02292706|Cirrhosis|cirrhosis
4857066|NCT02292706|Hepatitis C|hepatitis c
4857067|NCT02292693|intubation|intubation
4857068|NCT02292680|dentin|dentin
4857069|NCT02292680|environmental exposures|environmental exposures
4857070|NCT02292680|neurodevelopmental outcomes|neurodevelopmental outcomes
4857071|NCT02292667|Transversus Abdominis Plane Block|transversus abdominis plane block
4857072|NCT02292667|Postoperative Pain Management|postoperative pain management
4857073|NCT02292667|Open Repair of Aortic Abdominal Aneurysm|open repair of aortic abdominal aneurysm
4857074|NCT02292641|Lower Gastrointestinal Tract|lower gastrointestinal tract
4857075|NCT02292641|Rectum|rectum
4857076|NCT02292641|Diagnostic Imaging|diagnostic imaging
4857077|NCT02292641|Magnetic Resonance Imaging|magnetic resonance imaging
4857078|NCT02292641|Pelvic Exenteration|pelvic exenteration
4857079|NCT02292641|Neoplasms|neoplasms
4857080|NCT02292641|Adenocarcinoma|adenocarcinoma
4857081|NCT02292641|Carcinoma|carcinoma
4857082|NCT02292602|preschool|preschool
4857083|NCT02292602|obesity|obesity
4857084|NCT02292602|health disparities|health disparities
4857085|NCT02292602|intervention|intervention
4857086|NCT02292589|Traumatic Brain Injury|traumatic brain injury
4857087|NCT02292589|Post concussion syndrome|post concussion syndrome
4857088|NCT02292589|Transcranial Direct Current Stimulation|transcranial direct current stimulation
4857089|NCT02292589|Neuromodulation|neuromodulation
4857090|NCT02292576|volunteers|volunteers
4857091|NCT02292563|Nurse; Colonoscopy; Polyp; Adenoma;|nurse; colonoscopy; polyp; adenoma;
4857092|NCT02292550|Non-small cell lung cancer,|non-small cell lung cancer,
4857093|NCT02292550|ALK translocation,|alk translocation,
4857094|NCT02292550|ALK-positive,|alk-positive,
4857095|NCT02292550|NSCLC,|nsclc,
4857096|NCT02292550|LEE011,|lee011,
4857097|NCT02292550|CDK4/6 inhibitor,|cdk4/6 inhibitor,
4857098|NCT02292550|EML4-ALK|eml4-alk
4857099|NCT02292537|Spinal Muscular Atrophy|spinal muscular atrophy
4857100|NCT02292537|SMA|sma
4857101|NCT02292537|SMN|smn
4857102|NCT02292537|SMNRx|smnrx
4857103|NCT02292537|ISIS-SMNRx|isis-smnrx
4857104|NCT02292537|ISIS-SMN Rx|isis-smn rx
4857105|NCT02292537|ISIS 396443|isis 396443
4857106|NCT02292537|CHERISH|cherish
4857107|NCT02292537|IONIS-SMNRx|ionis-smnrx
4857108|NCT02292537|IONIS-SMN Rx|ionis-smn rx
4857109|NCT02292511|subjective cognitive impairment|subjective cognitive impairment
4857110|NCT02292511|mind-motor intervention|mind-motor intervention
4857111|NCT02292511|square-stepping exercise|square-stepping exercise
4857112|NCT02292511|older adults|older adults
4857113|NCT02292498|imaging, diagnostic|imaging, diagnostic
4857114|NCT02292498|feasibility|feasibility
4857115|NCT02292485|Lung Cancer Screening|lung cancer screening
4857116|NCT02292485|LCS|lcs
4857117|NCT02292485|Survey|survey
4857118|NCT02292485|Questionnaire|questionnaire
4857119|NCT02292485|Texas Academy of Family Physicians|texas academy of family physicians
4857120|NCT02292472|masticatory muscles|masticatory muscles
4857121|NCT02292446|Polycythemia Vera|polycythemia vera
4857122|NCT02292446|Hematologic Diseases|hematologic diseases
4857123|NCT02292446|Myeloproliferative Disorders|myeloproliferative disorders
4857124|NCT02292446|INC424|inc424
4857125|NCT02292446|Ruxolitinib|ruxolitinib
4857126|NCT02292433|Phase 1|phase 1
4857127|NCT02292433|type 2 diabetes|type 2 diabetes
4857128|NCT02292433|monotherapy|monotherapy
4857129|NCT02292433|PF-04937319|pf-04937319
4857130|NCT02292420|pulse oximetry plethymographic waveform|pulse oximetry plethymographic waveform
4857131|NCT02292420|area under curve|area under curve
4857132|NCT02292420|amplitude|amplitude
4857133|NCT02292394|Depression|depression
4857134|NCT02292394|Depressive symptoms|depressive symptoms
4857135|NCT02292394|Prevention|prevention
4857136|NCT02292394|Caregivers|caregivers
4857137|NCT02292394|Telephone intervention|telephone intervention
4857138|NCT02292368|Head and Neck Cancer|head and neck cancer
4857139|NCT02292368|Xerostomia|xerostomia
4857140|NCT02292368|Radiation-induced Xerostomia|radiation-induced xerostomia
4857141|NCT02292368|Acupuncture|acupuncture
4857142|NCT02292368|Nasopharyngeal cancer|nasopharyngeal cancer
4857143|NCT02292368|Radiation therapy|radiation therapy
4857144|NCT02292368|XRT|xrt
4857145|NCT02292368|Electroencephalogram|electroencephalogram
4857146|NCT02292368|EEG|eeg
4857147|NCT02292368|Xerostomia questionnaire|xerostomia questionnaire
4857148|NCT02292368|XQ|xq
4857149|NCT02292368|MD Anderson Symptom Inventory - Head & Neck|md anderson symptom inventory - head & neck
4857150|NCT02292368|MDASI-HN|mdasi-hn
4857151|NCT02292368|Questionnaires|questionnaires
4857152|NCT02292368|Surveys|surveys
4857153|NCT02292355|Temporomandibular Joint Disorders|temporomandibular joint disorders
4857154|NCT02292355|posture|posture
4857155|NCT02292355|pain|pain
4857156|NCT02292355|clinical trial|clinical trial
4857157|NCT02292355|Pilates|pilates
4857158|NCT02292342|Flow mediated dilatation|flow mediated dilatation
4857159|NCT02292329|flow-mediated dilation|flow-mediated dilation
4857160|NCT02292329|Acai polyphenols|acai polyphenols
4857161|NCT02292316|middle-aged and aged adults|middle-aged and aged adults
4857162|NCT02292316|fall in the previous year|fall in the previous year
4857163|NCT02292303|Zinc/pharmacokinetics|zinc/pharmacokinetics
4857164|NCT02292290|Diabetes|diabetes
4857165|NCT02292290|Liraglutide|liraglutide
4857166|NCT02292290|Ramadan|ramadan
4857167|NCT02292290|fasting|fasting
4857168|NCT02292277|Ticagrelor|ticagrelor
4857169|NCT02292277|Pharmacokinetics|pharmacokinetics
4857170|NCT02292277|Platelet Aggregation|platelet aggregation
4857171|NCT02292277|Platelet Function Tests|platelet function tests
4857172|NCT02292251|Stroke|stroke
4857173|NCT02292251|Transcranial direct current stimulation|transcranial direct current stimulation
4857174|NCT02292238|Alzheimer's disease|alzheimer's disease
4857175|NCT02292238|benfotiamine|benfotiamine
4857176|NCT02292238|glucose|glucose
4857177|NCT02292238|Amyloid|amyloid
4857178|NCT02292225|Phase 1b, CLL/SLL, PI3K|phase 1b, cll/sll, pi3k
4857179|NCT02292199|Hypertension|hypertension
4857180|NCT02292199|TENS|tens
4857181|NCT02292199|Sympathetic and Parasympathetic nervous system|sympathetic and parasympathetic nervous system
4857182|NCT02292186|Cardiomyopathy|cardiomyopathy
4857183|NCT02292186|Heart Failure|heart failure
4857184|NCT02292186|FAC|fac
4857185|NCT02292186|Amyloid|amyloid
4857186|NCT02292186|Transthyretin|transthyretin
4857187|NCT02292186|TTR|ttr
4857188|NCT02292186|RNAi therapeutic|rnai therapeutic
4857189|NCT02292173|Liver Neoplasms|liver neoplasms
4857190|NCT02292173|Liver Diseases|liver diseases
4857191|NCT02292173|Digestive System Diseases|digestive system diseases
4857192|NCT02292173|Advanced|advanced
4857193|NCT02292173|Mitogen-Activated Protein Kinase (MEK) Inhibitor|mitogen-activated protein kinase (mek) inhibitor
4857194|NCT02292173|Kinase Inhibitor|kinase inhibitor
4857195|NCT02292147|Cerebral anoxia|cerebral anoxia
4857196|NCT02292147|Functional outcome|functional outcome
4857197|NCT02292134|Sleep quality|sleep quality
4857198|NCT02292134|Sleep architecture|sleep architecture
4857199|NCT02292134|Intensive care unit|intensive care unit
4857200|NCT02292134|Light|light
4857201|NCT02292134|Noise|noise
4857202|NCT02292134|Earplug|earplug
4857203|NCT02292134|Sleep mask|sleep mask
4857204|NCT02292121|Obesity|obesity
4857205|NCT02292121|Intestinal permeability|intestinal permeability
4857206|NCT02292121|Adipose tissue inflammation|adipose tissue inflammation
4857207|NCT02292121|Low grade systemic inflammation|low grade systemic inflammation
4857208|NCT02292121|Bariatric surgery|bariatric surgery
4857209|NCT02292108|Hypnosis|hypnosis
4857210|NCT02292108|self-hypnosis|self-hypnosis
4857211|NCT02292108|obesity|obesity
4857212|NCT02292108|high food impulsiveness|high food impulsiveness
4857213|NCT02292095|anesthesia|anesthesia
4857214|NCT02292095|transverse abdominis plane block|transverse abdominis plane block
4857215|NCT02292095|patient controlled intravenous analgesia|patient controlled intravenous analgesia
4857216|NCT02292082|Nerve Block|nerve block
4857217|NCT02292082|Rehabilitation|rehabilitation
4857218|NCT02292082|Knee Replacement, Total|knee replacement, total
4857219|NCT02291991|Safety|safety
4857220|NCT02291991|Tolerability|tolerability
4857221|NCT02291991|Pharmacokinetics|pharmacokinetics
4857222|NCT02291991|Pharmacodynamics|pharmacodynamics
4857223|NCT02291991|Immunogenecity|immunogenecity
4857224|NCT02291978|back pain|back pain
4857225|NCT02291978|facet joint|facet joint
4857226|NCT02291978|spine|spine
4857227|NCT02291965|hematopoietic cell transplant|hematopoietic cell transplant
4857228|NCT02291952|Circadian Misalignment, Forced Desynchrony, Metabolism, Meal-timing, Circadian|circadian misalignment, forced desynchrony, metabolism, meal-timing, circadian
4857229|NCT02291926|Human Umbilical Cord Mesenchymal Stem Cell|human umbilical cord mesenchymal stem cell
4857230|NCT02291926|Mesenchymal Stem Cell|mesenchymal stem cell
4857231|NCT02291926|Osteoarthritis|osteoarthritis
4857232|NCT02291913|ER-Positive Breast Cancer|er-positive breast cancer
4857233|NCT02291913|HER2-Negative Breast Cancer|her2-negative breast cancer
4857234|NCT02291913|everolimus|everolimus
4857235|NCT02291913|anti-estrogen therapy|anti-estrogen therapy
4857236|NCT02291913|PR-Positive Breast Cancer|pr-positive breast cancer
4857237|NCT02291913|Afinitor|afinitor
4857238|NCT02291900|avascular necrosis, talus, medial femoral condyle|avascular necrosis, talus, medial femoral condyle
4857239|NCT02291874|Diabetes|diabetes
4857240|NCT02291874|Ipragliflozin|ipragliflozin
4857241|NCT02291874|GLP-1 receptor agonist|glp-1 receptor agonist
4857242|NCT02291861|Dyskinesias|dyskinesias
4857243|NCT02291861|Movement Disorders|movement disorders
4857244|NCT02291861|Central Nervous System Diseases|central nervous system diseases
4857245|NCT02291861|Nervous System Diseases|nervous system diseases
4857246|NCT02291861|Neurologic Manifestations|neurologic manifestations
4857247|NCT02291861|Signs and Symptoms|signs and symptoms
4857248|NCT02291848|Multiple Myeloma|multiple myeloma
4857249|NCT02291848|Cytotoxic T-lymphocytes|cytotoxic t-lymphocytes
4857250|NCT02291809|HIV/AIDS|hiv/aids
4857251|NCT02291809|Pediatric|pediatric
4857252|NCT02291809|Vaccine|vaccine
4857253|NCT02291809|HIV-1 Immunogen|hiv-1 immunogen
4857254|NCT02291796|Bezafibrate|bezafibrate
4857255|NCT02291796|Hyperfibrinogenemia|hyperfibrinogenemia
4857256|NCT02291796|Inflammatory response|inflammatory response
4857257|NCT02291796|Acute myocardial infarction|acute myocardial infarction
4857258|NCT02291796|Mayor cardiovascular events|mayor cardiovascular events
4857259|NCT02291770|Chronic Graft-Versus-Host Disease|chronic graft-versus-host disease
4857260|NCT02291770|Mesenchymal Stromal Cells|mesenchymal stromal cells
4857261|NCT02291744|TFS (time to failure of strategy)|tfs (time to failure of strategy)
4857262|NCT02291731|Autologous serum eye drops|autologous serum eye drops
4857263|NCT02291731|Silicone-hydrogel contact lens|silicone-hydrogel contact lens
4857264|NCT02291731|Persistent epithelial defects|persistent epithelial defects
4857265|NCT02291731|Corneal epithelial defects|corneal epithelial defects
4857266|NCT02291718|Suspected or confirmed|suspected or confirmed
4857267|NCT02291718|TAA|taa
4857268|NCT02291718|Computed tomography angiography|computed tomography angiography
4857269|NCT02291718|CTA|cta
4857270|NCT02291718|Contrast agent|contrast agent
4857271|NCT02291718|Radiation dose|radiation dose
4857272|NCT02291718|Thoracoabdominal aortic aneurysm|thoracoabdominal aortic aneurysm
4857273|NCT02291705|Ultrasound, rectus sheath block, children, inguinal hernia|ultrasound, rectus sheath block, children, inguinal hernia
4857274|NCT02291666|Cytochromes p450|cytochromes p450
4857275|NCT02291666|drug metabolism|drug metabolism
4857276|NCT02291666|pharmacokinetics|pharmacokinetics
4857277|NCT02291666|diabetes|diabetes
4857278|NCT02291666|probe markers|probe markers
4857279|NCT02291614|Amgen|amgen
4857280|NCT02291614|Phase 1|phase 1
4857281|NCT02291614|Clinical Trial|clinical trial
4857282|NCT02291614|Oncology|oncology
4857283|NCT02291614|GI adenocarcinoma|gi adenocarcinoma
4857284|NCT02291614|Immunotherapy|immunotherapy
4857285|NCT02291549|endoscopic sinus surgery|endoscopic sinus surgery
4857286|NCT02291549|corticosteroid|corticosteroid
4857287|NCT02291549|chronic rhinosinusitis|chronic rhinosinusitis
4857288|NCT02291549|mometasone furoate|mometasone furoate
4857289|NCT02291549|polyposis|polyposis
4857290|NCT02291536|THC and CBD|thc and cbd
4857291|NCT02291536|Attentional blink|attentional blink
4857292|NCT02291523|Fecal transplant|fecal transplant
4857293|NCT02291484|Computed tomography|computed tomography
4857294|NCT02291484|Coronary angiography|coronary angiography
4857295|NCT02291484|Coronary artery disease|coronary artery disease
4857296|NCT02291484|Perfusion imaging|perfusion imaging
4857297|NCT02291484|Comparative effectiveness|comparative effectiveness
4857298|NCT02291484|Randomized controlled trial|randomized controlled trial
4857299|NCT02291484|Cost-effectiveness|cost-effectiveness
4857300|NCT02291445|Peppermint oil|peppermint oil
4857301|NCT02291445|Menthol|menthol
4857302|NCT02291445|Volatile oil|volatile oil
4857303|NCT02291445|Plant oil|plant oil
4857304|NCT02291445|Visceral pain|visceral pain
4857305|NCT02291445|Abdominal pain|abdominal pain
4857306|NCT02291445|Irritable bowel syndrome (IBS)|irritable bowel syndrome (ibs)
4857307|NCT02291445|Colonic disease|colonic disease
4857308|NCT02291419|ticagrelor|ticagrelor
4857309|NCT02291419|non-cardiac surgery|non-cardiac surgery
4857310|NCT02291419|elevated troponin|elevated troponin
4857311|NCT02291419|myocardial injury|myocardial injury
4857312|NCT02291406|Hysterectomy|hysterectomy
4857313|NCT02291406|Insulin resistance|insulin resistance
4857314|NCT02291406|Metabolism|metabolism
4857315|NCT02291380|Chronic Migraine|chronic migraine
4857316|NCT02291380|Botulinum Toxin Type A for Injection|botulinum toxin type a for injection
4857317|NCT02291354|Fecal Microbiota Transplantation|fecal microbiota transplantation
4857318|NCT02291354|Soluble Dietary Fiber|soluble dietary fiber
4857319|NCT02291354|Slow Transit Constipation|slow transit constipation
4857320|NCT02291315|Triple Stable Isotope|triple stable isotope
4857321|NCT02291263|Polio|polio
4857322|NCT02291263|Inactivated polio vaccine|inactivated polio vaccine
4857323|NCT02291263|IPV|ipv
4857324|NCT02291263|oral polio vaccine|oral polio vaccine
4857325|NCT02291250|anthocyanin|anthocyanin
4857326|NCT02291250|blackcurrant|blackcurrant
4857327|NCT02291250|greencurrant|greencurrant
4857328|NCT02291250|glucose|glucose
4857329|NCT02291250|polyphenol|polyphenol
4857330|NCT02291250|post prandial glucose|post prandial glucose
4857331|NCT02291237|hypertrophic cardiomyopathy|hypertrophic cardiomyopathy
4857332|NCT02291237|hcm|hcm
4857333|NCT02291237|hocm|hocm
4857334|NCT02291237|hypertrophic myocardiopathy|hypertrophic myocardiopathy
4857335|NCT02291237|hypertrophic obstructive cardiomyopathies|hypertrophic obstructive cardiomyopathies
4857336|NCT02291237|cardiomyopathy|cardiomyopathy
4857337|NCT02291237|hypertrophic|hypertrophic
4857338|NCT02291237|familial hypertrophic cardiomyopathy|familial hypertrophic cardiomyopathy
4857339|NCT02291237|genetic heart disease|genetic heart disease
4857340|NCT02291237|echocardiography|echocardiography
4857341|NCT02291237|cardiopulmonary exercise testing|cardiopulmonary exercise testing
4857342|NCT02291237|exercise Capacity|exercise capacity
4857343|NCT02291237|heart failure|heart failure
4857344|NCT02291237|angina|angina
4857345|NCT02291237|dyspnea|dyspnea
4857346|NCT02291237|diastolic dysfunction|diastolic dysfunction
4857347|NCT02291237|microvascular ischemia|microvascular ischemia
4857348|NCT02291237|late sodium current inhibitor|late sodium current inhibitor
4857349|NCT02291237|GS-6615|gs-6615
4857350|NCT02291237|late INA|late ina
4857351|NCT02291224|dual protection|dual protection
4857352|NCT02291224|pregnancy|pregnancy
4857353|NCT02291224|reproductive health|reproductive health
4857354|NCT02291224|sexually transmitted diseases|sexually transmitted diseases
4857355|NCT02291224|condoms|condoms
4857356|NCT02291224|contraception|contraception
4857357|NCT02291224|adolescent health services|adolescent health services
4857358|NCT02291198|colorectal cancer|colorectal cancer
4857359|NCT02291198|natural killer cell activity|natural killer cell activity
4857360|NCT02291198|screening|screening
4857361|NCT02291198|NK cells|nk cells
4857362|NCT02291159|stroke|stroke
4857363|NCT02291159|spasticity|spasticity
4857364|NCT02291159|dry needling|dry needling
4857365|NCT02291159|upper motor neuron syndrome|upper motor neuron syndrome
4857366|NCT02291159|motor function|motor function
4857367|NCT02291146|gardening|gardening
4857368|NCT02291146|cooking|cooking
4857369|NCT02291146|nutrition education|nutrition education
4857370|NCT02291146|Hispanic Americans|hispanic americans
4857371|NCT02291133|Primary liver tumors|primary liver tumors
4857372|NCT02291133|Bleomycin|bleomycin
4857373|NCT02291133|Electrochemotherapy|electrochemotherapy
4857374|NCT02291107|Gait orthosis|gait orthosis
4857375|NCT02291107|Lokomat|lokomat
4857376|NCT02291107|Robotic Rehabilitation|robotic rehabilitation
4857377|NCT02291094|Intravenous lidocaine|intravenous lidocaine
4857378|NCT02291094|Mastectomy|mastectomy
4857379|NCT02291094|Pain|pain
4857380|NCT02291081|HIV, AIDS|hiv, aids
4857381|NCT02291081|antiretroviral therapy|antiretroviral therapy
4857382|NCT02291081|aging|aging
4857383|NCT02291081|heart failure|heart failure
4857384|NCT02291081|coronary heart disease|coronary heart disease
4857385|NCT02291081|myocardial infarction|myocardial infarction
4857386|NCT02291081|HIV-associated neurocognitive disorders|hiv-associated neurocognitive disorders
4857387|NCT02291042|Bladder|bladder
4857388|NCT02291042|Surgery|surgery
4857389|NCT02291029|Sjögren's syndrome, CFZ533, ESSDAI|sjögren's syndrome, cfz533, essdai
4857390|NCT02291016|COPD|copd
4857391|NCT02291016|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
4857392|NCT02291003|circadian|circadian
4857393|NCT02291003|sleep|sleep
4857394|NCT02290977|RT, TACE|rt, tace
4857395|NCT02290964|Acute normovolemic hemodilution|acute normovolemic hemodilution
4857396|NCT02290964|allogeneic transfusion|allogeneic transfusion
4857397|NCT02290938|adolescents|adolescents
4857398|NCT02290938|Native American|native american
4857399|NCT02290938|alcohol use|alcohol use
4857400|NCT02290938|drug use|drug use
4857401|NCT02290938|cultural|cultural
4857402|NCT02290938|traditional activities|traditional activities
4857403|NCT02290938|cultural identification|cultural identification
4857404|NCT02290925|biscuit containing Salacia reticulate|biscuit containing salacia reticulate
4857405|NCT02290925|randomised controlled trial|randomised controlled trial
4857406|NCT02290912|Alzheimer's disease prevention lifestyle intervention|alzheimer's disease prevention lifestyle intervention
4857407|NCT02290899|Attention Deficit Hyperactivity Disorder (ADHD)|attention deficit hyperactivity disorder (adhd)
4857408|NCT02290886|safety evaluation|safety evaluation
4857409|NCT02290886|intravenous administration|intravenous administration
4857410|NCT02290886|3 doses of autologous MSC|3 doses of autologous msc
4857411|NCT02290886|ALS|als
4857412|NCT02290834|Chemotherapy related cognitive impairment|chemotherapy related cognitive impairment
4857413|NCT02290834|Chemo-brain|chemo-brain
4857414|NCT02290808|physical|physical
4857415|NCT02290808|activity|activity
4857416|NCT02290808|exercise|exercise
4857417|NCT02290808|new-parents|new-parents
4857418|NCT02290808|intervention|intervention
4857419|NCT02290808|theory-based|theory-based
4857420|NCT02290795|Vitreopapillary traction|vitreopapillary traction
4857421|NCT02290782|toxicity|toxicity
4857422|NCT02290782|outcome|outcome
4857423|NCT02290782|TARGIT|targit
4857424|NCT02290782|quality of life|quality of life
4857425|NCT02290782|intraoperative radiotherapy (IORT)|intraoperative radiotherapy (iort)
4857426|NCT02290769|Guide wire cannulation ERCP|guide wire cannulation ercp
4857427|NCT02290769|Time of cannulation|time of cannulation
4857428|NCT02290769|Rapid exchange guide wire|rapid exchange guide wire
4857429|NCT02290769|Guide wire|guide wire
4857430|NCT02290756|Early child development|early child development
4857431|NCT02290756|Link Workers|link workers
4857432|NCT02290756|Community Birth attendants|community birth attendants
4857433|NCT02290756|Parenting Program|parenting program
4857434|NCT02290730|Lower trapezius|lower trapezius
4857435|NCT02290730|Kinesio taping|kinesio taping
4857436|NCT02290717|ultraviolet therapy|ultraviolet therapy
4857437|NCT02290717|non segmental|non segmental
4857438|NCT02290717|vitiligo|vitiligo
4857439|NCT02290717|topical corticosteroid|topical corticosteroid
4857440|NCT02290717|laser|laser
4857441|NCT02290717|fractional|fractional
4857442|NCT02290717|CO2|co2
4857443|NCT02290717|carbon dioxide|carbon dioxide
4857444|NCT02290717|UVB|uvb
4857445|NCT02290704|oxygen saturation|oxygen saturation
4857446|NCT02290704|retinal vessels|retinal vessels
4857447|NCT02290704|thyroid associated ophthalmopathy|thyroid associated ophthalmopathy
4857448|NCT02290691|Needle Free, Influenza|needle free, influenza
4857449|NCT02290678|Pilot Study|pilot study
4857450|NCT02290678|Adventure-based Programming|adventure-based programming
4857451|NCT02290665|enema|enema
4857452|NCT02290652|Sexual function in Orthopaedic patients|sexual function in orthopaedic patients
4857453|NCT02290639|Posttraumatic Stress|posttraumatic stress
4857454|NCT02290639|Posttraumatic Stress Disorder|posttraumatic stress disorder
4857455|NCT02290639|Military|military
4857456|NCT02290639|Primary Care|primary care
4857457|NCT02290639|Cognitive Behavioral Therapy|cognitive behavioral therapy
4857458|NCT02290639|Prolonged Exposure|prolonged exposure
4857459|NCT02290639|Cognitive Processing Therapy|cognitive processing therapy
4857460|NCT02290639|Behavioral Health Optimization Program|behavioral health optimization program
4857461|NCT02290639|Behavioral Health Consultant|behavioral health consultant
4857462|NCT02290626|Elemental diet|elemental diet
4857463|NCT02290626|semi-solid diet|semi-solid diet
4857464|NCT02290626|gastric emptying|gastric emptying
4857465|NCT02290626|GER|ger
4857466|NCT02290626|PEG|peg
4857467|NCT02290613|pulmonary hypertension|pulmonary hypertension
4857468|NCT02290613|systemic sclerosis|systemic sclerosis
4857469|NCT02290587|social cognitive|social cognitive
4857470|NCT02290587|theory of mind|theory of mind
4857471|NCT02290587|cognitive impairment|cognitive impairment
4857472|NCT02290587|functional MRI|functional mri
4857473|NCT02290587|brain activation network|brain activation network
4857474|NCT02290561|Prostatic Neoplasms|prostatic neoplasms
4857475|NCT02290561|Therapeutics|therapeutics
4857476|NCT02290561|Magnetic Resonance Imaging|magnetic resonance imaging
4857477|NCT02290561|Ultrasonography|ultrasonography
4857478|NCT02290561|High Intensity Focused Ultrasound|high intensity focused ultrasound
4857479|NCT02290561|Image Fusion|image fusion
4857480|NCT02290548|high flow nasal cannula|high flow nasal cannula
4857481|NCT02290548|extubation failure|extubation failure
4857482|NCT02290535|obstructive pulmonary disease|obstructive pulmonary disease
4857483|NCT02290535|children|children
4857484|NCT02290535|teenager|teenager
4857485|NCT02290535|EIT (Electrical Impedance Tomography)|eit (electrical impedance tomography)
4857486|NCT02290496|Insomnia|insomnia
4857487|NCT02290496|Depression|depression
4857488|NCT02290496|Teen|teen
4857489|NCT02290496|SSRI|ssri
4857490|NCT02290496|CBT|cbt
4857491|NCT02290496|Youth|youth
4857492|NCT02290470|Nausea|nausea
4857493|NCT02290470|Vomiting|vomiting
4857494|NCT02290457|resistance training|resistance training
4857495|NCT02290457|trunk muscle strength|trunk muscle strength
4857496|NCT02290457|physical fitness|physical fitness
4857497|NCT02290457|adolescent|adolescent
4857498|NCT02290444|Acute Relapsing Multiple Sclerosis|acute relapsing multiple sclerosis
4857499|NCT02290444|Relapsing-Remitting Multiple Sclerosis|relapsing-remitting multiple sclerosis
4857500|NCT02290444|Multiple Sclerosis, Chronic Progressive|multiple sclerosis, chronic progressive
4857501|NCT02290431|LBH589,|lbh589,
4857502|NCT02290431|panobinostat,|panobinostat,
4857503|NCT02290431|bortezomib,|bortezomib,
4857504|NCT02290431|dexamethasone,|dexamethasone,
4857505|NCT02290431|Phase II|phase ii
4857506|NCT02290418|Roux-en-Y Gastric Bypass|roux-en-y gastric bypass
4857507|NCT02290418|Omega-Loop Gastric Bypass|omega-loop gastric bypass
4857508|NCT02290418|"Mini-Gastric Bypass"|"mini-gastric bypass"
4857509|NCT02290405|insomnia|insomnia
4857510|NCT02290405|primary insomnia|primary insomnia
4857511|NCT02290405|chronic insomnia|chronic insomnia
4857512|NCT02290392|African American|african american
4857513|NCT02290353|Engagement|engagement
4857514|NCT02290353|Motivation|motivation
4857515|NCT02290353|Exergaming|exergaming
4857516|NCT02290340|Respiratory Syncytial Virus, RSV|respiratory syncytial virus, rsv
4857517|NCT02290327|Stress ulcer bleeding|stress ulcer bleeding
4857518|NCT02290327|proton pump inhibitors|proton pump inhibitors
4857519|NCT02290327|pneumonia|pneumonia
4857520|NCT02290327|clostridium difficile infection|clostridium difficile infection
4857521|NCT02290262|Heart disease|heart disease
4857522|NCT02290262|Phase one rehabilitation|phase one rehabilitation
4857523|NCT02290223|Chronic pain|chronic pain
4857524|NCT02290223|Analgesics, Opioid|analgesics, opioid
4857525|NCT02290223|Cognitive Therapy|cognitive therapy
4857526|NCT02290223|Behavior Therapy|behavior therapy
4857527|NCT02290223|Mindfulness|mindfulness
4857528|NCT02290223|Psychophysiology|psychophysiology
4857529|NCT02290223|Biofeedback, Psychology|biofeedback, psychology
4857530|NCT02290184|type 2 diabetes|type 2 diabetes
4857531|NCT02290184|cardiovascular disease prevention|cardiovascular disease prevention
4857532|NCT02290184|lifestyle intervention|lifestyle intervention
4857533|NCT02290184|physical activity|physical activity
4857534|NCT02290184|weight loss|weight loss
4857535|NCT02290184|nutrition|nutrition
4857536|NCT02290184|Filipinos|filipinos
4857537|NCT02290184|culturally appropriate|culturally appropriate
4857538|NCT02290158|treatment outcomes|treatment outcomes
4857539|NCT02290158|Malocclusion/therapy|malocclusion/therapy
4857540|NCT02290145|docetaxel, cisplatin, 5-FU, cyclinD1|docetaxel, cisplatin, 5-fu, cyclind1
4857541|NCT02290132|acute lymphoblastic leukemia|acute lymphoblastic leukemia
4857542|NCT02290132|lymphoblastic lymphoma|lymphoblastic lymphoma
4857543|NCT02290132|stem-cell transplant|stem-cell transplant
4857544|NCT02290132|T-cell lymphoma|t-cell lymphoma
4857545|NCT02290119|Primary PCL-retaining Total Knee Arthroplasty|primary pcl-retaining total knee arthroplasty
4857546|NCT02290119|Intraoperative Sensors|intraoperative sensors
4857547|NCT02290119|Ligament Balancing|ligament balancing
4857548|NCT02290119|Clinical Outcomes|clinical outcomes
4857549|NCT02290106|obesity|obesity
4857550|NCT02290106|insulin sensitivity|insulin sensitivity
4857551|NCT02290106|statin (HMG-CoA Reductase Inhibitor)|statin (hmg-coa reductase inhibitor)
4857552|NCT02290106|fatty liver|fatty liver
4857553|NCT02290093|Cathartics|cathartics
4857554|NCT02290093|Colonoscopy|colonoscopy
4857555|NCT02290093|Polyethylene Glycols|polyethylene glycols
4857556|NCT02290093|Elderly|elderly
4857557|NCT02290080|acute myocardial infarction (AMI)|acute myocardial infarction (ami)
4857558|NCT02290080|acute coronary syndrome (ACS)|acute coronary syndrome (acs)
4857559|NCT02290080|ST-segment elevation myocardial infarction (STEMI)|st-segment elevation myocardial infarction (stemi)
4857560|NCT02290080|Non ST-segment elevation myocardial infarction (NSTEMI)|non st-segment elevation myocardial infarction (nstemi)
4857561|NCT02290080|Ischemic Reperfusion injury (IR-injury)|ischemic reperfusion injury (ir-injury)
4857562|NCT02290080|Biomarkers|biomarkers
4857563|NCT02290080|Oxygen|oxygen
4857564|NCT02290080|Apoptosis|apoptosis
4857565|NCT02290080|Fluorescence-activated cell sorting (FACS)|fluorescence-activated cell sorting (facs)
4857566|NCT02290080|Flow cytometry|flow cytometry
4857567|NCT02290080|Matrix metalloproteinase (MMP)|matrix metalloproteinase (mmp)
4857568|NCT02290067|blood glucose monitoring system|blood glucose monitoring system
4857569|NCT02290067|system accuracy|system accuracy
4857570|NCT02290054|analgesia, epidural|analgesia, epidural
4857571|NCT02290054|urinary retention|urinary retention
4857572|NCT02290041|mesenchymal stem cells|mesenchymal stem cells
4857573|NCT02290041|HIV Infection|hiv infection
4857574|NCT02290041|discordant immunological response|discordant immunological response
4857575|NCT02290028|CRT-D therapy|crt-d therapy
4857576|NCT02290028|quadripolar left ventricular lead|quadripolar left ventricular lead
4857577|NCT02290015|Single Photon Emission Computed Tomography; Acupuncture|single photon emission computed tomography; acupuncture
4857578|NCT02289989|Atopic dermatitis|atopic dermatitis
4857579|NCT02289989|Oregano|oregano
4857580|NCT02289989|Atopic Dermatitis Quick (ADQ) score|atopic dermatitis quick (adq) score
4857581|NCT02289989|Eczema Area and Severity Index score|eczema area and severity index score
4857582|NCT02289989|Reflectance confocal microscopy|reflectance confocal microscopy
4857583|NCT02289976|talar avascular necrosis|talar avascular necrosis
4857584|NCT02289976|osteochondrosis dissecans|osteochondrosis dissecans
4857585|NCT02289976|femoral condyle|femoral condyle
4857586|NCT02289950|Ovarian Cancer in in first relapse|ovarian cancer in in first relapse
4857587|NCT02289950|Platinum-Sensitive|platinum-sensitive
4857588|NCT02289937|Postoperative pain|postoperative pain
4857589|NCT02289937|regional anaesthesia|regional anaesthesia
4857590|NCT02289937|total hip replacement|total hip replacement
4857591|NCT02289937|nervus cutaneous femoral lateralis|nervus cutaneous femoral lateralis
4857592|NCT02289924|wet AMD|wet amd
4857593|NCT02289911|ultrasound|ultrasound
4857594|NCT02289898|1st-line metastatic pancreatic ductal adenocarcinoma|1st-line metastatic pancreatic ductal adenocarcinoma
4857595|NCT02289885|trauma|trauma
4857596|NCT02289885|examination|examination
4857597|NCT02289885|knowledge|knowledge
4857598|NCT02289885|paramedic|paramedic
4857599|NCT02289820|RSV|rsv
4857600|NCT02289820|Older adults|older adults
4857601|NCT02289820|MEDI7510|medi7510
4857602|NCT02289820|Vaccine|vaccine
4857603|NCT02289807|Nasopharyngeal carcinoma|nasopharyngeal carcinoma
4857604|NCT02289807|Concurrent chemoradiotherapy|concurrent chemoradiotherapy
4857605|NCT02289807|intermediate risk|intermediate risk
4857606|NCT02289807|intensity-modulated radiotherapy|intensity-modulated radiotherapy
4857607|NCT02289794|Bioconjugate vaccine|bioconjugate vaccine
4857608|NCT02289794|Urinary tract infections|urinary tract infections
4857609|NCT02289755|Urine Oxalate|urine oxalate
4857610|NCT02289755|Nephrolithiasis|nephrolithiasis
4857611|NCT02289755|Kidney Stones|kidney stones
4857612|NCT02289755|Hyperoxaluria|hyperoxaluria
4857613|NCT02289755|Enteric Hyperoxaluria|enteric hyperoxaluria
4857614|NCT02289755|Idiopathic Hyperoxaluria|idiopathic hyperoxaluria
4857615|NCT02289755|Urological Diseases|urological diseases
4857616|NCT02289755|Kidney Diseases|kidney diseases
4857617|NCT02289742|Dailies AquaComfort Plus® Multifocal (DACP MF)|dailies aquacomfort plus® multifocal (dacp mf)
4857618|NCT02289742|Dailies AquaComfort Plus® Toric (DACP Toric)|dailies aquacomfort plus® toric (dacp toric)
4857619|NCT02289742|tear film stability|tear film stability
4857620|NCT02289742|Non-Invasive Keratograph Break-Up Time (NIK-BUT)|non-invasive keratograph break-up time (nik-but)
4857621|NCT02289729|Duodopa|duodopa
4857622|NCT02289729|Advanced Parkinson's Disease|advanced parkinson's disease
4857623|NCT02289729|Levodopa/Carbidopa intestinal gel|levodopa/carbidopa intestinal gel
4857624|NCT02289716|Osteoarthritis|osteoarthritis
4857625|NCT02289716|Pain|pain
4857626|NCT02289716|Fulranumab|fulranumab
4857627|NCT02289716|JNJ-42160443|jnj-42160443
4857628|NCT02289716|Monotherapy|monotherapy
4857629|NCT02289716|Hip|hip
4857630|NCT02289716|Knee|knee
4857631|NCT02289716|Joint replacement surgery|joint replacement surgery
4857632|NCT02289703|End-Stage Renal Disease|end-stage renal disease
4857633|NCT02289703|Healthy|healthy
4857634|NCT02289703|Rivaroxaban|rivaroxaban
4857635|NCT02289703|BAY 59-7939|bay 59-7939
4857636|NCT02289703|JNJ-39039039|jnj-39039039
4857637|NCT02289703|Xarelto|xarelto
4857638|NCT02289703|Hemodialysis|hemodialysis
4857639|NCT02289703|Blood Coagulation|blood coagulation
4857640|NCT02289703|Pharmacokinetics|pharmacokinetics
4857838|NCT02288676|driver mutations|driver mutations
4857641|NCT02289690|Extensive Stage Smal Cell Lung Cancer|extensive stage smal cell lung cancer
4857642|NCT02289690|ABT-888|abt-888
4857643|NCT02289690|Veliparib|veliparib
4857644|NCT02289690|PARP - Poly (ADP) ribose polymerase|parp - poly (adp) ribose polymerase
4857645|NCT02289677|intubation|intubation
4857646|NCT02289677|child|child
4857647|NCT02289677|resuscitation|resuscitation
4857648|NCT02289677|simulation|simulation
4857649|NCT02289677|Endotracheal|endotracheal
4857650|NCT02289664|intubation|intubation
4857651|NCT02289651|intubation|intubation
4857652|NCT02289638|intubation|intubation
4857653|NCT02289625|Obstructive Sleep Apnea|obstructive sleep apnea
4857654|NCT02289625|cognition|cognition
4857655|NCT02289625|neurovascular function|neurovascular function
4857656|NCT02289625|brain metabolism|brain metabolism
4857657|NCT02289625|exercise training|exercise training
4857658|NCT02289612|Risk for Type 2 Diabetes Mellitus|risk for type 2 diabetes mellitus
4857659|NCT02289612|Fibre|fibre
4857660|NCT02289612|Postprandial Glucose|postprandial glucose
4857661|NCT02289612|Postprandial Insulin|postprandial insulin
4857662|NCT02289612|Postprandial Acetaminophen|postprandial acetaminophen
4857663|NCT02289612|Satiety|satiety
4857664|NCT02289599|Healthy Japanese Subjects|healthy japanese subjects
4857665|NCT02289599|E2307|e2307
4857666|NCT02289599|Pharmacokinetics|pharmacokinetics
4857667|NCT02289547|chemotherapy|chemotherapy
4857668|NCT02289547|stomach neoplasms|stomach neoplasms
4857669|NCT02289521|Transcranial Direct Current stimulation|transcranial direct current stimulation
4857670|NCT02289521|Executive function|executive function
4857671|NCT02289521|Bilingualism|bilingualism
4857672|NCT02289521|Dorsolateral Prefrontal Cortex|dorsolateral prefrontal cortex
4857673|NCT02289508|Heart Failure|heart failure
4857674|NCT02289508|Hemodynamics|hemodynamics
4857675|NCT02289508|Echocardiography|echocardiography
4857676|NCT02289508|Diagnostic techniques and procedures|diagnostic techniques and procedures
4857677|NCT02289508|Ultrasonography|ultrasonography
4857678|NCT02289508|USCOM|uscom
4857679|NCT02289495|Single Dose Escalation|single dose escalation
4857680|NCT02289495|Repeat Dose Escalation|repeat dose escalation
4857681|NCT02289495|GSK2838232|gsk2838232
4857682|NCT02289495|Ritonavir|ritonavir
4857683|NCT02289482|Ritonavir|ritonavir
4857684|NCT02289482|Safety|safety
4857685|NCT02289482|Continuation Single Dose Escalation|continuation single dose escalation
4857686|NCT02289482|GSK2838232|gsk2838232
4857687|NCT02289456|Phase II, LOCALLY ADVANCED OR METASTATIC NON SMALL|phase ii, locally advanced or metastatic non small
4857688|NCT02289456|CELL LUNG CANCER (NSCLC) AND AN|cell lung cancer (nsclc) and an
4857689|NCT02289456|EASTERN COOPERATIVE ONCOLOGY GROUP|eastern cooperative oncology group
4857690|NCT02289456|PERFORMANCE STATUS OF 2|performance status of 2
4857691|NCT02289456|(ABOUND.PS2)|(abound.ps2)
4857692|NCT02289456|LOCALLY ADVANCED OR METASTATIC NON SMALL|locally advanced or metastatic non small
4857693|NCT02289456|CELL LUNG CANCER (NSCLC) SUBJECTS THAT AE NOT CANDIDATES FOR RADIATION OR CURATIVE SURGERY|cell lung cancer (nsclc) subjects that ae not candidates for radiation or curative surgery
4857694|NCT02289443|complete dentures|complete dentures
4857695|NCT02289443|10-year follow-up|10-year follow-up
4857696|NCT02289443|patient report outcomes|patient report outcomes
4857697|NCT02289417|Ulcerative Colitis|ulcerative colitis
4857698|NCT02289417|Inflammatory Bowel Disease|inflammatory bowel disease
4857699|NCT02289391|Dexmedetomidine|dexmedetomidine
4857700|NCT02289391|Inflammatory factor|inflammatory factor
4857701|NCT02289391|Inflammatory mediator|inflammatory mediator
4857702|NCT02289391|Cytokines|cytokines
4857703|NCT02289391|Asthma|asthma
4857704|NCT02289365|Radiodermatitis|radiodermatitis
4857705|NCT02289365|Breast cancer|breast cancer
4857706|NCT02289365|Radiotherapy|radiotherapy
4857707|NCT02289313|obesity prevention|obesity prevention
4857708|NCT02289313|CBPR|cbpr
4857709|NCT02289313|high risk youth|high risk youth
4857710|NCT02289313|school health|school health
4857711|NCT02289287|Self-Management|self-management
4857712|NCT02289287|Stroke|stroke
4857713|NCT02289287|Intervention|intervention
4857714|NCT02289287|Group Processes|group processes
4857715|NCT02289261|Chronic pain|chronic pain
4857716|NCT02289261|Morphine|morphine
4857717|NCT02289261|Dexmedetomidine|dexmedetomidine
4857718|NCT02289235|Ginger|ginger
4857719|NCT02289235|Medicine, traditional|medicine, traditional
4857720|NCT02289235|Herbal medicine|herbal medicine
4857721|NCT02289222|Relapsed/Refractory|relapsed/refractory
4857722|NCT02289222|MK-3475 & Pomalidomide|mk-3475 & pomalidomide
4857723|NCT02289222|Immunotherapy|immunotherapy
4857724|NCT02289209|head and neck cancer|head and neck cancer
4857725|NCT02289209|reirradiation|reirradiation
4857726|NCT02289209|MK-3475|mk-3475
4857727|NCT02289209|Anti-PD-1 monoclonal antibody|anti-pd-1 monoclonal antibody
4857728|NCT02289209|Squamous cell carcinoma|squamous cell carcinoma
4857729|NCT02289209|Keytruda|keytruda
4857730|NCT02289209|pembrolizumab|pembrolizumab
4857731|NCT02289196|Vaccine|vaccine
4857732|NCT02289183|Stomach Neoplasms|stomach neoplasms
4857733|NCT02289183|Laparoscopy|laparoscopy
4857734|NCT02289183|Billroth I Operation|billroth i operation
4857735|NCT02289170|Chronic low back pain|chronic low back pain
4857736|NCT02289170|Heating and cooling combination therapeutic device|heating and cooling combination therapeutic device
4857737|NCT02289170|Heating and cooling combination therapy|heating and cooling combination therapy
4857738|NCT02289170|Contrast therapy|contrast therapy
4857739|NCT02289131|oral care|oral care
4857740|NCT02289105|Advance Directive|advance directive
4857741|NCT02289105|Active Choice|active choice
4857742|NCT02289105|Decision making|decision making
4857743|NCT02289053|Colorectal Cancer|colorectal cancer
4857744|NCT02289040|Acute Kidney Injury|acute kidney injury
4857745|NCT02289040|Microvesicles|microvesicles
4857746|NCT02289040|microRNA|microrna
4857747|NCT02289040|Paediatric cardiac surgery|paediatric cardiac surgery
4857748|NCT02289027|Ebola, Ebolavirus|ebola, ebolavirus
4857749|NCT02289014|online intervention|online intervention
4857750|NCT02289014|stress management|stress management
4857751|NCT02289014|cognitive behavioral therapy|cognitive behavioral therapy
4857752|NCT02289014|acceptance and mindfulness based intervention|acceptance and mindfulness based intervention
4857753|NCT02289001|patient simulation|patient simulation
4857754|NCT02289001|simulation|simulation
4857755|NCT02289001|teamwork|teamwork
4857756|NCT02289001|interdisciplinary health team|interdisciplinary health team
4857757|NCT02289001|healthcare team|healthcare team
4857758|NCT02289001|nursing|nursing
4857759|NCT02289001|training programs|training programs
4857760|NCT02288988|GERD|gerd
4857761|NCT02288988|Short Esophagus|short esophagus
4857762|NCT02288988|Minimally Invasive Surgery|minimally invasive surgery
4857763|NCT02288988|Collis gastroplasty|collis gastroplasty
4857764|NCT02288975|hemoadsorption|hemoadsorption
4857765|NCT02288975|extracorporeal blood purification|extracorporeal blood purification
4857766|NCT02288975|CytoSorb|cytosorb
4857767|NCT02288975|hemofiltration|hemofiltration
4857768|NCT02288975|SIRS|sirs
4857769|NCT02288975|sepsis|sepsis
4857770|NCT02288975|septic shock|septic shock
4857771|NCT02288975|membranes|membranes
4857772|NCT02288975|ICU|icu
4857773|NCT02288975|dialysis|dialysis
4857774|NCT02288975|adsorption|adsorption
4857775|NCT02288962|dopamine agonists|dopamine agonists
4857776|NCT02288962|cabergoline|cabergoline
4857777|NCT02288949|mechanical ventilation, stratificacion, lung severity|mechanical ventilation, stratificacion, lung severity
4857778|NCT02288936|Hormone-refractory prostate cancer|hormone-refractory prostate cancer
4857779|NCT02288936|Enzalutamide|enzalutamide
4857780|NCT02288936|TMPRSS2-ETS fusion gene|tmprss2-ets fusion gene
4857781|NCT02288923|Total knee arthroplasty|total knee arthroplasty
4857782|NCT02288923|Femoral nerve block|femoral nerve block
4857783|NCT02288923|Local infiltration analgesia|local infiltration analgesia
4857784|NCT02288910|Liver Perfusion|liver perfusion
4857785|NCT02288910|DynaCT Perfusion|dynact perfusion
4857786|NCT02288910|Radioembolization|radioembolization
4857787|NCT02288910|Chemoembolization|chemoembolization
4857788|NCT02288897|Stage III|stage iii
4857789|NCT02288897|Stage IIIB|stage iiib
4857790|NCT02288897|Stage IIIC|stage iiic
4857791|NCT02288897|Stage IV (M1a)|stage iv (m1a)
4857792|NCT02288897|Stage 3|stage 3
4857793|NCT02288897|Stage 4|stage 4
4857794|NCT02288897|IVM1a|ivm1a
4857795|NCT02288897|IV(M1a)|iv(m1a)
4857796|NCT02288897|IV-M1a|iv-m1a
4857797|NCT02288897|in-transit|in-transit
4857798|NCT02288897|in transit|in transit
4857799|NCT02288897|intransit|intransit
4857800|NCT02288897|satellite|satellite
4857801|NCT02288897|recurrent|recurrent
4857802|NCT02288884|Complications|complications
4857803|NCT02288884|Cesarean Section|cesarean section
4857804|NCT02288884|Wound|wound
4857805|NCT02288884|Infection (Following Delivery)|infection (following delivery)
4857806|NCT02288871|aortic valve replacement|aortic valve replacement
4857807|NCT02288871|aortic valve bioprosthesis|aortic valve bioprosthesis
4857808|NCT02288871|hemodynamics|hemodynamics
4857809|NCT02288858|Hair thinning|hair thinning
4857810|NCT02288819|loop diuretics|loop diuretics
4857811|NCT02288819|heart failure|heart failure
4857812|NCT02288819|natriuresis|natriuresis
4857813|NCT02288819|urinary analysis|urinary analysis
4857814|NCT02288793|attitudes|attitudes
4857815|NCT02288793|knowledge|knowledge
4857816|NCT02288793|examination|examination
4857817|NCT02288754|DNA in Tumors|dna in tumors
4857818|NCT02288754|cfDNA|cfdna
4857819|NCT02288754|WGS|wgs
4857820|NCT02288754|Advanced stage cancer|advanced stage cancer
4857821|NCT02288754|Solid tumors|solid tumors
4857822|NCT02288741|high-dose chemotherapy|high-dose chemotherapy
4857823|NCT02288741|autologous blood stem-cell transplantation|autologous blood stem-cell transplantation
4857824|NCT02288741|induction chemotherapy|induction chemotherapy
4857825|NCT02288741|elderly patients|elderly patients
4857826|NCT02288728|Proximal gastrectomy|proximal gastrectomy
4857827|NCT02288728|quality of life|quality of life
4857828|NCT02288728|mortality|mortality
4857829|NCT02288728|morbidity|morbidity
4857830|NCT02288715|cerebral perfusion pressure|cerebral perfusion pressure
4857831|NCT02288715|septic encephalopathy|septic encephalopathy
4857832|NCT02288676|genomics|genomics
4857833|NCT02288676|molecular markers|molecular markers
4857834|NCT02288676|genetic mutations|genetic mutations
4857835|NCT02288676|high-grade serous cancer|high-grade serous cancer
4857836|NCT02288676|ovarian cancer|ovarian cancer
4857837|NCT02288676|endometrial cancer|endometrial cancer
4857839|NCT02288676|passenger mutations|passenger mutations
4857840|NCT02288676|molecular screening|molecular screening
4857841|NCT02288598|Stammering|stammering
4857842|NCT02288598|Brain stimulation|brain stimulation
4857843|NCT02288585|plant sterols|plant sterols
4857844|NCT02288585|blood lipids|blood lipids
4857845|NCT02288572|metabolic syndrome X|metabolic syndrome x
4857846|NCT02288572|obesity|obesity
4857847|NCT02288572|insulin resistance|insulin resistance
4857848|NCT02288572|dyslipidemia|dyslipidemia
4857849|NCT02288572|probiotic bacteria|probiotic bacteria
4857850|NCT02288546|nutritional status|nutritional status
4857851|NCT02288546|pesticides|pesticides
4857852|NCT02288546|nitrate|nitrate
4857853|NCT02288533|Minimally Conscious State|minimally conscious state
4857854|NCT02288533|tDCS|tdcs
4857855|NCT02288520|Methotrexate|methotrexate
4857856|NCT02288520|Therapeutic strategy|therapeutic strategy
4857857|NCT02288507|sorafenib, yttrium-90 radioembolization|sorafenib, yttrium-90 radioembolization
4857858|NCT02288494|hypoalbuminemia|hypoalbuminemia
4857859|NCT02288494|-acid base balance|-acid base balance
4857860|NCT02288494|acid base disorders|acid base disorders
4857861|NCT02288494|critical ill|critical ill
4857862|NCT02288494|Stewart approach|stewart approach
4857863|NCT02288494|human albumin infusion|human albumin infusion
4857864|NCT02288481|Tuberculosis|tuberculosis
4857865|NCT02288481|TBA-354|tba-354
4857866|NCT02288481|Pulmonary Tuberculosis|pulmonary tuberculosis
4857867|NCT02288481|TB|tb
4857868|NCT02288468|Parkinson's Disease|parkinson's disease
4857869|NCT02288455|SUI, incontinence, sphincter|sui, incontinence, sphincter
4857870|NCT02288429|pharmacokinetics|pharmacokinetics
4857871|NCT02288429|cystic fibrosis|cystic fibrosis
4857872|NCT02288429|critical illness|critical illness
4857873|NCT02288403|Aerobic Exercise|aerobic exercise
4857874|NCT02288403|Oxygen Consumption|oxygen consumption
4857875|NCT02288403|Blood Pressure|blood pressure
4857876|NCT02288390|VAP|vap
4857877|NCT02288390|Oral care|oral care
4857878|NCT02288390|Chlorhexidine|chlorhexidine
4857879|NCT02288390|Miswak (Sewak)|miswak (sewak)
4857880|NCT02288377|Lanreotide|lanreotide
4857881|NCT02288377|Duodeno-pancreatic neuroendocrine tumours|duodeno-pancreatic neuroendocrine tumours
4857882|NCT02288377|Maintenance treatment|maintenance treatment
4857883|NCT02288351|Roux-en-Y gastric bypass|roux-en-y gastric bypass
4857884|NCT02288325|Fetzima|fetzima
4857885|NCT02288325|Relapse-prevention|relapse-prevention
4857886|NCT02288325|Placebo-controlled|placebo-controlled
4857887|NCT02288299|Instrumental cough assistance|instrumental cough assistance
4857888|NCT02288299|positive pressure insufflation maneuver|positive pressure insufflation maneuver
4857889|NCT02288299|home mechanical ventilation|home mechanical ventilation
4857890|NCT02288299|prospective evaluation|prospective evaluation
4857891|NCT02288260|Acute Coronary Syndrome|acute coronary syndrome
4857892|NCT02288260|Russian ACS Registry|russian acs registry
4857893|NCT02288260|ticagrelor|ticagrelor
4857894|NCT02288247|Metastatic|metastatic
4857895|NCT02288247|Castration-resistant|castration-resistant
4857896|NCT02288247|Docetaxel|docetaxel
4857897|NCT02288247|Chemotherapy- Naïve|chemotherapy- naïve
4857898|NCT02288247|Enzalutamide|enzalutamide
4857899|NCT02288247|Prostate Cancer|prostate cancer
4857900|NCT02288247|Chemotherapy Naïve Metastatic Castration Resistant Prostate Cancer|chemotherapy naïve metastatic castration resistant prostate cancer
4857901|NCT02288247|Prednisolone|prednisolone
4857902|NCT02288247|Xtandi|xtandi
4857903|NCT02288247|Metastatic Castration Resistant Prostate Cancer|metastatic castration resistant prostate cancer
4857904|NCT02288234|Registry|registry
4857905|NCT02288195|Neoadjuvant Chemotherapy|neoadjuvant chemotherapy
4857906|NCT02288195|Preoperative radiotherapy|preoperative radiotherapy
4857907|NCT02288195|Chemoradiotherapy|chemoradiotherapy
4857908|NCT02288195|Capecitabine|capecitabine
4857909|NCT02288195|Oxaliplatin|oxaliplatin
4857910|NCT02288182|Sinus augmentation procedure|sinus augmentation procedure
4857911|NCT02288169|Symptom management|symptom management
4857912|NCT02288169|palliative care|palliative care
4857913|NCT02288117|PMCF|pmcf
4857914|NCT02288117|Post Market Clinical Follow up|post market clinical follow up
4857915|NCT02288117|SP-CL|sp-cl
4857916|NCT02288117|anatomic stem|anatomic stem
4857917|NCT02288104|Interventional Radiology|interventional radiology
4857918|NCT02288104|Liver|liver
4857919|NCT02288104|Kidney|kidney
4857920|NCT02288104|Confocal endomicroscopy|confocal endomicroscopy
4857921|NCT02288104|Optical Biopsy|optical biopsy
4857922|NCT02288104|Scanner|scanner
4857923|NCT02288104|Fluoroscopy|fluoroscopy
4857924|NCT02288104|CT|ct
4857925|NCT02288104|Computed Tomography|computed tomography
4857926|NCT02288104|Radiofrequency Ablation|radiofrequency ablation
4857927|NCT02288104|Fluorescein|fluorescein
4857928|NCT02288091|ALS|als
4857929|NCT02288091|Inosine|inosine
4857930|NCT02288091|Uric acid|uric acid
4857931|NCT02288091|Urate|urate
4857932|NCT02288091|Glutathione|glutathione
4857933|NCT02288091|Biomarker|biomarker
4857934|NCT02288091|Oxidative stress|oxidative stress
4857935|NCT02288091|Oxidative damage|oxidative damage
4857936|NCT02288091|proof-of-concept|proof-of-concept
4857937|NCT02288078|unresectable colorectal cancer|unresectable colorectal cancer
4857938|NCT02288078|regorafenib|regorafenib
4857939|NCT02288078|Steroid|steroid
4857940|NCT02288078|fatigue and malaise|fatigue and malaise
4857941|NCT02288078|Phase 2 randomized, controlled trial (RCT)|phase 2 randomized, controlled trial (rct)
4857942|NCT02288052|Handwriting|handwriting
4857943|NCT02288052|Motor learning|motor learning
4857944|NCT02288039|Pulmonary|pulmonary
4857945|NCT02288026|Carcinoma, Non-Small-Cell Lung|carcinoma, non-small-cell lung
4857946|NCT02288026|Lung Neoplasms|lung neoplasms
4857947|NCT02288026|Carcinoma, Bronchogenic|carcinoma, bronchogenic
4857948|NCT02288026|Bronchial Neoplasms|bronchial neoplasms
4857949|NCT02288013|Cesarean section|cesarean section
4857950|NCT02288013|uterine closure technique|uterine closure technique
4857951|NCT02288013|materials used|materials used
4857952|NCT02288000|Alzheimer|alzheimer
4857953|NCT02288000|Memantine|memantine
4857954|NCT02288000|biomarkers|biomarkers
4857955|NCT02288000|battery|battery
4857956|NCT02288000|cognition|cognition
4857957|NCT02288000|imaging|imaging
4857958|NCT02288000|neuropsychology|neuropsychology
4857959|NCT02287987|Renal function|renal function
4857960|NCT02287987|Off-clamp|off-clamp
4857961|NCT02287987|Partial nephrectomy|partial nephrectomy
4857962|NCT02287987|Robotic|robotic
4857963|NCT02287987|Hylar clamping|hylar clamping
4857964|NCT02287948|Balance|balance
4857965|NCT02287948|Multiple Sclerosis|multiple sclerosis
4857966|NCT02287948|Nintendo Wii Fit|nintendo wii fit
4857967|NCT02287935|Karydakis procedure|karydakis procedure
4857968|NCT02287935|Limberg flap|limberg flap
4857969|NCT02287935|recurrent pilonidal sinus|recurrent pilonidal sinus
4857970|NCT02287896|RhD-negative pregnant woman|rhd-negative pregnant woman
4857971|NCT02287896|anti-RhD antibody|anti-rhd antibody
4857972|NCT02287883|Patient activation and engagement|patient activation and engagement
4857973|NCT02287883|Patient reported outcomes|patient reported outcomes
4857974|NCT02287883|Accountable Care Organizations|accountable care organizations
4857975|NCT02287883|Chronic illness|chronic illness
4857976|NCT02287883|Vulnerable population|vulnerable population
4857977|NCT02287883|Comparison of approaches|comparison of approaches
4857978|NCT02287870|Epidural anesthesia|epidural anesthesia
4857979|NCT02287870|Chloroprocaine|chloroprocaine
4857980|NCT02287870|Lidocaine|lidocaine
4857981|NCT02287844|Xylo-oligosaccharides|xylo-oligosaccharides
4857982|NCT02287844|Immunonutrition|immunonutrition
4857983|NCT02287844|Prebiotics|prebiotics
4857984|NCT02287844|Lipopolysaccharides|lipopolysaccharides
4857985|NCT02287844|Cytokines|cytokines
4857986|NCT02287805|craniosynostosis|craniosynostosis
4857987|NCT02287805|simple form|simple form
4857988|NCT02287805|complex form|complex form
4857989|NCT02287805|diagnostic|diagnostic
4857990|NCT02287805|announcement|announcement
4857991|NCT02287805|impacts|impacts
4857992|NCT02287792|Infective endocarditis|infective endocarditis
4857993|NCT02287792|18-FDG PET/CT|18-fdg pet/ct
4857994|NCT02287792|Impact|impact
4857995|NCT02287792|Patient's management|patient's management
4857996|NCT02287792|Diagnostic|diagnostic
4857997|NCT02287753|vascular occlusion test|vascular occlusion test
4857998|NCT02287753|near infrared spectroscopy|near infrared spectroscopy
4857999|NCT02287740|Exercise|exercise
4858000|NCT02287714|Instep plantar fasciotomy|instep plantar fasciotomy
4858001|NCT02287701|bladder cancer|bladder cancer
4858002|NCT02287701|MRI|mri
4858003|NCT02287701|PET|pet
4858004|NCT02287688|safety of Meningococcal quadrivalent CRM-197 conjugate vaccine|safety of meningococcal quadrivalent crm-197 conjugate vaccine
4858005|NCT02287688|Children 2-23 months of age|children 2-23 months of age
4858006|NCT02287675|Sentinel Node|sentinel node
4858007|NCT02287662|Transcatheter Aortic Valve Replacement|transcatheter aortic valve replacement
4858008|NCT02287649|Immune thrombocytopenia|immune thrombocytopenia
4858009|NCT02287649|Fc gamma RIIIA V/F158 polymorphism|fc gamma riiia v/f158 polymorphism
4858010|NCT02287649|Rituximab|rituximab
4858011|NCT02287649|autoreactive B and T cells|autoreactive b and t cells
4858012|NCT02287649|ITP|itp
4858013|NCT02287610|RA|ra
4858014|NCT02287610|Delayed-release prednisone|delayed-release prednisone
4858015|NCT02287610|Immediate-release prednisone|immediate-release prednisone
4858016|NCT02287610|Non-interventional|non-interventional
4858017|NCT02287571|comfort|comfort
4858018|NCT02287571|satisfaction|satisfaction
4858019|NCT02287558|HHT|hht
4858020|NCT02287558|CASE4Z14|case4z14
4858021|NCT02287558|Pomalidomide|pomalidomide
4858022|NCT02287545|open angle glaucoma|open angle glaucoma
4858023|NCT02287545|corneal biomechanics|corneal biomechanics
4858024|NCT02287545|trabeculectomy|trabeculectomy
4858025|NCT02287506|diagnosis, strategy|diagnosis, strategy
4858026|NCT02287480|Ebolavirus Vaccines|ebolavirus vaccines
4858027|NCT02287467|Antiviral|antiviral
4858028|NCT02287467|IVIG|ivig
4858029|NCT02287467|Hemagglutination inhibition (HAI)|hemagglutination inhibition (hai)
4858030|NCT02287467|Antibody|antibody
4858031|NCT02287454|Multiple Sclerosis, cognitive rehabilitation, REHACOP|multiple sclerosis, cognitive rehabilitation, rehacop
4858032|NCT02287376|Migraine with and without aura|migraine with and without aura
4858033|NCT02287350|pain|pain
4858034|NCT02287350|moderate pain|moderate pain
4858035|NCT02287350|mild pain|mild pain
4858036|NCT02287350|acute pain|acute pain
4858037|NCT02287350|mild acute pain|mild acute pain
4858230|NCT02286245|Hotline|hotline
4858038|NCT02287350|moderate acute pain|moderate acute pain
4858039|NCT02287350|mild or moderate acute pain|mild or moderate acute pain
4858040|NCT02287350|NSAID|nsaid
4858041|NCT02287350|nonsteroidal anti-inflammatory drug|nonsteroidal anti-inflammatory drug
4858042|NCT02287337|Neck pain|neck pain
4858043|NCT02287324|Cervicalgia|cervicalgia
4858044|NCT02287311|EBV positive diseases|ebv positive diseases
4858045|NCT02287311|cytotoxic T lymphocytes|cytotoxic t lymphocytes
4858046|NCT02287285|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
4858047|NCT02287285|Gastric Bypass Surgery|gastric bypass surgery
4858048|NCT02287285|Exendin9|exendin9
4858049|NCT02287272|COPD- cimetidine- drug-drug interaction|copd- cimetidine- drug-drug interaction
4858050|NCT02287233|Myelogenous Leukemia|myelogenous leukemia
4858051|NCT02287233|Treatment Naive AML|treatment naive aml
4858052|NCT02287233|Untreated AML|untreated aml
4858053|NCT02287220|Non-Contact Oximetry|non-contact oximetry
4858054|NCT02287220|video plethysmography|video plethysmography
4858055|NCT02287220|oxygen desaturation|oxygen desaturation
4858056|NCT02287168|Peritoneal lavage|peritoneal lavage
4858057|NCT02287168|Dissemination|dissemination
4858058|NCT02287168|Gastrectomy|gastrectomy
4858059|NCT02287168|Cytology|cytology
4858060|NCT02287168|Lavage|lavage
4858061|NCT02287155|Health Promotion|health promotion
4858062|NCT02287155|Intervention Study|intervention study
4858063|NCT02287155|Occupational Therapy|occupational therapy
4858064|NCT02287155|Rural Population|rural population
4858065|NCT02287155|Quality of life|quality of life
4858066|NCT02287155|Sense of coherence|sense of coherence
4858067|NCT02287129|Potentially R0 - resectable AEG and primary tumor category|potentially r0 - resectable aeg and primary tumor category
4858068|NCT02287129|Histologically confirmed AEG I-III|histologically confirmed aeg i-iii
4858069|NCT02287129|Functional operability|functional operability
4858070|NCT02287129|Intense FDG tracer uptake of the tumor|intense fdg tracer uptake of the tumor
4858071|NCT02287116|preterm infants|preterm infants
4858072|NCT02287116|CPAP|cpap
4858074|NCT02287116|invasive mechanical ventilation|invasive mechanical ventilation
4858075|NCT02287116|we aimed determine that affect the rate of BPD and death of NCPAP therapy with nasal prongs or nasal mask as the initial treatment for RDS.|we aimed determine that affect the rate of bpd and death of ncpap therapy with nasal prongs or nasal mask as the initial treatment for rds.
4858076|NCT02287103|Skipping Breakfast|skipping breakfast
4858077|NCT02287038|PTSD|ptsd
4858078|NCT02287038|ADHD|adhd
4858079|NCT02287038|Comorbidity|comorbidity
4858080|NCT02287038|Combat Trauma|combat trauma
4858081|NCT02287038|Cognitive Deficit|cognitive deficit
4858082|NCT02286986|Epilepsy|epilepsy
4858083|NCT02286986|Dravet syndrome|dravet syndrome
4858084|NCT02286986|Seizures|seizures
4858085|NCT02286986|Intractable Epilepsy|intractable epilepsy
4858086|NCT02286986|Medically Refractory Epilepsy|medically refractory epilepsy
4858087|NCT02286973|Tranexamic acid|tranexamic acid
4858088|NCT02286947|DMD|dmd
4858089|NCT02286947|exon 51|exon 51
4858090|NCT02286947|dystrophin|dystrophin
4858091|NCT02286947|dystrophy|dystrophy
4858092|NCT02286947|eteplirsen|eteplirsen
4858093|NCT02286947|Duchenne|duchenne
4858094|NCT02286934|Carvedilol|carvedilol
4858095|NCT02286934|CYP2D6|cyp2d6
4858096|NCT02286934|Isoproterenol Sensitivity Test|isoproterenol sensitivity test
4858097|NCT02286921|Testosterone|testosterone
4858098|NCT02286921|Enzalutamide|enzalutamide
4858099|NCT02286921|Abiraterone|abiraterone
4858100|NCT02286921|Androgen Ablative Therapies|androgen ablative therapies
4858101|NCT02286921|Bipolar Androgen Therapy|bipolar androgen therapy
4858102|NCT02286908|Ejection fraction, Global Strain, Mechanical dispersion|ejection fraction, global strain, mechanical dispersion
4858103|NCT02286895|rotavirus|rotavirus
4858104|NCT02286895|rotavirus vaccine|rotavirus vaccine
4858105|NCT02286895|Mali|mali
4858106|NCT02286895|EPI vaccines|epi vaccines
4858107|NCT02286882|Single Ascending Dose|single ascending dose
4858108|NCT02286882|healthy subjects|healthy subjects
4858109|NCT02286869|mechanical ventilation|mechanical ventilation
4858110|NCT02286869|autonomic nervous system|autonomic nervous system
4858111|NCT02286869|heart rate variability|heart rate variability
4858112|NCT02286869|cardioventilatory coupling|cardioventilatory coupling
4858113|NCT02286856|malnutrition, diet intervention, Nutritional Assessment|malnutrition, diet intervention, nutritional assessment
4858114|NCT02286843|89Zr-trastuzumab|89zr-trastuzumab
4858115|NCT02286843|PET/CT|pet/ct
4858116|NCT02286843|14-156|14-156
4858117|NCT02286843|89Zr-pertuzumab|89zr-pertuzumab
4858118|NCT02286843|HER2-targeted|her2-targeted
4858119|NCT02286830|osteolysis|osteolysis
4858120|NCT02286830|zoledronic acid|zoledronic acid
4858121|NCT02286830|osteonecrosis|osteonecrosis
4858122|NCT02286830|bone markers|bone markers
4858123|NCT02286830|low-dose CT|low-dose ct
4858124|NCT02286791|Prevention of dementia|prevention of dementia
4858125|NCT02286791|Mindful awareness program|mindful awareness program
4858126|NCT02286791|Mild cognitive impairment|mild cognitive impairment
4858127|NCT02286791|Mindfulness|mindfulness
4858128|NCT02286791|Elderly|elderly
4858129|NCT02286791|Cognitive decline|cognitive decline
4858130|NCT02286765|Ulthera System|ulthera system
4858131|NCT02286765|Ultherapy|ultherapy
4858132|NCT02286739|Total Knee Arthroplasty|total knee arthroplasty
4858526|NCT02284191|Radiology|radiology
4858133|NCT02286739|Rotational Alignment|rotational alignment
4858134|NCT02286739|Intraoperative Sensors|intraoperative sensors
4858135|NCT02286739|Patient Outcomes|patient outcomes
4858136|NCT02286739|Soft Tissue Balance|soft tissue balance
4858137|NCT02286726|Leukemia|leukemia
4858138|NCT02286726|Acute myeloid leukemia|acute myeloid leukemia
4858139|NCT02286726|AML|aml
4858140|NCT02286726|CPX-351|cpx-351
4858141|NCT02286726|Phone call|phone call
4858142|NCT02286713|Lung Cancer Screening|lung cancer screening
4858143|NCT02286713|heavy smokers|heavy smokers
4858144|NCT02286713|state-based smoking cessation quitlines|state-based smoking cessation quitlines
4858145|NCT02286713|patient decision aid|patient decision aid
4858146|NCT02286713|low-dose computed tomography|low-dose computed tomography
4858147|NCT02286713|LDCT|ldct
4858148|NCT02286713|standard educational information|standard educational information
4858149|NCT02286700|dermatitis, eczema, itch, moisturizer, amino acid|dermatitis, eczema, itch, moisturizer, amino acid
4858150|NCT02286687|Advanced Cancers|advanced cancers
4858151|NCT02286687|Germline mutations|germline mutations
4858152|NCT02286687|Metastatic cancer|metastatic cancer
4858153|NCT02286687|Talazoparib Tosylate|talazoparib tosylate
4858154|NCT02286687|BMN 673|bmn 673
4858155|NCT02286687|Phone call|phone call
4858156|NCT02286674|mYpas|mypas
4858157|NCT02286674|anxiety|anxiety
4858158|NCT02286674|distraction|distraction
4858159|NCT02286674|inhalation induction|inhalation induction
4858160|NCT02286648|clinical signs|clinical signs
4858161|NCT02286648|child|child
4858162|NCT02286648|pulpotomy|pulpotomy
4858163|NCT02286583|RTM|rtm
4858164|NCT02286583|Female breast cancer|female breast cancer
4858165|NCT02286557|Methylphenidate|methylphenidate
4858166|NCT02286557|Multiple Sclerosis|multiple sclerosis
4858167|NCT02286557|Cognitive Fatigue|cognitive fatigue
4858168|NCT02286544|Myocardial Infarction|myocardial infarction
4858169|NCT02286544|Oxygen|oxygen
4858170|NCT02286544|Inflammation|inflammation
4858171|NCT02286544|Acute coronary syndrome (ACS)|acute coronary syndrome (acs)
4858172|NCT02286544|ST-segment elevation myocardial infarction (STEMI)|st-segment elevation myocardial infarction (stemi)
4858173|NCT02286544|Reperfusion injury (IR-injury)|reperfusion injury (ir-injury)
4858174|NCT02286544|Biomarkers|biomarkers
4858175|NCT02286544|Normoxemia|normoxemia
4858176|NCT02286544|Salmonella typhi|salmonella typhi
4858177|NCT02286544|Vaccine-induced inflammation|vaccine-induced inflammation
4858178|NCT02286544|Soluble markers of apoptosis|soluble markers of apoptosis
4858179|NCT02286544|Leukocyte subset distribution|leukocyte subset distribution
4858180|NCT02286544|Matrix metalloproteinase (MMP)|matrix metalloproteinase (mmp)
4858181|NCT02286544|Biological Markers|biological markers
4858182|NCT02286531|: Low grade glioma|: low grade glioma
4858183|NCT02286531|PET|pet
4858184|NCT02286531|FET|fet
4858185|NCT02286531|MRI|mri
4858186|NCT02286531|Standardized uptake value|standardized uptake value
4858187|NCT02286453|Osteoarthritis of The knee|osteoarthritis of the knee
4858188|NCT02286453|Benjakul|benjakul
4858189|NCT02286453|Alternative Medicine|alternative medicine
4858190|NCT02286440|Depression|depression
4858191|NCT02286440|Genotyping|genotyping
4858192|NCT02286440|Pharmacokinetic|pharmacokinetic
4858193|NCT02286440|Pharmacodynamic|pharmacodynamic
4858194|NCT02286414|oral anticoagulants|oral anticoagulants
4858195|NCT02286414|Geriatrics|geriatrics
4858196|NCT02286414|General Practitioner|general practitioner
4858198|NCT02286414|Misuse|misuse
4858199|NCT02286401|myocardial perfusion|myocardial perfusion
4858200|NCT02286401|coronary atherosclerosis|coronary atherosclerosis
4858201|NCT02286401|coronary blood flow|coronary blood flow
4858202|NCT02286401|fractional flow reserve|fractional flow reserve
4858203|NCT02286401|coronary flow reserve|coronary flow reserve
4858204|NCT02286388|Deep carious lesion|deep carious lesion
4858205|NCT02286388|incomplete caries removal|incomplete caries removal
4858206|NCT02286388|antibacterial adhesive system|antibacterial adhesive system
4858207|NCT02286388|dental composite resin|dental composite resin
4858208|NCT02286388|pulp vitality preservation|pulp vitality preservation
4858209|NCT02286388|randomized controlled trial|randomized controlled trial
4858210|NCT02286375|health-social partnership|health-social partnership
4858211|NCT02286375|self-efficacy|self-efficacy
4858212|NCT02286349|Neuromodulation Attention Deficit Hyperactivity Disorder|neuromodulation attention deficit hyperactivity disorder
4858213|NCT02286336|minimum effective concentration|minimum effective concentration
4858214|NCT02286336|ropivacaine|ropivacaine
4858215|NCT02286336|ultrasound-guided supraclavicular block|ultrasound-guided supraclavicular block
4858216|NCT02286323|Intubation, Endotracheal|intubation, endotracheal
4858217|NCT02286310|Exercise|exercise
4858218|NCT02286310|Kinematics|kinematics
4858219|NCT02286297|Intubation|intubation
4858220|NCT02286284|Early severe preeclampsia|early severe preeclampsia
4858221|NCT02286284|Angiogenic factor|angiogenic factor
4858222|NCT02286284|Apheresis|apheresis
4858223|NCT02286271|Seizure detection|seizure detection
4858224|NCT02286258|Inulin|inulin
4858225|NCT02286258|Ca-EDTA|ca-edta
4858226|NCT02286258|Gd-DOTA|gd-dota
4858227|NCT02286258|Chronic kidney disease|chronic kidney disease
4858228|NCT02286258|glomerular filtration rate measurement|glomerular filtration rate measurement
4858229|NCT02286245|Triage|triage
4858231|NCT02286245|Primary Health Care|primary health care
4858232|NCT02286245|Emergency Medical Service Communication Systems|emergency medical service communication systems
4858233|NCT02286232|Chronic low back pain|chronic low back pain
4858234|NCT02286232|stretching exercises|stretching exercises
4858235|NCT02286206|Clozapine|clozapine
4858236|NCT02286206|Psychotropic Drugs|psychotropic drugs
4858237|NCT02286206|Antipsychotic Agents|antipsychotic agents
4858238|NCT02286206|Psychotic Disorders|psychotic disorders
4858239|NCT02286206|Schizophrenia|schizophrenia
4858240|NCT02286206|Adverse Effects|adverse effects
4858241|NCT02286206|Drug Monitoring|drug monitoring
4858242|NCT02286180|near infrared spectroscopy|near infrared spectroscopy
4858243|NCT02286180|NIRS|nirs
4858244|NCT02286180|intern|intern
4858245|NCT02286167|modified-Atkins diet|modified-atkins diet
4858246|NCT02286167|ketogenic diet|ketogenic diet
4858247|NCT02286167|central nervous system malignancy|central nervous system malignancy
4858248|NCT02286167|glioma|glioma
4858249|NCT02286154|Hydroxyurea|hydroxyurea
4858250|NCT02286154|Sickle Cell|sickle cell
4858251|NCT02286154|Pharmacokinetics|pharmacokinetics
4858252|NCT02286154|dynamics|dynamics
4858253|NCT02286154|genomics|genomics
4858254|NCT02286128|Type 2 diabetes|type 2 diabetes
4858255|NCT02286128|RAGE|rage
4858256|NCT02286128|osteoblast|osteoblast
4858257|NCT02286115|Chronic Pelvic Pain|chronic pelvic pain
4858258|NCT02286115|Interstitial Cystitis|interstitial cystitis
4858259|NCT02286115|Vulvodynia|vulvodynia
4858260|NCT02286115|Dyspareunia|dyspareunia
4858261|NCT02286115|Pelvic Floor Dysfunction|pelvic floor dysfunction
4858262|NCT02286115|Emotional Processing|emotional processing
4858263|NCT02286089|dry-AMD|dry-amd
4858264|NCT02286089|Geographic Atrophy|geographic atrophy
4858265|NCT02286076|endometrioma|endometrioma
4858266|NCT02286076|laparoscopy|laparoscopy
4858267|NCT02286076|ovarian reserve|ovarian reserve
4858268|NCT02286037|Secondary Hyperalgesia|secondary hyperalgesia
4858269|NCT02286037|Method|method
4858270|NCT02286037|Pin-prick|pin-prick
4858271|NCT02286037|Monofilament|monofilament
4858272|NCT02285998|Influenza|influenza
4858273|NCT02285985|Adipose tissue|adipose tissue
4858274|NCT02285985|Inflammation|inflammation
4858275|NCT02285985|.Obesity|.obesity
4858276|NCT02285933|stroke|stroke
4858277|NCT02285933|physical therapy specialty|physical therapy specialty
4858278|NCT02285933|exercise therapy|exercise therapy
4858279|NCT02285933|virtual reality|virtual reality
4858280|NCT02285933|man-machine systems|man-machine systems
4858281|NCT02285933|randomized control trial|randomized control trial
4858282|NCT02285933|inpatients|inpatients
4858283|NCT02285933|rehabilitation|rehabilitation
4858284|NCT02285920|hemodialysis|hemodialysis
4858285|NCT02285920|spironolactone|spironolactone
4858286|NCT02285920|cardiac fibrosis|cardiac fibrosis
4858287|NCT02285920|diastolic function|diastolic function
4858288|NCT02285881|diabetes treatment|diabetes treatment
4858289|NCT02285881|personalized medicine|personalized medicine
4858290|NCT02285881|shared decision making|shared decision making
4858291|NCT02285881|goal setting|goal setting
4858292|NCT02285868|Orthopedic rehabilitation|orthopedic rehabilitation
4858293|NCT02285868|Rehabilitation outcomes|rehabilitation outcomes
4858294|NCT02285868|Physical therapy|physical therapy
4858295|NCT02285868|Physical therapy outcomes|physical therapy outcomes
4858296|NCT02285855|Lung Cancer|lung cancer
4858297|NCT02285855|Non small cell lung cancer|non small cell lung cancer
4858298|NCT02285855|Stereotactic body radiotherapy|stereotactic body radiotherapy
4858299|NCT02285855|SBRT|sbrt
4858300|NCT02285855|XRT|xrt
4858301|NCT02285855|Radiation therapy|radiation therapy
4858302|NCT02285855|Metformin|metformin
4858303|NCT02285855|Metformin ER|metformin er
4858304|NCT02285855|Placebo|placebo
4858305|NCT02285855|Sugar pill|sugar pill
4858306|NCT02285855|Lung adenocarcinoma|lung adenocarcinoma
4858307|NCT02285855|Genotypes|genotypes
4858308|NCT02285855|Genetic mutations|genetic mutations
4858309|NCT02285842|osteoarthritis|osteoarthritis
4858310|NCT02285842|avascular necrosis|avascular necrosis
4858311|NCT02285842|ankylosis|ankylosis
4858312|NCT02285842|protrusio acetabuli|protrusio acetabuli
4858313|NCT02285842|painful hip dysplasia|painful hip dysplasia
4858314|NCT02285842|rheumatoid arthritis|rheumatoid arthritis
4858315|NCT02285842|correction of functional deformity|correction of functional deformity
4858316|NCT02285842|revision procedures|revision procedures
4858317|NCT02285751|high on treatment platelet reactivity|high on treatment platelet reactivity
4858318|NCT02285751|acetylsalicylic acid|acetylsalicylic acid
4858319|NCT02285751|clopidogrel|clopidogrel
4858320|NCT02285751|prasugrel|prasugrel
4858321|NCT02285751|ticagrelor|ticagrelor
4858322|NCT02285751|critically ill|critically ill
4858323|NCT02285751|pharmacokinetic|pharmacokinetic
4858324|NCT02285751|pharmacodynamics|pharmacodynamics
4858325|NCT02285738|solid tumor, cancer, simvastatin, aspirin, blood clot, VTE, venous thromboembolism|solid tumor, cancer, simvastatin, aspirin, blood clot, vte, venous thromboembolism
4858326|NCT02285712|Peripheral venous catheter|peripheral venous catheter
4858327|NCT02285712|ultrasound|ultrasound
4858328|NCT02285712|nurse|nurse
4858329|NCT02285712|Intensive Care Units|intensive care units
4858529|NCT02284191|Cardiology|cardiology
4858330|NCT02285699|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors
4858331|NCT02285686|troponin|troponin
4858332|NCT02285686|biomarkers|biomarkers
4858333|NCT02285686|myocardial infarction|myocardial infarction
4858334|NCT02285686|critical illness|critical illness
4858335|NCT02285673|umbilical cord, mesenchymal stem cell|umbilical cord, mesenchymal stem cell
4858336|NCT02285621|Scoliosis|scoliosis
4858337|NCT02285621|Spine deformity|spine deformity
4858338|NCT02285621|Brace|brace
4858339|NCT02285621|3D|3d
4858340|NCT02285608|Medication adherence|medication adherence
4858341|NCT02285608|Patient education|patient education
4858342|NCT02285608|Mood disorders|mood disorders
4858343|NCT02285608|Economic assessment|economic assessment
4858344|NCT02285608|Mixed methods|mixed methods
4858345|NCT02285556|drug carving changes during rehabilitation|drug carving changes during rehabilitation
4858346|NCT02285556|community|community
4858347|NCT02285556|DNA|dna
4858348|NCT02285543|TPF induction chemotherapy, randomized, trial,OSCC|tpf induction chemotherapy, randomized, trial,oscc
4858349|NCT02285530|head and neck squamous cell carcinoma, GDF15, TPF|head and neck squamous cell carcinoma, gdf15, tpf
4858350|NCT02285504|Postpartum depression|postpartum depression
4858351|NCT02285465|Healthy volunteers|healthy volunteers
4858352|NCT02285465|Pharmacokinetics|pharmacokinetics
4858353|NCT02285465|Pharmacodynamics|pharmacodynamics
4858354|NCT02285465|ASP3700|asp3700
4858355|NCT02285452|physiologcal phenomena|physiologcal phenomena
4858356|NCT02285452|.HRV Parameters|.hrv parameters
4858357|NCT02285452|respiratory activity|respiratory activity
4858358|NCT02285452|thorax wraps|thorax wraps
4858359|NCT02285439|Pediatric Oncology|pediatric oncology
4858360|NCT02285439|Ras/Raf pathway|ras/raf pathway
4858361|NCT02285439|Low-Grade Glioma|low-grade glioma
4858362|NCT02285439|MEK inhibitor|mek inhibitor
4858363|NCT02285426|i-scan|i-scan
4858364|NCT02285426|histology|histology
4858365|NCT02285413|Melanoma|melanoma
4858366|NCT02285413|Dendritic cells|dendritic cells
4858367|NCT02285413|Cisplatin|cisplatin
4858368|NCT02285413|Vaccine|vaccine
4858369|NCT02285413|Immunotherapy|immunotherapy
4858370|NCT02285400|COPD|copd
4858371|NCT02285400|CPAP|cpap
4858372|NCT02285400|Central Drive|central drive
4858373|NCT02285348|Ataxia Telangiectasia|ataxia telangiectasia
4858374|NCT02285348|cerebrospinal fluid|cerebrospinal fluid
4858375|NCT02285348|inflammation|inflammation
4858376|NCT02285348|proteomic analysis|proteomic analysis
4858377|NCT02285309|Cardiac Surgery|cardiac surgery
4858378|NCT02285309|Diastolic Dysfunction|diastolic dysfunction
4858379|NCT02285309|Enoximone|enoximone
4858380|NCT02285296|geriatric assessment|geriatric assessment
4858381|NCT02285296|Caregivers|caregivers
4858382|NCT02285296|Needs Assessment|needs assessment
4858383|NCT02285296|oncology nursing|oncology nursing
4858384|NCT02285296|frail elderly|frail elderly
4858385|NCT02285296|Medical, psychologic and sociologic approach|medical, psychologic and sociologic approach
4858386|NCT02285270|Circadian rhythm|circadian rhythm
4858387|NCT02285270|Adipose tissue, brown|adipose tissue, brown
4858388|NCT02285270|Metabolism|metabolism
4858389|NCT02285257|Sepsis, Severe sepsis, septic shock, epidemiology, outcome|sepsis, severe sepsis, septic shock, epidemiology, outcome
4858390|NCT02285231|Anti-hyperglycemic effect|anti-hyperglycemic effect
4858391|NCT02285192|18F-FDG Injection|18f-fdg injection
4858392|NCT02285192|Positron Lymphography|positron lymphography
4858393|NCT02285192|Lymphatic Mapping|lymphatic mapping
4858394|NCT02285192|sentinel lymph nodes|sentinel lymph nodes
4858395|NCT02285192|PET/CT|pet/ct
4858396|NCT02285192|14-222|14-222
4858397|NCT02285179|GDC-0032|gdc-0032
4858398|NCT02285179|Pi3K inhibitor|pi3k inhibitor
4858399|NCT02285179|tamoxifen|tamoxifen
4858400|NCT02285179|hormone receptor positive|hormone receptor positive
4858401|NCT02285179|RECIST|recist
4858402|NCT02285179|pharmacodynamic|pharmacodynamic
4858403|NCT02285166|Pharmaocological therapy|pharmaocological therapy
4858404|NCT02285153|acetylsalicylic acid|acetylsalicylic acid
4858405|NCT02285153|intensive care unit|intensive care unit
4858406|NCT02285153|mortality|mortality
4858407|NCT02285153|Post mortem examination|post mortem examination
4858408|NCT02285153|bleeding|bleeding
4858409|NCT02285114|HIV|hiv
4858410|NCT02285114|emtricitabine|emtricitabine
4858411|NCT02285114|FTC|ftc
4858412|NCT02285114|tenofovir|tenofovir
4858413|NCT02285114|TDF|tdf
4858414|NCT02285114|TAF|taf
4858415|NCT02285114|antiretroviral|antiretroviral
4858416|NCT02285114|pharmacokinetic|pharmacokinetic
4858417|NCT02285114|PK|pk
4858418|NCT02285114|adolescents|adolescents
4858419|NCT02285114|children|children
4858420|NCT02285114|pediatric|pediatric
4858421|NCT02285114|Gilead|gilead
4858422|NCT02285101|arginine auxotrophic tumors|arginine auxotrophic tumors
4858423|NCT02285101|PEG-BCT-100|peg-bct-100
4858424|NCT02285101|arginase|arginase
4858425|NCT02285075|temocillin|temocillin
4858426|NCT02285075|PD/PD|pd/pd
4858427|NCT02285075|T>MIC|t>mic
4858428|NCT02285062|R-CHOP chemotherapy|r-chop chemotherapy
4858429|NCT02285062|DLBCL front line therapy|dlbcl front line therapy
4858527|NCT02284191|Acute Medicine|acute medicine
4858528|NCT02284191|Emergency Medicine|emergency medicine
4858430|NCT02285062|gene expression profiling (GEP) activated B-cell (ABC) type DLBCL biomarkers|gene expression profiling (gep) activated b-cell (abc) type dlbcl biomarkers
4858431|NCT02285062|Activated B-Cell (ABC) type|activated b-cell (abc) type
4858432|NCT02285062|Diffuse Large B-Cell Lymphoma, not otherwise specified|diffuse large b-cell lymphoma, not otherwise specified
4858433|NCT02285062|Diffuse Large B-Cell Lymphoma, associated with chronic inflammation|diffuse large b-cell lymphoma, associated with chronic inflammation
4858434|NCT02285062|Diffuse Large B-Cell Lymphoma, Epstein-Barr virus positive (EBS+) of the elderly|diffuse large b-cell lymphoma, epstein-barr virus positive (ebs+) of the elderly
4858688|NCT02283229|Plagiocephaly|plagiocephaly
4858435|NCT02285062|Diffuse Large B-Cell Lymphoma, T-cell / histiocyte-rich|diffuse large b-cell lymphoma, t-cell / histiocyte-rich
4858436|NCT02285049|Chronic urticaria|chronic urticaria
4858437|NCT02285049|Urticaria Control Test|urticaria control test
4858438|NCT02285023|Chronic urticaria|chronic urticaria
4858440|NCT02285010|pregabalin|pregabalin
4858441|NCT02285010|postoperative pain|postoperative pain
4858442|NCT02285010|abdominal hysterectomy|abdominal hysterectomy
4858443|NCT02284984|Antibodies, Monoclonal|antibodies, monoclonal
4858444|NCT02284984|mabthera|mabthera
4858445|NCT02284984|benlysta|benlysta
4858446|NCT02284984|Antinuclear Antibodies|antinuclear antibodies
4858447|NCT02284958|walking|walking
4858448|NCT02284958|pedometer|pedometer
4858449|NCT02284932|COPD|copd
4858450|NCT02284932|atrophy|atrophy
4858451|NCT02284932|muscle|muscle
4858452|NCT02284906|Drug therapy|drug therapy
4858453|NCT02284867|uterine natural killer cells|uterine natural killer cells
4858454|NCT02284867|CD16|cd16
4858455|NCT02284867|CD56|cd56
4858456|NCT02284867|Preterm labour|preterm labour
4858457|NCT02284815|Gluten|gluten
4858458|NCT02284815|T1D|t1d
4858459|NCT02284815|Remission|remission
4858460|NCT02284789|Hemophilia|hemophilia
4858461|NCT02284776|Therapeutic education|therapeutic education
4858462|NCT02284750|Bifurcation lesion|bifurcation lesion
4858463|NCT02284750|Percutaneous coronary intervention|percutaneous coronary intervention
4858464|NCT02284737|Pulmonary arterial hypertension|pulmonary arterial hypertension
4858465|NCT02284711|salpingectomy, ovarian reserve, coagulation technique|salpingectomy, ovarian reserve, coagulation technique
4858466|NCT02284685|Mental Health Services|mental health services
4858467|NCT02284646|Ankylosing spondylitis|ankylosing spondylitis
4858468|NCT02284646|Physical training program|physical training program
4858469|NCT02284633|EGFR mutation|egfr mutation
4858470|NCT02284633|Liquid biopsies|liquid biopsies
4858471|NCT02284633|Lung cancer|lung cancer
4858472|NCT02284633|erlotinib|erlotinib
4858473|NCT02284620|anesthesia|anesthesia
4858474|NCT02284620|nerve block|nerve block
4858475|NCT02284620|infltration|infltration
4858476|NCT02284581|MBC|mbc
4858477|NCT02284581|metastatic|metastatic
4858478|NCT02284581|breast|breast
4858479|NCT02284581|observational|observational
4858480|NCT02284581|disease management|disease management
4858481|NCT02284529|high-risk stage-Ⅱ Colorectal Cancer,Orectalip,oxaliplatin|high-risk stage-ⅱ colorectal cancer,orectalip,oxaliplatin
4858482|NCT02284503|MI reduction|mi reduction
4858483|NCT02284503|intensive statin treatment|intensive statin treatment
4858484|NCT02284503|NSTE-ACS|nste-acs
4858485|NCT02284490|Brain Metastases|brain metastases
4858486|NCT02284477|Insulin resistance|insulin resistance
4858487|NCT02284477|Pulmonary function|pulmonary function
4858488|NCT02284477|Phthalates|phthalates
4858489|NCT02284464|Kidney transplant|kidney transplant
4858490|NCT02284464|Immunosuppression|immunosuppression
4858491|NCT02284464|Steroid withdrawal|steroid withdrawal
4858492|NCT02284464|Donor specific antibodies|donor specific antibodies
4858493|NCT02284451|HIV/AIDS and HIV Testing Knowledge|hiv/aids and hiv testing knowledge
4858494|NCT02284438|ETT|ett
4858495|NCT02284438|Biofilm|biofilm
4858496|NCT02284438|Mechanical ventilation|mechanical ventilation
4858497|NCT02284438|Critical illness|critical illness
4858498|NCT02284438|Ventilator-associated pneumonia|ventilator-associated pneumonia
4858499|NCT02284412|Neostigmine|neostigmine
4858500|NCT02284412|Sugammadex|sugammadex
4858501|NCT02284399|aneuploidy|aneuploidy
4858502|NCT02284399|Trisomy 21|trisomy 21
4858503|NCT02284399|NIPT|nipt
4858504|NCT02284386|Total knee arthroplasty|total knee arthroplasty
4858505|NCT02284360|wound healing|wound healing
4858506|NCT02284360|APOSEC™|aposec™
4858507|NCT02284360|Safety|safety
4858508|NCT02284334|mitochondrial diseases|mitochondrial diseases
4858509|NCT02284334|nutrition|nutrition
4858510|NCT02284334|glycemic index|glycemic index
4858511|NCT02284308|NSCLC|nsclc
4858512|NCT02284295|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
4858513|NCT02284295|silica dust|silica dust
4858514|NCT02284295|aromatic hydrocarbons|aromatic hydrocarbons
4858515|NCT02284295|genetic|genetic
4858516|NCT02284295|occupational|occupational
4858517|NCT02284282|Spinal Morphine|spinal morphine
4858518|NCT02284282|Laparoscopic GI-surgery|laparoscopic gi-surgery
4858519|NCT02284282|Post-operative pain|post-operative pain
4858520|NCT02284243|Bunion|bunion
4858521|NCT02284243|Bunionectomy|bunionectomy
4858522|NCT02284243|Pain|pain
4858523|NCT02284243|Analgesia|analgesia
4858524|NCT02284243|dexmedetomidine|dexmedetomidine
4858525|NCT02284243|intranasal|intranasal
4858530|NCT02284178|mechanical ventilation|mechanical ventilation
4858531|NCT02284178|aspiration|aspiration
4858532|NCT02284178|suctioning|suctioning
4858533|NCT02284178|secretions|secretions
4858534|NCT02284178|ventilator-associated events|ventilator-associated events
4858535|NCT02284152|bottle feeding|bottle feeding
4858536|NCT02284152|feeding behavior|feeding behavior
4858537|NCT02284152|infants|infants
4858538|NCT02284152|mothers|mothers
4858539|NCT02284152|responsive feeding|responsive feeding
4858540|NCT02284152|maternal feeding practices|maternal feeding practices
4858541|NCT02284152|maternal feeding styles|maternal feeding styles
4858542|NCT02284139|EGF ointment|egf ointment
4858543|NCT02284139|EGFR inhibitor|egfr inhibitor
4858544|NCT02284139|Skin side effect|skin side effect
4858545|NCT02284126|Vancomycin|vancomycin
4858546|NCT02284126|Anti-Infective Agents, Local|anti-infective agents, local
4858547|NCT02284126|Craniotomy|craniotomy
4858548|NCT02284126|surgical site infection|surgical site infection
4858549|NCT02284126|wound prophylaxis|wound prophylaxis
4858550|NCT02284126|Anti-Bacterial Agents|anti-bacterial agents
4858551|NCT02284126|Neurosurgical Procedures|neurosurgical procedures
4858552|NCT02284126|Administration, Topical|administration, topical
4858553|NCT02284126|Antibiotic Prophylaxis|antibiotic prophylaxis
4858554|NCT02284126|antibiotics|antibiotics
4858555|NCT02284126|prophylaxis|prophylaxis
4858556|NCT02284126|neurosurgery|neurosurgery
4858557|NCT02284126|Bacterial Infections|bacterial infections
4858558|NCT02284126|Central Nervous System Infections|central nervous system infections
4858559|NCT02284087|transcranial magnetic stimulation|transcranial magnetic stimulation
4858560|NCT02284087|movement disorders|movement disorders
4858561|NCT02284074|Lipopolysaccharide (LPS)|lipopolysaccharide (lps)
4858562|NCT02284074|Biomarkers|biomarkers
4858563|NCT02284074|Chemokines|chemokines
4858564|NCT02284074|Cytokines|cytokines
4858565|NCT02284074|Gene Expression|gene expression
4858566|NCT02284074|Nasal Challenge|nasal challenge
4858567|NCT02284074|Inflammation|inflammation
4858568|NCT02284074|Nasal|nasal
4858569|NCT02284074|Nasosorption|nasosorption
4858570|NCT02284074|Respiratory|respiratory
4858571|NCT02284048|Ticagrelor|ticagrelor
4858572|NCT02284048|Coronary Flow Reserve|coronary flow reserve
4858573|NCT02284009|New-onset type 1 diabetes mellitus|new-onset type 1 diabetes mellitus
4858574|NCT02284009|Albiglutide|albiglutide
4858575|NCT02283996|Adhesive Capsulitis|adhesive capsulitis
4858576|NCT02283996|Frozen Shoulder|frozen shoulder
4858577|NCT02283996|Shoulder Frozen|shoulder frozen
4858578|NCT02283996|Physical Therapy|physical therapy
4858579|NCT02283996|Corticosteroid Injections|corticosteroid injections
4858580|NCT02283996|Hydrodilation, Hydro-dilation|hydrodilation, hydro-dilation
4858581|NCT02283996|Watchful Waiting|watchful waiting
4858582|NCT02283996|Prospective|prospective
4858583|NCT02283996|Glenohumeral Ligament|glenohumeral ligament
4858584|NCT02283905|amphotericin-B|amphotericin-b
4858585|NCT02283905|continuously infused|continuously infused
4858586|NCT02283905|voriconazole|voriconazole
4858587|NCT02283892|respiratory complaints|respiratory complaints
4858588|NCT02283892|dyspnea|dyspnea
4858589|NCT02283892|cough|cough
4858590|NCT02283892|checklist|checklist
4858591|NCT02283879|Human Umbilical Cord Mesenchymal Stem Cell|human umbilical cord mesenchymal stem cell
4858592|NCT02283879|Mesenchymal Stem Cell|mesenchymal stem cell
4858593|NCT02283879|Cerebral hemorrhage|cerebral hemorrhage
4858594|NCT02283853|Pediatrics|pediatrics
4858595|NCT02283749|NCSLC|ncslc
4858596|NCT02283749|lung cancer|lung cancer
4858597|NCT02283749|non small cell lung cancer|non small cell lung cancer
4858598|NCT02283749|bone metastases|bone metastases
4858599|NCT02283749|maintenance|maintenance
4858600|NCT02283736|Chronic periodontitis|chronic periodontitis
4858601|NCT02283736|Probiotics|probiotics
4858602|NCT02283736|Non- surgical treatment|non- surgical treatment
4858603|NCT02283723|older adults, goal attainment, optimal aging|older adults, goal attainment, optimal aging
4858604|NCT02283710|Pentoxifylline|pentoxifylline
4858605|NCT02283710|Aminotransferase|aminotransferase
4858606|NCT02283710|Steatohepatitis|steatohepatitis
4858607|NCT02283697|hypertension|hypertension
4858608|NCT02283697|high blood pressure|high blood pressure
4858609|NCT02283697|sodium|sodium
4858610|NCT02283697|prevention|prevention
4858611|NCT02283697|dietary sodium|dietary sodium
4858612|NCT02283697|salt|salt
4858613|NCT02283684|LASER|laser
4858614|NCT02283684|PROSTATE|prostate
4858615|NCT02283684|BIPOLAR|bipolar
4858616|NCT02283684|HYPERPLASIA|hyperplasia
4858617|NCT02283684|VAPORIZATION|vaporization
4858618|NCT02283580|COPD|copd
4858619|NCT02283580|Healthy adults|healthy adults
4858620|NCT02283580|Resistance training|resistance training
4858621|NCT02283580|Elastic bands|elastic bands
4858622|NCT02283580|Limb muscle function|limb muscle function
4858623|NCT02283580|Volunteers|volunteers
4858624|NCT02283554|Periodontal Surgery|periodontal surgery
4858625|NCT02283554|Periodontal Regeneration|periodontal regeneration
4858626|NCT02283554|Growth factors|growth factors
4858627|NCT02283554|Clinical trials|clinical trials
4858628|NCT02283541|Gait|gait
4858629|NCT02283541|late life depression|late life depression
4858630|NCT02283541|mind-body therapies|mind-body therapies
4858631|NCT02283515|chronic periodontitis|chronic periodontitis
4858632|NCT02283515|local drug delivery|local drug delivery
4858633|NCT02283515|rosuvastatin|rosuvastatin
4858634|NCT02283515|osseo-differentiation|osseo-differentiation
4858635|NCT02283502|Uterine fibroid|uterine fibroid
4858636|NCT02283502|magnetic resonance imaging|magnetic resonance imaging
4858637|NCT02283502|ultrasound|ultrasound
4858638|NCT02283502|non-invasive therapy|non-invasive therapy
4858639|NCT02283489|Recombinant Human Endostatin Adenovirus|recombinant human endostatin adenovirus
4858640|NCT02283489|Head and Neck Malignant Tumor|head and neck malignant tumor
4858641|NCT02283489|clinical trial|clinical trial
4858642|NCT02283489|randomized|randomized
4858643|NCT02283489|Endostatin|endostatin
4858644|NCT02283489|gene therapy|gene therapy
4858645|NCT02283476|efficacy and safety|efficacy and safety
4858646|NCT02283437|Bibliotherapy|bibliotherapy
4858647|NCT02283437|Problem-solving|problem-solving
4858648|NCT02283437|Randomized Controlled Trial|randomized controlled trial
4858649|NCT02283437|Schizophrenia Spectrum Disorders|schizophrenia spectrum disorders
4858650|NCT02283437|Family Caregivers|family caregivers
4858651|NCT02283385|Elder abuse|elder abuse
4858652|NCT02283385|Intervention|intervention
4858653|NCT02283385|Treatment|treatment
4858654|NCT02283385|Detection|detection
4858655|NCT02283359|Distal Esophagus|distal esophagus
4858656|NCT02283359|Esophageal|esophageal
4858657|NCT02283359|Gastric|gastric
4858658|NCT02283359|Carcinoma|carcinoma
4858659|NCT02283359|Adenocarcinoma|adenocarcinoma
4858660|NCT02283359|Stomach|stomach
4858661|NCT02283359|Gastro-esophageal junction|gastro-esophageal junction
4858662|NCT02283359|Recurrent|recurrent
4858663|NCT02283359|Metastatic|metastatic
4858664|NCT02283359|Unresectable|unresectable
4858665|NCT02283346|Prostate Cancer|prostate cancer
4858666|NCT02283346|HDR brachytherapy|hdr brachytherapy
4858667|NCT02283346|hypo fractionated external beam radiotherapy|hypo fractionated external beam radiotherapy
4858668|NCT02283346|toxicity|toxicity
4858669|NCT02283346|biochemical control|biochemical control
4858670|NCT02283333|Behavioral Activation|behavioral activation
4858671|NCT02283333|Therapeutic Exposure|therapeutic exposure
4858672|NCT02283333|Mental Health|mental health
4858673|NCT02283333|Veterans|veterans
4858674|NCT02283333|Complicated Grief|complicated grief
4858675|NCT02283333|Military|military
4858676|NCT02283333|Treatment|treatment
4858677|NCT02283333|Cognitive Therapy|cognitive therapy
4858678|NCT02283333|Bereavement|bereavement
4858679|NCT02283333|Complicated Bereavement|complicated bereavement
4858680|NCT02283255|Fontan|fontan
4858681|NCT02283255|Exercise|exercise
4858682|NCT02283255|Pulmonary Function|pulmonary function
4858683|NCT02283255|Aerobic Capacity|aerobic capacity
4858684|NCT02283255|Skeletal Muscle|skeletal muscle
4858685|NCT02283242|Cholinergic Antagonists|cholinergic antagonists
4858686|NCT02283242|Inflammation|inflammation
4858687|NCT02283242|Oxidative Stress|oxidative stress
4858689|NCT02283229|torticollis|torticollis
4858690|NCT02283229|occlusal defect|occlusal defect
4858691|NCT02283216|neuromodulation|neuromodulation
4858692|NCT02283216|noninvasive|noninvasive
4858693|NCT02283216|plasticity|plasticity
4858694|NCT02283216|transcranial magnetic stimulation|transcranial magnetic stimulation
4858695|NCT02283216|hearing|hearing
4858696|NCT02283216|hyperacusis|hyperacusis
4858697|NCT02283203|Paracetamol|paracetamol
4858698|NCT02283203|Management of fever|management of fever
4858699|NCT02283203|Infections|infections
4858700|NCT02283190|Asparaginase|asparaginase
4858701|NCT02283190|Glutamine|glutamine
4858702|NCT02283164|Occupational health|occupational health
4858703|NCT02283164|Hazardous material handling|hazardous material handling
4858704|NCT02283151|Very Low Carbohydrate Diet|very low carbohydrate diet
4858705|NCT02283151|Overweight/obese|overweight/obese
4858706|NCT02283138|FLV, VOCAL, PA-RI, preterm fetuses, RDS|flv, vocal, pa-ri, preterm fetuses, rds
4858707|NCT02283099|Ebola virus, vaccination, phase I, healthy volunteers|ebola virus, vaccination, phase i, healthy volunteers
4858708|NCT02283086|Quality Improvement|quality improvement
4858709|NCT02283086|Physician Feedback|physician feedback
4858710|NCT02283073|Diagnosis|diagnosis
4858711|NCT02283060|Atripla|atripla
4858712|NCT02283060|Stribild|stribild
4858713|NCT02283060|HIV|hiv
4858714|NCT02283060|Sleep architecture|sleep architecture
4858715|NCT02283060|Neuropsychological performance|neuropsychological performance
4858716|NCT02283047|cardiovascular risk, obesity, interval training, diet|cardiovascular risk, obesity, interval training, diet
4858717|NCT02283021|expression of L-type calcium subunits|expression of l-type calcium subunits
4858718|NCT02282995|Functional dyspepsia|functional dyspepsia
4858719|NCT02282995|symptom response|symptom response
4858720|NCT02282982|Immunoprophylaxis|immunoprophylaxis
4858721|NCT02282982|Palivizumab|palivizumab
4858722|NCT02282969|Cancer Prevention|cancer prevention
4858723|NCT02282969|Smokers|smokers
4858724|NCT02282969|Quit smoking|quit smoking
4858725|NCT02282969|Interviews|interviews
4858726|NCT02282969|Questionnaires|questionnaires
4858727|NCT02282969|Surveys|surveys
4858728|NCT02282969|Lung cancer screening|lung cancer screening
4858729|NCT02282969|Patient decision aid|patient decision aid
4858730|NCT02282943|endometriosis|endometriosis
4858731|NCT02282943|CO2 laser vapourisation|co2 laser vapourisation
4858732|NCT02282943|Harmonic scalpel|harmonic scalpel
4858733|NCT02282943|AFS stage I-III|afs stage i-iii
4858734|NCT02282930|ACTH|acth
4858735|NCT02282930|Acthar|acthar
4858736|NCT02282930|IgA|iga
4858737|NCT02282930|Progressive|progressive
4858738|NCT02282930|Nephropathy|nephropathy
4858739|NCT02282930|renal function|renal function
4858740|NCT02282917|NF2|nf2
4858741|NCT02282917|Vestibular Schwannoma|vestibular schwannoma
4858742|NCT02282917|Schwannoma|schwannoma
4858743|NCT02282917|Meningioma|meningioma
4858744|NCT02282904|Bone Marrow Transplant|bone marrow transplant
4858745|NCT02282904|Subablative Conditioning|subablative conditioning
4858746|NCT02282904|Graft Versus Host Disease|graft versus host disease
4858747|NCT02282904|Non-Myeloablative|non-myeloablative
4858748|NCT02282904|Reduced Intensity|reduced intensity
4858749|NCT02282891|propofol|propofol
4858750|NCT02282891|ketofol|ketofol
4858751|NCT02282878|High Sodium Diet|high sodium diet
4858752|NCT02282878|Low Sodium Diet|low sodium diet
4858753|NCT02282878|MS|ms
4858754|NCT02282865|Emergence agitation, Heart rate variability (HRV)|emergence agitation, heart rate variability (hrv)
4858755|NCT02282839|Head and neck cancer|head and neck cancer
4858756|NCT02282839|Glutamine|glutamine
4858757|NCT02282839|Oral mucositis|oral mucositis
4858758|NCT02282839|Quality of life|quality of life
4858759|NCT02282813|Parathyroid Diseases|parathyroid diseases
4858760|NCT02282813|Renal Insufficiency|renal insufficiency
4858761|NCT02282813|Kidney Failure, Chronic|kidney failure, chronic
4858762|NCT02282813|Hyperparathyroidism, Secondary|hyperparathyroidism, secondary
4858763|NCT02282813|Vitamin D|vitamin d
4858764|NCT02282813|Hyperparathyroidism|hyperparathyroidism
4858765|NCT02282813|Kidney Diseases|kidney diseases
4858766|NCT02282813|Kidney Failure|kidney failure
4858767|NCT02282813|Renal Insufficiency, Chronic|renal insufficiency, chronic
4858768|NCT02282787|local anesthesia|local anesthesia
4858769|NCT02282787|peribulbar anesthesia|peribulbar anesthesia
4858770|NCT02282787|DEXMEDETOMIDINE|dexmedetomidine
4858771|NCT02282787|vitreoretinal surgery|vitreoretinal surgery
4858772|NCT02282774|Vitreoretinal surgery|vitreoretinal surgery
4858773|NCT02282735|neuroblastoma|neuroblastoma
4858774|NCT02282735|end-of-life|end-of-life
4858775|NCT02282735|decision-making|decision-making
4858776|NCT02282735|parent|parent
4858777|NCT02282735|child|child
4858778|NCT02282735|prognosis|prognosis
4858779|NCT02282735|preferences|preferences
4858780|NCT02282735|childhood cancer|childhood cancer
4858781|NCT02282735|oncology|oncology
4858782|NCT02282722|cancer|cancer
4858783|NCT02282722|palliative|palliative
4858784|NCT02282722|chemotherapy|chemotherapy
4858785|NCT02282722|metastatic|metastatic
4858786|NCT02282722|colorectal|colorectal
4858787|NCT02282722|communication|communication
4858788|NCT02282722|informed consent|informed consent
4858789|NCT02282722|video|video
4858790|NCT02282722|education|education
4858791|NCT02282722|oncology|oncology
4858792|NCT02282722|patient-centered|patient-centered
4858793|NCT02282722|outcomes research|outcomes research
4858794|NCT02282709|Immunity|immunity
4858795|NCT02282657|extracorporreal|extracorporreal
4858796|NCT02282657|CO2 removal|co2 removal
4858797|NCT02282657|ARDS|ards
4858798|NCT02282657|lung|lung
4858799|NCT02282657|Protective ventilation|protective ventilation
4858800|NCT02282631|active school travel|active school travel
4858801|NCT02282631|active travel|active travel
4858802|NCT02282631|incentive scheme|incentive scheme
4858803|NCT02282631|children|children
4858804|NCT02282631|school|school
4858805|NCT02282631|behaviour change|behaviour change
4858806|NCT02282618|Cardiac Sympathetic Blockade|cardiac sympathetic blockade
4858807|NCT02282592|Metabolic syndrome|metabolic syndrome
4858808|NCT02282592|case-control study|case-control study
4858809|NCT02282592|Breast cancer|breast cancer
4858810|NCT02282566|Muscle protein synthesis|muscle protein synthesis
4858811|NCT02282514|Autoimmune Diseases|autoimmune diseases
4858812|NCT02282514|Autologous Hematopoietic Stem Cell Transplantation|autologous hematopoietic stem cell transplantation
4858813|NCT02282501|leptin levels|leptin levels
4858814|NCT02282501|ghrelin levels|ghrelin levels
4858815|NCT02282462|Chest tube|chest tube
4858816|NCT02282449|Venous access device|venous access device
4858817|NCT02282449|Port catheters|port catheters
4858818|NCT02282449|Chemotherapy|chemotherapy
4858819|NCT02282410|severe hemophilia A|severe hemophilia a
4858820|NCT02282410|moderately severe hemophilia A|moderately severe hemophilia a
4858821|NCT02282410|Recombinant Human Coagulation Factor VIII|recombinant human coagulation factor viii
4858822|NCT02282410|standard prophylaxis|standard prophylaxis
4858823|NCT02282397|Diabetes Mellitus|diabetes mellitus
4858824|NCT02282371|Cetuximab|cetuximab
4858825|NCT02282371|BYL719|byl719
4858826|NCT02282371|IMRT (Intensity-Modulated Radiation Therapy)|imrt (intensity-modulated radiation therapy)
4858827|NCT02282371|14-116|14-116
4858828|NCT02282358|Mocetinostat|mocetinostat
4858829|NCT02282358|14-106|14-106
4858830|NCT02282345|Breast cancer|breast cancer
4858831|NCT02282345|BRCA deleterious mutation|brca deleterious mutation
4858929|NCT02281825|Impulsivity|impulsivity
4858832|NCT02282345|Invasive adenocarcinoma of the breast|invasive adenocarcinoma of the breast
4858833|NCT02282345|BMN 673|bmn 673
4858834|NCT02282345|Talazoparib tosylate|talazoparib tosylate
4858835|NCT02282319|spinal or intravenous dexmedetomidine|spinal or intravenous dexmedetomidine
4858836|NCT02282293|Chemoprevention|chemoprevention
4858837|NCT02282293|Malaria|malaria
4858838|NCT02282293|Uganda|uganda
4858839|NCT02282293|Dihydroartemisinin-piperaquine|dihydroartemisinin-piperaquine
4858840|NCT02282293|Trimethoprim-sulfamethoxazole|trimethoprim-sulfamethoxazole
4858841|NCT02282293|Human Immunodeficiency Virus|human immunodeficiency virus
4858842|NCT02282267|Epidermal growth factor receptor|epidermal growth factor receptor
4858843|NCT02282267|Droplet digital PCR|droplet digital pcr
4858844|NCT02282254|Type 1 diabetes|type 1 diabetes
4858845|NCT02282254|Hypoglycemia unawareness|hypoglycemia unawareness
4858846|NCT02282254|Nocturnal hypoglycemia|nocturnal hypoglycemia
4858847|NCT02282254|Closed-loop strategy|closed-loop strategy
4858848|NCT02282254|Artificial pancreas|artificial pancreas
4858849|NCT02282254|Glucagon|glucagon
4858850|NCT02282254|Hypoglycemia|hypoglycemia
4858851|NCT02282254|Insulin|insulin
4858852|NCT02282241|Melatonin|melatonin
4858853|NCT02282241|Sleep|sleep
4858854|NCT02282241|Delirium|delirium
4858855|NCT02282215|Fever|fever
4858856|NCT02282215|Induction chemotherapy|induction chemotherapy
4858857|NCT02282215|Infection|infection
4858858|NCT02282215|Leukemia|leukemia
4858859|NCT02282215|Myeloid progenitor cells|myeloid progenitor cells
4858860|NCT02282215|Neutropenia|neutropenia
4858861|NCT02282202|Sputum|sputum
4858862|NCT02282202|Bronchiectasis|bronchiectasis
4858863|NCT02282202|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
4858864|NCT02282202|Airway clearance therapy|airway clearance therapy
4858865|NCT02282202|Oscillatory Positive Expiratory Pressure|oscillatory positive expiratory pressure
4858866|NCT02282189|Sputum|sputum
4858867|NCT02282189|Airway clearance therapy|airway clearance therapy
4858868|NCT02282189|Oscillatory Positive Expiratory Pressure|oscillatory positive expiratory pressure
4858869|NCT02282189|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
4858870|NCT02282176|Neonates|neonates
4858871|NCT02282176|Preterm|preterm
4858872|NCT02282176|Azithromycin|azithromycin
4858873|NCT02282176|Ureaplasma|ureaplasma
4858874|NCT02282176|Chronic Lung disease|chronic lung disease
4858875|NCT02282176|Bronchopulmonary dysplasia|bronchopulmonary dysplasia
4858876|NCT02282150|Fatigue|fatigue
4858877|NCT02282150|Quality of Life|quality of life
4858878|NCT02282150|Hydrocortisone|hydrocortisone
4858879|NCT02282150|Ecological Momentary Assessments|ecological momentary assessments
4858880|NCT02282124|weight|weight
4858881|NCT02282124|self-management|self-management
4858882|NCT02282124|exercise|exercise
4858883|NCT02282098|Atrial fibrillation|atrial fibrillation
4858884|NCT02282098|Arrhythmias, Cardiac|arrhythmias, cardiac
4858885|NCT02282098|Stroke|stroke
4858886|NCT02282098|agents, anti inflammatory|agents, anti inflammatory
4858887|NCT02282098|D-dimer|d-dimer
4858888|NCT02282098|C-reactive protein|c-reactive protein
4858889|NCT02282085|Medication Non-Adherence|medication non-adherence
4858890|NCT02282085|Antipsychotic|antipsychotic
4858891|NCT02282046|type 2 diabetes mellitus|type 2 diabetes mellitus
4858892|NCT02282046|dental implant|dental implant
4858893|NCT02282020|BRCA, ovarian, platinum, chemotherapy,|brca, ovarian, platinum, chemotherapy,
4858894|NCT02282007|Quality of life|quality of life
4858895|NCT02281994|PEMF|pemf
4858896|NCT02281994|odontoid fracture|odontoid fracture
4858897|NCT02281994|IDE|ide
4858898|NCT02281994|prospective|prospective
4858899|NCT02281955|Human Papillomavirus|human papillomavirus
4858900|NCT02281955|Oropharynx|oropharynx
4858901|NCT02281955|Oropharyngeal Squamous Cell Carcinoma|oropharyngeal squamous cell carcinoma
4858902|NCT02281955|Squamous Cell Carcinoma|squamous cell carcinoma
4858903|NCT02281955|Radiation Therapy|radiation therapy
4858904|NCT02281955|Chemotherapy|chemotherapy
4858905|NCT02281955|p16|p16
4858906|NCT02281929|Alcoholic hepatitis|alcoholic hepatitis
4858907|NCT02281929|corticotherapy|corticotherapy
4858908|NCT02281929|antibiotherapy|antibiotherapy
4858909|NCT02281929|survival|survival
4858910|NCT02281929|infection|infection
4858911|NCT02281929|hepato renal syndrome|hepato renal syndrome
4858912|NCT02281916|Crohn disease|crohn disease
4858913|NCT02281916|Immunotherapy|immunotherapy
4858914|NCT02281916|Helminth antigen|helminth antigen
4858915|NCT02281890|neurodevelopmental disability|neurodevelopmental disability
4858916|NCT02281877|Total Knee Arthroplasty (TKA)|total knee arthroplasty (tka)
4858917|NCT02281877|Gene Expression|gene expression
4858918|NCT02281851|Endogenous antioxidants|endogenous antioxidants
4858919|NCT02281851|Antioxidant supplements|antioxidant supplements
4858920|NCT02281851|Vitamin Supplements|vitamin supplements
4858921|NCT02281851|Exercise adaptations|exercise adaptations
4858922|NCT02281851|Oxidative stress|oxidative stress
4858923|NCT02281851|Redox regulation|redox regulation
4858924|NCT02281851|Cycling - exercise|cycling - exercise
4858925|NCT02281838|Stroke|stroke
4858926|NCT02281838|Hypertension|hypertension
4858927|NCT02281825|Attention-Deficit and Hyperactivity Disorder|attention-deficit and hyperactivity disorder
4858928|NCT02281825|Anxiety|anxiety
4858930|NCT02281825|Computer Games|computer games
4858931|NCT02281825|Depression|depression
4858932|NCT02281812|Ablation Technique|ablation technique
4858933|NCT02281812|Breast cancer|breast cancer
4858934|NCT02281812|Stage 1|stage 1
4858935|NCT02281812|Lumpectomy|lumpectomy
4858936|NCT02281799|Azathioprine (AZA)|azathioprine (aza)
4858937|NCT02281799|6-mercaptopurine (6-MP)|6-mercaptopurine (6-mp)
4858938|NCT02281799|Thiopurine-S-methyltransferase (TPMT)|thiopurine-s-methyltransferase (tpmt)
4858939|NCT02281799|Xanthine oxidase (XO)|xanthine oxidase (xo)
4858940|NCT02281799|6-thioguanine (6-TGN)|6-thioguanine (6-tgn)
4858941|NCT02281799|6-methyl-mercaptopurine (6-MMP)|6-methyl-mercaptopurine (6-mmp)
4858942|NCT02281799|inflammatory bowel disease (IBD)|inflammatory bowel disease (ibd)
4858943|NCT02281799|acute pancreatitis (AP)|acute pancreatitis (ap)
4858944|NCT02281799|inosine triphosphate pyrophosphohydrolase (ITPA)|inosine triphosphate pyrophosphohydrolase (itpa)
4858945|NCT02281799|rheumatoid arthritis (RA)|rheumatoid arthritis (ra)
4858946|NCT02281799|systemic lupus erythematosis (SLE)|systemic lupus erythematosis (sle)
4858947|NCT02281799|Crohn's disease (CD)|crohn's disease (cd)
4858948|NCT02281799|ulcerative colitis (UC)|ulcerative colitis (uc)
4858949|NCT02281760|Histiocytosis|histiocytosis
4858950|NCT02281760|Non Langerhans Cell Histiocytosis|non langerhans cell histiocytosis
4858951|NCT02281760|BRAF Inhibitor|braf inhibitor
4858952|NCT02281747|Biologic Therapy|biologic therapy
4858953|NCT02281747|Rheumatoid Arthritis|rheumatoid arthritis
4858954|NCT02281747|Arthroplasty|arthroplasty
4858955|NCT02281708|normogram|normogram
4858956|NCT02281708|recurrence|recurrence
4858957|NCT02281708|adjuvant chemotherapy|adjuvant chemotherapy
4858958|NCT02281708|disease free survival|disease free survival
4858959|NCT02281708|Quality of life|quality of life
4858960|NCT02281682|Keratosis, Actinic|keratosis, actinic
4858961|NCT02281682|Treatment Outcome|treatment outcome
4858962|NCT02281682|cost-effectiveness|cost-effectiveness
4858963|NCT02281682|economic evaluation|economic evaluation
4858964|NCT02281682|imiquimod|imiquimod
4858965|NCT02281682|photodynamic therapy|photodynamic therapy
4858966|NCT02281682|topical fluorouracil|topical fluorouracil
4858967|NCT02281682|ingenol mebutate|ingenol mebutate
4858968|NCT02281643|Coinfection|coinfection
4858969|NCT02281643|Buruli ulcer|buruli ulcer
4858970|NCT02281643|Tuberculosis|tuberculosis
4858971|NCT02281643|Mansonella perstans|mansonella perstans
4858972|NCT02281630|Chronic Constipation|chronic constipation
4858973|NCT02281630|CC|cc
4858974|NCT02281578|Sex Workers|sex workers
4858975|NCT02281578|Prevention|prevention
4858976|NCT02281565|attitudes|attitudes
4858977|NCT02281565|blood donation|blood donation
4858978|NCT02281565|blood shortage|blood shortage
4858979|NCT02281552|Tofacitinib, CP-690,550, Janis kinase, JAK inhibitor, modified release, Xeljanz|tofacitinib, cp-690,550, janis kinase, jak inhibitor, modified release, xeljanz
4858980|NCT02281539|Phantom Limb Pain|phantom limb pain
4858981|NCT02281539|Augmented Reality|augmented reality
4858982|NCT02281539|Myoelectric control|myoelectric control
4858983|NCT02281539|Virtual reality|virtual reality
4858984|NCT02281539|electromyography|electromyography
4858985|NCT02281539|pattern recognition|pattern recognition
4858986|NCT02281539|neurorehabilitation|neurorehabilitation
4858987|NCT02281513|Nutrition|nutrition
4858988|NCT02281487|tubal carcinoma|tubal carcinoma
4858989|NCT02281487|ovarian carcinoma|ovarian carcinoma
4858990|NCT02281487|tubectomy|tubectomy
4858991|NCT02281487|hysterectomy|hysterectomy
4858992|NCT02281487|dysplastic changes|dysplastic changes
4858993|NCT02281487|Anti Mullerian Hormone|anti mullerian hormone
4858994|NCT02281487|Tubal Intraepithelial Carcinoma|tubal intraepithelial carcinoma
4858995|NCT02281487|Salpingectomy|salpingectomy
4858996|NCT02281461|PrePex|prepex
4858997|NCT02281461|Infants|infants
4858998|NCT02281461|Early infants|early infants
4858999|NCT02281461|Children|children
4859000|NCT02281461|Circumcision|circumcision
4859001|NCT02281461|HIV|hiv
4859002|NCT02281461|AIDS|aids
4859003|NCT02281461|Non surgical|non surgical
4859004|NCT02281435|Male Circumcision|male circumcision
4859005|NCT02281435|HIV Prevention|hiv prevention
4859006|NCT02281435|Screen Failure Subjects|screen failure subjects
4859007|NCT02281435|PrePex with Incision|prepex with incision
4859008|NCT02281409|Mogamulizumab (KW-0761)|mogamulizumab (kw-0761)
4859009|NCT02281409|14-135|14-135
4859010|NCT02281396|safety|safety
4859011|NCT02281396|rabies vaccine|rabies vaccine
4859012|NCT02281396|MRC-5 cell|mrc-5 cell
4859013|NCT02281383|Bacillus Calmette-Guérin (BCG)|bacillus calmette-guérin (bcg)
4859014|NCT02281383|14-174|14-174
4859015|NCT02281370|cyclosporine|cyclosporine
4859016|NCT02281370|drug-drug interaction|drug-drug interaction
4859017|NCT02281370|pharmacokinetics|pharmacokinetics
4859018|NCT02281370|eltrombopag|eltrombopag
4859019|NCT02281370|SB-497115|sb-497115
4859020|NCT02281357|Asthma|asthma
4859021|NCT02281357|Reactive Airways|reactive airways
4859022|NCT02281357|Repiratory Tract Disease|repiratory tract disease
4859023|NCT02281357|Obstructive Lung Disease|obstructive lung disease
4859024|NCT02281357|Lung Diseases|lung diseases
4859025|NCT02281344|induced blood stage malaria infection|induced blood stage malaria infection
4859026|NCT02281318|Asthma control|asthma control
4859027|NCT02281318|Lung function|lung function
4859028|NCT02281318|Health-related quality of life|health-related quality of life
4859029|NCT02281318|Mepolizumab|mepolizumab
4859030|NCT02281318|Severe Eosinophilic asthma|severe eosinophilic asthma
4859031|NCT02281292|Diabetic Macular Edema|diabetic macular edema
4859032|NCT02281292|Intravitreal|intravitreal
4859033|NCT02281292|Retina|retina
4859034|NCT02281292|Ophthalmology|ophthalmology
4859035|NCT02281292|Lucentis|lucentis
4859036|NCT02281292|OCT|oct
4859037|NCT02281253|L-carnitine|l-carnitine
4859038|NCT02281253|fibre|fibre
4859039|NCT02281253|bakery product|bakery product
4859040|NCT02281253|insulin resistance|insulin resistance
4859041|NCT02281240|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
4859042|NCT02281214|lung cancer, mutations|lung cancer, mutations
4859043|NCT02281214|patients|patients
4859044|NCT02281214|mutations|mutations
4859045|NCT02281175|Benzodiazepine withdrawal|benzodiazepine withdrawal
4859046|NCT02281175|PASSE-65+ program|passe-65+ program
4859047|NCT02281175|Psychosocial (non-pharmacological) intervention|psychosocial (non-pharmacological) intervention
4859048|NCT02281175|Cognitive-Behavioral Therapy (CBT)|cognitive-behavioral therapy (cbt)
4859049|NCT02281175|Older adults|older adults
4859050|NCT02281149|breast cancer|breast cancer
4859051|NCT02281149|radiotherapy|radiotherapy
4859052|NCT02281149|intensity modulation|intensity modulation
4859053|NCT02281149|toxicity|toxicity
4859054|NCT02281136|Actinic keratosis|actinic keratosis
4859055|NCT02281110|Diagnostic coronary catheterization|diagnostic coronary catheterization
4859056|NCT02281110|Multi-vessel coronary disease|multi-vessel coronary disease
4859057|NCT02281110|Percutaneous Coronary Intervention|percutaneous coronary intervention
4859058|NCT02281110|Instantaneous wave free ratio|instantaneous wave free ratio
4859059|NCT02281110|Fractional flow reserve|fractional flow reserve
4859060|NCT02281097|Postural Orthostatic Tachycardia Syndrome|postural orthostatic tachycardia syndrome
4859061|NCT02281097|POTS|pots
4859062|NCT02281097|Vagal Stimulation|vagal stimulation
4859063|NCT02281084|Keywords provided by Celgene:|keywords provided by celgene:
4859064|NCT02281084|myelodysplastic syndromes|myelodysplastic syndromes
4859065|NCT02281084|MDS|mds
4859066|NCT02281084|azacitidine|azacitidine
4859067|NCT02281084|oral azacitidine (CC-486)|oral azacitidine (cc-486)
4859068|NCT02281084|decitabine|decitabine
4859069|NCT02281084|intermediate-1|intermediate-1
4859070|NCT02281084|intermediate-2 and high risk myelodysplastic syndromes (MDS)|intermediate-2 and high risk myelodysplastic syndromes (mds)
4859071|NCT02281084|proliferative chronic myelomonocytic leukemia (CMML)|proliferative chronic myelomonocytic leukemia (cmml)
4859072|NCT02281084|Chronic|chronic
4859073|NCT02281084|iHMA (injectable hypomethylating agents)|ihma (injectable hypomethylating agents)
4859074|NCT02281084|PD-L1|pd-l1
4859075|NCT02281032|Palliative Care|palliative care
4859076|NCT02281032|Nursing Homes|nursing homes
4859077|NCT02281032|interRAI Palliative Care instrument|interrai palliative care instrument
4859078|NCT02281032|Older adults|older adults
4859079|NCT02280980|Stroke|stroke
4859080|NCT02280980|Postural Balance|postural balance
4859081|NCT02280980|Oculomotor and Gaze Stability Exercises|oculomotor and gaze stability exercises
4859082|NCT02280980|Rehabilitation|rehabilitation
4859083|NCT02280980|Physical therapy|physical therapy
4859084|NCT02280980|Outpatient|outpatient
4859085|NCT02280967|Adolescent|adolescent
4859086|NCT02280967|Attitude|attitude
4859087|NCT02280967|Condom|condom
4859088|NCT02280967|Human Papillomavirus Vaccines|human papillomavirus vaccines
4859089|NCT02280967|Primary prevention|primary prevention
4859090|NCT02280967|School Health|school health
4859091|NCT02280954|Solid Tumor|solid tumor
4859092|NCT02280915|female|female
4859093|NCT02280915|subjects|subjects
4859094|NCT02280902|auto-immune diseases|auto-immune diseases
4859095|NCT02280902|inflammatory diseases|inflammatory diseases
4859096|NCT02280902|risk factors|risk factors
4859097|NCT02280902|infections|infections
4859098|NCT02280902|cohort study|cohort study
4859099|NCT02280889|quality of life|quality of life
4859100|NCT02280889|nevus or scar|nevus or scar
4859101|NCT02280889|stigmatization|stigmatization
4859102|NCT02280889|scar|scar
4859103|NCT02280876|MS|ms
4859104|NCT02280876|Demyelinating Autoimmune Diseases|demyelinating autoimmune diseases
4859105|NCT02280876|CNS|cns
4859106|NCT02280876|Nervous System Diseases|nervous system diseases
4859107|NCT02280850|Angina|angina
4859108|NCT02280837|GLP-1|glp-1
4859109|NCT02280824|Transcaval|transcaval
4859110|NCT02280824|TAVR|tavr
4859111|NCT02280824|AMPLATZER(R) Occluder|amplatzer(r) occluder
4859112|NCT02280811|HPV positive|hpv positive
4859113|NCT02280811|Metastatic|metastatic
4859114|NCT02280811|Diet|diet
4859115|NCT02280811|Screening|screening
4859116|NCT02280811|Risk Factors|risk factors
4859117|NCT02280811|Colorectal adenoma|colorectal adenoma
4859118|NCT02280811|Refractory|refractory
4859119|NCT02280811|Immunotherapy|immunotherapy
4859120|NCT02280811|Reproductive Cancers|reproductive cancers
4859121|NCT02280798|ERA|era
4859122|NCT02280772|glucomannan|glucomannan
4859123|NCT02280772|obesity|obesity
4859124|NCT02280772|children|children
4859125|NCT02280772|overweight|overweight
4859126|NCT02280772|adolescents|adolescents
4859127|NCT02280772|treatment|treatment
4859128|NCT02280759|diarrhea, gelatin tannate, acute gastroenteritis|diarrhea, gelatin tannate, acute gastroenteritis
4859129|NCT02280733|Qualified Clinical Data Registry|qualified clinical data registry
4859130|NCT02280733|Quality Measures|quality measures
4859131|NCT02280733|Meaningful Use Stage 2|meaningful use stage 2
4859132|NCT02280733|Electronic Health Records|electronic health records
4859133|NCT02280733|Clinical Data Research Network|clinical data research network
4859134|NCT02280733|Real world data|real world data
4859135|NCT02280720|titanium-nitride-oxide-coated stent|titanium-nitride-oxide-coated stent
4859136|NCT02280720|everolimus-eluting stent|everolimus-eluting stent
4859137|NCT02280720|optical coherence tomography|optical coherence tomography
4859138|NCT02280720|strut coverage|strut coverage
4859139|NCT02280681|reproductive medicine|reproductive medicine
4859140|NCT02280681|artificial gametes|artificial gametes
4859141|NCT02280681|patient preference|patient preference
4859142|NCT02280681|decision making|decision making
4859143|NCT02280668|muscle|muscle
4859144|NCT02280668|muscle repair|muscle repair
4859145|NCT02280668|tissue repair|tissue repair
4859146|NCT02280668|eccentric exercise|eccentric exercise
4859147|NCT02280668|force loss|force loss
4859148|NCT02280668|icing|icing
4859149|NCT02280668|cold therapy|cold therapy
4859150|NCT02280668|DOMS|doms
4859151|NCT02280668|soreness|soreness
4859152|NCT02280668|recovery|recovery
4859153|NCT02280655|Blood Transfusions|blood transfusions
4859154|NCT02280642|Human papillomavirus|human papillomavirus
4859155|NCT02280642|Cervical cancer|cervical cancer
4859156|NCT02280642|Genital warts|genital warts
4859157|NCT02280642|Vaccine|vaccine
4859158|NCT02280642|Immunogenicity|immunogenicity
4859159|NCT02280564|motivational interviewing|motivational interviewing
4859160|NCT02280564|problem solving skills|problem solving skills
4859161|NCT02280564|family communication|family communication
4859162|NCT02280564|technology support|technology support
4859163|NCT02280564|cell phone system|cell phone system
4859164|NCT02280551|adolescent|adolescent
4859165|NCT02280551|alcohol|alcohol
4859166|NCT02280551|parent|parent
4859167|NCT02280551|epidemiology|epidemiology
4859168|NCT02280538|Knee Osteoarthritis|knee osteoarthritis
4859169|NCT02280538|Intra-Articular Hyaluronic Acid|intra-articular hyaluronic acid
4859170|NCT02280538|disease modifying|disease modifying
4859171|NCT02280525|Leukemia|leukemia
4859172|NCT02280525|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
4859173|NCT02280525|CLL|cll
4859174|NCT02280525|Natural Killer Cells|natural killer cells
4859175|NCT02280525|NK|nk
4859176|NCT02280525|Umbilical Cord Blood|umbilical cord blood
4859177|NCT02280525|UCB|ucb
4859178|NCT02280525|Lenalidomide|lenalidomide
4859179|NCT02280525|CC-5013|cc-5013
4859180|NCT02280525|Revlimid|revlimid
4859181|NCT02280525|Rituximab|rituximab
4859182|NCT02280525|Rituxan|rituxan
4859183|NCT02280525|Fludarabine|fludarabine
4859184|NCT02280525|Fludarabine phosphate|fludarabine phosphate
4859185|NCT02280525|Fludara|fludara
4859186|NCT02280525|Cyclophosphamide|cyclophosphamide
4859187|NCT02280525|Cytoxan|cytoxan
4859188|NCT02280525|Neosar|neosar
4859189|NCT02280525|Cytarabine|cytarabine
4859190|NCT02280525|Ara-C|ara-c
4859191|NCT02280525|Cytosar|cytosar
4859192|NCT02280525|DepoCyt|depocyt
4859193|NCT02280525|Cytosine Arabinosine Hydrochloride|cytosine arabinosine hydrochloride
4859194|NCT02280512|noninvasive cardiac output measurement(NICOM)|noninvasive cardiac output measurement(nicom)
4859195|NCT02280512|Leg fractures|leg fractures
4859196|NCT02280512|Near-Infrared Spectroscopy (NIRS)|near-infrared spectroscopy (nirs)
4859197|NCT02280512|Intensive care unit(ICU)|intensive care unit(icu)
4859198|NCT02280486|saxagliptin|saxagliptin
4859199|NCT02280486|glimepiride|glimepiride
4859200|NCT02280486|metformin monotherapy|metformin monotherapy
4859201|NCT02280421|HSV|hsv
4859202|NCT02280421|Herpes|herpes
4859203|NCT02280421|volunteers|volunteers
4859204|NCT02280421|drug-drug interaction|drug-drug interaction
4859205|NCT02280421|transplant|transplant
4859206|NCT02280382|splinting|splinting
4859207|NCT02280369|posture detection|posture detection
4859208|NCT02280369|healthy subjects|healthy subjects
4859209|NCT02280356|Radiation Therapy|radiation therapy
4859210|NCT02280356|Brachytherapy|brachytherapy
4859211|NCT02280356|14-163|14-163
4859212|NCT02280343|forced oscillation tecnique|forced oscillation tecnique
4859213|NCT02280343|lung function|lung function
4859214|NCT02280343|asbestosis|asbestosis
4859215|NCT02280330|Iodine Deficiency|iodine deficiency
4859216|NCT02280330|Micronutrient Powder|micronutrient powder
4859217|NCT02280330|Hypothyroidism|hypothyroidism
4859218|NCT02280304|Stress Disorders, Post-Traumatic|stress disorders, post-traumatic
4859219|NCT02280304|Concussion, Mild|concussion, mild
4859220|NCT02280304|Brain Injuries|brain injuries
4859221|NCT02280304|Community Integration|community integration
4859222|NCT02280304|Meditation|meditation
4859223|NCT02280304|Magnetic Resonance Imaging|magnetic resonance imaging
4859224|NCT02280278|colon cancer|colon cancer
4859225|NCT02280278|cytokine-induced killer cell immunotherapy|cytokine-induced killer cell immunotherapy
4859226|NCT02280265|hemophilia A|hemophilia a
4859532|NCT02278861|tretinoin|tretinoin
4859227|NCT02280265|standard prophylaxis|standard prophylaxis
4859228|NCT02280265|Recombinant Human Coagulation Factor VIII for injection|recombinant human coagulation factor viii for injection
4859229|NCT02280265|ADVATE|advate
4859230|NCT02280265|Pediatric|pediatric
4859231|NCT02280252|Locally-advanced Breast Cancer|locally-advanced breast cancer
4859232|NCT02280252|LABC|labc
4859233|NCT02280252|breast cancer|breast cancer
4859234|NCT02280252|breast|breast
4859235|NCT02280252|cancer|cancer
4859236|NCT02280252|metastasis|metastasis
4859237|NCT02280252|metastatic|metastatic
4859238|NCT02280252|tumor|tumor
4859239|NCT02280252|radiation|radiation
4859240|NCT02280252|radiation therapy|radiation therapy
4859241|NCT02280252|radiotherapy|radiotherapy
4859242|NCT02280252|paclitaxel|paclitaxel
4859243|NCT02280239|Fever|fever
4859244|NCT02280239|Acetaminophen|acetaminophen
4859245|NCT02280239|Body Temperature Regulation|body temperature regulation
4859246|NCT02280239|Critical Illness|critical illness
4859247|NCT02280239|Hypotension|hypotension
4859248|NCT02280200|claudication|claudication
4859249|NCT02280200|ankle foot orthoses|ankle foot orthoses
4859250|NCT02280200|community walking exercise|community walking exercise
4859251|NCT02280187|InductOs|inductos
4859252|NCT02280187|rhBMP-2|rhbmp-2
4859253|NCT02280187|Retrospective|retrospective
4859254|NCT02280187|France|france
4859255|NCT02280187|Fusion|fusion
4859256|NCT02280187|real world use|real world use
4859257|NCT02280174|Apo B-48|apo b-48
4859258|NCT02280174|TRL|trl
4859259|NCT02280174|Linagliptin|linagliptin
4859260|NCT02280148|Propofol|propofol
4859261|NCT02280148|gastroscopy and colonoscopy|gastroscopy and colonoscopy
4859262|NCT02280148|driving simulator|driving simulator
4859263|NCT02280148|driving ability|driving ability
4859264|NCT02280148|cognitive function|cognitive function
4859265|NCT02280148|patients|patients
4859266|NCT02280122|activated matrix metalloproteinase 8|activated matrix metalloproteinase 8
4859267|NCT02280122|untreated moderate/severe chronic periodontitis|untreated moderate/severe chronic periodontitis
4859268|NCT02280122|saliva|saliva
4859269|NCT02280122|sensitivity/specificity|sensitivity/specificity
4859270|NCT02280109|Tenofovir|tenofovir
4859271|NCT02280109|Healthy Volunteers|healthy volunteers
4859272|NCT02280109|HIV|hiv
4859273|NCT02280109|pharmacokinetics of tenofovir gel and film|pharmacokinetics of tenofovir gel and film
4859274|NCT02280096|Cognitive function|cognitive function
4859275|NCT02280096|Multiple sclerosis|multiple sclerosis
4859276|NCT02280096|4-aminopyridine|4-aminopyridine
4859277|NCT02280096|Fatigue|fatigue
4859278|NCT02280083|Spasticity, Post-Stroke|spasticity, post-stroke
4859279|NCT02280083|Botulinum toxin type A for Injection|botulinum toxin type a for injection
4859280|NCT02280083|upper limb spasticity|upper limb spasticity
4859281|NCT02280070|resectable rectal cancer|resectable rectal cancer
4859282|NCT02280070|SOX|sox
4859283|NCT02280070|mFOLFOX6|mfolfox6
4859284|NCT02280070|neoadjuvant|neoadjuvant
4859285|NCT02280057|PCOS|pcos
4859286|NCT02280057|metformin|metformin
4859287|NCT02280057|obesity|obesity
4859288|NCT02280057|randomized controlled trial|randomized controlled trial
4859289|NCT02280044|Campylobacter jejuni|campylobacter jejuni
4859290|NCT02280044|rifaximin|rifaximin
4859291|NCT02280044|antibiotic prophylaxis|antibiotic prophylaxis
4859292|NCT02280044|dysentery|dysentery
4859293|NCT02280044|diarrhea|diarrhea
4859294|NCT02280031|Twin Pregnancy|twin pregnancy
4859295|NCT02280031|Pregnancy Complications|pregnancy complications
4859296|NCT02280018|Healthy|healthy
4859297|NCT02280018|JNJ-49122944|jnj-49122944
4859298|NCT02280018|Placebo|placebo
4859299|NCT02280005|Dialysis|dialysis
4859300|NCT02280005|Renal Failure|renal failure
4859301|NCT02280005|Wearable|wearable
4859302|NCT02280005|Artificial Kidney|artificial kidney
4859303|NCT02280005|Hemodialysis|hemodialysis
4859304|NCT02279992|Malignant Glioma|malignant glioma
4859305|NCT02279992|Brain Neoplasms, Malignant|brain neoplasms, malignant
4859306|NCT02279992|Brain metastasis|brain metastasis
4859307|NCT02279979|PHP|php
4859308|NCT02279979|Cardiogenic Shock|cardiogenic shock
4859309|NCT02279979|Percutaneous|percutaneous
4859310|NCT02279979|Ventricular Assist|ventricular assist
4859311|NCT02279979|Heart Pump|heart pump
4859312|NCT02279979|Catheter|catheter
4859313|NCT02279979|Thoratec Corporation|thoratec corporation
4859314|NCT02279940|rivaroxaban|rivaroxaban
4859315|NCT02279940|stroke|stroke
4859316|NCT02279940|transient ischemic attack|transient ischemic attack
4859317|NCT02279940|ischemia|ischemia
4859318|NCT02279927|Ureteroscopy|ureteroscopy
4859319|NCT02279901|Obstructive Sleep Apnea|obstructive sleep apnea
4859320|NCT02279901|CPAP|cpap
4859321|NCT02279901|Continuous positive airway pressure|continuous positive airway pressure
4859322|NCT02279901|CPAP compliance|cpap compliance
4859323|NCT02279901|Telemedicine|telemedicine
4859324|NCT02279901|Automated response mechanisms|automated response mechanisms
4859325|NCT02279901|Patient engagement|patient engagement
4859326|NCT02279901|OSA|osa
4859327|NCT02279888|Pulmonary Artery Pressure Monitoring|pulmonary artery pressure monitoring
4859328|NCT02279888|Implantable Hemodynamic Monitor|implantable hemodynamic monitor
4859329|NCT02279875|Tuberculosis|tuberculosis
4859330|NCT02279875|Drug-Sensitive Tuberculosis|drug-sensitive tuberculosis
4859331|NCT02279875|Linezolid|linezolid
4859332|NCT02279875|HRZE (isoniazid, rifampicin, pyrazinamide, ethambutol)|hrze (isoniazid, rifampicin, pyrazinamide, ethambutol)
4859333|NCT02279875|Pulmonary Tuberculosis|pulmonary tuberculosis
4859334|NCT02279875|TB|tb
4859335|NCT02279849|multi-level intervention|multi-level intervention
4859336|NCT02279849|price discounts|price discounts
4859337|NCT02279849|communication|communication
4859338|NCT02279849|low income population|low income population
4859339|NCT02279849|dietary intervention|dietary intervention
4859340|NCT02279849|obesity prevention|obesity prevention
4859341|NCT02279849|store-based intervention|store-based intervention
4859342|NCT02279836|Patients with any indication for colonoscopy in the U.S.A.|patients with any indication for colonoscopy in the u.s.a.
4859343|NCT02279823|androgen|androgen
4859344|NCT02279823|alopecia|alopecia
4859345|NCT02279823|CB-03-01|cb-03-01
4859346|NCT02279823|solution|solution
4859347|NCT02279823|topical|topical
4859348|NCT02279810|organ shortage|organ shortage
4859349|NCT02279810|attitudes to organ transplantation|attitudes to organ transplantation
4859350|NCT02279797|bone marrow|bone marrow
4859351|NCT02279797|attitude|attitude
4859352|NCT02279771|colorectal anastomosis|colorectal anastomosis
4859353|NCT02279771|anastomotic leak|anastomotic leak
4859354|NCT02279771|ileostomy|ileostomy
4859355|NCT02279771|complications|complications
4859356|NCT02279758|Neuroendocrine Tumors|neuroendocrine tumors
4859357|NCT02279758|The Mammalian Target of Rapamycin (mTOR)|the mammalian target of rapamycin (mtor)
4859358|NCT02279758|metformin|metformin
4859359|NCT02279693|Raypilot dosimetry|raypilot dosimetry
4859360|NCT02279693|CBCT (cone beam computed tomography)|cbct (cone beam computed tomography)
4859361|NCT02279654|Lenalidomide|lenalidomide
4859362|NCT02279654|Revlimid|revlimid
4859363|NCT02279654|Transfusion-dependent|transfusion-dependent
4859364|NCT02279654|international Prognostic Scoring System (IPSS) low|international prognostic scoring system (ipss) low
4859365|NCT02279654|Intermediate-1-risk|intermediate-1-risk
4859366|NCT02279654|MDS|mds
4859367|NCT02279654|Isolated del(5q)|isolated del(5q)
4859368|NCT02279654|Prospective|prospective
4859369|NCT02279654|Non-interventional|non-interventional
4859370|NCT02279654|Post-authorization safety study (PASS)|post-authorization safety study (pass)
4859371|NCT02279654|Disease registry|disease registry
4859372|NCT02279628|cesarean section|cesarean section
4859373|NCT02279628|spinal anesthesia|spinal anesthesia
4859374|NCT02279628|continuous wound infiltration|continuous wound infiltration
4859375|NCT02279628|intrathecal morphine|intrathecal morphine
4859376|NCT02279628|oral morphine|oral morphine
4859377|NCT02279615|Overactive Bladder|overactive bladder
4859378|NCT02279615|Benign Prostatic Hyperplasia|benign prostatic hyperplasia
4859379|NCT02279615|Combination Therapy|combination therapy
4859380|NCT02279615|β3-Adrenoceptor Agonist|β3-adrenoceptor agonist
4859381|NCT02279615|Mirabegron|mirabegron
4859382|NCT02279615|Myrbetriq|myrbetriq
4859383|NCT02279615|α-Adrenoceptor Antagonist|α-adrenoceptor antagonist
4859384|NCT02279615|Tamsulosin|tamsulosin
4859385|NCT02279615|Flomax|flomax
4859386|NCT02279602|Pancreatic|pancreatic
4859387|NCT02279602|Gastrointestional|gastrointestional
4859388|NCT02279589|hyporesponsiveness|hyporesponsiveness
4859389|NCT02279589|vaccination|vaccination
4859390|NCT02279589|recommendations|recommendations
4859391|NCT02279589|improvement|improvement
4859392|NCT02279589|schedule|schedule
4859393|NCT02279589|fractional dose|fractional dose
4859394|NCT02279589|conjugate polysaccharide vaccine|conjugate polysaccharide vaccine
4859395|NCT02279576|Penile squamous cell carcinoma|penile squamous cell carcinoma
4859396|NCT02279576|Pazopanib|pazopanib
4859397|NCT02279576|Weekly paclitaxel|weekly paclitaxel
4859398|NCT02279550|hip fracture, elderly|hip fracture, elderly
4859399|NCT02279537|Wet age-related macular Degeneration (Wet-AMD)|wet age-related macular degeneration (wet-amd)
4859400|NCT02279537|Naïve patients|naïve patients
4859401|NCT02279537|Real life|real life
4859402|NCT02279537|Aflibercept|aflibercept
4859403|NCT02279524|NASH|nash
4859404|NCT02279511|Alzheimer|alzheimer
4859405|NCT02279485|Healthy Subjects|healthy subjects
4859406|NCT02279485|Bioequivalence|bioequivalence
4859407|NCT02279485|Fasted|fasted
4859408|NCT02279485|Fed|fed
4859409|NCT02279433|Neoplasms|neoplasms
4859410|NCT02279433|Lung Neoplasms|lung neoplasms
4859411|NCT02279433|Colorectal Neoplasms|colorectal neoplasms
4859412|NCT02279433|Neuroendocrine Tumors|neuroendocrine tumors
4859413|NCT02279433|Pancreatic Neoplasms|pancreatic neoplasms
4859414|NCT02279407|omega-3 carboxylic acid|omega-3 carboxylic acid
4859415|NCT02279394|Smoldering myeloma|smoldering myeloma
4859416|NCT02279394|Smoldering Multiple Myeloma|smoldering multiple myeloma
4859417|NCT02279381|Chlorhexidine|chlorhexidine
4859418|NCT02279381|Kangaroo mother care|kangaroo mother care
4859419|NCT02279381|RCT|rct
4859420|NCT02279342|Coronary artery disease|coronary artery disease
4859421|NCT02279342|hyperuricemia|hyperuricemia
4859422|NCT02279342|coronary plaque volume|coronary plaque volume
4859423|NCT02279342|IVUS|ivus
4859424|NCT02279316|Dalcroze eurhythmics|dalcroze eurhythmics
4859425|NCT02279316|home exercise|home exercise
4859426|NCT02279316|vitamin D|vitamin d
4859427|NCT02279316|mild cognitive impairment|mild cognitive impairment
4859428|NCT02279316|MCI|mci
4859429|NCT02279316|mild dementia|mild dementia
4859430|NCT02279290|Childhood trauma|childhood trauma
4859431|NCT02279264|ph|ph
4859432|NCT02279264|RightSpot Infant|rightspot infant
4859433|NCT02279264|Feeding Tube|feeding tube
4859434|NCT02279264|RightBio Metrics|rightbio metrics
4859435|NCT02279264|placement|placement
4859436|NCT02279264|Nasogastric Tube|nasogastric tube
4859437|NCT02279264|NG|ng
4859438|NCT02279264|infant|infant
4859439|NCT02279251|Anxiety|anxiety
4859440|NCT02279251|adolescents|adolescents
4859441|NCT02279251|school-based|school-based
4859442|NCT02279251|low-intensity CBT|low-intensity cbt
4859443|NCT02279225|Phototherapy|phototherapy
4859444|NCT02279225|Laser|laser
4859445|NCT02279225|Fibromyalgia|fibromyalgia
4859446|NCT02279225|DTM/ TMD|dtm/ tmd
4859447|NCT02279225|Pain|pain
4859448|NCT02279212|Critical illness|critical illness
4859449|NCT02279212|pain|pain
4859450|NCT02279212|quality of life|quality of life
4859451|NCT02279199|hemophilia|hemophilia
4859452|NCT02279199|joint health|joint health
4859453|NCT02279199|motor development|motor development
4859454|NCT02279199|motor proficiency|motor proficiency
4859455|NCT02279173|Pediatric|pediatric
4859456|NCT02279173|Immune Thrombocytopenia|immune thrombocytopenia
4859457|NCT02279173|Amgen|amgen
4859458|NCT02279147|Systemic Inflammatory Response Syndrome|systemic inflammatory response syndrome
4859459|NCT02279147|Jaundice, Obstructive|jaundice, obstructive
4859460|NCT02279147|anti-inflammatory|anti-inflammatory
4859461|NCT02279134|StageⅡB-Ⅲ esophageal cancer|stageⅱb-ⅲ esophageal cancer
4859462|NCT02279134|adjuvant radiotherapy|adjuvant radiotherapy
4859463|NCT02279134|adjuvant chemoradiotherapy|adjuvant chemoradiotherapy
4859464|NCT02279121|central venous catheter|central venous catheter
4859465|NCT02279121|Taurolidine|taurolidine
4859466|NCT02279121|lock-therapy|lock-therapy
4859467|NCT02279108|sentinel lymph node|sentinel lymph node
4859468|NCT02279108|indocyanine green|indocyanine green
4859469|NCT02279108|fluorescence method|fluorescence method
4859470|NCT02279108|radioisotope conventional method|radioisotope conventional method
4859471|NCT02279108|breast cancer|breast cancer
4859472|NCT02279095|Open-label extension study|open-label extension study
4859473|NCT02279095|Clinical trial Phase 2|clinical trial phase 2
4859474|NCT02279095|Efficacy and safety|efficacy and safety
4859475|NCT02279095|Heterotopic ossification|heterotopic ossification
4859476|NCT02279095|Fibrodysplasia Ossificans Progressiva|fibrodysplasia ossificans progressiva
4859477|NCT02279095|Flare-up|flare-up
4859478|NCT02279095|Palovarotene|palovarotene
4859479|NCT02279095|Retinoic acid receptor agonist|retinoic acid receptor agonist
4859480|NCT02279095|Retinoic acid receptor gamma agonist|retinoic acid receptor gamma agonist
4859481|NCT02279095|Clementia|clementia
4859482|NCT02279095|Myositis Ossificans Progressiva|myositis ossificans progressiva
4859483|NCT02279095|Munchmeyer's Disease|munchmeyer's disease
4859484|NCT02279095|FOP|fop
4859485|NCT02279069|stroke|stroke
4859486|NCT02279069|walking|walking
4859487|NCT02279069|rehabilitation|rehabilitation
4859488|NCT02279043|IUD|iud
4859489|NCT02279043|IUC|iuc
4859490|NCT02279043|birth control|birth control
4859491|NCT02279043|contraception|contraception
4859492|NCT02279043|online|online
4859493|NCT02279030|ablation|ablation
4859494|NCT02279017|Mobile Technology|mobile technology
4859495|NCT02279017|Diet and Fitness|diet and fitness
4859496|NCT02279004|Plasma Genotyping|plasma genotyping
4859497|NCT02279004|NSCLC|nsclc
4859498|NCT02279004|Melanoma|melanoma
4859499|NCT02278978|urothelial carcinoma|urothelial carcinoma
4859500|NCT02278978|BIBF1120|bibf1120
4859501|NCT02278965|Breast Cancer|breast cancer
4859502|NCT02278965|Early Stage|early stage
4859503|NCT02278939|diabetes prevention|diabetes prevention
4859504|NCT02278939|Filipinos|filipinos
4859505|NCT02278939|lifestyle intervention|lifestyle intervention
4859506|NCT02278926|Ultrasound|ultrasound
4859507|NCT02278926|Lypo-hypertrophy|lypo-hypertrophy
4859508|NCT02278913|inpatient|inpatient
4859509|NCT02278913|hospital|hospital
4859510|NCT02278913|randomized trial|randomized trial
4859511|NCT02278913|diabetes|diabetes
4859512|NCT02278913|analogs|analogs
4859513|NCT02278913|human insulin|human insulin
4859514|NCT02278900|communication|communication
4859515|NCT02278900|shared decision-making|shared decision-making
4859516|NCT02278887|melanoma|melanoma
4859517|NCT02278887|TIL treatment|til treatment
4859518|NCT02278887|tumor infiltrating lymphocytes|tumor infiltrating lymphocytes
4859519|NCT02278887|ipilimumab|ipilimumab
4859520|NCT02278887|interleukin 2|interleukin 2
4859521|NCT02278887|non-myeloablative|non-myeloablative
4859522|NCT02278887|randomization|randomization
4859523|NCT02278874|Trisomy 13|trisomy 13
4859524|NCT02278874|Trisomy 18|trisomy 18
4859525|NCT02278874|Trisomy 21|trisomy 21
4859526|NCT02278874|Sex Chromosome Abnormalities|sex chromosome abnormalities
4859527|NCT02278874|Monosomy X|monosomy x
4859528|NCT02278874|XXX|xxx
4859529|NCT02278874|XXY|xxy
4859530|NCT02278874|XYY|xyy
4859531|NCT02278861|actinic keratosis|actinic keratosis
4859533|NCT02278861|isotretinoin|isotretinoin
4859534|NCT02278861|cryotherapy|cryotherapy
4859535|NCT02278861|sun protection factor|sun protection factor
4859536|NCT02278861|clinical clearance|clinical clearance
4859537|NCT02278848|Computerised gait analysis|computerised gait analysis
4859538|NCT02278848|Ultrasound measurement of cerebral pulsatility|ultrasound measurement of cerebral pulsatility
4859539|NCT02278848|MRI flow|mri flow
4859540|NCT02278848|Urinary incontinence scale|urinary incontinence scale
4859541|NCT02278848|Subtractive lumbar puncture|subtractive lumbar puncture
4859542|NCT02278835|Cardiac valve|cardiac valve
4859543|NCT02278809|physical activity|physical activity
4859544|NCT02278809|screen time|screen time
4859545|NCT02278809|vegetables|vegetables
4859546|NCT02278809|fruit|fruit
4859547|NCT02278809|snacks|snacks
4859548|NCT02278809|softdrink|softdrink
4859549|NCT02278809|water|water
4859550|NCT02278809|fruit juice|fruit juice
4859551|NCT02278809|parenting practices|parenting practices
4859552|NCT02278809|online videos|online videos
4859553|NCT02278809|intervention mapping protocol|intervention mapping protocol
4859554|NCT02278796|Diffuse large B-cell lymphomas (DLBC)|diffuse large b-cell lymphomas (dlbc)
4859555|NCT02278796|Follicular lymphomas (FL)|follicular lymphomas (fl)
4859556|NCT02278796|Mantle cell lymphomas (MCL)|mantle cell lymphomas (mcl)
4859557|NCT02278770|diverticular disease|diverticular disease
4859558|NCT02278770|MRI|mri
4859559|NCT02278770|visceral and subcutaneous fat|visceral and subcutaneous fat
4859560|NCT02278770|adipokines|adipokines
4859561|NCT02278757|Metabolic syndrome|metabolic syndrome
4859562|NCT02278757|Weight loss|weight loss
4859563|NCT02278757|Obesity|obesity
4859564|NCT02278757|Hypertension|hypertension
4859565|NCT02278757|Dyslipidemia|dyslipidemia
4859566|NCT02278744|Single-Fraction Stereotactic Radiosurgery|single-fraction stereotactic radiosurgery
4859567|NCT02278744|Salvage Re-Irradiation|salvage re-irradiation
4859568|NCT02278744|14-054|14-054
4859569|NCT02278731|Physical activity|physical activity
4859570|NCT02278731|Rehabilitation|rehabilitation
4859571|NCT02278731|Older adults|older adults
4859572|NCT02278731|Pilates|pilates
4859573|NCT02278731|Proprioceptive neuromuscular facilitation|proprioceptive neuromuscular facilitation
4859574|NCT02278705|childhood obesity|childhood obesity
4859575|NCT02278705|childhood overweight|childhood overweight
4859576|NCT02278705|primary care|primary care
4859577|NCT02278705|weight management|weight management
4859578|NCT02278692|Vitamin K|vitamin k
4859579|NCT02278692|Calciphylaxis|calciphylaxis
4859580|NCT02278692|Calcific uremic arteriolopathy|calcific uremic arteriolopathy
4859581|NCT02278692|Dialysis|dialysis
4859582|NCT02278692|End-stage renal disease|end-stage renal disease
4859583|NCT02278653|Restaging|restaging
4859584|NCT02278653|Watchful Waiting|watchful waiting
4859585|NCT02278653|Quality of Life|quality of life
4859586|NCT02278653|Manometry|manometry
4859587|NCT02278601|Breakthrough pain|breakthrough pain
4859588|NCT02278575|antithrombin, Atenativ, preeclampsia, blood flow.|antithrombin, atenativ, preeclampsia, blood flow.
4859589|NCT02278549|Spinal kinematics|spinal kinematics
4859590|NCT02278536|Trisomy 13|trisomy 13
4859591|NCT02278536|Trisomy 18|trisomy 18
4859592|NCT02278536|Trisomy 21|trisomy 21
4859593|NCT02278536|Sex Chromosome Abnormalities|sex chromosome abnormalities
4859594|NCT02278536|Monosomy X|monosomy x
4859596|NCT02278536|XXY|xxy
4859597|NCT02278536|XYY|xyy
4859598|NCT02278510|topotecan|topotecan
4859599|NCT02278510|convection-enhanced delivery|convection-enhanced delivery
4859600|NCT02278510|CED|ced
4859601|NCT02278510|High Grade Glioma|high grade glioma
4859602|NCT02278484|sinus infections|sinus infections
4859603|NCT02278484|sinusitis|sinusitis
4859604|NCT02278484|chronic sinusitis|chronic sinusitis
4859605|NCT02278484|rhinosinusitis|rhinosinusitis
4859606|NCT02278484|allergic sinusitis|allergic sinusitis
4859607|NCT02278484|allergic rhinitis|allergic rhinitis
4859608|NCT02278484|chronic rhinosinusitis|chronic rhinosinusitis
4859609|NCT02278484|sinus disease in children|sinus disease in children
4859610|NCT02278484|sinus balloon dilation|sinus balloon dilation
4859611|NCT02278484|balloon dilatation|balloon dilatation
4859612|NCT02278484|sinus disease|sinus disease
4859613|NCT02278484|pediatric|pediatric
4859614|NCT02278471|combination pill|combination pill
4859615|NCT02278471|polypill|polypill
4859616|NCT02278471|primary prevention|primary prevention
4859617|NCT02278445|Systemic Sclerosis|systemic sclerosis
4859618|NCT02278445|Pulmonary hypertension|pulmonary hypertension
4859619|NCT02278445|Lung Doppler Signals|lung doppler signals
4859620|NCT02278432|risk assessment|risk assessment
4859621|NCT02278432|pharmacovigilance|pharmacovigilance
4859622|NCT02278432|pharmacoepidemiology|pharmacoepidemiology
4859623|NCT02278432|drug toxicity|drug toxicity
4859624|NCT02278432|adverse drug reaction reporting system|adverse drug reaction reporting system
4859625|NCT02278432|omeprazole|omeprazole
4859626|NCT02278419|Hepatitis C|hepatitis c
4859627|NCT02278419|Simeprevir|simeprevir
4859628|NCT02278419|Sofosbuvir|sofosbuvir
4859629|NCT02278419|Healthy|healthy
4859630|NCT02278406|Parkinson's Disease|parkinson's disease
4859631|NCT02278406|Deep brain stimulator|deep brain stimulator
4859632|NCT02278406|dbs|dbs
4860224|NCT02274597|hypothermia|hypothermia
4859633|NCT02278393|Japanese healthy volunteers|japanese healthy volunteers
4859634|NCT02278393|High LDL-C|high ldl-c
4859635|NCT02278393|dairy drinks|dairy drinks
4859636|NCT02278393|phytosterols|phytosterols
4859637|NCT02278341|ASP1517|asp1517
4859638|NCT02278341|FG-4592|fg-4592
4859639|NCT02278341|Anemia|anemia
4859640|NCT02278341|End Stage Renal Disease (ESRD)|end stage renal disease (esrd)
4859641|NCT02278341|Erythropoetin Stimulating Agents (ESAs)|erythropoetin stimulating agents (esas)
4859642|NCT02278341|Chronic Kidney Disease|chronic kidney disease
4859643|NCT02278341|Hematopoetic Agents|hematopoetic agents
4859644|NCT02278341|HIF-PH inhibitor|hif-ph inhibitor
4859645|NCT02278341|Hemoglobin|hemoglobin
4859646|NCT02278341|Dialysis|dialysis
4859647|NCT02278341|roxadustat|roxadustat
4859648|NCT02278328|dose titration study|dose titration study
4859649|NCT02278328|electrophysiology|electrophysiology
4859650|NCT02278315|Multiple Myeloma|multiple myeloma
4859651|NCT02278315|Radiopharmaceutical|radiopharmaceutical
4859652|NCT02278315|Therapy|therapy
4859653|NCT02278315|Phase 1|phase 1
4859654|NCT02278263|tranexamic acid|tranexamic acid
4859655|NCT02278263|enhanced recovery|enhanced recovery
4859656|NCT02278263|arthroplasty|arthroplasty
4859657|NCT02278263|perioperative care|perioperative care
4859658|NCT02278250|VX14-803-001|vx14-803-001
4859659|NCT02278250|VX-803|vx-803
4859660|NCT02278250|M4344|m4344
4859661|NCT02278250|Advanced Solid Tumor|advanced solid tumor
4859662|NCT02278250|Cytotoxic Chemotherapy|cytotoxic chemotherapy
4859663|NCT02278250|Gemcitabine|gemcitabine
4859664|NCT02278250|Cisplatin|cisplatin
4859665|NCT02278250|Carboplatin|carboplatin
4859666|NCT02278198|thyroid cancer|thyroid cancer
4859667|NCT02278172|vitamin D|vitamin d
4859668|NCT02278172|athletes|athletes
4859669|NCT02278172|fitness|fitness
4859670|NCT02278159|end-stage kidney disease|end-stage kidney disease
4859671|NCT02278159|peritoneal dialysis|peritoneal dialysis
4859672|NCT02278159|home hemodialysis|home hemodialysis
4859673|NCT02278159|technique survival|technique survival
4859674|NCT02278159|patient survival|patient survival
4859675|NCT02278133|metastatic,|metastatic,
4859676|NCT02278133|Colorectal cancer,|colorectal cancer,
4859677|NCT02278133|WNT974,|wnt974,
4859678|NCT02278133|LGX818,|lgx818,
4859679|NCT02278133|cetuximab,|cetuximab,
4859680|NCT02278133|BRAF-mutant,|braf-mutant,
4859681|NCT02278133|mCRC,|mcrc,
4859682|NCT02278133|BRAFV600-mutant,|brafv600-mutant,
4859683|NCT02278133|KRAS|kras
4859684|NCT02278120|LEE011|lee011
4859685|NCT02278120|ribociclib|ribociclib
4859686|NCT02278120|HR-positive|hr-positive
4859687|NCT02278120|HER2-negative|her2-negative
4859688|NCT02278120|Advanced breast cancer|advanced breast cancer
4859689|NCT02278120|Letrozole|letrozole
4859690|NCT02278120|Anastrozole|anastrozole
4859691|NCT02278120|Tamoxifen|tamoxifen
4859692|NCT02278120|Goserelin|goserelin
4859693|NCT02278120|CDK|cdk
4859694|NCT02278120|CDK4|cdk4
4859695|NCT02278120|CDK6|cdk6
4859696|NCT02278120|CDK4/6|cdk4/6
4859697|NCT02278120|Phase III|phase iii
4859698|NCT02278120|ER-positive|er-positive
4859699|NCT02278120|PR-positive|pr-positive
4859700|NCT02278120|Premenopausal|premenopausal
4859701|NCT02278094|OSAS|osas
4859702|NCT02278094|Adult|adult
4859703|NCT02278094|Home-based|home-based
4859704|NCT02278094|Genioglossus|genioglossus
4859705|NCT02278094|Inspiratory muscle|inspiratory muscle
4859706|NCT02278094|Exercise|exercise
4859707|NCT02278081|Rhinitis (nasal obstruction) and GERD|rhinitis (nasal obstruction) and gerd
4859708|NCT02278068|Type 2 diabetes|type 2 diabetes
4859709|NCT02278055|Radium-223|radium-223
4859710|NCT02278055|14-098|14-098
4859711|NCT02278055|Prostate Cancer Clinical Trials Consortium|prostate cancer clinical trials consortium
4859712|NCT02278016|procalcitonin|procalcitonin
4859713|NCT02278016|interleukin-6|interleukin-6
4859714|NCT02278016|agiotensininⅡ|agiotensininⅱ
4859715|NCT02278003|Amnesic|amnesic
4859716|NCT02278003|Propofol|propofol
4859717|NCT02278003|12-006|12-006
4859718|NCT02277977|sepsis|sepsis
4859719|NCT02277977|septic shock|septic shock
4859720|NCT02277977|contrast-enhanced ultrasound|contrast-enhanced ultrasound
4859721|NCT02277977|microcirculation|microcirculation
4859722|NCT02277964|RRMS|rrms
4859723|NCT02277964|Natalizumab|natalizumab
4859724|NCT02277964|Fingolimod|fingolimod
4859725|NCT02277964|Treatment Change|treatment change
4859726|NCT02277964|Disease Activity|disease activity
4859727|NCT02277925|Pelvic Organ Prolapse|pelvic organ prolapse
4859728|NCT02277925|Vaginal mesh exposure rates|vaginal mesh exposure rates
4859729|NCT02277925|Vaginal suture exposure rates|vaginal suture exposure rates
4859730|NCT02277912|ICH|ich
4859731|NCT02277912|Stroke|stroke
4859732|NCT02277912|Navigated|navigated
4859733|NCT02277912|Placebo|placebo
4859734|NCT02277912|TMS|tms
4859735|NCT02277899|childhood obesity|childhood obesity
4859736|NCT02277899|overweight|overweight
4859737|NCT02277899|communication|communication
4859738|NCT02277899|primary care|primary care
4859739|NCT02277899|weight management|weight management
4859740|NCT02277899|communication methods|communication methods
4860226|NCT02274597|epitympanic|epitympanic
4859741|NCT02277899|patient-centered communication|patient-centered communication
4859742|NCT02277886|sodium alginate|sodium alginate
4859743|NCT02277886|esomeprazole|esomeprazole
4859744|NCT02277886|GERD|gerd
4859745|NCT02277873|moon|moon
4859746|NCT02277873|parturition|parturition
4859747|NCT02277873|moon phases|moon phases
4859748|NCT02277860|Exercise|exercise
4859749|NCT02277847|Idarubicin|idarubicin
4859750|NCT02277847|Cytosine arabinoside|cytosine arabinoside
4859751|NCT02277847|Efficacy|efficacy
4859752|NCT02277847|Safety|safety
4859753|NCT02277821|Essential Hypertension|essential hypertension
4859754|NCT02277821|Central Blood Pressure|central blood pressure
4859755|NCT02277821|Microcirculation|microcirculation
4859756|NCT02277821|Endothelium Stimulation|endothelium stimulation
4859757|NCT02277808|Pneumocystis|pneumocystis
4859758|NCT02277808|Nebulizer|nebulizer
4859759|NCT02277808|Pentamidine|pentamidine
4859760|NCT02277795|Early infant male circumcision|early infant male circumcision
4859761|NCT02277795|HIV|hiv
4859762|NCT02277795|Prevention|prevention
4859763|NCT02277795|AccuCirc|accucirc
4859764|NCT02277795|Kenya|kenya
4859765|NCT02277795|Providers|providers
4859766|NCT02277795|Parents|parents
4859767|NCT02277782|Labor|labor
4859768|NCT02277782|Analgesia|analgesia
4859769|NCT02277756|high functioning autism|high functioning autism
4859770|NCT02277756|endogenous modulation systems|endogenous modulation systems
4859771|NCT02277730|Hypotension|hypotension
4859772|NCT02277717|cancer|cancer
4859773|NCT02277717|metastasis|metastasis
4859774|NCT02277717|HER2|her2
4859775|NCT02277717|trastuzumab|trastuzumab
4859776|NCT02277717|duocarmycin|duocarmycin
4859777|NCT02277717|SYD985|syd985
4859778|NCT02277717|antibody-drug conjugate|antibody-drug conjugate
4859779|NCT02277717|ADC|adc
4859780|NCT02277717|trastuzumab vc-seco-DUBA|trastuzumab vc-seco-duba
4859781|NCT02277704|PTSD|ptsd
4859782|NCT02277704|Military-related PTSD and other related conditions|military-related ptsd and other related conditions
4859783|NCT02277691|Pharmacological therapy|pharmacological therapy
4859784|NCT02277691|Drug Therapy|drug therapy
4859785|NCT02277678|Pruritus|pruritus
4859786|NCT02277665|Cannabis Use Disorder|cannabis use disorder
4859787|NCT02277665|Tobacco Use|tobacco use
4859788|NCT02277665|Treatment|treatment
4859789|NCT02277639|Transplant related mortality|transplant related mortality
4859790|NCT02277639|Graft versus host disease|graft versus host disease
4859791|NCT02277639|Bone marrow transplant|bone marrow transplant
4859792|NCT02277613|stem cells|stem cells
4859793|NCT02277587|Plenadren|plenadren
4859794|NCT02277587|Addison's disease|addison's disease
4859795|NCT02277587|Hydrocortisone|hydrocortisone
4859796|NCT02277587|Cortisone Acetate|cortisone acetate
4859797|NCT02277587|Monocytes|monocytes
4859798|NCT02277587|Natural Killer cells|natural killer cells
4859799|NCT02277587|Immunological profile|immunological profile
4859800|NCT02277587|Inflammation|inflammation
4859801|NCT02277574|Rheumatoid arthritis|rheumatoid arthritis
4859802|NCT02277574|Arthritis|arthritis
4859803|NCT02277574|Joint diseases|joint diseases
4859804|NCT02277574|Musculoskeletal diseases|musculoskeletal diseases
4859805|NCT02277548|chemotherapy|chemotherapy
4859806|NCT02277548|radiation therapy|radiation therapy
4859807|NCT02277535|Malnutrition in the ICU (caloric deficit >4000 kcal or 150 g protein deficit) or >48hrs of admission without receiving nutrition|malnutrition in the icu (caloric deficit >4000 kcal or 150 g protein deficit) or >48hrs of admission without receiving nutrition
4859808|NCT02277470|pharmacokinetics, Golimumab, IBD|pharmacokinetics, golimumab, ibd
4859809|NCT02277444|Methotrexate|methotrexate
4859810|NCT02277444|Anti-TNFα Antibody|anti-tnfα antibody
4859811|NCT02277444|Golimumab|golimumab
4859812|NCT02277444|Pediatric Participants|pediatric participants
4859813|NCT02277379|cardiac surgery ; hemorrhage ; transfusion requirements|cardiac surgery ; hemorrhage ; transfusion requirements
4859814|NCT02277366|Lung Neoplasms|lung neoplasms
4859815|NCT02277366|Bronchoscopy|bronchoscopy
4859816|NCT02277366|Early Detection of Cancer|early detection of cancer
4859817|NCT02277353|Fluid responsiveness|fluid responsiveness
4859818|NCT02277353|NICOM|nicom
4859819|NCT02277353|Prone Position|prone position
4859820|NCT02277353|Stroke Volume Variation|stroke volume variation
4859821|NCT02277327|Hospitalization|hospitalization
4859822|NCT02277327|Readmissions|readmissions
4859823|NCT02277327|Medical complexity|medical complexity
4859824|NCT02277301|Pilot study|pilot study
4859825|NCT02277301|Randomised Controlled Trial|randomised controlled trial
4859826|NCT02277301|Parenting|parenting
4859827|NCT02277301|Paediatrics|paediatrics
4859828|NCT02277301|Mental Health|mental health
4859829|NCT02277275|Branched chain amino acid, high protein diet, weight loss|branched chain amino acid, high protein diet, weight loss
4859830|NCT02277262|peritonitis patients|peritonitis patients
4859831|NCT02277236|sarcopenia|sarcopenia
4859832|NCT02277236|aging|aging
4859833|NCT02277236|insulin resistance|insulin resistance
4859834|NCT02277236|screening|screening
4859835|NCT02277184|Intermediate Risk HNSCC|intermediate risk hnscc
4859836|NCT02277184|High Risk HNSCC|high risk hnscc
4859837|NCT02277184|Previously Untreated, Locally Advanced HNSCC|previously untreated, locally advanced hnscc
4859838|NCT02277184|Undifferentiated carcinoma|undifferentiated carcinoma
4859839|NCT02277184|Poorly differentiated carcinoma of the oral cavity|poorly differentiated carcinoma of the oral cavity
4859840|NCT02277184|Poorly differentiated carcinoma of the oropharynx|poorly differentiated carcinoma of the oropharynx
4859841|NCT02277184|Poorly differentiated carcinoma of the larynx|poorly differentiated carcinoma of the larynx
4859842|NCT02277184|Poorly differentiated carcinoma of the hypopharynx|poorly differentiated carcinoma of the hypopharynx
4859843|NCT02277158|Rectal cancer|rectal cancer
4859844|NCT02277158|S-1|s-1
4859845|NCT02277158|Chemoradiotherapy|chemoradiotherapy
4859846|NCT02277158|Phase I|phase i
4859847|NCT02277145|radiation-induced pulmonary fibrosis|radiation-induced pulmonary fibrosis
4859848|NCT02277145|MSCs|mscs
4859849|NCT02277132|Fetal growth restriction|fetal growth restriction
4859850|NCT02277132|Sildenafil|sildenafil
4859851|NCT02277080|Pain, opioids, immune system, endocrine system, quality of life|pain, opioids, immune system, endocrine system, quality of life
4859852|NCT02277067|PPH|pph
4859853|NCT02277041|PPH|pph
4859854|NCT02277002|Cabin Air Filtration|cabin air filtration
4859855|NCT02277002|Particulate Matter|particulate matter
4859856|NCT02277002|Commuter Exposure|commuter exposure
4859857|NCT02277002|Traffic Related Air Pollution|traffic related air pollution
4859858|NCT02276989|Chronic Pain|chronic pain
4859859|NCT02276989|Compliance Marker|compliance marker
4859860|NCT02276989|Narcotic Abuse|narcotic abuse
4859861|NCT02276989|Opioid related disorders|opioid related disorders
4859862|NCT02276989|Opiate substitution treatment|opiate substitution treatment
4859863|NCT02276989|Buprenorphrine|buprenorphrine
4859864|NCT02276989|Suboxone|suboxone
4859865|NCT02276989|Lyrica|lyrica
4859866|NCT02276989|Pregabalin|pregabalin
4859867|NCT02276989|Acetazolamide|acetazolamide
4859868|NCT02276989|Quinine|quinine
4859869|NCT02276989|Compliance|compliance
4859870|NCT02276976|crebral white matter lesions|crebral white matter lesions
4859871|NCT02276976|brain networks|brain networks
4859872|NCT02276976|MRI|mri
4859873|NCT02276976|DTI|dti
4859874|NCT02276976|fMRI|fmri
4859875|NCT02276976|cognitive impairment|cognitive impairment
4859876|NCT02276976|gene|gene
4859877|NCT02276963|Transverse myelitis, optic neuritis, neuromyelitis optica|transverse myelitis, optic neuritis, neuromyelitis optica
4859878|NCT02276950|Cardiac Surgery|cardiac surgery
4859879|NCT02276950|Epidemiologic Methods|epidemiologic methods
4859880|NCT02276950|Blood Transfusions|blood transfusions
4859881|NCT02276937|Recombinant Sendai virus|recombinant sendai virus
4859882|NCT02276937|fibroblast growth factor-2|fibroblast growth factor-2
4859883|NCT02276937|treadmill|treadmill
4859884|NCT02276924|Laser Confocal Microscopy|laser confocal microscopy
4859885|NCT02276924|Superior Urinary Tract Tumors|superior urinary tract tumors
4859886|NCT02276898|pediatric|pediatric
4859887|NCT02276898|lung clearance index|lung clearance index
4859888|NCT02276898|Multiple Breath Washout|multiple breath washout
4859889|NCT02276898|Hypertonic Saline|hypertonic saline
4859890|NCT02276885|breast|breast
4859891|NCT02276885|cancer|cancer
4859892|NCT02276885|breast cancer|breast cancer
4859893|NCT02276885|prone|prone
4859894|NCT02276885|partial breast irradiation|partial breast irradiation
4859895|NCT02276885|PBI|pbi
4859896|NCT02276872|pediatric|pediatric
4859897|NCT02276872|treprostinil|treprostinil
4859898|NCT02276872|transition|transition
4859899|NCT02276872|Remodulin|remodulin
4859900|NCT02276859|dual-wave bolus|dual-wave bolus
4859901|NCT02276859|square bolus|square bolus
4859902|NCT02276859|normal bolus|normal bolus
4859903|NCT02276859|standard bolus|standard bolus
4859904|NCT02276859|high-protein meal|high-protein meal
4859905|NCT02276859|prandial insulin requirement|prandial insulin requirement
4859906|NCT02276846|Palpitate-Eluting Balloon|palpitate-eluting balloon
4859907|NCT02276846|Bifurcation|bifurcation
4859908|NCT02276846|OCT|oct
4859909|NCT02276846|Transluminal|transluminal
4859910|NCT02276820|Adenovirus|adenovirus
4859911|NCT02276820|Virus specific T cells|virus specific t cells
4859912|NCT02276820|Viral infections|viral infections
4859913|NCT02276807|Depression|depression
4859914|NCT02276807|Behavioral Symptoms|behavioral symptoms
4859915|NCT02276807|Mental Disorders|mental disorders
4859916|NCT02276807|Depressive Disorder|depressive disorder
4859917|NCT02276807|suicidal ideation|suicidal ideation
4859918|NCT02276807|primary health care|primary health care
4859919|NCT02276807|Veterans|veterans
4859920|NCT02276794|Low back pain|low back pain
4859921|NCT02276794|Thrust manipulation|thrust manipulation
4859922|NCT02276794|Spinal manipulation|spinal manipulation
4859923|NCT02276794|Joint mobilization|joint mobilization
4859924|NCT02276794|Non-thrust manipulation|non-thrust manipulation
4859925|NCT02276794|proprioception|proprioception
4859926|NCT02276794|Postural stability|postural stability
4859927|NCT02276794|Baropodometry|baropodometry
4859928|NCT02276781|PAD|pad
4859929|NCT02276781|Peripheral Arterial Disease|peripheral arterial disease
4859930|NCT02276781|Biomarkers|biomarkers
4859931|NCT02276768|rectal distension|rectal distension
4859932|NCT02276768|rectal compliance|rectal compliance
4859933|NCT02276768|visceral pain|visceral pain
4859934|NCT02276768|pain intensity|pain intensity
4859935|NCT02276768|barostat|barostat
4859936|NCT02276768|distender|distender
4859937|NCT02276768|VAS (Visual Analog Scale)|vas (visual analog scale)
4859938|NCT02276768|rectal sensory threshold|rectal sensory threshold
4859939|NCT02276768|analgesia|analgesia
4859940|NCT02276768|trimebutine|trimebutine
4859941|NCT02276768|pain management|pain management
4859942|NCT02276768|peripheral|peripheral
4859943|NCT02276768|colon cancer|colon cancer
4859944|NCT02276768|H2S (hydrogen sulfide)|h2s (hydrogen sulfide)
4859945|NCT02276729|Upper limb|upper limb
4859946|NCT02276729|Rehabilitation|rehabilitation
4859947|NCT02276729|Occupational Therapy|occupational therapy
4859948|NCT02276729|Mirror Box Therapy|mirror box therapy
4859949|NCT02276690|iron deficiency|iron deficiency
4859950|NCT02276690|dosage of hepcidin|dosage of hepcidin
4859951|NCT02276690|usual biomarker (ferritin and transferrin saturation)|usual biomarker (ferritin and transferrin saturation)
4859952|NCT02276690|mass spectrometry|mass spectrometry
4859953|NCT02276690|immuno-detection|immuno-detection
4859954|NCT02276690|anaemia in intensive care unit|anaemia in intensive care unit
4859955|NCT02276664|lung cancer prevention|lung cancer prevention
4859956|NCT02276560|main tumor ranging from less than 3cm (T1 up to 7cm (T3)|main tumor ranging from less than 3cm (t1 up to 7cm (t3)
4859958|NCT02276547|Regurgitation|regurgitation
4859959|NCT02276547|Heart valve|heart valve
4859960|NCT02276547|Transcatheter|transcatheter
4859961|NCT02276547|Transapical|transapical
4859962|NCT02276547|Functional|functional
4859963|NCT02276547|Degenerative|degenerative
4859964|NCT02276547|Symptomatic, severe mitral valve regurgitation, high risk for open mitral valve surgery|symptomatic, severe mitral valve regurgitation, high risk for open mitral valve surgery
4859965|NCT02276495|pain management for total knee arthroplasty|pain management for total knee arthroplasty
4859966|NCT02276469|severe mental illness|severe mental illness
4859967|NCT02276443|Breast Cancer|breast cancer
4859968|NCT02276443|Triple-negative breast cancer|triple-negative breast cancer
4859969|NCT02276443|TNBC|tnbc
4859970|NCT02276443|Molecular testing|molecular testing
4859971|NCT02276443|Standard chemotherapy|standard chemotherapy
4859972|NCT02276443|Ultrasound|ultrasound
4859973|NCT02276430|Testicular cancer|testicular cancer
4859974|NCT02276430|Survivor|survivor
4859975|NCT02276430|Cardiovascular disease|cardiovascular disease
4859976|NCT02276430|Risk factors|risk factors
4859977|NCT02276417|Sepsis|sepsis
4859978|NCT02276417|Surgical ICU|surgical icu
4859979|NCT02276313|Peripheral|peripheral
4859980|NCT02276313|Infrainguinal|infrainguinal
4859981|NCT02276313|Drug Releasing Balloon|drug releasing balloon
4859982|NCT02276313|Drug Eluting Balloon|drug eluting balloon
4859983|NCT02276287|Adherence|adherence
4859984|NCT02276287|HAART|haart
4859985|NCT02276287|HIV|hiv
4859986|NCT02276287|Illness Perception|illness perception
4859987|NCT02276287|IPQ-R|ipq-r
4859988|NCT02276235|catgut embedding|catgut embedding
4859989|NCT02276235|obese women|obese women
4859990|NCT02276235|obesity-related hormones|obesity-related hormones
4859991|NCT02276222|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
4859992|NCT02276222|COPD|copd
4859993|NCT02276157|cholangioscopy|cholangioscopy
4859994|NCT02276105|Carpal Tunnel Syndrome|carpal tunnel syndrome
4859995|NCT02276105|Quality of Life|quality of life
4859996|NCT02276105|EQ-5D|eq-5d
4859997|NCT02276105|SF-12|sf-12
4859998|NCT02276105|Michigan Hand Questionnaire|michigan hand questionnaire
4859999|NCT02276092|Community-acquired pneumonia|community-acquired pneumonia
4860000|NCT02276092|Pragmatic study|pragmatic study
4860001|NCT02276092|Multi-center|multi-center
4860002|NCT02276092|Time-dependent bias|time-dependent bias
4860003|NCT02276092|antimicrobial stewardship|antimicrobial stewardship
4860004|NCT02276092|prospective audit and feedback|prospective audit and feedback
4860005|NCT02276079|Mild Traumatic Brain Injury|mild traumatic brain injury
4860006|NCT02276079|Aerobic Exercise|aerobic exercise
4860007|NCT02276079|Brain-Derived Neurotrophic Factor|brain-derived neurotrophic factor
4860008|NCT02276066|kidney dysfunction|kidney dysfunction
4860009|NCT02276066|chronic critical illness|chronic critical illness
4860010|NCT02276066|sepsis|sepsis
4860011|NCT02276066|Glomerular filtration rate|glomerular filtration rate
4860012|NCT02276053|Epilepsy|epilepsy
4860013|NCT02276053|Brain tumor|brain tumor
4860014|NCT02276053|lacosamide (LCM)|lacosamide (lcm)
4860015|NCT02276053|Anti-Epileptic Drugs (AEDs)|anti-epileptic drugs (aeds)
4860016|NCT02276040|Arthroplasty|arthroplasty
4860017|NCT02276040|Knee Replacement|knee replacement
4860018|NCT02276040|Analgesia|analgesia
4860019|NCT02276040|pain|pain
4860020|NCT02276027|adenocarcinoma lung cancer,squamous cell lung carcinoma, NSCLC|adenocarcinoma lung cancer,squamous cell lung carcinoma, nsclc
4860021|NCT02276014|Beta carotene|beta carotene
4860022|NCT02276014|Retinol|retinol
4860023|NCT02276001|Adult Volunteers|adult volunteers
4860024|NCT02275988|Adult Volunteers|adult volunteers
4860025|NCT02275975|Adult Volunteers|adult volunteers
4860026|NCT02275962|Adult Volunteers|adult volunteers
4860027|NCT02275949|SAH (Subarachnoid Hemorrhage)|sah (subarachnoid hemorrhage)
4860028|NCT02275949|Cerebral Vasospasm|cerebral vasospasm
4860029|NCT02275949|Acupuncture|acupuncture
4860030|NCT02275936|N91115|n91115
4860031|NCT02275936|Cavosonstat|cavosonstat
4860032|NCT02275910|Solid Tumors|solid tumors
4860033|NCT02275910|E7090|e7090
4860034|NCT02275897|Lower Segmental Caesarean Section (LSCS)|lower segmental caesarean section (lscs)
4860035|NCT02275897|Speed of Injection|speed of injection
4860036|NCT02275897|Spinal Anaesthesia|spinal anaesthesia
4860037|NCT02275897|Anesthesia|anesthesia
4860038|NCT02275884|Parkinson Disease|parkinson disease
4860039|NCT02275884|Cacao|cacao
4860040|NCT02275884|Biogenic amines|biogenic amines
4860041|NCT02275884|Xanthines|xanthines
4860042|NCT02275884|Neurodegenerative Diseases|neurodegenerative diseases
4860043|NCT02275871|Breast Cancer|breast cancer
4860044|NCT02275858|balloon assisted enteroscopy|balloon assisted enteroscopy
4860045|NCT02275858|terminal ileum intubation|terminal ileum intubation
4860046|NCT02275845|metformin|metformin
4860047|NCT02275845|prevention|prevention
4860048|NCT02275819|Heart Failure|heart failure
4860049|NCT02275819|Exercise|exercise
4860050|NCT02275819|Echocardiography|echocardiography
4860051|NCT02275741|Vaccine|vaccine
4860052|NCT02275741|Antibody response|antibody response
4860053|NCT02275741|relaps rate|relaps rate
4860054|NCT02275741|expanded disability status scale|expanded disability status scale
4860055|NCT02275728|Menopause|menopause
4860056|NCT02275728|Stress Urinary Incontinence|stress urinary incontinence
4860057|NCT02275728|EMG Biofeedback|emg biofeedback
4860058|NCT02275728|Pelvic Floor Muscle Training|pelvic floor muscle training
4860059|NCT02275728|Quality of life|quality of life
4860060|NCT02275728|Physical Therapie|physical therapie
4860061|NCT02275715|autism spectrum disorder (ASD)|autism spectrum disorder (asd)
4860062|NCT02275715|feeding problems|feeding problems
4860063|NCT02275702|Dexamethasone|dexamethasone
4860064|NCT02275702|Quality of recovery questionnaire|quality of recovery questionnaire
4860065|NCT02275702|QoR-40|qor-40
4860066|NCT02275702|Lung cancer|lung cancer
4860067|NCT02275702|Video-assisted thoracoscopic|video-assisted thoracoscopic
4860068|NCT02275689|Rotator cuff|rotator cuff
4860069|NCT02275689|Tendinosis|tendinosis
4860070|NCT02275689|Impingement|impingement
4860071|NCT02275689|radiofrequency|radiofrequency
4860072|NCT02275676|Inflammatory bowel disease|inflammatory bowel disease
4860073|NCT02275676|Nutritional Status|nutritional status
4860074|NCT02275676|Malnutrition|malnutrition
4860075|NCT02275676|Resting Energy Expenditure|resting energy expenditure
4860076|NCT02275663|relapsed AML|relapsed aml
4860077|NCT02275663|refractory AML|refractory aml
4860078|NCT02275663|azacytidine|azacytidine
4860079|NCT02275650|calcidiol|calcidiol
4860080|NCT02275650|25(oh)d|25(oh)d
4860081|NCT02275650|nbUVB|nbuvb
4860082|NCT02275650|cyp27A1|cyp27a1
4860083|NCT02275650|cyp27B1|cyp27b1
4860084|NCT02275650|vitamin D|vitamin d
4860085|NCT02275637|Implantable Cardioverter-Defibrillators|implantable cardioverter-defibrillators
4860086|NCT02275637|Ventricular Fibrillation|ventricular fibrillation
4860087|NCT02275637|ventricular Tachycardia|ventricular tachycardia
4860088|NCT02275611|oxytocin|oxytocin
4860089|NCT02275611|alcohol withdrawal|alcohol withdrawal
4860090|NCT02275611|alcohol dependence|alcohol dependence
4860091|NCT02275611|alcoholism|alcoholism
4860092|NCT02275585|Portal vein|portal vein
4860093|NCT02275585|Thrombosis|thrombosis
4860094|NCT02275585|Cirrhosis|cirrhosis
4860095|NCT02275481|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
4860096|NCT02275481|COPD|copd
4860097|NCT02275481|Emphysema|emphysema
4860098|NCT02275481|Chronic bronchitis|chronic bronchitis
4860099|NCT02275468|Chronic Kidney Disease|chronic kidney disease
4860100|NCT02275468|eGFR slope|egfr slope
4860101|NCT02275468|Herbal medicine Fu-zheng-qu-zhuo Oral liquid|herbal medicine fu-zheng-qu-zhuo oral liquid
4860102|NCT02275442|EPICES scale|epices scale
4860103|NCT02275442|Precarious situation|precarious situation
4860104|NCT02275442|Rural parturient women|rural parturient women
4860105|NCT02275442|Access to care|access to care
4860106|NCT02275442|Global Initiative for Sentinel E-health Network on Grid|global initiative for sentinel e-health network on grid
4860107|NCT02275442|General practice|general practice
4860108|NCT02275429|Metabolic Diseases|metabolic diseases
4860109|NCT02275429|Athletes|athletes
4860110|NCT02275429|Running|running
4860111|NCT02275429|Selenium|selenium
4860112|NCT02275429|Zinc|zinc
4860113|NCT02275429|Iron Metabolism Disorders|iron metabolism disorders
4860114|NCT02275429|Water-Electrolyte Imbalance|water-electrolyte imbalance
4860115|NCT02275429|Hyperkalemia|hyperkalemia
4860116|NCT02275429|Hypernatremia|hypernatremia
4860117|NCT02275429|Selenium levels before and after the race|selenium levels before and after the race
4860118|NCT02275429|Levels of other electrolytes and markers|levels of other electrolytes and markers
4860119|NCT02275390|mental illness|mental illness
4860120|NCT02275390|psychoeducation|psychoeducation
4860121|NCT02275390|nurse-led clinic|nurse-led clinic
4860122|NCT02275390|randomized controlled trial|randomized controlled trial
4860123|NCT02275377|Breathing Exercises; Autonomic Control; Blood Pressure.|breathing exercises; autonomic control; blood pressure.
4860124|NCT02275351|alopecia|alopecia
4860125|NCT02275351|topical|topical
4860126|NCT02275351|Samumed|samumed
4860127|NCT02275325|Posture|posture
4860128|NCT02275325|Unilateral vestibular deafferentation|unilateral vestibular deafferentation
4860129|NCT02275325|Medical management|medical management
4860225|NCT02274597|pre-hospital|pre-hospital
4860130|NCT02275325|Preoperative vestibular rehabilitation|preoperative vestibular rehabilitation
4860131|NCT02275325|Neural plasticity|neural plasticity
4860132|NCT02275286|sarcoma|sarcoma
4860133|NCT02275273|Adnexal Masses|adnexal masses
4860134|NCT02275273|Magnetic Resonance Imaging|magnetic resonance imaging
4860135|NCT02275273|Anatomopathology|anatomopathology
4860136|NCT02275247|Stellate ganglion block|stellate ganglion block
4860137|NCT02275247|Aneurysm surgery|aneurysm surgery
4860138|NCT02275247|Cognitive recovery|cognitive recovery
4860139|NCT02275247|Cerebral vasospasm|cerebral vasospasm
4860140|NCT02275234|cardiac arrest|cardiac arrest
4860141|NCT02275234|psychological intervention|psychological intervention
4860142|NCT02275221|Hepatitis B (HBV)|hepatitis b (hbv)
4860143|NCT02275221|Hepatitis C (HCV)|hepatitis c (hcv)
4860144|NCT02275195|hepatitis|hepatitis
4860145|NCT02275195|alcohol|alcohol
4860146|NCT02275182|Dexmedetomidine|dexmedetomidine
4860147|NCT02275169|follicle stimulating hormone treatment|follicle stimulating hormone treatment
4860148|NCT02275169|azoospermia nonobstructive|azoospermia nonobstructive
4860149|NCT02275169|male infertility|male infertility
4860150|NCT02275169|follicle stimulating hormone|follicle stimulating hormone
4860151|NCT02275156|Subjects with normal renal function or severe renal impairment (RI) or end stage renal disease (ESRD) receiving hemodialysis|subjects with normal renal function or severe renal impairment (ri) or end stage renal disease (esrd) receiving hemodialysis
4860152|NCT02275143|Computed Tomography of Thorax, Abdomen and Pelvis|computed tomography of thorax, abdomen and pelvis
4860153|NCT02275143|cancer patients|cancer patients
4860154|NCT02275143|coronary angiogram evaluation|coronary angiogram evaluation
4860155|NCT02275130|glottic insufficiency|glottic insufficiency
4860156|NCT02275130|calcium hydroxyapatite|calcium hydroxyapatite
4860157|NCT02275130|augmentation of vocal cords with injection technique|augmentation of vocal cords with injection technique
4860158|NCT02275117|Migraine Disorders|migraine disorders
4860159|NCT02275117|ALD403|ald403
4860160|NCT02275104|Ventricular arrhythmias|ventricular arrhythmias
4860161|NCT02275104|Persistent atrial fibrillation|persistent atrial fibrillation
4860162|NCT02275104|Ablation guidance|ablation guidance
4860163|NCT02275104|Software|software
4860164|NCT02275104|MRI (Magnetic resonance imaging)|mri (magnetic resonance imaging)
4860165|NCT02275091|Children|children
4860166|NCT02275091|Cholesterol|cholesterol
4860167|NCT02275078|COPD|copd
4860168|NCT02275078|Action Plan|action plan
4860169|NCT02275078|Telesystem|telesystem
4860170|NCT02275078|New technology|new technology
4860171|NCT02275065|HIV-1 Infected|hiv-1 infected
4860172|NCT02275065|Adults|adults
4860173|NCT02275065|Treatment Naive|treatment naive
4860174|NCT02275052|shuttle walk test|shuttle walk test
4860175|NCT02275052|umeclidinium|umeclidinium
4860176|NCT02275052|beta2-agonist|beta2-agonist
4860177|NCT02275052|exercise endurance time|exercise endurance time
4860178|NCT02275052|anticholinergic|anticholinergic
4860179|NCT02275052|combination product|combination product
4860180|NCT02275052|vilanterol|vilanterol
4860181|NCT02275052|exercise|exercise
4860182|NCT02275052|COPD|copd
4860183|NCT02275026|General Anesthesia, Postoperative Delirium, Recovery|general anesthesia, postoperative delirium, recovery
4860184|NCT02274974|incisional|incisional
4860185|NCT02274974|infiltration|infiltration
4860186|NCT02274974|cs|cs
4860187|NCT02274974|lidocaine|lidocaine
4860188|NCT02274974|epinephrine|epinephrine
4860189|NCT02274974|Adverse Reaction to Topical or Infiltrative Lidocaine|adverse reaction to topical or infiltrative lidocaine
4860190|NCT02274922|Campylobacter diagnosis,|campylobacter diagnosis,
4860191|NCT02274922|immuno-chromatographic test, ELISA, PCR, culture, stool|immuno-chromatographic test, elisa, pcr, culture, stool
4860192|NCT02274922|ELISA,|elisa,
4860193|NCT02274922|PCR,|pcr,
4860194|NCT02274922|culture, stool|culture, stool
4860195|NCT02274909|electromyography|electromyography
4860196|NCT02274909|aged|aged
4860197|NCT02274909|muscle strength|muscle strength
4860198|NCT02274909|wavelet analysis|wavelet analysis
4860199|NCT02274909|pilates|pilates
4860200|NCT02274909|proprioceptive neuromuscular facilitation|proprioceptive neuromuscular facilitation
4860201|NCT02274857|FIRMap|firmap
4860202|NCT02274857|Rotor|rotor
4860203|NCT02274857|FIRM-guided procedure|firm-guided procedure
4860204|NCT02274857|REAFFIRM|reaffirm
4860205|NCT02274805|Brown adipose tissue|brown adipose tissue
4860206|NCT02274805|Neck surgery|neck surgery
4860207|NCT02274779|Prostate Cancer,Oligometastasis,Radiotherapy,Hormonotherapy|prostate cancer,oligometastasis,radiotherapy,hormonotherapy
4860208|NCT02274766|Levodopa-Induced Dyskinesia|levodopa-induced dyskinesia
4860209|NCT02274766|LID|lid
4860210|NCT02274766|Parkinsonism|parkinsonism
4860211|NCT02274766|Parkinson's Disease|parkinson's disease
4860212|NCT02274727|Biomarker|biomarker
4860213|NCT02274727|Stroke|stroke
4860214|NCT02274727|Etiology|etiology
4860215|NCT02274727|Outcome|outcome
4860216|NCT02274675|Stroke|stroke
4860217|NCT02274675|Robot-assisted therapy|robot-assisted therapy
4860218|NCT02274675|Rehabilitation|rehabilitation
4860219|NCT02274623|Bone Neoplasms|bone neoplasms
4860220|NCT02274623|Hypocalcemia|hypocalcemia
4860221|NCT02274623|Hyperparathyroidism, Secondary|hyperparathyroidism, secondary
4860222|NCT02274610|docetaxel|docetaxel
4860223|NCT02274610|Pharmacokinetic|pharmacokinetic
4860227|NCT02274597|temperature|temperature
4860228|NCT02274584|Hodgkin's lymphoma|hodgkin's lymphoma
4860229|NCT02274584|Anaplastic large cell lymphoma|anaplastic large cell lymphoma
4860230|NCT02274584|CD30 positive lymphoma|cd30 positive lymphoma
4860231|NCT02274584|Peripheral T/Natural Killer (NK) cell lymphoma|peripheral t/natural killer (nk) cell lymphoma
4860232|NCT02274519|multiple myeloma|multiple myeloma
4860233|NCT02274519|plasma cell disorder|plasma cell disorder
4860234|NCT02274519|autologous stem cell transplant|autologous stem cell transplant
4860235|NCT02274506|Blood And Marrow Transplantation|blood and marrow transplantation
4860236|NCT02274506|Leukemia|leukemia
4860237|NCT02274506|Lymphoma|lymphoma
4860238|NCT02274506|CD19-specific T cells|cd19-specific t cells
4860239|NCT02274506|Acute lymphoblastic leukemia|acute lymphoblastic leukemia
4860240|NCT02274506|ALL|all
4860241|NCT02274506|Biphenotypic leukemia|biphenotypic leukemia
4860242|NCT02274506|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
4860243|NCT02274506|NHL|nhl
4860244|NCT02274506|Diffuse large B-cell lymphoma|diffuse large b-cell lymphoma
4860245|NCT02274506|Small lymphocytic lymphoma|small lymphocytic lymphoma
4860246|NCT02274506|Follicular lymphoma|follicular lymphoma
4860247|NCT02274506|Mantle cell lymphoma|mantle cell lymphoma
4860248|NCT02274506|Chronic lymphocytic leukemia|chronic lymphocytic leukemia
4860249|NCT02274506|CLL|cll
4860250|NCT02274493|da Vinci® robotic surgical system|da vinci® robotic surgical system
4860251|NCT02274493|latissimus dorsi muscle flap harvest procedures|latissimus dorsi muscle flap harvest procedures
4860252|NCT02274493|breast reconstruction|breast reconstruction
4860253|NCT02274493|scalp reconstruction|scalp reconstruction
4860254|NCT02274493|upper extremity reconstruction|upper extremity reconstruction
4860255|NCT02274493|lower extremity reconstruction|lower extremity reconstruction
4860256|NCT02274480|MRI|mri
4860257|NCT02274480|Diffusion Weighted Imaging|diffusion weighted imaging
4860258|NCT02274480|14-191|14-191
4860259|NCT02274467|Tsui Test|tsui test
4860260|NCT02274467|Labour|labour
4860261|NCT02274467|Epidural catheter|epidural catheter
4860262|NCT02274454|Uterine contraction|uterine contraction
4860263|NCT02274454|Oxytocin desensitization|oxytocin desensitization
4860264|NCT02274428|intraventricular hemorrhage|intraventricular hemorrhage
4860265|NCT02274415|Streptococcus pneumoniae|streptococcus pneumoniae
4860266|NCT02274415|Sickle cell disease|sickle cell disease
4860267|NCT02274415|Immunogenicity|immunogenicity
4860268|NCT02274415|Antibody response|antibody response
4860269|NCT02274402|Prednisone|prednisone
4860270|NCT02274402|Glucocorticoids|glucocorticoids
4860271|NCT02274402|pharmacokinetics|pharmacokinetics
4860272|NCT02274389|Pulmonary Multi-drug Resistant Tuberculosis|pulmonary multi-drug resistant tuberculosis
4860273|NCT02274389|Bedaquiline|bedaquiline
4860274|NCT02274389|Sirturo|sirturo
4860275|NCT02274389|Observational|observational
4860276|NCT02274389|Prospective|prospective
4860277|NCT02274363|Psoriasis|psoriasis
4860278|NCT02274363|Plaque|plaque
4860279|NCT02274363|Chronic|chronic
4860280|NCT02274350|prostate cancer|prostate cancer
4860281|NCT02274350|radiation therapy|radiation therapy
4860282|NCT02274350|sexual side effects|sexual side effects
4860283|NCT02274337|Epidermal Growth Factor Receptor|epidermal growth factor receptor
4860284|NCT02274337|Tyrosine Kinase Inhibitor|tyrosine kinase inhibitor
4860285|NCT02274337|T790M mutation|t790m mutation
4860286|NCT02274324|parkinson|parkinson
4860287|NCT02274324|duodopa|duodopa
4860288|NCT02274324|diet|diet
4860289|NCT02274324|proteins|proteins
4860290|NCT02274324|amino acids|amino acids
4860291|NCT02274311|Acromegaly|acromegaly
4860292|NCT02274311|SERM|serm
4860293|NCT02274311|Clomiphene|clomiphene
4860294|NCT02274285|Tetanus|tetanus
4860295|NCT02274285|Diphtheria|diphtheria
4860296|NCT02274285|Pertussis|pertussis
4860297|NCT02274285|Poliomyelitis|poliomyelitis
4860298|NCT02274285|Bacterial meningitis|bacterial meningitis
4860299|NCT02274285|DTaP-IPV/Hib Combination vaccine|dtap-ipv/hib combination vaccine
4860300|NCT02274272|lactobacillus reuteri|lactobacillus reuteri
4860301|NCT02274272|type 2 diabetes|type 2 diabetes
4860302|NCT02274246|Segmentation|segmentation
4860303|NCT02274246|GIMIAS® program|gimias® program
4860304|NCT02274246|Atrial fibrillation|atrial fibrillation
4860305|NCT02274246|Left atrial fibrosis|left atrial fibrosis
4860306|NCT02274246|Healthy volunteers|healthy volunteers
4860307|NCT02274233|Chelation|chelation
4860308|NCT02274233|Iron Overload|iron overload
4860309|NCT02274233|Thalassemia|thalassemia
4860310|NCT02274233|Transfusion|transfusion
4860311|NCT02274233|Iron Chelation|iron chelation
4860312|NCT02274220|systemic inflammation|systemic inflammation
4860313|NCT02274220|glucose metabolism|glucose metabolism
4860314|NCT02274220|glucose-insulin ratio|glucose-insulin ratio
4860315|NCT02274207|Silver dressing|silver dressing
4860316|NCT02274207|NPWT|npwt
4860317|NCT02274207|DMF|dmf
4860319|NCT02274194|obstructive sleep apnoea|obstructive sleep apnoea
4860320|NCT02274194|nasal mask|nasal mask
4860321|NCT02274194|oronasal mask|oronasal mask
4860322|NCT02274194|breathing route|breathing route
4860323|NCT02274194|CPAP|cpap
4860324|NCT02274155|Head and Neck Cancer|head and neck cancer
4860325|NCT02274155|anti-OX40 antibody|anti-ox40 antibody
4860326|NCT02274155|MEDI6469|medi6469
4860327|NCT02274155|Immunotherapy|immunotherapy
4860328|NCT02274142|dentinal caries|dentinal caries
4860329|NCT02274142|occlusal|occlusal
4860330|NCT02274142|occluso-proximal|occluso-proximal
4860331|NCT02274116|acute intermittent hypoxia|acute intermittent hypoxia
4860332|NCT02274116|walking|walking
4860333|NCT02274116|spasticity|spasticity
4860334|NCT02274116|incomplete spinal cord injury|incomplete spinal cord injury
4860335|NCT02274116|breathing|breathing
4860336|NCT02274116|strength|strength
4860337|NCT02274090|Metformin|metformin
4860338|NCT02274090|Pocket depth|pocket depth
4860339|NCT02274090|moderate periodontitis|moderate periodontitis
4860340|NCT02274090|severe periodontitis|severe periodontitis
4860341|NCT02274077|length of stay|length of stay
4860342|NCT02274077|nausea|nausea
4860343|NCT02274077|emesis|emesis
4860344|NCT02274077|bowel function|bowel function
4860345|NCT02274077|pain scores|pain scores
4860346|NCT02274077|narcotic pain medication|narcotic pain medication
4860347|NCT02274077|post operative period|post operative period
4860348|NCT02274064|Retention|retention
4860349|NCT02274064|Blood Donor Motivation|blood donor motivation
4860350|NCT02274025|Patient diagnosed with lung cancer|patient diagnosed with lung cancer
4860351|NCT02274012|Gastric|gastric
4860352|NCT02274012|Gastroesophageal Junction|gastroesophageal junction
4860353|NCT02274012|Gastroesophageal Cancer|gastroesophageal cancer
4860354|NCT02274012|Esophageal Cancer|esophageal cancer
4860355|NCT02274012|Metastatic|metastatic
4860356|NCT02274012|HER2 amplified|her2 amplified
4860357|NCT02274012|Afatinib|afatinib
4860358|NCT02273999|pulsed electromagnetic fields|pulsed electromagnetic fields
4860359|NCT02273999|post operative morbidity|post operative morbidity
4860360|NCT02273999|third molar|third molar
4860361|NCT02273999|extraction|extraction
4860362|NCT02273999|pain|pain
4860363|NCT02273986|Adult Volunteers|adult volunteers
4860364|NCT02273934|Home-based rehabilitation|home-based rehabilitation
4860365|NCT02273934|Activities of daily living|activities of daily living
4860366|NCT02273934|Restorative care|restorative care
4860367|NCT02273934|Reablement|reablement
4860368|NCT02273934|Everyday rehabilitation|everyday rehabilitation
4860369|NCT02273921|Dementia, Diagnosis, Electroencephalography|dementia, diagnosis, electroencephalography
4860370|NCT02273908|Low-Back Pain|low-back pain
4860371|NCT02273908|Neuropathic Pain|neuropathic pain
4860372|NCT02273908|Pregabalin|pregabalin
4860373|NCT02273895|Scopolamine, AD, EEG, MCI|scopolamine, ad, eeg, mci
4860374|NCT02273882|RSV|rsv
4860375|NCT02273882|RSVH|rsvh
4860376|NCT02273882|Infant|infant
4860377|NCT02273882|Gestational Age|gestational age
4860378|NCT02273882|wGA|wga
4860379|NCT02273882|PRETERM|preterm
4860380|NCT02273856|Chronic Lymphocytic Leukaemia (CLL)|chronic lymphocytic leukaemia (cll)
4860381|NCT02273856|Indolent Non Hodgkin's Lymphoma (iNHL)|indolent non hodgkin's lymphoma (inhl)
4860382|NCT02273843|Preterm|preterm
4860383|NCT02273843|late-onset sepsis|late-onset sepsis
4860384|NCT02273843|Vitamin D|vitamin d
4860385|NCT02273843|Dose|dose
4860386|NCT02273843|Interleukin-6|interleukin-6
4860387|NCT02273843|Tumor necrosis factor-alpha|tumor necrosis factor-alpha
4860388|NCT02273830|oxygen therapy|oxygen therapy
4860389|NCT02273830|COPD|copd
4860390|NCT02273830|exercise|exercise
4860391|NCT02273804|Topiramate|topiramate
4860392|NCT02273804|Obesity|obesity
4860393|NCT02273804|Children|children
4860394|NCT02273804|Adolescents|adolescents
4860395|NCT02273791|Frozen-thawed embryo transfer|frozen-thawed embryo transfer
4860396|NCT02273791|FET protocols|fet protocols
4860397|NCT02273739|solid tumor|solid tumor
4860398|NCT02273739|intrahepatic cholangiocarcinoma|intrahepatic cholangiocarcinoma
4860399|NCT02273739|ICC|icc
4860400|NCT02273739|chondrosarcoma|chondrosarcoma
4860401|NCT02273739|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
4860402|NCT02273739|AITL|aitl
4860403|NCT02273739|IDH|idh
4860404|NCT02273739|glioma|glioma
4860405|NCT02273739|solid tumor, including intrahepatic cholangiocarcinoma and chondrosarcoma|solid tumor, including intrahepatic cholangiocarcinoma and chondrosarcoma
4860406|NCT02273726|Anemia|anemia
4860407|NCT02273726|Chronic Kidney Disease|chronic kidney disease
4860408|NCT02273726|Dialysis|dialysis
4860409|NCT02273726|hemodialysis|hemodialysis
4860410|NCT02273726|peritoneal dialysis|peritoneal dialysis
4860411|NCT02273726|hemoglobin|hemoglobin
4860412|NCT02273726|End stage renal disease|end stage renal disease
4860413|NCT02273726|Stable Dialysis|stable dialysis
4860414|NCT02273726|erythropoietins|erythropoietins
4860415|NCT02273726|erythropoiesis stimulating agent|erythropoiesis stimulating agent
4860416|NCT02273713|Esophageal cancer|esophageal cancer
4860417|NCT02273713|Metastasized|metastasized
4860418|NCT02273713|Nab-paclitaxel|nab-paclitaxel
4860419|NCT02273713|Toxicity|toxicity
4860420|NCT02273713|First line treatment|first line treatment
4860421|NCT02273713|Phase Ib/II|phase ib/ii
4860422|NCT02273700|Xarelto®|xarelto®
4860423|NCT02273700|protein/peptide profiles|protein/peptide profiles
4860424|NCT02273687|diaphragm movement|diaphragm movement
4860425|NCT02273687|ultrasound|ultrasound
4860426|NCT02273687|emergency room|emergency room
4860427|NCT02273674|Borderline Personality Disorder|borderline personality disorder
4860428|NCT02273674|Transcranial Magnetic Stimulation, Repetitive|transcranial magnetic stimulation, repetitive
4860429|NCT02273648|national|national
4860430|NCT02273648|multicenter|multicenter
4860431|NCT02273648|observational registry|observational registry
4860432|NCT02273648|Orsiro Drug Eluting Stent|orsiro drug eluting stent
4860433|NCT02273648|Stenting Treatment of coronary artery disease|stenting treatment of coronary artery disease
4860434|NCT02273648|coronary revascularization|coronary revascularization
4860435|NCT02273648|PCI|pci
4860436|NCT02273648|STEMI|stemi
4860437|NCT02273648|NSTEMI|nstemi
4860438|NCT02273648|Ischemia|ischemia
4860439|NCT02273648|Angina|angina
4860440|NCT02273648|Acute Myocardial Infarction|acute myocardial infarction
4860441|NCT02273648|Small Vessels|small vessels
4860442|NCT02273648|Chronic Total Occlusion|chronic total occlusion
4860443|NCT02273622|hydroxytyrosol|hydroxytyrosol
4860444|NCT02273622|dietary supplement|dietary supplement
4860445|NCT02273622|gene expression regulation|gene expression regulation
4860446|NCT02273609|Atrial fibrillation|atrial fibrillation
4860447|NCT02273609|Anticoagulation|anticoagulation
4860448|NCT02273609|Vitamin K antagonists|vitamin k antagonists
4860449|NCT02273609|INR control|inr control
4860450|NCT02273583|of the extremity|of the extremity
4860451|NCT02273570|Hyperparathyroidism, Secondary|hyperparathyroidism, secondary
4860452|NCT02273570|Anemia|anemia
4860453|NCT02273570|Vascular Stiffness|vascular stiffness
4860454|NCT02273570|Vascular Calcification|vascular calcification
4860455|NCT02273323|Flow mediated dilation|flow mediated dilation
4860456|NCT02273323|tea|tea
4860457|NCT02273323|blood pressure|blood pressure
4860458|NCT02273297|Body composition|body composition
4860459|NCT02273297|Body size|body size
4860460|NCT02273284|Pain, Pediatrics, Botulinum Toxin injections, Buzzy|pain, pediatrics, botulinum toxin injections, buzzy
4860461|NCT02273271|FLT-PET|flt-pet
4860462|NCT02273271|DWI-MRI|dwi-mri
4860463|NCT02273232|Peripheral Arterial Disease|peripheral arterial disease
4860464|NCT02273232|Peripheral Vascular Disease|peripheral vascular disease
4860465|NCT02273232|Claudication|claudication
4860466|NCT02273232|Remote Ischemic Preconditioning|remote ischemic preconditioning
4860467|NCT02273232|EQ-5D|eq-5d
4860468|NCT02273232|Symptoms free distance|symptoms free distance
4860469|NCT02273232|ABI|abi
4860470|NCT02273232|micro vessel formation|micro vessel formation
4860471|NCT02273219|Uveal|uveal
4860472|NCT02273219|Melanoma|melanoma
4860473|NCT02273219|Advanced uveal melanoma|advanced uveal melanoma
4860474|NCT02273206|Depression|depression
4860475|NCT02273206|Breast Cancer Screening|breast cancer screening
4860476|NCT02273206|Cervical Cancer Screening|cervical cancer screening
4860477|NCT02273206|Colorectal Cancer Screening|colorectal cancer screening
4860478|NCT02273154|major depressive disorder|major depressive disorder
4860479|NCT02273154|Efficacy and safety of buspirone add-one treatment in patients with major depression disorder|efficacy and safety of buspirone add-one treatment in patients with major depression disorder
4860480|NCT02273154|buspirone|buspirone
4860481|NCT02273154|paroxetine|paroxetine
4860482|NCT02273154|anxiety|anxiety
4860483|NCT02273128|Osteoporosis|osteoporosis
4860484|NCT02273128|Chronic Periodontitis|chronic periodontitis
4860485|NCT02273128|Calcitonin gene Polymorphism|calcitonin gene polymorphism
4860486|NCT02273115|induction|induction
4860487|NCT02273115|Foley catheter|foley catheter
4860488|NCT02273115|oxytocin|oxytocin
4860489|NCT02273102|Acute Myelogenous Leukemia|acute myelogenous leukemia
4860490|NCT02273102|AML|aml
4860491|NCT02273102|Myelodysplastic Syndromes|myelodysplastic syndromes
4860492|NCT02273102|MDS|mds
4860493|NCT02273102|Tranylcypromine|tranylcypromine
4860494|NCT02273102|TCP|tcp
4860495|NCT02273102|ATRA|atra
4860496|NCT02273102|Tretinoin|tretinoin
4860497|NCT02273089|Obstructive sleep apnea|obstructive sleep apnea
4860498|NCT02273089|arterial stiffness|arterial stiffness
4860499|NCT02273089|CPAP|cpap
4860500|NCT02273089|excessive daytime sleepiness|excessive daytime sleepiness
4860501|NCT02273089|pulse wave velocity|pulse wave velocity
4860502|NCT02273063|PTSD|ptsd
4860503|NCT02273063|MDD|mdd
4860504|NCT02273063|TMS|tms
4860505|NCT02273063|5Hz|5hz
4860506|NCT02273050|Type 2 Diabetes Mellitus, Dipeptidyl-Peptidase 4 Inhibitors, Saxagliptin, Metformin, Endocrine System Diseases|type 2 diabetes mellitus, dipeptidyl-peptidase 4 inhibitors, saxagliptin, metformin, endocrine system diseases
4860507|NCT02273037|Labour|labour
4860508|NCT02273037|Birth asphyxia|birth asphyxia
4860509|NCT02273037|Fetal Heart Rate Monitor|fetal heart rate monitor
4860510|NCT02273037|Doppler Fetal Heart Rate Monitor|doppler fetal heart rate monitor
4860511|NCT02273037|Pinard Horn|pinard horn
4860512|NCT02273037|Pediatrics|pediatrics
4860513|NCT02273037|Uganda|uganda
4860514|NCT02273024|Exercise|exercise
4860515|NCT02273024|Quality of Life|quality of life
4860516|NCT02273024|Fatigue|fatigue
4860517|NCT02273024|Symptoms|symptoms
4860518|NCT02273024|Prehabilitation|prehabilitation
4860519|NCT02273024|Aerobic Capacity|aerobic capacity
4860520|NCT02272998|FGFR, RET, KIT|fgfr, ret, kit
4860521|NCT02272985|cerebral blood flow|cerebral blood flow
4860522|NCT02272985|hemodialysis|hemodialysis
4860523|NCT02272972|"fluoroscopy[MeSH], education, medical[MeSH]"|"fluoroscopy[mesh], education, medical[mesh]"
4860622|NCT02272400|partial breast irradiation|partial breast irradiation
4860524|NCT02272959|Anxiety/Anxiety disorders, Clinical trials, treatment, cognition, computer/Internet technology|anxiety/anxiety disorders, clinical trials, treatment, cognition, computer/internet technology
4860525|NCT02272907|Bariatric Surgery|bariatric surgery
4860526|NCT02272907|Laparoscopy|laparoscopy
4860527|NCT02272907|Weight Loss Surgery|weight loss surgery
4860528|NCT02272907|Staple Line Reinforcement|staple line reinforcement
4860529|NCT02272894|Gastric Cancer|gastric cancer
4860530|NCT02272894|D2 Lymphadenectomy|d2 lymphadenectomy
4860531|NCT02272894|Superior Mesenteric Vein Lymph Node|superior mesenteric vein lymph node
4860532|NCT02272855|HF10|hf10
4860533|NCT02272855|HSV-1|hsv-1
4860534|NCT02272855|Ipilimumab|ipilimumab
4860535|NCT02272855|Oncolytic virus|oncolytic virus
4860536|NCT02272855|Phase II|phase ii
4860537|NCT02272855|Stage IIIB melanoma|stage iiib melanoma
4860538|NCT02272855|Stage IIIC melanoma|stage iiic melanoma
4860539|NCT02272855|Stage IV melanoma|stage iv melanoma
4860540|NCT02272855|Unresectable malignant melanoma|unresectable malignant melanoma
4860541|NCT02272855|Metastatic malignant melanoma|metastatic malignant melanoma
4860542|NCT02272855|Combination treatment|combination treatment
4860543|NCT02272855|Intratumoral injection|intratumoral injection
4860544|NCT02272842|Nepal|nepal
4860545|NCT02272842|Cobalamin|cobalamin
4860546|NCT02272842|Neurodevelopment|neurodevelopment
4860547|NCT02272842|Stunting|stunting
4860548|NCT02272842|Growth|growth
4860549|NCT02272790|Ovarian, Fallopian Tube, or Primary Peritoneal Cancer|ovarian, fallopian tube, or primary peritoneal cancer
4860550|NCT02272777|Myelogenous|myelogenous
4860551|NCT02272777|Chronic|chronic
4860552|NCT02272777|BCR-ABL Positive|bcr-abl positive
4860553|NCT02272751|cancer survivorship|cancer survivorship
4860554|NCT02272751|exercise|exercise
4860555|NCT02272751|relaxation|relaxation
4860556|NCT02272751|mindfulness|mindfulness
4860557|NCT02272725|ultramarathon|ultramarathon
4860558|NCT02272725|ibuprofen|ibuprofen
4860559|NCT02272725|acute kidney injury|acute kidney injury
4860560|NCT02272725|exercise-associated hyponatremia|exercise-associated hyponatremia
4860561|NCT02272725|exertion|exertion
4860562|NCT02272712|cancer survivor|cancer survivor
4860563|NCT02272712|computerized treatment|computerized treatment
4860564|NCT02272712|symptom management|symptom management
4860565|NCT02272699|Esophageal Squamous Cell Carcinoma|esophageal squamous cell carcinoma
4860566|NCT02272699|Nimotuzumab|nimotuzumab
4860567|NCT02272699|Neoadjuvant treatment|neoadjuvant treatment
4860568|NCT02272686|Lymphoma|lymphoma
4860569|NCT02272686|Blood And Marrow Transplantation|blood and marrow transplantation
4860570|NCT02272686|Post Autologous Stem Cell Transplantation|post autologous stem cell transplantation
4860571|NCT02272686|SCT|sct
4860572|NCT02272686|B-cell lymphoma|b-cell lymphoma
4860573|NCT02272686|Ibrutinib|ibrutinib
4860574|NCT02272686|PCI-32765|pci-32765
4860575|NCT02272686|Imbruvica|imbruvica
4860576|NCT02272660|preemptive analgesia|preemptive analgesia
4860577|NCT02272660|parecoxib sodium|parecoxib sodium
4860578|NCT02272660|total knee arthroplasty|total knee arthroplasty
4860579|NCT02272660|total hip arthroplasty|total hip arthroplasty
4860580|NCT02272647|Normal Healthy Volunteers|normal healthy volunteers
4860581|NCT02272634|COPD|copd
4860582|NCT02272595|Biologic Markers|biologic markers
4860583|NCT02272595|Molecular testing|molecular testing
4860584|NCT02272595|Advanced cancers|advanced cancers
4860585|NCT02272595|Molecular information|molecular information
4860586|NCT02272595|Molecular profiling|molecular profiling
4860587|NCT02272595|Genetic Mutation|genetic mutation
4860588|NCT02272569|glaucoma|glaucoma
4860589|NCT02272569|glaucoma drainage device|glaucoma drainage device
4860590|NCT02272569|glaucoma shunt|glaucoma shunt
4860591|NCT02272530|Endothelial NO-synthase|endothelial no-synthase
4860592|NCT02272530|red blood cell|red blood cell
4860593|NCT02272530|erythrocytes|erythrocytes
4860594|NCT02272530|Peripheral Blood Mononuclear Cell|peripheral blood mononuclear cell
4860595|NCT02272530|cardiovascular disease|cardiovascular disease
4860596|NCT02272517|Vortioxetine|vortioxetine
4860597|NCT02272517|Cognition|cognition
4860598|NCT02272504|HCC|hcc
4860599|NCT02272504|AFP|afp
4860600|NCT02272504|AFP-L3|afp-l3
4860601|NCT02272504|DCP|dcp
4860602|NCT02272504|Surveillance|surveillance
4860603|NCT02272504|biomarkers|biomarkers
4860604|NCT02272478|AML|aml
4860605|NCT02272478|MDS|mds
4860606|NCT02272465|pre-hospital resuscitation, helicopter, trauma|pre-hospital resuscitation, helicopter, trauma
4860607|NCT02272452|High resolution magic angle spinning Nuclear magnetic resonance|high resolution magic angle spinning nuclear magnetic resonance
4860608|NCT02272452|Nuclear magnetic resonance|nuclear magnetic resonance
4860609|NCT02272452|Spectroscopy|spectroscopy
4860610|NCT02272452|Primary brain tumors|primary brain tumors
4860611|NCT02272452|Gliomas|gliomas
4860612|NCT02272452|extemporaneous analysis|extemporaneous analysis
4860613|NCT02272439|Bisphenol A|bisphenol a
4860614|NCT02272439|phthalates|phthalates
4860615|NCT02272439|infertility|infertility
4860616|NCT02272439|human|human
4860617|NCT02272426|Stroke|stroke
4860618|NCT02272426|Exercise Training|exercise training
4860619|NCT02272426|Cognitive Training|cognitive training
4860620|NCT02272426|Quality of Life|quality of life
4860621|NCT02272400|image guided radiation therapy|image guided radiation therapy
4860623|NCT02272400|breast cancer|breast cancer
4860624|NCT02272400|breast|breast
4860625|NCT02272400|cancer|cancer
4860626|NCT02272400|breast preservation|breast preservation
4860627|NCT02272400|IGRT|igrt
4860628|NCT02272400|PBI|pbi
4860629|NCT02272374|Hemodialysis|hemodialysis
4860630|NCT02272374|Arteriovenous fistula|arteriovenous fistula
4860631|NCT02272374|Tunneled cuffed catheter|tunneled cuffed catheter
4860632|NCT02272374|Arteriovenous graft|arteriovenous graft
4860633|NCT02272374|Elderly|elderly
4860634|NCT02272374|Very elderly|very elderly
4860635|NCT02272348|Therapeutic education|therapeutic education
4860636|NCT02272348|Functional insulin therapy|functional insulin therapy
4860637|NCT02272335|Breast Cancer|breast cancer
4860638|NCT02272335|Health Disparities|health disparities
4860639|NCT02272335|Psychosocial Intervention|psychosocial intervention
4860640|NCT02272335|Cancer Survivors|cancer survivors
4860641|NCT02272322|Anterior prolapse|anterior prolapse
4860642|NCT02272296|Injections, Jet|injections, jet
4860643|NCT02272296|pharmacology|pharmacology
4860644|NCT02272296|Insulin Aspart|insulin aspart
4860645|NCT02272296|Equipment and Supplies|equipment and supplies
4860646|NCT02272283|PCI optimization|pci optimization
4860647|NCT02272283|Coronary Remodeling|coronary remodeling
4860648|NCT02272283|Drug-Eluting Stent|drug-eluting stent
4860649|NCT02272283|Optical Coherence Tomography|optical coherence tomography
4860650|NCT02272283|Intravascular Ultrasound|intravascular ultrasound
4860651|NCT02272283|Strut Coverage|strut coverage
4860652|NCT02272283|Strut Apposition|strut apposition
4860653|NCT02272283|Vascular Healing Pattern|vascular healing pattern
4860654|NCT02272257|Musculoskeletal Pain|musculoskeletal pain
4860655|NCT02272257|Physical Therapists|physical therapists
4860656|NCT02272257|Drug Prescriptions|drug prescriptions
4860657|NCT02272257|Humans|humans
4860658|NCT02272257|Physical Therapy Modalities|physical therapy modalities
4860659|NCT02272257|Referral and Consultation|referral and consultation
4860660|NCT02272257|Workers' Compensation|workers' compensation
4860661|NCT02272257|United States|united states
4860662|NCT02272257|Primary Care|primary care
4860663|NCT02272257|Health Services Research|health services research
4860664|NCT02272257|Triage|triage
4860665|NCT02272257|Acute|acute
4860666|NCT02272257|Cost|cost
4860667|NCT02272257|Occupational Health|occupational health
4860668|NCT02272244|Colorectal Cancer|colorectal cancer
4860669|NCT02272244|Cancer Screening|cancer screening
4860670|NCT02272244|Decision Support|decision support
4860671|NCT02272244|Navigation|navigation
4860672|NCT02272231|women's health|women's health
4860673|NCT02272231|vaginosis, bacterial|vaginosis, bacterial
4860674|NCT02272231|african americans|african americans
4860675|NCT02272205|Hip replacement|hip replacement
4860676|NCT02272205|Knee replacement|knee replacement
4860677|NCT02272205|Knee infection|knee infection
4860678|NCT02272205|Hip infection|hip infection
4860679|NCT02272205|Antibiotic prophylaxis|antibiotic prophylaxis
4860680|NCT02272192|autism|autism
4860681|NCT02272192|autism spectrum disorder|autism spectrum disorder
4860682|NCT02272192|intensive intervention|intensive intervention
4860683|NCT02272192|early intervention|early intervention
4860684|NCT02272192|Early Start Denver Model|early start denver model
4860685|NCT02272179|adolescence|adolescence
4860686|NCT02272179|suicidality|suicidality
4860687|NCT02272179|depression|depression
4860688|NCT02272127|EGFR tyrosine kinase inhibitor|egfr tyrosine kinase inhibitor
4860689|NCT02272088|physical activity|physical activity
4860690|NCT02272088|energy expenditure|energy expenditure
4860691|NCT02272088|compensatory mechanisms|compensatory mechanisms
4860692|NCT02272088|adolescent|adolescent
4860693|NCT02272075|screeening|screeening
4860694|NCT02272062|Coronary artery disease|coronary artery disease
4860695|NCT02272062|Angina|angina
4860696|NCT02272062|Shared decision-making|shared decision-making
4860697|NCT02272062|Patient preferences|patient preferences
4860698|NCT02272062|Percutaneous coronary intervention|percutaneous coronary intervention
4860699|NCT02272062|Coronary artery bypass graft|coronary artery bypass graft
4860700|NCT02272049|Respiratory|respiratory
4860701|NCT02272036|Colonoscopy|colonoscopy
4860702|NCT02272036|Colonoscopy preparation|colonoscopy preparation
4860703|NCT02272036|screening|screening
4860704|NCT02272036|New media|new media
4860705|NCT02272036|SMS|sms
4860706|NCT02272036|Short message service|short message service
4860707|NCT02272023|alcohol|alcohol
4860708|NCT02272023|women|women
4860709|NCT02272023|motivational interviewing|motivational interviewing
4860710|NCT02271984|Healthy|healthy
4860711|NCT02271984|Praziquantel|praziquantel
4860712|NCT02271984|L-PZQ|l-pzq
4860713|NCT02271984|PZQ|pzq
4860714|NCT02271984|MSC2499550A|msc2499550a
4860715|NCT02271984|Bioavailability|bioavailability
4860716|NCT02271984|Pharmacokinetics|pharmacokinetics
4860717|NCT02271971|Psoriasis|psoriasis
4860718|NCT02271971|Vitamin D|vitamin d
4860719|NCT02271971|Metabolic syndrome|metabolic syndrome
4860720|NCT02271971|Insulin resistance|insulin resistance
4860721|NCT02271971|Cholesterol|cholesterol
4860722|NCT02271971|Methotrexate|methotrexate
4860723|NCT02271971|Dyslipidemia|dyslipidemia
4860724|NCT02271971|PASI|pasi
4860725|NCT02271971|Psoriasis Area Severity Index|psoriasis area severity index
4860726|NCT02271958|Mifepristone|mifepristone
4860727|NCT02271958|Endometriosis|endometriosis
4860728|NCT02271945|aggressive lymphoma, DLBCL, NHL|aggressive lymphoma, dlbcl, nhl
4860729|NCT02271932|appendicitis|appendicitis
4860730|NCT02271932|non-operative management|non-operative management
4860731|NCT02271932|children|children
4860732|NCT02271932|pediatric|pediatric
4860733|NCT02271919|Cancer Prevention|cancer prevention
4860734|NCT02271919|Tobacco Use Cessation|tobacco use cessation
4860735|NCT02271919|Nicotine replacement therapy|nicotine replacement therapy
4860736|NCT02271919|NRT|nrt
4860737|NCT02271919|Varenicline|varenicline
4860738|NCT02271919|Chantix|chantix
4860739|NCT02271919|Nicotine lozenge|nicotine lozenge
4860740|NCT02271919|Placebo tablet|placebo tablet
4860741|NCT02271919|Placebo patch|placebo patch
4860742|NCT02271919|Questionnaire|questionnaire
4860743|NCT02271919|Survey|survey
4860744|NCT02271919|Counseling|counseling
4860745|NCT02271906|Lung Cancer|lung cancer
4860746|NCT02271906|Non small cell lung cancer|non small cell lung cancer
4860747|NCT02271906|NSCLC|nsclc
4860748|NCT02271906|Adenocarcinoma|adenocarcinoma
4860749|NCT02271906|Squamous cell carcinoma|squamous cell carcinoma
4860750|NCT02271906|BIBW 2992|bibw 2992
4860751|NCT02271906|Afatinib|afatinib
4860752|NCT02271893|Chemotherapy-induced peripheral neuropathy|chemotherapy-induced peripheral neuropathy
4860753|NCT02271880|Medication nonadherence|medication nonadherence
4860754|NCT02271802|Butyrate|butyrate
4860755|NCT02271802|Interorgan metabolism|interorgan metabolism
4860756|NCT02271802|Short-chain fatty acids|short-chain fatty acids
4860757|NCT02271802|Gut production|gut production
4860758|NCT02271776|Insulin Sensitivity|insulin sensitivity
4860759|NCT02271763|cricothyroid membrane|cricothyroid membrane
4860760|NCT02271763|ultrasound|ultrasound
4860761|NCT02271750|IGF, Neurotrophic factors, Dementia, spinal fluid|igf, neurotrophic factors, dementia, spinal fluid
4860762|NCT02271737|Newborn|newborn
4860763|NCT02271737|infection|infection
4860764|NCT02271737|community health|community health
4860765|NCT02271724|CIDP|cidp
4860766|NCT02271724|MMN|mmn
4860767|NCT02271724|Spinal fluid|spinal fluid
4860768|NCT02271724|CD163|cd163
4860769|NCT02271724|CD19|cd19
4860770|NCT02271711|Brain Cancer|brain cancer
4860771|NCT02271711|Brain tumor|brain tumor
4860772|NCT02271711|Recurrent posterior fossa tumors|recurrent posterior fossa tumors
4860773|NCT02271711|Central nervous system|central nervous system
4860774|NCT02271711|CNS|cns
4860775|NCT02271711|Artificial antigen- presenting cells|artificial antigen- presenting cells
4860776|NCT02271711|aAPC|aapc
4860777|NCT02271711|Natural killer cells|natural killer cells
4860778|NCT02271711|NK|nk
4860779|NCT02271711|Ommaya reservoir|ommaya reservoir
4860780|NCT02271698|Knee arthroplasty|knee arthroplasty
4860781|NCT02271698|Dexamethasone|dexamethasone
4860782|NCT02271698|Acute pain|acute pain
4860783|NCT02271698|Chronic pain|chronic pain
4860784|NCT02271685|Diagnostic Information|diagnostic information
4860785|NCT02271685|Risk Perception|risk perception
4860786|NCT02271659|Prostate|prostate
4860787|NCT02271659|external beam radiotherapy|external beam radiotherapy
4860788|NCT02271659|brachytherapy boost|brachytherapy boost
4860789|NCT02271659|economical evaluation|economical evaluation
4860790|NCT02271646|paravertebral block|paravertebral block
4860791|NCT02271646|ultrasound guided|ultrasound guided
4860792|NCT02271633|Nitrate|nitrate
4860793|NCT02271633|Bioavailability|bioavailability
4860794|NCT02271633|Sports|sports
4860795|NCT02271620|1 prevalence|1 prevalence
4860796|NCT02271620|2 children|2 children
4860797|NCT02271620|3 local allergic rhinitis|3 local allergic rhinitis
4860798|NCT02271607|moxibustion|moxibustion
4860799|NCT02271555|electroconvulsive therapy|electroconvulsive therapy
4860800|NCT02271555|sevoflurane|sevoflurane
4860801|NCT02271555|remifentanil|remifentanil
4860802|NCT02271542|Propofol|propofol
4860803|NCT02271542|Polymorphism|polymorphism
4860804|NCT02271542|UGT1A9|ugt1a9
4860805|NCT02271542|CYP2B6|cyp2b6
4860806|NCT02271529|Peripheral Vascular Disease|peripheral vascular disease
4860807|NCT02271529|Femoral Artery|femoral artery
4860808|NCT02271529|Drug-Eluting Stent|drug-eluting stent
4860809|NCT02271490|Assisted Reproductive Technique|assisted reproductive technique
4860810|NCT02271490|ICSI|icsi
4860811|NCT02271490|Acrosome Reaction|acrosome reaction
4860812|NCT02271490|Pregnancy outcome|pregnancy outcome
4860813|NCT02271477|Fluid replacement|fluid replacement
4860814|NCT02271477|Trans-Thoracic Echocardiography|trans-thoracic echocardiography
4860815|NCT02271477|Spinal Anesthesia|spinal anesthesia
4860816|NCT02271477|Empirical Volemic Repletion|empirical volemic repletion
4860817|NCT02271464|Metastatic colorectal cancer|metastatic colorectal cancer
4860818|NCT02271464|Ist line therapy|ist line therapy
4860819|NCT02271464|metronimic therapy|metronimic therapy
4860820|NCT02271464|bevacizumab|bevacizumab
4860821|NCT02271451|concussion|concussion
4860822|NCT02271438|Healthy|healthy
4860823|NCT02271438|Ibrutinib|ibrutinib
4860824|NCT02271438|Moxifloxacin|moxifloxacin
4860825|NCT02271438|Cardiac Repolarization|cardiac repolarization
4860826|NCT02271438|Electrocardiogram|electrocardiogram
4860827|NCT02271438|QTc interval|qtc interval
4860828|NCT02271399|venous thromboembolism|venous thromboembolism
4860829|NCT02271399|total knee arthroplasty|total knee arthroplasty
4860830|NCT02271386|Evidence-Based Practice|evidence-based practice
4860831|NCT02271386|Provider Education|provider education
4860832|NCT02271373|Vision, Ocular|vision, ocular
4860833|NCT02271373|Physical activity|physical activity
4860834|NCT02271373|Schoolchildren|schoolchildren
4860835|NCT02271373|Intervention Studies|intervention studies
4860836|NCT02271360|infertility ICSI OHSS Calcium Dobesilate Cabergoline|infertility icsi ohss calcium dobesilate cabergoline
4860837|NCT02271334|Asthma|asthma
4860838|NCT02271334|Albuterol|albuterol
4860839|NCT02271321|dementia|dementia
4860840|NCT02271321|white noise|white noise
4860841|NCT02271321|agitation|agitation
4860842|NCT02271321|saliva cortisol|saliva cortisol
4860843|NCT02271308|elastic band resistance training|elastic band resistance training
4860844|NCT02271308|nursing home residents|nursing home residents
4860845|NCT02271308|muscle strength|muscle strength
4860846|NCT02271308|flexibility|flexibility
4860847|NCT02271308|quality of life|quality of life
4860848|NCT02271308|ease of care|ease of care
4860849|NCT02271295|Cirrhosis|cirrhosis
4860850|NCT02271295|Child B|child b
4860851|NCT02271295|decompensation|decompensation
4860852|NCT02271295|mortality|mortality
4860853|NCT02271295|portal thrombosis|portal thrombosis
4860854|NCT02271295|anticoagulation|anticoagulation
4860855|NCT02271269|glaucoma|glaucoma
4860856|NCT02271269|medication adherence|medication adherence
4860857|NCT02271269|financial incentives|financial incentives
4860858|NCT02271269|behavioral economics|behavioral economics
4860859|NCT02271256|Functional intimate apparel|functional intimate apparel
4860860|NCT02271256|Adolescent Idiopathic scoliosis|adolescent idiopathic scoliosis
4860861|NCT02271243|Central line-associated bloodstream infections|central line-associated bloodstream infections
4860862|NCT02271243|mucosal barrier injury|mucosal barrier injury
4860863|NCT02271243|laboratory-confirmed bloodstream infection|laboratory-confirmed bloodstream infection
4860864|NCT02271217|Post stroke|post stroke
4860865|NCT02271217|Ischemic stroke|ischemic stroke
4860866|NCT02271126|ECMO|ecmo
4860867|NCT02271126|Heparin|heparin
4860868|NCT02271126|Thromboelastography|thromboelastography
4860869|NCT02271126|Bleeding complications|bleeding complications
4860871|NCT02271074|Care|care
4860872|NCT02271074|Treatment|treatment
4860873|NCT02271074|Retention|retention
4860874|NCT02271074|Implementation Science|implementation science
4860875|NCT02271048|telemedicine|telemedicine
4860876|NCT02271048|ultrasonography|ultrasonography
4860877|NCT02271048|echocardiography|echocardiography
4860878|NCT02271035|VUR|vur
4860879|NCT02271022|ACS, Acute Coronary Syndromes|acs, acute coronary syndromes
4860880|NCT02271022|NSTEMI|nstemi
4860881|NCT02271022|MI, Myocardial Infarction|mi, myocardial infarction
4860882|NCT02270996|antibiotic, antimicrobial, stewardship, child|antibiotic, antimicrobial, stewardship, child
4860883|NCT02270983|Opioid-Induced Constipation|opioid-induced constipation
4860884|NCT02270983|Linaclotide|linaclotide
4860885|NCT02270983|Linzess|linzess
4860886|NCT02270944|GBS|gbs
4860887|NCT02270944|vaccine comparability|vaccine comparability
4860888|NCT02270944|Group B Strep|group b strep
4860889|NCT02270918|Xa inhibitor|xa inhibitor
4860890|NCT02270918|Prothrombin complex concentrate|prothrombin complex concentrate
4860891|NCT02270918|anticoagulation|anticoagulation
4860892|NCT02270905|meniscus|meniscus
4860893|NCT02270905|meniscectomy|meniscectomy
4860894|NCT02270905|decellularised|decellularised
4860895|NCT02270905|xenograft|xenograft
4860896|NCT02270892|Ulthera, Ulthera System, Ultherapy|ulthera, ulthera system, ultherapy
4860897|NCT02270866|aphasia|aphasia
4860898|NCT02270866|stroke|stroke
4860899|NCT02270853|ApneaLink|apnealink
4860900|NCT02270853|bronchial carcinoma|bronchial carcinoma
4860901|NCT02270853|sleep apnea screening|sleep apnea screening
4860902|NCT02270840|cardiac resynchronization therapy|cardiac resynchronization therapy
4860903|NCT02270801|recombinant human thrombopoietin|recombinant human thrombopoietin
4860904|NCT02270801|immune thrombocytopenia|immune thrombocytopenia
4860905|NCT02270801|pregnancy|pregnancy
4860906|NCT02270775|Questionnaire|questionnaire
4860907|NCT02270775|Translation|translation
4860908|NCT02270762|Early Physical Exercise|early physical exercise
4860909|NCT02270762|Early Passive Exercise|early passive exercise
4860910|NCT02270762|Alveolar Recruitment|alveolar recruitment
4860911|NCT02270762|Electrical Impedance Tomography|electrical impedance tomography
4860912|NCT02270762|Oxygenation|oxygenation
4860913|NCT02270762|Ventilation|ventilation
4860914|NCT02270684|Total Knee Arthroplasty|total knee arthroplasty
4860915|NCT02270684|Home monitoring|home monitoring
4860916|NCT02270671|Social Anxiety|social anxiety
4860917|NCT02270671|Social Phobia|social phobia
4860918|NCT02270671|Depression|depression
4860919|NCT02270671|Attention Bias Modification Training|attention bias modification training
4860920|NCT02270658|continuous positive airway pressure|continuous positive airway pressure
4860921|NCT02270658|hypertension|hypertension
4860922|NCT02270658|sleep apnea|sleep apnea
4860923|NCT02270606|Rectum|rectum
4860924|NCT02270541|Telemedicine|telemedicine
4860925|NCT02270541|Prehospital|prehospital
4860926|NCT02270541|Emergency Medicine|emergency medicine
4860927|NCT02270541|Stroke|stroke
4860928|NCT02270515|Patient-Centered Care|patient-centered care
4860929|NCT02270515|Medical Home|medical home
4860930|NCT02270502|critically illness|critically illness
4860931|NCT02270502|intensive care unit|intensive care unit
4860932|NCT02270502|outcome|outcome
4860933|NCT02270502|frailty|frailty
4860934|NCT02270476|Cystic Fibrosis|cystic fibrosis
4860935|NCT02270476|Infant|infant
4860936|NCT02270476|Toddler|toddler
4860937|NCT02270476|Children|children
4860938|NCT02270476|Newborn screening|newborn screening
4860939|NCT02270437|total knee arthroplasty|total knee arthroplasty
4860940|NCT02270437|cocktail analgesia|cocktail analgesia
4860941|NCT02270437|morphine consumption|morphine consumption
4860942|NCT02270424|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
4860943|NCT02270424|Medicine, Chinese Traditional|medicine, chinese traditional
4860944|NCT02270424|Humans|humans
4860945|NCT02270424|Treatment Outcome|treatment outcome
4860946|NCT02270398|Exercise|exercise
4860947|NCT02270398|Balance|balance
4860948|NCT02270398|Gait|gait
4860949|NCT02270398|Community|community
4860950|NCT02270398|Rehabilitation|rehabilitation
4860951|NCT02270398|Dual-task|dual-task
4860952|NCT02270385|pressure ulcer|pressure ulcer
4860953|NCT02270385|nursing home|nursing home
4860954|NCT02270372|Advanced breast carcinoma|advanced breast carcinoma
4860955|NCT02270372|Advanced ovarian carcinoma|advanced ovarian carcinoma
4860956|NCT02270372|MUC1|muc1
4860957|NCT02270372|vaccine|vaccine
4860958|NCT02270372|Phase 1b|phase 1b
4860959|NCT02270359|Myocardial Infarction|myocardial infarction
4860960|NCT02270359|CAD|cad
4860961|NCT02270346|Allogeneic HSCT, Inspiratory Muscle Training, Exercise Capacity|allogeneic hsct, inspiratory muscle training, exercise capacity
4860962|NCT02270333|sarcoidosis|sarcoidosis
4860963|NCT02270333|inspiratory muscle strength|inspiratory muscle strength
4860964|NCT02270333|exercise capacity|exercise capacity
4860965|NCT02270333|quality of life|quality of life
4860966|NCT02270320|Tai Chi Chuan|tai chi chuan
4860967|NCT02270320|cognitive function|cognitive function
4860968|NCT02270320|motor function|motor function
4860969|NCT02270320|MRI|mri
4860970|NCT02270294|Ischemic stroke|ischemic stroke
4860971|NCT02270294|Thai traditional massage|thai traditional massage
4860972|NCT02270294|Vascular function|vascular function
4860973|NCT02270294|Cerebral blood flow|cerebral blood flow
4860974|NCT02270294|Cerebrovascular reactivity|cerebrovascular reactivity
4860975|NCT02270268|Irritable bowel syndrome|irritable bowel syndrome
4860976|NCT02270268|Gut microbiota|gut microbiota
4860977|NCT02270268|Soluble dietary fiber|soluble dietary fiber
4860978|NCT02270255|embolization|embolization
4860979|NCT02270255|analgesia|analgesia
4860980|NCT02270242|PCI|pci
4860981|NCT02270242|DAPT|dapt
4860982|NCT02270242|ticagrelor|ticagrelor
4860983|NCT02270242|aspirin|aspirin
4860984|NCT02270216|isolated systolic hypertension|isolated systolic hypertension
4860985|NCT02270216|exercise pressor responses|exercise pressor responses
4860986|NCT02270203|si joint|si joint
4860987|NCT02270203|si joint injury|si joint injury
4860988|NCT02270203|si joint treatment|si joint treatment
4860989|NCT02270203|si joint inflammation|si joint inflammation
4860990|NCT02270203|si joint problems|si joint problems
4860991|NCT02270203|si joint symptoms|si joint symptoms
4860992|NCT02270203|hypermobile joint|hypermobile joint
4860993|NCT02270203|si joint arthritis|si joint arthritis
4860994|NCT02270203|si joint pain treatment|si joint pain treatment
4860995|NCT02270203|inflamed si joint|inflamed si joint
4860996|NCT02270203|si joint sclerosis|si joint sclerosis
4860997|NCT02270203|locked si joint|locked si joint
4860998|NCT02270203|si joint injuries|si joint injuries
4860999|NCT02270203|si joint disease|si joint disease
4861000|NCT02270203|si joint infection|si joint infection
4861001|NCT02270203|sacroiliac joint pelvic pain|sacroiliac joint pelvic pain
4861002|NCT02270203|sacroiliac joint arthritis treatment|sacroiliac joint arthritis treatment
4861003|NCT02270203|si joint pain|si joint pain
4861004|NCT02270203|si joint injections|si joint injections
4861005|NCT02270177|Headache|headache
4861006|NCT02270177|Telemedicine|telemedicine
4861007|NCT02270177|Videoconsultation|videoconsultation
4861008|NCT02270177|Headache-referrals|headache-referrals
4861009|NCT02270164|Lipids|lipids
4861010|NCT02270164|Cholesterol|cholesterol
4861011|NCT02270164|Dietary Supplements|dietary supplements
4861012|NCT02270164|Cynara scolymus|cynara scolymus
4861013|NCT02270164|Safety|safety
4861014|NCT02270151|Atrial fibrillation|atrial fibrillation
4861015|NCT02270151|Screening|screening
4861016|NCT02270151|Primary care|primary care
4861017|NCT02270151|Diagnostic|diagnostic
4861018|NCT02270138|physical activity|physical activity
4861019|NCT02270138|music|music
4861020|NCT02270138|sedentary lifestyle|sedentary lifestyle
4861021|NCT02270125|nasal mucosa|nasal mucosa
4861022|NCT02270125|chronic hypertrophic rhinosinusitis|chronic hypertrophic rhinosinusitis
4861023|NCT02270125|mucotomy|mucotomy
4861024|NCT02270125|nanoparticles|nanoparticles
4861025|NCT02270125|scanning electron microscopy|scanning electron microscopy
4861026|NCT02270125|Raman microspectroscopy|raman microspectroscopy
4861027|NCT02270125|nasal polyposis|nasal polyposis
4861028|NCT02270112|atrial fibrillation|atrial fibrillation
4861029|NCT02270112|atrial electrophysiology|atrial electrophysiology
4861030|NCT02270112|stroke|stroke
4861031|NCT02270112|vascular stiffness|vascular stiffness
4861032|NCT02270073|Psychotherapy process|psychotherapy process
4861033|NCT02270073|Change mechanisms|change mechanisms
4861034|NCT02270073|Mindfulness|mindfulness
4861035|NCT02270073|Micro-interventions|micro-interventions
4861036|NCT02270073|Mindfulness interventions|mindfulness interventions
4861037|NCT02270073|Progressive muscle relaxation|progressive muscle relaxation
4861038|NCT02270060|Music Therapy|music therapy
4861039|NCT02270060|Sickle Cell Disease|sickle cell disease
4861040|NCT02270060|Pain|pain
4861041|NCT02270047|Ad libitum energy intake|ad libitum energy intake
4861042|NCT02270047|Appetite sensation|appetite sensation
4861043|NCT02270021|Pap smear|pap smear
4861044|NCT02270021|Screening|screening
4861045|NCT02270021|Women|women
4861046|NCT02270021|Human papillomavirus|human papillomavirus
4861047|NCT02270021|Cervical precancer|cervical precancer
4861048|NCT02270021|Guideline adherence|guideline adherence
4861049|NCT02270008|anal incontinence|anal incontinence
4861050|NCT02270008|pregnancy-associated pelvic floor disorders|pregnancy-associated pelvic floor disorders
4861051|NCT02269995|Hepatocellular|hepatocellular
4861052|NCT02269995|Carcinoma|carcinoma
4861053|NCT02269969|Aminoglycoside|aminoglycoside
4861054|NCT02269969|Pharmacokinetics|pharmacokinetics
4861055|NCT02269969|Once daily dosing|once daily dosing
4861056|NCT02269943|Metastatic nasopharyngeal carcinoma|metastatic nasopharyngeal carcinoma
4861057|NCT02269943|oral azacitidine|oral azacitidine
4861058|NCT02269943|oral AZA|oral aza
4861059|NCT02269943|CC-486|cc-486
4861060|NCT02269943|metastatic|metastatic
4861061|NCT02269943|recurrent|recurrent
4861062|NCT02269943|nasopharyngeal carcinoma|nasopharyngeal carcinoma
4861063|NCT02269943|nasal|nasal
4861064|NCT02269943|solid tumors|solid tumors
4861065|NCT02269943|locally advanced|locally advanced
4861066|NCT02269943|rare head and neck cancer|rare head and neck cancer
4861067|NCT02269943|nasopharynx|nasopharynx
4861068|NCT02269943|single chemotherapy agent|single chemotherapy agent
4861069|NCT02269943|Epstein-Barr Virus (EBV) + nasopharyngeal carcinoma|epstein-barr virus (ebv) + nasopharyngeal carcinoma
4861070|NCT02269943|EBV-DN|ebv-dn
4861071|NCT02269943|Celgene|celgene
4861072|NCT02269943|Sponsor-study|sponsor-study
4861073|NCT02269943|oral chemotherapy|oral chemotherapy
4861074|NCT02269943|phase 2|phase 2
4861075|NCT02269943|oral Vidaza|oral vidaza
4861076|NCT02269943|EBV promoter methylation|ebv promoter methylation
4861077|NCT02269943|hypomethylation|hypomethylation
4861078|NCT02269943|tumor infiltrating lymphocytes (TILs)|tumor infiltrating lymphocytes (tils)
4861079|NCT02269943|EBV gene expression|ebv gene expression
4861080|NCT02269943|neoplasms|neoplasms
4861081|NCT02269917|Human Immunodeficiency Virus Type 1|human immunodeficiency virus type 1
4861082|NCT02269917|Emerald|emerald
4861083|NCT02269917|Darunavir|darunavir
4861084|NCT02269917|Cobicistat|cobicistat
4861085|NCT02269917|Emtricitabine|emtricitabine
4861086|NCT02269917|Tenofovir Alafenamide|tenofovir alafenamide
4861087|NCT02269891|Menopausal symptoms|menopausal symptoms
4861088|NCT02269891|Peri-menopause|peri-menopause
4861089|NCT02269891|Nu Femme|nu femme
4861090|NCT02269891|Labisia pumila|labisia pumila
4861091|NCT02269891|Eurycoma longifolia|eurycoma longifolia
4861092|NCT02269891|Hot flash|hot flash
4861093|NCT02269891|Joint pain|joint pain
4861094|NCT02269852|seasonal trivalent inactivated influenza vaccine|seasonal trivalent inactivated influenza vaccine
4861095|NCT02269852|immunogenicity|immunogenicity
4861096|NCT02269852|safety|safety
4861097|NCT02269852|cross-reactivity|cross-reactivity
4861098|NCT02269852|Northern hemisphere 2013-2014 formulation|northern hemisphere 2013-2014 formulation
4861099|NCT02269839|Tinnitus|tinnitus
4861100|NCT02269839|rTMS|rtms
4861101|NCT02269813|MammaPrint|mammaprint
4861102|NCT02269813|BluePrint|blueprint
4861103|NCT02269813|TargetPrint|targetprint
4861104|NCT02269774|Atrial Fibrillation|atrial fibrillation
4861105|NCT02269774|Obstructive Sleep Apnea|obstructive sleep apnea
4861106|NCT02269774|Atrial Premature Complexes|atrial premature complexes
4861107|NCT02269774|Pulmonary Vein Isolation|pulmonary vein isolation
4861108|NCT02269774|Mueller Manoeuvre|mueller manoeuvre
4861109|NCT02269761|Emergency Departments|emergency departments
4861110|NCT02269761|Chest|chest
4861111|NCT02269761|Lung|lung
4861112|NCT02269761|Cough|cough
4861113|NCT02269761|Dyspnea|dyspnea
4861114|NCT02269761|Wheezing|wheezing
4861115|NCT02269761|Ultrasound|ultrasound
4861116|NCT02269761|Ultrasonography|ultrasonography
4861117|NCT02269657|Scoliosis|scoliosis
4861118|NCT02269657|Postural balance|postural balance
4861119|NCT02269657|Lordosis|lordosis
4861120|NCT02269657|Kyphosis|kyphosis
4861121|NCT02269657|X-rays|x-rays
4861122|NCT02269631|Weight loss|weight loss
4861123|NCT02269631|Epidemiology|epidemiology
4861124|NCT02269631|Nutrition|nutrition
4861125|NCT02269618|Telehealth, Home-based, rehabilitation|telehealth, home-based, rehabilitation
4861126|NCT02269605|HIV reservoir|hiv reservoir
4861127|NCT02269605|Bryostatin|bryostatin
4861128|NCT02269592|MGUS|mgus
4861129|NCT02269592|Smoldering Myeloma|smoldering myeloma
4861130|NCT02269592|Chronic Lymphocytic leukemia|chronic lymphocytic leukemia
4861131|NCT02269592|Acute Myeloid Leukemia|acute myeloid leukemia
4861132|NCT02269592|Myeloproliferative neoplasms|myeloproliferative neoplasms
4861133|NCT02269592|Waldenstrom Macroglobulinemia|waldenstrom macroglobulinemia
4861134|NCT02269592|Monoclonal Gammopathy of Undermined Significance|monoclonal gammopathy of undermined significance
4861135|NCT02269592|Monoclonal B cell lymphocytosis|monoclonal b cell lymphocytosis
4861136|NCT02269592|Smoldering Multiple Myeloma|smoldering multiple myeloma
4861137|NCT02269592|Myelodysplastic syndromes|myelodysplastic syndromes
4861138|NCT02269579|Newly Diagnosed AML|newly diagnosed aml
4861139|NCT02269579|Secondary AML|secondary aml
4861140|NCT02269579|Relapsed/Refractory AML|relapsed/refractory aml
4861141|NCT02269579|Relapsed/Refractory ALL|relapsed/refractory all
4861142|NCT02269566|allergic rhinitis|allergic rhinitis
4861143|NCT02269566|immunotherapy|immunotherapy
4861144|NCT02269553|Migraine|migraine
4861145|NCT02269553|Headache|headache
4861146|NCT02269514|adoption|adoption
4861147|NCT02269514|electronic cigarettes|electronic cigarettes
4861148|NCT02269514|e-cigarettes|e-cigarettes
4861149|NCT02269514|combustible cigarettes|combustible cigarettes
4861150|NCT02269514|nicotine polacrilex|nicotine polacrilex
4861151|NCT02269514|own brand cigarette|own brand cigarette
4861152|NCT02269514|subjective measures|subjective measures
4861153|NCT02269514|pharmacokinetics|pharmacokinetics
4861154|NCT02269514|pharmacodynamics|pharmacodynamics
4861155|NCT02269488|Safety|safety
4861156|NCT02269488|Tolerability|tolerability
4861157|NCT02269488|MEDI3250|medi3250
4861158|NCT02269488|Japanese children|japanese children
4861159|NCT02269475|Efficacy|efficacy
4861160|NCT02269475|Safety|safety
4861161|NCT02269475|Tolerability|tolerability
4861162|NCT02269475|MEDI3250|medi3250
4861163|NCT02269475|Japanese children|japanese children
4861164|NCT02269449|transradial intervention|transradial intervention
4861165|NCT02269449|radial artery|radial artery
4861166|NCT02269410|Bariatric Surgery|bariatric surgery
4861167|NCT02269410|Nitrogen Balance|nitrogen balance
4861168|NCT02269410|Body composition|body composition
4861169|NCT02269410|Protein supplementation|protein supplementation
4861170|NCT02269410|Satiety|satiety
4861171|NCT02269410|Adherence|adherence
4861172|NCT02269397|Epilepsy|epilepsy
4861173|NCT02269397|Seizures|seizures
4861174|NCT02269397|Diagnosis|diagnosis
4861175|NCT02269397|Diagnostic|diagnostic
4861176|NCT02269397|Inflammation|inflammation
4861177|NCT02269384|Pain|pain
4861178|NCT02269384|Memory|memory
4861179|NCT02269384|Pressure Pain Threshold|pressure pain threshold
4861180|NCT02269384|Electromyography|electromyography
4861181|NCT02269384|Heart Rate Variability|heart rate variability
4861182|NCT02269319|ABSSSI|absssi
4861183|NCT02269319|MRX-I|mrx-i
4861184|NCT02269319|Acute Bacterial Skin and Skin Structure Infections|acute bacterial skin and skin structure infections
4861185|NCT02269306|PCOS|pcos
4861186|NCT02269306|clomiphene citrate|clomiphene citrate
4861187|NCT02269306|AMH|amh
4861188|NCT02269306|visceral fat area|visceral fat area
4861189|NCT02269306|HOMA-IR|homa-ir
4861190|NCT02269293|Selinexor (KPT-330)|selinexor (kpt-330)
4861191|NCT02269293|Paclitaxel|paclitaxel
4861192|NCT02269293|Carboplatin|carboplatin
4861193|NCT02269293|14-110|14-110
4861194|NCT02269280|Leukemia|leukemia
4861195|NCT02269280|Myelodysplastic syndrome|myelodysplastic syndrome
4861196|NCT02269280|MDS|mds
4861197|NCT02269280|Low or intermediate-1 risk|low or intermediate-1 risk
4861198|NCT02269280|Transfusion-dependent|transfusion-dependent
4861199|NCT02269280|Transfusion-independent|transfusion-independent
4861200|NCT02269280|Best supportive care|best supportive care
4861201|NCT02269280|BSC|bsc
4861202|NCT02269280|Azacitidine|azacitidine
4861203|NCT02269280|5-Azacytidine|5-azacytidine
4861204|NCT02269280|5-AZA|5-aza
4861205|NCT02269280|Vidaza|vidaza
4861206|NCT02269280|5-AZC|5-azc
4861207|NCT02269280|AZA-CR|aza-cr
4861208|NCT02269280|Ladakamycin|ladakamycin
4861209|NCT02269280|NSC-102816|nsc-102816
4861210|NCT02269280|Azacytidine|azacytidine
4861211|NCT02269280|Decitabine|decitabine
4861212|NCT02269280|Dacogen|dacogen
4861213|NCT02269254|Comparative Study|comparative study
4861214|NCT02269254|Knee Prosthesis|knee prosthesis
4861215|NCT02269254|Prosthesis Design|prosthesis design
4861216|NCT02269254|Treatment Outcome|treatment outcome
4861217|NCT02269254|Follow-Up Studies|follow-up studies
4861218|NCT02269254|Arthroplasty, Replacement, Knee/methods|arthroplasty, replacement, knee/methods
4861219|NCT02269241|contraception|contraception
4861220|NCT02269241|hormonal oral contraceptive agents|hormonal oral contraceptive agents
4861221|NCT02269241|hormonal oral contraceptive|hormonal oral contraceptive
4861222|NCT02269241|oral contraceptive|oral contraceptive
4861223|NCT02269241|drospirenone|drospirenone
4861224|NCT02269241|LF111|lf111
4861225|NCT02269241|birth control|birth control
4861226|NCT02269150|Recipients|recipients
4861227|NCT02269150|Transplantation|transplantation
4861228|NCT02269137|status epileptics|status epileptics
4861229|NCT02269137|prognosis|prognosis
4861230|NCT02269137|risk factor|risk factor
4861231|NCT02269137|outcome|outcome
4861232|NCT02269098|type 2 diabetes|type 2 diabetes
4861233|NCT02269098|hyperglycemia|hyperglycemia
4861234|NCT02269098|Emergency Department|emergency department
4861235|NCT02269098|Patient Education as Topic|patient education as topic
4861236|NCT02269098|Drug Therapy|drug therapy
4861237|NCT02269085|Lymphoma|lymphoma
4861238|NCT02269085|Mantle cell lymphoma|mantle cell lymphoma
4861239|NCT02269085|MCL|mcl
4861240|NCT02269085|Relapsed or refractory|relapsed or refractory
4861241|NCT02269085|Ibrutinib|ibrutinib
4861242|NCT02269085|PCI-32765|pci-32765
4861243|NCT02269085|Imbruvica|imbruvica
4861244|NCT02269085|Carfilzomib|carfilzomib
4861245|NCT02269072|Natriuretic Peptide|natriuretic peptide
4861246|NCT02269046|acupuncture|acupuncture
4861247|NCT02269046|moxibustion|moxibustion
4861248|NCT02269046|hyperlipidemias|hyperlipidemias
4861249|NCT02269046|effectiveness|effectiveness
4861250|NCT02269033|Breast cancer|breast cancer
4861251|NCT02269033|Patient Navigation|patient navigation
4861252|NCT02269033|Health Disparities|health disparities
4861253|NCT02269033|Latinas|latinas
4861254|NCT02269033|Breast Imaging Reporting and Data System, BI-RADS|breast imaging reporting and data system, bi-rads
4861255|NCT02269033|underserved|underserved
4861256|NCT02269020|Squamous Cell Carcinoma of the Epi-larynx|squamous cell carcinoma of the epi-larynx
4861257|NCT02269007|safety, tolerance, quadrivalent influenza vaccine|safety, tolerance, quadrivalent influenza vaccine
4861258|NCT02268994|ferric citrate|ferric citrate
4861259|NCT02268994|Chronic kidney disease|chronic kidney disease
4861260|NCT02268994|Anemia|anemia
4861261|NCT02268981|Oxymizer|oxymizer
4861262|NCT02268981|Oxygen conserving device|oxygen conserving device
4861263|NCT02268981|Conventional nasal cannula (CNC)|conventional nasal cannula (cnc)
4861264|NCT02268981|Idiopathic pulmonary fibrosis|idiopathic pulmonary fibrosis
4861265|NCT02268968|Topical Lidocaine|topical lidocaine
4861266|NCT02268968|Nasal CPAP|nasal cpap
4861267|NCT02268968|Pain|pain
4861268|NCT02268968|Preterm Infants|preterm infants
4861269|NCT02268968|Salivary cortisol|salivary cortisol
4861270|NCT02268955|Biliary Colic|biliary colic
4861271|NCT02268955|Abdominal pain|abdominal pain
4861272|NCT02268955|Intravenous Ibuprofen|intravenous ibuprofen
4861273|NCT02268916|diabetes|diabetes
4861274|NCT02268916|physical activity|physical activity
4861275|NCT02268916|participation|participation
4861276|NCT02268903|Pulmonary Embolism|pulmonary embolism
4861277|NCT02268903|Right Ventricle failure|right ventricle failure
4861278|NCT02268903|Diuretics|diuretics
4861279|NCT02268890|Multiple Myeloma|multiple myeloma
4861280|NCT02268890|Bortezomib|bortezomib
4861281|NCT02268890|Velcade|velcade
4861282|NCT02268877|ultrasonography|ultrasonography
4861283|NCT02268877|emergency department|emergency department
4861284|NCT02268864|Hepatitis C Chronic|hepatitis c chronic
4861285|NCT02268864|Simeprevir|simeprevir
4861286|NCT02268864|Daclatasvir|daclatasvir
4861287|NCT02268851|Mantle Cell Lymphoma|mantle cell lymphoma
4861288|NCT02268851|Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma|chronic lymphocytic leukemia/small lymphocytic lymphoma
4861289|NCT02268838|E6007|e6007
4861290|NCT02268838|Healthy Japanese male subjects|healthy japanese male subjects
4861291|NCT02268812|Pain Management|pain management
4861292|NCT02268812|Europe|europe
4861293|NCT02268812|Intrathecal|intrathecal
4861294|NCT02268799|Cardioversion|cardioversion
4861295|NCT02268799|High Sensitivity Troponin T (Hs-Trop T)|high sensitivity troponin t (hs-trop t)
4861296|NCT02268799|Brain Natriuretic Peptide (BNP)|brain natriuretic peptide (bnp)
4861297|NCT02268799|Neutrophil Gelatinase-associated Lipocalin (NGAL)|neutrophil gelatinase-associated lipocalin (ngal)
4861298|NCT02268786|Preimplantation Genetic Screening|preimplantation genetic screening
4861299|NCT02268786|Blastocyst|blastocyst
4861300|NCT02268786|Vitrification|vitrification
4861301|NCT02268786|In vitro fertilization|in vitro fertilization
4861302|NCT02268786|non-invasive prenatal testing|non-invasive prenatal testing
4861303|NCT02268786|next generation sequencing|next generation sequencing
4861304|NCT02268747|skin squamous cell cancer panHER inhibitor Dacomitinib|skin squamous cell cancer panher inhibitor dacomitinib
4861305|NCT02268734|Sporadic Medullary Thyroid Cancer Vandetanib miRNA|sporadic medullary thyroid cancer vandetanib mirna
4861306|NCT02268721|Pilot study|pilot study
4861307|NCT02268721|Frail elderly|frail elderly
4861308|NCT02268721|Malnutrition|malnutrition
4861309|NCT02268721|Functionality|functionality
4861310|NCT02268721|Life quality|life quality
4861311|NCT02268721|Health care technology|health care technology
4861312|NCT02268708|COPD|copd
4861313|NCT02268708|Surgery, Thoracic|surgery, thoracic
4861314|NCT02268695|Recurrent/Metastatic HNSCC|recurrent/metastatic hnscc
4861315|NCT02268695|Taxanes|taxanes
4861316|NCT02268682|Educator-Guided|educator-guided
4861317|NCT02268682|Patient-Guided|patient-guided
4861318|NCT02268682|Standard of Care (Control)|standard of care (control)
4861319|NCT02268669|primary angioplasty|primary angioplasty
4861320|NCT02268669|post-thrombolysis angioplasty|post-thrombolysis angioplasty
4861321|NCT02268669|ST elevation acute myocardial infarction|st elevation acute myocardial infarction
4861322|NCT02268643|breast cancer|breast cancer
4861323|NCT02268643|screening|screening
4861324|NCT02268643|ultrasound|ultrasound
4861325|NCT02268643|risk model|risk model
4861326|NCT02268630|Post-thrombotic syndrome|post-thrombotic syndrome
4861327|NCT02268630|Chronic thromboembolic pulmonary hypertension|chronic thromboembolic pulmonary hypertension
4861328|NCT02268630|Anticoagulation|anticoagulation
4861329|NCT02268630|Rivaroxaban|rivaroxaban
4861330|NCT02268617|Treadmill|treadmill
4861331|NCT02268617|Walking|walking
4861332|NCT02268617|Gait|gait
4861333|NCT02268617|Exercise|exercise
4861334|NCT02268578|Transcranial Direct Current Stimulation|transcranial direct current stimulation
4861335|NCT02268578|TDCS|tdcs
4861336|NCT02268578|Memory Dysfunction|memory dysfunction
4861337|NCT02268578|Depression|depression
4861338|NCT02268565|sleep, insomnia, inflammation, pain|sleep, insomnia, inflammation, pain
4861339|NCT02268565|Insomnia symptom induction/placebo|insomnia symptom induction/placebo
4861340|NCT02268565|Insomnia symptom induction/aspirin|insomnia symptom induction/aspirin
4861341|NCT02268552|Type 1 Spinal Muscular Atrophy|type 1 spinal muscular atrophy
4861342|NCT02268539|pilot study|pilot study
4861343|NCT02268539|atrial fibrillation|atrial fibrillation
4861344|NCT02268539|ablation|ablation
4861345|NCT02268539|implanted loop recorder|implanted loop recorder
4861346|NCT02268526|Safety, efficacy, pharmacokinetics, CSJ148, HCMV, HCMV viral load,|safety, efficacy, pharmacokinetics, csj148, hcmv, hcmv viral load,
4861347|NCT02268526|immunogenicity|immunogenicity
4861348|NCT02268513|Cardiovascular Disease|cardiovascular disease
4861349|NCT02268513|Social network|social network
4861350|NCT02268513|South Asians|south asians
4861351|NCT02268487|Early Improvement|early improvement
4861352|NCT02268487|Depression|depression
4861353|NCT02268487|Antidepressant|antidepressant
4861354|NCT02268474|532nm|532nm
4861355|NCT02268474|Excel V|excel v
4861356|NCT02268474|Cutera|cutera
4861357|NCT02268474|Laser|laser
4861358|NCT02268474|Laser Light|laser light
4861359|NCT02268474|PDL|pdl
4861360|NCT02268474|595nm|595nm
4861361|NCT02268474|Flash Lamp|flash lamp
4861362|NCT02268461|Post-Stroke Spasticity|post-stroke spasticity
4861363|NCT02268448|itch atopic dermatitis|itch atopic dermatitis
4861364|NCT02268422|Healthy volunteer|healthy volunteer
4861365|NCT02268422|crossover|crossover
4861366|NCT02268422|open-label|open-label
4861367|NCT02268422|randomised|randomised
4861368|NCT02268422|bioequivalence|bioequivalence
4861369|NCT02268422|pharmacokinetic study|pharmacokinetic study
4861370|NCT02268357|Dental Anxiety|dental anxiety
4861371|NCT02268357|Tooth Extraction|tooth extraction
4861372|NCT02268357|Propranolol|propranolol
4861373|NCT02268344|nerve regeneration|nerve regeneration
4861374|NCT02268344|spinal accessory nerve|spinal accessory nerve
4861375|NCT02268344|shoulder function|shoulder function
4861376|NCT02268344|head neck cancer|head neck cancer
4861377|NCT02268344|electrical stimulation|electrical stimulation
4861378|NCT02268318|Japanese Subjects, High LDL-C, fermented-dairy products, phytosterols|japanese subjects, high ldl-c, fermented-dairy products, phytosterols
4861379|NCT02268292|Metabolic syndrome|metabolic syndrome
4861380|NCT02268292|Diabetes|diabetes
4861381|NCT02268292|Muscle strength|muscle strength
4861382|NCT02268292|Aerobic exercise|aerobic exercise
4861383|NCT02268292|Bicycle|bicycle
4861384|NCT02268292|Brain-derived neurotrophic factor|brain-derived neurotrophic factor
4861385|NCT02268266|brain injury, early rehabilitation, tilt table|brain injury, early rehabilitation, tilt table
4861386|NCT02268214|Dapagliflozin|dapagliflozin
4861387|NCT02268214|Efficacy|efficacy
4861388|NCT02268214|Safety|safety
4861389|NCT02268214|Add on to insulin|add on to insulin
4861390|NCT02268214|Oral Antidiabetic|oral antidiabetic
4861391|NCT02268214|Type 1 diabetes|type 1 diabetes
4861392|NCT02268201|immunosuppressive therapy|immunosuppressive therapy
4861393|NCT02268201|tacrolimus|tacrolimus
4861394|NCT02268188|Cancer Survivors|cancer survivors
4861395|NCT02268175|prostate adenocarcinoma|prostate adenocarcinoma
4861396|NCT02268175|advanced prostate cancer|advanced prostate cancer
4861397|NCT02268175|high risk prostate cancer|high risk prostate cancer
4861398|NCT02268162|Lung Neoplasms|lung neoplasms
4861399|NCT02268162|Bronchoscopy|bronchoscopy
4861400|NCT02268162|Virtual Bronchoscopic Navigation(VBN)|virtual bronchoscopic navigation(vbn)
4861401|NCT02268162|Fluoroscopy|fluoroscopy
4861402|NCT02268162|Endobronchial Ultrasonography with a Guide Sheath(EBUS-GS)|endobronchial ultrasonography with a guide sheath(ebus-gs)
4861403|NCT02268162|Diagnosis|diagnosis
4861404|NCT02268123|Male Infertility|male infertility
4861405|NCT02268123|Sperm DNA Fragmentation|sperm dna fragmentation
4861406|NCT02268123|Sperm Abnormality|sperm abnormality
4861407|NCT02268110|diastasis recti|diastasis recti
4861408|NCT02268110|physiotherapy|physiotherapy
4861409|NCT02268110|exercise therapy|exercise therapy
4861410|NCT02268110|abdominal binding|abdominal binding
4861411|NCT02268097|patella|patella
4861412|NCT02268097|total knee arthroplasty|total knee arthroplasty
4861413|NCT02268097|resection|resection
4861414|NCT02268084|PTSD|ptsd
4861415|NCT02268084|TMS|tms
4861416|NCT02268084|EEG|eeg
4861417|NCT02268071|Hypertension|hypertension
4861418|NCT02268071|Stopping antihypertensive treatment|stopping antihypertensive treatment
4861419|NCT02268071|Primary care|primary care
4861420|NCT02268071|White coat hypertension|white coat hypertension
4861421|NCT02268071|Masked Hypertension|masked hypertension
4861422|NCT02268045|Non-Hodgkin Lymphoma|non-hodgkin lymphoma
4861423|NCT02268045|DLBCL|dlbcl
4861424|NCT02268045|Diffuse large b-cell lymphoma|diffuse large b-cell lymphoma
4861425|NCT02268032|hormone replacement therapy|hormone replacement therapy
4861426|NCT02268019|hypospadias|hypospadias
4861427|NCT02268019|dehiscence|dehiscence
4861428|NCT02268019|urethral stricture|urethral stricture
4861429|NCT02268019|side effects|side effects
4861430|NCT02268006|rectal carcinoma|rectal carcinoma
4861431|NCT02268006|preoperative radiochemotherapy|preoperative radiochemotherapy
4861432|NCT02268006|IMRT|imrt
4861433|NCT02268006|SIB|sib
4861434|NCT02267980|Electroconvulsive therapy; sevoflurane; ketamine|electroconvulsive therapy; sevoflurane; ketamine
4861435|NCT02267954|Calories|calories
4861436|NCT02267954|Fast Food Literacy|fast food literacy
4861437|NCT02267928|Symptom Assessment|symptom assessment
4861438|NCT02267915|Relapsed or refractory patients with mantle-cell lymphoma|relapsed or refractory patients with mantle-cell lymphoma
4861439|NCT02267915|Progression after high-dose chemotherapy and autologous HPT|progression after high-dose chemotherapy and autologous hpt
4861440|NCT02267902|Volunteers|volunteers
4861441|NCT02267889|Ganglionated plexi|ganglionated plexi
4861442|NCT02267850|Photobiomodulation|photobiomodulation
4861443|NCT02267850|Orthodontic treatment|orthodontic treatment
4861444|NCT02267850|Malocclusion|malocclusion
4861445|NCT02267850|OrthoPulse™|orthopulse™
4861446|NCT02267837|Alignment phase|alignment phase
4861447|NCT02267837|Photobiomodulation|photobiomodulation
4861448|NCT02267837|Orthodontic treatment|orthodontic treatment
4861449|NCT02267837|Malocclusion|malocclusion
4861450|NCT02267837|OrthoPulse™|orthopulse™
4861451|NCT02267824|Alignment phase|alignment phase
4861452|NCT02267824|Photobiomodulation|photobiomodulation
4861453|NCT02267824|Orthodontic treatment|orthodontic treatment
4861454|NCT02267824|Malocclusion|malocclusion
4861455|NCT02267824|OrthoPulse™|orthopulse™
4861456|NCT02267811|Photobiomodulation|photobiomodulation
4861457|NCT02267811|Orthodontic treatment|orthodontic treatment
4861458|NCT02267811|Malocclusion|malocclusion
4861459|NCT02267811|OrthoPulse™|orthopulse™
4861460|NCT02267798|Stroke|stroke
4861461|NCT02267798|Rehabilitation|rehabilitation
4861462|NCT02267798|Arm motor recovery|arm motor recovery
4861463|NCT02267798|biological biomarkers|biological biomarkers
4861464|NCT02267785|exercise|exercise
4861465|NCT02267785|mild cognitive impairment|mild cognitive impairment
4861466|NCT02267785|Parkinson's Disease|parkinson's disease
4861467|NCT02267720|Dental Atraumatic Restorative Treatment|dental atraumatic restorative treatment
4861468|NCT02267720|Glass ionomer cement|glass ionomer cement
4861469|NCT02267720|Occlusal-proximal leasons|occlusal-proximal leasons
4861470|NCT02267720|Primary molars|primary molars
4861471|NCT02267707|nab®-paclitaxel|nab®-paclitaxel
4861472|NCT02267707|ABI-007|abi-007
4861473|NCT02267707|Abraxane|abraxane
4861474|NCT02267707|Advanced Pancreatic Cancer|advanced pancreatic cancer
4861475|NCT02267707|Cholestatic Hyperbilirubinemia|cholestatic hyperbilirubinemia
4861476|NCT02267707|Bile Duct Obstruction|bile duct obstruction
4861477|NCT02267707|Pancreatic Cancer|pancreatic cancer
4861478|NCT02267668|concussion|concussion
4861479|NCT02267668|sports concussion|sports concussion
4861480|NCT02267668|exercise therapy|exercise therapy
4861481|NCT02267655|Inhaled Nitric Oxide (iNO)|inhaled nitric oxide (ino)
4861482|NCT02267655|Pulmonary Hypertension (PH)|pulmonary hypertension (ph)
4861483|NCT02267655|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
4861484|NCT02267655|Long Term Oxygen Therapy (LTOT)|long term oxygen therapy (ltot)
4861485|NCT02267655|Idiopathic Pulmonary Fibrosis (IPF)|idiopathic pulmonary fibrosis (ipf)
4861487|NCT02267616|Levonorgestrel intrauterine device (LNG IUD)|levonorgestrel intrauterine device (lng iud)
4861488|NCT02267616|Etonogestrel (ENG) Implant|etonogestrel (eng) implant
4861489|NCT02267616|Contraception|contraception
4861490|NCT02267564|patellar dislocation|patellar dislocation
4861491|NCT02267564|medial patellofemoral ligament|medial patellofemoral ligament
4861492|NCT02267564|tibial tubercle transfer|tibial tubercle transfer
4861493|NCT02267551|robotic surgery|robotic surgery
4861494|NCT02267551|simulation|simulation
4861495|NCT02267538|Delirium|delirium
4861496|NCT02267538|Cardiac Surgical Procedures|cardiac surgical procedures
4861497|NCT02267538|Postoperative Complications|postoperative complications
4861498|NCT02267538|Dexmedetomidine|dexmedetomidine
4861499|NCT02267538|Prevention|prevention
4861500|NCT02267525|Gastroparesis|gastroparesis
4861501|NCT02267525|Diabetic|diabetic
4861502|NCT02267525|Idiopathic|idiopathic
4861503|NCT02267512|Kidney Transplant Patients|kidney transplant patients
4861504|NCT02267512|ATG-F|atg-f
4861505|NCT02267499|cognitive training|cognitive training
4861506|NCT02267499|physical training|physical training
4861507|NCT02267499|exercise games|exercise games
4861508|NCT02267499|novelty serious games|novelty serious games
4861509|NCT02267499|computer training|computer training
4861510|NCT02267499|mild cognitive impairment|mild cognitive impairment
4861511|NCT02267499|mild dementia|mild dementia
4861512|NCT02267499|healthy elderly|healthy elderly
4861513|NCT02267486|Alzheimer Dementia, AD|alzheimer dementia, ad
4861514|NCT02267486|patients|patients
4861515|NCT02267486|cognitive|cognitive
4861516|NCT02267460|Peyronie's disease|peyronie's disease
4861517|NCT02267460|penile plaque|penile plaque
4861518|NCT02267460|penile curvature|penile curvature
4861519|NCT02267447|Cardiovascular diseases|cardiovascular diseases
4861520|NCT02267447|Clinical prediction rule|clinical prediction rule
4861521|NCT02267447|Population projection|population projection
4861522|NCT02267447|Risk stratification|risk stratification
4861523|NCT02267447|Health behavior|health behavior
4861524|NCT02267408|Heart valve prosthesis|heart valve prosthesis
4861525|NCT02267408|Anticoagulation|anticoagulation
4861526|NCT02267408|Warfarin|warfarin
4861527|NCT02267395|Musicians, Injuries|musicians, injuries
4861528|NCT02267369|online|online
4861529|NCT02267369|social media|social media
4861530|NCT02267369|online social network|online social network
4861531|NCT02267369|physical activity|physical activity
4861532|NCT02267369|message|message
4861533|NCT02267330|Gonadal Radiation Exposure|gonadal radiation exposure
4861534|NCT02267330|Fluoroscopic Imaging|fluoroscopic imaging
4861535|NCT02267330|Trauma Surgery|trauma surgery
4861536|NCT02267330|Pelvis fractures|pelvis fractures
4861537|NCT02267330|Femur fractures|femur fractures
4861538|NCT02267317|Insulin signaling and glucose disposal in muscle|insulin signaling and glucose disposal in muscle
4861539|NCT02267317|Hepatic insulin sensitivity|hepatic insulin sensitivity
4861540|NCT02267317|TLR4 signaling and inflammatory gene expression|tlr4 signaling and inflammatory gene expression
4861541|NCT02267317|Plasma cytokine concentration|plasma cytokine concentration
4861542|NCT02267317|Intramyocellular diacylglycerol and ceramide content|intramyocellular diacylglycerol and ceramide content
4861543|NCT02267304|volunteers|volunteers
4861544|NCT02267291|Cardiac Catheterization|cardiac catheterization
4861545|NCT02267291|Echocardiography|echocardiography
4861546|NCT02267291|Noninvasive Ventilation|noninvasive ventilation
4861547|NCT02267291|Positive-Pressure Respiration|positive-pressure respiration
4861548|NCT02267291|Ventricular Function|ventricular function
4861549|NCT02267278|Myeloproliferative Diseases|myeloproliferative diseases
4861550|NCT02267278|Myelofibrosis|myelofibrosis
4861551|NCT02267278|MF|mf
4861552|NCT02267278|Primary or post essential thrombocythemia/polycythemia vera|primary or post essential thrombocythemia/polycythemia vera
4861553|NCT02267278|Ruxolitinib|ruxolitinib
4861554|NCT02267278|Jakafi|jakafi
4861555|NCT02267278|INCB018424|incb018424
4861556|NCT02267278|INC424|inc424
4861557|NCT02267278|Pracinostat|pracinostat
4861558|NCT02267278|Questionnaire|questionnaire
4861559|NCT02267278|Survey|survey
4861560|NCT02267265|educational intervention|educational intervention
4861561|NCT02267265|language development|language development
4861562|NCT02267265|universal newborn hearing screening|universal newborn hearing screening
4861563|NCT02267265|postpartum|postpartum
4861564|NCT02267265|parental attachment|parental attachment
4861565|NCT02267265|loss to follow-up|loss to follow-up
4861566|NCT02267265|hearing loss|hearing loss
4861567|NCT02267265|achievement gap|achievement gap
4861568|NCT02267265|language gap|language gap
4861569|NCT02267265|school readiness|school readiness
4861570|NCT02267239|essential oils|essential oils
4861571|NCT02267239|chlorhexidine|chlorhexidine
4861572|NCT02267239|microscopy, confocal|microscopy, confocal
4861573|NCT02267239|immersion|immersion
4861574|NCT02267239|antiseptic|antiseptic
4861575|NCT02267200|biomarkers，pulmonary arterial hypertension|biomarkers，pulmonary arterial hypertension
4861576|NCT02267187|Craniomaxillofacial (CMF)|craniomaxillofacial (cmf)
4861577|NCT02267187|Battle-injured (BI)|battle-injured (bi)
4861578|NCT02267187|Facial Trauma|facial trauma
4861579|NCT02267187|Fat Grafts|fat grafts
4861580|NCT02267187|Autogenous Fat Transfers (AFT)|autogenous fat transfers (aft)
4861581|NCT02267187|Wounded Warriors|wounded warriors
4861582|NCT02267174|Implementation|implementation
4861583|NCT02267174|quality improvement|quality improvement
4861584|NCT02267174|patient safety|patient safety
4861585|NCT02267174|handoffs|handoffs
4861586|NCT02267174|intensive care unit|intensive care unit
4861587|NCT02267174|postoperative care|postoperative care
4861588|NCT02267174|simulation|simulation
4861589|NCT02267161|agenesis|agenesis
4861590|NCT02267161|corpus callosum|corpus callosum
4861591|NCT02267161|prenatal diagnosis|prenatal diagnosis
4861592|NCT02267148|Non-alcoholic fatty liver disease|non-alcoholic fatty liver disease
4861593|NCT02267148|Fatty liver|fatty liver
4861594|NCT02267148|Steatosis|steatosis
4861595|NCT02267148|Fibrosis|fibrosis
4861596|NCT02267148|Liver Stiffness|liver stiffness
4861597|NCT02267148|Cirrhosis|cirrhosis
4861598|NCT02267148|Genetics|genetics
4861599|NCT02267148|Single Nucleotide Polymorphism|single nucleotide polymorphism
4861600|NCT02267135|scalp psoriasis, plaque psoriasis, secukinumab, AIN457, biologic, monoclonal antibody, psoriasis, AIN457A|scalp psoriasis, plaque psoriasis, secukinumab, ain457, biologic, monoclonal antibody, psoriasis, ain457a
4861601|NCT02267096|lung cancer screening|lung cancer screening
4861602|NCT02267083|soft tissue sarcoma|soft tissue sarcoma
4861603|NCT02267070|cognitive training|cognitive training
4861604|NCT02267070|aerobic exercise|aerobic exercise
4861605|NCT02267070|neurotrophic factors|neurotrophic factors
4861606|NCT02267070|randomized controlled trial|randomized controlled trial
4861607|NCT02267057|Pain measurement|pain measurement
4861608|NCT02267057|Pain assessment|pain assessment
4861609|NCT02267057|Pain management|pain management
4861610|NCT02267057|Analgesia|analgesia
4861611|NCT02267057|Analgesics|analgesics
4861612|NCT02267057|Depressive symptoms|depressive symptoms
4861613|NCT02267057|Alzheimer disease|alzheimer disease
4861614|NCT02267057|Vascular dementia|vascular dementia
4861615|NCT02267057|Multi-infarct dementia|multi-infarct dementia
4861616|NCT02267057|Frontotemporal lobar degeneration|frontotemporal lobar degeneration
4861617|NCT02267057|Lewy body disease|lewy body disease
4861618|NCT02267031|cognitive dysfunction|cognitive dysfunction
4861619|NCT02267031|mechanical ventilation|mechanical ventilation
4861620|NCT02267031|hyperoxia|hyperoxia
4861621|NCT02267031|hypocapnia|hypocapnia
4861622|NCT02267018|nCPAP|ncpap
4861623|NCT02267018|High-Frequency Oscillator Ventilation|high-frequency oscillator ventilation
4861624|NCT02267018|Diaphragm Electrical Activity|diaphragm electrical activity
4861625|NCT02266979|peritoneal dialysis|peritoneal dialysis
4861626|NCT02266979|nursing staff|nursing staff
4861627|NCT02266979|nursing activities|nursing activities
4861628|NCT02266979|Personnel Downsizing|personnel downsizing
4861629|NCT02266953|Dietary services|dietary services
4861630|NCT02266953|Public Health Nursing|public health nursing
4861631|NCT02266953|Preschool child|preschool child
4861632|NCT02266940|pharmacokinetics|pharmacokinetics
4861633|NCT02266901|leaks after bariatric surgery|leaks after bariatric surgery
4861634|NCT02266901|fistulae after bariatric surgery|fistulae after bariatric surgery
4861635|NCT02266901|abdominal abcesses and bariatric surgery|abdominal abcesses and bariatric surgery
4861636|NCT02266901|endoscopic drainage of abcesses|endoscopic drainage of abcesses
4861637|NCT02266901|percutaneous drainage of abcesses|percutaneous drainage of abcesses
4861638|NCT02266901|gastric bypass|gastric bypass
4861639|NCT02266901|sleeve gastrectomy|sleeve gastrectomy
4861640|NCT02266901|necrotic collection and bariatric surgery|necrotic collection and bariatric surgery
4861641|NCT02266888|B cells|b cells
4861642|NCT02266888|lung transplant recipient|lung transplant recipient
4861643|NCT02266888|rituximab|rituximab
4861644|NCT02266888|placebo|placebo
4861645|NCT02266888|standard of care|standard of care
4861646|NCT02266836|Stroke|stroke
4861647|NCT02266836|Cerebrovascular accident|cerebrovascular accident
4861648|NCT02266836|Upper Extremity|upper extremity
4861649|NCT02266836|Cerebral Infarction|cerebral infarction
4861650|NCT02266836|Brain Infarction|brain infarction
4861651|NCT02266836|Brain Ischemia|brain ischemia
4861652|NCT02266836|Cerebrovascular Disorders|cerebrovascular disorders
4861653|NCT02266836|Cardiovascular Diseases|cardiovascular diseases
4861654|NCT02266836|Nervous System Diseases|nervous system diseases
4861655|NCT02266836|Central Nervous System Diseases|central nervous system diseases
4861656|NCT02266784|smoking, smoking cessation, contingency management, ADHD|smoking, smoking cessation, contingency management, adhd
4861657|NCT02266771|Negative Pressure Wound Therapy, Wound VAC, Instillation|negative pressure wound therapy, wound vac, instillation
4861658|NCT02266758|Gestational Diabetes|gestational diabetes
4861659|NCT02266758|Obesity|obesity
4861660|NCT02266758|Pregnancy|pregnancy
4861661|NCT02266719|Aortic Aneurysm, Abdominal [C14.907.055.239.075]|aortic aneurysm, abdominal [c14.907.055.239.075]
4861662|NCT02266693|Cognitive Behavioural Therapy|cognitive behavioural therapy
4861663|NCT02266693|Internet Based|internet based
4861664|NCT02266693|CBT|cbt
4861665|NCT02266693|Transdiagnostic|transdiagnostic
4861666|NCT02266693|MDD|mdd
4861667|NCT02266693|PD|pd
4861668|NCT02266693|SAD|sad
4861669|NCT02266693|GAD|gad
4861670|NCT02266693|iCBT|icbt
4861671|NCT02266680|Social Anxiety|social anxiety
4861672|NCT02266680|Yoga|yoga
4861673|NCT02266667|NEMOT device|nemot device
4861674|NCT02266667|pediatrics|pediatrics
4861675|NCT02266667|surgery|surgery
4861676|NCT02266667|progressive scoliosis|progressive scoliosis
4861677|NCT02266654|Emergency Medical Services|emergency medical services
4861678|NCT02266654|Lactic Acid|lactic acid
4861679|NCT02266654|Sepsis|sepsis
4861680|NCT02266641|one-carbon metabolism|one-carbon metabolism
4861681|NCT02266641|folate|folate
4861682|NCT02266641|choline|choline
4861683|NCT02266641|DNA methylation|dna methylation
4861684|NCT02266641|imprint marker|imprint marker
4861685|NCT02266641|cancer risks|cancer risks
4861686|NCT02266602|IORT|iort
4861687|NCT02266602|Breast Cancer|breast cancer
4861688|NCT02266589|coagulopathy|coagulopathy
4861689|NCT02266589|hydrocortisone|hydrocortisone
4861690|NCT02266589|organ failure|organ failure
4861691|NCT02266589|hemodynamic improvement induced by hydrocortisone|hemodynamic improvement induced by hydrocortisone
4861692|NCT02266563|Traumatic Brain Injury|traumatic brain injury
4861693|NCT02266563|Chronic Traumatic Encephalopathy|chronic traumatic encephalopathy
4861694|NCT02266563|Mild Cognitive Impairment|mild cognitive impairment
4861695|NCT02266563|PET imaging|pet imaging
4861696|NCT02266563|tauopathy|tauopathy
4861697|NCT02266563|amyloid|amyloid
4861698|NCT02266446|anxiety disorders|anxiety disorders
4861699|NCT02266446|cognitive bias modification|cognitive bias modification
4861700|NCT02266446|primary care|primary care
4861701|NCT02266446|attention|attention
4861702|NCT02266446|interpretation|interpretation
4861703|NCT02266446|computer|computer
4861704|NCT02266433|DeQuervains Tenosynovitis|dequervains tenosynovitis
4861705|NCT02266433|Lateral Epicondylitis|lateral epicondylitis
4861706|NCT02266433|Tennis Elbow|tennis elbow
4861707|NCT02266433|Trigger Finger|trigger finger
4861708|NCT02266433|Tenosynovitis|tenosynovitis
4861709|NCT02266433|Inflammatory Disease|inflammatory disease
4861710|NCT02266433|Dexamethasone|dexamethasone
4861711|NCT02266433|Ketorolac|ketorolac
4861712|NCT02266433|Toradol|toradol
4861713|NCT02266420|Triple negative breast cancer|triple negative breast cancer
4861714|NCT02266420|immuno-histochemistery|immuno-histochemistery
4861715|NCT02266420|genomic profiles|genomic profiles
4861716|NCT02266407|Revision TKA|revision tka
4861717|NCT02266407|Septic|septic
4861718|NCT02266407|Aseptic|aseptic
4861719|NCT02266407|Transfusion|transfusion
4861720|NCT02266407|Blood Loss|blood loss
4861721|NCT02266381|PCNL|pcnl
4861722|NCT02266381|MPCNL|mpcnl
4861723|NCT02266381|guidance|guidance
4861724|NCT02266381|puncture|puncture
4861725|NCT02266368|Ureteral stents|ureteral stents
4861726|NCT02266368|Double J stent|double j stent
4861727|NCT02266368|Antimicoreal coated stent|antimicoreal coated stent
4861728|NCT02266368|USSQ|ussq
4861729|NCT02266368|UTI|uti
4861730|NCT02266355|Oxaliplatin|oxaliplatin
4861731|NCT02266355|Omalizumab|omalizumab
4861732|NCT02266329|controlled clinical trial|controlled clinical trial
4861733|NCT02266329|randomized controlled clinical trial|randomized controlled clinical trial
4861734|NCT02266290|ADHESIVE TAPE|adhesive tape
4861735|NCT02266290|ANKLE INJURY|ankle injury
4861736|NCT02266290|POSTURAL BALANCE|postural balance
4861737|NCT02266290|FUNCTIONAL ANKLE INSTABILITY|functional ankle instability
4861738|NCT02266277|electronic health record, utilization|electronic health record, utilization
4861739|NCT02266277|randomized controlled trial|randomized controlled trial
4861740|NCT02266277|pragmatic clinical trial|pragmatic clinical trial
4861741|NCT02266277|influenza, prevention and control|influenza, prevention and control
4861742|NCT02266277|pneumococcal vaccines|pneumococcal vaccines
4861743|NCT02266277|qualitative research|qualitative research
4861744|NCT02266225|Chronic disease management|chronic disease management
4861745|NCT02266225|Physical activity|physical activity
4861746|NCT02266225|Fall prevention|fall prevention
4861747|NCT02266225|Strength and balance exercise|strength and balance exercise
4861748|NCT02266199|questionnaire|questionnaire
4861749|NCT02266199|quality assurance|quality assurance
4861750|NCT02266199|qualitative Verification|qualitative verification
4861751|NCT02266199|conservative patients|conservative patients
4861752|NCT02266199|interview|interview
4861753|NCT02266160|tinnitus|tinnitus
4861754|NCT02266160|local anaesthetic|local anaesthetic
4861755|NCT02266160|EMLA cream 5%|emla cream 5%
4861756|NCT02266147|Low Grade B-cell Lymphoma|low grade b-cell lymphoma
4861757|NCT02266134|implementation|implementation
4861758|NCT02266134|measurement based care|measurement based care
4861759|NCT02266134|standardized|standardized
4861760|NCT02266134|tailored|tailored
4861761|NCT02266121|Multiple Sclerosis|multiple sclerosis
4861762|NCT02266121|MS|ms
4861763|NCT02266121|Cognitive deficits|cognitive deficits
4861764|NCT02266121|Motor deficits|motor deficits
4861765|NCT02266121|Fatigue|fatigue
4861766|NCT02266121|Nervous System Diseases|nervous system diseases
4861767|NCT02266121|Brain Diseases|brain diseases
4861768|NCT02266121|Brain stimulation|brain stimulation
4861769|NCT02266121|Working memory|working memory
4861770|NCT02266121|Motor learning|motor learning
4861771|NCT02266121|Central Nervous System Diseases|central nervous system diseases
4861772|NCT02266121|Neuropsychological rehabilitation|neuropsychological rehabilitation
4861773|NCT02266108|Sexually Transmitted Infections|sexually transmitted infections
4861774|NCT02266108|Female Sex Workers|female sex workers
4861775|NCT02266095|Osteoarthritis|osteoarthritis
4861776|NCT02266095|Thumb spica splint|thumb spica splint
4861777|NCT02266095|Oval-8 splint|oval-8 splint
4861778|NCT02266095|Tee-Pee splint|tee-pee splint
4861779|NCT02266069|implementation|implementation
4861780|NCT02266069|anticipatory care planning|anticipatory care planning
4861781|NCT02266069|symptom assessment|symptom assessment
4861782|NCT02266069|interdisciplinary collaboration|interdisciplinary collaboration
4861783|NCT02266056|deep neuromuscular block|deep neuromuscular block
4861784|NCT02266056|sugammadex|sugammadex
4861785|NCT02266056|laparoscopic colorectal surgery|laparoscopic colorectal surgery
4861786|NCT02266056|hemodynamic change|hemodynamic change
4861787|NCT02266043|Upper airway obstruction|upper airway obstruction
4861788|NCT02266017|pain|pain
4861789|NCT02266017|coping|coping
4861790|NCT02266017|mhealth|mhealth
4861791|NCT02266017|cancer|cancer
4861792|NCT02266004|transcranial direct current stimulation|transcranial direct current stimulation
4861793|NCT02266004|neuromodulation|neuromodulation
4861794|NCT02265978|Emotional Self-Awareness|emotional self-awareness
4861795|NCT02265978|Positive Coping|positive coping
4861796|NCT02265978|Help-Seeking|help-seeking
4861797|NCT02265926|filtering facepiece respirators|filtering facepiece respirators
4861798|NCT02265926|N95 masks|n95 masks
4861799|NCT02265926|pandemic response|pandemic response
4861800|NCT02265926|pregnant healthcare workers|pregnant healthcare workers
4861801|NCT02265900|Positron Emission Tomography|positron emission tomography
4861802|NCT02265900|Dopamine|dopamine
4861803|NCT02265900|Parkinson's Disease|parkinson's disease
4861804|NCT02265887|Pulmonary Hypertension|pulmonary hypertension
4861805|NCT02265887|Africa|africa
4861806|NCT02265887|Heart Disease|heart disease
4861807|NCT02265887|Echocardiography|echocardiography
4861808|NCT02265861|Polycystic ovary syndrome; Vascular endothelial growth factor; Angiotensin-Ⅱ; Ovarian hyperstimulation syndrome|polycystic ovary syndrome; vascular endothelial growth factor; angiotensin-ⅱ; ovarian hyperstimulation syndrome
4861809|NCT02265848|Spinal cord stimulation|spinal cord stimulation
4861810|NCT02265848|Chronic pain|chronic pain
4861811|NCT02265848|Chronic low back pain|chronic low back pain
4861812|NCT02265848|Radiculopathy|radiculopathy
4861813|NCT02265848|Complex Regional Pain Syndrome (CRPS)|complex regional pain syndrome (crps)
4861814|NCT02265848|High Frequency stimulation|high frequency stimulation
4861815|NCT02265822|melatonin|melatonin
4861816|NCT02265822|midazolam|midazolam
4861817|NCT02265822|children|children
4861818|NCT02265809|Interleukin 2|interleukin 2
4861819|NCT02265809|Type 1 diabetes|type 1 diabetes
4861820|NCT02265809|T regulatory cells|t regulatory cells
4861821|NCT02265809|Adaptive trial|adaptive trial
4861822|NCT02265796|deferred percutaneous coronary intervention|deferred percutaneous coronary intervention
4861823|NCT02265796|fractional flow reserve|fractional flow reserve
4861824|NCT02265783|Focus of Study: Healthy Volunteers|focus of study: healthy volunteers
4861825|NCT02265757|Behavioral Intervention|behavioral intervention
4861826|NCT02265757|Mild Cognitive Impairment|mild cognitive impairment
4861827|NCT02265757|HABIT|habit
4861828|NCT02265757|Cognitive Rehabilitation|cognitive rehabilitation
4861829|NCT02265757|Multi-Component Intervention|multi-component intervention
4861830|NCT02265731|relapsed multiple myeloma|relapsed multiple myeloma
4861831|NCT02265731|refractory multiple myeloma|refractory multiple myeloma
4861832|NCT02265731|Lymphoma, Non-Hodgkin|lymphoma, non-hodgkin
4861833|NCT02265731|Lymphoproliferative Disorders|lymphoproliferative disorders
4861834|NCT02265731|Lymphatic Diseases|lymphatic diseases
4861835|NCT02265731|relapsed chronic lymphocytic leukemia|relapsed chronic lymphocytic leukemia
4861836|NCT02265731|small lymphocytic lymphoma|small lymphocytic lymphoma
4861837|NCT02265731|relapsed small lymphocytic lymphoma|relapsed small lymphocytic lymphoma
4861838|NCT02265731|refractory small lymphocytic lymphoma|refractory small lymphocytic lymphoma
4861839|NCT02265731|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
4861840|NCT02265731|acute myeloid leukemia|acute myeloid leukemia
4861841|NCT02265718|Healthy|healthy
4861842|NCT02265718|elderly volunteers|elderly volunteers
4861844|NCT02265614|blastocyst|blastocyst
4861845|NCT02265614|human|human
4861846|NCT02265614|IVF|ivf
4861847|NCT02265614|vitrification|vitrification
4861848|NCT02265614|single embryo transfer|single embryo transfer
4861849|NCT02265601|advance care planning|advance care planning
4861850|NCT02265601|living wills|living wills
4861851|NCT02265601|end of life|end of life
4861852|NCT02265601|cancer|cancer
4861853|NCT02265588|Inflammatory bowel disease (IBD)|inflammatory bowel disease (ibd)
4861854|NCT02265588|Ulcerative colitis|ulcerative colitis
4861855|NCT02265588|Crohn's disease|crohn's disease
4861856|NCT02265588|Children|children
4861857|NCT02265588|Adolescents|adolescents
4861858|NCT02265588|Anxiety|anxiety
4861859|NCT02265588|Depression|depression
4861860|NCT02265588|Cognitive behavioral therapy|cognitive behavioral therapy
4861861|NCT02265562|Hysterectomy|hysterectomy
4861862|NCT02265562|Misoprostol|misoprostol
4861863|NCT02265562|Blood loss|blood loss
4861864|NCT02265549|Metastases,|metastases,
4861865|NCT02265549|Neoplasm|neoplasm
4861866|NCT02265549|Cerebral|cerebral
4861867|NCT02265523|Arthroplasties, Replacement, Knee|arthroplasties, replacement, knee
4861868|NCT02265458|Respiratory failure|respiratory failure
4861869|NCT02265458|NIV|niv
4861870|NCT02265458|Musical intervention|musical intervention
4861871|NCT02265445|Carbapenems therapy/ESBL infections/Deescalation|carbapenems therapy/esbl infections/deescalation
4861872|NCT02265445|due to ESBL-PE|due to esbl-pe
4861873|NCT02265432|Physical activity|physical activity
4861874|NCT02265432|Sedentary behavior|sedentary behavior
4861875|NCT02265419|hyperinflammation, Cytosorb|hyperinflammation, cytosorb
4861876|NCT02265354|Tobacco Smoking Cessation|tobacco smoking cessation
4861877|NCT02265354|Computer tailored health communication|computer tailored health communication
4861878|NCT02265354|messaging|messaging
4861879|NCT02265354|collective intelligence|collective intelligence
4861880|NCT02265354|recommender systems|recommender systems
4861881|NCT02265354|machine learning|machine learning
4861882|NCT02265328|Severe Alcoholic Hepatitis in 'Extremis'|severe alcoholic hepatitis in 'extremis'
4861883|NCT02265328|Bovine Colostrum|bovine colostrum
4861884|NCT02265328|Glucocorticoids|glucocorticoids
4861885|NCT02265276|NAFLD, Diabetes, Glitazone|nafld, diabetes, glitazone
4861886|NCT02265250|magnetic resonance imaging|magnetic resonance imaging
4861887|NCT02265250|positron emission tomography|positron emission tomography
4861888|NCT02265237|Compensated Cirrhosis|compensated cirrhosis
4861889|NCT02265237|Hepatitis C|hepatitis c
4861890|NCT02265237|Hepatitis C Genotype 4|hepatitis c genotype 4
4861891|NCT02265237|Chronic Hepatitis C|chronic hepatitis c
4861892|NCT02265198|Pulmonary Contusion|pulmonary contusion
4861893|NCT02265198|ARDS|ards
4861894|NCT02265198|Respiratory Failure|respiratory failure
4861895|NCT02265172|Physiotherapy|physiotherapy
4861896|NCT02265172|Orthopaedic|orthopaedic
4861897|NCT02265172|Primary care|primary care
4862191|NCT02263092|Plasticity|plasticity
4861898|NCT02265146|Lipid Core Plaques (LCPs)|lipid core plaques (lcps)
4861899|NCT02265146|Vulnerable Plaque|vulnerable plaque
4861900|NCT02265146|Near Infrared Spectroscopy|near infrared spectroscopy
4861901|NCT02265107|endothelial function|endothelial function
4861902|NCT02265107|physical training|physical training
4861903|NCT02265107|exercise|exercise
4861904|NCT02265107|coronary artery bypass|coronary artery bypass
4861905|NCT02265094|Autism Spectrum Disorder|autism spectrum disorder
4861906|NCT02265094|Development|development
4861907|NCT02265094|Memory|memory
4861908|NCT02265094|ERD|erd
4861909|NCT02265068|Acute coronary syndrome (ACS), Ticagrelor|acute coronary syndrome (acs), ticagrelor
4861910|NCT02265029|fibromyalgia|fibromyalgia
4861911|NCT02265029|rheumatism|rheumatism
4861912|NCT02265029|fatigue syndrom|fatigue syndrom
4861913|NCT02265029|pain|pain
4861914|NCT02265029|spa treatment in rheumatology|spa treatment in rheumatology
4861915|NCT02265016|coronary artery disease|coronary artery disease
4861916|NCT02265016|acute coronary syndrome|acute coronary syndrome
4861917|NCT02265016|angina pectoris|angina pectoris
4861918|NCT02265016|non-ST-segment elevation myocardial infarction|non-st-segment elevation myocardial infarction
4861919|NCT02265016|red blood cells|red blood cells
4861920|NCT02265016|erythrocytes|erythrocytes
4861921|NCT02265003|red blood cells|red blood cells
4861922|NCT02265003|endothelial function|endothelial function
4861923|NCT02265003|nitric oxide pool in red blood cells|nitric oxide pool in red blood cells
4861924|NCT02265003|nitric oxide poll in blood plasma|nitric oxide poll in blood plasma
4861925|NCT02265003|nitric oxide synthase III - expression|nitric oxide synthase iii - expression
4861926|NCT02265003|oxidative status|oxidative status
4861927|NCT02265003|nitric oxide signalling|nitric oxide signalling
4861928|NCT02264990|veliparib|veliparib
4861929|NCT02264990|carboplatin|carboplatin
4861930|NCT02264990|paclitaxel|paclitaxel
4861931|NCT02264990|cisplatin|cisplatin
4861932|NCT02264990|pemetrexed|pemetrexed
4861933|NCT02264990|Poly Adenosine diphosphate (ADP)-ribose Polymerase (PARP)|poly adenosine diphosphate (adp)-ribose polymerase (parp)
4861934|NCT02264990|Metastatic|metastatic
4861935|NCT02264990|Non-squamous|non-squamous
4861936|NCT02264990|Non-small cell lung cancer|non-small cell lung cancer
4861937|NCT02264964|Hemodialysis|hemodialysis
4861938|NCT02264964|End-Stage Kidney Disease|end-stage kidney disease
4861939|NCT02264964|Central Venous Catheterization|central venous catheterization
4861940|NCT02264964|Digital Subtraction Angiography|digital subtraction angiography
4861941|NCT02264951|Short fatty acids|short fatty acids
4861942|NCT02264951|2-oleoyl glycerol|2-oleoyl glycerol
4861943|NCT02264951|GLP-1 secretion|glp-1 secretion
4861944|NCT02264951|C8-diet oil|c8-diet oil
4861945|NCT02264951|GIP secretion|gip secretion
4861946|NCT02264925|Essential tremor|essential tremor
4861947|NCT02264925|Deep brain stimulation (DBS)|deep brain stimulation (dbs)
4861948|NCT02264925|Ventral intermediate Thalamus (VIM)|ventral intermediate thalamus (vim)
4861949|NCT02264925|Local field potentials (LFPs)|local field potentials (lfps)
4861950|NCT02264925|Closed loop therapy|closed loop therapy
4861951|NCT02264912|antiplatelets, percutanous coronary intervention, acute coronary syndromes, laboratory efficacy|antiplatelets, percutanous coronary intervention, acute coronary syndromes, laboratory efficacy
4861952|NCT02264899|Alzheimer's disease|alzheimer's disease
4861953|NCT02264899|Mild Cognitive Impairment|mild cognitive impairment
4861954|NCT02264873|Relapse|relapse
4861955|NCT02264873|Autologous stem cell transplant|autologous stem cell transplant
4861956|NCT02264847|Clomiphene Citrate|clomiphene citrate
4861957|NCT02264847|Ovulation trigger|ovulation trigger
4861958|NCT02264847|Human chorionic gonadotrophin|human chorionic gonadotrophin
4861959|NCT02264834|epidural|epidural
4861960|NCT02264834|primiparous patient|primiparous patient
4861961|NCT02264834|deambulation|deambulation
4861962|NCT02264821|analgesia|analgesia
4861963|NCT02264821|caesarean|caesarean
4861964|NCT02264821|wound infiltration|wound infiltration
4861965|NCT02264821|intrathecal morphine.|intrathecal morphine.
4861966|NCT02264795|Cesarean section|cesarean section
4861967|NCT02264795|Lidocaine|lidocaine
4861968|NCT02264769|pregnancy|pregnancy
4861969|NCT02264769|postpartum hemorrhage|postpartum hemorrhage
4861970|NCT02264769|Cesarean delivery|cesarean delivery
4861971|NCT02264769|carbetocin|carbetocin
4861972|NCT02264756|Community-acquired pneumonia|community-acquired pneumonia
4861973|NCT02264756|Pragmatic clinical trial|pragmatic clinical trial
4861974|NCT02264756|Antimicrobial stewardship|antimicrobial stewardship
4861975|NCT02264756|length of stay|length of stay
4861976|NCT02264756|stepped-wedge design|stepped-wedge design
4861977|NCT02264756|time-dependent bias|time-dependent bias
4861978|NCT02264704|MS|ms
4861979|NCT02264704|Exercise|exercise
4861980|NCT02264704|Training|training
4861981|NCT02264704|Multiple sclerosis|multiple sclerosis
4861982|NCT02264704|Immune response|immune response
4861983|NCT02264704|Neurotrophin|neurotrophin
4861984|NCT02264704|Cytokine|cytokine
4861985|NCT02264704|Fatigue|fatigue
4861986|NCT02264678|ATM deficient, ATM proficient, HER2 negative, Breast, Gastric, Head & Neck, Lung|atm deficient, atm proficient, her2 negative, breast, gastric, head & neck, lung
4861987|NCT02264652|Refractory|refractory
4861988|NCT02264652|Partial|partial
4861989|NCT02264652|Epilepsy|epilepsy
4862291|NCT02262403|Treg|treg
4861990|NCT02264626|acute respiratory failure|acute respiratory failure
4861991|NCT02264626|noninvasive ventilation|noninvasive ventilation
4861992|NCT02264626|sedation|sedation
4861993|NCT02264626|patient/ventilator interaction|patient/ventilator interaction
4861994|NCT02264600|Restless Legs Syndrome, Apelin, Oxidative Stress|restless legs syndrome, apelin, oxidative stress
4861995|NCT02264535|Allergy|allergy
4861996|NCT02264535|Skin test|skin test
4861997|NCT02264535|Ginkgolides Meglumine Injection|ginkgolides meglumine injection
4861998|NCT02264509|Arterial Insufficiency|arterial insufficiency
4861999|NCT02264509|Human Immunodeficiency Virus|human immunodeficiency virus
4862000|NCT02264509|Atherosclerosis|atherosclerosis
4862001|NCT02264509|Ankle-brachial index|ankle-brachial index
4862002|NCT02264509|HAART|haart
4862003|NCT02264496|Colorectal cancer|colorectal cancer
4862004|NCT02264496|Exercise|exercise
4862005|NCT02264496|CPEX|cpex
4862006|NCT02264496|Exercise, Physical|exercise, physical
4862007|NCT02264496|Exercise, Aerobic|exercise, aerobic
4862008|NCT02264496|Surgery|surgery
4862009|NCT02264483|Pneumonia in COPD exacerbation|pneumonia in copd exacerbation
4862010|NCT02264470|Prediction|prediction
4862011|NCT02264470|Falls|falls
4862012|NCT02264470|Stroke|stroke
4862013|NCT02264457|Lenses, Intraocular|lenses, intraocular
4862014|NCT02264444|Cholecystectomy, visualization, single incision|cholecystectomy, visualization, single incision
4862015|NCT02264431|Obesity|obesity
4862016|NCT02264431|Obstructive Sleep Apnea|obstructive sleep apnea
4862017|NCT02264431|Sleep Habits|sleep habits
4862018|NCT02264431|Bariatric Surgery|bariatric surgery
4862019|NCT02264431|Cohort|cohort
4862020|NCT02264418|Solid tumours|solid tumours
4862021|NCT02264405|Autoimmune diseases|autoimmune diseases
4862022|NCT02264405|Systemic sclerosis|systemic sclerosis
4862023|NCT02264405|Autologous Hematopoietic stem cell transplant|autologous hematopoietic stem cell transplant
4862024|NCT02264379|Oligometastases|oligometastases
4862025|NCT02264379|Prostate Cancer|prostate cancer
4862026|NCT02264379|Stereotactic Radiotherapy|stereotactic radiotherapy
4862027|NCT02264379|Hypo fractionation|hypo fractionation
4862028|NCT02264379|Normal fractionation|normal fractionation
4862029|NCT02264353|Obstructive|obstructive
4862030|NCT02264353|Sleep Apnea|sleep apnea
4862031|NCT02264353|Arousal threshold|arousal threshold
4862032|NCT02264353|Donepezil|donepezil
4862033|NCT02264340|Tension-type headache|tension-type headache
4862034|NCT02264340|relaxation techniques|relaxation techniques
4862035|NCT02264340|physiotherapy|physiotherapy
4862036|NCT02264327|Motivational Interviewing|motivational interviewing
4862037|NCT02264327|Evidence Based Practice|evidence based practice
4862038|NCT02264327|Online Simulation|online simulation
4862039|NCT02264327|Workforce development|workforce development
4862040|NCT02264327|Training|training
4862041|NCT02264314|Aged|aged
4862042|NCT02264314|Hearing Aids|hearing aids
4862043|NCT02264314|Rehabilitation|rehabilitation
4862044|NCT02264288|Peripheral Arterial Disease|peripheral arterial disease
4862045|NCT02264288|Diabetic Foot|diabetic foot
4862046|NCT02264275|Aerobic Exercise|aerobic exercise
4862047|NCT02264275|Exercise|exercise
4862048|NCT02264275|Exergame|exergame
4862049|NCT02264275|Behavior|behavior
4862050|NCT02264275|Video Game|video game
4862051|NCT02264275|Inflammatory Bowel Disease|inflammatory bowel disease
4862052|NCT02264275|Children|children
4862053|NCT02264275|Adolescents|adolescents
4862054|NCT02264275|Pediatric|pediatric
4862055|NCT02264275|Physical Fitness|physical fitness
4862056|NCT02264223|Bioavailability|bioavailability
4862057|NCT02264223|Isoflavones|isoflavones
4862058|NCT02264223|Plasma|plasma
4862059|NCT02264223|Human|human
4862060|NCT02264223|Processing|processing
4862061|NCT02264223|Cross-over|cross-over
4862062|NCT02263950|Cancer|cancer
4862063|NCT02263950|Malignant Neoplasm|malignant neoplasm
4862064|NCT02263950|Artemether|artemether
4862065|NCT02263950|Sublingual|sublingual
4862066|NCT02263950|Neoplastic disease|neoplastic disease
4862067|NCT02263950|Solid Tumour|solid tumour
4862068|NCT02263950|Anti-cancer drug|anti-cancer drug
4862069|NCT02263950|Chemotherapy|chemotherapy
4862070|NCT02263950|LON002|lon002
4862071|NCT02263885|Parkinson's Disease|parkinson's disease
4862072|NCT02263885|ExAblate|exablate
4862073|NCT02263885|MRgFUS|mrgfus
4862074|NCT02263859|Obstructive Sleep Apnea|obstructive sleep apnea
4862075|NCT02263846|Breast cancer|breast cancer
4862076|NCT02263846|Menopause|menopause
4862077|NCT02263846|Estradiol|estradiol
4862078|NCT02263846|Follicle stimulating hormone|follicle stimulating hormone
4862079|NCT02263820|Acute Kidney Injury|acute kidney injury
4862080|NCT02263820|Acute Renal Failure|acute renal failure
4862081|NCT02263807|Patella luxation|patella luxation
4862082|NCT02263794|Bronchial Thermoplasty|bronchial thermoplasty
4862083|NCT02263755|CHB, cohort, fibroscan|chb, cohort, fibroscan
4862084|NCT02263742|Healthcare choice and outcomes|healthcare choice and outcomes
4862085|NCT02263742|Peer-led whole health|peer-led whole health
4862086|NCT02263742|Mental Illness|mental illness
4862087|NCT02263742|Peer Health Navigation|peer health navigation
4862088|NCT02263742|Health care Coordination|health care coordination
4862089|NCT02263716|Physical Activity|physical activity
4862090|NCT02263716|Intensive Care|intensive care
4862091|NCT02263716|Activities of Daily Living|activities of daily living
4862092|NCT02263716|Delirium|delirium
4862093|NCT02263716|Sepsis|sepsis
4862094|NCT02263716|Mechanical Ventilation|mechanical ventilation
4862095|NCT02263716|Critical Care|critical care
4862096|NCT02263716|Critical Illness|critical illness
4862097|NCT02263716|Aging|aging
4862098|NCT02263716|Accelerometery|accelerometery
4862099|NCT02263703|HPV vaccine, children, immunocompromised|hpv vaccine, children, immunocompromised
4862100|NCT02263677|diabetes|diabetes
4862101|NCT02263677|fatty liver|fatty liver
4862102|NCT02263664|microcirculation|microcirculation
4862103|NCT02263664|esophagectomy|esophagectomy
4862104|NCT02263664|side stream dark field|side stream dark field
4862105|NCT02263664|microcirculatory derangements|microcirculatory derangements
4862106|NCT02263651|Breast cancer|breast cancer
4862107|NCT02263651|Mastectomy|mastectomy
4862108|NCT02263651|Seroma|seroma
4862109|NCT02263651|Quilting suture|quilting suture
4862110|NCT02263638|hereditary haemochromatosis|hereditary haemochromatosis
4862111|NCT02263638|rheumatism|rheumatism
4862112|NCT02263638|anakinra|anakinra
4862113|NCT02263625|Indication|indication
4862114|NCT02263625|Differences|differences
4862115|NCT02263612|Incisional Hernia|incisional hernia
4862116|NCT02263612|Complications|complications
4862117|NCT02263612|Long-term|long-term
4862118|NCT02263586|Ironman|ironman
4862119|NCT02263586|Triathlon|triathlon
4862120|NCT02263573|PEP'C-R|pep'c-r
4862121|NCT02263573|Endurance parameters|endurance parameters
4862122|NCT02263573|Maximal cardio-respiratory function|maximal cardio-respiratory function
4862123|NCT02263573|Older seniors|older seniors
4862124|NCT02263573|Over 70|over 70
4862125|NCT02263547|teriflunomide|teriflunomide
4862126|NCT02263547|colestipol hcl|colestipol hcl
4862127|NCT02263534|stress urinary incontinence|stress urinary incontinence
4862128|NCT02263534|tension free vaginal tape|tension free vaginal tape
4862129|NCT02263534|single incision minisling|single incision minisling
4862130|NCT02263534|midurethral sling|midurethral sling
4862131|NCT02263508|Talimogene Laherparepvec|talimogene laherparepvec
4862132|NCT02263508|pembrolizumab|pembrolizumab
4862133|NCT02263508|KEYNOTE-034|keynote-034
4862134|NCT02263508|MASTERKEY-265|masterkey-265
4862135|NCT02263495|HER2-Negative|her2-negative
4862136|NCT02263482|muscle training|muscle training
4862137|NCT02263482|walking test|walking test
4862138|NCT02263482|chronic heart failure|chronic heart failure
4862139|NCT02263482|functional capacity|functional capacity
4862140|NCT02263443|bowel preparation|bowel preparation
4862141|NCT02263443|gynecologic surgery|gynecologic surgery
4862142|NCT02263443|laparotomy|laparotomy
4862143|NCT02263391|transmission|transmission
4862144|NCT02263391|prevention|prevention
4862145|NCT02263391|women|women
4862146|NCT02263391|childbearing age|childbearing age
4862147|NCT02263391|HIV testing|hiv testing
4862148|NCT02263391|testing strategy|testing strategy
4862149|NCT02263378|HPV, L-SIL|hpv, l-sil
4862150|NCT02263352|Diabetes, Periodontitis, Oxidative stress, Antioxidant|diabetes, periodontitis, oxidative stress, antioxidant
4862151|NCT02263339|Exercise|exercise
4862152|NCT02263339|MRI|mri
4862153|NCT02263313|Safety and efficacy|safety and efficacy
4862154|NCT02263313|Combo stent|combo stent
4862155|NCT02263313|Late loss thrombosis|late loss thrombosis
4862156|NCT02263313|Late loss catch up|late loss catch up
4862157|NCT02263300|Fiberoptic Intubation|fiberoptic intubation
4862158|NCT02263300|Medical student|medical student
4862159|NCT02263300|Virtual larynx|virtual larynx
4862160|NCT02263300|Didactic Training|didactic training
4862161|NCT02263300|Medical Education|medical education
4862162|NCT02263287|Alzheimer Disease|alzheimer disease
4862163|NCT02263287|Lewy Body Disease|lewy body disease
4862164|NCT02263261|dermal matrix|dermal matrix
4862165|NCT02263235|Alzheimer disease (AD)|alzheimer disease (ad)
4862166|NCT02263235|diagnosis biomarkers|diagnosis biomarkers
4862167|NCT02263235|cerebrospinal fluid (CSF)|cerebrospinal fluid (csf)
4862168|NCT02263235|targeted quantitative proteomics|targeted quantitative proteomics
4862169|NCT02263235|mass spectrometry|mass spectrometry
4862170|NCT02263235|stable isotope-labelled leucine|stable isotope-labelled leucine
4862171|NCT02263183|Metabolic risk|metabolic risk
4862172|NCT02263183|Abdominally overweight|abdominally overweight
4862173|NCT02263131|Influenza|influenza
4862174|NCT02263131|Influenza vaccine|influenza vaccine
4862175|NCT02263131|Split influenza vaccine|split influenza vaccine
4862176|NCT02263131|Seasonal influenza vaccine|seasonal influenza vaccine
4862177|NCT02263118|breastfeeding|breastfeeding
4862178|NCT02263118|rural|rural
4862179|NCT02263118|m-health|m-health
4862180|NCT02263118|mHealth|mhealth
4862181|NCT02263118|Patojitos|patojitos
4862182|NCT02263118|Guatemala|guatemala
4862183|NCT02263118|exclusive breastfeeding|exclusive breastfeeding
4862184|NCT02263118|mobile|mobile
4862185|NCT02263118|eHealth|ehealth
4862186|NCT02263118|e-health|e-health
4862187|NCT02263105|recurrent high-grade gliomas|recurrent high-grade gliomas
4862188|NCT02263105|cisplatin (CDDP)|cisplatin (cddp)
4862189|NCT02263105|temozolomide (TMZ)|temozolomide (tmz)
4862190|NCT02263092|Cortical excitability|cortical excitability
4862192|NCT02263092|Healthy subjects|healthy subjects
4862193|NCT02263040|influenza vaccine|influenza vaccine
4862194|NCT02263040|adult|adult
4862195|NCT02263040|immunogenicity|immunogenicity
4862196|NCT02263040|reactogenicity|reactogenicity
4862197|NCT02263027|influenza vaccine|influenza vaccine
4862198|NCT02263027|adult|adult
4862199|NCT02263027|safety|safety
4862200|NCT02263027|reactogenicity|reactogenicity
4862201|NCT02263014|Breast Cancer|breast cancer
4862202|NCT02263014|Contralateral Prophylactic Mastectomy|contralateral prophylactic mastectomy
4862203|NCT02263014|Questionnaires|questionnaires
4862204|NCT02263014|Surveys|surveys
4862205|NCT02263014|Psychosocial|psychosocial
4862206|NCT02263001|Auricular therapy|auricular therapy
4862207|NCT02263001|Acupuncture|acupuncture
4862208|NCT02263001|Acute, sub-acute pain|acute, sub-acute pain
4862209|NCT02263001|Auricular Acupuncture Needles|auricular acupuncture needles
4862210|NCT02262988|knee|knee
4862211|NCT02262988|joint replacement|joint replacement
4862212|NCT02262988|total knee|total knee
4862213|NCT02262988|cell therapy|cell therapy
4862214|NCT02262975|Alzheimer's disease|alzheimer's disease
4862215|NCT02262936|Aged|aged
4862216|NCT02262936|Deamino Arginine Vasopressin|deamino arginine vasopressin
4862217|NCT02262936|Fesoterodine|fesoterodine
4862218|NCT02262936|Randomized Controlled Trial|randomized controlled trial
4862219|NCT02262910|metastatic castration-resistant prostate cancer|metastatic castration-resistant prostate cancer
4862220|NCT02262910|CRPC|crpc
4862221|NCT02262897|small cell lung cancer|small cell lung cancer
4862222|NCT02262897|chemotherapy|chemotherapy
4862223|NCT02262897|Nab-paclitaxel|nab-paclitaxel
4862224|NCT02262871|Cystic fibrosis|cystic fibrosis
4862225|NCT02262871|High-flow nasal oxygen cannula|high-flow nasal oxygen cannula
4862226|NCT02262871|Non-invasive ventilation|non-invasive ventilation
4862227|NCT02262871|Respiratory distress|respiratory distress
4862228|NCT02262871|Oxygen therapy|oxygen therapy
4862229|NCT02262832|Diabetes|diabetes
4862230|NCT02262832|Leptin|leptin
4862231|NCT02262832|Lipodystrophy|lipodystrophy
4862232|NCT02262832|Hypertriglyceridemia|hypertriglyceridemia
4862233|NCT02262819|Skin Blister|skin blister
4862234|NCT02262819|Immune Response|immune response
4862235|NCT02262819|Suction Device|suction device
4862236|NCT02262819|Anti-Microbial|anti-microbial
4862237|NCT02262819|Killed Microbe|killed microbe
4862238|NCT02262806|Lipodystrophy|lipodystrophy
4862239|NCT02262806|Leptin|leptin
4862240|NCT02262806|Hypertriglyceridemia|hypertriglyceridemia
4862241|NCT02262806|Diabetes|diabetes
4862242|NCT02262767|Phase 1, Randomized, Double Blind, Placebo-Controlled, Single-Dose Escalation, Safety, Tolerability, Pharmacokinetic, PF-06649751, Trimethobenzamide|phase 1, randomized, double blind, placebo-controlled, single-dose escalation, safety, tolerability, pharmacokinetic, pf-06649751, trimethobenzamide
4862243|NCT02262728|Hepatitis C, Chronic|hepatitis c, chronic
4862244|NCT02262728|Simeprevir|simeprevir
4862245|NCT02262728|Daclatasvir|daclatasvir
4862246|NCT02262728|Sofosbuvir|sofosbuvir
4862247|NCT02262728|Decompensated Liver Disease|decompensated liver disease
4862248|NCT02262715|Oseltamivir|oseltamivir
4862249|NCT02262715|VX-787|vx-787
4862250|NCT02262689|GSK2256294|gsk2256294
4862251|NCT02262689|normoxic|normoxic
4862252|NCT02262689|hypoxic|hypoxic
4862253|NCT02262689|Pulmonary artery systolic pressure (PASP)|pulmonary artery systolic pressure (pasp)
4862254|NCT02262676|Stroke prevention on Atrial Fibrillation|stroke prevention on atrial fibrillation
4862255|NCT02262676|Prevention and Control|prevention and control
4862256|NCT02262676|Stroke|stroke
4862257|NCT02262507|Brain|brain
4862258|NCT02262507|Hearing|hearing
4862259|NCT02262507|MTBI|mtbi
4862260|NCT02262468|retrospective analysis|retrospective analysis
4862261|NCT02262455|Serous tumor|serous tumor
4862262|NCT02262455|Granulosa tumor|granulosa tumor
4862263|NCT02262455|Clear Cell tumor|clear cell tumor
4862264|NCT02262455|Endometrial cancer|endometrial cancer
4862265|NCT02262455|Advanced solid tumors|advanced solid tumors
4862266|NCT02262455|Adenocarcinoma|adenocarcinoma
4862267|NCT02262455|Prostate cancer|prostate cancer
4862268|NCT02262455|Head and Neck cancer|head and neck cancer
4862269|NCT02262455|Lung cancer|lung cancer
4862270|NCT02262455|Non-small cell lung cancer|non-small cell lung cancer
4862271|NCT02262455|Small cell lung cancer|small cell lung cancer
4862272|NCT02262455|Gastric cancer|gastric cancer
4862273|NCT02262455|Kidney cancer|kidney cancer
4862274|NCT02262455|Pancreatic cancer|pancreatic cancer
4862275|NCT02262455|Breast cancer|breast cancer
4862276|NCT02262455|Colorectal cancer|colorectal cancer
4862277|NCT02262455|Bladder cancer|bladder cancer
4862278|NCT02262455|Esophagus cancer|esophagus cancer
4862279|NCT02262455|Liver cancer|liver cancer
4862280|NCT02262455|Hepatobiliary cancer|hepatobiliary cancer
4862281|NCT02262455|Skin cancer|skin cancer
4862282|NCT02262442|flexible bronchoscopy|flexible bronchoscopy
4862283|NCT02262442|anaesthetics|anaesthetics
4862284|NCT02262442|transcutaneous pCO2|transcutaneous pco2
4862285|NCT02262442|capillary pCO2|capillary pco2
4862286|NCT02262442|special atomizing set|special atomizing set
4862287|NCT02262416|GnRH agonist|gnrh agonist
4862288|NCT02262416|IVF|ivf
4862289|NCT02262403|Hookworm|hookworm
4862290|NCT02262403|Helminths|helminths
4862292|NCT02262403|Immune regulation|immune regulation
4862293|NCT02262403|Vietnam|vietnam
4862294|NCT02262403|Allergic diseases|allergic diseases
4862295|NCT02262377|Group Medical Visits|group medical visits
4862296|NCT02262377|Integrative Medicine|integrative medicine
4862297|NCT02262377|Chronic Pain|chronic pain
4862298|NCT02262377|Depression|depression
4862299|NCT02262377|MBSR|mbsr
4862300|NCT02262377|Mindfulness Based Stress Reduction|mindfulness based stress reduction
4862301|NCT02262377|Web based|web based
4862302|NCT02262377|Virtual Patient Advocate|virtual patient advocate
4862303|NCT02262377|Internet Based|internet based
4862304|NCT02262351|Atrial Fibrillation|atrial fibrillation
4862305|NCT02262351|Screening|screening
4862306|NCT02262351|Family Practice|family practice
4862307|NCT02262351|Novel screening technologies|novel screening technologies
4862308|NCT02262338|MPS II|mps ii
4862309|NCT02262338|Hunter Syndrome|hunter syndrome
4862310|NCT02262325|Non-small cell|non-small cell
4862311|NCT02262325|Lung Cancer|lung cancer
4862312|NCT02262325|Chemoradiation|chemoradiation
4862313|NCT02262286|Brain Injury|brain injury
4862314|NCT02262273|women|women
4862315|NCT02262273|platinum sensitive|platinum sensitive
4862316|NCT02262273|recurrent|recurrent
4862317|NCT02262273|serous|serous
4862318|NCT02262273|ovarian cancer|ovarian cancer
4862319|NCT02262273|BRCA|brca
4862320|NCT02262273|PARP|parp
4862321|NCT02262273|Olaparib|olaparib
4862322|NCT02262260|Diabetic macular edema, DME, ranibizumab, wait and extend|diabetic macular edema, dme, ranibizumab, wait and extend
4862323|NCT02262247|Transoral|transoral
4862324|NCT02262247|Oropharynx|oropharynx
4862325|NCT02262247|Hypopharynx|hypopharynx
4862326|NCT02262247|Endoscopic|endoscopic
4862327|NCT02262247|TORS|tors
4862328|NCT02262247|Endoscopic Transoral|endoscopic transoral
4862329|NCT02262247|Larynx|larynx
4862330|NCT02262234|Spinal cord injury|spinal cord injury
4862331|NCT02262234|Chronic pain|chronic pain
4862332|NCT02262234|Education|education
4862333|NCT02262208|Glycemic variability, exercise, diabetes|glycemic variability, exercise, diabetes
4862334|NCT02262182|Atelectasis, Respiratory physiotherapy, end expiratory pressure, EzPAP®, cardiac surgery|atelectasis, respiratory physiotherapy, end expiratory pressure, ezpap®, cardiac surgery
4862335|NCT02262169|Non-Bleeding Peptic Ulcers, DLBS2411, Ulcer Healing|non-bleeding peptic ulcers, dlbs2411, ulcer healing
4862336|NCT02262156|Cognitive Behavioral Therapy|cognitive behavioral therapy
4862337|NCT02262156|Selective serotonin reuptake inhibitor|selective serotonin reuptake inhibitor
4862338|NCT02262156|depression|depression
4862339|NCT02262156|epilepsy|epilepsy
4862340|NCT02262130|Omalizumab|omalizumab
4862341|NCT02262130|Efficacy|efficacy
4862342|NCT02262130|Safety|safety
4862343|NCT02262117|IVF, pregnancy, immune endometrial profile, personalization of treatment|ivf, pregnancy, immune endometrial profile, personalization of treatment
4862344|NCT02262104|Exercise|exercise
4862345|NCT02262104|dementia|dementia
4862346|NCT02262104|nursing home|nursing home
4862347|NCT02262078|Preserved Ejection Fraction|preserved ejection fraction
4862348|NCT02262065|implant|implant
4862349|NCT02262065|allergy|allergy
4862350|NCT02262065|particle|particle
4862351|NCT02262065|cytokine|cytokine
4862352|NCT02262052|Deep vein thrombosis|deep vein thrombosis
4862353|NCT02262052|Diagnostic management|diagnostic management
4862354|NCT02262052|Recurrent|recurrent
4862355|NCT02262052|MRI|mri
4862356|NCT02262052|Ipsilateral|ipsilateral
4862357|NCT02262039|living|living
4862358|NCT02262039|kidney|kidney
4862359|NCT02262039|donors|donors
4862360|NCT02262013|Pediatric Obesity|pediatric obesity
4862361|NCT02262013|Lifestyle Intervention|lifestyle intervention
4862362|NCT02262013|Family-based Intervention|family-based intervention
4862363|NCT02262013|Motivational Interviewing|motivational interviewing
4862364|NCT02262000|Non Small Cell Lung Cancer|non small cell lung cancer
4862365|NCT02262000|Surgically inoperable|surgically inoperable
4862366|NCT02262000|Radiation Therapy|radiation therapy
4862367|NCT02261987|Autogenic drainage|autogenic drainage
4862368|NCT02261987|Resistive inspiratory manoeuvre|resistive inspiratory manoeuvre
4862369|NCT02261987|Computerized respiratory sounds|computerized respiratory sounds
4862370|NCT02261987|Airway clearance techniques|airway clearance techniques
4862371|NCT02261987|Mucus clearances|mucus clearances
4862372|NCT02261974|Vaginal laxity|vaginal laxity
4862373|NCT02261974|Sexual Function|sexual function
4862374|NCT02261961|resistance exercise|resistance exercise
4862375|NCT02261961|Juven|juven
4862376|NCT02261961|exercise training|exercise training
4862377|NCT02261961|interleukin-1|interleukin-1
4862378|NCT02261961|insulin-like growth factor|insulin-like growth factor
4862379|NCT02261948|Cardiac Failure|cardiac failure
4862380|NCT02261948|Severe Heart Failure|severe heart failure
4862381|NCT02261935|Family caregiver|family caregiver
4862382|NCT02261935|Home care nursing practice|home care nursing practice
4862383|NCT02261935|Palliative care|palliative care
4862384|NCT02261935|End of life care|end of life care
4862385|NCT02261935|Family caregiver quality of life|family caregiver quality of life
4862386|NCT02261935|Family caregiver grief symptoms|family caregiver grief symptoms
4862387|NCT02261935|Family caregiver burden|family caregiver burden
4862682|NCT02259699|Intravenous chemotherapy|intravenous chemotherapy
4862388|NCT02261935|Family caregiver preparedness for caregiving|family caregiver preparedness for caregiving
4862389|NCT02261935|Family caregiver perceived social supports|family caregiver perceived social supports
4862390|NCT02261935|Family caregiver health status|family caregiver health status
4862391|NCT02261935|Family caregiver satisfaction with healthcare provided|family caregiver satisfaction with healthcare provided
4862392|NCT02261909|Emergency Medicine|emergency medicine
4862393|NCT02261909|diagnosis|diagnosis
4862394|NCT02261896|cyst|cyst
4862395|NCT02261896|pancreatic cyst|pancreatic cyst
4862396|NCT02261896|EUS-FNA|eus-fna
4862397|NCT02261896|antibiotic prophylaxis|antibiotic prophylaxis
4862398|NCT02261883|PPHN|pphn
4862399|NCT02261870|MRI, T2 quantification|mri, t2 quantification
4862400|NCT02261857|Obstructive Sleep Apnea|obstructive sleep apnea
4862401|NCT02261857|Craniofacial Abnormalities|craniofacial abnormalities
4862402|NCT02261857|Pediatrics|pediatrics
4862403|NCT02261857|Computer-Aided Design|computer-aided design
4862404|NCT02261857|Continuous Positive Airway Pressure|continuous positive airway pressure
4862405|NCT02261857|Three-Dimensional Printing|three-dimensional printing
4862406|NCT02261857|Additive Manufacturing|additive manufacturing
4862407|NCT02261844|Hepatocellular carcinoma|hepatocellular carcinoma
4862408|NCT02261844|Metastatic colorectal cancer|metastatic colorectal cancer
4862409|NCT02261844|Metabolism|metabolism
4862410|NCT02261844|Hepatic function|hepatic function
4862411|NCT02261831|bacterial|bacterial
4862412|NCT02261831|gut|gut
4862413|NCT02261831|type 2 diabetes.|type 2 diabetes.
4862414|NCT02261831|16S rDNA gene|16s rdna gene
4862415|NCT02261831|intestinal crypt|intestinal crypt
4862416|NCT02261818|depression|depression
4862417|NCT02261818|aging|aging
4862418|NCT02261818|health services|health services
4862419|NCT02261792|Postural headache treatment|postural headache treatment
4862420|NCT02261792|Spontaneous intracranial hypotension|spontaneous intracranial hypotension
4862421|NCT02261792|Epidural blood patch|epidural blood patch
4862422|NCT02261792|Trendelenburg position|trendelenburg position
4862423|NCT02261792|Head-Down Tilt|head-down tilt
4862424|NCT02261792|Blood Patch, Epidural|blood patch, epidural
4862425|NCT02261753|epilepsy surgery, outcome, ketogenic diet, ortical dysplasia|epilepsy surgery, outcome, ketogenic diet, ortical dysplasia
4862426|NCT02261740|Pelvic Pain|pelvic pain
4862427|NCT02261740|Genital Pain|genital pain
4862428|NCT02261727|COPD|copd
4862429|NCT02261727|Theophylline|theophylline
4862430|NCT02261727|Oral corticosteroids|oral corticosteroids
4862431|NCT02261727|COPD exacerbations|copd exacerbations
4862432|NCT02261714|Pancreatic cancer, resected|pancreatic cancer, resected
4862433|NCT02261714|Vaccine|vaccine
4862434|NCT02261714|KRAS|kras
4862435|NCT02261701|shoulder surgery|shoulder surgery
4862436|NCT02261701|rotator cuff injury|rotator cuff injury
4862437|NCT02261701|rehabilitation|rehabilitation
4862438|NCT02261701|function|function
4862439|NCT02261701|pain|pain
4862440|NCT02261701|quality of life|quality of life
4862441|NCT02261675|dexmedetomidine|dexmedetomidine
4862442|NCT02261675|sevoflurane|sevoflurane
4862443|NCT02261675|MAC bar|mac bar
4862444|NCT02261675|drug interaction|drug interaction
4862445|NCT02261675|anesthesia|anesthesia
4862446|NCT02261649|Cerebellar tumor|cerebellar tumor
4862447|NCT02261649|Non-malignant low-grade cerebellar astrocytomas|non-malignant low-grade cerebellar astrocytomas
4862448|NCT02261610|PCT algorithm|pct algorithm
4862449|NCT02261610|Antibiotic|antibiotic
4862450|NCT02261610|Pulmonary embolism|pulmonary embolism
4862451|NCT02261597|insomnia, inflammation, stress|insomnia, inflammation, stress
4862452|NCT02261545|n-3 fatty acid|n-3 fatty acid
4862453|NCT02261545|Sirt-1|sirt-1
4862454|NCT02261545|AdipoR1|adipor1
4862455|NCT02261545|AdipoR2|adipor2
4862456|NCT02261545|MCP-1|mcp-1
4862457|NCT02261545|Adiponectin|adiponectin
4862458|NCT02261545|Resistin|resistin
4862459|NCT02261545|T2DM|t2dm
4862460|NCT02261506|Intensive care|intensive care
4862461|NCT02261506|bacteremia|bacteremia
4862462|NCT02261506|bloodstream infection|bloodstream infection
4862463|NCT02261506|antimicrobial|antimicrobial
4862464|NCT02261506|mortality|mortality
4862465|NCT02261506|antimicrobial stewardship|antimicrobial stewardship
4862466|NCT02261480|Parvovirus B19 Infection|parvovirus b19 infection
4862467|NCT02261454|postoperative ileus|postoperative ileus
4862468|NCT02261454|gum chewing|gum chewing
4862469|NCT02261454|postoperative care|postoperative care
4862470|NCT02261454|abdominal surgery|abdominal surgery
4862471|NCT02261454|child|child
4862472|NCT02261441|Cardiovascular disease|cardiovascular disease
4862473|NCT02261441|Hypertension|hypertension
4862474|NCT02261441|Diabetes|diabetes
4862475|NCT02261441|Smoking|smoking
4862476|NCT02261441|Hypercholesterolemia|hypercholesterolemia
4862477|NCT02261441|Cardiovascular risk factor|cardiovascular risk factor
4862478|NCT02261428|Nasotracheal suction, tracheal access|nasotracheal suction, tracheal access
4862479|NCT02261415|blood transfusion|blood transfusion
4862480|NCT02261415|blood loss|blood loss
4862481|NCT02261415|feasibility|feasibility
4862482|NCT02261415|outcome|outcome
4862483|NCT02261415|liver resection|liver resection
4862484|NCT02261402|Adherence|adherence
4862485|NCT02261402|Morisky Medication Adherence Scale|morisky medication adherence scale
4862486|NCT02261402|Beliefs about Medicines Questionnaire|beliefs about medicines questionnaire
4862487|NCT02261402|Medication Possession Ratio|medication possession ratio
4862488|NCT02261402|Medication-Related Problems|medication-related problems
4862489|NCT02261402|Pharmacist|pharmacist
4862490|NCT02261402|Pharmacist Intervention|pharmacist intervention
4862491|NCT02261402|Pharmacy|pharmacy
4862492|NCT02261402|Pharmacy Service|pharmacy service
4862493|NCT02261402|Pharmacy Practice|pharmacy practice
4862494|NCT02261402|Hypertension|hypertension
4862495|NCT02261402|Antihypertensive Agents|antihypertensive agents
4862496|NCT02261402|Anticoagulants|anticoagulants
4862497|NCT02261402|Statins|statins
4862498|NCT02261402|Dyslipidemia|dyslipidemia
4862499|NCT02261389|breast cancer|breast cancer
4862500|NCT02261389|follow-up|follow-up
4862501|NCT02261389|tumor markers|tumor markers
4862502|NCT02261376|pharmacokinetics|pharmacokinetics
4862503|NCT02261337|Sarcopenia|sarcopenia
4862504|NCT02261324|Percutaneous coronary intervention|percutaneous coronary intervention
4862505|NCT02261311|Breast|breast
4862506|NCT02261220|advanced solid tumors|advanced solid tumors
4862507|NCT02261220|durvalumab|durvalumab
4862508|NCT02261220|tremelimumab|tremelimumab
4862509|NCT02261194|depression|depression
4862510|NCT02261194|age-related macular degeneration|age-related macular degeneration
4862511|NCT02261194|self-care|self-care
4862512|NCT02261194|self-help|self-help
4862513|NCT02261181|head neck cancer XONRID radiation induced dermatitis|head neck cancer xonrid radiation induced dermatitis
4862514|NCT02261168|Circadian Rhythm|circadian rhythm
4862515|NCT02261051|Palliative Care|palliative care
4862516|NCT02261051|Hospice|hospice
4862517|NCT02261051|End of Life|end of life
4862518|NCT02261051|Health Service Utilization|health service utilization
4862519|NCT02261051|Quality of Life|quality of life
4862520|NCT02261038|total knee arthroplasty|total knee arthroplasty
4862521|NCT02261038|total knee prothesis|total knee prothesis
4862522|NCT02261038|X-Ray|x-ray
4862523|NCT02261038|Kanekasu radiographs|kanekasu radiographs
4862524|NCT02261038|femoral component rotation|femoral component rotation
4862525|NCT02261038|effects|effects
4862526|NCT02261025|aspirin|aspirin
4862527|NCT02260908|Trauma|trauma
4862528|NCT02260908|Thromboprophylaxis|thromboprophylaxis
4862529|NCT02260908|Intracranial haemorrhage|intracranial haemorrhage
4862530|NCT02260908|Deep vein thrombosis|deep vein thrombosis
4862531|NCT02260856|RCT|rct
4862532|NCT02260856|Epiphysiodesis|epiphysiodesis
4862533|NCT02260856|Tantalum beads|tantalum beads
4862534|NCT02260856|Patient centered outcome data|patient centered outcome data
4862535|NCT02260856|Cost effective analysis|cost effective analysis
4862536|NCT02260843|Insomnia|insomnia
4862537|NCT02260843|Sleeping|sleeping
4862538|NCT02260843|Quality|quality
4862539|NCT02260817|Prostate Cancer|prostate cancer
4862540|NCT02260817|11C Choline|11c choline
4862541|NCT02260817|PET Imaging|pet imaging
4862542|NCT02260791|Rheumatoid|rheumatoid
4862543|NCT02260791|Arthritis|arthritis
4862544|NCT02260778|Learning Collaborative|learning collaborative
4862545|NCT02260778|Treat-to-Target|treat-to-target
4862546|NCT02260778|Arthritis, Rheumatoid|arthritis, rheumatoid
4862547|NCT02260765|Treatment as Usual = TAU|treatment as usual = tau
4862548|NCT02260726|femoroacetabular impingement|femoroacetabular impingement
4862549|NCT02260726|morphometry|morphometry
4862550|NCT02260726|dynamic|dynamic
4862551|NCT02260726|magnetic resonance imaging|magnetic resonance imaging
4862552|NCT02260726|ultrasound|ultrasound
4862553|NCT02260726|screening|screening
4862554|NCT02260726|diagnosis|diagnosis
4862555|NCT02260700|Healthy|healthy
4862556|NCT02260700|Bioavailability|bioavailability
4862557|NCT02260700|Alzheimer's Disease|alzheimer's disease
4862558|NCT02260700|JNJ-54861911|jnj-54861911
4862559|NCT02260687|Aflibercept|aflibercept
4862560|NCT02260687|Anti-VEGF|anti-vegf
4862561|NCT02260674|Alzheimer's Disease|alzheimer's disease
4862562|NCT02260674|JNJ-54861911|jnj-54861911
4862563|NCT02260674|Placebo|placebo
4862564|NCT02260661|AZD8835|azd8835
4862565|NCT02260661|Fulvestrant|fulvestrant
4862566|NCT02260661|Breast Cancer|breast cancer
4862567|NCT02260661|PIK3CA Gene Mutation|pik3ca gene mutation
4862568|NCT02260622|Restenosis|restenosis
4862569|NCT02260622|Critical Limb Ischemia|critical limb ischemia
4862570|NCT02260622|Infrainguinal Percutaneous Transluminal Angioplasty|infrainguinal percutaneous transluminal angioplasty
4862571|NCT02260622|Rivaroxaban|rivaroxaban
4862572|NCT02260622|Clopidogrel|clopidogrel
4862573|NCT02260609|Complex Wound|complex wound
4862574|NCT02260609|Diabetic Foot Ulcer|diabetic foot ulcer
4862575|NCT02260609|DFU|dfu
4862576|NCT02260609|GrafixCORE|grafixcore
4862577|NCT02260609|Exposed tendon|exposed tendon
4862578|NCT02260609|Exposed bone|exposed bone
4862579|NCT02260609|Allograft tissue|allograft tissue
4862580|NCT02260570|concussion|concussion
4862581|NCT02260570|traumatic brain injury|traumatic brain injury
4862582|NCT02260570|MRI|mri
4862583|NCT02260570|memory|memory
4862584|NCT02260570|tolcapone|tolcapone
4862585|NCT02260557|Systemic Sclerosis|systemic sclerosis
4862586|NCT02260557|Raynaud's Phenomenon|raynaud's phenomenon
4862587|NCT02260531|Metastatic breast cancer and brain metastases|metastatic breast cancer and brain metastases
4862588|NCT02260531|HER-2 Positive Breast Cancer|her-2 positive breast cancer
4862589|NCT02260531|ER-Positive PR-Positive HER-2 Negative Breast Cancer|er-positive pr-positive her-2 negative breast cancer
4862590|NCT02260531|ER-Negative PR-Negative HER2-Negative Breast Cancer|er-negative pr-negative her2-negative breast cancer
4862591|NCT02260518|Gestational weight gain|gestational weight gain
4862592|NCT02260518|Lifestyle intervention|lifestyle intervention
4862593|NCT02260518|Pregnancy|pregnancy
4862594|NCT02260518|Postpartum|postpartum
4862595|NCT02260518|Physical activity|physical activity
4862596|NCT02260518|Nutrition|nutrition
4862597|NCT02260505|Gastrointestinal Stromal Tumors|gastrointestinal stromal tumors
4862598|NCT02260505|Non-metastatic|non-metastatic
4862599|NCT02260505|KIT +|kit +
4862600|NCT02260505|Imatinib|imatinib
4862601|NCT02260505|Adjuvant treatment|adjuvant treatment
4862602|NCT02260505|High risk of recurrence|high risk of recurrence
4862603|NCT02260505|Tyrosine kinase inhibitor|tyrosine kinase inhibitor
4862604|NCT02260505|Disease Free Survival|disease free survival
4862605|NCT02260505|Overall survival|overall survival
4862606|NCT02260505|Time To Secondary Resistance|time to secondary resistance
4862607|NCT02260505|Safety profile|safety profile
4862608|NCT02260505|Quality of Life during treatment|quality of life during treatment
4862609|NCT02260479|skin disinfection|skin disinfection
4862610|NCT02260479|bacterial colonization|bacterial colonization
4862611|NCT02260479|perioperative|perioperative
4862612|NCT02260479|chlorehexidine|chlorehexidine
4862613|NCT02260466|Amyloidosis|amyloidosis
4862614|NCT02260466|echocardiography|echocardiography
4862615|NCT02260466|magnetic resonance imaging|magnetic resonance imaging
4862616|NCT02260466|radionuclide imaging|radionuclide imaging
4862617|NCT02260427|elective surgery|elective surgery
4862618|NCT02260427|undergoing general anesthesia|undergoing general anesthesia
4862619|NCT02260427|elderly adult patients|elderly adult patients
4862620|NCT02260414|Endogenous Thrombin Potential|endogenous thrombin potential
4862621|NCT02260414|Lymphoma|lymphoma
4862622|NCT02260414|Multiple Myeloma|multiple myeloma
4862623|NCT02260414|tinzaparin|tinzaparin
4862624|NCT02260414|thrombin generation|thrombin generation
4862625|NCT02260414|Thromboplastin generation tests|thromboplastin generation tests
4862626|NCT02260388|CSPN|cspn
4862627|NCT02260388|neuropathy|neuropathy
4862628|NCT02260388|pain|pain
4862629|NCT02260388|pain management|pain management
4862630|NCT02260375|Mesenchymal stromal cells; liver transplantation; tolerance.|mesenchymal stromal cells; liver transplantation; tolerance.
4862631|NCT02260349|Prostatic Neoplasms|prostatic neoplasms
4862632|NCT02260349|Prostate cancer|prostate cancer
4862633|NCT02260349|surgical margins|surgical margins
4862634|NCT02260349|indocyanine green|indocyanine green
4862635|NCT02260349|characterization|characterization
4862636|NCT02260349|prostatectomy|prostatectomy
4862637|NCT02260349|peroperative|peroperative
4862638|NCT02260349|detection|detection
4862639|NCT02260297|Actigraphy|actigraphy
4862640|NCT02260297|overweight and obese adults|overweight and obese adults
4862641|NCT02260297|sleep disorders|sleep disorders
4862642|NCT02260258|Cardiac Arrest, NMB, Neuromuscular Blockade, Rocuronium|cardiac arrest, nmb, neuromuscular blockade, rocuronium
4862643|NCT02260219|Ahmed implant|ahmed implant
4862644|NCT02260219|Neovascular Glaucoma|neovascular glaucoma
4862645|NCT02260219|Intraocular pressure|intraocular pressure
4862646|NCT02260206|Pericardial Effusion|pericardial effusion
4862647|NCT02260206|Colchicine|colchicine
4862648|NCT02260206|arrhythmia Recurrence|arrhythmia recurrence
4862649|NCT02260206|pericardiocentesis|pericardiocentesis
4862650|NCT02260193|anemia|anemia
4862651|NCT02260193|end stage renal disease|end stage renal disease
4862652|NCT02260193|chronic kidney disease|chronic kidney disease
4862653|NCT02260193|CKD|ckd
4862654|NCT02260193|dialysis|dialysis
4862655|NCT02260193|chronic renal insufficiency|chronic renal insufficiency
4862656|NCT02260193|renal impairment|renal impairment
4862657|NCT02260193|erythropoietin|erythropoietin
4862658|NCT02260193|kidney|kidney
4862659|NCT02260193|oral anemia treatment|oral anemia treatment
4862660|NCT02260193|hemoglobin|hemoglobin
4862661|NCT02260193|hypoxia-inducible factor|hypoxia-inducible factor
4862662|NCT02260193|HIF|hif
4862663|NCT02260193|hypoxia-inducible factor propyl-hydroxylase inhibitor|hypoxia-inducible factor propyl-hydroxylase inhibitor
4862664|NCT02260193|HIF-PHI|hif-phi
4862665|NCT02260193|pharmacokinetics|pharmacokinetics
4862666|NCT02260154|Duspatalin|duspatalin
4862667|NCT02260154|mebeverine|mebeverine
4862668|NCT02260154|cholecystectomy|cholecystectomy
4862669|NCT02260154|gastrointestinal spasm|gastrointestinal spasm
4862670|NCT02260154|abdominal pain|abdominal pain
4862671|NCT02260154|dyspepsia|dyspepsia
4862672|NCT02260154|antispasmodics|antispasmodics
4862673|NCT02260128|postoperative ileus|postoperative ileus
4862674|NCT02260128|chewing gum|chewing gum
4862675|NCT02259712|Women|women
4862676|NCT02259712|Pelvic floor disorders|pelvic floor disorders
4862677|NCT02259712|Urinary incontinence|urinary incontinence
4862678|NCT02259712|Fecal incontinence|fecal incontinence
4862679|NCT02259712|Physical Therapy Modalities|physical therapy modalities
4862680|NCT02259699|Ovarian Cancer|ovarian cancer
4862681|NCT02259699|Intraperitoneal chemotherapy|intraperitoneal chemotherapy
4862784|NCT02259309|buccal|buccal
4862683|NCT02259699|decision making|decision making
4862684|NCT02259686|Apelin|apelin
4862685|NCT02259686|volunteers|volunteers
4862686|NCT02259660|obstructive sleep apnea|obstructive sleep apnea
4862687|NCT02259660|osa|osa
4862688|NCT02259660|breathing|breathing
4862689|NCT02259660|snoring|snoring
4862690|NCT02259660|respiratory|respiratory
4862691|NCT02259660|exercise|exercise
4862692|NCT02259660|inspiratory muscle strength training|inspiratory muscle strength training
4862693|NCT02259660|expiratory muscle strength training|expiratory muscle strength training
4862694|NCT02259634|Patient Navigation|patient navigation
4862695|NCT02259634|Motivational Interviewing|motivational interviewing
4862696|NCT02259634|Formerly Incarcerated|formerly incarcerated
4862697|NCT02259634|Health Education|health education
4862698|NCT02259634|Quality of Life|quality of life
4862699|NCT02259634|Healthcare Utilization|healthcare utilization
4862700|NCT02259608|Trained innate immunity|trained innate immunity
4862701|NCT02259608|Heterologous effects of BCG on immunity|heterologous effects of bcg on immunity
4862702|NCT02259595|Hearing Loss|hearing loss
4862703|NCT02259595|Sensorineural Hearing Loss|sensorineural hearing loss
4862704|NCT02259595|Noise-Induced Hearing Loss|noise-induced hearing loss
4862705|NCT02259595|Antioxidant|antioxidant
4862706|NCT02259595|NAC|nac
4862707|NCT02259595|N-acetylcysteine|n-acetylcysteine
4862708|NCT02259595|HPN-07|hpn-07
4862709|NCT02259582|Phase 2|phase 2
4862710|NCT02259582|histologically|histologically
4862711|NCT02259582|confirmed|confirmed
4862712|NCT02259582|malignancy|malignancy
4862713|NCT02259582|metastatic|metastatic
4862714|NCT02259582|pemetrexed|pemetrexed
4862715|NCT02259582|carboplatin|carboplatin
4862716|NCT02259582|carcinoma|carcinoma
4862717|NCT02259582|non small cell lung|non small cell lung
4862718|NCT02259582|lung neoplasms|lung neoplasms
4862719|NCT02259582|lung diseases|lung diseases
4862720|NCT02259569|Gastric insufflation|gastric insufflation
4862721|NCT02259569|I-gel|i-gel
4862722|NCT02259569|Peak airway pressure|peak airway pressure
4862723|NCT02259569|Pressure-controlled ventilation|pressure-controlled ventilation
4862724|NCT02259569|Volume-Controlled Ventilation|volume-controlled ventilation
4862725|NCT02259569|pediatric patient|pediatric patient
4862726|NCT02259543|gingival recession|gingival recession
4862727|NCT02259543|soft tissue|soft tissue
4862728|NCT02259543|root biomodification|root biomodification
4862729|NCT02259543|root coverage|root coverage
4862730|NCT02259543|citric acid|citric acid
4862731|NCT02259543|tetracycline|tetracycline
4862732|NCT02259517|ADHD|adhd
4862733|NCT02259517|Intuniv|intuniv
4862734|NCT02259517|Non-stimulant|non-stimulant
4862735|NCT02259517|Guanfacine extended-release|guanfacine extended-release
4862736|NCT02259517|Vyvanse|vyvanse
4862737|NCT02259517|Stimulant|stimulant
4862738|NCT02259517|Lisdexamfetamine|lisdexamfetamine
4862739|NCT02259504|aneurysms|aneurysms
4862740|NCT02259491|Wound Healing|wound healing
4862741|NCT02259491|Honey|honey
4862742|NCT02259491|Skin Grafts|skin grafts
4862743|NCT02259491|Free tissue transfer|free tissue transfer
4862744|NCT02259478|Intravenous Immunoglobulin (IVIG)|intravenous immunoglobulin (ivig)
4862745|NCT02259478|Hemolysis|hemolysis
4862746|NCT02259478|Transfusion Medicine|transfusion medicine
4862747|NCT02259478|Pharmacovigilance|pharmacovigilance
4862748|NCT02259465|microbiota|microbiota
4862749|NCT02259465|FODMAP|fodmap
4862750|NCT02259465|oligofructose|oligofructose
4862751|NCT02259465|Magnetic Resonance Imaging|magnetic resonance imaging
4862752|NCT02259465|Metabolomics|metabolomics
4862753|NCT02259465|Diet|diet
4862754|NCT02259452|Radiation Therapy|radiation therapy
4862755|NCT02259413|Hemodialysis|hemodialysis
4862756|NCT02259413|End-stage renal disease|end-stage renal disease
4862757|NCT02259413|Exercise|exercise
4862758|NCT02259413|Symptom Burden|symptom burden
4862759|NCT02259400|NIV|niv
4862760|NCT02259400|NSIPPV|nsippv
4862761|NCT02259400|BiPAP|bipap
4862762|NCT02259348|Hematological malignancies|hematological malignancies
4862763|NCT02259348|Allogeneic hematopoietic cell transplant|allogeneic hematopoietic cell transplant
4862764|NCT02259348|Refractory hematologic malignancy|refractory hematologic malignancy
4862765|NCT02259348|Relapsed hematologic malignancy|relapsed hematologic malignancy
4862766|NCT02259335|weaning from mechanical ventilation|weaning from mechanical ventilation
4862767|NCT02259335|extracorporeal CO2 removal|extracorporeal co2 removal
4862768|NCT02259335|post-extubation failure|post-extubation failure
4862769|NCT02259322|Bariatric surgery|bariatric surgery
4862770|NCT02259322|Weight loss surgery|weight loss surgery
4862771|NCT02259322|Behavioral weight loss treatment|behavioral weight loss treatment
4862772|NCT02259322|Cognitive behavioral therapy|cognitive behavioral therapy
4862773|NCT02259322|Behavioral treatment|behavioral treatment
4862774|NCT02259322|Obesity|obesity
4862775|NCT02259322|Morbid obesity|morbid obesity
4862776|NCT02259322|Binge eating|binge eating
4862777|NCT02259322|Binge eating disorder|binge eating disorder
4862778|NCT02259322|Loss of control eating|loss of control eating
4862779|NCT02259322|Overeating|overeating
4862780|NCT02259309|misoprostol|misoprostol
4862781|NCT02259309|mucosal|mucosal
4862782|NCT02259309|cervical|cervical
4862783|NCT02259309|immune|immune
4862785|NCT02259309|vaginal|vaginal
4862786|NCT02259283|achalasia|achalasia
4862787|NCT02259283|per oral endoscopic myotoymy|per oral endoscopic myotoymy
4862788|NCT02259283|endoscopy|endoscopy
4862789|NCT02259270|Acid suppressive therapy|acid suppressive therapy
4862790|NCT02259270|Appropriateness|appropriateness
4862791|NCT02259270|Long term treatment|long term treatment
4862792|NCT02259270|Risk factors|risk factors
4862793|NCT02259270|Hospitalisation|hospitalisation
4862794|NCT02259270|Non-critically ill|non-critically ill
4862795|NCT02259270|Adult|adult
4862796|NCT02259257|carotid arteriosclerosis|carotid arteriosclerosis
4862797|NCT02259257|contrast-enhanced ultrasound|contrast-enhanced ultrasound
4862798|NCT02259257|neovascularization|neovascularization
4862799|NCT02259257|quantitative analysis|quantitative analysis
4862800|NCT02259257|3D/4D imaging|3d/4d imaging
4862801|NCT02259257|CEUS|ceus
4862802|NCT02259257|Vasa vasorum|vasa vasorum
4862803|NCT02259231|RTA 408|rta 408
4862804|NCT02259231|RTA 408 Capsules|rta 408 capsules
4862931|NCT02258737|Case management|case management
4862805|NCT02259231|Myeloid-derived suppressor cells (MDSDs)|myeloid-derived suppressor cells (mdsds)
4862806|NCT02259231|iNOS|inos
4862807|NCT02259231|Melanoma|melanoma
4862808|NCT02259231|Checkpoint inhibitor|checkpoint inhibitor
4862809|NCT02259231|omaveloxolone|omaveloxolone
4862810|NCT02259218|Biomarker|biomarker
4862811|NCT02259218|Radiation|radiation
4862812|NCT02259205|platelet activating factor|platelet activating factor
4862813|NCT02259205|inflammatory markers|inflammatory markers
4862814|NCT02259205|yogurt|yogurt
4862815|NCT02259205|olive oil|olive oil
4862816|NCT02259205|platelet aggregation|platelet aggregation
4862817|NCT02259205|oxidative stress|oxidative stress
4862818|NCT02259205|endothelial damage|endothelial damage
4862819|NCT02259205|bioactive lipids|bioactive lipids
4862820|NCT02259192|deaf adult|deaf adult
4862821|NCT02259192|single-sided|single-sided
4862822|NCT02259192|cochlear implant|cochlear implant
4862823|NCT02259179|Obesity|obesity
4862824|NCT02259179|Overweight|overweight
4862825|NCT02259179|Contrave|contrave
4862826|NCT02259179|Antiobesity agents|antiobesity agents
4862827|NCT02259179|Antiobesity drugs|antiobesity drugs
4862828|NCT02259179|Weight loss drug|weight loss drug
4862829|NCT02259179|Bioequivalence|bioequivalence
4862830|NCT02259179|Pharmacokinetic|pharmacokinetic
4862831|NCT02259153|Lipids|lipids
4862832|NCT02259153|Non Cholesterol Sterols|non cholesterol sterols
4862833|NCT02259153|Oxysterols|oxysterols
4862834|NCT02259153|Cholesterol Metabolism|cholesterol metabolism
4862835|NCT02259140|cerebral palsy|cerebral palsy
4862836|NCT02259140|randomized controlled trial|randomized controlled trial
4862837|NCT02259140|hip dislocation|hip dislocation
4862838|NCT02259140|hip subluxation|hip subluxation
4862839|NCT02259140|patient centered outcomes|patient centered outcomes
4862840|NCT02259140|cost effectiveness analysis|cost effectiveness analysis
4862841|NCT02259088|DME, macular edema, vision impairment, Chinese, diabetes|dme, macular edema, vision impairment, chinese, diabetes
4862842|NCT02259075|Migraine with aura|migraine with aura
4862843|NCT02259075|Migraine without aura|migraine without aura
4862844|NCT02259075|Headache disorders|headache disorders
4862845|NCT02259075|Botulinum Toxin Type A|botulinum toxin type a
4862846|NCT02259075|Sphenopalatine Ganglion Block|sphenopalatine ganglion block
4862847|NCT02259075|Autonomic Nerve Block|autonomic nerve block
4862848|NCT02259036|child anxiety|child anxiety
4862849|NCT02259036|worries|worries
4862850|NCT02259036|fears|fears
4862851|NCT02259036|talk therapy|talk therapy
4862852|NCT02259023|Stress Perception|stress perception
4862853|NCT02259023|Discretionary Calories|discretionary calories
4862854|NCT02259023|Health|health
4862855|NCT02258997|sickle cell disease|sickle cell disease
4862856|NCT02258958|venous thromboembolism prophylaxis|venous thromboembolism prophylaxis
4862857|NCT02258958|deep venous thrombosis|deep venous thrombosis
4862858|NCT02258958|pulmonary embolus|pulmonary embolus
4862859|NCT02258958|thoracic surgery|thoracic surgery
4862860|NCT02258958|lung resection|lung resection
4862861|NCT02258958|incidence|incidence
4862862|NCT02258945|Type 1 diabetes|type 1 diabetes
4862863|NCT02258945|CSII|csii
4862864|NCT02258945|Continuous subcutaneous insulin infusion|continuous subcutaneous insulin infusion
4862865|NCT02258945|Insulin pump|insulin pump
4862866|NCT02258945|Nutrition|nutrition
4862867|NCT02258945|Eating behaviours|eating behaviours
4862868|NCT02258945|Quality of life|quality of life
4862869|NCT02258945|Cardiometabolic risks|cardiometabolic risks
4862870|NCT02258945|Liverpool|liverpool
4862872|NCT02258945|Metabolomics|metabolomics
4862873|NCT02258945|Observational|observational
4862874|NCT02258945|Lipoproteins|lipoproteins
4862875|NCT02258945|Lipids|lipids
4862876|NCT02258945|Food|food
4862877|NCT02258945|Food diary|food diary
4862878|NCT02258945|Cross-Sectional|cross-sectional
4862879|NCT02258932|Type 1 diabetes|type 1 diabetes
4862880|NCT02258932|CSII|csii
4862881|NCT02258932|Continuous subcutaneous insulin infusion|continuous subcutaneous insulin infusion
4862882|NCT02258932|Insulin pump|insulin pump
4862883|NCT02258932|Nutrition|nutrition
4862884|NCT02258932|Eating behaviours|eating behaviours
4862885|NCT02258932|Quality of life|quality of life
4862886|NCT02258932|Cardiometabolic risks|cardiometabolic risks
4862887|NCT02258932|Liverpool|liverpool
4862888|NCT02258932|NHS|nhs
4862889|NCT02258932|Metabolomics|metabolomics
4862890|NCT02258932|Observational|observational
4862891|NCT02258932|Lipoproteins|lipoproteins
4862892|NCT02258932|Lipids|lipids
4862893|NCT02258932|Food|food
4862894|NCT02258932|Food diary|food diary
4862895|NCT02258932|Longitudinal|longitudinal
4862896|NCT02258919|Intracerebral hemorrhage|intracerebral hemorrhage
4862897|NCT02258919|Decompressive craniectomy|decompressive craniectomy
4862898|NCT02258919|Randomized controlled trial|randomized controlled trial
4862899|NCT02258919|Acute stroke|acute stroke
4862900|NCT02258893|Nitrogen Dioxide|nitrogen dioxide
4862901|NCT02258893|Parts per billion|parts per billion
4862902|NCT02258880|Acute Stroke|acute stroke
4862903|NCT02258880|Outcome Measures|outcome measures
4862904|NCT02258880|Physical Performance|physical performance
4862905|NCT02258867|Uveitis|uveitis
4862906|NCT02258867|Behcet's Disease Uveitis|behcet's disease uveitis
4862907|NCT02258867|Behcet's Disease|behcet's disease
4862908|NCT02258854|Uveitis|uveitis
4862909|NCT02258854|Non-infectious Uveitis|non-infectious uveitis
4862910|NCT02258854|Intermediate Uveitis|intermediate uveitis
4862911|NCT02258854|Posterior Uveitis|posterior uveitis
4862912|NCT02258854|Panuveitis|panuveitis
4862913|NCT02258854|Behçet's disease uveitis|behçet's disease uveitis
4862914|NCT02258841|domestic violence|domestic violence
4862915|NCT02258841|mental health|mental health
4862916|NCT02258841|safety planning|safety planning
4862917|NCT02258815|pediatric|pediatric
4862918|NCT02258815|haploidentical|haploidentical
4862919|NCT02258815|stem cell transplantation|stem cell transplantation
4862920|NCT02258802|psychoeducational intervention|psychoeducational intervention
4862921|NCT02258802|nutrition intervention|nutrition intervention
4862922|NCT02258802|malnutrition|malnutrition
4862923|NCT02258802|micronutrient deficiency|micronutrient deficiency
4862924|NCT02258802|nutrition transition|nutrition transition
4862925|NCT02258789|Stroke, rehabilitation, spatial neglect|stroke, rehabilitation, spatial neglect
4862926|NCT02258763|Pneumonia|pneumonia
4862927|NCT02258763|Child|child
4862928|NCT02258763|Outcome|outcome
4862929|NCT02258763|Antibiotics|antibiotics
4862930|NCT02258763|Etiology|etiology
4862932|NCT02258737|psychiatric hospitalization|psychiatric hospitalization
4862933|NCT02258737|discharge|discharge
4862934|NCT02258724|Adult|adult
4862935|NCT02258724|Registry|registry
4862936|NCT02258724|Grown-up congenital heart disease|grown-up congenital heart disease
4862937|NCT02258711|Bipolar disorder|bipolar disorder
4862938|NCT02258711|Psychoeducation|psychoeducation
4862939|NCT02258711|Smart-phone monitoring|smart-phone monitoring
4862940|NCT02258685|Gut microbiota composition|gut microbiota composition
4862941|NCT02258672|Preoperative rehabilitation|preoperative rehabilitation
4862942|NCT02258672|Minimally invasive surgery|minimally invasive surgery
4862943|NCT02258672|Functional capacity|functional capacity
4862944|NCT02258646|Exercise|exercise
4862945|NCT02258646|Rehabilitation|rehabilitation
4862946|NCT02258646|Telemedicine|telemedicine
4862947|NCT02258646|Treatment Outcome|treatment outcome
4862948|NCT02258646|Costs and Cost Analysis|costs and cost analysis
4862949|NCT02258646|Physical Therapists|physical therapists
4862950|NCT02258646|Adaptation, Psychological|adaptation, psychological
4862951|NCT02258568|Cigarette Smoking|cigarette smoking
4862952|NCT02258568|Pregnancy|pregnancy
4862953|NCT02258568|Postpartum smoking relapse|postpartum smoking relapse
4862954|NCT02258568|Romania|romania
4862955|NCT02258555|Chronic lymphocytic leukemia (CLL)|chronic lymphocytic leukemia (cll)
4862956|NCT02258555|Follicular lymphoma (FL)|follicular lymphoma (fl)
4862957|NCT02258555|Small Lymphocytic Lymphoma (SLL)|small lymphocytic lymphoma (sll)
4862958|NCT02258555|Phosphatidylinositol 3 kinase (PI3K)|phosphatidylinositol 3 kinase (pi3k)
4862959|NCT02258555|Marginal Zone Lymphoma (MZL)|marginal zone lymphoma (mzl)
4862960|NCT02258542|Asthma, Bronchial Diseases, Respiratory Tract Diseases, Lung Diseases, Obstructive Lung Diseases|asthma, bronchial diseases, respiratory tract diseases, lung diseases, obstructive lung diseases
4862961|NCT02258529|Cancer|cancer
4862962|NCT02258529|Indolent Non-Hodgkin Lymphoma|indolent non-hodgkin lymphoma
4862963|NCT02258529|FL|fl
4862964|NCT02258529|SLL|sll
4862965|NCT02258503|Numerical scale|numerical scale
4862966|NCT02258503|Pain in elderly patients admitted in emergency department|pain in elderly patients admitted in emergency department
4862967|NCT02258490|chronic myeloid leukemia|chronic myeloid leukemia
4862968|NCT02258490|myelodysplastic syndrome|myelodysplastic syndrome
4862969|NCT02258490|acute myeloid leukemia|acute myeloid leukemia
4862970|NCT02258490|CD34+ cell mobilization therapy|cd34+ cell mobilization therapy
4862971|NCT02258490|graft versus host disease|graft versus host disease
4862972|NCT02258490|allogeneic hematopoietic stem cell|allogeneic hematopoietic stem cell
4862973|NCT02258490|G-CSF|g-csf
4862974|NCT02258464|Breast Cancer|breast cancer
4862975|NCT02258451|Breast Cancer|breast cancer
4862976|NCT02258438|Sedentary Behavior|sedentary behavior
4862977|NCT02258425|Homeless Women|homeless women
4862978|NCT02258425|Parolees|parolees
4862979|NCT02258425|Probationers|probationers
4862980|NCT02258425|Community Drug Treatment|community drug treatment
4862981|NCT02258425|Recidivism|recidivism
4862982|NCT02258412|antimicrobial|antimicrobial
4862983|NCT02258412|efficacy|efficacy
4862984|NCT02258412|hand|hand
4862985|NCT02258412|hygiene|hygiene
4862986|NCT02258412|bacteria|bacteria
4862987|NCT02258373|Diabetes Mellitus|diabetes mellitus
4862988|NCT02258373|Continuous Glucose Monitoring|continuous glucose monitoring
4862989|NCT02258360|Thromboelastometry|thromboelastometry
4862990|NCT02258360|Haemostasis|haemostasis
4862991|NCT02258360|Hypothermia|hypothermia
4862992|NCT02258360|Heart Arrest|heart arrest
4862993|NCT02258334|Influenza|influenza
4862994|NCT02258334|Fluzone® Quadrivalent, Influenza Vaccine|fluzone® quadrivalent, influenza vaccine
4862995|NCT02258334|Fluzone® Intradermal, Influenza Vaccine|fluzone® intradermal, influenza vaccine
4862996|NCT02258334|Fluzone® High-Dose, Influenza Vaccine|fluzone® high-dose, influenza vaccine
4862997|NCT02258295|Lateral Humeral Epicondylitis|lateral humeral epicondylitis
4862998|NCT02258295|Tendinitis|tendinitis
4862999|NCT02258295|Tendinosis|tendinosis
4863000|NCT02258295|Athletic Injuries|athletic injuries
4863001|NCT02258295|Elbow Joint|elbow joint
4863002|NCT02258295|Sports Medicine|sports medicine
4863003|NCT02258204|Cerebral Infarct|cerebral infarct
4863004|NCT02258204|Thrombolysis|thrombolysis
4863005|NCT02258204|Tissue-type plasminogen activator|tissue-type plasminogen activator
4863006|NCT02258204|Neuroprotection|neuroprotection
4863007|NCT02258204|Anesthetic agent|anesthetic agent
4863008|NCT02258204|Magnetic resonance imaging|magnetic resonance imaging
4863009|NCT02258191|NIV|niv
4863010|NCT02258191|COPD|copd
4863011|NCT02258191|telemonitoring|telemonitoring
4863012|NCT02258165|ovarian cancer|ovarian cancer
4863013|NCT02258165|imaging|imaging
4863014|NCT02258165|gated PET/CT scan|gated pet/ct scan
4863015|NCT02258152|PDD|pdd
4863016|NCT02258152|Parkinson's Disease Dementia|parkinson's disease dementia
4863017|NCT02258152|patients taking a cholinesterase inhibitor.|patients taking a cholinesterase inhibitor.
4863018|NCT02258126|overweight children|overweight children
4863019|NCT02258126|hepatic fat|hepatic fat
4863020|NCT02258126|exercise|exercise
4863021|NCT02258126|nutritional education program|nutritional education program
4863022|NCT02258126|cardiometabolic risk|cardiometabolic risk
4863023|NCT02258087|Prostate, Cancer, Brachytherapy, HDR, LDR, monotherapy|prostate, cancer, brachytherapy, hdr, ldr, monotherapy
4863024|NCT02258048|Cirrhosis|cirrhosis
4863025|NCT02258035|vitamin D binding protein (DBP)|vitamin d binding protein (dbp)
4863026|NCT02258022|Wounds and Injuries|wounds and injuries
4863027|NCT02258022|Sepsis|sepsis
4863028|NCT02257996|Psychoanalytic Psychotherapy|psychoanalytic psychotherapy
4863029|NCT02257996|Telepsychology|telepsychology
4863030|NCT02257996|Online Therapy|online therapy
4863031|NCT02257996|Web conferencing|web conferencing
4863032|NCT02257996|RCT|rct
4863033|NCT02257996|HIPAA|hipaa
4863034|NCT02257983|hearing|hearing
4863035|NCT02257983|noise|noise
4863036|NCT02257983|oxidative stress|oxidative stress
4863037|NCT02257970|Lymphedema|lymphedema
4863038|NCT02257970|edema|edema
4863039|NCT02257970|swelling|swelling
4863040|NCT02257931|infection|infection
4863041|NCT02257931|bacteria|bacteria
4863042|NCT02257931|gram-negative|gram-negative
4863043|NCT02257931|HSCT|hsct
4863044|NCT02257931|allogeneic|allogeneic
4863045|NCT02257931|autologous|autologous
4863046|NCT02257931|recipients, of all ages, for any indications|recipients, of all ages, for any indications
4863047|NCT02257918|antibiotic|antibiotic
4863048|NCT02257918|antimicrobial|antimicrobial
4863049|NCT02257918|AZD0914|azd0914
4863050|NCT02257918|Ceftriaxone|ceftriaxone
4863051|NCT02257918|drug-resistant|drug-resistant
4863052|NCT02257918|sexually transmitted infection|sexually transmitted infection
4863053|NCT02257918|urogenital gonorrhoea|urogenital gonorrhoea
4863054|NCT02257905|AL Amyloidosis|al amyloidosis
4863055|NCT02257905|Amyloidosis|amyloidosis
4863056|NCT02257905|allogeneic|allogeneic
4863057|NCT02257905|HSCT|hsct
4863058|NCT02257892|CTLA4|ctla4
4863059|NCT02257892|PI3KCD|pi3kcd
4863060|NCT02257892|MAG T1|mag t1
4863061|NCT02257892|Rare Immune Disorders|rare immune disorders
4863062|NCT02257892|Genetic Testing|genetic testing
4863063|NCT02257879|Midazolam|midazolam
4863064|NCT02257879|CYP3A|cyp3a
4863065|NCT02257879|Loperamide|loperamide
4863066|NCT02257866|Autoimmunity|autoimmunity
4863067|NCT02257866|Adult and Pediatric Disease|adult and pediatric disease
4863068|NCT02257866|Vasculitis|vasculitis
4863069|NCT02257866|Rheumatic Disease|rheumatic disease
4863070|NCT02257853|Caregiver Stress|caregiver stress
4863071|NCT02257853|Cancer Caregivers|cancer caregivers
4863072|NCT02257853|Yoga-Based Stress Reduction Intervention|yoga-based stress reduction intervention
4863073|NCT02257853|HSCT Caregivers|hsct caregivers
4863074|NCT02257827|Hypofractionated schedule|hypofractionated schedule
4863075|NCT02257827|Intensity Modulated Radiotherapy|intensity modulated radiotherapy
4863076|NCT02257827|Conformal radiotherapy|conformal radiotherapy
4863077|NCT02257801|Memory|memory
4863078|NCT02257801|Cognition|cognition
4863079|NCT02257801|Execute Function|execute function
4863080|NCT02257801|Attention|attention
4863081|NCT02257801|Mood|mood
4863082|NCT02257762|Ready-to-use supplementary food (RUSF)|ready-to-use supplementary food (rusf)
4863083|NCT02257762|Lipid-based nutrient supplement (LNS)|lipid-based nutrient supplement (lns)
4863084|NCT02257762|Multiple micronutrients (MMN)|multiple micronutrients (mmn)
4863085|NCT02257762|Complementary feeding|complementary feeding
4863086|NCT02257762|Home fortification|home fortification
4863087|NCT02257762|Efficacy/impact|efficacy/impact
4863088|NCT02257762|Infant and young child feeding (IYCF)|infant and young child feeding (iycf)
4863089|NCT02257762|Cambodia|cambodia
4863090|NCT02257762|Cluster randomised controlled trial|cluster randomised controlled trial
4863091|NCT02257749|Concussion|concussion
4863092|NCT02257749|Persistent Symptoms|persistent symptoms
4863093|NCT02257749|Children|children
4863094|NCT02257749|Exercise|exercise
4863095|NCT02257749|Adolescents|adolescents
4863096|NCT02257749|Active Rehabilitation|active rehabilitation
4863097|NCT02257749|Education|education
4863098|NCT02257736|Prostatic neoplasms|prostatic neoplasms
4863099|NCT02257736|JN56021927|jn56021927
4863100|NCT02257736|ZYTIGA|zytiga
4863101|NCT02257736|Prednisone|prednisone
4863102|NCT02257736|Abiraterone acetate|abiraterone acetate
4863103|NCT02257736|Apalutamide|apalutamide
4863104|NCT02257723|Inpatient care|inpatient care
4863105|NCT02257723|Complementary and alternative medicine|complementary and alternative medicine
4863106|NCT02257723|Integrated medicine|integrated medicine
4863107|NCT02257710|national|national
4863108|NCT02257710|Multicenter|multicenter
4863109|NCT02257710|Observational registry|observational registry
4863110|NCT02257710|Orsiro Drug Eluting Stent (DES)|orsiro drug eluting stent (des)
4863111|NCT02257710|Stenting|stenting
4863112|NCT02257710|Treatment of coronary artery disease|treatment of coronary artery disease
4863113|NCT02257710|Coronary revascularization|coronary revascularization
4863114|NCT02257710|Coronary Intervention|coronary intervention
4863115|NCT02257710|STEMI|stemi
4863116|NCT02257710|NSTEMI|nstemi
4863117|NCT02257710|Ischemia|ischemia
4863118|NCT02257710|Angina|angina
4863119|NCT02257710|Acute Myocardial Infarction (AMI)|acute myocardial infarction (ami)
4863120|NCT02257710|Small Vessels|small vessels
4863121|NCT02257710|Chronic Total Occlusion|chronic total occlusion
4863122|NCT02257684|ALL|all
4863123|NCT02257684|LBL|lbl
4863124|NCT02257658|Men who have Sex with Men|men who have sex with men
4863125|NCT02257658|HIV-positive|hiv-positive
4863126|NCT02257658|Syphilis|syphilis
4863127|NCT02257658|Contingency Management|contingency management
4863128|NCT02257619|Stage IIIb, IV, or Recurrent Non-Small Cell Lung Cancer|stage iiib, iv, or recurrent non-small cell lung cancer
4863129|NCT02257593|macronutrient|macronutrient
4863130|NCT02257593|malnutrition|malnutrition
4863131|NCT02257593|birth weight|birth weight
4863132|NCT02257593|protein leverage|protein leverage
4863133|NCT02257580|E-Aminocaproic Acid|e-aminocaproic acid
4863134|NCT02257580|Bilateral Varus Rotational Osteotomy|bilateral varus rotational osteotomy
4863135|NCT02257580|Blood Loss and Transfusion|blood loss and transfusion
4863136|NCT02257580|Complications|complications
4863137|NCT02257580|Safety|safety
4863138|NCT02257554|expectations|expectations
4863139|NCT02257541|BGJ398|bgj398
4863140|NCT02257541|Imatinib Mesylate|imatinib mesylate
4863141|NCT02257541|14-140|14-140
4863142|NCT02257502|aflibercept|aflibercept
4863143|NCT02257502|iodiopathic choroidal neovascularization|iodiopathic choroidal neovascularization
4863144|NCT02257502|young patient|young patient
4863145|NCT02257476|carfilzomib|carfilzomib
4863146|NCT02257476|advanced solid malignancies|advanced solid malignancies
4863147|NCT02257476|advanced solid cancers|advanced solid cancers
4863148|NCT02257476|prostate|prostate
4863149|NCT02257476|bladder|bladder
4863150|NCT02257476|colon|colon
4863151|NCT02257476|breast|breast
4863152|NCT02257476|lung|lung
4863153|NCT02257463|COPD|copd
4863154|NCT02257463|inspiratory muscle training|inspiratory muscle training
4863155|NCT02257463|dyspnea|dyspnea
4863156|NCT02257463|Quality of Life|quality of life
4863157|NCT02257450|Primary Aldosteronism|primary aldosteronism
4863158|NCT02257450|Hyperaldosteronism|hyperaldosteronism
4863159|NCT02257437|Ready-to-use supplementary food (RUSF)|ready-to-use supplementary food (rusf)
4863160|NCT02257437|Lipid-based nutrient supplement (LNS)|lipid-based nutrient supplement (lns)
4863161|NCT02257437|Multiple micronutrients (MMN)|multiple micronutrients (mmn)
4863162|NCT02257437|Complementary feeding|complementary feeding
4863163|NCT02257437|Home fortification|home fortification
4863164|NCT02257437|Acceptability|acceptability
4863165|NCT02257437|Infant and young child feeding (IYCF)|infant and young child feeding (iycf)
4863166|NCT02257437|Cambodia|cambodia
4863167|NCT02257437|Cross-over studies|cross-over studies
4863168|NCT02257411|child|child
4863169|NCT02257411|ear based|ear based
4863170|NCT02257411|Proseal LMA|proseal lma
4863171|NCT02257398|TQTc|tqtc
4863172|NCT02257398|Moxifloxacin|moxifloxacin
4863173|NCT02257398|GSK2140944|gsk2140944
4863174|NCT02257385|indacaterol|indacaterol
4863175|NCT02257385|efficacy|efficacy
4863176|NCT02257385|FEV1|fev1
4863177|NCT02257385|ELLIPTA|ellipta
4863178|NCT02257385|non inferiority|non inferiority
4863179|NCT02257385|vilanterol|vilanterol
4863180|NCT02257385|COPD|copd
4863181|NCT02257385|safety|safety
4863182|NCT02257385|tiotropium|tiotropium
4863183|NCT02257385|umeclidinium bromide|umeclidinium bromide
4863184|NCT02257385|GSK573719|gsk573719
4863185|NCT02257372|FEV1|fev1
4863186|NCT02257372|DPI|dpi
4863187|NCT02257372|ICS/LABA|ics/laba
4863188|NCT02257372|UMEC|umec
4863189|NCT02257372|COPD|copd
4863190|NCT02257359|Epelsiban|epelsiban
4863191|NCT02257359|Healthy Female Volunteers|healthy female volunteers
4863192|NCT02257359|Safety|safety
4863193|NCT02257359|Tolerability|tolerability
4863194|NCT02257359|Oxytocin|oxytocin
4863195|NCT02257359|Pharmacokinetics|pharmacokinetics
4863196|NCT02257346|Pregnancy|pregnancy
4863197|NCT02257346|Lidocaine|lidocaine
4863198|NCT02257346|Quality|quality
4863199|NCT02257346|Recovery|recovery
4863200|NCT02257333|Retinal Vein Occlusion|retinal vein occlusion
4863201|NCT02257333|Atherosclerosis|atherosclerosis
4863202|NCT02257333|Risk Factors|risk factors
4863203|NCT02257333|Major Adverse Cardiovascular Events|major adverse cardiovascular events
4863204|NCT02257307|ROP|rop
4863205|NCT02257307|retinopathy|retinopathy
4863206|NCT02257307|Referral warranted retinopathy|referral warranted retinopathy
4863207|NCT02257281|Sodium lauryl sulfate|sodium lauryl sulfate
4863208|NCT02257281|Skin irritants|skin irritants
4863209|NCT02257281|inflammation|inflammation
4863210|NCT02257281|therapeutic ultrasound|therapeutic ultrasound
4863211|NCT02257268|health behavior; risk factors;|health behavior; risk factors;
4863212|NCT02257255|cesarean section|cesarean section
4863213|NCT02257255|pain, postoperative/diagnosis|pain, postoperative/diagnosis
4863214|NCT02257255|pain measurement/methods|pain measurement/methods
4863215|NCT02257242|Bendamustine|bendamustine
4863216|NCT02257242|Rituximab|rituximab
4863217|NCT02257242|Vincristine sulfate|vincristine sulfate
4863218|NCT02257242|Vincristine sulfate liposome injection|vincristine sulfate liposome injection
4863219|NCT02257242|Phase I|phase i
4863220|NCT02257242|Escalation With Overdose Control|escalation with overdose control
4863221|NCT02257229|Feet, deformity, correction, management, gait|feet, deformity, correction, management, gait
4863222|NCT02257203|Dietary sucrose|dietary sucrose
4863223|NCT02257190|Glycemic control|glycemic control
4863224|NCT02257190|Exercise|exercise
4863225|NCT02257164|anterior cruciate ligament reconstruction|anterior cruciate ligament reconstruction
4863226|NCT02257164|femoral nerve block|femoral nerve block
4863227|NCT02257164|articular injection and obturator nerve block|articular injection and obturator nerve block
4863228|NCT02257151|Volunteers|volunteers
4863229|NCT02257138|Leukemia|leukemia
4863230|NCT02257138|Myeloproliferative Diseases|myeloproliferative diseases
4863231|NCT02257138|Acute Myeloid Leukemia|acute myeloid leukemia
4863232|NCT02257138|AML|aml
4863233|NCT02257138|Ruxolitinib|ruxolitinib
4863234|NCT02257138|Jakafi|jakafi
4863235|NCT02257138|INCB018424|incb018424
4863236|NCT02257138|INC424|inc424
4863237|NCT02257138|Decitabine|decitabine
4863238|NCT02257138|Dacogen|dacogen
4863239|NCT02257138|Post myeloproliferative neoplasm|post myeloproliferative neoplasm
4863240|NCT02257138|Post MPN-AML|post mpn-aml
4863241|NCT02257125|rehabilitation|rehabilitation
4863242|NCT02257125|virtual reality|virtual reality
4863243|NCT02257125|stroke|stroke
4863244|NCT02257125|upper extremity|upper extremity
4863245|NCT02257125|arm|arm
4863246|NCT02257125|feedback|feedback
4863247|NCT02257125|reward|reward
4863248|NCT02257060|Endocardial Ablation|endocardial ablation
4863249|NCT02257060|Atrial Flutter|atrial flutter
4863250|NCT02257060|Cavotricuspid Isthmus|cavotricuspid isthmus
4863251|NCT02256995|Pregnancy|pregnancy
4863252|NCT02256995|Preeclampsia|preeclampsia
4863253|NCT02256995|Eclampsia|eclampsia
4863254|NCT02256995|Proteinuria|proteinuria
4863255|NCT02256982|unresectable intrahepatic cholangiocarcinoma|unresectable intrahepatic cholangiocarcinoma
4863256|NCT02256982|resectable intrahepatic cholangiocarcinoma|resectable intrahepatic cholangiocarcinoma
4863257|NCT02256956|Pharmacogenetics of Amitriptyline|pharmacogenetics of amitriptyline
4863258|NCT02256943|Pharmacogenetics of Amitriptyline|pharmacogenetics of amitriptyline
4863259|NCT02256904|Alignment|alignment
4863260|NCT02256904|Kinematic|kinematic
4863261|NCT02256904|knee|knee
4863262|NCT02256904|satisfaction|satisfaction
4863263|NCT02256904|function|function
4863264|NCT02256904|survivorship|survivorship
4863265|NCT02256891|Rotator cuff tear|rotator cuff tear
4863266|NCT02256891|Rotator cuff injury|rotator cuff injury
4863267|NCT02256891|Shoulder pain|shoulder pain
4863268|NCT02256891|Shoulder injury|shoulder injury
4863269|NCT02256865|Sleep Restriction|sleep restriction
4863270|NCT02256865|Insulin Resistance|insulin resistance
4863271|NCT02256865|Testosterone|testosterone
4863272|NCT02256865|Cortisol|cortisol
4863273|NCT02256839|Tuberculosis|tuberculosis
4863274|NCT02256839|TB|tb
4863275|NCT02256683|atrial fibrillation|atrial fibrillation
4863276|NCT02256683|atrial flutter|atrial flutter
4863277|NCT02256683|Atrial-Appendage Thrombus|atrial-appendage thrombus
4863278|NCT02256683|Thrombus resolution|thrombus resolution
4863279|NCT02256683|Dabigatran|dabigatran
4863280|NCT02256683|Phenprocoumon|phenprocoumon
4863281|NCT02256683|Transesophageal Echocardiography|transesophageal echocardiography
4863574|NCT02255084|pap smear|pap smear
4863282|NCT02256670|Hormone Receptor Positive|hormone receptor positive
4863283|NCT02256618|neonatal encephalopathy|neonatal encephalopathy
4863284|NCT02256618|hypoxic-ischemic encephalopathy|hypoxic-ischemic encephalopathy
4863285|NCT02256618|newborn infants|newborn infants
4863286|NCT02256618|neonates|neonates
4863287|NCT02256618|umbilical cord blood cells|umbilical cord blood cells
4863288|NCT02256592|inflammation|inflammation
4863289|NCT02256592|microbiome|microbiome
4863290|NCT02256592|immune activation|immune activation
4863291|NCT02256592|fecal microbiota transplantation|fecal microbiota transplantation
4863292|NCT02256592|dysbiosis|dysbiosis
4863293|NCT02256579|TDF:Tenofovir, Urine beta2microglobulin|tdf:tenofovir, urine beta2microglobulin
4863294|NCT02256566|cognitive training|cognitive training
4863295|NCT02256566|depression|depression
4863296|NCT02256566|bipolar depression|bipolar depression
4863297|NCT02256566|anxiety|anxiety
4863298|NCT02256566|ptsd|ptsd
4863299|NCT02256566|generalized anxiety|generalized anxiety
4863300|NCT02256566|social phobia|social phobia
4863301|NCT02256514|therapeutic vaccine|therapeutic vaccine
4863302|NCT02256501|Dilated cardiomyopathy pediatric heart failure cell therapy|dilated cardiomyopathy pediatric heart failure cell therapy
4863303|NCT02256449|Coronary artery disease; angioplasty; bioresorbable device|coronary artery disease; angioplasty; bioresorbable device
4863304|NCT02256436|P-D1|p-d1
4863305|NCT02256436|PD-1|pd-1
4863306|NCT02256436|PD1|pd1
4863307|NCT02256436|P-DL1|p-dl1
4863308|NCT02256436|PD-L1|pd-l1
4863309|NCT02256436|PDL-1|pdl-1
4863310|NCT02256436|PDL1|pdl1
4863311|NCT02256436|Bladder cancer|bladder cancer
4863312|NCT02256423|Ibuprofen|ibuprofen
4863313|NCT02256423|healthy volunteer study|healthy volunteer study
4863314|NCT02256423|pharmacokinetics|pharmacokinetics
4863315|NCT02256410|low back pain|low back pain
4863316|NCT02256410|chronic pain|chronic pain
4863317|NCT02256410|sensitization|sensitization
4863318|NCT02256410|treatment|treatment
4863319|NCT02256410|trigger points|trigger points
4863320|NCT02256397|Asthma|asthma
4863321|NCT02256384|Respiration Rate|respiration rate
4863322|NCT02256384|Respiratory Acoustic Monitor|respiratory acoustic monitor
4863323|NCT02256384|postoperative|postoperative
4863324|NCT02256371|Neuropathic pain|neuropathic pain
4863325|NCT02256371|Hypnosis|hypnosis
4863326|NCT02256371|Relaxation|relaxation
4863327|NCT02256358|child, ketamine, midazolam|child, ketamine, midazolam
4863328|NCT02256319|Deep brain stimulation|deep brain stimulation
4863329|NCT02256319|Dexmedetomidine|dexmedetomidine
4863330|NCT02256319|Propofol|propofol
4863331|NCT02256293|Type 1 Diabetes|type 1 diabetes
4863332|NCT02256280|Neuromuscular blockade|neuromuscular blockade
4863333|NCT02256280|Thoracic surgery|thoracic surgery
4863334|NCT02256254|Oxidative stress|oxidative stress
4863335|NCT02256254|Simvastatin|simvastatin
4863336|NCT02256228|Analgesia|analgesia
4863337|NCT02256228|Local infiltration analgesia|local infiltration analgesia
4863338|NCT02256228|Pain, relief|pain, relief
4863339|NCT02256228|Pain, Postoperative|pain, postoperative
4863340|NCT02256228|Intra-peritoneal analgesia|intra-peritoneal analgesia
4863341|NCT02256228|Ropivacaine|ropivacaine
4863342|NCT02256228|Saline|saline
4863343|NCT02256228|Therapeutic Uses|therapeutic uses
4863344|NCT02256228|Analgesics, Non-Narcotic|analgesics, non-narcotic
4863345|NCT02256228|Analgesics|analgesics
4863346|NCT02256228|Opioids|opioids
4863347|NCT02256228|Morphine|morphine
4863348|NCT02256228|Pain|pain
4863349|NCT02256228|Postoperative Complications|postoperative complications
4863350|NCT02256228|Physiological Effects of Drugs|physiological effects of drugs
4863351|NCT02256228|Anesthetics, Local|anesthetics, local
4863352|NCT02256228|Anesthetic|anesthetic
4863353|NCT02256228|Cytoreductive|cytoreductive
4863354|NCT02256228|Surgery|surgery
4863355|NCT02256228|Cancer|cancer
4863356|NCT02256215|Vitamin D|vitamin d
4863357|NCT02256163|Thoracic Aortic Aneurysm (TAA)|thoracic aortic aneurysm (taa)
4863358|NCT02256163|gene|gene
4863359|NCT02256163|familial TAA|familial taa
4863360|NCT02256163|blood collection|blood collection
4863361|NCT02256137|Frailty phenotype|frailty phenotype
4863362|NCT02256137|Physical fitness|physical fitness
4863363|NCT02256137|Childhood cancer|childhood cancer
4863364|NCT02256137|Late onset of chronic health conditions|late onset of chronic health conditions
4863365|NCT02256137|Physical frailty|physical frailty
4863366|NCT02256124|Neurofibromatosis type 1|neurofibromatosis type 1
4863367|NCT02256124|NF1|nf1
4863368|NCT02256124|Cognition|cognition
4863369|NCT02256124|Learning problems|learning problems
4863370|NCT02256124|Lamotrigine|lamotrigine
4863371|NCT02256124|Transcranial magnetic stimulation|transcranial magnetic stimulation
4863372|NCT02256124|TMS|tms
4863373|NCT02256098|Comparative Study|comparative study
4863374|NCT02256098|Knee Prosthesis|knee prosthesis
4863375|NCT02256098|Prosthesis Design|prosthesis design
4863376|NCT02256098|Treatment Outcome|treatment outcome
4863377|NCT02256098|Follow-Up Studies|follow-up studies
4863378|NCT02256098|Arthroplasty, Replacement, Knee/methods|arthroplasty, replacement, knee/methods
4863379|NCT02256085|Dissociative|dissociative
4863380|NCT02256085|Dissociation|dissociation
4863381|NCT02256085|Depersonalization|depersonalization
4863382|NCT02256085|Depersonalization Disorder|depersonalization disorder
4863383|NCT02256085|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
4863384|NCT02256085|TMS|tms
4863385|NCT02256085|DPD|dpd
4863386|NCT02256085|rTMS|rtms
4863387|NCT02256085|Behavioral Symptoms|behavioral symptoms
4863388|NCT02256072|aging, geriatrics, aging in place, home services|aging, geriatrics, aging in place, home services
4863389|NCT02256033|Mild hepatic impairment|mild hepatic impairment
4863390|NCT02256033|Healthy volunteer|healthy volunteer
4863391|NCT02256033|Istradefylline|istradefylline
4863392|NCT02256020|Wheel-chair dependent, music aerobic exercise, depression, insomnia|wheel-chair dependent, music aerobic exercise, depression, insomnia
4863393|NCT02256007|Videogames; stroke|videogames; stroke
4863394|NCT02255981|macular, degeneration, acupuncture, visual acuity, OCT|macular, degeneration, acupuncture, visual acuity, oct
4863395|NCT02255968|Normal Volunteers|normal volunteers
4863396|NCT02255968|Safety|safety
4863397|NCT02255968|Pharmacokinetics|pharmacokinetics
4863398|NCT02255955|naproxen sodium codeine|naproxen sodium codeine
4863399|NCT02255955|paracetamol codeine|paracetamol codeine
4863400|NCT02255955|disk surgery|disk surgery
4863401|NCT02255929|Benign Essential Tremor|benign essential tremor
4863402|NCT02255929|Tremor|tremor
4863403|NCT02255929|Neurologic Manifestations|neurologic manifestations
4863404|NCT02255929|Nervous System Diseases|nervous system diseases
4863405|NCT02255929|Movement Disorders|movement disorders
4863406|NCT02255929|Central Nervous System Diseases|central nervous system diseases
4863407|NCT02255916|oncology|oncology
4863408|NCT02255916|psychology|psychology
4863409|NCT02255916|cancer|cancer
4863410|NCT02255916|music|music
4863411|NCT02255916|sound-bed|sound-bed
4863412|NCT02255877|Bi lateral knee surgery|bi lateral knee surgery
4863413|NCT02255877|uni compartmental|uni compartmental
4863414|NCT02255864|Stents|stents
4863415|NCT02255864|Angioplasty|angioplasty
4863416|NCT02255864|Coronary Vessels|coronary vessels
4863417|NCT02255864|Coronary Artery Disease|coronary artery disease
4863418|NCT02255864|Angina Pectoris|angina pectoris
4863419|NCT02255864|Myocardial Ischemia|myocardial ischemia
4863420|NCT02255864|Myocardial Infarction|myocardial infarction
4863421|NCT02255864|Myocardial Revascularization|myocardial revascularization
4863422|NCT02255851|selected for TAVR by heart team consensus|selected for tavr by heart team consensus
4863423|NCT02255851|treated with CE-Marked TAVR devices|treated with ce-marked tavr devices
4863424|NCT02255799|traumatic brain injury|traumatic brain injury
4863425|NCT02255799|TBI|tbi
4863426|NCT02255799|brain injury|brain injury
4863427|NCT02255799|memory|memory
4863428|NCT02255799|verbal memory deficits|verbal memory deficits
4863429|NCT02255799|memory problems|memory problems
4863430|NCT02255799|cognition|cognition
4863431|NCT02255799|cognitive impairment|cognitive impairment
4863432|NCT02255799|neuropsychiatric symptoms|neuropsychiatric symptoms
4863433|NCT02255799|donepezil|donepezil
4863434|NCT02255799|acetylcholinesterase inhibitor|acetylcholinesterase inhibitor
4863435|NCT02255786|Group Therapy|group therapy
4863436|NCT02255786|Parents|parents
4863437|NCT02255786|Autism|autism
4863438|NCT02255786|Quality of Life|quality of life
4863439|NCT02255773|Head and Neck Cancer|head and neck cancer
4863440|NCT02255773|HNC|hnc
4863441|NCT02255773|Moderate to severe fatigue|moderate to severe fatigue
4863442|NCT02255773|Computerized tasks|computerized tasks
4863443|NCT02255773|Questionnaires|questionnaires
4863444|NCT02255773|Surveys|surveys
4863445|NCT02255773|Disease-free adult males|disease-free adult males
4863446|NCT02255773|Cancer survivors|cancer survivors
4863447|NCT02255760|MEDI3902|medi3902
4863448|NCT02255760|Safety,|safety,
4863449|NCT02255760|Pharmacokinetics,|pharmacokinetics,
4863450|NCT02255760|Healthy Volunteers|healthy volunteers
4863451|NCT02255747|infants and children with constipation|infants and children with constipation
4863452|NCT02255734|Volunteers|volunteers
4863453|NCT02255695|posture|posture
4863454|NCT02255695|child|child
4863455|NCT02255695|prevention|prevention
4863456|NCT02255695|muscle strength|muscle strength
4863457|NCT02255695|muscle stretching exercises|muscle stretching exercises
4863458|NCT02255695|exercise therapy|exercise therapy
4863459|NCT02255695|disease management|disease management
4863460|NCT02255695|musculoskeletal pain|musculoskeletal pain
4863461|NCT02255695|adolescent|adolescent
4863462|NCT02255695|spinal curvatures|spinal curvatures
4863463|NCT02255682|physical activity|physical activity
4863464|NCT02255682|statin therapy|statin therapy
4863465|NCT02255682|diabetes mellitus|diabetes mellitus
4863466|NCT02255682|cardiovascular disease|cardiovascular disease
4863467|NCT02255682|Q10-supplementation|q10-supplementation
4863468|NCT02255643|motor cortex stimulation|motor cortex stimulation
4863469|NCT02255643|chronic neuropathic pain|chronic neuropathic pain
4863470|NCT02255630|salbutamol|salbutamol
4863471|NCT02255630|exercise-induced bronchoconstriction|exercise-induced bronchoconstriction
4863472|NCT02255630|anaerobic power|anaerobic power
4863473|NCT02255604|Allergic Rhinitis|allergic rhinitis
4863474|NCT02255604|Allergen immunotherapy|allergen immunotherapy
4863475|NCT02255591|Hip surgery anesthesia|hip surgery anesthesia
4863476|NCT02255591|Perioperative analgesia|perioperative analgesia
4863477|NCT02255565|Quillivant|quillivant
4863770|NCT02253732|metabolism|metabolism
4863478|NCT02255552|DMD, Duchenne, Eteplirsen, dystrophy, dystrophin, exon 51|dmd, duchenne, eteplirsen, dystrophy, dystrophin, exon 51
4863479|NCT02255500|Total knee arthroplasty|total knee arthroplasty
4863480|NCT02255487|surgical device|surgical device
4863481|NCT02255487|surgical irrigation device|surgical irrigation device
4863482|NCT02255487|surgical site infection prophylaxis|surgical site infection prophylaxis
4863483|NCT02255474|pediatrics|pediatrics
4863484|NCT02255474|refractive error - myopia|refractive error - myopia
4863485|NCT02255474|contact lenses|contact lenses
4863486|NCT02255474|intervention|intervention
4863487|NCT02255435|RTA 408|rta 408
4863488|NCT02255435|RTA 408 Capsules|rta 408 capsules
4863489|NCT02255435|Oxidative Stress|oxidative stress
4863490|NCT02255435|Mitochondrial dysfunction|mitochondrial dysfunction
4863491|NCT02255435|omaveloxolone|omaveloxolone
4863492|NCT02255422|omaveloxolone|omaveloxolone
4863493|NCT02255422|RTA 408 capsules|rta 408 capsules
4863494|NCT02255422|mitochondrial myopathies|mitochondrial myopathies
4863495|NCT02255383|Osteoarthritis|osteoarthritis
4863496|NCT02255383|Rheumatoid Arthritis|rheumatoid arthritis
4863497|NCT02255383|Traumatic Arthritis|traumatic arthritis
4863498|NCT02255383|Polyarthritis|polyarthritis
4863499|NCT02255383|Total Knee Arthroplasty|total knee arthroplasty
4863500|NCT02255370|Curcumin. Crohn's disease. Post-operative recurrence. Thiopurines . Rutgeerts endoscopic score|curcumin. crohn's disease. post-operative recurrence. thiopurines . rutgeerts endoscopic score
4863501|NCT02255357|Oxytocin|oxytocin
4863502|NCT02255357|Vasopressin|vasopressin
4863503|NCT02255357|Cocaine|cocaine
4863504|NCT02255344|Acute Coronary Syndromes|acute coronary syndromes
4863505|NCT02255344|Risk Model|risk model
4863506|NCT02255344|National Registry|national registry
4863507|NCT02255344|Comprehensive Care Program|comprehensive care program
4863508|NCT02255344|Major Cardiovascular Events|major cardiovascular events
4863509|NCT02255331|Arthroplasty|arthroplasty
4863510|NCT02255331|Replacement|replacement
4863511|NCT02255331|Hip|hip
4863512|NCT02255318|Taurolock®|taurolock®
4863513|NCT02255318|infections related to chambers implantable catheter|infections related to chambers implantable catheter
4863514|NCT02255318|patients with cancer receiving parenteral nutrition|patients with cancer receiving parenteral nutrition
4863515|NCT02255305|CDI|cdi
4863516|NCT02255305|C difficile|c difficile
4863517|NCT02255305|C diff|c diff
4863518|NCT02255305|Clostridium difficile|clostridium difficile
4863519|NCT02255253|Telmisartan|telmisartan
4863520|NCT02255253|Hydrochlorothiazide|hydrochlorothiazide
4863521|NCT02255253|Efficacy|efficacy
4863522|NCT02255253|hypertension|hypertension
4863523|NCT02255253|high sodium intake|high sodium intake
4863524|NCT02255240|breast cancer|breast cancer
4863525|NCT02255240|cancer|cancer
4863526|NCT02255240|survivorship|survivorship
4863527|NCT02255240|cancer survivor|cancer survivor
4863528|NCT02255240|physical activity|physical activity
4863529|NCT02255240|video game|video game
4863530|NCT02255240|women|women
4863531|NCT02255240|women's health|women's health
4863532|NCT02255227|vaccination|vaccination
4863533|NCT02255227|randomized|randomized
4863534|NCT02255227|anti-pneumococcal|anti-pneumococcal
4863535|NCT02255227|Pneumo 23|pneumo 23
4863536|NCT02255227|Prevenar 13|prevenar 13
4863537|NCT02255227|Chronic Inflammatory Bowel Disease|chronic inflammatory bowel disease
4863538|NCT02255188|Haemostas, prosthesis|haemostas, prosthesis
4863539|NCT02255175|Reproductive Affective Disorder|reproductive affective disorder
4863540|NCT02255175|Depression|depression
4863541|NCT02255175|Perimenopause|perimenopause
4863542|NCT02255175|Estrogen|estrogen
4863543|NCT02255175|Estradiol treatment|estradiol treatment
4863544|NCT02255175|Mood Disorders|mood disorders
4863545|NCT02255175|Estrogen Replacement Therapy|estrogen replacement therapy
4863546|NCT02255175|Sex Steroids|sex steroids
4863547|NCT02255175|Depressive disorder|depressive disorder
4863548|NCT02255175|Mental Disorders|mental disorders
4863549|NCT02255175|Estradiol|estradiol
4863550|NCT02255175|Hormones|hormones
4863551|NCT02255175|Physiological effects of drugs|physiological effects of drugs
4863552|NCT02255175|Reproductive Control Agents|reproductive control agents
4863553|NCT02255162|Acute Myeloid Leukemia (AML)|acute myeloid leukemia (aml)
4863554|NCT02255162|Acute Myelocytic Leukemia|acute myelocytic leukemia
4863555|NCT02255162|Acute Myelogenous Leukemia|acute myelogenous leukemia
4863556|NCT02255162|Acute Granulocytic Leukemia|acute granulocytic leukemia
4863557|NCT02255162|Acute Non-Lymphocytic Leukemia|acute non-lymphocytic leukemia
4863558|NCT02255136|Interleukin|interleukin
4863559|NCT02255136|Immunoglobulin|immunoglobulin
4863560|NCT02255136|Homeopathy|homeopathy
4863561|NCT02255136|Allergic Rhinitis|allergic rhinitis
4863562|NCT02255136|Asthma|asthma
4863563|NCT02255110|Locally Advanced Unresectable or Metastatic Soft Tissue Sarcoma|locally advanced unresectable or metastatic soft tissue sarcoma
4863564|NCT02255110|TH-302|th-302
4863565|NCT02255110|Doxorubicin|doxorubicin
4863566|NCT02255110|Evofosfamide|evofosfamide
4863567|NCT02255097|PD-1|pd-1
4863568|NCT02255097|PD1|pd1
4863569|NCT02255097|PD-L1|pd-l1
4863570|NCT02255097|PDL1|pdl1
4863571|NCT02255084|Cervical cancer screening|cervical cancer screening
4863572|NCT02255084|High Risk Human papillomavirus Infection|high risk human papillomavirus infection
4863573|NCT02255084|vaginal self-sampling|vaginal self-sampling
4863575|NCT02255084|general practitioner|general practitioner
4863576|NCT02255071|GERD|gerd
4863577|NCT02255071|Neiguan|neiguan
4863578|NCT02255071|Acupressure|acupressure
4863579|NCT02255071|P6|p6
4863580|NCT02255032|uveitis|uveitis
4863581|NCT02255032|macular edema|macular edema
4863582|NCT02255032|UME|ume
4863583|NCT02255032|posterior uveitis|posterior uveitis
4863584|NCT02255032|anterior uveitis|anterior uveitis
4863585|NCT02255032|panuveitis|panuveitis
4863586|NCT02255032|intermediate uveitis|intermediate uveitis
4863587|NCT02255032|noninfectious uveitis|noninfectious uveitis
4863588|NCT02255032|triamcinolone acetonide|triamcinolone acetonide
4863589|NCT02255032|suprachoroidal space|suprachoroidal space
4863590|NCT02255032|injection|injection
4863591|NCT02255032|microneedle|microneedle
4863592|NCT02255032|intravitreal injection|intravitreal injection
4863593|NCT02255032|corticosteroid|corticosteroid
4863594|NCT02255032|CME|cme
4863595|NCT02255032|choroid|choroid
4863596|NCT02255032|retina|retina
4863597|NCT02255032|microinjection|microinjection
4863598|NCT02255032|SCS|scs
4863599|NCT02255006|volunteer|volunteer
4863600|NCT02255006|BMI(25 kg/m2)|bmi(25 kg/m2)
4863601|NCT02254980|Total hip arthroplasty|total hip arthroplasty
4863602|NCT02254980|Cemented acetabular cup|cemented acetabular cup
4863603|NCT02254980|Vitamin-E|vitamin-e
4863604|NCT02254980|Radiostereometry|radiostereometry
4863605|NCT02254980|Fixation of cemented acetabular component in total hip arthroplasty|fixation of cemented acetabular component in total hip arthroplasty
4863606|NCT02254967|Aged|aged
4863607|NCT02254967|Fidaxomicin|fidaxomicin
4863608|NCT02254967|Clostridium Difficile|clostridium difficile
4863609|NCT02254967|Vancomycin|vancomycin
4863610|NCT02254954|glioblastoma|glioblastoma
4863611|NCT02254941|Metastatic Colon Cancer|metastatic colon cancer
4863612|NCT02254941|Monoclonal antibodies|monoclonal antibodies
4863613|NCT02254941|Chemotherapy|chemotherapy
4863614|NCT02254941|First line|first line
4863615|NCT02254928|poor ovarian response|poor ovarian response
4863616|NCT02254928|controlled ovarian stimulation|controlled ovarian stimulation
4863617|NCT02254928|randomised clinical trial|randomised clinical trial
4863618|NCT02254928|corifollitropin alfa|corifollitropin alfa
4863619|NCT02254928|recombinant follicle-stimulating hormone (rFSH)|recombinant follicle-stimulating hormone (rfsh)
4863620|NCT02254928|human menopausal gonadotropin (HMG)|human menopausal gonadotropin (hmg)
4863621|NCT02254915|Synergo|synergo
4863622|NCT02254915|RITE|rite
4863623|NCT02254915|SHTC|shtc
4863624|NCT02254915|Non Muscle Invasive Bladder Cancer|non muscle invasive bladder cancer
4863625|NCT02254915|NMIBC|nmibc
4863626|NCT02254915|Superficial Bladder Cancer|superficial bladder cancer
4863627|NCT02254915|Urothelial Cell Cancer|urothelial cell cancer
4863628|NCT02254915|Transitional Cell Cancer|transitional cell cancer
4863629|NCT02254915|Mitomycin|mitomycin
4863630|NCT02254902|sedentary lifestyle|sedentary lifestyle
4863631|NCT02254902|physical activity|physical activity
4863632|NCT02254902|Somali women|somali women
4863633|NCT02254902|prevention|prevention
4863634|NCT02254876|Stroke|stroke
4863635|NCT02254876|Hemiplegia|hemiplegia
4863636|NCT02254876|Painful shoulder Syndrome|painful shoulder syndrome
4863637|NCT02254876|NeuroMuscolar Taping|neuromuscolar taping
4863638|NCT02254863|Adrenoleukodystrophy|adrenoleukodystrophy
4863639|NCT02254863|Batten Disease|batten disease
4863640|NCT02254863|Hunter Syndrome|hunter syndrome
4863641|NCT02254863|Krabbe|krabbe
4863642|NCT02254863|Metachromatic Leukodystrophy|metachromatic leukodystrophy
4863643|NCT02254863|ALD|ald
4863644|NCT02254863|MLD|mld
4863645|NCT02254863|PMD|pmd
4863646|NCT02254850|Mesoglycan|mesoglycan
4863647|NCT02254850|Metabolic Syndrome|metabolic syndrome
4863648|NCT02254850|Flow Mediated Dilation|flow mediated dilation
4863649|NCT02254824|Xuezhikang|xuezhikang
4863650|NCT02254824|atorvastatin|atorvastatin
4863651|NCT02254785|poor prognosis|poor prognosis
4863652|NCT02254785|castrate-resistant prostate cancer|castrate-resistant prostate cancer
4863653|NCT02254785|cabazitaxel|cabazitaxel
4863654|NCT02254785|abiraterone|abiraterone
4863655|NCT02254785|enzalutamide|enzalutamide
4863656|NCT02254733|CBSST|cbsst
4863657|NCT02254733|Schizoaffective Disorder|schizoaffective disorder
4863658|NCT02254733|Psychotic Disorder|psychotic disorder
4863659|NCT02254733|Cognitive Behavioral Therapy|cognitive behavioral therapy
4863660|NCT02254733|Social Skills Training|social skills training
4863661|NCT02254733|Assertive Community Treatment|assertive community treatment
4863662|NCT02254694|sagittal balance|sagittal balance
4863663|NCT02254694|posture|posture
4863664|NCT02254694|lumbar lordosis|lumbar lordosis
4863665|NCT02254694|high heeled shoes|high heeled shoes
4863666|NCT02254681|low-dose radiotherapy|low-dose radiotherapy
4863667|NCT02254681|gemcitabine|gemcitabine
4863668|NCT02254681|cisplatin|cisplatin
4863669|NCT02254681|cholangiocarcinoma|cholangiocarcinoma
4863670|NCT02254668|intima|intima
4863671|NCT02254668|thickness|thickness
4863672|NCT02254668|transplantation|transplantation
4863673|NCT02254668|cardiology|cardiology
4863674|NCT02254668|immunosuppression|immunosuppression
4863675|NCT02254655|puerarin|puerarin
4863676|NCT02254655|rheumatoid arthritis|rheumatoid arthritis
4863677|NCT02254655|atherosclerosis|atherosclerosis
4863678|NCT02254655|carotid intima-media thickness|carotid intima-media thickness
4863679|NCT02254629|Fecal microflora|fecal microflora
4863680|NCT02254629|IBS|ibs
4863681|NCT02254629|Sequential treatment|sequential treatment
4863682|NCT02254629|Probiotic|probiotic
4863683|NCT02254629|Laxative|laxative
4863684|NCT02254616|Stroke Rehabilitation|stroke rehabilitation
4863685|NCT02254616|Hybrid therapy|hybrid therapy
4863686|NCT02254616|Mirror Therapy|mirror therapy
4863687|NCT02254616|Transcranial Direct Current Stimulation|transcranial direct current stimulation
4863688|NCT02254603|Obesity, ayuveda yoga exercise, acupuncture.|obesity, ayuveda yoga exercise, acupuncture.
4863689|NCT02254590|IEDL|iedl
4863690|NCT02254590|irrigation endoscopic decompressive laminotomy|irrigation endoscopic decompressive laminotomy
4863691|NCT02254590|irrigation endoscopic decompression|irrigation endoscopic decompression
4863692|NCT02254590|minimally invasive spine surgery|minimally invasive spine surgery
4863693|NCT02254590|endoscopic decompression|endoscopic decompression
4863694|NCT02254590|spinal stenosis|spinal stenosis
4863695|NCT02254577|Infertility|infertility
4863696|NCT02254577|Progesterone|progesterone
4863697|NCT02254577|ART|art
4863698|NCT02254577|IVF|ivf
4863699|NCT02254577|FET|fet
4863700|NCT02254577|FBT|fbt
4863701|NCT02254577|Frozen Embryo Transfer|frozen embryo transfer
4863702|NCT02254551|relapsed multiple myeloma|relapsed multiple myeloma
4863703|NCT02254551|refractory multiple myeloma|refractory multiple myeloma
4863704|NCT02254551|LDE225|lde225
4863705|NCT02254551|Sonidegib|sonidegib
4863706|NCT02254551|bortezomib|bortezomib
4863707|NCT02254551|smoothened (SMO) inhibitors|smoothened (smo) inhibitors
4863708|NCT02254551|Velcade|velcade
4863709|NCT02254473|Knee|knee
4863710|NCT02254473|Osteoarthritis|osteoarthritis
4863711|NCT02254447|relative bio-availability|relative bio-availability
4863712|NCT02254447|fasting|fasting
4863713|NCT02254447|GW615775|gw615775
4863714|NCT02254447|Candesartan cilexetil|candesartan cilexetil
4863715|NCT02254447|ATACAND|atacand
4863716|NCT02254434|eltrombopag 50 mg|eltrombopag 50 mg
4863717|NCT02254434|healthy volunteers|healthy volunteers
4863718|NCT02254434|pharmacokinetic|pharmacokinetic
4863719|NCT02254434|single-dose|single-dose
4863720|NCT02254434|Open-label|open-label
4863721|NCT02254434|fasting|fasting
4863722|NCT02254421|Respiratory Syncytial Virus (RSV)|respiratory syncytial virus (rsv)
4863723|NCT02254421|Antiviral|antiviral
4863724|NCT02254421|Hematopoietic Cell Transplant (HCT)|hematopoietic cell transplant (hct)
4863725|NCT02254421|Lower respiratory tract infection|lower respiratory tract infection
4863726|NCT02254408|Respiratory Syncytial Virus (RSV)|respiratory syncytial virus (rsv)
4863727|NCT02254408|Antiviral|antiviral
4863728|NCT02254408|Hematopoietic Cell Transplant (HCT)|hematopoietic cell transplant (hct)
4863729|NCT02254408|Upper respiratory tract infection|upper respiratory tract infection
4863730|NCT02254382|diastolic heart failure|diastolic heart failure
4863731|NCT02254356|drug-eluting stent, paclitaxel-eluting stent, peripheral artery disease, peripheral vascular disease, superficial femoral artery, popliteal artery|drug-eluting stent, paclitaxel-eluting stent, peripheral artery disease, peripheral vascular disease, superficial femoral artery, popliteal artery
4863732|NCT02254343|stroke rehabilitation|stroke rehabilitation
4863733|NCT02254343|robot-assisted therapy|robot-assisted therapy
4863734|NCT02254330|Adenoviral conjunctivitis diagnosed with AdenoPlus™ Test|adenoviral conjunctivitis diagnosed with adenoplus™ test
4863735|NCT02254317|Impaired Glucose Tolerance|impaired glucose tolerance
4863736|NCT02254317|Oral Glucose Tolerance Test|oral glucose tolerance test
4863737|NCT02254317|Grape Seed Extract|grape seed extract
4863738|NCT02254304|Relapsing multiple sclerosis|relapsing multiple sclerosis
4863739|NCT02254304|Clinically isolated syndrome|clinically isolated syndrome
4863740|NCT02254304|RMS|rms
4863741|NCT02254304|CIS|cis
4863742|NCT02254304|RebiSmart™|rebismart™
4863743|NCT02254304|Rebif®|rebif®
4863744|NCT02254304|Interferon beta-1a|interferon beta-1a
4863745|NCT02254252|Slow coronary flow phenomenon|slow coronary flow phenomenon
4863746|NCT02254252|Angina pectoris|angina pectoris
4863747|NCT02254252|chest pain|chest pain
4863748|NCT02254252|nicroandil|nicroandil
4863749|NCT02254213|Intra-individual stability, EEG|intra-individual stability, eeg
4863750|NCT02254200|exercise|exercise
4863751|NCT02254200|fat oxidation|fat oxidation
4863752|NCT02254200|indirect calorimetry|indirect calorimetry
4863753|NCT02254200|insulin sensitivity|insulin sensitivity
4863754|NCT02254200|weight management|weight management
4863755|NCT02253810|Dysplasia, Congenital Hip|dysplasia, congenital hip
4863756|NCT02253810|Osteotomy|osteotomy
4863757|NCT02253810|Blood Transfusion|blood transfusion
4863758|NCT02253810|Tranexamic Acid|tranexamic acid
4863759|NCT02253758|Magnetic Resonance Imaging|magnetic resonance imaging
4863760|NCT02253758|Electroencephalography|electroencephalography
4863761|NCT02253758|Conscious Sedation|conscious sedation
4863762|NCT02253758|Deep Sedation|deep sedation
4863763|NCT02253758|Arousal|arousal
4863764|NCT02253758|Consciousness|consciousness
4863765|NCT02253745|ADHD|adhd
4863766|NCT02253745|Attention Deficit/ Hyperactivity Disorder|attention deficit/ hyperactivity disorder
4863767|NCT02253732|MicroRNAs|micrornas
4863768|NCT02253732|exercise|exercise
4863769|NCT02253732|skeletal muscle|skeletal muscle
4863771|NCT02253719|cervical neoplasia|cervical neoplasia
4863772|NCT02253719|cervical cancer'|cervical cancer'
4863773|NCT02253719|visual inspection acetic acid|visual inspection acetic acid
4863774|NCT02253719|cryotherapy|cryotherapy
4863775|NCT02253706|bronchoscopy|bronchoscopy
4863776|NCT02253706|hypoxia|hypoxia
4863777|NCT02253706|oxygen supplementation|oxygen supplementation
4863778|NCT02253706|safety|safety
4863779|NCT02253693|Hemophilia A|hemophilia a
4863780|NCT02253693|Hemophilic arthropathy|hemophilic arthropathy
4863781|NCT02253693|Accelerometry|accelerometry
4863782|NCT02253680|Osteoarthritis|osteoarthritis
4863783|NCT02253680|Total knee replacement|total knee replacement
4863784|NCT02253680|Enhanced recovery|enhanced recovery
4863785|NCT02253680|Compression bandages|compression bandages
4863786|NCT02253667|Palliative care|palliative care
4863787|NCT02253667|Lung disease|lung disease
4863788|NCT02253667|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
4863789|NCT02253667|High-flow oxygen nasal cannula|high-flow oxygen nasal cannula
4863790|NCT02253667|Dyspnoea|dyspnoea
4863791|NCT02253667|Opioids|opioids
4863792|NCT02253654|Chronic Kidney Disease|chronic kidney disease
4863793|NCT02253654|Anemia|anemia
4863794|NCT02253654|Hemodialysis|hemodialysis
4863795|NCT02253654|Red Blood Cell Transfusion|red blood cell transfusion
4863796|NCT02253641|African American, Women|african american, women
4863797|NCT02253641|Weight Loss|weight loss
4863798|NCT02253628|Coffee|coffee
4863799|NCT02253628|Gastrin|gastrin
4863800|NCT02253628|Alpha-amylase|alpha-amylase
4863801|NCT02253628|Cortisol|cortisol
4863802|NCT02253628|Self-reported gastrointestinal symptoms|self-reported gastrointestinal symptoms
4863803|NCT02253628|Self-reported stress|self-reported stress
4863804|NCT02253628|Blood pressure|blood pressure
4863805|NCT02253615|Aging|aging
4863806|NCT02253615|Resistance training|resistance training
4863807|NCT02253615|Muscle strength|muscle strength
4863808|NCT02253615|Functional performance|functional performance
4863809|NCT02253615|Postural balance|postural balance
4863810|NCT02253602|Esophageal Neoplasms|esophageal neoplasms
4863811|NCT02253602|Lymph Nodes|lymph nodes
4863812|NCT02253602|USPIO|uspio
4863813|NCT02253602|Magnetic Resonance Imaging|magnetic resonance imaging
4863814|NCT02253576|infant|infant
4863815|NCT02253576|bronchiolitis|bronchiolitis
4863816|NCT02253576|hypertonic saline|hypertonic saline
4863817|NCT02253537|Tuberculosis|tuberculosis
4863818|NCT02253537|TB|tb
4863819|NCT02253524|Metoclopramide|metoclopramide
4863820|NCT02253524|Dimenhydrinate|dimenhydrinate
4863821|NCT02253524|emergency medicine|emergency medicine
4863822|NCT02253511|Hepatocellular carcinoma|hepatocellular carcinoma
4863823|NCT02253511|Hepotectomy|hepotectomy
4863824|NCT02253511|Recurrence-free survival|recurrence-free survival
4863825|NCT02253511|Overall survival|overall survival
4863826|NCT02253485|Mother-to-child transmission|mother-to-child transmission
4863827|NCT02253446|Dysmenorrhea|dysmenorrhea
4863828|NCT02253446|Piroxicam|piroxicam
4863829|NCT02253446|Diclofenac Sodium|diclofenac sodium
4863830|NCT02253446|Emergency department|emergency department
4863831|NCT02253433|asthma|asthma
4863832|NCT02253433|environmental triggers|environmental triggers
4863833|NCT02253433|home-based intervention|home-based intervention
4863834|NCT02253433|asthma home visits|asthma home visits
4863835|NCT02253420|Phase 1|phase 1
4863836|NCT02253420|Advanced solid tumor|advanced solid tumor
4863837|NCT02253420|non-Hodgkin's lymphoma|non-hodgkin's lymphoma
4863838|NCT02253420|PI3 Kinase inhibitor|pi3 kinase inhibitor
4863839|NCT02253420|Drug-drug Interaction|drug-drug interaction
4863840|NCT02253394|Pulmonary Arterial Hypertension (PAH)|pulmonary arterial hypertension (pah)
4863841|NCT02253394|Ambrisentan|ambrisentan
4863842|NCT02253394|Spironolactone|spironolactone
4863843|NCT02253394|Selective Endothelin A (ETA) inhibition|selective endothelin a (eta) inhibition
4863844|NCT02253394|Aldosterone antagonism|aldosterone antagonism
4863845|NCT02253394|Cardiac output (CO)|cardiac output (co)
4863846|NCT02253394|Right ventricular (RV) function|right ventricular (rv) function
4863847|NCT02253394|Heart failure|heart failure
4863848|NCT02253394|Quality of life|quality of life
4863849|NCT02253394|Pro-inflammatory cytokine|pro-inflammatory cytokine
4863850|NCT02253394|Interleukin-6 (IL-6)|interleukin-6 (il-6)
4863851|NCT02253394|Troponin-I|troponin-i
4863852|NCT02253394|N-terminal pro-brain natriuretic peptide (NT-BNP)|n-terminal pro-brain natriuretic peptide (nt-bnp)
4863853|NCT02253394|Collagen metabolism|collagen metabolism
4863854|NCT02253394|N-terminal procollagen type I|n-terminal procollagen type i
4863855|NCT02253394|Collagen III|collagen iii
4863856|NCT02253394|Echocardiography|echocardiography
4863857|NCT02253394|WHO Functional Class|who functional class
4863858|NCT02253394|Cardiopulmonary Exercise Test with Innocor|cardiopulmonary exercise test with innocor
4863859|NCT02253394|Peak oxygen consumption (pVO2)|peak oxygen consumption (pvo2)
4863860|NCT02253394|Liver function markers (AST/ALT)|liver function markers (ast/alt)
4863861|NCT02253394|Renal function markers (creatinine and potassium)|renal function markers (creatinine and potassium)
4863862|NCT02253381|lateral decubitus position|lateral decubitus position
4863863|NCT02253381|hypotension|hypotension
4863864|NCT02253381|cesarean section|cesarean section
4863865|NCT02253329|Neuromuscular electrical stimulation|neuromuscular electrical stimulation
4863866|NCT02253329|Ageing|ageing
4863867|NCT02253329|Protein ingestion|protein ingestion
4863868|NCT02253316|Multiple Myeloma|multiple myeloma
4863869|NCT02253316|Autologous Stem Cell Transplantation|autologous stem cell transplantation
4863870|NCT02253316|Ixazomib|ixazomib
4863871|NCT02253316|Lenalidomide|lenalidomide
4863872|NCT02253316|Dexamethasone|dexamethasone
4863873|NCT02253277|CML, Ph+ ALL|cml, ph+ all
4863874|NCT02253251|Breast Cancer|breast cancer
4863875|NCT02253251|Cancer Risk|cancer risk
4863876|NCT02253251|Family Breast and Ovarian Cancer|family breast and ovarian cancer
4863877|NCT02253251|Genetic Cancer Risk|genetic cancer risk
4863878|NCT02253251|Cancer Treatment|cancer treatment
4863879|NCT02253251|Familial multiple primary cancer risk|familial multiple primary cancer risk
4863880|NCT02253251|Autoimmunity|autoimmunity
4863881|NCT02253251|Endometriosis|endometriosis
4863882|NCT02253238|Head and Neck Cancer|head and neck cancer
4863883|NCT02253238|Dehydration|dehydration
4863884|NCT02253238|Sensor-based home monitoring|sensor-based home monitoring
4863885|NCT02253238|Radiation therapy|radiation therapy
4863886|NCT02253238|RT|rt
4863887|NCT02253238|XRT|xrt
4863888|NCT02253238|Oropharyngeal cancer|oropharyngeal cancer
4863889|NCT02253238|Hypopharyngeal cancer|hypopharyngeal cancer
4863890|NCT02253238|Nasopharyngeal cancer|nasopharyngeal cancer
4863891|NCT02253238|Salivary gland cancer|salivary gland cancer
4863892|NCT02253238|Oral cavity cancer|oral cavity cancer
4863893|NCT02253238|Questionnaires|questionnaires
4863894|NCT02253238|Surveys|surveys
4863895|NCT02253238|Quality of life|quality of life
4863896|NCT02253238|QOL|qol
4863897|NCT02253238|Phone calls|phone calls
4863898|NCT02253238|Self-monitoring devices|self-monitoring devices
4863899|NCT02253238|CYberinfrastructure for COmparative effectiveness REsearch|cyberinfrastructure for comparative effectiveness research
4863900|NCT02253238|CYCORE|cycore
4863901|NCT02253238|Emergency room visits|emergency room visits
4863902|NCT02253238|ER|er
4863903|NCT02253238|Emergency room visits with hospitalization|emergency room visits with hospitalization
4863904|NCT02253238|ERHV|erhv
4863905|NCT02253225|Bipolar Disorder|bipolar disorder
4863906|NCT02253225|Major Depression|major depression
4863907|NCT02253225|Rumination|rumination
4863908|NCT02253225|Self Processing|self processing
4863909|NCT02253173|VVA|vva
4863910|NCT02253173|Painful Sex|painful sex
4863911|NCT02253173|Postmenopausal|postmenopausal
4863912|NCT02253160|MNCs|mncs
4863913|NCT02253160|Mononuclear Cells|mononuclear cells
4863914|NCT02253160|Apheresis|apheresis
4863915|NCT02253160|Spectra Optia|spectra optia
4863916|NCT02253147|Nasolabial folds|nasolabial folds
4863917|NCT02253147|Dermal filler|dermal filler
4863918|NCT02253147|Hyaluronic acid (HA)|hyaluronic acid (ha)
4863919|NCT02253147|Wrinkles|wrinkles
4863920|NCT02253134|Syncopal events|syncopal events
4863921|NCT02253134|Palpitation events|palpitation events
4863922|NCT02253121|COPD|copd
4863923|NCT02253121|acute exacerbation|acute exacerbation
4863924|NCT02253121|glucocorticoid therapy|glucocorticoid therapy
4863925|NCT02253121|hyperglycemia|hyperglycemia
4863927|NCT02253108|Angina pectoris|angina pectoris
4863928|NCT02253108|Stent|stent
4863929|NCT02253108|Optical coherence tomography|optical coherence tomography
4863930|NCT02253108|Stent thrombosis|stent thrombosis
4863931|NCT02253056|Fasting|fasting
4863932|NCT02253056|Caloric Restriction|caloric restriction
4863933|NCT02253056|Focus is to observe effects of fasting in healthy volunteers.|focus is to observe effects of fasting in healthy volunteers.
4863934|NCT02253043|Alzheimer's Disease|alzheimer's disease
4863935|NCT02253030|AMD|amd
4863936|NCT02253030|OCT|oct
4863937|NCT02253030|Angiography|angiography
4863938|NCT02253030|Macular degeneration|macular degeneration
4863939|NCT02253017|Therapeutic strategies|therapeutic strategies
4863940|NCT02253017|Pediatrics|pediatrics
4863941|NCT02253017|Cataract|cataract
4863942|NCT02253017|Surgery|surgery
4863943|NCT02253017|Intra-ocular lens|intra-ocular lens
4863944|NCT02252991|Breast cancer|breast cancer
4863945|NCT02252991|Fatigue|fatigue
4863946|NCT02252991|Physical activity|physical activity
4863947|NCT02252965|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
4863948|NCT02252965|Metformin XR|metformin xr
4863949|NCT02252965|Metformin IR|metformin ir
4863950|NCT02252952|Sugar Sweetened Beverages, Diet Beverages, ectopic fat, Functional MRI|sugar sweetened beverages, diet beverages, ectopic fat, functional mri
4863951|NCT02252926|Anesthetics, Local|anesthetics, local
4863952|NCT02252926|Bupivacaine|bupivacaine
4863953|NCT02252926|Lozenge|lozenge
4863954|NCT02252926|Administration, Topical|administration, topical
4863955|NCT02252900|Brain damages|brain damages
4863956|NCT02252900|MRI|mri
4863957|NCT02252900|infectious endocarditis|infectious endocarditis
4863958|NCT02252887|Gemcitabine,|gemcitabine,
4863959|NCT02252887|Trastuzumab|trastuzumab
4863960|NCT02252887|Pertuzumab|pertuzumab
4863961|NCT02252887|14-124|14-124
4863962|NCT02252874|balance|balance
4863963|NCT02252874|visual function|visual function
4863964|NCT02252874|community-dwelling older adults|community-dwelling older adults
4863965|NCT02252874|action video-game|action video-game
4863966|NCT02252822|Eating Disorders|eating disorders
4863967|NCT02252822|Self Help|self help
4863968|NCT02252822|Anonymous CBT|anonymous cbt
4863969|NCT02252809|inflammation endotoxin anti-TNF corticosteroids|inflammation endotoxin anti-tnf corticosteroids
4863970|NCT02252796|Non-small Cell Lung Cancer|non-small cell lung cancer
4863971|NCT02252796|Radiotherapy Therapy|radiotherapy therapy
4863972|NCT02252783|Coronary Artery Disease|coronary artery disease
4863973|NCT02252783|Myocardial Ischemia|myocardial ischemia
4863974|NCT02252783|Coronary Disease|coronary disease
4863975|NCT02252783|Heart Diseases|heart diseases
4863976|NCT02252783|Cardiovascular Diseases|cardiovascular diseases
4863977|NCT02252783|Arteriosclerosis|arteriosclerosis
4863978|NCT02252783|Arterial Occlusive Diseases|arterial occlusive diseases
4863979|NCT02252783|Vascular Diseases|vascular diseases
4863980|NCT02252770|ASA|asa
4863981|NCT02252770|ASLD|asld
4863982|NCT02252770|UCD|ucd
4863983|NCT02252757|mHealth, hypertension, atherosclerotic disease, diabetes, obesity, metabolic syndrome, cardiotoxins, cardiomyopathy, dsypnea|mhealth, hypertension, atherosclerotic disease, diabetes, obesity, metabolic syndrome, cardiotoxins, cardiomyopathy, dsypnea
4863984|NCT02252744|dry eye disease|dry eye disease
4863985|NCT02252744|rheumatoid arthritis|rheumatoid arthritis
4863986|NCT02252731|Phase I|phase i
4863987|NCT02252731|FG-4592|fg-4592
4863988|NCT02252731|Warfarin|warfarin
4863989|NCT02252731|Pharmacokinetics|pharmacokinetics
4863990|NCT02252731|Pharmacodynamics|pharmacodynamics
4863991|NCT02252705|Pulmonary arterial hypertension|pulmonary arterial hypertension
4863992|NCT02252705|Mortality|mortality
4863993|NCT02252705|Survival|survival
4863994|NCT02252692|Bioavailability|bioavailability
4863995|NCT02252692|pharmacokinetics|pharmacokinetics
4863996|NCT02252692|enalapril|enalapril
4863997|NCT02252692|enalaprilat|enalaprilat
4863998|NCT02252679|Bone Turnover Markers|bone turnover markers
4863999|NCT02252679|Calcium Isotopes|calcium isotopes
4864000|NCT02252666|MS|ms
4864001|NCT02252666|balance|balance
4864002|NCT02252666|standing|standing
4864003|NCT02252666|control|control
4864004|NCT02252666|movement|movement
4864005|NCT02252653|Cardiomyopathy|cardiomyopathy
4864006|NCT02252653|Heart Failure|heart failure
4864007|NCT02252653|FAC|fac
4864008|NCT02252653|Amyloid|amyloid
4864009|NCT02252653|Transthyretin (TTR)|transthyretin (ttr)
4864010|NCT02252640|Plasmodium Falciparum|plasmodium falciparum
4864011|NCT02252640|Malaria|malaria
4864012|NCT02252640|Vaccine|vaccine
4864013|NCT02252640|Plasmodium|plasmodium
4864014|NCT02252640|Falciparum|falciparum
4864015|NCT02252614|naproxen sodium+codein, paracetamol+codein,lumbar disc surgery|naproxen sodium+codein, paracetamol+codein,lumbar disc surgery
4864016|NCT02252601|Cystic Fibrosis|cystic fibrosis
4864017|NCT02252601|Hearing Loss|hearing loss
4864018|NCT02252601|High Frequency Digit Triplet Test|high frequency digit triplet test
4864019|NCT02252588|COPD|copd
4864020|NCT02252588|Bacteria|bacteria
4864021|NCT02252562|Hand hygiene|hand hygiene
4864022|NCT02252562|Hospital acquired infections (HAI)|hospital acquired infections (hai)
4864023|NCT02252562|Healthcare acquired infections (HCAI)|healthcare acquired infections (hcai)
4864024|NCT02252536|alcohol use disorder|alcohol use disorder
4864025|NCT02252536|alcoholism|alcoholism
4864026|NCT02252536|alcohol dependence|alcohol dependence
4864027|NCT02252536|drinking alcohol|drinking alcohol
4864028|NCT02252523|Feasibility study|feasibility study
4864029|NCT02252497|hip arthroplasty|hip arthroplasty
4864030|NCT02252497|Tranexamic acid|tranexamic acid
4864031|NCT02252497|randomized control trial|randomized control trial
4864032|NCT02252484|prostate cancer|prostate cancer
4864033|NCT02252484|prostatectomy|prostatectomy
4864034|NCT02252484|weight loss|weight loss
4864035|NCT02252484|prevent weight gain|prevent weight gain
4864036|NCT02252471|alcohol-exposed pregnancy|alcohol-exposed pregnancy
4864037|NCT02252471|nicotine-exposed pregnancy|nicotine-exposed pregnancy
4864038|NCT02252471|tobacco-exposed pregnancy|tobacco-exposed pregnancy
4864039|NCT02252471|alcohol|alcohol
4864040|NCT02252471|contraception|contraception
4864041|NCT02252471|smoking|smoking
4864042|NCT02252471|pregnancy|pregnancy
4864043|NCT02252471|HIV|hiv
4864044|NCT02252471|prevention|prevention
4864045|NCT02252458|Opioid induced hyperalgesia|opioid induced hyperalgesia
4864046|NCT02252458|Fentanyl|fentanyl
4864047|NCT02252432|KETAMINE|ketamine
4864048|NCT02252432|METHADONE|methadone
4864049|NCT02252432|POSTOPERATIVE PAIN|postoperative pain
4864050|NCT02252432|OPIOID REQUIREMENTS|opioid requirements
4864051|NCT02252432|Length of hospital stay|length of hospital stay
4864052|NCT02252432|Perioperative outcomes|perioperative outcomes
4864053|NCT02252419|Postoperative Period|postoperative period
4864054|NCT02252419|Anesthesia, General|anesthesia, general
4864055|NCT02252419|Intubation, Intratracheal|intubation, intratracheal
4864056|NCT02252419|Dexamethasone|dexamethasone
4864057|NCT02252419|Acetaminophen|acetaminophen
4864058|NCT02252406|Stable Angina|stable angina
4864059|NCT02252406|Metabolic Syndrome|metabolic syndrome
4864060|NCT02252406|Women|women
4864061|NCT02252406|Biomarkers|biomarkers
4864062|NCT02252367|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors
4864063|NCT02252367|BPH/LUTS|bph/luts
4864064|NCT02252354|Drug therapy|drug therapy
4864065|NCT02252341|smoking|smoking
4864066|NCT02252341|inflammation|inflammation
4864067|NCT02252341|oxidative stress|oxidative stress
4864068|NCT02252341|NAC|nac
4864069|NCT02252341|treatment|treatment
4864070|NCT02252328|Uveitis|uveitis
4864071|NCT02252328|Simvastatin|simvastatin
4864072|NCT02252328|Visual acuity|visual acuity
4864073|NCT02252328|Corticosteroids|corticosteroids
4864074|NCT02252328|Immunosuppression|immunosuppression
4864075|NCT02252302|Exercise-induced bronchoconstriction|exercise-induced bronchoconstriction
4864076|NCT02252302|Air pollution|air pollution
4864077|NCT02252302|Exercise|exercise
4864078|NCT02252302|Inhaled beta-2-agonist|inhaled beta-2-agonist
4864079|NCT02252302|Cognitive Function|cognitive function
4864080|NCT02252289|Asthma|asthma
4864081|NCT02252289|children|children
4864082|NCT02252289|fluctuation analysis|fluctuation analysis
4864083|NCT02252289|exacerbations|exacerbations
4864084|NCT02252276|Manual therapy|manual therapy
4864085|NCT02252276|proprioception|proprioception
4864086|NCT02252276|exercises|exercises
4864087|NCT02252276|ankle sprain|ankle sprain
4864088|NCT02252250|rectal cancer|rectal cancer
4864089|NCT02252250|laparoscopic|laparoscopic
4864090|NCT02252250|NOTES|notes
4864091|NCT02252237|Prednisone|prednisone
4864092|NCT02252237|Prednisolone|prednisolone
4864093|NCT02252237|Methylprednisolone|methylprednisolone
4864094|NCT02252237|Glucocorticoids|glucocorticoids
4864095|NCT02252237|pharmacokinetics|pharmacokinetics
4864096|NCT02252211|EphA2 positive cancer|epha2 positive cancer
4864097|NCT02252211|DS-8895a monoclonal antibody|ds-8895a monoclonal antibody
4864098|NCT02252172|Multiple Myeloma|multiple myeloma
4864099|NCT02252172|Daratumumab|daratumumab
4864100|NCT02252172|JNJ-54767414|jnj-54767414
4864101|NCT02252172|Lenalidomide|lenalidomide
4864102|NCT02252172|Dexamethasone|dexamethasone
4864103|NCT02252159|Polycythemia|polycythemia
4864104|NCT02252159|Polycythemia Vera|polycythemia vera
4864105|NCT02252159|Hematologic Diseases|hematologic diseases
4864106|NCT02252159|Myeloproliferative Disorders|myeloproliferative disorders
4864107|NCT02252159|Bone Marrow Diseases|bone marrow diseases
4864108|NCT02252159|Hydroxyurea|hydroxyurea
4864109|NCT02252159|Antineoplastic Agents|antineoplastic agents
4864110|NCT02252159|Therapeutic Uses|therapeutic uses
4864111|NCT02252159|Pharmacologic Actions|pharmacologic actions
4864112|NCT02252159|Antisickling Agents|antisickling agents
4864113|NCT02252159|Hematologic Agents|hematologic agents
4864114|NCT02252159|Enzyme Inhibitors|enzyme inhibitors
4864115|NCT02252159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
4864116|NCT02252159|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors
4864117|NCT02252146|DLBCL|dlbcl
4864118|NCT02252146|MYD88 L265P|myd88 l265p
4864119|NCT02252146|Lymphoma|lymphoma
4864120|NCT02252146|Diffuse Large B Cell Lymphoma|diffuse large b cell lymphoma
4864121|NCT02252146|Idera|idera
4864122|NCT02252146|IMO 8400|imo 8400
4864123|NCT02252133|Contact lenses|contact lenses
4864124|NCT02252133|Myopia|myopia
4864125|NCT02252107|Decitabine|decitabine
4864126|NCT02252107|Hematopoietic stem cell transplantation (HSCT)|hematopoietic stem cell transplantation (hsct)
4864127|NCT02252107|Conditioning|conditioning
4864128|NCT02252107|AML|aml
4864129|NCT02252081|metformin|metformin
4864130|NCT02252081|cardiovascular disease|cardiovascular disease
4864131|NCT02252081|Chronic Kidney Disease|chronic kidney disease
4864132|NCT02252081|Metabolic Syndrome|metabolic syndrome
4864133|NCT02252042|Squamous cell carcinoma|squamous cell carcinoma
4864134|NCT02252042|Head and neck carcinoma|head and neck carcinoma
4864135|NCT02252042|PD1|pd1
4864136|NCT02252042|PD-1|pd-1
4864137|NCT02252042|PDL1|pdl1
4864138|NCT02252042|PD-L1|pd-l1
4864139|NCT02252029|Rotavirus|rotavirus
4864140|NCT02252029|Vaccine|vaccine
4864141|NCT02252003|Children|children
4864142|NCT02252003|Pain|pain
4864143|NCT02252003|Pain scale evaluation|pain scale evaluation
4864144|NCT02251964|IMID|imid
4864145|NCT02251964|Interstitial Pneumonitis|interstitial pneumonitis
4864146|NCT02251964|rituximab|rituximab
4864147|NCT02251964|Immuno PET|immuno pet
4864148|NCT02251964|PET/CT|pet/ct
4864149|NCT02251951|Cancer|cancer
4864150|NCT02251951|Stomach|stomach
4864151|NCT02251951|Gastro-Esophageal Junction|gastro-esophageal junction
4864152|NCT02251951|Salvage treatment|salvage treatment
4864153|NCT02251951|Nab-paclitaxel|nab-paclitaxel
4864154|NCT02251925|infertility froze emberyo transfer hormone replacement|infertility froze emberyo transfer hormone replacement
4864155|NCT02251912|Alcohol dependence|alcohol dependence
4864156|NCT02251912|Alcohol|alcohol
4864157|NCT02251912|Oxytocin|oxytocin
4864158|NCT02251912|Intranasal administration|intranasal administration
4864159|NCT02251847|cholesterol|cholesterol
4864160|NCT02251834|Healthcare Disparities|healthcare disparities
4864161|NCT02251834|stroke|stroke
4864162|NCT02251834|Hispanic Americans|hispanic americans
4864163|NCT02251834|community health worker|community health worker
4864164|NCT02251834|Mobile Health|mobile health
4864165|NCT02251834|Transient Ischemic Attack (TIA)|transient ischemic attack (tia)
4864166|NCT02251834|hypertension|hypertension
4864167|NCT02251834|Randomized Controlled Trial|randomized controlled trial
4864168|NCT02251834|high cholesterol|high cholesterol
4864169|NCT02251834|behavioral|behavioral
4864170|NCT02251834|exercise|exercise
4864171|NCT02251834|diabetes|diabetes
4864172|NCT02251834|diet|diet
4864173|NCT02251808|Parkinson's Disease, Deep brain stimulation|parkinson's disease, deep brain stimulation
4864174|NCT02251743|ADHD|adhd
4864175|NCT02251743|Attention-Deficit/Hyperactivity Disorder|attention-deficit/hyperactivity disorder
4864176|NCT02251743|neurofeedback|neurofeedback
4864177|NCT02251743|EEG|eeg
4864306|NCT02251041|Ischemia-reperfusion|ischemia-reperfusion
4864178|NCT02251730|radiation therapy,Smoking pattern,head and neck cancer|radiation therapy,smoking pattern,head and neck cancer
4864179|NCT02251717|renal transplant|renal transplant
4864180|NCT02251704|Malaria|malaria
4864181|NCT02251704|MTI|mti
4864182|NCT02251704|Surveillance study|surveillance study
4864183|NCT02251704|Africa|africa
4864184|NCT02251704|RTSS, adjuvant|rtss, adjuvant
4864185|NCT02251704|Epidemiology|epidemiology
4864186|NCT02251691|Compliance|compliance
4864187|NCT02251678|Plaque|plaque
4864188|NCT02251678|Psoriasis|psoriasis
4864189|NCT02251678|Biomarkers|biomarkers
4864190|NCT02251678|CRP|crp
4864191|NCT02251678|αTNF|αtnf
4864192|NCT02251678|Interleuken|interleuken
4864193|NCT02251665|Acute ischemic stroke|acute ischemic stroke
4864194|NCT02251665|Acute intracerebral hemorrhage|acute intracerebral hemorrhage
4864195|NCT02251665|Transient ischemic attack|transient ischemic attack
4864196|NCT02251652|Actinic|actinic
4864197|NCT02251639|Oral cancer|oral cancer
4864198|NCT02251639|Pre-cancer|pre-cancer
4864199|NCT02251639|Widefield Fluorescence Imaging|widefield fluorescence imaging
4864200|NCT02251639|VELScope|velscope
4864201|NCT02251639|Point Spectroscopy System|point spectroscopy system
4864202|NCT02251639|Oral brush biopsy|oral brush biopsy
4864203|NCT02251639|Questionnaire|questionnaire
4864204|NCT02251639|Survey|survey
4864205|NCT02251639|Diagnostic aid|diagnostic aid
4864206|NCT02251639|Screening|screening
4864207|NCT02251626|MGH|mgh
4864208|NCT02251626|Burn patient|burn patient
4864209|NCT02251626|Adult|adult
4864210|NCT02251626|CoQ10|coq10
4864211|NCT02251626|Ubiquinol|ubiquinol
4864212|NCT02251600|Pediatric|pediatric
4864213|NCT02251600|Adolescent|adolescent
4864214|NCT02251600|Deflazacort|deflazacort
4864215|NCT02251561|contact lenses|contact lenses
4864216|NCT02251561|contact lens solution|contact lens solution
4864217|NCT02251561|corneal staining|corneal staining
4864218|NCT02251561|fluorescein|fluorescein
4864219|NCT02251548|Chronic lymphocytic leukemia|chronic lymphocytic leukemia
4864220|NCT02251548|Leukemia|leukemia
4864221|NCT02251535|kinematic analysis|kinematic analysis
4864222|NCT02251535|femoral rollback|femoral rollback
4864223|NCT02251535|mobile bearing|mobile bearing
4864224|NCT02251535|cruciate retaining Primary Total Knee Arthroplasty|cruciate retaining primary total knee arthroplasty
4864225|NCT02251496|Malnutrition|malnutrition
4864226|NCT02251496|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
4864227|NCT02251496|Nutrition Therapy|nutrition therapy
4864228|NCT02251496|Oral Nutrition Supplement|oral nutrition supplement
4864229|NCT02251496|Food|food
4864230|NCT02251483|DIBS|dibs
4864231|NCT02251483|SIBO|sibo
4864232|NCT02251470|stroke|stroke
4864233|NCT02251470|balance|balance
4864234|NCT02251470|exer-gaming|exer-gaming
4864235|NCT02251470|home-based exercises|home-based exercises
4864236|NCT02251470|Wii|wii
4864237|NCT02251470|postural balance|postural balance
4864238|NCT02251470|Nintendo|nintendo
4864239|NCT02251470|balance board|balance board
4864240|NCT02251470|Wii-Fit|wii-fit
4864241|NCT02251470|home|home
4864242|NCT02251470|feasibility|feasibility
4864243|NCT02251457|Myotonia Congenita|myotonia congenita
4864244|NCT02251457|ranolazine|ranolazine
4864245|NCT02251457|Ohio State|ohio state
4864246|NCT02251457|Open Label|open label
4864247|NCT02251457|Paramyotonia Congenita|paramyotonia congenita
4864248|NCT02251457|Myotonic Dystrophy 1|myotonic dystrophy 1
4864249|NCT02251431|diabetes mellitus|diabetes mellitus
4864250|NCT02251431|chronic kidney disease|chronic kidney disease
4864251|NCT02251431|diastolic function|diastolic function
4864252|NCT02251431|cardiac fibrosis|cardiac fibrosis
4864253|NCT02251431|cardiac strain|cardiac strain
4864254|NCT02251431|cardiac biomarker|cardiac biomarker
4864255|NCT02251431|renal biomarker|renal biomarker
4864256|NCT02251418|Foot ulcer, diabetic|foot ulcer, diabetic
4864257|NCT02251418|ESWT (Extracorporeal Shockwave Therapy)|eswt (extracorporeal shockwave therapy)
4864258|NCT02251418|Endocrinology|endocrinology
4864259|NCT02251418|Dermatology|dermatology
4864260|NCT02251418|Wound healing|wound healing
4864261|NCT02251418|Ischemia|ischemia
4864262|NCT02251418|Neovascularization, Physiologic|neovascularization, physiologic
4864263|NCT02251418|Pain management|pain management
4864264|NCT02251405|Melamine|melamine
4864265|NCT02251405|Melamine tableware|melamine tableware
4864266|NCT02251392|chamomilla|chamomilla
4864267|NCT02251392|matricaria|matricaria
4864268|NCT02251392|chamomile|chamomile
4864269|NCT02251392|chamomila|chamomila
4864270|NCT02251392|recutita|recutita
4864271|NCT02251392|Breast Neoplasms|breast neoplasms
4864272|NCT02251392|head and neck neoplasms|head and neck neoplasms
4864273|NCT02251392|radiotherapy|radiotherapy
4864274|NCT02251366|Age-Related Macular Degeneration|age-related macular degeneration
4864275|NCT02251353|breast cancer, intervention to metastasis|breast cancer, intervention to metastasis
4864276|NCT02251314|BRAF mutant melanoma|braf mutant melanoma
4864277|NCT02251314|circulation tumour DNA|circulation tumour dna
4864278|NCT02251314|tumour heterogeneity|tumour heterogeneity
4864279|NCT02251314|liquid biopsy|liquid biopsy
4864280|NCT02251288|H7N9 pandemic|h7n9 pandemic
4864281|NCT02251288|inactivated influenza vaccine (pIIV)|inactivated influenza vaccine (piiv)
4864282|NCT02251288|live attenuated influenza vaccine (pLAIV)|live attenuated influenza vaccine (plaiv)
4864283|NCT02251288|MF59 adjuvant|mf59 adjuvant
4864284|NCT02251275|Autosomal Dominant Polycystic Kidney Disease|autosomal dominant polycystic kidney disease
4864285|NCT02251262|Pacemaker|pacemaker
4864286|NCT02251262|Endocarditis|endocarditis
4864287|NCT02251262|18FDG-PET-CT|18fdg-pet-ct
4864288|NCT02251262|Diagnostic accuracy|diagnostic accuracy
4864289|NCT02251262|Pacing or defibrillation lead|pacing or defibrillation lead
4864290|NCT02251236|Stribild|stribild
4864291|NCT02251236|Genvoya|genvoya
4864292|NCT02251236|elvitegravir|elvitegravir
4864293|NCT02251236|Cerebrospinal Fluid|cerebrospinal fluid
4864294|NCT02251236|HIV|hiv
4864295|NCT02251093|mycosis|mycosis
4864296|NCT02251093|vulvovaginal candidiasis|vulvovaginal candidiasis
4864297|NCT02251093|lcr35|lcr35
4864298|NCT02251093|Lcr Regenerans®|lcr regenerans®
4864299|NCT02251080|adherence|adherence
4864300|NCT02251080|internet-based|internet-based
4864301|NCT02251054|Overactive Bladder|overactive bladder
4864302|NCT02251054|Multimedia|multimedia
4864303|NCT02251054|Behavioral Therapy|behavioral therapy
4864304|NCT02251041|Liver|liver
4864305|NCT02251041|Transplantation|transplantation
4864307|NCT02251041|Effectiveness|effectiveness
4864308|NCT02251028|whiplash, prevention, pain, cognitive-behavioural therapy|whiplash, prevention, pain, cognitive-behavioural therapy
4864309|NCT02251015|Postural balance|postural balance
4864310|NCT02251015|Temporomandibular disorders|temporomandibular disorders
4864311|NCT02251015|splints|splints
4864312|NCT02250989|Endothelial disfunction|endothelial disfunction
4864313|NCT02250989|Intercellular Adhesion Molecule-1|intercellular adhesion molecule-1
4864314|NCT02250989|Vascular Cell Adhesion Molecule-1|vascular cell adhesion molecule-1
4864315|NCT02250989|8-epi-prostaglandin F2alpha|8-epi-prostaglandin f2alpha
4864316|NCT02250989|Nitric Oxide|nitric oxide
4864317|NCT02250989|Plasminogen Activator Inhibitor 1|plasminogen activator inhibitor 1
4864318|NCT02250989|Endothelin-1|endothelin-1
4864319|NCT02250989|Tumor Necrosis Factor-alpha|tumor necrosis factor-alpha
4864320|NCT02250989|Glucose|glucose
4864321|NCT02250989|Insulin|insulin
4864322|NCT02250989|C-peptide|c-peptide
4864323|NCT02250989|C-reactive protein|c-reactive protein
4864324|NCT02250989|3-nitrotyrosine|3-nitrotyrosine
4864325|NCT02250963|Dobutamine Stress Echocardiography|dobutamine stress echocardiography
4864326|NCT02250963|Computed tomography coronary angiography|computed tomography coronary angiography
4864327|NCT02250950|self-determination theory|self-determination theory
4864328|NCT02250950|motivational interviewing|motivational interviewing
4864329|NCT02250950|exercise|exercise
4864330|NCT02250950|physical activity|physical activity
4864331|NCT02250937|Acute Myeloid Leukemia|acute myeloid leukemia
4864332|NCT02250937|AML|aml
4864333|NCT02250937|Myelodysplastic Syndrome|myelodysplastic syndrome
4864334|NCT02250937|MDS|mds
4864335|NCT02250937|Stem Cell Transplantation|stem cell transplantation
4864336|NCT02250937|Busulfan|busulfan
4864337|NCT02250937|Busulfex|busulfex
4864338|NCT02250937|Myleran|myleran
4864339|NCT02250937|Fludarabine|fludarabine
4864340|NCT02250937|Fludarabine Phosphate|fludarabine phosphate
4864341|NCT02250937|Fludara|fludara
4864342|NCT02250937|Cladribine|cladribine
4864343|NCT02250937|Leustatin|leustatin
4864344|NCT02250937|2-CdA|2-cda
4864345|NCT02250937|G-CSF|g-csf
4864346|NCT02250937|Filgrastim|filgrastim
4864347|NCT02250937|Neupogen|neupogen
4864348|NCT02250937|Methotrexate|methotrexate
4864349|NCT02250911|Caregivers of patients|caregivers of patients
4864350|NCT02250911|CCC = Care for the Cancer Caregivers|ccc = care for the cancer caregivers
4864351|NCT02250911|MCP-C = Meaning-Centered Psychotherapy for Cancer Caregivers|mcp-c = meaning-centered psychotherapy for cancer caregivers
4864352|NCT02250911|14-208|14-208
4864353|NCT02250898|Post Breast Surgery|post breast surgery
4864354|NCT02250898|Myofascial Massage|myofascial massage
4864355|NCT02250898|Pain|pain
4864356|NCT02250898|Mobility Limitations|mobility limitations
4864357|NCT02250885|Selinexor|selinexor
4864358|NCT02250885|phase 2|phase 2
4864359|NCT02250885|Gabrail|gabrail
4864360|NCT02250872|Cisplatin|cisplatin
4864361|NCT02250872|Nephrotoxicity|nephrotoxicity
4864362|NCT02250872|Gemigliptin|gemigliptin
4864363|NCT02250872|DPP4 inhibitor|dpp4 inhibitor
4864364|NCT02250846|EGFR mutations|egfr mutations
4864365|NCT02250846|asymptomatic brain metastases|asymptomatic brain metastases
4864366|NCT02250846|EGFR-TKI|egfr-tki
4864367|NCT02250846|Erlotinib|erlotinib
4864368|NCT02250833|Hypertension|hypertension
4864369|NCT02250833|CKD-828|ckd-828
4864370|NCT02250833|Telmisartan|telmisartan
4864371|NCT02250833|S-amlodipine|s-amlodipine
4864372|NCT02250833|Pharmacokinetic|pharmacokinetic
4864373|NCT02250820|Pediatric|pediatric
4864374|NCT02250820|Sedation|sedation
4864375|NCT02250820|Transthoracic echocardiography|transthoracic echocardiography
4864376|NCT02250820|TTE|tte
4864377|NCT02250820|Dexmedetomidine|dexmedetomidine
4864378|NCT02250820|Pentobarbital|pentobarbital
4864379|NCT02250807|Chronic hepatitis C|chronic hepatitis c
4864380|NCT02250807|Genotype 4 chronic hepatitis C|genotype 4 chronic hepatitis c
4864381|NCT02250807|Simeprevir|simeprevir
4864382|NCT02250807|Sofosbuvir|sofosbuvir
4864383|NCT02250794|diabetes mellitus|diabetes mellitus
4864384|NCT02250794|inpatient management|inpatient management
4864385|NCT02250794|metformin|metformin
4864386|NCT02250794|sitagliptin|sitagliptin
4864387|NCT02250768|GM-CSF, repeated implantation failure|gm-csf, repeated implantation failure
4864388|NCT02250755|MRI perfusion|mri perfusion
4864389|NCT02250755|therapeutic response|therapeutic response
4864390|NCT02250755|chemotherapy|chemotherapy
4864391|NCT02250755|brain metastases|brain metastases
4864392|NCT02250742|ultrasound imaging|ultrasound imaging
4864393|NCT02250742|acupuncture|acupuncture
4864394|NCT02250742|back muscles|back muscles
4864395|NCT02250742|spine|spine
4864396|NCT02250742|muscle strength|muscle strength
4864397|NCT02250729|anaphylaxis|anaphylaxis
4864398|NCT02250729|pholcodine|pholcodine
4864399|NCT02250729|neuromuscular blocking agents|neuromuscular blocking agents
4864400|NCT02250716|CIN1|cin1
4864401|NCT02250716|HIV seropositive women|hiv seropositive women
4864402|NCT02250716|Cryotherapy|cryotherapy
4864403|NCT02250703|Premedication|premedication
4864404|NCT02250690|idiopathic PD|idiopathic pd
4864405|NCT02250690|Hoehn and Yahr stage I to III|hoehn and yahr stage i to iii
4864406|NCT02250690|stable medication usage|stable medication usage
4864407|NCT02250690|age 40 to 80 years|age 40 to 80 years
4864408|NCT02250690|absence of cognitive impairment|absence of cognitive impairment
4864409|NCT02250677|physical activity|physical activity
4864410|NCT02250677|Statin therapy|statin therapy
4864411|NCT02250677|cardiovascular disease|cardiovascular disease
4864412|NCT02250677|diabetes mellitus|diabetes mellitus
4864413|NCT02250664|Biomarkers of exposure|biomarkers of exposure
4864414|NCT02250664|Compensatory smoking|compensatory smoking
4864415|NCT02250664|Nicotine dependence|nicotine dependence
4864416|NCT02250664|Reduced nicotine cigarettes|reduced nicotine cigarettes
4864417|NCT02250664|Tobacco withdrawal|tobacco withdrawal
4864418|NCT02250664|Women|women
4864419|NCT02250664|Health disparities|health disparities
4864420|NCT02250664|Vulnerable populations|vulnerable populations
4864421|NCT02250612|SYL040012|syl040012
4864422|NCT02250612|bamosiran|bamosiran
4864423|NCT02250612|siRNA|sirna
4864424|NCT02250612|RNAi|rnai
4864425|NCT02250612|Glaucoma|glaucoma
4864426|NCT02250612|Ocular hypertension|ocular hypertension
4864427|NCT02250599|Metastatic Nasopharyngeal Carcinoma|metastatic nasopharyngeal carcinoma
4864428|NCT02250599|treatment|treatment
4864429|NCT02250586|concerned significant other|concerned significant other
4864430|NCT02250586|internet-delivered cognitive-behavioral therapy,|internet-delivered cognitive-behavioral therapy,
4864552|NCT02249884|chamomilla|chamomilla
4864431|NCT02250586|treatment-refusing problem gambler|treatment-refusing problem gambler
4864432|NCT02250534|Biomarkers of exposure|biomarkers of exposure
4864433|NCT02250534|Compensatory smoking|compensatory smoking
4864434|NCT02250534|Nicotine dependence|nicotine dependence
4864435|NCT02250534|Reduced nicotine cigarettes|reduced nicotine cigarettes
4864436|NCT02250534|Tobacco withdrawal|tobacco withdrawal
4864437|NCT02250534|Women|women
4864438|NCT02250534|Health disparities|health disparities
4864439|NCT02250534|Vulnerable populations|vulnerable populations
4864440|NCT02250521|BMI < 50 kg/m2|bmi < 50 kg/m2
4864441|NCT02250521|Mallampatti class: III-IV|mallampatti class: iii-iv
4864442|NCT02250521|Reduced mouth opening < 4 cm|reduced mouth opening < 4 cm
4864443|NCT02250521|Neck circumference > 40 cm for females and > 43 cm for males|neck circumference > 40 cm for females and > 43 cm for males
4864444|NCT02250521|Thyromental distance < 6 cm|thyromental distance < 6 cm
4864445|NCT02250521|Ratio of the patient's height to thyromental distance ≥ 23.5|ratio of the patient's height to thyromental distance ≥ 23.5
4864446|NCT02250521|Sternomental distance < 12 cm|sternomental distance < 12 cm
4864447|NCT02250443|Inclusion Body Myositis (IBM)|inclusion body myositis (ibm)
4864448|NCT02250430|acne|acne
4864449|NCT02250365|stroke, acute|stroke, acute
4864450|NCT02250365|upper extremity|upper extremity
4864451|NCT02250365|rehabilitation|rehabilitation
4864452|NCT02250365|electric stimulation therapy|electric stimulation therapy
4864453|NCT02250339|Child Mental Health|child mental health
4864454|NCT02250339|Parenting|parenting
4864455|NCT02250339|Family Issues|family issues
4864456|NCT02250326|Cancer of the lung|cancer of the lung
4864457|NCT02250326|lung neoplasm|lung neoplasm
4864458|NCT02250326|NSCLC - non-small cell lung cancer|nsclc - non-small cell lung cancer
4864459|NCT02250326|Nonsquamou|nonsquamou
4864460|NCT02250326|squamous|squamous
4864461|NCT02250326|squamous NSCLC|squamous nsclc
4864462|NCT02250326|Tumor|tumor
4864463|NCT02250326|locally advanced NSCLC|locally advanced nsclc
4864464|NCT02250326|metastatic NSCLC|metastatic nsclc
4864465|NCT02250326|advanced lung cancer|advanced lung cancer
4864466|NCT02250326|metastatic lung cancer|metastatic lung cancer
4864467|NCT02250326|non-squamous NSCLC|non-squamous nsclc
4864468|NCT02250326|lung cancer|lung cancer
4864469|NCT02250326|Abraxane|abraxane
4864470|NCT02250326|ABI-007|abi-007
4864471|NCT02250326|nab-paclitaxel|nab-paclitaxel
4864472|NCT02250326|albumin-bound paclitaxel|albumin-bound paclitaxel
4864473|NCT02250326|taxanes|taxanes
4864474|NCT02250326|CC-486|cc-486
4864475|NCT02250326|oral azacitidine|oral azacitidine
4864476|NCT02250326|azacitidine|azacitidine
4864477|NCT02250326|second line treatment of lung cancer|second line treatment of lung cancer
4864478|NCT02250326|second line treatment|second line treatment
4864479|NCT02250326|Celgene|celgene
4864480|NCT02250326|abound.2L|abound.2l
4864481|NCT02250326|third line treatment|third line treatment
4864482|NCT02250326|durvalumab|durvalumab
4864483|NCT02250326|immunotherapy|immunotherapy
4864484|NCT02250326|MEDI4736|medi4736
4864485|NCT02250313|prostate cancer|prostate cancer
4864486|NCT02250287|autosomal dominant polycystic kidney disease|autosomal dominant polycystic kidney disease
4864487|NCT02250287|magnetic resonance imaging parameters|magnetic resonance imaging parameters
4864488|NCT02250287|magnetic resonance elastography|magnetic resonance elastography
4864489|NCT02250287|apparent diffusion coefficient|apparent diffusion coefficient
4864490|NCT02250287|blood oxygen level determinations|blood oxygen level determinations
4864491|NCT02250287|diffusion weighted imaging|diffusion weighted imaging
4864492|NCT02250274|Immune response to influenza vaccine|immune response to influenza vaccine
4864493|NCT02250274|PCR confirmed Influenza A virus|pcr confirmed influenza a virus
4864494|NCT02250274|PCR confirmed Influenza B virus|pcr confirmed influenza b virus
4864495|NCT02250261|walking|walking
4864496|NCT02250261|cycling|cycling
4864497|NCT02250261|intervention|intervention
4864498|NCT02250261|physical activity|physical activity
4864499|NCT02250261|environment|environment
4864500|NCT02250261|promotion|promotion
4864501|NCT02250248|Degenerative disc disease|degenerative disc disease
4864502|NCT02250248|Lumbar spine|lumbar spine
4864503|NCT02250209|Gastric Cancer|gastric cancer
4864504|NCT02250209|HER2-positive|her2-positive
4864505|NCT02250209|Trastuzumab|trastuzumab
4864506|NCT02250209|XELOX|xelox
4864507|NCT02250209|Stage III|stage iii
4864508|NCT02250209|D2 Gastrectomy|d2 gastrectomy
4864509|NCT02250196|Bowel preparation|bowel preparation
4864510|NCT02250196|Polyethylene glycol with ascorbic acid|polyethylene glycol with ascorbic acid
4864511|NCT02250196|Sodium picosulfate with magnesium citrate|sodium picosulfate with magnesium citrate
4864512|NCT02250183|Medihoney|medihoney
4864513|NCT02250183|Santyl|santyl
4864514|NCT02250183|Burns|burns
4864515|NCT02250144|Patellofemoral pain syndrome|patellofemoral pain syndrome
4864516|NCT02250144|Feet orthoses|feet orthoses
4864517|NCT02250144|KOOS|koos
4864518|NCT02250131|cardiopulmonary bypass|cardiopulmonary bypass
4864519|NCT02250118|pleural|pleural
4864520|NCT02250118|effusion|effusion
4864521|NCT02250118|breast|breast
4864522|NCT02250118|cancer|cancer
4864523|NCT02250092|Cerebral Palsy|cerebral palsy
4864524|NCT02250092|Hemiparesis|hemiparesis
4864525|NCT02250092|Stroke|stroke
4864526|NCT02250092|Non-Invasive Brain Stimulation|non-invasive brain stimulation
4864527|NCT02250092|Transcranial Direct Current Stimulation|transcranial direct current stimulation
4864528|NCT02250092|Constraint-Induced Movement Therapy|constraint-induced movement therapy
4864529|NCT02250092|Diffusion Tensor Imaging|diffusion tensor imaging
4864530|NCT02250092|Congenital Hemiparesis|congenital hemiparesis
4864531|NCT02250092|Bimanual Therapy|bimanual therapy
4864532|NCT02250053|stage II and stage III colon cancer survivors, who have completed curative treatment i.e., surgical resection and chemotherapy for their colon cancer|stage ii and stage iii colon cancer survivors, who have completed curative treatment i.e., surgical resection and chemotherapy for their colon cancer
4864533|NCT02250040|Stroke|stroke
4864534|NCT02250040|Rehabilitation|rehabilitation
4864535|NCT02250040|Physiotherapy|physiotherapy
4864536|NCT02250040|Functional Recovery|functional recovery
4864537|NCT02250027|acute bronchitis|acute bronchitis
4864538|NCT02250027|acute exacerbations of chronic bronchitis|acute exacerbations of chronic bronchitis
4864539|NCT02250001|HCV|hcv
4864540|NCT02249962|prospective|prospective
4864541|NCT02249962|cohort|cohort
4864542|NCT02249936|Volunteers|volunteers
4864543|NCT02249923|Pulmonary Arterial Hypertension (PAH)|pulmonary arterial hypertension (pah)
4864544|NCT02249923|Pulmonary Vascular Disease (PVD)|pulmonary vascular disease (pvd)
4864545|NCT02249923|Registry|registry
4864546|NCT02249923|Pediatric|pediatric
4864547|NCT02249884|radiodermatitis|radiodermatitis
4864548|NCT02249884|head and neck neoplasms|head and neck neoplasms
4864549|NCT02249884|Breast Neoplasms|breast neoplasms
4864550|NCT02249884|Urea|urea
4864551|NCT02249884|Matricaria|matricaria
4864553|NCT02249884|chamomile|chamomile
4864554|NCT02249858|cervical spine|cervical spine
4864555|NCT02249858|OMT|omt
4864556|NCT02249858|HVLA|hvla
4864557|NCT02249858|ultrasound|ultrasound
4864558|NCT02249845|dehydration|dehydration
4864559|NCT02249845|children|children
4864560|NCT02249845|gastroenteritis|gastroenteritis
4864561|NCT02249832|stroke|stroke
4864562|NCT02249832|CVA|cva
4864563|NCT02249832|cerebrovascular accident|cerebrovascular accident
4864564|NCT02249832|cerebral stroke|cerebral stroke
4864565|NCT02249832|robotic therapy|robotic therapy
4864566|NCT02249832|anklebot|anklebot
4864567|NCT02249832|physical therapy|physical therapy
4864568|NCT02249819|stroke|stroke
4864569|NCT02249819|aphasia|aphasia
4864570|NCT02249819|CVA|cva
4864571|NCT02249819|apraxia|apraxia
4864572|NCT02249819|cerebrovascular accident|cerebrovascular accident
4864573|NCT02249819|cerebral stroke|cerebral stroke
4864574|NCT02249819|speech therapy|speech therapy
4864575|NCT02249819|aphasia therapy|aphasia therapy
4864576|NCT02249819|non-invasive brain stimulation|non-invasive brain stimulation
4864577|NCT02249819|transcranial direct current stimulation|transcranial direct current stimulation
4864578|NCT02249819|tDCS|tdcs
4864579|NCT02249806|Pulmonary Hypertension|pulmonary hypertension
4864580|NCT02249806|Chronic thromboembolic pulmonary hypertension|chronic thromboembolic pulmonary hypertension
4864581|NCT02249806|Pulmonary arterial hypertension|pulmonary arterial hypertension
4864582|NCT02249806|Outcome|outcome
4864583|NCT02249793|circadian|circadian
4864584|NCT02249793|oscillation|oscillation
4864585|NCT02249793|clock|clock
4864586|NCT02249793|human|human
4864587|NCT02249793|social behavior|social behavior
4864588|NCT02249793|cell phone with internet access (so-called smartphone)|cell phone with internet access (so-called smartphone)
4864589|NCT02249793|social sensing|social sensing
4864590|NCT02249793|behavioral feature|behavioral feature
4864591|NCT02249793|Ginger.io|ginger.io
4864592|NCT02249793|blood pressure|blood pressure
4864593|NCT02249793|metabolism|metabolism
4864594|NCT02249793|metabolomics|metabolomics
4864595|NCT02249793|gut bacteria|gut bacteria
4864596|NCT02249793|microbiome|microbiome
4864597|NCT02249780|Parathyroid gland angiography|parathyroid gland angiography
4864598|NCT02249780|Parathyroid gland indocyanine green angiography|parathyroid gland indocyanine green angiography
4864599|NCT02249780|Parathyroid gland indocyanine green fluoroscopy|parathyroid gland indocyanine green fluoroscopy
4864600|NCT02249754|Nutrition education|nutrition education
4864601|NCT02249754|Maternal counselling|maternal counselling
4864602|NCT02249754|Complementary feeding|complementary feeding
4864603|NCT02249754|Infant growth|infant growth
4864604|NCT02249754|Micronutrients|micronutrients
4864605|NCT02249754|Tanzania|tanzania
4864606|NCT02249715|Parkinson|parkinson
4864607|NCT02249715|TMS|tms
4864608|NCT02249715|BNA|bna
4864609|NCT02249702|trabectedin|trabectedin
4864610|NCT02249702|uterine leiomyosarcoma|uterine leiomyosarcoma
4864611|NCT02249676|Autologous mesenchymal stem cells|autologous mesenchymal stem cells
4864612|NCT02249676|neuromyelitis optica|neuromyelitis optica
4864613|NCT02249676|treatment|treatment
4864614|NCT02249663|Bioequivalence|bioequivalence
4864615|NCT02249650|metastatic colorectal cancer|metastatic colorectal cancer
4864616|NCT02249650|TSB-9-W1|tsb-9-w1
4864617|NCT02249624|Twin to twin transfusion syndrome|twin to twin transfusion syndrome
4864618|NCT02249624|Developmental disabilities|developmental disabilities
4864619|NCT02249624|Magnetic resonance imaging|magnetic resonance imaging
4864620|NCT02249611|Physical activity|physical activity
4864621|NCT02249611|mobile activity sensor and feedback system|mobile activity sensor and feedback system
4864622|NCT02249611|self-management of health|self-management of health
4864623|NCT02249572|Vestibular schwannoma|vestibular schwannoma
4864624|NCT02249572|Radiosurgery|radiosurgery
4864625|NCT02249572|Neurosurgery|neurosurgery
4864626|NCT02249572|Randomized|randomized
4864627|NCT02249533|Spot Light|spot light
4864628|NCT02249533|High School RIO|high school rio
4864629|NCT02249533|Concussion|concussion
4864630|NCT02249533|Injury Prevention|injury prevention
4864631|NCT02249533|Football|football
4864632|NCT02249533|Pop Warner|pop warner
4864633|NCT02249533|High School|high school
4864634|NCT02249533|Middle School|middle school
4864635|NCT02249520|Magnetic Resonance Imaging|magnetic resonance imaging
4864636|NCT02249520|MRI|mri
4864637|NCT02249520|Positron Emission Tomography|positron emission tomography
4864638|NCT02249520|PET|pet
4864639|NCT02249520|PET-MR|pet-mr
4864640|NCT02249520|mMR|mmr
4864641|NCT02249507|Resistant Hypertension|resistant hypertension
4864642|NCT02249507|Aerobic Exercise|aerobic exercise
4864643|NCT02249494|Nutritional Knowledge|nutritional knowledge
4864644|NCT02249494|Nutritional Counseling|nutritional counseling
4864645|NCT02249481|Anaesthetic|anaesthetic
4864646|NCT02249481|total knee replacement|total knee replacement
4864647|NCT02249481|Femoral nerve catheter|femoral nerve catheter
4864648|NCT02249481|Adductor canal catheter|adductor canal catheter
4864649|NCT02249429|Non Hodgkin Lymphoma|non hodgkin lymphoma
4864650|NCT02249377|Baker's Cyst|baker's cyst
4864651|NCT02249325|group B Streptococcus colonization|group b streptococcus colonization
4864652|NCT02249325|Probiotic|probiotic
4864653|NCT02249325|Pregnancy|pregnancy
4864654|NCT02249299|ADHD,|adhd,
4864655|NCT02249299|Cannabis,|cannabis,
4864656|NCT02249299|Sativex,|sativex,
4864657|NCT02249299|Endocannabinoid,|endocannabinoid,
4864658|NCT02249299|Cognition|cognition
4864659|NCT02249286|Child Centered Counseling|child centered counseling
4864660|NCT02249286|Home based food production|home based food production
4864661|NCT02249286|Nutrition|nutrition
4864662|NCT02249286|Health|health
4864663|NCT02249286|IYCF|iycf
4864664|NCT02249260|Exercise, cardiac rehabilitation, quality of life|exercise, cardiac rehabilitation, quality of life
4864665|NCT02249234|Scrotal pain|scrotal pain
4864666|NCT02249234|Botox|botox
4864667|NCT02249221|Influenza vaccine|influenza vaccine
4864668|NCT02249221|Vaccination|vaccination
4864669|NCT02249221|cell-culture based influenza vaccine|cell-culture based influenza vaccine
4864670|NCT02249221|cell culture derived influenza vaccine|cell culture derived influenza vaccine
4864671|NCT02249221|CCIV|cciv
4864672|NCT02249208|Breast Cancer|breast cancer
4864673|NCT02249208|Sentinel Lymph Node|sentinel lymph node
4864674|NCT02249208|Neoadjuvant Chemotherapy|neoadjuvant chemotherapy
4864675|NCT02249208|Clinically Node-Positive with biopsy-proven cN1|clinically node-positive with biopsy-proven cn1
4864676|NCT02249208|False-negative Rate|false-negative rate
4864677|NCT02249195|ECG loop recorder, pregnant women, arrhythmias|ecg loop recorder, pregnant women, arrhythmias
4864678|NCT02249169|IBS|ibs
4864679|NCT02249156|Health economics|health economics
4864680|NCT02249156|Financial incentives|financial incentives
4864681|NCT02249156|Health care spending|health care spending
4864682|NCT02249143|Continuous positive airway pressure|continuous positive airway pressure
4864683|NCT02249143|Prematurity|prematurity
4864684|NCT02249143|Respiratory distress syndrome|respiratory distress syndrome
4864685|NCT02249143|Bronchopulmonary dysplasia|bronchopulmonary dysplasia
4864686|NCT02249078|Crohn's Disease|crohn's disease
4864687|NCT02249013|Ovarian Cancer|ovarian cancer
4864688|NCT02248974|End-Stage Heart Failure|end-stage heart failure
4864689|NCT02248974|Left Ventricular Assist Device|left ventricular assist device
4864690|NCT02248974|Decision Aid|decision aid
4864691|NCT02248974|Medical Decision-Making|medical decision-making
4864692|NCT02248948|Omega-3|omega-3
4864693|NCT02248948|ADHD|adhd
4864694|NCT02248948|Quality of Life|quality of life
4864695|NCT02248948|Inattention|inattention
4864696|NCT02248948|Hyperactivity|hyperactivity
4864697|NCT02248935|Robotic Assisted Laparoscopic Sacrocolpopexy|robotic assisted laparoscopic sacrocolpopexy
4864698|NCT02248935|Y Mesh|y mesh
4864699|NCT02248935|Pelvic Organ Prolapse|pelvic organ prolapse
4864700|NCT02248922|Cystic Fibrosis, Pseudomonas aeruginosa, Lung Clearance Index, Multiple Breath Washout, Inhaled Tobramycin, Inhaled Antibiotics.|cystic fibrosis, pseudomonas aeruginosa, lung clearance index, multiple breath washout, inhaled tobramycin, inhaled antibiotics.
4864701|NCT02248909|COPD, Primary Care, Spirometry, Risk factors|copd, primary care, spirometry, risk factors
4864702|NCT02248870|femoral neck|femoral neck
4864703|NCT02248857|UMS|ums
4864704|NCT02248857|medication schedule|medication schedule
4864705|NCT02248857|diabetes|diabetes
4864706|NCT02248857|drug labeling|drug labeling
4864707|NCT02248831|Dyspnea|dyspnea
4864708|NCT02248831|Acute decompensated heart failure|acute decompensated heart failure
4864709|NCT02248831|Doppler ultrasound|doppler ultrasound
4864710|NCT02248831|Lung Doppler signals|lung doppler signals
4864711|NCT02248805|colon cancer|colon cancer
4864712|NCT02248805|colorectal carcinoma|colorectal carcinoma
4864713|NCT02248805|stage IV colorectal cancer|stage iv colorectal cancer
4864714|NCT02248779|Diabetes Risk|diabetes risk
4864715|NCT02248779|14-202|14-202
4864716|NCT02248753|Atrial fibrillation|atrial fibrillation
4864717|NCT02248753|Electrical cardioversion|electrical cardioversion
4864718|NCT02248753|Pharmacological cardioversion|pharmacological cardioversion
4864719|NCT02248753|Rhythm control|rhythm control
4864720|NCT02248753|Rate control|rate control
4864721|NCT02248740|chronic venous insufficiency|chronic venous insufficiency
4864722|NCT02248740|varicose vein|varicose vein
4864723|NCT02248740|small saphenous vein|small saphenous vein
4864724|NCT02248701|Testosterone|testosterone
4864725|NCT02248701|Testosterone enanthate|testosterone enanthate
4864726|NCT02248701|Testosterone undecanoate|testosterone undecanoate
4864727|NCT02248701|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate
4864728|NCT02248701|Methyltestosterone|methyltestosterone
4864729|NCT02248701|Androgens|androgens
4864730|NCT02248701|Hormones|hormones
4864731|NCT02248701|Hormone Substitutes, and Hormone Antagonists|hormone substitutes, and hormone antagonists
4864732|NCT02248701|Physiologic Effects of Drugs|physiologic effects of drugs
4864733|NCT02248701|Pharmacologic Actions|pharmacologic actions
4864734|NCT02248701|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal
4864735|NCT02248701|Antineoplastic Agents|antineoplastic agents
4864736|NCT02248701|Therapeutic Uses|therapeutic uses
4864737|NCT02248701|Anabolic Agents|anabolic agents
4864738|NCT02248701|Testosterone Replacement Therapy|testosterone replacement therapy
4864739|NCT02248701|Dual Energy X ray Absorptiometry|dual energy x ray absorptiometry
4864740|NCT02248701|Lean Tissue Mass|lean tissue mass
4864741|NCT02248701|Body Composition|body composition
4864742|NCT02248701|Lipid and Glucose profile|lipid and glucose profile
4864743|NCT02248701|Muscle Strength|muscle strength
4864744|NCT02248701|5-alpha Reductase|5-alpha reductase
4864745|NCT02248701|Muscle Mass|muscle mass
4864746|NCT02248701|Bone Mineral Density|bone mineral density
4864747|NCT02248701|Adipose Tissue|adipose tissue
4864748|NCT02248701|Body Fat|body fat
4864749|NCT02248701|Density, Bone|density, bone
4864750|NCT02248701|Bone Formation|bone formation
4864751|NCT02248701|Bone Resorption|bone resorption
4864853|NCT02248350|intervention|intervention
4864752|NCT02248701|Bone Density Conservation Agents|bone density conservation agents
4864753|NCT02248701|Magnetic Resonance Imaging|magnetic resonance imaging
4864754|NCT02248701|Muscle, Skeletal|muscle, skeletal
4864755|NCT02248701|Bone and Bones|bone and bones
4864756|NCT02248701|Gait|gait
4864757|NCT02248701|Walking|walking
4864758|NCT02248701|Locomotion|locomotion
4864759|NCT02248701|Motor Activity|motor activity
4864760|NCT02248688|Bariatric Embolization|bariatric embolization
4864761|NCT02248688|Gastric Artery Emboliziation|gastric artery emboliziation
4864762|NCT02248688|Left Gastric Artery Embolization|left gastric artery embolization
4864763|NCT02248688|Morbid Obesity|morbid obesity
4864764|NCT02248688|Obesity|obesity
4864765|NCT02248688|Weight Loss|weight loss
4864766|NCT02248688|Ghrelin|ghrelin
4864767|NCT02248688|Embolization|embolization
4864768|NCT02248675|sleep disorders|sleep disorders
4864769|NCT02248675|insomnia|insomnia
4864770|NCT02248675|suicidal ideation|suicidal ideation
4864771|NCT02248675|Depression|depression
4864772|NCT02248675|Depressive disorders|depressive disorders
4864773|NCT02248675|PTSD|ptsd
4864774|NCT02248675|anxiety disorders|anxiety disorders
4864775|NCT02248675|suicide|suicide
4864776|NCT02248675|cognitive behavioral therapy|cognitive behavioral therapy
4864777|NCT02248662|DCIS|dcis
4864778|NCT02248662|PCORI|pcori
4864779|NCT02248662|ductal carcinoma in situ|ductal carcinoma in situ
4864780|NCT02248662|radiation|radiation
4864781|NCT02248662|oncology|oncology
4864782|NCT02248662|patient-centered|patient-centered
4864783|NCT02248662|decision aid|decision aid
4864784|NCT02248662|decision-making|decision-making
4864785|NCT02248649|Parkinson's disease|parkinson's disease
4864786|NCT02248649|Exercise therapy|exercise therapy
4864787|NCT02248649|Mild cognitive impairment|mild cognitive impairment
4864788|NCT02248636|Alzheimer's disease|alzheimer's disease
4864789|NCT02248636|Cholinesterase inhibitor|cholinesterase inhibitor
4864790|NCT02248636|Discontinuation|discontinuation
4864791|NCT02248623|Anaesthesia|anaesthesia
4864792|NCT02248623|Isolated forearm test|isolated forearm test
4864793|NCT02248623|Responsiveness|responsiveness
4864794|NCT02248623|Laryngoscopy|laryngoscopy
4864795|NCT02248623|Intubation|intubation
4864796|NCT02248610|Pulmonary embolism|pulmonary embolism
4864797|NCT02248610|PE|pe
4864798|NCT02248610|Deep vein thrombosis|deep vein thrombosis
4864799|NCT02248610|DVT|dvt
4864800|NCT02248610|Rivaroxaban|rivaroxaban
4864801|NCT02248610|Venous thromboembolism|venous thromboembolism
4864802|NCT02248610|Chronic thromboembolic pulmonary hypertension|chronic thromboembolic pulmonary hypertension
4864803|NCT02248610|Post thrombotic limb syndrome|post thrombotic limb syndrome
4864804|NCT02248610|Root cause analysis|root cause analysis
4864805|NCT02248571|breast cancer|breast cancer
4864806|NCT02248571|advanced|advanced
4864807|NCT02248571|inoperable|inoperable
4864808|NCT02248571|metastatic|metastatic
4864809|NCT02248571|HER2/neu-negative|her2/neu-negative
4864810|NCT02248571|hormone receptor positive|hormone receptor positive
4864812|NCT02248571|female|female
4864813|NCT02248571|postmenopausal|postmenopausal
4864814|NCT02248558|Contest|contest
4864815|NCT02248558|Crowdsourcing|crowdsourcing
4864816|NCT02248558|Innovation|innovation
4864817|NCT02248558|Randomized controlled trial|randomized controlled trial
4864818|NCT02248558|China|china
4864819|NCT02248558|Social entrepreneurship|social entrepreneurship
4864820|NCT02248545|Non-Celiac Wheat Sensitivity|non-celiac wheat sensitivity
4864821|NCT02248545|Autoimmune diseases|autoimmune diseases
4864822|NCT02248545|Anti-nuclear antibodies|anti-nuclear antibodies
4864823|NCT02248545|Celiac disease|celiac disease
4864824|NCT02248545|Irritable bowel syndrome|irritable bowel syndrome
4864825|NCT02248519|Gastric cancer|gastric cancer
4864826|NCT02248519|Gastrectomy|gastrectomy
4864827|NCT02248519|Laparoscopy|laparoscopy
4864828|NCT02248506|Candidiasis|candidiasis
4864829|NCT02248493|Pain, Postoperative|pain, postoperative
4864830|NCT02248493|Paracetamol|paracetamol
4864831|NCT02248493|Administration, Intravenous|administration, intravenous
4864832|NCT02248493|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal
4864833|NCT02248493|Child|child
4864834|NCT02248493|Adolescent|adolescent
4864835|NCT02248467|Testosterone replacement therapy|testosterone replacement therapy
4864836|NCT02248428|multiple myeloma|multiple myeloma
4864837|NCT02248428|Clarithromycin|clarithromycin
4864838|NCT02248428|CTd|ctd
4864839|NCT02248415|Cardioplegic Solutions|cardioplegic solutions
4864840|NCT02248415|Myocardial Ischemia|myocardial ischemia
4864841|NCT02248389|carcinoma, renal cell|carcinoma, renal cell
4864842|NCT02248389|ablation|ablation
4864843|NCT02248389|laparoscopic surgery|laparoscopic surgery
4864844|NCT02248389|high intensity focused ultrasound|high intensity focused ultrasound
4864845|NCT02248376|Uterine synechiae Scraping surgery Natural miscarriage|uterine synechiae scraping surgery natural miscarriage
4864846|NCT02248363|Rehabilitation|rehabilitation
4864847|NCT02248363|Effectiveness|effectiveness
4864848|NCT02248363|Determinants|determinants
4864849|NCT02248363|Prediction|prediction
4864850|NCT02248350|prostate cancer|prostate cancer
4864851|NCT02248350|physical activity|physical activity
4864852|NCT02248350|exercise|exercise
4864854|NCT02248350|side effects|side effects
4864855|NCT02248350|androgen deprivation therapy|androgen deprivation therapy
4864856|NCT02248337|Colon preparation; Colonoscopy; Inflammatory bowel disease|colon preparation; colonoscopy; inflammatory bowel disease
4864857|NCT02248324|Age-related macular degeneration, genetic polymorphisms|age-related macular degeneration, genetic polymorphisms
4864858|NCT02248298|Ablative fractional laser|ablative fractional laser
4864859|NCT02248298|Actinic keratosis|actinic keratosis
4864860|NCT02248298|Efficacy|efficacy
4864861|NCT02248298|Photodynamic therapy|photodynamic therapy
4864862|NCT02248298|Short incubation time|short incubation time
4864863|NCT02248285|multiplex|multiplex
4864864|NCT02248285|polymerase chain reaction|polymerase chain reaction
4864865|NCT02248285|PCR|pcr
4864866|NCT02248285|BioFire Diagnostics|biofire diagnostics
4864867|NCT02248285|Infectious gastroenteritis|infectious gastroenteritis
4864868|NCT02248285|Diarrheal disease|diarrheal disease
4864869|NCT02248285|Emergency department|emergency department
4864870|NCT02248285|rapid diagnostics|rapid diagnostics
4864871|NCT02248285|FilmArray|filmarray
4864872|NCT02248285|FilmArray GI Panel|filmarray gi panel
4864873|NCT02248272|Polycystic ovary syndrome|polycystic ovary syndrome
4864874|NCT02248272|Type 2 Diabetes|type 2 diabetes
4864875|NCT02248272|Hyperinsulinemia|hyperinsulinemia
4864876|NCT02248272|Meal frequency|meal frequency
4864877|NCT02248246|Hemostasis|hemostasis
4864878|NCT02248246|Harmonic ACE®+7 Shears|harmonic ace®+7 shears
4864879|NCT02248246|Laparoscopic|laparoscopic
4864880|NCT02248246|Inferior mesenteric artery|inferior mesenteric artery
4864881|NCT02248246|Inferior mesenteric vein|inferior mesenteric vein
4864882|NCT02248246|Observational|observational
4864883|NCT02248233|nimodipine|nimodipine
4864884|NCT02248233|acute massive cerebral infarction|acute massive cerebral infarction
4864885|NCT02248233|Cerebral Infarction|cerebral infarction
4864886|NCT02248233|optimal therapeutic time window|optimal therapeutic time window
4864887|NCT02248233|optimal dose|optimal dose
4864888|NCT02248233|multi-center|multi-center
4864889|NCT02248194|Dysfunction uterine bleeding|dysfunction uterine bleeding
4864890|NCT02248194|Hysteroscopic endometrial ablation|hysteroscopic endometrial ablation
4864891|NCT02248194|Tactile endometrial ablation|tactile endometrial ablation
4864892|NCT02248194|Hysteroscopic difficulties|hysteroscopic difficulties
4864893|NCT02248194|Quality of life|quality of life
4864894|NCT02248194|Satisfaction|satisfaction
4864895|NCT02248090|Phase 1|phase 1
4864896|NCT02248090|Safety|safety
4864897|NCT02248090|Tolerability|tolerability
4864898|NCT02248090|Pharmacokinetics|pharmacokinetics
4864899|NCT02248090|Ascending Doses|ascending doses
4864900|NCT02248090|Estrogen Receptor Positive|estrogen receptor positive
4864901|NCT02248090|Her2 Negative|her2 negative
4864902|NCT02248090|Advanced Breast Cancer|advanced breast cancer
4864903|NCT02248064|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
4864904|NCT02248064|Long term oxygen therapy|long term oxygen therapy
4864905|NCT02248064|Auto-titrating oxygen system|auto-titrating oxygen system
4864906|NCT02248064|Intelligent oxygen therapy|intelligent oxygen therapy
4864907|NCT02248064|Idiopathic pulmonary fibrosis|idiopathic pulmonary fibrosis
4864908|NCT02248025|Fluid responsiveness|fluid responsiveness
4864909|NCT02248025|capillary refill time|capillary refill time
4864910|NCT02248025|microcirculation|microcirculation
4864911|NCT02248025|circulatory failure|circulatory failure
4864912|NCT02248025|passive leg raising|passive leg raising
4864913|NCT02248012|Gastroenteropancreatic|gastroenteropancreatic
4864914|NCT02248012|Neuroendocrine carcinoma|neuroendocrine carcinoma
4864915|NCT02248012|Chemotherapy|chemotherapy
4864916|NCT02247999|Cervical Cancer|cervical cancer
4864917|NCT02247999|HIV/AIDS|hiv/aids
4864918|NCT02247999|HPV|hpv
4864919|NCT02247999|Biomarkers|biomarkers
4864920|NCT02247999|Screening|screening
4864921|NCT02247986|Conduct Disorder|conduct disorder
4864922|NCT02247986|Methylphenidate|methylphenidate
4864923|NCT02247986|Disruptive Behavior Disorders|disruptive behavior disorders
4864924|NCT02247947|CPR|cpr
4864925|NCT02247934|Primary sclerosing cholangitis|primary sclerosing cholangitis
4864926|NCT02247934|PSC|psc
4864927|NCT02247921|caregiver delivered rehabilitation|caregiver delivered rehabilitation
4864928|NCT02247921|nurse-organized service|nurse-organized service
4864929|NCT02247921|disabled stroke patients|disabled stroke patients
4864930|NCT02247908|Cigarette smoking|cigarette smoking
4864931|NCT02247908|Smoke|smoke
4864932|NCT02247908|Smoking|smoking
4864933|NCT02247908|Tobacco Use|tobacco use
4864934|NCT02247895|ICU Acquired weakness|icu acquired weakness
4864935|NCT02247895|Critical illness|critical illness
4864936|NCT02247895|Mechanical ventilation|mechanical ventilation
4864937|NCT02247882|Osteoarthritis|osteoarthritis
4864938|NCT02247882|Patient Education|patient education
4864939|NCT02247882|Aquatic Exercise|aquatic exercise
4864940|NCT02247882|kinetic|kinetic
4864941|NCT02247869|HL|hl
4864942|NCT02247869|Hodgkin Lymphoma|hodgkin lymphoma
4864943|NCT02247869|First line therapy|first line therapy
4864944|NCT02247856|nebulizers,|nebulizers,
4864945|NCT02247856|noninvasive ventilation|noninvasive ventilation
4864946|NCT02247856|COPD|copd
4864947|NCT02247856|scintigraphy,|scintigraphy,
4864948|NCT02247856|aerosol|aerosol
4864949|NCT02247843|Sickle Cell Disease (SCD)|sickle cell disease (scd)
4864950|NCT02247843|Gene Therapy|gene therapy
4864951|NCT02247843|Lentiviral Vector|lentiviral vector
4864952|NCT02247843|Beta Globin|beta globin
4864953|NCT02247830|Radiodermatitis|radiodermatitis
4864954|NCT02247830|Head and neck neoplasms|head and neck neoplasms
4864955|NCT02247830|Radiotherapy|radiotherapy
4864956|NCT02247830|Urea|urea
4864957|NCT02247830|Matricaria|matricaria
4864958|NCT02247830|Breast Neoplasms|breast neoplasms
4864959|NCT02247830|chamomilla|chamomilla
4864960|NCT02247830|chamomile|chamomile
4864961|NCT02247778|clavicle|clavicle
4864962|NCT02247778|surgical intervention|surgical intervention
4864963|NCT02247778|mini-incision|mini-incision
4864964|NCT02247778|plate osteosynthesis|plate osteosynthesis
4864965|NCT02247752|hepatitis|hepatitis
4864966|NCT02247752|HBV|hbv
4864967|NCT02247752|chronic hepatitis|chronic hepatitis
4864968|NCT02247752|HCC|hcc
4864969|NCT02247752|cirrhosis|cirrhosis
4864970|NCT02247752|quantitative HBsAg|quantitative hbsag
4864971|NCT02247752|HBsAg inactive carriers|hbsag inactive carriers
4864972|NCT02247739|HAE|hae
4864973|NCT02247739|Hereditary Angioedema|hereditary angioedema
4864974|NCT02247739|Prophylaxis|prophylaxis
4864975|NCT02247726|RSV|rsv
4864976|NCT02247726|Third Trimester|third trimester
4864977|NCT02247726|Maternal Immunization|maternal immunization
4864978|NCT02247713|PET|pet
4864979|NCT02247713|radiotherapy|radiotherapy
4864980|NCT02247713|international|international
4864981|NCT02247713|NSCLC|nsclc
4864982|NCT02247713|overall survival|overall survival
4864983|NCT02247713|low and middle income countries|low and middle income countries
4864984|NCT02247700|Pediatrics|pediatrics
4864985|NCT02247700|ARDS|ards
4864986|NCT02247700|ARF|arf
4864987|NCT02247700|ALI|ali
4864988|NCT02247700|Respiratory|respiratory
4864989|NCT02247700|Mechanical ventilation|mechanical ventilation
4864990|NCT02247700|Ventilation|ventilation
4864991|NCT02247700|Noninvasive monitoring|noninvasive monitoring
4864992|NCT02247700|electrical impedance tomography|electrical impedance tomography
4864993|NCT02247700|EIT|eit
4864994|NCT02247687|HIV-1|hiv-1
4864995|NCT02247687|antiretroviral treatment|antiretroviral treatment
4864996|NCT02247687|viral load|viral load
4864997|NCT02247674|Stroke, Cerebrovascular accident, Rehabilitation, Upper extremity|stroke, cerebrovascular accident, rehabilitation, upper extremity
4864998|NCT02247661|Femoral neck fracture,surgical approach, limp, abductor strenght, trochanteric pain|femoral neck fracture,surgical approach, limp, abductor strenght, trochanteric pain
4864999|NCT02247648|tramadol|tramadol
4865000|NCT02247648|shoulder surgery|shoulder surgery
4865001|NCT02247648|pain|pain
4865002|NCT02247648|interscalen block|interscalen block
4865003|NCT02247648|BUPRENORPHINE/HYDROMORPHONE [VA Drug Interaction]|buprenorphine/hydromorphone [va drug interaction]
4865004|NCT02247635|Treatment adherence|treatment adherence
4865005|NCT02247635|Behavioral model of health care|behavioral model of health care
4865006|NCT02247635|Healthy lifestyle|healthy lifestyle
4865007|NCT02247635|Chronic metabolic diseases|chronic metabolic diseases
4865008|NCT02247635|Metabolic syndrome|metabolic syndrome
4865009|NCT02247635|Obesity|obesity
4865010|NCT02247622|telomeres|telomeres
4865011|NCT02247622|PSC|psc
4865012|NCT02247609|B cell lymphoma|b cell lymphoma
4865013|NCT02247609|non-Hodgkin's lymphoma|non-hodgkin's lymphoma
4865014|NCT02247609|Burkitt lymphoma|burkitt lymphoma
4865015|NCT02247609|diffused large B cell lymphoma|diffused large b cell lymphoma
4865016|NCT02247609|B cell malignancy|b cell malignancy
4865017|NCT02247596|Resveratrol|resveratrol
4865018|NCT02247596|obesity|obesity
4865019|NCT02247596|insulin resistance|insulin resistance
4865020|NCT02247596|energy expenditure|energy expenditure
4865021|NCT02247596|diabetes|diabetes
4865022|NCT02247570|Vestibular Rehabilitation|vestibular rehabilitation
4865023|NCT02247570|PTSD|ptsd
4865024|NCT02247570|DSM-IV|dsm-iv
4865025|NCT02247557|IC/PBS|ic/pbs
4865026|NCT02247557|VAS|vas
4865027|NCT02247557|Botulinum Toxin A|botulinum toxin a
4865028|NCT02247557|Lipotoxin|lipotoxin
4865029|NCT02247544|STS, leiomyosarcoma, liposarcoma, trabectedin|sts, leiomyosarcoma, liposarcoma, trabectedin
4865030|NCT02247518|Male|male
4865031|NCT02247518|Volunteers|volunteers
4865032|NCT02247492|International|international
4865033|NCT02247492|Multicenter|multicenter
4865034|NCT02247492|Observational registry|observational registry
4865035|NCT02247492|Orsiro Drug Eluting Stent (DES)|orsiro drug eluting stent (des)
4865036|NCT02247492|Stenting|stenting
4865037|NCT02247492|Treatment of coronary artery disease|treatment of coronary artery disease
4865038|NCT02247492|Coronary revascularization|coronary revascularization
4865039|NCT02247492|Percutaneous Coronary Intervention (PCI)|percutaneous coronary intervention (pci)
4865040|NCT02247492|STEMI|stemi
4865041|NCT02247492|NSTEMI|nstemi
4865042|NCT02247492|Ischemia|ischemia
4865043|NCT02247492|Angina|angina
4865044|NCT02247492|Acute Myocardial Infarction (AMI)|acute myocardial infarction (ami)
4865045|NCT02247492|Small Vessels|small vessels
4865046|NCT02247492|Chronic Total Occlusion (CTO|chronic total occlusion (cto
4865047|NCT02247466|Neuromuscular Blockade|neuromuscular blockade
4865048|NCT02247466|Laparoscopy|laparoscopy
4865049|NCT02247453|lung cancer|lung cancer
4865050|NCT02247453|clinical trial|clinical trial
4865051|NCT02247453|screening|screening
4865052|NCT02247453|microRNA|microrna
4865053|NCT02247453|biomarkers|biomarkers
4865055|NCT02247440|HIV|hiv
4865056|NCT02247440|Thailand|thailand
4865057|NCT02247440|pegylated interferon|pegylated interferon
4865058|NCT02247440|ribavirin|ribavirin
4865059|NCT02247427|Heart failure|heart failure
4865060|NCT02247427|Super responder|super responder
4865061|NCT02247414|Cirrhosis|cirrhosis
4865062|NCT02247414|Hypertension|hypertension
4865063|NCT02247414|venous thrombosis|venous thrombosis
4865064|NCT02247414|Warfarin|warfarin
4865065|NCT02247414|Splenectomy|splenectomy
4865066|NCT02247414|Azygoportal Disconnection|azygoportal disconnection
4865067|NCT02247414|Laparoscopy|laparoscopy
4865068|NCT02247401|Genotype 4|genotype 4
4865069|NCT02247401|non-responder|non-responder
4865070|NCT02247401|treatment experienced|treatment experienced
4865071|NCT02247401|HCV|hcv
4865072|NCT02247401|naive|naive
4865073|NCT02247401|relapser|relapser
4865074|NCT02247401|hepatitis infection|hepatitis infection
4865075|NCT02247401|compensated cirrhosis|compensated cirrhosis
4865076|NCT02247401|hepatitis c|hepatitis c
4865077|NCT02247401|Cirrhosis|cirrhosis
4865078|NCT02247401|Egypt|egypt
4865079|NCT02247401|null responder|null responder
4865080|NCT02247401|partial responder|partial responder
4865081|NCT02247388|Alcohol Dependence|alcohol dependence
4865082|NCT02247388|Alcoholism|alcoholism
4865083|NCT02247388|AB-CASI|ab-casi
4865084|NCT02247388|Emergency Department|emergency department
4865085|NCT02247362|Safety|safety
4865086|NCT02247362|Immunogenicity|immunogenicity
4865087|NCT02247336|colorectal cancer|colorectal cancer
4865088|NCT02247336|early detection of cancer|early detection of cancer
4865089|NCT02247297|Pancreatic stone protein (PSP)|pancreatic stone protein (psp)
4865090|NCT02247297|premature rupture of membranes (PPROM)|premature rupture of membranes (pprom)
4865091|NCT02247297|amniotic infection syndrome (AIS)|amniotic infection syndrome (ais)
4865092|NCT02247297|hemolysis, elevated liver enzymes, and low platelets (HELLP)|hemolysis, elevated liver enzymes, and low platelets (hellp)
4865093|NCT02247297|preeclampsia|preeclampsia
4865094|NCT02247297|pregnancy|pregnancy
4865095|NCT02247271|peer coaches|peer coaches
4865096|NCT02247245|CHF|chf
4865097|NCT02247245|AF|af
4865098|NCT02247245|SR|sr
4865099|NCT02247245|HFREF|hfref
4865100|NCT02247245|CRT|crt
4865101|NCT02247219|Health education|health education
4865102|NCT02247219|Health services research|health services research
4865103|NCT02247206|Tourette Syndrome|tourette syndrome
4865104|NCT02247206|tic disorders|tic disorders
4865105|NCT02247206|behavior therapy|behavior therapy
4865106|NCT02247206|web-based videoconferencing|web-based videoconferencing
4865107|NCT02247206|VoIP|voip
4865108|NCT02247193|Botulinum Toxin|botulinum toxin
4865109|NCT02247193|Botox|botox
4865110|NCT02247193|Craniofacial deformity|craniofacial deformity
4865111|NCT02247167|obstructive sleep apnoea, oxidative stress, FMD|obstructive sleep apnoea, oxidative stress, fmd
4865112|NCT02247128|Transcatheter Aortic Valve Implantation (TAVI)|transcatheter aortic valve implantation (tavi)
4865113|NCT02247128|Transcatheter Aortic Valve Replacement (TAVR)|transcatheter aortic valve replacement (tavr)
4865114|NCT02247128|Aortic Valve Disease|aortic valve disease
4865115|NCT02247128|Aortic Stenosis|aortic stenosis
4865116|NCT02247128|Myocardial Infarction|myocardial infarction
4865117|NCT02247128|Ischemic stroke|ischemic stroke
4865118|NCT02247128|Bleeding|bleeding
4865119|NCT02247128|Thrombosis|thrombosis
4865120|NCT02247128|Myocardial Ischemia|myocardial ischemia
4865121|NCT02247128|Heart Diseases|heart diseases
4865122|NCT02247128|Cardiovascular Diseases|cardiovascular diseases
4865123|NCT02247128|Vascular Diseases|vascular diseases
4865124|NCT02247128|Embolism and Thrombosis|embolism and thrombosis
4865125|NCT02247128|Aspirin|aspirin
4865126|NCT02247128|Clopidogrel|clopidogrel
4865127|NCT02247128|Prasugrel|prasugrel
4865128|NCT02247128|Ticagrelor|ticagrelor
4865129|NCT02247128|Antithrombotic treatment|antithrombotic treatment
4865130|NCT02247128|Oral anticoagulation|oral anticoagulation
4865131|NCT02247128|Warfarin|warfarin
4865132|NCT02247128|Platelet Aggregation Inhibitors|platelet aggregation inhibitors
4865133|NCT02247128|Genetic Testing|genetic testing
4865134|NCT02247128|Cytochrome P450 2C19 (CYP2C19)|cytochrome p450 2c19 (cyp2c19)
4865135|NCT02247128|Prostaglandin-endoperoxide synthase 2(PTGS2)|prostaglandin-endoperoxide synthase 2(ptgs2)
4865136|NCT02247115|endoscopic ultrasound|endoscopic ultrasound
4865137|NCT02247115|endoscopic retrograde cholangiopancreatography|endoscopic retrograde cholangiopancreatography
4865138|NCT02247115|competency|competency
4865139|NCT02247089|Night Shift work|night shift work
4865140|NCT02247089|Stress|stress
4865141|NCT02247089|Autonomic nervous system (ANS)|autonomic nervous system (ans)
4865142|NCT02247089|Heart rate variability (HRV)|heart rate variability (hrv)
4865143|NCT02247089|Pre-ejection period (PEP)|pre-ejection period (pep)
4865144|NCT02247089|Inflammation|inflammation
4865145|NCT02247089|Pro-inflammatory cytokines|pro-inflammatory cytokines
4865146|NCT02247089|Massage Therapy|massage therapy
4865147|NCT02247050|Costs and Cost Analysis|costs and cost analysis
4865148|NCT02247050|Professional Practice|professional practice
4865149|NCT02247050|Attitude of Health Personnel|attitude of health personnel
4865150|NCT02247050|Health Knowledge, Attitudes, and Practice|health knowledge, attitudes, and practice
4865151|NCT02247050|Decision Making|decision making
4865152|NCT02247050|Practice Guidelines as Topic|practice guidelines as topic
4865153|NCT02247050|Physician-Patient Relations|physician-patient relations
4865154|NCT02247050|Physician's Role|physician's role
4865155|NCT02247050|Health Care|health care
4865156|NCT02247050|Quality of Health Care|quality of health care
4865157|NCT02247050|Quality Assurance|quality assurance
4865158|NCT02247050|Physicians, Primary Care|physicians, primary care
4865159|NCT02247050|Evidence-Based Medicine|evidence-based medicine
4865160|NCT02247050|Evidence-Based Practice|evidence-based practice
4865161|NCT02247050|Decision Support Systems, Clinical|decision support systems, clinical
4865162|NCT02247050|Reminder Systems|reminder systems
4865163|NCT02247050|Judgment|judgment
4865164|NCT02247050|Cognition|cognition
4865165|NCT02247050|Patient Care|patient care
4865166|NCT02247050|Health Services Misuse|health services misuse
4865167|NCT02247050|Unnecessary Procedures|unnecessary procedures
4865168|NCT02247050|Prescribing Patterns, Physician|prescribing patterns, physician
4865169|NCT02247050|Inappropriate Prescribing|inappropriate prescribing
4865170|NCT02247050|Over Prescribing|over prescribing
4865171|NCT02247050|Low Back Pain|low back pain
4865172|NCT02247050|Sinusitis|sinusitis
4865173|NCT02247050|Infections, Upper Respiratory|infections, upper respiratory
4865174|NCT02247050|Generalized Headache|generalized headache
4865175|NCT02247050|Imaging, Diagnostic|imaging, diagnostic
4865176|NCT02247050|Antibiotics|antibiotics
4865177|NCT02247050|Humans|humans
4865178|NCT02247050|Overuse of Low-Value Services|overuse of low-value services
4865179|NCT02247050|Pragmatic Trial|pragmatic trial
4865180|NCT02247050|Stepped Wedge Design|stepped wedge design
4865181|NCT02247050|Cluster Randomized Trial|cluster randomized trial
4865182|NCT02247050|Choosing Wisely|choosing wisely
4865183|NCT02247037|Triple Negative Breast Cancer|triple negative breast cancer
4865184|NCT02247037|Patient Derived Xenograft|patient derived xenograft
4865185|NCT02247037|Neoadjuvant Chemotherapy|neoadjuvant chemotherapy
4865186|NCT02247037|Therapeutic Resistance|therapeutic resistance
4865187|NCT02247011|bone mineral density|bone mineral density
4865188|NCT02247011|25(OH)D|25(oh)d
4865189|NCT02246985|Processed foods|processed foods
4865190|NCT02246985|Carotenoids in plasma, urine and faeces|carotenoids in plasma, urine and faeces
4865191|NCT02246985|alpha-carotene|alpha-carotene
4865192|NCT02246985|beta-carotene|beta-carotene
4865193|NCT02246985|Vitamin A|vitamin a
4865194|NCT02246985|Lycopene|lycopene
4865195|NCT02246985|Gut absorption|gut absorption
4865196|NCT02246985|Bread|bread
4865197|NCT02246985|Mayonnaise|mayonnaise
4865198|NCT02246985|Bioavailability|bioavailability
4865199|NCT02246985|Fruits and Vegetables|fruits and vegetables
4865200|NCT02246985|Inflammation|inflammation
4865201|NCT02246985|Oxidative Stress|oxidative stress
4865202|NCT02246972|PTSD|ptsd
4865203|NCT02246972|Military sexual trauma|military sexual trauma
4865204|NCT02246972|Veterans|veterans
4865205|NCT02246972|Women in the military|women in the military
4865206|NCT02246972|Sexual assault|sexual assault
4865207|NCT02246946|pleural effusion|pleural effusion
4865208|NCT02246946|chest tube|chest tube
4865209|NCT02246946|respiratory therapy|respiratory therapy
4865210|NCT02246946|intermittent positive-pressure breathing|intermittent positive-pressure breathing
4865211|NCT02246946|lung function|lung function
4865212|NCT02246946|pulmonary complications|pulmonary complications
4865213|NCT02246920|Bioequivalence|bioequivalence
4865214|NCT02246920|Allergic Rhinitis|allergic rhinitis
4865215|NCT02246907|Health related quality of life|health related quality of life
4865216|NCT02246855|Subjects|subjects
4865217|NCT02246842|Volunteers|volunteers
4865218|NCT02246829|wet AMD, SD-OCT, intravitreal injection, central retinal thickness,|wet amd, sd-oct, intravitreal injection, central retinal thickness,
4865219|NCT02246816|Short Bowel Syndrome|short bowel syndrome
4865220|NCT02246816|SBS|sbs
4865221|NCT02246816|Chronic Diarrhea|chronic diarrhea
4865222|NCT02246816|Short Bowel|short bowel
4865223|NCT02246816|Short Gut|short gut
4865224|NCT02246816|Short Gut Syndrome|short gut syndrome
4865225|NCT02246816|Anti-Diarrheal|anti-diarrheal
4865226|NCT02246816|Opium Tincture|opium tincture
4865227|NCT02246816|loperamide|loperamide
4865228|NCT02246816|diphenoxylate|diphenoxylate
4865229|NCT02246816|ileostomies|ileostomies
4865230|NCT02246816|tincture of opium|tincture of opium
4865231|NCT02246816|DTO|dto
4865232|NCT02246816|codeine|codeine
4865233|NCT02246816|morphine|morphine
4865234|NCT02246816|opiate|opiate
4865235|NCT02246803|paroxysmal atrial fibrillation, CABG, pulmonary vein isolation|paroxysmal atrial fibrillation, cabg, pulmonary vein isolation
4865236|NCT02246790|ablation, CABG|ablation, cabg
4865237|NCT02246790|Long-standing persistent Atrial Fibrillation|long-standing persistent atrial fibrillation
4865238|NCT02246777|Glaucoma|glaucoma
4865239|NCT02246764|Ocular hypertension.|ocular hypertension.
4865240|NCT02246764|Glaucoma|glaucoma
4865241|NCT02246751|postural control|postural control
4865242|NCT02246751|Targeted Training|targeted training
4865243|NCT02246751|cerebral palsy|cerebral palsy
4865244|NCT02246751|sensorimotor control|sensorimotor control
4865245|NCT02246751|trunk segments|trunk segments
4865246|NCT02246725|Colorectal Neoplasms|colorectal neoplasms
4865247|NCT02246725|Depression|depression
4865248|NCT02246725|Intestinal Neoplasms|intestinal neoplasms
4865249|NCT02246725|Gastrointestinal Neoplasms|gastrointestinal neoplasms
4865250|NCT02246725|Digestive System Neoplasms|digestive system neoplasms
4865251|NCT02246725|Digestive System Diseases|digestive system diseases
4865252|NCT02246725|Gastrointestinal Diseases|gastrointestinal diseases
4865253|NCT02246725|Intestinal Diseases|intestinal diseases
4865254|NCT02246725|Palliative chemotherapy|palliative chemotherapy
4865255|NCT02246725|Palliative care|palliative care
4865256|NCT02246725|Palliative treatment|palliative treatment
4865257|NCT02246725|Quality of life|quality of life
4865258|NCT02246725|Quality of life for relatives|quality of life for relatives
4865259|NCT02246725|Survival|survival
4865260|NCT02246712|tramadol|tramadol
4865261|NCT02246712|pharmacokinetics|pharmacokinetics
4865262|NCT02246712|enantiomers|enantiomers
4865263|NCT02246712|metabolism|metabolism
4865264|NCT02246712|diabetes|diabetes
4865265|NCT02246699|obesity|obesity
4865266|NCT02246699|overweight|overweight
4865267|NCT02246699|chitosan|chitosan
4865268|NCT02246699|fungal chitosan|fungal chitosan
4865269|NCT02246699|weight management|weight management
4865270|NCT02246686|Iberogast N|iberogast n
4865271|NCT02246686|Mild to moderate ulcerative colitis|mild to moderate ulcerative colitis
4865272|NCT02246686|add-on therapy|add-on therapy
4865273|NCT02246686|efficacy|efficacy
4865274|NCT02246660|Peripheral Artery Disease|peripheral artery disease
4865275|NCT02246660|Peripheral Arterial Disease|peripheral arterial disease
4865276|NCT02246660|PAD|pad
4865277|NCT02246634|Colorectal Neoplasms|colorectal neoplasms
4865278|NCT02246634|Neoplasm Metastases|neoplasm metastases
4865279|NCT02246634|Magnetic Resonance Imaging|magnetic resonance imaging
4865280|NCT02246634|Diffusion Weighted MRI|diffusion weighted mri
4865281|NCT02246634|Hepatic Neoplasms|hepatic neoplasms
4865282|NCT02246634|Tumors|tumors
4865283|NCT02246634|Neoplasms, Rectal|neoplasms, rectal
4865284|NCT02246621|MONARCH 3|monarch 3
4865285|NCT02246595|Sepsis|sepsis
4865286|NCT02246595|Severe Sepsis|severe sepsis
4865287|NCT02246595|Septic Shock|septic shock
4865288|NCT02246595|Systemic Inflammatory Response Syndrome|systemic inflammatory response syndrome
4865289|NCT02246595|Organ Dysfunction|organ dysfunction
4865290|NCT02246582|Type 1 Diabetes|type 1 diabetes
4865291|NCT02246582|Type 2 Diabetes|type 2 diabetes
4865292|NCT02246582|Enlite 3|enlite 3
4865293|NCT02246569|Chronic obstructive pulmonary disease (COPD)|chronic obstructive pulmonary disease (copd)
4865294|NCT02246569|endoscopic lung volume reduction|endoscopic lung volume reduction
4865295|NCT02246569|RePneu®Coils|repneu®coils
4865296|NCT02246569|physical capacity|physical capacity
4865297|NCT02246569|quality of life|quality of life
4865298|NCT02246556|Amblyopia|amblyopia
4865299|NCT02246556|Dichoptic|dichoptic
4865300|NCT02246556|Virtual reality|virtual reality
4865301|NCT02246556|Stereopsis|stereopsis
4865302|NCT02246556|Stereo vision|stereo vision
4865303|NCT02246556|Visual acuity|visual acuity
4865304|NCT02246556|Binocular|binocular
4865305|NCT02246543|Appetite|appetite
4865306|NCT02246543|Gut Hormones|gut hormones
4865307|NCT02246543|Protein|protein
4865308|NCT02246543|Energy Density|energy density
4865309|NCT02246543|Gastric Emptying|gastric emptying
4865310|NCT02246465|Hypertrophic scar|hypertrophic scar
4865311|NCT02246465|Cicatrix|cicatrix
4865312|NCT02246465|Scar prevention|scar prevention
4865313|NCT02246465|Scar revision|scar revision
4865314|NCT02246452|Children and adolescents|children and adolescents
4865315|NCT02246452|Cancer|cancer
4865316|NCT02246452|Malnutrition|malnutrition
4865317|NCT02246452|BMI percentile|bmi percentile
4865318|NCT02246452|BMI-SDS|bmi-sds
4865319|NCT02246439|Gastroenteritis|gastroenteritis
4865320|NCT02246439|Gastritis|gastritis
4865321|NCT02246439|Vomiting|vomiting
4865322|NCT02246439|Nausea|nausea
4865323|NCT02246439|Diarrhea|diarrhea
4865324|NCT02246413|BMI|bmi
4865325|NCT02246413|Depressive symptoms|depressive symptoms
4865326|NCT02246413|Integrated therapy|integrated therapy
4865327|NCT02246413|Cardiometabolic risk|cardiometabolic risk
4865328|NCT02246413|Self-regulation|self-regulation
4865329|NCT02246413|Behavior change|behavior change
4865330|NCT02246413|Precision medicine|precision medicine
4865331|NCT02246413|Lifestyle|lifestyle
4865332|NCT02246400|eCMP|ecmp
4865333|NCT02246400|eHealth|ehealth
4865334|NCT02246400|mHealth|mhealth
4865335|NCT02246400|Lifestyle intervention|lifestyle intervention
4865336|NCT02246400|Cardiometabolic risk reduction|cardiometabolic risk reduction
4865337|NCT02246400|PAMF|pamf
4865338|NCT02246387|Pelvic Organ Prolapse|pelvic organ prolapse
4865339|NCT02246387|Gynecologic Surgery Procedures|gynecologic surgery procedures
4865340|NCT02246387|Treatment Outcome|treatment outcome
4865341|NCT02246374|Parkinson's Disease|parkinson's disease
4865342|NCT02246374|ExAblate|exablate
4865343|NCT02246374|MRgFUS|mrgfus
4865344|NCT02246361|Ankle sprain|ankle sprain
4865345|NCT02246361|Infectious colitis|infectious colitis
4865737|NCT02244502|Treatment|treatment
4865346|NCT02246361|Diverticulitis|diverticulitis
4865347|NCT02246361|Pyelonephritis|pyelonephritis
4865348|NCT02246361|Prostatitis|prostatitis
4865349|NCT02246361|Pneumonitis|pneumonitis
4865350|NCT02246361|Patient Information Leaflet (PIL)|patient information leaflet (pil)
4865351|NCT02246361|Doctor Patient Communication|doctor patient communication
4865352|NCT02246361|Adherence|adherence
4865353|NCT02246361|Satisfaction|satisfaction
4865354|NCT02246361|Scale|scale
4865355|NCT02246361|Doctor Patient Communication scale|doctor patient communication scale
4865356|NCT02246361|Adherence scale|adherence scale
4865357|NCT02246361|Satisfaction scale|satisfaction scale
4865358|NCT02246348|Systemic Sclerosis|systemic sclerosis
4865359|NCT02246348|Pulmonary hypertension|pulmonary hypertension
4865360|NCT02246348|Lung Doppler signals|lung doppler signals
4865361|NCT02246322|Pancreatic cancer|pancreatic cancer
4865362|NCT02246322|Neuroendocrine tumors|neuroendocrine tumors
4865363|NCT02246322|Lymphadenopathies|lymphadenopathies
4865364|NCT02246322|GIST|gist
4865365|NCT02246322|Gastrointestinal wall neoplasia|gastrointestinal wall neoplasia
4865366|NCT02246309|Infertility|infertility
4865367|NCT02246309|Embryo Culture|embryo culture
4865368|NCT02246309|Laboratory Technique|laboratory technique
4865369|NCT02246296|severe acute malnutrition|severe acute malnutrition
4865370|NCT02246296|wasting|wasting
4865371|NCT02246296|kwashiorkor|kwashiorkor
4865372|NCT02246296|nutrition|nutrition
4865373|NCT02246296|feeding|feeding
4865374|NCT02246296|milk|milk
4865375|NCT02246283|schizophrenia|schizophrenia
4865376|NCT02246283|elderly|elderly
4865377|NCT02246283|lifelong|lifelong
4865378|NCT02246283|quality of life|quality of life
4865379|NCT02246283|register|register
4865380|NCT02246283|questionaire|questionaire
4865381|NCT02246218|Urea Cycle Disorder|urea cycle disorder
4865382|NCT02246218|UCD|ucd
4865383|NCT02246218|Buphenyl|buphenyl
4865384|NCT02246218|Glycerol Phenylbutyrate|glycerol phenylbutyrate
4865385|NCT02246218|Ravicti|ravicti
4865386|NCT02246218|Hyperammonemia|hyperammonemia
4865387|NCT02246218|Sodium Phenylbutyrate|sodium phenylbutyrate
4865388|NCT02246218|GPB|gpb
4865389|NCT02246218|HPN-100|hpn-100
4865390|NCT02246205|pancreaticoduodenectomy|pancreaticoduodenectomy
4865391|NCT02246205|delayed gastric emptying|delayed gastric emptying
4865392|NCT02246205|Roux en-Y reconstruction|roux en-y reconstruction
4865393|NCT02246179|Fractional laser|fractional laser
4865394|NCT02246179|Topical anesthesia|topical anesthesia
4865395|NCT02246179|Drug delivery|drug delivery
4865396|NCT02246153|Laparoscopic gastrectomy|laparoscopic gastrectomy
4865397|NCT02246153|Advanced gastric cancer|advanced gastric cancer
4865398|NCT02246153|Elderly patients|elderly patients
4865399|NCT02246153|Morbidity|morbidity
4865400|NCT02246153|Mortality|mortality
4865401|NCT02246127|advanced pNET|advanced pnet
4865402|NCT02246127|everolimus|everolimus
4865403|NCT02246127|STZ-5FU|stz-5fu
4865404|NCT02246127|treatment sequence|treatment sequence
4865405|NCT02246114|Pregnancy|pregnancy
4865406|NCT02246114|Smoking|smoking
4865407|NCT02246114|Smoking cessation|smoking cessation
4865408|NCT02246101|cardiac disease|cardiac disease
4865409|NCT02246101|cardiopulmonary disease|cardiopulmonary disease
4865410|NCT02246101|renal disease|renal disease
4865411|NCT02246101|albuminuria|albuminuria
4865412|NCT02246101|cardiovascular disease|cardiovascular disease
4865413|NCT02246101|CVD|cvd
4865414|NCT02246101|particulate matter|particulate matter
4865415|NCT02246088|Osteoarthritis, Central Nervous System Sensitization|osteoarthritis, central nervous system sensitization
4865416|NCT02246075|Alzheimer's disease|alzheimer's disease
4865417|NCT02246075|Cognition|cognition
4865418|NCT02246075|Alpha-7 nAChR|alpha-7 nachr
4865419|NCT02246062|Anxiety|anxiety
4865420|NCT02246062|Anesthesia|anesthesia
4865421|NCT02246062|Evaluation|evaluation
4865422|NCT02246062|Preoperative care|preoperative care
4865423|NCT02246062|Child|child
4865424|NCT02246049|Metastatic colorectal cancer, bevacizumab, FOLFOXIRI|metastatic colorectal cancer, bevacizumab, folfoxiri
4865425|NCT02246010|diarrhea|diarrhea
4865426|NCT02246010|developing world|developing world
4865427|NCT02246010|lactose-free diet|lactose-free diet
4865428|NCT02246010|Clinical trial|clinical trial
4865429|NCT02245997|Reduced-dose Radiotherapy|reduced-dose radiotherapy
4865430|NCT02245997|14-186|14-186
4865431|NCT02245984|clinical competence, nursing process, nursing student|clinical competence, nursing process, nursing student
4865432|NCT02245945|HIV|hiv
4865433|NCT02245945|prevention|prevention
4865434|NCT02245932|Pulmonary disease, Chronic Obstructive|pulmonary disease, chronic obstructive
4865435|NCT02245932|Cardiovascular diseases|cardiovascular diseases
4865436|NCT02245932|Metabolism|metabolism
4865437|NCT02245932|Resveratrol|resveratrol
4865438|NCT02245919|Low Back Pain|low back pain
4865439|NCT02245919|Chronic Pain|chronic pain
4865440|NCT02245919|Cognitive Behavioral Therapy|cognitive behavioral therapy
4865441|NCT02245919|Primary Health Care|primary health care
4865442|NCT02245919|Physical Therapy|physical therapy
4865443|NCT02245906|Brazilian fruit peel|brazilian fruit peel
4865444|NCT02245906|Functional food|functional food
4865445|NCT02245906|Cardiometabolic risk|cardiometabolic risk
4865446|NCT02245906|Metabolic syndrome|metabolic syndrome
4865447|NCT02245906|Inflammation|inflammation
4865448|NCT02245906|Appetite|appetite
4865449|NCT02245906|Gut hormone|gut hormone
4865450|NCT02245880|cervical spine|cervical spine
4865451|NCT02245880|intubating laryngeal mask airway|intubating laryngeal mask airway
4865452|NCT02245880|Glidescope videolaryngoscope|glidescope videolaryngoscope
4865453|NCT02245880|collar|collar
4865454|NCT02245867|Amyloidosis|amyloidosis
4865455|NCT02245867|Relapse|relapse
4865456|NCT02245867|Refractory|refractory
4865457|NCT02245854|diminutive polyps|diminutive polyps
4865458|NCT02245854|small polyps|small polyps
4865459|NCT02245854|cold snare polypectomy|cold snare polypectomy
4865460|NCT02245854|complications|complications
4865461|NCT02245854|bleeding|bleeding
4865462|NCT02245841|dermatomyositis|dermatomyositis
4865463|NCT02245841|Acthar gel|acthar gel
4865464|NCT02245828|healthy subjects, inhaled|healthy subjects, inhaled
4865465|NCT02245815|Necrotizing enterocolitis|necrotizing enterocolitis
4865466|NCT02245815|Probiotics|probiotics
4865467|NCT02245815|Secreting IgA|secreting iga
4865468|NCT02245815|Preterm newborns|preterm newborns
4865469|NCT02245802|Bleeding peptic ulcer|bleeding peptic ulcer
4865470|NCT02245802|Prediction model|prediction model
4865471|NCT02245802|Mortality|mortality
4865472|NCT02245802|Prediction of in-hospital mortality for bleeding peptic ulcer|prediction of in-hospital mortality for bleeding peptic ulcer
4865473|NCT02245776|Incurable Neurological Disorders|incurable neurological disorders
4865474|NCT02245776|Autologous mononuclear cell therapy|autologous mononuclear cell therapy
4865475|NCT02245776|Stem cells|stem cells
4865476|NCT02245750|hysteroscopy - recurrent implantation failure|hysteroscopy - recurrent implantation failure
4865477|NCT02245737|Alzheimer's disease|alzheimer's disease
4865478|NCT02245737|Dementia|dementia
4865479|NCT02245737|Brain Diseases|brain diseases
4865480|NCT02245737|Neurogenerative Diseases|neurogenerative diseases
4865481|NCT02245737|Central Nervous System Diseases|central nervous system diseases
4865482|NCT02245737|Nervous System Diseases|nervous system diseases
4865483|NCT02245737|Mental Disorders|mental disorders
4865484|NCT02245737|Delirium, Dementia, Amnestic, Cognitive Disorders|delirium, dementia, amnestic, cognitive disorders
4865485|NCT02245737|Tauopathies|tauopathies
4865486|NCT02245724|Mental retardation|mental retardation
4865487|NCT02245724|Autologous mononuclear cell therapy|autologous mononuclear cell therapy
4865488|NCT02245724|Stem cell|stem cell
4865489|NCT02245711|Limb Girdle Muscular Dystrophy|limb girdle muscular dystrophy
4865490|NCT02245711|Autologous Bone Marrow Mononuclear cell therapy|autologous bone marrow mononuclear cell therapy
4865491|NCT02245711|Stem Cell|stem cell
4865492|NCT02245698|Chronic Stroke|chronic stroke
4865493|NCT02245698|Subacute stroke|subacute stroke
4865494|NCT02245698|Autologous Bone Marrow Mononuclear Cell therapy|autologous bone marrow mononuclear cell therapy
4865495|NCT02245698|Stem cell|stem cell
4865496|NCT02245685|Substitution Therapy|substitution therapy
4865497|NCT02245685|Specialized Care Center for Addicts|specialized care center for addicts
4865498|NCT02245672|Asthma|asthma
4865499|NCT02245672|fluticasone|fluticasone
4865500|NCT02245672|salmeterol|salmeterol
4865501|NCT02245672|CRC749|crc749
4865502|NCT02245672|Diskus|diskus
4865503|NCT02245672|Advair|advair
4865504|NCT02245672|FEV1|fev1
4865505|NCT02245672|MGR001|mgr001
4865506|NCT02245620|Skeletal muscle dysfunction, MTP-131, Bendavia™|skeletal muscle dysfunction, mtp-131, bendavia™
4865507|NCT02245620|elamipretide|elamipretide
4865508|NCT02245607|Psychotic Disorders|psychotic disorders
4865509|NCT02245607|Cognitive Training|cognitive training
4865510|NCT02245607|Mental Disorders|mental disorders
4865511|NCT02245607|Schizophrenia and Disorders with Psychotic Features|schizophrenia and disorders with psychotic features
4865512|NCT02245594|Gastrointestinal motility|gastrointestinal motility
4865513|NCT02245594|Motility Tracking System (MTS)|motility tracking system (mts)
4865514|NCT02245594|Transit time|transit time
4865515|NCT02245594|Sleep pattern|sleep pattern
4865516|NCT02245568|Dementia|dementia
4865517|NCT02245568|Alzheimer Disease|alzheimer disease
4865518|NCT02245568|bvFTD|bvftd
4865519|NCT02245568|Frontotemporal Dementia|frontotemporal dementia
4865520|NCT02245568|Neurodegenerative Diseases|neurodegenerative diseases
4865521|NCT02245568|Brain Diseases|brain diseases
4865522|NCT02245568|Cognitive Disorders|cognitive disorders
4865523|NCT02245516|Intraretinal Fluid|intraretinal fluid
4865524|NCT02245516|Subretinal Fluid|subretinal fluid
4865525|NCT02245516|Retinal Vein Occlusion|retinal vein occlusion
4865526|NCT02245516|Diabetic Macular Edema|diabetic macular edema
4865527|NCT02245477|Serum VEGF, FGR|serum vegf, fgr
4865528|NCT02245425|Neck pain|neck pain
4865529|NCT02245425|Thoracic spine manipulation|thoracic spine manipulation
4865530|NCT02245425|Range of Motion|range of motion
4865531|NCT02245425|Disability|disability
4865532|NCT02245412|GIGVHD|gigvhd
4865533|NCT02245399|Weight loss|weight loss
4865534|NCT02245399|Diabetes|diabetes
4865535|NCT02245399|Cardiovascular disease (CVD) risk|cardiovascular disease (cvd) risk
4865536|NCT02245399|Weight loss diet|weight loss diet
4865537|NCT02245399|mediterranean type diet|mediterranean type diet
4865538|NCT02245399|Canola oil|canola oil
4865539|NCT02245399|Low-carbohydrate diet|low-carbohydrate diet
4865540|NCT02245399|Glycemic index|glycemic index
4865541|NCT02245373|Depression|depression
4865542|NCT02245373|Primary Care|primary care
4865543|NCT02245373|Cost-effectiveness|cost-effectiveness
4865544|NCT02245373|Pharmacological treatment|pharmacological treatment
4865545|NCT02245373|Watchful-waiting or Active Monitoring.|watchful-waiting or active monitoring.
4865546|NCT02245360|GRAZAX|grazax
4865547|NCT02245347|TB|tb
4865548|NCT02245347|Tuberculosis|tuberculosis
4865549|NCT02245347|MDR TB|mdr tb
4865550|NCT02245347|Drug resistant TB|drug resistant tb
4865551|NCT02245321|hemoglobin recovery|hemoglobin recovery
4865552|NCT02245321|iron recovery|iron recovery
4865553|NCT02245321|iron supplements|iron supplements
4865554|NCT02245308|Tobacco use cessation|tobacco use cessation
4865555|NCT02245308|Homelessness|homelessness
4865556|NCT02245308|Veterans|veterans
4865557|NCT02245295|Bronchial endoscopy|bronchial endoscopy
4865558|NCT02245295|ultrasound|ultrasound
4865559|NCT02245295|EBUS|ebus
4865560|NCT02245295|anesthesia|anesthesia
4865561|NCT02245295|lung cancer|lung cancer
4865562|NCT02245295|diagnosis including staging|diagnosis including staging
4865563|NCT02245256|delirium|delirium
4865564|NCT02245256|incidence|incidence
4865565|NCT02245256|dexmedetomidine|dexmedetomidine
4865566|NCT02245243|Hepatic Impairment, single dose, intravenous|hepatic impairment, single dose, intravenous
4865567|NCT02245230|Hypertension|hypertension
4865568|NCT02245230|Autonomic Nervous System|autonomic nervous system
4865569|NCT02245230|Renin-Angiotensin System|renin-angiotensin system
4865570|NCT02245230|Angiotensin (1-7)|angiotensin (1-7)
4865571|NCT02245230|Ganglionic Blockers|ganglionic blockers
4865572|NCT02245230|Trimethaphan|trimethaphan
4865573|NCT02245230|Blood Pressure|blood pressure
4865574|NCT02245230|Hemodynamics|hemodynamics
4865575|NCT02245191|Vasopressor|vasopressor
4865576|NCT02245191|Cesarian delivery|cesarian delivery
4865577|NCT02245191|Hypotension|hypotension
4865578|NCT02245191|Maternal cardiac output|maternal cardiac output
4865579|NCT02245191|Uteroplacental blood flow|uteroplacental blood flow
4865580|NCT02245191|Cerebral fetal blood flow|cerebral fetal blood flow
4865581|NCT02245191|Preeclampsia|preeclampsia
4865582|NCT02245165|Nitric oxide|nitric oxide
4865583|NCT02245165|Nitric oxide synthase|nitric oxide synthase
4865584|NCT02245165|Gastrointestinal motility|gastrointestinal motility
4865585|NCT02245165|Gut peptide hormones|gut peptide hormones
4865586|NCT02245152|child acute malnutrition|child acute malnutrition
4865587|NCT02245152|prevention|prevention
4865588|NCT02245152|behavior change communication|behavior change communication
4865589|NCT02245152|lipid-based nutrient supplement|lipid-based nutrient supplement
4865590|NCT02245152|screening coverage|screening coverage
4865591|NCT02245139|diarrhea|diarrhea
4865592|NCT02245139|vomiting|vomiting
4865593|NCT02245139|fever|fever
4865594|NCT02245139|abdominal pain|abdominal pain
4865595|NCT02245139|oliguria|oliguria
4865596|NCT02245126|Pain, Visual analogue scale|pain, visual analogue scale
4865597|NCT02245087|atorvastatin|atorvastatin
4865598|NCT02245087|coronary artery disease|coronary artery disease
4865599|NCT02245087|myocardial infarction|myocardial infarction
4865600|NCT02245087|stroke|stroke
4865601|NCT02245087|revascularization|revascularization
4865602|NCT02245074|Infantile asthma|infantile asthma
4865603|NCT02245074|Induced sputum|induced sputum
4865604|NCT02245074|Phenotypes|phenotypes
4865605|NCT02245074|Eosinophils|eosinophils
4865606|NCT02245074|Neutrophils|neutrophils
4865607|NCT02245061|pharmacoresistant focal epilepsy|pharmacoresistant focal epilepsy
4865608|NCT02245061|cortical excitability|cortical excitability
4865609|NCT02245061|paired pulses|paired pulses
4865610|NCT02245061|TMS|tms
4865611|NCT02245061|SEEG|seeg
4865612|NCT02245061|DES|des
4865613|NCT02245048|Cardiovascular Risk Stratification|cardiovascular risk stratification
4865614|NCT02245048|Carotid intima-media thickness (CIMT)|carotid intima-media thickness (cimt)
4865615|NCT02245048|Stress echocardiography (SE)|stress echocardiography (se)
4865616|NCT02245035|Glutathione|glutathione
4865617|NCT02245035|Dairy consumption|dairy consumption
4865618|NCT02245035|Brain|brain
4865619|NCT02245035|Humans|humans
4865620|NCT02245022|HIV|hiv
4865621|NCT02245022|Prevention of mother to child transmission|prevention of mother to child transmission
4865622|NCT02245022|Africa|africa
4865623|NCT02245022|Uganda|uganda
4865624|NCT02245022|Pharmacokinetics|pharmacokinetics
4865625|NCT02245022|Pregnancy|pregnancy
4865626|NCT02245022|Breastfeeding|breastfeeding
4865627|NCT02244996|Retinitis pigmentosa|retinitis pigmentosa
4865628|NCT02244996|Lycium barbarum|lycium barbarum
4865629|NCT02244996|Antioxidation|antioxidation
4865630|NCT02244996|Visual field|visual field
4865631|NCT02244996|Electroretinogram|electroretinogram
4865632|NCT02244970|Mindfulness|mindfulness
4865633|NCT02244970|Depressive mood|depressive mood
4865634|NCT02244970|anxiety|anxiety
4865635|NCT02244970|early psychosis|early psychosis
4865636|NCT02244944|nonalcoholic fatty liver disease|nonalcoholic fatty liver disease
4865637|NCT02244944|NAFLD|nafld
4865638|NCT02244931|Spinal cord injuries, paraplegic, manual wheelchairs, assisting propelling device|spinal cord injuries, paraplegic, manual wheelchairs, assisting propelling device
4865639|NCT02244905|Positive Deviance|positive deviance
4865640|NCT02244905|Infection Control|infection control
4865641|NCT02244905|Healthcare-Associated Infections|healthcare-associated infections
4865642|NCT02244905|Staff Engagement|staff engagement
4865643|NCT02244905|Cluster Randomized Controlled Trial|cluster randomized controlled trial
4865644|NCT02244892|Disability glare|disability glare
4865645|NCT02244892|Corneal scar|corneal scar
4865646|NCT02244892|Corneal haze|corneal haze
4865647|NCT02244892|Scheimpflug densitometry|scheimpflug densitometry
4865648|NCT02244892|Contrast sensitivity|contrast sensitivity
4865649|NCT02244879|resveratrol|resveratrol
4865650|NCT02244879|type 2 diabetes mellitus|type 2 diabetes mellitus
4865651|NCT02244879|inflammation|inflammation
4865652|NCT02244879|insulin resistance|insulin resistance
4865653|NCT02244879|body composition|body composition
4865654|NCT02244879|bone mass|bone mass
4865655|NCT02244866|IVF|ivf
4865656|NCT02244866|LH supplementation|lh supplementation
4865657|NCT02244866|ovarian stimulation|ovarian stimulation
4865658|NCT02244866|poor responder|poor responder
4865659|NCT02244840|Bidet, Sitz bath, Anal resting pressure|bidet, sitz bath, anal resting pressure
4865660|NCT02244814|glucose|glucose
4865661|NCT02244814|insulin resistance|insulin resistance
4865662|NCT02244814|dietary carbohydrate|dietary carbohydrate
4865663|NCT02244814|dietary fat|dietary fat
4865664|NCT02244814|adiposity|adiposity
4865665|NCT02244814|Air displacement plethysmography|air displacement plethysmography
4865666|NCT02244814|Dual X-ray Absorptiometry|dual x-ray absorptiometry
4865667|NCT02244814|continuous glucose monitoring|continuous glucose monitoring
4865668|NCT02244775|osteo-arthritis|osteo-arthritis
4865669|NCT02244775|post traumatic arthritis|post traumatic arthritis
4865670|NCT02244736|Arterial stiffness|arterial stiffness
4865671|NCT02244736|Endothelial glycocalyx|endothelial glycocalyx
4865672|NCT02244736|Coronary flow reserve|coronary flow reserve
4865673|NCT02244723|Ventilator-Associated Pneumonia|ventilator-associated pneumonia
4865674|NCT02244723|diagnosis|diagnosis
4865675|NCT02244710|Circulating Endothelial Cells|circulating endothelial cells
4865676|NCT02244710|Endothelial Progenitor Cells|endothelial progenitor cells
4865677|NCT02244710|Acute coronary syndrome (ACS)|acute coronary syndrome (acs)
4865678|NCT02244710|Ticagrelor|ticagrelor
4865679|NCT02244697|Stridor|stridor
4865680|NCT02244697|Vocal Cord Paralysis (VCP)|vocal cord paralysis (vcp)
4865681|NCT02244697|Ultrasound (US)|ultrasound (us)
4865682|NCT02244684|Folate|folate
4865683|NCT02244684|Folic Acid|folic acid
4865684|NCT02244684|One-Carbon Nutrients|one-carbon nutrients
4865685|NCT02244684|Epigenetics|epigenetics
4865686|NCT02244684|Pregnancy|pregnancy
4865687|NCT02244684|Fetal Health|fetal health
4865688|NCT02244658|chemotherapy-induced thrombocytopenia|chemotherapy-induced thrombocytopenia
4865689|NCT02244658|recombinant human thrombopoietin|recombinant human thrombopoietin
4865690|NCT02244658|acute myelocytic leukemia|acute myelocytic leukemia
4865691|NCT02244645|Low back pain, physical therapy, yoga.|low back pain, physical therapy, yoga.
4865692|NCT02244632|Colorectal cancer|colorectal cancer
4865693|NCT02244632|Colorectal carcinoma|colorectal carcinoma
4865694|NCT02244632|Colorectal tumors|colorectal tumors
4865695|NCT02244632|Intestinal Neoplasm|intestinal neoplasm
4865696|NCT02244632|Gastrointestinal Neoplasm|gastrointestinal neoplasm
4865697|NCT02244632|Gastrointestinal disease|gastrointestinal disease
4865698|NCT02244632|5,10-methylenetetrahydrofolate|5,10-methylenetetrahydrofolate
4865699|NCT02244632|Tetrahydrofolates|tetrahydrofolates
4865700|NCT02244632|Therapeutic uses|therapeutic uses
4865701|NCT02244632|Pharmacokinetics|pharmacokinetics
4865702|NCT02244632|Pharmacodynamics|pharmacodynamics
4865703|NCT02244632|Safety assessments|safety assessments
4865704|NCT02244619|Hip replacement|hip replacement
4865705|NCT02244619|Knee replacement|knee replacement
4865706|NCT02244619|randomized trial|randomized trial
4865707|NCT02244619|acetaminophen|acetaminophen
4865708|NCT02244619|post-op pain management|post-op pain management
4865709|NCT02244606|Invasive Candidiasis|invasive candidiasis
4865710|NCT02244606|Invasive Candida infections|invasive candida infections
4865711|NCT02244606|Candidemia|candidemia
4865712|NCT02244606|SCY-078|scy-078
4865713|NCT02244606|Micafungin|micafungin
4865714|NCT02244606|Fluconazole|fluconazole
4865715|NCT02244606|Echinocandin|echinocandin
4865716|NCT02244593|breast cancer survivors|breast cancer survivors
4865717|NCT02244593|FAST MRI|fast mri
4865718|NCT02244593|mammography screening|mammography screening
4865719|NCT02244580|Subtyping of Invasive breast cancer|subtyping of invasive breast cancer
4865720|NCT02244567|PCOS|pcos
4865721|NCT02244554|tattoo removal|tattoo removal
4865722|NCT02244554|Q-switched laser|q-switched laser
4865723|NCT02244554|Nd:YAG laser|nd:yag laser
4865724|NCT02244554|nanosecond laser|nanosecond laser
4865725|NCT02244554|picosecond laser|picosecond laser
4865726|NCT02244554|laser therapy|laser therapy
4865727|NCT02244554|tattoo|tattoo
4865728|NCT02244554|pulsed-laser|pulsed-laser
4865729|NCT02244554|laser treatment|laser treatment
4865730|NCT02244554|remove tattoo|remove tattoo
4865731|NCT02244554|tattoo clearing|tattoo clearing
4865732|NCT02244554|tattoo lightening|tattoo lightening
4865733|NCT02244554|tattoo lighten|tattoo lighten
4865734|NCT02244554|resistant tattoo|resistant tattoo
4865735|NCT02244515|children|children
4865736|NCT02244502|Ovarian Carcinoma|ovarian carcinoma
4865738|NCT02244502|Minimal toxicity|minimal toxicity
4865739|NCT02244502|TTFields|ttfields
4865740|NCT02244502|Tumor Treating Fields|tumor treating fields
4865741|NCT02244502|Novocure|novocure
4865742|NCT02244502|Paclitaxel|paclitaxel
4865743|NCT02244502|Weekly paclitaxel|weekly paclitaxel
4865744|NCT02244476|mouth feel|mouth feel
4865745|NCT02244476|acoustic tribology|acoustic tribology
4865746|NCT02244476|vibration spectrum|vibration spectrum
4865747|NCT02244476|sensory perception|sensory perception
4865748|NCT02244463|Anaplastic Thyroid Cancer|anaplastic thyroid cancer
4865749|NCT02244463|Thyroid Cancer|thyroid cancer
4865750|NCT02244450|Neonatal screening|neonatal screening
4865751|NCT02244450|severe combined immunodeficiency|severe combined immunodeficiency
4865752|NCT02244450|T-cell Receptor Excision Circle|t-cell receptor excision circle
4865753|NCT02244437|altitude, altitude illnesses, headache|altitude, altitude illnesses, headache
4865754|NCT02244424|Infant|infant
4865755|NCT02244424|Obesity|obesity
4865756|NCT02244424|Adolescent|adolescent
4865757|NCT02244424|Social media|social media
4865758|NCT02244424|Prevention|prevention
4865759|NCT02244411|EQUAL|equal
4865760|NCT02244411|Exercise|exercise
4865761|NCT02244411|Diet|diet
4865762|NCT02244411|Physical activity|physical activity
4865763|NCT02244411|14-164|14-164
4865764|NCT02244385|vascular disease|vascular disease
4865765|NCT02244385|pregnancy|pregnancy
4865766|NCT02244385|chronic hypertension|chronic hypertension
4865767|NCT02244385|diabetes|diabetes
4865768|NCT02244385|obesity|obesity
4865769|NCT02244372|Cordyceps sinensis mycelium culture extract(Paecilomyces hepiali, CBG-CS-2)|cordyceps sinensis mycelium culture extract(paecilomyces hepiali, cbg-cs-2)
4865770|NCT02244372|immunity|immunity
4865771|NCT02244359|Shared Decision making|shared decision making
4865772|NCT02244359|Patient Centred care|patient centred care
4865773|NCT02244359|Interprofessionalism|interprofessionalism
4865774|NCT02244359|Home care|home care
4865775|NCT02244359|Frail elderly|frail elderly
4865776|NCT02244164|Type 2 Diabetes|type 2 diabetes
4865777|NCT02244164|Incretinomimetics|incretinomimetics
4865778|NCT02244164|DPP-4 inhibitors|dpp-4 inhibitors
4865779|NCT02244164|Pancreas|pancreas
4865780|NCT02244164|PanIN|panin
4865782|NCT02244164|Lipasemia|lipasemia
4865783|NCT02244151|ovulation induction,oocyte maturation timing and collection|ovulation induction,oocyte maturation timing and collection
4865784|NCT02244138|Adolescent|adolescent
4865785|NCT02244138|Screening|screening
4865786|NCT02244138|Primary Care|primary care
4865787|NCT02244138|Computer Decision Support Systems|computer decision support systems
4865788|NCT02244125|Myeloma|myeloma
4865789|NCT02244125|Multiple Myeloma|multiple myeloma
4865790|NCT02244125|Relapse|relapse
4865791|NCT02244125|Refractory|refractory
4865792|NCT02244125|PCD|pcd
4865793|NCT02244125|IFM/DFCI 2009|ifm/dfci 2009
4865794|NCT02244125|Transplantation|transplantation
4865795|NCT02244125|Autologous|autologous
4865796|NCT02244125|Pomalidomide|pomalidomide
4865797|NCT02244125|Immunoglobulin|immunoglobulin
4865798|NCT02244125|Ig|ig
4865799|NCT02244125|Free light Chain|free light chain
4865800|NCT02244099|Controlled substance prescribing|controlled substance prescribing
4865801|NCT02244099|Controlled substance treatment agreements|controlled substance treatment agreements
4865802|NCT02244099|Opioid use|opioid use
4865803|NCT02244086|obstetric pain, bupivacaine, analgesic efficacy|obstetric pain, bupivacaine, analgesic efficacy
4865804|NCT02244073|blood glucose target|blood glucose target
4865805|NCT02244073|ICU|icu
4865806|NCT02244073|insulin|insulin
4865807|NCT02244073|hypoglycemia|hypoglycemia
4865808|NCT02244073|hyperglycemia|hyperglycemia
4865809|NCT02244073|glycated hemoglobin|glycated hemoglobin
4865810|NCT02244060|Vignette|vignette
4865811|NCT02244060|Priming effect|priming effect
4865812|NCT02244021|HD|hd
4865813|NCT02244021|Hodgkin's Lymphoma|hodgkin's lymphoma
4865814|NCT02244021|RELAPSED-REFRACTORY|relapsed-refractory
4865815|NCT02244008|Mobilization|mobilization
4865816|NCT02244008|Joint Range of Motion|joint range of motion
4865817|NCT02244008|Ankle|ankle
4865818|NCT02244008|Manual Therapy|manual therapy
4865819|NCT02243995|Training program|training program
4865820|NCT02243995|Resistance training|resistance training
4865821|NCT02243995|Endurance training|endurance training
4865822|NCT02243995|Muscle strength|muscle strength
4865823|NCT02243995|Exercise capacity|exercise capacity
4865824|NCT02243995|Fatigue|fatigue
4865825|NCT02243995|Quality of life|quality of life
4865826|NCT02243982|Parkinson, dementia, FDDNP, tau, beta-amyloid|parkinson, dementia, fddnp, tau, beta-amyloid
4865827|NCT02243969|n-3 polyunsaturated fatty acids|n-3 polyunsaturated fatty acids
4865828|NCT02243969|Alpha-linolenic acid|alpha-linolenic acid
4865829|NCT02243969|Blood pressure|blood pressure
4865830|NCT02243969|Vascular function|vascular function
4865831|NCT02243943|Neuromuscular block|neuromuscular block
4865832|NCT02243943|neuromuscular reversal|neuromuscular reversal
4865833|NCT02243943|postoperative conditions|postoperative conditions
4865834|NCT02243943|respiratory failure|respiratory failure
4865835|NCT02243930|Sigmoidoscopy with or without cap|sigmoidoscopy with or without cap
4865836|NCT02243930|Pain during sigmoidoscopy|pain during sigmoidoscopy
4865837|NCT02243930|Sigmoidoscopy and time|sigmoidoscopy and time
4865838|NCT02243904|Autonomic nervous function|autonomic nervous function
4865839|NCT02243904|Blood pressure|blood pressure
4865840|NCT02243904|Cardiovascular regulation|cardiovascular regulation
4865841|NCT02243904|Lead|lead
4865842|NCT02243904|Occupational exposure|occupational exposure
4865843|NCT02243904|Renal function|renal function
4865844|NCT02243852|Growth Hormone Deficiency (GHD)|growth hormone deficiency (ghd)
4865845|NCT02243852|Growth Hormone Replacement Therapy|growth hormone replacement therapy
4865846|NCT02243852|Fibroblast Growth Factor 21 (FGF21)|fibroblast growth factor 21 (fgf21)
4865847|NCT02243852|Visceral Fat|visceral fat
4865848|NCT02243852|Subcutaneous Fat|subcutaneous fat
4865849|NCT02243839|Prosthetic valve|prosthetic valve
4865850|NCT02243839|Thrombosis|thrombosis
4865851|NCT02243839|Surgery|surgery
4865852|NCT02243839|Thrombolytic therapy|thrombolytic therapy
4865853|NCT02243839|Transesophageal echocardiography|transesophageal echocardiography
4865854|NCT02243826|Lumbar puncture|lumbar puncture
4865855|NCT02243826|Adults|adults
4865856|NCT02243826|Nitrous oxide|nitrous oxide
4865857|NCT02243826|Procedural pain|procedural pain
4865858|NCT02243826|Procedural anxiety|procedural anxiety
4865859|NCT02243813|Psilocybin|psilocybin
4865860|NCT02243813|Pharmacologic Actions|pharmacologic actions
4865861|NCT02243813|Psychotropic Drugs|psychotropic drugs
4865862|NCT02243800|Vitamin D|vitamin d
4865863|NCT02243800|Rheumatoid arthritis|rheumatoid arthritis
4865864|NCT02243800|Cholecalciferol|cholecalciferol
4865865|NCT02243774|Vaccination|vaccination
4865866|NCT02243774|Immunization|immunization
4865867|NCT02243774|Randomized Controlled Trial|randomized controlled trial
4865868|NCT02243774|Prevention & Control|prevention & control
4865869|NCT02243774|Preventive Measures|preventive measures
4865870|NCT02243774|Health Promotion|health promotion
4865871|NCT02243774|Medicare|medicare
4865872|NCT02243774|Intention Prompts|intention prompts
4865873|NCT02243774|Letters|letters
4865874|NCT02243761|Concurrent Disorders|concurrent disorders
4865875|NCT02243761|Mental Health|mental health
4865876|NCT02243761|Addictions|addictions
4865877|NCT02243761|Caregiver Burden|caregiver burden
4865878|NCT02243722|laryngeal electromyography|laryngeal electromyography
4865879|NCT02243722|intrinsic laryngeal muscles|intrinsic laryngeal muscles
4865880|NCT02243722|recurrent laryngeal nerve|recurrent laryngeal nerve
4865881|NCT02243722|superior laryngeal nerve|superior laryngeal nerve
4865882|NCT02243722|laryngeal sensation|laryngeal sensation
4865883|NCT02243722|tone language|tone language
4865884|NCT02243709|Stress, alcohol craving, alcohol use disorders|stress, alcohol craving, alcohol use disorders
4865885|NCT02243670|opioid addiction|opioid addiction
4865886|NCT02243670|opioid substitution therapy|opioid substitution therapy
4865887|NCT02243670|addiction|addiction
4865888|NCT02243670|buprenorphine maintenance treatment|buprenorphine maintenance treatment
4865889|NCT02243670|opioid dependence|opioid dependence
4865890|NCT02243670|substitution treatment|substitution treatment
4865891|NCT02243670|noncompliance|noncompliance
4865892|NCT02243670|opiate addiction|opiate addiction
4865893|NCT02243670|Zubzolv® maintenance|zubzolv® maintenance
4865894|NCT02243670|adherence monitoring|adherence monitoring
4865895|NCT02243670|directly observed therapy|directly observed therapy
4865896|NCT02243670|medication adherence|medication adherence
4865897|NCT02243670|adherence|adherence
4865898|NCT02243670|mobile|mobile
4865899|NCT02243670|electronic monitoring|electronic monitoring
4865900|NCT02243670|wireless|wireless
4865901|NCT02243670|mobile device|mobile device
4865902|NCT02243670|artificial intelligence|artificial intelligence
4865903|NCT02243670|facial recognition|facial recognition
4865904|NCT02243670|computer vision|computer vision
4865905|NCT02243670|visual confirmation|visual confirmation
4865906|NCT02243670|sublingual buprenorphine/naloxone|sublingual buprenorphine/naloxone
4865907|NCT02243670|nonadherence|nonadherence
4865908|NCT02243657|ASP3652|asp3652
4865909|NCT02243657|Age|age
4865910|NCT02243657|Gender|gender
4865911|NCT02243657|Pharmacokinetics|pharmacokinetics
4865912|NCT02243657|Pharmacodynamics|pharmacodynamics
4865913|NCT02243657|Phase 1|phase 1
4865914|NCT02243657|Multiple Ascending Doses (MAD)|multiple ascending doses (mad)
4865915|NCT02243644|parenchymal neurocysticercosis upto five lesions|parenchymal neurocysticercosis upto five lesions
4865916|NCT02243631|ATP|atp
4865917|NCT02243631|Probenecid|probenecid
4865918|NCT02243631|Chondrocalcinosis|chondrocalcinosis
4865919|NCT02243527|Exercise|exercise
4865920|NCT02243514|Hypertension|hypertension
4865921|NCT02243514|Heart failure|heart failure
4865922|NCT02243514|Sympathetic hyperactivity|sympathetic hyperactivity
4865923|NCT02243514|Renal nerve|renal nerve
4865924|NCT02243514|Remodeling|remodeling
4865925|NCT02243514|Nerve remodeling|nerve remodeling
4865926|NCT02243488|Menstruation|menstruation
4865927|NCT02243488|MHM|mhm
4865928|NCT02243488|Menstrual Hygiene Management|menstrual hygiene management
4865929|NCT02243488|Girls Education|girls education
4865930|NCT02243488|Absenteeism|absenteeism
4865931|NCT02243488|Access to Education|access to education
4865932|NCT02243488|Menstrual Health Education|menstrual health education
4865933|NCT02243488|Reusable Sanitary Product|reusable sanitary product
4865934|NCT02243462|Shivering|shivering
4865935|NCT02243462|Hypothermia|hypothermia
4865936|NCT02243462|Postoperative|postoperative
4865937|NCT02243462|Temperature|temperature
4865938|NCT02243462|Forced air warmer|forced air warmer
4865939|NCT02243449|mechanical ventilation|mechanical ventilation
4865940|NCT02243449|weaning|weaning
4865941|NCT02243449|elderly|elderly
4865942|NCT02243449|critically ill|critically ill
4865943|NCT02243449|screening|screening
4865944|NCT02243449|spontaneous breathing trial|spontaneous breathing trial
4865945|NCT02243449|invasive ventilation|invasive ventilation
4865946|NCT02243436|CLASSICAL HODGKIN LYMPHOMA|classical hodgkin lymphoma
4865947|NCT02243436|HODGKIN LYMPHOMA|hodgkin lymphoma
4865948|NCT02243436|LYMPHOMA|lymphoma
4865949|NCT02243436|HL|hl
4865950|NCT02243423|Aortocaval compression|aortocaval compression
4865951|NCT02243423|Cesarean Section|cesarean section
4865952|NCT02243423|Spinal Anesthesia|spinal anesthesia
4865953|NCT02243423|Phenylephrine|phenylephrine
4865954|NCT02243384|Early Hepatocellular Carcinoma|early hepatocellular carcinoma
4865955|NCT02243384|Laparoscopic Hepatectomy|laparoscopic hepatectomy
4865956|NCT02243384|Radiofrequency Ablation|radiofrequency ablation
4865957|NCT02243384|Micrometastases|micrometastases
4865958|NCT02243358|Pancreatic, cancer|pancreatic, cancer
4865959|NCT02243345|decompression|decompression
4865960|NCT02243345|recompression|recompression
4865961|NCT02243345|delayed|delayed
4865962|NCT02243345|late|late
4865963|NCT02243332|Knee|knee
4865964|NCT02243332|Pain|pain
4865965|NCT02243332|Joint|joint
4865966|NCT02243332|Rehabilitation|rehabilitation
4865967|NCT02243332|Patellofemoral Pain Syndrome|patellofemoral pain syndrome
4865968|NCT02243332|Anterior Knee Pain Syndrome|anterior knee pain syndrome
4865969|NCT02243332|Knee Pain|knee pain
4865970|NCT02243332|Quadriceps|quadriceps
4865971|NCT02243306|pharmacokinetics|pharmacokinetics
4865972|NCT02243306|Chronic kidney disease|chronic kidney disease
4865973|NCT02243306|peritoneal dialysis|peritoneal dialysis
4865974|NCT02243306|hemoglobin|hemoglobin
4865975|NCT02243306|Anemia|anemia
4865976|NCT02243306|GSK1278863|gsk1278863
4865977|NCT02243306|Prolyl hydroxylase inhibitor|prolyl hydroxylase inhibitor
4865978|NCT02243306|erythropoiesis stimulating agents|erythropoiesis stimulating agents
4865979|NCT02243293|Hepatitis C Virus (HCV)|hepatitis c virus (hcv)
4865980|NCT02243293|Hepatitis C|hepatitis c
4865981|NCT02243293|Chronic Hepatitis C|chronic hepatitis c
4865982|NCT02243293|interferon free|interferon free
4865983|NCT02243293|Hepatitis C Genotype 2|hepatitis c genotype 2
4865984|NCT02243293|Hepatitis C Genotype 3|hepatitis c genotype 3
4865985|NCT02243293|Hepatitis C Genotype 4|hepatitis c genotype 4
4865986|NCT02243293|Hepatitis C Genotype 5|hepatitis c genotype 5
4865987|NCT02243293|Hepatitis C Genotype 6|hepatitis c genotype 6
4865988|NCT02243280|HCV GT4|hcv gt4
4865989|NCT02243280|Hepatitis C virus|hepatitis c virus
4865990|NCT02243280|HCV GT1|hcv gt1
4865991|NCT02243280|HCV|hcv
4865992|NCT02243280|Compensated Cirrhosis|compensated cirrhosis
4865993|NCT02243280|HCV GT6|hcv gt6
4865994|NCT02243280|Hepatitis C Genotype 4 (GT 4)|hepatitis c genotype 4 (gt 4)
4865995|NCT02243280|Hepatitis C Genotype 1 (GT1)|hepatitis c genotype 1 (gt1)
4865996|NCT02243280|RBV|rbv
4865997|NCT02243280|Cirrhotic|cirrhotic
4865998|NCT02243280|Hepatitis C|hepatitis c
4865999|NCT02243280|Interferon (IFN) Free|interferon (ifn) free
4866000|NCT02243280|IFN free|ifn free
4866001|NCT02243280|HCV GT5|hcv gt5
4866002|NCT02243280|Chronic Hepatitis C|chronic hepatitis c
4866003|NCT02243280|Ribavirin|ribavirin
4866004|NCT02243280|Child Pugh A|child pugh a
4866005|NCT02243280|Hepatitis C Genotype 5 (GT 5)|hepatitis c genotype 5 (gt 5)
4866006|NCT02243280|Hepatitis C Genotype 6 (GT 6)|hepatitis c genotype 6 (gt 6)
4866007|NCT02243280|ABT-493|abt-493
4866008|NCT02243280|ABT-530|abt-530
4866009|NCT02243280|glecaprevir|glecaprevir
4866010|NCT02243280|pibrentasvir|pibrentasvir
4866011|NCT02243267|Colon Cancer Colon Cancer Prevention|colon cancer colon cancer prevention
4866012|NCT02243241|Healthy volunteers|healthy volunteers
4866013|NCT02243241|Opioid|opioid
4866014|NCT02243241|ECG|ecg
4866015|NCT02243241|QTcI|qtci
4866016|NCT02243228|granulocyte-macrophage colony stimulating factor(GM-CSF)|granulocyte-macrophage colony stimulating factor(gm-csf)
4866017|NCT02243228|Autoimmune pulmonary alveolar proteinosis (PAP)|autoimmune pulmonary alveolar proteinosis (pap)
4866018|NCT02243215|Laparoscopy|laparoscopy
4866019|NCT02243215|Training|training
4866020|NCT02243215|Off-site|off-site
4866021|NCT02243215|Box trainer|box trainer
4866022|NCT02243215|Virtual Reality Simulator|virtual reality simulator
4866023|NCT02243202|Obesity|obesity
4866024|NCT02243202|Overweight|overweight
4866025|NCT02243202|Canagliflozin|canagliflozin
4866026|NCT02243202|Phentermine|phentermine
4866027|NCT02243202|INVOKANA®|invokana®
4866028|NCT02243189|Healthy|healthy
4866029|NCT02243189|Asthma|asthma
4866030|NCT02243189|JNJ-43260295|jnj-43260295
4866031|NCT02243189|Nasal Allergen Challenge|nasal allergen challenge
4866032|NCT02243176|Saxagliptin|saxagliptin
4866033|NCT02243176|Acarbose|acarbose
4866034|NCT02243176|Type 2 Diabetes|type 2 diabetes
4866035|NCT02243176|Metformin|metformin
4866036|NCT02243124|Anemia|anemia
4866037|NCT02243124|Transfusion|transfusion
4866038|NCT02243124|AML|aml
4866039|NCT02243124|MDS|mds
4866040|NCT02243124|CLL|cll
4866041|NCT02243124|p53|p53
4866042|NCT02243124|erythropoiesis|erythropoiesis
4866043|NCT02243111|Systemic sclerosis, pulmonary hypertension|systemic sclerosis, pulmonary hypertension
4866044|NCT02243072|Insulin Dependent Diabetes Mellitus|insulin dependent diabetes mellitus
4866045|NCT02243072|family therapy|family therapy
4866046|NCT02243072|adolescents|adolescents
4866047|NCT02243072|regimen adherence|regimen adherence
4866048|NCT02243072|metabolic control|metabolic control
4866049|NCT02243059|Magnetic Resonance Imaging|magnetic resonance imaging
4866050|NCT02243059|Gadofosveset trisodium|gadofosveset trisodium
4866051|NCT02243059|Nodal imaging|nodal imaging
4866052|NCT02243033|Prostate cancer|prostate cancer
4866053|NCT02243033|Focal therapy|focal therapy
4866054|NCT02243033|Laser therapy|laser therapy
4866055|NCT02243033|Transrectal|transrectal
4866056|NCT02243033|MRI-guided|mri-guided
4866057|NCT02243007|Resectable pancreatic cancer|resectable pancreatic cancer
4866058|NCT02243007|Pancreatic Ductal Carcinoma|pancreatic ductal carcinoma
4866059|NCT02242968|Licensed Vaccines|licensed vaccines
4866060|NCT02242968|Blood Draw|blood draw
4866061|NCT02242968|Investigational Vaccines|investigational vaccines
4866062|NCT02242968|Healthy Volunteers|healthy volunteers
4866063|NCT02242968|Eligibility Screening|eligibility screening
4866064|NCT02242955|Alcohol-dependence|alcohol-dependence
4866065|NCT02242955|Relapse|relapse
4866066|NCT02242955|Detoxification|detoxification
4866067|NCT02242955|Diazepam|diazepam
4866068|NCT02242955|Benzodiazepines|benzodiazepines
4866069|NCT02242955|Anxiety|anxiety
4866070|NCT02242929|Nodular Basal Cell Carcinoma|nodular basal cell carcinoma
4866071|NCT02242929|Treatment|treatment
4866072|NCT02242929|Imiquimod|imiquimod
4866073|NCT02242929|Curettage|curettage
4866074|NCT02242929|Surgery|surgery
4866075|NCT02242916|reccurent Head and Neck tumors|reccurent head and neck tumors
4866076|NCT02242916|re-irradiation|re-irradiation
4866077|NCT02242916|photon|photon
4866078|NCT02242916|proton|proton
4866079|NCT02242916|carbon-ion|carbon-ion
4866080|NCT02242890|intrauterine contraception (IUC)|intrauterine contraception (iuc)
4866081|NCT02242890|social networks|social networks
4866082|NCT02242890|social influence|social influence
4866083|NCT02242890|diffusion of innovation|diffusion of innovation
4866084|NCT02242890|intrauterine device (IUD)|intrauterine device (iud)
4866085|NCT02242890|LARC|larc
4866086|NCT02242799|Malaria|malaria
4866087|NCT02242799|HIV|hiv
4866088|NCT02242799|Dolutegravir|dolutegravir
4866089|NCT02242799|Artemisinin|artemisinin
4866090|NCT02242799|Pharmacokinetics|pharmacokinetics
4866091|NCT02242799|Interactions|interactions
4866092|NCT02242773|Prostate Cancer|prostate cancer
4866093|NCT02242773|Active Surveillance|active surveillance
4866094|NCT02242773|MRI-Guided Biopsy|mri-guided biopsy
4866095|NCT02242773|Multi-parametric MRI|multi-parametric mri
4866096|NCT02242773|MP-MRI|mp-mri
4866097|NCT02242760|acne|acne
4866098|NCT02242747|actinic keratosis|actinic keratosis
4866099|NCT02242747|field cancerization|field cancerization
4866100|NCT02242747|ingenol mebutate|ingenol mebutate
4866101|NCT02242747|5-fluorouracil|5-fluorouracil
4866102|NCT02242747|tolerability|tolerability
4866103|NCT02242747|safety|safety
4866104|NCT02242695|vulvovaginal candidiasis|vulvovaginal candidiasis
4866105|NCT02242695|vulvovaginal candidosis|vulvovaginal candidosis
4866106|NCT02242695|mycotic vaginal infection|mycotic vaginal infection
4866107|NCT02242695|dequalinium chloride|dequalinium chloride
4866108|NCT02242695|Fluomizin|fluomizin
4866109|NCT02242695|clotrimazole|clotrimazole
4866110|NCT02242695|canesten|canesten
4866111|NCT02242656|Short Bowel Syndrome|short bowel syndrome
4866112|NCT02242656|SBS|sbs
4866113|NCT02242656|Chronic Diarrhea|chronic diarrhea
4866114|NCT02242656|Short Bowel|short bowel
4866115|NCT02242656|Short Gut|short gut
4866116|NCT02242656|Short Gut Syndrome|short gut syndrome
4866117|NCT02242656|Anti-Diarrheal|anti-diarrheal
4866118|NCT02242656|Opium Tincture|opium tincture
4866119|NCT02242656|loperamide|loperamide
4866120|NCT02242656|diphenoxylate|diphenoxylate
4866121|NCT02242656|ileostomies|ileostomies
4866122|NCT02242656|tincture of opium|tincture of opium
4866123|NCT02242656|DTO|dto
4866124|NCT02242656|codeine|codeine
4866125|NCT02242656|morphine|morphine
4866126|NCT02242656|opiate|opiate
4866127|NCT02242643|Fluzone Quadrivalent|fluzone quadrivalent
4866128|NCT02242643|Comparator|comparator
4866129|NCT02242643|Children|children
4866130|NCT02242643|Seasonal influenza|seasonal influenza
4866131|NCT02242643|Safety|safety
4866132|NCT02242643|Immunogenicity|immunogenicity
4866133|NCT02242630|Subacromial bursitis|subacromial bursitis
4866134|NCT02242630|Triamcinolone|triamcinolone
4866135|NCT02242630|Methylprednisolone|methylprednisolone
4866136|NCT02242630|Shoulder pain|shoulder pain
4866137|NCT02242617|Adherence|adherence
4866138|NCT02242617|CPAP|cpap
4866139|NCT02242617|Oral Appliance|oral appliance
4866140|NCT02242617|Mandibular Advancement Splints|mandibular advancement splints
4866141|NCT02242617|Preference|preference
4866142|NCT02242591|Knee surgery|knee surgery
4866143|NCT02242591|Saphenous nerve|saphenous nerve
4866144|NCT02242591|Perineural block|perineural block
4866145|NCT02242591|Adductor Canal Block|adductor canal block
4866146|NCT02242591|Postoperative Pain|postoperative pain
4866147|NCT02242591|Mobilization|mobilization
4866148|NCT02242578|Negative symptoms|negative symptoms
4866149|NCT02242565|HIV prevention|hiv prevention
4866150|NCT02242565|ShangRing|shangring
4866151|NCT02242565|adverse events|adverse events
4866152|NCT02242565|wound healing|wound healing
4866153|NCT02242565|voluntary medical male circumcision (VMMC)|voluntary medical male circumcision (vmmc)
4866154|NCT02242565|medical device|medical device
4866155|NCT02242565|Zambia|zambia
4866156|NCT02242526|hiatal hernia, recurrence, biologic mesh, synthetic mesh|hiatal hernia, recurrence, biologic mesh, synthetic mesh
4866157|NCT02242513|Pulsed mode radiofrequency|pulsed mode radiofrequency
4866158|NCT02242513|Plantar Fasciitis|plantar fasciitis
4866159|NCT02242513|Ultrasound-guided|ultrasound-guided
4866160|NCT02242500|Gingival recession/surgery|gingival recession/surgery
4866161|NCT02242500|Collagen/therapeutic use|collagen/therapeutic use
4866162|NCT02242500|Root coverage|root coverage
4866163|NCT02242500|Treatment outcome|treatment outcome
4866164|NCT02242487|Parkinson's Disease|parkinson's disease
4866165|NCT02242487|Motor fluctuations|motor fluctuations
4866166|NCT02242487|levodopa|levodopa
4866167|NCT02242487|inhaled drugs|inhaled drugs
4866168|NCT02242487|OFF episodes|off episodes
4866169|NCT02242474|Rheumatoid arthritis|rheumatoid arthritis
4866170|NCT02242474|Surgical Wound Infection|surgical wound infection
4866171|NCT02242474|Surgical Site Infection|surgical site infection
4866172|NCT02242474|Antirheumatic Agents|antirheumatic agents
4866173|NCT02242474|Perioperative Care|perioperative care
4866174|NCT02242474|Anti-TNF|anti-tnf
4866175|NCT02242474|Anti-TNF-alpha|anti-tnf-alpha
4866176|NCT02242461|COPD, Rhodiola L., clinical trial, biomarkers, spirometry|copd, rhodiola l., clinical trial, biomarkers, spirometry
4866177|NCT02242448|Healthy Volunteer|healthy volunteer
4866178|NCT02242448|Contrast|contrast
4866179|NCT02242409|Metastatic pancreatic cancer|metastatic pancreatic cancer
4866180|NCT02242409|Second Line treatment|second line treatment
4866181|NCT02242409|Gemcitabine|gemcitabine
4866182|NCT02242409|Nab-paclitaxel|nab-paclitaxel
4866183|NCT02242188|Breastfeeding|breastfeeding
4866184|NCT02242188|Iron supplementation|iron supplementation
4866185|NCT02242188|Psychomotor development|psychomotor development
4866186|NCT02242188|Safety|safety
4866187|NCT02242188|infants|infants
4866188|NCT02242162|phrenic nerves magnetic stimulations|phrenic nerves magnetic stimulations
4866189|NCT02242149|Fat liver|fat liver
4866190|NCT02242149|Diabetes|diabetes
4866191|NCT02242149|Diacerein|diacerein
4866192|NCT02242149|Transient elastography|transient elastography
4866193|NCT02242149|Treatment|treatment
4866194|NCT02242136|Posttraumatic Stress Disorder|posttraumatic stress disorder
4866195|NCT02242136|Aggressive Behavior|aggressive behavior
4866196|NCT02242136|Appetitive Aggression|appetitive aggression
4866197|NCT02242136|Treatment|treatment
4866198|NCT02242136|FORNET|fornet
4866199|NCT02242123|Celiac Disease|celiac disease
4866200|NCT02242123|Gluten-free diet|gluten-free diet
4866201|NCT02242123|EmA assay|ema assay
4866202|NCT02242123|Duodenal culture medium|duodenal culture medium
4866203|NCT02242110|Nightmares|nightmares
4866204|NCT02242110|Sleep|sleep
4866205|NCT02242110|PTSD|ptsd
4866206|NCT02242110|Exposure, Relaxation, and Rescripting Therapy|exposure, relaxation, and rescripting therapy
4866207|NCT02242071|Motor Neuron Disease|motor neuron disease
4866208|NCT02242071|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
4866209|NCT02242071|Autologous Mononuclear Cell therapy|autologous mononuclear cell therapy
4866210|NCT02242071|Stem cells|stem cells
4866211|NCT02242032|dry eye disease|dry eye disease
4866212|NCT02241993|glucose sensor|glucose sensor
4866213|NCT02241993|Inter-sensor distance|inter-sensor distance
4866214|NCT02241967|total knee arthroplasty|total knee arthroplasty
4866215|NCT02241967|pain|pain
4866216|NCT02241967|post-surgical pain|post-surgical pain
4866217|NCT02241967|opioid|opioid
4866218|NCT02241967|transcranial direct current stimulation|transcranial direct current stimulation
4866219|NCT02241967|tDCS|tdcs
4866220|NCT02241967|brain stimulation|brain stimulation
4866221|NCT02241967|total hip arthroplasty|total hip arthroplasty
4866222|NCT02241967|TKA|tka
4866223|NCT02241967|THA|tha
4866224|NCT02241928|Muscular Dystrophy|muscular dystrophy
4866225|NCT02241928|Autologous Mononuclear cell therapy|autologous mononuclear cell therapy
4866226|NCT02241928|Stem Cell|stem cell
4866227|NCT02241889|diabetes|diabetes
4866228|NCT02241889|closed-loop|closed-loop
4866229|NCT02241889|bi-hormonal|bi-hormonal
4866230|NCT02241889|exercise|exercise
4866231|NCT02241863|bipolar disorders|bipolar disorders
4866232|NCT02241863|medication adherence|medication adherence
4866233|NCT02241863|psychological intervention|psychological intervention
4866234|NCT02241863|multifaceted intervention|multifaceted intervention
4866235|NCT02241850|High Intensity Training|high intensity training
4866236|NCT02241850|Genetic Polymorphisms|genetic polymorphisms
4866237|NCT02241850|Genome Wide association study|genome wide association study
4866238|NCT02241850|Single Nucleotide Polymorphism genotype|single nucleotide polymorphism genotype
4866239|NCT02241850|Subjects|subjects
4866240|NCT02241837|heart failure|heart failure
4866241|NCT02241837|percutaneous|percutaneous
4866242|NCT02241837|interventional cardiology|interventional cardiology
4866243|NCT02241837|apical remodeling|apical remodeling
4866244|NCT02241837|LV dilatation|lv dilatation
4866245|NCT02241837|akinesis|akinesis
4866246|NCT02241837|dyskinesis|dyskinesis
4866247|NCT02241837|myocardial infarction|myocardial infarction
4866248|NCT02241824|Lumbar Orthosis|lumbar orthosis
4866249|NCT02241824|Lumbar brace|lumbar brace
4866250|NCT02241811|Diabetic|diabetic
4866251|NCT02241811|Foot|foot
4866252|NCT02241811|Wound|wound
4866253|NCT02241811|Sodium pentaborate pentahydrate|sodium pentaborate pentahydrate
4866254|NCT02241811|Hydrogel|hydrogel
4866255|NCT02241798|epilepsy|epilepsy
4866256|NCT02241798|oxygen saturation|oxygen saturation
4866257|NCT02241798|transcutaneous carbon dioxide|transcutaneous carbon dioxide
4866258|NCT02241798|sudep|sudep
4866259|NCT02241798|pre-oxygenation|pre-oxygenation
4866260|NCT02241733|exercise|exercise
4866261|NCT02241733|pulmonary rehabilitation|pulmonary rehabilitation
4866262|NCT02241733|dynamic hyperinflation|dynamic hyperinflation
4866263|NCT02241707|Varicose vein|varicose vein
4866264|NCT02241707|Endovenous ablation|endovenous ablation
4866265|NCT02241707|Compression|compression
4866266|NCT02241681|Medium Chain Triglycerides|medium chain triglycerides
4866267|NCT02241681|Medium Chain Triglycerides metabolites|medium chain triglycerides metabolites
4866268|NCT02241681|Peptamen 1.5|peptamen 1.5
4866269|NCT02241668|Brain tumor|brain tumor
4866270|NCT02241668|3'-Deoxy-3'-18f-Fluorothymidine|3'-deoxy-3'-18f-fluorothymidine
4866271|NCT02241668|Fluoro-L-Thymidine Positron Emission Tomography|fluoro-l-thymidine positron emission tomography
4866272|NCT02241668|FLT PET|flt pet
4866273|NCT02241668|Magnetic resonance imaging|magnetic resonance imaging
4866274|NCT02241668|MRI|mri
4866275|NCT02241655|Anesthesia|anesthesia
4866276|NCT02241655|Electroencephalography|electroencephalography
4866277|NCT02241655|Burst suppression|burst suppression
4866278|NCT02241655|Surgery|surgery
4866279|NCT02241655|Delirium|delirium
4866280|NCT02241655|Falls|falls
4866281|NCT02241655|Health related quality of life|health related quality of life
4866282|NCT02241642|Percutaneous vascular closure device|percutaneous vascular closure device
4866283|NCT02241642|vascular closure device|vascular closure device
4866284|NCT02241642|Large hole closure device|large hole closure device
4866285|NCT02241629|motion sickness|motion sickness
4866286|NCT02241603|Insulin resistance|insulin resistance
4866287|NCT02241603|Consummatory Reward|consummatory reward
4866288|NCT02241577|peri-implantitis|peri-implantitis
4866289|NCT02241577|dental implants|dental implants
4866290|NCT02241577|randomized controlled trial|randomized controlled trial
4866291|NCT02241577|non-surgical periodontal treatment|non-surgical periodontal treatment
4866292|NCT02241577|will be defined by the presence of alveolar bone loss of at least 3mm, pocket depth of at least 5mm and bleeding on probing.|will be defined by the presence of alveolar bone loss of at least 3mm, pocket depth of at least 5mm and bleeding on probing.
4866293|NCT02241564|Immunosuppression|immunosuppression
4866294|NCT02241551|Borderline|borderline
4866295|NCT02241551|Resectable|resectable
4866296|NCT02241551|Pancreatic|pancreatic
4866297|NCT02241551|Cancer|cancer
4866298|NCT02241551|Neoadjuvant|neoadjuvant
4866299|NCT02241551|Chemotheraphy|chemotheraphy
4866300|NCT02241551|Gemcitabine|gemcitabine
4866301|NCT02241551|Nab-Paclitaxel|nab-paclitaxel
4866302|NCT02241551|mFOFIRINOX|mfofirinox
4866303|NCT02241551|Sterotatic Body Radiation Therapy|sterotatic body radiation therapy
4866304|NCT02241538|Pilates-based exercises|pilates-based exercises
4866305|NCT02241525|Pulmonary|pulmonary
4866306|NCT02241525|Thromboembolic|thromboembolic
4866307|NCT02241525|Lung|lung
4866308|NCT02241512|post-ERCP pancreatitis|post-ercp pancreatitis
4866309|NCT02241512|pediatric|pediatric
4866310|NCT02241512|ibuprofen|ibuprofen
4866311|NCT02241499|Digestive System Diseases|digestive system diseases
4866312|NCT02241499|Esophageal cancer|esophageal cancer
4866313|NCT02241499|Intestinal Neoplasms|intestinal neoplasms
4866314|NCT02241499|Gastrointestinal Neoplasms|gastrointestinal neoplasms
4866315|NCT02241499|Digestive System Neoplasms|digestive system neoplasms
4866316|NCT02241499|Endoscopic response|endoscopic response
4866317|NCT02241499|Fluorouracil|fluorouracil
4866318|NCT02241499|Metabolic response|metabolic response
4866319|NCT02241499|Oxaliplatin|oxaliplatin
4866320|NCT02241499|Radiotherapy|radiotherapy
4866321|NCT02241486|Burn pain|burn pain
4866322|NCT02241486|Procedural pain|procedural pain
4866323|NCT02241486|Sublingual fentanyl|sublingual fentanyl
4866324|NCT02241486|Morphine|morphine
4866325|NCT02241473|gait|gait
4866326|NCT02241473|physical activity|physical activity
4866327|NCT02241473|energy cost|energy cost
4866328|NCT02241473|efficiency|efficiency
4866329|NCT02241460|Premature Ejaculation|premature ejaculation
4866330|NCT02241460|Lidocaine|lidocaine
4866331|NCT02241447|aortic valve Stenosis|aortic valve stenosis
4866332|NCT02241447|Echo|echo
4866333|NCT02241447|TAVI|tavi
4866334|NCT02241447|SAVR|savr
4866335|NCT02241447|referral|referral
4866336|NCT02241434|Duchenne muscular dystrophy|duchenne muscular dystrophy
4866337|NCT02241434|Autologous Bone marrow Mononuclear cell therapy|autologous bone marrow mononuclear cell therapy
4866338|NCT02241434|Stem Cells|stem cells
4866339|NCT02241421|Impaired glucose tolerance|impaired glucose tolerance
4866340|NCT02241421|Glucose Metabolism Disorders|glucose metabolism disorders
4866341|NCT02241421|Metabolic Diseases|metabolic diseases
4866342|NCT02241421|Endocrine System Diseases|endocrine system diseases
4866343|NCT02241421|Hyperinsulinism|hyperinsulinism
4866344|NCT02241421|Lipid metabolism|lipid metabolism
4866345|NCT02241421|Anti Bacterial Agents|anti bacterial agents
4866346|NCT02241421|Gastro Intestinal Tract|gastro intestinal tract
4866347|NCT02241395|Cerebral Palsy|cerebral palsy
4866348|NCT02241395|autologous bone marrow mononuclear cells|autologous bone marrow mononuclear cells
4866349|NCT02241395|stem cell|stem cell
4866350|NCT02241369|Aerodigestive Lesions and Malignancies|aerodigestive lesions and malignancies
4866351|NCT02241369|Human Papillomavirus|human papillomavirus
4866352|NCT02241369|Squamous Cell Carcinoma|squamous cell carcinoma
4866353|NCT02241356|Down syndrome|down syndrome
4866354|NCT02241356|visual functions|visual functions
4866355|NCT02241356|bifocals|bifocals
4866356|NCT02241356|children|children
4866357|NCT02241356|visual acuity at near|visual acuity at near
4866358|NCT02241343|Artificially and reversibly achieved with a blood pressure cuff|artificially and reversibly achieved with a blood pressure cuff
4866359|NCT02241330|Zinc|zinc
4866360|NCT02241330|deficiency|deficiency
4866361|NCT02241330|biofortification|biofortification
4866362|NCT02241330|wheat|wheat
4866363|NCT02241317|Diabetes mellitus|diabetes mellitus
4866364|NCT02241317|Hypoglycaemia|hypoglycaemia
4866365|NCT02241317|staff training|staff training
4866366|NCT02241317|Education|education
4866367|NCT02241317|blood glucose|blood glucose
4866368|NCT02241304|electromyography|electromyography
4866369|NCT02241304|neuromuscular blockade|neuromuscular blockade
4866370|NCT02241291|Percutaneous Coronary Intervention|percutaneous coronary intervention
4866371|NCT02241291|Registries|registries
4866372|NCT02241278|colon surgery|colon surgery
4866373|NCT02241278|ketamine|ketamine
4866374|NCT02241278|patient-controlled-analgesia|patient-controlled-analgesia
4866375|NCT02241278|preemptive analgesia|preemptive analgesia
4866376|NCT02241265|asthma|asthma
4866377|NCT02241265|thermoplasty|thermoplasty
4866378|NCT02241252|ECG|ecg
4866379|NCT02241252|QT interval|qt interval
4866380|NCT02241252|Sotalol|sotalol
4866381|NCT02241252|Dofetilide|dofetilide
4866382|NCT02241252|iPhone|iphone
4866383|NCT02241226|wellbeing|wellbeing
4866384|NCT02241226|meditation|meditation
4866385|NCT02241226|Ayurveda|ayurveda
4866386|NCT02241226|yoga|yoga
4866387|NCT02241226|herbs|herbs
4866388|NCT02241226|health|health
4866389|NCT02241226|longevity|longevity
4866390|NCT02241226|individuals|individuals
4866391|NCT02241213|Stroke|stroke
4866392|NCT02241213|Aphasia|aphasia
4866393|NCT02241213|Broca|broca
4866394|NCT02241187|PEGPH20|pegph20
4866395|NCT02241187|Cetuximab|cetuximab
4866396|NCT02241187|14-039|14-039
4866397|NCT02241174|Atopic Dermatitis|atopic dermatitis
4866398|NCT02241161|skin eythema|skin eythema
4866399|NCT02241161|rejuvenating cream|rejuvenating cream
4866400|NCT02241161|rejuvenating serum|rejuvenating serum
4866401|NCT02241161|antioxidant serum|antioxidant serum
4866402|NCT02241135|Rav G protein|rav g protein
4866403|NCT02241135|rabies|rabies
4866404|NCT02241135|VNT|vnt
4866405|NCT02241135|immunogenicity|immunogenicity
4866406|NCT02241135|PrEP vaccination|prep vaccination
4866407|NCT02241135|mRNA|mrna
4866408|NCT02241135|CV7201|cv7201
4866409|NCT02241122|prostate cancer|prostate cancer
4866410|NCT02241122|PSA|psa
4866411|NCT02241122|MRI|mri
4866412|NCT02241122|biopsy|biopsy
4866413|NCT02241122|biomarker|biomarker
4866414|NCT02241109|aortic stenosis progression|aortic stenosis progression
4866415|NCT02241109|aortic valve sclerosis progression|aortic valve sclerosis progression
4866416|NCT02241109|calcification propensity|calcification propensity
4866417|NCT02241070|mindfulness meditation|mindfulness meditation
4866418|NCT02241070|mental health promotion|mental health promotion
4866419|NCT02241070|worker|worker
4866420|NCT02241057|temperature profile|temperature profile
4866421|NCT02241057|air activated 3-cell patch|air activated 3-cell patch
4866422|NCT02241057|adhesion|adhesion
4866792|NCT02239250|PM2.5|pm2.5
4866423|NCT02241044|argon plasma coagulation, bleeding peptic ulcer|argon plasma coagulation, bleeding peptic ulcer
4866424|NCT02241031|Megakaryocytic Progenitor Products|megakaryocytic progenitor products
4866425|NCT02241031|Hematological Diseases|hematological diseases
4866426|NCT02241031|Thrombocytopenia|thrombocytopenia
4866427|NCT02241018|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
4866428|NCT02241018|Mesenchymal Stem Cells|mesenchymal stem cells
4866429|NCT02241018|CD25 Monoclonal Antibody|cd25 monoclonal antibody
4866430|NCT02241018|Acute Graft-versus-host disease|acute graft-versus-host disease
4866431|NCT02241005|Health-care associated infection|health-care associated infection
4866432|NCT02241005|Skin integrity|skin integrity
4866433|NCT02241005|Antimicrobial resistance|antimicrobial resistance
4866434|NCT02240992|Poor Graft Function|poor graft function
4866435|NCT02240992|Delayed platelet engraftment|delayed platelet engraftment
4866436|NCT02240992|Peripheral Blood Stem Cell|peripheral blood stem cell
4866437|NCT02240992|Mesenchymal Stem Cells|mesenchymal stem cells
4866438|NCT02240992|Allogeneic hematopoietic stem cell transplantation|allogeneic hematopoietic stem cell transplantation
4866439|NCT02240979|arterial waveform|arterial waveform
4866440|NCT02240979|cardiac magnetic resonance imaging|cardiac magnetic resonance imaging
4866441|NCT02240979|echocardiography|echocardiography
4866442|NCT02240979|intrinsic frequency measures of cardiac function|intrinsic frequency measures of cardiac function
4866443|NCT02240966|Testicular Neoplasms|testicular neoplasms
4866444|NCT02240966|Hypogonadism|hypogonadism
4866445|NCT02240966|Metabolic Syndrome|metabolic syndrome
4866446|NCT02240966|Treatment related late effects|treatment related late effects
4866447|NCT02240953|Anticoagulation|anticoagulation
4866448|NCT02240953|Prosthetic Heart Valves|prosthetic heart valves
4866449|NCT02240953|Acetylsalicylic acid|acetylsalicylic acid
4866450|NCT02240953|Warfarin|warfarin
4866451|NCT02240953|Thrombosis|thrombosis
4866452|NCT02240940|Heart Failure|heart failure
4866453|NCT02240940|Volume Reduction|volume reduction
4866454|NCT02240940|Pressure Reduction|pressure reduction
4866455|NCT02240940|Ischemic Heart Failure|ischemic heart failure
4866456|NCT02240940|LAD Infarct|lad infarct
4866457|NCT02240927|Anticoagulation|anticoagulation
4866458|NCT02240927|Prosthetic Heart Valves|prosthetic heart valves
4866459|NCT02240927|Pregnancy|pregnancy
4866460|NCT02240927|Warfarin|warfarin
4866461|NCT02240927|Thrombosis|thrombosis
4866462|NCT02240914|Iliac Vein Obstruction|iliac vein obstruction
4866463|NCT02240914|May-Thurner Syndrome|may-thurner syndrome
4866464|NCT02240914|Cockett Syndrome|cockett syndrome
4866465|NCT02240914|Vascular Ultrasound|vascular ultrasound
4866466|NCT02240914|IVUS|ivus
4866467|NCT02240901|Laryngeal mask airway|laryngeal mask airway
4866468|NCT02240901|endotracheal intubation|endotracheal intubation
4866469|NCT02240901|postoperative pulmonary complications|postoperative pulmonary complications
4866470|NCT02240901|elderly patients|elderly patients
4866471|NCT02240888|pneumococcal|pneumococcal
4866472|NCT02240888|vaccination|vaccination
4866473|NCT02240888|antibody|antibody
4866474|NCT02240888|response|response
4866475|NCT02240888|immunosuppressive|immunosuppressive
4866476|NCT02240888|treatment|treatment
4866477|NCT02240888|inflammatory|inflammatory
4866478|NCT02240888|rheumatic|rheumatic
4866479|NCT02240888|disease|disease
4866480|NCT02240875|Ebola|ebola
4866481|NCT02240875|Zaire|zaire
4866482|NCT02240849|Neck pain|neck pain
4866483|NCT02240849|functional pillow|functional pillow
4866484|NCT02240849|sleep|sleep
4866485|NCT02240849|cervical lordosis|cervical lordosis
4866486|NCT02240823|Erectile Function|erectile function
4866487|NCT02240823|Mesenchymal Stromal Cells|mesenchymal stromal cells
4866488|NCT02240823|Stem Cell|stem cell
4866489|NCT02240797|Anorexia Nervosa|anorexia nervosa
4866490|NCT02240797|Neuroimaging|neuroimaging
4866491|NCT02240797|Positron emission tomography (PET)|positron emission tomography (pet)
4866492|NCT02240797|[11C]PKAB|[11c]pkab
4866493|NCT02240784|Porphyria|porphyria
4866494|NCT02240784|AIP|aip
4866495|NCT02240784|VP|vp
4866496|NCT02240784|HCP|hcp
4866497|NCT02240784|Variegate|variegate
4866498|NCT02240784|Coproporphyria|coproporphyria
4866499|NCT02240771|Transarterial chemotherapy|transarterial chemotherapy
4866500|NCT02240771|Thalidomide|thalidomide
4866501|NCT02240771|Capecitabine|capecitabine
4866502|NCT02240758|glioma, confocal laser endomicroscopy|glioma, confocal laser endomicroscopy
4866503|NCT02240745|Echocardiography, Stress|echocardiography, stress
4866504|NCT02240745|Echocardiography, Three-Dimensional|echocardiography, three-dimensional
4866505|NCT02240745|Coronary Artery Disease|coronary artery disease
4866506|NCT02240745|Fractional Flow Reserve, Myocardial|fractional flow reserve, myocardial
4866507|NCT02240745|Coronary Circulation|coronary circulation
4866508|NCT02240615|Epiphora|epiphora
4866509|NCT02240615|Lacrimal Stent|lacrimal stent
4866510|NCT02240615|Lacrimal System|lacrimal system
4866511|NCT02240602|acute pain|acute pain
4866512|NCT02240602|postoperative|postoperative
4866513|NCT02240602|surgery|surgery
4866514|NCT02240589|Traumatic Brain Injury|traumatic brain injury
4866515|NCT02240589|Memantine|memantine
4866516|NCT02240589|Memory|memory
4866517|NCT02240576|surgery for nasal fracture|surgery for nasal fracture
4866518|NCT02240563|autoimmune thyroiditis|autoimmune thyroiditis
4866519|NCT02240563|LLLT|lllt
4866520|NCT02240563|safety|safety
4866521|NCT02240563|ultrasound|ultrasound
4866522|NCT02240550|Open Inguinal Hernia|open inguinal hernia
4866523|NCT02240537|AML|aml
4866524|NCT02240537|MM|mm
4866525|NCT02240537|MDS|mds
4866526|NCT02240537|sMM|smm
4866527|NCT02240524|Gastric adenocarcinoma|gastric adenocarcinoma
4866528|NCT02240524|HIPEC|hipec
4866529|NCT02240524|Paclitaxel|paclitaxel
4866530|NCT02240524|Oxaliplatin|oxaliplatin
4866531|NCT02240524|Capecitabine|capecitabine
4866532|NCT02240511|Body Composition|body composition
4866533|NCT02240511|Amino Acids Supplementation|amino acids supplementation
4866534|NCT02240511|Resistance Exercise|resistance exercise
4866535|NCT02240498|Abscess|abscess
4866536|NCT02240498|Drainage|drainage
4866537|NCT02240485|Pathological gambling|pathological gambling
4866538|NCT02240485|Treatment|treatment
4866539|NCT02240485|Marital relationship|marital relationship
4866540|NCT02240472|sentinel node biopsy, lymph node metastasis, survival|sentinel node biopsy, lymph node metastasis, survival
4866541|NCT02240459|crossover study|crossover study
4866542|NCT02240459|placebo controlled|placebo controlled
4866543|NCT02240459|double blind|double blind
4866544|NCT02240459|overactive bladder|overactive bladder
4866545|NCT02240420|Type 2 diabetes prevention in the post-partum|type 2 diabetes prevention in the post-partum
4866546|NCT02240420|Behavior change among Latinas,|behavior change among latinas,
4866547|NCT02240420|Health Coaching, Motivational interviewing techniques|health coaching, motivational interviewing techniques
4866548|NCT02240407|Pompe Disease|pompe disease
4866549|NCT02240407|Gene Therapy|gene therapy
4866550|NCT02240407|Repeated dosing|repeated dosing
4866551|NCT02240407|Immune modulation|immune modulation
4866552|NCT02240394|TCD Traumatic brain injury increased intracranial pressure|tcd traumatic brain injury increased intracranial pressure
4866553|NCT02240368|Depth anesthesia monitors|depth anesthesia monitors
4866554|NCT02240368|Children anesthesia|children anesthesia
4866555|NCT02240368|Bispectral monitor|bispectral monitor
4866556|NCT02240368|Entropy monitor|entropy monitor
4866557|NCT02240342|Ovarian reserve|ovarian reserve
4866558|NCT02240342|Poor response|poor response
4866559|NCT02240342|Follicle recruitment|follicle recruitment
4866560|NCT02240342|Bone marrow transplant|bone marrow transplant
4866561|NCT02240329|respiratory|respiratory
4866562|NCT02240329|cough|cough
4866563|NCT02240303|pain|pain
4866564|NCT02240303|mobility|mobility
4866565|NCT02240303|brain|brain
4866566|NCT02240303|cognition|cognition
4866567|NCT02240290|C14|c14
4866568|NCT02240290|Dosimetry|dosimetry
4866569|NCT02240290|Mass balance|mass balance
4866570|NCT02240290|ADME|adme
4866571|NCT02240277|Septic Shock|septic shock
4866572|NCT02240277|Meropenem|meropenem
4866573|NCT02240277|Ciprofloxacin|ciprofloxacin
4866574|NCT02240277|Pharmacokinetics|pharmacokinetics
4866575|NCT02240264|Omega-3 fatty acids|omega-3 fatty acids
4866576|NCT02240264|Cognitive function|cognitive function
4866577|NCT02240264|Academic performance|academic performance
4866578|NCT02240264|Mental health|mental health
4866579|NCT02240264|Eye tracking|eye tracking
4866580|NCT02240264|Krill oil|krill oil
4866581|NCT02240264|LCPUFA|lcpufa
4866582|NCT02240251|Inferior Vena Cava Filter|inferior vena cava filter
4866583|NCT02240251|IVC Filter|ivc filter
4866584|NCT02240251|IVC filter removal|ivc filter removal
4866585|NCT02240251|Excimer Laser|excimer laser
4866586|NCT02240225|COPD;SRI;Reliability;validity;|copd;sri;reliability;validity;
4866587|NCT02240212|second line treatment|second line treatment
4866588|NCT02240212|oncology|oncology
4866589|NCT02240212|AKT inhibitor|akt inhibitor
4866590|NCT02240212|paclitaxel|paclitaxel
4866591|NCT02240212|HER2 (ErbB2) negative advanced gastric cancer|her2 (erbb2) negative advanced gastric cancer
4866592|NCT02240212|Afuresertib|afuresertib
4866593|NCT02240186|Microprocessor-controlled knee|microprocessor-controlled knee
4866594|NCT02240186|prosthesis|prosthesis
4866595|NCT02240186|amputation|amputation
4866596|NCT02240173|antipsychotic Jobelyn schizophrenia sorghum bicolor|antipsychotic jobelyn schizophrenia sorghum bicolor
4866597|NCT02240160|Sativex|sativex
4866598|NCT02240160|Pharmacokinetics|pharmacokinetics
4866599|NCT02240160|Oral pH|oral ph
4866600|NCT02240147|adult congenital heart disease|adult congenital heart disease
4866601|NCT02240147|exercise capacity|exercise capacity
4866602|NCT02240147|exercise training|exercise training
4866603|NCT02240147|physical activity|physical activity
4866604|NCT02240121|Crohn's Disease|crohn's disease
4866605|NCT02240121|Rifaximin|rifaximin
4866606|NCT02240121|Clinical remission with endoscopic response|clinical remission with endoscopic response
4866607|NCT02240121|Inflammatory Bowel Disease|inflammatory bowel disease
4866608|NCT02240108|Crohn's Disease|crohn's disease
4866609|NCT02240108|Rifaximin|rifaximin
4866610|NCT02240108|Clinical remission with endoscopic response|clinical remission with endoscopic response
4866611|NCT02240108|Inflammatory Bowel Disease|inflammatory bowel disease
4866612|NCT02240082|Shiftwork|shiftwork
4866613|NCT02240082|Sleep disruption|sleep disruption
4866614|NCT02240082|Stress|stress
4866615|NCT02240030|Parkinson's Disease|parkinson's disease
4866616|NCT02240030|Motor fluctuations|motor fluctuations
4866617|NCT02240030|levodopa|levodopa
4866618|NCT02240030|inhaled drugs|inhaled drugs
4866619|NCT02240030|OFF episodes|off episodes
4866620|NCT02240017|Urothelial cancer, renal function impaired.|urothelial cancer, renal function impaired.
4866621|NCT02239991|Point of care|point of care
4866622|NCT02239991|perioperative hemostasis|perioperative hemostasis
4866623|NCT02239991|thromboelastometry|thromboelastometry
4866624|NCT02239991|bleeding risk|bleeding risk
4866625|NCT02239991|end-stage liver disease|end-stage liver disease
4866626|NCT02239991|hepatic coagulopathy|hepatic coagulopathy
4866627|NCT02239991|whole blood coagulation|whole blood coagulation
4866628|NCT02239978|Parkinson Disease|parkinson disease
4866629|NCT02239978|Posture Balance|posture balance
4866630|NCT02239978|Learning|learning
4866631|NCT02239978|Dopamine|dopamine
4866632|NCT02239965|Neuromuscular blockade|neuromuscular blockade
4866633|NCT02239965|Neuromuscular monitoring|neuromuscular monitoring
4867127|NCT02237560|Exercise|exercise
4866634|NCT02239965|Focus group interview|focus group interview
4866635|NCT02239965|Clinical observation|clinical observation
4866636|NCT02239939|older adults, body composition, weight loss, muscle mass|older adults, body composition, weight loss, muscle mass
4866637|NCT02239926|IBS-D|ibs-d
4866638|NCT02239913|Cocaine|cocaine
4866639|NCT02239913|Pharmacotherapy|pharmacotherapy
4866640|NCT02239913|Phentermine|phentermine
4866641|NCT02239913|Topiramate|topiramate
4866642|NCT02239913|Self-Administration|self-administration
4866643|NCT02239900|Liver Cancer|liver cancer
4866644|NCT02239900|Lung Cancer|lung cancer
4866645|NCT02239900|Adrenal Gland|adrenal gland
4866646|NCT02239900|Metastasis|metastasis
4866647|NCT02239900|Advanced Solid Malignancies|advanced solid malignancies
4866648|NCT02239900|Ipilimumab|ipilimumab
4866649|NCT02239900|Yervoy|yervoy
4866650|NCT02239900|BMS-734016|bms-734016
4866651|NCT02239900|MDX010|mdx010
4866652|NCT02239900|Stereotactic Body Radiation Therapy|stereotactic body radiation therapy
4866653|NCT02239900|SBRT|sbrt
4866654|NCT02239900|XRT|xrt
4866655|NCT02239887|LAA occlusion|laa occlusion
4866656|NCT02239887|Non-valvular Atrial Fibrillation|non-valvular atrial fibrillation
4866657|NCT02239887|Percutaneous|percutaneous
4866658|NCT02239887|Oral Anticoagulation|oral anticoagulation
4866659|NCT02239887|Occluder|occluder
4866660|NCT02239887|WAVECREST|wavecrest
4866661|NCT02239874|mammographic breast density, breast disease, breast tissue|mammographic breast density, breast disease, breast tissue
4866662|NCT02239861|Rhabdomyosarcoma|rhabdomyosarcoma
4866663|NCT02239861|cytotoxic T lymphocytes|cytotoxic t lymphocytes
4866664|NCT02239822|Electrodes, Implanted|electrodes, implanted
4866665|NCT02239822|Electric Stimulation Therapy|electric stimulation therapy
4866666|NCT02239809|Electrodes, Implanted|electrodes, implanted
4866667|NCT02239809|Electric Stimulation Therapy|electric stimulation therapy
4866668|NCT02239796|transcutaneous posterior tibial nerve stimulation|transcutaneous posterior tibial nerve stimulation
4866669|NCT02239796|Randomised controlled trial|randomised controlled trial
4866670|NCT02239796|Feasibility|feasibility
4866671|NCT02239783|osteoarthritis|osteoarthritis
4866672|NCT02239783|avascular necrosis|avascular necrosis
4866673|NCT02239783|ankylosis|ankylosis
4866674|NCT02239783|protrusio acetabuli|protrusio acetabuli
4866675|NCT02239783|painful hip dysplasia|painful hip dysplasia
4866676|NCT02239783|rheumatoid arthritis|rheumatoid arthritis
4866677|NCT02239783|correction of functional deformity|correction of functional deformity
4866678|NCT02239783|revision procedures|revision procedures
4866679|NCT02239770|Nicotine|nicotine
4866680|NCT02239770|Random Delivery|random delivery
4866681|NCT02239770|Smoking Cessation|smoking cessation
4866682|NCT02239770|Plasma Nicotine|plasma nicotine
4866683|NCT02239770|Oral Film|oral film
4866684|NCT02239757|Transradial Approach, Primary PCI, ST-segment elevation myocardial infarction|transradial approach, primary pci, st-segment elevation myocardial infarction
4866685|NCT02239744|air pollution|air pollution
4866686|NCT02239744|air purification|air purification
4866687|NCT02239744|intervention|intervention
4866688|NCT02239744|randomized controlled trial|randomized controlled trial
4866689|NCT02239744|cardiovascular health|cardiovascular health
4866690|NCT02239744|pulmonary health|pulmonary health
4866691|NCT02239731|EGFRI|egfri
4866692|NCT02239731|Epidermal Growth Factor Receptor Inhibition|epidermal growth factor receptor inhibition
4866693|NCT02239731|Skin toxicity|skin toxicity
4866694|NCT02239731|Topical|topical
4866695|NCT02239731|Doxycycline|doxycycline
4866696|NCT02239731|Foam|foam
4866697|NCT02239731|Phase II|phase ii
4866698|NCT02239731|Cetuximab|cetuximab
4866699|NCT02239731|Panitumumab|panitumumab
4866700|NCT02239731|Vectibix|vectibix
4866701|NCT02239731|Erbitux|erbitux
4866702|NCT02239731|Rash|rash
4866703|NCT02239718|Resin bonded bridges|resin bonded bridges
4866704|NCT02239718|Clinical trial|clinical trial
4866705|NCT02239718|Prospective|prospective
4866706|NCT02239718|Survival|survival
4866707|NCT02239718|Oral health related quality of life|oral health related quality of life
4866708|NCT02239705|Trans pulmonary thermodilution|trans pulmonary thermodilution
4866709|NCT02239705|Hemodynamic|hemodynamic
4866710|NCT02239679|Actinic Keratosis|actinic keratosis
4866711|NCT02239666|Dermatology, plaque psoriasis, biologic treatment, biologic naive|dermatology, plaque psoriasis, biologic treatment, biologic naive
4866712|NCT02239614|dengue fever|dengue fever
4866713|NCT02239614|dengue|dengue
4866714|NCT02239601|Physical Therapy|physical therapy
4866715|NCT02239601|Physiotherapy|physiotherapy
4866716|NCT02239601|Breast Cancer|breast cancer
4866717|NCT02239601|Chemotherapy Induced Peripheral Neuropathy (CIPN)|chemotherapy induced peripheral neuropathy (cipn)
4866718|NCT02239601|Nerve gliding exercises|nerve gliding exercises
4866719|NCT02239601|Nerve Entrapment|nerve entrapment
4866720|NCT02239575|Assorted cancers (oncology)|assorted cancers (oncology)
4866721|NCT02239562|sPIF|spif
4866722|NCT02239562|synthetic PreImplantation Factor|synthetic preimplantation factor
4866723|NCT02239562|Autoimmune|autoimmune
4866724|NCT02239562|Liver|liver
4866725|NCT02239562|Hepatitis|hepatitis
4866726|NCT02239549|Colonic Polyps|colonic polyps
4866727|NCT02239549|Polypectomy|polypectomy
4866728|NCT02239536|neoplastic colorectal polyp|neoplastic colorectal polyp
4867736|NCT02234921|Metastatic|metastatic
4866729|NCT02239536|hot snare polypectomy|hot snare polypectomy
4866730|NCT02239536|hot snare polypectomy after saline injection|hot snare polypectomy after saline injection
4866731|NCT02239523|Pathologic fracture|pathologic fracture
4866732|NCT02239523|Insufficiency fracture|insufficiency fracture
4866733|NCT02239523|Secondary fracture|secondary fracture
4866734|NCT02239523|Fracture with bone fragility|fracture with bone fragility
4866735|NCT02239523|Osteoporosis|osteoporosis
4866736|NCT02239523|Bone loss|bone loss
4866737|NCT02239523|Osteopenia|osteopenia
4866738|NCT02239523|Metabolic Bone Disease|metabolic bone disease
4866739|NCT02239523|Fragility fracture|fragility fracture
4866740|NCT02239510|constipation|constipation
4866741|NCT02239510|bowel habits|bowel habits
4866742|NCT02239497|postoperatory pain|postoperatory pain
4866743|NCT02239497|orthopaedic surgery|orthopaedic surgery
4866744|NCT02239497|femoral block|femoral block
4866745|NCT02239432|Adenocarcinoma of the Lung|adenocarcinoma of the lung
4866746|NCT02239432|Adenocarcinoma, Bronchiolo-Alveolar|adenocarcinoma, bronchiolo-alveolar
4866747|NCT02239419|Critical Limb Ischemia|critical limb ischemia
4866748|NCT02239419|Limb Ischemia|limb ischemia
4866749|NCT02239419|Wound Care|wound care
4866750|NCT02239419|Hemodialysis|hemodialysis
4866751|NCT02239419|Dialysis|dialysis
4866752|NCT02239419|Skin Ulceration|skin ulceration
4866753|NCT02239406|metal on metal total hip|metal on metal total hip
4866754|NCT02239406|avasuclar necrosis|avasuclar necrosis
4866755|NCT02239406|acetabular revision|acetabular revision
4866756|NCT02239406|bone vascularity|bone vascularity
4866757|NCT02239393|Multiple Sclerosis|multiple sclerosis
4866758|NCT02239393|Mesenchymal Stem Cells|mesenchymal stem cells
4866759|NCT02239393|MSC|msc
4866760|NCT02239380|Lorazepam|lorazepam
4866761|NCT02239380|Status Epilepticus|status epilepticus
4866762|NCT02239341|hospitalized|hospitalized
4866763|NCT02239341|activity restriction|activity restriction
4866764|NCT02239341|bed rest|bed rest
4866765|NCT02239341|antepartum|antepartum
4866766|NCT02239341|pregnant|pregnant
4866767|NCT02239341|high risk|high risk
4866768|NCT02239328|Lung cancer|lung cancer
4866769|NCT02239328|esophageal cancer|esophageal cancer
4866770|NCT02239315|Breast cancers|breast cancers
4866771|NCT02239315|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
4866772|NCT02239315|RNA Disruption Assay™ (RDA) score|rna disruption assay™ (rda) score
4866773|NCT02239315|Pathological Complete Response (pCR)|pathological complete response (pcr)
4866774|NCT02239315|Fine Needle Aspiration Biopsy|fine needle aspiration biopsy
4866775|NCT02239302|Obstructed defaecation syndrome|obstructed defaecation syndrome
4866776|NCT02239302|Transperineal Ultrasound|transperineal ultrasound
4866777|NCT02239302|Endovaginal Ultrasound|endovaginal ultrasound
4866778|NCT02239302|Evacuation Proctography|evacuation proctography
4866779|NCT02239289|Low back pain|low back pain
4866780|NCT02239289|Rehabilitation|rehabilitation
4866781|NCT02239289|Biofeedback|biofeedback
4866782|NCT02239289|Electromyography|electromyography
4866783|NCT02239289|Kinematic|kinematic
4866784|NCT02239276|Stiripentol|stiripentol
4866785|NCT02239276|Dravet syndrome|dravet syndrome
4866786|NCT02239276|Epilepsy|epilepsy
4866787|NCT02239276|Epileptic Encephalopathies|epileptic encephalopathies
4866788|NCT02239250|Child health|child health
4866789|NCT02239250|Pneumonia|pneumonia
4866790|NCT02239250|Diarrhoea|diarrhoea
4866791|NCT02239250|Household air pollution|household air pollution
4866793|NCT02239250|Stove intervention|stove intervention
4866794|NCT02239250|Biomass fuel|biomass fuel
4866795|NCT02239250|Monitoring and evaluation|monitoring and evaluation
4866796|NCT02239250|Water filter|water filter
4866797|NCT02239250|Compliance|compliance
4866798|NCT02239250|Thermotolerant coliforms|thermotolerant coliforms
4866799|NCT02239250|Rwanda|rwanda
4866800|NCT02239224|FSHD|fshd
4866801|NCT02239211|BUTEO|buteo
4866802|NCT02239211|Primary sclerosing cholangitis|primary sclerosing cholangitis
4866804|NCT02239211|VAP-1|vap-1
4866805|NCT02239211|BTT1023|btt1023
4866806|NCT02239211|Human monoclonal antibody|human monoclonal antibody
4866807|NCT02239198|HDL|hdl
4866808|NCT02239198|nutrition bar|nutrition bar
4866809|NCT02239185|Laparoscopy|laparoscopy
4866810|NCT02239185|purse string|purse string
4866811|NCT02239185|hernial sac|hernial sac
4866812|NCT02239159|transcutaneous electric acupoint stimulation|transcutaneous electric acupoint stimulation
4866813|NCT02239159|elderly patients|elderly patients
4866814|NCT02239133|Pelvic Organ Prolapse|pelvic organ prolapse
4866815|NCT02239133|POP|pop
4866816|NCT02239107|polycystic ovary syndrome|polycystic ovary syndrome
4866817|NCT02239107|laparoscopic drilling|laparoscopic drilling
4866818|NCT02239107|clomiphene citrate|clomiphene citrate
4866819|NCT02239107|n acetyl cysteine|n acetyl cysteine
4866820|NCT02239107|insulin resistance|insulin resistance
4866821|NCT02239094|Bipolar Disorder|bipolar disorder
4866822|NCT02239094|depression|depression
4866823|NCT02239094|Bipolar depression|bipolar depression
4866824|NCT02239081|Pharmacokinetics|pharmacokinetics
4866825|NCT02239081|Safety|safety
4866826|NCT02239068|CT, sedation, oral contrast|ct, sedation, oral contrast
4866827|NCT02239055|Borderline Personality Disorder|borderline personality disorder
4866828|NCT02239055|Mentalization Based Treatment|mentalization based treatment
4866829|NCT02239055|MBT Skills Training|mbt skills training
4866830|NCT02239055|Staff Nurse Perceptions|staff nurse perceptions
4866831|NCT02239055|Acute Mental Health|acute mental health
4866832|NCT02239042|Gingival recessions|gingival recessions
4866833|NCT02239029|Platelet rich plasma|platelet rich plasma
4866834|NCT02239029|Osteoarthritis of knee|osteoarthritis of knee
4866835|NCT02239029|Balance|balance
4866836|NCT02239029|Strength|strength
4866837|NCT02239016|Sickle cell disease|sickle cell disease
4866838|NCT02239016|Hgb SS|hgb ss
4866839|NCT02239016|Hgb SC|hgb sc
4866840|NCT02239016|Sβ-Thalassemia|sβ-thalassemia
4866841|NCT02238977|depression|depression
4866842|NCT02238977|ESRD|esrd
4866843|NCT02238977|hemodialysis|hemodialysis
4866844|NCT02238951|care coordination, mobile health, chemotherapy, technology|care coordination, mobile health, chemotherapy, technology
4866845|NCT02238938|piecemeal polypectomy|piecemeal polypectomy
4866846|NCT02238938|piecemeal endoscopic mucosal resection (EMR)|piecemeal endoscopic mucosal resection (emr)
4866847|NCT02238938|endoscopic submucosal dissection (ESD)|endoscopic submucosal dissection (esd)
4866848|NCT02238938|endoscopic en-bloc resection|endoscopic en-bloc resection
4866849|NCT02238925|Newly Diagnosed AML|newly diagnosed aml
4866850|NCT02238925|Secondary AML|secondary aml
4866851|NCT02238925|Relapsed/Refractory AML|relapsed/refractory aml
4866852|NCT02238925|Relapsed/Refractory ALL|relapsed/refractory all
4866853|NCT02238925|MDS|mds
4866854|NCT02238912|tinea|tinea
4866855|NCT02238886|Quality of Life|quality of life
4866856|NCT02238886|Enteral nutrition|enteral nutrition
4866857|NCT02238886|Nutrition Therapy|nutrition therapy
4866858|NCT02238886|Parenteral nutrition, total|parenteral nutrition, total
4866859|NCT02238873|lymphoma|lymphoma
4866860|NCT02238873|neutropenia|neutropenia
4866861|NCT02238873|pegfilgrastim|pegfilgrastim
4866862|NCT02238860|Hepatitis B|hepatitis b
4866863|NCT02238860|cirrhosis|cirrhosis
4866864|NCT02238860|Entacavir|entacavir
4866865|NCT02238860|enofovir|enofovir
4866866|NCT02238847|Pancreatic|pancreatic
4866867|NCT02238847|Pancreatic Cancer|pancreatic cancer
4866868|NCT02238847|Preoperative Biliary Drainage|preoperative biliary drainage
4866869|NCT02238847|Neoadjuvant Therapy|neoadjuvant therapy
4866870|NCT02238834|Phase I|phase i
4866871|NCT02238834|Safety and tolerability|safety and tolerability
4866872|NCT02238834|Pharmacokinetic|pharmacokinetic
4866873|NCT02238834|Randomized|randomized
4866874|NCT02238834|Double Blind|double blind
4866875|NCT02238834|Placebo-Controlled|placebo-controlled
4866876|NCT02238834|Single- & Multiple Dose Escalation|single- & multiple dose escalation
4866877|NCT02238834|FP-025|fp-025
4866878|NCT02238834|MMP-12 inhibitor|mmp-12 inhibitor
4866879|NCT02238821|resectable colorectal cancer|resectable colorectal cancer
4866880|NCT02238808|ER+ breast cancer|er+ breast cancer
4866881|NCT02238808|Luminal A|luminal a
4866882|NCT02238808|Estradiol|estradiol
4866883|NCT02238795|Purpura fulminans, Sepsis, Epidemiology, Morbidity, Therapy|purpura fulminans, sepsis, epidemiology, morbidity, therapy
4866884|NCT02238782|bioavailability|bioavailability
4866885|NCT02238782|pharmacokinetics|pharmacokinetics
4866886|NCT02238782|I phase|i phase
4866887|NCT02238782|AZD6244|azd6244
4866888|NCT02238782|cancer|cancer
4866889|NCT02238769|Hepatocellular Carcinoma, 18F-FluoroethylCholine PET|hepatocellular carcinoma, 18f-fluoroethylcholine pet
4866890|NCT02238730|Depression|depression
4866891|NCT02238730|Depressive Disorder|depressive disorder
4866892|NCT02238730|Treatment Resistant Depressive Disorder|treatment resistant depressive disorder
4866893|NCT02238730|Bipolar Disorder|bipolar disorder
4866894|NCT02238730|Major Depressive Disorder|major depressive disorder
4866895|NCT02238730|Electroconvulsive therapy|electroconvulsive therapy
4866896|NCT02238717|Pain|pain
4866897|NCT02238717|evoked pain|evoked pain
4866898|NCT02238717|healthy volunteer|healthy volunteer
4866899|NCT02238717|pharmacodynamics|pharmacodynamics
4866900|NCT02238704|Adherence|adherence
4866901|NCT02238704|Calcium supplementation|calcium supplementation
4866902|NCT02238704|Prevention of preeclampsia|prevention of preeclampsia
4866903|NCT02238704|Adherence to calcium supplementation|adherence to calcium supplementation
4866904|NCT02238691|PEEP|peep
4866905|NCT02238691|Air insufflation|air insufflation
4866906|NCT02238691|Mask ventilation|mask ventilation
4866907|NCT02238691|Esophageal manometry|esophageal manometry
4866908|NCT02238691|Esophageal impedance|esophageal impedance
4866909|NCT02238652|Nursing homes|nursing homes
4866910|NCT02238652|Dementia|dementia
4866911|NCT02238652|Quality of Life|quality of life
4866912|NCT02238652|Geriatrics|geriatrics
4866913|NCT02238652|Aged|aged
4866914|NCT02238652|Activities of Daily Living|activities of daily living
4866915|NCT02238652|Pain|pain
4866916|NCT02238652|Pain management|pain management
4866917|NCT02238652|Advance Care Planning|advance care planning
4866918|NCT02238652|Patient Safety|patient safety
4866919|NCT02238652|Costs and Cost Analysis|costs and cost analysis
4866920|NCT02238652|Medication Errors|medication errors
4866921|NCT02238652|Medical Order Entry Systems|medical order entry systems
4866922|NCT02238652|Medication Reconciliation|medication reconciliation
4866923|NCT02238652|Medication Therapy Management|medication therapy management
4866924|NCT02238652|Depression|depression
4866925|NCT02238652|Psychotropic Drugs|psychotropic drugs
4866926|NCT02238652|Informed Consent|informed consent
4866927|NCT02238652|Presumed Consent|presumed consent
4866928|NCT02238652|Anxiety|anxiety
4866929|NCT02238652|Apathy|apathy
4866930|NCT02238652|Hospitalization|hospitalization
4866931|NCT02238652|Mortality|mortality
4866932|NCT02238639|Venous thromboembolism|venous thromboembolism
4866933|NCT02238639|COPD exacerbations|copd exacerbations
4866934|NCT02238639|Anticoagulation|anticoagulation
4866935|NCT02238639|Mortality|mortality
4866936|NCT02238626|amyotrophic lateral sclerosis|amyotrophic lateral sclerosis
4866937|NCT02238626|pharmacotherapy|pharmacotherapy
4866938|NCT02238626|intervention|intervention
4866939|NCT02238626|prospective|prospective
4866940|NCT02238626|safety endpoint|safety endpoint
4866941|NCT02238626|preliminary efficacy|preliminary efficacy
4866942|NCT02238626|ibudilast|ibudilast
4866943|NCT02238613|Radioactive stents|radioactive stents
4866944|NCT02238613|Brachytherapy|brachytherapy
4866945|NCT02238613|Biliary obstruction|biliary obstruction
4866946|NCT02238613|Intrahepatic Cholangiocarcinoma|intrahepatic cholangiocarcinoma
4866947|NCT02238613|Cholangiocarcinoma of the Extrahepatic Bile Duct|cholangiocarcinoma of the extrahepatic bile duct
4866948|NCT02238613|ampullary carcinoma|ampullary carcinoma
4866949|NCT02238587|Gandoerma Spores Powder Capsules, head-and-neck cancer.|gandoerma spores powder capsules, head-and-neck cancer.
4866950|NCT02238561|non-invasive|non-invasive
4866951|NCT02238561|measurement of oxygen|measurement of oxygen
4866952|NCT02238561|consumption|consumption
4866953|NCT02238561|delivery|delivery
4866954|NCT02238561|post-operative complications|post-operative complications
4866955|NCT02238548|immunity|immunity
4866956|NCT02238548|vaccination|vaccination
4866957|NCT02238548|milk|milk
4866958|NCT02238522|Chronic lymphocytic leukemia|chronic lymphocytic leukemia
4866959|NCT02238522|B-prolymphocytic leukemia|b-prolymphocytic leukemia
4866960|NCT02238522|Non-Hodgkin's lymphoma|non-hodgkin's lymphoma
4866961|NCT02238522|follicular lymphoma|follicular lymphoma
4866962|NCT02238522|mantle cell lymphoma|mantle cell lymphoma
4866963|NCT02238522|marginal zone lymphoma|marginal zone lymphoma
4866964|NCT02238522|small lymphocytic lymphoma|small lymphocytic lymphoma
4866965|NCT02238522|diffuse large B-cell lymphoma|diffuse large b-cell lymphoma
4866966|NCT02238522|unclassifiable lymphoma|unclassifiable lymphoma
4866967|NCT02238522|T-cell lymphoma|t-cell lymphoma
4866968|NCT02238522|Richter's syndrome|richter's syndrome
4866969|NCT02238522|Waldenström's macroglobulinemia|waldenström's macroglobulinemia
4866970|NCT02238509|Breast cancer|breast cancer
4866971|NCT02238509|HER2 Positive|her2 positive
4866972|NCT02238509|HER2+|her2+
4866974|NCT02238509|Metastatic|metastatic
4866975|NCT02238509|Metastatic breast cancer|metastatic breast cancer
4866976|NCT02238509|Chemotherapy|chemotherapy
4866977|NCT02238509|Lapatinib|lapatinib
4866978|NCT02238509|Trastuzumab|trastuzumab
4866979|NCT02238509|anti HER2 therapies|anti her2 therapies
4866980|NCT02238496|Glioblastoma|glioblastoma
4866981|NCT02238496|Anaplastic Astrocytoma|anaplastic astrocytoma
4866982|NCT02238496|Anaplastic Oligodendroglioma|anaplastic oligodendroglioma
4866983|NCT02238496|Mixed Glioma|mixed glioma
4866984|NCT02238496|akt-Oncogene Protein|akt-oncogene protein
4866985|NCT02238496|mTOR Protein|mtor protein
4866986|NCT02238496|Glioma|glioma
4866987|NCT02238496|Brain Neoplasms|brain neoplasms
4866988|NCT02238496|Brain Tumor, Recurrent|brain tumor, recurrent
4866989|NCT02238483|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
4866990|NCT02238483|COPD patients|copd patients
4866991|NCT02238483|Exacerbations|exacerbations
4866992|NCT02238483|ICS|ics
4866993|NCT02238483|LABA|laba
4866994|NCT02238470|Ischemic stroke|ischemic stroke
4866995|NCT02238470|Intracerebral hemorrhage|intracerebral hemorrhage
4866996|NCT02238470|Subdural hemorrhage|subdural hemorrhage
4866997|NCT02238470|Microbleed|microbleed
4866998|NCT02238470|Leukoaraiosis|leukoaraiosis
4866999|NCT02238470|Oral anticoagulants|oral anticoagulants
4867000|NCT02238457|Heart failure|heart failure
4867001|NCT02238457|Losartan|losartan
4867002|NCT02238444|Warfarin|warfarin
4867003|NCT02238444|Portal Vein|portal vein
4867004|NCT02238444|Anticoagulants|anticoagulants
4867005|NCT02238444|Cirrhosis|cirrhosis
4867006|NCT02238444|Hypertension|hypertension
4867007|NCT02238444|Venous Thrombosis|venous thrombosis
4867008|NCT02238444|Splenectomy|splenectomy
4867009|NCT02238431|Lucrin depot,|lucrin depot,
4867010|NCT02238431|frozen embryo transfer,|frozen embryo transfer,
4867011|NCT02238431|artificial cycle,|artificial cycle,
4867012|NCT02238431|pregnancy,|pregnancy,
4867013|NCT02238431|cancellation|cancellation
4867014|NCT02238418|Vitamin D, Calciuria, Paediatrics, Nephrology|vitamin d, calciuria, paediatrics, nephrology
4867015|NCT02238392|paroxysmal atrial fibrillation|paroxysmal atrial fibrillation
4867016|NCT02238392|pulmonary vein isolation|pulmonary vein isolation
4867017|NCT02238392|adenosine|adenosine
4867018|NCT02238392|AF terminatin|af terminatin
4867019|NCT02238379|Intranasal oxytocin|intranasal oxytocin
4867020|NCT02238379|Social perception|social perception
4867021|NCT02238379|EEG/ERP|eeg/erp
4867022|NCT02238340|Postoperatory pain|postoperatory pain
4867023|NCT02238340|Oxycodone|oxycodone
4867024|NCT02238327|Antiretroviral therapy|antiretroviral therapy
4867025|NCT02238327|pulmonary function|pulmonary function
4867026|NCT02238327|biomarkers|biomarkers
4867027|NCT02238301|Intrauterine growth restriction|intrauterine growth restriction
4867028|NCT02238301|BOLD effect|bold effect
4867029|NCT02238288|anticoagulation|anticoagulation
4867030|NCT02238288|extraction|extraction
4867031|NCT02238288|epsilon amino caproic|epsilon amino caproic
4867032|NCT02238054|Cardiology|cardiology
4867033|NCT02238054|Intracoronary angioplasty|intracoronary angioplasty
4867034|NCT02238054|Bioresorbable stent|bioresorbable stent
4867035|NCT02238041|Glucose monitoring|glucose monitoring
4867036|NCT02238041|Intensive care unit|intensive care unit
4867037|NCT02238028|Heart rate variability|heart rate variability
4867038|NCT02238028|Blood pressure|blood pressure
4867039|NCT02238028|Circulating biomarkers|circulating biomarkers
4867040|NCT02238028|Respirator|respirator
4867041|NCT02238028|Fine particulate matter|fine particulate matter
4867042|NCT02238015|cataract ,tear film,SS-OCT|cataract ,tear film,ss-oct
4867043|NCT02238002|shallow anterior chamber|shallow anterior chamber
4867044|NCT02238002|narrow angle|narrow angle
4867046|NCT02237989|knee osteoarthritis, native collagen type 2, paracetamol|knee osteoarthritis, native collagen type 2, paracetamol
4867047|NCT02237937|Depression, Affective Disorder|depression, affective disorder
4867048|NCT02237924|nasopharyngeal carcinoma|nasopharyngeal carcinoma
4867049|NCT02237924|endostar|endostar
4867050|NCT02237924|IMRT|imrt
4867051|NCT02237924|chemoradiation|chemoradiation
4867052|NCT02237911|total knee replacement|total knee replacement
4867053|NCT02237911|rehabilitation|rehabilitation
4867054|NCT02237911|exercise program|exercise program
4867055|NCT02237911|total knee arthroplasty|total knee arthroplasty
4867056|NCT02237898|Tobacco cessation|tobacco cessation
4867057|NCT02237885|Military Veterans|military veterans
4867058|NCT02237872|Brown Adipose Tissue|brown adipose tissue
4867059|NCT02237859|cdiff|cdiff
4867060|NCT02237859|vancomycin|vancomycin
4867061|NCT02237859|infection|infection
4867062|NCT02237859|clostridium difficile|clostridium difficile
4867063|NCT02237846|osteoarthritis|osteoarthritis
4867064|NCT02237846|knee|knee
4867065|NCT02237846|stem cells|stem cells
4867066|NCT02237846|mesenchymal|mesenchymal
4867067|NCT02237846|umbilical cord|umbilical cord
4867068|NCT02237833|septic shock|septic shock
4867069|NCT02237833|cerebral oximetry|cerebral oximetry
4867070|NCT02237833|vasopressor|vasopressor
4867071|NCT02237833|norepinephrine|norepinephrine
4867072|NCT02237807|Fed Conditions|fed conditions
4867073|NCT02237781|AMH|amh
4867074|NCT02237781|IVF|ivf
4867075|NCT02237781|ovarian stimulation|ovarian stimulation
4867076|NCT02237768|Fasting conditions|fasting conditions
4867077|NCT02237755|Clomiphene citrate|clomiphene citrate
4867078|NCT02237755|IVF|ivf
4867079|NCT02237755|Pregnancy Rates|pregnancy rates
4867080|NCT02237755|Ovarian Reserve|ovarian reserve
4867081|NCT02237729|healthy subjects|healthy subjects
4867082|NCT02237729|immunology|immunology
4867083|NCT02237729|PK|pk
4867084|NCT02237729|Phase 1|phase 1
4867085|NCT02237729|bioequivalence|bioequivalence
4867086|NCT02237729|biosimilarity|biosimilarity
4867087|NCT02237729|adalimumab|adalimumab
4867088|NCT02237729|single dose.|single dose.
4867089|NCT02237703|Post-traumatic Stress Disorder (PTSD)|post-traumatic stress disorder (ptsd)
4867090|NCT02237703|Positron emission tomography (PET)|positron emission tomography (pet)
4867091|NCT02237703|Neuroimaging|neuroimaging
4867092|NCT02237703|Kappa opioid receptor (KOR)|kappa opioid receptor (kor)
4867093|NCT02237677|Post-traumatic stress disorder (PTSD)|post-traumatic stress disorder (ptsd)
4867094|NCT02237677|Trauma|trauma
4867095|NCT02237677|Neuroimaging|neuroimaging
4867096|NCT02237677|Positron emission tomography (PET)|positron emission tomography (pet)
4867097|NCT02237677|[11C]OMAR|[11c]omar
4867098|NCT02237677|Endocannabinoid|endocannabinoid
4867099|NCT02237664|Thoracoscopy|thoracoscopy
4867100|NCT02237664|Patient-controlled analgesia|patient-controlled analgesia
4867101|NCT02237664|Paravertebral analgesia|paravertebral analgesia
4867102|NCT02237651|anesthesia|anesthesia
4867103|NCT02237651|bronchosocopy|bronchosocopy
4867104|NCT02237651|lung transplantation|lung transplantation
4867105|NCT02237638|VEGF|vegf
4867106|NCT02237638|Vaccine|vaccine
4867107|NCT02237638|Angiogenesis|angiogenesis
4867108|NCT02237625|Hypophosphatasia|hypophosphatasia
4867109|NCT02237625|HPP|hpp
4867110|NCT02237599|SSEP|ssep
4867111|NCT02237599|neuropraxia|neuropraxia
4867112|NCT02237599|intraoperative|intraoperative
4867113|NCT02237599|automated|automated
4867114|NCT02237586|Plasmodium falciparum malaria|plasmodium falciparum malaria
4867115|NCT02237586|Malaria|malaria
4867116|NCT02237586|PfSPZ Challenge|pfspz challenge
4867117|NCT02237586|Controlled Human Malaria Infection (CHMI)|controlled human malaria infection (chmi)
4867118|NCT02237586|Sickle Cell Trait|sickle cell trait
4867119|NCT02237586|Sporozoites|sporozoites
4867120|NCT02237573|general practice|general practice
4867121|NCT02237573|viral infections|viral infections
4867122|NCT02237573|consultation reports|consultation reports
4867123|NCT02237573|drug prescription|drug prescription
4867124|NCT02237560|MCI|mci
4867125|NCT02237560|Exergaming|exergaming
4867126|NCT02237560|Cognition|cognition
4867128|NCT02237560|Older Adults|older adults
4867129|NCT02237547|spinal cord injury|spinal cord injury
4867130|NCT02237547|mesenchymal|mesenchymal
4867131|NCT02237547|bone marrow|bone marrow
4867132|NCT02237547|mononuclear cells|mononuclear cells
4867133|NCT02237547|stem cells|stem cells
4867134|NCT02237547|umbilical cord|umbilical cord
4867135|NCT02237534|Lanthanum|lanthanum
4867136|NCT02237534|Calcium Carbonate|calcium carbonate
4867137|NCT02237534|Vascular Calcification|vascular calcification
4867138|NCT02237521|Incretin hormones|incretin hormones
4867139|NCT02237521|End-stage renal disease|end-stage renal disease
4867140|NCT02237521|ESRD|esrd
4867141|NCT02237521|GLP-1|glp-1
4867142|NCT02237521|GIP|gip
4867143|NCT02237521|Insulin|insulin
4867144|NCT02237521|Glucagon|glucagon
4867145|NCT02237469|Breast cancer|breast cancer
4867146|NCT02237469|Breast conserving surgery.|breast conserving surgery.
4867147|NCT02237469|Radiotherapy.|radiotherapy.
4867148|NCT02237469|Treatment planning.|treatment planning.
4867149|NCT02237469|Prone.|prone.
4867150|NCT02237456|Myocardial infarction|myocardial infarction
4867151|NCT02237456|Atherosclerosis|atherosclerosis
4867152|NCT02237456|PCI|pci
4867153|NCT02237456|OCT|oct
4867154|NCT02237456|Optical coherence tomography|optical coherence tomography
4867155|NCT02237456|Stent|stent
4867156|NCT02237456|Bioresorbable stents|bioresorbable stents
4867157|NCT02237443|Patient Safety|patient safety
4867158|NCT02237430|Coronary angiography (CAG)|coronary angiography (cag)
4867159|NCT02237417|MRI|mri
4867160|NCT02237417|Imaging|imaging
4867161|NCT02237417|Antipsychotic|antipsychotic
4867162|NCT02237404|Follow-Up studies|follow-up studies
4867163|NCT02237404|Biological Pacemakers|biological pacemakers
4867164|NCT02237404|Telemedicine|telemedicine
4867165|NCT02237404|Efficiency|efficiency
4867166|NCT02237391|High Frequency Emergency Department Visits|high frequency emergency department visits
4867167|NCT02237391|Healthcare Utilization|healthcare utilization
4867168|NCT02237391|Chronic Pain|chronic pain
4867169|NCT02237391|Interdisciplinary|interdisciplinary
4867170|NCT02237378|FDG lung and RV uptake|fdg lung and rv uptake
4867171|NCT02237365|neurological disability|neurological disability
4867172|NCT02237365|tuberculous meningitis (TBM)|tuberculous meningitis (tbm)
4867173|NCT02237365|safety|safety
4867174|NCT02237365|aspirin|aspirin
4867175|NCT02237365|efficacy|efficacy
4867176|NCT02237352|Diabetes mellitus|diabetes mellitus
4867177|NCT02237352|Diabetic nephropathy|diabetic nephropathy
4867178|NCT02237352|Social Factors|social factors
4867179|NCT02237352|Biological Factors|biological factors
4867180|NCT02237352|VEGF-A|vegf-a
4867181|NCT02237352|Tenascin C|tenascin c
4867182|NCT02237352|Disease characterization|disease characterization
4867183|NCT02237352|Mechanisms|mechanisms
4867184|NCT02237352|Kidney|kidney
4867185|NCT02237352|Chronic kidney disease|chronic kidney disease
4867186|NCT02237352|Secondary nephropathy|secondary nephropathy
4867187|NCT02237352|South America|south america
4867188|NCT02237352|Hispanics|hispanics
4867189|NCT02237352|Ecuador|ecuador
4867190|NCT02237352|Biomarkers|biomarkers
4867191|NCT02237339|Allopurinol|allopurinol
4867192|NCT02237339|Cardiac MRI (CMR)|cardiac mri (cmr)
4867193|NCT02237339|Flow mediated dilatation (FMD)|flow mediated dilatation (fmd)
4867194|NCT02237339|Pulse wave analysis (PWA)|pulse wave analysis (pwa)
4867195|NCT02237339|Endothelial function|endothelial function
4867196|NCT02237339|Scar|scar
4867197|NCT02237339|Hypertrophy|hypertrophy
4867198|NCT02237339|Hypertension|hypertension
4867199|NCT02237326|Visual Inspection with Acetic Acid|visual inspection with acetic acid
4867200|NCT02237326|Visual Inspection with Lugol's Iodine|visual inspection with lugol's iodine
4867201|NCT02237326|Cervical Intraepithelial neoplasia|cervical intraepithelial neoplasia
4867202|NCT02237326|Cervical Cancer Screening|cervical cancer screening
4867203|NCT02237326|HIV infected women|hiv infected women
4867204|NCT02237313|psychological support|psychological support
4867205|NCT02237313|therapeutic education|therapeutic education
4867206|NCT02237313|vulnerability of patients|vulnerability of patients
4867207|NCT02237300|Bulimia nervosa|bulimia nervosa
4867208|NCT02237300|Binge eating disorder|binge eating disorder
4867209|NCT02237300|Food craving|food craving
4867210|NCT02237300|Anxiety|anxiety
4867211|NCT02237300|Bingeing|bingeing
4867212|NCT02237300|Cue Exposure Therapy|cue exposure therapy
4867213|NCT02237300|Virtual Reality|virtual reality
4867214|NCT02237274|Fontan circulation|fontan circulation
4867215|NCT02237274|High altitude exposure|high altitude exposure
4867216|NCT02237261|Newly diagnosed symptomatic multiple myeloma|newly diagnosed symptomatic multiple myeloma
4867217|NCT02237248|Adolescent Idiopathic Scoliosis|adolescent idiopathic scoliosis
4867218|NCT02237248|Functional Movement Screen|functional movement screen
4867219|NCT02237248|Y Balance Test|y balance test
4867220|NCT02237235|Schizophrenia|schizophrenia
4867221|NCT02237235|Schizoaffective disorder|schizoaffective disorder
4867222|NCT02237235|Cognition|cognition
4867223|NCT02237235|Magnesium|magnesium
4867224|NCT02237235|Imaging|imaging
4867225|NCT02237235|Negative symptoms|negative symptoms
4867226|NCT02237222|Outcome Assessment|outcome assessment
4867227|NCT02237222|Gait|gait
4867737|NCT02234921|DRibble|dribble
4867228|NCT02237222|Neuromuscular Diseases|neuromuscular diseases
4867229|NCT02237222|Psychometrics|psychometrics
4867230|NCT02237222|Clinical Assessment Tools|clinical assessment tools
4867231|NCT02237196|cat-allergic|cat-allergic
4867232|NCT02237196|cat immunotherapy|cat immunotherapy
4867233|NCT02237196|anti-thymic stromal lymphopoietin (anti-TSLP)|anti-thymic stromal lymphopoietin (anti-tslp)
4867234|NCT02237170|Sipuleucel-T|sipuleucel-t
4867235|NCT02237170|Castration Resistant Prostate Cancer|castration resistant prostate cancer
4867236|NCT02237170|Provenge|provenge
4867237|NCT02237157|pancreatic cancer|pancreatic cancer
4867238|NCT02237157|unresectable|unresectable
4867239|NCT02237157|gemcitabine|gemcitabine
4867240|NCT02237157|device|device
4867241|NCT02237157|local delivery|local delivery
4867242|NCT02237157|chemoembolization|chemoembolization
4867243|NCT02237131|Endometriosis|endometriosis
4867244|NCT02237131|Oral contraceptives|oral contraceptives
4867245|NCT02237131|Laparoscopy|laparoscopy
4867246|NCT02237118|Acute|acute
4867247|NCT02237118|wound|wound
4867248|NCT02237118|management|management
4867249|NCT02237118|measured|measured
4867250|NCT02237118|Visual analoge scale|visual analoge scale
4867252|NCT02237066|PTA|pta
4867253|NCT02237066|Balloon|balloon
4867254|NCT02237053|Energy expenditure|energy expenditure
4867255|NCT02237053|Glucagon|glucagon
4867256|NCT02237053|Octreotide|octreotide
4867257|NCT02237053|Weight loss|weight loss
4867258|NCT02237040|Children|children
4867259|NCT02237040|mandible|mandible
4867260|NCT02237040|condylar fracture|condylar fracture
4867261|NCT02237040|conservative treatment|conservative treatment
4867262|NCT02237040|functional treatment|functional treatment
4867263|NCT02237027|HIV|hiv
4867264|NCT02237027|Early treatment as prevention (TasP)|early treatment as prevention (tasp)
4867265|NCT02237027|Pre-exposure prophylaxis (PrEP)|pre-exposure prophylaxis (prep)
4867266|NCT02237027|antiretroviral treatment|antiretroviral treatment
4867267|NCT02237027|prevention|prevention
4867268|NCT02237027|feasibility|feasibility
4867269|NCT02237027|female sex workers|female sex workers
4867270|NCT02237027|Benin|benin
4867271|NCT02237027|West Africa|west africa
4867272|NCT02237001|meniscal|meniscal
4867273|NCT02237001|meniscus|meniscus
4867274|NCT02237001|repair|repair
4867275|NCT02237001|knee|knee
4867276|NCT02237001|arthroscopy knee|arthroscopy knee
4867277|NCT02237001|horizontal|horizontal
4867278|NCT02236988|Apremilast|apremilast
4867279|NCT02236988|Healthy male subjects|healthy male subjects
4867280|NCT02236988|Pharmacokinetics|pharmacokinetics
4867281|NCT02236949|pediatric pain|pediatric pain
4867282|NCT02236949|intervention sustainability|intervention sustainability
4867283|NCT02236936|Squamous Cell Carcinoma|squamous cell carcinoma
4867284|NCT02236936|Head and neck|head and neck
4867285|NCT02236936|SCCHN|scchn
4867286|NCT02236936|Parenteral nutrition|parenteral nutrition
4867287|NCT02236936|Larynx|larynx
4867288|NCT02236936|Hypopharynx|hypopharynx
4867289|NCT02236936|Cavum oris|cavum oris
4867290|NCT02236936|Radiotherapy|radiotherapy
4867291|NCT02236936|Cetuximab|cetuximab
4867292|NCT02236936|Cisplatin|cisplatin
4867293|NCT02236923|cardiovascular|cardiovascular
4867294|NCT02236923|surgery|surgery
4867295|NCT02236923|ascending aorta|ascending aorta
4867296|NCT02236923|aortic dissection|aortic dissection
4867297|NCT02236910|somatostatin receptor positive tumour|somatostatin receptor positive tumour
4867298|NCT02236884|rectal cancer|rectal cancer
4867299|NCT02236884|no scar|no scar
4867300|NCT02236884|NOTES|notes
4867301|NCT02236884|TaTME|tatme
4867302|NCT02236884|feasibility|feasibility
4867303|NCT02236884|safety|safety
4867304|NCT02236871|Adolescents|adolescents
4867305|NCT02236871|Dairy|dairy
4867306|NCT02236871|Bone|bone
4867307|NCT02236858|COPD|copd
4867308|NCT02236845|Insomnia, medical device, sleep latency|insomnia, medical device, sleep latency
4867309|NCT02236806|Breast cancer|breast cancer
4867310|NCT02236806|Adjuvant chemotherapy|adjuvant chemotherapy
4867311|NCT02236806|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
4867312|NCT02236806|Cardioprotection|cardioprotection
4867313|NCT02236806|Anthracyclines|anthracyclines
4867314|NCT02236780|in vitro fertilisation|in vitro fertilisation
4867315|NCT02236780|environmental conditions|environmental conditions
4867316|NCT02236780|pregnancy|pregnancy
4867317|NCT02236780|live birth rate|live birth rate
4867318|NCT02236754|dihydrotetrabenazine|dihydrotetrabenazine
4867319|NCT02236754|beta cell mass|beta cell mass
4867320|NCT02236754|diabetes mellitus|diabetes mellitus
4867321|NCT02236702|Major Depressive Disorder|major depressive disorder
4867322|NCT02236702|Anhedonia|anhedonia
4867323|NCT02236702|Positron Emission Tomography (PET)|positron emission tomography (pet)
4867324|NCT02236702|Kappa Opioid Receptor (KOR)|kappa opioid receptor (kor)
4867325|NCT02236676|motor learning TBI|motor learning tbi
4867326|NCT02236663|Intimate Partner Violence|intimate partner violence
4867327|NCT02236663|Dating Violence|dating violence
4867328|NCT02236663|Relationships|relationships
4867329|NCT02236663|Safety Planning|safety planning
4867330|NCT02236663|College|college
4867331|NCT02236663|Student|student
4867332|NCT02236663|App|app
4867333|NCT02236650|Parental Resilience|parental resilience
4867334|NCT02236650|Parental Stress|parental stress
4867335|NCT02236650|Family Adaptation|family adaptation
4867336|NCT02236650|Autistic Disorder|autistic disorder
4867337|NCT02236650|Behavior|behavior
4867338|NCT02236650|Child Behavior|child behavior
4867339|NCT02236650|Child Development Disorders|child development disorders
4867340|NCT02236650|Pervasive Developmental Disabilities|pervasive developmental disabilities
4867341|NCT02236650|Caregivers|caregivers
4867342|NCT02236650|Parents|parents
4867343|NCT02236650|Parenting|parenting
4867344|NCT02236650|Primary Health Care|primary health care
4867345|NCT02236637|Adenocarcinoma of the Prostate|adenocarcinoma of the prostate
4867346|NCT02236637|Registry|registry
4867347|NCT02236637|metastatic castration-resistant prostate cancer|metastatic castration-resistant prostate cancer
4867348|NCT02236611|COPD|copd
4867349|NCT02236611|inhaler ease of use|inhaler ease of use
4867350|NCT02236611|glycopyrronium|glycopyrronium
4867351|NCT02236611|umeclidinium|umeclidinium
4867352|NCT02236611|novel dry powder inhaler|novel dry powder inhaler
4867353|NCT02236611|long-acting muscarinic antagonist|long-acting muscarinic antagonist
4867354|NCT02236611|inhaler errors|inhaler errors
4867355|NCT02236598|borderline hypokalemia|borderline hypokalemia
4867356|NCT02236598|glucose tolerance|glucose tolerance
4867357|NCT02236598|insulin secretion|insulin secretion
4867358|NCT02236598|insulin sensitivity|insulin sensitivity
4867359|NCT02236598|fasting glucose|fasting glucose
4867360|NCT02236598|African American|african american
4867361|NCT02236585|uterine artery embolization, epidural , patient-controlled analgesia|uterine artery embolization, epidural , patient-controlled analgesia
4867362|NCT02236572|Postmenopausal|postmenopausal
4867363|NCT02236572|ER-positive, PR-positive, HER2-negative|er-positive, pr-positive, her2-negative
4867364|NCT02236572|Low and intermediate risk|low and intermediate risk
4867365|NCT02236559|high flow therapy|high flow therapy
4867366|NCT02236559|high flow nasal cannula|high flow nasal cannula
4867367|NCT02236559|acute respiratory failure|acute respiratory failure
4867368|NCT02236559|noninvasive ventilation|noninvasive ventilation
4867369|NCT02236546|fluorodeoxyglucose|fluorodeoxyglucose
4867370|NCT02236546|FDG|fdg
4867371|NCT02236546|PET/CT|pet/ct
4867372|NCT02236546|melanoma|melanoma
4867373|NCT02236546|imaging biomarkers|imaging biomarkers
4867374|NCT02236546|cancer imaging|cancer imaging
4867375|NCT02236520|Na+ MRI|na+ mri
4867376|NCT02236520|salt stores|salt stores
4867377|NCT02236494|alcoholism|alcoholism
4867378|NCT02236494|dangerous behavior|dangerous behavior
4867379|NCT02236494|aged|aged
4867380|NCT02236494|emergency medicine|emergency medicine
4867381|NCT02236455|complementary medicine|complementary medicine
4867382|NCT02236455|state anxiety|state anxiety
4867383|NCT02236455|acute pain|acute pain
4867384|NCT02236455|self-efficacy|self-efficacy
4867385|NCT02236455|surgery|surgery
4867386|NCT02236455|medical music intervention|medical music intervention
4867387|NCT02236455|nature therapy|nature therapy
4867388|NCT02236455|relaxation technique|relaxation technique
4867389|NCT02236442|Cephalalgia|cephalalgia
4867390|NCT02236442|Headache|headache
4867391|NCT02236442|Migraine|migraine
4867392|NCT02236442|Pain|pain
4867393|NCT02236442|Global|global
4867394|NCT02236442|Treatment|treatment
4867395|NCT02236442|Oxygen|oxygen
4867396|NCT02236442|Emergency|emergency
4867397|NCT02236442|Treatment of cephalalgia in emergency department|treatment of cephalalgia in emergency department
4867398|NCT02236429|bacterial vaginitis|bacterial vaginitis
4867399|NCT02236429|vaginal flora|vaginal flora
4867400|NCT02236429|microbiome|microbiome
4867401|NCT02236416|Dementia|dementia
4867402|NCT02236416|Prevention|prevention
4867403|NCT02236416|Physical Activity|physical activity
4867404|NCT02236403|Blepharitis , Demodex, Ivermectin, Metronidazole|blepharitis , demodex, ivermectin, metronidazole
4867405|NCT02236390|Nightmare|nightmare
4867406|NCT02236390|PTSD|ptsd
4867407|NCT02236390|Sleep|sleep
4867408|NCT02236390|Emotion Regulation|emotion regulation
4867409|NCT02236390|Exposure Relaxation and Rescripting Therapy|exposure relaxation and rescripting therapy
4867410|NCT02236390|Cognitive Processing Therapy|cognitive processing therapy
4867411|NCT02236377|ERRT|errt
4867412|NCT02236377|Nightmares|nightmares
4867413|NCT02236377|Sleep|sleep
4867414|NCT02236377|Trauma|trauma
4867415|NCT02236377|PTSD|ptsd
4867416|NCT02236351|patching|patching
4867417|NCT02236351|pediatric ophthalmology|pediatric ophthalmology
4867418|NCT02236338|chronic venous insufficiency|chronic venous insufficiency
4867419|NCT02236338|varicose vein|varicose vein
4867420|NCT02236338|greater saphenous vein|greater saphenous vein
4867421|NCT02236299|Right Coronary Artery|right coronary artery
4867422|NCT02236299|Percutaneous Coronary Intervention|percutaneous coronary intervention
4867423|NCT02236299|Diastolic Dysfunction|diastolic dysfunction
4867424|NCT02236299|Glucagon-like peptide-1|glucagon-like peptide-1
4867425|NCT02236299|GLP-1|glp-1
4867426|NCT02236299|Stunning|stunning
4867427|NCT02236299|Cardioprotection|cardioprotection
4867428|NCT02236286|freezing of gait (FOG)|freezing of gait (fog)
4867429|NCT02236286|balance|balance
4867430|NCT02236286|gait|gait
4867431|NCT02236286|exercise|exercise
4867432|NCT02236273|Human papillomavirus|human papillomavirus
4867433|NCT02236273|vaccination|vaccination
4867434|NCT02236273|text message|text message
4867435|NCT02236273|reminder|reminder
4867436|NCT02236247|ivabradine|ivabradine
4867437|NCT02236247|heart rate|heart rate
4867438|NCT02236247|heart failure|heart failure
4867439|NCT02236234|HIV|hiv
4867440|NCT02236234|HPV|hpv
4867441|NCT02236234|Clinical trial|clinical trial
4867442|NCT02236234|outcome|outcome
4867443|NCT02236195|Urothelial|urothelial
4867444|NCT02236195|Bladder|bladder
4867445|NCT02236195|HDAC|hdac
4867446|NCT02236195|MGCD0103|mgcd0103
4867447|NCT02236195|Mocetinostat|mocetinostat
4867448|NCT02236195|CREBBP|crebbp
4867449|NCT02236195|EP300|ep300
4867450|NCT02236195|Mirati|mirati
4867451|NCT02236195|MethylGene|methylgene
4867452|NCT02236143|Healthy|healthy
4867453|NCT02236130|pediatric regional|pediatric regional
4867454|NCT02236117|heart rate variability|heart rate variability
4867455|NCT02236117|children|children
4867456|NCT02236117|progressive test|progressive test
4867457|NCT02236104|neuromuscular disorders|neuromuscular disorders
4867458|NCT02236104|mechanical insufflation-exsufflation|mechanical insufflation-exsufflation
4867459|NCT02236104|respiratory parameters|respiratory parameters
4867460|NCT02236104|plethysmography opto electronic|plethysmography opto electronic
4867461|NCT02236104|Vital capacity|vital capacity
4867462|NCT02236091|cerebral palsy|cerebral palsy
4867463|NCT02236091|stroke|stroke
4867464|NCT02236091|traumatic brain injury|traumatic brain injury
4867465|NCT02236065|Umbilical cord blood|umbilical cord blood
4867466|NCT02236065|Granulocyte-colony stimulating factor|granulocyte-colony stimulating factor
4867467|NCT02236065|Brain injury|brain injury
4867468|NCT02236065|Neurodegenerative disorder|neurodegenerative disorder
4867469|NCT02236065|Efficacy|efficacy
4867470|NCT02236065|Safety|safety
4867471|NCT02236052|Influenza|influenza
4867472|NCT02236052|Human|human
4867473|NCT02236052|RNA Virus Infections|rna virus infections
4867474|NCT02236052|Immunologic|immunologic
4867475|NCT02236052|Immunogenic Factors|immunogenic factors
4867476|NCT02236052|Physiological Effects of Drugs|physiological effects of drugs
4867477|NCT02236052|Virus diseases|virus diseases
4867478|NCT02236052|Orthomyxoviridae Infections|orthomyxoviridae infections
4867479|NCT02236052|Infection|infection
4867480|NCT02236039|Diesel exhaust|diesel exhaust
4867481|NCT02236039|Air pollution|air pollution
4867482|NCT02236039|Airway responsivness|airway responsivness
4867483|NCT02236026|Nestorone use as an IV solution on heart rate;|nestorone use as an iv solution on heart rate;
4867484|NCT02236026|Abnormality in Heart Rate or Rhythm, Unspecified as to Time of Onset|abnormality in heart rate or rhythm, unspecified as to time of onset
4867485|NCT02236013|ASP2215|asp2215
4867486|NCT02236013|Daunorubicin|daunorubicin
4867487|NCT02236013|Gilteritinib|gilteritinib
4867488|NCT02236013|Acute Myeloid Leukemia|acute myeloid leukemia
4867489|NCT02236013|Idarubicin|idarubicin
4867490|NCT02236013|Cytarabine|cytarabine
4867491|NCT02236000|NSABP|nsabp
4867492|NCT02236000|Trastuzumab Emtansine|trastuzumab emtansine
4867493|NCT02236000|T DM1|t dm1
4867494|NCT02236000|Neratinib|neratinib
4867495|NCT02236000|Metastatic Breast Cancer|metastatic breast cancer
4867496|NCT02236000|HER2 positive|her2 positive
4867497|NCT02236000|Dose Escalation|dose escalation
4867498|NCT02235974|stroke|stroke
4867499|NCT02235974|critical periods|critical periods
4867500|NCT02235974|sensitive periods|sensitive periods
4867501|NCT02235974|hemiparesis|hemiparesis
4867502|NCT02235974|upper extremity|upper extremity
4867503|NCT02235974|physical rehabilitation|physical rehabilitation
4867504|NCT02235974|arm therapy|arm therapy
4867505|NCT02235974|occupational therapy|occupational therapy
4867506|NCT02235974|physical therapy|physical therapy
4867507|NCT02235974|task oriented training|task oriented training
4867508|NCT02235974|patient focused|patient focused
4867509|NCT02235974|arm function|arm function
4867510|NCT02235974|hand function|hand function
4867511|NCT02235974|neurorehabilitation|neurorehabilitation
4867512|NCT02235974|motor learning|motor learning
4867513|NCT02235974|motor control|motor control
4867514|NCT02235974|motor function|motor function
4867515|NCT02235974|motor recovery|motor recovery
4867516|NCT02235974|skill acquisition|skill acquisition
4867517|NCT02235974|skill training|skill training
4867518|NCT02235948|arsenic induced health problem|arsenic induced health problem
4867519|NCT02235948|modifying effects|modifying effects
4867520|NCT02235948|folic acid|folic acid
4867521|NCT02235948|oxidative damage|oxidative damage
4867522|NCT02235948|clinical trial|clinical trial
4867523|NCT02235922|Aged|aged
4867524|NCT02235922|Exercise|exercise
4867525|NCT02235922|Cognition|cognition
4867526|NCT02235922|Functional capacity|functional capacity
4867527|NCT02235909|Pediatric Hypertension|pediatric hypertension
4867528|NCT02235909|High Blood Pressure|high blood pressure
4867529|NCT02235909|Hypertension|hypertension
4867530|NCT02235909|Pediatric|pediatric
4867531|NCT02235909|Primary Hypertension|primary hypertension
4867532|NCT02235909|Secondary Hypertension|secondary hypertension
4867533|NCT02235896|risk factors, African American, lipids, blood pressure|risk factors, african american, lipids, blood pressure
4867534|NCT02235883|Coronary artery disease|coronary artery disease
4867535|NCT02235883|FFR|ffr
4867536|NCT02235883|diagnosis|diagnosis
4867537|NCT02235883|computational model|computational model
4867538|NCT02235883|non-invasive|non-invasive
4867539|NCT02235870|Weight Loss|weight loss
4867540|NCT02235870|Obesity|obesity
4867541|NCT02235870|BMI|bmi
4867542|NCT02235857|pediatric, renal transplantation, recurrence, drug-resistant|pediatric, renal transplantation, recurrence, drug-resistant
4867543|NCT02235844|Mesenchymal|mesenchymal
4867544|NCT02235844|Stem Cells|stem cells
4867545|NCT02235844|Umbilical Cord|umbilical cord
4867546|NCT02235844|Duchenne's|duchenne's
4867547|NCT02235844|Muscular Dystrophy|muscular dystrophy
4867548|NCT02235831|DACP MF|dacp mf
4867549|NCT02235831|DAILIES AquaComfort Plus® Multifocal|dailies aquacomfort plus® multifocal
4867550|NCT02235831|presbyopia|presbyopia
4867551|NCT02235831|visual performance|visual performance
4867552|NCT02235818|tennis elbow, treatment, lateral epicondylitis, immediate effects|tennis elbow, treatment, lateral epicondylitis, immediate effects
4867553|NCT02235805|Metabolic Syndrome|metabolic syndrome
4867554|NCT02235805|Obesity|obesity
4867555|NCT02235805|Magnesium Supplementation|magnesium supplementation
4867556|NCT02235805|Vascular Stiffness|vascular stiffness
4867557|NCT02235805|Vascular Function|vascular function
4867558|NCT02235779|ILD|ild
4867559|NCT02235779|Pulmonary fibrosis|pulmonary fibrosis
4867560|NCT02235779|Cryobiopsy|cryobiopsy
4867561|NCT02235779|Transbronchial|transbronchial
4867562|NCT02235766|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
4867563|NCT02235766|Satellite Tele-Echocardiography|satellite tele-echocardiography
4867564|NCT02235740|Open label|open label
4867565|NCT02235740|carfilzomib|carfilzomib
4867566|NCT02235740|Phase I|phase i
4867567|NCT02235740|clinical activity|clinical activity
4867568|NCT02235740|pharmacokinetics|pharmacokinetics
4867569|NCT02235740|afuresertib|afuresertib
4867570|NCT02235740|relapsed|relapsed
4867571|NCT02235740|refractory|refractory
4867572|NCT02235740|safety|safety
4867573|NCT02235740|multiple myeloma|multiple myeloma
4867574|NCT02235714|Airway inflammation|airway inflammation
4867575|NCT02235714|Tetraplegia|tetraplegia
4867576|NCT02235714|Asthma|asthma
4867577|NCT02235714|Exhaled breath condensate|exhaled breath condensate
4867578|NCT02235714|Spirometry|spirometry
4867579|NCT02235714|Pulmonary Function Testing|pulmonary function testing
4867580|NCT02235701|soft tissue sarcoma|soft tissue sarcoma
4867581|NCT02235701|aldoxorubicin|aldoxorubicin
4867582|NCT02235701|ifosfamide|ifosfamide
4867583|NCT02235701|mesna|mesna
4867584|NCT02235701|phase 1|phase 1
4867585|NCT02235701|INNO-206|inno-206
4867586|NCT02235688|aldoxorubicin|aldoxorubicin
4867587|NCT02235688|INNO-206|inno-206
4867588|NCT02235688|solid tumors|solid tumors
4867589|NCT02235688|gemcitabine|gemcitabine
4867590|NCT02235688|phase 1|phase 1
4867591|NCT02235675|Angioplasty|angioplasty
4867592|NCT02235675|Peripheral Artery Disease|peripheral artery disease
4867593|NCT02235675|Critical Limb Ischemia|critical limb ischemia
4867594|NCT02235675|CLI|cli
4867595|NCT02235675|PAD|pad
4867596|NCT02235662|HIV|hiv
4867597|NCT02235662|LNG|lng
4867598|NCT02235662|IVR|ivr
4867599|NCT02235662|Contraception|contraception
4867600|NCT02235662|Prevention|prevention
4867601|NCT02235623|Laparoscopic Surgery|laparoscopic surgery
4867602|NCT02235623|Orchiopexy|orchiopexy
4867603|NCT02235610|Lung Transplantation|lung transplantation
4867604|NCT02235610|Ex Vivo Lung Perfusion|ex vivo lung perfusion
4867605|NCT02235610|EVLP|evlp
4867606|NCT02235597|patient access|patient access
4867607|NCT02235597|patient centered care|patient centered care
4867608|NCT02235597|scheduling|scheduling
4867609|NCT02235597|access barriers|access barriers
4867610|NCT02235597|improve efficiency|improve efficiency
4867611|NCT02235597|decision making tools|decision making tools
4867612|NCT02235597|underserved|underserved
4867613|NCT02235584|Incretin hormones|incretin hormones
4867614|NCT02235584|GLP-1|glp-1
4867615|NCT02235584|GIP|gip
4867616|NCT02235584|Dexamethasone|dexamethasone
4867617|NCT02235558|Acute Ischemic Stoke|acute ischemic stoke
4867618|NCT02235558|Thrombectomy|thrombectomy
4867619|NCT02235558|Intraarterial Pharmacotherapy|intraarterial pharmacotherapy
4867620|NCT02235558|Neuroprotection|neuroprotection
4867621|NCT02235545|HV Lead|hv lead
4867622|NCT02235545|ICD|icd
4867623|NCT02235545|CRT-D System|crt-d system
4867624|NCT02235545|Treatment of Heart Failure|treatment of heart failure
4867625|NCT02235545|Treamtent of life-threatening ventricular tachyarrhythmia|treamtent of life-threatening ventricular tachyarrhythmia
4867626|NCT02235545|Optisure|optisure
4867627|NCT02235532|clinical trial|clinical trial
4867628|NCT02235532|oral hygiene|oral hygiene
4867629|NCT02235532|Gingivitis|gingivitis
4867630|NCT02235532|Aloevera|aloevera
4867631|NCT02235532|Toothpaste|toothpaste
4867632|NCT02235532|anti-inflammatory agents|anti-inflammatory agents
4867633|NCT02235493|HPP|hpp
4867634|NCT02235493|Soft Bones|soft bones
4867635|NCT02235493|low Alkaline Phosphatase|low alkaline phosphatase
4867636|NCT02235493|genetic metabolic disorder|genetic metabolic disorder
4867637|NCT02235493|alkaline phosphatase|alkaline phosphatase
4867638|NCT02235493|tissue non-specific alkaline phosphatase|tissue non-specific alkaline phosphatase
4867639|NCT02235493|rickets|rickets
4867640|NCT02235493|osteomalacia|osteomalacia
4867641|NCT02235467|autism|autism
4867642|NCT02235467|videomodeling|videomodeling
4867643|NCT02235467|behavioral therapy|behavioral therapy
4867644|NCT02235467|parental training|parental training
4867645|NCT02235454|glaucoma|glaucoma
4867646|NCT02235454|OCT|oct
4867647|NCT02235454|spectral domain optical coherence tomography|spectral domain optical coherence tomography
4867648|NCT02235441|Gastrointestinal malignancy|gastrointestinal malignancy
4867649|NCT02235441|Cardiopulmonary fitness|cardiopulmonary fitness
4867650|NCT02235441|Chemoradiation therapy|chemoradiation therapy
4867651|NCT02235376|Critical Care|critical care
4867652|NCT02235376|Brain injured patients|brain injured patients
4867653|NCT02235376|Mechanical Ventilation|mechanical ventilation
4867654|NCT02235376|Weaning|weaning
4867655|NCT02235376|Extubation|extubation
4867656|NCT02235376|Prognostic score|prognostic score
4867657|NCT02235376|Clinical examination|clinical examination
4867658|NCT02235363|face lift|face lift
4867659|NCT02235363|thread lift|thread lift
4867660|NCT02235363|retaining ligament|retaining ligament
4867661|NCT02235363|V-Loc sutures|v-loc sutures
4867662|NCT02235363|tensiometer|tensiometer
4867663|NCT02235363|FACE-Q|face-q
4867664|NCT02235350|Adult|adult
4867665|NCT02235350|Male|male
4867666|NCT02235350|Female|female
4867667|NCT02235350|Neuronal Plasticity|neuronal plasticity
4867668|NCT02235350|Imitative Behavior/physiology|imitative behavior/physiology
4867669|NCT02235350|Magnetic Resonance Imaging|magnetic resonance imaging
4867670|NCT02235350|Psychomotor Disorders/rehabilitation|psychomotor disorders/rehabilitation
4867671|NCT02235350|Follow-up Studies|follow-up studies
4867672|NCT02235350|Video Recording|video recording
4867673|NCT02235350|Physical Therapy Modalities|physical therapy modalities
4867674|NCT02235350|Recovery of Function|recovery of function
4867675|NCT02235350|Action Observation Treatment|action observation treatment
4867676|NCT02235350|Mirror Neuron System|mirror neuron system
4867677|NCT02235350|Stroke/rehabilitation|stroke/rehabilitation
4867678|NCT02235350|Upper Limb|upper limb
4867679|NCT02235337|Concussion|concussion
4867680|NCT02235337|Sports related concussion|sports related concussion
4867681|NCT02235337|mTBI|mtbi
4867682|NCT02235337|Vitamin B|vitamin b
4867683|NCT02235337|Riboflavin|riboflavin
4867684|NCT02235311|Proton pump inhibitor|proton pump inhibitor
4867685|NCT02235311|Upper gastrointestinal bleed|upper gastrointestinal bleed
4867686|NCT02235311|Ulcer healing|ulcer healing
4867687|NCT02235298|epicardial fat|epicardial fat
4867688|NCT02235298|diabetes|diabetes
4867689|NCT02235298|dapagliflozin|dapagliflozin
4867690|NCT02235285|capsular contracture|capsular contracture
4867691|NCT02235285|reoperation|reoperation
4867692|NCT02235285|breast augmentation|breast augmentation
4867693|NCT02235246|perioperative intravenous magnesium|perioperative intravenous magnesium
4867694|NCT02235246|endoscopic submucosal dissection|endoscopic submucosal dissection
4867695|NCT02235220|Bruxism|bruxism
4867696|NCT02235207|sedentary work|sedentary work
4867697|NCT02235207|musculoskeletal pain|musculoskeletal pain
4867698|NCT02235207|neuromuscular exercise|neuromuscular exercise
4867699|NCT02235207|physical fitness|physical fitness
4867700|NCT02235207|quality of life|quality of life
4867701|NCT02235207|work ability|work ability
4867702|NCT02235181|Twin Pregnancy|twin pregnancy
4867703|NCT02235181|Prevention of Preterm birth|prevention of preterm birth
4867704|NCT02235181|Short Cervix|short cervix
4867705|NCT02235181|Arabin cervical pessary|arabin cervical pessary
4867706|NCT02235116|Number of patients|number of patients
4867707|NCT02235116|full body skin exam|full body skin exam
4867708|NCT02235116|Survey|survey
4867709|NCT02235116|preferences|preferences
4867710|NCT02235090|Spinal muscular atrophy|spinal muscular atrophy
4867711|NCT02235090|Neuromuscular disorders|neuromuscular disorders
4867712|NCT02235090|Outcome measures|outcome measures
4867713|NCT02235090|Visit-free clinical trial design|visit-free clinical trial design
4867714|NCT02235077|Heart Failure|heart failure
4867715|NCT02235077|Heart Diseases|heart diseases
4867716|NCT02235077|Cardiovascular Diseases|cardiovascular diseases
4867717|NCT02235077|Spironolactone|spironolactone
4867718|NCT02235077|Aldactone|aldactone
4867719|NCT02235025|mild COPD|mild copd
4867720|NCT02235025|dyspnea|dyspnea
4867721|NCT02235025|exercise|exercise
4867722|NCT02235025|respiratory mechanics|respiratory mechanics
4867723|NCT02235012|Schizophrenia|schizophrenia
4867724|NCT02235012|Ketamine|ketamine
4867725|NCT02235012|Cognitive biases|cognitive biases
4867726|NCT02235012|Uncertainty|uncertainty
4867727|NCT02234999|Pharmacokinetics, Healthy Subjects|pharmacokinetics, healthy subjects
4867728|NCT02234986|Advanced Fibrolamellar Carcinoma|advanced fibrolamellar carcinoma
4867729|NCT02234947|type 1 diabetes|type 1 diabetes
4867730|NCT02234947|pancreas volume|pancreas volume
4867731|NCT02234934|Gene Therapy|gene therapy
4867732|NCT02234934|X-Linked Chronic Granulomatous Disease (X-CGD)|x-linked chronic granulomatous disease (x-cgd)
4867733|NCT02234934|Lentiviral Vector|lentiviral vector
4867734|NCT02234921|Prostate|prostate
4867735|NCT02234921|Adenocarcinoma|adenocarcinoma
4867738|NCT02234921|Immunotherapy|immunotherapy
4867739|NCT02234921|Microbiome|microbiome
4867740|NCT02234908|Tuberculosis|tuberculosis
4867741|NCT02234908|Drug-resistant tuberculosis|drug-resistant tuberculosis
4867742|NCT02234908|Incentives|incentives
4867743|NCT02234908|Symptom screening|symptom screening
4867744|NCT02234895|osteoarthritis|osteoarthritis
4867745|NCT02234895|knee|knee
4867746|NCT02234895|biomechanics|biomechanics
4867747|NCT02234895|treatment|treatment
4867748|NCT02234895|symptoms|symptoms
4867749|NCT02234869|Peginterferon Beta-1a|peginterferon beta-1a
4867750|NCT02234869|Relapsing Multiple Sclerosis|relapsing multiple sclerosis
4867751|NCT02234869|RMS|rms
4867752|NCT02234869|flu-like symptoms|flu-like symptoms
4867753|NCT02234856|Hysterectomy|hysterectomy
4867754|NCT02234856|Laparoscopy|laparoscopy
4867755|NCT02234856|Surgical assessment|surgical assessment
4867756|NCT02234856|Education|education
4867757|NCT02234843|Pediatric|pediatric
4867758|NCT02234830|PCI|pci
4867759|NCT02234804|Coronary angiography (CAG)|coronary angiography (cag)
4867760|NCT02234804|Percutaneous coronary intervention (PCI)|percutaneous coronary intervention (pci)
4867761|NCT02234804|OCT|oct
4867762|NCT02234804|Stent|stent
4867763|NCT02234778|critical limb ischemia|critical limb ischemia
4867764|NCT02234778|autologous stromal vascular fraction|autologous stromal vascular fraction
4867765|NCT02234765|OSA|osa
4867766|NCT02234765|OSAS|osas
4867767|NCT02234765|Sleep apnea|sleep apnea
4867768|NCT02234765|Management|management
4867769|NCT02234765|Primary Care|primary care
4867770|NCT02234765|Sleep Unit|sleep unit
4867771|NCT02234765|Cost-Effectiveness|cost-effectiveness
4867772|NCT02234765|ESS|ess
4867773|NCT02234752|Schizophrenia|schizophrenia
4867774|NCT02234752|Schizoaffective Disorder|schizoaffective disorder
4867775|NCT02234752|Cognition|cognition
4867776|NCT02234752|Cognitive Impairment|cognitive impairment
4867777|NCT02234752|Galantamine|galantamine
4867778|NCT02234752|Memantine|memantine
4867779|NCT02234739|voriconazole|voriconazole
4867780|NCT02234739|COPD|copd
4867781|NCT02234739|invasive pulmonary aspergillosis|invasive pulmonary aspergillosis
4867782|NCT02234739|efficacy|efficacy
4867783|NCT02234739|safety|safety
4867784|NCT02234726|child health|child health
4867785|NCT02234726|child development|child development
4867786|NCT02234726|malnutrition|malnutrition
4867787|NCT02234726|stunting|stunting
4867788|NCT02234726|community-based health services|community-based health services
4867789|NCT02234687|post-traumatic stress disorder|post-traumatic stress disorder
4867790|NCT02234674|Pulsating suit|pulsating suit
4867791|NCT02234674|lymphedema|lymphedema
4867792|NCT02234674|leg volume|leg volume
4867793|NCT02234661|Low income|low income
4867794|NCT02234661|Education|education
4867795|NCT02234661|Poverty|poverty
4867796|NCT02234661|Children|children
4867797|NCT02234661|Parents|parents
4867798|NCT02234661|Head Start|head start
4867799|NCT02234648|Vascular Function|vascular function
4867800|NCT02234648|tart Montmorency cherries|tart montmorency cherries
4867801|NCT02234648|Arterial Stiffness|arterial stiffness
4867802|NCT02234648|Blood Flow|blood flow
4867803|NCT02234635|visual acuity|visual acuity
4867804|NCT02234635|objective visual quality|objective visual quality
4867805|NCT02234635|multifocal intraocular lens|multifocal intraocular lens
4867806|NCT02234635|tear-film quality dynamics|tear-film quality dynamics
4867807|NCT02234622|Stress Disorders, Post-Traumatic|stress disorders, post-traumatic
4867808|NCT02234622|Yoga|yoga
4867809|NCT02234622|Veterans|veterans
4867810|NCT02234609|dentistry|dentistry
4867811|NCT02234609|dental caries|dental caries
4867812|NCT02234609|atraumatic restorative Treatment|atraumatic restorative treatment
4867813|NCT02234609|effectiveness|effectiveness
4867814|NCT02234596|Nintedanib|nintedanib
4867815|NCT02234596|14-094|14-094
4867816|NCT02234583|pain|pain
4867817|NCT02234583|fibromyalgia|fibromyalgia
4867818|NCT02234570|neurocysticercosis|neurocysticercosis
4867819|NCT02234570|pork tapeworm|pork tapeworm
4867820|NCT02234570|Taenia solium|taenia solium
4867821|NCT02234557|Motor Control|motor control
4867822|NCT02234557|Attention|attention
4867823|NCT02234557|Cognitive Control|cognitive control
4867824|NCT02234544|vitamin D|vitamin d
4867825|NCT02234544|absorption|absorption
4867826|NCT02234544|ezetimibe|ezetimibe
4867827|NCT02234531|Virtual Reality,|virtual reality,
4867828|NCT02234531|Enhanced Feedback,|enhanced feedback,
4867829|NCT02234531|Stroke,|stroke,
4867830|NCT02234531|Rehabilitation,|rehabilitation,
4867831|NCT02234531|Motor Learning|motor learning
4867832|NCT02234505|prosthetics|prosthetics
4867833|NCT02234505|amputation|amputation
4867834|NCT02234505|gait stability|gait stability
4867835|NCT02234505|step variability|step variability
4867836|NCT02234505|load cell|load cell
4867837|NCT02234492|Human immunodeficiency virus (HIV)|human immunodeficiency virus (hiv)
4867838|NCT02234492|Statin therapy|statin therapy
4867839|NCT02234492|Cardiovascular disease (CVD)|cardiovascular disease (cvd)
4867840|NCT02234492|Coronary Flow Reserve (CFR)|coronary flow reserve (cfr)
4867841|NCT02234492|Positron Emission Tomography (PET)|positron emission tomography (pet)
4867842|NCT02234492|Myocardial contrast echocardiography (MCE)|myocardial contrast echocardiography (mce)
4867843|NCT02234479|Breast Cancer|breast cancer
4867844|NCT02234479|Radiation Dermatitis|radiation dermatitis
4867845|NCT02234466|Quality of Recovery (QOR40)|quality of recovery (qor40)
4867846|NCT02234466|Breast Surgery|breast surgery
4867847|NCT02234466|Clinically significant Nausea and Vomiting|clinically significant nausea and vomiting
4867848|NCT02234466|Postoperative Nausea and Vomiting|postoperative nausea and vomiting
4867849|NCT02234453|cancer|cancer
4867850|NCT02234453|chemotherapy|chemotherapy
4867851|NCT02234453|home|home
4867852|NCT02234453|blood count|blood count
4867853|NCT02234453|remote|remote
4867854|NCT02234427|aspirin, atherosclerosis|aspirin, atherosclerosis
4867855|NCT02234414|vertebral fracture assessment (vfa)|vertebral fracture assessment (vfa)
4867856|NCT02234414|vitamin D|vitamin d
4867857|NCT02234401|Cystic Fibrosis|cystic fibrosis
4867858|NCT02234401|Noninvasive ventilation|noninvasive ventilation
4867859|NCT02234401|Non invasive ventilation|non invasive ventilation
4867860|NCT02234401|Acute respiratory exacerbation|acute respiratory exacerbation
4867861|NCT02234401|Bi level pressure support|bi level pressure support
4867862|NCT02234388|connective tissue disease|connective tissue disease
4867863|NCT02234388|registry|registry
4867864|NCT02234388|hospital for special surgery|hospital for special surgery
4867865|NCT02234375|Pulmonary embolism|pulmonary embolism
4867866|NCT02234375|Contrast|contrast
4867867|NCT02234375|Computed tomography|computed tomography
4867868|NCT02234375|Gadolinium|gadolinium
4867869|NCT02234349|bile acids|bile acids
4867870|NCT02234349|pancreas kidney transplantation|pancreas kidney transplantation
4867871|NCT02234349|incretins|incretins
4867872|NCT02234349|intestinal flora|intestinal flora
4867873|NCT02234336|Echocardiography|echocardiography
4867874|NCT02234336|hypertrophic cardiomyopathy|hypertrophic cardiomyopathy
4867875|NCT02234336|cardiomyopathy|cardiomyopathy
4867876|NCT02234336|magnetic resonance imaging|magnetic resonance imaging
4867877|NCT02234336|contrast|contrast
4867878|NCT02234323|prophylaxis treatment|prophylaxis treatment
4867879|NCT02234323|Hemophilia A|hemophilia a
4867880|NCT02234323|Hemophilia|hemophilia
4867881|NCT02234323|episodic treatment|episodic treatment
4867882|NCT02234310|prophylaxis treatment|prophylaxis treatment
4867883|NCT02234310|episodic treatment|episodic treatment
4867884|NCT02234297|Glioma|glioma
4867885|NCT02234297|Tumor Paint|tumor paint
4867886|NCT02234297|BLZ100|blz100
4867887|NCT02234284|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
4867888|NCT02234284|Health Coaching|health coaching
4867889|NCT02234284|Health Disparities|health disparities
4867890|NCT02234284|Self-management|self-management
4867891|NCT02234284|Chronic Disease Model|chronic disease model
4867892|NCT02234245|Follow-Up studies|follow-up studies
4867893|NCT02234245|Biological Pacemakers|biological pacemakers
4867894|NCT02234245|Telemedicine|telemedicine
4867895|NCT02234245|Efficiency|efficiency
4867896|NCT02234232|Hemodialysis|hemodialysis
4867897|NCT02234232|Exercise, aerobic|exercise, aerobic
4867898|NCT02234232|Exercise, resistance|exercise, resistance
4867899|NCT02234232|Intradialytic|intradialytic
4867900|NCT02234232|Randomized Controlled Trial|randomized controlled trial
4867901|NCT02234232|Safety|safety
4867902|NCT02234232|Quality of life|quality of life
4867903|NCT02234232|Physical performance|physical performance
4867904|NCT02234206|Hypospermatogenesis, Low Sperm Count, Oligozoospermia|hypospermatogenesis, low sperm count, oligozoospermia
4867905|NCT02234193|wound healing|wound healing
4867906|NCT02234128|Ex Vivo Lung Perfusion|ex vivo lung perfusion
4867907|NCT02234128|EVLP|evlp
4867908|NCT02234128|Lung Transplant|lung transplant
4867909|NCT02234128|Lung Transplantation|lung transplantation
4867910|NCT02234128|Toronto EVLP System™|toronto evlp system™
4867911|NCT02234128|PERFUSIX|perfusix
4867912|NCT02234115|Prostate Neoplasm Cancer Carcinoma|prostate neoplasm cancer carcinoma
4867913|NCT02234076|Posttraumatic Stress Disorder|posttraumatic stress disorder
4867914|NCT02234076|Depression|depression
4867915|NCT02234076|Treatment|treatment
4867916|NCT02234076|VRET|vret
4867917|NCT02234063|Hypertension|hypertension
4867918|NCT02234063|Chronic Kidney Disease|chronic kidney disease
4867919|NCT02234063|End Stage Renal Disease|end stage renal disease
4867920|NCT02234063|APOL1|apol1
4867921|NCT02234063|Genomics|genomics
4867922|NCT02234063|Genetics|genetics
4867923|NCT02234063|Community-engaged|community-engaged
4867924|NCT02234050|Grade 2 Chordoid meningioma|grade 2 chordoid meningioma
4867925|NCT02234050|Grade 2 Clear cell meningioma|grade 2 clear cell meningioma
4867926|NCT02234050|Grade 2 Atypical meningioma|grade 2 atypical meningioma
4867927|NCT02234050|Grade 3 Papillary meningioma|grade 3 papillary meningioma
4867928|NCT02234050|Grade 3 Rhabdoid meningioma|grade 3 rhabdoid meningioma
4867929|NCT02234050|Grade 3 Anaplastic meningioma|grade 3 anaplastic meningioma
4867930|NCT02234050|Grade 3 Malignant meningioma|grade 3 malignant meningioma
4867931|NCT02234037|AML|aml
4867932|NCT02233998|Plaque|plaque
4867933|NCT02233998|Bleeding|bleeding
4867934|NCT02233998|Gums|gums
4867935|NCT02233998|Gingiva|gingiva
4867936|NCT02233998|Gingival Inflammation|gingival inflammation
4867937|NCT02233998|Gingival Bleeding|gingival bleeding
4867938|NCT02233985|bronchiolitis|bronchiolitis
4867939|NCT02233985|hypertonic|hypertonic
4867940|NCT02233985|saline|saline
4867941|NCT02233985|salbutamol|salbutamol
4867942|NCT02233972|Pharmacokinetics|pharmacokinetics
4867943|NCT02233972|Ginkgolides Meglumine Injection|ginkgolides meglumine injection
4867944|NCT02233946|Substance Abuse|substance abuse
4867945|NCT02233946|Prevention|prevention
4867946|NCT02233946|Youth|youth
4867947|NCT02233946|Alcohol|alcohol
4867948|NCT02233946|Drugs|drugs
4867949|NCT02233933|radiation proctitis|radiation proctitis
4867950|NCT02233933|bleeding|bleeding
4867951|NCT02233933|therapy|therapy
4867952|NCT02233868|Imaging Studies|imaging studies
4867953|NCT02233868|Alcoholism|alcoholism
4867954|NCT02233868|Inflammation|inflammation
4867955|NCT02233855|Seizures|seizures
4867956|NCT02233855|Cestode|cestode
4867957|NCT02233855|Hydrocephalus|hydrocephalus
4867958|NCT02233855|Taenia Solium|taenia solium
4867959|NCT02233855|Helminth|helminth
4867960|NCT02233842|Qualitative Data|qualitative data
4867961|NCT02233842|Questionnaire|questionnaire
4867962|NCT02233829|C-11 Raclopride|c-11 raclopride
4867963|NCT02233829|015 PET|015 pet
4867964|NCT02233829|Circadian Rhythm|circadian rhythm
4867965|NCT02233816|Influenza|influenza
4867966|NCT02233816|Human|human
4867967|NCT02233816|RNA Virus Infections|rna virus infections
4867968|NCT02233816|Immunologic|immunologic
4867969|NCT02233816|Immunogenic Factors|immunogenic factors
4867970|NCT02233816|Physiological Effects of Drugs|physiological effects of drugs
4867971|NCT02233816|Virus diseases|virus diseases
4867972|NCT02233816|Orthomyxoviridae Infections|orthomyxoviridae infections
4867973|NCT02233816|Infection|infection
4867974|NCT02233803|tolerability|tolerability
4867975|NCT02233803|NEUMOTEROL|neumoterol
4867976|NCT02233803|efficacy|efficacy
4867977|NCT02233803|budesonide/formoterol fumarate 400/12 mcg|budesonide/formoterol fumarate 400/12 mcg
4867978|NCT02233803|safety|safety
4867979|NCT02233803|Asthma|asthma
4867980|NCT02233803|pharmacodynamics|pharmacodynamics
4867981|NCT02233790|Myocardial infarction|myocardial infarction
4867982|NCT02233790|No-Reflow Phenomenon|no-reflow phenomenon
4867983|NCT02233790|Ticagrelor|ticagrelor
4867984|NCT02233790|Clopidogrel|clopidogrel
4867985|NCT02233790|Single-Photon Emission Computerized Tomography|single-photon emission computerized tomography
4867986|NCT02233777|Pregabalin|pregabalin
4867987|NCT02233777|Bioequivalence|bioequivalence
4867988|NCT02233777|Bioavailability|bioavailability
4867989|NCT02233777|Pharmacokinetic|pharmacokinetic
4867990|NCT02233777|Antiepileptic|antiepileptic
4867991|NCT02233764|iron|iron
4867992|NCT02233764|zinc|zinc
4867993|NCT02233764|pearl millet|pearl millet
4867994|NCT02233764|India|india
4867995|NCT02233764|children|children
4867996|NCT02233764|trial|trial
4867997|NCT02233764|randomized|randomized
4867998|NCT02233751|Healthy Adult Males|healthy adult males
4867999|NCT02233738|Alcoholism|alcoholism
4868000|NCT02233738|Substance-related disorders|substance-related disorders
4868001|NCT02233738|Dual Diagnosis|dual diagnosis
4868002|NCT02233725|Prostatic Neoplasms|prostatic neoplasms
4868003|NCT02233725|Magnetic Resonance Imaging|magnetic resonance imaging
4868004|NCT02233725|MRI / Ultrasound Fusion|mri / ultrasound fusion
4868005|NCT02233725|Contrast-Enhanced Ultrasound (CEUS)|contrast-enhanced ultrasound (ceus)
4868006|NCT02233712|gastric cancer, stomach neoplasms,|gastric cancer, stomach neoplasms,
4868007|NCT02233673|Obesity|obesity
4868008|NCT02233673|Pregnancy|pregnancy
4868009|NCT02233647|cocaine|cocaine
4868010|NCT02233647|phendimetrazine|phendimetrazine
4868011|NCT02233647|pharmacotherapy|pharmacotherapy
4868012|NCT02233634|Coronary Angiography|coronary angiography
4868013|NCT02233634|Magnetic Resonance Imaging|magnetic resonance imaging
4868014|NCT02233634|Oxygen|oxygen
4868015|NCT02233634|Hyperoxia|hyperoxia
4868016|NCT02233634|Carbon Dioxide|carbon dioxide
4868017|NCT02233634|Apnea|apnea
4868018|NCT02233634|Hyperventilation|hyperventilation
4868019|NCT02233608|Prostate cancer|prostate cancer
4868020|NCT02233608|Radical prostatectomy|radical prostatectomy
4868021|NCT02233608|Pelvic floor muscle exercises|pelvic floor muscle exercises
4868022|NCT02233608|Pfilates|pfilates
4868023|NCT02233608|Hypopressives|hypopressives
4868024|NCT02233608|Urinary Incontinence|urinary incontinence
4868025|NCT02233595|MRI|mri
4868026|NCT02233595|PET|pet
4868027|NCT02233595|rectal cancer|rectal cancer
4868028|NCT02233595|adjuvant chemotherapy|adjuvant chemotherapy
4868029|NCT02233582|altitude|altitude
4868030|NCT02233582|mountain sickness|mountain sickness
4868031|NCT02233582|ibuprofen|ibuprofen
4868032|NCT02233582|hypoxia|hypoxia
4868033|NCT02233569|Laparoscopic hernia repair|laparoscopic hernia repair
4868034|NCT02233569|Ventral hernia|ventral hernia
4868035|NCT02233569|Incisional hernia|incisional hernia
4868036|NCT02233569|IPOM|ipom
4868037|NCT02233556|event-related potential|event-related potential
4868038|NCT02233556|mismatch negativity|mismatch negativity
4868039|NCT02233556|NMDA|nmda
4868040|NCT02233556|Glutamate|glutamate
4868041|NCT02233543|COPD|copd
4868042|NCT02233543|QVA149|qva149
4868043|NCT02233543|nocturnal oxygen levels|nocturnal oxygen levels
4868044|NCT02233543|combination bronchodilator|combination bronchodilator
4868045|NCT02233530|Dementia|dementia
4868046|NCT02233530|Cognitive Stimulation Therapy|cognitive stimulation therapy
4868047|NCT02233530|Quality of life|quality of life
4868048|NCT02233530|Cognitive impairment|cognitive impairment
4868049|NCT02233530|Africa|africa
4868050|NCT02233530|Tanzania|tanzania
4868051|NCT02233530|Nigeria|nigeria
4868052|NCT02233530|Low- and Middle-income countries|low- and middle-income countries
4868053|NCT02233530|Non-pharmacological intervention|non-pharmacological intervention
4868054|NCT02233530|Task-shifting|task-shifting
4868055|NCT02233530|Cognitive screening|cognitive screening
4868056|NCT02233517|Veterans|veterans
4868057|NCT02233517|Cognitive-Behavioral Therapy|cognitive-behavioral therapy
4868058|NCT02233517|Aggression|aggression
4868059|NCT02233517|Anger|anger
4868060|NCT02233517|Posttraumatic Stress Disorder|posttraumatic stress disorder
4868061|NCT02233517|Combat Disorders|combat disorders
4868062|NCT02233491|PTDM|ptdm
4868063|NCT02233491|kidney transplant|kidney transplant
4868064|NCT02233491|lifestyle intervention|lifestyle intervention
4868065|NCT02233491|diet|diet
4868066|NCT02233491|exercise|exercise
4868067|NCT02233478|Pomegranate polyphenols|pomegranate polyphenols
4868068|NCT02233478|Soy Protein|soy protein
4868069|NCT02233478|Ellagitannins|ellagitannins
4868070|NCT02233465|parastomal|parastomal
4868071|NCT02233465|hernia|hernia
4868072|NCT02233465|mesh|mesh
4868073|NCT02233465|parastomal hernia-repair with mesh|parastomal hernia-repair with mesh
4868074|NCT02233452|Neuropathic pain|neuropathic pain
4868075|NCT02233452|Methadone|methadone
4868076|NCT02233452|Ketamine|ketamine
4868077|NCT02233452|Multimodal analgesia|multimodal analgesia
4868078|NCT02233439|galactagogues|galactagogues
4868079|NCT02233439|herbs|herbs
4868080|NCT02233439|breastfeeding|breastfeeding
4868081|NCT02233439|supplements|supplements
4868082|NCT02233439|Silybum marianum|silybum marianum
4868083|NCT02233439|Galega officinalis|galega officinalis
4868084|NCT02233426|allergic rhinitis|allergic rhinitis
4868085|NCT02233426|nasal steroid|nasal steroid
4868086|NCT02233426|hypertonic saline|hypertonic saline
4868087|NCT02233426|eosinophil|eosinophil
4868088|NCT02233426|symptom score|symptom score
4868089|NCT02233413|Traumatic brain injury|traumatic brain injury
4868090|NCT02233413|TBI|tbi
4868091|NCT02233413|Low-level light therapy|low-level light therapy
4868092|NCT02233413|LLLT|lllt
4868093|NCT02233413|LLLT helmet|lllt helmet
4868094|NCT02233400|Acetaminophen|acetaminophen
4868095|NCT02233400|Gastric Bypass|gastric bypass
4868096|NCT02233400|Sleeve Gastrectomy|sleeve gastrectomy
4868097|NCT02233400|Pain|pain
4868098|NCT02233400|Cost|cost
4868099|NCT02233387|cervix cancer|cervix cancer
4868100|NCT02233387|[18F] HX4 PET imaging|[18f] hx4 pet imaging
4868101|NCT02233387|hypoxia|hypoxia
4868102|NCT02233387|phase II trial|phase ii trial
4868103|NCT02233374|Rectal Cancer|rectal cancer
4868104|NCT02233374|Magnetic Resonance Imaging|magnetic resonance imaging
4868105|NCT02233374|Positron Emission Tomography|positron emission tomography
4868106|NCT02233374|pathologic complete response|pathologic complete response
4868107|NCT02233374|Diffusion-weighted magnetic resonance imaging|diffusion-weighted magnetic resonance imaging
4868108|NCT02233374|Microstructural Imaging|microstructural imaging
4868109|NCT02233374|FDG PET|fdg pet
4868110|NCT02233361|Hearing rehabilitation|hearing rehabilitation
4868111|NCT02233361|Elderly|elderly
4868112|NCT02233361|Hearing aid use|hearing aid use
4868113|NCT02233322|ADHR|adhr
4868114|NCT02233322|Rickets|rickets
4868115|NCT02233322|Hypophosphatemia|hypophosphatemia
4868116|NCT02233283|LH pulsatility|lh pulsatility
4868117|NCT02233283|Insulin sensitivity|insulin sensitivity
4868118|NCT02233283|Metabolism|metabolism
4868119|NCT02233283|hypercaloric feeding|hypercaloric feeding
4868120|NCT02233257|Adrenoleukodystrophy|adrenoleukodystrophy
4868121|NCT02233257|Lorenzo's oil|lorenzo's oil
4868122|NCT02233257|erucic acid|erucic acid
4868123|NCT02233244|Drug Interaction|drug interaction
4868124|NCT02233205|microbubble|microbubble
4868125|NCT02233205|chemotherapy|chemotherapy
4868126|NCT02233205|alimentary|alimentary
4868127|NCT02233192|PrEP|prep
4868128|NCT02233192|conception|conception
4868129|NCT02233192|HIV|hiv
4868130|NCT02233192|serodiscordant|serodiscordant
4868131|NCT02233179|Diabetic foot ulcer|diabetic foot ulcer
4868132|NCT02233153|Senior|senior
4868133|NCT02233153|Elderly|elderly
4868134|NCT02233153|Acute Care|acute care
4868135|NCT02233153|Emergency Surgery|emergency surgery
4868136|NCT02233140|Diabetes|diabetes
4868137|NCT02233140|Ankle equinus|ankle equinus
4868138|NCT02233140|ankle dorsiflexion|ankle dorsiflexion
4868139|NCT02233140|dynamic plantar pressure|dynamic plantar pressure
4868140|NCT02233140|shockwave therapy|shockwave therapy
4868141|NCT02233127|Birth cohort|birth cohort
4868142|NCT02233127|Pakistan|pakistan
4868143|NCT02233127|Child mortality|child mortality
4868144|NCT02233088|Prediabetic State|prediabetic state
4868145|NCT02233088|Hypertension|hypertension
4868146|NCT02233088|Enlarged Waist Elevated Triglycerides|enlarged waist elevated triglycerides
4868242|NCT02232490|AFP|afp
4868147|NCT02233088|HDL Cholesterol, Low Serum|hdl cholesterol, low serum
4868148|NCT02233062|Crohn's Disease|crohn's disease
4868149|NCT02233062|semen quality|semen quality
4868150|NCT02233062|enteral nutrition|enteral nutrition
4868151|NCT02233062|CDAI score higher than 150|cdai score higher than 150
4868152|NCT02233049|Children|children
4868153|NCT02233049|adolescents|adolescents
4868154|NCT02233049|young adults|young adults
4868155|NCT02233049|newly diagnosed|newly diagnosed
4868156|NCT02233036|Young Adults|young adults
4868157|NCT02233036|Transfer|transfer
4868158|NCT02233036|Chronic Disease|chronic disease
4868159|NCT02232997|Chronic kidney disease|chronic kidney disease
4868160|NCT02232997|contrast induced nephropathy|contrast induced nephropathy
4868161|NCT02232997|diabetes mellitus|diabetes mellitus
4868162|NCT02232997|congestive heart failure|congestive heart failure
4868163|NCT02232997|hypertension|hypertension
4868164|NCT02232984|Heart Failure|heart failure
4868165|NCT02232984|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
4868166|NCT02232984|CRT-D|crt-d
4868167|NCT02232984|Quadripolar pacing|quadripolar pacing
4868168|NCT02232971|glucagon|glucagon
4868169|NCT02232971|insulin pump|insulin pump
4868170|NCT02232971|artificial pancreas|artificial pancreas
4868171|NCT02232971|closed-loop|closed-loop
4868172|NCT02232958|Hyperbaric Oxygen|hyperbaric oxygen
4868173|NCT02232958|Small Vessel Disease of the Brain|small vessel disease of the brain
4868174|NCT02232958|Impaired Brain Circuit Connections|impaired brain circuit connections
4868175|NCT02232945|influenza A (H1N1,H3N2)|influenza a (h1n1,h3n2)
4868176|NCT02232945|influenza B virus|influenza b virus
4868177|NCT02232932|Hilar cholangiocarcinoma|hilar cholangiocarcinoma
4868178|NCT02232932|Liver transplantation|liver transplantation
4868179|NCT02232932|Radiochemotherapy|radiochemotherapy
4868180|NCT02232919|Deep Brain Stimulation|deep brain stimulation
4868181|NCT02232906|Chronic kidney disease|chronic kidney disease
4868182|NCT02232906|CKD|ckd
4868183|NCT02232906|non-dialysis-dependent|non-dialysis-dependent
4868184|NCT02232906|ND-CKD|nd-ckd
4868185|NCT02232906|Erythropoiesis-stimulating agent|erythropoiesis-stimulating agent
4868186|NCT02232906|Ferric carboxymaltose|ferric carboxymaltose
4868187|NCT02232906|Iron|iron
4868188|NCT02232893|Gastrointestinal Quality of Life Index (GIQLI)|gastrointestinal quality of life index (giqli)
4868189|NCT02232893|Abdominal Discomfort|abdominal discomfort
4868190|NCT02232893|Abdominal Bloating|abdominal bloating
4868191|NCT02232893|Laparoscopic colectomy|laparoscopic colectomy
4868192|NCT02232893|Postoperative ileus (POI)|postoperative ileus (poi)
4868193|NCT02232880|hypertension|hypertension
4868194|NCT02232880|inflammation|inflammation
4868195|NCT02232867|rehabilitation|rehabilitation
4868196|NCT02232867|stroke|stroke
4868197|NCT02232867|walking|walking
4868198|NCT02232867|interlimb connections|interlimb connections
4868199|NCT02232854|Depression|depression
4868200|NCT02232841|Electrical impedance tomography|electrical impedance tomography
4868201|NCT02232841|lung imaging|lung imaging
4868202|NCT02232789|Mephedrone|mephedrone
4868203|NCT02232789|3,4-methylenedioxymethamphetamine|3,4-methylenedioxymethamphetamine
4868204|NCT02232789|Abuse liability|abuse liability
4868205|NCT02232789|Human Pharmacology|human pharmacology
4868206|NCT02232776|Losartan|losartan
4868207|NCT02232776|Ig A nephropathy|ig a nephropathy
4868208|NCT02232776|children|children
4868209|NCT02232776|proteinuria|proteinuria
4868210|NCT02232763|Losartan|losartan
4868211|NCT02232763|children|children
4868212|NCT02232763|proteinuria|proteinuria
4868213|NCT02232737|Biomarkers of exposure|biomarkers of exposure
4868214|NCT02232737|Compensatory smoking|compensatory smoking
4868215|NCT02232737|Nicotine dependence|nicotine dependence
4868216|NCT02232737|Reduced nicotine cigarettes|reduced nicotine cigarettes
4868217|NCT02232737|Tobacco withdrawal|tobacco withdrawal
4868218|NCT02232737|Women|women
4868219|NCT02232737|Health disparaties|health disparaties
4868220|NCT02232737|Vulnerable populations|vulnerable populations
4868221|NCT02232724|Prostate Cancer|prostate cancer
4868222|NCT02232724|Staging|staging
4868223|NCT02232724|PET/CT|pet/ct
4868224|NCT02232711|multiplex, polymerase chain reaction, PCR, BioFire, respiratory infection, infectious disease, point of care, CLIA waived, rapid diagnostics|multiplex, polymerase chain reaction, pcr, biofire, respiratory infection, infectious disease, point of care, clia waived, rapid diagnostics
4868225|NCT02232698|Sensing Technology|sensing technology
4868226|NCT02232698|Type 1 Diabetes,|type 1 diabetes,
4868227|NCT02232685|Prostate cancer|prostate cancer
4868228|NCT02232685|Staging|staging
4868229|NCT02232685|PET/CT|pet/ct
4868230|NCT02232672|Prostate Cancer|prostate cancer
4868231|NCT02232672|Staging|staging
4868232|NCT02232672|PET/CT|pet/ct
4868233|NCT02232659|SynCardia|syncardia
4868234|NCT02232659|Total Artificial Heart|total artificial heart
4868235|NCT02232659|Biventricular heart failure|biventricular heart failure
4868236|NCT02232659|Ineligible for cardiac transplant|ineligible for cardiac transplant
4868237|NCT02232568|Patient blood management|patient blood management
4868238|NCT02232568|RBC transfusion|rbc transfusion
4868239|NCT02232568|Restrictive transfusion strategy|restrictive transfusion strategy
4868240|NCT02232529|modified release formulation|modified release formulation
4868241|NCT02232529|pharmacokinetics|pharmacokinetics
4868243|NCT02232490|alpha-fetoprotein|alpha-fetoprotein
4868244|NCT02232490|cancer vaccine|cancer vaccine
4868245|NCT02232490|cirrhosis|cirrhosis
4868246|NCT02232490|hepatitis|hepatitis
4868247|NCT02232490|HCC|hcc
4868248|NCT02232490|hepatocellular carcinoma|hepatocellular carcinoma
4868249|NCT02232490|immunotherapy|immunotherapy
4868250|NCT02232490|liver tumor|liver tumor
4868251|NCT02232490|Cholangiocarcinoma|cholangiocarcinoma
4868252|NCT02232464|Adult ADHD|adult adhd
4868253|NCT02232464|diffusion spectrum imaging|diffusion spectrum imaging
4868254|NCT02232464|resting-state fMRI|resting-state fmri
4868255|NCT02232464|frontostriatal circuitries|frontostriatal circuitries
4868256|NCT02232464|frontoparietal circuitries|frontoparietal circuitries
4868257|NCT02232464|executive function|executive function
4868258|NCT02232451|loop|loop
4868259|NCT02232451|ERCP|ercp
4868260|NCT02232451|cannulation|cannulation
4868261|NCT02232451|biliary|biliary
4868262|NCT02232451|wire|wire
4868263|NCT02232438|Depression|depression
4868264|NCT02232438|Psychotherapy|psychotherapy
4868265|NCT02232438|Anxiety|anxiety
4868266|NCT02232438|Cancer|cancer
4868267|NCT02232412|Anemia|anemia
4868268|NCT02232412|NIRS|nirs
4868269|NCT02232412|Near Infrared Spectroscopy|near infrared spectroscopy
4868270|NCT02232412|RBC transfusion|rbc transfusion
4868271|NCT02232412|critical ill|critical ill
4868272|NCT02232412|regional cerebral oxygen saturation|regional cerebral oxygen saturation
4868273|NCT02232412|tissue oxygenation|tissue oxygenation
4868274|NCT02232386|Chronic lymphocyte leukemia|chronic lymphocyte leukemia
4868275|NCT02232386|Adults|adults
4868276|NCT02232386|Ibrutinib|ibrutinib
4868277|NCT02232373|FODMAPs|fodmaps
4868278|NCT02232373|microbiota|microbiota
4868279|NCT02232373|oligofructose|oligofructose
4868280|NCT02232373|IBS|ibs
4868281|NCT02232373|Irritable bowel syndrome|irritable bowel syndrome
4868282|NCT02232360|Atherosclerotic plaque|atherosclerotic plaque
4868283|NCT02232360|Virtual histology intravascular ultrasound|virtual histology intravascular ultrasound
4868284|NCT02232360|Plaque composition|plaque composition
4868285|NCT02232360|Rosuvastatin|rosuvastatin
4868286|NCT02232360|Fenofibrate|fenofibrate
4868287|NCT02232360|Coronary artery disease|coronary artery disease
4868288|NCT02232347|traumatic brain injury|traumatic brain injury
4868289|NCT02232347|ketamine|ketamine
4868290|NCT02232347|microdialysis|microdialysis
4868291|NCT02232347|PtiO2|ptio2
4868292|NCT02232347|glutamate|glutamate
4868293|NCT02232334|Idiopathic Gastroparesis, Nausea, Vomiting, Abdominal Pain, Gastrectomy, Osteopathy, Gastroparesis Cardinal Symptom Index, GCSI|idiopathic gastroparesis, nausea, vomiting, abdominal pain, gastrectomy, osteopathy, gastroparesis cardinal symptom index, gcsi
4868294|NCT02232295|Upper extremity, motor imagery, mirror therapy|upper extremity, motor imagery, mirror therapy
4868295|NCT02232282|Painful Bladder Syndrome|painful bladder syndrome
4868296|NCT02232282|Interstitial Cystitis|interstitial cystitis
4868297|NCT02232282|Suprapubic Pain|suprapubic pain
4868298|NCT02232282|Urinary Urgency|urinary urgency
4868299|NCT02232269|Coffee|coffee
4868300|NCT02232269|Grapefruit Juice|grapefruit juice
4868301|NCT02232269|Felodipine|felodipine
4868302|NCT02232269|Calcium Channel Blocker|calcium channel blocker
4868303|NCT02232269|Hemodynamics|hemodynamics
4868304|NCT02232269|CYP3A4|cyp3a4
4868305|NCT02232256|Chronic non-cancer pain|chronic non-cancer pain
4868306|NCT02232256|Insomnia|insomnia
4868307|NCT02232256|California poppy|california poppy
4868308|NCT02232256|Eschscholzia californica|eschscholzia californica
4868309|NCT02232256|Pain|pain
4868310|NCT02232256|Sleep quality|sleep quality
4868311|NCT02232243|Cancer|cancer
4868312|NCT02232243|Surgery|surgery
4868313|NCT02232243|Hydroxychloroquine|hydroxychloroquine
4868314|NCT02232217|Children|children
4868315|NCT02232217|Sleep|sleep
4868316|NCT02232217|Obesity|obesity
4868317|NCT02232204|insomnia|insomnia
4868318|NCT02232204|implantable cardioverter defibrillator|implantable cardioverter defibrillator
4868319|NCT02232204|cardiac arrhythmia|cardiac arrhythmia
4868320|NCT02232204|cognitive behavioral treatment|cognitive behavioral treatment
4868321|NCT02232178|unilateral inguinal hernioplasty|unilateral inguinal hernioplasty
4868322|NCT02232165|acute spinal cord injury|acute spinal cord injury
4868323|NCT02232165|hemodynamic therapy|hemodynamic therapy
4868324|NCT02232165|functional outcome|functional outcome
4868325|NCT02232126|Hospital readmissions|hospital readmissions
4868326|NCT02232126|Randomized controlled trial|randomized controlled trial
4868327|NCT02232126|Older adults|older adults
4868328|NCT02232126|Care transitions|care transitions
4868329|NCT02232126|Social work|social work
4868330|NCT02232113|malnutrition, inflammation, and anemia (MIA) syndrome,|malnutrition, inflammation, and anemia (mia) syndrome,
4868331|NCT02232113|hemodialysis,|hemodialysis,
4868332|NCT02232113|erythropoietin stimulating agent (ESA),|erythropoietin stimulating agent (esa),
4868333|NCT02232113|cost-effectiveness,|cost-effectiveness,
4868334|NCT02232113|pharmacokinetics,|pharmacokinetics,
4868335|NCT02232113|endothelial dysfunction|endothelial dysfunction
4868336|NCT02232100|Attentional bias modification|attentional bias modification
4868337|NCT02232100|Chronic pain|chronic pain
4868338|NCT02232100|Visual-probe task|visual-probe task
4868339|NCT02232100|Internet-delivered therapy|internet-delivered therapy
4868340|NCT02232087|long-acting beta agonist (LABA)|long-acting beta agonist (laba)
4868341|NCT02232087|corticosteroid|corticosteroid
4868342|NCT02232087|pMDI|pmdi
4868343|NCT02232087|inhaler|inhaler
4868344|NCT02232074|Patient Navigation|patient navigation
4868345|NCT02232074|Medical Legal Partnership|medical legal partnership
4868346|NCT02232074|Healthcare Disparities|healthcare disparities
4868347|NCT02232061|multiple sclerosis, fingolimod,|multiple sclerosis, fingolimod,
4868348|NCT02232035|diazepam|diazepam
4868349|NCT02232035|active phase|active phase
4868350|NCT02232022|Stroke|stroke
4868351|NCT02232022|Ischemic stroke|ischemic stroke
4868352|NCT02232022|Atrial fibrillation|atrial fibrillation
4868353|NCT02232022|Insertable cardiac monitor|insertable cardiac monitor
4868354|NCT02232022|Non-cryptogenic|non-cryptogenic
4868355|NCT02232009|Neonate|neonate
4868356|NCT02232009|Infant|infant
4868357|NCT02231983|Clinical Characteristics|clinical characteristics
4868358|NCT02231983|Genetic Profiles|genetic profiles
4868359|NCT02231970|Obesity|obesity
4868360|NCT02231970|Endoscopic sleeve gastroplasty|endoscopic sleeve gastroplasty
4868361|NCT02231970|Weight loss|weight loss
4868362|NCT02231892|Repetitive TMS (rTMS)|repetitive tms (rtms)
4868363|NCT02231892|Parameter Development|parameter development
4868364|NCT02231892|Cognitive Tasks|cognitive tasks
4868365|NCT02231892|MRI (Magnetic Resonance Imaging)|mri (magnetic resonance imaging)
4868366|NCT02231879|Infections|infections
4868367|NCT02231879|Hypogammaglobulinemia|hypogammaglobulinemia
4868368|NCT02231879|CXCR4|cxcr4
4868369|NCT02231879|Myelokathexis|myelokathexis
4868370|NCT02231879|Warts|warts
4868371|NCT02231866|Filovirus|filovirus
4868372|NCT02231866|Healthy|healthy
4868373|NCT02231866|Ebola Hemorrhagic Fever|ebola hemorrhagic fever
4868374|NCT02231866|Immunity|immunity
4868375|NCT02231866|Ebola Virus|ebola virus
4868376|NCT02231853|BK Virus|bk virus
4868377|NCT02231853|Cytotoxic T Cells|cytotoxic t cells
4868378|NCT02231853|EBV|ebv
4868379|NCT02231853|Adenovirus|adenovirus
4868380|NCT02231853|CMV|cmv
4868381|NCT02231840|Phenotypes|phenotypes
4868382|NCT02231840|Alcohol Use|alcohol use
4868383|NCT02231840|Alcohol|alcohol
4868384|NCT02231840|Alcohol Dependence|alcohol dependence
4868385|NCT02231840|Genetics|genetics
4868386|NCT02231827|subjects|subjects
4868387|NCT02231814|Crohn's disease|crohn's disease
4868388|NCT02231814|Mild to moderate Crohn's Disease|mild to moderate crohn's disease
4868389|NCT02231814|Diet|diet
4868390|NCT02231814|Enteral Nutrition|enteral nutrition
4868391|NCT02231801|Preterm|preterm
4868392|NCT02231801|Kangaroo Care|kangaroo care
4868393|NCT02231801|Skin-to-Skin|skin-to-skin
4868394|NCT02231801|Vital Sign|vital sign
4868395|NCT02231801|Heart Rate|heart rate
4868396|NCT02231801|Respiratory Rate|respiratory rate
4868397|NCT02231801|Oxygen Saturation|oxygen saturation
4868398|NCT02231788|Telminuvo|telminuvo
4868399|NCT02231788|Telmitrend|telmitrend
4868400|NCT02231788|Hypertension|hypertension
4868401|NCT02231788|24hr ABPM|24hr abpm
4868402|NCT02231788|Telmisartan|telmisartan
4868403|NCT02231788|S-amlodipine|s-amlodipine
4868404|NCT02231775|Neoadjuvant|neoadjuvant
4868405|NCT02231775|Dabrafenib|dabrafenib
4868406|NCT02231775|Tafinlar|tafinlar
4868407|NCT02231775|GSK2118436|gsk2118436
4868408|NCT02231775|Trametinib|trametinib
4868409|NCT02231775|GSK1120212|gsk1120212
4868410|NCT02231775|Combination therapy|combination therapy
4868411|NCT02231775|Surgery|surgery
4868412|NCT02231775|Adjuvant therapy|adjuvant therapy
4868413|NCT02231775|Melanoma|melanoma
4868414|NCT02231736|Type 2 Diabetes|type 2 diabetes
4868415|NCT02231736|Chromosomal damage|chromosomal damage
4868416|NCT02231736|Micronuclei|micronuclei
4868417|NCT02231736|DNA damage|dna damage
4868418|NCT02231736|HbA1c|hba1c
4868419|NCT02231736|Comet Assay|comet assay
4868420|NCT02231736|Glycemic control|glycemic control
4868421|NCT02231723|Digestive System Neoplasms|digestive system neoplasms
4868422|NCT02231723|Endocrine Gland Neoplasms|endocrine gland neoplasms
4868423|NCT02231723|Pancreatic neoplasms|pancreatic neoplasms
4868424|NCT02231723|Pancreatic cancer, adult|pancreatic cancer, adult
4868425|NCT02231723|Pancreatic cancer|pancreatic cancer
4868426|NCT02231723|Pancreas cancer|pancreas cancer
4868427|NCT02231723|Pancreatic diseases|pancreatic diseases
4868428|NCT02231723|Adenoma, Islet Cell|adenoma, islet cell
4868429|NCT02231723|Carcinoma, Islet Cell|carcinoma, islet cell
4868430|NCT02231723|Carcinoma, Pancreatic Ductal|carcinoma, pancreatic ductal
4868431|NCT02231723|Gemcitabine|gemcitabine
4868432|NCT02231723|Gemzar|gemzar
4868433|NCT02231723|Nab-paclitaxel|nab-paclitaxel
4868434|NCT02231723|Paclitaxel|paclitaxel
4868435|NCT02231723|Abraxane|abraxane
4868436|NCT02231723|Oxaliplatin|oxaliplatin
4868437|NCT02231723|Leucovorin|leucovorin
4868438|NCT02231723|Irinotecan|irinotecan
4868439|NCT02231723|Fluorouracil|fluorouracil
4868440|NCT02231723|5-FU|5-fu
4868441|NCT02231723|MM-398|mm-398
4868442|NCT02231710|Severe Combined Immune Deficiency|severe combined immune deficiency
4868443|NCT02231710|Congenital T-cell Defect|congenital t-cell defect
4868444|NCT02231710|Congenital T-cell Deficiency|congenital t-cell deficiency
4868539|NCT02231229|Pyrazinamide (PZA or Z)|pyrazinamide (pza or z)
4868445|NCT02231710|Chronic Granulomatous Disease|chronic granulomatous disease
4868446|NCT02231710|Shwachman Diamond Syndrome|shwachman diamond syndrome
4868447|NCT02231710|Diamond Blackfan Anemia|diamond blackfan anemia
4868448|NCT02231710|Dyskeratosis Congenita|dyskeratosis congenita
4868449|NCT02231710|Fanconi Anemia|fanconi anemia
4868450|NCT02231710|Sickle Cell Disease|sickle cell disease
4868451|NCT02231710|Thalassemia|thalassemia
4868452|NCT02231710|Mucopolysaccharidosis|mucopolysaccharidosis
4868453|NCT02231710|Sphingolipidoses|sphingolipidoses
4868454|NCT02231697|XLMTM|xlmtm
4868455|NCT02231645|Parkinson's disease|parkinson's disease
4868456|NCT02231645|Deep brain stimulation|deep brain stimulation
4868457|NCT02231645|Subthalamic nucleus|subthalamic nucleus
4868458|NCT02231645|decision-making|decision-making
4868459|NCT02231645|cognition|cognition
4868460|NCT02231645|behavior|behavior
4868461|NCT02231632|Poliomyelitis|poliomyelitis
4868462|NCT02231632|Vaccine|vaccine
4868463|NCT02231632|Safety|safety
4868464|NCT02231632|efficacy|efficacy
4868465|NCT02231619|feasibility|feasibility
4868466|NCT02231619|self assessment|self assessment
4868467|NCT02231619|medical abortion|medical abortion
4868468|NCT02231619|low sensitivity urine pregnancy test|low sensitivity urine pregnancy test
4868469|NCT02231619|South Africa|south africa
4868470|NCT02231606|Myopia Prevalence|myopia prevalence
4868471|NCT02231606|Proportion of Purchase of free Spectacles|proportion of purchase of free spectacles
4868472|NCT02231606|Proportion of Purchase of update Spectacles|proportion of purchase of update spectacles
4868473|NCT02231606|Proportion of Wearing Spectacles|proportion of wearing spectacles
4868474|NCT02231580|Neurodegenerative genetic disorder|neurodegenerative genetic disorder
4868475|NCT02231567|hip replacement|hip replacement
4868476|NCT02231567|neurocognitive rehabilitation|neurocognitive rehabilitation
4868477|NCT02231567|WOMAC questionnaire|womac questionnaire
4868478|NCT02231554|low back pain|low back pain
4868479|NCT02231554|quality of life|quality of life
4868480|NCT02231554|rehabilitation|rehabilitation
4868481|NCT02231554|exercise|exercise
4868482|NCT02231541|Fibromylgia|fibromylgia
4868483|NCT02231541|Magnetic Fields|magnetic fields
4868484|NCT02231541|Pain|pain
4868485|NCT02231541|Visual Analogue scale|visual analogue scale
4868486|NCT02231528|anesthesia|anesthesia
4868487|NCT02231528|central venous catheter|central venous catheter
4868488|NCT02231528|jugular vein|jugular vein
4868489|NCT02231528|ultrasound guidance|ultrasound guidance
4868490|NCT02231502|Bioavailability in healthy individuals|bioavailability in healthy individuals
4868491|NCT02231489|Healthy|healthy
4868492|NCT02231489|JNJ-42756493|jnj-42756493
4868493|NCT02231489|JNJ-61818549|jnj-61818549
4868494|NCT02231463|ultrasound|ultrasound
4868495|NCT02231450|AE58054|ae58054
4868496|NCT02231450|Hepatic impairment|hepatic impairment
4868497|NCT02231411|Delayed Cord Clamping|delayed cord clamping
4868498|NCT02231411|Pulmonary Ventilation|pulmonary ventilation
4868499|NCT02231398|Cardiovascular disease|cardiovascular disease
4868500|NCT02231398|Pregnant women|pregnant women
4868501|NCT02231398|Nulliparity|nulliparity
4868502|NCT02231398|Pregnancy outcomes|pregnancy outcomes
4868503|NCT02231398|Pregnancy complications|pregnancy complications
4868504|NCT02231398|Sleep disordered breathing|sleep disordered breathing
4868505|NCT02231385|Colorectal cancer|colorectal cancer
4868506|NCT02231385|Serrated adenomas|serrated adenomas
4868507|NCT02231385|Screening|screening
4868508|NCT02231385|Adenoma detection rate|adenoma detection rate
4868509|NCT02231385|Polypectomy|polypectomy
4868510|NCT02231307|sublingual immunotherapy|sublingual immunotherapy
4868511|NCT02231307|birch pollen|birch pollen
4868512|NCT02231307|allergic rhinitis / rhinoconjunctivitis|allergic rhinitis / rhinoconjunctivitis
4868513|NCT02231307|efficacy|efficacy
4868514|NCT02231281|HIV Infections|hiv infections
4868515|NCT02231281|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
4868516|NCT02231281|Immunologic Deficiency Syndromes|immunologic deficiency syndromes
4868517|NCT02231281|Immune System Diseases|immune system diseases
4868518|NCT02231281|Lentivirus Infections|lentivirus infections
4868519|NCT02231281|Retroviridae Infections|retroviridae infections
4868520|NCT02231281|Virus Diseases|virus diseases
4868521|NCT02231281|RNA Virus Infections|rna virus infections
4868522|NCT02231281|Sexually Transmitted Diseases, Viral|sexually transmitted diseases, viral
4868523|NCT02231281|Slow Virus Diseases|slow virus diseases
4868524|NCT02231281|Therapeutic Uses|therapeutic uses
4868525|NCT02231281|Pharmacologic Actions|pharmacologic actions
4868526|NCT02231281|Antiretroviral therapy|antiretroviral therapy
4868527|NCT02231281|Early therapy|early therapy
4868528|NCT02231242|brain|brain
4868529|NCT02231242|children|children
4868530|NCT02231242|cerebral palsy|cerebral palsy
4868531|NCT02231242|bone marrow stem cells|bone marrow stem cells
4868532|NCT02231242|intrathecal autologous total nucleated cells|intrathecal autologous total nucleated cells
4868533|NCT02231242|quadriparesis|quadriparesis
4868534|NCT02231229|Pulmonary tuberculosis|pulmonary tuberculosis
4868535|NCT02231229|Mycobacterium tuberculosis (MTB)|mycobacterium tuberculosis (mtb)
4868536|NCT02231229|Drug Resistance (DR)|drug resistance (dr)
4868537|NCT02231229|Isoniazid (INH or H)|isoniazid (inh or h)
4868538|NCT02231229|Rifampicin (RIF or RMP or R)|rifampicin (rif or rmp or r)
4868540|NCT02231229|Ethambutol (EMB or E)|ethambutol (emb or e)
4868541|NCT02231229|Fast-TB|fast-tb
4868542|NCT02231229|Isoniazid, Rifampicin, Pyrazinamide (HRZ)|isoniazid, rifampicin, pyrazinamide (hrz)
4868543|NCT02231229|Isoniazid, Rifampicin, Pyrazinamide, Ethambutol (HRZE)|isoniazid, rifampicin, pyrazinamide, ethambutol (hrze)
4868544|NCT02231229|drug susceptibility testing (DST)|drug susceptibility testing (dst)
4868545|NCT02231229|Acid-Fast Bacilli (AFB+)|acid-fast bacilli (afb+)
4868546|NCT02231229|Polymerase Chain Reaction (PCR)|polymerase chain reaction (pcr)
4868547|NCT02231216|rhinoseptoplasty|rhinoseptoplasty
4868548|NCT02231203|fish oil|fish oil
4868549|NCT02231203|omega-3 fatty acids|omega-3 fatty acids
4868550|NCT02231203|postoperative inflammatory response|postoperative inflammatory response
4868551|NCT02231203|erythrocyte function|erythrocyte function
4868552|NCT02231190|muscle soreness|muscle soreness
4868553|NCT02231190|Muscle damage and recovery|muscle damage and recovery
4868554|NCT02231190|muscle function|muscle function
4868555|NCT02231190|eccentric exercise|eccentric exercise
4868556|NCT02231151|CPR quality assessment|cpr quality assessment
4868557|NCT02231151|Visual CPR assessment|visual cpr assessment
4868689|NCT02230683|Portal Hypertension|portal hypertension
4868558|NCT02231151|Position relative to patient|position relative to patient
4868559|NCT02231138|Abelmoschus manihot|abelmoschus manihot
4868560|NCT02231138|Chronic Kidney Disease|chronic kidney disease
4868561|NCT02231138|proteinuria|proteinuria
4868562|NCT02231138|efficacy|efficacy
4868563|NCT02231138|safety|safety
4868564|NCT02231125|Abelmoschus manihot|abelmoschus manihot
4868565|NCT02231125|IgA Nephropathy|iga nephropathy
4868566|NCT02231125|proteinuria|proteinuria
4868567|NCT02231125|efficacy|efficacy
4868568|NCT02231125|safety|safety
4868569|NCT02231112|Korean|korean
4868570|NCT02231112|Left side|left side
4868571|NCT02231099|recurrent pelvic organ prolapse|recurrent pelvic organ prolapse
4868572|NCT02231099|mesh|mesh
4868573|NCT02231086|Chemotherapy, Adjuvant|chemotherapy, adjuvant
4868574|NCT02231086|Laparoscopy|laparoscopy
4868575|NCT02231086|Peritoneal Lavage|peritoneal lavage
4868576|NCT02231086|HIPEC|hipec
4868577|NCT02231073|Freezing of gait|freezing of gait
4868578|NCT02231073|Idiopathic Parkinson's disease|idiopathic parkinson's disease
4868579|NCT02231073|Exercise|exercise
4868580|NCT02231073|parkinsonism|parkinsonism
4868581|NCT02231060|Outcome Prediction|outcome prediction
4868582|NCT02231060|Anoxic-Ischemic Encephalopathy|anoxic-ischemic encephalopathy
4868583|NCT02231060|Coma|coma
4868584|NCT02231060|Vegetative State|vegetative state
4868585|NCT02231060|Minimally Conscious State|minimally conscious state
4868586|NCT02231060|Chronic Disorders of Consciousness|chronic disorders of consciousness
4868587|NCT02231047|Diarrhea|diarrhea
4868588|NCT02231047|Pneumonia|pneumonia
4868589|NCT02231047|Child, Preschool|child, preschool
4868590|NCT02231047|Infant|infant
4868591|NCT02231047|Dietary Supplements|dietary supplements
4868592|NCT02231047|Colostrums|colostrums
4868593|NCT02231047|Developing Countries|developing countries
4868594|NCT02231021|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
4868595|NCT02231021|alogliptin|alogliptin
4868596|NCT02231021|pioglitazone|pioglitazone
4868597|NCT02231021|DPP4 inhibitor|dpp4 inhibitor
4868598|NCT02231021|thiazolidinedione|thiazolidinedione
4868600|NCT02230969|peginterferon|peginterferon
4868601|NCT02230969|relapsing|relapsing
4868602|NCT02230969|pegylated|pegylated
4868603|NCT02230969|Subcutaneous|subcutaneous
4868604|NCT02230969|Injectable|injectable
4868605|NCT02230969|Multiple Sclerosis|multiple sclerosis
4868606|NCT02230943|rheumatoid|rheumatoid
4868607|NCT02230943|arthritis|arthritis
4868608|NCT02230943|osteoarthritis|osteoarthritis
4868609|NCT02230943|gout|gout
4868610|NCT02230930|Parkinson's disease|parkinson's disease
4868611|NCT02230930|Apomorphine|apomorphine
4868612|NCT02230930|Infusion|infusion
4868613|NCT02230930|Skin reactions|skin reactions
4868614|NCT02230930|Subcutaneous nodules|subcutaneous nodules
4868615|NCT02230930|Hydrocortisone|hydrocortisone
4868616|NCT02230930|Massage|massage
4868617|NCT02230930|Dilution|dilution
4868618|NCT02230904|Rotigotine patch|rotigotine patch
4868619|NCT02230904|Neupro|neupro
4868620|NCT02230904|Parkinson's Disease|parkinson's disease
4868621|NCT02230891|heart failure|heart failure
4868622|NCT02230891|biomarkers|biomarkers
4868623|NCT02230891|troponin|troponin
4868624|NCT02230891|BNP|bnp
4868625|NCT02230891|carvedilol|carvedilol
4868626|NCT02230891|spironolactone|spironolactone
4868627|NCT02230891|prevention|prevention
4868628|NCT02230878|JNJ-42847922|jnj-42847922
4868629|NCT02230878|Phase 1|phase 1
4868630|NCT02230878|Healthy|healthy
4868631|NCT02230878|Placebo|placebo
4868632|NCT02230865|Funnel chest (Pectus excavatum)|funnel chest (pectus excavatum)
4868633|NCT02230852|Telemedicine|telemedicine
4868634|NCT02230852|Prehospital|prehospital
4868635|NCT02230852|Emergency Medicine|emergency medicine
4868636|NCT02230852|Stroke|stroke
4868637|NCT02230839|insulin resistance|insulin resistance
4868638|NCT02230839|muscle|muscle
4868639|NCT02230839|health education|health education
4868640|NCT02230839|exercise|exercise
4868641|NCT02230826|Arthroplasty|arthroplasty
4868847|NCT02230033|Gemfibrozil|gemfibrozil
4868642|NCT02230826|Hip Replacement|hip replacement
4868643|NCT02230826|Acetabular cup|acetabular cup
4868644|NCT02230826|Femoral stem|femoral stem
4868645|NCT02230813|Cohort Study,|cohort study,
4868646|NCT02230813|Cellulitis,|cellulitis,
4868647|NCT02230813|Skin and Soft Tissue Infection,|skin and soft tissue infection,
4868648|NCT02230813|Emergency Department,|emergency department,
4868649|NCT02230813|Clinical Prediction Rule|clinical prediction rule
4868650|NCT02230787|Pilot study|pilot study
4868651|NCT02230787|randomized clinical trial|randomized clinical trial
4868652|NCT02230787|periodontal disease|periodontal disease
4868653|NCT02230787|gingival recession|gingival recession
4868654|NCT02230787|Emdogain|emdogain
4868655|NCT02230787|connective tissue|connective tissue
4868656|NCT02230787|wound healing|wound healing
4868657|NCT02230787|inflammation|inflammation
4868658|NCT02230774|hydration|hydration
4868659|NCT02230774|cognitive function|cognitive function
4868660|NCT02230774|doctors|doctors
4868661|NCT02230774|nurses|nurses
4868662|NCT02230774|Nurses and Doctors oncall|nurses and doctors oncall
4868663|NCT02230761|steatoblepharon|steatoblepharon
4868664|NCT02230761|blepharoptosis|blepharoptosis
4868665|NCT02230761|dermatochalasis|dermatochalasis
4868666|NCT02230761|blepharoplasty|blepharoplasty
4868667|NCT02230761|periorbital|periorbital
4868668|NCT02230761|orbital|orbital
4868669|NCT02230761|eyelid|eyelid
4868670|NCT02230761|eyebags|eyebags
4868671|NCT02230761|eye bags|eye bags
4868672|NCT02230748|LAA|laa
4868673|NCT02230748|LAA-Occluder|laa-occluder
4868674|NCT02230748|Atrial Fibrillation|atrial fibrillation
4868675|NCT02230748|AF|af
4868676|NCT02230735|Robotic|robotic
4868677|NCT02230735|Hysterectomy|hysterectomy
4868678|NCT02230735|Uterosacral|uterosacral
4868679|NCT02230735|Bupivacaine|bupivacaine
4868680|NCT02230735|Robotic hysterectomy pain control|robotic hysterectomy pain control
4868681|NCT02230722|opioids|opioids
4868682|NCT02230722|chronic pain|chronic pain
4868683|NCT02230722|collaborative care|collaborative care
4868684|NCT02230709|Neck pain|neck pain
4868685|NCT02230709|Myofascial pain syndrome|myofascial pain syndrome
4868686|NCT02230709|Soreness|soreness
4868687|NCT02230683|Liver Cirrhosis|liver cirrhosis
4868688|NCT02230683|Hepatic Cirrhosis|hepatic cirrhosis
4868690|NCT02230670|Liver Cirrhosis|liver cirrhosis
4868691|NCT02230670|Hepatic Cirrhosis|hepatic cirrhosis
4868692|NCT02230605|Delirium|delirium
4868693|NCT02230605|Post Operative Delirium|post operative delirium
4868694|NCT02230605|PD|pd
4868695|NCT02230605|POD|pod
4868696|NCT02230605|Anesthesia|anesthesia
4868697|NCT02230605|Anesthesiology|anesthesiology
4868698|NCT02230605|Post Operative Recovery|post operative recovery
4868699|NCT02230605|Post Anesthesia Care Unit|post anesthesia care unit
4868700|NCT02230605|PACU|pacu
4868701|NCT02230605|Cognition|cognition
4868702|NCT02230605|Cognitive Impairment|cognitive impairment
4868703|NCT02230605|Memory|memory
4868704|NCT02230605|Thinking|thinking
4868705|NCT02230605|Confusion Assessment Method|confusion assessment method
4868706|NCT02230605|CAM|cam
4868707|NCT02230605|Neurobics|neurobics
4868708|NCT02230605|Neuroplasticity|neuroplasticity
4868709|NCT02230605|Lumosity|lumosity
4868710|NCT02230605|Brain Games|brain games
4868711|NCT02230605|Cognitive Exercise|cognitive exercise
4868712|NCT02230605|Cognitive Training|cognitive training
4868713|NCT02230605|Perioperative Cognitive Protection|perioperative cognitive protection
4868714|NCT02230605|Cognitive Reserve|cognitive reserve
4868715|NCT02230605|Neurobics Trial|neurobics trial
4868716|NCT02230605|Surgery|surgery
4868717|NCT02230605|Elderly Patients|elderly patients
4868718|NCT02230592|PET|pet
4868719|NCT02230592|Metabolic Glutamate Receptors|metabolic glutamate receptors
4868720|NCT02230592|Brain Imaging|brain imaging
4868721|NCT02230579|safety|safety
4868722|NCT02230579|tolerability|tolerability
4868723|NCT02230579|malaria|malaria
4868724|NCT02230566|MPS 7|mps 7
4868725|NCT02230566|Sly Syndrome|sly syndrome
4868726|NCT02230566|Mucopolysaccharidosis|mucopolysaccharidosis
4868727|NCT02230566|MPS VII|mps vii
4868728|NCT02230566|Enzyme Replacement Therapy|enzyme replacement therapy
4868729|NCT02230566|Mucopolysaccharidosis type 7|mucopolysaccharidosis type 7
4868730|NCT02230566|rare disease|rare disease
4868731|NCT02230566|lysosomal storage disease|lysosomal storage disease
4868732|NCT02230566|metabolic disorder|metabolic disorder
4868733|NCT02230514|Nonunion fracture|nonunion fracture
4868734|NCT02230514|Long bones|long bones
4868735|NCT02230514|Pseudoarthrosis|pseudoarthrosis
4868736|NCT02230514|Cell therapy|cell therapy
4868737|NCT02230514|Tissue engineering|tissue engineering
4868738|NCT02230514|Mesenchymal stromal cells|mesenchymal stromal cells
4868739|NCT02230488|Inpatient Diabetes Management|inpatient diabetes management
4868740|NCT02230488|Prevent <31 day readmission in patients with Diabetes|prevent <31 day readmission in patients with diabetes
4868741|NCT02230488|CDEs role in transition of care of inpatients with diabetes|cdes role in transition of care of inpatients with diabetes
4868742|NCT02230475|Allergic Rhinitis|allergic rhinitis
4868743|NCT02230475|NMR|nmr
4868744|NCT02230462|patient satisfaction|patient satisfaction
4868745|NCT02230462|Mohs surgery|mohs surgery
4868746|NCT02230436|Pancreatectomy|pancreatectomy
4868747|NCT02230436|Time of drain removal|time of drain removal
4868748|NCT02230423|Functional nasal surgery|functional nasal surgery
4868749|NCT02230423|Empty Nose Syndrome (ENS)|empty nose syndrome (ens)
4868750|NCT02230410|Barrett's|barrett's
4868751|NCT02230410|high grade dysplasia|high grade dysplasia
4868752|NCT02230410|ablation|ablation
4868753|NCT02230410|cyrotherapy|cyrotherapy
4868754|NCT02230397|skin aging|skin aging
4868755|NCT02230397|anti-aging cream|anti-aging cream
4868756|NCT02230397|wrinkles|wrinkles
4868757|NCT02230384|Attempt at Smoking Cessation|attempt at smoking cessation
4868758|NCT02230384|Schizophrenia or Schizoaffective disorder|schizophrenia or schizoaffective disorder
4868759|NCT02230384|Novel nicotinergic drug|novel nicotinergic drug
4868760|NCT02230371|Myofascial pain|myofascial pain
4868761|NCT02230371|TMD|tmd
4868762|NCT02230371|5-HT3|5-ht3
4868763|NCT02230371|Granisetron|granisetron
4868764|NCT02230371|Placebo-controlled|placebo-controlled
4868765|NCT02230371|Patients|patients
4868766|NCT02230371|Randomized|randomized
4868767|NCT02230371|Double-blind|double-blind
4868768|NCT02230358|carotid endarterectomy|carotid endarterectomy
4868769|NCT02230358|cardiac output|cardiac output
4868770|NCT02230358|trans-cranial Doppler|trans-cranial doppler
4868771|NCT02230358|CEA|cea
4868772|NCT02230358|regional anesthesia|regional anesthesia
4868773|NCT02230358|general anesthesia|general anesthesia
4868774|NCT02230345|Probiotic|probiotic
4868775|NCT02230345|Yoghourt|yoghourt
4868776|NCT02230345|Inflammation|inflammation
4868777|NCT02230345|Metabolomics|metabolomics
4868778|NCT02230319|Cryotherapy|cryotherapy
4868779|NCT02230319|Cold therapy|cold therapy
4868780|NCT02230319|Peripheral Neuropathy|peripheral neuropathy
4868781|NCT02230319|Paclitaxel|paclitaxel
4868782|NCT02230319|Breast Cancer|breast cancer
4868783|NCT02230319|Symptom management|symptom management
4868784|NCT02230319|Prevention|prevention
4868785|NCT02230293|ambulatory care,|ambulatory care,
4868786|NCT02230293|hypertension,|hypertension,
4868787|NCT02230293|health personnel,|health personnel,
4868788|NCT02230293|clinical trial|clinical trial
4868789|NCT02230280|Mobile health technology|mobile health technology
4868790|NCT02230280|Multiple chronic conditions|multiple chronic conditions
4868791|NCT02230280|Older adults|older adults
4868792|NCT02230280|Home and community care|home and community care
4868793|NCT02230280|Effectiveness|effectiveness
4868794|NCT02230280|Cost analysis|cost analysis
4868795|NCT02230280|Interprofessional Stroke Rehabilitation|interprofessional stroke rehabilitation
4868796|NCT02230267|boot camp|boot camp
4868797|NCT02230267|exercise|exercise
4868798|NCT02230267|balance training|balance training
4868799|NCT02230267|fall prevention|fall prevention
4868800|NCT02230267|falling|falling
4868801|NCT02230267|strength training|strength training
4868802|NCT02230254|Coronary Artery Disease|coronary artery disease
4868803|NCT02230241|Dyslipidaemia|dyslipidaemia
4868804|NCT02230241|LDL-C goals|ldl-c goals
4868805|NCT02230241|Guidelines|guidelines
4868806|NCT02230215|Total Knee Replacement|total knee replacement
4868807|NCT02230215|Visionaire|visionaire
4868808|NCT02230189|Asthma|asthma
4868809|NCT02230189|Allergen challenge|allergen challenge
4868810|NCT02230163|Chikungunya virus|chikungunya virus
4868811|NCT02230163|Human anti-CHIKV hyperimmune intravenous immunoglobulins|human anti-chikv hyperimmune intravenous immunoglobulins
4868812|NCT02230163|Neonates|neonates
4868813|NCT02230150|Adhesion, Knowledge, Nursing|adhesion, knowledge, nursing
4868814|NCT02230137|adolescents|adolescents
4868815|NCT02230137|type 1 diabetes|type 1 diabetes
4868816|NCT02230137|poorly controlled|poorly controlled
4868817|NCT02230137|SMS|sms
4868818|NCT02230137|Improve glycaemic control|improve glycaemic control
4868819|NCT02230137|HbA1c reduction|hba1c reduction
4868820|NCT02230137|poorly controlled type 1 diabetic adolescents|poorly controlled type 1 diabetic adolescents
4868821|NCT02230124|Hydrocephalus|hydrocephalus
4868822|NCT02230111|Women|women
4868823|NCT02230111|Caloric restriction|caloric restriction
4868824|NCT02230111|Cognitive dietary restraint|cognitive dietary restraint
4868825|NCT02230111|Eating behaviours|eating behaviours
4868826|NCT02230111|Food habits|food habits
4868827|NCT02230111|Appetite sensations|appetite sensations
4868828|NCT02230111|Stress|stress
4868829|NCT02230111|Weight management|weight management
4868830|NCT02230098|remote ischemic conditioning|remote ischemic conditioning
4868831|NCT02230098|ischemic heart disease|ischemic heart disease
4868832|NCT02230072|myelomeningocele|myelomeningocele
4868833|NCT02230072|MMC|mmc
4868834|NCT02230072|NTD|ntd
4868835|NCT02230072|neural|neural
4868836|NCT02230072|defect|defect
4868837|NCT02230072|Spina bifida|spina bifida
4868838|NCT02230072|Neural Tube Defect|neural tube defect
4868839|NCT02230059|Prostatic Neoplasms|prostatic neoplasms
4868840|NCT02230059|observational Study|observational study
4868841|NCT02230059|Metastatic castration-resistant prostate cancer|metastatic castration-resistant prostate cancer
4868842|NCT02230046|Healthy,|healthy,
4868843|NCT02230046|Abiraterone Acetate,|abiraterone acetate,
4868844|NCT02230046|Bioequivalence.|bioequivalence.
4868845|NCT02230033|JNJ-56021927|jnj-56021927
4868846|NCT02230033|Itraconazole|itraconazole
4868848|NCT02229994|Dyspnea|dyspnea
4868849|NCT02229994|Self-administered questionnaire|self-administered questionnaire
4868850|NCT02229994|Chronic respiratory disease|chronic respiratory disease
4868851|NCT02229994|COPD|copd
4868852|NCT02229994|Diffuse interstitial lung diseases|diffuse interstitial lung diseases
4868853|NCT02229994|Pulmonary arterial hypertension|pulmonary arterial hypertension
4868854|NCT02229994|Cystic fibrosis|cystic fibrosis
4868855|NCT02229981|Lymphoma|lymphoma
4868856|NCT02229981|B-cell Lymphomas|b-cell lymphomas
4868857|NCT02229981|Diffuse Large B-cell Lymphoma|diffuse large b-cell lymphoma
4868858|NCT02229981|Lymphosarcoma|lymphosarcoma
4868859|NCT02229981|Kaposi's Sarcoma-associated Herpesvirus|kaposi's sarcoma-associated herpesvirus
4868860|NCT02229981|KHSV|khsv
4868861|NCT02229981|Human Immunodeficiency Virus|human immunodeficiency virus
4868862|NCT02229981|HIV|hiv
4868863|NCT02229981|Epstein-Barr Virus|epstein-barr virus
4868864|NCT02229981|EBV|ebv
4868865|NCT02229981|Kaposi sarcoma|kaposi sarcoma
4868866|NCT02229968|craniosynostosis|craniosynostosis
4868867|NCT02229968|craniofacial|craniofacial
4868868|NCT02229968|amicar|amicar
4868869|NCT02229968|epsilon aminocaproic acid|epsilon aminocaproic acid
4868870|NCT02229968|ε-aminocaproic acid|ε-aminocaproic acid
4868871|NCT02229955|Dry Eye Syndromes|dry eye syndromes
4868872|NCT02229942|Chronic Fatigue Syndrome (CFS)|chronic fatigue syndrome (cfs)
4868873|NCT02229942|Myalgic Encephalitis (ME)|myalgic encephalitis (me)
4868874|NCT02229942|Rituximab|rituximab
4868875|NCT02229942|B-lymphocyte depletion|b-lymphocyte depletion
4868876|NCT02229942|B-cell depletion|b-cell depletion
4868877|NCT02229929|Pruritus|pruritus
4868878|NCT02229929|uremic pruritus|uremic pruritus
4868879|NCT02229929|kappa opioid|kappa opioid
4868880|NCT02229929|CR845|cr845
4868881|NCT02229916|Testicular Neoplasms|testicular neoplasms
4868882|NCT02229916|Testicular Cancer|testicular cancer
4868883|NCT02229916|Cohort Study|cohort study
4868884|NCT02229903|OCD|ocd
4868885|NCT02229864|Absorb™ BVS|absorb™ bvs
4868886|NCT02229864|Angioplasty|angioplasty
4868887|NCT02229864|Bioabsorbable|bioabsorbable
4868888|NCT02229864|BVS|bvs
4868889|NCT02229864|Coronary Artery Disease|coronary artery disease
4868890|NCT02229864|Coronary Artery Endothelial Responsiveness|coronary artery endothelial responsiveness
4868891|NCT02229864|Coronary artery restenosis|coronary artery restenosis
4868892|NCT02229864|Coronary artery stenosis|coronary artery stenosis
4868893|NCT02229864|Coronary scaffold|coronary scaffold
4868894|NCT02229864|Coronary Stent|coronary stent
4868895|NCT02229864|Drug eluting stents|drug eluting stents
4868896|NCT02229864|Everolimus|everolimus
4868897|NCT02229864|Myocardial ischemia|myocardial ischemia
4868898|NCT02229864|Stent thrombosis|stent thrombosis
4868899|NCT02229864|Stents|stents
4868900|NCT02229708|Pregnancy|pregnancy
4868901|NCT02229708|Weight control|weight control
4868902|NCT02229708|Behavioral|behavioral
4868903|NCT02229708|technology-based intervention|technology-based intervention
4868904|NCT02229695|Trauma|trauma
4868905|NCT02229695|Sepsis|sepsis
4868906|NCT02229695|Temporary abdominal closure|temporary abdominal closure
4868907|NCT02229695|Bogota bag|bogota bag
4868908|NCT02229695|Vacuum assisted closure|vacuum assisted closure
4868909|NCT02229682|extranodal NK/T-cell lymphoma,nasal-type,|extranodal nk/t-cell lymphoma,nasal-type,
4868910|NCT02229682|radiotherapy,|radiotherapy,
4868911|NCT02229682|intensity-modulated radiation treatment,|intensity-modulated radiation treatment,
4868912|NCT02229682|asparaginase-based chemotherapy,|asparaginase-based chemotherapy,
4868913|NCT02229682|loco-regional control,|loco-regional control,
4868914|NCT02229682|survival|survival
4868915|NCT02229656|olaparib|olaparib
4868916|NCT02229656|radiotherapy|radiotherapy
4868917|NCT02229656|Laryngeal SCC|laryngeal scc
4868918|NCT02229656|oropharyngeal SCC|oropharyngeal scc
4868919|NCT02229643|Traumatic brain injury|traumatic brain injury
4868920|NCT02229643|Neuroglobin|neuroglobin
4868921|NCT02229643|Nogo-A|nogo-a
4868922|NCT02229643|Prognosis|prognosis
4868923|NCT02229630|intra-uterine growth restriction|intra-uterine growth restriction
4868924|NCT02229630|MRI|mri
4868925|NCT02229630|apparent diffusion coefficient|apparent diffusion coefficient
4868926|NCT02229617|Intramuscular testosterone|intramuscular testosterone
4868927|NCT02229617|Subcutaneous testosterone|subcutaneous testosterone
4868928|NCT02229604|electroacupuncture|electroacupuncture
4868929|NCT02229604|diminished ovarian reserve|diminished ovarian reserve
4868930|NCT02229604|cohort study|cohort study
4868931|NCT02229578|Burn pain|burn pain
4868932|NCT02229578|lidocaine|lidocaine
4868933|NCT02229578|donor site pain|donor site pain
4868934|NCT02229578|Narcotic use|narcotic use
4868935|NCT02229565|prostate cancer|prostate cancer
4868936|NCT02229565|prostate biopsy|prostate biopsy
4868937|NCT02229565|prostatectomy|prostatectomy
4868938|NCT02229526|Fish oil supplementation|fish oil supplementation
4868939|NCT02229526|RCT|rct
4868940|NCT02229526|High risk pregnancies|high risk pregnancies
4868941|NCT02229526|Twin pregnancy|twin pregnancy
4868942|NCT02229526|Preterm birth|preterm birth
4868943|NCT02229526|Intrauterine growth retardation|intrauterine growth retardation
4868944|NCT02229526|Pregnancy induced hypertension|pregnancy induced hypertension
4868945|NCT02229513|postpartum hemorrhage|postpartum hemorrhage
4868946|NCT02229513|uterine atony|uterine atony
4868947|NCT02229513|cesarean section|cesarean section
4868948|NCT02229513|cesarean hysterectomy|cesarean hysterectomy
4868949|NCT02229513|acute blood loss anemia|acute blood loss anemia
4868950|NCT02229513|uterotonics|uterotonics
4868951|NCT02229513|obstetric hemorrhage|obstetric hemorrhage
4868952|NCT02229513|severe hemorrhage|severe hemorrhage
4868953|NCT02229513|blood transfusion|blood transfusion
4868954|NCT02229513|obstetric emergencies|obstetric emergencies
4868955|NCT02229513|obstetrics|obstetrics
4868956|NCT02229513|massive hemorrhage|massive hemorrhage
4868957|NCT02229513|hemorrhage|hemorrhage
4868958|NCT02229513|uterine cooling|uterine cooling
4868959|NCT02229500|Propionate|propionate
4868960|NCT02229500|Microbiome|microbiome
4868961|NCT02229500|Dietary Fibre|dietary fibre
4868962|NCT02229500|Short chain fatty acids|short chain fatty acids
4868963|NCT02229487|Prediabetes|prediabetes
4868964|NCT02229487|Short sleepers|short sleepers
4868965|NCT02229487|GLP-1|glp-1
4868966|NCT02229474|Dementia|dementia
4868967|NCT02229474|Cognitive Stimulation Therapy|cognitive stimulation therapy
4868968|NCT02229474|Quality of life|quality of life
4868969|NCT02229474|Cognitive impairment|cognitive impairment
4868970|NCT02229474|Africa|africa
4868971|NCT02229474|Tanzania|tanzania
4868972|NCT02229474|Nigeria|nigeria
4868973|NCT02229474|Low- and Middle-income countries|low- and middle-income countries
4868974|NCT02229474|Non-pharmacological intervention|non-pharmacological intervention
4868975|NCT02229474|Task-shifting|task-shifting
4868976|NCT02229474|Cognitive screening|cognitive screening
4868977|NCT02229448|Immunoglobulin G|immunoglobulin g
4868978|NCT02229448|focus|focus
4868979|NCT02229448|study|study
4868980|NCT02229448|detect|detect
4868981|NCT02229448|patients|patients
4868982|NCT02229435|Chronic kidney disease|chronic kidney disease
4868983|NCT02229435|Urological care|urological care
4868984|NCT02229435|Nephrological care|nephrological care
4868985|NCT02229409|adults|adults
4868986|NCT02229396|Diabetes Mellitus|diabetes mellitus
4868987|NCT02229396|Exenatide|exenatide
4868988|NCT02229396|Dapagliflozin|dapagliflozin
4868989|NCT02229396|Diabetes medication|diabetes medication
4868990|NCT02229396|Treatment efficacy|treatment efficacy
4868991|NCT02229396|Placebo|placebo
4868992|NCT02229396|Metabolism|metabolism
4868993|NCT02229396|Cardiovascular metabolic|cardiovascular metabolic
4868994|NCT02229383|Diabetes Mellitus|diabetes mellitus
4868995|NCT02229383|Exenatide|exenatide
4868996|NCT02229383|Diabetes drug|diabetes drug
4868997|NCT02229383|Treatment efficacy|treatment efficacy
4868998|NCT02229383|Placebo|placebo
4868999|NCT02229383|Metabolism|metabolism
4869000|NCT02229383|Cardiovascilar metabolic|cardiovascilar metabolic
4869001|NCT02229370|extracranial|extracranial
4869002|NCT02229370|carotid|carotid
4869003|NCT02229370|artery|artery
4869004|NCT02229370|aneurysm|aneurysm
4869005|NCT02229370|registry|registry
4869006|NCT02229370|CAR|car
4869007|NCT02229357|H5N2 Vaccine|h5n2 vaccine
4869008|NCT02229344|colitis, ulcerative|colitis, ulcerative
4869009|NCT02229344|MOSAIK|mosaik
4869010|NCT02229344|REMICADE|remicade
4869011|NCT02229344|Infliximab|infliximab
4869012|NCT02229331|haemophilia|haemophilia
4869013|NCT02229331|arthropathy|arthropathy
4869014|NCT02229331|pediatrics|pediatrics
4869015|NCT02229331|ankle|ankle
4869016|NCT02229331|biomechanics|biomechanics
4869017|NCT02229305|Anxiety|anxiety
4869018|NCT02229305|Trauma|trauma
4869019|NCT02229305|Depression|depression
4869020|NCT02229305|Problem Behavior|problem behavior
4869021|NCT02229305|evidence-based treatments|evidence-based treatments
4869022|NCT02229279|Surgical Procedures, Operative|surgical procedures, operative
4869023|NCT02229266|AML|aml
4869024|NCT02229266|high-risk AML|high-risk aml
4869025|NCT02229266|acute myeloid leukemia|acute myeloid leukemia
4869026|NCT02229266|NK cells|nk cells
4869027|NCT02229266|haploidentical natural killer cells|haploidentical natural killer cells
4869028|NCT02229266|immunotherapy|immunotherapy
4869029|NCT02229240|Albiglutide|albiglutide
4869030|NCT02229240|Add-on to basal-bolus insulin therapy|add-on to basal-bolus insulin therapy
4869031|NCT02229240|Glucagon-like peptide-1 receptor agonist|glucagon-like peptide-1 receptor agonist
4869032|NCT02229240|Type 2 diabetes mellitus|type 2 diabetes mellitus
4869033|NCT02229227|switch study|switch study
4869034|NCT02229227|albiglutide|albiglutide
4869035|NCT02229227|glucagon-like peptide-1 receptor agonist|glucagon-like peptide-1 receptor agonist
4869036|NCT02229227|Type 2 diabetes mellitus|type 2 diabetes mellitus
4869037|NCT02229227|basal-bolus insulin therapy|basal-bolus insulin therapy
4869038|NCT02229214|Renal function|renal function
4869039|NCT02229214|Glomerular Filtration Rate|glomerular filtration rate
4869040|NCT02229214|Kidney function|kidney function
4869041|NCT02229214|Qsymia|qsymia
4869042|NCT02229214|Iohexol|iohexol
4869043|NCT02229214|Serum Creatinine|serum creatinine
4869044|NCT02229214|Creatinine clearance|creatinine clearance
4869045|NCT02229214|Renal Clearance|renal clearance
4869046|NCT02229214|VI-0521|vi-0521
4869047|NCT02229214|Healthy volunteers|healthy volunteers
4869048|NCT02229201|propofol|propofol
4869049|NCT02229201|sevoflurane|sevoflurane
4869050|NCT02229201|Interleukin 6|interleukin 6
4869051|NCT02229201|Interleukin 10|interleukin 10
4869052|NCT02229188|Depression; mood; cognitive training|depression; mood; cognitive training
4869053|NCT02229175|Diabetic Macular Edema|diabetic macular edema
4869054|NCT02229175|Diabetic Retinopathy|diabetic retinopathy
4869055|NCT02229175|Type 1 Diabetes|type 1 diabetes
4869056|NCT02229175|Type 2 Diabetes|type 2 diabetes
4869057|NCT02229175|Macular Edema|macular edema
4869058|NCT02229175|bevacizumab|bevacizumab
4869059|NCT02229175|intravitreal injection|intravitreal injection
4869060|NCT02229175|Avastin|avastin
4869061|NCT02229175|PASCAL Endpoint Management (EpM) system|pascal endpoint management (epm) system
4869062|NCT02229175|Subthreshold focal laser treatments|subthreshold focal laser treatments
4869063|NCT02229162|umbilical cord|umbilical cord
4869064|NCT02229162|cesarean section|cesarean section
4869065|NCT02229162|Blood Loss, Surgical|blood loss, surgical
4869066|NCT02229149|breast cancer|breast cancer
4869067|NCT02229149|metastatic breast cancer|metastatic breast cancer
4869068|NCT02229149|HER2+ breast cancer|her2+ breast cancer
4869069|NCT02229136|Mouth sores from chemotherapy|mouth sores from chemotherapy
4869070|NCT02229136|mouth sores|mouth sores
4869071|NCT02229136|hormone receptor-positive metastatic breast cancer|hormone receptor-positive metastatic breast cancer
4869072|NCT02229136|metastatic breast cancer|metastatic breast cancer
4869073|NCT02229123|seizures|seizures
4869074|NCT02229123|neonates|neonates
4869075|NCT02229123|anticonvulsant treatment|anticonvulsant treatment
4869076|NCT02229123|levetiracetam|levetiracetam
4869077|NCT02229123|hypoxic-ischemic encephalopathy|hypoxic-ischemic encephalopathy
4869078|NCT02229123|electroencephalography|electroencephalography
4869079|NCT02229110|type 2 diabetes mellitus|type 2 diabetes mellitus
4869080|NCT02229110|e-Health|e-health
4869081|NCT02229110|allocation of care|allocation of care
4869082|NCT02229110|clinical inertia|clinical inertia
4869083|NCT02229110|quality of care|quality of care
4869084|NCT02229110|patient satisfaction|patient satisfaction
4869085|NCT02229097|type 1 diabetes|type 1 diabetes
4869086|NCT02229071|Donafenib|donafenib
4869087|NCT02229071|HCC|hcc
4869088|NCT02229071|Advanced|advanced
4869089|NCT02229071|inoperable|inoperable
4869090|NCT02229071|Phase 1B|phase 1b
4869091|NCT02229058|Gastric Cancer|gastric cancer
4869092|NCT02229058|Albumin Bound Paclitaxel|albumin bound paclitaxel
4869093|NCT02229058|S-1|s-1
4869094|NCT02229058|First Line|first line
4869095|NCT02229045|gastric caner|gastric caner
4869096|NCT02229045|Albumin Bound Paclitaxel|albumin bound paclitaxel
4869097|NCT02229045|5-FU/CF|5-fu/cf
4869098|NCT02229045|taxanes naive|taxanes naive
4869099|NCT02229032|Dravet Syndrome|dravet syndrome
4869100|NCT02229032|cannabidiol therapy|cannabidiol therapy
4869101|NCT02229032|Charlotte's Web|charlotte's web
4869102|NCT02229019|Volunteers|volunteers
4869103|NCT02229019|Mealtime assistance|mealtime assistance
4869104|NCT02229019|Older adults|older adults
4869105|NCT02229019|Nutrition|nutrition
4869106|NCT02229019|Nursing|nursing
4869107|NCT02229006|Aortic aneurysm, abdominal|aortic aneurysm, abdominal
4869108|NCT02229006|Sodium Fluoride|sodium fluoride
4869109|NCT02229006|Positron Emission Tomography|positron emission tomography
4869110|NCT02228980|Influenza|influenza
4869111|NCT02228980|Trivalent influenza vaccine|trivalent influenza vaccine
4869112|NCT02228980|Sanofi Pasteur Shenzhen trivalent influenza vaccine|sanofi pasteur shenzhen trivalent influenza vaccine
4869113|NCT02228967|Alcohol Use|alcohol use
4869114|NCT02228967|SBIRT|sbirt
4869115|NCT02228967|Military|military
4869116|NCT02228967|Health Behavior|health behavior
4869117|NCT02228967|Emergency Room|emergency room
4869118|NCT02228967|Health Promotion|health promotion
4869119|NCT02228967|Formative Research|formative research
4869120|NCT02228967|Randomized Trial|randomized trial
4869121|NCT02228954|Clear-cell metastatic renal cell carcinoma|clear-cell metastatic renal cell carcinoma
4869122|NCT02228954|Positron-Emission Tomography|positron-emission tomography
4869123|NCT02228928|Peripheral Nerve Injury|peripheral nerve injury
4869124|NCT02228928|Postherpetic Neuralgia|postherpetic neuralgia
4869125|NCT02228889|Hernia|hernia
4869126|NCT02228889|Abdominal wall reconstruction|abdominal wall reconstruction
4869127|NCT02228889|Abdominal wall defect|abdominal wall defect
4869128|NCT02228889|Porcine mesh|porcine mesh
4869129|NCT02228889|Component separation|component separation
4869130|NCT02228889|Abdominal wall tumor|abdominal wall tumor
4869131|NCT02228889|Desmoid|desmoid
4869132|NCT02228863|Stroke|stroke
4869133|NCT02228863|Spasticity|spasticity
4869134|NCT02228850|Secondary Raynaud's Phenomenon|secondary raynaud's phenomenon
4869135|NCT02228850|Secondary Raynaud's Disease|secondary raynaud's disease
4869136|NCT02228850|Scleroderma|scleroderma
4869137|NCT02228850|Raynaud's Disease secondary to systemic sclerosis|raynaud's disease secondary to systemic sclerosis
4869138|NCT02228850|CREST|crest
4869139|NCT02228850|Apricus Biosciences|apricus biosciences
4869140|NCT02228850|laser doppler|laser doppler
4869141|NCT02228850|thermography|thermography
4869142|NCT02228824|Smoking|smoking
4869143|NCT02228824|Non-daily smokers|non-daily smokers
4869144|NCT02228824|Ecological Momentary Assessment|ecological momentary assessment
4869145|NCT02228824|Biomarkers|biomarkers
4869146|NCT02228798|anticoagulant|anticoagulant
4869147|NCT02228798|atrial fibrillation|atrial fibrillation
4869148|NCT02228798|surgery|surgery
4869149|NCT02228798|oral anticoagulant|oral anticoagulant
4869150|NCT02228798|discontinue|discontinue
4869151|NCT02228798|DOAC|doac
4869152|NCT02228798|NOAC|noac
4869153|NCT02228798|blood thinner|blood thinner
4869154|NCT02228798|interruption|interruption
4869155|NCT02228772|Acute lymphoblastic Leukemia|acute lymphoblastic leukemia
4869156|NCT02228772|Lymphoblastic lymphoma|lymphoblastic lymphoma
4869157|NCT02228772|B-cell Adult Acute Lymphoblastic Leukemia|b-cell adult acute lymphoblastic leukemia
4869158|NCT02228772|T-cell Adult Acute Lymphoblastic Leukemia|t-cell adult acute lymphoblastic leukemia
4869159|NCT02228759|Ambulatory home regional|ambulatory home regional
4869160|NCT02228759|adductor canal block|adductor canal block
4869161|NCT02228759|Postoperative pain|postoperative pain
4869162|NCT02228759|total knee arthroplasty|total knee arthroplasty
4869163|NCT02228759|Home regional|home regional
4869164|NCT02228759|Fast track arthroplasty|fast track arthroplasty
4869165|NCT02228720|Chronic Sinusitis|chronic sinusitis
4869166|NCT02228720|Endoscopic Sinus Surgery|endoscopic sinus surgery
4869167|NCT02228694|ADC|adc
4869168|NCT02228694|Pre installation|pre installation
4869169|NCT02228694|Post installation|post installation
4869170|NCT02228694|Safety|safety
4869171|NCT02228694|Time|time
4869172|NCT02228668|AVANT|avant
4869173|NCT02228668|GERCOR|gercor
4869174|NCT02228668|Follow up|follow up
4869175|NCT02228668|Colon cancer|colon cancer
4869176|NCT02228668|Bevacizumab|bevacizumab
4869177|NCT02228668|Overall survival|overall survival
4869178|NCT02228655|Chronic Kidney Disease|chronic kidney disease
4869179|NCT02228655|CKD|ckd
4869180|NCT02228655|Anemia of Chronic Illness|anemia of chronic illness
4869181|NCT02228642|Type 1 diabetes|type 1 diabetes
4869182|NCT02228642|Type 2 diabetes|type 2 diabetes
4869183|NCT02228642|Hypoglycemia|hypoglycemia
4869184|NCT02228642|Cognition disorders|cognition disorders
4869185|NCT02228642|Inpatient|inpatient
4869186|NCT02228629|Diabetes|diabetes
4869187|NCT02228629|Foot complications|foot complications
4869188|NCT02228629|plantar keratoma|plantar keratoma
4869189|NCT02228629|plantar pressure|plantar pressure
4869190|NCT02228616|Constipation|constipation
4869191|NCT02228616|Chronic constipation|chronic constipation
4869192|NCT02228616|Prucalopride|prucalopride
4869193|NCT02228616|Women|women
4869194|NCT02228603|exercise therapy|exercise therapy
4869195|NCT02228603|rehabilitation|rehabilitation
4869196|NCT02228590|Parkinson's Disease|parkinson's disease
4869197|NCT02228564|Lack of perfusion in the extremities|lack of perfusion in the extremities
4869198|NCT02228564|Atherosclerosis|atherosclerosis
4869199|NCT02228564|Intermittent claudication|intermittent claudication
4869200|NCT02228564|BOLSTER|bolster
4869201|NCT02228551|Augmented renal clearance|augmented renal clearance
4869202|NCT02228551|non-critically ill|non-critically ill
4869203|NCT02228551|surgery|surgery
4869204|NCT02228551|prevalence|prevalence
4869205|NCT02228551|risk factors|risk factors
4869206|NCT02228538|total knee arthroplasty|total knee arthroplasty
4869207|NCT02228538|osteoarthritis|osteoarthritis
4869208|NCT02228525|Selinexor (KPT-330)|selinexor (kpt-330)
4869209|NCT02228525|Selective Inhibitor of Nuclear Export (SINE)|selective inhibitor of nuclear export (sine)
4869210|NCT02228525|14-005|14-005
4869211|NCT02228512|HHV8|hhv8
4869212|NCT02228512|PEL|pel
4869213|NCT02228512|Immune Modulation|immune modulation
4869214|NCT02228512|CC-4047|cc-4047
4869215|NCT02228512|IMiD|imid
4869216|NCT02228499|asthma|asthma
4869217|NCT02228499|academics|academics
4869218|NCT02228499|GPA|gpa
4869219|NCT02228499|attendance|attendance
4869220|NCT02228447|Adolescent|adolescent
4869221|NCT02228447|Randomized controlled trial|randomized controlled trial
4869222|NCT02228447|Eating behavior|eating behavior
4869223|NCT02228447|Physical Activity|physical activity
4869224|NCT02228447|Sedentary lifestyle|sedentary lifestyle
4869225|NCT02228434|Childhood obesity, intervention, effectiveness, comparison|childhood obesity, intervention, effectiveness, comparison
4869226|NCT02228408|hemodialysis|hemodialysis
4869227|NCT02228408|ESRD|esrd
4869228|NCT02228408|Cardiovascular Disease|cardiovascular disease
4869229|NCT02228408|Isosorbide Dinitrate|isosorbide dinitrate
4869230|NCT02228408|Hydralazine|hydralazine
4869231|NCT02228395|Single ascending doses|single ascending doses
4869232|NCT02228395|pharmacokinetics|pharmacokinetics
4869233|NCT02228395|safety|safety
4869234|NCT02228395|tolerability|tolerability
4869235|NCT02228395|healthy volunteers|healthy volunteers
4869236|NCT02228395|cognitive impairment associated with schizophrenia (CIAS)|cognitive impairment associated with schizophrenia (cias)
4869237|NCT02228382|Bosutinib|bosutinib
4869238|NCT02228382|Chronic Myeloid Leukemia|chronic myeloid leukemia
4869239|NCT02228382|CML|cml
4869240|NCT02228382|Leukemia|leukemia
4869241|NCT02228382|Myelogenous|myelogenous
4869242|NCT02228382|Chronic|chronic
4869243|NCT02228382|BC-ABL Positive|bc-abl positive
4869244|NCT02228369|Non Small Cell Lung Cancer, EGFR, Tyrosine kinase inhibitor,EGFR mutation positive, Brain Metastasis, Leptomeningeal Metastasis|non small cell lung cancer, egfr, tyrosine kinase inhibitor,egfr mutation positive, brain metastasis, leptomeningeal metastasis
4869346|NCT02227992|Hemostatics|hemostatics
4869245|NCT02228356|Neoplasm Metastasis|neoplasm metastasis
4869246|NCT02228356|oligometastatic cancer|oligometastatic cancer
4869247|NCT02228356|Stereotactic Body Radiation Therapy|stereotactic body radiation therapy
4869248|NCT02228356|SBRT|sbrt
4869249|NCT02228356|Real-time Tumor Tracking (RTTT)|real-time tumor tracking (rttt)
4869250|NCT02228356|ITV|itv
4869251|NCT02228356|Internal Target Volume|internal target volume
4869252|NCT02228356|Respiratory Motion Management|respiratory motion management
4869253|NCT02228356|Image-guided Radiotherapy|image-guided radiotherapy
4869254|NCT02228356|IGRT|igrt
4869255|NCT02228330|Transurethral resection of bladder tumors|transurethral resection of bladder tumors
4869256|NCT02228330|Obturator nerve reflex|obturator nerve reflex
4869257|NCT02228330|Obturator nerve block|obturator nerve block
4869258|NCT02228317|Emergency Medical Dispatch|emergency medical dispatch
4869259|NCT02228317|Telemedicine|telemedicine
4869260|NCT02228317|Emergency Medical Services|emergency medical services
4869261|NCT02228317|Pre-hospital|pre-hospital
4869262|NCT02228304|Wet AMD|wet amd
4869263|NCT02228304|Wet Age Related Macular Degeneration|wet age related macular degeneration
4869264|NCT02228304|Recurrent CNV Secondary to AMD|recurrent cnv secondary to amd
4869265|NCT02228304|Active subfoveal CNV|active subfoveal cnv
4869266|NCT02228291|Polyphenols|polyphenols
4869267|NCT02228291|Endothelial function|endothelial function
4869268|NCT02228291|Gut barrier function|gut barrier function
4869269|NCT02228278|Pediatric|pediatric
4869270|NCT02228278|Obesity|obesity
4869271|NCT02228278|Overweight|overweight
4869272|NCT02228278|Texting|texting
4869273|NCT02228278|Text message|text message
4869274|NCT02228278|SMS|sms
4869275|NCT02228278|Diet|diet
4869276|NCT02228278|Weight Loss|weight loss
4869277|NCT02228278|Nutrition|nutrition
4869278|NCT02228278|Physical activity|physical activity
4869279|NCT02228278|BMI z-score|bmi z-score
4869280|NCT02228278|BMI|bmi
4869281|NCT02228252|Proteins|proteins
4869282|NCT02228252|Postprandial lipemia|postprandial lipemia
4869283|NCT02228252|Pre-meal|pre-meal
4869284|NCT02228252|Metabolic syndrome|metabolic syndrome
4869285|NCT02228239|Healthy|healthy
4869286|NCT02228239|Esketamine|esketamine
4869287|NCT02228239|Mirtazapine|mirtazapine
4869288|NCT02228239|Psychomotor.|psychomotor.
4869289|NCT02228226|Arthroscopic Bankart repair|arthroscopic bankart repair
4869290|NCT02228226|Bone hole|bone hole
4869291|NCT02228226|Ossification|ossification
4869292|NCT02228226|Suture anchor|suture anchor
4869293|NCT02228226|Shoulder dislocation|shoulder dislocation
4869294|NCT02228213|multiple sclerosis|multiple sclerosis
4869295|NCT02228213|SPMS|spms
4869296|NCT02228200|Oncology Nursing|oncology nursing
4869297|NCT02228200|Advanced Practice Nursing|advanced practice nursing
4869298|NCT02228200|Nurse-led care|nurse-led care
4869299|NCT02228200|Chemotherapy|chemotherapy
4869300|NCT02228174|Abnormal Uterine Bleeding associated with fibroids|abnormal uterine bleeding associated with fibroids
4869301|NCT02228174|AUB-L|aub-l
4869302|NCT02228174|Fibroids|fibroids
4869303|NCT02228174|Heavy menstrual bleeding|heavy menstrual bleeding
4869304|NCT02228174|HMB|hmb
4869305|NCT02228174|Myoma|myoma
4869306|NCT02228174|Menorrhagia|menorrhagia
4869307|NCT02228161|Yoga|yoga
4869308|NCT02228161|Work-related Stress,|work-related stress,
4869309|NCT02228161|Stress Adaptation.|stress adaptation.
4869310|NCT02228148|Post linguistically deafness, severe to profound deafness|post linguistically deafness, severe to profound deafness
4869311|NCT02228122|Chronic wounds|chronic wounds
4869312|NCT02228122|Biofilms|biofilms
4869313|NCT02228122|Bacteria|bacteria
4869314|NCT02228096|relapsed/refractory|relapsed/refractory
4869315|NCT02228096|Philadelphia chromosome positive acute lymphoblastic leukemia|philadelphia chromosome positive acute lymphoblastic leukemia
4869316|NCT02228096|Pharmaceuticals|pharmaceuticals
4869317|NCT02228096|Philadelphia chromosome positive|philadelphia chromosome positive
4869318|NCT02228096|Acute Lymphoid Leukemia (ALL)|acute lymphoid leukemia (all)
4869319|NCT02228096|Acute Lymphocytic Leukemia (ALL)|acute lymphocytic leukemia (all)
4869320|NCT02228083|dental|dental
4869321|NCT02228083|epinephrine|epinephrine
4869322|NCT02228083|local anesthetic|local anesthetic
4869323|NCT02228083|lidocaine|lidocaine
4869324|NCT02228083|cardiac arrhythmias|cardiac arrhythmias
4869325|NCT02228083|procedure|procedure
4869326|NCT02228070|strabismus|strabismus
4869327|NCT02228070|oculomotor palsy|oculomotor palsy
4869328|NCT02228070|abducens palsy|abducens palsy
4869329|NCT02228070|trochlear palsy|trochlear palsy
4869330|NCT02228057|arterial patency|arterial patency
4869331|NCT02228057|upper extremity|upper extremity
4869332|NCT02228057|anastomosis|anastomosis
4869333|NCT02228057|sensibility|sensibility
4869334|NCT02228057|pain|pain
4869335|NCT02228057|cold intolerance|cold intolerance
4869336|NCT02228044|suicide|suicide
4869337|NCT02228044|alcohol|alcohol
4869338|NCT02228044|marijuana|marijuana
4869339|NCT02228044|HIV|hiv
4869340|NCT02228044|prevention|prevention
4869341|NCT02228044|adolescent|adolescent
4869342|NCT02228031|Mirror neurons|mirror neurons
4869343|NCT02228031|Imitation|imitation
4869344|NCT02228031|Oxytocin|oxytocin
4869345|NCT02227992|Fibrin Sealant|fibrin sealant
4869347|NCT02227992|Coagulants|coagulants
4869348|NCT02227966|Mild Cognitive Impairment|mild cognitive impairment
4869349|NCT02227966|MCI|mci
4869350|NCT02227966|tDCS|tdcs
4869351|NCT02227966|transcranial Direct Current Stimulation|transcranial direct current stimulation
4869352|NCT02227953|Alzheimer's Disease|alzheimer's disease
4869353|NCT02227953|AD|ad
4869354|NCT02227953|tDCS|tdcs
4869355|NCT02227953|transcranial direct current stimulation|transcranial direct current stimulation
4869356|NCT02227927|Gastroesophageal Reflux Disease|gastroesophageal reflux disease
4869357|NCT02227927|GERD|gerd
4869358|NCT02227927|Gastroparesis|gastroparesis
4869359|NCT02227927|Domperidone|domperidone
4869360|NCT02227888|CF|cf
4869361|NCT02227888|F508Del|f508del
4869362|NCT02227888|Cavosonstat|cavosonstat
4869363|NCT02227888|N91115|n91115
4869364|NCT02227849|insulin resistance|insulin resistance
4869365|NCT02227836|Allergy Patch testing|allergy patch testing
4869366|NCT02227836|Eosinophilic Esophagitis|eosinophilic esophagitis
4869367|NCT02227836|EoE|eoe
4869368|NCT02227823|spinal muscular atrophy type 3|spinal muscular atrophy type 3
4869369|NCT02227823|electromyography|electromyography
4869370|NCT02227823|fatigability|fatigability
4869371|NCT02227823|decrement|decrement
4869372|NCT02227810|Prolong mechanical ventilator,|prolong mechanical ventilator,
4869373|NCT02227810|Electrical stimulation,|electrical stimulation,
4869374|NCT02227810|Activities of daily life,|activities of daily life,
4869375|NCT02227810|Hospitalization outcomes.|hospitalization outcomes.
4869376|NCT02227797|stem cell transplant|stem cell transplant
4869377|NCT02227797|hematopoietic stem cell transplant|hematopoietic stem cell transplant
4869378|NCT02227797|fungal infection|fungal infection
4869379|NCT02227797|voriconazole|voriconazole
4869380|NCT02227797|pediatric|pediatric
4869381|NCT02227719|after augmentation|after augmentation
4869382|NCT02227719|procedure|procedure
4869383|NCT02227706|Fibrin Sealant|fibrin sealant
4869384|NCT02227706|Hemostatics|hemostatics
4869385|NCT02227706|Coagulants|coagulants
4869386|NCT02227693|Thrombocytopenia|thrombocytopenia
4869387|NCT02227693|Chronic Liver Disease|chronic liver disease
4869388|NCT02227680|music therapy|music therapy
4869389|NCT02227680|massage therapy|massage therapy
4869390|NCT02227667|MEDI4736|medi4736
4869391|NCT02227667|14-109|14-109
4869392|NCT02227654|Ovary|ovary
4869393|NCT02227654|Cancer|cancer
4869394|NCT02227654|Morphology|morphology
4869395|NCT02227654|Surgery|surgery
4869396|NCT02227641|CMV|cmv
4869397|NCT02227641|Cytomegalovirus|cytomegalovirus
4869398|NCT02227641|EBV|ebv
4869399|NCT02227641|Epstein Barr Virus|epstein barr virus
4869400|NCT02227641|virus|virus
4869401|NCT02227641|T cell|t cell
4869402|NCT02227641|adoptive transfer|adoptive transfer
4869403|NCT02227641|transplantation|transplantation
4869404|NCT02227641|allogeneic|allogeneic
4869405|NCT02227589|adolescent,|adolescent,
4869406|NCT02227589|alcohol abuse|alcohol abuse
4869407|NCT02227589|depression,|depression,
4869408|NCT02227589|cognitive behavior therapy|cognitive behavior therapy
4869409|NCT02227589|cannabis abuse|cannabis abuse
4869410|NCT02227576|glioblastoma, thrombocytopenia, temozolomide, chemotherapy|glioblastoma, thrombocytopenia, temozolomide, chemotherapy
4869411|NCT02227563|dorsolateral prefrontal cortex|dorsolateral prefrontal cortex
4869412|NCT02227563|left superior temporal gyrus|left superior temporal gyrus
4869413|NCT02227563|auditory hallucinations|auditory hallucinations
4869414|NCT02227563|transcranial direct current stimulation (tDCS)|transcranial direct current stimulation (tdcs)
4869415|NCT02227550|Atrilal fibrillation|atrilal fibrillation
4869416|NCT02227550|anticoagulation|anticoagulation
4869417|NCT02227550|prevention of peri-procedural complication|prevention of peri-procedural complication
4869418|NCT02227550|catheter ablation|catheter ablation
4869419|NCT02227537|Adolescence Idiopathic Scoliosis|adolescence idiopathic scoliosis
4869420|NCT02227537|nighttime Bracing|nighttime bracing
4869421|NCT02227537|Providence|providence
4869422|NCT02227524|Multiple Sclerosis|multiple sclerosis
4869423|NCT02227524|Walking|walking
4869424|NCT02227524|Gait|gait
4869425|NCT02227511|fruit, nuts, liver fat, insulin, glucose|fruit, nuts, liver fat, insulin, glucose
4869426|NCT02227511|Focus of the study is to compare the often given advice to eat fruit, containing large amount of glucose and fructose, with nuts that are more rich in fat.|focus of the study is to compare the often given advice to eat fruit, containing large amount of glucose and fructose, with nuts that are more rich in fat.
4869427|NCT02227485|Gingivitis|gingivitis
4869428|NCT02227485|Diabetes mellitus|diabetes mellitus
4869429|NCT02227485|Medicine, Traditional|medicine, traditional
4869430|NCT02227485|Herbal medicine|herbal medicine
4869431|NCT02227485|Punica granatum|punica granatum
4869432|NCT02227446|Surgical site infection risk prevention|surgical site infection risk prevention
4869433|NCT02227446|Bacterial species type and antibacterial sensitives|bacterial species type and antibacterial sensitives
4869434|NCT02227433|Hodgkin Lymphoma, Elderly Patients, brentuximab vedotin (BV)|hodgkin lymphoma, elderly patients, brentuximab vedotin (bv)
4869435|NCT02227407|SCI|sci
4869436|NCT02227407|SMA|sma
4869437|NCT02227407|Paralysis|paralysis
4869438|NCT02227394|Asthma|asthma
4869439|NCT02227394|Functional Respiratory Imaging|functional respiratory imaging
4869440|NCT02227394|Computational Fluid Dynamic|computational fluid dynamic
4869536|NCT02227004|MRI|mri
4869441|NCT02227368|Myocardial Infarction|myocardial infarction
4869442|NCT02227368|Peripheral Arterial disease|peripheral arterial disease
4869443|NCT02227368|Mycardial Ischemia|mycardial ischemia
4869444|NCT02227368|Heart Diseases|heart diseases
4869445|NCT02227368|Cardiovascular Diseases|cardiovascular diseases
4869446|NCT02227368|Vascular Diseases|vascular diseases
4869447|NCT02227368|Altherosclerosis|altherosclerosis
4869448|NCT02227368|Arteriosclerosis|arteriosclerosis
4869449|NCT02227368|Arterial Occlusive Diseases|arterial occlusive diseases
4869450|NCT02227368|Peripheral Vascular Diseases|peripheral vascular diseases
4869451|NCT02227368|Ticagrelor|ticagrelor
4869452|NCT02227368|Ticlopidine|ticlopidine
4869453|NCT02227368|Platelet Aggregation inhibitors|platelet aggregation inhibitors
4869454|NCT02227368|Hematologic Agents|hematologic agents
4869455|NCT02227368|Therapeutic Uses|therapeutic uses
4869456|NCT02227368|Pharmacologic Actions|pharmacologic actions
4869457|NCT02227368|Purinegic P2Y Receptor Antagonists|purinegic p2y receptor antagonists
4869458|NCT02227368|Purinegic P2 Receptor Antagonists|purinegic p2 receptor antagonists
4869459|NCT02227368|Purinergic Antagonists|purinergic antagonists
4869460|NCT02227368|Purinergic Agents|purinergic agents
4869461|NCT02227368|Neurotransmitter Agents|neurotransmitter agents
4869462|NCT02227368|Molecular Mechanisms of Pharmacological Actions|molecular mechanisms of pharmacological actions
4869463|NCT02227368|Physiological Effects of Drugs|physiological effects of drugs
4869464|NCT02227368|Fibrinolytic Agents|fibrinolytic agents
4869465|NCT02227368|Crardiovascular Agents|crardiovascular agents
4869466|NCT02227355|Parkinson's Disease|parkinson's disease
4869467|NCT02227355|Neupro®|neupro®
4869468|NCT02227355|Rotigotine|rotigotine
4869469|NCT02227355|Transdermal patch|transdermal patch
4869470|NCT02227355|NEUPART|neupart
4869471|NCT02227355|Levodopa|levodopa
4869472|NCT02227355|Noninterventional|noninterventional
4869473|NCT02227355|Combination therapy|combination therapy
4869474|NCT02227329|Home Parenteral Nutrition|home parenteral nutrition
4869475|NCT02227329|Infection Prevention|infection prevention
4869476|NCT02227329|CRBSI|crbsi
4869477|NCT02227329|Ethanol Lock Therapy|ethanol lock therapy
4869478|NCT02227316|Uterine Fibroid Embolization|uterine fibroid embolization
4869479|NCT02227316|Pain|pain
4869480|NCT02227316|UFE|ufe
4869481|NCT02227316|Fibroids|fibroids
4869482|NCT02227316|Adenomyosis|adenomyosis
4869483|NCT02227316|Bleeding|bleeding
4869484|NCT02227316|IV Acetaminophen|iv acetaminophen
4869485|NCT02227316|IV Ibuprofen|iv ibuprofen
4869486|NCT02227316|Menorrhagia|menorrhagia
4869487|NCT02227316|Leiomyoma|leiomyoma
4869488|NCT02227316|Patient Satisfaction|patient satisfaction
4869489|NCT02227290|Tinea Corporis|tinea corporis
4869490|NCT02227290|Ringworm|ringworm
4869491|NCT02227277|HIV|hiv
4869492|NCT02227277|HIV-1|hiv-1
4869493|NCT02227277|Pegintron|pegintron
4869494|NCT02227277|Peg-IFN-α2b|peg-ifn-α2b
4869495|NCT02227277|Viral suppression|viral suppression
4869496|NCT02227277|ART cessation|art cessation
4869497|NCT02227277|Immune function|immune function
4869498|NCT02227277|Innate immunity|innate immunity
4869499|NCT02227277|Toxicity|toxicity
4869500|NCT02227277|Immune-based therapy|immune-based therapy
4869501|NCT02227277|Treatment interruption|treatment interruption
4869502|NCT02227277|HIV Cure|hiv cure
4869503|NCT02227277|HIV Eradication|hiv eradication
4869504|NCT02227277|BEAT-HIV|beat-hiv
4869505|NCT02227277|HIV Cure Trial|hiv cure trial
4869506|NCT02227277|Cure Trial|cure trial
4869507|NCT02227264|Primary hyperparathyroidism|primary hyperparathyroidism
4869508|NCT02227264|Calcimimetic Agents|calcimimetic agents
4869509|NCT02227264|Parathyroid adenomectomy|parathyroid adenomectomy
4869510|NCT02227251|Diffuse large B-cell Lymphoma|diffuse large b-cell lymphoma
4869511|NCT02227251|DLBCL|dlbcl
4869512|NCT02227251|Karyopharm|karyopharm
4869513|NCT02227251|KPT-330|kpt-330
4869514|NCT02227251|selinexor|selinexor
4869515|NCT02227238|integrase inhibitor|integrase inhibitor
4869516|NCT02227238|non-inferiority|non-inferiority
4869517|NCT02227238|dolutegravir|dolutegravir
4869518|NCT02227238|lopinavir/ritonavir|lopinavir/ritonavir
4869519|NCT02227238|second-line treatment|second-line treatment
4869520|NCT02227238|HIV-1|hiv-1
4869521|NCT02227238|antiretroviral therapy-experienced|antiretroviral therapy-experienced
4869522|NCT02227225|Postoperative Delirium|postoperative delirium
4869523|NCT02227186|Influenza vaccination rates|influenza vaccination rates
4869524|NCT02227147|Neurotrophic Keratitis|neurotrophic keratitis
4869525|NCT02227108|pediatric cancer,pediatric acute lymphoblastic leukemia, lymphoblastic lymphoma, B-cell leukemia, ALL, moxetumomab pasudotox, CD22|pediatric cancer,pediatric acute lymphoblastic leukemia, lymphoblastic lymphoma, b-cell leukemia, all, moxetumomab pasudotox, cd22
4869526|NCT02227082|radiotherapy|radiotherapy
4869527|NCT02227082|olaparib|olaparib
4869528|NCT02227082|breast cancer|breast cancer
4869529|NCT02227082|locally advanced breast cancer|locally advanced breast cancer
4869530|NCT02227056|Acquired pediatric brain injury|acquired pediatric brain injury
4869531|NCT02227056|Methylphenidate|methylphenidate
4869532|NCT02227056|Traumatic brain injury|traumatic brain injury
4869533|NCT02227056|Cerebrovascular event|cerebrovascular event
4869534|NCT02227056|Hypoxic ischemic brain injury|hypoxic ischemic brain injury
4869535|NCT02227056|Function (ecologic)|function (ecologic)
4869537|NCT02227004|Magnetic Resonance Imaging|magnetic resonance imaging
4869538|NCT02227004|pacemakers|pacemakers
4869539|NCT02227004|ICD|icd
4869540|NCT02226965|PNT2258|pnt2258
4869541|NCT02226965|DLBCL|dlbcl
4869542|NCT02226965|Diffuse Large B-cell Lymphoma|diffuse large b-cell lymphoma
4869543|NCT02226965|NHL|nhl
4869544|NCT02226965|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
4869545|NCT02226965|Lymphoma|lymphoma
4869546|NCT02226913|Buffered|buffered
4869547|NCT02226913|inferior alveolar nerve block|inferior alveolar nerve block
4869548|NCT02226913|irreversible pulpitis|irreversible pulpitis
4869549|NCT02226913|local anesthesia|local anesthesia
4869550|NCT02226913|sodium bicarbonate|sodium bicarbonate
4869551|NCT02226900|Multivessel Coronary Artery Disease|multivessel coronary artery disease
4869552|NCT02226900|Hybrid Revascularization|hybrid revascularization
4869553|NCT02226887|Loop ileostomy|loop ileostomy
4869554|NCT02226887|Eventration|eventration
4869555|NCT02226874|Dose Estimation|dose estimation
4869556|NCT02226874|Dose Reconstruction|dose reconstruction
4869557|NCT02226874|Methods|methods
4869558|NCT02226874|Fallout|fallout
4869559|NCT02226874|Radiation Exposure|radiation exposure
4869560|NCT02226861|Acute Lymphoblastic Leukemia (ALL)|acute lymphoblastic leukemia (all)
4869561|NCT02226861|MDS|mds
4869562|NCT02226861|Chronic Myelogenous Leukemia (CML)|chronic myelogenous leukemia (cml)
4869691|NCT02226237|urinary incontinence|urinary incontinence
4869563|NCT02226861|Chronic Lymphocytic Leukemia (CLL)|chronic lymphocytic leukemia (cll)
4869564|NCT02226861|Acute Myelogenous Leukemia (AML)|acute myelogenous leukemia (aml)
4869565|NCT02226848|Endothelial Progenitor Cells|endothelial progenitor cells
4869566|NCT02226848|Angiogenesis|angiogenesis
4869567|NCT02226848|Traumatic Brain Injury|traumatic brain injury
4869568|NCT02226835|OCT|oct
4869569|NCT02226835|Alzheimer's Disease|alzheimer's disease
4869570|NCT02226835|Age-Related Macular Degeneration (AMD)|age-related macular degeneration (amd)
4869571|NCT02226822|Type 2 diabetes mellitus|type 2 diabetes mellitus
4869572|NCT02226809|Muscle relaxants|muscle relaxants
4869573|NCT02226809|Postoperative complications, respiratory|postoperative complications, respiratory
4869574|NCT02226809|General anesthesia|general anesthesia
4869575|NCT02226809|Postanesthesia care unit|postanesthesia care unit
4869576|NCT02226809|Neuromuscular block reversal|neuromuscular block reversal
4869577|NCT02226796|Broca's Aphasia|broca's aphasia
4869578|NCT02226796|Transcranial Direct Current Stimulation|transcranial direct current stimulation
4869579|NCT02226783|Phase I|phase i
4869580|NCT02226783|Healthy subjects|healthy subjects
4869581|NCT02226783|PK|pk
4869582|NCT02226783|PD|pd
4869583|NCT02226757|NSCLC|nsclc
4869584|NCT02226757|HER2-expression|her2-expression
4869585|NCT02226757|EGFR-mutation|egfr-mutation
4869586|NCT02226757|Trastuzumab|trastuzumab
4869587|NCT02226757|Paclitaxel|paclitaxel
4869588|NCT02226744|breathing|breathing
4869589|NCT02226744|mind-body practices|mind-body practices
4869590|NCT02226744|yoga|yoga
4869591|NCT02226744|meditation|meditation
4869592|NCT02226731|Immediate postpartum hemorrhage|immediate postpartum hemorrhage
4869593|NCT02226731|Intrauterine balloon tamponade|intrauterine balloon tamponade
4869594|NCT02226705|Rhinocerebral Mucormycosis|rhinocerebral mucormycosis
4869595|NCT02226705|Surgery|surgery
4869596|NCT02226705|Fungal Infection|fungal infection
4869597|NCT02226705|Survival|survival
4869598|NCT02226692|chronic low back pain|chronic low back pain
4869599|NCT02226692|prognostic factors|prognostic factors
4869600|NCT02226692|disabling low back pain|disabling low back pain
4869601|NCT02226692|lumbar muscle activity|lumbar muscle activity
4869602|NCT02226692|start back screening tool|start back screening tool
4869603|NCT02226692|physical evaluation|physical evaluation
4869604|NCT02226679|crossover|crossover
4869605|NCT02226679|rollover study|rollover study
4869606|NCT02226679|open label|open label
4869607|NCT02226666|MRI|mri
4869608|NCT02226666|Eovist|eovist
4869609|NCT02226666|MultiHance|multihance
4869610|NCT02226601|drowsiness|drowsiness
4869611|NCT02226601|loopiness|loopiness
4869612|NCT02226601|nausea|nausea
4869613|NCT02226575|Sense of coherence|sense of coherence
4869614|NCT02226549|hepatitis C|hepatitis c
4869615|NCT02226549|Gilead|gilead
4869616|NCT02226549|GS-9451|gs-9451
4869617|NCT02226536|Posture|posture
4869618|NCT02226536|Vertigo|vertigo
4869619|NCT02226536|glucose metabolism|glucose metabolism
4869620|NCT02226536|diet|diet
4869621|NCT02226536|scales|scales
4869622|NCT02226536|dinamic posturography|dinamic posturography
4869623|NCT02226523|immunomagnetic reduction|immunomagnetic reduction
4869624|NCT02226523|acute coronary syndrome|acute coronary syndrome
4869625|NCT02226523|serum biomarkers|serum biomarkers
4869626|NCT02226484|Gastroesophageal reflux disease|gastroesophageal reflux disease
4869627|NCT02226484|GERD|gerd
4869628|NCT02226484|Acid reflux|acid reflux
4869629|NCT02226484|Reflux|reflux
4869630|NCT02226484|Quercetin|quercetin
4869631|NCT02226458|Autism|autism
4869632|NCT02226458|Mitochondrial Disorders|mitochondrial disorders
4869633|NCT02226458|EPI-743|epi-743
4869634|NCT02226458|EPI743|epi743
4869635|NCT02226458|Rett syndrome|rett syndrome
4869636|NCT02226458|Angelman syndrome|angelman syndrome
4869637|NCT02226445|Adults|adults
4869638|NCT02226445|Outpatients|outpatients
4869639|NCT02226432|Barthel Scale|barthel scale
4869640|NCT02226432|Disability|disability
4869641|NCT02226432|Modified Ashworth Scale|modified ashworth scale
4869642|NCT02226432|Right Arm|right arm
4869643|NCT02226432|Neuromodulation|neuromodulation
4869644|NCT02226432|Spasticity|spasticity
4869645|NCT02226432|Stroke|stroke
4869646|NCT02226419|Fatty acid oxidation disorder|fatty acid oxidation disorder
4869647|NCT02226419|Primary carnitine deficiency|primary carnitine deficiency
4869648|NCT02226419|Exercise|exercise
4869649|NCT02226419|L-carnitine treatment|l-carnitine treatment
4869650|NCT02226419|Stable isotopes|stable isotopes
4869651|NCT02226419|Carnitine transporter deficiency|carnitine transporter deficiency
4869652|NCT02226406|Early Physical Exercise|early physical exercise
4869653|NCT02226406|Alveolar Recruitment|alveolar recruitment
4869654|NCT02226406|Electrical Impedance Tomography|electrical impedance tomography
4869655|NCT02226406|Oxygenation|oxygenation
4869656|NCT02226406|Ventilation|ventilation
4869657|NCT02226393|Toddlers; Preschoolers; PTSD|toddlers; preschoolers; ptsd
4869658|NCT02226367|prazosin|prazosin
4869659|NCT02226367|alcohol use disorders|alcohol use disorders
4869660|NCT02226367|posttraumatic stress disorder|posttraumatic stress disorder
4869661|NCT02226367|PTSD|ptsd
4869662|NCT02226367|combat trauma|combat trauma
4869663|NCT02226367|military|military
4869664|NCT02226367|alpha-1 adrenoreceptor antagonist|alpha-1 adrenoreceptor antagonist
4869665|NCT02226354|Dietary vegetable oil|dietary vegetable oil
4869666|NCT02226354|Stearidonic acid|stearidonic acid
4869667|NCT02226354|Tissue|tissue
4869668|NCT02226354|Fatty Acid|fatty acid
4869669|NCT02226354|composition|composition
4869670|NCT02226341|Lupus|lupus
4869671|NCT02226341|Lupus Nephritis|lupus nephritis
4869672|NCT02226341|ACTHar|acthar
4869673|NCT02226341|Columbia|columbia
4869674|NCT02226341|Rheumatology|rheumatology
4869675|NCT02226341|CUMC|cumc
4869676|NCT02226341|Autoimmune|autoimmune
4869677|NCT02226341|SLE|sle
4869678|NCT02226341|Proliferative Lupus Nephritis|proliferative lupus nephritis
4869679|NCT02226315|noninvasive prenatal testing|noninvasive prenatal testing
4869680|NCT02226302|Endometrial cancer|endometrial cancer
4869681|NCT02226302|Obesity|obesity
4869682|NCT02226289|bevacizumab|bevacizumab
4869683|NCT02226289|refractory|refractory
4869684|NCT02226289|colorectal cancer|colorectal cancer
4869685|NCT02226289|metastatic|metastatic
4869686|NCT02226263|Necrotizing enterocolitis|necrotizing enterocolitis
4869687|NCT02226263|Probiotics|probiotics
4869688|NCT02226263|Preterm newborns|preterm newborns
4869689|NCT02226250|sugar-based beverage|sugar-based beverage
4869690|NCT02226250|Time Influence|time influence
4869692|NCT02226237|erectile dysfunction|erectile dysfunction
4869693|NCT02226237|Retropubic Prostatectomy|retropubic prostatectomy
4869694|NCT02226237|Physiotherapy|physiotherapy
4869695|NCT02226224|gastrointestinal neoplasms|gastrointestinal neoplasms
4869696|NCT02226224|endosonography|endosonography
4869697|NCT02226224|in vitro|in vitro
4869698|NCT02226224|Staging|staging
4869699|NCT02226198|LDL-C|ldl-c
4869700|NCT02226198|HoFH|hofh
4869701|NCT02226198|Hyperlipidemia|hyperlipidemia
4869702|NCT02226172|Primary myelofibrosis|primary myelofibrosis
4869703|NCT02226172|Secondary myelofibrosis|secondary myelofibrosis
4869704|NCT02226172|PMF|pmf
4869705|NCT02226172|PET-MF|pet-mf
4869706|NCT02226172|PPV-MF|ppv-mf
4869707|NCT02226172|Ruxolitinib resistant or intolerant|ruxolitinib resistant or intolerant
4869708|NCT02226172|previously treated myelofibrosis|previously treated myelofibrosis
4869709|NCT02226172|smoothened inhibitor|smoothened inhibitor
4869710|NCT02226172|oral|oral
4869711|NCT02226172|single agent.|single agent.
4869712|NCT02226159|cervical|cervical
4869713|NCT02226159|radicular pain|radicular pain
4869714|NCT02226159|transforaminal epidural steroid injections|transforaminal epidural steroid injections
4869715|NCT02226146|Pemphigoid Bullous|pemphigoid bullous
4869716|NCT02226146|Bullous|bullous
4869717|NCT02226146|Blisters|blisters
4869718|NCT02226146|SKIN DISEASES|skin diseases
4869719|NCT02226146|BP|bp
4869720|NCT02226120|LCZ696, chronic heart failure, open-label study, ARNI|lcz696, chronic heart failure, open-label study, arni
4869721|NCT02226107|Lay health worker|lay health worker
4869722|NCT02226107|Patient navigation|patient navigation
4869723|NCT02226107|Screening colonoscopy|screening colonoscopy
4869724|NCT02226107|Colon cancer|colon cancer
4869725|NCT02226107|Training|training
4869726|NCT02226107|Hispanic|hispanic
4869727|NCT02226107|Latino|latino
4869728|NCT02226094|intra-ocular pressure|intra-ocular pressure
4869729|NCT02226094|primary open-angle glaucoma|primary open-angle glaucoma
4869730|NCT02226094|intra ocular pressure|intra ocular pressure
4869731|NCT02226094|primary open angle glaucoma|primary open angle glaucoma
4869732|NCT02226094|glaucoma|glaucoma
4869733|NCT02226094|deep wave trabeculoplasty|deep wave trabeculoplasty
4869734|NCT02226094|ocular hypertension|ocular hypertension
4869735|NCT02226081|breast lesion|breast lesion
4869736|NCT02226081|ultrasound|ultrasound
4869737|NCT02226081|BI-RADS|bi-rads
4869738|NCT02226081|women|women
4869739|NCT02226081|malignancy|malignancy
4869740|NCT02226068|Atopic dermatitis|atopic dermatitis
4869741|NCT02226068|Ciclosporine|ciclosporine
4869742|NCT02226068|Extracorporal photopheresis|extracorporal photopheresis
4869743|NCT02226055|Chronic kidney disease of unknown origin|chronic kidney disease of unknown origin
4869744|NCT02226055|Chronic kidney disease of unknown aetiology|chronic kidney disease of unknown aetiology
4869745|NCT02226055|Sri Lanka|sri lanka
4869746|NCT02226055|CKDu|ckdu
4869747|NCT02226055|Arterial stiffness|arterial stiffness
4869748|NCT02226055|Cardiovascular risk|cardiovascular risk
4869749|NCT02226055|North Central Province|north central province
4869750|NCT02226029|MRI, fat fraction, stomach, lipid emulsion|mri, fat fraction, stomach, lipid emulsion
4869751|NCT02226016|ptosis|ptosis
4869752|NCT02226016|blepharochalasis|blepharochalasis
4869753|NCT02226016|dermatochalasis|dermatochalasis
4869754|NCT02225990|stroke|stroke
4869755|NCT02225990|stroke rehabilitation|stroke rehabilitation
4869756|NCT02225990|stroke therapy|stroke therapy
4869757|NCT02225964|APOEε4|apoeε4
4869758|NCT02225938|Intensive Care|intensive care
4869759|NCT02225938|Recovery|recovery
4869760|NCT02225938|Long term outcome|long term outcome
4869761|NCT02225938|Function|function
4869762|NCT02225925|brachytherapy|brachytherapy
4869763|NCT02225886|Renal anaemia|renal anaemia
4869764|NCT02225886|Intravenous ascorbic acid|intravenous ascorbic acid
4869765|NCT02225886|Intravenous iron administration|intravenous iron administration
4869766|NCT02225860|ADPKD|adpkd
4869767|NCT02225860|Copeptin|copeptin
4869768|NCT02225860|Vasopressin|vasopressin
4869769|NCT02225860|Diet|diet
4869770|NCT02225860|Water|water
4869771|NCT02225847|Gardening|gardening
4869772|NCT02225847|Therapeutic Horticulture|therapeutic horticulture
4869773|NCT02225847|Functional Magnetic Resonance Imaging|functional magnetic resonance imaging
4869774|NCT02225847|Psychometric Assessment|psychometric assessment
4869775|NCT02225847|Stress|stress
4869776|NCT02225847|Depression|depression
4869777|NCT02225847|Anxiety|anxiety
4869778|NCT02225847|Quality of Life|quality of life
4869779|NCT02225847|Wellness|wellness
4869780|NCT02225834|Atorvastatin, ischemic stroke, cytokines|atorvastatin, ischemic stroke, cytokines
4869781|NCT02225821|Implant Removal|implant removal
4869782|NCT02225821|Antibiotic Prophylaxis|antibiotic prophylaxis
4869783|NCT02225821|Postoperative wound infection|postoperative wound infection
4869784|NCT02225821|Orthopedics|orthopedics
4869785|NCT02225808|CBT|cbt
4869786|NCT02225808|autism|autism
4869787|NCT02225808|anxiety|anxiety
4869788|NCT02225808|treatment|treatment
4869789|NCT02225808|fMRI|fmri
4869790|NCT02225795|Crohn's Disease|crohn's disease
4869791|NCT02225795|Hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
4869792|NCT02225795|Children|children
4869793|NCT02225795|Young Adults|young adults
4869794|NCT02225782|Alteplase; Hemodialysis Catheter; Occlusion; Renal Failure|alteplase; hemodialysis catheter; occlusion; renal failure
4869795|NCT02225769|fever|fever
4869796|NCT02225769|point-of-care tests|point-of-care tests
4869797|NCT02225769|clinical algorithms|clinical algorithms
4869798|NCT02225769|electronic support|electronic support
4869799|NCT02225769|host biomarkers|host biomarkers
4869800|NCT02225756|Drug therapy|drug therapy
4869801|NCT02225756|Prevention and control|prevention and control
4869802|NCT02225756|Healing|healing
4869803|NCT02225756|Tissue regeneration|tissue regeneration
4869804|NCT02225756|Therapy|therapy
4869805|NCT02225743|Hypothermia|hypothermia
4869806|NCT02225743|Total Hip Joint Prosthesis|total hip joint prosthesis
4869807|NCT02225743|Total Knee Joint Prosthesis|total knee joint prosthesis
4869808|NCT02225717|Preterm labor|preterm labor
4869809|NCT02225717|cervicovaginal secretions|cervicovaginal secretions
4869810|NCT02225717|markers of fetal membranes remodelling|markers of fetal membranes remodelling
4869811|NCT02225717|Multiplex test|multiplex test
4869812|NCT02225691|type 1 diabetes|type 1 diabetes
4869813|NCT02225691|type 2 diabetes|type 2 diabetes
4869814|NCT02225691|paired testing|paired testing
4869815|NCT02225678|healthy volunteers|healthy volunteers
4869816|NCT02225678|asthma|asthma
4869817|NCT02225678|sputum eosinophils|sputum eosinophils
4869818|NCT02225639|ADHD|adhd
4869819|NCT02225639|Adult|adult
4869820|NCT02225613|Cruciate ligament injury|cruciate ligament injury
4869821|NCT02225613|Balance control|balance control
4869822|NCT02225613|Rehabilitation|rehabilitation
4869823|NCT02225613|Spa therapy|spa therapy
4869824|NCT02225613|Sport|sport
4869825|NCT02225600|Borderline Personality Disorder|borderline personality disorder
4869826|NCT02225600|BPD|bpd
4869827|NCT02225600|Intranasal oxytocin|intranasal oxytocin
4869828|NCT02225574|Leukemia|leukemia
4869829|NCT02225574|Advanced phase chronic myeloid leukemia|advanced phase chronic myeloid leukemia
4869830|NCT02225574|refractory chronic phase chronic myeloid leukemia|refractory chronic phase chronic myeloid leukemia
4869831|NCT02225574|CML|cml
4869832|NCT02225574|Accelerated phase|accelerated phase
4869833|NCT02225574|(AP)|(ap)
4869834|NCT02225574|Blast phase|blast phase
4869835|NCT02225574|(BP)|(bp)
4869836|NCT02225574|Philadelphia-positive acute leukemia|philadelphia-positive acute leukemia
4869837|NCT02225574|MEK-162|mek-162
4869838|NCT02225574|Nilotinib|nilotinib
4869839|NCT02225574|AMN107|amn107
4869840|NCT02225574|Tasigna|tasigna
4869841|NCT02225574|Questionnaires|questionnaires
4869842|NCT02225574|Surveys|surveys
4869843|NCT02225561|Cardiopulmonary resuscitation|cardiopulmonary resuscitation
4869844|NCT02225561|Nitroprusside|nitroprusside
4869845|NCT02225561|Transthoracic|transthoracic
4869846|NCT02225561|Impedances|impedances
4869847|NCT02225535|low back pain|low back pain
4869848|NCT02225535|telehealth|telehealth
4869849|NCT02225535|videoconferencing|videoconferencing
4869850|NCT02225535|access to physical therapy|access to physical therapy
4869851|NCT02225535|interprofessional care|interprofessional care
4869852|NCT02225535|rural health|rural health
4869853|NCT02225522|Intensive Care Units, Neonatal|intensive care units, neonatal
4869854|NCT02225522|Infant, Newborn|infant, newborn
4869855|NCT02225522|Genetic Diseases, Inborn|genetic diseases, inborn
4869856|NCT02225509|Thyroid cancer|thyroid cancer
4869857|NCT02225509|Thyroid cancer diagnostic|thyroid cancer diagnostic
4869858|NCT02225509|Thyroid nodule|thyroid nodule
4869859|NCT02225509|Fine needle aspiration biopsy|fine needle aspiration biopsy
4869860|NCT02225509|Indeterminate cytological result|indeterminate cytological result
4869861|NCT02225509|Molecular diagnostic|molecular diagnostic
4869862|NCT02225509|Transcriptomics|transcriptomics
4869863|NCT02225509|Molecular signature|molecular signature
4869864|NCT02225496|Oropharyngeal cancer|oropharyngeal cancer
4869865|NCT02225496|Oropharynx|oropharynx
4869866|NCT02225496|Human papilloma virus|human papilloma virus
4869867|NCT02225496|HPV positive|hpv positive
4869868|NCT02225496|Squamous cell carcinoma|squamous cell carcinoma
4869869|NCT02225496|SCC|scc
4869870|NCT02225496|Transoral robotic surgery|transoral robotic surgery
4869871|NCT02225496|TORS|tors
4869872|NCT02225496|Intuitive Surgical da Vinci Surgical System|intuitive surgical da vinci surgical system
4869873|NCT02225496|Modified barium swallow|modified barium swallow
4869874|NCT02225496|MBS|mbs
4869875|NCT02225496|Questionnaires|questionnaires
4869876|NCT02225496|Surveys|surveys
4869877|NCT02225496|Speech and swallowing function|speech and swallowing function
4869878|NCT02225470|Locally Recurrent or Metastatic Breast Cancer|locally recurrent or metastatic breast cancer
4869879|NCT02225457|insulin resistance|insulin resistance
4869880|NCT02225457|type 2 diabetes|type 2 diabetes
4869881|NCT02225457|obesity|obesity
4869882|NCT02225457|polyphenols|polyphenols
4869883|NCT02225457|adipose tissue|adipose tissue
4869884|NCT02225457|overfeeding|overfeeding
4869885|NCT02225444|degenerative lumbosacral spine disease|degenerative lumbosacral spine disease
4869886|NCT02225444|posterolateral fusion evaluation|posterolateral fusion evaluation
4869887|NCT02225444|OsteoAMP growth factor|osteoamp growth factor
4869888|NCT02225444|autograft|autograft
4869889|NCT02225431|Contrast-induced nephropathy|contrast-induced nephropathy
4869890|NCT02225431|Contrast-Induced acute kidney injury|contrast-induced acute kidney injury
4869891|NCT02225431|Contrast media|contrast media
4869892|NCT02225431|Angiography|angiography
4869893|NCT02225431|Coronary percutaneous intervention|coronary percutaneous intervention
4869894|NCT02225418|Laparoscopic|laparoscopic
4869895|NCT02225418|Cholecystectomy|cholecystectomy
4869896|NCT02225418|Postoperative|postoperative
4869897|NCT02225418|Pain|pain
4869898|NCT02225418|Quadratus lumborum|quadratus lumborum
4869899|NCT02225418|Ultrasound|ultrasound
4869900|NCT02225405|Lung Cancer|lung cancer
4869901|NCT02225405|Non-small Cell Lung Cancers|non-small cell lung cancers
4869902|NCT02225405|NCLC|nclc
4869903|NCT02225405|Chemotherapy|chemotherapy
4869904|NCT02225405|Nintedanib|nintedanib
4869905|NCT02225405|BIBF 1120|bibf 1120
4869906|NCT02225405|Cisplatin|cisplatin
4869907|NCT02225405|Platinol-AQ|platinol-aq
4869908|NCT02225405|Platinol|platinol
4869909|NCT02225405|CDDP|cddp
4869910|NCT02225405|Docetaxel|docetaxel
4869911|NCT02225405|Taxotere|taxotere
4869912|NCT02225392|Bronchial thermoplasty|bronchial thermoplasty
4869913|NCT02225392|Severe asthma|severe asthma
4869914|NCT02225379|Type 1 Diabetes|type 1 diabetes
4869915|NCT02225379|Hypoglycemia detection|hypoglycemia detection
4869916|NCT02225379|Non-invasive sensor|non-invasive sensor
4869917|NCT02225379|Nocturnal hypoglycemia|nocturnal hypoglycemia
4869918|NCT02225366|Melanoma|melanoma
4869919|NCT02225366|Metastatic|metastatic
4869920|NCT02225366|Antimicrobial peptide|antimicrobial peptide
4869921|NCT02225366|LL37|ll37
4869922|NCT02225366|Photographs|photographs
4869923|NCT02225353|Cervical Pessaries|cervical pessaries
4869924|NCT02225353|Progesterone|progesterone
4869925|NCT02225314|Parkinson's Disease|parkinson's disease
4869926|NCT02225314|Mild Cognitive Impairment|mild cognitive impairment
4869927|NCT02225301|Child maltreatment|child maltreatment
4869928|NCT02225301|Child Care|child care
4869929|NCT02225301|Knowledge|knowledge
4869930|NCT02225301|Attitude|attitude
4869931|NCT02225288|Healthy Subjects|healthy subjects
4869932|NCT02225288|Japanese|japanese
4869933|NCT02225288|Males|males
4869934|NCT02225275|Leukemia|leukemia
4869935|NCT02225275|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
4869936|NCT02225275|CLL|cll
4869937|NCT02225275|Small Lymphocytic Lymphoma|small lymphocytic lymphoma
4869938|NCT02225275|SLL|sll
4869939|NCT02225275|Recurrent|recurrent
4869940|NCT02225275|Lenalidomide|lenalidomide
4869941|NCT02225275|CC-5013|cc-5013
4869942|NCT02225275|Revlimid|revlimid
4869943|NCT02225275|Obinutuzumab|obinutuzumab
4869944|NCT02225275|GA101|ga101
4869945|NCT02225275|Gazyva|gazyva
4869946|NCT02225262|Prostate cancer|prostate cancer
4869947|NCT02225262|CyberKnife|cyberknife
4869948|NCT02225262|Stereotactic|stereotactic
4869949|NCT02225262|Radiation|radiation
4869950|NCT02225236|executive functioning|executive functioning
4869951|NCT02225236|metacognition|metacognition
4869952|NCT02225236|self-regulation|self-regulation
4869953|NCT02225236|preschoolers|preschoolers
4869954|NCT02225223|metastatic lesions|metastatic lesions
4869955|NCT02225223|vertebral body|vertebral body
4869956|NCT02225223|ablation|ablation
4869957|NCT02225223|radiation|radiation
4869958|NCT02225223|targeted radio-frequency ablation|targeted radio-frequency ablation
4869959|NCT02225223|radio-frequency targeted vertebral augmentation|radio-frequency targeted vertebral augmentation
4869960|NCT02225223|radiofrequency kyphoplasty|radiofrequency kyphoplasty
4869961|NCT02225223|spine|spine
4869962|NCT02225223|vertebral augmentation|vertebral augmentation
4869963|NCT02225223|kyphoplasty|kyphoplasty
4869964|NCT02225223|spinal ablation|spinal ablation
4869965|NCT02225223|pain|pain
4869966|NCT02225223|quality of life|quality of life
4869967|NCT02225223|spinal tumors|spinal tumors
4869968|NCT02225210|Dexmedetomidine ,Delirium ,Haemodynamic, Mechanical ventilation|dexmedetomidine ,delirium ,haemodynamic, mechanical ventilation
4869969|NCT02225197|Perioptic|perioptic
4869970|NCT02225197|Stereotactic|stereotactic
4869971|NCT02225197|Radiation|radiation
4869972|NCT02225197|Benign brain tumor|benign brain tumor
4869973|NCT02225197|Optic apparatus|optic apparatus
4869974|NCT02225184|Opioid Dependence|opioid dependence
4869975|NCT02225184|OPRM1|oprm1
4869976|NCT02225184|Outcome|outcome
4869977|NCT02225184|Treatment|treatment
4869978|NCT02225171|Genetic Knowledge|genetic knowledge
4869979|NCT02225171|Genetic Testing|genetic testing
4869980|NCT02225158|Immunity|immunity
4869981|NCT02225158|Co-Infection|co-infection
4869982|NCT02225158|Parasite|parasite
4869983|NCT02225158|Mycobacteria|mycobacteria
4869984|NCT02225145|Bone Marrow Transplant|bone marrow transplant
4869985|NCT02225145|Fertility|fertility
4869986|NCT02225145|Ovary|ovary
4869987|NCT02225132|Hydroxyurea|hydroxyurea
4869988|NCT02225132|Sickle Cell Disease|sickle cell disease
4869989|NCT02225132|Fetal Hemoglobin Induction|fetal hemoglobin induction
4869990|NCT02225119|Retinal Images|retinal images
4869991|NCT02225119|Retinal Pigment Epithelium|retinal pigment epithelium
4869992|NCT02225106|Dopamine Receptors|dopamine receptors
4869993|NCT02225106|Methylphenidate|methylphenidate
4869994|NCT02225106|Traumatic Brain Injury|traumatic brain injury
4869995|NCT02225106|C-11 Raclopride|c-11 raclopride
4869996|NCT02225106|Dopamine Release|dopamine release
4869997|NCT02225093|Safety|safety
4869998|NCT02225093|Dextromethorphan|dextromethorphan
4869999|NCT02225093|CYP2D6|cyp2d6
4870000|NCT02225093|Phase 1|phase 1
4870001|NCT02225093|Prostate cancer|prostate cancer
4870002|NCT02225093|CYP1A2|cyp1a2
4870003|NCT02225093|Pharmacokinetics|pharmacokinetics
4870004|NCT02225093|Drug-drug interactions|drug-drug interactions
4870005|NCT02225093|Caffeine|caffeine
4870006|NCT02225093|Enzalutamide|enzalutamide
4870007|NCT02225067|Patients|patients
4870008|NCT02225067|Volunteers|volunteers
4870009|NCT02225054|duration of analgesia|duration of analgesia
4870010|NCT02225041|intensive care|intensive care
4870011|NCT02225041|critical care|critical care
4870012|NCT02225041|child|child
4870013|NCT02225041|family|family
4870014|NCT02225041|survivors|survivors
4870015|NCT02225028|physical activity|physical activity
4870016|NCT02225028|physical fitness|physical fitness
4870017|NCT02225028|exercise program|exercise program
4870018|NCT02225028|telephone coaching|telephone coaching
4870019|NCT02225028|motivational counseling|motivational counseling
4870020|NCT02225028|stretching|stretching
4870021|NCT02225028|fitness improvement|fitness improvement
4870022|NCT02225028|exercise coaching|exercise coaching
4870023|NCT02225028|toning|toning
4870025|NCT02225028|spinal cord injury|spinal cord injury
4870026|NCT02225028|home-based|home-based
4870027|NCT02225028|home exercise|home exercise
4870028|NCT02225015|Cancer|cancer
4870029|NCT02225015|Breast cancer|breast cancer
4870030|NCT02225015|Ovarian cancer|ovarian cancer
4870031|NCT02225015|BRCA Mutation|brca mutation
4870032|NCT02225015|BRCA1 Gene Mutation|brca1 gene mutation
4870033|NCT02225015|BRCA2 Gene Mutation|brca2 gene mutation
4870034|NCT02225015|Telephone genetic counselling|telephone genetic counselling
4870035|NCT02225015|Cancer prevention|cancer prevention
4870036|NCT02225002|relapsed|relapsed
4870037|NCT02225002|refractory to standard therapy|refractory to standard therapy
4870038|NCT02225002|no effective therapy exists|no effective therapy exists
4870039|NCT02224976|exercise training|exercise training
4870040|NCT02224963|Aging,|aging,
4870041|NCT02224963|Macular Degeneration,|macular degeneration,
4870042|NCT02224963|Preparation for Future Care,|preparation for future care,
4870043|NCT02224963|Psychological Well-being,|psychological well-being,
4870044|NCT02224963|Problem Solving|problem solving
4870045|NCT02224963|Prevention|prevention
4870046|NCT02224963|Mental Health Promotion|mental health promotion
4870047|NCT02224950|Atopic dermatitis|atopic dermatitis
4870048|NCT02224950|eczema|eczema
4870049|NCT02224950|alternative therapy|alternative therapy
4870050|NCT02224950|complementary therapy|complementary therapy
4870051|NCT02224950|moisturizer|moisturizer
4870052|NCT02224937|Melatonin|melatonin
4870053|NCT02224937|Cognitive parameters|cognitive parameters
4870054|NCT02224937|pharmacodynamic|pharmacodynamic
4870055|NCT02224937|pharmacokinetics|pharmacokinetics
4870056|NCT02224924|Experimental: autologous blood patch injection (ABPI)|experimental: autologous blood patch injection (abpi)
4870057|NCT02224924|Experimental: BioSentry (formerly known as Bio-Seal) hydrogel Tract Plug|experimental: biosentry (formerly known as bio-seal) hydrogel tract plug
4870058|NCT02224924|14-141|14-141
4870059|NCT02224911|focal therapy|focal therapy
4870060|NCT02224911|prostate cancer treatment|prostate cancer treatment
4870061|NCT02224911|laser treatment|laser treatment
4870062|NCT02224885|Interventional radiology|interventional radiology
4870063|NCT02224885|Lung|lung
4870064|NCT02224885|Liver|liver
4870065|NCT02224885|Confocal endomicroscopy|confocal endomicroscopy
4870066|NCT02224885|Optical biopsy|optical biopsy
4870067|NCT02224885|Scanner|scanner
4870068|NCT02224885|Fluoroscopy|fluoroscopy
4870069|NCT02224885|CT|ct
4870070|NCT02224885|Computed Tomography|computed tomography
4870071|NCT02224885|Radiofrequency Ablation|radiofrequency ablation
4870072|NCT02224885|Fluorescein|fluorescein
4870073|NCT02224872|bone marrow transplant|bone marrow transplant
4870074|NCT02224872|thymoglobulin|thymoglobulin
4870075|NCT02224872|cyclophosphamide|cyclophosphamide
4870076|NCT02224872|fludarabine|fludarabine
4870077|NCT02224872|tacrolimus|tacrolimus
4870078|NCT02224872|Mycophenolic Acid Mofetil|mycophenolic acid mofetil
4870079|NCT02224872|chemotherapy|chemotherapy
4870080|NCT02224872|GVHD|gvhd
4870081|NCT02224872|haploidentical|haploidentical
4870082|NCT02224833|appropriateness|appropriateness
4870083|NCT02224833|elderly|elderly
4870084|NCT02224833|polypharmacy|polypharmacy
4870085|NCT02224833|primary care|primary care
4870086|NCT02224820|transplantation|transplantation
4870087|NCT02224820|sensitised patients|sensitised patients
4870088|NCT02224820|HLA-antibodies|hla-antibodies
4870089|NCT02224807|breast cancer|breast cancer
4870090|NCT02224807|diet|diet
4870091|NCT02224807|exercise|exercise
4870092|NCT02224807|weight loss|weight loss
4870093|NCT02224794|abdominal|abdominal
4870094|NCT02224794|aortic|aortic
4870095|NCT02224794|aneurysm|aneurysm
4870096|NCT02224755|Heart Failure|heart failure
4870097|NCT02224755|Left Ventricular Assist Device|left ventricular assist device
4870098|NCT02224755|Ventricular Dysfunction|ventricular dysfunction
4870099|NCT02224755|Cardiomyopathy|cardiomyopathy
4870100|NCT02224755|Heart Disease|heart disease
4870101|NCT02224755|Cardiovascular Disease|cardiovascular disease
4870102|NCT02224755|Heart-assist devices|heart-assist devices
4870103|NCT02224755|Thoratec Corporation|thoratec corporation
4870104|NCT02224703|Cannabidiol|cannabidiol
4870105|NCT02224703|CBD|cbd
4870106|NCT02224703|GWP42003-P|gwp42003-p
4870107|NCT02224690|Cannabidiol|cannabidiol
4870108|NCT02224690|CBD|cbd
4870109|NCT02224690|Epidiolex|epidiolex
4870110|NCT02224690|GWP42003-P|gwp42003-p
4870111|NCT02224677|CFM|cfm
4870112|NCT02224677|facial asymmetry|facial asymmetry
4870113|NCT02224677|skin tag|skin tag
4870114|NCT02224677|facial tag|facial tag
4870115|NCT02224677|missing ear|missing ear
4870116|NCT02224677|small ear|small ear
4870117|NCT02224677|anotia|anotia
4870118|NCT02224677|microtia|microtia
4870119|NCT02224677|epibulbar dermoid|epibulbar dermoid
4870120|NCT02224677|coloboma|coloboma
4870121|NCT02224677|macrostomia|macrostomia
4870122|NCT02224677|lateral cleft|lateral cleft
4870123|NCT02224677|infant|infant
4870124|NCT02224677|toddler|toddler
4870125|NCT02224677|baby|baby
4870126|NCT02224677|neurodevelopment|neurodevelopment
4870127|NCT02224677|cognition|cognition
4870128|NCT02224677|socialization|socialization
4870129|NCT02224638|skin ulcers|skin ulcers
4870130|NCT02224612|Pediatric Face Masks|pediatric face masks
4870131|NCT02224612|children|children
4870132|NCT02224599|Immunotherapy|immunotherapy
4870133|NCT02224599|TAPA-Pulsed Dendritic Cell Therapy|tapa-pulsed dendritic cell therapy
4870134|NCT02224599|Dendritic Cell Therapy|dendritic cell therapy
4870135|NCT02224573|Cannabidiol|cannabidiol
4870136|NCT02224573|CBD|cbd
4870137|NCT02224573|GWP42003-P|gwp42003-p
4870138|NCT02224573|GWPCARE5|gwpcare5
4870139|NCT02224560|Cannabidiol|cannabidiol
4870140|NCT02224560|CBD|cbd
4870141|NCT02224560|Epidiolex|epidiolex
4870142|NCT02224560|GWP42003-P|gwp42003-p
4870143|NCT02224547|non-small cell lung cancer|non-small cell lung cancer
4870144|NCT02224547|lung carcinoma|lung carcinoma
4870145|NCT02224547|NSCLC|nsclc
4870146|NCT02224534|ST elevation myocardial infarction.|st elevation myocardial infarction.
4870147|NCT02224534|Ticagrelor|ticagrelor
4870148|NCT02224534|Left ventricular remodeling|left ventricular remodeling
4870149|NCT02224534|Platelet reactivity|platelet reactivity
4870150|NCT02224521|FLAP inhibitor|flap inhibitor
4870151|NCT02224521|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
4870152|NCT02224521|COPD|copd
4870153|NCT02224521|Bioavailability|bioavailability
4870154|NCT02224469|Brain-Computer Interface|brain-computer interface
4870155|NCT02224469|Motor Cortex|motor cortex
4870156|NCT02224469|Dorsolateral Prefrontal Cortex|dorsolateral prefrontal cortex
4870157|NCT02224469|Quality of Life|quality of life
4870158|NCT02224456|Tenofovir disoproxil fumarate|tenofovir disoproxil fumarate
4870159|NCT02224456|hepatocellular carcinoma|hepatocellular carcinoma
4870160|NCT02224456|chronic hepatitis B|chronic hepatitis b
4870161|NCT02224456|Cirrhosis|cirrhosis
4870162|NCT02224443|Dexmedetomidine,postoperative cognitive dysfunction|dexmedetomidine,postoperative cognitive dysfunction
4870163|NCT02224430|biomarker of relapse|biomarker of relapse
4870164|NCT02224430|schizophrenia|schizophrenia
4870165|NCT02224430|schizoaffective disorder|schizoaffective disorder
4870166|NCT02224430|on-body sensors|on-body sensors
4870167|NCT02224430|smartphone|smartphone
4870168|NCT02224430|observational|observational
4870169|NCT02224417|Diabetes|diabetes
4870170|NCT02224417|Treatment medication adherence|treatment medication adherence
4870171|NCT02224417|Physical activity|physical activity
4870172|NCT02224417|Financial incentives|financial incentives
4870173|NCT02224417|Outcome incentives|outcome incentives
4870174|NCT02224417|Process incentives|process incentives
4870175|NCT02224417|HbA1c|hba1c
4870176|NCT02224391|Smoking Cessation|smoking cessation
4870177|NCT02224391|Attentional bias modification|attentional bias modification
4870178|NCT02224391|ABM|abm
4870179|NCT02224391|Smartphone|smartphone
4870180|NCT02224391|Nicotine replacement therapy|nicotine replacement therapy
4870181|NCT02224391|Nicotine patch|nicotine patch
4870182|NCT02224391|NRT|nrt
4870183|NCT02224391|Questionnaires|questionnaires
4870184|NCT02224391|Surveys|surveys
4870185|NCT02224391|Saliva collection|saliva collection
4870186|NCT02224391|Cotinine level|cotinine level
4870187|NCT02224391|Counseling sessions|counseling sessions
4870188|NCT02224391|Electroencephalography|electroencephalography
4870189|NCT02224391|EEG|eeg
4870190|NCT02224378|fluid responsiveness|fluid responsiveness
4870191|NCT02224378|atrial fibrillation|atrial fibrillation
4870192|NCT02224378|passive leg raising|passive leg raising
4870193|NCT02224378|central venous pressure|central venous pressure
4870194|NCT02224378|valvular heart surgery|valvular heart surgery
4870195|NCT02224365|Diabetes|diabetes
4870196|NCT02224365|Arterial Stiffness|arterial stiffness
4870197|NCT02224365|Blood Pressure|blood pressure
4870198|NCT02224365|Endothelial Function|endothelial function
4870199|NCT02224365|Body Composition|body composition
4870200|NCT02224365|Glycemic Control|glycemic control
4870201|NCT02224365|Apples|apples
4870202|NCT02224365|Functional Foods|functional foods
4870203|NCT02224365|Polyphenols|polyphenols
4870204|NCT02224365|Fiber|fiber
4870205|NCT02224352|Electric Stimulation|electric stimulation
4870206|NCT02224352|Respiration|respiration
4870207|NCT02224352|Abdominal wall|abdominal wall
4870208|NCT02224352|Lung Diseases|lung diseases
4870209|NCT02224352|Respiratory Tract Diseases|respiratory tract diseases
4870210|NCT02224352|COPD|copd
4870211|NCT02224339|Atherosclerosis|atherosclerosis
4870212|NCT02224339|carotid plaque|carotid plaque
4870213|NCT02224339|Contrast-enhanced ultrasound|contrast-enhanced ultrasound
4870214|NCT02224339|Major Adverse Cardiovascular Events|major adverse cardiovascular events
4870215|NCT02224326|Alzheimer´s disease|alzheimer´s disease
4870216|NCT02224326|early diagnosis|early diagnosis
4870217|NCT02224326|evoked potentials|evoked potentials
4870218|NCT02224326|near-infrared spectroscopy|near-infrared spectroscopy
4870219|NCT02224313|vaginal cytokine|vaginal cytokine
4870220|NCT02224287|Urolithiasis|urolithiasis
4870221|NCT02224287|Kidney Stones|kidney stones
4870222|NCT02224287|Ureteroscopy|ureteroscopy
4870223|NCT02224287|Fluoroscopy|fluoroscopy
4870224|NCT02224274|Antiplatelet Therapy|antiplatelet therapy
4870225|NCT02224274|Cardiac Arrest|cardiac arrest
4870226|NCT02224274|Therapeutic hypothermia|therapeutic hypothermia
4870227|NCT02224274|Myocardial infarction (STEMI and NSTEMI)|myocardial infarction (stemi and nstemi)
4870228|NCT02224261|Axillary web syndrome|axillary web syndrome
4870229|NCT02224261|cording|cording
4870230|NCT02224261|physical therapy|physical therapy
4870231|NCT02224261|breast cancer|breast cancer
4870232|NCT02224248|cardiorespiratory fitness|cardiorespiratory fitness
4870233|NCT02224248|exercise tolerance|exercise tolerance
4870234|NCT02224248|exercise test|exercise test
4870235|NCT02224248|health behavior|health behavior
4870236|NCT02224248|motor activity|motor activity
4870237|NCT02224248|motivation|motivation
4870238|NCT02224248|intention|intention
4870239|NCT02224248|self-rated health|self-rated health
4870240|NCT02224235|Stable angina|stable angina
4870242|NCT02224235|Percutaneous Coronary Intervention|percutaneous coronary intervention
4870243|NCT02224209|Carotid artery stenosis|carotid artery stenosis
4870244|NCT02224209|High risk of hyperperfusion|high risk of hyperperfusion
4870245|NCT02224209|Staged angioplasty|staged angioplasty
4870246|NCT02224209|Routine single-stage stenting|routine single-stage stenting
4870247|NCT02224196|manual ventilation|manual ventilation
4870248|NCT02224196|pressure-controlled ventilation|pressure-controlled ventilation
4870249|NCT02224196|peak airway pressure|peak airway pressure
4870250|NCT02224196|antral area|antral area
4870251|NCT02224183|low back pain|low back pain
4870252|NCT02224183|yoga|yoga
4870253|NCT02224183|education|education
4870254|NCT02224183|Veterans|veterans
4870255|NCT02224183|cost-effectiveness|cost-effectiveness
4870256|NCT02224183|military|military
4870257|NCT02224183|back pain|back pain
4870258|NCT02224170|Dexamethasone|dexamethasone
4870259|NCT02224170|Lidocaine|lidocaine
4870260|NCT02224170|Quality of Recovery|quality of recovery
4870261|NCT02224170|Laparoscopic cholecystectomy|laparoscopic cholecystectomy
4870262|NCT02224144|Kidney Transplantation|kidney transplantation
4870263|NCT02224144|Calcitriol|calcitriol
4870264|NCT02224144|Bone Mineral Density|bone mineral density
4870265|NCT02224144|Bone Mass and Strength|bone mass and strength
4870266|NCT02224144|Vascular Calcifications|vascular calcifications
4870267|NCT02224144|Hyperparathyroidism|hyperparathyroidism
4870268|NCT02224144|Parathyroid Hormone|parathyroid hormone
4870269|NCT02224131|platelet function test|platelet function test
4870270|NCT02224131|stent;|stent;
4870271|NCT02224118|Healthy|healthy
4870272|NCT02224118|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
4870273|NCT02224118|CNTO 3649|cnto 3649
4870274|NCT02224092|heart health|heart health
4870275|NCT02224092|general well-being|general well-being
4870276|NCT02224066|Aortic stenosis|aortic stenosis
4870277|NCT02224066|TAVI|tavi
4870278|NCT02224066|TAVR|tavr
4870279|NCT02224066|Transcatheter aortic valve implantation|transcatheter aortic valve implantation
4870280|NCT02224066|Ticagrelor|ticagrelor
4870281|NCT02224066|Antiplatelet reactivity|antiplatelet reactivity
4870282|NCT02224053|oncology, cancer, non small cell lung cancer, anticancer druge, omeprazole, healthy volunteer|oncology, cancer, non small cell lung cancer, anticancer druge, omeprazole, healthy volunteer
4870283|NCT02224001|tip plasty|tip plasty
4870284|NCT02224001|septal cartilage|septal cartilage
4870285|NCT02223988|Patients|patients
4870286|NCT02223988|mechanical|mechanical
4870287|NCT02223988|ventilation|ventilation
4870288|NCT02223988|tracheostomy|tracheostomy
4870289|NCT02223975|Spectrum Analysis, vibrational|spectrum analysis, vibrational
4870290|NCT02223975|Spectrum Analysis, infrared|spectrum analysis, infrared
4870291|NCT02223975|Spectrum Analysis, Raman|spectrum analysis, raman
4870292|NCT02223975|Spectrum Analysis|spectrum analysis
4870293|NCT02223975|Fourier transform infrared spectroscopy|fourier transform infrared spectroscopy
4870294|NCT02223975|Raman probe|raman probe
4870295|NCT02223975|Optical|optical
4870296|NCT02223975|Diagnosis|diagnosis
4870297|NCT02223975|Cancer|cancer
4870298|NCT02223975|Multivariate analysis|multivariate analysis
4870299|NCT02223975|Vulval Intraepithelial Neoplasia|vulval intraepithelial neoplasia
4870300|NCT02223975|Vulvar Neoplasm|vulvar neoplasm
4870301|NCT02223975|Vulva|vulva
4870302|NCT02223975|Vulvar Diseases|vulvar diseases
4870303|NCT02223962|physical activity|physical activity
4870304|NCT02223962|COPD|copd
4870305|NCT02223962|activity monitors|activity monitors
4870306|NCT02223949|Obesity|obesity
4870307|NCT02223949|Labor complications|labor complications
4870308|NCT02223949|Induction of labor|induction of labor
4870309|NCT02223949|Mechanical cervical ripening|mechanical cervical ripening
4870310|NCT02223936|nuchal translucency, neurological developpment, anxiety, depression, prenatal diagnosis, normal karyotype|nuchal translucency, neurological developpment, anxiety, depression, prenatal diagnosis, normal karyotype
4870311|NCT02223923|Phase 1|phase 1
4870312|NCT02223923|Maximimum tolerated dose|maximimum tolerated dose
4870313|NCT02223923|ATR Inhibitor|atr inhibitor
4870314|NCT02223923|Radiotherapy|radiotherapy
4870315|NCT02223910|brain computer interface|brain computer interface
4870316|NCT02223910|neurofeedback|neurofeedback
4870317|NCT02223910|functional connectivity|functional connectivity
4870318|NCT02223897|Liver transplantation|liver transplantation
4870319|NCT02223897|Biliary complication|biliary complication
4870320|NCT02223897|mesenchymal stem cells|mesenchymal stem cells
4870321|NCT02223884|Malignant melanoma, second-line treatment, docetaxel, carboplatin|malignant melanoma, second-line treatment, docetaxel, carboplatin
4870322|NCT02223871|Malaria|malaria
4870323|NCT02223871|ACT-451840|act-451840
4870324|NCT02223858|Health Status Disparities|health status disparities
4870325|NCT02223858|Arthritis|arthritis
4870326|NCT02223858|Psychology|psychology
4870327|NCT02223858|Pain Management|pain management
4870328|NCT02223858|Affect|affect
4870329|NCT02223845|Music, Anxiety, IVF|music, anxiety, ivf
4870330|NCT02223832|ACT-128800|act-128800
4870331|NCT02223832|Safety|safety
4870332|NCT02223832|Tolerability|tolerability
4870333|NCT02223832|Pharmacokinetics|pharmacokinetics
4870334|NCT02223819|Crizotinib|crizotinib
4870335|NCT02223819|14-063|14-063
4870336|NCT02223806|Postpartum hemorrhage|postpartum hemorrhage
4870337|NCT02223806|Uterine tonus assessment|uterine tonus assessment
4870338|NCT02223806|Active management of third stage of labor|active management of third stage of labor
4870339|NCT02223793|Vascular screening|vascular screening
4870340|NCT02223793|Cardiovascular risk factors|cardiovascular risk factors
4870341|NCT02223793|Blood pressure|blood pressure
4870342|NCT02223793|Lipids|lipids
4870343|NCT02223793|Lifestyle|lifestyle
4870344|NCT02223793|Identifying unknown risk|identifying unknown risk
4870345|NCT02223793|Low socioeconomic status|low socioeconomic status
4870346|NCT02223793|low threshold|low threshold
4870347|NCT02223780|COPD|copd
4870348|NCT02223780|palliative care|palliative care
4870350|NCT02223767|VR|vr
4870351|NCT02223767|Exposure therapy|exposure therapy
4870352|NCT02223767|TMS augmentations of exposure therapy|tms augmentations of exposure therapy
4870353|NCT02223741|Cerebral palsy|cerebral palsy
4870354|NCT02223741|GMFM-66|gmfm-66
4870355|NCT02223741|PEDI|pedi
4870356|NCT02223702|Aggressive periodontitis|aggressive periodontitis
4870357|NCT02223702|amoxicillin|amoxicillin
4870358|NCT02223702|metronidazole|metronidazole
4870359|NCT02223702|moxifloxacin|moxifloxacin
4870360|NCT02223702|nonsurgical periodontal debridement.|nonsurgical periodontal debridement.
4870361|NCT02223689|SkinAffix|skinaffix
4870362|NCT02223676|Pharmacy|pharmacy
4870363|NCT02223676|Length-of-stay|length-of-stay
4870364|NCT02223676|Emergency Department|emergency department
4870365|NCT02223650|Intermittent Exotropia|intermittent exotropia
4870366|NCT02223650|IXT|ixt
4870367|NCT02223650|overminus|overminus
4870368|NCT02223624|eccentric|eccentric
4870369|NCT02223624|exercise|exercise
4870370|NCT02223624|heart disease|heart disease
4870371|NCT02223624|chronic heart failure|chronic heart failure
4870372|NCT02223624|rehabilitation|rehabilitation
4870373|NCT02223611|Stage Ⅱ-ⅢA NSCLC S1 capsule Completely resection|stage ⅱ-ⅲa nsclc s1 capsule completely resection
4870374|NCT02223598|Lymphoid Hematological Malignancies|lymphoid hematological malignancies
4870375|NCT02223585|Gut microbial|gut microbial
4870376|NCT02223585|response|response
4870377|NCT02223585|to protein-based|to protein-based
4870378|NCT02223585|diet|diet
4870379|NCT02223585|challenges|challenges
4870380|NCT02223585|population|population
4870381|NCT02223533|analgesia|analgesia
4870382|NCT02223533|post-operative|post-operative
4870383|NCT02223533|wound catheter infusion|wound catheter infusion
4870384|NCT02223533|laparoscopic colon surgery|laparoscopic colon surgery
4870385|NCT02223520|Staphylococcus aureus|staphylococcus aureus
4870386|NCT02223520|Infection|infection
4870387|NCT02223520|Colonization|colonization
4870388|NCT02223520|Transmission|transmission
4870389|NCT02223520|Neonate|neonate
4870390|NCT02223468|Intestinal Microbiota|intestinal microbiota
4870391|NCT02223468|Liver Transplant|liver transplant
4870392|NCT02223468|Acute Rejection|acute rejection
4870393|NCT02223468|Infection|infection
4870394|NCT02223455|Methicillin-resistant Staphylococcus aureus (MRSA)|methicillin-resistant staphylococcus aureus (mrsa)
4870395|NCT02223455|Infection Control (IC)|infection control (ic)
4870396|NCT02223455|Hospital-associated infections (HAI)|hospital-associated infections (hai)
4870397|NCT02223455|Hand Hygiene (HH)|hand hygiene (hh)
4870398|NCT02223455|Compliance|compliance
4870399|NCT02223455|Health Care Workers (HCWs)|health care workers (hcws)
4870400|NCT02223442|chronic pain|chronic pain
4870401|NCT02223442|central analgesic drugs|central analgesic drugs
4870402|NCT02223442|adherence to therapy|adherence to therapy
4870403|NCT02223442|side effects|side effects
4870404|NCT02223442|quality of life|quality of life
4870405|NCT02223442|MOR-NRI drugs|mor-nri drugs
4870406|NCT02223429|Paternal nurturance|paternal nurturance
4870407|NCT02223429|Oxytocin|oxytocin
4870408|NCT02223429|Vasopressin|vasopressin
4870409|NCT02223429|fMRI|fmri
4870410|NCT02223429|Neurobiology|neurobiology
4870411|NCT02223416|female|female
4870412|NCT02223416|volunteers|volunteers
4870413|NCT02223403|Nitrate-rich beetroot juice|nitrate-rich beetroot juice
4870414|NCT02223403|heart failure|heart failure
4870415|NCT02223403|exercise performance|exercise performance
4870416|NCT02223403|oxygen consumption|oxygen consumption
4870417|NCT02223390|South Africa|south africa
4870418|NCT02223390|HIV|hiv
4870419|NCT02223390|Mental health|mental health
4870420|NCT02223390|Trauma|trauma
4870421|NCT02223390|Women|women
4870422|NCT02223351|HSV|hsv
4870423|NCT02223351|HIV|hiv
4870424|NCT02223351|Herpes|herpes
4870425|NCT02223351|volunteers|volunteers
4870426|NCT02223351|drug-drug interaction|drug-drug interaction
4870427|NCT02223325|Elderly|elderly
4870428|NCT02223325|Prognosis|prognosis
4870429|NCT02223299|Depression|depression
4870430|NCT02223299|SSRI|ssri
4870431|NCT02223299|Nutritional Supplements|nutritional supplements
4870432|NCT02223299|Beck Depression Scale|beck depression scale
4870433|NCT02223299|L-tyrosine|l-tyrosine
4870434|NCT02223299|L-tryptophan|l-tryptophan
4870435|NCT02223286|Corus CAD|corus cad
4870436|NCT02223286|ASGES|asges
4870437|NCT02223286|Age/Sex/Gene Expression Score|age/sex/gene expression score
4870438|NCT02223286|Gene Expression|gene expression
4870439|NCT02223286|GES|ges
4870440|NCT02223286|CAD|cad
4870441|NCT02223286|CVD|cvd
4870442|NCT02223286|CHD|chd
4870443|NCT02223286|Precision Medicine|precision medicine
4870444|NCT02223286|Clinical Utility|clinical utility
4870445|NCT02223286|Coronary Artery Disease|coronary artery disease
4870446|NCT02223286|Angina Pectoris|angina pectoris
4870447|NCT02223286|Chest Pain|chest pain
4870448|NCT02223286|Cardiovascular Disease|cardiovascular disease
4870449|NCT02223286|Coronary Heart Disease|coronary heart disease
4870450|NCT02223286|UCU-CARD|ucu-card
4870451|NCT02223273|stroke,|stroke,
4870452|NCT02223273|quality improvement|quality improvement
4870453|NCT02223247|solid tumors|solid tumors
4870454|NCT02223247|cancer|cancer
4870455|NCT02223221|In Vitro Fertilization|in vitro fertilization
4870456|NCT02223221|Intracytoplasmic Sperm Injections|intracytoplasmic sperm injections
4870457|NCT02223221|Infertility, Female|infertility, female
4870458|NCT02223221|Abortion, Habitual|abortion, habitual
4870459|NCT02223221|recurrent pregnancy loss|recurrent pregnancy loss
4870460|NCT02223221|comprehensive chromosome screening|comprehensive chromosome screening
4870461|NCT02223221|preimplantation genetic screening|preimplantation genetic screening
4870462|NCT02223221|SNP array|snp array
4870463|NCT02223208|PTCL|ptcl
4870464|NCT02223208|PTCL-NOS|ptcl-nos
4870465|NCT02223208|AITL|aitl
4870466|NCT02223208|ALCL|alcl
4870467|NCT02223195|Juvenile Idiopathic Arthritis|juvenile idiopathic arthritis
4870468|NCT02223195|Saliva|saliva
4870469|NCT02223182|Milk Allergy,|milk allergy,
4870470|NCT02223182|Viaskin Milk,|viaskin milk,
4870471|NCT02223182|Specific Immunotherapy,|specific immunotherapy,
4870472|NCT02223182|Epicutaneous ImmunoTherapy (EPIT)|epicutaneous immunotherapy (epit)
4870473|NCT02223182|IgE-Mediated Cow's Milk Allergy|ige-mediated cow's milk allergy
4870474|NCT02223169|Blood Pressure|blood pressure
4870475|NCT02223169|Hypertension|hypertension
4870476|NCT02223169|Cardiovascular disease|cardiovascular disease
4870477|NCT02223143|Lipid lowering therapy|lipid lowering therapy
4870478|NCT02223130|HIV|hiv
4870479|NCT02223130|Discrimination|discrimination
4870480|NCT02223130|Coping|coping
4870481|NCT02223130|Medical Mistrust|medical mistrust
4870482|NCT02223130|HIV Outcomes|hiv outcomes
4870483|NCT02223130|Cognitive Behavioral Therapy|cognitive behavioral therapy
4870484|NCT02223091|complementary therapies|complementary therapies
4870485|NCT02223091|consultants|consultants
4870486|NCT02223091|medical oncology|medical oncology
4870487|NCT02223091|breast-cancer|breast-cancer
4870488|NCT02223091|education|education
4870489|NCT02223052|CC-486|cc-486
4870490|NCT02223052|Oral Azacitidine|oral azacitidine
4870491|NCT02223052|Soli Tumor Malignancy|soli tumor malignancy
4870492|NCT02223052|Hematological Malignancy|hematological malignancy
4870493|NCT02223052|Leukemia|leukemia
4870494|NCT02223052|Lymphoma|lymphoma
4870495|NCT02223052|Multiple Myeloma|multiple myeloma
4870496|NCT02223052|Acute Myeloid Leukemia|acute myeloid leukemia
4870497|NCT02223052|Myelodysplastic Syndromes|myelodysplastic syndromes
4870498|NCT02223052|Neoplasms|neoplasms
4870499|NCT02223052|Melanoma|melanoma
4870500|NCT02223052|Breast Cancer|breast cancer
4870501|NCT02223052|Metastatic Breast Cancer|metastatic breast cancer
4870502|NCT02223052|Non-Small Cell Lung Cancer|non-small cell lung cancer
4870503|NCT02223052|Small Cell Lung Cancer|small cell lung cancer
4870504|NCT02223052|Renal Cell Carcinoma|renal cell carcinoma
4870505|NCT02223052|Glioblastoma Multiforme|glioblastoma multiforme
4870506|NCT02223052|Brain Cancer|brain cancer
4870507|NCT02223052|Kidney Cancer|kidney cancer
4870508|NCT02223052|Lung cancer|lung cancer
4870509|NCT02223052|Blood Cancer|blood cancer
4870510|NCT02223052|Thyroid Cancer|thyroid cancer
4870511|NCT02223052|Bone Cancer|bone cancer
4870512|NCT02223052|Bone Metastasis|bone metastasis
4870513|NCT02223052|Testicular Cancer|testicular cancer
4870514|NCT02223052|Prostate Cancer|prostate cancer
4870515|NCT02223052|Bladder Cancer|bladder cancer
4870516|NCT02223052|Ovarian Cancer|ovarian cancer
4870517|NCT02223052|Skin Cancer|skin cancer
4870518|NCT02223052|Cancer general|cancer general
4870519|NCT02223052|Survival|survival
4870520|NCT02223052|Chemotherapy|chemotherapy
4870521|NCT02223052|Targeted Therapy|targeted therapy
4870522|NCT02223052|Genitourinary|genitourinary
4870523|NCT02223052|MM|mm
4870524|NCT02223052|MDS|mds
4870525|NCT02223052|AML|aml
4870526|NCT02223052|NHL|nhl
4870527|NCT02223052|HL|hl
4870528|NCT02223052|MBC|mbc
4870529|NCT02223052|NSCLC|nsclc
4870530|NCT02223052|SCLC|sclc
4870531|NCT02223052|GBM|gbm
4870532|NCT02223039|Psoriasis|psoriasis
4870533|NCT02223039|Dermatology|dermatology
4870534|NCT02223039|Monoclonal antibody|monoclonal antibody
4870535|NCT02222935|Balance training|balance training
4870536|NCT02222935|low back pain|low back pain
4870537|NCT02222935|balance test|balance test
4870538|NCT02222935|routine back exercise|routine back exercise
4870539|NCT02222922|ADC|adc
4870540|NCT02222922|PF-06647020|pf-06647020
4870541|NCT02222922|solid tumors|solid tumors
4870542|NCT02222922|tumors|tumors
4870543|NCT02222922|neoplasm metastasis|neoplasm metastasis
4870544|NCT02222922|TNBC|tnbc
4870545|NCT02222922|triple negative breast cancer|triple negative breast cancer
4870546|NCT02222922|NSCLC|nsclc
4870547|NCT02222922|non small cell lung cancer|non small cell lung cancer
4870548|NCT02222922|advanced metastatic breast cancer|advanced metastatic breast cancer
4870549|NCT02222922|ovarian cancer|ovarian cancer
4870550|NCT02222922|OVCA|ovca
4870551|NCT02222909|Community Based Organization|community based organization
4870552|NCT02222909|Reverse Innovation|reverse innovation
4870553|NCT02222909|Social Services|social services
4870554|NCT02222909|Referral|referral
4870555|NCT02222909|Chronic disease|chronic disease
4870556|NCT02222870|Influenza|influenza
4870557|NCT02222870|Influenza virus vaccine|influenza virus vaccine
4870558|NCT02222870|Quadrivalent Influenza Virus Vaccine (No Preservative)|quadrivalent influenza virus vaccine (no preservative)
4870559|NCT02222870|Fluzone®|fluzone®
4870560|NCT02222857|Acute retinal necrosis|acute retinal necrosis
4870561|NCT02222857|Retinal detachment|retinal detachment
4870562|NCT02222857|Laser photocoagulation|laser photocoagulation
4870563|NCT02222857|Vitrectomy|vitrectomy
4870564|NCT02222844|Cancer|cancer
4870565|NCT02222844|Colorectal Neoplasms|colorectal neoplasms
4870566|NCT02222844|Colon, Sigmoid|colon, sigmoid
4870567|NCT02222844|Magnetic Resonance Imaging|magnetic resonance imaging
4870568|NCT02222844|General Surgery|general surgery
4870569|NCT02222844|Postoperative Complications|postoperative complications
4870570|NCT02222831|IVF|ivf
4870571|NCT02222831|Embryo Quality|embryo quality
4870572|NCT02222831|Time Lapse Culture|time lapse culture
4870573|NCT02222831|Preimplantation factor|preimplantation factor
4870574|NCT02222805|Cord clamping|cord clamping
4870575|NCT02222805|Iron deficiency|iron deficiency
4870576|NCT02222805|Anemia|anemia
4870577|NCT02222805|Iron|iron
4870578|NCT02222805|Hyperbilirubinemia|hyperbilirubinemia
4870579|NCT02222805|Jaundice|jaundice
4870580|NCT02222805|Neurodevelopment|neurodevelopment
4870831|NCT02221596|25(OH)D|25(oh)d
4870581|NCT02222792|Staphylococci, Streptococci, P acnes and Gram-negative bacteria|staphylococci, streptococci, p acnes and gram-negative bacteria
4870582|NCT02222740|Safety|safety
4870583|NCT02222740|Tolerability|tolerability
4870584|NCT02222740|Pharmacokinetics|pharmacokinetics
4870585|NCT02222714|ischemic stroke|ischemic stroke
4870586|NCT02222714|stroke|stroke
4870587|NCT02222714|APC|apc
4870588|NCT02222714|3K3A|3k3a
4870589|NCT02222714|3K3A-APC|3k3a-apc
4870590|NCT02222714|activated protein C|activated protein c
4870591|NCT02222714|RHAPSODY|rhapsody
4870592|NCT02222701|composite|composite
4870593|NCT02222701|dental|dental
4870594|NCT02222701|longevity|longevity
4870595|NCT02222688|cancer|cancer
4870596|NCT02222688|CLL|cll
4870597|NCT02222662|Massage|massage
4870598|NCT02222662|effectiveness|effectiveness
4870599|NCT02222662|autism|autism
4870600|NCT02222662|parent stress|parent stress
4870601|NCT02222649|Elderly|elderly
4870602|NCT02222649|vitamin D insufficiency|vitamin d insufficiency
4870603|NCT02222649|High dose vitamin D3 supplementation|high dose vitamin d3 supplementation
4870604|NCT02222649|Polymorphism of the VDR gene|polymorphism of the vdr gene
4870605|NCT02222636|The efficacy and safety of intranasal dexmedetomidine|the efficacy and safety of intranasal dexmedetomidine
4870606|NCT02222623|insulin|insulin
4870607|NCT02222623|basal|basal
4870608|NCT02222623|diabetes|diabetes
4870609|NCT02222623|hospital|hospital
4870610|NCT02222623|glucose|glucose
4870611|NCT02222623|hypoglycemia|hypoglycemia
4870612|NCT02222623|glargine|glargine
4870613|NCT02222623|NPH|nph
4870614|NCT02222623|neutral protamine hagedorn|neutral protamine hagedorn
4870615|NCT02222610|Radiation Retinopathy|radiation retinopathy
4870616|NCT02222597|head injury|head injury
4870617|NCT02222597|infrascanner|infrascanner
4870618|NCT02222597|intracranial hemorrhage|intracranial hemorrhage
4870619|NCT02222584|inflammatory bowel disease|inflammatory bowel disease
4870620|NCT02222584|physical activity|physical activity
4870621|NCT02222584|disease activity|disease activity
4870622|NCT02222584|quality of life|quality of life
4870623|NCT02222558|hypogonadism|hypogonadism
4870624|NCT02222558|Gonadal Disorders|gonadal disorders
4870625|NCT02222558|Endocrine System Diseases|endocrine system diseases
4870626|NCT02222558|Testosterone|testosterone
4870627|NCT02222558|Testosterone enanthate|testosterone enanthate
4870628|NCT02222558|Testosterone undecanoate|testosterone undecanoate
4870629|NCT02222558|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate
4870630|NCT02222558|Methyltestosterone|methyltestosterone
4870631|NCT02222558|Androgens|androgens
4870632|NCT02222558|Hormones|hormones
4870633|NCT02222558|Hormones,|hormones,
4870634|NCT02222558|Hormone Substitutes,|hormone substitutes,
4870635|NCT02222558|Hormone Antagonists|hormone antagonists
4870636|NCT02222558|Physiological Effects of Drugs|physiological effects of drugs
4870637|NCT02222558|Pharmacologic Actions|pharmacologic actions
4870638|NCT02222558|Therapeutic Uses|therapeutic uses
4870639|NCT02222558|Anabolic Agents|anabolic agents
4870640|NCT02222558|dihydrotestosterone|dihydrotestosterone
4870641|NCT02222545|TMA, aHUS, HSCT-associated TMA, TTP|tma, ahus, hsct-associated tma, ttp
4870642|NCT02222532|tetronine|tetronine
4870643|NCT02222532|congenital heart disease|congenital heart disease
4870644|NCT02222532|cardiopulmonary bypass|cardiopulmonary bypass
4870645|NCT02222532|euthyroid sick syndrome|euthyroid sick syndrome
4870646|NCT02222519|statins|statins
4870647|NCT02222519|nondepolarizing muscle relaxants|nondepolarizing muscle relaxants
4870648|NCT02222519|rocuronium|rocuronium
4870649|NCT02222519|myalgia|myalgia
4870650|NCT02222493|Phase 3|phase 3
4870651|NCT02222493|infliximab|infliximab
4870652|NCT02222493|rheumatoid arthritis|rheumatoid arthritis
4870653|NCT02222480|Patients|patients
4870654|NCT02222480|with mild|with mild
4870655|NCT02222480|moderate|moderate
4870656|NCT02222480|essential|essential
4870657|NCT02222441|Palbociclib|palbociclib
4870658|NCT02222441|Modafinil|modafinil
4870659|NCT02222441|Pioglitazone|pioglitazone
4870660|NCT02222441|Pharmacokinetics|pharmacokinetics
4870661|NCT02222441|Drug-Drug Interaction Study|drug-drug interaction study
4870662|NCT02222441|Healthy Volunteers|healthy volunteers
4870663|NCT02222441|CYP3A Inducers|cyp3a inducers
4870664|NCT02222415|Muscle mass|muscle mass
4870665|NCT02222415|Strength|strength
4870666|NCT02222415|Cross-sectional area|cross-sectional area
4870667|NCT02222415|Protein|protein
4870668|NCT02222402|Quality of Life|quality of life
4870669|NCT02222402|Exercise|exercise
4870670|NCT02222402|Functional Capacity|functional capacity
4870671|NCT02222376|Diabetic ulcer, diabetic foot|diabetic ulcer, diabetic foot
4870672|NCT02222363|Phase I|phase i
4870673|NCT02222363|Iron chelator|iron chelator
4870674|NCT02222363|Refractory advanced solid tumors|refractory advanced solid tumors
4870675|NCT02222363|Dose escalation study|dose escalation study
4870676|NCT02222363|Safety and tolerability|safety and tolerability
4870677|NCT02222363|Tumor response by RECIST 1.1|tumor response by recist 1.1
4870678|NCT02222363|Progression-free survival|progression-free survival
4870679|NCT02222363|Overall survival Pharmacokinetics|overall survival pharmacokinetics
4870680|NCT02222350|type 2 diabetes mellitus|type 2 diabetes mellitus
4870681|NCT02222337|behavioral intervention|behavioral intervention
4870682|NCT02222337|quality of life|quality of life
4870683|NCT02222337|breast cancer|breast cancer
4870684|NCT02222337|Latina|latina
4870685|NCT02222337|caregiver|caregiver
4870686|NCT02222337|PCORI|pcori
4870687|NCT02222324|QTc Interval|qtc interval
4870688|NCT02222324|Healthy Subjects|healthy subjects
4870689|NCT02222272|cml|cml
4870690|NCT02222272|chronic myeloid leukemia|chronic myeloid leukemia
4870691|NCT02222272|dasatinib|dasatinib
4870692|NCT02222272|nilotinib|nilotinib
4870693|NCT02222272|tki|tki
4870694|NCT02222272|second generation tki|second generation tki
4870695|NCT02222272|2nd generation tki|2nd generation tki
4870696|NCT02222259|Geriatric Oncology|geriatric oncology
4870697|NCT02222259|Quality of Life|quality of life
4870698|NCT02222259|Comprehensive Geriatric Assessment|comprehensive geriatric assessment
4870699|NCT02222259|Functional Status|functional status
4870700|NCT02222259|Chemotherapy|chemotherapy
4870701|NCT02222259|Older Adults|older adults
4870702|NCT02222246|Sickle Cell Disease|sickle cell disease
4870703|NCT02222246|Emergency Department|emergency department
4870704|NCT02222246|Vaso-occlusive Crisis|vaso-occlusive crisis
4870705|NCT02222246|Pain Management|pain management
4870706|NCT02222246|Pilot Project|pilot project
4870832|NCT02221596|Aerobic training|aerobic training
4870707|NCT02222207|neovascular Age-related Macular Degeneration|neovascular age-related macular degeneration
4870708|NCT02222194|Lung cancer|lung cancer
4870709|NCT02222194|Surgery|surgery
4870710|NCT02222194|Videomediastinoscopy|videomediastinoscopy
4870711|NCT02222181|elderly, medication adherence,pharmaceutical care|elderly, medication adherence,pharmaceutical care
4870712|NCT02222155|ANCA-associated vasculitis|anca-associated vasculitis
4870713|NCT02222155|complement|complement
4870714|NCT02222155|vasculitis|vasculitis
4870715|NCT02222155|C5aR|c5ar
4870716|NCT02222142|Ischemic heart disease|ischemic heart disease
4870717|NCT02222142|Off pump coronary artery bypass graft|off pump coronary artery bypass graft
4870718|NCT02222142|Isoflurane|isoflurane
4870719|NCT02222142|Propofol|propofol
4870720|NCT02222129|Randomized controlled trial|randomized controlled trial
4870721|NCT02222129|anesthetics-local|anesthetics-local
4870722|NCT02222129|bupivacaine|bupivacaine
4870723|NCT02222129|analgesia|analgesia
4870724|NCT02222129|Pain, Postoperative|pain, postoperative
4870725|NCT02222116|STEMI|stemi
4870726|NCT02222116|BMS|bms
4870727|NCT02222116|DES|des
4870728|NCT02222116|mesh|mesh
4870729|NCT02222090|patients with atrial fibrillation (AF) recommend the use of novel oral anticoagulants (NOACs) in patients with non-valvular AF|patients with atrial fibrillation (af) recommend the use of novel oral anticoagulants (noacs) in patients with non-valvular af
4870730|NCT02222077|Central blood pressure|central blood pressure
4870731|NCT02222077|Ambulatory blood pressure monitoring|ambulatory blood pressure monitoring
4870732|NCT02222077|Target-organ damage|target-organ damage
4870733|NCT02222077|Adolescents and young adults|adolescents and young adults
4870734|NCT02222051|neck pain|neck pain
4870735|NCT02222051|chronic pain|chronic pain
4870736|NCT02221986|Interdisciplinary rehabilitation|interdisciplinary rehabilitation
4870737|NCT02221986|Neurooncology|neurooncology
4870738|NCT02221986|Physiotherapy|physiotherapy
4870739|NCT02221986|Occupational therapy|occupational therapy
4870740|NCT02221986|Neurorehabilitation|neurorehabilitation
4870741|NCT02221986|Glioma|glioma
4870742|NCT02221960|Recurrent or metastatic solid tumors, MEDI6383, OX40|recurrent or metastatic solid tumors, medi6383, ox40
4870743|NCT02221947|Alzheimer's|alzheimer's
4870744|NCT02221947|bryostatin|bryostatin
4870745|NCT02221947|PKC epsilon|pkc epsilon
4870746|NCT02221934|Pain|pain
4870747|NCT02221934|Chronic|chronic
4870748|NCT02221934|Amputation|amputation
4870749|NCT02221934|Phantom Pain|phantom pain
4870750|NCT02221934|Stump Pain|stump pain
4870751|NCT02221908|Systolic Blood pressure < 100 mm Hg|systolic blood pressure < 100 mm hg
4870752|NCT02221895|postpartum appointment|postpartum appointment
4870753|NCT02221895|breastfeeding|breastfeeding
4870754|NCT02221895|postpartum contraception|postpartum contraception
4870755|NCT02221895|postpartum cervical cancer screening|postpartum cervical cancer screening
4870756|NCT02221895|postpartum depression screening|postpartum depression screening
4870757|NCT02221856|Conventional orthodontic treatment|conventional orthodontic treatment
4870758|NCT02221856|Motion View|motion view
4870759|NCT02221843|sun behavior|sun behavior
4870760|NCT02221843|immunosuppression|immunosuppression
4870761|NCT02221843|skin neoplasms|skin neoplasms
4870762|NCT02221843|sunbit|sunbit
4870763|NCT02221843|uv sensor|uv sensor
4870764|NCT02221843|uv dosimeter|uv dosimeter
4870765|NCT02221843|solar radiation|solar radiation
4870766|NCT02221843|uv exposition|uv exposition
4870767|NCT02221843|uv index|uv index
4870768|NCT02221804|Physical Inactivity|physical inactivity
4870769|NCT02221804|Skeletal Muscle|skeletal muscle
4870770|NCT02221804|Cachexia|cachexia
4870771|NCT02221791|Flavan-3-ol|flavan-3-ol
4870772|NCT02221791|Flavonoids|flavonoids
4870773|NCT02221791|Epicatechin|epicatechin
4870774|NCT02221791|Cocoa|cocoa
4870775|NCT02221791|Chocolate|chocolate
4870776|NCT02221791|Endothelial function|endothelial function
4870777|NCT02221791|Bioavailability|bioavailability
4870778|NCT02221778|Carcinoma, Hepatocellular|carcinoma, hepatocellular
4870779|NCT02221778|SBRT|sbrt
4870780|NCT02221765|Obesity|obesity
4870781|NCT02221765|Overnutrition|overnutrition
4870782|NCT02221765|Nutrition Disorders|nutrition disorders
4870783|NCT02221765|Overweight|overweight
4870784|NCT02221765|Body Weight|body weight
4870785|NCT02221765|Signs and Symptoms|signs and symptoms
4870786|NCT02221752|iron deficiency|iron deficiency
4870787|NCT02221752|iron deficiency anemia|iron deficiency anemia
4870788|NCT02221752|infant|infant
4870789|NCT02221752|pregnancy|pregnancy
4870790|NCT02221739|lung cancer|lung cancer
4870791|NCT02221739|NSCLC|nsclc
4870792|NCT02221739|lung|lung
4870793|NCT02221739|cancer|cancer
4870794|NCT02221739|radiation|radiation
4870795|NCT02221739|immunotherapy|immunotherapy
4870796|NCT02221739|metastatic|metastatic
4870797|NCT02221726|Healthy|healthy
4870798|NCT02221726|JNJ-35685-AAA-G-023|jnj-35685-aaa-g-023
4870799|NCT02221726|Placebo|placebo
4870800|NCT02221726|Transdermal delivery device system|transdermal delivery device system
4870801|NCT02221713|diverticulitis|diverticulitis
4870802|NCT02221713|diverticulosis|diverticulosis
4870803|NCT02221713|diverticular disease|diverticular disease
4870804|NCT02221700|Gastrointestinal cancer|gastrointestinal cancer
4870805|NCT02221700|Chemotherapy Induced Peripheral Neuropathy|chemotherapy induced peripheral neuropathy
4870806|NCT02221700|CIPN|cipn
4870807|NCT02221700|Symptom reduction|symptom reduction
4870808|NCT02221700|Massage|massage
4870809|NCT02221700|Symptom questionnaires|symptom questionnaires
4870810|NCT02221700|Surveys|surveys
4870811|NCT02221700|Leg function and balance tests|leg function and balance tests
4870812|NCT02221687|synbiotic formula|synbiotic formula
4870813|NCT02221687|infant formula|infant formula
4870814|NCT02221687|diarrhea|diarrhea
4870815|NCT02221674|Post-surgical pain|post-surgical pain
4870816|NCT02221674|Opioid|opioid
4870817|NCT02221661|Alzheimer|alzheimer
4870818|NCT02221661|cognitive impairment|cognitive impairment
4870819|NCT02221661|blood test|blood test
4870820|NCT02221648|Back|back
4870821|NCT02221648|Pain|pain
4870822|NCT02221648|Muscle|muscle
4870823|NCT02221635|Schizoaffective Disorder|schizoaffective disorder
4870824|NCT02221635|Repetitive transcranial magnetic stimulation (rTMS)|repetitive transcranial magnetic stimulation (rtms)
4870825|NCT02221622|Alzheimer's disease|alzheimer's disease
4870826|NCT02221622|Mild Cognitive Impairment|mild cognitive impairment
4870827|NCT02221622|Dementia|dementia
4870828|NCT02221622|Regenerative therapeutic|regenerative therapeutic
4870829|NCT02221609|Low Back Pain, Mechanical Low Back Pain, Low Back Ache, Low Backache, Lower Back Pain, Lumbago|low back pain, mechanical low back pain, low back ache, low backache, lower back pain, lumbago
4870830|NCT02221596|Vitamin D|vitamin d
4870833|NCT02221596|Near-infrared spectroscopy|near-infrared spectroscopy
4870834|NCT02221596|Diffuse correlation spectroscopy|diffuse correlation spectroscopy
4870835|NCT02221596|MRS|mrs
4870836|NCT02221583|End stage renal disease|end stage renal disease
4870837|NCT02221583|Renal transplant candidate|renal transplant candidate
4870838|NCT02221583|Laparoscopic sleeve gastrectomy|laparoscopic sleeve gastrectomy
4870839|NCT02221583|Immunosuppressants|immunosuppressants
4870840|NCT02221544|Parkinson's disease, rTMS, Freezing of Gait|parkinson's disease, rtms, freezing of gait
4870841|NCT02221518|OCD|ocd
4870842|NCT02221518|Functional Magnetic Resonance Imaging (fMRI)|functional magnetic resonance imaging (fmri)
4870843|NCT02221505|LOP628,|lop628,
4870844|NCT02221505|cKit,|ckit,
4870845|NCT02221505|ADC,|adc,
4870846|NCT02221505|Antibody drug conjugates,|antibody drug conjugates,
4870847|NCT02221505|maytansine|maytansine
4870848|NCT02221466|diabetes|diabetes
4870849|NCT02221466|foot|foot
4870850|NCT02221466|wounds|wounds
4870851|NCT02221466|nitric oxide|nitric oxide
4870852|NCT02221466|endothelium|endothelium
4870853|NCT02221466|infection|infection
4870854|NCT02221466|biological markers|biological markers
4870855|NCT02221466|observational study|observational study
4870856|NCT02221466|hyperbaric oxygen|hyperbaric oxygen
4870857|NCT02221466|ulcers|ulcers
4870858|NCT02221466|cytokines|cytokines
4870859|NCT02221466|inflammation|inflammation
4870860|NCT02221453|Diabetic Macular Edema|diabetic macular edema
4870861|NCT02221453|Ocular Cytokines|ocular cytokines
4870862|NCT02221453|Triamcinolone Acetonide|triamcinolone acetonide
4870863|NCT02221427|First time mothers|first time mothers
4870864|NCT02221427|Labour progression|labour progression
4870865|NCT02221427|Prolonged labour|prolonged labour
4870866|NCT02221427|Oxytocin|oxytocin
4870867|NCT02221427|Mode of delivery|mode of delivery
4870868|NCT02221427|Maternal birth outcome|maternal birth outcome
4870869|NCT02221427|Neonatal birth outcome|neonatal birth outcome
4870870|NCT02221349|Sensitivity|sensitivity
4870871|NCT02221336|Bipolar disorder|bipolar disorder
4870872|NCT02221336|Daily electronic monitoring|daily electronic monitoring
4870873|NCT02221336|Smartphones|smartphones
4870874|NCT02221336|Subjective and objective smartphone data|subjective and objective smartphone data
4870875|NCT02221336|Feedback loop|feedback loop
4870876|NCT02221310|targeted therapy|targeted therapy
4870877|NCT02221310|leukemia|leukemia
4870878|NCT02221310|MDS|mds
4870879|NCT02221310|immune therapy|immune therapy
4870880|NCT02221284|Pharmacological therapy|pharmacological therapy
4870881|NCT02221258|Rheumatoid Arthritis|rheumatoid arthritis
4870882|NCT02221258|Rheumatic Disease|rheumatic disease
4870883|NCT02221258|RA|ra
4870884|NCT02221258|Stem cell|stem cell
4870885|NCT02221258|Cell therapy|cell therapy
4870886|NCT02221258|furestem|furestem
4870887|NCT02221258|Umbilical cord Blood|umbilical cord blood
4870888|NCT02221258|hUCB-MSC|hucb-msc
4870889|NCT02221258|UCB-MSC|ucb-msc
4870890|NCT02221245|Esophageal cancer|esophageal cancer
4870891|NCT02221245|Cancer Stem Cell|cancer stem cell
4870892|NCT02221245|CSC|csc
4870893|NCT02221245|Wnt|wnt
4870894|NCT02221245|Hegdehog|hegdehog
4870895|NCT02221245|Notch|notch
4870896|NCT02221245|Signaling|signaling
4870897|NCT02221245|Pathway|pathway
4870898|NCT02221245|Chemo-naive|chemo-naive
4870899|NCT02221232|ZuraPrep|zuraprep
4870900|NCT02221232|Antimicrobial|antimicrobial
4870901|NCT02221232|Bio-Science Laboratories|bio-science laboratories
4870902|NCT02221232|Zurex Pharma|zurex pharma
4870903|NCT02221232|Surgical/Patient preoperative skin preparation|surgical/patient preoperative skin preparation
4870904|NCT02221219|infant|infant
4870905|NCT02221219|brain injury|brain injury
4870906|NCT02221219|renal|renal
4870907|NCT02221219|indomethacin|indomethacin
4870908|NCT02221206|Mini-Screw implant anchorage|mini-screw implant anchorage
4870909|NCT02221206|retraction of maxillary incisors|retraction of maxillary incisors
4870910|NCT02221180|Bioequivalence|bioequivalence
4870911|NCT02221180|Metformin|metformin
4870912|NCT02221180|Canagliflozin|canagliflozin
4870913|NCT02221180|Healthy|healthy
4870914|NCT02221167|breastfeeding|breastfeeding
4870915|NCT02221167|donor milk|donor milk
4870916|NCT02221167|formula|formula
4870917|NCT02221167|exclusive breastfeeding|exclusive breastfeeding
4870918|NCT02221167|newborn|newborn
4870919|NCT02221154|in vitro fertilization|in vitro fertilization
4870920|NCT02221154|ovarian hyperstimulation|ovarian hyperstimulation
4870921|NCT02221154|pregnancy|pregnancy
4870922|NCT02221115|Google Glass device|google glass device
4870923|NCT02221115|Evaluation|evaluation
4870924|NCT02221115|patient's|patient's
4870925|NCT02221115|response|response
4870926|NCT02221115|to new technology|to new technology
4870927|NCT02221115|clinical setting|clinical setting
4870928|NCT02221102|edoxaban|edoxaban
4870929|NCT02221102|aspirin|aspirin
4870930|NCT02221102|new oral anticoagulant|new oral anticoagulant
4870931|NCT02221102|TIA|tia
4870932|NCT02221102|acute minor ischemic stroke|acute minor ischemic stroke
4870933|NCT02221089|Effect of Retaron on imparied retinal vascular reactivity after LPS administration in healthy subjects|effect of retaron on imparied retinal vascular reactivity after lps administration in healthy subjects
4870934|NCT02221076|Cellvizio|cellvizio
4870935|NCT02221076|Endomicroscopy|endomicroscopy
4870936|NCT02221076|Robot-assisted procedure|robot-assisted procedure
4870937|NCT02221076|Cervix cancer|cervix cancer
4870938|NCT02221076|Endocervix cancer|endocervix cancer
4870939|NCT02221076|Endometrium cancer|endometrium cancer
4870940|NCT02221076|Ovarian cancer|ovarian cancer
4870941|NCT02221076|Tubal cancer|tubal cancer
4870942|NCT02221076|Colposcopy|colposcopy
4870943|NCT02221076|Hysteroscopy|hysteroscopy
4870944|NCT02221063|thiamin|thiamin
4870945|NCT02221063|thiamin diphosphate|thiamin diphosphate
4870946|NCT02221063|beriberi|beriberi
4870947|NCT02221063|Cambodia|cambodia
4870948|NCT02221063|fish sauce|fish sauce
4870949|NCT02221063|fortification|fortification
4870950|NCT02221063|pregnancy|pregnancy
4870951|NCT02221063|breastfeeding|breastfeeding
4870952|NCT02221063|childbearing age|childbearing age
4870953|NCT02221037|PaO2/FiO2|pao2/fio2
4870954|NCT02221037|Peri-operative lung injury|peri-operative lung injury
4870955|NCT02221037|EVLWI|evlwi
4870956|NCT02221037|ARDS|ards
4870957|NCT02221037|PVPI|pvpi
4870958|NCT02221037|SOFA scores|sofa scores
4870959|NCT02221037|GSK2862277|gsk2862277
4870960|NCT02221037|Oesophagectomy|oesophagectomy
4870961|NCT02221024|Peripheral intravenous catheter|peripheral intravenous catheter
4870962|NCT02221024|Peripheral intravenous lock|peripheral intravenous lock
4870963|NCT02221024|Normal saline|normal saline
4870964|NCT02221024|Patency|patency
4870965|NCT02221024|Management|management
4870966|NCT02221024|of peripheral|of peripheral
4870967|NCT02221024|intravenous catheter|intravenous catheter
4870968|NCT02221011|Shock wave|shock wave
4870969|NCT02221011|Spasticity|spasticity
4870970|NCT02221011|Effect|effect
4870971|NCT02220998|Hepatitis C|hepatitis c
4870972|NCT02220998|HCV|hcv
4870973|NCT02220998|cirrhosis|cirrhosis
4870974|NCT02220998|Sofosbuvir|sofosbuvir
4870975|NCT02220998|Sovaldi|sovaldi
4870976|NCT02220998|SOF/VEL|sof/vel
4870977|NCT02220998|GS-5816|gs-5816
4870978|NCT02220998|GS-7977|gs-7977
4870979|NCT02220998|liver|liver
4870980|NCT02220998|Treatment naive|treatment naive
4870981|NCT02220998|Treatment Experience|treatment experience
4870982|NCT02220998|genotype 2|genotype 2
4870983|NCT02220972|Epilepsy|epilepsy
4870984|NCT02220972|Partial Onset Seizures|partial onset seizures
4870985|NCT02220972|Insomnia|insomnia
4870986|NCT02220959|morbid obesity surgery|morbid obesity surgery
4870987|NCT02220959|walk test|walk test
4870988|NCT02220959|exercise|exercise
4870989|NCT02220946|Vaginal Electrical Stimulation|vaginal electrical stimulation
4870990|NCT02220933|Multiple Sclerosis|multiple sclerosis
4870991|NCT02220933|MS|ms
4870992|NCT02220933|EDSS|edss
4870993|NCT02220920|insulin resistance|insulin resistance
4870994|NCT02220907|MT-2412|mt-2412
4870995|NCT02220907|MP-513|mp-513
4870996|NCT02220907|TA-7284|ta-7284
4870997|NCT02220907|Teneligliptin|teneligliptin
4870998|NCT02220907|Canagliflozin|canagliflozin
4870999|NCT02220894|PD-1|pd-1
4871000|NCT02220894|PD1|pd1
4871001|NCT02220894|PD-L1|pd-l1
4871002|NCT02220894|PDL1|pdl1
4871003|NCT02220881|Hallux valgus, Mold making silicone toe separator, Toe separator|hallux valgus, mold making silicone toe separator, toe separator
4871004|NCT02220868|HIV|hiv
4871005|NCT02220868|HCV|hcv
4871006|NCT02220868|DAA|daa
4871007|NCT02220829|alpha-blocker|alpha-blocker
4871008|NCT02220829|symptomatic urinary problems|symptomatic urinary problems
4871009|NCT02220829|radiation therapy|radiation therapy
4871010|NCT02220829|prostate cancer|prostate cancer
4871011|NCT02220816|Attention|attention
4871012|NCT02220816|Competitive|competitive
4871013|NCT02220816|Training|training
4871014|NCT02220803|Acetazolamide|acetazolamide
4871015|NCT02220803|Zonegran|zonegran
4871016|NCT02220803|Obstructive Sleep apnea|obstructive sleep apnea
4871017|NCT02220803|Apnea|apnea
4871018|NCT02220803|Respiration Disorders|respiration disorders
4871019|NCT02220803|Sleep Disorders|sleep disorders
4871020|NCT02220803|Cardiovascular|cardiovascular
4871021|NCT02220803|Hypertension|hypertension
4871022|NCT02220803|Carbonic Anhydrase|carbonic anhydrase
4871023|NCT02220803|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors
4871024|NCT02220803|Enzyme Inhibitors|enzyme inhibitors
4871025|NCT02220803|Sulfonamides|sulfonamides
4871026|NCT02220803|Therapeutic Uses|therapeutic uses
4871027|NCT02220803|Pharmacologic Actions|pharmacologic actions
4871028|NCT02220803|Vascular stifness|vascular stifness
4871029|NCT02220790|IPFN|ipfn
4871030|NCT02220790|Pediatric|pediatric
4871031|NCT02220790|Fungal|fungal
4871032|NCT02220790|Biomarker Assays|biomarker assays
4871033|NCT02220790|Candida|candida
4871034|NCT02220790|Pediatric ICU patient|pediatric icu patient
4871035|NCT02220777|MTD (Maximum Tolerated Dose)|mtd (maximum tolerated dose)
4871036|NCT02220777|Food effect|food effect
4871037|NCT02220777|Postmenopausal subjects|postmenopausal subjects
4871038|NCT02220777|Vasectomized subjects|vasectomized subjects
4871039|NCT02220777|FIH (First In Humans)|fih (first in humans)
4871040|NCT02220777|SAD (Single Ascending Dose)|sad (single ascending dose)
4871041|NCT02220777|DDI (Drug-Drug Interaction)|ddi (drug-drug interaction)
4871042|NCT02220764|prospective study|prospective study
4871043|NCT02220764|chipping|chipping
4871044|NCT02220764|survival rate|survival rate
4871045|NCT02220764|fracture resistance|fracture resistance
4871046|NCT02220764|zirconia|zirconia
4871047|NCT02220751|Periodontal Attachment Loss|periodontal attachment loss
4871048|NCT02220751|Genes|genes
4871049|NCT02220751|Saliva|saliva
4871050|NCT02220751|Diagnosis|diagnosis
4871051|NCT02220738|Alzheimer's Disease|alzheimer's disease
4871052|NCT02220725|Andexanet alpha|andexanet alpha
4871053|NCT02220725|Anticoagulation|anticoagulation
4871054|NCT02220725|Antidote|antidote
4871055|NCT02220725|Rivaroxaban|rivaroxaban
4871056|NCT02220725|Anti-fXa inhibitor|anti-fxa inhibitor
4871057|NCT02220725|PRT4445|prt4445
4871058|NCT02220725|Xarelto|xarelto
4871059|NCT02220725|Reversal agent|reversal agent
4871060|NCT02220712|Aripiprazole|aripiprazole
4871061|NCT02220712|Deltoid|deltoid
4871062|NCT02220699|Ostoporosis|ostoporosis
4871063|NCT02220699|Primary Prevention|primary prevention
4871064|NCT02220699|Health Promotion|health promotion
4871065|NCT02220699|General Practice|general practice
4871066|NCT02220699|Secondary screening|secondary screening
4871266|NCT02219711|NTRK|ntrk
4871067|NCT02220699|Patients at increased risk of osteoporosis|patients at increased risk of osteoporosis
4871068|NCT02220686|VAPOR|vapor
4871069|NCT02220686|smoking cessation|smoking cessation
4871070|NCT02220686|PAD|pad
4871071|NCT02220621|Intrauterine adhesion|intrauterine adhesion
4871072|NCT02220621|crosslinked hyaluronan gel|crosslinked hyaluronan gel
4871073|NCT02220621|hysteroscopy|hysteroscopy
4871074|NCT02220621|clinical trial|clinical trial
4871075|NCT02220608|Multiple Myeloma|multiple myeloma
4871076|NCT02220608|G-CSF|g-csf
4871077|NCT02220608|Bortezomib|bortezomib
4871078|NCT02220595|Stenting|stenting
4871079|NCT02220595|Endarterectomy|endarterectomy
4871080|NCT02220595|Cognition|cognition
4871081|NCT02220582|Cardiac Magnetic Resonance (CMR)|cardiac magnetic resonance (cmr)
4871082|NCT02220582|Cardiovascular Diseases|cardiovascular diseases
4871083|NCT02220582|socio-environmental factors|socio-environmental factors
4871084|NCT02220582|Contextual factors|contextual factors
4871085|NCT02220543|Cognitive behavioral therapy|cognitive behavioral therapy
4871086|NCT02220543|Primary health care|primary health care
4871087|NCT02220543|Physical Therapy|physical therapy
4871088|NCT02220530|Sedation.|sedation.
4871089|NCT02220530|Colonoscopy quality.|colonoscopy quality.
4871090|NCT02220530|Scientific and technical quality.|scientific and technical quality.
4871091|NCT02220530|Perceived quality (patient's satisfaction).|perceived quality (patient's satisfaction).
4871092|NCT02220530|Safety|safety
4871093|NCT02220517|MRI/US fusion-guided prostate biopsy|mri/us fusion-guided prostate biopsy
4871094|NCT02220517|MR-guided in-bore prostate biopsy|mr-guided in-bore prostate biopsy
4871095|NCT02220517|prostate cancer|prostate cancer
4871096|NCT02220504|Treatment|treatment
4871097|NCT02220504|Maintenance|maintenance
4871098|NCT02220478|hip|hip
4871099|NCT02220478|Signature|signature
4871100|NCT02220465|sedentary|sedentary
4871101|NCT02220465|smoking|smoking
4871102|NCT02220465|cue reactivity|cue reactivity
4871103|NCT02220465|physical activity|physical activity
4871104|NCT02220439|rotavirus|rotavirus
4871105|NCT02220439|immunogenicity|immunogenicity
4871106|NCT02220439|enteric vaccine|enteric vaccine
4871107|NCT02220439|vaccine immunogenicity|vaccine immunogenicity
4871108|NCT02220439|rotavirus vaccine|rotavirus vaccine
4871109|NCT02220439|gut microbiome|gut microbiome
4871110|NCT02220439|microbiome|microbiome
4871111|NCT02220426|Brown adipose tissue|brown adipose tissue
4871112|NCT02220426|Hyperpolarized xenon gas MRI|hyperpolarized xenon gas mri
4871113|NCT02220413|Breastmilk|breastmilk
4871114|NCT02220413|Lactogenesis|lactogenesis
4871115|NCT02220413|Obesity|obesity
4871116|NCT02220400|Postoperative cognitive dysfunction|postoperative cognitive dysfunction
4871117|NCT02220400|Ketamine|ketamine
4871118|NCT02220400|Surgery|surgery
4871119|NCT02220387|occupational COPD|occupational copd
4871120|NCT02220387|phenotype|phenotype
4871121|NCT02220387|genetic|genetic
4871122|NCT02220374|Osteoarthritis|osteoarthritis
4871123|NCT02220374|Finger|finger
4871124|NCT02220374|Supportive|supportive
4871125|NCT02220374|Tape|tape
4871126|NCT02220374|Pain|pain
4871127|NCT02220374|Function|function
4871128|NCT02220374|Trial|trial
4871129|NCT02220348|Linzess|linzess
4871130|NCT02220335|pulmonary hypertension|pulmonary hypertension
4871131|NCT02220335|pulmonary arterial denervation|pulmonary arterial denervation
4871132|NCT02220335|left heart failure|left heart failure
4871133|NCT02220335|6-min walk distance|6-min walk distance
4871134|NCT02220322|cortical thickness|cortical thickness
4871135|NCT02220322|age|age
4871136|NCT02220309|Anxiety|anxiety
4871137|NCT02220309|Depression|depression
4871138|NCT02220309|Social Anxiety Disorder|social anxiety disorder
4871139|NCT02220309|Bipolar disorder II|bipolar disorder ii
4871140|NCT02220309|PTSD|ptsd
4871141|NCT02220309|GAD|gad
4871142|NCT02220309|Phobia|phobia
4871143|NCT02220283|Acute kidney injury,aortic dissection|acute kidney injury,aortic dissection
4871144|NCT02220257|diabetes mellitus type 1|diabetes mellitus type 1
4871145|NCT02220257|remission, honeymoon|remission, honeymoon
4871146|NCT02220257|microangiopathy|microangiopathy
4871147|NCT02220244|multiple sclerosis (MS)|multiple sclerosis (ms)
4871148|NCT02220244|optic neuritis|optic neuritis
4871149|NCT02220244|visual defect|visual defect
4871150|NCT02220244|visual loss|visual loss
4871151|NCT02220244|relapsing remitting multiple sclerosis (RRMS)|relapsing remitting multiple sclerosis (rrms)
4871152|NCT02220244|primary progressive multiple sclerosis (PPMS)|primary progressive multiple sclerosis (ppms)
4871153|NCT02220244|secondary progressive multiple sclerosis (SPMS)|secondary progressive multiple sclerosis (spms)
4871154|NCT02220231|mediastinal mass, one-lung ventilation, capnothorax, transesophageal echocardiography|mediastinal mass, one-lung ventilation, capnothorax, transesophageal echocardiography
4871155|NCT02220218|Healthy|healthy
4871156|NCT02220218|Metformin|metformin
4871157|NCT02220218|Canagliflozin|canagliflozin
4871158|NCT02220218|JNJ-28431754|jnj-28431754
4871159|NCT02220205|IUD|iud
4871160|NCT02220205|training|training
4871161|NCT02220205|simulation|simulation
4871162|NCT02220192|cervical neoplasia|cervical neoplasia
4871163|NCT02220192|cervix|cervix
4871164|NCT02220192|high-grade dysplasia|high-grade dysplasia
4871267|NCT02219711|DDR2|ddr2
4871268|NCT02219711|KDR|kdr
4871165|NCT02220192|LEEP (loop electrosurgical excision procedure)|leep (loop electrosurgical excision procedure)
4871166|NCT02220192|precancerous cells|precancerous cells
4871167|NCT02220192|colposcopy|colposcopy
4871168|NCT02220166|Celiac Disease|celiac disease
4871169|NCT02220166|Gluten|gluten
4871170|NCT02220166|Gluten free diet|gluten free diet
4871171|NCT02220166|Triticum monococcum|triticum monococcum
4871172|NCT02220153|Monoclonal antibody|monoclonal antibody
4871173|NCT02220153|subjects|subjects
4871174|NCT02220153|First in human|first in human
4871175|NCT02220127|Brain|brain
4871176|NCT02220127|Neoplasm Micrometastasis|neoplasm micrometastasis
4871177|NCT02220127|Gamma Knife Radiosurgery|gamma knife radiosurgery
4871178|NCT02220114|Infantile spasms|infantile spasms
4871179|NCT02220114|vigabatrin|vigabatrin
4871180|NCT02220114|soluble tablets|soluble tablets
4871181|NCT02220114|acceptability|acceptability
4871182|NCT02220114|adherence|adherence
4871183|NCT02220114|pharmacokinetics|pharmacokinetics
4871184|NCT02220101|hypothermia|hypothermia
4871185|NCT02220101|core temperature|core temperature
4871186|NCT02220101|temperature measurement methods|temperature measurement methods
4871187|NCT02220088|Hepatocellular Carcinoma|hepatocellular carcinoma
4871188|NCT02220088|TACE|tace
4871189|NCT02220088|TACE failure|tace failure
4871190|NCT02220088|TACE refractoriness|tace refractoriness
4871191|NCT02220088|BCLC B|bclc b
4871192|NCT02220075|fiberoptic, LMA, caudal block|fiberoptic, lma, caudal block
4871193|NCT02220036|Diabetic nephropathy|diabetic nephropathy
4871194|NCT02220036|Renal function|renal function
4871195|NCT02220036|Insulin resistance|insulin resistance
4871196|NCT02220036|Metabolic profile|metabolic profile
4871197|NCT02220036|Serum magnesium level|serum magnesium level
4871198|NCT02220010|Post operative pancreatic fistulas|post operative pancreatic fistulas
4871199|NCT02220010|Pancreatic stenting|pancreatic stenting
4871200|NCT02219997|Cataract|cataract
4871201|NCT02219997|Intraocular lens (IOL)|intraocular lens (iol)
4871202|NCT02219997|AcrySof|acrysof
4871203|NCT02219984|Anticoagulation|anticoagulation
4871204|NCT02219984|vitamin K antagonists|vitamin k antagonists
4871205|NCT02219984|Warfarin|warfarin
4871206|NCT02219984|low molecular weight heparin|low molecular weight heparin
4871207|NCT02219984|fondaparinux|fondaparinux
4871208|NCT02219984|antithrombotics|antithrombotics
4871209|NCT02219984|Direct oral anticoagulants|direct oral anticoagulants
4871210|NCT02219984|dabigatran|dabigatran
4871211|NCT02219984|rivaroxaban|rivaroxaban
4871212|NCT02219984|apixaban|apixaban
4871213|NCT02219984|edoxaban|edoxaban
4871214|NCT02219984|atrial fibrillation|atrial fibrillation
4871215|NCT02219984|venous thromboembolism|venous thromboembolism
4871216|NCT02219971|Healthy|healthy
4871217|NCT02219958|Hypertension|hypertension
4871218|NCT02219945|pulmonary tuberculosis; electronic nose; diagnostic accuracy|pulmonary tuberculosis; electronic nose; diagnostic accuracy
4871219|NCT02219932|Fampridine|fampridine
4871220|NCT02219919|Carpal Tunnel Syndrome|carpal tunnel syndrome
4871221|NCT02219919|Pain|pain
4871222|NCT02219919|Sensitivity|sensitivity
4871223|NCT02219919|Pain Thresholds|pain thresholds
4871224|NCT02219919|Sensitization|sensitization
4871225|NCT02219919|Physical Therapy|physical therapy
4871226|NCT02219893|Peritoneal Carcinomatosis|peritoneal carcinomatosis
4871227|NCT02219893|Peritoneal Metastasis|peritoneal metastasis
4871228|NCT02219893|Colorectal Cancer|colorectal cancer
4871229|NCT02219893|Cytoreductive surgery|cytoreductive surgery
4871230|NCT02219893|HIPEC|hipec
4871231|NCT02219893|Intraperitoneal treatment|intraperitoneal treatment
4871232|NCT02219893|Immunotoxin|immunotoxin
4871233|NCT02219893|MOC31PE|moc31pe
4871234|NCT02219880|Kava|kava
4871235|NCT02219880|Anxiety|anxiety
4871236|NCT02219880|Generalized Anxiety Disorder|generalized anxiety disorder
4871237|NCT02219880|Psychiatric|psychiatric
4871238|NCT02219880|Anxiolytic|anxiolytic
4871239|NCT02219880|GABA|gaba
4871240|NCT02219880|Kavalactones|kavalactones
4871241|NCT02219867|ketamine|ketamine
4871242|NCT02219867|MDD|mdd
4871243|NCT02219841|Obesity, low-calorie diet, exercise, atrial fibrillation|obesity, low-calorie diet, exercise, atrial fibrillation
4871244|NCT02219828|pericarditis|pericarditis
4871245|NCT02219828|recurrent pericarditis|recurrent pericarditis
4871246|NCT02219828|corticosteroids|corticosteroids
4871247|NCT02219828|anakinra|anakinra
4871248|NCT02219815|Preoperative Care|preoperative care
4871249|NCT02219815|Exercise Therapy|exercise therapy
4871250|NCT02219815|Cardiac Surgery|cardiac surgery
4871251|NCT02219815|Frailty|frailty
4871252|NCT02219802|Coronary artery disease|coronary artery disease
4871253|NCT02219802|Acute myocardial infarction|acute myocardial infarction
4871254|NCT02219802|Drug-coated balloon|drug-coated balloon
4871255|NCT02219802|Drug-eluting stent|drug-eluting stent
4871256|NCT02219776|Infection,|infection,
4871257|NCT02219776|Proprionbacterium Acne,|proprionbacterium acne,
4871258|NCT02219776|Shoulder,|shoulder,
4871259|NCT02219776|skin preparation|skin preparation
4871260|NCT02219750|premix insuiln, basal-plus insulin|premix insuiln, basal-plus insulin
4871261|NCT02219711|MGCD516|mgcd516
4871262|NCT02219711|MET|met
4871263|NCT02219711|AXL|axl
4871264|NCT02219711|RET|ret
4871265|NCT02219711|TRK|trk
4871269|NCT02219711|VEGFR|vegfr
4871270|NCT02219711|PDGFRA|pdgfra
4871271|NCT02219711|KIT|kit
4871272|NCT02219711|Tyrosine kinase inhibitor|tyrosine kinase inhibitor
4871273|NCT02219711|NSCLC|nsclc
4871274|NCT02219711|Non-small cell lung cancer|non-small cell lung cancer
4871275|NCT02219711|Head and neck cancer|head and neck cancer
4871276|NCT02219711|Renal cell carcinoma|renal cell carcinoma
4871277|NCT02219711|Prostate cancer|prostate cancer
4871278|NCT02219711|Phase 1|phase 1
4871279|NCT02219711|CBL|cbl
4871280|NCT02219672|Triptolide wilfordii HIV-1 reservoir acute hiv infection|triptolide wilfordii hiv-1 reservoir acute hiv infection
4871281|NCT02219659|sedation strategy|sedation strategy
4871282|NCT02219659|mechanical ventilation|mechanical ventilation
4871283|NCT02219659|ventilator weaning|ventilator weaning
4871284|NCT02219646|T2DM|t2dm
4871285|NCT02219646|ED|ed
4871286|NCT02219620|creative arts|creative arts
4871287|NCT02219620|older adults|older adults
4871288|NCT02219620|intervention study|intervention study
4871289|NCT02219594|gemstone CT|gemstone ct
4871290|NCT02219594|320-detector row spiral CT|320-detector row spiral ct
4871291|NCT02219594|optical coherence tomography(OCT)|optical coherence tomography(oct)
4871292|NCT02219594|in-stent restenosis|in-stent restenosis
4871293|NCT02219594|coronary heart disease|coronary heart disease
4871294|NCT02219581|Osteoarthritis|osteoarthritis
4871295|NCT02219581|Postoperative pain|postoperative pain
4871296|NCT02219581|Total knee arthroplasty|total knee arthroplasty
4871297|NCT02219581|Orthopaedics|orthopaedics
4871298|NCT02219581|Inflammation|inflammation
4871299|NCT02219568|obscure gastrointestinal bleeding, CT enterography|obscure gastrointestinal bleeding, ct enterography
4871300|NCT02219555|Carpal tunnel|carpal tunnel
4871301|NCT02219542|cytokine Transversus Abdominis Plane Block|cytokine transversus abdominis plane block
4871302|NCT02219503|Hepatitis C|hepatitis c
4871303|NCT02219503|Chronic Hepatitis C|chronic hepatitis c
4871304|NCT02219503|Compensated Cirrhosis|compensated cirrhosis
4871305|NCT02219503|Cirrhotic|cirrhotic
4871306|NCT02219503|Hepatitis C Genotype 1b|hepatitis c genotype 1b
4871307|NCT02219503|Hepatitis C Virus|hepatitis c virus
4871308|NCT02219503|Interferon-Free|interferon-free
4871309|NCT02219503|Child Pugh A|child pugh a
4871310|NCT02219503|Ribavirin-Free|ribavirin-free
4871311|NCT02219490|Hepatitis C Genotype 1|hepatitis c genotype 1
4871312|NCT02219490|Compensated Cirrhosis|compensated cirrhosis
4871313|NCT02219490|Cirrhosis|cirrhosis
4871314|NCT02219490|Naive|naive
4871315|NCT02219490|Treatment-Experienced|treatment-experienced
4871316|NCT02219490|Relapser|relapser
4871317|NCT02219490|Null responder|null responder
4871318|NCT02219490|Non responder|non responder
4871319|NCT02219477|Cirrhosis|cirrhosis
4871320|NCT02219477|Hepatitis C|hepatitis c
4871321|NCT02219477|Child-Pugh B|child-pugh b
4871322|NCT02219477|Hepatitis C Genotype 4|hepatitis c genotype 4
4871323|NCT02219477|Interferon-Free|interferon-free
4871324|NCT02219477|Hepatitis C Genotype 1|hepatitis c genotype 1
4871325|NCT02219477|Chronic Hepatitis C|chronic hepatitis c
4871326|NCT02219477|Decompensated Cirrhosis|decompensated cirrhosis
4871327|NCT02219477|Hepatitis C Virus|hepatitis c virus
4871328|NCT02219464|nasopharyngeal catheter|nasopharyngeal catheter
4871329|NCT02219464|nasal cannula|nasal cannula
4871330|NCT02219451|Chronic heart failure|chronic heart failure
4871331|NCT02219451|exercise training|exercise training
4871332|NCT02219451|Sympathetic modulation|sympathetic modulation
4871333|NCT02219451|arterial baroreflex control|arterial baroreflex control
4871334|NCT02219425|Infertility|infertility
4871335|NCT02219425|Endometrium|endometrium
4871336|NCT02219425|Endometrial biopsy|endometrial biopsy
4871337|NCT02219425|Gene expression|gene expression
4871338|NCT02219412|ticagrelor|ticagrelor
4871339|NCT02219412|platelet aggregation rate|platelet aggregation rate
4871340|NCT02219412|ADP antagonist|adp antagonist
4871341|NCT02219412|antiplatelet therapy|antiplatelet therapy
4871342|NCT02219399|Pregnancy|pregnancy
4871343|NCT02219399|DHA|dha
4871344|NCT02219399|Gestational Length|gestational length
4871345|NCT02219399|Cognitive Development|cognitive development
4871346|NCT02219386|Myofascial pain syndromes,physiotherapy,muscle stretching exercises,neck pain,dry needling|myofascial pain syndromes,physiotherapy,muscle stretching exercises,neck pain,dry needling
4871347|NCT02219360|acute|acute
4871348|NCT02219360|exacerbation|exacerbation
4871349|NCT02219360|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
4871350|NCT02219347|rheumatoid arthritis|rheumatoid arthritis
4871351|NCT02219347|biological markers|biological markers
4871352|NCT02219347|remission|remission
4871353|NCT02219347|ultrasonography|ultrasonography
4871354|NCT02219347|microarray|microarray
4871355|NCT02219347|survival analysis|survival analysis
4871356|NCT02219347|T cell|t cell
4871357|NCT02219334|Children|children
4871358|NCT02219334|Nasal suction devices|nasal suction devices
4871359|NCT02219334|Suctioning|suctioning
4871360|NCT02219321|Pain, Opioid dependence, Lidocaine infusion|pain, opioid dependence, lidocaine infusion
4871361|NCT02219308|Contraception|contraception
4871362|NCT02219308|Pain|pain
4871363|NCT02219308|Intrauterine Device|intrauterine device
4871364|NCT02219308|Paracervical Block|paracervical block
4871365|NCT02219295|SGLT1 (sodium dependent glucose transporter)|sglt1 (sodium dependent glucose transporter)
4871366|NCT02219295|Glut-transporters|glut-transporters
4871367|NCT02219295|taste receptors genes|taste receptors genes
4871368|NCT02219295|sweet taste receptor T1R2T1R3|sweet taste receptor t1r2t1r3
4871369|NCT02219295|bitter taste receptors of the hTAS2gene family|bitter taste receptors of the htas2gene family
4871370|NCT02219282|laryngeal mask airway, edentulate geriatric patients|laryngeal mask airway, edentulate geriatric patients
4871371|NCT02219269|contraception|contraception
4871372|NCT02219269|family planning|family planning
4871373|NCT02219269|complex medical conditions|complex medical conditions
4871374|NCT02219256|Drug therapy|drug therapy
4871375|NCT02219243|Social Anxiety Disorder|social anxiety disorder
4871376|NCT02219243|Cognitive Training|cognitive training
4871377|NCT02219243|Interpretation Modification Program|interpretation modification program
4871378|NCT02219204|Acupuncture|acupuncture
4871379|NCT02219204|Herbal treatment|herbal treatment
4871380|NCT02219191|Puerarin tablet|puerarin tablet
4871381|NCT02219191|rheumatoid arthritis|rheumatoid arthritis
4871382|NCT02219191|metabolism syndrome|metabolism syndrome
4871383|NCT02219165|Paediatrics|paediatrics
4871384|NCT02219165|Toxic Shock Syndrome|toxic shock syndrome
4871385|NCT02219165|Intravenous human immunoglobulin|intravenous human immunoglobulin
4871386|NCT02219165|feasibility|feasibility
4871387|NCT02219139|Edentulous|edentulous
4871388|NCT02219139|Roxolid|roxolid
4871389|NCT02219139|SLAclive surface|slaclive surface
4871390|NCT02219139|Titanium/zirconium|titanium/zirconium
4871391|NCT02219113|Damage of articular cartilage|damage of articular cartilage
4871392|NCT02219113|Cartilage degeneration|cartilage degeneration
4871393|NCT02219113|Intraarticular injection|intraarticular injection
4871394|NCT02219113|ADRC|adrc
4871395|NCT02219113|Adipose-derived regenerative cells|adipose-derived regenerative cells
4871396|NCT02219113|Adipose tissue|adipose tissue
4871397|NCT02219113|Stem cells|stem cells
4871398|NCT02219087|Total knee arthroplasty|total knee arthroplasty
4871399|NCT02219087|Total joint arthroplasty|total joint arthroplasty
4871400|NCT02219087|Knee replacement|knee replacement
4871401|NCT02219087|Osteoarthritis of the knee|osteoarthritis of the knee
4871402|NCT02219061|Measles|measles
4871403|NCT02219061|Meningitis C|meningitis c
4871404|NCT02219061|waning|waning
4871405|NCT02219061|Geometric Mean Titer|geometric mean titer
4871406|NCT02219061|China|china
4871407|NCT02219048|Asthma|asthma
4871408|NCT02219048|Staged withdrawal of background therapy|staged withdrawal of background therapy
4871409|NCT02219035|presentation with|presentation with
4871410|NCT02219022|Rheumatoid arthritis|rheumatoid arthritis
4871411|NCT02219022|Progressive resistance exercise|progressive resistance exercise
4871412|NCT02219022|Pain|pain
4871413|NCT02219022|Functional capacity|functional capacity
4871414|NCT02219022|Quality of life|quality of life
4871415|NCT02219022|Muscle strength|muscle strength
4871416|NCT02219009|OPC-14597 Digital|opc-14597 digital
4871417|NCT02219009|Aripiprazole|aripiprazole
4871418|NCT02219009|Medical Information Device #1 System (MIND1)|medical information device #1 system (mind1)
4871419|NCT02219009|Treatment Adherence|treatment adherence
4871420|NCT02219009|Ingestible Event Marker|ingestible event marker
4871421|NCT02218996|Anxiety|anxiety
4871422|NCT02218996|Children|children
4871423|NCT02218996|Adolescent|adolescent
4871424|NCT02218996|Effectiveness|effectiveness
4871425|NCT02218996|Outpatient|outpatient
4871426|NCT02218983|trauma|trauma
4871427|NCT02218983|echo|echo
4871428|NCT02218983|echocardiogram|echocardiogram
4871429|NCT02218983|ultrasound|ultrasound
4871430|NCT02218983|inferior vena cava collapsibility|inferior vena cava collapsibility
4871431|NCT02218970|rehabilitation|rehabilitation
4871432|NCT02218970|strength training|strength training
4871433|NCT02218970|muscle strength|muscle strength
4871434|NCT02218970|physical fitness|physical fitness
4871435|NCT02218957|Bariatric surgery|bariatric surgery
4871436|NCT02218957|Roux-en-Y Gastric Bypass|roux-en-y gastric bypass
4871437|NCT02218931|Pre-eclampsia|pre-eclampsia
4871438|NCT02218931|Gestational diabetes|gestational diabetes
4871439|NCT02218931|Stillbirth|stillbirth
4871440|NCT02218931|Small for gestational age|small for gestational age
4871441|NCT02218931|Admission to neonatal intensive care unit|admission to neonatal intensive care unit
4871442|NCT02218931|Obesity|obesity
4871443|NCT02218931|Raised Lipids|raised lipids
4871444|NCT02218931|High Blood Pressure|high blood pressure
4871445|NCT02218931|Cardiovascular risk|cardiovascular risk
4871446|NCT02218931|Insulin resistance|insulin resistance
4871447|NCT02218931|Mediterranean dietary pattern|mediterranean dietary pattern
4871448|NCT02218931|Dietary interventions|dietary interventions
4871449|NCT02218918|Ground walk|ground walk
4871450|NCT02218918|treadmill walk|treadmill walk
4871451|NCT02218918|Functional walk capacity|functional walk capacity
4871452|NCT02218918|COPD|copd
4871453|NCT02218918|Quality of Life|quality of life
4871454|NCT02218905|Correlation|correlation
4871455|NCT02218905|Sit to stand repetitions|sit to stand repetitions
4871456|NCT02218905|Anthropometric variables|anthropometric variables
4871457|NCT02218905|Age|age
4871458|NCT02218905|Height|height
4871459|NCT02218905|weight|weight
4871460|NCT02218905|Gender|gender
4871461|NCT02218905|Regression|regression
4871462|NCT02218866|Bariatric surgery|bariatric surgery
4871463|NCT02218866|Obesity|obesity
4871464|NCT02218866|Neuropathy|neuropathy
4871465|NCT02218853|Bipolar disorder|bipolar disorder
4871466|NCT02218853|Psychosis|psychosis
4871467|NCT02218853|Schizophrenia|schizophrenia
4871468|NCT02218840|cigar smoker|cigar smoker
4871469|NCT02218840|smoking|smoking
4871470|NCT02218840|behavioral pharmacology|behavioral pharmacology
4871471|NCT02218840|smoking topography|smoking topography
4871472|NCT02218827|Dry Eye|dry eye
4871473|NCT02218827|Inflammatory reaction|inflammatory reaction
4871474|NCT02218827|steroids|steroids
4871475|NCT02218814|Femoral Nerve Block|femoral nerve block
4871476|NCT02218814|Adductor Canal Nerve Block|adductor canal nerve block
4871477|NCT02218801|Liver metastasis|liver metastasis
4871478|NCT02218801|Colorectal carcinoma|colorectal carcinoma
4871479|NCT02218801|Unresectable|unresectable
4871480|NCT02218801|Borderline resectable|borderline resectable
4871481|NCT02218801|Initially unresectable|initially unresectable
4871482|NCT02218788|Nasolabial folds|nasolabial folds
4871483|NCT02218788|Marionette lines|marionette lines
4871484|NCT02218788|Cheek bones|cheek bones
4871485|NCT02218788|Jaw lines|jaw lines
4871486|NCT02218775|Kappa opioid receptor|kappa opioid receptor
4871487|NCT02218775|Mu opioid receptor|mu opioid receptor
4871488|NCT02218775|LY2456302|ly2456302
4871489|NCT02218775|Anhedonia|anhedonia
4871490|NCT02218775|Mood and Anxiety Spectrum Disorders|mood and anxiety spectrum disorders
4871491|NCT02218762|Fluticasone propionate/salmeterol in a capsule-based inhaler|fluticasone propionate/salmeterol in a capsule-based inhaler
4871492|NCT02218762|replicated cross-over design|replicated cross-over design
4871493|NCT02218762|Respiratory|respiratory
4871494|NCT02218762|asthma|asthma
4871495|NCT02218762|safety|safety
4871496|NCT02218762|pharmacokinetics|pharmacokinetics
4871497|NCT02218762|Fluticasone propionate/salmeterol|fluticasone propionate/salmeterol
4871498|NCT02218762|pharmacodynamics|pharmacodynamics
4871499|NCT02218762|Fluticasone propionate/salmeterol in a multi-dose dry powder inhaler|fluticasone propionate/salmeterol in a multi-dose dry powder inhaler
4871500|NCT02218736|Anhedonia|anhedonia
4871501|NCT02218736|Mood and Anxiety Spectrum Disorders|mood and anxiety spectrum disorders
4871502|NCT02218736|CERC-501 (investigational product)|cerc-501 (investigational product)
4871503|NCT02218736|Kappa Opioid Receptor (KOR)|kappa opioid receptor (kor)
4871504|NCT02218723|healthy volunteer|healthy volunteer
4871505|NCT02218723|Asthma|asthma
4871506|NCT02218723|inhaled corticosteroid|inhaled corticosteroid
4871507|NCT02218723|UD-DPI|ud-dpi
4871508|NCT02218723|ELLIPTA DPI|ellipta dpi
4871509|NCT02218723|Fluticasone furoate|fluticasone furoate
4871510|NCT02218697|Immunogenicity|immunogenicity
4871511|NCT02218697|Influsplit Tetra (Fluarix Tetra) 2014/2015 season|influsplit tetra (fluarix tetra) 2014/2015 season
4871512|NCT02218697|Safety|safety
4871513|NCT02218697|Adults|adults
4871514|NCT02218697|Pneumovax 23/Pneumovax|pneumovax 23/pneumovax
4871515|NCT02218697|Co-administration|co-administration
4871516|NCT02218697|Elderly|elderly
4871517|NCT02218697|Seasonal influenza|seasonal influenza
4871518|NCT02218697|Pneumococcal infection|pneumococcal infection
4871519|NCT02218632|Galactosaemia|galactosaemia
4871520|NCT02218632|Dysglycosylation|dysglycosylation
4871521|NCT02218632|Diet|diet
4871522|NCT02218619|type 1 diabetes (T1D)|type 1 diabetes (t1d)
4871523|NCT02218619|endoplasmic reticulum (ER) stress|endoplasmic reticulum (er) stress
4871524|NCT02218619|induced pluripotential stem (iPS) cells|induced pluripotential stem (ips) cells
4871525|NCT02218619|Tauroursodeoxycholic Acid (TUDCA)|tauroursodeoxycholic acid (tudca)
4871526|NCT02218606|Abiraterone Acetate|abiraterone acetate
4871527|NCT02218606|CABAZITAXEL|cabazitaxel
4871528|NCT02218606|CASTRATION RESISTANT|castration resistant
4871529|NCT02218606|14-046|14-046
4871530|NCT02218606|Prostate Cancer Clinical Trials Consortium|prostate cancer clinical trials consortium
4871531|NCT02218580|massage therapy|massage therapy
4871532|NCT02218580|juvenile arthritis|juvenile arthritis
4871533|NCT02218580|pain|pain
4871534|NCT02218554|BRONJ|bronj
4871535|NCT02218528|subjects|subjects
4871536|NCT02218515|Autogenous bone graft|autogenous bone graft
4871537|NCT02218515|Chronic periodontitis|chronic periodontitis
4871538|NCT02218515|Enamel matrix derivatives|enamel matrix derivatives
4871539|NCT02218515|Gingival crevicular fluid|gingival crevicular fluid
4871540|NCT02218515|Periodontal flap surgery|periodontal flap surgery
4871541|NCT02218502|Ovarian cancer|ovarian cancer
4871542|NCT02218502|Diagnosis|diagnosis
4871543|NCT02218502|Risk of Malignancy Index|risk of malignancy index
4871544|NCT02218502|RMI|rmi
4871545|NCT02218502|Ultrasound|ultrasound
4871546|NCT02218502|Simple ultrasound-based rules|simple ultrasound-based rules
4871547|NCT02218502|DW-MRI|dw-mri
4871548|NCT02218502|Subjective assessment|subjective assessment
4871549|NCT02218489|Pain|pain
4871550|NCT02218489|Corticosteroid|corticosteroid
4871551|NCT02218489|Meibomian Gland Disease|meibomian gland disease
4871552|NCT02218489|Blepharitis|blepharitis
4871553|NCT02218489|Eyelid|eyelid
4871554|NCT02218489|Ocular Discomfort|ocular discomfort
4871555|NCT02218463|Vulvar disease, adhesions, topical therapy|vulvar disease, adhesions, topical therapy
4871556|NCT02218463|Labial adhesions prepubertal girls|labial adhesions prepubertal girls
4871557|NCT02218463|Labial agglutination|labial agglutination
4871558|NCT02218463|Labial fusion|labial fusion
4871559|NCT02218437|Mesenchymal Stem Cells (MSC)|mesenchymal stem cells (msc)
4871560|NCT02218437|Umbilical Cord|umbilical cord
4871561|NCT02218437|thymocyte globulin (ATG)|thymocyte globulin (atg)
4871562|NCT02218437|Severe Aplastic Anemia (SAA)|severe aplastic anemia (saa)
4871563|NCT02218398|airway resistance|airway resistance
4871564|NCT02218398|lung compliance|lung compliance
4871565|NCT02218398|Duration of mechanical ventilation|duration of mechanical ventilation
4871566|NCT02218385|Nipple Aspirate Fluid|nipple aspirate fluid
4871567|NCT02218385|Breast Health Screening|breast health screening
4871568|NCT02218385|Cytology|cytology
4871569|NCT02218372|Clostridium difficile-associated Diarrhea (CDAD)|clostridium difficile-associated diarrhea (cdad)
4871570|NCT02218372|vancomycin|vancomycin
4871571|NCT02218372|Clostridium difficile infection|clostridium difficile infection
4871572|NCT02218372|fidaxomicin|fidaxomicin
4871573|NCT02218359|Gram-negative pneumonia|gram-negative pneumonia
4871574|NCT02218359|Aerosol antibiotics|aerosol antibiotics
4871575|NCT02218359|Mechanical ventilation|mechanical ventilation
4871576|NCT02218359|Amikacin|amikacin
4871577|NCT02218359|Fosfomycin|fosfomycin
4871578|NCT02218359|Pneumonia, Bacterial|pneumonia, bacterial
4871579|NCT02218359|Pneumonia|pneumonia
4871580|NCT02218359|Bacterial Infections|bacterial infections
4871581|NCT02218359|Lung Diseases|lung diseases
4871582|NCT02218359|Respiratory Tract Diseases|respiratory tract diseases
4871583|NCT02218359|Respiratory Tract Infections|respiratory tract infections
4871584|NCT02218359|Anti-Bacterial Agents|anti-bacterial agents
4871585|NCT02218359|Anti-Infective Agents|anti-infective agents
4871586|NCT02218359|Therapeutic Uses|therapeutic uses
4871587|NCT02218359|Pharmacologic Actions|pharmacologic actions
4871588|NCT02218359|MRSA|mrsa
4871589|NCT02218346|Healthy volunteers|healthy volunteers
4871590|NCT02218320|HIV|hiv
4871591|NCT02218320|Gut-associated lymphoid tissue|gut-associated lymphoid tissue
4871592|NCT02218320|raltegravir|raltegravir
4871593|NCT02218320|Isentress|isentress
4871594|NCT02218320|dolutegravir|dolutegravir
4871595|NCT02218320|Tivicay|tivicay
4871596|NCT02218320|pharmacodynamics|pharmacodynamics
4871597|NCT02218294|BCX4161|bcx4161
4871598|NCT02218294|BioCryst|biocryst
4871599|NCT02218294|hereditary angioedema|hereditary angioedema
4871600|NCT02218294|mass balance|mass balance
4871601|NCT02218294|kallikrein inhibitor|kallikrein inhibitor
4871602|NCT02218294|ADME|adme
4871603|NCT02218268|type I diabetes|type i diabetes
4871604|NCT02218268|healthy|healthy
4871605|NCT02218268|children|children
4871606|NCT02218268|adolescents|adolescents
4871607|NCT02218268|young adults|young adults
4871608|NCT02218255|In Vitro Fertilization|in vitro fertilization
4871609|NCT02218242|Lung|lung
4871610|NCT02218242|Cancer|cancer
4871611|NCT02218242|Ultrasound|ultrasound
4871612|NCT02218242|Staging|staging
4871613|NCT02218229|shock wave|shock wave
4871614|NCT02218229|carpal tunnel syndrome|carpal tunnel syndrome
4871615|NCT02218216|Mild Traumatic Brain Injury|mild traumatic brain injury
4871616|NCT02218203|chronic pain|chronic pain
4871617|NCT02218203|central neuropathic pain|central neuropathic pain
4871618|NCT02218203|spinal cord injury|spinal cord injury
4871619|NCT02218203|dextromethorphan|dextromethorphan
4871620|NCT02218203|lidocaine|lidocaine
4871621|NCT02218203|combination therapy|combination therapy
4871622|NCT02218203|analgesia|analgesia
4871623|NCT02218190|Alvimopan|alvimopan
4871624|NCT02218190|Ileus|ileus
4871625|NCT02218190|Posterior spinal fusion|posterior spinal fusion
4871626|NCT02218177|wet Age Related Macular Degeneration|wet age related macular degeneration
4871627|NCT02218177|Ranibizumab|ranibizumab
4871628|NCT02218177|Aflibercept|aflibercept
4871629|NCT02218177|Combination Photodynamic Therapy|combination photodynamic therapy
4871630|NCT02218177|Cytokine analysis|cytokine analysis
4871631|NCT02218164|metastatic|metastatic
4871632|NCT02218164|cutaneous|cutaneous
4871633|NCT02218164|skin cancer|skin cancer
4871634|NCT02218151|Hematopoietic|hematopoietic
4871635|NCT02218151|Stem Cell|stem cell
4871636|NCT02218151|Transplant|transplant
4871637|NCT02218151|patient-centered|patient-centered
4871638|NCT02218151|Microbiota|microbiota
4871639|NCT02218151|GVHD|gvhd
4871640|NCT02218138|Adolescent|adolescent
4871641|NCT02218138|Diabetes|diabetes
4871642|NCT02218138|Depression|depression
4871643|NCT02218138|Obesity|obesity
4871644|NCT02218138|Stress|stress
4871645|NCT02218125|Healthy|healthy
4871646|NCT02218125|Human immunodeficiency virus type 1 (HIV-1) infection|human immunodeficiency virus type 1 (hiv-1) infection
4871647|NCT02218125|Acquired immunodeficiency syndrome (AIDS)|acquired immunodeficiency syndrome (aids)
4871648|NCT02218125|recombinant adenovirus (rAd) vector-based vaccines|recombinant adenovirus (rad) vector-based vaccines
4871649|NCT02218125|Vaccination|vaccination
4871650|NCT02218125|Ad26.ENVA.01|ad26.enva.01
4871651|NCT02218125|Recombinant|recombinant
4871652|NCT02218125|Modified Vaccinia Ankara (MVA) vector-based vaccines|modified vaccinia ankara (mva) vector-based vaccines
4871653|NCT02218112|Blood pressure|blood pressure
4871654|NCT02218112|Obesity|obesity
4871655|NCT02218112|Glomerular filtration rate|glomerular filtration rate
4871656|NCT02218112|Renal Sodium handling|renal sodium handling
4871657|NCT02218099|Phase 1|phase 1
4871658|NCT02218099|ASP8232|asp8232
4871659|NCT02218099|Single dose|single dose
4871660|NCT02218099|Multiple doses|multiple doses
4871661|NCT02218086|postural control|postural control
4871662|NCT02218086|postural balance|postural balance
4871663|NCT02218086|slackline|slackline
4871664|NCT02218073|Healthy|healthy
4871665|NCT02218073|JNJ-42756493|jnj-42756493
4871666|NCT02218073|JNJ-61818549|jnj-61818549
4871667|NCT02218073|Isotope|isotope
4871668|NCT02218047|Pegylated-Proline-interferon alpha-2b (AOP2014)|pegylated-proline-interferon alpha-2b (aop2014)
4871669|NCT02218047|Polycythemia Vera|polycythemia vera
4871670|NCT02218047|PROUD-PV|proud-pv
4871671|NCT02218047|CONTINUATION-PV|continuation-pv
4871672|NCT02218047|AOP Orphan|aop orphan
4871673|NCT02218047|Polycythemia|polycythemia
4871674|NCT02218047|Hematologic Diseases|hematologic diseases
4871675|NCT02218047|Myeloproliferative Disorders|myeloproliferative disorders
4871676|NCT02218047|Bone Marrow Diseases|bone marrow diseases
4871677|NCT02218047|Interferon-alpha|interferon-alpha
4871678|NCT02218047|Peginterferon alfa-2b|peginterferon alfa-2b
4871679|NCT02218021|Alkermes|alkermes
4871680|NCT02218021|ALKS 33|alks 33
4871681|NCT02218021|ALKS 5461|alks 5461
4871682|NCT02218021|Samidorphan|samidorphan
4871683|NCT02218008|Major depressive disorder (MDD)|major depressive disorder (mdd)
4871684|NCT02218008|depression|depression
4871685|NCT02218008|Alkermes|alkermes
4871686|NCT02218008|ALKS 5461|alks 5461
4871687|NCT02218008|samidorphan|samidorphan
4871688|NCT02217995|Mindfulness-Based Cognitive Therapy|mindfulness-based cognitive therapy
4871689|NCT02217995|Mindfulness|mindfulness
4871690|NCT02217969|Anesthesia|anesthesia
4871691|NCT02217969|Hypotension|hypotension
4871692|NCT02217930|TQT|tqt
4871693|NCT02217917|Healthy subjects|healthy subjects
4871694|NCT02217917|Randomized|randomized
4871695|NCT02217917|Double-blind|double-blind
4871696|NCT02217917|Single ascending dose|single ascending dose
4871697|NCT02217917|Multiple ascending dose|multiple ascending dose
4871698|NCT02217878|ST-segment elevation myocardial infarction|st-segment elevation myocardial infarction
4871699|NCT02217878|non-ST-segment elevation myocardial infarction|non-st-segment elevation myocardial infarction
4871700|NCT02217878|ticagrelor|ticagrelor
4871701|NCT02217878|morphine|morphine
4871702|NCT02217878|pharmacokinetics|pharmacokinetics
4871703|NCT02217878|pharmacodynamics|pharmacodynamics
4871704|NCT02217878|drug interactions|drug interactions
4871705|NCT02217878|VASP assay|vasp assay
4871706|NCT02217878|Multiple Electrode Aggregometry|multiple electrode aggregometry
4871707|NCT02217878|VerifyNow|verifynow
4871708|NCT02217865|Colorectal Cancer|colorectal cancer
4871709|NCT02217865|CRC|crc
4871710|NCT02217865|Curative resection of colorectal cancer|curative resection of colorectal cancer
4871711|NCT02217865|Caregivers|caregivers
4871712|NCT02217865|Interviews|interviews
4871713|NCT02217865|Focus groups|focus groups
4871714|NCT02217865|Questionnaires|questionnaires
4871715|NCT02217865|Surveys|surveys
4871716|NCT02217852|hypertension|hypertension
4871717|NCT02217852|Tibetan|tibetan
4871718|NCT02217852|Nitrendipine|nitrendipine
4871719|NCT02217852|hydrochlorothiazide|hydrochlorothiazide
4871720|NCT02217852|captopril|captopril
4871721|NCT02217852|Beijing hypotensive No.0|beijing hypotensive no.0
4871722|NCT02217774|Computer-Aided Design/instrumentation|computer-aided design/instrumentation
4871723|NCT02217774|Cone-Beam Computed Tomography|cone-beam computed tomography
4871724|NCT02217774|Dental Implant|dental implant
4871725|NCT02217774|MGuide|mguide
4871726|NCT02217761|Pharmacokinetics|pharmacokinetics
4871727|NCT02217761|Antifungal Agents|antifungal agents
4871728|NCT02217735|Parkinson's Disease|parkinson's disease
4871729|NCT02217735|Caregivers|caregivers
4871730|NCT02217735|Expressive Writing|expressive writing
4871731|NCT02217735|Complementary Medicine|complementary medicine
4871732|NCT02217735|Cortisol|cortisol
4871733|NCT02217696|Electroencephalography (EEG)|electroencephalography (eeg)
4871734|NCT02217696|Magnetic Resonance Imaging (MRI)|magnetic resonance imaging (mri)
4871735|NCT02217696|Multimodal Neuroimaging|multimodal neuroimaging
4871736|NCT02217696|Development|development
4871737|NCT02217696|Prediction|prediction
4871738|NCT02217696|Intervention|intervention
4871739|NCT02217683|Catheterization, Swan-Ganz|catheterization, swan-ganz
4871740|NCT02217683|Cardiac Surgical Procedures|cardiac surgical procedures
4871741|NCT02217683|Blood Transfusion|blood transfusion
4871742|NCT02217683|Nitric Oxide|nitric oxide
4871743|NCT02217657|Smart-Touch|smart-touch
4871744|NCT02217657|Contact force|contact force
4871745|NCT02217605|NAFLD|nafld
4871746|NCT02217605|Oral Fructose Challenge|oral fructose challenge
4871747|NCT02217605|31P MRS|31p mrs
4871748|NCT02217605|Liver|liver
4871749|NCT02217605|Subjects|subjects
4871750|NCT02217579|Weight loss|weight loss
4871751|NCT02217579|Appetite|appetite
4871752|NCT02217579|Overweight|overweight
4871753|NCT02217579|Obesity|obesity
4871754|NCT02217579|Dietary fiber|dietary fiber
4871755|NCT02217579|Dietary protein|dietary protein
4871756|NCT02217566|Prostatic neoplasms|prostatic neoplasms
4871757|NCT02217566|Diethylstilbestrol therapy|diethylstilbestrol therapy
4871758|NCT02217566|Abiraterone acetate|abiraterone acetate
4871759|NCT02217566|Prednisone|prednisone
4871760|NCT02217566|Androgen deprivation therapy|androgen deprivation therapy
4871761|NCT02217553|platelet|platelet
4871762|NCT02217553|P-selectin|p-selectin
4871763|NCT02217553|platelet-fibrinogen binding|platelet-fibrinogen binding
4871764|NCT02217553|platelet-monocye aggregate formation|platelet-monocye aggregate formation
4871765|NCT02217553|vitamin D|vitamin d
4871766|NCT02217540|Shoulder, disability evaluation, physiotherapy modalities|shoulder, disability evaluation, physiotherapy modalities
4871767|NCT02217527|crossover|crossover
4871768|NCT02217501|peripheral arterial disease, antiplatelet therapy|peripheral arterial disease, antiplatelet therapy
4871769|NCT02217462|pregnancy|pregnancy
4871770|NCT02217462|gestational weight gain|gestational weight gain
4871771|NCT02217462|dietary intake|dietary intake
4871772|NCT02217462|food reward|food reward
4871773|NCT02217423|Physical Therapy Modalities|physical therapy modalities
4871774|NCT02217423|Respiration Disorders|respiration disorders
4871775|NCT02217423|Respiratory Therapy|respiratory therapy
4871776|NCT02217410|renal, de novo,|renal, de novo,
4871777|NCT02217397|Apnea-hyponea Index, CPAP, Obstructive Sleep Apnea, Oral Appliance|apnea-hyponea index, cpap, obstructive sleep apnea, oral appliance
4871778|NCT02217384|Microbiome|microbiome
4871779|NCT02217384|DNA sequencing|dna sequencing
4871780|NCT02217384|Leptin|leptin
4871781|NCT02217384|Adiponectin|adiponectin
4871782|NCT02217384|Insulin|insulin
4871783|NCT02217384|IGF-I|igf-i
4871784|NCT02217371|ADHD Patient|adhd patient
4871785|NCT02217371|Healthy subjects|healthy subjects
4871786|NCT02217371|Sleepiness|sleepiness
4871787|NCT02217371|PSG|psg
4871788|NCT02217371|MWT|mwt
4871789|NCT02217371|EEG|eeg
4871790|NCT02217371|cognitive tests|cognitive tests
4871791|NCT02217358|squamous cell carcinoma of the head and neck|squamous cell carcinoma of the head and neck
4871792|NCT02217358|NBI endoscopy|nbi endoscopy
4871793|NCT02217358|videoendoscopy|videoendoscopy
4871794|NCT02217358|white light endoscopy|white light endoscopy
4871795|NCT02217358|magnifying endoscopy|magnifying endoscopy
4871796|NCT02217358|direct laryngoscopy|direct laryngoscopy
4871797|NCT02217332|Sinusitis|sinusitis
4871798|NCT02217332|Rhinosinusitis|rhinosinusitis
4871799|NCT02217332|CRS|crs
4871800|NCT02217332|CRSwNP|crswnp
4871801|NCT02217332|CSNP-E|csnp-e
4871802|NCT02217332|Nasal polyps|nasal polyps
4871803|NCT02217332|Nasal polyposis|nasal polyposis
4871804|NCT02217332|Eosinophilia|eosinophilia
4871805|NCT02217332|Asthma|asthma
4871806|NCT02217319|Volatile Anesthetic|volatile anesthetic
4871807|NCT02217319|Cardioprotection|cardioprotection
4871808|NCT02217319|Lung surgery|lung surgery
4871809|NCT02217319|non cardiac surgery|non cardiac surgery
4871810|NCT02217293|Pulsed radiofrequency|pulsed radiofrequency
4871811|NCT02217293|Ultrasound-guided|ultrasound-guided
4871812|NCT02217293|Carpal tunnel syndrome|carpal tunnel syndrome
4871813|NCT02217280|Cervical Radiculopathy|cervical radiculopathy
4871814|NCT02217267|Peripheral neuropathy|peripheral neuropathy
4871815|NCT02217215|Spectroscopy|spectroscopy
4871816|NCT02217215|HPV|hpv
4871817|NCT02217202|knee replacement|knee replacement
4871818|NCT02217202|knee arthroplasty|knee arthroplasty
4871819|NCT02217202|revision|revision
4871820|NCT02217202|high risk|high risk
4871821|NCT02217189|Zinc supplementation.|zinc supplementation.
4871822|NCT02217189|Oxidative stress.|oxidative stress.
4871823|NCT02217189|Superoxide radical scavengers.|superoxide radical scavengers.
4871824|NCT02217189|Asthenospermia.|asthenospermia.
4871825|NCT02217189|Oxido-sensitive index.|oxido-sensitive index.
4871826|NCT02217137|Dry Eye|dry eye
4871827|NCT02217137|Rheumatoid Arthritis|rheumatoid arthritis
4871828|NCT02217137|Systemic Lupus Erythematosus|systemic lupus erythematosus
4871829|NCT02217137|Tear cytokines and immune response|tear cytokines and immune response
4871830|NCT02217124|apple|apple
4871831|NCT02217124|high fiber|high fiber
4871832|NCT02217124|body composition|body composition
4871833|NCT02217124|children|children
4871834|NCT02217111|vocal fold nodules|vocal fold nodules
4871835|NCT02217111|pediatric|pediatric
4871836|NCT02217111|voice therapy|voice therapy
4871837|NCT02217111|acoustic|acoustic
4871838|NCT02217111|aerodynamic|aerodynamic
4871839|NCT02217111|quality of life|quality of life
4871840|NCT02217111|Adventures in Voice|adventures in voice
4871841|NCT02217098|ART|art
4871842|NCT02217098|Occlusal|occlusal
4871843|NCT02217098|Occlusoproximal|occlusoproximal
4871844|NCT02217098|Primary teeth|primary teeth
4871845|NCT02217085|Colorectal Cancer Screening|colorectal cancer screening
4871846|NCT02217085|Colon Cancer Screening|colon cancer screening
4871847|NCT02217085|Polyps|polyps
4871848|NCT02217085|Colonoscopy|colonoscopy
4871849|NCT02217072|academic performance|academic performance
4871850|NCT02217072|cognitive development|cognitive development
4871851|NCT02217072|children in care|children in care
4871852|NCT02217072|prevention of school failure|prevention of school failure
4871853|NCT02217059|Emergency Medical Services|emergency medical services
4871854|NCT02217059|Emergency Care|emergency care
4871855|NCT02217059|Hypertension|hypertension
4871856|NCT02217059|BpTRU|bptru
4871857|NCT02217059|Blood pressure|blood pressure
4871858|NCT02217046|Infection|infection
4871859|NCT02217046|prevention|prevention
4871860|NCT02217046|cardiac devices|cardiac devices
4871861|NCT02217033|Breast Cancer|breast cancer
4871862|NCT02217033|Stage I breast cancer|stage i breast cancer
4871863|NCT02217033|Stage II breast cancer|stage ii breast cancer
4871864|NCT02217033|Water study|water study
4871865|NCT02217033|'R'|'r'
4871866|NCT02217033|Electro-kinetically altered beverage|electro-kinetically altered beverage
4871867|NCT02217033|altered beverage|altered beverage
4871868|NCT02217033|Insomnia|insomnia
4871869|NCT02217033|Fatigue|fatigue
4871870|NCT02217033|Depression|depression
4871871|NCT02217033|Adjuvant chemotherapy|adjuvant chemotherapy
4871872|NCT02217020|Rectal Cancer|rectal cancer
4871873|NCT02217020|Locally advanced rectal cancer|locally advanced rectal cancer
4871874|NCT02217020|Neoadjuvant|neoadjuvant
4871875|NCT02217020|chemotherapy|chemotherapy
4871876|NCT02217020|FOLFOXIRI|folfoxiri
4871877|NCT02217007|Tourette|tourette
4871878|NCT02217007|Tourette's|tourette's
4871879|NCT02217007|tic|tic
4871880|NCT02216994|Intestinal dysganglinosis|intestinal dysganglinosis
4871881|NCT02216994|Hirschsprung disease|hirschsprung disease
4871882|NCT02216994|Hirschsprung disease allied disorders|hirschsprung disease allied disorders
4871883|NCT02216994|diagnostic scoring system|diagnostic scoring system
4871884|NCT02216994|Prospective study|prospective study
4871885|NCT02216981|Obsessive Compulsive Disorder (OCD)|obsessive compulsive disorder (ocd)
4871886|NCT02216981|Cognitive Behavioural Therapy (CBT)|cognitive behavioural therapy (cbt)
4871887|NCT02216981|Intensive therapy|intensive therapy
4871888|NCT02216981|Intensive treatment|intensive treatment
4871889|NCT02216981|Treatment Resistant|treatment resistant
4871890|NCT02216968|vegetables|vegetables
4871891|NCT02216968|Head Start|head start
4871892|NCT02216968|preschool|preschool
4871893|NCT02216968|children|children
4871894|NCT02216968|theater|theater
4871895|NCT02216968|puppet|puppet
4871896|NCT02216942|Endodontics|endodontics
4871897|NCT02216942|Deciduous teeth|deciduous teeth
4871898|NCT02216942|Iodoform pastes|iodoform pastes
4871899|NCT02216942|Treatment Refusal|treatment refusal
4871900|NCT02216929|intubation|intubation
4871901|NCT02216929|intensive care|intensive care
4871902|NCT02216929|withholding treatment|withholding treatment
4871903|NCT02216929|cancer|cancer
4871904|NCT02216929|terminal care|terminal care
4871905|NCT02216929|APACHE|apache
4871906|NCT02216903|Atrial fibrillation, sleep apnea|atrial fibrillation, sleep apnea
4871907|NCT02216890|Renal Cell Carcinoma|renal cell carcinoma
4871908|NCT02216890|Mantle-Cell Lymphoma|mantle-cell lymphoma
4871909|NCT02216890|Diffuse, Large B-Cell, Lymphoma|diffuse, large b-cell, lymphoma
4871910|NCT02216890|Follicular Lymphoma, Grade 3|follicular lymphoma, grade 3
4871911|NCT02216890|Antibody-Drug Conjugate|antibody-drug conjugate
4871912|NCT02216890|CD70 Antigen|cd70 antigen
4871913|NCT02216890|Drug Therapy|drug therapy
4871914|NCT02216877|Chronic Kidney Disease|chronic kidney disease
4871915|NCT02216877|Hypomagnesemia|hypomagnesemia
4871916|NCT02216851|hyaluronic acid|hyaluronic acid
4871917|NCT02216851|no-treatment control|no-treatment control
4871918|NCT02216851|enhancement|enhancement
4871919|NCT02216812|Finger stiffness|finger stiffness
4871920|NCT02216812|Range of motion|range of motion
4871921|NCT02216812|Distal radius fracture|distal radius fracture
4871922|NCT02216812|Vitamin C|vitamin c
4871923|NCT02216799|Parenteral nutrition|parenteral nutrition
4871924|NCT02216799|Hyperglycemia|hyperglycemia
4871925|NCT02216799|Glargine insulin|glargine insulin
4871926|NCT02216799|Regular insulin|regular insulin
4871927|NCT02216773|Liver hypertrophy|liver hypertrophy
4871928|NCT02216773|Liver resection|liver resection
4871929|NCT02216773|Liver metastases|liver metastases
4871930|NCT02216773|Portal vein ligation|portal vein ligation
4871931|NCT02216773|Portal vein embolization|portal vein embolization
4871932|NCT02216773|Radiofrequency splitting|radiofrequency splitting
4871933|NCT02216760|Monomorphic Ventricular Tachycardia|monomorphic ventricular tachycardia
4871934|NCT02216760|Myocardial infarction|myocardial infarction
4871935|NCT02216760|Dilated cardiomyopathy|dilated cardiomyopathy
4871936|NCT02216760|Catheter ablation|catheter ablation
4871937|NCT02216760|Substrate mapping|substrate mapping
4871938|NCT02216760|Ripple Conduction channels|ripple conduction channels
4871939|NCT02216747|Idiopathic Nephrotic syndrome relapse|idiopathic nephrotic syndrome relapse
4871940|NCT02216734|HIV/AIDS|hiv/aids
4871941|NCT02216734|Prevention of mother-to-child transmission|prevention of mother-to-child transmission
4871942|NCT02216734|Mother support groups|mother support groups
4871943|NCT02216734|Retention-in-care|retention-in-care
4871944|NCT02216734|Male participation|male participation
4871945|NCT02216734|Anti-retroviral treatment|anti-retroviral treatment
4871946|NCT02216734|Infants|infants
4871947|NCT02216721|bone mineral density|bone mineral density
4871948|NCT02216721|bone turnover markers|bone turnover markers
4871949|NCT02216721|primary aldosteronism treatment|primary aldosteronism treatment
4871950|NCT02216708|Severe malnutrition|severe malnutrition
4871951|NCT02216708|severe dehydration|severe dehydration
4871952|NCT02216708|cholera|cholera
4871953|NCT02216695|acute kidney injury|acute kidney injury
4871954|NCT02216695|epidemiology|epidemiology
4871955|NCT02216695|mortality|mortality
4871956|NCT02216682|Acetaminophen|acetaminophen
4871957|NCT02216682|Total knee replacement|total knee replacement
4871958|NCT02216682|Numeric rating scale|numeric rating scale
4871959|NCT02216669|Solid tumors|solid tumors
4871960|NCT02216669|Head and Neck Neoplasms|head and neck neoplasms
4871961|NCT02216643|Stroke|stroke
4871962|NCT02216643|Ischemic Stroke|ischemic stroke
4871963|NCT02216643|Thrombectomy|thrombectomy
4871964|NCT02216643|Reperfusion Therapy|reperfusion therapy
4871965|NCT02216643|Treatment|treatment
4871966|NCT02216630|COPD|copd
4871967|NCT02216604|Exercise|exercise
4871968|NCT02216604|Pediatric oncology|pediatric oncology
4871969|NCT02216604|Physical Performance|physical performance
4871970|NCT02216604|Quality of Life|quality of life
4871971|NCT02216604|Feasibility|feasibility
4871972|NCT02216604|during primary|during primary
4871973|NCT02216604|anticancer treatment|anticancer treatment
4871974|NCT02216591|HIV|hiv
4871975|NCT02216591|Medication Adherence|medication adherence
4871976|NCT02216591|Working Memory|working memory
4871977|NCT02216578|tyrosine kinase inhibitor|tyrosine kinase inhibitor
4871978|NCT02216578|progressed|progressed
4871979|NCT02216578|(GIST)|(gist)
4871980|NCT02216565|Stroke|stroke
4871981|NCT02216565|Endovascular treatment|endovascular treatment
4871982|NCT02216565|Tandem carotid occlusions|tandem carotid occlusions
4871983|NCT02216565|Fibrinolysis|fibrinolysis
4871984|NCT02216552|Pediatrics|pediatrics
4871985|NCT02216552|Adolescents|adolescents
4871986|NCT02216552|NAFLD|nafld
4871987|NCT02216552|Spectroscopy|spectroscopy
4871988|NCT02216552|Type 2 diabetes|type 2 diabetes
4871989|NCT02216539|All terminal|all terminal
4871990|NCT02216539|leading|leading
4871991|NCT02216539|indication|indication
4871992|NCT02216539|lung transplantation|lung transplantation
4871993|NCT02216526|Skin health|skin health
4871994|NCT02216526|Nursing|nursing
4871995|NCT02216526|Long-term care|long-term care
4871996|NCT02216513|subarachnoid hemorrhage|subarachnoid hemorrhage
4871997|NCT02216513|SAH|sah
4871998|NCT02216513|DFO|dfo
4871999|NCT02216513|cerebral autoregulation|cerebral autoregulation
4872000|NCT02216513|delayed cerebral ischemia|delayed cerebral ischemia
4872001|NCT02216500|Ketogenic Therapy|ketogenic therapy
4872002|NCT02216500|Ketogenic Diet|ketogenic diet
4872003|NCT02216487|mCRC|mcrc
4872004|NCT02216487|colorectal cancer|colorectal cancer
4872005|NCT02216448|Arthroscopy skills|arthroscopy skills
4872006|NCT02216448|Knee|knee
4872007|NCT02216448|Virtual reality|virtual reality
4872008|NCT02216448|Simulator|simulator
4872009|NCT02216422|Chronic Hepatitis C|chronic hepatitis c
4872010|NCT02216422|Hepatitis C|hepatitis c
4872011|NCT02216422|Hepatitis C Virus|hepatitis c virus
4872012|NCT02216422|Hepatitis C Genotype 1b|hepatitis c genotype 1b
4872013|NCT02216422|Interferon-Free|interferon-free
4872014|NCT02216396|dementia|dementia
4872015|NCT02216396|care home|care home
4872016|NCT02216396|agitation|agitation
4872017|NCT02216396|coping|coping
4872018|NCT02216383|Post partum haemorrhage|post partum haemorrhage
4872019|NCT02216383|Active Management of Third Stage of Labour|active management of third stage of labour
4872020|NCT02216383|Carbetocin|carbetocin
4872021|NCT02216383|Syntocinon|syntocinon
4872022|NCT02216383|Syntometrine|syntometrine
4872023|NCT02216383|Birth experience|birth experience
4872024|NCT02216383|Labour|labour
4872025|NCT02216370|Cryptogenic stroke /TIA|cryptogenic stroke /tia
4872026|NCT02216370|Atrial Fibrillation|atrial fibrillation
4872027|NCT02216370|Implantable Loop Recorder|implantable loop recorder
4872028|NCT02216370|Genetic Mutation|genetic mutation
4872029|NCT02216357|Samster's triad|samster's triad
4872030|NCT02216357|Acetylsalicylic acid triad|acetylsalicylic acid triad
4872031|NCT02216357|Widal's triad|widal's triad
4872032|NCT02216357|Francis' triad|francis' triad
4872033|NCT02216357|Aspirin triad|aspirin triad
4872034|NCT02216357|Aspirin-induced asthma and rhinitis (AIAR)|aspirin-induced asthma and rhinitis (aiar)
4872035|NCT02216344|Patient safety monitors|patient safety monitors
4872036|NCT02216331|tuberculosis|tuberculosis
4872037|NCT02216331|PK|pk
4872038|NCT02216331|TMC207|tmc207
4872039|NCT02216331|bedaquiline|bedaquiline
4872040|NCT02216331|rifapentine|rifapentine
4872041|NCT02216331|rifampicin|rifampicin
4872042|NCT02216331|drug drug interaction|drug drug interaction
4872043|NCT02216318|sleep|sleep
4872044|NCT02216318|circadian|circadian
4872045|NCT02216318|melatonine|melatonine
4872046|NCT02216318|pupil response|pupil response
4872047|NCT02216305|HAL-RAR|hal-rar
4872048|NCT02216305|Hemorrhoids|hemorrhoids
4872049|NCT02216305|Hemorrhoid artery ligation|hemorrhoid artery ligation
4872050|NCT02216305|Anal repair|anal repair
4872051|NCT02216305|Quality of Life|quality of life
4872052|NCT02216305|Postoperative Complications|postoperative complications
4872053|NCT02216292|preterm single donor milk|preterm single donor milk
4872054|NCT02216292|human milk|human milk
4872055|NCT02216292|very lo birth weight infants|very lo birth weight infants
4872056|NCT02216292|enteral feedings|enteral feedings
4872057|NCT02216292|NEC|nec
4872058|NCT02216279|Pulmonary|pulmonary
4872059|NCT02216279|Hypertension|hypertension
4872060|NCT02216279|PH|ph
4872061|NCT02216279|PulmoBind|pulmobind
4872062|NCT02216279|Imaging|imaging
4872063|NCT02216266|Delirium|delirium
4872064|NCT02216266|CAM-ICU|cam-icu
4872065|NCT02216253|Urinary tract infection|urinary tract infection
4872066|NCT02216253|Pelvic organ prolapse|pelvic organ prolapse
4872067|NCT02216253|Urinary incontinence|urinary incontinence
4872068|NCT02216253|Stress urinary incontinence|stress urinary incontinence
4872069|NCT02216253|Mixed Urinary incontinence|mixed urinary incontinence
4872070|NCT02216253|L-methionine|l-methionine
4872071|NCT02216253|Placebo|placebo
4872072|NCT02216227|MRSA|mrsa
4872073|NCT02216227|surgical site infection|surgical site infection
4872074|NCT02216214|Urinary Incontinence|urinary incontinence
4872075|NCT02216214|Mirabegron|mirabegron
4872076|NCT02216214|Overactive Bladder|overactive bladder
4872077|NCT02216175|Cow's milk allergy|cow's milk allergy
4872078|NCT02216175|Desensitisation|desensitisation
4872079|NCT02216175|Safety|safety
4872080|NCT02216162|oncogeriatrics|oncogeriatrics
4872081|NCT02216162|adjuvant endocrine therapy|adjuvant endocrine therapy
4872082|NCT02216162|compliance|compliance
4872083|NCT02216162|elderly|elderly
4872084|NCT02216162|Taï Chi|taï chi
4872085|NCT02216162|Physical training|physical training
4872086|NCT02216149|fluoropyrimidine|fluoropyrimidine
4872087|NCT02216149|S-1|s-1
4872088|NCT02216149|Teysuno|teysuno
4872089|NCT02216149|oxaliplatin|oxaliplatin
4872090|NCT02216149|coronary artery flow|coronary artery flow
4872091|NCT02216149|coronary artery dysfunction|coronary artery dysfunction
4872092|NCT02216149|gastrointestinal tract cancer|gastrointestinal tract cancer
4872093|NCT02216136|Mastectomy|mastectomy
4872094|NCT02216136|Breast Cancer|breast cancer
4872095|NCT02216136|Reconstruction|reconstruction
4872096|NCT02216136|Lumpectomy|lumpectomy
4872097|NCT02216136|Breast Conservation Therapy|breast conservation therapy
4872098|NCT02216123|Tafenoquine|tafenoquine
4872099|NCT02216123|Plasmodium vivax|plasmodium vivax
4872100|NCT02216123|Hemolysis|hemolysis
4872101|NCT02216123|Primaquine|primaquine
4872102|NCT02216123|Chloroquine|chloroquine
4872103|NCT02216123|Glucose-6-phosphate dehydrogenase (G6PD)|glucose-6-phosphate dehydrogenase (g6pd)
4872104|NCT02216123|Relapse|relapse
4872105|NCT02216110|Endoscopic submucosal dissection|endoscopic submucosal dissection
4872106|NCT02216110|Gastrectomy|gastrectomy
4872107|NCT02216110|Survival|survival
4872108|NCT02216110|Outcome|outcome
4872109|NCT02216045|Hepatitis C ,Chronic Hepatitis C ,camel milk|hepatitis c ,chronic hepatitis c ,camel milk
4872110|NCT02216019|cardiac surgery|cardiac surgery
4872111|NCT02216019|infectious complication|infectious complication
4872112|NCT02216006|Atelectasis|atelectasis
4872113|NCT02216006|Fresh gas flow|fresh gas flow
4872114|NCT02216006|Prevention|prevention
4872115|NCT02216006|Oxygenation|oxygenation
4872116|NCT02216006|Anaesthesia|anaesthesia
4872117|NCT02215993|Ticagrelor|ticagrelor
4872118|NCT02215993|Prasugrel|prasugrel
4872119|NCT02215993|VerifyNow|verifynow
4872120|NCT02215993|Acute coronary syndrome|acute coronary syndrome
4872121|NCT02215980|Multiple myeloma|multiple myeloma
4872122|NCT02215980|Diagnosis|diagnosis
4872123|NCT02215980|Elderly and unfit patients|elderly and unfit patients
4872124|NCT02215980|Lenalidomide plus steroids|lenalidomide plus steroids
4872125|NCT02215967|Immunotherapy|immunotherapy
4872126|NCT02215967|Anti-BCMA-CAR|anti-bcma-car
4872127|NCT02215967|Gene Therapy|gene therapy
4872128|NCT02215967|Adoptive T Cell Therapy|adoptive t cell therapy
4872129|NCT02215967|Plasma Cell Malignancy|plasma cell malignancy
4872130|NCT02215915|Percutaneous coronary intervention|percutaneous coronary intervention
4872131|NCT02215915|Drug-eluting stent|drug-eluting stent
4872132|NCT02215915|Intravascular ultrasound|intravascular ultrasound
4872133|NCT02215902|ESRD|esrd
4872134|NCT02215902|Hepatitis C|hepatitis c
4872135|NCT02215889|Liver metastases|liver metastases
4872136|NCT02215889|Transplantation|transplantation
4872137|NCT02215876|Her 2-negative breast cancer|her 2-negative breast cancer
4872138|NCT02215876|neoadjuvant doxorubicin/cyclophosphamide followed by Eribulin chemotherapy|neoadjuvant doxorubicin/cyclophosphamide followed by eribulin chemotherapy
4872139|NCT02215863|Immunogenicity, Safety, MF59, Influenza vaccine, Pneumococcal vaccine|immunogenicity, safety, mf59, influenza vaccine, pneumococcal vaccine
4872140|NCT02215837|Gastric cancer|gastric cancer
4872141|NCT02215837|D-CIK|d-cik
4872142|NCT02215837|Autologous tumor lysate|autologous tumor lysate
4872143|NCT02215811|Extracorporeal membrane oxygenation|extracorporeal membrane oxygenation
4872144|NCT02215785|Funtional constipation|funtional constipation
4872145|NCT02215785|Kiwifruit|kiwifruit
4872146|NCT02215785|Health promotion|health promotion
4872147|NCT02215707|PfSPZ Vaccine|pfspz vaccine
4872148|NCT02215707|Plasmodium falciparum|plasmodium falciparum
4872149|NCT02215707|Malaria|malaria
4872150|NCT02215707|Controlled Human Malaria Infection (CHMI)|controlled human malaria infection (chmi)
4872151|NCT02215694|Apolipoprotein A-V|apolipoprotein a-v
4872152|NCT02215694|LDL particle size|ldl particle size
4872153|NCT02215694|probiotic|probiotic
4872154|NCT02215694|triglyceride|triglyceride
4872155|NCT02215681|otitis media with effusion|otitis media with effusion
4872156|NCT02215681|acupuncture|acupuncture
4872157|NCT02215681|inflammatory markers|inflammatory markers
4872158|NCT02215655|phosphate binder adherence|phosphate binder adherence
4872550|NCT02213887|Ziprasidone|ziprasidone
4872159|NCT02215655|autonomous motivation|autonomous motivation
4872160|NCT02215629|Leukemia|leukemia
4872161|NCT02215629|Acute Leukemia|acute leukemia
4872162|NCT02215629|Relapsed Leukemia|relapsed leukemia
4872163|NCT02215629|Refractory Leukemia|refractory leukemia
4872164|NCT02215629|Acute Myeloid Leukemia|acute myeloid leukemia
4872165|NCT02215629|B-Cell Acute Lymphoblastic Leukemia|b-cell acute lymphoblastic leukemia
4872166|NCT02215590|Postural balance|postural balance
4872167|NCT02215590|Motor Learning and Motor Control|motor learning and motor control
4872168|NCT02215590|Community integration|community integration
4872169|NCT02215590|Quality of life|quality of life
4872170|NCT02215590|Functional ambulation|functional ambulation
4872171|NCT02215577|cancer, colorectal|cancer, colorectal
4872172|NCT02215577|hepatectomy|hepatectomy
4872173|NCT02215577|portal vein|portal vein
4872174|NCT02215577|embolization|embolization
4872175|NCT02215577|two-stage|two-stage
4872176|NCT02215564|Bordetella pertussis|bordetella pertussis
4872177|NCT02215564|Carriage rates in young adults|carriage rates in young adults
4872178|NCT02215551|laminectomy|laminectomy
4872179|NCT02215538|ADHD|adhd
4872180|NCT02215538|adult|adult
4872181|NCT02215538|WRAADDS|wraadds
4872182|NCT02215538|OROS MPH|oros mph
4872183|NCT02215538|emotional dysregulation|emotional dysregulation
4872184|NCT02215525|HCV|hcv
4872185|NCT02215525|UVA|uva
4872186|NCT02215525|Herbal therapy|herbal therapy
4872187|NCT02215499|JZP-386, Xyrem, sodium oxybate|jzp-386, xyrem, sodium oxybate
4872188|NCT02215486|Head massage therapy|head massage therapy
4872189|NCT02215486|Massage therapy|massage therapy
4872190|NCT02215486|Autonomic nervous system (ANS)|autonomic nervous system (ans)
4872191|NCT02215486|Heart rate variability (HRV)|heart rate variability (hrv)
4872192|NCT02215486|Pre-ejection period (PEP)|pre-ejection period (pep)
4872193|NCT02215473|gingivitis|gingivitis
4872194|NCT02215473|periodontitis|periodontitis
4872195|NCT02215473|mouth rinse|mouth rinse
4872196|NCT02215473|bacteremia|bacteremia
4872197|NCT02215447|NAB-paclitaxel|nab-paclitaxel
4872198|NCT02215447|Gastrointestinal Neuroendocrine Carcinomas|gastrointestinal neuroendocrine carcinomas
4872199|NCT02215447|phase II|phase ii
4872200|NCT02215447|carboplatin|carboplatin
4872201|NCT02215434|Libido; Sexual Dysfunction; testosterone|libido; sexual dysfunction; testosterone
4872202|NCT02215421|vegetables|vegetables
4872203|NCT02215421|dietary intake|dietary intake
4872204|NCT02215421|preschoolers|preschoolers
4872205|NCT02215421|parents|parents
4872206|NCT02215421|video game|video game
4872207|NCT02215408|Diabetes|diabetes
4872208|NCT02215408|Hyperlipidemia|hyperlipidemia
4872209|NCT02215408|Hypertension|hypertension
4872210|NCT02215408|Cardiovascular Disease|cardiovascular disease
4872211|NCT02215395|Nestorone|nestorone
4872212|NCT02215395|miconazole nitrate|miconazole nitrate
4872213|NCT02215382|two reversal methods|two reversal methods
4872214|NCT02215382|changes in IOP|changes in iop
4872215|NCT02215382|heart rate|heart rate
4872216|NCT02215382|blood pressure|blood pressure
4872217|NCT02215382|tracheal extubation|tracheal extubation
4872218|NCT02215330|Central serous chorioretinopathy|central serous chorioretinopathy
4872219|NCT02215330|Eplerenone|eplerenone
4872220|NCT02215330|Photodynamic Therapy|photodynamic therapy
4872221|NCT02215330|Macula|macula
4872222|NCT02215330|Retina|retina
4872223|NCT02215317|Sleep Apnea|sleep apnea
4872224|NCT02215317|Stent|stent
4872225|NCT02215317|Coronary Artery Disease|coronary artery disease
4872226|NCT02215317|Percutaneous Coronary Intervention|percutaneous coronary intervention
4872227|NCT02215304|Dietary supplementation|dietary supplementation
4872228|NCT02215304|Probiotics|probiotics
4872229|NCT02215304|Safety/Efficiency|safety/efficiency
4872230|NCT02215304|Healthy infants|healthy infants
4872231|NCT02215291|Undergoing Esophagogastroduodenoscopy (EGD) or endoscopy|undergoing esophagogastroduodenoscopy (egd) or endoscopy
4872232|NCT02215278|iron biofortification|iron biofortification
4872233|NCT02215278|lpa bean|lpa bean
4872234|NCT02215278|stable iron isotope study|stable iron isotope study
4872235|NCT02215278|phytic acid|phytic acid
4872236|NCT02215265|Human papillomavirus HPV positive oropharyngeal cancer|human papillomavirus hpv positive oropharyngeal cancer
4872237|NCT02215239|health lifestyle|health lifestyle
4872238|NCT02215239|health promotion|health promotion
4872239|NCT02215239|occupational health|occupational health
4872240|NCT02215239|Work site health promotion|work site health promotion
4872241|NCT02215226|Group B Streptococcus, early onset disease, late onset disease, anticapsular antibodies, serotype specific|group b streptococcus, early onset disease, late onset disease, anticapsular antibodies, serotype specific
4872242|NCT02215213|Vitamin D|vitamin d
4872243|NCT02215213|pregnancy|pregnancy
4872244|NCT02215213|Pakistan|pakistan
4872245|NCT02215200|Type 1 Diabetes TrialNet|type 1 diabetes trialnet
4872246|NCT02215174|Rosuvastatin|rosuvastatin
4872247|NCT02215174|PK|pk
4872248|NCT02215174|Interethnic|interethnic
4872249|NCT02215174|Morbid obese|morbid obese
4872250|NCT02215135|Corifollitropin alfa|corifollitropin alfa
4872251|NCT02215135|polycystic ovarian syndrome (PCOS)|polycystic ovarian syndrome (pcos)
4872252|NCT02215135|controlled ovarian hyperstimulation (COS)|controlled ovarian hyperstimulation (cos)
4872253|NCT02215135|GnRH antagonist protocol|gnrh antagonist protocol
4872254|NCT02215135|Ovarian hyperstimulation syndrome (OHSS)|ovarian hyperstimulation syndrome (ohss)
4872255|NCT02215122|Fluticasone Propionate|fluticasone propionate
4872256|NCT02215122|Salmeterol|salmeterol
4872257|NCT02215122|Pharmacokinetics|pharmacokinetics
4872258|NCT02215122|Healthy Subjects|healthy subjects
4872259|NCT02215122|MGR001|mgr001
4872260|NCT02215122|CRC749|crc749
4872261|NCT02215122|Dry Powder Inhaler|dry powder inhaler
4872262|NCT02215122|generic|generic
4872263|NCT02215122|Advair Diskus|advair diskus
4872264|NCT02215122|Seretide Accuhaler|seretide accuhaler
4872265|NCT02215096|enzalutamide|enzalutamide
4872266|NCT02215096|metastatic castration-resistant prostate cancer|metastatic castration-resistant prostate cancer
4872267|NCT02215096|GSK2636771|gsk2636771
4872268|NCT02215096|PI3K-beta|pi3k-beta
4872269|NCT02215096|PTEN deficiency|pten deficiency
4872270|NCT02215083|peripheral neuropathy|peripheral neuropathy
4872271|NCT02215083|breast cancer|breast cancer
4872272|NCT02215083|taxane induced peripheral neuropathy|taxane induced peripheral neuropathy
4872273|NCT02215083|chemotherapy induced peripheral neuropathy|chemotherapy induced peripheral neuropathy
4872274|NCT02215070|Allogeneic Stem Cell Transplantation|allogeneic stem cell transplantation
4872275|NCT02215070|Acute Myeloid Leukemia|acute myeloid leukemia
4872276|NCT02215070|Acute Lymphoid Leukemia|acute lymphoid leukemia
4872277|NCT02215070|Acute Non-Lymphocytic Leukemia|acute non-lymphocytic leukemia
4872278|NCT02215070|Myelodysplastic Syndrome|myelodysplastic syndrome
4872279|NCT02215070|Chronic Myeloid Leukemia|chronic myeloid leukemia
4872280|NCT02215070|Lymphoma|lymphoma
4872281|NCT02215057|topical anesthesia|topical anesthesia
4872282|NCT02215057|intracameral lidocaine|intracameral lidocaine
4872283|NCT02215057|implantable collamer lens|implantable collamer lens
4872284|NCT02214875|Retention|retention
4872285|NCT02214862|Unclassifiable Parkinsonism, [F18]-FDDNP-PET, Tauopathy, PSP,MSA|unclassifiable parkinsonism, [f18]-fddnp-pet, tauopathy, psp,msa
4872286|NCT02214849|Breastfeeding|breastfeeding
4872287|NCT02214849|Breastfeeding peer counseling|breastfeeding peer counseling
4872288|NCT02214849|Exclusive breastfeeding|exclusive breastfeeding
4872289|NCT02214849|Formula supplementation|formula supplementation
4872290|NCT02214849|Mobile health|mobile health
4872291|NCT02214849|WIC program|wic program
4872292|NCT02214836|kidney stones|kidney stones
4872293|NCT02214836|ultrasound imaging|ultrasound imaging
4872294|NCT02214836|ureter stones|ureter stones
4872295|NCT02214810|Bupivacaine|bupivacaine
4872296|NCT02214810|multimodal|multimodal
4872297|NCT02214810|exparel|exparel
4872298|NCT02214810|open reduction|open reduction
4872299|NCT02214810|internal fixation|internal fixation
4872300|NCT02214810|post-surgical pain control|post-surgical pain control
4872301|NCT02214797|Presbyopia|presbyopia
4872302|NCT02214797|Refractive Error|refractive error
4872303|NCT02214797|Contact Lenses|contact lenses
4872304|NCT02214784|Stress urinary Incontinence|stress urinary incontinence
4872305|NCT02214784|SUI|sui
4872306|NCT02214784|Continence|continence
4872307|NCT02214771|Clostridium difficile infection CDI|clostridium difficile infection cdi
4872308|NCT02214771|Observational|observational
4872309|NCT02214771|Fidaxomicin recurrence|fidaxomicin recurrence
4872310|NCT02214771|France|france
4872311|NCT02214758|Home care clients, nutrition, oral health, medication|home care clients, nutrition, oral health, medication
4872312|NCT02214745|Israeli Arab population|israeli arab population
4872313|NCT02214745|Israeli/ethnology|israeli/ethnology
4872314|NCT02214732|Pregnancy|pregnancy
4872315|NCT02214732|Postpartum|postpartum
4872316|NCT02214732|Mindfulness Based Cognitive Therapy|mindfulness based cognitive therapy
4872317|NCT02214732|Depression|depression
4872318|NCT02214732|Anxiety|anxiety
4872319|NCT02214732|Stress|stress
4872320|NCT02214732|MBCT|mbct
4872321|NCT02214732|Actigraphy|actigraphy
4872322|NCT02214719|type 1 diabetes, insulin therapy, bolus calculator|type 1 diabetes, insulin therapy, bolus calculator
4872323|NCT02214693|patients|patients
4872324|NCT02214680|Pupil diameter|pupil diameter
4872325|NCT02214680|Brimonidine|brimonidine
4872326|NCT02214680|Timolol|timolol
4872327|NCT02214680|Combigan|combigan
4872328|NCT02214667|Jail|jail
4872329|NCT02214667|co-occurring disorders|co-occurring disorders
4872330|NCT02214667|implementation|implementation
4872331|NCT02214667|acceptability|acceptability
4872332|NCT02214667|feasibility|feasibility
4872333|NCT02214667|fidelity|fidelity
4872334|NCT02214628|Wet AMD|wet amd
4872335|NCT02214628|Choroidal neovascularization|choroidal neovascularization
4872336|NCT02214628|Fovista®|fovista®
4872337|NCT02214628|E10030|e10030
4872338|NCT02214628|Avastin®|avastin®
4872339|NCT02214628|Eylea®|eylea®
4872340|NCT02214602|non muscle invasive bladder cancer|non muscle invasive bladder cancer
4872341|NCT02214602|intermediate and high risk|intermediate and high risk
4872342|NCT02214602|immediate single instillation|immediate single instillation
4872343|NCT02214602|Intravesical chemotherapy|intravesical chemotherapy
4872344|NCT02214602|Disease prevention|disease prevention
4872345|NCT02214576|Respiratory Distress Syndrome, Adult|respiratory distress syndrome, adult
4872346|NCT02214576|intubation, intratracheal|intubation, intratracheal
4872347|NCT02214576|Oxygen Inhalation Therapy|oxygen inhalation therapy
4872348|NCT02214576|Positive-Pressure Respiration|positive-pressure respiration
4872349|NCT02214576|laryngoscopy|laryngoscopy
4872350|NCT02214563|Vitamin D|vitamin d
4872351|NCT02214563|Cholecalciferol|cholecalciferol
4872352|NCT02214563|Hepcidins|hepcidins
4872353|NCT02214563|Renal Dialysis|renal dialysis
4872354|NCT02214550|Cystitis, Interstitial|cystitis, interstitial
4872355|NCT02214550|Dysmenorrhea|dysmenorrhea
4872356|NCT02214550|Migraine Disorders|migraine disorders
4872357|NCT02214550|Cross Organ Sensitization|cross organ sensitization
4872358|NCT02214550|Pelvic Pain|pelvic pain
4872359|NCT02214550|Endometriosis|endometriosis
4872360|NCT02214550|Contraceptives, Oral|contraceptives, oral
4872361|NCT02214550|Birth Control Pills|birth control pills
4872362|NCT02214550|Painful Bladder Syndrome|painful bladder syndrome
4872363|NCT02214550|Visceral Pain|visceral pain
4872364|NCT02214550|Chronic Pain|chronic pain
4872365|NCT02214524|perioperative hypothermia|perioperative hypothermia
4872366|NCT02214524|Tympanic temperature|tympanic temperature
4872367|NCT02214524|Blood loss|blood loss
4872368|NCT02214524|Blood Coagulation Disorders|blood coagulation disorders
4872369|NCT02214524|Major surgery|major surgery
4872370|NCT02214511|major depressive disorder|major depressive disorder
4872371|NCT02214511|social rejection|social rejection
4872372|NCT02214511|rapid facial reaction|rapid facial reaction
4872373|NCT02214511|facial mimicry|facial mimicry
4872374|NCT02214511|prosocial behavior|prosocial behavior
4872375|NCT02214511|inflammation|inflammation
4872376|NCT02214511|self esteem|self esteem
4872377|NCT02214498|Dipper|dipper
4872378|NCT02214498|Non-dipper|non-dipper
4872379|NCT02214498|Chronopharmacology|chronopharmacology
4872380|NCT02214485|frailty|frailty
4872381|NCT02214485|exercise|exercise
4872382|NCT02214485|intervention|intervention
4872383|NCT02214472|Rumination síndrome|rumination síndrome
4872384|NCT02214472|Regurgitation|regurgitation
4872385|NCT02214472|Vomiting|vomiting
4872386|NCT02214472|Biofeedback|biofeedback
4872387|NCT02214472|Electromyography|electromyography
4872388|NCT02214472|Abdominal accommodation|abdominal accommodation
4872389|NCT02214459|mHealth|mhealth
4872390|NCT02214459|Hypertension|hypertension
4872391|NCT02214459|Mobile|mobile
4872392|NCT02214459|smartphone|smartphone
4872393|NCT02214459|diet|diet
4872394|NCT02214459|lifestyle|lifestyle
4872395|NCT02214459|bluetooth|bluetooth
4872396|NCT02214459|physical acitvity|physical acitvity
4872397|NCT02214459|behavior change|behavior change
4872398|NCT02214459|motivational interviewing|motivational interviewing
4872399|NCT02214446|truth telling|truth telling
4872400|NCT02214446|hope|hope
4872401|NCT02214446|quality of life|quality of life
4872402|NCT02214446|care burden|care burden
4872403|NCT02214446|children with cancer|children with cancer
4872404|NCT02214433|Antibiotic|antibiotic
4872405|NCT02214433|Antibiotic Resistant Bacterial Infection|antibiotic resistant bacterial infection
4872406|NCT02214381|breast cancer|breast cancer
4872407|NCT02214381|elderly|elderly
4872408|NCT02214329|Postural Balance|postural balance
4872409|NCT02214329|Gait|gait
4872410|NCT02214329|Fall risk|fall risk
4872411|NCT02214303|Allergic asthma|allergic asthma
4872412|NCT02214303|Allergic rhinitis|allergic rhinitis
4872413|NCT02214303|Healthy subjects|healthy subjects
4872414|NCT02214290|Cardiovascular|cardiovascular
4872415|NCT02214290|Caffeine|caffeine
4872416|NCT02214290|L-citrulline|l-citrulline
4872417|NCT02214290|Arterial Function|arterial function
4872418|NCT02214290|Hemodynamics|hemodynamics
4872419|NCT02214290|Blood Pressure|blood pressure
4872420|NCT02214290|Pulse Wave Velocity|pulse wave velocity
4872421|NCT02214290|Pulse Wave Analysis|pulse wave analysis
4872422|NCT02214277|Embolic Protection|embolic protection
4872423|NCT02214277|Edwards SAPIEN THV|edwards sapien thv
4872424|NCT02214277|Edwards SAPIEN XT|edwards sapien xt
4872425|NCT02214277|TAVR|tavr
4872426|NCT02214277|Transfemoral|transfemoral
4872427|NCT02214277|Transapical|transapical
4872428|NCT02214277|Heart Valve Diseases|heart valve diseases
4872429|NCT02214277|Heart Diseases|heart diseases
4872430|NCT02214277|TAVI|tavi
4872431|NCT02214277|Aortic Stenosis|aortic stenosis
4872432|NCT02214277|Aortic Valve|aortic valve
4872433|NCT02214277|Transcatheter Heart Valve|transcatheter heart valve
4872434|NCT02214251|Parkinson's disease|parkinson's disease
4872435|NCT02214251|freezing of gait|freezing of gait
4872436|NCT02214251|movement disorders|movement disorders
4872437|NCT02214251|neuroscience|neuroscience
4872438|NCT02214251|neural|neural
4872439|NCT02214251|mechanism|mechanism
4872440|NCT02214212|traumatic brain injury|traumatic brain injury
4872441|NCT02214212|TBI|tbi
4872442|NCT02214212|Sleep|sleep
4872443|NCT02214212|Bright White Light Therapy|bright white light therapy
4872444|NCT02214212|Red Light Therapy|red light therapy
4872445|NCT02214212|Recovery|recovery
4872446|NCT02214212|Central Nervous System Diseases|central nervous system diseases
4872447|NCT02214212|Brain Diseases|brain diseases
4872448|NCT02214212|Nervous System Diseases|nervous system diseases
4872449|NCT02214212|Signs and Symptoms|signs and symptoms
4872450|NCT02214212|Rehabilitation|rehabilitation
4872451|NCT02214212|Actigraphy|actigraphy
4872452|NCT02214199|Shoulder Pain|shoulder pain
4872453|NCT02214199|Shoulder Impingement Syndrome|shoulder impingement syndrome
4872454|NCT02214199|Exercise therapy|exercise therapy
4872455|NCT02214199|Randomized Controlled Trial|randomized controlled trial
4872456|NCT02214186|Pre-Eclampsia|pre-eclampsia
4872457|NCT02214186|Acute Kidney Injury|acute kidney injury
4872458|NCT02214186|Fluid Therapy|fluid therapy
4872459|NCT02214186|Anesthesia, Spinal|anesthesia, spinal
4872460|NCT02214173|HIV, BRM4, hydrolyzed rice bran, metabolic syndrome|hiv, brm4, hydrolyzed rice bran, metabolic syndrome
4872461|NCT02214160|Long-Chain Fatty Acid Oxidation Disorders (LC-FAOD)|long-chain fatty acid oxidation disorders (lc-faod)
4872462|NCT02214160|carnitine palmitoyltransferase (CPT I or CPT II) deficiency|carnitine palmitoyltransferase (cpt i or cpt ii) deficiency
4872463|NCT02214160|very long chain acyl-CoA dehydrogenase (VLCAD) deficiency|very long chain acyl-coa dehydrogenase (vlcad) deficiency
4872464|NCT02214160|long-chain 3-hydroxy-acyl-CoA dehydrogenase (LCHAD) deficiency|long-chain 3-hydroxy-acyl-coa dehydrogenase (lchad) deficiency
4872465|NCT02214160|trifunctional protein (TFP) deficiency|trifunctional protein (tfp) deficiency
4872466|NCT02214160|carnitine-acylcarnitine translocase (CACT) deficiency|carnitine-acylcarnitine translocase (cact) deficiency
4872467|NCT02214160|Triheptanoin|triheptanoin
4872468|NCT02214160|UX007|ux007
4872469|NCT02214160|C7|c7
4872470|NCT02214147|Alisertib|alisertib
4872471|NCT02214147|MLN8237|mln8237
4872472|NCT02214147|Relapsed/refractory lymphoma|relapsed/refractory lymphoma
4872473|NCT02214134|Lung cancer|lung cancer
4872474|NCT02214134|Malignant pleural mesothelioma|malignant pleural mesothelioma
4872475|NCT02214134|Thymic malignancy|thymic malignancy
4872476|NCT02214134|Biomarkers|biomarkers
4872477|NCT02214134|Screening|screening
4872478|NCT02214121|sickle cell anemia|sickle cell anemia
4872479|NCT02214121|paediatric|paediatric
4872480|NCT02214108|BMI|bmi
4872481|NCT02214108|Obesity|obesity
4872482|NCT02214108|overweight|overweight
4872483|NCT02214108|child|child
4872484|NCT02214108|Physical activity|physical activity
4872485|NCT02214095|Cytokines|cytokines
4872486|NCT02214095|interleukin-1β|interleukin-1β
4872487|NCT02214095|chronic periodontitis|chronic periodontitis
4872488|NCT02214095|host modulation|host modulation
4872489|NCT02214095|glucosamine sulphate.|glucosamine sulphate.
4872490|NCT02214056|mobile screening team|mobile screening team
4872491|NCT02214056|feasibility|feasibility
4872492|NCT02214030|Femoral compression device|femoral compression device
4872493|NCT02214030|manual compression|manual compression
4872494|NCT02214030|arterial hemostasis|arterial hemostasis
4872495|NCT02214030|coronary intervention|coronary intervention
4872496|NCT02214030|coronary artery disease|coronary artery disease
4872497|NCT02214017|diabetes|diabetes
4872498|NCT02214017|telemedicine|telemedicine
4872499|NCT02214017|glycemia|glycemia
4872500|NCT02214017|lipids|lipids
4872501|NCT02214017|blood pressure|blood pressure
4872502|NCT02214004|Breast cancer|breast cancer
4872503|NCT02214004|HER2|her2
4872504|NCT02214004|ER|er
4872505|NCT02214004|Postmenopausal|postmenopausal
4872506|NCT02214004|Trastuzumab|trastuzumab
4872507|NCT02214004|Letrozole|letrozole
4872508|NCT02214004|Neoadjuvant endocrine treatment|neoadjuvant endocrine treatment
4872509|NCT02213991|Breast Cancer|breast cancer
4872510|NCT02213991|Breast Conservative Surgery|breast conservative surgery
4872511|NCT02213991|Intraoperative Radiotherapy|intraoperative radiotherapy
4872512|NCT02213991|Local Toxicity|local toxicity
4872513|NCT02213991|Whole breast radiotherapy|whole breast radiotherapy
4872514|NCT02213965|Intravenous Catheter|intravenous catheter
4872515|NCT02213965|Vasofix safety|vasofix safety
4872516|NCT02213965|Introcan safety|introcan safety
4872517|NCT02213952|Ulcer|ulcer
4872518|NCT02213952|Platelet-Rich Plasma|platelet-rich plasma
4872519|NCT02213939|Myocardial revascularization|myocardial revascularization
4872520|NCT02213939|Cytosorb|cytosorb
4872521|NCT02213939|Inflammatory response|inflammatory response
4872522|NCT02213939|Cardiopulmonary bypass|cardiopulmonary bypass
4872523|NCT02213926|Bruton tyrosine kinase inhibitor|bruton tyrosine kinase inhibitor
4872524|NCT02213926|Btk|btk
4872525|NCT02213926|Mantle Cell Lymphoma|mantle cell lymphoma
4872526|NCT02213926|MCL|mcl
4872527|NCT02213926|ACP-196|acp-196
4872528|NCT02213926|Acalabrutinib|acalabrutinib
4872529|NCT02213926|ACE-LY-004|ace-ly-004
4872530|NCT02213900|delirium|delirium
4872531|NCT02213900|confusion|confusion
4872532|NCT02213900|surgery|surgery
4872533|NCT02213900|cognitive Impairment|cognitive impairment
4872534|NCT02213900|post-traumatic Stress disorder|post-traumatic stress disorder
4872535|NCT02213900|depression|depression
4872536|NCT02213900|anxiety|anxiety
4872537|NCT02213887|Drug Interactions|drug interactions
4872538|NCT02213887|Pantoprazole|pantoprazole
4872539|NCT02213887|Proton Pump Inhibitors|proton pump inhibitors
4872540|NCT02213887|Psychotropic Drugs|psychotropic drugs
4872541|NCT02213887|Antipsychotic Agents|antipsychotic agents
4872542|NCT02213887|Aripiprazole|aripiprazole
4872543|NCT02213887|Asenapine|asenapine
4872544|NCT02213887|Clozapine|clozapine
4872545|NCT02213887|Lurasidone|lurasidone
4872546|NCT02213887|Olanzapine|olanzapine
4872547|NCT02213887|9-hydroxy-risperidone|9-hydroxy-risperidone
4872548|NCT02213887|Quetiapine|quetiapine
4872549|NCT02213887|Risperidone|risperidone
4872551|NCT02213887|Valproic Acid|valproic acid
4872552|NCT02213887|Lithium|lithium
4872553|NCT02213887|Gastrins|gastrins
4872554|NCT02213887|Psychotic Disorders|psychotic disorders
4872555|NCT02213887|Gastroesophageal Reflux|gastroesophageal reflux
4872556|NCT02213874|Pregnant Women|pregnant women
4872557|NCT02213874|Women's Health|women's health
4872558|NCT02213874|Contraception|contraception
4872559|NCT02213874|Trust in Health Care|trust in health care
4872560|NCT02213861|CTCL|ctcl
4872561|NCT02213861|Cutaneous T-Cell Lymphoma|cutaneous t-cell lymphoma
4872562|NCT02213861|Early-stage|early-stage
4872563|NCT02213861|SHAPE|shape
4872564|NCT02213861|SHP-141|shp-141
4872565|NCT02213861|topical|topical
4872566|NCT02213861|Histone deacetylase inhibitor|histone deacetylase inhibitor
4872567|NCT02213861|CAILS|cails
4872568|NCT02213861|mSWAT|mswat
4872569|NCT02213861|mycosis fungoides|mycosis fungoides
4872570|NCT02213848|Neuromuscular blockade reversal|neuromuscular blockade reversal
4872571|NCT02213848|TOF ratio|tof ratio
4872572|NCT02213848|Calcium chloride|calcium chloride
4872573|NCT02213835|Crohn's disease and Ulcerative colitis|crohn's disease and ulcerative colitis
4872574|NCT02213822|genome|genome
4872575|NCT02213822|transcriptome|transcriptome
4872576|NCT02213822|molecular|molecular
4872577|NCT02213822|proteome|proteome
4872578|NCT02213822|oncogenic mutations|oncogenic mutations
4872579|NCT02213822|sequencing|sequencing
4872580|NCT02213822|solid tumor|solid tumor
4872581|NCT02213822|hematological malignancy|hematological malignancy
4872582|NCT02213822|cancer|cancer
4872583|NCT02213822|analysis|analysis
4872584|NCT02213822|genetic|genetic
4872585|NCT02213822|mutation|mutation
4872586|NCT02213796|meropenem, early phase, severe sepsis and septic shock, critically ill, population pharmacokinetics|meropenem, early phase, severe sepsis and septic shock, critically ill, population pharmacokinetics
4872587|NCT02213783|Imipenem|imipenem
4872588|NCT02213783|Febrile neutropenia|febrile neutropenia
4872589|NCT02213783|Gram-negative infection|gram-negative infection
4872590|NCT02213783|Pharmacodynamic|pharmacodynamic
4872591|NCT02213783|Monte Carlo Simulation|monte carlo simulation
4872592|NCT02213757|Hematuria|hematuria
4872593|NCT02213757|Menopause|menopause
4872594|NCT02213757|Urinalysis|urinalysis
4872595|NCT02213744|HER2-positive|her2-positive
4872596|NCT02213744|HER2+|her2+
4872597|NCT02213744|HER2|her2
4872598|NCT02213744|Locally Advanced Breast Cancer|locally advanced breast cancer
4872599|NCT02213744|Metastatic Breast Cancer|metastatic breast cancer
4872600|NCT02213744|trastuzumab|trastuzumab
4872601|NCT02213744|Herceptin|herceptin
4872602|NCT02213744|pertuzumab|pertuzumab
4872603|NCT02213744|ado-trastuzumab emtansine|ado-trastuzumab emtansine
4872604|NCT02213744|TDM-1|tdm-1
4872605|NCT02213744|Perjeta|perjeta
4872606|NCT02213744|Kadcyla|kadcyla
4872607|NCT02213731|Atrial Fibrillation|atrial fibrillation
4872608|NCT02213731|Persistent Atrial Fibrillation|persistent atrial fibrillation
4872609|NCT02213731|Cryoablation|cryoablation
4872610|NCT02213731|Cryoballoon|cryoballoon
4872611|NCT02213731|Pulmonary Vein Isolation|pulmonary vein isolation
4872612|NCT02213718|Desflurane|desflurane
4872613|NCT02213718|myocardial function|myocardial function
4872614|NCT02213718|Coronary Artery Bypass Surgery|coronary artery bypass surgery
4872615|NCT02213705|SYSTEMIC SCLERODERMA|systemic scleroderma
4872616|NCT02213705|TRANSPLANTATION|transplantation
4872617|NCT02213705|ALLOGENEIC MESENCHYMAL STEM CELLS|allogeneic mesenchymal stem cells
4872618|NCT02213705|ADULT|adult
4872619|NCT02213692|Liver Resection|liver resection
4872620|NCT02213692|Harmonic Scalpel|harmonic scalpel
4872621|NCT02213692|Crush-clamping|crush-clamping
4872622|NCT02213692|A Prospective Randomized Study|a prospective randomized study
4872623|NCT02213679|Creatine|creatine
4872624|NCT02213679|Guanidinoacetic acid|guanidinoacetic acid
4872625|NCT02213679|Intervention|intervention
4872626|NCT02213679|Fatigue|fatigue
4872627|NCT02213679|Muscle strength|muscle strength
4872628|NCT02213666|Atrial fibrillation ablation|atrial fibrillation ablation
4872629|NCT02213666|Intracardiac echocardiography|intracardiac echocardiography
4872630|NCT02213666|Thrombus|thrombus
4872631|NCT02213666|Left atrial appendage|left atrial appendage
4872632|NCT02213666|Right atrial appendage|right atrial appendage
4872633|NCT02213653|Functional iron deficiency|functional iron deficiency
4872634|NCT02213653|Metastatic|metastatic
4872635|NCT02213640|Neurologic neglect syndrome|neurologic neglect syndrome
4872636|NCT02213640|post stroke|post stroke
4872637|NCT02213640|transcranial direct current stimulation (tDCS)|transcranial direct current stimulation (tdcs)
4872638|NCT02213640|prismatic adaptation|prismatic adaptation
4872639|NCT02213627|Corifollitropin alfa, recombinant FSH, HP-hMG, apoptosis, oocyte donation|corifollitropin alfa, recombinant fsh, hp-hmg, apoptosis, oocyte donation
4872640|NCT02213601|Yoga|yoga
4872641|NCT02213601|Complementary and Alternative Medicine Interventions|complementary and alternative medicine interventions
4872642|NCT02213601|Treatment|treatment
4872643|NCT02213601|Postpartum Depression|postpartum depression
4872644|NCT02213588|Antioxidant|antioxidant
4872645|NCT02213575|Resistent Hypertension|resistent hypertension
4872646|NCT02213536|Metastatic brain cancer|metastatic brain cancer
4872647|NCT02213536|Whole brain radiotherapy|whole brain radiotherapy
4872648|NCT02213536|Scalp sparing whole brain radiotherapy|scalp sparing whole brain radiotherapy
4872649|NCT02213536|Prophylactic whole brain radiotherapy|prophylactic whole brain radiotherapy
4872650|NCT02213523|antioxidant|antioxidant
4872651|NCT02213510|pacemaker|pacemaker
4872652|NCT02213510|implantable cardioverter defibrillator|implantable cardioverter defibrillator
4872653|NCT02213510|ICD|icd
4872654|NCT02213510|surgical wound closure|surgical wound closure
4872655|NCT02213510|sutures|sutures
4872656|NCT02213510|Zipline|zipline
4872657|NCT02213510|Zips|zips
4872658|NCT02213510|CIED|cied
4872659|NCT02213510|cardiovascular implantable electronic devices|cardiovascular implantable electronic devices
4872660|NCT02213510|arrhythmia|arrhythmia
4872661|NCT02213497|Patients with esophageal cancer to be treated with concurrent preoperative chemoradiation with carboplatin and paclitaxel.|patients with esophageal cancer to be treated with concurrent preoperative chemoradiation with carboplatin and paclitaxel.
4872662|NCT02213484|aortopathy syndrome|aortopathy syndrome
4872663|NCT02213484|aortic aneurysm|aortic aneurysm
4872664|NCT02213484|aortic dissection|aortic dissection
4872665|NCT02213484|connective tissue disorder|connective tissue disorder
4872666|NCT02213458|Pragmatic Clinical Trial|pragmatic clinical trial
4872667|NCT02213458|Family Caregivers|family caregivers
4872668|NCT02213458|Patient Care Management|patient care management
4872669|NCT02213432|influenza vaccine|influenza vaccine
4872670|NCT02213432|cancer|cancer
4872671|NCT02213419|Cystic Tumors of the Pancreas|cystic tumors of the pancreas
4872672|NCT02213419|Endoscopic Ultrasound|endoscopic ultrasound
4872673|NCT02213419|Ethanol|ethanol
4872674|NCT02213393|undernutrition|undernutrition
4872675|NCT02213393|nutritional status|nutritional status
4872676|NCT02213393|elderly patients|elderly patients
4872677|NCT02213393|protein|protein
4872678|NCT02213393|enriched products|enriched products
4872679|NCT02213393|recovery|recovery
4872680|NCT02213393|physical function|physical function
4872681|NCT02213393|quality of life|quality of life
4872682|NCT02213393|activities of daily living|activities of daily living
4872683|NCT02213380|delirium|delirium
4872684|NCT02213380|general anesthesia|general anesthesia
4872685|NCT02213380|regional anesthesia|regional anesthesia
4872686|NCT02213380|elderly patient|elderly patient
4872687|NCT02213380|hip fracture|hip fracture
4872688|NCT02213354|Influenza, H7N9, Elderly, Vaccine, MF59 Adjuvant|influenza, h7n9, elderly, vaccine, mf59 adjuvant
4872689|NCT02213341|Milk Allergy|milk allergy
4872690|NCT02213341|Egg Allergy|egg allergy
4872691|NCT02213341|Peanut Allergy|peanut allergy
4872692|NCT02213341|Infant Vaccination|infant vaccination
4872693|NCT02213315|Healthy Volunteers, Rheumatoid Arthritis, mavrilimumab|healthy volunteers, rheumatoid arthritis, mavrilimumab
4872694|NCT02213302|premedication|premedication
4872695|NCT02213302|preoperative anxiety|preoperative anxiety
4872696|NCT02213302|salivary cortisol level|salivary cortisol level
4872697|NCT02213302|anxiety visual analog scale|anxiety visual analog scale
4872698|NCT02213289|Gastric|gastric
4872699|NCT02213289|Esophagogastric|esophagogastric
4872700|NCT02213276|Glucose infusion|glucose infusion
4872701|NCT02213276|Bone markers|bone markers
4872702|NCT02213276|Inflammatory markers|inflammatory markers
4872703|NCT02213263|rituximab|rituximab
4872704|NCT02213263|follicular lymphoma|follicular lymphoma
4872705|NCT02213263|Non-Hodgkin lymphoma|non-hodgkin lymphoma
4872706|NCT02213263|Non-Hodgkin's lymphoma|non-hodgkin's lymphoma
4872707|NCT02213224|Perindopril,Telmisartan, Efficacy, NAFLD|perindopril,telmisartan, efficacy, nafld
4872708|NCT02213211|Malawi|malawi
4872709|NCT02213211|Case management|case management
4872710|NCT02213211|Rapid diagnostic tests|rapid diagnostic tests
4872711|NCT02213211|Artemether lumefantrine|artemether lumefantrine
4872712|NCT02213211|School children|school children
4872713|NCT02213211|School health services|school health services
4872714|NCT02213211|Attendance|attendance
4872715|NCT02213211|Anaemia|anaemia
4872716|NCT02213211|Parasitic diseases|parasitic diseases
4872717|NCT02213198|Serious mental illness transitions shared decision making|serious mental illness transitions shared decision making
4872718|NCT02213185|Sterile water injections|sterile water injections
4872719|NCT02213185|Pain|pain
4872720|NCT02213185|VAS|vas
4872721|NCT02213185|Complementary method|complementary method
4872722|NCT02213172|IBS|ibs
4872723|NCT02213172|Probiotic|probiotic
4872724|NCT02213172|Constipation|constipation
4872725|NCT02213172|Bifidobacterium longum|bifidobacterium longum
4872726|NCT02213172|Lactobacillus paracasei|lactobacillus paracasei
4872727|NCT02213172|Lallemand Health Solutions|lallemand health solutions
4872728|NCT02213159|Dexmedetomidine|dexmedetomidine
4872729|NCT02213159|bariatric surgery|bariatric surgery
4872730|NCT02213159|postoperative pain|postoperative pain
4872731|NCT02213159|morphine consumption|morphine consumption
4872732|NCT02213159|Quality of recovery|quality of recovery
4872733|NCT02213133|Squamous|squamous
4872734|NCT02213133|SCC|scc
4872735|NCT02213133|Carcinoma|carcinoma
4872736|NCT02213133|KPT-330|kpt-330
4872737|NCT02213133|SINE|sine
4872738|NCT02213133|Selinexor|selinexor
4872739|NCT02213133|Karyopharm|karyopharm
4872740|NCT02213133|Karyopharm Therapeutics|karyopharm therapeutics
4872741|NCT02213133|Lung|lung
4872742|NCT02213133|Head|head
4872743|NCT02213133|Neck|neck
4872744|NCT02213133|Esophageal|esophageal
4872745|NCT02213120|Vertigo, Dizziness|vertigo, dizziness
4872746|NCT02213107|prostate|prostate
4872747|NCT02213094|preeclampsia|preeclampsia
4872748|NCT02213094|pregnancy-induced hypertension|pregnancy-induced hypertension
4872749|NCT02213094|nicotinamide|nicotinamide
4872750|NCT02213081|Endometriosis|endometriosis
4872751|NCT02213081|chronic pelvic pain|chronic pelvic pain
4872752|NCT02213081|dysmenorrhea|dysmenorrhea
4872753|NCT02213081|dyschezia|dyschezia
4872754|NCT02213081|bleeding|bleeding
4872755|NCT02213081|ulipristal|ulipristal
4872756|NCT02213081|progesterone|progesterone
4872757|NCT02213068|Kidney|kidney
4872758|NCT02213068|Renal|renal
4872759|NCT02213068|Transplant|transplant
4872760|NCT02213068|EBV|ebv
4872761|NCT02213068|Immunosuppressants|immunosuppressants
4872762|NCT02213068|Belatacept|belatacept
4872763|NCT02213055|Lice|lice
4872764|NCT02213042|biomarker|biomarker
4872765|NCT02213042|Lapatinib|lapatinib
4872766|NCT02213042|Prosigna|prosigna
4872767|NCT02213042|ErbB2|erbb2
4872768|NCT02213042|PAM50|pam50
4872769|NCT02213042|HER2|her2
4872770|NCT02213042|HER2-overexpressing metastatic breast cancer|her2-overexpressing metastatic breast cancer
4872771|NCT02213042|HER2-enriched|her2-enriched
4872772|NCT02213042|Trastuzumab|trastuzumab
4872773|NCT02213029|epelsiban|epelsiban
4872774|NCT02213029|pharmacokinetics|pharmacokinetics
4872775|NCT02213029|patient reported pain / discomfort|patient reported pain / discomfort
4872776|NCT02213029|pharmacodynamics|pharmacodynamics
4872777|NCT02213029|oxytocin infusions|oxytocin infusions
4872778|NCT02213029|Uterine contractions|uterine contractions
4872779|NCT02213016|Stimulation magnetic transcranial, major depression, cognitive impairment|stimulation magnetic transcranial, major depression, cognitive impairment
4872780|NCT02213003|islet transplantation|islet transplantation
4872781|NCT02212990|Fever|fever
4872782|NCT02212990|Antipyretics|antipyretics
4872783|NCT02212990|Acetaminophen|acetaminophen
4872784|NCT02212990|Ibuprofen|ibuprofen
4872785|NCT02212990|Influenza vaccine|influenza vaccine
4872786|NCT02212990|Influenza|influenza
4872787|NCT02212990|Body temperature changes|body temperature changes
4872788|NCT02212990|Signs and symptoms|signs and symptoms
4872789|NCT02212977|Port Catheter|port catheter
4872790|NCT02212977|Octyl 2-cyanoacrylate|octyl 2-cyanoacrylate
4872791|NCT02212977|2-octylcyanoacrylate|2-octylcyanoacrylate
4872792|NCT02212964|Radiation Injury|radiation injury
4872793|NCT02212964|Radiation Necrosis|radiation necrosis
4872794|NCT02212964|Ultra-high field MRI|ultra-high field mri
4872795|NCT02212964|Susceptibility Weighted Imaging|susceptibility weighted imaging
4872796|NCT02212964|Post-treatment radiographic imaging change|post-treatment radiographic imaging change
4872797|NCT02212912|acute ischemic stroke, performance measure, acute treatment|acute ischemic stroke, performance measure, acute treatment
4872798|NCT02212899|Spinal Surgery|spinal surgery
4872799|NCT02212899|Spinal Fusion|spinal fusion
4872800|NCT02212899|Deformity Correction|deformity correction
4872801|NCT02212899|Spinal Instrumentation|spinal instrumentation
4872802|NCT02212886|Glatiramer acetate|glatiramer acetate
4872803|NCT02212886|Copaxone|copaxone
4872804|NCT02212886|Multiple sclerosis|multiple sclerosis
4872805|NCT02212886|Relapsing remitting multiple sclerosis|relapsing remitting multiple sclerosis
4872806|NCT02212886|RRMS|rrms
4872807|NCT02212886|GA Depot|ga depot
4872808|NCT02212886|Monthly injection|monthly injection
4872809|NCT02212873|school based intervention|school based intervention
4872810|NCT02212873|overweight|overweight
4872811|NCT02212873|obese|obese
4872812|NCT02212873|BMI z score|bmi z score
4872813|NCT02212873|fat mass|fat mass
4872814|NCT02212860|neoadjuvant|neoadjuvant
4872815|NCT02212860|radiation|radiation
4872816|NCT02212860|breast|breast
4872817|NCT02212860|cancer|cancer
4872818|NCT02212860|hypofractionation|hypofractionation
4872819|NCT02212860|stereotactic|stereotactic
4872820|NCT02212860|preoperative|preoperative
4872821|NCT02212834|Breast|breast
4872822|NCT02212834|Cancer|cancer
4872823|NCT02212834|Surveillance|surveillance
4872824|NCT02212834|Imaging|imaging
4872825|NCT02212834|Comparative|comparative
4872826|NCT02212834|Effectiveness|effectiveness
4872827|NCT02212808|Cluster-randomized crossover trial|cluster-randomized crossover trial
4872828|NCT02212808|Antimicrobial stewardship|antimicrobial stewardship
4872829|NCT02212808|Community hospitals|community hospitals
4872830|NCT02212808|Feasibility|feasibility
4872831|NCT02212795|healthy|healthy
4872832|NCT02212782|Healthy|healthy
4872833|NCT02212769|healthy|healthy
4872834|NCT02212756|healthy|healthy
4872835|NCT02212717|Acute cholecystitis|acute cholecystitis
4872836|NCT02212717|EUS-guided gallbladder drainage|eus-guided gallbladder drainage
4872837|NCT02212717|Percutaneous cholecystostomy|percutaneous cholecystostomy
4872838|NCT02212704|vestibular|vestibular
4872839|NCT02212704|proprioception|proprioception
4872840|NCT02212704|spatial orientation|spatial orientation
4872841|NCT02212704|bayesian|bayesian
4872842|NCT02212691|Sickle Cell|sickle cell
4872843|NCT02212652|Bariatric surgery|bariatric surgery
4872844|NCT02212652|Vitamin D deficiency|vitamin d deficiency
4872947|NCT02212119|Paratonia|paratonia
4872845|NCT02212652|Vitamin D insufficiency|vitamin d insufficiency
4872846|NCT02212652|Adverse surgical outcomes|adverse surgical outcomes
4872847|NCT02212652|Clinical outcomes|clinical outcomes
4872848|NCT02212639|Kaposi' s sarcoma|kaposi' s sarcoma
4872849|NCT02212639|Digoxin|digoxin
4872850|NCT02212613|Major Depressive Disorder|major depressive disorder
4872851|NCT02212613|Mental Disorders, nonpsychotic episode, antipsychotic|mental disorders, nonpsychotic episode, antipsychotic
4872852|NCT02212613|Mood Disorder, psychotic disorder|mood disorder, psychotic disorder
4872853|NCT02212587|inhaled antibiotics|inhaled antibiotics
4872854|NCT02212574|Wnt|wnt
4872855|NCT02212574|Medulloblastoma|medulloblastoma
4872856|NCT02212574|Chemotherapy|chemotherapy
4872857|NCT02212548|SpaceOAR Hydrogel Image Guided Modulated Radiotherapy|spaceoar hydrogel image guided modulated radiotherapy
4872858|NCT02212535|Sickle cell disease|sickle cell disease
4872859|NCT02212535|Open monocenter study|open monocenter study
4872860|NCT02212535|Phase I/II|phase i/ii
4872861|NCT02212535|hematopoietic stem cells|hematopoietic stem cells
4872862|NCT02212535|Plerixafor|plerixafor
4872863|NCT02212522|Diabetes Mellitus|diabetes mellitus
4872864|NCT02212522|Insulin-Dependent|insulin-dependent
4872865|NCT02212522|Genome-Wide Association Study|genome-wide association study
4872866|NCT02212522|Environment-Wide Association Study|environment-wide association study
4872867|NCT02212522|Predisposition|predisposition
4872868|NCT02212522|Complications|complications
4872869|NCT02212483|Asthma|asthma
4872870|NCT02212483|Medical Indoor Environment Counselors|medical indoor environment counselors
4872871|NCT02212483|Pediatric|pediatric
4872872|NCT02212483|Environment|environment
4872873|NCT02212483|Clinical effectiveness|clinical effectiveness
4872874|NCT02212483|Economical impact|economical impact
4872875|NCT02212444|plantar fasciitis|plantar fasciitis
4872876|NCT02212444|dynamic elastomeric fabric orthoses (DEFO)|dynamic elastomeric fabric orthoses (defo)
4872877|NCT02212444|feasibility|feasibility
4872878|NCT02212444|Physiotherapy|physiotherapy
4872879|NCT02212444|Musculoskeletal|musculoskeletal
4872880|NCT02212431|Cystic Fibrosis|cystic fibrosis
4872881|NCT02212431|Cysteamine|cysteamine
4872882|NCT02212431|Pharmacokinetics|pharmacokinetics
4872883|NCT02212405|Deep rTMS|deep rtms
4872884|NCT02212405|Insular cortex|insular cortex
4872885|NCT02212405|PET|pet
4872886|NCT02212405|[11C]-PHNO|[11c]-phno
4872887|NCT02212392|acute pancreatitis|acute pancreatitis
4872888|NCT02212379|Raltegravir|raltegravir
4872889|NCT02212379|Etravirine|etravirine
4872890|NCT02212379|aged, 45 and over|aged, 45 and over
4872891|NCT02212379|Viral load|viral load
4872892|NCT02212379|Efficacy|efficacy
4872893|NCT02212379|Safety|safety
4872894|NCT02212366|TDCS|tdcs
4872895|NCT02212366|Depression|depression
4872896|NCT02212366|Brain Stimulation|brain stimulation
4872897|NCT02212366|Memory|memory
4872898|NCT02212366|Cognition|cognition
4872899|NCT02212366|EEG|eeg
4872900|NCT02212340|propofol|propofol
4872901|NCT02212340|desflurane|desflurane
4872902|NCT02212340|quality of recovery|quality of recovery
4872903|NCT02212340|vitrectomy|vitrectomy
4872904|NCT02212327|Na+ MRI|na+ mri
4872905|NCT02212327|salt stores|salt stores
4872906|NCT02212314|Response Inhibition, Williams Syndrome|response inhibition, williams syndrome
4872907|NCT02212275|ASD|asd
4872908|NCT02212275|autism|autism
4872909|NCT02212275|typical development|typical development
4872910|NCT02212275|sensory testing|sensory testing
4872911|NCT02212275|the cortical metric|the cortical metric
4872912|NCT02212249|soluble VE-cadherin|soluble ve-cadherin
4872913|NCT02212249|antibody|antibody
4872914|NCT02212249|systemic slerosis|systemic slerosis
4872915|NCT02212236|Distress|distress
4872916|NCT02212236|Depression|depression
4872917|NCT02212236|Anxiety|anxiety
4872918|NCT02212236|Stress|stress
4872919|NCT02212236|Coping|coping
4872920|NCT02212236|Illness perceptions|illness perceptions
4872921|NCT02212236|Stem cell transplantation|stem cell transplantation
4872922|NCT02212236|Bone marrow transplantation|bone marrow transplantation
4872923|NCT02212223|Vitamin D|vitamin d
4872924|NCT02212223|Serum 25-hydroxyvitamin D (25OHD)|serum 25-hydroxyvitamin d (25ohd)
4872925|NCT02212223|Dietary supplement|dietary supplement
4872926|NCT02212223|Ethnicity|ethnicity
4872927|NCT02212223|Immigrant|immigrant
4872928|NCT02212197|prostate cancer|prostate cancer
4872929|NCT02212197|leuprolide|leuprolide
4872930|NCT02212184|Diaphragm|diaphragm
4872931|NCT02212184|COPD|copd
4872932|NCT02212184|Musculoskeletal Manipulations|musculoskeletal manipulations
4872933|NCT02212184|Ultrasonography|ultrasonography
4872934|NCT02212184|Optoelectronic Plethysmography.|optoelectronic plethysmography.
4872935|NCT02212158|Type 1 diabetes|type 1 diabetes
4872936|NCT02212158|adolescents|adolescents
4872937|NCT02212158|HA1c|ha1c
4872938|NCT02212158|psychological intervention|psychological intervention
4872939|NCT02212145|prevention|prevention
4872940|NCT02212145|cardiovascular disease|cardiovascular disease
4872941|NCT02212145|risk factors|risk factors
4872942|NCT02212132|metamemory|metamemory
4872943|NCT02212132|memory complaints|memory complaints
4872944|NCT02212132|performance mnemonic|performance mnemonic
4872945|NCT02212132|cancer|cancer
4872946|NCT02212119|Dementia|dementia
4872948|NCT02212119|Caregiver Burden|caregiver burden
4872949|NCT02212119|Botulinum toxin|botulinum toxin
4872950|NCT02212093|Pneumonia, mechanical ventilation, ICU, mortality|pneumonia, mechanical ventilation, icu, mortality
4872951|NCT02212041|electronic cigarettes|electronic cigarettes
4872952|NCT02212041|smoking|smoking
4872953|NCT02212041|schizophrenia|schizophrenia
4872954|NCT02212041|serious mental illness|serious mental illness
4872955|NCT02212028|ST-elevation myocardial infarction|st-elevation myocardial infarction
4872956|NCT02212028|prasugrel|prasugrel
4872957|NCT02212028|pharmacodynamic|pharmacodynamic
4872958|NCT02212028|pharmacokinetic|pharmacokinetic
4872959|NCT02212002|Group B Streptococcus|group b streptococcus
4872960|NCT02212002|Intrapartum Antibiotic Prophylaxis|intrapartum antibiotic prophylaxis
4872961|NCT02212002|term infants|term infants
4872962|NCT02212002|vaginal delivery|vaginal delivery
4872963|NCT02212002|gut microbiota|gut microbiota
4872964|NCT02212002|feeding|feeding
4872965|NCT02212002|molecular analysis|molecular analysis
4872966|NCT02212002|real-time PCR|real-time pcr
4872967|NCT02211846|Pharmacokinetics|pharmacokinetics
4872968|NCT02211846|Mirabegron|mirabegron
4872969|NCT02211846|Neurogenic detrusor overactivity (NDO)|neurogenic detrusor overactivity (ndo)
4872970|NCT02211846|Overactive bladder (OAB)|overactive bladder (oab)
4872971|NCT02211820|Encephalopathy|encephalopathy
4872972|NCT02211820|Imaging Studies|imaging studies
4872973|NCT02211820|Dementia|dementia
4872974|NCT02211820|Cerebellar Cortical Atrophy|cerebellar cortical atrophy
4872975|NCT02211794|Total Knee Arthroplasty|total knee arthroplasty
4872976|NCT02211794|degenerative joint disease|degenerative joint disease
4872977|NCT02211781|Tribal Communities|tribal communities
4872978|NCT02211781|Radiation|radiation
4872979|NCT02211781|Cancer|cancer
4872980|NCT02211768|Genetic Analysis|genetic analysis
4872981|NCT02211768|Biopsy|biopsy
4872982|NCT02211768|FDG-PET|fdg-pet
4872983|NCT02211768|FLT-PET|flt-pet
4872984|NCT02211755|Purine Nucleoside Inhibitor|purine nucleoside inhibitor
4872985|NCT02211755|Proteasome Inhibitor|proteasome inhibitor
4872986|NCT02211755|Combination Treatment|combination treatment
4872987|NCT02211755|Solid Tumors|solid tumors
4872988|NCT02211755|Hematologic|hematologic
4872989|NCT02211742|dapagliflozin|dapagliflozin
4872990|NCT02211742|fasting glucose|fasting glucose
4872991|NCT02211742|postprandial glucose excursion|postprandial glucose excursion
4872992|NCT02211742|euglycemic hyperinsulinemic clamp|euglycemic hyperinsulinemic clamp
4872993|NCT02211742|euglycemic oral glucose tolerance test|euglycemic oral glucose tolerance test
4872994|NCT02211703|perioperative hypothermia|perioperative hypothermia
4872995|NCT02211703|Epidemiology|epidemiology
4872996|NCT02211703|Tympanic temperature|tympanic temperature
4872997|NCT02211651|adipose tissue|adipose tissue
4872998|NCT02211651|placenta|placenta
4872999|NCT02211651|pregnancy|pregnancy
4873000|NCT02211651|umbilical cord|umbilical cord
4873001|NCT02211638|Drug Therapy|drug therapy
4873002|NCT02211625|Healthy|healthy
4873003|NCT02211625|Pharmacodynamics (PD)|pharmacodynamics (pd)
4873004|NCT02211625|Pharmacokinetics (PK)|pharmacokinetics (pk)
4873005|NCT02211612|Overfeeding|overfeeding
4873006|NCT02211612|Weight gain|weight gain
4873007|NCT02211612|Liver fat|liver fat
4873008|NCT02211612|Pancreatic fat|pancreatic fat
4873009|NCT02211612|Ectopic fat|ectopic fat
4873010|NCT02211612|Skeletal muscle|skeletal muscle
4873011|NCT02211612|Adipose tissue|adipose tissue
4873012|NCT02211612|Gene expression|gene expression
4873013|NCT02211612|DNA methylation|dna methylation
4873014|NCT02211612|Palmitate|palmitate
4873015|NCT02211612|Linoleic acid|linoleic acid
4873016|NCT02211612|Saturated fat|saturated fat
4873017|NCT02211612|Polyunsaturated fat|polyunsaturated fat
4873018|NCT02211612|Metabolism|metabolism
4873019|NCT02211612|Insulin sensitivity|insulin sensitivity
4873020|NCT02211599|protein|protein
4873021|NCT02211599|carbohydrate|carbohydrate
4873022|NCT02211599|lipid|lipid
4873023|NCT02211599|oxidation|oxidation
4873024|NCT02211599|fat|fat
4873025|NCT02211599|sugar|sugar
4873026|NCT02211599|juice|juice
4873027|NCT02211599|obesity|obesity
4873028|NCT02211573|Autonomic Nervous System, Body composition, Oxygen Uptake,|autonomic nervous system, body composition, oxygen uptake,
4873029|NCT02211573|Water Based Physical Training.|water based physical training.
4873030|NCT02211534|Pulsed Electromagnetic Energy Fields|pulsed electromagnetic energy fields
4873031|NCT02211534|Total Knee Arthroplasty|total knee arthroplasty
4873032|NCT02211534|Pain Intensity|pain intensity
4873033|NCT02211521|Osteoarthritis, platelet-rich plasma, hyaluronic acid|osteoarthritis, platelet-rich plasma, hyaluronic acid
4873034|NCT02211508|fibromyalgia|fibromyalgia
4873035|NCT02211508|pain|pain
4873036|NCT02211508|stimulation|stimulation
4873037|NCT02211482|HIV-1 infected patients|hiv-1 infected patients
4873038|NCT02211482|dual therapy|dual therapy
4873039|NCT02211456|Endocardial pacing|endocardial pacing
4873040|NCT02211456|Multi site pacing|multi site pacing
4873041|NCT02211443|Full human anti-EGFR monoclonal antibody (SCT200) ;|full human anti-egfr monoclonal antibody (sct200) ;
4873042|NCT02211443|metastatic colorectal cancer （mCRC）;|metastatic colorectal cancer （mcrc）;
4873043|NCT02211443|Escalating doses ;|escalating doses ;
4873044|NCT02211443|single dose and multiple doses;|single dose and multiple doses;
4873045|NCT02211443|safety, tolerability and pharmacokinetics.|safety, tolerability and pharmacokinetics.
4873046|NCT02211430|smoking cessation|smoking cessation
4873047|NCT02211430|pregnancy|pregnancy
4873048|NCT02211430|postpartum|postpartum
4873049|NCT02211430|intervention|intervention
4873050|NCT02211391|Nighttime Eating|nighttime eating
4873051|NCT02211391|Protein|protein
4873052|NCT02211391|Obesity|obesity
4873053|NCT02211391|Lipolysis|lipolysis
4873054|NCT02211391|Metabolism|metabolism
4873055|NCT02211378|stress|stress
4873056|NCT02211378|performance|performance
4873057|NCT02211378|cortisol|cortisol
4873058|NCT02211365|Hypertension|hypertension
4873059|NCT02211365|CVD|cvd
4873060|NCT02211352|blood pressure, ginseng|blood pressure, ginseng
4873061|NCT02211339|Social skills|social skills
4873062|NCT02211339|Social communication|social communication
4873063|NCT02211339|Cognitive communication|cognitive communication
4873064|NCT02211339|Traumatic brain injury|traumatic brain injury
4873065|NCT02211339|Acquired brain injury|acquired brain injury
4873066|NCT02211339|Communication partner training|communication partner training
4873067|NCT02211339|Peer partner training|peer partner training
4873068|NCT02211339|Peer mentoring|peer mentoring
4873069|NCT02211339|Rating scales|rating scales
4873070|NCT02211339|Rehabilitation|rehabilitation
4873071|NCT02211326|AF or DVT|af or dvt
4873072|NCT02211326|Age Over 18 Years, Acquired|age over 18 years, acquired
4873073|NCT02211300|glucose monitoring|glucose monitoring
4873074|NCT02211300|OptiScanner|optiscanner
4873075|NCT02211287|Dementia|dementia
4873076|NCT02211287|Decision-making|decision-making
4873077|NCT02211287|Communication|communication
4873078|NCT02211287|Advance Care Planning|advance care planning
4873079|NCT02211274|Quality of Life|quality of life
4873080|NCT02211274|Nursing Homes|nursing homes
4873081|NCT02211274|Housing for the Elderly|housing for the elderly
4873082|NCT02211274|Homes for the Aged|homes for the aged
4873083|NCT02211261|first in human|first in human
4873084|NCT02211261|single dose|single dose
4873085|NCT02211261|multiple dose|multiple dose
4873086|NCT02211261|escalation|escalation
4873087|NCT02211261|safety study|safety study
4873088|NCT02211261|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
4873089|NCT02211248|Cardiac Frequency Variability|cardiac frequency variability
4873090|NCT02211248|multidisciplinary care|multidisciplinary care
4873091|NCT02211248|clinical trial|clinical trial
4873092|NCT02211235|Cystic Fibrosis|cystic fibrosis
4873093|NCT02211235|Healthy Controls|healthy controls
4873094|NCT02211235|Diabetes|diabetes
4873095|NCT02211235|Cystic Fibrosis Related Diabetes (CFRD)|cystic fibrosis related diabetes (cfrd)
4873096|NCT02211235|CFRD|cfrd
4873097|NCT02211222|Thyroid Cancer|thyroid cancer
4873098|NCT02211222|Radioiodine-Refractory|radioiodine-refractory
4873099|NCT02211222|Differentiated|differentiated
4873100|NCT02211183|Massive Rotator Cuff Tear|massive rotator cuff tear
4873101|NCT02211183|Sub-acromial spacer|sub-acromial spacer
4873102|NCT02211183|Best repair of rotator cuff|best repair of rotator cuff
4873103|NCT02211105|GastroEsophageal Reflux Disease|gastroesophageal reflux disease
4873104|NCT02211105|Transoral Incisionless Fundoplication|transoral incisionless fundoplication
4873105|NCT02211105|Laparoscopic Nissen Fundoplication|laparoscopic nissen fundoplication
4873106|NCT02211092|Family Caregivers|family caregivers
4873107|NCT02211092|Advanced Cancer|advanced cancer
4873108|NCT02211092|Palliative Care|palliative care
4873109|NCT02211092|Support|support
4873110|NCT02211092|Self Care|self care
4873111|NCT02211092|Physical Activity|physical activity
4873112|NCT02211079|Healthy|healthy
4873113|NCT02211079|JNJ-54861911|jnj-54861911
4873114|NCT02211079|Caffeine|caffeine
4873115|NCT02211079|Midazolam|midazolam
4873116|NCT02211079|Tolbutamide|tolbutamide
4873117|NCT02211079|Cytochrome P450 3A4|cytochrome p450 3a4
4873118|NCT02211079|Cytochrome P450 2C9|cytochrome p450 2c9
4873119|NCT02211079|Cytochrome P450 1A2|cytochrome p450 1a2
4873120|NCT02211079|Alzheimer's disease|alzheimer's disease
4873121|NCT02211053|Organ donation|organ donation
4873122|NCT02211053|Brain dead|brain dead
4873123|NCT02211053|Levothyroxine|levothyroxine
4873124|NCT02211040|Intervention Mapping Protocol|intervention mapping protocol
4873125|NCT02211040|physical activity|physical activity
4873126|NCT02211040|fruit intake|fruit intake
4873127|NCT02211040|vegetable intake|vegetable intake
4873128|NCT02211040|computer tailoring|computer tailoring
4873129|NCT02211040|eHealth|ehealth
4873130|NCT02211040|self-regulation|self-regulation
4873131|NCT02211040|goal setting|goal setting
4873132|NCT02211040|problem solving|problem solving
4873133|NCT02211040|general practice|general practice
4873134|NCT02211027|Squamous Cell Carcinoma|squamous cell carcinoma
4873135|NCT02211027|Head & Neck Cancer|head & neck cancer
4873136|NCT02211027|Vaccine|vaccine
4873137|NCT02211027|Carcinoma|carcinoma
4873138|NCT02211027|Immunization|immunization
4873139|NCT02211027|Autologous Tumor|autologous tumor
4873140|NCT02211014|Bruton tyrosine kinase inhibitor|bruton tyrosine kinase inhibitor
4873141|NCT02211014|Btk|btk
4873142|NCT02211014|Multiple Myeloma|multiple myeloma
4873143|NCT02211014|MM|mm
4873144|NCT02211014|ACP-196|acp-196
4873145|NCT02211014|acalabrutinib|acalabrutinib
4873245|NCT02210507|carotenoids|carotenoids
4873146|NCT02211001|Exercise Movement Techniques|exercise movement techniques
4873147|NCT02211001|Exercise Therapy|exercise therapy
4873148|NCT02211001|Physical Therapy Modalities.|physical therapy modalities.
4873149|NCT02210988|Acupuncture therapy, Acute stroke, Randomized controlled trials|acupuncture therapy, acute stroke, randomized controlled trials
4873150|NCT02210975|GERD|gerd
4873151|NCT02210975|LES|les
4873152|NCT02210975|Sleeve Gastrectomy|sleeve gastrectomy
4873153|NCT02210975|Electrical Stimulation Therapy|electrical stimulation therapy
4873154|NCT02210962|early psychosis|early psychosis
4873155|NCT02210962|chronic schizophrenia|chronic schizophrenia
4873156|NCT02210962|first episode psychosis|first episode psychosis
4873157|NCT02210962|omega-3 and omega-6 essential fatty acids|omega-3 and omega-6 essential fatty acids
4873158|NCT02210962|relapse prevention|relapse prevention
4873159|NCT02210962|efficacy|efficacy
4873160|NCT02210949|Blood transfusion|blood transfusion
4873161|NCT02210949|Erythropoietin|erythropoietin
4873162|NCT02210949|Iron suppletion|iron suppletion
4873163|NCT02210923|Baroreflex|baroreflex
4873164|NCT02210923|Electrical stimulation|electrical stimulation
4873165|NCT02210923|Carotid body|carotid body
4873166|NCT02210923|Chemoreceptors|chemoreceptors
4873167|NCT02210923|Resistant hypertension|resistant hypertension
4873168|NCT02210910|Massive Rotator Cuff Tear, Sub-acromial spacer, Best repair of rotator cuff|massive rotator cuff tear, sub-acromial spacer, best repair of rotator cuff
4873169|NCT02210884|Vitamin D supplementation|vitamin d supplementation
4873170|NCT02210884|Lactation|lactation
4873171|NCT02210884|25 hydroxyvitamin D|25 hydroxyvitamin d
4873172|NCT02210884|Breast feeding|breast feeding
4873173|NCT02210845|Diabetes|diabetes
4873174|NCT02210845|Supervised Exercise|supervised exercise
4873175|NCT02210845|Weight loss|weight loss
4873176|NCT02210832|smoking|smoking
4873177|NCT02210832|pregnancy|pregnancy
4873178|NCT02210832|cessation|cessation
4873179|NCT02210832|incentives|incentives
4873180|NCT02210819|Thromboembolism|thromboembolism
4873181|NCT02210819|Embolism and Thrombosis|embolism and thrombosis
4873182|NCT02210819|Vascular Diseases|vascular diseases
4873183|NCT02210819|Cardiovascular Diseases|cardiovascular diseases
4873184|NCT02210819|Thrombosis|thrombosis
4873185|NCT02210806|Asthma|asthma
4873186|NCT02210806|Mild-to-moderate persistent asthma|mild-to-moderate persistent asthma
4873187|NCT02210806|Mild asthma|mild asthma
4873188|NCT02210806|Moderate asthma|moderate asthma
4873189|NCT02210806|Persistent asthma|persistent asthma
4873190|NCT02210793|Transepithelial PRK|transepithelial prk
4873191|NCT02210793|Dry eye|dry eye
4873192|NCT02210793|Schirmer test|schirmer test
4873193|NCT02210793|Tear break up time|tear break up time
4873194|NCT02210793|Dry eye after advanced surface ablation technique|dry eye after advanced surface ablation technique
4873195|NCT02210754|Nicotine|nicotine
4873196|NCT02210754|Pharmacokinetics|pharmacokinetics
4873197|NCT02210754|Pharmacodynamics|pharmacodynamics
4873198|NCT02210754|blu e-cigs|blu e-cigs
4873199|NCT02210754|Tolerability|tolerability
4873200|NCT02210754|Safety|safety
4873201|NCT02210754|Smoke urge|smoke urge
4873202|NCT02210741|immune repertoire|immune repertoire
4873203|NCT02210741|Graves' disease|graves' disease
4873204|NCT02210728|cognitive behavioral therapy|cognitive behavioral therapy
4873205|NCT02210728|stimulant medication|stimulant medication
4873206|NCT02210728|efficacy|efficacy
4873207|NCT02210728|symptoms|symptoms
4873208|NCT02210728|functional outcomes|functional outcomes
4873209|NCT02210663|Breast cancer|breast cancer
4873210|NCT02210663|PARP|parp
4873211|NCT02210663|Primary peritoneal cancer|primary peritoneal cancer
4873212|NCT02210663|Fallopian tube|fallopian tube
4873213|NCT02210663|Ovarian cancer|ovarian cancer
4873214|NCT02210663|veliparib|veliparib
4873215|NCT02210663|ABT-888|abt-888
4873216|NCT02210663|BRCA|brca
4873217|NCT02210650|kidney stone|kidney stone
4873218|NCT02210637|Appointments and Schedules|appointments and schedules
4873219|NCT02210637|Outpatient Clinics, Hospital/Economics|outpatient clinics, hospital/economics
4873220|NCT02210637|Emergency Department|emergency department
4873221|NCT02210637|Hospitalization|hospitalization
4873222|NCT02210637|Mortality|mortality
4873223|NCT02210624|Anoxic Brain Injury|anoxic brain injury
4873224|NCT02210624|Autologous bone marrow derived stem cell|autologous bone marrow derived stem cell
4873225|NCT02210624|stoke|stoke
4873226|NCT02210598|labor, induced|labor, induced
4873227|NCT02210598|catheter|catheter
4873228|NCT02210598|oxytocin|oxytocin
4873229|NCT02210598|Cesarean section|cesarean section
4873230|NCT02210572|Intestinal microbiota|intestinal microbiota
4873231|NCT02210572|Intestinal gas|intestinal gas
4873232|NCT02210572|Dietary intervention|dietary intervention
4873233|NCT02210572|Low-FODMAPs diet|low-fodmaps diet
4873234|NCT02210572|Prebiotics|prebiotics
4873235|NCT02210559|locally|locally
4873236|NCT02210559|advanced|advanced
4873237|NCT02210559|pancreatic|pancreatic
4873238|NCT02210559|cancer|cancer
4873239|NCT02210559|unresectable|unresectable
4873240|NCT02210559|pancreatic cancer|pancreatic cancer
4873241|NCT02210546|breast cancer|breast cancer
4873242|NCT02210546|intermediate risk|intermediate risk
4873243|NCT02210507|vitamin A|vitamin a
4873244|NCT02210507|retinol|retinol
4873246|NCT02210481|vitrectomy,|vitrectomy,
4873247|NCT02210481|macular thinning,|macular thinning,
4873248|NCT02210481|retinal detachment,|retinal detachment,
4873249|NCT02210481|epimacular membrane,|epimacular membrane,
4873250|NCT02210481|intravitreal glucose,|intravitreal glucose,
4873251|NCT02210481|OCT|oct
4873252|NCT02210468|Osteoarthritis|osteoarthritis
4873253|NCT02210468|Protease Inhibitors|protease inhibitors
4873254|NCT02210468|Alpha-2-macroglobulin|alpha-2-macroglobulin
4873255|NCT02210468|Autologous treatment|autologous treatment
4873256|NCT02210468|APIC-CF|apic-cf
4873257|NCT02210468|Pain due to Mild to Moderate osteoarthritis (OA) of the knee|pain due to mild to moderate osteoarthritis (oa) of the knee
4873258|NCT02210455|FASD|fasd
4873259|NCT02210455|pFAS|pfas
4873260|NCT02210455|ARND|arnd
4873261|NCT02210455|Fetal Alcohol Syndrome|fetal alcohol syndrome
4873262|NCT02210455|Partial Fetal Alcohol Syndrome|partial fetal alcohol syndrome
4873263|NCT02210455|Alcohol Related Neurodevelopmental Disorder|alcohol related neurodevelopmental disorder
4873264|NCT02210455|Static Encephalopathy (Alcohol Exposed)|static encephalopathy (alcohol exposed)
4873265|NCT02210455|Neurobehavioural Disorder (Alcohol Exposed)|neurobehavioural disorder (alcohol exposed)
4873266|NCT02210442|educational games|educational games
4873267|NCT02210442|clinical practice guideline|clinical practice guideline
4873268|NCT02210442|family medicine|family medicine
4873269|NCT02210442|primary health care|primary health care
4873270|NCT02210442|cluster clinical trial|cluster clinical trial
4873271|NCT02210429|Supraclavicular Block|supraclavicular block
4873272|NCT02210429|Supraclavicular Catheter|supraclavicular catheter
4873273|NCT02210429|Pediatric Anesthesia|pediatric anesthesia
4873274|NCT02210429|Regional Anesthesia|regional anesthesia
4873275|NCT02210429|Supracondylar Elbow Fracture|supracondylar elbow fracture
4873276|NCT02210390|Psycho-education, Bipolar , cultural adaptation, Pakistan|psycho-education, bipolar , cultural adaptation, pakistan
4873277|NCT02210377|Auto-moxibusition, intra-dialytic hypotension, hemodialysis|auto-moxibusition, intra-dialytic hypotension, hemodialysis
4873278|NCT02210325|gonorrhea|gonorrhea
4873279|NCT02210325|chlamydia|chlamydia
4873280|NCT02210325|solithromycin|solithromycin
4873281|NCT02210299|Healthy young children (2-6 months ; 12-18 months)|healthy young children (2-6 months ; 12-18 months)
4873282|NCT02210286|dementia|dementia
4873283|NCT02210286|magnesium|magnesium
4873284|NCT02210286|learning|learning
4873285|NCT02210286|memory|memory
4873286|NCT02210286|Alzheimer's disease|alzheimer's disease
4873287|NCT02210273|Stress Urinary Incontinence|stress urinary incontinence
4873288|NCT02210273|SUI|sui
4873289|NCT02210260|Cancer|cancer
4873290|NCT02210260|Colorectal|colorectal
4873291|NCT02210260|Pain relief|pain relief
4873292|NCT02210234|wheat bran|wheat bran
4873293|NCT02210234|healthy immunity|healthy immunity
4873294|NCT02210234|T cells|t cells
4873295|NCT02210221|TBI|tbi
4873296|NCT02210195|Cannabis Treatment|cannabis treatment
4873297|NCT02210195|Alcohol Treatment|alcohol treatment
4873298|NCT02210195|Alcohol-Related Disorders|alcohol-related disorders
4873299|NCT02210195|Cannabis-Related Disorders|cannabis-related disorders
4873300|NCT02210195|Substance-Related Disorders|substance-related disorders
4873301|NCT02210195|Emend|emend
4873302|NCT02210195|NK1 receptor antagonist|nk1 receptor antagonist
4873303|NCT02210195|Alcohol|alcohol
4873304|NCT02210195|Cannabis|cannabis
4873305|NCT02210195|aprepitant|aprepitant
4873306|NCT02210182|Hepatocellular carcinoma|hepatocellular carcinoma
4873307|NCT02210182|Oral Pentamidine|oral pentamidine
4873308|NCT02210182|Endo-exonuclease|endo-exonuclease
4873309|NCT02210156|Respiratory tract infection|respiratory tract infection
4873310|NCT02210156|Incidence|incidence
4873311|NCT02210156|Dietary supplements|dietary supplements
4873312|NCT02210156|Micronutrients|micronutrients
4873313|NCT02210156|Plant extracts|plant extracts
4873314|NCT02210117|Kidney Cancer|kidney cancer
4873315|NCT02210117|Metastatic Renal Cell Carcinoma|metastatic renal cell carcinoma
4873316|NCT02210117|mRCC|mrcc
4873317|NCT02210117|Cytoreductive Nephrectomy|cytoreductive nephrectomy
4873318|NCT02210117|Presurgical therapy|presurgical therapy
4873319|NCT02210117|Nivolumab|nivolumab
4873320|NCT02210117|BMS-936558|bms-936558
4873321|NCT02210117|Bevacizumab|bevacizumab
4873322|NCT02210117|Avastin|avastin
4873323|NCT02210117|Anti-VEGF monoclonal antibody|anti-vegf monoclonal antibody
4873324|NCT02210117|fhuMab-VEGF|fhumab-vegf
4873325|NCT02210117|Ipilimumab|ipilimumab
4873326|NCT02210117|Yervoy|yervoy
4873327|NCT02210117|BMS-734016|bms-734016
4873328|NCT02210117|MDX010|mdx010
4873329|NCT02210104|Melanoma|melanoma
4873330|NCT02210104|Sarcoma|sarcoma
4873331|NCT02210104|Mixed round cell liposarcoma|mixed round cell liposarcoma
4873332|NCT02210104|Advanced|advanced
4873333|NCT02210104|Metastatic|metastatic
4873334|NCT02210104|Immunotherapy|immunotherapy
4873335|NCT02210104|Ipilimumab|ipilimumab
4873336|NCT02210104|Yervoy|yervoy
4873337|NCT02210104|BMS-734016|bms-734016
4873338|NCT02210104|MDX010|mdx010
4873339|NCT02210104|Cyclophosphamide|cyclophosphamide
4873340|NCT02210104|Cytoxan|cytoxan
4873341|NCT02210104|Neosar|neosar
4873342|NCT02210104|CD4+T Cells|cd4+t cells
4873343|NCT02210078|Blood And Marrow Transplantation|blood and marrow transplantation
4873344|NCT02210078|Infection|infection
4873345|NCT02210078|Cytomegalovirus|cytomegalovirus
4873346|NCT02210078|CMV|cmv
4873347|NCT02210078|Stem cell transplant|stem cell transplant
4873348|NCT02210078|Hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
4873349|NCT02210078|HSCT|hsct
4873350|NCT02210078|Human Leukocyte Antigen|human leukocyte antigen
4873351|NCT02210078|HLA|hla
4873352|NCT02210078|Cytotoxic T-Lymphocytes|cytotoxic t-lymphocytes
4873353|NCT02210078|CTL|ctl
4873354|NCT02210065|Leukemia|leukemia
4873355|NCT02210065|Lymphoma|lymphoma
4873356|NCT02210065|Blood And Marrow Transplantation|blood and marrow transplantation
4873357|NCT02210065|Hematological malignancies|hematological malignancies
4873358|NCT02210065|Cytotoxic T cells|cytotoxic t cells
4873359|NCT02210065|CTL|ctl
4873360|NCT02210065|Cytomegalovirus|cytomegalovirus
4873361|NCT02210065|CMV|cmv
4873362|NCT02210065|Allogeneic hematopoietic stem cell transplantation|allogeneic hematopoietic stem cell transplantation
4873363|NCT02210065|HSCT|hsct
4873364|NCT02210052|radiofrequency ablation|radiofrequency ablation
4873365|NCT02210039|SECM|secm
4873366|NCT02210039|Esophagus|esophagus
4873367|NCT02210039|Imaging|imaging
4873368|NCT02210026|bubble nasal continuous positive airway pressure (Bn-CPAP)|bubble nasal continuous positive airway pressure (bn-cpap)
4873369|NCT02210026|work of breathing|work of breathing
4873370|NCT02210026|pressure-rate products|pressure-rate products
4873371|NCT02210013|AMH, AFC, aging, ethnicity|amh, afc, aging, ethnicity
4873372|NCT02210000|repeat dose|repeat dose
4873373|NCT02210000|phase II|phase ii
4873374|NCT02210000|GCSI-DD|gcsi-dd
4873375|NCT02210000|pharmacodynamics|pharmacodynamics
4873376|NCT02210000|gastroparesis|gastroparesis
4873377|NCT02210000|type 1 and type 2 diabetes mellitus|type 1 and type 2 diabetes mellitus
4873378|NCT02210000|camicinal|camicinal
4873379|NCT02210000|GSK962040|gsk962040
4873380|NCT02210000|symptoms|symptoms
4873381|NCT02210000|gut motility|gut motility
4873382|NCT02209974|emphysema|emphysema
4873383|NCT02209974|CRP|crp
4873384|NCT02209974|interleukin-8|interleukin-8
4873385|NCT02209974|dynamic hyperinflation|dynamic hyperinflation
4873386|NCT02209935|pediatric|pediatric
4873387|NCT02209935|acute neurologic disease|acute neurologic disease
4873388|NCT02209935|critical care|critical care
4873389|NCT02209935|rehabilitation|rehabilitation
4873390|NCT02209935|outcome|outcome
4873391|NCT02209922|tDCS, stroke, postural control|tdcs, stroke, postural control
4873392|NCT02209909|preoperative aspirin use|preoperative aspirin use
4873393|NCT02209909|platelet activation|platelet activation
4873394|NCT02209909|off pump coronary artery bypass|off pump coronary artery bypass
4873395|NCT02209896|Peripheral Neuropathic Pain|peripheral neuropathic pain
4873396|NCT02209896|PNP|pnp
4873397|NCT02209883|sevoflurane, anesthesia, washout time,COPD|sevoflurane, anesthesia, washout time,copd
4873398|NCT02209870|Cardiopulmonary resuscitation|cardiopulmonary resuscitation
4873399|NCT02209870|Teamwork|teamwork
4873400|NCT02209870|electronic checklist|electronic checklist
4873401|NCT02209857|Breastcancer|breastcancer
4873402|NCT02209857|Adjuvant chemotherapy|adjuvant chemotherapy
4873403|NCT02209857|70-gene expression profile|70-gene expression profile
4873404|NCT02209857|MammaPrint|mammaprint
4873405|NCT02209818|Low level laser therapy|low level laser therapy
4873406|NCT02209818|Elastomeric separator|elastomeric separator
4873407|NCT02209818|Placebo|placebo
4873408|NCT02209818|Visual analog scale|visual analog scale
4873409|NCT02209818|Laser irradiation|laser irradiation
4873410|NCT02209766|Safety|safety
4873411|NCT02209766|Tolerability|tolerability
4873412|NCT02209766|Pharmacokinetics|pharmacokinetics
4873413|NCT02209766|Pharmacodynamics|pharmacodynamics
4873414|NCT02209766|D5884|d5884
4873415|NCT02209766|Japanese|japanese
4873416|NCT02209766|Caucasian|caucasian
4873417|NCT02209740|renal toxicity, HIV, antiretroviral, outcome|renal toxicity, hiv, antiretroviral, outcome
4873418|NCT02209675|hepatitis C recurrence|hepatitis c recurrence
4873419|NCT02209675|Rejection|rejection
4873420|NCT02209675|Liver Transplantation|liver transplantation
4873421|NCT02209675|Liver biopsy|liver biopsy
4873422|NCT02209662|APIC-PRP|apic-prp
4873423|NCT02209662|Chronic Wounds|chronic wounds
4873424|NCT02209662|Diabetic foot ulcer|diabetic foot ulcer
4873425|NCT02209636|hyperphosphatemia|hyperphosphatemia
4873426|NCT02209636|vascular dysfunction|vascular dysfunction
4873427|NCT02209636|chronic kidney disease|chronic kidney disease
4873428|NCT02209636|cardiovascular disease|cardiovascular disease
4873429|NCT02209636|endothelial dysfunction|endothelial dysfunction
4873430|NCT02209610|Heart Failure|heart failure
4873431|NCT02209597|Major Depressive Disorder|major depressive disorder
4873432|NCT02209597|MDD|mdd
4873433|NCT02209597|bupropion XL|bupropion xl
4873434|NCT02209597|Wellbutrin XL|wellbutrin xl
4873435|NCT02209571|Breath Tests|breath tests
4873436|NCT02209545|fibroids, leiomyomata, blood loss, misoprostol|fibroids, leiomyomata, blood loss, misoprostol
4873437|NCT02209532|Lymph node mapping|lymph node mapping
4873438|NCT02209532|Endometrial cancer|endometrial cancer
4873439|NCT02209532|Uterine cancer|uterine cancer
4873440|NCT02209532|Cervical cancer|cervical cancer
4873441|NCT02209519|bacterial vaginosis|bacterial vaginosis
4873442|NCT02209519|recurrence|recurrence
4873443|NCT02209519|male partner|male partner
4873444|NCT02209506|MLN3126|mln3126
4873445|NCT02209493|Dietary intervention|dietary intervention
4873446|NCT02209493|Hypercholesterolemic adults|hypercholesterolemic adults
4873447|NCT02209493|Vegetable intake|vegetable intake
4873448|NCT02209493|Functional food|functional food
4873449|NCT02209493|Prevention|prevention
4873450|NCT02209467|walking|walking
4873451|NCT02209467|postural balance|postural balance
4873452|NCT02209467|falls|falls
4873453|NCT02209454|Dexketoprofen|dexketoprofen
4873454|NCT02209454|Bioavailability|bioavailability
4873455|NCT02209454|Comparative|comparative
4873456|NCT02209454|Pharmacokinetic|pharmacokinetic
4873457|NCT02209441|sorafenib, gastric cancer, FOLFOX4|sorafenib, gastric cancer, folfox4
4873458|NCT02209428|Temozolomide|temozolomide
4873459|NCT02209428|IDH mutation|idh mutation
4873460|NCT02209428|Low grade glioma|low grade glioma
4873461|NCT02209389|breast cancer|breast cancer
4873462|NCT02209389|cancer associated auto antibodies|cancer associated auto antibodies
4873463|NCT02209389|breast cancer blood test|breast cancer blood test
4873464|NCT02209363|Parkinson's disease|parkinson's disease
4873465|NCT02209363|OSA|osa
4873466|NCT02209363|CPAP|cpap
4873467|NCT02209363|cognition|cognition
4873468|NCT02209311|Alveolar Bone Loss|alveolar bone loss
4873469|NCT02209311|Alveolar Bone Atrophy|alveolar bone atrophy
4873470|NCT02209311|Dental Implantation|dental implantation
4873471|NCT02209311|Bone Tissue Reconstruction|bone tissue reconstruction
4873472|NCT02209311|Sinus Lift|sinus lift
4873473|NCT02209311|Autologous Multipotent Mesenchymal Stem Cell|autologous multipotent mesenchymal stem cell
4873474|NCT02209311|Autologous MMSCs|autologous mmscs
4873475|NCT02209311|Synthetic Tricalcium Phosphate|synthetic tricalcium phosphate
4873476|NCT02209311|Tissue Engineered Construction|tissue engineered construction
4873477|NCT02209311|Oral Mucosa|oral mucosa
4873478|NCT02209285|Older adults|older adults
4873479|NCT02209285|Home and community care|home and community care
4873480|NCT02209285|Effectiveness|effectiveness
4873481|NCT02209285|Cost analysis|cost analysis
4873482|NCT02209285|Stroke|stroke
4873483|NCT02209285|TIA|tia
4873484|NCT02209285|Hypertension|hypertension
4873485|NCT02209285|Cardiovascular disease|cardiovascular disease
4873486|NCT02209220|Obstructive sleep apnea|obstructive sleep apnea
4873487|NCT02209220|Treatment compliance|treatment compliance
4873488|NCT02209220|Automatic positive airway pressure|automatic positive airway pressure
4873489|NCT02209220|Continuous positive airway pressure|continuous positive airway pressure
4873490|NCT02209220|Bariatric surgery|bariatric surgery
4873491|NCT02209207|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
4873492|NCT02209207|endurance training|endurance training
4873493|NCT02209207|interval training|interval training
4873494|NCT02209207|continuous training|continuous training
4873495|NCT02209207|walking training|walking training
4873496|NCT02209194|aneurysms|aneurysms
4873497|NCT02209194|vascular disease|vascular disease
4873498|NCT02209194|E-liac Stent Graft|e-liac stent graft
4873499|NCT02209194|E-liac Stent Graft System|e-liac stent graft system
4873500|NCT02209194|iliac aneurysm|iliac aneurysm
4873501|NCT02209194|branched stent graft|branched stent graft
4873502|NCT02209194|self expanding stent graft|self expanding stent graft
4873503|NCT02209181|dental pain|dental pain
4873504|NCT02209181|post-surgical dental pain|post-surgical dental pain
4873505|NCT02209168|AMH, ACF, VIT D, Ethnicity|amh, acf, vit d, ethnicity
4873506|NCT02209142|Major depression|major depression
4873507|NCT02209129|digital breast tomosynthesis|digital breast tomosynthesis
4873508|NCT02209116|ADHD|adhd
4873509|NCT02209116|QB Test|qb test
4873510|NCT02209116|Activity|activity
4873511|NCT02209116|Attention|attention
4873512|NCT02209116|Children|children
4873513|NCT02209116|Clinical Decision Making|clinical decision making
4873514|NCT02209103|Polyphenols|polyphenols
4873515|NCT02209103|Orange|orange
4873516|NCT02209103|Sleep|sleep
4873517|NCT02209103|Fatigue|fatigue
4873518|NCT02209090|occiput-posterior|occiput-posterior
4873519|NCT02209090|occipitoposterior|occipitoposterior
4873520|NCT02209090|labour|labour
4873521|NCT02209064|Subxiphoid|subxiphoid
4873522|NCT02209064|Access|access
4873523|NCT02209051|Diabetic Foot Ulcers|diabetic foot ulcers
4873524|NCT02209051|AMNIOEXCEL|amnioexcel
4873525|NCT02209051|Wagner Grade 1 or 2 foot ulcers|wagner grade 1 or 2 foot ulcers
4873526|NCT02209051|Wound|wound
4873527|NCT02209051|Foot health|foot health
4873528|NCT02209051|Ulcer|ulcer
4873529|NCT02209051|Foot Ulcer|foot ulcer
4873530|NCT02209051|Diabetic Foot|diabetic foot
4873531|NCT02209051|Foot Diseases|foot diseases
4873532|NCT02209051|Skin Diseases|skin diseases
4873533|NCT02209051|Leg Ulcer|leg ulcer
4873534|NCT02209051|Skin Ulcer|skin ulcer
4873535|NCT02209051|Diabetic Angiopathies|diabetic angiopathies
4873536|NCT02209051|Vascular Diseases|vascular diseases
4873537|NCT02209051|Cardiovascular Diseases|cardiovascular diseases
4873538|NCT02209051|Diabetes Complications|diabetes complications
4873539|NCT02209051|Diabetes Mellitus|diabetes mellitus
4873540|NCT02209051|Endocrine System Diseases|endocrine system diseases
4873541|NCT02209051|Diabetic Neuropathies|diabetic neuropathies
4873542|NCT02209038|end stage renal disease|end stage renal disease
4873543|NCT02209038|hemodialysis|hemodialysis
4873544|NCT02209038|dialysis|dialysis
4873545|NCT02209025|Atherosclerosis|atherosclerosis
4873546|NCT02209025|Cholesterol|cholesterol
4873547|NCT02209025|Cholesterol, HDL|cholesterol, hdl
4873548|NCT02209025|Apolipoprotein A-I|apolipoprotein a-i
4873549|NCT02209025|Theobromine|theobromine
4873550|NCT02209012|Actinic Keratosis|actinic keratosis
4873551|NCT02208999|medullary neurostimulation|medullary neurostimulation
4873552|NCT02208999|pain|pain
4873553|NCT02208999|Precision|precision
4873554|NCT02208999|rechargeable|rechargeable
4873555|NCT02208999|implantable|implantable
4873556|NCT02208986|GnRH antagonist|gnrh antagonist
4873557|NCT02208986|GnRH agonist trigger|gnrh agonist trigger
4873558|NCT02208986|Oocyte donor|oocyte donor
4873559|NCT02208973|Adenosine A1 receptor antagonist|adenosine a1 receptor antagonist
4873560|NCT02208973|adenosine receptor modulator|adenosine receptor modulator
4873561|NCT02208973|Asthma|asthma
4873562|NCT02208973|COPD|copd
4873563|NCT02208960|Neurodevelopment|neurodevelopment
4873564|NCT02208960|Neonatal kit|neonatal kit
4873565|NCT02208960|Kenya|kenya
4873566|NCT02208960|Cluster Randomized Controlled Trial|cluster randomized controlled trial
4873567|NCT02208960|Chlorhexidine|chlorhexidine
4873568|NCT02208960|ThermoSpot|thermospot
4873569|NCT02208947|advance care planning|advance care planning
4873570|NCT02208947|decision making|decision making
4873571|NCT02208947|patient engagement|patient engagement
4873572|NCT02208947|patient education|patient education
4873573|NCT02208947|financial incentives|financial incentives
4873574|NCT02208947|behavioral economics|behavioral economics
4873575|NCT02208934|PDE10 inhibitor|pde10 inhibitor
4873576|NCT02208934|Huntington's disease|huntington's disease
4873577|NCT02208934|phosphodiesterase 10 inhibitor|phosphodiesterase 10 inhibitor
4873578|NCT02208934|psychiatric disorders|psychiatric disorders
4873579|NCT02208921|Type 2 Diabetes|type 2 diabetes
4873580|NCT02208908|Oral care|oral care
4873581|NCT02208908|cancer|cancer
4873582|NCT02208908|palliative|palliative
4873583|NCT02208908|training|training
4873584|NCT02208895|pleural|pleural
4873585|NCT02208895|glucose|glucose
4873586|NCT02208895|glucometer|glucometer
4873587|NCT02208895|i-STAT|i-stat
4873588|NCT02208869|familial hypercholesterolemia|familial hypercholesterolemia
4873589|NCT02208869|cholesterol|cholesterol
4873590|NCT02208869|prevention|prevention
4873591|NCT02208869|registry|registry
4873592|NCT02208869|atherosclerosis|atherosclerosis
4873593|NCT02208869|treatment|treatment
4873594|NCT02208869|prevalence|prevalence
4873595|NCT02208830|bronchiectasis|bronchiectasis
4873596|NCT02208830|functional capacity|functional capacity
4873597|NCT02208830|lung functional|lung functional
4873598|NCT02208817|capillary refill|capillary refill
4873599|NCT02208817|paediatric early warning score|paediatric early warning score
4873600|NCT02208817|photoplethysmography|photoplethysmography
4873601|NCT02208804|Colorectal Cancer Liver Metastases|colorectal cancer liver metastases
4873602|NCT02208791|Kidney Transplantation|kidney transplantation
4873603|NCT02208791|Graft Rejection|graft rejection
4873604|NCT02208791|Immunossupression|immunossupression
4873605|NCT02208778|Osteoarthritis|osteoarthritis
4873606|NCT02208778|Chronic Pain|chronic pain
4873607|NCT02208778|Pain relief|pain relief
4873608|NCT02208765|Coronary Circulation|coronary circulation
4873609|NCT02208765|Coronary Artery Disease|coronary artery disease
4873610|NCT02208765|Myocardial perfusion imaging|myocardial perfusion imaging
4873611|NCT02208765|Prognosis|prognosis
4873612|NCT02208752|rotator cuff tears|rotator cuff tears
4873613|NCT02208752|ultrasound measure|ultrasound measure
4873614|NCT02208752|pain|pain
4873615|NCT02208752|range of motion|range of motion
4873616|NCT02208752|muscle force|muscle force
4873617|NCT02208739|Chronic periodontitis|chronic periodontitis
4873618|NCT02208739|periodontal pathogens|periodontal pathogens
4873619|NCT02208739|inflammatory mediators|inflammatory mediators
4873620|NCT02208739|Non surgical periodontal therapy|non surgical periodontal therapy
4873621|NCT02208739|Oral hygiene instructions|oral hygiene instructions
4873622|NCT02208739|Polymerase chain reaction|polymerase chain reaction
4873623|NCT02208739|Elisa|elisa
4873624|NCT02208726|anxiety|anxiety
4873625|NCT02208726|students|students
4873626|NCT02208726|examinations|examinations
4873627|NCT02208726|Homeopathy|homeopathy
4873628|NCT02208713|FSHD muscle derived stem cell adipose derived mesenchymal stem cell intramuscular injection|fshd muscle derived stem cell adipose derived mesenchymal stem cell intramuscular injection
4873629|NCT02208687|Social Participation|social participation
4873630|NCT02208687|Fatigue|fatigue
4873631|NCT02208687|Self-Management|self-management
4873632|NCT02208687|Rehabilitation|rehabilitation
4873633|NCT02208687|Physical therapy|physical therapy
4873634|NCT02208687|Occupational therapy|occupational therapy
4873635|NCT02208687|Group intervention|group intervention
4873636|NCT02208687|Exercise|exercise
4873637|NCT02208674|chronic kidney disease|chronic kidney disease
4873638|NCT02208674|albuminuria|albuminuria
4873639|NCT02208674|hypertension|hypertension
4873640|NCT02208674|dyslipidemia|dyslipidemia
4873641|NCT02208674|cardiovascular disease|cardiovascular disease
4873642|NCT02208674|pragmatic trial|pragmatic trial
4874028|NCT02206958|Frailty|frailty
4873643|NCT02208674|cluster randomized trial|cluster randomized trial
4873644|NCT02208661|Morquio A syndrome|morquio a syndrome
4873645|NCT02208661|Mucopolysaccharidosis IV A|mucopolysaccharidosis iv a
4873646|NCT02208661|Psychological health|psychological health
4873647|NCT02208648|coronary calcification|coronary calcification
4873648|NCT02208648|Computed Tomography|computed tomography
4873649|NCT02208648|Coronary artery calcium|coronary artery calcium
4873650|NCT02208648|calcium scores|calcium scores
4873651|NCT02208648|post-operative mortality|post-operative mortality
4873652|NCT02208635|Zinc Absorption|zinc absorption
4873653|NCT02208635|Biofortification|biofortification
4873654|NCT02208635|Maize|maize
4873655|NCT02208635|Zambia|zambia
4873656|NCT02208635|Stable isotopes of Zn|stable isotopes of zn
4873657|NCT02208622|Zinc absorption|zinc absorption
4873658|NCT02208622|Iron Absorption|iron absorption
4873659|NCT02208622|Whey Protein|whey protein
4873660|NCT02208622|Mexico|mexico
4873661|NCT02208622|Stable isotopes|stable isotopes
4873662|NCT02208609|Zinc Absorption|zinc absorption
4873663|NCT02208609|Maize|maize
4873664|NCT02208609|Amaranth|amaranth
4873665|NCT02208609|Guatemala|guatemala
4873666|NCT02208609|Stable isotopes of Zn|stable isotopes of zn
4873667|NCT02208583|Molecular phenotypic；CRPC; personalized treatment|molecular phenotypic；crpc; personalized treatment
4873668|NCT02208570|Hypotension during anesthesia induction|hypotension during anesthesia induction
4873669|NCT02208557|Incisional hernia|incisional hernia
4873670|NCT02208557|prevention|prevention
4873671|NCT02208557|laparotomy closure|laparotomy closure
4873672|NCT02208557|absorbable mesh|absorbable mesh
4873673|NCT02208544|Thyroid Nodule|thyroid nodule
4873674|NCT02208544|Indeterminate Cytology|indeterminate cytology
4873675|NCT02208544|FDG-PET/CT|fdg-pet/ct
4873676|NCT02208544|Diagnostic Thyroid Surgery|diagnostic thyroid surgery
4873677|NCT02208544|Efficacy|efficacy
4873678|NCT02208544|Cost-Effectiveness|cost-effectiveness
4873679|NCT02208544|Quality-of-Life|quality-of-life
4873680|NCT02208544|Thyroidectomy|thyroidectomy
4873681|NCT02208531|Early Childhood Development (ECD)|early childhood development (ecd)
4873682|NCT02208531|Psychosocial stimulation|psychosocial stimulation
4873683|NCT02208531|Malnutrition|malnutrition
4873684|NCT02208531|Bangladesh|bangladesh
4873685|NCT02208531|Scaling up ECD|scaling up ecd
4873686|NCT02208518|Endoscopic Ultrasound elastography|endoscopic ultrasound elastography
4873687|NCT02208518|Quantitative elastography|quantitative elastography
4873688|NCT02208518|Qualitative elastography|qualitative elastography
4873689|NCT02208518|Endoscopic Ultrasound|endoscopic ultrasound
4873690|NCT02208518|Elastography|elastography
4873691|NCT02208492|Levetiracetam, Carabamazepine|levetiracetam, carabamazepine
4873692|NCT02208479|cardiac surgery|cardiac surgery
4873693|NCT02208479|diaphragm dysfunction|diaphragm dysfunction
4873694|NCT02208479|mechanical ventilation weaning|mechanical ventilation weaning
4873695|NCT02208479|respiratory paralysis|respiratory paralysis
4873696|NCT02208479|muscle weakness|muscle weakness
4873697|NCT02208479|cardiac bypass|cardiac bypass
4873698|NCT02208479|valvular surgery|valvular surgery
4873699|NCT02208479|respiratory insufficiency|respiratory insufficiency
4873700|NCT02208466|repetitive transcranial magnetic stimulation|repetitive transcranial magnetic stimulation
4873701|NCT02208466|rTMS|rtms
4873703|NCT02208466|fluoxetine|fluoxetine
4873704|NCT02208453|Massive Rotator Cuff Tear|massive rotator cuff tear
4873705|NCT02208453|Local anesthesia|local anesthesia
4873706|NCT02208453|Sub-acromial spacer|sub-acromial spacer
4873707|NCT02208440|Massive Rotator Cuff Tear, Sub-acromial spacer, Best repair of rotator cuff|massive rotator cuff tear, sub-acromial spacer, best repair of rotator cuff
4873708|NCT02208427|isoniazid, LTBI, rifapentine, TST|isoniazid, ltbi, rifapentine, tst
4873709|NCT02208414|Food Allergies|food allergies
4873710|NCT02208388|Computed tomography perfusion|computed tomography perfusion
4873711|NCT02208388|Fractional flow reserve|fractional flow reserve
4873712|NCT02208375|Breast Cancer|breast cancer
4873713|NCT02208375|Malignant Female Reproductive System Neoplasm|malignant female reproductive system neoplasm
4873714|NCT02208375|Recurrent endometrial cancer|recurrent endometrial cancer
4873715|NCT02208375|Recurrent endometrial adenocarcinoma|recurrent endometrial adenocarcinoma
4873716|NCT02208375|Triple negative breast cancer|triple negative breast cancer
4873717|NCT02208375|Ovarian cancer|ovarian cancer
4873718|NCT02208375|Primary peritoneal cancer|primary peritoneal cancer
4873719|NCT02208375|Fallopian tube cancer|fallopian tube cancer
4873720|NCT02208375|Olaparib|olaparib
4873721|NCT02208375|AZD2014|azd2014
4873722|NCT02208375|AZD5363|azd5363
4873723|NCT02208362|chimeric antigen receptor|chimeric antigen receptor
4873724|NCT02208362|glioblastoma|glioblastoma
4873725|NCT02208349|intubation, laryngoscopy, prehospital, emergency medical services|intubation, laryngoscopy, prehospital, emergency medical services
4873726|NCT02208323|Hypoxia|hypoxia
4873727|NCT02208323|Respiratory Distress|respiratory distress
4873728|NCT02208310|Crohn's disease|crohn's disease
4873729|NCT02208310|Vitamin D deficiency|vitamin d deficiency
4873730|NCT02208284|Single Ascending Dose|single ascending dose
4873731|NCT02208284|healthy subjects|healthy subjects
4873732|NCT02208284|Hyperlipidemia|hyperlipidemia
4873733|NCT02208284|Lipid Metabolism Disorders|lipid metabolism disorders
4873734|NCT02208284|Metabolic Diseases|metabolic diseases
4873735|NCT02208271|tissue necrosis|tissue necrosis
4873736|NCT02208271|metal on metal total hip|metal on metal total hip
4873737|NCT02208271|biomarker|biomarker
4873738|NCT02208258|fecal incontinence, consure medical, semi formed stool, stool management system|fecal incontinence, consure medical, semi formed stool, stool management system
4873739|NCT02208232|IOL rotation|iol rotation
4873740|NCT02208219|Stroke|stroke
4873741|NCT02208219|Paresis|paresis
4873742|NCT02208219|Upper extremity|upper extremity
4873743|NCT02208219|Motor deficits|motor deficits
4873744|NCT02208219|Music Therapy|music therapy
4873745|NCT02208219|Neurorehabilitation|neurorehabilitation
4873746|NCT02208206|Neuropathic pain|neuropathic pain
4873747|NCT02208206|Phenotype|phenotype
4873748|NCT02208206|Genotype|genotype
4873749|NCT02208206|Biomarkers|biomarkers
4873750|NCT02208206|HIV|hiv
4873751|NCT02208206|Diabetes mellitus|diabetes mellitus
4873752|NCT02208206|Breast cancer|breast cancer
4873753|NCT02208206|Genomics|genomics
4873754|NCT02208206|Quantitative sensory testing|quantitative sensory testing
4873755|NCT02208193|Alzheimer disease Art Healing gardens Discourse analysis|alzheimer disease art healing gardens discourse analysis
4873756|NCT02208180|Return of results|return of results
4873757|NCT02208180|Genomics|genomics
4873758|NCT02208167|Antigen Expanded Specific T Cell Therapy|antigen expanded specific t cell therapy
4873759|NCT02208167|HXTC|hxtc
4873760|NCT02208167|Antiretroviral Therapy|antiretroviral therapy
4873761|NCT02208167|Acute HIV infection|acute hiv infection
4873762|NCT02208167|Chronic HIV infection|chronic hiv infection
4873763|NCT02208167|Leukapheresis|leukapheresis
4873764|NCT02208154|ICU acquired bacteraemia|icu acquired bacteraemia
4873765|NCT02208154|colonization|colonization
4873766|NCT02208154|decolonization|decolonization
4873767|NCT02208154|selective decontamination|selective decontamination
4873768|NCT02208154|multidrug resistant bacteria|multidrug resistant bacteria
4873769|NCT02208141|children|children
4873770|NCT02208141|obesity|obesity
4873771|NCT02208141|adipose tissue dysfunction|adipose tissue dysfunction
4873772|NCT02208141|inflammation|inflammation
4873773|NCT02208141|macrophage infiltration|macrophage infiltration
4873774|NCT02208141|insulin resistance|insulin resistance
4873775|NCT02208141|dyslipidemia|dyslipidemia
4873776|NCT02208128|Renal cell carcinoma|renal cell carcinoma
4873777|NCT02208128|Biomarkers|biomarkers
4873778|NCT02208128|Molecular modifications|molecular modifications
4873779|NCT02208115|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
4873780|NCT02208115|Exercise|exercise
4873781|NCT02208115|Appetite|appetite
4873782|NCT02208102|atrial fibrillation, catheter ablation, blood-biomarkers|atrial fibrillation, catheter ablation, blood-biomarkers
4873783|NCT02208089|Keratoconus|keratoconus
4873784|NCT02208089|Corneal collagen cross-linking|corneal collagen cross-linking
4873785|NCT02208089|Photorefractive keratectomy|photorefractive keratectomy
4873786|NCT02208076|Growth disorders|growth disorders
4873787|NCT02208076|Saizen|saizen
4873788|NCT02208076|Easypod|easypod
4873789|NCT02208076|Growth hormone|growth hormone
4873790|NCT02208076|Pediatric subject|pediatric subject
4873791|NCT02208063|Bacteremia|bacteremia
4873792|NCT02208063|Staphylococcus aureus|staphylococcus aureus
4873793|NCT02208050|Secondary Progressive Multiple Sclerosis|secondary progressive multiple sclerosis
4873794|NCT02208050|Primary Progressive Multiple Sclerosis|primary progressive multiple sclerosis
4873795|NCT02208050|Multiple Sclerosis|multiple sclerosis
4873796|NCT02208050|Upper limb function|upper limb function
4873797|NCT02208050|Mobility|mobility
4873798|NCT02208050|Fampridine|fampridine
4873799|NCT02208050|DASH|dash
4873800|NCT02208050|AMSQ|amsq
4873801|NCT02208050|MSWS-12|msws-12
4873802|NCT02208050|MSIS-29|msis-29
4873803|NCT02208050|SF-36|sf-36
4873804|NCT02208050|9HPT|9hpt
4873805|NCT02208050|25FTW|25ftw
4873806|NCT02208050|JTT|jtt
4873807|NCT02208037|Acute Lymphoblastic Leukemia/Lymphoma|acute lymphoblastic leukemia/lymphoma
4873808|NCT02208037|Acute Myelogenous Leukemia|acute myelogenous leukemia
4873809|NCT02208037|Mantel-Cell Lymphoma|mantel-cell lymphoma
4873810|NCT02208037|Hematopoietic Transplant|hematopoietic transplant
4873811|NCT02208037|GVHD Prophylaxis|gvhd prophylaxis
4873812|NCT02207998|osteoarthritis, physiotherapy, homeopathy, complex|osteoarthritis, physiotherapy, homeopathy, complex
4873813|NCT02207985|Pancreatic adenocarcinoma|pancreatic adenocarcinoma
4873814|NCT02207985|Hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
4873815|NCT02207972|Pregnant|pregnant
4873816|NCT02207972|labor|labor
4873817|NCT02207972|Epidural|epidural
4873818|NCT02207959|Gastric cancer|gastric cancer
4873819|NCT02207959|Neoplasia|neoplasia
4873820|NCT02207959|Endoscopic imaging|endoscopic imaging
4873821|NCT02207959|In vivo imaging|in vivo imaging
4873822|NCT02207933|anterioposterior|anterioposterior
4873823|NCT02207933|weight|weight
4873824|NCT02207933|shifting|shifting
4873825|NCT02207933|training|training
4873826|NCT02207933|patient|patient
4873827|NCT02207894|Haemophilia A, factor VIII, development of inhibitor|haemophilia a, factor viii, development of inhibitor
4873828|NCT02207881|herpes labialis|herpes labialis
4873829|NCT02207881|cold sore|cold sore
4873830|NCT02207829|COPD|copd
4873831|NCT02207829|inhaler critical errors|inhaler critical errors
4873832|NCT02207829|double-dummy|double-dummy
4873833|NCT02207829|novel dry powder inhaler|novel dry powder inhaler
4873834|NCT02207829|inhaler preference|inhaler preference
4873835|NCT02207829|tiotropium|tiotropium
4873836|NCT02207829|umeclidinium|umeclidinium
4873837|NCT02207829|long-acting muscarinic antagonist|long-acting muscarinic antagonist
4873838|NCT02207816|Infants|infants
4873839|NCT02207816|Efficacy|efficacy
4873840|NCT02207816|Children|children
4873841|NCT02207816|Malaria|malaria
4873842|NCT02207816|Plasmodium falciparum|plasmodium falciparum
4873843|NCT02207816|Safety|safety
4873844|NCT02207816|Surveillance|surveillance
4873845|NCT02207816|Immunogenicity|immunogenicity
4873846|NCT02207816|RTS,S/AS01E|rts,s/as01e
4873847|NCT02207816|Africa|africa
4873848|NCT02207803|Brain Injuries|brain injuries
4873849|NCT02207803|Caregivers|caregivers
4873850|NCT02207803|Intervention Studies|intervention studies
4873851|NCT02207803|Latin America|latin america
4873852|NCT02207790|Clinical Trial, Phase I|clinical trial, phase i
4873853|NCT02207790|Healthy Volunteers|healthy volunteers
4873854|NCT02207777|Obesity|obesity
4873855|NCT02207777|Roux-en-Y gastric bypass (RYGB)|roux-en-y gastric bypass (rygb)
4873856|NCT02207777|Type 2 Diabetes|type 2 diabetes
4873857|NCT02207777|Sleeve Gastrectomy (SG)|sleeve gastrectomy (sg)
4873858|NCT02207777|Weight Loss|weight loss
4873859|NCT02207777|Low-Calorie Diet|low-calorie diet
4873860|NCT02207751|Chronic Kidney Disease|chronic kidney disease
4873861|NCT02207751|Peritoneal Dialysis Access|peritoneal dialysis access
4873862|NCT02207751|Peritoneal Dialysis Catheter|peritoneal dialysis catheter
4873863|NCT02207751|Catheter Function|catheter function
4873864|NCT02207738|acne|acne
4873865|NCT02207738|acne scar|acne scar
4873866|NCT02207738|microneedling radiofrequency|microneedling radiofrequency
4873867|NCT02207738|bipolar radiofrequency|bipolar radiofrequency
4873868|NCT02207725|Andexanet alpha|andexanet alpha
4873869|NCT02207725|Anticoagulation|anticoagulation
4873870|NCT02207725|Antidote|antidote
4873871|NCT02207725|Apixaban|apixaban
4873872|NCT02207725|Anti-fXa inhibitor|anti-fxa inhibitor
4873873|NCT02207725|PRT4445|prt4445
4873874|NCT02207725|Eliquis|eliquis
4873875|NCT02207725|Reversal agent|reversal agent
4873876|NCT02207712|Diabetes|diabetes
4873877|NCT02207712|Macular Oedema|macular oedema
4873878|NCT02207712|Diabetic retinopathy|diabetic retinopathy
4873879|NCT02207712|Noctura|noctura
4873880|NCT02207686|CNS hemangioblastoma|cns hemangioblastoma
4873881|NCT02207686|Renal Cell Carcinoma|renal cell carcinoma
4873882|NCT02207686|VHL germline mutation|vhl germline mutation
4873883|NCT02207686|VHL somatic mutation|vhl somatic mutation
4873884|NCT02207686|Tumor development|tumor development
4873885|NCT02207673|epilepsy surgery|epilepsy surgery
4873886|NCT02207673|biomarker|biomarker
4873887|NCT02207673|high frequency oscillations (HFOs)|high frequency oscillations (hfos)
4873888|NCT02207673|acute electrocorticography (aECoG)|acute electrocorticography (aecog)
4873889|NCT02207660|cisplatin|cisplatin
4873890|NCT02207660|Cervical cancer|cervical cancer
4873891|NCT02207660|metastasis|metastasis
4873892|NCT02207660|recurrence|recurrence
4873893|NCT02207634|High cholesterol|high cholesterol
4873894|NCT02207634|Treatment for high cholesterol|treatment for high cholesterol
4873895|NCT02207634|Lowering cholesterol|lowering cholesterol
4873896|NCT02207634|Lowering high cholesterol|lowering high cholesterol
4873897|NCT02207634|Hypercholesterolemia|hypercholesterolemia
4873898|NCT02207621|Glaucoma|glaucoma
4873899|NCT02207608|BCG|bcg
4873900|NCT02207608|hyaluronic acid|hyaluronic acid
4873901|NCT02207608|non-muscle invasive bladder cancer|non-muscle invasive bladder cancer
4873902|NCT02207608|non bacterial cystitis|non bacterial cystitis
4873903|NCT02207582|depression; trns|depression; trns
4873904|NCT02207556|AL amyloidosis|al amyloidosis
4873905|NCT02207556|amyloidosis|amyloidosis
4873906|NCT02207556|light chain amyloidosis|light chain amyloidosis
4873907|NCT02207543|Cancer|cancer
4873908|NCT02207543|Palliative care|palliative care
4873909|NCT02207543|home|home
4873910|NCT02207530|Head and neck cancer; SCCHN|head and neck cancer; scchn
4873911|NCT02207517|convergence insufficiency|convergence insufficiency
4873912|NCT02207517|vision therapy|vision therapy
4873913|NCT02207517|reading|reading
4873914|NCT02207517|attention|attention
4873915|NCT02207504|Castration-resistant Prostate Cancer|castration-resistant prostate cancer
4873916|NCT02207491|Glaucoma|glaucoma
4873917|NCT02207478|Electromagnetic navigation bronchoscopy with a guide sheath|electromagnetic navigation bronchoscopy with a guide sheath
4873918|NCT02207478|Transbronchial lung biopsy|transbronchial lung biopsy
4873919|NCT02207478|Peripheral lung lesions|peripheral lung lesions
4873920|NCT02207478|Solitary pulmonary nodule|solitary pulmonary nodule
4873921|NCT02207452|Hyperpolarised helium-3|hyperpolarised helium-3
4873922|NCT02207452|Lung Imaging|lung imaging
4873923|NCT02207452|Magnetic Resonance Imaging|magnetic resonance imaging
4873924|NCT02207426|Healthy volunteers|healthy volunteers
4873925|NCT02207413|Quadrivalent influenza vaccine|quadrivalent influenza vaccine
4873926|NCT02207413|Safety|safety
4873927|NCT02207413|Children|children
4873928|NCT02207413|Adults|adults
4873929|NCT02207413|Immunogenicity|immunogenicity
4874029|NCT02206958|Physical activity|physical activity
4873930|NCT02207322|Hematopoietic stem cell transplantation (HSCT)|hematopoietic stem cell transplantation (hsct)
4873931|NCT02207322|autologous stem cell transplant|autologous stem cell transplant
4873932|NCT02207322|allogeneic stem cell transplant|allogeneic stem cell transplant
4873933|NCT02207309|high-risk soft tissue sarcoma|high-risk soft tissue sarcoma
4873934|NCT02207309|pazopanib|pazopanib
4873935|NCT02207309|retroperitoneal soft tissue sarcoma|retroperitoneal soft tissue sarcoma
4873936|NCT02207309|visceral soft tissue sarcoma|visceral soft tissue sarcoma
4873937|NCT02207309|votrient|votrient
4873938|NCT02207270|Coronary artery disease|coronary artery disease
4873939|NCT02207270|Costs|costs
4873940|NCT02207270|Cost minimization|cost minimization
4873941|NCT02207270|Percutaneous coronary intervention|percutaneous coronary intervention
4873942|NCT02207270|Risk score|risk score
4873943|NCT02207270|Same day discharge|same day discharge
4873944|NCT02207257|PER977|per977
4873945|NCT02207257|anticoagulation reversal|anticoagulation reversal
4873946|NCT02207257|pharmacokinetics|pharmacokinetics
4873947|NCT02207257|edoxaban|edoxaban
4873948|NCT02207257|whole blood clotting time|whole blood clotting time
4873949|NCT02207257|D-dimer|d-dimer
4873950|NCT02207257|prothrombin fragments 1 and 2|prothrombin fragments 1 and 2
4873951|NCT02207257|tissue factor pathway inhibitor|tissue factor pathway inhibitor
4873952|NCT02207257|prothrombin time|prothrombin time
4873953|NCT02207244|Psoriasis|psoriasis
4873954|NCT02207244|Plaque-type psoriasis|plaque-type psoriasis
4873955|NCT02207244|Guselkumab|guselkumab
4873956|NCT02207244|Adalimumab|adalimumab
4873957|NCT02207244|CNTO 1959|cnto 1959
4873958|NCT02207244|Monoclonal antibody|monoclonal antibody
4873959|NCT02207231|Psoriasis|psoriasis
4873960|NCT02207231|Plaque-type psoriasis|plaque-type psoriasis
4873961|NCT02207231|Guselkumab|guselkumab
4873962|NCT02207231|Adalimumab|adalimumab
4873963|NCT02207231|CNTO 1959|cnto 1959
4873964|NCT02207231|Monoclonal antibody|monoclonal antibody
4873965|NCT02207192|obesity, lung volumes, postural changes|obesity, lung volumes, postural changes
4873966|NCT02207179|Intraoperative|intraoperative
4873967|NCT02207179|Cancer margin|cancer margin
4873968|NCT02207179|Spectroscopy|spectroscopy
4873969|NCT02207179|Polarization|polarization
4873970|NCT02207166|hypertension|hypertension
4873971|NCT02207166|device|device
4873972|NCT02207166|errors|errors
4873973|NCT02207166|human factor engineering|human factor engineering
4873974|NCT02207166|usability engineering|usability engineering
4873975|NCT02207153|Chronic Hemodialysis|chronic hemodialysis
4873976|NCT02207153|Chronic Peritoneal Dialysis|chronic peritoneal dialysis
4873977|NCT02207127|obstructive sleep apnea|obstructive sleep apnea
4873978|NCT02207127|sleep apnea|sleep apnea
4873979|NCT02207114|Sepsis|sepsis
4873980|NCT02207114|Systemic Inflammatory Response Syndrome (SIRS)|systemic inflammatory response syndrome (sirs)
4873981|NCT02207114|Antibiotic use|antibiotic use
4873982|NCT02207114|Intensive Care Unit|intensive care unit
4873983|NCT02207101|Young athletes|young athletes
4873984|NCT02207101|Cardiac endurance|cardiac endurance
4873985|NCT02207101|Herbal|herbal
4873986|NCT02207101|Ejection Fraction|ejection fraction
4873987|NCT02207101|Basic Research|basic research
4873988|NCT02207101|Cardiovascular Injury|cardiovascular injury
4873989|NCT02207088|Chronic Hepatitis C|chronic hepatitis c
4873990|NCT02207088|Hepatitis C|hepatitis c
4873991|NCT02207088|End-stage renal disease|end-stage renal disease
4873992|NCT02207088|Hepatitis C Genotype 1|hepatitis c genotype 1
4873993|NCT02207088|Severe Renal Impairment|severe renal impairment
4873994|NCT02207088|renal disease|renal disease
4873995|NCT02207088|Compensated Cirrhosis|compensated cirrhosis
4873996|NCT02207088|Renal impairment|renal impairment
4873997|NCT02207088|dialysis|dialysis
4873998|NCT02207088|Hepatitis C Virus|hepatitis c virus
4873999|NCT02207088|cirrhosis|cirrhosis
4874000|NCT02207075|SPMS|spms
4874001|NCT02207075|Myelin Water Fraction|myelin water fraction
4874002|NCT02207075|activated microglia|activated microglia
4874003|NCT02207036|Tobacco|tobacco
4874004|NCT02207036|cigarettes|cigarettes
4874005|NCT02207036|cessation|cessation
4874006|NCT02207036|intervention|intervention
4874007|NCT02207036|young adults|young adults
4874008|NCT02207036|Internet|internet
4874009|NCT02207036|social media|social media
4874010|NCT02207036|mobile health|mobile health
4874011|NCT02207023|Stroke|stroke
4874012|NCT02207023|Telehealth|telehealth
4874013|NCT02207023|Rehabilitation|rehabilitation
4874014|NCT02207023|Stroke Coach|stroke coach
4874015|NCT02207023|Randomized controlled trial|randomized controlled trial
4874016|NCT02207023|Lifestyle behaviours|lifestyle behaviours
4874017|NCT02207023|Secondary prevention|secondary prevention
4874018|NCT02207023|Chronic disease self-management|chronic disease self-management
4874019|NCT02207010|Glioblastoma|glioblastoma
4874020|NCT02207010|GBM|gbm
4874021|NCT02207010|first recurrence|first recurrence
4874022|NCT02206997|perioperative hypothermia|perioperative hypothermia
4874023|NCT02206997|prewarming|prewarming
4874024|NCT02206997|treatment guideline|treatment guideline
4874025|NCT02206958|Toileting disability|toileting disability
4874026|NCT02206958|Functional urinary incontinence|functional urinary incontinence
4874027|NCT02206958|Urinary incontinence|urinary incontinence
4874030|NCT02206932|Hepatitis C|hepatitis c
4874031|NCT02206932|HIV|hiv
4874032|NCT02206932|Simeprevir|simeprevir
4874033|NCT02206932|Sofosbuvir|sofosbuvir
4874034|NCT02206919|Flow mediated dilation|flow mediated dilation
4874035|NCT02206919|Magnetic Resonance Imaging MRI|magnetic resonance imaging mri
4874036|NCT02206919|Diabetes|diabetes
4874037|NCT02206919|Endothelial dysfunction|endothelial dysfunction
4874038|NCT02206919|Popliteal artery|popliteal artery
4874039|NCT02206919|Atherosclerosis|atherosclerosis
4874040|NCT02206919|Cardiovascular disease|cardiovascular disease
4874041|NCT02206919|Vascular disease|vascular disease
4874042|NCT02206906|Medication Adherence|medication adherence
4874043|NCT02206906|Incentives|incentives
4874044|NCT02206906|Real-time Medication Monitoring|real-time medication monitoring
4874045|NCT02206880|Thoracic Surgery|thoracic surgery
4874046|NCT02206880|Delirium|delirium
4874047|NCT02206880|Cardiopulmonary Bypass|cardiopulmonary bypass
4874048|NCT02206880|Intensive Care|intensive care
4874049|NCT02206854|Pharmakokinetic|pharmakokinetic
4874050|NCT02206854|capsules|capsules
4874051|NCT02206854|R-Flurbiprofen|r-flurbiprofen
4874052|NCT02206841|fibrosis|fibrosis
4874053|NCT02206841|markers|markers
4874054|NCT02206828|HERNIA|hernia
4874055|NCT02206828|SYMCHRO|symchro
4874056|NCT02206828|SOFRADIM|sofradim
4874057|NCT02206828|REGISTRY|registry
4874058|NCT02206828|SYMBOTEX|symbotex
4874059|NCT02206802|Alopecia|alopecia
4874060|NCT02206802|Androgenetic Alopecia|androgenetic alopecia
4874061|NCT02206802|Female Pattern Hair Loss|female pattern hair loss
4874062|NCT02206802|Hair Loss|hair loss
4874063|NCT02206802|Minoxidil|minoxidil
4874064|NCT02206802|Hair Thinning|hair thinning
4874065|NCT02206776|OCD|ocd
4874066|NCT02206750|Controlled Human exposure study|controlled human exposure study
4874067|NCT02206750|Air Pollution|air pollution
4874068|NCT02206750|Cardiovascular|cardiovascular
4874069|NCT02206750|Social factors|social factors
4874070|NCT02206750|Cognitive function|cognitive function
4874071|NCT02206724|Metastatic prostate cancer|metastatic prostate cancer
4874072|NCT02206698|Intraabdominal Injury|intraabdominal injury
4874073|NCT02206698|CT Abdomen and Pelvis|ct abdomen and pelvis
4874074|NCT02206698|Pediatric trauma|pediatric trauma
4874075|NCT02206698|blunt abdominal injury|blunt abdominal injury
4874076|NCT02206698|blunt trauma|blunt trauma
4874077|NCT02206698|clinical prediction model|clinical prediction model
4874078|NCT02206633|dehydration|dehydration
4874079|NCT02206607|Phase 1|phase 1
4874080|NCT02206607|bioavailability|bioavailability
4874081|NCT02206607|type 2 diabetes mellitus|type 2 diabetes mellitus
4874082|NCT02206607|PF-04937319|pf-04937319
4874083|NCT02206581|dehydration|dehydration
4874084|NCT02206568|diabetes mellitus|diabetes mellitus
4874085|NCT02206568|phase 1|phase 1
4874086|NCT02206568|insulin lispro|insulin lispro
4874087|NCT02206568|male subjects|male subjects
4874088|NCT02206555|HIV|hiv
4874089|NCT02206555|prevention|prevention
4874090|NCT02206555|prophylaxis|prophylaxis
4874091|NCT02206555|antiretroviral|antiretroviral
4874092|NCT02206555|biomedical|biomedical
4874093|NCT02206555|bio-behavioural|bio-behavioural
4874094|NCT02206555|evaluation|evaluation
4874095|NCT02206555|demonstration study|demonstration study
4874096|NCT02206542|acupuncture,frozen shoulder,robot,sonography,MRI|acupuncture,frozen shoulder,robot,sonography,mri
4874097|NCT02206529|obesity|obesity
4874098|NCT02206529|child|child
4874099|NCT02206529|weight management|weight management
4874100|NCT02206529|behavioral|behavioral
4874101|NCT02206529|social networks|social networks
4874102|NCT02206529|social support|social support
4874103|NCT02206503|LENALIDOMIDE|lenalidomide
4874104|NCT02206503|BIOCHEMICAL PROGRESSION|biochemical progression
4874105|NCT02206503|RELAPSED/REFRACTORY MM|relapsed/refractory mm
4874106|NCT02206503|WITHOUT CRAB|without crab
4874107|NCT02206490|Gulf War Illness|gulf war illness
4874108|NCT02206490|treatment|treatment
4874109|NCT02206490|dextromethorphan|dextromethorphan
4874110|NCT02206490|naltrexone|naltrexone
4874111|NCT02206477|breast capsular contructure|breast capsular contructure
4874112|NCT02206477|dimethyl sulfoxide|dimethyl sulfoxide
4874113|NCT02206477|radiotherapy|radiotherapy
4874114|NCT02206477|breast reconstruction|breast reconstruction
4874115|NCT02206464|A/Anhui/1/2013 (H7N9)|a/anhui/1/2013 (h7n9)
4874116|NCT02206464|Antibody Response|antibody response
4874117|NCT02206464|Avian Influenza|avian influenza
4874118|NCT02206464|A/Shanghai/2/2013 (H7N9)|a/shanghai/2/2013 (h7n9)
4874119|NCT02206464|Immunogenicity|immunogenicity
4874120|NCT02206451|Assay|assay
4874121|NCT02206451|Infection|infection
4874122|NCT02206451|Direct Skin Feed|direct skin feed
4874123|NCT02206451|Midgut|midgut
4874124|NCT02206451|Parasite|parasite
4874125|NCT02206438|supraglottic airway devices|supraglottic airway devices
4874126|NCT02206438|the classic laryngeal mask airway|the classic laryngeal mask airway
4874127|NCT02206438|the self-pressurised air-Q intubating laryngeal airway in adult patients|the self-pressurised air-q intubating laryngeal airway in adult patients
4874128|NCT02206438|elective surgery of short duration (less than 2 hr) undergoing general anesthesia using supraglottic airway in adult patients|elective surgery of short duration (less than 2 hr) undergoing general anesthesia using supraglottic airway in adult patients
4874129|NCT02206425|multiple myeloma|multiple myeloma
4874130|NCT02206425|Relapsed/refractory|relapsed/refractory
4874131|NCT02206425|Ixazomib|ixazomib
4874132|NCT02206425|Proteasome inhibitor|proteasome inhibitor
4874133|NCT02206425|Oral|oral
4874134|NCT02206412|high mobility group box 1|high mobility group box 1
4874135|NCT02206412|prognostic biomarker|prognostic biomarker
4874136|NCT02206412|off-pump coronary artery bypass graft|off-pump coronary artery bypass graft
4874137|NCT02206412|patients|patients
4874138|NCT02206373|creatinine|creatinine
4874139|NCT02206373|glomerular filtration rate|glomerular filtration rate
4874140|NCT02206373|renal insufficiency, chronic|renal insufficiency, chronic
4874141|NCT02206360|Pancreatic Cancer|pancreatic cancer
4874142|NCT02206360|Pancreatic Cancer Screening|pancreatic cancer screening
4874143|NCT02206360|Pancreas Cancer|pancreas cancer
4874144|NCT02206360|Pancreatic Adenocarcinoma|pancreatic adenocarcinoma
4874145|NCT02206360|Pancreatic Adenocarcinoma screening|pancreatic adenocarcinoma screening
4874146|NCT02206360|Familial Pancreatic Cancer|familial pancreatic cancer
4874147|NCT02206360|BRCA 1/2|brca 1/2
4874148|NCT02206360|HNPCC|hnpcc
4874149|NCT02206360|Lynch Syndrome|lynch syndrome
4874150|NCT02206360|Hereditary Pancreatitis|hereditary pancreatitis
4874151|NCT02206360|FAMMM|fammm
4874152|NCT02206360|Familial atypical multiple mole melanoma|familial atypical multiple mole melanoma
4874153|NCT02206360|Peutz Jeghers Syndrome|peutz jeghers syndrome
4874154|NCT02206360|MRI|mri
4874155|NCT02206360|Magnetic Resonance Imaging|magnetic resonance imaging
4874156|NCT02206360|EUS|eus
4874157|NCT02206360|Endoscopic Ultrasound|endoscopic ultrasound
4874158|NCT02206360|Early detection|early detection
4874159|NCT02206360|Screening|screening
4874160|NCT02206308|Chimeric anti-CD20 monoclonal antibody(SCT400)|chimeric anti-cd20 monoclonal antibody(sct400)
4874161|NCT02206308|escalating doses|escalating doses
4874162|NCT02206308|safety|safety
4874163|NCT02206308|pharmacokinetics and pharmacodynamics|pharmacokinetics and pharmacodynamics
4874164|NCT02206295|selexipag|selexipag
4874165|NCT02206295|ACT-333679|act-333679
4874166|NCT02206243|Benign prostatic hyperplasia|benign prostatic hyperplasia
4874167|NCT02206243|BPH|bph
4874168|NCT02206230|glioblastoma|glioblastoma
4874169|NCT02206230|radiotherapy|radiotherapy
4874170|NCT02206230|hypofractionated radiotherapy|hypofractionated radiotherapy
4874171|NCT02206204|Selexipag|selexipag
4874172|NCT02206204|ACT-333679|act-333679
4874173|NCT02206152|Diabetes|diabetes
4874174|NCT02206152|Hypoglycemia|hypoglycemia
4874175|NCT02206152|Unawareness|unawareness
4874176|NCT02206152|HAAF|haaf
4874177|NCT02206126|Obstructive sleep apnea|obstructive sleep apnea
4874178|NCT02206126|Weight loss|weight loss
4874179|NCT02206126|Obesity|obesity
4874180|NCT02206126|Sympathetic activity|sympathetic activity
4874181|NCT02206126|Metabolic profile|metabolic profile
4874182|NCT02206126|Endothelial function|endothelial function
4874183|NCT02206113|Standing workstation|standing workstation
4874184|NCT02206100|PER977|per977
4874185|NCT02206100|enoxaparin|enoxaparin
4874186|NCT02206100|anticoagulation reversal|anticoagulation reversal
4874187|NCT02206100|whole blood clotting time|whole blood clotting time
4874188|NCT02206087|PER977|per977
4874189|NCT02206087|heparin|heparin
4874190|NCT02206087|anticoagulation reversal|anticoagulation reversal
4874191|NCT02206087|whole blood clotting time|whole blood clotting time
4874192|NCT02206048|Cervix Carcinoma|cervix carcinoma
4874193|NCT02206048|Cervical adenocarcinoma in situ|cervical adenocarcinoma in situ
4874194|NCT02206048|AIS|ais
4874195|NCT02206048|Cervical intraepithelial neoplasia|cervical intraepithelial neoplasia
4874196|NCT02206048|CIN|cin
4874197|NCT02206048|microinvasive carcinoma of the cervix|microinvasive carcinoma of the cervix
4874198|NCT02206048|cold knife cone of the cervix|cold knife cone of the cervix
4874199|NCT02206048|CKC|ckc
4874200|NCT02206048|High-Resolution Microendoscopy|high-resolution microendoscopy
4874201|NCT02206048|HRME|hrme
4874202|NCT02206048|Proflavine|proflavine
4874203|NCT02206022|Central Venous Catheter|central venous catheter
4874204|NCT02206022|Remifentanil|remifentanil
4874205|NCT02206022|local anesthesia|local anesthesia
4874206|NCT02206022|pain|pain
4874207|NCT02205996|Type 2 diabetes|type 2 diabetes
4874208|NCT02205996|Hypoglycaemia|hypoglycaemia
4874209|NCT02205996|Platelets|platelets
4874210|NCT02205996|Inflammation|inflammation
4874211|NCT02205983|enrolling|enrolling
4874212|NCT02205983|adult|adult
4874213|NCT02205983|volunteers|volunteers
4874214|NCT02205970|TENS|tens
4874215|NCT02205970|Dysmenorrhea|dysmenorrhea
4874216|NCT02205970|analgesia|analgesia
4874217|NCT02205970|interactive|interactive
4874218|NCT02205957|anesthesiology and intensive care, quality, training|anesthesiology and intensive care, quality, training
4874219|NCT02205944|chronic kidney disease|chronic kidney disease
4874220|NCT02205944|hemodialysis|hemodialysis
4874221|NCT02205944|vascular access|vascular access
4874222|NCT02205944|arteriovenous fistula|arteriovenous fistula
4874223|NCT02205944|forearm exercise|forearm exercise
4874224|NCT02205931|Epilepsy|epilepsy
4874225|NCT02205931|Ketogenic diet|ketogenic diet
4874226|NCT02205931|Antiepileptic drugs|antiepileptic drugs
4874227|NCT02205931|Randomised controlled trial|randomised controlled trial
4874228|NCT02205905|PER977|per977
4874229|NCT02205905|metabolic disposition|metabolic disposition
4874230|NCT02205905|mass balance|mass balance
4874231|NCT02205905|metabolites|metabolites
4874232|NCT02205905|radiolabeled|radiolabeled
4874233|NCT02205892|natural product|natural product
4874234|NCT02205892|clinical trial|clinical trial
4874235|NCT02205879|pregabalin|pregabalin
4874236|NCT02205879|patients|patients
4874237|NCT02205879|treatment|treatment
4874238|NCT02205853|Oncology Service Hospital|oncology service hospital
4874239|NCT02205853|Patient-centred|patient-centred
4874240|NCT02205853|Exercise|exercise
4874241|NCT02205853|Neoplasms|neoplasms
4874242|NCT02205853|Rehabilitation|rehabilitation
4874243|NCT02205853|Qualitative Research|qualitative research
4874244|NCT02205853|Health Plan Implementation|health plan implementation
4874245|NCT02205853|Quality of Health Care|quality of health care
4874246|NCT02205853|Guidelines|guidelines
4874247|NCT02205853|Quality of Life|quality of life
4874248|NCT02205827|whole blood clotting time|whole blood clotting time
4874249|NCT02205814|Osteoarthritis, Knee|osteoarthritis, knee
4874250|NCT02205814|Arthritis|arthritis
4874251|NCT02205814|WOMAC|womac
4874252|NCT02205814|Injections, intra-articular|injections, intra-articular
4874253|NCT02205814|Fasitibant|fasitibant
4874254|NCT02205814|MEN 16132|men 16132
4874255|NCT02205762|Langerhans cell histiocytosis|langerhans cell histiocytosis
4874256|NCT02205749|biobanks|biobanks
4874257|NCT02205749|informed consent|informed consent
4874258|NCT02205749|health literacy|health literacy
4874259|NCT02205736|Breast health education|breast health education
4874260|NCT02205736|Latino women|latino women
4874261|NCT02205736|Group education|group education
4874262|NCT02205736|Breast cancer|breast cancer
4874263|NCT02205723|Asthma|asthma
4874264|NCT02205723|Asthma exacerbations|asthma exacerbations
4874265|NCT02205723|Pediatric|pediatric
4874266|NCT02205697|Fruit|fruit
4874267|NCT02205697|Vegetable|vegetable
4874268|NCT02205684|Physical activity|physical activity
4874269|NCT02205684|Exercise|exercise
4874270|NCT02205684|High intensity training|high intensity training
4874271|NCT02205684|Schizophrenia|schizophrenia
4874272|NCT02205684|Symptoms|symptoms
4874273|NCT02205684|Well-being|well-being
4874274|NCT02205684|Cognition|cognition
4874275|NCT02205684|Hippocampal volume|hippocampal volume
4874276|NCT02205684|Neuroplasticity|neuroplasticity
4874277|NCT02205684|Smoking|smoking
4874278|NCT02205684|Substance use|substance use
4874279|NCT02205684|Metabolic indices|metabolic indices
4874280|NCT02205671|caregiving|caregiving
4874281|NCT02205671|chronic illness|chronic illness
4874282|NCT02205671|patient education|patient education
4874283|NCT02205671|self management|self management
4874284|NCT02205658|Sensory Processing|sensory processing
4874285|NCT02205658|Autism|autism
4874286|NCT02205645|medial|medial
4874287|NCT02205645|meniscus|meniscus
4874288|NCT02205645|scaffold|scaffold
4874289|NCT02205645|repair|repair
4874290|NCT02205645|tear|tear
4874291|NCT02205645|injury|injury
4874292|NCT02205619|Residual cementum|residual cementum
4874293|NCT02205619|root surface instrumentation|root surface instrumentation
4874294|NCT02205619|ultrasonic scaling|ultrasonic scaling
4874295|NCT02205619|air polishing with glycine|air polishing with glycine
4874296|NCT02205593|psoriasis|psoriasis
4874297|NCT02205593|atopic dermatitis|atopic dermatitis
4874298|NCT02205593|eczema|eczema
4874299|NCT02205593|patient education|patient education
4874300|NCT02205593|stress reduction|stress reduction
4874301|NCT02205593|quality of life|quality of life
4874302|NCT02205554|Analgesia|analgesia
4874303|NCT02205554|Pharmacokinetics|pharmacokinetics
4874304|NCT02205554|Treatment|treatment
4874305|NCT02205541|Eculizumab|eculizumab
4874306|NCT02205541|Shiga-toxin|shiga-toxin
4874307|NCT02205541|hemolytic and uremic syndrome|hemolytic and uremic syndrome
4874308|NCT02205541|pediatric|pediatric
4874309|NCT02205476|Phase 2|phase 2
4874310|NCT02205476|open-label|open-label
4874311|NCT02205476|safety|safety
4874312|NCT02205476|hypertrophic scar revision surgery|hypertrophic scar revision surgery
4874313|NCT02205463|Esophagus|esophagus
4874314|NCT02205463|Gastroesophageal Junction|gastroesophageal junction
4874315|NCT02205463|Stomach|stomach
4874316|NCT02205463|Gastric|gastric
4874317|NCT02205463|Cancer|cancer
4874318|NCT02205463|HER2|her2
4874319|NCT02205463|Metastatic|metastatic
4874320|NCT02205463|Adenocarcinoma|adenocarcinoma
4874321|NCT02205450|Prader-Willi Syndrome|prader-willi syndrome
4874322|NCT02205450|Growth Hormone|growth hormone
4874323|NCT02205450|Children|children
4874324|NCT02205437|Schizophrenia|schizophrenia
4874325|NCT02205437|Psychosis|psychosis
4874326|NCT02205437|Antipsychotics|antipsychotics
4874327|NCT02205437|Treatment response|treatment response
4874328|NCT02205437|Metabolic side effects|metabolic side effects
4874329|NCT02205437|Gene expression|gene expression
4874330|NCT02205437|RNA|rna
4874331|NCT02205437|Genes|genes
4874332|NCT02205424|Ischaemic stroke|ischaemic stroke
4874333|NCT02205424|Alzheimer's disease|alzheimer's disease
4874334|NCT02205424|Brain volume|brain volume
4874335|NCT02205424|Cortical thickness|cortical thickness
4874336|NCT02205424|Magnetic Resonance Imaging|magnetic resonance imaging
4874337|NCT02205411|heart assist device|heart assist device
4874338|NCT02205411|ventricular assist device|ventricular assist device
4874339|NCT02205398|INC280|inc280
4874340|NCT02205398|c-MET inhibitor|c-met inhibitor
4874341|NCT02205398|cetuximab|cetuximab
4874342|NCT02205398|metastatic colorectal cancer|metastatic colorectal cancer
4874343|NCT02205398|head and neck|head and neck
4874344|NCT02205398|squamous cell carcinoma|squamous cell carcinoma
4874345|NCT02205398|resistance to cetuximab/panitumumab|resistance to cetuximab/panitumumab
4874346|NCT02205398|SCCHN,|scchn,
4874347|NCT02205398|cancer|cancer
4874348|NCT02205398|oral and nasal cavity|oral and nasal cavity
4874349|NCT02205398|paranasal sinuses|paranasal sinuses
4874350|NCT02205398|pharynx|pharynx
4874351|NCT02205398|larynx|larynx
4874352|NCT02205398|parotid glands|parotid glands
4874353|NCT02205398|lympth nodes of neck|lympth nodes of neck
4874354|NCT02205398|mucosal lining|mucosal lining
4874355|NCT02205398|epithelium|epithelium
4874356|NCT02205398|colon|colon
4874357|NCT02205398|large intestine|large intestine
4874358|NCT02205398|rectal cancer|rectal cancer
4874359|NCT02205385|Neuroma|neuroma
4874360|NCT02205385|Amputee|amputee
4874361|NCT02205385|Amputation Stump|amputation stump
4874362|NCT02205385|Assessment, Pain|assessment, pain
4874363|NCT02205372|Diabetic Nephropathy|diabetic nephropathy
4874364|NCT02205359|AdaptivCRT|adaptivcrt
4874365|NCT02205359|aCRT|acrt
4874366|NCT02205346|obstructive sleep apnea|obstructive sleep apnea
4874367|NCT02205333|Advanced Solid tumors|advanced solid tumors
4874368|NCT02205333|Diffuse Large B-cell Lymphoma|diffuse large b-cell lymphoma
4874369|NCT02205333|programmed death 1|programmed death 1
4874370|NCT02205333|programmed dealth ligand 1|programmed dealth ligand 1
4874371|NCT02205333|cytotoxic T-lymphocyte-associated antigen-4|cytotoxic t-lymphocyte-associated antigen-4
4874372|NCT02205333|OX40 ligand|ox40 ligand
4874373|NCT02205320|Pegfilgrastim|pegfilgrastim
4874374|NCT02205320|Pharmacokinetics|pharmacokinetics
4874375|NCT02205320|Pharmacodynamics|pharmacodynamics
4874376|NCT02205320|Healthy volunteers|healthy volunteers
4874377|NCT02205307|Rectal cancer|rectal cancer
4874378|NCT02205307|Rectal neoplasm|rectal neoplasm
4874379|NCT02205307|Colorectal surgery|colorectal surgery
4874380|NCT02205307|Anastomosis|anastomosis
4874381|NCT02205294|Osteopathic treatment|osteopathic treatment
4874382|NCT02205294|Deep Vein Thrombosis|deep vein thrombosis
4874383|NCT02205294|Proximal Leg DVT|proximal leg dvt
4874384|NCT02205281|Overweight|overweight
4874385|NCT02205281|Obese|obese
4874386|NCT02205281|Pregnancy|pregnancy
4874387|NCT02205281|Weight Gain|weight gain
4874388|NCT02205281|Weight Loss|weight loss
4874389|NCT02205268|Attention Deficit Disorder with Hyperactivity|attention deficit disorder with hyperactivity
4874390|NCT02205268|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
4874391|NCT02205268|Biofeedback|biofeedback
4874392|NCT02205268|Neurofeedback Training|neurofeedback training
4874393|NCT02205268|Prefrontal Cortex|prefrontal cortex
4874394|NCT02205268|Near infrared spectroscopy|near infrared spectroscopy
4874395|NCT02205255|AECOPD|aecopd
4874396|NCT02205255|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
4874397|NCT02205255|Acute exacerbation|acute exacerbation
4874398|NCT02205255|Hospitalization|hospitalization
4874399|NCT02205255|Azithromycin|azithromycin
4874400|NCT02205255|Macrolides|macrolides
4874401|NCT02205255|Randomized Controlled Trial|randomized controlled trial
4874402|NCT02205255|Placebo|placebo
4874403|NCT02205255|Economic Impact|economic impact
4874404|NCT02205255|Cost-effectiveness|cost-effectiveness
4874405|NCT02205255|EQ5D|eq5d
4874406|NCT02205242|AECOPD|aecopd
4874407|NCT02205242|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
4874408|NCT02205242|Acute exacerbation|acute exacerbation
4874409|NCT02205242|Hospitalization|hospitalization
4874410|NCT02205242|Azithromycin|azithromycin
4874411|NCT02205242|Macrolides|macrolides
4874412|NCT02205242|Randomized Controlled Trial|randomized controlled trial
4874413|NCT02205242|Placebo|placebo
4874414|NCT02205242|Physical Activity|physical activity
4874415|NCT02205242|PRO-Active|pro-active
4874416|NCT02205242|Activity Monitor|activity monitor
4874417|NCT02205216|tDCS|tdcs
4874418|NCT02205216|FOG|fog
4874419|NCT02205216|Freezing of Gait|freezing of gait
4874420|NCT02205216|Parkinson|parkinson
4874421|NCT02205216|Rehabilitation|rehabilitation
4874422|NCT02205203|Anxiety|anxiety
4874423|NCT02205203|Social Anxiety|social anxiety
4874424|NCT02205203|Social Phobia|social phobia
4874425|NCT02205203|Separation Anxiety|separation anxiety
4874426|NCT02205203|Generalized Anxiety|generalized anxiety
4874427|NCT02205203|GAD|gad
4874428|NCT02205203|Phobia|phobia
4874429|NCT02205203|Panic|panic
4874430|NCT02205203|Agoraphobia|agoraphobia
4874431|NCT02205203|Obsessive Compulsive Disorder|obsessive compulsive disorder
4874432|NCT02205203|OCD|ocd
4874433|NCT02205203|Child|child
4874434|NCT02205203|Adolescent|adolescent
4874435|NCT02205203|Smartphone|smartphone
4874436|NCT02205203|Teen|teen
4874437|NCT02205203|Youth|youth
4874438|NCT02205190|Fimasartan|fimasartan
4874439|NCT02205177|Anxiety|anxiety
4874440|NCT02205177|Social Anxiety|social anxiety
4874441|NCT02205177|Social Phobia|social phobia
4874442|NCT02205177|Separation Anxiety|separation anxiety
4874443|NCT02205177|Generalized Anxiety|generalized anxiety
4874444|NCT02205177|GAD|gad
4874445|NCT02205177|Phobia|phobia
4874446|NCT02205177|Panic|panic
4874447|NCT02205177|Agoraphobia|agoraphobia
4874448|NCT02205177|Obsessive Compulsive Disorder|obsessive compulsive disorder
4874449|NCT02205177|OCD|ocd
4874450|NCT02205177|Child|child
4874451|NCT02205177|Adolescent|adolescent
4874452|NCT02205177|Smartphone|smartphone
4874453|NCT02205177|Teen|teen
4874454|NCT02205177|Youth|youth
4874455|NCT02205164|palonosetron|palonosetron
4874456|NCT02205164|aprepitant|aprepitant
4874457|NCT02205164|CINV|cinv
4874458|NCT02205164|AML|aml
4874459|NCT02205164|multiple-days|multiple-days
4874460|NCT02205151|Fimasartan|fimasartan
4874461|NCT02205138|Spinal Fusion|spinal fusion
4874462|NCT02205138|Lumbar Interbody Fusion|lumbar interbody fusion
4874463|NCT02205138|Degenerative Disc Disease|degenerative disc disease
4874464|NCT02205138|Cell Therapy|cell therapy
4874465|NCT02205138|Bone Graft|bone graft
4874466|NCT02205125|polyp|polyp
4874467|NCT02205125|colon|colon
4874468|NCT02205125|polypectomy|polypectomy
4874469|NCT02205125|snare|snare
4874470|NCT02205112|intravenous nemonoxacin|intravenous nemonoxacin
4874471|NCT02205112|community-acquired pneumonia|community-acquired pneumonia
4874472|NCT02205099|Schizophrenia|schizophrenia
4874473|NCT02205047|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
4874474|NCT02205034|Prader Willi|prader willi
4874475|NCT02205008|advanced gastric cancer|advanced gastric cancer
4874476|NCT02205008|serosal invasion|serosal invasion
4874477|NCT02205008|peritoneal recurrence|peritoneal recurrence
4874478|NCT02205008|intraperitoneal chemotherapy|intraperitoneal chemotherapy
4874479|NCT02204995|Osteoarthritis|osteoarthritis
4874480|NCT02204995|Thumb|thumb
4874481|NCT02204995|LRTI|lrti
4874482|NCT02204995|Trapeziectomy|trapeziectomy
4874483|NCT02204982|Phase 3, Follicular Lymphoma, FL, PI3K|phase 3, follicular lymphoma, fl, pi3k
4874484|NCT02204956|Smoking cessation|smoking cessation
4874485|NCT02204956|Tobacco use cessation|tobacco use cessation
4874486|NCT02204956|Psychiatric comorbidity|psychiatric comorbidity
4874487|NCT02204930|Haemostat|haemostat
4874488|NCT02204930|Liver surgery|liver surgery
4874489|NCT02204930|Primary liver cancer|primary liver cancer
4874490|NCT02204930|Metastatic liver cancer|metastatic liver cancer
4874491|NCT02204930|Benign liver disease such as adenoma|benign liver disease such as adenoma
4874492|NCT02204930|Hepatitis-related or alcoholic-related liver cirrhosis|hepatitis-related or alcoholic-related liver cirrhosis
4874493|NCT02204930|Living donation for liver transplant|living donation for liver transplant
4874494|NCT02204917|Ultrasound|ultrasound
4874495|NCT02204917|Ultrasound Contrast Agents|ultrasound contrast agents
4874496|NCT02204917|Optison|optison
4874497|NCT02204917|contrast enhanced Voiding Urosonography|contrast enhanced voiding urosonography
4874498|NCT02204917|ceVUS|cevus
4874499|NCT02204917|Vesicoureteral Reflux|vesicoureteral reflux
4874500|NCT02204917|Children|children
4874501|NCT02204917|Kidney|kidney
4874502|NCT02204917|Bladder|bladder
4874503|NCT02204917|Urethra|urethra
4874504|NCT02204917|Voiding Cystourethrography|voiding cystourethrography
4874505|NCT02204917|VCUG|vcug
4874506|NCT02204917|Safety|safety
4874507|NCT02204917|Urinary tract|urinary tract
4874508|NCT02204904|X-linked Adrenoleukodystrophy|x-linked adrenoleukodystrophy
4874509|NCT02204904|Hematopoietic Stem Cells|hematopoietic stem cells
4874510|NCT02204891|Abdominal pain|abdominal pain
4874511|NCT02204891|Abdominal discomfort|abdominal discomfort
4874512|NCT02204891|Flatulence|flatulence
4874513|NCT02204891|Diarrhea|diarrhea
4874514|NCT02204891|Bacterial overgrowth|bacterial overgrowth
4874515|NCT02204891|Cytokines|cytokines
4874516|NCT02204865|Sleep-Disordered Breathing|sleep-disordered breathing
4874517|NCT02204865|Sleep Apnoea|sleep apnoea
4874518|NCT02204865|Heart failure|heart failure
4874519|NCT02204839|T1DM, Exercise, Hypoglycaemia|t1dm, exercise, hypoglycaemia
4874520|NCT02204826|Effects of Korean Red Ginseng on semen parameters in male infertility patients: a randomized, placebo-controlled, double-blind clinical study|effects of korean red ginseng on semen parameters in male infertility patients: a randomized, placebo-controlled, double-blind clinical study
4874521|NCT02204813|Gastric Bypass|gastric bypass
4874522|NCT02204813|RYGB|rygb
4874523|NCT02204813|GLP-1|glp-1
4874524|NCT02204813|Xenin|xenin
4874525|NCT02204813|Insulin Secretion|insulin secretion
4874526|NCT02204813|Glucose Homeostasis|glucose homeostasis
4874527|NCT02204813|Vertical Sleeve|vertical sleeve
4874528|NCT02204813|Lap Band|lap band
4874529|NCT02204800|Tumor growth rate in maximal dimension, biomarker assessment based on driver gene alterations (specifically CRG)|tumor growth rate in maximal dimension, biomarker assessment based on driver gene alterations (specifically crg)
4874530|NCT02204774|aortic aneurysm|aortic aneurysm
4874531|NCT02204774|obstructive sleep apnea|obstructive sleep apnea
4874532|NCT02204735|Meal Time|meal time
4874533|NCT02204735|Weight Loss|weight loss
4874534|NCT02204735|Circadian Rhythm|circadian rhythm
4874535|NCT02204709|obese|obese
4874536|NCT02204709|obesity|obesity
4874537|NCT02204709|metabolic syndrome|metabolic syndrome
4874538|NCT02204709|omega-3 fatty acids|omega-3 fatty acids
4874539|NCT02204709|fish|fish
4874540|NCT02204696|sleep apnea|sleep apnea
4874541|NCT02204696|obstructive sleep apnea|obstructive sleep apnea
4874542|NCT02204696|sleepiness|sleepiness
4874543|NCT02204696|quality of life|quality of life
4874544|NCT02204683|AMD|amd
4874545|NCT02204683|Neovascularization|neovascularization
4874546|NCT02204683|macular degeneration|macular degeneration
4874547|NCT02204683|wet macular degeneration|wet macular degeneration
4874548|NCT02204683|vitrectomy|vitrectomy
4874549|NCT02204670|Irisin|irisin
4874550|NCT02204670|Obesity|obesity
4874551|NCT02204670|Exercise|exercise
4874552|NCT02204670|Myokine|myokine
4874553|NCT02204670|Impaired Glucose Tolerance|impaired glucose tolerance
4874554|NCT02204657|Continuous glucose monitoring in GDM|continuous glucose monitoring in gdm
4874555|NCT02204631|Head and Neck Cancer|head and neck cancer
4874556|NCT02204618|single sided deafness|single sided deafness
4874557|NCT02204618|Asymmetrical hearing loss|asymmetrical hearing loss
4874558|NCT02204618|Cost-utility|cost-utility
4874559|NCT02204618|Tinnitus|tinnitus
4874560|NCT02204618|Cochlear implants|cochlear implants
4874561|NCT02204618|Bone conduction device|bone conduction device
4874562|NCT02204618|Dichotic hearing|dichotic hearing
4874563|NCT02204618|Squelch effect.|squelch effect.
4874564|NCT02204605|patients|patients
4874565|NCT02204605|puzzling|puzzling
4874566|NCT02204605|conditions|conditions
4874567|NCT02204579|Autosomal Dominant Hypocalcemia|autosomal dominant hypocalcemia
4874568|NCT02204579|Hypocalcemia|hypocalcemia
4874569|NCT02204579|ADH|adh
4874570|NCT02204579|Hypoparathyroidism|hypoparathyroidism
4874571|NCT02204566|OFDI|ofdi
4874572|NCT02204566|RF Ablation|rf ablation
4874573|NCT02204566|Atrial Fibrillation|atrial fibrillation
4874574|NCT02204566|Imaging|imaging
4874575|NCT02204566|Esophagus|esophagus
4874576|NCT02204553|Multiple Myeloma|multiple myeloma
4874577|NCT02204553|Panobinostat|panobinostat
4874578|NCT02204553|LBH589|lbh589
4874579|NCT02204553|Expanded Access|expanded access
4874580|NCT02204553|EAP, ETP|eap, etp
4874581|NCT02204553|Expanded Treatment|expanded treatment
4874582|NCT02204553|Bortezomib|bortezomib
4874583|NCT02204553|HDAC|hdac
4874584|NCT02204553|histone deacetylace inhibitor|histone deacetylace inhibitor
4874585|NCT02204540|Webcams, video monitoring, compliance, adherence|webcams, video monitoring, compliance, adherence
4874586|NCT02204527|hypertension|hypertension
4874587|NCT02204527|diabetes mellitus|diabetes mellitus
4874588|NCT02204527|vitamin D|vitamin d
4874589|NCT02204501|Aviragen Therapeutics, Inc.|aviragen therapeutics, inc.
4874590|NCT02204501|Aviragen Therapeutics|aviragen therapeutics
4874591|NCT02204501|Aviragen|aviragen
4874592|NCT02204488|Osteoarthritis|osteoarthritis
4874593|NCT02204488|Thumb|thumb
4874594|NCT02204488|Total joint arthroplasty|total joint arthroplasty
4874595|NCT02204488|Trapeziectomy|trapeziectomy
4874596|NCT02204462|PET|pet
4874597|NCT02204462|Positron Emission Tomography|positron emission tomography
4874598|NCT02204462|Breast Cancer|breast cancer
4874599|NCT02204462|Imaging|imaging
4874600|NCT02204449|cardiac rehabilitation|cardiac rehabilitation
4874601|NCT02204449|peer mentorship|peer mentorship
4874602|NCT02204449|healthcare utilization|healthcare utilization
4874603|NCT02204449|continuity of cardiac care|continuity of cardiac care
4874604|NCT02204436|hyperpigmentation|hyperpigmentation
4874605|NCT02204436|depigmenting treatment|depigmenting treatment
4874606|NCT02204436|hand|hand
4874607|NCT02204423|Upper extremity dysfunction|upper extremity dysfunction
4874608|NCT02204423|Trans-Radial Percutaneous Coronary Interventions|trans-radial percutaneous coronary interventions
4874609|NCT02204410|ADHD|adhd
4874610|NCT02204410|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
4874611|NCT02204410|DESR|desr
4874612|NCT02204410|Deficient Emotional Self-Regulation|deficient emotional self-regulation
4874613|NCT02204410|Emotional Dysregulation|emotional dysregulation
4874614|NCT02204410|Omega-3 Fatty Acids|omega-3 fatty acids
4874615|NCT02204410|Fish Oil|fish oil
4874616|NCT02204397|Type 1 Diabetes mellitus|type 1 diabetes mellitus
4874617|NCT02204397|INGAP|ingap
4874618|NCT02204397|Ustekinumab|ustekinumab
4874619|NCT02204384|Dietary fiber|dietary fiber
4874620|NCT02204384|Dietary Supplements|dietary supplements
4874621|NCT02204384|Type 2 diabetes|type 2 diabetes
4874622|NCT02204384|Postprandial Period|postprandial period
4874623|NCT02204384|Plasma insulin|plasma insulin
4874624|NCT02204384|Plasma glucose|plasma glucose
4874625|NCT02204384|Area Under Curve|area under curve
4874626|NCT02204384|Soluble fiber|soluble fiber
4874627|NCT02204371|Pazopanib|pazopanib
4874628|NCT02204371|hereditary haemorrhagic telangiectasia|hereditary haemorrhagic telangiectasia
4874629|NCT02204371|bleeding|bleeding
4874630|NCT02204319|provoked or non-provoked vulvar vestibulitis|provoked or non-provoked vulvar vestibulitis
4874631|NCT02204319|low level laser light device|low level laser light device
4874632|NCT02204293|Adult-Onset Still´s Disease|adult-onset still´s disease
4874633|NCT02204293|Canakinumab|canakinumab
4874634|NCT02204293|Joint involvement|joint involvement
4874635|NCT02204293|AOSD|aosd
4874636|NCT02204280|UbA52;diabetic nephropathy ;diabetic;ELISA|uba52;diabetic nephropathy ;diabetic;elisa
4874637|NCT02204267|Stroke|stroke
4874638|NCT02204267|atrial fibrillation|atrial fibrillation
4874639|NCT02204267|ECG|ecg
4874640|NCT02204241|Multiple myeloma|multiple myeloma
4874641|NCT02204241|Diagnosis|diagnosis
4874642|NCT02204241|CCyd|ccyd
4874643|NCT02204228|osteoarthritis|osteoarthritis
4874644|NCT02204228|rheumatoid arthritis|rheumatoid arthritis
4874645|NCT02204228|post traumatic arthritis|post traumatic arthritis
4874646|NCT02204228|avascular necrosis|avascular necrosis
4874647|NCT02204228|severe fractures|severe fractures
4874648|NCT02204215|Weakness|weakness
4874649|NCT02204215|Mechanical Ventilation|mechanical ventilation
4874650|NCT02204215|Acupuncture Therapy|acupuncture therapy
4874651|NCT02204202|acute lung transplant rejection|acute lung transplant rejection
4874652|NCT02204202|neutrophilic lung inflammation|neutrophilic lung inflammation
4874653|NCT02204202|positron emission tomography imaging|positron emission tomography imaging
4874654|NCT02204202|[18F] fluorodeoxyglucose|[18f] fluorodeoxyglucose
4874655|NCT02204202|[18F] ISO-1|[18f] iso-1
4874656|NCT02204189|acute pancreatitis|acute pancreatitis
4874657|NCT02204189|gastrointestinal dysfunction|gastrointestinal dysfunction
4874658|NCT02204189|TongFuSan|tongfusan
4874659|NCT02204189|ShenQue acupoint|shenque acupoint
4874660|NCT02204150|Optical Coherence Tomography|optical coherence tomography
4874661|NCT02204150|Barrett's Esophagus|barrett's esophagus
4874662|NCT02204150|Esophagus|esophagus
4874663|NCT02204150|Imaging|imaging
4874664|NCT02204124|Whipple procedure|whipple procedure
4874665|NCT02204111|Palliative Treatment|palliative treatment
4874666|NCT02204111|Trabectedin|trabectedin
4874667|NCT02204111|Patient Reported Outcome|patient reported outcome
4874668|NCT02204085|Refractory acute myeloid leukemia|refractory acute myeloid leukemia
4874669|NCT02204085|Relapsed acute myeloid leukemia|relapsed acute myeloid leukemia
4874670|NCT02204020|Acute Myeloid Leukemia (AML)|acute myeloid leukemia (aml)
4874671|NCT02204020|Myelodysplastic Syndrome (MDS)|myelodysplastic syndrome (mds)
4874672|NCT02204020|allogeneic|allogeneic
4874673|NCT02204020|5-azacytidine (5-aza)|5-azacytidine (5-aza)
4874674|NCT02204020|hematopoietic|hematopoietic
4874675|NCT02204020|transplantation|transplantation
4874676|NCT02204020|transplant|transplant
4874677|NCT02204020|graft-versus-tumor|graft-versus-tumor
4874678|NCT02204020|graft-versus-host disease (GVHD)|graft-versus-host disease (gvhd)
4874679|NCT02204020|epigenetic|epigenetic
4874680|NCT02204020|maintenance|maintenance
4874681|NCT02204020|hypomethylation|hypomethylation
4874682|NCT02204020|relapse|relapse
4874683|NCT02204007|Acetabular Shell|acetabular shell
4874684|NCT02204007|Total Hip Arthroplasty|total hip arthroplasty
4874685|NCT02204007|3D imaging|3d imaging
4874686|NCT02203994|extracorporal shock wave therapy (ESWT)|extracorporal shock wave therapy (eswt)
4874687|NCT02203994|spasticity|spasticity
4874688|NCT02203994|spinal cord injury|spinal cord injury
4874689|NCT02203981|normal Eyes|normal eyes
4874690|NCT02203968|Fibrinogen replacement|fibrinogen replacement
4874691|NCT02203968|Trauma coagulopathy|trauma coagulopathy
4874692|NCT02203968|Hypofibrinogenemia|hypofibrinogenemia
4874693|NCT02203968|Early trauma coagulopathy|early trauma coagulopathy
4874694|NCT02203968|Haemorrhage|haemorrhage
4874695|NCT02203968|Fibrinogen concentrate|fibrinogen concentrate
4874696|NCT02203968|Feasibility trial|feasibility trial
4874697|NCT02203968|Clinical trials|clinical trials
4874698|NCT02203942|Bacterial Vaginosis|bacterial vaginosis
4874699|NCT02203942|Vulvovaginal Candidiasis|vulvovaginal candidiasis
4874700|NCT02203942|Trichomoniasis|trichomoniasis
4874701|NCT02203929|Macular Holes|macular holes
4874702|NCT02203929|Progression|progression
4874703|NCT02203916|Drug therapy|drug therapy
4874704|NCT02203890|Growth|growth
4874705|NCT02203890|Hematology|hematology
4874706|NCT02203890|Hydration|hydration
4874707|NCT02203890|Oxidation|oxidation
4874708|NCT02203890|Infection|infection
4874709|NCT02203890|Inflammation|inflammation
4874710|NCT02203890|Guatemalan children|guatemalan children
4874711|NCT02203851|BI 655066|bi 655066
4874712|NCT02203851|risankizumab|risankizumab
4874713|NCT02203838|Schizophrenia|schizophrenia
4874714|NCT02203838|Schizophrenic|schizophrenic
4874715|NCT02203838|Schizophrenias|schizophrenias
4874716|NCT02203838|Risperidone|risperidone
4874717|NCT02203838|Long-acting Risperidone|long-acting risperidone
4874718|NCT02203838|Atrigel|atrigel
4874719|NCT02203838|Subcutaneous|subcutaneous
4874720|NCT02203825|Acute Myeloid Leukemia|acute myeloid leukemia
4874721|NCT02203825|NKG2D|nkg2d
4874722|NCT02203825|Multiple Myeloma|multiple myeloma
4874723|NCT02203825|Cell Therapy|cell therapy
4874724|NCT02203799|Peanut Allergy|peanut allergy
4874725|NCT02203799|Anaphylaxis|anaphylaxis
4874726|NCT02203799|Desensitization|desensitization
4874727|NCT02203799|Food Allergy|food allergy
4874728|NCT02203799|Oral Immunotherapy|oral immunotherapy
4874729|NCT02203786|amphetamine|amphetamine
4874730|NCT02203786|d1 and d2 receptors|d1 and d2 receptors
4874731|NCT02203786|dopamine antagonists|dopamine antagonists
4874732|NCT02203786|pathological gambling|pathological gambling
4874733|NCT02203786|priming|priming
4874734|NCT02203786|reinforcement|reinforcement
4875139|NCT02201901|Hepatitis C|hepatitis c
4874735|NCT02203773|Acute Myelogenous Leukemia|acute myelogenous leukemia
4874736|NCT02203773|AML|aml
4874737|NCT02203773|Myelogenous Leukemia|myelogenous leukemia
4874738|NCT02203773|ABT-199|abt-199
4874739|NCT02203773|GDC-0199|gdc-0199
4874740|NCT02203773|Treatment Naive AML|treatment naive aml
4874741|NCT02203773|Untreated AML|untreated aml
4874742|NCT02203760|Relapsed or metastatic uterine leiomyosarcomas or carcinosarcomas|relapsed or metastatic uterine leiomyosarcomas or carcinosarcomas
4874743|NCT02203734|Pregnancy|pregnancy
4874744|NCT02203734|Depression|depression
4874745|NCT02203734|Massage|massage
4874746|NCT02203708|BPD (Borderline Personality Disorder)|bpd (borderline personality disorder)
4874747|NCT02203708|Mother/child|mother/child
4874748|NCT02203695|Salvage Radiation Therapy (SRT)|salvage radiation therapy (srt)
4874749|NCT02203695|Enzalutamide|enzalutamide
4874750|NCT02203682|Graves' orbitopathy|graves' orbitopathy
4874751|NCT02203682|Graves´ ophthalmopathy|graves´ ophthalmopathy
4874752|NCT02203682|Thyroid eye disease|thyroid eye disease
4874753|NCT02203682|Thyroid-associated ophthalmopathy|thyroid-associated ophthalmopathy
4874754|NCT02203682|Doxycycline|doxycycline
4874755|NCT02203682|EUGOGO|eugogo
4874756|NCT02203682|CAS|cas
4874757|NCT02203669|breast reconstruction|breast reconstruction
4874758|NCT02203669|occupational therapy|occupational therapy
4874759|NCT02203669|physical therapy|physical therapy
4874760|NCT02203669|upper extremity morbidity|upper extremity morbidity
4874761|NCT02203656|intervention studies|intervention studies
4874762|NCT02203656|nutrition|nutrition
4874763|NCT02203656|exercise|exercise
4874764|NCT02203656|testosterone|testosterone
4874765|NCT02203656|patient readmission|patient readmission
4874766|NCT02203630|Septic shock|septic shock
4874767|NCT02203630|Vasopressor Agents|vasopressor agents
4874768|NCT02203630|Phenylephrine|phenylephrine
4874769|NCT02203630|Norepinephrine|norepinephrine
4874770|NCT02203630|Tachycardia|tachycardia
4874771|NCT02203630|Heart Rate|heart rate
4874772|NCT02203630|Arrhythmia|arrhythmia
4874773|NCT02203630|Catecholamine|catecholamine
4874774|NCT02203617|anticipatory guidance|anticipatory guidance
4874775|NCT02203617|baby books|baby books
4874776|NCT02203617|safety|safety
4874777|NCT02203591|surgical skin prep|surgical skin prep
4874778|NCT02203591|CHG|chg
4874779|NCT02203591|IPA|ipa
4874780|NCT02203552|Breast Cancer|breast cancer
4874781|NCT02203539|circadian rhythm|circadian rhythm
4874782|NCT02203539|light exposure|light exposure
4874783|NCT02203539|exercise capacity|exercise capacity
4874784|NCT02203539|endurance|endurance
4874785|NCT02203539|strength|strength
4874786|NCT02203539|reaction|reaction
4874787|NCT02203526|Tyrosine Kinase Inhibitor|tyrosine kinase inhibitor
4874788|NCT02203526|ABC DLBCL|abc dlbcl
4874789|NCT02203526|Lymphoma in Brain and CNS|lymphoma in brain and cns
4874790|NCT02203526|Diffuse Large B-Cell Lymphomas in CNS|diffuse large b-cell lymphomas in cns
4874791|NCT02203513|p53 Dysfunction|p53 dysfunction
4874792|NCT02203513|Cell Cycle Arrest|cell cycle arrest
4874793|NCT02203513|Checkpoint Kinases|checkpoint kinases
4874794|NCT02203513|DNA Damage Repair Pathways|dna damage repair pathways
4874795|NCT02203513|Hereditary Breast and Ovarian Cancer Syndrome|hereditary breast and ovarian cancer syndrome
4874796|NCT02203461|ART, HIV, insulin resistance|art, hiv, insulin resistance
4874797|NCT02203435|code blue|code blue
4874798|NCT02203435|Cardiopulmonary Resuscitation|cardiopulmonary resuscitation
4874799|NCT02203435|APACHE|apache
4874800|NCT02203422|Immune Thrombocytopenia|immune thrombocytopenia
4874801|NCT02203422|Recombinant Human Thrombopoietin|recombinant human thrombopoietin
4874802|NCT02203422|Cyclosporin A|cyclosporin a
4874803|NCT02203409|liver tumor|liver tumor
4874804|NCT02203409|Two stage hepatectomy|two stage hepatectomy
4874805|NCT02203409|Hypertrophy|hypertrophy
4874806|NCT02203409|laparoscopy|laparoscopy
4874807|NCT02203409|ALPPS|alpps
4874808|NCT02203396|SAA|saa
4874809|NCT02203396|Immunosuppressive treatment|immunosuppressive treatment
4874810|NCT02203396|ATG|atg
4874811|NCT02203396|Cyclosporine|cyclosporine
4874812|NCT02203396|Levamisole|levamisole
4874813|NCT02203383|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
4874814|NCT02203383|Central Sleep Apnoea|central sleep apnoea
4874815|NCT02203383|Sleep Disordered Breathing|sleep disordered breathing
4874816|NCT02203383|Heart Failure|heart failure
4874817|NCT02203383|Hypercapnic Ventilatory Response|hypercapnic ventilatory response
4874818|NCT02203357|hepatitis B|hepatitis b
4874819|NCT02203357|hepatitis B vaccine|hepatitis b vaccine
4874820|NCT02203357|immunogenicity|immunogenicity
4874821|NCT02203357|adults|adults
4874822|NCT02203318|cryptorchidism, undescended testis, hypertrophy of contralateral testis|cryptorchidism, undescended testis, hypertrophy of contralateral testis
4874823|NCT02203305|Unilateral hearing loss|unilateral hearing loss
4874824|NCT02203305|Single Sided Deafness|single sided deafness
4874825|NCT02203305|Asymmetric hearing loss|asymmetric hearing loss
4874826|NCT02203292|Traumatic Brain Injury|traumatic brain injury
4874827|NCT02203292|Blood Transfusion|blood transfusion
4874828|NCT02203279|Chair-side hard relining|chair-side hard relining
4874829|NCT02203279|complete denture|complete denture
4874830|NCT02203279|patients' satisfaction|patients' satisfaction
4874831|NCT02203279|supporting tissues|supporting tissues
4874832|NCT02203279|autopolymerized reline resins|autopolymerized reline resins
4874833|NCT02203279|heat cured relining material|heat cured relining material
4874834|NCT02203266|Medication Adherence|medication adherence
4874835|NCT02203266|Patient Compliance|patient compliance
4874836|NCT02203253|solid tumor|solid tumor
4874837|NCT02203253|chemotherapy-induced delayed nausea and vomiting|chemotherapy-induced delayed nausea and vomiting
4874838|NCT02203253|thalidomide|thalidomide
4874839|NCT02203253|prevention|prevention
4874840|NCT02203240|Cacao|cacao
4874841|NCT02203240|Polyphenols|polyphenols
4874842|NCT02203240|Prediabetic State|prediabetic state
4874843|NCT02203240|Blood Glucose|blood glucose
4874844|NCT02203240|Glucose Intolerance|glucose intolerance
4874845|NCT02203240|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
4874846|NCT02203240|Obesity|obesity
4874847|NCT02203240|Muscle, Skeletal|muscle, skeletal
4874848|NCT02203240|Endotoxins|endotoxins
4874849|NCT02203240|Gut Permeability|gut permeability
4874850|NCT02203240|Incretins|incretins
4874851|NCT02203240|Metabolic Flexibility|metabolic flexibility
4874852|NCT02203227|Dietary supplements|dietary supplements
4874853|NCT02203227|Cotinine level|cotinine level
4874854|NCT02203227|Malondialdehyde|malondialdehyde
4874855|NCT02203227|Chronic smokers|chronic smokers
4874856|NCT02203227|Hyperlipidemia|hyperlipidemia
4874857|NCT02203214|Ligamys|ligamys
4874858|NCT02203214|ACL|acl
4874859|NCT02203214|healing|healing
4874860|NCT02203201|Not-celiac gluten sensitivity|not-celiac gluten sensitivity
4874861|NCT02203201|Celiac Disease|celiac disease
4874862|NCT02203201|Gluten-free diet|gluten-free diet
4874863|NCT02203201|EMA assay|ema assay
4874864|NCT02203201|Duodenal culture medium|duodenal culture medium
4874865|NCT02203175|propofol|propofol
4874866|NCT02203175|pretreatment|pretreatment
4874867|NCT02203175|mixture|mixture
4874868|NCT02203162|cough|cough
4874869|NCT02203162|cough reflex sensitivity|cough reflex sensitivity
4874870|NCT02203162|electronic cigarette|electronic cigarette
4874871|NCT02203162|capsaicin|capsaicin
4874872|NCT02203136|Bladder cancer|bladder cancer
4874873|NCT02203136|Muscle invasive bladder cancer|muscle invasive bladder cancer
4874874|NCT02203136|MIBC|mibc
4874875|NCT02203136|Biopsy specimen molecular profiling|biopsy specimen molecular profiling
4874876|NCT02203136|Bladder surgery|bladder surgery
4874877|NCT02203136|Magnetic resonance imaging|magnetic resonance imaging
4874878|NCT02203136|MRI|mri
4874879|NCT02203136|Trans urethral resection of bladder|trans urethral resection of bladder
4874880|NCT02203110|simultaneous bacterial and viral pneumonia|simultaneous bacterial and viral pneumonia
4874881|NCT02203097|Target controlled infusion|target controlled infusion
4874882|NCT02203097|propofol|propofol
4874883|NCT02203097|cerebral vasoreactivity|cerebral vasoreactivity
4874884|NCT02203097|arterial stiffness|arterial stiffness
4874885|NCT02203097|Transcranial Doppler|transcranial doppler
4874886|NCT02203097|SphygmoCor|sphygmocor
4874887|NCT02203084|Cystic Fibrosis|cystic fibrosis
4874888|NCT02203084|Diabetes Mellitus Type I|diabetes mellitus type i
4874889|NCT02203084|Chronic Renal Insufficiency|chronic renal insufficiency
4874890|NCT02203084|The influence of socioeconomic variables upon outcome in children with three chronic medical diseases.|the influence of socioeconomic variables upon outcome in children with three chronic medical diseases.
4874891|NCT02203071|sports|sports
4874892|NCT02203071|injury|injury
4874893|NCT02203071|knee|knee
4874894|NCT02203071|pain|pain
4874895|NCT02203071|cartilage|cartilage
4874896|NCT02203058|Inspiratory capacity|inspiratory capacity
4874897|NCT02203058|Positive-pressure respiration|positive-pressure respiration
4874898|NCT02203058|Exercise|exercise
4874899|NCT02203058|Activities of daily living|activities of daily living
4874900|NCT02203058|COPD.|copd.
4874901|NCT02203045|Total Knee Arthroplasty|total knee arthroplasty
4874902|NCT02203032|Psoriasis|psoriasis
4874903|NCT02203032|Plaque-type psoriasis|plaque-type psoriasis
4874904|NCT02203032|Guselkumab|guselkumab
4874905|NCT02203032|Ustekinumab|ustekinumab
4874906|NCT02203032|CNTO 1959|cnto 1959
4874907|NCT02203032|Monoclonal antibody|monoclonal antibody
4874908|NCT02203019|Dexmedetomidine|dexmedetomidine
4874909|NCT02203019|Propofol|propofol
4874910|NCT02203019|Sepsis|sepsis
4874911|NCT02203019|Mechanical Ventilation|mechanical ventilation
4874912|NCT02203019|Respiratory Failure|respiratory failure
4874913|NCT02203006|HIV,|hiv,
4874914|NCT02203006|infection,|infection,
4874915|NCT02203006|cohort|cohort
4874916|NCT02202967|Aspirin|aspirin
4874917|NCT02202967|Intestinal bleeding|intestinal bleeding
4874918|NCT02202967|Misoprostol|misoprostol
4874919|NCT02202967|NSAIDs|nsaids
4874920|NCT02202967|Small intestine|small intestine
4874921|NCT02202967|Video capsule endoscopy|video capsule endoscopy
4874922|NCT02202954|Stroke|stroke
4874923|NCT02202954|Muscle Spasticity|muscle spasticity
4874924|NCT02202954|Rehabilitation|rehabilitation
4874925|NCT02202928|Colorectal cancer|colorectal cancer
4874926|NCT02202928|DC-CIK|dc-cik
4874927|NCT02202928|Autologous tumor lysate|autologous tumor lysate
4874928|NCT02202902|Cushing's syndrome|cushing's syndrome
4874929|NCT02202902|cardiac steatosis|cardiac steatosis
4874930|NCT02202902|intramyocardial triglyceride content|intramyocardial triglyceride content
4875140|NCT02201901|HCV|hcv
4874931|NCT02202902|1H magnetic resonance spectroscopy and cardiac magnetic resonance imaging|1h magnetic resonance spectroscopy and cardiac magnetic resonance imaging
4874932|NCT02202902|Left Ventricularly hypertrophy|left ventricularly hypertrophy
4874933|NCT02202889|Adolescents|adolescents
4874934|NCT02202889|Bone mass|bone mass
4874935|NCT02202889|Calcium|calcium
4874936|NCT02202889|Perceived milk intolerance|perceived milk intolerance
4874937|NCT02202889|lactose maldigestion|lactose maldigestion
4874938|NCT02202863|Dietary intervention|dietary intervention
4874939|NCT02202863|Wine grape pomace flour|wine grape pomace flour
4874940|NCT02202863|Metabolic Syndrome|metabolic syndrome
4874941|NCT02202863|Oxidative stress|oxidative stress
4874942|NCT02202863|Antioxidants|antioxidants
4874943|NCT02202863|Fiber|fiber
4874944|NCT02202785|Drug therapy|drug therapy
4874945|NCT02202772|Urothelial|urothelial
4874946|NCT02202772|Cisplatin|cisplatin
4874947|NCT02202772|Gemcitabine|gemcitabine
4874948|NCT02202772|Cabazitaxel|cabazitaxel
4874949|NCT02202772|Bladder|bladder
4874950|NCT02202772|Carcinoma|carcinoma
4874951|NCT02202772|Bacillus Calmette-Guerin|bacillus calmette-guerin
4874952|NCT02202772|Intravesical|intravesical
4874953|NCT02202772|Recurrent|recurrent
4874954|NCT02202772|Non-muscle|non-muscle
4874955|NCT02202772|Invasive|invasive
4874956|NCT02202772|Cancer|cancer
4874957|NCT02202759|Drug therapy|drug therapy
4874958|NCT02202746|Breast cancer|breast cancer
4874959|NCT02202746|Metastatic breast cancer|metastatic breast cancer
4874960|NCT02202746|MBC|mbc
4874961|NCT02202746|HER2 positive|her2 positive
4874962|NCT02202746|HER2+|her2+
4874963|NCT02202746|Estrogen receptor positive|estrogen receptor positive
4874964|NCT02202746|ER+|er+
4874965|NCT02202746|Triple negative|triple negative
4874966|NCT02202746|FGFR1|fgfr1
4874967|NCT02202746|11q|11q
4874968|NCT02202746|FGF aberrant|fgf aberrant
4874969|NCT02202746|Biomarker negative|biomarker negative
4874970|NCT02202746|FGF non-aberrant|fgf non-aberrant
4874971|NCT02202733|cooking skills|cooking skills
4874972|NCT02202733|eating out|eating out
4874973|NCT02202733|foods prepared away from home|foods prepared away from home
4874974|NCT02202720|Sevoflurane|sevoflurane
4874975|NCT02202720|RASS score|rass score
4874976|NCT02202720|Sedation|sedation
4874977|NCT02202720|Minimal alveolar concentration (MAC)|minimal alveolar concentration (mac)
4874978|NCT02202694|CBT, Psychosis, cultural adaptation, Pakistan|cbt, psychosis, cultural adaptation, pakistan
4874979|NCT02202681|Duodenum|duodenum
4874980|NCT02202681|Optical Frequency Domain Imaging (OFDI)|optical frequency domain imaging (ofdi)
4874981|NCT02202681|Optical Coherence Tomography|optical coherence tomography
4874982|NCT02202681|Imaging|imaging
4874983|NCT02202681|Celiac Disease|celiac disease
4874984|NCT02202668|Foot ulcer, diabetic|foot ulcer, diabetic
4874985|NCT02202668|Spectrum analysis, Raman|spectrum analysis, raman
4874986|NCT02202655|non- small cell lung cancer;|non- small cell lung cancer;
4874987|NCT02202655|lymphocyte subsets|lymphocyte subsets
4874988|NCT02202616|COPD,|copd,
4874989|NCT02202616|QVA149,|qva149,
4874990|NCT02202616|Tiotropium,|tiotropium,
4874991|NCT02202616|FDC,|fdc,
4874992|NCT02202616|GlycOpyrronium With IndacatERol,|glycopyrronium with indacaterol,
4874993|NCT02202616|POWER|power
4874994|NCT02202590|SECM|secm
4874995|NCT02202590|Esophagus|esophagus
4874996|NCT02202590|Eosinophilic Esophagitis|eosinophilic esophagitis
4874997|NCT02202590|Allergy|allergy
4874998|NCT02202577|Surgical site infection|surgical site infection
4874999|NCT02202577|Surgical site antisepsis|surgical site antisepsis
4875000|NCT02202577|Cesarean Delivery|cesarean delivery
4875001|NCT02202564|hepatocellular carcinoma|hepatocellular carcinoma
4875002|NCT02202564|liver transplantation|liver transplantation
4875003|NCT02202564|adenovirus-thymidine kinase|adenovirus-thymidine kinase
4875004|NCT02202564|gene therapy|gene therapy
4875005|NCT02202551|Levodopa Induced Dyskinesia|levodopa induced dyskinesia
4875006|NCT02202551|LID|lid
4875007|NCT02202551|Parkinsonism|parkinsonism
4875008|NCT02202551|Parkinson's Disease|parkinson's disease
4875009|NCT02202538|SCI|sci
4875010|NCT02202538|Indego|indego
4875011|NCT02202538|Walking|walking
4875012|NCT02202499|pharmacotherapy|pharmacotherapy
4875013|NCT02202473|Oxymatrine Capsules, lamivudine, chronic Hepatitis B|oxymatrine capsules, lamivudine, chronic hepatitis b
4875014|NCT02202447|EC1169|ec1169
4875015|NCT02202447|prostate cancer|prostate cancer
4875016|NCT02202447|EC0652|ec0652
4875017|NCT02202421|Autism|autism
4875018|NCT02202421|Applied Behavior Analysis|applied behavior analysis
4875019|NCT02202395|Hydroxytriptolide|hydroxytriptolide
4875020|NCT02202395|Rheumatoid Arthritis|rheumatoid arthritis
4875021|NCT02202395|Methotrexate|methotrexate
4875022|NCT02202395|T8|t8
4875023|NCT02202395|LTS|lts
4875024|NCT02202369|Multimodal Analgesia|multimodal analgesia
4875025|NCT02202369|Pain Management|pain management
4875026|NCT02202356|RSV|rsv
4875027|NCT02202356|Respiratory Syncytial Virus|respiratory syncytial virus
4875028|NCT02202343|Nutrition|nutrition
4875029|NCT02202343|Food|food
4875030|NCT02202343|Security|security
4875031|NCT02202343|School|school
4875032|NCT02202343|Health|health
4875033|NCT02202317|Liver Cancer|liver cancer
4875034|NCT02202317|Hepatic Tumors|hepatic tumors
4875035|NCT02202317|Primary Liver Tumors|primary liver tumors
4875036|NCT02202317|Metastatic Liver Tumors|metastatic liver tumors
4875037|NCT02202317|Yttrium-90|yttrium-90
4875038|NCT02202317|Y-90|y-90
4875039|NCT02202291|Raynaud's phenomenon, Vasospasm, Genetics|raynaud's phenomenon, vasospasm, genetics
4875040|NCT02202278|ovarian hyperstimulation|ovarian hyperstimulation
4875041|NCT02202278|Oxidative Stress|oxidative stress
4875042|NCT02202278|IMA|ima
4875043|NCT02202278|OHSS|ohss
4875044|NCT02202278|ICSI|icsi
4875045|NCT02202278|long agonist protocol|long agonist protocol
4875046|NCT02202278|TAC|tac
4875047|NCT02202278|TOS|tos
4875048|NCT02202278|OSI|osi
4875049|NCT02202278|MDA|mda
4875050|NCT02202265|Heart Diseases|heart diseases
4875051|NCT02202252|Patient comfort|patient comfort
4875052|NCT02202252|Drains|drains
4875053|NCT02202252|Breast cancer|breast cancer
4875054|NCT02202252|Modified radical mastectomy|modified radical mastectomy
4875055|NCT02202252|Seroma|seroma
4875056|NCT02202200|Melanoma|melanoma
4875057|NCT02202200|BRAF mutated|braf mutated
4875058|NCT02202174|supraglottic airway|supraglottic airway
4875059|NCT02202174|children|children
4875060|NCT02202174|safety|safety
4875061|NCT02202174|efficacy|efficacy
4875062|NCT02202161|pharmacokinetic|pharmacokinetic
4875063|NCT02202161|intestinal bile acid transporter inhibitor|intestinal bile acid transporter inhibitor
4875064|NCT02202161|metformin|metformin
4875065|NCT02202161|sitagliptin|sitagliptin
4875066|NCT02202161|GSK2330672|gsk2330672
4875067|NCT02202161|pharmacodynamic|pharmacodynamic
4875068|NCT02202148|Fibroscan|fibroscan
4875069|NCT02202148|alcohol dependence|alcohol dependence
4875070|NCT02202148|alcohol withdrawal|alcohol withdrawal
4875071|NCT02202148|controlled attenuation parameter|controlled attenuation parameter
4875072|NCT02202148|BDNF|bdnf
4875073|NCT02202135|complicated skin and soft tissue infections (cSSTI)|complicated skin and soft tissue infections (cssti)
4875074|NCT02202135|skin infection|skin infection
4875075|NCT02202135|ceftaroline|ceftaroline
4875076|NCT02202135|wound infection|wound infection
4875077|NCT02202135|cellulitis|cellulitis
4875078|NCT02202135|burn infection|burn infection
4875079|NCT02202135|bacterial infection|bacterial infection
4875080|NCT02202135|vancomycin|vancomycin
4875081|NCT02202122|Femoral Neck Fractures|femoral neck fractures
4875082|NCT02202122|Obstructive Sleep Apnea|obstructive sleep apnea
4875083|NCT02202122|Perioperative Complications|perioperative complications
4875084|NCT02202109|Screen|screen
4875085|NCT02202109|self-sampler|self-sampler
4875086|NCT02202109|cervical, cancer|cervical, cancer
4875087|NCT02202109|women|women
4875088|NCT02202109|community health workers|community health workers
4875089|NCT02202109|Hispanic/ Latinas|hispanic/ latinas
4875090|NCT02202109|Haitian|haitian
4875091|NCT02202109|Focus of study is cervical cancer|focus of study is cervical cancer
4875092|NCT02202083|Oxytocin|oxytocin
4875093|NCT02202083|Cook Balloon|cook balloon
4875094|NCT02202070|onabotulinumtoxinA|onabotulinumtoxina
4875095|NCT02202070|Temporomandibular Joint Disorders|temporomandibular joint disorders
4875096|NCT02202070|Bruxism|bruxism
4875097|NCT02202070|Temporomandibular Joint Dysfunction Syndrome|temporomandibular joint dysfunction syndrome
4875098|NCT02202070|Myofascial Pain Dysfunction Syndrome, Temporomandibular Joint|myofascial pain dysfunction syndrome, temporomandibular joint
4875099|NCT02202057|respiratory sensation|respiratory sensation
4875100|NCT02202057|somatosensation|somatosensation
4875101|NCT02202057|resistive load|resistive load
4875102|NCT02202057|magnitude estimation|magnitude estimation
4875103|NCT02202044|Bladder Cancer|bladder cancer
4875104|NCT02202018|Knowledge Translation|knowledge translation
4875105|NCT02202018|Chronic Kidney Disease|chronic kidney disease
4875106|NCT02202018|Dialysis|dialysis
4875107|NCT02202018|Home dialysis|home dialysis
4875108|NCT02202018|Cluster randomized trial|cluster randomized trial
4875109|NCT02202005|Bioequivalence|bioequivalence
4875110|NCT02201979|breast|breast
4875111|NCT02201979|ptosis|ptosis
4875112|NCT02201979|sagging|sagging
4875113|NCT02201979|implant|implant
4875114|NCT02201979|lift|lift
4875115|NCT02201966|low back pain|low back pain
4875116|NCT02201966|pediatric|pediatric
4875117|NCT02201966|gymnasts|gymnasts
4875118|NCT02201953|Sofosbuvir|sofosbuvir
4875119|NCT02201953|Velpatasvir|velpatasvir
4875120|NCT02201953|SOF/VEL|sof/vel
4875121|NCT02201953|GS-5816|gs-5816
4875122|NCT02201953|Hepatitis C|hepatitis c
4875123|NCT02201953|HCV|hcv
4875124|NCT02201953|Cirrhosis|cirrhosis
4875125|NCT02201953|Genotype 3|genotype 3
4875126|NCT02201940|Sofosbuvir|sofosbuvir
4875127|NCT02201940|SOF/VEL|sof/vel
4875128|NCT02201940|Velpatasvir|velpatasvir
4875129|NCT02201940|Hepatitis C|hepatitis c
4875130|NCT02201940|HCV|hcv
4875131|NCT02201940|cirrhosis|cirrhosis
4875132|NCT02201927|galvanic vestibular stimulation|galvanic vestibular stimulation
4875133|NCT02201927|right parietal lobe lesion|right parietal lobe lesion
4875134|NCT02201927|egocentric space|egocentric space
4875135|NCT02201901|Sofosbuvir|sofosbuvir
4875136|NCT02201901|Velpatasvir|velpatasvir
4875137|NCT02201901|SOF/VEL|sof/vel
4875138|NCT02201901|GS-5816|gs-5816
4875141|NCT02201901|Cirrhosis|cirrhosis
4875142|NCT02201901|CPT-B|cpt-b
4875143|NCT02201888|Schizophrenia|schizophrenia
4875144|NCT02201888|Rehabilitation|rehabilitation
4875145|NCT02201888|Cognition|cognition
4875146|NCT02201875|hypoxia|hypoxia
4875147|NCT02201875|exercise|exercise
4875148|NCT02201875|periodic breathing|periodic breathing
4875149|NCT02201875|hypercapnia|hypercapnia
4875150|NCT02201875|apneas|apneas
4875151|NCT02201875|cardiac failure|cardiac failure
4875152|NCT02201862|Aneuploidy|aneuploidy
4875153|NCT02201862|Down Syndrome|down syndrome
4875154|NCT02201862|amniocentesis|amniocentesis
4875155|NCT02201862|chronic villus sampling|chronic villus sampling
4875156|NCT02201862|Trisomy|trisomy
4875157|NCT02201862|non-invasive prenatal testing|non-invasive prenatal testing
4875158|NCT02201862|Chromosome disorders|chromosome disorders
4875159|NCT02201849|Alkermes|alkermes
4875160|NCT02201849|ALKS 8700|alks 8700
4875161|NCT02201810|smoking cessation|smoking cessation
4875162|NCT02201810|quit line|quit line
4875163|NCT02201810|nicotine replacement therapy|nicotine replacement therapy
4875164|NCT02201810|tobacco intervention|tobacco intervention
4875165|NCT02201797|Reproducibility of Results|reproducibility of results
4875166|NCT02201797|Liver neoplasm|liver neoplasm
4875167|NCT02201797|Neoplasm metastasis|neoplasm metastasis
4875168|NCT02201797|Regional Perfusion|regional perfusion
4875169|NCT02201797|Perfusion Magnetic Resonance Imaging|perfusion magnetic resonance imaging
4875170|NCT02201784|Subarachnoid block|subarachnoid block
4875171|NCT02201784|intrathecal|intrathecal
4875172|NCT02201784|spinal anesthesia|spinal anesthesia
4875173|NCT02201784|isobaric|isobaric
4875174|NCT02201784|levobupivacaine|levobupivacaine
4875175|NCT02201784|ropivacaine|ropivacaine
4875176|NCT02201771|CABG|cabg
4875177|NCT02201771|Antiplatelet|antiplatelet
4875178|NCT02201771|Ticagrelor|ticagrelor
4875179|NCT02201758|Inflammatory Bowel Disease (IBD), ulcerative colitis (UC), flaxseed lignan-enriched complex (FLC)|inflammatory bowel disease (ibd), ulcerative colitis (uc), flaxseed lignan-enriched complex (flc)
4875180|NCT02201732|Incomplete miscarriage|incomplete miscarriage
4875181|NCT02201732|Hysteroscopy|hysteroscopy
4875182|NCT02201732|curettage, pregnancy|curettage, pregnancy
4875183|NCT02201732|RCT|rct
4875184|NCT02201719|Adenomyosis|adenomyosis
4875185|NCT02201719|Dysmenorrhea|dysmenorrhea
4875186|NCT02201719|Chronic pelvic pain|chronic pelvic pain
4875187|NCT02201719|Infertility|infertility
4875188|NCT02201719|Sensitivity histology|sensitivity histology
4875189|NCT02201719|womens health|womens health
4875190|NCT02201719|junction zone|junction zone
4875191|NCT02201706|Retinal detachment|retinal detachment
4875192|NCT02201706|silicone oil|silicone oil
4875193|NCT02201706|retinectomy|retinectomy
4875194|NCT02201693|Crohn's disease,|crohn's disease,
4875195|NCT02201693|pediatric GETAID (Therapeutic study group of inflammatory bowel diseases of the child),|pediatric getaid (therapeutic study group of inflammatory bowel diseases of the child),
4875196|NCT02201693|enteral nutrition,|enteral nutrition,
4875197|NCT02201693|randomized multicenter study|randomized multicenter study
4875198|NCT02201680|anxiety|anxiety
4875199|NCT02201680|preoperative|preoperative
4875200|NCT02201667|non-ST elevation acute coronary syndrome|non-st elevation acute coronary syndrome
4875201|NCT02201667|myocardial perfusion|myocardial perfusion
4875202|NCT02201667|magnetic Resonance Imaging|magnetic resonance imaging
4875203|NCT02201667|antiplatelet|antiplatelet
4875204|NCT02201641|Indirect pulp capping|indirect pulp capping
4875205|NCT02201641|reversible pulpitis|reversible pulpitis
4875206|NCT02201641|periapical radiolucency|periapical radiolucency
4875207|NCT02201641|periapical radiographs|periapical radiographs
4875208|NCT02201641|cone beam computed tomography|cone beam computed tomography
4875209|NCT02201641|calcium silicate cements|calcium silicate cements
4875210|NCT02201641|glass ionomer cements|glass ionomer cements
4875211|NCT02201641|caries|caries
4875212|NCT02201628|Oesophageal|oesophageal
4875213|NCT02201628|Nasopharyngeal|nasopharyngeal
4875214|NCT02201628|temperature|temperature
4875215|NCT02201628|Intubation, endotracheal|intubation, endotracheal
4875216|NCT02201628|Pediatric|pediatric
4875217|NCT02201628|Anesthesia|anesthesia
4875218|NCT02201628|Hypothermia|hypothermia
4875219|NCT02201615|Perineal Massage; Episiotomy; Perineal Laceration|perineal massage; episiotomy; perineal laceration
4875220|NCT02201602|sulphonylureas|sulphonylureas
4875221|NCT02201602|gliclazide|gliclazide
4875222|NCT02201602|glibenclamide|glibenclamide
4875223|NCT02201589|Lesions in the ascending thoracic aorta|lesions in the ascending thoracic aorta
4875224|NCT02201576|Chronic antibody-mediated rejection,|chronic antibody-mediated rejection,
4875225|NCT02201576|transplant rejection, kidney transplantation,|transplant rejection, kidney transplantation,
4875226|NCT02201576|proteasome inhibitor,|proteasome inhibitor,
4875227|NCT02201576|anti-HLA antibodies,|anti-hla antibodies,
4875228|NCT02201576|immunosuppressive agents|immunosuppressive agents
4875229|NCT02201563|Adverse radiation effects (ARE)|adverse radiation effects (are)
4875230|NCT02201563|Radiosurgery|radiosurgery
4875231|NCT02201563|Brain metastases|brain metastases
4875232|NCT02201563|Minocycline|minocycline
4875233|NCT02201537|Ultrasound functional imaging|ultrasound functional imaging
4875234|NCT02201537|Chronic kidney Nephropathy|chronic kidney nephropathy
4875235|NCT02201524|Phase 2|phase 2
4875236|NCT02201524|randomized|randomized
4875237|NCT02201524|double-blind|double-blind
4875238|NCT02201524|placebo|placebo
4875239|NCT02201524|plaque|plaque
4875240|NCT02201524|psoriasis|psoriasis
4875241|NCT02201524|safety|safety
4875242|NCT02201524|efficacy|efficacy
4875243|NCT02201524|JAK|jak
4875244|NCT02201524|janus kinase|janus kinase
4875245|NCT02201524|moderate|moderate
4875246|NCT02201524|severe|severe
4875247|NCT02201511|relative bioavailbility|relative bioavailbility
4875248|NCT02201511|food effect|food effect
4875249|NCT02201511|pharmacokinetics|pharmacokinetics
4875250|NCT02201511|ALTERATION OF COGNITIVE FUNCTIONS|alteration of cognitive functions
4875251|NCT02201485|Budd-Chiari syndrome|budd-chiari syndrome
4875252|NCT02201485|percutaneous recanalization|percutaneous recanalization
4875253|NCT02201485|treatment|treatment
4875254|NCT02201485|reocclusion|reocclusion
4875255|NCT02201485|patency|patency
4875256|NCT02201472|liver|liver
4875257|NCT02201472|mre|mre
4875258|NCT02201472|mri|mri
4875259|NCT02201472|neonatal|neonatal
4875260|NCT02201472|mr touch|mr touch
4875261|NCT02201459|Peg-IFN, nilotinib, MR4.5, CML, chronic phase, first-line|peg-ifn, nilotinib, mr4.5, cml, chronic phase, first-line
4875262|NCT02201433|breastfeeding|breastfeeding
4875263|NCT02201433|fathers|fathers
4875264|NCT02201433|preterm newborns|preterm newborns
4875265|NCT02201433|partner influence|partner influence
4875266|NCT02201394|Antiplatelet|antiplatelet
4875267|NCT02201394|Ticagrelor|ticagrelor
4875268|NCT02201394|Platelets|platelets
4875269|NCT02201394|Thrombosis|thrombosis
4875270|NCT02201394|Coronary artery disease|coronary artery disease
4875271|NCT02201381|Cancer|cancer
4875272|NCT02201381|Cancer Treatments|cancer treatments
4875273|NCT02201381|Cancer Palliative Care|cancer palliative care
4875274|NCT02201381|Metabolic|metabolic
4875275|NCT02201381|Metabolism|metabolism
4875276|NCT02201381|Existing Medicines|existing medicines
4875277|NCT02201381|Licensed Medicines|licensed medicines
4875278|NCT02201381|Real World|real world
4875279|NCT02201381|Breast Cancer|breast cancer
4875280|NCT02201381|Triple Negative Breast Cancer|triple negative breast cancer
4875281|NCT02201381|Colon Cancer|colon cancer
4875282|NCT02201381|Prostrate Cancer|prostrate cancer
4875283|NCT02201381|Brain Cancer|brain cancer
4875284|NCT02201381|Ovarian Cancer|ovarian cancer
4875285|NCT02201381|Pancreatic Cancer|pancreatic cancer
4875286|NCT02201381|AML|aml
4875287|NCT02201381|CML|cml
4875288|NCT02201381|Leukemea|leukemea
4875289|NCT02201381|Metformin|metformin
4875290|NCT02201381|Statins|statins
4875291|NCT02201381|Mebendazole|mebendazole
4875292|NCT02201381|Doxycycline|doxycycline
4875293|NCT02201381|Ibuprofen|ibuprofen
4875294|NCT02201381|Metastatic|metastatic
4875295|NCT02201368|Triglycerides; Lipid Metabolism; Fatty Acids.|triglycerides; lipid metabolism; fatty acids.
4875296|NCT02201355|Head and Neck cancer|head and neck cancer
4875297|NCT02201342|Fontan|fontan
4875298|NCT02201342|Pharmacokinetics|pharmacokinetics
4875299|NCT02201342|Pharmacodynamics|pharmacodynamics
4875300|NCT02201342|Exercise capacity|exercise capacity
4875301|NCT02201342|Maximal Oxygen Consumption|maximal oxygen consumption
4875302|NCT02201342|Vascular function|vascular function
4875303|NCT02201342|EndoPAT|endopat
4875304|NCT02201342|Myocardial performance|myocardial performance
4875305|NCT02201316|Healthy adult human subjects|healthy adult human subjects
4875306|NCT02201316|Mosapride citrate anhydrous|mosapride citrate anhydrous
4875307|NCT02201316|Bioequivalence|bioequivalence
4875308|NCT02201316|Dyspepsia|dyspepsia
4875309|NCT02201303|CD11b|cd11b
4875310|NCT02201303|Neutrophils|neutrophils
4875311|NCT02201303|CXCL1|cxcl1
4875312|NCT02201303|Danirixin|danirixin
4875313|NCT02201303|Respiratory Syncytial Virus|respiratory syncytial virus
4875314|NCT02201303|Children|children
4875315|NCT02201303|CXCR2|cxcr2
4875316|NCT02201290|Chronic immune thrombocytopenic purpura, ITP, eltrombopag olamine, thrombopoietin receptor agonist, pediatrics|chronic immune thrombocytopenic purpura, itp, eltrombopag olamine, thrombopoietin receptor agonist, pediatrics
4875317|NCT02201277|IVC|ivc
4875318|NCT02201277|IVC Filter|ivc filter
4875319|NCT02201277|Filter|filter
4875320|NCT02201277|Option|option
4875321|NCT02201277|Denali|denali
4875322|NCT02201277|filter tilt|filter tilt
4875323|NCT02201277|filter migration|filter migration
4875324|NCT02201277|filter fracture|filter fracture
4875325|NCT02201277|filter thrombus|filter thrombus
4875326|NCT02201277|filter penetration|filter penetration
4875327|NCT02201264|myocardial infarction|myocardial infarction
4875328|NCT02201264|Angioplasty|angioplasty
4875329|NCT02201264|Stent|stent
4875330|NCT02201251|Epilepsy|epilepsy
4875331|NCT02201251|Topiramate|topiramate
4875332|NCT02201251|Levetiracetam|levetiracetam
4875333|NCT02201251|Pediatric|pediatric
4875334|NCT02201212|TSC1|tsc1
4875335|NCT02201212|TSC2|tsc2
4875336|NCT02201212|Tuberous Sclerosis Complex|tuberous sclerosis complex
4875337|NCT02201212|MTOR|mtor
4875338|NCT02201186|honey enema for pouchitis|honey enema for pouchitis
4875339|NCT02201160|NAFLD|nafld
4875340|NCT02201160|Fatty acid composition|fatty acid composition
4875341|NCT02201160|Omega 3 supplementation|omega 3 supplementation
4875342|NCT02201160|Metabolism|metabolism
4875343|NCT02201134|Cardiac arrest|cardiac arrest
4875344|NCT02201134|Therapeutic hypothermia|therapeutic hypothermia
4875345|NCT02201134|Sevoflurane|sevoflurane
4875346|NCT02201134|Sedation|sedation
4875347|NCT02201134|Patient resuscitated from cardiac arrest|patient resuscitated from cardiac arrest
4875348|NCT02201134|Requiring sedation|requiring sedation
4875349|NCT02201134|Adult patients|adult patients
4875350|NCT02201134|Patient covered by french health care system|patient covered by french health care system
4875351|NCT02201095|caesarean section|caesarean section
4875352|NCT02201095|perioperative hypothermia|perioperative hypothermia
4875353|NCT02201095|active warming|active warming
4875354|NCT02201095|forced air warming|forced air warming
4875355|NCT02201095|conduction mattress warming|conduction mattress warming
4875356|NCT02201095|thermal comfort|thermal comfort
4875357|NCT02201095|Prevention of|prevention of
4875358|NCT02201069|nutrition|nutrition
4875359|NCT02201069|physical activity|physical activity
4875360|NCT02201069|sleep|sleep
4875361|NCT02201069|weight loss|weight loss
4875362|NCT02201056|Drug Therapy|drug therapy
4875363|NCT02201043|ankylosing spondylitis|ankylosing spondylitis
4875364|NCT02201043|thalidomide|thalidomide
4875365|NCT02200952|OHSS|ohss
4875366|NCT02200952|Oocytes triggering|oocytes triggering
4875367|NCT02200952|GnRh agonist triggering|gnrh agonist triggering
4875368|NCT02200952|Luteal phase supplementation|luteal phase supplementation
4875369|NCT02200952|recombinant LH|recombinant lh
4875370|NCT02200900|High flow nasal cannula|high flow nasal cannula
4875371|NCT02200900|Continuous Positive Airway Pressure|continuous positive airway pressure
4875372|NCT02200900|Respiratory physiology|respiratory physiology
4875373|NCT02200887|Dyskinesia|dyskinesia
4875374|NCT02200887|Slow Wave Sleep|slow wave sleep
4875375|NCT02200874|disease related malnutrition|disease related malnutrition
4875376|NCT02200874|influence of Nutrition Support Team|influence of nutrition support team
4875377|NCT02200874|length of hospital stay|length of hospital stay
4875378|NCT02200874|quality of life|quality of life
4875379|NCT02200874|body composition|body composition
4875380|NCT02200874|health care costs|health care costs
4875381|NCT02200861|sedation,|sedation,
4875382|NCT02200861|tooth extraction,|tooth extraction,
4875383|NCT02200848|Lenalidomide|lenalidomide
4875384|NCT02200848|Ibrutinib|ibrutinib
4875385|NCT02200848|Rituximab|rituximab
4875387|NCT02200848|SLL|sll
4875388|NCT02200835|aortic dissection|aortic dissection
4875389|NCT02200835|Chinese patients|chinese patients
4875390|NCT02200835|gender differences|gender differences
4875391|NCT02200822|neurohumoral blocker therapy|neurohumoral blocker therapy
4875392|NCT02200822|renin-angiotensin-aldosterone system (RAAS)|renin-angiotensin-aldosterone system (raas)
4875393|NCT02200822|RAAS-blocker|raas-blocker
4875394|NCT02200822|beta blocker|beta blocker
4875395|NCT02200822|spironolactone|spironolactone
4875396|NCT02200822|angiotensin converting enzyme inhibitor (ACE-I)|angiotensin converting enzyme inhibitor (ace-i)
4875397|NCT02200822|angiotensin receptor blocker (ARB)|angiotensin receptor blocker (arb)
4875398|NCT02200822|cardiac resynchronization therapy (CRT)|cardiac resynchronization therapy (crt)
4875399|NCT02200822|heart failure|heart failure
4875400|NCT02200822|dyssynchrony|dyssynchrony
4875401|NCT02200822|left bundle branch block|left bundle branch block
4875402|NCT02200809|MR-guided therapy|mr-guided therapy
4875403|NCT02200809|Focal laser ablation|focal laser ablation
4875404|NCT02200809|Prostate cancer|prostate cancer
4875405|NCT02200796|Dietary Protein|dietary protein
4875406|NCT02200796|Satiety|satiety
4875407|NCT02200796|Food Intake|food intake
4875408|NCT02200796|Thermic Effect of Food|thermic effect of food
4875409|NCT02200796|Diet Induced Thermogenesis|diet induced thermogenesis
4875410|NCT02200783|Cardiac catheterization|cardiac catheterization
4875411|NCT02200783|Radiation Protection|radiation protection
4875412|NCT02200783|Radial artery|radial artery
4875413|NCT02200783|Femoral artery|femoral artery
4875414|NCT02200770|NMO, NMOSD, Neuromyelitis Optica, Neuromyelitis Optica Spectrum Disorders, autoimmune, demyelination, MEDI-551, monoclonal antibody, Devic's syndrome, B-cell|nmo, nmosd, neuromyelitis optica, neuromyelitis optica spectrum disorders, autoimmune, demyelination, medi-551, monoclonal antibody, devic's syndrome, b-cell
4875415|NCT02200744|Procedural sedation|procedural sedation
4875416|NCT02200744|emergency department|emergency department
4875417|NCT02200744|adults|adults
4875418|NCT02200744|propofol|propofol
4875419|NCT02200744|recall assessment|recall assessment
4875420|NCT02200731|Childhood cancer|childhood cancer
4875421|NCT02200731|Psychosocial intervention|psychosocial intervention
4875422|NCT02200731|Family|family
4875423|NCT02200731|Siblings|siblings
4875424|NCT02200731|Childhood cancer survivors|childhood cancer survivors
4875425|NCT02200731|Cogntive Behavioural|cogntive behavioural
4875426|NCT02200731|Manualized|manualized
4875427|NCT02200718|Multiple Sclerosis Pediatric MS NeuroVax Vaccine Therapeutic|multiple sclerosis pediatric ms neurovax vaccine therapeutic
4875428|NCT02200705|cryoablation, cryotherapy, breast cancer|cryoablation, cryotherapy, breast cancer
4875429|NCT02200692|plasma transfusion|plasma transfusion
4875430|NCT02200692|allergic transfusion reaction|allergic transfusion reaction
4875431|NCT02200692|transfusion reaction|transfusion reaction
4875432|NCT02200692|blood transfusion|blood transfusion
4875433|NCT02200692|Solvent detergent plasma|solvent detergent plasma
4875434|NCT02200679|Autism spectrum disorders|autism spectrum disorders
4875435|NCT02200679|Prevalence|prevalence
4875436|NCT02200679|Diagnosis|diagnosis
4875437|NCT02200679|Screen|screen
4875438|NCT02200679|Risk Factor|risk factor
4875439|NCT02200679|SRS|srs
4875440|NCT02200679|ASRS|asrs
4875441|NCT02200666|Type 2 diabetes mellitus|type 2 diabetes mellitus
4875442|NCT02200666|Diabetes|diabetes
4875443|NCT02200666|Forxiga|forxiga
4875444|NCT02200666|Long-term use|long-term use
4875445|NCT02200627|Type 2 diabetes mellitus|type 2 diabetes mellitus
4875446|NCT02200627|Diabetes|diabetes
4875447|NCT02200627|Forxiga|forxiga
4875448|NCT02200627|Elderly|elderly
4875449|NCT02200601|Seipher Wellness|seipher wellness
4875450|NCT02200601|algorithm|algorithm
4875451|NCT02200601|secure samples of SGC waveform|secure samples of sgc waveform
4875452|NCT02200601|volunteers|volunteers
4875453|NCT02200601|validation|validation
4875454|NCT02200601|heart health algorithm|heart health algorithm
4875455|NCT02200588|psychosis|psychosis
4875456|NCT02200588|schizophrenia|schizophrenia
4875457|NCT02200549|pulmonary rehabilitation|pulmonary rehabilitation
4875458|NCT02200549|inspiratory muscle training|inspiratory muscle training
4875459|NCT02200549|exercise training|exercise training
4875460|NCT02200523|EEG|eeg
4875461|NCT02200523|electrode|electrode
4875462|NCT02200510|Anemia, Sickle Cell|anemia, sickle cell
4875463|NCT02200510|Transition to Adult Care|transition to adult care
4875464|NCT02200510|Self Care|self care
4875465|NCT02200510|Personal Electronic Health Records|personal electronic health records
4875466|NCT02200510|Adolescent|adolescent
4875467|NCT02200510|Young Adult|young adult
4875468|NCT02200510|Disease Management|disease management
4875469|NCT02200510|Physician-Patient Relations|physician-patient relations
4875470|NCT02200484|obesity|obesity
4875471|NCT02200484|adolescents, females|adolescents, females
4875472|NCT02200484|child development|child development
4875473|NCT02200484|weight loss programs|weight loss programs
4875474|NCT02200484|child rearing|child rearing
4875475|NCT02200484|parenting|parenting
4875476|NCT02200471|Cosmetic dermatology|cosmetic dermatology
4875477|NCT02200471|near-infrared|near-infrared
4875478|NCT02200471|patient preference|patient preference
4875479|NCT02200471|physician preference|physician preference
4875480|NCT02200445|Ulcerative colitis|ulcerative colitis
4875481|NCT02200445|Inflammatory bowel disease|inflammatory bowel disease
4875482|NCT02200445|Interleukin 2|interleukin 2
4875483|NCT02200445|Interleukin-2|interleukin-2
4875484|NCT02200445|IL-2|il-2
4875485|NCT02200445|Regulatory T Cells|regulatory t cells
4875486|NCT02200445|Tregs|tregs
4875487|NCT02200445|T-Lymphocytes, Regulatory|t-lymphocytes, regulatory
4875488|NCT02200432|Smoking Cessation|smoking cessation
4875489|NCT02200432|Persuasive Communication Tailoring|persuasive communication tailoring
4875490|NCT02200432|Health Behavior Change|health behavior change
4875491|NCT02200432|Patient decision support|patient decision support
4875492|NCT02200419|Rotem|rotem
4875493|NCT02200419|Point of care coagulation tests|point of care coagulation tests
4875494|NCT02200419|Cardiac surgery|cardiac surgery
4875495|NCT02200419|Vascular surgery|vascular surgery
4875496|NCT02200419|Cardiopulmonary bypass|cardiopulmonary bypass
4875497|NCT02200419|Blood products|blood products
4875498|NCT02200419|Transfusion|transfusion
4875499|NCT02200419|Viscoelastic coagulation|viscoelastic coagulation
4875500|NCT02200406|Desvenlafaxine|desvenlafaxine
4875501|NCT02200406|Opioid-dependent|opioid-dependent
4875502|NCT02200406|Addiction|addiction
4875503|NCT02200406|Depression|depression
4875504|NCT02200406|Methadone|methadone
4875505|NCT02200406|Comorbidity|comorbidity
4875506|NCT02200393|Spinal cord injury|spinal cord injury
4875507|NCT02200393|Tetraplegia|tetraplegia
4875508|NCT02200393|Ventilator|ventilator
4875509|NCT02200367|Primary health care|primary health care
4875510|NCT02200367|Computer communication network|computer communication network
4875511|NCT02200367|Depression|depression
4875512|NCT02200328|Clostridium difficile infection|clostridium difficile infection
4875513|NCT02200328|Diarrhea|diarrhea
4875514|NCT02200328|Flagyl|flagyl
4875515|NCT02200328|Metronidazole|metronidazole
4875516|NCT02200315|Stomach neoplasms|stomach neoplasms
4875517|NCT02200315|Surgical site infection|surgical site infection
4875518|NCT02200315|Laparoscopic gastrectomy|laparoscopic gastrectomy
4875519|NCT02200315|Antimicrobial prophylaxis|antimicrobial prophylaxis
4875520|NCT02200289|Birth cohort|birth cohort
4875521|NCT02200289|Ghana|ghana
4875522|NCT02200289|Biomass|biomass
4875523|NCT02200289|Cook stove|cook stove
4875524|NCT02200289|Oxidative stress|oxidative stress
4875525|NCT02200289|Lung development|lung development
4875526|NCT02200263|ocular albinism (OA)|ocular albinism (oa)
4875527|NCT02200263|oculocutaneous albinism (OCA)|oculocutaneous albinism (oca)
4875528|NCT02200263|macular pigment|macular pigment
4875529|NCT02200263|visual function|visual function
4875530|NCT02200237|EV71 Vaccine|ev71 vaccine
4875531|NCT02200211|Amblyopia|amblyopia
4875532|NCT02200198|undernutrition|undernutrition
4876315|NCT02196454|video|video
4875533|NCT02200198|abdominal surgery|abdominal surgery
4875534|NCT02200198|respiratory muscles|respiratory muscles
4875535|NCT02200198|muscles strength|muscles strength
4875536|NCT02200198|pulmonary complication|pulmonary complication
4875537|NCT02200198|perioperative care|perioperative care
4875538|NCT02200185|post traumatic pain|post traumatic pain
4875539|NCT02200185|titrated morphine|titrated morphine
4875540|NCT02200185|nebulised morphine|nebulised morphine
4875541|NCT02200172|Cancer|cancer
4875542|NCT02200172|Melatonin|melatonin
4875543|NCT02200172|Delirium|delirium
4875544|NCT02200172|Feasibility Studies|feasibility studies
4875545|NCT02200172|Palliative Care|palliative care
4875546|NCT02200159|Sedation|sedation
4875547|NCT02200159|Dexmedetomidine|dexmedetomidine
4875549|NCT02200159|Delirium|delirium
4875550|NCT02200146|sarcoidosis|sarcoidosis
4875551|NCT02200146|treatment|treatment
4875552|NCT02200146|lung|lung
4875553|NCT02200146|glucocorticoids|glucocorticoids
4875554|NCT02200146|hydroxychloroquine|hydroxychloroquine
4875555|NCT02200133|Hematopoietic cell transplant (HCT) survivors|hematopoietic cell transplant (hct) survivors
4875556|NCT02200133|Survivorship Care Plan|survivorship care plan
4875557|NCT02200107|Osteoarthritis Knee|osteoarthritis knee
4875558|NCT02200107|Self Care|self care
4875559|NCT02200107|Treatment Outcome|treatment outcome
4875560|NCT02200107|Patient Education as Topic|patient education as topic
4875561|NCT02200107|Physical Therapy Modalities|physical therapy modalities
4875562|NCT02200081|Extensive disease|extensive disease
4875563|NCT02200081|After first line therapy|after first line therapy
4875564|NCT02200081|Immuno therapy|immuno therapy
4875565|NCT02200068|Perceived Efficacy of Patient Physician Interactions|perceived efficacy of patient physician interactions
4875566|NCT02200068|Patient Reported Outcomes|patient reported outcomes
4875567|NCT02200068|Personal Health Record|personal health record
4875568|NCT02200055|Electrical Bioimpedance|electrical bioimpedance
4875569|NCT02200055|Major Intra-abdominal Surgical Procedures|major intra-abdominal surgical procedures
4875570|NCT02200055|Total Body Volume|total body volume
4875571|NCT02200055|Fluid Resuscitation|fluid resuscitation
4875572|NCT02200029|Intrahepatic Cholestasis|intrahepatic cholestasis
4875573|NCT02200016|Postoperative pain|postoperative pain
4875574|NCT02200016|Regional anesteshia|regional anesteshia
4875575|NCT02200016|Nerve catheters|nerve catheters
4875576|NCT02200016|Sciatic nerve catheters|sciatic nerve catheters
4875577|NCT02200003|attention bias modification, anxiety, event-related potentials|attention bias modification, anxiety, event-related potentials
4875578|NCT02199990|cognitive function; propofol; etomidate;|cognitive function; propofol; etomidate;
4875579|NCT02199977|Malaria|malaria
4875580|NCT02199977|Antimalarial subsidy|antimalarial subsidy
4875581|NCT02199977|Malaria rapid diagnostic test (RDT)|malaria rapid diagnostic test (rdt)
4875582|NCT02199977|public-private partnership|public-private partnership
4875583|NCT02199964|Dry eye|dry eye
4875584|NCT02199964|environmental stress|environmental stress
4875585|NCT02199964|artificial tears|artificial tears
4875586|NCT02199964|cyclosporin|cyclosporin
4875587|NCT02199964|Restasis|restasis
4875588|NCT02199951|Uncomplicated Malaria|uncomplicated malaria
4875589|NCT02199951|dihydroartemisinin|dihydroartemisinin
4875590|NCT02199951|piperaquine|piperaquine
4875591|NCT02199925|Autism|autism
4875592|NCT02199925|Autism spectrum|autism spectrum
4875593|NCT02199925|Autism children|autism children
4875594|NCT02199912|cachexia|cachexia
4875595|NCT02199912|nutrition|nutrition
4875596|NCT02199912|cancer|cancer
4875597|NCT02199912|colorectal tumor|colorectal tumor
4875598|NCT02199834|diabetes|diabetes
4875599|NCT02199834|peer support|peer support
4875600|NCT02199834|personalized feedback report|personalized feedback report
4875601|NCT02199795|stroke|stroke
4875602|NCT02199795|hemiplegia|hemiplegia
4875603|NCT02199795|footdrop|footdrop
4875604|NCT02199795|electrical stimulation|electrical stimulation
4875605|NCT02199769|Clinical decision support|clinical decision support
4875606|NCT02199769|Diabetes screening|diabetes screening
4875607|NCT02199756|Uterine contractions|uterine contractions
4875608|NCT02199756|Indomethacin|indomethacin
4875609|NCT02199756|Nanovectors|nanovectors
4875610|NCT02199743|schizophrenia|schizophrenia
4875611|NCT02199743|schizoaffective|schizoaffective
4875612|NCT02199743|cognition|cognition
4875613|NCT02199743|lurasidone|lurasidone
4875614|NCT02199743|Latuda|latuda
4875615|NCT02199717|Physical Activity|physical activity
4875616|NCT02199717|Accelerometer|accelerometer
4875617|NCT02199717|Exercise|exercise
4875618|NCT02199717|Obesity|obesity
4875619|NCT02199717|BMI|bmi
4875620|NCT02199704|Parenting|parenting
4875621|NCT02199704|Psychosis|psychosis
4875622|NCT02199704|Schizophrenia|schizophrenia
4875623|NCT02199704|Delusions|delusions
4875624|NCT02199704|Hallucinations|hallucinations
4875625|NCT02199691|Meningitis|meningitis
4875626|NCT02199691|Meningococcal Meningitis|meningococcal meningitis
4875627|NCT02199691|MenACYW conjugate vaccine|menacyw conjugate vaccine
4875628|NCT02199691|MENVEO vaccine|menveo vaccine
4875629|NCT02199691|Adacel®|adacel®
4875630|NCT02199691|GARDASIL®|gardasil®
4875631|NCT02199639|Haemophilia|haemophilia
4875632|NCT02199639|Arthropathy|arthropathy
4875633|NCT02199639|Range of Movement|range of movement
4875634|NCT02199639|Strength|strength
4875635|NCT02199639|Proprioception|proprioception
4875636|NCT02199639|Gait|gait
4875637|NCT02199639|Quality of Life|quality of life
4875638|NCT02199613|HIV|hiv
4875639|NCT02199613|antiretroviral therapy|antiretroviral therapy
4875640|NCT02199587|Medical clown|medical clown
4875641|NCT02199587|Growth hormone|growth hormone
4875642|NCT02199587|Precocious puberty|precocious puberty
4875643|NCT02199548|Adolescent|adolescent
4875644|NCT02199548|Decision-making|decision-making
4875645|NCT02199548|Social network|social network
4875646|NCT02199535|operating room,|operating room,
4875647|NCT02199535|risk factors|risk factors
4875648|NCT02199535|anesthesiologists|anesthesiologists
4875649|NCT02199509|Levetiracetam|levetiracetam
4875650|NCT02199509|Cranial Dystonia|cranial dystonia
4875651|NCT02199509|Oromandibular Dystonia|oromandibular dystonia
4875652|NCT02199496|Malabsorption|malabsorption
4875653|NCT02199496|Enteropathy|enteropathy
4875654|NCT02199496|Diarrhea|diarrhea
4875655|NCT02199496|IL-23|il-23
4875656|NCT02199496|IL-12|il-12
4875657|NCT02199483|Energy Expenditure|energy expenditure
4875658|NCT02199483|Behavioral Weight Loss Treatment|behavioral weight loss treatment
4875659|NCT02199483|Neurocognitive Function|neurocognitive function
4875660|NCT02199483|Weight Loss|weight loss
4875661|NCT02199470|β-CELLS,|β-cells,
4875662|NCT02199470|MIXED MEAL TEST,|mixed meal test,
4875663|NCT02199470|C-PEPTİDE|c-peptide
4875664|NCT02199431|Lu AF11167|lu af11167
4875665|NCT02199431|Interaction|interaction
4875666|NCT02199405|Spondylosis, Massage Therapy, Exercise Therapy ,Treatment Efficacy|spondylosis, massage therapy, exercise therapy ,treatment efficacy
4875667|NCT02199392|P-glycoprotein|p-glycoprotein
4875668|NCT02199392|Healthy Volunteers|healthy volunteers
4875669|NCT02199379|renal impairment|renal impairment
4875670|NCT02199379|disease severity|disease severity
4875671|NCT02199366|Cardiac MRI|cardiac mri
4875672|NCT02199366|Radiation|radiation
4875673|NCT02199366|Proton Radiation|proton radiation
4875674|NCT02199366|Breast Cancer|breast cancer
4875675|NCT02199353|Activities of daily living, Occupational Therapy, Dementia|activities of daily living, occupational therapy, dementia
4875676|NCT02199340|Exercise testing|exercise testing
4875677|NCT02199340|Children|children
4875678|NCT02199340|Exercise capacity|exercise capacity
4875679|NCT02199327|Conjunctival-corneal intraepithelial neoplasia|conjunctival-corneal intraepithelial neoplasia
4875680|NCT02199327|Mitomycin C|mitomycin c
4875681|NCT02199327|Interferon alfa 2b|interferon alfa 2b
4875682|NCT02199314|intra|intra
4875683|NCT02199314|operative|operative
4875684|NCT02199314|neurophysiologic|neurophysiologic
4875685|NCT02199314|monitoring|monitoring
4875686|NCT02199314|transcranial|transcranial
4875687|NCT02199314|motor|motor
4875688|NCT02199314|evoked|evoked
4875689|NCT02199314|potential|potential
4875690|NCT02199314|anesthesia|anesthesia
4875691|NCT02199314|pulses|pulses
4875692|NCT02199301|Kidney transplantation|kidney transplantation
4875693|NCT02199301|Tolerance induction|tolerance induction
4875694|NCT02199301|Immunosuppression withdrawal|immunosuppression withdrawal
4875695|NCT02199301|Bone marrow transplantation|bone marrow transplantation
4875696|NCT02199301|Transplantation conditioning|transplantation conditioning
4875697|NCT02199301|Hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
4875698|NCT02199301|Living donor|living donor
4875699|NCT02199301|Haplotype|haplotype
4875700|NCT02199301|Immune tolerance|immune tolerance
4875701|NCT02199275|Non-urgent surgery|non-urgent surgery
4875702|NCT02199275|General anesthesia|general anesthesia
4875703|NCT02199275|Enterocyte damage|enterocyte damage
4875704|NCT02199275|Intestinal fatty acid-binding protein|intestinal fatty acid-binding protein
4875705|NCT02199262|Intensive care unit|intensive care unit
4875706|NCT02199262|Incidents|incidents
4875707|NCT02199262|prevention|prevention
4875708|NCT02199262|music|music
4875709|NCT02199262|reflexology|reflexology
4875710|NCT02199249|open anatomic reduction|open anatomic reduction
4875711|NCT02199249|syndesmosis screw fixation, syndesmosis Tightrope fixation|syndesmosis screw fixation, syndesmosis tightrope fixation
4875712|NCT02199236|High-Dose-Rate Brachytherapy|high-dose-rate brachytherapy
4875713|NCT02199236|oral capecitabine|oral capecitabine
4875714|NCT02199236|infusional 5-FU|infusional 5-fu
4875715|NCT02199236|Questionnaires|questionnaires
4875716|NCT02199236|14-104|14-104
4875717|NCT02199210|Massive transfusion protocols|massive transfusion protocols
4875718|NCT02199210|Self-regulatory learning|self-regulatory learning
4875719|NCT02199210|Forethought|forethought
4875720|NCT02199210|Clinical expertise|clinical expertise
4875721|NCT02199210|Simulation|simulation
4875722|NCT02199210|Education|education
4875723|NCT02199184|Leukemia|leukemia
4875724|NCT02199184|Burkitt leukemia|burkitt leukemia
4875725|NCT02199184|Burkitt-like leukemia/lymphoma|burkitt-like leukemia/lymphoma
4875726|NCT02199184|Newly diagnosed|newly diagnosed
4875727|NCT02199184|Relapsed/refractory|relapsed/refractory
4875728|NCT02199184|Ofatumumab|ofatumumab
4875729|NCT02199184|Arzerra|arzerra
4875730|NCT02199184|Etoposide|etoposide
4875731|NCT02199184|VePesid|vepesid
4875732|NCT02199184|Doxorubicin|doxorubicin
4875733|NCT02199184|Doxorubicin Hydrochloride|doxorubicin hydrochloride
4875734|NCT02199184|Adriamycin PFS|adriamycin pfs
4875735|NCT02199184|Adriamycin RDF|adriamycin rdf
4875736|NCT02199184|Adriamycin|adriamycin
4875737|NCT02199184|Rubex|rubex
4875738|NCT02199184|Vincristine|vincristine
4875739|NCT02199184|Cyclophosphamide|cyclophosphamide
4875740|NCT02199184|Cytoxan|cytoxan
4875741|NCT02199184|Neosar|neosar
4875742|NCT02199184|Prednisone|prednisone
4875743|NCT02199184|Rituximab|rituximab
4875744|NCT02199184|Rituxan|rituxan
4875745|NCT02199184|DA-EPOCH|da-epoch
4875746|NCT02199184|Pegfilgrastim|pegfilgrastim
4875747|NCT02199184|Neulasta|neulasta
4875748|NCT02199184|PEG-G-CSF|peg-g-csf
4875749|NCT02199184|G-CSF|g-csf
4875750|NCT02199184|Filgrastim|filgrastim
4875751|NCT02199184|Neupogen|neupogen
4875752|NCT02199184|Phone calls|phone calls
4875753|NCT02199171|hyperthermic intraoperative intraperitoneal chemotherapy (HIPEC) carboplatin|hyperthermic intraoperative intraperitoneal chemotherapy (hipec) carboplatin
4875754|NCT02199171|intraperitoneal (IP) chemotherapy|intraperitoneal (ip) chemotherapy
4875755|NCT02199171|cytoreductive surgery|cytoreductive surgery
4875756|NCT02199158|iridoplasty|iridoplasty
4875757|NCT02199158|angle|angle
4875758|NCT02199158|glaucoma|glaucoma
4875759|NCT02199158|anterior chamber|anterior chamber
4875760|NCT02199158|laser treatment|laser treatment
4875761|NCT02199132|Nasopharyngeal Carcinoma|nasopharyngeal carcinoma
4875762|NCT02199119|children|children
4875763|NCT02199119|television|television
4875764|NCT02199119|exercise|exercise
4875765|NCT02199119|food intake|food intake
4875766|NCT02199119|appetite|appetite
4875767|NCT02199119|satiation|satiation
4875768|NCT02199093|MeSH terms:|mesh terms:
4875769|NCT02199093|Apraxias|apraxias
4875770|NCT02199093|Apraxia, Ideomotor|apraxia, ideomotor
4875771|NCT02199093|Stroke|stroke
4875772|NCT02199093|Cerebral Stroke|cerebral stroke
4875773|NCT02199093|Rehabilitation|rehabilitation
4875774|NCT02199093|Occupational therapy|occupational therapy
4875775|NCT02199093|Treatment Outcome|treatment outcome
4875776|NCT02199093|Activities of Daily Living|activities of daily living
4875777|NCT02199054|Snack Foods|snack foods
4875778|NCT02199054|Safflower Oil|safflower oil
4875779|NCT02199054|Soy|soy
4875780|NCT02199054|Postmenopausal women|postmenopausal women
4875781|NCT02199054|Metabolic Syndrome|metabolic syndrome
4875782|NCT02199041|Cord Blood|cord blood
4875783|NCT02199041|Haploidentical|haploidentical
4875784|NCT02199041|Reduced Intensity Regimen|reduced intensity regimen
4875785|NCT02199028|hyaluronidase|hyaluronidase
4875786|NCT02199028|infusion sets|infusion sets
4875787|NCT02199028|insulin pump|insulin pump
4875788|NCT02199028|Continuous glucose monitor|continuous glucose monitor
4875789|NCT02199015|Dysarthria|dysarthria
4875790|NCT02199015|Electrical Stimulation|electrical stimulation
4875791|NCT02199015|Lateral Cord Stimulation|lateral cord stimulation
4875792|NCT02199015|Spasticity|spasticity
4875793|NCT02199015|Treatment|treatment
4875794|NCT02199002|acid pocket|acid pocket
4875795|NCT02199002|GERD|gerd
4875796|NCT02199002|Barrett|barrett
4875797|NCT02198963|Skin irritation potential of RUT058-60.|skin irritation potential of rut058-60.
4875798|NCT02198950|sepsis|sepsis
4875799|NCT02198950|diagnosis|diagnosis
4875800|NCT02198950|biomarker|biomarker
4875801|NCT02198937|smokers|smokers
4875802|NCT02198937|non-smokers|non-smokers
4875803|NCT02198924|sequential administration|sequential administration
4875804|NCT02198924|pain control|pain control
4875805|NCT02198924|inflammation control|inflammation control
4875806|NCT02198924|function recovery|function recovery
4875807|NCT02198911|Habituation|habituation
4875808|NCT02198911|Orosensory cues|orosensory cues
4875809|NCT02198911|Satiation|satiation
4875810|NCT02198885|FAST|fast
4875811|NCT02198885|Thoracoabdominal Trauma|thoracoabdominal trauma
4875812|NCT02198885|Prehospital care|prehospital care
4875813|NCT02198885|ultrasound|ultrasound
4875814|NCT02198885|NanoMaxx Ultrasound|nanomaxx ultrasound
4875815|NCT02198885|RP-Xpress|rp-xpress
4875816|NCT02198872|Autonomic Nervous System, Body composition, Oxygen Uptake,|autonomic nervous system, body composition, oxygen uptake,
4875817|NCT02198872|Water Based Physical Training, Land Based Physical Training.|water based physical training, land based physical training.
4875818|NCT02198859|Prostate Cancer|prostate cancer
4875819|NCT02198859|Lithium|lithium
4875820|NCT02198859|Androgen|androgen
4875821|NCT02198859|PSA|psa
4875822|NCT02198833|Urinary Tract Infection|urinary tract infection
4875823|NCT02198833|Bacteriuria|bacteriuria
4875824|NCT02198833|Transurethral Foley Catheter|transurethral foley catheter
4875825|NCT02198833|Suprapubic Foley Catheter|suprapubic foley catheter
4875826|NCT02198833|Spinal Cord injury|spinal cord injury
4875827|NCT02198820|Femoral Neck Fractures|femoral neck fractures
4875828|NCT02198820|Perioperative Care|perioperative care
4875829|NCT02198820|Perioperative Period|perioperative period
4875830|NCT02198820|Postoperative Complications|postoperative complications
4875831|NCT02198794|Dyskinesias|dyskinesias
4875832|NCT02198794|Movement Disorders|movement disorders
4875833|NCT02198794|Central Nervous System Diseases|central nervous system diseases
4875834|NCT02198794|Nervous System Diseases|nervous system diseases
4875835|NCT02198794|Neurologic Manifestations|neurologic manifestations
4875836|NCT02198794|Signs and Symptoms|signs and symptoms
4875837|NCT02198781|atrial fibrilation|atrial fibrilation
4875838|NCT02198781|atrial-ventricula|atrial-ventricula
4875839|NCT02198781|right ventricle|right ventricle
4875840|NCT02198781|left ventricle|left ventricle
4875841|NCT02198781|surrogate marker|surrogate marker
4875842|NCT02198781|ventricular dysfunction|ventricular dysfunction
4875843|NCT02198781|pacing|pacing
4875844|NCT02198768|ankle fracture|ankle fracture
4875845|NCT02198768|ankle fracture-dislocation|ankle fracture-dislocation
4875846|NCT02198768|prospective|prospective
4875847|NCT02198768|observational|observational
4875848|NCT02198755|high resolution ultrasound|high resolution ultrasound
4875849|NCT02198755|osteomyelitis|osteomyelitis
4875850|NCT02198716|Percutaneous coronary intervention|percutaneous coronary intervention
4875851|NCT02198716|Elderly|elderly
4875852|NCT02198716|Angina|angina
4875853|NCT02198703|Probiotics|probiotics
4875854|NCT02198703|AB-Life|ab-life
4875855|NCT02198703|LDL-cholesterol|ldl-cholesterol
4875856|NCT02198703|Hypercholesterolemia|hypercholesterolemia
4875857|NCT02198690|Mammography, Older women, decision making|mammography, older women, decision making
4875858|NCT02198664|Characterized Peanut Allergen|characterized peanut allergen
4875859|NCT02198664|Peanut|peanut
4875861|NCT02198664|Oral Desensitization|oral desensitization
4875862|NCT02198664|Peanut Allergen|peanut allergen
4875863|NCT02198664|Peanut-Allergic Children|peanut-allergic children
4875864|NCT02198664|Children|children
4875865|NCT02198664|Peanut-Allergic Adults|peanut-allergic adults
4875866|NCT02198651|Rheumatoid Arthritis|rheumatoid arthritis
4875867|NCT02198651|Adalimumab|adalimumab
4875868|NCT02198651|Taper|taper
4875869|NCT02198651|Flare|flare
4875870|NCT02198651|Arthritis|arthritis
4875871|NCT02198651|Anti-rheumatic drugs|anti-rheumatic drugs
4875872|NCT02198651|Remission|remission
4875873|NCT02198651|Magnetic Resonance Imaging|magnetic resonance imaging
4875874|NCT02198651|Ultrasound|ultrasound
4875875|NCT02198651|Biomarker|biomarker
4875876|NCT02198651|Drug Level|drug level
4875877|NCT02198651|Reduced dose|reduced dose
4875878|NCT02198638|Influenza|influenza
4875879|NCT02198638|Vaccination rate|vaccination rate
4875880|NCT02198638|Hospital acquired infection|hospital acquired infection
4875881|NCT02198625|Moderate FiO2|moderate fio2
4875882|NCT02198625|Protective lung ventilation|protective lung ventilation
4875883|NCT02198625|Postoperative pulmonary complications|postoperative pulmonary complications
4875884|NCT02198625|Positive end-expiratory pressure|positive end-expiratory pressure
4875885|NCT02198625|recruitment maneuvers|recruitment maneuvers
4875886|NCT02198599|Multiple sclerosis|multiple sclerosis
4875887|NCT02198599|Stroke|stroke
4875888|NCT02198599|Nursing|nursing
4875889|NCT02198599|Mobility|mobility
4875890|NCT02198599|Rehabilitation|rehabilitation
4875891|NCT02198586|Alzheimer's, MRI, APOE|alzheimer's, mri, apoe
4875892|NCT02198573|malaria|malaria
4875893|NCT02198573|K13|k13
4875894|NCT02198573|pfmrp1|pfmrp1
4875895|NCT02198573|Myanmar|myanmar
4875896|NCT02198560|Normal (Eyes without pathologies)|normal (eyes without pathologies)
4875897|NCT02198547|Local anesthetic adjuvant,|local anesthetic adjuvant,
4875898|NCT02198547|Magnesium solfatus,|magnesium solfatus,
4875899|NCT02198547|Sciatic block|sciatic block
4875900|NCT02198534|visual acuity|visual acuity
4875901|NCT02198534|Landolt C|landolt c
4875902|NCT02198534|ETDRS charts|etdrs charts
4875903|NCT02198534|Freiburg Visual Acuity Test|freiburg visual acuity test
4875904|NCT02198534|FrACT|fract
4875905|NCT02198534|Comparison|comparison
4875906|NCT02198534|acceptance|acceptance
4875907|NCT02198534|Test retest reliability|test retest reliability
4875908|NCT02198534|duration|duration
4875909|NCT02198534|questionnaire|questionnaire
4875910|NCT02198521|Patients undergoing staged bilateral open Carpal Tunnel Release (CTR) have no difference in overall pain intensity of pain between sides.|patients undergoing staged bilateral open carpal tunnel release (ctr) have no difference in overall pain intensity of pain between sides.
4875911|NCT02198482|Acute Myeloid Leukemia (AML)|acute myeloid leukemia (aml)
4875912|NCT02198482|Volasertib|volasertib
4875913|NCT02198482|High-risk Myelodysplastic Syndrome (MDS)|high-risk myelodysplastic syndrome (mds)
4875914|NCT02198469|actinic cheilitis|actinic cheilitis
4875915|NCT02198469|Er:YAG ablative fractional laser|er:yag ablative fractional laser
4875916|NCT02198469|methyl aminolevulinate photodynamic therapy|methyl aminolevulinate photodynamic therapy
4875917|NCT02198456|pulmonary arterial hypertension|pulmonary arterial hypertension
4875918|NCT02198430|Haemophilia|haemophilia
4875919|NCT02198430|Arthropathy|arthropathy
4875920|NCT02198430|Range of motion|range of motion
4875921|NCT02198430|Strength|strength
4875922|NCT02198430|Proprioception|proprioception
4875923|NCT02198430|Gait|gait
4875924|NCT02198430|Quality of Life.|quality of life.
4875925|NCT02198417|Polycystic Ovary Syndrome|polycystic ovary syndrome
4875926|NCT02198417|PCOS|pcos
4875927|NCT02198417|Acne|acne
4875928|NCT02198417|Infertility|infertility
4875929|NCT02198417|Irregular menses|irregular menses
4875930|NCT02198417|Irregular period|irregular period
4875931|NCT02198417|Mitochondria|mitochondria
4875932|NCT02198417|Metabolism|metabolism
4875933|NCT02198378|premixed nitrous oxide and oxygen|premixed nitrous oxide and oxygen
4875934|NCT02198378|pain|pain
4875935|NCT02198378|prehospital setting|prehospital setting
4875936|NCT02198378|acute coronary syndrome|acute coronary syndrome
4875937|NCT02198365|mRNA,|mrna,
4875938|NCT02198365|DNA,|dna,
4875939|NCT02198365|integrated HPV DNA|integrated hpv dna
4875940|NCT02198365|human papillomavirus,|human papillomavirus,
4875941|NCT02198365|cervical neoplasia|cervical neoplasia
4875942|NCT02198300|dedicated bifurcation stent|dedicated bifurcation stent
4875943|NCT02198300|sirolimus eluting stent|sirolimus eluting stent
4875944|NCT02198261|alopecia|alopecia
4875945|NCT02198261|androgenetic alopecia|androgenetic alopecia
4875946|NCT02198261|hair loss|hair loss
4875947|NCT02198261|minoxidil|minoxidil
4875948|NCT02198261|5% minoxidil foam|5% minoxidil foam
4875949|NCT02198261|male pattern hair loss|male pattern hair loss
4875950|NCT02198209|liraglutide|liraglutide
4875951|NCT02198209|GLP-1|glp-1
4875952|NCT02198209|liver glucokinase|liver glucokinase
4875953|NCT02198170|Healthy Volunteers|healthy volunteers
4875954|NCT02198157|duration of second stage|duration of second stage
4875955|NCT02198157|urinary catheterization|urinary catheterization
4875956|NCT02198157|epidural anaesthesia|epidural anaesthesia
4875957|NCT02198144|Hypertension|hypertension
4875958|NCT02198144|High Blood Pressure|high blood pressure
4875959|NCT02198144|African American Men|african american men
4875960|NCT02198144|Black Men|black men
4875961|NCT02198118|breast cancer|breast cancer
4875962|NCT02198118|physiotherapy|physiotherapy
4875963|NCT02198118|radiotherapy|radiotherapy
4875964|NCT02198105|PAD|pad
4875965|NCT02198105|femoropoliteal stenosis/occlusion|femoropoliteal stenosis/occlusion
4875966|NCT02198105|cutting-balloon|cutting-balloon
4875967|NCT02198105|drug-coated-balloon|drug-coated-balloon
4875968|NCT02198092|familial adenomatous polyposis|familial adenomatous polyposis
4875969|NCT02198092|multiple adenomatous polyposis|multiple adenomatous polyposis
4875970|NCT02198092|lynch syndrome|lynch syndrome
4875971|NCT02198092|hnpcc|hnpcc
4875972|NCT02198092|colorectal cancer|colorectal cancer
4875973|NCT02198092|genetic syndrome|genetic syndrome
4875974|NCT02198092|epigenomics|epigenomics
4875975|NCT02198092|septin9|septin9
4875976|NCT02198079|non-tuberculous mycobacteria|non-tuberculous mycobacteria
4875977|NCT02198079|Pediatrics|pediatrics
4875978|NCT02198079|Cystic Fibrosis|cystic fibrosis
4875979|NCT02198066|Sternotomy incision|sternotomy incision
4875980|NCT02198066|Silver dressing|silver dressing
4875981|NCT02198066|Sternal wound infection|sternal wound infection
4875982|NCT02198040|Elbow|elbow
4875983|NCT02198040|Joint disease|joint disease
4875984|NCT02198040|Hemophilia|hemophilia
4875985|NCT02198040|Physiotherapy modalities|physiotherapy modalities
4875986|NCT02198027|Percutaneous nephrolithotomy|percutaneous nephrolithotomy
4875987|NCT02198027|postoperative analgesia|postoperative analgesia
4875988|NCT02198027|peritubal block|peritubal block
4875989|NCT02198027|pain|pain
4875990|NCT02198027|Visual Analog Pain Scale|visual analog pain scale
4875991|NCT02198014|Knee|knee
4875992|NCT02198014|Joint disease|joint disease
4875993|NCT02198014|Haemophilia|haemophilia
4875994|NCT02198014|Physiotherapy modalities|physiotherapy modalities
4875995|NCT02198001|Platelets|platelets
4875996|NCT02198001|fibrin|fibrin
4875997|NCT02198001|growth factors|growth factors
4875998|NCT02198001|bisphosphonates|bisphosphonates
4875999|NCT02198001|tooth extraction|tooth extraction
4876000|NCT02197988|Surgery|surgery
4876001|NCT02197988|Abdominal|abdominal
4876002|NCT02197988|Epidural Anesthesia|epidural anesthesia
4876003|NCT02197988|Transversus Abdominis Plane Block|transversus abdominis plane block
4876004|NCT02197988|TAP block|tap block
4876005|NCT02197975|Healthy Volunteers|healthy volunteers
4876006|NCT02197962|Osteoarthritis|osteoarthritis
4876007|NCT02197962|Radial shockwaves|radial shockwaves
4876008|NCT02197936|Peristalsis|peristalsis
4876009|NCT02197936|ultrasound|ultrasound
4876010|NCT02197923|Menorrhagia|menorrhagia
4876011|NCT02197923|Dysmenorrhea|dysmenorrhea
4876012|NCT02197923|Pelvic pain|pelvic pain
4876013|NCT02197923|expression profiling|expression profiling
4876014|NCT02197923|uterine biopsies|uterine biopsies
4876015|NCT02197923|serum hormones|serum hormones
4876016|NCT02197897|Tamoxifen citrate|tamoxifen citrate
4876017|NCT02197897|Bladder Cancer|bladder cancer
4876018|NCT02197884|Healthy|healthy
4876019|NCT02197884|JNJ-54861911|jnj-54861911
4876020|NCT02197884|Cytochrome P450 3A4 inhibitor|cytochrome p450 3a4 inhibitor
4876021|NCT02197884|Itraconazole|itraconazole
4876022|NCT02197884|Clarithromycin|clarithromycin
4876023|NCT02197884|Alzheimer's disease|alzheimer's disease
4876024|NCT02197871|COPD|copd
4876025|NCT02197871|malnutrition|malnutrition
4876026|NCT02197871|nutrition supplementation|nutrition supplementation
4876027|NCT02197858|invasive arterial pressure|invasive arterial pressure
4876028|NCT02197858|extended hemodynamic monitoring|extended hemodynamic monitoring
4876029|NCT02197858|propofol|propofol
4876030|NCT02197858|remifentanil|remifentanil
4876031|NCT02197845|sickle cell disease|sickle cell disease
4876032|NCT02197845|hydroxyurea|hydroxyurea
4876033|NCT02197845|patient navigator|patient navigator
4876034|NCT02197845|community health worker|community health worker
4876035|NCT02197845|public health worker|public health worker
4876036|NCT02197845|fetal hemoglobin|fetal hemoglobin
4876037|NCT02197845|health services research|health services research
4876038|NCT02197832|Frozen thawed embryo transfer|frozen thawed embryo transfer
4876039|NCT02197832|Endometrial injury|endometrial injury
4876040|NCT02197832|Ongoing pregnancy rates|ongoing pregnancy rates
4876041|NCT02197780|Diagnostic accuracy|diagnostic accuracy
4876042|NCT02197780|Fecal biomarker|fecal biomarker
4876043|NCT02197780|Clinical Decision Rule|clinical decision rule
4876044|NCT02197780|Cohort Study|cohort study
4876045|NCT02197767|fibrillary GN|fibrillary gn
4876046|NCT02197767|rituximab|rituximab
4876047|NCT02197767|Rituxan|rituxan
4876048|NCT02197767|MabThera|mabthera
4876049|NCT02197767|Zytux|zytux
4876050|NCT02197754|pharmacokinetics|pharmacokinetics
4876051|NCT02197754|polyphenol metabolites|polyphenol metabolites
4876052|NCT02197754|lean individuals|lean individuals
4876053|NCT02197754|obese individuals|obese individuals
4876054|NCT02197728|hysterectomy, uterine manipulator, thermal damage, laparoscopy, colpotomy|hysterectomy, uterine manipulator, thermal damage, laparoscopy, colpotomy
4876055|NCT02197715|Pregnancy|pregnancy
4876056|NCT02197715|Contraceptive Methods|contraceptive methods
4876057|NCT02197715|Family Planning Services|family planning services
4876058|NCT02197702|RCT|rct
4876059|NCT02197702|asthma|asthma
4876060|NCT02197702|pediatric|pediatric
4876061|NCT02197702|virus|virus
4876062|NCT02197702|corticosteroid|corticosteroid
4876063|NCT02197689|Personalized Medication Management|personalized medication management
4876064|NCT02197689|Medication Adherence|medication adherence
4876065|NCT02197689|SMS Medication Reminder|sms medication reminder
4876066|NCT02197663|acupuncture|acupuncture
4876067|NCT02197663|stroke|stroke
4876068|NCT02197663|Randomized Controlled Trial|randomized controlled trial
4876069|NCT02197650|ALL L-asparaginase encapsulated erythrocytes|all l-asparaginase encapsulated erythrocytes
4876070|NCT02197624|Non-heme iron absorption; HFE|non-heme iron absorption; hfe
4876071|NCT02197611|Haemophilia|haemophilia
4876072|NCT02197611|Adherence of Treatment|adherence of treatment
4876073|NCT02197611|Knowledge of Illness|knowledge of illness
4876074|NCT02197611|Medical-patient Relationship|medical-patient relationship
4876075|NCT02197611|Illness Behavior|illness behavior
4876076|NCT02197611|Treatment Difficulties.|treatment difficulties.
4876077|NCT02197598|nalmefene, alcohol consumption, liver effects|nalmefene, alcohol consumption, liver effects
4876078|NCT02197585|Male patients|male patients
4876079|NCT02197585|Age > 18 year|age > 18 year
4876080|NCT02197585|Primary hernia|primary hernia
4876081|NCT02197585|glue|glue
4876082|NCT02197572|Drug therapy|drug therapy
4876083|NCT02197559|Ischemic Stroke, restenosis,bare-metal stents, drug -eluting stents|ischemic stroke, restenosis,bare-metal stents, drug -eluting stents
4876084|NCT02197546|Injection pain|injection pain
4876085|NCT02197546|local anesthesia|local anesthesia
4876086|NCT02197546|acupuncture|acupuncture
4876087|NCT02197481|BiClamp forceps hepatectomy|biclamp forceps hepatectomy
4876088|NCT02197481|Clamp crushing technique|clamp crushing technique
4876089|NCT02197481|Liver parenchyma transection|liver parenchyma transection
4876090|NCT02197481|Randomized controlled trial|randomized controlled trial
4876091|NCT02197468|Gut microbiome|gut microbiome
4876092|NCT02197468|Necrotizing enterocolitis|necrotizing enterocolitis
4876093|NCT02197468|Antibiotics|antibiotics
4876094|NCT02197429|Vulvodynia|vulvodynia
4876095|NCT02197429|Acupuncture|acupuncture
4876096|NCT02197429|Provoked Vestibulodynia|provoked vestibulodynia
4876097|NCT02197429|Vulvar Vestibulitis|vulvar vestibulitis
4876098|NCT02197429|Vulvar Pain|vulvar pain
4876099|NCT02197429|Dyspareunia|dyspareunia
4876100|NCT02197429|Female Sexual Function|female sexual function
4876101|NCT02197403|Dexmedetomidine|dexmedetomidine
4876102|NCT02197403|Sedation|sedation
4876103|NCT02197403|Paradoxical excitement response|paradoxical excitement response
4876104|NCT02197403|Alcohol drinkers|alcohol drinkers
4876105|NCT02197390|Childhood obesity|childhood obesity
4876106|NCT02197390|Latino|latino
4876107|NCT02197390|Hispanic|hispanic
4876108|NCT02197377|Laryngeal mask airway, edentulous geriatric patient|laryngeal mask airway, edentulous geriatric patient
4876109|NCT02197364|Interstitial Lung Disease|interstitial lung disease
4876110|NCT02197364|Diagnosis|diagnosis
4876111|NCT02197364|Krebs Von Den Lungen-6|krebs von den lungen-6
4876112|NCT02197351|stomach neoplasms|stomach neoplasms
4876113|NCT02197351|narrow band imaging|narrow band imaging
4876114|NCT02197351|gastroscopy|gastroscopy
4876115|NCT02197338|cholangiopancreatography, endoscopic retrograde|cholangiopancreatography, endoscopic retrograde
4876116|NCT02197325|NSTEMI and STEMI|nstemi and stemi
4876117|NCT02197312|yttrium-oxide|yttrium-oxide
4876118|NCT02197312|Y-TZP|y-tzp
4876119|NCT02197312|bridge|bridge
4876120|NCT02197312|NobelProcera|nobelprocera
4876121|NCT02197312|Shaded Zirconia|shaded zirconia
4876122|NCT02197273|Total knee arthroplasty|total knee arthroplasty
4876123|NCT02197273|Total shoulder arthroplasty|total shoulder arthroplasty
4876124|NCT02197273|Total hip arthroplasty|total hip arthroplasty
4876125|NCT02197273|Total joint arthroplasty|total joint arthroplasty
4876126|NCT02197273|Hip replacement|hip replacement
4876127|NCT02197273|Knee replacement|knee replacement
4876128|NCT02197273|Shoulder replacement|shoulder replacement
4876129|NCT02197260|Periodontitis|periodontitis
4876130|NCT02197260|amoxicillin|amoxicillin
4876131|NCT02197260|metronidazole|metronidazole
4876132|NCT02197260|case management|case management
4876133|NCT02197247|oncology, cancer, non small cell lung cancer, anticancer drug, pharmacokinetics, AZD9291, rifampicin, CYP P450 inducer, EGFR genes|oncology, cancer, non small cell lung cancer, anticancer drug, pharmacokinetics, azd9291, rifampicin, cyp p450 inducer, egfr genes
4876134|NCT02197234|oncology, cancer, non small cell lung cancer, anticancer drug, pharmacokinetics, AZD9291, simvastatin, EGFR genes|oncology, cancer, non small cell lung cancer, anticancer drug, pharmacokinetics, azd9291, simvastatin, egfr genes
4876135|NCT02197208|Frozen-thawed embryo transfer|frozen-thawed embryo transfer
4876136|NCT02197208|natural cycle|natural cycle
4876137|NCT02197208|spontaneous ovulation|spontaneous ovulation
4876138|NCT02197208|hCG induced natural cycles|hcg induced natural cycles
4876139|NCT02197182|Bacterial Vaginosis (BV)|bacterial vaginosis (bv)
4876140|NCT02197182|Amsel's criteria|amsel's criteria
4876141|NCT02197182|Pap smear|pap smear
4876142|NCT02197169|Brain|brain
4876143|NCT02197169|Brain Cancer|brain cancer
4876144|NCT02197169|Brain Neoplasms|brain neoplasms
4876145|NCT02197169|Central Nervous System Diseases|central nervous system diseases
4876146|NCT02197169|Central Nervous System Neoplasms|central nervous system neoplasms
4876147|NCT02197169|CNS|cns
4876148|NCT02197169|Conditionally Replication-Competent Adenovirus|conditionally replication-competent adenovirus
4876149|NCT02197169|DNX-2401|dnx-2401
4876150|NCT02197169|Delta-24-RGD|delta-24-rgd
4876151|NCT02197169|Glioma|glioma
4876152|NCT02197169|Glioblastoma|glioblastoma
4876153|NCT02197169|Gliosarcoma|gliosarcoma
4876154|NCT02197169|Interferon gamma|interferon gamma
4876155|NCT02197169|Malignant brain tumor|malignant brain tumor
4876156|NCT02197169|Neoplasms, Neuroepithelial|neoplasms, neuroepithelial
4876157|NCT02197169|Neuroectodermal Tumors|neuroectodermal tumors
4876158|NCT02197169|Neoplasms, Germ Cell and Embryonal|neoplasms, germ cell and embryonal
4876159|NCT02197169|Neoplasms by Histologic Type|neoplasms by histologic type
4876160|NCT02197169|Neoplasms, Glandular and Epithelial|neoplasms, glandular and epithelial
4876161|NCT02197169|Neoplasms, Nerve Tissue|neoplasms, nerve tissue
4876162|NCT02197169|Nervous System Diseases|nervous system diseases
4876163|NCT02197169|Alcyone Lifesciences|alcyone lifesciences
4876164|NCT02197169|AMC™|amc™
4876165|NCT02197169|Cannula|cannula
4876166|NCT02197169|Alcyone MEMS Cannula (AMC™) System|alcyone mems cannula (amc™) system
4876167|NCT02197143|esomeprazole|esomeprazole
4876168|NCT02197143|ranitidine|ranitidine
4876169|NCT02197143|hydrotalcid|hydrotalcid
4876170|NCT02197143|treatment of dyspepsia|treatment of dyspepsia
4876171|NCT02197143|emergancy medicine|emergancy medicine
4876172|NCT02197130|Huntington; chorea; total motor score; CAG repeat: total functional capacity; motor cognitive and behavioral symptoms|huntington; chorea; total motor score; cag repeat: total functional capacity; motor cognitive and behavioral symptoms
4876173|NCT02197117|ST-segment elevation myocardial infarction (STEMI); thrombolysis, remote ischemic conditioning, myocardial infarct size, cardioprotection|st-segment elevation myocardial infarction (stemi); thrombolysis, remote ischemic conditioning, myocardial infarct size, cardioprotection
4876174|NCT02197065|hip fracture|hip fracture
4876175|NCT02197065|myocardial ischemia|myocardial ischemia
4876176|NCT02197065|statin|statin
4876177|NCT02197065|surgery|surgery
4876178|NCT02197065|troponin|troponin
4876179|NCT02197065|complication|complication
4876180|NCT02197065|arthroplasty|arthroplasty
4876181|NCT02197065|hip|hip
4876182|NCT02197065|knee|knee
4876183|NCT02197065|orthopedic|orthopedic
4876184|NCT02197065|atorvastatin|atorvastatin
4876185|NCT02197065|cardiovascular|cardiovascular
4876186|NCT02197039|Peptic ulcer hemorrhage, second-look endoscopy|peptic ulcer hemorrhage, second-look endoscopy
4876187|NCT02197000|BRCA mutation|brca mutation
4876188|NCT02197000|Breast cancer|breast cancer
4876189|NCT02197000|Estrogen metabolism|estrogen metabolism
4876190|NCT02197000|3,3-Diindolylmethane|3,3-diindolylmethane
4876191|NCT02197000|Breast density|breast density
4876192|NCT02196987|Pain|pain
4876193|NCT02196987|Catheter|catheter
4876194|NCT02196987|Urethra|urethra
4876195|NCT02196987|Urination|urination
4876196|NCT02196974|bronchoscopy|bronchoscopy
4876197|NCT02196974|lung nodule|lung nodule
4876198|NCT02196974|diagnosis|diagnosis
4876199|NCT02196974|cryobiopsy|cryobiopsy
4876200|NCT02196961|Merkel cell carcinoma|merkel cell carcinoma
4876201|NCT02196961|Adjuvant|adjuvant
4876202|NCT02196961|Nivolumab|nivolumab
4876203|NCT02196961|Ipilimumab|ipilimumab
4876204|NCT02196948|Supraspinatus, tendinopathy, pain, disability, EPTE|supraspinatus, tendinopathy, pain, disability, epte
4876205|NCT02196935|Cholangitis|cholangitis
4876206|NCT02196935|Choledocholithiasis|choledocholithiasis
4876207|NCT02196935|Gastrointestinal Neoplasms|gastrointestinal neoplasms
4876208|NCT02196935|Medically underserved area|medically underserved area
4876209|NCT02196935|Anesthesia|anesthesia
4876210|NCT02196922|Chronic Heart Failure|chronic heart failure
4876211|NCT02196922|Telehealth|telehealth
4876212|NCT02196922|Self Management|self management
4876213|NCT02196909|HIBM|hibm
4876214|NCT02196909|GNE|gne
4876215|NCT02196870|Airway pressure stress index|airway pressure stress index
4876316|NCT02196454|health education|health education
4876216|NCT02196870|Transpulmonary pressure stress index|transpulmonary pressure stress index
4876217|NCT02196870|Acute Respiratory Failure|acute respiratory failure
4876218|NCT02196870|Chest wall elastance|chest wall elastance
4876219|NCT02196870|Lung stress|lung stress
4876220|NCT02196857|Leukemia|leukemia
4876221|NCT02196857|Acute myeloid leukemia|acute myeloid leukemia
4876222|NCT02196857|AML|aml
4876223|NCT02196857|High risk myelodysplastic syndrome|high risk myelodysplastic syndrome
4876224|NCT02196857|MDS|mds
4876225|NCT02196857|FLT3-ITD mutation|flt3-itd mutation
4876226|NCT02196857|Azacytidine|azacytidine
4876227|NCT02196857|5-Azacytidine|5-azacytidine
4876228|NCT02196857|5-AZA|5-aza
4876229|NCT02196857|Vidaza|vidaza
4876230|NCT02196857|5-AZC|5-azc
4876231|NCT02196857|AZA-CR|aza-cr
4876232|NCT02196857|Ladakamycin|ladakamycin
4876233|NCT02196857|NSC-102816|nsc-102816
4876234|NCT02196857|Sorafenib|sorafenib
4876235|NCT02196857|Nexavar|nexavar
4876236|NCT02196857|BAY 43-9006|bay 43-9006
4876237|NCT02196844|Lung cancer|lung cancer
4876238|NCT02196844|Hatha Yoga|hatha yoga
4876239|NCT02196844|Questionnaires|questionnaires
4876240|NCT02196844|Surveys|surveys
4876241|NCT02196844|Walk Test|walk test
4876242|NCT02196844|Caregiver|caregiver
4876243|NCT02196831|Human immunodeficiency virus (HIV)|human immunodeficiency virus (hiv)
4876244|NCT02196831|Nonalcoholic fatty liver disease (NAFLD)|nonalcoholic fatty liver disease (nafld)
4876245|NCT02196831|Nonalcoholic steatohepatitis (NASH)|nonalcoholic steatohepatitis (nash)
4876246|NCT02196831|Growth hormone releasing hormone|growth hormone releasing hormone
4876247|NCT02196831|tesamorelin|tesamorelin
4876248|NCT02196805|bioequivalence|bioequivalence
4876249|NCT02196805|imported PROBUCOL table|imported probucol table
4876250|NCT02196805|Lorelco|lorelco
4876251|NCT02196805|marketed PROBUCOL tablet|marketed probucol tablet
4876252|NCT02196805|Chang Tai|chang tai
4876253|NCT02196792|Joint Diseases|joint diseases
4876254|NCT02196792|Musculoskeletal Diseases|musculoskeletal diseases
4876255|NCT02196792|radiostereometric analysis|radiostereometric analysis
4876256|NCT02196792|Total hip arthroplasty|total hip arthroplasty
4876257|NCT02196779|Abdominoplasty|abdominoplasty
4876258|NCT02196779|circulation|circulation
4876259|NCT02196779|skin|skin
4876260|NCT02196779|dissection|dissection
4876261|NCT02196779|laser|laser
4876262|NCT02196779|fluorescence|fluorescence
4876263|NCT02196779|imaging|imaging
4876264|NCT02196753|Positron emission tomography combined with computed tomography|positron emission tomography combined with computed tomography
4876265|NCT02196753|PET CT|pet ct
4876266|NCT02196753|Cardiovascular Implantable Electronic Device|cardiovascular implantable electronic device
4876267|NCT02196753|Infective endocarditis|infective endocarditis
4876268|NCT02196753|Generator pocket infection|generator pocket infection
4876269|NCT02196753|Fever of unknown origin|fever of unknown origin
4876270|NCT02196740|periapical periodontitis,primary teeth|periapical periodontitis,primary teeth
4876271|NCT02196727|Postoperative pain|postoperative pain
4876272|NCT02196727|Multimodal analgesia|multimodal analgesia
4876273|NCT02196727|Bascom Cleft Lift|bascom cleft lift
4876274|NCT02196727|Day-case.|day-case.
4876275|NCT02196714|Japanese Healthy Volunteers|japanese healthy volunteers
4876276|NCT02196701|methotrexate|methotrexate
4876277|NCT02196701|adalimumab|adalimumab
4876278|NCT02196701|biologic|biologic
4876279|NCT02196701|psoriasis|psoriasis
4876280|NCT02196701|Tumor necrosis factor (TNF)-α inhibitor|tumor necrosis factor (tnf)-α inhibitor
4876281|NCT02196688|subjects with mCRC who failed at least 2nd line therapy|subjects with mcrc who failed at least 2nd line therapy
4876282|NCT02196610|End-Stage Renal Disease,|end-stage renal disease,
4876283|NCT02196610|arterial or vascular stiffness,|arterial or vascular stiffness,
4876284|NCT02196610|hemodialysis,|hemodialysis,
4876285|NCT02196610|Pulse wave velocity|pulse wave velocity
4876286|NCT02196610|Renal insufficiency,|renal insufficiency,
4876287|NCT02196610|tonometry|tonometry
4876288|NCT02196597|anorectal manometry|anorectal manometry
4876289|NCT02196571|GDM|gdm
4876290|NCT02196571|Exercise|exercise
4876291|NCT02196571|Diabetes|diabetes
4876292|NCT02196571|Pregnancy|pregnancy
4876293|NCT02196558|Rheumatoid Arthritis|rheumatoid arthritis
4876294|NCT02196558|Japanese subjects|japanese subjects
4876295|NCT02196532|retinal nerve fiber layer thickness|retinal nerve fiber layer thickness
4876296|NCT02196532|optical coherence tomography|optical coherence tomography
4876297|NCT02196532|migraine|migraine
4876298|NCT02196506|OPC-34712|opc-34712
4876299|NCT02196506|brexpiprazole|brexpiprazole
4876300|NCT02196506|Major Depressive Disorder|major depressive disorder
4876301|NCT02196506|Adjunctive Treatment|adjunctive treatment
4876302|NCT02196506|Anxious Distress|anxious distress
4876303|NCT02196493|Productive|productive
4876304|NCT02196493|Cough|cough
4876305|NCT02196493|Bronchitis|bronchitis
4876306|NCT02196493|Azithromycin|azithromycin
4876307|NCT02196467|myoblast|myoblast
4876308|NCT02196467|transplantation|transplantation
4876309|NCT02196467|strength|strength
4876310|NCT02196467|tacrolimus|tacrolimus
4876311|NCT02196467|immunosuppression|immunosuppression
4876312|NCT02196454|HPV vaccine|hpv vaccine
4876313|NCT02196454|vaccination|vaccination
4876314|NCT02196454|immunization|immunization
4876317|NCT02196454|communication|communication
4876318|NCT02196441|deep topical fornix nerve block|deep topical fornix nerve block
4876319|NCT02196441|topical anesthesia|topical anesthesia
4876320|NCT02196441|implantable contact lens procedure|implantable contact lens procedure
4876321|NCT02196428|Ambient Assisted Living (AAL)|ambient assisted living (aal)
4876322|NCT02196428|Telemonitoring|telemonitoring
4876323|NCT02196428|Teleconsultation|teleconsultation
4876324|NCT02196415|Hindfoot Alignment|hindfoot alignment
4876325|NCT02196415|Rearfoot|rearfoot
4876326|NCT02196415|Malalignment|malalignment
4876327|NCT02196415|biplanar radiography|biplanar radiography
4876328|NCT02196415|3D measurement|3d measurement
4876329|NCT02196376|Postural orthostatic syndrome|postural orthostatic syndrome
4876330|NCT02196376|orthostatic intolerance|orthostatic intolerance
4876331|NCT02196376|autonomic dysfunction|autonomic dysfunction
4876332|NCT02196350|personalized treatment|personalized treatment
4876333|NCT02196350|prevention|prevention
4876334|NCT02196350|improved diagnosis|improved diagnosis
4876335|NCT02196337|Iodine deficiency|iodine deficiency
4876336|NCT02196324|Prurigo Nodularis|prurigo nodularis
4876337|NCT02196324|Atopic Dermatitis|atopic dermatitis
4876338|NCT02196324|Lichen-simplex chronicus|lichen-simplex chronicus
4876339|NCT02196311|Supracondylar humerus fractures, external fixation, open reduction, and internal fixation.|supracondylar humerus fractures, external fixation, open reduction, and internal fixation.
4876340|NCT02196298|physical therapy|physical therapy
4876341|NCT02196298|gait|gait
4876342|NCT02196298|pediatric rehabilitation|pediatric rehabilitation
4876343|NCT02196298|gross motor function|gross motor function
4876344|NCT02196298|participation|participation
4876345|NCT02196285|Double|double
4876346|NCT02196285|Viral|viral
4876347|NCT02196285|Vaccine|vaccine
4876348|NCT02196285|Measles|measles
4876349|NCT02196285|Rubella|rubella
4876350|NCT02196285|Safety|safety
4876351|NCT02196285|Efficacy|efficacy
4876352|NCT02196285|Imunogenicity|imunogenicity
4876353|NCT02196259|Pre-Post|pre-post
4876354|NCT02196233|Trigger Finger|trigger finger
4876355|NCT02196233|Prospective Clinical Research|prospective clinical research
4876356|NCT02196233|Randomized|randomized
4876357|NCT02196233|Questionnaires|questionnaires
4876358|NCT02196233|Transverse|transverse
4876359|NCT02196233|Longitudinal|longitudinal
4876360|NCT02196207|Severe Hemophilia A|severe hemophilia a
4876361|NCT02196207|Previously Untreated Patients|previously untreated patients
4876362|NCT02196207|Hemophilia Inhibitor Formation|hemophilia inhibitor formation
4876363|NCT02196207|Long-Acting Factor VIII|long-acting factor viii
4876364|NCT02196207|Prophylaxis|prophylaxis
4876365|NCT02196155|plantar fasciitis|plantar fasciitis
4876366|NCT02196155|Botulinum toxin A|botulinum toxin a
4876367|NCT02196155|Cortisone|cortisone
4876368|NCT02196155|RCT|rct
4876369|NCT02196142|Cortisol|cortisol
4876370|NCT02196142|Alcohol Craving|alcohol craving
4876371|NCT02196142|Alcohol Dependence|alcohol dependence
4876372|NCT02196129|low back pain|low back pain
4876373|NCT02196129|pharmacoacupuncture|pharmacoacupuncture
4876374|NCT02196129|sinbaro-3|sinbaro-3
4876375|NCT02196116|Alzheimer disease|alzheimer disease
4876376|NCT02196116|amyloid load|amyloid load
4876377|NCT02196116|educational level|educational level
4876378|NCT02196116|cognitive performances|cognitive performances
4876379|NCT02196103|TOLAC|tolac
4876380|NCT02196103|PROM|prom
4876381|NCT02196103|Previous Cesarian section|previous cesarian section
4876382|NCT02196103|Mechanical cervical ripening|mechanical cervical ripening
4876383|NCT02196090|OCD, Exposure and Response Prevention, Vagal Stimulation|ocd, exposure and response prevention, vagal stimulation
4876384|NCT02196077|Budesonide and formoterol inhalation aerosol|budesonide and formoterol inhalation aerosol
4876385|NCT02196064|HIV HCV antiretroviral|hiv hcv antiretroviral
4876386|NCT02196051|Insulin resistance|insulin resistance
4876387|NCT02196051|Exercise|exercise
4876388|NCT02196051|de novo lipogenesis|de novo lipogenesis
4876389|NCT02196051|NAFLD|nafld
4876390|NCT02196051|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
4876391|NCT02196038|heart failure|heart failure
4876392|NCT02196025|Insomnia|insomnia
4876393|NCT02196012|overweight|overweight
4876394|NCT02196012|obesity|obesity
4876395|NCT02196012|Technology|technology
4876396|NCT02196012|College Students|college students
4876397|NCT02195986|vaginal dryness|vaginal dryness
4876398|NCT02195986|vaginal and/or vulvar irritation/itching|vaginal and/or vulvar irritation/itching
4876399|NCT02195986|dysuria|dysuria
4876400|NCT02195986|vaginal pain and bleeding associated with sexual activity|vaginal pain and bleeding associated with sexual activity
4876401|NCT02195986|vaginal atrophy|vaginal atrophy
4876402|NCT02195973|ovarian cancer|ovarian cancer
4876403|NCT02195973|platinum resistant|platinum resistant
4876404|NCT02195973|LED225|led225
4876405|NCT02195973|Sonidegib|sonidegib
4876406|NCT02195973|Paclitaxel|paclitaxel
4876407|NCT02195960|skin toxicity, radiotherapy, antioxidants|skin toxicity, radiotherapy, antioxidants
4876408|NCT02195947|Growth hormone|growth hormone
4876409|NCT02195947|IVF/ICSI|ivf/icsi
4876410|NCT02195947|Poor responder|poor responder
4876411|NCT02195947|Antagonist protocol|antagonist protocol
4876511|NCT02195479|Velcade|velcade
4876512|NCT02195479|Melphalan|melphalan
4876412|NCT02195934|Cardiovascular disease, blood orange juice, anthocyanins|cardiovascular disease, blood orange juice, anthocyanins
4876413|NCT02195895|Teriparatide|teriparatide
4876414|NCT02195895|Alendronate|alendronate
4876415|NCT02195895|Alendronic Acid|alendronic acid
4876416|NCT02195895|Osteoporosis|osteoporosis
4876417|NCT02195895|Bone Fracture|bone fracture
4876418|NCT02195895|Bone Loss|bone loss
4876419|NCT02195895|Spinal Cord Injury|spinal cord injury
4876420|NCT02195895|Bone Diseases|bone diseases
4876421|NCT02195895|Metabolic Bone Diseases|metabolic bone diseases
4876422|NCT02195895|Musculoskeletal Diseases|musculoskeletal diseases
4876423|NCT02195895|Spinal Cord Diseases|spinal cord diseases
4876424|NCT02195895|Central Nervous System Diseases|central nervous system diseases
4876425|NCT02195895|Nervous System Diseases|nervous system diseases
4876426|NCT02195895|Nervous System|nervous system
4876427|NCT02195895|Wounds and Injuries|wounds and injuries
4876428|NCT02195895|Bone Density Conservation Agents|bone density conservation agents
4876429|NCT02195895|Physiological Effects of Drugs|physiological effects of drugs
4876430|NCT02195895|Pharmacologic Actions|pharmacologic actions
4876431|NCT02195882|strength training|strength training
4876432|NCT02195882|scapular stabilization|scapular stabilization
4876433|NCT02195882|kayakers.|kayakers.
4876434|NCT02195869|PCYC1129|pcyc1129
4876435|NCT02195869|PCYC1129CA|pcyc1129ca
4876436|NCT02195869|1129|1129
4876437|NCT02195869|Ibrutinib|ibrutinib
4876438|NCT02195869|PCI32765|pci32765
4876439|NCT02195869|IMBRUVICA|imbruvica
4876440|NCT02195869|Pharmacyclics|pharmacyclics
4876441|NCT02195869|PCYC|pcyc
4876442|NCT02195869|GVHD|gvhd
4876443|NCT02195869|Steroid dependent|steroid dependent
4876444|NCT02195869|refractory|refractory
4876445|NCT02195869|chronic|chronic
4876446|NCT02195869|graft versus host disease|graft versus host disease
4876447|NCT02195869|chronic graft versus host disease|chronic graft versus host disease
4876448|NCT02195869|immunology|immunology
4876449|NCT02195856|Diabetes|diabetes
4876450|NCT02195856|Nitrate|nitrate
4876451|NCT02195856|Nitrite|nitrite
4876452|NCT02195856|Hepatic|hepatic
4876453|NCT02195856|MRI|mri
4876454|NCT02195856|Incretin|incretin
4876455|NCT02195856|Insulin|insulin
4876456|NCT02195856|Glucose|glucose
4876457|NCT02195843|CRT-D|crt-d
4876458|NCT02195843|Heart Failure|heart failure
4876459|NCT02195843|Middle East|middle east
4876460|NCT02195843|Quadripolar|quadripolar
4876461|NCT02195830|Sepsis|sepsis
4876462|NCT02195830|ultrasound|ultrasound
4876463|NCT02195830|inferior vena cava collapsibility|inferior vena cava collapsibility
4876464|NCT02195778|Health Literacy|health literacy
4876465|NCT02195778|Adult|adult
4876466|NCT02195778|UAE|uae
4876467|NCT02195778|Disease|disease
4876468|NCT02195778|Age|age
4876469|NCT02195765|Chronic Periodontitis|chronic periodontitis
4876470|NCT02195765|Periodontal disease|periodontal disease
4876471|NCT02195752|Compounded pain cream|compounded pain cream
4876472|NCT02195752|Ordinary care|ordinary care
4876473|NCT02195752|Compounding|compounding
4876474|NCT02195752|Topical treatment|topical treatment
4876475|NCT02195752|Analgesia|analgesia
4876476|NCT02195739|smoking|smoking
4876477|NCT02195739|smoking cessation|smoking cessation
4876478|NCT02195739|cardiovascular disease|cardiovascular disease
4876479|NCT02195739|pharmacological intervention|pharmacological intervention
4876480|NCT02195739|UK primary care population|uk primary care population
4876481|NCT02195739|nicotine replacement therapy|nicotine replacement therapy
4876482|NCT02195700|Dyskinesias|dyskinesias
4876483|NCT02195700|Movement Disorders|movement disorders
4876484|NCT02195700|Central Nervous System Diseases|central nervous system diseases
4876485|NCT02195700|Nervous System Diseases|nervous system diseases
4876486|NCT02195700|Neurologic Manifestations|neurologic manifestations
4876487|NCT02195700|Signs and Symptoms|signs and symptoms
4876488|NCT02195661|Epilepsy|epilepsy
4876489|NCT02195661|Electroencephalogram|electroencephalogram
4876490|NCT02195661|children|children
4876491|NCT02195661|sedation|sedation
4876492|NCT02195648|Tension-Type Headache|tension-type headache
4876493|NCT02195648|Physical Therapy Modalities|physical therapy modalities
4876494|NCT02195648|Musculoskeletal Manipulations|musculoskeletal manipulations
4876495|NCT02195648|Sub-occipital muscle inhibition technique|sub-occipital muscle inhibition technique
4876496|NCT02195609|Vasomotor Symptoms Associated With Menopause|vasomotor symptoms associated with menopause
4876497|NCT02195609|Menopause|menopause
4876498|NCT02195609|Hot Flashes|hot flashes
4876499|NCT02195609|Postmenopausal Women|postmenopausal women
4876500|NCT02195596|Alzheimer disease, exercise, cognition|alzheimer disease, exercise, cognition
4876501|NCT02195570|contingency management|contingency management
4876502|NCT02195570|smoking cessation|smoking cessation
4876503|NCT02195570|prenatal tobacco exposure|prenatal tobacco exposure
4876504|NCT02195570|maternal smoking|maternal smoking
4876505|NCT02195531|Adherence|adherence
4876506|NCT02195518|Chronic Hepatitis B|chronic hepatitis b
4876507|NCT02195518|Tenofovir disoproxil fumarate|tenofovir disoproxil fumarate
4876508|NCT02195518|Failure of multiple NAs treatment|failure of multiple nas treatment
4876509|NCT02195479|Multiple Myeloma|multiple myeloma
4876510|NCT02195479|Bortezomib|bortezomib
4876513|NCT02195479|Prednisone|prednisone
4876514|NCT02195479|Daratumumab|daratumumab
4876515|NCT02195453|Non-small cell lung cancer|non-small cell lung cancer
4876516|NCT02195453|FACT-L scale|fact-l scale
4876517|NCT02195453|Yangzhengxiaoji|yangzhengxiaoji
4876518|NCT02195440|Hepatitis C virus, cirrhosis|hepatitis c virus, cirrhosis
4876519|NCT02195427|Nasolabial folds|nasolabial folds
4876520|NCT02195427|Dermal filler|dermal filler
4876521|NCT02195427|Hyaluronic acid (HA)|hyaluronic acid (ha)
4876522|NCT02195427|Wrinkles|wrinkles
4876523|NCT02195414|NeoVas|neovas
4876524|NCT02195414|Bioresorbable scaffold|bioresorbable scaffold
4876525|NCT02195414|Sirolimus|sirolimus
4876526|NCT02195414|First-in-Man|first-in-man
4876527|NCT02195401|autism, cleanroom, immune dysregulation, toxins|autism, cleanroom, immune dysregulation, toxins
4876528|NCT02195388|Arterial stiffness,|arterial stiffness,
4876529|NCT02195388|endothelial function,|endothelial function,
4876530|NCT02195388|autonomic nervous system,|autonomic nervous system,
4876531|NCT02195388|acute coronary syndrome,|acute coronary syndrome,
4876532|NCT02195388|arterial hypertension,|arterial hypertension,
4876533|NCT02195388|pulse wave velocity,|pulse wave velocity,
4876534|NCT02195388|augmentation index,|augmentation index,
4876535|NCT02195388|arterial stiffness index,|arterial stiffness index,
4876536|NCT02195388|heart rate variability,|heart rate variability,
4876537|NCT02195388|heart rate turbulence,|heart rate turbulence,
4876538|NCT02195388|vascular endothelial growth factor,|vascular endothelial growth factor,
4876539|NCT02195388|asymmetric dimethylarginine|asymmetric dimethylarginine
4876540|NCT02195375|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
4876541|NCT02195375|FEV1 ≤ 50%|fev1 ≤ 50%
4876542|NCT02195349|Tuberculin Purified Protein Derivative|tuberculin purified protein derivative
4876543|NCT02195349|Delayed Type Hypersensitivity|delayed type hypersensitivity
4876544|NCT02195349|Biopsy|biopsy
4876545|NCT02195349|Induration|induration
4876546|NCT02195349|First time in human|first time in human
4876547|NCT02195349|T-cells|t-cells
4876548|NCT02195349|LAG-3|lag-3
4876549|NCT02195349|safety|safety
4876550|NCT02195349|GSK2831781|gsk2831781
4876551|NCT02195349|psoriasis|psoriasis
4876552|NCT02195323|autologous bone marrow mesenchymal stem cells chronic kidney disease|autologous bone marrow mesenchymal stem cells chronic kidney disease
4876553|NCT02195310|Sternotomy|sternotomy
4876554|NCT02195310|Surgical site Occurences|surgical site occurences
4876555|NCT02195310|Negative Pressure Wound Therapy|negative pressure wound therapy
4876556|NCT02195310|Surgical Site Infection|surgical site infection
4876557|NCT02195297|cellulitis|cellulitis
4876558|NCT02195297|anticellulitis|anticellulitis
4876559|NCT02195284|Inhaler preference|inhaler preference
4876560|NCT02195284|Overall inhaler error|overall inhaler error
4876561|NCT02195284|DISKUS/ACCUHALER|diskus/accuhaler
4876562|NCT02195284|MDI|mdi
4876563|NCT02195284|TURBUHALER|turbuhaler
4876564|NCT02195284|ELLIPTA|ellipta
4876565|NCT02195284|Ease of use|ease of use
4876566|NCT02195284|Critical inhaler error|critical inhaler error
4876567|NCT02195271|Melatonin|melatonin
4876568|NCT02195271|Transcranial Direct Current Stimulation|transcranial direct current stimulation
4876569|NCT02195271|Neuroplasticity|neuroplasticity
4876570|NCT02195271|Analgesia|analgesia
4876571|NCT02195271|Pain|pain
4876572|NCT02195245|CO2 filter|co2 filter
4876573|NCT02195245|anesthesia|anesthesia
4876574|NCT02195245|device|device
4876575|NCT02195232|Venous Thromboembolic Events in Cancer Patients|venous thromboembolic events in cancer patients
4876576|NCT02195232|Thromboembolism of Vein in Colorectal Cancer|thromboembolism of vein in colorectal cancer
4876577|NCT02195232|Thromboembolism of Vein in Pancreatic Cancer|thromboembolism of vein in pancreatic cancer
4876578|NCT02195232|Thromboembolism of Vein in Non-small Cell Lung Cancer|thromboembolism of vein in non-small cell lung cancer
4876579|NCT02195219|conservative|conservative
4876580|NCT02195219|treatment|treatment
4876581|NCT02195219|surgical|surgical
4876582|NCT02195219|Acromioclavicular|acromioclavicular
4876583|NCT02195219|Joint|joint
4876584|NCT02195219|dislocation|dislocation
4876585|NCT02195206|Hyperpolarized gas magnetic resonance imaging|hyperpolarized gas magnetic resonance imaging
4876586|NCT02195206|Hyperpolarized Xenon-129 magnetic resonance imaging|hyperpolarized xenon-129 magnetic resonance imaging
4876587|NCT02195206|Lung Imaging|lung imaging
4876588|NCT02195206|Healthy Adults|healthy adults
4876589|NCT02195193|Health Services Research|health services research
4876590|NCT02195193|Acute Coronary Syndromes|acute coronary syndromes
4876591|NCT02195193|Depression|depression
4876592|NCT02195193|Integrated care|integrated care
4876593|NCT02195180|Pancreas|pancreas
4876594|NCT02195180|adenocarcinoma|adenocarcinoma
4876595|NCT02195180|cancer|cancer
4876596|NCT02195180|asparaginase|asparaginase
4876597|NCT02195180|erythrocytes|erythrocytes
4876598|NCT02195180|red blood cell|red blood cell
4876599|NCT02195180|Encapsulation|encapsulation
4876600|NCT02195180|folfox|folfox
4876601|NCT02195180|gemcitabine|gemcitabine
4876602|NCT02195154|18F-DTBZ|18f-dtbz
4876603|NCT02195141|Preoperative Chemoradiotherapy|preoperative chemoradiotherapy
4876604|NCT02195141|Locally Advanced Rectal Cancer|locally advanced rectal cancer
4876605|NCT02195141|boost|boost
4876606|NCT02195141|IMRT|imrt
4877098|NCT02193113|KVD001|kvd001
4876607|NCT02195102|transcatheter aortic valve Replacement|transcatheter aortic valve replacement
4876608|NCT02195089|Treatment of Cervical Intraepithelial Neoplasia(CIN3)|treatment of cervical intraepithelial neoplasia(cin3)
4876609|NCT02195076|Lung cancer|lung cancer
4876610|NCT02195076|Breast Cancer|breast cancer
4876611|NCT02195076|Biosensors|biosensors
4876612|NCT02195076|Volatile Organic Compounds|volatile organic compounds
4876613|NCT02195076|Odor|odor
4876614|NCT02195076|Urine Sample|urine sample
4876615|NCT02195076|Exhaled Breath Samples|exhaled breath samples
4876616|NCT02195063|Pain management|pain management
4876617|NCT02195063|Scar care|scar care
4876618|NCT02195063|Wound care|wound care
4876620|NCT02195063|Urinary drug testing|urinary drug testing
4876621|NCT02195037|Delayed Cord Clamping|delayed cord clamping
4876622|NCT02195024|pacemaker|pacemaker
4876623|NCT02195024|magnetic resonance imaging|magnetic resonance imaging
4876624|NCT02195024|MRI conditional|mri conditional
4876625|NCT02195024|pacemaker leads|pacemaker leads
4876626|NCT02195011|Regorafenib|regorafenib
4876627|NCT02195011|90Y|90y
4876628|NCT02195011|Radioembolization|radioembolization
4876629|NCT02195011|SIR-Spheres Microspheres|sir-spheres microspheres
4876630|NCT02195011|Metastatic Colorectal Cancer|metastatic colorectal cancer
4876631|NCT02195011|Liver Metastases|liver metastases
4876632|NCT02195011|SIRT|sirt
4876633|NCT02195011|Refractory|refractory
4876634|NCT02194985|Fabry disease|fabry disease
4876635|NCT02194985|Lysosomal storage disease|lysosomal storage disease
4876636|NCT02194985|migalastat HCl|migalastat hcl
4876637|NCT02194985|AT1001|at1001
4876638|NCT02194972|constipation|constipation
4876639|NCT02194972|colon transit time|colon transit time
4876640|NCT02194972|gut microbiota|gut microbiota
4876641|NCT02194972|soluble dietary fiber|soluble dietary fiber
4876642|NCT02194972|disturbance of gut microbiota in constipation|disturbance of gut microbiota in constipation
4876643|NCT02194959|Patient Navigation|patient navigation
4876644|NCT02194959|Screening Colonoscopy|screening colonoscopy
4876645|NCT02194959|Colorectal Cancer Screening|colorectal cancer screening
4876646|NCT02194959|African Americans|african americans
4876647|NCT02194946|Chronic Kidney Disease,|chronic kidney disease,
4876648|NCT02194946|End-Stage Renal Disease,|end-stage renal disease,
4876649|NCT02194946|Traditional Chinese Medicine,|traditional chinese medicine,
4876650|NCT02194946|dialysis initiation.|dialysis initiation.
4876651|NCT02194933|Schizophrenia|schizophrenia
4876652|NCT02194933|Mental Disorders, Antipsychotic,|mental disorders, antipsychotic,
4876653|NCT02194933|Psychotic disorder, Impulsivity|psychotic disorder, impulsivity
4876654|NCT02194907|Emotional Aging|emotional aging
4876655|NCT02194907|Neurofeedback|neurofeedback
4876656|NCT02194894|Acetaminophen, Non-alcoholic Fatty Liver Disease (NAFLD)|acetaminophen, non-alcoholic fatty liver disease (nafld)
4876657|NCT02194881|Cystic fibrosis|cystic fibrosis
4876658|NCT02194881|CFTR|cftr
4876659|NCT02194881|G551D mutation|g551d mutation
4876660|NCT02194881|Novel treatments|novel treatments
4876661|NCT02194881|Potentiator|potentiator
4876662|NCT02194881|Ivacaftor|ivacaftor
4876663|NCT02194868|Allogeneic hematopoietic stem cell transplantation,|allogeneic hematopoietic stem cell transplantation,
4876664|NCT02194868|Immunoregulatory T lymphocytes,|immunoregulatory t lymphocytes,
4876665|NCT02194868|acute graft versus host disease|acute graft versus host disease
4876666|NCT02194855|rocuronium|rocuronium
4876667|NCT02194855|cisatracurium|cisatracurium
4876668|NCT02194855|pharmacokinetic|pharmacokinetic
4876669|NCT02194842|metastatic|metastatic
4876670|NCT02194842|prostate cancer|prostate cancer
4876671|NCT02194816|Parkinson's Disease|parkinson's disease
4876672|NCT02194816|PD|pd
4876673|NCT02194816|Complementary and Alternative|complementary and alternative
4876674|NCT02194816|CAM|cam
4876675|NCT02194790|Chronic Kidney Disease|chronic kidney disease
4876676|NCT02194790|Diabetic Nephropathy|diabetic nephropathy
4876677|NCT02194790|Integrated Chronic Kidney Disease Care|integrated chronic kidney disease care
4876678|NCT02194725|Stress and Coping Model|stress and coping model
4876679|NCT02194725|Coping|coping
4876680|NCT02194712|circulating anodic antigen|circulating anodic antigen
4876681|NCT02194686|cilostazol|cilostazol
4876682|NCT02194686|progenitor cells|progenitor cells
4876683|NCT02194686|cardiovascular disease|cardiovascular disease
4876684|NCT02194686|risk factors|risk factors
4876685|NCT02194686|angiogenesis|angiogenesis
4876686|NCT02194686|biological markers|biological markers
4876687|NCT02194686|endothelial function|endothelial function
4876688|NCT02194660|Fractures Liaison Service|fractures liaison service
4876689|NCT02194660|Osteoporosis|osteoporosis
4876690|NCT02194660|Fracture|fracture
4876691|NCT02194660|Medication adherence|medication adherence
4876692|NCT02194647|Osteoporosis|osteoporosis
4876693|NCT02194647|Medication Monitoring|medication monitoring
4876694|NCT02194647|Education|education
4876695|NCT02194647|Adherence|adherence
4876696|NCT02194647|Management|management
4876697|NCT02194595|type 2 diabetes|type 2 diabetes
4876698|NCT02194595|beta-cell function|beta-cell function
4876699|NCT02194595|GLP-1|glp-1
4876700|NCT02194595|insulin|insulin
4876701|NCT02194582|FSGS|fsgs
4876702|NCT02194582|NS|ns
4876703|NCT02194582|Kidney disease|kidney disease
4876704|NCT02194582|Kidney failure|kidney failure
4876705|NCT02194582|Renal disease|renal disease
4876706|NCT02194582|nephrotic syndrome|nephrotic syndrome
4876707|NCT02194582|focal segmental glomerulosclerosis|focal segmental glomerulosclerosis
4876708|NCT02194582|familial kidney disease|familial kidney disease
4876709|NCT02194582|minimal change disease|minimal change disease
4876710|NCT02194582|proteinuria|proteinuria
4876711|NCT02194543|Cataract|cataract
4876712|NCT02194543|HD 3D|hd 3d
4876713|NCT02194543|Microscope|microscope
4876714|NCT02194530|Peanut allergic individuals|peanut allergic individuals
4876715|NCT02194530|Allergic/atopic individuals (not allergic to peanut)|allergic/atopic individuals (not allergic to peanut)
4876716|NCT02194530|Non-allergic individuals|non-allergic individuals
4876717|NCT02194517|diabetes|diabetes
4876718|NCT02194517|diet control toolset|diet control toolset
4876719|NCT02194517|food exchanges|food exchanges
4876720|NCT02194517|CHO|cho
4876721|NCT02194517|FP|fp
4876722|NCT02194504|Metabolic health|metabolic health
4876723|NCT02194504|Phenotyping|phenotyping
4876724|NCT02194504|Abdominal obesity|abdominal obesity
4876725|NCT02194504|Abdominal adiposity|abdominal adiposity
4876726|NCT02194504|Liver fat|liver fat
4876727|NCT02194504|Belly fat|belly fat
4876728|NCT02194491|[11C]AS2471907|[11c]as2471907
4876729|NCT02194491|ASP3662|asp3662
4876730|NCT02194491|Positron Emission Tomography (PET)|positron emission tomography (pet)
4876731|NCT02194491|Brain enzyme occupancy|brain enzyme occupancy
4876732|NCT02194478|Stress|stress
4876733|NCT02194478|Meditation|meditation
4876734|NCT02194478|Mind body|mind body
4876735|NCT02194439|Acute Graft Versus Host Disease|acute graft versus host disease
4876736|NCT02194439|Affect|affect
4876737|NCT02194439|Anti-inflammatory|anti-inflammatory
4876738|NCT02194439|Anti-inflammatory Agents|anti-inflammatory agents
4876739|NCT02194439|Antigen-Presenting Cells|antigen-presenting cells
4876740|NCT02194439|Alloantigen|alloantigen
4876741|NCT02194439|Allogeneic|allogeneic
4876742|NCT02194439|Allograft rejection|allograft rejection
4876743|NCT02194439|Allograft Tolerance|allograft tolerance
4876744|NCT02194439|Antigens|antigens
4876745|NCT02194439|Autoimmunity|autoimmunity
4876746|NCT02194439|Biomarkers|biomarkers
4876747|NCT02194439|Biospecimen Repository|biospecimen repository
4876748|NCT02194439|BMT|bmt
4876749|NCT02194439|Bone Marrow Transplantation|bone marrow transplantation
4876750|NCT02194439|Cell Transplantation|cell transplantation
4876751|NCT02194439|Cells|cells
4876752|NCT02194439|Clonal Expansion|clonal expansion
4876753|NCT02194439|Complex|complex
4876754|NCT02194439|Cytokine|cytokine
4876755|NCT02194439|Data|data
4876756|NCT02194439|Development|development
4876757|NCT02194439|Environment|environment
4876758|NCT02194439|Failure (biologic function)|failure (biologic function)
4876759|NCT02194439|Genomics|genomics
4876760|NCT02194439|Graft-vs-Host Disease|graft-vs-host disease
4876761|NCT02194439|Graft-vs-Leukemia|graft-vs-leukemia
4876762|NCT02194439|GVHD|gvhd
4876763|NCT02194439|GVL|gvl
4876764|NCT02194439|Hematopoietic|hematopoietic
4876765|NCT02194439|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
4876766|NCT02194439|HCT|hct
4876767|NCT02194439|HSCT|hsct
4876768|NCT02194439|IL-33 Receptor|il-33 receptor
4876769|NCT02194439|Immune Reconstitution|immune reconstitution
4876770|NCT02194439|Immune Response|immune response
4876771|NCT02194439|Inflammatory|inflammatory
4876772|NCT02194439|Modeling|modeling
4876773|NCT02194439|Novel|novel
4876774|NCT02194439|Novel therapeutics|novel therapeutics
4876775|NCT02194439|Outcome|outcome
4876776|NCT02194439|Pathway interactions|pathway interactions
4876777|NCT02194439|Peptides|peptides
4876778|NCT02194439|Prevent|prevent
4876779|NCT02194439|Process|process
4876780|NCT02194439|Production|production
4876781|NCT02194439|Proteomics|proteomics
4876782|NCT02194439|Regulatory T-Lymphocyte|regulatory t-lymphocyte
4876783|NCT02194439|Response|response
4876784|NCT02194439|Role|role
4876785|NCT02194439|Signal|signal
4876786|NCT02194439|ST2|st2
4876787|NCT02194439|Transduction|transduction
4876788|NCT02194439|T-cell response|t-cell response
4876789|NCT02194439|T-cell Activation|t-cell activation
4876790|NCT02194439|T-Lymphocytes|t-lymphocytes
4876791|NCT02194439|Tissues|tissues
4876792|NCT02194400|RSLV-132|rslv-132
4876793|NCT02194400|Systemic Lupus Erythematosus|systemic lupus erythematosus
4876794|NCT02194400|Lupus|lupus
4876795|NCT02194400|SLE|sle
4876796|NCT02194400|Resolve|resolve
4876797|NCT02194387|Breast Cancer|breast cancer
4876798|NCT02194387|Ovarian Cancer|ovarian cancer
4876799|NCT02194387|Triple negative breast cancer|triple negative breast cancer
4876800|NCT02194387|TNBC|tnbc
4876801|NCT02194387|BRCA-positive survivor|brca-positive survivor
4876802|NCT02194387|High-grade serous ovarian cancer|high-grade serous ovarian cancer
4876803|NCT02194387|HGSOC|hgsoc
4876804|NCT02194387|Female biological relative of a BRCA positive TNBC or HGSOC survivor|female biological relative of a brca positive tnbc or hgsoc survivor
4876805|NCT02194387|Cancer survivors|cancer survivors
4876806|NCT02194387|Employees at MD Anderson|employees at md anderson
4876807|NCT02194387|Multi-phase Optimization Strategy|multi-phase optimization strategy
4876808|NCT02194387|MOST|most
4876809|NCT02194387|Energy balance interventions|energy balance interventions
4876810|NCT02194387|EB|eb
4876811|NCT02194387|Telephone Coaching|telephone coaching
4876812|NCT02194387|Text Messaging|text messaging
4876813|NCT02194387|Resistance Training|resistance training
4876814|NCT02194387|Daily Self-Monitoring|daily self-monitoring
4876815|NCT02194387|Weekly Self-Monitoring|weekly self-monitoring
4876816|NCT02194387|Email Coaching|email coaching
4876817|NCT02194387|Questionnaires|questionnaires
4876818|NCT02194387|Surveys|surveys
4876819|NCT02194374|Leukemia|leukemia
4876820|NCT02194374|Chronic lymphocytic leukemia|chronic lymphocytic leukemia
4876821|NCT02194374|CLL|cll
4876822|NCT02194374|Small lymphocytic lymphoma|small lymphocytic lymphoma
4876823|NCT02194374|SLL|sll
4876824|NCT02194374|B cell|b cell
4876825|NCT02194374|ROR1-specific T cells|ror1-specific t cells
4876826|NCT02194374|Fludarabine|fludarabine
4876827|NCT02194374|Fludarabine Phosphate|fludarabine phosphate
4876828|NCT02194374|Fludara|fludara
4876829|NCT02194374|Cyclophosphamide|cyclophosphamide
4876830|NCT02194374|Cytoxan|cytoxan
4876831|NCT02194374|Neosar|neosar
4876832|NCT02194374|Rituximab|rituximab
4876833|NCT02194374|Rituxan|rituxan
4876834|NCT02194374|Bendamustine|bendamustine
4876835|NCT02194374|Bendamustine Hydrochloride|bendamustine hydrochloride
4876836|NCT02194374|Bendamustine HCL|bendamustine hcl
4876837|NCT02194374|CEP-18083|cep-18083
4876838|NCT02194374|SDX-105|sdx-105
4876839|NCT02194374|Treanda|treanda
4876840|NCT02194231|Mesothelioma|mesothelioma
4876841|NCT02194231|MPM|mpm
4876842|NCT02194231|Trabectedin|trabectedin
4876843|NCT02194192|prevention of hypotension|prevention of hypotension
4876844|NCT02194192|spinal anesthesia|spinal anesthesia
4876845|NCT02194192|cesarean section|cesarean section
4876846|NCT02194192|ephedrine|ephedrine
4876847|NCT02194192|ondansetron|ondansetron
4876848|NCT02194140|ultrasound|ultrasound
4876849|NCT02194140|iodinated contrast material|iodinated contrast material
4876850|NCT02194140|computed tomography|computed tomography
4876851|NCT02194114|Chronic Renal Failure|chronic renal failure
4876852|NCT02194114|End-Stage Renal Disease|end-stage renal disease
4876853|NCT02194114|Nitrogen Balance|nitrogen balance
4876854|NCT02194114|Dietary Protein Intake|dietary protein intake
4876855|NCT02194101|oxygen delivery|oxygen delivery
4876856|NCT02194101|proximal femoral fracture|proximal femoral fracture
4876857|NCT02194101|goal-directed therapy|goal-directed therapy
4876858|NCT02194062|Chronic rhinosinusitis with polyps|chronic rhinosinusitis with polyps
4876859|NCT02194062|Nasal steroids|nasal steroids
4876860|NCT02194062|Functional endoscopic sinus surgery|functional endoscopic sinus surgery
4876861|NCT02194062|SNOT-22|snot-22
4876862|NCT02194062|Lund-Kennedy|lund-kennedy
4876863|NCT02194036|Ownership of body|ownership of body
4876864|NCT02194036|Bodily and mental balance|bodily and mental balance
4876865|NCT02194036|Learning|learning
4876866|NCT02194036|Body image|body image
4876867|NCT02194036|Sensations|sensations
4876868|NCT02194036|Expectations|expectations
4876869|NCT02194023|chlorhexidine digluconate|chlorhexidine digluconate
4876870|NCT02194023|gingivitis|gingivitis
4876871|NCT02194023|cetylpyridinium chloride|cetylpyridinium chloride
4876872|NCT02194023|mouthrinse|mouthrinse
4876873|NCT02194023|dental plaque|dental plaque
4876874|NCT02194023|de novo|de novo
4876875|NCT02194023|in vivo|in vivo
4876876|NCT02194010|Outcome Measure|outcome measure
4876877|NCT02194010|Patient Reported Questionnaires|patient reported questionnaires
4876878|NCT02193984|Diabetes|diabetes
4876879|NCT02193984|Peer support|peer support
4876880|NCT02193984|Hispanic|hispanic
4876881|NCT02193984|Latino|latino
4876882|NCT02193971|Acute coronary syndrome|acute coronary syndrome
4876883|NCT02193971|Drug eluting stent|drug eluting stent
4876884|NCT02193971|Everolimus|everolimus
4876885|NCT02193971|Prasugrel|prasugrel
4876886|NCT02193958|Acute Myeloid Leukemia|acute myeloid leukemia
4876887|NCT02193958|Chronic Myelomonocytic Leukemia|chronic myelomonocytic leukemia
4876888|NCT02193958|Myelodysplastic Syndrome|myelodysplastic syndrome
4876889|NCT02193932|EEG triggered|eeg triggered
4876890|NCT02193932|fMRI|fmri
4876891|NCT02193932|epilepsy|epilepsy
4876892|NCT02193932|intractable|intractable
4876893|NCT02193919|psoriasis|psoriasis
4876894|NCT02193906|Cognitive training|cognitive training
4876895|NCT02193906|Multiple sclerosis|multiple sclerosis
4876896|NCT02193906|Cognitive deficits|cognitive deficits
4876897|NCT02193893|cell-based therapy|cell-based therapy
4876898|NCT02193893|autologous bone marrow-derived stem/progenitor cells|autologous bone marrow-derived stem/progenitor cells
4876899|NCT02193893|stem cell infusion, stem cell transplantation|stem cell infusion, stem cell transplantation
4876900|NCT02193893|biological therapy with neurotrophic factors|biological therapy with neurotrophic factors
4876901|NCT02193893|bioactive neurotrophic factors|bioactive neurotrophic factors
4876902|NCT02193880|stem cell transplant|stem cell transplant
4876903|NCT02193867|LIPA|lipa
4876904|NCT02193867|Wolman Disease|wolman disease
4876905|NCT02193867|Wolman Phenotype|wolman phenotype
4876906|NCT02193867|Acid Lipase Deficiency|acid lipase deficiency
4876907|NCT02193867|Acid Cholesteryl Hydrolase|acid cholesteryl hydrolase
4876908|NCT02193867|Acid Lipase Disease Deficiency, type 2|acid lipase disease deficiency, type 2
4876909|NCT02193867|Cholesteryl Ester Storage Disease (CESD)|cholesteryl ester storage disease (cesd)
4876910|NCT02193867|Cholesteryl Ester Hydrolase Deficiency|cholesteryl ester hydrolase deficiency
4876911|NCT02193867|Early Onset Lysosomal Acid Lipase Deficiency (Wolman Disease)|early onset lysosomal acid lipase deficiency (wolman disease)
4876912|NCT02193867|LAL Deficiency|lal deficiency
4876913|NCT02193867|Late Onset Lysosomal Acid Lipase Deficiency (CESD)|late onset lysosomal acid lipase deficiency (cesd)
4876914|NCT02193867|Wolman Disease (early onset LAL Deficiency)|wolman disease (early onset lal deficiency)
4876915|NCT02193867|Related Disorders:|related disorders:
4876916|NCT02193867|Non-alcoholic Fatty Liver Disease (NAFLD)|non-alcoholic fatty liver disease (nafld)
4876917|NCT02193867|Non-alcoholic Steatohepatitis (NASH)|non-alcoholic steatohepatitis (nash)
4876918|NCT02193867|Alcoholic Liver Disease|alcoholic liver disease
4876919|NCT02193867|Cryptogenic Cirrhosis|cryptogenic cirrhosis
4876920|NCT02193867|Niemann-Pick Disease (NPD) Type C|niemann-pick disease (npd) type c
4876921|NCT02193867|Chanarin Dorfman Syndrome|chanarin dorfman syndrome
4876922|NCT02193854|Telemedicine|telemedicine
4876923|NCT02193854|Mobile phone|mobile phone
4876924|NCT02193854|Rural physicians|rural physicians
4876925|NCT02193854|Mongolia|mongolia
4876926|NCT02193841|Simple bone cyst|simple bone cyst
4876927|NCT02193841|Unicameral bone cyst|unicameral bone cyst
4876928|NCT02193828|Dupuytren's nodules|dupuytren's nodules
4876929|NCT02193815|psoriasis|psoriasis
4876930|NCT02193815|plaque|plaque
4876931|NCT02193815|vulgaris|vulgaris
4876932|NCT02193815|phase 1|phase 1
4876933|NCT02193815|randomized|randomized
4876934|NCT02193815|double-blind|double-blind
4876935|NCT02193815|topical|topical
4876936|NCT02193815|safety|safety
4876937|NCT02193802|Crohn's disease|crohn's disease
4876938|NCT02193802|small bowel (SB)|small bowel (sb)
4876939|NCT02193802|capsule endoscopy|capsule endoscopy
4876940|NCT02193802|ileocolonoscopy|ileocolonoscopy
4876941|NCT02193802|anti-TNF-alpha antibodies|anti-tnf-alpha antibodies
4876942|NCT02193789|Anastomosis site structure|anastomosis site structure
4876943|NCT02193789|Stent insertion|stent insertion
4876944|NCT02193789|Stent migration|stent migration
4876945|NCT02193776|Tuberculosis|tuberculosis
4876946|NCT02193776|Multi Drug-Resistant Tuberculosis|multi drug-resistant tuberculosis
4876947|NCT02193776|Drug-Sensitive Tuberculosis|drug-sensitive tuberculosis
4876948|NCT02193776|PA-824|pa-824
4876949|NCT02193776|Bedaquiline|bedaquiline
4876950|NCT02193776|Moxifloxacin|moxifloxacin
4876951|NCT02193776|Pyrazinamide|pyrazinamide
4876952|NCT02193776|Quinolone|quinolone
4876953|NCT02193776|Pretomanid|pretomanid
4876954|NCT02193776|NC-005|nc-005
4876955|NCT02193763|pediatric|pediatric
4876956|NCT02193763|lumbar puncture|lumbar puncture
4876957|NCT02193763|ultrasonography|ultrasonography
4876958|NCT02193763|efficacy|efficacy
4876959|NCT02193750|Crohn's Disease|crohn's disease
4876960|NCT02193724|Heritable Retinoblastoma|heritable retinoblastoma
4876961|NCT02193724|Familial Retinoblastoma|familial retinoblastoma
4876962|NCT02193724|Pluripotent Stem Cells|pluripotent stem cells
4876963|NCT02193698|POEMS syndrome|poems syndrome
4876964|NCT02193698|lenalidomide|lenalidomide
4877214|NCT02192606|Total Hysterectomy|total hysterectomy
4876965|NCT02193685|(HAEC) Hirschsprung Associated Entrocolistis|(haec) hirschsprung associated entrocolistis
4876966|NCT02193685|(HD) Hirschsprung Disease|(hd) hirschsprung disease
4876967|NCT02193685|(IBD) Inflammatory Bowel Disease|(ibd) inflammatory bowel disease
4876968|NCT02193685|Children|children
4876969|NCT02193672|Advanced cancers|advanced cancers
4876970|NCT02193672|PET/CT|pet/ct
4876971|NCT02193672|Positron emission tomography / computed tomography|positron emission tomography / computed tomography
4876972|NCT02193672|[18F]Fluciclatide|[18f]fluciclatide
4876973|NCT02193672|Chemotherapy|chemotherapy
4876974|NCT02193672|Phone calls|phone calls
4876975|NCT02193659|breakfast cereal|breakfast cereal
4876976|NCT02193659|omega-3|omega-3
4876977|NCT02193659|cholesterol|cholesterol
4876978|NCT02193659|lipidic profile|lipidic profile
4876979|NCT02193659|consumption|consumption
4876980|NCT02193659|acceptability|acceptability
4876981|NCT02193646|Colonoscopy|colonoscopy
4876982|NCT02193646|Adenoma|adenoma
4876983|NCT02193646|ADR|adr
4876984|NCT02193646|Screening Colon Cancer|screening colon cancer
4876985|NCT02193620|Analgesic|analgesic
4876986|NCT02193620|Narcotics|narcotics
4876987|NCT02193620|Opioids|opioids
4876988|NCT02193620|Pain relief after surgery|pain relief after surgery
4876989|NCT02193607|Occult stress incontinence|occult stress incontinence
4876990|NCT02193607|Pelvic Organ Prolapse|pelvic organ prolapse
4876991|NCT02193607|Surgical Intervention|surgical intervention
4876992|NCT02193607|TVT-O(Tension-free vaginal tape-obturator)|tvt-o(tension-free vaginal tape-obturator)
4876993|NCT02193607|Improved Reconstructive Pelvic Surgery|improved reconstructive pelvic surgery
4876994|NCT02193607|Combined Surgery|combined surgery
4876995|NCT02193607|Two-step Approach|two-step approach
4876996|NCT02193607|Prophylactic Incontinence Procedure|prophylactic incontinence procedure
4876997|NCT02193607|Randomized Controlled Trial|randomized controlled trial
4876998|NCT02193594|Preoperative concurrent chemoradiotherapy|preoperative concurrent chemoradiotherapy
4876999|NCT02193594|Neoadjuvant chemoradiotherapy|neoadjuvant chemoradiotherapy
4877097|NCT02193113|Plasma Kallikrein inhibitor|plasma kallikrein inhibitor
4877000|NCT02193594|Gastroesophageal junction adenocarcinoma|gastroesophageal junction adenocarcinoma
4877001|NCT02193568|Supratentorial Glioma|supratentorial glioma
4877002|NCT02193568|Craniotomy|craniotomy
4877003|NCT02193555|Presbyopia|presbyopia
4877004|NCT02193555|Refractive error correction|refractive error correction
4877005|NCT02193555|Contact lenses|contact lenses
4877006|NCT02193542|regional anesthesia|regional anesthesia
4877007|NCT02193542|general anesthesia|general anesthesia
4877008|NCT02193542|obstetric|obstetric
4877009|NCT02193529|sleeve gastrectomy, dietary intake, morbid obesity.|sleeve gastrectomy, dietary intake, morbid obesity.
4877010|NCT02193503|cancer|cancer
4877011|NCT02193503|solid tumors|solid tumors
4877012|NCT02193503|gene therapy|gene therapy
4877013|NCT02193503|cell therapy|cell therapy
4877014|NCT02193503|encapsulation|encapsulation
4877015|NCT02193490|DNase, Pulmozyme, dry eye disease, treatment|dnase, pulmozyme, dry eye disease, treatment
4877016|NCT02193464|inflammatory bowel disease, registry, incidence, Korea|inflammatory bowel disease, registry, incidence, korea
4877017|NCT02193451|Lower urinary tract symptoms|lower urinary tract symptoms
4877018|NCT02193451|Male LUTS|male luts
4877019|NCT02193451|Voiding dysfunction|voiding dysfunction
4877020|NCT02193451|Benign prostate obstruction|benign prostate obstruction
4877021|NCT02193451|Detrusor underactivity|detrusor underactivity
4877022|NCT02193438|Heart rate variability|heart rate variability
4877023|NCT02193438|Resting energy expenditure|resting energy expenditure
4877024|NCT02193438|Facial thermography|facial thermography
4877025|NCT02193438|Blood pressure|blood pressure
4877026|NCT02193438|Spices ingestion|spices ingestion
4877027|NCT02193425|Brain|brain
4877028|NCT02193425|Connectivity|connectivity
4877029|NCT02193425|PET|pet
4877030|NCT02193425|fcMRI|fcmri
4877031|NCT02193425|18FDG|18fdg
4877032|NCT02193412|analgesia nociception index|analgesia nociception index
4877033|NCT02193412|heart rate variability|heart rate variability
4877034|NCT02193412|autonomic nervous system|autonomic nervous system
4877035|NCT02193412|specificity|specificity
4877036|NCT02193412|systemic venous return|systemic venous return
4877037|NCT02193412|pulse pressure variation|pulse pressure variation
4877038|NCT02193412|Intraoperative Monitoring|intraoperative monitoring
4877039|NCT02193399|Stem cell transplantation|stem cell transplantation
4877040|NCT02193399|Fatigue|fatigue
4877041|NCT02193399|Physiotherapy|physiotherapy
4877042|NCT02193399|Quality of Life|quality of life
4877043|NCT02193399|Cancer|cancer
4877044|NCT02193399|Psychosocial aspects|psychosocial aspects
4877045|NCT02193386|Cerebral Palsy|cerebral palsy
4877046|NCT02193386|Physical Therapy|physical therapy
4877047|NCT02193386|gait analysis|gait analysis
4877048|NCT02193386|gross motor function|gross motor function
4877049|NCT02193373|Osteopathic Manipulative Medicine|osteopathic manipulative medicine
4877050|NCT02193373|Autonomic Nervous System|autonomic nervous system
4877051|NCT02193373|Heart Rate Variability|heart rate variability
4877052|NCT02193373|Sub-Occipital Release|sub-occipital release
4877053|NCT02193373|Rib-Raising|rib-raising
4877054|NCT02193373|Stellate Ganglion Release|stellate ganglion release
4877055|NCT02193360|Inflammation|inflammation
4877056|NCT02193360|PBC|pbc
4877057|NCT02193347|Immunotherapy|immunotherapy
4877058|NCT02193347|Adult|adult
4877059|NCT02193334|Hepatocyte Growth Factor|hepatocyte growth factor
4877060|NCT02193334|HGF|hgf
4877061|NCT02193334|KP-100IT|kp-100it
4877062|NCT02193334|Intrathecal injection|intrathecal injection
4877063|NCT02193321|Atrial Fibrillation|atrial fibrillation
4877064|NCT02193321|Amniotic Membrane|amniotic membrane
4877065|NCT02193295|Weight Reduction|weight reduction
4877066|NCT02193295|Caloric Restriction|caloric restriction
4877067|NCT02193295|Euglycemic Hyperinsulinemic Clamp|euglycemic hyperinsulinemic clamp
4877068|NCT02193295|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
4877069|NCT02193269|Abstinent cocaine users|abstinent cocaine users
4877070|NCT02193269|minocycline|minocycline
4877071|NCT02193269|antibiotic|antibiotic
4877072|NCT02193256|varenicline|varenicline
4877073|NCT02193256|prazosin|prazosin
4877074|NCT02193256|cigarette smoking|cigarette smoking
4877075|NCT02193256|alcohol drinking|alcohol drinking
4877076|NCT02193256|sleep|sleep
4877077|NCT02193256|dreams|dreams
4877078|NCT02193243|Congenital Heart Disease|congenital heart disease
4877079|NCT02193243|Six Minute Walk Test|six minute walk test
4877080|NCT02193243|Exercise Testing|exercise testing
4877081|NCT02193243|Peak oxygen uptake|peak oxygen uptake
4877082|NCT02193230|Atopic dermatitis, Feasibility, Adherence to treatment|atopic dermatitis, feasibility, adherence to treatment
4877083|NCT02193204|Alcohol dependence|alcohol dependence
4877084|NCT02193204|Stress|stress
4877085|NCT02193204|Cytokines|cytokines
4877086|NCT02193204|Depressive Symptomatology|depressive symptomatology
4877087|NCT02193191|Plerixafor|plerixafor
4877088|NCT02193191|13-229|13-229
4877089|NCT02193152|Advanced Non-Small Cell Lung Cancer|advanced non-small cell lung cancer
4877090|NCT02193152|NSCLC|nsclc
4877091|NCT02193152|Pazopanib|pazopanib
4877092|NCT02193126|Long term foster care|long term foster care
4877093|NCT02193126|child abuse and neglect|child abuse and neglect
4877094|NCT02193126|trauma|trauma
4877095|NCT02193113|Diabetic Macular Edema|diabetic macular edema
4877096|NCT02193113|DME|dme
4877099|NCT02193113|KVD001-001|kvd001-001
4877100|NCT02193113|Intravitreal|intravitreal
4877101|NCT02193113|IVT|ivt
4877102|NCT02193113|Diabetes mellitus|diabetes mellitus
4877103|NCT02193087|Drug therapy|drug therapy
4877104|NCT02193074|Spinal Muscular Atrophy|spinal muscular atrophy
4877105|NCT02193074|SMA|sma
4877106|NCT02193074|SMN|smn
4877107|NCT02193074|SMNRx|smnrx
4877108|NCT02193074|ISIS-SMNRx|isis-smnrx
4877109|NCT02193074|ISIS-SMN Rx|isis-smn rx
4877110|NCT02193074|ISIS 396443|isis 396443
4877111|NCT02193074|IONIS-SMNRx|ionis-smnrx
4877112|NCT02193074|IONIS-SMN Rx|ionis-smn rx
4877113|NCT02193074|Spinraza|spinraza
4877114|NCT02193074|ENDEAR|endear
4877115|NCT02193061|Rotavirus|rotavirus
4877116|NCT02193061|immunological behavior|immunological behavior
4877117|NCT02193061|Rotarix|rotarix
4877118|NCT02193061|RotaTeq|rotateq
4877119|NCT02193061|vaccine interchangeability|vaccine interchangeability
4877120|NCT02193035|Microparticles|microparticles
4877121|NCT02193035|Severe aortic stenosis|severe aortic stenosis
4877122|NCT02193035|Calcified aortic stenosis|calcified aortic stenosis
4877123|NCT02193035|transcatheter aortic valve replacement|transcatheter aortic valve replacement
4877124|NCT02193022|Bangladesh, PKDL, Visceral Leishmaniasis, Children, Miltefosine|bangladesh, pkdl, visceral leishmaniasis, children, miltefosine
4877125|NCT02192996|VLBW preterm|vlbw preterm
4877126|NCT02192996|GUT microbiota|gut microbiota
4877127|NCT02192996|probiotics supplementation|probiotics supplementation
4877128|NCT02192996|immune compounds|immune compounds
4877129|NCT02192970|Retinal detachment|retinal detachment
4877130|NCT02192970|Proliferative vitreoretinopathy|proliferative vitreoretinopathy
4877131|NCT02192957|cardioversion|cardioversion
4877132|NCT02192957|electrical cardioversion|electrical cardioversion
4877133|NCT02192957|atrial fibrillation|atrial fibrillation
4877134|NCT02192957|cardioversion protocol|cardioversion protocol
4877135|NCT02192944|ECG|ecg
4877136|NCT02192944|Pharmacokinetic profile|pharmacokinetic profile
4877137|NCT02192892|Young children|young children
4877138|NCT02192892|Acceptability|acceptability
4877139|NCT02192892|Food intake|food intake
4877140|NCT02192892|Energy dense porridge|energy dense porridge
4877141|NCT02192879|thoracic epidural|thoracic epidural
4877142|NCT02192879|continuous paravertebral catheter|continuous paravertebral catheter
4877143|NCT02192879|PCA|pca
4877144|NCT02192879|liver resection|liver resection
4877145|NCT02192879|pain management|pain management
4877146|NCT02192853|Diabetes Mellitus|diabetes mellitus
4877147|NCT02192853|Glucagon-like peptide 1|glucagon-like peptide 1
4877148|NCT02192853|Dipeptidyl peptidase 4|dipeptidyl peptidase 4
4877149|NCT02192853|Dipeptidyl peptidase 4 inhibitor|dipeptidyl peptidase 4 inhibitor
4877150|NCT02192853|sitagliptin|sitagliptin
4877151|NCT02192853|Enzyme activity|enzyme activity
4877152|NCT02192840|provisional T stenting|provisional t stenting
4877153|NCT02192840|dedicated bifurcation stent|dedicated bifurcation stent
4877154|NCT02192827|Pediatric|pediatric
4877155|NCT02192827|Asthma|asthma
4877156|NCT02192827|Exacerbation|exacerbation
4877157|NCT02192827|Dexamethasone|dexamethasone
4877158|NCT02192827|Peak flow|peak flow
4877159|NCT02192814|Lacosamide|lacosamide
4877160|NCT02192814|LCM|lcm
4877161|NCT02192814|Epilepsy|epilepsy
4877162|NCT02192814|Partial-onset seizures|partial-onset seizures
4877163|NCT02192814|iv|iv
4877164|NCT02192801|Classic Bladder Exstrophy|classic bladder exstrophy
4877165|NCT02192801|Renal function|renal function
4877166|NCT02192801|GFR|gfr
4877167|NCT02192801|Proteinuria|proteinuria
4877168|NCT02192788|SBRT|sbrt
4877169|NCT02192788|Oligometastases|oligometastases
4877170|NCT02192788|Prostate Cancer|prostate cancer
4877171|NCT02192775|Measles virus|measles virus
4877172|NCT02192775|Sodium Iodide Symporter|sodium iodide symporter
4877173|NCT02192775|Cyclophosphamide|cyclophosphamide
4877174|NCT02192775|Refractory multiple myeloma|refractory multiple myeloma
4877175|NCT02192749|autism|autism
4877176|NCT02192749|umbilical cord|umbilical cord
4877177|NCT02192749|mesenchymal|mesenchymal
4877178|NCT02192749|stem cells|stem cells
4877179|NCT02192736|asthma|asthma
4877180|NCT02192736|umbilical cord|umbilical cord
4877181|NCT02192736|mesenchymal|mesenchymal
4877182|NCT02192736|stem cells|stem cells
4877183|NCT02192736|trophic factors|trophic factors
4877184|NCT02192710|outpatient surgery|outpatient surgery
4877185|NCT02192710|anaesthesia|anaesthesia
4877186|NCT02192710|midazolam|midazolam
4877187|NCT02192710|electronic tab|electronic tab
4877188|NCT02192697|safety|safety
4877189|NCT02192697|pharmacokinetics|pharmacokinetics
4877190|NCT02192697|tolerability|tolerability
4877191|NCT02192697|ASP8273|asp8273
4877192|NCT02192697|Non-small Cell Lung Cancer|non-small cell lung cancer
4877193|NCT02192697|T790M resistance mutation|t790m resistance mutation
4877194|NCT02192697|NSCLC|nsclc
4877195|NCT02192697|Epidermal Growth Factor Receptor mutations|epidermal growth factor receptor mutations
4877196|NCT02192697|irreversible EGFR inhibitor|irreversible egfr inhibitor
4877197|NCT02192697|antitumor activity|antitumor activity
4877198|NCT02192697|EGFR|egfr
4877199|NCT02192684|obstructive sleep apnea|obstructive sleep apnea
4877200|NCT02192684|insulin sensitivity|insulin sensitivity
4877201|NCT02192684|cardiovascular risk|cardiovascular risk
4877202|NCT02192684|positive airway pressure therapy|positive airway pressure therapy
4877203|NCT02192671|hepatocellular carcinoma|hepatocellular carcinoma
4877204|NCT02192671|radiofrequency ablation|radiofrequency ablation
4877205|NCT02192671|hepatic resection|hepatic resection
4877206|NCT02192671|portal hypertension|portal hypertension
4877207|NCT02192671|Milan criteria|milan criteria
4877208|NCT02192671|randomized critical trial|randomized critical trial
4877209|NCT02192619|APL|apl
4877210|NCT02192619|acute promyelocytic leukemia|acute promyelocytic leukemia
4877211|NCT02192619|AML M3|aml m3
4877212|NCT02192606|Laparoscopy|laparoscopy
4877213|NCT02192606|3D Visual System|3d visual system
4877215|NCT02192567|Advanced solid malignant tumor|advanced solid malignant tumor
4877216|NCT02192567|phase 1|phase 1
4877217|NCT02192567|oncology|oncology
4877218|NCT02192554|OPC-34712|opc-34712
4877219|NCT02192554|brexpiprazole|brexpiprazole
4877220|NCT02192554|Dementia|dementia
4877221|NCT02192554|Alzheimer's Disease|alzheimer's disease
4877222|NCT02192554|Cognitive Disorders|cognitive disorders
4877223|NCT02192554|Memory|memory
4877224|NCT02192554|Agitation|agitation
4877225|NCT02192541|Urothelial Carcinomas|urothelial carcinomas
4877226|NCT02192541|Non-Squamous Non-Small Cell Lung Carcinomas|non-squamous non-small cell lung carcinomas
4877227|NCT02192541|Refractory Gastrointestinal Carcinomas|refractory gastrointestinal carcinomas
4877228|NCT02192541|Hsp90 Inhibitor|hsp90 inhibitor
4877229|NCT02192541|Sarcomas|sarcomas
4877230|NCT02192528|vitamin D|vitamin d
4877231|NCT02192528|25-hydroxyvitamin D|25-hydroxyvitamin d
4877232|NCT02192528|1,25-dihydroxyvitamin D|1,25-dihydroxyvitamin d
4877233|NCT02192528|MACCE|macce
4877234|NCT02192528|mortality|mortality
4877235|NCT02192528|cardiac|cardiac
4877236|NCT02192528|cerebrovascular|cerebrovascular
4877237|NCT02192515|Healthy Subjects|healthy subjects
4877238|NCT02192515|Japanese Adult|japanese adult
4877239|NCT02192489|Chronic Cutaneous Sarcoidosis|chronic cutaneous sarcoidosis
4877240|NCT02192489|Cutaneous Sarcoidosis|cutaneous sarcoidosis
4877241|NCT02192489|Skin Sarcoidosis|skin sarcoidosis
4877242|NCT02192489|Sarcoidosis|sarcoidosis
4877243|NCT02192476|Stroke, subluxation|stroke, subluxation
4877244|NCT02192450|Diabetes Mellitus|diabetes mellitus
4877245|NCT02192450|Hypoglycaemia|hypoglycaemia
4877246|NCT02192450|Glucose Metabolism Disorders|glucose metabolism disorders
4877247|NCT02192450|Metabolic Diseases|metabolic diseases
4877248|NCT02192450|Endocrine System Diseases|endocrine system diseases
4877249|NCT02192450|Autoimmune Diseases|autoimmune diseases
4877250|NCT02192450|Insulin|insulin
4877251|NCT02192450|Hypoglycaemic Agents|hypoglycaemic agents
4877252|NCT02192450|Physiological Effetcs of Drugs|physiological effetcs of drugs
4877253|NCT02192437|methionine|methionine
4877254|NCT02192437|cysteine|cysteine
4877255|NCT02192437|sulfur amino acid restriction|sulfur amino acid restriction
4877256|NCT02192424|beta-cell function,|beta-cell function,
4877257|NCT02192424|type 2 diabetes,|type 2 diabetes,
4877258|NCT02192424|intermittent insulin|intermittent insulin
4877259|NCT02192411|lidocaine|lidocaine
4877260|NCT02192411|tumescent|tumescent
4877261|NCT02192411|endovenous|endovenous
4877262|NCT02192411|laser|laser
4877263|NCT02192411|pain|pain
4877264|NCT02192398|Pain|pain
4877265|NCT02192398|Pain management|pain management
4877266|NCT02192398|Neck|neck
4877267|NCT02192398|Back|back
4877268|NCT02192372|creatinine|creatinine
4877269|NCT02192372|glomerular filtration rate|glomerular filtration rate
4877270|NCT02192372|metabolic syndrome|metabolic syndrome
4877271|NCT02192346|metastatic|metastatic
4877272|NCT02192346|refractory|refractory
4877273|NCT02192346|progressive|progressive
4877274|NCT02192320|Atorvastatin|atorvastatin
4877275|NCT02192320|Atorvastatin and Dexamethasone|atorvastatin and dexamethasone
4877276|NCT02192320|Chronic Subdural Hematoma|chronic subdural hematoma
4877277|NCT02192320|conservative treatment|conservative treatment
4877278|NCT02192307|Sensitivity|sensitivity
4877279|NCT02192294|Bosutinib|bosutinib
4877280|NCT02192294|absolute bioavailability|absolute bioavailability
4877281|NCT02192281|Physical activity|physical activity
4877282|NCT02192281|Recess|recess
4877283|NCT02192281|Accelerometer|accelerometer
4877284|NCT02192281|Play|play
4877285|NCT02192255|diabetes type 2|diabetes type 2
4877286|NCT02192255|primary care|primary care
4877287|NCT02192255|chronic disease care improvement|chronic disease care improvement
4877288|NCT02192255|adherence, randomized trial|adherence, randomized trial
4877289|NCT02192255|BP control|bp control
4877290|NCT02192255|lipid control|lipid control
4877291|NCT02192255|glucose control|glucose control
4877292|NCT02192255|natural language processing.|natural language processing.
4877293|NCT02192242|acute ischemic pain|acute ischemic pain
4877294|NCT02192242|model|model
4877295|NCT02192242|S100|s100
4877296|NCT02192242|interleukine 6|interleukine 6
4877297|NCT02192216|Body composition|body composition
4877298|NCT02192216|Chemotherapy|chemotherapy
4877299|NCT02192216|Muscle mass|muscle mass
4877300|NCT02192216|Muscle function|muscle function
4877301|NCT02192216|Exercise|exercise
4877302|NCT02192177|Apoptosis|apoptosis
4877303|NCT02192177|intrahepatic cholestasis|intrahepatic cholestasis
4877304|NCT02192177|obstetric outcomes|obstetric outcomes
4877305|NCT02192164|plaque psoriasis|plaque psoriasis
4877306|NCT02192164|smoking|smoking
4877307|NCT02192164|etanercept|etanercept
4877308|NCT02192151|Analgesic|analgesic
4877309|NCT02192151|Narcotics|narcotics
4877310|NCT02192151|Opioids|opioids
4877311|NCT02192151|Non-scheduled substanse|non-scheduled substanse
4877312|NCT02192138|Pleural effusion|pleural effusion
4877313|NCT02192138|Pleural fluid|pleural fluid
4877314|NCT02192138|Thoracentesis|thoracentesis
4877315|NCT02192138|Intrapleural pressure|intrapleural pressure
4877316|NCT02192138|Pleural manometry|pleural manometry
4877317|NCT02192125|stroke|stroke
4877318|NCT02192125|rehabilitation|rehabilitation
4877319|NCT02192125|balance|balance
4877320|NCT02192125|training|training
4877321|NCT02192125|posture|posture
4877322|NCT02192086|Kidney transplantation|kidney transplantation
4877323|NCT02192060|Biofilm|biofilm
4877324|NCT02192060|Triclosan|triclosan
4877325|NCT02192060|Crossover|crossover
4877326|NCT02192060|Clinical trial|clinical trial
4877327|NCT02192034|Colonoscopy|colonoscopy
4877328|NCT02192034|Colon cancer|colon cancer
4877329|NCT02192034|screening|screening
4877330|NCT02192034|navigation|navigation
4877331|NCT02192021|CTCL|ctcl
4877332|NCT02192021|Cutaneous T-cell Lymphoma|cutaneous t-cell lymphoma
4877333|NCT02192021|Mycosis Fungoides|mycosis fungoides
4877334|NCT02192008|Challenge|challenge
4877335|NCT02192008|Re-challenge|re-challenge
4877336|NCT02192008|Controlled Infection|controlled infection
4877337|NCT02192008|Enteric fever|enteric fever
4877338|NCT02191982|Cancer|cancer
4877339|NCT02191982|Chemotherapy|chemotherapy
4877340|NCT02191982|Fatigue|fatigue
4877341|NCT02191982|Elderly|elderly
4877342|NCT02191982|Geriatric|geriatric
4877343|NCT02191982|Any Cancer|any cancer
4877344|NCT02191982|Cancer Treatment|cancer treatment
4877345|NCT02191982|Weakness|weakness
4877346|NCT02191982|Tiredness|tiredness
4877347|NCT02191969|Chemotherapy|chemotherapy
4877348|NCT02191969|Adjuvant Chemotherapy|adjuvant chemotherapy
4877349|NCT02191969|Cancer Therapy|cancer therapy
4877350|NCT02191969|Fatigue|fatigue
4877351|NCT02191969|Physical Activity|physical activity
4877352|NCT02191969|Physical Function|physical function
4877353|NCT02191969|Tiredness|tiredness
4877354|NCT02191969|Colon Cancer|colon cancer
4877355|NCT02191969|Rectal Cancer|rectal cancer
4877356|NCT02191969|Walk With Ease|walk with ease
4877357|NCT02191969|Colorectal Cancer|colorectal cancer
4877358|NCT02191969|Geriatric Assessment|geriatric assessment
4877359|NCT02191969|Geriatric|geriatric
4877360|NCT02191969|Elderly|elderly
4877361|NCT02191956|Disruptive behavior disorders|disruptive behavior disorders
4877362|NCT02191956|Early Onset|early onset
4877363|NCT02191956|Young Children|young children
4877364|NCT02191956|Parenting|parenting
4877365|NCT02191956|Behavioral Parent Training|behavioral parent training
4877366|NCT02191943|caries|caries
4877367|NCT02191943|proximal|proximal
4877368|NCT02191943|non-cavitated|non-cavitated
4877369|NCT02191943|fluoridation|fluoridation
4877370|NCT02191878|Liver Cancer|liver cancer
4877371|NCT02191878|Liver Neoplasms|liver neoplasms
4877372|NCT02191878|Liver Epithelial Neoplasms|liver epithelial neoplasms
4877373|NCT02191878|Liver Cancer, malignant|liver cancer, malignant
4877374|NCT02191839|cardiac surgery|cardiac surgery
4877375|NCT02191839|alpha 1 antitrypsin|alpha 1 antitrypsin
4877376|NCT02191839|inflammation|inflammation
4877377|NCT02191839|post operative bleeding|post operative bleeding
4877378|NCT02191839|organ function|organ function
4877379|NCT02191826|Transthyretin|transthyretin
4877381|NCT02191826|Amyloidosis|amyloidosis
4877382|NCT02191826|SOM0226|som0226
4877383|NCT02191826|Familiar Amyloid Polyneuropathy|familiar amyloid polyneuropathy
4877384|NCT02191774|Medical abortion|medical abortion
4877385|NCT02191774|Home abortion|home abortion
4877386|NCT02191683|Anaemia|anaemia
4877387|NCT02191683|Pregnancy|pregnancy
4877388|NCT02191683|Foetal programming|foetal programming
4877389|NCT02191683|Epigenetics|epigenetics
4877390|NCT02191683|Non-communicable diseases|non-communicable diseases
4877391|NCT02191683|Tanzania|tanzania
4877392|NCT02191657|HIV|hiv
4877393|NCT02191657|deferiprone|deferiprone
4877394|NCT02191657|iron chelation|iron chelation
4877395|NCT02191631|OCD|ocd
4877396|NCT02191631|adolescents|adolescents
4877397|NCT02191631|pediatric|pediatric
4877398|NCT02191631|internet|internet
4877399|NCT02191631|online|online
4877400|NCT02191631|CBT|cbt
4877401|NCT02191618|Aneurysm|aneurysm
4877402|NCT02191618|Intracranial Aneurysm|intracranial aneurysm
4877403|NCT02191618|Vascular Diseases|vascular diseases
4877404|NCT02191618|Cardiovascular Diseases|cardiovascular diseases
4877405|NCT02191618|Intracranial Arterial Diseases|intracranial arterial diseases
4877406|NCT02191618|Cerebrovascular Disorders|cerebrovascular disorders
4877407|NCT02191618|Brain Diseases|brain diseases
4877408|NCT02191618|Central Nervous System Diseases|central nervous system diseases
4877409|NCT02191618|Nervous System Diseases|nervous system diseases
4877410|NCT02191605|Computerized Brief Intervention|computerized brief intervention
4877411|NCT02191592|Tinnitus|tinnitus
4877412|NCT02191592|EMA|ema
4877413|NCT02191592|Bothersome|bothersome
4877414|NCT02191566|Stomach Cancer|stomach cancer
4877415|NCT02191553|mindfulness meditation|mindfulness meditation
4877416|NCT02191553|alpha rhythm|alpha rhythm
4877417|NCT02191553|EEG|eeg
4877418|NCT02191553|brain mapping|brain mapping
4877419|NCT02191553|emotion|emotion
4877420|NCT02191553|attention|attention
4877421|NCT02191527|PMTCT|pmtct
4877422|NCT02191527|HIV|hiv
4877423|NCT02191527|Syphilis|syphilis
4877424|NCT02191527|Anemia during pregnancy|anemia during pregnancy
4877425|NCT02191527|Point of care diagnostics|point of care diagnostics
4877426|NCT02191514|Prehospital|prehospital
4877427|NCT02191514|EMS|ems
4877428|NCT02191514|EMD|emd
4877429|NCT02191514|Stroke|stroke
4877430|NCT02191514|Dispatch|dispatch
4877431|NCT02191501|Obesity Treatment|obesity treatment
4877432|NCT02191501|Endoscopy|endoscopy
4877433|NCT02191501|Pyloric Suturing|pyloric suturing
4877434|NCT02191501|Pyloric restriction|pyloric restriction
4877435|NCT02191488|Fluorescence|fluorescence
4877436|NCT02191488|Brain Tumors|brain tumors
4877437|NCT02191488|Brain Metastases|brain metastases
4877438|NCT02191488|Malignant Glioma|malignant glioma
4877439|NCT02191488|Brain Lesions|brain lesions
4877440|NCT02191475|sepsis shock|sepsis shock
4877441|NCT02191475|Tigecycline|tigecycline
4877442|NCT02191475|Piperacillin / tazobactam|piperacillin / tazobactam
4877443|NCT02191475|Abdominal infection|abdominal infection
4877444|NCT02191462|Pharmacokinetics|pharmacokinetics
4877445|NCT02191462|Niagen|niagen
4877446|NCT02191462|Nicotinamide riboside|nicotinamide riboside
4877447|NCT02191436|Haemophilia|haemophilia
4877448|NCT02191436|Adherence|adherence
4877449|NCT02191436|Family Functioning|family functioning
4877450|NCT02191436|Quality of Life|quality of life
4877451|NCT02191436|Anxiety|anxiety
4877452|NCT02191436|Illness Behavior|illness behavior
4877453|NCT02191436|Coping Strategies|coping strategies
4877454|NCT02191423|postpartum Depression|postpartum depression
4877455|NCT02191423|Diadic psychotherapy|diadic psychotherapy
4877456|NCT02191423|Oxytocin|oxytocin
4877457|NCT02191423|fMRI|fmri
4877458|NCT02191423|attachment|attachment
4877459|NCT02191423|empathy|empathy
4877460|NCT02191410|Video-assisted thoracoscopic surgery|video-assisted thoracoscopic surgery
4877461|NCT02191410|one-lung ventilation|one-lung ventilation
4877462|NCT02191410|continuous positive-airway ventilation|continuous positive-airway ventilation
4877463|NCT02191410|high-frequency positive-pressure ventilation|high-frequency positive-pressure ventilation
4877464|NCT02191410|stroke volume variation|stroke volume variation
4877465|NCT02191410|fluid responsiveness|fluid responsiveness
4877466|NCT02191397|Escitalopram|escitalopram
4877467|NCT02191397|Major depressive disorder|major depressive disorder
4877468|NCT02191397|Non-inferiority|non-inferiority
4877469|NCT02191397|Bupropion|bupropion
4877470|NCT02191371|oxygenation|oxygenation
4877471|NCT02191371|microcirculation|microcirculation
4877472|NCT02191371|one-lung ventilation|one-lung ventilation
4877473|NCT02191371|thoracic surgery|thoracic surgery
4877474|NCT02191358|Cytochrome drug interactions|cytochrome drug interactions
4877475|NCT02191358|Drug-drug interaction|drug-drug interaction
4877476|NCT02191358|Drug-gene interaction|drug-gene interaction
4877477|NCT02191358|Drug-drug-gene interaction|drug-drug-gene interaction
4877478|NCT02191358|Drug Metabolism|drug metabolism
4877479|NCT02191358|Elderly|elderly
4877480|NCT02191358|Geriatric medicine|geriatric medicine
4877481|NCT02191358|Geriatrics|geriatrics
4877482|NCT02191358|Personalized medicine|personalized medicine
4877483|NCT02191358|Pharmacist|pharmacist
4877484|NCT02191358|Pharmacogenetics|pharmacogenetics
4877485|NCT02191358|Pharmacogenomics|pharmacogenomics
4877486|NCT02191358|Pharmacokinetics|pharmacokinetics
4877487|NCT02191358|Polymorphism|polymorphism
4877488|NCT02191358|Polypharmacy|polypharmacy
4877489|NCT02191358|Precision medicine|precision medicine
4877490|NCT02191358|Seniors|seniors
4877491|NCT02191358|YouScript|youscript
4877492|NCT02191358|CYP2C9|cyp2c9
4877493|NCT02191358|CYP2C19|cyp2c19
4877494|NCT02191358|CYP2D6|cyp2d6
4877495|NCT02191358|CYP3A4|cyp3a4
4877496|NCT02191358|CYP3A5|cyp3a5
4877497|NCT02191358|VKORC1|vkorc1
4877498|NCT02191358|Amitriptyline|amitriptyline
4877499|NCT02191358|Aripiprazole|aripiprazole
4877500|NCT02191358|Atomoxetine|atomoxetine
4877501|NCT02191358|Carvedilol|carvedilol
4877502|NCT02191358|Celecoxib|celecoxib
4877503|NCT02191358|Citalopram|citalopram
4877504|NCT02191358|Clobazam|clobazam
4877505|NCT02191358|Clomipramine|clomipramine
4877506|NCT02191358|Clopidogrel|clopidogrel
4877507|NCT02191358|Clozapine|clozapine
4877508|NCT02191358|Codeine|codeine
4877509|NCT02191358|Desipramine|desipramine
4877510|NCT02191358|Dextromethorphan|dextromethorphan
4877511|NCT02191358|Diazepam|diazepam
4877512|NCT02191358|Doxepin|doxepin
4877513|NCT02191358|Escitalopram|escitalopram
4877514|NCT02191358|Esomeprazole|esomeprazole
4877515|NCT02191358|Fesoterodine|fesoterodine
4877516|NCT02191358|Flecainide|flecainide
4877517|NCT02191358|Fluoxetine|fluoxetine
4877518|NCT02191358|Flurbiprofen|flurbiprofen
4877519|NCT02191358|Fluvoxamine|fluvoxamine
4877520|NCT02191358|Haloperidol|haloperidol
4877521|NCT02191358|Hydrocodone|hydrocodone
4877522|NCT02191358|Ibuprofen|ibuprofen
4877523|NCT02191358|Iloperidone|iloperidone
4877524|NCT02191358|Imipramine|imipramine
4877525|NCT02191358|Indomethacin|indomethacin
4877526|NCT02191358|Meloxicam|meloxicam
4877527|NCT02191358|Metoprolol|metoprolol
4877528|NCT02191358|Mexiletine|mexiletine
4877529|NCT02191358|Nortriptyline|nortriptyline
4877530|NCT02191358|Omeprazole|omeprazole
4877531|NCT02191358|Oxycodone|oxycodone
4877532|NCT02191358|Paroxetine|paroxetine
4877533|NCT02191358|Perphenazine|perphenazine
4877534|NCT02191358|Phenobarbital|phenobarbital
4877535|NCT02191358|Phenytoin|phenytoin
4877536|NCT02191358|Pimozide|pimozide
4877537|NCT02191358|Piroxicam|piroxicam
4877538|NCT02191358|Proguanil|proguanil
4877539|NCT02191358|Propafenone|propafenone
4877540|NCT02191358|Propranolol|propranolol
4877541|NCT02191358|Risperidone|risperidone
4877542|NCT02191358|Sertraline|sertraline
4877543|NCT02191358|Tetrabenazine|tetrabenazine
4877544|NCT02191358|Thioridazine|thioridazine
4877545|NCT02191358|Timolol|timolol
4877546|NCT02191358|Tolterodine|tolterodine
4877547|NCT02191358|Torsemide|torsemide
4877548|NCT02191358|Tramadol|tramadol
4877549|NCT02191358|Trimipramine|trimipramine
4877550|NCT02191358|Venlafaxine|venlafaxine
4877551|NCT02191358|Voriconazole|voriconazole
4877552|NCT02191358|Vortioxetine|vortioxetine
4877553|NCT02191345|guided imagery|guided imagery
4877554|NCT02191345|burnout|burnout
4877555|NCT02191345|compassion fatigue|compassion fatigue
4877556|NCT02191345|state anxiety|state anxiety
4877557|NCT02191267|CTE|cte
4877558|NCT02191267|Positron Emission Topography|positron emission topography
4877559|NCT02191267|Tau|tau
4877560|NCT02191267|Beta-amyloid|beta-amyloid
4877561|NCT02191267|Magnetic Resonance Imaging|magnetic resonance imaging
4877562|NCT02191267|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
4877563|NCT02191267|Diffusion Tensor Imaging|diffusion tensor imaging
4877564|NCT02191150|Anaemia, Chronic Kidney Disease, Switching, Aranesp, Darbepoetin Alfa, Epoetin Alfa Biosimilars, Haemodialysis.|anaemia, chronic kidney disease, switching, aranesp, darbepoetin alfa, epoetin alfa biosimilars, haemodialysis.
4877565|NCT02191137|Pulmonary Hypertension,Riociguat,Living with Pulmonary Hypertension Questionnaire|pulmonary hypertension,riociguat,living with pulmonary hypertension questionnaire
4877566|NCT02191124|Measurement-based care|measurement-based care
4877567|NCT02191124|Unipolar depression|unipolar depression
4877568|NCT02191124|Outpatients|outpatients
4877569|NCT02191111|Pharmacist|pharmacist
4877570|NCT02191111|Pharmacy practice|pharmacy practice
4877571|NCT02191111|Patient care|patient care
4877572|NCT02191111|Community pharmacy|community pharmacy
4877573|NCT02191111|Hypertension|hypertension
4877574|NCT02191111|Diabetes|diabetes
4877575|NCT02191111|Dyslipidemia|dyslipidemia
4877576|NCT02191111|Pharmaceutical care|pharmaceutical care
4877577|NCT02191098|HIV|hiv
4877578|NCT02191098|ART|art
4877579|NCT02191072|urticaria,omalizumab|urticaria,omalizumab
4877580|NCT02191059|Non Small Cell Lung Cancer|non small cell lung cancer
4877581|NCT02191059|Wild Type EGFR|wild type egfr
4877582|NCT02191059|Icotinib|icotinib
4877583|NCT02191059|Second-line Treatment|second-line treatment
4877584|NCT02191046|nasal irrigation|nasal irrigation
4877585|NCT02191046|sinusitis|sinusitis
4877586|NCT02191046|children|children
4877587|NCT02191046|buffered hypertonic saline|buffered hypertonic saline
4877588|NCT02191046|nasal irrigation device|nasal irrigation device
4877589|NCT02191033|cigarette smoking|cigarette smoking
4877590|NCT02191033|tobacco use cessation products|tobacco use cessation products
4877591|NCT02191020|Total Glucosides of Paeony(TGP)|total glucosides of paeony(tgp)
4877592|NCT02191020|Acitretin Capsules|acitretin capsules
4877593|NCT02191020|Psoriasis Vulgaris|psoriasis vulgaris
4877594|NCT02190994|Hydrocortisone|hydrocortisone
4877595|NCT02190994|Pituitary adenomas|pituitary adenomas
4877596|NCT02190994|Replacement therapy|replacement therapy
4877597|NCT02190981|Small bowel obstruction|small bowel obstruction
4877598|NCT02190981|Ultrasound|ultrasound
4877599|NCT02190981|Emergency department|emergency department
4877600|NCT02190968|Mindfulness Based Cognitive Therapy|mindfulness based cognitive therapy
4877601|NCT02190968|Internet interventions|internet interventions
4877602|NCT02190968|Residual depressive symptoms|residual depressive symptoms
4877603|NCT02190968|Depressive relapse prevention|depressive relapse prevention
4877604|NCT02190903|delirium|delirium
4877605|NCT02190903|hip fracture|hip fracture
4877606|NCT02190903|general anesthesia|general anesthesia
4877607|NCT02190903|spinal anesthesia|spinal anesthesia
4877608|NCT02190903|postoperative complications|postoperative complications
4877609|NCT02190877|Heart Failure|heart failure
4877610|NCT02190877|Impedance|impedance
4877611|NCT02190877|Fluids|fluids
4877612|NCT02190851|urinary disorders|urinary disorders
4877613|NCT02190851|Parkinson's disease|parkinson's disease
4877614|NCT02190838|Melanoma|melanoma
4877615|NCT02190838|Melatonin|melatonin
4877616|NCT02190838|Metformin|metformin
4877617|NCT02190838|Dacarbazine|dacarbazine
4877618|NCT02190812|wrist muscle strength|wrist muscle strength
4877619|NCT02190799|Corona Virus|corona virus
4877620|NCT02190799|Convalescent plasma|convalescent plasma
4877621|NCT02190799|Serology|serology
4877622|NCT02190786|Hyperuricemia|hyperuricemia
4877623|NCT02190773|Chronic Periodontitis, Aggressive Periodontitis, RANKL/OPG ratio, Gingival crevicular fluid|chronic periodontitis, aggressive periodontitis, rankl/opg ratio, gingival crevicular fluid
4877624|NCT02190747|Intervention study|intervention study
4877625|NCT02190747|Clinical trial Phase 2|clinical trial phase 2
4877626|NCT02190747|Efficacy and safety|efficacy and safety
4877627|NCT02190747|Heterotopic ossification|heterotopic ossification
4877628|NCT02190747|Flare-up|flare-up
4877629|NCT02190747|Palovarotene|palovarotene
4877630|NCT02190747|Retinoic acid receptor agonist|retinoic acid receptor agonist
4877631|NCT02190747|Retinoic acid receptor gamma agonist|retinoic acid receptor gamma agonist
4877632|NCT02190747|Clementia|clementia
4877633|NCT02190747|Myositis Ossificans Progressiva|myositis ossificans progressiva
4877634|NCT02190747|Munchmeyer's Disease|munchmeyer's disease
4877635|NCT02190747|FOP|fop
4877636|NCT02190734|Stroke|stroke
4877637|NCT02190734|Pusher Syndrome|pusher syndrome
4877638|NCT02190734|Lateropulsion|lateropulsion
4877639|NCT02190734|Pushing Behaviors|pushing behaviors
4877640|NCT02190734|Burke Lateropulsion Scale|burke lateropulsion scale
4877641|NCT02190721|Neutropenia|neutropenia
4877642|NCT02190708|PQ912|pq912
4877643|NCT02190708|Midazolam|midazolam
4877644|NCT02190708|Omeprazole|omeprazole
4877645|NCT02190708|Pharmacokinetics|pharmacokinetics
4877646|NCT02190708|Drug Interaction|drug interaction
4877647|NCT02190682|postoperative|postoperative
4877648|NCT02190682|chronic|chronic
4877649|NCT02190682|pain|pain
4877650|NCT02190682|software|software
4877651|NCT02190656|Rectal cancer|rectal cancer
4877652|NCT02190656|Anterior Resection Syndrome|anterior resection syndrome
4877653|NCT02190656|Functional outcomes|functional outcomes
4877654|NCT02190643|Smoking|smoking
4877655|NCT02190643|HIV|hiv
4877656|NCT02190643|Latino|latino
4877657|NCT02190643|Cessation|cessation
4877658|NCT02190643|Nicotine patch|nicotine patch
4877659|NCT02190617|Asthma|asthma
4877660|NCT02190617|Guidelines|guidelines
4877661|NCT02190617|Community Health Worker|community health worker
4877662|NCT02190604|FEV1- Forced Expiratory volume|fev1- forced expiratory volume
4877663|NCT02190604|LCI - Lung Clearance Index|lci - lung clearance index
4877664|NCT02190604|CFTR - cystic fibrosis transmembrane conductance regulator|cftr - cystic fibrosis transmembrane conductance regulator
4877665|NCT02190604|cystic fibrosis|cystic fibrosis
4877666|NCT02190604|allergic bronchopulmonary aspergillosis|allergic bronchopulmonary aspergillosis
4877667|NCT02190591|epidural|epidural
4877668|NCT02190591|pregnant|pregnant
4877669|NCT02190591|Cesarean Section|cesarean section
4877670|NCT02190591|forceps|forceps
4877671|NCT02190591|vaginal|vaginal
4877672|NCT02190565|pregnancy, lactation, food supplement, anaemia|pregnancy, lactation, food supplement, anaemia
4877673|NCT02190552|Brain|brain
4877674|NCT02190552|Brain Clot|brain clot
4877675|NCT02190552|Brain Diseases|brain diseases
4877676|NCT02190552|Brain Infarction|brain infarction
4877677|NCT02190552|Cerebral Ischemia|cerebral ischemia
4877678|NCT02190552|Cerebrovascular Disorders|cerebrovascular disorders
4877679|NCT02190552|EmboTrap® Revascularization Device|embotrap® revascularization device
4877680|NCT02190552|EmboTrap|embotrap
4877681|NCT02190552|Ischemia|ischemia
4877682|NCT02190552|Ischemic|ischemic
4877683|NCT02190552|Ischemic Stroke|ischemic stroke
4877684|NCT02190552|Mechanical Thrombectomy|mechanical thrombectomy
4877685|NCT02190552|Neurovascular Intervention|neurovascular intervention
4877686|NCT02190552|Revascularization|revascularization
4877687|NCT02190552|Stent Retriever|stent retriever
4877688|NCT02190552|Stroke|stroke
4877689|NCT02190552|Vascular Diseases|vascular diseases
4877690|NCT02190539|Breast cancer|breast cancer
4877691|NCT02190539|complementary medicine|complementary medicine
4877692|NCT02190539|homeopathy|homeopathy
4877693|NCT02190539|quality of life|quality of life
4877694|NCT02190526|mesalamine|mesalamine
4877695|NCT02190526|amitriptyline|amitriptyline
4877696|NCT02190526|Severity of Illness Index|severity of illness index
4877697|NCT02190500|stroke|stroke
4877698|NCT02190500|tpa|tpa
4877699|NCT02190500|emergency medical service|emergency medical service
4877700|NCT02190500|ems|ems
4877701|NCT02190500|mobile|mobile
4877702|NCT02190500|ct scan|ct scan
4877703|NCT02190474|fibromyalgia|fibromyalgia
4877704|NCT02190474|juvenile fibromyalgia|juvenile fibromyalgia
4877705|NCT02190474|juvenile primary fibromyalgia syndrome (JPFS)|juvenile primary fibromyalgia syndrome (jpfs)
4877706|NCT02190474|adolescent pain|adolescent pain
4877707|NCT02190474|mindfulness|mindfulness
4877708|NCT02190474|MBSR|mbsr
4877709|NCT02190461|Early Respiratory Rehabilitation|early respiratory rehabilitation
4877710|NCT02190461|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
4877711|NCT02190461|Re-admitted patients|re-admitted patients
4877712|NCT02190461|Open clinical trial|open clinical trial
4877713|NCT02190461|Exacerbations|exacerbations
4877714|NCT02190448|galactogogue|galactogogue
4877715|NCT02190448|lactation|lactation
4877716|NCT02190448|milk production|milk production
4877717|NCT02190448|breastfeeding|breastfeeding
4877718|NCT02190435|Computer-assisted navigation|computer-assisted navigation
4877719|NCT02190435|ADAPT|adapt
4877720|NCT02190435|Intramedullary nail|intramedullary nail
4877721|NCT02190435|Intertrochanteric femur fracture|intertrochanteric femur fracture
4877722|NCT02190422|reproductive technologies, assisted|reproductive technologies, assisted
4877723|NCT02190422|echocardiography|echocardiography
4877724|NCT02190422|cardiology|cardiology
4877725|NCT02190422|pediatrics|pediatrics
4877726|NCT02190409|Dental Implant,|dental implant,
4877727|NCT02190396|Calcium|calcium
4877728|NCT02190396|Vitamin D|vitamin d
4877729|NCT02190396|Placental calcification.|placental calcification.
4877730|NCT02190383|Tic-Disorder, Tourette-Disorder, Habit Reversal Training|tic-disorder, tourette-disorder, habit reversal training
4877731|NCT02190370|Tic-Disorder, Tourette-Disorder, Resources activation|tic-disorder, tourette-disorder, resources activation
4877732|NCT02190357|Cirrhosis|cirrhosis
4877733|NCT02190344|Eight|eight
4877734|NCT02190344|Channel|channel
4877735|NCT02190344|Paddle|paddle
4877736|NCT02190344|Coil|coil
4877737|NCT02190344|MRI|mri
4877738|NCT02190344|Prostate|prostate
4877739|NCT02190344|Healthy Male|healthy male
4877740|NCT02190331|Detraining|detraining
4877741|NCT02190331|Neck|neck
4877742|NCT02190331|Exercise|exercise
4877743|NCT02190331|Posture|posture
4877744|NCT02190331|Rehabilitation|rehabilitation
4877745|NCT02190318|peritoneal dialysis；|peritoneal dialysis；
4877746|NCT02190318|residual renal function；|residual renal function；
4877747|NCT02190318|RAAS|raas
4877748|NCT02190279|Prostate Specific Membrane Antigen|prostate specific membrane antigen
4877749|NCT02190279|Radiolabeled PET Agent|radiolabeled pet agent
4877750|NCT02190279|Imaging|imaging
4877751|NCT02190279|NaF|naf
4877752|NCT02190266|Extrapulmonary|extrapulmonary
4877753|NCT02190266|Immunodeficiency|immunodeficiency
4877754|NCT02190266|Genetics|genetics
4877755|NCT02190266|Infection|infection
4877756|NCT02190266|Fungal|fungal
4877757|NCT02190253|Renal Threshold|renal threshold
4877758|NCT02190253|Liver Transplant|liver transplant
4877759|NCT02190253|Transplantation|transplantation
4877760|NCT02190253|Hepatitis E|hepatitis e
4877761|NCT02190240|Complementary and Alternative Medicine|complementary and alternative medicine
4877762|NCT02190240|Integrative Medicine|integrative medicine
4877763|NCT02190240|Pain Management|pain management
4877764|NCT02190227|Breast Cancer|breast cancer
4877765|NCT02190227|Chemotherapy|chemotherapy
4877766|NCT02190227|Neoadjuvant|neoadjuvant
4877767|NCT02190227|RNA Disruption Assay|rna disruption assay
4877768|NCT02190227|Biopsies|biopsies
4877769|NCT02190227|Response|response
4877770|NCT02190214|Hyperthyroidism|hyperthyroidism
4877771|NCT02190214|Hypothyroidism|hypothyroidism
4877772|NCT02190214|Autoimmune thyroid disorders|autoimmune thyroid disorders
4877773|NCT02190214|Iodine deficiency|iodine deficiency
4877774|NCT02190214|Genetic susceptibility|genetic susceptibility
4877775|NCT02190201|videolaryngoscope|videolaryngoscope
4877776|NCT02190201|double lumen intubation|double lumen intubation
4877777|NCT02190188|wedge insoles,|wedge insoles,
4877778|NCT02190188|knee brace,|knee brace,
4877779|NCT02190188|orthotic device|orthotic device
4877780|NCT02190188|goal|goal
4877781|NCT02190162|Patients undergoing tonsillectomy with or without adenoidectomy|patients undergoing tonsillectomy with or without adenoidectomy
4877782|NCT02190149|Factor VIII Deficiency|factor viii deficiency
4877783|NCT02190149|Factor FIX Deficiency|factor fix deficiency
4877784|NCT02190136|obesity|obesity
4877785|NCT02190136|protein-rich whole foods diet|protein-rich whole foods diet
4877786|NCT02190136|aerobic fitness|aerobic fitness
4877787|NCT02190136|resistance training|resistance training
4877788|NCT02190136|stretching/yoga training|stretching/yoga training
4877789|NCT02190136|glycemia|glycemia
4877790|NCT02190136|mood state|mood state
4877791|NCT02190123|Acute Coronary Syndrome (ACS)|acute coronary syndrome (acs)
4877792|NCT02190123|Oral antiplatelets (ticagrelor, prasugrel, clopidogrel) (OAP)|oral antiplatelets (ticagrelor, prasugrel, clopidogrel) (oap)
4877793|NCT02190123|Treatment persistence.|treatment persistence.
4877794|NCT02190110|Pulmonary embolism|pulmonary embolism
4877795|NCT02190110|diagnosis|diagnosis
4877796|NCT02190110|emergency medicine|emergency medicine
4877797|NCT02190110|ultrasonography|ultrasonography
4877798|NCT02190097|PCOS|pcos
4877799|NCT02190097|insulin sensitivity|insulin sensitivity
4877800|NCT02190097|paleolithic diet|paleolithic diet
4877801|NCT02190084|apathy|apathy
4877802|NCT02190084|Alzheimer's|alzheimer's
4877803|NCT02190084|executive function|executive function
4877804|NCT02190071|EUS-FNA|eus-fna
4877805|NCT02190071|cytopathology|cytopathology
4877806|NCT02190071|slide smear|slide smear
4877807|NCT02190058|safety|safety
4877808|NCT02190058|pharmacokinetics|pharmacokinetics
4877809|NCT02190058|DS-1971a|ds-1971a
4877810|NCT02190045|Balance|balance
4877811|NCT02190045|gait|gait
4877812|NCT02190045|Wii-Fit|wii-fit
4877813|NCT02190019|Mild Cognitive Impairment|mild cognitive impairment
4877814|NCT02190019|apathy|apathy
4877815|NCT02190019|executive function|executive function
4877816|NCT02190006|Polycystic ovarian syndrome|polycystic ovarian syndrome
4877817|NCT02190006|Follicle output rate|follicle output rate
4877818|NCT02190006|preovulatory count|preovulatory count
4877819|NCT02190006|ICSI|icsi
4877820|NCT02189993|Mortality|mortality
4877821|NCT02189993|Long term follow-up|long term follow-up
4877822|NCT02189993|Parenteral Nutrition, Total|parenteral nutrition, total
4877823|NCT02189980|Nausea|nausea
4877824|NCT02189980|Post-operative|post-operative
4877825|NCT02189967|non-small cell lung cancer|non-small cell lung cancer
4877826|NCT02189967|radiotherapy|radiotherapy
4877827|NCT02189967|accelerated fractionation|accelerated fractionation
4877828|NCT02189967|conventional fractionation|conventional fractionation
4877829|NCT02189967|postoperative|postoperative
4877830|NCT02189954|elderly; laryngeal masks; postoperative complications|elderly; laryngeal masks; postoperative complications
4877831|NCT02189941|Deferiprone|deferiprone
4877832|NCT02189941|Deferiprone sustained-release tablets|deferiprone sustained-release tablets
4877833|NCT02189941|Pharmacokinetics|pharmacokinetics
4877834|NCT02189902|Vitamin D|vitamin d
4877835|NCT02189889|Active preoperative anemia management|active preoperative anemia management
4877836|NCT02189889|Erythrocyte transfusion|erythrocyte transfusion
4877837|NCT02189889|RBC transfusion|rbc transfusion
4877838|NCT02189889|Red cell transfusion|red cell transfusion
4877839|NCT02189889|Transfusion in cardiac surgery|transfusion in cardiac surgery
4877840|NCT02189889|Anemia treatment with erythropoietin|anemia treatment with erythropoietin
4877841|NCT02189889|Anemic cardiac surgery patients|anemic cardiac surgery patients
4877842|NCT02189889|Erythrocyte stimulating agent (ESA)|erythrocyte stimulating agent (esa)
4877843|NCT02189889|Iron deficiency anemia|iron deficiency anemia
4877844|NCT02189889|EPO|epo
4877845|NCT02189889|Feraheme|feraheme
4877846|NCT02189876|HIV Prevention|hiv prevention
4877847|NCT02189876|Behavioral Intervention|behavioral intervention
4877848|NCT02189876|Condom Use|condom use
4877849|NCT02189876|African American|african american
4877850|NCT02189876|Sexually Transmitted Disease|sexually transmitted disease
4877851|NCT02189876|Sexually Transmitted Infection|sexually transmitted infection
4877852|NCT02189876|Internet|internet
4877853|NCT02189863|Driving Simulator|driving simulator
4877854|NCT02189863|Air Optix Aqua|air optix aqua
4877855|NCT02189863|AOAMF|aoamf
4877856|NCT02189850|colonoscopy|colonoscopy
4877857|NCT02189850|pediatric|pediatric
4877858|NCT02189837|Raised cholesterol|raised cholesterol
4877859|NCT02189837|Cholesterol|cholesterol
4877860|NCT02189837|Elevated Cholesterol|elevated cholesterol
4877861|NCT02189837|Hyperlipidemias|hyperlipidemias
4877862|NCT02189837|Dyslipidemias|dyslipidemias
4877863|NCT02189837|Lipid Metabolism Disorders|lipid metabolism disorders
4877864|NCT02189837|Metabolic Diseases|metabolic diseases
4877865|NCT02189811|IPV|ipv
4877866|NCT02189811|OPV|opv
4877867|NCT02189811|tOPV|topv
4877868|NCT02189811|bOPV|bopv
4877869|NCT02189811|Polio|polio
4877870|NCT02189811|Endgame|endgame
4877871|NCT02189811|Pakistan|pakistan
4877872|NCT02189798|Cochlear Implant|cochlear implant
4877873|NCT02189798|HiRes™ 90K Advantage implant|hires™ 90k advantage implant
4877874|NCT02189798|Cochlear Implantation|cochlear implantation
4877875|NCT02189798|HiFocus™ Mid-Scala electrode|hifocus™ mid-scala electrode
4877876|NCT02189798|Listening Benefits|listening benefits
4877877|NCT02189798|Adults|adults
4877878|NCT02189798|Cochlear Implant Benefit|cochlear implant benefit
4877879|NCT02189798|Electrical Stimulation|electrical stimulation
4877880|NCT02189798|Electro-Acoustic Stimulation (EAS)|electro-acoustic stimulation (eas)
4877881|NCT02189785|social|social
4877882|NCT02189785|rejection|rejection
4877883|NCT02189785|acceptance|acceptance
4877884|NCT02189785|PET|pet
4877885|NCT02189785|opioid|opioid
4877886|NCT02189785|fMRI|fmri
4877887|NCT02189785|reward|reward
4877888|NCT02189785|exclusion|exclusion
4877889|NCT02189772|ADHD|adhd
4877890|NCT02189772|Inattention|inattention
4877891|NCT02189772|MDX|mdx
4877892|NCT02189759|Hypothermia|hypothermia
4877893|NCT02189759|Hyperthermia|hyperthermia
4877894|NCT02189759|Kangaroo Mother Care|kangaroo mother care
4877895|NCT02189759|Newborn|newborn
4877896|NCT02189746|Hypothermia|hypothermia
4877897|NCT02189746|Newborn|newborn
4877898|NCT02189746|Hyperthermia|hyperthermia
4877899|NCT02189746|Kangaroo mother care|kangaroo mother care
4877900|NCT02189720|Amifampridine Phosphate|amifampridine phosphate
4877901|NCT02189720|Amifampridine|amifampridine
4877902|NCT02189720|3,4-Diaminopyridine Phosphate|3,4-diaminopyridine phosphate
4877903|NCT02189720|3,4-Diaminopyridine|3,4-diaminopyridine
4877904|NCT02189720|3,4-DAP|3,4-dap
4877905|NCT02189720|LEMS|lems
4877906|NCT02189720|CMS|cms
4877907|NCT02189720|Lambert-Eaton Myasthenic Syndrome|lambert-eaton myasthenic syndrome
4877908|NCT02189720|Congenital Myasthenic Syndrome|congenital myasthenic syndrome
4877909|NCT02189720|Neuromuscular disorders|neuromuscular disorders
4877910|NCT02189720|Neuromuscular|neuromuscular
4877911|NCT02189720|eye movement|eye movement
4877912|NCT02189720|electromyography|electromyography
4877913|NCT02189720|EMG|emg
4877914|NCT02189720|Expanded Access|expanded access
4877915|NCT02189720|Firdapse®|firdapse®
4877916|NCT02189720|Downbeat Nystagmus|downbeat nystagmus
4877917|NCT02189707|Gastrointestinal disorder|gastrointestinal disorder
4877918|NCT02189707|Constipation|constipation
4877919|NCT02189707|Probiotics|probiotics
4877920|NCT02189707|Dietary supplement|dietary supplement
4877921|NCT02189694|Type 1 diabetes|type 1 diabetes
4877922|NCT02189694|Hypoglycemia|hypoglycemia
4877923|NCT02189694|Insulin|insulin
4877924|NCT02189694|Glucagon|glucagon
4877925|NCT02189694|Closed-loop system|closed-loop system
4877926|NCT02189694|Artificial pancreas|artificial pancreas
4877927|NCT02189681|spinal anaesthesia|spinal anaesthesia
4877928|NCT02189681|ultrasound|ultrasound
4877929|NCT02189681|paramedian|paramedian
4877930|NCT02189668|Appendicitis|appendicitis
4877931|NCT02189668|Non-operative|non-operative
4877932|NCT02189668|Children|children
4877933|NCT02189668|Appendicolith|appendicolith
4877934|NCT02189668|fecalith|fecalith
4877935|NCT02189668|Pediatrics|pediatrics
4877936|NCT02189655|shivering spinal anesthesia|shivering spinal anesthesia
4877937|NCT02189629|Acne vulgaris|acne vulgaris
4877938|NCT02189629|Safety|safety
4877939|NCT02189629|Face|face
4877940|NCT02189629|Trunk|trunk
4877941|NCT02189616|asthma management|asthma management
4877942|NCT02189616|SMS reminder|sms reminder
4877943|NCT02189616|SMS consultation|sms consultation
4877944|NCT02189603|hepatitis E|hepatitis e
4877945|NCT02189603|Immunogenicity|immunogenicity
4877946|NCT02189603|vaccine|vaccine
4877947|NCT02189603|safety|safety
4877948|NCT02189590|supraglottic airway|supraglottic airway
4877949|NCT02189590|children|children
4877950|NCT02189590|fiberoptic guided tracheal intubation|fiberoptic guided tracheal intubation
4877951|NCT02189590|air-Q|air-q
4877952|NCT02189590|i-gel|i-gel
4877953|NCT02189577|Chronic Obstructive Pulmonary disease|chronic obstructive pulmonary disease
4877954|NCT02189577|COPD|copd
4877955|NCT02189538|Infections, Enteral nutrition, SIRS, critically ill|infections, enteral nutrition, sirs, critically ill
4877956|NCT02189525|traumatic brain injury|traumatic brain injury
4877957|NCT02189525|sports head injury|sports head injury
4877958|NCT02189525|sports concussion|sports concussion
4877959|NCT02189512|brain-death organ donors|brain-death organ donors
4877960|NCT02189512|intestinal manipulation|intestinal manipulation
4877961|NCT02189512|monocytes|monocytes
4877962|NCT02189499|Stents|stents
4877963|NCT02189499|Angioplasty|angioplasty
4877964|NCT02189499|Coronary Vessels|coronary vessels
4877965|NCT02189499|Coronary Artery Disease|coronary artery disease
4877966|NCT02189499|Angina Pectoris|angina pectoris
4877967|NCT02189499|Myocardial Ischemia|myocardial ischemia
4877968|NCT02189499|Myocardial Infarction|myocardial infarction
4877969|NCT02189499|Myocardial Revascularization|myocardial revascularization
4877970|NCT02189486|Prostate Cancer|prostate cancer
4877971|NCT02189486|Radical Prostatectomy|radical prostatectomy
4877972|NCT02189486|Prostate biopsy|prostate biopsy
4877973|NCT02189486|Upgrading|upgrading
4877974|NCT02189486|Upgrading Reference set|upgrading reference set
4877975|NCT02189473|metastatic epidural spinal cord compression|metastatic epidural spinal cord compression
4877976|NCT02189473|motor function|motor function
4877977|NCT02189473|ambulatory status|ambulatory status
4877978|NCT02189473|pain|pain
4877979|NCT02189473|quality of life|quality of life
4877980|NCT02189473|overall survival|overall survival
4877981|NCT02189473|local control|local control
4877982|NCT02189473|toxicity|toxicity
4877983|NCT02189460|Cognition|cognition
4877984|NCT02189447|Keratoconus|keratoconus
4877986|NCT02189447|Corneal Cross-linking|corneal cross-linking
4877987|NCT02189421|peroral cholangioscopy|peroral cholangioscopy
4877988|NCT02189421|ultra-slim upper endoscope|ultra-slim upper endoscope
4877989|NCT02189421|multibending endoscope|multibending endoscope
4877990|NCT02189408|Platelet rich plasma|platelet rich plasma
4877991|NCT02189408|Autologous conditioned plasma|autologous conditioned plasma
4877992|NCT02189408|Outerbridge|outerbridge
4877993|NCT02189395|Type 2 diabetes|type 2 diabetes
4877994|NCT02189395|Uncontrolled blood glucose|uncontrolled blood glucose
4877995|NCT02189395|insulin|insulin
4877996|NCT02189395|glargine|glargine
4877997|NCT02189395|NPH|nph
4877998|NCT02189382|Sensitivity|sensitivity
4877999|NCT02189356|Pregnancy-related low back and pelvic pain|pregnancy-related low back and pelvic pain
4878000|NCT02189356|exercise program|exercise program
4878001|NCT02189356|nurse|nurse
4878002|NCT02189343|Multiple Myeloma|multiple myeloma
4878003|NCT02189343|Relapsed and Refractory|relapsed and refractory
4878004|NCT02189343|Refractory Disease|refractory disease
4878005|NCT02189343|Progressive Disease|progressive disease
4878006|NCT02189343|Pomalidomide|pomalidomide
4878007|NCT02189343|Dexamethasone|dexamethasone
4878008|NCT02189343|Proteasome Inhibitor|proteasome inhibitor
4878009|NCT02189343|Ricolinostat|ricolinostat
4878010|NCT02189304|Healthy volunteers|healthy volunteers
4878011|NCT02189291|Indwelling catheter|indwelling catheter
4878012|NCT02189291|Hospital stay|hospital stay
4878013|NCT02189291|Urinary tract infection|urinary tract infection
4878014|NCT02189291|Sacrocolpopexy|sacrocolpopexy
4878015|NCT02189278|Breast Cancer|breast cancer
4878016|NCT02189278|Surveillance|surveillance
4878017|NCT02189278|Mammography|mammography
4878018|NCT02189278|Adherence|adherence
4878019|NCT02189265|Live birth [MeSH]|live birth [mesh]
4878020|NCT02189265|Infant [MeSH]|infant [mesh]
4878021|NCT02189265|Infant, newborn [MeSH]|infant, newborn [mesh]
4878022|NCT02189265|Second-hand smoke|second-hand smoke
4878023|NCT02189265|Tobacco smoke pollution [MeSH]|tobacco smoke pollution [mesh]
4878024|NCT02189265|Smoke-free|smoke-free
4878025|NCT02189265|Smoke-free policy [MeSH]|smoke-free policy [mesh]
4878026|NCT02189226|probe-based confocal laser endomicroscopy (pCLE), early gastric cancer (EGC), endoscopic submucosal dissection (ESD), margin|probe-based confocal laser endomicroscopy (pcle), early gastric cancer (egc), endoscopic submucosal dissection (esd), margin
4878027|NCT02189213|anxiety|anxiety
4878028|NCT02189213|SSRI|ssri
4878029|NCT02189213|biomarker|biomarker
4878030|NCT02189213|sleep|sleep
4878031|NCT02189213|children|children
4878032|NCT02189213|adolescents|adolescents
4878033|NCT02189213|young adults|young adults
4878034|NCT02189200|nutritional counseling|nutritional counseling
4878035|NCT02189200|oat bran|oat bran
4878036|NCT02189200|dyslipidemia|dyslipidemia
4878037|NCT02189200|cardiovascular disease|cardiovascular disease
4878038|NCT02189187|Weight Loss|weight loss
4878039|NCT02189187|Body Weight Changes|body weight changes
4878040|NCT02189187|Body Weight|body weight
4878041|NCT02189187|Magnetic Resonance Imaging|magnetic resonance imaging
4878042|NCT02189187|Emotions|emotions
4878043|NCT02189187|Emotion regulation|emotion regulation
4878044|NCT02189187|Health Behavior|health behavior
4878045|NCT02189187|Eating behavior|eating behavior
4878046|NCT02189174|Solid tumor,|solid tumor,
4878047|NCT02189174|breast cancer,|breast cancer,
4878048|NCT02189174|lung cancer,|lung cancer,
4878049|NCT02189174|endometrial cancer|endometrial cancer
4878050|NCT02189161|anal intraepithelial neoplasia|anal intraepithelial neoplasia
4878051|NCT02189161|AIN|ain
4878052|NCT02189161|Radiofrequency Ablation|radiofrequency ablation
4878053|NCT02189161|RFA|rfa
4878054|NCT02189148|Prediction|prediction
4878055|NCT02189148|Preeclampsia|preeclampsia
4878056|NCT02189148|Preterm birth|preterm birth
4878057|NCT02189148|Pregnancy|pregnancy
4878058|NCT02189148|Placenta|placenta
4878059|NCT02189148|Intra-uterine growth restriction|intra-uterine growth restriction
4878060|NCT02189148|fetal growth restriction|fetal growth restriction
4878061|NCT02189148|Ultrasound|ultrasound
4878062|NCT02189148|Doppler|doppler
4878063|NCT02189148|Biomarkers|biomarkers
4878064|NCT02189148|PAPP-A|papp-a
4878065|NCT02189148|Placental growth factor (PlGF)|placental growth factor (plgf)
4878066|NCT02189109|glioblastoma|glioblastoma
4878067|NCT02189109|multiforme|multiforme
4878068|NCT02189109|radiation|radiation
4878069|NCT02189109|radiation therapy|radiation therapy
4878070|NCT02189096|Sepsis|sepsis
4878071|NCT02189096|National Early Warning Score|national early warning score
4878072|NCT02189096|Lactate|lactate
4878073|NCT02189083|Leiomyoma|leiomyoma
4878074|NCT02189083|Medicine, Chinese Traditional|medicine, chinese traditional
4878075|NCT02189083|Randomized Controlled Trial|randomized controlled trial
4878076|NCT02189070|Follow-up|follow-up
4878077|NCT02189070|Percutaneous coronary intervention|percutaneous coronary intervention
4878078|NCT02189070|Patient preference|patient preference
4878079|NCT02189070|DUTCH PEERS|dutch peers
4878080|NCT02189070|TWENTE|twente
4878081|NCT02189057|Bipolar|bipolar
4878082|NCT02189057|Unipolar|unipolar
4878083|NCT02189057|Genotyping|genotyping
4878084|NCT02189057|Pharmacokinetic|pharmacokinetic
4878085|NCT02189057|Pharmacodynamic|pharmacodynamic
4878086|NCT02189044|aged;|aged;
4878087|NCT02189044|breathing exercises;|breathing exercises;
4878088|NCT02189044|muscle strength.|muscle strength.
4878089|NCT02189031|Upper limb Amputee|upper limb amputee
4878090|NCT02189031|Targeted Muscle Reinnervation|targeted muscle reinnervation
4878091|NCT02189031|Prosthetic|prosthetic
4878092|NCT02189018|Peripheral arterial disease|peripheral arterial disease
4878093|NCT02189018|Endovascular|endovascular
4878094|NCT02189018|Exercise|exercise
4878095|NCT02189018|Perfusion|perfusion
4878096|NCT02189018|Functional capacity|functional capacity
4878097|NCT02189005|High blood sugar|high blood sugar
4878098|NCT02189005|High HbA1C|high hba1c
4878099|NCT02189005|hyperglycemia|hyperglycemia
4878100|NCT02189005|Pre-Diabetes|pre-diabetes
4878101|NCT02189005|Natural Supplement for Diabetes|natural supplement for diabetes
4878102|NCT02188992|Sepsis|sepsis
4878103|NCT02188992|Immune activation|immune activation
4878104|NCT02188992|Systemic Inflammation|systemic inflammation
4878105|NCT02188992|Emergency Medicine|emergency medicine
4878106|NCT02188992|Critical Care|critical care
4878107|NCT02188979|airway|airway
4878108|NCT02188979|equipment - laryngoscopes|equipment - laryngoscopes
4878109|NCT02188979|intubation - tracheal|intubation - tracheal
4878110|NCT02188979|obesity.|obesity.
4878111|NCT02188966|Geographic Information System|geographic information system
4878112|NCT02188966|Emergency Care Information Systems|emergency care information systems
4878113|NCT02188966|Telemedicine|telemedicine
4878114|NCT02188966|Emergency Hospital Service|emergency hospital service
4878115|NCT02188953|aflatoxin|aflatoxin
4878116|NCT02188953|Kenya|kenya
4878117|NCT02188940|Asthma|asthma
4878118|NCT02188940|Obesity|obesity
4878119|NCT02188940|Clinical control|clinical control
4878120|NCT02188940|Exercise|exercise
4878121|NCT02188940|Weight-loss|weight-loss
4878122|NCT02188927|Advanced notification letter|advanced notification letter
4878123|NCT02188927|Standard invitation|standard invitation
4878124|NCT02188927|Participation rate|participation rate
4878125|NCT02188927|Colonoscopy|colonoscopy
4878126|NCT02188927|Screening|screening
4878127|NCT02188927|Colorectal Neoplasms|colorectal neoplasms
4878128|NCT02188927|Digestive System Diseases|digestive system diseases
4878129|NCT02188914|Inhalant use disorder|inhalant use disorder
4878130|NCT02188914|Positron emission tomography|positron emission tomography
4878131|NCT02188914|Magnetic Resonance Imaging|magnetic resonance imaging
4878132|NCT02188914|Executive functions assessment|executive functions assessment
4878133|NCT02188914|Transcriptome|transcriptome
4878134|NCT02188901|HCC|hcc
4878135|NCT02188901|Sonazoid|sonazoid
4878136|NCT02188901|Ultrasonography|ultrasonography
4878137|NCT02188901|Screening|screening
4878138|NCT02188888|septic shock|septic shock
4878139|NCT02188888|esmolol|esmolol
4878140|NCT02188888|tachycardia|tachycardia
4878141|NCT02188888|betablockers|betablockers
4878142|NCT02188875|Fitbit One|fitbit one
4878143|NCT02188875|wearable sensor|wearable sensor
4878144|NCT02188875|wearable device|wearable device
4878145|NCT02188875|web-based intervention|web-based intervention
4878146|NCT02188875|SMS text messages|sms text messages
4878147|NCT02188875|randomized controlled trial|randomized controlled trial
4878148|NCT02188875|physical activity|physical activity
4878149|NCT02188875|behavioral intervention|behavioral intervention
4878150|NCT02188875|text message prompts|text message prompts
4878151|NCT02188875|text messaging|text messaging
4878152|NCT02188875|technology|technology
4878153|NCT02188875|exercise|exercise
4878154|NCT02188862|Rheumatic heart disease|rheumatic heart disease
4878155|NCT02188862|Acute rheumatic fever|acute rheumatic fever
4878156|NCT02188862|Group A streptococcal disease|group a streptococcal disease
4878157|NCT02188862|Streptococcus pyogenes|streptococcus pyogenes
4878158|NCT02188862|Genetics|genetics
4878159|NCT02188862|Oceania|oceania
4878160|NCT02188849|creatine|creatine
4878161|NCT02188849|resistance training|resistance training
4878162|NCT02188849|older women|older women
4878163|NCT02188849|muscle strength|muscle strength
4878164|NCT02188823|prediabetes|prediabetes
4878165|NCT02188823|obesity|obesity
4878166|NCT02188823|mindful eating|mindful eating
4878167|NCT02188823|positive affect|positive affect
4878168|NCT02188823|low carbohydrate|low carbohydrate
4878169|NCT02188823|ketogenic|ketogenic
4878170|NCT02188823|diet|diet
4878171|NCT02188810|PAL|pal
4878172|NCT02188810|fluviral|fluviral
4878173|NCT02188810|healthy volunteer|healthy volunteer
4878174|NCT02188810|adjuvant|adjuvant
4878175|NCT02188810|TH1 immune response|th1 immune response
4878176|NCT02188797|homeless|homeless
4878177|NCT02188797|young adults|young adults
4878178|NCT02188797|substance use|substance use
4878179|NCT02188797|HIV risk|hiv risk
4878180|NCT02188797|sexual risk behavior|sexual risk behavior
4878181|NCT02188797|group motivational interviewing|group motivational interviewing
4878182|NCT02188771|Moderate to Severe OA|moderate to severe oa
4878183|NCT02188771|VAS score of ≥ 5|vas score of ≥ 5
4878184|NCT02188771|grade III-IV Kellgren Lawrence of OA|grade iii-iv kellgren lawrence of oa
4878185|NCT02188771|subjects who failed conservative treatment|subjects who failed conservative treatment
4878186|NCT02188771|subjects who candidates for total knee replacement (TKR)|subjects who candidates for total knee replacement (tkr)
4878187|NCT02188771|subject 45 and 75 years old|subject 45 and 75 years old
4878188|NCT02188771|subject is experiencing pain in the intended study knee with a VAS score of ≥ 5|subject is experiencing pain in the intended study knee with a vas score of ≥ 5
4878189|NCT02188771|subject has a Body Mass Index (BMI) between 18.5 and 35|subject has a body mass index (bmi) between 18.5 and 35
4878190|NCT02188758|iron|iron
4878191|NCT02188758|hepcidin-25|hepcidin-25
4878192|NCT02188758|pulmonary exacerbation|pulmonary exacerbation
4878193|NCT02188758|interleukin-6|interleukin-6
4878194|NCT02188745|metastatic|metastatic
4878195|NCT02188745|locally advanced|locally advanced
4878196|NCT02188745|ER+|er+
4878197|NCT02188745|Estrogen therapy|estrogen therapy
4878198|NCT02188745|Estradiol therapy|estradiol therapy
4878199|NCT02188732|Community Mental Health|community mental health
4878200|NCT02188732|Serious Mental Illness|serious mental illness
4878201|NCT02188732|Medical Comorbidity|medical comorbidity
4878202|NCT02188732|Self-Management|self-management
4878203|NCT02188732|Automated Telehealth|automated telehealth
4878204|NCT02188732|Early Mortality|early mortality
4878205|NCT02188719|Donor-Alloantigen-Reactive Regulatory T Cell Therapy|donor-alloantigen-reactive regulatory t cell therapy
4878206|NCT02188719|Tregs|tregs
4878207|NCT02188719|Cell- and Tissue-Based Therapy|cell- and tissue-based therapy
4878208|NCT02188719|Immunotherapy, Adoptive|immunotherapy, adoptive
4878209|NCT02188719|Liver Transplantation|liver transplantation
4878210|NCT02188680|fructose test|fructose test
4878211|NCT02188667|Chronic Noncancer Pain|chronic noncancer pain
4878212|NCT02188667|Musculoskeletal Pain|musculoskeletal pain
4878213|NCT02188667|Neuropathic Pain|neuropathic pain
4878214|NCT02188667|Headache Pain|headache pain
4878215|NCT02188654|psoriatic arthritis|psoriatic arthritis
4878216|NCT02188654|inflammation|inflammation
4878217|NCT02188654|metabolic syndrome|metabolic syndrome
4878218|NCT02188654|metformin|metformin
4878219|NCT02188641|Psoriatic arthritis|psoriatic arthritis
4878220|NCT02188641|inflammation|inflammation
4878221|NCT02188641|obesity|obesity
4878222|NCT02188641|diet|diet
4878223|NCT02188641|exercise|exercise
4878224|NCT02188628|Motor recovery, robotics, stroke rehabilitation|motor recovery, robotics, stroke rehabilitation
4878225|NCT02188615|Squamous Cell Esophageal Carcinoma|squamous cell esophageal carcinoma
4878226|NCT02188615|minimally invasive esophagectomy|minimally invasive esophagectomy
4878227|NCT02188615|laparoscopy|laparoscopy
4878228|NCT02188615|thoracoscopy|thoracoscopy
4878229|NCT02188576|Craniofacial Surgery|craniofacial surgery
4878230|NCT02188576|tranexamic acid|tranexamic acid
4878231|NCT02188576|Antifibrinolytic|antifibrinolytic
4878232|NCT02188563|Smoking cessation|smoking cessation
4878233|NCT02188563|Head and neck neoplasms|head and neck neoplasms
4878234|NCT02188563|Lung neoplasms|lung neoplasms
4878235|NCT02188563|Thoracic neoplasms|thoracic neoplasms
4878236|NCT02188563|Radiation|radiation
4878237|NCT02188550|relapse or refractory or persistent epithelial ovarian fallopian tube|relapse or refractory or persistent epithelial ovarian fallopian tube
4878238|NCT02188550|primary peritoneal carcinoma or endometrial cancer|primary peritoneal carcinoma or endometrial cancer
4878239|NCT02188537|Myeloma|myeloma
4878240|NCT02188537|proteasome inhibitor-nonresponsive myeloma|proteasome inhibitor-nonresponsive myeloma
4878241|NCT02188537|Nelfinavir|nelfinavir
4878242|NCT02188537|bortezomib|bortezomib
4878243|NCT02188537|bortezomib-sensitizing drug|bortezomib-sensitizing drug
4878244|NCT02188524|balance, exercise, compensatory stepping, tai chi|balance, exercise, compensatory stepping, tai chi
4878245|NCT02188511|E-Cigarettes|e-cigarettes
4878246|NCT02188511|Lung|lung
4878247|NCT02188511|Non-Smokers|non-smokers
4878248|NCT02188511|Lung Biology|lung biology
4878249|NCT02188472|Oxidative Stress|oxidative stress
4878250|NCT02188472|antibiotics|antibiotics
4878251|NCT02188446|Radical cystectomy|radical cystectomy
4878252|NCT02188446|Bladder cancer|bladder cancer
4878253|NCT02188446|Smoking cessation|smoking cessation
4878254|NCT02188446|Alcohol cessation|alcohol cessation
4878255|NCT02188446|Postoperative complications|postoperative complications
4878256|NCT02188433|Effectiveness of quit immediately (QI) and cut down to quit (CDTQ) interventions in achieving smoking abstinence|effectiveness of quit immediately (qi) and cut down to quit (cdtq) interventions in achieving smoking abstinence
4878257|NCT02188420|PAS|pas
4878258|NCT02188420|TMS|tms
4878259|NCT02188420|Stroke|stroke
4878260|NCT02188420|Paired Associative Stimulation|paired associative stimulation
4878261|NCT02188420|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
4878262|NCT02188407|thoracotomy|thoracotomy
4878263|NCT02188407|one-lung ventilation (OLV)|one-lung ventilation (olv)
4878264|NCT02188407|total intravenous anaesthesia (TIVA)|total intravenous anaesthesia (tiva)
4878265|NCT02188407|volatile induced and maintained anaesthesia (VIMA)|volatile induced and maintained anaesthesia (vima)
4878266|NCT02188407|cytokines|cytokines
4878267|NCT02188407|interleukine (IL)|interleukine (il)
4878268|NCT02188394|migraine,|migraine,
4878269|NCT02188394|pressure pain,|pressure pain,
4878270|NCT02188394|anesthetic blocks|anesthetic blocks
4878271|NCT02188394|patients|patients
4878272|NCT02188381|Resistant Hypertension|resistant hypertension
4878273|NCT02188381|Uncontrolled Hypertension|uncontrolled hypertension
4878274|NCT02188368|Pomalidomide|pomalidomide
4878275|NCT02188368|Lenalidomide refractory|lenalidomide refractory
4878276|NCT02188368|multiple myeloma|multiple myeloma
4878277|NCT02188355|Ultimaster|ultimaster
4878278|NCT02188355|registry|registry
4878279|NCT02188355|DES|des
4878280|NCT02188355|DAPT|dapt
4878281|NCT02188329|Early care and education|early care and education
4878282|NCT02188329|ECE|ece
4878283|NCT02188329|workforce|workforce
4878284|NCT02188329|child care|child care
4878285|NCT02188329|caregivers|caregivers
4878286|NCT02188329|home-based providers|home-based providers
4878287|NCT02188329|center-based providers|center-based providers
4878288|NCT02188316|Cold forceps polypectomy|cold forceps polypectomy
4878289|NCT02188316|Diminutive colorectal polyp|diminutive colorectal polyp
4878290|NCT02188316|Hot biopsy forceps electrocauterization|hot biopsy forceps electrocauterization
4878291|NCT02188316|Jumbo forceps.|jumbo forceps.
4878292|NCT02188290|Haploidentical donor|haploidentical donor
4878293|NCT02188290|Unrelated donor|unrelated donor
4878294|NCT02188290|Umbilical cord blood|umbilical cord blood
4878295|NCT02188290|Graft versus host disease|graft versus host disease
4878296|NCT02188290|Transplant-related mortality|transplant-related mortality
4878297|NCT02188290|Hematologic malignancy|hematologic malignancy
4878298|NCT02188290|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
4878299|NCT02188251|Activamp|activamp
4878300|NCT02188251|Gynostemma pentaphyllum|gynostemma pentaphyllum
4878301|NCT02188251|Body weight|body weight
4878302|NCT02188251|Fat Loss|fat loss
4878303|NCT02188251|Metabolic markers|metabolic markers
4878304|NCT02188251|Overweight participants|overweight participants
4878305|NCT02188251|DXA|dxa
4878306|NCT02188251|AMPK|ampk
4878307|NCT02188238|saliva|saliva
4878308|NCT02188238|protein|protein
4878309|NCT02188238|oral health|oral health
4878310|NCT02188238|film|film
4878311|NCT02188238|pellicle|pellicle
4878312|NCT02188225|Hot flash|hot flash
4878313|NCT02188225|Acupuncture|acupuncture
4878314|NCT02188225|Fluoxetine|fluoxetine
4878315|NCT02188225|Quality of life|quality of life
4878316|NCT02188199|Hip|hip
4878317|NCT02188199|Knee|knee
4878318|NCT02188199|Hip replacement|hip replacement
4878319|NCT02188199|Knee replacement|knee replacement
4878320|NCT02188199|Total Joint|total joint
4878321|NCT02188186|triple combination|triple combination
4878322|NCT02188186|metformin|metformin
4878323|NCT02188186|sitagliptin|sitagliptin
4878324|NCT02188186|thiazolidinedione|thiazolidinedione
4878325|NCT02188160|Pain|pain
4878326|NCT02188160|Corticosteroid|corticosteroid
4878327|NCT02188160|Dry Eye|dry eye
4878328|NCT02188160|Hyperemia|hyperemia
4878329|NCT02188160|Ocular Discomfort|ocular discomfort
4878330|NCT02188147|Syncope|syncope
4878331|NCT02188147|Sudden Cardiac Arrest|sudden cardiac arrest
4878332|NCT02188147|Sudden Cardiac Death|sudden cardiac death
4878333|NCT02188147|Cardiac Arrest|cardiac arrest
4878334|NCT02188147|Emergency Service|emergency service
4878335|NCT02188147|Emergency Department|emergency department
4878336|NCT02188147|Ambulatory Electrocardiography|ambulatory electrocardiography
4878337|NCT02188147|Holter|holter
4878338|NCT02188147|Holter Electrocardiography|holter electrocardiography
4878339|NCT02188147|Holter Monitoring|holter monitoring
4878340|NCT02188134|Adverse events,|adverse events,
4878341|NCT02188134|adverse drug reactions,|adverse drug reactions,
4878342|NCT02188134|medication error,|medication error,
4878343|NCT02188134|noncompliance|noncompliance
4878344|NCT02188108|quality of life|quality of life
4878345|NCT02188108|QOL|qol
4878346|NCT02188108|urolithiasis|urolithiasis
4878347|NCT02188108|nephrolithiasis|nephrolithiasis
4878348|NCT02188108|kidney stones|kidney stones
4878349|NCT02188108|patient-reported outcomes|patient-reported outcomes
4878350|NCT02188069|Non-atherosclerotic Coronary Artery Disease|non-atherosclerotic coronary artery disease
4878351|NCT02188056|Venous|venous
4878352|NCT02188056|Thromboembolic|thromboembolic
4878353|NCT02188056|Pulmonary embolism|pulmonary embolism
4878354|NCT02188043|Alcohol use disorder|alcohol use disorder
4878355|NCT02188043|Motivational Intervention|motivational intervention
4878356|NCT02188043|Health expenditures|health expenditures
4878357|NCT02188043|efficacy study|efficacy study
4878358|NCT02188030|musculoskeletal symptom|musculoskeletal symptom
4878359|NCT02188030|industrial workers|industrial workers
4878360|NCT02188030|physical-activity program|physical-activity program
4878361|NCT02188030|resistance training|resistance training
4878362|NCT02188030|randomized controlled trial|randomized controlled trial
4878363|NCT02188017|prednisone, methotrexate, sarcoidosis, azathioprine|prednisone, methotrexate, sarcoidosis, azathioprine
4878364|NCT02188004|HPV|hpv
4878365|NCT02188004|genital warts|genital warts
4878366|NCT02187991|metastatic breast cancer|metastatic breast cancer
4878367|NCT02187991|Human Epidermal Growth Factor Receptor 2-negative (HER2-) breast cancer|human epidermal growth factor receptor 2-negative (her2-) breast cancer
4878368|NCT02187991|Estrogen Receptor-positive (ER+) breast cancer|estrogen receptor-positive (er+) breast cancer
4878369|NCT02187991|Triple Negative breast cancer|triple negative breast cancer
4878370|NCT02187991|alisertib|alisertib
4878371|NCT02187991|paclitaxel|paclitaxel
4878372|NCT02187978|Early total enteral feeding (ETEF)|early total enteral feeding (etef)
4878373|NCT02187978|Conventional enteral feeding (CEF)|conventional enteral feeding (cef)
4878374|NCT02187978|VLBW infants|vlbw infants
4878375|NCT02187978|NEC|nec
4878376|NCT02187978|Preterm infants|preterm infants
4878377|NCT02187926|Drug therapy|drug therapy
4878378|NCT02187900|Tripterygium Wilfordii HOOK. f.|tripterygium wilfordii hook. f.
4878379|NCT02187900|Mycophenolate mofetil|mycophenolate mofetil
4878380|NCT02187887|alcohol|alcohol
4878381|NCT02187887|young adult veterans|young adult veterans
4878382|NCT02187887|brief intervention|brief intervention
4878383|NCT02187887|online|online
4878384|NCT02187887|perceived norms|perceived norms
4878385|NCT02187835|complexity|complexity
4878386|NCT02187835|electroencephalogram|electroencephalogram
4878387|NCT02187835|entropy|entropy
4878388|NCT02187835|negative symptoms|negative symptoms
4878389|NCT02187835|schizophrenia.|schizophrenia.
4878390|NCT02187822|Brain|brain
4878391|NCT02187822|Advanced solid tumors|advanced solid tumors
4878392|NCT02187822|Fractionated Stereotactic Radiotherapy (FSRT)|fractionated stereotactic radiotherapy (fsrt)
4878393|NCT02187822|Brain lesions|brain lesions
4878394|NCT02187822|Primary solid malignancy|primary solid malignancy
4878395|NCT02187796|HIV|hiv
4878396|NCT02187796|Dementia|dementia
4878397|NCT02187796|HAND|hand
4878398|NCT02187796|COGNISION System|cognision system
4878399|NCT02187796|ERP|erp
4878400|NCT02187796|event-related potentials|event-related potentials
4878401|NCT02187783|Solid malignancy,|solid malignancy,
4878402|NCT02187783|Hematologic malignancy,|hematologic malignancy,
4878403|NCT02187783|Mutations,|mutations,
4878404|NCT02187783|Amplifications,|amplifications,
4878405|NCT02187783|Signature,|signature,
4878406|NCT02187783|CDK4,|cdk4,
4878407|NCT02187783|CDK6,|cdk6,
4878408|NCT02187783|CDK4/6,|cdk4/6,
4878409|NCT02187783|Cyclin D1,|cyclin d1,
4878410|NCT02187783|CCND1,|ccnd1,
4878411|NCT02187783|Cyclin D3,|cyclin d3,
4878412|NCT02187783|CCND3,|ccnd3,
4878413|NCT02187783|p16 mutation,|p16 mutation,
4878414|NCT02187783|CDKN2A,|cdkn2a,
4878415|NCT02187783|LEE011,|lee011,
4878416|NCT02187783|Breast cancer,|breast cancer,
4878417|NCT02187783|Ovarian cancer,|ovarian cancer,
4878418|NCT02187783|Lymphoma,|lymphoma,
4878419|NCT02187783|Mesothelioma,|mesothelioma,
4878420|NCT02187783|Pancreatic neuroendocrine,|pancreatic neuroendocrine,
4878421|NCT02187783|Leukemia|leukemia
4878422|NCT02187783|Tumor|tumor
4878423|NCT02187757|Dyslipidemia|dyslipidemia
4878424|NCT02187757|High cholesterol|high cholesterol
4878425|NCT02187757|High LDL|high ldl
4878426|NCT02187757|Triglycerides|triglycerides
4878427|NCT02187744|Biosimilars|biosimilars
4878428|NCT02187744|Non-inferiority|non-inferiority
4878429|NCT02187744|Neoadjuvant Setting|neoadjuvant setting
4878430|NCT02187744|Early Breast Cancer|early breast cancer
4878431|NCT02187744|PK|pk
4878432|NCT02187744|Phase 3|phase 3
4878433|NCT02187744|Trastuzumab|trastuzumab
4878434|NCT02187744|Herceptin|herceptin
4878435|NCT02187744|HER2 Positive|her2 positive
4878436|NCT02187731|Multiple Myeloma|multiple myeloma
4878437|NCT02187731|Functional Imaging|functional imaging
4878438|NCT02187731|PET/CT|pet/ct
4878439|NCT02187731|Diffusion Weighted MRI|diffusion weighted mri
4878440|NCT02187718|Sentinel Lymph Node Biopsy|sentinel lymph node biopsy
4878441|NCT02187718|Local Anaesthesia|local anaesthesia
4878442|NCT02187692|schizophrenia;|schizophrenia;
4878443|NCT02187692|meta-cognition;|meta-cognition;
4878444|NCT02187692|general functioning;|general functioning;
4878445|NCT02187692|positive symptoms;|positive symptoms;
4878446|NCT02187692|insight;|insight;
4878447|NCT02187679|Tourette Syndrome|tourette syndrome
4878448|NCT02187679|Tourette's Syndrome|tourette's syndrome
4878449|NCT02187679|Chronic Vocal Tic|chronic vocal tic
4878450|NCT02187679|Vocal Tic|vocal tic
4878451|NCT02187666|Cervical|cervical
4878452|NCT02187666|Lumbar|lumbar
4878453|NCT02187666|Spine|spine
4878454|NCT02187666|Spinal Disease|spinal disease
4878455|NCT02187653|IOM|iom
4878456|NCT02187653|IONM|ionm
4878457|NCT02187653|Intraoperative Monitoring|intraoperative monitoring
4878458|NCT02187653|Intraoperative Neuromonitoring|intraoperative neuromonitoring
4878459|NCT02187653|Spine|spine
4878460|NCT02187653|Lumbar|lumbar
4878461|NCT02187653|Cervical|cervical
4878462|NCT02187640|Acupressure|acupressure
4878463|NCT02187640|Self-administration|self-administration
4878464|NCT02187640|Psychiatric in-patients|psychiatric in-patients
4878465|NCT02187640|Constipation|constipation
4878466|NCT02187640|Self-administered acupressure program|self-administered acupressure program
4878467|NCT02187640|Sham control group|sham control group
4878468|NCT02187614|Acute Renal colic|acute renal colic
4878469|NCT02187614|Acute Ureteric Colic|acute ureteric colic
4878470|NCT02187614|Renal or Ureteral Calculi|renal or ureteral calculi
4878471|NCT02187614|Urolithiasis|urolithiasis
4878472|NCT02187614|Kidney or Ureteral stones|kidney or ureteral stones
4878473|NCT02187601|CLD|cld
4878474|NCT02187549|Hyaluronic Acid|hyaluronic acid
4878475|NCT02187549|Osteoarthritis|osteoarthritis
4878476|NCT02187549|Knee|knee
4878477|NCT02187549|Hyaluronan|hyaluronan
4878478|NCT02187549|Viscoelastic|viscoelastic
4878479|NCT02187549|Hydrogel|hydrogel
4878480|NCT02187510|Hemodynamics|hemodynamics
4878481|NCT02187510|Premature Infant|premature infant
4878482|NCT02187510|Umbilical cord|umbilical cord
4878484|NCT02187510|Delayed clamping|delayed clamping
4878485|NCT02187471|pain|pain
4878486|NCT02187471|fibromyalgia|fibromyalgia
4878487|NCT02187445|Sickle Cell Disease|sickle cell disease
4878488|NCT02187445|Budesonide inhalation suspension|budesonide inhalation suspension
4878489|NCT02187445|Acute Chest Syndrome|acute chest syndrome
4878490|NCT02187419|Sleep|sleep
4878491|NCT02187419|Menopause|menopause
4878492|NCT02187419|Hypnosis|hypnosis
4878493|NCT02187419|Relaxation|relaxation
4878494|NCT02187419|Hypnotic Relaxation Therapy|hypnotic relaxation therapy
4878495|NCT02187419|Hot Flash|hot flash
4878496|NCT02187406|athletic tape|athletic tape
4878497|NCT02187406|tennis|tennis
4878498|NCT02187406|warm-up exercise|warm-up exercise
4878499|NCT02187393|Epithelial cell function of cells from individuals with various genotypes|epithelial cell function of cells from individuals with various genotypes
4878500|NCT02187302|nanopharmaceutical,|nanopharmaceutical,
4878501|NCT02187289|NCSG|ncsg
4878502|NCT02187289|Compression bandages|compression bandages
4878503|NCT02187289|devices|devices
4878504|NCT02187289|Night time compression|night time compression
4878505|NCT02187289|Breast cancer treatment side effects|breast cancer treatment side effects
4878506|NCT02187289|Compression therapy|compression therapy
4878507|NCT02187289|Reid Sleeve|reid sleeve
4878508|NCT02187289|Comprefit|comprefit
4878509|NCT02187289|Medassist|medassist
4878510|NCT02187289|Tribute|tribute
4878511|NCT02187289|Comprilan|comprilan
4878512|NCT02187276|Predictive factors of response|predictive factors of response
4878513|NCT02187276|mild and moderate|mild and moderate
4878514|NCT02187276|Alzheimer disease|alzheimer disease
4878515|NCT02187276|mixed dementia|mixed dementia
4878516|NCT02187276|APOE|apoe
4878517|NCT02187276|polymorphisms of CYP 2D6|polymorphisms of cyp 2d6
4878518|NCT02187263|hereditary cardiomyopathy,|hereditary cardiomyopathy,
4878519|NCT02187263|inflammatory cardiomyopathy,|inflammatory cardiomyopathy,
4878520|NCT02187263|registry,|registry,
4878521|NCT02187263|biomaterial,|biomaterial,
4878522|NCT02187263|clinical trial|clinical trial
4878523|NCT02187263|Patients|patients
4878524|NCT02187250|PCOS|pcos
4878525|NCT02187250|PDE-4 inhibitor|pde-4 inhibitor
4878526|NCT02187250|roflumilast|roflumilast
4878527|NCT02187250|liraglutide|liraglutide
4878528|NCT02187250|metformin|metformin
4878529|NCT02187250|obesity|obesity
4878530|NCT02187224|Alcohol Dependence|alcohol dependence
4878531|NCT02187224|Post-Traumatic stress disorder (PTSD)|post-traumatic stress disorder (ptsd)
4878532|NCT02187224|Progesterone|progesterone
4878533|NCT02187211|Alcohol Dependence|alcohol dependence
4878534|NCT02187211|Minocycline|minocycline
4878535|NCT02187198|Opioid Dependence|opioid dependence
4878536|NCT02187198|Buprenorphine|buprenorphine
4878537|NCT02187185|Inflammatory biomarkers|inflammatory biomarkers
4878538|NCT02187185|Periodontitis|periodontitis
4878539|NCT02187172|Psoriasis|psoriasis
4878540|NCT02187172|Cardiovascular Disease|cardiovascular disease
4878541|NCT02187172|Vascular Inflammation|vascular inflammation
4878542|NCT02187172|Lipid Biomarkers|lipid biomarkers
4878543|NCT02187172|FDG-PET/CT|fdg-pet/ct
4878544|NCT02187159|pain|pain
4878545|NCT02187159|fibromyalgia|fibromyalgia
4878546|NCT02187146|Vitamin D|vitamin d
4878547|NCT02187146|Infertility|infertility
4878548|NCT02187146|IVF|ivf
4878549|NCT02187146|ART|art
4878550|NCT02187133|Relapsed|relapsed
4878551|NCT02187133|Refractory|refractory
4878552|NCT02187120|Wounds and Injuries|wounds and injuries
4878553|NCT02187120|Acute Coagulopathy|acute coagulopathy
4878554|NCT02187120|Tranexamic Acid|tranexamic acid
4878555|NCT02187120|Emergency Medical Services|emergency medical services
4878556|NCT02187107|HIV|hiv
4878557|NCT02187107|AIDS|aids
4878558|NCT02187107|TMC114|tmc114
4878559|NCT02187107|Ritonavir|ritonavir
4878560|NCT02187107|Norvir|norvir
4878561|NCT02187107|Darunavir|darunavir
4878562|NCT02187081|HCC|hcc
4878563|NCT02187081|RFA|rfa
4878564|NCT02187081|Sorafenib|sorafenib
4878565|NCT02187081|Tumor recurrence|tumor recurrence
4878566|NCT02187081|Overall survival|overall survival
4878567|NCT02187068|Anaesthetics iv|anaesthetics iv
4878568|NCT02187068|Dexmedetomidine|dexmedetomidine
4878569|NCT02187068|Pharmacokinetic|pharmacokinetic
4878570|NCT02187042|sunitinib|sunitinib
4878571|NCT02187042|call center|call center
4878572|NCT02187042|management of patients|management of patients
4878573|NCT02187042|nurses|nurses
4878574|NCT02187042|metastatic renal carcinoma|metastatic renal carcinoma
4878575|NCT02187029|Hyperuricemia|hyperuricemia
4878576|NCT02187029|gout|gout
4878577|NCT02187029|serum uric acid|serum uric acid
4878578|NCT02187016|Gingivitis|gingivitis
4878579|NCT02187016|plaque|plaque
4878580|NCT02187016|interproximal cleaning|interproximal cleaning
4878581|NCT02187016|dental floss|dental floss
4878582|NCT02187003|Sickle Cell Anemia|sickle cell anemia
4878583|NCT02187003|Sickle Cell Disease|sickle cell disease
4878584|NCT02187003|Sickle Cell Disorders|sickle cell disorders
4878585|NCT02187003|pain crisis|pain crisis
4878586|NCT02187003|vaso-occlusive crisis|vaso-occlusive crisis
4878587|NCT02187003|rivipansel|rivipansel
4878588|NCT02187003|GMI-1070|gmi-1070
4878589|NCT02187003|selectin inhibitor|selectin inhibitor
4878590|NCT02187003|SCD|scd
4878591|NCT02187003|VOC|voc
4878592|NCT02186977|immunogenicity|immunogenicity
4878593|NCT02186977|safety|safety
4878594|NCT02186977|proof of concept|proof of concept
4878595|NCT02186951|ventilator-associated pneumonia|ventilator-associated pneumonia
4878596|NCT02186951|cardiac arrests with shockable rhythm|cardiac arrests with shockable rhythm
4878597|NCT02186951|Mild therapeutic hypothermia|mild therapeutic hypothermia
4878598|NCT02186951|preventive antibiotics|preventive antibiotics
4878599|NCT02186938|head and neck cancer|head and neck cancer
4878600|NCT02186938|patients requiring a free flap surgery|patients requiring a free flap surgery
4878601|NCT02186925|Kidney Cancer|kidney cancer
4878602|NCT02186925|Prostate Cancer|prostate cancer
4878603|NCT02186925|Bladder Cancer|bladder cancer
4878604|NCT02186912|edentulous|edentulous
4878605|NCT02186912|Nobel Active|nobel active
4878606|NCT02186912|Nobel Procera|nobel procera
4878607|NCT02186912|IBO|ibo
4878608|NCT02186912|CAD/CAM|cad/cam
4878609|NCT02186886|Ulcerative Colitis|ulcerative colitis
4878610|NCT02186886|Golimumab|golimumab
4878611|NCT02186886|Physiological Intermolecular Modification Spectroscopy|physiological intermolecular modification spectroscopy
4878612|NCT02186886|PIMS|pims
4878613|NCT02186873|Ankylosing Spondylitis|ankylosing spondylitis
4878614|NCT02186873|Golimumab|golimumab
4878615|NCT02186873|SIMPONI|simponi
4878616|NCT02186834|Relapsed|relapsed
4878617|NCT02186834|Refractory|refractory
4878618|NCT02186834|Myeloma|myeloma
4878619|NCT02186821|hematological malignancy|hematological malignancy
4878620|NCT02186821|solid tumor malignancy|solid tumor malignancy
4878621|NCT02186821|mutation|mutation
4878622|NCT02186821|translocation|translocation
4878623|NCT02186821|rearrangement|rearrangement
4878624|NCT02186821|amplification|amplification
4878625|NCT02186821|ALK|alk
4878626|NCT02186821|ROS1|ros1
4878627|NCT02186821|NSCLC|nsclc
4878628|NCT02186821|B-cell lymphoma|b-cell lymphoma
4878629|NCT02186795|Arthroplasty|arthroplasty
4878630|NCT02186795|Replacement, Hip|replacement, hip
4878631|NCT02186782|Clomiphene citrate|clomiphene citrate
4878632|NCT02186782|Estradiol|estradiol
4878633|NCT02186782|Endometrial thickness|endometrial thickness
4878634|NCT02186756|Fibromyalgia|fibromyalgia
4878635|NCT02186756|Complementary Therapies|complementary therapies
4878636|NCT02186756|Biofeedback|biofeedback
4878637|NCT02186756|Randomized controlled trial|randomized controlled trial
4878638|NCT02186756|Relaxation Therapy|relaxation therapy
4878639|NCT02186743|Irritable Bowel Syndrome|irritable bowel syndrome
4878640|NCT02186743|IBS|ibs
4878641|NCT02186743|Diet|diet
4878642|NCT02186743|Food sensitivity|food sensitivity
4878643|NCT02186730|Computerised Cognitive Behaviour Therapy|computerised cognitive behaviour therapy
4878644|NCT02186730|Adolescents|adolescents
4878645|NCT02186730|Depression|depression
4878646|NCT02186730|Low Mood|low mood
4878647|NCT02186704|Atrial Fibrillation|atrial fibrillation
4878648|NCT02186704|Implantable Defibrillators|implantable defibrillators
4878649|NCT02186704|Implanted Electrodes|implanted electrodes
4878650|NCT02186691|pulmonary valve replacement|pulmonary valve replacement
4878651|NCT02186691|tetralogy of Fallot|tetralogy of fallot
4878652|NCT02186652|obese|obese
4878653|NCT02186652|children|children
4878654|NCT02186652|adolescents|adolescents
4878655|NCT02186652|GERD|gerd
4878656|NCT02186652|pharmacokinetic|pharmacokinetic
4878657|NCT02186639|exhaled breath|exhaled breath
4878658|NCT02186639|volatile organic compounds (VOCs)|volatile organic compounds (vocs)
4878659|NCT02186639|SESI-MS|sesi-ms
4878660|NCT02186626|West Nile Virus, vaccine|west nile virus, vaccine
4878661|NCT02186613|Breast Feeding|breast feeding
4878662|NCT02186613|Telephone|telephone
4878663|NCT02186613|Education|education
4878664|NCT02186613|Primary Health Care|primary health care
4878665|NCT02186600|Low bone mass|low bone mass
4878666|NCT02186600|Post-menopausal women|post-menopausal women
4878667|NCT02186600|Bone mineral density|bone mineral density
4878668|NCT02186600|Bone structure|bone structure
4878669|NCT02186600|Bone turnover|bone turnover
4878670|NCT02186600|Bone-loading exercises|bone-loading exercises
4878671|NCT02186600|calcium and vitamin D|calcium and vitamin d
4878672|NCT02186600|risedronate|risedronate
4878673|NCT02186574|Non-Hodgkin|non-hodgkin
4878674|NCT02186574|Lymphoma|lymphoma
4878675|NCT02186574|Hepatitis B|hepatitis b
4878676|NCT02186574|Tenofovir|tenofovir
4878677|NCT02186574|Viread|viread
4878678|NCT02186561|intracranial aneurysm|intracranial aneurysm
4878679|NCT02186561|brain aneurysm|brain aneurysm
4878680|NCT02186522|Sepsis|sepsis
4878681|NCT02186522|Septic shock|septic shock
4878682|NCT02186522|Critical care|critical care
4878683|NCT02186522|Immune dysfunction|immune dysfunction
4878684|NCT02186522|Inflammatory markers|inflammatory markers
4878685|NCT02186522|Neutrophil|neutrophil
4878686|NCT02186522|Monocyte|monocyte
4878687|NCT02186522|Tregs|tregs
4878688|NCT02186470|Breast Cancer|breast cancer
4878689|NCT02186470|Early Stage Breast Cancer|early stage breast cancer
4878690|NCT02186470|Hormone responsive breast cancer|hormone responsive breast cancer
4878691|NCT02186457|Pancreatoduodenectomy|pancreatoduodenectomy
4878692|NCT02186457|Whipple|whipple
4878693|NCT02186444|newly diagnosed prostate cancer|newly diagnosed prostate cancer
4878694|NCT02186444|prostate|prostate
4878695|NCT02186431|Contact lenses|contact lenses
4878696|NCT02186418|sickle cell disease|sickle cell disease
4878697|NCT02186418|sickle cell anemia|sickle cell anemia
4878698|NCT02186418|hemoglobinopathies|hemoglobinopathies
4878699|NCT02186418|hematopoietic stem cell|hematopoietic stem cell
4878700|NCT02186418|gene transfer|gene transfer
4878701|NCT02186418|gene therapy|gene therapy
4878702|NCT02186392|Depression|depression
4878703|NCT02186392|Anxiety|anxiety
4878704|NCT02186392|Stroke|stroke
4878705|NCT02186392|Cerebral Infarction|cerebral infarction
4878706|NCT02186392|Sleep disorders|sleep disorders
4878707|NCT02186392|Circadian Rhythm disorders|circadian rhythm disorders
4878708|NCT02186392|Circadian Light|circadian light
4878709|NCT02186392|Light therapy|light therapy
4878710|NCT02186392|Melatonin|melatonin
4878711|NCT02186392|Sleep|sleep
4878712|NCT02186392|Sleep apnea|sleep apnea
4878713|NCT02186392|Coagulation disturbances|coagulation disturbances
4878714|NCT02186392|Bone metabolism|bone metabolism
4878715|NCT02186392|Rehabilitation|rehabilitation
4878716|NCT02186392|Mood disorders|mood disorders
4878717|NCT02186392|Mental disorders|mental disorders
4878718|NCT02186392|Neurologic Manifestations|neurologic manifestations
4878719|NCT02186392|Signs and Symptoms Cerebrovascular Disorders|signs and symptoms cerebrovascular disorders
4878720|NCT02186392|Brain Diseases|brain diseases
4878721|NCT02186392|Vascular Disease|vascular disease
4878722|NCT02186392|Brain Infarction|brain infarction
4878723|NCT02186392|Brain Ischemia|brain ischemia
4878724|NCT02186379|Obesity|obesity
4878725|NCT02186379|Obesity Prevention|obesity prevention
4878726|NCT02186379|Childhood obesity prevention|childhood obesity prevention
4878727|NCT02186379|Rapid Eating Style|rapid eating style
4878728|NCT02186366|Anxiety Disorders, Massage Therapy, Treatment Efficacy|anxiety disorders, massage therapy, treatment efficacy
4878729|NCT02186353|Whole grains|whole grains
4878730|NCT02186353|Food processing|food processing
4878731|NCT02186353|Cardiometabolic risk factors|cardiometabolic risk factors
4878732|NCT02186327|Integrative Health Coaching|integrative health coaching
4878733|NCT02186314|atrial fibrillation, heart failure, pacemaker|atrial fibrillation, heart failure, pacemaker
4878734|NCT02186301|cancer|cancer
4878735|NCT02186301|metastatic|metastatic
4878736|NCT02186301|locally advanced|locally advanced
4878737|NCT02186301|lung|lung
4878738|NCT02186301|non-small cell lung cancer|non-small cell lung cancer
4878739|NCT02186301|NSCLC|nsclc
4878740|NCT02186301|epidermal growth factor receptor|epidermal growth factor receptor
4878741|NCT02186301|EGFR|egfr
4878742|NCT02186301|T790M|t790m
4878743|NCT02186301|CO-1686|co-1686
4878744|NCT02186301|unresectable|unresectable
4878745|NCT02186301|recurrent|recurrent
4878746|NCT02186301|EGFR-directed therapy|egfr-directed therapy
4878747|NCT02186301|irreversible EGFR inhibitor|irreversible egfr inhibitor
4878748|NCT02186301|TIGER|tiger
4878749|NCT02186301|rociletinib|rociletinib
4878750|NCT02186288|Critical Care|critical care
4878751|NCT02186288|High-flow nasal cannula oxygen|high-flow nasal cannula oxygen
4878752|NCT02186288|Electrical impedance tomography|electrical impedance tomography
4878753|NCT02186288|End expiratory lung volume|end expiratory lung volume
4878754|NCT02186288|End expiratory lung impedance|end expiratory lung impedance
4878755|NCT02186288|Diaphragmatic ultrasound|diaphragmatic ultrasound
4878756|NCT02186275|Crohn|crohn
4878757|NCT02186275|vitamin D|vitamin d
4878758|NCT02186275|remission|remission
4878759|NCT02186275|inflammation|inflammation
4878760|NCT02186275|tolerance|tolerance
4878761|NCT02186262|Glioma|glioma
4878762|NCT02186262|MRI|mri
4878763|NCT02186262|Rotating frame relaxation|rotating frame relaxation
4878764|NCT02186262|DWI|dwi
4878765|NCT02186262|treatment response|treatment response
4878766|NCT02186236|Detection of Oncogenic Tumor Mutations|detection of oncogenic tumor mutations
4878767|NCT02186236|blood|blood
4878768|NCT02186236|urine|urine
4878769|NCT02186236|14-114|14-114
4878770|NCT02186223|Pulmonary Embolism|pulmonary embolism
4878771|NCT02186223|PE|pe
4878772|NCT02186223|DVT|dvt
4878773|NCT02186223|Deep Vein Thrombosis|deep vein thrombosis
4878774|NCT02186223|VTE|vte
4878775|NCT02186223|Venous Thromboembolism|venous thromboembolism
4878776|NCT02186223|prophylaxis|prophylaxis
4878777|NCT02186223|thromboprophylaxis|thromboprophylaxis
4878778|NCT02186223|contraindications to thromboprophylaxis|contraindications to thromboprophylaxis
4878779|NCT02186223|prophylactic|prophylactic
4878780|NCT02186223|prevention|prevention
4878781|NCT02186223|Inferior vena cava filter|inferior vena cava filter
4878782|NCT02186223|IVC filter|ivc filter
4878783|NCT02186223|filter|filter
4878784|NCT02186223|prevention of pulmonary embolism|prevention of pulmonary embolism
4878785|NCT02186223|trauma|trauma
4878786|NCT02186223|critically-ill|critically-ill
4878787|NCT02186210|microcirculation|microcirculation
4878788|NCT02186210|off-pump coronary artery bypass surgery|off-pump coronary artery bypass surgery
4878789|NCT02186210|tissue oxygen saturation|tissue oxygen saturation
4878790|NCT02186210|vascular occlusion test|vascular occlusion test
4878791|NCT02186210|recovery slope|recovery slope
4878792|NCT02186197|Volume Responsiveness|volume responsiveness
4878793|NCT02186184|Myopia progression|myopia progression
4878794|NCT02186184|Orthokeratology|orthokeratology
4878795|NCT02186171|Osteoporosis in men|osteoporosis in men
4878796|NCT02186158|Pneumonia|pneumonia
4878797|NCT02186158|Elderly|elderly
4878798|NCT02186158|Ascorbic acid|ascorbic acid
4878799|NCT02186158|Vitamin C|vitamin c
4878800|NCT02186158|Hospitalized patient|hospitalized patient
4878801|NCT02186132|heart rate|heart rate
4878802|NCT02186132|neostigmine|neostigmine
4878803|NCT02186132|atropine|atropine
4878804|NCT02186132|dosage|dosage
4878805|NCT02186093|Coronary Artery Disease|coronary artery disease
4878806|NCT02186093|Angina, Stable|angina, stable
4878807|NCT02186093|Fractional Flow Reserve, Myocardial|fractional flow reserve, myocardial
4878808|NCT02186093|Coronary Angiography|coronary angiography
4878809|NCT02186080|diabetes mellitus|diabetes mellitus
4878810|NCT02186080|metabolic endotoxemia|metabolic endotoxemia
4878811|NCT02186080|gemigliptin|gemigliptin
4878812|NCT02186080|DPP-4 inhibitor|dpp-4 inhibitor
4878813|NCT02186067|Hypertension|hypertension
4878814|NCT02186067|Uncontrolled Hypertension|uncontrolled hypertension
4878815|NCT02186054|Abdominal-Pelvic MRI (magnetic resonance image)|abdominal-pelvic mri (magnetic resonance image)
4878816|NCT02186054|T2W (T2 weighted)|t2w (t2 weighted)
4878817|NCT02186054|FSE Flex (recently developed MRI pulse sequence)|fse flex (recently developed mri pulse sequence)
4878818|NCT02186054|Enhanced single shot FSE (fast spin echo).|enhanced single shot fse (fast spin echo).
4878819|NCT02186028|oral daily supplementation with vitamin D for 6 months|oral daily supplementation with vitamin d for 6 months
4878820|NCT02186015|Metastatic Breast Cancer|metastatic breast cancer
4878821|NCT02186015|MBC|mbc
4878822|NCT02186015|Vitamin D Supplementation|vitamin d supplementation
4878823|NCT02186015|Symptom Management|symptom management
4878824|NCT02186002|ACT-451840|act-451840
4878825|NCT02186002|Safety|safety
4878826|NCT02186002|Tolerability|tolerability
4878827|NCT02186002|Pharmacokinetics|pharmacokinetics
4878828|NCT02185989|Critical Illness/*rehabilitation|critical illness/*rehabilitation
4878829|NCT02185989|Humans|humans
4878830|NCT02185989|*Intensive Care Units|*intensive care units
4878831|NCT02185989|Muscle Weakness/diagnosis/*etiology/physiopathology/prevention & control|muscle weakness/diagnosis/*etiology/physiopathology/prevention & control
4878832|NCT02185989|Polyneuropathies/diagnosis/*etiology/physiopathology|polyneuropathies/diagnosis/*etiology/physiopathology
4878833|NCT02185976|preoperative anxiety|preoperative anxiety
4878834|NCT02185976|paediatric patients|paediatric patients
4878835|NCT02185976|Cartoon|cartoon
4878836|NCT02185963|Diabetes|diabetes
4878837|NCT02185963|Dyslipidemia|dyslipidemia
4878838|NCT02185963|HDL function|hdl function
4878839|NCT02185963|Cholesterol efflux|cholesterol efflux
4878840|NCT02185963|MCA assay|mca assay
4878841|NCT02185963|MCP-1|mcp-1
4878842|NCT02185950|Burn|burn
4878843|NCT02185950|Skin graft|skin graft
4878844|NCT02185950|Elasticity|elasticity
4878845|NCT02185950|Skin|skin
4878846|NCT02185950|Physical therapy modalities|physical therapy modalities
4878847|NCT02185937|imatinib|imatinib
4878848|NCT02185937|gastrectomy|gastrectomy
4878849|NCT02185937|gastrointestinal stromal tumor|gastrointestinal stromal tumor
4878850|NCT02185937|pharmacokinetics|pharmacokinetics
4878851|NCT02185924|PARECOXIB|parecoxib
4878852|NCT02185924|CONTINUOUS FEMORAL BLOCK|continuous femoral block
4878853|NCT02185911|chronic kidney disease,|chronic kidney disease,
4878854|NCT02185911|anaemia correction/maintenance,|anaemia correction/maintenance,
4878855|NCT02185911|non dialysis,|non dialysis,
4878856|NCT02185898|electronic cigarettes|electronic cigarettes
4878857|NCT02185898|e-cigarettes|e-cigarettes
4878858|NCT02185898|combustible cigarettes|combustible cigarettes
4878859|NCT02185898|second-hand smoke|second-hand smoke
4878860|NCT02185898|environmental tobacco smoke|environmental tobacco smoke
4878861|NCT02185898|tobacco-burning|tobacco-burning
4878862|NCT02185885|Ischemic stroke|ischemic stroke
4878863|NCT02185885|Embolic stroke|embolic stroke
4878864|NCT02185885|Postoperative Cognitive Dysfunction|postoperative cognitive dysfunction
4878865|NCT02185885|Cardiac Bypass Surgery|cardiac bypass surgery
4878866|NCT02185885|Cardiac Anaesthesia|cardiac anaesthesia
4878867|NCT02185872|Exercise|exercise
4878868|NCT02185872|Physical Fitness|physical fitness
4878869|NCT02185872|Body Composition, Beneficial|body composition, beneficial
4878870|NCT02185859|Lidocaine|lidocaine
4878871|NCT02185859|Magnesium|magnesium
4878872|NCT02185859|Mastectomy|mastectomy
4878873|NCT02185859|Functional Recovery|functional recovery
4878874|NCT02185846|Fed condition|fed condition
4878875|NCT02185833|Fasting condition|fasting condition
4878876|NCT02185820|Multiple myeloma|multiple myeloma
4878877|NCT02185820|Relapsed and/or refractory|relapsed and/or refractory
4878878|NCT02185820|CPD|cpd
4878879|NCT02185807|cataract|cataract
4878880|NCT02185807|surgery|surgery
4878881|NCT02185807|consent process|consent process
4878882|NCT02185807|video-assisted|video-assisted
4878883|NCT02185794|HCV genotype 1 (GT-1)|hcv genotype 1 (gt-1)
4878884|NCT02185794|HCV genotype 2 (GT-2)|hcv genotype 2 (gt-2)
4878885|NCT02185794|HCV genotype 3 (GT-3)|hcv genotype 3 (gt-3)
4878886|NCT02185794|HCV genotype 4 (GT-4)|hcv genotype 4 (gt-4)
4878887|NCT02185794|HCV|hcv
4878888|NCT02185794|Sustained Virologic Response|sustained virologic response
4878889|NCT02185794|Direct Acting Antiviral|direct acting antiviral
4878890|NCT02185794|Combination Therapy|combination therapy
4878891|NCT02185794|Open Label|open label
4878892|NCT02185794|Hepatitis|hepatitis
4878893|NCT02185794|Hepatitis, Chronic|hepatitis, chronic
4878894|NCT02185794|Hepatitis C|hepatitis c
4878895|NCT02185794|Hepatitis C, Chronic|hepatitis c, chronic
4878896|NCT02185794|Liver Diseases|liver diseases
4878897|NCT02185794|Digestive System Diseases|digestive system diseases
4878898|NCT02185794|Hepatitis, Viral, Human|hepatitis, viral, human
4878899|NCT02185794|Virus Diseases|virus diseases
4878900|NCT02185794|Enterovirus Infections|enterovirus infections
4878901|NCT02185794|Picornaviridae Infections|picornaviridae infections
4878902|NCT02185794|RNA Virus Infections|rna virus infections
4878903|NCT02185794|Flaviviridae Infections|flaviviridae infections
4878904|NCT02185794|Antiviral Agents|antiviral agents
4878905|NCT02185794|Anti-Infective Agents|anti-infective agents
4878906|NCT02185794|Therapeutic Uses|therapeutic uses
4878907|NCT02185794|Pharmacologic Actions|pharmacologic actions
4878908|NCT02185794|Antimetabolites|antimetabolites
4878909|NCT02185794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
4878910|NCT02185781|Phase I|phase i
4878911|NCT02185781|Adoptive immunotherapy|adoptive immunotherapy
4878912|NCT02185781|Enriched and expanded autologous natural killer (NK) cells|enriched and expanded autologous natural killer (nk) cells
4878913|NCT02185781|Ph+ acute lymphoblastic leukemia|ph+ acute lymphoblastic leukemia
4878914|NCT02185781|≥60 years|≥60 years
4878915|NCT02185781|Not eligible for other post-CHR treatment modalities|not eligible for other post-chr treatment modalities
4878916|NCT02185768|Liver cancer|liver cancer
4878917|NCT02185755|Internet-Based Glucose Monitoring System|internet-based glucose monitoring system
4878918|NCT02185755|Type 2 Diabetes|type 2 diabetes
4878919|NCT02185742|HIV|hiv
4878920|NCT02185742|jail|jail
4878921|NCT02185742|detainee|detainee
4878922|NCT02185742|Linkage and Retention|linkage and retention
4878923|NCT02185742|Treatment as Prevention|treatment as prevention
4878924|NCT02185742|Strength Based Case Management|strength based case management
4878925|NCT02185742|releases|releases
4878926|NCT02185729|Intravenous Feeding|intravenous feeding
4878927|NCT02185729|Lipid Emulsions, Intravenous|lipid emulsions, intravenous
4878928|NCT02185716|Transversus abdominis plane block|transversus abdominis plane block
4878929|NCT02185716|levobupivacaine|levobupivacaine
4878930|NCT02185690|Lung cancer|lung cancer
4878931|NCT02185690|Non small cell lung cancer|non small cell lung cancer
4878932|NCT02185690|non squamous|non squamous
4878933|NCT02185690|pemetrexed|pemetrexed
4878934|NCT02185690|carboplatin|carboplatin
4878935|NCT02185690|binimetinib|binimetinib
4878936|NCT02185690|chemotherapy|chemotherapy
4878937|NCT02185690|combination chemotherapy|combination chemotherapy
4878938|NCT02185690|Phase 1|phase 1
4878939|NCT02185690|Princess Margaret Cancer Centre|princess margaret cancer centre
4878940|NCT02185690|carcinoma|carcinoma
4878941|NCT02185677|dysexecutive syndrome|dysexecutive syndrome
4878942|NCT02185677|multiple system atrophy|multiple system atrophy
4878943|NCT02185677|imaging study|imaging study
4878944|NCT02185664|internal jugular vein|internal jugular vein
4878945|NCT02185664|landmark|landmark
4878946|NCT02185664|ultrasound|ultrasound
4878947|NCT02185664|static|static
4878948|NCT02185664|cardiac surgery|cardiac surgery
4878949|NCT02185651|Pompe Disease|pompe disease
4878950|NCT02185651|Enzyme Replacement Therapy|enzyme replacement therapy
4878951|NCT02185651|Infusion Associated Reaction|infusion associated reaction
4878952|NCT02185638|obesity|obesity
4878953|NCT02185638|herbal bioactive compounds|herbal bioactive compounds
4878954|NCT02185638|appetite|appetite
4878955|NCT02185638|GLP-1|glp-1
4878956|NCT02185638|ghrelin|ghrelin
4878957|NCT02185638|CCK|cck
4878958|NCT02185599|colposcopy|colposcopy
4878959|NCT02185599|CIN|cin
4878960|NCT02185599|cervical neoplasia|cervical neoplasia
4878961|NCT02185599|cervical dysplasia|cervical dysplasia
4878962|NCT02185599|cervical cancer|cervical cancer
4878963|NCT02185599|CIN2+|cin2+
4878964|NCT02185573|Bulk fill|bulk fill
4878965|NCT02185573|SonicFill|sonicfill
4878966|NCT02185573|resin composite application|resin composite application
4878967|NCT02185573|class II restoration|class ii restoration
4878968|NCT02185560|Sorafenib|sorafenib
4878969|NCT02185560|Differentiated Thyroid Carcinoma,|differentiated thyroid carcinoma,
4878970|NCT02185560|Japan|japan
4878971|NCT02185560|Post Marketing Surveillance|post marketing surveillance
4878972|NCT02185560|Drug Use Investigation|drug use investigation
4878973|NCT02185547|women|women
4878974|NCT02185534|Clopidogrel, Zyllt, Plavix, Phase I, Healthy Subjects, Pharmacokinetics, Bioequivalence|clopidogrel, zyllt, plavix, phase i, healthy subjects, pharmacokinetics, bioequivalence
4878975|NCT02185521|Hemodynamics|hemodynamics
4878976|NCT02185521|Medical Informatics|medical informatics
4878977|NCT02185508|IONM|ionm
4878978|NCT02185508|Lumbar Disk Disease|lumbar disk disease
4878979|NCT02185508|Degenerative Spine Disease|degenerative spine disease
4878980|NCT02185508|Radiculopathy|radiculopathy
4878981|NCT02185508|Intraoperative Neurophysiological Monitoring|intraoperative neurophysiological monitoring
4878982|NCT02185508|Somatosensory Evoked Potentials|somatosensory evoked potentials
4878983|NCT02185508|Electromyography|electromyography
4879109|NCT02184871|RNAseq|rnaseq
4878984|NCT02185482|Psychological counselling|psychological counselling
4878985|NCT02185482|Randomized single blind study|randomized single blind study
4878986|NCT02185482|Depression|depression
4878987|NCT02185482|Diabetes|diabetes
4878988|NCT02185469|Corneal Endothelial Cell Loss|corneal endothelial cell loss
4878989|NCT02185469|pneumatic retinopexy|pneumatic retinopexy
4878990|NCT02185469|vitrectomy|vitrectomy
4878991|NCT02185443|SBRT|sbrt
4878992|NCT02185443|radiation|radiation
4878993|NCT02185443|Neoplasm Metastasis|neoplasm metastasis
4878994|NCT02185443|Colorectal Neoplasms|colorectal neoplasms
4878995|NCT02185443|Anal Canal|anal canal
4878996|NCT02185443|Neuroendocrine Tumors|neuroendocrine tumors
4878997|NCT02185417|Hypertension|hypertension
4878998|NCT02185417|Diuretic|diuretic
4878999|NCT02185417|Comparative Effectiveness Research|comparative effectiveness research
4879000|NCT02185417|Point of Care Research|point of care research
4879001|NCT02185391|Coronary Disease|coronary disease
4879002|NCT02185391|Audience Response System|audience response system
4879003|NCT02185365|T1-rho MRI|t1-rho mri
4879004|NCT02185365|dGEMRIC MRI|dgemric mri
4879005|NCT02185365|DDH|ddh
4879006|NCT02185365|Developmental dysplasia of the hip|developmental dysplasia of the hip
4879007|NCT02185352|Bevacizumab|bevacizumab
4879008|NCT02185352|Brain Metastases|brain metastases
4879009|NCT02185352|Breast Cancer|breast cancer
4879010|NCT02185352|Chemotherapy|chemotherapy
4879011|NCT02185352|Whole Brain Radiotherapy|whole brain radiotherapy
4879012|NCT02185339|Respiratory mechanics|respiratory mechanics
4879013|NCT02185339|Respiratory function test|respiratory function test
4879014|NCT02185339|Hemodynamics|hemodynamics
4879015|NCT02185326|Poor responders|poor responders
4879214|NCT02184481|Anxiety|anxiety
4879016|NCT02185326|Poor ovarian response|poor ovarian response
4879017|NCT02185326|IVF/ICSI|ivf/icsi
4879018|NCT02185326|Microflare protocol|microflare protocol
4879019|NCT02185326|Growth hormone|growth hormone
4879020|NCT02185326|Oral contraceptive pills|oral contraceptive pills
4879021|NCT02185300|GSK1349572|gsk1349572
4879022|NCT02185300|granule|granule
4879023|NCT02185300|pediatric|pediatric
4879024|NCT02185300|CONTREX mineral water|contrex mineral water
4879025|NCT02185300|free-acid|free-acid
4879026|NCT02185300|chelating|chelating
4879027|NCT02185300|cations|cations
4879028|NCT02185300|divalent|divalent
4879029|NCT02185300|dolutegravir|dolutegravir
4879030|NCT02185300|dispersible tablet|dispersible tablet
4879031|NCT02185300|relative bioavailability|relative bioavailability
4879032|NCT02185274|Transsexualism|transsexualism
4879033|NCT02185274|Cross-sex hormone treatment|cross-sex hormone treatment
4879034|NCT02185274|Sex hormones|sex hormones
4879035|NCT02185274|Mood|mood
4879036|NCT02185274|Stress|stress
4879037|NCT02185274|Cortisol|cortisol
4879038|NCT02185274|Cardiovascular|cardiovascular
4879039|NCT02185274|Metabolome|metabolome
4879040|NCT02185261|Relapse|relapse
4879041|NCT02185261|Minimal residual disease|minimal residual disease
4879042|NCT02185261|Graft-versus-host disease|graft-versus-host disease
4879043|NCT02185261|Acute leukemia|acute leukemia
4879044|NCT02185261|Interferon Alfa-2b|interferon alfa-2b
4879045|NCT02185248|Pediatric Obesity|pediatric obesity
4879046|NCT02185248|Body Mass Index|body mass index
4879047|NCT02185248|Weight Perception|weight perception
4879048|NCT02185248|Counseling|counseling
4879049|NCT02185248|Health Behavior|health behavior
4879050|NCT02185235|Electrical stimulation|electrical stimulation
4879051|NCT02185235|Biofeedback|biofeedback
4879052|NCT02185222|Vitamin D|vitamin d
4879053|NCT02185222|Cholecalciferol|cholecalciferol
4879054|NCT02185222|25-hydroxyvitamin D|25-hydroxyvitamin d
4879055|NCT02185222|Memory complaint|memory complaint
4879056|NCT02185222|Subjective memory complaint|subjective memory complaint
4879057|NCT02185222|Mild cognitive impairment|mild cognitive impairment
4879058|NCT02185222|Preventive therapy|preventive therapy
4879059|NCT02185222|Cognitive disorders|cognitive disorders
4879060|NCT02185196|Vitamin D,|vitamin d,
4879061|NCT02185196|Severe pneumonia,|severe pneumonia,
4879062|NCT02185196|Under-five children,|under-five children,
4879063|NCT02185196|Randomised|randomised
4879064|NCT02185196|Controlled|controlled
4879065|NCT02185196|Trial (RCT)|trial (rct)
4879066|NCT02185196|Morbidity|morbidity
4879067|NCT02185170|Prostate|prostate
4879068|NCT02185170|Cancer|cancer
4879069|NCT02185170|Medical Device|medical device
4879070|NCT02185170|Fluorescence|fluorescence
4879071|NCT02185157|elderly|elderly
4879072|NCT02185157|dual-task training|dual-task training
4879073|NCT02185157|aerobic training|aerobic training
4879074|NCT02185157|gait|gait
4879075|NCT02185157|cognition|cognition
4879076|NCT02185144|HIV, mental health, substance abuse|hiv, mental health, substance abuse
4879077|NCT02185131|Major Depressive Disorder|major depressive disorder
4879078|NCT02185131|Alcohol Use Disorder|alcohol use disorder
4879079|NCT02185092|exacerbations|exacerbations
4879080|NCT02185092|COPD|copd
4879081|NCT02185092|pneumonia|pneumonia
4879082|NCT02185092|probiotic|probiotic
4879083|NCT02185079|labor|labor
4879084|NCT02185079|epidural|epidural
4879085|NCT02185040|Lupus, Systemic Lupus, SLE|lupus, systemic lupus, sle
4879086|NCT02185027|Oral anticoagulants|oral anticoagulants
4879087|NCT02185027|Surgery|surgery
4879088|NCT02185027|Haemorrhage|haemorrhage
4879089|NCT02185027|Emergency|emergency
4879090|NCT02185014|Crohn's Disease|crohn's disease
4879091|NCT02185001|Medial patellofemoral ligament|medial patellofemoral ligament
4879092|NCT02185001|MPFL|mpfl
4879093|NCT02185001|Repair|repair
4879094|NCT02185001|Patellar dislocation|patellar dislocation
4879095|NCT02185001|Knee|knee
4879096|NCT02184988|Glabellar Lines|glabellar lines
4879097|NCT02184988|Botulinum purifies neurotoxin, Type A (DWP-450)|botulinum purifies neurotoxin, type a (dwp-450)
4879098|NCT02184975|cold knife conization|cold knife conization
4879099|NCT02184975|lateral hemostatic sutures|lateral hemostatic sutures
4879100|NCT02184975|cervix|cervix
4879101|NCT02184949|PCI|pci
4879102|NCT02184949|Coronary angioplasty|coronary angioplasty
4879103|NCT02184949|Percutaneous transluminal coronary angioplasty|percutaneous transluminal coronary angioplasty
4879104|NCT02184949|PTCA|ptca
4879105|NCT02184936|CT Angiography, CT Perfusion, Ischemic Stroke, Collaterals|ct angiography, ct perfusion, ischemic stroke, collaterals
4879106|NCT02184910|atrophic gastritis, pepsinogen, Helicobacter pylori|atrophic gastritis, pepsinogen, helicobacter pylori
4879107|NCT02184884|off-pump coronary artery bypass surgery, clopidogrel responsiveness, ischemic outcome|off-pump coronary artery bypass surgery, clopidogrel responsiveness, ischemic outcome
4879108|NCT02184871|intrahepatic cholangiocarcinoma|intrahepatic cholangiocarcinoma
4879110|NCT02184871|risk factors|risk factors
4879111|NCT02184871|asbestos|asbestos
4879112|NCT02184845|single tooth implant|single tooth implant
4879113|NCT02184845|supported restoration(s)|supported restoration(s)
4879114|NCT02184845|maxillary lateral incisor|maxillary lateral incisor
4879115|NCT02184845|mandibular central incisor|mandibular central incisor
4879116|NCT02184845|lateral incisor|lateral incisor
4879117|NCT02184845|areas of the mouth|areas of the mouth
4879118|NCT02184819|coronary artery bypass graft|coronary artery bypass graft
4879119|NCT02184819|left ventricular dysfunction|left ventricular dysfunction
4879120|NCT02184819|low cardiac output syndrome|low cardiac output syndrome
4879121|NCT02184819|levosimendan|levosimendan
4879122|NCT02184819|mortality|mortality
4879123|NCT02184819|inotropic agents|inotropic agents
4879124|NCT02184819|cardiac mechanical assist devices|cardiac mechanical assist devices
4879125|NCT02184819|renal replacement therapy|renal replacement therapy
4879126|NCT02184819|mechanical ventilation duration|mechanical ventilation duration
4879127|NCT02184819|ICU stay|icu stay
4879128|NCT02184806|Ovarian tissue transplantation|ovarian tissue transplantation
4879129|NCT02184806|Cryopreserved ovarian tissue|cryopreserved ovarian tissue
4879130|NCT02184793|mechanical ventilation|mechanical ventilation
4879131|NCT02184793|semirecumbent position|semirecumbent position
4879132|NCT02184793|electronic monitoring device|electronic monitoring device
4879133|NCT02184780|Neurodevelopment|neurodevelopment
4879134|NCT02184780|General Anaesthesia|general anaesthesia
4879135|NCT02184780|Infants|infants
4879136|NCT02184780|Epidural|epidural
4879137|NCT02184780|Spinal|spinal
4879138|NCT02184780|Anxiety and depression|anxiety and depression
4879139|NCT02184754|Magnetic endoscope imaging|magnetic endoscope imaging
4879140|NCT02184754|single-balloon-enteroscopy|single-balloon-enteroscopy
4879141|NCT02184741|IVIG|ivig
4879142|NCT02184741|Unexplained Recurrent miscarriage|unexplained recurrent miscarriage
4879143|NCT02184741|Recurrent abortion|recurrent abortion
4879144|NCT02184741|Intravenous immunoglobulin|intravenous immunoglobulin
4879145|NCT02184728|end-tidal CO2|end-tidal co2
4879146|NCT02184728|capnometer|capnometer
4879147|NCT02184715|virtual reality system, children, developmental delay|virtual reality system, children, developmental delay
4879148|NCT02184676|Type 1 diabetes|type 1 diabetes
4879149|NCT02184676|risk assessment|risk assessment
4879150|NCT02184676|immunological marker|immunological marker
4879151|NCT02184676|children|children
4879152|NCT02184676|relatives|relatives
4879153|NCT02184676|autoantibodies|autoantibodies
4879154|NCT02184676|lymphocytes|lymphocytes
4879155|NCT02184676|T cells|t cells
4879156|NCT02184676|epitopes|epitopes
4879157|NCT02184676|Children born to mother/father with type 1 diabetes and their parents|children born to mother/father with type 1 diabetes and their parents
4879158|NCT02184663|Unresectable|unresectable
4879159|NCT02184663|Pancreatic cancer|pancreatic cancer
4879160|NCT02184663|GERCOR|gercor
4879161|NCT02184663|Adapted physical activity (APA)|adapted physical activity (apa)
4879162|NCT02184663|Quality of life|quality of life
4879163|NCT02184663|Fatigue|fatigue
4879164|NCT02184650|Premature infants|premature infants
4879165|NCT02184650|Nutritional status|nutritional status
4879166|NCT02184650|Polyunsaturated fatty acids status|polyunsaturated fatty acids status
4879167|NCT02184637|Malaria|malaria
4879168|NCT02184637|Artemisinin-based Combination Therapies (ACT)|artemisinin-based combination therapies (act)
4879169|NCT02184624|BREEZHALER|breezhaler
4879170|NCT02184624|DISKUS/ACCUHALER|diskus/accuhaler
4879172|NCT02184624|Inhaler preference|inhaler preference
4879173|NCT02184624|Overall inhaler error|overall inhaler error
4879174|NCT02184624|HANDIHALER|handihaler
4879175|NCT02184624|Ease of use|ease of use
4879176|NCT02184624|TURBUHALER|turbuhaler
4879177|NCT02184624|ELLIPTA|ellipta
4879178|NCT02184624|Critical inhaler error|critical inhaler error
4879179|NCT02184611|lung function|lung function
4879180|NCT02184611|Umeclidinium|umeclidinium
4879181|NCT02184611|GSK573719|gsk573719
4879182|NCT02184611|anticholinergic|anticholinergic
4879183|NCT02184611|novel dry powder inhaler|novel dry powder inhaler
4879184|NCT02184611|long-acting muscarinic receptor antagonist|long-acting muscarinic receptor antagonist
4879185|NCT02184611|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
4879186|NCT02184598|ADHD|adhd
4879187|NCT02184598|Cognitive training|cognitive training
4879188|NCT02184598|fMRI|fmri
4879189|NCT02184598|Cognitive function|cognitive function
4879190|NCT02184585|bioavailability|bioavailability
4879191|NCT02184585|crossover design|crossover design
4879192|NCT02184585|healthy male volunteers|healthy male volunteers
4879193|NCT02184585|tamsulosin hydrochloride|tamsulosin hydrochloride
4879194|NCT02184585|Dutasteride|dutasteride
4879195|NCT02184572|Rubella|rubella
4879196|NCT02184572|Healthy children|healthy children
4879197|NCT02184572|Measles|measles
4879198|NCT02184572|Safety|safety
4879199|NCT02184572|Mumps|mumps
4879200|NCT02184572|12 to 15 months|12 to 15 months
4879201|NCT02184572|Immunogenicity|immunogenicity
4879202|NCT02184507|insulin resistance|insulin resistance
4879203|NCT02184507|blood glucose|blood glucose
4879204|NCT02184507|CABG|cabg
4879205|NCT02184507|oxidative stress|oxidative stress
4879206|NCT02184494|Parkinson's Disease|parkinson's disease
4879207|NCT02184494|Multiple Sclerosis|multiple sclerosis
4879208|NCT02184494|Fatigue|fatigue
4879209|NCT02184494|Resting Energy Expenditure|resting energy expenditure
4879210|NCT02184494|Whole Body Vibration|whole body vibration
4879211|NCT02184494|Exercise|exercise
4879212|NCT02184494|Blood Lactate|blood lactate
4879213|NCT02184481|Depression|depression
4879215|NCT02184481|Working memory|working memory
4879216|NCT02184481|Rumination|rumination
4879217|NCT02184481|Cognitive training|cognitive training
4879218|NCT02184481|Executive functioning|executive functioning
4879219|NCT02184468|Cardiac Arrest|cardiac arrest
4879220|NCT02184468|Out-of-Hospital Cardiac Arrest|out-of-hospital cardiac arrest
4879221|NCT02184468|Firefighters|firefighters
4879222|NCT02184468|Police|police
4879223|NCT02184468|Defibrillators|defibrillators
4879224|NCT02184468|Survival|survival
4879225|NCT02184455|Diabetic|diabetic
4879226|NCT02184455|Chronic Ulcer|chronic ulcer
4879227|NCT02184455|Wound Healing|wound healing
4879228|NCT02184455|Leg|leg
4879229|NCT02184442|SAPIEN|sapien
4879230|NCT02184442|TAVR|tavr
4879231|NCT02184442|THV|thv
4879232|NCT02184442|Aortic Stenosis|aortic stenosis
4879233|NCT02184442|Heart Valve Disease|heart valve disease
4879234|NCT02184442|Aortic Valve|aortic valve
4879235|NCT02184442|Retroflex|retroflex
4879236|NCT02184442|SAPIEN XT|sapien xt
4879237|NCT02184429|First in human|first in human
4879238|NCT02184429|single ascending dose study|single ascending dose study
4879239|NCT02184429|multiple ascending dose study|multiple ascending dose study
4879240|NCT02184429|safety and tolerability|safety and tolerability
4879241|NCT02184429|pharmacokinetics|pharmacokinetics
4879242|NCT02184429|food effect|food effect
4879243|NCT02184429|Parkinson's Disease|parkinson's disease
4879244|NCT02184416|Inlyta|inlyta
4879245|NCT02184416|axitinib|axitinib
4879246|NCT02184416|Sutent|sutent
4879247|NCT02184416|sunitinib|sunitinib
4879248|NCT02184416|renal|renal
4879249|NCT02184390|Internet|internet
4879250|NCT02184390|Education|education
4879251|NCT02184377|quantitative laryngeal electromyography|quantitative laryngeal electromyography
4879252|NCT02184377|cricothyroid muscle|cricothyroid muscle
4879253|NCT02184377|unilateral vocal fold paralysis|unilateral vocal fold paralysis
4879254|NCT02184377|superior laryngeal nerve|superior laryngeal nerve
4879255|NCT02184377|lexical tone|lexical tone
4879256|NCT02184377|Mandarin|mandarin
4879257|NCT02184221|Deep-brain magnetic stimulation|deep-brain magnetic stimulation
4879258|NCT02184221|Brain derived neurotropic factor|brain derived neurotropic factor
4879259|NCT02184221|Effectiveness|effectiveness
4879260|NCT02184221|Safety|safety
4879261|NCT02184208|ARDS|ards
4879262|NCT02184208|ALI|ali
4879263|NCT02184208|mechanical ventilation|mechanical ventilation
4879264|NCT02184195|BRCA, metastatic adenocarcinoma pancreas, maintenance olaparib monotherapy, first line platinum chemotherapy, pancreatic cancer, PARP inhibitor|brca, metastatic adenocarcinoma pancreas, maintenance olaparib monotherapy, first line platinum chemotherapy, pancreatic cancer, parp inhibitor
4879265|NCT02184169|hemodynamics|hemodynamics
4879266|NCT02184169|neonatal|neonatal
4879267|NCT02184169|cardiac disease|cardiac disease
4879268|NCT02184169|congenital heart disease|congenital heart disease
4879269|NCT02184169|volumetric oxygen consumption|volumetric oxygen consumption
4879270|NCT02184117|Fractional Flow Reserve, Myocardial|fractional flow reserve, myocardial
4879271|NCT02184117|Adenosine|adenosine
4879272|NCT02184117|Contrast Media|contrast media
4879273|NCT02184104|caffeine|caffeine
4879274|NCT02184104|pharmacokinetics|pharmacokinetics
4879275|NCT02184104|pharmacodynamics|pharmacodynamics
4879276|NCT02184026|nightmare|nightmare
4879277|NCT02184026|PTSD|ptsd
4879278|NCT02184026|trauma|trauma
4879279|NCT02184026|children|children
4879280|NCT02184026|Children Age 8 to 13|children age 8 to 13
4879281|NCT02184013|Atrial fibrillation|atrial fibrillation
4879282|NCT02184013|Catheter ablation|catheter ablation
4879283|NCT02184013|Delayed gadolinium enhanced MRI|delayed gadolinium enhanced mri
4879284|NCT02184013|C-metahydroxyepherdrine (HED) PET scan|c-metahydroxyepherdrine (hed) pet scan
4879285|NCT02184013|ECGI mapping|ecgi mapping
4879286|NCT02184013|Atrial Fibrosis|atrial fibrosis
4879287|NCT02184013|Atrial sympathetic denervation|atrial sympathetic denervation
4879288|NCT02184000|strain elastography|strain elastography
4879289|NCT02184000|hepatopathy|hepatopathy
4879290|NCT02184000|liver fibrosis|liver fibrosis
4879291|NCT02183987|Knowledge Translation|knowledge translation
4879292|NCT02183987|Chronic Kidney Disease|chronic kidney disease
4879293|NCT02183987|Dialysis|dialysis
4879294|NCT02183987|Intent-to-defer|intent-to-defer
4879295|NCT02183987|Early dialysis|early dialysis
4879296|NCT02183987|Cluster randomized trial|cluster randomized trial
4879297|NCT02183974|otitis media with effusion|otitis media with effusion
4879298|NCT02183974|Laryngopharyngeal Reflux|laryngopharyngeal reflux
4879299|NCT02183961|otitis media with effusion|otitis media with effusion
4879300|NCT02183961|peptest|peptest
4879301|NCT02183961|restech|restech
4879302|NCT02183961|oropharyngeal pH monitoring|oropharyngeal ph monitoring
4879303|NCT02183961|laryngopharyngeal reflux|laryngopharyngeal reflux
4879304|NCT02183948|treatment|treatment
4879305|NCT02183948|mask face exoressions|mask face exoressions
4879306|NCT02183948|genier|genier
4879307|NCT02183935|Obesity|obesity
4879308|NCT02183935|Diabetes|diabetes
4879309|NCT02183935|Metabolic syndrome|metabolic syndrome
4879310|NCT02183935|Gut hormones|gut hormones
4879311|NCT02183935|Adipokines|adipokines
4879312|NCT02183935|Appetite|appetite
4879313|NCT02183935|Adolescent|adolescent
4879314|NCT02183896|Femoroacetabular impingement (FAI)|femoroacetabular impingement (fai)
4879315|NCT02183896|Chondral lesions|chondral lesions
4879316|NCT02183896|Hip|hip
4879317|NCT02183896|Microfracture|microfracture
4879318|NCT02183896|Platelet-rich plasma (PRP)|platelet-rich plasma (prp)
4879319|NCT02183883|Non-small cell lung cancer|non-small cell lung cancer
4879320|NCT02183883|NSCLC|nsclc
4879321|NCT02183883|Afatinib|afatinib
4879322|NCT02183883|Intra-tumour heterogeneity|intra-tumour heterogeneity
4879323|NCT02183883|Clonal dominance|clonal dominance
4879324|NCT02183883|Drug resistance|drug resistance
4879325|NCT02183883|EGFR|egfr
4879326|NCT02183883|HER2|her2
4879327|NCT02183883|Phase 2|phase 2
4879328|NCT02183870|lung cancer|lung cancer
4879329|NCT02183870|adenocarcinoma|adenocarcinoma
4879330|NCT02183870|NSCLC|nsclc
4879331|NCT02183870|ROS1|ros1
4879332|NCT02183870|ROS1 translocation|ros1 translocation
4879333|NCT02183870|crizotinib|crizotinib
4879334|NCT02183870|phase II|phase ii
4879335|NCT02183857|children|children
4879336|NCT02183857|congenital heart disease|congenital heart disease
4879337|NCT02183844|Medical Informatics|medical informatics
4879338|NCT02183844|Patient-Centered|patient-centered
4879339|NCT02183844|Healthcare Preferences|healthcare preferences
4879340|NCT02183844|Health Education|health education
4879341|NCT02183844|Quality Improvement|quality improvement
4879342|NCT02183844|Weight Loss|weight loss
4879343|NCT02183844|Personal Satisfaction|personal satisfaction
4879344|NCT02183844|Humans|humans
4879345|NCT02183844|Cognition|cognition
4879346|NCT02183844|Body Weight|body weight
4879347|NCT02183818|Smoking|smoking
4879348|NCT02183818|COPD|copd
4879349|NCT02183818|Non-Smokers|non-smokers
4879350|NCT02183818|Smokers|smokers
4879351|NCT02183805|triple negative breast cancer|triple negative breast cancer
4879352|NCT02183805|autologous hematopoietic stem-cell transplantation|autologous hematopoietic stem-cell transplantation
4879353|NCT02183779|post-occlusive hyperaemia|post-occlusive hyperaemia
4879354|NCT02183779|laser-speckle contrast imaging|laser-speckle contrast imaging
4879355|NCT02183779|epoxyeicosatrienoic acid|epoxyeicosatrienoic acid
4879356|NCT02183779|nitrous oxide|nitrous oxide
4879357|NCT02183753|LAIV|laiv
4879358|NCT02183753|Flumist|flumist
4879359|NCT02183753|wood smoke|wood smoke
4879360|NCT02183740|Education|education
4879361|NCT02183740|Nurses|nurses
4879362|NCT02183740|Nursing homes|nursing homes
4879363|NCT02183740|Fecal incontinence|fecal incontinence
4879364|NCT02183740|Cluster-randomized controlled trial|cluster-randomized controlled trial
4879365|NCT02183727|ACL|acl
4879366|NCT02183727|knee injury|knee injury
4879367|NCT02183727|anterior cruciate ligament|anterior cruciate ligament
4879368|NCT02183597|Magnetic Resonance Imaging|magnetic resonance imaging
4879369|NCT02183597|Data Accuracy|data accuracy
4879370|NCT02183597|Reproducibility of Results|reproducibility of results
4879371|NCT02183597|Diagnosis|diagnosis
4879372|NCT02183558|PCOS|pcos
4879373|NCT02183558|GDM|gdm
4879374|NCT02183558|OGTT|ogtt
4879375|NCT02183558|Glucose metabolism|glucose metabolism
4879376|NCT02183519|Cough|cough
4879377|NCT02183519|Reflex|reflex
4879378|NCT02183519|Voluntary|voluntary
4879379|NCT02183519|Healthy older adults|healthy older adults
4879380|NCT02183519|Parkinson's disease|parkinson's disease
4879381|NCT02183519|Respiratory kinematics|respiratory kinematics
4879382|NCT02183519|Cueing|cueing
4879383|NCT02183454|intracoronary stent|intracoronary stent
4879384|NCT02183454|drug eluting stent|drug eluting stent
4879385|NCT02183454|sirolimus|sirolimus
4879386|NCT02183454|endothelial progenitor cells|endothelial progenitor cells
4879387|NCT02183272|Depression|depression
4879388|NCT02183272|Suicidal Ideation|suicidal ideation
4879389|NCT02183272|Ketamine|ketamine
4879390|NCT02183272|Emergency Department|emergency department
4879391|NCT02183207|percutaneous endoscopic gastrostomy|percutaneous endoscopic gastrostomy
4879392|NCT02183207|Introducer method|introducer method
4879393|NCT02182999|Hallux valgus surgery|hallux valgus surgery
4879394|NCT02182999|wound infiltration|wound infiltration
4879395|NCT02182999|pain|pain
4879396|NCT02182986|Biomarkers|biomarkers
4879397|NCT02182986|Post-Transplant Lymphoproliferative Disorders (PTLDs)|post-transplant lymphoproliferative disorders (ptlds)
4879398|NCT02182973|neonatal abstinence syndrome, infant opiate withdrawal|neonatal abstinence syndrome, infant opiate withdrawal
4879399|NCT02182947|Pediatric|pediatric
4879400|NCT02182947|Inflammatory Bowel Disease|inflammatory bowel disease
4879401|NCT02182947|capsule endoscopy|capsule endoscopy
4879402|NCT02182947|MRI|mri
4879403|NCT02182947|Crohn's Disease|crohn's disease
4879404|NCT02182947|Indeterminant Colitis|indeterminant colitis
4879405|NCT02182947|Small bowel Crohn's Disease|small bowel crohn's disease
4879406|NCT02182908|Aneurysm of abdominal aorta|aneurysm of abdominal aorta
4879407|NCT02182908|18F-fluorodesoxyglucose (FDG-F18)|18f-fluorodesoxyglucose (fdg-f18)
4879408|NCT02182843|Cellentra ACDF|cellentra acdf
4879409|NCT02182817|General Anaesthesia|general anaesthesia
4879410|NCT02182817|Neurocognitive Development|neurocognitive development
4879411|NCT02182817|Behaviour|behaviour
4879412|NCT02182804|Confocal Laser Endomicroscopy|confocal laser endomicroscopy
4879413|NCT02182804|Narrow Band Imaging|narrow band imaging
4879414|NCT02182804|Lugol Chromoendoscopy|lugol chromoendoscopy
4879415|NCT02182804|Esophageal Neoplasm|esophageal neoplasm
4879416|NCT02182804|Head and Neck Cancer|head and neck cancer
4879417|NCT02182687|Hepatocellular carcinoma (HCC)|hepatocellular carcinoma (hcc)
4879418|NCT02182687|Orthotopic liver transplant|orthotopic liver transplant
4879419|NCT02182687|Bridge to transplant|bridge to transplant
4879420|NCT02182687|stereotactic body radiation therapy (SBRT)|stereotactic body radiation therapy (sbrt)
4879421|NCT02182687|trans-arterial chemoembolization (TACE)|trans-arterial chemoembolization (tace)
4879422|NCT02182596|Acute Myeloid Leukemia|acute myeloid leukemia
4879423|NCT02182596|First relapsing AML|first relapsing aml
4879424|NCT02182466|Colon capsule endoscopy|colon capsule endoscopy
4879425|NCT02182466|Colonoscopy|colonoscopy
4879426|NCT02182466|Screening colonoscopy|screening colonoscopy
4879427|NCT02182440|SA-AKI|sa-aki
4879428|NCT02182440|Sepsis|sepsis
4879429|NCT02182440|AKI|aki
4879430|NCT02182440|Recombinant Alkaline Phosphatase|recombinant alkaline phosphatase
4879431|NCT02182440|recAP|recap
4879432|NCT02182167|Drug Induced Hepatitis (DIH)|drug induced hepatitis (dih)
4879433|NCT02182167|Toxic Liver|toxic liver
4879434|NCT02182167|Drug Induced Liver Injury (DILI)|drug induced liver injury (dili)
4879435|NCT02182115|Staphylococcus aureus infection|staphylococcus aureus infection
4879436|NCT02182115|Decolonization|decolonization
4879437|NCT02182115|Surgical site infection|surgical site infection
4879438|NCT02181894|Infant|infant
4879439|NCT02181894|Newborn|newborn
4879440|NCT02181894|Neonate|neonate
4879441|NCT02181894|Intubation|intubation
4879442|NCT02181894|Neonatal resuscitation|neonatal resuscitation
4879443|NCT02181842|Pharmacological therapy|pharmacological therapy
4879444|NCT02181829|Whole Lung IMRT|whole lung imrt
4879445|NCT02181829|14-075|14-075
4879446|NCT02181816|Pharmacological therapy|pharmacological therapy
4879447|NCT02181790|psoriasis|psoriasis
4879448|NCT02181790|palmoplantar|palmoplantar
4879449|NCT02181790|acitretin|acitretin
4879450|NCT02181790|retinoids|retinoids
4879451|NCT02181790|laser treatment|laser treatment
4879452|NCT02181777|Psychosis|psychosis
4879453|NCT02181777|Schizophrenia|schizophrenia
4879454|NCT02181777|Social Skills|social skills
4879455|NCT02181777|Therapy|therapy
4879456|NCT02181764|XLH|xlh
4879457|NCT02181751|Child Sexual Abuse|child sexual abuse
4879458|NCT02181751|CSA|csa
4879459|NCT02181751|Treatment|treatment
4879460|NCT02181751|Prevention|prevention
4879461|NCT02181751|PTSD|ptsd
4879462|NCT02181751|Post Traumatic Stress Disorder|post traumatic stress disorder
4879463|NCT02181751|Depression|depression
4879464|NCT02181751|Anxiety|anxiety
4879465|NCT02181751|Quality of Life|quality of life
4879466|NCT02181751|Attachment|attachment
4879467|NCT02181751|Cognitive Behavioural Therapy|cognitive behavioural therapy
4879468|NCT02181751|Group Therapy|group therapy
4879469|NCT02181725|Chronic Pain|chronic pain
4879470|NCT02181725|Adolescent|adolescent
4879471|NCT02181725|Graded Exposure|graded exposure
4879472|NCT02181712|Bronchiolitis obliterans|bronchiolitis obliterans
4879473|NCT02181712|lung transplant|lung transplant
4879474|NCT02181712|mesenchymal stem cell|mesenchymal stem cell
4879475|NCT02181712|cell therapy|cell therapy
4879476|NCT02181686|Heart Failure|heart failure
4879477|NCT02181686|Iperia ICD family|iperia icd family
4879478|NCT02181686|Sentus QP left ventricular lead|sentus qp left ventricular lead
4879479|NCT02181686|Quadripolar CRT-D system|quadripolar crt-d system
4879480|NCT02181673|Psoriatic arthritis|psoriatic arthritis
4879481|NCT02181673|Golimumab|golimumab
4879482|NCT02181673|Simponi|simponi
4879483|NCT02181660|AML|aml
4879484|NCT02181660|Acute myeloid leukemia|acute myeloid leukemia
4879485|NCT02181660|Gilteritinib|gilteritinib
4879486|NCT02181660|ASP2215|asp2215
4879487|NCT02181634|Advanced Cholangiocarcinoma|advanced cholangiocarcinoma
4879488|NCT02181634|Metastatic Cholangiocarcinoma|metastatic cholangiocarcinoma
4879489|NCT02181634|CCA|cca
4879490|NCT02181634|Bile Duct Cancer|bile duct cancer
4879491|NCT02181634|Nab-Paclitaxel|nab-paclitaxel
4879492|NCT02181634|Abraxane®|abraxane®
4879493|NCT02181634|Gemcitabine|gemcitabine
4879494|NCT02181634|Gemzar®|gemzar®
4879495|NCT02181608|Alcohol Dependence|alcohol dependence
4879496|NCT02181608|Fear Conditioning|fear conditioning
4879497|NCT02181608|Stress|stress
4879498|NCT02181608|Alcohol|alcohol
4879499|NCT02181595|Reading|reading
4879500|NCT02181595|FACIT-SP|facit-sp
4879501|NCT02181595|Primary Ovarian Insufficiency|primary ovarian insufficiency
4879502|NCT02181582|Health Humans|health humans
4879503|NCT02181582|Receptor Occupancy|receptor occupancy
4879504|NCT02181569|Addiction Severity Index|addiction severity index
4879505|NCT02181569|Addiction|addiction
4879506|NCT02181569|Sleep Measures|sleep measures
4879507|NCT02181569|Sleep Disorders|sleep disorders
4879508|NCT02181556|colorectal cancer|colorectal cancer
4879509|NCT02181556|Metastatic|metastatic
4879510|NCT02181543|Clonidine|clonidine
4879511|NCT02181543|Psychomotor agitation|psychomotor agitation
4879512|NCT02181543|Anesthesia recovery period|anesthesia recovery period
4879513|NCT02181543|Tonsillectomy|tonsillectomy
4879514|NCT02181543|Child, preschool|child, preschool
4879515|NCT02181478|Total Body Irradiation|total body irradiation
4879516|NCT02181478|Human Mesenchymal Stromal Cells|human mesenchymal stromal cells
4879517|NCT02181478|hMSC|hmsc
4879518|NCT02181478|Cyclophosphamide|cyclophosphamide
4879519|NCT02181478|Fludarabine|fludarabine
4879520|NCT02181478|Dimethyl Sulfoxide|dimethyl sulfoxide
4879521|NCT02181478|DMSO|dmso
4879522|NCT02181478|Cyclosporine|cyclosporine
4879523|NCT02181478|Mycophenolate Mofetil|mycophenolate mofetil
4879524|NCT02181478|MMF|mmf
4879525|NCT02181478|Granulocyte- Colony Stimulating Factor|granulocyte- colony stimulating factor
4879526|NCT02181478|G-CSF|g-csf
4879527|NCT02181478|GVHD|gvhd
4879528|NCT02181478|Cancer|cancer
4879529|NCT02181478|feasibility|feasibility
4879530|NCT02181452|liver|liver
4879531|NCT02181452|fibrosis|fibrosis
4879532|NCT02181452|ShearWave Elastography|shearwave elastography
4879533|NCT02181452|ultrasound|ultrasound
4879534|NCT02181426|Knee Arthroscopy|knee arthroscopy
4879535|NCT02181413|Drug therapy|drug therapy
4879536|NCT02181413|TOURMALINE|tourmaline
4879537|NCT02181413|ixazomib|ixazomib
4879538|NCT02181400|diabetic retinopathy|diabetic retinopathy
4879539|NCT02181400|diabetic macular edema|diabetic macular edema
4879540|NCT02181400|diabetic macular oedema|diabetic macular oedema
4879541|NCT02181400|near infrared light therapy|near infrared light therapy
4879542|NCT02181387|labor pain|labor pain
4879543|NCT02181387|acetaminophen|acetaminophen
4879544|NCT02181374|atrial fibrillation|atrial fibrillation
4879545|NCT02181374|NT-proBNP|nt-probnp
4879546|NCT02181374|Cardioembolic Stroke|cardioembolic stroke
4879547|NCT02181361|atrial fibrillation|atrial fibrillation
4879548|NCT02181361|cardioembolic stroke|cardioembolic stroke
4879549|NCT02181361|Hirudin|hirudin
4879550|NCT02181361|aspirin|aspirin
4879551|NCT02181361|warfarin|warfarin
4879552|NCT02181348|Vitamin E, Hemoglobin, mild anemia|vitamin e, hemoglobin, mild anemia
4879553|NCT02181296|Shoulder arthroscopy|shoulder arthroscopy
4879554|NCT02181296|Interscalene block|interscalene block
4879555|NCT02181296|Drug concentration|drug concentration
4879556|NCT02181296|0.1% ropivacaine or 0.2% ropivacaine|0.1% ropivacaine or 0.2% ropivacaine
4879557|NCT02181283|alcohol|alcohol
4879558|NCT02181283|prescribed drugs|prescribed drugs
4879559|NCT02181283|National Guard|national guard
4879560|NCT02181270|NAFLD|nafld
4879561|NCT02181270|obesity|obesity
4879562|NCT02181270|ck18|ck18
4879563|NCT02181270|blood lipids|blood lipids
4879564|NCT02181270|high intensity exercise training|high intensity exercise training
4879565|NCT02181270|individuals|individuals
4879566|NCT02181270|>5% liver fat|>5% liver fat
4879567|NCT02181257|Bronchiolitis Obliterans Syndrome|bronchiolitis obliterans syndrome
4879568|NCT02181257|Lung Transplantation|lung transplantation
4879569|NCT02181257|Extracorporeal Photopheresis|extracorporeal photopheresis
4879570|NCT02181257|Methoxsalen|methoxsalen
4879571|NCT02181244|egg|egg
4879572|NCT02181244|oatmeal|oatmeal
4879573|NCT02181244|atherogenic dyslipidemia|atherogenic dyslipidemia
4879574|NCT02181244|glycosylated hemoglobin|glycosylated hemoglobin
4879575|NCT02181244|inflammatory markers|inflammatory markers
4879576|NCT02181231|depression|depression
4879577|NCT02181231|older adult|older adult
4879578|NCT02181231|buprenorphine|buprenorphine
4879579|NCT02181231|Effexor XR|effexor xr
4879580|NCT02181231|treatment resistant|treatment resistant
4879581|NCT02181231|venlafaxine|venlafaxine
4879582|NCT02181231|Saint Louis|saint louis
4879583|NCT02181231|late life|late life
4879584|NCT02181231|major depression|major depression
4879585|NCT02181192|biochemical recurrence|biochemical recurrence
4879586|NCT02181192|prostate carcinoma|prostate carcinoma
4879587|NCT02181192|prostate cancer|prostate cancer
4879588|NCT02181192|PSA|psa
4879589|NCT02181192|postoperative|postoperative
4879590|NCT02181192|radiotherapy|radiotherapy
4879591|NCT02181192|imaging diagnostic|imaging diagnostic
4879592|NCT02181192|PET/CT|pet/ct
4879593|NCT02181192|social economic aspects|social economic aspects
4879594|NCT02181192|quality of life|quality of life
4879595|NCT02181179|yoga|yoga
4879596|NCT02181179|exercise intervention|exercise intervention
4879597|NCT02181179|smoking|smoking
4879598|NCT02181179|stress|stress
4879599|NCT02181179|mind-body|mind-body
4879600|NCT02181179|intervention|intervention
4879601|NCT02181166|Breast Neoplasms|breast neoplasms
4879602|NCT02181166|Mastectomy|mastectomy
4879603|NCT02181166|Myofascial pain syndromes|myofascial pain syndromes
4879604|NCT02181166|Physical Therapy Modalities|physical therapy modalities
4879605|NCT02181153|inflammatory bowel disease|inflammatory bowel disease
4879606|NCT02181153|siblings|siblings
4879607|NCT02181140|fine needle aspiration|fine needle aspiration
4879608|NCT02181140|core biopsy|core biopsy
4879609|NCT02181140|endoscopic ultrasound|endoscopic ultrasound
4879610|NCT02181140|space occupying process mediastinal, perigastral, perihilar|space occupying process mediastinal, perigastral, perihilar
4879611|NCT02181140|suspect lymph nodes mediastinal, perigastral or perihilar|suspect lymph nodes mediastinal, perigastral or perihilar
4879612|NCT02181140|diagnostic accuracy of EUS guided core biopsy|diagnostic accuracy of eus guided core biopsy
4879613|NCT02181127|bionic pancreas|bionic pancreas
4879614|NCT02181127|artificial pancreas|artificial pancreas
4879615|NCT02181127|insulin|insulin
4879616|NCT02181127|glucagon|glucagon
4879617|NCT02181127|continuous glucose monitoring (CGM)|continuous glucose monitoring (cgm)
4879618|NCT02181127|outpatient|outpatient
4879619|NCT02181127|insulin pump|insulin pump
4879620|NCT02181127|glucagon pump|glucagon pump
4879621|NCT02181114|Coaching|coaching
4879622|NCT02181114|Educational Materials|educational materials
4879623|NCT02181114|Expert System|expert system
4879624|NCT02181114|Living Donor Kidney Transplant|living donor kidney transplant
4879625|NCT02181088|Malaria|malaria
4879626|NCT02181088|Plasmodium falciparum|plasmodium falciparum
4879627|NCT02181088|RH5|rh5
4879628|NCT02181075|ThermoDox|thermodox
4879629|NCT02181075|High Intensity Focused Ultrasound|high intensity focused ultrasound
4879630|NCT02181075|Lyso thermosensitive Liposomal|lyso thermosensitive liposomal
4879631|NCT02181075|Non invasive drug delivery|non invasive drug delivery
4879632|NCT02181075|Hepatic metastatic disease|hepatic metastatic disease
4879633|NCT02181075|Liver tumour(s)|liver tumour(s)
4879634|NCT02181075|Targeted Release of Chemotherapy|targeted release of chemotherapy
4879635|NCT02181062|Stroke|stroke
4879636|NCT02181062|Stroke prevention|stroke prevention
4879637|NCT02181062|older adults|older adults
4879638|NCT02181062|self efficacy|self efficacy
4879639|NCT02181062|walking|walking
4879640|NCT02181062|minorities|minorities
4879641|NCT02181062|minority older adults|minority older adults
4879642|NCT02181062|hypertension|hypertension
4879643|NCT02181062|high blood pressure|high blood pressure
4879644|NCT02181062|elderly|elderly
4879645|NCT02181062|sedentary lifestyle|sedentary lifestyle
4879646|NCT02181049|Childhood cancer survivors|childhood cancer survivors
4879647|NCT02181049|Cardiac|cardiac
4879648|NCT02181049|Vascular|vascular
4879649|NCT02181049|Cardiovascular|cardiovascular
4879650|NCT02181049|Late-sequelae|late-sequelae
4879651|NCT02181036|Family work shop|family work shop
4879652|NCT02181036|speech developmental delays|speech developmental delays
4879653|NCT02181036|children|children
4879654|NCT02181023|COPD|copd
4879655|NCT02181023|Hyperinflation|hyperinflation
4879656|NCT02181023|Aclidinium|aclidinium
4879657|NCT02181023|Glycopyrronium|glycopyrronium
4879658|NCT02181023|Volume distribution|volume distribution
4879659|NCT02181023|Anticholinergic|anticholinergic
4879660|NCT02181023|Pharmacokinetics|pharmacokinetics
4879661|NCT02181023|Single Breath Nitrogen Test|single breath nitrogen test
4879662|NCT02181023|Phase III|phase iii
4879663|NCT02181010|African American|african american
4879664|NCT02181010|Adolescents|adolescents
4879665|NCT02181010|Urban|urban
4879666|NCT02181010|Food Desert|food desert
4879667|NCT02181010|Food Insecurity|food insecurity
4879668|NCT02181010|Obesity|obesity
4879669|NCT02181010|Baltimore City|baltimore city
4879670|NCT02181010|Peer mentors|peer mentors
4879671|NCT02181010|Multi level|multi level
4879672|NCT02181010|Policy|policy
4879673|NCT02181010|Caregivers|caregivers
4879674|NCT02181010|Systems|systems
4879675|NCT02181010|Agent Based Model|agent based model
4879676|NCT02181010|Systems Dynamic Model|systems dynamic model
4879677|NCT02181010|Corner Store|corner store
4879678|NCT02181010|Carryout|carryout
4879679|NCT02181010|Recreation Center|recreation center
4879680|NCT02181010|Text Messaging|text messaging
4879681|NCT02181010|Social Media|social media
4879682|NCT02181010|Mapping|mapping
4879683|NCT02180997|α1-blockers|α1-blockers
4879684|NCT02180997|antimuscarinic agent|antimuscarinic agent
4879685|NCT02180984|Binge Eating|binge eating
4879686|NCT02180984|Obesity|obesity
4879687|NCT02180984|TMS|tms
4879688|NCT02180984|Neuroimage|neuroimage
4879689|NCT02180984|Neuromodulation|neuromodulation
4879690|NCT02180984|Biomarkers|biomarkers
4879691|NCT02180984|Eating Disorders|eating disorders
4879692|NCT02180984|Cognition|cognition
4879693|NCT02180984|Endocrine|endocrine
4879694|NCT02180984|Hormones|hormones
4879695|NCT02180984|BDNF|bdnf
4879696|NCT02180984|Inflammatory biomarkers|inflammatory biomarkers
4879697|NCT02180971|Multi-detector computed tomography angiography|multi-detector computed tomography angiography
4879698|NCT02180971|Coronary vessel distensibility|coronary vessel distensibility
4879699|NCT02180971|Coronary spasm|coronary spasm
4879700|NCT02180958|cerebral arteriovenous malformations|cerebral arteriovenous malformations
4879701|NCT02180958|cAVM|cavm
4879702|NCT02180958|ONYX|onyx
4879703|NCT02180945|dAVF|davf
4879704|NCT02180945|Arteriovenous fistula|arteriovenous fistula
4879705|NCT02180945|ONYX|onyx
4879706|NCT02180919|Telemonitoring|telemonitoring
4879707|NCT02180919|COPD|copd
4879708|NCT02180919|Heart failure|heart failure
4879709|NCT02180919|Exacerbation|exacerbation
4879710|NCT02180919|Respiratory failure|respiratory failure
4879711|NCT02180919|Prevention|prevention
4879712|NCT02180919|Self monitoring|self monitoring
4879713|NCT02180906|Fasciitis|fasciitis
4879714|NCT02180906|Gangrene|gangrene
4879715|NCT02180906|Fasciitis, Necrotizing|fasciitis, necrotizing
4879716|NCT02180906|Soft Tissue Infections|soft tissue infections
4879717|NCT02180906|Fournier's Gangrene|fournier's gangrene
4879718|NCT02180906|Streptococcal septic shock syndrome|streptococcal septic shock syndrome
4879719|NCT02180906|Flesh eating bacteria|flesh eating bacteria
4879720|NCT02180906|Meleneys ulcer|meleneys ulcer
4879721|NCT02180906|Wounds and Injuries|wounds and injuries
4879722|NCT02180906|Streptococcus pyogenes|streptococcus pyogenes
4879723|NCT02180906|Staphylococcus aureus|staphylococcus aureus
4879724|NCT02180906|Immunopathogenesis|immunopathogenesis
4879725|NCT02180906|Soft Tissue Infections/blood|soft tissue infections/blood
4879726|NCT02180906|Necrosis/blood|necrosis/blood
4879727|NCT02180906|Necrosis/diagnosis|necrosis/diagnosis
4879728|NCT02180906|Necrosis/mortality|necrosis/mortality
4879729|NCT02180906|Necrosis/surgery|necrosis/surgery
4879730|NCT02180906|Prognosis|prognosis
4879731|NCT02180906|Risk Factors|risk factors
4879732|NCT02180906|Bacterial Infections|bacterial infections
4879733|NCT02180906|Infection|infection
4879734|NCT02180906|Skin Diseases, Bacterial|skin diseases, bacterial
4879735|NCT02180906|Observational study|observational study
4879736|NCT02180906|Biological markers|biological markers
4879737|NCT02180880|Neuralgia|neuralgia
4879738|NCT02180880|Spinal cord|spinal cord
4879739|NCT02180880|Oxcarbazepine|oxcarbazepine
4879740|NCT02180880|Pregabalin|pregabalin
4879741|NCT02180880|Drug therapy|drug therapy
4879742|NCT02180880|Algorithms|algorithms
4879743|NCT02180854|Early warning score|early warning score
4879744|NCT02180854|Rapid response systems|rapid response systems
4879745|NCT02180854|Medical emergency team|medical emergency team
4879746|NCT02180841|soy|soy
4879747|NCT02180841|hypertension|hypertension
4879748|NCT02180841|HDL-C|hdl-c
4879749|NCT02180841|cholesterol efflux|cholesterol efflux
4879750|NCT02180841|cardiovascular disease|cardiovascular disease
4879751|NCT02180815|Obstructive Sleep Apnea|obstructive sleep apnea
4879752|NCT02180815|Obstructive Sleep Apnea due to primary tongue base closure|obstructive sleep apnea due to primary tongue base closure
4879753|NCT02180815|Minimally invasive surgery|minimally invasive surgery
4879754|NCT02180815|ReVENT Sleep Apnea System|revent sleep apnea system
4879755|NCT02180815|Tongue implants|tongue implants
4879756|NCT02180802|obese adolescents|obese adolescents
4879757|NCT02180802|BMI ≥ 95th percentile for age and gender|bmi ≥ 95th percentile for age and gender
4879758|NCT02180789|tamsulosin,|tamsulosin,
4879759|NCT02180789|benign prostatic hyperplasia,|benign prostatic hyperplasia,
4879760|NCT02180789|α1-adrenoceptor antagonists|α1-adrenoceptor antagonists
4879761|NCT02180763|Primary Immunodeficiency, PID|primary immunodeficiency, pid
4879762|NCT02180750|Children|children
4879763|NCT02180750|HIV|hiv
4879764|NCT02180750|orphans|orphans
4879765|NCT02180737|dexmedetomedine|dexmedetomedine
4879766|NCT02180737|sedation|sedation
4879767|NCT02180737|interventional radiology|interventional radiology
4879768|NCT02180724|Bruton tyrosine kinase inhibitor|bruton tyrosine kinase inhibitor
4879769|NCT02180724|Btk|btk
4879770|NCT02180724|Waldenström Macroglobulinemia|waldenström macroglobulinemia
4879771|NCT02180724|WM|wm
4879772|NCT02180724|Waldenström|waldenström
4879773|NCT02180724|Macroglobulinemia|macroglobulinemia
4879774|NCT02180711|Bruton tyrosine kinase inhibitor|bruton tyrosine kinase inhibitor
4879775|NCT02180711|Btk|btk
4879776|NCT02180711|Follicular Lymphoma|follicular lymphoma
4879777|NCT02180711|FL|fl
4879778|NCT02180711|acalabrutinib|acalabrutinib
4879779|NCT02180711|ACP-196|acp-196
4879780|NCT02180711|MZL|mzl
4879781|NCT02180711|Marginal Zone Lymphoma|marginal zone lymphoma
4879782|NCT02180672|Obstructive sleep apnea syndrome|obstructive sleep apnea syndrome
4879783|NCT02180672|OSA|osa
4879784|NCT02180672|sleep apnea|sleep apnea
4879785|NCT02180672|nasal steroids|nasal steroids
4879786|NCT02180672|corticosteroids|corticosteroids
4879787|NCT02180646|GLP-1|glp-1
4879788|NCT02180646|GIP|gip
4879789|NCT02180646|second meal phenomena|second meal phenomena
4879790|NCT02180646|type 2 diabetes|type 2 diabetes
4879791|NCT02180633|Idiopathic Macular Hole|idiopathic macular hole
4879792|NCT02180620|GIP|gip
4879793|NCT02180620|GLP-1|glp-1
4879794|NCT02180620|exercise timing|exercise timing
4879795|NCT02180620|resistance exercise|resistance exercise
4879796|NCT02180620|glucose concentrations|glucose concentrations
4879797|NCT02180607|depression|depression
4879798|NCT02180607|social|social
4879799|NCT02180607|rejection|rejection
4879800|NCT02180607|acceptance|acceptance
4879801|NCT02180607|fMRI|fmri
4879802|NCT02180607|reward|reward
4879803|NCT02180607|exclusion|exclusion
4879804|NCT02180581|Infections|infections
4879805|NCT02180581|Allergy|allergy
4879806|NCT02180581|Immune function|immune function
4879807|NCT02180581|Microbiota|microbiota
4879808|NCT02180581|Infant|infant
4879809|NCT02180568|Ground-glass-opacity (GGO)|ground-glass-opacity (ggo)
4879810|NCT02180568|Lung localization|lung localization
4879811|NCT02180568|Lipiodol|lipiodol
4879812|NCT02180568|Hook wire|hook wire
4879813|NCT02180568|Video assisted thoracic surgery (VATS)|video assisted thoracic surgery (vats)
4879814|NCT02180542|stroke|stroke
4879815|NCT02180542|Ischemic stroke|ischemic stroke
4879816|NCT02180542|Cerebral infarction|cerebral infarction
4879817|NCT02180542|recurrent stroke|recurrent stroke
4879818|NCT02180542|atrial fibrillation|atrial fibrillation
4879819|NCT02180542|premature atrial complexes|premature atrial complexes
4879820|NCT02180542|heart rhythm monitoring|heart rhythm monitoring
4879821|NCT02180542|left atrial function|left atrial function
4879822|NCT02180542|carotid artery|carotid artery
4879823|NCT02180542|plaque morphology|plaque morphology
4879824|NCT02180529|methylphenidate, elderly, mild cognitive impairment|methylphenidate, elderly, mild cognitive impairment
4879825|NCT02180464|psoriasis, topical|psoriasis, topical
4879826|NCT02180438|HIV-2|hiv-2
4879827|NCT02180425|acne|acne
4879828|NCT02180425|lipid|lipid
4879829|NCT02180425|tretinoin|tretinoin
4879830|NCT02180425|isotretinoin|isotretinoin
4879831|NCT02180412|Acute porphyria|acute porphyria
4879832|NCT02180412|Hemin|hemin
4879833|NCT02180399|Sepsis|sepsis
4879834|NCT02180399|Capillary blood lactate|capillary blood lactate
4879835|NCT02180399|Serial measurement of capillary|serial measurement of capillary
4879836|NCT02180386|Audiovisual distraction|audiovisual distraction
4879837|NCT02180386|Pediatric dentistry|pediatric dentistry
4879838|NCT02180360|Capoeira training|capoeira training
4879839|NCT02180360|Range of motion|range of motion
4879840|NCT02180360|Flexibility|flexibility
4879841|NCT02180360|beginners|beginners
4879842|NCT02180347|Pediatrics|pediatrics
4879843|NCT02180347|Contact lenses|contact lenses
4879844|NCT02180334|Gastric Emptying|gastric emptying
4879845|NCT02180334|Gastrointestinal Motility|gastrointestinal motility
4879846|NCT02180334|Incretins|incretins
4879847|NCT02180334|Glucagon-Like Peptide 1|glucagon-like peptide 1
4879848|NCT02180334|Diabetes Mellitus|diabetes mellitus
4879849|NCT02180321|Tranexamic acid|tranexamic acid
4879850|NCT02180321|pharmacokinetics|pharmacokinetics
4879851|NCT02180321|craniosynostosis|craniosynostosis
4879852|NCT02180308|Head cancer|head cancer
4879853|NCT02180308|Neck cancer|neck cancer
4879854|NCT02180308|MRI|mri
4879855|NCT02180308|PET|pet
4879856|NCT02180282|Acne Treatment|acne treatment
4879857|NCT02180269|Healthy|healthy
4879858|NCT02180269|JNJ-54861911|jnj-54861911
4879859|NCT02180269|Alzheimer's disease|alzheimer's disease
4879860|NCT02180256|IVF|ivf
4879861|NCT02180256|ICSI|icsi
4879862|NCT02180256|Embryo transfer|embryo transfer
4879863|NCT02180256|Assisted reproduction|assisted reproduction
4879864|NCT02180256|Endometrial injury|endometrial injury
4879865|NCT02180256|Endometrial scratching|endometrial scratching
4879866|NCT02180243|meditation|meditation
4879867|NCT02180243|acupuncture|acupuncture
4879868|NCT02180243|Gulf War Veterans' Illness|gulf war veterans' illness
4879869|NCT02180243|Gulf War health education|gulf war health education
4879870|NCT02180243|iRest yoga|irest yoga
4879871|NCT02180230|Short implants|short implants
4879872|NCT02180230|prospective multicenter study|prospective multicenter study
4879873|NCT02180230|maxilla & mandible|maxilla & mandible
4879874|NCT02180217|LCI699|lci699
4879875|NCT02180217|Cushing's disease|cushing's disease
4879876|NCT02180204|Cerebral Infarction|cerebral infarction
4879877|NCT02180204|Ischemic Stroke|ischemic stroke
4879878|NCT02180204|Thrombolysis|thrombolysis
4879879|NCT02180191|Gut microbiota|gut microbiota
4879880|NCT02180178|microvascular disease|microvascular disease
4879881|NCT02180178|coronary artery disease|coronary artery disease
4879882|NCT02180178|Coronary artery disease, with or without microvascular dysfuntion|coronary artery disease, with or without microvascular dysfuntion
4879883|NCT02180152|Perinatal outcomes|perinatal outcomes
4879884|NCT02180113|Cirrhotic patients|cirrhotic patients
4879885|NCT02180113|Fibroscan|fibroscan
4879886|NCT02180113|Liver Stiffness Measurement|liver stiffness measurement
4879887|NCT02180113|Oesophageal Varices|oesophageal varices
4879888|NCT02180113|Portal Hypertension|portal hypertension
4879889|NCT02180113|Spleen Stiffness Measurement|spleen stiffness measurement
4879890|NCT02180087|Cardiac surgery|cardiac surgery
4879891|NCT02180087|Post-operative pain|post-operative pain
4879892|NCT02180087|Kétoprofène|kétoprofène
4879893|NCT02180087|Minimum analgesic dose|minimum analgesic dose
4879894|NCT02180087|Morphin consumption|morphin consumption
4879895|NCT02180087|Morphin secondary effects|morphin secondary effects
4879896|NCT02180087|Patient comfort and satisfaction|patient comfort and satisfaction
4879897|NCT02180087|Renal fonction|renal fonction
4879898|NCT02180074|Hydrogen Sulfide Pools,|hydrogen sulfide pools,
4879899|NCT02180061|PD1|pd1
4879900|NCT02180061|PD-1|pd-1
4879901|NCT02180061|PDL1|pdl1
4879902|NCT02180061|PD-L1|pd-l1
4879903|NCT02180035|diet therapy|diet therapy
4879904|NCT02180035|symbiotic|symbiotic
4879905|NCT02180035|dyslipidemia|dyslipidemia
4879906|NCT02180035|gastrointestinal symptoms|gastrointestinal symptoms
4879907|NCT02180035|body composition|body composition
4879908|NCT02180035|adherence|adherence
4879909|NCT02180035|HIV|hiv
4879910|NCT02180035|HAART|haart
4879911|NCT02180022|Quercetin|quercetin
4879912|NCT02180022|Endothelial function|endothelial function
4879913|NCT02180022|Onion peel extract|onion peel extract
4879914|NCT02180022|volunteers|volunteers
4879915|NCT02179996|Vaccination|vaccination
4879916|NCT02179996|Very preterm-born infants|very preterm-born infants
4879917|NCT02179996|Hib immunisation|hib immunisation
4879918|NCT02179996|Pertussis immunisation|pertussis immunisation
4879919|NCT02179983|Bronchiectasis|bronchiectasis
4879920|NCT02179983|rehabilitation|rehabilitation
4879921|NCT02179983|exercise|exercise
4879922|NCT02179983|exacerbations|exacerbations
4879923|NCT02179970|Advanced pancreatic cancer|advanced pancreatic cancer
4880122|NCT02179008|Glaucoma|glaucoma
4879924|NCT02179970|Advanced ovarian cancer|advanced ovarian cancer
4879925|NCT02179970|Advanced colorectal cancer|advanced colorectal cancer
4879926|NCT02179970|Metastatic pancreatic cancer|metastatic pancreatic cancer
4879927|NCT02179970|Metastatic ovarian cancer|metastatic ovarian cancer
4879928|NCT02179970|Metastatic colorectal cancer|metastatic colorectal cancer
4879929|NCT02179957|Stenoses|stenoses
4879930|NCT02179957|Ischaemia|ischaemia
4879931|NCT02179957|haemodynamics|haemodynamics
4879932|NCT02179957|fractional flow reserve (FFR)|fractional flow reserve (ffr)
4879933|NCT02179957|computed tomography (CT)|computed tomography (ct)
4879934|NCT02179957|cardiac|cardiac
4879935|NCT02179944|medication abortion|medication abortion
4879936|NCT02179944|serum hCG|serum hcg
4879937|NCT02179918|Advanced Solid Tumors|advanced solid tumors
4879938|NCT02179905|MRI|mri
4879939|NCT02179905|Heart rate variability|heart rate variability
4879940|NCT02179905|Fatty acid|fatty acid
4879941|NCT02179892|anesthesia|anesthesia
4879942|NCT02179892|surgery|surgery
4879943|NCT02179892|pain|pain
4879944|NCT02179879|labor,epidural,analgesia|labor,epidural,analgesia
4879945|NCT02179853|Kawasaki disease|kawasaki disease
4879946|NCT02179853|Anakinra|anakinra
4879947|NCT02179853|IL-1|il-1
4879948|NCT02179840|Cerebral microvascular circulation|cerebral microvascular circulation
4879949|NCT02179840|Cerebral autoregulation|cerebral autoregulation
4879950|NCT02179814|bulimia nervosa|bulimia nervosa
4879951|NCT02179814|dopamine|dopamine
4879952|NCT02179814|reward|reward
4879953|NCT02179814|catechol-O-methyltransferase|catechol-o-methyltransferase
4879954|NCT02179814|gene|gene
4879955|NCT02179814|catecholamines|catecholamines
4879956|NCT02179814|alpha-methyl-para-tyrosine|alpha-methyl-para-tyrosine
4879957|NCT02179814|magnetic resonance imaging|magnetic resonance imaging
4879958|NCT02179801|Abdominal aortic aneurysm|abdominal aortic aneurysm
4879959|NCT02179801|AAA|aaa
4879960|NCT02179801|Screening|screening
4879961|NCT02179788|lactation|lactation
4879962|NCT02179788|breastfeeding|breastfeeding
4879963|NCT02179788|human milk|human milk
4879964|NCT02179788|insulin|insulin
4879965|NCT02179788|metformin|metformin
4879966|NCT02179788|prediabetes|prediabetes
4879967|NCT02179788|pre-diabetes|pre-diabetes
4879968|NCT02179788|insulin resistance|insulin resistance
4879969|NCT02179762|cancer survivor|cancer survivor
4879970|NCT02179762|prostate cancer|prostate cancer
4879971|NCT02179762|exercise|exercise
4879972|NCT02179762|Active surveillance|active surveillance
4879973|NCT02179762|EASE|ease
4879974|NCT02179749|Alcohol-Related Disorders|alcohol-related disorders
4879975|NCT02179749|Substance-Related Disorders|substance-related disorders
4879976|NCT02179749|Mental Disorders|mental disorders
4879977|NCT02179749|Mifepristone|mifepristone
4879978|NCT02179749|Glucocorticoid Antagonists|glucocorticoid antagonists
4879979|NCT02179749|Alcohol Treatment|alcohol treatment
4879980|NCT02179749|Alcohol|alcohol
4879981|NCT02179736|Correction of moderate to severe nasolabial folds|correction of moderate to severe nasolabial folds
4879982|NCT02179723|wound healing|wound healing
4879983|NCT02179723|cosmetic results|cosmetic results
4879984|NCT02179723|trocar incision|trocar incision
4879985|NCT02179710|adherence|adherence
4879986|NCT02179710|cystic fibrosis|cystic fibrosis
4879987|NCT02179710|adolescents|adolescents
4879988|NCT02179710|adults|adults
4879989|NCT02179697|Groups:|groups:
4879990|NCT02179697|Group 1 (2 Treatment Arms (Randomized between 2 treatments))|group 1 (2 treatment arms (randomized between 2 treatments))
4879991|NCT02179697|Treatment 1: Surgery + Bracing|treatment 1: surgery + bracing
4879992|NCT02179697|Treatment 2: Bracing Alone|treatment 2: bracing alone
4879993|NCT02179697|Group 2|group 2
4880118|NCT02179021|Hypothermia|hypothermia
4879994|NCT02179697|The patient will decide which group is best for themselves.|the patient will decide which group is best for themselves.
4879995|NCT02179684|Cranial Nerve fascial paresis|cranial nerve fascial paresis
4879996|NCT02179671|Lung cancer; NSCLC|lung cancer; nsclc
4879997|NCT02179658|Clostridium|clostridium
4879998|NCT02179658|Infections|infections
4879999|NCT02179658|Difficile|difficile
4880000|NCT02179658|Vancomycin|vancomycin
4880001|NCT02179658|Fidaxomicin|fidaxomicin
4880002|NCT02179632|disclosure|disclosure
4880003|NCT02179632|conflicts of interest|conflicts of interest
4880004|NCT02179632|trust|trust
4880005|NCT02179632|patient doctor relationship|patient doctor relationship
4880006|NCT02179593|Maxillary expansion|maxillary expansion
4880007|NCT02179593|Orthognathic surgery|orthognathic surgery
4880008|NCT02179593|Symmetry|symmetry
4880009|NCT02179593|Palatal expansion technique|palatal expansion technique
4880010|NCT02179593|Maxilla abnormality|maxilla abnormality
4880011|NCT02179580|Traditional Chinese Medicine|traditional chinese medicine
4880012|NCT02179580|Clinical trial|clinical trial
4880013|NCT02179580|Good Clinical Practice|good clinical practice
4880014|NCT02179567|Metastatic NSCLC|metastatic nsclc
4880015|NCT02179567|Elderly|elderly
4880016|NCT02179567|1st Line|1st line
4880017|NCT02179567|Bevacizumab-based treatment|bevacizumab-based treatment
4880018|NCT02179541|Otitis media with effusion, viscosity, RGB (red-green-blue).|otitis media with effusion, viscosity, rgb (red-green-blue).
4880019|NCT02179515|Immune Response|immune response
4880020|NCT02179515|Maximum Tolerated Dose|maximum tolerated dose
4880021|NCT02179515|Vaccine Therapy|vaccine therapy
4880022|NCT02179515|Increased Expression of Brachyury|increased expression of brachyury
4880023|NCT02179515|Immunotherapy|immunotherapy
4880024|NCT02179489|Peritoneal carcinomatosis|peritoneal carcinomatosis
4880025|NCT02179489|HIPEC|hipec
4880026|NCT02179489|controlled clinical trial|controlled clinical trial
4880027|NCT02179489|colorectal cancer|colorectal cancer
4880028|NCT02179476|Facet joint|facet joint
4880029|NCT02179476|facet joint pain|facet joint pain
4880030|NCT02179476|facet joint disease|facet joint disease
4880031|NCT02179476|lumbar pain|lumbar pain
4880032|NCT02179476|back pain|back pain
4880033|NCT02179463|Gastric Cancer|gastric cancer
4880034|NCT02179463|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
4880035|NCT02179463|Response Evaluation|response evaluation
4880036|NCT02179437|TIVA|tiva
4880037|NCT02179437|Propofol|propofol
4880038|NCT02179437|Postoperative pain|postoperative pain
4880039|NCT02179437|Liver resection surgery|liver resection surgery
4880040|NCT02179437|Retrospective study|retrospective study
4880041|NCT02179424|smoking cessation interventions|smoking cessation interventions
4880042|NCT02179398|Fever without source|fever without source
4880043|NCT02179398|Antibiotic prescription|antibiotic prescription
4880044|NCT02179398|Serious bacterial infection|serious bacterial infection
4880045|NCT02179385|Type 2 diabetes|type 2 diabetes
4880046|NCT02179385|Type II diabetes|type ii diabetes
4880047|NCT02179359|Stem Cell Transplant|stem cell transplant
4880048|NCT02179346|cartilage defect|cartilage defect
4880049|NCT02179346|hip|hip
4880050|NCT02179346|impingement|impingement
4880051|NCT02179320|Myofascial Pain Syndrome|myofascial pain syndrome
4880052|NCT02179320|Dry needling|dry needling
4880053|NCT02179320|Clinical Trial|clinical trial
4880054|NCT02179307|muscle hypertrophy|muscle hypertrophy
4880055|NCT02179307|strength|strength
4880056|NCT02179307|resistance training|resistance training
4880057|NCT02179307|exercise|exercise
4880058|NCT02179307|physical fitness|physical fitness
4880059|NCT02179307|health|health
4880060|NCT02179307|physical conditioning|physical conditioning
4880061|NCT02179294|Pain relief|pain relief
4880062|NCT02179294|Labour|labour
4880063|NCT02179294|Child birth|child birth
4880064|NCT02179294|Anaesthetics|anaesthetics
4880065|NCT02179268|Antidepressants|antidepressants
4880066|NCT02179268|bone mineral density|bone mineral density
4880067|NCT02179268|bone turnover markers|bone turnover markers
4880068|NCT02179255|DOR|dor
4880069|NCT02179255|Premature Ovarian Failure (POF)|premature ovarian failure (pof)
4880070|NCT02179255|Ovarian Failure|ovarian failure
4880071|NCT02179255|Human Growth Hormone|human growth hormone
4880072|NCT02179242|cardiac rehab|cardiac rehab
4880073|NCT02179242|heart failure|heart failure
4880074|NCT02179242|KCCQ|kccq
4880075|NCT02179242|6 minute walk test|6 minute walk test
4880076|NCT02179242|readmission|readmission
4880077|NCT02179229|Kidney transplantation|kidney transplantation
4880078|NCT02179229|pCresol|pcresol
4880079|NCT02179229|Immunosuppressant drugs|immunosuppressant drugs
4880080|NCT02179216|Orthostatic hypotension in the elderly|orthostatic hypotension in the elderly
4880081|NCT02179216|Efficacity of Hydration|efficacity of hydration
4880082|NCT02179216|Difference between hydratation and venous contention|difference between hydratation and venous contention
4880083|NCT02179177|Vaso-occlusive crisis|vaso-occlusive crisis
4880084|NCT02179177|Reduction in hospitalizations|reduction in hospitalizations
4880085|NCT02179177|Sickle Cell Disease|sickle cell disease
4880086|NCT02179151|Prader-Willi Syndrome|prader-willi syndrome
4880087|NCT02179151|Obesity|obesity
4880088|NCT02179151|Hyperphagia|hyperphagia
4880089|NCT02179125|COPD|copd
4880090|NCT02179125|Endobronchial treatment|endobronchial treatment
4880091|NCT02179112|Surgery|surgery
4880092|NCT02179112|Specialties, Surgical|specialties, surgical
4880093|NCT02179112|Geography, Medical|geography, medical
4880094|NCT02179112|Developing Countries|developing countries
4880095|NCT02179112|Developed Countries|developed countries
4880096|NCT02179112|Laparotomy|laparotomy
4880097|NCT02179112|Outcome and Process Assessment (Health Care)|outcome and process assessment (health care)
4880098|NCT02179112|Treatment Outcome|treatment outcome
4880099|NCT02179112|Quality of Health Care|quality of health care
4880100|NCT02179099|overactive bladder|overactive bladder
4880101|NCT02179099|OAB|oab
4880102|NCT02179099|urgency|urgency
4880103|NCT02179099|botulinum toxin|botulinum toxin
4880104|NCT02179099|BTX|btx
4880105|NCT02179099|botox|botox
4880106|NCT02179099|intravesical|intravesical
4880107|NCT02179099|TheraCoat|theracoat
4880108|NCT02179099|TCGel|tcgel
4880109|NCT02179099|TC-3 Gel|tc-3 gel
4880110|NCT02179060|Sudden cardiac arrest, RhinoChill -cooling, MRI|sudden cardiac arrest, rhinochill -cooling, mri
4880111|NCT02179047|SYNTAX ,NGAL,Cystatin C,Galectin-3,Copeptin.MR-ProANP,sST2.|syntax ,ngal,cystatin c,galectin-3,copeptin.mr-proanp,sst2.
4880112|NCT02179034|tobacco|tobacco
4880113|NCT02179034|electronic cigarettes|electronic cigarettes
4880114|NCT02179034|menthol|menthol
4880115|NCT02179034|flavors|flavors
4880116|NCT02179021|Thromboelastometry|thromboelastometry
4880117|NCT02179021|Haemostasis|haemostasis
4880119|NCT02179021|Heart arrest|heart arrest
4880120|NCT02179008|Santen|santen
4880121|NCT02179008|Eye|eye
4880123|NCT02179008|Ocular hypertension|ocular hypertension
4880124|NCT02178982|mechanical ventilation|mechanical ventilation
4880125|NCT02178982|ARDS|ards
4880126|NCT02178982|Ventilator strategy|ventilator strategy
4880127|NCT02178982|outcome|outcome
4880128|NCT02178943|Molecular Diagnostics|molecular diagnostics
4880129|NCT02178943|Heart Transplantation|heart transplantation
4880130|NCT02178943|Risk Factors|risk factors
4880131|NCT02178943|Prognosis|prognosis
4880132|NCT02178930|HIV|hiv
4880133|NCT02178930|cardiovascular disease|cardiovascular disease
4880134|NCT02178930|self-management|self-management
4880135|NCT02178930|HIV co-morbidities|hiv co-morbidities
4880136|NCT02178930|self-efficacy|self-efficacy
4880137|NCT02178930|coronary heart disease risk|coronary heart disease risk
4880138|NCT02178930|quality of life|quality of life
4880139|NCT02178904|Ischemia|ischemia
4880140|NCT02178904|Dual Energy Computed Tomography|dual energy computed tomography
4880141|NCT02178904|Computed Tomographic Perfusion|computed tomographic perfusion
4880142|NCT02178904|Fractional Flow Rate|fractional flow rate
4880143|NCT02178904|Invasive Coronary Angiography|invasive coronary angiography
4880144|NCT02178904|Coronary Artery Stenosis|coronary artery stenosis
4880145|NCT02178891|short implants|short implants
4880146|NCT02178891|Nobel Biocare|nobel biocare
4880147|NCT02178891|partially edentulous|partially edentulous
4880148|NCT02178891|maxilla or mandible|maxilla or mandible
4880149|NCT02178878|Labor pain and progress, variation, genetic|labor pain and progress, variation, genetic
4880150|NCT02178865|translocation|translocation
4880151|NCT02178839|Non Alcoholic Fatty Liver Disease(NAFLD)|non alcoholic fatty liver disease(nafld)
4880152|NCT02178839|β- glucan|β- glucan
4880153|NCT02178839|Appetite|appetite
4880154|NCT02178839|Insulin Resistance|insulin resistance
4880155|NCT02178826|Nocturnal Enuresis|nocturnal enuresis
4880156|NCT02178826|Rapid Maxillary Expansion|rapid maxillary expansion
4880157|NCT02178826|Orthodontics|orthodontics
4880158|NCT02178826|Polysomnography|polysomnography
4880159|NCT02178826|Quality of life|quality of life
4880160|NCT02178813|Minocycline|minocycline
4880161|NCT02178813|Neuroprotection|neuroprotection
4880162|NCT02178813|Stroke|stroke
4880163|NCT02178787|cerebral blood flow|cerebral blood flow
4880164|NCT02178787|near infrared spectroscopy|near infrared spectroscopy
4880165|NCT02178787|transcranial Doppler|transcranial doppler
4880166|NCT02178787|diabetes mellitus|diabetes mellitus
4880167|NCT02178787|cerebral autoregulation|cerebral autoregulation
4880168|NCT02178774|Near-Infrared Spectroscopy (NIRS)|near-infrared spectroscopy (nirs)
4880169|NCT02178774|spinal anesthesia|spinal anesthesia
4880170|NCT02178774|cesarean section|cesarean section
4880171|NCT02178761|Erectile dysfunction|erectile dysfunction
4880172|NCT02178761|Lower Urinary Tract Symptoms|lower urinary tract symptoms
4880173|NCT02178761|Peripheral Arterial Disease|peripheral arterial disease
4880174|NCT02178761|Angioplasty|angioplasty
4880175|NCT02178761|Multidetector Computed Tomography|multidetector computed tomography
4880176|NCT02178748|Tuberculosis|tuberculosis
4880177|NCT02178748|Phase II|phase ii
4880178|NCT02178748|MVA85A|mva85a
4880179|NCT02178748|Schistosoma mansoni|schistosoma mansoni
4880180|NCT02178735|pelvic organ prolapse, vaginal mesh, urodynamic studies|pelvic organ prolapse, vaginal mesh, urodynamic studies
4880181|NCT02178709|Pancreatic|pancreatic
4880182|NCT02178709|Cancer|cancer
4880183|NCT02178709|Resectable|resectable
4880184|NCT02178683|TACROLIMUS|tacrolimus
4880185|NCT02178683|MYCOPHENOLATE MOFETIL|mycophenolate mofetil
4880186|NCT02178683|FLUDARABINE|fludarabine
4880187|NCT02178683|HLA-MATCHED|hla-matched
4880188|NCT02178683|MIS-MATCHED|mis-matched
4880189|NCT02178657|Stroke|stroke
4880190|NCT02178657|Cell therapy|cell therapy
4880191|NCT02178657|Bone marrow|bone marrow
4880192|NCT02178605|rhBMP-2|rhbmp-2
4880193|NCT02178605|arthrodesis|arthrodesis
4880194|NCT02178605|cervical|cervical
4880195|NCT02178592|integrase inhibitor|integrase inhibitor
4880196|NCT02178592|Mycobacterium tuberculosis|mycobacterium tuberculosis
4880197|NCT02178592|rifampicin-sensitive|rifampicin-sensitive
4880198|NCT02178592|dolutegravir|dolutegravir
4880199|NCT02178592|antiretroviral therapy-naïve|antiretroviral therapy-naïve
4880200|NCT02178592|HIV-1 infection|hiv-1 infection
4880201|NCT02178592|efavirenz|efavirenz
4880202|NCT02178592|co-infection|co-infection
4880203|NCT02178579|Heart Failure|heart failure
4880204|NCT02178579|Cardiac Toxicity|cardiac toxicity
4880205|NCT02178579|Multiple Myeloma|multiple myeloma
4880206|NCT02178579|Bortezomib|bortezomib
4880207|NCT02178579|Carfilzomib|carfilzomib
4880208|NCT02178566|COPD|copd
4880209|NCT02178566|Trepostinil|trepostinil
4880210|NCT02178566|Pulmonary Rehabilitation|pulmonary rehabilitation
4880211|NCT02178553|Thoracotomy|thoracotomy
4880212|NCT02178553|Pain|pain
4880213|NCT02178540|Human factors, TOBI® Podhaler™, Instructions For use, IFU, CF patients|human factors, tobi® podhaler™, instructions for use, ifu, cf patients
4880214|NCT02178527|Geriatrics|geriatrics
4880215|NCT02178527|Accidental Falls|accidental falls
4880216|NCT02178527|Podiatry|podiatry
4880217|NCT02178527|Exercise Therapy|exercise therapy
4880218|NCT02178527|Orthotic Devices|orthotic devices
4880219|NCT02178527|Foot|foot
4880220|NCT02178501|OMEGA-3 PUFA|omega-3 pufa
4880221|NCT02178501|type 2 diabetes|type 2 diabetes
4880222|NCT02178501|cardiovascular diseases|cardiovascular diseases
4880223|NCT02178475|NHL|nhl
4880224|NCT02178475|Breast Cancer|breast cancer
4880225|NCT02178423|children, ultrasound, central catheter|children, ultrasound, central catheter
4880226|NCT02178410|Atrial Fibrillation|atrial fibrillation
4880227|NCT02178410|Vitamin D3|vitamin d3
4880228|NCT02178410|Omega-3 fatty acids|omega-3 fatty acids
4880229|NCT02178410|Fish oil|fish oil
4880230|NCT02178397|erlotinib|erlotinib
4880231|NCT02178397|lung cancer|lung cancer
4880232|NCT02178397|EGFR mutation|egfr mutation
4880233|NCT02178384|Loading Forces|loading forces
4880234|NCT02178384|Removable partial dentures|removable partial dentures
4880235|NCT02178384|Bilateral distal extension|bilateral distal extension
4880236|NCT02178371|Upper extremity|upper extremity
4880237|NCT02178371|Physical therapy modalities|physical therapy modalities
4880238|NCT02178358|transforming growth factor beta (TGF-β)|transforming growth factor beta (tgf-β)
4880239|NCT02178345|MRI|mri
4880240|NCT02178345|14-126|14-126
4880241|NCT02178332|Children|children
4880242|NCT02178332|socio-emotional|socio-emotional
4880243|NCT02178332|socio-emotional skills|socio-emotional skills
4880244|NCT02178332|psychiatric symptoms|psychiatric symptoms
4880245|NCT02178332|SDQ|sdq
4880246|NCT02178332|Finland|finland
4880247|NCT02178332|School|school
4880248|NCT02178332|School community|school community
4880249|NCT02178332|Teacher|teacher
4880250|NCT02178332|Whole school approach|whole school approach
4880251|NCT02178332|Intervention|intervention
4880252|NCT02178332|Effectiveness study|effectiveness study
4880253|NCT02178332|Cluster randomised trial|cluster randomised trial
4880254|NCT02178319|portal hypertension|portal hypertension
4880255|NCT02178319|Randomized clinical trial|randomized clinical trial
4880256|NCT02178319|laparoscopic|laparoscopic
4880257|NCT02178319|open|open
4880258|NCT02178267|Newborn, preterm, probiotic, resistant microorganisms|newborn, preterm, probiotic, resistant microorganisms
4880259|NCT02178254|Pseudomonas aeruginosa, ZTI-101, phosphonic acid derivative, Monurol, fosfomycin tromethamine|pseudomonas aeruginosa, zti-101, phosphonic acid derivative, monurol, fosfomycin tromethamine
4880260|NCT02178228|Anastomotic Leaks|anastomotic leaks
4880261|NCT02178228|Bowel Resection|bowel resection
4880262|NCT02178228|Postoperative Complication|postoperative complication
4880263|NCT02178215|atopic dermatitis|atopic dermatitis
4880264|NCT02178215|skin barrier function|skin barrier function
4880265|NCT02178215|transepidermal water loss|transepidermal water loss
4880266|NCT02178215|skin pH|skin ph
4880267|NCT02178215|stratum corneum hydration|stratum corneum hydration
4880268|NCT02178215|sebum|sebum
4880269|NCT02178215|wrinkle|wrinkle
4880270|NCT02178202|Harmonic technique, Low Back Pain, McKenzie exercise, Pain, Disability|harmonic technique, low back pain, mckenzie exercise, pain, disability
4880271|NCT02178189|prenatal opioid exposure|prenatal opioid exposure
4880272|NCT02178189|infant|infant
4880273|NCT02178189|weight gain|weight gain
4880274|NCT02178189|infant formula|infant formula
4880275|NCT02178150|Magnesium|magnesium
4880276|NCT02178150|Insulin Resistance|insulin resistance
4880277|NCT02178150|Lipid profile|lipid profile
4880278|NCT02178150|Sex hormones|sex hormones
4880279|NCT02178150|Inflammatory factors|inflammatory factors
4880280|NCT02178111|episiotomy, vaginal delivery, randomized, perineum|episiotomy, vaginal delivery, randomized, perineum
4880281|NCT02178098|LDL|ldl
4880282|NCT02178098|Cholesterol|cholesterol
4880283|NCT02178085|glaucoma|glaucoma
4880284|NCT02178085|phase-contrast MRI|phase-contrast mri
4880285|NCT02178085|blood flow|blood flow
4880286|NCT02178085|cerebrospinal fluid|cerebrospinal fluid
4880287|NCT02178072|HNSCC|hnscc
4880288|NCT02178059|Healthy volunteers, pharmacokinetic, inhalation|healthy volunteers, pharmacokinetic, inhalation
4880289|NCT02178046|Gingivitis|gingivitis
4880290|NCT02178033|adenoma detection rate, screening colonoscopy|adenoma detection rate, screening colonoscopy
4880291|NCT02178020|Knee Arthroplasty|knee arthroplasty
4880292|NCT02178020|Osteolysis|osteolysis
4880293|NCT02178020|Radiolucent Lines|radiolucent lines
4880294|NCT02177994|Elective Cesarean Section|elective cesarean section
4880295|NCT02177994|Antibiotic prophylaxis|antibiotic prophylaxis
4880296|NCT02177994|Timing of Antibiotic prophylaxis|timing of antibiotic prophylaxis
4880297|NCT02177994|post cesarean section infection|post cesarean section infection
4880298|NCT02177981|Remote Ischemic Preconditioning|remote ischemic preconditioning
4880299|NCT02177981|Coronary Artery Bypass Grafting|coronary artery bypass grafting
4880300|NCT02177981|Diffusion Weighted Magnetic Resonance Imaging|diffusion weighted magnetic resonance imaging
4880301|NCT02177981|Resting State Functional Magnetic Resonance Imaging|resting state functional magnetic resonance imaging
4880302|NCT02177981|Postoperative Cognitive Dysfunction|postoperative cognitive dysfunction
4880303|NCT02177968|fall|fall
4880304|NCT02177968|elderly|elderly
4880305|NCT02177968|characteristics|characteristics
4880306|NCT02177955|Third Molar|third molar
4880307|NCT02177955|Anty-anxiety drugs|anty-anxiety drugs
4880308|NCT02177955|hemodynamic|hemodynamic
4880309|NCT02177955|Benzodiazepines|benzodiazepines
4880310|NCT02177929|Spinal cord injury,|spinal cord injury,
4880311|NCT02177929|adaptive sport,|adaptive sport,
4880312|NCT02177929|dynamometry,|dynamometry,
4880313|NCT02177929|electromyography,|electromyography,
4880314|NCT02177929|force platform.|force platform.
4880315|NCT02177916|lung transplantation|lung transplantation
4880316|NCT02177903|hypothermia|hypothermia
4880317|NCT02177903|surgical site infection|surgical site infection
4880318|NCT02177903|opioid usage|opioid usage
4880319|NCT02177903|blood loss|blood loss
4880320|NCT02177903|pain severity|pain severity
4880321|NCT02177903|anxiety|anxiety
4880322|NCT02177903|Length of Stay|length of stay
4880323|NCT02177877|Epilepsy|epilepsy
4880324|NCT02177877|Seizures|seizures
4880325|NCT02177877|Wrist accelerometer|wrist accelerometer
4880326|NCT02177877|Epilepsy diary|epilepsy diary
4880327|NCT02177877|Seizure detection|seizure detection
4880328|NCT02177877|Biosensor|biosensor
4880329|NCT02177851|Iron bio-availability|iron bio-availability
4880330|NCT02177851|Hepcidin|hepcidin
4880331|NCT02177851|Iron absorption|iron absorption
4880332|NCT02177812|Oncology|oncology
4880333|NCT02177812|LSD1|lsd1
4880334|NCT02177812|GSK2879552|gsk2879552
4880335|NCT02177812|Acute myeloid leukemia|acute myeloid leukemia
4880336|NCT02177799|Gastroenteritis|gastroenteritis
4880337|NCT02177799|Hospitalized|hospitalized
4880338|NCT02177799|Children|children
4880339|NCT02177786|Diabetic Kidney Disease|diabetic kidney disease
4880340|NCT02177786|Gilead|gilead
4880341|NCT02177760|SCID|scid
4880342|NCT02177760|severe combined immunodeficiency|severe combined immunodeficiency
4880343|NCT02177760|maternal engraftment|maternal engraftment
4880344|NCT02177760|aGVHD prophylaxis|agvhd prophylaxis
4880345|NCT02177760|sirolimus|sirolimus
4880346|NCT02177734|Adjuvant|adjuvant
4880347|NCT02177734|Safety|safety
4880348|NCT02177734|Influenza|influenza
4880349|NCT02177734|H7N9|h7n9
4880350|NCT02177734|Immunogenicity|immunogenicity
4880351|NCT02177734|Adults|adults
4880352|NCT02177721|Raxibacumab|raxibacumab
4880353|NCT02177721|anthrax|anthrax
4880354|NCT02177721|anti-toxin|anti-toxin
4880355|NCT02177695|Bladder Cancer|bladder cancer
4880356|NCT02177695|Neoadjuvant Chemotherapy|neoadjuvant chemotherapy
4880357|NCT02177695|Coexpression Extrapolation|coexpression extrapolation
4880358|NCT02177695|COXEN|coxen
4880359|NCT02177695|S1314|s1314
4880360|NCT02177695|SWOG|swog
4880361|NCT02177682|AKT inhibitor|akt inhibitor
4880362|NCT02177682|Afuresertib|afuresertib
4880363|NCT02177682|multiple myeloma|multiple myeloma
4880364|NCT02177669|Normal, healthy individuals without ocular disease|normal, healthy individuals without ocular disease
4880365|NCT02177669|Ages 20-89|ages 20-89
4880366|NCT02177669|English speaking|english speaking
4880367|NCT02177669|Visual acuity better than 20/25|visual acuity better than 20/25
4880368|NCT02177656|heart failure|heart failure
4880369|NCT02177656|self-care|self-care
4880370|NCT02177656|self-care maintenance|self-care maintenance
4880371|NCT02177656|self-care management|self-care management
4880372|NCT02177656|self-efficacy|self-efficacy
4880373|NCT02177656|quality of life|quality of life
4880374|NCT02177656|symptoms|symptoms
4880375|NCT02177643|Diabetes|diabetes
4880376|NCT02177643|Diacerein|diacerein
4880377|NCT02177630|myocarditis, myocardial inflammation, imaging, magnetic resonance|myocarditis, myocardial inflammation, imaging, magnetic resonance
4880378|NCT02177617|Cervical Dystonia|cervical dystonia
4880379|NCT02177617|Botox|botox
4880380|NCT02177578|Subventricular Zone|subventricular zone
4880381|NCT02177578|progenitor cell|progenitor cell
4880382|NCT02177578|radiation therapy|radiation therapy
4880383|NCT02177578|temozolomide|temozolomide
4880384|NCT02177565|Non-union|non-union
4880385|NCT02177565|fracture|fracture
4880386|NCT02177565|bone marrow stem cells|bone marrow stem cells
4880387|NCT02177552|Esophageal cancer|esophageal cancer
4880388|NCT02177552|Gastric cancer|gastric cancer
4880389|NCT02177539|cycloplegia|cycloplegia
4880390|NCT02177539|refraction in children|refraction in children
4880391|NCT02177539|cycloplegic agents|cycloplegic agents
4880392|NCT02177539|cycloplegic schemes|cycloplegic schemes
4880393|NCT02177539|cyclopentolate|cyclopentolate
4880394|NCT02177526|CT|ct
4880395|NCT02177526|MRI|mri
4880396|NCT02177513|Cannabis|cannabis
4880397|NCT02177513|Pharmacodynamics|pharmacodynamics
4880398|NCT02177513|Marijuana|marijuana
4880399|NCT02177513|Cannabinoids|cannabinoids
4880400|NCT02177513|Vaporized|vaporized
4880401|NCT02177474|depressive symptoms|depressive symptoms
4880402|NCT02177474|perceived social support|perceived social support
4880403|NCT02177474|coronary heart disease|coronary heart disease
4880404|NCT02177474|peer support|peer support
4880405|NCT02177474|women|women
4880406|NCT02177279|Wheat bran cereals, bran phytochemicals, phytochemicals bioavailability|wheat bran cereals, bran phytochemicals, phytochemicals bioavailability
4880407|NCT02177240|GlideScope®|glidescope®
4880408|NCT02177240|GlideRite®|gliderite®
4880409|NCT02177240|Flex-it®|flex-it®
4880410|NCT02177240|Difficult intubation|difficult intubation
4880411|NCT02177227|Total Knee Arthroplasty (TKA)|total knee arthroplasty (tka)
4880412|NCT02177227|Attune|attune
4880413|NCT02177227|Primary Total Knee Prosthesis|primary total knee prosthesis
4880414|NCT02177227|TruMatch|trumatch
4880415|NCT02177188|Hypovolaemic shock|hypovolaemic shock
4880416|NCT02177188|Monitoring|monitoring
4880417|NCT02177188|Haemorrhage|haemorrhage
4880418|NCT02177188|Transthoracic Echocardiography|transthoracic echocardiography
4880419|NCT02177175|Carvedilol|carvedilol
4880420|NCT02177175|Anthracycline|anthracycline
4880421|NCT02177175|HER2|her2
4880422|NCT02177175|14-099|14-099
4880423|NCT02177136|PSC|psc
4880424|NCT02177123|glaucoma shunt|glaucoma shunt
4880425|NCT02177123|glaucoma drainage device|glaucoma drainage device
4880426|NCT02177110|advanced melanoma|advanced melanoma
4880427|NCT02177110|metastatic melanoma|metastatic melanoma
4880428|NCT02177110|fresh frozen tissue|fresh frozen tissue
4880429|NCT02177110|FFPE tissue|ffpe tissue
4880430|NCT02177097|Pain|pain
4880431|NCT02177097|Infection|infection
4880432|NCT02177097|Inflammation|inflammation
4880433|NCT02177097|Prosthesis|prosthesis
4880434|NCT02177084|PTNS|ptns
4880435|NCT02177084|rectal cancer|rectal cancer
4880436|NCT02177084|low anterior resection syndrome|low anterior resection syndrome
4880437|NCT02177071|CROHN DISEASE|crohn disease
4880438|NCT02177071|INFLIXIMAB|infliximab
4880439|NCT02177071|COMBINATION THERAPY|combination therapy
4880440|NCT02177071|steroid free remission|steroid free remission
4880441|NCT02177071|anti-metabolites|anti-metabolites
4880442|NCT02177058|Nursing homes|nursing homes
4880443|NCT02177058|Hospitalizations|hospitalizations
4880444|NCT02177032|Rabies vaccines|rabies vaccines
4880445|NCT02177032|intradermal|intradermal
4880446|NCT02177032|human rabies immunoglobulins|human rabies immunoglobulins
4880447|NCT02177019|frequent headaches|frequent headaches
4880448|NCT02177019|personalized health plan|personalized health plan
4880449|NCT02176993|Acute stroke|acute stroke
4880450|NCT02176993|Therapeutic Hypothermia|therapeutic hypothermia
4880451|NCT02176980|HCV|hcv
4880452|NCT02176980|hepatitis C|hepatitis c
4880453|NCT02176980|alcohol|alcohol
4880454|NCT02176980|integrated care|integrated care
4880455|NCT02176941|Telomere Length|telomere length
4880456|NCT02176941|Arterial Aging|arterial aging
4880457|NCT02176941|Endothelial Progenitor Cells|endothelial progenitor cells
4880458|NCT02176941|Inflammation|inflammation
4880459|NCT02176941|Atherosclerosis|atherosclerosis
4880460|NCT02176889|Lactospore|lactospore
4880461|NCT02176889|Bacillus coagulans|bacillus coagulans
4880462|NCT02176889|Safety|safety
4880463|NCT02176889|Probiotic|probiotic
4880464|NCT02176889|Healthy Adults|healthy adults
4880465|NCT02176889|Tolerability|tolerability
4880466|NCT02176876|rheumatoid arthritis|rheumatoid arthritis
4880467|NCT02176876|RA|ra
4880468|NCT02176876|GS-5745|gs-5745
4880469|NCT02176876|MMP9|mmp9
4880470|NCT02176876|phase 1|phase 1
4880471|NCT02176863|FORCE|force
4880472|NCT02176863|post-polio syndrome|post-polio syndrome
4880473|NCT02176863|Flebogamma|flebogamma
4880474|NCT02176863|Immune Globulin Intravenous|immune globulin intravenous
4880475|NCT02176863|IGIV|igiv
4880476|NCT02176837|subarachnoid hemorrhage|subarachnoid hemorrhage
4880477|NCT02176837|vasospasm|vasospasm
4880478|NCT02176837|nitrite|nitrite
4880479|NCT02176837|sodium nitrite|sodium nitrite
4880480|NCT02176811|Non-alcoholic Fatty Liver Disease|non-alcoholic fatty liver disease
4880481|NCT02176811|Betatrophin|betatrophin
4880482|NCT02176785|Sleep|sleep
4880483|NCT02176785|Transcranial Electric Stimulation|transcranial electric stimulation
4880484|NCT02176720|Glioma|glioma
4880485|NCT02176720|Glioblastoma|glioblastoma
4880486|NCT02176720|Glioblastoma multiforme|glioblastoma multiforme
4880487|NCT02176720|GBM|gbm
4880488|NCT02176720|Recurrence|recurrence
4880489|NCT02176720|PET|pet
4880490|NCT02176720|FDOPA|fdopa
4880491|NCT02176707|Lung Function|lung function
4880492|NCT02176707|Exercise Capacity|exercise capacity
4880493|NCT02176694|persistent asthma|persistent asthma
4880494|NCT02176694|adherence|adherence
4880495|NCT02176694|text message reminders|text message reminders
4880496|NCT02176655|Delayed Alcohol Induced Headache|delayed alcohol induced headache
4880497|NCT02176642|Urinary Urge Incontinence|urinary urge incontinence
4880498|NCT02176642|Posterior Tibial Nerve Stimulation|posterior tibial nerve stimulation
4880499|NCT02176642|PTNS|ptns
4880500|NCT02176642|Neuromodulation|neuromodulation
4880501|NCT02176642|Oxybutynin|oxybutynin
4880502|NCT02176642|Anticholinergic Medication|anticholinergic medication
4880503|NCT02176629|Virtual Reality|virtual reality
4880504|NCT02176629|mild cognitive impairment|mild cognitive impairment
4880505|NCT02176629|Alzheimer's disease|alzheimer's disease
4880506|NCT02176603|phenylketonuria, endothelial dysfunction, CKD|phenylketonuria, endothelial dysfunction, ckd
4880507|NCT02176590|PATHS Social Emotional Learning|paths social emotional learning
4880508|NCT02176590|Coping Power|coping power
4880509|NCT02176590|Power PATH|power path
4880510|NCT02176590|Head Start|head start
4880511|NCT02176486|Drug therapy|drug therapy
4880512|NCT02176473|Depression|depression
4880513|NCT02176460|Knee Osteoarthritis|knee osteoarthritis
4880514|NCT02176460|Double-blind|double-blind
4880515|NCT02176460|placebo-controlled|placebo-controlled
4880516|NCT02176460|randomized|randomized
4880517|NCT02176460|colchicine|colchicine
4880518|NCT02176434|End stage renal disease|end stage renal disease
4880519|NCT02176434|Transplantation|transplantation
4880520|NCT02176434|Tolerance|tolerance
4880521|NCT02176408|Major Depressive Disorder|major depressive disorder
4880522|NCT02176408|Depression|depression
4880523|NCT02176408|MDD|mdd
4880524|NCT02176408|Exercise|exercise
4880525|NCT02176408|Physical Activity|physical activity
4880526|NCT02176408|Treatment|treatment
4880527|NCT02176408|Behavioral Activation|behavioral activation
4880528|NCT02176395|Acute Ischemic Stroke|acute ischemic stroke
4880529|NCT02176395|Randomized Controlled Trial|randomized controlled trial
4880530|NCT02176395|Traditional Chinese Medicine|traditional chinese medicine
4880531|NCT02176395|Proteomics|proteomics
4880532|NCT02176369|Non small cell lung cancer (NSCLC)|non small cell lung cancer (nsclc)
4880533|NCT02176369|Lung tumor in advanced phase|lung tumor in advanced phase
4880534|NCT02176343|Cataract|cataract
4880535|NCT02176343|Intraocular lens|intraocular lens
4880536|NCT02176343|ACRYSOF IQ ReSTOR + 2.5 D Multifocal Toric IOL|acrysof iq restor + 2.5 d multifocal toric iol
4880537|NCT02176330|Randomised Controlled Trial|randomised controlled trial
4880538|NCT02176330|Virtual Clinic|virtual clinic
4880539|NCT02176330|ePAQ-PF|epaq-pf
4880540|NCT02176330|Pelvic Floor Disorders|pelvic floor disorders
4880541|NCT02176330|Economic Analysis|economic analysis
4880542|NCT02176317|Autism Spectrum Disorder|autism spectrum disorder
4880543|NCT02176317|ASD|asd
4880544|NCT02176317|Umbilical cord blood|umbilical cord blood
4880545|NCT02176317|Autologous cord blood|autologous cord blood
4880546|NCT02176317|cord blood|cord blood
4880547|NCT02176304|knee|knee
4880548|NCT02176304|arthritis|arthritis
4880549|NCT02176304|injections|injections
4880550|NCT02176304|corticosteroids|corticosteroids
4880551|NCT02176291|Buprenorphine|buprenorphine
4880552|NCT02176291|Receptors, opioid|receptors, opioid
4880553|NCT02176291|Receptors, opioid kappa and mu|receptors, opioid kappa and mu
4880554|NCT02176278|Diabetic Kidney Disease|diabetic kidney disease
4880555|NCT02176278|Diabetes|diabetes
4880556|NCT02176278|Asian|asian
4880557|NCT02176278|Joint Asia Diabetes Evaluation (JADE) Program|joint asia diabetes evaluation (jade) program
4880558|NCT02176265|CAD|cad
4880559|NCT02176265|PCI|pci
4880560|NCT02176265|bioactive coronary stent|bioactive coronary stent
4880561|NCT02176265|OCT|oct
4880562|NCT02176226|Major Depressive Disorder|major depressive disorder
4880563|NCT02176226|Anxiety Disorders|anxiety disorders
4880564|NCT02176226|Behavior Therapy|behavior therapy
4880565|NCT02176226|Technology Assisted|technology assisted
4880566|NCT02176226|Mobile Phone|mobile phone
4880567|NCT02176226|Cellular Phone|cellular phone
4880568|NCT02176226|Smartphone|smartphone
4880569|NCT02176226|App|app
4880570|NCT02176213|Relapsed|relapsed
4880571|NCT02176213|Refractory|refractory
4880572|NCT02176213|Multiple Myeloma|multiple myeloma
4880573|NCT02176213|Pomalidomide|pomalidomide
4880574|NCT02176213|Cyclophosphamide|cyclophosphamide
4880575|NCT02176213|Dexamethasone|dexamethasone
4880576|NCT02176174|Ethnic group|ethnic group
4880577|NCT02176174|Cardiovascular disease|cardiovascular disease
4880578|NCT02176174|Atherosclerosis|atherosclerosis
4880579|NCT02176161|Prostate Cancer|prostate cancer
4880580|NCT02176161|Prostate Cancer Recurrent|prostate cancer recurrent
4880581|NCT02176148|cutaneous lupus|cutaneous lupus
4880582|NCT02176148|systemic lupus|systemic lupus
4880583|NCT02176148|systemic therapy|systemic therapy
4880584|NCT02176148|medication|medication
4880585|NCT02176135|HIV|hiv
4880586|NCT02176135|HAART suppressed|haart suppressed
4880587|NCT02176135|Auranofin|auranofin
4880588|NCT02176135|HIV latent reservoir|hiv latent reservoir
4880589|NCT02176057|trachoma|trachoma
4880590|NCT02176044|Nitric Oxide|nitric oxide
4880591|NCT02176044|Sodium Nitroprusside|sodium nitroprusside
4880592|NCT02176044|Spatial Working Memory|spatial working memory
4880593|NCT02176044|Psychosis|psychosis
4880594|NCT02176044|Schizophrenia|schizophrenia
4880595|NCT02176031|Graft Versus Host Disease|graft versus host disease
4880596|NCT02176018|Episodic Migraine|episodic migraine
4880597|NCT02176018|Migraine|migraine
4880598|NCT02176018|Headache|headache
4880599|NCT02175979|postoperative ileus|postoperative ileus
4880600|NCT02175979|anastomotic leak|anastomotic leak
4880601|NCT02175979|colorectal surgery|colorectal surgery
4880602|NCT02175979|inflammation|inflammation
4880603|NCT02175953|caregiver burden|caregiver burden
4880604|NCT02175953|stress|stress
4880605|NCT02175953|depression|depression
4880606|NCT02175953|dementia|dementia
4880607|NCT02175927|Helicobacter pylori|helicobacter pylori
4880608|NCT02175927|Treatment Failure|treatment failure
4880609|NCT02175927|second-line therapy|second-line therapy
4880610|NCT02175914|Erythromycin|erythromycin
4880611|NCT02175914|Familial Adenomatous Polyposis (FAP).|familial adenomatous polyposis (fap).
4880612|NCT02175914|APC gene|apc gene
4880613|NCT02175914|nonsense mutations|nonsense mutations
4880614|NCT02175901|helicobacter pylori eradication|helicobacter pylori eradication
4880615|NCT02175901|antibiotic|antibiotic
4880616|NCT02175888|Iron bio availability|iron bio availability
4880617|NCT02175888|Hepcidin|hepcidin
4880618|NCT02175888|Iron absorption|iron absorption
4880619|NCT02175875|ticagrelor|ticagrelor
4880620|NCT02175875|platelet function test|platelet function test
4880621|NCT02175875|comatose|comatose
4880622|NCT02175875|PCI|pci
4880623|NCT02175875|naso-gastric tube|naso-gastric tube
4880624|NCT02175862|Helicopter Emergency Medical Service|helicopter emergency medical service
4880625|NCT02175862|Trauma|trauma
4880626|NCT02175862|Early retirement|early retirement
4880628|NCT02175862|Quality of life|quality of life
4880629|NCT02175849|Multi-Drug Resistant Tuberculosis|multi-drug resistant tuberculosis
4880630|NCT02175849|Social Network Analysis|social network analysis
4880631|NCT02175836|Arrhythmic Sudden Cardiac Death|arrhythmic sudden cardiac death
4880632|NCT02175836|Heart Failure|heart failure
4880633|NCT02175836|Risk Stratification|risk stratification
4880634|NCT02175836|Autonomic Nervous System|autonomic nervous system
4880635|NCT02175836|Heart Rate|heart rate
4880636|NCT02175836|Repolarization|repolarization
4880637|NCT02175823|Cancer survivors|cancer survivors
4880638|NCT02175823|circadian rhythm|circadian rhythm
4880639|NCT02175823|Elderly Patients|elderly patients
4880640|NCT02175823|frailty|frailty
4880641|NCT02175810|Obesity|obesity
4880642|NCT02175810|Bariatric surgery|bariatric surgery
4880643|NCT02175810|physical activity|physical activity
4880644|NCT02175810|cardiopulmonary exercise test|cardiopulmonary exercise test
4880645|NCT02175797|Pacemaker, leads and MRI exam|pacemaker, leads and mri exam
4880646|NCT02175784|Blood glucose|blood glucose
4880647|NCT02175784|insulin|insulin
4880648|NCT02175784|ipragliflozin|ipragliflozin
4880649|NCT02175784|SGLT2 inhibitor|sglt2 inhibitor
4880650|NCT02175732|Type 1 Diabetes|type 1 diabetes
4880651|NCT02175732|Distress|distress
4880652|NCT02175719|Torticollis|torticollis
4880653|NCT02175719|rimabotulinumtoxinB|rimabotulinumtoxinb
4880654|NCT02175693|Torticollis|torticollis
4880655|NCT02175693|rimabotulinumtoxinB|rimabotulinumtoxinb
4880656|NCT02175680|HIV-1|hiv-1
4880657|NCT02175680|HIV|hiv
4880658|NCT02175680|Treatment Substitution|treatment substitution
4880659|NCT02175680|PRO 140|pro 140
4880660|NCT02175680|PRO140|pro140
4880661|NCT02175680|CytoDyn|cytodyn
4880662|NCT02175680|Amarex|amarex
4880663|NCT02175667|Global postural reeducation|global postural reeducation
4880664|NCT02175667|Stabilometry|stabilometry
4880665|NCT02175667|Postural Sway|postural sway
4880666|NCT02175667|Range of motion|range of motion
4880667|NCT02175667|Personality traits|personality traits
4880668|NCT02175654|metastatic colorectal cancer|metastatic colorectal cancer
4880669|NCT02175654|RAS/BRAF mutation|ras/braf mutation
4880670|NCT02175654|Regorafenib|regorafenib
4880671|NCT02175654|FOLFOXIRI|folfoxiri
4880672|NCT02175654|Bevacizumab|bevacizumab
4880673|NCT02175641|Healthy lifestyle Intervention|healthy lifestyle intervention
4880674|NCT02175641|Serious Mental Illness|serious mental illness
4880675|NCT02175641|Effectiveness trial|effectiveness trial
4880676|NCT02175641|Supportive housing|supportive housing
4880677|NCT02175641|Racial and Ethnic Health Disparities|racial and ethnic health disparities
4880678|NCT02175628|Ultrasound|ultrasound
4880679|NCT02175628|Breast|breast
4880680|NCT02175628|Angiography|angiography
4880681|NCT02175615|CYCLOSPORINE|cyclosporine
4880682|NCT02175615|ACUTE GRAFT VERSUS HOST DISEASE|acute graft versus host disease
4880683|NCT02175615|PROPHYLAXIS|prophylaxis
4880684|NCT02175615|CHILDREN|children
4880685|NCT02175615|HAEMATOPOIETIC STEM CELL TRANSPLANT|haematopoietic stem cell transplant
4880686|NCT02175589|Familial Mediterranean Fever|familial mediterranean fever
4880687|NCT02175589|Monozygous|monozygous
4880688|NCT02175589|MEFV|mefv
4880689|NCT02175589|Colchicine|colchicine
4880690|NCT02175589|Serum Amyloid A|serum amyloid a
4880691|NCT02175563|Chest|chest
4880692|NCT02175563|Compression|compression
4880693|NCT02175550|partially edentulous|partially edentulous
4880694|NCT02175550|maxilla|maxilla
4880695|NCT02175550|implants|implants
4880696|NCT02175550|Conical connection|conical connection
4880697|NCT02175550|Nobel Biocare|nobel biocare
4880698|NCT02175550|NobelReplace|nobelreplace
4880699|NCT02175550|Immediate loading|immediate loading
4880700|NCT02175550|One- stage surgery|one- stage surgery
4880701|NCT02175550|Two- stage surgery|two- stage surgery
4880702|NCT02175550|supported restoration|supported restoration
4880703|NCT02175550|patients|patients
4880704|NCT02175537|Diabetes Mellitus, Type II|diabetes mellitus, type ii
4880705|NCT02175537|Disease management|disease management
4880706|NCT02175537|Obesity|obesity
4880707|NCT02175537|Social Network|social network
4880708|NCT02175537|Chronic disease|chronic disease
4880709|NCT02175537|Prevention and control|prevention and control
4880710|NCT02175537|Education|education
4880711|NCT02175524|nut chewing|nut chewing
4880712|NCT02175511|Home Blood Pressure|home blood pressure
4880713|NCT02175511|Computerized physician order entry (CPOE)|computerized physician order entry (cpoe)
4880714|NCT02175511|Telemonitoring|telemonitoring
4880715|NCT02175511|Hypertension|hypertension
4880716|NCT02175498|Homoeopathy Similimum female infertility|homoeopathy similimum female infertility
4880717|NCT02175472|Parkinson's disease|parkinson's disease
4880718|NCT02175472|Light therapy|light therapy
4880719|NCT02175472|Circadian rhythm|circadian rhythm
4880720|NCT02175446|Breast cancer|breast cancer
4880721|NCT02175446|HER2Negative|her2negative
4880722|NCT02175446|Second line treatment|second line treatment
4880723|NCT02175446|HER2-|her2-
4880724|NCT02175446|MBC|mbc
4880725|NCT02175446|Metastatic|metastatic
4880726|NCT02175446|Metastatic breast cancer|metastatic breast cancer
4880727|NCT02175446|bevacizumab|bevacizumab
4880728|NCT02175446|eribulin|eribulin
4880729|NCT02175446|Human Epidermal Growth Factor Receptor 2-Negative|human epidermal growth factor receptor 2-negative
4880730|NCT02175433|Refractory or relapsed chronic lymphocytic leukemia (CLL) prolymphocytic leukemia (PLL)|refractory or relapsed chronic lymphocytic leukemia (cll) prolymphocytic leukemia (pll)
4880731|NCT02175433|Relapsed lymphoid malignancy|relapsed lymphoid malignancy
4880732|NCT02175433|Refractory lymphoid malignancy|refractory lymphoid malignancy
4880733|NCT02175433|Pharmacokinetics of AGS67E|pharmacokinetics of ags67e
4880734|NCT02175433|hairy cell leukemia (HCL)|hairy cell leukemia (hcl)
4880735|NCT02175433|AGS67C|ags67c
4880736|NCT02175433|non-Hodgkin lymphoma (NHL)|non-hodgkin lymphoma (nhl)
4880737|NCT02175433|AGS67E|ags67e
4880738|NCT02175420|BCG|bcg
4880739|NCT02175420|Salmonella|salmonella
4880740|NCT02175420|Trained immunity|trained immunity
4880741|NCT02175420|Non-specific effect vaccines|non-specific effect vaccines
4880742|NCT02175407|Healthy subjects|healthy subjects
4880743|NCT02175407|ASP1707|asp1707
4880744|NCT02175407|Itraconazole|itraconazole
4880745|NCT02175381|Metastatic NSCLC|metastatic nsclc
4880746|NCT02175381|Elderly|elderly
4880747|NCT02175381|1st Line|1st line
4880748|NCT02175381|Platinum-based treatment|platinum-based treatment
4880749|NCT02175368|total etch protocol|total etch protocol
4880750|NCT02175368|direct filling therapy|direct filling therapy
4880751|NCT02175329|CAD/CAM, three-unit posterior bridges, zirconia framework|cad/cam, three-unit posterior bridges, zirconia framework
4880752|NCT02175277|Myelodysplastic Syndrome (MDS)|myelodysplastic syndrome (mds)
4880753|NCT02175277|Darbepoetin alfa|darbepoetin alfa
4880754|NCT02175277|low risk MDS|low risk mds
4880755|NCT02175277|intermediate-1 risk MDS|intermediate-1 risk mds
4880756|NCT02175277|International Prognostic Scoring System (IPSS)|international prognostic scoring system (ipss)
4880757|NCT02175264|Isolated non syndromic CDH|isolated non syndromic cdh
4880758|NCT02175251|rTMS|rtms
4880759|NCT02175251|Schizophrenia|schizophrenia
4880760|NCT02175251|high frequency rTMS|high frequency rtms
4880761|NCT02175251|low frequency rTMS|low frequency rtms
4880762|NCT02175251|AHRS|ahrs
4880763|NCT02175251|SAPS SANS PANSS|saps sans panss
4880764|NCT02175251|GAF|gaf
4880765|NCT02175251|UKU|uku
4880766|NCT02175225|Brain hemorrhage|brain hemorrhage
4880767|NCT02175225|Cerebral hemorrhage|cerebral hemorrhage
4880768|NCT02175225|Bleeding in the brain|bleeding in the brain
4880769|NCT02175225|Deferoxamine|deferoxamine
4880770|NCT02175225|iDEF trial|idef trial
4880771|NCT02175212|Patients with prostate adenocarcinoma|patients with prostate adenocarcinoma
4880772|NCT02175199|Contact lens|contact lens
4880773|NCT02175199|Vision care|vision care
4880774|NCT02175199|Daily wear|daily wear
4880775|NCT02175199|Color contact lens|color contact lens
4880776|NCT02175186|Gastritis|gastritis
4880777|NCT02175186|Gastroduodenal Ulcer|gastroduodenal ulcer
4880778|NCT02175186|Percutaneous Coronary Revascularization|percutaneous coronary revascularization
4880779|NCT02175186|Dual Antiplatelet Therapy|dual antiplatelet therapy
4880780|NCT02175173|Epileptic encephalopathy, Lennox-Gastaut type|epileptic encephalopathy, lennox-gastaut type
4880781|NCT02175160|Driver reaction time|driver reaction time
4880782|NCT02175134|tuberculosis|tuberculosis
4880783|NCT02175134|peritonitis|peritonitis
4880784|NCT02175134|laparoscopy|laparoscopy
4880785|NCT02175108|Cerebral palsy|cerebral palsy
4880786|NCT02175108|Adolescents|adolescents
4880787|NCT02175108|Adults|adults
4880788|NCT02175108|Diet|diet
4880789|NCT02175108|Activity|activity
4880790|NCT02175108|Metabolic Syndrome|metabolic syndrome
4880791|NCT02175095|regorafenib|regorafenib
4880792|NCT02175095|fluorothymidine|fluorothymidine
4880793|NCT02175095|positron emission tomography|positron emission tomography
4880794|NCT02175095|metastatic colorectal cancer|metastatic colorectal cancer
4880795|NCT02175082|Parkinson Disease|parkinson disease
4880796|NCT02175082|Exercise|exercise
4880797|NCT02175082|Rehabilitation|rehabilitation
4880798|NCT02175082|Physical Therapy|physical therapy
4880799|NCT02175082|Cycling|cycling
4880800|NCT02175069|Shoulder surgery|shoulder surgery
4880801|NCT02175056|First In Human|first in human
4880802|NCT02175056|CAPS, SoJIA, AOSD, Bechet Disease, Rheumatoid arthritis|caps, sojia, aosd, bechet disease, rheumatoid arthritis
4880803|NCT02175043|atrial fibrillation, catheter ablation, recurrence|atrial fibrillation, catheter ablation, recurrence
4880804|NCT02175030|Emergency contraception|emergency contraception
4880805|NCT02175030|Levonorgestrel IUD|levonorgestrel iud
4880806|NCT02175030|Copper IUD|copper iud
4880807|NCT02175017|ONO-4538|ono-4538
4880808|NCT02175017|Advanced non-small cell lung cancer|advanced non-small cell lung cancer
4880809|NCT02175004|FAP|fap
4880810|NCT02175004|Familial Amyloid Polyneuropathy|familial amyloid polyneuropathy
4880811|NCT02175004|TTR|ttr
4880812|NCT02175004|Transthyretin|transthyretin
4880813|NCT02175004|Amyloidosis|amyloidosis
4880814|NCT02174978|Malaria vaccine|malaria vaccine
4880815|NCT02174952|Parenting interventions|parenting interventions
4880816|NCT02174952|ADHD|adhd
4880817|NCT02174952|Family functioning|family functioning
4880818|NCT02174952|Parent Training|parent training
4880819|NCT02174939|cilostazol|cilostazol
4880820|NCT02174939|progenitor cells|progenitor cells
4880821|NCT02174939|coronary artery disease|coronary artery disease
4880822|NCT02174939|myocardial infarction|myocardial infarction
4880823|NCT02174939|angiogenesis|angiogenesis
4880824|NCT02174939|biological markers|biological markers
4880825|NCT02174939|endothelial function|endothelial function
4880826|NCT02174913|Awakening time|awakening time
4880827|NCT02174913|Bispectral index|bispectral index
4880828|NCT02174913|clinical signs|clinical signs
4880829|NCT02174913|neurophysiologic monitoring|neurophysiologic monitoring
4880830|NCT02174913|spine surgery|spine surgery
4880831|NCT02174900|G6PD deficiency|g6pd deficiency
4880832|NCT02174900|safety|safety
4880833|NCT02174900|transmission|transmission
4880834|NCT02174887|pancreatic adenocarcinoma|pancreatic adenocarcinoma
4880835|NCT02174887|liver metastases|liver metastases
4880836|NCT02174861|Chronic Migraine|chronic migraine
4880837|NCT02174848|Pantothenate Kinase-Associated Neurodegeneration|pantothenate kinase-associated neurodegeneration
4880838|NCT02174848|PKAN|pkan
4880839|NCT02174848|Neurodegeneration with Brain Iron Accumulation|neurodegeneration with brain iron accumulation
4880840|NCT02174848|NBIA|nbia
4880841|NCT02174848|Deferiprone|deferiprone
4880842|NCT02174848|Ferriprox|ferriprox
4880843|NCT02174835|Pharmacokinetics|pharmacokinetics
4880844|NCT02174835|Healthy Volunteers|healthy volunteers
4880845|NCT02174835|deuterated dextromethorphan|deuterated dextromethorphan
4880846|NCT02174835|deuterated dextromethorphan with quinidine|deuterated dextromethorphan with quinidine
4880847|NCT02174822|Drug-drug interaction|drug-drug interaction
4880848|NCT02174822|Pharmacokinetics|pharmacokinetics
4880849|NCT02174822|Healthy Volunteers|healthy volunteers
4880850|NCT02174822|deuterated dextromethorphan|deuterated dextromethorphan
4880851|NCT02174822|deuterated dextromethorphan with quinidine|deuterated dextromethorphan with quinidine
4880852|NCT02174809|Pregnancy|pregnancy
4880853|NCT02174809|Gestational Weight Gain|gestational weight gain
4880854|NCT02174809|Primary Care|primary care
4880855|NCT02174809|Guidelines|guidelines
4880856|NCT02174796|Pectus excavatum|pectus excavatum
4880857|NCT02174796|cardiac output|cardiac output
4880858|NCT02174796|transthoracic impedancemetry|transthoracic impedancemetry
4880859|NCT02174783|Weight Loss|weight loss
4880860|NCT02174783|Diet, Mediterranean|diet, mediterranean
4880861|NCT02174783|Diet, Reducing|diet, reducing
4880862|NCT02174783|protein sparing modified diet|protein sparing modified diet
4880863|NCT02174744|Pain in elderly patients having communication disorders|pain in elderly patients having communication disorders
4880864|NCT02174744|Numerical scale|numerical scale
4880865|NCT02174744|Algoplus® scale|algoplus® scale
4880866|NCT02174744|Doloplus® scale|doloplus® scale
4880867|NCT02174731|Renal,|renal,
4880868|NCT02174731|CKD,|ckd,
4880869|NCT02174731|Epoetin alfa,|epoetin alfa,
4880870|NCT02174731|Roxadustat,|roxadustat,
4880871|NCT02174731|dialysis,|dialysis,
4880872|NCT02174731|anemia|anemia
4880873|NCT02174718|Cholecalciferol|cholecalciferol
4880874|NCT02174718|Transdermal patch|transdermal patch
4880875|NCT02174705|vaccination|vaccination
4880876|NCT02174705|pain management|pain management
4880877|NCT02174705|sucrose|sucrose
4880878|NCT02174705|rotavirus|rotavirus
4880879|NCT02174666|Aglycones|aglycones
4880880|NCT02174666|Isoflavones|isoflavones
4880881|NCT02174666|Red clover|red clover
4880882|NCT02174666|Osteopenia|osteopenia
4880883|NCT02174666|Menopause|menopause
4880884|NCT02174666|Bone turnover|bone turnover
4880885|NCT02174666|Bone mineral density|bone mineral density
4880886|NCT02174640|Coffee|coffee
4880887|NCT02174640|Polyphenolics|polyphenolics
4880888|NCT02174627|Renal,|renal,
4880889|NCT02174627|CKD,|ckd,
4880890|NCT02174627|Roxadustat,|roxadustat,
4880891|NCT02174627|anemia,|anemia,
4880892|NCT02174627|non-dialysis|non-dialysis
4880893|NCT02174614|Cocaine use disorder|cocaine use disorder
4880894|NCT02174601|bowel preparation|bowel preparation
4880895|NCT02174601|coolprep|coolprep
4880896|NCT02174601|colonoscopy|colonoscopy
4880897|NCT02174601|prediction model|prediction model
4880898|NCT02174588|sedation, propofol, midazolam|sedation, propofol, midazolam
4880899|NCT02174575|Hepatectomy|hepatectomy
4880900|NCT02174562|Type 2 diabetes|type 2 diabetes
4880901|NCT02174562|Mild Cognitive Impairment|mild cognitive impairment
4880902|NCT02174549|Hypoxia|hypoxia
4880903|NCT02174549|Embolization|embolization
4880904|NCT02174549|Tirapazamine|tirapazamine
4880905|NCT02174523|pharmacokinetic|pharmacokinetic
4880906|NCT02174523|lurasidone|lurasidone
4880907|NCT02174523|multiple dose|multiple dose
4880908|NCT02174510|pharmacokinetic|pharmacokinetic
4880909|NCT02174510|lurasidone|lurasidone
4880910|NCT02174510|single dose|single dose
4880911|NCT02174497|Pediatric Colonoscopy|pediatric colonoscopy
4880912|NCT02174497|Bowel Preparation|bowel preparation
4880913|NCT02174497|Safety|safety
4880914|NCT02174497|Tolerability|tolerability
4880915|NCT02174484|Pacemaker|pacemaker
4880916|NCT02174484|Remote monitoring|remote monitoring
4880917|NCT02174484|Remote follow-up|remote follow-up
4880918|NCT02174484|Home monitoring|home monitoring
4880919|NCT02174484|Periodic IEGM|periodic iegm
4880920|NCT02174484|Intracardiac electrogram|intracardiac electrogram
4880921|NCT02174471|Aortic Stenosis|aortic stenosis
4880922|NCT02174471|Aortic Valve Replacement|aortic valve replacement
4880923|NCT02174471|T1 Mapping|t1 mapping
4880924|NCT02174471|Extracellular Volume Fraction|extracellular volume fraction
4880925|NCT02174471|Cardiovascular Magnetic Resonance|cardiovascular magnetic resonance
4880926|NCT02174471|Diffuse Myocardial Fibrosis|diffuse myocardial fibrosis
4880927|NCT02174458|Bariatric surgery; Body contouring; Quality of life|bariatric surgery; body contouring; quality of life
4880928|NCT02174445|Patients with CML in chronic phase|patients with cml in chronic phase
4880929|NCT02174445|Imatinib|imatinib
4880930|NCT02174445|Nilotinib|nilotinib
4880931|NCT02174432|Itch|itch
4880932|NCT02174432|Chronic Itch|chronic itch
4880933|NCT02174432|Nalbupine|nalbupine
4880934|NCT02174419|Itch|itch
4880935|NCT02174419|Chronic Itch|chronic itch
4880936|NCT02174419|nalbuphine|nalbuphine
4880937|NCT02174406|Ultrasound|ultrasound
4880938|NCT02174406|Digital Breast Tomosynthesis|digital breast tomosynthesis
4880939|NCT02174406|14-119|14-119
4880940|NCT02174367|Chronic plaque psoriasis|chronic plaque psoriasis
4880941|NCT02174367|Liver fibrosis|liver fibrosis
4880942|NCT02174367|Fatty liver disease|fatty liver disease
4880943|NCT02174367|Non-alcoholic fatty liver disease|non-alcoholic fatty liver disease
4880944|NCT02174367|Transient elastography|transient elastography
4880945|NCT02174367|Fibroscan|fibroscan
4880946|NCT02174367|Procollagen-3 N-Terminal peptide|procollagen-3 n-terminal peptide
4880947|NCT02174367|Alanine aminotransferase|alanine aminotransferase
4880948|NCT02174367|Liver function tests|liver function tests
4880949|NCT02174354|Psoriasis|psoriasis
4880950|NCT02174354|Methotrexate|methotrexate
4880951|NCT02174354|Methotrexate Polyglutamates|methotrexate polyglutamates
4880952|NCT02174354|Injury of Liver|injury of liver
4880953|NCT02174341|Chikungunya fever|chikungunya fever
4880954|NCT02174341|Chikungunya Virus|chikungunya virus
4880955|NCT02174328|See incidence of Pre-Eclampsia in acetylsalicylic acid group|see incidence of pre-eclampsia in acetylsalicylic acid group
4880956|NCT02174328|See incidence of Pre-Eclampsia in placebo group|see incidence of pre-eclampsia in placebo group
4880957|NCT02174289|Heart Failure|heart failure
4880958|NCT02174289|Cardiac Resynchronisation Therapy|cardiac resynchronisation therapy
4880959|NCT02174289|Transseptal left ventricular endocardial lead|transseptal left ventricular endocardial lead
4880960|NCT02174250|PD|pd
4880961|NCT02174237|Phase 1, safety, tolerability, PK, PD|phase 1, safety, tolerability, pk, pd
4880962|NCT02174224|Violence|violence
4880963|NCT02174224|At-risk youth|at-risk youth
4880964|NCT02174224|Intentional Injury|intentional injury
4880965|NCT02174224|Violence Intervention|violence intervention
4880966|NCT02174224|Youth|youth
4880967|NCT02174224|recidivism|recidivism
4880968|NCT02174198|Immediate implant|immediate implant
4880969|NCT02174198|bone graft|bone graft
4880970|NCT02174198|immediate restoration|immediate restoration
4880971|NCT02174185|bladder cancer|bladder cancer
4880972|NCT02174185|conduit diversion|conduit diversion
4880973|NCT02174185|orthotopic neobladder|orthotopic neobladder
4880974|NCT02174185|health-related quality of life|health-related quality of life
4880975|NCT02174185|validated questionnaire|validated questionnaire
4880976|NCT02174146|leptin|leptin
4880977|NCT02174146|visfatin|visfatin
4880978|NCT02174146|chronic periodontitis|chronic periodontitis
4880979|NCT02174146|diabetes mellitus|diabetes mellitus
4880980|NCT02174146|non-surgical periodontal therapy|non-surgical periodontal therapy
4880981|NCT02174133|left ventricular assist device|left ventricular assist device
4880982|NCT02174133|endothelial function|endothelial function
4880983|NCT02174133|microvascular perfusion|microvascular perfusion
4880984|NCT02174133|microparticles|microparticles
4880985|NCT02174107|Health economics|health economics
4880986|NCT02174107|Percutaneous vertebroplasty|percutaneous vertebroplasty
4880987|NCT02174107|Radiation therapy|radiation therapy
4880988|NCT02174107|Painful spine metastases|painful spine metastases
4880989|NCT02174081|mechanical ventilation, ARDS, Ventilator strategy, outcome|mechanical ventilation, ards, ventilator strategy, outcome
4880990|NCT02174068|Paracetamol|paracetamol
4880991|NCT02174068|Nefopam|nefopam
4880992|NCT02174068|Pharmacokinetic|pharmacokinetic
4880993|NCT02174068|Drug interaction|drug interaction
4880994|NCT02174055|Depression|depression
4880995|NCT02174055|14-101|14-101
4880996|NCT02174029|Atrophy|atrophy
4880997|NCT02174029|Ventilator|ventilator
4880998|NCT02174029|Induced|induced
4880999|NCT02174029|Diaphragm|diaphragm
4881000|NCT02174029|Dysfunction|dysfunction
4881001|NCT02174016|Intensive Care Units|intensive care units
4881002|NCT02174016|Pediatric|pediatric
4881003|NCT02174003|whole body hyperthermia|whole body hyperthermia
4881004|NCT02174003|depression|depression
4881005|NCT02174003|fibromyalgia|fibromyalgia
4881006|NCT02174003|rheumatoid arthritis|rheumatoid arthritis
4881007|NCT02174003|perimenopausal symptoms|perimenopausal symptoms
4881008|NCT02174003|open treatment|open treatment
4881009|NCT02173990|adenocarcinoma|adenocarcinoma
4881010|NCT02173990|colon and/or rectum|colon and/or rectum
4881011|NCT02173977|GnRH Agonist|gnrh agonist
4881012|NCT02173977|GnRH Antagonist|gnrh antagonist
4881013|NCT02173977|OHSS|ohss
4881014|NCT02173964|fluorodeoxyglucose|fluorodeoxyglucose
4881103|NCT02173379|Angioplasty|angioplasty
4881015|NCT02173964|positron emission tomography|positron emission tomography
4881016|NCT02173964|computed tomography|computed tomography
4881017|NCT02173964|bowel|bowel
4881018|NCT02173964|pinaverium bromide|pinaverium bromide
4881019|NCT02173951|young minimally transfused beta thalassemia major|young minimally transfused beta thalassemia major
4881020|NCT02173951|labile plasma iron (LPI)|labile plasma iron (lpi)
4881021|NCT02173951|Transferrin saturation (TSAT)|transferrin saturation (tsat)
4881022|NCT02173951|Deferiprone|deferiprone
4881023|NCT02173951|Transfusional iron loading rate|transfusional iron loading rate
4881024|NCT02173951|Transfusion units|transfusion units
4881025|NCT02173938|Smokers|smokers
4881026|NCT02173938|outpatient|outpatient
4881027|NCT02173938|Tobacco Dependence Treatment Program|tobacco dependence treatment program
4881028|NCT02173873|Age related macular degeneration|age related macular degeneration
4881029|NCT02173873|central retinal vein occlusion|central retinal vein occlusion
4881030|NCT02173860|Coronary artery disease|coronary artery disease
4881031|NCT02173860|Valvular heart disease|valvular heart disease
4881032|NCT02173860|Fractional flow reserve|fractional flow reserve
4881033|NCT02173860|Coronary artery bypass surgery|coronary artery bypass surgery
4881034|NCT02173860|Coronary graft failure or patency|coronary graft failure or patency
4881035|NCT02173847|anvil-shaped corneal graft|anvil-shaped corneal graft
4881036|NCT02173847|penetrating keratoplasty|penetrating keratoplasty
4881037|NCT02173847|femtosecond laser|femtosecond laser
4881038|NCT02173847|laser welding|laser welding
4881039|NCT02173834|Brown Adipose Tissue|brown adipose tissue
4881040|NCT02173834|Weight|weight
4881041|NCT02173834|Sympathetic Nervous System|sympathetic nervous system
4881042|NCT02173756|chemotherapy|chemotherapy
4881043|NCT02173756|mucositis|mucositis
4881044|NCT02173756|systemic opioids|systemic opioids
4881045|NCT02173756|morphine|morphine
4881046|NCT02173743|plasma, calcific tendinitis, rotator cuff, PRP|plasma, calcific tendinitis, rotator cuff, prp
4881047|NCT02173704|Meningitis|meningitis
4881048|NCT02173704|Infants|infants
4881049|NCT02173704|Meningococcal B Recombinant Vaccine|meningococcal b recombinant vaccine
4881050|NCT02173626|Mindfulness|mindfulness
4881051|NCT02173613|infection lung elderly patients|infection lung elderly patients
4881052|NCT02173600|Cardiovascular risk|cardiovascular risk
4881053|NCT02173600|Primary prevention|primary prevention
4881054|NCT02173600|Intensive dietary counselling|intensive dietary counselling
4881055|NCT02173600|Physical exercise|physical exercise
4881056|NCT02173587|Anti-inflammation, Rheumatoid arthritis, Thick shell mussel lipid extract, Chinese|anti-inflammation, rheumatoid arthritis, thick shell mussel lipid extract, chinese
4881057|NCT02173574|Hepatitis C Virus, Viral, Antiviral, Infection, Infectious disease, alisporivir, EDP239, DEB025|hepatitis c virus, viral, antiviral, infection, infectious disease, alisporivir, edp239, deb025
4881058|NCT02173561|Posttraumatic Stress Disorder|posttraumatic stress disorder
4881059|NCT02173561|Cognitive Processing Therapy|cognitive processing therapy
4881060|NCT02173561|combat|combat
4881061|NCT02173561|military|military
4881062|NCT02173561|CPT|cpt
4881063|NCT02173561|group therapy|group therapy
4881064|NCT02173548|heart failure|heart failure
4881065|NCT02173548|HFpEF|hfpef
4881066|NCT02173548|diastole|diastole
4881067|NCT02173548|diastolic heart failure|diastolic heart failure
4881068|NCT02173548|inflammation|inflammation
4881069|NCT02173548|interleukin-1|interleukin-1
4881070|NCT02173548|C-reactive protein|c-reactive protein
4881071|NCT02173522|Prostate cancer|prostate cancer
4881072|NCT02173522|Prostate artery embolization|prostate artery embolization
4881073|NCT02173522|Robot-assisted laparoscopic radical prostatectomy|robot-assisted laparoscopic radical prostatectomy
4881074|NCT02173496|Wet age-related macular degeneration|wet age-related macular degeneration
4881075|NCT02173496|Assessment modalities for preclinical, pre-symptomatic ARMD|assessment modalities for preclinical, pre-symptomatic armd
4881076|NCT02173457|Chiglitazar|chiglitazar
4881077|NCT02173457|Sitagliptin|sitagliptin
4881078|NCT02173457|diabetes|diabetes
4881079|NCT02173457|type 2 diabetes|type 2 diabetes
4881080|NCT02173444|in-vitro fertilization|in-vitro fertilization
4881081|NCT02173444|ovarian stimulation|ovarian stimulation
4881082|NCT02173431|BMI|bmi
4881083|NCT02173431|Pressure|pressure
4881084|NCT02173431|Bedsore|bedsore
4881085|NCT02173418|Postoperative pain|postoperative pain
4881086|NCT02173418|Acute postoperative pain|acute postoperative pain
4881087|NCT02173418|Chronic postoperative pain|chronic postoperative pain
4881088|NCT02173418|Shoulder pain|shoulder pain
4881089|NCT02173418|Thoracotomy|thoracotomy
4881090|NCT02173418|Thoracoscopy|thoracoscopy
4881091|NCT02173405|Myofascial Pain Syndromes|myofascial pain syndromes
4881092|NCT02173405|Pelvic pain|pelvic pain
4881093|NCT02173405|Trigger points + injections|trigger points + injections
4881094|NCT02173405|Myofascial Trigger Point Pain|myofascial trigger point pain
4881095|NCT02173405|Trigger Point Pain, Myofascial|trigger point pain, myofascial
4881096|NCT02173405|Botulinum Toxins, Type A|botulinum toxins, type a
4881097|NCT02173405|Botulinum Neurotoxin A|botulinum neurotoxin a
4881098|NCT02173405|Botulinum Toxin Type A|botulinum toxin type a
4881099|NCT02173405|Clostridium botulinum A Toxin|clostridium botulinum a toxin
4881100|NCT02173405|Clostridium Botulinum Toxin Type A|clostridium botulinum toxin type a
4881101|NCT02173405|Oculinum|oculinum
4881102|NCT02173379|Absorb™ BVS|absorb™ bvs
4881104|NCT02173379|Bioabsorbable|bioabsorbable
4881105|NCT02173379|BVS|bvs
4881106|NCT02173379|Coronary Artery Disease|coronary artery disease
4881107|NCT02173379|Coronary Artery Endothelial Responsiveness|coronary artery endothelial responsiveness
4881108|NCT02173379|Coronary artery restenosis|coronary artery restenosis
4881109|NCT02173379|Coronary artery stenosis|coronary artery stenosis
4881110|NCT02173379|Coronary scaffold|coronary scaffold
4881111|NCT02173379|Coronary Stent|coronary stent
4881112|NCT02173379|Drug eluting stents|drug eluting stents
4881113|NCT02173379|Everolimus|everolimus
4881114|NCT02173379|Myocardial ischemia|myocardial ischemia
4881115|NCT02173379|Stent thrombosis|stent thrombosis
4881116|NCT02173379|Stents|stents
4881117|NCT02173353|Ultrasound use during radiation therapy for Pancreas cancer|ultrasound use during radiation therapy for pancreas cancer
4881118|NCT02173314|Long term foster care|long term foster care
4881119|NCT02173314|child abuse and neglect|child abuse and neglect
4881120|NCT02173262|Breast|breast
4881121|NCT02173236|Dental Implant Platform Switching|dental implant platform switching
4881122|NCT02173236|Early Dental Implant Loading|early dental implant loading
4881123|NCT02173210|Premature birth|premature birth
4881124|NCT02173210|Premature delivery|premature delivery
4881125|NCT02173210|Metabolomics|metabolomics
4881126|NCT02173210|Microbiota|microbiota
4881127|NCT02173210|Genetics|genetics
4881128|NCT02173210|17 hydroxyprogesterone caproate|17 hydroxyprogesterone caproate
4881129|NCT02173197|Occupational Therapy|occupational therapy
4881130|NCT02173197|Complex patients|complex patients
4881131|NCT02173197|Occupational performance problem|occupational performance problem
4881132|NCT02173197|Rehabilitation Complexity Scale|rehabilitation complexity scale
4881133|NCT02173184|bacterial vaginosis|bacterial vaginosis
4881134|NCT02173184|Gynevac Lactobacillus vaccine|gynevac lactobacillus vaccine
4881135|NCT02173171|Melanoma|melanoma
4881136|NCT02173171|talimogene laherparepvec|talimogene laherparepvec
4881137|NCT02173145|idiopathic pulmonary fibrosis|idiopathic pulmonary fibrosis
4881138|NCT02173145|cough|cough
4881139|NCT02173145|immunomodulation|immunomodulation
4881140|NCT02173145|macrolide|macrolide
4881141|NCT02173119|Hepatocellular|hepatocellular
4881142|NCT02173119|Carcinoma|carcinoma
4881143|NCT02173119|HCC|hcc
4881144|NCT02173119|lipiodol|lipiodol
4881145|NCT02173093|Neuroblastoma|neuroblastoma
4881146|NCT02173093|Osteosarcoma|osteosarcoma
4881147|NCT02173093|Solid tumor|solid tumor
4881148|NCT02173093|Immunotherapy targeting GD2|immunotherapy targeting gd2
4881149|NCT02173093|Bispecific antibodies|bispecific antibodies
4881150|NCT02173093|Activated T cells|activated t cells
4881151|NCT02173080|autosomal dominant polycystic liver disease|autosomal dominant polycystic liver disease
4881152|NCT02173080|autosomal dominant polycystic kidney disease|autosomal dominant polycystic kidney disease
4881153|NCT02173080|quality of life|quality of life
4881154|NCT02173080|patient reported outcome tool|patient reported outcome tool
4881155|NCT02173067|Diabetes mellitus|diabetes mellitus
4881156|NCT02173067|Epinephrine|epinephrine
4881157|NCT02173067|Anesthesia, Dental|anesthesia, dental
4881158|NCT02173067|lidocaine|lidocaine
4881159|NCT02173067|Ambulatory Surgical Procedures|ambulatory surgical procedures
4881160|NCT02173054|Acne|acne
4881161|NCT02173054|Moisturizer|moisturizer
4881162|NCT02173054|Efficacy|efficacy
4881163|NCT02173054|Irritation|irritation
4881164|NCT02173041|Prevention and Awareness Groups (PAG),|prevention and awareness groups (pag),
4881165|NCT02173041|Substance Use Disorder,|substance use disorder,
4881166|NCT02173041|Community based intervention|community based intervention
4881167|NCT02173028|Beta Blocker Intolerance;|beta blocker intolerance;
4881168|NCT02173028|Remote Patient Management system;|remote patient management system;
4881169|NCT02173028|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
4881170|NCT02173015|accidental falls|accidental falls
4881171|NCT02173015|older adults|older adults
4881172|NCT02173015|long-term care|long-term care
4881173|NCT02173015|nursing home|nursing home
4881174|NCT02173015|postural balance|postural balance
4881175|NCT02173002|Telemedicine|telemedicine
4881176|NCT02173002|Patient empowerment|patient empowerment
4881177|NCT02173002|Integrated care|integrated care
4881178|NCT02172989|Near-infrared fluorescence|near-infrared fluorescence
4881179|NCT02172989|Indocyanine green, ICG|indocyanine green, icg
4881180|NCT02172989|Radio-guided surgery|radio-guided surgery
4881181|NCT02172989|breast cancer|breast cancer
4881182|NCT02172976|pancreas cancer|pancreas cancer
4881183|NCT02172976|neoadjuvant chemotherapy|neoadjuvant chemotherapy
4881184|NCT02172976|Folfirinox|folfirinox
4881185|NCT02172976|gemcitabine|gemcitabine
4881186|NCT02172963|Stem Cell Transplantation|stem cell transplantation
4881187|NCT02172963|Decidual Stromal Cells|decidual stromal cells
4881188|NCT02172937|Stem Cell Transplantation|stem cell transplantation
4881189|NCT02172937|Decidual Stromal Cells|decidual stromal cells
4881190|NCT02172924|Stem Cell Transplantation|stem cell transplantation
4881191|NCT02172924|Decidual Stromal Cells|decidual stromal cells
4881192|NCT02172911|Cervical cancer|cervical cancer
4881193|NCT02172911|Papillomavirus|papillomavirus
4881194|NCT02172911|Chemoradiation|chemoradiation
4881195|NCT02172911|Recurrent cervical cancer|recurrent cervical cancer
4881196|NCT02172911|Persistent cervical cancer|persistent cervical cancer
4881197|NCT02172885|Mesenchymal stem cell based therapy|mesenchymal stem cell based therapy
4881198|NCT02172885|cell infusion|cell infusion
4881199|NCT02172872|Newly diagnosed|newly diagnosed
4881200|NCT02172872|AML|aml
4881201|NCT02172872|Elderly|elderly
4881202|NCT02172872|Decitabine|decitabine
4881203|NCT02172872|Transplant|transplant
4881204|NCT02172859|lumiVida™, cognition, mood, sleep, tryptophane|lumivida™, cognition, mood, sleep, tryptophane
4881205|NCT02172820|cardiac rehabilitation|cardiac rehabilitation
4881206|NCT02172820|contingency management|contingency management
4881207|NCT02172768|pharmacokinetics|pharmacokinetics
4881208|NCT02172768|alternate dosing|alternate dosing
4881209|NCT02172768|micafungin|micafungin
4881210|NCT02172755|Eslicarbazepine acetate|eslicarbazepine acetate
4881211|NCT02172755|BIA 2-093|bia 2-093
4881212|NCT02172742|Eslicarbazepine acetate|eslicarbazepine acetate
4881213|NCT02172742|BIA 2-093|bia 2-093
4881214|NCT02172729|adductor canal block|adductor canal block
4881215|NCT02172729|healthy volunteers|healthy volunteers
4881216|NCT02172729|US-guided peripheral nerve block|us-guided peripheral nerve block
4881217|NCT02172729|lower limb|lower limb
4881218|NCT02172729|duration|duration
4881219|NCT02172729|Muscle Strength|muscle strength
4881220|NCT02172729|Anesthetics, Local|anesthetics, local
4881221|NCT02172729|Sensation|sensation
4881222|NCT02172703|TBI|tbi
4881223|NCT02172703|SAH|sah
4881224|NCT02172703|ICP|icp
4881225|NCT02172703|non invasive measurement|non invasive measurement
4881226|NCT02172690|Gastric Cancer|gastric cancer
4881227|NCT02172690|Laparoscopic Staging|laparoscopic staging
4881228|NCT02172690|Cytology|cytology
4881229|NCT02172690|Peritoneal Metastases|peritoneal metastases
4881230|NCT02172664|noncarious cervical lesions|noncarious cervical lesions
4881231|NCT02172664|dental adhesive|dental adhesive
4881232|NCT02172664|retention|retention
4881233|NCT02172664|enamel margin discoloration|enamel margin discoloration
4881234|NCT02172664|self etch|self etch
4881235|NCT02172664|selective etch procedures|selective etch procedures
4881236|NCT02172651|Vitamin D|vitamin d
4881237|NCT02172651|Stage I-III colon cancer|stage i-iii colon cancer
4881238|NCT02172651|Stage IV colon cancer|stage iv colon cancer
4881239|NCT02172651|Resectable liver metastases|resectable liver metastases
4881240|NCT02172638|Enhanced Recovery After Surgery|enhanced recovery after surgery
4881241|NCT02172638|ERAS|eras
4881242|NCT02172638|Fast-Track|fast-track
4881243|NCT02172638|Ovarian cancer|ovarian cancer
4881244|NCT02172638|Gynecologic surgery|gynecologic surgery
4881245|NCT02172638|Gynecology oncology|gynecology oncology
4881246|NCT02172638|Median length of stay|median length of stay
4881247|NCT02172638|Readmission rate|readmission rate
4881248|NCT02172638|Surgery related complications|surgery related complications
4881249|NCT02172638|Cost|cost
4881250|NCT02172625|Athletic performance|athletic performance
4881251|NCT02172625|Running|running
4881252|NCT02172625|Dietary supplementation|dietary supplementation
4881253|NCT02172625|Quality of life|quality of life
4881254|NCT02172625|Running performance|running performance
4881255|NCT02172625|oxidative damage|oxidative damage
4881256|NCT02172612|Anticholinergic drugs|anticholinergic drugs
4881257|NCT02172599|sit-stand workstation|sit-stand workstation
4881258|NCT02172599|workplace|workplace
4881259|NCT02172599|multi-component intervention|multi-component intervention
4881260|NCT02172599|randomised control trial design|randomised control trial design
4881261|NCT02172599|physical activity|physical activity
4881262|NCT02172599|sitting|sitting
4881263|NCT02172599|sedentary behaviour|sedentary behaviour
4881264|NCT02172599|process evaluation|process evaluation
4881265|NCT02172599|health|health
4881266|NCT02172365|Chronic myeloid leukemia|chronic myeloid leukemia
4881267|NCT02172365|Allogeneic hematopoietic cell transplantation|allogeneic hematopoietic cell transplantation
4881268|NCT02172365|Tyrosine kinase inhibitor|tyrosine kinase inhibitor
4881269|NCT02172365|TKI failure|tki failure
4881270|NCT02172183|cognitive-behavioral therapy, adolescents, ADHD.|cognitive-behavioral therapy, adolescents, adhd.
4881271|NCT02172092|Diabetes|diabetes
4881272|NCT02172092|Ketoacidosis|ketoacidosis
4881273|NCT02172092|fluid shift|fluid shift
4881274|NCT02172079|shoulder impingement, manual therapy, pain, motion.|shoulder impingement, manual therapy, pain, motion.
4881275|NCT02172066|Posttraumatic Stress Disorder|posttraumatic stress disorder
4881276|NCT02172066|Childhood maltreatment|childhood maltreatment
4881277|NCT02172053|Workplace|workplace
4881278|NCT02172053|Industrial workers|industrial workers
4881279|NCT02172053|Resistance exercise|resistance exercise
4881280|NCT02172053|Fatigue|fatigue
4881281|NCT02172053|Occupational risk|occupational risk
4881282|NCT02172053|Physical therapy|physical therapy
4881283|NCT02172040|High blood pressure|high blood pressure
4881284|NCT02172040|Systolic blood pressure|systolic blood pressure
4881285|NCT02172040|Diastolic blood pressure|diastolic blood pressure
4881286|NCT02172040|Antihypertensive|antihypertensive
4881287|NCT02172014|Mechanical Ventilation|mechanical ventilation
4881288|NCT02172014|Sedation|sedation
4881289|NCT02172014|Fentanyl|fentanyl
4881290|NCT02172014|Midazolam|midazolam
4881291|NCT02172014|Comfort behavior scale|comfort behavior scale
4881292|NCT02172001|IDA|ida
4881293|NCT02172001|Iron deficiency|iron deficiency
4881294|NCT02172001|iron deficiency anemia and who are intolerant or unresponsive to oral iron therapy|iron deficiency anemia and who are intolerant or unresponsive to oral iron therapy
4881295|NCT02171988|Postural Orthostatic Tachycardia Syndrome|postural orthostatic tachycardia syndrome
4881296|NCT02171988|propranolol|propranolol
4881297|NCT02171988|bisoprolol|bisoprolol
4881298|NCT02171988|pyridostigmine|pyridostigmine
4881299|NCT02171975|Spinal anaesthesia|spinal anaesthesia
4881300|NCT02171975|Ultrasound pre-procedure guided|ultrasound pre-procedure guided
4881301|NCT02171975|Paramedian spinal|paramedian spinal
4881302|NCT02171962|Zilver® PTX® Drug-Eluting Peripheral Stent|zilver® ptx® drug-eluting peripheral stent
4881303|NCT02171962|Above-the-Knee Femoropopliteal Artery|above-the-knee femoropopliteal artery
4881304|NCT02171962|Chinese patient|chinese patient
4881305|NCT02171949|Chronic hepatitis|chronic hepatitis
4881306|NCT02171949|Hepatic cirrhosis|hepatic cirrhosis
4881307|NCT02171936|Pain|pain
4881308|NCT02171936|Precariousness|precariousness
4881309|NCT02171936|EPICES Score|epices score
4881310|NCT02171936|CETD|cetd
4881311|NCT02171923|depression|depression
4881312|NCT02171910|Cholangiopancreatography, Endoscopic Retrograde|cholangiopancreatography, endoscopic retrograde
4881313|NCT02171910|Sedation|sedation
4881314|NCT02171871|EFFECTS,|effects,
4881315|NCT02171871|PASSIVE SMOKING ,|passive smoking ,
4881316|NCT02171871|RESPIRATORY SYSTEM MECHANICS,|respiratory system mechanics,
4881317|NCT02171871|DIFFERENT BODY POSITIONS.|different body positions.
4881318|NCT02171858|Stroke|stroke
4881319|NCT02171858|National Institutes of Health Stroke Scale|national institutes of health stroke scale
4881320|NCT02171858|Serum high sensitivity C-Reactive Protein|serum high sensitivity c-reactive protein
4881321|NCT02171845|Male foetuses of 10 to 37 weeks|male foetuses of 10 to 37 weeks
4881322|NCT02171819|Influenza|influenza
4881323|NCT02171819|Avian|avian
4881324|NCT02171819|H5N1|h5n1
4881325|NCT02171819|Vaccine|vaccine
4881326|NCT02171390|Hypogonadism|hypogonadism
4881327|NCT02171390|Endothelial dysfunction|endothelial dysfunction
4881328|NCT02171390|Insulin resistance|insulin resistance
4881329|NCT02171390|Inflammation|inflammation
4881330|NCT02171390|Testosterone replacement therapy|testosterone replacement therapy
4881331|NCT02171377|COPD|copd
4881332|NCT02171377|electrical stimulation|electrical stimulation
4881333|NCT02171377|Rehabilitation|rehabilitation
4881334|NCT02171377|exercise test|exercise test
4881335|NCT02171364|Atrial fibrillation, Virtual ablation, electrocardiography, electroanatomical mapping data|atrial fibrillation, virtual ablation, electrocardiography, electroanatomical mapping data
4881336|NCT02171351|sympathetic nerve reactivity|sympathetic nerve reactivity
4881337|NCT02171351|neuromuscular electrostimulation|neuromuscular electrostimulation
4881338|NCT02171338|Procalcitonin|procalcitonin
4881339|NCT02171338|Antibiotic therapy|antibiotic therapy
4881340|NCT02171338|Lower respiratory tract diseases|lower respiratory tract diseases
4881341|NCT02171325|irinotecan|irinotecan
4881342|NCT02171325|Small Cell Lung Cancer|small cell lung cancer
4881343|NCT02171312|Dizziness|dizziness
4881344|NCT02171312|Imbalance|imbalance
4881345|NCT02171286|KRAS|kras
4881346|NCT02171286|EGFR|egfr
4881347|NCT02171286|BRAF|braf
4881348|NCT02171286|NRAS and HRAS|nras and hras
4881349|NCT02171286|PIK3CA|pik3ca
4881350|NCT02171286|RAS-RAF-MEK-MAPK|ras-raf-mek-mapk
4881351|NCT02171286|HER2|her2
4881352|NCT02171286|IDH1 and IDH2|idh1 and idh2
4881353|NCT02171286|ALK|alk
4881354|NCT02171286|TP53|tp53
4881355|NCT02171286|c-KIT|c-kit
4881356|NCT02171286|STAT1&3|stat1&3
4881357|NCT02171286|PDGFRA|pdgfra
4881358|NCT02171286|Metastatic colorectal cancer|metastatic colorectal cancer
4881359|NCT02171286|Advanced non-small cell lung cancer|advanced non-small cell lung cancer
4881360|NCT02171286|Advanced melanoma|advanced melanoma
4881361|NCT02171286|Gastrointestingal Struma Tumor|gastrointestingal struma tumor
4881362|NCT02171286|Candidate genes implicated as potential prognostic and predictive biomarkers in patients with solid tumours|candidate genes implicated as potential prognostic and predictive biomarkers in patients with solid tumours
4881363|NCT02171286|Circulating Tumor DNA|circulating tumor dna
4881364|NCT02171273|Sleep|sleep
4881365|NCT02171273|Aging|aging
4881366|NCT02171273|Metabolism|metabolism
4881367|NCT02171273|Circadian|circadian
4881368|NCT02171273|Genetic|genetic
4881369|NCT02171273|Alertness|alertness
4881370|NCT02171260|Tumors|tumors
4881371|NCT02171260|Lymphomas|lymphomas
4881372|NCT02171260|Solid Tumors|solid tumors
4881373|NCT02171260|Pediatric|pediatric
4881374|NCT02171247|coronary computed tomographic angiography|coronary computed tomographic angiography
4881375|NCT02171247|contrast|contrast
4881376|NCT02171234|Epilepsy|epilepsy
4881377|NCT02171234|BIA 2-093|bia 2-093
4881378|NCT02171234|Eslicarbazepine acetate|eslicarbazepine acetate
4881379|NCT02171221|Refractory or relapsed tumors|refractory or relapsed tumors
4881380|NCT02171221|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic
4881381|NCT02171221|Fluorouracil|fluorouracil
4881382|NCT02171195|Eslicarbazepine acetate|eslicarbazepine acetate
4881383|NCT02171195|BIA 2-093|bia 2-093
4881384|NCT02171195|Epilepsy|epilepsy
4881385|NCT02171182|Qutenza|qutenza
4881386|NCT02171182|8% capsaicin patch|8% capsaicin patch
4881387|NCT02171182|Non-interventional|non-interventional
4881388|NCT02171182|Post-operative peripheral neuropathic pain|post-operative peripheral neuropathic pain
4881389|NCT02171182|Observational|observational
4881390|NCT02171182|Czech Republic|czech republic
4881391|NCT02171143|ASP2409|asp2409
4881392|NCT02171143|Rheumatoid Arthritis|rheumatoid arthritis
4881393|NCT02171143|methotrexate|methotrexate
4881394|NCT02171130|Diabetes Mellitus|diabetes mellitus
4881395|NCT02171130|Hypoglycemia|hypoglycemia
4881396|NCT02171130|Glucagon|glucagon
4881397|NCT02171130|Anti-glucagon Antibody|anti-glucagon antibody
4881398|NCT02171130|Immunogenicity|immunogenicity
4881399|NCT02171117|Acute Myeloid Leukemia|acute myeloid leukemia
4881400|NCT02171117|microtransplantation|microtransplantation
4881401|NCT02171117|elderly patients|elderly patients
4881402|NCT02171117|HLA-mismatched|hla-mismatched
4881403|NCT02171117|donor|donor
4881404|NCT02171117|Peripheral|peripheral
4881405|NCT02171117|stem cell|stem cell
4881406|NCT02171117|infusion|infusion
4881407|NCT02171104|allogeneic hematopoietic cell transplantation|allogeneic hematopoietic cell transplantation
4881408|NCT02171104|bone marrow transplantation|bone marrow transplantation
4881410|NCT02171104|AMACRD|amacrd
4881411|NCT02171104|MNGIE|mngie
4881412|NCT02171104|HDLS|hdls
4881413|NCT02171104|OP|op
4881414|NCT02171104|ALD|ald
4881415|NCT02171091|endotracheal|endotracheal
4881416|NCT02171091|intubation|intubation
4881417|NCT02171091|airway|airway
4881418|NCT02171091|inflammation|inflammation
4881419|NCT02171078|Breast Cancer|breast cancer
4881420|NCT02171078|Breast Neoplasms|breast neoplasms
4881421|NCT02171078|Health Services Research|health services research
4881422|NCT02171078|Surveillance|surveillance
4881423|NCT02171078|Diagnostic Imaging|diagnostic imaging
4881424|NCT02171078|Magnetic Resonance Imaging|magnetic resonance imaging
4881425|NCT02171078|Mammography|mammography
4881426|NCT02171078|Toxicity|toxicity
4881427|NCT02171078|Adverse Effects|adverse effects
4881428|NCT02171078|Side Effects|side effects
4881429|NCT02171078|Recurrence|recurrence
4881430|NCT02171065|NIRS/IVUS|nirs/ivus
4881431|NCT02171065|multimodality imaging|multimodality imaging
4881432|NCT02171065|PROSPECT|prospect
4881433|NCT02170961|Acute heart failure|acute heart failure
4881434|NCT02170961|RAAS|raas
4881435|NCT02170961|MMP3|mmp3
4881436|NCT02170961|MMP12|mmp12
4881437|NCT02170961|Polymorphysm|polymorphysm
4881438|NCT02170948|ultrasound-guided regional anesthesia|ultrasound-guided regional anesthesia
4881439|NCT02170948|nerve block|nerve block
4881440|NCT02170948|ankle block|ankle block
4881441|NCT02170948|dexmedetomidine|dexmedetomidine
4881442|NCT02170948|Precedex|precedex
4881443|NCT02170948|ankle surgery|ankle surgery
4881444|NCT02170948|forefoot surgery|forefoot surgery
4881445|NCT02170948|duration|duration
4881446|NCT02170948|anesthetic duration following ankle block for forefoot surgery|anesthetic duration following ankle block for forefoot surgery
4881447|NCT02170883|asthma|asthma
4881448|NCT02170883|mHealth|mhealth
4881449|NCT02170883|cluster randomized controlled trial|cluster randomized controlled trial
4881450|NCT02170883|pharmacy practice|pharmacy practice
4881451|NCT02170883|pharmacist|pharmacist
4881452|NCT02170857|Hyaluronic acid|hyaluronic acid
4881453|NCT02170857|infra-bony defects|infra-bony defects
4881454|NCT02170857|chronic periodontitis|chronic periodontitis
4881455|NCT02170857|experimental|experimental
4881456|NCT02170857|radiographic|radiographic
4881457|NCT02170857|clinical|clinical
4881458|NCT02170857|periodontal surgical treatment|periodontal surgical treatment
4881459|NCT02170857|open flap curettage|open flap curettage
4881460|NCT02170818|Education|education
4881461|NCT02170818|Curriculum|curriculum
4881462|NCT02170818|Anesthesiology|anesthesiology
4881463|NCT02170818|Operating Rooms|operating rooms
4881464|NCT02170779|multiple sclerosis|multiple sclerosis
4881465|NCT02170779|spasticity|spasticity
4881466|NCT02170779|stretching|stretching
4881467|NCT02170779|exercise|exercise
4881468|NCT02170779|rehabilitation|rehabilitation
4881469|NCT02170714|Acute severe colitis|acute severe colitis
4881470|NCT02170714|Children|children
4881471|NCT02170714|Infliximab|infliximab
4881472|NCT02170714|colectomy|colectomy
4881473|NCT02170688|IV contrast|iv contrast
4881474|NCT02170688|contrast dosing|contrast dosing
4881475|NCT02170662|male pattern hair loss|male pattern hair loss
4881476|NCT02170662|androgenetic alopecia|androgenetic alopecia
4881477|NCT02170662|bimatoprost|bimatoprost
4881478|NCT02170649|BIA 2-093|bia 2-093
4881479|NCT02170649|Eslicarbazepine acetate|eslicarbazepine acetate
4881480|NCT02170558|Trabecular Metal|trabecular metal
4881481|NCT02170558|Metal reduction CT|metal reduction ct
4881482|NCT02170558|TM- Ardis|tm- ardis
4881483|NCT02170545|avascular necrosis|avascular necrosis
4881484|NCT02170545|humeral head fracture|humeral head fracture
4881485|NCT02170545|proximal arm fracture|proximal arm fracture
4881486|NCT02170545|arthroplasty|arthroplasty
4881487|NCT02170532|asthma|asthma
4881488|NCT02170519|pulmonary hypertension|pulmonary hypertension
4881489|NCT02170493|Insole Sensor|insole sensor
4881490|NCT02170493|Optimial Limb Loading|optimial limb loading
4881491|NCT02170493|42IIIB|42iiib
4881492|NCT02170493|IIIC|iiic
4881493|NCT02170493|Lower Extremity Fractures|lower extremity fractures
4881494|NCT02170467|Intestinal permeability - Anorexia nervosa- Re feeding - auto-antibodies α-MSH|intestinal permeability - anorexia nervosa- re feeding - auto-antibodies α-msh
4881495|NCT02170454|neuromodulation|neuromodulation
4881496|NCT02170454|swallowing|swallowing
4881497|NCT02170454|magnetic stimulation|magnetic stimulation
4881498|NCT02170454|healthy subjects|healthy subjects
4881499|NCT02170441|Tuberculosis|tuberculosis
4881500|NCT02170441|Multi-drug resistant tuberculosis|multi-drug resistant tuberculosis
4881501|NCT02170441|Extensively drug-resistant tuberculosis|extensively drug-resistant tuberculosis
4881502|NCT02170441|Drug-resistant tuberculosis|drug-resistant tuberculosis
4881503|NCT02170441|Mycobacterial Growth Indicator Tube Drug Susceptibility Test|mycobacterial growth indicator tube drug susceptibility test
4881504|NCT02170441|Line Probe Assay|line probe assay
4881505|NCT02170441|Microscopic Observation Drug Susceptibility Assay|microscopic observation drug susceptibility assay
4881506|NCT02170441|Pyrosequencing|pyrosequencing
4881507|NCT02170428|growth,|growth,
4881508|NCT02170428|infancy,|infancy,
4881509|NCT02170428|children,|children,
4881510|NCT02170428|diet,|diet,
4881511|NCT02170428|breastfeeding|breastfeeding
4881512|NCT02170428|complementary feeding|complementary feeding
4881513|NCT02170428|early life programming|early life programming
4881514|NCT02170428|tracking|tracking
4881515|NCT02170428|physical activity|physical activity
4881516|NCT02170415|Persistent post-surgical pain|persistent post-surgical pain
4881517|NCT02170415|Breast surgery|breast surgery
4881518|NCT02170415|Complex intervention|complex intervention
4881519|NCT02170415|Pain treatment|pain treatment
4881520|NCT02170376|Parkinson's disease (PD)|parkinson's disease (pd)
4881521|NCT02170376|BIA 9-1067|bia 9-1067
4881522|NCT02170376|Opicapone|opicapone
4881523|NCT02170363|Heart Failure|heart failure
4881524|NCT02170363|Ventricular Dysfunction|ventricular dysfunction
4881525|NCT02170363|Cardiomyopathies|cardiomyopathies
4881526|NCT02170363|Heart Disease|heart disease
4881527|NCT02170363|Cardiovascular Disease|cardiovascular disease
4881528|NCT02170363|Heart-assist devices|heart-assist devices
4881529|NCT02170363|Thoratec Corporation|thoratec corporation
4881530|NCT02170311|Z-213, Ferric carboxymaltose, Iron, Iron-deficiency-anemia|z-213, ferric carboxymaltose, iron, iron-deficiency-anemia
4881531|NCT02170298|ADHD|adhd
4881532|NCT02170298|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
4881533|NCT02170298|Vyvanse|vyvanse
4881534|NCT02170298|Lisdexamfetamine|lisdexamfetamine
4881535|NCT02170285|perinatal stroke|perinatal stroke
4881536|NCT02170285|hemiparetic cerebral palsy|hemiparetic cerebral palsy
4881537|NCT02170285|brain stimulation|brain stimulation
4881538|NCT02170285|tDCS|tdcs
4881539|NCT02170285|constraint-induced movement therapy|constraint-induced movement therapy
4881540|NCT02170285|hand arm bimanual intensive therapy|hand arm bimanual intensive therapy
4881541|NCT02170259|Tension-type headache|tension-type headache
4881542|NCT02170259|Depression|depression
4881543|NCT02170259|Anxiety|anxiety
4881544|NCT02170259|Manual therapy|manual therapy
4881545|NCT02170259|Spinal manipulation|spinal manipulation
4881546|NCT02170259|Patients diagnosed with tension-type headache|patients diagnosed with tension-type headache
4881547|NCT02170246|Acute HIV infection|acute hiv infection
4881548|NCT02170246|Central nervous system|central nervous system
4881549|NCT02170246|Antiretroviral therapy|antiretroviral therapy
4881550|NCT02170246|Telmisartan|telmisartan
4881551|NCT02170246|Cerebrospinal fluid|cerebrospinal fluid
4881552|NCT02170220|Drug therapy|drug therapy
4881553|NCT02170207|Pharmacological therapy|pharmacological therapy
4881554|NCT02170194|smart phone apps|smart phone apps
4881555|NCT02170194|subthreshold PTSD|subthreshold ptsd
4881556|NCT02170194|resilience enhancement|resilience enhancement
4881557|NCT02170194|military veterans|military veterans
4881558|NCT02170194|natural disasters|natural disasters
4881559|NCT02170194|terrorism|terrorism
4881560|NCT02170194|shootings|shootings
4881561|NCT02170194|fMRI|fmri
4881562|NCT02170194|physiology|physiology
4881563|NCT02170181|SBRT|sbrt
4881564|NCT02170181|prostate cancer|prostate cancer
4881565|NCT02170181|lung cancer|lung cancer
4881566|NCT02170181|bladder cancer|bladder cancer
4881567|NCT02170181|kidney cancer|kidney cancer
4881568|NCT02170181|oligometastatic disease|oligometastatic disease
4881569|NCT02170168|Community health services|community health services
4881570|NCT02170168|Models, organizational|models, organizational
4881571|NCT02170168|Referral and consultation|referral and consultation
4881572|NCT02170168|Palliative medicine|palliative medicine
4881573|NCT02170168|Terminal care|terminal care
4881574|NCT02170142|MRI|mri
4881575|NCT02170142|perinatal brain|perinatal brain
4881576|NCT02170142|development, neonates|development, neonates
4881577|NCT02170103|segment elevation myocardial infarctions (STEMIs),|segment elevation myocardial infarctions (stemis),
4881578|NCT02170103|sonothrombolysis|sonothrombolysis
4881579|NCT02170103|reperfusion|reperfusion
4881580|NCT02170103|percutaneous intervention (PCI),|percutaneous intervention (pci),
4881581|NCT02170103|antithrombotic therapy,|antithrombotic therapy,
4881582|NCT02170103|antiplatelet therapy,|antiplatelet therapy,
4881583|NCT02170090|adjuvant chemotherapy|adjuvant chemotherapy
4881584|NCT02170090|cholangiocarcinoma|cholangiocarcinoma
4881585|NCT02170090|muscle invasive gall bladder carcinoma|muscle invasive gall bladder carcinoma
4881586|NCT02170090|translational research|translational research
4881587|NCT02170090|multidisciplinary|multidisciplinary
4881588|NCT02170090|AIO, DGAV, DGVS|aio, dgav, dgvs
4881589|NCT02170077|Epilepsy|epilepsy
4881590|NCT02170077|BIA 2-093|bia 2-093
4881591|NCT02170064|Epilepsy|epilepsy
4881592|NCT02170064|BIA 2-093|bia 2-093
4881593|NCT02170051|negative symptoms|negative symptoms
4881594|NCT02170051|cognition|cognition
4881595|NCT02170051|functioning|functioning
4881596|NCT02170051|defeatist attitudes|defeatist attitudes
4881597|NCT02170051|psychosocial treatment|psychosocial treatment
4881598|NCT02170038|Drug Kinetics|drug kinetics
4881599|NCT02170025|Cystic fibrosis|cystic fibrosis
4881600|NCT02170025|delta F508|delta f508
4881601|NCT02170025|Safety|safety
4881602|NCT02170025|Tolerability|tolerability
4881603|NCT02170025|Sweat Chloride|sweat chloride
4881604|NCT02170025|Pharmacokinetics|pharmacokinetics
4881605|NCT02170012|Multiple dose|multiple dose
4881606|NCT02170012|safety|safety
4881607|NCT02170012|tolerability|tolerability
4881608|NCT02170012|PK|pk
4881609|NCT02169973|Healthy|healthy
4881610|NCT02169973|Positron Emission Tomography|positron emission tomography
4881611|NCT02169973|11C-MK-3168|11c-mk-3168
4881612|NCT02169973|JNJ-42165279|jnj-42165279
4881613|NCT02169973|Human Brain|human brain
4881614|NCT02169895|Parkinson's disease (PD)|parkinson's disease (pd)
4881615|NCT02169895|Opicapone|opicapone
4881616|NCT02169895|Bia 9-1067|bia 9-1067
4881617|NCT02169882|Tuberculous meningitis|tuberculous meningitis
4881618|NCT02169882|Rifampicin|rifampicin
4881619|NCT02169882|Dose finding study|dose finding study
4881620|NCT02169882|Pharmacokinetics|pharmacokinetics
4881621|NCT02169869|intrauterine device, postpartum, contraception, Mirena, Paragard, intrauterine system|intrauterine device, postpartum, contraception, mirena, paragard, intrauterine system
4881622|NCT02169856|Cholecystectomy|cholecystectomy
4881623|NCT02169856|Laparoscopic|laparoscopic
4881624|NCT02169856|Postoperative Nausea and Vomiting|postoperative nausea and vomiting
4881625|NCT02169843|Dexmedetomidine,|dexmedetomidine,
4881626|NCT02169843|agitation,|agitation,
4881627|NCT02169843|AFPS,|afps,
4881628|NCT02169843|NRS,|nrs,
4881629|NCT02169843|mean arterial pressure|mean arterial pressure
4881630|NCT02169843|heart rate(HR)|heart rate(hr)
4881631|NCT02169830|vestibular migraines, nortriptyline and topiramate|vestibular migraines, nortriptyline and topiramate
4881632|NCT02169791|hematologic malignancies|hematologic malignancies
4881633|NCT02169778|Weight loss|weight loss
4881634|NCT02169778|Intermittent energy restriction|intermittent energy restriction
4881635|NCT02169778|Metabolic compensation|metabolic compensation
4881636|NCT02169778|Diet therapy|diet therapy
4881637|NCT02169765|Hepatocellular Carcinoma|hepatocellular carcinoma
4881638|NCT02169765|Liver Cancer|liver cancer
4881639|NCT02169752|Pre-Pulmonary Atrial Hypertension|pre-pulmonary atrial hypertension
4881640|NCT02169739|ischemic preconditioning|ischemic preconditioning
4881641|NCT02169739|remote ischemic preconditioning|remote ischemic preconditioning
4881642|NCT02169739|ischemic stroke|ischemic stroke
4881643|NCT02169739|white matter disease|white matter disease
4881644|NCT02169739|cerebral small vessel disease|cerebral small vessel disease
4881645|NCT02169739|cognitive decline|cognitive decline
4881646|NCT02169739|leukoaraiosis|leukoaraiosis
4881647|NCT02169739|diffusion tensor imaging|diffusion tensor imaging
4881648|NCT02169739|white matter hyper intensity score|white matter hyper intensity score
4881649|NCT02169739|European scale of age-related white matter change|european scale of age-related white matter change
4881650|NCT02169713|Healthy subjects|healthy subjects
4881651|NCT02169713|Mirabegron|mirabegron
4881652|NCT02169713|Solifenacin|solifenacin
4881653|NCT02169713|Tamsulosin HCl|tamsulosin hcl
4881654|NCT02169700|Ischemic compression|ischemic compression
4881655|NCT02169700|Myofascial trigger points|myofascial trigger points
4881656|NCT02169700|Post-needling soreness|post-needling soreness
4881657|NCT02169687|Thyroid, HIFU, hyperfunctioning, autonomous|thyroid, hifu, hyperfunctioning, autonomous
4881658|NCT02169674|Hepatitis B|hepatitis b
4881659|NCT02169674|Vaccine|vaccine
4881660|NCT02169674|Immunogenicity|immunogenicity
4881661|NCT02169661|Oxidative stress|oxidative stress
4881662|NCT02169661|Lipid peroxides|lipid peroxides
4881663|NCT02169661|Phytochemicals|phytochemicals
4881664|NCT02169661|Ready meals|ready meals
4881665|NCT02169661|Beetroot|beetroot
4881666|NCT02169661|Blood pressure|blood pressure
4881667|NCT02169648|macular edema|macular edema
4881668|NCT02169648|branch retinal vein occlusion|branch retinal vein occlusion
4881669|NCT02169648|central retinal vein occlusion|central retinal vein occlusion
4881670|NCT02169648|ranibizumab|ranibizumab
4881671|NCT02169648|cytokines|cytokines
4881672|NCT02169648|visual acuity|visual acuity
4881673|NCT02169648|central macular thickness|central macular thickness
4881674|NCT02169635|macular buckle|macular buckle
4881675|NCT02169635|high myopia|high myopia
4881676|NCT02169635|posterior staphyloma|posterior staphyloma
4881677|NCT02169609|Neuroblastoma|neuroblastoma
4881678|NCT02169609|Immunotherapy|immunotherapy
4881679|NCT02169609|Dinutuximab|dinutuximab
4881680|NCT02169596|Acute Coronary Syndrome|acute coronary syndrome
4881681|NCT02169596|Nitric oxide|nitric oxide
4881682|NCT02169596|Ticagrelor|ticagrelor
4881683|NCT02169596|Antiplatelet agents|antiplatelet agents
4881684|NCT02169596|Endothelial function|endothelial function
4881685|NCT02169583|GSK1325756|gsk1325756
4881686|NCT02169583|Safety|safety
4881687|NCT02169583|Bioavailability|bioavailability
4881688|NCT02169583|Pharmacokinetics|pharmacokinetics
4881689|NCT02169570|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
4881690|NCT02169570|Pulmonary Tuberculosis|pulmonary tuberculosis
4881691|NCT02169570|Vitamin D|vitamin d
4881692|NCT02169570|Calcium|calcium
4881693|NCT02169531|Diabetes Mellitus Type 2|diabetes mellitus type 2
4881694|NCT02169531|Hyperglycemia|hyperglycemia
4881695|NCT02169531|Immunotherapy|immunotherapy
4881696|NCT02169531|Autologous|autologous
4881697|NCT02169518|PON1 activity|pon1 activity
4881698|NCT02169518|HDL functionality|hdl functionality
4881699|NCT02169518|LDL oxidation|ldl oxidation
4881700|NCT02169518|Diabetes Mellitus Type 1|diabetes mellitus type 1
4881701|NCT02169518|Obesity|obesity
4881702|NCT02169518|Diabetes Mellitus Type 2|diabetes mellitus type 2
4881703|NCT02169518|Bariatric Surgery|bariatric surgery
4881704|NCT02169505|Lymphoma|lymphoma
4881705|NCT02169505|Hodgkin lymphoma|hodgkin lymphoma
4881706|NCT02169505|HL|hl
4881707|NCT02169505|CD30 positive Hodgkin Lymphoma|cd30 positive hodgkin lymphoma
4881708|NCT02169505|Anaplastic large cell lymphoma|anaplastic large cell lymphoma
4881709|NCT02169505|ALCL|alcl
4881710|NCT02169505|Allogeneic Stem Cell Transplantation|allogeneic stem cell transplantation
4881711|NCT02169505|ASCT|asct
4881712|NCT02169505|Graft-versus-host disease|graft-versus-host disease
4881713|NCT02169505|GVHD|gvhd
4881714|NCT02169505|Brentuximab Vedotin|brentuximab vedotin
4881715|NCT02169505|SGN-35|sgn-35
4881716|NCT02169505|Adcetris|adcetris
4881717|NCT02169492|Thrombectomy|thrombectomy
4881718|NCT02169492|Stroke|stroke
4881719|NCT02169492|ReVive SE|revive se
4881720|NCT02169479|Parkinson's disease (PD)|parkinson's disease (pd)
4881721|NCT02169479|Opicapone|opicapone
4881722|NCT02169479|BIA 9-1067|bia 9-1067
4881723|NCT02169466|Parkinson's disease (PD)|parkinson's disease (pd)
4881724|NCT02169466|Opicapone|opicapone
4881725|NCT02169466|BIA 9-1067|bia 9-1067
4881726|NCT02169453|Parkinson's disease (PD)|parkinson's disease (pd)
4881727|NCT02169453|BIA 9-1067|bia 9-1067
4881728|NCT02169453|Opicapone|opicapone
4881729|NCT02169440|Parkinson's disease (PD)|parkinson's disease (pd)
4881730|NCT02169440|BIA 9-1067|bia 9-1067
4881731|NCT02169440|Opicapone|opicapone
4881732|NCT02169427|Parkinson's disease (PD)|parkinson's disease (pd)
4881733|NCT02169427|BIA 9-1067|bia 9-1067
4881734|NCT02169427|Opicapone|opicapone
4881735|NCT02169414|Parkinson's disease (PD)|parkinson's disease (pd)
4881736|NCT02169414|BIA 9-1067|bia 9-1067
4881737|NCT02169414|Opicapone|opicapone
4881738|NCT02169388|Gut microflora|gut microflora
4881739|NCT02169388|colorectal cancer|colorectal cancer
4881740|NCT02169388|Chemotherapy|chemotherapy
4881741|NCT02169388|Immunity|immunity
4881742|NCT02169388|Nutrition|nutrition
4881743|NCT02169362|Burns|burns
4881744|NCT02169362|Thermal burns|thermal burns
4881745|NCT02169362|Second degree burns|second degree burns
4881746|NCT02169362|Partial thickness burns|partial thickness burns
4881747|NCT02169362|Deep partial thickness burns|deep partial thickness burns
4881748|NCT02169362|Acute burns|acute burns
4881749|NCT02169362|Burn wounds|burn wounds
4881750|NCT02169336|Bunion|bunion
4881751|NCT02169336|Bunionectomy|bunionectomy
4881752|NCT02169336|Pain|pain
4881753|NCT02169336|Analgesia|analgesia
4881754|NCT02169336|dexmedetomidine|dexmedetomidine
4881755|NCT02169336|intranasal|intranasal
4881756|NCT02169323|Non-eosinophilic Asthma|non-eosinophilic asthma
4881757|NCT02169323|Inhaled corticosteroids|inhaled corticosteroids
4881758|NCT02169323|Step-down|step-down
4881759|NCT02169310|Traumatic Brain Injury|traumatic brain injury
4881760|NCT02169310|Decision-Making|decision-making
4881761|NCT02169310|Dopaminergic Network|dopaminergic network
4881762|NCT02169310|Brain Imaging|brain imaging
4881763|NCT02169310|Non-Invasive Brain Stimulation|non-invasive brain stimulation
4881764|NCT02169297|Pain Management|pain management
4881765|NCT02169297|Anesthesia: Nerve Block|anesthesia: nerve block
4881766|NCT02169258|coronary artery disease|coronary artery disease
4881767|NCT02169258|peripheral artery disease|peripheral artery disease
4881768|NCT02169258|percutaneous transluminal angioplasty|percutaneous transluminal angioplasty
4881769|NCT02169258|coronary angiography|coronary angiography
4881770|NCT02169258|revascularization|revascularization
4881771|NCT02169258|gene polymorphisms|gene polymorphisms
4881772|NCT02169258|microRNAs|micrornas
4881773|NCT02169232|Awake intubation|awake intubation
4881774|NCT02169232|Videolaryngoscope|videolaryngoscope
4881775|NCT02169232|Fiberoptic|fiberoptic
4881776|NCT02169206|Frozen shoulder|frozen shoulder
4881777|NCT02169206|scapulothoracic angle|scapulothoracic angle
4881778|NCT02169206|scapulohumeral angle|scapulohumeral angle
4881779|NCT02169206|acromiohumeral distance|acromiohumeral distance
4881780|NCT02169206|center equator distance|center equator distance
4881781|NCT02169206|shoulder radiography|shoulder radiography
4882270|NCT02166879|Survey|survey
4881782|NCT02169193|microaspiration|microaspiration
4881783|NCT02169193|mechanical ventilation|mechanical ventilation
4881784|NCT02169193|enteral feeding|enteral feeding
4881785|NCT02169193|99m technetium|99m technetium
4881786|NCT02169193|pepsin|pepsin
4881787|NCT02169180|Ibrutinib|ibrutinib
4881788|NCT02169180|IMBRUVICA|imbruvica
4881789|NCT02169180|PCI-32765|pci-32765
4881790|NCT02169180|JNJ-54179060|jnj-54179060
4881791|NCT02169180|Lymphoma, Mantle-cell|lymphoma, mantle-cell
4881792|NCT02169167|Diabetes complications|diabetes complications
4881793|NCT02169167|Diabetic foot|diabetic foot
4881794|NCT02169167|Foot ulcer|foot ulcer
4881795|NCT02169167|Wound healing|wound healing
4881796|NCT02169167|Wound infection|wound infection
4881797|NCT02169141|pharmacokinetics|pharmacokinetics
4881798|NCT02169141|pharmacodynamics|pharmacodynamics
4881799|NCT02169141|MDR-TB|mdr-tb
4881800|NCT02169141|Levofloxacin|levofloxacin
4881801|NCT02169141|Capreomycin|capreomycin
4881802|NCT02169102|Low power laser|low power laser
4881803|NCT02169102|Pulpitis|pulpitis
4881804|NCT02169102|Pain|pain
4881805|NCT02169076|Ventricular Assist Device, Cardiac Resynchronization Therapy|ventricular assist device, cardiac resynchronization therapy
4881806|NCT02169050|Vitamin D deficiency|vitamin d deficiency
4881807|NCT02169050|Inflammation|inflammation
4881808|NCT02169050|Obesity|obesity
4881809|NCT02169037|Rotor|rotor
4881810|NCT02169037|FIRM|firm
4881811|NCT02169037|Paroxysmal Atrial Fibrillation|paroxysmal atrial fibrillation
4881812|NCT02169037|Atrial tachyarrhythmia|atrial tachyarrhythmia
4881813|NCT02169037|Ablation|ablation
4881814|NCT02169037|Contact mapping|contact mapping
4881815|NCT02169037|Clinical trial|clinical trial
4881816|NCT02169037|Signal processing.|signal processing.
4881817|NCT02169024|prenatal care|prenatal care
4881818|NCT02169024|group care|group care
4881819|NCT02169024|Expect With Me|expect with me
4881820|NCT02169024|evaluation studies|evaluation studies
4881821|NCT02169024|group prenatal care|group prenatal care
4881822|NCT02169011|Breast reconstruction|breast reconstruction
4881823|NCT02169011|Breast cancer|breast cancer
4881824|NCT02168998|Medical clown|medical clown
4881825|NCT02168998|Pediatric emergency medicine|pediatric emergency medicine
4881826|NCT02168985|Child violence|child violence
4881827|NCT02168985|HIV AIDS conflicted couples|hiv aids conflicted couples
4881828|NCT02168985|Intimate partner violence|intimate partner violence
4881829|NCT02168985|Tanzania|tanzania
4881830|NCT02168985|Marriage counseling|marriage counseling
4881831|NCT02168985|Child maltreatment|child maltreatment
4881832|NCT02168985|Couples communication|couples communication
4881833|NCT02168972|atrial fibrillation|atrial fibrillation
4881834|NCT02168972|global|global
4881835|NCT02168972|radiofrequency RF ablation|radiofrequency rf ablation
4881836|NCT02168972|left atrium anatomical and electrophysiological mapping|left atrium anatomical and electrophysiological mapping
4881837|NCT02168959|Femoral Nerve Block|femoral nerve block
4881838|NCT02168959|Pain Control|pain control
4881839|NCT02168959|Tibial Plateau Fracture|tibial plateau fracture
4881840|NCT02168959|Prospective|prospective
4881841|NCT02168959|Randomized|randomized
4881842|NCT02168933|psoriasis|psoriasis
4881843|NCT02168933|nail|nail
4881844|NCT02168933|laser|laser
4881845|NCT02168933|excimer|excimer
4881846|NCT02168933|treatment|treatment
4881847|NCT02168920|Alzeheimer|alzeheimer
4881848|NCT02168894|Peripheral neuropathy|peripheral neuropathy
4881849|NCT02168894|Chemotherapy-Induced Peripheral Neuropathy|chemotherapy-induced peripheral neuropathy
4881850|NCT02168894|Cancer Survivors|cancer survivors
4881851|NCT02168894|Acupuncture|acupuncture
4881852|NCT02168894|Electrical stimulation|electrical stimulation
4881853|NCT02168894|Nerve function tests|nerve function tests
4881854|NCT02168894|Hand function tests|hand function tests
4881855|NCT02168894|Balance tests|balance tests
4881856|NCT02168894|Questionnaires|questionnaires
4881857|NCT02168894|Surveys|surveys
4881858|NCT02168881|labour|labour
4881859|NCT02168881|induction|induction
4881860|NCT02168881|misoprostol|misoprostol
4881861|NCT02168881|dinoprostone|dinoprostone
4881862|NCT02168868|Autoimmune Diseases|autoimmune diseases
4881863|NCT02168868|Child Development Disorders, Pervasive|child development disorders, pervasive
4881864|NCT02168868|Inflammation|inflammation
4881865|NCT02168868|Risk Factors|risk factors
4881866|NCT02168855|Smoking cessation|smoking cessation
4881867|NCT02168855|Non-daily smokers|non-daily smokers
4881868|NCT02168855|Ecological Momentary Assessment|ecological momentary assessment
4881869|NCT02168855|nicotine replacement therapy|nicotine replacement therapy
4881870|NCT02168842|Parkinson|parkinson
4881871|NCT02168842|Parkinson Disease|parkinson disease
4881872|NCT02168842|Parkinson's Disease|parkinson's disease
4881873|NCT02168829|AF ablation|af ablation
4881874|NCT02168829|Anticoagulation AF ablation|anticoagulation af ablation
4881875|NCT02168829|Stroke prevention|stroke prevention
4881876|NCT02168816|Osteomyelitis|osteomyelitis
4881877|NCT02168816|Diabetes|diabetes
4881878|NCT02168816|Foot Infection|foot infection
4881879|NCT02168803|abnormal cholesterol|abnormal cholesterol
4881880|NCT02168790|amniotic membrane holder, aminiotic membrane transplantation|amniotic membrane holder, aminiotic membrane transplantation
4882365|NCT02166450|Dentures|dentures
4881881|NCT02168777|Patients with Cancer|patients with cancer
4881882|NCT02168751|one lung ventilation|one lung ventilation
4881883|NCT02168751|inflammatory response|inflammatory response
4881884|NCT02168751|thoracic surgery|thoracic surgery
4881885|NCT02168738|nutrition|nutrition
4881886|NCT02168725|briciclib|briciclib
4881887|NCT02168725|Dose escalation|dose escalation
4881888|NCT02168725|Maximum tolerated dose|maximum tolerated dose
4881889|NCT02168712|Coronary Heart Disease|coronary heart disease
4881890|NCT02168712|Interval exercise training|interval exercise training
4881891|NCT02168712|Continuous exercise training|continuous exercise training
4881892|NCT02168712|Quality of life|quality of life
4881893|NCT02168712|Safety|safety
4881894|NCT02168699|children|children
4881895|NCT02168699|infants|infants
4881896|NCT02168699|musculocutaneous nerve|musculocutaneous nerve
4881897|NCT02168699|ultrasonography|ultrasonography
4881898|NCT02168686|alpha-1 antitrypsin deficiency|alpha-1 antitrypsin deficiency
4881899|NCT02168686|alpha1-antitrypsin deficiency|alpha1-antitrypsin deficiency
4881900|NCT02168686|alpha-1-antitrypsin deficiency|alpha-1-antitrypsin deficiency
4881901|NCT02168686|alpha1AT|alpha1at
4881902|NCT02168686|A1AT|a1at
4881903|NCT02168686|ADVM-043|advm-043
4881904|NCT02168686|AAVrh.10halpha1AT|aavrh.10halpha1at
4881905|NCT02168686|AAVrh.10hA1AT|aavrh.10ha1at
4881906|NCT02168686|Gene transfer vector|gene transfer vector
4881907|NCT02168686|Gene therapy|gene therapy
4881908|NCT02168686|Lung disease|lung disease
4881909|NCT02168686|Emphysema|emphysema
4881910|NCT02168686|COPD|copd
4881911|NCT02168686|ADVANCE study|advance study
4881912|NCT02168673|COPD|copd
4881913|NCT02168673|Cigarette Smoke|cigarette smoke
4881914|NCT02168673|Smoker|smoker
4881915|NCT02168673|Nonsmoker|nonsmoker
4881916|NCT02168673|ODF2|odf2
4881917|NCT02168673|Cilia|cilia
4881918|NCT02168660|Obesity|obesity
4881919|NCT02168660|Insulin Resistance|insulin resistance
4881920|NCT02168660|Vitamin D Deficiency|vitamin d deficiency
4881921|NCT02168660|Children|children
4881922|NCT02168660|Adolescents|adolescents
4881923|NCT02168647|Excessive gestational weight gain|excessive gestational weight gain
4881924|NCT02168647|Insulin resistance|insulin resistance
4881925|NCT02168647|Physical activity|physical activity
4881926|NCT02168647|Behavioral prenatal lifestyle intervention|behavioral prenatal lifestyle intervention
4881927|NCT02168647|Reduced carbohydrate intake|reduced carbohydrate intake
4881928|NCT02168647|Self-determination theory|self-determination theory
4881929|NCT02168647|Motivational interviewing|motivational interviewing
4881930|NCT02168621|Chronic periodontitis|chronic periodontitis
4881931|NCT02168621|Non-surgical therapy|non-surgical therapy
4881932|NCT02168621|Ultrasonic debridement|ultrasonic debridement
4881933|NCT02168621|Scaling and root planing|scaling and root planing
4881934|NCT02168608|hepatic ischemia reperfusion injury|hepatic ischemia reperfusion injury
4881935|NCT02168608|ischemia precondition|ischemia precondition
4881936|NCT02168608|remote ischemia precondition|remote ischemia precondition
4881937|NCT02168608|anti-inflammation|anti-inflammation
4881938|NCT02168595|healthy volunteers, GMI-1271|healthy volunteers, gmi-1271
4881939|NCT02168582|Physical Therapy Modalities|physical therapy modalities
4881940|NCT02168582|Prognosis|prognosis
4881941|NCT02168582|Patient Selection|patient selection
4881942|NCT02168569|treatment|treatment
4881943|NCT02168569|artemisin-based combinations|artemisin-based combinations
4881944|NCT02168569|children|children
4881945|NCT02168556|Urodynamics, Anxiety|urodynamics, anxiety
4881946|NCT02168517|Obesity|obesity
4881947|NCT02168517|Pain|pain
4881948|NCT02168517|Fertility|fertility
4881949|NCT02168478|Neo-Synalar|neo-synalar
4881950|NCT02168478|Patch Test|patch test
4881951|NCT02168478|Sodium lauryl sulfate|sodium lauryl sulfate
4881952|NCT02168478|Saline|saline
4881953|NCT02168478|Presensitization|presensitization
4881954|NCT02168465|self-efficacy|self-efficacy
4881955|NCT02168465|self-management|self-management
4881956|NCT02168465|web-based intervention research|web-based intervention research
4881957|NCT02168452|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
4881958|NCT02168452|Indocyanine green (ICG)|indocyanine green (icg)
4881959|NCT02168452|Radioisotope (RI)|radioisotope (ri)
4881960|NCT02168452|Near infrared fluorescence camera|near infrared fluorescence camera
4881961|NCT02168439|Dexmedetomidine|dexmedetomidine
4881962|NCT02168439|Midazolam|midazolam
4881963|NCT02168413|cortical excitability|cortical excitability
4881964|NCT02168413|robotized TMS|robotized tms
4881966|NCT02168413|EMG|emg
4881967|NCT02168387|atelectasis|atelectasis
4881968|NCT02168387|continuous high frequency oscillator|continuous high frequency oscillator
4881969|NCT02168387|acetylcysteine|acetylcysteine
4881970|NCT02168387|dornase alfa|dornase alfa
4881971|NCT02168374|Glass ionomer cement|glass ionomer cement
4881972|NCT02168374|Indirect pulp therapy|indirect pulp therapy
4881973|NCT02168361|cirrhosis|cirrhosis
4881974|NCT02168322|growth factors|growth factors
4881975|NCT02168322|periodontal regeneration|periodontal regeneration
4881976|NCT02168322|modefied perforated membranes|modefied perforated membranes
4881977|NCT02168296|Pharmacokinetics|pharmacokinetics
4881978|NCT02168296|Blood glucose|blood glucose
4881979|NCT02168296|subjects|subjects
4881980|NCT02168283|cardiovascular disease|cardiovascular disease
4881981|NCT02168283|hypertension|hypertension
4881982|NCT02168257|Nasal Cannula|nasal cannula
4881983|NCT02168244|psoriasis|psoriasis
4881984|NCT02168244|biologics|biologics
4881985|NCT02168244|subcutaneous|subcutaneous
4881986|NCT02168244|pain|pain
4881987|NCT02168244|heat|heat
4881989|NCT02168231|Complex abdominal wall hernia|complex abdominal wall hernia
4881990|NCT02168231|Biologic mesh|biologic mesh
4881991|NCT02168231|Strattice|strattice
4881992|NCT02168218|protein synthesis|protein synthesis
4881993|NCT02168218|intrahepatic fat|intrahepatic fat
4881994|NCT02168218|lean body mass|lean body mass
4881995|NCT02168218|IGF1|igf1
4881996|NCT02168218|energy metabolism|energy metabolism
4881997|NCT02168205|Healthy volunteer|healthy volunteer
4881998|NCT02168205|Pharmacokinetics|pharmacokinetics
4881999|NCT02168205|Pomalyst|pomalyst
4882000|NCT02168205|Pomalidomide|pomalidomide
4882001|NCT02168205|Food effect|food effect
4882002|NCT02168205|smoker|smoker
4882003|NCT02168192|Breaking bad news skills|breaking bad news skills
4882004|NCT02168192|Communications skills|communications skills
4882005|NCT02168192|Medical education|medical education
4882006|NCT02168192|Obstetrics|obstetrics
4882007|NCT02168192|Simulation|simulation
4882008|NCT02168166|Neurological Disorders|neurological disorders
4882009|NCT02168166|Neuroscience|neuroscience
4882010|NCT02168166|Neuropsychology|neuropsychology
4882011|NCT02168166|EEG|eeg
4882012|NCT02168166|Cognitive remediation|cognitive remediation
4882013|NCT02168166|Cognitive Response|cognitive response
4882014|NCT02168153|Chiropractic Manipulative Therapy|chiropractic manipulative therapy
4882015|NCT02168153|Reaction Times|reaction times
4882016|NCT02168153|Response Times|response times
4882017|NCT02168153|Special Forces|special forces
4882018|NCT02168153|Biomechanical Assessments|biomechanical assessments
4882019|NCT02168114|Duchenne Muscular Dystrophy|duchenne muscular dystrophy
4882020|NCT02168114|Exercise|exercise
4882021|NCT02168114|Optical Imaging|optical imaging
4882022|NCT02168114|Magnetic Resonance|magnetic resonance
4882023|NCT02168101|MLN9708|mln9708
4882024|NCT02168101|allogeneic stem cell transplant|allogeneic stem cell transplant
4882025|NCT02168101|multiple myeloma|multiple myeloma
4882026|NCT02168101|ixazomib|ixazomib
4882027|NCT02168101|autologous stem cell transplant|autologous stem cell transplant
4882028|NCT02168088|Sudden unexplained death|sudden unexplained death
4882029|NCT02168049|cardiac, respiratory, monitoring|cardiac, respiratory, monitoring
4882030|NCT02168036|lung disease|lung disease
4882031|NCT02168036|mediastinal lymph node|mediastinal lymph node
4882032|NCT02168036|bronchoscopy|bronchoscopy
4882033|NCT02168036|Endobronchial-Guided Transbronchial Needle Aspiration|endobronchial-guided transbronchial needle aspiration
4882034|NCT02168023|surgical site infection|surgical site infection
4882035|NCT02168023|dialkylcarbamoylchloride impregnated dressing|dialkylcarbamoylchloride impregnated dressing
4882036|NCT02168023|caesarean section|caesarean section
4882037|NCT02168023|wound dehiscence|wound dehiscence
4882038|NCT02167984|esophageal swallow|esophageal swallow
4882039|NCT02167984|gastroesophageal reflux|gastroesophageal reflux
4882040|NCT02167984|esophageal impedance|esophageal impedance
4882041|NCT02167984|newborn|newborn
4882042|NCT02167984|preterm|preterm
4882043|NCT02167971|traumatic brain injury|traumatic brain injury
4882044|NCT02167971|diffuse axonal injury|diffuse axonal injury
4882045|NCT02167971|repetitive transcranial magnetic stimulation|repetitive transcranial magnetic stimulation
4882046|NCT02167971|neuromodulation|neuromodulation
4882047|NCT02167971|cognitive rehabilitation|cognitive rehabilitation
4882048|NCT02167945|Hepatitis C Genotype 1|hepatitis c genotype 1
4882049|NCT02167945|Compensated Cirrhosis|compensated cirrhosis
4882050|NCT02167945|Cirrhosis|cirrhosis
4882051|NCT02167945|Naïve|naïve
4882052|NCT02167945|Hepatitis C|hepatitis c
4882053|NCT02167945|Hepatitis C Virus|hepatitis c virus
4882054|NCT02167945|Treatment-Experienced|treatment-experienced
4882055|NCT02167945|Relapser|relapser
4882056|NCT02167945|Null responder|null responder
4882057|NCT02167945|Non responder|non responder
4882058|NCT02167932|Breast Cancer|breast cancer
4882059|NCT02167932|Walk With Ease|walk with ease
4882060|NCT02167932|Physical Activity|physical activity
4882061|NCT02167932|Walking|walking
4882062|NCT02167932|Younger Women|younger women
4882063|NCT02167932|Cancer|cancer
4882064|NCT02167932|p16|p16
4882065|NCT02167932|Aging|aging
4882066|NCT02167932|Biomarkers|biomarkers
4882067|NCT02167932|Biomarkers of Aging|biomarkers of aging
4882068|NCT02167932|Chemotherapy|chemotherapy
4882069|NCT02167932|Chemotherapy Treatment|chemotherapy treatment
4882070|NCT02167932|Adjuvant Chemotherapy|adjuvant chemotherapy
4882071|NCT02167932|Neoadjuvant Chemotherapy|neoadjuvant chemotherapy
4882072|NCT02167919|Prostate|prostate
4882073|NCT02167919|Men|men
4882074|NCT02167919|Hyperplasia|hyperplasia
4882075|NCT02167893|Pharmacological therapy|pharmacological therapy
4882076|NCT02167867|body contouring|body contouring
4882077|NCT02167867|circumference reduction|circumference reduction
4882078|NCT02167867|body shaping|body shaping
4882079|NCT02167867|low level laser|low level laser
4882080|NCT02167854|LJM716|ljm716
4882081|NCT02167854|BYL719 [Alpelisib]|byl719 [alpelisib]
4882082|NCT02167854|TRASTUZUMAB|trastuzumab
4882083|NCT02167854|HER2+|her2+
4882084|NCT02167854|14-057|14-057
4882085|NCT02167841|Breech presentation,|breech presentation,
4882086|NCT02167841|External cephalic version,|external cephalic version,
4882087|NCT02167841|Maternal posture,|maternal posture,
4882088|NCT02167841|Pregnancy,|pregnancy,
4882089|NCT02167841|Caesarean section.|caesarean section.
4882090|NCT02167828|HIV|hiv
4882091|NCT02167828|AIDS|aids
4882092|NCT02167828|treatment adherence|treatment adherence
4882093|NCT02167828|social network|social network
4882094|NCT02167802|severe infection, pediatrics, sub-optimal care, term care|severe infection, pediatrics, sub-optimal care, term care
4882095|NCT02167789|HF, diagnosis|hf, diagnosis
4882096|NCT02167763|contraception|contraception
4882097|NCT02167763|IUD|iud
4882098|NCT02167763|copper|copper
4882099|NCT02167750|cognitive|cognitive
4882100|NCT02167750|phytochmicals|phytochmicals
4882101|NCT02167750|caffeine|caffeine
4882102|NCT02167750|cognitive performance after ingestion of test beverage|cognitive performance after ingestion of test beverage
4882103|NCT02167737|Accident Prevention|accident prevention
4882104|NCT02167737|Accidental Falls|accidental falls
4882105|NCT02167737|Geriatric Health Services|geriatric health services
4882106|NCT02167737|Gender Differences|gender differences
4882107|NCT02167698|Pediatric acute respiratory distress syndrome|pediatric acute respiratory distress syndrome
4882108|NCT02167698|Mechanical ventilation|mechanical ventilation
4882109|NCT02167698|Airway pressure release ventilation|airway pressure release ventilation
4882110|NCT02167698|Conventional low-tidal volume ventilation|conventional low-tidal volume ventilation
4882111|NCT02167672|total abdominal hysterectomy, total laparoscopic hysterectomy, vaginal hysterectomy|total abdominal hysterectomy, total laparoscopic hysterectomy, vaginal hysterectomy
4882112|NCT02167659|Lymphedema|lymphedema
4882113|NCT02167659|Breast cancer|breast cancer
4882114|NCT02167659|Bioimpedance Spectroscopy|bioimpedance spectroscopy
4882115|NCT02167659|L-Dex|l-dex
4882116|NCT02167646|Soft tissue defect|soft tissue defect
4882117|NCT02167646|dorsal branch of the digital nerve|dorsal branch of the digital nerve
4882118|NCT02167646|dorsal branch of the digital artery|dorsal branch of the digital artery
4882119|NCT02167646|dorsal digital flap|dorsal digital flap
4882120|NCT02167633|Radiosurgery|radiosurgery
4882121|NCT02167633|Laminectomy|laminectomy
4882122|NCT02167633|Radiotherapy|radiotherapy
4882123|NCT02167633|Spinal Cord Compression|spinal cord compression
4882124|NCT02167633|Neoplasm Metastasis|neoplasm metastasis
4882125|NCT02167633|Randomized Controlled Trial|randomized controlled trial
4882126|NCT02167607|Purple Potatoes|purple potatoes
4882127|NCT02167607|Polyphenolics|polyphenolics
4882128|NCT02167581|Maxillofacial surgery|maxillofacial surgery
4882129|NCT02167581|Epithelial odontogenic tumours|epithelial odontogenic tumours
4882130|NCT02167568|corpus callosum agenesis/dysgenesis|corpus callosum agenesis/dysgenesis
4882131|NCT02167568|mental deficiency/ Intellectual deficiency|mental deficiency/ intellectual deficiency
4882132|NCT02167568|genetic and phenotypic characterization|genetic and phenotypic characterization
4882133|NCT02167555|Wild Blueberries|wild blueberries
4882134|NCT02167555|Polyphenolics|polyphenolics
4882135|NCT02167542|Severe hypoxemic respiratory failure|severe hypoxemic respiratory failure
4882136|NCT02167542|Fiberoptic bronchoscopy|fiberoptic bronchoscopy
4882137|NCT02167542|Noninvasive possitive pressure ventilation|noninvasive possitive pressure ventilation
4882138|NCT02167542|Continuous positive airway pressure|continuous positive airway pressure
4882139|NCT02167529|Quality of life-Thyroidectomy-Morbidity|quality of life-thyroidectomy-morbidity
4882140|NCT02167516|Xinfeng capsule|xinfeng capsule
4882141|NCT02167516|Knee osteoarthritis|knee osteoarthritis
4882142|NCT02167516|Randomized controlled trials|randomized controlled trials
4882143|NCT02167516|Double-blind|double-blind
4882144|NCT02167490|BC; conservative surgery; SNB; AD; axillary US imaging|bc; conservative surgery; snb; ad; axillary us imaging
4882145|NCT02167477|Intubation, Endotracheal|intubation, endotracheal
4882146|NCT02167464|Hypertension|hypertension
4882147|NCT02167451|stem cell transplant|stem cell transplant
4882148|NCT02167451|GVHD prevention|gvhd prevention
4882149|NCT02167438|Cesarean|cesarean
4882150|NCT02167438|Section|section
4882151|NCT02167438|second|second
4882152|NCT02167438|stage|stage
4882153|NCT02167438|labor|labor
4882154|NCT02167425|People who Inject Drugs|people who inject drugs
4882155|NCT02167425|HIV|hiv
4882156|NCT02167425|Methadone|methadone
4882157|NCT02167425|Sub Saharan Africa|sub saharan africa
4882158|NCT02167425|Tanzania|tanzania
4882159|NCT02167425|Implementation Science|implementation science
4882160|NCT02167412|POTS|pots
4882161|NCT02167412|Syncope|syncope
4882162|NCT02167386|Men who have sex with men (MSM)|men who have sex with men (msm)
4882163|NCT02167386|Black/African-American|black/african-american
4882164|NCT02167360|adult patients|adult patients
4882165|NCT02167360|B-cell ALL|b-cell all
4882166|NCT02167360|chemo-refractory|chemo-refractory
4882167|NCT02167360|relapsed after allogeneic SCT|relapsed after allogeneic sct
4882168|NCT02167360|ineligible for allogeneic SCT|ineligible for allogeneic sct
4882169|NCT02167347|CBT, Psychosis, cultural adaptation, Pakistan|cbt, psychosis, cultural adaptation, pakistan
4882170|NCT02167334|panendoscopy|panendoscopy
4882171|NCT02167334|preoxygenation|preoxygenation
4882172|NCT02167334|non invasive ventilation|non invasive ventilation
4882173|NCT02167295|betel nut|betel nut
4882174|NCT02167295|dependence|dependence
4882175|NCT02167295|withdraw|withdraw
4882176|NCT02167295|deprivation test|deprivation test
4882177|NCT02167269|enclosed afferent reservoir|enclosed afferent reservoir
4882178|NCT02167269|Jackson Rees system|jackson rees system
4882179|NCT02167269|anesthesia breathing circuit|anesthesia breathing circuit
4882180|NCT02167269|spontaneous breathing|spontaneous breathing
4882181|NCT02167269|pediatric anesthesia|pediatric anesthesia
4882182|NCT02167230|Coronary Artery Disease|coronary artery disease
4882183|NCT02167230|Percutaneous Coronary Intervention|percutaneous coronary intervention
4882184|NCT02167230|Bifurcation|bifurcation
4882185|NCT02167230|Jailed-balloon technique|jailed-balloon technique
4882186|NCT02167217|Duchenne Muscular Dystrophy|duchenne muscular dystrophy
4882187|NCT02167217|Corticosteroids|corticosteroids
4882188|NCT02167217|Infants|infants
4882189|NCT02167217|Young Children|young children
4882190|NCT02167217|Toddlers|toddlers
4882191|NCT02167165|Atrial Fibrillation|atrial fibrillation
4882192|NCT02167165|Digoxin|digoxin
4882193|NCT02167165|SNP|snp
4882194|NCT02167139|Rheumatoid Arthritis, Adalimumab|rheumatoid arthritis, adalimumab
4882195|NCT02167126|Athletic Performance;|athletic performance;
4882196|NCT02167126|Muscle Strength;|muscle strength;
4882197|NCT02167126|Isometric Contraction;|isometric contraction;
4882198|NCT02167126|Kinesio Taping|kinesio taping
4882199|NCT02167100|HIV|hiv
4882200|NCT02167100|Highly Active Antiretroviral Therapy|highly active antiretroviral therapy
4882201|NCT02167100|Patient Care|patient care
4882202|NCT02167100|Patient Care Management|patient care management
4882203|NCT02167100|Lost to Follow-Up|lost to follow-up
4882204|NCT02167087|Sentinel node mapping|sentinel node mapping
4882205|NCT02167087|lymphatic mapping|lymphatic mapping
4882206|NCT02167087|lymphatic metastasis|lymphatic metastasis
4882207|NCT02167087|Aberrant lymphatic drainage|aberrant lymphatic drainage
4882208|NCT02167087|indocyanine green|indocyanine green
4882209|NCT02167087|ICG|icg
4882210|NCT02167087|near infrared|near infrared
4882211|NCT02167087|colon cancer|colon cancer
4882212|NCT02167087|laparoscopic surgery|laparoscopic surgery
4882213|NCT02167074|Diagnostic accuracy|diagnostic accuracy
4882214|NCT02167074|Endoscopic Ultrasound-Guided Fine Needle Aspiration|endoscopic ultrasound-guided fine needle aspiration
4882215|NCT02167074|EUS-FNA|eus-fna
4882216|NCT02167074|Endoscopic Ultrasound-Guided Fine Needle Biopsy|endoscopic ultrasound-guided fine needle biopsy
4882217|NCT02167074|EUS-FNB|eus-fnb
4882218|NCT02167074|Pancreatic mass|pancreatic mass
4882219|NCT02167074|Lymph node|lymph node
4882220|NCT02167048|Attention Deficit Hyperactivity Disorders|attention deficit hyperactivity disorders
4882221|NCT02167048|Executive Function|executive function
4882222|NCT02167048|Methylphenidate|methylphenidate
4882223|NCT02167048|Psychostimulants|psychostimulants
4882224|NCT02167048|Adolescent|adolescent
4882225|NCT02167048|Child|child
4882226|NCT02167048|Working Memory|working memory
4882227|NCT02167048|Prefrontal Cortex|prefrontal cortex
4882228|NCT02167048|Attention|attention
4882229|NCT02167048|Cognitive Function|cognitive function
4882230|NCT02167048|Inhibition|inhibition
4882231|NCT02167035|Open-Angle Glaucoma|open-angle glaucoma
4882232|NCT02167035|Ocular Hypertension|ocular hypertension
4882233|NCT02167022|intense therapy|intense therapy
4882234|NCT02167022|brain plasticity|brain plasticity
4882235|NCT02167022|Perception-Action approach|perception-action approach
4882236|NCT02167009|ARTERY EMBOLIZATION|artery embolization
4882237|NCT02167009|BPH|bph
4882238|NCT02166970|Hilar tumor|hilar tumor
4882239|NCT02166970|Metal stent|metal stent
4882240|NCT02166970|Single|single
4882241|NCT02166970|Multiple|multiple
4882242|NCT02166957|Esophageal disruption|esophageal disruption
4882243|NCT02166957|anterograde-retrograde endoscopy|anterograde-retrograde endoscopy
4882244|NCT02166957|rendez-vous technique|rendez-vous technique
4882245|NCT02166957|NOTES|notes
4882246|NCT02166957|recanalization|recanalization
4882247|NCT02166957|dilatations|dilatations
4882248|NCT02166957|Stenting|stenting
4882249|NCT02166957|radiation therapy|radiation therapy
4882250|NCT02166957|head and neck carcinoma|head and neck carcinoma
4882251|NCT02166944|amyotrophic lateral sclerosis|amyotrophic lateral sclerosis
4882252|NCT02166944|ALS functional ration scale|als functional ration scale
4882253|NCT02166944|TAR-DNA-binding protein-43|tar-dna-binding protein-43
4882254|NCT02166944|tamoxifen|tamoxifen
4882255|NCT02166944|mTOR|mtor
4882256|NCT02166931|Essence of Chicken|essence of chicken
4882257|NCT02166931|stress|stress
4882258|NCT02166931|cognitive function|cognitive function
4882259|NCT02166918|Schizophrenia|schizophrenia
4882260|NCT02166918|Real-Life Functioning|real-life functioning
4882261|NCT02166918|Schizophrenia Endophenotypes|schizophrenia endophenotypes
4882262|NCT02166892|Childhood obesity|childhood obesity
4882263|NCT02166892|Plate|plate
4882264|NCT02166892|Food consumption|food consumption
4882265|NCT02166879|Obstructive Sleep Apnea-Hypopnea Syndrome|obstructive sleep apnea-hypopnea syndrome
4882266|NCT02166879|Obstructive sleep apnea|obstructive sleep apnea
4882267|NCT02166879|OSA|osa
4882268|NCT02166879|Chart review|chart review
4882269|NCT02166879|Questionnaire|questionnaire
4882271|NCT02166853|Acute respiratory distress syndrome (ARDS)|acute respiratory distress syndrome (ards)
4882272|NCT02166853|Sevoflurane|sevoflurane
4882273|NCT02166853|Mechanical ventilation|mechanical ventilation
4882274|NCT02166853|Intensive Care Unit (ICU)|intensive care unit (icu)
4882275|NCT02166853|Prospective study|prospective study
4882276|NCT02166853|Lung injury|lung injury
4882277|NCT02166853|Gas exchange|gas exchange
4882278|NCT02166853|Inflammation|inflammation
4882279|NCT02166853|Receptor for advanced glycation end-produts (RAGE)|receptor for advanced glycation end-produts (rage)
4882280|NCT02166853|sRAGE|srage
4882281|NCT02166827|TMS|tms
4882282|NCT02166827|Cognitive Stimulation|cognitive stimulation
4882283|NCT02166827|NeuroAD|neuroad
4882284|NCT02166801|Cerebral palsy|cerebral palsy
4882285|NCT02166801|Children|children
4882286|NCT02166801|Early Intervention|early intervention
4882287|NCT02166801|Communication|communication
4882288|NCT02166801|Gross motor function|gross motor function
4882289|NCT02166801|Hand function|hand function
4882290|NCT02166788|metastatic melanoma|metastatic melanoma
4882291|NCT02166788|groin lymph nodes|groin lymph nodes
4882292|NCT02166788|surgery|surgery
4882293|NCT02166788|lymphadenectomy|lymphadenectomy
4882294|NCT02166762|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
4882295|NCT02166762|Biventricular implantable cardioverter defibrillators|biventricular implantable cardioverter defibrillators
4882296|NCT02166762|Heart failure|heart failure
4882297|NCT02166762|Cardiomyopathy|cardiomyopathy
4882298|NCT02166762|QLV|qlv
4882299|NCT02166762|LV lead placement|lv lead placement
4882300|NCT02166762|Arrhythmia|arrhythmia
4882301|NCT02166749|Hysterectomy, long term follow up, subjective outcome|hysterectomy, long term follow up, subjective outcome
4882302|NCT02166736|Instantaneous wave Free Ratio|instantaneous wave free ratio
4882303|NCT02166736|Fractional Flow Reserve|fractional flow reserve
4882304|NCT02166723|persistent atrial fibrillation|persistent atrial fibrillation
4882305|NCT02166723|Cryoballoon ablation|cryoballoon ablation
4882306|NCT02166710|Knee arthroplasty|knee arthroplasty
4882307|NCT02166710|Adductor canal block|adductor canal block
4882308|NCT02166710|Quadriceps strength|quadriceps strength
4882309|NCT02166697|Pharmacological therapy|pharmacological therapy
4882310|NCT02166684|Do-it-yourself devices|do-it-yourself devices
4882311|NCT02166684|User-experiences|user-experiences
4882312|NCT02166684|Health behavior|health behavior
4882313|NCT02166684|Self-measurement|self-measurement
4882314|NCT02166684|Methodology, Evaluation|methodology, evaluation
4882315|NCT02166684|Personal health records|personal health records
4882316|NCT02166684|Blood Glucose Self-Monitoring|blood glucose self-monitoring
4882317|NCT02166684|Self Blood Pressure Monitoring|self blood pressure monitoring
4882318|NCT02166658|Patients with breast or lung cancer and recurrent or progressive brain|patients with breast or lung cancer and recurrent or progressive brain
4882319|NCT02166658|metastases|metastases
4882320|NCT02166645|patient positioning|patient positioning
4882321|NCT02166645|premature infant|premature infant
4882322|NCT02166645|mechanical ventilation|mechanical ventilation
4882323|NCT02166645|airway extubation|airway extubation
4882324|NCT02166632|Knee arthroplasty|knee arthroplasty
4882325|NCT02166632|Exparel|exparel
4882326|NCT02166632|Bupivacaine liposome|bupivacaine liposome
4882327|NCT02166632|Total knee replacement|total knee replacement
4882328|NCT02166632|Pain control|pain control
4882329|NCT02166619|Stroke|stroke
4882330|NCT02166619|Rehabilitation|rehabilitation
4882331|NCT02166619|Electric stimulation therapy|electric stimulation therapy
4882332|NCT02166619|Neuroplasticity|neuroplasticity
4882333|NCT02166567|intracytoplasmic sperm injection|intracytoplasmic sperm injection
4882334|NCT02166567|Male infertility|male infertility
4882335|NCT02166567|apoptosis|apoptosis
4882336|NCT02166567|flow cytometry and sorting|flow cytometry and sorting
4882337|NCT02166567|DNA fragmentation|dna fragmentation
4882338|NCT02166554|Adhesions|adhesions
4882339|NCT02166554|Hyaluronan|hyaluronan
4882340|NCT02166554|Gynaecological surgery|gynaecological surgery
4882341|NCT02166554|Clinical outcomes|clinical outcomes
4882342|NCT02166541|cerebral palsy, spastic, diplegic,|cerebral palsy, spastic, diplegic,
4882343|NCT02166541|children,|children,
4882344|NCT02166541|intervention study,|intervention study,
4882345|NCT02166541|manipulation, spinal|manipulation, spinal
4882346|NCT02166541|randomized controlled trial|randomized controlled trial
4882347|NCT02166528|female pelvic floor dysfunction|female pelvic floor dysfunction
4882348|NCT02166528|pelvic organ prolaps|pelvic organ prolaps
4882349|NCT02166528|urinary incontinence|urinary incontinence
4882350|NCT02166528|massively parallel sequencing|massively parallel sequencing
4882351|NCT02166515|cervical cancer|cervical cancer
4882352|NCT02166515|ovarian cancer|ovarian cancer
4882353|NCT02166515|endometrial cancer|endometrial cancer
4882354|NCT02166515|high-throughput sequencing|high-throughput sequencing
4882355|NCT02166502|pediatric|pediatric
4882357|NCT02166502|prevention|prevention
4882358|NCT02166502|prophylaxis|prophylaxis
4882359|NCT02166502|nevirapine|nevirapine
4882360|NCT02166489|autologous mesenchymal stem cells|autologous mesenchymal stem cells
4882361|NCT02166489|polycystic kidney disease|polycystic kidney disease
4882362|NCT02166489|intravenous injection|intravenous injection
4882363|NCT02166489|CRF|crf
4882364|NCT02166450|Denture stomatitis|denture stomatitis
4882366|NCT02166450|Denture wearers|denture wearers
4882367|NCT02166437|osteoporosis|osteoporosis
4882368|NCT02166437|BMD|bmd
4882369|NCT02166437|teriparatide|teriparatide
4882370|NCT02166437|bisphosphonate|bisphosphonate
4882371|NCT02166437|denosmab|denosmab
4882372|NCT02166424|Pregnancy|pregnancy
4882373|NCT02166424|Depression|depression
4882374|NCT02166424|omega-3 fatty acids|omega-3 fatty acids
4882375|NCT02166411|Myomectomy ,Laparoscopy , Barbed sutures|myomectomy ,laparoscopy , barbed sutures
4882376|NCT02166398|Amlodipine basylate, Losartan potassium|amlodipine basylate, losartan potassium
4882377|NCT02166359|Icodextrin|icodextrin
4882378|NCT02166359|Triglyceride|triglyceride
4882379|NCT02166346|Transverse myelitis|transverse myelitis
4882380|NCT02166333|vitamin D|vitamin d
4882381|NCT02166333|falls|falls
4882382|NCT02166333|high risk of falling|high risk of falling
4882383|NCT02166333|insufficient or deficient serum vitamin D levels|insufficient or deficient serum vitamin d levels
4882384|NCT02166333|10-29 ng/ml|10-29 ng/ml
4882385|NCT02166307|formaldehyde; Maillard Reaction; cross-linkage; human aging|formaldehyde; maillard reaction; cross-linkage; human aging
4882386|NCT02166294|Foot|foot
4882387|NCT02166294|Ulcer|ulcer
4882388|NCT02166294|Diabetes|diabetes
4882389|NCT02166294|Amputation|amputation
4882390|NCT02166294|Limb salvage|limb salvage
4882391|NCT02166281|Insomnia|insomnia
4882392|NCT02166281|Anxiety|anxiety
4882393|NCT02166281|Depression|depression
4882394|NCT02166281|Restless leg syndrome|restless leg syndrome
4882395|NCT02166281|Aromatase inhibitor|aromatase inhibitor
4882396|NCT02166281|Body composition|body composition
4882397|NCT02166268|Allergic rhinoconjunctivitis|allergic rhinoconjunctivitis
4882398|NCT02166268|Allergic rhinitis|allergic rhinitis
4882399|NCT02166268|Allergy|allergy
4882400|NCT02166268|Grass pollen|grass pollen
4882401|NCT02166242|non-small cell lung cancer|non-small cell lung cancer
4882402|NCT02166242|thioredoxin reductase|thioredoxin reductase
4882403|NCT02166216|Prolonged high intensity exercise|prolonged high intensity exercise
4882404|NCT02166216|Healthy subjects|healthy subjects
4882405|NCT02166216|Cardiovascular risk markers|cardiovascular risk markers
4882406|NCT02166216|Troponin|troponin
4882407|NCT02166216|Leisure sports athletes|leisure sports athletes
4882408|NCT02166216|Cycling|cycling
4882409|NCT02166216|CT coronary angiography|ct coronary angiography
4882410|NCT02166216|Outcomes|outcomes
4882411|NCT02166190|Pancreatic cancer|pancreatic cancer
4882412|NCT02166190|cholangiocarcinoma|cholangiocarcinoma
4882413|NCT02166190|radiofrequency ablation|radiofrequency ablation
4882414|NCT02166164|Pain|pain
4882415|NCT02166164|Secondary hyperalgesia|secondary hyperalgesia
4882416|NCT02166164|thermal sensitization|thermal sensitization
4882417|NCT02166164|Catastrophization|catastrophization
4882418|NCT02166164|Anxiety|anxiety
4882419|NCT02166125|gastric bypass|gastric bypass
4882420|NCT02166125|sleeve gastrectomy|sleeve gastrectomy
4882421|NCT02166125|esophageal stent|esophageal stent
4882422|NCT02166125|suturing|suturing
4882423|NCT02166112|Hernia of Abdominal Wall|hernia of abdominal wall
4882424|NCT02166112|Biologic implant|biologic implant
4882425|NCT02166112|Infected Hernioplasty Mesh|infected hernioplasty mesh
4882426|NCT02166047|Hepatitis B|hepatitis b
4882427|NCT02166047|HBV|hbv
4882428|NCT02166047|GS-9620|gs-9620
4882429|NCT02166047|TLR-7 Agonist|tlr-7 agonist
4882430|NCT02166034|children|children
4882431|NCT02166034|fruit|fruit
4882432|NCT02166034|vegetable|vegetable
4882433|NCT02166034|diet|diet
4882434|NCT02166034|school|school
4882435|NCT02166034|garden|garden
4882436|NCT02166021|Multiple Sclerosis (MS)|multiple sclerosis (ms)
4882437|NCT02166021|Stem Cells|stem cells
4882438|NCT02166008|Repamipide|repamipide
4882439|NCT02166008|Dual antiplatelet|dual antiplatelet
4882440|NCT02166008|Peptic ulcer|peptic ulcer
4882441|NCT02165995|Brain Tumor|brain tumor
4882442|NCT02165995|Glioma|glioma
4882443|NCT02165995|Tumor resection|tumor resection
4882444|NCT02165995|Navigated Transcranial Magnetic Stimulation|navigated transcranial magnetic stimulation
4882445|NCT02165995|nTMS|ntms
4882446|NCT02165995|Brain mapping|brain mapping
4882447|NCT02165995|Motor function|motor function
4882448|NCT02165995|Speech function|speech function
4882449|NCT02165995|Speech mapping|speech mapping
4882450|NCT02165969|tumor|tumor
4882451|NCT02165969|inflammatory process|inflammatory process
4882452|NCT02165969|fracture|fracture
4882453|NCT02165969|defect|defect
4882454|NCT02165956|Cereals|cereals
4882455|NCT02165956|Obesity|obesity
4882456|NCT02165956|Complementary Feeding|complementary feeding
4882457|NCT02165930|Bioavailability|bioavailability
4882458|NCT02165930|oxycodone|oxycodone
4882459|NCT02165930|ethanol interaction|ethanol interaction
4882460|NCT02165930|healthy volunteers|healthy volunteers
4882461|NCT02165917|Endometriosis|endometriosis
4882462|NCT02165917|Adhesions|adhesions
4882463|NCT02165917|Hyalobarrier®|hyalobarrier®
4882464|NCT02165917|Hyaluronic acid|hyaluronic acid
4882465|NCT02165917|Antiadhesion agent|antiadhesion agent
4882466|NCT02165917|Adhesionbarrier|adhesionbarrier
4882467|NCT02165917|Pregnancy rate|pregnancy rate
4882565|NCT02165397|WM|wm
4882566|NCT02165397|Rituximab|rituximab
4882468|NCT02165904|Analyze clinical efficacy of subarachnoid administration of|analyze clinical efficacy of subarachnoid administration of
4882469|NCT02165904|"autologous BMSC expanded in vitro"|"autologous bmsc expanded in vitro"
4882470|NCT02165878|Chronic kidney disease(CKD)|chronic kidney disease(ckd)
4882471|NCT02165865|hand transplantation|hand transplantation
4882472|NCT02165865|hand allotransplantation|hand allotransplantation
4882473|NCT02165865|upper extremity transplantation|upper extremity transplantation
4882474|NCT02165865|upper extremity amputation|upper extremity amputation
4882475|NCT02165865|hand amputation|hand amputation
4882476|NCT02165865|vascularized composite allotransplantation|vascularized composite allotransplantation
4882477|NCT02165865|composite tissue allotransplantation|composite tissue allotransplantation
4882478|NCT02165865|variance component analysis (VCA)|variance component analysis (vca)
4882479|NCT02165865|composite tissue allograft (CTA)|composite tissue allograft (cta)
4882480|NCT02165852|ampulla of Vater|ampulla of vater
4882481|NCT02165852|adenoma|adenoma
4882482|NCT02165852|papillectomy|papillectomy
4882483|NCT02165852|injection|injection
4882484|NCT02165852|non-injection|non-injection
4882485|NCT02165826|Drug therapy|drug therapy
4882486|NCT02165774|sacral neuromodulation, neurogenic lower urinary tract dysfunction|sacral neuromodulation, neurogenic lower urinary tract dysfunction
4882487|NCT02165761|Hemodialysis|hemodialysis
4882488|NCT02165761|End Stage Renal Disease|end stage renal disease
4882489|NCT02165761|Vascular Graft|vascular graft
4882490|NCT02165722|Influenza|influenza
4882491|NCT02165722|HPV|hpv
4882492|NCT02165722|Tdap|tdap
4882493|NCT02165722|MCV|mcv
4882494|NCT02165722|vaccination|vaccination
4882495|NCT02165722|adolescents|adolescents
4882496|NCT02165696|compression bandage, manual lymphatic drainage, lymphedema, breast cancer, qualitative research.|compression bandage, manual lymphatic drainage, lymphedema, breast cancer, qualitative research.
4882497|NCT02165683|Cancer|cancer
4882498|NCT02165683|Pediatric|pediatric
4882499|NCT02165683|PET Scan|pet scan
4882500|NCT02165670|Ischemic heart disesase|ischemic heart disesase
4882501|NCT02165670|Myocardial infarction|myocardial infarction
4882502|NCT02165670|Angina pectoris|angina pectoris
4882503|NCT02165657|Excimer laser|excimer laser
4882504|NCT02165657|UVB|uvb
4882505|NCT02165657|Psoriasis|psoriasis
4882506|NCT02165644|Subarachnoid Hemorrhage|subarachnoid hemorrhage
4882507|NCT02165644|Vasospasm|vasospasm
4882508|NCT02165644|Acetazolamide|acetazolamide
4882509|NCT02165618|frailty|frailty
4882510|NCT02165618|geriatric, elderly|geriatric, elderly
4882511|NCT02165618|polypharmacy|polypharmacy
4882512|NCT02165605|external beam radiotherapy|external beam radiotherapy
4882513|NCT02165605|breast cancer|breast cancer
4882514|NCT02165592|Hemophilia|hemophilia
4882515|NCT02165592|Arthropathy|arthropathy
4882516|NCT02165592|Range of Motion|range of motion
4882517|NCT02165592|Strength|strength
4882518|NCT02165592|Proprioception|proprioception
4882519|NCT02165592|Gait|gait
4882520|NCT02165592|Quality of Life|quality of life
4882521|NCT02165579|procalcitonin|procalcitonin
4882522|NCT02165579|biomarkers|biomarkers
4882523|NCT02165579|Osteomyelitis|osteomyelitis
4882524|NCT02165579|diabetes|diabetes
4882525|NCT02165579|foot ulcer(s)|foot ulcer(s)
4882526|NCT02165579|Infectious Disease Society of America stage 3 infection|infectious disease society of america stage 3 infection
4882527|NCT02165566|intensive insulin therapy|intensive insulin therapy
4882528|NCT02165566|critical care patients|critical care patients
4882529|NCT02165566|blood glucose concentration>180 mg/dl|blood glucose concentration>180 mg/dl
4882530|NCT02165553|Hibiscus sabdariffa calyces|hibiscus sabdariffa calyces
4882531|NCT02165553|Blood Pressure|blood pressure
4882532|NCT02165553|Vascular Function|vascular function
4882533|NCT02165553|Inflammation|inflammation
4882534|NCT02165553|Cardiometabolic risk markers|cardiometabolic risk markers
4882535|NCT02165553|Systemic antioxidant capacity|systemic antioxidant capacity
4882536|NCT02165540|Doula|doula
4882537|NCT02165540|Pain management|pain management
4882538|NCT02165540|Miscarriage|miscarriage
4882539|NCT02165540|Abortion|abortion
4882540|NCT02165514|spinal curvatures|spinal curvatures
4882541|NCT02165488|ketamine|ketamine
4882542|NCT02165488|abuse|abuse
4882543|NCT02165488|abdominal discomfort|abdominal discomfort
4882544|NCT02165488|cholangiopathy|cholangiopathy
4882545|NCT02165462|Haemophilia|haemophilia
4882546|NCT02165462|Arthropathy|arthropathy
4882547|NCT02165462|Bilateral deficit phenomenon|bilateral deficit phenomenon
4882548|NCT02165462|Proprioception|proprioception
4882549|NCT02165449|ketamine|ketamine
4882550|NCT02165449|major depression|major depression
4882551|NCT02165449|imaging|imaging
4882552|NCT02165449|gene expression|gene expression
4882553|NCT02165423|pediatric|pediatric
4882554|NCT02165423|solid organ transplant|solid organ transplant
4882555|NCT02165423|parents|parents
4882556|NCT02165423|heart|heart
4882557|NCT02165423|kidney|kidney
4882558|NCT02165423|liver|liver
4882559|NCT02165410|Autism, mental retardation, Magnetic Resonance Imaging|autism, mental retardation, magnetic resonance imaging
4882560|NCT02165397|Ibrutinib|ibrutinib
4882561|NCT02165397|Pharmacyclics|pharmacyclics
4882562|NCT02165397|PCYC|pcyc
4882563|NCT02165397|Lymphoma|lymphoma
4882564|NCT02165397|Btk inhibitor|btk inhibitor
4882567|NCT02165397|Rituxan|rituxan
4882568|NCT02165397|Waldenström's|waldenström's
4882569|NCT02165397|Waldenstrom Macroglobulinemia|waldenstrom macroglobulinemia
4882570|NCT02165397|non-Hodgkin lymphoma|non-hodgkin lymphoma
4882571|NCT02165397|NHL|nhl
4882572|NCT02165384|tympanostomy|tympanostomy
4882573|NCT02165384|myringotomy|myringotomy
4882574|NCT02165384|otitis media|otitis media
4882575|NCT02165384|ear tubes|ear tubes
4882576|NCT02165384|ear infection|ear infection
4882577|NCT02165358|BMD|bmd
4882578|NCT02165358|LGMD2I|lgmd2i
4882579|NCT02165358|Calf enlargement|calf enlargement
4882580|NCT02165358|Muscular dystrophy|muscular dystrophy
4882581|NCT02165358|MRI|mri
4882582|NCT02165306|epilepsy|epilepsy
4882583|NCT02165280|Pelvic Organ Prolapse|pelvic organ prolapse
4882584|NCT02165280|Surgery|surgery
4882585|NCT02165254|physical activity|physical activity
4882586|NCT02165254|coronary heart disease|coronary heart disease
4882587|NCT02165254|exercise|exercise
4882588|NCT02165254|affect|affect
4882589|NCT02165254|mind/body therapies|mind/body therapies
4882590|NCT02165254|stress, psychological|stress, psychological
4882591|NCT02165241|Hypertension|hypertension
4882592|NCT02165241|Cardiac remodeling|cardiac remodeling
4882593|NCT02165241|Immune system|immune system
4882594|NCT02165202|HIV Pre-exposure Prophylaxis;|hiv pre-exposure prophylaxis;
4882595|NCT02165202|long-acting injectable;|long-acting injectable;
4882596|NCT02165202|HIV PrEP;|hiv prep;
4882597|NCT02165202|biomedical HIV prevention research|biomedical hiv prevention research
4882598|NCT02165189|Simeprevir|simeprevir
4882599|NCT02165189|Sofosbuvir|sofosbuvir
4882600|NCT02165189|Ribavirin|ribavirin
4882601|NCT02165189|Hepatitits C|hepatitits c
4882602|NCT02165189|Hepatitis C virus ribonucleic acid|hepatitis c virus ribonucleic acid
4882603|NCT02165176|cannabis|cannabis
4882604|NCT02165176|toxicology|toxicology
4882605|NCT02165176|intoxication|intoxication
4882606|NCT02165150|Elastic Band|elastic band
4882607|NCT02165150|Institutional Elders|institutional elders
4882608|NCT02165150|Functional Fitness|functional fitness
4882609|NCT02165150|Sleep Quality|sleep quality
4882610|NCT02165150|Depression|depression
4882611|NCT02165137|trauma|trauma
4882612|NCT02165137|major trauma|major trauma
4882613|NCT02165137|multiple trauma|multiple trauma
4882614|NCT02165137|outcome|outcome
4882615|NCT02165137|quality|quality
4882616|NCT02165137|process Management|process management
4882617|NCT02165137|emergency room|emergency room
4882618|NCT02165137|trauma center|trauma center
4882619|NCT02165124|Obesity|obesity
4882620|NCT02165124|Morbid Obesity|morbid obesity
4882621|NCT02165124|Bariatric Surgery|bariatric surgery
4882622|NCT02165124|Embolization|embolization
4882623|NCT02165124|Minimally Invasive|minimally invasive
4882624|NCT02165124|Weight Loss|weight loss
4882625|NCT02165111|Scleroderma, Systemic|scleroderma, systemic
4882626|NCT02165111|Raynaud Disease|raynaud disease
4882627|NCT02165111|Botulinum Toxins, Type A|botulinum toxins, type a
4882628|NCT02165085|Biomarkers|biomarkers
4882629|NCT02165085|Ehlers-Danlos syndrome, vascular type|ehlers-danlos syndrome, vascular type
4882630|NCT02165085|Pathophysiology|pathophysiology
4882631|NCT02165072|Inferior vena cava|inferior vena cava
4882632|NCT02165072|Kidney injury|kidney injury
4882633|NCT02165072|Ultrasound|ultrasound
4882634|NCT02165059|Nausea|nausea
4882635|NCT02165059|Vomiting|vomiting
4882636|NCT02165059|Functional dyspepsia|functional dyspepsia
4882637|NCT02165059|Bloating|bloating
4882638|NCT02165059|Regurgitation|regurgitation
4882639|NCT02165059|Retching|retching
4882640|NCT02165020|Prostate|prostate
4882641|NCT02165020|Hypofractionated radiotherapy|hypofractionated radiotherapy
4882642|NCT02165020|Hyaluronic acid|hyaluronic acid
4882643|NCT02165020|Spacer|spacer
4882644|NCT02165020|Rectum toxicity|rectum toxicity
4882645|NCT02165020|Rectal toxicities after hypofractionated irradiation and injection of hyaluronic acid in patients with low- to intermediate-risk Prostate Cancer|rectal toxicities after hypofractionated irradiation and injection of hyaluronic acid in patients with low- to intermediate-risk prostate cancer
4882646|NCT02164994|Astigmatism, arcuate incisions, astigmatic keratotomy|astigmatism, arcuate incisions, astigmatic keratotomy
4882647|NCT02164968|Device investigation|device investigation
4882648|NCT02164955|Pomalidomide|pomalidomide
4882649|NCT02164955|Multiple Myeloma|multiple myeloma
4882650|NCT02164955|Relapsed, Refractory|relapsed, refractory
4882651|NCT02164955|Observational|observational
4882652|NCT02164955|Imnovid|imnovid
4882653|NCT02164955|Registry|registry
4882654|NCT02164955|Post-approval|post-approval
4882655|NCT02164955|Safety|safety
4882656|NCT02164929|TAP block|tap block
4882657|NCT02164929|Paravertebral block|paravertebral block
4882658|NCT02164929|Epidural|epidural
4882659|NCT02164929|Laparoscopic colectomy|laparoscopic colectomy
4882660|NCT02164916|BRAF Mutant|braf mutant
4882661|NCT02164916|Metastatic|metastatic
4882662|NCT02164903|Quality of Life|quality of life
4882663|NCT02164903|Chronic Myeloid Leukemia|chronic myeloid leukemia
4882664|NCT02164903|Imatinib|imatinib
4882665|NCT02164903|Dasatinib|dasatinib
4882666|NCT02164877|Dietary fiber|dietary fiber
4882667|NCT02164851|shock, emergencies, inflammation, infection|shock, emergencies, inflammation, infection
4882668|NCT02164851|pathologic process|pathologic process
4882669|NCT02164799|Shock|shock
4882670|NCT02164799|Predicting diagnosis|predicting diagnosis
4882671|NCT02164799|Predicting adverse outcomes|predicting adverse outcomes
4882672|NCT02164786|Acute severe disease|acute severe disease
4882673|NCT02164786|Intensive care unit|intensive care unit
4882674|NCT02164786|adult|adult
4882675|NCT02164786|cohort study|cohort study
4882676|NCT02164786|metabolomics|metabolomics
4882677|NCT02164786|NMR|nmr
4882678|NCT02164786|High Performance Liquid Chromatography|high performance liquid chromatography
4882679|NCT02164773|sevoflurane|sevoflurane
4882680|NCT02164773|pediatric|pediatric
4882681|NCT02164773|lower abdominal surgery|lower abdominal surgery
4882682|NCT02164773|caudal|caudal
4882683|NCT02164773|magnesium sulfate|magnesium sulfate
4882684|NCT02164773|Magnesium Sulfate Causing Adverse Effects in Therapeutic Use|magnesium sulfate causing adverse effects in therapeutic use
4882685|NCT02164773|Agitation States as Acute Reaction to Exceptional Stress|agitation states as acute reaction to exceptional stress
4882686|NCT02164760|burns|burns
4882687|NCT02164760|dermal substitute|dermal substitute
4882688|NCT02164760|scar quality|scar quality
4882689|NCT02164760|reconstruction|reconstruction
4882690|NCT02164760|wound healing|wound healing
4882691|NCT02164760|wound closure|wound closure
4882692|NCT02164734|surfactant|surfactant
4882693|NCT02164721|Heart failure|heart failure
4882694|NCT02164721|Chemotherapy-induced cardiomyopathy|chemotherapy-induced cardiomyopathy
4882695|NCT02164721|Cardiac resynchronization therapy|cardiac resynchronization therapy
4882696|NCT02164708|mindfulness meditation, mental health, self-criticism|mindfulness meditation, mental health, self-criticism
4882697|NCT02164695|ST-segment elevation myocardial infarction|st-segment elevation myocardial infarction
4882698|NCT02164695|Remote ischemic perconditioning|remote ischemic perconditioning
4882699|NCT02164695|Primary percutaneous coronary intervention|primary percutaneous coronary intervention
4882700|NCT02164695|Cardiac magnetic resonance|cardiac magnetic resonance
4882701|NCT02164682|Hypospadias repair|hypospadias repair
4882702|NCT02164682|Caudal block|caudal block
4882703|NCT02164682|Postoperative complications|postoperative complications
4882704|NCT02164669|Inflammation|inflammation
4882705|NCT02164669|Coronary artery bypass graft|coronary artery bypass graft
4882706|NCT02164669|Magnetic Resonance Imaging|magnetic resonance imaging
4882707|NCT02164643|Alzheimer's disease|alzheimer's disease
4882708|NCT02164643|Mild Cognitive Impairment|mild cognitive impairment
4882709|NCT02164630|Temporomandibular Joint Disorder|temporomandibular joint disorder
4882710|NCT02164630|TMD|tmd
4882711|NCT02164630|Hope|hope
4882712|NCT02164630|Resilience|resilience
4882713|NCT02164630|Cognitive Behavior Therapy|cognitive behavior therapy
4882714|NCT02164617|Dementia|dementia
4882715|NCT02164617|Wheelchair-bound seniors|wheelchair-bound seniors
4882716|NCT02164617|Long-term care facilities|long-term care facilities
4882717|NCT02164617|Elastic band exercise|elastic band exercise
4882718|NCT02164617|Functional fitness|functional fitness
4882719|NCT02164617|Daily life function|daily life function
4882720|NCT02164617|Depression|depression
4882721|NCT02164617|Problem behaviors|problem behaviors
4882722|NCT02164604|ranibizumab|ranibizumab
4882723|NCT02164604|intravitreal therapy|intravitreal therapy
4882724|NCT02164604|ROP|rop
4882725|NCT02164604|Plus disease|plus disease
4882726|NCT02164604|stage 3 plus|stage 3 plus
4882727|NCT02164591|gastroparesis|gastroparesis
4882728|NCT02164591|gastric electrical stimulator|gastric electrical stimulator
4882729|NCT02164591|GES|ges
4882730|NCT02164591|vomiting|vomiting
4882731|NCT02164591|nausea|nausea
4882732|NCT02164591|bloating|bloating
4882733|NCT02164591|postprandial fullness|postprandial fullness
4882734|NCT02164591|epigastric pain|epigastric pain
4882735|NCT02164552|PCOS|pcos
4882736|NCT02164552|vitamin D|vitamin d
4882737|NCT02164552|insulin resistance|insulin resistance
4882738|NCT02164552|glycemic control|glycemic control
4882739|NCT02164539|GSK573719|gsk573719
4882740|NCT02164539|asthma|asthma
4882741|NCT02164539|UMEC|umec
4882742|NCT02164539|FF|ff
4882743|NCT02164539|GSK2829332|gsk2829332
4882744|NCT02164539|persistent obstruction|persistent obstruction
4882745|NCT02164539|GW685698|gw685698
4882746|NCT02164539|Fluticasone Furoate|fluticasone furoate
4882747|NCT02164539|COPD|copd
4882748|NCT02164539|umeclidinium bromide|umeclidinium bromide
4882749|NCT02164526|Pulmonary Hypertension|pulmonary hypertension
4882750|NCT02164526|Left Heart Disease|left heart disease
4882751|NCT02164526|Heart failure|heart failure
4882752|NCT02164526|Registry|registry
4882753|NCT02164526|China|china
4882754|NCT02164513|COPD|copd
4882755|NCT02164513|umeclidinium|umeclidinium
4882756|NCT02164513|fluticasone furoate|fluticasone furoate
4882757|NCT02164513|vilanterol|vilanterol
4882758|NCT02164513|triple therapy|triple therapy
4882759|NCT02164513|exacerbation|exacerbation
4882760|NCT02164487|B1 adolescents Eating disorders Thaimine|b1 adolescents eating disorders thaimine
4882761|NCT02164461|Adenocarcinoma|adenocarcinoma
4882762|NCT02164461|Carcinoma|carcinoma
4882763|NCT02164461|Carcinoma, Squamous Cell|carcinoma, squamous cell
4882764|NCT02164461|Uterine Cervical Neoplasms|uterine cervical neoplasms
4882765|NCT02164461|Small Cell Lung Carcinoma|small cell lung carcinoma
4882766|NCT02164461|Carcinoma, Small Cell|carcinoma, small cell
4882767|NCT02164461|Carcinoma, Adenosquamous|carcinoma, adenosquamous
4882768|NCT02164461|Neoplasms, Glandular and Epithelial|neoplasms, glandular and epithelial
4882769|NCT02164461|Neoplasms by Histologic Type|neoplasms by histologic type
4882770|NCT02164461|Neoplasms|neoplasms
4882771|NCT02164461|Neoplasms, Squamous Cell|neoplasms, squamous cell
4882772|NCT02164461|Uterine Neoplasms|uterine neoplasms
4882773|NCT02164461|Genital Neoplasms, Female|genital neoplasms, female
4882774|NCT02164461|Urogenital Neoplasms|urogenital neoplasms
4882775|NCT02164461|Neoplasms by Site|neoplasms by site
4882776|NCT02164461|Uterine Cervical Diseases|uterine cervical diseases
4882777|NCT02164461|Uterine Diseases|uterine diseases
4882778|NCT02164461|Genital Diseases, Female|genital diseases, female
4882779|NCT02164448|dexmedetomidine|dexmedetomidine
4882780|NCT02164448|postoperative bowel movement|postoperative bowel movement
4882781|NCT02164448|laparoscopic gastrectomy|laparoscopic gastrectomy
4882782|NCT02164435|Uncontrolled hypertension|uncontrolled hypertension
4882783|NCT02164435|Renal denervation|renal denervation
4882784|NCT02164435|Renal artery|renal artery
4882785|NCT02164422|Alcohol|alcohol
4882786|NCT02164422|Drinkers|drinkers
4882787|NCT02164422|Guanfacine|guanfacine
4882788|NCT02164383|Smoking Cessation|smoking cessation
4882789|NCT02164383|Smoking|smoking
4882790|NCT02164383|Nicotine|nicotine
4882791|NCT02164357|Ischaemic Stroke|ischaemic stroke
4882792|NCT02164357|Main artery occlusion|main artery occlusion
4882793|NCT02164357|Endovascular treatment|endovascular treatment
4882794|NCT02164357|Intravenous Thrombolytic Therapy|intravenous thrombolytic therapy
4882795|NCT02164344|HIV|hiv
4882796|NCT02164344|Gut|gut
4882797|NCT02164344|probiotics|probiotics
4882798|NCT02164344|immune activation|immune activation
4882799|NCT02164305|Rotator cuff muscle|rotator cuff muscle
4882800|NCT02164305|Excitability|excitability
4882801|NCT02164305|Proprioception|proprioception
4882802|NCT02164305|Kinematics|kinematics
4882803|NCT02164305|Muscle activity|muscle activity
4882804|NCT02164305|Electromyography|electromyography
4882805|NCT02164292|Liver tumor|liver tumor
4882806|NCT02164292|ALPPS|alpps
4882807|NCT02164292|Two-stage hepatectomy|two-stage hepatectomy
4882808|NCT02164292|Morbidity|morbidity
4882809|NCT02164292|Hypertrophy|hypertrophy
4882810|NCT02164279|Microalbuminuria|microalbuminuria
4882811|NCT02164279|diabetic nephropathy|diabetic nephropathy
4882812|NCT02164279|type I diabetes|type i diabetes
4882813|NCT02164279|early predictive urinary biomarkers|early predictive urinary biomarkers
4882814|NCT02164240|Gastrointestinal Stromal Tumor|gastrointestinal stromal tumor
4882815|NCT02164227|anxiety|anxiety
4882816|NCT02164227|breathing exercise|breathing exercise
4882817|NCT02164227|labour|labour
4882818|NCT02164201|Type A Aortic Dissection (where the use of BioFoam is limited to the anastomotic site)|type a aortic dissection (where the use of biofoam is limited to the anastomotic site)
4882819|NCT02164188|Stress|stress
4882820|NCT02164188|Well-being|well-being
4882821|NCT02164188|Functional magnetic resonance imaging|functional magnetic resonance imaging
4882822|NCT02164188|Positive psychology|positive psychology
4882823|NCT02164175|HeRO Graft|hero graft
4882824|NCT02164162|Parkinson's disease, Lokomat, gait training, rehabilitation.|parkinson's disease, lokomat, gait training, rehabilitation.
4882825|NCT02164149|Colon cancer|colon cancer
4882826|NCT02164149|Quality of surgery|quality of surgery
4882827|NCT02164149|Length of tumour feeding artery|length of tumour feeding artery
4882828|NCT02164123|Autonomic effects|autonomic effects
4882829|NCT02164123|spinal mobilization|spinal mobilization
4882830|NCT02164123|clinical trial|clinical trial
4882831|NCT02164097|ICE|ice
4882832|NCT02164097|ODSH|odsh
4882833|NCT02164097|platelet recovery|platelet recovery
4882834|NCT02164097|recurrent solid tumor|recurrent solid tumor
4882835|NCT02164084|acne|acne
4882836|NCT02164071|Haematological malignancy|haematological malignancy
4882837|NCT02164071|Elderly|elderly
4882838|NCT02164071|Health Status|health status
4882839|NCT02164071|Scale validation|scale validation
4882840|NCT02164058|Myocardial infarction|myocardial infarction
4882841|NCT02164058|STEMI|stemi
4882842|NCT02164058|ST elevation MI|st elevation mi
4882843|NCT02164058|Acute MI|acute mi
4882844|NCT02164019|Pathologic Fractures|pathologic fractures
4882845|NCT02164019|hip replacements|hip replacements
4882846|NCT02164019|12-287|12-287
4882847|NCT02164006|Hodgkin's|hodgkin's
4882848|NCT02163980|dexmedetomidine|dexmedetomidine
4882849|NCT02163980|caudal block|caudal block
4882850|NCT02163980|children|children
4882851|NCT02163980|children (1-6 years) undergoing ambulatory orchipexy|children (1-6 years) undergoing ambulatory orchipexy
4882852|NCT02163967|cranial electrical stimulation|cranial electrical stimulation
4882853|NCT02163967|CES|ces
4882854|NCT02163967|heart rate variability|heart rate variability
4882855|NCT02163967|parasympathetic|parasympathetic
4882856|NCT02163967|Vagal|vagal
4882857|NCT02163954|platelet|platelet
4882858|NCT02163954|ticagrelor|ticagrelor
4882859|NCT02163954|clopidogrel|clopidogrel
4882860|NCT02163954|end stage renal disease|end stage renal disease
4882861|NCT02163954|hemodialysis|hemodialysis
4882862|NCT02163941|PTSD|ptsd
4882863|NCT02163941|empathy|empathy
4882864|NCT02163941|meditation|meditation
4882865|NCT02163941|compassion|compassion
4882866|NCT02163941|inflammation|inflammation
4882867|NCT02163941|oxytocin|oxytocin
4882868|NCT02163941|fMRI|fmri
4882869|NCT02163928|Antioxidants|antioxidants
4882870|NCT02163928|Carotenoids|carotenoids
4882871|NCT02163928|Diet|diet
4882872|NCT02163915|Drug therapy|drug therapy
4882873|NCT02163889|Candida|candida
4882874|NCT02163889|Blood culture|blood culture
4882875|NCT02163889|Antifungal therapy|antifungal therapy
4882876|NCT02163889|Sepsis|sepsis
4882877|NCT02163876|spine|spine
4882878|NCT02163876|injury|injury
4882879|NCT02163876|trauma|trauma
4882880|NCT02163876|spine injury|spine injury
4882881|NCT02163876|cervical spine injury|cervical spine injury
4882882|NCT02163876|cervical spine|cervical spine
4882883|NCT02163876|stemcells transplantation|stemcells transplantation
4882884|NCT02163863|Peripheral arterial disease (PAD)|peripheral arterial disease (pad)
4882885|NCT02163863|Peripheral vascular disease (PVD)|peripheral vascular disease (pvd)
4882886|NCT02163863|Biomimetic stent|biomimetic stent
4882887|NCT02163863|Helical centerline|helical centerline
4882888|NCT02163837|sleep quality|sleep quality
4882889|NCT02163837|physical activity|physical activity
4882890|NCT02163837|daytime sleepiness|daytime sleepiness
4882891|NCT02163837|actigraphy|actigraphy
4882892|NCT02163837|quality of life|quality of life
4882893|NCT02163824|postsurgical|postsurgical
4882894|NCT02163824|postoperative|postoperative
4882895|NCT02163824|ocular|ocular
4882896|NCT02163824|cataract|cataract
4882897|NCT02163824|inflammation|inflammation
4882898|NCT02163824|pain|pain
4882899|NCT02163824|corticosteroid|corticosteroid
4882900|NCT02163811|Self-management|self-management
4882901|NCT02163811|Functional status|functional status
4882902|NCT02163811|Depression|depression
4882903|NCT02163798|Tai Chi|tai chi
4882904|NCT02163798|Walking|walking
4882905|NCT02163798|Physical activity|physical activity
4882906|NCT02163798|Randomized controlled trial|randomized controlled trial
4882907|NCT02163798|Chinese population|chinese population
4882908|NCT02163798|Exercise|exercise
4882909|NCT02163798|Body composition|body composition
4882910|NCT02163798|Cardiovascular risk factor|cardiovascular risk factor
4882911|NCT02163798|Energy expenditure|energy expenditure
4882912|NCT02163798|Fitness|fitness
4882913|NCT02163798|SF-12|sf-12
4882914|NCT02163785|Inferior rectal cancer|inferior rectal cancer
4882915|NCT02163785|Abdominoperineal resection|abdominoperineal resection
4882916|NCT02163785|Miles operation|miles operation
4882917|NCT02163785|Supine Miles operation|supine miles operation
4882918|NCT02163785|Prone Miles operation|prone miles operation
4882919|NCT02163785|Total mesorectal excision|total mesorectal excision
4882920|NCT02163785|Circumferential radial margin|circumferential radial margin
4882921|NCT02163746|Hidradenitis suppurativa|hidradenitis suppurativa
4882922|NCT02163733|oncology, cancer, non small cell lung cancer, anticancer drug, pharmacokinetics, AZD9291, EGFR sensitivity mutation, food effect|oncology, cancer, non small cell lung cancer, anticancer drug, pharmacokinetics, azd9291, egfr sensitivity mutation, food effect
4882923|NCT02163720|ovarian cancer|ovarian cancer
4882924|NCT02163720|fallopian tube or primary peritoneal|fallopian tube or primary peritoneal
4882925|NCT02163720|relapse|relapse
4882926|NCT02163720|platinum-sensitive|platinum-sensitive
4882927|NCT02163720|Yondelis®-Caelyx®|yondelis®-caelyx®
4882928|NCT02163707|Psilocybin|psilocybin
4882929|NCT02163707|Pharmacokinetics|pharmacokinetics
4882930|NCT02163694|PARP Inhibitor|parp inhibitor
4882931|NCT02163694|Veliparib|veliparib
4882932|NCT02163694|BRCA1|brca1
4882933|NCT02163694|BRCA2|brca2
4882934|NCT02163694|HER2-negative|her2-negative
4882935|NCT02163694|Locally recurrent|locally recurrent
4882936|NCT02163694|Breast Cancer|breast cancer
4882937|NCT02163694|Metastatic Breast Cancer|metastatic breast cancer
4882938|NCT02163694|ABT-888|abt-888
4882939|NCT02163694|Genetic breast cancer|genetic breast cancer
4882940|NCT02163694|Paclitaxel|paclitaxel
4882941|NCT02163694|BRCA Mutation|brca mutation
4882942|NCT02163694|PARP|parp
4882943|NCT02163694|Carboplatin|carboplatin
4882944|NCT02163668|Yoga|yoga
4882945|NCT02163668|Bone turnover markers|bone turnover markers
4882946|NCT02163668|Bone strength|bone strength
4882947|NCT02163668|Bone mineral density|bone mineral density
4882948|NCT02163655|preeclampsia, very high blood pressure, diuretics|preeclampsia, very high blood pressure, diuretics
4882949|NCT02163642|Bronchiectasis|bronchiectasis
4882950|NCT02163642|Immunity|immunity
4882951|NCT02163629|Psychotherapeutic intervention|psychotherapeutic intervention
4882952|NCT02163629|stress management|stress management
4882953|NCT02163629|cardiac transplantation|cardiac transplantation
4882954|NCT02163629|quality of life|quality of life
4882955|NCT02163616|Primary postpartum hemorrhage|primary postpartum hemorrhage
4882956|NCT02163616|PPH|pph
4882957|NCT02163616|uterine atony|uterine atony
4882958|NCT02163616|high fever|high fever
4882959|NCT02163616|hyperpyrexia|hyperpyrexia
4882960|NCT02163616|shock index|shock index
4882961|NCT02163590|Spinal mobilisation|spinal mobilisation
4882962|NCT02163590|Pressure pain threshold|pressure pain threshold
4882963|NCT02163590|Thoracic spine|thoracic spine
4882964|NCT02163577|X-linked hypophosphatemia|x-linked hypophosphatemia
4882965|NCT02163577|XLH|xlh
4882966|NCT02163577|FGF23|fgf23
4882967|NCT02163577|KRN23|krn23
4882968|NCT02163564|Adolescent|adolescent
4882969|NCT02163564|Depression|depression
4882970|NCT02163564|Insomnia|insomnia
4882971|NCT02163551|dyspnea|dyspnea
4882972|NCT02163551|respiratory sensation|respiratory sensation
4882973|NCT02163551|event-related potentials|event-related potentials
4882974|NCT02163551|spinal cord injury|spinal cord injury
4882975|NCT02163538|energy device|energy device
4882976|NCT02163538|laparoscopic|laparoscopic
4882977|NCT02163538|hysterectomy|hysterectomy
4882978|NCT02163538|enseal|enseal
4882979|NCT02163538|ligasure|ligasure
4882980|NCT02163538|raw tlx|raw tlx
4882981|NCT02163525|Fibroids|fibroids
4882982|NCT02163525|Myomas|myomas
4882983|NCT02163525|leiomyomata|leiomyomata
4882984|NCT02163525|menorrhagia|menorrhagia
4882985|NCT02163525|Acessa Procedure|acessa procedure
4882986|NCT02163525|Radiofrequency Ablation (RFA)|radiofrequency ablation (rfa)
4882988|NCT02163525|Acessa|acessa
4882989|NCT02163512|Hepatic cirrhosis|hepatic cirrhosis
4882990|NCT02163512|Ascites|ascites
4882991|NCT02163512|Beta blockers treatment|beta blockers treatment
4882992|NCT02163486|I-gel|i-gel
4882993|NCT02163486|oropharyngeal leak pressure|oropharyngeal leak pressure
4882994|NCT02163486|head position|head position
4882995|NCT02163460|ventral hernia|ventral hernia
4882996|NCT02163460|seroma|seroma
4882997|NCT02163460|drainage|drainage
4882998|NCT02163460|infection|infection
4882999|NCT02163447|Chemoprevention|chemoprevention
4883000|NCT02163447|Malaria|malaria
4883001|NCT02163447|Uganda|uganda
4883002|NCT02163447|Sulfadoxine-pyrimethamine|sulfadoxine-pyrimethamine
4883003|NCT02163447|Dihydroartemisinin-piperaquine|dihydroartemisinin-piperaquine
4883004|NCT02163434|pregnancy|pregnancy
4883005|NCT02163434|nausea|nausea
4883006|NCT02163434|vomiting|vomiting
4883007|NCT02163434|hyperemesis|hyperemesis
4883008|NCT02163434|treatment|treatment
4883009|NCT02163434|gabapentin|gabapentin
4883010|NCT02163434|metoclopramide|metoclopramide
4883011|NCT02163434|safety|safety
4883012|NCT02163421|Drug therapy|drug therapy
4883013|NCT02163408|MRI|mri
4883014|NCT02163408|Plaque Characterization|plaque characterization
4883015|NCT02163395|Ceramic implant|ceramic implant
4883016|NCT02163382|Nava|nava
4883017|NCT02163382|Non Invasive Ventilation|non invasive ventilation
4883018|NCT02163356|neuroblastoma|neuroblastoma
4883019|NCT02163356|recurrent|recurrent
4883020|NCT02163356|resistant|resistant
4883021|NCT02163343|Serum metal ion levels|serum metal ion levels
4883022|NCT02163343|Cathcart/Corail hemiarthroplasty|cathcart/corail hemiarthroplasty
4883023|NCT02163343|Hip replacement|hip replacement
4883024|NCT02163291|advanced gastric cancer|advanced gastric cancer
4883025|NCT02163291|neoadjuvant chemotherapy|neoadjuvant chemotherapy
4883026|NCT02163291|safety|safety
4883027|NCT02163291|feasibility|feasibility
4883028|NCT02163278|DBPR108|dbpr108
4883029|NCT02163278|DPP4|dpp4
4883030|NCT02163278|Diabetes|diabetes
4883031|NCT02163278|Glucagon-like peptide-1 (GLP-1)|glucagon-like peptide-1 (glp-1)
4883032|NCT02163278|Incretins|incretins
4883033|NCT02163239|FloShield|floshield
4883034|NCT02163239|MID|mid
4883035|NCT02163239|Minimally invasive surgery|minimally invasive surgery
4883036|NCT02163239|Minimally Invasive devices|minimally invasive devices
4883037|NCT02163239|Robot-assisted Laparoscopic Surgery|robot-assisted laparoscopic surgery
4883038|NCT02163239|Single-site Laparoscopic Surgery|single-site laparoscopic surgery
4883039|NCT02163239|Single Incision Laparoscopic Surgery|single incision laparoscopic surgery
4883040|NCT02163239|Cannula|cannula
4883041|NCT02163239|Blunt Obturator|blunt obturator
4883042|NCT02163239|Cholecystectomy|cholecystectomy
4883043|NCT02163239|Benign hysterectomy|benign hysterectomy
4883044|NCT02163239|Salpingo-oophorectomy|salpingo-oophorectomy
4883045|NCT02163226|Bone metastases|bone metastases
4883046|NCT02163226|Hypofractionated Radiation Therapy|hypofractionated radiation therapy
4883047|NCT02163226|Standard Radiation Therapy|standard radiation therapy
4883048|NCT02163226|XRT|xrt
4883049|NCT02163226|Pain control|pain control
4883050|NCT02163226|Palliation of symptoms|palliation of symptoms
4883051|NCT02163226|Questionnaire|questionnaire
4883052|NCT02163226|Survey|survey
4883053|NCT02163213|diarrhea|diarrhea
4883054|NCT02163213|irritable bowel syndrome|irritable bowel syndrome
4883055|NCT02163200|Bedsores|bedsores
4883056|NCT02163200|pressure|pressure
4883057|NCT02163200|hip|hip
4883058|NCT02163187|Neuromodulation (SNM)|neuromodulation (snm)
4883059|NCT02163187|sphincter preservation|sphincter preservation
4883060|NCT02163187|rectal polyp|rectal polyp
4883061|NCT02163187|InterStimTM|interstimtm
4883062|NCT02163187|14-100|14-100
4883063|NCT02163174|neonatal|neonatal
4883064|NCT02163174|pentoxifylline|pentoxifylline
4883065|NCT02163174|randomized controlled trial|randomized controlled trial
4883066|NCT02163161|Phase I|phase i
4883067|NCT02163161|Open Label|open label
4883068|NCT02163161|Single dose|single dose
4883069|NCT02163161|Crossover|crossover
4883070|NCT02163161|Bioavailability|bioavailability
4883071|NCT02163161|Fasting|fasting
4883072|NCT02163161|Fed|fed
4883073|NCT02163161|PF-04965842|pf-04965842
4883074|NCT02163161|Healthy|healthy
4883075|NCT02163122|Cat Allergy|cat allergy
4883076|NCT02163122|Feld1|feld1
4883077|NCT02163109|Oxygen consumption|oxygen consumption
4883078|NCT02163109|Pulmonary gas exchange|pulmonary gas exchange
4883079|NCT02163109|Cardiac output|cardiac output
4883080|NCT02163070|whey protein|whey protein
4883081|NCT02163070|malnutrition|malnutrition
4883082|NCT02163070|oxidative stress|oxidative stress
4883083|NCT02163070|hemodialysis|hemodialysis
4883084|NCT02163057|Head and neck squamous cell cancer|head and neck squamous cell cancer
4883085|NCT02163057|Papillomavirus|papillomavirus
4883086|NCT02163031|heart transplant|heart transplant
4883087|NCT02163031|radial approach|radial approach
4883088|NCT02163031|catheterization|catheterization
4883089|NCT02163005|GDL contrast agent|gdl contrast agent
4883090|NCT02162992|Antibodies, Antinuclear|antibodies, antinuclear
4883091|NCT02162992|SS-A antigen|ss-a antigen
4883092|NCT02162992|Lupus Erythematosus, Systemic|lupus erythematosus, systemic
4883093|NCT02162992|Atrioventricular Block|atrioventricular block
4883094|NCT02162992|Sudden death|sudden death
4883095|NCT02162979|Parkinson's disease|parkinson's disease
4883096|NCT02162979|PD|pd
4883097|NCT02162979|dyskinesia|dyskinesia
4883098|NCT02162979|treatment|treatment
4883099|NCT02162979|motor complications|motor complications
4883100|NCT02162966|colistin|colistin
4883101|NCT02162966|ICU|icu
4883102|NCT02162966|critical care|critical care
4883103|NCT02162953|eye disease|eye disease
4883104|NCT02162953|retinal|retinal
4883105|NCT02162953|best1|best1
4883106|NCT02162940|low back pain|low back pain
4883107|NCT02162940|epidural steroid injection|epidural steroid injection
4883108|NCT02162940|statin|statin
4883109|NCT02162940|quality of life|quality of life
4883110|NCT02162927|muscular strength|muscular strength
4883111|NCT02162927|muscular endurance|muscular endurance
4883112|NCT02162927|muscular power|muscular power
4883113|NCT02162927|rowing|rowing
4883114|NCT02162927|CrossFit|crossfit
4883115|NCT02162927|dietary nitrate|dietary nitrate
4883116|NCT02162914|Intra-hepatic|intra-hepatic
4883117|NCT02162914|Hilar|hilar
4883118|NCT02162914|Locally Advanced|locally advanced
4883119|NCT02162914|Non Resectable|non resectable
4883120|NCT02162914|Metastatic|metastatic
4883121|NCT02162914|Regorafenib|regorafenib
4883122|NCT02162914|Placebo|placebo
4883123|NCT02162901|Diabetes prevention|diabetes prevention
4883124|NCT02162875|Schistosoma mansoni|schistosoma mansoni
4883125|NCT02162875|treatment|treatment
4883126|NCT02162875|school children|school children
4883127|NCT02162875|adults|adults
4883128|NCT02162862|Inflammatory Bowel Disease|inflammatory bowel disease
4883129|NCT02162862|Physical Illness|physical illness
4883130|NCT02162862|Wellbutrin|wellbutrin
4883131|NCT02162849|Tobacco Use Cessation|tobacco use cessation
4883132|NCT02162849|Smoking Cessation|smoking cessation
4883133|NCT02162849|Cancer Prevention|cancer prevention
4883134|NCT02162849|Behavioral Counseling|behavioral counseling
4883135|NCT02162849|Nicotine Replacement Therapy|nicotine replacement therapy
4883137|NCT02162849|Nicotine patch|nicotine patch
4883138|NCT02162849|Placebo patch|placebo patch
4883139|NCT02162849|Placebo pill|placebo pill
4883140|NCT02162849|Sugar pill|sugar pill
4883141|NCT02162849|Varenicline|varenicline
4883142|NCT02162849|Chantix|chantix
4883143|NCT02162849|Questionnaires|questionnaires
4883144|NCT02162849|Surveys|surveys
4883145|NCT02162849|Saliva test|saliva test
4883146|NCT02162836|Prostatic Neoplasms, Castration-Resistant|prostatic neoplasms, castration-resistant
4883147|NCT02162836|Metastatic Castration-Resistant Prostate Cancer|metastatic castration-resistant prostate cancer
4883148|NCT02162836|Prostate Cancer|prostate cancer
4883149|NCT02162836|Androgen Receptor|androgen receptor
4883150|NCT02162836|JNJ-56021927|jnj-56021927
4883151|NCT02162823|The MeSH name is Carcinoma, Pancreatic Ductal|the mesh name is carcinoma, pancreatic ductal
4883152|NCT02162810|hypospadias|hypospadias
4883153|NCT02162797|HIV|hiv
4883154|NCT02162797|AIDS|aids
4883155|NCT02162797|zinc|zinc
4883156|NCT02162797|zinc supplement|zinc supplement
4883157|NCT02162797|immunological deficiency|immunological deficiency
4883158|NCT02162771|Advanced Follicular Lymphoma|advanced follicular lymphoma
4883159|NCT02162758|Drug therapy|drug therapy
4883160|NCT02162745|Bronchiolitis|bronchiolitis
4883161|NCT02162745|Normal saline solution|normal saline solution
4883162|NCT02162745|Hypertonic solution|hypertonic solution
4883163|NCT02162745|Nasal irrigation|nasal irrigation
4883164|NCT02162680|local anesthesia|local anesthesia
4883165|NCT02162680|intravenous catheter|intravenous catheter
4883166|NCT02162654|neuroprotection|neuroprotection
4883167|NCT02162654|ischemic preconditioning|ischemic preconditioning
4883168|NCT02162654|cerebral aneurysm|cerebral aneurysm
4883169|NCT02162628|Pelvic Floor Disorder|pelvic floor disorder
4883170|NCT02162628|Pelvic Organ Prolapse|pelvic organ prolapse
4883171|NCT02162628|Sexual Dysfunction|sexual dysfunction
4883172|NCT02162628|Mesh|mesh
4883173|NCT02162628|POP|pop
4883174|NCT02162628|Transvaginal|transvaginal
4883175|NCT02162628|Total Repair|total repair
4883176|NCT02162628|Uterine Prolapse|uterine prolapse
4883177|NCT02162628|Cystocele|cystocele
4883178|NCT02162628|Rectocele|rectocele
4883179|NCT02162628|Enterocele|enterocele
4883180|NCT02162628|Vaginal Vault Prolapse|vaginal vault prolapse
4883181|NCT02162628|Native Tissue Repair|native tissue repair
4883182|NCT02162628|Repair Augmented with Mesh|repair augmented with mesh
4883183|NCT02162628|Pathological Conditions, Anatomical|pathological conditions, anatomical
4883184|NCT02162628|Exair Prolapse Repair System|exair prolapse repair system
4883185|NCT02162628|Vaginal Mesh|vaginal mesh
4883186|NCT02162628|Transvaginal Mesh|transvaginal mesh
4883187|NCT02162615|Pelvic Floor Disorder|pelvic floor disorder
4883188|NCT02162615|Pelvic Organ Prolapse|pelvic organ prolapse
4883189|NCT02162615|Sexual Dysfunction|sexual dysfunction
4883190|NCT02162615|Mesh|mesh
4883191|NCT02162615|POP|pop
4883192|NCT02162615|Transvaginal|transvaginal
4883193|NCT02162615|Anterior|anterior
4883194|NCT02162615|Posterior|posterior
4883195|NCT02162615|Apical|apical
4883196|NCT02162615|Uterine Prolapse|uterine prolapse
4883197|NCT02162615|Cystocele|cystocele
4883198|NCT02162615|Rectocele|rectocele
4883199|NCT02162615|Enterocele|enterocele
4883200|NCT02162615|Vaginal Vault Prolapse|vaginal vault prolapse
4883201|NCT02162615|Native Tissue Repair|native tissue repair
4883202|NCT02162615|Repair Augmented with Mesh|repair augmented with mesh
4883203|NCT02162615|Pathological Conditions, Anatomical|pathological conditions, anatomical
4883204|NCT02162615|Restorelle Direct Fix|restorelle direct fix
4883205|NCT02162615|Vaginal Mesh|vaginal mesh
4883206|NCT02162615|Transvaginal Mesh|transvaginal mesh
4883207|NCT02162576|asthma|asthma
4883208|NCT02162576|asthma control|asthma control
4883209|NCT02162576|healthcare utilization costs|healthcare utilization costs
4883210|NCT02162576|community hotspots|community hotspots
4883211|NCT02162576|public health research|public health research
4883212|NCT02162563|Colorectal cancer|colorectal cancer
4883213|NCT02162563|Chemotherapy|chemotherapy
4883214|NCT02162563|Anti-EGFR|anti-egfr
4883215|NCT02162563|Liver metastases|liver metastases
4883216|NCT02162563|R0 R1 liver resection|r0 r1 liver resection
4883217|NCT02162563|Resectability of liver|resectability of liver
4883218|NCT02162563|Liver expert panel|liver expert panel
4883219|NCT02162550|Type 2 Diabetes|type 2 diabetes
4883220|NCT02162550|Cardiovascular Disease|cardiovascular disease
4883221|NCT02162550|Hyperglycemia|hyperglycemia
4883222|NCT02162550|Carotid Plaque|carotid plaque
4883223|NCT02162550|Endothelial function|endothelial function
4883224|NCT02162550|Incretins|incretins
4883225|NCT02162550|Atherosclerosis|atherosclerosis
4883226|NCT02162537|Strategy|strategy
4883227|NCT02162537|Radiotherapy|radiotherapy
4883228|NCT02162537|Chemotherapy|chemotherapy
4883229|NCT02162537|Cisplatin|cisplatin
4883230|NCT02162524|aerobic exercise|aerobic exercise
4883231|NCT02162524|obesity|obesity
4883232|NCT02162524|energy balance|energy balance
4883233|NCT02162511|Haplocompatible|haplocompatible
4883234|NCT02162511|Stem cell transplant|stem cell transplant
4883235|NCT02162511|Borderline organ function|borderline organ function
4883236|NCT02162511|Alternative donor stem cell transplant|alternative donor stem cell transplant
4883237|NCT02162498|Peer support|peer support
4883238|NCT02162498|Adherence|adherence
4883239|NCT02162498|Exclusive breastfeeding|exclusive breastfeeding
4883240|NCT02162498|Early infant diagnosis|early infant diagnosis
4883241|NCT02162498|Stigma and disclosure|stigma and disclosure
4883242|NCT02162472|videocapillaroscopy, psoriasis, systemic agent|videocapillaroscopy, psoriasis, systemic agent
4883243|NCT02162459|Adolescent|adolescent
4883244|NCT02162459|supplements|supplements
4883245|NCT02162459|strength|strength
4883246|NCT02162459|whey protein|whey protein
4883247|NCT02162459|bench press strength|bench press strength
4883248|NCT02162459|squat strength|squat strength
4883249|NCT02162420|severe aplastic anemia|severe aplastic anemia
4883250|NCT02162420|Hematopoietic Stem Cell Transplant|hematopoietic stem cell transplant
4883251|NCT02162381|Humphrey visual fields|humphrey visual fields
4883252|NCT02162381|methylphenidate|methylphenidate
4883253|NCT02162381|attention deficit disorder|attention deficit disorder
4883254|NCT02162381|MoCa questionnaire|moca questionnaire
4883255|NCT02162368|laryngeal mask, prone position, spine surgery|laryngeal mask, prone position, spine surgery
4883256|NCT02162342|upper extremity|upper extremity
4883257|NCT02162342|muscle activity|muscle activity
4883258|NCT02162342|kinematics|kinematics
4883259|NCT02162342|motion capture|motion capture
4883260|NCT02162342|Electromyography|electromyography
4883261|NCT02162329|Breast Cancer|breast cancer
4883262|NCT02162329|Cognitive function|cognitive function
4883263|NCT02162329|Questionnaires|questionnaires
4883264|NCT02162329|Surveys|surveys
4883265|NCT02162329|Electroencephalography|electroencephalography
4883266|NCT02162329|EEG|eeg
4883267|NCT02162329|Magnetic resonance imaging|magnetic resonance imaging
4883268|NCT02162329|fMRI|fmri
4883269|NCT02162329|Tibetan meditation|tibetan meditation
4883270|NCT02162329|Quality of life|quality of life
4883271|NCT02162329|QOL|qol
4883272|NCT02162303|Atherosclerosis|atherosclerosis
4883273|NCT02162303|Vascular|vascular
4883274|NCT02162303|Cardiovascular|cardiovascular
4883275|NCT02162303|Coronary artery disease|coronary artery disease
4883276|NCT02162303|Imaging|imaging
4883277|NCT02162303|PET|pet
4883278|NCT02162303|Scan|scan
4883279|NCT02162303|anti-inflammatory|anti-inflammatory
4883280|NCT02162277|To decrease|to decrease
4883281|NCT02162277|number|number
4883282|NCT02162277|osteoporotic|osteoporotic
4883283|NCT02162277|patients in|patients in
4883284|NCT02162277|Kami-Ina area|kami-ina area
4883285|NCT02162277|Nagano prefecture|nagano prefecture
4883286|NCT02162264|Alzheimer's Disease|alzheimer's disease
4883287|NCT02162264|donepezil hydrochloride|donepezil hydrochloride
4883288|NCT02162251|Alzheimer's Disease|alzheimer's disease
4883289|NCT02162251|donepezil hydrochloride|donepezil hydrochloride
4883290|NCT02162238|zinc|zinc
4883291|NCT02162238|diet|diet
4883292|NCT02162238|water|water
4883293|NCT02162238|morbidity|morbidity
4883294|NCT02162238|growth|growth
4883295|NCT02162225|Erythrocyte Deformability|erythrocyte deformability
4883296|NCT02162225|Platelet Activation|platelet activation
4883297|NCT02162225|Platelet Aggregation|platelet aggregation
4883298|NCT02162225|Nitrite|nitrite
4883299|NCT02162225|Sickle Cell Anemia|sickle cell anemia
4883300|NCT02162225|Diet Therapy|diet therapy
4883301|NCT02162199|Antibiotic|antibiotic
4883302|NCT02162199|Antibiotic Resistant Bacterial Infection|antibiotic resistant bacterial infection
4883303|NCT02162186|Arthroplasty, Replacement, Hip/methods|arthroplasty, replacement, hip/methods
4883304|NCT02162186|Hip Joint/physiopathology|hip joint/physiopathology
4883305|NCT02162186|Hip Joint/radiography|hip joint/radiography
4883306|NCT02162186|Hip Joint/surgery|hip joint/surgery
4883307|NCT02162186|Hip Prosthesis|hip prosthesis
4883308|NCT02162186|Outcome Assessment (Health Care)|outcome assessment (health care)
4883309|NCT02162186|Female|female
4883310|NCT02162186|Male|male
4883311|NCT02162186|Adult|adult
4883312|NCT02162173|Familial adenomatous polyposis syndrome|familial adenomatous polyposis syndrome
4883313|NCT02162173|Non-ampullary polyp|non-ampullary polyp
4883314|NCT02162173|Ampullary polyp|ampullary polyp
4883315|NCT02162173|Narrow band imaging endoscopy|narrow band imaging endoscopy
4883316|NCT02162173|Confocal laser endomicroscopy|confocal laser endomicroscopy
4883317|NCT02162160|probiotic|probiotic
4883318|NCT02162160|post-menopausal|post-menopausal
4883319|NCT02162160|atrophic vaginitis|atrophic vaginitis
4883320|NCT02162147|patient safety|patient safety
4883321|NCT02162147|pediatrics|pediatrics
4883322|NCT02162147|emergency medicine|emergency medicine
4883323|NCT02162134|cholecystectomy|cholecystectomy
4883324|NCT02162134|laparoscopic|laparoscopic
4883325|NCT02162134|postoperative|postoperative
4883326|NCT02162134|ileus|ileus
4883327|NCT02162134|chewing gum|chewing gum
4883328|NCT02162095|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
4883329|NCT02162095|Coronary artery disease|coronary artery disease
4883330|NCT02162095|Coronary calcium score|coronary calcium score
4883331|NCT02162043|Glaucoma|glaucoma
4883332|NCT02162043|Perimetry|perimetry
4883333|NCT02162043|Diagnostic self-evaluation|diagnostic self-evaluation
4883334|NCT02162043|Screening|screening
4883335|NCT02162043|Visual fields|visual fields
4883336|NCT02162017|Acute ischemic stroke|acute ischemic stroke
4883337|NCT02162017|Acute intracerebral haemorrhage|acute intracerebral haemorrhage
4883338|NCT02162017|Head position|head position
4883339|NCT02162017|Lying flat head position|lying flat head position
4883340|NCT02162017|Sitting up head position|sitting up head position
4883341|NCT02162017|Death|death
4883342|NCT02162017|Disability|disability
4883343|NCT02162017|Clinical trial|clinical trial
4883344|NCT02162004|Type 1 diabetes|type 1 diabetes
4883345|NCT02162004|Continuous Glucose Monitoring|continuous glucose monitoring
4883346|NCT02162004|Insulin pump|insulin pump
4883347|NCT02162004|Sensor-augmented pump|sensor-augmented pump
4883348|NCT02162004|Continuous correction of high blood glucose|continuous correction of high blood glucose
4883349|NCT02161991|aprepitant|aprepitant
4883350|NCT02161991|non-small cell lung cancer|non-small cell lung cancer
4883351|NCT02161978|antiangiogenic|antiangiogenic
4883352|NCT02161978|cancer|cancer
4883353|NCT02161978|vascular|vascular
4883354|NCT02161978|biomarker|biomarker
4883355|NCT02161978|tyrosine kinase inhibitor|tyrosine kinase inhibitor
4883356|NCT02161965|Anticoagulation|anticoagulation
4883357|NCT02161965|Coronary and peripheral calcification|coronary and peripheral calcification
4883358|NCT02161965|Arterial stiffness|arterial stiffness
4883359|NCT02161965|Biomarker|biomarker
4883360|NCT02161952|Fibrosis, necroinflammation, hepatitis C chronic|fibrosis, necroinflammation, hepatitis c chronic
4883361|NCT02161926|Obesity|obesity
4883362|NCT02161926|dietary restrictions|dietary restrictions
4883363|NCT02161926|metabolism|metabolism
4883364|NCT02161926|nutrition|nutrition
4883365|NCT02161926|elderly|elderly
4883366|NCT02161874|edentulism|edentulism
4883367|NCT02161874|dental implants|dental implants
4883368|NCT02161874|clinical study|clinical study
4883369|NCT02161874|endosseous|endosseous
4883370|NCT02161874|randomized|randomized
4883371|NCT02161874|crestal bone level|crestal bone level
4883372|NCT02161874|T3|t3
4883373|NCT02161874|Nanotite Certain|nanotite certain
4883374|NCT02161874|Nanotite Certain Prevail|nanotite certain prevail
4883375|NCT02161874|Tapered|tapered
4883376|NCT02161861|tripeptide FEE|tripeptide fee
4883377|NCT02161861|fertilization rates|fertilization rates
4883378|NCT02161861|embryos|embryos
4883379|NCT02161861|oocytes|oocytes
4883380|NCT02161835|Congenital myotonia|congenital myotonia
4883381|NCT02161835|Myotonia congenita|myotonia congenita
4883382|NCT02161835|Thomsons disease|thomsons disease
4883383|NCT02161835|Becker type|becker type
4883384|NCT02161835|Training|training
4883385|NCT02161835|Exercise|exercise
4883386|NCT02161822|locally advanced rectal cancer, neoadjuvant chemoradiation|locally advanced rectal cancer, neoadjuvant chemoradiation
4883387|NCT02161809|MVPA|mvpa
4883388|NCT02161809|Healthy Eating|healthy eating
4883389|NCT02161809|children|children
4883390|NCT02161809|childhood obesity|childhood obesity
4883391|NCT02161796|Phase 1|phase 1
4883392|NCT02161796|FG-4592|fg-4592
4883393|NCT02161796|Age/gender comparison|age/gender comparison
4883394|NCT02161783|Hematopoietic stem cell transplant|hematopoietic stem cell transplant
4883395|NCT02161770|oncology, cancer, neoplasm, anticancer drug, pharmacokinetics, area under curve, AZD9291, solid tumour, mild hepatic impairment, moderate hepatic impairment|oncology, cancer, neoplasm, anticancer drug, pharmacokinetics, area under curve, azd9291, solid tumour, mild hepatic impairment, moderate hepatic impairment
4883396|NCT02161757|Asthma|asthma
4883397|NCT02161757|Reactive Airways|reactive airways
4883398|NCT02161757|Respiratory Tract Disease|respiratory tract disease
4883399|NCT02161757|Obstructive Lung Disease|obstructive lung disease
4883400|NCT02161757|Lung Diseases|lung diseases
4883401|NCT02161744|Adipose derived stem cells|adipose derived stem cells
4883402|NCT02161744|Stromal vascular fraction cells|stromal vascular fraction cells
4883403|NCT02161744|Pulmonary Function Tests|pulmonary function tests
4883404|NCT02161744|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
4883405|NCT02161718|Alkermes|alkermes
4883406|NCT02161718|Schizophrenia|schizophrenia
4883407|NCT02161718|Alcohol Use Disorder|alcohol use disorder
4883408|NCT02161718|ALKS 3831|alks 3831
4883409|NCT02161705|Immediate breast reconstruction|immediate breast reconstruction
4883410|NCT02161705|pain control|pain control
4883411|NCT02161705|post mastectomy pain control|post mastectomy pain control
4883412|NCT02161679|Antibody drug conjugate|antibody drug conjugate
4883413|NCT02161679|IMMU-132|immu-132
4883414|NCT02161679|Triple-negative breast cancer|triple-negative breast cancer
4883415|NCT02161679|Safety and tolerability|safety and tolerability
4883416|NCT02161679|Progression Free Survival (PFS)|progression free survival (pfs)
4883417|NCT02161666|Obesity|obesity
4883418|NCT02161666|Gastric Bypass|gastric bypass
4883419|NCT02161666|Bariatric Surgery|bariatric surgery
4883420|NCT02161666|Incretin Function|incretin function
4883421|NCT02161666|Islet Function|islet function
4883422|NCT02161653|Severe alcoholic hepatitis|severe alcoholic hepatitis
4883423|NCT02161653|survival|survival
4883424|NCT02161653|oxidative stress|oxidative stress
4883425|NCT02161627|spinal cord stimulation|spinal cord stimulation
4883426|NCT02161627|automatic control|automatic control
4883427|NCT02161614|hormone replacement therapy|hormone replacement therapy
4883428|NCT02161614|Dopplervelocimetry|dopplervelocimetry
4883429|NCT02161614|Flow-mediated dilation|flow-mediated dilation
4883430|NCT02161614|menopause|menopause
4883431|NCT02161614|Estradiol valerate|estradiol valerate
4883432|NCT02161601|Cricoid pressure|cricoid pressure
4883433|NCT02161601|Rapid Sequence Induction|rapid sequence induction
4883434|NCT02161562|chronic spontaneous urticaria, CSU, chronic idiopathic urticaria, CIU, hives, angioedema, itch|chronic spontaneous urticaria, csu, chronic idiopathic urticaria, ciu, hives, angioedema, itch
4883435|NCT02161523|mast cells, lung cancer, cancer associated fibroblasts (CAF)|mast cells, lung cancer, cancer associated fibroblasts (caf)
4883436|NCT02161497|Medical History Taking|medical history taking
4883437|NCT02161497|Electronic Health Records|electronic health records
4883438|NCT02161497|Pediatrics|pediatrics
4883439|NCT02161497|Parents|parents
4883440|NCT02161484|Peripheral Nerve Block|peripheral nerve block
4883441|NCT02161484|Total Hip Replacement|total hip replacement
4883442|NCT02161471|Atria, Heart|atria, heart
4883443|NCT02161471|Function, Atrial|function, atrial
4883444|NCT02161471|Heart Defects, Congenital|heart defects, congenital
4883445|NCT02161471|Cardiovascular Abnormalities|cardiovascular abnormalities
4883446|NCT02161471|Congenital Abnormalities|congenital abnormalities
4883447|NCT02161471|Tetralogy, Fallot|tetralogy, fallot
4883448|NCT02161471|Transposition of Great Arteries|transposition of great arteries
4883449|NCT02161471|Coarctation of the Aorta|coarctation of the aorta
4883450|NCT02161458|Escitalopram|escitalopram
4883451|NCT02161458|Amyloid Beta|amyloid beta
4883452|NCT02161458|Cerebrospinal Fluid|cerebrospinal fluid
4883453|NCT02161445|impedance|impedance
4883454|NCT02161445|pep|pep
4883455|NCT02161445|tevg|tevg
4883456|NCT02161445|dyspnea|dyspnea
4883457|NCT02161445|AHF|ahf
4883458|NCT02161445|BNP|bnp
4883459|NCT02161419|Small Cell Lung Carcinoma,|small cell lung carcinoma,
4883460|NCT02161419|First line|first line
4883461|NCT02161419|Extensive disease|extensive disease
4883462|NCT02161419|Small cell lung cancer|small cell lung cancer
4883463|NCT02161406|Scleroderma|scleroderma
4883464|NCT02161393|Physical Activity|physical activity
4883465|NCT02161393|Pulmonary Rehabilitation|pulmonary rehabilitation
4883466|NCT02161393|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
4883467|NCT02161380|Gene therapy|gene therapy
4883468|NCT02161380|Mitochondrial Genes|mitochondrial genes
4883469|NCT02161380|Leber's|leber's
4883470|NCT02161380|AAV2 Viral vectors|aav2 viral vectors
4883471|NCT02161367|colorectal surgery|colorectal surgery
4883472|NCT02161367|postoperative ileus|postoperative ileus
4883473|NCT02161367|simethicone|simethicone
4883474|NCT02161367|randomized controlled trial|randomized controlled trial
4883475|NCT02161367|double blind|double blind
4883476|NCT02161367|pilot study|pilot study
4883477|NCT02161367|anti-foaming agent|anti-foaming agent
4883478|NCT02161367|abdominal pain|abdominal pain
4883479|NCT02161367|abdominal distention|abdominal distention
4883480|NCT02161367|nausea vomiting|nausea vomiting
4883481|NCT02161367|flatus|flatus
4883482|NCT02161367|bowel movement|bowel movement
4883483|NCT02161367|placebo|placebo
4883484|NCT02161367|postoperative complications|postoperative complications
4883485|NCT02161367|polydimethylsiloxane|polydimethylsiloxane
4883486|NCT02161367|hydrated silica gel|hydrated silica gel
4883487|NCT02161367|gas bubbles|gas bubbles
4883488|NCT02161367|intestinal tract|intestinal tract
4883489|NCT02161354|Dental Pain|dental pain
4883490|NCT02161354|Acute Pain|acute pain
4883491|NCT02161354|Mild Pain|mild pain
4883492|NCT02161354|Moderate Pain|moderate pain
4883493|NCT02161341|Bacterial microbiome|bacterial microbiome
4883494|NCT02161341|Gene expression|gene expression
4883495|NCT02161315|SAID, Progestogens, nSAID-resistanced, LSBC|said, progestogens, nsaid-resistanced, lsbc
4883496|NCT02161302|Endometriosis|endometriosis
4883497|NCT02161302|Transcranial Direct Current Stimulation|transcranial direct current stimulation
4883498|NCT02161302|tDCS|tdcs
4883499|NCT02161302|Near Infrared Spectroscopy|near infrared spectroscopy
4883500|NCT02161302|NIRS|nirs
4883501|NCT02161302|Chronic Pelvic Pain|chronic pelvic pain
4883502|NCT02161289|100 HIV-negagtve MSM|100 hiv-negagtve msm
4883503|NCT02161263|LASIK|lasik
4883504|NCT02161263|Satisfaction|satisfaction
4883505|NCT02161237|Acute rejection|acute rejection
4883506|NCT02161237|Advagraf|advagraf
4883507|NCT02161237|Renal function|renal function
4883508|NCT02161224|Phase 1|phase 1
4883509|NCT02161224|FG-4592|fg-4592
4883510|NCT02161224|Single dose|single dose
4883511|NCT02161224|Moderate hepatic impairment|moderate hepatic impairment
4883512|NCT02161211|alcohol|alcohol
4883513|NCT02161211|anxiety|anxiety
4883514|NCT02161198|Panax ginseng CA|panax ginseng ca
4883515|NCT02161198|ginsan|ginsan
4883516|NCT02161198|polysaccharide|polysaccharide
4883517|NCT02161198|immunity|immunity
4883518|NCT02161198|natural killer cell|natural killer cell
4883519|NCT02161185|Epilepsy|epilepsy
4883520|NCT02161185|seizure cluster|seizure cluster
4883521|NCT02161185|acute repetitive seizures|acute repetitive seizures
4883522|NCT02161185|open-label|open-label
4883523|NCT02161185|intranasal Midazolam|intranasal midazolam
4883524|NCT02161185|USL261|usl261
4883525|NCT02161185|Upsher-Smith|upsher-smith
4883526|NCT02161172|Mild traumatic brain injury|mild traumatic brain injury
4883527|NCT02161172|Cognitive outcome|cognitive outcome
4883528|NCT02161172|Psychological outcome|psychological outcome
4883529|NCT02161133|Veterans|veterans
4883530|NCT02161133|neuropsychology|neuropsychology
4883531|NCT02161133|fatigue|fatigue
4883532|NCT02161133|Chronic Multisymptom Illness|chronic multisymptom illness
4883533|NCT02161133|Gulf War Illness|gulf war illness
4883534|NCT02161133|behavioral treatment|behavioral treatment
4883535|NCT02161120|IBS, irritable bowel syndrome, functional gastrointestinal disorder, diet, bread, rye, FODMAP, microbiota|ibs, irritable bowel syndrome, functional gastrointestinal disorder, diet, bread, rye, fodmap, microbiota
4883536|NCT02161107|Grass|grass
4883537|NCT02161107|Allergy|allergy
4883538|NCT02161107|rhinoconjunctivitis|rhinoconjunctivitis
4883539|NCT02161107|rhinitis|rhinitis
4883540|NCT02161107|asthma|asthma
4883541|NCT02161094|Community management incentives|community management incentives
4883542|NCT02161081|Myocardial ischemia|myocardial ischemia
4883543|NCT02161081|Coronary artery disease|coronary artery disease
4883544|NCT02161081|Myocardial CT perfusion|myocardial ct perfusion
4883545|NCT02161081|Modified scan protocol|modified scan protocol
4883546|NCT02161081|Diagnostic performance|diagnostic performance
4883547|NCT02161081|Radiation dose|radiation dose
4883548|NCT02161068|ADPKD|adpkd
4883549|NCT02161068|Chart Review|chart review
4883550|NCT02161068|PKD Genotyping|pkd genotyping
4883551|NCT02161055|Insulin|insulin
4883552|NCT02161055|Hyperglycemia|hyperglycemia
4883553|NCT02161055|Postoperative Mortality|postoperative mortality
4883554|NCT02161055|Intensive insulin therapy|intensive insulin therapy
4883555|NCT02161055|Non-intensive insulin therapy|non-intensive insulin therapy
4883556|NCT02161055|Brain Injuries|brain injuries
4883557|NCT02161055|Wounds and Injuries|wounds and injuries
4883558|NCT02161055|Craniocerebral Trauma|craniocerebral trauma
4883559|NCT02161055|Trauma, Nervous System|trauma, nervous system
4883560|NCT02161042|Blood transfusion|blood transfusion
4883561|NCT02161042|Storage Lesion|storage lesion
4883562|NCT02161042|Endothelial dysfunction|endothelial dysfunction
4883563|NCT02161042|Nitric Oxide|nitric oxide
4883564|NCT02161029|Gastric tumor|gastric tumor
4883565|NCT02161003|Fecal Incontinence|fecal incontinence
4883566|NCT02161003|Posterior Sagittal Ano-rectoplasty|posterior sagittal ano-rectoplasty
4883567|NCT02161003|Mesenchymal Stem Cell|mesenchymal stem cell
4883568|NCT02160990|Obesity|obesity
4883569|NCT02160977|Surgical procedures|surgical procedures
4883570|NCT02160977|Minimally invasive|minimally invasive
4883571|NCT02160977|Arthroplasty|arthroplasty
4883572|NCT02160977|Knee|knee
4883573|NCT02160964|Inferior Vena Cava|inferior vena cava
4883574|NCT02160951|Multiple Myeloma,|multiple myeloma,
4883575|NCT02160951|Phase I,|phase i,
4883576|NCT02160951|PIM,|pim,
4883577|NCT02160951|Japanese patients,|japanese patients,
4883578|NCT02160951|LGH447|lgh447
4883579|NCT02160938|microarray|microarray
4883580|NCT02160938|prenatal|prenatal
4883581|NCT02160938|copy number variant|copy number variant
4883582|NCT02160938|CNV|cnv
4883583|NCT02160938|microdeletion|microdeletion
4883584|NCT02160938|microduplication|microduplication
4883585|NCT02160938|genetic|genetic
4883586|NCT02160899|High Lipoprotein(a)|high lipoprotein(a)
4883587|NCT02160847|children|children
4883588|NCT02160847|pediatric obesity|pediatric obesity
4883589|NCT02160847|parent training|parent training
4883590|NCT02160847|home-based|home-based
4883591|NCT02160847|nutrition|nutrition
4883592|NCT02160847|physical activity|physical activity
4883593|NCT02160847|parent-child interaction|parent-child interaction
4883594|NCT02160847|parenting|parenting
4883595|NCT02160834|Sedentary behavior|sedentary behavior
4883596|NCT02160834|Physical activity|physical activity
4883597|NCT02160834|Obesity|obesity
4883598|NCT02160834|Mobile health|mobile health
4883599|NCT02160834|Smartphone|smartphone
4883600|NCT02160834|Time spent sedentary|time spent sedentary
4883601|NCT02160821|Transversus Abdominis Plane Block|transversus abdominis plane block
4883602|NCT02160821|Caudal Epidural|caudal epidural
4883603|NCT02160821|Pediatric Pain control|pediatric pain control
4883604|NCT02160821|Pain control for Lower Abdominal Surgery|pain control for lower abdominal surgery
4883605|NCT02160795|Periconceptional|periconceptional
4883606|NCT02160795|Folic Acid|folic acid
4883607|NCT02160795|Leukemia|leukemia
4883608|NCT02160795|Childhood Cancer|childhood cancer
4883609|NCT02160769|Tear Lipid Thickness|tear lipid thickness
4883610|NCT02160769|Pterygium surgery|pterygium surgery
4883611|NCT02160756|Healthy|healthy
4883612|NCT02160756|JNJ-56021927|jnj-56021927
4883613|NCT02160756|JNJ-56142060|jnj-56142060
4883614|NCT02160756|ARN-509|arn-509
4883615|NCT02160730|Cushings disease|cushings disease
4883616|NCT02160730|R-roscovitine|r-roscovitine
4883617|NCT02160717|Turner Syndrome|turner syndrome
4883618|NCT02160717|Diabetes|diabetes
4883619|NCT02160704|Sperm density|sperm density
4883620|NCT02160704|Testosterone|testosterone
4883621|NCT02160704|Hypogonadism|hypogonadism
4883622|NCT02160652|Ureteral Obstruction|ureteral obstruction
4883623|NCT02160652|HYDRONEPHROSIS|hydronephrosis
4883624|NCT02160652|nephrostomy tube|nephrostomy tube
4883625|NCT02160639|diabetes self management education|diabetes self management education
4883626|NCT02160639|diabetes self management support|diabetes self management support
4883627|NCT02160639|type 2 diabetes|type 2 diabetes
4883628|NCT02160626|Seborrheic keratosis|seborrheic keratosis
4883629|NCT02160626|A101|a101
4883630|NCT02160613|Osteoprotegerin|osteoprotegerin
4883631|NCT02160613|Biomarker|biomarker
4883632|NCT02160613|Chronic periodontitis|chronic periodontitis
4883633|NCT02160613|Open flap debridement|open flap debridement
4883634|NCT02160561|mechanical|mechanical
4883635|NCT02160561|ventilation|ventilation
4883636|NCT02160561|acute|acute
4883637|NCT02160561|respiratory|respiratory
4883638|NCT02160561|failure|failure
4883639|NCT02160548|Organophosphate, insectiside, Salbutamol, Atropine|organophosphate, insectiside, salbutamol, atropine
4883640|NCT02160535|Mild Traumatic Brain Injury|mild traumatic brain injury
4883641|NCT02160535|Concussion|concussion
4883642|NCT02160535|Post Concussive Headache|post concussive headache
4883643|NCT02160522|Intubation|intubation
4883644|NCT02160522|cuff|cuff
4883645|NCT02160522|cuffed|cuffed
4883646|NCT02160522|endotracheal|endotracheal
4883647|NCT02160522|tube|tube
4883648|NCT02160522|pressure|pressure
4883649|NCT02160522|pediatric|pediatric
4883650|NCT02160522|child|child
4883651|NCT02160522|children|children
4883652|NCT02160522|emergency|emergency
4883653|NCT02160509|real time, ultrasonography, handheld|real time, ultrasonography, handheld
4883654|NCT02160496|Weight Loss|weight loss
4883655|NCT02160496|Obesity|obesity
4883656|NCT02160496|Overweight|overweight
4883657|NCT02160496|Diet, Reducing|diet, reducing
4883658|NCT02160496|Lipids|lipids
4883659|NCT02160483|Chronic pelvic pain|chronic pelvic pain
4883660|NCT02160483|Endometriosis|endometriosis
4883661|NCT02160457|Cerebral palsy|cerebral palsy
4883662|NCT02160457|Instrumented gait analysis|instrumented gait analysis
4883663|NCT02160457|Gait Deviation Index|gait deviation index
4883664|NCT02160444|CBT|cbt
4883665|NCT02160444|Parent Training|parent training
4883666|NCT02160444|Anxiety Disorders in Children|anxiety disorders in children
4883667|NCT02160431|Children|children
4883668|NCT02160431|OCD|ocd
4883669|NCT02160431|CBT|cbt
4883670|NCT02160431|Neuropsychological profiles|neuropsychological profiles
4883671|NCT02160405|Iron levels|iron levels
4883672|NCT02160392|HIV|hiv
4883673|NCT02160392|female|female
4883674|NCT02160392|genital tract|genital tract
4883675|NCT02160379|roux-en-Y-gastric bypass|roux-en-y-gastric bypass
4883676|NCT02160379|brain responses to food|brain responses to food
4883677|NCT02160379|gastrointestinal hormones|gastrointestinal hormones
4883678|NCT02160379|bile acids|bile acids
4883679|NCT02160366|Advanced Cancers|advanced cancers
4883680|NCT02160366|Molecular profiling|molecular profiling
4883681|NCT02160366|Biomarker data|biomarker data
4883682|NCT02160366|Data analysis|data analysis
4883683|NCT02160366|Tumor marker|tumor marker
4883684|NCT02160340|Posterior Vitreous Detachment|posterior vitreous detachment
4883685|NCT02160340|Vitreomacular Traction|vitreomacular traction
4883686|NCT02160340|Vitreous|vitreous
4883687|NCT02160314|stress urinary incontinence, SUI, pessary|stress urinary incontinence, sui, pessary
4883688|NCT02160301|pain|pain
4883689|NCT02160301|postoperative|postoperative
4883690|NCT02160301|multimodal|multimodal
4883691|NCT02160301|satisfaction|satisfaction
4883692|NCT02160301|narcotic|narcotic
4883693|NCT02160288|Botox|botox
4883694|NCT02160288|Obstructed Defecation Syndrome|obstructed defecation syndrome
4883695|NCT02160288|ODS|ods
4883696|NCT02160288|Outlet-Type Constipation|outlet-type constipation
4883697|NCT02160288|injection|injection
4883698|NCT02160275|Artificial pancreas|artificial pancreas
4883699|NCT02160275|Bi-hormonal closed loop|bi-hormonal closed loop
4883700|NCT02160275|Diabetes Type 1|diabetes type 1
4883701|NCT02160249|Schizophrenia|schizophrenia
4883702|NCT02160249|Psychotic disorders|psychotic disorders
4883703|NCT02160249|Schizophrenia spectrum disorder (schizophrenia, schizoaffective disorder or schizophreniform disorder) using DSM-IV criteria|schizophrenia spectrum disorder (schizophrenia, schizoaffective disorder or schizophreniform disorder) using dsm-iv criteria
4883704|NCT02160236|dexketoprofen trometamol|dexketoprofen trometamol
4883705|NCT02160236|tenoxicam|tenoxicam
4883706|NCT02160236|postoperative pain|postoperative pain
4883707|NCT02160223|sugammadex|sugammadex
4883708|NCT02160223|neostigmine|neostigmine
4883709|NCT02160223|obstructive sleep apnea|obstructive sleep apnea
4883710|NCT02160197|Ankle Fractures|ankle fractures
4883711|NCT02160197|Fracture Fixation|fracture fixation
4883712|NCT02160197|Early Ambulation|early ambulation
4883713|NCT02160197|Fracture Healing|fracture healing
4883714|NCT02160197|Return to Work|return to work
4883715|NCT02160171|Decision Support Algorithm|decision support algorithm
4883716|NCT02160171|Neonatal Seizures|neonatal seizures
4883717|NCT02160171|EEG|eeg
4883718|NCT02160158|Fesoterodine|fesoterodine
4883719|NCT02160158|SR3|sr3
4883720|NCT02160158|SR4|sr4
4883721|NCT02160158|bioavailability|bioavailability
4883722|NCT02160158|pharmacokinetics|pharmacokinetics
4883723|NCT02160158|sprinkle|sprinkle
4883724|NCT02160158|applesauce|applesauce
4883725|NCT02160145|Chronic Kidney Disease|chronic kidney disease
4883726|NCT02160145|Autosomal Dominant Polycystic Kidney Disease|autosomal dominant polycystic kidney disease
4883727|NCT02160119|Autism Spectrum Disorders|autism spectrum disorders
4883728|NCT02160119|Emotion|emotion
4883729|NCT02160119|Attention|attention
4883730|NCT02160119|Event-related potential|event-related potential
4883731|NCT02160119|Functional neuroimaging|functional neuroimaging
4884106|NCT02158533|ALKS 5461|alks 5461
4883732|NCT02160119|Diffusion Tensor Imaging|diffusion tensor imaging
4883733|NCT02160119|Development|development
4883734|NCT02160106|Cancer|cancer
4883735|NCT02160106|advanced solid tumors|advanced solid tumors
4883736|NCT02160106|metastatic|metastatic
4883737|NCT02160106|phase I|phase i
4883738|NCT02160106|transforming growth factor beta|transforming growth factor beta
4883739|NCT02160106|TGF-β|tgf-β
4883740|NCT02160106|first-in-human|first-in-human
4883741|NCT02160106|TEW-7197|tew-7197
4883742|NCT02160106|activin receptor-like kinase 5|activin receptor-like kinase 5
4883743|NCT02160106|ALK5|alk5
4883744|NCT02160106|Smad2|smad2
4883745|NCT02160106|Smad3|smad3
4883746|NCT02160106|phospho-Smad|phospho-smad
4883747|NCT02160106|phospho Smad|phospho smad
4883748|NCT02160106|psmad|psmad
4883749|NCT02160106|serine / threonine kinase inhibitor|serine / threonine kinase inhibitor
4883750|NCT02160106|pharmacokinetics|pharmacokinetics
4883751|NCT02160106|MedPacto|medpacto
4883752|NCT02160106|National OncoVenture|national oncoventure
4883753|NCT02160093|sarcopenia|sarcopenia
4883754|NCT02160093|frailty|frailty
4883755|NCT02160093|chronic disease control|chronic disease control
4883756|NCT02160093|aging psychology|aging psychology
4883757|NCT02160080|Boceprevir;|boceprevir;
4883758|NCT02160080|Liver pre-transplant|liver pre-transplant
4883759|NCT02160067|Healthy Volunteers|healthy volunteers
4883760|NCT02160067|Pharmacokinetics|pharmacokinetics
4883761|NCT02160054|tacrolimus|tacrolimus
4883762|NCT02160054|cyclosporine|cyclosporine
4883763|NCT02160054|Graceptor®|graceptor®
4883764|NCT02160054|kidney transplantation|kidney transplantation
4883765|NCT02160041|Solid tumor malignancy|solid tumor malignancy
4883766|NCT02160041|hematologic malignancy|hematologic malignancy
4883767|NCT02160041|mutation|mutation
4883768|NCT02160041|translocations|translocations
4883769|NCT02160041|amplifications,|amplifications,
4883770|NCT02160041|fusions|fusions
4883771|NCT02160041|signature|signature
4883772|NCT02160041|FGFR|fgfr
4883773|NCT02160041|ligand|ligand
4883774|NCT02160041|BGJ398|bgj398
4883775|NCT02160028|Information|information
4883776|NCT02160028|Pain|pain
4883777|NCT02160028|Stress|stress
4883778|NCT02160028|Fear|fear
4883779|NCT02160028|Placebo analgesia|placebo analgesia
4883780|NCT02160002|Incubator Weaning|incubator weaning
4883781|NCT02160002|Moderately Preterm Infants|moderately preterm infants
4883782|NCT02160002|Growth Velocity|growth velocity
4883783|NCT02159976|Helicobacter pylori|helicobacter pylori
4883784|NCT02159963|FSHD|fshd
4883785|NCT02159963|HIT|hit
4883786|NCT02159963|Training|training
4883787|NCT02159963|Exercise|exercise
4883788|NCT02159963|10-20-30 interval training|10-20-30 interval training
4883789|NCT02159937|cancer|cancer
4883790|NCT02159937|in vitro|in vitro
4883791|NCT02159937|peptides|peptides
4883792|NCT02159937|dendritic cells|dendritic cells
4883793|NCT02159924|Smartphone measurements|smartphone measurements
4883794|NCT02159924|Orientation|orientation
4883795|NCT02159924|Range of motion|range of motion
4883796|NCT02159924|Median nerve neurodynamic test|median nerve neurodynamic test
4883797|NCT02159924|Posture|posture
4883798|NCT02159924|Thoracic spine|thoracic spine
4883799|NCT02159924|Shoulder girdle|shoulder girdle
4883800|NCT02159911|Cervical|cervical
4883801|NCT02159911|Hysteroscopy|hysteroscopy
4883802|NCT02159911|Misoprostol|misoprostol
4883803|NCT02159911|Oral|oral
4883804|NCT02159898|Esophageal Cancer|esophageal cancer
4883805|NCT02159898|Dysphagia|dysphagia
4883806|NCT02159898|Regurgitation|regurgitation
4883807|NCT02159885|obstructive sleep apnea|obstructive sleep apnea
4883808|NCT02159885|adherence|adherence
4883809|NCT02159885|telemedicine|telemedicine
4883810|NCT02159885|auto-titrating continuous positive airway pressure|auto-titrating continuous positive airway pressure
4883811|NCT02159872|Leukemia|leukemia
4883812|NCT02159872|Myelodysplastic Syndrome|myelodysplastic syndrome
4883813|NCT02159872|MDS|mds
4883814|NCT02159872|Omacetaxine|omacetaxine
4883815|NCT02159872|Synribo|synribo
4883816|NCT02159872|Homoharringtonine|homoharringtonine
4883817|NCT02159859|ertapenem|ertapenem
4883818|NCT02159859|pharmacokinetic|pharmacokinetic
4883819|NCT02159859|pharmacodynamics|pharmacodynamics
4883820|NCT02159859|hemodialysis|hemodialysis
4883821|NCT02159859|requires hemodialysis three times a week|requires hemodialysis three times a week
4883822|NCT02159846|Herbs|herbs
4883823|NCT02159846|Diabetes Mellitus|diabetes mellitus
4883824|NCT02159846|HbA1c|hba1c
4883825|NCT02159846|Lipid Profile|lipid profile
4883826|NCT02159833|Food allergy|food allergy
4883827|NCT02159833|Diagnosis|diagnosis
4883828|NCT02159807|Pain control|pain control
4883829|NCT02159807|labor|labor
4883830|NCT02159807|epidural|epidural
4883831|NCT02159807|pregnant|pregnant
4883832|NCT02159794|Transcatheter Aortic Valve Replacement|transcatheter aortic valve replacement
4883833|NCT02159794|Aortic valve stenosis|aortic valve stenosis
4883834|NCT02159794|Severe aortic stenosis|severe aortic stenosis
4883835|NCT02159768|tracheal intubation|tracheal intubation
4883836|NCT02159742|Adult subjects|adult subjects
4883837|NCT02159742|history|history
4883838|NCT02159742|treatment|treatment
4883839|NCT02159742|photodynamic therapy|photodynamic therapy
4883840|NCT02159716|Subjects|subjects
4883841|NCT02159703|T1-2 N2 M0,|t1-2 n2 m0,
4883842|NCT02159703|stage IVa SCCA|stage iva scca
4883843|NCT02159703|oropharynx|oropharynx
4883844|NCT02159703|negative for PNI,|negative for pni,
4883845|NCT02159703|negative surgical margins|negative surgical margins
4883846|NCT02159690|prostate cancer|prostate cancer
4883847|NCT02159690|prostatectomy|prostatectomy
4883848|NCT02159690|localized prostate cancer|localized prostate cancer
4883849|NCT02159677|EIM|eim
4883850|NCT02159664|didgeridoo|didgeridoo
4883851|NCT02159664|sleep apnea|sleep apnea
4883852|NCT02159664|drug induced sleep endoscopy|drug induced sleep endoscopy
4883853|NCT02159651|tacrolimus|tacrolimus
4883854|NCT02159651|interstitial pneumonia|interstitial pneumonia
4883855|NCT02159651|prograf|prograf
4883856|NCT02159638|Diabetes Mellitus|diabetes mellitus
4883857|NCT02159638|Diabetes Mellitus, Type 1|diabetes mellitus, type 1
4883858|NCT02159638|Diabetes Mellitus, Insulin-Dependent|diabetes mellitus, insulin-dependent
4883859|NCT02159638|Endocrine System Diseases|endocrine system diseases
4883860|NCT02159638|Blood glucose|blood glucose
4883861|NCT02159638|Blood Glucose, Self-Monitoring|blood glucose, self-monitoring
4883862|NCT02159625|Abdominal Compression Elastic Support|abdominal compression elastic support
4883863|NCT02159625|Hemodialysis|hemodialysis
4883864|NCT02159625|hypotension|hypotension
4883865|NCT02159625|occurrence rate|occurrence rate
4883866|NCT02159612|FSHD|fshd
4883867|NCT02159612|MRI|mri
4883868|NCT02159612|Disease progression|disease progression
4883869|NCT02159586|gastroparesis|gastroparesis
4883870|NCT02159586|gastric electrical stimulator|gastric electrical stimulator
4883871|NCT02159586|GES|ges
4883872|NCT02159586|vomiting|vomiting
4883873|NCT02159586|nausea|nausea
4883874|NCT02159586|bloating|bloating
4883875|NCT02159586|postprandial fullness|postprandial fullness
4883876|NCT02159586|epigastric pain|epigastric pain
4883877|NCT02159547|migraine, emergency department, dexketoprofen, placebo|migraine, emergency department, dexketoprofen, placebo
4883878|NCT02159521|deep vein thrombosis|deep vein thrombosis
4883879|NCT02159521|post-thrombotic syndrome|post-thrombotic syndrome
4883880|NCT02159521|chronic deep vein thrombosis|chronic deep vein thrombosis
4883881|NCT02159508|nutritional status|nutritional status
4883882|NCT02159508|nutritional intervention|nutritional intervention
4883883|NCT02159508|handgrip strength|handgrip strength
4883884|NCT02159508|patient-generated subjective global assessment|patient-generated subjective global assessment
4883885|NCT02159508|chemoradiotherapy|chemoradiotherapy
4883886|NCT02159508|survival|survival
4883887|NCT02159469|Hypogonadism|hypogonadism
4883888|NCT02159469|Testosterone enanthate|testosterone enanthate
4883889|NCT02159443|Hu14.18K322A|hu14.18k322a
4883890|NCT02159443|Human anti-human antibodies (HAHA)|human anti-human antibodies (haha)
4883891|NCT02159443|Pretreatment anti-therapeutic antibodies (PATA)|pretreatment anti-therapeutic antibodies (pata)
4883892|NCT02159417|Evolution of the sport, HbA1C, IMC|evolution of the sport, hba1c, imc
4883893|NCT02159391|Accident Prevention|accident prevention
4883894|NCT02159391|Alcohol Drinking|alcohol drinking
4883895|NCT02159391|Substance-Related Disorders|substance-related disorders
4883896|NCT02159391|Motivational Interviewing|motivational interviewing
4883897|NCT02159391|Adult|adult
4883898|NCT02159391|Humans|humans
4883899|NCT02159391|Intervention Studies|intervention studies
4883900|NCT02159391|Recurrence|recurrence
4883901|NCT02159391|Risk Factors|risk factors
4883902|NCT02159391|Trauma Centers|trauma centers
4883903|NCT02159391|Wounds and Injuries/epidemiology|wounds and injuries/epidemiology
4883904|NCT02159391|Wounds and Injuries/etiology*|wounds and injuries/etiology*
4883905|NCT02159391|Wounds and Injuries/prevention & control*|wounds and injuries/prevention & control*
4883906|NCT02159378|Gestational Diabetes|gestational diabetes
4883907|NCT02159378|Fructosamines|fructosamines
4883908|NCT02159378|Insulin treatment|insulin treatment
4883909|NCT02159339|DNA methylation|dna methylation
4883910|NCT02159313|Biological Availability|biological availability
4883911|NCT02159300|Fibromyalgia|fibromyalgia
4883912|NCT02159300|Pain|pain
4883913|NCT02159287|ischemic stroke|ischemic stroke
4883914|NCT02159287|atrial fibrillation|atrial fibrillation
4883915|NCT02159287|bridging therapy|bridging therapy
4883916|NCT02159274|Late symptoms|late symptoms
4883917|NCT02159274|Shoulder function|shoulder function
4883918|NCT02159274|Cosmetic results|cosmetic results
4883919|NCT02159274|EORTC|eortc
4883920|NCT02159274|Lymphoedema|lymphoedema
4883921|NCT02159261|Personal Satisfaction|personal satisfaction
4883922|NCT02159248|pancreatic, gemcitabine, radiation, tolfenamic acid|pancreatic, gemcitabine, radiation, tolfenamic acid
4883923|NCT02159235|cadmium|cadmium
4883924|NCT02159235|lead|lead
4883925|NCT02159235|mercury|mercury
4883926|NCT02159235|zinc|zinc
4883927|NCT02159235|endostatin|endostatin
4883928|NCT02159235|angiostatin|angiostatin
4883929|NCT02159235|VEGF|vegf
4883930|NCT02159235|CAD|cad
4883931|NCT02159235|osteopontin|osteopontin
4883932|NCT02159209|Acute Kidney Injury|acute kidney injury
4883933|NCT02159209|Adverse Drug Reaction|adverse drug reaction
4883934|NCT02159209|Acute Kidney Failure|acute kidney failure
4883935|NCT02159209|Kidney|kidney
4883936|NCT02159209|Kidneys|kidneys
4883937|NCT02159196|mechanical ventilation|mechanical ventilation
4883938|NCT02159196|nebulisation|nebulisation
4883939|NCT02159196|respiratory failure|respiratory failure
4883940|NCT02159170|Use of NGF injection as a model of non-inflammatory neuropathic pain in healthy subjects|use of ngf injection as a model of non-inflammatory neuropathic pain in healthy subjects
4883941|NCT02159157|breast cancer, exercise|breast cancer, exercise
4883942|NCT02159144|Brown adipose tissue|brown adipose tissue
4883943|NCT02159144|Subcutaneous white adipose tissue|subcutaneous white adipose tissue
4883944|NCT02159144|White adipose tissue|white adipose tissue
4883945|NCT02159131|ethinyl estradiol|ethinyl estradiol
4883946|NCT02159131|GSK1265744|gsk1265744
4883947|NCT02159131|pharmacokinetics|pharmacokinetics
4883948|NCT02159131|oral contraceptive|oral contraceptive
4883949|NCT02159131|oral contraceptive containing levonorgestrel and ethinyl estradiol|oral contraceptive containing levonorgestrel and ethinyl estradiol
4883950|NCT02159131|levonorgestrel|levonorgestrel
4883951|NCT02159118|bone marrow aspiration|bone marrow aspiration
4883952|NCT02159118|bone marrow biopsy|bone marrow biopsy
4883953|NCT02159118|OnControl|oncontrol
4883954|NCT02159118|powered bone marrow aspiration and biopsy device|powered bone marrow aspiration and biopsy device
4883955|NCT02159118|standard manual bone marrow aspiration and biopsy device|standard manual bone marrow aspiration and biopsy device
4883956|NCT02159105|postpartum hemorrhage|postpartum hemorrhage
4883957|NCT02159105|postsurgical bleeding|postsurgical bleeding
4883958|NCT02159105|abdominal ultrasound|abdominal ultrasound
4883959|NCT02159105|FAST scan|fast scan
4883960|NCT02159105|non-invasive hemoglobin measurement|non-invasive hemoglobin measurement
4883961|NCT02159092|Waterpipe|waterpipe
4883962|NCT02159092|Smoking cessation|smoking cessation
4883963|NCT02159092|Contingency management|contingency management
4883964|NCT02159092|Dependence|dependence
4883965|NCT02159079|Sepsis|sepsis
4883966|NCT02159079|Severe Sepsis|severe sepsis
4883967|NCT02159079|Septic Shock|septic shock
4883968|NCT02159079|Conservative Fluid Management|conservative fluid management
4883969|NCT02159079|Fluid Balance|fluid balance
4883970|NCT02159079|Fluid Restriction|fluid restriction
4883971|NCT02159066|Melanoma|melanoma
4883972|NCT02159053|AIN457, ankylosing spondylitis, chronic inflammatory disease, inflammatory back pain, secukinumab, self-injection|ain457, ankylosing spondylitis, chronic inflammatory disease, inflammatory back pain, secukinumab, self-injection
4883973|NCT02159040|Int-2 MDS|int-2 mds
4883974|NCT02159027|Human Immunodeficiency Virus|human immunodeficiency virus
4883975|NCT02159027|AIDS Dementia Complex|aids dementia complex
4883976|NCT02159014|Physical activity intervention|physical activity intervention
4883977|NCT02159014|Aerobic dance|aerobic dance
4883978|NCT02159014|Nutritional intervention|nutritional intervention
4883979|NCT02159014|Online participation|online participation
4883980|NCT02159014|Primary Care settings|primary care settings
4883981|NCT02159014|General Practice Physical Activity Questionnaire GPPAQ|general practice physical activity questionnaire gppaq
4883982|NCT02159014|Qrisk2|qrisk2
4883983|NCT02159014|QDS Diabetes|qds diabetes
4883984|NCT02159001|clozapine|clozapine
4883986|NCT02159001|PANSS|panss
4883987|NCT02159001|schizoaffective disorder|schizoaffective disorder
4883988|NCT02159001|schizophrenia|schizophrenia
4883989|NCT02159001|treatment|treatment
4883990|NCT02158988|Gastric cancer|gastric cancer
4883991|NCT02158988|cancer of the esophagogastric junction|cancer of the esophagogastric junction
4883992|NCT02158988|peritoneal carcinomatosis|peritoneal carcinomatosis
4883993|NCT02158988|hyperthermic intraperitoneal chemotherapy|hyperthermic intraperitoneal chemotherapy
4883994|NCT02158988|HIPEC|hipec
4883995|NCT02158962|Partner abuse|partner abuse
4883996|NCT02158962|Abuse African Caribbean women|abuse african caribbean women
4883997|NCT02158962|Intimate Partner Violence|intimate partner violence
4883998|NCT02158949|alcohol|alcohol
4883999|NCT02158949|mHealth|mhealth
4884000|NCT02158949|SBIRT|sbirt
4884001|NCT02158936|thrombocytopenia|thrombocytopenia
4884002|NCT02158936|myelodysplastic syndromes|myelodysplastic syndromes
4884003|NCT02158936|MDS|mds
4884004|NCT02158936|thrombopoietin|thrombopoietin
4884005|NCT02158936|azacitidine|azacitidine
4884006|NCT02158936|Eltrombopag|eltrombopag
4884007|NCT02158936|myelodysplastic syndromes (MDS)|myelodysplastic syndromes (mds)
4884008|NCT02158923|ventilation|ventilation
4884009|NCT02158923|lung|lung
4884010|NCT02158923|lung complications|lung complications
4884011|NCT02158923|postoperative complications|postoperative complications
4884012|NCT02158923|perioperative lung protective ventilation|perioperative lung protective ventilation
4884013|NCT02158910|Alzheimer's disease|alzheimer's disease
4884014|NCT02158884|Major extremity trauma|major extremity trauma
4884015|NCT02158884|wounded warriors|wounded warriors
4884016|NCT02158884|IDEO|ideo
4884017|NCT02158884|return to run|return to run
4884018|NCT02158871|Education|education
4884019|NCT02158871|Early intervention|early intervention
4884020|NCT02158871|Workplace|workplace
4884021|NCT02158871|Stigma|stigma
4884022|NCT02158871|Mental Health Literacy|mental health literacy
4884023|NCT02158858|Phase 1/2|phase 1/2
4884024|NCT02158858|Oncology|oncology
4884025|NCT02158858|BET Inhibitor|bet inhibitor
4884026|NCT02158858|Ruxolitinib|ruxolitinib
4884027|NCT02158845|endometriosis|endometriosis
4884028|NCT02158845|blood coagulation|blood coagulation
4884029|NCT02158845|levonorgestrel|levonorgestrel
4884030|NCT02158845|GnRH agonist|gnrh agonist
4884031|NCT02158845|progesterone-releasing intrauterine device|progesterone-releasing intrauterine device
4884032|NCT02158832|Lymphoedema|lymphoedema
4884033|NCT02158832|Edema|edema
4884034|NCT02158832|Oedema|oedema
4884035|NCT02158832|Cancer|cancer
4884036|NCT02158832|Breast Cancer|breast cancer
4884037|NCT02158819|Visionaire|visionaire
4884038|NCT02158819|Health Economics|health economics
4884039|NCT02158819|Degenerative arthritis|degenerative arthritis
4884040|NCT02158819|total knee arthroplasty|total knee arthroplasty
4884041|NCT02158806|Venous ulcer, varicose ulcer, gravitational ulcer, aspirin|venous ulcer, varicose ulcer, gravitational ulcer, aspirin
4884042|NCT02158793|face transplant|face transplant
4884043|NCT02158793|Craniomaxillofacial Allotransplantation|craniomaxillofacial allotransplantation
4884044|NCT02158793|facial disfigurement|facial disfigurement
4884045|NCT02158793|facial trauma|facial trauma
4884046|NCT02158754|Corus CAD|corus cad
4884047|NCT02158754|ASGES|asges
4884048|NCT02158754|Coronary Artery Disease|coronary artery disease
4884049|NCT02158754|Gene Expression|gene expression
4884050|NCT02158754|Age/Sex/Gene Expression Score|age/sex/gene expression score
4884051|NCT02158754|GES|ges
4884052|NCT02158754|Angina Pectoris|angina pectoris
4884053|NCT02158754|Chest Pain|chest pain
4884054|NCT02158754|Cardiovascular Disease|cardiovascular disease
4884055|NCT02158754|CAD|cad
4884056|NCT02158754|CVD|cvd
4884057|NCT02158754|CHD|chd
4884058|NCT02158754|Coronary Heart Disease|coronary heart disease
4884059|NCT02158754|Precision Medicine|precision medicine
4884060|NCT02158754|Clinical Utility|clinical utility
4884061|NCT02158741|Self-Management|self-management
4884062|NCT02158741|Home Visits|home visits
4884063|NCT02158702|Relapsed Myeloma Patients|relapsed myeloma patients
4884064|NCT02158702|Relapsed after use of Bortezomib and Lenalidomide|relapsed after use of bortezomib and lenalidomide
4884065|NCT02158702|Pomalidomide and Dexamethasone|pomalidomide and dexamethasone
4884066|NCT02158702|Efficacy and Safety|efficacy and safety
4884067|NCT02158689|Poor responders|poor responders
4884068|NCT02158689|letrozole|letrozole
4884069|NCT02158689|human menopausal gonadotropin|human menopausal gonadotropin
4884070|NCT02158676|Roux-en-y gastric bypass|roux-en-y gastric bypass
4884071|NCT02158676|Inflammatory markers|inflammatory markers
4884072|NCT02158676|Nutritional status|nutritional status
4884073|NCT02158676|Fatty acids|fatty acids
4884074|NCT02158676|Glucose|glucose
4884075|NCT02158676|Prebiotic|prebiotic
4884076|NCT02158676|Synbiotic|synbiotic
4884077|NCT02158663|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
4884078|NCT02158663|TMS|tms
4884079|NCT02158663|PTSD|ptsd
4884080|NCT02158650|informed consent|informed consent
4884081|NCT02158650|video-based|video-based
4884082|NCT02158637|PRO-CTCAE|pro-ctcae
4884083|NCT02158637|Patient-Reported Outcomes|patient-reported outcomes
4884084|NCT02158637|Common Terminology Criteria for Adverse Events|common terminology criteria for adverse events
4884085|NCT02158637|Questionnaire|questionnaire
4884086|NCT02158637|Adverse Events|adverse events
4884087|NCT02158637|Symptoms|symptoms
4884088|NCT02158611|Individual Counseling service|individual counseling service
4884089|NCT02158611|Group Counseling service|group counseling service
4884090|NCT02158585|Lamotrigine|lamotrigine
4884091|NCT02158585|Lamictal|lamictal
4884092|NCT02158585|Anticonvulsant|anticonvulsant
4884093|NCT02158585|Ménière's disease|ménière's disease
4884094|NCT02158585|Vertigo attack|vertigo attack
4884095|NCT02158585|Dizziness|dizziness
4884096|NCT02158585|Vestibular disorder|vestibular disorder
4884097|NCT02158572|prevention of pregnancy|prevention of pregnancy
4884098|NCT02158546|Major Depressive Disorder|major depressive disorder
4884099|NCT02158546|Depression|depression
4884100|NCT02158546|Alkermes|alkermes
4884101|NCT02158546|ALKS 5461|alks 5461
4884102|NCT02158546|Samidorphan|samidorphan
4884103|NCT02158533|Major Depressive Disorder|major depressive disorder
4884104|NCT02158533|Depression|depression
4884105|NCT02158533|Alkermes|alkermes
4884107|NCT02158533|Samidorphan|samidorphan
4884108|NCT02158507|metastatic|metastatic
4884109|NCT02158507|triple negative breast cancer (TNBC)|triple negative breast cancer (tnbc)
4884110|NCT02158507|Veliparib|veliparib
4884111|NCT02158507|Lapatinib|lapatinib
4884112|NCT02158507|estrogen receptor (ER) negative|estrogen receptor (er) negative
4884113|NCT02158507|progesterone receptor (PR) negative|progesterone receptor (pr) negative
4884114|NCT02158507|human epidermal growth factor receptor 2 (HER-2-Neu) negative|human epidermal growth factor receptor 2 (her-2-neu) negative
4884115|NCT02158494|Cranial Nerve Noninvasive Neuromodulation|cranial nerve noninvasive neuromodulation
4884116|NCT02158494|Portable Neuromodulation Stimulator (PoNS)|portable neuromodulation stimulator (pons)
4884117|NCT02158494|Balance and Gait Training|balance and gait training
4884118|NCT02158494|Breathing Awareness Training|breathing awareness training
4884119|NCT02158481|Vascular function|vascular function
4884120|NCT02158481|Dietary ingredients|dietary ingredients
4884121|NCT02158481|Acute glucose load|acute glucose load
4884122|NCT02158481|Oxidative stress|oxidative stress
4884123|NCT02158468|STEMI, reperfusion, preconditioning, postconditioning, reperfusion injury, myocardial salvage|stemi, reperfusion, preconditioning, postconditioning, reperfusion injury, myocardial salvage
4884124|NCT02158455|CABG|cabg
4884125|NCT02158455|Saphenous vein|saphenous vein
4884126|NCT02158455|Radial artery|radial artery
4884127|NCT02158442|Diabetes|diabetes
4884128|NCT02158442|Lower limb infection|lower limb infection
4884129|NCT02158442|Significant wound infections|significant wound infections
4884130|NCT02158442|Intravenous antibiotics|intravenous antibiotics
4884131|NCT02158442|Timentin|timentin
4884132|NCT02158429|substance use disorders|substance use disorders
4884133|NCT02158429|pregnancy|pregnancy
4884134|NCT02158429|maternal attachment|maternal attachment
4884135|NCT02158429|paternal attachment|paternal attachment
4884136|NCT02158429|three dimensional ultrasound|three dimensional ultrasound
4884137|NCT02158416|platelet|platelet
4884138|NCT02158416|transfusion|transfusion
4884139|NCT02158416|ThromboLUX|thrombolux
4884140|NCT02158416|corrected count increment|corrected count increment
4884141|NCT02158416|thrombocytopenic|thrombocytopenic
4884142|NCT02158403|HeartMate II|heartmate ii
4884143|NCT02158403|heart assist device|heart assist device
4884144|NCT02158403|pump thrombosis|pump thrombosis
4884145|NCT02158403|hypercoagulable disorder|hypercoagulable disorder
4884146|NCT02158403|thrombus|thrombus
4884147|NCT02158403|Thoratec Corporation|thoratec corporation
4884148|NCT02158390|Down syndrome|down syndrome
4884149|NCT02158390|Language intervention|language intervention
4884150|NCT02158390|Communication intervention|communication intervention
4884151|NCT02158377|Dental implants|dental implants
4884152|NCT02158377|Trabecular Metal dental implants|trabecular metal dental implants
4884153|NCT02158377|TSV dental implants|tsv dental implants
4884154|NCT02158377|Zimmer Dental|zimmer dental
4884155|NCT02158377|Implant stability|implant stability
4884156|NCT02158377|Implant stability quotient (ISQ)|implant stability quotient (isq)
4884157|NCT02158377|Resonance Frequency Analysis (RFA)|resonance frequency analysis (rfa)
4884158|NCT02158364|Pharmacological therapy|pharmacological therapy
4884159|NCT02158351|Simple steatosis (SS)|simple steatosis (ss)
4884160|NCT02158351|Non-alcoholic steatohepatitis (NASH)|non-alcoholic steatohepatitis (nash)
4884161|NCT02158351|Gut microbiota (GM)|gut microbiota (gm)
4884162|NCT02158351|Non alcoholic fatty liver disease (NAFLD)|non alcoholic fatty liver disease (nafld)
4884163|NCT02158338|asthma|asthma
4884164|NCT02158338|maternal bonding|maternal bonding
4884165|NCT02158338|maternal bonding disruptions|maternal bonding disruptions
4884166|NCT02158338|mother-infant interaction|mother-infant interaction
4884167|NCT02158312|neuroplasticity|neuroplasticity
4884168|NCT02158273|Alcohol|alcohol
4884169|NCT02158273|Relapse|relapse
4884170|NCT02158260|Capsule endoscopy|capsule endoscopy
4884171|NCT02158260|Patient position changing|patient position changing
4884172|NCT02158234|squamous cell carcinoma|squamous cell carcinoma
4884173|NCT02158234|head and neck cancer|head and neck cancer
4884174|NCT02158234|paranasal sinuses|paranasal sinuses
4884175|NCT02158234|nasal cavity|nasal cavity
4884176|NCT02158234|nasopharynx|nasopharynx
4884177|NCT02158234|oropharynx|oropharynx
4884178|NCT02158234|oral cavity|oral cavity
4884179|NCT02158234|larynx|larynx
4884180|NCT02158234|hypopharynx|hypopharynx
4884181|NCT02158234|salivary glands|salivary glands
4884182|NCT02158234|cervical lymph nodes|cervical lymph nodes
4884183|NCT02158208|before any treatment|before any treatment
4884184|NCT02158208|at the diagnosis|at the diagnosis
4884185|NCT02158182|Hepatic Encephalopathy|hepatic encephalopathy
4884186|NCT02158182|Acute Variceal Bleeding|acute variceal bleeding
4884187|NCT02158182|Cirrhosis|cirrhosis
4884188|NCT02158130|Physical Inactivity|physical inactivity
4884189|NCT02158130|Aerobic Exercise Detraining|aerobic exercise detraining
4884190|NCT02158130|Body Weight|body weight
4884191|NCT02158130|Energy Expenditure|energy expenditure
4884192|NCT02158130|Metabolic Syndrome|metabolic syndrome
4884193|NCT02158117|Emergency Treatment|emergency treatment
4884194|NCT02158117|Morphine Derivates|morphine derivates
4884195|NCT02158117|Heroin|heroin
4884196|NCT02158117|Antidotes|antidotes
4884197|NCT02158117|Administration, Intranasal|administration, intranasal
4884198|NCT02158091|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
4884199|NCT02158078|Diabetes Mellitus|diabetes mellitus
4884200|NCT02158078|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
4884201|NCT02158078|Glucose Metabolism Disorders|glucose metabolism disorders
4884202|NCT02158078|Metabolic Diseases|metabolic diseases
4884203|NCT02158078|Endocrine System Diseases|endocrine system diseases
4884204|NCT02158078|Insulin|insulin
4884205|NCT02158078|Continuous subcutaneous insulin infusion (CSII)|continuous subcutaneous insulin infusion (csii)
4884206|NCT02158078|Insulin pumps|insulin pumps
4884207|NCT02158065|Chronic obstructive pulmonary disease (COPD)|chronic obstructive pulmonary disease (copd)
4884208|NCT02158065|physical activity|physical activity
4884209|NCT02158065|PROactive|proactive
4884210|NCT02158065|telecoaching|telecoaching
4884211|NCT02158052|HLA matched|hla matched
4884212|NCT02158052|bone marrow transplantation|bone marrow transplantation
4884213|NCT02158052|kidney transplantation|kidney transplantation
4884214|NCT02158039|Intraductal Papillary Mucinous Neoplasm|intraductal papillary mucinous neoplasm
4884215|NCT02158039|Mucinous Cystic Neoplasm|mucinous cystic neoplasm
4884216|NCT02158039|Endoscopic Ultrasound|endoscopic ultrasound
4884217|NCT02158039|Ethanol|ethanol
4884218|NCT02158026|Follicular sensitivity index|follicular sensitivity index
4884219|NCT02158026|ICSI|icsi
4884220|NCT02158026|IVF|ivf
4884221|NCT02157987|telangietasia hereditary hemorragic|telangietasia hereditary hemorragic
4884222|NCT02157987|epistaxis|epistaxis
4884223|NCT02157987|safety|safety
4884224|NCT02157987|quality of life|quality of life
4884225|NCT02157987|bevacizumab|bevacizumab
4884226|NCT02157987|spray|spray
4884227|NCT02157948|postmenopausal osteoporosis|postmenopausal osteoporosis
4884228|NCT02157948|osteoporosis|osteoporosis
4884229|NCT02157948|postmenopausal|postmenopausal
4884230|NCT02157948|denosumab|denosumab
4884231|NCT02157948|women|women
4884232|NCT02157935|COPD, turbuhaler, pMDI|copd, turbuhaler, pmdi
4884233|NCT02157922|Cystic fibrosis|cystic fibrosis
4884234|NCT02157922|mucolytic|mucolytic
4884235|NCT02157922|mucociliary clearance|mucociliary clearance
4884236|NCT02157922|lung clearance|lung clearance
4884237|NCT02157909|Lens fit|lens fit
4884238|NCT02157909|contact lenses|contact lenses
4884239|NCT02157909|myopia|myopia
4884240|NCT02157896|Acute ischemic stroke|acute ischemic stroke
4884241|NCT02157896|Vascular endothelial growth factor|vascular endothelial growth factor
4884242|NCT02157896|Endostatin|endostatin
4884243|NCT02157883|oncology, cancer, non small cell lung cancer, anticancer drug, pharmacokinetics, AZD9291, intraconazole, EGFR sensitivity mutation|oncology, cancer, non small cell lung cancer, anticancer drug, pharmacokinetics, azd9291, intraconazole, egfr sensitivity mutation
4884244|NCT02157870|Ovary|ovary
4884245|NCT02157870|ovarian cancer|ovarian cancer
4884246|NCT02157870|biologic therapy|biologic therapy
4884247|NCT02157870|platinum-resistant|platinum-resistant
4884639|NCT02155972|YMRS|ymrs
4884248|NCT02157870|platinum-refractory ovarian cancer|platinum-refractory ovarian cancer
4884249|NCT02157870|platinum-resistant ovarian cancer|platinum-resistant ovarian cancer
4884250|NCT02157870|paclitaxel|paclitaxel
4884251|NCT02157870|tgDCC-E1A|tgdcc-e1a
4884252|NCT02157870|E1A|e1a
4884253|NCT02157870|Taxol|taxol
4884254|NCT02157857|NSCLC, SCLC, lung cancer, EBUS-TBNA|nsclc, sclc, lung cancer, ebus-tbna
4884255|NCT02157844|Obstructive Sleep Apnea|obstructive sleep apnea
4884256|NCT02157844|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
4884257|NCT02157844|Obesity|obesity
4884258|NCT02157844|Hepatic fat metabolism|hepatic fat metabolism
4884259|NCT02157844|fat digestion|fat digestion
4884260|NCT02157844|whole body protein synthesis|whole body protein synthesis
4884261|NCT02157844|protein digestion|protein digestion
4884262|NCT02157844|amino acid metabolism|amino acid metabolism
4884263|NCT02157844|adipose tissue fat metabolism|adipose tissue fat metabolism
4884264|NCT02157844|lipolysis|lipolysis
4884265|NCT02157831|Subjects with Clinical Benefit After a Single Infusion of CP - 870, 893|subjects with clinical benefit after a single infusion of cp - 870, 893
4884266|NCT02157805|Meat processes|meat processes
4884267|NCT02157805|Amino acids bioavailability|amino acids bioavailability
4884268|NCT02157805|Digestion rate|digestion rate
4884269|NCT02157805|Protein synthesis|protein synthesis
4884270|NCT02157805|Aging|aging
4884271|NCT02157805|Sarcopenia|sarcopenia
4884272|NCT02157792|Solid Tumor|solid tumor
4884273|NCT02157792|Advanced Solid Tumor|advanced solid tumor
4884274|NCT02157792|VX12-970-001|vx12-970-001
4884275|NCT02157792|M6620|m6620
4884276|NCT02157792|VX-970|vx-970
4884277|NCT02157792|Gemcitabine|gemcitabine
4884278|NCT02157792|Cisplatin|cisplatin
4884279|NCT02157792|Etoposide|etoposide
4884280|NCT02157792|Carboplatin|carboplatin
4884281|NCT02157792|Irinotecan|irinotecan
4884282|NCT02157779|Veterans|veterans
4884283|NCT02157779|Anger|anger
4884284|NCT02157779|Cognitive Behavioral Therapy|cognitive behavioral therapy
4884285|NCT02157779|Treatment|treatment
4884286|NCT02157766|Mental Health|mental health
4884287|NCT02157766|Asthma|asthma
4884288|NCT02157766|Mindfulness|mindfulness
4884289|NCT02157766|Compassion|compassion
4884290|NCT02157766|Meditation|meditation
4884291|NCT02157753|Osteoporotic fracture|osteoporotic fracture
4884292|NCT02157753|treatment for osteoporosis|treatment for osteoporosis
4884293|NCT02157753|adherence and compliance|adherence and compliance
4884294|NCT02157701|Dietary herbs|dietary herbs
4884295|NCT02157701|Polyherbal capsule|polyherbal capsule
4884296|NCT02157701|Functional exercise capacity|functional exercise capacity
4884297|NCT02157701|Joint health|joint health
4884298|NCT02157688|folliculitis decalvans|folliculitis decalvans
4884299|NCT02157688|Staphylococcus Aureus|staphylococcus aureus
4884300|NCT02157688|antibiotics|antibiotics
4884301|NCT02157675|Delayed onset muscle soreness|delayed onset muscle soreness
4884302|NCT02157675|Muscle damage|muscle damage
4884303|NCT02157675|Eccentric exercise|eccentric exercise
4884304|NCT02157636|Phase 1|phase 1
4884305|NCT02157636|Oncology|oncology
4884306|NCT02157636|BET Inhibitor|bet inhibitor
4884307|NCT02157623|Basal Cell Nevus Syndrome|basal cell nevus syndrome
4884308|NCT02157623|Gorlin's Syndrome|gorlin's syndrome
4884309|NCT02157610|Cervical Cancer|cervical cancer
4884310|NCT02157610|Cervical Cancer Survivors|cervical cancer survivors
4884311|NCT02157610|Smoking Cessation|smoking cessation
4884312|NCT02157610|Motivation And Problem-Solving|motivation and problem-solving
4884313|NCT02157610|MAPS|maps
4884314|NCT02157610|Saliva test|saliva test
4884315|NCT02157610|Self help materials|self help materials
4884316|NCT02157610|Pamphlets|pamphlets
4884317|NCT02157610|Texas Quitline|texas quitline
4884318|NCT02157610|Nicotine patch|nicotine patch
4884319|NCT02157610|Questionnaires|questionnaires
4884320|NCT02157610|Surveys|surveys
4884321|NCT02157610|Telephone counseling sessions|telephone counseling sessions
4884322|NCT02157571|prulifloxacin|prulifloxacin
4884323|NCT02157571|AECB|aecb
4884324|NCT02157571|Levofloxacin|levofloxacin
4884325|NCT02157545|muscle relaxants|muscle relaxants
4884326|NCT02157545|pyridostigmine|pyridostigmine
4884327|NCT02157545|pharmacodynamics|pharmacodynamics
4884328|NCT02157545|potency|potency
4884329|NCT02157532|Severe stroke|severe stroke
4884330|NCT02157532|IV tPA|iv tpa
4884331|NCT02157532|mechanical thrombectomy|mechanical thrombectomy
4884332|NCT02157519|Oral Chemotherapy|oral chemotherapy
4884333|NCT02157519|Cancer|cancer
4884334|NCT02157506|Acute Heart failure|acute heart failure
4884335|NCT02157506|Hemodynamics|hemodynamics
4884336|NCT02157506|Pharmacokinetics|pharmacokinetics
4884337|NCT02157506|Renal Function|renal function
4884338|NCT02157493|American Indian|american indian
4884339|NCT02157493|Adolescents|adolescents
4884340|NCT02157493|Entrepreneurship|entrepreneurship
4884341|NCT02157493|Paraprofessional|paraprofessional
4884342|NCT02157493|Life skills|life skills
4884343|NCT02157480|glucose profile|glucose profile
4884344|NCT02157480|continuous glucose monitoring|continuous glucose monitoring
4884345|NCT02157480|electrostimulation|electrostimulation
4884346|NCT02157441|Postpartum Hemorrhage|postpartum hemorrhage
4884347|NCT02157441|Placenta Previa|placenta previa
4884348|NCT02157441|uterine cavity|uterine cavity
4884349|NCT02157402|Adolescent|adolescent
4884350|NCT02157376|SUP|sup
4884351|NCT02157376|Upper GI bleeding|upper gi bleeding
4884352|NCT02157376|Seriously ill patients|seriously ill patients
4884353|NCT02157350|Eye Diseases|eye diseases
4884354|NCT02157350|Proliferative Diabetic Retinopathy|proliferative diabetic retinopathy
4884355|NCT02157350|Retinal Vessel Geometry|retinal vessel geometry
4884356|NCT02157350|Retinal Oxymetry|retinal oxymetry
4884357|NCT02157350|Retina Ischemia|retina ischemia
4884358|NCT02157350|Panretinal Photocoagulation|panretinal photocoagulation
4884359|NCT02157350|Lasers, Semiconductor|lasers, semiconductor
4884360|NCT02157350|Fluorescein Angiography|fluorescein angiography
4884361|NCT02157337|aortic surgery|aortic surgery
4884362|NCT02157337|postoperative acute kidney injury|postoperative acute kidney injury
4884363|NCT02157337|statin|statin
4884364|NCT02157337|the patient undergoing aortic surgery|the patient undergoing aortic surgery
4884365|NCT02157324|Bruton tyrosine kinase inhibitor|bruton tyrosine kinase inhibitor
4884366|NCT02157324|Btk|btk
4884367|NCT02157311|HIV-1|hiv-1
4884368|NCT02157311|simplification,|simplification,
4884369|NCT02157311|treatment discontinuation|treatment discontinuation
4884370|NCT02157311|virological success|virological success
4884371|NCT02157311|four days a week|four days a week
4884372|NCT02157298|Japanese patients with type 2 diabetes with inadequate glycemic control on insulin|japanese patients with type 2 diabetes with inadequate glycemic control on insulin
4884373|NCT02157285|Unintended pregnancy in adolescence|unintended pregnancy in adolescence
4884374|NCT02157285|LARC|larc
4884375|NCT02157285|contraception|contraception
4884376|NCT02157272|Antiphospholipid|antiphospholipid
4884377|NCT02157272|Syndrome|syndrome
4884378|NCT02157272|Rivaroxaban|rivaroxaban
4884379|NCT02157272|Warfarin|warfarin
4884380|NCT02157272|Thrombosis|thrombosis
4884381|NCT02157272|Treatment|treatment
4884382|NCT02157246|hypoxia|hypoxia
4884383|NCT02157246|rectal cancer|rectal cancer
4884384|NCT02157207|antioxidants|antioxidants
4884385|NCT02157207|Caucasians|caucasians
4884386|NCT02157207|healthy|healthy
4884387|NCT02157207|African Americans|african americans
4884388|NCT02157207|vascular|vascular
4884389|NCT02157207|aging|aging
4884390|NCT02157207|racial differences|racial differences
4884391|NCT02157181|HCL variant|hcl variant
4884392|NCT02157181|HCL relapse|hcl relapse
4884393|NCT02157181|Risk stratified|risk stratified
4884394|NCT02157168|Affordable Care Act|affordable care act
4884395|NCT02157168|Medically underserved minorities|medically underserved minorities
4884396|NCT02157168|Community health workers|community health workers
4884397|NCT02157168|Health disparities among Mexican origin|health disparities among mexican origin
4884398|NCT02157142|Severe aortic stenosis|severe aortic stenosis
4884399|NCT02157142|Aortic valve stenosis|aortic valve stenosis
4884400|NCT02157142|Transcatheter aortic valve replacement|transcatheter aortic valve replacement
4884401|NCT02157129|Tracheostomy|tracheostomy
4884402|NCT02157129|inflammation|inflammation
4884403|NCT02157129|mucous congestion|mucous congestion
4884404|NCT02157129|inhalation therapy|inhalation therapy
4884405|NCT02157129|phospholipids|phospholipids
4884406|NCT02157116|Dose-Dense Chemotherapy|dose-dense chemotherapy
4884407|NCT02157103|GBM|gbm
4884408|NCT02157103|Glioblastoma|glioblastoma
4884409|NCT02157103|Bevacizumab|bevacizumab
4884410|NCT02157103|Avastin|avastin
4884411|NCT02157103|Subcutaneous|subcutaneous
4884412|NCT02157090|HSL of lips|hsl of lips
4884413|NCT02157090|perioral skin|perioral skin
4884414|NCT02157090|duration of HSL symptoms not more than three days|duration of hsl symptoms not more than three days
4884415|NCT02157090|not acyclovir or other cold sore therapies|not acyclovir or other cold sore therapies
4884416|NCT02157077|Eye diseases|eye diseases
4884417|NCT02157077|Vision Impairment and Blindness|vision impairment and blindness
4884418|NCT02157077|Eyes and Vision|eyes and vision
4884419|NCT02157077|Seniors|seniors
4884420|NCT02157077|Neovascular Age-Related Macular Degeneration (AMD)|neovascular age-related macular degeneration (amd)
4884421|NCT02157077|Retinal Disease|retinal disease
4884422|NCT02157038|whiplash|whiplash
4884423|NCT02157038|neck pain|neck pain
4884424|NCT02157038|chronic pain|chronic pain
4884425|NCT02157038|motor vehicle accident|motor vehicle accident
4884426|NCT02157038|car accident|car accident
4884427|NCT02157038|MRI|mri
4884428|NCT02157038|DNA|dna
4884429|NCT02157038|RNA|rna
4884430|NCT02157025|Humphrey visual fields|humphrey visual fields
4884431|NCT02157025|perimetry|perimetry
4884432|NCT02157025|pediatrics|pediatrics
4884433|NCT02156973|cardiac computed tomography|cardiac computed tomography
4884434|NCT02156973|Image quality|image quality
4884435|NCT02156947|Power Doppler sonography|power doppler sonography
4884436|NCT02156947|cholecystitis, adhesion|cholecystitis, adhesion
4884437|NCT02156934|autologous stress urinary incontinence muscle derived cells|autologous stress urinary incontinence muscle derived cells
4884438|NCT02156908|cognitive remediation|cognitive remediation
4884439|NCT02156895|Korean PMS of Axitinib|korean pms of axitinib
4884440|NCT02156895|Metastatic RCC ; 2nd line only|metastatic rcc ; 2nd line only
4884441|NCT02156882|TB|tb
4884442|NCT02156882|Tuberculosis|tuberculosis
4884443|NCT02156882|MaTuTU - Maputo Tuberculosis Trial Unit|matutu - maputo tuberculosis trial unit
4884444|NCT02156882|Clinical Trial Capacity Development|clinical trial capacity development
4884445|NCT02156869|Prostate cancer|prostate cancer
4884446|NCT02156869|Screening|screening
4884447|NCT02156869|Decision aids|decision aids
4884448|NCT02156856|hemodynamic monitoring|hemodynamic monitoring
4884449|NCT02156856|cardiac output|cardiac output
4884450|NCT02156856|cardiac surgery|cardiac surgery
4884451|NCT02156843|Diabetic Kidney Disease|diabetic kidney disease
4884452|NCT02156843|Nephropathy|nephropathy
4884453|NCT02156843|Diabetic Nephropathy|diabetic nephropathy
4884454|NCT02156843|Kidney Disease|kidney disease
4884455|NCT02156843|Type 2 Diabetes|type 2 diabetes
4884456|NCT02156817|Amplitude integrated electroencephalogram|amplitude integrated electroencephalogram
4884457|NCT02156817|Heart rate variability|heart rate variability
4884458|NCT02156817|Respiratory rate variability|respiratory rate variability
4884459|NCT02156817|Preterm Infants|preterm infants
4884460|NCT02156817|Length of Hospital Stay|length of hospital stay
4884461|NCT02156791|Seasonal allergic rhinoconjunctivitis|seasonal allergic rhinoconjunctivitis
4884462|NCT02156791|Grass pollen|grass pollen
4884463|NCT02156791|Allergen specific immunotherapy|allergen specific immunotherapy
4884464|NCT02156778|Post-Stroke Disease Management|post-stroke disease management
4884465|NCT02156778|Post-Stroke Complication|post-stroke complication
4884466|NCT02156778|Risk Factor Control|risk factor control
4884467|NCT02156778|Quality-of-Life|quality-of-life
4884468|NCT02156765|Atrial Fibrillation|atrial fibrillation
4884469|NCT02156765|Screening|screening
4884470|NCT02156765|Stroke patients|stroke patients
4884471|NCT02156739|Liver Neoplasms|liver neoplasms
4884472|NCT02156739|Liver lesions|liver lesions
4884473|NCT02156739|Benign liver lesions|benign liver lesions
4884474|NCT02156739|Malignant liver lesions|malignant liver lesions
4884475|NCT02156739|Contrast-Enhanced Magnetic Resonance Imaging|contrast-enhanced magnetic resonance imaging
4884476|NCT02156739|MRI|mri
4884477|NCT02156739|Gadoxetate|gadoxetate
4884478|NCT02156739|Eovist|eovist
4884479|NCT02156739|Gadopentetate Dimeglumine|gadopentetate dimeglumine
4884480|NCT02156739|Magnevist|magnevist
4884481|NCT02156726|chronic lymphocytic leukemia|chronic lymphocytic leukemia
4884482|NCT02156726|fludarabine|fludarabine
4884483|NCT02156726|rituximab|rituximab
4884484|NCT02156726|elderly|elderly
4884485|NCT02156726|comorbid|comorbid
4884486|NCT02156726|FCR|fcr
4884487|NCT02156726|CIRS|cirs
4884488|NCT02156713|Hemiparesis|hemiparesis
4884489|NCT02156713|Occupational Therapy|occupational therapy
4884490|NCT02156700|shear wave elastography|shear wave elastography
4884491|NCT02156700|haemangiomas|haemangiomas
4884492|NCT02156700|metastases|metastases
4884493|NCT02156700|hepatocellular carcinoma|hepatocellular carcinoma
4884494|NCT02156700|focal nodular hyperplasia|focal nodular hyperplasia
4884495|NCT02156700|cholangiocellular carcinoma|cholangiocellular carcinoma
4884496|NCT02156674|Maroteaux-Lamy Syndrome|maroteaux-lamy syndrome
4884497|NCT02156674|mucopolysaccharide VI|mucopolysaccharide vi
4884498|NCT02156674|MPS VI|mps vi
4884499|NCT02156648|Invasive ductal|invasive ductal
4884500|NCT02156648|HER2-neu positive|her2-neu positive
4884501|NCT02156635|Rehabilitation|rehabilitation
4884502|NCT02156635|Direct Current Stimulation|direct current stimulation
4884503|NCT02156635|Acute Stroke|acute stroke
4884504|NCT02156622|HIV|hiv
4884505|NCT02156622|Depression|depression
4884506|NCT02156622|Measurement-based care|measurement-based care
4884507|NCT02156622|Outcomes|outcomes
4884508|NCT02156622|Viral load|viral load
4884509|NCT02156609|HeartMate PHP|heartmate php
4884510|NCT02156609|HeartMate PHP CE Mark|heartmate php ce mark
4884511|NCT02156609|Percutaneous coronary intervention|percutaneous coronary intervention
4884512|NCT02156609|PCI|pci
4884513|NCT02156609|Percutaneous ventricular assist|percutaneous ventricular assist
4884514|NCT02156609|Thoratec Corporation|thoratec corporation
4884515|NCT02156596|renal colic|renal colic
4884516|NCT02156596|nebulised morphine|nebulised morphine
4884517|NCT02156596|Intravenous NSAID|intravenous nsaid
4884518|NCT02156583|Ventricular Assist Device|ventricular assist device
4884519|NCT02156583|Skeletal Muscle|skeletal muscle
4884520|NCT02156583|Frailty|frailty
4884521|NCT02156583|Older adults|older adults
4884522|NCT02156570|Hepatitis C|hepatitis c
4884523|NCT02156570|Acute/early chronic|acute/early chronic
4884524|NCT02156570|Recently acquired|recently acquired
4884525|NCT02156570|Directly acting antiviral therapy|directly acting antiviral therapy
4884526|NCT02156570|Sofosbuvir|sofosbuvir
4884527|NCT02156570|Ribavirin|ribavirin
4884528|NCT02156531|Anxiety|anxiety
4884529|NCT02156531|Youth Anxiety|youth anxiety
4884530|NCT02156531|CBM|cbm
4884531|NCT02156531|Cognitive Bias Modification|cognitive bias modification
4884532|NCT02156531|Adolescents|adolescents
4884533|NCT02156518|radiation therapy, laryngeal cancer, voice therapy, vocal function exercises|radiation therapy, laryngeal cancer, voice therapy, vocal function exercises
4884534|NCT02156505|stent|stent
4884535|NCT02156505|gastric outlet obstruction|gastric outlet obstruction
4884536|NCT02156505|restenosis|restenosis
4884537|NCT02156479|CMV|cmv
4884538|NCT02156479|T-Track CMV|t-track cmv
4884539|NCT02156479|allo-HSCT|allo-hsct
4884540|NCT02156479|CMI|cmi
4884541|NCT02156466|Psoriasis|psoriasis
4884542|NCT02156466|MSB0010841|msb0010841
4884543|NCT02156466|Anti-IL17A/F Nanobody|anti-il17a/f nanobody
4884544|NCT02156466|M1095|m1095
4884545|NCT02156453|Functional recovery|functional recovery
4884546|NCT02156453|Total knee arthroplasty|total knee arthroplasty
4884547|NCT02156440|Ostearthritis|ostearthritis
4884548|NCT02156440|Knee|knee
4884549|NCT02156440|SierraSil|sierrasil
4884550|NCT02156414|Prostatectomy|prostatectomy
4884551|NCT02156414|Extended Lymphadenectomy|extended lymphadenectomy
4884552|NCT02156414|Pelvic lymph node dissection|pelvic lymph node dissection
4884553|NCT02156414|Prostatic Neoplasm|prostatic neoplasm
4884554|NCT02156414|Prospective Studies|prospective studies
4884555|NCT02156401|Venous thromboembolism|venous thromboembolism
4884556|NCT02156401|Deep vein thrombosis|deep vein thrombosis
4884557|NCT02156401|Pulmonary embolism|pulmonary embolism
4884558|NCT02156401|Cohort study/epidemiology|cohort study/epidemiology
4884559|NCT02156401|Outcome|outcome
4884560|NCT02156401|Prognosis|prognosis
4884561|NCT02156375|Healthy|healthy
4884562|NCT02156375|Ustekinumab|ustekinumab
4884563|NCT02156375|STELARA®|stelara®
4884564|NCT02156362|Thyroid carcinoma|thyroid carcinoma
4884565|NCT02156362|predictive factors|predictive factors
4884566|NCT02156362|refractory|refractory
4884567|NCT02156362|Differentiated|differentiated
4884568|NCT02156362|follicular origin|follicular origin
4884569|NCT02156349|Diabetes|diabetes
4884570|NCT02156336|Diabetic Peripheral Neuropathic Pain|diabetic peripheral neuropathic pain
4884571|NCT02156336|Ranexa|ranexa
4884572|NCT02156336|Ranolazine|ranolazine
4884573|NCT02156336|Neurology|neurology
4884574|NCT02156284|Fear; Thoracic Surgery; Nursing Care; Preoperative Care|fear; thoracic surgery; nursing care; preoperative care
4884575|NCT02156271|Insomnia|insomnia
4884576|NCT02156258|Imaging|imaging
4884577|NCT02156258|Mammography|mammography
4884578|NCT02156232|hepatic encephalopathy (HE)|hepatic encephalopathy (he)
4884579|NCT02156232|vericeal bleeding|vericeal bleeding
4884580|NCT02156232|spontaneous portosystemic shunts (SPSS)|spontaneous portosystemic shunts (spss)
4884581|NCT02156232|transjugular intrahepatic portosystemic shunt (TIPS)|transjugular intrahepatic portosystemic shunt (tips)
4884582|NCT02156232|embolization|embolization
4884583|NCT02156180|exhaled breath|exhaled breath
4884584|NCT02156180|volatile organic compounds|volatile organic compounds
4884585|NCT02156180|surgery|surgery
4884586|NCT02156180|chemotherapy|chemotherapy
4884587|NCT02156180|radiotherapy|radiotherapy
4884588|NCT02156167|Otosclerosis, cochlear implant, acoustic stimulation|otosclerosis, cochlear implant, acoustic stimulation
4884589|NCT02156141|Kennedy's disease|kennedy's disease
4884590|NCT02156141|Spinal and bulbar muscular atrophy|spinal and bulbar muscular atrophy
4884591|NCT02156141|High Intensity Training|high intensity training
4884592|NCT02156141|High Intensity Interval Training|high intensity interval training
4884593|NCT02156141|HIT|hit
4884594|NCT02156141|HIIT|hiit
4884595|NCT02156141|Training|training
4884596|NCT02156141|Exercise|exercise
4884597|NCT02156141|10-20-30|10-20-30
4884598|NCT02156128|Cognitive therapy|cognitive therapy
4884599|NCT02156115|Lymphangiomatosis|lymphangiomatosis
4884600|NCT02156115|Lymphangiogenesis|lymphangiogenesis
4884601|NCT02156115|Smooth Muscle Cell|smooth muscle cell
4884602|NCT02156115|Vascular Anomalies|vascular anomalies
4884603|NCT02156102|Genetic Disorders|genetic disorders
4884604|NCT02156102|Sickle Cell Disease|sickle cell disease
4884605|NCT02156102|African American|african american
4884606|NCT02156102|Leg Ulcers|leg ulcers
4884607|NCT02156102|Skin|skin
4884608|NCT02156089|fMRI|fmri
4884609|NCT02156089|Reward Processing|reward processing
4884610|NCT02156089|Nutrition|nutrition
4884611|NCT02156089|Omega-3 Fatty Acids|omega-3 fatty acids
4884612|NCT02156089|ADHD|adhd
4884613|NCT02156063|Recurrent Pregnancy Loss|recurrent pregnancy loss
4884614|NCT02156063|Recurrent Miscarriage|recurrent miscarriage
4884615|NCT02156063|Miscarriage|miscarriage
4884616|NCT02156063|Pregnancy Loss|pregnancy loss
4884617|NCT02156063|Repeated Pregnancy Loss|repeated pregnancy loss
4884618|NCT02156037|Hispanic|hispanic
4884619|NCT02156037|clinical decision support|clinical decision support
4884620|NCT02156037|diabetes|diabetes
4884621|NCT02156037|Hba1c|hba1c
4884622|NCT02156037|psychosocial|psychosocial
4884623|NCT02156024|clinical trials|clinical trials
4884624|NCT02156024|Gastrodia and Uncaria Drink|gastrodia and uncaria drink
4884625|NCT02156011|In vivo knee joint kinematics|in vivo knee joint kinematics
4884626|NCT02156011|In vivo knee joint loading|in vivo knee joint loading
4884627|NCT02156011|Video-fluoroscopy|video-fluoroscopy
4884628|NCT02156011|Instrumented implants|instrumented implants
4884629|NCT02156011|Optical motion capture|optical motion capture
4884630|NCT02156011|Ground reaction forces|ground reaction forces
4884631|NCT02156011|Electromyography|electromyography
4884632|NCT02155998|prostate adenocarcinoma, locally advanced prostate cancer with high and very high risk of recurrence, adjuvant endocrine treatment, prostate specific antigen|prostate adenocarcinoma, locally advanced prostate cancer with high and very high risk of recurrence, adjuvant endocrine treatment, prostate specific antigen
4884633|NCT02155972|Bipolar|bipolar
4884634|NCT02155972|Depression|depression
4884635|NCT02155972|Probiotic|probiotic
4884636|NCT02155972|ALIGN|align
4884637|NCT02155972|HAMD|hamd
4884638|NCT02155972|STAI|stai
4884640|NCT02155972|CGI|cgi
4884641|NCT02155972|SDS|sds
4884642|NCT02155972|WHOQOL-BREF|whoqol-bref
4884643|NCT02155972|C-SSRS|c-ssrs
4884644|NCT02155972|TSES|tses
4884645|NCT02155959|astigmatism|astigmatism
4884646|NCT02155959|cataract|cataract
4884647|NCT02155959|toric|toric
4884648|NCT02155959|lens|lens
4884649|NCT02155946|Aging|aging
4884650|NCT02155946|Alzheimer's Disease/Dementia|alzheimer's disease/dementia
4884651|NCT02155946|Cognitive Disorders|cognitive disorders
4884652|NCT02155946|Imaging|imaging
4884653|NCT02155946|Magnetic Resonance Imaging (MRI)|magnetic resonance imaging (mri)
4884654|NCT02155946|Neurology|neurology
4884655|NCT02155946|Physical Medicine & Rehabilitation|physical medicine & rehabilitation
4884656|NCT02155946|transcranial direct current stimulation|transcranial direct current stimulation
4884657|NCT02155920|Ependymoma|ependymoma
4884658|NCT02155920|Anaplastic Ependymoma|anaplastic ependymoma
4884659|NCT02155894|Rheumatoid arthritis, treat to target, telemedicine|rheumatoid arthritis, treat to target, telemedicine
4884660|NCT02155881|Drug therapy|drug therapy
4884661|NCT02155868|Cerebral near-infrared spectroscopy monitoring|cerebral near-infrared spectroscopy monitoring
4884662|NCT02155868|Postoperative complications|postoperative complications
4884663|NCT02155868|Cardiac surgery|cardiac surgery
4884664|NCT02155855|type 1 diabetes, home glucose monitor, upload, cloud|type 1 diabetes, home glucose monitor, upload, cloud
4884665|NCT02155842|exercise therapy|exercise therapy
4884666|NCT02155829|PTSD|ptsd
4884667|NCT02155829|TBI|tbi
4884668|NCT02155829|Riluzole|riluzole
4884669|NCT02155829|Rilutek|rilutek
4884670|NCT02155829|augmentation|augmentation
4884671|NCT02155829|supplement|supplement
4884672|NCT02155829|double blinded|double blinded
4884673|NCT02155829|clinical trial|clinical trial
4884674|NCT02155829|placebo|placebo
4884675|NCT02155829|RCT|rct
4884676|NCT02155829|Randomized Control Trial|randomized control trial
4884677|NCT02155816|inflammation|inflammation
4884678|NCT02155816|lipoproteins|lipoproteins
4884679|NCT02155816|omega 3|omega 3
4884680|NCT02155816|omega 7|omega 7
4884681|NCT02155803|Sarcoidosis-Associated Calcium Dysregulation|sarcoidosis-associated calcium dysregulation
4884682|NCT02155803|Sarcoidosis-Associated hypercalciuria|sarcoidosis-associated hypercalciuria
4884683|NCT02155803|hypercalcemia|hypercalcemia
4884684|NCT02155803|hypercalciuria|hypercalciuria
4884685|NCT02155803|nephrocalcinosis|nephrocalcinosis
4884686|NCT02155803|nephrolithiasis|nephrolithiasis
4884687|NCT02155803|interstitial nephritis|interstitial nephritis
4884688|NCT02155803|glomerulonephritis|glomerulonephritis
4884689|NCT02155803|acute kidney disease|acute kidney disease
4884690|NCT02155803|chronic kidney disease|chronic kidney disease
4884691|NCT02155790|safety, performance, hypertension, renal denervation|safety, performance, hypertension, renal denervation
4884692|NCT02155777|BRCA1|brca1
4884693|NCT02155777|BRCA2|brca2
4884694|NCT02155777|Risk-reducing surgery|risk-reducing surgery
4884695|NCT02155777|Oral Contraceptives|oral contraceptives
4884696|NCT02155764|tooth|tooth
4884697|NCT02155764|extraction|extraction
4884698|NCT02155764|alveolar socket|alveolar socket
4884699|NCT02155764|socket preservation|socket preservation
4884700|NCT02155764|ridge preservation|ridge preservation
4884701|NCT02155764|bone graft|bone graft
4884702|NCT02155764|tricalcium phosphate|tricalcium phosphate
4884703|NCT02155764|octacalcium phosphate|octacalcium phosphate
4884704|NCT02155764|xenograft|xenograft
4884705|NCT02155764|bio oss|bio oss
4884706|NCT02155751|Obesity prevention|obesity prevention
4884707|NCT02155751|Nutrition and exercise in pregnancy|nutrition and exercise in pregnancy
4884708|NCT02155751|Postpartum|postpartum
4884709|NCT02155751|Maternal obesity risk|maternal obesity risk
4884710|NCT02155738|IV acetaminophen|iv acetaminophen
4884711|NCT02155738|Postoperative pain|postoperative pain
4884712|NCT02155738|Pelvic organ prolapse surgery|pelvic organ prolapse surgery
4884713|NCT02155738|Pelvic organ prolapse repair|pelvic organ prolapse repair
4884714|NCT02155725|PPH|pph
4884715|NCT02155725|fibrinogen|fibrinogen
4884716|NCT02155725|vaginal delivery|vaginal delivery
4884717|NCT02155699|UHR, Remediation, Exercise, Intervention, Psychosis|uhr, remediation, exercise, intervention, psychosis
4884718|NCT02155686|Elderly|elderly
4884719|NCT02155686|Prevention|prevention
4884720|NCT02155686|Multiple chronic disease|multiple chronic disease
4884721|NCT02155686|Telemonitoring|telemonitoring
4884722|NCT02155686|Geriatric teleexpertise|geriatric teleexpertise
4884723|NCT02155686|Home heath care|home heath care
4884724|NCT02155686|Medico-economics|medico-economics
4884725|NCT02155660|Obstructive Lung Diseases|obstructive lung diseases
4884726|NCT02155660|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
4884727|NCT02155660|Lung Disease|lung disease
4884728|NCT02155660|Bronchial Diseases|bronchial diseases
4884729|NCT02155660|COPD Exacerbation|copd exacerbation
4884730|NCT02155660|Respiratory Tract Diseases|respiratory tract diseases
4884731|NCT02155647|Carcinoma, Merkel Cell|carcinoma, merkel cell
4884732|NCT02155647|MSB0010718C|msb0010718c
4884733|NCT02155647|avelumab|avelumab
4884734|NCT02155647|Bavencio|bavencio
4884735|NCT02155647|anti PD-L1|anti pd-l1
4884736|NCT02155647|JAVELIN Merkel 200|javelin merkel 200
4884737|NCT02155634|Newly Diagnosed Multiple Myeloma|newly diagnosed multiple myeloma
4884738|NCT02155634|Multiple Myeloma|multiple myeloma
4884739|NCT02155634|Lenalidomide|lenalidomide
4884740|NCT02155634|Revlimid|revlimid
4884741|NCT02155634|Phase III|phase iii
4884742|NCT02155634|Phase IIIb|phase iiib
4884743|NCT02155634|Plasma Cell Dyscrasia|plasma cell dyscrasia
4884744|NCT02155621|cancer genomics|cancer genomics
4884745|NCT02155621|precision medicine|precision medicine
4884746|NCT02155621|metastatic cancer|metastatic cancer
4884747|NCT02155621|clinical decision-making|clinical decision-making
4884748|NCT02155608|ADHD|adhd
4884749|NCT02155608|neuromodulation|neuromodulation
4884750|NCT02155608|trigeminal nerve stimulation|trigeminal nerve stimulation
4884751|NCT02155608|cognition|cognition
4884752|NCT02155582|Solid tumors|solid tumors
4884753|NCT02155569|Cesarean, extraperitoneal|cesarean, extraperitoneal
4884754|NCT02155569|Cesarean|cesarean
4884755|NCT02155569|Pain|pain
4884756|NCT02155517|TCI,Schnider Model, Cortinez Model, BIS, Cardiac Output.|tci,schnider model, cortinez model, bis, cardiac output.
4884757|NCT02155504|Healthy volunteers|healthy volunteers
4884758|NCT02155504|Pharmacokinetics|pharmacokinetics
4884759|NCT02155504|ASP3700|asp3700
4884760|NCT02155504|Itraconazole|itraconazole
4884761|NCT02155504|Drug-drug interaction|drug-drug interaction
4884762|NCT02155491|venous, thromboembolism, embolism, DVT, Pulmonary Embolism, thrombosis|venous, thromboembolism, embolism, dvt, pulmonary embolism, thrombosis
4884763|NCT02155465|Ruxolitinib|ruxolitinib
4884764|NCT02155465|Erlotinib|erlotinib
4884765|NCT02155465|EGFR-mutant|egfr-mutant
4884766|NCT02155465|14-043|14-043
4884767|NCT02155452|ALA|ala
4884768|NCT02155452|Malignant gliomas|malignant gliomas
4884769|NCT02155439|Prospective, randomized controlled trial - pilot study|prospective, randomized controlled trial - pilot study
4884770|NCT02155413|Acute pain|acute pain
4884771|NCT02155413|Audit|audit
4884772|NCT02155413|Safety|safety
4884773|NCT02155413|Tolerability|tolerability
4884774|NCT02155400|perioperative hypothermia|perioperative hypothermia
4884775|NCT02155400|thermal compression|thermal compression
4884776|NCT02155400|forced air warming|forced air warming
4884777|NCT02155387|EVLW|evlw
4884778|NCT02155387|EVLWI|evlwi
4884779|NCT02155387|PVPI|pvpi
4884780|NCT02155387|MICS|mics
4884781|NCT02155374|Glucocorticoid induced hyperglycemia, insulin, chemotherapy|glucocorticoid induced hyperglycemia, insulin, chemotherapy
4884782|NCT02155361|Diabetes mellitus|diabetes mellitus
4884783|NCT02155361|Diabetes complications|diabetes complications
4884784|NCT02155361|Pain|pain
4884785|NCT02155309|scopolamine|scopolamine
4884786|NCT02155309|motion|motion
4884787|NCT02155309|sickness|sickness
4884788|NCT02155296|positive youth development|positive youth development
4884789|NCT02155296|restorative practices|restorative practices
4884790|NCT02155296|school climate|school climate
4884791|NCT02155296|social competency|social competency
4884792|NCT02155283|Chronic Low Back Pain|chronic low back pain
4884793|NCT02155283|Mild-to-Moderate Chronic Low Back Pain|mild-to-moderate chronic low back pain
4884794|NCT02155283|Continuous Passive Motion Devices|continuous passive motion devices
4884795|NCT02155270|Cataract|cataract
4884796|NCT02155270|Incision|incision
4884797|NCT02155270|Precut|precut
4884798|NCT02155270|Corneal|corneal
4884799|NCT02155270|OCT|oct
4884800|NCT02155270|Intraoperative OCT|intraoperative oct
4884801|NCT02155270|Imaging|imaging
4884802|NCT02155270|Astigmatism|astigmatism
4884803|NCT02155270|Clear corneal incision|clear corneal incision
4884804|NCT02155257|Osteoarthritis|osteoarthritis
4884805|NCT02155244|CBDS|cbds
4884806|NCT02155244|ERCP|ercp
4884807|NCT02155244|Dindo-Clavien classification|dindo-clavien classification
4884808|NCT02155231|Male with history of anal sex with men or previous participants of the MSM VCT study|male with history of anal sex with men or previous participants of the msm vct study
4884809|NCT02155218|Magnetic Resonance Angiography|magnetic resonance angiography
4884810|NCT02155218|Contrast Media|contrast media
4884811|NCT02155192|CNTO1959PSO2001|cnto1959pso2001
4884812|NCT02155192|C0743T08|c0743t08
4884813|NCT02155192|C0743T09|c0743t09
4884814|NCT02155192|C0743T12|c0743t12
4884815|NCT02155192|Psoriasis|psoriasis
4884816|NCT02155192|Pharmacogenomics|pharmacogenomics
4884817|NCT02155166|Levonorgestrel-releasing intrauterine system|levonorgestrel-releasing intrauterine system
4884818|NCT02155166|anesthesia|anesthesia
4884819|NCT02155166|pain|pain
4884820|NCT02155166|nulliparous|nulliparous
4884821|NCT02155140|enteral feeding|enteral feeding
4884822|NCT02155140|Discharged|discharged
4884823|NCT02155140|surgical resection of an upper gastrointestinal malignancy|surgical resection of an upper gastrointestinal malignancy
4884824|NCT02155140|Nutritional supplementation via a jejunostomy|nutritional supplementation via a jejunostomy
4884825|NCT02155127|chronic kidney disease|chronic kidney disease
4884826|NCT02155127|physical function|physical function
4884827|NCT02155114|Hepcidins|hepcidins
4884828|NCT02155114|Homeostasis|homeostasis
4884829|NCT02155114|Iron/administration & dosage|iron/administration & dosage
4884830|NCT02155114|Biological Markers/blood|biological markers/blood
4884831|NCT02155101|Efficacy|efficacy
4884832|NCT02155101|Safety|safety
4884833|NCT02155101|Darunavir|darunavir
4884834|NCT02155101|HIV-1 RNA level|hiv-1 rna level
4884835|NCT02155101|Cameroon|cameroon
4884836|NCT02155088|Locally Advanced|locally advanced
4884837|NCT02155088|Metastatic|metastatic
4884838|NCT02155088|Recurrent|recurrent
4884839|NCT02155088|Pancreas|pancreas
4884840|NCT02155075|Breast neoplasm|breast neoplasm
4884841|NCT02155075|Breast implants|breast implants
4884842|NCT02155075|Mammography|mammography
4884843|NCT02155075|Breast imaging|breast imaging
4884844|NCT02155075|Imaging augmented breast|imaging augmented breast
4884845|NCT02155062|Nutritional biomarker|nutritional biomarker
4884846|NCT02155062|Dietary assessment|dietary assessment
4884847|NCT02155062|Whole grain|whole grain
4884848|NCT02155062|Wheat|wheat
4884849|NCT02155062|Rye|rye
4884850|NCT02155062|Alkylresorcinol|alkylresorcinol
4884851|NCT02155062|Urine|urine
4884852|NCT02155049|TED|ted
4884853|NCT02155049|Prostaglandin Analogues|prostaglandin analogues
4884854|NCT02155036|exercise|exercise
4884855|NCT02155036|rehabilitation|rehabilitation
4884856|NCT02155036|kidney function|kidney function
4884857|NCT02155036|cardiovascular disease risk|cardiovascular disease risk
4884858|NCT02155010|Dexmedetomidine|dexmedetomidine
4884859|NCT02155010|Spinal anesthesia|spinal anesthesia
4884860|NCT02154971|HIV Seropositivity|hiv seropositivity
4884861|NCT02154971|Audiometry|audiometry
4884862|NCT02154971|Hearing Loss|hearing loss
4884863|NCT02154958|Follicular output rate|follicular output rate
4884864|NCT02154958|IVF|ivf
4884865|NCT02154958|ICSI|icsi
4884866|NCT02154932|Myomectomy, Misoprostol|myomectomy, misoprostol
4884867|NCT02154906|periodontal disease|periodontal disease
4884868|NCT02154906|periodontitis|periodontitis
4884869|NCT02154893|Ultrasound|ultrasound
4884870|NCT02154893|Laser|laser
4884871|NCT02154893|Therapeutic exercise|therapeutic exercise
4884872|NCT02154893|Rehabilitation|rehabilitation
4884873|NCT02154893|Osteoarthritis|osteoarthritis
4884874|NCT02154880|HIV|hiv
4884875|NCT02154880|lung|lung
4884876|NCT02154880|aging|aging
4884877|NCT02154867|IBS-D|ibs-d
4884878|NCT02154867|FMT|fmt
4884879|NCT02154867|metagenomics|metagenomics
4884880|NCT02154867|gut microbiome|gut microbiome
4884881|NCT02154854|Renal|renal
4884882|NCT02154854|Transplantation|transplantation
4884883|NCT02154854|Tacrolimus|tacrolimus
4884884|NCT02154854|Arterial stiffness|arterial stiffness
4884885|NCT02154854|Vascular fibrose plasma markers|vascular fibrose plasma markers
4884886|NCT02154841|Postoperative|postoperative
4884887|NCT02154841|nutrition|nutrition
4884888|NCT02154841|taste|taste
4884889|NCT02154841|perception|perception
4884890|NCT02154841|preference|preference
4884891|NCT02154841|choice|choice
4884892|NCT02154828|Children|children
4884893|NCT02154828|aged|aged
4884894|NCT02154828|3 to 6 years|3 to 6 years
4884895|NCT02154815|End Stage Renal Disease|end stage renal disease
4884896|NCT02154815|Renal transplantation|renal transplantation
4884897|NCT02154815|Dialysis|dialysis
4884898|NCT02154815|Pre-emptive transplantation|pre-emptive transplantation
4884899|NCT02154815|Psychological adjustment|psychological adjustment
4884900|NCT02154815|Quality of life.|quality of life.
4884901|NCT02154776|LEE011,|lee011,
4884902|NCT02154776|buparlisib,|buparlisib,
4884903|NCT02154776|letrozole,|letrozole,
4884904|NCT02154776|HR +,|hr +,
4884905|NCT02154776|HER2 - negative,|her2 - negative,
4884906|NCT02154776|post-menopausal,|post-menopausal,
4884907|NCT02154776|breast cancer,|breast cancer,
4884908|NCT02154776|CDK 4/6,|cdk 4/6,
4884909|NCT02154776|PI3K,|pi3k,
4884910|NCT02154776|MTD|mtd
4884911|NCT02154763|Bariatric surgery|bariatric surgery
4884912|NCT02154763|Bariatrics|bariatrics
4884913|NCT02154763|Local anesthetic|local anesthetic
4884914|NCT02154763|Ropivacaine|ropivacaine
4884915|NCT02154763|Intraperitoneal|intraperitoneal
4884916|NCT02154750|Atrioventricular delay|atrioventricular delay
4884917|NCT02154750|AV delay|av delay
4884918|NCT02154750|Pacemaker|pacemaker
4884919|NCT02154750|Sick Sinus Syndrome|sick sinus syndrome
4884920|NCT02154750|Bradycardia|bradycardia
4884921|NCT02154750|PR interval|pr interval
4884922|NCT02154750|Atrioventricular block|atrioventricular block
4884923|NCT02154750|AV block|av block
4884924|NCT02154750|Echocardiography|echocardiography
4884925|NCT02154750|Arrhythmia|arrhythmia
4884926|NCT02154750|AV optimization|av optimization
4884927|NCT02154737|Pancreatic|pancreatic
4884928|NCT02154737|Gemcitabine|gemcitabine
4884929|NCT02154737|Gemzar|gemzar
4884930|NCT02154737|erlotinib|erlotinib
4884931|NCT02154737|Tarceva|tarceva
4884932|NCT02154711|mitochondrial disease|mitochondrial disease
4884933|NCT02154711|magnetic resonance imaging|magnetic resonance imaging
4884934|NCT02154711|magnetic resonance spectroscopy|magnetic resonance spectroscopy
4884935|NCT02154711|creatine|creatine
4884936|NCT02154711|phosphocreatine|phosphocreatine
4884937|NCT02154685|Smoking|smoking
4884938|NCT02154685|Nicotine|nicotine
4884939|NCT02154685|Addiction|addiction
4884940|NCT02154685|Cessation|cessation
4884941|NCT02154620|Distal radius fracture|distal radius fracture
4884942|NCT02154620|wrist fracture|wrist fracture
4884943|NCT02154620|volar plate|volar plate
4884944|NCT02154620|surgical treatment|surgical treatment
4884945|NCT02154620|plaster immobilisation|plaster immobilisation
4884946|NCT02154607|oral lichen planus|oral lichen planus
4884947|NCT02154607|recurrence|recurrence
4884948|NCT02154607|Treatment|treatment
4884949|NCT02154607|cancer|cancer
4884950|NCT02154607|Primary disease Management|primary disease management
4884951|NCT02154594|Acacia|acacia
4884952|NCT02154594|Chlorhexidine|chlorhexidine
4884953|NCT02154594|Gingivitis|gingivitis
4884954|NCT02154594|Orthodontic appliances.|orthodontic appliances.
4884955|NCT02154581|Dental implants|dental implants
4884956|NCT02154581|Esthetic score|esthetic score
4884957|NCT02154581|Immediate implants|immediate implants
4884958|NCT02154581|Gingival biotype|gingival biotype
4884959|NCT02154568|Hyperpolarized gas MRI|hyperpolarized gas mri
4884960|NCT02154542|Nava|nava
4884961|NCT02154542|Mechanical ventilation|mechanical ventilation
4884962|NCT02154477|hypogonadotropic hypogonadism|hypogonadotropic hypogonadism
4884963|NCT02154464|Morphine-sparing|morphine-sparing
4884964|NCT02154464|Paracetamol|paracetamol
4884965|NCT02154464|Obesity|obesity
4884966|NCT02154464|Gastric banding|gastric banding
4884967|NCT02154425|Cimzia®|cimzia®
4884968|NCT02154425|CZP|czp
4884969|NCT02154425|Breastfeeding|breastfeeding
4884970|NCT02154425|Nursing|nursing
4884971|NCT02154425|Autoimmune diseases and pregnancy|autoimmune diseases and pregnancy
4884972|NCT02154412|Respiration|respiration
4884973|NCT02154412|Motor control|motor control
4884974|NCT02154412|Blood Pressure|blood pressure
4884975|NCT02154412|Orthostatic Hypotension|orthostatic hypotension
4884976|NCT02154386|bone augmentation|bone augmentation
4884977|NCT02154386|tooth extraction|tooth extraction
4884978|NCT02154386|dental implant|dental implant
4884979|NCT02154360|HIV infection|hiv infection
4884980|NCT02154360|NK-1R antagonists|nk-1r antagonists
4884981|NCT02154360|aprepitant|aprepitant
4884982|NCT02154360|ritonavir boosting|ritonavir boosting
4884983|NCT02154347|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
4884984|NCT02154347|HbA1c|hba1c
4884985|NCT02154334|Allergic Rhinitis|allergic rhinitis
4884986|NCT02154334|Healthy|healthy
4884987|NCT02154334|Esketamine|esketamine
4884988|NCT02154334|Mometasone|mometasone
4884989|NCT02154334|Oxymetazoline|oxymetazoline
4884990|NCT02154334|Phase 1|phase 1
4884991|NCT02154308|Influenza|influenza
4884992|NCT02154308|Influenza vaccine|influenza vaccine
4884993|NCT02154308|Split influenza vaccine|split influenza vaccine
4884994|NCT02154308|Seasonal influenza vaccine|seasonal influenza vaccine
4884995|NCT02154282|hepatic encephalopathy|hepatic encephalopathy
4884996|NCT02154282|covert hepatic encephalopathy|covert hepatic encephalopathy
4884997|NCT02154282|cirrhosis|cirrhosis
4884998|NCT02154269|Chagas disease|chagas disease
4884999|NCT02154269|G-CSF|g-csf
4885000|NCT02154269|Cell therapy|cell therapy
4885001|NCT02154256|walking|walking
4885002|NCT02154256|incentives|incentives
4885003|NCT02154256|exercise|exercise
4885004|NCT02154256|habits|habits
4885005|NCT02154230|weight loss|weight loss
4885006|NCT02154230|sulphate-bicarbonate-calcium water|sulphate-bicarbonate-calcium water
4885007|NCT02154230|gut microbiota|gut microbiota
4885008|NCT02154230|body composition|body composition
4885009|NCT02154230|bile salts|bile salts
4885010|NCT02154191|Lumbosacral Region|lumbosacral region
4885011|NCT02154191|Sedentary Lifestyle|sedentary lifestyle
4885012|NCT02154191|Surgical Procedure, Operative|surgical procedure, operative
4885013|NCT02154178|empiric antifungal therapy|empiric antifungal therapy
4885014|NCT02154178|biomarkers|biomarkers
4885015|NCT02154178|invasive fungal infection|invasive fungal infection
4885016|NCT02154178|Candida|candida
4885017|NCT02154165|Neonatal hyperbilirubinemia|neonatal hyperbilirubinemia
4885018|NCT02154165|Phototherapy|phototherapy
4885019|NCT02154165|Light emitting diodes|light emitting diodes
4885020|NCT02154165|Blue light|blue light
4885021|NCT02154165|Turquoise light|turquoise light
4885022|NCT02154152|Bed wetting|bed wetting
4885023|NCT02154152|Primary Enuresis|primary enuresis
4885024|NCT02154152|Frequency|frequency
4885025|NCT02154152|Efficacy|efficacy
4885026|NCT02154152|Homoeopathic Medicine|homoeopathic medicine
4885027|NCT02154152|Causticum 200c|causticum 200c
4885028|NCT02154139|Pharmacological therapy|pharmacological therapy
4885029|NCT02154113|Syneron|syneron
4885030|NCT02154113|Velashape|velashape
4885031|NCT02154113|ELOS|elos
4885032|NCT02154113|Ultrashape|ultrashape
4885033|NCT02154100|Metabolic Syndrome|metabolic syndrome
4885034|NCT02154100|Arterial Stiffness|arterial stiffness
4885035|NCT02154100|Blood Pressure|blood pressure
4885036|NCT02154100|Endothelial Function|endothelial function
4885037|NCT02154100|Tart Cherries|tart cherries
4885038|NCT02154087|Venous leg ulcer|venous leg ulcer
4885039|NCT02154087|Ulcer|ulcer
4885040|NCT02154087|Venous stasis|venous stasis
4885041|NCT02154087|Compression|compression
4885042|NCT02154074|Dexmedetomidine perioperative blood glucose and insulin|dexmedetomidine perioperative blood glucose and insulin
4885043|NCT02154061|Flu Vaccine, Intestinal Microbiome, Antibiotics|flu vaccine, intestinal microbiome, antibiotics
4885044|NCT02154035|Viral Suppression|viral suppression
4885045|NCT02154035|Functional Cure|functional cure
4885046|NCT02154022|PK|pk
4885047|NCT02154009|Autonomic Nervous System|autonomic nervous system
4885048|NCT02154009|Catecholamines|catecholamines
4885049|NCT02154009|Dysautonomia|dysautonomia
4885050|NCT02154009|Parasympathetic Cholinergic System|parasympathetic cholinergic system
4885051|NCT02154009|Sympathetic Adrenergic System|sympathetic adrenergic system
4885052|NCT02153996|Malaria Immunity Longevity|malaria immunity longevity
4885053|NCT02153983|Obesity|obesity
4885054|NCT02153983|Colchicine|colchicine
4885055|NCT02153983|Inflammation|inflammation
4885056|NCT02153983|Metabolic Syndrome|metabolic syndrome
4885057|NCT02153983|Dyslipidemia|dyslipidemia
4885058|NCT02153970|Clinical Outcomes Measures|clinical outcomes measures
4885059|NCT02153970|Proxy Reported Outcome|proxy reported outcome
4885060|NCT02153970|Pediatric|pediatric
4885061|NCT02153970|Neuromuscular Disease|neuromuscular disease
4885062|NCT02153970|Cerebral Palsy|cerebral palsy
4885063|NCT02153957|Exercise|exercise
4885064|NCT02153957|Memory|memory
4885065|NCT02153957|BDNF|bdnf
4885066|NCT02153957|Zamzee|zamzee
4885067|NCT02153957|QOL|qol
4885068|NCT02153944|Startle|startle
4885069|NCT02153944|Induced-Threat|induced-threat
4885070|NCT02153944|Memory|memory
4885071|NCT02153944|Stimulant|stimulant
4885072|NCT02153944|Cognitive Interference|cognitive interference
4885073|NCT02153931|Children's Tumor Foundation|children's tumor foundation
4885074|NCT02153931|Social Support|social support
4885075|NCT02153931|Online|online
4885076|NCT02153931|Anxiety|anxiety
4885077|NCT02153931|Depression|depression
4885078|NCT02153918|Surgery|surgery
4885079|NCT02153918|Neoadjuvant|neoadjuvant
4885080|NCT02153918|CD8 Cell Infiltrate Response|cd8 cell infiltrate response
4885081|NCT02153918|CD4 Cell Infiltrate Response|cd4 cell infiltrate response
4885082|NCT02153918|Vaccine|vaccine
4885083|NCT02153905|Melanoma|melanoma
4885084|NCT02153905|Immunotherapy|immunotherapy
4885085|NCT02153905|Metastatic Cancer|metastatic cancer
4885086|NCT02153905|Gene Therapy|gene therapy
4885087|NCT02153905|T Cells|t cells
4885088|NCT02153892|Functional Mitral Regurgitation|functional mitral regurgitation
4885089|NCT02153892|Heart Failure|heart failure
4885090|NCT02153892|Ventricular Reshaping|ventricular reshaping
4885091|NCT02153879|HDL|hdl
4885092|NCT02153879|Niacin|niacin
4885093|NCT02153879|Fenofibrate|fenofibrate
4885094|NCT02153879|Diabetes|diabetes
4885095|NCT02153879|Metabolomics|metabolomics
4885096|NCT02153866|rotavirus vaccine|rotavirus vaccine
4885097|NCT02153840|Stable Plaque Psoriasis|stable plaque psoriasis
4885098|NCT02153827|Shoulder|shoulder
4885099|NCT02153827|Eccentric Training|eccentric training
4885100|NCT02153827|Subacromial Impingement Syndrome|subacromial impingement syndrome
4885101|NCT02153814|Infertility|infertility
4885102|NCT02153814|In vitro fertilization|in vitro fertilization
4885103|NCT02153814|Endometrial injury|endometrial injury
4885104|NCT02153801|High Ligation, Low ligation, Genito-urinary function, laparoscopy, rectal cancer, aterior resection, Total mesorectal Excision, anastomotic leak.|high ligation, low ligation, genito-urinary function, laparoscopy, rectal cancer, aterior resection, total mesorectal excision, anastomotic leak.
4885105|NCT02153788|Insomnia|insomnia
4885106|NCT02153788|HIV|hiv
4885107|NCT02153775|Progressive muscle relaxation|progressive muscle relaxation
4885108|NCT02153775|Cigarette|cigarette
4885109|NCT02153775|Smoking|smoking
4885110|NCT02153775|Craving|craving
4885111|NCT02153762|Atopic Dermatitis|atopic dermatitis
4885112|NCT02153762|AD|ad
4885113|NCT02153723|Treatment trial|treatment trial
4885114|NCT02153710|Aphasia|aphasia
4885115|NCT02153710|Anomia|anomia
4885116|NCT02153697|solar lentigines|solar lentigines
4885117|NCT02153697|Q-switches Laser|q-switches laser
4885118|NCT02153697|bleaching cream|bleaching cream
4885119|NCT02153684|smoking|smoking
4885120|NCT02153684|small airway dysfunction|small airway dysfunction
4885121|NCT02153684|mild COPD|mild copd
4885122|NCT02153684|dyspnea|dyspnea
4885123|NCT02153684|exercise|exercise
4885124|NCT02153684|clinical outcomes|clinical outcomes
4885125|NCT02153671|LAIV H5N2|laiv h5n2
4885126|NCT02153671|Influenza vaccine|influenza vaccine
4885127|NCT02153671|Russia|russia
4885128|NCT02153658|PrePex|prepex
4885129|NCT02153658|Odor|odor
4885130|NCT02153658|Cleaning technique|cleaning technique
4885131|NCT02153658|Male Circumcision|male circumcision
4885132|NCT02153658|HIV|hiv
4885133|NCT02153658|AIDS|aids
4885134|NCT02153658|Chlorhexidine|chlorhexidine
4885135|NCT02153658|Soap|soap
4885136|NCT02153645|Parkinson's Disease|parkinson's disease
4885137|NCT02153645|Levodopa Induced Dyskinesias (LID)|levodopa induced dyskinesias (lid)
4885138|NCT02153645|Dyskinesias|dyskinesias
4885139|NCT02153645|Parkinsonism|parkinsonism
4885140|NCT02153632|Parkinson's Disease|parkinson's disease
4885141|NCT02153632|Levodopa Induced Dyskinesia (LID)|levodopa induced dyskinesia (lid)
4885142|NCT02153632|LID|lid
4885143|NCT02153632|Parkinsonism|parkinsonism
4885144|NCT02153632|Dyskinesia|dyskinesia
4885145|NCT02153619|Grief|grief
4885146|NCT02153619|bereavement|bereavement
4885147|NCT02153619|questionnaires|questionnaires
4885148|NCT02153619|therapy sessions|therapy sessions
4885149|NCT02153619|14-102|14-102
4885150|NCT02153606|Glycerin Suppositories|glycerin suppositories
4885151|NCT02153606|Enteral Nutrition|enteral nutrition
4885152|NCT02153606|Enterocolitis, Necrotizing|enterocolitis, necrotizing
4885153|NCT02153606|Infant, Premature|infant, premature
4885154|NCT02153606|Meconium|meconium
4885155|NCT02153593|Clinical trial|clinical trial
4885156|NCT02153593|Randomized|randomized
4885157|NCT02153593|Fibrin glue|fibrin glue
4885158|NCT02153593|Tranexamic acid|tranexamic acid
4885159|NCT02153593|Blood loss|blood loss
4885160|NCT02153567|Functional dyspepsia|functional dyspepsia
4885161|NCT02153567|symptom response|symptom response
4885162|NCT02153567|postprandial fullness|postprandial fullness
4885163|NCT02153567|Anxiety|anxiety
4885164|NCT02153567|Depression|depression
4885165|NCT02153528|Bangladesh|bangladesh
4885166|NCT02153528|Rimfapicin|rimfapicin
4885167|NCT02153515|Finger prick with diabetic lancet|finger prick with diabetic lancet
4885168|NCT02153515|Fingerprick|fingerprick
4885169|NCT02153515|Fresh|fresh
4885170|NCT02153515|Your own blood|your own blood
4885171|NCT02153515|autologous blood|autologous blood
4885172|NCT02153515|Dry eyes|dry eyes
4885173|NCT02153515|Sjogren's disease with dry eyes|sjogren's disease with dry eyes
4885174|NCT02153515|Persistent corneal epithelial defects|persistent corneal epithelial defects
4885175|NCT02153515|Chronic corneal ulcers|chronic corneal ulcers
4885176|NCT02153463|Tourette Syndrome|tourette syndrome
4885177|NCT02153463|Persistent Tic Disorder|persistent tic disorder
4885178|NCT02153463|Physical Activity|physical activity
4885179|NCT02153463|Quality of Life|quality of life
4885180|NCT02153450|pancreatic cancer|pancreatic cancer
4885181|NCT02153450|Radiation|radiation
4885182|NCT02153450|Metformin|metformin
4885183|NCT02153450|Pancreatic Adenocarcinomas|pancreatic adenocarcinomas
4885184|NCT02153411|Asthma control|asthma control
4885185|NCT02153398|Gastric ulcer (GU)|gastric ulcer (gu)
4885186|NCT02153398|Duodenal ulcer (DU)|duodenal ulcer (du)
4885187|NCT02153398|Anastomotic ulcer (AU)|anastomotic ulcer (au)
4885188|NCT02153398|Non-erosive reflux esophagitis disease (NERD)|non-erosive reflux esophagitis disease (nerd)
4885189|NCT02153398|Reflux esophagitis (RE)|reflux esophagitis (re)
4885190|NCT02153398|Zollinger-Ellison syndrome|zollinger-ellison syndrome
4885191|NCT02153385|Yoga, heart rate variability, stress, mood, women|yoga, heart rate variability, stress, mood, women
4885192|NCT02153372|large bone defect, bone marrow-derived mononuclear cells|large bone defect, bone marrow-derived mononuclear cells
4885193|NCT02153359|asthma|asthma
4885194|NCT02153359|HEPA|hepa
4885195|NCT02153359|air pollutants|air pollutants
4885196|NCT02153359|lung function|lung function
4885197|NCT02153359|home environment|home environment
4885198|NCT02153359|respiratory symptoms|respiratory symptoms
4885199|NCT02153359|diet|diet
4885200|NCT02153346|indirect cost|indirect cost
4885201|NCT02153346|asthma|asthma
4885202|NCT02153333|Human rotavirus (HRV) vaccine|human rotavirus (hrv) vaccine
4885203|NCT02153333|Serologic response|serologic response
4885204|NCT02153333|Porcine circovirus type 1 (PCV-1)|porcine circovirus type 1 (pcv-1)
4885205|NCT02153333|Laboratory evaluations|laboratory evaluations
4885206|NCT02153320|HBsAg|hbsag
4885207|NCT02153320|Persistence of the immune response|persistence of the immune response
4885208|NCT02153320|Adjuvants|adjuvants
4885209|NCT02153294|low tidal volume|low tidal volume
4885210|NCT02153294|high tidal volume|high tidal volume
4885211|NCT02153294|protective ventilation|protective ventilation
4885212|NCT02153294|ARDS|ards
4885213|NCT02153281|Depression|depression
4885214|NCT02153281|Positron Emission Tomography (PET)|positron emission tomography (pet)
4885215|NCT02153281|MAO-B|mao-b
4885216|NCT02153268|Safety|safety
4885217|NCT02153268|efficacy|efficacy
4885218|NCT02153268|BonoFill|bonofill
4885219|NCT02153268|bone filler|bone filler
4885220|NCT02153268|autologous adipose tissue derived cells (HATDCs)|autologous adipose tissue derived cells (hatdcs)
4885221|NCT02153268|Bone augmentation|bone augmentation
4885222|NCT02153268|sinus augmentation|sinus augmentation
4885223|NCT02153268|Bone grafting after removal of cysts from jaws|bone grafting after removal of cysts from jaws
4885224|NCT02153255|Morquio|morquio
4885225|NCT02153255|Mucopolysaccharidosis|mucopolysaccharidosis
4885226|NCT02153255|Galactosamine-6-Sulfatase|galactosamine-6-sulfatase
4885227|NCT02153255|GALNS|galns
4885228|NCT02153242|Pacing|pacing
4885229|NCT02153242|Haemodynamics|haemodynamics
4885230|NCT02153242|Pilot|pilot
4885231|NCT02153229|Histological diagnosis of MPM|histological diagnosis of mpm
4885232|NCT02153229|epitheliod subtype|epitheliod subtype
4885233|NCT02153229|limited to the hemithorax|limited to the hemithorax
4885234|NCT02153229|macroscopically complete resection of the tumor|macroscopically complete resection of the tumor
4885235|NCT02153203|Autism spectrum disorder|autism spectrum disorder
4885236|NCT02153203|Problem behavior|problem behavior
4885237|NCT02153190|Type 1 Diabetes,|type 1 diabetes,
4885238|NCT02153190|T1DM,|t1dm,
4885239|NCT02153190|Artificial Pancreas|artificial pancreas
4885240|NCT02153177|Randomized Controlled Trial (RCT)|randomized controlled trial (rct)
4885241|NCT02153177|RCT|rct
4885242|NCT02153177|rotator cuff tear|rotator cuff tear
4885243|NCT02153177|NSAIDs|nsaids
4885244|NCT02153177|non-steroidal anti-inflammatory drugs|non-steroidal anti-inflammatory drugs
4885245|NCT02153177|rotator cuff repair|rotator cuff repair
4885246|NCT02153164|Enthalpy|enthalpy
4885247|NCT02153164|Trendelenberg position|trendelenberg position
4885248|NCT02153164|Mechanical ventilation|mechanical ventilation
4885249|NCT02153138|vegetarian diet|vegetarian diet
4885250|NCT02153138|vegan|vegan
4885251|NCT02153138|cardiovascular diseases|cardiovascular diseases
4885252|NCT02153138|endothelial function|endothelial function
4885253|NCT02153138|carotid intima-media thickness|carotid intima-media thickness
4885254|NCT02153112|Drug therapy|drug therapy
4885255|NCT02153099|Drug therapy|drug therapy
4885256|NCT02153086|Pharmacological therapy|pharmacological therapy
4885257|NCT02153073|Pharmacological therapy|pharmacological therapy
4885258|NCT02153060|immune thrombocytopenia|immune thrombocytopenia
4885259|NCT02153060|dexamethasone|dexamethasone
4885260|NCT02153060|efficacy|efficacy
4885261|NCT02153060|safety|safety
4885262|NCT02153047|Smoking cessation|smoking cessation
4885263|NCT02153047|Spirometry|spirometry
4885264|NCT02153047|Primary health care|primary health care
4885265|NCT02153034|Buruli ulcer|buruli ulcer
4885266|NCT02153034|Mycobacterium ulcerans disease|mycobacterium ulcerans disease
4885267|NCT02153034|M. ulcerans disease|m. ulcerans disease
4885268|NCT02153021|anthropometric parameters;|anthropometric parameters;
4885269|NCT02153021|biochemical parameters;|biochemical parameters;
4885270|NCT02153021|inflammatory markers|inflammatory markers
4885271|NCT02153021|neuropeptide markers|neuropeptide markers
4885272|NCT02153021|phototherapy|phototherapy
4885273|NCT02153008|Strep throat|strep throat
4885274|NCT02152956|AML|aml
4885275|NCT02152956|leukemia|leukemia
4885276|NCT02152956|myelogenous|myelogenous
4885277|NCT02152956|myeloid|myeloid
4885278|NCT02152956|refractory|refractory
4885279|NCT02152956|MDS|mds
4885280|NCT02152956|Myelodysplastic|myelodysplastic
4885281|NCT02152943|Breast Cancer|breast cancer
4885282|NCT02152943|Advanced Metastatic Breast Cancer|advanced metastatic breast cancer
4885283|NCT02152943|Solid Tumors|solid tumors
4885284|NCT02152943|Advanced Solid Tumors|advanced solid tumors
4885285|NCT02152943|Everolimus|everolimus
4885286|NCT02152943|Afinitor|afinitor
4885287|NCT02152943|Zortress|zortress
4885288|NCT02152943|RAD001|rad001
4885289|NCT02152943|Trastuzumab|trastuzumab
4885290|NCT02152943|Herceptin|herceptin
4885291|NCT02152943|Letrozole|letrozole
4885292|NCT02152943|Femara|femara
4885293|NCT02152930|Fish oil supplements|fish oil supplements
4885294|NCT02152930|Supervised Exercise Training|supervised exercise training
4885295|NCT02152930|Walking distance|walking distance
4885296|NCT02152930|Hemorheological factors|hemorheological factors
4885297|NCT02152930|Cardiovascular risk|cardiovascular risk
4885298|NCT02152904|Peptic ulcer bleeding|peptic ulcer bleeding
4885299|NCT02152904|rebleeding|rebleeding
4885300|NCT02152904|mortality|mortality
4885301|NCT02152904|nationwide|nationwide
4885302|NCT02152891|Emergency Medical Services|emergency medical services
4885303|NCT02152891|Elderly|elderly
4885304|NCT02152878|transcranial direct current stimulation|transcranial direct current stimulation
4885305|NCT02152878|non invasive brain stimulation|non invasive brain stimulation
4885306|NCT02152878|bipolar disorder|bipolar disorder
4885307|NCT02152878|depression|depression
4885308|NCT02152865|medication|medication
4885309|NCT02152852|Type 2 Diabetes|type 2 diabetes
4885310|NCT02152826|Sensitivity|sensitivity
4885311|NCT02152813|Electrical stimulation, exercise, stroke , rehabilitation|electrical stimulation, exercise, stroke , rehabilitation
4885312|NCT02152787|emergence agitation|emergence agitation
4885313|NCT02152787|propofol|propofol
4885314|NCT02152787|strabismus surgery|strabismus surgery
4885315|NCT02152787|children|children
4885316|NCT02152787|elective strabismus surgery|elective strabismus surgery
4885317|NCT02152761|bimagrumab,|bimagrumab,
4885318|NCT02152761|BYM338,|bym338,
4885319|NCT02152761|hip fracture,|hip fracture,
4885320|NCT02152761|elderly,|elderly,
4885321|NCT02152761|controlled clinical trial,|controlled clinical trial,
4885322|NCT02152761|randomized,|randomized,
4885323|NCT02152761|muscle wasting (atrophy)|muscle wasting (atrophy)
4885324|NCT02152748|glioblastoma|glioblastoma
4885325|NCT02152748|morphological and molecular changes|morphological and molecular changes
4885326|NCT02152748|progression|progression
4885327|NCT02152748|therapy-resistance|therapy-resistance
4885328|NCT02152722|Breath test|breath test
4885329|NCT02152722|Volatile Organic Compounds|volatile organic compounds
4885330|NCT02152722|VOC|voc
4885331|NCT02152722|oxidative stress|oxidative stress
4885332|NCT02152722|radiation biodosimetry|radiation biodosimetry
4885333|NCT02152722|metabolomics|metabolomics
4885334|NCT02152722|GCxGC TOF-MS|gcxgc tof-ms
4885335|NCT02152709|Safety|safety
4885336|NCT02152709|Immunogenicity|immunogenicity
4885337|NCT02152709|Vaccine|vaccine
4885338|NCT02152709|Hepatitis B|hepatitis b
4885339|NCT02152657|Spinal cord injury|spinal cord injury
4885340|NCT02152657|Stem cell transplantation|stem cell transplantation
4885341|NCT02152657|Mesenchymal stem cell|mesenchymal stem cell
4885342|NCT02152644|amyloidosis-carpal tunnel|amyloidosis-carpal tunnel
4885343|NCT02152631|Therapy, Platinum, Kras +|therapy, platinum, kras +
4885344|NCT02152618|Serious emotional disturbance|serious emotional disturbance
4885345|NCT02152618|foster care|foster care
4885346|NCT02152618|child protective services|child protective services
4885347|NCT02152605|SGRQ|sgrq
4885348|NCT02152605|vilanterol|vilanterol
4885454|NCT02152150|anemia|anemia
4885349|NCT02152605|long-acting beta2-agonist|long-acting beta2-agonist
4885350|NCT02152605|long-acting muscarinic antagonist|long-acting muscarinic antagonist
4885351|NCT02152605|COPD|copd
4885352|NCT02152605|umeclidinium|umeclidinium
4885353|NCT02152592|Postoperative pain|postoperative pain
4885354|NCT02152592|Ambulatory surgery|ambulatory surgery
4885355|NCT02152592|NSAIDS|nsaids
4885356|NCT02152592|CR Oxycodone|cr oxycodone
4885357|NCT02152592|Compliance to study medication|compliance to study medication
4885358|NCT02152579|Stable Angina|stable angina
4885359|NCT02152553|Biomarker|biomarker
4885360|NCT02152553|Glucocorticoids|glucocorticoids
4885361|NCT02152553|Metabolism|metabolism
4885362|NCT02152553|Pharmacology|pharmacology
4885363|NCT02152553|Metabolomics|metabolomics
4885364|NCT02152540|TBI|tbi
4885365|NCT02152540|Transcranial Magnetic Stimulation, Repetitive|transcranial magnetic stimulation, repetitive
4885366|NCT02152540|magnetic resonance imaging functional|magnetic resonance imaging functional
4885367|NCT02152540|Quality of life|quality of life
4885368|NCT02152540|Executive Function|executive function
4885369|NCT02152540|Veterans|veterans
4885370|NCT02152501|obese|obese
4885371|NCT02152501|overweight|overweight
4885372|NCT02152501|exercise|exercise
4885373|NCT02152501|energy expenditure differences|energy expenditure differences
4885374|NCT02152501|relative reinforcing values (RRV)|relative reinforcing values (rrv)
4885375|NCT02152501|food|food
4885376|NCT02152501|physical activity|physical activity
4885377|NCT02152501|biological|biological
4885378|NCT02152501|neurobehavioral|neurobehavioral
4885379|NCT02152501|behavioral|behavioral
4885380|NCT02152488|cerebral blood flow|cerebral blood flow
4885381|NCT02152488|position|position
4885382|NCT02152488|cervical spine|cervical spine
4885383|NCT02152475|Blue-LED|blue-led
4885384|NCT02152475|Curcumin|curcumin
4885385|NCT02152475|PDT|pdt
4885386|NCT02152475|Oral disinfection|oral disinfection
4885387|NCT02152462|exergaming|exergaming
4885388|NCT02152462|breast cancer|breast cancer
4885389|NCT02152462|African American women|african american women
4885390|NCT02152462|obesity|obesity
4885391|NCT02152423|enoxaparin|enoxaparin
4885392|NCT02152423|Enoxamed|enoxamed
4885393|NCT02152423|lovenox|lovenox
4885394|NCT02152423|anti Xa|anti xa
4885395|NCT02152423|acute coronary syndrome|acute coronary syndrome
4885396|NCT02152410|acupuncture|acupuncture
4885397|NCT02152410|renal colic|renal colic
4885398|NCT02152358|Cytomegalovirus|cytomegalovirus
4885399|NCT02152358|Herpes simplex virus|herpes simplex virus
4885400|NCT02152358|ICU|icu
4885401|NCT02152358|mechanical ventilation|mechanical ventilation
4885402|NCT02152358|mortality|mortality
4885403|NCT02152358|ventilator-free days|ventilator-free days
4885404|NCT02152358|PCR|pcr
4885405|NCT02152345|kidney|kidney
4885406|NCT02152345|renal|renal
4885407|NCT02152345|transplant|transplant
4885408|NCT02152345|belatacept|belatacept
4885409|NCT02152345|delayed graft function|delayed graft function
4885410|NCT02152345|thymoglobulin|thymoglobulin
4885411|NCT02152345|tacrolimus|tacrolimus
4885412|NCT02152345|kidney function|kidney function
4885413|NCT02152345|immunosuppression|immunosuppression
4885414|NCT02152345|NGAL|ngal
4885415|NCT02152332|JNJ-54861912|jnj-54861912
4885416|NCT02152332|RSC-385896|rsc-385896
4885417|NCT02152332|MTS-0385896A|mts-0385896a
4885418|NCT02152332|Phase 1|phase 1
4885419|NCT02152332|Moxifloxacin|moxifloxacin
4885420|NCT02152332|Placebo|placebo
4885421|NCT02152332|Healthy|healthy
4885422|NCT02152319|Parkinson's disease|parkinson's disease
4885423|NCT02152319|Telemedicine|telemedicine
4885424|NCT02152319|Telehealth|telehealth
4885425|NCT02152319|Kinesia|kinesia
4885426|NCT02152319|Tremor|tremor
4885427|NCT02152319|Bradykinesia|bradykinesia
4885428|NCT02152319|Dyskinesia|dyskinesia
4885429|NCT02152306|Fimasartan|fimasartan
4885430|NCT02152306|Fimasartan and Amlodipine|fimasartan and amlodipine
4885431|NCT02152306|Antihypertension|antihypertension
4885432|NCT02152267|Temporomandibular|temporomandibular
4885433|NCT02152267|Musculoskeletal Diseases|musculoskeletal diseases
4885434|NCT02152267|Electrical Stimulation of the Brain|electrical stimulation of the brain
4885435|NCT02152267|Prefrontal Cortex|prefrontal cortex
4885436|NCT02152254|Metastatic Cancer|metastatic cancer
4885437|NCT02152254|Molecular Profiling|molecular profiling
4885438|NCT02152254|Genomic alteration analysis of the tumor|genomic alteration analysis of the tumor
4885439|NCT02152254|Advanced Cancer Therapy|advanced cancer therapy
4885440|NCT02152254|Gene mutations|gene mutations
4885441|NCT02152254|Tumor biopsy|tumor biopsy
4885442|NCT02152254|Personalized medicine|personalized medicine
4885443|NCT02152241|IBD|ibd
4885444|NCT02152241|Crohn|crohn
4885445|NCT02152241|Colitis|colitis
4885446|NCT02152241|Function|function
4885447|NCT02152176|pain|pain
4885448|NCT02152176|analgesia|analgesia
4885449|NCT02152176|morphine|morphine
4885450|NCT02152176|PCA|pca
4885451|NCT02152176|Nurse|nurse
4885452|NCT02152163|Assessing the efficacy of IV Ibuprofen for Treatment of Pain in Orthopedic Trauma Patients|assessing the efficacy of iv ibuprofen for treatment of pain in orthopedic trauma patients
4885453|NCT02152150|iron|iron
4885455|NCT02152150|bio-fortification|bio-fortification
4885456|NCT02152150|children|children
4885457|NCT02152150|India|india
4885458|NCT02152124|Acromegaly|acromegaly
4885459|NCT02152124|Acromegaly treatment|acromegaly treatment
4885460|NCT02152124|Long-acting somatostatin analogs|long-acting somatostatin analogs
4885461|NCT02152124|Pegvisomant|pegvisomant
4885462|NCT02152124|Insulin sensitivity|insulin sensitivity
4885463|NCT02152124|Gut hormones|gut hormones
4885464|NCT02152124|Lipid metabolism|lipid metabolism
4885465|NCT02152124|Adipokines|adipokines
4885466|NCT02152111|Obesity|obesity
4885467|NCT02152111|Coconut flour|coconut flour
4885468|NCT02152111|Diet quality|diet quality
4885469|NCT02152111|Cardiovascular risk factor|cardiovascular risk factor
4885470|NCT02152085|Walking|walking
4885471|NCT02152085|Mobility|mobility
4885472|NCT02152085|Neuromuscular electrical stimulation|neuromuscular electrical stimulation
4885473|NCT02152085|Multiple sclerosis|multiple sclerosis
4885474|NCT02152059|Small cell lung cancer|small cell lung cancer
4885475|NCT02152059|BIBF1120|bibf1120
4885476|NCT02152059|nintedanib|nintedanib
4885477|NCT02152059|platinum-sensitive|platinum-sensitive
4885478|NCT02152033|Substance Abuse|substance abuse
4885479|NCT02152033|Continuing Care|continuing care
4885480|NCT02152033|Recovery|recovery
4885481|NCT02152033|Substance Abuse Treatment|substance abuse treatment
4885482|NCT02152033|Parent|parent
4885483|NCT02152033|Family|family
4885484|NCT02152033|Young Adult|young adult
4885485|NCT02152007|pachyonychia congenita|pachyonychia congenita
4885486|NCT02151994|BIA 5-1058|bia 5-1058
4885487|NCT02151994|hypertension|hypertension
4885488|NCT02151994|chronic heart failure|chronic heart failure
4885489|NCT02151994|cardiovascular disorders|cardiovascular disorders
4885490|NCT02151981|Advanced Non-Small Cell Lung Cancer; T790M Mutation Positive|advanced non-small cell lung cancer; t790m mutation positive
4885491|NCT02151942|elective endovascular AAA repair|elective endovascular aaa repair
4885492|NCT02151929|myocardial infarction|myocardial infarction
4885493|NCT02151929|primary PCI|primary pci
4885494|NCT02151929|stent|stent
4885495|NCT02151916|dental caries|dental caries
4885496|NCT02151916|early childhood caries|early childhood caries
4885497|NCT02151916|topical fluorides|topical fluorides
4885498|NCT02151916|fluoride varnish|fluoride varnish
4885499|NCT02151903|NHL|nhl
4885500|NCT02151903|Immunocytokine|immunocytokine
4885501|NCT02151903|Lymphoma|lymphoma
4885502|NCT02151903|Non-Hodgkin|non-hodgkin
4885503|NCT02151903|B-cell|b-cell
4885504|NCT02151903|IL (interleukin)|il (interleukin)
4885505|NCT02151890|POF|pof
4885506|NCT02151890|ESS|ess
4885507|NCT02151890|stem cell|stem cell
4885508|NCT02151877|Ischemia/reperfusion injury|ischemia/reperfusion injury
4885509|NCT02151864|liver cancer|liver cancer
4885510|NCT02151864|cirrhosis|cirrhosis
4885511|NCT02151864|Child-Pugh A|child-pugh a
4885512|NCT02151864|Hedgehog|hedgehog
4885513|NCT02151851|Rheumatoid Arthritis|rheumatoid arthritis
4885514|NCT02151851|TNFα antagonist|tnfα antagonist
4885515|NCT02151851|Certolizumab Pegol|certolizumab pegol
4885516|NCT02151851|Chinese patients|chinese patients
4885517|NCT02151838|HIV-infected pregnant women who request HAART from the TRCSPMTCT|hiv-infected pregnant women who request haart from the trcspmtct
4885518|NCT02151825|Gut microbiota|gut microbiota
4885519|NCT02151825|Probiotics|probiotics
4885520|NCT02151825|Prebiotics|prebiotics
4885521|NCT02151825|Synbiotic|synbiotic
4885522|NCT02151825|Bifidobacterium lactis BB-12|bifidobacterium lactis bb-12
4885523|NCT02151825|Lactobacillus acidophilus LA-5|lactobacillus acidophilus la-5
4885524|NCT02151825|Lactobacillus casei 431|lactobacillus casei 431
4885525|NCT02151825|Inulin|inulin
4885526|NCT02151825|GOS|gos
4885527|NCT02151825|Body Weight|body weight
4885528|NCT02151825|Overweight|overweight
4885529|NCT02151825|Adiposity|adiposity
4885530|NCT02151825|Obesity|obesity
4885531|NCT02151825|ANGPTL4|angptl4
4885532|NCT02151786|Pharmacological therapy|pharmacological therapy
4885533|NCT02151773|Pharmacological therapy|pharmacological therapy
4885534|NCT02151760|Metastatic Prostate Cancer|metastatic prostate cancer
4885535|NCT02151747|breast neoplasms, BRCA1, Sanger, NGS, Next generation sequencing|breast neoplasms, brca1, sanger, ngs, next generation sequencing
4885536|NCT02151721|Vorinostat|vorinostat
4885537|NCT02151721|Gefitinib|gefitinib
4885538|NCT02151721|BIM polymorphism|bim polymorphism
4885539|NCT02151721|EGFR-TKI resistance|egfr-tki resistance
4885540|NCT02151708|accommodation, emptying,motilitone|accommodation, emptying,motilitone
4885541|NCT02151682|chronic pain|chronic pain
4885542|NCT02151682|opioid|opioid
4885543|NCT02151669|Mediterranean diet|mediterranean diet
4885544|NCT02151669|Smoking/tobacco|smoking/tobacco
4885545|NCT02151669|Spirometry|spirometry
4885546|NCT02151656|Schizophrenia|schizophrenia
4885547|NCT02151656|Mental disorders|mental disorders
4885548|NCT02151656|Antipsychotic Drugs|antipsychotic drugs
4885549|NCT02151643|Dialysis Dependent Chronic Kidney Disease|dialysis dependent chronic kidney disease
4885550|NCT02151630|wart|wart
4885551|NCT02151630|verruca vulgaris|verruca vulgaris
4885552|NCT02151630|topical therapy|topical therapy
4885553|NCT02151630|pyruvic acid|pyruvic acid
4885554|NCT02151630|salicylic acid|salicylic acid
4885555|NCT02151617|Multiple dose|multiple dose
4885556|NCT02151617|safety|safety
4885557|NCT02151617|tolerability|tolerability
4885558|NCT02151617|PK|pk
4885559|NCT02151591|Quit smoking|quit smoking
4885560|NCT02151591|Quit drinking|quit drinking
4885561|NCT02151578|Impact of home management of malaria and pneumonia on child mortality|impact of home management of malaria and pneumonia on child mortality
4885562|NCT02151578|home management of malaria and pneumonia|home management of malaria and pneumonia
4885563|NCT02151565|back pain|back pain
4885564|NCT02151565|sciatica|sciatica
4885565|NCT02151565|electrotherapy|electrotherapy
4885566|NCT02151565|HTEMS|htems
4885567|NCT02151565|TENS|tens
4885568|NCT02151552|lung inflammation|lung inflammation
4885569|NCT02151552|positron emission tomography|positron emission tomography
4885570|NCT02151552|inducible nitric oxide synthase|inducible nitric oxide synthase
4885571|NCT02151513|Cancer-associated pain|cancer-associated pain
4885572|NCT02151513|Immune function|immune function
4885573|NCT02151500|Medically Unexplained Symptoms (MUPS)|medically unexplained symptoms (mups)
4885574|NCT02151500|Somatoform disorders|somatoform disorders
4885575|NCT02151500|Chronic pain|chronic pain
4885576|NCT02151500|Somatic symptoms|somatic symptoms
4885577|NCT02151500|Emotional processing|emotional processing
4885578|NCT02151500|Primary Care|primary care
4885579|NCT02151487|Supraclavicular block|supraclavicular block
4885580|NCT02151487|Ropivacaine|ropivacaine
4885581|NCT02151487|Dexamethasone|dexamethasone
4885582|NCT02151487|Clonidine|clonidine
4885583|NCT02151461|Diabetes|diabetes
4885584|NCT02151461|Type 2 Diabetes|type 2 diabetes
4885585|NCT02151435|Idiopathic Pulmonary Fibrosis|idiopathic pulmonary fibrosis
4885586|NCT02151435|Biomarkers|biomarkers
4885587|NCT02151435|Forced Vital Capacity|forced vital capacity
4885588|NCT02151435|Diffusion Capacity for Carbon Monoxide|diffusion capacity for carbon monoxide
4885589|NCT02151435|Prognosis|prognosis
4885590|NCT02151422|Adults|adults
4885591|NCT02151422|age 18-65|age 18-65
4885592|NCT02151422|physician-diagnosed|physician-diagnosed
4885593|NCT02151422|persistent asthma|persistent asthma
4885594|NCT02151396|ADHD, hyperactivity, inattention, working memory|adhd, hyperactivity, inattention, working memory
4885595|NCT02151383|Acute heart failure,|acute heart failure,
4885596|NCT02151383|RELAX−AHF−PEDIATRIC PK|relax−ahf−pediatric pk
4885597|NCT02151357|first in man|first in man
4885598|NCT02151357|dose escalating|dose escalating
4885599|NCT02151357|MTD|mtd
4885600|NCT02151357|DLT|dlt
4885601|NCT02151331|Chronic care model|chronic care model
4885602|NCT02151331|Mood disorders|mood disorders
4885603|NCT02151331|Adaptive implementation|adaptive implementation
4885604|NCT02151279|Shrimp allergy|shrimp allergy
4885605|NCT02151279|Chitosan|chitosan
4885606|NCT02151279|fining agent|fining agent
4885607|NCT02151266|Heart failure|heart failure
4885608|NCT02151266|Exercise|exercise
4885609|NCT02151266|Cognitive training|cognitive training
4885610|NCT02151253|Nocturia|nocturia
4885611|NCT02151253|Daytime sleepiness|daytime sleepiness
4885612|NCT02151240|herpes zoster, Foscarnet Sodium, Acyclovir, Postherpetic neuralgia|herpes zoster, foscarnet sodium, acyclovir, postherpetic neuralgia
4885613|NCT02151227|Meta-Analysis|meta-analysis
4885614|NCT02151227|Metabolic Syndrome|metabolic syndrome
4885615|NCT02151227|Magnesium|magnesium
4885616|NCT02151227|Dose Response Effect|dose response effect
4885617|NCT02151227|Systematic Review|systematic review
4885618|NCT02151214|Palliative Phase of Cancer|palliative phase of cancer
4885619|NCT02151214|Quality of life|quality of life
4885620|NCT02151214|Parenteral nutrition|parenteral nutrition
4885621|NCT02151214|Undernutrition|undernutrition
4885622|NCT02151201|pregnancy vaccination influenza education|pregnancy vaccination influenza education
4885623|NCT02151149|NSCLC advanced non-small cell lung cancer squamous adenocarcinoma large cell carcinoma lung cancer elderly first line treatment abraxane carbo nab-paclitaxel|nsclc advanced non-small cell lung cancer squamous adenocarcinoma large cell carcinoma lung cancer elderly first line treatment abraxane carbo nab-paclitaxel
4885624|NCT02151136|Sucrose|sucrose
4885625|NCT02151136|Pain|pain
4885626|NCT02151123|Colonic Neoplasms|colonic neoplasms
4885627|NCT02151123|Colon Cancer|colon cancer
4885628|NCT02151123|Microbiome|microbiome
4885629|NCT02151110|Healthy Male|healthy male
4885630|NCT02151110|Healthy Female of non child bearing potential|healthy female of non child bearing potential
4885631|NCT02151097|Prostatectomy|prostatectomy
4885632|NCT02151097|Prostate cancer|prostate cancer
4885633|NCT02151097|Cerenkov Luminescence Imaging|cerenkov luminescence imaging
4885634|NCT02151084|randomized|randomized
4885635|NCT02151084|selumetinib|selumetinib
4885636|NCT02151084|tablets|tablets
4885637|NCT02151084|cisplatin|cisplatin
4885638|NCT02151084|gemcitabine|gemcitabine
4885639|NCT02151084|non-resectable|non-resectable
4885640|NCT02151084|recurrent|recurrent
4885641|NCT02151084|metstatic|metstatic
4885642|NCT02151071|Breast Cancer|breast cancer
4885643|NCT02151071|Mastectomy, Segmental|mastectomy, segmental
4885644|NCT02151071|Breast Conserving Surgery|breast conserving surgery
4885645|NCT02151071|Cerenkov Luminescence Imaging|cerenkov luminescence imaging
4885646|NCT02151071|Beta particle detection|beta particle detection
4885647|NCT02151058|Staining|staining
4885648|NCT02151058|Intensity|intensity
4885649|NCT02151058|Area|area
4885650|NCT02151045|Epidural infiltration of Corticoids|epidural infiltration of corticoids
4885651|NCT02151045|L3-L4 stage|l3-l4 stage
4885652|NCT02151045|On contact of disco radicular conflict|on contact of disco radicular conflict
4885653|NCT02151045|Scan control|scan control
4885654|NCT02151032|Colorectal Cancer|colorectal cancer
4885655|NCT02151032|Colorectal cancer screening|colorectal cancer screening
4885656|NCT02151032|Multimedia|multimedia
4885657|NCT02151032|Booklet|booklet
4885658|NCT02151032|Pamphlet|pamphlet
4885659|NCT02151032|Audio CD|audio cd
4885660|NCT02151032|Video with animated images|video with animated images
4885661|NCT02151032|Video with non-moving images|video with non-moving images
4885662|NCT02151032|Questionnaires|questionnaires
4885663|NCT02151032|Surveys|surveys
4885664|NCT02151006|DHEA|dhea
4885665|NCT02151006|IVF|ivf
4885666|NCT02151006|ICSI|icsi
4885667|NCT02150993|Africa|africa
4885668|NCT02150993|Antiretroviral Treatment|antiretroviral treatment
4885669|NCT02150993|HIV-2|hiv-2
4885670|NCT02150993|firsts line ART|firsts line art
4885671|NCT02150993|Adults|adults
4885672|NCT02150980|Fractures|fractures
4885673|NCT02150980|burden of fractures|burden of fractures
4885674|NCT02150980|orthopaedic fractures|orthopaedic fractures
4885675|NCT02150980|orthopaedic injuries|orthopaedic injuries
4885676|NCT02150980|orthopaedic trauma|orthopaedic trauma
4885677|NCT02150980|observational study|observational study
4885678|NCT02150980|outcomes of fracture care|outcomes of fracture care
4885679|NCT02150980|epidemiology|epidemiology
4885680|NCT02150967|cholangiocarcinoma,|cholangiocarcinoma,
4885681|NCT02150967|FGFR2 gene fusion,|fgfr2 gene fusion,
4885682|NCT02150967|FGFR genetic alteration|fgfr genetic alteration
4885683|NCT02150954|induction of labor|induction of labor
4885684|NCT02150954|pitocin|pitocin
4885685|NCT02150954|foley bulb|foley bulb
4885686|NCT02150941|Upper gastrointestinal tract|upper gastrointestinal tract
4885687|NCT02150941|Endoscopy|endoscopy
4885688|NCT02150941|Endoscopic Hemostasis|endoscopic hemostasis
4885689|NCT02150915|Acupoints|acupoints
4885690|NCT02150915|Acupuncture therapy|acupuncture therapy
4885691|NCT02150915|Median nerve|median nerve
4885692|NCT02150915|Biomechanics|biomechanics
4885693|NCT02150902|Catheter ablation for atrial fibrillation|catheter ablation for atrial fibrillation
4885694|NCT02150902|treatment for atrial fibrillation|treatment for atrial fibrillation
4885695|NCT02150902|comparison of catheter ablation techniques for atrial fibrillation|comparison of catheter ablation techniques for atrial fibrillation
4885696|NCT02150889|insulin resistance|insulin resistance
4885697|NCT02150889|lipid metabolism|lipid metabolism
4885698|NCT02150889|diabetes|diabetes
4885699|NCT02150876|DES|des
4885700|NCT02150876|SDF|sdf
4885701|NCT02150876|MACE|mace
4885702|NCT02150876|SYNERGY|synergy
4885703|NCT02150863|actinic keratosis|actinic keratosis
4885704|NCT02150863|field cancerization|field cancerization
4885705|NCT02150863|organ transplant patients|organ transplant patients
4885706|NCT02150850|Femoral Fractures|femoral fractures
4885707|NCT02150850|Subtrochanteric Fractures|subtrochanteric fractures
4885708|NCT02150850|Osteoporotic Fractures|osteoporotic fractures
4885709|NCT02150850|Fractures, Spontaneous|fractures, spontaneous
4885710|NCT02150850|Stress Fractures|stress fractures
4885711|NCT02150850|Bone Fractures|bone fractures
4885712|NCT02150850|Hip Fractures|hip fractures
4885713|NCT02150850|Osteoporosis|osteoporosis
4885714|NCT02150837|Obesity|obesity
4885715|NCT02150837|Weight Loss|weight loss
4885716|NCT02150837|Meal replacements|meal replacements
4885717|NCT02150837|Weight maintenance|weight maintenance
4885718|NCT02150798|Diet Therapy|diet therapy
4885719|NCT02150798|Diet, Carbohydrate Restricted|diet, carbohydrate restricted
4885720|NCT02150798|Fatty Acids, Omega 3|fatty acids, omega 3
4885721|NCT02150798|Oximetry|oximetry
4885722|NCT02150798|phase angle|phase angle
4885723|NCT02150798|Triglycerides, blood|triglycerides, blood
4885724|NCT02150798|Lipids, blood|lipids, blood
4885725|NCT02150798|Hand Strength|hand strength
4885726|NCT02150798|Body Composition|body composition
4885727|NCT02150798|Electric Impedance|electric impedance
4885728|NCT02150785|Thrombolysis|thrombolysis
4885729|NCT02150785|Safety of Streptokinase|safety of streptokinase
4885730|NCT02150785|tissue plasminogen activator tPA|tissue plasminogen activator tpa
4885731|NCT02150785|Stroke treatment|stroke treatment
4885732|NCT02150759|Dexmedetomidine|dexmedetomidine
4885733|NCT02150759|Ketamine|ketamine
4885734|NCT02150759|Pain|pain
4885735|NCT02150746|Pancreatic ductal adenocarcinoma|pancreatic ductal adenocarcinoma
4885736|NCT02150746|Pancreatic cancer|pancreatic cancer
4885737|NCT02150746|PDAC|pdac
4885738|NCT02150746|Circulating tumor cells|circulating tumor cells
4885739|NCT02150720|Hip fractures|hip fractures
4885740|NCT02150720|Clinical Trial|clinical trial
4885741|NCT02150720|Randomized|randomized
4885742|NCT02150720|Fibrin glue|fibrin glue
4885743|NCT02150720|Tranexamic acid|tranexamic acid
4885744|NCT02150720|Blood loss|blood loss
4885745|NCT02150681|preconception|preconception
4885746|NCT02150681|pregnancy|pregnancy
4885747|NCT02150681|postpartum|postpartum
4885748|NCT02150681|women|women
4885749|NCT02150668|ADHD|adhd
4885750|NCT02150668|Homework|homework
4885751|NCT02150668|School|school
4885752|NCT02150668|Organization|organization
4885753|NCT02150668|Time-management|time-management
4885754|NCT02150616|Pulmonary hypertension|pulmonary hypertension
4885755|NCT02150616|Interstitial lung disease|interstitial lung disease
4885756|NCT02150616|Pulmonary fibrosis|pulmonary fibrosis
4885757|NCT02150603|Heart defects, congenital|heart defects, congenital
4885758|NCT02150603|Patient-reported outcomes|patient-reported outcomes
4885759|NCT02150603|Health status|health status
4885760|NCT02150603|Factors, psychosocial|factors, psychosocial
4885761|NCT02150603|Health behavior|health behavior
4885762|NCT02150603|Quality of life|quality of life
4885763|NCT02150603|Sense of coherence|sense of coherence
4885764|NCT02150603|Illness perceptions|illness perceptions
4885765|NCT02150603|Depression|depression
4885766|NCT02150603|Anxiety|anxiety
4885767|NCT02150590|airway disease|airway disease
4885768|NCT02150590|bronchitis|bronchitis
4885769|NCT02150590|emphysema|emphysema
4885770|NCT02150590|lung|lung
4885771|NCT02150577|Screening|screening
4885772|NCT02150577|Mood Stabilizers|mood stabilizers
4885773|NCT02150577|Computer delivered psychotherapy|computer delivered psychotherapy
4885774|NCT02150577|Peer Support|peer support
4885775|NCT02150577|Telepsychiatry|telepsychiatry
4885776|NCT02150577|Implementation|implementation
4885777|NCT02150577|Rural|rural
4885778|NCT02150564|Malignant gliomas|malignant gliomas
4885779|NCT02150564|Sono RCT|sono rct
4885780|NCT02150551|Crohn disease|crohn disease
4885781|NCT02150551|ulcerative colitis|ulcerative colitis
4885782|NCT02150551|mesenchymal stromal cells|mesenchymal stromal cells
4885783|NCT02150551|inflammatory bowel diseases|inflammatory bowel diseases
4885784|NCT02150538|Cardiac Resynchronization therapy|cardiac resynchronization therapy
4885785|NCT02150538|Minimized Right ventricular pacing|minimized right ventricular pacing
4885786|NCT02150538|Prolonged AV conduction|prolonged av conduction
4885787|NCT02150525|breast cancer|breast cancer
4885788|NCT02150525|vaginal dryness|vaginal dryness
4885789|NCT02150525|dyspareunia|dyspareunia
4885790|NCT02150525|genital irritation|genital irritation
4885791|NCT02150512|Septic shock|septic shock
4885792|NCT02150512|Critically ill patients|critically ill patients
4885793|NCT02150512|Transpulmonary thermodilution|transpulmonary thermodilution
4885794|NCT02150512|Fluid resuscitation|fluid resuscitation
4885795|NCT02150499|Acute Asthma exacerbation|acute asthma exacerbation
4885796|NCT02150473|rheumatoid Arthritis|rheumatoid arthritis
4885797|NCT02150460|ophthalmic surgery, peribulbar local anaesthesia|ophthalmic surgery, peribulbar local anaesthesia
4885798|NCT02150447|Gastric cancer bleeding|gastric cancer bleeding
4885799|NCT02150447|Proton pump inhibitor|proton pump inhibitor
4885800|NCT02150434|Oxygen therapy|oxygen therapy
4885801|NCT02150434|Hypoxemia|hypoxemia
4885802|NCT02150434|COPD|copd
4885803|NCT02150434|Closed-loop|closed-loop
4885804|NCT02150434|Automated titration,|automated titration,
4885805|NCT02150382|hypertension|hypertension
4885806|NCT02150382|rural|rural
4885807|NCT02150382|China|china
4885808|NCT02150382|protocol-based treatment|protocol-based treatment
4885809|NCT02150343|Cat allergy|cat allergy
4885810|NCT02150343|Rhinoconjunctivitis|rhinoconjunctivitis
4885811|NCT02150330|Dehydroepiandrosterone|dehydroepiandrosterone
4885812|NCT02150330|DHEAS|dheas
4885813|NCT02150330|Gene expression of cumulus cells.|gene expression of cumulus cells.
4885814|NCT02150330|Folliculogenesis.|folliculogenesis.
4885815|NCT02150330|Oocyte maturation.|oocyte maturation.
4885816|NCT02150330|Ovarian hyper-stimulation protocol.|ovarian hyper-stimulation protocol.
4885817|NCT02150330|Artificial reproduction technology.|artificial reproduction technology.
4885818|NCT02150317|Carcinoma, Hepatocellular|carcinoma, hepatocellular
4885819|NCT02150317|Chemoembolization, Therapeutic|chemoembolization, therapeutic
4885820|NCT02150317|Sorafenib|sorafenib
4885821|NCT02150278|Driving|driving
4885822|NCT02150278|Alcohol consumption|alcohol consumption
4885823|NCT02150278|Risk perception|risk perception
4885824|NCT02150252|Clinical trial|clinical trial
4885825|NCT02150252|Ischemic stroke|ischemic stroke
4885826|NCT02150252|Bu-Yang-Huan-Wu Tang (BYHWT）|bu-yang-huan-wu tang (byhwt）
4885827|NCT02150252|Gait parameter|gait parameter
4885828|NCT02150252|Quality of life|quality of life
4885829|NCT02150239|pain|pain
4885830|NCT02150239|postoperative|postoperative
4885831|NCT02150213|Adrenocortical Adenoma,|adrenocortical adenoma,
4885832|NCT02150213|Endometrial Stromal sarcomas|endometrial stromal sarcomas
4885833|NCT02150213|BGG492|bgg492
4885834|NCT02150187|Androgenetic Alopecia|androgenetic alopecia
4885835|NCT02150187|Male|male
4885836|NCT02150187|Baldness|baldness
4885837|NCT02150187|hair loss pattern|hair loss pattern
4885838|NCT02150174|Schizophrenia|schizophrenia
4885839|NCT02150174|Episodic memory deficits|episodic memory deficits
4885840|NCT02150148|breast cancer|breast cancer
4885841|NCT02150148|prostate cancer|prostate cancer
4885842|NCT02150148|colorectal cancer|colorectal cancer
4885843|NCT02150148|small intestine cancer|small intestine cancer
4885844|NCT02150148|thyroid cancer|thyroid cancer
4885845|NCT02150148|Hodgkin lymphoma|hodgkin lymphoma
4885846|NCT02150148|non-Hodgkin lymphoma|non-hodgkin lymphoma
4885847|NCT02150148|endometrial cancer|endometrial cancer
4885848|NCT02150148|kidney cancer|kidney cancer
4885849|NCT02150148|cervical cancer|cervical cancer
4885850|NCT02150148|diet|diet
4885851|NCT02150148|exercise|exercise
4885852|NCT02150148|physical activity|physical activity
4885853|NCT02150148|garden|garden
4885854|NCT02150135|Pancreatic cancer|pancreatic cancer
4885855|NCT02150135|Quality of life|quality of life
4885856|NCT02150135|Pain|pain
4885857|NCT02150122|Vitamin D|vitamin d
4885858|NCT02150122|Serum 25-hydroxyvitamin D (25OHD)|serum 25-hydroxyvitamin d (25ohd)
4885859|NCT02150122|Adolescents|adolescents
4885860|NCT02150096|chronic non-specific low back pain|chronic non-specific low back pain
4885861|NCT02150096|clinical trial|clinical trial
4885862|NCT02150096|disability|disability
4885863|NCT02150096|women|women
4885864|NCT02150083|midurethral sling|midurethral sling
4885865|NCT02150083|voiding study|voiding study
4885866|NCT02150083|voiding trial|voiding trial
4885867|NCT02150083|retrograde voiding trial|retrograde voiding trial
4885868|NCT02150070|Healthy subjects|healthy subjects
4885869|NCT02150070|ASP2408|asp2408
4885870|NCT02150070|Rheumatoid arthritis|rheumatoid arthritis
4885871|NCT02150070|Safety and Tolerability|safety and tolerability
4885872|NCT02150070|Pharmacokinetics|pharmacokinetics
4885873|NCT02150057|knee osteoarthritis unicompartmental unloading brace|knee osteoarthritis unicompartmental unloading brace
4885874|NCT02150031|prevention and control|prevention and control
4885875|NCT02150031|chlorhexidine|chlorhexidine
4885876|NCT02150031|therapeutic irrigation|therapeutic irrigation
4885877|NCT02150031|mouthwashes|mouthwashes
4885878|NCT02150031|culture|culture
4885879|NCT02150018|- Critical Care|- critical care
4885880|NCT02150018|Non invasive ventilation|non invasive ventilation
4885881|NCT02150018|Electrical impedance tomography|electrical impedance tomography
4885882|NCT02150018|End expiratory lung volume|end expiratory lung volume
4885883|NCT02150018|End expiratory lung impedance|end expiratory lung impedance
4885884|NCT02150005|periodontal diseases|periodontal diseases
4885885|NCT02150005|cardiovascular diseases|cardiovascular diseases
4885886|NCT02150005|periodontitis treatment|periodontitis treatment
4885887|NCT02149992|gestational diabetes|gestational diabetes
4885888|NCT02149992|myoinositol|myoinositol
4885889|NCT02149979|Incision|incision
4885890|NCT02149979|Wound Closure|wound closure
4885891|NCT02149979|Laser Tissue Soldering|laser tissue soldering
4885892|NCT02149966|safety and tolerability|safety and tolerability
4885893|NCT02149966|pharmacokinetic study|pharmacokinetic study
4885894|NCT02149953|Pregnancy|pregnancy
4885895|NCT02149953|Glycine requirements|glycine requirements
4885896|NCT02149953|Indicator Amino Acid Oxidation (IAAO) method|indicator amino acid oxidation (iaao) method
4885897|NCT02149953|Stable isotopes|stable isotopes
4885898|NCT02149940|Elderly|elderly
4885899|NCT02149940|Frailty|frailty
4885900|NCT02149940|Polypharmacy|polypharmacy
4885901|NCT02149940|Medication review|medication review
4885902|NCT02149940|Clinical pharmacy services|clinical pharmacy services
4885903|NCT02149927|EEG|eeg
4885904|NCT02149927|fMRI|fmri
4885905|NCT02149927|connectivity|connectivity
4885906|NCT02149927|sevoflurane|sevoflurane
4885907|NCT02149914|Ryodoraku|ryodoraku
4885908|NCT02149914|Meridian energy|meridian energy
4885909|NCT02149914|Heart rate variability|heart rate variability
4885910|NCT02149914|Autonomic Nervous System|autonomic nervous system
4885911|NCT02149914|GERD|gerd
4885912|NCT02149901|Pure Autonomic Failure|pure autonomic failure
4885913|NCT02149901|Multiple System Atrophy|multiple system atrophy
4885914|NCT02149901|Pseudoephedrine|pseudoephedrine
4885915|NCT02149901|Water|water
4885916|NCT02149901|Osmopressor|osmopressor
4885917|NCT02149888|HIV|hiv
4885918|NCT02149888|Pre-Exposure Prophylaxis|pre-exposure prophylaxis
4885919|NCT02149888|PrEP|prep
4885920|NCT02149888|Human Immunodeficiency Virus|human immunodeficiency virus
4885921|NCT02149875|Acute ischemic stroke|acute ischemic stroke
4885922|NCT02149875|Dl-3-n-butylphthalide|dl-3-n-butylphthalide
4885923|NCT02149875|Cerebrolysin|cerebrolysin
4885924|NCT02149862|Bladder cancer|bladder cancer
4885925|NCT02149862|Diagnostic|diagnostic
4885926|NCT02149862|Infrared|infrared
4885927|NCT02149862|Spectrum|spectrum
4885928|NCT02149862|Urina|urina
4885929|NCT02149862|Patients with an indication of partial or total bladder resection|patients with an indication of partial or total bladder resection
4885930|NCT02149862|or|or
4885931|NCT02149862|"Lithiasic patients should be operated a urinary calculation, without catheter double J"|"lithiasic patients should be operated a urinary calculation, without catheter double j"
4885932|NCT02149849|Ipsilateral shoulder pain|ipsilateral shoulder pain
4885933|NCT02149849|Surgical positioning|surgical positioning
4885934|NCT02149849|Lung cancer|lung cancer
4885935|NCT02149849|Thoracotomy|thoracotomy
4885936|NCT02149849|Video assisted thoracic surgery|video assisted thoracic surgery
4885937|NCT02149836|major depressive disorder|major depressive disorder
4885938|NCT02149836|depression|depression
4885939|NCT02149836|treatment resistent depression|treatment resistent depression
4885940|NCT02149823|Oxytocin, Social Cognition|oxytocin, social cognition
4885941|NCT02149823|Borderline Personality Disorder|borderline personality disorder
4885942|NCT02149823|Schizotypal Personality Disorder|schizotypal personality disorder
4885943|NCT02149823|Social Cognition|social cognition
4885944|NCT02149823|BPD|bpd
4885945|NCT02149823|SPD|spd
4885946|NCT02149823|MASC|masc
4885947|NCT02149823|Autism Spectrum Disorder|autism spectrum disorder
4885948|NCT02149823|Schizophrenia|schizophrenia
4885949|NCT02149823|Schizoaffective Disorder|schizoaffective disorder
4885950|NCT02149823|Bipolar Disorder|bipolar disorder
4885951|NCT02149810|MDD|mdd
4885952|NCT02149784|Metastasis colorectal cancer|metastasis colorectal cancer
4885953|NCT02149784|Chemotherapy|chemotherapy
4885954|NCT02149784|Resection of primary tumor|resection of primary tumor
4885955|NCT02149771|hepatocellular carcinoma|hepatocellular carcinoma
4885956|NCT02149771|portal vein tumor thrombosis|portal vein tumor thrombosis
4885957|NCT02149771|stents|stents
4885958|NCT02149771|chemoembolization|chemoembolization
4885959|NCT02149758|Cyclooxygenase two inhibitors|cyclooxygenase two inhibitors
4885960|NCT02149758|Etoricoxib|etoricoxib
4885961|NCT02149758|Periodontitis|periodontitis
4885962|NCT02149758|Superoxide dismutase|superoxide dismutase
4885963|NCT02149758|Saliva|saliva
4885964|NCT02149732|Limbal stem cell deficiency|limbal stem cell deficiency
4885965|NCT02149732|Cultivated oral mucosal cell sheet transplantation|cultivated oral mucosal cell sheet transplantation
4885966|NCT02149732|Ocular surface reconstruction|ocular surface reconstruction
4885967|NCT02149719|Peanut allergy|peanut allergy
4885968|NCT02149719|Desensitisation|desensitisation
4885969|NCT02149719|Safety|safety
4885970|NCT02149706|Secondary Progress Multiple Sclerosis|secondary progress multiple sclerosis
4885971|NCT02149706|SPMS|spms
4885972|NCT02149706|Multiple Sclerosis|multiple sclerosis
4885973|NCT02149706|NeuroVax|neurovax
4885974|NCT02149693|Flipped classroom|flipped classroom
4885975|NCT02149693|High-fidelity simulation|high-fidelity simulation
4885976|NCT02149693|Medical education reform|medical education reform
4885977|NCT02149693|Medical teamwork|medical teamwork
4885978|NCT02149693|Resuscitation training|resuscitation training
4885979|NCT02149680|Post-dural puncture headache|post-dural puncture headache
4885980|NCT02149680|epidural blood patch|epidural blood patch
4885981|NCT02149680|labour analgesia|labour analgesia
4885982|NCT02149680|epidural analgesia|epidural analgesia
4885983|NCT02149667|osteoarthritis|osteoarthritis
4885984|NCT02149667|avascular necrosis|avascular necrosis
4885985|NCT02149667|ankylosis|ankylosis
4885986|NCT02149667|protrusio acetabuli|protrusio acetabuli
4885987|NCT02149667|painful hip dysplasia|painful hip dysplasia
4885988|NCT02149667|rheumatoid arthritis|rheumatoid arthritis
4885989|NCT02149667|correction of functional deformity|correction of functional deformity
4885990|NCT02149667|revision procedures|revision procedures
4885991|NCT02149654|Transcatheter aortic valve implantation|transcatheter aortic valve implantation
4885992|NCT02149654|Transcatheter aortic valve replacement|transcatheter aortic valve replacement
4885993|NCT02149654|Engager transcatheter aortic valve implantation system|engager transcatheter aortic valve implantation system
4885994|NCT02149654|Engager bioprosthesis|engager bioprosthesis
4885995|NCT02149615|idiopathic intracranial hypertension|idiopathic intracranial hypertension
4885996|NCT02149615|optic disc swelling|optic disc swelling
4885997|NCT02149615|antiacne medication|antiacne medication
4885998|NCT02149615|isotretinoin|isotretinoin
4885999|NCT02149602|involvement of bilateral parapharyngeal spaces|involvement of bilateral parapharyngeal spaces
4886001|NCT02149589|PEEP|peep
4886002|NCT02149589|Recruitment manoeuvres|recruitment manoeuvres
4886003|NCT02149589|Lung Morphology|lung morphology
4886004|NCT02149576|Retrospective Review|retrospective review
4886005|NCT02149576|Pilot Study|pilot study
4886006|NCT02149576|Early Stage NSCLC|early stage nsclc
4886007|NCT02149576|Post-Surgical Surveillance|post-surgical surveillance
4886008|NCT02149576|Re-intervention Rates|re-intervention rates
4886009|NCT02149550|Plasmodium falciparum|plasmodium falciparum
4886010|NCT02149550|malaria|malaria
4886011|NCT02149537|sickle cell disease|sickle cell disease
4886012|NCT02149537|sickle cell anemia|sickle cell anemia
4886013|NCT02149537|hydroxyurea|hydroxyurea
4886014|NCT02149537|Nigeria|nigeria
4886015|NCT02149537|low income country|low income country
4886016|NCT02149537|middle income country|middle income country
4886017|NCT02149537|developing country|developing country
4886018|NCT02149524|HER2 Positive Breast Cancer|her2 positive breast cancer
4886019|NCT02149524|Trastuzumab|trastuzumab
4886020|NCT02149524|Biosimilar|biosimilar
4886021|NCT02149498|Parkinson|parkinson
4886022|NCT02149498|EEG|eeg
4886023|NCT02149498|BNA|bna
4886024|NCT02149485|PGD,|pgd,
4886025|NCT02149485|follow up|follow up
4886026|NCT02149459|Radiotherapy|radiotherapy
4886027|NCT02149459|Ketosis|ketosis
4886028|NCT02149459|Metformin|metformin
4886029|NCT02149459|Magnetic Resonance Imaging|magnetic resonance imaging
4886030|NCT02149459|Metabolome|metabolome
4886031|NCT02149459|Insulin|insulin
4886032|NCT02149459|recurrent brain tumors|recurrent brain tumors
4886033|NCT02149459|gliomas|gliomas
4886034|NCT02149459|glioblastomas|glioblastomas
4886035|NCT02149459|astrocytomas|astrocytomas
4886036|NCT02149446|Left sided pancreatic resections|left sided pancreatic resections
4886037|NCT02149446|Distal pancreatic resections|distal pancreatic resections
4886038|NCT02149446|Reinforced staple line|reinforced staple line
4886039|NCT02149446|Post operative pancreatic fistula|post operative pancreatic fistula
4886040|NCT02149433|Pneumocystis Jiroveci|pneumocystis jiroveci
4886041|NCT02149433|Steroids|steroids
4886042|NCT02149433|Infants|infants
4886043|NCT02149420|primary Sjögren's syndrome, pharmacodynamics|primary sjögren's syndrome, pharmacodynamics
4886044|NCT02149394|Thirst|thirst
4886045|NCT02149394|Ice|ice
4886046|NCT02149394|Water|water
4886047|NCT02149394|Perioperative Nursing|perioperative nursing
4886048|NCT02149394|Recovery Room|recovery room
4886049|NCT02149381|Depression|depression
4886050|NCT02149381|treatment as usual|treatment as usual
4886051|NCT02149381|CBASP|cbasp
4886052|NCT02149381|befriending|befriending
4886053|NCT02149355|teeth position|teeth position
4886054|NCT02149355|jaw alignment|jaw alignment
4886055|NCT02149342|Actinic keratoses|actinic keratoses
4886056|NCT02149342|Daylight-PDT|daylight-pdt
4886057|NCT02149342|Hexylaminolaevulinate|hexylaminolaevulinate
4886058|NCT02149342|HAL|hal
4886059|NCT02149342|Methylaminolaevulinate|methylaminolaevulinate
4886060|NCT02149342|MAL|mal
4886061|NCT02149342|Hyperspectral imaging|hyperspectral imaging
4886062|NCT02149329|fever|fever
4886063|NCT02149329|neutropenia|neutropenia
4886064|NCT02149329|febrile neutropenia|febrile neutropenia
4886065|NCT02149329|carbapenem|carbapenem
4886066|NCT02149329|imipenem|imipenem
4886067|NCT02149329|meropenem|meropenem
4886068|NCT02149329|antibiotic stewardship|antibiotic stewardship
4886069|NCT02149329|hematology|hematology
4886070|NCT02149329|oncology|oncology
4886071|NCT02149290|Heart Failure|heart failure
4886072|NCT02149290|Six minute walk test|six minute walk test
4886073|NCT02149277|Infertility|infertility
4886074|NCT02149277|IVF|ivf
4886075|NCT02149277|Embryo transfer|embryo transfer
4886076|NCT02149251|Pre-genetic diagnosis|pre-genetic diagnosis
4886077|NCT02149251|ICSI|icsi
4886078|NCT02149238|flavanols|flavanols
4886079|NCT02149238|cardiovascular effects|cardiovascular effects
4886080|NCT02149238|nutrition-nutrition interaction|nutrition-nutrition interaction
4886081|NCT02149225|Actively personalized peptide vaccinations|actively personalized peptide vaccinations
4886082|NCT02149225|Newly diagnosed Glioblastoma|newly diagnosed glioblastoma
4886083|NCT02149225|Concurrent to first line temozolomide maintenance therapy|concurrent to first line temozolomide maintenance therapy
4886084|NCT02149212|Iliac|iliac
4886085|NCT02149212|Vein|vein
4886086|NCT02149212|Stent|stent
4886087|NCT02149160|Histone deacetylase inhibitor|histone deacetylase inhibitor
4886088|NCT02149160|Frontotemporal dementia|frontotemporal dementia
4886089|NCT02149160|Granulin|granulin
4886090|NCT02149147|physical activity|physical activity
4886091|NCT02149147|environmental factors|environmental factors
4886092|NCT02149147|variety|variety
4886093|NCT02149147|MVPA|mvpa
4886094|NCT02149095|treprostinil|treprostinil
4886095|NCT02149082|Intracranial hematoma|intracranial hematoma
4886096|NCT02149082|traumatic brain injury|traumatic brain injury
4886097|NCT02149082|Near infrared spectroscopy|near infrared spectroscopy
4886098|NCT02149082|NIRS|nirs
4886099|NCT02149056|Platelets/Lymphocytes Rate;Serological Index;|platelets/lymphocytes rate;serological index;
4886100|NCT02149043|Inflammatory bowel disease|inflammatory bowel disease
4886101|NCT02149043|Ulcerative Colitis|ulcerative colitis
4886102|NCT02149043|Thermography|thermography
4886103|NCT02149043|Endoscopy|endoscopy
4886104|NCT02149043|CRP|crp
4886105|NCT02149043|Fecal Calprotectin|fecal calprotectin
4886106|NCT02149017|amyloid plaque|amyloid plaque
4886107|NCT02149017|Positron-Emission Tomography|positron-emission tomography
4886108|NCT02149017|radiopharmaceuticals|radiopharmaceuticals
4886109|NCT02149004|Human immunodeficiency virus (HIV)|human immunodeficiency virus (hiv)
4886110|NCT02149004|Prevention|prevention
4886111|NCT02149004|Long-term life|long-term life
4886112|NCT02149004|Cure|cure
4886113|NCT02149004|Cohort|cohort
4886114|NCT02148965|motor activity|motor activity
4886115|NCT02148965|clinical trials|clinical trials
4886116|NCT02148965|pregnancy|pregnancy
4886117|NCT02148965|hypertension|hypertension
4886118|NCT02148965|cohort studies|cohort studies
4886119|NCT02148952|Maternal Health|maternal health
4886120|NCT02148952|Maternal Death|maternal death
4886121|NCT02148952|Maternal Morbidity|maternal morbidity
4886122|NCT02148952|Stillbirth|stillbirth
4886123|NCT02148952|Neonatal Mortality|neonatal mortality
4886124|NCT02148952|Quality Improvement|quality improvement
4886125|NCT02148952|Resource Limited Settings|resource limited settings
4886126|NCT02148952|Checklist|checklist
4886127|NCT02148952|Safe Childbirth|safe childbirth
4886128|NCT02148939|ischemic stroke|ischemic stroke
4886129|NCT02148939|Antiplatelet Effects|antiplatelet effects
4886130|NCT02148939|aspirin|aspirin
4886131|NCT02148939|metamizole|metamizole
4886132|NCT02148939|dipyrone|dipyrone
4886133|NCT02148900|Marfan syndrome|marfan syndrome
4886134|NCT02148900|blood test|blood test
4886135|NCT02148900|aortic root size|aortic root size
4886136|NCT02148900|Marfan related disorders|marfan related disorders
4886137|NCT02148874|pregnant|pregnant
4886138|NCT02148874|flu shot|flu shot
4886139|NCT02148874|influenza|influenza
4886140|NCT02148874|vaccine|vaccine
4886141|NCT02148848|Osteoporosis|osteoporosis
4886142|NCT02148848|Femoral neck fracture|femoral neck fracture
4886143|NCT02148848|hemiarthroplasty|hemiarthroplasty
4886144|NCT02148835|Omega-3 Index|omega-3 index
4886145|NCT02148835|Bioavailability|bioavailability
4886146|NCT02148835|Eicosapentaenoic acid|eicosapentaenoic acid
4886147|NCT02148835|Docosahexaenoic acid|docosahexaenoic acid
4886148|NCT02148835|Fortified food|fortified food
4886149|NCT02148822|Visceral leishmaniasis|visceral leishmaniasis
4886150|NCT02148822|kala azar|kala azar
4886151|NCT02148822|malnutrition|malnutrition
4886152|NCT02148822|stunting|stunting
4886153|NCT02148822|thinness|thinness
4886154|NCT02148822|Leishmania donovani|leishmania donovani
4886155|NCT02148796|Wheezing|wheezing
4886156|NCT02148796|Lower respiratory tract illness|lower respiratory tract illness
4886157|NCT02148796|Asthma|asthma
4886158|NCT02148796|Atopy|atopy
4886159|NCT02148783|Traumatic brain injury|traumatic brain injury
4886160|NCT02148783|Attention deficit and memory problems|attention deficit and memory problems
4886161|NCT02148783|Methylphenidate|methylphenidate
4886162|NCT02148783|Dopamine receptor imaging|dopamine receptor imaging
4886163|NCT02148783|Motivation and reward|motivation and reward
4886164|NCT02148783|Positron emission tomography|positron emission tomography
4886165|NCT02148783|Transcranial magnetic stimulation|transcranial magnetic stimulation
4886166|NCT02148770|rt-fmri|rt-fmri
4886167|NCT02148770|self-control|self-control
4886168|NCT02148770|eating behaviour|eating behaviour
4886169|NCT02148770|overweight|overweight
4886170|NCT02148770|neurofeedback|neurofeedback
4886171|NCT02148757|DVT|dvt
4886172|NCT02148731|Colon cancer|colon cancer
4886173|NCT02148731|Elderly patients|elderly patients
4886174|NCT02148718|Crohn's Disease|crohn's disease
4886175|NCT02148705|fire/flame|fire/flame
4886176|NCT02148705|scalds|scalds
4886177|NCT02148705|contact|contact
4886178|NCT02148679|Heart Failure|heart failure
4886179|NCT02148679|Diet|diet
4886180|NCT02148653|Cardiometabolic risk|cardiometabolic risk
4886181|NCT02148653|Diet|diet
4886182|NCT02148653|Dietary prevention|dietary prevention
4886183|NCT02148653|Functional diet|functional diet
4886184|NCT02148653|Functional foods|functional foods
4886185|NCT02148653|Metabolic Syndrome|metabolic syndrome
4886186|NCT02148653|Overweight|overweight
4886187|NCT02148627|antibody|antibody
4886188|NCT02148627|autoimmune|autoimmune
4886189|NCT02148601|Fecal microbiota transplantation|fecal microbiota transplantation
4886190|NCT02148601|Recurrent C. difficile infection|recurrent c. difficile infection
4886191|NCT02148601|Colonoscopy|colonoscopy
4886192|NCT02148601|Randomized clinical trial|randomized clinical trial
4886193|NCT02148588|Central Post Stroke Pain|central post stroke pain
4886194|NCT02148588|Nerve block|nerve block
4886195|NCT02148575|Palliative Care|palliative care
4886196|NCT02148575|Self-management|self-management
4886197|NCT02148575|Breast Cancer|breast cancer
4886198|NCT02148549|Borderline resectable pancreatic cancer|borderline resectable pancreatic cancer
4886199|NCT02148549|R0 resection|r0 resection
4886200|NCT02148549|Resection rate|resection rate
4886201|NCT02148549|Optimal schedule|optimal schedule
4886202|NCT02148523|Medication Adherence|medication adherence
4886203|NCT02148523|High Blood Pressure|high blood pressure
4886204|NCT02148523|Diabetes|diabetes
4886205|NCT02148523|Statins|statins
4886206|NCT02148510|human|human
4886207|NCT02148510|sleep apnea|sleep apnea
4886208|NCT02148510|adults|adults
4886209|NCT02148510|oral appliance|oral appliance
4886210|NCT02148510|efficacy|efficacy
4886211|NCT02148510|safety|safety
4886212|NCT02148510|polygraphy|polygraphy
4886213|NCT02148510|bruxism|bruxism
4886214|NCT02148510|cost|cost
4886215|NCT02148497|volunteers|volunteers
4886216|NCT02148484|PTSD|ptsd
4886217|NCT02148484|Cognitive Behavioral Treatment|cognitive behavioral treatment
4886218|NCT02148484|Child Sexual Abuse|child sexual abuse
4886219|NCT02148471|Nonalcoholic fatty liver disease|nonalcoholic fatty liver disease
4886220|NCT02148471|Steatosis|steatosis
4886221|NCT02148471|Nonalcoholic steatohepatitis|nonalcoholic steatohepatitis
4886222|NCT02148458|Intermittent fasting|intermittent fasting
4886223|NCT02148458|Mediterranean diet|mediterranean diet
4886224|NCT02148458|overweight|overweight
4886225|NCT02148458|Calorie restriction|calorie restriction
4886226|NCT02148445|smoking cessation|smoking cessation
4886227|NCT02148445|tobacco use cessation products|tobacco use cessation products
4886228|NCT02148445|nicotine|nicotine
4886229|NCT02148432|sleep apnea syndrome, fiberoptic bronchoscopy, IV sedation|sleep apnea syndrome, fiberoptic bronchoscopy, iv sedation
4886230|NCT02148419|quality of life|quality of life
4886231|NCT02148419|maltreatment|maltreatment
4886232|NCT02148419|neglect|neglect
4886233|NCT02148419|childhood|childhood
4886234|NCT02148406|Yoga|yoga
4886235|NCT02148406|Mind-body therapies|mind-body therapies
4886236|NCT02148406|Fatigue|fatigue
4886237|NCT02148406|Colorectal cancer|colorectal cancer
4886238|NCT02148406|Depressive symptoms|depressive symptoms
4886239|NCT02148380|Lung adenocarcinoma,EGFR mutation, chemotherapy, gefitinib|lung adenocarcinoma,egfr mutation, chemotherapy, gefitinib
4886240|NCT02148367|Traumatic brain injury|traumatic brain injury
4886241|NCT02148367|Endothelial progenitor cells|endothelial progenitor cells
4886242|NCT02148367|Cerebrovascular reactivity|cerebrovascular reactivity
4886243|NCT02148367|Angiogenesis|angiogenesis
4886244|NCT02148354|Depression|depression
4886245|NCT02148354|Self-applied treatment|self-applied treatment
4886246|NCT02148354|Internet|internet
4886247|NCT02148354|Support by the therapist|support by the therapist
4886248|NCT02148354|Cognitive-Behavioural Treatment|cognitive-behavioural treatment
4886249|NCT02148354|Positive Psychology|positive psychology
4886250|NCT02148354|Behavioral Activation|behavioral activation
4886251|NCT02148328|Healthy participants|healthy participants
4886252|NCT02148328|Immunogenicity|immunogenicity
4886253|NCT02148328|Influenza|influenza
4886254|NCT02148328|Prevention|prevention
4886255|NCT02148328|Safety|safety
4886256|NCT02148315|physical activity|physical activity
4886257|NCT02148315|children|children
4886258|NCT02148315|school|school
4886259|NCT02148315|garden|garden
4886260|NCT02148302|Venous Leg Ulcerations|venous leg ulcerations
4886261|NCT02148302|Epidermal Grafts|epidermal grafts
4886262|NCT02148302|Chronic wounds|chronic wounds
4886263|NCT02148302|Clinical trial|clinical trial
4886264|NCT02148302|Protease levels in chronic wounds|protease levels in chronic wounds
4886265|NCT02148289|COPD, beetroot, dietary nitrate, nitric oxide|copd, beetroot, dietary nitrate, nitric oxide
4886266|NCT02148276|Social harm detection|social harm detection
4886267|NCT02148276|Instrument development|instrument development
4886268|NCT02148276|HIV-related clinical trials|hiv-related clinical trials
4886269|NCT02148276|Substance abuse|substance abuse
4886270|NCT02148276|Research participation|research participation
4886271|NCT02148263|Contact Lenses|contact lenses
4886272|NCT02148263|Neophytes|neophytes
4886273|NCT02148263|Contact Lens Adaptation|contact lens adaptation
4886274|NCT02148263|Randomized|randomized
4886275|NCT02148250|Type 2 diabetes|type 2 diabetes
4886276|NCT02148250|Insulin resistance|insulin resistance
4886277|NCT02148250|High insulin requirements|high insulin requirements
4886278|NCT02148250|U 500|u 500
4886279|NCT02148237|Breastfeeding duration|breastfeeding duration
4886280|NCT02148237|Puerto Rican mothers|puerto rican mothers
4886281|NCT02148237|WIC program|wic program
4886282|NCT02148237|Home-based individual breastfeeding consultation|home-based individual breastfeeding consultation
4886283|NCT02148224|glycemic index|glycemic index
4886284|NCT02148224|body composition|body composition
4886285|NCT02148211|Fluarix Quadrivalent|fluarix quadrivalent
4886286|NCT02148211|Fluarix|fluarix
4886287|NCT02148211|FluLaval|flulaval
4886288|NCT02148211|FluLaval Quadrivalent|flulaval quadrivalent
4886289|NCT02148211|Pregnancy Registry|pregnancy registry
4886290|NCT02148211|Pregnancy outcome|pregnancy outcome
4886291|NCT02148185|Crohn's disease|crohn's disease
4886292|NCT02148172|Knee|knee
4886293|NCT02148172|plyometrics|plyometrics
4886294|NCT02148172|motor learning|motor learning
4886295|NCT02148172|psychological factors|psychological factors
4886296|NCT02148159|anorexia|anorexia
4886297|NCT02148159|cachexia|cachexia
4886298|NCT02148159|cancer|cancer
4886299|NCT02148159|unintentional weigh loss|unintentional weigh loss
4886300|NCT02148159|gastrointestinal tract|gastrointestinal tract
4886301|NCT02148159|adults|adults
4886302|NCT02148146|short bowel syndrome|short bowel syndrome
4886303|NCT02148146|intestinal failure|intestinal failure
4886304|NCT02148146|total parenteral nutrition associated cholestasis|total parenteral nutrition associated cholestasis
4886305|NCT02148133|Thrombocytopenia|thrombocytopenia
4886306|NCT02148133|Eltrombopag|eltrombopag
4886307|NCT02148133|Aplastic Anemia (AA)|aplastic anemia (aa)
4886308|NCT02148133|Thrombopoietin|thrombopoietin
4886309|NCT02148094|HIV|hiv
4886310|NCT02148094|AIDS|aids
4886311|NCT02148094|India|india
4886312|NCT02148094|Prevention|prevention
4886313|NCT02148094|Female sex workers|female sex workers
4886314|NCT02148094|PrEP|prep
4886315|NCT02148094|Pre-exposure prophylaxis|pre-exposure prophylaxis
4886316|NCT02148094|Truvada|truvada
4886317|NCT02148094|Tenofovir|tenofovir
4886318|NCT02148081|pediatrics, critical illness, recovery, function, health|pediatrics, critical illness, recovery, function, health
4886319|NCT02148068|Obesity|obesity
4886320|NCT02148068|Bariatric Surgery|bariatric surgery
4886321|NCT02148068|Roux-en-y Gastric Bypass|roux-en-y gastric bypass
4886322|NCT02148068|Sleeve Gastrectomy|sleeve gastrectomy
4886323|NCT02148055|spontaneous intrauterine death|spontaneous intrauterine death
4886324|NCT02148055|fetal MRI|fetal mri
4886325|NCT02148055|autopsy|autopsy
4886326|NCT02148042|Anorexia|anorexia
4886327|NCT02148042|Generalized anxiety|generalized anxiety
4886328|NCT02148042|Fear|fear
4886329|NCT02148029|Deep vein thrombosis|deep vein thrombosis
4886330|NCT02148029|Post thrombotic syndrome|post thrombotic syndrome
4886331|NCT02148029|Thrombus resolution|thrombus resolution
4886332|NCT02148016|Corneal disorders|corneal disorders
4886333|NCT02148016|Chemical injury|chemical injury
4886334|NCT02148016|Pterygium|pterygium
4886335|NCT02148016|Refractive error|refractive error
4886336|NCT02148016|Myopia|myopia
4886337|NCT02148016|Hyperopia|hyperopia
4886338|NCT02148016|Cornea|cornea
4886339|NCT02148016|Monocular|monocular
4886340|NCT02148016|Transparent|transparent
4886341|NCT02148016|Transplantation|transplantation
4886342|NCT02148016|Visual function|visual function
4886343|NCT02147990|cancer|cancer
4886344|NCT02147990|metastatic|metastatic
4886345|NCT02147990|locally advanced|locally advanced
4886346|NCT02147990|lung|lung
4886347|NCT02147990|non-small cell lung cancer|non-small cell lung cancer
4886348|NCT02147990|NSCLC|nsclc
4886349|NCT02147990|epidermal growth factor receptor|epidermal growth factor receptor
4886350|NCT02147990|EGFR|egfr
4886351|NCT02147990|T790M|t790m
4886352|NCT02147990|CO-1686|co-1686
4886353|NCT02147990|unresectable|unresectable
4886354|NCT02147990|recurrent|recurrent
4886355|NCT02147990|EGFR-directed therapy|egfr-directed therapy
4886356|NCT02147990|irreversible EGFR inhibitor|irreversible egfr inhibitor
4886357|NCT02147990|TIGER|tiger
4886358|NCT02147990|Rociletinib|rociletinib
4886359|NCT02147977|Renal Dialysis|renal dialysis
4886360|NCT02147977|Arrhythmias Cardiac|arrhythmias cardiac
4886361|NCT02147977|Death Sudden Cardiac|death sudden cardiac
4886362|NCT02147977|Fatty Acids Omega 3|fatty acids omega 3
4886363|NCT02147964|intratesticular androgens|intratesticular androgens
4886364|NCT02147964|testosterone|testosterone
4886365|NCT02147964|dutasteride|dutasteride
4886366|NCT02147964|gonadotropin suppression|gonadotropin suppression
4886367|NCT02147964|male contraception|male contraception
4886368|NCT02147964|spermatogenesis|spermatogenesis
4886369|NCT02147951|Melanoma|melanoma
4886370|NCT02147938|France|france
4886371|NCT02147938|Tacrolimus|tacrolimus
4886372|NCT02147938|Prograf|prograf
4886373|NCT02147938|Observational|observational
4886374|NCT02147938|Advagraf|advagraf
4886375|NCT02147925|Non-alcoholic fatty liver disease|non-alcoholic fatty liver disease
4886376|NCT02147925|Glucagon-like peptide-1 receptor agonists|glucagon-like peptide-1 receptor agonists
4886377|NCT02147925|Diabetes mellitus, type 2|diabetes mellitus, type 2
4886378|NCT02147912|Depression|depression
4886379|NCT02147912|COPD|copd
4886380|NCT02147912|Aerobic Exercise|aerobic exercise
4886381|NCT02147912|Anxiety|anxiety
4886382|NCT02147912|Quality of life|quality of life
4886383|NCT02147912|neurocognitive functioning|neurocognitive functioning
4886384|NCT02147886|Bioblast, Randomized, parallel-group, and dose-controlled|bioblast, randomized, parallel-group, and dose-controlled
4886385|NCT02147873|MDS|mds
4886386|NCT02147873|CMML|cmml
4886387|NCT02147873|myelodysplastic syndrome|myelodysplastic syndrome
4886388|NCT02147873|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
4886389|NCT02147873|TL32711|tl32711
4886390|NCT02147873|TL32711-0094|tl32711-0094
4886391|NCT02147873|azacitidine|azacitidine
4886392|NCT02147873|birinapant|birinapant
4886393|NCT02147873|higher risk|higher risk
4886394|NCT02147873|naive|naive
4886395|NCT02147873|double blind|double blind
4886396|NCT02147873|placebo|placebo
4886397|NCT02147873|placebo controlled|placebo controlled
4886398|NCT02147873|randomized|randomized
4886399|NCT02147860|Diabetes Mellitus, Type 1|diabetes mellitus, type 1
4886400|NCT02147860|Artificial Pancreas Project (APP)|artificial pancreas project (app)
4886401|NCT02147860|Diabetes Assistant (DiAs)|diabetes assistant (dias)
4886402|NCT02147860|Closed-Loop Control (CLC)|closed-loop control (clc)
4886403|NCT02147860|Continuous Glucose Monitor (CGM)|continuous glucose monitor (cgm)
4886404|NCT02147860|Insulin Pump|insulin pump
4886405|NCT02147847|Presbycusis|presbycusis
4886406|NCT02147847|Hearing In Noise|hearing in noise
4886407|NCT02147847|Hearing Impairment|hearing impairment
4886408|NCT02147847|Hearing Loss|hearing loss
4886409|NCT02147847|Aging|aging
4886410|NCT02147847|Plasticity|plasticity
4886411|NCT02147847|Video Games|video games
4886412|NCT02147847|Perceptual Learning|perceptual learning
4886413|NCT02147834|deferred percutaneous coronary intervention|deferred percutaneous coronary intervention
4886414|NCT02147834|fractional flow reserve|fractional flow reserve
4886415|NCT02147795|Patient Blood Management|patient blood management
4886416|NCT02147795|Red Blood Cell Transfusion Practice|red blood cell transfusion practice
4886417|NCT02147795|Patient Safety|patient safety
4886418|NCT02147795|Anemia|anemia
4886419|NCT02147795|Clinical Outcome|clinical outcome
4886420|NCT02147795|perioperative care|perioperative care
4886421|NCT02147782|chronic renal insufficient, renal osteodystrophy, bone mineral density, bone turnover, kidney function|chronic renal insufficient, renal osteodystrophy, bone mineral density, bone turnover, kidney function
4886422|NCT02147769|cerebral autoregulation|cerebral autoregulation
4886423|NCT02147769|preterm|preterm
4886424|NCT02147769|near-infrared spectroscopy|near-infrared spectroscopy
4886425|NCT02147756|Skin pigmentation, skin texture disorders, fractional laser, CO2, fractional CO2, Syneron, Solta.|skin pigmentation, skin texture disorders, fractional laser, co2, fractional co2, syneron, solta.
4886426|NCT02147743|Adolescents|adolescents
4886427|NCT02147743|Family-Based treatment|family-based treatment
4886428|NCT02147743|Multidimensional Family Therapy|multidimensional family therapy
4886429|NCT02147730|chronic pain|chronic pain
4886430|NCT02147717|preterm newborns|preterm newborns
4886431|NCT02147717|Transfontanellar ultrafast doppler|transfontanellar ultrafast doppler
4886432|NCT02147717|Acupuncture|acupuncture
4886433|NCT02147717|perioperative pain|perioperative pain
4886434|NCT02147717|surgery of the ductus arteriosus|surgery of the ductus arteriosus
4886435|NCT02147665|Hookah|hookah
4886436|NCT02147665|waterpipe|waterpipe
4886437|NCT02147665|smoking|smoking
4886438|NCT02147665|sympathetic|sympathetic
4886539|NCT02147184|adolescents|adolescents
4886439|NCT02147652|moderate dementia|moderate dementia
4886440|NCT02147652|severe dementia|severe dementia
4886441|NCT02147652|Alzheimer's disease|alzheimer's disease
4886442|NCT02147652|Vascular dementia|vascular dementia
4886443|NCT02147652|agitation|agitation
4886444|NCT02147652|personalized music therapy|personalized music therapy
4886445|NCT02147626|preeclampsia|preeclampsia
4886446|NCT02147626|cardiovascular disease|cardiovascular disease
4886447|NCT02147626|health behaviors|health behaviors
4886448|NCT02147626|behavioral intervention|behavioral intervention
4886449|NCT02147626|web-based|web-based
4886450|NCT02147626|Hypertension|hypertension
4886451|NCT02147626|Post-partum Weight Retention|post-partum weight retention
4886452|NCT02147600|adalimumab|adalimumab
4886453|NCT02147600|biologicals|biologicals
4886454|NCT02147600|immunogenicity|immunogenicity
4886455|NCT02147574|slow-transit constipation|slow-transit constipation
4886456|NCT02147574|laparoscope Sub-total Colectomy|laparoscope sub-total colectomy
4886457|NCT02147574|anti-peristaltic anastomosis|anti-peristaltic anastomosis
4886458|NCT02147522|community health worker|community health worker
4886459|NCT02147522|promotoras|promotoras
4886460|NCT02147522|self-care behaviors activation|self-care behaviors activation
4886461|NCT02147522|depression|depression
4886462|NCT02147522|low-income patients|low-income patients
4886463|NCT02147522|safety-net care|safety-net care
4886464|NCT02147509|Dry eye|dry eye
4886465|NCT02147509|Therapeutic bandage contact lenses|therapeutic bandage contact lenses
4886466|NCT02147509|The quality of life|the quality of life
4886467|NCT02147496|Food intake|food intake
4886468|NCT02147496|Appetite|appetite
4886469|NCT02147496|Blood glucose|blood glucose
4886470|NCT02147496|Insulin|insulin
4886471|NCT02147496|Dairy|dairy
4886472|NCT02147496|Milk|milk
4886473|NCT02147483|Mindfulness|mindfulness
4886474|NCT02147483|Alcohol use disorders|alcohol use disorders
4886475|NCT02147470|cirrhosis of the liver|cirrhosis of the liver
4886476|NCT02147470|Acute kidney injury|acute kidney injury
4886477|NCT02147457|Prematurity|prematurity
4886478|NCT02147457|Extremely low birth weight|extremely low birth weight
4886479|NCT02147457|Phenotyping|phenotyping
4886480|NCT02147444|Rivaroxaban|rivaroxaban
4886481|NCT02147444|Non-valvular atrial fibrillation|non-valvular atrial fibrillation
4886482|NCT02147444|NOAC|noac
4886483|NCT02147444|Xa inhibitor|xa inhibitor
4886484|NCT02147418|Head and neck cancer|head and neck cancer
4886485|NCT02147418|Throat cancer|throat cancer
4886486|NCT02147418|Human papillomavirus|human papillomavirus
4886487|NCT02147418|HPV|hpv
4886488|NCT02147418|Exosome|exosome
4886489|NCT02147418|Diagnostic|diagnostic
4886490|NCT02147418|Early Detection|early detection
4886491|NCT02147405|FDG PET/CT Scan|fdg pet/ct scan
4886492|NCT02147405|Lymph Node Biopsy|lymph node biopsy
4886493|NCT02147405|Apheresis|apheresis
4886494|NCT02147392|PET Imaging|pet imaging
4886495|NCT02147379|Bipolar Disorder|bipolar disorder
4886496|NCT02147379|Cognition|cognition
4886497|NCT02147379|Euthymic|euthymic
4886498|NCT02147379|Lurasidone|lurasidone
4886499|NCT02147366|Hypertension,ambulatory pressure,autonomic function,music|hypertension,ambulatory pressure,autonomic function,music
4886500|NCT02147353|External Genital Warts|external genital warts
4886501|NCT02147353|Sinecatechins|sinecatechins
4886502|NCT02147353|Cryotherapy|cryotherapy
4886503|NCT02147340|Heart Failure patients|heart failure patients
4886504|NCT02147340|Remote Patient Management|remote patient management
4886505|NCT02147340|External Sensors|external sensors
4886506|NCT02147327|vitamin D|vitamin d
4886507|NCT02147327|cord blood|cord blood
4886508|NCT02147327|neonatal sepsis|neonatal sepsis
4886509|NCT02147327|neonatal morbidity|neonatal morbidity
4886510|NCT02147314|diabetes|diabetes
4886511|NCT02147314|glucometer|glucometer
4886512|NCT02147314|Yofimeter|yofimeter
4886513|NCT02147314|diabetes monitoring|diabetes monitoring
4886514|NCT02147275|hypertension|hypertension
4886515|NCT02147275|cerebral oxygen saturation|cerebral oxygen saturation
4886516|NCT02147275|near-infrared spectroscopy|near-infrared spectroscopy
4886517|NCT02147275|cognitive function|cognitive function
4886518|NCT02147262|chronic atrophic acrodermatitis|chronic atrophic acrodermatitis
4886519|NCT02147262|Lyme borreliosis|lyme borreliosis
4886520|NCT02147262|molecular characteristics|molecular characteristics
4886521|NCT02147262|outcome|outcome
4886522|NCT02147249|erythema migrans|erythema migrans
4886523|NCT02147249|Lyme borreliosis|lyme borreliosis
4886524|NCT02147249|inflammation|inflammation
4886525|NCT02147249|outcome|outcome
4886526|NCT02147236|autism|autism
4886527|NCT02147236|pervasive developmental disorders|pervasive developmental disorders
4886528|NCT02147236|social skills intervention|social skills intervention
4886529|NCT02147223|flavanols|flavanols
4886530|NCT02147223|sex-related cardiovascular effects|sex-related cardiovascular effects
4886531|NCT02147210|Chronic transplant glomerulopathy|chronic transplant glomerulopathy
4886532|NCT02147210|antibody mediated rejection|antibody mediated rejection
4886533|NCT02147210|Ephrin-B1|ephrin-b1
4886534|NCT02147184|SSRI|ssri
4886535|NCT02147184|serotonin transporter|serotonin transporter
4886536|NCT02147184|DXA|dxa
4886537|NCT02147184|pQCT|pqct
4886538|NCT02147184|bone mass|bone mass
4886540|NCT02147171|Retinal ageing, macular pigment, visual function|retinal ageing, macular pigment, visual function
4886541|NCT02147145|GIST|gist
4886542|NCT02147145|endoscopy|endoscopy
4886543|NCT02147145|endoscopic ultrasound|endoscopic ultrasound
4886544|NCT02147132|Cigarette|cigarette
4886545|NCT02147132|Methadone|methadone
4886546|NCT02147132|Smoking|smoking
4886547|NCT02147132|Cessation|cessation
4886548|NCT02147132|Varenicline|varenicline
4886549|NCT02147132|Nicotine|nicotine
4886550|NCT02147106|Neuroendocrine tumor|neuroendocrine tumor
4886551|NCT02147106|Videoconsultation|videoconsultation
4886552|NCT02147106|Feasibility|feasibility
4886553|NCT02147080|prevention or control|prevention or control
4886554|NCT02147067|microvascular angina|microvascular angina
4886555|NCT02147067|coronary microvascular disease|coronary microvascular disease
4886556|NCT02147067|coronary physiology|coronary physiology
4886557|NCT02147067|ranolazine|ranolazine
4886558|NCT02147054|Organophosphate poisoning|organophosphate poisoning
4886559|NCT02147054|Intermediate syndrome|intermediate syndrome
4886560|NCT02147054|Rocuronium|rocuronium
4886561|NCT02147041|diabetes mellitus|diabetes mellitus
4886562|NCT02147041|hyperlipidemia|hyperlipidemia
4886563|NCT02147041|green tea|green tea
4886564|NCT02147041|epigallocatechin gallate|epigallocatechin gallate
4886565|NCT02147028|whole brain RT|whole brain rt
4886566|NCT02147028|hippocampal sparing|hippocampal sparing
4886567|NCT02147028|neurocognitive function|neurocognitive function
4886568|NCT02147015|Acute Exacerbations|acute exacerbations
4886569|NCT02147015|Corticosteroids|corticosteroids
4886570|NCT02147015|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
4886571|NCT02147015|Doses|doses
4886572|NCT02147002|Chronic Kidney Disease|chronic kidney disease
4886573|NCT02147002|Cardiovascular Complications|cardiovascular complications
4886574|NCT02146989|Cerebral Palsy|cerebral palsy
4886575|NCT02146989|child|child
4886576|NCT02146989|upper extremity|upper extremity
4886577|NCT02146989|strength, reproducibility|strength, reproducibility
4886578|NCT02146976|postoperative|postoperative
4886579|NCT02146976|sleep quality|sleep quality
4886580|NCT02146976|propofol|propofol
4886581|NCT02146976|sevoflurane|sevoflurane
4886582|NCT02146950|LCS-12|lcs-12
4886583|NCT02146950|Intrauterine Device (IUD)|intrauterine device (iud)
4886584|NCT02146950|Intrauterine System (IUS)|intrauterine system (ius)
4886585|NCT02146950|Levonorgestrel|levonorgestrel
4886586|NCT02146950|Pearl Index|pearl index
4886587|NCT02146950|Hormonal Contraception|hormonal contraception
4886588|NCT02146937|active surveillance|active surveillance
4886589|NCT02146937|MRI/transrectal ultrasound fusion guided biopsy|mri/transrectal ultrasound fusion guided biopsy
4886590|NCT02146937|biopsy|biopsy
4886591|NCT02146911|Smoking Cessation Medication|smoking cessation medication
4886592|NCT02146911|Smoking Treatment|smoking treatment
4886593|NCT02146911|Tobacco Treatment|tobacco treatment
4886594|NCT02146911|Quitting Smoking|quitting smoking
4886595|NCT02146911|Bupropion|bupropion
4886596|NCT02146911|Varenicline|varenicline
4886597|NCT02146911|Efficacy|efficacy
4886598|NCT02146911|Pharmacogenetics of Smoking Treatment|pharmacogenetics of smoking treatment
4886599|NCT02146911|Genetics analysis|genetics analysis
4886600|NCT02146911|Smoking Personality|smoking personality
4886601|NCT02146911|Dependence|dependence
4886602|NCT02146911|Addiction|addiction
4886603|NCT02146911|Cigarettes|cigarettes
4886604|NCT02146911|Primary Care Physicians|primary care physicians
4886605|NCT02146911|Biochemical Confirmation|biochemical confirmation
4886606|NCT02146898|spinal anesthesia|spinal anesthesia
4886607|NCT02146898|hypotension|hypotension
4886608|NCT02146898|pregnancy|pregnancy
4886609|NCT02146872|Coronary Artery Disease|coronary artery disease
4886610|NCT02146872|Myocardial Infarction|myocardial infarction
4886611|NCT02146872|Atherosclerosis|atherosclerosis
4886612|NCT02146872|High-Throughput Nucleotide Sequencing|high-throughput nucleotide sequencing
4886613|NCT02146872|Sequence Analysis, DNA|sequence analysis, dna
4886614|NCT02146872|Genetic Testing|genetic testing
4886615|NCT02146872|Genetic Linkage|genetic linkage
4886616|NCT02146859|residual neuromuscular blockade|residual neuromuscular blockade
4886617|NCT02146846|cml|cml
4886618|NCT02146833|castrate-resistant prostate cancer|castrate-resistant prostate cancer
4886619|NCT02146833|prostate cancer|prostate cancer
4886620|NCT02146833|Karyopharm|karyopharm
4886621|NCT02146833|KPT-330|kpt-330
4886622|NCT02146833|selinexor|selinexor
4886623|NCT02146820|Pigmented Lesions, Skin Pigment, Picosecond Laser, Syneron|pigmented lesions, skin pigment, picosecond laser, syneron
4886624|NCT02146807|Tattoos, Picosecond Laser, Syneron|tattoos, picosecond laser, syneron
4886625|NCT02146742|ASP1707|asp1707
4886626|NCT02146742|Japanese subjects|japanese subjects
4886627|NCT02146742|Safety|safety
4886628|NCT02146742|Pharmacokinetics|pharmacokinetics
4886629|NCT02146742|Pharmacodynamics|pharmacodynamics
4886630|NCT02146729|Randomized|randomized
4886631|NCT02146729|Thoracolumbar fractures|thoracolumbar fractures
4886632|NCT02146729|Spine Trauma|spine trauma
4886633|NCT02146729|Percutaneous Pedicle Screw Fixation|percutaneous pedicle screw fixation
4886634|NCT02146729|Functional Outcome|functional outcome
4886635|NCT02146716|RESC, alcohol withdrawal syndrome|resc, alcohol withdrawal syndrome
4886636|NCT02146703|biliary tract neoplasm|biliary tract neoplasm
4886637|NCT02146703|gemcitabine|gemcitabine
4886638|NCT02146703|S-1|s-1
4886639|NCT02146690|pathology|pathology
4886640|NCT02146690|newborn|newborn
4886641|NCT02146690|osteopathic manipulative treatment|osteopathic manipulative treatment
4886642|NCT02146690|pain|pain
4886643|NCT02146677|prematurity|prematurity
4886644|NCT02146677|newborns|newborns
4886645|NCT02146677|pain|pain
4886646|NCT02146677|cost|cost
4886647|NCT02146664|Acute NSTEMI|acute nstemi
4886648|NCT02146664|DLBS1033|dlbs1033
4886649|NCT02146664|SPECT|spect
4886650|NCT02146664|Infarct size|infarct size
4886651|NCT02146664|Left ventricular function|left ventricular function
4886652|NCT02146638|post operative analgesia, morphine, fentanyl|post operative analgesia, morphine, fentanyl
4886653|NCT02146573|Intensive Care Units, Pediatric|intensive care units, pediatric
4886654|NCT02146573|Communication|communication
4886655|NCT02146573|Health personnel|health personnel
4886656|NCT02146573|Decision making|decision making
4886657|NCT02146573|Critical Care|critical care
4886658|NCT02146573|Length of Stay|length of stay
4886659|NCT02146573|Iatrogenic Disease|iatrogenic disease
4886660|NCT02146560|Surgery|surgery
4886661|NCT02146560|Non-cardiac|non-cardiac
4886662|NCT02146560|Elective|elective
4886663|NCT02146560|Adult|adult
4886664|NCT02146560|Patients|patients
4886665|NCT02146560|Troponin|troponin
4886666|NCT02146560|Myocardial|myocardial
4886667|NCT02146560|Injury|injury
4886668|NCT02146560|Postoperative|postoperative
4886669|NCT02146560|Recovery|recovery
4886670|NCT02146560|Outcome|outcome
4886671|NCT02146547|depot, oral, antipsychotics, paliperidone, aripiprazole|depot, oral, antipsychotics, paliperidone, aripiprazole
4886672|NCT02146521|z-axis limited CT|z-axis limited ct
4886673|NCT02146521|computed tomography|computed tomography
4886674|NCT02146521|CT|ct
4886675|NCT02146521|abdominal non-traumatic pain and tenderness|abdominal non-traumatic pain and tenderness
4886676|NCT02146521|emergency patients|emergency patients
4886677|NCT02146508|Esophageal cancer|esophageal cancer
4886678|NCT02146508|Radiofrequency, catheter ablation|radiofrequency, catheter ablation
4886679|NCT02146508|Endoscopic mucosal resection|endoscopic mucosal resection
4886680|NCT02146508|Esophageal squamous dysplasia|esophageal squamous dysplasia
4886681|NCT02146508|Cancer prevention|cancer prevention
4886682|NCT02146482|back pain|back pain
4886683|NCT02146482|low back pain|low back pain
4886684|NCT02146482|sit-stand workstation|sit-stand workstation
4886685|NCT02146482|standing desk|standing desk
4886686|NCT02146469|varicella vaccination|varicella vaccination
4886687|NCT02146443|Manual dexterity|manual dexterity
4886688|NCT02146443|hand to eye coordination|hand to eye coordination
4886689|NCT02146443|stress|stress
4886690|NCT02146443|fatigue|fatigue
4886691|NCT02146430|pain|pain
4886692|NCT02146430|fibromyalgia|fibromyalgia
4886693|NCT02146417|Low pressure pneumoperitoneum|low pressure pneumoperitoneum
4886694|NCT02146417|Deep neuromuscular block|deep neuromuscular block
4886695|NCT02146404|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
4886696|NCT02146404|Hypoglycemia unawareness|hypoglycemia unawareness
4886697|NCT02146404|1H MRS|1h mrs
4886698|NCT02146404|Lactate|lactate
4886699|NCT02146352|Pancreatic pseudocyst|pancreatic pseudocyst
4886700|NCT02146339|nutrition|nutrition
4886701|NCT02146339|milk|milk
4886702|NCT02146339|polar lipids|polar lipids
4886703|NCT02146339|cardiometabolic risk|cardiometabolic risk
4886704|NCT02146300|birch pollen|birch pollen
4886705|NCT02146300|allergy|allergy
4886706|NCT02146300|breathing|breathing
4886707|NCT02146300|pattern|pattern
4886708|NCT02146300|exposure|exposure
4886709|NCT02146287|cycled light|cycled light
4886710|NCT02146287|preterm infants|preterm infants
4886711|NCT02146287|infant neurodevelopment|infant neurodevelopment
4886712|NCT02146287|infant sleep|infant sleep
4886713|NCT02146274|PROSPER|prosper
4886714|NCT02146274|Stroke|stroke
4886715|NCT02146274|Ischemic Stroke|ischemic stroke
4886716|NCT02146261|Volunteers|volunteers
4886717|NCT02146261|Japanese|japanese
4886718|NCT02146261|Males|males
4886719|NCT02146248|hysterosalpingography, DMPA, combined oral contraceptive, tubal patency|hysterosalpingography, dmpa, combined oral contraceptive, tubal patency
4886720|NCT02146235|Music Therapy|music therapy
4886721|NCT02146235|Pulmonary Disease|pulmonary disease
4886722|NCT02146235|COPD|copd
4886723|NCT02146235|Music Visualization|music visualization
4886724|NCT02146235|Therapeutic Singing|therapeutic singing
4886725|NCT02146235|Wind-playing|wind-playing
4886726|NCT02146235|Lung Condition|lung condition
4886727|NCT02146196|Heart failure|heart failure
4886728|NCT02146196|robotic assisted gait therapy|robotic assisted gait therapy
4886729|NCT02146183|Stevio glycosides|stevio glycosides
4886730|NCT02146183|sport|sport
4886731|NCT02146183|glycogen|glycogen
4886732|NCT02146170|Sample Acquisition|sample acquisition
4886733|NCT02146170|Generic and Epigenetic Alterations|generic and epigenetic alterations
4886734|NCT02146170|Mig6 Expression|mig6 expression
4886735|NCT02146170|Proteomic Analysis|proteomic analysis
4886736|NCT02146170|Genomic Analysis|genomic analysis
4886737|NCT02146144|Idiopathic epimacular membrane|idiopathic epimacular membrane
4887028|NCT02145000|Diarrhea|diarrhea
4886738|NCT02146144|internal limiting membrane peeling|internal limiting membrane peeling
4886739|NCT02146144|microscotomas|microscotomas
4886740|NCT02146131|Peripheral pulmonary lesions|peripheral pulmonary lesions
4886741|NCT02146131|Solitary pulmonary lesions|solitary pulmonary lesions
4886742|NCT02146131|Multiple pulmonary lesions|multiple pulmonary lesions
4886743|NCT02146118|Erlotinib|erlotinib
4886744|NCT02146118|Silybin-phytosome|silybin-phytosome
4886745|NCT02146118|EGFR mutant lung adenocarcinoma|egfr mutant lung adenocarcinoma
4886746|NCT02146092|lung resection|lung resection
4886747|NCT02146092|incentive spirometry|incentive spirometry
4886748|NCT02146092|physiotherapy|physiotherapy
4886749|NCT02146092|quality improvement|quality improvement
4886750|NCT02146092|outcomes|outcomes
4886751|NCT02146092|post operative complications|post operative complications
4886752|NCT02146066|GBM|gbm
4886753|NCT02146066|Brain tumor|brain tumor
4886754|NCT02146066|glioblastoma|glioblastoma
4886755|NCT02146066|Brain tumor WHO grade IV|brain tumor who grade iv
4886756|NCT02146053|healthy participants|healthy participants
4886757|NCT02146053|gastrointestinal side-effects associated with oral iron|gastrointestinal side-effects associated with oral iron
4886758|NCT02146040|anticoagulation|anticoagulation
4886759|NCT02146040|atrial fibrillation|atrial fibrillation
4886760|NCT02146040|cardioversion|cardioversion
4886761|NCT02146040|complications|complications
4886762|NCT02146040|hemorrhage|hemorrhage
4886763|NCT02146040|medications|medications
4886764|NCT02146040|thromboembolism|thromboembolism
4886765|NCT02146040|TIA|tia
4886766|NCT02146040|stroke|stroke
4886767|NCT02146040|treatment|treatment
4886768|NCT02146027|HIV|hiv
4886769|NCT02146027|Lactobacillus casei Shirota|lactobacillus casei shirota
4886770|NCT02146027|NK cell|nk cell
4886771|NCT02146027|CD4|cd4
4886772|NCT02146027|Lymphocyte|lymphocyte
4886773|NCT02146027|Cell activation|cell activation
4886774|NCT02146027|Antiretroviral therapy|antiretroviral therapy
4886775|NCT02146027|Immune discordants|immune discordants
4886776|NCT02146014|cigarette smoking, smoking|cigarette smoking, smoking
4886777|NCT02146001|sedentary behavior|sedentary behavior
4886778|NCT02146001|physical activity|physical activity
4886779|NCT02146001|older adults|older adults
4886780|NCT02145988|DLBS1033|dlbs1033
4886781|NCT02145988|Peripheral arterial disease|peripheral arterial disease
4886782|NCT02145988|Ankle-brachial index|ankle-brachial index
4886783|NCT02145975|Severe postoperative pain|severe postoperative pain
4886784|NCT02145975|Morphine|morphine
4886785|NCT02145975|Fentanyl|fentanyl
4886786|NCT02145975|Time to titration of pain|time to titration of pain
4886787|NCT02145975|Pain and PACU|pain and pacu
4886788|NCT02145975|Anesthesiology|anesthesiology
4886789|NCT02145962|diabetic foot ulcer healing|diabetic foot ulcer healing
4886790|NCT02145962|magnetic therapy|magnetic therapy
4886791|NCT02145962|safety and efficacy|safety and efficacy
4886792|NCT02145962|wound care|wound care
4886793|NCT02145949|aging|aging
4886794|NCT02145949|clinical|clinical
4886795|NCT02145949|translational|translational
4886796|NCT02145949|functional mobility|functional mobility
4886797|NCT02145949|total knee arthroplasty|total knee arthroplasty
4886798|NCT02145936|fatty acid|fatty acid
4886799|NCT02145923|Hodgkin Lymphoma|hodgkin lymphoma
4886800|NCT02145923|Non-Hodgkin's Lymphomas|non-hodgkin's lymphomas
4886801|NCT02145923|Allogeneic Mesenchymal Stem Cell Transplantation|allogeneic mesenchymal stem cell transplantation
4886802|NCT02145923|Autologous Peripheral Blood Stem Cell Transplantation|autologous peripheral blood stem cell transplantation
4886803|NCT02145923|Neutropenic Enterocolitis|neutropenic enterocolitis
4886804|NCT02145923|Myeloablative Chemotherapy|myeloablative chemotherapy
4886805|NCT02145923|Bone Marrow Aplasia|bone marrow aplasia
4886806|NCT02145897|CLI|cli
4886807|NCT02145884|hemangioma|hemangioma
4886808|NCT02145884|birthmark|birthmark
4886809|NCT02145884|strawberry hemangioma|strawberry hemangioma
4886810|NCT02145884|timolol|timolol
4886811|NCT02145871|Radical Cystectomy|radical cystectomy
4886812|NCT02145871|Perioperative Fluid Management|perioperative fluid management
4886813|NCT02145871|EV1000|ev1000
4886814|NCT02145871|14-069|14-069
4886815|NCT02145858|atrial fibrillation, pericardial effusion, pleural effusion|atrial fibrillation, pericardial effusion, pleural effusion
4886816|NCT02145845|critical limb ischemia|critical limb ischemia
4886817|NCT02145845|wound healing|wound healing
4886818|NCT02145845|amputation|amputation
4886819|NCT02145832|TINN|tinn
4886820|NCT02145832|Pharmacokinetic|pharmacokinetic
4886821|NCT02145832|Neonates|neonates
4886822|NCT02145832|Antifungal|antifungal
4886823|NCT02145832|Fluconazole|fluconazole
4886824|NCT02145832|Micafungin|micafungin
4886825|NCT02145806|Urinary incontinence|urinary incontinence
4886826|NCT02145806|Validation study|validation study
4886827|NCT02145806|Pregnant women|pregnant women
4886828|NCT02145806|Postpartum period|postpartum period
4886829|NCT02145793|primary care|primary care
4886830|NCT02145793|pediatrics|pediatrics
4886831|NCT02145793|parenting|parenting
4886832|NCT02145793|education|education
4886833|NCT02145780|Overfeeding|overfeeding
4886834|NCT02145780|Fat distribution|fat distribution
4886835|NCT02145780|Subcutaneous and visceral adipose tissue|subcutaneous and visceral adipose tissue
4887029|NCT02145000|Vaccine|vaccine
4886836|NCT02145780|Insulin sensitivity|insulin sensitivity
4886837|NCT02145780|Insulin resistance|insulin resistance
4886838|NCT02145780|Peripheral and hepatic insulin sensitivity|peripheral and hepatic insulin sensitivity
4886839|NCT02145780|Stable isotopes|stable isotopes
4886840|NCT02145780|Lipid oxidation|lipid oxidation
4886841|NCT02145780|Energy expenditure|energy expenditure
4886842|NCT02145780|Muscle and subcutaneous adipose tissue gene expression|muscle and subcutaneous adipose tissue gene expression
4886843|NCT02145754|erythema migrans|erythema migrans
4886844|NCT02145754|Lyme borreliosis|lyme borreliosis
4886845|NCT02145754|Borrelia burgdorferi|borrelia burgdorferi
4886846|NCT02145754|skin culture|skin culture
4886847|NCT02145754|culture media|culture media
4886848|NCT02145728|Non-specific chronic low back pain|non-specific chronic low back pain
4886849|NCT02145728|Cognitive functional therapy|cognitive functional therapy
4886850|NCT02145728|Exercise classes|exercise classes
4886851|NCT02145702|ESRD|esrd
4886852|NCT02145702|Kidney Failure|kidney failure
4886853|NCT02145702|Exercise|exercise
4886854|NCT02145702|Cognitive impairment|cognitive impairment
4886855|NCT02145637|Cancer, Lung cancer, Head and neck squamous cell carcinoma, Afatinib, Ruxolitinib, EGFR, JAK, STAT|cancer, lung cancer, head and neck squamous cell carcinoma, afatinib, ruxolitinib, egfr, jak, stat
4886856|NCT02145624|pertussis|pertussis
4886857|NCT02145624|maternal vaccination|maternal vaccination
4886858|NCT02145624|maternal immunisation|maternal immunisation
4886859|NCT02145624|immune response|immune response
4886860|NCT02145611|hypertension, diabetes, endothelial function|hypertension, diabetes, endothelial function
4886861|NCT02145598|Multiple Myeloma|multiple myeloma
4886862|NCT02145598|Revlimid|revlimid
4886863|NCT02145598|Lenalidomide maintenance|lenalidomide maintenance
4886864|NCT02145585|Cardiac surgery|cardiac surgery
4886865|NCT02145585|Robotic pharmacological anesthesia|robotic pharmacological anesthesia
4886866|NCT02145585|Anesthesia|anesthesia
4886867|NCT02145546|Pacing dependent|pacing dependent
4886868|NCT02145546|Atrial Fibrillation|atrial fibrillation
4886869|NCT02145546|Amiodarone|amiodarone
4886870|NCT02145546|Propafenone|propafenone
4886871|NCT02145546|Sotalol|sotalol
4886872|NCT02145546|AF burden|af burden
4886873|NCT02145533|MMP|mmp
4886874|NCT02145533|NGAL|ngal
4886875|NCT02145533|Arterial Aneurysms|arterial aneurysms
4886876|NCT02145520|bronchiolitis|bronchiolitis
4886877|NCT02145507|Leukoreduction|leukoreduction
4886878|NCT02145507|Red Blood Cell post-leukoreduction recovery|red blood cell post-leukoreduction recovery
4886879|NCT02145507|Packed red blood cell post storage hemolysis|packed red blood cell post storage hemolysis
4886880|NCT02145507|Red blood cell recovery|red blood cell recovery
4886881|NCT02145507|Plasma clotting factors|plasma clotting factors
4886882|NCT02145507|2,3-DPG rejuvenation|2,3-dpg rejuvenation
4886883|NCT02145494|SBRT (stereotactic body radiotherapy)|sbrt (stereotactic body radiotherapy)
4886884|NCT02145494|Focal boost|focal boost
4886885|NCT02145494|Prostate|prostate
4886886|NCT02145481|coronary artery disease|coronary artery disease
4886887|NCT02145481|decision quality|decision quality
4886888|NCT02145481|decision making|decision making
4886889|NCT02145481|survey|survey
4886890|NCT02145481|measure development|measure development
4886891|NCT02145481|patient-centered care|patient-centered care
4886892|NCT02145481|cardiology|cardiology
4886893|NCT02145481|heart disease|heart disease
4886894|NCT02145468|Myocardial infarction|myocardial infarction
4886895|NCT02145468|Acute coronary syndrome|acute coronary syndrome
4886896|NCT02145468|Cardiovascular disease|cardiovascular disease
4886897|NCT02145468|p38 mitogen-activated protein kinase (MAPK) inhibitor|p38 mitogen-activated protein kinase (mapk) inhibitor
4886898|NCT02145468|NSTEMI|nstemi
4886899|NCT02145468|Losmapimod|losmapimod
4886900|NCT02145468|STEMI|stemi
4886901|NCT02145455|Arthroplasty, Replacement, Knee/methods|arthroplasty, replacement, knee/methods
4886902|NCT02145455|Knee Joint/physiopathology|knee joint/physiopathology
4886903|NCT02145455|Knee Joint/radiography|knee joint/radiography
4886904|NCT02145455|Knee Joint/surgery|knee joint/surgery
4886905|NCT02145455|Knee Prosthesis|knee prosthesis
4886906|NCT02145455|Outcome Assessment (Health Care)|outcome assessment (health care)
4886907|NCT02145455|Female|female
4886908|NCT02145455|Male|male
4886909|NCT02145455|Adult|adult
4886910|NCT02145442|Impaired fasting glucose|impaired fasting glucose
4886911|NCT02145442|Prediabetes|prediabetes
4886912|NCT02145442|Obesity|obesity
4886913|NCT02145442|Overweight|overweight
4886914|NCT02145442|Insulin sensitivity|insulin sensitivity
4886915|NCT02145442|Weight loss|weight loss
4886916|NCT02145442|Nutritional supplement|nutritional supplement
4886917|NCT02145442|Waist|waist
4886918|NCT02145442|Body composition|body composition
4886919|NCT02145429|Prevention of depression and anxiety disorder|prevention of depression and anxiety disorder
4886920|NCT02145429|Depression Prevention|depression prevention
4886921|NCT02145416|Imaging|imaging
4886922|NCT02145416|Chemoradiotherapy|chemoradiotherapy
4886923|NCT02145403|Allogeneic Transplantation|allogeneic transplantation
4886924|NCT02145403|Carfilzomib|carfilzomib
4886925|NCT02145403|Relapse|relapse
4886926|NCT02145403|Graft-Versus-Host Disease|graft-versus-host disease
4886927|NCT02145403|Multiple Myeloma|multiple myeloma
4886928|NCT02145403|Lymphoma|lymphoma
4886929|NCT02145403|Leukemia|leukemia
4886930|NCT02145390|Bladder Cancer|bladder cancer
4886931|NCT02145390|Bladder Carcinoma|bladder carcinoma
4886932|NCT02145390|Transition Cell Cancer|transition cell cancer
4886933|NCT02145390|TCC|tcc
4886934|NCT02145390|Muscle Invasive Bladder Carcinoma|muscle invasive bladder carcinoma
4886935|NCT02145377|Cholera|cholera
4886936|NCT02145377|Vaccine|vaccine
4886937|NCT02145377|Mali|mali
4886938|NCT02145364|Ulthera System®|ulthera system®
4886939|NCT02145364|Ultherapy®|ultherapy®
4886940|NCT02145364|Ulthera, Inc.|ulthera, inc.
4886941|NCT02145351|HFpEF|hfpef
4886942|NCT02145351|Heart failure|heart failure
4886943|NCT02145351|Heart failure with preserved ejection fraction|heart failure with preserved ejection fraction
4886944|NCT02145351|Chronotropic incompetence|chronotropic incompetence
4886945|NCT02145338|Urinary tract infection|urinary tract infection
4886946|NCT02145338|Clean intermittent self-catheterisation|clean intermittent self-catheterisation
4886947|NCT02145338|Antibiotic prophylaxis|antibiotic prophylaxis
4886948|NCT02145325|Kidney transplant|kidney transplant
4886949|NCT02145325|Regulatory T cells|regulatory t cells
4886950|NCT02145325|Leukopheresis|leukopheresis
4886951|NCT02145325|Immune cells|immune cells
4886952|NCT02145325|Stem Cells|stem cells
4886953|NCT02145325|Tolerance|tolerance
4886954|NCT02145273|Maternal Depression|maternal depression
4886955|NCT02145273|Interpersonal Psychotherapy|interpersonal psychotherapy
4886956|NCT02145273|School Readiness|school readiness
4886957|NCT02145260|Hemodialysis|hemodialysis
4886958|NCT02145260|Hypotension|hypotension
4886959|NCT02145260|Hospitalization|hospitalization
4886960|NCT02145208|BPH|bph
4886961|NCT02145195|Vitamin D|vitamin d
4886962|NCT02145195|Children|children
4886963|NCT02145195|Supplements|supplements
4886964|NCT02145195|Cardiometabolic markers|cardiometabolic markers
4886965|NCT02145195|Immune defense|immune defense
4886966|NCT02145195|Bone turnover|bone turnover
4886967|NCT02145195|Muscle strength|muscle strength
4886968|NCT02145182|DGF|dgf
4886969|NCT02145182|Dialysis|dialysis
4886970|NCT02145182|Kidney|kidney
4886971|NCT02145182|Kidney Transplantation|kidney transplantation
4886972|NCT02145182|eGFR|egfr
4886973|NCT02145182|Complement|complement
4886974|NCT02145182|Eculizumab|eculizumab
4886975|NCT02145169|procedural sedation|procedural sedation
4886976|NCT02145169|emergence reaction|emergence reaction
4886977|NCT02145169|nitrous oxide|nitrous oxide
4886978|NCT02145169|ketamine|ketamine
4886979|NCT02145156|HPV vaccination|hpv vaccination
4886980|NCT02145156|Tailored health messaging|tailored health messaging
4886981|NCT02145143|Radioiodine (RAI) Incorporation|radioiodine (rai) incorporation
4886982|NCT02145143|Vemurafenib|vemurafenib
4886983|NCT02145143|14-031|14-031
4886984|NCT02145130|Skin|skin
4886985|NCT02145130|Tissue-engineering|tissue-engineering
4886986|NCT02145130|Autologous|autologous
4886987|NCT02145130|Dermis|dermis
4886988|NCT02145130|Epidermis|epidermis
4886989|NCT02145117|MBSR|mbsr
4886990|NCT02145117|fMRI|fmri
4886991|NCT02145117|PTH|pth
4886992|NCT02145091|Psilocybin|psilocybin
4886993|NCT02145091|Hallucinogens|hallucinogens
4886994|NCT02145091|Pharmacologic Actions|pharmacologic actions
4886995|NCT02145091|Central Nervous System Agents|central nervous system agents
4886996|NCT02145091|Therapeutic Uses|therapeutic uses
4886997|NCT02145091|Psychotropic Drugs|psychotropic drugs
4886998|NCT02145065|paclitaxel coated balloon|paclitaxel coated balloon
4886999|NCT02145065|restenosis|restenosis
4887000|NCT02145065|Femoropopliteal artery disease|femoropopliteal artery disease
4887001|NCT02145052|Fascial closure|fascial closure
4887002|NCT02145052|Interrupted suture|interrupted suture
4887003|NCT02145052|Running suture|running suture
4887004|NCT02145052|Continuous suture|continuous suture
4887005|NCT02145039|Acute Lymphoblastic Leukemia (ALL)|acute lymphoblastic leukemia (all)
4887006|NCT02145039|Acute Myelogenous Leukemia (AML)|acute myelogenous leukemia (aml)
4887007|NCT02145039|Burkitt's lymphoma|burkitt's lymphoma
4887008|NCT02145039|Natural killer cell malignancies|natural killer cell malignancies
4887009|NCT02145039|Chronic myelogenous leukemia|chronic myelogenous leukemia
4887010|NCT02145039|Myelodysplastic syndrome|myelodysplastic syndrome
4887011|NCT02145039|Large-cell lymphoma|large-cell lymphoma
4887012|NCT02145039|Hodgkin lymphoma|hodgkin lymphoma
4887013|NCT02145039|Multiple myeloma|multiple myeloma
4887014|NCT02145039|Chronic lymphocytic leukemia (CLL)|chronic lymphocytic leukemia (cll)
4887015|NCT02145039|Small lymphocytic lymphoma (SLL)|small lymphocytic lymphoma (sll)
4887016|NCT02145039|Marginal zone B-cell lymphoma|marginal zone b-cell lymphoma
4887017|NCT02145039|Follicular lymphoma|follicular lymphoma
4887018|NCT02145039|Lymphoplasmacytic lymphoma|lymphoplasmacytic lymphoma
4887019|NCT02145039|Mantle-cell lymphoma|mantle-cell lymphoma
4887020|NCT02145039|Prolymphocytic leukemia|prolymphocytic leukemia
4887021|NCT02145039|Refractory leukemia|refractory leukemia
4887022|NCT02145039|MDS|mds
4887023|NCT02145039|Bone marrow failure syndromes|bone marrow failure syndromes
4887024|NCT02145039|Myeloproliferative syndromes|myeloproliferative syndromes
4887025|NCT02145013|portal hypertension, hepatocellular carcinoma, resection|portal hypertension, hepatocellular carcinoma, resection
4887026|NCT02145000|Rotavirus|rotavirus
4887027|NCT02145000|Gastroenteritis|gastroenteritis
4887030|NCT02145000|Niger|niger
4887031|NCT02144974|Total pelvic exenteration.|total pelvic exenteration.
4887032|NCT02144961|breast reconstruction|breast reconstruction
4887033|NCT02144961|Deep Inferior Epigastric Artery Perforator (DIEP)|deep inferior epigastric artery perforator (diep)
4887034|NCT02144961|Indocyanine Green Angiography (IGA)|indocyanine green angiography (iga)
4887035|NCT02144961|autologous tissue transfer|autologous tissue transfer
4887036|NCT02144948|diabetes|diabetes
4887037|NCT02144935|pediatrics|pediatrics
4887038|NCT02144922|Hypertension|hypertension
4887039|NCT02144922|Statin|statin
4887040|NCT02144909|Diabetes self management|diabetes self management
4887041|NCT02144909|support group|support group
4887042|NCT02144909|semi structured support group|semi structured support group
4887043|NCT02144883|telephone counseling|telephone counseling
4887044|NCT02144870|Tic-Disorder, Tourette-Disorder, Habit Reversal Training, Resources activation|tic-disorder, tourette-disorder, habit reversal training, resources activation
4887045|NCT02144844|Antepartum depressive symptoms|antepartum depressive symptoms
4887046|NCT02144844|Antepartum depression|antepartum depression
4887047|NCT02144844|Cognitive behavioral intervention|cognitive behavioral intervention
4887048|NCT02144844|Feasibility|feasibility
4887049|NCT02144844|randomized clinical trial|randomized clinical trial
4887050|NCT02144831|TIA|tia
4887051|NCT02144831|stroke prevention|stroke prevention
4887052|NCT02144831|ASA|asa
4887053|NCT02144831|clopidogrel|clopidogrel
4887054|NCT02144831|dual antiplatelet treatment|dual antiplatelet treatment
4887055|NCT02144753|IBS-C|ibs-c
4887056|NCT02144753|Constipation|constipation
4887057|NCT02144753|IBS|ibs
4887058|NCT02144740|Flow-mediated dilation|flow-mediated dilation
4887059|NCT02144688|Human Immunodeficiency Virus|human immunodeficiency virus
4887060|NCT02144688|HIV|hiv
4887061|NCT02144688|Cognitive symptoms|cognitive symptoms
4887062|NCT02144688|Cognitive evaluation|cognitive evaluation
4887063|NCT02144688|Neuropsychological testing|neuropsychological testing
4887064|NCT02144688|Quality of life|quality of life
4887065|NCT02144688|Anxiety|anxiety
4887066|NCT02144688|Viral load|viral load
4887067|NCT02144688|Antiretroviral|antiretroviral
4887068|NCT02144688|Cerebrospinal fluid|cerebrospinal fluid
4887069|NCT02144688|Lumbar puncture|lumbar puncture
4887070|NCT02144688|Magnetic resonance imaging|magnetic resonance imaging
4887071|NCT02144688|MRI|mri
4887072|NCT02144649|Prostate Cancer|prostate cancer
4887073|NCT02144649|Tangerine Juice|tangerine juice
4887074|NCT02144649|Tomato Juice|tomato juice
4887075|NCT02144623|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
4887076|NCT02144623|Valproate|valproate
4887077|NCT02144623|Cluster of differentiation antigen 20|cluster of differentiation antigen 20
4887078|NCT02144623|Lymphomas|lymphomas
4887079|NCT02144623|B-cell lymphomas|b-cell lymphomas
4887080|NCT02144623|Translational research|translational research
4887081|NCT02144623|Monoclonal antibodies|monoclonal antibodies
4887082|NCT02144610|CLI|cli
4887083|NCT02144597|morbid obesity|morbid obesity
4887084|NCT02144597|gastric bypass|gastric bypass
4887085|NCT02144597|bariatrics|bariatrics
4887086|NCT02144597|diet|diet
4887087|NCT02144597|caloric restriction|caloric restriction
4887088|NCT02144597|liver fat|liver fat
4887089|NCT02144597|appetite|appetite
4887090|NCT02144584|ischemic stroke|ischemic stroke
4887091|NCT02144584|memantine|memantine
4887092|NCT02144584|upper extremity weakness|upper extremity weakness
4887093|NCT02144584|motor recovery|motor recovery
4887094|NCT02144558|Sperm parameters|sperm parameters
4887095|NCT02144558|Spinal cord injuries|spinal cord injuries
4887096|NCT02144558|Oxidative stress|oxidative stress
4887097|NCT02144558|Inflammatory syndrome|inflammatory syndrome
4887098|NCT02144545|Surgery|surgery
4887099|NCT02144545|Morbid Obesity|morbid obesity
4887100|NCT02144545|Bariatric surgery|bariatric surgery
4887101|NCT02144545|Sleeve gastrectomy|sleeve gastrectomy
4887102|NCT02144545|Bougie Size|bougie size
4887103|NCT02144545|Distance from pylorus|distance from pylorus
4887104|NCT02144545|Hormones|hormones
4887105|NCT02144545|Gastric remanent|gastric remanent
4887106|NCT02144532|Ehlers-Danlos syndrome|ehlers-danlos syndrome
4887107|NCT02144532|hypermobility|hypermobility
4887108|NCT02144532|Compression garment|compression garment
4887110|NCT02144532|isokinetic evaluation|isokinetic evaluation
4887111|NCT02144506|Elderly, home-based exercises programm|elderly, home-based exercises programm
4887112|NCT02144493|common bile duct stones|common bile duct stones
4887113|NCT02144493|diverticulum|diverticulum
4887114|NCT02144480|coronary bypass surgery|coronary bypass surgery
4887115|NCT02144480|rehabilitation|rehabilitation
4887116|NCT02144480|exercise training|exercise training
4887117|NCT02144480|platelet activation|platelet activation
4887118|NCT02144480|cardiopulmonary fitness|cardiopulmonary fitness
4887119|NCT02144467|Multiple-MRI, Gene, Cognition|multiple-mri, gene, cognition
4887120|NCT02144454|Cardiovascular disease|cardiovascular disease
4887121|NCT02144454|Fatty acids|fatty acids
4887122|NCT02144454|Vascular function|vascular function
4887123|NCT02144454|Blood pressure|blood pressure
4887124|NCT02144454|Plasma lipids|plasma lipids
4887125|NCT02144454|Insulin resistance|insulin resistance
4887126|NCT02144454|Endothelial activation|endothelial activation
4887127|NCT02144441|Diabetes Mellitus|diabetes mellitus
4887128|NCT02144441|Insulin|insulin
4887129|NCT02144441|Self Administration|self administration
4887130|NCT02144441|Patient Satisfaction|patient satisfaction
4887131|NCT02144441|Glucose|glucose
4887132|NCT02144441|Hypoglycemia|hypoglycemia
4887133|NCT02144441|Hyperglycemia|hyperglycemia
4887134|NCT02144415|abuse liability|abuse liability
4887135|NCT02144415|recreational drug user|recreational drug user
4887136|NCT02144415|stimulant|stimulant
4887137|NCT02144415|d-amphetamine|d-amphetamine
4887138|NCT02144415|ADHD|adhd
4887139|NCT02144389|Arachidonic acid|arachidonic acid
4887140|NCT02144389|Bilharzia|bilharzia
4887141|NCT02144389|Mansoni|mansoni
4887142|NCT02144389|Schistosomiasis|schistosomiasis
4887143|NCT02144389|Polyunsaturated fatty acid|polyunsaturated fatty acid
4887144|NCT02144376|Constipation|constipation
4887145|NCT02144376|psyllium|psyllium
4887146|NCT02144376|ispaghula|ispaghula
4887147|NCT02144376|Magnetic Resonance Imaging|magnetic resonance imaging
4887148|NCT02144376|MRI|mri
4887149|NCT02144376|microbiota|microbiota
4887150|NCT02144363|Preterm|preterm
4887151|NCT02144363|RDS|rds
4887152|NCT02144363|Mechanical Ventilation|mechanical ventilation
4887153|NCT02144363|Extubation failure|extubation failure
4887154|NCT02144350|hyperbaric oxygen|hyperbaric oxygen
4887155|NCT02144337|Physical activity|physical activity
4887156|NCT02144337|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
4887157|NCT02144337|Children|children
4887158|NCT02144337|Intervention|intervention
4887159|NCT02144324|Maxillary protraction|maxillary protraction
4887160|NCT02144324|Modified Tandem Appliance|modified tandem appliance
4887161|NCT02144324|Face mask therapy|face mask therapy
4887162|NCT02144324|Class III malocclusion|class iii malocclusion
4887163|NCT02144324|Maxillary deficiency|maxillary deficiency
4887164|NCT02144311|MRI|mri
4887165|NCT02144311|FDG PET/CT|fdg pet/ct
4887166|NCT02144311|histologic heterogeneity|histologic heterogeneity
4887167|NCT02144311|14-061|14-061
4887168|NCT02144298|microcirculation|microcirculation
4887169|NCT02144298|coronary artery bypass grafting|coronary artery bypass grafting
4887170|NCT02144298|cold blood cardioplegia|cold blood cardioplegia
4887171|NCT02144298|cristalloid cardioplegia|cristalloid cardioplegia
4887172|NCT02144285|Renal dialysis|renal dialysis
4887173|NCT02144272|Antibody|antibody
4887174|NCT02144272|Tumor Necrosis Factor alpha|tumor necrosis factor alpha
4887175|NCT02144272|Interleukin-17|interleukin-17
4887176|NCT02144233|Pain|pain
4887177|NCT02144233|Temporomandibular joint disorders|temporomandibular joint disorders
4887178|NCT02144233|Occlusal adjustment|occlusal adjustment
4887179|NCT02144233|Therapy|therapy
4887180|NCT02144233|Randomized clinical trial|randomized clinical trial
4887181|NCT02144233|Mastication|mastication
4887182|NCT02144233|Habitual chewing side|habitual chewing side
4887183|NCT02144233|Handedness preference|handedness preference
4887184|NCT02144233|Hemimandibular retrognathia|hemimandibular retrognathia
4887185|NCT02144220|Telemedicine|telemedicine
4887186|NCT02144220|Virtual care visit|virtual care visit
4887187|NCT02144220|Remote visit|remote visit
4887188|NCT02144220|Video-conferencing|video-conferencing
4887189|NCT02144194|Oral Vinorelbine|oral vinorelbine
4887190|NCT02144194|Oral Chemotherapy|oral chemotherapy
4887191|NCT02144194|Metastatic Breast Cancer|metastatic breast cancer
4887192|NCT02144194|Advanced Breast Cancer|advanced breast cancer
4887193|NCT02144194|Maintenance treatment|maintenance treatment
4887194|NCT02144181|Ulthera® System|ulthera® system
4887195|NCT02144181|Ultherapy® Treatment|ultherapy® treatment
4887196|NCT02144181|Ulthera, Inc.|ulthera, inc.
4887197|NCT02144168|Prebiotics|prebiotics
4887198|NCT02144168|diarrhoea|diarrhoea
4887199|NCT02144168|Enteral nutrition|enteral nutrition
4887200|NCT02144168|Fibre|fibre
4887201|NCT02144168|Bifidobacteria|bifidobacteria
4887202|NCT02144168|SCFA|scfa
4887203|NCT02144155|Oxytocin|oxytocin
4887204|NCT02144142|Microbiome|microbiome
4887205|NCT02144142|Atopic dermatitis|atopic dermatitis
4887206|NCT02144142|Eczema|eczema
4887207|NCT02144142|Bacteriotherapy|bacteriotherapy
4887208|NCT02144129|Whole Body Electromyostimulation|whole body electromyostimulation
4887209|NCT02144129|Inflammatory Bowel Disease|inflammatory bowel disease
4887210|NCT02144129|Lean Body Mass|lean body mass
4887211|NCT02144129|Muscle Strength|muscle strength
4887212|NCT02144116|dance-movement therapy|dance-movement therapy
4887213|NCT02144116|balance|balance
4887214|NCT02144116|Fibromyalgia|fibromyalgia
4887215|NCT02144103|Glaucomatous Neurodegeneration|glaucomatous neurodegeneration
4887216|NCT02144103|Retinal Degeneration|retinal degeneration
4887217|NCT02144103|Primary Open-Angle Glaucoma|primary open-angle glaucoma
4887218|NCT02144103|Optic Neuropathy|optic neuropathy
4887219|NCT02144103|Intraocular pressure|intraocular pressure
4887220|NCT02144103|Retinal ganglion cell degeneration|retinal ganglion cell degeneration
4887221|NCT02144103|Optic nerve atrophy|optic nerve atrophy
4887222|NCT02144103|Subtenon injection|subtenon injection
4887223|NCT02144103|Glaucomatous damage|glaucomatous damage
4887224|NCT02144103|ADRC|adrc
4887225|NCT02144103|Adipose-derived regenerative cells|adipose-derived regenerative cells
4887226|NCT02144103|Fat tissue|fat tissue
4887227|NCT02144103|Stem cells|stem cells
4887228|NCT02144090|Angiography|angiography
4887229|NCT02144090|Angioplasty|angioplasty
4887230|NCT02144090|Coronary artery disease|coronary artery disease
4887231|NCT02144090|Diagnostic|diagnostic
4887232|NCT02144090|Fractional flow reserve|fractional flow reserve
4887233|NCT02144077|Photodynamic Therapy|photodynamic therapy
4887234|NCT02144077|PDT|pdt
4887235|NCT02144077|non-aggressive BCC|non-aggressive bcc
4887236|NCT02144064|Aspirin, heparin, pregnancy, recurrent pregnancy loss|aspirin, heparin, pregnancy, recurrent pregnancy loss
4887237|NCT02144051|solid tumor, prostate cancer, breast cancer, bladder cancer, ovarian cancer, gastric cancer, salivary duct cancer|solid tumor, prostate cancer, breast cancer, bladder cancer, ovarian cancer, gastric cancer, salivary duct cancer
4887238|NCT02144038|multiple myeloma,|multiple myeloma,
4887239|NCT02144038|relapsed and refractory,|relapsed and refractory,
4887240|NCT02144038|LGH447,|lgh447,
4887241|NCT02144038|pan-PIM inhibitor,|pan-pim inhibitor,
4887242|NCT02144038|PIM Kinase,|pim kinase,
4887243|NCT02144038|BYL719,|byl719,
4887244|NCT02144038|PI3K inhibitor|pi3k inhibitor
4887245|NCT02144025|Ocular Graft-Versus-Host-Disease|ocular graft-versus-host-disease
4887246|NCT02144025|Topical Cyclosporine|topical cyclosporine
4887247|NCT02143986|sepsis|sepsis
4887248|NCT02143986|Macrophagic activation syndrome|macrophagic activation syndrome
4887249|NCT02143986|Ferritin|ferritin
4887250|NCT02143986|Still's disease|still's disease
4887251|NCT02143973|Uremic|uremic
4887252|NCT02143973|Pruritus|pruritus
4887253|NCT02143973|Itch|itch
4887254|NCT02143973|Chronic Itch|chronic itch
4887255|NCT02143973|Nalbuphine|nalbuphine
4887256|NCT02143960|Syneron|syneron
4887257|NCT02143960|Velashape|velashape
4887258|NCT02143960|ELOS|elos
4887259|NCT02143960|Zeltiq|zeltiq
4887260|NCT02143960|Cryolipolysis|cryolipolysis
4887261|NCT02143947|Orthoses|orthoses
4887262|NCT02143947|Foot|foot
4887263|NCT02143947|Kinematics|kinematics
4887264|NCT02143947|EMG|emg
4887265|NCT02143947|Biomechanics|biomechanics
4887266|NCT02143934|Plasmodium vivax|plasmodium vivax
4887267|NCT02143934|Hypnozoites|hypnozoites
4887268|NCT02143934|Primaquine|primaquine
4887269|NCT02143934|Liver-stage|liver-stage
4887270|NCT02143934|Blood-stage|blood-stage
4887271|NCT02143934|Plasmodium falciparum|plasmodium falciparum
4887272|NCT02143921|NGO zinc scale|ngo zinc scale
4887273|NCT02143921|compliance with WHO zinc treatment recommendations|compliance with who zinc treatment recommendations
4887274|NCT02143908|Diarrhea|diarrhea
4887275|NCT02143908|L-lysine supplementation|l-lysine supplementation
4887276|NCT02143908|immune status|immune status
4887277|NCT02143908|adults|adults
4887278|NCT02143908|Bangladesh|bangladesh
4887279|NCT02143908|aged 18-45 years|aged 18-45 years
4887280|NCT02143908|urban community|urban community
4887281|NCT02143882|Live attenuated influenza vaccine|live attenuated influenza vaccine
4887282|NCT02143882|fluenz|fluenz
4887283|NCT02143882|pandemrix|pandemrix
4887284|NCT02143882|pandemic influenza vaccine|pandemic influenza vaccine
4887285|NCT02143882|immunogenicity|immunogenicity
4887286|NCT02143869|Gastrointestinal cancer|gastrointestinal cancer
4887287|NCT02143869|Lung cancer|lung cancer
4887288|NCT02143869|Bioelectrical Impedance analysis|bioelectrical impedance analysis
4887289|NCT02143869|Body composition|body composition
4887290|NCT02143869|Perioperative|perioperative
4887291|NCT02143830|marrow aplasia|marrow aplasia
4887292|NCT02143830|cytopenia|cytopenia
4887293|NCT02143830|myelodysplasia|myelodysplasia
4887294|NCT02143830|AML|aml
4887295|NCT02143830|bone marrow transplant|bone marrow transplant
4887296|NCT02143830|cytoreductive regimen|cytoreductive regimen
4887297|NCT02143830|T-cell reduction|t-cell reduction
4887298|NCT02143817|whole body vibration training|whole body vibration training
4887299|NCT02143817|L-citrulline|l-citrulline
4887300|NCT02143817|hypertension|hypertension
4887301|NCT02143817|obesity|obesity
4887302|NCT02143817|arterial function|arterial function
4887303|NCT02143817|arterial stiffness|arterial stiffness
4887304|NCT02143817|autonomic function|autonomic function
4887305|NCT02143817|endothelial function|endothelial function
4887306|NCT02143804|Oncolytic virus|oncolytic virus
4887307|NCT02143804|GMCSF|gmcsf
4887308|NCT02143804|pRb|prb
4887309|NCT02143804|PDL1|pdl1
4887310|NCT02143804|Immunotherapy|immunotherapy
4887311|NCT02143804|Adenovirus|adenovirus
4887312|NCT02143791|SCS|scs
4887313|NCT02143791|Burst stimulation|burst stimulation
4887314|NCT02143778|MBT|mbt
4887315|NCT02143778|CSPH|csph
4887316|NCT02143778|HVPG|hvpg
4887317|NCT02143765|Mitiglinide|mitiglinide
4887318|NCT02143765|Acarbose|acarbose
4887319|NCT02143765|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
4887320|NCT02143752|Smoking|smoking
4887321|NCT02143752|Tobacco|tobacco
4887322|NCT02143752|Addiction|addiction
4887323|NCT02143752|Mindfulness|mindfulness
4887324|NCT02143752|Meditation|meditation
4887325|NCT02143739|asthma|asthma
4887326|NCT02143713|Dyspareunia|dyspareunia
4887327|NCT02143713|Endometriosis-associated pain|endometriosis-associated pain
4887328|NCT02143713|Dysmenorrhea (DYS)|dysmenorrhea (dys)
4887329|NCT02143713|Elagolix|elagolix
4887330|NCT02143713|Gonadotropin-releasing Hormone Antagonist|gonadotropin-releasing hormone antagonist
4887331|NCT02143713|Non-menstrual Pelvic Pain (NMPP)|non-menstrual pelvic pain (nmpp)
4887332|NCT02143700|exacerbation|exacerbation
4887333|NCT02143700|cognitive|cognitive
4887334|NCT02143700|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
4887335|NCT02143687|Pulmonary hypertension|pulmonary hypertension
4887336|NCT02143687|Interstitial lung disease|interstitial lung disease
4887337|NCT02143687|Pulmonary fibrosis|pulmonary fibrosis
4887338|NCT02143674|Stretching exercise muscle|stretching exercise muscle
4887339|NCT02143674|Elderly|elderly
4887340|NCT02143674|Techniques and exercise|techniques and exercise
4887341|NCT02143674|Physiotherapy|physiotherapy
4887342|NCT02143648|uremic|uremic
4887343|NCT02143648|pruritus|pruritus
4887344|NCT02143648|itch|itch
4887345|NCT02143648|chronic itch|chronic itch
4887346|NCT02143648|nalbuphine|nalbuphine
4887347|NCT02143635|HDM201,TP53wt, p53, MDM2, HDM2, advanced tumors, BLRM (Bayesian logistic regression model)|hdm201,tp53wt, p53, mdm2, hdm2, advanced tumors, blrm (bayesian logistic regression model)
4887348|NCT02143622|Head and neck cancer|head and neck cancer
4887349|NCT02143609|airway disease|airway disease
4887350|NCT02143609|bronchitis|bronchitis
4887351|NCT02143609|emphysema|emphysema
4887352|NCT02143609|lung|lung
4887353|NCT02143596|stroke|stroke
4887354|NCT02143596|dehydration|dehydration
4887355|NCT02143596|prognosis|prognosis
4887356|NCT02143583|rhinoconjunctivitis|rhinoconjunctivitis
4887357|NCT02143583|birch pollen|birch pollen
4887358|NCT02143583|desensitization|desensitization
4887359|NCT02143583|allergen immunotherapy|allergen immunotherapy
4887360|NCT02143570|Urinary Bladder, Overactive|urinary bladder, overactive
4887361|NCT02143570|Darifenacin|darifenacin
4887362|NCT02143570|Physiotherapy|physiotherapy
4887363|NCT02143570|Quality of Life|quality of life
4887364|NCT02143557|breast milk|breast milk
4887365|NCT02143557|infants|infants
4887366|NCT02143557|chylothorax|chylothorax
4887367|NCT02143557|cardiac surgery|cardiac surgery
4887368|NCT02143557|modified breast milk|modified breast milk
4887369|NCT02143544|Intra-aortic balloon counterpulsation|intra-aortic balloon counterpulsation
4887370|NCT02143544|Cardiac surgery|cardiac surgery
4887371|NCT02143544|High-risk patients|high-risk patients
4887372|NCT02143518|Human Hookworm|human hookworm
4887373|NCT02143518|Necator americanus|necator americanus
4887374|NCT02143518|Hookworm|hookworm
4887375|NCT02143518|Hookworm Disease|hookworm disease
4887376|NCT02143518|Iron-deficiency anemia|iron-deficiency anemia
4887377|NCT02143518|Soil-transmitted helminth infection|soil-transmitted helminth infection
4887378|NCT02143518|Neglected Tropical Disease|neglected tropical disease
4887379|NCT02143518|Na-GST-1|na-gst-1
4887380|NCT02143518|CpG|cpg
4887381|NCT02143479|France|france
4887382|NCT02143479|Prograf|prograf
4887383|NCT02143479|Pharmaco-epidemiology|pharmaco-epidemiology
4887384|NCT02143479|Tacrolimus|tacrolimus
4887385|NCT02143479|Observational|observational
4887386|NCT02143466|Phase I|phase i
4887387|NCT02143466|Safety|safety
4887388|NCT02143466|Tolerability|tolerability
4887389|NCT02143466|Efficacy|efficacy
4887390|NCT02143466|Anti-tumour|anti-tumour
4887391|NCT02143466|AZD9291|azd9291
4887392|NCT02143466|AZD6094|azd6094
4887393|NCT02143466|MEDI4736|medi4736
4887394|NCT02143466|Osimertinib|osimertinib
4887395|NCT02143466|Savolitinib|savolitinib
4887396|NCT02143466|Selumetinib|selumetinib
4887397|NCT02143466|Durvalumab|durvalumab
4887398|NCT02143466|Ascending Doses|ascending doses
4887399|NCT02143466|Expansion cohorts|expansion cohorts
4887400|NCT02143466|EGFR|egfr
4887401|NCT02143466|Advanced Non-Small Cell Lung Cancer|advanced non-small cell lung cancer
4887402|NCT02143466|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors
4887403|NCT02143453|exercise|exercise
4887404|NCT02143453|overweight|overweight
4887405|NCT02143453|children|children
4887406|NCT02143427|social skills training,|social skills training,
4887407|NCT02143427|computer based,|computer based,
4887408|NCT02143427|social competence training,|social competence training,
4887409|NCT02143427|Oppositional Defiant Disorder|oppositional defiant disorder
4887410|NCT02143427|peer related aggressive behavior|peer related aggressive behavior
4887411|NCT02143427|randomized controlled trial|randomized controlled trial
4887412|NCT02143388|Local advanced|local advanced
4887413|NCT02143388|high risk|high risk
4887414|NCT02143388|nasopharyngeal carcinoma|nasopharyngeal carcinoma
4887415|NCT02143362|Intraoperative wake up|intraoperative wake up
4887416|NCT02143362|Closed loop of target controlled infusion|closed loop of target controlled infusion
4887417|NCT02143362|Dexmedetomidine|dexmedetomidine
4887418|NCT02143362|Propofol|propofol
4887419|NCT02143349|obesity|obesity
4887420|NCT02143349|herbal remedies|herbal remedies
4887421|NCT02143349|metabolic disorders|metabolic disorders
4887422|NCT02143336|Surgical site infections|surgical site infections
4887423|NCT02143336|Skin closure techniques|skin closure techniques
4887424|NCT02143336|Colorectal surgery|colorectal surgery
4887425|NCT02143323|GST, DILI, biomarker|gst, dili, biomarker
4887426|NCT02143297|Sleep Apnea/Hypopnea Syndrome|sleep apnea/hypopnea syndrome
4887427|NCT02143297|Pulse Oximetry|pulse oximetry
4887428|NCT02143297|Nonlinear Dynamics|nonlinear dynamics
4887429|NCT02143297|Fourier Analysis|fourier analysis
4887631|NCT02142166|biomarker|biomarker
4887430|NCT02143297|Neural Networks (Computer)|neural networks (computer)
4887431|NCT02143271|Secondary Hyperparathyroidism in Patients Receiving Peritoneal Dialysis|secondary hyperparathyroidism in patients receiving peritoneal dialysis
4887432|NCT02143258|stenting venous sinus|stenting venous sinus
4887433|NCT02143258|intracranial hypertension|intracranial hypertension
4887434|NCT02143258|quality of life|quality of life
4887435|NCT02143258|headache|headache
4887436|NCT02143258|visual impairment|visual impairment
4887437|NCT02143232|knee replacement|knee replacement
4887438|NCT02143232|hip replacement|hip replacement
4887439|NCT02143232|patient monitor|patient monitor
4887440|NCT02143219|Pancreatic metastatic cancer|pancreatic metastatic cancer
4887441|NCT02143219|FOLFIRINOX|folfirinox
4887442|NCT02143219|toxicity|toxicity
4887443|NCT02143219|efficacy|efficacy
4887444|NCT02143206|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
4887445|NCT02143206|Pain|pain
4887446|NCT02143206|Arthritis|arthritis
4887447|NCT02143206|Dyspnea|dyspnea
4887448|NCT02143206|Exercise|exercise
4887449|NCT02143206|Aerobic|aerobic
4887450|NCT02143193|Breastfeeding|breastfeeding
4887451|NCT02143193|Newborn|newborn
4887452|NCT02143193|Formula|formula
4887453|NCT02143193|Temperature|temperature
4887454|NCT02143193|Initial Bath|initial bath
4887455|NCT02143180|real-time tissue elastography|real-time tissue elastography
4887456|NCT02143180|hepatic fibrosis|hepatic fibrosis
4887457|NCT02143154|vancomycin, GBS|vancomycin, gbs
4887458|NCT02143141|postoperative pain|postoperative pain
4887459|NCT02143141|narcotic side effects|narcotic side effects
4887460|NCT02143128|score|score
4887461|NCT02143128|postoperative|postoperative
4887462|NCT02143128|pain|pain
4887463|NCT02143128|nausea|nausea
4887464|NCT02143128|mental status|mental status
4887465|NCT02143128|tool|tool
4887466|NCT02143115|Colorectal cancer surveillance|colorectal cancer surveillance
4887467|NCT02143089|CCSWI|ccswi
4887468|NCT02143076|Medication Adherence|medication adherence
4887469|NCT02143076|Hydroxyurea|hydroxyurea
4887470|NCT02143050|Unresectable melanoma Stage IIIC and Stage IV BRAF V600E+|unresectable melanoma stage iiic and stage iv braf v600e+
4887471|NCT02143024|depression|depression
4887472|NCT02143024|family|family
4887473|NCT02143024|primary health care|primary health care
4887474|NCT02143011|sugar|sugar
4887475|NCT02143011|sucrose|sucrose
4887476|NCT02143011|fruit juice|fruit juice
4887477|NCT02143011|orange juice|orange juice
4887478|NCT02143011|metabolism|metabolism
4887479|NCT02143011|immune cell aging|immune cell aging
4887480|NCT02143011|lipids|lipids
4887481|NCT02142998|GERD|gerd
4887482|NCT02142998|Laparoscopic|laparoscopic
4887483|NCT02142998|sleeve|sleeve
4887484|NCT02142998|gastrectomy|gastrectomy
4887485|NCT02142972|Low back pain|low back pain
4887486|NCT02142972|Oswestry questionnaire|oswestry questionnaire
4887487|NCT02142972|Post-partum Depression|post-partum depression
4887488|NCT02142972|Pelvic pain|pelvic pain
4887489|NCT02142959|RTA 408|rta 408
4887490|NCT02142959|RTA 408 Lotion|rta 408 lotion
4887491|NCT02142959|Breast cancer|breast cancer
4887492|NCT02142959|Radiation therapy|radiation therapy
4887493|NCT02142959|Radiation dermatitis|radiation dermatitis
4887494|NCT02142959|Oxidative stress|oxidative stress
4887495|NCT02142959|Inflammation|inflammation
4887496|NCT02142959|omaveloxolone|omaveloxolone
4887497|NCT02142933|colonization|colonization
4887498|NCT02142933|screening|screening
4887499|NCT02142933|group B streptococci|group b streptococci
4887500|NCT02142933|extended-spectrum beta-lactamase|extended-spectrum beta-lactamase
4887501|NCT02142933|enterobacteriaceae|enterobacteriaceae
4887502|NCT02142920|Healthy Volunteers|healthy volunteers
4887503|NCT02142907|Breast conservative surgery|breast conservative surgery
4887504|NCT02142907|boost radiation|boost radiation
4887505|NCT02142907|acute toxicity|acute toxicity
4887506|NCT02142907|cosmesis|cosmesis
4887507|NCT02142907|local control|local control
4887508|NCT02142894|Tuberculosis|tuberculosis
4887509|NCT02142894|TB|tb
4887510|NCT02142868|Expanded Access|expanded access
4887511|NCT02142868|Advanced Breast Cancer|advanced breast cancer
4887512|NCT02142855|volunteers|volunteers
4887513|NCT02142855|young (18-30 y)|young (18-30 y)
4887514|NCT02142855|older (65-75 y)|older (65-75 y)
4887515|NCT02142855|age groups|age groups
4887516|NCT02142842|Adipose stem cell|adipose stem cell
4887517|NCT02142842|Platelet rich plasma|platelet rich plasma
4887518|NCT02142842|Knee Osteoarthritis|knee osteoarthritis
4887519|NCT02142842|Injured cartilage|injured cartilage
4887520|NCT02142829|bariatric surgery, postoperative pain|bariatric surgery, postoperative pain
4887521|NCT02142777|S-equol|s-equol
4887522|NCT02142777|COX activity|cox activity
4887523|NCT02142764|Multiple Sclerosis|multiple sclerosis
4887524|NCT02142764|CD8+ T-cells|cd8+ t-cells
4887525|NCT02142764|Class I Major Histocompatibility Complex (MHC)|class i major histocompatibility complex (mhc)
4887526|NCT02142764|pentamers|pentamers
4887527|NCT02142751|Escherichia coli|escherichia coli
4887528|NCT02142751|Extended-spectrum β-lactamases (ESBLs)|extended-spectrum β-lactamases (esbls)
4887529|NCT02142751|Bacteremia|bacteremia
4887530|NCT02142751|Urinary tract infection|urinary tract infection
4887531|NCT02142751|Bloodstream infection|bloodstream infection
4887532|NCT02142751|Fosfomycin|fosfomycin
4887533|NCT02142751|Meropenem|meropenem
4887534|NCT02142751|Pharmacokinetics|pharmacokinetics
4887535|NCT02142751|intestinal colonization|intestinal colonization
4887536|NCT02142751|Recurrence|recurrence
4887537|NCT02142751|multidrug resistance E.coli|multidrug resistance e.coli
4887538|NCT02142751|Ceftriaxone|ceftriaxone
4887539|NCT02142738|PD-1|pd-1
4887540|NCT02142738|PD1|pd1
4887541|NCT02142738|PD-L1|pd-l1
4887542|NCT02142738|PDL1|pdl1
4887543|NCT02142712|Ischemic Stroke|ischemic stroke
4887544|NCT02142712|Brain Edema|brain edema
4887545|NCT02142712|Diphenhydramine|diphenhydramine
4887546|NCT02142712|Dextromethorphan|dextromethorphan
4887547|NCT02142712|Famotidine|famotidine
4887548|NCT02142699|Acute kidney injury|acute kidney injury
4887549|NCT02142699|Cardiac surgery|cardiac surgery
4887550|NCT02142699|Ischaemia reperfusion injury|ischaemia reperfusion injury
4887551|NCT02142699|hemearginate|hemearginate
4887552|NCT02142686|Hysteroscopy|hysteroscopy
4887553|NCT02142686|Filling pressures|filling pressures
4887554|NCT02142673|Operative hysteroscopy|operative hysteroscopy
4887555|NCT02142673|Filling pressure|filling pressure
4887556|NCT02142660|Adhesion barrier system|adhesion barrier system
4887557|NCT02142660|Bariatric surgery|bariatric surgery
4887558|NCT02142647|infant growth|infant growth
4887559|NCT02142647|dietary protein|dietary protein
4887560|NCT02142647|body composition|body composition
4887561|NCT02142647|gut microbiome|gut microbiome
4887562|NCT02142608|Prostate cancer|prostate cancer
4887563|NCT02142608|Ultrasound Imaging|ultrasound imaging
4887564|NCT02142595|dexmedetomidine|dexmedetomidine
4887565|NCT02142595|midazolam|midazolam
4887566|NCT02142595|sleep quality|sleep quality
4887567|NCT02142595|delirium|delirium
4887568|NCT02142582|Home Parenteral Nutrition|home parenteral nutrition
4887569|NCT02142582|Compliance|compliance
4887570|NCT02142582|Short Bowel Syndrome|short bowel syndrome
4887571|NCT02142582|Oral Rehydration Solution|oral rehydration solution
4887572|NCT02142569|Monacolin K|monacolin k
4887573|NCT02142569|Cholesterol|cholesterol
4887574|NCT02142569|Tocotrienol-enriched fraction of palm oil (TRF)|tocotrienol-enriched fraction of palm oil (trf)
4887575|NCT02142569|Chinese Red Yeast Rice (CRYR|chinese red yeast rice (cryr
4887576|NCT02142530|NHL|nhl
4887577|NCT02142530|DLBCL|dlbcl
4887578|NCT02142530|PTCL|ptcl
4887579|NCT02142530|Marginal zone lymphoma|marginal zone lymphoma
4887580|NCT02142530|lymphoplasmacytic lymphoma|lymphoplasmacytic lymphoma
4887581|NCT02142530|Waldenstrom's macroglobulinemia|waldenstrom's macroglobulinemia
4887582|NCT02142517|pancreaticoduodenectomy, pancreatic fistula|pancreaticoduodenectomy, pancreatic fistula
4887583|NCT02142504|Drug therapy|drug therapy
4887584|NCT02142491|Egg allergy|egg allergy
4887585|NCT02142491|live attenuated influenza vaccine|live attenuated influenza vaccine
4887586|NCT02142478|physical activity|physical activity
4887587|NCT02142478|behaviour change|behaviour change
4887588|NCT02142478|exercise referral|exercise referral
4887589|NCT02142478|self-determination theory|self-determination theory
4887590|NCT02142478|mixed-method|mixed-method
4887591|NCT02142478|evaluation|evaluation
4887592|NCT02142478|qualitative|qualitative
4887593|NCT02142452|Pregnancy|pregnancy
4887594|NCT02142452|Obesity/Overweight|obesity/overweight
4887595|NCT02142452|postpartum|postpartum
4887596|NCT02142452|mobile health|mobile health
4887597|NCT02142452|cardiovascular disease|cardiovascular disease
4887598|NCT02142439|Anorexia|anorexia
4887599|NCT02142439|Bulimia|bulimia
4887600|NCT02142439|Physical activity|physical activity
4887601|NCT02142439|Treatment|treatment
4887602|NCT02142426|wound chronic|wound chronic
4887603|NCT02142413|Stroke|stroke
4887604|NCT02142413|Atrial fibrillation|atrial fibrillation
4887605|NCT02142413|Holter ECG|holter ecg
4887606|NCT02142413|cardiac MRI|cardiac mri
4887607|NCT02142335|B-Raf, inoperable stage III melanoma, metastatic stage IV melanoma,|b-raf, inoperable stage iii melanoma, metastatic stage iv melanoma,
4887608|NCT02142296|Pigment Epithelial Detachment|pigment epithelial detachment
4887609|NCT02142296|Age-related Macular degeneration|age-related macular degeneration
4887610|NCT02142283|Mechanical thrombectomy|mechanical thrombectomy
4887611|NCT02142283|Acute ischemic stroke|acute ischemic stroke
4887612|NCT02142283|Wake up stroke|wake up stroke
4887613|NCT02142283|Late presenting stroke|late presenting stroke
4887614|NCT02142257|Obesity|obesity
4887615|NCT02142257|Gastric Bypass|gastric bypass
4887616|NCT02142257|Aspiration Therapy|aspiration therapy
4887617|NCT02142257|AspireAssist|aspireassist
4887618|NCT02142244|Sentinel node biopsy|sentinel node biopsy
4887619|NCT02142244|Near infra red light|near infra red light
4887620|NCT02142244|Indocyanine green|indocyanine green
4887621|NCT02142244|micrometastasis|micrometastasis
4887622|NCT02142231|acupuncture|acupuncture
4887623|NCT02142231|test anxiety|test anxiety
4887624|NCT02142231|neuroenhancer|neuroenhancer
4887625|NCT02142231|placebo|placebo
4887626|NCT02142179|Asthma|asthma
4887627|NCT02142179|Knowledge|knowledge
4887628|NCT02142179|School-Based Service|school-based service
4887629|NCT02142179|Adolescents|adolescents
4887630|NCT02142166|aneurysmal subarachnoid hemorrhage (ASH)|aneurysmal subarachnoid hemorrhage (ash)
4887632|NCT02142153|First in man|first in man
4887633|NCT02142153|Antifungal|antifungal
4887634|NCT02142153|Intravenous infusion|intravenous infusion
4887635|NCT02142153|Healthy volunteers|healthy volunteers
4887636|NCT02142140|Treatment of ADHD|treatment of adhd
4887637|NCT02142140|Long-term treatment follow-up|long-term treatment follow-up
4887638|NCT02142127|GFT505|gft505
4887639|NCT02142127|Mass balance|mass balance
4887640|NCT02142127|Pharmacokinetics|pharmacokinetics
4887641|NCT02142127|Metabolites|metabolites
4887642|NCT02142127|Healthy subjects|healthy subjects
4887643|NCT02142127|Healthy male volunteers|healthy male volunteers
4887644|NCT02142114|Intravitreal injection|intravitreal injection
4887645|NCT02142114|Needle size|needle size
4887646|NCT02142114|Pain|pain
4887647|NCT02142114|Intraocular pressure|intraocular pressure
4887648|NCT02142114|Pain following an Intravitreal injection|pain following an intravitreal injection
4887649|NCT02142101|Gut Microbiota|gut microbiota
4887650|NCT02142101|Polycystic kidney disease|polycystic kidney disease
4887651|NCT02142101|Chronic kidney disease|chronic kidney disease
4887652|NCT02142101|Uremic metabolites|uremic metabolites
4887653|NCT02142088|Glycaemic Control|glycaemic control
4887654|NCT02142088|Glucose Monitoring|glucose monitoring
4887655|NCT02142088|Intravascular Glucose Monitoring|intravascular glucose monitoring
4887656|NCT02142075|Pharmacokinetics|pharmacokinetics
4887657|NCT02142062|Venous outflow obstruction|venous outflow obstruction
4887658|NCT02142062|Iliac Vein|iliac vein
4887659|NCT02142062|Common Femoral Vein|common femoral vein
4887660|NCT02142062|Iliac Compression|iliac compression
4887661|NCT02142049|DLBCL|dlbcl
4887662|NCT02142049|ABC|abc
4887663|NCT02142049|GCB|gcb
4887664|NCT02142049|Primary Mediastinal B-cell lymphoma|primary mediastinal b-cell lymphoma
4887665|NCT02142049|Pharmacyclics|pharmacyclics
4887666|NCT02142049|Lenalidomide|lenalidomide
4887667|NCT02142049|lymphoma|lymphoma
4887668|NCT02142049|Rituximab|rituximab
4887669|NCT02142049|EPOCH|epoch
4887670|NCT02142036|Metastatic disease|metastatic disease
4887671|NCT02142036|Metastasis|metastasis
4887672|NCT02142036|Targeted therapy|targeted therapy
4887673|NCT02142036|Solid tumor|solid tumor
4887674|NCT02142036|Personalized medicine|personalized medicine
4887675|NCT02142036|N-of-1 trial|n-of-1 trial
4887676|NCT02141997|efficacy|efficacy
4887677|NCT02141997|Methotrexate|methotrexate
4887678|NCT02141997|safety|safety
4887679|NCT02141984|Korean regulatory required Postmarketing Surveillance|korean regulatory required postmarketing surveillance
4887680|NCT02141971|Down syndrome|down syndrome
4887681|NCT02141971|Alzheimer's disease|alzheimer's disease
4887682|NCT02141971|biomarkers|biomarkers
4887683|NCT02141971|amyloid|amyloid
4887684|NCT02141971|tau|tau
4887685|NCT02141945|Cancer|cancer
4887686|NCT02141945|Colon Cancer|colon cancer
4887687|NCT02141945|Colorectal Cancer|colorectal cancer
4887688|NCT02141945|Neoplasm|neoplasm
4887689|NCT02141945|Colorectal Neoplasm|colorectal neoplasm
4887690|NCT02141945|Intestinal Neoplasms|intestinal neoplasms
4887691|NCT02141945|Gastrointestinal Neoplasms|gastrointestinal neoplasms
4887692|NCT02141945|Digestive System Neoplasms|digestive system neoplasms
4887693|NCT02141945|Neoplasms by Site|neoplasms by site
4887694|NCT02141945|Neoplasms|neoplasms
4887695|NCT02141945|Colonic Diseases|colonic diseases
4887696|NCT02141945|Digestive System Diseases|digestive system diseases
4887697|NCT02141945|Gastrointestinal Diseases|gastrointestinal diseases
4887698|NCT02141945|Intestinal Diseases|intestinal diseases
4887699|NCT02141945|Rectal Diseases|rectal diseases
4887700|NCT02141932|Hand-held|hand-held
4887701|NCT02141932|Ultrasound|ultrasound
4887702|NCT02141932|Diagnosis|diagnosis
4887703|NCT02141932|Cardiovascular|cardiovascular
4887704|NCT02141932|Carotid artery stenosis|carotid artery stenosis
4887705|NCT02141919|renal cancer|renal cancer
4887706|NCT02141880|Obesity|obesity
4887707|NCT02141867|Surgery|surgery
4887708|NCT02141867|Mortality|mortality
4887709|NCT02141841|intrathecal;|intrathecal;
4887710|NCT02141841|bupivacaine;|bupivacaine;
4887711|NCT02141841|concentration;|concentration;
4887712|NCT02141828|Leukemia|leukemia
4887713|NCT02141828|Advanced hematologic malignancies|advanced hematologic malignancies
4887714|NCT02141828|Epizyme|epizyme
4887715|NCT02141828|Phase 1b|phase 1b
4887716|NCT02141828|MLL gene|mll gene
4887717|NCT02141828|11q23|11q23
4887718|NCT02141828|Ambiguous lineage|ambiguous lineage
4887719|NCT02141828|ALL|all
4887720|NCT02141828|AML|aml
4887721|NCT02141828|Acute leukemias|acute leukemias
4887722|NCT02141828|MLL-r|mll-r
4887723|NCT02141763|Psoriatic Arthritis|psoriatic arthritis
4887724|NCT02141724|Neuromuscular|neuromuscular
4887725|NCT02141724|Wheelchair|wheelchair
4887726|NCT02141724|Pain|pain
4887727|NCT02141724|Bedsore|bedsore
4887728|NCT02141724|Trouble postural|trouble postural
4887729|NCT02141711|Drug therapy|drug therapy
4887730|NCT02141698|Drug therapy|drug therapy
4887731|NCT02141685|in vitro fertilization|in vitro fertilization
4887732|NCT02141685|assisted reproduction techniques|assisted reproduction techniques
4887733|NCT02141685|noninvasive imaging of embryos|noninvasive imaging of embryos
4887829|NCT02141204|Healthy infants|healthy infants
4887734|NCT02141685|time lapse imaging of embryos|time lapse imaging of embryos
4887735|NCT02141685|traditional morphological grading of embryos|traditional morphological grading of embryos
4887736|NCT02141685|prediction of blastocysts|prediction of blastocysts
4887737|NCT02141685|infertility|infertility
4887738|NCT02141685|preimplantation genetic diagnosis|preimplantation genetic diagnosis
4887739|NCT02141685|array-Comparative Genomic Hybridization|array-comparative genomic hybridization
4887740|NCT02141672|lupus nephritis|lupus nephritis
4887741|NCT02141672|calcineurin inhibitors|calcineurin inhibitors
4887742|NCT02141672|voclosporin|voclosporin
4887743|NCT02141646|HIV/AIDS, motivational interviewing, behavioral skills training, MRI|hiv/aids, motivational interviewing, behavioral skills training, mri
4887744|NCT02141633|smokers|smokers
4887745|NCT02141633|airway blood flow|airway blood flow
4887746|NCT02141633|fluticasone|fluticasone
4887747|NCT02141633|echocardiogram|echocardiogram
4887748|NCT02141607|shock|shock
4887749|NCT02141607|heart failure|heart failure
4887750|NCT02141607|inflammation|inflammation
4887751|NCT02141607|biomarkers|biomarkers
4887752|NCT02141607|cardiovascular instability|cardiovascular instability
4887753|NCT02141607|metabolic pathways|metabolic pathways
4887754|NCT02141607|proteolysis|proteolysis
4887755|NCT02141581|Intramuscular inactivated trivalent influenza vaccine|intramuscular inactivated trivalent influenza vaccine
4887756|NCT02141581|Intradermal inactivated trivalent influenza vaccine|intradermal inactivated trivalent influenza vaccine
4887757|NCT02141581|Live, attenuated influenza vaccine|live, attenuated influenza vaccine
4887758|NCT02141581|Young adults|young adults
4887759|NCT02141568|Cost-effective|cost-effective
4887760|NCT02141568|Unexplained Medical Symptoms|unexplained medical symptoms
4887761|NCT02141568|Frequent Attenders|frequent attenders
4887762|NCT02141555|misoprostol, early pregnancy loss, missed abortion|misoprostol, early pregnancy loss, missed abortion
4887763|NCT02141542|Metastatic Melanoma|metastatic melanoma
4887764|NCT02141529|Intraarticular|intraarticular
4887765|NCT02141529|pulsed radiofrequency|pulsed radiofrequency
4887766|NCT02141529|osteoarthritis|osteoarthritis
4887767|NCT02141516|Meningitis|meningitis
4887768|NCT02141516|vaccination|vaccination
4887769|NCT02141516|complement deficiency|complement deficiency
4887770|NCT02141516|asplenia|asplenia
4887771|NCT02141516|splenic dysfunction|splenic dysfunction
4887772|NCT02141503|Biomarkers|biomarkers
4887773|NCT02141503|Alpha-Manosidosis|alpha-manosidosis
4887774|NCT02141490|Lymph Node|lymph node
4887775|NCT02141490|Biopsy|biopsy
4887776|NCT02141490|Metastatic Nodes|metastatic nodes
4887777|NCT02141490|Imaging Agent|imaging agent
4887778|NCT02141477|Leukemia|leukemia
4887779|NCT02141477|Acute Myelogenous Leukemia|acute myelogenous leukemia
4887780|NCT02141477|AML|aml
4887781|NCT02141477|High Risk Myelodysplastic Syndrome|high risk myelodysplastic syndrome
4887782|NCT02141477|MDS|mds
4887783|NCT02141477|Omacetaxine|omacetaxine
4887784|NCT02141477|Synribo|synribo
4887785|NCT02141477|Homoharringtonine|homoharringtonine
4887786|NCT02141477|Decitabine|decitabine
4887787|NCT02141477|Dacogen|dacogen
4887788|NCT02141451|DLBCL|dlbcl
4887789|NCT02141438|Radium-223|radium-223
4887790|NCT02141438|Metastatic castration-resistant prostate cancer|metastatic castration-resistant prostate cancer
4887791|NCT02141438|CRPC|crpc
4887792|NCT02141438|Phase IV|phase iv
4887793|NCT02141438|Safety study|safety study
4887794|NCT02141425|Healthy volunteers|healthy volunteers
4887795|NCT02141425|ASP015K|asp015k
4887796|NCT02141412|optimal dose of dexmedetomidine|optimal dose of dexmedetomidine
4887797|NCT02141412|prevent shivering|prevent shivering
4887798|NCT02141412|improve quality of emergence|improve quality of emergence
4887799|NCT02141412|anesthesia|anesthesia
4887800|NCT02141412|without delay|without delay
4887801|NCT02141412|recovery|recovery
4887802|NCT02141386|Multiple Sclerosis|multiple sclerosis
4887803|NCT02141386|Cognitive remediation|cognitive remediation
4887804|NCT02141386|Plasticity-based, adaptive, computerized cognitive remediation|plasticity-based, adaptive, computerized cognitive remediation
4887805|NCT02141386|Cognitive impairment|cognitive impairment
4887806|NCT02141373|seroma|seroma
4887807|NCT02141373|axillary|axillary
4887808|NCT02141373|dissection|dissection
4887809|NCT02141360|Mild Traumatic Brain Injury|mild traumatic brain injury
4887810|NCT02141321|IUD|iud
4887811|NCT02141321|Misoprostol|misoprostol
4887812|NCT02141321|Rectal administration|rectal administration
4887813|NCT02141308|Retina|retina
4887814|NCT02141308|Optical coherence tomography|optical coherence tomography
4887815|NCT02141308|Imaging|imaging
4887816|NCT02141282|Oncology|oncology
4887817|NCT02141282|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
4887818|NCT02141282|Cancer of the blood and bone marrow|cancer of the blood and bone marrow
4887819|NCT02141269|Transthoracic echocardiogram|transthoracic echocardiogram
4887820|NCT02141269|Hand-held Echocardiography|hand-held echocardiography
4887821|NCT02141256|elderly|elderly
4887822|NCT02141256|protein enrichment|protein enrichment
4887823|NCT02141256|undernutrition|undernutrition
4887824|NCT02141217|Odontogenic (Dental) Infections|odontogenic (dental) infections
4887825|NCT02141217|Dental infections, periapical abscess|dental infections, periapical abscess
4887826|NCT02141217|Bacterial infection|bacterial infection
4887827|NCT02141204|Rotarix|rotarix
4887828|NCT02141204|HRV|hrv
4887830|NCT02141204|Liquid formulation|liquid formulation
4887831|NCT02141204|Lyophilized formulation|lyophilized formulation
4887832|NCT02141204|Human rotavirus vaccine|human rotavirus vaccine
4887833|NCT02141191|cystic fibrosis|cystic fibrosis
4887834|NCT02141191|hypertonic saline|hypertonic saline
4887835|NCT02141191|nebulizer|nebulizer
4887836|NCT02141191|nasal cannula|nasal cannula
4887837|NCT02141165|sleep apnea|sleep apnea
4887838|NCT02141165|portable monitor|portable monitor
4887839|NCT02141165|primary care|primary care
4887840|NCT02141165|cost-effectiveness|cost-effectiveness
4887841|NCT02141165|OSAS|osas
4887842|NCT02141139|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal
4887843|NCT02141139|Inflammation|inflammation
4887844|NCT02141139|Perioperative Period|perioperative period
4887845|NCT02141126|Older adults|older adults
4887846|NCT02141126|Strength training|strength training
4887847|NCT02141126|Muscle mass|muscle mass
4887848|NCT02141126|Function|function
4887849|NCT02141126|Inpatients|inpatients
4887850|NCT02141100|thioguanine|thioguanine
4887851|NCT02141100|mercaptopurine|mercaptopurine
4887852|NCT02141100|methotrexate|methotrexate
4887853|NCT02141048|Parenting programme|parenting programme
4887854|NCT02141048|Randomised controlled trial|randomised controlled trial
4887855|NCT02141048|South Africa|south africa
4887856|NCT02141048|Positive parenting|positive parenting
4887857|NCT02141048|Child behaviour problems|child behaviour problems
4887858|NCT02141048|Implementation fidelity|implementation fidelity
4887859|NCT02141048|Low- and middle-income country|low- and middle-income country
4887860|NCT02141035|Acetyl-l-carnitine|acetyl-l-carnitine
4887861|NCT02141035|Carpal tunnel syndrome|carpal tunnel syndrome
4887862|NCT02141035|Motor unit number estimation|motor unit number estimation
4887863|NCT02141035|Compression neuropathy|compression neuropathy
4887864|NCT02141022|Multiple Sclerosis|multiple sclerosis
4887865|NCT02141022|Cognition|cognition
4887866|NCT02141022|Cognitive Remediation|cognitive remediation
4887867|NCT02141022|Gilenya|gilenya
4887868|NCT02141022|Computerized Cognitive Exercise|computerized cognitive exercise
4887869|NCT02141009|Vaccination, prevnar, PCV13|vaccination, prevnar, pcv13
4887870|NCT02140996|MUC-1 vector vaccine; epithelial cancers; immunotherapy; safety; antigen specific vaccine, dendritic cell activation|muc-1 vector vaccine; epithelial cancers; immunotherapy; safety; antigen specific vaccine, dendritic cell activation
4887871|NCT02140983|Insulin Resistance|insulin resistance
4887872|NCT02140983|Family History of Dementia|family history of dementia
4887873|NCT02140983|Cognition|cognition
4887874|NCT02140970|ureteral stent|ureteral stent
4887875|NCT02140970|stent pain|stent pain
4887876|NCT02140970|ureteral spasm|ureteral spasm
4887877|NCT02140970|NSAID|nsaid
4887878|NCT02140970|ibuprofen|ibuprofen
4887879|NCT02140970|placebo|placebo
4887880|NCT02140970|ureteropelvic junction obstruction|ureteropelvic junction obstruction
4887881|NCT02140970|urolithiasis|urolithiasis
4887882|NCT02140957|Toddler Bottle Use|toddler bottle use
4887883|NCT02140957|Educational Intervention|educational intervention
4887884|NCT02140957|Pediatrics|pediatrics
4887885|NCT02140957|Iron Deficiency|iron deficiency
4887886|NCT02140944|Cord blood transplantation|cord blood transplantation
4887887|NCT02140944|CCR5Δ32|ccr5δ32
4887888|NCT02140944|HIV cure|hiv cure
4887889|NCT02140931|Cell therapy|cell therapy
4887890|NCT02140931|Autologous|autologous
4887891|NCT02140918|Fludrocortisone|fludrocortisone
4887892|NCT02140918|Mineralocorticoids|mineralocorticoids
4887893|NCT02140918|Hemodynamics|hemodynamics
4887894|NCT02140918|Pharmacokinetics|pharmacokinetics
4887895|NCT02140905|Hemodialysis|hemodialysis
4887896|NCT02140905|Heart failure|heart failure
4887897|NCT02140905|Impedance|impedance
4887898|NCT02140905|Fluids|fluids
4887899|NCT02140879|pregnancy|pregnancy
4887900|NCT02140879|inflammation|inflammation
4887901|NCT02140879|infant assessment|infant assessment
4887902|NCT02140853|MDR gram-negative bacilli|mdr gram-negative bacilli
4887903|NCT02140853|Mortality|mortality
4887904|NCT02140853|Therapy|therapy
4887905|NCT02140840|TMTB|tmtb
4887906|NCT02140840|Mekinist|mekinist
4887907|NCT02140840|Trametinib|trametinib
4887908|NCT02140840|relapse|relapse
4887909|NCT02140840|refractory|refractory
4887910|NCT02140840|response rate|response rate
4887911|NCT02140827|bowel preparation|bowel preparation
4887912|NCT02140827|instant messaging program|instant messaging program
4887913|NCT02140814|PKD|pkd
4887914|NCT02140814|niacinamide|niacinamide
4887915|NCT02140814|Vitamin B3|vitamin b3
4887916|NCT02140814|Vitamin B|vitamin b
4887917|NCT02140801|Percutaneous coronary intervention|percutaneous coronary intervention
4887918|NCT02140801|Drug-eluting stent|drug-eluting stent
4887919|NCT02140801|Thrombosis|thrombosis
4887920|NCT02140788|schizophrenia|schizophrenia
4887921|NCT02140788|schizo-affective disorder|schizo-affective disorder
4887922|NCT02140775|HIV|hiv
4887923|NCT02140775|AIDS|aids
4887924|NCT02140775|Fatigue|fatigue
4887925|NCT02140775|armodafinil|armodafinil
4887926|NCT02140775|Unemployment|unemployment
4887927|NCT02140762|Meningitis ABCWY|meningitis abcwy
4887928|NCT02140762|Adolescents|adolescents
4887929|NCT02140762|Vaccination|vaccination
4887930|NCT02140762|Meningococcal disease|meningococcal disease
4887931|NCT02140749|Bifidobacteria|bifidobacteria
4887932|NCT02140749|Bristol Stool Scale|bristol stool scale
4887933|NCT02140749|Constipation|constipation
4887934|NCT02140749|Diet|diet
4887935|NCT02140749|Fructooligosacchardes|fructooligosacchardes
4887936|NCT02140749|Microbiota|microbiota
4887937|NCT02140749|Oligofructose|oligofructose
4887938|NCT02140736|Chemotherapy-induced anemia|chemotherapy-induced anemia
4887939|NCT02140736|Epoetin biosimilar|epoetin biosimilar
4887940|NCT02140723|preoperative short course radiotherapy|preoperative short course radiotherapy
4887941|NCT02140723|delay of surgery|delay of surgery
4887942|NCT02140723|rectal cancer|rectal cancer
4887943|NCT02140723|TP53|tp53
4887944|NCT02140723|predictive marker|predictive marker
4887945|NCT02140723|MRT imaging|mrt imaging
4887946|NCT02140710|premature infant|premature infant
4887947|NCT02140710|visceral osteopathy|visceral osteopathy
4887948|NCT02140710|alternative medicine|alternative medicine
4887949|NCT02140710|meconium passage|meconium passage
4887950|NCT02140710|enteral feedings|enteral feedings
4887951|NCT02140710|hospital stay|hospital stay
4887952|NCT02140684|Real-world|real-world
4887953|NCT02140684|observational|observational
4887954|NCT02140684|Nitric oxide|nitric oxide
4887955|NCT02140684|Inhaled corticosteroid|inhaled corticosteroid
4887956|NCT02140684|UK|uk
4887957|NCT02140671|asthma management|asthma management
4887958|NCT02140671|anti-inflammatory therapy|anti-inflammatory therapy
4887959|NCT02140671|compliance|compliance
4887960|NCT02140671|hospital admission|hospital admission
4887961|NCT02140671|educations|educations
4887962|NCT02140671|self-management|self-management
4887963|NCT02140671|guidelines|guidelines
4887964|NCT02140671|exacerbations|exacerbations
4887965|NCT02140671|diagnostic accuracy|diagnostic accuracy
4887966|NCT02140671|symptom control|symptom control
4887967|NCT02140658|ischemic stroke|ischemic stroke
4887968|NCT02140658|Statins Medication Compliance|statins medication compliance
4887969|NCT02140658|outcome|outcome
4887970|NCT02140632|Carpal tunnel syndrome|carpal tunnel syndrome
4887971|NCT02140632|Local steroid injection|local steroid injection
4887972|NCT02140632|Wrist splinting|wrist splinting
4887973|NCT02140619|ischemic stroke|ischemic stroke
4887974|NCT02140619|Medication Compliance|medication compliance
4887975|NCT02140619|outcome|outcome
4887976|NCT02140606|AML|aml
4887977|NCT02140606|phase1|phase1
4887978|NCT02140606|MTD|mtd
4887979|NCT02140606|Cafusertib|cafusertib
4887980|NCT02140580|Minimally-invasive surfactant therapy|minimally-invasive surfactant therapy
4887981|NCT02140541|Asthma|asthma
4887982|NCT02140541|Blood eosinophils|blood eosinophils
4887983|NCT02140541|Sputum eosinophils|sputum eosinophils
4887984|NCT02140541|Clinical predictor|clinical predictor
4887985|NCT02140541|UK primary care|uk primary care
4887986|NCT02140541|Global Initiative for Asthma (GINA)|global initiative for asthma (gina)
4887987|NCT02140528|Allogenic adipose derived mesenchymal stem cell tibial fracture|allogenic adipose derived mesenchymal stem cell tibial fracture
4887988|NCT02140515|Gonal-F Luveris Assisted Reproductive Technology Hypogonadotropic Hypogonadism|gonal-f luveris assisted reproductive technology hypogonadotropic hypogonadism
4887989|NCT02140502|Enterobacterial Infections|enterobacterial infections
4887990|NCT02140502|Prostate cancer|prostate cancer
4887991|NCT02140502|Biopsy|biopsy
4887992|NCT02140502|Incidence of fluoroquinolone resistant enteric bacteria|incidence of fluoroquinolone resistant enteric bacteria
4887993|NCT02140476|Thyroid goiter|thyroid goiter
4887994|NCT02140476|Papillary thyroid cancer|papillary thyroid cancer
4887995|NCT02140476|Bipolar device|bipolar device
4887996|NCT02140476|Sealing and cutting device|sealing and cutting device
4887997|NCT02140476|Thyroidectomy|thyroidectomy
4887998|NCT02140450|intraocular pressure, intravitreal injection, short term|intraocular pressure, intravitreal injection, short term
4887999|NCT02140437|Fulvestrant|fulvestrant
4888000|NCT02140437|Anastrozole|anastrozole
4888001|NCT02140437|Luminal A-like|luminal a-like
4888002|NCT02140437|Postmenopausal|postmenopausal
4888003|NCT02140437|Advanced breast cancer|advanced breast cancer
4888004|NCT02140424|type 1 diabetes|type 1 diabetes
4888005|NCT02140424|osteoporosis|osteoporosis
4888006|NCT02140424|children|children
4888007|NCT02140398|infertility|infertility
4888008|NCT02140398|PCOS|pcos
4888009|NCT02140398|scratching|scratching
4888010|NCT02140398|endometrial receptivity|endometrial receptivity
4888011|NCT02140372|colchicine|colchicine
4888012|NCT02140372|platelet activity|platelet activity
4888013|NCT02140372|neutrophil|neutrophil
4888014|NCT02140359|homelessness|homelessness
4888015|NCT02140359|housing first|housing first
4888016|NCT02140359|social networks|social networks
4888017|NCT02140359|drug abuse|drug abuse
4888018|NCT02140359|alcohol use|alcohol use
4888019|NCT02140359|HIV|hiv
4888020|NCT02140333|erlotinib|erlotinib
4888021|NCT02140333|EGFR mutation|egfr mutation
4888022|NCT02140307|Health Promotion|health promotion
4888023|NCT02140307|Prevention|prevention
4888024|NCT02140307|Relaxation Response|relaxation response
4888025|NCT02140307|Meditation|meditation
4888026|NCT02140307|Cortisol|cortisol
4888027|NCT02140281|Phase I, Healthy Volunteers|phase i, healthy volunteers
4888028|NCT02140268|Phase I|phase i
4888029|NCT02140268|Healthy|healthy
4888030|NCT02140268|Pharmacokinetics|pharmacokinetics
4888031|NCT02140255|HIV Remission|hiv remission
4888032|NCT02140242|AML|aml
4888033|NCT02140242|leukemia|leukemia
4888034|NCT02140242|induction treatment|induction treatment
4888035|NCT02140242|daunorubicin|daunorubicin
4888036|NCT02140242|7+3|7+3
4888037|NCT02140229|Rheumatoid Arthritis|rheumatoid arthritis
4888038|NCT02140229|Remission,|remission,
4888039|NCT02140229|DAS28,|das28,
4888040|NCT02140229|ACR/EULAR,|acr/eular,
4888041|NCT02140229|RAPID, Randomized study,|rapid, randomized study,
4888042|NCT02140229|Longitudinal follow-up|longitudinal follow-up
4888043|NCT02140216|Blood transfusion|blood transfusion
4888044|NCT02140216|Immune|immune
4888045|NCT02140216|Surgery|surgery
4888046|NCT02140203|Metabolic Syndrome|metabolic syndrome
4888047|NCT02140203|Waist circumference|waist circumference
4888048|NCT02140203|blood pressure|blood pressure
4888049|NCT02140203|triglyceride|triglyceride
4888050|NCT02140203|HDL|hdl
4888051|NCT02140177|Screening|screening
4888052|NCT02140177|Adults|adults
4888053|NCT02140177|Medical Inpatients|medical inpatients
4888054|NCT02140177|Suicide|suicide
4888055|NCT02140164|Cystoid Macular Edema|cystoid macular edema
4888056|NCT02140164|Minocycline|minocycline
4888057|NCT02140164|Microglia|microglia
4888058|NCT02140164|Retinitis Pigmentosa|retinitis pigmentosa
4888059|NCT02140151|amd|amd
4888060|NCT02140151|non-exudative macular degeneration|non-exudative macular degeneration
4888061|NCT02140151|exudative macular degeneration|exudative macular degeneration
4888062|NCT02140151|age-related macular degeneration|age-related macular degeneration
4888063|NCT02140151|ranibizumab|ranibizumab
4888064|NCT02140151|anti-VEGF|anti-vegf
4888065|NCT02140125|ASP2408|asp2408
4888066|NCT02140112|T. suis ova|t. suis ova
4888067|NCT02140112|Trichuris suis ova|trichuris suis ova
4888068|NCT02140112|Autism Spectrum Disorder|autism spectrum disorder
4888069|NCT02140112|ASD|asd
4888070|NCT02140099|Mental health|mental health
4888071|NCT02140099|Violence|violence
4888072|NCT02140099|Substance use|substance use
4888073|NCT02140099|Adolescent|adolescent
4888074|NCT02140099|Prevention|prevention
4888075|NCT02140086|asthma|asthma
4888076|NCT02140086|Buteyko|buteyko
4888077|NCT02140086|remedial breathing|remedial breathing
4888078|NCT02140086|children|children
4888079|NCT02140073|GERD|gerd
4888080|NCT02140073|Omez|omez
4888081|NCT02140073|Omez DSR|omez dsr
4888082|NCT02140073|heartburn|heartburn
4888083|NCT02140073|esophagitis|esophagitis
4888084|NCT02140073|omeprazole|omeprazole
4888085|NCT02140073|omeprazole+domperidone|omeprazole+domperidone
4888086|NCT02140060|Glaucoma|glaucoma
4888087|NCT02140060|Ocular|ocular
4888088|NCT02140060|Hypertension|hypertension
4888089|NCT02140060|OAG|oag
4888090|NCT02140060|POAG|poag
4888091|NCT02140060|OHT|oht
4888092|NCT02140047|Haemophilus influenza type b|haemophilus influenza type b
4888093|NCT02140047|Hib|hib
4888094|NCT02140034|Extensive Peritoneal Lavage|extensive peritoneal lavage
4888095|NCT02140034|Overall Survival|overall survival
4888096|NCT02140034|Disease Free Survival|disease free survival
4888097|NCT02140034|Peritoneal Recurrence Rate|peritoneal recurrence rate
4888098|NCT02140034|T3 and T4 Gastric Cancer|t3 and t4 gastric cancer
4888099|NCT02140021|Malignant Female Reproductive System Neoplasm|malignant female reproductive system neoplasm
4888100|NCT02140021|Gynecological Cancer|gynecological cancer
4888101|NCT02140021|High-grade dysplasia|high-grade dysplasia
4888102|NCT02140021|Carcinoma of the cervix|carcinoma of the cervix
4888103|NCT02140021|Carcinoma of the vagina|carcinoma of the vagina
4888104|NCT02140021|Carcinoma of the vulva|carcinoma of the vulva
4888105|NCT02140021|Invasive squamous cell carcinoma|invasive squamous cell carcinoma
4888106|NCT02140021|Anal pap test|anal pap test
4888107|NCT02140021|Anoscopy|anoscopy
4888108|NCT02140008|supraglottic airway devices|supraglottic airway devices
4888109|NCT02140008|the i-gel|the i-gel
4888110|NCT02140008|the self-pressurised air-Q intubating laryngeal airway,|the self-pressurised air-q intubating laryngeal airway,
4888111|NCT02140008|children|children
4888112|NCT02139995|transfusion|transfusion
4888113|NCT02139995|trigger|trigger
4888114|NCT02139995|critically-ill|critically-ill
4888115|NCT02139982|hemodynamics|hemodynamics
4888116|NCT02139982|anaesthetics|anaesthetics
4888117|NCT02139982|brachial plexus|brachial plexus
4888118|NCT02139982|peripheral nerves|peripheral nerves
4888119|NCT02139982|skin temperature|skin temperature
4888120|NCT02139982|sympathetic nervous system|sympathetic nervous system
4888121|NCT02139982|dose-response relationship|dose-response relationship
4888122|NCT02139943|Diabetes Mellitus, Type 1|diabetes mellitus, type 1
4888123|NCT02139943|Canagliflozin|canagliflozin
4888124|NCT02139943|Continuous Glucose Monitoring|continuous glucose monitoring
4888125|NCT02139930|smoking|smoking
4888126|NCT02139930|nicotine reduction|nicotine reduction
4888127|NCT02139917|transitional palliative care|transitional palliative care
4888128|NCT02139917|end stage renal failure|end stage renal failure
4888129|NCT02139904|Mesothelioma|mesothelioma
4888130|NCT02139904|Vinorelbine|vinorelbine
4888131|NCT02139904|BRCA1|brca1
4888132|NCT02139891|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
4888133|NCT02139891|non responders|non responders
4888134|NCT02139891|MultiPoint Pacing (MPP)|multipoint pacing (mpp)
4888135|NCT02139813|Obesity -|obesity -
4888136|NCT02139813|Bariatric surgery|bariatric surgery
4888137|NCT02139813|Gastric bypass|gastric bypass
4888138|NCT02139800|Neonatal resuscitation|neonatal resuscitation
4888139|NCT02139800|Extreme Low Gestational Age Newborn (ELGAN)|extreme low gestational age newborn (elgan)
4888140|NCT02139800|Delivery Room|delivery room
4888141|NCT02139800|Continuous positive airway pressure (CPAP)|continuous positive airway pressure (cpap)
4888142|NCT02139800|Positive pressure ventilation (PPV)|positive pressure ventilation (ppv)
4888143|NCT02139800|Sustained inflation|sustained inflation
4888144|NCT02139787|Hypertension, obesity|hypertension, obesity
4888145|NCT02139787|Dietary behaviors|dietary behaviors
4888146|NCT02139787|Physical activity behaviors|physical activity behaviors
4888147|NCT02139787|Radio story, entertainment health education|radio story, entertainment health education
4888148|NCT02139787|Immigrants|immigrants
4888149|NCT02139787|Somali, Latino, Hmong|somali, latino, hmong
4888150|NCT02139787|Families with 3-18 year old children|families with 3-18 year old children
4888151|NCT02139774|Prostate Cancer|prostate cancer
4888152|NCT02139774|Elderly|elderly
4888153|NCT02139774|Geriatric|geriatric
4888154|NCT02139774|Radiation|radiation
4888155|NCT02139774|Arthritis|arthritis
4888156|NCT02139774|Exercise|exercise
4888157|NCT02139774|Walking|walking
4888158|NCT02139774|Endocrine Therapy|endocrine therapy
4888159|NCT02139774|Androgen Deprivation Therapy|androgen deprivation therapy
4888160|NCT02139774|Active Surveillance|active surveillance
4888161|NCT02139774|Men|men
4888162|NCT02139761|Cocaine|cocaine
4888163|NCT02139761|Treatment|treatment
4888164|NCT02139748|Dental Implants|dental implants
4888165|NCT02139748|Alveolar Bone Grafting|alveolar bone grafting
4888166|NCT02139748|Acellular Dermis|acellular dermis
4888167|NCT02139735|Temporomandibular Joint Disorders,|temporomandibular joint disorders,
4888168|NCT02139735|Ultrasonics,|ultrasonics,
4888169|NCT02139735|Electromyography,|electromyography,
4888170|NCT02139735|Pain Measurement,|pain measurement,
4888171|NCT02139735|Muscle Stretching Exercise|muscle stretching exercise
4888172|NCT02139722|hepatitis B|hepatitis b
4888173|NCT02139722|hepatitis C|hepatitis c
4888174|NCT02139722|screening|screening
4888175|NCT02139722|Asian Americans|asian americans
4888176|NCT02139722|mobile technology|mobile technology
4888177|NCT02139657|Rabies|rabies
4888178|NCT02139657|Rabies virus|rabies virus
4888179|NCT02139657|Rhabdoviridae|rhabdoviridae
4888180|NCT02139657|Rabies immune globulin|rabies immune globulin
4888181|NCT02139657|Rabies antibodies|rabies antibodies
4888182|NCT02139657|Passive rabies immunization|passive rabies immunization
4888183|NCT02139644|fluticasone propionate|fluticasone propionate
4888184|NCT02139644|multidose dry powder inhaler|multidose dry powder inhaler
4888185|NCT02139631|hemodynamic|hemodynamic
4888186|NCT02139631|mechanical ventilation|mechanical ventilation
4888187|NCT02139631|respiration with positive pressure|respiration with positive pressure
4888188|NCT02139618|Randomized-controlled-trial|randomized-controlled-trial
4888189|NCT02139618|Methyl-Aminolevulinate|methyl-aminolevulinate
4888190|NCT02139618|Daylight|daylight
4888191|NCT02139618|Photodynamic-therapy|photodynamic-therapy
4888192|NCT02139605|D2 versus D3 Lymphadenectomy|d2 versus d3 lymphadenectomy
4888193|NCT02139592|Pharmacological therapy|pharmacological therapy
4888194|NCT02139579|chemotherapy|chemotherapy
4888195|NCT02139579|EGFR-TKI resistance|egfr-tki resistance
4888196|NCT02139579|Bevacizumab|bevacizumab
4888197|NCT02139553|Rhythmic versus discrete movements|rhythmic versus discrete movements
4888198|NCT02139553|Rehabilitation|rehabilitation
4888199|NCT02139540|Treatment|treatment
4888200|NCT02139527|arthroplasty|arthroplasty
4888201|NCT02139527|spinal|spinal
4888202|NCT02139527|CHARITE|charite
4888203|NCT02139527|PRODISC-L|prodisc-l
4888204|NCT02139527|PRODISC|prodisc
4888205|NCT02139527|disc|disc
4888206|NCT02139527|replacement|replacement
4888207|NCT02139527|lumbar|lumbar
4888208|NCT02139514|Social Skills|social skills
4888209|NCT02139514|Adults|adults
4888210|NCT02139501|Recombinant Human Thrombopoietin|recombinant human thrombopoietin
4888211|NCT02139501|Dose and frequency|dose and frequency
4888212|NCT02139501|Immune Thrombocytopenia|immune thrombocytopenia
4888213|NCT02139488|Esophageal cancer|esophageal cancer
4888214|NCT02139488|Chemoradiation|chemoradiation
4888215|NCT02139475|bowel cleansing, colorectal cancer surgery|bowel cleansing, colorectal cancer surgery
4888216|NCT02139462|FBT, fidelity, training|fbt, fidelity, training
4888217|NCT02139449|CRT, heart failure, ICD|crt, heart failure, icd
4888218|NCT02139423|Congenital cytomegalovirus infection|congenital cytomegalovirus infection
4888219|NCT02139423|newborn universal hearing screening|newborn universal hearing screening
4888220|NCT02139410|sarcopenia|sarcopenia
4888221|NCT02139410|mortality|mortality
4888222|NCT02139384|procalcitonin|procalcitonin
4888223|NCT02139384|community acquired pneumonia|community acquired pneumonia
4888224|NCT02139384|pneumonia score|pneumonia score
4888225|NCT02139371|Positron Emission Tomography|positron emission tomography
4888226|NCT02139371|Uroplasminogen Plasminogen Activator Receptor|uroplasminogen plasminogen activator receptor
4888227|NCT02139371|Breast cancer|breast cancer
4888228|NCT02139371|Prostate cancer|prostate cancer
4888326|NCT02138929|Zortress|zortress
4888229|NCT02139371|Urinary bladder cancer|urinary bladder cancer
4888230|NCT02139371|Biodistribution|biodistribution
4888231|NCT02139371|Radiation exposure|radiation exposure
4888232|NCT02139358|Breast - Female|breast - female
4888233|NCT02139358|Metastatic|metastatic
4888234|NCT02139358|HER2+|her2+
4888235|NCT02139345|Osteoarthritis|osteoarthritis
4888236|NCT02139345|Rheumatoid arthritis|rheumatoid arthritis
4888237|NCT02139345|Post-traumatic arthritis|post-traumatic arthritis
4888238|NCT02139345|Avascular necrosis|avascular necrosis
4888239|NCT02139345|AVN|avn
4888240|NCT02139332|Attachment theory|attachment theory
4888241|NCT02139332|Parent- child relationship|parent- child relationship
4888242|NCT02139332|Child mental health|child mental health
4888243|NCT02139332|Behavioral health|behavioral health
4888244|NCT02139293|vagus nerve stimulation effects on heart rate variability and peripheral blood perfusion|vagus nerve stimulation effects on heart rate variability and peripheral blood perfusion
4888245|NCT02139280|Cyclophosphamide|cyclophosphamide
4888246|NCT02139280|Hematopoietic|hematopoietic
4888247|NCT02139280|Stem Cell|stem cell
4888248|NCT02139280|Mobilization|mobilization
4888249|NCT02139280|Hematologic Malignancy|hematologic malignancy
4888250|NCT02139267|CIN3|cin3
4888251|NCT02139267|Cervical Intraepithelial Neoplasia|cervical intraepithelial neoplasia
4888252|NCT02139267|High-Risk HPV|high-risk hpv
4888253|NCT02139267|HPV Infection|hpv infection
4888254|NCT02139267|Neoplasm|neoplasm
4888255|NCT02139267|Precancerous Diseases|precancerous diseases
4888256|NCT02139267|Uterine Diseases|uterine diseases
4888257|NCT02139267|Genital Diseases, Female|genital diseases, female
4888258|NCT02139254|Gestational Diabetes|gestational diabetes
4888259|NCT02139254|HbA1c|hba1c
4888260|NCT02139254|Glucose|glucose
4888261|NCT02139254|First Trimenon|first trimenon
4888262|NCT02139228|Haemophilus influenzae type b|haemophilus influenzae type b
4888263|NCT02139228|persistency|persistency
4888264|NCT02139228|children|children
4888265|NCT02139228|CRM197|crm197
4888266|NCT02139228|anti-PRP antibody|anti-prp antibody
4888267|NCT02139202|Acute|acute
4888268|NCT02139202|Myocardial|myocardial
4888269|NCT02139202|Infarction|infarction
4888270|NCT02139202|AMI|ami
4888271|NCT02139176|couple HIV testing and counseling|couple hiv testing and counseling
4888272|NCT02139176|disclosure|disclosure
4888273|NCT02139176|discordant|discordant
4888274|NCT02139176|HIV|hiv
4888275|NCT02139176|Malawi|malawi
4888276|NCT02139163|Community acquired pneumonia|community acquired pneumonia
4888277|NCT02139163|CAP|cap
4888278|NCT02139163|CAPNETZ|capnetz
4888279|NCT02139163|age ≥18|age ≥18
4888280|NCT02139163|infiltrate on chest X-ray|infiltrate on chest x-ray
4888281|NCT02139163|cough or production of purulent sputum|cough or production of purulent sputum
4888282|NCT02139163|pathologic lung auscultation|pathologic lung auscultation
4888283|NCT02139163|fever|fever
4888284|NCT02139150|FLT PET Imaging|flt pet imaging
4888285|NCT02139150|3'deoxy-3' [18F] fluorothymidine ([18F] FLT)|3'deoxy-3' [18f] fluorothymidine ([18f] flt)
4888286|NCT02139150|CT|ct
4888287|NCT02139150|scans|scans
4888288|NCT02139150|14-050|14-050
4888289|NCT02139098|sleep architecture|sleep architecture
4888290|NCT02139098|conditioning of pharmacological responses|conditioning of pharmacological responses
4888291|NCT02139098|insomnia|insomnia
4888292|NCT02139085|varicose veins|varicose veins
4888293|NCT02139085|catheter ablation|catheter ablation
4888294|NCT02139085|Catheter Ablation, Electrical|catheter ablation, electrical
4888295|NCT02139085|Catheter Ablation, Radiofrequency|catheter ablation, radiofrequency
4888296|NCT02139072|Anticoagulation|anticoagulation
4888297|NCT02139072|International normalized ratio|international normalized ratio
4888298|NCT02139072|Warfarin|warfarin
4888299|NCT02139059|anuria|anuria
4888300|NCT02139059|children|children
4888301|NCT02139059|ureteroscopy|ureteroscopy
4888302|NCT02139059|initial urinary drainage|initial urinary drainage
4888303|NCT02139059|ureteric stones|ureteric stones
4888304|NCT02139046|Drug therapy|drug therapy
4888305|NCT02139033|Dry Eye, Dry Eye Syndrome, Retaine, KCS, Keratoconjunctivitis sicca|dry eye, dry eye syndrome, retaine, kcs, keratoconjunctivitis sicca
4888306|NCT02139020|Targeted therapies|targeted therapies
4888307|NCT02139020|Plasma samples|plasma samples
4888308|NCT02138981|Hepatocellular Carcinoma|hepatocellular carcinoma
4888309|NCT02138981|Milan Criteria|milan criteria
4888310|NCT02138968|Pre-frailty|pre-frailty
4888311|NCT02138968|Frail|frail
4888312|NCT02138968|Exercise|exercise
4888313|NCT02138968|Nutritional assessment|nutritional assessment
4888314|NCT02138968|Functional capacity|functional capacity
4888315|NCT02138942|automated vascular filling|automated vascular filling
4888316|NCT02138942|Learning Intravenous Resuscitator (LIR)|learning intravenous resuscitator (lir)
4888317|NCT02138942|General Surgery|general surgery
4888318|NCT02138942|Fluid Therapy|fluid therapy
4888319|NCT02138929|Esophageal Cancer|esophageal cancer
4888320|NCT02138929|Advanced adenocarcinoma of the esophagus|advanced adenocarcinoma of the esophagus
4888321|NCT02138929|Advanced adenocarcinoma of the gastroesophageal junction|advanced adenocarcinoma of the gastroesophageal junction
4888322|NCT02138929|GEJ|gej
4888323|NCT02138929|Metastatic|metastatic
4888324|NCT02138929|Everolimus|everolimus
4888325|NCT02138929|Afinitor|afinitor
4888327|NCT02138929|RAD001|rad001
4888328|NCT02138929|LDE 225|lde 225
4888329|NCT02138916|Obstructive Lung Diseases|obstructive lung diseases
4888330|NCT02138916|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
4888331|NCT02138916|Lung Disease|lung disease
4888332|NCT02138916|Bronchial Diseases|bronchial diseases
4888333|NCT02138916|COPD Exacerbation|copd exacerbation
4888334|NCT02138916|Respiratory Tract Diseases|respiratory tract diseases
4888335|NCT02138903|weaning|weaning
4888336|NCT02138903|Cardiac|cardiac
4888337|NCT02138903|Echocardiography|echocardiography
4888338|NCT02138903|Mechanical Ventilation|mechanical ventilation
4888339|NCT02138890|Autologous Protein Solution|autologous protein solution
4888340|NCT02138890|APS|aps
4888341|NCT02138890|Osteoarthritis|osteoarthritis
4888342|NCT02138890|Intra Articular Injection|intra articular injection
4888343|NCT02138877|Pelviureteric junction obstruction|pelviureteric junction obstruction
4888344|NCT02138877|pyeloplasty|pyeloplasty
4888345|NCT02138877|Neonate affected by hydronephrosis|neonate affected by hydronephrosis
4888346|NCT02138877|obstructive uropathy|obstructive uropathy
4888347|NCT02138877|urinary stent|urinary stent
4888348|NCT02138864|carbon monoxide intoxication|carbon monoxide intoxication
4888349|NCT02138864|Parkinsonism|parkinsonism
4888350|NCT02138864|18F-DTBZ AV-133|18f-dtbz av-133
4888351|NCT02138838|Chronic Kidney Disease, Secondary Hyperparathyroidism, Dialysis, Pediatric|chronic kidney disease, secondary hyperparathyroidism, dialysis, pediatric
4888352|NCT02138812|Phase 1|phase 1
4888353|NCT02138812|Solid tumors|solid tumors
4888354|NCT02138812|Breast cancer|breast cancer
4888355|NCT02138812|Paclitaxel|paclitaxel
4888356|NCT02138812|MPS-1 inhibitor|mps-1 inhibitor
4888357|NCT02138812|Taxanes|taxanes
4888358|NCT02138799|Phase I|phase i
4888359|NCT02138799|Pharmacokinetics|pharmacokinetics
4888360|NCT02138799|Safety|safety
4888361|NCT02138799|Drug-drug interactions|drug-drug interactions
4888362|NCT02138799|Enzalutamide|enzalutamide
4888363|NCT02138799|Rifampin|rifampin
4888364|NCT02138799|CYP3A4|cyp3a4
4888365|NCT02138799|CYP2D8|cyp2d8
4888366|NCT02138799|Enzyme induction|enzyme induction
4888367|NCT02138786|Richter's Transformation|richter's transformation
4888368|NCT02138786|Richter's Syndrome|richter's syndrome
4888369|NCT02138786|Karyopharm|karyopharm
4888370|NCT02138786|selinexor|selinexor
4888371|NCT02138786|KPT-330|kpt-330
4888372|NCT02138786|SIRRT|sirrt
4888373|NCT02138786|CLL|cll
4888374|NCT02138773|prolonged release formulation|prolonged release formulation
4888375|NCT02138773|adrenergic blocker|adrenergic blocker
4888376|NCT02138773|Bioequivalence|bioequivalence
4888377|NCT02138760|prostate cancer|prostate cancer
4888378|NCT02138760|prostate biopsy|prostate biopsy
4888379|NCT02138760|magnetic resonance imaging guidance|magnetic resonance imaging guidance
4888380|NCT02138760|detection rates|detection rates
4888381|NCT02138760|performance|performance
4888382|NCT02138747|Overactive bladder (OAB)|overactive bladder (oab)
4888383|NCT02138747|tolterodine ER|tolterodine er
4888384|NCT02138747|mirabegron|mirabegron
4888385|NCT02138734|antitumor|antitumor
4888386|NCT02138734|BCG|bcg
4888387|NCT02138734|bladder cancer|bladder cancer
4888388|NCT02138734|cancer|cancer
4888389|NCT02138734|immunotherapy|immunotherapy
4888390|NCT02138734|instillation|instillation
4888391|NCT02138734|interleukin-15|interleukin-15
4888392|NCT02138734|intravesical|intravesical
4888393|NCT02138734|naive|naive
4888394|NCT02138734|non-muscle invasive|non-muscle invasive
4888395|NCT02138734|transitional cell carcinoma|transitional cell carcinoma
4888396|NCT02138734|ALT-803|alt-803
4888397|NCT02138721|Metastatic Prostate Cancer|metastatic prostate cancer
4888398|NCT02138721|Prostatectomy|prostatectomy
4888399|NCT02138708|Pulmonary arterial hypertension,|pulmonary arterial hypertension,
4888400|NCT02138708|congenital heart disease,|congenital heart disease,
4888401|NCT02138708|heart shunt,|heart shunt,
4888402|NCT02138708|acetylcholine|acetylcholine
4888403|NCT02138708|Pharmacological test of pulmonary vascular reactivity (acetylcholine) in|pharmacological test of pulmonary vascular reactivity (acetylcholine) in
4888404|NCT02138695|atrial fibrillation|atrial fibrillation
4888405|NCT02138695|catheter ablation|catheter ablation
4888406|NCT02138695|recurrence|recurrence
4888407|NCT02138682|DaT-SPECT scan|dat-spect scan
4888408|NCT02138682|Parkinson's|parkinson's
4888409|NCT02138682|Diagnostic|diagnostic
4888410|NCT02138669|Cornea|cornea
4888411|NCT02138669|Keratoconus|keratoconus
4888412|NCT02138669|Steep cornea|steep cornea
4888413|NCT02138656|Crying|crying
4888414|NCT02138656|Chiropractic|chiropractic
4888415|NCT02138656|Infant|infant
4888416|NCT02138656|pediatric|pediatric
4888417|NCT02138656|Infantile colic|infantile colic
4888418|NCT02138656|Clinical Trial|clinical trial
4888419|NCT02138643|Achalasia|achalasia
4888420|NCT02138643|Megaesophagus|megaesophagus
4888421|NCT02138643|Peropal endoscopic myotomy(POEM)|peropal endoscopic myotomy(poem)
4888422|NCT02138643|Laparoscopic Heller myotomy|laparoscopic heller myotomy
4888423|NCT02138630|Exercise|exercise
4888424|NCT02138617|Colon Cancer|colon cancer
4888425|NCT02138617|Irinotecan|irinotecan
4888426|NCT02138617|FOLFIRI|folfiri
4888427|NCT02138617|Genotyping|genotyping
4888428|NCT02138617|UGT1A1|ugt1a1
4888429|NCT02138604|chest pain|chest pain
4888430|NCT02138604|myocardial ischemia|myocardial ischemia
4888431|NCT02138604|acute myocardial dysfunction|acute myocardial dysfunction
4888432|NCT02138604|plethesmography|plethesmography
4888433|NCT02138604|non invasive dP/dt|non invasive dp/dt
4888434|NCT02138591|vitamin d deficiency|vitamin d deficiency
4888435|NCT02138591|cathelicidin antimicrobial peptide|cathelicidin antimicrobial peptide
4888436|NCT02138591|resistin, human|resistin, human
4888437|NCT02138591|protein, human|protein, human
4888438|NCT02138591|1,25-dihydroxy-16,23-diene vitamin D3|1,25-dihydroxy-16,23-diene vitamin d3
4888439|NCT02138591|Cholecalciferol|cholecalciferol
4888440|NCT02138591|Nutritional Status|nutritional status
4888441|NCT02138591|length of stay|length of stay
4888442|NCT02138539|hyperpigmentation|hyperpigmentation
4888443|NCT02138539|melasma|melasma
4888444|NCT02138539|sun spots|sun spots
4888445|NCT02138539|dark spots|dark spots
4888446|NCT02138526|cancer|cancer
4888447|NCT02138526|pazopanib|pazopanib
4888448|NCT02138526|food|food
4888449|NCT02138526|pharmacokinetics|pharmacokinetics
4888450|NCT02138513|Mindfulness|mindfulness
4888451|NCT02138513|MBCT|mbct
4888452|NCT02138513|Cancer|cancer
4888453|NCT02138513|Oncology|oncology
4888454|NCT02138513|E-health|e-health
4888455|NCT02138513|Cost-effectiveness|cost-effectiveness
4888456|NCT02138500|PF-06372865|pf-06372865
4888457|NCT02138500|phase 1|phase 1
4888458|NCT02138500|open-label|open-label
4888459|NCT02138500|GABA-A receptor occupancy|gaba-a receptor occupancy
4888460|NCT02138500|positron emission tomography|positron emission tomography
4888461|NCT02138500|healthy subjects|healthy subjects
4888462|NCT02138487|pelvic organ prolapse|pelvic organ prolapse
4888463|NCT02138487|reconstructive pelvic surgery|reconstructive pelvic surgery
4888464|NCT02138487|postoperative restrictions|postoperative restrictions
4888465|NCT02138487|patient satisfaction|patient satisfaction
4888466|NCT02138474|Lacticum acidum homaccord|lacticum acidum homaccord
4888467|NCT02138474|homeopathy|homeopathy
4888468|NCT02138474|chronic tension-type headaches|chronic tension-type headaches
4888469|NCT02138461|glaucoma|glaucoma
4888470|NCT02138461|bimatoprost|bimatoprost
4888471|NCT02138461|latanoprost|latanoprost
4888472|NCT02138461|tolerability|tolerability
4888473|NCT02138448|Cancer Screenings|cancer screenings
4888474|NCT02138448|Health Information Technology|health information technology
4888475|NCT02138448|Patient Health Record|patient health record
4888476|NCT02138448|Preventive Services|preventive services
4888477|NCT02138422|colorectal cancer|colorectal cancer
4888478|NCT02138383|advanced pancreatic cancer|advanced pancreatic cancer
4888479|NCT02138383|pancreas|pancreas
4888480|NCT02138383|malignant neoplasm|malignant neoplasm
4888481|NCT02138383|endocrine system|endocrine system
4888482|NCT02138357|Restless Legs Syndrome|restless legs syndrome
4888483|NCT02138357|Willis Ekbom Disease|willis ekbom disease
4888484|NCT02138357|Twitchy Legs|twitchy legs
4888485|NCT02138357|Periodic Limb Movements|periodic limb movements
4888486|NCT02138357|Leg Movements|leg movements
4888487|NCT02138357|Augmentation|augmentation
4888488|NCT02138357|Requip|requip
4888489|NCT02138357|ropinirole|ropinirole
4888490|NCT02138357|Mirapex|mirapex
4888491|NCT02138357|pramipexole|pramipexole
4888492|NCT02138357|gabapentin|gabapentin
4888493|NCT02138357|Horizant|horizant
4888494|NCT02138357|Neupro|neupro
4888495|NCT02138357|rotigotine|rotigotine
4888496|NCT02138331|Diabetes Mellitus Type 1|diabetes mellitus type 1
4888497|NCT02138331|Microvesicles|microvesicles
4888498|NCT02138331|Exosomes|exosomes
4888499|NCT02138331|Cord Blood|cord blood
4888500|NCT02138331|Mesenchymal Stem Cells|mesenchymal stem cells
4888501|NCT02138305|Fractional Flow Reserve (FFR)|fractional flow reserve (ffr)
4888502|NCT02138305|Instantaneous Wave Free Ratio (iFR)|instantaneous wave free ratio (ifr)
4888503|NCT02138305|Coronary Flow Reserve (CFR)|coronary flow reserve (cfr)
4888504|NCT02138305|Hyperemic Stenosis Resistance Index (HSR)|hyperemic stenosis resistance index (hsr)
4888505|NCT02138305|Hyperemic microvascular resistance (HMR)|hyperemic microvascular resistance (hmr)
4888506|NCT02138305|Wave intensity analysis (WIA)|wave intensity analysis (wia)
4888507|NCT02138305|Myocardial Perfusion|myocardial perfusion
4888508|NCT02138305|SPY NIRF Regional Myocardial Perfusion Analysis|spy nirf regional myocardial perfusion analysis
4888509|NCT02138253|liver transplant|liver transplant
4888510|NCT02138253|hepatitis C|hepatitis c
4888511|NCT02138253|liver fibrosis|liver fibrosis
4888512|NCT02138253|hepatic fibrosis|hepatic fibrosis
4888513|NCT02138253|liver cirrhosis|liver cirrhosis
4888514|NCT02138253|hepatic cirrhosis|hepatic cirrhosis
4888515|NCT02138227|Organ donation request|organ donation request
4888516|NCT02138227|Effective Communication|effective communication
4888517|NCT02138201|diffusion tensor imaging fiber tracking|diffusion tensor imaging fiber tracking
4888518|NCT02138201|magnetic resonance Imaging|magnetic resonance imaging
4888519|NCT02138201|spinal cord injury|spinal cord injury
4888520|NCT02138201|neurogenic lower urinary tract dysfunction|neurogenic lower urinary tract dysfunction
4888521|NCT02138175|bleeding|bleeding
4888522|NCT02138175|blood loss|blood loss
4888523|NCT02138175|hemoglobin|hemoglobin
4888524|NCT02138175|hemoglobin monitoring|hemoglobin monitoring
4888525|NCT02138175|noninvasive monitoring|noninvasive monitoring
4888526|NCT02138162|Phase 1|phase 1
4888527|NCT02138162|Pharmacokinetics|pharmacokinetics
4888528|NCT02138162|Safety|safety
4888529|NCT02138162|Severe hepatic impairment|severe hepatic impairment
4888530|NCT02138162|Enzalutamide|enzalutamide
4888531|NCT02138149|spinal cord injury|spinal cord injury
4888532|NCT02138149|neurogenic lower urinary tract dysfunction|neurogenic lower urinary tract dysfunction
4888533|NCT02138149|nerve growth factor|nerve growth factor
4888534|NCT02138149|neurogenic detrusor overactivity|neurogenic detrusor overactivity
4888535|NCT02138149|urodynamics|urodynamics
4888536|NCT02138123|dense cataract|dense cataract
4888537|NCT02138123|phacoemulsification|phacoemulsification
4888538|NCT02138123|lens-shell technique|lens-shell technique
4888539|NCT02138123|intraocular lens|intraocular lens
4888540|NCT02138110|Spinal Cord Injury (SCI)|spinal cord injury (sci)
4888541|NCT02138110|Complete (AIS A) Traumatic Acute Spinal Cord Injury|complete (ais a) traumatic acute spinal cord injury
4888542|NCT02138071|low back pain|low back pain
4888543|NCT02138071|lumbar pain|lumbar pain
4888544|NCT02138058|compulsive buying, compulsive shopping, topiramate|compulsive buying, compulsive shopping, topiramate
4888545|NCT02138045|Diabetes Mellitus, Type 1|diabetes mellitus, type 1
4888546|NCT02138045|Diabetic Neuropathy|diabetic neuropathy
4888547|NCT02138045|Liraglutide|liraglutide
4888548|NCT02138032|message framing|message framing
4888549|NCT02138032|smoking cessation|smoking cessation
4888550|NCT02138032|peripheral artery disease|peripheral artery disease
4888551|NCT02138019|corneal ulcers|corneal ulcers
4888552|NCT02138019|conjunctival closure in strabismus surgery|conjunctival closure in strabismus surgery
4888553|NCT02138019|surgery for retinal detachment|surgery for retinal detachment
4888554|NCT02138019|cataract surgery|cataract surgery
4888555|NCT02138019|mucous membrane grafting|mucous membrane grafting
4888556|NCT02137954|cancer|cancer
4888557|NCT02137954|pain|pain
4888558|NCT02137941|Stress|stress
4888559|NCT02137941|occupations|occupations
4888560|NCT02137941|biomarkers|biomarkers
4888561|NCT02137941|firefighters|firefighters
4888562|NCT02137928|Retinoblastoma|retinoblastoma
4888563|NCT02137928|carboplatin|carboplatin
4888565|NCT02137902|Tobacco dependence|tobacco dependence
4888566|NCT02137902|Cardiovascular disease|cardiovascular disease
4888567|NCT02137902|Risk behaviors|risk behaviors
4888568|NCT02137902|Smoking|smoking
4888569|NCT02137902|Physical activity|physical activity
4888570|NCT02137902|Alaska Native people|alaska native people
4888571|NCT02137889|CLL|cll
4888572|NCT02137876|B cells|b cells
4888573|NCT02137876|Thymoglubulin|thymoglubulin
4888574|NCT02137876|humoral rejections|humoral rejections
4888575|NCT02137876|transplant|transplant
4888576|NCT02137876|rATG|ratg
4888577|NCT02137863|Contrast induced nephropathy|contrast induced nephropathy
4888578|NCT02137863|Diabetes Mellitus|diabetes mellitus
4888579|NCT02137863|Dexmedetomidine|dexmedetomidine
4888580|NCT02137837|Metastatic breast cancer|metastatic breast cancer
4888581|NCT02137837|Invasive breast carcinoma|invasive breast carcinoma
4888582|NCT02137837|estrogen receptor-positive breast cancer|estrogen receptor-positive breast cancer
4888583|NCT02137837|HER2-negative breast cancer|her2-negative breast cancer
4888584|NCT02137837|Stage IV breast cancer|stage iv breast cancer
4888585|NCT02137837|progesterone receptor-positive breast cancer|progesterone receptor-positive breast cancer
4888586|NCT02137811|cancer|cancer
4888587|NCT02137811|CorrectChemo|correctchemo
4888588|NCT02137811|assay|assay
4888589|NCT02137811|lab test|lab test
4888590|NCT02137811|MICK assay|mick assay
4888591|NCT02137811|apoptosis|apoptosis
4888592|NCT02137811|increase survival|increase survival
4888593|NCT02137811|increase response rates|increase response rates
4888594|NCT02137811|decrease time to progression|decrease time to progression
4888595|NCT02137811|chemotherapy|chemotherapy
4888596|NCT02137811|cancer treatment|cancer treatment
4888597|NCT02137798|fluoroscopy exposure|fluoroscopy exposure
4888598|NCT02137798|paroxysmal atrial fibrillation Ablation|paroxysmal atrial fibrillation ablation
4888599|NCT02137798|fluoroscopy|fluoroscopy
4888600|NCT02137798|Atrial Fibrillation Ablation|atrial fibrillation ablation
4888601|NCT02137785|Actinic Keratosis|actinic keratosis
4888602|NCT02137759|Glioblastoma|glioblastoma
4888603|NCT02137746|Prostate Cancer|prostate cancer
4888604|NCT02137746|Radical Prostatectomy|radical prostatectomy
4888605|NCT02137720|Diabetes|diabetes
4888606|NCT02137720|Treatment Adherence|treatment adherence
4888607|NCT02137720|Self-management|self-management
4888608|NCT02137720|Emotional Distress|emotional distress
4888609|NCT02137720|Diabetes-related Distress|diabetes-related distress
4888610|NCT02137707|Multiple Sclerosis, Relapsing-Remitting|multiple sclerosis, relapsing-remitting
4888611|NCT02137707|Gilenya|gilenya
4888612|NCT02137707|Fingolimod|fingolimod
4888613|NCT02137694|Papillomavirus|papillomavirus
4888614|NCT02137694|Vaginal auto-takings|vaginal auto-takings
4888615|NCT02137694|Urinary test|urinary test
4888616|NCT02137681|immune thrombocytopenia|immune thrombocytopenia
4888617|NCT02137681|rituximab|rituximab
4888618|NCT02137681|efficacy|efficacy
4888619|NCT02137681|safety|safety
4888620|NCT02137642|constipation|constipation
4888621|NCT02137629|Myelodysplastic syndromes|myelodysplastic syndromes
4888622|NCT02137629|Vidaza|vidaza
4888623|NCT02137629|Observational study|observational study
4888624|NCT02137629|Korea|korea
4888625|NCT02137616|psychosis|psychosis
4888626|NCT02137616|syndrome|syndrome
4888627|NCT02137616|risk|risk
4888628|NCT02137616|antipsychotic|antipsychotic
4888629|NCT02137603|Suppurative appendicitis, appendicitis, pediatric|suppurative appendicitis, appendicitis, pediatric
4888630|NCT02137590|Spanish Black Radish|spanish black radish
4888631|NCT02137590|Phase I detoxification enzymes|phase i detoxification enzymes
4888632|NCT02137590|Phase II detoxification enzymes|phase ii detoxification enzymes
4888633|NCT02137590|Acetaminophen|acetaminophen
4888634|NCT02137577|drug eluting balloon catheter|drug eluting balloon catheter
4888635|NCT02137551|adherence|adherence
4888636|NCT02137551|healthcare costs|healthcare costs
4888637|NCT02137551|appointment based model|appointment based model
4888638|NCT02137551|accountable care organization|accountable care organization
4888639|NCT02137512|Artificial Pancreas|artificial pancreas
4888640|NCT02137486|stable angina|stable angina
4888641|NCT02137486|high angulated bifurcation|high angulated bifurcation
4888642|NCT02137486|SYNTAX|syntax
4888643|NCT02137486|DES|des
4888644|NCT02137486|BMS|bms
4888645|NCT02137460|Alzheimer's disease|alzheimer's disease
4888646|NCT02137460|Early diagnosis|early diagnosis
4888647|NCT02137460|Prediction|prediction
4888648|NCT02137460|Biomarker|biomarker
4888649|NCT02137460|Imaging|imaging
4888650|NCT02137447|Prevena|prevena
4888651|NCT02137447|faster healing time|faster healing time
4888652|NCT02137447|surgical site infection|surgical site infection
4888653|NCT02137434|Acute calcium|acute calcium
4888654|NCT02137434|Dietary calcium|dietary calcium
4888655|NCT02137434|Supplementary calcium|supplementary calcium
4888656|NCT02137434|Postprandial metabolism|postprandial metabolism
4888657|NCT02137421|Coronary artery disease|coronary artery disease
4888658|NCT02137421|Metabolic syndrome|metabolic syndrome
4888659|NCT02137421|Resveratrol|resveratrol
4888660|NCT02137421|β-catenin|β-catenin
4888661|NCT02137421|Wnt signaling|wnt signaling
4888662|NCT02137421|FOXO|foxo
4888663|NCT02137421|MnSOD|mnsod
4888664|NCT02137408|Chronic hypertension in pregnancy|chronic hypertension in pregnancy
4888665|NCT02137408|Pre-term delivery|pre-term delivery
4888666|NCT02137408|Preeclampsia|preeclampsia
4888667|NCT02137408|Endothelial Health|endothelial health
4888668|NCT02137408|Docosahexaenoic acid (DHA)|docosahexaenoic acid (dha)
4888669|NCT02137395|Children, Dexamethasone, Sugammadex,|children, dexamethasone, sugammadex,
4888670|NCT02137382|maldigestion of dietary macronutrients (pancreas not producing enough enzymes for digestion of fat, sugars and proteins) in Cystic Fibrosis|maldigestion of dietary macronutrients (pancreas not producing enough enzymes for digestion of fat, sugars and proteins) in cystic fibrosis
4888671|NCT02137369|MDD|mdd
4888672|NCT02137369|Major Depressive Disorder|major depressive disorder
4888673|NCT02137369|Treatment|treatment
4888674|NCT02137369|Antidepressants|antidepressants
4888675|NCT02137369|Lexapro|lexapro
4888676|NCT02137369|Talk therapy|talk therapy
4888677|NCT02137356|rectal cancer|rectal cancer
4888678|NCT02137356|rectal adenocarcinoma|rectal adenocarcinoma
4888679|NCT02137356|Selinexor|selinexor
4888680|NCT02137356|capecitabine|capecitabine
4888681|NCT02137356|chemoradiation|chemoradiation
4888682|NCT02137356|radiation|radiation
4888683|NCT02137356|radiotherapy|radiotherapy
4888684|NCT02137356|neoadjuvant|neoadjuvant
4888685|NCT02137356|locally advanced rectal cancer|locally advanced rectal cancer
4888686|NCT02137343|Gastric Cancer|gastric cancer
4888687|NCT02137343|First Line Treatment Gastroesophageal Junction (GEJ)|first line treatment gastroesophageal junction (gej)
4888688|NCT02137343|Gastroesophageal Junction Cancer (GEJ)|gastroesophageal junction cancer (gej)
4888689|NCT02137343|GEJ Cancer|gej cancer
4888690|NCT02137330|Obalon swallowable intragastric balloons|obalon swallowable intragastric balloons
4888691|NCT02137330|Severe obesity|severe obesity
4888692|NCT02137330|Children|children
4888693|NCT02137317|Pesticides|pesticides
4888694|NCT02137317|Personal protective equipment|personal protective equipment
4888695|NCT02137317|Developing countries|developing countries
4888696|NCT02137317|Tropical Climate|tropical climate
4888697|NCT02137304|cough help|cough help
4888698|NCT02137304|in-exsufflation|in-exsufflation
4888699|NCT02137304|neuromuscular disease|neuromuscular disease
4888700|NCT02137304|cough assistance optimization|cough assistance optimization
4888701|NCT02137304|efficient cough flow|efficient cough flow
4888702|NCT02137291|Video-assisted thoracoscopic surgery (VATS)|video-assisted thoracoscopic surgery (vats)
4888703|NCT02137291|Lung isolation device|lung isolation device
4888704|NCT02137291|One-lung ventilation|one-lung ventilation
4888705|NCT02137291|Double lumen endotracheal tube|double lumen endotracheal tube
4888706|NCT02137291|Bronchial blocker|bronchial blocker
4888707|NCT02137278|Syncope|syncope
4888708|NCT02137278|Presyncope|presyncope
4888709|NCT02137278|Vasoactive drugs|vasoactive drugs
4888710|NCT02137278|Hypotension|hypotension
4888711|NCT02137278|Carotid sinus massage|carotid sinus massage
4888712|NCT02137278|Tilt table test|tilt table test
4888713|NCT02137265|Azoospermia|azoospermia
4888714|NCT02137265|Hypogonadism|hypogonadism
4888715|NCT02137265|Clomiphene|clomiphene
4888716|NCT02137252|Invasive Breast Cancer (Stage I-III)|invasive breast cancer (stage i-iii)
4888717|NCT02137252|Ductal Carcinoma in Situ|ductal carcinoma in situ
4888718|NCT02137252|Lobular Carcinoma in Situ|lobular carcinoma in situ
4888719|NCT02137252|Lobular Carcinoma|lobular carcinoma
4888720|NCT02137252|Fatigue Related to Cancer Treatment|fatigue related to cancer treatment
4888721|NCT02137213|Opioid-induced constipation|opioid-induced constipation
4888722|NCT02137213|Methadone|methadone
4888723|NCT02137213|Naloxone|naloxone
4888724|NCT02137187|Atrial fibrillation|atrial fibrillation
4888725|NCT02137187|Heart failure|heart failure
4888726|NCT02137187|Catheter ablation|catheter ablation
4888727|NCT02137187|Cardiac resynchronization therapy|cardiac resynchronization therapy
4888728|NCT02137187|Implantable defibrillator|implantable defibrillator
4888729|NCT02137148|Vascular Access|vascular access
4888730|NCT02137148|Sonic Window|sonic window
4888731|NCT02137148|Ultrasound|ultrasound
4888732|NCT02137135|chronic postoperative pain|chronic postoperative pain
4888733|NCT02137135|menstrual cycle|menstrual cycle
4888734|NCT02137122|Volunteers|volunteers
4888735|NCT02137109|Pediatric|pediatric
4888736|NCT02137096|Recurrent nasopharynx carcinoma|recurrent nasopharynx carcinoma
4888737|NCT02137083|Chemotherapy|chemotherapy
4888738|NCT02137083|Endocrine therapy|endocrine therapy
4888739|NCT02137083|Docetaxel|docetaxel
4888740|NCT02137083|Fulvestrant|fulvestrant
4888741|NCT02137070|Weightloss and brain function|weightloss and brain function
4888742|NCT02137070|Effects of bariatric surgery on brain function|effects of bariatric surgery on brain function
4888743|NCT02137070|Reduced glucose insulin changes and brain function|reduced glucose insulin changes and brain function
4888744|NCT02137057|Heart Rate Variability|heart rate variability
4888745|NCT02137057|spinal anesthesia|spinal anesthesia
4888746|NCT02137057|DM|dm
4888747|NCT02137057|cardiac autonomic dysfunction|cardiac autonomic dysfunction
4888748|NCT02137044|multiple sclerosis|multiple sclerosis
4888749|NCT02137044|pain|pain
4888750|NCT02137044|depression|depression
4888751|NCT02137018|hernia|hernia
4888752|NCT02137018|incisional hernia|incisional hernia
4888753|NCT02137018|device|device
4888754|NCT02137018|pig|pig
4888755|NCT02137005|walking|walking
4888756|NCT02137005|gait disorders, neurologic|gait disorders, neurologic
4888757|NCT02137005|health status|health status
4888758|NCT02137005|cognition|cognition
4888759|NCT02137005|quality of life|quality of life
4888760|NCT02137005|Transition to Adult Care|transition to adult care
4888761|NCT02136953|Obsessive-Compulsive Disorder|obsessive-compulsive disorder
4888762|NCT02136953|Exercise|exercise
4888763|NCT02136953|Cognitive Behavior Therapy|cognitive behavior therapy
4888764|NCT02136953|Cognitive Behavioral Therapy|cognitive behavioral therapy
4888765|NCT02136953|Treatment Efficacy|treatment efficacy
4888766|NCT02136953|Brain-Derived Neurotrophic Factor|brain-derived neurotrophic factor
4888767|NCT02136914|Levodopa Induced Dyskinesia|levodopa induced dyskinesia
4888768|NCT02136914|LID|lid
4888769|NCT02136914|Parkinsonism|parkinsonism
4888770|NCT02136901|NuSurface|nusurface
4888771|NCT02136901|Meniscus|meniscus
4888772|NCT02136901|Prosthesis|prosthesis
4888773|NCT02136901|KOOS|koos
4888774|NCT02136888|Ponesimod|ponesimod
4888775|NCT02136888|Safety|safety
4888776|NCT02136875|COPD|copd
4888777|NCT02136875|COPD exacerbation|copd exacerbation
4888778|NCT02136862|Alport syndrome|alport syndrome
4888779|NCT02136862|kidney disease|kidney disease
4888780|NCT02136849|severe intellectual disability, genetic, de novo exome|severe intellectual disability, genetic, de novo exome
4888781|NCT02136836|Genes, erbB-2|genes, erbb-2
4888782|NCT02136836|Prognosis|prognosis
4888783|NCT02136823|Spinal Cord Injury|spinal cord injury
4888784|NCT02136810|Hypertension|hypertension
4888785|NCT02136810|Perioperative Care|perioperative care
4888786|NCT02136797|CMVpp65 Specific T-cells|cmvpp65 specific t-cells
4888787|NCT02136797|Allogeneic Hematopoietic Stem Cell Transplantation|allogeneic hematopoietic stem cell transplantation
4888788|NCT02136797|14-070|14-070
4888789|NCT02136784|pain|pain
4888790|NCT02136784|cold presser test|cold presser test
4888791|NCT02136784|buprenorphine|buprenorphine
4888792|NCT02136784|opioids|opioids
4888793|NCT02136758|lifestyle modification|lifestyle modification
4888794|NCT02136758|diet|diet
4888795|NCT02136758|exercise|exercise
4888796|NCT02136758|cardiovascular disease|cardiovascular disease
4888797|NCT02136758|gene expression|gene expression
4888798|NCT02136758|obesity|obesity
4888799|NCT02136745|Irritable Bowel Syndrome|irritable bowel syndrome
4888800|NCT02136745|Inflammatory Bowel Disease|inflammatory bowel disease
4888801|NCT02136745|mind body|mind body
4888802|NCT02136745|intervention|intervention
4888803|NCT02136745|group|group
4888804|NCT02136745|Relaxation Response|relaxation response
4888805|NCT02136745|genomic effects|genomic effects
4888806|NCT02136732|chronic conditions|chronic conditions
4888807|NCT02136732|multimorbid|multimorbid
4888808|NCT02136719|Uterine massage|uterine massage
4888809|NCT02136719|vaginal birth|vaginal birth
4888810|NCT02136719|postpartum haemorrhage|postpartum haemorrhage
4888811|NCT02136706|Stable coronary artery disease|stable coronary artery disease
4888812|NCT02136693|obstructed defecation|obstructed defecation
4888813|NCT02136693|STARR|starr
4888814|NCT02136693|constipation|constipation
4888815|NCT02136693|incontinence|incontinence
4888816|NCT02136693|psyllium|psyllium
4888817|NCT02136680|HIV disease|hiv disease
4888818|NCT02136680|palliative care|palliative care
4888819|NCT02136680|educational intervention|educational intervention
4888820|NCT02136667|Preeclampsia|preeclampsia
4888821|NCT02136667|Cardiovascular disease (CVD) risk|cardiovascular disease (cvd) risk
4888822|NCT02136654|diabetes|diabetes
4888823|NCT02136654|ethnicity|ethnicity
4888824|NCT02136654|South Asian|south asian
4888825|NCT02136654|diabetes management|diabetes management
4888826|NCT02136641|Anesthesia|anesthesia
4888827|NCT02136641|Spinal Anesthesia|spinal anesthesia
4888828|NCT02136641|Conscious Sedation|conscious sedation
4888829|NCT02136641|Operating Rooms.|operating rooms.
4888830|NCT02136628|RTL Technique|rtl technique
4888831|NCT02136615|hyperbaric oxygenation|hyperbaric oxygenation
4888832|NCT02136615|insulin sensitivity|insulin sensitivity
4888833|NCT02136615|human|human
4888834|NCT02136615|inflammation|inflammation
4888835|NCT02136615|adipose tissue|adipose tissue
4888836|NCT02136563|Chronic kidney disease|chronic kidney disease
4888837|NCT02136563|Erythropoiesis stimulating agent response index|erythropoiesis stimulating agent response index
4888838|NCT02136563|Hyporesponsive anemia to erythropoiesis stimulating agent|hyporesponsive anemia to erythropoiesis stimulating agent
4888839|NCT02136563|Observational study|observational study
4888840|NCT02136550|smoking|smoking
4888841|NCT02136550|smoking cessation|smoking cessation
4888842|NCT02136550|mucociliary clearance|mucociliary clearance
4888843|NCT02136550|proteomics|proteomics
4888844|NCT02136550|miRNA|mirna
4888845|NCT02136498|smoking cessation|smoking cessation
4888846|NCT02136498|varenicline|varenicline
4888847|NCT02136498|adherence|adherence
4888848|NCT02136472|Subfertility|subfertility
4888849|NCT02136472|Metabolic syndrome|metabolic syndrome
4888850|NCT02136472|Plasma volume|plasma volume
4888851|NCT02136472|Intima media thickness|intima media thickness
4888852|NCT02136472|Flow mediated dilatation|flow mediated dilatation
4888853|NCT02136459|Thyroidectomy|thyroidectomy
4888854|NCT02136459|Endotracheal tube|endotracheal tube
4888855|NCT02136459|Voice|voice
4888856|NCT02136459|Complications|complications
4888857|NCT02136459|Patients undergoing elective thyroidectomy|patients undergoing elective thyroidectomy
4888858|NCT02136446|Paravertebral block|paravertebral block
4888859|NCT02136446|Mastectomy|mastectomy
4888860|NCT02136446|Post-operative pain|post-operative pain
4888861|NCT02136446|Echogenic|echogenic
4888862|NCT02136446|Peripheral nerve block catheter|peripheral nerve block catheter
4888863|NCT02136433|Hand|hand
4888864|NCT02136433|Rehabilitation|rehabilitation
4888865|NCT02136433|Stroke|stroke
4888866|NCT02136433|Brain-injury|brain-injury
4888867|NCT02136433|Tablet|tablet
4888868|NCT02136407|Vitamin D|vitamin d
4888869|NCT02136407|vitamin D deficiency|vitamin d deficiency
4888870|NCT02136407|parathyroid hormone|parathyroid hormone
4888871|NCT02136381|Lifestyle, interventions, retirement|lifestyle, interventions, retirement
4888872|NCT02136368|older adults|older adults
4888873|NCT02136368|multiple-modality exercise|multiple-modality exercise
4888874|NCT02136368|mind-motor exercise|mind-motor exercise
4888875|NCT02136368|self-reported cognitive complaints|self-reported cognitive complaints
4888876|NCT02136368|global cognitive functioning|global cognitive functioning
4888877|NCT02136368|mobility|mobility
4888878|NCT02136368|vascular function|vascular function
4888879|NCT02136368|sensorimotor function|sensorimotor function
4888880|NCT02136368|brain imaging|brain imaging
4888881|NCT02136368|community-based research|community-based research
4888882|NCT02136368|subjective cognitive complaints|subjective cognitive complaints
4888883|NCT02136342|no available effective treatment|no available effective treatment
4888884|NCT02136316|Healthy volunteers|healthy volunteers
4888885|NCT02136316|ASP7962|asp7962
4888886|NCT02136316|pharmacokinetics|pharmacokinetics
4888887|NCT02136290|Weight loss|weight loss
4888888|NCT02136277|colorectal surgery|colorectal surgery
4888889|NCT02136277|cardiac output|cardiac output
4888890|NCT02136264|hypertension|hypertension
4888891|NCT02136264|dietary intervention|dietary intervention
4888892|NCT02136264|personalized nutrition|personalized nutrition
4888893|NCT02136264|randomized controlled trial|randomized controlled trial
4888894|NCT02136251|Total Shoulder Arthroplasty|total shoulder arthroplasty
4888895|NCT02136251|Glenoid anchor peg component fixation|glenoid anchor peg component fixation
4888896|NCT02136251|Autologous bone grafting|autologous bone grafting
4888897|NCT02136238|amputation|amputation
4888898|NCT02136238|transradial|transradial
4888899|NCT02136238|prosthesis|prosthesis
4888900|NCT02136238|terminal device|terminal device
4888901|NCT02136225|youth|youth
4888902|NCT02136225|gun|gun
4888903|NCT02136225|access|access
4888904|NCT02136225|home|home
4888905|NCT02136186|home telemonitoring|home telemonitoring
4888906|NCT02136186|readmission|readmission
4888907|NCT02136186|high risk|high risk
4888908|NCT02136160|elementary school|elementary school
4888909|NCT02136160|children|children
4888910|NCT02136160|health promotion|health promotion
4888911|NCT02136160|teachers|teachers
4888912|NCT02136160|prevention|prevention
4888913|NCT02136147|Attention Deficit Disorder with Hyperactivity|attention deficit disorder with hyperactivity
4888914|NCT02136147|Neuropsychiatry|neuropsychiatry
4888915|NCT02136147|Drug therapy|drug therapy
4888916|NCT02136147|Pharmacogenetics|pharmacogenetics
4888917|NCT02136147|Child Psychiatry|child psychiatry
4888918|NCT02136134|Multiple Myeloma|multiple myeloma
4888919|NCT02136134|Plasmacytoma|plasmacytoma
4888920|NCT02136134|Refractory Multiple Myeloma|refractory multiple myeloma
4888921|NCT02136134|Relapsed Multiple Myeloma|relapsed multiple myeloma
4888922|NCT02136134|Daratumumab|daratumumab
4888923|NCT02136134|VELCADE|velcade
4888924|NCT02136108|Chronic pain|chronic pain
4888925|NCT02136108|Complementary and alternative therapies|complementary and alternative therapies
4888926|NCT02136108|Mobile health|mobile health
4888927|NCT02136108|Medicaid|medicaid
4888928|NCT02136108|Patient navigation|patient navigation
4888929|NCT02136095|Fluorescent cholangiography|fluorescent cholangiography
4888930|NCT02136095|Laparoscopic cholecystectomy|laparoscopic cholecystectomy
4888931|NCT02136082|HIV|hiv
4888932|NCT02136082|Women|women
4888933|NCT02136082|Children|children
4888934|NCT02136082|Nutrition|nutrition
4888935|NCT02136056|Sick-leave|sick-leave
4888936|NCT02136056|Return to work|return to work
4888937|NCT02136056|Self-management|self-management
4888938|NCT02136056|Self-efficacy|self-efficacy
4888939|NCT02136056|Quality of Life and Well-being|quality of life and well-being
4888940|NCT02136056|Motivation|motivation
4888941|NCT02136030|Cryptococcal meningitis|cryptococcal meningitis
4888942|NCT02136017|AEFI|aefi
4888943|NCT02136017|influenza vaccine|influenza vaccine
4888944|NCT02136004|arteriotomy|arteriotomy
4888945|NCT02136004|vessel closure|vessel closure
4888946|NCT02136004|femoral access site|femoral access site
4888947|NCT02135978|Spinal Cord Injury|spinal cord injury
4888948|NCT02135978|Shoulder Pain|shoulder pain
4888949|NCT02135978|Exercise|exercise
4888950|NCT02135952|Periodontitis|periodontitis
4888951|NCT02135952|Diabetes|diabetes
4888952|NCT02135926|Cerebral Stroke, Stroke, Acute, Brain Infarction|cerebral stroke, stroke, acute, brain infarction
4888953|NCT02135913|Obese|obese
4888954|NCT02135913|Children|children
4888955|NCT02135913|Vitamin D deficiency|vitamin d deficiency
4888956|NCT02135913|Low HDL|low hdl
4888957|NCT02135900|Heliox|heliox
4888958|NCT02135900|Obstructive Sleep Apnea|obstructive sleep apnea
4888959|NCT02135887|Stage III Colorectal Cancer|stage iii colorectal cancer
4888960|NCT02135887|Grade 4 Neutropenia|grade 4 neutropenia
4888961|NCT02135887|MB-6|mb-6
4888962|NCT02135874|Leukemia|leukemia
4888963|NCT02135874|Mixed Phenotype Acute Leukemia|mixed phenotype acute leukemia
4888964|NCT02135874|MPAL|mpal
4888965|NCT02135874|Newly Diagnosed|newly diagnosed
4888966|NCT02135874|Relapsed|relapsed
4888967|NCT02135874|Clofarabine|clofarabine
4888968|NCT02135874|Clofarex|clofarex
4888969|NCT02135874|Clolar|clolar
4888970|NCT02135874|Idarubicin|idarubicin
4888971|NCT02135874|Idamycin|idamycin
4888972|NCT02135874|Cytarabine|cytarabine
4888973|NCT02135874|Ara-C|ara-c
4888974|NCT02135874|Cytosar|cytosar
4888975|NCT02135874|DepoCyt|depocyt
4888976|NCT02135874|Cytosine arabinosine hydrochloride|cytosine arabinosine hydrochloride
4888977|NCT02135874|Vincristine|vincristine
4888978|NCT02135874|Rituximab|rituximab
4888979|NCT02135874|Rituxan|rituxan
4888980|NCT02135874|Dexamethasone|dexamethasone
4888981|NCT02135874|Decadron|decadron
4888982|NCT02135861|Acute decompensated heart failure|acute decompensated heart failure
4888983|NCT02135861|heart failure|heart failure
4888984|NCT02135861|MRI|mri
4888985|NCT02135861|trpV4 channel inhibitors|trpv4 channel inhibitors
4888986|NCT02135861|pulmonary oedema|pulmonary oedema
4888987|NCT02135822|nanoparticle albumin-bound paclitaxel|nanoparticle albumin-bound paclitaxel
4888988|NCT02135822|gemcitabine|gemcitabine
4888989|NCT02135822|advanced pancreatic cancer|advanced pancreatic cancer
4888990|NCT02135796|Septic Shock|septic shock
4888991|NCT02135796|Severe Sepsis|severe sepsis
4888992|NCT02135796|ICU|icu
4888993|NCT02135770|heparin|heparin
4888994|NCT02135770|sepsis|sepsis
4888995|NCT02135770|inflammation|inflammation
4888996|NCT02135744|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
4888997|NCT02135744|COPD|copd
4888998|NCT02135744|Readmissions|readmissions
4888999|NCT02135718|ELLIPTA|ellipta
4889000|NCT02135718|Asthma|asthma
4889001|NCT02135718|Inhaler preference|inhaler preference
4889002|NCT02135718|Fluticasone furoate|fluticasone furoate
4889003|NCT02135718|ELLIPTA inhaler|ellipta inhaler
4889004|NCT02135718|Dry Powder Inhaler|dry powder inhaler
4889005|NCT02135692|Severe eosinophilic asthma|severe eosinophilic asthma
4889006|NCT02135692|Extension study|extension study
4889007|NCT02135692|Expanded access|expanded access
4889008|NCT02135692|Safety|safety
4889009|NCT02135692|Mepolizumab|mepolizumab
4889010|NCT02135692|Eosinophils|eosinophils
4889011|NCT02135666|Twinrix|twinrix
4889012|NCT02135666|Long-term follow-up|long-term follow-up
4889013|NCT02135666|Persistence|persistence
4889014|NCT02135666|Hepatitis A|hepatitis a
4889015|NCT02135666|Antibody|antibody
4889016|NCT02135666|Immunity|immunity
4889017|NCT02135666|Hepatitis B|hepatitis b
4889018|NCT02135666|Combination vaccine|combination vaccine
4889019|NCT02135666|Adult|adult
4889020|NCT02135601|colonoscopy|colonoscopy
4889021|NCT02135601|water|water
4889022|NCT02135601|adenoma|adenoma
4889023|NCT02135601|pain|pain
4889024|NCT02135575|premenopausal|premenopausal
4889025|NCT02135575|postmenopausal|postmenopausal
4889026|NCT02135575|cardiovascular|cardiovascular
4889027|NCT02135575|exercise training|exercise training
4889028|NCT02135575|vascular function|vascular function
4889029|NCT02135575|cardiac function|cardiac function
4889030|NCT02135575|cardiac morphology|cardiac morphology
4889031|NCT02135575|health|health
4889032|NCT02135562|endometrial cancer|endometrial cancer
4889033|NCT02135562|survivor|survivor
4889034|NCT02135562|obesity|obesity
4889035|NCT02135562|diet|diet
4889036|NCT02135562|high protein|high protein
4889037|NCT02135562|protein-sparing modified fast intervention|protein-sparing modified fast intervention
4889038|NCT02135562|PSMF|psmf
4889039|NCT02135523|ovarian cancer|ovarian cancer
4889040|NCT02135523|involved-field radiation therapy|involved-field radiation therapy
4889041|NCT02135523|progression free survival|progression free survival
4889042|NCT02135484|Prostate Cancer|prostate cancer
4889043|NCT02135484|Adenocarcinoma of the prostate|adenocarcinoma of the prostate
4889044|NCT02135484|Castrate resistant prostate cancer|castrate resistant prostate cancer
4889045|NCT02135484|CRPC|crpc
4889046|NCT02135484|Skeletal metastases|skeletal metastases
4889047|NCT02135484|Alpharadin|alpharadin
4889048|NCT02135484|Xofigo|xofigo
4889049|NCT02135484|Radium-223 chloride|radium-223 chloride
4889050|NCT02135484|Radium-223 dichloride|radium-223 dichloride
4889051|NCT02135471|gingival recession|gingival recession
4889052|NCT02135471|dental enamel proteins|dental enamel proteins
4889053|NCT02135471|acellular dermal matrix graft|acellular dermal matrix graft
4889054|NCT02135471|tobacco|tobacco
4889055|NCT02135458|Heart failure|heart failure
4889056|NCT02135458|Telemonitoring|telemonitoring
4889057|NCT02135458|therapeutic education|therapeutic education
4889058|NCT02135458|care network|care network
4889059|NCT02135458|hospitalization|hospitalization
4889060|NCT02135445|Drug therapy|drug therapy
4889061|NCT02135432|Chronic Obstructive pulmonary disease, Ivacaftor|chronic obstructive pulmonary disease, ivacaftor
4889062|NCT02135406|Adult|adult
4889063|NCT02135406|18 years or older|18 years or older
4889064|NCT02135406|multiple myeloma|multiple myeloma
4889065|NCT02135406|poor prognosis|poor prognosis
4889066|NCT02135406|relapsed/progressive disease|relapsed/progressive disease
4889067|NCT02135406|within one year of first autologous stem cell transplantation|within one year of first autologous stem cell transplantation
4889068|NCT02135367|PRP|prp
4889069|NCT02135367|growth factors|growth factors
4889070|NCT02135367|Viscosupplementation|viscosupplementation
4889071|NCT02135367|injections|injections
4889072|NCT02135367|chondropathy|chondropathy
4889073|NCT02135367|randomized controlled trial|randomized controlled trial
4889074|NCT02135354|AECOPD|aecopd
4889075|NCT02135354|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
4889076|NCT02135354|Acute exacerbation|acute exacerbation
4889077|NCT02135354|Hospitalization|hospitalization
4889078|NCT02135354|Azithromycin|azithromycin
4889079|NCT02135354|Macrolides|macrolides
4889080|NCT02135354|Randomized Controlled Trial|randomized controlled trial
4889081|NCT02135354|Placebo|placebo
4889082|NCT02135341|Detrusor Overactivity|detrusor overactivity
4889083|NCT02135341|Impaired Contractility|impaired contractility
4889084|NCT02135341|Botulinum Toxin A (BoNT-A)|botulinum toxin a (bont-a)
4889085|NCT02135328|Type 2 diabetes|type 2 diabetes
4889086|NCT02135328|Dietary behaviors|dietary behaviors
4889087|NCT02135328|Physical activity behaviors|physical activity behaviors
4889088|NCT02135328|Radio story, entertainment health education|radio story, entertainment health education
4889089|NCT02135328|Immigrants|immigrants
4889090|NCT02135328|Somali, Latino, Hmong|somali, latino, hmong
4889091|NCT02135328|Families with 3-18 year old children|families with 3-18 year old children
4889092|NCT02135315|Acute Coronary Syndrome, arterial pressure|acute coronary syndrome, arterial pressure
4889093|NCT02135302|hepatic|hepatic
4889094|NCT02135250|Traditional Chinese Medicine|traditional chinese medicine
4889095|NCT02135211|non-small cell lung cancer (NSCLC)|non-small cell lung cancer (nsclc)
4889096|NCT02135211|multiple risk factor|multiple risk factor
4889097|NCT02135211|lifestyle intervention|lifestyle intervention
4889098|NCT02135211|health behavior|health behavior
4889099|NCT02135211|lifestyle risk reduction|lifestyle risk reduction
4889100|NCT02135211|health related quality of life|health related quality of life
4889101|NCT02135198|GABA modulator|gaba modulator
4889102|NCT02135198|AZD7325|azd7325
4889103|NCT02135198|Short interval intracortical inhibition|short interval intracortical inhibition
4889104|NCT02135198|volunteers|volunteers
4889105|NCT02135146|Hypotension|hypotension
4889106|NCT02135146|Kidney injury|kidney injury
4889107|NCT02135133|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
4889108|NCT02135133|Small Lymphocytic Lymphoma|small lymphocytic lymphoma
4889109|NCT02135107|Gastroesophageal reflux disease|gastroesophageal reflux disease
4889110|NCT02135094|trapezius|trapezius
4889111|NCT02135094|upper back|upper back
4889112|NCT02135094|muscle pain|muscle pain
4889113|NCT02135094|pain relief|pain relief
4889114|NCT02135094|ultrasound|ultrasound
4889115|NCT02135094|double blind|double blind
4889117|NCT02135094|ZetrOZ|zetroz
4889118|NCT02135094|muscle|muscle
4889119|NCT02135094|LITUS|litus
4889120|NCT02135094|low intensity therapeutic ultrasound|low intensity therapeutic ultrasound
4889121|NCT02135081|Single ventricle|single ventricle
4889122|NCT02135081|Hypoplastic Left Heart Syndrome|hypoplastic left heart syndrome
4889123|NCT02135081|Congenital heart lesion|congenital heart lesion
4889124|NCT02135081|Right or left ventricle|right or left ventricle
4889125|NCT02135081|Cerebral blood flow|cerebral blood flow
4889126|NCT02135081|Pulmonary blood flow|pulmonary blood flow
4889127|NCT02135081|Staged Fontan reconstruction|staged fontan reconstruction
4889128|NCT02135081|hemi Fontan/bidirectional Glenn stages|hemi fontan/bidirectional glenn stages
4889129|NCT02135068|type 1 diabetes|type 1 diabetes
4889130|NCT02135068|closed loop insulin delivery systems|closed loop insulin delivery systems
4889131|NCT02135068|exercise|exercise
4889132|NCT02135068|hypoglycemia|hypoglycemia
4889133|NCT02135055|organ function|organ function
4889134|NCT02135055|sedation|sedation
4889135|NCT02135029|Hyperlipidemia|hyperlipidemia
4889136|NCT02135029|statin intolerance|statin intolerance
4889137|NCT02135016|effect-site concentration|effect-site concentration
4889138|NCT02135016|propofol|propofol
4889139|NCT02135016|thoracic epidural anesthesia|thoracic epidural anesthesia
4889140|NCT02134990|Carcinoma, Non-Small-Cell Lung|carcinoma, non-small-cell lung
4889141|NCT02134990|Docetaxel|docetaxel
4889142|NCT02134977|Pharmacological therapy|pharmacological therapy
4889143|NCT02134964|Safety|safety
4889144|NCT02134964|Tolerability|tolerability
4889145|NCT02134964|Pharmacokinetics|pharmacokinetics
4889146|NCT02134964|Dose escalation|dose escalation
4889147|NCT02134964|Randomized|randomized
4889148|NCT02134964|Healthy volunteers|healthy volunteers
4889149|NCT02134964|OLT1177|olt1177
4889150|NCT02134964|Olatec|olatec
4889151|NCT02134899|Autosomal dominant polycystic kidney disease|autosomal dominant polycystic kidney disease
4889152|NCT02134899|cyst|cyst
4889153|NCT02134899|kidney|kidney
4889154|NCT02134899|liver|liver
4889155|NCT02134899|kidney transplantation|kidney transplantation
4889156|NCT02134899|IF/TA|if/ta
4889157|NCT02134899|fibrosis|fibrosis
4889158|NCT02134899|DSA|dsa
4889159|NCT02134899|mTOR inhibitors|mtor inhibitors
4889160|NCT02134899|calcineurin inhibitors|calcineurin inhibitors
4889161|NCT02134873|Pain|pain
4889162|NCT02134873|Pain management|pain management
4889163|NCT02134873|Hospitalized|hospitalized
4889164|NCT02134873|Infants|infants
4889165|NCT02134873|Sucrose|sucrose
4889166|NCT02134847|Resident|resident
4889167|NCT02134847|Fatigue|fatigue
4889168|NCT02134847|Sleep deprivation|sleep deprivation
4889169|NCT02134847|medical errors|medical errors
4889170|NCT02134808|Major Depressive Disorder|major depressive disorder
4889171|NCT02134808|Creatine|creatine
4889172|NCT02134808|Brain Chemistry|brain chemistry
4889173|NCT02134808|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
4889174|NCT02134808|Treatment Resistance|treatment resistance
4889175|NCT02134808|Selective Serotonin Reuptake Inhibitor (SSRI) Resistance|selective serotonin reuptake inhibitor (ssri) resistance
4889176|NCT02134795|Parkinson's disease|parkinson's disease
4889177|NCT02134782|Randomized Controlled Trial, yoga, children, chemotherapy, haematopoietic stem cell transplantation, fatigue, quality of life|randomized controlled trial, yoga, children, chemotherapy, haematopoietic stem cell transplantation, fatigue, quality of life
4889178|NCT02134769|catheter-related bloodstream infections|catheter-related bloodstream infections
4889179|NCT02134756|Supplement impact|supplement impact
4889180|NCT02134756|Performance|performance
4889181|NCT02134756|Fatigue|fatigue
4889182|NCT02134743|dental implant|dental implant
4889183|NCT02134743|Surface energy|surface energy
4889184|NCT02134743|Hydrophilicity|hydrophilicity
4889185|NCT02134743|Contact angle|contact angle
4889186|NCT02134743|Titanium implant roughness|titanium implant roughness
4889187|NCT02134743|Surface conditioning|surface conditioning
4889188|NCT02134730|FRIENDS for life|friends for life
4889189|NCT02134730|universal prevention|universal prevention
4889190|NCT02134730|school children|school children
4889191|NCT02134730|anxiety|anxiety
4889192|NCT02134717|sarcoidosis|sarcoidosis
4889193|NCT02134717|CCR5 inhibition|ccr5 inhibition
4889194|NCT02134717|maraviroc|maraviroc
4889195|NCT02134691|Posttraumatic Stress Disorder (PTSD)|posttraumatic stress disorder (ptsd)
4889196|NCT02134691|Prolonged Exposure (PE)|prolonged exposure (pe)
4889197|NCT02134678|self-system therapy|self-system therapy
4889198|NCT02134678|cognitive therapy|cognitive therapy
4889199|NCT02134678|depression|depression
4889200|NCT02134678|psychotherapy|psychotherapy
4889201|NCT02134678|mechanisms of action|mechanisms of action
4889202|NCT02134665|Vancomycin|vancomycin
4889203|NCT02134665|severe acute pancreatitis|severe acute pancreatitis
4889204|NCT02134665|Creatinine clearance|creatinine clearance
4889205|NCT02134652|Ultrasonography|ultrasonography
4889206|NCT02134652|World Health|world health
4889207|NCT02134626|Portal Hypertension|portal hypertension
4889208|NCT02134626|Hepatic Venous Pressure Gradient|hepatic venous pressure gradient
4889209|NCT02134626|Esophageal Varices|esophageal varices
4889210|NCT02134626|Liver Cirrhosis|liver cirrhosis
4889211|NCT02134626|Simvastatin|simvastatin
4889212|NCT02134626|Nitric oxide|nitric oxide
4889213|NCT02134626|HVPG|hvpg
4889214|NCT02134613|99mTc-anti-TNF|99mtc-anti-tnf
4889215|NCT02134613|Inflammation|inflammation
4889216|NCT02134613|Psoriatic arthritis|psoriatic arthritis
4889217|NCT02134613|Rheumatoid arthritis|rheumatoid arthritis
4889218|NCT02134600|Omega-3 fatty acids|omega-3 fatty acids
4889219|NCT02134600|DHA|dha
4889220|NCT02134600|EPA|epa
4889221|NCT02134600|Docosahexaenoic acid|docosahexaenoic acid
4889222|NCT02134600|Eicosapentaenoic acid|eicosapentaenoic acid
4889223|NCT02134600|Childhood cancer|childhood cancer
4889224|NCT02134600|Body composition|body composition
4889225|NCT02134600|Inflammation|inflammation
4889226|NCT02134600|Neuropsychiatric symptoms|neuropsychiatric symptoms
4889227|NCT02134587|Health knowledge, attitudes, practices.|health knowledge, attitudes, practices.
4889228|NCT02134587|Adverse drug reaction reporting systems.|adverse drug reaction reporting systems.
4889229|NCT02134587|Pharmacovigilance. Product Surveillance, Postmarketing.|pharmacovigilance. product surveillance, postmarketing.
4889230|NCT02134587|Drug-related side effects and adverse reactions.|drug-related side effects and adverse reactions.
4889231|NCT02134574|Lymphoma,|lymphoma,
4889232|NCT02134574|leukemia,|leukemia,
4889233|NCT02134574|multiple myeloma,|multiple myeloma,
4889234|NCT02134574|hodgkin disease|hodgkin disease
4889235|NCT02134522|non alcoholic fatty liver|non alcoholic fatty liver
4889236|NCT02134522|childhood obesity|childhood obesity
4889237|NCT02134522|Sleep Apnea|sleep apnea
4889238|NCT02134509|Cigarette smoking|cigarette smoking
4889239|NCT02134496|hip|hip
4889240|NCT02134496|knee|knee
4889241|NCT02134496|arthroplasty|arthroplasty
4889242|NCT02134496|spinal|spinal
4889243|NCT02134496|anesthesia|anesthesia
4889244|NCT02134483|Parathyroid|parathyroid
4889245|NCT02134483|Permanent hypocalcemia|permanent hypocalcemia
4889246|NCT02134483|Transplantation|transplantation
4889247|NCT02134470|saliva|saliva
4889248|NCT02134470|blood|blood
4889249|NCT02134470|urine|urine
4889250|NCT02134444|Dizziness|dizziness
4889251|NCT02134444|Vertigo|vertigo
4889252|NCT02134444|Vestibular Diseases|vestibular diseases
4889253|NCT02134444|Vestibular Neuritis|vestibular neuritis
4889254|NCT02134444|Labyrinth Diseases|labyrinth diseases
4889255|NCT02134444|Ear Diseases|ear diseases
4889256|NCT02134444|Vestibular rehabilitation|vestibular rehabilitation
4889257|NCT02134444|Telerehabilitation|telerehabilitation
4889258|NCT02134444|Gaze control|gaze control
4889259|NCT02134444|Balance|balance
4889260|NCT02134431|HIV|hiv
4889261|NCT02134431|tenofovir|tenofovir
4889262|NCT02134431|miocrobicide|miocrobicide
4889263|NCT02134431|endoscopy (colonoscopy, sigmoidoscopy)|endoscopy (colonoscopy, sigmoidoscopy)
4889264|NCT02134431|adolescents|adolescents
4889265|NCT02134431|pediatrics|pediatrics
4889266|NCT02134418|Schizophrenia|schizophrenia
4889267|NCT02134418|Irony|irony
4889268|NCT02134418|Hemispheric processing|hemispheric processing
4889269|NCT02134418|Theory of mind|theory of mind
4889270|NCT02134405|functional dyspepsia|functional dyspepsia
4889271|NCT02134405|symptoms|symptoms
4889272|NCT02134405|proton pump inhibitor|proton pump inhibitor
4889273|NCT02134405|gastritis|gastritis
4889274|NCT02134392|C-diff|c-diff
4889275|NCT02134392|Clostridium difficile|clostridium difficile
4889276|NCT02134392|Fecal Transplant|fecal transplant
4889277|NCT02134392|FMT|fmt
4889278|NCT02134392|Fecal Microbiota Transplant|fecal microbiota transplant
4889279|NCT02134379|Thoracic Impedance|thoracic impedance
4889280|NCT02134379|Diagnostic Marker|diagnostic marker
4889281|NCT02134379|Bed Rest Test|bed rest test
4889282|NCT02134379|Transthoracic Impedance|transthoracic impedance
4889283|NCT02134379|Heart Failure|heart failure
4889284|NCT02134379|HF|hf
4889285|NCT02134366|Epilepsia Partialis Continua|epilepsia partialis continua
4889286|NCT02134366|Kojewnikov's Epilepsy|kojewnikov's epilepsy
4889287|NCT02134366|Epilepsy|epilepsy
4889288|NCT02134366|Clobazam|clobazam
4889289|NCT02134366|Focal Motor Epilepsy|focal motor epilepsy
4889290|NCT02134366|Partial Motor Seizure|partial motor seizure
4889291|NCT02134340|IGF1R|igf1r
4889292|NCT02134314|ESRD (End Stage Renal Disease)|esrd (end stage renal disease)
4889293|NCT02134314|CKD (Chronic Kidney Disease)|ckd (chronic kidney disease)
4889294|NCT02134314|Kidney Transplant|kidney transplant
4889295|NCT02134314|ECD|ecd
4889296|NCT02134314|delayed graft function|delayed graft function
4889297|NCT02134314|chronic kidney disease|chronic kidney disease
4889298|NCT02134314|expanded-criteria donor|expanded-criteria donor
4889299|NCT02134314|end stage renal disease|end stage renal disease
4889300|NCT02134301|oritavancin|oritavancin
4889301|NCT02134301|pediatrics|pediatrics
4889302|NCT02134301|gram positive|gram positive
4889303|NCT02134301|bacterial infection|bacterial infection
4889304|NCT02134301|Confirmed|confirmed
4889305|NCT02134301|Suspected|suspected
4889306|NCT02134288|Dialysis|dialysis
4889307|NCT02134288|Kidney Transplant|kidney transplant
4889308|NCT02134288|immunosuppressive therapy|immunosuppressive therapy
4889309|NCT02134288|Delayed Graft Function|delayed graft function
4889310|NCT02134288|Belatacept|belatacept
4889311|NCT02134275|whole body vibration training|whole body vibration training
4889312|NCT02134275|young adult|young adult
4889313|NCT02134275|weight gain|weight gain
4889314|NCT02134275|obesity|obesity
4889315|NCT02134275|randomized clinical trial|randomized clinical trial
4889316|NCT02134262|Anti-CD19 CAR Expressing T cells Therapy|anti-cd19 car expressing t cells therapy
4889317|NCT02134262|CD19 CAR Gene-Transduced Lymphocyte|cd19 car gene-transduced lymphocyte
4889318|NCT02134262|Adoptive Immunotherapy|adoptive immunotherapy
4889319|NCT02134262|Genetically Engineered Lymphocyte Therapy|genetically engineered lymphocyte therapy
4889320|NCT02134262|Retroviral Vector|retroviral vector
4889321|NCT02134262|Burkitt Lymphoma|burkitt lymphoma
4889322|NCT02134262|Lymphoma|lymphoma
4889323|NCT02134262|Lymphoma, Follicular|lymphoma, follicular
4889324|NCT02134262|Lymphoma, Non-Hodgkin|lymphoma, non-hodgkin
4889325|NCT02134262|Lymphomatoid Granulomatosis|lymphomatoid granulomatosis
4889326|NCT02134262|Lymphoma, B-Cell|lymphoma, b-cell
4889327|NCT02134262|Lymphoma, Large B-Cell, Diffuse|lymphoma, large b-cell, diffuse
4889328|NCT02134262|Lymphoma, Large-Cell, Immunoblastic|lymphoma, large-cell, immunoblastic
4889329|NCT02134262|Lymphoma, B-Cell, Marginal Zone|lymphoma, b-cell, marginal zone
4889330|NCT02134262|Lymphoma, Extranodal NK-T-Cell|lymphoma, extranodal nk-t-cell
4889331|NCT02134262|Lymphoma, Mantle-Cell|lymphoma, mantle-cell
4889332|NCT02134262|Neoplasms by Histologic Type|neoplasms by histologic type
4889333|NCT02134262|Neoplasms|neoplasms
4889334|NCT02134262|Neoplasms, Experimental|neoplasms, experimental
4889335|NCT02134262|Immune System Diseases|immune system diseases
4889336|NCT02134249|infertility|infertility
4889337|NCT02134249|ICSI|icsi
4889338|NCT02134249|OHSS|ohss
4889339|NCT02134249|Diosmin|diosmin
4889340|NCT02134249|Cabergoline|cabergoline
4889341|NCT02134210|PsO|pso
4889342|NCT02134197|Oncology|oncology
4889343|NCT02134197|Solid tumors|solid tumors
4889344|NCT02134197|Antibody drug conjugate|antibody drug conjugate
4889345|NCT02134197|Maximum tolerated dose|maximum tolerated dose
4889346|NCT02134171|Thrombotic microangiopathy,|thrombotic microangiopathy,
4889347|NCT02134171|haemolytic uremic syndrome,|haemolytic uremic syndrome,
4889348|NCT02134171|thrombotic thrombocytopenic purpura,|thrombotic thrombocytopenic purpura,
4889349|NCT02134171|ADAMTS13,|adamts13,
4889350|NCT02134171|troponin,|troponin,
4889351|NCT02134171|plasma exchange.|plasma exchange.
4889352|NCT02134158|tDCS, gait disorders, equilibrium, hemiplegic, stroke|tdcs, gait disorders, equilibrium, hemiplegic, stroke
4889353|NCT02134145|Mobile Health|mobile health
4889354|NCT02134145|mHealth|mhealth
4889355|NCT02134145|Technology|technology
4889356|NCT02134132|Platelet gel|platelet gel
4889357|NCT02134132|diabetic foot ulcer|diabetic foot ulcer
4889358|NCT02134132|umbilical cord blood|umbilical cord blood
4889359|NCT02134119|dietary supplement|dietary supplement
4889360|NCT02134119|endurance athletes|endurance athletes
4889361|NCT02134119|VO2max|vo2max
4889362|NCT02134119|red blood cells|red blood cells
4889363|NCT02134106|Multicenter|multicenter
4889364|NCT02134106|Open-label|open-label
4889365|NCT02134106|Randomized|randomized
4889366|NCT02134106|Controlled|controlled
4889367|NCT02134106|RCT|rct
4889368|NCT02134106|antibiotic|antibiotic
4889369|NCT02134106|drug-resistant|drug-resistant
4889370|NCT02134106|Gram-negative|gram-negative
4889371|NCT02134106|bacteria|bacteria
4889372|NCT02134080|Tourette Syndrome|tourette syndrome
4889373|NCT02134080|FAAH-Inhibitor|faah-inhibitor
4889374|NCT02134080|Tics|tics
4889375|NCT02134080|Tic Disorders|tic disorders
4889376|NCT02134067|advanced solid tumors|advanced solid tumors
4889377|NCT02134067|tumor|tumor
4889378|NCT02134067|Dose Escalation|dose escalation
4889379|NCT02134067|TAS-119|tas-119
4889380|NCT02134067|Taxane|taxane
4889381|NCT02134067|Paclitaxel|paclitaxel
4889382|NCT02134067|Aurora A kinase inhibitor|aurora a kinase inhibitor
4889383|NCT02134067|AurA|aura
4889384|NCT02134054|Therapeutic drug monitoring|therapeutic drug monitoring
4889385|NCT02134054|Biological treatment|biological treatment
4889386|NCT02134054|IBD|ibd
4889387|NCT02134041|traumatic brain injury|traumatic brain injury
4889388|NCT02134041|Alzheimer disease|alzheimer disease
4889389|NCT02134015|Carcinoma|carcinoma
4889390|NCT02134015|Non-Small-Cell Lung|non-small-cell lung
4889391|NCT02134015|Lung Neoplasms|lung neoplasms
4889392|NCT02134015|Bronchogenic|bronchogenic
4889393|NCT02134015|Bronchial Neoplasms|bronchial neoplasms
4889394|NCT02134015|Respiratory Tract Neoplasms|respiratory tract neoplasms
4889395|NCT02134015|Thoracic Neoplasms|thoracic neoplasms
4889396|NCT02134015|Neoplasms by Site|neoplasms by site
4889397|NCT02134015|Neoplasms|neoplasms
4889398|NCT02134015|Lung Diseases|lung diseases
4889399|NCT02134015|Respiratory Tract Diseases|respiratory tract diseases
4889400|NCT02134015|Erlotinib|erlotinib
4889401|NCT02134015|Therapeutic Uses|therapeutic uses
4889402|NCT02134015|Pharmacologic Actions|pharmacologic actions
4889403|NCT02134015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
4889404|NCT02134002|cocaine|cocaine
4889405|NCT02134002|disulfiram|disulfiram
4889406|NCT02134002|beta-dopamine hydroxylase|beta-dopamine hydroxylase
4889407|NCT02133989|Carotid stenosis|carotid stenosis
4889408|NCT02133989|Stenting|stenting
4889409|NCT02133989|Clopidogrel resistance|clopidogrel resistance
4889410|NCT02133989|Stroke, ischemic|stroke, ischemic
4889411|NCT02133976|chronic low back pain|chronic low back pain
4889412|NCT02133976|psychosocial interventions|psychosocial interventions
4889413|NCT02133976|mechanisms|mechanisms
4889414|NCT02133963|depression|depression
4889415|NCT02133963|postpartum depression|postpartum depression
4889416|NCT02133963|pregnancy|pregnancy
4889417|NCT02133963|perinatal depression|perinatal depression
4889418|NCT02133963|sleep|sleep
4889419|NCT02133963|life stress|life stress
4889420|NCT02133950|preimplantation genetic diagnosis|preimplantation genetic diagnosis
4889421|NCT02133950|cryopreservation|cryopreservation
4889422|NCT02133950|pregnancy|pregnancy
4889423|NCT02133924|Graft vs Host Disease|graft vs host disease
4889424|NCT02133924|Graft vs Host Reaction|graft vs host reaction
4889425|NCT02133924|allogeneic bone marrow transplantation|allogeneic bone marrow transplantation
4889426|NCT02133924|allogeneic hematopoietic stem cell transplantation|allogeneic hematopoietic stem cell transplantation
4889427|NCT02133924|adverse effects|adverse effects
4889428|NCT02133898|Depression|depression
4889429|NCT02133898|MTHFR|mthfr
4889430|NCT02133898|L-methylfolate|l-methylfolate
4889431|NCT02133885|Resistent Hypertension|resistent hypertension
4889432|NCT02133885|Systolic Blood Pressure|systolic blood pressure
4889433|NCT02133872|Resistent Hypertension|resistent hypertension
4889434|NCT02133846|4RT, CBS, PSP, CBD, TPI-287|4rt, cbs, psp, cbd, tpi-287
4889435|NCT02133820|Healthy Volunteer|healthy volunteer
4889436|NCT02133820|Pharmacokinetics|pharmacokinetics
4889437|NCT02133807|Lipoprotein(a);|lipoprotein(a);
4889438|NCT02133807|Lp(a) immunoadsorption;|lp(a) immunoadsorption;
4889439|NCT02133807|Apheresis;|apheresis;
4889440|NCT02133807|Coronary atherosclerosis;|coronary atherosclerosis;
4889441|NCT02133807|Carotid Atherosclerosis;|carotid atherosclerosis;
4889442|NCT02133807|Intima-media thickness;|intima-media thickness;
4889443|NCT02133807|Regression;|regression;
4889444|NCT02133807|Quantitative Coronary Angiography;|quantitative coronary angiography;
4889445|NCT02133807|Intravascular Ultrasound;|intravascular ultrasound;
4889446|NCT02133807|Virtual Histology;|virtual histology;
4889447|NCT02133807|Plaque;|plaque;
4889448|NCT02133807|Atorvastatin;|atorvastatin;
4889449|NCT02133794|Hip fracture|hip fracture
4889450|NCT02133794|Tomosynthesis|tomosynthesis
4889451|NCT02133794|X-ray|x-ray
4889452|NCT02133794|Emergency room|emergency room
4889453|NCT02133781|Inactivated influenza vaccine|inactivated influenza vaccine
4889454|NCT02133781|Live, attenuated influenza vaccine|live, attenuated influenza vaccine
4889455|NCT02133781|Child identical twins|child identical twins
4889456|NCT02133781|Young and elderly adults|young and elderly adults
4889457|NCT02133742|Axitinib and MK-3475|axitinib and mk-3475
4889458|NCT02133742|patients with advanced Renal Cell Cancer.|patients with advanced renal cell cancer.
4889459|NCT02133716|pain|pain
4889460|NCT02133716|premature infant|premature infant
4889461|NCT02133716|sucrose|sucrose
4889462|NCT02133716|breastfeeding|breastfeeding
4889463|NCT02133716|expressed breast milk|expressed breast milk
4889464|NCT02133716|PIPP|pipp
4889465|NCT02133703|Genetic counseling|genetic counseling
4889466|NCT02133703|genetic testing|genetic testing
4889467|NCT02133703|BRCA1|brca1
4889468|NCT02133703|BRCA2|brca2
4889469|NCT02133703|Hereditary breast cancer|hereditary breast cancer
4889470|NCT02133703|Hereditary ovarian cancer|hereditary ovarian cancer
4889471|NCT02133690|rotavirus|rotavirus
4889472|NCT02133690|rotavirus vaccine|rotavirus vaccine
4889473|NCT02133690|BRV-PV|brv-pv
4889474|NCT02133677|lung cancer and breast cancer patients with brain metastases|lung cancer and breast cancer patients with brain metastases
4889475|NCT02133664|multiple sclerosis|multiple sclerosis
4889476|NCT02133664|cognition|cognition
4889477|NCT02133664|clinical trial|clinical trial
4889478|NCT02133664|thiotic acid|thiotic acid
4889479|NCT02133664|Omega-3 fatty acids|omega-3 fatty acids
4889480|NCT02133651|Clostridium difficile|clostridium difficile
4889481|NCT02133651|Intestinal Microbiota Transplantation|intestinal microbiota transplantation
4889482|NCT02133651|Diarrhea|diarrhea
4889483|NCT02133651|Fecal Microbiota Transplant|fecal microbiota transplant
4889484|NCT02133638|Delirium|delirium
4889485|NCT02133638|Hypoxic Brain Damage|hypoxic brain damage
4889486|NCT02133638|Propofol|propofol
4889487|NCT02133638|S100b protein|s100b protein
4889488|NCT02133638|Sevoflurane|sevoflurane
4889489|NCT02133625|Advanced solid tumor|advanced solid tumor
4889490|NCT02133625|Metastatic solid tumor|metastatic solid tumor
4889491|NCT02133612|esophageal cancer|esophageal cancer
4889492|NCT02133612|adjuvant chemotherapy|adjuvant chemotherapy
4889493|NCT02133612|esophageal surgery|esophageal surgery
4889494|NCT02133612|paclitaxel|paclitaxel
4889495|NCT02133612|cisplatin|cisplatin
4889496|NCT02133586|Air pollution|air pollution
4889498|NCT02133586|Nitrogen dioxide|nitrogen dioxide
4889499|NCT02133586|Lung function|lung function
4889500|NCT02133586|Cytokines|cytokines
4889501|NCT02133573|progesterone|progesterone
4889502|NCT02133573|congenital heart disease|congenital heart disease
4889503|NCT02133573|periventricular leucomalacia|periventricular leucomalacia
4889504|NCT02133573|brain development|brain development
4889505|NCT02133573|cardiac surgery|cardiac surgery
4889506|NCT02133573|neurodevelopmental disability|neurodevelopmental disability
4889507|NCT02133573|fetus|fetus
4889508|NCT02133573|fetal neuroprotection|fetal neuroprotection
4889509|NCT02133560|Sickle cell|sickle cell
4889510|NCT02133560|Thalassemia|thalassemia
4889511|NCT02133560|Adherence|adherence
4889512|NCT02133547|Nitric Oxide|nitric oxide
4889513|NCT02133547|Nose|nose
4889514|NCT02133547|Healthy Volunteers|healthy volunteers
4889515|NCT02133547|Kartagener Syndrome|kartagener syndrome
4889516|NCT02133547|Primary Ciliary Dyskinesia|primary ciliary dyskinesia
4889517|NCT02133534|Chronic kidney disease|chronic kidney disease
4889518|NCT02133534|High cholesterol|high cholesterol
4889519|NCT02133521|DLBS1033|dlbs1033
4889520|NCT02133521|Acute ischemic stroke|acute ischemic stroke
4889521|NCT02133521|NIHSS|nihss
4889522|NCT02133521|Barthel Index|barthel index
4889523|NCT02133495|lower eyelid|lower eyelid
4889524|NCT02133495|retraction|retraction
4889525|NCT02133469|Effectiveness|effectiveness
4889526|NCT02133469|Prevenar|prevenar
4889527|NCT02133469|nasopharyngeal carriage|nasopharyngeal carriage
4889528|NCT02133469|vaccine serotype|vaccine serotype
4889529|NCT02133456|safety|safety
4889530|NCT02133456|influenza vaccine|influenza vaccine
4889531|NCT02133456|post-marketing|post-marketing
4889532|NCT02133443|Mechanical ventilation|mechanical ventilation
4889533|NCT02133443|Acute respiratory failure|acute respiratory failure
4889534|NCT02133443|Weaning|weaning
4889535|NCT02133443|Pressure support ventilation|pressure support ventilation
4889536|NCT02133443|Neurally adjusted ventilatory assist|neurally adjusted ventilatory assist
4889537|NCT02133430|Postoperative delirium|postoperative delirium
4889538|NCT02133417|Quantitative Transmission Ultrasound|quantitative transmission ultrasound
4889539|NCT02133417|QTUS|qtus
4889540|NCT02133404|secondary hyperparathyroidism(SHPT)|secondary hyperparathyroidism(shpt)
4889541|NCT02133404|Chronic kidney disease(CKD)|chronic kidney disease(ckd)
4889542|NCT02133404|Mineral bone disease(MBD)|mineral bone disease(mbd)
4889543|NCT02133391|Accountable Care Organization|accountable care organization
4889544|NCT02133391|Comparative Effectiveness Research|comparative effectiveness research
4889545|NCT02133391|Immunization/statistics & numerical data|immunization/statistics & numerical data
4889546|NCT02133391|Medicaid|medicaid
4889547|NCT02133391|Reminder Systems/economics|reminder systems/economics
4889548|NCT02133391|Reminder Systems/statistics & numerical data|reminder systems/statistics & numerical data
4889549|NCT02133378|Bleeding|bleeding
4889550|NCT02133378|Hemostatic|hemostatic
4889551|NCT02133352|pulmonary hypertension|pulmonary hypertension
4889552|NCT02133352|diastolic dyfunction|diastolic dyfunction
4889553|NCT02133326|Analgesia|analgesia
4889554|NCT02133326|Third Molar Extraction|third molar extraction
4889555|NCT02133326|Ibuprofen|ibuprofen
4889556|NCT02133326|Acetaminophen|acetaminophen
4889557|NCT02133326|Pain Medicine|pain medicine
4889558|NCT02133326|Nonsteroidal|nonsteroidal
4889559|NCT02133326|Anti-inflammatory|anti-inflammatory
4889560|NCT02133313|Peritoneal Dialysis|peritoneal dialysis
4889561|NCT02133313|Peritoneal Fibrosis|peritoneal fibrosis
4889562|NCT02133313|Glucose Transporters|glucose transporters
4889563|NCT02133274|Neoplasms|neoplasms
4889564|NCT02133274|Early Palliative Care|early palliative care
4889565|NCT02133274|Psychosocial Intervention|psychosocial intervention
4889566|NCT02133274|Symptoms|symptoms
4889567|NCT02133274|Quality of life|quality of life
4889568|NCT02133274|Depression|depression
4889569|NCT02133248|donor specific antibodies|donor specific antibodies
4889570|NCT02133248|B cells|b cells
4889571|NCT02133248|antibody mediated rejection|antibody mediated rejection
4889572|NCT02133248|kidney transplant|kidney transplant
4889573|NCT02133248|desensitization|desensitization
4889574|NCT02133235|endobronchial blocker|endobronchial blocker
4889575|NCT02133235|lung separation|lung separation
4889576|NCT02133235|vedio-assisted thoracic operation|vedio-assisted thoracic operation
4889577|NCT02133209|migraine|migraine
4889578|NCT02133209|headache|headache
4889579|NCT02133209|meditation|meditation
4889580|NCT02133209|mindfulness based stress reduction|mindfulness based stress reduction
4889581|NCT02133209|MBSR|mbsr
4889582|NCT02133196|Metastatic|metastatic
4889583|NCT02133196|Non-Small Cell Lung Cancer|non-small cell lung cancer
4889584|NCT02133196|NSCLC|nsclc
4889585|NCT02133196|Lung Cancer|lung cancer
4889586|NCT02133170|BIPOLAR DISORDER|bipolar disorder
4889587|NCT02133170|DEPRESSIVE SYMPTOMS|depressive symptoms
4889588|NCT02133170|MINDFULNESS|mindfulness
4889589|NCT02133170|PSYCHOEDUCATION|psychoeducation
4889590|NCT02133170|BIPOLAR PATIENTS WITH DEPRESSIVE SYMPTOMS|bipolar patients with depressive symptoms
4889591|NCT02133157|tumor|tumor
4889592|NCT02133144|NAFLD|nafld
4889593|NCT02133144|insulin resistance|insulin resistance
4889594|NCT02133144|metabolic syndrome|metabolic syndrome
4889595|NCT02133144|de novo lipogenesis|de novo lipogenesis
4889596|NCT02133144|overfeeding|overfeeding
4889597|NCT02133118|Type 2 diabetes|type 2 diabetes
4889598|NCT02133118|New-user design|new-user design
4889599|NCT02133118|Weight trajectory|weight trajectory
4889600|NCT02133118|Add-on therapy|add-on therapy
4889601|NCT02133118|Sulphonylureas.|sulphonylureas.
4889602|NCT02133105|Heart failure|heart failure
4889603|NCT02133105|Renal failure|renal failure
4889604|NCT02133105|Inotropic drugs|inotropic drugs
4889605|NCT02133105|Levosimendan|levosimendan
4889606|NCT02133105|Dobutamine|dobutamine
4889607|NCT02133092|Respiratory syncytial virus|respiratory syncytial virus
4889608|NCT02133092|RSV|rsv
4889609|NCT02133092|Lower respiratory tract infection|lower respiratory tract infection
4889610|NCT02133092|LRTI|lrti
4889611|NCT02133092|Acute respiratory infection|acute respiratory infection
4889612|NCT02133092|Belgian children|belgian children
4889613|NCT02133066|Ultrasound|ultrasound
4889614|NCT02133066|Lumbar Puncture|lumbar puncture
4889615|NCT02133066|Spinal Tap|spinal tap
4889616|NCT02133066|Pediatric|pediatric
4889617|NCT02133066|Infant|infant
4889618|NCT02133066|Bedside Ultrasonography|bedside ultrasonography
4889619|NCT02133053|Allergic Rhinitis|allergic rhinitis
4889620|NCT02133053|Ectoine|ectoine
4889621|NCT02133053|bitop|bitop
4889622|NCT02133053|Ectoin|ectoin
4889623|NCT02133040|Brown Adipose Tissue|brown adipose tissue
4889624|NCT02133027|Laparoscopic cholecystectomy|laparoscopic cholecystectomy
4889625|NCT02133014|pancreatitis|pancreatitis
4889626|NCT02133014|laparoscopic|laparoscopic
4889627|NCT02133014|drainage|drainage
4889628|NCT02133014|surgery|surgery
4889629|NCT02133001|Major Depressive Disorder|major depressive disorder
4889630|NCT02133001|Esketamine|esketamine
4889631|NCT02133001|Intranasal esketamine|intranasal esketamine
4889632|NCT02133001|Placebo|placebo
4889633|NCT02132975|prostate|prostate
4889634|NCT02132975|cancer|cancer
4889635|NCT02132923|Respiratory syncytial virus|respiratory syncytial virus
4889636|NCT02132923|RSV|rsv
4889637|NCT02132923|Lower respiratory tract infection|lower respiratory tract infection
4889638|NCT02132923|LRTI|lrti
4889639|NCT02132923|Acute respiratory infection|acute respiratory infection
4889640|NCT02132923|Japanese children|japanese children
4889641|NCT02132897|Antiepileptic|antiepileptic
4889642|NCT02132897|Carbamazepine|carbamazepine
4889643|NCT02132897|Bio-equivalence|bio-equivalence
4889644|NCT02132897|Fed|fed
4889645|NCT02132897|Crossover|crossover
4889646|NCT02132832|marijuana|marijuana
4889647|NCT02132832|attentional bias|attentional bias
4889648|NCT02132832|stress|stress
4889649|NCT02132832|buspirone|buspirone
4889650|NCT02132819|transfusion|transfusion
4889651|NCT02132819|feeding|feeding
4889652|NCT02132819|TRAGI|tragi
4889653|NCT02132819|NEC|nec
4889654|NCT02132806|class II furcation involvement|class ii furcation involvement
4889655|NCT02132806|piezoelectric surgery|piezoelectric surgery
4889656|NCT02132806|regeneration|regeneration
4889657|NCT02132806|biomaterial|biomaterial
4889658|NCT02132793|technology|technology
4889659|NCT02132793|mobile|mobile
4889660|NCT02132793|anger management|anger management
4889661|NCT02132793|anger|anger
4889662|NCT02132793|PTSD|ptsd
4889663|NCT02132793|veterans|veterans
4889664|NCT02132767|Heart surgery|heart surgery
4889665|NCT02132767|Cardiac surgery|cardiac surgery
4889666|NCT02132767|Coronary artery bypass|coronary artery bypass
4889667|NCT02132767|Mitral valve surgery|mitral valve surgery
4889668|NCT02132767|Aortic valve surgery|aortic valve surgery
4889669|NCT02132767|Atrial fibrillation|atrial fibrillation
4889670|NCT02132767|Atrial flutter|atrial flutter
4889671|NCT02132767|Cardiac arrhythmia|cardiac arrhythmia
4889672|NCT02132767|Valve surgery|valve surgery
4889673|NCT02132741|OCT; hypertension; CKD|oct; hypertension; ckd
4889674|NCT02132728|flaxseed|flaxseed
4889675|NCT02132728|lignans|lignans
4889676|NCT02132728|inflammation|inflammation
4889677|NCT02132728|Nutrition|nutrition
4889678|NCT02132728|enterolactone|enterolactone
4889679|NCT02132728|enterodiol|enterodiol
4889680|NCT02132689|Moderate Risk Acute Pulmonary Embolism|moderate risk acute pulmonary embolism
4889681|NCT02132676|Self-Management|self-management
4889682|NCT02132676|Patient Care Management|patient care management
4889683|NCT02132676|Peer Group|peer group
4889684|NCT02132676|Disease Management|disease management
4889685|NCT02132676|Health Plan Implementation|health plan implementation
4889686|NCT02132676|Diabetes Mellitus|diabetes mellitus
4889687|NCT02132650|Rehabilitation|rehabilitation
4889688|NCT02132650|Walking|walking
4889689|NCT02132650|Motor skills disorders|motor skills disorders
4889690|NCT02132650|Electromyography|electromyography
4889691|NCT02132598|Lung Cancer|lung cancer
4889692|NCT02132598|Non Small Cell|non small cell
4889693|NCT02132598|Brain metastases|brain metastases
4889694|NCT02132598|c-MET|c-met
4889695|NCT02132520|Hemiparesis|hemiparesis
4889696|NCT02132520|Stroke|stroke
4889697|NCT02132520|Rehabilitation|rehabilitation
4889698|NCT02132520|Transcranial Magnetic Stimulation, Repetitive|transcranial magnetic stimulation, repetitive
4889699|NCT02132520|Electroencephalography|electroencephalography
4889700|NCT02132520|Functional Neuroimaging|functional neuroimaging
4889701|NCT02132520|Brain-Computer Interface|brain-computer interface
4889702|NCT02132507|epilepsy|epilepsy
4889703|NCT02132507|fMRI|fmri
4889704|NCT02132507|EEG|eeg
4889705|NCT02132507|ICA|ica
4889706|NCT02132481|Smartphones|smartphones
4889707|NCT02132481|Mobile phones|mobile phones
4889708|NCT02132481|Substance use disorder|substance use disorder
4889709|NCT02132481|Recovery Support Services|recovery support services
4889710|NCT02132481|Ecological Momentary Assessment (EMA)|ecological momentary assessment (ema)
4889808|NCT02132052|Multiple System Atrophy|multiple system atrophy
4889711|NCT02132481|Ecological Momentary Intervention (EMI)|ecological momentary intervention (emi)
4889712|NCT02132481|Randomized field experiment|randomized field experiment
4889713|NCT02132481|Effectiveness|effectiveness
4889714|NCT02132481|Post-Discharge|post-discharge
4889715|NCT02132468|PNET|pnet
4889716|NCT02132468|GI-NET|gi-net
4889717|NCT02132468|neuroendocrine|neuroendocrine
4889718|NCT02132468|carcinoid|carcinoid
4889719|NCT02132455|Screening colonoscopy|screening colonoscopy
4889720|NCT02132455|Surveillance colonoscopy|surveillance colonoscopy
4889721|NCT02132442|Children|children
4889722|NCT02132442|Adolescents|adolescents
4889723|NCT02132442|Adults|adults
4889724|NCT02132442|Type 2 diabetes|type 2 diabetes
4889725|NCT02132442|Nonalcoholic fatty liver disease|nonalcoholic fatty liver disease
4889726|NCT02132442|Vitamin D deficiency|vitamin d deficiency
4889727|NCT02132429|Migraine|migraine
4889728|NCT02132416|Prospective study|prospective study
4889729|NCT02132416|Surgical management|surgical management
4889730|NCT02132416|Unstable thoracic cage injuries|unstable thoracic cage injuries
4889731|NCT02132416|Trauma|trauma
4889732|NCT02132416|Ventilator support|ventilator support
4889733|NCT02132403|pancreatic cancer|pancreatic cancer
4889734|NCT02132403|adenocarcinoma of the pancreas (PDAC)|adenocarcinoma of the pancreas (pdac)
4889860|NCT02131844|postoperative recovery|postoperative recovery
4889735|NCT02132403|mixed adenocarcinoma of the pancreas|mixed adenocarcinoma of the pancreas
4889736|NCT02132403|locally advanced|locally advanced
4889737|NCT02132403|recurrent|recurrent
4889738|NCT02132403|metastatic|metastatic
4889739|NCT02132390|Breast cancer|breast cancer
4889740|NCT02132390|Chemotherapy induced amenorrhea|chemotherapy induced amenorrhea
4889741|NCT02132390|Goserelin|goserelin
4889742|NCT02132364|stroke|stroke
4889743|NCT02132364|hypertension|hypertension
4889744|NCT02132364|secondary prevention|secondary prevention
4889745|NCT02132364|educational program|educational program
4889746|NCT02132338|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
4889747|NCT02132338|Prevention|prevention
4889748|NCT02132338|Health Education|health education
4889749|NCT02132325|Pancreatic Cancer|pancreatic cancer
4889750|NCT02132325|Dignity Therapy|dignity therapy
4889751|NCT02132325|Palliative Care|palliative care
4889752|NCT02132325|Advanced Lung Cancer|advanced lung cancer
4889753|NCT02132325|Non-Small-Cell Lung Cancer|non-small-cell lung cancer
4889754|NCT02132312|Cataract|cataract
4889755|NCT02132312|Lens replacement|lens replacement
4889756|NCT02132312|pediatric|pediatric
4889757|NCT02132299|Malaria|malaria
4889758|NCT02132299|Plasmodium falciparum malaria|plasmodium falciparum malaria
4889759|NCT02132299|PfSPZ Vaccine|pfspz vaccine
4889760|NCT02132299|PfSPZ Challenge|pfspz challenge
4889761|NCT02132299|Controlled human malaria infection (CHMI)|controlled human malaria infection (chmi)
4889762|NCT02132286|Functional magnetic resonance neuroimaging|functional magnetic resonance neuroimaging
4889763|NCT02132286|Serotonin transporter gene polymorphism|serotonin transporter gene polymorphism
4889764|NCT02132286|Amygdala|amygdala
4889765|NCT02132286|Antidepressant|antidepressant
4889766|NCT02132286|Quetiapine|quetiapine
4889767|NCT02132286|Citalopram|citalopram
4889768|NCT02132286|imaging biomarker|imaging biomarker
4889769|NCT02132260|Naftifine|naftifine
4889770|NCT02132260|Naftin®|naftin®
4889771|NCT02132260|Tinea pedis|tinea pedis
4889772|NCT02132247|Minor athletic injuries|minor athletic injuries
4889773|NCT02132247|Pain|pain
4889774|NCT02132247|Diclofenac|diclofenac
4889775|NCT02132247|Topical|topical
4889776|NCT02132221|Chronic non cancer pain|chronic non cancer pain
4889777|NCT02132221|Long term opioid therapy|long term opioid therapy
4889778|NCT02132221|Side effects|side effects
4889779|NCT02132221|risks|risks
4889780|NCT02132221|function|function
4889781|NCT02132221|negative benefit/risk ratio|negative benefit/risk ratio
4889782|NCT02132143|Lung adenocarcinoma|lung adenocarcinoma
4889783|NCT02132143|Concurrent chemoradiotherapy|concurrent chemoradiotherapy
4889784|NCT02132143|Sequential chemoradiotherapy|sequential chemoradiotherapy
4889785|NCT02132143|Progression-free survival|progression-free survival
4889786|NCT02132130|gene therapy|gene therapy
4889787|NCT02132130|unilateral hearing loss|unilateral hearing loss
4889788|NCT02132130|bilateral hearing loss|bilateral hearing loss
4889789|NCT02132130|balance|balance
4889790|NCT02132130|vestibular|vestibular
4889791|NCT02132130|cochlear implant|cochlear implant
4889792|NCT02132130|hearing restoration|hearing restoration
4889793|NCT02132104|Intrauterine adhesions|intrauterine adhesions
4889794|NCT02132104|Asherman Syndrome|asherman syndrome
4889795|NCT02132104|Amnion graft|amnion graft
4889796|NCT02132091|Sirtuins|sirtuins
4889797|NCT02132091|Calorie Restriction|calorie restriction
4889798|NCT02132091|Intermittent Fasting|intermittent fasting
4889799|NCT02132091|Antioxidant|antioxidant
4889800|NCT02132091|Aging|aging
4889801|NCT02132091|Metabolism|metabolism
4889802|NCT02132091|Mitochondria|mitochondria
4889803|NCT02132091|Oxidative Stress|oxidative stress
4889804|NCT02132078|Lung transplant recipients|lung transplant recipients
4889805|NCT02132078|diverticulitis|diverticulitis
4889806|NCT02132078|immunosuppression|immunosuppression
4889807|NCT02132052|Essential Tremor|essential tremor
4889809|NCT02132052|Corticobasal Degeneration|corticobasal degeneration
4889810|NCT02132052|Supranuclear Palsy, Progressive|supranuclear palsy, progressive
4889811|NCT02132052|Parkinson's Disease|parkinson's disease
4889812|NCT02132052|PD|pd
4889813|NCT02132039|Tai Chi, dementia, caregivers|tai chi, dementia, caregivers
4889814|NCT02132026|Aortic Stenosis|aortic stenosis
4889815|NCT02132026|Denosumab|denosumab
4889816|NCT02132026|Alendronic Acid|alendronic acid
4889817|NCT02132026|Osteoporosis|osteoporosis
4889818|NCT02131987|Dislocation|dislocation
4889819|NCT02131987|Hemiarthroplasty|hemiarthroplasty
4889820|NCT02131987|Femoral neck fracture|femoral neck fracture
4889821|NCT02131987|Femoral offset|femoral offset
4889822|NCT02131987|Leg length difference|leg length difference
4889823|NCT02131987|Wiberg angle|wiberg angle
4889824|NCT02131974|intubation, pediatric, endotracheal, cuffed ETT|intubation, pediatric, endotracheal, cuffed ett
4889825|NCT02131961|diabetic foot|diabetic foot
4889826|NCT02131961|foot ulcer|foot ulcer
4889827|NCT02131961|foot wound|foot wound
4889828|NCT02131961|plantar ulcer|plantar ulcer
4889829|NCT02131961|plantar wound|plantar wound
4889830|NCT02131961|contact cast|contact cast
4889831|NCT02131961|collagenase|collagenase
4889832|NCT02131948|Insulin resistance|insulin resistance
4889833|NCT02131948|Brain insulin action|brain insulin action
4889834|NCT02131948|Type 2 Diabetes|type 2 diabetes
4889835|NCT02131909|unilateral cerebral palsy|unilateral cerebral palsy
4889836|NCT02131909|children|children
4889837|NCT02131909|upper-limb|upper-limb
4889838|NCT02131909|mirror therapy|mirror therapy
4889839|NCT02131909|bimanual coordination|bimanual coordination
4889840|NCT02131909|kinematics analysis|kinematics analysis
4889841|NCT02131896|Type 1 Diabetes|type 1 diabetes
4889842|NCT02131896|Newly diagnosed|newly diagnosed
4889843|NCT02131896|Lipid profile|lipid profile
4889844|NCT02131896|Mediterranean diet|mediterranean diet
4889845|NCT02131883|Health Anxiety|health anxiety
4889846|NCT02131883|Hypochondriasis|hypochondriasis
4889847|NCT02131883|Illness Anxiety Disorder|illness anxiety disorder
4889848|NCT02131883|Somatic Symptom Disorder|somatic symptom disorder
4889849|NCT02131883|Personality Disorders|personality disorders
4889850|NCT02131883|Cognitive Behavioral Therapy|cognitive behavioral therapy
4889851|NCT02131883|Group-CBT|group-cbt
4889852|NCT02131883|Illness Perception|illness perception
4889853|NCT02131883|Cost-effectiveness|cost-effectiveness
4889854|NCT02131870|iron absorption|iron absorption
4889855|NCT02131870|healthy females|healthy females
4889856|NCT02131870|child bearing age|child bearing age
4889857|NCT02131857|Mindfulness|mindfulness
4889858|NCT02131857|stress reduction|stress reduction
4889859|NCT02131844|colorectal surgery|colorectal surgery
4889861|NCT02131844|early mobilization|early mobilization
4889862|NCT02131831|telomere|telomere
4889863|NCT02131831|telomerase|telomerase
4889864|NCT02131831|cirrhosis|cirrhosis
4889865|NCT02131818|amoxicillin|amoxicillin
4889866|NCT02131818|postpartum infections|postpartum infections
4889867|NCT02131818|puerperal infection|puerperal infection
4889868|NCT02131805|skin|skin
4889869|NCT02131805|Brachytherapy|brachytherapy
4889870|NCT02131805|14-001|14-001
4889871|NCT02131779|prostate cancer disparities|prostate cancer disparities
4889872|NCT02131779|African American|african american
4889873|NCT02131779|Spiritually based intervention|spiritually based intervention
4889874|NCT02131779|Men's Health|men's health
4889875|NCT02131779|Informed Decision Making|informed decision making
4889876|NCT02131779|Community Based Participatory Research|community based participatory research
4889877|NCT02131779|Health Communication|health communication
4889878|NCT02131779|Health Information Technology|health information technology
4889879|NCT02131779|Community Health Advisors|community health advisors
4889880|NCT02131766|Diabetes Mellitus, Type 1|diabetes mellitus, type 1
4889881|NCT02131766|Artificial Pancreas Project (APP)|artificial pancreas project (app)
4889882|NCT02131766|Diabetes Assistant (DiAs)|diabetes assistant (dias)
4889883|NCT02131766|Closed-Loop Control (CLC)|closed-loop control (clc)
4889884|NCT02131753|hairy cell leukemia|hairy cell leukemia
4889885|NCT02131753|untreated|untreated
4889886|NCT02131753|cladribine subcutaneous|cladribine subcutaneous
4889887|NCT02131740|corneal|corneal
4889888|NCT02131740|eye rubbing|eye rubbing
4889889|NCT02131727|hand hygiene|hand hygiene
4889890|NCT02131727|communicable diseases|communicable diseases
4889891|NCT02131727|respiratory tract infections|respiratory tract infections
4889892|NCT02131727|primary prevention|primary prevention
4889893|NCT02131727|employees|employees
4889894|NCT02131714|pressure pain threshold|pressure pain threshold
4889895|NCT02131714|temporomandibular disorder syndrome|temporomandibular disorder syndrome
4889896|NCT02131714|therapeutic exercise|therapeutic exercise
4889897|NCT02131714|conservative treatment|conservative treatment
4889898|NCT02131714|facial pain|facial pain
4889899|NCT02131701|Physical fitness|physical fitness
4889900|NCT02131701|Family history of type 2 diabetes|family history of type 2 diabetes
4889901|NCT02131701|Prescription of exercise|prescription of exercise
4889902|NCT02131688|safety;malignant lymphoma;|safety;malignant lymphoma;
4889903|NCT02131675|C-peptide|c-peptide
4889904|NCT02131675|type 1 diabetes|type 1 diabetes
4889905|NCT02131662|Uterine fibroids|uterine fibroids
4889906|NCT02131649|Prostate Cancer|prostate cancer
4889907|NCT02131649|PET|pet
4889908|NCT02131649|MRI|mri
4889909|NCT02131649|Fluorocholine|fluorocholine
4889910|NCT02131649|Radiotherapy|radiotherapy
4889911|NCT02131649|Prostatectomy|prostatectomy
4889912|NCT02131610|Sleep apnea|sleep apnea
4889913|NCT02131610|Obstructive sleep apnea|obstructive sleep apnea
4889914|NCT02131610|Subclinical atherosclerosis|subclinical atherosclerosis
4889915|NCT02131610|Epigenetics|epigenetics
4889916|NCT02131610|T cells|t cells
4889917|NCT02131597|Leukemia|leukemia
4889918|NCT02131597|Myelodysplastic syndrome|myelodysplastic syndrome
4889919|NCT02131597|MDS|mds
4889920|NCT02131597|Higher risk|higher risk
4889921|NCT02131597|SGI-110|sgi-110
4889922|NCT02131584|Leukemia|leukemia
4889923|NCT02131584|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
4889924|NCT02131584|CLL|cll
4889925|NCT02131584|Fatigue|fatigue
4889926|NCT02131584|Brief Fatigue Inventory|brief fatigue inventory
4889927|NCT02131584|BFI|bfi
4889928|NCT02131584|Questionnaires|questionnaires
4889929|NCT02131584|Surveys|surveys
4889930|NCT02131584|Ruxolitinib|ruxolitinib
4889931|NCT02131584|Jakafi|jakafi
4889932|NCT02131584|INCB018424|incb018424
4889933|NCT02131584|INC424|inc424
4889934|NCT02131571|HIV|hiv
4889935|NCT02131571|bone|bone
4889936|NCT02131571|fractures|fractures
4889937|NCT02131571|vitamin D|vitamin d
4889938|NCT02131571|biomarkers|biomarkers
4889939|NCT02131558|Endometrial cancer|endometrial cancer
4889940|NCT02131558|Sentinel lymph node|sentinel lymph node
4889941|NCT02131558|Indocyanine green|indocyanine green
4889942|NCT02131558|Near infrared imaging|near infrared imaging
4889943|NCT02131545|quetiapine|quetiapine
4889944|NCT02131545|pharmacokinetics|pharmacokinetics
4889945|NCT02131545|dementia|dementia
4889946|NCT02131545|delirium|delirium
4889947|NCT02131545|palliative care|palliative care
4889948|NCT02131532|Post-stroke fatigue|post-stroke fatigue
4889949|NCT02131532|Psychological intervention|psychological intervention
4889950|NCT02131532|Feasibility|feasibility
4889951|NCT02131506|Advanced HER2 positive Breast Cancer|advanced her2 positive breast cancer
4889952|NCT02131506|pretreated breast cancer|pretreated breast cancer
4889953|NCT02131506|advanced disease|advanced disease
4889954|NCT02131454|asthma and COPD treatment|asthma and copd treatment
4889955|NCT02131454|inhalation techniques|inhalation techniques
4889956|NCT02131454|training of inhalation|training of inhalation
4889957|NCT02131428|Heart Failure|heart failure
4889958|NCT02131428|Depression|depression
4889959|NCT02131428|BNP|bnp
4889960|NCT02131415|schizophrenia|schizophrenia
4889961|NCT02131415|real-life|real-life
4889962|NCT02131415|long-acting injectable|long-acting injectable
4889963|NCT02131415|Reliam|reliam
4889964|NCT02131389|Hip|hip
4889965|NCT02131389|Arthroplasty|arthroplasty
4889966|NCT02131389|Arthroplasties|arthroplasties
4889967|NCT02131389|Prosthesis|prosthesis
4889968|NCT02131389|Iconacy|iconacy
4889969|NCT02131389|Osteoarthritis|osteoarthritis
4889970|NCT02131389|Arthritis|arthritis
4889971|NCT02131389|THA|tha
4889972|NCT02131389|THR|thr
4889973|NCT02131389|DJD|djd
4889974|NCT02131376|carcinoma, renal cell|carcinoma, renal cell
4889975|NCT02131376|partial nephrectomy|partial nephrectomy
4889976|NCT02131376|kidney function test|kidney function test
4889977|NCT02131376|robotics|robotics
4889978|NCT02131324|Psoriasis|psoriasis
4889979|NCT02131311|single use|single use
4889980|NCT02131311|disposable|disposable
4889981|NCT02131311|pessary|pessary
4889982|NCT02131311|stress urinary incontinence|stress urinary incontinence
4889983|NCT02131311|sui|sui
4889984|NCT02131298|Palbociclib|palbociclib
4889985|NCT02131298|Itraconazole|itraconazole
4889986|NCT02131298|Pharmacokinetics|pharmacokinetics
4889987|NCT02131298|Drug-Drug Interaction Study|drug-drug interaction study
4889988|NCT02131298|Healthy Volunteers|healthy volunteers
4889989|NCT02131285|Rehabilitation,|rehabilitation,
4889990|NCT02131285|Balance,|balance,
4889991|NCT02131285|Sensory strategies,|sensory strategies,
4889992|NCT02131285|Multiple Sclerosis,|multiple sclerosis,
4889993|NCT02131285|Postural control|postural control
4889994|NCT02131220|No-Reflow Phenomenon|no-reflow phenomenon
4889995|NCT02131194|Cataract|cataract
4889996|NCT02131194|Nutritional Supplement|nutritional supplement
4889997|NCT02131181|Delirium, postoperative delirium, elderly|delirium, postoperative delirium, elderly
4889998|NCT02131142|ischemic heart disease|ischemic heart disease
4890000|NCT02131129|schizophrenia|schizophrenia
4890001|NCT02131129|schizophreniform disorder|schizophreniform disorder
4890002|NCT02131129|schizoaffective disorder|schizoaffective disorder
4890003|NCT02131129|first episode|first episode
4890004|NCT02131129|psychosis|psychosis
4890005|NCT02131129|cognition|cognition
4890006|NCT02131116|schizophrenia|schizophrenia
4890007|NCT02131116|schizophreniform disorder|schizophreniform disorder
4890008|NCT02131116|schizoaffective disorder|schizoaffective disorder
4890009|NCT02131116|cognition|cognition
4890010|NCT02131116|metacognition|metacognition
4890011|NCT02131116|insight|insight
4890012|NCT02131116|first episode psychosis|first episode psychosis
4890013|NCT02131116|psychosis|psychosis
4890014|NCT02131103|Pharmacoinvasive strategy|pharmacoinvasive strategy
4890015|NCT02131090|Epidural|epidural
4890016|NCT02131090|Catheter|catheter
4890017|NCT02131090|Fixation|fixation
4890018|NCT02131090|Device|device
4890019|NCT02131090|Intrapartum|intrapartum
4890020|NCT02131077|Lateral Epicondylitis|lateral epicondylitis
4890021|NCT02131051|ectoine|ectoine
4890022|NCT02131051|allergic rhinitis|allergic rhinitis
4890023|NCT02131051|bitop|bitop
4890024|NCT02131038|Ectoine|ectoine
4890025|NCT02131038|bitop|bitop
4890026|NCT02131038|Allergic Rhinitis|allergic rhinitis
4890027|NCT02131012|Macular edema|macular edema
4890028|NCT02130999|Non-24|non-24
4890029|NCT02130999|absolute bioavailability|absolute bioavailability
4890030|NCT02130999|tasimelteon|tasimelteon
4890031|NCT02130999|Hetlioz™|hetlioz™
4890032|NCT02130986|procalcitonin (PCT)|procalcitonin (pct)
4890033|NCT02130986|lower respiratory tract infection (LRTI)|lower respiratory tract infection (lrti)
4890034|NCT02130986|antibiotic exposure|antibiotic exposure
4890035|NCT02130986|antibiotic decision making|antibiotic decision making
4890036|NCT02130986|community acquired pneumonia (CAP)|community acquired pneumonia (cap)
4890037|NCT02130986|chronic obstructive pulmonary disease (COPD) exacerbation|chronic obstructive pulmonary disease (copd) exacerbation
4890038|NCT02130986|acute asthma exacerbation|acute asthma exacerbation
4890039|NCT02130986|acute bronchitis|acute bronchitis
4890040|NCT02130986|procalcitonin guideline|procalcitonin guideline
4890041|NCT02130973|teriparatide|teriparatide
4890042|NCT02130973|Forteo|forteo
4890043|NCT02130973|Denosumab|denosumab
4890044|NCT02130973|Prolia|prolia
4890045|NCT02130973|bone density|bone density
4890046|NCT02130973|treatment|treatment
4890047|NCT02130960|RMR|rmr
4890048|NCT02130960|Reliability|reliability
4890049|NCT02130960|Obese|obese
4890050|NCT02130960|Energy Expenditure|energy expenditure
4890051|NCT02130960|Resting Energy Expenditure|resting energy expenditure
4890052|NCT02130960|Resting Metabolic Rate|resting metabolic rate
4890053|NCT02130947|Metastatic Castration Resistant Prostate Cancer|metastatic castration resistant prostate cancer
4890054|NCT02130947|Prostate Cancer|prostate cancer
4890055|NCT02130947|mCRPC|mcrpc
4890056|NCT02130947|Pilot Study|pilot study
4890057|NCT02130947|UNC Lineberger|unc lineberger
4890058|NCT02130947|Exercise|exercise
4890059|NCT02130934|Childhood cancer|childhood cancer
4890060|NCT02130934|anthracyclines|anthracyclines
4890061|NCT02130934|cardiotoxicity|cardiotoxicity
4890062|NCT02130934|cardiac MRI|cardiac mri
4890063|NCT02130934|cumulative does of at least 150 mg/m2 of anthracyclines|cumulative does of at least 150 mg/m2 of anthracyclines
4890064|NCT02130934|Ventricular function|ventricular function
4890065|NCT02130921|Stigma|stigma
4890066|NCT02130921|HIV|hiv
4890067|NCT02130921|CHWs|chws
4890068|NCT02130921|PLH|plh
4890069|NCT02130921|Injecting Drug Users|injecting drug users
4890070|NCT02130921|FM|fm
4890071|NCT02130895|prescribing|prescribing
4890072|NCT02130895|STOPP Criteria|stopp criteria
4890073|NCT02130895|potentially inappropriate prescribing|potentially inappropriate prescribing
4890074|NCT02130895|clinical decision support|clinical decision support
4890075|NCT02130895|Electronic Medical Records|electronic medical records
4890076|NCT02130895|primary care|primary care
4890077|NCT02130882|Interleukin-5|interleukin-5
4890078|NCT02130882|Monoclonal Antibody|monoclonal antibody
4890079|NCT02130882|Treatment|treatment
4890080|NCT02130869|Autologous stem cell transplantation|autologous stem cell transplantation
4890081|NCT02130869|Natural killer cells|natural killer cells
4890082|NCT02130856|Neonatal mortality|neonatal mortality
4890083|NCT02130856|Neonatal kit|neonatal kit
4890084|NCT02130856|Pakistan|pakistan
4890085|NCT02130856|Randomized Control Trial|randomized control trial
4890086|NCT02130856|Chlorhexidine|chlorhexidine
4890087|NCT02130856|ThermoSpot|thermospot
4890088|NCT02130856|Birth|birth
4890089|NCT02130843|URINARY INCONTINENCE|urinary incontinence
4890090|NCT02130843|URODYNAMICS|urodynamics
4890091|NCT02130843|URINARY RETENTION|urinary retention
4890092|NCT02130843|URINARY CATHETERIZATION|urinary catheterization
4890093|NCT02130830|hemorrhoids|hemorrhoids
4890094|NCT02130830|Rubber band ligation|rubber band ligation
4890095|NCT02130830|pain|pain
4890096|NCT02130817|Renal Transplant|renal transplant
4890097|NCT02130817|Kidney Transplant|kidney transplant
4890098|NCT02130817|Mean flourescent Intensity|mean flourescent intensity
4890099|NCT02130817|Delayed Graft Function|delayed graft function
4890100|NCT02130817|Antagonist of Thymocyte Cell Activation|antagonist of thymocyte cell activation
4890101|NCT02130804|Obesity|obesity
4890102|NCT02130804|Adipose tissue inflammation|adipose tissue inflammation
4890103|NCT02130804|Salsalate|salsalate
4890104|NCT02130804|Hispanics|hispanics
4890105|NCT02130765|Monomorphic Ventricular Tachycardia|monomorphic ventricular tachycardia
4890106|NCT02130765|Ischemic|ischemic
4890107|NCT02130765|Non-ischemic|non-ischemic
4890108|NCT02130765|Catheter Ablation|catheter ablation
4890109|NCT02130752|Stomach Neoplasms|stomach neoplasms
4890110|NCT02130752|Operative Time|operative time
4890111|NCT02130752|Gastrectomy|gastrectomy
4890112|NCT02130752|Surgical Hemorrhage|surgical hemorrhage
4890113|NCT02130752|Mortality|mortality
4890114|NCT02130752|Morbidity|morbidity
4890115|NCT02130739|Anesthesia|anesthesia
4890116|NCT02130739|Epidural|epidural
4890117|NCT02130739|Thoracic Nerves|thoracic nerves
4890118|NCT02130739|Horner syndrome|horner syndrome
4890119|NCT02130726|Gastric cancer|gastric cancer
4890120|NCT02130726|Minimally-invasive|minimally-invasive
4890121|NCT02130726|Oncological quality of resection|oncological quality of resection
4890122|NCT02130700|mCRPC|mcrpc
4890123|NCT02130700|metastatic|metastatic
4890124|NCT02130700|castration-resistant prostate cancer|castration-resistant prostate cancer
4890125|NCT02130687|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
4890126|NCT02130687|Hypertension|hypertension
4890127|NCT02130687|Angiotensin Converting Enzyme Inhibitors|angiotensin converting enzyme inhibitors
4890128|NCT02130687|Dipeptidyl Peptidase IV Inhibitors|dipeptidyl peptidase iv inhibitors
4890129|NCT02130687|Sitagliptin|sitagliptin
4890130|NCT02130687|Aprepitant|aprepitant
4890131|NCT02130687|Ramipril|ramipril
4890132|NCT02130674|traumatic brain injury|traumatic brain injury
4890133|NCT02130674|glutamine|glutamine
4890134|NCT02130674|microdialysis|microdialysis
4890135|NCT02130674|metabolism|metabolism
4890136|NCT02130661|drug interaction|drug interaction
4890137|NCT02130661|healthy volunteer|healthy volunteer
4890138|NCT02130661|rilapladib|rilapladib
4890139|NCT02130661|SB-659032|sb-659032
4890140|NCT02130661|Alzheimer's disease|alzheimer's disease
4890141|NCT02130661|itraconazole|itraconazole
4890142|NCT02130648|Non-invasive Prenatal Diagnosis (NIPD)|non-invasive prenatal diagnosis (nipd)
4890143|NCT02130648|Cystic Fibrosis|cystic fibrosis
4890144|NCT02130648|Quantitative real time MEMO-PCR|quantitative real time memo-pcr
4890145|NCT02130635|PI3Kd|pi3kd
4890146|NCT02130635|Pharmacodynamics|pharmacodynamics
4890147|NCT02130635|dry powder inhaler|dry powder inhaler
4890148|NCT02130635|GSK2269557|gsk2269557
4890149|NCT02130635|safety|safety
4890150|NCT02130635|COPD subjects|copd subjects
4890151|NCT02130622|Diabetic Gastroparesis|diabetic gastroparesis
4890152|NCT02130622|Promethazine|promethazine
4890153|NCT02130570|Adverse events|adverse events
4890154|NCT02130570|Readmissions|readmissions
4890155|NCT02130570|Patient Centered Medical Home (PCMH)|patient centered medical home (pcmh)
4890156|NCT02130570|Accountable Care Organizations (ACO)|accountable care organizations (aco)
4890157|NCT02130570|Medication reconciliation|medication reconciliation
4890158|NCT02130570|Discharge Advocate|discharge advocate
4890159|NCT02130570|Patient engagement|patient engagement
4890160|NCT02130570|Transitions of care|transitions of care
4890161|NCT02130570|Transitions coach|transitions coach
4890162|NCT02130570|Pharmacist intervention|pharmacist intervention
4890163|NCT02130557|Leukemia|leukemia
4890164|NCT02130557|Myelogenous|myelogenous
4890165|NCT02130557|Chronic|chronic
4890166|NCT02130557|BCR-ABL Positive|bcr-abl positive
4890167|NCT02130557|Bosutinib|bosutinib
4890168|NCT02130557|Leukemia, Myeloid|leukemia, myeloid
4890169|NCT02130557|Leukemia, Myelogenous, Chronic, BCR-ABL Positive|leukemia, myelogenous, chronic, bcr-abl positive
4890170|NCT02130557|Philadelphia Chromosome|philadelphia chromosome
4890171|NCT02130557|Neoplasms by Histologic Type|neoplasms by histologic type
4890172|NCT02130557|Bone Marrow Diseases|bone marrow diseases
4890173|NCT02130557|Hematologic Diseases|hematologic diseases
4890174|NCT02130557|Translocation, Genetic|translocation, genetic
4890175|NCT02130557|Pathologic Processes|pathologic processes
4890176|NCT02130557|Imatinib|imatinib
4890177|NCT02130557|Therapeutic Uses|therapeutic uses
4890178|NCT02130557|Pharmacologic Actions|pharmacologic actions
4890179|NCT02130557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
4890180|NCT02130466|PD1|pd1
4890181|NCT02130466|PD-1|pd-1
4890182|NCT02130466|PDL1|pdl1
4890183|NCT02130466|PD-L1|pd-l1
4890184|NCT02130453|Ischemia|ischemia
4890185|NCT02130453|Coronary artery disease|coronary artery disease
4890186|NCT02130453|Nuclear stress test|nuclear stress test
4890187|NCT02130453|Stress Echocardiogram|stress echocardiogram
4890188|NCT02130453|Echocardiography strain measurement|echocardiography strain measurement
4890189|NCT02130453|Ultrasound cardiac imaging|ultrasound cardiac imaging
4890190|NCT02130453|ReSTE|reste
4890191|NCT02130453|SPECT|spect
4890192|NCT02130453|Regadenoson|regadenoson
4890193|NCT02130440|nasal obstruction|nasal obstruction
4890194|NCT02130440|sneezing|sneezing
4890195|NCT02130440|itching|itching
4890196|NCT02130440|rhinorrhea|rhinorrhea
4890197|NCT02130440|respiratory infections|respiratory infections
4890198|NCT02130440|wheezing|wheezing
4890199|NCT02130427|Adult subjects|adult subjects
4890200|NCT02130427|NSCLC|nsclc
4890201|NCT02130414|Cyclosporine|cyclosporine
4890202|NCT02130414|Healthy Volunteers|healthy volunteers
4890203|NCT02130414|Immunosuppressive Agents|immunosuppressive agents
4890204|NCT02130414|CyCol|cycol
4890205|NCT02130414|Pharmacokinetics|pharmacokinetics
4890206|NCT02130401|neuromodulation|neuromodulation
4890207|NCT02130401|caloric vestibular stimulation|caloric vestibular stimulation
4890208|NCT02130401|Type 2 Diabetes|type 2 diabetes
4890209|NCT02130362|Adalimumab|adalimumab
4890210|NCT02130362|Crohn's|crohn's
4890211|NCT02130362|Crohn's Disease|crohn's disease
4890212|NCT02130362|Registry|registry
4890213|NCT02130362|Gastrointestinal Diseases|gastrointestinal diseases
4890214|NCT02130362|Inflammatory Bowel Diseases|inflammatory bowel diseases
4890215|NCT02130349|IBD|ibd
4890216|NCT02130349|Crohns Disease|crohns disease
4890217|NCT02130349|Ulcerative Colitis|ulcerative colitis
4890218|NCT02130349|Cohort|cohort
4890219|NCT02130349|Biobank|biobank
4890220|NCT02130349|Population based|population based
4890221|NCT02130349|IBDSL|ibdsl
4890222|NCT02130336|Metabolic syndrome|metabolic syndrome
4890223|NCT02130336|Metabolic risk factors|metabolic risk factors
4890224|NCT02130336|High-intensity interval training|high-intensity interval training
4890225|NCT02130336|Moderate-intensity exercise|moderate-intensity exercise
4890226|NCT02130323|Cervical intraepithelial neoplasia, Imiquimod|cervical intraepithelial neoplasia, imiquimod
4890227|NCT02130310|Chronic ulcers|chronic ulcers
4890228|NCT02130310|Venous ulcers|venous ulcers
4890229|NCT02130297|Mohs|mohs
4890230|NCT02130297|scar|scar
4890231|NCT02130297|post excision|post excision
4890232|NCT02130297|CO2 laser|co2 laser
4890233|NCT02130297|laser|laser
4890234|NCT02130297|skin cancer|skin cancer
4890235|NCT02130297|resurfacing|resurfacing
4890236|NCT02130271|Sciatica|sciatica
4890237|NCT02130271|PET scan|pet scan
4890238|NCT02130271|MRI|mri
4890239|NCT02130271|Inflammation|inflammation
4890240|NCT02130271|Epidural Steroid Injection (ESI)|epidural steroid injection (esi)
4890241|NCT02130258|Radicular|radicular
4890242|NCT02130258|Pain|pain
4890243|NCT02130258|Epidural Steroid Injection|epidural steroid injection
4890244|NCT02130245|Laparoscopic cholecystectomy|laparoscopic cholecystectomy
4890245|NCT02130245|Acute cholecystitis|acute cholecystitis
4890246|NCT02130245|Early|early
4890247|NCT02130245|Delayed|delayed
4890248|NCT02130232|Gestational weight gain|gestational weight gain
4890249|NCT02130232|Lifestyle|lifestyle
4890250|NCT02130232|Intervention|intervention
4890251|NCT02130219|ICP, intracranial hypertension, Vittamed 205|icp, intracranial hypertension, vittamed 205
4890252|NCT02130206|Plaque, Saliva, Cavities|plaque, saliva, cavities
4890253|NCT02130193|Efficacy|efficacy
4890254|NCT02130193|Danirixin|danirixin
4890255|NCT02130193|EXACT-PRO|exact-pro
4890256|NCT02130193|COPD|copd
4890257|NCT02130193|Safety|safety
4890258|NCT02130193|RD|rd
4890259|NCT02130193|CXCR2 inhibitor|cxcr2 inhibitor
4890260|NCT02130193|EXACT-RS|exact-rs
4890261|NCT02130193|PK|pk
4890262|NCT02130193|HCRU exacerbations|hcru exacerbations
4890263|NCT02130193|PD|pd
4890264|NCT02130167|Myopia progression|myopia progression
4890265|NCT02130167|Low concentration atropine|low concentration atropine
4890266|NCT02130154|Brown adipose Tissue|brown adipose tissue
4890267|NCT02130154|Ageing|ageing
4890268|NCT02130154|Sympathetic Nervous Stimulation|sympathetic nervous stimulation
4890269|NCT02130154|Obesity|obesity
4890270|NCT02130141|cocoa|cocoa
4890271|NCT02130141|dark chocolate|dark chocolate
4890272|NCT02130141|hypertension|hypertension
4890273|NCT02130141|blood pressure monitoring, ambulatory|blood pressure monitoring, ambulatory
4890274|NCT02130141|flavanols|flavanols
4890275|NCT02130102|technology acceptance|technology acceptance
4890276|NCT02130102|ambient assisted living|ambient assisted living
4890277|NCT02130102|independent living|independent living
4890278|NCT02130102|quality of life|quality of life
4890279|NCT02130102|socioeconomic impact|socioeconomic impact
4890280|NCT02130102|usability of information and communication technologies|usability of information and communication technologies
4890281|NCT02130063|IDA|ida
4890282|NCT02130063|Iron deficiency|iron deficiency
4890283|NCT02130063|iron deficiency anaemia and who are intolerant or unresponsive to oral iron therapy|iron deficiency anaemia and who are intolerant or unresponsive to oral iron therapy
4890284|NCT02130050|Obstructive Sleep Apnea|obstructive sleep apnea
4890285|NCT02130050|Continuous Positive Airway Pressure|continuous positive airway pressure
4890286|NCT02130050|Cardiovascular disease|cardiovascular disease
4890287|NCT02130050|Polysomnography|polysomnography
4890288|NCT02130050|Metabolomic|metabolomic
4890289|NCT02130037|APPLICATION|application
4890290|NCT02130037|SMARTPHONE|smartphone
4890291|NCT02130037|BULIMIA|bulimia
4890292|NCT02130037|B.E.D|b.e.d
4890293|NCT02130037|BINGE EATING DISORDER|binge eating disorder
4890294|NCT02130024|Age-related macular degeneration, ranibizumab, aflibercept, geographic atrophy, inject and extend|age-related macular degeneration, ranibizumab, aflibercept, geographic atrophy, inject and extend
4890295|NCT02129998|Infertility|infertility
4890296|NCT02129998|IVF/ICSI|ivf/icsi
4890297|NCT02129998|Progesterone|progesterone
4890298|NCT02129998|Preimplantation Factor (PIF)|preimplantation factor (pif)
4890299|NCT02129985|the newly onset type 2 diabetes|the newly onset type 2 diabetes
4890300|NCT02129985|short-term insulin treatment|short-term insulin treatment
4890301|NCT02129985|exenatide sequential therapy|exenatide sequential therapy
4890302|NCT02129985|beta cell function|beta cell function
4890303|NCT02129985|glycaemic remission|glycaemic remission
4890304|NCT02129972|Inflammatory Bowel Disease, colon lesions, colon capsule endoscopy|inflammatory bowel disease, colon lesions, colon capsule endoscopy
4890305|NCT02129959|laparoscopic cholecystectomy, laparoscopic gastrectomy, laparoscopic colectomy, laparoscopic appendectomy, laparoscopic|laparoscopic cholecystectomy, laparoscopic gastrectomy, laparoscopic colectomy, laparoscopic appendectomy, laparoscopic
4890500|NCT02129348|Lithium|lithium
4890306|NCT02129959|assisted vaginal hysterectomy, robot-assisted laparoscopic radical prostatectomy|assisted vaginal hysterectomy, robot-assisted laparoscopic radical prostatectomy
4890307|NCT02129946|Type 2 Diabetes|type 2 diabetes
4890308|NCT02129946|Resistant Starch|resistant starch
4890309|NCT02129946|Postprandial Glucose|postprandial glucose
4890310|NCT02129946|Postprandial Insulin|postprandial insulin
4890311|NCT02129946|Satiety|satiety
4890312|NCT02129933|EAC|eac
4890313|NCT02129933|HGD|hgd
4890314|NCT02129933|Esophagus|esophagus
4890315|NCT02129920|Stroke|stroke
4890316|NCT02129920|Cerebral Infarction|cerebral infarction
4890317|NCT02129920|Atrial Fibrillation|atrial fibrillation
4890318|NCT02129920|Arrhythmias, Cardiac|arrhythmias, cardiac
4890319|NCT02129920|Heart Diseases|heart diseases
4890320|NCT02129920|Cardiovascular Diseases|cardiovascular diseases
4890321|NCT02129920|Cerebrovascular Disorders|cerebrovascular disorders
4890322|NCT02129920|Brain Diseases|brain diseases
4890323|NCT02129920|Central Nervous System Diseases|central nervous system diseases
4890324|NCT02129920|Nervous System Diseases|nervous system diseases
4890325|NCT02129920|Vascular Diseases|vascular diseases
4890326|NCT02129920|Brain Infarction|brain infarction
4890327|NCT02129920|Brain Ischemia|brain ischemia
4890328|NCT02129920|Anticoagulants|anticoagulants
4890329|NCT02129920|Hematologic Agents|hematologic agents
4890330|NCT02129920|Therapeutic Uses|therapeutic uses
4890331|NCT02129907|Anemias|anemias
4890332|NCT02129907|Iron-Deficiency|iron-deficiency
4890333|NCT02129907|thrombin|thrombin
4890334|NCT02129894|cesarean section|cesarean section
4890335|NCT02129894|postoperative pain|postoperative pain
4890336|NCT02129894|pregnancy|pregnancy
4890337|NCT02129894|abdominal binder|abdominal binder
4890338|NCT02129868|Type 1 diabetes|type 1 diabetes
4890339|NCT02129868|Closed-loop glucose control|closed-loop glucose control
4890340|NCT02129868|Artificial Pancreas|artificial pancreas
4890341|NCT02129868|Continuous subcutaneous insulin infusion|continuous subcutaneous insulin infusion
4890342|NCT02129868|Continuous glucose monitoring|continuous glucose monitoring
4890343|NCT02129842|AFib|afib
4890344|NCT02129842|AF|af
4890345|NCT02129842|ablation|ablation
4890346|NCT02129842|EndoPAT|endopat
4890347|NCT02129842|Endothelial dysfunction|endothelial dysfunction
4890348|NCT02129842|PAT|pat
4890349|NCT02129829|Cirrhosis|cirrhosis
4890350|NCT02129829|HBV|hbv
4890351|NCT02129829|HIV|hiv
4890352|NCT02129829|HCV|hcv
4890353|NCT02129816|Female|female
4890354|NCT02129816|Postmenopause|postmenopause
4890355|NCT02129803|Cystic Fibrosis, high flow 20 liters per minute (LPM) humidification therapy|cystic fibrosis, high flow 20 liters per minute (lpm) humidification therapy
4890356|NCT02129790|Bipolar Disorder|bipolar disorder
4890357|NCT02129790|Suicidal|suicidal
4890358|NCT02129790|Depression|depression
4890359|NCT02129790|Self-harm|self-harm
4890360|NCT02129790|Psychosocial intervention|psychosocial intervention
4890361|NCT02129777|Drug therapy|drug therapy
4890362|NCT02129751|able to swallow medications without difficulty|able to swallow medications without difficulty
4890363|NCT02129751|bupropion hydrobromide|bupropion hydrobromide
4890365|NCT02129699|stage IV|stage iv
4890366|NCT02129686|Chemotherapy-induced peripheral neuropathy (CIPN)|chemotherapy-induced peripheral neuropathy (cipn)
4890367|NCT02129686|Acupuncture|acupuncture
4890368|NCT02129686|Early-Stage Breast Carcinoma|early-stage breast carcinoma
4890369|NCT02129686|Stage I Breast Cancer|stage i breast cancer
4890370|NCT02129686|Stage II Breast Cancer|stage ii breast cancer
4890371|NCT02129686|Stage III Breast Cancer|stage iii breast cancer
4890372|NCT02129673|Glaucoma|glaucoma
4890373|NCT02129673|Intra-ocular pressure|intra-ocular pressure
4890374|NCT02129673|Slow Release|slow release
4890375|NCT02129673|Controlled release|controlled release
4890376|NCT02129647|Neurofibromatosis Type 2|neurofibromatosis type 2
4890377|NCT02129647|Vestibular Schwannomas|vestibular schwannomas
4890378|NCT02129647|Axitinib|axitinib
4890379|NCT02129634|Percutaneous Transluminal Angioplasty|percutaneous transluminal angioplasty
4890380|NCT02129634|Limb-salvage|limb-salvage
4890381|NCT02129634|Randomized Controlled Trial|randomized controlled trial
4890382|NCT02129634|Paclitaxel|paclitaxel
4890383|NCT02129621|Lipocalin|lipocalin
4890384|NCT02129621|mineralocorticoid receptor|mineralocorticoid receptor
4890385|NCT02129608|overweight|overweight
4890386|NCT02129608|obese|obese
4890387|NCT02129608|central adiposity|central adiposity
4890388|NCT02129608|Laser|laser
4890389|NCT02129608|lorcaserin|lorcaserin
4890390|NCT02129608|low level laser therapy|low level laser therapy
4890391|NCT02129608|belviq|belviq
4890392|NCT02129595|Resveratrol|resveratrol
4890393|NCT02129595|Diabetes Mellitus|diabetes mellitus
4890394|NCT02129595|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
4890395|NCT02129595|Insulin Resistance|insulin resistance
4890396|NCT02129595|Glucose Metabolism Disorders|glucose metabolism disorders
4890397|NCT02129595|Metabolic Diseases|metabolic diseases
4890398|NCT02129595|Endocrine System Diseases|endocrine system diseases
4890399|NCT02129595|Hyperinsulinism|hyperinsulinism
4890400|NCT02129595|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal
4890401|NCT02129595|Analgesics, Non-Narcotic|analgesics, non-narcotic
4890402|NCT02129595|Analgesics|analgesics
4890501|NCT02129348|delusions|delusions
4890403|NCT02129595|Sensory System Agents|sensory system agents
4890404|NCT02129595|Peripheral Nervous System Agents|peripheral nervous system agents
4890405|NCT02129595|Physiological Effects of Drugs|physiological effects of drugs
4890406|NCT02129595|Pharmacologic Actions|pharmacologic actions
4890407|NCT02129595|Anti-Inflammatory Agents|anti-inflammatory agents
4890408|NCT02129595|Therapeutic Uses|therapeutic uses
4890409|NCT02129595|Antirheumatic Agents|antirheumatic agents
4890410|NCT02129595|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic
4890411|NCT02129595|Antineoplastic Agents|antineoplastic agents
4890412|NCT02129595|Antioxidants|antioxidants
4890413|NCT02129595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
4890414|NCT02129595|Protective Agents|protective agents
4890415|NCT02129595|Enzyme Inhibitors|enzyme inhibitors
4890416|NCT02129595|Platelet Aggregation Inhibitors|platelet aggregation inhibitors
4890417|NCT02129595|Hematologic Agents|hematologic agents
4890418|NCT02129595|Antimutagenic Agents|antimutagenic agents
4890419|NCT02129595|Anticarcinogenic Agents|anticarcinogenic agents
4890420|NCT02129595|Central Nervous System Agents|central nervous system agents
4890421|NCT02129595|Brown Adipose Tissue|brown adipose tissue
4890422|NCT02129556|Metastatic|metastatic
4890423|NCT02129556|Breast|breast
4890424|NCT02129556|trastuzumab-resistant|trastuzumab-resistant
4890425|NCT02129556|PD-L1 expressing|pd-l1 expressing
4890426|NCT02129556|HER2-positive|her2-positive
4890427|NCT02129543|SCT|sct
4890428|NCT02129543|Stem Cell Transplantation|stem cell transplantation
4890429|NCT02129543|Stem Cell Transplant|stem cell transplant
4890430|NCT02129530|Community Mobilization|community mobilization
4890431|NCT02129530|HIV|hiv
4890432|NCT02129530|Intimate Partner Violence|intimate partner violence
4890433|NCT02129530|Gender Norms|gender norms
4890434|NCT02129504|root coverage|root coverage
4890435|NCT02129504|gingival recession|gingival recession
4890436|NCT02129504|periodontal surgery|periodontal surgery
4890437|NCT02129491|stroke|stroke
4890438|NCT02129491|Congenital stroke|congenital stroke
4890439|NCT02129491|neonatal|neonatal
4890440|NCT02129491|hemiplegia|hemiplegia
4890441|NCT02129478|olanzapine|olanzapine
4890442|NCT02129478|pediatrics|pediatrics
4890443|NCT02129478|chemotherapy-induced nausea|chemotherapy-induced nausea
4890444|NCT02129478|chemotherapy-induced vomiting|chemotherapy-induced vomiting
4890445|NCT02129465|Cytomegalovirus|cytomegalovirus
4890446|NCT02129465|CMV|cmv
4890447|NCT02129465|pregnancy|pregnancy
4890448|NCT02129465|transmission|transmission
4890449|NCT02129452|Alzheimer disease|alzheimer disease
4890450|NCT02129452|Dementia|dementia
4890451|NCT02129452|Neurodegenerative Diseases|neurodegenerative diseases
4890452|NCT02129452|Tauopathies|tauopathies
4890453|NCT02129452|Amyloid beta Peptides|amyloid beta peptides
4890454|NCT02129452|Amyloid Plaque|amyloid plaque
4890455|NCT02129452|MicroRNAs|micrornas
4890456|NCT02129452|Early Diagnosis|early diagnosis
4890457|NCT02129439|Antisense oligonucleotide|antisense oligonucleotide
4890458|NCT02129439|Colitis Ulcerosa|colitis ulcerosa
4890459|NCT02129439|Ulcerative colitis|ulcerative colitis
4890460|NCT02129439|Phase II|phase ii
4890461|NCT02129439|Transcription factor GATA-3|transcription factor gata-3
4890462|NCT02129439|intrarectal application|intrarectal application
4890463|NCT02129439|proof-of-concept|proof-of-concept
4890464|NCT02129426|Sedation|sedation
4890465|NCT02129426|MRI|mri
4890466|NCT02129413|Aneurysmal subarachnoid hemorrhage|aneurysmal subarachnoid hemorrhage
4890467|NCT02129413|Subarachnoid hemorrhage|subarachnoid hemorrhage
4890468|NCT02129413|Cerebral vasospasm|cerebral vasospasm
4890469|NCT02129413|Ruptured aneurysm|ruptured aneurysm
4890470|NCT02129413|Delayed Cerebral Ischemia|delayed cerebral ischemia
4890471|NCT02129413|Delayed Ischemic Deficit|delayed ischemic deficit
4890472|NCT02129413|Delayed ischemic neurological deficit|delayed ischemic neurological deficit
4890473|NCT02129413|Neurostimulation|neurostimulation
4890474|NCT02129413|Carotid body|carotid body
4890475|NCT02129400|Xenon-inhalation|xenon-inhalation
4890476|NCT02129400|Erythropoetin|erythropoetin
4890477|NCT02129400|Pharmakokinetic|pharmakokinetic
4890478|NCT02129400|Pharmacodynamic|pharmacodynamic
4890479|NCT02129400|Hemodynamic parameters|hemodynamic parameters
4890480|NCT02129400|Inflammatory parameters|inflammatory parameters
4890481|NCT02129400|Growth factors|growth factors
4890482|NCT02129400|Oxidative stress parameters|oxidative stress parameters
4890483|NCT02129387|Nicotine|nicotine
4890484|NCT02129387|Smoking Progression|smoking progression
4890485|NCT02129387|EEG|eeg
4890486|NCT02129387|Young adults|young adults
4890487|NCT02129387|Light smokers|light smokers
4890488|NCT02129387|rs1051730 genotype|rs1051730 genotype
4890489|NCT02129374|Spondylolysis|spondylolysis
4890490|NCT02129374|Lumbar spine|lumbar spine
4890491|NCT02129374|Young population|young population
4890492|NCT02129374|Direct repair|direct repair
4890493|NCT02129374|Union rate|union rate
4890494|NCT02129374|Functional outcome|functional outcome
4890495|NCT02129361|traumatic brain injury|traumatic brain injury
4890496|NCT02129348|Alzheimer's disease|alzheimer's disease
4890497|NCT02129348|psychosis|psychosis
4890498|NCT02129348|agitation|agitation
4890499|NCT02129348|aggression|aggression
4890502|NCT02129348|hallucinations|hallucinations
4890503|NCT02129335|glioblastoma|glioblastoma
4890504|NCT02129335|partner|partner
4890505|NCT02129335|stress|stress
4890506|NCT02129335|exercise|exercise
4890507|NCT02129335|outcome|outcome
4890508|NCT02129309|COPD|copd
4890509|NCT02129309|Apelin|apelin
4890510|NCT02129309|agonist|agonist
4890511|NCT02129309|antagonist|antagonist
4890512|NCT02129296|Morbid obesity|morbid obesity
4890513|NCT02129296|Gastric balloon|gastric balloon
4890514|NCT02129296|Weight loss|weight loss
4890515|NCT02129296|Tolerance|tolerance
4890516|NCT02129296|Safety|safety
4890517|NCT02129283|physicians, nurses, ICU, end-of-life, simulation training|physicians, nurses, icu, end-of-life, simulation training
4890518|NCT02129270|Fractures of the distal radius|fractures of the distal radius
4890519|NCT02129270|Hematoma block|hematoma block
4890520|NCT02129270|Lidocaine|lidocaine
4890521|NCT02129244|MDR-TB|mdr-tb
4890522|NCT02129244|HIV|hiv
4890523|NCT02129244|Nurse Case Management (NCM)|nurse case management (ncm)
4890524|NCT02129231|ezetimibe/simvastatin|ezetimibe/simvastatin
4890525|NCT02129231|rosuvastatin|rosuvastatin
4890526|NCT02129231|diabetic polyneuropathy|diabetic polyneuropathy
4890527|NCT02129231|oxidative stress|oxidative stress
4890528|NCT02129231|mitochondrial dysfunction|mitochondrial dysfunction
4890529|NCT02129205|solid tumors|solid tumors
4890530|NCT02129205|triple negative breast cancer|triple negative breast cancer
4890531|NCT02129205|PF-06650808|pf-06650808
4890532|NCT02129205|Phase 1|phase 1
4890533|NCT02129153|Randomized controlled trial|randomized controlled trial
4890534|NCT02129153|Population, School Age|population, school age
4890535|NCT02129140|hernia repair|hernia repair
4890536|NCT02129140|ventral incisional hernia|ventral incisional hernia
4890537|NCT02129140|biologic mesh|biologic mesh
4890538|NCT02129140|hernia graft|hernia graft
4890539|NCT02129088|Healthy|healthy
4890540|NCT02129088|Esketamine|esketamine
4890541|NCT02129088|Phase 1|phase 1
4890542|NCT02129088|Placebo|placebo
4890543|NCT02129088|Elderly|elderly
4890544|NCT02129088|Adult|adult
4890545|NCT02129036|Ovarian cancer|ovarian cancer
4890546|NCT02129036|Clear cell carcinoma|clear cell carcinoma
4890547|NCT02129036|Paclitaxel-platinum|paclitaxel-platinum
4890548|NCT02129036|Chemotherapy|chemotherapy
4890549|NCT02129036|response to chemotherapy|response to chemotherapy
4890550|NCT02129036|survival of clear cell ovarian carcinoma|survival of clear cell ovarian carcinoma
4890551|NCT02129036|Prognostic factors|prognostic factors
4890552|NCT02129023|Exergame|exergame
4890553|NCT02129023|user health|user health
4890554|NCT02129023|exercise|exercise
4890555|NCT02129010|subarachnoid hemorrhage|subarachnoid hemorrhage
4890556|NCT02129010|terson syndrome|terson syndrome
4890557|NCT02129010|CSF-proteines|csf-proteines
4890558|NCT02129010|phospho-tau|phospho-tau
4890559|NCT02129010|beta-amyloid|beta-amyloid
4890560|NCT02128997|obesity, cesarean section, wound complication|obesity, cesarean section, wound complication
4890561|NCT02128984|Malnutrition|malnutrition
4890562|NCT02128984|Dietary supplement|dietary supplement
4890563|NCT02128984|Nutritional supplement|nutritional supplement
4890564|NCT02128984|Symbiotic formula|symbiotic formula
4890565|NCT02128984|DHA|dha
4890566|NCT02128984|Cystic Fibrosis|cystic fibrosis
4890567|NCT02128984|Failure to Thrive|failure to thrive
4890568|NCT02128971|Iron supplement study|iron supplement study
4890569|NCT02128958|Hepatocellular Carcinoma|hepatocellular carcinoma
4890570|NCT02128958|Child-Pugh Class B Cirrhosis|child-pugh class b cirrhosis
4890571|NCT02128945|PET|pet
4890572|NCT02128945|Chronic lymphocytic Leukemia (CLL)|chronic lymphocytic leukemia (cll)
4890573|NCT02128945|Diffuse Large B Cells Lymphoma (DLBCL)|diffuse large b cells lymphoma (dlbcl)
4890574|NCT02128945|Fludarabine|fludarabine
4890575|NCT02128919|Schizophrenia|schizophrenia
4890576|NCT02128919|Cigarette smoking|cigarette smoking
4890577|NCT02128919|Cognition|cognition
4890578|NCT02128919|Craving|craving
4890579|NCT02128919|MATRICS|matrics
4890580|NCT02128906|ERCC1|ercc1
4890581|NCT02128906|squamous cell carcinoma|squamous cell carcinoma
4890582|NCT02128906|oropharynx|oropharynx
4890583|NCT02128906|larynx|larynx
4890584|NCT02128906|hypopharynx|hypopharynx
4890585|NCT02128906|p16|p16
4890586|NCT02128906|radiotherapy|radiotherapy
4890587|NCT02128906|docetaxel|docetaxel
4890588|NCT02128906|cetuximab|cetuximab
4890589|NCT02128906|cisplatin|cisplatin
4890590|NCT02128906|EGFR|egfr
4890591|NCT02128906|Biomarker|biomarker
4890592|NCT02128906|efficacy|efficacy
4890593|NCT02128906|head and neck|head and neck
4890594|NCT02128906|tongue|tongue
4890595|NCT02128906|throat|throat
4890596|NCT02128893|Isavuconazole|isavuconazole
4890597|NCT02128893|Esomeprazole|esomeprazole
4890598|NCT02128893|BAL4815|bal4815
4890599|NCT02128893|BAL8728|bal8728
4890600|NCT02128893|Healthy Subjects|healthy subjects
4890601|NCT02128880|AEP, drinking, contraception, FASD, Internet interventions|aep, drinking, contraception, fasd, internet interventions
4890602|NCT02128867|gastro-esophageal reflux|gastro-esophageal reflux
4890603|NCT02128867|GOR|gor
4890604|NCT02128867|GER|ger
4890605|NCT02128867|airway clearance techniques|airway clearance techniques
4890987|NCT02127099|obstructive|obstructive
4890606|NCT02128854|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
4890607|NCT02128854|Diabetes Mellitus, Adult-Onset|diabetes mellitus, adult-onset
4890608|NCT02128854|Diabetes Mellitus, Non-Insulin-Dependent|diabetes mellitus, non-insulin-dependent
4890609|NCT02128854|Diabetes Mellitus, Noninsulin Dependent|diabetes mellitus, noninsulin dependent
4890857|NCT02127762|cortisol|cortisol
4890610|NCT02128854|Diabetes Mellitus, Type II|diabetes mellitus, type ii
4890611|NCT02128854|African Americans|african americans
4890612|NCT02128854|Blacks|blacks
4890613|NCT02128854|Non-Hispanic Blacks|non-hispanic blacks
4890614|NCT02128854|Randomized Control Trial|randomized control trial
4890615|NCT02128854|Controlled Clinical Trial|controlled clinical trial
4890616|NCT02128854|Behavioral Research|behavioral research
4890617|NCT02128854|Behavioral Medicine|behavioral medicine
4890618|NCT02128841|rivaroxaban|rivaroxaban
4890619|NCT02128841|Heart Valve Prosthesis Implantation|heart valve prosthesis implantation
4890620|NCT02128841|anticoagulants|anticoagulants
4890621|NCT02128841|Factor Xa/antagonists & inhibitors|factor xa/antagonists & inhibitors
4890622|NCT02128828|AIDS Dementia Complex|aids dementia complex
4890623|NCT02128828|HIV-1-Associated Cognitive Motor Complex|hiv-1-associated cognitive motor complex
4890624|NCT02128828|Human Immunodeficiency Virus|human immunodeficiency virus
4890625|NCT02128815|adults|adults
4890626|NCT02128815|coaching|coaching
4890627|NCT02128815|type 2 diabetes|type 2 diabetes
4890628|NCT02128802|Obesity|obesity
4890629|NCT02128802|Renal failure|renal failure
4890630|NCT02128802|Gastric bypass|gastric bypass
4890631|NCT02128789|Older Adults|older adults
4890632|NCT02128789|Caregivers|caregivers
4890633|NCT02128789|Aging|aging
4890634|NCT02128789|Support|support
4890635|NCT02128776|Children|children
4890636|NCT02128776|Chronic illnesses|chronic illnesses
4890637|NCT02128724|Lung cancer|lung cancer
4890638|NCT02128724|BKM120|bkm120
4890639|NCT02128724|Hypoxia|hypoxia
4890640|NCT02128724|Misonidazole|misonidazole
4890641|NCT02128724|Radiotherapy|radiotherapy
4890642|NCT02128711|lung|lung
4890643|NCT02128711|cystic fibrosis|cystic fibrosis
4890644|NCT02128711|bacteria|bacteria
4890645|NCT02128711|positive diagnosis of CF,|positive diagnosis of cf,
4890646|NCT02128698|Bariatric surgery|bariatric surgery
4890647|NCT02128698|Protein supplementation|protein supplementation
4890648|NCT02128698|Physical activity|physical activity
4890649|NCT02128698|Muscle mass|muscle mass
4890650|NCT02128698|Weight loss|weight loss
4890651|NCT02128698|Physical fitness|physical fitness
4890652|NCT02128698|Muscle strength|muscle strength
4890653|NCT02128685|Threatened miscarriage|threatened miscarriage
4890654|NCT02128685|Dydrogesterone|dydrogesterone
4890655|NCT02128685|Randomized controlled trial|randomized controlled trial
4890656|NCT02128646|Pain Management|pain management
4890657|NCT02128646|Exparel|exparel
4890658|NCT02128646|Abdominal Hernia Repair|abdominal hernia repair
4890659|NCT02128646|Laparoscopic Surgery|laparoscopic surgery
4890660|NCT02128633|Dentin hypersensitivity|dentin hypersensitivity
4890661|NCT02128633|Dentin Sensitivities|dentin sensitivities
4890662|NCT02128620|Sexually transmitted diseases|sexually transmitted diseases
4890663|NCT02128620|Internet|internet
4890664|NCT02128620|Education|education
4890665|NCT02128620|Appointments and Schedules|appointments and schedules
4890666|NCT02128607|low back pain|low back pain
4890667|NCT02128607|manual therapy|manual therapy
4890668|NCT02128607|Mulligan|mulligan
4890669|NCT02128607|sustained natural apophyseal glide (SNAG)|sustained natural apophyseal glide (snag)
4890670|NCT02128607|Kinematic spine model|kinematic spine model
4890671|NCT02128568|Depression/therapy;|depression/therapy;
4890672|NCT02128568|Developing Countries;|developing countries;
4890673|NCT02128568|Interpersonal Relations;|interpersonal relations;
4890674|NCT02128568|Life Change Events;|life change events;
4890675|NCT02128568|Psychotherapy, Group;|psychotherapy, group;
4890676|NCT02128568|Resilience, Psychological;|resilience, psychological;
4890677|NCT02128568|Sierra Leone;|sierra leone;
4890678|NCT02128568|Survivors/psychology;|survivors/psychology;
4890679|NCT02128568|Social Adjustment;|social adjustment;
4890680|NCT02128568|Social Behavior;|social behavior;
4890681|NCT02128568|War|war
4890682|NCT02128555|ankle arthritis|ankle arthritis
4890683|NCT02128555|osteoarthritis|osteoarthritis
4890684|NCT02128555|total ankle replacement|total ankle replacement
4890685|NCT02128555|arthrodesis|arthrodesis
4890686|NCT02128555|quality of life|quality of life
4890687|NCT02128555|musculoskeletal|musculoskeletal
4890688|NCT02128542|Veterans HCV|veterans hcv
4890689|NCT02128529|COPD|copd
4890690|NCT02128490|Drug therapy|drug therapy
4890691|NCT02128477|Myocardial infarction|myocardial infarction
4890692|NCT02128477|Repolarization instability|repolarization instability
4890693|NCT02128477|Ventricular fibrillation|ventricular fibrillation
4890694|NCT02128464|Knee Osteoarthritis|knee osteoarthritis
4890695|NCT02128464|Total Knee Arthroplasty|total knee arthroplasty
4890696|NCT02128464|Customized Cutting Block|customized cutting block
4890697|NCT02128464|Conventional Intramedullary Cutting Guide|conventional intramedullary cutting guide
4890698|NCT02128451|meperdine ,fentanyl, clonidine, orthopedic surgery .|meperdine ,fentanyl, clonidine, orthopedic surgery .
4890699|NCT02128425|Colorectal cancer|colorectal cancer
4890988|NCT02127099|sleep|sleep
4890700|NCT02128425|Metastatic colorectal cancer|metastatic colorectal cancer
4890701|NCT02128425|FOLFOXIRI|folfoxiri
4890702|NCT02128425|FOLFOX|folfox
4890703|NCT02128425|Oxaliplatin|oxaliplatin
4890704|NCT02128425|irinotecan|irinotecan
4890705|NCT02128425|Leucovorin|leucovorin
4890706|NCT02128425|5-FU|5-fu
4890707|NCT02128412|Patients scheduled to undergo coronary angioplasty and stenting because of symptoms related to a single de novo coronary artery stenoses|patients scheduled to undergo coronary angioplasty and stenting because of symptoms related to a single de novo coronary artery stenoses
4890708|NCT02128399|antimicrobial stewardship|antimicrobial stewardship
4890709|NCT02128360|Low ovarian reserve|low ovarian reserve
4890710|NCT02128360|Poor responder|poor responder
4890711|NCT02128360|Infertility|infertility
4890712|NCT02128347|Hemodialysis, Home|hemodialysis, home
4890713|NCT02128347|Peritoneal Dialysis|peritoneal dialysis
4890714|NCT02128347|Telemedicine|telemedicine
4890715|NCT02128334|Uro-Oncologists|uro-oncologists
4890716|NCT02128334|PSA|psa
4890717|NCT02128334|Eligard|eligard
4890718|NCT02128334|prostate carcinoma|prostate carcinoma
4890719|NCT02128321|Isavuconazole|isavuconazole
4890720|NCT02128321|Repaglinide|repaglinide
4890721|NCT02128321|Caffeine|caffeine
4890722|NCT02128321|BAL4815|bal4815
4890723|NCT02128321|BAL8728|bal8728
4890724|NCT02128321|Healthy Subjects|healthy subjects
4890725|NCT02128308|Antituberculosis agents|antituberculosis agents
4890726|NCT02128308|Pharmacokinetics|pharmacokinetics
4890727|NCT02128295|Breast pumps, breast milk, expression, term infants|breast pumps, breast milk, expression, term infants
4890728|NCT02128282|Cholangiocarcinoma|cholangiocarcinoma
4890729|NCT02128282|Bile duct cancer|bile duct cancer
4890730|NCT02128282|Biliary tract cancer|biliary tract cancer
4890731|NCT02128269|Antiphospholipid (aPL)-positive|antiphospholipid (apl)-positive
4890858|NCT02127749|antibiotics|antibiotics
4890732|NCT02128269|Antiphospholid syndrome (APS)|antiphospholid syndrome (aps)
4890733|NCT02128256|Osteomyelitis|osteomyelitis
4890734|NCT02128256|Bone substitute|bone substitute
4890735|NCT02128256|Ceramic|ceramic
4890736|NCT02128256|Gentamicin|gentamicin
4890737|NCT02128230|High risk|high risk
4890738|NCT02128230|Carfilzomib|carfilzomib
4890739|NCT02128191|Patent ductus arteriosus|patent ductus arteriosus
4890740|NCT02128191|Ibuprofen|ibuprofen
4890741|NCT02128191|Bronchopulmonary dysplasia|bronchopulmonary dysplasia
4890742|NCT02128178|Morbid obesity|morbid obesity
4890743|NCT02128178|Laparoscopic surgery|laparoscopic surgery
4890744|NCT02128178|Compression ultrasonography|compression ultrasonography
4890745|NCT02128178|Pulmonary embolism|pulmonary embolism
4890746|NCT02128178|Bleeding|bleeding
4890747|NCT02128165|gastric balloon|gastric balloon
4890748|NCT02128165|morbid obesity|morbid obesity
4890749|NCT02128152|stroke|stroke
4890750|NCT02128152|exoskeleton|exoskeleton
4890751|NCT02128152|Ekso|ekso
4890752|NCT02128152|ambulation|ambulation
4890753|NCT02128152|robotics|robotics
4890754|NCT02128139|Infective endocarditis|infective endocarditis
4890755|NCT02128139|Developing country|developing country
4890756|NCT02128139|Global health|global health
4890757|NCT02128139|Cardiac surgery|cardiac surgery
4890758|NCT02128139|Heart valve disease|heart valve disease
4890759|NCT02128139|Bacteremia|bacteremia
4890760|NCT02128126|Advanced or recurrent cervical cancer|advanced or recurrent cervical cancer
4890761|NCT02128126|HPV16 positive|hpv16 positive
4890762|NCT02128126|No curative treatment options|no curative treatment options
4890763|NCT02128113|RTA 408|rta 408
4890764|NCT02128113|Cataract surgery|cataract surgery
4890765|NCT02128113|Corneal Endothelial Cells|corneal endothelial cells
4890766|NCT02128113|omaveloxolone|omaveloxolone
4890767|NCT02128100|Pancreatic Cancer|pancreatic cancer
4890768|NCT02128087|HIV|hiv
4890769|NCT02128087|Antiretroviral (ARV)|antiretroviral (arv)
4890770|NCT02128087|co-trimoxazole|co-trimoxazole
4890771|NCT02128087|SMS|sms
4890772|NCT02128087|mobile Health (mHealth)|mobile health (mhealth)
4890773|NCT02128087|Adolescents|adolescents
4890774|NCT02128087|Uganda|uganda
4890775|NCT02128087|Adherence|adherence
4890776|NCT02128035|radiation protection|radiation protection
4890777|NCT02128035|interventional cardiologist|interventional cardiologist
4890778|NCT02128035|percutaneous coronary intervention (PCI)|percutaneous coronary intervention (pci)
4890779|NCT02128035|angiography|angiography
4890780|NCT02128035|lead shield|lead shield
4890781|NCT02128022|Glucagon-Like Peptide 1|glucagon-like peptide 1
4890782|NCT02128022|Angina Pectoris|angina pectoris
4890783|NCT02128022|Percutaneous Coronary Intervention|percutaneous coronary intervention
4890784|NCT02128022|Ischemic Preconditioning|ischemic preconditioning
4890785|NCT02128022|Myocardial Reperfusion Injury|myocardial reperfusion injury
4890786|NCT02127996|Angina Pectoris|angina pectoris
4890787|NCT02127996|Percutaneous Coronary Intervention|percutaneous coronary intervention
4890788|NCT02127996|Myocardial Infarction|myocardial infarction
4890789|NCT02127996|Glucagon-Like Peptide 1|glucagon-like peptide 1
4890790|NCT02127996|Reperfusion Injury|reperfusion injury
4890791|NCT02127983|TB, HIV, case finding, access, informal providers|tb, hiv, case finding, access, informal providers
4890792|NCT02127957|cystic fibrosis|cystic fibrosis
4890793|NCT02127957|exercise|exercise
4890794|NCT02127957|Cystic fibrosis related diabetes|cystic fibrosis related diabetes
4890795|NCT02127918|Electrical status epilepticus in sleep|electrical status epilepticus in sleep
4890796|NCT02127918|Continuous spikes and waves during sleep|continuous spikes and waves during sleep
4890797|NCT02127918|Children|children
4890798|NCT02127918|Electroencephalogram|electroencephalogram
4890799|NCT02127918|Neuropsychology|neuropsychology
4890800|NCT02127918|Development|development
4890801|NCT02127918|Antiepileptic drugs|antiepileptic drugs
4890802|NCT02127918|Clobazam|clobazam
4890803|NCT02127918|Seizures|seizures
4890804|NCT02127905|Fanconi Anemia|fanconi anemia
4890805|NCT02127905|compassionate treatment|compassionate treatment
4890806|NCT02127905|BMT|bmt
4890807|NCT02127905|HSCT|hsct
4890808|NCT02127905|unrelated|unrelated
4890809|NCT02127905|bone marrow transplantation|bone marrow transplantation
4890810|NCT02127905|PBSC|pbsc
4890811|NCT02127905|peripheral blood|peripheral blood
4890812|NCT02127905|CD34+|cd34+
4890813|NCT02127892|Severe Combined Immune Deficiency|severe combined immune deficiency
4890814|NCT02127892|SCID|scid
4890815|NCT02127892|HLA-matched unrelated donor|hla-matched unrelated donor
4890816|NCT02127892|unrelated|unrelated
4890817|NCT02127892|MUD|mud
4890818|NCT02127892|bone marrow|bone marrow
4890819|NCT02127892|cord blood|cord blood
4890820|NCT02127892|haplo-identical|haplo-identical
4890821|NCT02127892|peripheral blood|peripheral blood
4890822|NCT02127892|CD34+ selection|cd34+ selection
4890823|NCT02127892|T cell depletion|t cell depletion
4890824|NCT02127892|HSCT|hsct
4890825|NCT02127892|BMT|bmt
4890826|NCT02127892|CliniMACS|clinimacs
4890827|NCT02127879|Repetitive Transcranial Magnetic Stimulation|repetitive transcranial magnetic stimulation
4890828|NCT02127879|Schizophrenia|schizophrenia
4890829|NCT02127879|Negative symptoms|negative symptoms
4890830|NCT02127879|Intensive|intensive
4890831|NCT02127879|Transcranial Magnetic Stimulation, Repetitive|transcranial magnetic stimulation, repetitive
4890832|NCT02127866|Asthma, anticholinergics|asthma, anticholinergics
4890833|NCT02127853|serial cataract surgery|serial cataract surgery
4890834|NCT02127853|hyperalgesia|hyperalgesia
4890835|NCT02127853|gabapentin|gabapentin
4890836|NCT02127853|central sensitization|central sensitization
4890837|NCT02127840|primary aldosteronism|primary aldosteronism
4890838|NCT02127840|adrenal adenoma|adrenal adenoma
4890839|NCT02127840|arterial hypertension|arterial hypertension
4890840|NCT02127814|induced diarrhea|induced diarrhea
4890841|NCT02127814|Clostridium difficile toxicity|clostridium difficile toxicity
4890842|NCT02127788|Haematology|haematology
4890843|NCT02127788|Micafungin|micafungin
4890844|NCT02127788|Observational study|observational study
4890845|NCT02127788|Prophylaxis|prophylaxis
4890846|NCT02127788|Invasive Fungal Infection|invasive fungal infection
4890847|NCT02127788|France|france
4890848|NCT02127762|Pain|pain
4890849|NCT02127762|Quality of Life|quality of life
4890850|NCT02127762|Glycemic Control|glycemic control
4890851|NCT02127762|diabetic neuropathy|diabetic neuropathy
4890852|NCT02127762|mindfulness|mindfulness
4890853|NCT02127762|stress reduction|stress reduction
4890854|NCT02127762|adult|adult
4890855|NCT02127762|chronic pain|chronic pain
4890856|NCT02127762|depression|depression
4890859|NCT02127749|gut microbiota|gut microbiota
4890860|NCT02127749|endotoxemia|endotoxemia
4890861|NCT02127749|innate immunity|innate immunity
4890862|NCT02127723|cellulite|cellulite
4890863|NCT02127710|AZD6094|azd6094
4890864|NCT02127710|Savolitinib|savolitinib
4890865|NCT02127710|Papillary Renal Cell Cancer|papillary renal cell cancer
4890866|NCT02127697|Asthma, poorly controlled asthma, LAMA, Long-Acting Muscarinic Antagonist, Glycopyrronium, Glycopyrronium bromide, Anticholinergic|asthma, poorly controlled asthma, lama, long-acting muscarinic antagonist, glycopyrronium, glycopyrronium bromide, anticholinergic
4890867|NCT02127684|diabetic macular edema|diabetic macular edema
4890868|NCT02127645|RADIOTHERAPY|radiotherapy
4890869|NCT02127645|TRANSANAL ENDOSCOPIC MICROSURGERY|transanal endoscopic microsurgery
4890870|NCT02127645|LOCAL EXCISION|local excision
4890871|NCT02127632|laryngeal mask Supreme|laryngeal mask supreme
4890872|NCT02127632|laparoscopic gynecologic surgery|laparoscopic gynecologic surgery
4890873|NCT02127632|Laryngeal mask during surgery|laryngeal mask during surgery
4890874|NCT02127619|knee prosthesis|knee prosthesis
4890875|NCT02127619|total knee replacement|total knee replacement
4890876|NCT02127619|total knee arthroplasty|total knee arthroplasty
4890877|NCT02127619|prospective study|prospective study
4890878|NCT02127619|Therapeutic level IV|therapeutic level iv
4890879|NCT02127593|Norgestimate|norgestimate
4890880|NCT02127593|Ethinyl estradiol|ethinyl estradiol
4890881|NCT02127593|Norgestrel|norgestrel
4890882|NCT02127593|Norelgestromin|norelgestromin
4890883|NCT02127593|Ortho cyclen|ortho cyclen
4890884|NCT02127593|Phase 1|phase 1
4890885|NCT02127593|Healthy Women|healthy women
4890886|NCT02127580|THV|thv
4890887|NCT02127580|BAV|bav
4890888|NCT02127580|pre-dilation|pre-dilation
4890889|NCT02127580|Aortic valve stenosis|aortic valve stenosis
4890890|NCT02127567|medical writing, reporting, randomized controlled trial|medical writing, reporting, randomized controlled trial
4890891|NCT02127541|Localisation of Insulinoma|localisation of insulinoma
4890892|NCT02127541|beta-cell imaging|beta-cell imaging
4890893|NCT02127541|exendin-4|exendin-4
4890989|NCT02127099|apnea|apnea
4890894|NCT02127541|68Ga-DOTA-exendin-4 PET/CT|68ga-dota-exendin-4 pet/ct
4890895|NCT02127541|111In-DOTA-exendin-4 SPECT/CT|111in-dota-exendin-4 spect/ct
4890896|NCT02127515|Down, trisomy 21|down, trisomy 21
4890897|NCT02127515|NIPT|nipt
4890898|NCT02127515|Amniocentesis|amniocentesis
4890899|NCT02127515|miscarriage|miscarriage
4890900|NCT02127515|invasive|invasive
4890901|NCT02127515|prenatal|prenatal
4890902|NCT02127515|screening.|screening.
4890903|NCT02127489|Bupivacaine, caudal, rectal midazolam, children|bupivacaine, caudal, rectal midazolam, children
4890904|NCT02127463|AMD|amd
4890905|NCT02127463|Dry AMD|dry amd
4890906|NCT02127463|Non-Exudative AMD|non-exudative amd
4890907|NCT02127463|MC-1101|mc-1101
4890908|NCT02127450|Enterobacteriaceae|enterobacteriaceae
4890909|NCT02127450|non-susceptible to carbapenem|non-susceptible to carbapenem
4890910|NCT02127450|carbapenemases|carbapenemases
4890911|NCT02127450|prevalence|prevalence
4890912|NCT02127450|screening algorithm|screening algorithm
4890913|NCT02127437|Autosomal dominant polycystic kidney disease,|autosomal dominant polycystic kidney disease,
4890914|NCT02127437|Glomerular filtration rate,|glomerular filtration rate,
4890915|NCT02127437|Somatostatin,|somatostatin,
4890916|NCT02127437|lanreotide|lanreotide
4890917|NCT02127424|Nurse|nurse
4890918|NCT02127424|Nursing|nursing
4890919|NCT02127424|Screening|screening
4890920|NCT02127424|HIV|hiv
4890921|NCT02127424|Emergency Service Hospital|emergency service hospital
4890922|NCT02127411|Mindfulness|mindfulness
4890923|NCT02127411|Benzodiazepines|benzodiazepines
4890924|NCT02127411|Sleep|sleep
4890925|NCT02127411|Dependence|dependence
4890926|NCT02127411|Relapse Prevention|relapse prevention
4890927|NCT02127398|C. difficile colitis|c. difficile colitis
4890928|NCT02127398|fecal microbiota transplantation|fecal microbiota transplantation
4890929|NCT02127372|non-small cell|non-small cell
4890930|NCT02127372|lung cancer|lung cancer
4890931|NCT02127359|Metastatic|metastatic
4890932|NCT02127346|Chronic Periodontitis|chronic periodontitis
4890933|NCT02127346|Vitamin D concentration|vitamin d concentration
4890934|NCT02127346|Calcium concentration|calcium concentration
4890935|NCT02127333|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
4890936|NCT02127333|Coronary artery disease|coronary artery disease
4890937|NCT02127333|Endothelial function|endothelial function
4890938|NCT02127307|Myocardial sympathetic innervation|myocardial sympathetic innervation
4890939|NCT02127307|Heart failure (HF)|heart failure (hf)
4890940|NCT02127307|Nuclear imaging|nuclear imaging
4890941|NCT02127307|Radiopharmaceutical|radiopharmaceutical
4890942|NCT02127294|Foramen Ovale, Patent|foramen ovale, patent
4890943|NCT02127294|migraine|migraine
4890944|NCT02127294|transcatheter patent foramen ovale closure|transcatheter patent foramen ovale closure
4890945|NCT02127294|contrast-enhanced transcranial Doppler|contrast-enhanced transcranial doppler
4890946|NCT02127294|Transthoracic Echocardiography|transthoracic echocardiography
4890947|NCT02127281|Revision total knee arthroplasty|revision total knee arthroplasty
4890948|NCT02127281|Revision total hip arthroplasty|revision total hip arthroplasty
4890949|NCT02127281|Negative pressure wound therapy system (NPWT)|negative pressure wound therapy system (npwt)
4890950|NCT02127281|Drainage|drainage
4890951|NCT02127255|chemotherapy|chemotherapy
4890952|NCT02127255|nausea|nausea
4890953|NCT02127255|vomiting|vomiting
4890954|NCT02127255|cancer|cancer
4890955|NCT02127242|hepatolithiasis|hepatolithiasis
4890956|NCT02127242|ureteroscope|ureteroscope
4890957|NCT02127242|air-pressure ballistic lithotripsy|air-pressure ballistic lithotripsy
4890958|NCT02127242|hepatectomy|hepatectomy
4890959|NCT02127229|endoscopic retrograde cholangiopancreatography|endoscopic retrograde cholangiopancreatography
4890960|NCT02127229|disposable accessory cost|disposable accessory cost
4890961|NCT02127229|endoscopy cost analysis|endoscopy cost analysis
4890962|NCT02127216|Mobile Health|mobile health
4890963|NCT02127216|Diabetes|diabetes
4890964|NCT02127216|Self-Care of Diabetes|self-care of diabetes
4890965|NCT02127203|oxidative stress|oxidative stress
4890966|NCT02127203|periodontal disease|periodontal disease
4890967|NCT02127203|nitric oxide|nitric oxide
4890968|NCT02127190|nitro-fatty acids|nitro-fatty acids
4890969|NCT02127190|anti-inflammatory|anti-inflammatory
4890970|NCT02127190|Nrf2 activation|nrf2 activation
4890971|NCT02127190|contrast induced AKI|contrast induced aki
4890972|NCT02127177|obstructive sleep apnea|obstructive sleep apnea
4890973|NCT02127177|coronary heart disease|coronary heart disease
4890974|NCT02127177|continuous positive airway pressure|continuous positive airway pressure
4890975|NCT02127177|lipid profiles|lipid profiles
4890976|NCT02127177|high-sensitivity C-reactive protein|high-sensitivity c-reactive protein
4890977|NCT02127138|unprotected distal left main bifurcation lesion|unprotected distal left main bifurcation lesion
4890978|NCT02127138|Percutaneous coronary intervention|percutaneous coronary intervention
4890979|NCT02127138|clinical study|clinical study
4890980|NCT02127138|Active Transfer of Plaque （ATP）|active transfer of plaque （atp）
4890981|NCT02127138|Provisional T Stenting|provisional t stenting
4890982|NCT02127112|Ridge Augmentation|ridge augmentation
4890983|NCT02127112|Bone regeneration|bone regeneration
4890984|NCT02127112|Guided Bone Regeneration|guided bone regeneration
4890985|NCT02127112|Partially Edentulous|partially edentulous
4890986|NCT02127099|OSA|osa
4890990|NCT02127099|operation|operation
4890991|NCT02127086|Acute pain severity|acute pain severity
4890992|NCT02127086|Non-communicative patients|non-communicative patients
4890993|NCT02127086|PAIN algorithm|pain algorithm
4890994|NCT02127086|Multi-dimensional Pain Assessment Tool (MOPAT)|multi-dimensional pain assessment tool (mopat)
4890995|NCT02127073|Breast cancer|breast cancer
4890996|NCT02127073|Ductal carcinoma in situ (DCIS)|ductal carcinoma in situ (dcis)
4890997|NCT02127073|Oxytocin|oxytocin
4890998|NCT02127060|vitamin C|vitamin c
4890999|NCT02127060|effectiveness|effectiveness
4891000|NCT02127060|pain management|pain management
4891001|NCT02127060|posterior lumbar interbody fusion|posterior lumbar interbody fusion
4891002|NCT02127034|Healthy subjects|healthy subjects
4891003|NCT02127034|Mirabegron|mirabegron
4891004|NCT02127034|Solifenacin|solifenacin
4891005|NCT02127034|Digoxin|digoxin
4891006|NCT02127021|Pancreaticoduodenectomy|pancreaticoduodenectomy
4891007|NCT02127021|Nutritional Status|nutritional status
4891008|NCT02127021|Quality of Life|quality of life
4891009|NCT02127021|Biochemical Marker|biochemical marker
4891010|NCT02127008|epidural fat|epidural fat
4891011|NCT02127008|resection|resection
4891012|NCT02127008|spinal stenosis|spinal stenosis
4891013|NCT02127008|lumbar spine|lumbar spine
4891014|NCT02126995|Fragile X Syndrome, Fra(X) Syndrome, FRAXA Syndrome|fragile x syndrome, fra(x) syndrome, fraxa syndrome
4891015|NCT02126982|clopidogrel besylate|clopidogrel besylate
4891016|NCT02126982|clopidogrel hydrogen sulfate|clopidogrel hydrogen sulfate
4891017|NCT02126982|Generic clopidogrel|generic clopidogrel
4891018|NCT02126982|Coronary Artery Disease|coronary artery disease
4891019|NCT02126969|Cancer|cancer
4891020|NCT02126969|Low dose radiation|low dose radiation
4891021|NCT02126956|ACT-128800|act-128800
4891022|NCT02126943|PAH|pah
4891023|NCT02126943|pulmonary arterial hypertension|pulmonary arterial hypertension
4891024|NCT02126930|anti-infectious treatment|anti-infectious treatment
4891025|NCT02126930|observance|observance
4891026|NCT02126930|pharmaceutical consultation|pharmaceutical consultation
4891027|NCT02126917|Phase 1|phase 1
4891028|NCT02126917|Alcohol|alcohol
4891029|NCT02126917|Hydrocodone Bitartrate|hydrocodone bitartrate
4891030|NCT02126917|Pharmacokinetics|pharmacokinetics
4891031|NCT02126891|Cardiac functions|cardiac functions
4891032|NCT02126891|Endurance training|endurance training
4891033|NCT02126891|Senior athletes|senior athletes
4891034|NCT02126852|residual paralysis,neuromuscular blockade,acceleromyography,electromyography|residual paralysis,neuromuscular blockade,acceleromyography,electromyography
4891035|NCT02126813|Postoperative urinary retention|postoperative urinary retention
4891036|NCT02126813|Fast-track total hip (THA) and knee arthroplasty (TKA)|fast-track total hip (tha) and knee arthroplasty (tka)
4891037|NCT02126813|Urinary bladder volume|urinary bladder volume
4891038|NCT02126800|breast cancer|breast cancer
4891039|NCT02126787|Anxiety disorders|anxiety disorders
4891040|NCT02126787|Depressive disorders|depressive disorders
4891041|NCT02126787|Personality disorders|personality disorders
4891042|NCT02126787|Psychodynamic psychotherapy|psychodynamic psychotherapy
4891043|NCT02126787|Cognitive-behavioral psychotherapy|cognitive-behavioral psychotherapy
4891044|NCT02126787|Group psychotherapy|group psychotherapy
4891045|NCT02126787|Day treatment|day treatment
4891046|NCT02126774|epilepsy|epilepsy
4891047|NCT02126774|focal epilepsy|focal epilepsy
4891048|NCT02126761|Influenza|influenza
4891049|NCT02126761|elderly|elderly
4891050|NCT02126761|adjuvant|adjuvant
4891051|NCT02126748|bronchiolitis|bronchiolitis
4891052|NCT02126748|Wang score|wang score
4891053|NCT02126748|Sa02|sa02
4891054|NCT02126748|airway clearance techniques|airway clearance techniques
4891055|NCT02126748|intrapulmonary percussive ventilation|intrapulmonary percussive ventilation
4891056|NCT02126748|assisted autogenic drainage|assisted autogenic drainage
4891057|NCT02126722|Helicobacter pylori|helicobacter pylori
4891058|NCT02126722|Gastritis|gastritis
4891059|NCT02126709|Povidone Iodine|povidone iodine
4891060|NCT02126709|Safety|safety
4891061|NCT02126709|Efficacy|efficacy
4891062|NCT02126709|Acne treatment|acne treatment
4891063|NCT02126696|Anti-retroviral Therapy|anti-retroviral therapy
4891064|NCT02126696|Lesotho|lesotho
4891065|NCT02126696|Southern Africa|southern africa
4891066|NCT02126696|Comorbidity|comorbidity
4891067|NCT02126696|Virologic failure|virologic failure
4891068|NCT02126683|Hashimoto's thyroiditis|hashimoto's thyroiditis
4891069|NCT02126683|Plaquenil|plaquenil
4891070|NCT02126657|Acne scars|acne scars
4891071|NCT02126657|70% Glycolic acid peel|70% glycolic acid peel
4891072|NCT02126644|Photoaging|photoaging
4891073|NCT02126644|70% glycolic acid peel|70% glycolic acid peel
4891074|NCT02126618|Lower urinary tract symptoms|lower urinary tract symptoms
4891075|NCT02126618|urodynamic studies|urodynamic studies
4891076|NCT02126618|diuresis|diuresis
4891077|NCT02126605|diabetes alert dogs|diabetes alert dogs
4891078|NCT02126605|hypoglycemia|hypoglycemia
4891079|NCT02126579|melanoma|melanoma
4891080|NCT02126579|neoplasms|neoplasms
4891081|NCT02126579|Poly ICLC|poly iclc
4891082|NCT02126579|Freund's Adjuvant|freund's adjuvant
4891083|NCT02126579|Metastatic melanoma|metastatic melanoma
4891084|NCT02126579|resiquimod|resiquimod
4891085|NCT02126579|adjuvants|adjuvants
4891086|NCT02126579|peptide vaccine|peptide vaccine
4891087|NCT02126566|striae distensiae|striae distensiae
4891088|NCT02126553|Leukemia|leukemia
4891089|NCT02126553|Acute myeloid leukemia|acute myeloid leukemia
4891090|NCT02126553|AML|aml
4891091|NCT02126553|Remission|remission
4891092|NCT02126553|Lenalidomide|lenalidomide
4891093|NCT02126553|CC-5013|cc-5013
4891094|NCT02126553|Revlimid|revlimid
4891095|NCT02126540|Peripheral Arterial Disease|peripheral arterial disease
4891096|NCT02126540|Atherectomy|atherectomy
4891097|NCT02126540|Optical Coherence Tomography|optical coherence tomography
4891098|NCT02126514|Beta secretase inhibitor|beta secretase inhibitor
4891099|NCT02126514|Alzheimer disease|alzheimer disease
4891100|NCT02126501|weaning|weaning
4891101|NCT02126501|NCPAP|ncpap
4891102|NCT02126501|Preterm|preterm
4891103|NCT02126501|sudden wean|sudden wean
4891104|NCT02126501|gradual pressure off wean|gradual pressure off wean
4891105|NCT02126488|treadmill training|treadmill training
4891106|NCT02126488|generalization|generalization
4891107|NCT02126488|retention|retention
4891108|NCT02126475|"parkinson patients ON"|"parkinson patients on"
4891109|NCT02126475|"parkinson patients OFF"|"parkinson patients off"
4891110|NCT02126475|time estimation|time estimation
4891111|NCT02126475|anticipation|anticipation
4891112|NCT02126462|Human Hookworm|human hookworm
4891113|NCT02126462|Necator americanus|necator americanus
4891114|NCT02126462|Hookworm|hookworm
4891115|NCT02126462|Hookworm Disease|hookworm disease
4891116|NCT02126462|Iron-deficiency anemia|iron-deficiency anemia
4891117|NCT02126462|Soil-transmitted helminth infection|soil-transmitted helminth infection
4891118|NCT02126462|Neglected Tropical Disease|neglected tropical disease
4891119|NCT02126462|Na-APR-1|na-apr-1
4891120|NCT02126462|Na-GST-1|na-gst-1
4891121|NCT02126436|phantom limb pain|phantom limb pain
4891122|NCT02126436|phantom limb sensation|phantom limb sensation
4891123|NCT02126436|acupuncture|acupuncture
4891124|NCT02126436|randomised controlled trial|randomised controlled trial
4891125|NCT02126423|Drug Resistance, Microbial|drug resistance, microbial
4891126|NCT02126410|sarcopenia|sarcopenia
4891127|NCT02126410|sleep duration|sleep duration
4891128|NCT02126410|body composition|body composition
4891129|NCT02126410|skeletal muscle|skeletal muscle
4891130|NCT02126397|endometrial polyp|endometrial polyp
4891131|NCT02126397|resection of endometrial polyps|resection of endometrial polyps
4891132|NCT02126397|hysteroscopy|hysteroscopy
4891133|NCT02126397|bipolar electrode Versapoint|bipolar electrode versapoint
4891134|NCT02126397|Laser Diode|laser diode
4891135|NCT02126384|Immunology|immunology
4891136|NCT02126384|human|human
4891137|NCT02126384|B-lymphocytes subsets|b-lymphocytes subsets
4891138|NCT02126384|Antibody-Producing Cells|antibody-producing cells
4891139|NCT02126384|23 valent pneumococcal capsular polysaccharide vaccine|23 valent pneumococcal capsular polysaccharide vaccine
4891140|NCT02126332|Severe acute pancreatitis|severe acute pancreatitis
4891141|NCT02126332|Epidural analgesia|epidural analgesia
4891142|NCT02126332|Acute respiratory failure|acute respiratory failure
4891143|NCT02126332|Mechanical ventilation|mechanical ventilation
4891144|NCT02126332|Intensive Care Unit (ICU)|intensive care unit (icu)
4891145|NCT02126319|Cognitive-affective preparation|cognitive-affective preparation
4891146|NCT02126319|prostate cancer counseling|prostate cancer counseling
4891147|NCT02126280|proinflammatory cytokines|proinflammatory cytokines
4891148|NCT02126280|anti-inflammatory cytokines|anti-inflammatory cytokines
4891149|NCT02126280|human monocytes|human monocytes
4891150|NCT02126280|activation|activation
4891151|NCT02126280|biomarkers|biomarkers
4891152|NCT02126280|asymptomatic atherosclerosis|asymptomatic atherosclerosis
4891153|NCT02126267|periodontal disease|periodontal disease
4891154|NCT02126267|therapy|therapy
4891155|NCT02126267|anti-bacterial agents|anti-bacterial agents
4891156|NCT02126267|Randomized Controlled Trials|randomized controlled trials
4891157|NCT02126241|Heart Failure|heart failure
4891158|NCT02126241|Cardiac Resyncronization Therapy|cardiac resyncronization therapy
4891159|NCT02126241|Optimization|optimization
4891160|NCT02126241|Non-invasive cardiac system|non-invasive cardiac system
4891161|NCT02126241|Impedance measured cardiac output|impedance measured cardiac output
4891162|NCT02126228|antibiotics, cesarean|antibiotics, cesarean
4891163|NCT02126215|magnetic resonance imaging|magnetic resonance imaging
4891164|NCT02126215|carbon dioxide|carbon dioxide
4891165|NCT02126215|abdominal aortic aneurysm|abdominal aortic aneurysm
4891166|NCT02126215|post-op delirium|post-op delirium
4891167|NCT02126202|Elderly|elderly
4891168|NCT02126202|Octogenarians|octogenarians
4891169|NCT02126202|PCI|pci
4891170|NCT02126202|Myocardial infarction|myocardial infarction
4891171|NCT02126202|NSTEMI|nstemi
4891172|NCT02126202|Unstable angina pectoris|unstable angina pectoris
4891173|NCT02126189|Head and Neck Squamous Cell Carcinoma|head and neck squamous cell carcinoma
4891174|NCT02126189|Human Papillomavirus|human papillomavirus
4891175|NCT02126189|Aetiology|aetiology
4891176|NCT02126189|prevalence|prevalence
4891177|NCT02126189|risk factors|risk factors
4891178|NCT02126189|clinical outcome|clinical outcome
4891179|NCT02126163|Excessive Drinking|excessive drinking
4891180|NCT02126163|Hazardous Drinking|hazardous drinking
4891181|NCT02126137|HCV|hcv
4891182|NCT02126137|Ezetimibe|ezetimibe
4891183|NCT02126137|Cholesterol|cholesterol
4891184|NCT02126137|Host|host
4891185|NCT02126124|Brainsway, dTMS, Deep Transcranial Magnetic Stimulation, Smoking Cessation|brainsway, dtms, deep transcranial magnetic stimulation, smoking cessation
4891186|NCT02126098|ANCA-associated vasculitis|anca-associated vasculitis
4891187|NCT02126098|Granulomatosis with polyangiitis|granulomatosis with polyangiitis
4891188|NCT02126098|Microscopic polyangiitis|microscopic polyangiitis
4891189|NCT02126098|Wegner's granulomatosis|wegner's granulomatosis
4891190|NCT02126098|Eosinphilic granulomatosis with polyangiitis|eosinphilic granulomatosis with polyangiitis
4891191|NCT02126085|ischemic stroke|ischemic stroke
4891192|NCT02126085|recanalisation|recanalisation
4891193|NCT02126085|sedation|sedation
4891194|NCT02126072|Ethanol|ethanol
4891195|NCT02126072|Alcohol|alcohol
4891196|NCT02126072|Consumption|consumption
4891197|NCT02126072|Gut wall integrity|gut wall integrity
4891198|NCT02126072|Endotoxemia|endotoxemia
4891199|NCT02126059|dementia|dementia
4891200|NCT02126059|behavioral and psychological symptoms|behavioral and psychological symptoms
4891201|NCT02126059|quality of life|quality of life
4891202|NCT02126046|Cord Blood Transplant|cord blood transplant
4891203|NCT02126046|Haploidentical HSCT|haploidentical hsct
4891204|NCT02126046|Thalassemia major|thalassemia major
4891205|NCT02126033|celiac|celiac
4891206|NCT02126033|telomere|telomere
4891207|NCT02126033|telomerase|telomerase
4891208|NCT02126020|Keratoprosthesis|keratoprosthesis
4891209|NCT02126020|corneal melt|corneal melt
4891210|NCT02126020|keratolysis|keratolysis
4891211|NCT02126020|Tumor necrosis factor alpha|tumor necrosis factor alpha
4891212|NCT02126020|infliximab|infliximab
4891213|NCT02126020|matrix metalloproteinase|matrix metalloproteinase
4891214|NCT02126007|fatigue|fatigue
4891215|NCT02126007|HIV|hiv
4891216|NCT02126007|behavioral intervention|behavioral intervention
4891217|NCT02126007|sleep|sleep
4891218|NCT02125981|limaprost alfadex|limaprost alfadex
4891219|NCT02125981|cervical myelopathy|cervical myelopathy
4891220|NCT02125981|surgery|surgery
4891221|NCT02125968|chronic low back pain|chronic low back pain
4891222|NCT02125968|video game|video game
4891223|NCT02125968|therapeutic effects|therapeutic effects
4891224|NCT02125955|Pediatric|pediatric
4891225|NCT02125955|Overweight|overweight
4891226|NCT02125955|Obesity|obesity
4891227|NCT02125955|Gut microbiota|gut microbiota
4891228|NCT02125955|Adiposity|adiposity
4891229|NCT02125955|Prebiotic|prebiotic
4891230|NCT02125955|Dietary fiber|dietary fiber
4891231|NCT02125942|Borderline Personality Disorder|borderline personality disorder
4891232|NCT02125877|Iron overload|iron overload
4891233|NCT02125877|Chelation|chelation
4891234|NCT02125877|Thalassemia|thalassemia
4891235|NCT02125877|Myelodysplastic syndrome (MDS)|myelodysplastic syndrome (mds)
4891236|NCT02125877|Transfusional hemisiderosis|transfusional hemisiderosis
4891237|NCT02125877|Deferasirox|deferasirox
4891238|NCT02125877|ICL670|icl670
4891239|NCT02125877|Dispersible tablet|dispersible tablet
4891240|NCT02125877|Film-coated tablet|film-coated tablet
4891241|NCT02125864|AMD|amd
4891242|NCT02125864|VEGF|vegf
4891243|NCT02125864|Aflibercept|aflibercept
4891244|NCT02125851|slurry|slurry
4891245|NCT02125851|splenda|splenda
4891246|NCT02125851|sucralose|sucralose
4891247|NCT02125851|budesonide|budesonide
4891248|NCT02125851|mucosal contact time|mucosal contact time
4891249|NCT02125838|laryngeal mask Supreme|laryngeal mask supreme
4891250|NCT02125838|laparoscopic gynecologic surgery|laparoscopic gynecologic surgery
4891251|NCT02125838|Laryngeal mask during surgery|laryngeal mask during surgery
4891252|NCT02125812|Aggressive Periodontitis|aggressive periodontitis
4891253|NCT02125812|antimicrobial(s)|antimicrobial(s)
4891254|NCT02125812|microbiology|microbiology
4891255|NCT02125773|PrEP|prep
4891256|NCT02125773|Risk score|risk score
4891257|NCT02125773|Self-perception|self-perception
4891258|NCT02125760|Respiratory muscle training|respiratory muscle training
4891259|NCT02125760|stroke|stroke
4891260|NCT02125760|rehabilitation|rehabilitation
4891261|NCT02125747|Respiratory muscle training; high-intensity training|respiratory muscle training; high-intensity training
4891262|NCT02125721|cystinuria|cystinuria
4891263|NCT02125721|D-penicillamine (Cuprimine®)|d-penicillamine (cuprimine®)
4891264|NCT02125721|tiopronin (Thiola®)|tiopronin (thiola®)
4891265|NCT02125708|preterm prelabor rupture of membranes|preterm prelabor rupture of membranes
4891266|NCT02125708|Ovula Ring|ovula ring
4891267|NCT02125708|body-core-temperature|body-core-temperature
4891268|NCT02125708|biomarkers|biomarkers
4891269|NCT02125708|Single pregnancies|single pregnancies
4891270|NCT02125708|PPROM|pprom
4891271|NCT02125708|gestation week 22 and 27|gestation week 22 and 27
4891272|NCT02125682|HDL|hdl
4891273|NCT02125682|Hyperlipidemia|hyperlipidemia
4891274|NCT02125682|Diabetes|diabetes
4891275|NCT02125682|Inflammation|inflammation
4891276|NCT02125669|basal cell carcinoma|basal cell carcinoma
4891277|NCT02125669|laser surgery|laser surgery
4891278|NCT02125669|pulsed dye laser|pulsed dye laser
4891279|NCT02125669|randomized controlled trial|randomized controlled trial
4891280|NCT02125643|Exercise-induced muscle damage|exercise-induced muscle damage
4891281|NCT02125643|Caffeine|caffeine
4891282|NCT02125643|Maximal voluntary strength|maximal voluntary strength
4891378|NCT02125149|pregnancy|pregnancy
4891283|NCT02125630|Metastatic breast carcer|metastatic breast carcer
4891284|NCT02125630|Bone metastasis|bone metastasis
4891285|NCT02125630|surgery|surgery
4891286|NCT02125617|Castration-resistant prostate cancer|castration-resistant prostate cancer
4891287|NCT02125617|Abiraterone|abiraterone
4891288|NCT02125617|Biomarker|biomarker
4891289|NCT02125617|Urokinase Plasminogen Activator Receptor|urokinase plasminogen activator receptor
4891290|NCT02125617|Plasma|plasma
4891291|NCT02125617|Predictive markers|predictive markers
4891292|NCT02125604|Gastrointestinal event|gastrointestinal event
4891293|NCT02125591|Mild Traumatic Brain Injury|mild traumatic brain injury
4891294|NCT02125565|Arterial|arterial
4891295|NCT02125565|Blood|blood
4891296|NCT02125565|Gas|gas
4891297|NCT02125565|Needle|needle
4891298|NCT02125565|Pain|pain
4891299|NCT02125565|Local|local
4891300|NCT02125565|Anaesthesia|anaesthesia
4891301|NCT02125565|Anaesthetic|anaesthetic
4891302|NCT02125552|vascular access device|vascular access device
4891303|NCT02125552|ultrasonography|ultrasonography
4891304|NCT02125539|Online adolescent substance abuse relapse prevention program|online adolescent substance abuse relapse prevention program
4891305|NCT02125526|Acute myocardial infarction|acute myocardial infarction
4891306|NCT02125526|Persisting ischemia|persisting ischemia
4891307|NCT02125526|No reflow|no reflow
4891308|NCT02125526|Intra-aortic balloon pump|intra-aortic balloon pump
4891309|NCT02125526|Exhausted autoregulation|exhausted autoregulation
4891310|NCT02125513|neoadjuvant chemotherapy|neoadjuvant chemotherapy
4891311|NCT02125513|ovarian cancer|ovarian cancer
4891312|NCT02125513|fallopian tube carcinoma|fallopian tube carcinoma
4891313|NCT02125513|peritoneal carcinoma|peritoneal carcinoma
4891314|NCT02125513|randomized study|randomized study
4891315|NCT02125500|HCV/HIV coinfection|hcv/hiv coinfection
4891316|NCT02125500|HCV genotype 1|hcv genotype 1
4891317|NCT02125487|Clinical Breast Examination|clinical breast examination
4891318|NCT02125487|Breast Cancer detection|breast cancer detection
4891319|NCT02125487|Breast Simulator|breast simulator
4891320|NCT02125487|Hybrid Simulation|hybrid simulation
4891321|NCT02125487|Patient Simulation|patient simulation
4891322|NCT02125487|Standardized Patient|standardized patient
4891323|NCT02125487|Medical student education|medical student education
4891324|NCT02125487|Health Communication|health communication
4891325|NCT02125487|Communication Barriers|communication barriers
4891326|NCT02125487|Cultural competency|cultural competency
4891327|NCT02125487|Cultural|cultural
4891328|NCT02125487|Middle East|middle east
4891329|NCT02125487|Lebanon|lebanon
4891330|NCT02125474|Neuroendocrine Tumors|neuroendocrine tumors
4891331|NCT02125474|Lutetium|lutetium
4891332|NCT02125474|Treatment Outcome|treatment outcome
4891333|NCT02125461|Locally advanced|locally advanced
4891334|NCT02125461|Unresectable Non-Small Cell Lung Cancer|unresectable non-small cell lung cancer
4891335|NCT02125461|MEDI4736|medi4736
4891336|NCT02125461|PD-L1|pd-l1
4891337|NCT02125461|Stage III Non-Small Cell Lung Cancer|stage iii non-small cell lung cancer
4891338|NCT02125461|Chemoradiation|chemoradiation
4891339|NCT02125461|Immune-mediated cancer therapy|immune-mediated cancer therapy
4891340|NCT02125448|Esophageal cancer|esophageal cancer
4891341|NCT02125448|MRI|mri
4891342|NCT02125448|PET-CT|pet-ct
4891343|NCT02125448|Response assessment|response assessment
4891344|NCT02125435|Healthy subjects|healthy subjects
4891345|NCT02125435|ASP2408|asp2408
4891346|NCT02125435|pharmacokinetics|pharmacokinetics
4891347|NCT02125396|hepatocellular carcinoma|hepatocellular carcinoma
4891348|NCT02125396|liver cancer|liver cancer
4891349|NCT02125396|transarterial chemoembolization|transarterial chemoembolization
4891350|NCT02125396|radiotherapy|radiotherapy
4891351|NCT02125396|adjuvant therapy|adjuvant therapy
4891352|NCT02125383|Parkinson's disease|parkinson's disease
4891353|NCT02125383|Transcranial direct current stimulation|transcranial direct current stimulation
4891354|NCT02125357|sequencing|sequencing
4891355|NCT02125357|abiraterone|abiraterone
4891356|NCT02125357|enzalutamide|enzalutamide
4891357|NCT02125357|metastatic castration-resistant prostate cancer|metastatic castration-resistant prostate cancer
4891358|NCT02125357|randomized|randomized
4891359|NCT02125331|Blood Pressure|blood pressure
4891360|NCT02125318|myeloproliferative neoplasm|myeloproliferative neoplasm
4891361|NCT02125318|chronic myelogenous leukemia|chronic myelogenous leukemia
4891362|NCT02125318|polycythemia vera|polycythemia vera
4891363|NCT02125318|primary myelofibrosis|primary myelofibrosis
4891364|NCT02125318|essential thrombocythemia|essential thrombocythemia
4891365|NCT02125318|anagrelide|anagrelide
4891366|NCT02125318|thrombocytosis|thrombocytosis
4891367|NCT02125318|GALE-401|gale-401
4891368|NCT02125305|Metformin|metformin
4891369|NCT02125305|Pharmacokinetics/ Pharmacodynamics|pharmacokinetics/ pharmacodynamics
4891370|NCT02125214|consciousness, anesthesia, electroencephalogram, microstate, long-range dependency|consciousness, anesthesia, electroencephalogram, microstate, long-range dependency
4891371|NCT02125201|intranasal fentanyl|intranasal fentanyl
4891372|NCT02125201|newborn|newborn
4891373|NCT02125162|BCX4161|bcx4161
4891374|NCT02125162|BioCryst|biocryst
4891375|NCT02125162|hereditary angioedema|hereditary angioedema
4891376|NCT02125162|relative bioavailability|relative bioavailability
4891377|NCT02125162|kallikrein inhibitor|kallikrein inhibitor
4891379|NCT02125149|obese|obese
4891380|NCT02125136|unresectable|unresectable
4891381|NCT02125136|borderline resectable|borderline resectable
4891382|NCT02125110|neurotoxicants|neurotoxicants
4891383|NCT02125110|MRI|mri
4891384|NCT02125110|developing brain|developing brain
4891385|NCT02125097|Intracranial Aneurysm Treatment|intracranial aneurysm treatment
4891386|NCT02125097|Endovascular Therapy|endovascular therapy
4891387|NCT02125084|Metastatic Prostate Cancer|metastatic prostate cancer
4891388|NCT02125084|Castrate-resistant|castrate-resistant
4891389|NCT02125084|Enzalutamide|enzalutamide
4891390|NCT02125084|Everolimus|everolimus
4891391|NCT02125058|intracutaneous sutures|intracutaneous sutures
4891392|NCT02125058|transcutaneous sutures|transcutaneous sutures
4891393|NCT02125058|dermatological surgery|dermatological surgery
4891394|NCT02125058|facial area|facial area
4891395|NCT02125045|GSH|gsh
4891396|NCT02125045|cardiovascular risk factors|cardiovascular risk factors
4891397|NCT02125045|endothelial dysfunction|endothelial dysfunction
4891398|NCT02125045|oxidative stress|oxidative stress
4891399|NCT02125019|Breast Cancer|breast cancer
4891400|NCT02125019|Taxane|taxane
4891401|NCT02125019|Gait|gait
4891402|NCT02125019|Men|men
4891403|NCT02125019|Women|women
4891404|NCT02125006|Mindfulness|mindfulness
4891405|NCT02125006|Breast Cancer|breast cancer
4891406|NCT02125006|Painful Neuropathy|painful neuropathy
4891407|NCT02125006|Chronic Pain|chronic pain
4891408|NCT02125006|fMRI|fmri
4891409|NCT02125006|Disability|disability
4891410|NCT02125006|Quality of Life|quality of life
4891411|NCT02125006|Cytokines|cytokines
4891412|NCT02125006|Cortisol|cortisol
4891413|NCT02124993|Gastrectomy|gastrectomy
4891414|NCT02124980|Opioid Substitution Treatment|opioid substitution treatment
4891415|NCT02124980|Cognitive Behavioral Therapy|cognitive behavioral therapy
4891416|NCT02124980|Mobile Health|mobile health
4891417|NCT02124928|stroke|stroke
4891418|NCT02124928|biomarkers|biomarkers
4891419|NCT02124928|vulnerable plaque|vulnerable plaque
4891420|NCT02124928|carotid endarterectomy|carotid endarterectomy
4891421|NCT02124928|carotid artery disease|carotid artery disease
4891422|NCT02124915|prosthetic socket|prosthetic socket
4891423|NCT02124915|amputee|amputee
4891424|NCT02124889|bariatric surgery|bariatric surgery
4891425|NCT02124889|multivitamin|multivitamin
4891426|NCT02124889|weight loss|weight loss
4891427|NCT02124889|adherence|adherence
4891428|NCT02124876|amputee|amputee
4891429|NCT02124876|prosthetics|prosthetics
4891430|NCT02124837|lunch breaks, recovery, nature, park walking, relaxation|lunch breaks, recovery, nature, park walking, relaxation
4891431|NCT02124811|Schizophrenia|schizophrenia
4891432|NCT02124811|Clozapine|clozapine
4891433|NCT02124811|Minocycline|minocycline
4891434|NCT02124798|Subcutaneous|subcutaneous
4891435|NCT02124798|Autoinjector|autoinjector
4891436|NCT02124798|Belimumab|belimumab
4891437|NCT02124798|Real-Life Use Study|real-life use study
4891438|NCT02124798|Reliability|reliability
4891439|NCT02124785|Long-term persistence|long-term persistence
4891440|NCT02124785|Havrix|havrix
4891441|NCT02124785|Hepatitis A|hepatitis a
4891442|NCT02124772|v600-mutation|v600-mutation
4891443|NCT02124772|neuroblastoma|neuroblastoma
4891444|NCT02124772|Trametinib|trametinib
4891445|NCT02124772|pediatrics|pediatrics
4891446|NCT02124772|Langerhans Cell Histiocytosis|langerhans cell histiocytosis
4891447|NCT02124772|low grade glioma plexiform neurofibromas|low grade glioma plexiform neurofibromas
4891448|NCT02124746|Primary Myelofibrosis|primary myelofibrosis
4891449|NCT02124746|Post Polycythemia Vera Myelofibrosis|post polycythemia vera myelofibrosis
4891450|NCT02124746|Post Essential Thrombocythemia Myelofibrosis|post essential thrombocythemia myelofibrosis
4891451|NCT02124746|Polycythemia Vera|polycythemia vera
4891452|NCT02124746|Essential Thrombocythemia|essential thrombocythemia
4891453|NCT02124746|blood disorders|blood disorders
4891454|NCT02124733|Actinic Keratosis|actinic keratosis
4891455|NCT02124733|Actinic Keratoses|actinic keratoses
4891456|NCT02124733|AK|ak
4891457|NCT02124733|PDT|pdt
4891458|NCT02124733|Photodynamic Therapy|photodynamic therapy
4891459|NCT02124733|Blue Light Therapy|blue light therapy
4891460|NCT02124733|ALA|ala
4891461|NCT02124733|aminolevulinic acid|aminolevulinic acid
4891462|NCT02124733|Levulan|levulan
4891463|NCT02124720|Autism spectrum disorders|autism spectrum disorders
4891464|NCT02124720|Stereotypy|stereotypy
4891465|NCT02124720|Repetitive behavior|repetitive behavior
4891466|NCT02124707|Head and neck cancer|head and neck cancer
4891467|NCT02124707|Squamous cell carcinoma|squamous cell carcinoma
4891468|NCT02124707|Metastatic|metastatic
4891469|NCT02124707|Recurrent|recurrent
4891470|NCT02124707|Phase II|phase ii
4891471|NCT02124707|Carboplatin|carboplatin
4891472|NCT02124707|Paclitaxel|paclitaxel
4891473|NCT02124707|Cetuximab|cetuximab
4891474|NCT02124694|historical trauma and unresolved grief|historical trauma and unresolved grief
4891475|NCT02124694|complicated grief|complicated grief
4891476|NCT02124694|prolonged grief|prolonged grief
4891477|NCT02124694|interpersonal conflicts|interpersonal conflicts
4891478|NCT02124694|depression|depression
4891479|NCT02124694|American Indians|american indians
4891480|NCT02124694|interpersonal psychotherapy|interpersonal psychotherapy
4891481|NCT02124694|traumatic grief|traumatic grief
4891482|NCT02124694|posttraumatic stress disorder|posttraumatic stress disorder
4891483|NCT02124668|Xtandi|xtandi
4891484|NCT02124668|MDV3100|mdv3100
4891485|NCT02124668|Progressive Castration-Resistant Prostate Cancer|progressive castration-resistant prostate cancer
4891486|NCT02124668|Enzalutamide|enzalutamide
4891487|NCT02124655|Biofilms|biofilms
4891488|NCT02124655|Chlorhexidine|chlorhexidine
4891489|NCT02124655|Microscopy, confocal|microscopy, confocal
4891490|NCT02124655|Dental plaque|dental plaque
4891491|NCT02124655|Mouthwashes|mouthwashes
4891492|NCT02124642|Folate requirements|folate requirements
4891493|NCT02124642|Pregnancy|pregnancy
4891494|NCT02124642|Folic acid|folic acid
4891495|NCT02124642|DNA methylation|dna methylation
4891496|NCT02124642|Folate biomarkers|folate biomarkers
4891497|NCT02124616|spinal muscular atrophy|spinal muscular atrophy
4891498|NCT02124616|Muscular dystrophy|muscular dystrophy
4891499|NCT02124616|Muscle diseases|muscle diseases
4891500|NCT02124616|myasthenic syndromes|myasthenic syndromes
4891501|NCT02124616|Polyneuropathies|polyneuropathies
4891502|NCT02124616|Myopathies|myopathies
4891503|NCT02124603|cataract|cataract
4891504|NCT02124603|prophylaxis|prophylaxis
4891505|NCT02124603|susceptibility|susceptibility
4891506|NCT02124590|Carnitine|carnitine
4891507|NCT02124590|Acylcarnitine|acylcarnitine
4891508|NCT02124590|Exercise|exercise
4891509|NCT02124590|Exercise Intensity|exercise intensity
4891510|NCT02124590|Insulin Sensitivity|insulin sensitivity
4891511|NCT02124564|Lacosamide|lacosamide
4891512|NCT02124564|Epilepsy|epilepsy
4891513|NCT02124564|Focal, Partial-Onset Seizures with or without secondary generalization|focal, partial-onset seizures with or without secondary generalization
4891514|NCT02124564|Monotherapy|monotherapy
4891515|NCT02124551|Goal-directed fluid therapy|goal-directed fluid therapy
4891516|NCT02124512|obese|obese
4891517|NCT02124512|insulin resistance|insulin resistance
4891518|NCT02124512|metabolic syndrome|metabolic syndrome
4891519|NCT02124499|anesthesia recovery period|anesthesia recovery period
4891520|NCT02124499|postoperative complications|postoperative complications
4891521|NCT02124499|pain|pain
4891522|NCT02124499|pain measurement|pain measurement
4891523|NCT02124499|postoperative nausea and vomiting|postoperative nausea and vomiting
4891524|NCT02124499|quality of life|quality of life
4891525|NCT02124499|genetic association study|genetic association study
4891527|NCT02124486|Weight loss|weight loss
4891528|NCT02124486|Bariatric surgery|bariatric surgery
4891529|NCT02124473|Resistant hypertension|resistant hypertension
4891530|NCT02124473|Homeopathy|homeopathy
4891531|NCT02124473|Blood pressure|blood pressure
4891532|NCT02124473|Ambulatory blood pressure monitoring|ambulatory blood pressure monitoring
4891533|NCT02124460|Pediatric|pediatric
4891534|NCT02124460|Obesity|obesity
4891535|NCT02124460|Overweight|overweight
4891536|NCT02124460|Intervention|intervention
4891537|NCT02124434|Laparoscopic Sleeve Gastrectomy surgery|laparoscopic sleeve gastrectomy surgery
4891538|NCT02124421|Ovarian cancer|ovarian cancer
4891539|NCT02124421|Cytoreductive surgery|cytoreductive surgery
4891540|NCT02124421|Hyperthermic Intraperitoneal chemotherapy|hyperthermic intraperitoneal chemotherapy
4891541|NCT02124421|Systemic chemotherapy|systemic chemotherapy
4891542|NCT02124421|Primary peritoneal carcinoma|primary peritoneal carcinoma
4891543|NCT02124421|Fallopian Tube cancer|fallopian tube cancer
4891544|NCT02124421|Intraperitoneal chemotherapy|intraperitoneal chemotherapy
4891545|NCT02124421|IV/IP chemotherapy|iv/ip chemotherapy
4891546|NCT02124421|IV chemotherapy|iv chemotherapy
4891547|NCT02124382|liver failure|liver failure
4891548|NCT02124382|liver malignancy|liver malignancy
4891549|NCT02124382|metabolic diseases|metabolic diseases
4891550|NCT02124382|Pediatric liver transplanted recipients and their healthy donors|pediatric liver transplanted recipients and their healthy donors
4891551|NCT02124369|Pancreatic cancer|pancreatic cancer
4891552|NCT02124369|locally advanced|locally advanced
4891553|NCT02124369|unresectable|unresectable
4891554|NCT02124343|Neutrophil|neutrophil
4891555|NCT02124343|Exercise|exercise
4891556|NCT02124343|COPD|copd
4891557|NCT02124343|Pulmonary Rehabilitation|pulmonary rehabilitation
4891558|NCT02124330|Montmorillonite, proteic diet, in vitro and in vivo models|montmorillonite, proteic diet, in vitro and in vivo models
4891559|NCT02124317|nanoparticle albumin-bound paclitaxel|nanoparticle albumin-bound paclitaxel
4891560|NCT02124317|S-1|s-1
4891561|NCT02124317|advanced pancreatic cancer|advanced pancreatic cancer
4891562|NCT02124317|objective response rate|objective response rate
4891563|NCT02124304|Sternocleidomastoid|sternocleidomastoid
4891564|NCT02124304|Neck pain|neck pain
4891565|NCT02124304|EMG|emg
4891566|NCT02124304|Perceived Exertion|perceived exertion
4891567|NCT02124304|Thera-Band|thera-band
4891568|NCT02124304|Cervical Paraspinals|cervical paraspinals
4891569|NCT02124291|In Vitro Fertilization|in vitro fertilization
4891570|NCT02124291|Vitrification|vitrification
4891571|NCT02124291|Frozen Embryo|frozen embryo
4891572|NCT02124291|Assisted Hatching|assisted hatching
4891573|NCT02124291|Pregnancy Rate|pregnancy rate
4891574|NCT02124278|Single ascending dose|single ascending dose
4891575|NCT02124278|Safety and tolerability in healthy subjects|safety and tolerability in healthy subjects
4891869|NCT02122913|TRK|trk
4891576|NCT02124265|Oral Rehydration Therapy|oral rehydration therapy
4891577|NCT02124252|cervical cancer screening|cervical cancer screening
4891578|NCT02124252|human papillomavirus testing|human papillomavirus testing
4891579|NCT02124252|Kenya|kenya
4891580|NCT02124252|implementation science|implementation science
4891581|NCT02124226|Chronic severe asthma, immunomodulation, methotrexate, steroids, omalizumab|chronic severe asthma, immunomodulation, methotrexate, steroids, omalizumab
4891582|NCT02124213|Receptor Occupancy|receptor occupancy
4891583|NCT02124213|PET|pet
4891584|NCT02124213|D1 Receptor Agonist|d1 receptor agonist
4891585|NCT02124174|acute myelogenous leukemia (AML)|acute myelogenous leukemia (aml)
4891586|NCT02124174|myelodysplastic syndrome (MDS)|myelodysplastic syndrome (mds)
4891587|NCT02124161|Pneumococcal polysaccharide vaccine|pneumococcal polysaccharide vaccine
4891588|NCT02124161|13-valent pneumococcal conjugate vaccine|13-valent pneumococcal conjugate vaccine
4891589|NCT02124161|invasive pneumococcal disease|invasive pneumococcal disease
4891590|NCT02124161|flu vaccine|flu vaccine
4891591|NCT02124148|cancer|cancer
4891592|NCT02124135|Nutrition|nutrition
4891593|NCT02124122|Focus|focus
4891594|NCT02124122|safety|safety
4891595|NCT02124109|Rheumatic Fever|rheumatic fever
4891596|NCT02124109|Acquired Heart Disease|acquired heart disease
4891597|NCT02124109|Rheumatic Heart Disease|rheumatic heart disease
4891598|NCT02124109|Endomyocardial Fibrosis|endomyocardial fibrosis
4891599|NCT02124096|Zoonotic|zoonotic
4891600|NCT02124096|Influenza|influenza
4891601|NCT02124096|Infections|infections
4891602|NCT02124096|Ohio|ohio
4891603|NCT02124096|Fairs|fairs
4891604|NCT02124083|Niemann Pick Disease, Type C1|niemann pick disease, type c1
4891605|NCT02124083|Phase I, Phase 2|phase i, phase 2
4891606|NCT02124083|Vorinostat|vorinostat
4891607|NCT02124070|Cystinosis|cystinosis
4891608|NCT02124070|Myopathy|myopathy
4891609|NCT02124070|Recombiant Growth Hormone|recombiant growth hormone
4891610|NCT02124057|Liver|liver
4891611|NCT02124057|Motor Neuron Disease|motor neuron disease
4891612|NCT02124044|Coinfection|coinfection
4891613|NCT02124044|HCV Genotype 1b|hcv genotype 1b
4891614|NCT02124044|Interferon Free therapy|interferon free therapy
4891615|NCT02124044|Liver Biopsy|liver biopsy
4891616|NCT02124044|Virological Response|virological response
4891617|NCT02124031|Osteoarthritis|osteoarthritis
4891618|NCT02124031|Rheumatoid Arthritis|rheumatoid arthritis
4891619|NCT02124031|Disability|disability
4891620|NCT02124031|Joint function|joint function
4891621|NCT02124018|Myocardial infarction|myocardial infarction
4891622|NCT02124018|Risk stratification|risk stratification
4891623|NCT02124018|Sudden cardiac death|sudden cardiac death
4891624|NCT02124018|Preserved ejection fraction|preserved ejection fraction
4891625|NCT02124018|Programmed ventricular stimulation|programmed ventricular stimulation
4891626|NCT02124005|Knee surgery|knee surgery
4891627|NCT02124005|Femoral block|femoral block
4891628|NCT02124005|Bupivacaine|bupivacaine
4891629|NCT02124005|Ultrasound|ultrasound
4891630|NCT02123966|Chronic Graft-versus-Host-Disease|chronic graft-versus-host-disease
4891631|NCT02123966|Oral mucosal disease|oral mucosal disease
4891632|NCT02123953|Drug therapy|drug therapy
4891633|NCT02123940|Weaning from mechanical ventilation|weaning from mechanical ventilation
4891634|NCT02123940|Lung ultrasound|lung ultrasound
4891635|NCT02123940|Nasal humidified high flow therapy|nasal humidified high flow therapy
4891636|NCT02123940|Weaning failure|weaning failure
4891637|NCT02123940|Postextubation distress|postextubation distress
4891638|NCT02123927|Drug therapy|drug therapy
4891639|NCT02123914|Exercise training|exercise training
4891640|NCT02123914|Allergic rhinitis|allergic rhinitis
4891641|NCT02123914|Vitamin C|vitamin c
4891642|NCT02123914|Cytokine|cytokine
4891643|NCT02123914|Rhinitis symptoms|rhinitis symptoms
4891644|NCT02123901|Mind and body Exercise|mind and body exercise
4891645|NCT02123901|Flow mediated dilation|flow mediated dilation
4891646|NCT02123901|Diabetes|diabetes
4891647|NCT02123888|Prostate|prostate
4891648|NCT02123888|Lung|lung
4891649|NCT02123862|Prostate Cancer|prostate cancer
4891650|NCT02123862|Breast Cancer|breast cancer
4891651|NCT02123862|Colorectal Cancer|colorectal cancer
4891652|NCT02123862|Colon Cancer|colon cancer
4891653|NCT02123862|Rectal Cancer|rectal cancer
4891654|NCT02123862|Cancer|cancer
4891655|NCT02123862|Solid Tumor|solid tumor
4891656|NCT02123862|Metastatic|metastatic
4891657|NCT02123862|Circulating Tumor Cells|circulating tumor cells
4891658|NCT02123810|fatigue|fatigue
4891659|NCT02123810|motor skills|motor skills
4891660|NCT02123810|cardiopulmonary resuscitation|cardiopulmonary resuscitation
4891661|NCT02123784|Rotator Cuff Tear|rotator cuff tear
4891662|NCT02123784|Rotator Cuff Repair|rotator cuff repair
4891663|NCT02123784|Biomarker|biomarker
4891664|NCT02123784|Predictive factors|predictive factors
4891665|NCT02123784|Skeletal Muscle|skeletal muscle
4891666|NCT02123784|Tendon|tendon
4891667|NCT02123784|Subacromial Bursa|subacromial bursa
4891668|NCT02123771|Focus of Study : HELICOBACTER PYLORI INFECTIONS|focus of study : helicobacter pylori infections
4891669|NCT02123758|Prostatic Neoplasms|prostatic neoplasms
4891670|NCT02123758|Metastatic Castration-Resistant Prostate Cancer (mCRPC)|metastatic castration-resistant prostate cancer (mcrpc)
4891671|NCT02123758|Prostate cancer|prostate cancer
4891672|NCT02123758|Abiraterone Acetate (ZYTIGA)|abiraterone acetate (zytiga)
4891673|NCT02123758|Prednisone|prednisone
4891674|NCT02123758|JNJ-56021927|jnj-56021927
4891675|NCT02123745|infiltration|infiltration
4891676|NCT02123745|extravasation|extravasation
4891677|NCT02123745|peripheral intravenous therapy|peripheral intravenous therapy
4891678|NCT02123732|Diabetes|diabetes
4891679|NCT02123732|Diabetes Mellitus|diabetes mellitus
4891680|NCT02123732|Herbal|herbal
4891681|NCT02123732|food supplement|food supplement
4891682|NCT02123693|Osteopathic manipulative treatment|osteopathic manipulative treatment
4891683|NCT02123693|Low back pain|low back pain
4891684|NCT02123693|Dynamic MRI|dynamic mri
4891685|NCT02123680|expectation|expectation
4891686|NCT02123680|chronic illness|chronic illness
4891687|NCT02123680|trajectory|trajectory
4891688|NCT02123628|diabetic foot osteomyelitis, antibiotic treatment duration|diabetic foot osteomyelitis, antibiotic treatment duration
4891689|NCT02123615|Primary Immunodeficiency|primary immunodeficiency
4891690|NCT02123615|Subdermal bloodless space|subdermal bloodless space
4891691|NCT02123615|Subdermal injection|subdermal injection
4891692|NCT02123615|Subcutaneous injection|subcutaneous injection
4891693|NCT02123615|Injectable electromyography needle|injectable electromyography needle
4891694|NCT02123615|Electrical stimulation|electrical stimulation
4891695|NCT02123615|MRI with Gadolinium|mri with gadolinium
4891696|NCT02123602|patellofemoral pain syndrome|patellofemoral pain syndrome
4891697|NCT02123602|abdominal muscles|abdominal muscles
4891698|NCT02123576|Hepatorenal syndrome|hepatorenal syndrome
4891699|NCT02123576|Renal failure|renal failure
4891700|NCT02123576|Pentoxyfylline|pentoxyfylline
4891701|NCT02123576|Liver transplantation|liver transplantation
4891702|NCT02123576|Cirrhosis|cirrhosis
4891703|NCT02123550|deep|deep
4891704|NCT02123550|venous|venous
4891705|NCT02123550|thrombosis|thrombosis
4891706|NCT02123550|Doppler|doppler
4891707|NCT02123550|ultrasound|ultrasound
4891708|NCT02123550|plastic|plastic
4891709|NCT02123550|surgery|surgery
4891710|NCT02123550|thromboembolism|thromboembolism
4891711|NCT02123550|prevention|prevention
4891712|NCT02123537|Bioness L300 Foot Drop System|bioness l300 foot drop system
4891713|NCT02123537|Functional electrical stimulation|functional electrical stimulation
4891714|NCT02123524|Superficial Vein Thrombosis|superficial vein thrombosis
4891715|NCT02123498|ear pressure|ear pressure
4891716|NCT02123498|ear fullness|ear fullness
4891717|NCT02123498|ear pain|ear pain
4891718|NCT02123498|ETD|etd
4891719|NCT02123498|laryngopharyngeal reflux|laryngopharyngeal reflux
4891721|NCT02123498|gastroesophageal reflux disease|gastroesophageal reflux disease
4891722|NCT02123498|GERD|gerd
4891723|NCT02123498|nasopharyngeal reflux|nasopharyngeal reflux
4891724|NCT02123498|acid reflux|acid reflux
4891725|NCT02123485|Depression,|depression,
4891726|NCT02123485|ECT,|ect,
4891727|NCT02123485|rTMS,|rtms,
4891728|NCT02123485|Right prefrontal,|right prefrontal,
4891729|NCT02123485|antidepressive efficacy|antidepressive efficacy
4891730|NCT02123485|Inflammation markers|inflammation markers
4891731|NCT02123433|HIV|hiv
4891732|NCT02123433|Streptococcus pneumoniae|streptococcus pneumoniae
4891733|NCT02123433|13-valent conjugate pneumococcal vaccine|13-valent conjugate pneumococcal vaccine
4891734|NCT02123433|Vaccine|vaccine
4891735|NCT02123433|Immunological Response|immunological response
4891736|NCT02123433|Pneumococcal Carriage|pneumococcal carriage
4891737|NCT02123420|Platform Switching vs Regular Platform|platform switching vs regular platform
4891738|NCT02123407|Advanced Gastric Cancer|advanced gastric cancer
4891739|NCT02123407|Carbon Nanoparticles|carbon nanoparticles
4891740|NCT02123407|Lymph Nodes|lymph nodes
4891741|NCT02123394|Low Back Pain|low back pain
4891742|NCT02123394|Mechanical Low Back Pain|mechanical low back pain
4891743|NCT02123394|Low Back Ache|low back ache
4891744|NCT02123394|Low Backache|low backache
4891745|NCT02123394|Lower Back Pain|lower back pain
4891746|NCT02123394|Lumbago|lumbago
4891747|NCT02123381|tumor tissue and serum biomarkers|tumor tissue and serum biomarkers
4891748|NCT02123381|cetuximab|cetuximab
4891749|NCT02123381|preoperative radiotherapy|preoperative radiotherapy
4891750|NCT02123381|esophageal squamous cell carcinoma|esophageal squamous cell carcinoma
4891751|NCT02123368|Osteoarthritis|osteoarthritis
4891752|NCT02123368|Mesenchimal stem cell|mesenchimal stem cell
4891753|NCT02123368|Knee|knee
4891754|NCT02123342|health|health
4891755|NCT02123342|older adults|older adults
4891756|NCT02123342|mobile phone|mobile phone
4891757|NCT02123329|Qatar|qatar
4891758|NCT02123329|Pharmacy|pharmacy
4891759|NCT02123329|Pharmacist|pharmacist
4891760|NCT02123329|Smoking cessation|smoking cessation
4891761|NCT02123316|local allergic rhinitis|local allergic rhinitis
4891762|NCT02123316|subcutaneous immunotherapy|subcutaneous immunotherapy
4891763|NCT02123316|house dust mite allergy|house dust mite allergy
4891764|NCT02123316|Dermatophagoides pteronyssinus allergy|dermatophagoides pteronyssinus allergy
4891765|NCT02123303|Hypotension, Orthostatic Hypotension|hypotension, orthostatic hypotension
4891766|NCT02123290|Plasmodium|plasmodium
4891767|NCT02123290|falciparum|falciparum
4891768|NCT02123290|malaria|malaria
4891769|NCT02123290|vivax|vivax
4891770|NCT02123290|DSM265|dsm265
4891870|NCT02122913|TRKA|trka
4891771|NCT02123290|pharmacokinetics|pharmacokinetics
4891772|NCT02123290|adult|adult
4891773|NCT02123251|Incentives,|incentives,
4891774|NCT02123251|Diabetes,|diabetes,
4891775|NCT02123251|Medicaid,|medicaid,
4891776|NCT02123251|Health behavior,|health behavior,
4891777|NCT02123251|Cost effectiveness|cost effectiveness
4891778|NCT02123225|STOP-BANG|stop-bang
4891779|NCT02123225|Obstructive sleep apnea (OSA)|obstructive sleep apnea (osa)
4891780|NCT02123225|total knee arthroplasty (TKA)|total knee arthroplasty (tka)
4891781|NCT02123225|portable monitoring|portable monitoring
4891782|NCT02123225|sleep medicine|sleep medicine
4891783|NCT02123225|unattended sleep study|unattended sleep study
4891784|NCT02123225|postoperative sleep study|postoperative sleep study
4891785|NCT02123212|Hepatitis C|hepatitis c
4891786|NCT02123212|Chronic Hepatitis C|chronic hepatitis c
4891787|NCT02123212|Screening|screening
4891788|NCT02123199|COPD|copd
4891789|NCT02123186|Newborn Screening , spinal muscular atrophy|newborn screening , spinal muscular atrophy
4891790|NCT02123173|one lung ventilation,|one lung ventilation,
4891791|NCT02123173|cardiac output|cardiac output
4891792|NCT02123173|fluid responsiveness|fluid responsiveness
4891793|NCT02123160|Depression|depression
4891794|NCT02123160|Dyadic therapy|dyadic therapy
4891795|NCT02123160|Behavioral Problems|behavioral problems
4891796|NCT02123160|Child parent therapy|child parent therapy
4891797|NCT02123160|Affect regulation|affect regulation
4891798|NCT02123160|Immune markers|immune markers
4891799|NCT02123160|Cortisol|cortisol
4891800|NCT02123121|Aging|aging
4891801|NCT02123121|Biogenesis|biogenesis
4891802|NCT02123121|Cell Respiration|cell respiration
4891803|NCT02123121|Elderly|elderly
4891804|NCT02123121|Enzymes|enzymes
4891805|NCT02123121|Mitochondria|mitochondria
4891806|NCT02123121|Mitochondrial DNA|mitochondrial dna
4891807|NCT02123121|Muscle Fatigue|muscle fatigue
4891808|NCT02123121|Physical Function|physical function
4891809|NCT02123121|Resveratrol|resveratrol
4891810|NCT02123108|Simulect, Myfortic, OLT, Renal Dysfunction, Liver Transplant, Orthotopic Liver Transplantation|simulect, myfortic, olt, renal dysfunction, liver transplant, orthotopic liver transplantation
4891811|NCT02123082|Urolithiasis|urolithiasis
4891812|NCT02123082|Kidney stones|kidney stones
4891813|NCT02123082|Ureteral Obstruction|ureteral obstruction
4891814|NCT02123082|Ureteroscopes|ureteroscopes
4891815|NCT02123082|Ureteroscopies|ureteroscopies
4891816|NCT02123069|Autonomic nervous system|autonomic nervous system
4891817|NCT02123069|Blood pressure|blood pressure
4891818|NCT02123069|Blood vessels|blood vessels
4891819|NCT02123069|Physiological effects of drugs|physiological effects of drugs
4891820|NCT02123069|Vascular stiffness|vascular stiffness
4891821|NCT02123056|reflex fainting|reflex fainting
4891822|NCT02123056|vasovagal syncope|vasovagal syncope
4891823|NCT02123056|metoprolol|metoprolol
4891824|NCT02123056|randomized clinical trial|randomized clinical trial
4891825|NCT02123056|quality of life|quality of life
4891826|NCT02123043|rehabilitation|rehabilitation
4891827|NCT02123043|wheelchair|wheelchair
4891828|NCT02123043|older adults|older adults
4891829|NCT02123043|manual wheelchair|manual wheelchair
4891830|NCT02123043|motor learning|motor learning
4891831|NCT02123043|biomechanics|biomechanics
4891832|NCT02123043|gross mechanical efficiency|gross mechanical efficiency
4891833|NCT02123030|Lung cancer|lung cancer
4891834|NCT02123030|pulmonary disease|pulmonary disease
4891835|NCT02123017|Bowel Evacuation|bowel evacuation
4891836|NCT02123017|Colonoscopy Preparation|colonoscopy preparation
4891837|NCT02123004|ST-Segment Elevation Myocardial Infarction|st-segment elevation myocardial infarction
4891838|NCT02123004|Percutaneous Coronary Intervention|percutaneous coronary intervention
4891839|NCT02122991|spinal cord injury|spinal cord injury
4891840|NCT02122991|autonomic dysreflexia|autonomic dysreflexia
4891841|NCT02122991|baroreceptor integrity|baroreceptor integrity
4891842|NCT02122991|sympathetic integrity|sympathetic integrity
4891843|NCT02122991|vagal integrity|vagal integrity
4891844|NCT02122991|autonomic integrity|autonomic integrity
4891845|NCT02122991|arterial stiffness|arterial stiffness
4891846|NCT02122991|cognitive function|cognitive function
4891847|NCT02122991|traumatic brain injury|traumatic brain injury
4891848|NCT02122991|cerebral blood flow|cerebral blood flow
4891849|NCT02122978|psoriasis|psoriasis
4891850|NCT02122978|dermatology|dermatology
4891851|NCT02122978|mindfulness|mindfulness
4891852|NCT02122978|self-compassion|self-compassion
4891853|NCT02122952|Gene Transfer|gene transfer
4891854|NCT02122952|Gene Therapy|gene therapy
4891855|NCT02122952|Adeno-associated virus|adeno-associated virus
4891856|NCT02122952|Survival Motor Neuron|survival motor neuron
4891857|NCT02122952|SMN|smn
4891858|NCT02122952|AAV9|aav9
4891859|NCT02122926|Transitions in care|transitions in care
4891860|NCT02122926|discharge intervention|discharge intervention
4891861|NCT02122926|RCT|rct
4891862|NCT02122926|readmission rates|readmission rates
4891863|NCT02122926|medication adherence|medication adherence
4891864|NCT02122926|glycemic control|glycemic control
4891865|NCT02122926|ED visits|ed visits
4891866|NCT02122926|medication reconciliation|medication reconciliation
4891867|NCT02122926|Coleman Transitions Coach|coleman transitions coach
4891868|NCT02122926|telemonitoring; hypoglycemic events|telemonitoring; hypoglycemic events
4891871|NCT02122913|TRKB|trkb
4891872|NCT02122913|TRKC|trkc
4891873|NCT02122913|NTRK1|ntrk1
4891874|NCT02122913|NTRK2|ntrk2
4891875|NCT02122913|NTRK3|ntrk3
4891876|NCT02122913|larotrectinib|larotrectinib
4891877|NCT02122913|NTRK fusion positive|ntrk fusion positive
4891878|NCT02122913|NTRK gene rearrangements|ntrk gene rearrangements
4891879|NCT02122913|NTRK1 fusion|ntrk1 fusion
4891880|NCT02122913|NTRK2 fusion|ntrk2 fusion
4891881|NCT02122913|NTRK3 fusion|ntrk3 fusion
4891882|NCT02122913|NTRK1 gene rearrangement|ntrk1 gene rearrangement
4891883|NCT02122913|NTRK2 gene rearrangement|ntrk2 gene rearrangement
4891884|NCT02122913|NTRK3 gene rearrangement|ntrk3 gene rearrangement
4891885|NCT02122913|ETV6-NTRK3|etv6-ntrk3
4891886|NCT02122913|fusion|fusion
4891887|NCT02122913|tumors|tumors
4891888|NCT02122913|solid tumors|solid tumors
4891889|NCT02122913|CNS tumors|cns tumors
4891890|NCT02122913|central nervous system tumors|central nervous system tumors
4891891|NCT02122913|TRK fusion|trk fusion
4891892|NCT02122913|ETV6|etv6
4891893|NCT02122913|ETV6 fusion|etv6 fusion
4891894|NCT02122913|ETV6 gene rearrangement|etv6 gene rearrangement
4891895|NCT02122913|solid CNS tumor|solid cns tumor
4891896|NCT02122913|Advanced CNS tumor|advanced cns tumor
4891897|NCT02122913|Primary CNS tumor|primary cns tumor
4891898|NCT02122913|Metastatic CNS tumor|metastatic cns tumor
4891899|NCT02122913|LOXO-101|loxo-101
4891900|NCT02122887|jewish, arab, israel, teenagers|jewish, arab, israel, teenagers
4891901|NCT02122874|Percutaneous neurostimulation; dermatome T7, type 2 diabetes|percutaneous neurostimulation; dermatome t7, type 2 diabetes
4891902|NCT02122861|Melanoma|melanoma
4891903|NCT02122848|Heart failure|heart failure
4891904|NCT02122848|Exercise tolerance|exercise tolerance
4891905|NCT02122848|Noninvasive ventilation|noninvasive ventilation
4891906|NCT02122835|exercise|exercise
4891907|NCT02122835|aerobic exercise|aerobic exercise
4891908|NCT02122822|supratentoria glioma|supratentoria glioma
4891909|NCT02122809|Chiauranib, advanced solid tumors, phase 1 study|chiauranib, advanced solid tumors, phase 1 study
4891910|NCT02122796|Breast Cancer|breast cancer
4891911|NCT02122796|Mastectomy|mastectomy
4891912|NCT02122796|Acupuncture|acupuncture
4891913|NCT02122770|Drug Therapy|drug therapy
4891914|NCT02122731|antihypertensive therapy|antihypertensive therapy
4891915|NCT02122731|amiloride|amiloride
4891916|NCT02122731|add-on|add-on
4891917|NCT02122731|resistant hypertension|resistant hypertension
4891918|NCT02122731|blood pressure control|blood pressure control
4891919|NCT02122731|type 2 diabetes mellitus,|type 2 diabetes mellitus,
4891920|NCT02122731|microalbuminuria.|microalbuminuria.
4891921|NCT02122705|Remifentanil|remifentanil
4891922|NCT02122705|Labour analgesia|labour analgesia
4891923|NCT02122666|Metabolic Syndrome|metabolic syndrome
4891924|NCT02122666|Pre-diabetes|pre-diabetes
4891925|NCT02122666|impaired glucose tolerance|impaired glucose tolerance
4891926|NCT02122666|Phospholipids|phospholipids
4891927|NCT02122653|Fatigue|fatigue
4891928|NCT02122653|aging|aging
4891929|NCT02122653|transcranial magnetic stimulation|transcranial magnetic stimulation
4891930|NCT02122653|interpolated|interpolated
4891931|NCT02122653|twitch technique|twitch technique
4891932|NCT02122627|Vitamin D, COPD, immunomodulation, pulmonary function|vitamin d, copd, immunomodulation, pulmonary function
4891933|NCT02122614|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
4891934|NCT02122614|COPD|copd
4891935|NCT02122614|Pulmonary rehabilitation|pulmonary rehabilitation
4891936|NCT02122614|Physical activity|physical activity
4891937|NCT02122614|Exercise|exercise
4891938|NCT02122588|serous and endometrioid ovarian, peritoneal, fallopian tube cancer, hereditary ovarian cancer, BRCA (breast cancer gene) mutation, genetic testing|serous and endometrioid ovarian, peritoneal, fallopian tube cancer, hereditary ovarian cancer, brca (breast cancer gene) mutation, genetic testing
4891939|NCT02122575|Inflammasome|inflammasome
4891940|NCT02122575|Fasting|fasting
4891941|NCT02122575|Sirt3|sirt3
4891942|NCT02122562|Ketamine|ketamine
4891943|NCT02122562|Major Depression|major depression
4891944|NCT02122562|Alcohol|alcohol
4891945|NCT02122562|Alcohol Clamp|alcohol clamp
4891946|NCT02122562|NMDA Antagonist|nmda antagonist
4891947|NCT02122549|In-Hospital Cardiac Arrest|in-hospital cardiac arrest
4891948|NCT02122549|Telemetry|telemetry
4891949|NCT02122523|Image guided surgery|image guided surgery
4891950|NCT02122510|Analgesia, casarean section, TAP block|analgesia, casarean section, tap block
4891951|NCT02122497|abdominal aortic aneurysm|abdominal aortic aneurysm
4891952|NCT02122497|aortic occlusive disease|aortic occlusive disease
4891953|NCT02122497|cardiovascular biomarkers|cardiovascular biomarkers
4891954|NCT02122497|open surgical repair|open surgical repair
4891955|NCT02122497|endovascular aortic repair|endovascular aortic repair
4891956|NCT02122484|reperfusion damage|reperfusion damage
4891957|NCT02122471|CIC|cic
4891958|NCT02122471|Constipation|constipation
4891959|NCT02122471|Chronic Constipation|chronic constipation
4891960|NCT02122471|Synergy|synergy
4891961|NCT02122471|Plecanatide|plecanatide
4891962|NCT02122458|hearing impairment|hearing impairment
4891963|NCT02122458|post-traumatic stress disorder|post-traumatic stress disorder
4891964|NCT02122458|traumatic brain injury|traumatic brain injury
4892167|NCT02121574|Hypothermia|hypothermia
4891965|NCT02122458|auditory processing disorder|auditory processing disorder
4891966|NCT02122445|Gluteus Maximum|gluteus maximum
4891967|NCT02122445|Gluteus Medius|gluteus medius
4891969|NCT02122445|EMG|emg
4891970|NCT02122445|Flexion-Response Phenomenon|flexion-response phenomenon
4891971|NCT02122445|Thera-Band|thera-band
4891972|NCT02122445|kinesiology tape|kinesiology tape
4891973|NCT02122432|teledermatology|teledermatology
4891974|NCT02122432|dermatology|dermatology
4891975|NCT02122432|general practice|general practice
4891976|NCT02122432|organization of care|organization of care
4891977|NCT02122406|Rheumatoid Arthritis|rheumatoid arthritis
4891978|NCT02122406|Depression|depression
4891979|NCT02122406|Anxiety|anxiety
4891980|NCT02122406|DAS28|das28
4891981|NCT02122406|HADS|hads
4891982|NCT02122380|Growth Hormone|growth hormone
4891983|NCT02122380|Dipeptidyl Peptidase 4|dipeptidyl peptidase 4
4891984|NCT02122380|Polycystic Ovary Syndrome|polycystic ovary syndrome
4891985|NCT02122328|Twin twin transfusion syndrome|twin twin transfusion syndrome
4891986|NCT02122328|Sequential laser photocoagulation of communicating vessels|sequential laser photocoagulation of communicating vessels
4891987|NCT02122302|Altered gastrointestinal anatomy|altered gastrointestinal anatomy
4891988|NCT02122302|Chronic pancreatic disease|chronic pancreatic disease
4891989|NCT02122302|Chronic pancreatic pain|chronic pancreatic pain
4891990|NCT02122302|Patient self-assessment|patient self-assessment
4891991|NCT02122302|Online assessment|online assessment
4891992|NCT02122289|Exacerbation, QoL|exacerbation, qol
4891993|NCT02122276|Spinal cord injury|spinal cord injury
4891994|NCT02122276|Passive motion|passive motion
4891995|NCT02122276|Fatigue index|fatigue index
4891996|NCT02122276|Hypertonia|hypertonia
4891997|NCT02122250|Diabetes|diabetes
4891998|NCT02122250|Health literacy|health literacy
4891999|NCT02122250|web intervention|web intervention
4892000|NCT02122224|satiety|satiety
4892001|NCT02122224|satiation|satiation
4892002|NCT02122224|diet quality|diet quality
4892003|NCT02122224|memory|memory
4892004|NCT02122224|obesity|obesity
4892005|NCT02122224|protein|protein
4892006|NCT02122224|fiber|fiber
4892007|NCT02122211|Sperm motility|sperm motility
4892008|NCT02122198|Cognitive impairment|cognitive impairment
4892009|NCT02122198|Executive function|executive function
4892010|NCT02122198|Arterial stiffness|arterial stiffness
4892011|NCT02122198|Endothelial function|endothelial function
4892012|NCT02122198|Menopause|menopause
4892013|NCT02122198|Women's health|women's health
4892014|NCT02122198|Hormone therapy|hormone therapy
4892015|NCT02122198|functional MRI|functional mri
4892016|NCT02122159|safety|safety
4892017|NCT02122159|tolerability|tolerability
4892018|NCT02122159|RPE cellular therapy|rpe cellular therapy
4892019|NCT02122159|MMD|mmd
4892020|NCT02122146|ADC|adc
4892021|NCT02122146|PF-06664178|pf-06664178
4892022|NCT02122146|solid tumors|solid tumors
4892023|NCT02122146|tumors|tumors
4892024|NCT02122146|neoplasm metastasis|neoplasm metastasis
4892025|NCT02122146|NSCLC|nsclc
4892026|NCT02122146|non small cell lung cancer|non small cell lung cancer
4892027|NCT02122146|OVCA|ovca
4892028|NCT02122146|ovarian cancer|ovarian cancer
4892029|NCT02122146|Phase 1|phase 1
4892030|NCT02122146|breast cancer|breast cancer
4892031|NCT02122133|IC aneurysms, coil embolization, PC 400, radiation exposure,|ic aneurysms, coil embolization, pc 400, radiation exposure,
4892032|NCT02122120|enteral nutrition, tube feeding, nutritional support|enteral nutrition, tube feeding, nutritional support
4892033|NCT02122107|Treatment Exposure|treatment exposure
4892034|NCT02122107|Smoking History|smoking history
4892035|NCT02122107|14-071|14-071
4892036|NCT02122068|Meditation|meditation
4892037|NCT02122068|Mindfulness|mindfulness
4892038|NCT02122068|Caregiver|caregiver
4892039|NCT02122068|Dementia|dementia
4892040|NCT02122068|Depression|depression
4892041|NCT02122055|combined sedation|combined sedation
4892042|NCT02122029|Lifestyle intervention|lifestyle intervention
4892043|NCT02122029|Bariatric surgery|bariatric surgery
4892044|NCT02122029|Weight management|weight management
4892045|NCT02122029|Physical activity|physical activity
4892046|NCT02122016|Ventilator weaning|ventilator weaning
4892047|NCT02122016|Protocols|protocols
4892048|NCT02122016|Computer driven weaning|computer driven weaning
4892049|NCT02122016|Decision Making, Computer-Assisted|decision making, computer-assisted
4892050|NCT02122016|Therapy, Computer-Assisted|therapy, computer-assisted
4892051|NCT02122016|Respiration, Artificial|respiration, artificial
4892052|NCT02122003|sorafenib|sorafenib
4892053|NCT02122003|pazopanib|pazopanib
4892054|NCT02122003|cross-resistance|cross-resistance
4892055|NCT02122003|TKI|tki
4892056|NCT02122003|mRCC|mrcc
4892057|NCT02121990|(IP) Cisplatin|(ip) cisplatin
4892058|NCT02121990|IV/IP Paclitaxel|iv/ip paclitaxel
4892059|NCT02121990|IV Bevacizumab|iv bevacizumab
4892060|NCT02121990|Oral Olaparib (AZD2281)|oral olaparib (azd2281)
4892061|NCT02121990|Optimally Debulked|optimally debulked
4892062|NCT02121990|Stage II/III|stage ii/iii
4892063|NCT02121990|Ovary|ovary
4892064|NCT02121990|Pertoneum|pertoneum
4892065|NCT02121990|10-220|10-220
4892066|NCT02121964|unilateral primary total hip arthroplasty|unilateral primary total hip arthroplasty
4892168|NCT02121574|anesthesia|anesthesia
4892067|NCT02121964|bilateral primary total hip arthroplasty|bilateral primary total hip arthroplasty
4892068|NCT02121964|Arthritis|arthritis
4892069|NCT02121964|Orthopedic Disorders|orthopedic disorders
4892070|NCT02121964|Orthopedics|orthopedics
4892071|NCT02121964|Surgery,|surgery,
4892072|NCT02121964|Orthopedic|orthopedic
4892073|NCT02121964|arthroplasty|arthroplasty
4892074|NCT02121964|hip|hip
4892075|NCT02121964|osteoarthritis|osteoarthritis
4892076|NCT02121964|capsulectomy|capsulectomy
4892077|NCT02121964|capsulotomy|capsulotomy
4892078|NCT02121951|Percutaneous Nephrostomy|percutaneous nephrostomy
4892079|NCT02121951|Quadtatus Lumborum Block|quadtatus lumborum block
4892080|NCT02121951|Cancer|cancer
4892081|NCT02121951|Monitored Anaesthesia Care|monitored anaesthesia care
4892082|NCT02121938|Very Low Birth Weight (VLBW)|very low birth weight (vlbw)
4892083|NCT02121938|Microbiome|microbiome
4892084|NCT02121925|Registry|registry
4892085|NCT02121899|Registry|registry
4892086|NCT02121873|breast cancer, nipple aspirate, ductal lavage, hyperplasia|breast cancer, nipple aspirate, ductal lavage, hyperplasia
4892087|NCT02121860|Hepatic Impairment|hepatic impairment
4892088|NCT02121860|Pharmacokinetics|pharmacokinetics
4892089|NCT02121860|Pharmacodynamics|pharmacodynamics
4892090|NCT02121808|Morbid Obesity|morbid obesity
4892091|NCT02121808|Bariatric Surgery Candidate|bariatric surgery candidate
4892092|NCT02121808|Pre-Oxygenation|pre-oxygenation
4892093|NCT02121808|Functional Residual Capacity|functional residual capacity
4892094|NCT02121795|HIV|hiv
4892095|NCT02121795|HIV-1 Positive|hiv-1 positive
4892096|NCT02121795|Virologically-suppressed|virologically-suppressed
4892097|NCT02121782|QIV|qiv
4892098|NCT02121782|Quadrivalent Influenza Vaccine|quadrivalent influenza vaccine
4892099|NCT02121782|Influenza vaccine|influenza vaccine
4892100|NCT02121782|Vaccination|vaccination
4892101|NCT02121769|cholestasis|cholestasis
4892102|NCT02121769|short bowel syndrome|short bowel syndrome
4892103|NCT02121756|Dipyridamole|dipyridamole
4892104|NCT02121756|HIV|hiv
4892105|NCT02121756|Immune Markers|immune markers
4892106|NCT02121756|Immune Activation|immune activation
4892107|NCT02121756|Inflammation|inflammation
4892108|NCT02121743|strattice|strattice
4892109|NCT02121743|colostomy|colostomy
4892110|NCT02121743|parastomal hernia|parastomal hernia
4892111|NCT02121730|grafting kidney|grafting kidney
4892112|NCT02121730|Cancer|cancer
4892113|NCT02121717|Chiglitazar,diabetes,type 2 diabetes|chiglitazar,diabetes,type 2 diabetes
4892114|NCT02121704|Sedation|sedation
4892115|NCT02121704|Colonoscopy|colonoscopy
4892116|NCT02121704|Propofol|propofol
4892117|NCT02121704|Scope guide|scope guide
4892118|NCT02121691|Cancer|cancer
4892119|NCT02121691|Obesity|obesity
4892120|NCT02121691|Body Mass Index|body mass index
4892121|NCT02121678|Resistance training|resistance training
4892122|NCT02121678|Aerobic exercise|aerobic exercise
4892123|NCT02121678|Isokinetic muscle strength|isokinetic muscle strength
4892124|NCT02121678|Bicycle ergometry test|bicycle ergometry test
4892125|NCT02121678|Subcutaneous immunoglobulin|subcutaneous immunoglobulin
4892126|NCT02121652|lung cancer survivors|lung cancer survivors
4892127|NCT02121652|insomnia treatment|insomnia treatment
4892128|NCT02121652|cognitive behavioral therapy|cognitive behavioral therapy
4892129|NCT02121639|Metastatic Castration Resistant Prostate Cancer|metastatic castration resistant prostate cancer
4892130|NCT02121639|AZD5363|azd5363
4892131|NCT02121639|Docetaxel|docetaxel
4892132|NCT02121639|Prednisolone|prednisolone
4892133|NCT02121626|Cancer|cancer
4892134|NCT02121626|Chemotheraphy|chemotheraphy
4892135|NCT02121626|Small Bowel Bacterial Overgrowth|small bowel bacterial overgrowth
4892136|NCT02121626|Bile Acid Malabsorption|bile acid malabsorption
4892137|NCT02121626|Pancreatic Insufficiency|pancreatic insufficiency
4892138|NCT02121626|Carbohydrate Malabsorption|carbohydrate malabsorption
4892139|NCT02121626|Anorexia|anorexia
4892140|NCT02121626|Borborygmi|borborygmi
4892141|NCT02121626|Bloating|bloating
4892142|NCT02121626|Constipation|constipation
4892143|NCT02121626|Diarrhoea|diarrhoea
4892144|NCT02121626|Mucositis|mucositis
4892145|NCT02121626|Dysphagia|dysphagia
4892146|NCT02121626|Early satiety|early satiety
4892147|NCT02121626|Frequency of defaecation|frequency of defaecation
4892148|NCT02121626|Incontinence|incontinence
4892149|NCT02121626|Mucus discharge|mucus discharge
4892150|NCT02121626|Nausea|nausea
4892151|NCT02121626|Nocturnal defaecation|nocturnal defaecation
4892152|NCT02121626|Pain|pain
4892153|NCT02121626|Reflux|reflux
4892154|NCT02121626|Regurgitation|regurgitation
4892155|NCT02121626|Steatorrhoea|steatorrhoea
4892156|NCT02121626|Tenesmus|tenesmus
4892157|NCT02121626|Urgency of defaecation|urgency of defaecation
4892158|NCT02121626|Vomiting|vomiting
4892159|NCT02121626|Weight loss|weight loss
4892160|NCT02121626|Wind.|wind.
4892161|NCT02121600|Fluorocholine (FCH)|fluorocholine (fch)
4892162|NCT02121600|Positron Emission Tomography (PET)|positron emission tomography (pet)
4892163|NCT02121600|Magnetic Resonance Imaging (MRI)|magnetic resonance imaging (mri)
4892164|NCT02121587|Musculoskeletal Pain, Osteopathy, Mindfulness|musculoskeletal pain, osteopathy, mindfulness
4892165|NCT02121574|Surgery|surgery
4892166|NCT02121574|thermometers|thermometers
4892169|NCT02121574|temperature|temperature
4892170|NCT02121561|Shame|shame
4892171|NCT02121548|Screen|screen
4892172|NCT02121548|cervical, cancer|cervical, cancer
4892173|NCT02121548|HPV|hpv
4892174|NCT02121548|women|women
4892175|NCT02121548|community health workers|community health workers
4892176|NCT02121548|Hispanic/ Latinas|hispanic/ latinas
4892177|NCT02121548|Haitian|haitian
4892178|NCT02121496|Depression|depression
4892179|NCT02121496|Development|development
4892180|NCT02121496|Infant sleep|infant sleep
4892181|NCT02121470|AKI|aki
4892182|NCT02121470|Acute Kidney Injury|acute kidney injury
4892183|NCT02121470|Renal failure|renal failure
4892184|NCT02121470|NGAL|ngal
4892185|NCT02121470|neutrophil gelatinase-associated lipocalin|neutrophil gelatinase-associated lipocalin
4892186|NCT02121470|lipocalin-2|lipocalin-2
4892187|NCT02121470|siderocalin|siderocalin
4892188|NCT02121470|Intensive care|intensive care
4892189|NCT02121470|ICU|icu
4892190|NCT02121470|Critical care|critical care
4892191|NCT02121457|cognitive performance|cognitive performance
4892192|NCT02121457|selenium|selenium
4892193|NCT02121457|brazil nuts|brazil nuts
4892194|NCT02121457|oxidative stress|oxidative stress
4892195|NCT02121444|RRMS|rrms
4892196|NCT02121444|CIS|cis
4892197|NCT02121366|Endoscopic Ultrasound-Guided Fine Needle Aspiration|endoscopic ultrasound-guided fine needle aspiration
4892198|NCT02121366|Insulinoma|insulinoma
4892199|NCT02121366|Ethanol|ethanol
4892200|NCT02121366|Ablation Techniques|ablation techniques
4892201|NCT02121353|Age related macular degeneration|age related macular degeneration
4892202|NCT02121353|AMD|amd
4892203|NCT02121353|Wet AMD|wet amd
4892204|NCT02121353|Eye conditions|eye conditions
4892205|NCT02121353|CFT|cft
4892206|NCT02121353|OCT|oct
4892207|NCT02121353|CNV|cnv
4892208|NCT02121353|FA|fa
4892209|NCT02121353|Ocular|ocular
4892210|NCT02121353|Eye|eye
4892211|NCT02121353|Disorder of the eye|disorder of the eye
4892212|NCT02121340|Depression|depression
4892213|NCT02121340|Health disparities|health disparities
4892214|NCT02121340|African American|african american
4892215|NCT02121340|Geriatric|geriatric
4892216|NCT02121327|stroke, disease management programs, self-management|stroke, disease management programs, self-management
4892217|NCT02121314|TB|tb
4892218|NCT02121314|bioavailability|bioavailability
4892219|NCT02121314|HRZE|hrze
4892220|NCT02121314|fasting|fasting
4892221|NCT02121314|fed|fed
4892222|NCT02121301|Dry Eye|dry eye
4892223|NCT02121301|Dry Eye Syndrome|dry eye syndrome
4892224|NCT02121301|SkQ1|skq1
4892225|NCT02121301|KCS|kcs
4892226|NCT02121301|Keratoconjunctivitis|keratoconjunctivitis
4892227|NCT02121288|Peripheral Artery Disease|peripheral artery disease
4892228|NCT02121288|Myocardial Blood Flow|myocardial blood flow
4892229|NCT02121288|Cardiac Blood Flow|cardiac blood flow
4892230|NCT02121236|CBCT|cbct
4892231|NCT02121236|Ultrasonic diagnosis|ultrasonic diagnosis
4892232|NCT02121236|Benign radiolucent lesions|benign radiolucent lesions
4892233|NCT02121236|Histopathology|histopathology
4892234|NCT02121223|acute ST segment elevated myocardial infarction|acute st segment elevated myocardial infarction
4892235|NCT02121223|primary percutaneous intervention|primary percutaneous intervention
4892236|NCT02121223|Stent Incomplete Apposition|stent incomplete apposition
4892237|NCT02121197|Macular Diabetic Edema|macular diabetic edema
4892238|NCT02121197|Ozurdex|ozurdex
4892239|NCT02121197|Retrospective|retrospective
4892240|NCT02121197|European|european
4892241|NCT02121197|Intra-vitreal injections|intra-vitreal injections
4892242|NCT02121184|Oxytocin|oxytocin
4892243|NCT02121184|Labor, Obstetric|labor, obstetric
4892244|NCT02121184|Non-reassuring fetal heart rate|non-reassuring fetal heart rate
4892245|NCT02121184|Epidural|epidural
4892246|NCT02121158|CSP 592|csp 592
4892247|NCT02121158|ICD|icd
4892248|NCT02121158|cardiovascular|cardiovascular
4892249|NCT02121158|heart|heart
4892250|NCT02121158|aging|aging
4892251|NCT02121158|chronic diseases|chronic diseases
4892252|NCT02121158|multi-site trial|multi-site trial
4892253|NCT02121158|investigational device|investigational device
4892254|NCT02121158|cardiomyopathy|cardiomyopathy
4892255|NCT02121158|coronary artery disease|coronary artery disease
4892256|NCT02121158|congestive heart failure|congestive heart failure
4892257|NCT02121158|myocardial infarction|myocardial infarction
4892258|NCT02121158|I-70|i-70
4892259|NCT02121158|I70|i70
4892260|NCT02121158|elderly|elderly
4892261|NCT02121158|defibrillator|defibrillator
4892262|NCT02121145|Vivotif|vivotif
4892263|NCT02121145|Typherix|typherix
4892264|NCT02121145|Salmonella Typhi|salmonella typhi
4892265|NCT02121145|non-typhoid Salmonella|non-typhoid salmonella
4892266|NCT02121145|Salmonella Paratyphi|salmonella paratyphi
4892267|NCT02121145|enzyme-linked immunospot assay|enzyme-linked immunospot assay
4892268|NCT02121145|Plasmablast|plasmablast
4892269|NCT02121132|Overweight|overweight
4892270|NCT02121132|Obesity|obesity
4892271|NCT02121119|Peripheral nerve block|peripheral nerve block
4892272|NCT02121119|Lidocaine|lidocaine
4892273|NCT02121119|Bupivacaine|bupivacaine
4892274|NCT02121093|vibration|vibration
4892275|NCT02121093|physiotherapy|physiotherapy
4892276|NCT02121093|cortex|cortex
4892277|NCT02121093|muscles|muscles
4892278|NCT02121067|postpartum|postpartum
4892279|NCT02121067|contraception|contraception
4892280|NCT02121067|intrauterine device|intrauterine device
4892281|NCT02121067|intrauterine system|intrauterine system
4892282|NCT02121067|mirena|mirena
4892283|NCT02121067|uterine involution|uterine involution
4892284|NCT02121054|Antiplatelet Agents|antiplatelet agents
4892285|NCT02121054|Drug Resistance|drug resistance
4892286|NCT02121041|Hypertension|hypertension
4892287|NCT02121041|Blood Pressure|blood pressure
4892288|NCT02121041|Ambulatory Blood Pressure Monitoring|ambulatory blood pressure monitoring
4892289|NCT02121028|Intracranial Atherosclerotic Disease|intracranial atherosclerotic disease
4892290|NCT02121028|Stroke|stroke
4892291|NCT02121028|Transient Ischemic Attack|transient ischemic attack
4892292|NCT02121028|Imaging|imaging
4892293|NCT02121015|Postpartum Depression|postpartum depression
4892294|NCT02121015|Depression Prevention|depression prevention
4892295|NCT02121015|Supportive Accountability|supportive accountability
4892296|NCT02121015|Individual Internet Interventions (IIIs)|individual internet interventions (iiis)
4892297|NCT02121015|Internet Support Groups (ISGs)|internet support groups (isgs)
4892298|NCT02121002|Knee|knee
4892299|NCT02120989|insomnia|insomnia
4892300|NCT02120989|cognitive behavioral therapy for insomnia (CBT-I)|cognitive behavioral therapy for insomnia (cbt-i)
4892301|NCT02120989|partner-assisted|partner-assisted
4892302|NCT02120976|Safety|safety
4892303|NCT02120976|Tolerability|tolerability
4892304|NCT02120976|Pharmacokinetics|pharmacokinetics
4892305|NCT02120976|Food-effect|food-effect
4892306|NCT02120976|Diabetes|diabetes
4892307|NCT02120963|Fatigue|fatigue
4892308|NCT02120963|Rheumatoid Arthritis|rheumatoid arthritis
4892309|NCT02120963|Physical Therapy|physical therapy
4892310|NCT02120963|Person-Centred Care|person-centred care
4892311|NCT02120950|PCV|pcv
4892312|NCT02120937|amygdala|amygdala
4892313|NCT02120937|mindfulness|mindfulness
4892314|NCT02120937|mood|mood
4892315|NCT02120937|emotion|emotion
4892316|NCT02120937|bipolar disorder|bipolar disorder
4892317|NCT02120937|parental bipolar disorder|parental bipolar disorder
4892318|NCT02120937|adolescence|adolescence
4892319|NCT02120924|Moderate facial rosacea|moderate facial rosacea
4892320|NCT02120924|Azelaic acid|azelaic acid
4892321|NCT02120924|Rosacea|rosacea
4892322|NCT02120911|Her2+|her2+
4892323|NCT02120911|Resectable esophageal carcinoma|resectable esophageal carcinoma
4892324|NCT02120911|Pertuzumab|pertuzumab
4892325|NCT02120911|Trastuzumab|trastuzumab
4892326|NCT02120898|Actinic Keratosis|actinic keratosis
4892327|NCT02120898|Imiquimod|imiquimod
4892328|NCT02120898|Zyclara|zyclara
4892329|NCT02120885|Gastric cancer|gastric cancer
4892330|NCT02120885|minimally invasive gastrectomy|minimally invasive gastrectomy
4892331|NCT02120885|Physical activity intervention|physical activity intervention
4892332|NCT02120859|PCI|pci
4892333|NCT02120859|Drug-eluting balloon (DEB)|drug-eluting balloon (deb)
4892334|NCT02120859|Fractional flow reserve (FFR)|fractional flow reserve (ffr)
4892335|NCT02120846|Stroke|stroke
4892336|NCT02120846|Flywheel resistance exercise|flywheel resistance exercise
4892337|NCT02120846|Muscle function|muscle function
4892338|NCT02120846|Cognitive function|cognitive function
4892339|NCT02120833|Atopic Dermatitis|atopic dermatitis
4892340|NCT02120820|massage|massage
4892341|NCT02120820|multisensory environment|multisensory environment
4892342|NCT02120820|challenging behaviours|challenging behaviours
4892343|NCT02120820|relaxation|relaxation
4892344|NCT02120807|Certolizumab|certolizumab
4892345|NCT02120807|Cisplatin|cisplatin
4892346|NCT02120807|Pemetrexed|pemetrexed
4892347|NCT02120807|thoracic|thoracic
4892348|NCT02120807|13-063|13-063
4892349|NCT02120794|Type 1 diabetes|type 1 diabetes
4892350|NCT02120794|Pediatric|pediatric
4892351|NCT02120794|Threshold Suspend|threshold suspend
4892352|NCT02120794|Sensor augmented pump|sensor augmented pump
4892353|NCT02120768|Barrier resection|barrier resection
4892354|NCT02120768|Local recurrence|local recurrence
4892355|NCT02120768|Complication|complication
4892356|NCT02120742|Road traffic injury prevention|road traffic injury prevention
4892357|NCT02120742|Helmet use|helmet use
4892358|NCT02120742|mHealth intervention|mhealth intervention
4892359|NCT02120729|Pharmacogenetics|pharmacogenetics
4892360|NCT02120729|CYP2D6 Mutations|cyp2d6 mutations
4892361|NCT02120729|Major Depressive Disorder|major depressive disorder
4892362|NCT02120729|Psychiatric Inpatients|psychiatric inpatients
4892363|NCT02120729|Length of Stay|length of stay
4892364|NCT02120729|30 Day Readmission Rate|30 day readmission rate
4892365|NCT02120729|Psychiatric hospital inpatients|psychiatric hospital inpatients
4892366|NCT02120716|HIV|hiv
4892367|NCT02120716|STIs|stis
4892368|NCT02120716|Health Check Up|health check up
4892369|NCT02120716|Intervention|intervention
4892370|NCT02120703|Pregabalin|pregabalin
4892371|NCT02120703|gabapentin|gabapentin
4892372|NCT02120703|microdiscectomy|microdiscectomy
4892373|NCT02120703|pain|pain
4892374|NCT02120690|pain|pain
4892375|NCT02120690|fibromyagia|fibromyagia
4892376|NCT02120690|TNS|tns
4892377|NCT02120677|skin cancer|skin cancer
4892572|NCT02119936|Anxiety|anxiety
4892378|NCT02120677|basal cell carcinoma|basal cell carcinoma
4892379|NCT02120651|Fibrin monomer|fibrin monomer
4892380|NCT02120651|Tympanoplasty|tympanoplasty
4892381|NCT02120651|Hemostatic sponge|hemostatic sponge
4892382|NCT02120638|Multidrug Resistant Tuberculosis|multidrug resistant tuberculosis
4892383|NCT02120638|Pyrazinamide|pyrazinamide
4892384|NCT02120625|radiofrequency ablation|radiofrequency ablation
4892385|NCT02120625|neurotomy|neurotomy
4892386|NCT02120625|facet joint|facet joint
4892387|NCT02120625|medial branch|medial branch
4892388|NCT02120625|low back pain|low back pain
4892389|NCT02120612|Opioid Dependence|opioid dependence
4892390|NCT02120612|Addiction|addiction
4892391|NCT02120612|Naloxone|naloxone
4892392|NCT02120612|Naloxone Education|naloxone education
4892393|NCT02120612|Opiate Overdose Knowledge Scale|opiate overdose knowledge scale
4892394|NCT02120612|OOKS|ooks
4892395|NCT02120586|Elderly|elderly
4892396|NCT02120586|Institutionalization|institutionalization
4892397|NCT02120586|Sarcopenia|sarcopenia
4892398|NCT02120586|Strength training|strength training
4892399|NCT02120586|Muscle mass|muscle mass
4892400|NCT02120586|Muscle strength|muscle strength
4892401|NCT02120586|Physical performance|physical performance
4892402|NCT02120573|Cardiac Arrest|cardiac arrest
4892403|NCT02120573|Cardiopulmonary Resuscitation|cardiopulmonary resuscitation
4892404|NCT02120573|Training|training
4892405|NCT02120560|Atrial Fibrillation Ablation|atrial fibrillation ablation
4892406|NCT02120560|Cerebrothromboemboli|cerebrothromboemboli
4892407|NCT02120560|Neurocognitive Function|neurocognitive function
4892408|NCT02120547|Liver Insufficiency|liver insufficiency
4892409|NCT02120547|Hepatic impairment|hepatic impairment
4892410|NCT02120534|soluble CD14 ,serum CD88,sepsis , SIRS.|soluble cd14 ,serum cd88,sepsis , sirs.
4892411|NCT02120521|Sepsis and SIRS, ICU|sepsis and sirs, icu
4892412|NCT02120508|stroke|stroke
4892413|NCT02120508|aphasia|aphasia
4892414|NCT02120508|rTMS|rtms
4892415|NCT02120508|Functional MRI|functional mri
4892416|NCT02120508|Speech training|speech training
4892417|NCT02120495|condylectomy|condylectomy
4892418|NCT02120495|TMJ function|tmj function
4892419|NCT02120495|intraoral approach|intraoral approach
4892420|NCT02120482|ABO isoagglutinins|abo isoagglutinins
4892421|NCT02120482|ABO incompatible transplantation|abo incompatible transplantation
4892422|NCT02120482|immunoadsorption|immunoadsorption
4892423|NCT02120482|membrane filtration|membrane filtration
4892424|NCT02120482|plasmapheresis|plasmapheresis
4892425|NCT02120443|infiltration|infiltration
4892426|NCT02120443|extravasation|extravasation
4892427|NCT02120443|peripheral intravenous therapy|peripheral intravenous therapy
4892428|NCT02120430|Early childhood|early childhood
4892429|NCT02120430|Audiovisual materials|audiovisual materials
4892430|NCT02120430|Parent-child interaction|parent-child interaction
4892431|NCT02120430|Parenting programs|parenting programs
4892432|NCT02120430|Timing|timing
4892433|NCT02120417|Breast Cancer|breast cancer
4892434|NCT02120404|septic shock, hemodynamic tolerance, esmolol|septic shock, hemodynamic tolerance, esmolol
4892435|NCT02120378|miscarriage|miscarriage
4892436|NCT02120378|fetal viability|fetal viability
4892437|NCT02120378|prematurity|prematurity
4892438|NCT02120365|Alcoholism|alcoholism
4892439|NCT02120365|Heavy Drinking|heavy drinking
4892440|NCT02120365|Perampanel|perampanel
4892441|NCT02120352|bi-monthly|bi-monthly
4892442|NCT02120352|GSK744|gsk744
4892443|NCT02120352|injectable|injectable
4892444|NCT02120352|long acting|long acting
4892445|NCT02120352|maintenance|maintenance
4892446|NCT02120352|abacavir|abacavir
4892447|NCT02120352|every other month|every other month
4892448|NCT02120352|rilpivirine|rilpivirine
4892449|NCT02120352|HIV-1 infection|hiv-1 infection
4892450|NCT02120352|integrase inhibitor|integrase inhibitor
4892451|NCT02120352|TMC278 LA|tmc278 la
4892452|NCT02120352|RPV|rpv
4892453|NCT02120352|non-nucleoside reverse transcriptase inhibitor|non-nucleoside reverse transcriptase inhibitor
4892454|NCT02120352|LA|la
4892455|NCT02120352|once monthly|once monthly
4892456|NCT02120352|GSK1265744|gsk1265744
4892457|NCT02120352|induction|induction
4892458|NCT02120352|treatment satisfication|treatment satisfication
4892459|NCT02120352|once daily|once daily
4892460|NCT02120352|lamivudine|lamivudine
4892461|NCT02120352|adherence|adherence
4892462|NCT02120352|TMC278|tmc278
4892463|NCT02120352|therapy-naive|therapy-naive
4892464|NCT02120339|Hypertension|hypertension
4892465|NCT02120339|PAH|pah
4892466|NCT02120326|Chronic migraine, tDCS, Transcranial direct current stimulation|chronic migraine, tdcs, transcranial direct current stimulation
4892467|NCT02120313|rehabilitation|rehabilitation
4892468|NCT02120313|total knee arthroplasty|total knee arthroplasty
4892469|NCT02120287|Border Zone Stereotactic Radiosurgery|border zone stereotactic radiosurgery
4892470|NCT02120287|Bevacizumab|bevacizumab
4892471|NCT02120287|Recurrent Glioblastoma Multiforme|recurrent glioblastoma multiforme
4892472|NCT02120287|Progressive Glioblastoma Multiforme|progressive glioblastoma multiforme
4892473|NCT02120287|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
4892474|NCT02120287|Glioblastoma|glioblastoma
4892475|NCT02120287|Brain Cancer|brain cancer
4892476|NCT02120287|Brain Tumor|brain tumor
4892477|NCT02120287|Radiosurgery|radiosurgery
4892478|NCT02120274|RNA Virus Infections|rna virus infections
4892479|NCT02120274|Flaviviridae Infections|flaviviridae infections
4892480|NCT02120274|Hepatitis C|hepatitis c
4892481|NCT02120274|Hepatitis C, Chronic|hepatitis c, chronic
4892482|NCT02120274|Vitamin D|vitamin d
4892483|NCT02120274|Cholecalciferol|cholecalciferol
4892484|NCT02120274|Vitamin B 12|vitamin b 12
4892485|NCT02120261|Myofascial Pain Syndrome|myofascial pain syndrome
4892486|NCT02120261|trigger point injection|trigger point injection
4892487|NCT02120248|WIC|wic
4892488|NCT02120248|Oregon|oregon
4892489|NCT02120248|Breastfeeding|breastfeeding
4892490|NCT02120248|Peer Counseling|peer counseling
4892491|NCT02120248|Exclusive Breastfeeding|exclusive breastfeeding
4892492|NCT02120235|Lysosomal storage disorders|lysosomal storage disorders
4892493|NCT02120235|LSD|lsd
4892494|NCT02120235|Gaucher disease|gaucher disease
4892495|NCT02120235|Fabry disease|fabry disease
4892496|NCT02120235|Pompe disease|pompe disease
4892497|NCT02120235|Niemann-Pick disease|niemann-pick disease
4892498|NCT02120222|melanoma|melanoma
4892499|NCT02120209|assessment; falls; older adults; prediction scale; standardized declaration|assessment; falls; older adults; prediction scale; standardized declaration
4892500|NCT02120183|Caregivers|caregivers
4892501|NCT02120183|Quality of life|quality of life
4892502|NCT02120183|Neoplasms|neoplasms
4892503|NCT02120183|Psychotherapy, group|psychotherapy, group
4892504|NCT02120183|Family|family
4892505|NCT02120183|Adaptation, psychological|adaptation, psychological
4892506|NCT02120183|Psycho-educational support group therapy|psycho-educational support group therapy
4892507|NCT02120183|Cancer patients|cancer patients
4892508|NCT02120170|Hemoclip, Heparin bridging therapy, colon polypectomy, warfarin|hemoclip, heparin bridging therapy, colon polypectomy, warfarin
4892509|NCT02120157|Acute lymphoblastic leukemia|acute lymphoblastic leukemia
4892510|NCT02120157|Acute myeloid leukemia|acute myeloid leukemia
4892511|NCT02120157|Juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
4892512|NCT02120157|Treatment related leukemia|treatment related leukemia
4892513|NCT02120157|Biphenotypic leukemia|biphenotypic leukemia
4892514|NCT02120131|third molar surgery, periodontal probing depth , flap design|third molar surgery, periodontal probing depth , flap design
4892515|NCT02120118|Treatment failure|treatment failure
4892516|NCT02120105|Renal aminoaciduria|renal aminoaciduria
4892517|NCT02120105|cystinuria|cystinuria
4892518|NCT02120105|D-penicillamine|d-penicillamine
4892519|NCT02120105|renal tubular transport|renal tubular transport
4892520|NCT02120105|inborn errors|inborn errors
4892521|NCT02120105|tiopronin|tiopronin
4892522|NCT02120105|urolithiasis|urolithiasis
4892523|NCT02120092|ACS, Acute coronary syndrome|acs, acute coronary syndrome
4892524|NCT02120079|Dry Eye|dry eye
4892525|NCT02120066|Submacular hemorrhage|submacular hemorrhage
4892526|NCT02120066|Vitrectomy|vitrectomy
4892527|NCT02120066|tissue- plasminogen activator|tissue- plasminogen activator
4892528|NCT02120053|Immediate complete denture|immediate complete denture
4892529|NCT02120053|Alveolar ridge resorption|alveolar ridge resorption
4892530|NCT02120053|Alveolar bone loss|alveolar bone loss
4892531|NCT02120053|Bone substitute material|bone substitute material
4892532|NCT02120053|Edentulism|edentulism
4892533|NCT02120027|Irritable Bowel Syndrome|irritable bowel syndrome
4892534|NCT02120027|Colon, irritable|colon, irritable
4892535|NCT02120027|Bowel disease|bowel disease
4892536|NCT02120027|Diarrhea|diarrhea
4892537|NCT02120014|Heart Failure|heart failure
4892538|NCT02120014|Heart Failure Reduced Ejection Fraction|heart failure reduced ejection fraction
4892539|NCT02120014|Heart Failure Preserved Ejection Fraction|heart failure preserved ejection fraction
4892540|NCT02120014|Venous Plethysmography|venous plethysmography
4892541|NCT02120014|Blood Volume Study|blood volume study
4892542|NCT02120001|Medical Devices|medical devices
4892543|NCT02120001|Ventilator-Associated Pneumonia (VAP)|ventilator-associated pneumonia (vap)
4892544|NCT02120001|Ventilator-Associated Events (VAE)|ventilator-associated events (vae)
4892545|NCT02120001|Endotracheal Tube|endotracheal tube
4892546|NCT02120001|Microbial Diversity|microbial diversity
4892547|NCT02120001|Drug-Resistance|drug-resistance
4892548|NCT02120001|biofilms|biofilms
4892549|NCT02120001|endotracheal intubation|endotracheal intubation
4892550|NCT02120001|mechanical ventilation|mechanical ventilation
4892551|NCT02119988|TIPS|tips
4892552|NCT02119988|Embolization|embolization
4892553|NCT02119988|Variceal rebleeding|variceal rebleeding
4892554|NCT02119975|Rumination|rumination
4892555|NCT02119975|Working memory|working memory
4892556|NCT02119975|Depression|depression
4892557|NCT02119975|Anxiety|anxiety
4892558|NCT02119975|Working memory training|working memory training
4892559|NCT02119975|Overgeneral memories|overgeneral memories
4892560|NCT02119962|burnout|burnout
4892561|NCT02119962|working memory|working memory
4892562|NCT02119962|working memory training|working memory training
4892563|NCT02119962|cognitive behavioral therapy|cognitive behavioral therapy
4892564|NCT02119962|executive control|executive control
4892565|NCT02119949|Substance abuse|substance abuse
4892566|NCT02119949|Addiction|addiction
4892567|NCT02119949|Working memory|working memory
4892568|NCT02119949|Craving|craving
4892569|NCT02119949|Impulsivity|impulsivity
4892570|NCT02119949|Attention control|attention control
4892571|NCT02119936|Stress|stress
4892573|NCT02119936|Mental Health|mental health
4892574|NCT02119936|Mental Health Services|mental health services
4892575|NCT02119936|Maternal Mental Health|maternal mental health
4892576|NCT02119923|Depression|depression
4892577|NCT02119923|Anxiety|anxiety
4892578|NCT02119923|Working memory|working memory
4892579|NCT02119923|Rumination|rumination
4892580|NCT02119923|Cognitive training|cognitive training
4892581|NCT02119923|Executive functioning|executive functioning
4892582|NCT02119910|pediatric feeding disorders|pediatric feeding disorders
4892583|NCT02119910|behavioral intervention|behavioral intervention
4892584|NCT02119910|treatment manual|treatment manual
4892585|NCT02119910|feeding|feeding
4892586|NCT02119910|food refusal|food refusal
4892587|NCT02119910|diet|diet
4892588|NCT02119897|Oropharyngeal Mucositis|oropharyngeal mucositis
4892589|NCT02119897|Myeloablative Hematopoietic Cell Transplantation|myeloablative hematopoietic cell transplantation
4892590|NCT02119897|Low Level Light Therapy|low level light therapy
4892591|NCT02119884|Gastric and Esophageal Varices|gastric and esophageal varices
4892592|NCT02119884|Hepatic Venous Pressure Gradient|hepatic venous pressure gradient
4892593|NCT02119884|Terlipressin|terlipressin
4892594|NCT02119884|Octreotide|octreotide
4892595|NCT02119871|Cerebral air emboli, heart surgery|cerebral air emboli, heart surgery
4892596|NCT02119845|Chronic kidney disease|chronic kidney disease
4892597|NCT02119845|Arteriovenous fistula (AVF)|arteriovenous fistula (avf)
4892598|NCT02119845|Hemodialysis|hemodialysis
4892599|NCT02119845|Vascular access|vascular access
4892600|NCT02119845|Endovascular AVF (EndoAVF)|endovascular avf (endoavf)
4892601|NCT02119832|Chronic kidney disease|chronic kidney disease
4892602|NCT02119832|Arteriovenous fistula|arteriovenous fistula
4892603|NCT02119832|Hemodialysis|hemodialysis
4892604|NCT02119832|Vascular access|vascular access
4892605|NCT02119819|Weight loss|weight loss
4892606|NCT02119806|cardiac surgery, benzodiazepines, delirium|cardiac surgery, benzodiazepines, delirium
4892607|NCT02119767|Atherosclerosis|atherosclerosis
4892609|NCT02119754|Ulcer|ulcer
4892610|NCT02119754|Infected|infected
4892611|NCT02119754|Infection|infection
4892612|NCT02119741|Interdental papilla|interdental papilla
4892613|NCT02119741|hyaluronic acid|hyaluronic acid
4892614|NCT02119741|esthetic zone|esthetic zone
4892615|NCT02119741|black triangles|black triangles
4892616|NCT02119715|Breast Cancer|breast cancer
4892617|NCT02119715|Neutropenia|neutropenia
4892618|NCT02119715|Febrile Neutropenia|febrile neutropenia
4892619|NCT02119702|HIV/AIDS, perinatal HIV infection|hiv/aids, perinatal hiv infection
4892620|NCT02119689|Diabetes|diabetes
4892621|NCT02119689|Retinopathy|retinopathy
4892622|NCT02119676|Metastatic Colorectal Cancer|metastatic colorectal cancer
4892623|NCT02119676|Colon Cancer|colon cancer
4892624|NCT02119676|Ruxolitinib|ruxolitinib
4892625|NCT02119676|adenocarcinoma|adenocarcinoma
4892626|NCT02119676|regorafenib|regorafenib
4892627|NCT02119676|Jakavi ®|jakavi ®
4892628|NCT02119676|Jakafi ®|jakafi ®
4892629|NCT02119676|Stivarga ®|stivarga ®
4892630|NCT02119663|Metastatic pancreatic cancer|metastatic pancreatic cancer
4892631|NCT02119650|Non small cell lung cancer|non small cell lung cancer
4892632|NCT02119637|Emotion|emotion
4892633|NCT02119637|Tactile Discrimination|tactile discrimination
4892634|NCT02119637|Transcranial Magnetic Stimulation (TMS)|transcranial magnetic stimulation (tms)
4892635|NCT02119637|Somatosensory|somatosensory
4892636|NCT02119637|Somatosensory Cortex|somatosensory cortex
4892637|NCT02119624|Neural Networks|neural networks
4892638|NCT02119624|Alcoholism|alcoholism
4892639|NCT02119624|fMRI|fmri
4892640|NCT02119624|Reward|reward
4892641|NCT02119624|Addiction|addiction
4892642|NCT02119611|Deep Brain Stimulation|deep brain stimulation
4892643|NCT02119611|Movement Disorders|movement disorders
4892644|NCT02119611|Parkinson's Disease|parkinson's disease
4892645|NCT02119611|Dystonia|dystonia
4892646|NCT02119611|Essential Tremor|essential tremor
4892647|NCT02119598|Prehospital care|prehospital care
4892648|NCT02119598|Telemedicine|telemedicine
4892649|NCT02119598|Ambulance-based telemedicine|ambulance-based telemedicine
4892650|NCT02119585|orthotopic liver transplantation|orthotopic liver transplantation
4892651|NCT02119585|ischemia reperfusion syndrome|ischemia reperfusion syndrome
4892652|NCT02119585|cytokines|cytokines
4892653|NCT02119585|respiratory system elastance|respiratory system elastance
4892654|NCT02119585|lung elastance|lung elastance
4892655|NCT02119585|chest wall elastance|chest wall elastance
4892656|NCT02119585|shunt|shunt
4892657|NCT02119585|dead space|dead space
4892658|NCT02119585|acute respiratory failure|acute respiratory failure
4892659|NCT02119585|atelectasis|atelectasis
4892660|NCT02119585|pleural effusion|pleural effusion
4892661|NCT02119572|diabetes,peer support|diabetes,peer support
4892662|NCT02119559|Circulating Tumor Cells|circulating tumor cells
4892663|NCT02119559|Treatment Efficiency|treatment efficiency
4892664|NCT02119559|Biomarker|biomarker
4892665|NCT02119546|Mild CognitIve impairment|mild cognitive impairment
4892666|NCT02119546|Alzheimer's disease|alzheimer's disease
4892667|NCT02119546|Cognitive function|cognitive function
4892668|NCT02119546|Exercise training|exercise training
4892669|NCT02119533|brain injury|brain injury
4892670|NCT02119533|concussion|concussion
4892872|NCT02118701|Dementia|dementia
4892671|NCT02119533|post traumatic stress|post traumatic stress
4892672|NCT02119520|Periodontitis|periodontitis
4892673|NCT02119520|Surgery|surgery
4892674|NCT02119520|Growth Factors|growth factors
4892675|NCT02119520|Statins|statins
4892676|NCT02119507|Dental caries|dental caries
4892677|NCT02119507|Curodont Repair|curodont repair
4892678|NCT02119507|P11-4|p11-4
4892679|NCT02119494|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
4892680|NCT02119494|phenotypes|phenotypes
4892681|NCT02119494|categories|categories
4892682|NCT02119494|stage|stage
4892683|NCT02119494|GOLD|gold
4892684|NCT02119494|treatment|treatment
4892685|NCT02119481|Mindfulness stress reduction training|mindfulness stress reduction training
4892686|NCT02119481|Expressive writing condition|expressive writing condition
4892687|NCT02119481|Waiting list control condition|waiting list control condition
4892688|NCT02119442|Eisenmenger Syndrome, Pulmonary Arterial Hyptertension|eisenmenger syndrome, pulmonary arterial hyptertension
4892689|NCT02119429|Blood pressure|blood pressure
4892690|NCT02119429|Pre-menopausal|pre-menopausal
4892691|NCT02119429|Supplementation|supplementation
4892692|NCT02119416|Cardiovascular influences|cardiovascular influences
4892693|NCT02119416|caffeine|caffeine
4892694|NCT02119416|healthy children|healthy children
4892695|NCT02119403|Minimal Sedation nitrous oxide|minimal sedation nitrous oxide
4892696|NCT02119390|adolescents|adolescents
4892697|NCT02119390|young adults|young adults
4892698|NCT02119390|medication adherence|medication adherence
4892699|NCT02119377|trans|trans
4892700|NCT02119377|transsexual|transsexual
4892701|NCT02119377|transgender|transgender
4892702|NCT02119377|sistergirl|sistergirl
4892703|NCT02119377|brotherboy|brotherboy
4892704|NCT02119377|androgynous|androgynous
4892705|NCT02119377|genderqueer|genderqueer
4892706|NCT02119364|cerebral palsy|cerebral palsy
4892707|NCT02119364|working memory|working memory
4892708|NCT02119364|cognitive training|cognitive training
4892709|NCT02119351|peripheral intravenous catheters|peripheral intravenous catheters
4892710|NCT02119351|blood exposure|blood exposure
4892711|NCT02119351|blood control|blood control
4892712|NCT02119351|IV catheter insertion|iv catheter insertion
4892713|NCT02119338|5-ala|5-ala
4892714|NCT02119338|5-aminolevulinic acid|5-aminolevulinic acid
4892715|NCT02119338|fluorescence-guided surgery|fluorescence-guided surgery
4892716|NCT02119338|glioma|glioma
4892717|NCT02119338|astrocytoma|astrocytoma
4892718|NCT02119338|glioblastoma|glioblastoma
4892719|NCT02119338|oligodendroglioma|oligodendroglioma
4892720|NCT02119338|recurrence of glioma|recurrence of glioma
4892721|NCT02119325|fibre|fibre
4892722|NCT02119325|overweight|overweight
4892723|NCT02119325|impaired fasting glucose|impaired fasting glucose
4892724|NCT02119312|Malaria|malaria
4892725|NCT02119312|Plasmodium|plasmodium
4892726|NCT02119312|Plasmodium falciparum|plasmodium falciparum
4892727|NCT02119312|Clinical Trials|clinical trials
4892728|NCT02119312|Vaccine Study|vaccine study
4892729|NCT02119312|Drug Study|drug study
4892730|NCT02119312|Malaria Clinical Trials Center|malaria clinical trials center
4892731|NCT02119312|Seattle BioMed|seattle biomed
4892732|NCT02119312|Center for Infectious Disease Research|center for infectious disease research
4892733|NCT02119286|long acting beta2- receptor agonist|long acting beta2- receptor agonist
4892734|NCT02119286|long acting muscarininc receptor antagonist|long acting muscarininc receptor antagonist
4892735|NCT02119286|dry powder inhaler|dry powder inhaler
4892736|NCT02119286|safety|safety
4892737|NCT02119286|COPD|copd
4892738|NCT02119286|inhaled corticosteroid|inhaled corticosteroid
4892739|NCT02119286|efficacy|efficacy
4892740|NCT02119286|fluticasone furoate/vilanterol|fluticasone furoate/vilanterol
4892741|NCT02119286|umeclidinium bromide|umeclidinium bromide
4892742|NCT02119273|CRSsNP|crssnp
4892743|NCT02119273|Steroids|steroids
4892744|NCT02119273|Corticosteroids|corticosteroids
4892745|NCT02119273|Endoscopic|endoscopic
4892746|NCT02119273|Surgery|surgery
4892747|NCT02119273|Perioperative|perioperative
4892748|NCT02119260|First Time in Human|first time in human
4892749|NCT02119260|TRPV4 inhibitor|trpv4 inhibitor
4892750|NCT02119260|Heart failure|heart failure
4892751|NCT02119247|systemic availability , pharmacokinetics, COPD|systemic availability , pharmacokinetics, copd
4892752|NCT02119195|composite|composite
4892753|NCT02119195|sealant|sealant
4892754|NCT02119195|longevity|longevity
4892755|NCT02119182|Traumatic Brain Injury|traumatic brain injury
4892756|NCT02119182|Biomarkers|biomarkers
4892757|NCT02119182|Neuroimaging|neuroimaging
4892758|NCT02119182|Psychological Health|psychological health
4892759|NCT02119182|Comparative Effectiveness Research|comparative effectiveness research
4892760|NCT02119156|treatment holiday|treatment holiday
4892761|NCT02119156|PGA|pga
4892762|NCT02119156|belimumab|belimumab
4892763|NCT02119156|Lymphostat-B|lymphostat-b
4892764|NCT02119156|rebound|rebound
4892765|NCT02119156|SELENA SLEDAI|selena sledai
4892766|NCT02119156|Systemic Lupus Erythematosus|systemic lupus erythematosus
4892767|NCT02119156|immunogenicity|immunogenicity
4892768|NCT02119143|common cold, immunity, oxidative stress|common cold, immunity, oxidative stress
4892769|NCT02119130|cluster randomized trial|cluster randomized trial
4892770|NCT02119130|interferon-gamma|interferon-gamma
4892771|NCT02119130|tuberculin test|tuberculin test
4892772|NCT02119130|operational comparison|operational comparison
4892773|NCT02119130|cost effectiveness|cost effectiveness
4892774|NCT02119130|qualitative evaluation|qualitative evaluation
4892775|NCT02119117|mtDNA|mtdna
4892776|NCT02119117|aneuploidy|aneuploidy
4892777|NCT02119117|IVF|ivf
4892778|NCT02119117|blastocyst|blastocyst
4892779|NCT02119117|COQ10|coq10
4892780|NCT02119091|QT prolongation|qt prolongation
4892781|NCT02119091|Chinese|chinese
4892782|NCT02119091|Caucasian|caucasian
4892783|NCT02119091|Moxifloxacin|moxifloxacin
4892784|NCT02119078|Geriatrics|geriatrics
4892785|NCT02119078|Acute Care for Elders|acute care for elders
4892786|NCT02119078|Geriatric syndromes|geriatric syndromes
4892787|NCT02119078|Delirium|delirium
4892788|NCT02119078|Falls|falls
4892789|NCT02119078|Polypharmacy|polypharmacy
4892790|NCT02119065|Yttrium-90 Radioembolization|yttrium-90 radioembolization
4892791|NCT02119065|hepatic malignancy|hepatic malignancy
4892792|NCT02119065|hepatic metastatic disease|hepatic metastatic disease
4892793|NCT02119039|Cross-linking|cross-linking
4892794|NCT02119039|RGTA OTR4120 (CACICOL20)|rgta otr4120 (cacicol20)
4892795|NCT02119026|metastatic colorectal cancer|metastatic colorectal cancer
4892796|NCT02119026|Patients with metastatic colorectal cancer who did not receive|patients with metastatic colorectal cancer who did not receive
4892797|NCT02119026|systemic treatment for their metastatic disease|systemic treatment for their metastatic disease
4892798|NCT02118987|Drug Desensitization|drug desensitization
4892799|NCT02118987|Hypersensitivity reactions to chemotherapeutic agents|hypersensitivity reactions to chemotherapeutic agents
4892800|NCT02118974|Hysterectomy|hysterectomy
4892801|NCT02118974|Robot-assisted|robot-assisted
4892802|NCT02118974|Laparoscopy|laparoscopy
4892803|NCT02118961|Diphtheria|diphtheria
4892804|NCT02118961|Tetanus|tetanus
4892805|NCT02118961|Pertussis|pertussis
4892806|NCT02118961|DTaP vaccine|dtap vaccine
4892807|NCT02118961|Adolescents|adolescents
4892808|NCT02118948|abuse|abuse
4892809|NCT02118948|sexual behavior|sexual behavior
4892810|NCT02118948|sexual risk reduction|sexual risk reduction
4892811|NCT02118948|behavioral intervention|behavioral intervention
4892812|NCT02118896|Tacrolimus|tacrolimus
4892813|NCT02118896|FK506E|fk506e
4892814|NCT02118896|MR4|mr4
4892815|NCT02118896|Advagraf|advagraf
4892816|NCT02118896|Kidney Transplantation|kidney transplantation
4892817|NCT02118896|Renal Transplantation|renal transplantation
4892818|NCT02118896|Heart Transplantation|heart transplantation
4892819|NCT02118883|exercise|exercise
4892820|NCT02118883|hydration|hydration
4892821|NCT02118883|dehydration|dehydration
4892822|NCT02118883|rehydration|rehydration
4892823|NCT02118883|alkaline water|alkaline water
4892824|NCT02118883|blood viscosity|blood viscosity
4892825|NCT02118883|plasma osmolality|plasma osmolality
4892826|NCT02118883|bioimpedance|bioimpedance
4892827|NCT02118870|ACS patients|acs patients
4892828|NCT02118870|Older than 18 years|older than 18 years
4892829|NCT02118870|PCI|pci
4892830|NCT02118870|Combo stent|combo stent
4892831|NCT02118857|Microorganisms and foods|microorganisms and foods
4892832|NCT02118857|Fecal microbiota|fecal microbiota
4892833|NCT02118857|Salivary microbiota|salivary microbiota
4892834|NCT02118844|bariatric surgery|bariatric surgery
4892835|NCT02118844|surgical conditions|surgical conditions
4892836|NCT02118844|deep neuromuscular blockade|deep neuromuscular blockade
4892837|NCT02118831|macular degeneration|macular degeneration
4892838|NCT02118831|diabetic macular edema|diabetic macular edema
4892839|NCT02118831|vein occlusion|vein occlusion
4892840|NCT02118831|vascular endothelial growth factor|vascular endothelial growth factor
4892841|NCT02118805|ALS|als
4892842|NCT02118805|Myasthenia Gravis|myasthenia gravis
4892843|NCT02118805|Myopathy|myopathy
4892844|NCT02118805|Stroke|stroke
4892845|NCT02118805|Parkinson's Disease|parkinson's disease
4892846|NCT02118805|Bulbar|bulbar
4892847|NCT02118805|Orofacial|orofacial
4892848|NCT02118805|Ultrasound|ultrasound
4892849|NCT02118805|Electrical Impedance Myography|electrical impedance myography
4892850|NCT02118792|atopic dermatitis|atopic dermatitis
4892851|NCT02118779|Myotonic Dystrophy Type 1|myotonic dystrophy type 1
4892852|NCT02118779|DM1|dm1
4892853|NCT02118779|Physical Exercise|physical exercise
4892854|NCT02118779|Cognitive Behavioural Therapy|cognitive behavioural therapy
4892855|NCT02118779|Biomarkers|biomarkers
4892856|NCT02118766|atopic dermatitis|atopic dermatitis
4892857|NCT02118753|ischemia-reperfusion injury|ischemia-reperfusion injury
4892858|NCT02118740|Autologous Stem Cells|autologous stem cells
4892859|NCT02118740|Spinal Cord Injury|spinal cord injury
4892860|NCT02118740|Preclinical|preclinical
4892861|NCT02118727|ALS|als
4892862|NCT02118727|FTD|ftd
4892863|NCT02118727|Tau|tau
4892864|NCT02118727|pNF-H/C3|pnf-h/c3
4892865|NCT02118714|Diabetic Nephropathies|diabetic nephropathies
4892866|NCT02118714|Kidney Diseases|kidney diseases
4892867|NCT02118714|Urologic Diseases|urologic diseases
4892868|NCT02118714|Diabetes Complications|diabetes complications
4892869|NCT02118714|Diabetes Mellitus|diabetes mellitus
4892870|NCT02118714|Endocrine System Diseases|endocrine system diseases
4892871|NCT02118701|Shared decision making|shared decision making
4892873|NCT02118701|Long-term care|long-term care
4892874|NCT02118701|Nursing home|nursing home
4892875|NCT02118701|Care plan|care plan
4892876|NCT02118636|Joint pain|joint pain
4892877|NCT02118636|Hormone receptor positive breast cancer|hormone receptor positive breast cancer
4892878|NCT02118636|Estrogen|estrogen
4892879|NCT02118636|Androgen|androgen
4892880|NCT02118623|Bipolar Disorder|bipolar disorder
4892881|NCT02118623|Bipolar|bipolar
4892882|NCT02118623|Online intervention|online intervention
4892883|NCT02118623|Internet intervention|internet intervention
4892884|NCT02118623|Self help|self help
4892885|NCT02118545|vWF|vwf
4892886|NCT02118545|Liver Resection|liver resection
4892887|NCT02118545|Liver Dysfunction|liver dysfunction
4892888|NCT02118545|Liver Regeneration|liver regeneration
4892889|NCT02118545|Postoperative Outcome|postoperative outcome
4892890|NCT02118532|Atherosclerosis|atherosclerosis
4892891|NCT02118532|Superficial Femoral Artery|superficial femoral artery
4892892|NCT02118532|Proximal Popliteal Artery|proximal popliteal artery
4892893|NCT02118519|Bone marrow derived Mesenchymal Stem Cells|bone marrow derived mesenchymal stem cells
4892894|NCT02118519|Knee articular cartilage injury|knee articular cartilage injury
4892895|NCT02118519|Chondrogenesis|chondrogenesis
4892896|NCT02118519|orthopedics|orthopedics
4892897|NCT02118506|Primary Parkinsonism.|primary parkinsonism.
4892898|NCT02118506|Rehabilitation.|rehabilitation.
4892899|NCT02118506|Biomechanics.|biomechanics.
4892900|NCT02118506|Neurological gait disorders.|neurological gait disorders.
4892901|NCT02118493|Benign Biliary Stenosis|benign biliary stenosis
4892902|NCT02118493|Laser Excision|laser excision
4892903|NCT02118480|Parkinson disease, cognitive rehabilitation, REHACOP|parkinson disease, cognitive rehabilitation, rehacop
4892904|NCT02118467|Shock|shock
4892905|NCT02118467|Vasopressor agents|vasopressor agents
4892906|NCT02118467|Norepinephrine|norepinephrine
4892907|NCT02118467|Epinephrine|epinephrine
4892908|NCT02118467|Phenylephrine|phenylephrine
4892909|NCT02118467|Vasopressin|vasopressin
4892910|NCT02118467|Atrial fibrillation|atrial fibrillation
4892911|NCT02118467|Tachyarrhythmia|tachyarrhythmia
4892912|NCT02118454|Medication adherence|medication adherence
4892913|NCT02118454|Self-management|self-management
4892914|NCT02118454|Depression|depression
4892915|NCT02118454|Coping|coping
4892916|NCT02118454|Social support|social support
4892917|NCT02118454|Mobile health|mobile health
4892918|NCT02118454|Antiretroviral treatment|antiretroviral treatment
4892919|NCT02118428|whole blood|whole blood
4892920|NCT02118428|transfusion|transfusion
4892921|NCT02118428|Plasmodium|plasmodium
4892922|NCT02118428|Malaria|malaria
4892923|NCT02118428|Pathogen Reduction Technology|pathogen reduction technology
4892924|NCT02118428|Whole blood transfusion|whole blood transfusion
4892925|NCT02118415|not eligible for surgery|not eligible for surgery
4892926|NCT02118415|efficacy of immunotherapy following RCTx|efficacy of immunotherapy following rctx
4892927|NCT02118376|obesity; fat distribution; inflammation|obesity; fat distribution; inflammation
4892928|NCT02118363|upper limb|upper limb
4892929|NCT02118363|lower limb|lower limb
4892930|NCT02118363|monitoring|monitoring
4892931|NCT02118363|assessment|assessment
4892932|NCT02118363|sensor|sensor
4892933|NCT02118337|select advanced malignancies,|select advanced malignancies,
4892934|NCT02118337|kidney cancer,|kidney cancer,
4892935|NCT02118337|clear cell renal cell carcinoma|clear cell renal cell carcinoma
4892936|NCT02118324|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
4892937|NCT02118324|ALL|all
4892938|NCT02118324|fitness intervention|fitness intervention
4892939|NCT02118311|Acute Leukemias|acute leukemias
4892940|NCT02118311|Burkitt's Lymphoma|burkitt's lymphoma
4892941|NCT02118311|Natural Killer Cell Malignancies|natural killer cell malignancies
4892942|NCT02118311|Chronic Myelogenous Leukemia|chronic myelogenous leukemia
4892943|NCT02118311|Myelodysplastic Syndrome|myelodysplastic syndrome
4892944|NCT02118311|Large-Cell Lymphoma|large-cell lymphoma
4892945|NCT02118311|Hodgkin Lymphoma|hodgkin lymphoma
4892946|NCT02118311|Multiple Myeloma|multiple myeloma
4892947|NCT02118311|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
4892948|NCT02118311|Small Lymphocytic Lymphoma|small lymphocytic lymphoma
4892949|NCT02118311|Marginal Zone B-Cell Lymphoma|marginal zone b-cell lymphoma
4892950|NCT02118311|Follicular Lymphoma:|follicular lymphoma:
4892951|NCT02118311|Lymphoplasmacytic Lymphoma|lymphoplasmacytic lymphoma
4892952|NCT02118311|Mantle-Cell Lymphoma|mantle-cell lymphoma
4892953|NCT02118311|Prolymphocytic Leukemia|prolymphocytic leukemia
4892954|NCT02118285|Ovarian cancer|ovarian cancer
4892955|NCT02118285|Fallopian cancer|fallopian cancer
4892956|NCT02118285|Primary peritoneal cancer|primary peritoneal cancer
4892957|NCT02118259|Multidisciplinary review of drug prescriptions|multidisciplinary review of drug prescriptions
4892958|NCT02118259|Adverse drug events geriatric risk score|adverse drug events geriatric risk score
4892959|NCT02118259|Residence for dependent elderly|residence for dependent elderly
4892960|NCT02118246|Knee pain,Dry Needling, kinesioTape,Trigger point|knee pain,dry needling, kinesiotape,trigger point
4892961|NCT02118233|carotid|carotid
4892962|NCT02118233|stenosis|stenosis
4892963|NCT02118233|surgery|surgery
4892964|NCT02118233|cognitive|cognitive
4892965|NCT02118233|unilateral|unilateral
4892966|NCT02118207|SCUBA diving|scuba diving
4892967|NCT02118207|Exercise|exercise
4892968|NCT02118207|Microparticles|microparticles
4892969|NCT02118207|Repetitive diving|repetitive diving
4892970|NCT02118207|Endothelial function|endothelial function
4892971|NCT02118194|paraplegia|paraplegia
4892972|NCT02118194|paralysis|paralysis
4892973|NCT02118194|robotics|robotics
4892974|NCT02118194|walking|walking
4892975|NCT02118194|immobilization|immobilization
4892976|NCT02118168|HIV|hiv
4892977|NCT02118168|HAART|haart
4892978|NCT02118168|Tat Protein|tat protein
4892979|NCT02118129|Vitamin D|vitamin d
4892980|NCT02118129|Intervention|intervention
4892981|NCT02118129|Behaviour|behaviour
4892982|NCT02118129|Mobile app|mobile app
4892983|NCT02118116|ASIST, gatekeeper, suicide, intervention, First Nations, Aboriginal, educational, prevention, safety|asist, gatekeeper, suicide, intervention, first nations, aboriginal, educational, prevention, safety
4892984|NCT02118103|Lumbosacral Region|lumbosacral region
4892985|NCT02118103|Psychomotor Performance|psychomotor performance
4892986|NCT02118103|Manipulation, Spinal|manipulation, spinal
4892987|NCT02118090|malaria|malaria
4892988|NCT02118090|Plasmodium vivax|plasmodium vivax
4892989|NCT02118090|drug resistance|drug resistance
4892990|NCT02118090|chloroquine|chloroquine
4892991|NCT02118090|Cambodia|cambodia
4892992|NCT02118064|G17DT|g17dt
4892993|NCT02118064|irinotecan|irinotecan
4892994|NCT02118064|Colorectal Cancer|colorectal cancer
4892995|NCT02118051|Infertility|infertility
4892996|NCT02118051|IVF|ivf
4892997|NCT02118051|Corifollitropin Alfa treatment|corifollitropin alfa treatment
4892998|NCT02118051|Ovarian stimulation|ovarian stimulation
4892999|NCT02118038|Postpartum haemorrhage|postpartum haemorrhage
4893000|NCT02118038|Sulprostone|sulprostone
4893001|NCT02118038|Cardiac impact|cardiac impact
4893002|NCT02118038|Emotional impact|emotional impact
4893003|NCT02118038|Cardiac magnetic imaging resonance|cardiac magnetic imaging resonance
4893004|NCT02118025|Off-pump bypass graft surgery|off-pump bypass graft surgery
4893005|NCT02118025|Mini extracorporeal circulation bypass surgery|mini extracorporeal circulation bypass surgery
4893006|NCT02118012|Chlorcyclizine HCL|chlorcyclizine hcl
4893007|NCT02118012|Direct Acting Antivirals|direct acting antivirals
4893008|NCT02118012|Ribavirin|ribavirin
4893009|NCT02118012|Hepatitis C|hepatitis c
4893010|NCT02117999|corneal cross-linking|corneal cross-linking
4893011|NCT02117999|transepithelial corneal cross-linking|transepithelial corneal cross-linking
4893012|NCT02117999|iontophoresis|iontophoresis
4893013|NCT02117999|progressive keratoconus|progressive keratoconus
4893014|NCT02117986|critically ill patients|critically ill patients
4893015|NCT02117986|colistin dosing|colistin dosing
4893016|NCT02117986|multidrug resistant bacteria|multidrug resistant bacteria
4893017|NCT02117960|atherosclerotic|atherosclerotic
4893018|NCT02117960|BMP-4|bmp-4
4893019|NCT02117960|YKL40|ykl40
4893020|NCT02117960|HSP70|hsp70
4893021|NCT02117960|HSP27|hsp27
4893022|NCT02117947|child secondhand smoke|child secondhand smoke
4893023|NCT02117947|maternal smoking|maternal smoking
4893024|NCT02117947|tobacco|tobacco
4893025|NCT02117947|nicotine|nicotine
4893026|NCT02117947|behavioral counseling|behavioral counseling
4893027|NCT02117947|low-income|low-income
4893028|NCT02117947|underserved|underserved
4893029|NCT02117934|HBV vaccine|hbv vaccine
4893030|NCT02117934|HEPLISAV-B|heplisav-b
4893031|NCT02117934|Hepatitis B vaccine|hepatitis b vaccine
4893032|NCT02117934|Hepatitis B|hepatitis b
4893033|NCT02117934|Hepatitis|hepatitis
4893034|NCT02117934|Hepatitis B virus (HBV)|hepatitis b virus (hbv)
4893035|NCT02117934|Prevention and Control|prevention and control
4893036|NCT02117934|Healthy|healthy
4893037|NCT02117934|Healthy volunteers|healthy volunteers
4893038|NCT02117921|Mind Body Syndrome|mind body syndrome
4893039|NCT02117921|MBS|mbs
4893040|NCT02117921|Chronic Pain|chronic pain
4893041|NCT02117908|prevention|prevention
4893042|NCT02117908|radiofrequency treatment|radiofrequency treatment
4893043|NCT02117908|lung cancer ablation|lung cancer ablation
4893044|NCT02117895|Distal Pancreatectomy|distal pancreatectomy
4893045|NCT02117895|Celiac Plexus|celiac plexus
4893046|NCT02117895|Resection|resection
4893047|NCT02117895|Pancreatic Cancer|pancreatic cancer
4893048|NCT02117895|Body and Tail|body and tail
4893049|NCT02117882|lateral approach, bone augmentation , sinus floor elevation|lateral approach, bone augmentation , sinus floor elevation
4893050|NCT02117869|Grapefruit juice|grapefruit juice
4893051|NCT02117856|Implant-Supported Denture|implant-supported denture
4893052|NCT02117856|Single-Implant Denture|single-implant denture
4893053|NCT02117856|Patient Satisfaction|patient satisfaction
4893054|NCT02117856|Edentulous Mandible|edentulous mandible
4893055|NCT02117856|Dental Implants|dental implants
4893056|NCT02117856|Standard of Care|standard of care
4893057|NCT02117856|Randomized Clinical Trial|randomized clinical trial
4893058|NCT02117830|To determine|to determine
4893059|NCT02117830|effects|effects
4893060|NCT02117830|once|once
4893061|NCT02117830|daily|daily
4893062|NCT02117830|oral doses|oral doses
4893063|NCT02117830|Androxal|androxal
4893064|NCT02117804|Discharge Planning|discharge planning
4893065|NCT02117804|Decision Support|decision support
4893168|NCT02117362|Providence Health & Services|providence health & services
4893066|NCT02117791|Riociguat, Adempas, sGC stimulator, CTEPH, Japan, PMS|riociguat, adempas, sgc stimulator, cteph, japan, pms
4893067|NCT02117765|T1D|t1d
4893068|NCT02117765|ustekinumab|ustekinumab
4893069|NCT02117765|new-onset|new-onset
4893070|NCT02117765|diabetes|diabetes
4893071|NCT02117726|Sedation;|sedation;
4893072|NCT02117726|ARDS;|ards;
4893073|NCT02117726|Mechanical ventilation|mechanical ventilation
4893074|NCT02117726|Hypnotics|hypnotics
4893075|NCT02117726|Antianxiety Drugs|antianxiety drugs
4893076|NCT02117726|Causing|causing
4893077|NCT02117726|Adverse Effects|adverse effects
4893078|NCT02117726|Therapeutic Use|therapeutic use
4893079|NCT02117700|fatty liver|fatty liver
4893080|NCT02117700|obesity|obesity
4893081|NCT02117700|children|children
4893082|NCT02117700|oxidative stress|oxidative stress
4893083|NCT02117700|antioxidants|antioxidants
4893084|NCT02117674|colonoscopy|colonoscopy
4893085|NCT02117674|adenoma detection rate|adenoma detection rate
4893086|NCT02117674|full spectrum colonoscopy|full spectrum colonoscopy
4893087|NCT02117674|right colon retroflexion|right colon retroflexion
4893088|NCT02117674|feasibility|feasibility
4893089|NCT02117661|L-carnitine|l-carnitine
4893090|NCT02117661|Metabolic syndrome|metabolic syndrome
4893091|NCT02117661|Atherosclerosis|atherosclerosis
4893092|NCT02117661|Coronary artery disease|coronary artery disease
4893093|NCT02117661|Carotid|carotid
4893094|NCT02117661|Plaque|plaque
4893095|NCT02117661|Cardiovascular disease|cardiovascular disease
4893096|NCT02117661|Heart disease|heart disease
4893097|NCT02117661|Vascular disease|vascular disease
4893098|NCT02117648|advanced cancer|advanced cancer
4893099|NCT02117648|metastatic cancer|metastatic cancer
4893100|NCT02117635|Efficacy|efficacy
4893101|NCT02117635|Non comparative|non comparative
4893102|NCT02117635|Neural stem cells|neural stem cells
4893103|NCT02117635|Intracranial administration|intracranial administration
4893104|NCT02117609|Elderly|elderly
4893105|NCT02117609|Nursing home|nursing home
4893106|NCT02117609|Functional impairment|functional impairment
4893107|NCT02117609|High-protein oral supplement|high-protein oral supplement
4893108|NCT02117596|Pediatric|pediatric
4893109|NCT02117596|Renal|renal
4893110|NCT02117596|Transplant|transplant
4893111|NCT02117583|pharmacokinetics|pharmacokinetics
4893112|NCT02117583|relative bioavailability|relative bioavailability
4893113|NCT02117583|food effects|food effects
4893114|NCT02117583|oxycodone|oxycodone
4893115|NCT02117570|Clostridium difficile|clostridium difficile
4893116|NCT02117570|vaccine|vaccine
4893117|NCT02117557|Single-incision|single-incision
4893118|NCT02117557|Laparoscopy|laparoscopy
4893119|NCT02117557|Colorectal Cancer|colorectal cancer
4893120|NCT02117544|Contact lens|contact lens
4893121|NCT02117544|Presbyopia|presbyopia
4893122|NCT02117544|Multifocal|multifocal
4893123|NCT02117518|type 1 diabetes|type 1 diabetes
4893124|NCT02117518|autoreactive T cells|autoreactive t cells
4893125|NCT02117518|beta cell peptides|beta cell peptides
4893126|NCT02117518|genetically modified T cells|genetically modified t cells
4893127|NCT02117518|mRNA electroporation|mrna electroporation
4893128|NCT02117505|Biological Availability|biological availability
4893129|NCT02117505|JNJ-39220675|jnj-39220675
4893130|NCT02117505|Healthy|healthy
4893131|NCT02117505|Phase 1|phase 1
4893132|NCT02117492|hysterectomy|hysterectomy
4893133|NCT02117492|vaginal cuff|vaginal cuff
4893134|NCT02117479|Metastatic pancreatic cancer|metastatic pancreatic cancer
4893135|NCT02117479|Metastatic pancreatic adenocarcinoma that is recurrent|metastatic pancreatic adenocarcinoma that is recurrent
4893136|NCT02117466|cetuximab|cetuximab
4893137|NCT02117466|PET-imaging|pet-imaging
4893138|NCT02117453|ANCA vasculitis|anca vasculitis
4893139|NCT02117453|Statin|statin
4893140|NCT02117453|Subclinical markers of atherosclerosis|subclinical markers of atherosclerosis
4893141|NCT02117453|Cardiovascular events|cardiovascular events
4893142|NCT02117453|Myocardial infarction|myocardial infarction
4893143|NCT02117453|Stroke|stroke
4893144|NCT02117453|Arterial revascularization|arterial revascularization
4893145|NCT02117453|Unstable angina|unstable angina
4893146|NCT02117453|Death|death
4893147|NCT02117440|Lung Cancer|lung cancer
4893148|NCT02117440|Lung Neoplasms|lung neoplasms
4893149|NCT02117414|Magnetic Resonance Imaging (MRI)|magnetic resonance imaging (mri)
4893150|NCT02117388|Older adults|older adults
4893151|NCT02117388|insomnia|insomnia
4893152|NCT02117388|CBT-I (cognitive behavioral therapy-insomnia)|cbt-i (cognitive behavioral therapy-insomnia)
4893153|NCT02117388|Behavioral Therapy|behavioral therapy
4893154|NCT02117388|SRT (sleep restriction therapy)|srt (sleep restriction therapy)
4893155|NCT02117388|Cognitive Therapy|cognitive therapy
4893156|NCT02117375|multiple sclerosis|multiple sclerosis
4893157|NCT02117375|spinal cord|spinal cord
4893158|NCT02117375|MRI|mri
4893159|NCT02117375|longitudinal study|longitudinal study
4893160|NCT02117375|disability|disability
4893161|NCT02117362|Melanoma|melanoma
4893162|NCT02117362|Ipilimumab|ipilimumab
4893163|NCT02117362|Yervoy|yervoy
4893164|NCT02117362|Galectin|galectin
4893165|NCT02117362|GR-MD-02|gr-md-02
4893166|NCT02117362|galactoarabino-rhamnogalacturonate|galactoarabino-rhamnogalacturonate
4893167|NCT02117362|galectin-3 inhibitor|galectin-3 inhibitor
4893169|NCT02117362|Earle A. Chiles Research Institute|earle a. chiles research institute
4893170|NCT02117362|Robert W. Franz Cancer Center|robert w. franz cancer center
4893171|NCT02117362|Immunotherapy|immunotherapy
4893172|NCT02117349|surgical hemostasis|surgical hemostasis
4893173|NCT02117349|bleeding|bleeding
4893174|NCT02117349|fibrin sealant|fibrin sealant
4893175|NCT02117349|fibrinogen|fibrinogen
4893176|NCT02117349|thrombin|thrombin
4893177|NCT02117349|spray dried|spray dried
4893178|NCT02117323|corneal opacities|corneal opacities
4893179|NCT02117323|Optical coherence tomography|optical coherence tomography
4893180|NCT02117284|positron emission tomography (PET)|positron emission tomography (pet)
4893181|NCT02117284|Rubidium-82|rubidium-82
4893182|NCT02117284|myocardial perfusion imaging|myocardial perfusion imaging
4893183|NCT02117284|automated elution system|automated elution system
4893184|NCT02117284|controlled radioactivity delivery|controlled radioactivity delivery
4893185|NCT02117271|obstructive sleep apnea|obstructive sleep apnea
4893186|NCT02117271|treatment|treatment
4893187|NCT02117271|placebo|placebo
4893188|NCT02117271|appearance|appearance
4893189|NCT02117271|skin quality|skin quality
4893190|NCT02117258|Z-360, Pancreatic cancer, Pancreatic Adenocarcinoma|z-360, pancreatic cancer, pancreatic adenocarcinoma
4893191|NCT02117245|Food effect on MGCD265 bioavailability in healthy volunteers|food effect on mgcd265 bioavailability in healthy volunteers
4893192|NCT02117232|colonoscopy|colonoscopy
4893193|NCT02117232|cecal intubation|cecal intubation
4893194|NCT02117232|carbon dioxide insufflation|carbon dioxide insufflation
4893195|NCT02117219|Myelodysplastic syndrome|myelodysplastic syndrome
4893196|NCT02117219|MDS|mds
4893197|NCT02117206|L-arginine|l-arginine
4893198|NCT02117180|functional gastrointestinal disorders|functional gastrointestinal disorders
4893199|NCT02117180|FGID|fgid
4893200|NCT02117180|children|children
4893201|NCT02117180|FODMAP|fodmap
4893202|NCT02117154|Continuous Glucose Monitoring System|continuous glucose monitoring system
4893203|NCT02117154|HbA1c|hba1c
4893204|NCT02117154|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
4893205|NCT02117141|Food Effect|food effect
4893206|NCT02117141|Pharmacokinetics|pharmacokinetics
4893207|NCT02117128|Tranexamic Acid|tranexamic acid
4893208|NCT02117128|Antifibrinolytic|antifibrinolytic
4893209|NCT02117128|Blood transfusion|blood transfusion
4893210|NCT02117128|Total knee arthroplasty|total knee arthroplasty
4893211|NCT02117076|Restless leg syndrome|restless leg syndrome
4893212|NCT02117076|RLS|rls
4893213|NCT02117076|gabapentin|gabapentin
4893214|NCT02117076|gabapentin enacarbil|gabapentin enacarbil
4893215|NCT02117076|Neurontin|neurontin
4893216|NCT02117076|Horizant|horizant
4893217|NCT02117050|Multiple Sclerosis|multiple sclerosis
4893218|NCT02117050|Rebif ®|rebif ®
4893219|NCT02117050|Tecfidera ™|tecfidera ™
4893220|NCT02117050|treatment change|treatment change
4893221|NCT02117024|lung|lung
4893222|NCT02117024|cancer|cancer
4893223|NCT02117024|gp96|gp96
4893224|NCT02117024|vaccine|vaccine
4893225|NCT02117024|immunotherapy|immunotherapy
4893226|NCT02117024|Heat Biologics|heat biologics
4893227|NCT02117024|cyclophosphamide|cyclophosphamide
4893228|NCT02117024|vinorelbine|vinorelbine
4893229|NCT02117024|erlotinib|erlotinib
4893230|NCT02117024|gemcitabine|gemcitabine
4893231|NCT02117024|paclitaxel|paclitaxel
4893232|NCT02117024|docetaxel|docetaxel
4893233|NCT02117024|pemetrexed|pemetrexed
4893234|NCT02116998|GEN-004|gen-004
4893235|NCT02116998|Aluminum hydroxide|aluminum hydroxide
4893236|NCT02116998|Vaccine|vaccine
4893237|NCT02116998|Streptococcus pneumoniae|streptococcus pneumoniae
4893238|NCT02116998|Pneumococcal Infections|pneumococcal infections
4893239|NCT02116998|Strep pneumoniae|strep pneumoniae
4893240|NCT02116998|Pneumonia|pneumonia
4893241|NCT02116985|Dual-Loop TCI|dual-loop tci
4893242|NCT02116985|NI|ni
4893243|NCT02116985|Laparoscopic Cholecystectomy|laparoscopic cholecystectomy
4893244|NCT02116972|osteoarthritis|osteoarthritis
4893245|NCT02116972|knee|knee
4893246|NCT02116972|pain|pain
4893247|NCT02116972|corticosteroid|corticosteroid
4893248|NCT02116972|intra-articular|intra-articular
4893249|NCT02116972|injection|injection
4893250|NCT02116959|Systemic|systemic
4893251|NCT02116959|Chemotherapy|chemotherapy
4893252|NCT02116959|Melphalan|melphalan
4893253|NCT02116933|Autologous Fat Grafting|autologous fat grafting
4893254|NCT02116933|Breast Augmentation|breast augmentation
4893255|NCT02116933|Stromal Vascular Fraction|stromal vascular fraction
4893256|NCT02116933|Adipose Derived Stem Cell|adipose derived stem cell
4893257|NCT02116920|CIN|cin
4893258|NCT02116920|HPV DNA|hpv dna
4893259|NCT02116920|mRNA E6/E7|mrna e6/e7
4893260|NCT02116920|CIN triage|cin triage
4893261|NCT02116920|Cervix Biopsy|cervix biopsy
4893262|NCT02116920|VIA|via
4893263|NCT02116920|Cervix Cancer|cervix cancer
4893264|NCT02116907|Healthy|healthy
4893265|NCT02116907|Male Subjects|male subjects
4893266|NCT02116894|Colorectal cancer|colorectal cancer
4893267|NCT02116894|PF-03446962|pf-03446962
4893268|NCT02116894|regorafenib|regorafenib
4893269|NCT02116881|Incisional hernia|incisional hernia
4893270|NCT02116881|colorectal surgery|colorectal surgery
4893271|NCT02116881|bowel obstruction|bowel obstruction
4893272|NCT02116868|Pupillometry|pupillometry
4893273|NCT02116868|Pupillary reflex|pupillary reflex
4893274|NCT02116868|Analgesia|analgesia
4893275|NCT02116868|Laparoscopic surgery|laparoscopic surgery
4893276|NCT02116868|Total intravenous anesthesia|total intravenous anesthesia
4893277|NCT02116868|Target controlled infusion|target controlled infusion
4893278|NCT02116803|solid tumors|solid tumors
4893279|NCT02116803|TKI258|tki258
4893280|NCT02116803|Dovitinib|dovitinib
4893281|NCT02116803|fulvestrant|fulvestrant
4893282|NCT02116803|cancers with a mass|cancers with a mass
4893283|NCT02116803|bulky tumor|bulky tumor
4893284|NCT02116803|nodule|nodule
4893285|NCT02116803|lump|lump
4893286|NCT02116803|cancer|cancer
4893287|NCT02116803|solid malignancies|solid malignancies
4893288|NCT02116790|acute|acute
4893289|NCT02116790|pain|pain
4893290|NCT02116764|Hematopoietic (Stem) Cell Transplantation|hematopoietic (stem) cell transplantation
4893291|NCT02116764|Primary Immune Deficiency Consortium|primary immune deficiency consortium
4893292|NCT02116751|HIV, antiretroviral, toxicity, eGFR, tubular disease, BMD|hiv, antiretroviral, toxicity, egfr, tubular disease, bmd
4893293|NCT02116738|flap|flap
4893294|NCT02116738|pilonidal sinus|pilonidal sinus
4893295|NCT02116738|vas|vas
4893296|NCT02116738|recurrence|recurrence
4893297|NCT02116712|LAM|lam
4893298|NCT02116712|saracatinib|saracatinib
4893299|NCT02116712|Lymphangioleiomyomatosis|lymphangioleiomyomatosis
4893300|NCT02116699|oropharyngeal|oropharyngeal
4893301|NCT02116699|colostrum|colostrum
4893302|NCT02116699|mother's milk|mother's milk
4893303|NCT02116699|premature|premature
4893304|NCT02116699|neonate|neonate
4893305|NCT02116699|infection|infection
4893306|NCT02116699|necrotizing enterocolitis|necrotizing enterocolitis
4893307|NCT02116699|ventilator-associated pneumonia|ventilator-associated pneumonia
4893308|NCT02116699|breastmilk|breastmilk
4893309|NCT02116699|human milk|human milk
4893310|NCT02116699|late-onset sepsis|late-onset sepsis
4893311|NCT02116699|microbiome|microbiome
4893312|NCT02116699|antioxidant|antioxidant
4893313|NCT02116699|enteral feeds|enteral feeds
4893314|NCT02116686|chronic heart failure|chronic heart failure
4893315|NCT02116686|Polysomnography|polysomnography
4893316|NCT02116686|Sleep Apnea Syndromes|sleep apnea syndromes
4893317|NCT02116686|Electrocardiogram|electrocardiogram
4893318|NCT02116673|Head injury|head injury
4893319|NCT02116673|Concussion|concussion
4893320|NCT02116673|Cognitive rest|cognitive rest
4893321|NCT02116673|Emergency department|emergency department
4893322|NCT02116647|Gender discrimination|gender discrimination
4893323|NCT02116647|Psychoanalysis|psychoanalysis
4893324|NCT02116647|Randomized controlled trial|randomized controlled trial
4893325|NCT02116621|Musculoskeletal pain|musculoskeletal pain
4893326|NCT02116621|Chronic pain|chronic pain
4893327|NCT02116621|Patient centered outcomes research|patient centered outcomes research
4893328|NCT02116621|Physician patient relationship|physician patient relationship
4893329|NCT02116621|Mobile applications|mobile applications
4893330|NCT02116595|volunteers|volunteers
4893331|NCT02116582|MDV3100|mdv3100
4893332|NCT02116582|Xtandi|xtandi
4893333|NCT02116582|Abiraterone|abiraterone
4893334|NCT02116582|Metastatic Castration-Resistant Prostate Cancer|metastatic castration-resistant prostate cancer
4893335|NCT02116582|Enzalutamide|enzalutamide
4893336|NCT02116569|Multiple Myeloma|multiple myeloma
4893337|NCT02116569|Daratumumab|daratumumab
4893338|NCT02116569|JNJ-54767414|jnj-54767414
4893339|NCT02116569|Phase 1|phase 1
4893340|NCT02116569|Relapse|relapse
4893341|NCT02116569|Refractory|refractory
4893342|NCT02116556|Alcoholic Hepatitis|alcoholic hepatitis
4893343|NCT02116556|Bacterial Infections|bacterial infections
4893344|NCT02116556|Acute-on-Chronic Liver Failure|acute-on-chronic liver failure
4893345|NCT02116543|Hepatitis C|hepatitis c
4893346|NCT02116543|HCV|hcv
4893347|NCT02116517|obese women|obese women
4893348|NCT02116517|high LDL-C|high ldl-c
4893349|NCT02116504|Rheumatoid arthritis|rheumatoid arthritis
4893350|NCT02116504|Juvenile Idiopathic Arthritis|juvenile idiopathic arthritis
4893351|NCT02116504|Biopharmaceutical|biopharmaceutical
4893352|NCT02116504|Immunogenicity|immunogenicity
4893353|NCT02116504|Anti-Drug Antibody|anti-drug antibody
4893354|NCT02116504|Prediction|prediction
4893355|NCT02116478|plantar fasciitis|plantar fasciitis
4893356|NCT02116478|gastrocnemius recession|gastrocnemius recession
4893357|NCT02116439|Violence|violence
4893358|NCT02116426|copeptin|copeptin
4893359|NCT02116426|troponin HS|troponin hs
4893360|NCT02116413|fluid challenge|fluid challenge
4893361|NCT02116413|fluid resuscitation|fluid resuscitation
4893362|NCT02116400|Suicidal ideation|suicidal ideation
4893363|NCT02116387|Proprioception|proprioception
4893364|NCT02116348|Cerebral palsy children|cerebral palsy children
4893365|NCT02116348|Cerebrolysin|cerebrolysin
4893366|NCT02116348|Sleep questionnaire|sleep questionnaire
4893367|NCT02116348|Quality of life|quality of life
4893368|NCT02116348|Bayley III scale|bayley iii scale
4893369|NCT02116335|arterial stiffness|arterial stiffness
4893370|NCT02116335|flow-mediated dilation|flow-mediated dilation
4893371|NCT02116335|endothelial function|endothelial function
4893372|NCT02116335|pulse wave velocity|pulse wave velocity
4893373|NCT02116335|inflammation|inflammation
4893374|NCT02116335|oxidative stress|oxidative stress
4893375|NCT02116335|Nitric Oxide|nitric oxide
4893376|NCT02116335|Cold Pressor Test|cold pressor test
4893377|NCT02116335|physio flow|physio flow
4893378|NCT02116335|Bosentan|bosentan
4893379|NCT02116335|Endothelin Receptor|endothelin receptor
4893380|NCT02116335|Endothelin-1|endothelin-1
4893381|NCT02116335|BMI|bmi
4893382|NCT02116335|stress|stress
4893383|NCT02116335|blood pressure|blood pressure
4893384|NCT02116283|smoking|smoking
4893385|NCT02116283|healthy|healthy
4893386|NCT02116283|smartphone|smartphone
4893387|NCT02116270|Renal Failure|renal failure
4893388|NCT02116270|Dialysis|dialysis
4893389|NCT02116270|Biological Aging|biological aging
4893390|NCT02116257|Nausea|nausea
4893391|NCT02116257|Vomiting|vomiting
4893392|NCT02116244|Dry Eye|dry eye
4893393|NCT02116244|Civamide|civamide
4893394|NCT02116244|Zucapsaicin|zucapsaicin
4893395|NCT02116244|Neuropeptides|neuropeptides
4893396|NCT02116244|TRPV-1|trpv-1
4893397|NCT02116231|Nasopharyngeal neoplasm;IMRT; Concurrent chemotherapy|nasopharyngeal neoplasm;imrt; concurrent chemotherapy
4893398|NCT02116218|Traditional Chinese Medicine|traditional chinese medicine
4893399|NCT02116218|acupuncture|acupuncture
4893400|NCT02116218|complementary alternative medicine|complementary alternative medicine
4893401|NCT02116218|cancer pain|cancer pain
4893402|NCT02116218|emergency department|emergency department
4893403|NCT02116205|Hantaan virus|hantaan virus
4893404|NCT02116205|Puumala virus|puumala virus
4893405|NCT02116205|HFRS|hfrs
4893406|NCT02116192|Non-alcoholic Fatty Liver Disease|non-alcoholic fatty liver disease
4893407|NCT02116192|Adolescent|adolescent
4893408|NCT02116179|Human Immunodeficiency Virus|human immunodeficiency virus
4893409|NCT02116179|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
4893410|NCT02116179|Hepatitis C|hepatitis c
4893411|NCT02116179|Hispanic|hispanic
4893412|NCT02116179|Criminal Justice|criminal justice
4893413|NCT02116166|aging|aging
4893414|NCT02116166|sarcopenia|sarcopenia
4893415|NCT02116166|mitochondria|mitochondria
4893416|NCT02116166|skeletal muscle|skeletal muscle
4893417|NCT02116166|inflammation|inflammation
4893418|NCT02116153|Cardiac Troponin T|cardiac troponin t
4893419|NCT02116153|Micro-RNA|micro-rna
4893420|NCT02116153|Sensitivity|sensitivity
4893421|NCT02116153|Specificity|specificity
4893422|NCT02116140|positron emission tomography|positron emission tomography
4893423|NCT02116140|[11C]hydroxyephedrine (HED)|[11c]hydroxyephedrine (hed)
4893424|NCT02116140|[11C]acetate|[11c]acetate
4893425|NCT02116140|Adaptive Servoventilation (ASV)|adaptive servoventilation (asv)
4893426|NCT02116140|Myocardial Energetics|myocardial energetics
4893427|NCT02116140|work-metabolic index (WMI)|work-metabolic index (wmi)
4893428|NCT02116140|Myocardial sympathetic neuron (SN) presynaptic function continuous positive airway pressure|myocardial sympathetic neuron (sn) presynaptic function continuous positive airway pressure
4893429|NCT02116140|heart rate variability|heart rate variability
4893430|NCT02116140|overnight polysomnogram|overnight polysomnogram
4893431|NCT02116140|Plasma Norepinephrine|plasma norepinephrine
4893432|NCT02116140|Urine Normetanephrine|urine normetanephrine
4893433|NCT02116140|Quality of Life|quality of life
4893434|NCT02116127|Depression|depression
4893435|NCT02116127|Pregnancy|pregnancy
4893436|NCT02116127|Transcranial Direct Current Stimulation|transcranial direct current stimulation
4893437|NCT02116114|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
4893438|NCT02116101|Intestinal Health|intestinal health
4893439|NCT02116101|Prebiotics|prebiotics
4893440|NCT02116101|Blood Lipid|blood lipid
4893441|NCT02116088|Externalizing problem behavior, teacher training, teacher coaching, primary school, elementary school, continuing professional development, advanced training|externalizing problem behavior, teacher training, teacher coaching, primary school, elementary school, continuing professional development, advanced training
4893442|NCT02116049|Disclosure, intervention|disclosure, intervention
4893443|NCT02116049|HIV|hiv
4893444|NCT02116049|prevention|prevention
4893445|NCT02116049|Disclosure Intervention|disclosure intervention
4893446|NCT02116049|Attention Control Case Management|attention control case management
4893447|NCT02116036|Antiphospholipid Antibody Syndrome|antiphospholipid antibody syndrome
4893448|NCT02116036|Rivaroxaban|rivaroxaban
4893449|NCT02116036|Thromboembolism|thromboembolism
4893450|NCT02116036|Bleeding|bleeding
4893451|NCT02116036|Feasibility|feasibility
4893452|NCT02116023|Satiety, beverage, crossover|satiety, beverage, crossover
4893453|NCT02116010|Wound Infection in burned patient|wound infection in burned patient
4893454|NCT02115971|chronic|chronic
4893455|NCT02115971|functional|functional
4893456|NCT02115971|instability|instability
4893457|NCT02115971|ankle|ankle
4893458|NCT02115945|chronic postoperative pain|chronic postoperative pain
4893459|NCT02115945|total knee arthroplasty|total knee arthroplasty
4893460|NCT02115945|femoral block|femoral block
4893461|NCT02115945|We aimed to compare the effects of epidural and femoral block on acute and chronic postoperative pain.|we aimed to compare the effects of epidural and femoral block on acute and chronic postoperative pain.
4893462|NCT02115932|Diabetes Mellitus|diabetes mellitus
4893463|NCT02115932|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
4893464|NCT02115932|Diabetes Complications|diabetes complications
4893465|NCT02115932|Diabetic Foot|diabetic foot
4893466|NCT02115932|Diabetic Neuropathies|diabetic neuropathies
4893467|NCT02115932|Gait|gait
4893468|NCT02115932|Balance, Postural|balance, postural
4893469|NCT02115932|Muscle Strength|muscle strength
4893470|NCT02115932|Exercise Therapy|exercise therapy
4893471|NCT02115932|Physical Therapy Modalities|physical therapy modalities
4893472|NCT02115932|Endocrine System Diseases|endocrine system diseases
4893473|NCT02115932|Peripheral Nervous System Diseases|peripheral nervous system diseases
4893474|NCT02115932|Metabolic Diseases|metabolic diseases
4893475|NCT02115932|Glucose Metabolism Diseases|glucose metabolism diseases
4893476|NCT02115932|Quality of Life|quality of life
4893477|NCT02115932|Training|training
4893478|NCT02115919|condyloma|condyloma
4893480|NCT02115893|Nitrate|nitrate
4893481|NCT02115893|Performance|performance
4893482|NCT02115893|Sports|sports
4893483|NCT02115880|Depression|depression
4893484|NCT02115880|Prevention|prevention
4893485|NCT02115880|Adolescent|adolescent
4893486|NCT02115880|Child|child
4893487|NCT02115880|Randomised Controlled Trial|randomised controlled trial
4893488|NCT02115880|Risk|risk
4893489|NCT02115880|Cognitive behavioural therapy|cognitive behavioural therapy
4893490|NCT02115880|Group-based therapy|group-based therapy
4893491|NCT02115867|diverticular disease|diverticular disease
4893492|NCT02115867|diverticulitis|diverticulitis
4893493|NCT02115867|diverticulosis|diverticulosis
4893494|NCT02115854|usefullness of labial biopsy to distinguish between tuberculosis and sarcoidosis|usefullness of labial biopsy to distinguish between tuberculosis and sarcoidosis
4893495|NCT02115841|Transcutaneous Nerve Stimulation|transcutaneous nerve stimulation
4893496|NCT02115841|serial reaction time task|serial reaction time task
4893497|NCT02115841|functional near infrared spectroscopy|functional near infrared spectroscopy
4893498|NCT02115841|transcranial magnetic stimulation|transcranial magnetic stimulation
4893499|NCT02115828|Vismodegib|vismodegib
4893500|NCT02115828|Metastatic Castration-Resistant Prostate Cancer|metastatic castration-resistant prostate cancer
4893501|NCT02115828|Accessible Metastatic Lesions for Tumor Biopsy|accessible metastatic lesions for tumor biopsy
4893502|NCT02115815|Respiratory Syncytial Virus (RSV)|respiratory syncytial virus (rsv)
4893503|NCT02115815|MEDI7510|medi7510
4893504|NCT02115789|cicatrix|cicatrix
4893505|NCT02115789|Demonstrate|demonstrate
4893506|NCT02115789|that there|that there
4893507|NCT02115789|is no perception of superiority|is no perception of superiority
4893508|NCT02115776|bacteremia|bacteremia
4893509|NCT02115776|prophylaxis|prophylaxis
4893510|NCT02115776|antibiotics|antibiotics
4893511|NCT02115776|dentistry|dentistry
4893512|NCT02115763|physically active,|physically active,
4893513|NCT02115763|18-35 year old men|18-35 year old men
4893514|NCT02115750|CHS-0214|chs-0214
4893515|NCT02115750|Enbrel|enbrel
4893516|NCT02115750|RA|ra
4893517|NCT02115750|Biosimilar|biosimilar
4893518|NCT02115750|Etanercept|etanercept
4893519|NCT02115724|Low childhood SES|low childhood ses
4893520|NCT02115724|Early Life Stress|early life stress
4893521|NCT02115724|Endothelial function|endothelial function
4893522|NCT02115724|Flow mediated dilation|flow mediated dilation
4893523|NCT02115724|Cardiovascular disease|cardiovascular disease
4893524|NCT02115724|Subcutaneous adipose arterioles|subcutaneous adipose arterioles
4893525|NCT02115711|India|india
4893526|NCT02115711|Cardiovascular risk factors|cardiovascular risk factors
4893527|NCT02115711|Community health workers|community health workers
4893528|NCT02115711|Hypertension|hypertension
4893529|NCT02115711|Diabetes|diabetes
4893530|NCT02115711|Smoking|smoking
4893531|NCT02115698|Sarcopenia|sarcopenia
4893532|NCT02115698|Frailty|frailty
4893533|NCT02115698|Ageing|ageing
4893534|NCT02115698|Protein supplementation|protein supplementation
4893535|NCT02115698|Protein quality|protein quality
4893536|NCT02115698|Exercise training|exercise training
4893537|NCT02115698|Muscle protein turnover|muscle protein turnover
4893538|NCT02115685|spinal cord injury|spinal cord injury
4893539|NCT02115685|sympathetic nervous system|sympathetic nervous system
4893540|NCT02115685|locomotor training|locomotor training
4893541|NCT02115685|exercise|exercise
4893542|NCT02115672|Chronic myeloid leukemia|chronic myeloid leukemia
4893543|NCT02115672|imatinib|imatinib
4893544|NCT02115672|CXCR4 antagonist|cxcr4 antagonist
4893545|NCT02115672|BL-8040|bl-8040
4893546|NCT02115659|ADPKD|adpkd
4893547|NCT02115659|triptolide|triptolide
4893548|NCT02115646|burn|burn
4893549|NCT02115646|scar|scar
4893550|NCT02115620|Heart failure|heart failure
4893551|NCT02115620|Cardiac failure|cardiac failure
4893552|NCT02115620|Congestive Heart Failure|congestive heart failure
4893553|NCT02115620|Cardiomyopathy|cardiomyopathy
4893554|NCT02115620|Myocardial Failure|myocardial failure
4893555|NCT02115620|Telemedicine|telemedicine
4893556|NCT02115620|Telehealth|telehealth
4893557|NCT02115620|Remote Consultation|remote consultation
4893558|NCT02115607|Breast cancer|breast cancer
4893559|NCT02115607|Interstitial fluid pressure|interstitial fluid pressure
4893560|NCT02115607|Angiogenesis|angiogenesis
4893561|NCT02115607|Contrast enhanced ultrasound imaging|contrast enhanced ultrasound imaging
4893562|NCT02115607|Subharmonic imaging|subharmonic imaging
4893563|NCT02115607|Subharmonic pressure estimation|subharmonic pressure estimation
4893757|NCT02114879|Depression|depression
4893564|NCT02115594|metastatic breast cancer|metastatic breast cancer
4893565|NCT02115594|estrogen receptor|estrogen receptor
4893566|NCT02115594|Histone Deacetylase Inhibitors|histone deacetylase inhibitors
4893567|NCT02115594|Histone Deacetylases|histone deacetylases
4893568|NCT02115594|HDAC inhibitors|hdac inhibitors
4893569|NCT02115594|selective estrogen receptor modulator|selective estrogen receptor modulator
4893570|NCT02115594|estrogen receptor modulator, selective|estrogen receptor modulator, selective
4893571|NCT02115594|Estrogen receptor modulators, selective|estrogen receptor modulators, selective
4893572|NCT02115581|Coenzyme O10|coenzyme o10
4893573|NCT02115581|Children|children
4893574|NCT02115581|Idiopathic Dilated Cardiomyopathy|idiopathic dilated cardiomyopathy
4893575|NCT02115555|type 1|type 1
4893576|NCT02115555|diabetes|diabetes
4893577|NCT02115555|adolescents|adolescents
4893578|NCT02115555|heath information technology|heath information technology
4893579|NCT02115542|biliary|biliary
4893580|NCT02115542|liver|liver
4893581|NCT02115542|Refractory Advanced Biliary Cancers|refractory advanced biliary cancers
4893582|NCT02115542|gallbladder cancer|gallbladder cancer
4893583|NCT02115542|carcinoma|carcinoma
4893584|NCT02115542|intra-hepatic biliary system|intra-hepatic biliary system
4893585|NCT02115542|extra-hepatic biliary system|extra-hepatic biliary system
4893586|NCT02115542|gall bladder|gall bladder
4893587|NCT02115542|unresectable|unresectable
4893588|NCT02115542|locally advanced|locally advanced
4893589|NCT02115542|metastatic disease|metastatic disease
4893590|NCT02115542|Bile Duct Diseases|bile duct diseases
4893591|NCT02115542|Gallbladder Diseases|gallbladder diseases
4893592|NCT02115542|regorafenib|regorafenib
4893593|NCT02115542|stivarga|stivarga
4893594|NCT02115542|Bay 73-4506|bay 73-4506
4893595|NCT02115542|multikinase inhibitor|multikinase inhibitor
4893596|NCT02115516|Malaria|malaria
4893597|NCT02115516|Plasmodium falciparum malaria|plasmodium falciparum malaria
4893598|NCT02115516|Antimalarial chemoprophylaxis|antimalarial chemoprophylaxis
4893599|NCT02115516|PfSPZ Challenge|pfspz challenge
4893600|NCT02115516|Cryopreserved Plasmodium Falciparum Sporozoites|cryopreserved plasmodium falciparum sporozoites
4893601|NCT02115516|PfSPZ-CVac|pfspz-cvac
4893602|NCT02115490|Alveolar bone|alveolar bone
4893603|NCT02115490|Bisphosphonates|bisphosphonates
4893604|NCT02115490|Cone-beam CT|cone-beam ct
4893605|NCT02115490|Osteoporosis|osteoporosis
4893606|NCT02115477|Uterus cancer|uterus cancer
4893607|NCT02115477|Hysterectomy|hysterectomy
4893608|NCT02115477|Lymphadenectomy|lymphadenectomy
4893609|NCT02115477|Lymphedema|lymphedema
4893610|NCT02115464|Metformin|metformin
4893611|NCT02115464|Non-small cell lung cancer|non-small cell lung cancer
4893612|NCT02115464|Locally advanced|locally advanced
4893613|NCT02115464|Chemo-radiotherapy|chemo-radiotherapy
4893614|NCT02115464|Lung cancer treatment|lung cancer treatment
4893615|NCT02115399|Dermatitis|dermatitis
4893616|NCT02115399|Staphylococcus|staphylococcus
4893617|NCT02115399|Staphylococcus aureus|staphylococcus aureus
4893618|NCT02115399|Dermatitis, Atopic|dermatitis, atopic
4893619|NCT02115399|Non-atopic controls|non-atopic controls
4893620|NCT02115386|Ph+ CML, chronic myeloid leukemia|ph+ cml, chronic myeloid leukemia
4893621|NCT02115373|Hepatocellular Carcinoma|hepatocellular carcinoma
4893622|NCT02115373|c-Met inhibitor|c-met inhibitor
4893623|NCT02115373|Phase 1b|phase 1b
4893624|NCT02115373|Sorafenib|sorafenib
4893625|NCT02115373|MSC2156119J|msc2156119j
4893626|NCT02115360|epidural calcitonin|epidural calcitonin
4893627|NCT02115360|amputation|amputation
4893628|NCT02115360|postoperative pain|postoperative pain
4893629|NCT02115360|Later Complication|later complication
4893630|NCT02115334|Developmental delay|developmental delay
4893631|NCT02115334|Early Intervention|early intervention
4893632|NCT02115334|Home programs|home programs
4893633|NCT02115334|Preschool activities|preschool activities
4893634|NCT02115295|Leukemia|leukemia
4893635|NCT02115295|Acute Myeloid Leukemia|acute myeloid leukemia
4893636|NCT02115295|AML|aml
4893637|NCT02115295|High Risk Myelodysplastic Syndrome|high risk myelodysplastic syndrome
4893638|NCT02115295|HR MDS|hr mds
4893639|NCT02115295|Myeloid Blast Phase of Chronic Myeloid Leukemia|myeloid blast phase of chronic myeloid leukemia
4893640|NCT02115295|CML|cml
4893641|NCT02115295|Acute Biphenotypic Leukemia|acute biphenotypic leukemia
4893642|NCT02115295|Cladribine|cladribine
4893643|NCT02115295|Leustatin|leustatin
4893644|NCT02115295|2-CdA|2-cda
4893645|NCT02115295|Cytarabine|cytarabine
4893646|NCT02115295|Ara-C|ara-c
4893647|NCT02115295|Cytosar|cytosar
4893648|NCT02115295|DepoCyt|depocyt
4893649|NCT02115295|Cytosine Arabinosine Hydrochloride|cytosine arabinosine hydrochloride
4893650|NCT02115295|Idarubicin|idarubicin
4893651|NCT02115295|Idamycin|idamycin
4893652|NCT02115295|Phone calls|phone calls
4893653|NCT02115269|Indoprocaf|indoprocaf
4893654|NCT02115269|Indomethacin|indomethacin
4893655|NCT02115269|Caffeine|caffeine
4893656|NCT02115269|Prochlorperazine|prochlorperazine
4893657|NCT02115269|Migraine with Aura|migraine with aura
4893658|NCT02115269|Migraine without Aura|migraine without aura
4893659|NCT02115269|Tension-Type Headache|tension-type headache
4893660|NCT02115256|External Cephalic Version|external cephalic version
4893661|NCT02115256|breech|breech
4893662|NCT02115230|Heart Failure|heart failure
4893663|NCT02115230|Heart Failure, Diastolic|heart failure, diastolic
4893664|NCT02115230|Hypertension|hypertension
4893665|NCT02115230|Renal Denervation|renal denervation
4893666|NCT02115230|Irrigated Radiofrequency Catheter|irrigated radiofrequency catheter
4893667|NCT02115217|Kinestiotaping|kinestiotaping
4893668|NCT02115217|Basketball players|basketball players
4893669|NCT02115217|Effect of kinesiotaping|effect of kinesiotaping
4893670|NCT02115217|on postural stability|on postural stability
4893671|NCT02115191|2-octylcyanoacrylate|2-octylcyanoacrylate
4893672|NCT02115191|Urethrocutaneous fistulas.|urethrocutaneous fistulas.
4893673|NCT02115191|Closure.|closure.
4893674|NCT02115191|Recurrence.|recurrence.
4893675|NCT02115178|Hemodynamic changes|hemodynamic changes
4893676|NCT02115178|Spinal anesthesia|spinal anesthesia
4893677|NCT02115178|Patient position|patient position
4893678|NCT02115178|Impedance cardiography|impedance cardiography
4893679|NCT02115152|Capecitabine|capecitabine
4893680|NCT02115152|Neoadjuvant therapy|neoadjuvant therapy
4893681|NCT02115152|Early Breast Cancer|early breast cancer
4893682|NCT02115139|melanoma|melanoma
4893683|NCT02115139|brain|brain
4893684|NCT02115139|metastases|metastases
4893685|NCT02115139|Patients with melanoma and brain metastases|patients with melanoma and brain metastases
4893686|NCT02115113|Liver transplantation, everolimus, CNI-minimization, CNI-elimination, renal function|liver transplantation, everolimus, cni-minimization, cni-elimination, renal function
4893687|NCT02115100|Paroxysmal atrial fibrillation|paroxysmal atrial fibrillation
4893688|NCT02115100|Persistent atrial fibrillation|persistent atrial fibrillation
4893689|NCT02115100|Out of range hypertension|out of range hypertension
4893690|NCT02115100|Signs of sympathetic overdrive|signs of sympathetic overdrive
4893691|NCT02115087|laparotomy|laparotomy
4893692|NCT02115087|levobupivacaine|levobupivacaine
4893693|NCT02115087|patient controlled analgesia|patient controlled analgesia
4893694|NCT02115074|Low-grade gliomas|low-grade gliomas
4893695|NCT02115074|high-grade gliomas|high-grade gliomas
4893696|NCT02115074|optico-chiasmatic|optico-chiasmatic
4893697|NCT02115074|relapsed|relapsed
4893698|NCT02115074|refractory|refractory
4893699|NCT02115061|Gastric varices,coil,cyanoacrylate,treating gastric varices.|gastric varices,coil,cyanoacrylate,treating gastric varices.
4893700|NCT02115035|Multiple Myeloma|multiple myeloma
4893701|NCT02115022|pancreatic cancer|pancreatic cancer
4893702|NCT02115022|resectability|resectability
4893703|NCT02115022|endosonography (EUS)|endosonography (eus)
4893704|NCT02115022|multidetection computer tomography (MDCT)|multidetection computer tomography (mdct)
4893705|NCT02115022|staging|staging
4893706|NCT02115009|sacroiliac joint lumbopelvic ,chronic low back pain|sacroiliac joint lumbopelvic ,chronic low back pain
4893707|NCT02114996|mechanical ventilation|mechanical ventilation
4893708|NCT02114996|ischemic stroke|ischemic stroke
4893709|NCT02114983|deep vein thrombosis|deep vein thrombosis
4893710|NCT02114983|diagnostic accuracy|diagnostic accuracy
4893711|NCT02114983|general practitioner|general practitioner
4893712|NCT02114983|test|test
4893713|NCT02114983|compression ultrasonography|compression ultrasonography
4893714|NCT02114983|ultrasound|ultrasound
4893715|NCT02114970|Older Adults|older adults
4893716|NCT02114970|Informed Consent|informed consent
4893717|NCT02114970|Technology|technology
4893718|NCT02114970|Tablet-delivered|tablet-delivered
4893719|NCT02114957|bio-availability|bio-availability
4893720|NCT02114957|decursin|decursin
4893721|NCT02114957|decursinol angelate|decursinol angelate
4893722|NCT02114957|decursinol|decursinol
4893723|NCT02114957|subjects|subjects
4893724|NCT02114944|Do-not-intubate|do-not-intubate
4893725|NCT02114944|DNI|dni
4893726|NCT02114944|Palliative treatment|palliative treatment
4893727|NCT02114944|Acute respiratory failure|acute respiratory failure
4893728|NCT02114944|Acute on chronic respiratory failure|acute on chronic respiratory failure
4893729|NCT02114944|Hypoxia|hypoxia
4893730|NCT02114944|Respiratory acidosis|respiratory acidosis
4893731|NCT02114944|Hypercarbia|hypercarbia
4893732|NCT02114944|Non invasive ventilation|non invasive ventilation
4893733|NCT02114944|NIV|niv
4893734|NCT02114944|CPAP|cpap
4893735|NCT02114944|Oxygen-therapy|oxygen-therapy
4893736|NCT02114944|High-flow oxygen therapy|high-flow oxygen therapy
4893737|NCT02114931|arthritis|arthritis
4893738|NCT02114931|rheumatoid|rheumatoid
4893739|NCT02114918|obsessive compulsive disorder|obsessive compulsive disorder
4893740|NCT02114918|children|children
4893741|NCT02114918|adolescents|adolescents
4893742|NCT02114918|attention bias modification|attention bias modification
4893743|NCT02114905|Tourette's|tourette's
4893744|NCT02114905|Tic Disorder|tic disorder
4893745|NCT02114905|CBIT|cbit
4893746|NCT02114905|Dissemination|dissemination
4893747|NCT02114905|Occupational Therapist|occupational therapist
4893748|NCT02114892|metabolic syndrome|metabolic syndrome
4893749|NCT02114892|central obesity|central obesity
4893750|NCT02114892|resveratrol|resveratrol
4893751|NCT02114892|insulin secretion|insulin secretion
4893752|NCT02114892|insulin sensitivity|insulin sensitivity
4893753|NCT02114879|Physical Therapy|physical therapy
4893754|NCT02114879|Occupational Therapy|occupational therapy
4893755|NCT02114879|Rehabilitation|rehabilitation
4893756|NCT02114879|Older adults|older adults
4893758|NCT02114879|Physical Functioning|physical functioning
4893759|NCT02114827|Multiple Myeloma|multiple myeloma
4893760|NCT02114814|Diabetes|diabetes
4893761|NCT02114814|Hispanic|hispanic
4893762|NCT02114814|Adult|adult
4893763|NCT02114814|Family Member|family member
4893764|NCT02114801|Cerebral Palsy;|cerebral palsy;
4893765|NCT02114801|Toothbrushing;|toothbrushing;
4893766|NCT02114801|Dental Plaque|dental plaque
4893767|NCT02114775|mild traumatic brain injury|mild traumatic brain injury
4893768|NCT02114775|growth hormone|growth hormone
4893769|NCT02114775|fatigue|fatigue
4893770|NCT02114775|sildenafil|sildenafil
4893771|NCT02114775|neurology|neurology
4893772|NCT02114762|otitis media|otitis media
4893773|NCT02114762|eustachian tube|eustachian tube
4893774|NCT02114762|eustachian tube dysfunction|eustachian tube dysfunction
4893775|NCT02114762|eustachian tube function testing|eustachian tube function testing
4893776|NCT02114749|Healthy volunteers|healthy volunteers
4893777|NCT02114749|Physiological variables : respiration and circulation|physiological variables : respiration and circulation
4893778|NCT02114736|Stroke|stroke
4893779|NCT02114736|Muscle spasticity|muscle spasticity
4893780|NCT02114736|Stiff knee gait|stiff knee gait
4893781|NCT02114736|Botulinum toxin|botulinum toxin
4893782|NCT02114736|Tenotomy|tenotomy
4893783|NCT02114723|Mediacal Taping concept|mediacal taping concept
4893784|NCT02114723|Neuromuscular bandage|neuromuscular bandage
4893785|NCT02114723|Physiotherapy techniques|physiotherapy techniques
4893786|NCT02114723|Kinesio Tape|kinesio tape
4893787|NCT02114710|coagulopathy|coagulopathy
4893788|NCT02114710|hydrocortisone|hydrocortisone
4893789|NCT02114710|organ failure|organ failure
4893790|NCT02114697|Cancer survivorship|cancer survivorship
4893791|NCT02114697|Cardiovascular disease|cardiovascular disease
4893792|NCT02114697|Stroke|stroke
4893793|NCT02114697|Transient ischemic attack (TIA)|transient ischemic attack (tia)
4893794|NCT02114658|Anaplastic and medullary thyroid carcinoma|anaplastic and medullary thyroid carcinoma
4893795|NCT02114658|Thyroid Neoplasms|thyroid neoplasms
4893796|NCT02114645|Luteal phase support,GnRH agonist,ART cycles|luteal phase support,gnrh agonist,art cycles
4893797|NCT02114632|ADHD, attention deficit/hyperactivity disorder, attention deficit disorder, inattention, cognitive skills, children, polyunsaturated fatty acids, PUFA|adhd, attention deficit/hyperactivity disorder, attention deficit disorder, inattention, cognitive skills, children, polyunsaturated fatty acids, pufa
4893798|NCT02114619|radioiodine therapy|radioiodine therapy
4893799|NCT02114619|Graves' disease|graves' disease
4893800|NCT02114619|Hyperthyroidism|hyperthyroidism
4893801|NCT02114619|calculated dose|calculated dose
4893802|NCT02114606|Eosinophilic Esophagitis|eosinophilic esophagitis
4893803|NCT02114606|EoE|eoe
4893804|NCT02114606|Cytosponge|cytosponge
4893805|NCT02114593|Mental Health|mental health
4893806|NCT02114593|Children|children
4893807|NCT02114593|Parent support program|parent support program
4893808|NCT02114593|Somali families|somali families
4893809|NCT02114593|Sweden|sweden
4893810|NCT02114580|mild cognitive impairment|mild cognitive impairment
4893811|NCT02114580|exercise|exercise
4893812|NCT02114580|brain plasticity|brain plasticity
4893813|NCT02114580|FMRI|fmri
4893814|NCT02114567|AECOPD|aecopd
4893815|NCT02114567|work of breathing|work of breathing
4893816|NCT02114567|patient-ventilator synchrony|patient-ventilator synchrony
4893817|NCT02114554|MELAS|melas
4893818|NCT02114554|MIDD|midd
4893819|NCT02114554|Heteroplasmy|heteroplasmy
4893820|NCT02114528|Ventricular Tachycardia|ventricular tachycardia
4893821|NCT02114528|Ventricular Arrhythmia|ventricular arrhythmia
4893822|NCT02114528|Anti-arrhythmic drugs|anti-arrhythmic drugs
4893823|NCT02114528|Catheter Ablation|catheter ablation
4893824|NCT02114528|ICD Shocks|icd shocks
4893825|NCT02114515|Patient Navigators|patient navigators
4893826|NCT02114515|Readmissions|readmissions
4893827|NCT02114515|Peer Coaching|peer coaching
4893828|NCT02114502|Myeloma|myeloma
4893829|NCT02114502|Multiple myeloma|multiple myeloma
4893830|NCT02114502|MM|mm
4893831|NCT02114502|Refractory|refractory
4893832|NCT02114502|Relapsed|relapsed
4893833|NCT02114502|Stem Cell Transplant|stem cell transplant
4893834|NCT02114502|SCT|sct
4893835|NCT02114502|Carfilzomib|carfilzomib
4893836|NCT02114502|SAHA|saha
4893837|NCT02114502|Vorinostat|vorinostat
4893838|NCT02114502|Suberoylanilide Hydroxamic Acid|suberoylanilide hydroxamic acid
4893839|NCT02114502|MSK-390|msk-390
4893840|NCT02114502|Zolinza|zolinza
4893841|NCT02114502|Gemcitabine|gemcitabine
4893842|NCT02114502|Gemcitabine Hydrochloride|gemcitabine hydrochloride
4893843|NCT02114502|Gemzar|gemzar
4893844|NCT02114502|Busulfan|busulfan
4893845|NCT02114502|Busulfex|busulfex
4893846|NCT02114502|Myleran|myleran
4893847|NCT02114502|Palifermin|palifermin
4893848|NCT02114502|Kepivance|kepivance
4893849|NCT02114502|Dexamethasone|dexamethasone
4893850|NCT02114502|Decadron|decadron
4893851|NCT02114502|Melphalan|melphalan
4893852|NCT02114502|Alkeran|alkeran
4893853|NCT02114502|Caphosol|caphosol
4893854|NCT02114502|Glutamine|glutamine
4893855|NCT02114502|Enterex|enterex
4893856|NCT02114502|Glutapak-10|glutapak-10
4893857|NCT02114502|NutreStore|nutrestore
4893858|NCT02114502|Resource|resource
4893859|NCT02114502|GlutaSolve|glutasolve
4893860|NCT02114502|Sympt-X G.I.|sympt-x g.i.
4893861|NCT02114502|Sympt-X|sympt-x
4893862|NCT02114502|Pyridoxine|pyridoxine
4893863|NCT02114489|AOH|aoh
4893864|NCT02114489|ibandronate|ibandronate
4893865|NCT02114476|GDM|gdm
4893866|NCT02114476|implant|implant
4893867|NCT02114476|diabetes mellitus|diabetes mellitus
4893868|NCT02114476|metabolic syndrome|metabolic syndrome
4893869|NCT02114463|Local analgesia system|local analgesia system
4893870|NCT02114463|Ropivacaine|ropivacaine
4893871|NCT02114463|Analgesic efficacy after operation|analgesic efficacy after operation
4893872|NCT02114463|Postoperative|postoperative
4893873|NCT02114450|Stroke|stroke
4893874|NCT02114450|Paresis|paresis
4893875|NCT02114450|Gait rehabilitation|gait rehabilitation
4893876|NCT02114450|Human-Machine Interaction|human-machine interaction
4893877|NCT02114450|Wearable Robotic Devices|wearable robotic devices
4893878|NCT02114437|Closed-Loop TCI|closed-loop tci
4893879|NCT02114437|NI|ni
4893880|NCT02114437|Laparoscopic Cholecystectomy|laparoscopic cholecystectomy
4893881|NCT02114424|Positional Obstructive sleep apnea syndrome (POSAS)|positional obstructive sleep apnea syndrome (posas)
4893882|NCT02114424|Obstructive sleep apnea syndrome (OSAS)|obstructive sleep apnea syndrome (osas)
4893883|NCT02114424|Apnea-Hypnea Index (AHI)|apnea-hypnea index (ahi)
4893884|NCT02114424|Sleep questionnaire|sleep questionnaire
4893885|NCT02114424|Positional sleep apnea belt|positional sleep apnea belt
4893886|NCT02114424|Adverse events|adverse events
4893887|NCT02114424|Compliance|compliance
4893888|NCT02114385|Prevention|prevention
4893889|NCT02114372|Alzheimer's disease|alzheimer's disease
4893890|NCT02114372|Asymptomatic at risk for Alzheimer's disease|asymptomatic at risk for alzheimer's disease
4893891|NCT02114372|Retinal diagnosis for Alzheimer's disease|retinal diagnosis for alzheimer's disease
4893892|NCT02114359|gastric cancer, elderly, chemotherapy|gastric cancer, elderly, chemotherapy
4893893|NCT02114346|Computed Tomography Angiogram|computed tomography angiogram
4893894|NCT02114346|Side Effects|side effects
4893895|NCT02114346|Contrast-Induced Nephropathy|contrast-induced nephropathy
4893896|NCT02114346|Prevention|prevention
4893897|NCT02114333|Shingles vaccine|shingles vaccine
4893898|NCT02114333|Immune response|immune response
4893899|NCT02114333|Zoster vaccine|zoster vaccine
4893900|NCT02114320|Endoscopic ultrasonography|endoscopic ultrasonography
4893901|NCT02114320|Biliary drainage|biliary drainage
4893902|NCT02114320|Metal stent|metal stent
4893903|NCT02114307|electrical stimulation|electrical stimulation
4893904|NCT02114307|venous insufficiency|venous insufficiency
4893905|NCT02114307|post thrombotic syndrome|post thrombotic syndrome
4893906|NCT02114307|varicose veins|varicose veins
4893907|NCT02114294|Patellofemoral pain syndrome|patellofemoral pain syndrome
4893908|NCT02114294|Anterior knee pain|anterior knee pain
4893909|NCT02114294|Randomised controlled trial|randomised controlled trial
4893910|NCT02114294|Exercise intervention|exercise intervention
4893911|NCT02114294|Hip strengthening|hip strengthening
4893912|NCT02114294|Quadriceps based training|quadriceps based training
4893913|NCT02114294|Anterior knee pain score|anterior knee pain score
4893914|NCT02114281|Oral Health|oral health
4893915|NCT02114281|Periodontitis|periodontitis
4893916|NCT02114281|Tooth cavities|tooth cavities
4893917|NCT02114281|Saliva|saliva
4893918|NCT02114281|Halitosis|halitosis
4893919|NCT02114281|Mucosa|mucosa
4893920|NCT02114281|Chronic kidney disease|chronic kidney disease
4893921|NCT02114281|Inflammation|inflammation
4893922|NCT02114281|Nutrition|nutrition
4893923|NCT02114268|Respiratory Syncytial Virus, RSV|respiratory syncytial virus, rsv
4893924|NCT02114255|Influenza|influenza
4893925|NCT02114255|Trained immunity|trained immunity
4893926|NCT02114255|BCG|bcg
4893927|NCT02114242|Parkinson's disease|parkinson's disease
4893928|NCT02114242|multiple system atrophy|multiple system atrophy
4893929|NCT02114242|progressive supranuclear palsy|progressive supranuclear palsy
4893930|NCT02114242|alpha-synuclein|alpha-synuclein
4893931|NCT02114229|Alisertib|alisertib
4893932|NCT02114229|MLN8237|mln8237
4893933|NCT02114229|AT/RT|at/rt
4893934|NCT02114229|MRT|mrt
4893935|NCT02114190|Overweight Adolescents|overweight adolescents
4893936|NCT02114190|Mindful Eating and Living|mindful eating and living
4893937|NCT02114190|Family Systems|family systems
4893938|NCT02114190|Body-Mass Index|body-mass index
4893939|NCT02114190|Mindfulness|mindfulness
4893940|NCT02114177|Hepatitis C Virus Infection|hepatitis c virus infection
4893941|NCT02114177|Simeprevir|simeprevir
4893942|NCT02114177|Sofosbuvir|sofosbuvir
4893943|NCT02114177|HCV|hcv
4893944|NCT02114177|Cirrhosis|cirrhosis
4893945|NCT02114164|AirSeal|airseal
4893946|NCT02114164|Trocar|trocar
4893947|NCT02114164|Carbon Dioxide Exchange and Absorption|carbon dioxide exchange and absorption
4893948|NCT02114151|Hepatitis C Virus Infection|hepatitis c virus infection
4893949|NCT02114151|Simeprevir|simeprevir
4893950|NCT02114151|Sofosbuvir|sofosbuvir
4893951|NCT02114151|HCV|hcv
4893952|NCT02114151|Cirrhosis|cirrhosis
4893953|NCT02114138|postoperative acute kidney injury|postoperative acute kidney injury
4893954|NCT02114138|pAKI|paki
4893955|NCT02114138|stress injury on the kidney|stress injury on the kidney
4893956|NCT02114138|chronic kidney disease|chronic kidney disease
4893957|NCT02114138|CKD|ckd
4893958|NCT02114125|Physical activity|physical activity
4893959|NCT02114125|Cognitive training|cognitive training
4893960|NCT02114112|Bronchopulmonary dysplasia|bronchopulmonary dysplasia
4893961|NCT02114112|Continuous positive airway pressure pressure|continuous positive airway pressure pressure
4893962|NCT02114112|Preterms|preterms
4893963|NCT02114099|Kawasaki Disease|kawasaki disease
4893964|NCT02114099|Aneurysm, Coronary|aneurysm, coronary
4893965|NCT02114086|Observational Study|observational study
4893966|NCT02114086|intraoperative Radiation of Breast Cancer|intraoperative radiation of breast cancer
4893967|NCT02114086|early and late effects of radiation|early and late effects of radiation
4893968|NCT02114086|cosmesis and quality of life|cosmesis and quality of life
4893969|NCT02114073|glaucoma|glaucoma
4893970|NCT02114073|trabeculectomy|trabeculectomy
4893971|NCT02114073|cyclosporine|cyclosporine
4893972|NCT02114073|betamethasone|betamethasone
4893973|NCT02114060|HSV|hsv
4893974|NCT02114060|Herpes|herpes
4893975|NCT02114060|genital infection|genital infection
4893976|NCT02114060|vaccine|vaccine
4893977|NCT02114034|Severe asthma,|severe asthma,
4893978|NCT02114034|child,|child,
4893979|NCT02114034|outcome,|outcome,
4893980|NCT02114021|Syndrome incidence after intubation|syndrome incidence after intubation
4893981|NCT02114021|Betamethasone gel|betamethasone gel
4893982|NCT02114021|lidocaine jelly|lidocaine jelly
4893983|NCT02114021|sore throat|sore throat
4893984|NCT02114021|cough|cough
4893985|NCT02114021|hoarseness of voice|hoarseness of voice
4893986|NCT02114008|Gastric emptying.|gastric emptying.
4893987|NCT02114008|Residual gastric volume.|residual gastric volume.
4893988|NCT02114008|Preoperative fasting.|preoperative fasting.
4893989|NCT02114008|Morbid Obesity.|morbid obesity.
4893990|NCT02114008|Diabetes.|diabetes.
4893991|NCT02113995|Obesity, Morbid|obesity, morbid
4893992|NCT02113995|Insulin Resistance|insulin resistance
4893993|NCT02113995|Acute-Phase Reaction|acute-phase reaction
4893994|NCT02113995|Gastroplasty|gastroplasty
4893995|NCT02113995|Length of Stay|length of stay
4893996|NCT02113995|Protocols|protocols
4893997|NCT02113995|Randomized Controlled Trial.|randomized controlled trial.
4893998|NCT02113969|Pelvic Organ Prolapse|pelvic organ prolapse
4893999|NCT02113969|Quality of Life|quality of life
4894000|NCT02113969|Symptoms|symptoms
4894001|NCT02113969|Pessary|pessary
4894002|NCT02113969|Treatment|treatment
4894003|NCT02113956|HIV Prevention|hiv prevention
4894004|NCT02113956|Adolescent Men who Have Sex with Men (AMSM)|adolescent men who have sex with men (amsm)
4894005|NCT02113956|Text-Messaging|text-messaging
4894006|NCT02113956|Information-Motivation-Behavioral Skills(IMB)Model|information-motivation-behavioral skills(imb)model
4894007|NCT02113917|infant, adolescent and adult Hemophagocytic Syndrome|infant, adolescent and adult hemophagocytic syndrome
4894008|NCT02113917|Hemophagocytic lymphohistiocytosis|hemophagocytic lymphohistiocytosis
4894009|NCT02113904|Netherton syndrome|netherton syndrome
4894010|NCT02113904|Adalimumab|adalimumab
4894011|NCT02113904|TNF-alpha|tnf-alpha
4894012|NCT02113904|Orphan genetic syndrome|orphan genetic syndrome
4894013|NCT02113891|Antibody-mediated rejection|antibody-mediated rejection
4894014|NCT02113891|Complement blockade|complement blockade
4894015|NCT02113891|Eculizumab|eculizumab
4894016|NCT02113891|Kidney transplantation|kidney transplantation
4894017|NCT02113878|Carcinoma, Squamous Cell of Head and Neck|carcinoma, squamous cell of head and neck
4894018|NCT02113878|Human Papillomavirus Positive Oropharyngeal Carcinoma|human papillomavirus positive oropharyngeal carcinoma
4894019|NCT02113878|Hypopharyngeal Cancer|hypopharyngeal cancer
4894020|NCT02113878|Early Invasive Cervical Squamous Cell Carcinoma|early invasive cervical squamous cell carcinoma
4894021|NCT02113878|Carcinoma of Larynx|carcinoma of larynx
4894022|NCT02113878|Cancer of Nasopharynx|cancer of nasopharynx
4894023|NCT02113852|Non small cell Lung Cancer|non small cell lung cancer
4894024|NCT02113852|Heavy smokers|heavy smokers
4894025|NCT02113852|Treatment naive patients|treatment naive patients
4894026|NCT02113839|Dyspnea perception|dyspnea perception
4894027|NCT02113839|COPD|copd
4894028|NCT02113839|Exacerbations|exacerbations
4894029|NCT02113839|CO2 rebreathing test|co2 rebreathing test
4894030|NCT02113826|Pazopanib|pazopanib
4894031|NCT02113826|Alveolar soft part sarcoma|alveolar soft part sarcoma
4894032|NCT02113813|irreversible EGFR inhibitor|irreversible egfr inhibitor
4894033|NCT02113813|Non-Small-Cell Lung Cancer|non-small-cell lung cancer
4894034|NCT02113813|Midazolam|midazolam
4894035|NCT02113813|T790M resistance mutation|t790m resistance mutation
4894036|NCT02113813|EGFR|egfr
4894037|NCT02113813|NSCLC|nsclc
4894038|NCT02113813|naquotinib|naquotinib
4894039|NCT02113813|Epidermal Growth Factor Receptor mutations|epidermal growth factor receptor mutations
4894040|NCT02113813|ASP8273|asp8273
4894041|NCT02113787|epilepsy|epilepsy
4894042|NCT02113787|anticonvulsants|anticonvulsants
4894043|NCT02113787|generic drugs|generic drugs
4894044|NCT02113748|Pulmonary disease, chronic obstructive|pulmonary disease, chronic obstructive
4894045|NCT02113748|Downhill walking|downhill walking
4894046|NCT02113748|exercise|exercise
4894047|NCT02113735|ARDS|ards
4894048|NCT02113735|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
4894049|NCT02113735|Acthar|acthar
4894050|NCT02113735|ACTH|acth
4894051|NCT02113735|H.P. Acthar Gel|h.p. acthar gel
4894052|NCT02113722|Sudden cardiac death|sudden cardiac death
4894053|NCT02113722|Ganglionectomy|ganglionectomy
4894054|NCT02113722|Ventricular arrhythmia|ventricular arrhythmia
4894055|NCT02113722|Cardiac surgery|cardiac surgery
4894056|NCT02113722|Implanted cardiac defibrillator|implanted cardiac defibrillator
4894057|NCT02113709|Amblyopia|amblyopia
4894058|NCT02113709|Strabismus|strabismus
4894059|NCT02113709|Occlusion therapy|occlusion therapy
4894060|NCT02113709|Visual improvement|visual improvement
4894061|NCT02113696|morbid obesity|morbid obesity
4894062|NCT02113696|BMI at or above 4O kg/m2|bmi at or above 4o kg/m2
4894063|NCT02113696|ingestion of omega 3|ingestion of omega 3
4894064|NCT02113696|inflammatory cytokines|inflammatory cytokines
4894065|NCT02113696|biochemical factors|biochemical factors
4894066|NCT02113696|anthropometric factors|anthropometric factors
4894067|NCT02113683|colo-rectal cancer|colo-rectal cancer
4894068|NCT02113683|stomach cancer|stomach cancer
4894069|NCT02113683|melanoma|melanoma
4894070|NCT02113683|MMS test|mms test
4894071|NCT02113683|therapy monitoring|therapy monitoring
4894072|NCT02113683|Sarcoma|sarcoma
4894073|NCT02113670|stress urinary incontinence|stress urinary incontinence
4894074|NCT02113670|abdominal leak point pressure|abdominal leak point pressure
4894075|NCT02113670|urodynamic study|urodynamic study
4894076|NCT02113657|Prostate cancer|prostate cancer
4894077|NCT02113657|Castration-resistant prostate cancer|castration-resistant prostate cancer
4894078|NCT02113657|CRPC|crpc
4894079|NCT02113657|Metastatic|metastatic
4894080|NCT02113657|Hormone therapy treatment|hormone therapy treatment
4894081|NCT02113657|Androgen deprivation therapy|androgen deprivation therapy
4894082|NCT02113657|gonadotropin-releasing hormone|gonadotropin-releasing hormone
4894083|NCT02113657|GnRH|gnrh
4894084|NCT02113657|Ipilimumab|ipilimumab
4894085|NCT02113657|Yervoy|yervoy
4894086|NCT02113657|BMS-734016|bms-734016
4894087|NCT02113657|MDX010|mdx010
4894088|NCT02113631|Hepatitis C treatment,|hepatitis c treatment,
4894089|NCT02113631|Boceprevir,|boceprevir,
4894090|NCT02113631|Telaprevir,|telaprevir,
4894091|NCT02113631|Safety|safety
4894092|NCT02113631|Effectiveness|effectiveness
4894093|NCT02113631|Head-to-head trial|head-to-head trial
4894221|NCT02113163|dyslipidemia|dyslipidemia
4894094|NCT02113618|Cognitive function, alcohol dependence, working memory|cognitive function, alcohol dependence, working memory
4894095|NCT02113605|Functional gastrointestinal disorders|functional gastrointestinal disorders
4894096|NCT02113605|FGID|fgid
4894097|NCT02113605|Recurrent abdominal pain|recurrent abdominal pain
4894098|NCT02113605|Abdominal pain|abdominal pain
4894099|NCT02113605|pain-predominant functional gastrointestinal disorders|pain-predominant functional gastrointestinal disorders
4894100|NCT02113605|Pediatric pain|pediatric pain
4894101|NCT02113592|Pain management|pain management
4894102|NCT02113592|Opioid use|opioid use
4894103|NCT02113592|Pragmatic|pragmatic
4894104|NCT02113592|Collaborative care|collaborative care
4894105|NCT02113592|Primary care|primary care
4894106|NCT02113579|Tooth Sensitivity|tooth sensitivity
4894107|NCT02113566|Delayed onset muscle soreness|delayed onset muscle soreness
4894108|NCT02113566|DOMS|doms
4894109|NCT02113540|coronary angiography|coronary angiography
4894110|NCT02113540|chronic stable angina|chronic stable angina
4894111|NCT02113540|CIN|cin
4894112|NCT02113527|Electrogastrography|electrogastrography
4894113|NCT02113527|Functional dyspepsia|functional dyspepsia
4894114|NCT02113527|Gastric emptying|gastric emptying
4894115|NCT02113527|Gastrointestinal peptides|gastrointestinal peptides
4894116|NCT02113527|Rome III criteria|rome iii criteria
4894117|NCT02113514|Appalachian|appalachian
4894118|NCT02113514|abnormal pap test|abnormal pap test
4894119|NCT02113501|HGT1|hgt1
4894120|NCT02113501|high risk bladder cancer|high risk bladder cancer
4894121|NCT02113501|substaging|substaging
4894122|NCT02113501|repeat transurethral resection (reTUR)|repeat transurethral resection (retur)
4894123|NCT02113501|lamina propria|lamina propria
4894124|NCT02113475|CDT|cdt
4894125|NCT02113475|PCDT|pcdt
4894126|NCT02113475|DVT|dvt
4894127|NCT02113475|PTS|pts
4894128|NCT02113475|Quality of Life|quality of life
4894129|NCT02113462|Chronic kidney disease|chronic kidney disease
4894130|NCT02113462|Endothelial dysfunction|endothelial dysfunction
4894131|NCT02113462|Inflammation|inflammation
4894132|NCT02113462|Insulin resistance|insulin resistance
4894133|NCT02113462|Tg/hdl ratio|tg/hdl ratio
4894134|NCT02113449|Carbon Dioxide, Allergy symptoms|carbon dioxide, allergy symptoms
4894135|NCT02113436|FP/SLM|fp/slm
4894136|NCT02113436|Asthma|asthma
4894137|NCT02113436|Infant|infant
4894138|NCT02113436|Efficacy|efficacy
4894139|NCT02113436|Safety|safety
4894140|NCT02113423|superiority, re-irradiation, IMRT, recurrent T1-2 NPC|superiority, re-irradiation, imrt, recurrent t1-2 npc
4894141|NCT02113410|osteoarthritis|osteoarthritis
4894142|NCT02113410|Older adults|older adults
4894143|NCT02113410|Sit 'N' Chair Yoga|sit 'n' chair yoga
4894144|NCT02113410|Pain|pain
4894145|NCT02113410|Physical Function|physical function
4894146|NCT02113410|Balance|balance
4894147|NCT02113410|Fatigue|fatigue
4894148|NCT02113410|Depression|depression
4894149|NCT02113410|Life Satisfaction|life satisfaction
4894150|NCT02113397|Cystic fibrosis|cystic fibrosis
4894151|NCT02113397|Microbiome|microbiome
4894152|NCT02113397|Sputum|sputum
4894153|NCT02113397|Tobramycin|tobramycin
4894154|NCT02113397|Colistimethate|colistimethate
4894155|NCT02113384|Rectal cancer|rectal cancer
4894156|NCT02113384|Locally advanced rectal cancer|locally advanced rectal cancer
4894157|NCT02113384|Peritoneal carcinomatosis|peritoneal carcinomatosis
4894158|NCT02113384|Exfoliated peritoneal cells|exfoliated peritoneal cells
4894159|NCT02113384|Peritoneal lavage|peritoneal lavage
4894160|NCT02113371|Injury Prevention|injury prevention
4894161|NCT02113371|Health Promotion|health promotion
4894162|NCT02113371|Well being|well being
4894163|NCT02113371|Safety|safety
4894164|NCT02113371|Nutrition|nutrition
4894165|NCT02113371|Physical Activity|physical activity
4894166|NCT02113371|Sleep|sleep
4894167|NCT02113371|Stress|stress
4894168|NCT02113358|fluid therapy|fluid therapy
4894169|NCT02113358|neurosurgery|neurosurgery
4894170|NCT02113345|metamemory|metamemory
4894171|NCT02113345|memory|memory
4894172|NCT02113345|mild cognitive impairment|mild cognitive impairment
4894173|NCT02113332|Insulin injections|insulin injections
4894174|NCT02113332|Overweight|overweight
4894175|NCT02113332|Inadequate glycaemic control|inadequate glycaemic control
4894176|NCT02113319|Core Binding Factors|core binding factors
4894177|NCT02113319|Acute Myelogenous Leukemia refractory to conventional chemotherapy|acute myelogenous leukemia refractory to conventional chemotherapy
4894178|NCT02113319|molecular relapse|molecular relapse
4894179|NCT02113293|phase I study|phase i study
4894180|NCT02113293|tolerability|tolerability
4894181|NCT02113293|safety|safety
4894182|NCT02113293|CyclASol®|cyclasol®
4894183|NCT02113293|eye drops|eye drops
4894184|NCT02113267|esophagitis|esophagitis
4894185|NCT02113267|eosinophils|eosinophils
4894186|NCT02113267|allergy|allergy
4894187|NCT02113267|inflammation|inflammation
4894188|NCT02113267|corticosteroids|corticosteroids
4894189|NCT02113254|corn|corn
4894190|NCT02113254|macular pigment|macular pigment
4894191|NCT02113254|lutein|lutein
4894192|NCT02113254|zeaxanthin|zeaxanthin
4894193|NCT02113254|Age Macular Degeneration|age macular degeneration
4894194|NCT02113254|AMD|amd
4894195|NCT02113241|metabolic syndrome|metabolic syndrome
4894196|NCT02113241|forxiga|forxiga
4894197|NCT02113241|dapagliflozin|dapagliflozin
4894198|NCT02113241|insulin secretion|insulin secretion
4894199|NCT02113241|insulin sensitivity|insulin sensitivity
4894200|NCT02113228|Energy metabolism|energy metabolism
4894201|NCT02113228|Stable isotopes|stable isotopes
4894202|NCT02113228|Short bowel syndrome|short bowel syndrome
4894203|NCT02113228|Doubly labeled water|doubly labeled water
4894204|NCT02113215|aging|aging
4894205|NCT02113215|lipid metabolism|lipid metabolism
4894206|NCT02113215|very low density lipoproteins|very low density lipoproteins
4894207|NCT02113202|Optical imaging|optical imaging
4894208|NCT02113202|Fluorescence endoscopy|fluorescence endoscopy
4894209|NCT02113202|Near infrared fluorescence|near infrared fluorescence
4894210|NCT02113202|Familial Adenomatous Polyposis|familial adenomatous polyposis
4894211|NCT02113202|IRDye800CW|irdye800cw
4894212|NCT02113202|Vascular Endothelial Growth Factor A|vascular endothelial growth factor a
4894213|NCT02113202|Gastrointestinal endoscopy|gastrointestinal endoscopy
4894214|NCT02113189|gait|gait
4894215|NCT02113189|Parkinson's disease|parkinson's disease
4894216|NCT02113176|SAH|sah
4894217|NCT02113163|Type 2 diabetes|type 2 diabetes
4894218|NCT02113163|T2DM|t2dm
4894219|NCT02113163|hypertriglyceridemia|hypertriglyceridemia
4894220|NCT02113163|severe hypertriglyceridemia|severe hypertriglyceridemia
4894222|NCT02113163|triglycerides|triglycerides
4894223|NCT02113163|lipids|lipids
4894224|NCT02113163|omega-3 fatty acids|omega-3 fatty acids
4894225|NCT02113163|EPA|epa
4894226|NCT02113163|ethyl-EPA|ethyl-epa
4894227|NCT02113163|Metformin|metformin
4894228|NCT02113163|Glucophage|glucophage
4894229|NCT02113163|Lovaza|lovaza
4894230|NCT02113163|Vascepa|vascepa
4894231|NCT02113163|Epanova|epanova
4894232|NCT02113163|Astra Zeneca|astra zeneca
4894233|NCT02113163|Amarin|amarin
4894234|NCT02113163|GSK|gsk
4894235|NCT02113150|troponin t,cystatin-c,ketamine,remifentanil|troponin t,cystatin-c,ketamine,remifentanil
4894236|NCT02113137|halitosis|halitosis
4894237|NCT02113137|chlorine dioxide|chlorine dioxide
4894238|NCT02113137|tongue cleaning|tongue cleaning
4894239|NCT02113124|Chronic Brain Injury|chronic brain injury
4894240|NCT02113124|Traumatic brain injury (TBI)|traumatic brain injury (tbi)
4894241|NCT02113124|Amino Acids|amino acids
4894242|NCT02113124|Microbiome|microbiome
4894243|NCT02113098|Stroke|stroke
4894244|NCT02113098|Gait|gait
4894245|NCT02113098|Rehabilitation|rehabilitation
4894246|NCT02113085|Adolescents, foster care, self-determination|adolescents, foster care, self-determination
4894247|NCT02113072|wheezing, immune system, cytokines, probiotics, infants.|wheezing, immune system, cytokines, probiotics, infants.
4894248|NCT02113059|Liver regeneration|liver regeneration
4894249|NCT02113059|liver dysfunction|liver dysfunction
4894250|NCT02113059|platelets|platelets
4894251|NCT02113059|plasma|plasma
4894252|NCT02113059|serum|serum
4894253|NCT02113059|platelet activation|platelet activation
4894254|NCT02113059|morbidity|morbidity
4894255|NCT02113059|mortality|mortality
4894256|NCT02113059|Growth factors|growth factors
4894257|NCT02113059|Postoperative clinical outcome|postoperative clinical outcome
4894258|NCT02113046|pancreas|pancreas
4894259|NCT02113046|pancreatico-jejunal anastomosis|pancreatico-jejunal anastomosis
4894260|NCT02113046|postoperative pancreatic fistulae|postoperative pancreatic fistulae
4894261|NCT02113007|Lymphoma; CNS; rituximab; temozolomide|lymphoma; cns; rituximab; temozolomide
4894262|NCT02112994|Enzyme Replacement Therapy (ERT)|enzyme replacement therapy (ert)
4894263|NCT02112994|Lysosomal Storage Disease|lysosomal storage disease
4894264|NCT02112994|Late Onset Lysosomal Acid Lipase (LAL) Deficiency|late onset lysosomal acid lipase (lal) deficiency
4894265|NCT02112994|Acid cholesteryl ester hydrolase deficiency, type 2|acid cholesteryl ester hydrolase deficiency, type 2
4894266|NCT02112994|Acid lipase disease|acid lipase disease
4894267|NCT02112994|Cholesterol ester hydrolase deficiency|cholesterol ester hydrolase deficiency
4894268|NCT02112994|LAL Deficiency|lal deficiency
4894269|NCT02112994|LIPA Deficiency|lipa deficiency
4894270|NCT02112994|Wolman disease|wolman disease
4894271|NCT02112994|Additional relevant MeSH terms:|additional relevant mesh terms:
4894272|NCT02112994|Cholesterol Ester Storage Disease|cholesterol ester storage disease
4894273|NCT02112994|Metabolic Diseases|metabolic diseases
4894274|NCT02112994|Lipidoses|lipidoses
4894275|NCT02112994|Lipid Metabolism, Inborn Errors|lipid metabolism, inborn errors
4894276|NCT02112994|Metabolism, Inborn Errors|metabolism, inborn errors
4894277|NCT02112994|Genetic Diseases, Inborn|genetic diseases, inborn
4894278|NCT02112994|Lysosomal Storage Diseases|lysosomal storage diseases
4894279|NCT02112994|Lipid Metabolism Disorders|lipid metabolism disorders
4894280|NCT02112994|Infant, Newborn, Diseases|infant, newborn, diseases
4894281|NCT02112981|Coronary Arteriosclerosis|coronary arteriosclerosis
4894282|NCT02112968|Myopia|myopia
4894283|NCT02112968|Hyperopia|hyperopia
4894284|NCT02112968|Presbyopia|presbyopia
4894285|NCT02112968|Supracor|supracor
4894286|NCT02112968|Zyoptix|zyoptix
4894287|NCT02112968|Proscan|proscan
4894288|NCT02112968|LASIK|lasik
4894289|NCT02112955|Stroke|stroke
4894290|NCT02112955|Disease management|disease management
4894291|NCT02112955|Self efficacy|self efficacy
4894292|NCT02112955|Quality of life|quality of life
4894293|NCT02112955|Community integration|community integration
4894294|NCT02112942|Hepatitis C virus|hepatitis c virus
4894295|NCT02112942|HCV|hcv
4894296|NCT02112929|Magnetic Resonance Imaging|magnetic resonance imaging
4894297|NCT02112929|Lung Diseases|lung diseases
4894298|NCT02112890|Mexico|mexico
4894299|NCT02112890|Adolescents|adolescents
4894300|NCT02112890|Hepatitis|hepatitis
4894301|NCT02112890|Seroprevalence|seroprevalence
4894302|NCT02112890|Pertussis|pertussis
4894303|NCT02112890|Young adults|young adults
4894304|NCT02112877|iliofemoral vein|iliofemoral vein
4894305|NCT02112877|venous|venous
4894306|NCT02112877|venous obstruction|venous obstruction
4894307|NCT02112838|IGA Glomerulonephritis|iga glomerulonephritis
4894308|NCT02112838|Nephritis, IGA Type|nephritis, iga type
4894309|NCT02112825|Exercise|exercise
4894310|NCT02112825|blood pressure|blood pressure
4894311|NCT02112825|chronic kidney disease|chronic kidney disease
4894312|NCT02112812|Parkinsons disease|parkinsons disease
4894313|NCT02112812|Helicobacter pylori|helicobacter pylori
4894314|NCT02112812|Eradication|eradication
4894315|NCT02112812|Levodopa response|levodopa response
4894316|NCT02112812|Motor outcomes|motor outcomes
4894317|NCT02112812|Quality of Life|quality of life
4894318|NCT02112812|Open label|open label
4894319|NCT02112799|Hepatitis B|hepatitis b
4894320|NCT02112786|Overactive Bladder|overactive bladder
4894321|NCT02112773|Adenoviral conjunctivitis diagnosed with AdenoPlus™ Test|adenoviral conjunctivitis diagnosed with adenoplus™ test
4894322|NCT02112760|specific stabilization exercise|specific stabilization exercise
4894323|NCT02112760|ultrasound|ultrasound
4894324|NCT02112760|low back pain|low back pain
4894325|NCT02112747|Colorectal Cancer Prevention|colorectal cancer prevention
4894326|NCT02112747|Colorectal Cancer Screening|colorectal cancer screening
4894327|NCT02112747|ACCS|accs
4894328|NCT02112747|Lynch Syndrome|lynch syndrome
4894329|NCT02112747|LS|ls
4894330|NCT02112734|vitamin D|vitamin d
4894331|NCT02112734|food allergy|food allergy
4894332|NCT02112734|eczema|eczema
4894333|NCT02112708|Psychotherapy, Rational-Emotive|psychotherapy, rational-emotive
4894334|NCT02112708|Depression|depression
4894335|NCT02112708|Social Work|social work
4894336|NCT02112708|Primary Health Care|primary health care
4894337|NCT02112695|endurance sportswomen|endurance sportswomen
4894338|NCT02112695|addiction|addiction
4894339|NCT02112695|undernutrition|undernutrition
4894340|NCT02112695|[11C]diprenorphine Pet|[11c]diprenorphine pet
4894341|NCT02112695|pituitary region|pituitary region
4894342|NCT02112682|Sentinel lymph node metastasis|sentinel lymph node metastasis
4894343|NCT02112682|Completion axillary lymph node dissection|completion axillary lymph node dissection
4894344|NCT02112682|Axillary radiotherapy|axillary radiotherapy
4894345|NCT02112656|Carcinoma|carcinoma
4894346|NCT02112656|Carcinoma, Hepatocellular|carcinoma, hepatocellular
4894347|NCT02112656|Neoplasms, Glandular and Epithelial|neoplasms, glandular and epithelial
4894348|NCT02112656|Neoplasms by Histologic Type|neoplasms by histologic type
4894349|NCT02112656|Neoplasms|neoplasms
4894350|NCT02112656|Adenocarcinoma|adenocarcinoma
4894351|NCT02112656|Liver Neoplasms|liver neoplasms
4894352|NCT02112656|Digestive System Neoplasms|digestive system neoplasms
4894353|NCT02112656|Neoplasms by Site|neoplasms by site
4894354|NCT02112656|Digestive System Diseases|digestive system diseases
4894355|NCT02112656|Liver Diseases|liver diseases
4894356|NCT02112656|Doxorubicin|doxorubicin
4894357|NCT02112656|Antibiotics, Antineoplastic|antibiotics, antineoplastic
4894358|NCT02112656|Antineoplastic Agents|antineoplastic agents
4894359|NCT02112656|Therapeutic Uses|therapeutic uses
4894360|NCT02112656|Pharmacologic Actions|pharmacologic actions
4894361|NCT02112643|Thyroid eye disease|thyroid eye disease
4894362|NCT02112643|Thyroid orbitopathy|thyroid orbitopathy
4894363|NCT02112643|Graves' orbitopathy|graves' orbitopathy
4894364|NCT02112643|Graves' ophthalmopathy|graves' ophthalmopathy
4894365|NCT02112630|Hepatitis C Infection|hepatitis c infection
4894366|NCT02112630|HCV, genotype 1|hcv, genotype 1
4894367|NCT02112630|End Stage Renal Disease|end stage renal disease
4894368|NCT02112630|ESRD|esrd
4894369|NCT02112630|Boceprevir|boceprevir
4894370|NCT02112630|Pegylated Interferon|pegylated interferon
4894371|NCT02112630|Ribavirin|ribavirin
4894372|NCT02112617|Neuroblastoma|neuroblastoma
4894373|NCT02112617|Childhood neuroblastoma|childhood neuroblastoma
4894374|NCT02112617|Ganglioneuroblastoma|ganglioneuroblastoma
4894375|NCT02112617|Pediatric neuroblastoma|pediatric neuroblastoma
4894376|NCT02112604|critically ill, OSA, mechanical ventilation|critically ill, osa, mechanical ventilation
4894377|NCT02112591|Stress urinary incontinence|stress urinary incontinence
4894378|NCT02112591|mesh|mesh
4894379|NCT02112591|tape|tape
4894380|NCT02112591|micturition dysfunction|micturition dysfunction
4894381|NCT02112591|urinary obstruction|urinary obstruction
4894382|NCT02112591|TOT|tot
4894383|NCT02112578|Vertigo, Meclizine, dimenhydrinate, Peripheral Origin|vertigo, meclizine, dimenhydrinate, peripheral origin
4894384|NCT02112526|de Novo Activated B-cell (ABC) Subtype of Diffuse Large B-Cell Lymphoma|de novo activated b-cell (abc) subtype of diffuse large b-cell lymphoma
4894385|NCT02112526|Diffuse Large B-Cell Lymphoma|diffuse large b-cell lymphoma
4894386|NCT02112526|Novo Activated B-cell (ABC)|novo activated b-cell (abc)
4894387|NCT02112526|Novo Activated B-cell|novo activated b-cell
4894388|NCT02112526|ABC DLBCL|abc dlbcl
4894389|NCT02112526|DLBCL|dlbcl
4894390|NCT02112526|Lymphoma|lymphoma
4894391|NCT02112526|B-Cell|b-cell
4894392|NCT02112526|Immunoproliferative Disorders|immunoproliferative disorders
4894393|NCT02112526|Immune System Diseases|immune system diseases
4894394|NCT02112487|pulmonary arterial hypertension|pulmonary arterial hypertension
4894395|NCT02112487|PAH-SYMPACT|pah-sympact
4894396|NCT02112487|PAH|pah
4894397|NCT02112487|psychometric instrument|psychometric instrument
4894398|NCT02112474|Failed Back Surgery Syndrome|failed back surgery syndrome
4894399|NCT02112474|Neuropathic pain|neuropathic pain
4894400|NCT02112474|Leg Pain|leg pain
4894401|NCT02112474|Chronic Pain|chronic pain
4894402|NCT02112474|Spinal Cord Stimulation|spinal cord stimulation
4894403|NCT02112474|Neurostimulation|neurostimulation
4894404|NCT02112461|end of life care|end of life care
4894405|NCT02112448|congenital heart disease, pediatric cardiothoracic surgery|congenital heart disease, pediatric cardiothoracic surgery
4894406|NCT02112435|obstructive sleep apnea|obstructive sleep apnea
4894407|NCT02112435|mandibular advancement splint|mandibular advancement splint
4894408|NCT02112435|active mandibular advancement splint|active mandibular advancement splint
4894409|NCT02112435|oral appliance|oral appliance
4894410|NCT02112422|Parturients|parturients
4894411|NCT02112409|Adolescent idiopathic scoliosis|adolescent idiopathic scoliosis
4894412|NCT02112409|scoliosis corrective surgery|scoliosis corrective surgery
4894413|NCT02112409|autologous blood transfusion|autologous blood transfusion
4894414|NCT02112409|cell salvage|cell salvage
4894415|NCT02112409|acute normovolemic hemodilution|acute normovolemic hemodilution
4894416|NCT02112409|hemoglobin level|hemoglobin level
4894417|NCT02112396|CRAFT|craft
4894418|NCT02112396|Concerned Significant Others|concerned significant others
4894419|NCT02112396|Contingency management|contingency management
4894420|NCT02112396|Reinforcement|reinforcement
4894421|NCT02112396|Family Intervention|family intervention
4894422|NCT02112383|Procrastination|procrastination
4894423|NCT02112383|Cognitive behavior therapy|cognitive behavior therapy
4894424|NCT02112383|Internet interventions|internet interventions
4894425|NCT02112383|Group intervention|group intervention
4894426|NCT02112383|Students|students
4894427|NCT02112383|Randomized controlled trial|randomized controlled trial
4894428|NCT02112370|Ropivacaine|ropivacaine
4894429|NCT02112370|Epinephrine|epinephrine
4894430|NCT02112370|Endoscopy|endoscopy
4894431|NCT02112370|Robotics|robotics
4894432|NCT02112370|Thyroidectomy|thyroidectomy
4894433|NCT02112357|molecular profiling|molecular profiling
4894434|NCT02112357|genetic sequencing|genetic sequencing
4894435|NCT02112357|personalised medicine|personalised medicine
4894436|NCT02112357|gastrointestinal cancer|gastrointestinal cancer
4894437|NCT02112331|Preterm newborns|preterm newborns
4894438|NCT02112331|Gastric lipolysis|gastric lipolysis
4894439|NCT02112331|Physical treatments|physical treatments
4894440|NCT02112331|Human milk|human milk
4894441|NCT02112305|Magnesium sulphate nebulized|magnesium sulphate nebulized
4894442|NCT02112279|Microbiota|microbiota
4894443|NCT02112279|c-difficile|c-difficile
4894444|NCT02112279|colonoscopy|colonoscopy
4894445|NCT02112279|stool transplant|stool transplant
4894446|NCT02112266|depression|depression
4894447|NCT02112266|online therapy|online therapy
4894448|NCT02112266|cognitive behavioural therapy|cognitive behavioural therapy
4894449|NCT02112266|quality of life|quality of life
4894450|NCT02112266|alexithymia|alexithymia
4894451|NCT02112266|therapy expectation and satisfaction|therapy expectation and satisfaction
4894452|NCT02112253|Tourette's syndrome|tourette's syndrome
4894453|NCT02112253|Deep brain stimulation|deep brain stimulation
4894454|NCT02112253|Stereotactic surgery|stereotactic surgery
4894455|NCT02112253|Globus pallidus interna|globus pallidus interna
4894456|NCT02112253|Tics|tics
4894457|NCT02112240|sentinel lymph node|sentinel lymph node
4894458|NCT02112240|lymphatic mapping|lymphatic mapping
4894459|NCT02112240|rectal tumor|rectal tumor
4894460|NCT02112227|Heart Failure|heart failure
4894461|NCT02112227|Transitional Care|transitional care
4894462|NCT02112227|Knowledge Translation|knowledge translation
4894463|NCT02112227|Outcomes|outcomes
4894464|NCT02112214|Helicobacter pylori treatment|helicobacter pylori treatment
4894465|NCT02112214|Gastric cancer|gastric cancer
4894466|NCT02112214|Screening|screening
4894467|NCT02112175|Multiple Myeloma|multiple myeloma
4894468|NCT02112175|Lenalidomide|lenalidomide
4894469|NCT02112175|Revlimid|revlimid
4894470|NCT02112175|MPV|mpv
4894471|NCT02112175|Melphalan|melphalan
4894472|NCT02112175|Prednisone|prednisone
4894473|NCT02112175|Velcade|velcade
4894474|NCT02112175|Placebo|placebo
4894475|NCT02112149|Body Composition|body composition
4894476|NCT02112149|Exercise|exercise
4894477|NCT02112149|Survivorship|survivorship
4894478|NCT02112136|Autosomal Dominant Polycystic Kidney Disease (ADPKD)|autosomal dominant polycystic kidney disease (adpkd)
4894479|NCT02112136|Renal cysts|renal cysts
4894480|NCT02112136|Chronic Kidney Diseases|chronic kidney diseases
4894481|NCT02112136|Genetic|genetic
4894482|NCT02112123|icariin|icariin
4894483|NCT02112123|pharmacokinetics|pharmacokinetics
4894484|NCT02112123|healthy participants|healthy participants
4894485|NCT02112097|Plaque Psoriasis.|plaque psoriasis.
4894486|NCT02112097|Subdermal bloodless space|subdermal bloodless space
4894487|NCT02112097|Subdermal injection|subdermal injection
4894488|NCT02112097|Subcutaneous injection|subcutaneous injection
4894489|NCT02112097|Injectable electromyography needle|injectable electromyography needle
4894490|NCT02112097|Electrical stimulation|electrical stimulation
4894491|NCT02112097|MRI with Gadolinium|mri with gadolinium
4894492|NCT02112071|Exercise|exercise
4894493|NCT02112071|Diabetic kidney disease|diabetic kidney disease
4894494|NCT02112071|vascular function|vascular function
4894495|NCT02112071|physical function|physical function
4894496|NCT02112032|melanoma|melanoma
4894497|NCT02112032|advanced|advanced
4894498|NCT02112019|Sjögren's Syndrome|sjögren's syndrome
4894499|NCT02112019|Sialoendoscopy|sialoendoscopy
4894500|NCT02112019|Saliva|saliva
4894501|NCT02112019|Dry Mouth|dry mouth
4894502|NCT02112006|hand surgery|hand surgery
4894503|NCT02112006|wrist surgery|wrist surgery
4894504|NCT02112006|finger surgery|finger surgery
4894505|NCT02112006|anesthesia|anesthesia
4894506|NCT02112006|regional anesthesia|regional anesthesia
4894507|NCT02112006|postoperative pain|postoperative pain
4894508|NCT02111993|Defibrillation testing|defibrillation testing
4894509|NCT02111993|Upper Limit of Vulnerability|upper limit of vulnerability
4894510|NCT02111993|ULV|ulv
4894511|NCT02111993|DFT|dft
4894512|NCT02111993|ICD|icd
4894513|NCT02111993|implantable cardioverter defibrillator|implantable cardioverter defibrillator
4894514|NCT02111993|cardiomyopathy|cardiomyopathy
4894515|NCT02111993|cardiac arrhythmia|cardiac arrhythmia
4894516|NCT02111993|cardiac device testing|cardiac device testing
4894517|NCT02111980|CIED|cied
4894518|NCT02111980|pacemaker|pacemaker
4894519|NCT02111980|implantable cardioverter defibrillator|implantable cardioverter defibrillator
4894520|NCT02111980|ICD|icd
4894521|NCT02111980|radiofrequency|radiofrequency
4894522|NCT02111980|cardiac device programming|cardiac device programming
4894523|NCT02111980|RF sponge detection|rf sponge detection
4894524|NCT02111980|RF assure|rf assure
4894525|NCT02111980|cardiac internal electronic devices|cardiac internal electronic devices
4894526|NCT02111980|temporary pacing|temporary pacing
4894527|NCT02111980|pulmonary thromboendarterectomy|pulmonary thromboendarterectomy
4894528|NCT02111980|pacing interference|pacing interference
4894529|NCT02111980|Arrhythmia|arrhythmia
4894530|NCT02111954|prostate cancer|prostate cancer
4894531|NCT02111954|primary|primary
4894532|NCT02111954|recurrence|recurrence
4894533|NCT02111954|F-18-FCH PET/CT|f-18-fch pet/ct
4894534|NCT02111954|Ga-68-NODAGA-MJ9 PET/CT|ga-68-nodaga-mj9 pet/ct
4894535|NCT02111915|Maternal depression|maternal depression
4894536|NCT02111902|Cardiovascular Disease|cardiovascular disease
4894537|NCT02111902|Obesity|obesity
4894538|NCT02111902|Physical Activity|physical activity
4894539|NCT02111902|Vitamin D deficiency|vitamin d deficiency
4894540|NCT02111902|African Americans|african americans
4894541|NCT02111876|ICU, COPD, OHS, OSA, heart failure|icu, copd, ohs, osa, heart failure
4894542|NCT02111863|Skin Cancer|skin cancer
4894643|NCT02111486|Glucose|glucose
4894543|NCT02111863|Metastatic Melanoma|metastatic melanoma
4894544|NCT02111863|Adoptive Cell Therapy|adoptive cell therapy
4894545|NCT02111863|Immunotherapy|immunotherapy
4894546|NCT02111863|Clinical Response|clinical response
4894547|NCT02111850|Gene Therapy|gene therapy
4894548|NCT02111850|Tumor Regression|tumor regression
4894549|NCT02111850|Immunotherapy|immunotherapy
4894550|NCT02111850|Adoptive Cell Therapy|adoptive cell therapy
4894551|NCT02111824|Lung Cancer|lung cancer
4894552|NCT02111824|Peripheral lung lesions|peripheral lung lesions
4894553|NCT02111824|Lung biopsy|lung biopsy
4894554|NCT02111824|Minimally invasive|minimally invasive
4894555|NCT02111824|multimodality image-guided intervention system|multimodality image-guided intervention system
4894556|NCT02111824|MIMIG|mimig
4894557|NCT02111824|Indocyanine green|indocyanine green
4894558|NCT02111824|ICG|icg
4894559|NCT02111811|Depression|depression
4894560|NCT02111811|Treatment Outcome|treatment outcome
4894561|NCT02111811|Delivery of Healthcare, Integrated|delivery of healthcare, integrated
4894562|NCT02111811|Employment|employment
4894563|NCT02111811|Rehabilitation|rehabilitation
4894564|NCT02111798|substance abuse treatment|substance abuse treatment
4894565|NCT02111798|cocaine dependence|cocaine dependence
4894566|NCT02111798|contingency management; abstinence incentives|contingency management; abstinence incentives
4894567|NCT02111798|medication-enhanced behavioral therapy|medication-enhanced behavioral therapy
4894568|NCT02111785|Dexamethasone|dexamethasone
4894569|NCT02111785|Burr hole craniostomy|burr hole craniostomy
4894570|NCT02111785|Chronic subdural hematoma|chronic subdural hematoma
4894571|NCT02111772|mild asthma, rhinovirus, young adults|mild asthma, rhinovirus, young adults
4894572|NCT02111746|Postoperative pain|postoperative pain
4894573|NCT02111746|sternotomy|sternotomy
4894574|NCT02111746|laparotomy|laparotomy
4894575|NCT02111746|thoracotomy|thoracotomy
4894576|NCT02111746|mini-thoracotomy|mini-thoracotomy
4894577|NCT02111746|truncal surgical incisions|truncal surgical incisions
4894578|NCT02111746|local anaesthetics|local anaesthetics
4894579|NCT02111746|bupivacaine|bupivacaine
4894580|NCT02111720|HIV|hiv
4894581|NCT02111720|Disclosure|disclosure
4894582|NCT02111720|Family|family
4894583|NCT02111720|Intervention|intervention
4894584|NCT02111694|infant|infant
4894585|NCT02111694|intake|intake
4894586|NCT02111694|satiation|satiation
4894587|NCT02111694|mother|mother
4894588|NCT02111694|feeding practices|feeding practices
4894589|NCT02111694|bottle feeding|bottle feeding
4894590|NCT02111694|formula feeding|formula feeding
4894591|NCT02111694|maternal responsiveness|maternal responsiveness
4894592|NCT02111694|infant cues|infant cues
4894593|NCT02111681|Calypso-based Deep Inspiration Breath Hold (DIBH)|calypso-based deep inspiration breath hold (dibh)
4894594|NCT02111681|radiation treatments|radiation treatments
4894596|NCT02111668|Aorta|aorta
4894597|NCT02111668|Dilatation|dilatation
4894598|NCT02111668|Marfan syndrome|marfan syndrome
4894599|NCT02111668|Genetic|genetic
4894600|NCT02111668|Fbn1|fbn1
4894601|NCT02111655|Thrombosis|thrombosis
4894602|NCT02111655|Arteriovenous fistulae|arteriovenous fistulae
4894603|NCT02111655|Hemodialysis|hemodialysis
4894604|NCT02111655|Doppler ultrasound|doppler ultrasound
4894605|NCT02111655|Vascular access blood flow|vascular access blood flow
4894606|NCT02111655|Surveillance|surveillance
4894607|NCT02111642|Pelvic organ prolapse|pelvic organ prolapse
4894608|NCT02111642|Stress urinary incontinence|stress urinary incontinence
4894609|NCT02111642|Midurethral sling|midurethral sling
4894610|NCT02111642|Patient satisfaction|patient satisfaction
4894611|NCT02111629|Vaginosis, bacterial; Candidiasis, vulvovaginal|vaginosis, bacterial; candidiasis, vulvovaginal
4894612|NCT02111616|cancer survivorship care|cancer survivorship care
4894613|NCT02111616|provider communication|provider communication
4894614|NCT02111616|provider care coordination|provider care coordination
4894615|NCT02111590|Immunoglobulins, Intravenous|immunoglobulins, intravenous
4894616|NCT02111590|Immunoglobulins, Subcutaneous|immunoglobulins, subcutaneous
4894617|NCT02111577|Immunotherapy|immunotherapy
4894618|NCT02111577|Metastatic|metastatic
4894619|NCT02111577|Castrate Resistant|castrate resistant
4894620|NCT02111577|Prostate Cancer|prostate cancer
4894621|NCT02111577|Biological|biological
4894622|NCT02111577|Vaccine|vaccine
4894623|NCT02111564|Heart Failure|heart failure
4894624|NCT02111564|Respiratory Insufficiency|respiratory insufficiency
4894625|NCT02111564|Stroke Acute|stroke acute
4894626|NCT02111564|Infectious Diseases|infectious diseases
4894627|NCT02111564|Rheumatic Diseases|rheumatic diseases
4894628|NCT02111564|Medically ill Patient|medically ill patient
4894629|NCT02111564|Rivaroxaban|rivaroxaban
4894630|NCT02111564|Thromboembolism|thromboembolism
4894631|NCT02111564|Prophylactic Anti-Coagulation|prophylactic anti-coagulation
4894632|NCT02111551|Autism|autism
4894633|NCT02111551|Nicotinic agonist|nicotinic agonist
4894634|NCT02111551|Cognition|cognition
4894635|NCT02111551|P50|p50
4894636|NCT02111551|Alpha 7|alpha 7
4894637|NCT02111499|psoriasis plaque test|psoriasis plaque test
4894638|NCT02111499|topical application|topical application
4894639|NCT02111499|atrophy measure|atrophy measure
4894640|NCT02111486|Breakfast|breakfast
4894641|NCT02111486|Satiety|satiety
4894642|NCT02111486|Fibre|fibre
4894644|NCT02111486|Gastric emptying|gastric emptying
4894645|NCT02111473|endothelial dysfunction|endothelial dysfunction
4894646|NCT02111473|bone mineral metabolism|bone mineral metabolism
4894647|NCT02111473|testosteron replacement treatment|testosteron replacement treatment
4894648|NCT02111460|Initially|initially
4894649|NCT02111460|Untreated|untreated
4894650|NCT02111460|Distant metastatic|distant metastatic
4894651|NCT02111447|children|children
4894652|NCT02111447|sevoflurane|sevoflurane
4894653|NCT02111447|isoflurane|isoflurane
4894654|NCT02111447|propofol|propofol
4894655|NCT02111447|anesthesia|anesthesia
4894656|NCT02111447|MRI|mri
4894657|NCT02111447|delirium|delirium
4894658|NCT02111434|visceral adiposity index|visceral adiposity index
4894659|NCT02111434|triglycerides / hdl cholesterol ratio|triglycerides / hdl cholesterol ratio
4894660|NCT02111434|testosterone|testosterone
4894661|NCT02111421|dexmedetomidine|dexmedetomidine
4894662|NCT02111421|parturient|parturient
4894663|NCT02111421|nonpregnant women|nonpregnant women
4894664|NCT02111421|sedation|sedation
4894665|NCT02111408|Sleep apnea syndromes|sleep apnea syndromes
4894666|NCT02111408|Autonomic nervous system +/- disease|autonomic nervous system +/- disease
4894667|NCT02111408|Depression|depression
4894668|NCT02111408|Peripheral arterial disease|peripheral arterial disease
4894669|NCT02111382|Low back pain|low back pain
4894670|NCT02111382|osteopathic manipulations|osteopathic manipulations
4894671|NCT02111382|electroencephalography|electroencephalography
4894672|NCT02111369|Essential Tremor|essential tremor
4894673|NCT02111369|Essential Vocal Tremor|essential vocal tremor
4894674|NCT02111369|Essential Voice Tremor|essential voice tremor
4894675|NCT02111343|auditory processing disorder|auditory processing disorder
4894676|NCT02111343|central auditory processing disorder|central auditory processing disorder
4894677|NCT02111343|auditory processing|auditory processing
4894678|NCT02111343|auditory training|auditory training
4894679|NCT02111330|Adenosine A2a receptor antagonist|adenosine a2a receptor antagonist
4894680|NCT02111330|adenosine receptor modulator|adenosine receptor modulator
4894681|NCT02111330|Cancer|cancer
4894682|NCT02111317|ASP015K|asp015k
4894683|NCT02111317|Pharmacokinetics|pharmacokinetics
4894684|NCT02111317|Healthy Subjects|healthy subjects
4894685|NCT02111304|cholera|cholera
4894686|NCT02111304|diarrhea|diarrhea
4894687|NCT02111304|secretory diarrhea|secretory diarrhea
4894688|NCT02111304|ORS|ors
4894689|NCT02111304|V. cholerae O1|v. cholerae o1
4894690|NCT02111304|iOWH032|iowh032
4894691|NCT02111304|children|children
4894692|NCT02111304|pharmacokinetic|pharmacokinetic
4894693|NCT02111304|Bangladesh|bangladesh
4894694|NCT02111291|Diabetic Foot Ulcers|diabetic foot ulcers
4894695|NCT02111278|Manipulation|manipulation
4894696|NCT02111278|Lumbar|lumbar
4894697|NCT02111278|Low Back Pain|low back pain
4894698|NCT02111278|Manual Therapy|manual therapy
4894699|NCT02111278|Adolescents|adolescents
4894700|NCT02111252|Drug Therapy|drug therapy
4894701|NCT02111239|DIEP|diep
4894702|NCT02111239|DIEP flap|diep flap
4894703|NCT02111239|Breast reconstruction|breast reconstruction
4894704|NCT02111239|Breast Cancer|breast cancer
4894705|NCT02111239|CTA|cta
4894706|NCT02111239|MRA|mra
4894707|NCT02111226|hypertension|hypertension
4894708|NCT02111226|cardiovascular disease|cardiovascular disease
4894709|NCT02111226|diabetes|diabetes
4894710|NCT02111226|chronic disease management|chronic disease management
4894711|NCT02111213|physical activity|physical activity
4894712|NCT02111213|Intervention|intervention
4894713|NCT02111213|Attitude to Computers|attitude to computers
4894714|NCT02111200|urea cycle disorders|urea cycle disorders
4894715|NCT02111187|LDE225|lde225
4894716|NCT02111187|High risk localized prostate cancer|high risk localized prostate cancer
4894717|NCT02111187|Pre-surgical|pre-surgical
4894718|NCT02111174|Neuropathy|neuropathy
4894719|NCT02111174|Peripheral neuropathy|peripheral neuropathy
4894720|NCT02111174|Chemotherapy-induced peripheral neuropathy|chemotherapy-induced peripheral neuropathy
4894721|NCT02111161|Randomised controlled trial (RCT)|randomised controlled trial (rct)
4894722|NCT02111161|Immunoglobulin|immunoglobulin
4894723|NCT02111161|Patient Reported Outcome|patient reported outcome
4894724|NCT02111161|Health-Related Quality of Life|health-related quality of life
4894725|NCT02111161|Short Form-36 (SF-36)|short form-36 (sf-36)
4894726|NCT02111148|rupture of membranes, nitrazine, urea, creatinine|rupture of membranes, nitrazine, urea, creatinine
4894727|NCT02111122|excessive daytime sleepiness|excessive daytime sleepiness
4894728|NCT02111122|Parkinson`s Disease|parkinson`s disease
4894729|NCT02111122|sleep-wake disturbances|sleep-wake disturbances
4894730|NCT02111122|Sodium Oxybate|sodium oxybate
4894731|NCT02111109|Microcirculation|microcirculation
4894732|NCT02111109|Trauma|trauma
4894733|NCT02111109|Haemorrhage|haemorrhage
4894734|NCT02111109|Shock|shock
4894735|NCT02111070|Influenza|influenza
4894736|NCT02111070|Influenza vaccine|influenza vaccine
4894737|NCT02111070|Split influenza vaccine|split influenza vaccine
4894738|NCT02111057|Rheumatoid Arthritis|rheumatoid arthritis
4894739|NCT02111057|Total Hip Replacement|total hip replacement
4894740|NCT02111057|Flare|flare
4894741|NCT02111057|Perioperative Outcomes|perioperative outcomes
4894742|NCT02111044|de novo or partial responder to somatostatin analogues|de novo or partial responder to somatostatin analogues
4894743|NCT02111031|CELLSEARCH|cellsearch
4894744|NCT02111031|CTC|ctc
4894745|NCT02111031|metastatic breast cancer|metastatic breast cancer
4894746|NCT02111031|Registry|registry
4894747|NCT02111031|mBC|mbc
4894748|NCT02111005|apoptosis|apoptosis
4894749|NCT02111005|periodontal disease|periodontal disease
4894750|NCT02111005|smoking|smoking
4894751|NCT02110979|Patient Decision Aid|patient decision aid
4894752|NCT02110979|Shared Decision Making|shared decision making
4894753|NCT02110966|Anaesthetic effect|anaesthetic effect
4894754|NCT02110966|Inferior alveolar nerve block|inferior alveolar nerve block
4894755|NCT02110966|Local tramadol|local tramadol
4894756|NCT02110966|Mepivacaine|mepivacaine
4894757|NCT02110966|Symptomatic irreversible pulpitis.|symptomatic irreversible pulpitis.
4894758|NCT02110927|Abdominal fat|abdominal fat
4894759|NCT02110927|Metabolic syndrome|metabolic syndrome
4894760|NCT02110927|Microcurrent|microcurrent
4894761|NCT02110927|Aerobic exercise|aerobic exercise
4894762|NCT02110927|Lipolysis|lipolysis
4894763|NCT02110914|Feasibility study|feasibility study
4894764|NCT02110914|Coaching|coaching
4894765|NCT02110914|Health related quality of life|health related quality of life
4894766|NCT02110914|Adherence|adherence
4894767|NCT02110901|radiocephalic|radiocephalic
4894768|NCT02110901|arteriovenous fistula|arteriovenous fistula
4894769|NCT02110901|AVF|avf
4894770|NCT02110901|hemodialysis|hemodialysis
4894771|NCT02110901|PRT-201|prt-201
4894772|NCT02110901|vascular access|vascular access
4894773|NCT02110901|kidney|kidney
4894774|NCT02110901|renal|renal
4894775|NCT02110901|vonapanitase|vonapanitase
4894776|NCT02110901|PATENCY-1|patency-1
4894777|NCT02110875|Healthy Volunteers|healthy volunteers
4894778|NCT02110849|Prostate|prostate
4894779|NCT02110849|Proton Therapy|proton therapy
4894780|NCT02110849|Cancer|cancer
4894781|NCT02110810|post-ERCP Acute Pancreatitis|post-ercp acute pancreatitis
4894782|NCT02110810|Indomethacin|indomethacin
4894783|NCT02110810|NSAIDs|nsaids
4894784|NCT02110797|RETT syndrome|rett syndrome
4894785|NCT02110797|MECP2|mecp2
4894786|NCT02110797|Osteoporosis|osteoporosis
4894787|NCT02110797|RANK-ligand|rank-ligand
4894788|NCT02110797|osteoprotegerin|osteoprotegerin
4894789|NCT02110784|Artemisinin based Combination Therapies|artemisinin based combination therapies
4894790|NCT02110784|eurartesim|eurartesim
4894791|NCT02110784|Dihydroartemisinin/Piperaquine|dihydroartemisinin/piperaquine
4894792|NCT02110771|schizophrenia|schizophrenia
4894793|NCT02110771|social cognition|social cognition
4894794|NCT02110771|facial affects recognition|facial affects recognition
4894795|NCT02110771|cognitive remediation|cognitive remediation
4894796|NCT02110758|Patient Care Management|patient care management
4894797|NCT02110758|Patient Care Planning|patient care planning
4894798|NCT02110758|Patient-Centered Care|patient-centered care
4894799|NCT02110758|Patient Care Team|patient care team
4894800|NCT02110758|Advance Care Planning|advance care planning
4894801|NCT02110758|Delivery of Health Care|delivery of health care
4894802|NCT02110758|Evidence-based Practice|evidence-based practice
4894803|NCT02110758|Health Care Costs|health care costs
4894804|NCT02110758|Health Care Quality, Access, and Evaluation|health care quality, access, and evaluation
4894805|NCT02110758|Quality of Health Care|quality of health care
4894806|NCT02110758|Neoplasms|neoplasms
4894807|NCT02110758|Medical Oncology|medical oncology
4894808|NCT02110719|narcotic use|narcotic use
4894809|NCT02110719|pain|pain
4894810|NCT02110719|constipation|constipation
4894811|NCT02110719|nausea|nausea
4894812|NCT02110706|Myasthenia Gravis|myasthenia gravis
4894813|NCT02110706|Rituximab|rituximab
4894814|NCT02110693|Substance Use|substance use
4894815|NCT02110693|Substance Use Disorder|substance use disorder
4894816|NCT02110693|Screening|screening
4894817|NCT02110693|Brief Assessment|brief assessment
4894818|NCT02110680|overactive bladder|overactive bladder
4894819|NCT02110680|transcutaneous electric stimulation|transcutaneous electric stimulation
4894820|NCT02110680|posterior tibial nerve stimulation|posterior tibial nerve stimulation
4894821|NCT02110667|Prostate cancer|prostate cancer
4894822|NCT02110667|Prostatectomy|prostatectomy
4894823|NCT02110667|Ultrasound|ultrasound
4894824|NCT02110667|TPUS|tpus
4894825|NCT02110654|chronic rhinosinusitis|chronic rhinosinusitis
4894826|NCT02110654|asthma|asthma
4894827|NCT02110654|montelukast|montelukast
4894828|NCT02110654|surgery|surgery
4894829|NCT02110654|treatment outcomes|treatment outcomes
4894830|NCT02110641|Breast Cancer|breast cancer
4894831|NCT02110641|Survivorship|survivorship
4894832|NCT02110641|Weight Loss|weight loss
4894833|NCT02110628|total gastrectomy|total gastrectomy
4894834|NCT02110628|pouch|pouch
4894835|NCT02110628|roux-en-y|roux-en-y
4894836|NCT02110628|quality of life|quality of life
4894837|NCT02110602|Nutrition|nutrition
4894838|NCT02110589|seizures|seizures
4894839|NCT02110550|endocrown|endocrown
4894840|NCT02110550|marginal adaptation|marginal adaptation
4894841|NCT02110550|anatomic form|anatomic form
4894842|NCT02110550|retention loss|retention loss
4894843|NCT02110550|IPS.emmax crowns|ips.emmax crowns
4894844|NCT02110537|Atrial fibrillation|atrial fibrillation
4894845|NCT02110537|Acupuncture|acupuncture
4894846|NCT02110537|Recurrence|recurrence
4894847|NCT02110537|Electrical cardioversion|electrical cardioversion
4894848|NCT02110524|Peripheral Arterial Disease|peripheral arterial disease
4894849|NCT02110498|Pancreatic cyst|pancreatic cyst
4894850|NCT02110498|IPMN|ipmn
4894851|NCT02110498|SCA|sca
4894852|NCT02110498|SPN|spn
4894853|NCT02110498|MCN|mcn
4894854|NCT02110498|pancreatic cystic neoplasm|pancreatic cystic neoplasm
4894855|NCT02110485|Appendicitis|appendicitis
4894856|NCT02110485|Pediatric|pediatric
4894857|NCT02110485|Children|children
4894858|NCT02110485|Non-operative|non-operative
4894859|NCT02110485|Antibiotics alone|antibiotics alone
4894860|NCT02110472|Emmetropic presbyopes|emmetropic presbyopes
4894861|NCT02110472|Presbyopic|presbyopic
4894862|NCT02110459|POL7080|pol7080
4894863|NCT02110459|Pharmacokinetics|pharmacokinetics
4894864|NCT02110446|Sjögren's syndrome|sjögren's syndrome
4894865|NCT02110446|SS-1|ss-1
4894866|NCT02110446|Gan-Lu-Yin|gan-lu-yin
4894867|NCT02110446|Sang-Ju-Yin|sang-ju-yin
4894868|NCT02110446|Xuefu-Zhuyu-Decoction|xuefu-zhuyu-decoction
4894869|NCT02110433|chronic heart failure|chronic heart failure
4894870|NCT02110433|BNP|bnp
4894871|NCT02110433|telemedicine|telemedicine
4894872|NCT02110433|telemonitoring|telemonitoring
4894873|NCT02110433|weight|weight
4894874|NCT02110433|education|education
4894875|NCT02110433|self management|self management
4894876|NCT02110433|cost effectiveness|cost effectiveness
4894877|NCT02110420|Safety|safety
4894878|NCT02110420|Pharmacokinetics|pharmacokinetics
4894879|NCT02110420|Healthy Subjects|healthy subjects
4894880|NCT02110420|First-in-Human|first-in-human
4894881|NCT02110407|healthy young adults|healthy young adults
4894882|NCT02110407|tDCS|tdcs
4894883|NCT02110407|LOCATO task|locato task
4894884|NCT02110407|visual-spatial learning|visual-spatial learning
4894885|NCT02110394|observational|observational
4894886|NCT02110394|chronic lymphocytic leukemia|chronic lymphocytic leukemia
4894887|NCT02110394|bendamustine|bendamustine
4894888|NCT02110381|High blood pressure|high blood pressure
4894889|NCT02110355|Metastatic melanoma|metastatic melanoma
4894890|NCT02110342|PF-04449913|pf-04449913
4894891|NCT02110342|[14C]PF-04449913|[14c]pf-04449913
4894892|NCT02110342|Human ADME|human adme
4894893|NCT02110342|Radiolabel|radiolabel
4894894|NCT02110342|Mass Balance|mass balance
4894895|NCT02110342|Pharmacokinetics|pharmacokinetics
4894896|NCT02110329|colorectal cancer|colorectal cancer
4894897|NCT02110329|stage II and III|stage ii and iii
4894898|NCT02110329|somatic quantitative molecular alterations|somatic quantitative molecular alterations
4894899|NCT02110329|Qantitative Multiplex Pcr of Short fluorescent Fragments method (QMPSF)|qantitative multiplex pcr of short fluorescent fragments method (qmpsf)
4894900|NCT02110290|quality of life|quality of life
4894901|NCT02110290|adaptive sports|adaptive sports
4894902|NCT02110290|therapeutic recreation|therapeutic recreation
4894903|NCT02110290|mental health|mental health
4894904|NCT02110277|Ovarian Cancer|ovarian cancer
4894905|NCT02110277|Epithelial ovarian cancer|epithelial ovarian cancer
4894906|NCT02110264|Opioid Use|opioid use
4894907|NCT02110264|Incarceration|incarceration
4894908|NCT02110264|Vivitrol|vivitrol
4894909|NCT02110264|Patient Navigator|patient navigator
4894910|NCT02110264|Drug Education|drug education
4894911|NCT02110238|osteoarthritis|osteoarthritis
4894912|NCT02110238|knee pain|knee pain
4894913|NCT02110238|Supartz|supartz
4894914|NCT02110238|Euflexxa|euflexxa
4894915|NCT02110238|HA|ha
4894916|NCT02110238|hyaluronic acid|hyaluronic acid
4894917|NCT02110225|Cone-Rod Degenerations|cone-rod degenerations
4894918|NCT02110225|Cone-Rod Dystrophy|cone-rod dystrophy
4894919|NCT02110225|Cone-Rod Dystrophy 2|cone-rod dystrophy 2
4894920|NCT02110225|Cone-Rod Retinal Dystrophy|cone-rod retinal dystrophy
4894921|NCT02110225|Pigmentary Retinopathy|pigmentary retinopathy
4894922|NCT02110225|Retinal Cone-Rod Dystrophy|retinal cone-rod dystrophy
4894923|NCT02110225|Rod Cone Dystrophies|rod cone dystrophies
4894924|NCT02110225|Rod-Cone Dystrophy|rod-cone dystrophy
4894925|NCT02110225|Tapetoretinal Degeneration|tapetoretinal degeneration
4894926|NCT02110212|Cataract|cataract
4894927|NCT02110212|Surgery, cataract extraction|surgery, cataract extraction
4894928|NCT02110212|Optical devices, laser|optical devices, laser
4894929|NCT02110186|lumbar disc herniation|lumbar disc herniation
4894930|NCT02110186|dynamic stabilization|dynamic stabilization
4894931|NCT02110186|discectomy with posterior dynamic stabilization|discectomy with posterior dynamic stabilization
4894932|NCT02110186|discectomy alone|discectomy alone
4894933|NCT02110186|discectomy with internal fixation and fusion|discectomy with internal fixation and fusion
4894934|NCT02110069|KHE|khe
4894935|NCT02110069|Vascular anomaly|vascular anomaly
4894936|NCT02110069|Kasabach-Merritt Syndrome|kasabach-merritt syndrome
4894937|NCT02110069|Tufted angioma|tufted angioma
4894938|NCT02110069|hemangioendothelioma|hemangioendothelioma
4894939|NCT02110056|healthy older adults|healthy older adults
4894940|NCT02110056|tDCS|tdcs
4894941|NCT02110056|LOCATO task|locato task
4894942|NCT02110056|visual-spatial learning|visual-spatial learning
4894943|NCT02110043|mild cognitive impairment (MCI)|mild cognitive impairment (mci)
4894944|NCT02110043|tDCS|tdcs
4894945|NCT02110043|LOCATO task|locato task
4894946|NCT02110043|visual-spatial learning|visual-spatial learning
4894947|NCT02110030|Transcutaneous electrical nerve stimulation (TENS)|transcutaneous electrical nerve stimulation (tens)
4894948|NCT02110030|Ultrasound|ultrasound
4894949|NCT02110030|Interferential current therapy|interferential current therapy
4894950|NCT02110030|Rehabilitation|rehabilitation
4894951|NCT02110030|Shoulder pain|shoulder pain
4894952|NCT02110017|Ecological task|ecological task
4894953|NCT02110017|fMRI|fmri
4894954|NCT02110017|Schizophrenia|schizophrenia
4894955|NCT02110017|Social Cognition|social cognition
4894956|NCT02109978|Diabetes|diabetes
4894957|NCT02109978|Type 2 diabetes|type 2 diabetes
4894958|NCT02109978|Diabetes therapy response|diabetes therapy response
4894959|NCT02109978|Diabetes progression|diabetes progression
4894960|NCT02109939|MDD|mdd
4894961|NCT02109939|Pharmacogenomic|pharmacogenomic
4894962|NCT02109939|Pharmacogenomic Testing|pharmacogenomic testing
4894963|NCT02109939|Pharmacogenomics|pharmacogenomics
4894964|NCT02109939|Genetic Testing|genetic testing
4894965|NCT02109939|Genetics|genetics
4894966|NCT02109939|Major Depressive Disorder|major depressive disorder
4894967|NCT02109939|GeneSight|genesight
4894968|NCT02109939|Assurex|assurex
4894969|NCT02109939|AssureRx|assurerx
4894970|NCT02109939|Psychotropic|psychotropic
4894971|NCT02109939|Randomized|randomized
4894972|NCT02109939|Double Blind|double blind
4894973|NCT02109939|Placebo Controlled|placebo controlled
4894974|NCT02109913|Breast Cancer|breast cancer
4894975|NCT02109913|metastatic|metastatic
4894976|NCT02109913|hormone receptor positive|hormone receptor positive
4894977|NCT02109913|everolimus|everolimus
4894978|NCT02109913|biomarker|biomarker
4894979|NCT02109887|Pneumocystis jiroveci, cytomegalovirus, co-infection|pneumocystis jiroveci, cytomegalovirus, co-infection
4894980|NCT02109861|Multiple Myeloma|multiple myeloma
4894981|NCT02109861|Phase 0 study|phase 0 study
4894982|NCT02109861|Microdose study|microdose study
4894983|NCT02109861|Micro array|micro array
4894984|NCT02109861|Gene expression profiling|gene expression profiling
4894985|NCT02109848|keratoconus|keratoconus
4894986|NCT02109848|post-keratoplasty|post-keratoplasty
4894987|NCT02109835|Diabetes|diabetes
4894988|NCT02109835|coronary artery disease|coronary artery disease
4894989|NCT02109835|Cardiac computed tomography|cardiac computed tomography
4894990|NCT02109835|Computed tomographics coronary angiography|computed tomographics coronary angiography
4894991|NCT02109835|Plaque progression|plaque progression
4894992|NCT02109822|Cystic Fibrosis|cystic fibrosis
4894993|NCT02109822|Pulmonary Exacerbation|pulmonary exacerbation
4894994|NCT02109822|Lung Infection|lung infection
4894995|NCT02109822|Cystic Fibrosis Foundation|cystic fibrosis foundation
4894996|NCT02109822|Cystic Fibrosis Foundation National Patient Registry|cystic fibrosis foundation national patient registry
4894997|NCT02109796|tDCS|tdcs
4894998|NCT02109796|Stroke|stroke
4894999|NCT02109796|Force|force
4895000|NCT02109796|Spasticity|spasticity
4895001|NCT02109796|Gait|gait
4895002|NCT02109796|EMG|emg
4895003|NCT02109796|Isokinetic|isokinetic
4895004|NCT02109783|Athletes|athletes
4895005|NCT02109783|Ergogenic aids|ergogenic aids
4895006|NCT02109783|Caffeine|caffeine
4895007|NCT02109783|Nutrigenomics|nutrigenomics
4895008|NCT02109783|Genotype|genotype
4895009|NCT02109770|22q|22q
4895010|NCT02109770|DiGeorge|digeorge
4895011|NCT02109770|Angelman|angelman
4895012|NCT02109770|Cri du chat|cri du chat
4895013|NCT02109770|Miller Dieker|miller dieker
4895014|NCT02109770|1p36|1p36
4895015|NCT02109770|Phelan McDermid|phelan mcdermid
4895016|NCT02109770|Prader Willi|prader willi
4895017|NCT02109770|Wolf Hirschorn|wolf hirschorn
4895018|NCT02109770|Smith Magenis|smith magenis
4895019|NCT02109770|Trisomy 21|trisomy 21
4895020|NCT02109770|Down syndrome|down syndrome
4895021|NCT02109770|Trisomy 18|trisomy 18
4895022|NCT02109770|Edwards syndrome|edwards syndrome
4895023|NCT02109770|Trisomy 13|trisomy 13
4895024|NCT02109770|Patau syndrome|patau syndrome
4895025|NCT02109770|Monosomy X|monosomy x
4895026|NCT02109770|Turner syndrome|turner syndrome
4895027|NCT02109770|XXY|xxy
4895028|NCT02109770|Klinefelter syndrome|klinefelter syndrome
4895029|NCT02109770|XXX|xxx
4895030|NCT02109770|XYY|xyy
4895031|NCT02109757|Hearing conservation|hearing conservation
4895032|NCT02109757|Personal attenuation rating|personal attenuation rating
4895033|NCT02109757|earplug|earplug
4895034|NCT02109731|Obstructive Sleep Apnea Syndrome (OSAS)|obstructive sleep apnea syndrome (osas)
4895035|NCT02109731|Sleep Apnea|sleep apnea
4895036|NCT02109718|Burns|burns
4895037|NCT02109718|Dressings|dressings
4895038|NCT02109718|Outpatient Management|outpatient management
4895039|NCT02109718|Petrolatum Jelly|petrolatum jelly
4895040|NCT02109718|Superficial Partial Thickness Burns|superficial partial thickness burns
4895041|NCT02109718|Less than or equal to 10% Total Body Surface Area|less than or equal to 10% total body surface area
4895042|NCT02109692|muscle dystrophies|muscle dystrophies
4895043|NCT02109692|dystromirs|dystromirs
4895044|NCT02109692|longitudinal study|longitudinal study
4895045|NCT02109692|miRNA|mirna
4895046|NCT02109653|NSCLC,|nsclc,
4895047|NCT02109653|Non-Small Cell Lung Cancer,|non-small cell lung cancer,
4895048|NCT02109653|BRAF V600,|braf v600,
4895049|NCT02109653|LGX818|lgx818
4895050|NCT02109640|Colorectal|colorectal
4895051|NCT02109640|Surgery|surgery
4895052|NCT02109640|Laparoscopic|laparoscopic
4895053|NCT02109640|Analgesia|analgesia
4895054|NCT02109640|Enhanced Recovery|enhanced recovery
4895055|NCT02109640|Targinact|targinact
4895056|NCT02109627|Acute Myeloid Leukemia|acute myeloid leukemia
4895057|NCT02109627|Ficlatuzumab|ficlatuzumab
4895058|NCT02109627|High Dose Cytarabine|high dose cytarabine
4895059|NCT02109627|antibody|antibody
4895060|NCT02109614|lipoprotein(a)|lipoprotein(a)
4895061|NCT02109614|aortic stenosis|aortic stenosis
4895062|NCT02109601|Patient Portals|patient portals
4895063|NCT02109601|Personal Health Records|personal health records
4895064|NCT02109601|Patient Engagement|patient engagement
4895065|NCT02109601|Mobile Health|mobile health
4895066|NCT02109601|Tablet Computers|tablet computers
4895067|NCT02109575|Acute Rejection|acute rejection
4895068|NCT02109575|Cardiac Biomarkers|cardiac biomarkers
4895069|NCT02109575|Cardiac Catheterization|cardiac catheterization
4895070|NCT02109575|Cardiomyopathy|cardiomyopathy
4895071|NCT02109575|Cell-Free DNA|cell-free dna
4895072|NCT02109575|Congenital Heart Defect|congenital heart defect
4895073|NCT02109575|Congenital Heart Disease|congenital heart disease
4895074|NCT02109575|Coronary Angiogram|coronary angiogram
4895075|NCT02109575|Donor Specific DNA|donor specific dna
4895076|NCT02109575|Donor Specific Cell-Free DNA|donor specific cell-free dna
4895077|NCT02109575|Endomyocardial Biopsy|endomyocardial biopsy
4895078|NCT02109575|Heart Failure|heart failure
4895079|NCT02109575|Heart Transplant Failure|heart transplant failure
4895080|NCT02109575|Heart Transplant|heart transplant
4895081|NCT02109575|Heart Transplant Rejection|heart transplant rejection
4895082|NCT02109562|Schizophrenia|schizophrenia
4895083|NCT02109562|Schizophrenic|schizophrenic
4895084|NCT02109562|Schizophrenias|schizophrenias
4895085|NCT02109562|Risperidone|risperidone
4895086|NCT02109536|Colonoscopy|colonoscopy
4895087|NCT02109536|Looping|looping
4895088|NCT02109536|Loop recognition|loop recognition
4895089|NCT02109536|magnetic endoscopic imager|magnetic endoscopic imager
4895090|NCT02109471|corneal opacities|corneal opacities
4895091|NCT02109471|Optical coherence tomography|optical coherence tomography
4895092|NCT02109458|Lung nodule biopsy|lung nodule biopsy
4895093|NCT02109432|Pedal Desk|pedal desk
4895094|NCT02109432|Physical Activity|physical activity
4895095|NCT02109432|Workplace|workplace
4895096|NCT02109432|Energy Expenditure|energy expenditure
4895097|NCT02109419|computerized assessments|computerized assessments
4895098|NCT02109419|mood|mood
4895099|NCT02109419|life space|life space
4895100|NCT02109419|cognition|cognition
4895101|NCT02109393|Rehabilitation|rehabilitation
4895102|NCT02109393|Robot-assisted walking training|robot-assisted walking training
4895103|NCT02109393|Treadmill|treadmill
4895104|NCT02109393|Lokomat|lokomat
4895105|NCT02109367|ovarian cancer|ovarian cancer
4895106|NCT02109367|ovarian mass|ovarian mass
4895107|NCT02109367|CA-125|ca-125
4895108|NCT02109367|HE4|he4
4895109|NCT02109367|culdocentesis|culdocentesis
4895110|NCT02109367|biomarker(s)|biomarker(s)
4895111|NCT02109354|HIV infection|hiv infection
4895112|NCT02109354|Vaccine|vaccine
4895113|NCT02109341|mPC|mpc
4895114|NCT02109328|Bladder cancer|bladder cancer
4895115|NCT02109328|Urothelial cancer|urothelial cancer
4895116|NCT02109328|Alisertib|alisertib
4895117|NCT02109328|Phase 2|phase 2
4895118|NCT02109328|Advanced disease|advanced disease
4895119|NCT02109289|Anti-Tumor necrosis factor alpha|anti-tumor necrosis factor alpha
4895120|NCT02109289|18-FluoroDeoxyGlucose Positron Emission Tomography|18-fluorodeoxyglucose positron emission tomography
4895121|NCT02109289|High-sensitivity C- Reactive protein|high-sensitivity c- reactive protein
4895122|NCT02109276|Fuch's endothelial dystrophy|fuch's endothelial dystrophy
4895123|NCT02109276|Aspheric intraocular lens|aspheric intraocular lens
4895124|NCT02109276|Higher Order Aberrations|higher order aberrations
4895125|NCT02109276|Contrast Sensitivity|contrast sensitivity
4895126|NCT02109263|Breast-feeding|breast-feeding
4895127|NCT02109263|Saccharose|saccharose
4895128|NCT02109263|Breast-feeding newborn|breast-feeding newborn
4895129|NCT02109263|cortical pain responses|cortical pain responses
4895130|NCT02109263|near infrared spectroscopy (NIRS)|near infrared spectroscopy (nirs)
4895131|NCT02109263|Salivary rate cortisol|salivary rate cortisol
4895132|NCT02109263|heel lance|heel lance
4895133|NCT02109250|Medullary Thyroid Cancer (MTC) vandetanib caprelsa|medullary thyroid cancer (mtc) vandetanib caprelsa
4895134|NCT02109237|Lung transplantation|lung transplantation
4895135|NCT02109237|Bronchiolitis obliterans|bronchiolitis obliterans
4895136|NCT02109198|Mild Traumatic Brain Injury|mild traumatic brain injury
4895137|NCT02109185|seasonal allergic rhinitis|seasonal allergic rhinitis
4895138|NCT02109185|grass/tree/ragweed allergies|grass/tree/ragweed allergies
4895139|NCT02109185|nasal congestion/stuffiness|nasal congestion/stuffiness
4895140|NCT02109185|rhinnorea|rhinnorea
4895141|NCT02109185|nasal itching|nasal itching
4895142|NCT02109185|sneezing|sneezing
4895143|NCT02109172|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
4895144|NCT02109172|COPD|copd
4895145|NCT02109146|TACE|tace
4895146|NCT02109146|Postoperation|postoperation
4895147|NCT02109133|deep neuromuscular blockade|deep neuromuscular blockade
4895148|NCT02109133|intraocular pressure|intraocular pressure
4895149|NCT02109107|body contouring|body contouring
4895150|NCT02109107|body shaping|body shaping
4895151|NCT02109107|circumference reduction|circumference reduction
4895152|NCT02109094|insulin|insulin
4895153|NCT02109094|metabolomics|metabolomics
4895154|NCT02109081|dexamethasone|dexamethasone
4895155|NCT02109081|delirium|delirium
4895156|NCT02109081|postoperative cognitive dysfunction|postoperative cognitive dysfunction
4895157|NCT02109081|postoperative|postoperative
4895158|NCT02109081|elderly|elderly
4895159|NCT02109068|Breast Cancer|breast cancer
4895160|NCT02109068|Survivorship|survivorship
4895161|NCT02109068|Weight Loss|weight loss
4895162|NCT02109055|Cardiovascular Diseases|cardiovascular diseases
4895163|NCT02109055|Thoracic Surgery|thoracic surgery
4895164|NCT02109055|Exercise Therapy|exercise therapy
4895165|NCT02109016|FGFR1 amplification|fgfr1 amplification
4895166|NCT02109016|FGF alteration|fgf alteration
4895167|NCT02109016|VEGF alteration|vegf alteration
4895168|NCT02109016|PDGF alteration|pdgf alteration
4895169|NCT02109016|Tyrosine kinase inhibitor|tyrosine kinase inhibitor
4895170|NCT02109016|VEGFR inhibitor|vegfr inhibitor
4895171|NCT02109016|FGFR inhibitor|fgfr inhibitor
4895172|NCT02109016|PDGFR inhibitor|pdgfr inhibitor
4895173|NCT02109016|VEGFR-FGFR inhibitor|vegfr-fgfr inhibitor
4895174|NCT02109003|tracheal cuff|tracheal cuff
4895175|NCT02109003|cuff overinflation|cuff overinflation
4895176|NCT02109003|cuff underinflation|cuff underinflation
4895177|NCT02108990|borderline personality disorder|borderline personality disorder
4895178|NCT02108990|rejection|rejection
4895179|NCT02108990|social pain|social pain
4895180|NCT02108977|Remote Consultation|remote consultation
4895181|NCT02108977|Teleconsultation|teleconsultation
4895182|NCT02108977|Videoconferencing|videoconferencing
4895183|NCT02108977|Genetic Counseling|genetic counseling
4895184|NCT02108977|Costs and Cost Analysis|costs and cost analysis
4895185|NCT02108977|Comparative Effectiveness Research|comparative effectiveness research
4895186|NCT02108977|Telehealth|telehealth
4895187|NCT02108964|NSCLC|nsclc
4895188|NCT02108964|Non-small Cell Lung Cancer EGFRmut|non-small cell lung cancer egfrmut
4895189|NCT02108964|EGFR TKIs (EGF816)|egfr tkis (egf816)
4895190|NCT02108964|acquired T790M mutation|acquired t790m mutation
4895191|NCT02108964|de novo T790M mutation|de novo t790m mutation
4895192|NCT02108964|EGFR TKI activating mutation (i.e. L858R or ex19del)|egfr tki activating mutation (i.e. l858r or ex19del)
4895193|NCT02108964|Treatment naive advanced NSCLC with EGFR activating mutations|treatment naive advanced nsclc with egfr activating mutations
4895194|NCT02108964|Locally advanced NSCLC (Stage IIIB NSCLC not amenable to definitive multi-modality therapy including surgery)|locally advanced nsclc (stage iiib nsclc not amenable to definitive multi-modality therapy including surgery)
4895195|NCT02108964|Metastatic NSCLC refers to Stage IV NSCLC|metastatic nsclc refers to stage iv nsclc
4895196|NCT02108964|1st line|1st line
4895197|NCT02108951|CML|cml
4895198|NCT02108951|Ph-CML|ph-cml
4895199|NCT02108951|leukaemia|leukaemia
4895200|NCT02108951|leukemia|leukemia
4895201|NCT02108951|chronic myeloid leukemia|chronic myeloid leukemia
4895202|NCT02108951|chronic myeloid leukaemia|chronic myeloid leukaemia
4895203|NCT02108951|TKI intolerance|tki intolerance
4895204|NCT02108951|tyrosine kinase inhibitor|tyrosine kinase inhibitor
4895205|NCT02108951|tyrosine kinase inhibitor intolerance|tyrosine kinase inhibitor intolerance
4895206|NCT02108912|stroke|stroke
4895207|NCT02108912|gait|gait
4895208|NCT02108912|cardiovascular|cardiovascular
4895209|NCT02108899|Schizophrenia|schizophrenia
4895210|NCT02108899|Episodic memory deficits|episodic memory deficits
4895211|NCT02108886|preterm labor|preterm labor
4895212|NCT02108886|montelukast|montelukast
4895213|NCT02108886|uterine contractions|uterine contractions
4895214|NCT02108873|Appointments and Schedules|appointments and schedules
4895215|NCT02108873|Outpatient Clinics, Hospital/economics|outpatient clinics, hospital/economics
4895216|NCT02108860|Granulomatosis with polyangiitis (Wegener's)|granulomatosis with polyangiitis (wegener's)
4895217|NCT02108860|Granulomatosis with polyangiitis|granulomatosis with polyangiitis
4895218|NCT02108860|GPA|gpa
4895219|NCT02108860|Wegener's granulomatosis|wegener's granulomatosis
4895220|NCT02108860|Wegener granulomatosis|wegener granulomatosis
4895221|NCT02108860|Anti Neutrophil Cytoplasmic Antibody Associated Vasculitis|anti neutrophil cytoplasmic antibody associated vasculitis
4895222|NCT02108860|ANCA Associated Vasculitis|anca associated vasculitis
4895223|NCT02108860|AAV|aav
4895224|NCT02108860|Vasculitis|vasculitis
4895225|NCT02108860|Systemic vasculitis|systemic vasculitis
4895226|NCT02108860|Systemic inflammatory disease|systemic inflammatory disease
4895227|NCT02108860|Lung Diseases|lung diseases
4895228|NCT02108860|Respiratory Tract Diseases|respiratory tract diseases
4895229|NCT02108860|Vascular Diseases|vascular diseases
4895230|NCT02108860|Abatacept|abatacept
4895231|NCT02108860|CTLA4-Ig|ctla4-ig
4895232|NCT02108860|Immunosuppressive agent|immunosuppressive agent
4895233|NCT02108860|Prednisone|prednisone
4895234|NCT02108860|Glucocorticoids|glucocorticoids
4895235|NCT02108860|Glucocorticoid|glucocorticoid
4895236|NCT02108860|Corticosteroid|corticosteroid
4895237|NCT02108860|Corticosteroids|corticosteroids
4895238|NCT02108860|Treatment|treatment
4895239|NCT02108860|Pharmacologic Actions|pharmacologic actions
4895240|NCT02108860|Therapeutic Uses|therapeutic uses
4895241|NCT02108860|Anti Inflammatory Agents|anti inflammatory agents
4895242|NCT02108847|Arthroplasty, Replacement, Hip|arthroplasty, replacement, hip
4895243|NCT02108847|Pain, Postoperative|pain, postoperative
4895244|NCT02108847|Nerve Block|nerve block
4895245|NCT02108847|Anesthesia, Regional|anesthesia, regional
4895246|NCT02108847|Fascia Iliaca Block|fascia iliaca block
4895247|NCT02108847|Ultrasound Guided|ultrasound guided
4895248|NCT02108834|chronic postsurgery pain|chronic postsurgery pain
4895249|NCT02108834|acute pain|acute pain
4895250|NCT02108821|Inflammatory Bowel Diseases (IBD)|inflammatory bowel diseases (ibd)
4895251|NCT02108821|Crohn's Disease (CD)|crohn's disease (cd)
4895252|NCT02108821|Ulcerative Colitis (UC)|ulcerative colitis (uc)
4895253|NCT02108808|FFR|ffr
4895254|NCT02108808|adenosine|adenosine
4895255|NCT02108808|Ticagrelor|ticagrelor
4895256|NCT02108769|Yoga|yoga
4895257|NCT02108769|Yogic breathing|yogic breathing
4895258|NCT02108769|Saliva|saliva
4895259|NCT02108769|Proteomics|proteomics
4895260|NCT02108769|Lipdomics|lipdomics
4895261|NCT02108769|Nerve growth factor|nerve growth factor
4895262|NCT02108769|Thirumanthiram|thirumanthiram
4895263|NCT02108717|Telemedicine|telemedicine
4895264|NCT02108717|appendicitis|appendicitis
4895265|NCT02108717|remote consultation|remote consultation
4895266|NCT02108704|Parkinson's Disease|parkinson's disease
4895267|NCT02108704|Helicobacter pylori infection|helicobacter pylori infection
4895268|NCT02108678|Acceptance and Commitment Therapy (ACT)|acceptance and commitment therapy (act)
4895269|NCT02108678|Depression|depression
4895270|NCT02108678|Illness Management|illness management
4895271|NCT02108678|Behavioral Treatment|behavioral treatment
4895272|NCT02108678|Impairment|impairment
4895273|NCT02108652|anti-PD-L1|anti-pd-l1
4895274|NCT02108652|PD-L1|pd-l1
4895275|NCT02108652|MPDL3280A|mpdl3280a
4895276|NCT02108652|PD-1|pd-1
4895277|NCT02108652|bladder cancer|bladder cancer
4895278|NCT02108652|atezolizumab|atezolizumab
4895279|NCT02108652|Tecentriq|tecentriq
4895280|NCT02108626|Electronic Cigarettes|electronic cigarettes
4895281|NCT02108626|Lozenge|lozenge
4895282|NCT02108626|Nicotine|nicotine
4895283|NCT02108626|Tobacco|tobacco
4895284|NCT02108626|Dependence|dependence
4895285|NCT02108626|Withdrawal|withdrawal
4895286|NCT02108613|Androgen deprivation therapy|androgen deprivation therapy
4895287|NCT02108613|Supportive care|supportive care
4895288|NCT02108613|Quality of life|quality of life
4895289|NCT02108600|Kidney transplantation|kidney transplantation
4895290|NCT02108600|Inflammation|inflammation
4895291|NCT02108561|Breast Cancer Heterogeneity Her2|breast cancer heterogeneity her2
4895292|NCT02108548|ASP7657|asp7657
4895293|NCT02108548|Pharmacokinetics|pharmacokinetics
4895294|NCT02108548|Pharmacodynamics|pharmacodynamics
4895295|NCT02108548|Healthy Subjects|healthy subjects
4895296|NCT02108548|First in man|first in man
4895297|NCT02108548|Safety|safety
4895298|NCT02108535|burns|burns
4895299|NCT02108535|dressings|dressings
4895300|NCT02108535|silver sulfadiazine|silver sulfadiazine
4895301|NCT02108535|silver compounds|silver compounds
4895302|NCT02108535|cost|cost
4895303|NCT02108522|CMV infection|cmv infection
4895304|NCT02108522|EBV infection|ebv infection
4895305|NCT02108522|HHV6 virus infection|hhv6 virus infection
4895306|NCT02108522|BK virus infection|bk virus infection
4895307|NCT02108522|Adenovirus infection|adenovirus infection
4895308|NCT02108522|JC virus infection|jc virus infection
4895309|NCT02108522|allogeneic stem cell transplant|allogeneic stem cell transplant
4895310|NCT02108522|Virus Specific T cells|virus specific t cells
4895311|NCT02108509|Chronic Pancreatitis|chronic pancreatitis
4895312|NCT02108509|Osteopenia|osteopenia
4895313|NCT02108509|Osteoporosis|osteoporosis
4895314|NCT02108509|Hypogonadism|hypogonadism
4895315|NCT02108509|Opioid medications|opioid medications
4895316|NCT02108470|Oral Health Related Quality of Life (OHRQoL)|oral health related quality of life (ohrqol)
4895317|NCT02108470|Oral Health Impact Profile (OHIP)|oral health impact profile (ohip)
4895318|NCT02108470|Dentist-Patient Relations|dentist-patient relations
4895319|NCT02108470|patients' participation.|patients' participation.
4895320|NCT02108470|patients' satisfaction with the consultation.|patients' satisfaction with the consultation.
4895321|NCT02108457|concurrent chemotherapy|concurrent chemotherapy
4895322|NCT02108444|hepatitis|hepatitis
4895323|NCT02108444|hepatitis B|hepatitis b
4895324|NCT02108444|lymphoma|lymphoma
4895325|NCT02108444|Hematologic Diseases|hematologic diseases
4895326|NCT02108431|urinary diversion|urinary diversion
4895327|NCT02108431|urethral catheter|urethral catheter
4895328|NCT02108431|suprapubic tube|suprapubic tube
4895329|NCT02108431|radical prostatectomy|radical prostatectomy
4895330|NCT02108431|robotic surgery|robotic surgery
4895331|NCT02108431|discomfort|discomfort
4895332|NCT02108431|pain|pain
4895333|NCT02108405|critically ill patient.|critically ill patient.
4895334|NCT02108392|PXE|pxe
4895335|NCT02108392|phenotype|phenotype
4895336|NCT02108392|eye|eye
4895337|NCT02108392|biomarkers|biomarkers
4895338|NCT02108366|severe|severe
4895339|NCT02108366|influenza A|influenza a
4895340|NCT02108366|celecoxib|celecoxib
4895341|NCT02108353|Type 2 Diabetes|type 2 diabetes
4895342|NCT02108353|metabolic control|metabolic control
4895343|NCT02108353|Metabolomics|metabolomics
4895344|NCT02108353|Circadian Rhythm|circadian rhythm
4895345|NCT02108353|Melatonin|melatonin
4895346|NCT02108353|Biomarker|biomarker
4895347|NCT02108353|Clock Gene|clock gene
4895348|NCT02108353|PBMC|pbmc
4895349|NCT02108353|Cardiovascular function|cardiovascular function
4895350|NCT02108353|Epigenetic modification|epigenetic modification
4895351|NCT02108353|Lifestyle Intervention|lifestyle intervention
4895352|NCT02108340|Appendicitis|appendicitis
4895353|NCT02108340|Diagnosis|diagnosis
4895354|NCT02108340|Microwave radiometry|microwave radiometry
4895355|NCT02108340|Ultrasonography|ultrasonography
4895356|NCT02108327|Blood loss|blood loss
4895357|NCT02108327|total knee arthroplasty|total knee arthroplasty
4895358|NCT02108327|hot knife|hot knife
4895359|NCT02108327|cold knife|cold knife
4895360|NCT02108327|unipolar electrocautery|unipolar electrocautery
4895361|NCT02108327|surgical blade|surgical blade
4895362|NCT02108301|chronic hepatitis C-virus infection|chronic hepatitis c-virus infection
4895363|NCT02108301|renal transplantation|renal transplantation
4895364|NCT02108301|glucose tolerance|glucose tolerance
4895365|NCT02108301|immunosuppression|immunosuppression
4895366|NCT02108236|acupuncture|acupuncture
4895367|NCT02108236|chinese traditional medicine|chinese traditional medicine
4895368|NCT02108223|ICSI|icsi
4895369|NCT02108223|Suboptimal Ovarian Response|suboptimal ovarian response
4895370|NCT02108223|rLH|rlh
4895371|NCT02108210|Chronic fatigue syndrome|chronic fatigue syndrome
4895372|NCT02108210|Cytokines|cytokines
4895373|NCT02108210|Interleukin-1|interleukin-1
4895374|NCT02108210|Fatigue|fatigue
4895375|NCT02108210|Anakinra|anakinra
4895376|NCT02108184|helicobacter eradication rates|helicobacter eradication rates
4895377|NCT02108171|intranasal|intranasal
4895378|NCT02108171|dexmedetomidine|dexmedetomidine
4895379|NCT02108171|early recovery|early recovery
4895380|NCT02108171|suspension laryngoscopy|suspension laryngoscopy
4895381|NCT02108145|cholangiocarcinoma|cholangiocarcinoma
4895382|NCT02108145|jaundice|jaundice
4895383|NCT02108145|metal stent|metal stent
4895384|NCT02108145|PTBS|ptbs
4895385|NCT02108132|hemophilia|hemophilia
4895386|NCT02108132|mesenchymal stem cells|mesenchymal stem cells
4895387|NCT02108132|in-vitro transdifferentiation|in-vitro transdifferentiation
4895388|NCT02108106|safety and tolerability|safety and tolerability
4895389|NCT02108106|pharmacokinetic study|pharmacokinetic study
4895390|NCT02108080|Alcohol|alcohol
4895391|NCT02108080|Adolescents|adolescents
4895392|NCT02108080|Adults|adults
4895393|NCT02108054|fMRI|fmri
4895394|NCT02108054|Alcoholism|alcoholism
4895395|NCT02108054|Phenotype|phenotype
4895396|NCT02108054|Imaging|imaging
4895397|NCT02108041|Physicians|physicians
4895398|NCT02108041|Pharmacogenetic Testing|pharmacogenetic testing
4895399|NCT02108041|Decision-Making|decision-making
4895400|NCT02108041|Communicative Behaviors|communicative behaviors
4895401|NCT02108028|Advance Care Planning Guide|advance care planning guide
4895402|NCT02108028|End-of-Life|end-of-life
4895403|NCT02108015|Transmembrane AMPA Receptor Regulatory Protein|transmembrane ampa receptor regulatory protein
4895404|NCT02108015|Glutamate Receptors|glutamate receptors
4895405|NCT02108015|Healthy Volunteers|healthy volunteers
4895406|NCT02108002|Missense Mutations|missense mutations
4895407|NCT02108002|Hemangioblastoma|hemangioblastoma
4895408|NCT02108002|Histone Deacytelase Inhibitors|histone deacytelase inhibitors
4895409|NCT02108002|Von Hippel-Lindau Disease|von hippel-lindau disease
4895410|NCT02107989|Epilepsy|epilepsy
4895411|NCT02107989|MRI|mri
4895412|NCT02107989|fMRI|fmri
4895413|NCT02107989|MEG|meg
4895414|NCT02107976|Diabetes|diabetes
4895415|NCT02107976|Red Blood Cells|red blood cells
4895416|NCT02107976|Vitamin C|vitamin c
4895417|NCT02107976|Plasma Vitamin C Levels|plasma vitamin c levels
4895418|NCT02107963|GD2-Expressing Tumors|gd2-expressing tumors
4895419|NCT02107963|Anti-GD2 Chimeric Antigen Receptor|anti-gd2 chimeric antigen receptor
4895420|NCT02107963|Osteosarcoma|osteosarcoma
4895421|NCT02107963|Adoptive Immunotherapy|adoptive immunotherapy
4895422|NCT02107963|Sarcomas|sarcomas
4895423|NCT02107950|Ovarian|ovarian
4895424|NCT02107950|Platinum Sensitive|platinum sensitive
4895425|NCT02107950|Epithelial|epithelial
4895426|NCT02107937|serous|serous
4895427|NCT02107937|endometrioid|endometrioid
4895428|NCT02107937|mucinous|mucinous
4895429|NCT02107937|epithelial ovarian cancer|epithelial ovarian cancer
4895430|NCT02107924|Total|total
4895431|NCT02107924|Knee|knee
4895432|NCT02107924|Replacment|replacment
4895433|NCT02107924|Infection|infection
4895434|NCT02107924|Stimulan|stimulan
4895435|NCT02107911|men who have sex with men|men who have sex with men
4895436|NCT02107911|non-occupational post exposure prophylaxis|non-occupational post exposure prophylaxis
4895437|NCT02107911|HIV infection|hiv infection
4895438|NCT02107859|Cystic fibrosis|cystic fibrosis
4895439|NCT02107859|Nonsense mutation|nonsense mutation
4895440|NCT02107859|Premature stop codon|premature stop codon
4895441|NCT02107859|PTC124|ptc124
4895442|NCT02107859|Ataluren|ataluren
4895443|NCT02107820|Bladder training|bladder training
4895444|NCT02107820|Percutaneous Tibial nerve stimulation|percutaneous tibial nerve stimulation
4895445|NCT02107820|Overactive bladder|overactive bladder
4895446|NCT02107820|Randomised controlled study|randomised controlled study
4895447|NCT02107807|Influenza,|influenza,
4895448|NCT02107807|H5N1|h5n1
4895449|NCT02107807|aH5N1|ah5n1
4895450|NCT02107807|H5N1 vaccine|h5n1 vaccine
4895451|NCT02107807|Pandemic Influenza vaccine|pandemic influenza vaccine
4895452|NCT02107807|MF59|mf59
4895453|NCT02107807|Adjuvant|adjuvant
4895454|NCT02107807|Avian flu|avian flu
4895455|NCT02107807|Underlying Immunosuppressive|underlying immunosuppressive
4895456|NCT02107807|immunosuppressive conditions|immunosuppressive conditions
4895457|NCT02107807|Pandemic vaccine|pandemic vaccine
4895458|NCT02107807|Adjuvanted vaccine|adjuvanted vaccine
4895459|NCT02107794|Grave's|grave's
4895460|NCT02107794|Disease|disease
4895461|NCT02107794|Thyroid|thyroid
4895462|NCT02107794|Hyperthyroidism|hyperthyroidism
4895463|NCT02107794|Thyroidectomy|thyroidectomy
4895464|NCT02107794|Radioactive|radioactive
4895465|NCT02107794|Iodine|iodine
4895466|NCT02107794|Antithyroid|antithyroid
4895467|NCT02107794|Shared|shared
4895468|NCT02107794|Decision|decision
4895469|NCT02107794|Making|making
4895470|NCT02107794|Aid|aid
4895471|NCT02107794|Evidence|evidence
4895472|NCT02107794|Based|based
4895473|NCT02107794|Endocrinology|endocrinology
4895474|NCT02107794|Mayo|mayo
4895475|NCT02107794|Clinic|clinic
4895476|NCT02107781|Open abdomen|open abdomen
4895477|NCT02107781|abdominal compartment pressure|abdominal compartment pressure
4895478|NCT02107768|Stroke|stroke
4895479|NCT02107768|Exercise|exercise
4895480|NCT02107768|Randomized trial|randomized trial
4895481|NCT02107768|Quality of Life|quality of life
4895482|NCT02107755|oligometastatic melanoma|oligometastatic melanoma
4895483|NCT02107755|melanoma|melanoma
4895484|NCT02107742|Injections|injections
4895485|NCT02107742|Time factors|time factors
4895486|NCT02107742|Pain|pain
4895487|NCT02107742|Healthy volunteers|healthy volunteers
4895488|NCT02107742|Lidocaine|lidocaine
4895489|NCT02107729|Injections|injections
4895490|NCT02107729|Pain|pain
4895491|NCT02107729|Healthy volunteers|healthy volunteers
4895492|NCT02107729|Lidocaine|lidocaine
4895493|NCT02107716|Pain|pain
4895494|NCT02107716|Injections|injections
4895495|NCT02107716|Lidocaine|lidocaine
4895496|NCT02107716|Healthy volunteers|healthy volunteers
4895497|NCT02107703|MONARCH 2|monarch 2
4895498|NCT02107690|Injections|injections
4895499|NCT02107690|Temperature|temperature
4895500|NCT02107690|Pain|pain
4895501|NCT02107690|Healthy volunteers|healthy volunteers
4895502|NCT02107690|Lidocaine|lidocaine
4895503|NCT02107664|Radiotherapy|radiotherapy
4895504|NCT02107664|Cachexia|cachexia
4895505|NCT02107664|Inflammation|inflammation
4895506|NCT02107664|Depression|depression
4895507|NCT02107651|Bleeding|bleeding
4895508|NCT02107651|Anticoagulation|anticoagulation
4895509|NCT02107638|Parkinson's Disease|parkinson's disease
4895510|NCT02107638|Osteopathic Manipulative Medicine|osteopathic manipulative medicine
4895511|NCT02107638|Falls|falls
4895512|NCT02107638|Balance|balance
4895513|NCT02107638|Motor function|motor function
4895514|NCT02107625|Defecation|defecation
4895515|NCT02107625|Abdominal pain|abdominal pain
4895516|NCT02107612|Mini-Dental Implant|mini-dental implant
4895517|NCT02107612|Implant-Supported Dental Prosthesis|implant-supported dental prosthesis
4895518|NCT02107612|Minimally Invasive Surgical procedures|minimally invasive surgical procedures
4895519|NCT02107612|Overdentures|overdentures
4895520|NCT02107612|Aged|aged
4895521|NCT02107586|biceps tenodesis|biceps tenodesis
4895522|NCT02107586|biceps tenotomy|biceps tenotomy
4895523|NCT02107586|biceps tendonitis|biceps tendonitis
4895524|NCT02107586|biceps inflammation|biceps inflammation
4895525|NCT02107586|shoulder surgery|shoulder surgery
4895526|NCT02107573|Randomized Controlled Trial|randomized controlled trial
4895527|NCT02107573|Rotator Cuff Tear|rotator cuff tear
4895528|NCT02107573|Suprascapular Nerve|suprascapular nerve
4895529|NCT02107573|Decompression|decompression
4895530|NCT02107573|Shoulder Surgery|shoulder surgery
4895531|NCT02107560|Cholangitis|cholangitis
4895532|NCT02107560|Bacteremia|bacteremia
4895533|NCT02107560|Endotoxemia|endotoxemia
4895534|NCT02107560|Blood|blood
4895535|NCT02107560|Bile|bile
4895536|NCT02107547|Randomized Controlled Trial (RCT)|randomized controlled trial (rct)
4895537|NCT02107547|Type 2 SLAP lesions|type 2 slap lesions
4895538|NCT02107547|labral tear|labral tear
4895539|NCT02107547|biceps tenodesis|biceps tenodesis
4895540|NCT02107547|shoulder surgery|shoulder surgery
4895541|NCT02107547|RCT|rct
4895542|NCT02107547|Comparison between two alternative surgical procedures|comparison between two alternative surgical procedures
4895543|NCT02107534|parent training|parent training
4895544|NCT02107534|homework|homework
4895545|NCT02107534|parenting stress|parenting stress
4895546|NCT02107521|sperm morphology|sperm morphology
4895547|NCT02107521|ICSI|icsi
4895548|NCT02107521|IMSI|imsi
4895549|NCT02107521|implantation|implantation
4895550|NCT02107521|pregnancy|pregnancy
4895551|NCT02107508|activity energy expenditure|activity energy expenditure
4895552|NCT02107508|body composition|body composition
4895553|NCT02107495|CHF|chf
4895554|NCT02107469|Diabetic Polyneuropathy|diabetic polyneuropathy
4895555|NCT02107469|Diabetic|diabetic
4895556|NCT02107469|Polyneuropathy|polyneuropathy
4895557|NCT02107469|Ayurvedic|ayurvedic
4895558|NCT02107469|Ayurveda|ayurveda
4895559|NCT02107469|Neuralgia|neuralgia
4895560|NCT02107469|Diabetic Neuralgia|diabetic neuralgia
4895561|NCT02107469|Sida cordifolia|sida cordifolia
4895562|NCT02107469|Phyllanthus Niruri|phyllanthus niruri
4895563|NCT02107469|Phyllanthus Amarus|phyllanthus amarus
4895564|NCT02107469|Extracts|extracts
4895565|NCT02107469|Extract|extract
4895566|NCT02107469|Crude Herb|crude herb
4895567|NCT02107469|Crude|crude
4895568|NCT02107469|Herb|herb
4895569|NCT02107469|Herbal|herbal
4895570|NCT02107469|Herbal Extract|herbal extract
4895571|NCT02107469|Decoction|decoction
4895572|NCT02107469|Churna|churna
4895573|NCT02107469|Powder|powder
4895574|NCT02107469|Bala|bala
4895575|NCT02107469|Bhumyamalaki|bhumyamalaki
4895576|NCT02107469|Tamalaki|tamalaki
4895577|NCT02107456|Dry Needling, Myofascial trigger point, Upper trapezius|dry needling, myofascial trigger point, upper trapezius
4895578|NCT02107430|Immunotherapy|immunotherapy
4895579|NCT02107430|Prostate Cancer|prostate cancer
4895580|NCT02107430|Biological, Vaccine|biological, vaccine
4895581|NCT02107417|chemotherapy|chemotherapy
4895582|NCT02107417|pain|pain
4895583|NCT02107417|paresthesia|paresthesia
4895584|NCT02107417|Physiotherapy|physiotherapy
4895585|NCT02107417|Transcutaneous Electrical Nerve Stimulation|transcutaneous electrical nerve stimulation
4895586|NCT02107404|Immunotherapy|immunotherapy
4895587|NCT02107404|Prostate Cancer|prostate cancer
4895588|NCT02107404|Biological|biological
4895589|NCT02107404|Vaccine|vaccine
4895590|NCT02107391|Immunotherapy|immunotherapy
4895591|NCT02107391|Prostate Cancer|prostate cancer
4895592|NCT02107391|Biological|biological
4895593|NCT02107391|Vaccine|vaccine
4895594|NCT02107391|Androgen Deprivation Therapy|androgen deprivation therapy
4895595|NCT02107378|Immunotherapy|immunotherapy
4895596|NCT02107378|Serous|serous
4895597|NCT02107378|Relapsed|relapsed
4895598|NCT02107378|Platinum resistant (pt)|platinum resistant (pt)
4895599|NCT02107378|Ovarian Cancer (OvCa)|ovarian cancer (ovca)
4895600|NCT02107378|Biological|biological
4895601|NCT02107378|Vaccine|vaccine
4895602|NCT02107365|Hepatitis C|hepatitis c
4895603|NCT02107365|HCV infection|hcv infection
4895604|NCT02107365|HCV genotype 4|hcv genotype 4
4895732|NCT02106832|Exacerbation|exacerbation
4895605|NCT02107365|Non-responders HCV infected patients|non-responders hcv infected patients
4895606|NCT02107365|Asunaprevir|asunaprevir
4895607|NCT02107365|Daclatasvir|daclatasvir
4895608|NCT02107365|Pegylated Interferon|pegylated interferon
4895609|NCT02107365|Ribavirin|ribavirin
4895610|NCT02107352|Anti-craving medication|anti-craving medication
4895611|NCT02107352|Inhibition|inhibition
4895612|NCT02107352|Attentional Bias|attentional bias
4895613|NCT02107352|Event-Related Potentials|event-related potentials
4895614|NCT02107352|Relapse|relapse
4895615|NCT02107339|methadone|methadone
4895616|NCT02107339|hydromorphone|hydromorphone
4895617|NCT02107339|acute postoperative pain|acute postoperative pain
4895618|NCT02107339|chronic persistent surgical pain|chronic persistent surgical pain
4895619|NCT02107326|Type 1 diabetes|type 1 diabetes
4895620|NCT02107326|HbA1C|hba1c
4895621|NCT02107326|Quality of Life|quality of life
4895622|NCT02107326|Hypoglycaemia|hypoglycaemia
4895623|NCT02107326|Self-management|self-management
4895624|NCT02107326|Telemedicine|telemedicine
4895625|NCT02107300|Obstructive Sleep Apnea Syndrome|obstructive sleep apnea syndrome
4895626|NCT02107274|Azithromycin|azithromycin
4895627|NCT02107274|Bronchiectasis|bronchiectasis
4895628|NCT02107274|Macrolide|macrolide
4895629|NCT02107274|Inflammation|inflammation
4895630|NCT02107274|Pulmonary|pulmonary
4895631|NCT02107261|Musician's Dystonia|musician's dystonia
4895632|NCT02107248|Arthroplasty|arthroplasty
4895633|NCT02107248|Replacement|replacement
4895634|NCT02107248|Hip|hip
4895635|NCT02107248|Posterolateral surgery|posterolateral surgery
4895636|NCT02107248|Precautions|precautions
4895637|NCT02107235|Chemoradiotherapy|chemoradiotherapy
4895638|NCT02107235|cisplatin|cisplatin
4895639|NCT02107222|COPD|copd
4895640|NCT02107222|Exacerbation|exacerbation
4895641|NCT02107222|invasive ventilation|invasive ventilation
4895642|NCT02107222|CO2-Removal|co2-removal
4895643|NCT02107196|Irritable Bowel Syndrome|irritable bowel syndrome
4895644|NCT02107196|Colon, irritable|colon, irritable
4895645|NCT02107196|Bowel disease|bowel disease
4895646|NCT02107196|Diarrhea|diarrhea
4895647|NCT02107183|Oxygen therapy|oxygen therapy
4895648|NCT02107183|Extubation|extubation
4895649|NCT02107183|Weaning|weaning
4895650|NCT02107183|Reintubation|reintubation
4895651|NCT02107183|Acute respiratory failure|acute respiratory failure
4895652|NCT02107144|trimetazidine|trimetazidine
4895653|NCT02107144|microcirculation|microcirculation
4895654|NCT02107144|stenting|stenting
4895655|NCT02107144|pressure wire|pressure wire
4895656|NCT02107118|Stem cells|stem cells
4895657|NCT02107118|cardiovascular disease|cardiovascular disease
4895658|NCT02107118|erectile dysfunction|erectile dysfunction
4895659|NCT02107105|Rectal cancer|rectal cancer
4895660|NCT02107105|Adenocarcinoma of the rectum|adenocarcinoma of the rectum
4895661|NCT02107105|Quality of Life|quality of life
4895662|NCT02107105|QOL|qol
4895663|NCT02107105|Post surgery|post surgery
4895664|NCT02107105|Pre-surgery|pre-surgery
4895665|NCT02107105|Questionnaires|questionnaires
4895666|NCT02107105|Surveys|surveys
4895667|NCT02107079|melatonin|melatonin
4895668|NCT02107079|bioavailability|bioavailability
4895669|NCT02107079|pharmacokinetics|pharmacokinetics
4895670|NCT02107066|exercise|exercise
4895671|NCT02107066|physical activity|physical activity
4895672|NCT02107066|ovarian cancer|ovarian cancer
4895673|NCT02107066|quality of life|quality of life
4895674|NCT02107066|fatigue|fatigue
4895675|NCT02107066|weight|weight
4895676|NCT02107053|Oxidative stress,|oxidative stress,
4895677|NCT02107053|hemodialysis,|hemodialysis,
4895678|NCT02107053|pomegranate juice,|pomegranate juice,
4895679|NCT02107053|dietary supplement|dietary supplement
4895680|NCT02107053|patients|patients
4895681|NCT02107001|Lung ultrasound|lung ultrasound
4895682|NCT02107001|Community acquired p neumonia (CAP)|community acquired p neumonia (cap)
4895683|NCT02107001|Pleuritis|pleuritis
4895684|NCT02107001|Pulmonary embolism|pulmonary embolism
4895685|NCT02107001|Lung Cancer|lung cancer
4895686|NCT02106988|Lymphoma|lymphoma
4895687|NCT02106988|NK cell lymphoma-nasal type|nk cell lymphoma-nasal type
4895688|NCT02106988|Radiation therapy|radiation therapy
4895689|NCT02106988|XRT|xrt
4895690|NCT02106988|Dexamethasone|dexamethasone
4895691|NCT02106988|Decadron|decadron
4895692|NCT02106988|Etoposide|etoposide
4895693|NCT02106988|VePesid|vepesid
4895694|NCT02106988|Ifosfamide|ifosfamide
4895695|NCT02106988|Ifex|ifex
4895696|NCT02106988|Mesna|mesna
4895697|NCT02106988|Mesnex|mesnex
4895698|NCT02106988|Carboplatin|carboplatin
4895699|NCT02106988|Paraplatin|paraplatin
4895700|NCT02106962|hemodialysis|hemodialysis
4895701|NCT02106962|fistula|fistula
4895702|NCT02106962|clotting|clotting
4895703|NCT02106962|tranexamic acid|tranexamic acid
4895704|NCT02106962|bacitracin|bacitracin
4895705|NCT02106949|suicide attempt, SMS monitoring, recurrence, phone, prevention control, tertiary healthcare|suicide attempt, sms monitoring, recurrence, phone, prevention control, tertiary healthcare
4895706|NCT02106936|Focal Hand Dystonia|focal hand dystonia
4895707|NCT02106936|Depotentiation|depotentiation
4895708|NCT02106936|Transcranial Magnetic Stimulation (TMS)|transcranial magnetic stimulation (tms)
4895709|NCT02106936|Rapid Paired Associative Stimulation|rapid paired associative stimulation
4895710|NCT02106936|Healthy Volunteer|healthy volunteer
4895711|NCT02106910|Barrett's Esophagus|barrett's esophagus
4895712|NCT02106910|Radiofrequency Ablation|radiofrequency ablation
4895713|NCT02106884|Pancreatic cancer|pancreatic cancer
4895714|NCT02106884|Locally advanced|locally advanced
4895715|NCT02106884|Metastatic|metastatic
4895716|NCT02106871|cancer|cancer
4895717|NCT02106871|pancreas|pancreas
4895718|NCT02106871|cholangiocarcinoma|cholangiocarcinoma
4895719|NCT02106871|fatigue|fatigue
4895720|NCT02106871|sildenafil|sildenafil
4895721|NCT02106871|lean mass|lean mass
4895722|NCT02106871|muscle|muscle
4895723|NCT02106858|Stivarga / Regorafenib / Metastatic Colorectal Cancer / Metastatic or unresectable locally advanced GIST (Gastrointestinal stromal tumors)|stivarga / regorafenib / metastatic colorectal cancer / metastatic or unresectable locally advanced gist (gastrointestinal stromal tumors)
4895724|NCT02106845|Regorafenib|regorafenib
4895725|NCT02106845|Probe substrates|probe substrates
4895726|NCT02106845|Pharmacokinetics|pharmacokinetics
4895727|NCT02106845|Cancer|cancer
4895728|NCT02106845|Safety|safety
4895729|NCT02106845|Advanced solid malignant tumors|advanced solid malignant tumors
4895730|NCT02106832|Ciprofloxacin|ciprofloxacin
4895731|NCT02106832|Dry Powder for Inhalation|dry powder for inhalation
4895733|NCT02106832|Bronchiectasis|bronchiectasis
4895734|NCT02106819|Cerebellar Ataxia|cerebellar ataxia
4895735|NCT02106819|Emotions|emotions
4895736|NCT02106819|Affective Prosody|affective prosody
4895737|NCT02106819|Facial Expression|facial expression
4895738|NCT02106819|Magnetic Resonance Imaging|magnetic resonance imaging
4895739|NCT02106806|Oxidative stress|oxidative stress
4895740|NCT02106806|Zinc|zinc
4895741|NCT02106806|Chemotherapy|chemotherapy
4895742|NCT02106806|Colorectal cancer|colorectal cancer
4895743|NCT02106793|Chronic Rhinosinusitis|chronic rhinosinusitis
4895744|NCT02106793|Mitomicin C|mitomicin c
4895745|NCT02106793|Postoperative nasal synerchia|postoperative nasal synerchia
4895746|NCT02106780|Phase 1|phase 1
4895747|NCT02106780|Healthy subjects|healthy subjects
4895748|NCT02106780|Excretion|excretion
4895749|NCT02106780|14C-labeled ASP1707|14c-labeled asp1707
4895750|NCT02106767|rosuvastatin|rosuvastatin
4895751|NCT02106767|rifampin|rifampin
4895752|NCT02106767|pharmacokinetics|pharmacokinetics
4895753|NCT02106767|drug interaction|drug interaction
4896052|NCT02105571|Body Weight|body weight
4895754|NCT02106767|healthy volunteer|healthy volunteer
4895755|NCT02106767|drug transporter|drug transporter
4895756|NCT02106767|Asian|asian
4895757|NCT02106767|White|white
4895758|NCT02106741|Pain|pain
4895759|NCT02106741|Acupressure|acupressure
4895760|NCT02106741|Symptoms|symptoms
4895761|NCT02106741|Fatigue|fatigue
4895762|NCT02106741|Self-administered|self-administered
4895763|NCT02106728|Eating Disorders|eating disorders
4895764|NCT02106728|Family Therapy|family therapy
4895765|NCT02106728|Multi-Family Therapy|multi-family therapy
4895766|NCT02106728|Bulimia Nervosa|bulimia nervosa
4895767|NCT02106728|Eating Disorder Not Otherwise Specified|eating disorder not otherwise specified
4895768|NCT02106702|HIV|hiv
4895769|NCT02106702|detention|detention
4895770|NCT02106702|substance abuse|substance abuse
4895771|NCT02106689|infertility, superovulation, gonadotropins, needle free injection system|infertility, superovulation, gonadotropins, needle free injection system
4895772|NCT02106676|polycystic ovary Syndrome|polycystic ovary syndrome
4895773|NCT02106676|hyperandrogenism|hyperandrogenism
4895774|NCT02106676|cordblood|cordblood
4895775|NCT02106676|androgens|androgens
4895776|NCT02106663|atrial fibrillation|atrial fibrillation
4895777|NCT02106663|paroxysmal atrial fibrillation|paroxysmal atrial fibrillation
4895778|NCT02106663|PAF|paf
4895779|NCT02106663|arrhythmia|arrhythmia
4895780|NCT02106663|atrial fibrillation ablation|atrial fibrillation ablation
4895781|NCT02106663|circumferential ablation|circumferential ablation
4895782|NCT02106663|CPVA|cpva
4895783|NCT02106663|segmental ablation|segmental ablation
4895784|NCT02106663|PVI|pvi
4895785|NCT02106663|pulmonary vein isolation|pulmonary vein isolation
4895786|NCT02106650|Relapsed PTCL|relapsed ptcl
4895787|NCT02106650|Refractory PTCL|refractory ptcl
4895788|NCT02106637|ACS|acs
4895789|NCT02106637|Cessation|cessation
4895790|NCT02106624|mechanical ventilation|mechanical ventilation
4895791|NCT02106611|MRI|mri
4895792|NCT02106611|stress echo|stress echo
4895793|NCT02106611|Clinical Assessment|clinical assessment
4895794|NCT02106611|14-017|14-017
4895795|NCT02106598|Sentinel Lymph Node Mapping|sentinel lymph node mapping
4895796|NCT02106598|Intraoperative Sentinel|intraoperative sentinel
4895797|NCT02106598|Head and Neck Melanoma|head and neck melanoma
4895798|NCT02106598|Targeted Silica Nanoparticles|targeted silica nanoparticles
4895799|NCT02106598|cRGDY-PEG-Cy5.5-C dots|crgdy-peg-cy5.5-c dots
4895800|NCT02106598|13-249|13-249
4895801|NCT02106585|Safety|safety
4895802|NCT02106585|Tolerability|tolerability
4895803|NCT02106585|Pharmacokinetics|pharmacokinetics
4895804|NCT02106585|Food-effect|food-effect
4895805|NCT02106585|Diabetes|diabetes
4895806|NCT02106572|superficial bladder cancer|superficial bladder cancer
4895807|NCT02106572|viscum album extract|viscum album extract
4895808|NCT02106572|mistletoe extract|mistletoe extract
4895809|NCT02106572|abnobaVISCUM|abnobaviscum
4895810|NCT02106572|recurrence rate|recurrence rate
4895811|NCT02106559|Pleural Photodynamic Therapy|pleural photodynamic therapy
4895812|NCT02106559|Pleural Malignancy|pleural malignancy
4895813|NCT02106559|PDT|pdt
4895814|NCT02106546|veliparib|veliparib
4895815|NCT02106546|carboplatin|carboplatin
4895816|NCT02106546|paclitaxel|paclitaxel
4895817|NCT02106546|Poly Adenosine diphosphate (ADP)-ribose Polymerase (PARP)|poly adenosine diphosphate (adp)-ribose polymerase (parp)
4895818|NCT02106546|Overall Survival|overall survival
4895819|NCT02106546|Advanced|advanced
4895820|NCT02106546|Metastatic|metastatic
4895821|NCT02106546|ABT-888|abt-888
4895822|NCT02106546|Squamous|squamous
4895823|NCT02106546|Randomized|randomized
4895824|NCT02106546|non-small cell lung cancer|non-small cell lung cancer
4895825|NCT02106546|placebo controlled|placebo controlled
4895826|NCT02106533|Coronary artery disease|coronary artery disease
4895827|NCT02106533|Exercise|exercise
4895828|NCT02106533|Ventilatory efficiency|ventilatory efficiency
4895829|NCT02106520|Epistaxis|epistaxis
4895830|NCT02106520|Bevacizumab|bevacizumab
4895831|NCT02106507|Apalutamide|apalutamide
4895832|NCT02106507|RAD001|rad001
4895833|NCT02106507|Everolimus|everolimus
4895834|NCT02106507|Castration-resistant|castration-resistant
4895835|NCT02106507|13-025|13-025
4895836|NCT02106507|ARN-509|arn-509
4895837|NCT02106494|Highly emetogenic chemotherapy (HEC)|highly emetogenic chemotherapy (hec)
4895838|NCT02106494|Chemotherapy-Induced Nausea and Vomiting (CINV)|chemotherapy-induced nausea and vomiting (cinv)
4895839|NCT02106481|TKA|tka
4895840|NCT02106481|TKR|tkr
4895841|NCT02106481|Knee OA|knee oa
4895842|NCT02106481|pain management|pain management
4895843|NCT02106481|Femoral Nerve Catheter|femoral nerve catheter
4895844|NCT02106481|Single Shot Femoral Nerve Blocks|single shot femoral nerve blocks
4895845|NCT02106468|Oral Lichen Planus|oral lichen planus
4895846|NCT02106468|Corticosteroid|corticosteroid
4895847|NCT02106468|Omega -3|omega -3
4895848|NCT02106455|Pharmacological theapy|pharmacological theapy
4895849|NCT02106442|Pharmacological therapy|pharmacological therapy
4895850|NCT02106429|Vascular Surgery|vascular surgery
4895851|NCT02106416|prostate cancer|prostate cancer
4895852|NCT02106416|bladder cancer|bladder cancer
4895853|NCT02106416|MRI|mri
4895854|NCT02106416|PET|pet
4895855|NCT02106416|perfusion|perfusion
4895856|NCT02106390|Central Nervous System Diseases|central nervous system diseases
4895857|NCT02106390|Nervous System Diseases|nervous system diseases
4895858|NCT02106390|Meningitis|meningitis
4895982|NCT02105896|dental bonding|dental bonding
4895859|NCT02106338|follow-up to 10-0008, Clostridium difficile, dose-escalating, CRS3123|follow-up to 10-0008, clostridium difficile, dose-escalating, crs3123
4895860|NCT02106325|Ketamine|ketamine
4895861|NCT02106325|Ketlar|ketlar
4895862|NCT02106325|Depression|depression
4895863|NCT02106325|Antidepressants|antidepressants
4895864|NCT02106325|Treatment|treatment
4895865|NCT02106325|Acute|acute
4895866|NCT02106312|Radiotherapy|radiotherapy
4895867|NCT02106312|Myxoid liposarcoma|myxoid liposarcoma
4895868|NCT02106312|Soft tissue sarcoma|soft tissue sarcoma
4895869|NCT02106286|Cardiopulmonary exercise test|cardiopulmonary exercise test
4895870|NCT02106286|surgery|surgery
4895871|NCT02106286|abdominal aortic aneurysm|abdominal aortic aneurysm
4895872|NCT02106286|anaerobic threshold|anaerobic threshold
4895873|NCT02106286|fitness|fitness
4895874|NCT02106286|beta-blockers|beta-blockers
4895875|NCT02106273|LMA|lma
4895876|NCT02106273|Bronchial blocker|bronchial blocker
4895877|NCT02106260|safety|safety
4895878|NCT02106260|pharmacokinetics (PK)|pharmacokinetics (pk)
4895879|NCT02106260|pharmacodynamics (PD)|pharmacodynamics (pd)
4895880|NCT02106260|CLS003|cls003
4895881|NCT02106234|contrast induced nephropathy|contrast induced nephropathy
4895882|NCT02106234|prophylactic intravenous hydration|prophylactic intravenous hydration
4895883|NCT02106234|intravenous normal saline|intravenous normal saline
4895884|NCT02106234|acute kidney injury|acute kidney injury
4895885|NCT02106221|Care coordination|care coordination
4895886|NCT02106221|nurse care management|nurse care management
4895887|NCT02106221|practice facilitation|practice facilitation
4895888|NCT02106221|health information technology|health information technology
4895889|NCT02106182|Benign prostatic hyperplasia|benign prostatic hyperplasia
4895890|NCT02106182|Nocturia|nocturia
4895891|NCT02106182|Silodosin|silodosin
4895892|NCT02106182|Thrupas|thrupas
4895893|NCT02106169|Food allergy|food allergy
4895894|NCT02106169|Children and families|children and families
4895895|NCT02106169|Therapeutic education|therapeutic education
4895896|NCT02106169|Quality of life|quality of life
4895897|NCT02106130|Mosapride citrate|mosapride citrate
4895898|NCT02106130|Rebamipide|rebamipide
4895899|NCT02106130|pharmacokinetic drug drug interaction|pharmacokinetic drug drug interaction
4895900|NCT02106130|oral administration|oral administration
4895901|NCT02106130|healthy male subjects|healthy male subjects
4895902|NCT02106104|Type 2 diabetes mellitus|type 2 diabetes mellitus
4895903|NCT02106104|Diabetic kidney disease|diabetic kidney disease
4895904|NCT02106104|Diabetic nephropathy|diabetic nephropathy
4895905|NCT02106104|Renoprotection|renoprotection
4895906|NCT02106104|DPP-4 inhibitors|dpp-4 inhibitors
4895907|NCT02106104|Linagliptin|linagliptin
4895908|NCT02106104|SU derivatives|su derivatives
4895909|NCT02106104|Glimepiride|glimepiride
4895910|NCT02106078|Bipolar Disorder|bipolar disorder
4895911|NCT02106078|Bipolar|bipolar
4895912|NCT02106078|Online Intervention|online intervention
4895913|NCT02106078|Internet intervention|internet intervention
4895914|NCT02106078|Self-Help|self-help
4895915|NCT02106065|Dementia|dementia
4895916|NCT02106065|Caregivers|caregivers
4895917|NCT02106065|Neurodegenerative Diseases|neurodegenerative diseases
4895918|NCT02106065|Brain Diseases|brain diseases
4895919|NCT02106065|Cost of Illness|cost of illness
4895920|NCT02106065|Stress, Psychological|stress, psychological
4895921|NCT02106065|Depression|depression
4895922|NCT02106065|Vital Statistics|vital statistics
4895923|NCT02106065|Mortality|mortality
4895924|NCT02106065|Behavioral Symptoms|behavioral symptoms
4895925|NCT02106065|Residential Facilities|residential facilities
4895926|NCT02106065|Emergency Medical Services|emergency medical services
4895927|NCT02106065|Long-Term Care|long-term care
4895928|NCT02106052|cognitive function|cognitive function
4895929|NCT02106052|cognitive impairment|cognitive impairment
4895930|NCT02106052|cognitive intervention|cognitive intervention
4895931|NCT02106052|cognitive improvement|cognitive improvement
4895932|NCT02106052|information processing speed|information processing speed
4895933|NCT02106052|exercise training program|exercise training program
4895934|NCT02106052|aerobic exercise|aerobic exercise
4895935|NCT02106052|stretching and toning|stretching and toning
4895936|NCT02106052|Multiple sclerosis|multiple sclerosis
4895937|NCT02106052|executive function|executive function
4895938|NCT02106039|diabetes mellitus|diabetes mellitus
4895939|NCT02106039|tuberculosis|tuberculosis
4895940|NCT02106039|management|management
4895941|NCT02106039|randomized controlled trial|randomized controlled trial
4895942|NCT02106026|Breastfeeding|breastfeeding
4895943|NCT02106026|Nursing|nursing
4895944|NCT02106026|Patient Education as Topic|patient education as topic
4895945|NCT02106026|Health Knowledge, Attitudes, Practice|health knowledge, attitudes, practice
4895946|NCT02106026|Hispanic Americans.|hispanic americans.
4895947|NCT02106013|HDL|hdl
4895948|NCT02106013|Carotid artery intima-media thickness|carotid artery intima-media thickness
4895949|NCT02106013|Cholesterol efflux capacity|cholesterol efflux capacity
4895950|NCT02106013|Antioxidant effect of HDL|antioxidant effect of hdl
4895951|NCT02106013|Susceptibility to oxidation of HDL|susceptibility to oxidation of hdl
4895952|NCT02106013|Anti-inflammatory effect of HDL|anti-inflammatory effect of hdl
4895953|NCT02106013|Platelet aggregation inhibition by HDL|platelet aggregation inhibition by hdl
4895954|NCT02106000|Post Partum|post partum
4895955|NCT02106000|Inhaled Oxytocin|inhaled oxytocin
4895956|NCT02106000|Inhalation Profiles|inhalation profiles
4895957|NCT02105987|Abacavir/dolutegravir/lamivudine|abacavir/dolutegravir/lamivudine
4895958|NCT02105987|Fixed-dose combination|fixed-dose combination
4895959|NCT02105987|Once daily|once daily
4895960|NCT02105987|Trii|trii
4895961|NCT02105987|Single-tablet regimen|single-tablet regimen
4895962|NCT02105974|COPD|copd
4895963|NCT02105974|Fluticasone Furoate (FF)|fluticasone furoate (ff)
4895964|NCT02105974|Vilanterol (VI)|vilanterol (vi)
4895965|NCT02105974|Dry Powder Inhaler|dry powder inhaler
4895966|NCT02105961|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
4895967|NCT02105961|exacerbations|exacerbations
4895968|NCT02105961|SB240563|sb240563
4895969|NCT02105961|mepolizumab|mepolizumab
4895970|NCT02105961|eosinophils|eosinophils
4895971|NCT02105948|eosinophils|eosinophils
4895972|NCT02105948|SB240563|sb240563
4895973|NCT02105948|exacerbations|exacerbations
4895974|NCT02105948|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
4895975|NCT02105948|mepolizumab|mepolizumab
4895976|NCT02105922|Frailty|frailty
4895977|NCT02105922|Ageing|ageing
4895978|NCT02105922|Protein supplementation|protein supplementation
4895979|NCT02105922|Protein quality|protein quality
4895980|NCT02105922|Exercise training|exercise training
4895981|NCT02105922|Sarcopenia|sarcopenia
4895983|NCT02105857|knee mobilazation|knee mobilazation
4895984|NCT02105857|TKA|tka
4895985|NCT02105857|joint replacement|joint replacement
4895986|NCT02105857|rehabilitation|rehabilitation
4895987|NCT02105844|atrial fibrillation|atrial fibrillation
4895988|NCT02105844|dementia|dementia
4895989|NCT02105844|cognitive dysfunction|cognitive dysfunction
4895990|NCT02105844|stroke|stroke
4895991|NCT02105844|Magnetic resonance imaging|magnetic resonance imaging
4895992|NCT02105831|left ventricular assist device|left ventricular assist device
4895993|NCT02105831|contrast ultrasound|contrast ultrasound
4895994|NCT02105831|perfusion imaging|perfusion imaging
4895995|NCT02105818|Self-reported questionnaire|self-reported questionnaire
4895996|NCT02105818|Swallowing disorders|swallowing disorders
4895997|NCT02105818|Systemic sclerosis|systemic sclerosis
4895998|NCT02105818|Drug therapy|drug therapy
4895999|NCT02105818|Adherence to medication regime|adherence to medication regime
4896000|NCT02105818|Coping strategy|coping strategy
4896001|NCT02105818|Pharmaceutical care|pharmaceutical care
4896002|NCT02105818|Patient safety|patient safety
4896003|NCT02105818|Patient oriented care|patient oriented care
4896004|NCT02105805|intention weight loss|intention weight loss
4896005|NCT02105805|heart failure|heart failure
4896006|NCT02105805|6-minute walk test|6-minute walk test
4896007|NCT02105792|Diabetes|diabetes
4896008|NCT02105792|Type 2 diabetes|type 2 diabetes
4896009|NCT02105792|Diabetes therapy response|diabetes therapy response
4896010|NCT02105792|Diabetes progression|diabetes progression
4896011|NCT02105766|Sickle Cell Disease|sickle cell disease
4896012|NCT02105766|Allogeneic Hematopoietic Stem Cell Transplant|allogeneic hematopoietic stem cell transplant
4896013|NCT02105766|Pentostatin (Nipent)|pentostatin (nipent)
4896014|NCT02105766|Cyclophosphamide|cyclophosphamide
4896015|NCT02105766|Alemtuzumab (Campath)|alemtuzumab (campath)
4896016|NCT02105740|BEHAVIORAL|behavioral
4896017|NCT02105740|HYPNOSIS|hypnosis
4896018|NCT02105740|ANXIETY|anxiety
4896019|NCT02105740|DEPRESSION|depression
4896020|NCT02105727|Dietary sodium|dietary sodium
4896021|NCT02105727|Urinary sodium excretion|urinary sodium excretion
4896022|NCT02105727|Urinary iodine excretion|urinary iodine excretion
4896023|NCT02105714|Diarrhoea|diarrhoea
4896024|NCT02105714|Abdominal pain|abdominal pain
4896025|NCT02105714|Bacterial|bacterial
4896026|NCT02105714|Protozoal|protozoal
4896027|NCT02105714|Helminth|helminth
4896028|NCT02105675|Immunotherapy|immunotherapy
4896029|NCT02105675|Metastatic|metastatic
4896030|NCT02105675|Castrate Resistant|castrate resistant
4896031|NCT02105675|Prostate Cancer|prostate cancer
4896032|NCT02105675|Biological|biological
4896033|NCT02105675|Vaccine|vaccine
4896034|NCT02105649|cerebral palsy|cerebral palsy
4896035|NCT02105649|standing|standing
4896036|NCT02105649|strengthening|strengthening
4896037|NCT02105623|Coronary Arteriosclerosis|coronary arteriosclerosis
4896038|NCT02105623|rosuvastatin|rosuvastatin
4896039|NCT02105610|volatile anesthetics|volatile anesthetics
4896040|NCT02105610|desflurane|desflurane
4896041|NCT02105610|isoflurane|isoflurane
4896042|NCT02105610|sevoflurane|sevoflurane
4896043|NCT02105610|TIVA|tiva
4896044|NCT02105610|cardiac surgery|cardiac surgery
4896045|NCT02105610|mortality|mortality
4896046|NCT02105610|anesthesia|anesthesia
4896047|NCT02105610|intensive care|intensive care
4896048|NCT02105597|Diabetes mellitus|diabetes mellitus
4896049|NCT02105597|Medication adherence|medication adherence
4896050|NCT02105597|Compliance|compliance
4896051|NCT02105597|Mobile health|mobile health
4896053|NCT02105571|Nutrition|nutrition
4896054|NCT02105571|Physical Activity|physical activity
4896055|NCT02105571|Sleep|sleep
4896056|NCT02105571|Health Promotion|health promotion
4896057|NCT02105571|Stress|stress
4896058|NCT02105571|Safety|safety
4896059|NCT02105558|trial of labor after cesarean|trial of labor after cesarean
4896060|NCT02105558|vaginal birth after cesarean|vaginal birth after cesarean
4896061|NCT02105558|epidural vs combined spinal epidural|epidural vs combined spinal epidural
4896062|NCT02105545|cancer|cancer
4896063|NCT02105545|oncology|oncology
4896064|NCT02105545|malignant|malignant
4896065|NCT02105545|malignancy|malignancy
4896066|NCT02105545|genetics|genetics
4896067|NCT02105545|genomics|genomics
4896068|NCT02105545|exome|exome
4896069|NCT02105545|DNA|dna
4896070|NCT02105545|RNA|rna
4896071|NCT02105545|sequencing|sequencing
4896072|NCT02105545|epigenetic|epigenetic
4896073|NCT02105545|clinically actionable findings|clinically actionable findings
4896074|NCT02105545|CAF|caf
4896075|NCT02105545|secondary findings|secondary findings
4896076|NCT02105545|SF|sf
4896077|NCT02105545|single nucleotide variants|single nucleotide variants
4896078|NCT02105545|SNV|snv
4896079|NCT02105545|bioinformatics|bioinformatics
4896080|NCT02105545|genotype|genotype
4896081|NCT02105545|The American College of Medical Genetics and Genomics|the american college of medical genetics and genomics
4896082|NCT02105545|ACMG|acmg
4896083|NCT02105532|Transfusion in gastrointestinal bleeding|transfusion in gastrointestinal bleeding
4896084|NCT02105519|trivalent influenza vaccine, chronic kidney disease|trivalent influenza vaccine, chronic kidney disease
4896085|NCT02105506|Esophagus|esophagus
4896086|NCT02105506|Stomach|stomach
4896087|NCT02105506|Resection|resection
4896088|NCT02105506|Esophageal disease requiring surgery|esophageal disease requiring surgery
4896089|NCT02105506|Gastric disease requiring surgery|gastric disease requiring surgery
4896090|NCT02105493|Nitroglycerin|nitroglycerin
4896091|NCT02105493|Radial Artery Occlusion|radial artery occlusion
4896092|NCT02105493|Transradial Catheterization|transradial catheterization
4896093|NCT02105480|Computer aided auscultation (CAA)|computer aided auscultation (caa)
4896094|NCT02105480|Phonocardiogram analysis|phonocardiogram analysis
4896095|NCT02105480|Murmur detection|murmur detection
4896096|NCT02105480|Heart auscultation|heart auscultation
4896097|NCT02105441|cochlear implant|cochlear implant
4896098|NCT02105428|Polycystic Ovarian Syndrome (PCOS)|polycystic ovarian syndrome (pcos)
4896099|NCT02105428|Insulin Resistance|insulin resistance
4896100|NCT02105428|Overweight, Obese Women|overweight, obese women
4896101|NCT02105428|Protein Metabolism|protein metabolism
4896102|NCT02105428|Post Translational Modifications|post translational modifications
4896103|NCT02105415|Critical care|critical care
4896104|NCT02105415|Emergent|emergent
4896105|NCT02105415|Etomidate|etomidate
4896106|NCT02105415|Hemodynamics|hemodynamics
4896107|NCT02105415|Intensive care unit|intensive care unit
4896108|NCT02105415|Intubation|intubation
4896109|NCT02105415|Ketamine-Propofol admixture|ketamine-propofol admixture
4896110|NCT02105402|Speech sound disorders|speech sound disorders
4896111|NCT02105402|Randomized Controlled Trial|randomized controlled trial
4896112|NCT02105402|Speech intelligibility|speech intelligibility
4896113|NCT02105402|PROMPT treatment|prompt treatment
4896114|NCT02105402|Developmental motor speech disorders|developmental motor speech disorders
4896115|NCT02105402|Children|children
4896116|NCT02105402|Functional outcomes|functional outcomes
4896117|NCT02105402|Treatment efficacy|treatment efficacy
4896118|NCT02105389|fatigue|fatigue
4896119|NCT02105389|quality of life|quality of life
4896120|NCT02105389|chemotherapy|chemotherapy
4896121|NCT02105389|haematopoietic stem cell transplantation|haematopoietic stem cell transplantation
4896122|NCT02105389|children|children
4896123|NCT02105389|pilot|pilot
4896124|NCT02105389|yoga|yoga
4896125|NCT02105376|depression|depression
4896126|NCT02105376|cranial nerve stimulation|cranial nerve stimulation
4896127|NCT02105376|trigeminal stimulation|trigeminal stimulation
4896128|NCT02105350|MEK162|mek162
4896129|NCT02105350|Gemcitabine|gemcitabine
4896130|NCT02105350|Oxaliplatin|oxaliplatin
4896131|NCT02105350|Non-resectable|non-resectable
4896132|NCT02105350|Recurrent or metastatic|recurrent or metastatic
4896133|NCT02105324|bionic pancreas|bionic pancreas
4896134|NCT02105324|artificial pancreas|artificial pancreas
4896135|NCT02105324|insulin|insulin
4896136|NCT02105324|glucagon|glucagon
4896137|NCT02105324|continuous glucose monitoring (CGM)|continuous glucose monitoring (cgm)
4896138|NCT02105324|outpatient|outpatient
4896139|NCT02105324|insulin pump|insulin pump
4896140|NCT02105324|pediatrics|pediatrics
4896141|NCT02105324|children|children
4896142|NCT02105324|camp|camp
4896143|NCT02105324|summer camp|summer camp
4896144|NCT02105311|Intraocular pressure|intraocular pressure
4896145|NCT02105311|Selective laser trabeculoplasty|selective laser trabeculoplasty
4896146|NCT02105311|Travoprost|travoprost
4896147|NCT02105311|Ocular surface disease|ocular surface disease
4896148|NCT02105311|Glaucoma symptom scale|glaucoma symptom scale
4896149|NCT02105298|Fluids|fluids
4896150|NCT02105298|Intraoperative|intraoperative
4896151|NCT02105298|Respiratory|respiratory
4896152|NCT02105298|Outcomes|outcomes
4896153|NCT02105298|Surgery|surgery
4896154|NCT02105298|Anesthesia|anesthesia
4896155|NCT02105259|Test|test
4896156|NCT02105259|psychodynamic|psychodynamic
4896157|NCT02105259|Internet-delivered psychodynamic treatment|internet-delivered psychodynamic treatment
4896158|NCT02105259|patients with social anxiety disorder|patients with social anxiety disorder
4896159|NCT02105246|cardiovascular disease|cardiovascular disease
4896160|NCT02105246|cardiac rehabilitation|cardiac rehabilitation
4896161|NCT02105246|secondary prevention|secondary prevention
4896162|NCT02105246|comparative effectiveness|comparative effectiveness
4896163|NCT02105246|6 minute walk test|6 minute walk test
4896164|NCT02105233|ultrasonography|ultrasonography
4896165|NCT02105233|ultrasonics|ultrasonics
4896166|NCT02105233|brain|brain
4896167|NCT02105233|surgery|surgery
4896168|NCT02105220|Respiratory mechanics|respiratory mechanics
4896169|NCT02105220|Esophageal pressure|esophageal pressure
4896170|NCT02105220|Functional residual capacity|functional residual capacity
4896171|NCT02105220|positive end-expiratory pressure|positive end-expiratory pressure
4896172|NCT02105194|cerebral decompression illness|cerebral decompression illness
4896173|NCT02105181|benign biliary stricture|benign biliary stricture
4896174|NCT02105181|anastomotic biliary stricture after liver transplantation|anastomotic biliary stricture after liver transplantation
4896175|NCT02105181|chronic pancreatitis|chronic pancreatitis
4896176|NCT02105181|biliary surgical procedure|biliary surgical procedure
4896177|NCT02105181|fully covered metal stent|fully covered metal stent
4896178|NCT02105155|Liver transplantation,|liver transplantation,
4896179|NCT02105155|Conversion (Prograf® to Advagraf®),|conversion (prograf® to advagraf®),
4896180|NCT02105155|Prograf® ,|prograf® ,
4896181|NCT02105155|Advagraf® ,|advagraf® ,
4896182|NCT02105155|acute rejection,|acute rejection,
4896183|NCT02105155|GFR|gfr
4896184|NCT02105142|Attention deficit hyperactivity disorder|attention deficit hyperactivity disorder
4896185|NCT02105142|Interventions|interventions
4896186|NCT02105142|Primary care|primary care
4896187|NCT02105142|Pediatric|pediatric
4896188|NCT02105090|Upper gastrointestinal tract|upper gastrointestinal tract
4896189|NCT02105090|Endoscopy|endoscopy
4896190|NCT02105090|Lozenge|lozenge
4896191|NCT02105090|Articaine|articaine
4896192|NCT02105090|Dyspepsia|dyspepsia
4896193|NCT02105090|Hematemesis|hematemesis
4896194|NCT02105090|Abdominal pain|abdominal pain
4896195|NCT02105090|Heartburn|heartburn
4896196|NCT02105077|xenon|xenon
4896197|NCT02105077|doping|doping
4896198|NCT02105077|anesthesia|anesthesia
4896199|NCT02105077|mass spectrometry|mass spectrometry
4896200|NCT02105077|surgery|surgery
4896201|NCT02105038|distal radius fracture|distal radius fracture
4896202|NCT02105038|steering|steering
4896203|NCT02105038|steering wheel spinner knob|steering wheel spinner knob
4896204|NCT02105025|insertion time|insertion time
4896205|NCT02105012|Mild|mild
4896206|NCT02105012|moderate persistent|moderate persistent
4896207|NCT02105012|Adult|adult
4896208|NCT02104986|non seminomateous malignant germ cell tumour (NSMGCT)|non seminomateous malignant germ cell tumour (nsmgct)
4896209|NCT02104986|Dose De-escalation|dose de-escalation
4896210|NCT02104986|Chemotherapy|chemotherapy
4896211|NCT02104960|Skin Surface Microscopy|skin surface microscopy
4896212|NCT02104960|Skin Aging|skin aging
4896213|NCT02104960|PROOF|proof
4896214|NCT02104895|Breast cancer|breast cancer
4896215|NCT02104895|Early breast cancer|early breast cancer
4896216|NCT02104895|Adjuvant breast cancer|adjuvant breast cancer
4896217|NCT02104895|Accelerated partial breast irradiation|accelerated partial breast irradiation
4896218|NCT02104895|Intensity modulated radiotherapy|intensity modulated radiotherapy
4896219|NCT02104882|Glioblastoma Multiforme|glioblastoma multiforme
4896220|NCT02104882|High-Grade Glioma|high-grade glioma
4896221|NCT02104882|Malignant Glioma|malignant glioma
4896222|NCT02104882|IORT|iort
4896223|NCT02104869|Influenza vaccine|influenza vaccine
4896224|NCT02104856|Asthma|asthma
4896225|NCT02104856|Bronchial Thermoplasty|bronchial thermoplasty
4896226|NCT02104856|Registry|registry
4896227|NCT02104856|Device|device
4896228|NCT02104856|Alair|alair
4896229|NCT02104830|empegfilgrastim|empegfilgrastim
4896230|NCT02104830|pegylated filgrastim|pegylated filgrastim
4896231|NCT02104830|neutropenia|neutropenia
4896232|NCT02104830|febrile neutropenia|febrile neutropenia
4896233|NCT02104830|chemotherapy-associated neutropenia|chemotherapy-associated neutropenia
4896234|NCT02104830|breast cancer|breast cancer
4896235|NCT02104830|docetaxel|docetaxel
4896236|NCT02104830|doxorubicin|doxorubicin
4896237|NCT02104817|omega-3 carboxylic acid|omega-3 carboxylic acid
4896238|NCT02104804|Type 2 Diabetes Mellitus, Insulin, Dipeptidyl-Peptidase 4 Inhibitors, Metformin,saxagliptin,Endocrine System Diseases|type 2 diabetes mellitus, insulin, dipeptidyl-peptidase 4 inhibitors, metformin,saxagliptin,endocrine system diseases
4896239|NCT02104791|Procalcitonin|procalcitonin
4896240|NCT02104791|intra-amniotic subclinical infection.|intra-amniotic subclinical infection.
4896241|NCT02104752|Curcumin|curcumin
4896242|NCT02104752|Turmeric|turmeric
4896243|NCT02104752|Schizophrenia|schizophrenia
4896244|NCT02104752|Cognition|cognition
4896245|NCT02104752|Psychosis|psychosis
4896246|NCT02104739|prediabetes|prediabetes
4896247|NCT02104739|diabetes mellitus type 2|diabetes mellitus type 2
4896248|NCT02104739|exenatide|exenatide
4896249|NCT02104739|saxagliptin|saxagliptin
4896250|NCT02104739|exenatide ER|exenatide er
4896251|NCT02104713|Skin Burn Degree Second|skin burn degree second
4896252|NCT02104713|Second degree Burn|second degree burn
4896253|NCT02104713|Burn wound|burn wound
4896254|NCT02104700|HIV|hiv
4896255|NCT02104687|GTD, goal-directed haemodynamic therapy|gtd, goal-directed haemodynamic therapy
4896256|NCT02104687|CI, cardiac index|ci, cardiac index
4896257|NCT02104687|MAP, mean arterial pressure|map, mean arterial pressure
4896258|NCT02104687|CVP, central venous pressure|cvp, central venous pressure
4896259|NCT02104622|spinal cord injury|spinal cord injury
4896260|NCT02104622|exoskeleton|exoskeleton
4896261|NCT02104622|ambulation|ambulation
4896262|NCT02104622|walking|walking
4896263|NCT02104622|robotics|robotics
4896264|NCT02104609|Obesity|obesity
4896265|NCT02104609|Emergency contraception|emergency contraception
4896266|NCT02104609|Levonorgestrel emergency contraception|levonorgestrel emergency contraception
4896267|NCT02104583|VT|vt
4896268|NCT02104583|VF|vf
4896269|NCT02104583|Ventricular Tachycardia|ventricular tachycardia
4896270|NCT02104583|Ventricular Fibrillation|ventricular fibrillation
4896271|NCT02104583|shock|shock
4896272|NCT02104583|ATP|atp
4896273|NCT02104570|Fatigue|fatigue
4896274|NCT02104570|Proprioception|proprioception
4896275|NCT02104570|Shoulder|shoulder
4896276|NCT02104557|Sayana|sayana
4896277|NCT02104557|Pregnancy|pregnancy
4896278|NCT02104557|Contraception|contraception
4896279|NCT02104557|Endometriosis-associated pain|endometriosis-associated pain
4896280|NCT02104557|PMS|pms
4896281|NCT02104557|Post Marketing Surveillance|post marketing surveillance
4896282|NCT02104544|DHA intake;|dha intake;
4896283|NCT02104544|Plasma;|plasma;
4896284|NCT02104544|Erythrocyte;|erythrocyte;
4896285|NCT02104544|Breast milk.|breast milk.
4896286|NCT02104518|glucose-6-phosphate dehydrogenase|glucose-6-phosphate dehydrogenase
4896287|NCT02104518|point-of-care diagnostic testing|point-of-care diagnostic testing
4896288|NCT02104492|multiple sclerosis|multiple sclerosis
4896289|NCT02104492|respiratory muscle strength|respiratory muscle strength
4896290|NCT02104492|maximal inspiratory pressure (MIP)|maximal inspiratory pressure (mip)
4896291|NCT02104492|maximal expiratory pressure (MEP)|maximal expiratory pressure (mep)
4896292|NCT02104492|respiratory muscle endurance|respiratory muscle endurance
4896293|NCT02104492|quality of life|quality of life
4896294|NCT02104492|qualitative research|qualitative research
4896295|NCT02104466|acupuncture|acupuncture
4896296|NCT02104466|pain|pain
4896297|NCT02104466|neuropathy|neuropathy
4896298|NCT02104453|airway maneuver|airway maneuver
4896299|NCT02104440|Cytopenia|cytopenia
4896300|NCT02104414|Liposomal Bupivacaine|liposomal bupivacaine
4896301|NCT02104414|Exparel|exparel
4896302|NCT02104375|wave reflection|wave reflection
4896303|NCT02104375|augmentation Index|augmentation index
4896304|NCT02104375|heart rate variability|heart rate variability
4896305|NCT02104375|arterial stiffness|arterial stiffness
4896306|NCT02104349|spine surgery|spine surgery
4896307|NCT02104349|post op pain management|post op pain management
4896308|NCT02104336|Pearson|pearson
4896309|NCT02104336|EPI743|epi743
4896310|NCT02104336|EPI-743|epi-743
4896311|NCT02104336|Vincerinone|vincerinone
4896312|NCT02104336|Mitochondrial disorder|mitochondrial disorder
4896313|NCT02104336|Mitochondrial disease|mitochondrial disease
4896314|NCT02104323|Neurofibromatosis Type 2|neurofibromatosis type 2
4896315|NCT02104323|Vestibular Schwannoma|vestibular schwannoma
4896316|NCT02104323|Other NF2-related tumors|other nf2-related tumors
4896317|NCT02104310|malignant glioma|malignant glioma
4896318|NCT02104310|FDOPA|fdopa
4896319|NCT02104310|PET CT|pet ct
4896320|NCT02104310|radiation therapy|radiation therapy
4896321|NCT02104297|Nasal septum operation|nasal septum operation
4896322|NCT02104297|agitation|agitation
4896323|NCT02104284|Bronchial provocation test|bronchial provocation test
4896324|NCT02104284|Mannitol|mannitol
4896325|NCT02104284|Methacholine|methacholine
4896326|NCT02104284|Bronchial hyperreactivity|bronchial hyperreactivity
4896327|NCT02104284|Sensitivity and specificity|sensitivity and specificity
4896328|NCT02104271|chronic radiation proctitis|chronic radiation proctitis
4896329|NCT02104271|argon plasma coagulation|argon plasma coagulation
4896330|NCT02104271|rectal bleeding|rectal bleeding
4896331|NCT02104258|Hamstring|hamstring
4896332|NCT02104258|Muscle|muscle
4896333|NCT02104258|Injury|injury
4896334|NCT02104258|Treatment|treatment
4896335|NCT02104258|Rehabilitation|rehabilitation
4896336|NCT02104245|Non Cystic Fibrosis Bronchiectasis, Pulmaquin, Ciprofloxacin, Pseudomonas aeruginosa|non cystic fibrosis bronchiectasis, pulmaquin, ciprofloxacin, pseudomonas aeruginosa
4896337|NCT02104232|Maternal depression|maternal depression
4896338|NCT02104219|Hypophosphatasia|hypophosphatasia
4896339|NCT02104219|HPP|hpp
4896340|NCT02104219|bone disease|bone disease
4896341|NCT02104219|Soft Bones|soft bones
4896342|NCT02104219|low Alkaline Phosphatase|low alkaline phosphatase
4896343|NCT02104219|genetic metabolic disorder|genetic metabolic disorder
4896344|NCT02104219|alkaline phosphatase|alkaline phosphatase
4896345|NCT02104219|tissue non-specific alkaline phosphatase|tissue non-specific alkaline phosphatase
4896346|NCT02104219|rickets|rickets
4896347|NCT02104219|osteomalacia|osteomalacia
4896348|NCT02104193|brain metastases|brain metastases
4896349|NCT02104193|simvastatin|simvastatin
4896350|NCT02104193|radiation therapy|radiation therapy
4896351|NCT02104180|non-inferiority|non-inferiority
4896352|NCT02104180|randomized|randomized
4896353|NCT02104180|TulleGras|tullegras
4896354|NCT02104180|Urgotul|urgotul
4896355|NCT02104180|pain|pain
4896356|NCT02104180|venous leg ulcer|venous leg ulcer
4896357|NCT02104180|healing|healing
4896358|NCT02104167|DDD|ddd
4896359|NCT02104167|degenerative disc disease|degenerative disc disease
4896360|NCT02104167|cervical spine|cervical spine
4896361|NCT02104167|fusion rate|fusion rate
4896362|NCT02104141|DDD|ddd
4896363|NCT02104141|lumbar spine|lumbar spine
4896364|NCT02104141|fusion rate|fusion rate
4896365|NCT02104141|degenerative disc disease|degenerative disc disease
4896366|NCT02104128|Anhedonia|anhedonia
4896367|NCT02104128|Dopamine|dopamine
4896368|NCT02104128|Bupropion|bupropion
4896369|NCT02104128|fMRI|fmri
4896370|NCT02104128|emotional processing|emotional processing
4896371|NCT02104128|reward|reward
4896372|NCT02104115|Stomach|stomach
4896373|NCT02104115|Small bowel|small bowel
4896374|NCT02104115|Colon|colon
4896375|NCT02104115|MRI|mri
4896376|NCT02104115|Function|function
4896377|NCT02104115|Gastrointestinal volumes|gastrointestinal volumes
4896378|NCT02104102|Elderly|elderly
4896379|NCT02104102|mirror therapy|mirror therapy
4896380|NCT02104102|hands|hands
4896381|NCT02104089|Thoracoabdominal aortic aneurysm|thoracoabdominal aortic aneurysm
4896382|NCT02104089|Endovascular|endovascular
4896383|NCT02104089|Fenestration|fenestration
4896384|NCT02104089|Branch|branch
4896385|NCT02104089|Off-the-shelf|off-the-shelf
4896386|NCT02104076|Bile Duct Obstructions|bile duct obstructions
4896387|NCT02104076|Biliary Stases|biliary stases
4896388|NCT02104076|Biliary Tract|biliary tract
4896389|NCT02104076|Stents|stents
4896390|NCT02104024|Kidney|kidney
4896391|NCT02104024|Pancreas|pancreas
4896392|NCT02104024|Transplant|transplant
4896393|NCT02104024|Contrast Enhanced Ultrasound|contrast enhanced ultrasound
4896394|NCT02104011|Angiomyolipomas in tuberous sclerosis|angiomyolipomas in tuberous sclerosis
4896395|NCT02104011|Beta-blockers|beta-blockers
4896396|NCT02104011|Anti-angiogenic therapies|anti-angiogenic therapies
4896397|NCT02103998|extremely low gestational age neonate|extremely low gestational age neonate
4896398|NCT02103998|hypothyroxinemia of prematurity|hypothyroxinemia of prematurity
4896399|NCT02103998|brain development|brain development
4896400|NCT02103998|cerebral palsy|cerebral palsy
4896401|NCT02103998|cognitive dealy|cognitive dealy
4896402|NCT02103985|Healthy|healthy
4896403|NCT02103985|JNJ-39823277|jnj-39823277
4896404|NCT02103985|JNJ-40917006|jnj-40917006
4896405|NCT02103985|Pharmacokinetics|pharmacokinetics
4896406|NCT02103972|All subjects of any ethnicity aged from 4 to 30 months with atopic dermatitis skin symptoms with a SCORAD equal or above 20|all subjects of any ethnicity aged from 4 to 30 months with atopic dermatitis skin symptoms with a scorad equal or above 20
4896407|NCT02103946|serratus|serratus
4896408|NCT02103946|paravertebral|paravertebral
4896409|NCT02103946|breast|breast
4896410|NCT02103946|cancer|cancer
4896411|NCT02103946|axilla|axilla
4896412|NCT02103907|balance|balance
4896413|NCT02103907|knee|knee
4896414|NCT02103907|osteoarthritis|osteoarthritis
4896415|NCT02103907|physical function|physical function
4896416|NCT02103894|Alzheimer's disease (AD)|alzheimer's disease (ad)
4896417|NCT02103894|Parkinson's disease (PD)|parkinson's disease (pd)
4896418|NCT02103894|Progressive supranuclear palsy (PSP)|progressive supranuclear palsy (psp)
4896419|NCT02103894|Chronic traumatic encephalopathy (CTE)|chronic traumatic encephalopathy (cte)
4896420|NCT02103894|Frontal temporal dementia (FTD)|frontal temporal dementia (ftd)
4896421|NCT02103894|Pick's disease|pick's disease
4896422|NCT02103894|tauopathies|tauopathies
4896423|NCT02103881|Agitation|agitation
4896424|NCT02103881|Ketamine|ketamine
4896425|NCT02103881|Haloperidol|haloperidol
4896426|NCT02103881|Emergency Medical Services|emergency medical services
4896427|NCT02103881|Feeling of restlessness|feeling of restlessness
4896428|NCT02103881|Increased motor activity|increased motor activity
4896429|NCT02103868|Tobacco cessation|tobacco cessation
4896430|NCT02103868|Zari worker|zari worker
4896431|NCT02103868|Behavior therapy|behavior therapy
4896432|NCT02103868|Qualitative Research|qualitative research
4896433|NCT02103868|Mumbai|mumbai
4896434|NCT02103855|pancreas transplantation|pancreas transplantation
4896435|NCT02103855|immunosuppression|immunosuppression
4896436|NCT02103855|belatacept|belatacept
4896437|NCT02103829|Cigarette smoking|cigarette smoking
4896438|NCT02103829|Tobacco smoking|tobacco smoking
4896439|NCT02103829|Smoking, Tobacco|smoking, tobacco
4896440|NCT02103803|concussion|concussion
4896441|NCT02103803|sports-related concussion|sports-related concussion
4896442|NCT02103803|mild traumatic brain injury (mTBI)|mild traumatic brain injury (mtbi)
4896443|NCT02103803|eye tracking|eye tracking
4896444|NCT02103803|oculometrics|oculometrics
4896445|NCT02103777|high dose of caffeine|high dose of caffeine
4896446|NCT02103777|low dose of caffeine|low dose of caffeine
4896447|NCT02103777|prevention|prevention
4896448|NCT02103764|Anovulatory Dysfunctional Uterine Bleeding|anovulatory dysfunctional uterine bleeding
4896449|NCT02103764|cyclic desogestrel|cyclic desogestrel
4896450|NCT02103764|cyclic medroxyprogesterone acetate|cyclic medroxyprogesterone acetate
4896451|NCT02103764|lipid metabolism|lipid metabolism
4896452|NCT02103764|glucose metabolism|glucose metabolism
4896453|NCT02103764|endometrial histology changing|endometrial histology changing
4896454|NCT02103751|biomarkers|biomarkers
4896455|NCT02103751|HPHCs|hphcs
4896456|NCT02103751|CVD|cvd
4896457|NCT02103751|smoking|smoking
4896458|NCT02103751|Smokers|smokers
4896459|NCT02103751|non-smokers|non-smokers
4896460|NCT02103738|Lucentis|lucentis
4896461|NCT02103738|Ranibizumab|ranibizumab
4896462|NCT02103738|Treat and Extend|treat and extend
4896463|NCT02103738|wetAMD|wetamd
4896464|NCT02103738|Age related macular degeneration|age related macular degeneration
4896465|NCT02103699|Hepatitis C virus|hepatitis c virus
4896466|NCT02103699|Simeprevir|simeprevir
4896467|NCT02103699|Ribonucleic acid|ribonucleic acid
4896468|NCT02103699|Sustained virologic response|sustained virologic response
4896469|NCT02103686|Neuropathic pain|neuropathic pain
4896470|NCT02103686|pregabalin|pregabalin
4896471|NCT02103660|contraceptive implant|contraceptive implant
4896472|NCT02103660|Depo-Medroxyprogesterone Acetate|depo-medroxyprogesterone acetate
4896473|NCT02103660|Hormonal Contraception|hormonal contraception
4896474|NCT02103660|progestin|progestin
4896475|NCT02103647|Neuropathic pain|neuropathic pain
4896476|NCT02103647|pregabalin|pregabalin
4896477|NCT02103634|breast cancer|breast cancer
4896478|NCT02103634|FDG PET/CT|fdg pet/ct
4896479|NCT02103634|MRI|mri
4896480|NCT02103634|NaF PET/MRI|naf pet/mri
4896481|NCT02103634|NaF PET/CT|naf pet/ct
4896610|NCT02102958|visual impairment|visual impairment
4896482|NCT02103608|at Home Photo depilation device, Silk'n.|at home photo depilation device, silk'n.
4896483|NCT02103556|Constipation|constipation
4896484|NCT02103556|Rome III criteria|rome iii criteria
4896485|NCT02103556|Hemodialysis|hemodialysis
4896486|NCT02103491|Half-ironman|half-ironman
4896487|NCT02103491|Triathlon|triathlon
4896488|NCT02103491|Salt|salt
4896489|NCT02103491|Exercise|exercise
4896490|NCT02103491|Performance|performance
4896491|NCT02103478|Myelodysplastic Syndrome|myelodysplastic syndrome
4896493|NCT02103465|Parkinson's Disease|parkinson's disease
4896494|NCT02103465|treatment|treatment
4896495|NCT02103465|old patients|old patients
4896496|NCT02103465|Rotigotine|rotigotine
4896497|NCT02103439|Hepatitis C|hepatitis c
4896498|NCT02103439|Cepeginterferon alfa|cepeginterferon alfa
4896499|NCT02103439|Peginterferon|peginterferon
4896500|NCT02103439|Treatment|treatment
4896501|NCT02103426|Cytomegalovirus|cytomegalovirus
4896502|NCT02103426|ASP0113|asp0113
4896503|NCT02103426|CMV-seropositive|cmv-seropositive
4896504|NCT02103426|Healthy subjects|healthy subjects
4896505|NCT02103426|CMV-seronegative|cmv-seronegative
4896506|NCT02103426|Dialysis|dialysis
4896507|NCT02103374|weaned tobacco|weaned tobacco
4896508|NCT02103374|Has not submitted an exacerbation in the past 3 months|has not submitted an exacerbation in the past 3 months
4896509|NCT02103361|autoimmune disease|autoimmune disease
4896510|NCT02103361|pregnancy|pregnancy
4896511|NCT02103361|psoriasis|psoriasis
4896512|NCT02103361|Stelara|stelara
4896513|NCT02103361|ustekinumab|ustekinumab
4896514|NCT02103361|birth outcome|birth outcome
4896515|NCT02103361|malformation|malformation
4896516|NCT02103361|birth defect|birth defect
4896517|NCT02103361|psoriatic arthritis|psoriatic arthritis
4896518|NCT02103361|Crohn's Disease|crohn's disease
4896519|NCT02103348|Severe asthma|severe asthma
4896520|NCT02103348|Sputum|sputum
4896521|NCT02103348|Mucolysis|mucolysis
4896522|NCT02103335|Myeloma|myeloma
4896523|NCT02103335|Multiple Myeloma|multiple myeloma
4896524|NCT02103335|Pomalidomide|pomalidomide
4896525|NCT02103335|Marizomib|marizomib
4896526|NCT02103335|Low dose Dexamethasone|low dose dexamethasone
4896527|NCT02103335|Relapsed|relapsed
4896528|NCT02103335|Refractory|refractory
4896529|NCT02103309|Soft contact lenses|soft contact lenses
4896530|NCT02103309|DACP|dacp
4896531|NCT02103283|Diabetic Macular Edema|diabetic macular edema
4896532|NCT02103244|pharmacokinetics|pharmacokinetics
4896533|NCT02103244|safety|safety
4896534|NCT02103231|Preterm birth|preterm birth
4896535|NCT02103231|Hypertension|hypertension
4896536|NCT02103231|Exercise capacity|exercise capacity
4896537|NCT02103231|Cardiovascular risk|cardiovascular risk
4896538|NCT02103218|HIV|hiv
4896539|NCT02103218|risky sex prevention|risky sex prevention
4896540|NCT02103218|intervention|intervention
4896541|NCT02103205|Lactoferrin|lactoferrin
4896542|NCT02103205|Infant formula|infant formula
4896543|NCT02103205|Iron|iron
4896544|NCT02103179|Extrahepatic cholangiocarcinoma|extrahepatic cholangiocarcinoma
4896545|NCT02103179|ECC|ecc
4896546|NCT02103179|VEGF signaling|vegf signaling
4896547|NCT02103140|Breast Cancer|breast cancer
4896548|NCT02103140|Obesity|obesity
4896549|NCT02103140|African American female|african american female
4896550|NCT02103140|exergaming|exergaming
4896551|NCT02103101|polymorphism|polymorphism
4896552|NCT02103101|ABCB1|abcb1
4896553|NCT02103101|P-glycoprotein|p-glycoprotein
4896554|NCT02103101|oral anticoagulant|oral anticoagulant
4896555|NCT02103101|dabigatran|dabigatran
4896556|NCT02103101|apixaban|apixaban
4896557|NCT02103101|rivaroxaban|rivaroxaban
4896558|NCT02103101|hemorrhagic complication|hemorrhagic complication
4896559|NCT02103101|thrombo-embolism|thrombo-embolism
4896560|NCT02103101|serious adverse event|serious adverse event
4896561|NCT02103088|Prostate cancer|prostate cancer
4896562|NCT02103088|Intervention|intervention
4896563|NCT02103088|Rehabilitation|rehabilitation
4896564|NCT02103088|Couple|couple
4896565|NCT02103088|Sexology|sexology
4896566|NCT02103088|Urology|urology
4896567|NCT02103088|Late effects|late effects
4896568|NCT02103075|spinocerebellar ataxia (SCA)|spinocerebellar ataxia (sca)
4896569|NCT02103075|motor evoked potential (MEP)|motor evoked potential (mep)
4896570|NCT02103075|Neuromuscular electrical stimulation (NMES)|neuromuscular electrical stimulation (nmes)
4896571|NCT02103075|silent period|silent period
4896572|NCT02103075|cerebellum|cerebellum
4896573|NCT02103062|Metastatic Colorectal Cancer|metastatic colorectal cancer
4896574|NCT02103062|nab®Paclitaxel|nab®paclitaxel
4896575|NCT02103062|Response Evaluation in Solid Tumors|response evaluation in solid tumors
4896576|NCT02103062|Progression Free Survival|progression free survival
4896577|NCT02103062|Overall Survival|overall survival
4896578|NCT02103062|Duration of Response|duration of response
4896579|NCT02103062|RAS|ras
4896580|NCT02103036|Low Back Pain|low back pain
4896581|NCT02103036|Core stability exercise|core stability exercise
4896582|NCT02103036|Back school|back school
4896583|NCT02103036|TENS|tens
4896584|NCT02103036|Infra- red light|infra- red light
4896585|NCT02102997|DTS|dts
4896586|NCT02102997|Stents|stents
4896587|NCT02102997|Stent|stent
4896588|NCT02102997|DES|des
4896589|NCT02102997|Drug eluting|drug eluting
4896590|NCT02102997|Drug Eluting Stent (DES)|drug eluting stent (des)
4896591|NCT02102997|Drug eluting stents|drug eluting stents
4896592|NCT02102997|Endothelial Progenitor Cell (EPC)|endothelial progenitor cell (epc)
4896593|NCT02102997|Endothelial progenitor cell capturing|endothelial progenitor cell capturing
4896594|NCT02102997|Sirolimus|sirolimus
4896595|NCT02102997|Sirolimus eluting|sirolimus eluting
4896596|NCT02102997|Percutaneous Coronary Intervention (PCI)|percutaneous coronary intervention (pci)
4896597|NCT02102997|PCI|pci
4896598|NCT02102997|Registry|registry
4896599|NCT02102997|Registries|registries
4896600|NCT02102997|Multi center|multi center
4896601|NCT02102997|Multi centre|multi centre
4896602|NCT02102984|distal malignancy of the extra-hepatic biliary tract|distal malignancy of the extra-hepatic biliary tract
4896603|NCT02102984|metallic biliary stents|metallic biliary stents
4896604|NCT02102984|covered biliary stents|covered biliary stents
4896605|NCT02102984|uncovered biliary stents|uncovered biliary stents
4896606|NCT02102971|liver|liver
4896607|NCT02102971|ischemia|ischemia
4896608|NCT02102971|reperfusion|reperfusion
4896609|NCT02102958|diabetes|diabetes
4896611|NCT02102958|foot care|foot care
4896612|NCT02102958|diabetes self-management education|diabetes self-management education
4896613|NCT02102945|Computed tomography|computed tomography
4896614|NCT02102945|Perfusion imaging|perfusion imaging
4896615|NCT02102945|Coma|coma
4896616|NCT02102945|Heart arrest|heart arrest
4896617|NCT02102945|Brain death|brain death
4896618|NCT02102906|Adult|adult
4896619|NCT02102906|Humans|humans
4896620|NCT02102906|Conversion disorder|conversion disorder
4896621|NCT02102906|Somatoform Disorders/therapy|somatoform disorders/therapy
4896622|NCT02102906|Nervous System Disorders/therapy|nervous system disorders/therapy
4896623|NCT02102893|for Gastroentero-Pancreatic Neuroendocrine Tumors in Taiwan|for gastroentero-pancreatic neuroendocrine tumors in taiwan
4896624|NCT02102880|Genetic Association Studies|genetic association studies
4896625|NCT02102867|HIV|hiv
4896626|NCT02102867|STI|sti
4896627|NCT02102867|Primary Prevention|primary prevention
4896628|NCT02102867|Topical Microbicides|topical microbicides
4896629|NCT02102867|User Experience|user experience
4896630|NCT02102867|Drug Delivery Systems|drug delivery systems
4896631|NCT02102854|kidney transplantation|kidney transplantation
4896632|NCT02102854|acute rejection|acute rejection
4896633|NCT02102854|rabbit antithymocyte globulin|rabbit antithymocyte globulin
4896634|NCT02102828|DVT|dvt
4896635|NCT02102828|Total Knee Arthroplasty|total knee arthroplasty
4896636|NCT02102815|total knee arthroplasty|total knee arthroplasty
4896637|NCT02102815|pain control|pain control
4896638|NCT02102815|dexamethasone|dexamethasone
4896639|NCT02102815|steroids|steroids
4896640|NCT02102802|PTSD|ptsd
4896641|NCT02102802|MDMA|mdma
4896642|NCT02102802|Brain activity|brain activity
4896643|NCT02102802|fMRI|fmri
4896644|NCT02102802|Heart rate variability|heart rate variability
4896645|NCT02102802|Physiological correlate|physiological correlate
4896646|NCT02102776|Primary Pterygium|primary pterygium
4896647|NCT02102776|Mitomycin C|mitomycin c
4896648|NCT02102776|Amniotic membrane transplantation|amniotic membrane transplantation
4896649|NCT02102776|Conjunctival autograft|conjunctival autograft
4896650|NCT02102776|Multi-center randomized clinical trial|multi-center randomized clinical trial
4896651|NCT02102763|Overweight|overweight
4896652|NCT02102763|Obesity|obesity
4896653|NCT02102763|Dietary intake|dietary intake
4896654|NCT02102763|Physical activity levels|physical activity levels
4896655|NCT02102763|Blood pressure levels|blood pressure levels
4896656|NCT02102763|Family perceptions|family perceptions
4896657|NCT02102737|insulin resistance|insulin resistance
4896658|NCT02102737|Scintigraphy|scintigraphy
4896659|NCT02102737|Hyperinsulinemic euglycemic clamp|hyperinsulinemic euglycemic clamp
4896660|NCT02102724|African Americans|african americans
4896661|NCT02102724|Older Adults|older adults
4896662|NCT02102711|VITAMIN A|vitamin a
4896663|NCT02102711|BLOOD CONCENTRATION|blood concentration
4896664|NCT02102711|retinopathy of prematurity|retinopathy of prematurity
4896665|NCT02102698|Tourette's Syndrome|tourette's syndrome
4896666|NCT02102698|Ecopipam|ecopipam
4896667|NCT02102698|D1 Receptor|d1 receptor
4896668|NCT02102698|Phase 2|phase 2
4896669|NCT02102685|VAC Therapy|vac therapy
4896670|NCT02102685|Neck Abscess|neck abscess
4896671|NCT02102685|Traditional Therapy|traditional therapy
4896672|NCT02102685|Wound Healing|wound healing
4896673|NCT02102659|Nutritional Assessment|nutritional assessment
4896674|NCT02102659|Oral Epithelial Cell|oral epithelial cell
4896675|NCT02102659|Apoptosis|apoptosis
4896676|NCT02102633|bosutinib|bosutinib
4896677|NCT02102633|dabigatran|dabigatran
4896678|NCT02102633|drug interaction|drug interaction
4896679|NCT02102633|p-glycoprotein|p-glycoprotein
4896680|NCT02102633|pharmacokinetics|pharmacokinetics
4896681|NCT02102620|intra-articular injection|intra-articular injection
4896682|NCT02102620|corticosteroid|corticosteroid
4896683|NCT02102620|osteoarthritis|osteoarthritis
4896684|NCT02102620|Interphalangeal joint|interphalangeal joint
4896685|NCT02102607|intrathecal; ropivacaine; motor blockade; local anesthetics|intrathecal; ropivacaine; motor blockade; local anesthetics
4896686|NCT02102594|Myasthenia Gravis|myasthenia gravis
4896687|NCT02102594|Systemic Lupus Erythematosus|systemic lupus erythematosus
4896688|NCT02102594|Rheumatoid Arthritis|rheumatoid arthritis
4896689|NCT02102594|proteasome inhibitor|proteasome inhibitor
4896690|NCT02102594|Bortezomib|bortezomib
4896691|NCT02102594|Velcade|velcade
4896692|NCT02102594|antibody-mediated autoimmune disease|antibody-mediated autoimmune disease
4896693|NCT02102581|Tourniquet|tourniquet
4896694|NCT02102581|Total knee arthroplasty|total knee arthroplasty
4896695|NCT02102581|Blood loss|blood loss
4896696|NCT02102581|Limb swelling|limb swelling
4896697|NCT02102581|Limb circumference|limb circumference
4896698|NCT02102542|glycopyrrolate|glycopyrrolate
4896699|NCT02102542|efficacy|efficacy
4896700|NCT02102542|antisialagogue|antisialagogue
4896701|NCT02102529|pain|pain
4896702|NCT02102529|quality of life|quality of life
4896703|NCT02102516|Post operative pain management|post operative pain management
4896704|NCT02102490|Endocrine Therapy, Taxane, MONARCH 1|endocrine therapy, taxane, monarch 1
4896705|NCT02102477|Prostatic neoplasms|prostatic neoplasms
4896706|NCT02102477|Locally advanced|locally advanced
4896707|NCT02102477|Radiotherapy|radiotherapy
4896708|NCT02102477|Surgery|surgery
4896709|NCT02102477|Mortality|mortality
4896710|NCT02102451|Interferon-free|interferon-free
4896711|NCT02102451|Direct acting antiviral (DAA)|direct acting antiviral (daa)
4896712|NCT02102451|Treatment as prevention|treatment as prevention
4896713|NCT02102451|Surveillance|surveillance
4896714|NCT02102451|Feasibility|feasibility
4896715|NCT02102438|Elderly patients|elderly patients
4896716|NCT02102438|Localized HER2+ Breast Cancer|localized her2+ breast cancer
4896717|NCT02102438|Omission of anthracyclines|omission of anthracyclines
4896718|NCT02102438|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
4896719|NCT02102438|Adjuvant chemotherapy|adjuvant chemotherapy
4896720|NCT02102438|Safety information|safety information
4896721|NCT02102425|Peritoneal Dialysis|peritoneal dialysis
4896722|NCT02102425|Exit site infection|exit site infection
4896723|NCT02102425|Exit site care|exit site care
4896724|NCT02102425|Bandage|bandage
4896725|NCT02102425|Prevention|prevention
4896726|NCT02102425|Guidelines|guidelines
4896727|NCT02102412|crc|crc
4896728|NCT02102412|colonoscopy|colonoscopy
4896729|NCT02102412|colon cancer|colon cancer
4896730|NCT02102399|Voice training|voice training
4896731|NCT02102399|Education|education
4896732|NCT02102399|Voice|voice
4896733|NCT02102399|Faculty|faculty
4896734|NCT02102386|elective|elective
4896735|NCT02102386|carotid endarterectomy surgery|carotid endarterectomy surgery
4896736|NCT02102373|colonoscopy, pediatric, preparation, diet|colonoscopy, pediatric, preparation, diet
4896737|NCT02102360|microsurgery, furcation defects, periodontal disease, enamel matrix proteins, bone substitutes|microsurgery, furcation defects, periodontal disease, enamel matrix proteins, bone substitutes
4896738|NCT02102347|Physical Therapy Modalities|physical therapy modalities
4896739|NCT02102347|osteoarthritis|osteoarthritis
4896740|NCT02102334|Osteoarthritis, hip,|osteoarthritis, hip,
4896741|NCT02102334|radiograpghic measurements|radiograpghic measurements
4896742|NCT02102334|femoral offset|femoral offset
4896743|NCT02102334|leg length discrepancy|leg length discrepancy
4896744|NCT02102334|cup anteversion|cup anteversion
4896745|NCT02102334|cup inclination|cup inclination
4896746|NCT02102321|hookworm|hookworm
4896747|NCT02102321|albendazole|albendazole
4896748|NCT02102321|iron supplementation|iron supplementation
4896844|NCT02101970|EPA|epa
4896749|NCT02102321|democratic republic of congo|democratic republic of congo
4896750|NCT02102321|subsistence farmers|subsistence farmers
4896751|NCT02102321|randomized control trial|randomized control trial
4896752|NCT02102321|neglected tropical disease|neglected tropical disease
4896753|NCT02102321|helminths|helminths
4896754|NCT02102295|Gingivitis|gingivitis
4896755|NCT02102295|antioxidant|antioxidant
4896756|NCT02102295|dentifrice|dentifrice
4896757|NCT02102295|Ascorbic Acid Derivative|ascorbic acid derivative
4896758|NCT02102295|L ascorbic acid 2 phosphate magnesium salt|l ascorbic acid 2 phosphate magnesium salt
4896759|NCT02102282|Pregnancy|pregnancy
4896760|NCT02102282|Breast Cancer|breast cancer
4896761|NCT02102282|Chemotherapy|chemotherapy
4896762|NCT02102282|Surgery|surgery
4896763|NCT02102282|Obstetric managment|obstetric managment
4896764|NCT02102256|deafness|deafness
4896765|NCT02102256|congenital|congenital
4896766|NCT02102256|pediatric|pediatric
4896767|NCT02102256|device|device
4896768|NCT02102243|hypertension|hypertension
4896769|NCT02102243|blood pressure|blood pressure
4896770|NCT02102243|sympathetic nerve activity|sympathetic nerve activity
4896771|NCT02102243|vascular oxidative stress|vascular oxidative stress
4896772|NCT02102243|nitric oxide|nitric oxide
4896773|NCT02102243|nitric oxide synthase (eNOS)|nitric oxide synthase (enos)
4896774|NCT02102243|endothelium|endothelium
4896775|NCT02102243|endothelial dysfunction|endothelial dysfunction
4896776|NCT02102243|endothelial cell protein expression|endothelial cell protein expression
4896777|NCT02102243|microvascular blood flow|microvascular blood flow
4896778|NCT02102243|flow mediated dilation|flow mediated dilation
4896779|NCT02102243|endothelial cell collection|endothelial cell collection
4896780|NCT02102243|microbubbles|microbubbles
4896781|NCT02102243|Definity|definity
4896782|NCT02102230|Sleep Initiation and Maintenance Disorders|sleep initiation and maintenance disorders
4896783|NCT02102230|marijuana abuse|marijuana abuse
4896784|NCT02102230|Veterans|veterans
4896785|NCT02102217|Major Abdominal Surgery|major abdominal surgery
4896786|NCT02102217|C-reactive protein|c-reactive protein
4896787|NCT02102217|Computed Tomography|computed tomography
4896788|NCT02102217|Quality Control|quality control
4896789|NCT02102217|Postoperative complications|postoperative complications
4896790|NCT02102204|Secondary Hyperparathyroidism (SHPT), chrominc kidney disease (CKD), hemodialysis|secondary hyperparathyroidism (shpt), chrominc kidney disease (ckd), hemodialysis
4896791|NCT02102178|oncological pain|oncological pain
4896792|NCT02102178|therapeutic activities|therapeutic activities
4896793|NCT02102178|occupational therapy.|occupational therapy.
4896794|NCT02102165|Aurora|aurora
4896795|NCT02102165|breast cancer|breast cancer
4896796|NCT02102165|metastatic|metastatic
4896797|NCT02102165|molecular screening|molecular screening
4896798|NCT02102165|targeted gene sequencing|targeted gene sequencing
4896799|NCT02102165|molecular aberrations|molecular aberrations
4896800|NCT02102165|exploratory|exploratory
4896801|NCT02102165|biomarker|biomarker
4896802|NCT02102152|Tobramycin Podhaler|tobramycin podhaler
4896803|NCT02102152|bronchiectasis|bronchiectasis
4896804|NCT02102152|chronic infection|chronic infection
4896805|NCT02102152|Pseudomonas Aeruginosa|pseudomonas aeruginosa
4896806|NCT02102126|Renal denervation therapy|renal denervation therapy
4896807|NCT02102126|Aortic blood pressure|aortic blood pressure
4896808|NCT02102126|Blood pressure variability|blood pressure variability
4896809|NCT02102126|Arterial stiffness|arterial stiffness
4896810|NCT02102126|Target organ damage|target organ damage
4896811|NCT02102126|Biomarker|biomarker
4896812|NCT02102100|menthol, electronic cigarette, nicotine, smoking, tobacco|menthol, electronic cigarette, nicotine, smoking, tobacco
4896813|NCT02102074|colon and rectal tumors|colon and rectal tumors
4896814|NCT02102074|colon cancer markers|colon cancer markers
4896815|NCT02102061|overweight|overweight
4896816|NCT02102061|exercise|exercise
4896817|NCT02102061|nutrition|nutrition
4896818|NCT02102061|philosophy|philosophy
4896819|NCT02102048|HIV|hiv
4896820|NCT02102048|diabetes|diabetes
4896821|NCT02102048|glucose metabolism|glucose metabolism
4896822|NCT02102048|antiretroviral therapy|antiretroviral therapy
4896823|NCT02102048|ritonavir|ritonavir
4896824|NCT02102048|atazanavir|atazanavir
4896825|NCT02102035|defect|defect
4896826|NCT02102035|dorsal branch of the proper digital nerve|dorsal branch of the proper digital nerve
4896827|NCT02102035|dorsal digital island flap|dorsal digital island flap
4896828|NCT02102035|sensory reconstruction.|sensory reconstruction.
4896829|NCT02102022|argininosuccinate synthetase|argininosuccinate synthetase
4896830|NCT02102022|arginine|arginine
4896831|NCT02102022|arginine deiminase|arginine deiminase
4896832|NCT02102009|Malnutrition|malnutrition
4896833|NCT02102009|Dietary supplement|dietary supplement
4896834|NCT02102009|Nutritional supplement|nutritional supplement
4896835|NCT02102009|Complete enteral formula|complete enteral formula
4896836|NCT02102009|COPD|copd
4896837|NCT02101996|stable isotopes|stable isotopes
4896838|NCT02101996|triacylglycerol|triacylglycerol
4896839|NCT02101983|Acute myeloid leukemia|acute myeloid leukemia
4896840|NCT02101983|outpatient consolidation treatment|outpatient consolidation treatment
4896841|NCT02101970|Breast cancer risk|breast cancer risk
4896842|NCT02101970|DHA|dha
4896843|NCT02101970|Omega-3 Fatty Acids|omega-3 fatty acids
4896845|NCT02101970|Weight Loss|weight loss
4896846|NCT02101931|Bladder Cancer|bladder cancer
4896847|NCT02101931|Laser Diagnosis|laser diagnosis
4896848|NCT02101931|Amino levulinic Acid|amino levulinic acid
4896849|NCT02101931|Photodynamic Detection|photodynamic detection
4896850|NCT02101931|spectra of urine|spectra of urine
4896851|NCT02101892|migraine|migraine
4896852|NCT02101892|Amitriptyline|amitriptyline
4896853|NCT02101892|pain modulation|pain modulation
4896854|NCT02101892|pain psychophysics|pain psychophysics
4896855|NCT02101892|pain neurophysiology|pain neurophysiology
4896856|NCT02101892|preventive treatment|preventive treatment
4896857|NCT02101866|Bioavailability Study|bioavailability study
4896858|NCT02101866|Aviragen Therapeutics, Inc.|aviragen therapeutics, inc.
4896859|NCT02101866|Aviragen Therapeutics|aviragen therapeutics
4896860|NCT02101866|Aviragen|aviragen
4896861|NCT02101840|Substance-Related Disorders|substance-related disorders
4896862|NCT02101840|Prescription Drug Misuse|prescription drug misuse
4896863|NCT02101840|Analgesics, Opioid|analgesics, opioid
4896864|NCT02101840|Oxycodone|oxycodone
4896865|NCT02101840|Randomized Controlled Trial|randomized controlled trial
4896866|NCT02101840|Cross-Over Studies|cross-over studies
4896867|NCT02101840|Placebo|placebo
4896868|NCT02101840|Healthy Volunteers|healthy volunteers
4896869|NCT02101801|environment, recycled wastewater, carbamazepine|environment, recycled wastewater, carbamazepine
4896870|NCT02101762|Foley|foley
4896871|NCT02101762|Catheters|catheters
4896872|NCT02101762|CAUTI|cauti
4896873|NCT02101762|ERASE CAUTI|erase cauti
4896874|NCT02101749|trivalent inactivated influenza vaccine|trivalent inactivated influenza vaccine
4896875|NCT02101736|Ages 3 - 15 years|ages 3 - 15 years
4896876|NCT02101736|Cabozantinib|cabozantinib
4896877|NCT02101736|XL184|xl184
4896878|NCT02101736|Plexiform Neurofibromas|plexiform neurofibromas
4896879|NCT02101736|Neurofibromatosis|neurofibromatosis
4896880|NCT02101736|Pathogenetic NF1 Mutations|pathogenetic nf1 mutations
4896881|NCT02101736|Cometriq|cometriq
4896882|NCT02101736|NF1|nf1
4896883|NCT02101723|Zinc absorption|zinc absorption
4896884|NCT02101723|Micronutrient supplement|micronutrient supplement
4896885|NCT02101723|Microbiome|microbiome
4896886|NCT02101723|Kenya|kenya
4896887|NCT02101723|Complementary foods|complementary foods
4896888|NCT02101723|Home fortification|home fortification
4896889|NCT02101710|Bioequivalence|bioequivalence
4896890|NCT02101710|Isosorbide 5-mononitrate|isosorbide 5-mononitrate
4896891|NCT02101710|Elantan|elantan
4896892|NCT02101710|Imdur|imdur
4896893|NCT02101710|Korean|korean
4896894|NCT02101710|Healthy|healthy
4896895|NCT02101697|reduce|reduce
4896896|NCT02101697|Indian health providers|indian health providers
4896897|NCT02101684|Orteronel, Granulosa Cell Tumour|orteronel, granulosa cell tumour
4896898|NCT02101671|agitation|agitation
4896899|NCT02101671|anaesthesia|anaesthesia
4896900|NCT02101671|laparoscopy|laparoscopy
4896901|NCT02101671|surgery|surgery
4896902|NCT02101671|delirium|delirium
4896903|NCT02101671|sedation|sedation
4896904|NCT02101671|emergence|emergence
4896905|NCT02101671|steep|steep
4896906|NCT02101671|trendelemburg|trendelemburg
4896907|NCT02101671|position|position
4896908|NCT02101671|delayed|delayed
4896909|NCT02101671|Confusion|confusion
4896910|NCT02101671|Disorientation|disorientation
4896911|NCT02101645|Bioimpedance|bioimpedance
4896912|NCT02101645|Venous ulcer|venous ulcer
4896913|NCT02101645|Edema|edema
4896914|NCT02101645|LIDC|lidc
4896915|NCT02101645|Electrical stimulation|electrical stimulation
4896916|NCT02101632|TMD|tmd
4896917|NCT02101632|bee venom|bee venom
4896918|NCT02101632|muscle tension|muscle tension
4896919|NCT02101632|muscle pain|muscle pain
4896920|NCT02101619|aortic stenosis|aortic stenosis
4896921|NCT02101619|myocardial tissue|myocardial tissue
4896922|NCT02101619|echocardiography|echocardiography
4896923|NCT02101619|MRI|mri
4896924|NCT02101606|Acute Stroke|acute stroke
4896925|NCT02101606|Cerebral Stroke|cerebral stroke
4896926|NCT02101606|Brain Ischemia|brain ischemia
4896927|NCT02101606|Perfusion Imaging|perfusion imaging
4896928|NCT02101606|MRI, Diffusion Weighted|mri, diffusion weighted
4896929|NCT02101606|MRI, Perfusion Weighted|mri, perfusion weighted
4896930|NCT02101593|argininosuccinate synthetase|argininosuccinate synthetase
4896931|NCT02101593|arginine|arginine
4896932|NCT02101593|arginine deiminase|arginine deiminase
4896933|NCT02101580|argininosuccinate synthetase|argininosuccinate synthetase
4896934|NCT02101580|arginine|arginine
4896935|NCT02101580|arginine deiminase|arginine deiminase
4896936|NCT02101567|Postpartum hemorrhage, Cesarean section, Uterotonics|postpartum hemorrhage, cesarean section, uterotonics
4896937|NCT02101554|Pediatric|pediatric
4896938|NCT02101554|pain indication|pain indication
4896939|NCT02101554|controlled release morphine|controlled release morphine
4896940|NCT02101541|Atrial fibrillation|atrial fibrillation
4896941|NCT02101541|Arrhythmias, Cardiac|arrhythmias, cardiac
4896942|NCT02101541|Heart diseases|heart diseases
4896943|NCT02101541|Cardiovascular diseases|cardiovascular diseases
4896944|NCT02101541|Pathological processes|pathological processes
4896945|NCT02101528|Strength in PD patients|strength in pd patients
4896946|NCT02101528|Isokinetic muscle strength|isokinetic muscle strength
4896947|NCT02101515|randomized controlled trial|randomized controlled trial
4896948|NCT02101515|labor complications|labor complications
4896949|NCT02101515|cesarean section|cesarean section
4896950|NCT02101515|second stage|second stage
4896951|NCT02101502|Healthcare,educational effectiveness, institutional capacity|healthcare,educational effectiveness, institutional capacity
4896952|NCT02101489|TVT|tvt
4896953|NCT02101489|Stress urinary incontinence|stress urinary incontinence
4896954|NCT02101476|Pain|pain
4896955|NCT02101463|aortic|aortic
4896956|NCT02101463|sm-FBSG|sm-fbsg
4896957|NCT02101463|aneurysms|aneurysms
4896958|NCT02101463|fenestrated|fenestrated
4896959|NCT02101463|stent-grafts|stent-grafts
4896960|NCT02101463|Vascular|vascular
4896961|NCT02101463|Endovascular|endovascular
4896962|NCT02101450|extra-abdominal|extra-abdominal
4896963|NCT02101450|intra-abdominal|intra-abdominal
4896964|NCT02101450|removal of placenta|removal of placenta
4896965|NCT02101450|cesarean section|cesarean section
4896966|NCT02101450|bleeding|bleeding
4896967|NCT02101424|Overdose|overdose
4896968|NCT02101424|Emergency Department|emergency department
4896969|NCT02101424|Supplemental Oxygen|supplemental oxygen
4896970|NCT02101424|Pulse Oximeter|pulse oximeter
4896971|NCT02101424|Capnography|capnography
4896972|NCT02101398|tDCS|tdcs
4896973|NCT02101398|Stroke|stroke
4896974|NCT02101398|Aphasia|aphasia
4896975|NCT02101398|Naming|naming
4896976|NCT02101385|Genomically-Directed Therapy|genomically-directed therapy
4896977|NCT02101385|DNA Sequencing|dna sequencing
4896978|NCT02101385|RNA Sequencing|rna sequencing
4896979|NCT02101372|first episode psychosis|first episode psychosis
4896980|NCT02101372|psychoeducation|psychoeducation
4896981|NCT02101372|group therapy|group therapy
4896982|NCT02101333|TAKAYASU ARTERITIS|takayasu arteritis
4896983|NCT02101333|STEROID SPARING|steroid sparing
4896984|NCT02101333|TOCILIZUMAB|tocilizumab
4896985|NCT02101333|EFFICACY|efficacy
4896986|NCT02101333|SAFETY|safety
4896987|NCT02101320|surgery|surgery
4896988|NCT02101320|nuclear medicine|nuclear medicine
4896989|NCT02101320|Lymphoscintigraphy|lymphoscintigraphy
4896990|NCT02101320|Gamma Camera|gamma camera
4896991|NCT02101320|SNOLL|snoll
4896992|NCT02101320|breast cancer|breast cancer
4896993|NCT02101294|carpal tunnel syndrome|carpal tunnel syndrome
4896994|NCT02101294|repetitive stress disorder|repetitive stress disorder
4896995|NCT02101281|Dry Eye|dry eye
4896996|NCT02101255|Dental caries|dental caries
4896997|NCT02101255|Curodont Repair|curodont repair
4896998|NCT02101255|P11-4|p11-4
4896999|NCT02101242|Near-infrared-Spectroscopy|near-infrared-spectroscopy
4897000|NCT02101229|Glycemic control algorithm|glycemic control algorithm
4897001|NCT02101229|closed loop|closed loop
4897002|NCT02101229|artificial pancreas|artificial pancreas
4897003|NCT02101216|bioequivalence|bioequivalence
4897004|NCT02101216|pharmacokinetics|pharmacokinetics
4897005|NCT02101216|psoriasis|psoriasis
4897006|NCT02101203|HSDD|hsdd
4897007|NCT02101190|BIA 9-1067|bia 9-1067
4897008|NCT02101190|Opicapone|opicapone
4897009|NCT02101190|catechol-O-methyltransferase (COMT)|catechol-o-methyltransferase (comt)
4897010|NCT02101177|Viral Hepatitis C|viral hepatitis c
4897011|NCT02101177|Genotype 4|genotype 4
4897012|NCT02101177|SVR|svr
4897013|NCT02101177|Egyptian National Program|egyptian national program
4897014|NCT02101151|Type 2 diabetes mellitus|type 2 diabetes mellitus
4897015|NCT02101151|vitamin D|vitamin d
4897016|NCT02101151|cholecalciferol|cholecalciferol
4897017|NCT02101151|obesity|obesity
4897018|NCT02101138|Corticosteroids|corticosteroids
4897019|NCT02101138|Eosinophilia|eosinophilia
4897020|NCT02101099|Colonoscopy|colonoscopy
4897021|NCT02101099|Force|force
4897022|NCT02101099|Monitor|monitor
4897023|NCT02101099|Endoscopist|endoscopist
4897024|NCT02101099|Conscious|conscious
4897025|NCT02101099|Sedation|sedation
4897026|NCT02101099|Propofol|propofol
4897027|NCT02101086|umbilical cord blood|umbilical cord blood
4897028|NCT02101086|premature|premature
4897029|NCT02101086|autologous transfusion|autologous transfusion
4897030|NCT02101086|allogeneic transfusion|allogeneic transfusion
4897031|NCT02101060|exercise|exercise
4897032|NCT02101060|aging|aging
4897033|NCT02101060|aerobic capacity|aerobic capacity
4897034|NCT02101060|cardiac function|cardiac function
4897035|NCT02101060|inflammation|inflammation
4897036|NCT02101047|cesarean section|cesarean section
4897037|NCT02101047|hypotension|hypotension
4897038|NCT02101047|phenylephrine|phenylephrine
4897039|NCT02100982|Multimorbidity|multimorbidity
4897040|NCT02100982|Communication|communication
4897041|NCT02100982|Primary Care|primary care
4897042|NCT02100982|Mental Health|mental health
4897043|NCT02100969|MG|mg
4897044|NCT02100969|Hizentra|hizentra
4897045|NCT02100969|autoimmune neuromuscular disorder|autoimmune neuromuscular disorder
4897046|NCT02100956|chronic pain|chronic pain
4897047|NCT02100956|neuropathic pain|neuropathic pain
4897048|NCT02100943|Obstructive Sleep Apnea|obstructive sleep apnea
4897049|NCT02100930|Anti-GD2 3F8 Monoclonal Antibody|anti-gd2 3f8 monoclonal antibody
4897050|NCT02100930|oral isotretinoin|oral isotretinoin
4897051|NCT02100930|GM-CSF|gm-csf
4897052|NCT02100930|Sargramostim|sargramostim
4897053|NCT02100930|13-260|13-260
4897054|NCT02100917|Bioequivalence|bioequivalence
4897055|NCT02100917|Biosimilarity|biosimilarity
4897056|NCT02100917|Similarity|similarity
4897057|NCT02100917|Pharmacokinetics|pharmacokinetics
4897058|NCT02100917|Phase I|phase i
4897059|NCT02100917|Trastuzumab|trastuzumab
4897060|NCT02100917|Healthy Male Volunteers|healthy male volunteers
4897061|NCT02100917|Single-dose|single-dose
4897062|NCT02100917|HER-2|her-2
4897063|NCT02100917|Oncology|oncology
4897064|NCT02100904|Fibroids|fibroids
4897065|NCT02100904|Radiofrequency ablation|radiofrequency ablation
4897066|NCT02100891|Ewing Sarcoma|ewing sarcoma
4897067|NCT02100891|Neuroblastoma|neuroblastoma
4897068|NCT02100891|Rhabdomyosarcoma|rhabdomyosarcoma
4897069|NCT02100891|Osteosarcoma|osteosarcoma
4897070|NCT02100891|CNS tumors|cns tumors
4897071|NCT02100891|Brain Tumors|brain tumors
4897072|NCT02100839|hypercholesterolemia|hypercholesterolemia
4897073|NCT02100839|apolipoprotein E|apolipoprotein e
4897074|NCT02100839|First in Human|first in human
4897075|NCT02100839|Apolipoprotein E (ApoE)|apolipoprotein e (apoe)
4897076|NCT02100839|Apolipoprotein E Mimetic (AEM)|apolipoprotein e mimetic (aem)
4897077|NCT02100800|COPD|copd
4897078|NCT02100800|Emphysema|emphysema
4897079|NCT02100800|MRI|mri
4897080|NCT02100800|UTE|ute
4897081|NCT02100800|Quantification|quantification
4897082|NCT02100800|CT|ct
4897083|NCT02100787|tear osmolarity|tear osmolarity
4897084|NCT02100787|keratitis sicca|keratitis sicca
4897085|NCT02100787|ocular surface disease|ocular surface disease
4897086|NCT02100787|TheraTears|theratears
4897087|NCT02100774|bioavailability|bioavailability
4897088|NCT02100774|postprandial period|postprandial period
4897089|NCT02100774|genetic variants|genetic variants
4897090|NCT02100774|single nucleotide polymorphisms|single nucleotide polymorphisms
4897091|NCT02100774|vitamin|vitamin
4897092|NCT02100774|carotenoid|carotenoid
4897093|NCT02100774|lutein|lutein
4897094|NCT02100774|lycopene|lycopene
4897095|NCT02100774|tocopherol|tocopherol
4897096|NCT02100774|cholecalciferol|cholecalciferol
4897097|NCT02100761|Voriconazole|voriconazole
4897098|NCT02100761|Invasive pulmonary aspergillosis|invasive pulmonary aspergillosis
4897099|NCT02100761|Therapeutic drug monitoring|therapeutic drug monitoring
4897100|NCT02100761|CYP genetic polymorphism|cyp genetic polymorphism
4897101|NCT02100761|Efficacy|efficacy
4897102|NCT02100761|Safety|safety
4897103|NCT02100748|moderate to severe acute pain|moderate to severe acute pain
4897104|NCT02100748|bunionectomy|bunionectomy
4897105|NCT02100735|sedatives|sedatives
4897106|NCT02100735|analgesics|analgesics
4897107|NCT02100735|protocol|protocol
4897108|NCT02100735|mechanical ventilation|mechanical ventilation
4897109|NCT02100735|analgosedation|analgosedation
4897110|NCT02100683|Occluder|occluder
4897111|NCT02100657|multiple myeloma|multiple myeloma
4897112|NCT02100657|plitidepsin|plitidepsin
4897113|NCT02100657|APLIDIN|aplidin
4897114|NCT02100618|Adolescents|adolescents
4897115|NCT02100618|Adults|adults
4897116|NCT02100618|Immunogenicity|immunogenicity
4897117|NCT02100618|6.5 years|6.5 years
4897118|NCT02100618|Safety|safety
4897119|NCT02100618|Antibody persistence|antibody persistence
4897120|NCT02100618|Human Papillomavirus (HPV) vaccine|human papillomavirus (hpv) vaccine
4897121|NCT02100605|Nasal|nasal
4897122|NCT02100605|Congestion|congestion
4897123|NCT02100605|Decongestion|decongestion
4897124|NCT02100605|Hypertonic|hypertonic
4897125|NCT02100605|Saline solution|saline solution
4897126|NCT02100592|brain injury|brain injury
4897127|NCT02100592|coma|coma
4897128|NCT02100592|intensive care|intensive care
4897129|NCT02100592|early rehabilitation|early rehabilitation
4897130|NCT02100566|Advance Directive|advance directive
4897131|NCT02100553|Postmenopausal Women|postmenopausal women
4897132|NCT02100553|Obese|obese
4897133|NCT02100553|Non-obese|non-obese
4897134|NCT02100553|Drug Interaction with Itraconazole|drug interaction with itraconazole
4897135|NCT02100553|Pharmacokinetic|pharmacokinetic
4897136|NCT02100540|PMS|pms
4897137|NCT02100540|hot flashes|hot flashes
4897138|NCT02100527|safety|safety
4897139|NCT02100527|tolerability|tolerability
4897140|NCT02100527|pharmacokinetics|pharmacokinetics
4897141|NCT02100527|oral dosing|oral dosing
4897142|NCT02100527|moderate to severe acne vulgaris|moderate to severe acne vulgaris
4897143|NCT02100514|Primary hyperlipidemia or mixed dyslipidemia|primary hyperlipidemia or mixed dyslipidemia
4897144|NCT02100514|high risk of cardiovascular events|high risk of cardiovascular events
4897145|NCT02100514|multiple cardiovascular disease risk factors.|multiple cardiovascular disease risk factors.
4897146|NCT02100501|Seizure control through dietary therapy in pediatric intractable epilepsy patients.|seizure control through dietary therapy in pediatric intractable epilepsy patients.
4897147|NCT02100488|Closed-loop insulin infusion|closed-loop insulin infusion
4897148|NCT02100488|Postprandial glucose control|postprandial glucose control
4897149|NCT02100488|Glucose variability|glucose variability
4897150|NCT02100462|Hypertension|hypertension
4897151|NCT02100462|Platelet activation|platelet activation
4897152|NCT02100462|Platelet aggregation|platelet aggregation
4897153|NCT02100462|Chlorthalidone|chlorthalidone
4897154|NCT02100449|Atelectasis|atelectasis
4897155|NCT02100449|Pneumonia|pneumonia
4897156|NCT02100449|Lung ultrasound|lung ultrasound
4897157|NCT02100449|Doppler|doppler
4897158|NCT02100436|children|children
4897159|NCT02100436|H3N2|h3n2
4897160|NCT02100436|H3N2v|h3n2v
4897161|NCT02100436|influenza|influenza
4897162|NCT02100436|pediatric|pediatric
4897163|NCT02100436|unadjuvanted|unadjuvanted
4897164|NCT02100436|vaccine|vaccine
4897165|NCT02100410|Contact Lens|contact lens
4897166|NCT02100410|Toric|toric
4897167|NCT02100397|Enteric fever|enteric fever
4897168|NCT02100397|Paratyphoid|paratyphoid
4897169|NCT02100397|Salmonella Paratyphi|salmonella paratyphi
4897170|NCT02100397|Challenge study|challenge study
4897171|NCT02100397|Human model of infection|human model of infection
4897172|NCT02100384|peri implant|peri implant
4897173|NCT02100384|Maintenance|maintenance
4897174|NCT02100384|Ultrasonic|ultrasonic
4897175|NCT02100384|Scalers|scalers
4897176|NCT02100371|BMS-833923|bms-833923
4897177|NCT02100371|CA194002|ca194002
4897178|NCT02100358|acute cholecystitis|acute cholecystitis
4897179|NCT02100332|Drug Therapy|drug therapy
4897180|NCT02100319|Pharmacological therapy|pharmacological therapy
4897181|NCT02100293|magnesium sulfate, rocuronium|magnesium sulfate, rocuronium
4897182|NCT02100280|Neuromuscular blockade|neuromuscular blockade
4897183|NCT02100280|Sugammadex|sugammadex
4897184|NCT02100280|Laparoscopic surgery|laparoscopic surgery
4897185|NCT02100280|IL-6|il-6
4897186|NCT02100241|Young adult|young adult
4897187|NCT02100241|Muscle Stretching Exercises|muscle stretching exercises
4897188|NCT02100241|Range of Motion, Articular|range of motion, articular
4897189|NCT02100228|apixaban|apixaban
4897190|NCT02100228|oral anticoagulant|oral anticoagulant
4897191|NCT02100228|non-valvular atrial fibrillation|non-valvular atrial fibrillation
4897192|NCT02100228|cardioversion|cardioversion
4897193|NCT02100215|simulation|simulation
4897194|NCT02100215|competence|competence
4897195|NCT02100215|self-efficacy|self-efficacy
4897196|NCT02100215|novice nurses|novice nurses
4897197|NCT02100202|Dietary supplements|dietary supplements
4897198|NCT02100202|Cotinine level|cotinine level
4897199|NCT02100202|Malondialdehyde|malondialdehyde
4897200|NCT02100202|Chronic smokers|chronic smokers
4897201|NCT02100202|Hyperlipidemia|hyperlipidemia
4897202|NCT02100176|Rehabilitation treatment|rehabilitation treatment
4897203|NCT02100163|Ortho trauma. Virtual Reality. Pain. Anxiety|ortho trauma. virtual reality. pain. anxiety
4897204|NCT02100150|Concussion|concussion
4897205|NCT02100124|reproductive life planning|reproductive life planning
4897206|NCT02100124|action planning|action planning
4897207|NCT02100124|contraceptive use|contraceptive use
4897208|NCT02100124|unintended pregnancy|unintended pregnancy
4897209|NCT02100098|Ankle fracture|ankle fracture
4897210|NCT02100098|Nerve block|nerve block
4897211|NCT02100098|Postoperative pain|postoperative pain
4897212|NCT02100098|Pain profile|pain profile
4897213|NCT02100098|Rebound pain|rebound pain
4897214|NCT02100085|Phase 1 follow up|phase 1 follow up
4897215|NCT02100085|Cervical Intraepithelial Neoplasia|cervical intraepithelial neoplasia
4897216|NCT02100085|Adult|adult
4897217|NCT02100085|Safety|safety
4897218|NCT02100085|Efficacy|efficacy
4897219|NCT02100059|meniscectomy|meniscectomy
4897220|NCT02100059|arthroscopic partial meniscectomy|arthroscopic partial meniscectomy
4897221|NCT02100059|meniscus|meniscus
4897222|NCT02100046|Ethosuximide|ethosuximide
4897223|NCT02100046|Neuropathic pain|neuropathic pain
4897224|NCT02100046|Pain|pain
4897225|NCT02100046|Quality of life|quality of life
4897226|NCT02100046|Neuropathic Pain diagnostic questionnaire ≥ 4|neuropathic pain diagnostic questionnaire ≥ 4
4897227|NCT02100046|Analgesic treatment failure for at least 3 months|analgesic treatment failure for at least 3 months
4897228|NCT02100020|physical activity|physical activity
4897229|NCT02100020|exercise guidelines|exercise guidelines
4897230|NCT02100020|multiple sclerosis|multiple sclerosis
4897231|NCT02100007|solid tumors|solid tumors
4897232|NCT02100007|relapsed|relapsed
4897233|NCT02100007|advanced|advanced
4897234|NCT02100007|metastatic|metastatic
4897235|NCT02100007|small cell lung cancer|small cell lung cancer
4897236|NCT02100007|ovarian cancer|ovarian cancer
4897237|NCT02100007|refractory|refractory
4897238|NCT02099994|HIV|hiv
4897239|NCT02099994|vaccine|vaccine
4897240|NCT02099981|Diabetes|diabetes
4897241|NCT02099981|Diabetic|diabetic
4897242|NCT02099981|Retinopathy|retinopathy
4897243|NCT02099981|Ophthalmology|ophthalmology
4897244|NCT02099981|Eye|eye
4897245|NCT02099981|Eyes|eyes
4897246|NCT02099955|spinal cord injury|spinal cord injury
4897247|NCT02099955|vitamin D deficiency|vitamin d deficiency
4897248|NCT02099955|pulmonary function|pulmonary function
4897249|NCT02099955|metabolic diseases|metabolic diseases
4897250|NCT02099942|Balloon Aortic Valvuloplasty|balloon aortic valvuloplasty
4897251|NCT02099942|Valvuloplasty|valvuloplasty
4897252|NCT02099942|Transcatheter Aortic Valve Replacement|transcatheter aortic valve replacement
4897253|NCT02099942|Surgical Aortic Valve Replacement|surgical aortic valve replacement
4897254|NCT02099929|Coffee|coffee
4897255|NCT02099929|Glucose|glucose
4897256|NCT02099929|Insulin|insulin
4897257|NCT02099929|Diabetes|diabetes
4897258|NCT02099929|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
4897259|NCT02099916|DHEA, pregnancy, ovarian reserve, AMH|dhea, pregnancy, ovarian reserve, amh
4897260|NCT02099903|Heart Failure|heart failure
4897261|NCT02099903|Heart Failure, Systolic|heart failure, systolic
4897262|NCT02099903|Chagas Disease|chagas disease
4897263|NCT02099903|Chagas Cardiomyopathy|chagas cardiomyopathy
4897264|NCT02099903|Renal Denervation|renal denervation
4897265|NCT02099903|Irrigated Radiofrequency Catheter|irrigated radiofrequency catheter
4897266|NCT02099890|Chronic Inflammation|chronic inflammation
4897267|NCT02099890|Spinal Cord Injury|spinal cord injury
4897268|NCT02099890|Anti-inflammatory Diet|anti-inflammatory diet
4897269|NCT02099890|Neuropathic Pain|neuropathic pain
4897270|NCT02099890|Depression|depression
4897271|NCT02099890|Cognitive Impairment|cognitive impairment
4897272|NCT02099890|Somatic Nerve Function|somatic nerve function
4897273|NCT02099890|Autonomic Nerve Function|autonomic nerve function
4897274|NCT02099877|µ-opioid receptor polymorphism|µ-opioid receptor polymorphism
4897275|NCT02099877|Opioids|opioids
4897276|NCT02099877|Opioid analgesia|opioid analgesia
4897277|NCT02099877|Labor analgesia|labor analgesia
4897278|NCT02099838|Pioglitazone|pioglitazone
4897279|NCT02099838|Metformin|metformin
4897280|NCT02099838|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
4897281|NCT02099825|adult male|adult male
4897282|NCT02099825|anxiety|anxiety
4897283|NCT02099825|public speaking|public speaking
4897284|NCT02099825|healthy controls|healthy controls
4897285|NCT02099825|exposure therapy|exposure therapy
4897286|NCT02099825|social anxiety|social anxiety
4897287|NCT02099825|mifepristone|mifepristone
4897288|NCT02099825|d-cycloserine|d-cycloserine
4897289|NCT02099799|Physical Activity|physical activity
4897290|NCT02099799|COPD Self-Management|copd self-management
4897291|NCT02099799|Internet|internet
4897292|NCT02099799|6-Minute Walk Test|6-minute walk test
4897293|NCT02099799|COPD Exacerbation|copd exacerbation
4897294|NCT02099799|Health-related Quality of Life|health-related quality of life
4897295|NCT02099786|hearing|hearing
4897296|NCT02099786|cisplatin|cisplatin
4897297|NCT02099786|Ototoxicity|ototoxicity
4897298|NCT02099786|Veterans|veterans
4897299|NCT02099773|AAC|aac
4897300|NCT02099773|support worker|support worker
4897301|NCT02099773|direct care staff|direct care staff
4897302|NCT02099773|intellectual disability|intellectual disability
4897303|NCT02099773|learning disability|learning disability
4897304|NCT02099773|communication|communication
4897305|NCT02099773|adults|adults
4897306|NCT02099760|gonorrhea|gonorrhea
4897307|NCT02099760|chlamydia|chlamydia
4897308|NCT02099760|trichomonas|trichomonas
4897309|NCT02099747|Aplastic Anaemia|aplastic anaemia
4897310|NCT02099747|Eltrombopag|eltrombopag
4897311|NCT02099747|HATG|hatg
4897312|NCT02099747|ATGAM|atgam
4897313|NCT02099734|14-016|14-016
4897314|NCT02099721|Sudden Cardiac Arrest (SCA)|sudden cardiac arrest (sca)
4897315|NCT02099721|Syncope|syncope
4897316|NCT02099721|Non Sustained Ventricular Tachycardia (NSVT)|non sustained ventricular tachycardia (nsvt)
4897317|NCT02099721|Premature Ventricular Contractions (PVC)|premature ventricular contractions (pvc)
4897318|NCT02099721|Left Ventricular Ejection Fraction (LVEF)|left ventricular ejection fraction (lvef)
4897319|NCT02099721|Primary Prevention|primary prevention
4897320|NCT02099721|Secondary Prevention|secondary prevention
4897321|NCT02099721|Antitachycardia pacing (ATP)|antitachycardia pacing (atp)
4897322|NCT02099721|shock|shock
4897323|NCT02099721|appropriate therapy|appropriate therapy
4897324|NCT02099708|Pharmacological therapy|pharmacological therapy
4897325|NCT02099695|Hyperhidrosis|hyperhidrosis
4897326|NCT02099695|Oxybutynin|oxybutynin
4897327|NCT02099682|Pharmacological therapy|pharmacological therapy
4897328|NCT02099604|Hepatitis C - Genotype 4|hepatitis c - genotype 4
4897329|NCT02099604|SVR (Sustained Virological Response)|svr (sustained virological response)
4897330|NCT02099604|Vitamin D|vitamin d
4897331|NCT02099604|Treatment Naïve|treatment naïve
4897332|NCT02099591|Constipation|constipation
4897333|NCT02099591|Colonic Inertia|colonic inertia
4897334|NCT02099591|Dyschezia|dyschezia
4897335|NCT02099591|Pharmacokinetics|pharmacokinetics
4897336|NCT02099591|Naloxegol|naloxegol
4897337|NCT02099591|Paediatric|paediatric
4897338|NCT02099591|Opioids|opioids
4897339|NCT02099591|Opioid induced constipation|opioid induced constipation
4897340|NCT02099591|OIC|oic
4897341|NCT02099591|Phase 1|phase 1
4897342|NCT02099578|Blood pressure|blood pressure
4897343|NCT02099578|Arterial stiffness|arterial stiffness
4897344|NCT02099578|Pulse wave velocity|pulse wave velocity
4897345|NCT02099578|Strawberries|strawberries
4897346|NCT02099578|Endothelial function|endothelial function
4897347|NCT02099578|Oxidative stress|oxidative stress
4897348|NCT02099578|Postmenopausal women|postmenopausal women
4897349|NCT02099565|Major Adverse Cardiovascular and Cerebrovascular Events (MACCE)|major adverse cardiovascular and cerebrovascular events (macce)
4897350|NCT02099565|Statins|statins
4897351|NCT02099565|LDL-cholesterol|ldl-cholesterol
4897352|NCT02099565|Inflammatory markers|inflammatory markers
4897353|NCT02099565|Percutaneous Coronary Intervention (PCI)|percutaneous coronary intervention (pci)
4897354|NCT02099552|X-Linked hypohidrotic ectodermal dysplasia|x-linked hypohidrotic ectodermal dysplasia
4897355|NCT02099552|XLHED|xlhed
4897356|NCT02099552|Hypohidrotic ectodermal dysplasia|hypohidrotic ectodermal dysplasia
4897357|NCT02099552|HED|hed
4897358|NCT02099552|Christ-Siemens-Touraine syndrome|christ-siemens-touraine syndrome
4897359|NCT02099539|absolute lymphocyte count|absolute lymphocyte count
4897360|NCT02099539|antitumor|antitumor
4897361|NCT02099539|cancer|cancer
4897362|NCT02099539|immunotherapy|immunotherapy
4897363|NCT02099539|immunochemotherapy|immunochemotherapy
4897364|NCT02099539|interleukin-15|interleukin-15
4897365|NCT02099539|multiple myeloma|multiple myeloma
4897366|NCT02099539|NK cell|nk cell
4897367|NCT02099539|refractory|refractory
4897368|NCT02099539|relapsed|relapsed
4897369|NCT02099539|T cell|t cell
4897370|NCT02099539|white blood cell count|white blood cell count
4897371|NCT02099526|cancer|cancer
4897372|NCT02099526|caregiver|caregiver
4897373|NCT02099526|caregiving|caregiving
4897374|NCT02099526|care give|care give
4897375|NCT02099526|elderly|elderly
4897376|NCT02099526|older adults|older adults
4897377|NCT02099526|unmet needs|unmet needs
4897378|NCT02099526|post-discharge|post-discharge
4897379|NCT02099526|cancer symptoms|cancer symptoms
4897380|NCT02099513|Mobile Technology|mobile technology
4897381|NCT02099513|Chronic illness|chronic illness
4897382|NCT02099513|Wireless blood pressure device|wireless blood pressure device
4897383|NCT02099513|Wireless scale|wireless scale
4897384|NCT02099513|Pedometer|pedometer
4897385|NCT02099500|Critical Limb Ischemia|critical limb ischemia
4897386|NCT02099500|Peripheral Vascular Disease|peripheral vascular disease
4897387|NCT02099500|Lower Limb Ulcer|lower limb ulcer
4897388|NCT02099500|Gangrene|gangrene
4897389|NCT02099500|Amputation|amputation
4897390|NCT02099500|Lower Limb Wound|lower limb wound
4897391|NCT02099487|HGG|hgg
4897392|NCT02099474|HIV-1|hiv-1
4897393|NCT02099474|HIV mother to child prevention|hiv mother to child prevention
4897394|NCT02099474|Raltegravir|raltegravir
4897395|NCT02099474|Pharmacokinetic|pharmacokinetic
4897396|NCT02099435|Gastriointestinal|gastriointestinal
4897397|NCT02099435|Lower gastriointestinal|lower gastriointestinal
4897398|NCT02099435|Digestive|digestive
4897399|NCT02099435|Hemostasis|hemostasis
4897400|NCT02099435|Recurrent bleeding|recurrent bleeding
4897401|NCT02099435|Hemospray|hemospray
4897402|NCT02099409|Type 1 diabetes mellitus|type 1 diabetes mellitus
4897403|NCT02099409|children|children
4897404|NCT02099409|closed loop|closed loop
4897405|NCT02099409|cross over|cross over
4897406|NCT02099409|overnight|overnight
4897407|NCT02099409|FLORENCED2|florenced2
4897408|NCT02099409|DANA Diabecare R pump|dana diabecare r pump
4897409|NCT02099409|FreeStyle Navigator II|freestyle navigator ii
4897410|NCT02099409|Dexcom G4|dexcom g4
4897411|NCT02099396|PFS,efficacy and safety,lobaplatin and gemcitabine in combination, second-line treatments on advanced osteosarcoma|pfs,efficacy and safety,lobaplatin and gemcitabine in combination, second-line treatments on advanced osteosarcoma
4897412|NCT02099383|Stroke|stroke
4897413|NCT02099383|Dehydration|dehydration
4897414|NCT02099383|Fluid Therapy|fluid therapy
4897415|NCT02099370|Multiple Sclerosis|multiple sclerosis
4897416|NCT02099370|Tecfidera(R)|tecfidera(r)
4897417|NCT02099370|Oral medication|oral medication
4897418|NCT02099370|Adherence|adherence
4897419|NCT02099331|Atrial Fibrillation|atrial fibrillation
4897420|NCT02099331|Reactive Oxygen Species|reactive oxygen species
4897421|NCT02099331|Cardiac Surgery|cardiac surgery
4897422|NCT02099318|Rehearsal Platform|rehearsal platform
4897423|NCT02099305|Adolescent; Depression|adolescent; depression
4897424|NCT02099305|Early intervention (education)|early intervention (education)
4897425|NCT02099305|Randomized Controlled Trial|randomized controlled trial
4897426|NCT02099305|Primary Prevention|primary prevention
4897427|NCT02099305|schools|schools
4897428|NCT02099305|Health Literacy|health literacy
4897429|NCT02099305|Discrimination (Psychology)|discrimination (psychology)
4897430|NCT02099305|Mental Health Services|mental health services
4897431|NCT02099292|lymphoma|lymphoma
4897432|NCT02099292|high dose therapy|high dose therapy
4897433|NCT02099292|DexaBEAM|dexabeam
4897434|NCT02099292|Rituximab|rituximab
4897435|NCT02099292|role of alternative salvage treatment - dexaBEAM|role of alternative salvage treatment - dexabeam
4897436|NCT02099266|Umbilical Cord Blood (UCB) Stem Cell Transplant|umbilical cord blood (ucb) stem cell transplant
4897437|NCT02099266|Hyperbaric oxygen|hyperbaric oxygen
4897438|NCT02099266|Leukemia|leukemia
4897439|NCT02099266|Lymphoma|lymphoma
4897440|NCT02099266|MDS|mds
4897441|NCT02099253|Age|age
4897442|NCT02099253|Pharmacodynamics|pharmacodynamics
4897443|NCT02099253|dexmedetomidine|dexmedetomidine
4897444|NCT02099240|Osteomyelitis|osteomyelitis
4897445|NCT02099240|IV Antibiotics|iv antibiotics
4897446|NCT02099240|Oral Antibiotics|oral antibiotics
4897447|NCT02099227|pediatric|pediatric
4897448|NCT02099227|soft tissue infections|soft tissue infections
4897449|NCT02099227|ultrasonography|ultrasonography
4897450|NCT02099227|effectiveness|effectiveness
4897451|NCT02099214|myocardial iron overload|myocardial iron overload
4897452|NCT02099214|HFE-Associated Hereditary Hemochromatosis|hfe-associated hereditary hemochromatosis
4897453|NCT02099214|3 Tesla MRI|3 tesla mri
4897454|NCT02099214|cardiological strategy in haemochromatosis|cardiological strategy in haemochromatosis
4897455|NCT02099214|congestive heart failure|congestive heart failure
4897456|NCT02099201|ACT-389949|act-389949
4897457|NCT02099162|OCT|oct
4897458|NCT02099162|Coronary|coronary
4897459|NCT02099162|Stenting|stenting
4897460|NCT02099149|Group B Streptococcus|group b streptococcus
4897461|NCT02099149|early onset disease|early onset disease
4897462|NCT02099149|late onset disease|late onset disease
4897463|NCT02099149|anticapsular antibodies|anticapsular antibodies
4897464|NCT02099149|serotype specific|serotype specific
4897465|NCT02099123|Survival|survival
4897466|NCT02099123|Functional Disability|functional disability
4897467|NCT02099123|Cardiovascular Disease|cardiovascular disease
4897468|NCT02099123|Diabetes|diabetes
4897469|NCT02099123|Dementia|dementia
4897470|NCT02099123|Cancer|cancer
4897471|NCT02099097|3D Coping Skills Game|3d coping skills game
4897472|NCT02099097|Quit smoking|quit smoking
4897473|NCT02099097|14-062|14-062
4897474|NCT02099071|ACT-389949|act-389949
4897475|NCT02099058|Cancer|cancer
4897476|NCT02099058|Advanced Solid Tumor|advanced solid tumor
4897477|NCT02099058|Neoplasm|neoplasm
4897478|NCT02099032|nutrition|nutrition
4897479|NCT02099032|milk|milk
4897480|NCT02099032|polar lipids|polar lipids
4897481|NCT02099032|cardiometabolic risk|cardiometabolic risk
4897482|NCT02099019|Coronary CT angiography; Revascularization; Decision-making|coronary ct angiography; revascularization; decision-making
4897483|NCT02098993|Sickle cell disease|sickle cell disease
4897484|NCT02098993|Acute chest syndrome|acute chest syndrome
4897485|NCT02098993|Hemoglobinopathy|hemoglobinopathy
4897486|NCT02098993|Hemolytic anemia|hemolytic anemia
4897487|NCT02098993|Heparin|heparin
4897488|NCT02098993|Anticoagulant|anticoagulant
4897489|NCT02098954|TKI|tki
4897490|NCT02098954|resistance|resistance
4897491|NCT02098954|erlotinib|erlotinib
4897492|NCT02098954|combined chemotherapy|combined chemotherapy
4897493|NCT02098941|topiramate|topiramate
4897494|NCT02098941|oxcarbazepine|oxcarbazepine
4897495|NCT02098941|levetiracetam|levetiracetam
4897496|NCT02098941|retention rate|retention rate
4897497|NCT02098928|Acupuncture|acupuncture
4897498|NCT02098928|Electro acupuncture|electro acupuncture
4897499|NCT02098928|Menopause|menopause
4897500|NCT02098915|gastroschisis|gastroschisis
4897501|NCT02098915|intestinal motility|intestinal motility
4897502|NCT02098915|prokinetic agents|prokinetic agents
4897503|NCT02098915|intravenous metoclopramide|intravenous metoclopramide
4897504|NCT02098915|time to full enteral feeding|time to full enteral feeding
4897505|NCT02098902|Overweight|overweight
4897506|NCT02098902|Obesity|obesity
4897507|NCT02098902|Overnutrition|overnutrition
4897508|NCT02098902|Weight Loss|weight loss
4897509|NCT02098902|Body Weight|body weight
4897510|NCT02098902|Nutrition Disorders|nutrition disorders
4897511|NCT02098889|Cervix, active phase of labor, Hyoscine-N-Butylbromide (HBB)|cervix, active phase of labor, hyoscine-n-butylbromide (hbb)
4897512|NCT02098876|neointimal tissue area|neointimal tissue area
4897513|NCT02098876|angulated coronary vessels|angulated coronary vessels
4897514|NCT02098876|wall shear stress|wall shear stress
4897515|NCT02098876|zotarolimus eluting stent|zotarolimus eluting stent
4897516|NCT02098876|everolimus eluting stent|everolimus eluting stent
4897517|NCT02098863|Sickle Cell Anemia|sickle cell anemia
4897518|NCT02098863|Sickle Cell Disease|sickle cell disease
4897519|NCT02098863|Survival|survival
4897520|NCT02098863|Mortality|mortality
4897521|NCT02098863|End-Order Dysfunction|end-order dysfunction
4897522|NCT02098850|Staphylococcus aureus|staphylococcus aureus
4897523|NCT02098850|bloodstream infection|bloodstream infection
4897524|NCT02098850|bacteremia|bacteremia
4897525|NCT02098837|HIV|hiv
4897526|NCT02098824|vascular cognitive impairment|vascular cognitive impairment
4897527|NCT02098824|treatment|treatment
4897528|NCT02098824|cerebrovascular lesions|cerebrovascular lesions
4897529|NCT02098824|memory impairment|memory impairment
4897530|NCT02098824|executive dysfunction|executive dysfunction
4897531|NCT02098824|neuronal networks|neuronal networks
4897532|NCT02098824|white matter tracts|white matter tracts
4897533|NCT02098824|monoaminergic systems|monoaminergic systems
4897534|NCT02098824|cholinergic systems|cholinergic systems
4897535|NCT02098824|DTI|dti
4897536|NCT02098824|rs-fMRI|rs-fmri
4897537|NCT02098798|Dysplasia, Inflammatory Bowel Disease|dysplasia, inflammatory bowel disease
4897538|NCT02098785|VAP|vap
4897539|NCT02098785|liver|liver
4897540|NCT02098785|hepatology|hepatology
4897541|NCT02098785|caffeine|caffeine
4897542|NCT02098772|aortic valve disease|aortic valve disease
4897543|NCT02098772|coronary bypass surgery|coronary bypass surgery
4897544|NCT02098772|cardioplegic solutions|cardioplegic solutions
4897545|NCT02098759|TSC|tsc
4897546|NCT02098759|tuberous sclerosis complex|tuberous sclerosis complex
4897547|NCT02098759|epilepsy|epilepsy
4897548|NCT02098746|Pharmacological therapy|pharmacological therapy
4897549|NCT02098733|Pharmacological therapy|pharmacological therapy
4897550|NCT02098707|Stabilometric Platform|stabilometric platform
4897551|NCT02098707|Rehabilitation|rehabilitation
4897552|NCT02098707|Balance Disorders|balance disorders
4897553|NCT02098707|Falls|falls
4897554|NCT02098694|Physiotherapy|physiotherapy
4897555|NCT02098694|Outpatient clinic|outpatient clinic
4897556|NCT02098681|Pectus Excavatum|pectus excavatum
4897557|NCT02098668|menstrual cycle dynamics|menstrual cycle dynamics
4897558|NCT02098668|PCOS|pcos
4897559|NCT02098668|hyperprolactinemia|hyperprolactinemia
4897560|NCT02098668|endometriosis|endometriosis
4897561|NCT02098668|infertility|infertility
4897562|NCT02098655|Stabilometric Platform|stabilometric platform
4897563|NCT02098655|Postural instability|postural instability
4897564|NCT02098642|Gait Disturbances|gait disturbances
4897565|NCT02098642|Metatarsophalangeal joint|metatarsophalangeal joint
4897566|NCT02098629|Myocardial infarction|myocardial infarction
4897567|NCT02098629|myocardial ischemia|myocardial ischemia
4897568|NCT02098629|reperfusion injury|reperfusion injury
4897569|NCT02098616|Hepatitis|hepatitis
4897570|NCT02098616|Hepatitis, Chronic|hepatitis, chronic
4897571|NCT02098616|Hepatitis C|hepatitis c
4897572|NCT02098616|Hepatitis C, Chronic|hepatitis c, chronic
4897573|NCT02098616|Liver Diseases|liver diseases
4897574|NCT02098616|Digestive System Diseases|digestive system diseases
4897575|NCT02098616|Hepatitis, Viral, Human|hepatitis, viral, human
4897576|NCT02098616|RNA Virus Infections|rna virus infections
4897577|NCT02098616|Antiviral Agents|antiviral agents
4897578|NCT02098616|Drug Resistance, Viral|drug resistance, viral
4897579|NCT02098590|Malaria|malaria
4897580|NCT02098590|Plasmodium falciparum|plasmodium falciparum
4897581|NCT02098577|Balance|balance
4897582|NCT02098564|hand therapy|hand therapy
4897583|NCT02098564|activity-based training|activity-based training
4897584|NCT02098564|hand related injuries|hand related injuries
4897585|NCT02098564|sense of coherence|sense of coherence
4897586|NCT02098551|atopic dermatitis|atopic dermatitis
4897587|NCT02098551|bet v 1|bet v 1
4897588|NCT02098551|bet v 1 fragments|bet v 1 fragments
4897589|NCT02098551|allergy|allergy
4897590|NCT02098538|Regorafenib|regorafenib
4897591|NCT02098538|13-244|13-244
4897592|NCT02098525|Cryptococcal meningitis|cryptococcal meningitis
4897593|NCT02098525|HIV/AIDS|hiv/aids
4897594|NCT02098525|Antiretroviral therapy|antiretroviral therapy
4897595|NCT02098525|Prognosis|prognosis
4897596|NCT02098525|Thailand|thailand
4897597|NCT02098512|Brentuximab Vedotin|brentuximab vedotin
4897598|NCT02098512|Immunotherapy|immunotherapy
4897599|NCT02098512|Relapsed Hodgkin Lymphoma|relapsed hodgkin lymphoma
4897600|NCT02098512|Refractory Hodgkin Lymphoma|refractory hodgkin lymphoma
4897601|NCT02098512|Reduced Intensity Conditioning|reduced intensity conditioning
4897602|NCT02098512|Allogeneic Stem Cell Transplantation|allogeneic stem cell transplantation
4897603|NCT02098486|Bile duct obstruction|bile duct obstruction
4897604|NCT02098486|Cholangitis|cholangitis
4897605|NCT02098486|Moxifloxacin|moxifloxacin
4897606|NCT02098486|Ceftriaxone|ceftriaxone
4897607|NCT02098486|Sepsis|sepsis
4897608|NCT02098460|the Achilles tendon|the achilles tendon
4897609|NCT02098460|intima-media thickness|intima-media thickness
4897610|NCT02098447|vagus nerve stimulation effects on heart rate variability and peripheral blood perfusion|vagus nerve stimulation effects on heart rate variability and peripheral blood perfusion
4897611|NCT02098421|Induction of Labor|induction of labor
4897612|NCT02098421|Pitocin|pitocin
4897613|NCT02098421|Oxytocin|oxytocin
4897614|NCT02098421|Foley bulb|foley bulb
4897615|NCT02098408|Ultra-high risk psychosis|ultra-high risk psychosis
4897616|NCT02098408|Schizophrenia prodrome|schizophrenia prodrome
4897617|NCT02098408|Cognitive remediation|cognitive remediation
4897618|NCT02098382|Cervical ripening|cervical ripening
4897619|NCT02098369|Chronic obstructive pulmonary disease (COPD)|chronic obstructive pulmonary disease (copd)
4897620|NCT02098369|Supplemental oxygen|supplemental oxygen
4897621|NCT02098369|Adherence|adherence
4897622|NCT02098369|Telephonic education|telephonic education
4897623|NCT02098369|Peer coaching|peer coaching
4897624|NCT02098356|hemodialysis|hemodialysis
4897625|NCT02098356|dialysis|dialysis
4897626|NCT02098356|acidosis|acidosis
4897627|NCT02098356|bicarbonate|bicarbonate
4897628|NCT02098343|Ovarian cancer|ovarian cancer
4897629|NCT02098343|Ovarian carcinoma|ovarian carcinoma
4897630|NCT02098343|High Grade Serous Ovarian Cancer|high grade serous ovarian cancer
4897631|NCT02098343|Recurrent Cancer|recurrent cancer
4897632|NCT02098343|Resistant Cancer|resistant cancer
4897633|NCT02098330|Vestibular neuritis|vestibular neuritis
4897634|NCT02098330|Vertigo|vertigo
4897635|NCT02098330|Head impulse test|head impulse test
4897636|NCT02098330|Steroid|steroid
4897637|NCT02098317|NAFLD|nafld
4897638|NCT02098317|NASH|nash
4897639|NCT02098317|DHA|dha
4897640|NCT02098317|VITAMIN D|vitamin d
4897641|NCT02098317|OBESITY|obesity
4897642|NCT02098317|CHILDREN|children
4897643|NCT02098304|Caries|caries
4897644|NCT02098304|ICDAS|icdas
4897645|NCT02098304|Lesion activity|lesion activity
4897646|NCT02098304|Demineralisation|demineralisation
4897647|NCT02098304|Imaging|imaging
4897648|NCT02098265|aneurysm|aneurysm
4897649|NCT02098265|transient ischemic attack|transient ischemic attack
4897650|NCT02098252|brain arteriovenous malformation|brain arteriovenous malformation
4897651|NCT02098252|Arteriovenous Malformations|arteriovenous malformations
4897652|NCT02098252|AVM|avm
4897653|NCT02098252|BAVM|bavm
4897654|NCT02098252|Stroke|stroke
4897655|NCT02098252|Intracranial Hemorrhage|intracranial hemorrhage
4897656|NCT02098252|Congenital Abnormalities|congenital abnormalities
4897657|NCT02098252|Aneurysm|aneurysm
4897658|NCT02098252|Vascular Malformations|vascular malformations
4897659|NCT02098252|Cardiovascular Abnormalities|cardiovascular abnormalities
4897660|NCT02098252|Cardiovascular Diseases|cardiovascular diseases
4897661|NCT02098252|Vascular Diseases|vascular diseases
4897662|NCT02098213|plaque psoriasis|plaque psoriasis
4897663|NCT02098213|DLQI|dlqi
4897664|NCT02098213|VQ Dermato|vq dermato
4897665|NCT02098213|PASI|pasi
4897666|NCT02098213|PASI change|pasi change
4897667|NCT02098213|phototherapy|phototherapy
4897668|NCT02098213|balneotherapy|balneotherapy
4897669|NCT02098213|hydrotherapy|hydrotherapy
4897670|NCT02098213|Euroquol EQ 5d scale|euroquol eq 5d scale
4897671|NCT02098213|Visual analogic scale|visual analogic scale
4897672|NCT02098213|SPA treatment Scale|spa treatment scale
4897673|NCT02098213|PSS|pss
4897674|NCT02098200|tricuspid|tricuspid
4897675|NCT02098200|regurgitation|regurgitation
4897676|NCT02098200|repair|repair
4897677|NCT02098200|outcomes|outcomes
4897678|NCT02098187|Glomerular Filtration Rate|glomerular filtration rate
4897679|NCT02098187|Acute Kidney Injury|acute kidney injury
4897680|NCT02098174|Glomerular Filtration Rate|glomerular filtration rate
4897681|NCT02098174|Acute kidney injury|acute kidney injury
4897682|NCT02098161|Leukemia|leukemia
4897683|NCT02098161|Primary Myelofibrosis|primary myelofibrosis
4897684|NCT02098161|PMF|pmf
4897685|NCT02098161|Post-Polycythemia Vera Myelofibrosis|post-polycythemia vera myelofibrosis
4897686|NCT02098161|Post-PV MF|post-pv mf
4897687|NCT02098161|Post-Essential Thrombocytosis Myelofibrosis|post-essential thrombocytosis myelofibrosis
4897688|NCT02098161|Post-ET MF|post-et mf
4897689|NCT02098161|LCL-161|lcl-161
4897690|NCT02098161|Questionnaire|questionnaire
4897691|NCT02098161|Survey|survey
4897692|NCT02098161|Phone Call|phone call
4897693|NCT02098096|knee|knee
4897694|NCT02098096|arthritis|arthritis
4897695|NCT02098096|Veterans|veterans
4897696|NCT02098096|strength|strength
4897697|NCT02098096|exercise|exercise
4897698|NCT02098096|muscle|muscle
4897699|NCT02098083|acute|acute
4897700|NCT02098083|stroke|stroke
4897701|NCT02098083|gait|gait
4897702|NCT02098070|Knee Pain|knee pain
4897703|NCT02098070|Community Study|community study
4897704|NCT02098070|Knee Osteoarthritis|knee osteoarthritis
4897705|NCT02098070|Risk Factors|risk factors
4897706|NCT02098057|IBS-diarrhea|ibs-diarrhea
4897707|NCT02098044|knee osteoarthritis|knee osteoarthritis
4897708|NCT02098044|epidemiology|epidemiology
4897709|NCT02098044|risk factors|risk factors
4897710|NCT02098044|prevalence|prevalence
4897711|NCT02098044|professional football|professional football
4897712|NCT02098031|Child Nutrition Sciences|child nutrition sciences
4897713|NCT02098031|Growth and Development|growth and development
4897714|NCT02098031|Developing Countries|developing countries
4897715|NCT02097992|COPD|copd
4897716|NCT02097992|airway blood flow|airway blood flow
4897717|NCT02097979|glaucoma|glaucoma
4897718|NCT02097979|adherence|adherence
4897719|NCT02097979|medication possession ratio|medication possession ratio
4897720|NCT02097979|intervention|intervention
4897721|NCT02097953|Daptomycin|daptomycin
4897722|NCT02097953|Rifampin|rifampin
4897723|NCT02097953|P-glycoprotein|p-glycoprotein
4897724|NCT02097953|Pharmacokinetic|pharmacokinetic
4897725|NCT02097940|Postural balance|postural balance
4897726|NCT02097940|Athletes|athletes
4897727|NCT02097940|Sports|sports
4897728|NCT02097940|Soccer|soccer
4897729|NCT02097940|Physiotherapy|physiotherapy
4897730|NCT02097927|Appetite|appetite
4897731|NCT02097927|Satiety|satiety
4897732|NCT02097927|Energy intake|energy intake
4897733|NCT02097927|Saliva|saliva
4897734|NCT02097927|Biomarkers|biomarkers
4897735|NCT02097914|Secondhand smoke exposure|secondhand smoke exposure
4897736|NCT02097914|Secondhand smoke|secondhand smoke
4897737|NCT02097914|Environmental Tobacco Smoke|environmental tobacco smoke
4897738|NCT02097914|Smoke-free homes|smoke-free homes
4897739|NCT02097914|Smoke-free homes ban|smoke-free homes ban
4897740|NCT02097901|Rotator Cuff|rotator cuff
4897741|NCT02097901|Injury|injury
4897742|NCT02097901|Repair|repair
4897743|NCT02097901|Microfracture|microfracture
4897744|NCT02097901|Healing|healing
4897745|NCT02097875|Skin cancer|skin cancer
4897746|NCT02097875|Basal cell carcinoma|basal cell carcinoma
4897747|NCT02097875|Squamous cell carcinoma|squamous cell carcinoma
4897748|NCT02097875|Melanoma|melanoma
4897749|NCT02097862|Degenerative Disc Disease|degenerative disc disease
4897750|NCT02097862|Disc Disease|disc disease
4897751|NCT02097862|Back pain|back pain
4897752|NCT02097862|stem cells|stem cells
4897753|NCT02097862|adipose stem cells|adipose stem cells
4897754|NCT02097862|ADSCs|adscs
4897755|NCT02097849|vaccine|vaccine
4897756|NCT02097849|pneumococcal|pneumococcal
4897757|NCT02097849|meningococcal|meningococcal
4897758|NCT02097849|tetanus diphtheria|tetanus diphtheria
4897759|NCT02097849|immune response|immune response
4897760|NCT02097836|postural control|postural control
4897761|NCT02097836|Targeted Training|targeted training
4897762|NCT02097836|cerebral palsy|cerebral palsy
4897763|NCT02097836|trunk segments|trunk segments
4897764|NCT02097823|olanzapine|olanzapine
4897765|NCT02097823|Nausea and vomiting|nausea and vomiting
4897766|NCT02097823|aprepitant|aprepitant
4897767|NCT02097823|pediatrics|pediatrics
4897768|NCT02097797|Inflammatory bowel disease|inflammatory bowel disease
4897769|NCT02097797|Crohn's disease|crohn's disease
4897770|NCT02097797|microbiota|microbiota
4897771|NCT02097797|fecal transplantation|fecal transplantation
4897772|NCT02097784|cirrhosis|cirrhosis
4897773|NCT02097784|hepatorenal syndrome|hepatorenal syndrome
4897774|NCT02097784|acute kidney injury|acute kidney injury
4897775|NCT02097784|diastolic function|diastolic function
4897776|NCT02097771|laryngeal mask airway ventilation|laryngeal mask airway ventilation
4897777|NCT02097732|Metastatic melanoma|metastatic melanoma
4897778|NCT02097732|Brain metastases|brain metastases
4897779|NCT02097732|Radiation therapy|radiation therapy
4897780|NCT02097732|Immune therapy|immune therapy
4897781|NCT02097706|Boderline Personality Disorder|boderline personality disorder
4897782|NCT02097706|Mental Illness|mental illness
4897783|NCT02097706|Cognition|cognition
4897784|NCT02097693|DBS|dbs
4897785|NCT02097693|quality of life|quality of life
4897786|NCT02097693|dystonia|dystonia
4897787|NCT02097693|dyskinetic cerebral palsy|dyskinetic cerebral palsy
4897788|NCT02097680|with disturbed glucose metabolism|with disturbed glucose metabolism
4897789|NCT02097680|without disturbed glucose metabolism|without disturbed glucose metabolism
4897790|NCT02097667|Severe early onset Fetal Growth Restrictions|severe early onset fetal growth restrictions
4897791|NCT02097654|Hospital acquired|hospital acquired
4897792|NCT02097654|Elderly|elderly
4897793|NCT02097641|Allogeneic Bone Marrow-derived Human Mesenchymal Stem Cells|allogeneic bone marrow-derived human mesenchymal stem cells
4897794|NCT02097641|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
4897795|NCT02097628|volume controlled ventilation|volume controlled ventilation
4897796|NCT02097628|pressure controlled ventilation|pressure controlled ventilation
4897797|NCT02097615|soft|soft
4897798|NCT02097615|tissue|tissue
4897799|NCT02097615|infections|infections
4897800|NCT02097602|Reticulated platelets|reticulated platelets
4897801|NCT02097602|noncardiac surgery|noncardiac surgery
4897802|NCT02097602|MACCEs|macces
4897803|NCT02097602|major adverse cardiac and cerebrovascular events|major adverse cardiac and cerebrovascular events
4897804|NCT02097602|outcome|outcome
4897805|NCT02097602|High-risk or intermediate-risk noncardiac surgery|high-risk or intermediate-risk noncardiac surgery
4897806|NCT02097589|Health Controls|health controls
4897807|NCT02097576|Chronic Rhinosinusitis|chronic rhinosinusitis
4897808|NCT02097563|Mood Disorders|mood disorders
4897809|NCT02097563|Psychosis|psychosis
4897810|NCT02097563|Subthreshold|subthreshold
4897811|NCT02097563|Bipolar Disorder|bipolar disorder
4897812|NCT02097550|Renal Insufficiency, Chronic|renal insufficiency, chronic
4897813|NCT02097550|Kidney Failure, Chronic|kidney failure, chronic
4897814|NCT02097550|Self Care|self care
4897815|NCT02097550|Consumer Participation|consumer participation
4897816|NCT02097550|Patient Participation|patient participation
4897817|NCT02097550|Marketing|marketing
4897818|NCT02097550|Consumer Health Information|consumer health information
4897819|NCT02097511|Drug-drug interaction|drug-drug interaction
4897820|NCT02097511|Pharmacokinetics|pharmacokinetics
4897821|NCT02097511|Pharmacodynamics|pharmacodynamics
4897822|NCT02097498|Simulation|simulation
4897823|NCT02097498|Enhance|enhance
4897824|NCT02097498|Safety|safety
4897825|NCT02097498|Proficiency|proficiency
4897826|NCT02097498|Paramedics.|paramedics.
4897827|NCT02097498|Airway Management|airway management
4897828|NCT02097498|Intubation|intubation
4897829|NCT02097459|Breast cancer|breast cancer
4897830|NCT02097459|Endocrine therapy|endocrine therapy
4897831|NCT02097459|Perimenopausal and recently postmenopausal patients|perimenopausal and recently postmenopausal patients
4897832|NCT02097459|Early-stage hormone receptor-positive|early-stage hormone receptor-positive
4897833|NCT02097446|cystectomy|cystectomy
4897834|NCT02097433|Dacomitinib|dacomitinib
4897835|NCT02097433|PF299804|pf299804
4897836|NCT02097433|pharmacokinetics|pharmacokinetics
4897837|NCT02097433|healthy|healthy
4897838|NCT02097433|Chinese|chinese
4897839|NCT02097420|Mitral valve|mitral valve
4897840|NCT02097381|HIV infection|hiv infection
4897841|NCT02097381|GUT|gut
4897842|NCT02097381|microbial translocation|microbial translocation
4897843|NCT02097381|chronic inflammation|chronic inflammation
4897844|NCT02097381|antiretroviral therapy|antiretroviral therapy
4897845|NCT02097381|cART|cart
4897846|NCT02097381|HAART|haart
4897847|NCT02097381|Th17|th17
4897848|NCT02097381|Th1|th1
4897849|NCT02097381|CD4+|cd4+
4897850|NCT02097368|Tongue strength|tongue strength
4897851|NCT02097368|neuromuscular|neuromuscular
4897852|NCT02097368|swallowing|swallowing
4897853|NCT02097355|chronic disease|chronic disease
4897854|NCT02097355|patient portal|patient portal
4897855|NCT02097355|health information technology|health information technology
4897856|NCT02097355|patient provider communication|patient provider communication
4897857|NCT02097355|quality improvement|quality improvement
4897858|NCT02097342|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
4897859|NCT02097342|Insulin sensitivity- hyperinsulinemic euglycemic clamp|insulin sensitivity- hyperinsulinemic euglycemic clamp
4897860|NCT02097342|Pancreatic beta cell function|pancreatic beta cell function
4897861|NCT02097342|Linagliptin|linagliptin
4897862|NCT02097342|Voglibose|voglibose
4897863|NCT02097342|Mixed meal test|mixed meal test
4897864|NCT02097342|GLP-1 response|glp-1 response
4897865|NCT02097329|bioavailability|bioavailability
4897866|NCT02097329|antacid|antacid
4897867|NCT02097329|rabeprazole|rabeprazole
4897868|NCT02097329|famotidine|famotidine
4897869|NCT02097329|palbociclib|palbociclib
4897870|NCT02097316|Glycemic control|glycemic control
4897871|NCT02097316|JewelPump accuracy|jewelpump accuracy
4897872|NCT02097303|Prostate Cancer|prostate cancer
4897873|NCT02097303|Bone Metastasis|bone metastasis
4897874|NCT02097303|Symptomatic|symptomatic
4897875|NCT02097303|Androgen Independent|androgen independent
4897876|NCT02097303|Hormone Refractory|hormone refractory
4897877|NCT02097303|Castrate Resistant|castrate resistant
4897878|NCT02097303|AIPC|aipc
4897879|NCT02097303|pre-chemotherapy|pre-chemotherapy
4897880|NCT02097303|Post-chemotherapy|post-chemotherapy
4897881|NCT02097290|Threshold algorithms|threshold algorithms
4897882|NCT02097290|CRT-D|crt-d
4897883|NCT02097251|Mucopolysaccharidosis Type 7|mucopolysaccharidosis type 7
4897884|NCT02097251|Sly syndrome|sly syndrome
4897885|NCT02097251|UX003|ux003
4897886|NCT02097251|Enzyme Replacement Therapy|enzyme replacement therapy
4897887|NCT02097251|rare disease|rare disease
4897888|NCT02097251|Lysosomal Storage Disease|lysosomal storage disease
4897889|NCT02097251|metabolic disorder|metabolic disorder
4897890|NCT02097212|Tracheobronchomalacia|tracheobronchomalacia
4897891|NCT02097212|TBM|tbm
4897892|NCT02097212|HyperDynamic Airway Collapse|hyperdynamic airway collapse
4897893|NCT02097212|HDAC|hdac
4897894|NCT02097212|Obstructive Sleep Apnea|obstructive sleep apnea
4897895|NCT02097212|OSA|osa
4897896|NCT02097199|activity, osteoprotegerin, endocan, atherosclerosis, biomarker|activity, osteoprotegerin, endocan, atherosclerosis, biomarker
4897897|NCT02097186|Vascular disease|vascular disease
4897898|NCT02097186|Open aortic aneurysm repair|open aortic aneurysm repair
4897899|NCT02097186|Endovascular aneurysm repair|endovascular aneurysm repair
4897900|NCT02097186|Carotid endartrectomy|carotid endartrectomy
4897901|NCT02097186|Lower limb surgical revascularisation|lower limb surgical revascularisation
4897902|NCT02097186|Major lower limb amputation|major lower limb amputation
4897903|NCT02097160|childhood|childhood
4897904|NCT02097160|healthy|healthy
4897905|NCT02097160|vitamin D|vitamin d
4897906|NCT02097160|bone|bone
4897907|NCT02097160|dairy products|dairy products
4897908|NCT02097147|Viibryd|viibryd
4897909|NCT02097108|HIV infection|hiv infection
4897910|NCT02097108|Raltegravir|raltegravir
4897911|NCT02097108|Switch|switch
4897912|NCT02097108|Hyperlipidemia|hyperlipidemia
4897913|NCT02097108|Women|women
4897914|NCT02097095|Correlates of risk|correlates of risk
4897915|NCT02097095|TB|tb
4897916|NCT02097095|Tuberculosis|tuberculosis
4897917|NCT02097095|Sub-study|sub-study
4897918|NCT02097095|TB-018|tb-018
4897919|NCT02097082|Peripheral Arterial Disease|peripheral arterial disease
4897920|NCT02097082|Intermittent Claudication|intermittent claudication
4897921|NCT02097082|Vascular Diseases|vascular diseases
4897922|NCT02097082|Cardiovascular Diseases|cardiovascular diseases
4897923|NCT02097082|Superficial Femoral Artery|superficial femoral artery
4897924|NCT02097069|Gestational diabetes mellitus|gestational diabetes mellitus
4897925|NCT02097069|Myo-inositol|myo-inositol
4897926|NCT02097069|D-chiro-inositol|d-chiro-inositol
4897927|NCT02097069|Insulin resistance|insulin resistance
4897928|NCT02097056|Alzheimer's disease|alzheimer's disease
4897929|NCT02097017|lidocaine|lidocaine
4897930|NCT02097017|laminaria|laminaria
4897931|NCT02097017|dilatation and evacuation|dilatation and evacuation
4897932|NCT02097017|pain|pain
4897933|NCT02097004|chronic hepatitis B|chronic hepatitis b
4897934|NCT02097004|Pegasys|pegasys
4897935|NCT02097004|Euvax B|euvax b
4897936|NCT02097004|Baracrude|baracrude
4897937|NCT02096978|Implant|implant
4897938|NCT02096978|Stability|stability
4897939|NCT02096978|placement|placement
4897940|NCT02096978|Osteotome|osteotome
4897941|NCT02096965|Calcium oxalate|calcium oxalate
4897942|NCT02096965|Calcium phosphate|calcium phosphate
4897943|NCT02096965|Kidney stone|kidney stone
4897944|NCT02096952|Attention-deficit/hyperactivity disorder|attention-deficit/hyperactivity disorder
4897945|NCT02096952|ADHD|adhd
4897946|NCT02096952|Autism spectrum disorder|autism spectrum disorder
4897947|NCT02096952|ASD|asd
4897948|NCT02096952|High-functioning ASD|high-functioning asd
4897949|NCT02096952|Asperger's disorder|asperger's disorder
4897950|NCT02096952|Asperger's|asperger's
4897951|NCT02096926|Third Molar Extraction|third molar extraction
4897952|NCT02096913|Rho-Inhibition|rho-inhibition
4897953|NCT02096913|Plasticity|plasticity
4897954|NCT02096913|Neurological Function|neurological function
4897955|NCT02096913|RhoA|rhoa
4897956|NCT02096913|Ibuprofen|ibuprofen
4897957|NCT02096913|NSAIDs|nsaids
4897958|NCT02096900|Pre-medication|pre-medication
4897959|NCT02096900|Pre-operative anxiety|pre-operative anxiety
4897960|NCT02096887|education|education
4897961|NCT02096887|compliance|compliance
4897962|NCT02096887|risk factors|risk factors
4897963|NCT02096874|Peripheral retinal ischemia|peripheral retinal ischemia
4897964|NCT02096874|ultra wide field fluorescein angiography|ultra wide field fluorescein angiography
4897965|NCT02096874|Bevacizumab|bevacizumab
4897966|NCT02096848|otitis media|otitis media
4897967|NCT02096848|microbiology|microbiology
4897968|NCT02096848|vaccines|vaccines
4897969|NCT02096835|Postoperative nausea and vomiting|postoperative nausea and vomiting
4897970|NCT02096835|Transcutaneous electrical acupoint stimulation|transcutaneous electrical acupoint stimulation
4897971|NCT02096835|Gynecological laparoscopic surgery|gynecological laparoscopic surgery
4897972|NCT02096835|Tropisetron|tropisetron
4897973|NCT02096835|Dexamethasone|dexamethasone
4897974|NCT02096822|Facilitated tucking|facilitated tucking
4897975|NCT02096822|Non nutritive sucking|non nutritive sucking
4897976|NCT02096822|Preterm|preterm
4897977|NCT02096822|Pain relief|pain relief
4897978|NCT02096809|Bone Conduction|bone conduction
4897979|NCT02096809|Hearing loss - conductive|hearing loss - conductive
4897980|NCT02096809|Osseointegration|osseointegration
4897981|NCT02096809|Prostheses and Implants|prostheses and implants
4897982|NCT02096757|Claudication|claudication
4897983|NCT02096757|Critical Limb Ischemia|critical limb ischemia
4897984|NCT02096757|Endovascular procedure|endovascular procedure
4897985|NCT02096757|Atherosclerosis|atherosclerosis
4897986|NCT02096679|Phase I, healthy, pharmacokinetics, Mass balance|phase i, healthy, pharmacokinetics, mass balance
4897987|NCT02096666|MET Amplified Gastric/ Gastroesophageal Junction/ Esophageal Adenocarcinomas, or other solid tumors|met amplified gastric/ gastroesophageal junction/ esophageal adenocarcinomas, or other solid tumors
4897988|NCT02096653|sacroiliac joint|sacroiliac joint
4897989|NCT02096653|low back pain|low back pain
4897990|NCT02096653|steroid injection|steroid injection
4897991|NCT02096627|Cataract, femtosecond laser, FLACS|cataract, femtosecond laser, flacs
4897992|NCT02096614|Adoptive cell transfer|adoptive cell transfer
4897993|NCT02096614|Cell therapy|cell therapy
4897994|NCT02096614|Immunotherapy|immunotherapy
4897995|NCT02096614|MAGE-A4|mage-a4
4897996|NCT02096614|Esophageal cancer|esophageal cancer
4897997|NCT02096614|Melanoma|melanoma
4897998|NCT02096614|Head and neck cancer|head and neck cancer
4897999|NCT02096614|Ovarian cancer|ovarian cancer
4898000|NCT02096614|TCR gene therapy|tcr gene therapy
4898001|NCT02096601|Motor fluctuations|motor fluctuations
4898002|NCT02096601|levodopa pharmacokinetics|levodopa pharmacokinetics
4898003|NCT02096601|levodopa and carbidopa solution|levodopa and carbidopa solution
4898004|NCT02096601|continuous subcutaneous delivery|continuous subcutaneous delivery
4898005|NCT02096588|Breast cancer|breast cancer
4898006|NCT02096588|Adriamycin|adriamycin
4898007|NCT02096588|Simvastatin|simvastatin
4898008|NCT02096588|Statin|statin
4898009|NCT02096588|Echocardiogram|echocardiogram
4898010|NCT02096575|nitrous oxide|nitrous oxide
4898011|NCT02096575|pain|pain
4898012|NCT02096562|knee welling outpatient compression stockings|knee welling outpatient compression stockings
4898013|NCT02096549|cerebral palsy|cerebral palsy
4898014|NCT02096549|Botulinum toxin|botulinum toxin
4898015|NCT02096549|Propofol|propofol
4898016|NCT02096549|Deep sedation|deep sedation
4898017|NCT02096549|Bispectral index monitor|bispectral index monitor
4898018|NCT02096536|Neonate|neonate
4898019|NCT02096536|Vancomycin|vancomycin
4898020|NCT02096536|LC/MS-MS|lc/ms-ms
4898021|NCT02096536|protein binding|protein binding
4898022|NCT02096523|inherited platelet disorders|inherited platelet disorders
4898023|NCT02096523|proteome|proteome
4898024|NCT02096510|Addison Disease|addison disease
4898025|NCT02096510|Adrenal Hyperplasia Congenital|adrenal hyperplasia congenital
4898026|NCT02096484|Metacognitive therapy|metacognitive therapy
4898027|NCT02096484|mindfulness meditation therapy|mindfulness meditation therapy
4898028|NCT02096484|group therapy|group therapy
4898029|NCT02096484|generalized anxiety disorder|generalized anxiety disorder
4898030|NCT02096484|Group Based Metacognitive Therapy|group based metacognitive therapy
4898031|NCT02096484|Group Based Mindfulness Meditation Therapy|group based mindfulness meditation therapy
4898032|NCT02096471|Neurofibromatosis Type 1 (Neurofibromas)|neurofibromatosis type 1 (neurofibromas)
4898033|NCT02096471|PD-0325901|pd-0325901
4898034|NCT02096471|Radiographic Response|radiographic response
4898035|NCT02096471|Inoperable Plexiform Neurofibromas|inoperable plexiform neurofibromas
4898036|NCT02096458|Drug therapy|drug therapy
4898037|NCT02096445|stroke|stroke
4898038|NCT02096445|acute|acute
4898039|NCT02096445|rehabilitation|rehabilitation
4898040|NCT02096445|robot therapy|robot therapy
4898041|NCT02096445|hand function|hand function
4898042|NCT02096445|fine motor skills|fine motor skills
4898043|NCT02096445|neurocognitive|neurocognitive
4898044|NCT02096445|sensory|sensory
4898045|NCT02096445|Perfetti|perfetti
4898046|NCT02096445|haptics|haptics
4898047|NCT02096419|clopidogrel|clopidogrel
4898048|NCT02096419|platelet reactivity|platelet reactivity
4898049|NCT02096419|acute coronary syndrome|acute coronary syndrome
4898050|NCT02096419|tailoring therapy|tailoring therapy
4898051|NCT02096419|outcome|outcome
4898052|NCT02096406|Coronary artery disease|coronary artery disease
4898053|NCT02096406|Coronary artery bypass grafting|coronary artery bypass grafting
4898156|NCT02096042|5-aza|5-aza
4898054|NCT02096406|angiotensin converting enzyme inhibitor|angiotensin converting enzyme inhibitor
4898055|NCT02096406|angiotensin receptor blocker|angiotensin receptor blocker
4898056|NCT02096406|Surgical valve repair|surgical valve repair
4898057|NCT02096406|Valve Replacement|valve replacement
4898058|NCT02096380|Nasopharyngeal Carcinoma|nasopharyngeal carcinoma
4898059|NCT02096380|cycle|cycle
4898060|NCT02096380|induction chemotherapy|induction chemotherapy
4898061|NCT02096380|docetaxel|docetaxel
4898062|NCT02096367|vibrations|vibrations
4898063|NCT02096367|stroke|stroke
4898064|NCT02096367|posture|posture
4898065|NCT02096367|gait|gait
4898066|NCT02096367|readaptation|readaptation
4898067|NCT02096328|Ventilator Associated Pneumonia (VAP)|ventilator associated pneumonia (vap)
4898068|NCT02096328|Lower respiratory infection|lower respiratory infection
4898069|NCT02096328|POL7080|pol7080
4898070|NCT02096328|Pseudomonas aeruginosa|pseudomonas aeruginosa
4898071|NCT02096328|Nosocomial pneumonia|nosocomial pneumonia
4898072|NCT02096315|POL7080|pol7080
4898073|NCT02096315|Pseudomonas aeruginosa|pseudomonas aeruginosa
4898074|NCT02096315|Non cystic fibrosis bronchiectasis|non cystic fibrosis bronchiectasis
4898075|NCT02096315|Exacerbation|exacerbation
4898076|NCT02096302|Probiotics|probiotics
4898077|NCT02096302|Infant Formula|infant formula
4898078|NCT02096302|Microbiota|microbiota
4898079|NCT02096302|Bifidobacterium longum biovar infantis CECT7210|bifidobacterium longum biovar infantis cect7210
4898080|NCT02096302|Growth|growth
4898081|NCT02096289|Relapsed Acute Myeloid Leukemia|relapsed acute myeloid leukemia
4898082|NCT02096289|Refractory Acute Myeloid Leukemia|refractory acute myeloid leukemia
4898083|NCT02096289|Thioridazine|thioridazine
4898084|NCT02096289|Phase I|phase i
4898085|NCT02096289|Clinical Trial|clinical trial
4898086|NCT02096276|Pregnancy Registry|pregnancy registry
4898087|NCT02096276|Boostrix|boostrix
4898088|NCT02096276|Women|women
4898089|NCT02096276|Cohort|cohort
4898090|NCT02096276|Prospective|prospective
4898091|NCT02096276|Pregnancy outcome|pregnancy outcome
4898092|NCT02096276|Exploratory|exploratory
4898093|NCT02096263|Infants|infants
4898094|NCT02096263|Safety|safety
4898095|NCT02096263|Healthy|healthy
4898096|NCT02096263|Infanrix Hexa|infanrix hexa
4898097|NCT02096263|Immunogenicity|immunogenicity
4898098|NCT02096237|asthma, bronchial|asthma, bronchial
4898099|NCT02096237|immunoadsorbents|immunoadsorbents
4898100|NCT02096237|apheresis|apheresis
4898101|NCT02096237|immunoglobulin E|immunoglobulin e
4898102|NCT02096211|Total hip replacement|total hip replacement
4898103|NCT02096211|Total hip arthroplasty|total hip arthroplasty
4898104|NCT02096211|Hip joint replacement|hip joint replacement
4898105|NCT02096211|Hip prosthesis replacement|hip prosthesis replacement
4898106|NCT02096198|Total Hip Replacement|total hip replacement
4898107|NCT02096198|Total Hip Arthroplasty|total hip arthroplasty
4898108|NCT02096198|Hip Joint Replacement|hip joint replacement
4898109|NCT02096198|Hip Prosthesis Replacement|hip prosthesis replacement
4898110|NCT02096185|Breast cancer|breast cancer
4898111|NCT02096185|Surgery|surgery
4898112|NCT02096185|Specimen imaging|specimen imaging
4898113|NCT02096159|Hypospadias|hypospadias
4898114|NCT02096159|Anti-Bacterial Agents|anti-bacterial agents
4898115|NCT02096146|Plate|plate
4898116|NCT02096146|Hallux valgus|hallux valgus
4898117|NCT02096146|Foot deformity|foot deformity
4898118|NCT02096146|Screw|screw
4898119|NCT02096146|Tarsometatarsal angle|tarsometatarsal angle
4898120|NCT02096146|Cost effectiveness|cost effectiveness
4898249|NCT02095561|HPV self testing|hpv self testing
4898121|NCT02096133|Multiple sclerosis, vitamin D, HPA-axis, cortisol|multiple sclerosis, vitamin d, hpa-axis, cortisol
4898122|NCT02096120|Periodontitis|periodontitis
4898123|NCT02096107|Everolimus|everolimus
4898124|NCT02096107|Graft dysfunction|graft dysfunction
4898125|NCT02096107|Interstitial fibrosis|interstitial fibrosis
4898126|NCT02096094|Antiseptics|antiseptics
4898127|NCT02096094|Administration cutaneously|administration cutaneously
4898128|NCT02096094|Chlorine compounds|chlorine compounds
4898129|NCT02096094|Infection control|infection control
4898130|NCT02096094|Anti-infecting agents, local|anti-infecting agents, local
4898131|NCT02096081|Glabellar Frown Lines|glabellar frown lines
4898132|NCT02096081|Frown Lines|frown lines
4898133|NCT02096081|Facial Wrinkles|facial wrinkles
4898134|NCT02096068|Neuroprotection|neuroprotection
4898135|NCT02096055|Leukemia|leukemia
4898136|NCT02096055|Acute Myeloid Leukemia|acute myeloid leukemia
4898138|NCT02096055|Elderly|elderly
4898139|NCT02096055|SGI-110|sgi-110
4898140|NCT02096055|Idarubicin|idarubicin
4898141|NCT02096055|Idamycin|idamycin
4898142|NCT02096055|Leustatin|leustatin
4898143|NCT02096055|2-CdA|2-cda
4898144|NCT02096042|Leukemia|leukemia
4898145|NCT02096042|Acute Myeloid Leukemia|acute myeloid leukemia
4898146|NCT02096042|AML|aml
4898147|NCT02096042|CD30-Positive|cd30-positive
4898148|NCT02096042|Relapsed|relapsed
4898149|NCT02096042|Refractory|refractory
4898150|NCT02096042|Brentuximab Vedotin|brentuximab vedotin
4898151|NCT02096042|SGN-35|sgn-35
4898152|NCT02096042|Adcetris|adcetris
4898153|NCT02096042|5-Azacytidine|5-azacytidine
4898154|NCT02096042|Azacytidine|azacytidine
4898155|NCT02096042|Azacitidine|azacitidine
4898157|NCT02096042|Vidaza|vidaza
4898158|NCT02096042|5-AZC|5-azc
4898159|NCT02096042|AZA-CR|aza-cr
4898160|NCT02096042|Ladakamycin|ladakamycin
4898161|NCT02096042|NSC-102816|nsc-102816
4898162|NCT02096029|smoking|smoking
4898163|NCT02096029|smoking cessation|smoking cessation
4898164|NCT02096029|nicotine replacement therapy|nicotine replacement therapy
4898165|NCT02096029|primary care|primary care
4898166|NCT02096029|comparative effectiveness|comparative effectiveness
4898167|NCT02096016|Surveillance|surveillance
4898168|NCT02096016|Follow up|follow up
4898169|NCT02096003|Intrathecal hydromorphone|intrathecal hydromorphone
4898170|NCT02096003|Intrathecal morphine|intrathecal morphine
4898171|NCT02096003|Primary cesarean section|primary cesarean section
4898172|NCT02096003|Analgesia|analgesia
4898173|NCT02095990|Facial Melasma|facial melasma
4898174|NCT02095977|St. Jude Riata lead failure|st. jude riata lead failure
4898175|NCT02095977|implantable cardioverter-defibrillator (ICD)|implantable cardioverter-defibrillator (icd)
4898176|NCT02095977|externalized conductors|externalized conductors
4898177|NCT02095977|ventricular tachyarrythmia|ventricular tachyarrythmia
4898178|NCT02095977|electrophysiology|electrophysiology
4898179|NCT02095964|cardiac syndrome X|cardiac syndrome x
4898180|NCT02095964|inflammation|inflammation
4898181|NCT02095964|dyslipidemia|dyslipidemia
4898182|NCT02095938|schizophrenia|schizophrenia
4898183|NCT02095938|brain structure|brain structure
4898184|NCT02095938|treatment response|treatment response
4898185|NCT02095938|solian|solian
4898186|NCT02095938|gene|gene
4898187|NCT02095938|mri|mri
4898188|NCT02095912|Squamous Cell Carcinoma|squamous cell carcinoma
4898189|NCT02095899|Thoracic Surgical Procedures|thoracic surgical procedures
4898190|NCT02095873|Oral glucose tolerance test|oral glucose tolerance test
4898191|NCT02095873|Flow mediated dilatation|flow mediated dilatation
4898192|NCT02095873|Aortal pulse wave velocity|aortal pulse wave velocity
4898193|NCT02095873|Finger-fold capillary density by capillaroscopy|finger-fold capillary density by capillaroscopy
4898194|NCT02095847|Uterine Cancer|uterine cancer
4898195|NCT02095847|Endometrial cancer|endometrial cancer
4898196|NCT02095847|Hysterectomy|hysterectomy
4898197|NCT02095847|Hysteroscopy|hysteroscopy
4898198|NCT02095847|High-resolution microendoscopy|high-resolution microendoscopy
4898199|NCT02095847|HRME|hrme
4898200|NCT02095847|Hysteroscopic-guided resection|hysteroscopic-guided resection
4898201|NCT02095847|Proflavine|proflavine
4898202|NCT02095834|Myeloma|myeloma
4898203|NCT02095834|Multiple Myeloma|multiple myeloma
4898204|NCT02095834|Relapsed|relapsed
4898205|NCT02095834|Refractory|refractory
4898206|NCT02095834|Carfilzomib|carfilzomib
4898207|NCT02095834|Bendamustine|bendamustine
4898208|NCT02095834|Bendamustine Hydrochloride|bendamustine hydrochloride
4898209|NCT02095834|Bendamustine HCL|bendamustine hcl
4898210|NCT02095834|CEP-18083|cep-18083
4898211|NCT02095834|SDX-105|sdx-105
4898212|NCT02095834|Treanda|treanda
4898213|NCT02095834|Dexamethasone|dexamethasone
4898214|NCT02095834|Decadron|decadron
4898215|NCT02095795|Exercise Therapy|exercise therapy
4898216|NCT02095782|non-small cell lung cancer|non-small cell lung cancer
4898217|NCT02095782|erlotinib|erlotinib
4898218|NCT02095782|chemotherapy|chemotherapy
4898219|NCT02095769|Pharmacogenomics|pharmacogenomics
4898220|NCT02095769|Adverse Drug Reactions|adverse drug reactions
4898221|NCT02095743|Early breast cancer|early breast cancer
4898222|NCT02095743|Chemotherapy|chemotherapy
4898223|NCT02095743|PICC line|picc line
4898224|NCT02095743|Implanted port|implanted port
4898225|NCT02095730|crosslinking|crosslinking
4898226|NCT02095730|cornea|cornea
4898227|NCT02095730|keratoconus|keratoconus
4898228|NCT02095730|ectasia|ectasia
4898229|NCT02095730|irradiance|irradiance
4898230|NCT02095730|riboflavin|riboflavin
4898231|NCT02095691|Renal Sympathetic Denervation|renal sympathetic denervation
4898232|NCT02095678|Hepatocellular Carcinoma|hepatocellular carcinoma
4898233|NCT02095678|Hepatoma|hepatoma
4898234|NCT02095678|Liver Cancer, Adult|liver cancer, adult
4898235|NCT02095678|Liver Cell Carcinoma|liver cell carcinoma
4898236|NCT02095678|Liver Cell Carcinoma, Adult|liver cell carcinoma, adult
4898237|NCT02095678|HCC|hcc
4898238|NCT02095665|ureteric stents|ureteric stents
4898239|NCT02095665|LUTS|luts
4898240|NCT02095665|lower urinary tract symptoms|lower urinary tract symptoms
4898241|NCT02095587|Phase 1|phase 1
4898242|NCT02095587|hepatic impairment|hepatic impairment
4898243|NCT02095574|GDC-0199|gdc-0199
4898244|NCT02095574|ADME|adme
4898245|NCT02095574|Relapsed|relapsed
4898246|NCT02095574|Refractory|refractory
4898247|NCT02095574|ABT-199|abt-199
4898248|NCT02095574|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
4898250|NCT02095561|screening uptake|screening uptake
4898251|NCT02095561|cervical cáncer|cervical cáncer
4898252|NCT02095561|cervical intraepithelial neoplasia|cervical intraepithelial neoplasia
4898253|NCT02095535|obstetric patients|obstetric patients
4898254|NCT02095535|chloraprep|chloraprep
4898255|NCT02095535|chlorhexidine|chlorhexidine
4898256|NCT02095535|drying time|drying time
4898257|NCT02095522|colchicine NSTEMI endothelial function inflammation|colchicine nstemi endothelial function inflammation
4898258|NCT02095496|sleep|sleep
4898259|NCT02095496|intensive care|intensive care
4898260|NCT02095496|mechanical ventilation|mechanical ventilation
4898261|NCT02095470|Laryngoscopy|laryngoscopy
4898262|NCT02095470|Equipment|equipment
4898263|NCT02095470|Video Laryngoscope|video laryngoscope
4898264|NCT02095457|Routine Outcome Monitoring|routine outcome monitoring
4898265|NCT02095457|Psychotherapy|psychotherapy
4898266|NCT02095457|Alliance|alliance
4898267|NCT02095457|Feedback Informed Treatment|feedback informed treatment
4898268|NCT02095457|Mental Health Outpatients|mental health outpatients
4898269|NCT02095431|patients undergoing the liver transplantation|patients undergoing the liver transplantation
4898270|NCT02095431|acute kidney injury|acute kidney injury
4898271|NCT02095418|New-onset diabetes after transplantation (NODAT)|new-onset diabetes after transplantation (nodat)
4898272|NCT02095418|Liver transplantation|liver transplantation
4898273|NCT02095405|Supraventricular Tachycardia|supraventricular tachycardia
4898274|NCT02095405|Atrial Fibrillation|atrial fibrillation
4898275|NCT02095405|Electrophysiology Study|electrophysiology study
4898276|NCT02095405|Programmed Electrical Stimulation|programmed electrical stimulation
4898277|NCT02095392|soluble phosphate|soluble phosphate
4898278|NCT02095392|phosphorus metabolism|phosphorus metabolism
4898279|NCT02095392|calcium metabolism|calcium metabolism
4898280|NCT02095392|bone metabolism|bone metabolism
4898281|NCT02095392|human study|human study
4898282|NCT02095379|oligosecretary multiple myeloma|oligosecretary multiple myeloma
4898283|NCT02095366|Acute Pain|acute pain
4898284|NCT02095366|Traumatic Pain|traumatic pain
4898285|NCT02095366|Emergency setting|emergency setting
4898286|NCT02095366|Prehospital setting|prehospital setting
4898287|NCT02095366|Analgesia|analgesia
4898288|NCT02095366|Intranasal device|intranasal device
4898289|NCT02095366|Intra veinous injection|intra veinous injection
4898290|NCT02095366|Sufentanil citrate|sufentanil citrate
4898291|NCT02095366|Morphine Sulfate|morphine sulfate
4898292|NCT02095353|Brain tumor|brain tumor
4898293|NCT02095353|extraaxial|extraaxial
4898294|NCT02095353|metastasis|metastasis
4898295|NCT02095353|glioma|glioma
4898296|NCT02095353|primary brain tumor|primary brain tumor
4898297|NCT02095353|secondary brain tumor|secondary brain tumor
4898298|NCT02095353|MRI|mri
4898299|NCT02095353|perfusion|perfusion
4898300|NCT02095353|dynamic contrast enhancement|dynamic contrast enhancement
4898301|NCT02095353|CBV|cbv
4898302|NCT02095353|CBF|cbf
4898303|NCT02095353|ktrans|ktrans
4898304|NCT02095314|DTP-HB-Hib|dtp-hb-hib
4898305|NCT02095314|Pentavalen|pentavalen
4898306|NCT02095314|Pentabio|pentabio
4898307|NCT02095314|Booster|booster
4898308|NCT02095288|lipidomics|lipidomics
4898309|NCT02095288|in vitro human whole blood assay|in vitro human whole blood assay
4898310|NCT02095288|anti-inflammatory drugs|anti-inflammatory drugs
4898311|NCT02095288|Lipidomics screening of anti-inflammatory drugs|lipidomics screening of anti-inflammatory drugs
4898312|NCT02095275|BNP, acute kidney injury, fluid status|bnp, acute kidney injury, fluid status
4898313|NCT02095249|prostate cancer|prostate cancer
4898314|NCT02095249|radical prostatectomy|radical prostatectomy
4898315|NCT02095223|Knee injury|knee injury
4898316|NCT02095223|Meniscus injury|meniscus injury
4898317|NCT02095223|Anterior cruciate ligament injury|anterior cruciate ligament injury
4898318|NCT02095223|Knee ligament injury|knee ligament injury
4898319|NCT02095210|PET scan|pet scan
4898320|NCT02095210|HER2|her2
4898321|NCT02095210|breast cancer|breast cancer
4898322|NCT02095184|Breast Cancer|breast cancer
4898323|NCT02095184|Postmenopausal|postmenopausal
4898324|NCT02095184|Hormone-Receptor Positive|hormone-receptor positive
4898325|NCT02095119|Uterine cervical cancer|uterine cervical cancer
4898326|NCT02095119|Palliative|palliative
4898327|NCT02095119|Treatment|treatment
4898328|NCT02095119|Monoclonal antibody|monoclonal antibody
4898329|NCT02095119|Nimotuzumab|nimotuzumab
4898330|NCT02095106|forearm fractures|forearm fractures
4898331|NCT02095106|pediatric fractures|pediatric fractures
4898332|NCT02095106|distal radius|distal radius
4898333|NCT02095093|Total Hip Arthroplasty|total hip arthroplasty
4898334|NCT02095093|Navigation|navigation
4898335|NCT02095093|Imageless|imageless
4898336|NCT02095093|THA|tha
4898337|NCT02095093|Computer navigated|computer navigated
4898338|NCT02095080|Leucine|leucine
4898339|NCT02095080|Upper Intake Level (UL)|upper intake level (ul)
4898340|NCT02095080|Elderly|elderly
4898341|NCT02095080|Amino acids|amino acids
4898342|NCT02095080|Protein|protein
4898343|NCT02095067|Telemedicine|telemedicine
4898344|NCT02095067|Emergency medical dispatch|emergency medical dispatch
4898345|NCT02095067|Prehospital care|prehospital care
4898346|NCT02095067|Video conference|video conference
4898347|NCT02095054|Advanced Cancers|advanced cancers
4898348|NCT02095054|Advanced malignancy|advanced malignancy
4898349|NCT02095054|Metastatic cancer|metastatic cancer
4898350|NCT02095054|Advanced solid tumor|advanced solid tumor
4898351|NCT02095054|Regorafenib|regorafenib
4898352|NCT02095054|Stivarga|stivarga
4898353|NCT02095054|Cetuximab|cetuximab
4898354|NCT02095054|C225|c225
4898355|NCT02095054|Erbitux|erbitux
4898356|NCT02095054|IMC-C225|imc-c225
4898357|NCT02095054|MOAB C225|moab c225
4898358|NCT02095054|Questionnaire|questionnaire
4898359|NCT02095054|Survey|survey
4898360|NCT02095041|Oxygen saturation.|oxygen saturation.
4898361|NCT02095041|Term infants.|term infants.
4898362|NCT02095041|Saturation trend.|saturation trend.
4898363|NCT02095041|Histogram.|histogram.
4898364|NCT02095041|Public health nurse.|public health nurse.
4898365|NCT02095041|congenital heart disease screening.|congenital heart disease screening.
4898366|NCT02095015|MPS II|mps ii
4898367|NCT02095015|iduronate-2-sulfatase|iduronate-2-sulfatase
4898368|NCT02095015|Mucopolysaccharidosis VI|mucopolysaccharidosis vi
4898369|NCT02095015|MPS|mps
4898370|NCT02095015|MPS VI|mps vi
4898371|NCT02095015|ear, nose and throat|ear, nose and throat
4898372|NCT02095015|Mucopolysaccharidosis II|mucopolysaccharidosis ii
4898373|NCT02095015|Hunter syndrome|hunter syndrome
4898374|NCT02095015|ENT|ent
4898375|NCT02095015|Mucopolysaccharidosis I|mucopolysaccharidosis i
4898376|NCT02095015|Hurler, Hurler-Scheie, or Scheie syndrome|hurler, hurler-scheie, or scheie syndrome
4898377|NCT02095015|Mucopolysaccharidosis|mucopolysaccharidosis
4898379|NCT02095015|Maroteaux-Lamy syndrome|maroteaux-lamy syndrome
4898380|NCT02095002|modified valsalva maneuver, internal jugular vein|modified valsalva maneuver, internal jugular vein
4898381|NCT02094989|electrocardiogram|electrocardiogram
4898382|NCT02094989|vectorcardiogram|vectorcardiogram
4898383|NCT02094989|telecardiology|telecardiology
4898384|NCT02094989|linear regression|linear regression
4898385|NCT02094989|individual transformation matrix|individual transformation matrix
4898386|NCT02094989|posture|posture
4898387|NCT02094976|Prone position|prone position
4898388|NCT02094976|Intra-abdominal pressure|intra-abdominal pressure
4898389|NCT02094976|Respiratory system compliance|respiratory system compliance
4898390|NCT02094976|Jackson table|jackson table
4898391|NCT02094976|Wilson frame|wilson frame
4898392|NCT02094976|Chest roll|chest roll
4898393|NCT02094963|acute coronary syndrome|acute coronary syndrome
4898394|NCT02094963|coronary disease|coronary disease
4898395|NCT02094963|coronary artery disease|coronary artery disease
4898396|NCT02094950|concurrent chemotherapy|concurrent chemotherapy
4898397|NCT02094950|concurrent radiation|concurrent radiation
4898398|NCT02094937|fluticasone propionate|fluticasone propionate
4898399|NCT02094937|step-down regimen|step-down regimen
4898400|NCT02094937|well-controlled subjects|well-controlled subjects
4898401|NCT02094937|adults|adults
4898402|NCT02094937|switching regimen|switching regimen
4898403|NCT02094937|asthma|asthma
4898404|NCT02094937|fluticasone furoate|fluticasone furoate
4898405|NCT02094937|fluticasone furoate/Vilanterol|fluticasone furoate/vilanterol
4898406|NCT02094924|Candesartan cilexetil|candesartan cilexetil
4898407|NCT02094924|Hypertension|hypertension
4898408|NCT02094924|Hydrochlorothiazide|hydrochlorothiazide
4898409|NCT02094924|Healthy adult human subjects|healthy adult human subjects
4898410|NCT02094924|Bioequivalence|bioequivalence
4898411|NCT02094911|Prevention|prevention
4898412|NCT02094911|Combined lifestyle intervention|combined lifestyle intervention
4898413|NCT02094911|Primary health care|primary health care
4898414|NCT02094898|Depression|depression
4898415|NCT02094898|Unipolar|unipolar
4898416|NCT02094898|Bipolar|bipolar
4898417|NCT02094898|Suicidal|suicidal
4898418|NCT02094859|Glucose Monitoring|glucose monitoring
4898419|NCT02094846|Cellular phones|cellular phones
4898420|NCT02094846|Type 2 diabetes|type 2 diabetes
4898421|NCT02094846|Glycated hemoglobin|glycated hemoglobin
4898422|NCT02094846|glycemic control|glycemic control
4898423|NCT02094833|Diphtheria|diphtheria
4898424|NCT02094833|Tetanus|tetanus
4898425|NCT02094833|Pertussis|pertussis
4898426|NCT02094833|Haemophilus influenzae type b infection|haemophilus influenzae type b infection
4898427|NCT02094833|Hepatitis B|hepatitis b
4898428|NCT02094833|DTaP-IPV-Hep - PRP-T vaccine|dtap-ipv-hep - prp-t vaccine
4898429|NCT02094807|prospective study|prospective study
4898430|NCT02094807|surgical management|surgical management
4898431|NCT02094807|rib fractures|rib fractures
4898432|NCT02094807|trauma|trauma
4898433|NCT02094755|critical limb ischemia, High on-treatment platelet reactivity, HPR, aspirin, clopidogrel|critical limb ischemia, high on-treatment platelet reactivity, hpr, aspirin, clopidogrel
4898434|NCT02094742|screening program|screening program
4898435|NCT02094742|metastatic breast cancer|metastatic breast cancer
4898436|NCT02094742|molecular profile|molecular profile
4898437|NCT02094742|gene sequencing|gene sequencing
4898438|NCT02094729|mild cognitive impairment|mild cognitive impairment
4898439|NCT02094729|Alzheimer's disease|alzheimer's disease
4898440|NCT02094716|Sarcoptes|sarcoptes
4898441|NCT02094716|Scabiei|scabiei
4898442|NCT02094716|Scabies|scabies
4898443|NCT02094716|ectoparasite|ectoparasite
4898444|NCT02094716|parasite|parasite
4898445|NCT02094716|infestation|infestation
4898446|NCT02094716|Renaissance|renaissance
4898447|NCT02094703|female|female
4898448|NCT02094703|age 18-65 years|age 18-65 years
4898449|NCT02094703|storage symptoms|storage symptoms
4898450|NCT02094703|clinical urinary tract infection|clinical urinary tract infection
4898451|NCT02094703|non complicated|non complicated
4898452|NCT02094690|head and neck neoplasms|head and neck neoplasms
4898453|NCT02094690|radiotherapy|radiotherapy
4898454|NCT02094690|physical therapy|physical therapy
4898455|NCT02094690|trismus|trismus
4898456|NCT02094664|Heat|heat
4898457|NCT02094664|Humidification|humidification
4898458|NCT02094664|Oxygen|oxygen
4898459|NCT02094651|Abnormal EEGs|abnormal eegs
4898460|NCT02094638|Traditional Chinese Medicine Injection|traditional chinese medicine injection
4898461|NCT02094625|Cisplatin|cisplatin
4898462|NCT02094625|N-acetylcysteine|n-acetylcysteine
4898463|NCT02094625|Hearing Loss|hearing loss
4898464|NCT02094625|Otoprotection|otoprotection
4898465|NCT02094612|Attention Deficit and Disruptive Behavior Disorders|attention deficit and disruptive behavior disorders
4898466|NCT02094612|Attention Deficit Disorder with Hyperactivity|attention deficit disorder with hyperactivity
4898467|NCT02094612|Pediatrics|pediatrics
4898468|NCT02094612|Patient Outcome Assessment|patient outcome assessment
4898469|NCT02094573|Drug Therapy|drug therapy
4898470|NCT02094560|therapy refractory|therapy refractory
4898471|NCT02094560|endstage|endstage
4898472|NCT02094560|solid tumours|solid tumours
4898473|NCT02094547|Infant Formula|infant formula
4898474|NCT02094547|Cognition|cognition
4898475|NCT02094547|Neurodevelopment|neurodevelopment
4898476|NCT02094547|Immunity|immunity
4898477|NCT02094547|Microbiota|microbiota
4898478|NCT02094534|Diabetes type 1|diabetes type 1
4898479|NCT02094534|Oral Insulin|oral insulin
4898480|NCT02094534|Safety|safety
4898481|NCT02094534|Tolerability|tolerability
4898482|NCT02094534|Phase 2a|phase 2a
4898483|NCT02094534|Randomized|randomized
4898484|NCT02094534|Blinded|blinded
4898485|NCT02094534|Parallel|parallel
4898486|NCT02094508|Parasitemia|parasitemia
4898487|NCT02094508|HIV-Exposed|hiv-exposed
4898488|NCT02094508|HIV-Unexposed|hiv-unexposed
4898489|NCT02094508|Liver Stage|liver stage
4898490|NCT02094508|Randomized|randomized
4898491|NCT02094495|Tamoxifen|tamoxifen
4898492|NCT02094495|Breast cancer|breast cancer
4898493|NCT02094495|Knowkedge|knowkedge
4898494|NCT02094469|Treatment for vasospastic angina|treatment for vasospastic angina
4898495|NCT02094456|diverticular disease|diverticular disease
4898496|NCT02094456|diverticular bleeding|diverticular bleeding
4898497|NCT02094456|endoscopic clipping|endoscopic clipping
4898498|NCT02094456|endoscopy|endoscopy
4898499|NCT02094456|lower gastrointestinal bleeding|lower gastrointestinal bleeding
4898500|NCT02094443|Chronic hepatitis C genotype 2|chronic hepatitis c genotype 2
4898501|NCT02094443|Chronic hepatitis C genotype 3|chronic hepatitis c genotype 3
4898502|NCT02094443|Cyclophilin inhibitor|cyclophilin inhibitor
4898503|NCT02094443|Interferon intolerant|interferon intolerant
4898504|NCT02094417|Anemia, Aplastic|anemia, aplastic
4898505|NCT02094417|Thrombopoietin|thrombopoietin
4898506|NCT02094417|Thrombocytopenia|thrombocytopenia
4898507|NCT02094404|Emergency Department|emergency department
4898508|NCT02094404|Pediatric Early Warning Score|pediatric early warning score
4898509|NCT02094404|Manchester Triage System|manchester triage system
4898510|NCT02094378|Healthy|healthy
4898511|NCT02094378|Esketamine|esketamine
4898512|NCT02094378|Cognitive functioning|cognitive functioning
4898513|NCT02094352|Complex Regional Pain Syndrome|complex regional pain syndrome
4898514|NCT02094352|Pain management|pain management
4898515|NCT02094352|Ketamine infusion|ketamine infusion
4898516|NCT02094339|Local analgesia system|local analgesia system
4898517|NCT02094339|Ropivacaine|ropivacaine
4898518|NCT02094339|Analgesic efficacy after operation|analgesic efficacy after operation
4898519|NCT02094339|Postoperative|postoperative
4898520|NCT02094313|Atorvastatin|atorvastatin
4898521|NCT02094313|Human Spermatozoa|human spermatozoa
4898522|NCT02094313|Seminal fluid|seminal fluid
4898523|NCT02094313|Accessory Glands|accessory glands
4898524|NCT02094313|Cholesterol|cholesterol
4898525|NCT02094313|Gonadotropins,|gonadotropins,
4898526|NCT02094313|Testosterone|testosterone
4898527|NCT02094300|Aorta|aorta
4898528|NCT02094300|Thoracic|thoracic
4898529|NCT02094300|Aortic dissection|aortic dissection
4898530|NCT02094300|Rupture|rupture
4898531|NCT02094300|Type B|type b
4898532|NCT02094300|DeBakey type III|debakey type iii
4898533|NCT02094300|Endovascular|endovascular
4898534|NCT02094261|Phase II, open label study; safety and efficacy of AZD9291; diagnosis of Epidermal Growth Factor Receptor mutation positive and T790M mutation positive NSCLC|phase ii, open label study; safety and efficacy of azd9291; diagnosis of epidermal growth factor receptor mutation positive and t790m mutation positive nsclc
4898535|NCT02094235|Dermatitis|dermatitis
4898536|NCT02094235|Atopic|atopic
4898537|NCT02094235|Pediatric|pediatric
4898538|NCT02094235|Adolescent|adolescent
4898539|NCT02094235|Child|child
4898540|NCT02094209|External Fixation|external fixation
4898541|NCT02094209|Tibial fracture|tibial fracture
4898542|NCT02094209|Fracture healing|fracture healing
4898543|NCT02094196|Reward- based learning|reward- based learning
4898544|NCT02094196|Pavlovian-to-instrumental transfer|pavlovian-to-instrumental transfer
4898545|NCT02094196|Relapse Risk|relapse risk
4898546|NCT02094196|Positron emission tomography (PET)|positron emission tomography (pet)
4898547|NCT02094196|Magnetic resonance spectroscopy (MRS)|magnetic resonance spectroscopy (mrs)
4898548|NCT02094196|Dopamine receptor availability|dopamine receptor availability
4898549|NCT02094196|Glutamate|glutamate
4898550|NCT02094157|Atrial fibrillation|atrial fibrillation
4898551|NCT02094157|Mechanical heart valve|mechanical heart valve
4898552|NCT02094157|Stroke|stroke
4898553|NCT02094157|Venous thromboembolism|venous thromboembolism
4898554|NCT02094157|Hemorrhage|hemorrhage
4898555|NCT02094144|Sedentary|sedentary
4898556|NCT02094144|Physical activity|physical activity
4898557|NCT02094144|Brisk walking|brisk walking
4898558|NCT02094144|Postmenopausal women|postmenopausal women
4898559|NCT02094144|Body composition|body composition
4898560|NCT02094144|Balance|balance
4898561|NCT02094144|Muscle strength|muscle strength
4898562|NCT02094144|Depression, bone density|depression, bone density
4898563|NCT02094144|Nutrition|nutrition
4898564|NCT02094144|Biological effects|biological effects
4898565|NCT02094131|incentive spirometry|incentive spirometry
4898566|NCT02094131|flow-oriented spirometer|flow-oriented spirometer
4898567|NCT02094131|volume-oriented spirometer|volume-oriented spirometer
4898568|NCT02094131|physical therapy|physical therapy
4898569|NCT02094131|respiratory muscle training|respiratory muscle training
4898570|NCT02094118|Transfusion|transfusion
4898571|NCT02094118|RBC|rbc
4898572|NCT02094118|cardiac|cardiac
4898573|NCT02094118|surgery|surgery
4898574|NCT02094118|transfusion related acute lung injury (TRALI)|transfusion related acute lung injury (trali)
4898575|NCT02094118|transfusion associated circulatory overload (TACO)|transfusion associated circulatory overload (taco)
4898576|NCT02094105|esophageal cancer|esophageal cancer
4898577|NCT02094105|screening|screening
4898578|NCT02094105|endoscopy|endoscopy
4898579|NCT02094105|prevention|prevention
4898580|NCT02094092|L.reuteri ProTectis DSM 17938|l.reuteri protectis dsm 17938
4898581|NCT02094092|Infantile colic|infantile colic
4898582|NCT02094092|Maternal mental health.|maternal mental health.
4898583|NCT02094092|Infant crying/fussing|infant crying/fussing
4898584|NCT02094092|Edinburgh Postnatal Depression Scale (EPDS)|edinburgh postnatal depression scale (epds)
4898585|NCT02094079|hypothyroidism|hypothyroidism
4898586|NCT02094079|pregnancy|pregnancy
4898587|NCT02094066|tranexamic acid|tranexamic acid
4898588|NCT02094066|total hip arthroplasty|total hip arthroplasty
4898589|NCT02094053|Down syndrome|down syndrome
4898590|NCT02094053|regression symptoms|regression symptoms
4898591|NCT02094053|disabled activities of daily living|disabled activities of daily living
4898592|NCT02094040|frailty|frailty
4898593|NCT02094040|readmission|readmission
4898594|NCT02094040|transition|transition
4898595|NCT02094040|discharge|discharge
4898596|NCT02094040|primary care|primary care
4898597|NCT02094027|Obesity|obesity
4898598|NCT02094027|Bariatric surgery|bariatric surgery
4898599|NCT02094027|Binge eating|binge eating
4898600|NCT02094027|Self help|self help
4898601|NCT02094014|Perceptual masking|perceptual masking
4898602|NCT02094014|Auditory stimulation|auditory stimulation
4898603|NCT02094014|Speech|speech
4898604|NCT02094014|Language|language
4898605|NCT02094014|Verbal Fluency Disorders|verbal fluency disorders
4898606|NCT02093962|TH-302|th-302
4898607|NCT02093962|TH-CR-415|th-cr-415
4898608|NCT02093962|Pemetrexed|pemetrexed
4898609|NCT02093962|Non-small cell lung cancer|non-small cell lung cancer
4898610|NCT02093962|Lung cancer|lung cancer
4898611|NCT02093962|Evofosfamide|evofosfamide
4898612|NCT02093936|airway inflammation|airway inflammation
4898613|NCT02093936|induced sputum|induced sputum
4898614|NCT02093936|normal values|normal values
4898615|NCT02093936|lymphocyte|lymphocyte
4898616|NCT02093936|eosinophil|eosinophil
4898617|NCT02093936|neutrophil|neutrophil
4898618|NCT02093923|HAE|hae
4898619|NCT02093910|multiple myeloma|multiple myeloma
4898620|NCT02093910|peripheral neuropathy|peripheral neuropathy
4898621|NCT02093910|prophylaxis|prophylaxis
4898622|NCT02093884|Pregnancy|pregnancy
4898623|NCT02093884|Pregnancy, unplanned|pregnancy, unplanned
4898624|NCT02093884|Reproductive behavior|reproductive behavior
4898625|NCT02093884|Pregnancy in Adolescence|pregnancy in adolescence
4898626|NCT02093884|Text messaging|text messaging
4898627|NCT02093871|Ovarian cancer|ovarian cancer
4898628|NCT02093871|Therapeutic hyperthermia|therapeutic hyperthermia
4898629|NCT02093871|HEATT|heatt
4898630|NCT02093871|whole body hyperthermia|whole body hyperthermia
4898631|NCT02093871|hyperthermia|hyperthermia
4898632|NCT02093871|PISH|pish
4898633|NCT02093871|Verthermia|verthermia
4898634|NCT02093871|Phase 1 clinical trial|phase 1 clinical trial
4898635|NCT02093871|stage 3 ovarian cancer|stage 3 ovarian cancer
4898636|NCT02093871|stage 4 ovarian cancer|stage 4 ovarian cancer
4898637|NCT02093871|stage III ovarian cancer|stage iii ovarian cancer
4898638|NCT02093871|stage IV ovarian cancer|stage iv ovarian cancer
4898639|NCT02093871|late stage ovarian cancer|late stage ovarian cancer
4898640|NCT02093871|Core HFC|core hfc
4898641|NCT02093871|Lilja|lilja
4898642|NCT02093871|Vertrees|vertrees
4898643|NCT02093871|Bastidas|bastidas
4898644|NCT02093871|total body hyperthermia|total body hyperthermia
4898645|NCT02093858|Metabolic Syndrome|metabolic syndrome
4898646|NCT02093845|Percutaneous coronary intervention|percutaneous coronary intervention
4898647|NCT02093845|DES|des
4898648|NCT02093845|Angina pectoris|angina pectoris
4898649|NCT02093845|Stent|stent
4898650|NCT02093832|femoral head size|femoral head size
4898651|NCT02093832|cup size|cup size
4898652|NCT02093832|Total hip arthroplasty|total hip arthroplasty
4898653|NCT02093767|prebiotics|prebiotics
4898654|NCT02093767|Synergy1|synergy1
4899047|NCT02091934|Wavelight|wavelight
4898655|NCT02093728|Phase I, healthy, pharmacokinetics|phase i, healthy, pharmacokinetics
4898656|NCT02093715|Bronchiolitis|bronchiolitis
4898657|NCT02093715|FeNO|feno
4898658|NCT02093715|Asthma|asthma
4898659|NCT02093715|wheezing, RSV|wheezing, rsv
4898660|NCT02093676|diabetes|diabetes
4898661|NCT02093676|type 1|type 1
4898662|NCT02093676|adolescents|adolescents
4898663|NCT02093676|parents counselling|parents counselling
4898664|NCT02093663|Mild|mild
4898665|NCT02093663|Moderate|moderate
4898666|NCT02093650|Menopausal symptoms|menopausal symptoms
4898667|NCT02093650|menopause related quality of life|menopause related quality of life
4898668|NCT02093650|black cohosh|black cohosh
4898669|NCT02093650|cimicifuga racemosa|cimicifuga racemosa
4898670|NCT02093650|MENQOL|menqol
4898671|NCT02093650|Kupperman index|kupperman index
4898672|NCT02093650|KI|ki
4898673|NCT02093650|liver function tests|liver function tests
4898674|NCT02093598|pharmacokinetic|pharmacokinetic
4898675|NCT02093598|pharmacodynamic|pharmacodynamic
4898676|NCT02093598|Carcinoma, Endometrioid|carcinoma, endometrioid
4898677|NCT02093598|mTOR protein|mtor protein
4898678|NCT02093598|temsirolimus|temsirolimus
4898679|NCT02093598|torisel|torisel
4898680|NCT02093598|biological marker|biological marker
4898681|NCT02093598|phase II|phase ii
4898682|NCT02093585|HIV-1|hiv-1
4898683|NCT02093585|Abacavir|abacavir
4898684|NCT02093585|Platelet activation|platelet activation
4898685|NCT02093585|Thromboelastography|thromboelastography
4898686|NCT02093585|Coagulation|coagulation
4898687|NCT02093572|Clock genes|clock genes
4898688|NCT02093572|Metabolism|metabolism
4898689|NCT02093572|Insulin sensitivity|insulin sensitivity
4898690|NCT02093559|Clinical Trial|clinical trial
4898691|NCT02093559|Naloxone|naloxone
4898692|NCT02093559|Motivational Interviewing|motivational interviewing
4898693|NCT02093546|Endometrial cancer|endometrial cancer
4898694|NCT02093546|Endometrioid adenocarcinoma|endometrioid adenocarcinoma
4898695|NCT02093546|Serous adenocarcinoma|serous adenocarcinoma
4898696|NCT02093546|Undifferentiated carcinoma|undifferentiated carcinoma
4898697|NCT02093546|Mixed epithelial carcinoma|mixed epithelial carcinoma
4898698|NCT02093546|Adenocarcinoma not otherwise specified|adenocarcinoma not otherwise specified
4898699|NCT02093546|NOS|nos
4898700|NCT02093546|Companion Protocol to GOG229O|companion protocol to gog229o
4898701|NCT02093546|Biomarkers|biomarkers
4898702|NCT02093546|Circulating tumor cells|circulating tumor cells
4898703|NCT02093546|CTCs|ctcs
4898704|NCT02093546|Blood draw|blood draw
4898705|NCT02093546|Biopsy|biopsy
4898706|NCT02093533|Membranoproliferative glomerulonephritis|membranoproliferative glomerulonephritis
4898707|NCT02093533|Nephrotic syndrome|nephrotic syndrome
4898708|NCT02093533|Proteinuria|proteinuria
4898709|NCT02093533|Alternative complement pathway|alternative complement pathway
4898710|NCT02093533|Complement inhibition|complement inhibition
4898711|NCT02093533|Eculizumab|eculizumab
4898712|NCT02093520|Lumbar Spinal Stenosis|lumbar spinal stenosis
4898713|NCT02093520|Spinal Stenosis|spinal stenosis
4898714|NCT02093520|Neurogenic Claudication|neurogenic claudication
4898715|NCT02093507|newborn|newborn
4898716|NCT02093507|foot deformity congenital|foot deformity congenital
4898717|NCT02093494|Septicemia|septicemia
4898718|NCT02093494|Blood culture|blood culture
4898719|NCT02093494|Contamination|contamination
4898720|NCT02093468|Acute limb ischemia|acute limb ischemia
4898721|NCT02093468|ALI|ali
4898722|NCT02093468|Acute lower extremity arterial occlusion|acute lower extremity arterial occlusion
4898723|NCT02093455|Endothelial function|endothelial function
4898724|NCT02093416|Obesity|obesity
4898725|NCT02093416|Leptin|leptin
4898726|NCT02093403|AML|aml
4898727|NCT02093403|Acute Myeloid Leukemia|acute myeloid leukemia
4898728|NCT02093403|Adult Acute Myeloid Leukemia with T(8;21)(Q22;Q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
4898729|NCT02093403|adult Acute Myeloid Leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
4898730|NCT02093403|adult Acute Myeloid Leukemia with del(5q)|adult acute myeloid leukemia with del(5q)
4898731|NCT02093403|adult Acute Myeloid Leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
4898732|NCT02093377|acute myocardial infarction|acute myocardial infarction
4898733|NCT02093377|sleep apnea|sleep apnea
4898734|NCT02093377|adaptive servo-ventilation|adaptive servo-ventilation
4898735|NCT02093351|oncology, cancer, tumour, neoplasm, anticancer drug, pharmacokinetics, olaparib, anastrozole, tamoxifen, letrozole,|oncology, cancer, tumour, neoplasm, anticancer drug, pharmacokinetics, olaparib, anastrozole, tamoxifen, letrozole,
4898736|NCT02093338|breast pain|breast pain
4898737|NCT02093338|probiotic|probiotic
4898738|NCT02093338|mastitis|mastitis
4898739|NCT02093338|lactobacillus fermentun|lactobacillus fermentun
4898740|NCT02093338|Staphylococcus|staphylococcus
4898741|NCT02093325|eltrombopag , thrombocytopenia, solid tumor|eltrombopag , thrombocytopenia, solid tumor
4898742|NCT02093312|Cancer|cancer
4898743|NCT02093312|Food-delivery|food-delivery
4898744|NCT02093312|Nutritional Intervention|nutritional intervention
4898745|NCT02093312|Quality of life|quality of life
4898746|NCT02093312|Outpatients|outpatients
4898747|NCT02093286|Pentabio Vaccine|pentabio vaccine
4898748|NCT02093286|Safety|safety
4898749|NCT02093286|Infants|infants
4898750|NCT02093286|Booster Dose|booster dose
4899048|NCT02091934|PRK|prk
4898751|NCT02093286|DTwP/HepB/Hib|dtwp/hepb/hib
4898752|NCT02093273|tOPV|topv
4898753|NCT02093273|Antibody response|antibody response
4898754|NCT02093273|Safety|safety
4898755|NCT02093260|Flubio Vaccine (Influenza HA)|flubio vaccine (influenza ha)
4898756|NCT02093260|Infants|infants
4898757|NCT02093260|Children|children
4898758|NCT02093260|Safety|safety
4898759|NCT02093260|Immunogenicity|immunogenicity
4898760|NCT02093234|self care of diabetes type 2 patients|self care of diabetes type 2 patients
4898761|NCT02093234|mobile health cell phone application impact on health|mobile health cell phone application impact on health
4898762|NCT02093234|community health workers impact on health|community health workers impact on health
4898763|NCT02093221|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
4898764|NCT02093221|Alpha1-Proteinase Inhibitor|alpha1-proteinase inhibitor
4898765|NCT02093221|Beta Cell|beta cell
4898766|NCT02093221|Alpha1-Antitrypsin|alpha1-antitrypsin
4898767|NCT02093195|Treatment, COPD, bosentan|treatment, copd, bosentan
4898768|NCT02093156|bowel preparation|bowel preparation
4898769|NCT02093156|Ottawa Score|ottawa score
4898770|NCT02093143|Diagnostic panendoscopy of the upper airway|diagnostic panendoscopy of the upper airway
4898771|NCT02093143|Total intravenous general anesthesia|total intravenous general anesthesia
4898772|NCT02093143|Remifentanil|remifentanil
4898773|NCT02093143|Propofol|propofol
4898774|NCT02093143|Target controlled infusion|target controlled infusion
4898775|NCT02093143|Direct laryngoscopy|direct laryngoscopy
4898776|NCT02093143|Tracheoscopy|tracheoscopy
4898777|NCT02093143|Oesophagoscopy|oesophagoscopy
4898778|NCT02093143|Ear Nose and Throat (ENT) tumor|ear nose and throat (ent) tumor
4898779|NCT02093143|Ear Nose and Throat (ENT) cancer|ear nose and throat (ent) cancer
4898780|NCT02093130|Double-blind Trial|double-blind trial
4898781|NCT02093130|Placebo-controlled|placebo-controlled
4898782|NCT02093130|Pomegranate|pomegranate
4898783|NCT02093130|Memory|memory
4898784|NCT02093130|Memory Impairment|memory impairment
4898785|NCT02093130|Cognition|cognition
4898786|NCT02093130|Ages 50-75|ages 50-75
4898787|NCT02093117|Supratentorial neurosurgery|supratentorial neurosurgery
4898788|NCT02093117|Recruitment maneuver|recruitment maneuver
4898789|NCT02093117|Subdural pressure|subdural pressure
4898790|NCT02093117|Brain relaxation|brain relaxation
4898791|NCT02093117|Cerebral perfusion pressure|cerebral perfusion pressure
4898792|NCT02093104|unresectable hepatocellular carcinoma|unresectable hepatocellular carcinoma
4898793|NCT02093104|(undergoing chemoembolization and radioembolization)|(undergoing chemoembolization and radioembolization)
4898794|NCT02093091|nano-filled resin modified glass ionomer|nano-filled resin modified glass ionomer
4898795|NCT02093091|clinical performance|clinical performance
4898796|NCT02093091|class I|class i
4898797|NCT02093091|primary teeth|primary teeth
4898798|NCT02093091|dentin bond strength|dentin bond strength
4898799|NCT02093091|Filling of class I|filling of class i
4898800|NCT02093065|severe hemophilia A|severe hemophilia a
4898801|NCT02093065|coated platelets|coated platelets
4898802|NCT02093065|bleeding|bleeding
4898803|NCT02093052|Parenting|parenting
4898804|NCT02093052|Parent child relations|parent child relations
4898805|NCT02093052|Middle childhood outcomes|middle childhood outcomes
4898806|NCT02093039|breast cancer screening|breast cancer screening
4898807|NCT02093039|patient decision aids|patient decision aids
4898808|NCT02093039|informed decision|informed decision
4898809|NCT02093039|empowerment|empowerment
4898810|NCT02093039|randomized control trial|randomized control trial
4898811|NCT02093039|From 50 to 74 years old|from 50 to 74 years old
4898812|NCT02093039|invited to national breast cancer screening|invited to national breast cancer screening
4898813|NCT02093013|asthma|asthma
4898814|NCT02093013|intervention|intervention
4898815|NCT02093013|medication adherence|medication adherence
4898816|NCT02093013|inhaled corticosteroids|inhaled corticosteroids
4898817|NCT02093013|asthma control|asthma control
4898818|NCT02093013|integrated care|integrated care
4898819|NCT02092987|Hispanic|hispanic
4898820|NCT02092987|Dementia|dementia
4898821|NCT02092987|Caregivers|caregivers
4898822|NCT02092987|Depressive symptoms|depressive symptoms
4898823|NCT02092987|Burden|burden
4898824|NCT02092987|Pragmatic randomized trial|pragmatic randomized trial
4898825|NCT02092974|transcranial direct current stimulation (tDCS)|transcranial direct current stimulation (tdcs)
4898826|NCT02092974|selective serotonin reuptake inhibitor (SSRI)|selective serotonin reuptake inhibitor (ssri)
4898827|NCT02092974|young|young
4898828|NCT02092974|older adults|older adults
4898829|NCT02092961|Rheumatoid Arthritis|rheumatoid arthritis
4898830|NCT02092961|OSKIRA|oskira
4898831|NCT02092961|fostamatinib|fostamatinib
4898832|NCT02092961|CE-MRI|ce-mri
4898833|NCT02092961|DCE-MRI|dce-mri
4898834|NCT02092948|metastatic|metastatic
4898835|NCT02092948|PSCA|psca
4898836|NCT02092948|minibody|minibody
4898837|NCT02092948|PET/CT|pet/ct
4898838|NCT02092935|CDAD|cdad
4898839|NCT02092935|Clostridium Difficile|clostridium difficile
4898840|NCT02092896|Diabetes Mellitus|diabetes mellitus
4898841|NCT02092896|Diabetes Mellitus, Type 1|diabetes mellitus, type 1
4898842|NCT02092896|Glucose Metabolism Disorders|glucose metabolism disorders
4898843|NCT02092896|Metabolic Diseases|metabolic diseases
4898844|NCT02092896|Cognitive performance|cognitive performance
4898845|NCT02092896|Hypoglycemia|hypoglycemia
4898846|NCT02092896|Insulin|insulin
4898847|NCT02092896|Glucagon-Like Peptide 1|glucagon-like peptide 1
4898848|NCT02092896|Hypoglycemic Agents|hypoglycemic agents
4898849|NCT02092896|Physiological Effects of Drugs|physiological effects of drugs
4898850|NCT02092896|Pharmacologic Actions|pharmacologic actions
4898851|NCT02092896|Incretins|incretins
4898852|NCT02092896|Hormones|hormones
4898853|NCT02092883|Infantile Spasms|infantile spasms
4898854|NCT02092883|Neuroinflammation|neuroinflammation
4898855|NCT02092883|PK11195|pk11195
4898856|NCT02092883|PET|pet
4898857|NCT02092883|ACTH|acth
4898858|NCT02092870|Chronic Wounds|chronic wounds
4898859|NCT02092870|Diabetes|diabetes
4898860|NCT02092870|Adipose Derived Stem Cells|adipose derived stem cells
4898861|NCT02092870|Diabetic Foot|diabetic foot
4898862|NCT02092857|nutrient|nutrient
4898863|NCT02092857|nutrition|nutrition
4898864|NCT02092857|arachidonic acid|arachidonic acid
4898865|NCT02092857|essential fatty acids|essential fatty acids
4898866|NCT02092844|Menopause|menopause
4898867|NCT02092844|Insomnia|insomnia
4898868|NCT02092844|Hot Flashes|hot flashes
4898869|NCT02092805|VAS|vas
4898870|NCT02092805|VDS|vds
4898871|NCT02092805|HAM-D|ham-d
4898872|NCT02092805|Visceral pain|visceral pain
4898873|NCT02092805|Malignancy|malignancy
4898874|NCT02092805|rTMS|rtms
4898875|NCT02092805|Motor cortex|motor cortex
4898876|NCT02092805|Analgesia|analgesia
4898877|NCT02092805|Dynorphin|dynorphin
4898878|NCT02092766|malaria|malaria
4898879|NCT02092766|anaemia|anaemia
4898880|NCT02092766|artesunate|artesunate
4898881|NCT02092753|Ketogenic diet, logi diet, breast cancer, rehabilitation|ketogenic diet, logi diet, breast cancer, rehabilitation
4898882|NCT02092740|Testicular cancer|testicular cancer
4898883|NCT02092727|Dialysis facilities|dialysis facilities
4898884|NCT02092727|African Americans|african americans
4898885|NCT02092727|Racial disparity|racial disparity
4898886|NCT02092727|Kidney Transplantation|kidney transplantation
4898887|NCT02092727|Community-based Participatory Research|community-based participatory research
4898888|NCT02092727|Coalition|coalition
4898889|NCT02092727|Georgia|georgia
4898890|NCT02092688|time to delivery|time to delivery
4898891|NCT02092688|PROM|prom
4898892|NCT02092688|PTL|ptl
4898893|NCT02092688|positive predictive value|positive predictive value
4898894|NCT02092675|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
4898895|NCT02092675|frequent exacerbator|frequent exacerbator
4898896|NCT02092675|endothelial dysfunction|endothelial dysfunction
4898897|NCT02092675|Flow mediated dilatation|flow mediated dilatation
4898898|NCT02092675|Systemic inflammation|systemic inflammation
4898899|NCT02092649|Omega-3|omega-3
4898900|NCT02092649|Resting metabolic rate|resting metabolic rate
4898901|NCT02092649|Eicosapentaenoic acid|eicosapentaenoic acid
4898902|NCT02092649|Docosahexaenoic acid|docosahexaenoic acid
4898903|NCT02092636|Hybrid NIR/US imaging technique|hybrid nir/us imaging technique
4898904|NCT02092636|NIR/US imaging|nir/us imaging
4898905|NCT02092636|US imaging|us imaging
4898906|NCT02092636|US imaging technique|us imaging technique
4898907|NCT02092623|Female|female
4898908|NCT02092623|Prolapse surgery with transvaginal mesh|prolapse surgery with transvaginal mesh
4898909|NCT02092623|Subjective outcome|subjective outcome
4898910|NCT02092584|atherosclerotic|atherosclerotic
4898911|NCT02092584|IGF-1|igf-1
4898912|NCT02092584|IGFBP-3|igfbp-3
4898913|NCT02092558|metaplasia, dysfunction, urinary bladder, children|metaplasia, dysfunction, urinary bladder, children
4898914|NCT02092545|Obesity|obesity
4898915|NCT02092519|EUSFNA|eusfna
4898916|NCT02092519|endoscopic ultrasound|endoscopic ultrasound
4898917|NCT02092519|pancreatic masses|pancreatic masses
4898918|NCT02092506|H pylori|h pylori
4898919|NCT02092506|therapy|therapy
4898920|NCT02092493|ScopeGuide|scopeguide
4898921|NCT02092493|Colonoscopy|colonoscopy
4898922|NCT02092493|Mental workload|mental workload
4898923|NCT02092480|Feasibility Trial|feasibility trial
4898924|NCT02092480|Educational Intervention|educational intervention
4898925|NCT02092480|Teenage Pregnancy|teenage pregnancy
4898926|NCT02092480|Boys|boys
4898927|NCT02092480|Gender sensitive interventions|gender sensitive interventions
4898928|NCT02092480|Unintended pregnancy|unintended pregnancy
4898929|NCT02092480|Parents|parents
4898930|NCT02092480|Process evaluation|process evaluation
4898931|NCT02092480|Economic costing|economic costing
4898932|NCT02092467|Post-marketing|post-marketing
4898933|NCT02092467|Phase 4|phase 4
4898934|NCT02092467|Open-label|open-label
4898935|NCT02092467|Safety Surveillance|safety surveillance
4898936|NCT02092467|CP690550|cp690550
4898937|NCT02092467|Xeljanz|xeljanz
4898938|NCT02092467|oral treatment|oral treatment
4898939|NCT02092441|Nausea|nausea
4898940|NCT02092441|Vomiting|vomiting
4898941|NCT02092441|Antiemetic|antiemetic
4898942|NCT02092428|Coronary Magnetic Resonance Imaging|coronary magnetic resonance imaging
4898943|NCT02092428|CAD|cad
4898944|NCT02092428|Coronary Magnetic Resonance Angiography|coronary magnetic resonance angiography
4898945|NCT02092428|MRA|mra
4898946|NCT02092428|3 Tesla MRI|3 tesla mri
4898947|NCT02092415|Tourniquet|tourniquet
4898948|NCT02092415|Muscle perfusion|muscle perfusion
4898949|NCT02092415|Contrast ultrasound|contrast ultrasound
4898950|NCT02092402|Fecal transplantation|fecal transplantation
4898951|NCT02092402|microbiota transplantation|microbiota transplantation
4898952|NCT02092402|irritable bowel syndrome|irritable bowel syndrome
4898953|NCT02092402|IBS|ibs
4898954|NCT02092389|Ulcerative Colitis|ulcerative colitis
4898955|NCT02092389|Inflammatory Bowel Syndrome|inflammatory bowel syndrome
4898956|NCT02092389|Adalimumab|adalimumab
4898957|NCT02092389|Tumor necrosis factor (TNF) alpha Antibody|tumor necrosis factor (tnf) alpha antibody
4898958|NCT02092389|Calprotectin|calprotectin
4898959|NCT02092376|Bariatric surgery|bariatric surgery
4898960|NCT02092376|vitamin D|vitamin d
4898961|NCT02092376|supplementation|supplementation
4898962|NCT02092363|Platinum-Sensitive Ovarian Cancer|platinum-sensitive ovarian cancer
4898963|NCT02092337|CAST, Hearing aids, Speech recognition, Cochlear implants|cast, hearing aids, speech recognition, cochlear implants
4898964|NCT02092311|varicocele|varicocele
4898965|NCT02092311|varicocelectomy|varicocelectomy
4898966|NCT02092311|complications of varicocelectomy|complications of varicocelectomy
4898967|NCT02092311|Recurrence of varicocele|recurrence of varicocele
4898968|NCT02092311|Post-varicocelectomy testicular atrophy|post-varicocelectomy testicular atrophy
4898969|NCT02092311|Post-varicocelectomy hydrocele|post-varicocelectomy hydrocele
4898970|NCT02092298|Gastrointestinal cancer|gastrointestinal cancer
4898971|NCT02092298|Hyperthermic Intraperitoneal Chemoperfusion|hyperthermic intraperitoneal chemoperfusion
4898972|NCT02092298|HIPEC|hipec
4898973|NCT02092298|Gastric carcinomatosis|gastric carcinomatosis
4898974|NCT02092298|Gastroesophageal cancer|gastroesophageal cancer
4898975|NCT02092298|Mitomycin C|mitomycin c
4898976|NCT02092298|Mitomycin|mitomycin
4898977|NCT02092298|Cisplatin|cisplatin
4898978|NCT02092298|Platinol-AQ|platinol-aq
4898979|NCT02092298|Platinol|platinol
4898980|NCT02092298|CDDP|cddp
4898981|NCT02092298|Sodium Thiosulfate|sodium thiosulfate
4898982|NCT02092298|Tinver|tinver
4898983|NCT02092233|ARIES HSV 1&2|aries hsv 1&2
4898984|NCT02092220|Bionic Pancreas|bionic pancreas
4898985|NCT02092220|Insulin|insulin
4898986|NCT02092220|Glucagon|glucagon
4898987|NCT02092220|Continuous Glucose Monitor|continuous glucose monitor
4898988|NCT02092194|beta 2-Microglobulin|beta 2-microglobulin
4898989|NCT02092194|Hemodiafiltration|hemodiafiltration
4898990|NCT02092194|convective volume|convective volume
4898991|NCT02092168|Opicapone|opicapone
4898992|NCT02092168|BIAL|bial
4898993|NCT02092142|Q fever|q fever
4898994|NCT02092142|Coxiella burnetii|coxiella burnetii
4898995|NCT02092129|Acromegaly, surgery, histopathology, hyperprolactinaemia,|acromegaly, surgery, histopathology, hyperprolactinaemia,
4898996|NCT02092103|Premature Birth|premature birth
4898997|NCT02092103|Umbilical Cord Clamping|umbilical cord clamping
4898998|NCT02092090|salt substitute|salt substitute
4898999|NCT02092090|sodium reduction|sodium reduction
4899000|NCT02092090|stroke|stroke
4899001|NCT02092090|cluster randomized trial|cluster randomized trial
4899002|NCT02092090|China|china
4899003|NCT02092077|Growth Hormone-Deficient|growth hormone-deficient
4899004|NCT02092077|recombinant human growth hormone|recombinant human growth hormone
4899005|NCT02092064|basal proteinuria|basal proteinuria
4899006|NCT02092064|FMF|fmf
4899007|NCT02092064|pregnancy|pregnancy
4899008|NCT02092051|Continuous glucose monitoring|continuous glucose monitoring
4899009|NCT02092051|Type 1 diabetes|type 1 diabetes
4899010|NCT02092051|Insulin injections|insulin injections
4899011|NCT02092051|Cross-over|cross-over
4899012|NCT02092038|glioblastoma|glioblastoma
4899013|NCT02092038|temozolomide|temozolomide
4899014|NCT02092038|radiation therapy|radiation therapy
4899015|NCT02092038|radiotherapy|radiotherapy
4899016|NCT02092038|surgery|surgery
4899017|NCT02092038|pre-operative|pre-operative
4899018|NCT02092038|neoadjuvant|neoadjuvant
4899019|NCT02092025|Pharmacological therapy|pharmacological therapy
4899020|NCT02092012|postoperative pain|postoperative pain
4899021|NCT02092012|dexketoprofen trometamol|dexketoprofen trometamol
4899022|NCT02092012|dexmedetomidine|dexmedetomidine
4899023|NCT02091999|enfortumab vedotin|enfortumab vedotin
4899024|NCT02091999|Metastatic Urothelial Cancer|metastatic urothelial cancer
4899025|NCT02091999|Safety|safety
4899026|NCT02091999|AGS-22C3E|ags-22c3e
4899027|NCT02091999|EV-101|ev-101
4899028|NCT02091999|Nectin 4 protein, humans|nectin 4 protein, humans
4899029|NCT02091999|Clinical Trial, Phase 1|clinical trial, phase 1
4899030|NCT02091999|ASG-22CE|asg-22ce
4899031|NCT02091999|ASG-22ME|asg-22me
4899032|NCT02091999|Pharmacokinetics of ASG-22CE|pharmacokinetics of asg-22ce
4899033|NCT02091986|asthma, children, budesonide pMDI|asthma, children, budesonide pmdi
4899034|NCT02091973|everolimus|everolimus
4899035|NCT02091973|tacrolimus|tacrolimus
4899036|NCT02091973|kidney transplantation|kidney transplantation
4899037|NCT02091973|microRNA|microrna
4899038|NCT02091960|Enzalutamide|enzalutamide
4899039|NCT02091960|Trastuzumab|trastuzumab
4899040|NCT02091960|Breast cancer|breast cancer
4899041|NCT02091960|HER2|her2
4899042|NCT02091960|Androgen receptor positive|androgen receptor positive
4899043|NCT02091960|Xtandi|xtandi
4899044|NCT02091947|FMS|fms
4899045|NCT02091947|Urine incontinence|urine incontinence
4899046|NCT02091934|Alcon|alcon
4899049|NCT02091934|Wavefront-guided|wavefront-guided
4899050|NCT02091934|Wavefront-optimized|wavefront-optimized
4899051|NCT02091934|Myopia|myopia
4899052|NCT02091934|Astigmatism|astigmatism
4899053|NCT02091921|Critical Limb Ischemia, ticagrelor, Brilinta|critical limb ischemia, ticagrelor, brilinta
4899054|NCT02091908|Influenza|influenza
4899055|NCT02091908|H5N1|h5n1
4899056|NCT02091908|aH5N1|ah5n1
4899057|NCT02091908|H5N1 vaccine|h5n1 vaccine
4899058|NCT02091908|Pandemic Influenza vaccine|pandemic influenza vaccine
4899059|NCT02091908|MF59, Adjuvant, Avian flu|mf59, adjuvant, avian flu
4899060|NCT02091908|Underlying medical conditions|underlying medical conditions
4899061|NCT02091908|Underlying cardiovascular medical condition|underlying cardiovascular medical condition
4899062|NCT02091908|Pandemic vaccine|pandemic vaccine
4899063|NCT02091908|Charlson Comorbidity Index (CCI)|charlson comorbidity index (cci)
4899064|NCT02091908|Adjuvanted vaccine|adjuvanted vaccine
4899065|NCT02091895|probe-based confocal laser endomicroscopy, lower gastrointestinal disorders|probe-based confocal laser endomicroscopy, lower gastrointestinal disorders
4899066|NCT02091882|OPC-14597 Digital|opc-14597 digital
4899067|NCT02091882|Aripiprazole|aripiprazole
4899068|NCT02091882|Medical Information Device #1 System (MIND1)|medical information device #1 system (mind1)
4899069|NCT02091882|Ingestible Event Marker|ingestible event marker
4899070|NCT02091869|Adolescents|adolescents
4899071|NCT02091869|Asthma|asthma
4899072|NCT02091869|Asthma Symptoms|asthma symptoms
4899073|NCT02091817|oxytocin|oxytocin
4899074|NCT02091817|face|face
4899075|NCT02091817|memory|memory
4899076|NCT02091804|Attachment theory|attachment theory
4899077|NCT02091804|Parent- child relationship|parent- child relationship
4899078|NCT02091804|Child mental health|child mental health
4899079|NCT02091804|Behavioral health|behavioral health
4899080|NCT02091791|acute lumbar sciatica, lumbar traction, traction force, radicular pain, lumbar functional parameters, disc herniation|acute lumbar sciatica, lumbar traction, traction force, radicular pain, lumbar functional parameters, disc herniation
4899081|NCT02091765|Sexual dysfunction|sexual dysfunction
4899082|NCT02091765|Intimacy problems|intimacy problems
4899083|NCT02091765|Breast cancer survivors|breast cancer survivors
4899084|NCT02091765|Internet-based|internet-based
4899085|NCT02091765|Cognitive behavioral therapy|cognitive behavioral therapy
4899086|NCT02091752|Primary Myelofibrosis|primary myelofibrosis
4899087|NCT02091752|Hematologic Diseases|hematologic diseases
4899088|NCT02091752|Myeloproliferative Disorders|myeloproliferative disorders
4899089|NCT02091752|INC424|inc424
4899090|NCT02091752|Ruxolitinib|ruxolitinib
4899091|NCT02091726|Circumcision|circumcision
4899092|NCT02091726|HIV prevention|hiv prevention
4899093|NCT02091726|Surgical device|surgical device
4899094|NCT02091726|Cyanoacrylate|cyanoacrylate
4899095|NCT02091726|Tissue Adhesive|tissue adhesive
4899096|NCT02091726|voluntary|voluntary
4899097|NCT02091713|FMS|fms
4899098|NCT02091713|functional movement screen|functional movement screen
4899099|NCT02091700|Normal|normal
4899100|NCT02091700|Healthy|healthy
4899101|NCT02091700|Normal healthy patient|normal healthy patient
4899102|NCT02091674|ankle sprain|ankle sprain
4899103|NCT02091674|hyaluronic acid|hyaluronic acid
4899104|NCT02091661|Clinically localized prostate cancer|clinically localized prostate cancer
4899105|NCT02091661|Radical retropubic prostatectomy|radical retropubic prostatectomy
4899106|NCT02091661|External beam radiotherapy|external beam radiotherapy
4899107|NCT02091661|Efficacy|efficacy
4899108|NCT02091661|Quality of life|quality of life
4899109|NCT02091661|adverse events|adverse events
4899110|NCT02091648|Asthma|asthma
4899111|NCT02091648|Stress|stress
4899112|NCT02091648|Children|children
4899113|NCT02091648|Psychosocial Factors|psychosocial factors
4899114|NCT02091648|Relaxation|relaxation
4899115|NCT02091648|Stress management|stress management
4899116|NCT02091635|accommodation, emptying, motilitone|accommodation, emptying, motilitone
4899117|NCT02091609|plaque removal around dental implants|plaque removal around dental implants
4899118|NCT02091596|Wound|wound
4899119|NCT02091596|Ulcer|ulcer
4899120|NCT02091596|Infected|infected
4899121|NCT02091596|Infection|infection
4899122|NCT02091583|Metabolic syndrome|metabolic syndrome
4899123|NCT02091583|Cardiovascular disease|cardiovascular disease
4899124|NCT02091583|High Oleic Canola Oil|high oleic canola oil
4899125|NCT02091583|DHA|dha
4899126|NCT02091583|β-glucan|β-glucan
4899127|NCT02091583|Barley|barley
4899128|NCT02091583|Cholesterol|cholesterol
4899129|NCT02091583|Lipoproteins|lipoproteins
4899130|NCT02091583|Lipids|lipids
4899131|NCT02091583|Inflammation|inflammation
4899132|NCT02091583|Glucose|glucose
4899133|NCT02091583|Insulin|insulin
4899134|NCT02091583|Satiety|satiety
4899135|NCT02091583|Body composition|body composition
4899136|NCT02091583|Blood pressure|blood pressure
4899137|NCT02091570|Hunger|hunger
4899138|NCT02091570|Fullness|fullness
4899139|NCT02091570|Satiety|satiety
4899140|NCT02091570|Nutrition bar|nutrition bar
4899141|NCT02091570|Crossover|crossover
4899142|NCT02091557|GnRH-a|gnrh-a
4899143|NCT02091557|endometriosis|endometriosis
4899144|NCT02091557|chronic pelvic pain|chronic pelvic pain
4899145|NCT02091557|VAS score|vas score
4899146|NCT02091557|diagnostic accuracy|diagnostic accuracy
4899147|NCT02091544|overweight|overweight
4899148|NCT02091544|obesity|obesity
4899149|NCT02091544|children|children
4899150|NCT02091544|lifestyle intervention|lifestyle intervention
4899151|NCT02091531|mTOR Inhibitor MLN0128|mtor inhibitor mln0128
4899152|NCT02091531|PSA|psa
4899153|NCT02091531|13-143|13-143
4899154|NCT02091518|MRI|mri
4899155|NCT02091518|13-239|13-239
4899156|NCT02091518|volunteers|volunteers
4899157|NCT02091518|patients|patients
4899158|NCT02091492|Proximal humerus fracture, teriparatide|proximal humerus fracture, teriparatide
4899159|NCT02091479|hæmorrhage, thrombosis|hæmorrhage, thrombosis
4899160|NCT02091466|Hypothermia|hypothermia
4899161|NCT02091466|Perioperative Care|perioperative care
4899162|NCT02091466|Anesthesia|anesthesia
4899163|NCT02091466|Spinal|spinal
4899164|NCT02091466|Rewarming|rewarming
4899165|NCT02091453|Brain injury|brain injury
4899166|NCT02091453|stroke|stroke
4899167|NCT02091453|cognitive rehabilitation|cognitive rehabilitation
4899168|NCT02091440|Medical Device|medical device
4899169|NCT02091440|Thoracic Surgical Procedure|thoracic surgical procedure
4899170|NCT02091440|Pumps Heart Assist|pumps heart assist
4899171|NCT02091440|Ventricular Assist Device|ventricular assist device
4899172|NCT02091401|magnesium sulfate|magnesium sulfate
4899173|NCT02091375|Cannabidiol|cannabidiol
4899174|NCT02091375|CBD|cbd
4899175|NCT02091375|Epidiolex|epidiolex
4899176|NCT02091375|GWP42003-P|gwp42003-p
4899177|NCT02091336|gestational diabetes|gestational diabetes
4899178|NCT02091336|metformin|metformin
4899179|NCT02091336|glyburide|glyburide
4899180|NCT02091336|fetal growth|fetal growth
4899181|NCT02091336|capillar glucose|capillar glucose
4899182|NCT02091323|T2DM, gastric bypass surgery, BMI<35, obesity|t2dm, gastric bypass surgery, bmi<35, obesity
4899183|NCT02091310|GFT505|gft505
4899184|NCT02091310|TQT|tqt
4899185|NCT02091310|QT/QTc|qt/qtc
4899186|NCT02091310|Pharmacokinetic|pharmacokinetic
4899187|NCT02091310|Healthy subjects|healthy subjects
4899188|NCT02091310|Moxifloxacin|moxifloxacin
4899189|NCT02091297|Buprenorphine|buprenorphine
4899190|NCT02091297|Suboxone|suboxone
4899191|NCT02091297|Subutex|subutex
4899192|NCT02091297|Buprenex|buprenex
4899193|NCT02091297|Caesarean Delivery|caesarean delivery
4899194|NCT02091284|alcoholism|alcoholism
4899195|NCT02091284|tDCS|tdcs
4899196|NCT02091284|dlPFC|dlpfc
4899197|NCT02091284|craving|craving
4899198|NCT02091284|cognition|cognition
4899199|NCT02091271|Evaluation|evaluation
4899200|NCT02091271|Research|research
4899201|NCT02091271|Healthy Volunteers|healthy volunteers
4899202|NCT02091245|Relapsed acute lymphoblastic leukemia (ALL)|relapsed acute lymphoblastic leukemia (all)
4899203|NCT02091245|Refractory acute lymphoblastic leukemia (ALL)|refractory acute lymphoblastic leukemia (all)
4899204|NCT02091245|Relapsed acute myelogenous leukemia (AML)|relapsed acute myelogenous leukemia (aml)
4899205|NCT02091245|Refractory acute myelogenous leukemia (AML)|refractory acute myelogenous leukemia (aml)
4899206|NCT02091245|Relapsed childhood leukemia|relapsed childhood leukemia
4899207|NCT02091245|Relapsed mixed lineage leukemia|relapsed mixed lineage leukemia
4899208|NCT02091245|Refractory mixed lineage leukemia|refractory mixed lineage leukemia
4899209|NCT02091245|Relapsed biphenotypic leukemia|relapsed biphenotypic leukemia
4899210|NCT02091245|Refractory biphenotypic leukemia|refractory biphenotypic leukemia
4899211|NCT02091245|Chronic myelogenous leukemia (CML) in blast crisis|chronic myelogenous leukemia (cml) in blast crisis
4899212|NCT02091219|Hypovitaminosis D|hypovitaminosis d
4899213|NCT02091219|Free 25-hydroxyvitamin D|free 25-hydroxyvitamin d
4899214|NCT02091219|Total 25-hydroxyvitamin D|total 25-hydroxyvitamin d
4899215|NCT02091206|Cannabidiol|cannabidiol
4899216|NCT02091206|CBD|cbd
4899217|NCT02091206|Epidiolex|epidiolex
4899218|NCT02091206|GWP42003-P|gwp42003-p
4899219|NCT02091193|Krill Oil|krill oil
4899220|NCT02091193|Endothelial Function|endothelial function
4899221|NCT02091193|Type II Diabetes Mellitus|type ii diabetes mellitus
4899222|NCT02091180|Anesthesia|anesthesia
4899223|NCT02091180|Recovery|recovery
4899224|NCT02091180|laparoscopy|laparoscopy
4899225|NCT02091180|cholecystectomy|cholecystectomy
4899226|NCT02091167|crack-cocaine addiction|crack-cocaine addiction
4899227|NCT02091167|tDCS|tdcs
4899228|NCT02091167|dlPFC|dlpfc
4899229|NCT02091167|craving|craving
4899230|NCT02091167|cognition|cognition
4899231|NCT02091154|Food Intake Regulation|food intake regulation
4899232|NCT02091154|Fruit|fruit
4899233|NCT02091154|Vegetable|vegetable
4899234|NCT02091115|Constipation|constipation
4899235|NCT02091115|ROMA III criteria|roma iii criteria
4899236|NCT02091115|Scale Bristol|scale bristol
4899237|NCT02091076|Silk fibroin with bioactive coating layer dressing|silk fibroin with bioactive coating layer dressing
4899238|NCT02091076|Wound healing|wound healing
4899239|NCT02091076|Skin graft donor|skin graft donor
4899240|NCT02091063|hematologic malignancies|hematologic malignancies
4899241|NCT02091063|hodgkin|hodgkin
4899242|NCT02091063|hodgkins|hodgkins
4899243|NCT02091063|non-hodgkin|non-hodgkin
4899244|NCT02091063|non-hodgkins|non-hodgkins
4899245|NCT02091063|mantle cell lymphoma|mantle cell lymphoma
4899246|NCT02091063|follicular|follicular
4899247|NCT02091063|lymphoma|lymphoma
4900110|NCT02086565|portal,|portal,
4899248|NCT02091063|lymphoid malignancies|lymphoid malignancies
4899249|NCT02091050|3D Brachytherapy|3d brachytherapy
4899250|NCT02091050|cervical cancer|cervical cancer
4899251|NCT02091050|endometrial cancer|endometrial cancer
4899252|NCT02091050|vaginal vault brachytherapy|vaginal vault brachytherapy
4899253|NCT02091037|Atopic dermatitis|atopic dermatitis
4899254|NCT02091037|Bacterial colonization|bacterial colonization
4899255|NCT02091011|This study is designed to efficiently provide device and battery longevity data on market released|this study is designed to efficiently provide device and battery longevity data on market released
4899256|NCT02091011|Boston Scientific ICD and CRT-D (Cardiac Resynchronization Therapy Defibrillator) devices. In addition, the data collected will allow for|boston scientific icd and crt-d (cardiac resynchronization therapy defibrillator) devices. in addition, the data collected will allow for
4899257|NCT02091011|comparisons of device survival probability estimated in the Product Performance Report versus|comparisons of device survival probability estimated in the product performance report versus
4899258|NCT02091011|those collected in the study. The data collected will also provide a better understanding on the|those collected in the study. the data collected will also provide a better understanding on the
4899259|NCT02091011|potential predictors of pulse generator battery longevity.|potential predictors of pulse generator battery longevity.
4899260|NCT02090998|Migraine Headache|migraine headache
4899261|NCT02090998|Menstrual Migraine|menstrual migraine
4899262|NCT02090998|Vascular Headache|vascular headache
4899263|NCT02090998|Temporal Lobe Seizure|temporal lobe seizure
4899264|NCT02090985|Stoma|stoma
4899265|NCT02090985|Peri-stomal|peri-stomal
4899266|NCT02090985|Lipomodelling|lipomodelling
4899267|NCT02090959|Duchenne muscular dystrophy|duchenne muscular dystrophy
4899268|NCT02090959|Dystrophinopathy|dystrophinopathy
4899269|NCT02090959|Nonsense mutation|nonsense mutation
4899270|NCT02090959|Premature stop codon|premature stop codon
4899271|NCT02090959|Becker muscular dystrophy|becker muscular dystrophy
4899272|NCT02090959|DMD/BMD|dmd/bmd
4899273|NCT02090959|PTC124|ptc124
4899274|NCT02090959|Ataluren|ataluren
4899275|NCT02090946|children with physical disabilities|children with physical disabilities
4899276|NCT02090946|home activity programs|home activity programs
4899277|NCT02090946|home programmes|home programmes
4899278|NCT02090946|learning|learning
4899279|NCT02090946|therapeutic relationship|therapeutic relationship
4899280|NCT02090946|phenomenology|phenomenology
4899281|NCT02090946|physiotherapy|physiotherapy
4899282|NCT02090946|clinicians who teach|clinicians who teach
4899283|NCT02090946|parent perspective|parent perspective
4899284|NCT02090946|parent-professional relationships|parent-professional relationships
4899285|NCT02090946|Parents/carers|parents/carers
4899286|NCT02090946|long term physiotherapy needs|long term physiotherapy needs
4899287|NCT02090907|Subclinical hypothyroidism|subclinical hypothyroidism
4899288|NCT02090907|Atherosclerosis|atherosclerosis
4899289|NCT02090907|Cardiovascular disease|cardiovascular disease
4899290|NCT02090907|Endothelial function|endothelial function
4899291|NCT02090907|Prevention|prevention
4899292|NCT02090868|Non-Invasive Ventilation|non-invasive ventilation
4899293|NCT02090868|Bi-Level Positive Airway Pressure|bi-level positive airway pressure
4899294|NCT02090868|Continuous Positive Airway Pressure|continuous positive airway pressure
4899295|NCT02090868|Critical Care|critical care
4899296|NCT02090868|Nutrition|nutrition
4899297|NCT02090868|Malnutrition|malnutrition
4899298|NCT02090868|Staff attitudes, knowledge and beliefs|staff attitudes, knowledge and beliefs
4899299|NCT02090842|Milk proteins|milk proteins
4899300|NCT02090842|Blood pressure|blood pressure
4899301|NCT02090842|Vascular function|vascular function
4899302|NCT02090829|Autism|autism
4899303|NCT02090829|Oxytocin|oxytocin
4899304|NCT02090829|Syntocinon|syntocinon
4899305|NCT02090790|dexamethasone|dexamethasone
4899306|NCT02090790|femoral block|femoral block
4899307|NCT02090790|total knee arthroplasty|total knee arthroplasty
4899308|NCT02090751|Retinal Rod Photoreceptor Cells|retinal rod photoreceptor cells
4899309|NCT02090751|Dark Adaptation|dark adaptation
4899310|NCT02090725|fluctuating muscle weakness|fluctuating muscle weakness
4899311|NCT02090725|hyporeflexia|hyporeflexia
4899312|NCT02090725|autonomic Dysfunction|autonomic dysfunction
4899313|NCT02090712|myocardial infarction|myocardial infarction
4899314|NCT02090712|acute coronary syndrome|acute coronary syndrome
4899315|NCT02090712|coronary disease|coronary disease
4899316|NCT02090699|thalassemia major|thalassemia major
4899317|NCT02090699|chronic blood transfusion related iron overload|chronic blood transfusion related iron overload
4899318|NCT02090699|magnetic resonance imaging|magnetic resonance imaging
4899319|NCT02090699|myocardium|myocardium
4899320|NCT02090699|fibrosis|fibrosis
4899321|NCT02090647|dental implant, aesthetic, implant abutment|dental implant, aesthetic, implant abutment
4899322|NCT02090634|HIV|hiv
4899323|NCT02090634|Bipolar Disorder|bipolar disorder
4899324|NCT02090634|Medication Adherence|medication adherence
4899325|NCT02090621|Liver|liver
4899326|NCT02090621|transplantation|transplantation
4899327|NCT02090621|Immunosuppression|immunosuppression
4899328|NCT02090621|photopheresis|photopheresis
4899329|NCT02090621|extracorporeal|extracorporeal
4899330|NCT02090595|bipolar disorder|bipolar disorder
4899331|NCT02090595|anxiety|anxiety
4899332|NCT02090595|mindfulness|mindfulness
4899333|NCT02090595|high risk|high risk
4901604|NCT02079935|purge|purge
4899334|NCT02090595|cognitive behavioral|cognitive behavioral
4899335|NCT02090569|Functional micro-Doppler Sonography, fmDS, dysplasia, epilepsy, neurosurgery, cerebral blood volume, echography, hemodynamics|functional micro-doppler sonography, fmds, dysplasia, epilepsy, neurosurgery, cerebral blood volume, echography, hemodynamics
4899336|NCT02090530|Cancer Genomics|cancer genomics
4899337|NCT02090530|Tumor Sequencing|tumor sequencing
4899338|NCT02090517|Nasal telangiectasis|nasal telangiectasis
4899339|NCT02090504|alcohol withdrawal syndrome|alcohol withdrawal syndrome
4899340|NCT02090504|treatment|treatment
4899341|NCT02090504|sodium oxybate|sodium oxybate
4899342|NCT02090504|oxazepam|oxazepam
4899343|NCT02090491|autism|autism
4899344|NCT02090465|Actinic Keratosis|actinic keratosis
4899345|NCT02090452|Telemedicine|telemedicine
4899346|NCT02090452|Mobile|mobile
4899347|NCT02090452|Vital signs|vital signs
4899348|NCT02090452|Prehospital care|prehospital care
4899349|NCT02090452|Emergency medicine|emergency medicine
4899350|NCT02090413|multiple sclerosis|multiple sclerosis
4899351|NCT02090413|flushing|flushing
4899352|NCT02090413|aspirin|aspirin
4899353|NCT02090400|Women|women
4899354|NCT02090400|Osteoporosis, Postmenopausal|osteoporosis, postmenopausal
4899355|NCT02090400|Bazedoxifene|bazedoxifene
4899356|NCT02090400|BMD|bmd
4899357|NCT02090374|Allergy|allergy
4899358|NCT02090374|Asthma|asthma
4899359|NCT02090374|Biomarkers|biomarkers
4899360|NCT02090374|Chemokines|chemokines
4899361|NCT02090374|Cytokines|cytokines
4899362|NCT02090374|Eosinophil|eosinophil
4899363|NCT02090374|Gene Expression|gene expression
4899364|NCT02090374|Grass pollen|grass pollen
4899365|NCT02090374|Hay Fever|hay fever
4899366|NCT02090374|Human Challenge Study|human challenge study
4899367|NCT02090374|Inflammation|inflammation
4899368|NCT02090374|Innate Immune Response|innate immune response
4899369|NCT02090374|Lipopolysaccharide|lipopolysaccharide
4899370|NCT02090374|Mucosal Lining Fluid|mucosal lining fluid
4899371|NCT02090374|Nasal|nasal
4899372|NCT02090374|Nasorption|nasorption
4899373|NCT02090374|Respiratory|respiratory
4899374|NCT02090374|Respiratory Tract Infection|respiratory tract infection
4899375|NCT02090374|T cells|t cells
4899376|NCT02090374|Tuberculosis|tuberculosis
4899377|NCT02090374|Virus|virus
4899378|NCT02090361|collagen -elastin matrix|collagen -elastin matrix
4899379|NCT02090361|skin graft|skin graft
4899380|NCT02090361|loss of cutaneous substance|loss of cutaneous substance
4899381|NCT02090335|community mental health|community mental health
4899382|NCT02090335|health coach|health coach
4899383|NCT02090335|weight loss|weight loss
4899384|NCT02090335|fitness|fitness
4899385|NCT02090335|serious mental illness|serious mental illness
4899386|NCT02090335|health promotion|health promotion
4899387|NCT02090322|ROP|rop
4899388|NCT02090322|Bevacizumab|bevacizumab
4899389|NCT02090322|No inferiority|no inferiority
4899390|NCT02090283|Epidermolysis Bullosa|epidermolysis bullosa
4899391|NCT02090283|Simplex|simplex
4899392|NCT02090283|Recessive Dystrophic|recessive dystrophic
4899393|NCT02090283|Junctional non-Herlitz|junctional non-herlitz
4899394|NCT02090270|hair cortisol|hair cortisol
4899395|NCT02090270|stroke|stroke
4899396|NCT02090257|Heart transplant recipients who are entering into adult care.|heart transplant recipients who are entering into adult care.
4899397|NCT02090244|PTH|pth
4899398|NCT02090244|Spinal stenosis|spinal stenosis
4899399|NCT02090244|Teriparatide|teriparatide
4899400|NCT02090231|stroke|stroke
4899401|NCT02090231|dysphagia|dysphagia
4899402|NCT02090231|rTMS|rtms
4899403|NCT02090205|cardio-pulmonary bypass|cardio-pulmonary bypass
4899404|NCT02090205|cardiac surgery|cardiac surgery
4899405|NCT02090205|lung injury prevention|lung injury prevention
4899406|NCT02090205|mechanical ventilation|mechanical ventilation
4899407|NCT02090205|pulmonary insufficiency|pulmonary insufficiency
4899408|NCT02090192|Whole-body vibration;|whole-body vibration;
4899409|NCT02090192|Frail Elderly;|frail elderly;
4899410|NCT02090192|Blood flow;|blood flow;
4899411|NCT02090192|Bone density|bone density
4899412|NCT02090192|Mobility;|mobility;
4899413|NCT02090192|Balance;|balance;
4899414|NCT02090192|Muscle strength;|muscle strength;
4899415|NCT02090192|Lower Extremity;|lower extremity;
4899416|NCT02090192|Musculoskeletal System;|musculoskeletal system;
4899417|NCT02090192|Health Status;|health status;
4899418|NCT02090192|Exercise;|exercise;
4899419|NCT02090192|Mechanical Oscillation|mechanical oscillation
4899420|NCT02090179|MPS IIIB|mps iiib
4899421|NCT02090179|Mucopolysaccharidosis|mucopolysaccharidosis
4899422|NCT02090179|Mucopolysaccharidosis type IIIB|mucopolysaccharidosis type iiib
4899423|NCT02090179|Sanfilippo Syndrome|sanfilippo syndrome
4899424|NCT02090179|Metabolism, Inborn Errors|metabolism, inborn errors
4899425|NCT02090179|Metabolic Diseases|metabolic diseases
4899426|NCT02090179|Genetic Diseases, Inborn|genetic diseases, inborn
4899427|NCT02090153|Advance Gastric Cancer,|advance gastric cancer,
4899428|NCT02090153|S-1 plus leucovorin,|s-1 plus leucovorin,
4899429|NCT02090153|ORR,|orr,
4899430|NCT02090153|OS,|os,
4899431|NCT02090153|TTP,|ttp,
4899432|NCT02090153|TTF,|ttf,
4899433|NCT02090153|Adverse events,|adverse events,
4899434|NCT02090153|Pharmacokinetics|pharmacokinetics
4901807|NCT02078973|Tolvaptan|tolvaptan
4899435|NCT02090140|cartilage/transplantation|cartilage/transplantation
4899436|NCT02090140|cartilage, articular/injuries|cartilage, articular/injuries
4899437|NCT02090140|cartilage, articular/surgery|cartilage, articular/surgery
4899438|NCT02090140|chondrocytes/cytology|chondrocytes/cytology
4899439|NCT02090140|knee injuries/surgery|knee injuries/surgery
4899440|NCT02090140|knee joint/surgery|knee joint/surgery
4899441|NCT02090140|orthopedic procedures/methods|orthopedic procedures/methods
4899442|NCT02090140|tissue engineering|tissue engineering
4899443|NCT02090140|tissue scaffolds|tissue scaffolds
4899444|NCT02090140|arthroscopy/methods|arthroscopy/methods
4899445|NCT02090140|chondrocytes/transplantation|chondrocytes/transplantation
4899446|NCT02090140|adipose tissue/cytology|adipose tissue/cytology
4899447|NCT02090140|cartilage, articular/cytology|cartilage, articular/cytology
4899448|NCT02090140|chondrogenesis/physiology|chondrogenesis/physiology
4899449|NCT02090140|osteogenesis/physiology|osteogenesis/physiology
4899450|NCT02090140|stem cell transplantation/methods|stem cell transplantation/methods
4899451|NCT02090140|stem cells|stem cells
4899452|NCT02090140|tissue engineering/methods|tissue engineering/methods
4899453|NCT02090140|cartilage, articular/pathology|cartilage, articular/pathology
4899454|NCT02090140|chondrocytes/pathology|chondrocytes/pathology
4899455|NCT02090140|knee joint/pathology|knee joint/pathology
4899456|NCT02090140|platelet-rich plasma|platelet-rich plasma
4899457|NCT02090114|Bipolar Androgen Therapy|bipolar androgen therapy
4899458|NCT02090114|Testosterone|testosterone
4899459|NCT02090114|Enzalutamide|enzalutamide
4899460|NCT02090114|Abiraterone|abiraterone
4899461|NCT02090114|Androgen Ablative Therapies|androgen ablative therapies
4899462|NCT02090075|cardiac Computed tomography|cardiac computed tomography
4899463|NCT02090075|coronary calcification|coronary calcification
4899464|NCT02090075|intervention|intervention
4899465|NCT02090075|warfarin|warfarin
4899466|NCT02090075|apixaban|apixaban
4899467|NCT02090062|endoscopic resection|endoscopic resection
4899468|NCT02090062|H. pylori infection|h. pylori infection
4899469|NCT02090049|Appetite|appetite
4899470|NCT02090049|Satiety|satiety
4899471|NCT02090049|Bread|bread
4899472|NCT02090049|Dietary fiber|dietary fiber
4899473|NCT02090049|Gastrointestinal hormones|gastrointestinal hormones
4899474|NCT02090049|Glycemia|glycemia
4899475|NCT02090049|Insulinemia|insulinemia
4899476|NCT02090036|Efficacy|efficacy
4899477|NCT02090036|Safety|safety
4899478|NCT02090036|Primaquine|primaquine
4899479|NCT02090036|Artemether-lumefantrine|artemether-lumefantrine
4899480|NCT02090036|Gametocytes|gametocytes
4899481|NCT02090023|Obstructive sleep apnea|obstructive sleep apnea
4899482|NCT02090023|National Health Insurance Research Database in Taiwan|national health insurance research database in taiwan
4899483|NCT02090023|Survival Analysis|survival analysis
4899484|NCT02090023|Validation Studies|validation studies
4899485|NCT02090023|Cohort Studies|cohort studies
4899486|NCT02089997|Pharmacological therapy|pharmacological therapy
4899487|NCT02089984|Cognitive Behavior Therapy|cognitive behavior therapy
4899488|NCT02089984|On-line training|on-line training
4899614|NCT02089230|Advanced leukemias|advanced leukemias
4899489|NCT02089958|Lapraoscopy, incisional hernia repair, mesh|lapraoscopy, incisional hernia repair, mesh
4899490|NCT02089945|transcatheter aortic valve implantation|transcatheter aortic valve implantation
4899491|NCT02089945|severe aortic stenosis|severe aortic stenosis
4899492|NCT02089945|cognition|cognition
4899493|NCT02089945|functional capacity|functional capacity
4899494|NCT02089945|quality of life|quality of life
4899495|NCT02089932|femoral nerve block|femoral nerve block
4899496|NCT02089932|peri-neural dexmedetomidine|peri-neural dexmedetomidine
4899497|NCT02089867|Ezetimibe|ezetimibe
4899498|NCT02089867|Plant sterol|plant sterol
4899499|NCT02089867|Hydroxymethylglutaryl coenzyme A Reductase Inhibitors|hydroxymethylglutaryl coenzyme a reductase inhibitors
4899500|NCT02089867|Coronary artery disease|coronary artery disease
4899501|NCT02089867|LDL-cholesterol|ldl-cholesterol
4899502|NCT02089854|triple negative breast cancer|triple negative breast cancer
4899503|NCT02089854|estrogen receptor-beta|estrogen receptor-beta
4899504|NCT02089854|endocrine therapy|endocrine therapy
4899505|NCT02089841|Efficacy|efficacy
4899506|NCT02089841|Artemether/lumefantrine|artemether/lumefantrine
4899507|NCT02089841|Malaria|malaria
4899508|NCT02089841|Children|children
4899510|NCT02089789|Thrombosis|thrombosis
4899511|NCT02089789|Intellectual Disability|intellectual disability
4899512|NCT02089789|Hypotonia|hypotonia
4899513|NCT02089789|Hypoglycemia|hypoglycemia
4899514|NCT02089789|Hypothyroidism|hypothyroidism
4899515|NCT02089776|Stroke|stroke
4899516|NCT02089776|fMRI|fmri
4899517|NCT02089776|Real Time fMRI Feedback|real time fmri feedback
4899518|NCT02089763|Hepatocellular carcinoma|hepatocellular carcinoma
4899519|NCT02089763|HCC|hcc
4899520|NCT02089763|Pegylated recombinant human arginase|pegylated recombinant human arginase
4899521|NCT02089763|PEG-BCT-100|peg-bct-100
4899522|NCT02089763|ASS|ass
4899523|NCT02089763|OTC|otc
4899524|NCT02089750|Low Back Pain|low back pain
4899525|NCT02089750|Chiropractic|chiropractic
4899526|NCT02089750|Shoe Orthotics|shoe orthotics
4899527|NCT02089711|Normal subjects|normal subjects
4899528|NCT02089698|Kelman tip|kelman tip
4899529|NCT02089698|Mini-flared|mini-flared
4901808|NCT02078973|L-NMMA|l-nmma
4899530|NCT02089698|phacoemulsification|phacoemulsification
4899531|NCT02089698|cataract|cataract
4899532|NCT02089633|hepatocellular carcinoma|hepatocellular carcinoma
4899533|NCT02089633|HCC|hcc
4899534|NCT02089633|pegylated recombinant human arginase|pegylated recombinant human arginase
4899535|NCT02089633|PEG-BCT-100|peg-bct-100
4899536|NCT02089633|oxaliplatin|oxaliplatin
4899537|NCT02089633|capecitabine|capecitabine
4899538|NCT02089620|Premenstrual syndrome|premenstrual syndrome
4899539|NCT02089620|Oral contraceptive pills|oral contraceptive pills
4899540|NCT02089620|Calcium Supplements|calcium supplements
4899541|NCT02089594|Hyperbaric Oxygen Treatment|hyperbaric oxygen treatment
4899542|NCT02089594|Mild Traumatic Brain Injury|mild traumatic brain injury
4899543|NCT02089594|Persistent Post-Concussion Syndrome|persistent post-concussion syndrome
4899544|NCT02089581|Healthy Volunteer|healthy volunteer
4899545|NCT02089581|Pharmacokinetics|pharmacokinetics
4899546|NCT02089581|Bioequivalence|bioequivalence
4899547|NCT02089568|Living donation|living donation
4899548|NCT02089568|Antibiotics|antibiotics
4899549|NCT02089568|Laparoscopic surgery|laparoscopic surgery
4899550|NCT02089542|thyroidectomy|thyroidectomy
4899551|NCT02089542|parathyroid surgery|parathyroid surgery
4899552|NCT02089542|parathyroid identification|parathyroid identification
4899553|NCT02089542|methylene blue|methylene blue
4899554|NCT02089542|near infrared fluorescence|near infrared fluorescence
4899555|NCT02089542|intraoperative imaging|intraoperative imaging
4899556|NCT02089529|Axial Spondyloarthritis|axial spondyloarthritis
4899557|NCT02089529|Pain|pain
4899558|NCT02089529|NSAIDs|nsaids
4899559|NCT02089529|Placebo|placebo
4899560|NCT02089529|Placebo intervention|placebo intervention
4899561|NCT02089529|Stress|stress
4899562|NCT02089529|Conditioning|conditioning
4899563|NCT02089516|Frailty|frailty
4899564|NCT02089516|Accelerometry|accelerometry
4899565|NCT02089516|Physical activity|physical activity
4899566|NCT02089516|validity|validity
4899567|NCT02089477|Type 2 diabetes, InterWalk, Individual Support, Motivation|type 2 diabetes, interwalk, individual support, motivation
4899568|NCT02089412|Healthy Subjects|healthy subjects
4899569|NCT02089412|Absorption|absorption
4899570|NCT02089412|High-Fat Meal|high-fat meal
4899571|NCT02089360|Advanced glycation end product|advanced glycation end product
4899572|NCT02089360|coronary|coronary
4899573|NCT02089360|atherosclerosis|atherosclerosis
4899574|NCT02089360|inflammation|inflammation
4899575|NCT02089360|outcome|outcome
4899576|NCT02089347|Tetanus|tetanus
4899577|NCT02089347|Diphtheria|diphtheria
4899578|NCT02089347|Pertussis|pertussis
4899579|NCT02089347|TdaP vaccine|tdap vaccine
4899580|NCT02089347|DT vaccine|dt vaccine
4899581|NCT02089334|renal cell carcinoma|renal cell carcinoma
4899582|NCT02089334|clear cell|clear cell
4899583|NCT02089334|renal cancer|renal cancer
4899584|NCT02089334|metastatic renal cancer|metastatic renal cancer
4899585|NCT02089334|Carcinoma, Renal Cell*/therapy|carcinoma, renal cell*/therapy
4899586|NCT02089334|Humans|humans
4899587|NCT02089334|Kidney Neoplasms*/therapy|kidney neoplasms*/therapy
4899588|NCT02089321|low back pain|low back pain
4899589|NCT02089321|lumbopelvic assessment|lumbopelvic assessment
4899590|NCT02089321|active straight leg raise|active straight leg raise
4899591|NCT02089321|active hip abduction|active hip abduction
4899592|NCT02089308|Smoking cessation|smoking cessation
4899593|NCT02089308|Nicotine|nicotine
4899594|NCT02089308|Tobacco Use Disorder|tobacco use disorder
4899595|NCT02089308|Central Nervous System Agents|central nervous system agents
4899596|NCT02089295|dose proportionality|dose proportionality
4899597|NCT02089295|oxycodone|oxycodone
4899598|NCT02089269|pancreatic neoplasms|pancreatic neoplasms
4899599|NCT02089269|neoplasms|neoplasms
4899600|NCT02089269|registry|registry
4899601|NCT02089269|advanced pancreatic cancer|advanced pancreatic cancer
4899602|NCT02089269|health services research|health services research
4899603|NCT02089269|epidemiology|epidemiology
4899604|NCT02089269|Germany|germany
4899605|NCT02089269|palliative treatment|palliative treatment
4899606|NCT02089269|palliative care|palliative care
4899607|NCT02089269|localized, resectable pancreatic cancer|localized, resectable pancreatic cancer
4899608|NCT02089269|adjuvant treatment|adjuvant treatment
4899609|NCT02089243|Epilepsy,Temporal Lobe|epilepsy,temporal lobe
4899610|NCT02089243|Brain Diseases|brain diseases
4899611|NCT02089230|Leukemia|leukemia
4899612|NCT02089230|Acute Myeloid Leukemia|acute myeloid leukemia
4899613|NCT02089230|AML|aml
4899615|NCT02089230|Myelodysplastic syndrome|myelodysplastic syndrome
4899616|NCT02089230|MDS|mds
4899617|NCT02089230|Acute lymphoblastic leukemia|acute lymphoblastic leukemia
4899618|NCT02089230|ALL|all
4899619|NCT02089230|Relapsed|relapsed
4899620|NCT02089230|Refractory|refractory
4899621|NCT02089230|MEK 162|mek 162
4899622|NCT02089217|asymptomatic|asymptomatic
4899623|NCT02089217|carotid|carotid
4899624|NCT02089217|stent|stent
4899625|NCT02089217|endarterectomy|endarterectomy
4899626|NCT02089217|embolic protection|embolic protection
4899627|NCT02089217|medical management|medical management
4899628|NCT02089217|hypertension|hypertension
4899629|NCT02089217|hyperlipidemia|hyperlipidemia
4899630|NCT02089217|cognition|cognition
4899631|NCT02089217|risk factor control|risk factor control
4899632|NCT02089204|Hypoxia Imaging -Guided Radiotherapy|hypoxia imaging -guided radiotherapy
4899633|NCT02089204|PET/CT|pet/ct
4899634|NCT02089204|simultaneous modulated accelerated radiation therapy (SMART)|simultaneous modulated accelerated radiation therapy (smart)
4899635|NCT02089191|DACP|dacp
4899636|NCT02089191|DAILIES® AquaComfort Plus|dailies® aquacomfort plus
4899637|NCT02089191|Tear film stability|tear film stability
4899638|NCT02089191|NIK-BUT|nik-but
4899639|NCT02089178|total intravenous anesthesia, inhalation anesthesia, cancer cell cytotoxicity, breast tumor|total intravenous anesthesia, inhalation anesthesia, cancer cell cytotoxicity, breast tumor
4899640|NCT02089152|Diabetes|diabetes
4899641|NCT02089152|Melioidosis|melioidosis
4899642|NCT02089152|stepped wedge trial|stepped wedge trial
4899643|NCT02089152|behaviour change|behaviour change
4899644|NCT02089152|Education program|education program
4899645|NCT02089139|Back pain|back pain
4899646|NCT02089139|Discogel|discogel
4899647|NCT02089087|Rheumatoid arthritis, RA, first-in-human, single ascending dose, safety, tolerability|rheumatoid arthritis, ra, first-in-human, single ascending dose, safety, tolerability
4899648|NCT02089074|Secondary Prevention|secondary prevention
4899649|NCT02089074|Pharmacists|pharmacists
4899650|NCT02089074|Directive Counseling|directive counseling
4899651|NCT02089074|Medication Adherence|medication adherence
4899652|NCT02089074|Patient Compliance|patient compliance
4899653|NCT02089048|Amebiasis|amebiasis
4899654|NCT02089048|auranofin|auranofin
4899655|NCT02089048|pharmacodynamics|pharmacodynamics
4899656|NCT02089048|pharmokinetics|pharmokinetics
4899657|NCT02089035|Milk fatty acids|milk fatty acids
4899658|NCT02089035|Total cholesterol|total cholesterol
4899659|NCT02089035|Vascular function|vascular function
4899660|NCT02089035|Blood pressure|blood pressure
4899661|NCT02089022|Ice|ice
4899662|NCT02089022|Heat|heat
4899663|NCT02089022|Ground reaction forces|ground reaction forces
4899664|NCT02089022|Electromyography|electromyography
4899665|NCT02089022|Lower Limb|lower limb
4899666|NCT02089022|Center of pressure|center of pressure
4899667|NCT02088970|Infectious keratitis|infectious keratitis
4899668|NCT02088970|Corneal cross linking|corneal cross linking
4899669|NCT02088970|Topical antibiotics|topical antibiotics
4899670|NCT02088957|Brivaracetam|brivaracetam
4899671|NCT02088957|Phenytoin|phenytoin
4899672|NCT02088957|Nonconvulsive electrographic seizures|nonconvulsive electrographic seizures
4899673|NCT02088931|Tregs|tregs
4899674|NCT02088931|Kidney transplantation|kidney transplantation
4899675|NCT02088905|PCIT, autism, parent training, noncompliance|pcit, autism, parent training, noncompliance
4899676|NCT02088892|BCG challenge study|bcg challenge study
4899677|NCT02088866|Tinnitus|tinnitus
4899678|NCT02088866|Otolaryngology|otolaryngology
4899679|NCT02088853|intestinal|intestinal
4899680|NCT02088853|metabolic control|metabolic control
4899681|NCT02088853|mucosa|mucosa
4899682|NCT02088853|human|human
4899683|NCT02088853|diet|diet
4899684|NCT02088840|SIGNB|signb
4899685|NCT02088840|severe infections gram negative bacteria|severe infections gram negative bacteria
4899686|NCT02088840|stem cell transplant|stem cell transplant
4899687|NCT02088827|Exercise|exercise
4899688|NCT02088827|Sedentary Behaviour|sedentary behaviour
4899689|NCT02088827|Type 2 Diabetes|type 2 diabetes
4899690|NCT02088827|Older Adults|older adults
4899691|NCT02088814|posttraumatic stress|posttraumatic stress
4899692|NCT02088814|burns|burns
4899693|NCT02088814|injuries|injuries
4899694|NCT02088814|children|children
4899695|NCT02088801|Intubation; Difficult|intubation; difficult
4899696|NCT02088788|radiation|radiation
4899697|NCT02088788|radiation injury|radiation injury
4899698|NCT02088788|occupational risk|occupational risk
4899699|NCT02088762|margin of safety|margin of safety
4899700|NCT02088749|obesity|obesity
4899701|NCT02088749|weight loss|weight loss
4899702|NCT02088749|treatment|treatment
4899703|NCT02088749|lifestyle|lifestyle
4899704|NCT02088723|Sleep Apnea, Obstructive|sleep apnea, obstructive
4899705|NCT02088723|Sleep Apnea Syndromes|sleep apnea syndromes
4899706|NCT02088723|Polysomnography|polysomnography
4899707|NCT02088723|Sleep|sleep
4899708|NCT02088723|Patient Positioning|patient positioning
4899709|NCT02088710|Patients´ Expectations|patients´ expectations
4899710|NCT02088710|Breast Cancer|breast cancer
4899711|NCT02088710|Adjuvant Endocrine Treatment|adjuvant endocrine treatment
4899712|NCT02088710|Nocebo|nocebo
4899713|NCT02088710|Psycho-oncology|psycho-oncology
4899714|NCT02088710|Satisfaction with information|satisfaction with information
4899715|NCT02088684|Hormone receptor positive, HER2 negative|hormone receptor positive, her2 negative
4899716|NCT02088671|NeuroSENSE|neurosense
4899717|NCT02088671|Anesthesia|anesthesia
4899718|NCT02088671|Hypnosis|hypnosis
4899719|NCT02088671|Desflurane|desflurane
4899720|NCT02088671|Propofol|propofol
4899721|NCT02088658|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
4899722|NCT02088658|Diabetes Mellitus, Adult-Onset|diabetes mellitus, adult-onset
4899723|NCT02088658|Diabetes Mellitus, Non-Insulin-Dependent|diabetes mellitus, non-insulin-dependent
4899724|NCT02088658|Diabetes Mellitus, Noninsulin Dependent|diabetes mellitus, noninsulin dependent
4899725|NCT02088658|Diabetes Mellitus, Type II|diabetes mellitus, type ii
4899726|NCT02088658|African Americans|african americans
4899727|NCT02088658|Blacks|blacks
4899728|NCT02088658|non-Hispanic Blacks|non-hispanic blacks
4899729|NCT02088658|Randomized Control Trial|randomized control trial
4899730|NCT02088658|Controlled Clinical Trial|controlled clinical trial
4899731|NCT02088658|Behavioral Research|behavioral research
4899732|NCT02088658|Behavioral Medicine|behavioral medicine
4899733|NCT02088645|Calcitonin|calcitonin
4899734|NCT02088645|Medullary thyroid carcinoma|medullary thyroid carcinoma
4899735|NCT02088645|Peptide receptor radionuclide therapy|peptide receptor radionuclide therapy
4899736|NCT02088645|Gastrin|gastrin
4899737|NCT02088645|Cholecystokinin-2 receptor|cholecystokinin-2 receptor
4899738|NCT02088619|psychological wellbeing|psychological wellbeing
4899739|NCT02088619|anxiety|anxiety
4899740|NCT02088619|depression|depression
4899741|NCT02088619|autonomic functioning|autonomic functioning
4899742|NCT02088606|Atrial fibrillation|atrial fibrillation
4899743|NCT02088593|Medical Students|medical students
4899744|NCT02088541|Relapsed/Refractory Acute Myeloid Leukemia|relapsed/refractory acute myeloid leukemia
4899745|NCT02088541|Acute Myeloid Leukemia|acute myeloid leukemia
4899746|NCT02088541|AML|aml
4899747|NCT02088541|Karyopharm|karyopharm
4899748|NCT02088541|Selinexor|selinexor
4899749|NCT02088541|KPT-330|kpt-330
4899750|NCT02088515|Nedaplatin|nedaplatin
4899751|NCT02088515|lung squamous cell carcinoma|lung squamous cell carcinoma
4899752|NCT02088502|Coronary Angiography|coronary angiography
4899753|NCT02088502|Side Effects|side effects
4899754|NCT02088502|Contrast-Induced Nephropathy|contrast-induced nephropathy
4899755|NCT02088502|Prevention|prevention
4899756|NCT02088489|Atrial flutter|atrial flutter
4899757|NCT02088489|Thermocool catheter|thermocool catheter
4899758|NCT02088489|Thermocool SF catheter|thermocool sf catheter
4899759|NCT02088476|candidemia|candidemia
4899760|NCT02088476|children|children
4899761|NCT02088476|mortality|mortality
4899762|NCT02088476|risk factors|risk factors
4899763|NCT02088463|Mechanical LBP|mechanical lbp
4899764|NCT02088463|Mobilization|mobilization
4899765|NCT02088463|Postpartum|postpartum
4899766|NCT02088450|Cardiovascular complications|cardiovascular complications
4899767|NCT02088450|Clinical trial|clinical trial
4899768|NCT02088450|Elderly|elderly
4899769|NCT02088450|Isolated systolic hypertension|isolated systolic hypertension
4899770|NCT02088450|Stroke|stroke
4899771|NCT02088398|relative bioavailability|relative bioavailability
4899772|NCT02088398|food-effect|food-effect
4899773|NCT02088359|cycled light, near darkness, growth|cycled light, near darkness, growth
4899774|NCT02088346|Stroke|stroke
4899775|NCT02088346|Thrombolysis|thrombolysis
4899776|NCT02088346|Tissue plasminogen activator|tissue plasminogen activator
4899777|NCT02088346|Urokinase|urokinase
4899778|NCT02088346|Telemedicine|telemedicine
4899779|NCT02088333|colorectal cancer screening|colorectal cancer screening
4899780|NCT02088333|computer-assisted instruction|computer-assisted instruction
4899781|NCT02088333|mHealth|mhealth
4899782|NCT02088333|text message|text message
4899783|NCT02088307|cardiovascular supplement|cardiovascular supplement
4899784|NCT02088307|cardiovascular disease|cardiovascular disease
4899785|NCT02088307|coronary artery disease|coronary artery disease
4899786|NCT02088294|obesity|obesity
4899787|NCT02088294|stress|stress
4899788|NCT02088294|intuitive eating|intuitive eating
4899789|NCT02088294|guided imagery|guided imagery
4899790|NCT02088294|adolescents|adolescents
4899791|NCT02088294|insulin resistance|insulin resistance
4899792|NCT02088294|latinos|latinos
4899793|NCT02088294|minorities|minorities
4899794|NCT02088281|Indigo naturalis, indirubin, Th1 cells, Th17 cells|indigo naturalis, indirubin, th1 cells, th17 cells
4899795|NCT02088255|Rehabilitation|rehabilitation
4899796|NCT02088255|Gait|gait
4899797|NCT02088255|Stroke|stroke
4899798|NCT02088255|Biomechanics|biomechanics
4899799|NCT02088229|Diabetic Macular Edema|diabetic macular edema
4899800|NCT02088216|N-acetylcysteine；|n-acetylcysteine；
4899801|NCT02088216|Bronchiectasis；|bronchiectasis；
4899802|NCT02088216|Acute exacerbations；|acute exacerbations；
4899803|NCT02088216|Antioxidant；|antioxidant；
4899804|NCT02088216|Anti-inflammatory|anti-inflammatory
4899805|NCT02088177|Cannabis|cannabis
4899806|NCT02088177|Cannabis Dependence|cannabis dependence
4899807|NCT02088177|Cannabis Use Disorder|cannabis use disorder
4899808|NCT02088177|Marijuana|marijuana
4899809|NCT02088177|Naltrexone|naltrexone
4899810|NCT02088177|Long Acting Injectable Naltrexone|long acting injectable naltrexone
4899811|NCT02088177|Treatment|treatment
4899812|NCT02088164|PSA,|psa,
4899813|NCT02088164|asian men,|asian men,
4899814|NCT02088164|survival|survival
4899815|NCT02088151|selective laser therapy|selective laser therapy
4899816|NCT02088151|retinal pigment epithelium|retinal pigment epithelium
4899817|NCT02088151|macular edema|macular edema
4899818|NCT02088151|diabetic retinopathy|diabetic retinopathy
4899819|NCT02088151|central serous chorioretinopathy|central serous chorioretinopathy
4899820|NCT02088151|age-related macular degeneration|age-related macular degeneration
4899821|NCT02088151|retinal vein occlusion|retinal vein occlusion
4899822|NCT02088138|Thoracic Surgery|thoracic surgery
4899823|NCT02088138|Electrical Stimulation|electrical stimulation
4901906|NCT02078609|PIM,|pim,
4899824|NCT02088138|Rehabilitation|rehabilitation
4899825|NCT02088138|Quality of Life|quality of life
4899826|NCT02088125|Stroke|stroke
4899827|NCT02088125|Incentive Spirometry|incentive spirometry
4899828|NCT02088125|Breath Stacking|breath stacking
4899829|NCT02088125|Optoelectronic Plethysmography|optoelectronic plethysmography
4899830|NCT02088112|NSCLC|nsclc
4899831|NCT02088099|Traumatic brain injury|traumatic brain injury
4899832|NCT02088099|Telehealth|telehealth
4899833|NCT02088099|ehealth|ehealth
4899834|NCT02088099|Mobile Health|mobile health
4899835|NCT02088099|social participation|social participation
4899836|NCT02088099|patient participation|patient participation
4899837|NCT02088099|consumer participation|consumer participation
4899838|NCT02088099|Patient Outcome Assessment|patient outcome assessment
4899839|NCT02088086|Pediatric obesity|pediatric obesity
4899840|NCT02088086|Overweight|overweight
4899841|NCT02088086|Body mass index|body mass index
4899842|NCT02088086|Primary schools|primary schools
4899843|NCT02088086|Secondary schools|secondary schools
4899844|NCT02088047|Autism|autism
4899845|NCT02088047|Self-Stimulating behaviors|self-stimulating behaviors
4899846|NCT02088047|Autism Spectrum Disorders|autism spectrum disorders
4899847|NCT02087995|Diabetes Mellitus|diabetes mellitus
4899848|NCT02087956|Women|women
4899849|NCT02087956|Depression|depression
4899850|NCT02087956|Socioeconomically Disadvantaged|socioeconomically disadvantaged
4899851|NCT02087956|Navigation|navigation
4899852|NCT02087943|Atopic Dermatitis|atopic dermatitis
4899853|NCT02087943|Atopic Eczema|atopic eczema
4899854|NCT02087917|hypercholesterolemia|hypercholesterolemia
4899855|NCT02087917|cholesterol absorption inhibitor|cholesterol absorption inhibitor
4899856|NCT02087917|placebo-controlled trial|placebo-controlled trial
4899857|NCT02087904|Pain|pain
4899858|NCT02087904|Osteoarthritis|osteoarthritis
4899859|NCT02087904|Synovitis|synovitis
4899860|NCT02087904|Knee|knee
4899861|NCT02087878|Hepatosplenic T-Cell Lymphoma|hepatosplenic t-cell lymphoma
4899862|NCT02087852|Questionnaire|questionnaire
4899863|NCT02087852|DNA|dna
4899864|NCT02087852|saliva|saliva
4899865|NCT02087852|kidney cancer|kidney cancer
4899866|NCT02087852|13-218|13-218
4899867|NCT02087839|Non-Small Cell Lung Cancer|non-small cell lung cancer
4899868|NCT02087839|Lung Cancer|lung cancer
4899869|NCT02087839|NSCLC|nsclc
4899870|NCT02087839|ZD6474|zd6474
4899871|NCT02087839|ZACTIMA|zactima
4899872|NCT02087839|Vandetanib|vandetanib
4899873|NCT02087839|Inoperable NSCLC|inoperable nsclc
4899874|NCT02087839|Unresectable NSCLC|unresectable nsclc
4899875|NCT02087839|Radiation Therapy|radiation therapy
4899876|NCT02087839|Palliative radiation therapy|palliative radiation therapy
4899877|NCT02087839|Angiogenesis|angiogenesis
4899878|NCT02087813|neuromyelitis optica|neuromyelitis optica
4899879|NCT02087813|optic neuritis|optic neuritis
4899880|NCT02087813|longitudinally extensive transverse myelitis|longitudinally extensive transverse myelitis
4899881|NCT02087800|smoking cessation|smoking cessation
4899882|NCT02087800|smoking abstinence|smoking abstinence
4899883|NCT02087800|allopregnanolone|allopregnanolone
4899884|NCT02087787|bone marrow transplant|bone marrow transplant
4899885|NCT02087787|hematologic malignancies|hematologic malignancies
4899886|NCT02087761|ARIES Flu|aries flu
4899887|NCT02087748|DOMS|doms
4899888|NCT02087735|Cranberry|cranberry
4899889|NCT02087735|Proanthocyanidins|proanthocyanidins
4899890|NCT02087735|Urinary catabolites|urinary catabolites
4899891|NCT02087722|Primary Insomnia|primary insomnia
4899892|NCT02087696|Arthritis, Rheumatoid|arthritis, rheumatoid
4899893|NCT02087696|methotrexate|methotrexate
4899894|NCT02087696|intolerance|intolerance
4899895|NCT02087696|poor compliance|poor compliance
4899896|NCT02087696|contraindication|contraindication
4899897|NCT02087696|Tocilizumab|tocilizumab
4899898|NCT02087696|monotherapy|monotherapy
4899899|NCT02087683|heart failure|heart failure
4899900|NCT02087683|vitamin D deficiency|vitamin d deficiency
4899901|NCT02087683|ventricular function|ventricular function
4899902|NCT02087683|cytokines|cytokines
4899903|NCT02087670|chronic heart failure|chronic heart failure
4899904|NCT02087670|cardiac rehabilitation|cardiac rehabilitation
4899905|NCT02087670|exercise|exercise
4899906|NCT02087670|Natriuretic Brain Pro-peptid|natriuretic brain pro-peptid
4899907|NCT02087657|Peripheral Blood Stem Cell (PBSC) Transplant|peripheral blood stem cell (pbsc) transplant
4899908|NCT02087657|Hyperbaric oxygen|hyperbaric oxygen
4899909|NCT02087657|Lymphoma|lymphoma
4899910|NCT02087657|Myeloma|myeloma
4899911|NCT02087631|multiple sclerosis|multiple sclerosis
4899912|NCT02087631|quetiapine|quetiapine
4899913|NCT02087631|remyelination|remyelination
4899914|NCT02087618|MCI|mci
4899915|NCT02087618|Alzheimer's|alzheimer's
4899916|NCT02087618|Dementia|dementia
4899917|NCT02087618|Tablet|tablet
4899918|NCT02087618|Non-Pharmacological Intervention|non-pharmacological intervention
4899919|NCT02087618|Cognition|cognition
4899920|NCT02087605|Vascular stiffness, retinal vessels, target organ damage|vascular stiffness, retinal vessels, target organ damage
4899921|NCT02087592|hereditary breast and ovarian cancer (HBOC)|hereditary breast and ovarian cancer (hboc)
4899922|NCT02087592|BRCA1/2 mutation carriers|brca1/2 mutation carriers
4901907|NCT02078609|LGH447,|lgh447,
4899923|NCT02087592|Mediterranean diet|mediterranean diet
4899924|NCT02087592|Structured exercise training|structured exercise training
4899925|NCT02087592|prevention|prevention
4899926|NCT02087579|Psychotic Disorders|psychotic disorders
4899927|NCT02087579|Schizophrenia|schizophrenia
4899928|NCT02087579|Bipolar Disorder|bipolar disorder
4899929|NCT02087579|Depressive Disorder|depressive disorder
4899930|NCT02087579|Antipsychotics|antipsychotics
4899931|NCT02087579|Aripiprazole|aripiprazole
4899932|NCT02087579|Olanzapine|olanzapine
4899933|NCT02087579|Paliperidone|paliperidone
4899934|NCT02087579|Quetiapine|quetiapine
4899935|NCT02087579|Risperidone|risperidone
4899936|NCT02087579|Capillary Concentration|capillary concentration
4899937|NCT02087566|Linezolid|linezolid
4899938|NCT02087566|Pharmacokinetics|pharmacokinetics
4899939|NCT02087566|Haemodialysis|haemodialysis
4899940|NCT02087566|Dosing adjustment|dosing adjustment
4899941|NCT02087566|Eligible subjects were classified into three groups depending on their 24-h urinary creatinine clearance (CLcr) values or HD status.|eligible subjects were classified into three groups depending on their 24-h urinary creatinine clearance (clcr) values or hd status.
4899942|NCT02087566|Group 1, included 6 healthy subjects with normal renal function (CLcr ˃80 ml/min);|group 1, included 6 healthy subjects with normal renal function (clcr ˃80 ml/min);
4899943|NCT02087566|Group 2, included 6 patients with acute renal failure (RF) (30˂CLcr˂80 ml/mine);|group 2, included 6 patients with acute renal failure (rf) (30˂clcr˂80 ml/mine);
4899944|NCT02087566|Group 3, included 6 patients on long term haemodialysis (minimum period of dialysis was 40 month while maximum period were 130 month)|group 3, included 6 patients on long term haemodialysis (minimum period of dialysis was 40 month while maximum period were 130 month)
4899945|NCT02087553|Blood Transfusion|blood transfusion
4899946|NCT02087553|Iron|iron
4899947|NCT02087553|Packed Red Blood Cells|packed red blood cells
4899948|NCT02087553|PRBC|prbc
4899949|NCT02087553|NTBI|ntbi
4899950|NCT02087527|Cellulitis|cellulitis
4899951|NCT02087527|Soft Tissue Infections|soft tissue infections
4899952|NCT02087527|Skin Diseases, Infectious|skin diseases, infectious
4899953|NCT02087527|Corticosteroids|corticosteroids
4899954|NCT02087527|Glucocorticoids|glucocorticoids
4899955|NCT02087527|Dexamethasone|dexamethasone
4899956|NCT02087514|Blood Transfusion|blood transfusion
4899957|NCT02087514|Iron|iron
4899958|NCT02087514|Red Blood Cells|red blood cells
4899959|NCT02087501|Abdominal Aortic Aneurysm|abdominal aortic aneurysm
4899960|NCT02087501|AAA|aaa
4899961|NCT02087501|Abdominal Aortoiliac Aneurysm|abdominal aortoiliac aneurysm
4899962|NCT02087501|Endovascular Aortic Repair|endovascular aortic repair
4899963|NCT02087501|EVAR|evar
4899964|NCT02087488|primary insomnia|primary insomnia
4899965|NCT02087488|auricular acupuncture|auricular acupuncture
4899966|NCT02087462|Sciatica|sciatica
4899967|NCT02087462|Electroacupuncture|electroacupuncture
4899968|NCT02087462|Intervertebral disc displacement|intervertebral disc displacement
4899969|NCT02087423|Locally advanced, metastatic, Non-Small Cell Lung Cancer, MEDI4736, Durvalumab, PD-L1|locally advanced, metastatic, non-small cell lung cancer, medi4736, durvalumab, pd-l1
4899970|NCT02087397|Stem Cell|stem cell
4899971|NCT02087397|Erectile Dysfunction|erectile dysfunction
4899972|NCT02087384|Anal intraepithelial neoplasia|anal intraepithelial neoplasia
4899973|NCT02087384|HIV|hiv
4899974|NCT02087384|HPV|hpv
4899975|NCT02087384|Vaccination|vaccination
4899976|NCT02087384|Gardasil|gardasil
4899977|NCT02087384|Prophylactic|prophylactic
4899978|NCT02087358|alcohol dependence|alcohol dependence
4899979|NCT02087358|Stress- correlation|stress- correlation
4899980|NCT02087358|genetic|genetic
4899981|NCT02087358|CRHR1|crhr1
4900106|NCT02086565|asthma,|asthma,
4900107|NCT02086565|asthma control,|asthma control,
4899982|NCT02087332|Kidney damage hypertension cardiovascular diseases, congestive heart failure renal function natriuresis natriuresis monitoring|kidney damage hypertension cardiovascular diseases, congestive heart failure renal function natriuresis natriuresis monitoring
4899983|NCT02087306|Adenovirus Infection|adenovirus infection
4899984|NCT02087241|Stage IV Lung Cancer|stage iv lung cancer
4899985|NCT02087228|Endometrial ablation, menorrhagia|endometrial ablation, menorrhagia
4899986|NCT02087215|diabetes mellitus|diabetes mellitus
4899987|NCT02087215|foot ulcer|foot ulcer
4899988|NCT02087215|boron|boron
4899989|NCT02087215|wound care|wound care
4899990|NCT02087202|pain|pain
4899991|NCT02087189|ICD, CRT-D, lead|icd, crt-d, lead
4899992|NCT02087176|NSCLC|nsclc
4899993|NCT02087137|aging|aging
4899994|NCT02087137|memory|memory
4899995|NCT02087137|memory training|memory training
4899996|NCT02087124|Whey protein|whey protein
4899997|NCT02087124|Postprandial lipaemia|postprandial lipaemia
4899998|NCT02087124|Pre-meal|pre-meal
4899999|NCT02087124|Metabolic syndrome|metabolic syndrome
4900000|NCT02087111|Telaprevir|telaprevir
4900001|NCT02087111|Genotype 3 HCV|genotype 3 hcv
4900002|NCT02087098|overactive bladder|overactive bladder
4900003|NCT02087098|solifenacin|solifenacin
4900004|NCT02087098|quality of life|quality of life
4900005|NCT02087072|home visits|home visits
4900006|NCT02087072|transitions of care|transitions of care
4900007|NCT02087072|pharmacist|pharmacist
4900008|NCT02087059|Post-Polycythemia Vera (PV) MF|post-polycythemia vera (pv) mf
4900009|NCT02087059|Post-Essential Thrombocythemia (ET) MF|post-essential thrombocythemia (et) mf
4900111|NCT02086565|health literacy|health literacy
4900010|NCT02087033|supraventricular ectopic beats|supraventricular ectopic beats
4900011|NCT02087020|Joint Prosthesis|joint prosthesis
4900012|NCT02087020|Prosthesis-Related Infections|prosthesis-related infections
4900013|NCT02087020|Joint Diseases|joint diseases
4900014|NCT02087020|Therapeutic Irrigation|therapeutic irrigation
4900015|NCT02087020|Prostheses and Implants|prostheses and implants
4900016|NCT02087020|Arthroplasty Replacement|arthroplasty replacement
4900017|NCT02087007|Treatment for vasospastic angina|treatment for vasospastic angina
4900018|NCT02086994|carbetocin, misoprostol, pre-eclampsia, pph|carbetocin, misoprostol, pre-eclampsia, pph
4900019|NCT02086955|Diabetes|diabetes
4900020|NCT02086955|Nursing counseling|nursing counseling
4900021|NCT02086955|Foot ulceration|foot ulceration
4900022|NCT02086955|Outpatient|outpatient
4900023|NCT02086955|Advanced Practice Nurse|advanced practice nurse
4900024|NCT02086929|Trazodone|trazodone
4900025|NCT02086929|Venlafaxine|venlafaxine
4900026|NCT02086929|Major depressive disorder|major depressive disorder
4900027|NCT02086916|Clostridium difficile|clostridium difficile
4900028|NCT02086916|Prediction|prediction
4900029|NCT02086916|Treatment|treatment
4900030|NCT02086916|Failure|failure
4900031|NCT02086903|Ticagrelor|ticagrelor
4900032|NCT02086903|Clopidogrel|clopidogrel
4900033|NCT02086903|Platelet function test|platelet function test
4900034|NCT02086890|retinitis pigmentosa|retinitis pigmentosa
4900035|NCT02086890|acupuncture|acupuncture
4900036|NCT02086890|electroacupuncture|electroacupuncture
4900037|NCT02086890|transcorneal electrical stimulation|transcorneal electrical stimulation
4900038|NCT02086890|microcurrent|microcurrent
4900039|NCT02086864|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
4900040|NCT02086864|ADHD|adhd
4900041|NCT02086864|Homeopathy|homeopathy
4900042|NCT02086851|pediatric obesity|pediatric obesity
4900043|NCT02086851|motivational interviewing|motivational interviewing
4900044|NCT02086851|lifestyle intervention|lifestyle intervention
4900045|NCT02086838|Iron deficiency anemia|iron deficiency anemia
4900046|NCT02086838|Pregnancy|pregnancy
4900047|NCT02086838|Iron therapy|iron therapy
4900048|NCT02086799|asthma|asthma
4900049|NCT02086799|thyroid hormones|thyroid hormones
4900050|NCT02086799|treatment|treatment
4900051|NCT02086799|asthma exacerbation|asthma exacerbation
4900052|NCT02086773|Acute Leukemia|acute leukemia
4900053|NCT02086773|Red Cell Transfusion|red cell transfusion
4900054|NCT02086760|hydronephrosis|hydronephrosis
4900055|NCT02086747|Abdominal Hysterectomy, Acetaminophen, chronic pain|abdominal hysterectomy, acetaminophen, chronic pain
4900056|NCT02086734|Perfusion-CT|perfusion-ct
4900057|NCT02086734|mRCC|mrcc
4900058|NCT02086734|antiangiogenic therapy|antiangiogenic therapy
4900059|NCT02086734|response assessment|response assessment
4900060|NCT02086708|Sonoelastography,|sonoelastography,
4900061|NCT02086708|Diffuse liver disease,|diffuse liver disease,
4900062|NCT02086708|chronic liver disease,|chronic liver disease,
4900063|NCT02086708|NASH,|nash,
4900064|NCT02086708|NAFLD,|nafld,
4900065|NCT02086708|Elevated Transaminases,|elevated transaminases,
4900066|NCT02086708|Liver Biopsy,|liver biopsy,
4900067|NCT02086708|Fibrosis,|fibrosis,
4900068|NCT02086708|METAVIR|metavir
4900069|NCT02086695|Chemotherapy|chemotherapy
4900070|NCT02086695|Cardiotoxicity|cardiotoxicity
4900071|NCT02086682|hemodialysis|hemodialysis
4900072|NCT02086682|dialysis|dialysis
4900073|NCT02086682|renal dialysis|renal dialysis
4900074|NCT02086682|clotting|clotting
4900075|NCT02086682|coagulation|coagulation
4900076|NCT02086682|blood lines|blood lines
4900077|NCT02086656|liver metastases|liver metastases
4900078|NCT02086656|colorectal cancer|colorectal cancer
4900079|NCT02086656|perioperative treatment|perioperative treatment
4900080|NCT02086643|Infraclavicular block|infraclavicular block
4900081|NCT02086643|Brachial Plexus|brachial plexus
4900082|NCT02086643|Retroclavicular Approach|retroclavicular approach
4900083|NCT02086643|Complications of retroclavicular approach|complications of retroclavicular approach
4900084|NCT02086643|Success of retroclavicular approach|success of retroclavicular approach
4900085|NCT02086643|Obese Patients|obese patients
4900086|NCT02086643|Obesity and Anesthesia|obesity and anesthesia
4900087|NCT02086630|disparities|disparities
4900088|NCT02086630|antiretroviral|antiretroviral
4900089|NCT02086630|HIV|hiv
4900090|NCT02086630|barriers|barriers
4900091|NCT02086630|access|access
4900092|NCT02086630|delay|delay
4900093|NCT02086630|decline|decline
4900094|NCT02086630|discontinue|discontinue
4900095|NCT02086630|African American|african american
4900096|NCT02086630|Black|black
4900097|NCT02086630|Latino|latino
4900098|NCT02086630|Hispanic|hispanic
4900099|NCT02086630|care continuum|care continuum
4900100|NCT02086630|Heart to Heart Behavioral intervention|heart to heart behavioral intervention
4900101|NCT02086630|Treatment as Usual|treatment as usual
4900102|NCT02086591|Non Hodgkin Lymphoma|non hodgkin lymphoma
4900103|NCT02086591|Doxycycline|doxycycline
4900104|NCT02086578|multi-beam Intensity-Modulated Radiation Therapy (IMRT)|multi-beam intensity-modulated radiation therapy (imrt)
4900105|NCT02086578|14-028|14-028
4900108|NCT02086565|asthma-related quality of life|asthma-related quality of life
4900109|NCT02086565|electronic health record,|electronic health record,
4900112|NCT02086513|Graft versus Host Disease|graft versus host disease
4900113|NCT02086513|Allogeneic Stem Cell Transplantation|allogeneic stem cell transplantation
4900114|NCT02086500|Tranexamic acid|tranexamic acid
4900115|NCT02086500|randomized|randomized
4900116|NCT02086500|hemorrhage|hemorrhage
4900117|NCT02086500|blinded|blinded
4900118|NCT02086487|NIlotinib , Suboptimal Response , Imatinib|nilotinib , suboptimal response , imatinib
4900119|NCT02086435|Myomectomy|myomectomy
4900120|NCT02086435|Laparoscopic myomectomy|laparoscopic myomectomy
4900121|NCT02086435|Morcellation|morcellation
4900122|NCT02086435|Risk of dissemination|risk of dissemination
4900123|NCT02086435|Uterine Sarcoma|uterine sarcoma
4900124|NCT02086435|Parasitic myoma|parasitic myoma
4900125|NCT02086396|obesity|obesity
4900126|NCT02086396|cardiovascular risk factors|cardiovascular risk factors
4900127|NCT02086396|pumpkin seed|pumpkin seed
4900128|NCT02086396|diet quality|diet quality
4900129|NCT02086383|Pulmonary Rehabilitation|pulmonary rehabilitation
4900130|NCT02086383|Self-Efficacy|self-efficacy
4900131|NCT02086383|Physical Activity|physical activity
4900132|NCT02086370|PBS|pbs
4900133|NCT02086370|Prophylactic bilateral salpingectomy|prophylactic bilateral salpingectomy
4900134|NCT02086370|Ovarian cancer prevention|ovarian cancer prevention
4900135|NCT02086370|Ovarian reserve|ovarian reserve
4900136|NCT02086370|Permanent contraception|permanent contraception
4900137|NCT02086370|Surgical sterilization|surgical sterilization
4900138|NCT02086344|Total Laparoscopic Hysterectomy|total laparoscopic hysterectomy
4900139|NCT02086344|TLH|tlh
4900140|NCT02086344|Ovarian reserve|ovarian reserve
4900141|NCT02086344|Prophylactic bilateral salpingectomy|prophylactic bilateral salpingectomy
4900142|NCT02086344|Ovarian cancer prevention|ovarian cancer prevention
4900143|NCT02086344|Ovarian cancer|ovarian cancer
4900144|NCT02086344|Fallopian Tubes|fallopian tubes
4900145|NCT02086318|Ovarian reserve|ovarian reserve
4900146|NCT02086318|Ovarian age|ovarian age
4900147|NCT02086318|Fertility|fertility
4900148|NCT02086318|Reproductive prognosis|reproductive prognosis
4900149|NCT02086318|Distance to menopause|distance to menopause
4900150|NCT02086305|Transitional care|transitional care
4900151|NCT02086305|Supportive and palliative care|supportive and palliative care
4900152|NCT02086292|Injections|injections
4900153|NCT02086292|Lidocaine|lidocaine
4900154|NCT02086292|Pain|pain
4900155|NCT02086292|Healthy volunteers|healthy volunteers
4900156|NCT02086279|AMH levels|amh levels
4900157|NCT02086279|Ovarian reserve|ovarian reserve
4900158|NCT02086279|GnRH analogue|gnrh analogue
4900159|NCT02086279|Ovarian reserve after GnRH analogue|ovarian reserve after gnrh analogue
4900160|NCT02086279|Ovarian reserve modification|ovarian reserve modification
4900161|NCT02086279|Antral follicle count|antral follicle count
4900162|NCT02086279|Antral follicle count after GnRH analogue|antral follicle count after gnrh analogue
4900163|NCT02086266|Prostatectomy|prostatectomy
4900164|NCT02086266|Urinary Continence|urinary continence
4900165|NCT02086266|Physical Therapy Modalities|physical therapy modalities
4900166|NCT02086266|Pelvic Floor|pelvic floor
4900167|NCT02086266|Randomized Trial.|randomized trial.
4900168|NCT02086253|Endothelin, endothelium, flow-mediated dilatation|endothelin, endothelium, flow-mediated dilatation
4900169|NCT02086227|Bioequivalence|bioequivalence
4900170|NCT02086214|Upper limb|upper limb
4900171|NCT02086214|Proprioceptive pressure therapy|proprioceptive pressure therapy
4900172|NCT02086214|Children|children
4900173|NCT02086214|Assisting Hand Assessment performance|assisting hand assessment performance
4900174|NCT02086201|major depression|major depression
4900175|NCT02086201|depression|depression
4900176|NCT02086201|depressive disorder|depressive disorder
4900177|NCT02086201|mental health|mental health
4900178|NCT02086201|mental disorder|mental disorder
4900179|NCT02086188|Multiple Sclerosis|multiple sclerosis
4900180|NCT02086188|Overactive Bladder|overactive bladder
4900181|NCT02086188|Incontinence|incontinence
4900182|NCT02086188|Voiding|voiding
4900183|NCT02086188|Bladder Urgency|bladder urgency
4900184|NCT02086188|Pelvic Floor Exercises|pelvic floor exercises
4900185|NCT02086175|relapsed/refractory indolent B cell non-Hodgkin lymphomas|relapsed/refractory indolent b cell non-hodgkin lymphomas
4900186|NCT02086162|Schizophrenia|schizophrenia
4900187|NCT02086162|Smoking|smoking
4900188|NCT02086162|Tobacco|tobacco
4900189|NCT02086162|Motivation|motivation
4900190|NCT02086162|Cessation Treatment|cessation treatment
4900191|NCT02086149|Quit smoking|quit smoking
4900192|NCT02086149|Exercise|exercise
4900193|NCT02086149|Tobacco|tobacco
4900194|NCT02086149|Smoking|smoking
4900195|NCT02086136|aortic dissection|aortic dissection
4900196|NCT02086136|diagnosis|diagnosis
4900197|NCT02086136|emergency medicine|emergency medicine
4900198|NCT02086136|d-dimer|d-dimer
4900199|NCT02086123|Analgesia|analgesia
4900200|NCT02086123|Epidural Analgesia|epidural analgesia
4900201|NCT02086123|Narcotic Analgesia|narcotic analgesia
4900202|NCT02086123|Patient Controlled Analgesia|patient controlled analgesia
4900203|NCT02086123|Anesthesia and Analgesia|anesthesia and analgesia
4900204|NCT02086123|Anti inflammatory Analgesics|anti inflammatory analgesics
4900205|NCT02086123|NSAIDS|nsaids
4900206|NCT02086110|probiotic|probiotic
4900207|NCT02086110|prebiotic|prebiotic
4900208|NCT02086110|autism|autism
4900209|NCT02086110|oligosaccharides|oligosaccharides
4900210|NCT02086110|Bifidobacterium infantis|bifidobacterium infantis
4900211|NCT02086097|pain|pain
4900212|NCT02086097|symptomatic irreversible pulpitis|symptomatic irreversible pulpitis
4900213|NCT02086097|postoperative dental pain|postoperative dental pain
4900214|NCT02086084|Acute Exacerbation Chronic Obstructive Pulmonary Disease|acute exacerbation chronic obstructive pulmonary disease
4900215|NCT02086084|AECOPD|aecopd
4900216|NCT02086084|Non invasive ventilation|non invasive ventilation
4900217|NCT02086084|NIV|niv
4900218|NCT02086084|Extracorporeal carbon dioxide removal|extracorporeal carbon dioxide removal
4900219|NCT02086084|ECCO2R|ecco2r
4900220|NCT02086071|REBIOP re-biopsies advanced or metastatic NSCLC|rebiop re-biopsies advanced or metastatic nsclc
4900221|NCT02086058|overactive bladder|overactive bladder
4900222|NCT02086058|daytime urinary incontinence|daytime urinary incontinence
4900223|NCT02086058|children|children
4900224|NCT02086058|gene expression|gene expression
4900225|NCT02086045|Coronary artery disease|coronary artery disease
4900226|NCT02086032|Sleeping quality|sleeping quality
4900227|NCT02086032|menopause|menopause
4900228|NCT02086032|climacteric|climacteric
4900229|NCT02086032|progestin|progestin
4900230|NCT02086032|dydrogesterone|dydrogesterone
4900231|NCT02086032|micronized progesterone|micronized progesterone
4900232|NCT02086019|Revascularisation, octogenarian,acute coronary syndromes|revascularisation, octogenarian,acute coronary syndromes
4900233|NCT02086006|Coronary artery disease|coronary artery disease
4900234|NCT02085993|romiplostim,|romiplostim,
4900235|NCT02085993|Nplate,|nplate,
4900236|NCT02085993|immune thrombocytopenic purpura|immune thrombocytopenic purpura
4900237|NCT02085967|Healthy|healthy
4900238|NCT02085967|Metabolism|metabolism
4900239|NCT02085967|Drug-Drug Interactions|drug-drug interactions
4900240|NCT02085941|Head and Neck Neoplasms|head and neck neoplasms
4900241|NCT02085941|Malignant Neoplasm of Vertebral Column|malignant neoplasm of vertebral column
4900242|NCT02085928|Tennis elbow|tennis elbow
4900243|NCT02085928|Lateral epicondylitis|lateral epicondylitis
4900244|NCT02085928|Intratissue percutaneous electrolysis|intratissue percutaneous electrolysis
4900245|NCT02085928|Eccentric exercise|eccentric exercise
4900246|NCT02085928|Ultrasonography|ultrasonography
4900247|NCT02085876|patients|patients
4900248|NCT02085876|present|present
4900249|NCT02085876|undergo bariatric surgery|undergo bariatric surgery
4900250|NCT02085811|Kyphoplasty|kyphoplasty
4900251|NCT02085811|at a single level|at a single level
4900252|NCT02085811|(between T11 and L5)|(between t11 and l5)
4900253|NCT02085811|associated surgery|associated surgery
4900254|NCT02085798|Leukemia, Myelomonocytic, Chronic, myelodysplastic syndrome, Prospective, Treatment strategy, epidemiologic data|leukemia, myelomonocytic, chronic, myelodysplastic syndrome, prospective, treatment strategy, epidemiologic data
4900255|NCT02085785|weight loss|weight loss
4900256|NCT02085785|exercise|exercise
4900257|NCT02085785|home-based|home-based
4900258|NCT02085785|lower extremity amputation|lower extremity amputation
4900259|NCT02085785|pilot study|pilot study
4900260|NCT02085759|Healthy|healthy
4900261|NCT02085733|Arthritis, Septic|arthritis, septic
4900262|NCT02085681|Diabetic Retinopathy|diabetic retinopathy
4900263|NCT02085681|Screening|screening
4900264|NCT02085681|Tele-medicine|tele-medicine
4900265|NCT02085681|Retinal Imaging|retinal imaging
4900266|NCT02085681|Remote diagnosis|remote diagnosis
4900267|NCT02085668|Chronic Heart Failure|chronic heart failure
4900268|NCT02085668|Cardio-Renal Syndrome|cardio-renal syndrome
4900269|NCT02085668|Renal Denervation|renal denervation
4900270|NCT02085668|Symplicity|symplicity
4900271|NCT02085668|Sympathetic activation|sympathetic activation
4900272|NCT02085655|Extranodal NK/T-cell lymphoma|extranodal nk/t-cell lymphoma
4900273|NCT02085655|PA-Gemox regimen|pa-gemox regimen
4900274|NCT02085655|thalidomide|thalidomide
4900275|NCT02085642|Stroke|stroke
4900276|NCT02085642|Acupuncture|acupuncture
4900277|NCT02085642|Gait|gait
4900278|NCT02085642|Spasticity|spasticity
4900279|NCT02085629|renal failure, end stage|renal failure, end stage
4900280|NCT02085629|renal transplantation|renal transplantation
4900281|NCT02085629|cell therapy|cell therapy
4900282|NCT02085629|macrophages, monocyte derived|macrophages, monocyte derived
4900283|NCT02085629|immune tolerance|immune tolerance
4900284|NCT02085629|ONE Study|one study
4900285|NCT02085629|immunotherapy|immunotherapy
4900286|NCT02085616|Smoking cessation|smoking cessation
4900287|NCT02085616|Tobacco cessation|tobacco cessation
4900288|NCT02085616|Quitline|quitline
4900289|NCT02085616|Telephone counselling|telephone counselling
4900290|NCT02085616|Intensity|intensity
4900291|NCT02085603|advanced solid malignancies|advanced solid malignancies
4900292|NCT02085590|BCG vaccine|bcg vaccine
4900293|NCT02085590|Sepsis|sepsis
4900294|NCT02085590|Immunity|immunity
4900295|NCT02085577|Morphine consumption|morphine consumption
4900296|NCT02085577|Postoperative pain|postoperative pain
4900297|NCT02085577|Ketamine|ketamine
4900298|NCT02085577|Side effects|side effects
4900299|NCT02085577|Spine surgery|spine surgery
4900300|NCT02085577|Chronic pain|chronic pain
4900301|NCT02085564|Gastroesophageal-junction cancer|gastroesophageal-junction cancer
4900302|NCT02085564|neoadjuvant chemotherapy|neoadjuvant chemotherapy
4900303|NCT02085551|peripheral arterial occlusion|peripheral arterial occlusion
4900304|NCT02085551|visceral emboli|visceral emboli
4900305|NCT02085551|limb ischemia|limb ischemia
4900306|NCT02085551|adverse events|adverse events
4900307|NCT02085551|Indigo System|indigo system
4900308|NCT02085551|aspiration|aspiration
4900309|NCT02085551|mechanical thrombectomy|mechanical thrombectomy
4900310|NCT02085538|renal impairment|renal impairment
4900311|NCT02085538|AUC|auc
4900312|NCT02085538|Cmax|cmax
4900313|NCT02085538|palbociclib|palbociclib
4900314|NCT02085538|normal matched subjects|normal matched subjects
4900315|NCT02085512|Post Traumatic Stress Disorder (PTSD)|post traumatic stress disorder (ptsd)
4900316|NCT02085512|Major Depression|major depression
4900317|NCT02085512|Secondary Prevention|secondary prevention
4900318|NCT02085512|Neurocognitive Retraining|neurocognitive retraining
4900319|NCT02085512|Randomized Controlled Trial|randomized controlled trial
4900320|NCT02085499|nasal ventilation|nasal ventilation
4900321|NCT02085499|premature infants|premature infants
4900322|NCT02085499|synchronized ventilation|synchronized ventilation
4900323|NCT02085486|dialysis|dialysis
4900324|NCT02085486|av shunt|av shunt
4900325|NCT02085486|cannulation|cannulation
4900326|NCT02085486|ultrasound|ultrasound
4900327|NCT02085486|outcome|outcome
4900328|NCT02085447|Homelessness|homelessness
4900329|NCT02085447|Antipsychotic Drugs|antipsychotic drugs
4900330|NCT02085447|Antipsychotics|antipsychotics
4900331|NCT02085447|Injectables|injectables
4900332|NCT02085447|Long Acting Injectable Antipsychotic|long acting injectable antipsychotic
4900333|NCT02085447|Psychotic Disorders|psychotic disorders
4900334|NCT02085447|Schizophrenia|schizophrenia
4900335|NCT02085447|Schizoaffective Disorder|schizoaffective disorder
4900336|NCT02085447|Medication Adherence|medication adherence
4900337|NCT02085447|Medication Non-Adherence|medication non-adherence
4900338|NCT02085447|Community Mental Health Centers|community mental health centers
4900339|NCT02085421|tdcs, neuromodulation, CRT, psychosis, schizophrenia|tdcs, neuromodulation, crt, psychosis, schizophrenia
4900340|NCT02085395|Actinic Keratosis, AK, Bowen's Disease, Bowen|actinic keratosis, ak, bowen's disease, bowen
4900341|NCT02085382|Kangaroo Mother Care(KMC), Low-birth weight, neonates|kangaroo mother care(kmc), low-birth weight, neonates
4900342|NCT02085369|bariatric surgery|bariatric surgery
4900343|NCT02085369|cognitive function|cognitive function
4900344|NCT02085369|gene expression|gene expression
4900345|NCT02085356|HIV|hiv
4900346|NCT02085356|PMTCT|pmtct
4900347|NCT02085356|South Africa|south africa
4900348|NCT02085356|Couples|couples
4900349|NCT02085356|Male involvement|male involvement
4900350|NCT02085343|Exposure therapy|exposure therapy
4900351|NCT02085343|Specific phobia|specific phobia
4900352|NCT02085343|Fear of heights|fear of heights
4900353|NCT02085343|Acrophobia|acrophobia
4900354|NCT02085343|Safety behavior fading|safety behavior fading
4900355|NCT02085343|Anti-phobic Actions|anti-phobic actions
4900356|NCT02085317|Microcirculation|microcirculation
4900357|NCT02085317|Leprosy|leprosy
4900358|NCT02085317|Nervous system|nervous system
4900359|NCT02085317|Orthogonal polarization spectral (OPS) imaging|orthogonal polarization spectral (ops) imaging
4900360|NCT02085317|Laser Doppler flowmetry|laser doppler flowmetry
4900361|NCT02085317|Iontophoresis.|iontophoresis.
4900362|NCT02085304|Glioblastoma|glioblastoma
4900363|NCT02085304|GBM|gbm
4900364|NCT02085304|Radiation|radiation
4900365|NCT02085304|GammaKnife(R)|gammaknife(r)
4900366|NCT02085304|Radiosurgery|radiosurgery
4900367|NCT02085304|Gliadel(R)|gliadel(r)
4900368|NCT02085304|Temozolomide|temozolomide
4900369|NCT02085304|Temodar(R)|temodar(r)
4900370|NCT02085291|septic shock; microcirculation; norepinephrine|septic shock; microcirculation; norepinephrine
4900371|NCT02085278|arteriovenous malformation|arteriovenous malformation
4900372|NCT02085278|Brain|brain
4900373|NCT02085278|AVM|avm
4900374|NCT02085278|Onyx|onyx
4900375|NCT02085278|Micro catheter|micro catheter
4900376|NCT02085278|catheter entrapment,|catheter entrapment,
4900377|NCT02085278|Embolization|embolization
4900378|NCT02085278|Vein Of Galen|vein of galen
4900379|NCT02085265|Alzheimer's Disease|alzheimer's disease
4900380|NCT02085265|Hypertension|hypertension
4900381|NCT02085265|Perindopril|perindopril
4900382|NCT02085265|Telmisartan|telmisartan
4900383|NCT02085265|Brain atrophy|brain atrophy
4900384|NCT02085252|Drug Therapy|drug therapy
4900385|NCT02085239|Breast Biopsy|breast biopsy
4900386|NCT02085239|Ultrasound|ultrasound
4900387|NCT02085239|Lidocaine|lidocaine
4900388|NCT02085239|Ropivacaine|ropivacaine
4900389|NCT02085239|Breast Lesion|breast lesion
4900390|NCT02085226|Stroke|stroke
4900391|NCT02085226|Rehabilitation|rehabilitation
4900392|NCT02085226|Creative Engagement|creative engagement
4900393|NCT02085226|Psychosocial|psychosocial
4900394|NCT02085226|Art|art
4900395|NCT02085213|Retained placenta|retained placenta
4900396|NCT02085213|Manual Removal of Placenta|manual removal of placenta
4900397|NCT02085213|Glyceryl Trinitrate|glyceryl trinitrate
4900398|NCT02085200|glenohumeral internal rotation deficit|glenohumeral internal rotation deficit
4900399|NCT02085200|overhead athlete|overhead athlete
4900400|NCT02085200|shoulder exercise|shoulder exercise
4900401|NCT02085200|posterior glenohumeral capsule|posterior glenohumeral capsule
4900402|NCT02085200|posteroinferior glenohumeral ligament|posteroinferior glenohumeral ligament
4900403|NCT02085200|posterior rotator cuff|posterior rotator cuff
4900404|NCT02085187|Pulmonary rehabilitation|pulmonary rehabilitation
4900405|NCT02085187|Training|training
4900406|NCT02085187|Counselling|counselling
4900407|NCT02085187|Telemedicine|telemedicine
4900408|NCT02085187|Videoconference|videoconference
4900409|NCT02085187|COPD|copd
4900410|NCT02085187|Chronic disease|chronic disease
4900411|NCT02085187|Internet.|internet.
4900412|NCT02085148|Pediatric cancer|pediatric cancer
4900413|NCT02085148|Rhabdomyosarcoma,|rhabdomyosarcoma,
4900414|NCT02085148|Ewing sarcoma|ewing sarcoma
4900415|NCT02085148|Hepatoblastoma|hepatoblastoma
4900416|NCT02085148|Neuroblastoma|neuroblastoma
4900417|NCT02085148|Wilm's tumor|wilm's tumor
4900418|NCT02085135|depression|depression
4900419|NCT02085135|major depressive disorder|major depressive disorder
4900420|NCT02085135|Alkermes|alkermes
4900421|NCT02085135|ALKS 5461|alks 5461
4900422|NCT02085135|samidorphan|samidorphan
4900423|NCT02085135|buprenorphine|buprenorphine
4900424|NCT02085109|Cardiovascular Diseases|cardiovascular diseases
4900425|NCT02085109|HDL metabolism|hdl metabolism
4900426|NCT02085109|ApoA-I|apoa-i
4900427|NCT02085109|High fat|high fat
4900428|NCT02085109|Theobromine|theobromine
4900429|NCT02085096|Caregivers|caregivers
4900430|NCT02085096|Coping Skills|coping skills
4900431|NCT02085083|Inflammatory Bowel Disease|inflammatory bowel disease
4900432|NCT02085083|Transition|transition
4900433|NCT02085083|Adolescent|adolescent
4900434|NCT02085083|Chronic Disease|chronic disease
4900435|NCT02085083|Colitis, Ulcerative|colitis, ulcerative
4900436|NCT02085044|malnutrition|malnutrition
4900437|NCT02085044|children's health|children's health
4900438|NCT02085044|prevention|prevention
4900439|NCT02085044|ready-to-use supplementary food|ready-to-use supplementary food
4900440|NCT02085044|lipid based nutrient supplement|lipid based nutrient supplement
4900441|NCT02085044|chad|chad
4900442|NCT02085044|children|children
4900443|NCT02085031|Roux-en-Y Anastomosis|roux-en-y anastomosis
4900444|NCT02085031|laparoscopic surgery|laparoscopic surgery
4900445|NCT02085031|minilaparotomy|minilaparotomy
4900446|NCT02085031|stomach neoplasms|stomach neoplasms
4900447|NCT02085018|omeprazole, idiopathic pulmonary fibrosis|omeprazole, idiopathic pulmonary fibrosis
4900448|NCT02084992|Congestive Heart Failure|congestive heart failure
4900449|NCT02084992|Disease management|disease management
4900450|NCT02084992|Hospitalization|hospitalization
4900451|NCT02084979|Primary care mental health consultation|primary care mental health consultation
4900452|NCT02084979|Telepsychiatry|telepsychiatry
4900453|NCT02084979|Asynchronous telepsychiatry|asynchronous telepsychiatry
4900454|NCT02084966|Kidney|kidney
4900455|NCT02084966|Transplantation|transplantation
4900456|NCT02084966|Imaging|imaging
4900457|NCT02084966|Renal function|renal function
4900458|NCT02084966|Optical Coherence Tomography|optical coherence tomography
4900459|NCT02084940|PCOS|pcos
4900460|NCT02084940|OHSS|ohss
4900461|NCT02084940|GnRH antagonist|gnrh antagonist
4900462|NCT02084940|IVF|ivf
4900463|NCT02084940|COH|coh
4900464|NCT02084914|endometrial scratching|endometrial scratching
4900465|NCT02084914|pipelle|pipelle
4900466|NCT02084914|pregnancy rate|pregnancy rate
4900467|NCT02084914|unexplained infertility|unexplained infertility
4900468|NCT02084901|Biodegradable stents|biodegradable stents
4900469|NCT02084901|converage|converage
4900470|NCT02084901|OCT|oct
4900471|NCT02084875|Food effect|food effect
4900472|NCT02084875|pharmacokinetic|pharmacokinetic
4900473|NCT02084875|healthy volunteer|healthy volunteer
4900474|NCT02084862|Tracheostomy|tracheostomy
4900475|NCT02084862|Ultrasound|ultrasound
4900476|NCT02084836|fMRI obesity adolescents|fmri obesity adolescents
4900477|NCT02084797|arginine vasopressin|arginine vasopressin
4900478|NCT02084797|sweat sodium|sweat sodium
4900479|NCT02084797|V2 antagonist|v2 antagonist
4900480|NCT02084797|running|running
4900854|NCT02083237|healthy lifestyle|healthy lifestyle
4900481|NCT02084784|Near-infrared fluorescence|near-infrared fluorescence
4900482|NCT02084784|Image guided surgery|image guided surgery
4900483|NCT02084784|Breast cancer;|breast cancer;
4900484|NCT02084784|Sentinel lymph node biopsy|sentinel lymph node biopsy
4900485|NCT02084784|Indocyanine green|indocyanine green
4900486|NCT02084784|Methylene blue|methylene blue
4900487|NCT02084771|contrast nephropathy|contrast nephropathy
4900488|NCT02084771|contrast induced acute kidney injury|contrast induced acute kidney injury
4900489|NCT02084771|acute kidney injury|acute kidney injury
4900490|NCT02084771|prophylaxis|prophylaxis
4900491|NCT02084771|randomized trial|randomized trial
4900492|NCT02084758|COPD|copd
4900493|NCT02084758|nitrate supplementation|nitrate supplementation
4900494|NCT02084758|metabolic efficiency|metabolic efficiency
4900495|NCT02084745|Boston keratoprosthesis|boston keratoprosthesis
4900496|NCT02084745|Glaucoma drainage device|glaucoma drainage device
4900497|NCT02084745|Ahmed tube shunt|ahmed tube shunt
4900498|NCT02084732|Sorafenib, thyroid neoplasms, salicylic acid|sorafenib, thyroid neoplasms, salicylic acid
4900499|NCT02084680|Prenatal|prenatal
4900500|NCT02084680|Newborn care|newborn care
4900698|NCT02083861|grade 2|grade 2
4900501|NCT02084680|mobile phones|mobile phones
4900502|NCT02084654|prediabetes|prediabetes
4900503|NCT02084654|exenatide|exenatide
4900504|NCT02084654|weight loss|weight loss
4900505|NCT02084654|insulin resistance|insulin resistance
4900506|NCT02084654|acute insulin response|acute insulin response
4900507|NCT02084654|insulin secretion|insulin secretion
4900508|NCT02084641|ectopic fat|ectopic fat
4900509|NCT02084641|obesity|obesity
4900510|NCT02084641|triglyceride storage|triglyceride storage
4900511|NCT02084641|adipocyte|adipocyte
4900512|NCT02084641|overfeeding|overfeeding
4900513|NCT02084641|intrahepatic fat|intrahepatic fat
4900514|NCT02084641|adipocyte proliferation|adipocyte proliferation
4900515|NCT02084641|inflammation|inflammation
4900516|NCT02084641|macrophage|macrophage
4900517|NCT02084615|Aspirin|aspirin
4900518|NCT02084615|Postoperative hemorrhage|postoperative hemorrhage
4900519|NCT02084615|Inguinal hernia|inguinal hernia
4900520|NCT02084602|artesunate|artesunate
4900521|NCT02084602|mefloquine|mefloquine
4900522|NCT02084602|falciparum|falciparum
4900523|NCT02084602|peruvian amazon|peruvian amazon
4900524|NCT02084589|PCEA, labor analgesia, background infusion, ropivacaine|pcea, labor analgesia, background infusion, ropivacaine
4900525|NCT02084576|Cystoid macular edema|cystoid macular edema
4900526|NCT02084576|nonsteroidal anti-inflammatory drug|nonsteroidal anti-inflammatory drug
4900527|NCT02084576|OCT|oct
4900528|NCT02084576|phacoemulsification.|phacoemulsification.
4900529|NCT02084563|Acute Myeloid Leukemia|acute myeloid leukemia
4900530|NCT02084563|Myeloproliferative Neoplasms|myeloproliferative neoplasms
4900531|NCT02084563|Myelodysplastic Syndromes|myelodysplastic syndromes
4900532|NCT02084563|Myeloproliferative/Myelodysplastic Neoplasm|myeloproliferative/myelodysplastic neoplasm
4900533|NCT02084563|Leukemia|leukemia
4900534|NCT02084563|MDS|mds
4900535|NCT02084563|MPN|mpn
4900536|NCT02084563|AML|aml
4900537|NCT02084563|Chronic myelomonocytic leukemia (CMML)|chronic myelomonocytic leukemia (cmml)
4900538|NCT02084563|Polycythemia Vera (PV)|polycythemia vera (pv)
4900539|NCT02084563|Essential Thrombocythemia (ET)|essential thrombocythemia (et)
4900540|NCT02084563|Myelofibrosis (MF)|myelofibrosis (mf)
4900541|NCT02084537|symptomatic|symptomatic
4900542|NCT02084537|infected|infected
4900543|NCT02084537|necrotic collection|necrotic collection
4900544|NCT02084524|vulnerable|vulnerable
4900545|NCT02084524|nutrition|nutrition
4900546|NCT02084524|cancer|cancer
4900547|NCT02084524|colorectal|colorectal
4900548|NCT02084524|tumor|tumor
4900549|NCT02084498|Automated bolus calculator (ABC)|automated bolus calculator (abc)
4900550|NCT02084498|Advanced carbohydrate counting (ACC)|advanced carbohydrate counting (acc)
4900551|NCT02084498|Patient empowerment|patient empowerment
4900552|NCT02084485|COPD|copd
4900553|NCT02084485|LPS|lps
4900554|NCT02084472|atopic eczema|atopic eczema
4900555|NCT02084472|moisturisers|moisturisers
4900556|NCT02084472|alternatives|alternatives
4900557|NCT02084472|affordable|affordable
4900558|NCT02084459|Chronic pain|chronic pain
4900559|NCT02084459|Supportive care|supportive care
4900560|NCT02084459|Psychosocial Circumstances|psychosocial circumstances
4900561|NCT02084459|Autonomy support|autonomy support
4900562|NCT02084459|Nursing intervention|nursing intervention
4900563|NCT02084446|Everolimus|everolimus
4900564|NCT02084446|Tacrolimus|tacrolimus
4900565|NCT02084446|Sodium Mycophenolate|sodium mycophenolate
4900566|NCT02084446|CMV|cmv
4900567|NCT02084446|Graft function|graft function
4900568|NCT02084446|Acute rejection|acute rejection
4900569|NCT02084433|MIH of the first permanent molar|mih of the first permanent molar
4900570|NCT02084407|DM1|dm1
4900571|NCT02084407|Cardiopathy|cardiopathy
4900572|NCT02084407|Adult|adult
4900573|NCT02084394|CBF autoregulation, rSO2,doppler, TCD, delirium,|cbf autoregulation, rso2,doppler, tcd, delirium,
4900574|NCT02084381|CKD5, dialysis, high porous membranes|ckd5, dialysis, high porous membranes
4900575|NCT02084368|combined lumbar plexus and sciatic nerve block，|combined lumbar plexus and sciatic nerve block，
4900576|NCT02084368|combined spinal and epidural anesthesia|combined spinal and epidural anesthesia
4900577|NCT02084355|Significant cancer pain|significant cancer pain
4900578|NCT02084355|at least numeric rating scale 4|at least numeric rating scale 4
4900579|NCT02084342|desmopressin|desmopressin
4900580|NCT02084342|tranexamic acid|tranexamic acid
4900581|NCT02084342|blood loss|blood loss
4900582|NCT02084342|transfusion need|transfusion need
4900583|NCT02084342|posterior scoliosis orthopedics|posterior scoliosis orthopedics
4900584|NCT02084329|Physiotherapy|physiotherapy
4900585|NCT02084329|Physical therapy|physical therapy
4900586|NCT02084329|neurotrauma rehabilitation|neurotrauma rehabilitation
4900587|NCT02084329|Rehabilitation|rehabilitation
4900588|NCT02084329|Balance|balance
4900589|NCT02084329|Balance Confidence|balance confidence
4900590|NCT02084329|concussion|concussion
4900591|NCT02084329|Post-Concussion|post-concussion
4900592|NCT02084329|Mild Traumatic Brain Injury|mild traumatic brain injury
4900593|NCT02084316|China CDC|china cdc
4900594|NCT02084316|One4All testing algorithm|one4all testing algorithm
4900595|NCT02084316|Guangxi Autonomous Region|guangxi autonomous region
4900596|NCT02084316|Testing and Linkage to HIV Care in China|testing and linkage to hiv care in china
4900597|NCT02084290|Crohn's disease|crohn's disease
4900996|NCT02082652|Efavirenz|efavirenz
4900598|NCT02084290|Shared Decision Making|shared decision making
4900599|NCT02084290|Decision Aid|decision aid
4900600|NCT02084277|Oral health-related quality of life (OHRQoL)|oral health-related quality of life (ohrqol)
4900601|NCT02084277|Self-ligating brackets (SLB)|self-ligating brackets (slb)
4900602|NCT02084277|Conventional brackets (CB)|conventional brackets (cb)
4900603|NCT02084277|Oral Health Impact Profile-14 (OHIP-14)|oral health impact profile-14 (ohip-14)
4900604|NCT02084277|Short Form-36 (SF-36)|short form-36 (sf-36)
4900605|NCT02084264|Adolescent Idiopathic Scoliosis|adolescent idiopathic scoliosis
4900606|NCT02084264|Pediatric Scoliosis|pediatric scoliosis
4900607|NCT02084251|safety,|safety,
4900608|NCT02084251|pharmacokinetics,|pharmacokinetics,
4900609|NCT02084251|Long acting GLP-1 analogue|long acting glp-1 analogue
4900610|NCT02084238|SLE, IL-2|sle, il-2
4900611|NCT02084225|low resource|low resource
4900612|NCT02084225|conflict setting|conflict setting
4900613|NCT02084225|ultrasound guided regional anesthesia|ultrasound guided regional anesthesia
4900614|NCT02084225|acute injuries|acute injuries
4900615|NCT02084225|pain management|pain management
4900616|NCT02084225|education|education
4900617|NCT02084225|ultrasound|ultrasound
4900618|NCT02084225|trauma|trauma
4900619|NCT02084225|emergency department|emergency department
4900620|NCT02084173|alcohol|alcohol
4900621|NCT02084173|60+ years|60+ years
4900622|NCT02084173|treatment|treatment
4900623|NCT02084173|met|met
4900624|NCT02084173|cra|cra
4900625|NCT02084173|multi site|multi site
4900626|NCT02084173|multi country|multi country
4900627|NCT02084173|questionnaire|questionnaire
4900628|NCT02084173|random|random
4900629|NCT02084134|pituitary adenoma|pituitary adenoma
4900630|NCT02084134|Pituitary Tumor|pituitary tumor
4900631|NCT02084134|transsphenoidal resection|transsphenoidal resection
4900632|NCT02084134|pituitary cyst|pituitary cyst
4900633|NCT02084121|metachromatic leukodystrophy|metachromatic leukodystrophy
4900634|NCT02084108|Frail and dependent older adults|frail and dependent older adults
4900635|NCT02084108|Integrated care|integrated care
4900636|NCT02084108|Home care|home care
4900637|NCT02084108|Multidimensional geriatric assessment|multidimensional geriatric assessment
4900638|NCT02084108|RAI-HC (resident assessment instrument- Home care)|rai-hc (resident assessment instrument- home care)
4900639|NCT02084108|Palliative care.|palliative care.
4900640|NCT02084043|aerosol delivery|aerosol delivery
4900641|NCT02084043|vibrating mesh nebulizer|vibrating mesh nebulizer
4900642|NCT02084043|breath-actuated nebulizer|breath-actuated nebulizer
4900643|NCT02084043|non invasive ventilation|non invasive ventilation
4900644|NCT02084043|bilevel ventilator|bilevel ventilator
4900645|NCT02084043|single limb circuit ventilator|single limb circuit ventilator
4900646|NCT02084043|Amikacin|amikacin
4900647|NCT02084030|cardiac surgery|cardiac surgery
4900648|NCT02084030|POCD|pocd
4900649|NCT02084030|GWAS|gwas
4900650|NCT02084030|Susceptibility gene|susceptibility gene
4900651|NCT02084017|Surgical Site Infection|surgical site infection
4900652|NCT02084017|Vascular Surgery|vascular surgery
4900653|NCT02084017|Negative Pressure Wound Therapy|negative pressure wound therapy
4900654|NCT02084004|Type 2 diabetes mellitus|type 2 diabetes mellitus
4900655|NCT02084004|Berberine Hydrochloride|berberine hydrochloride
4900656|NCT02084004|Bifidobacterium|bifidobacterium
4900657|NCT02083991|NODAT|nodat
4900658|NCT02083991|Renal transplantation|renal transplantation
4900659|NCT02083991|Corticosteroids avoidance|corticosteroids avoidance
4900660|NCT02083991|CNI minimization|cni minimization
4900661|NCT02083978|Bipolar Disorder|bipolar disorder
4900662|NCT02083978|Magnetic Resonance Imaging (MRI) scanning|magnetic resonance imaging (mri) scanning
4900663|NCT02083939|Inguinal hernia|inguinal hernia
4900664|NCT02083939|Mesh repair|mesh repair
4900665|NCT02083939|Prophylactic Antibiotics|prophylactic antibiotics
4900666|NCT02083939|Herniorrhaphy|herniorrhaphy
4900667|NCT02083939|Laparoscopic Inguinal Hernia Repair|laparoscopic inguinal hernia repair
4900668|NCT02083926|Social Anxiety Disorder|social anxiety disorder
4900669|NCT02083926|SAD|sad
4900670|NCT02083926|Ketamine|ketamine
4900671|NCT02083913|Severely obese|severely obese
4900672|NCT02083913|Bariatric surgery|bariatric surgery
4900673|NCT02083913|Physical activity|physical activity
4900674|NCT02083913|Physical fitness|physical fitness
4900675|NCT02083913|Telehealth|telehealth
4900676|NCT02083913|Quality of life|quality of life
4900677|NCT02083887|Immune response|immune response
4900678|NCT02083887|Vaccine|vaccine
4900679|NCT02083887|Malaria|malaria
4900680|NCT02083874|cannabidiol|cannabidiol
4900681|NCT02083874|CBD|cbd
4900682|NCT02083874|marijuana|marijuana
4900683|NCT02083874|withdrawal|withdrawal
4900684|NCT02083874|treatment|treatment
4900685|NCT02083861|osteoarthritis|osteoarthritis
4900686|NCT02083861|arthritis|arthritis
4900687|NCT02083861|musculoskeletal|musculoskeletal
4900688|NCT02083861|connective tissue disease|connective tissue disease
4900689|NCT02083861|ultrasound|ultrasound
4900690|NCT02083861|pain|pain
4900691|NCT02083861|mobility|mobility
4900692|NCT02083861|heat|heat
4900693|NCT02083861|strength|strength
4900694|NCT02083861|ZetrOZ|zetroz
4900695|NCT02083861|LITUS|litus
4900696|NCT02083861|Sam|sam
4900697|NCT02083861|grade 1|grade 1
4900699|NCT02083848|Locoregional invasion|locoregional invasion
4900700|NCT02083848|Stage IB1, IB2, IIA or IIB|stage ib1, ib2, iia or iib
4900701|NCT02083835|post-operative pain|post-operative pain
4900702|NCT02083835|paitent reported outcomes|paitent reported outcomes
4900703|NCT02083835|quality improvement|quality improvement
4900704|NCT02083822|premature baby|premature baby
4900705|NCT02083822|MRI : conventional and advanced images|mri : conventional and advanced images
4900706|NCT02083822|Executive function testing at 5 years of age|executive function testing at 5 years of age
4900707|NCT02083796|manual therapy|manual therapy
4900708|NCT02083796|rehabilitation|rehabilitation
4900709|NCT02083796|shoulder|shoulder
4900710|NCT02083796|spine|spine
4900711|NCT02083770|Hispanics|hispanics
4900712|NCT02083770|Patient Participation|patient participation
4900713|NCT02083770|Refusal to Participate|refusal to participate
4900714|NCT02083770|Education|education
4900715|NCT02083770|Clinical Trials|clinical trials
4900716|NCT02083757|Fluid responsiveness; Passive leg raising|fluid responsiveness; passive leg raising
4900717|NCT02083744|Congestive Heart Failure|congestive heart failure
4900718|NCT02083744|Self-care|self-care
4900719|NCT02083744|Spanish|spanish
4900720|NCT02083731|CMV infection|cmv infection
4900721|NCT02083731|Mesenchymal Stem Cells|mesenchymal stem cells
4900722|NCT02083731|Allogeneic hematopoietic stem cell transplantation|allogeneic hematopoietic stem cell transplantation
4900723|NCT02083718|Poor Graft Function|poor graft function
4900724|NCT02083718|Peripheral Blood Stem Cell|peripheral blood stem cell
4900725|NCT02083718|Mesenchymal Stem Cells|mesenchymal stem cells
4900726|NCT02083718|Allogeneic hematopoietic stem cell transplantation|allogeneic hematopoietic stem cell transplantation
4900727|NCT02083705|Chest compression, Delivery Room, NICU,|chest compression, delivery room, nicu,
4900728|NCT02083679|Carcinoma, Non-Small-Cell Lung|carcinoma, non-small-cell lung
4900729|NCT02083679|Sym004|sym004
4900730|NCT02083666|Phase I|phase i
4900731|NCT02083666|Dose cohorts|dose cohorts
4900732|NCT02083666|Escalating dose|escalating dose
4900733|NCT02083666|Single dose|single dose
4900734|NCT02083666|Multiple dose|multiple dose
4900735|NCT02083666|Safety|safety
4900736|NCT02083666|Tolerability|tolerability
4900737|NCT02083666|Pharmacokinetics|pharmacokinetics
4900738|NCT02083666|Pharmacodynamics|pharmacodynamics
4900739|NCT02083666|volunteers|volunteers
4900740|NCT02083653|Metastatic Colorectal Cancer|metastatic colorectal cancer
4900741|NCT02083653|Sym004|sym004
4900742|NCT02083653|Best Supportive Care|best supportive care
4900743|NCT02083653|Capecitabine|capecitabine
4900744|NCT02083653|Fluorouracil (5-FU)|fluorouracil (5-fu)
4900745|NCT02083640|healthy volunteer|healthy volunteer
4900746|NCT02083640|bioavailability|bioavailability
4900747|NCT02083640|palbociclib|palbociclib
4900748|NCT02083640|formulation|formulation
4900749|NCT02083627|Pharmacokinetics|pharmacokinetics
4900750|NCT02083627|Drug-Drug Interaction|drug-drug interaction
4900751|NCT02083627|Intestinal Absorption|intestinal absorption
4900752|NCT02083627|Fidaxomicin|fidaxomicin
4900753|NCT02083627|Rosuvastatin|rosuvastatin
4900754|NCT02083627|Multiple Doses|multiple doses
4900755|NCT02083627|Single Doses|single doses
4900756|NCT02083601|Caregivers|caregivers
4900757|NCT02083601|Spinal Cord Injuries|spinal cord injuries
4900758|NCT02083601|Psychology, Educational|psychology, educational
4900759|NCT02083601|Counseling|counseling
4900760|NCT02083601|Outcome Assessment (Health Care)|outcome assessment (health care)
4900761|NCT02083588|Fibromyalgia|fibromyalgia
4900762|NCT02083588|dTMS|dtms
4900763|NCT02083588|pain|pain
4900764|NCT02083588|PFC|pfc
4900765|NCT02083588|Subjects with Fibromyalgia|subjects with fibromyalgia
4900766|NCT02083575|vitamin c|vitamin c
4900767|NCT02083575|thalassemia major|thalassemia major
4900768|NCT02083575|iron chelation|iron chelation
4900769|NCT02083562|Bronchopulmonary dysplasia, preterm infant|bronchopulmonary dysplasia, preterm infant
4900770|NCT02083549|Massive Transfusion Protocol|massive transfusion protocol
4900771|NCT02083536|Low Dose Fractionated Whole Abdominal Radiation Therapy|low dose fractionated whole abdominal radiation therapy
4900772|NCT02083536|LDFWART|ldfwart
4900773|NCT02083536|Docetaxel|docetaxel
4900774|NCT02083536|Ovarian Cancer|ovarian cancer
4900775|NCT02083536|Ovarian Carcinoma|ovarian carcinoma
4900776|NCT02083536|Platinum-Resistant|platinum-resistant
4900777|NCT02083523|Motivational Interview, normative feedback, adolescents|motivational interview, normative feedback, adolescents
4900778|NCT02083510|Colchicine|colchicine
4900779|NCT02083510|Hypertriglyceridemia|hypertriglyceridemia
4900780|NCT02083510|Apolipoprotein CIII|apolipoprotein ciii
4900781|NCT02083497|kick|kick
4900782|NCT02083497|taping|taping
4900783|NCT02083497|dynamic equilibrium|dynamic equilibrium
4900784|NCT02083458|critical care|critical care
4900785|NCT02083458|catheterization|catheterization
4900786|NCT02083458|axillary vein|axillary vein
4900787|NCT02083445|Traumatic brain injury|traumatic brain injury
4900788|NCT02083445|Exercise|exercise
4900789|NCT02083445|Psychology|psychology
4900790|NCT02083445|Physiology|physiology
4900791|NCT02083445|Progenitor cells|progenitor cells
4900792|NCT02083445|Hypoxia|hypoxia
4900793|NCT02083432|intra-oral injections|intra-oral injections
4900794|NCT02083432|CBT|cbt
4900997|NCT02082652|Nevirapine|nevirapine
4900795|NCT02083432|Blood-Injury-Injection-phobia|blood-injury-injection-phobia
4900796|NCT02083432|DSM-IV. 300.29|dsm-iv. 300.29
4900797|NCT02083419|Left Ventricular Assist Devices (LVAD)|left ventricular assist devices (lvad)
4900798|NCT02083419|Cardiac Resynchronization Devices (CRT)|cardiac resynchronization devices (crt)
4900799|NCT02083406|Malaria|malaria
4900800|NCT02083406|Bio-availability|bio-availability
4900801|NCT02083393|dendritic cell|dendritic cell
4900802|NCT02083380|Plasmodium falciparum malaria|plasmodium falciparum malaria
4900803|NCT02083380|malaria|malaria
4900804|NCT02083380|OZ439|oz439
4900805|NCT02083380|piperaquine|piperaquine
4900806|NCT02083380|PQP|pqp
4900807|NCT02083354|melanoma|melanoma
4900808|NCT02083354|dabrafenib|dabrafenib
4900809|NCT02083354|trametinib|trametinib
4900810|NCT02083328|heart rate variability|heart rate variability
4900811|NCT02083328|exercise performance|exercise performance
4900812|NCT02083315|acute pain, analgesia, respiratory drive, ventilator response to hypercapnia, pupillometry|acute pain, analgesia, respiratory drive, ventilator response to hypercapnia, pupillometry
4900813|NCT02083302|campus sexual assault|campus sexual assault
4900814|NCT02083302|bystander intervention|bystander intervention
4900815|NCT02083289|ONO-9054|ono-9054
4900816|NCT02083289|ocular hypertension (OHT)|ocular hypertension (oht)
4900817|NCT02083289|Open angle-glaucoma (OAG)|open angle-glaucoma (oag)
4900818|NCT02083289|Glaucoma|glaucoma
4900819|NCT02083289|Eye Diseases|eye diseases
4900820|NCT02083289|Mild to moderate|mild to moderate
4900821|NCT02083276|Chlamydia trachomatis|chlamydia trachomatis
4900822|NCT02083276|Urethritis|urethritis
4900823|NCT02083276|Genital Diseases, Male|genital diseases, male
4900824|NCT02083263|Lung function|lung function
4900825|NCT02083250|Leukemia|leukemia
4900826|NCT02083250|Blood And Marrow Transplantation|blood and marrow transplantation
4900827|NCT02083250|Acute lymphoblastic leukemia|acute lymphoblastic leukemia
4900828|NCT02083250|ALL|all
4900829|NCT02083250|Acute myeloid leukemia|acute myeloid leukemia
4900830|NCT02083250|AML|aml
4900831|NCT02083250|Myelodysplastic syndrome|myelodysplastic syndrome
4900832|NCT02083250|MDS|mds
4900833|NCT02083250|Allogeneic stem cell transplant|allogeneic stem cell transplant
4900834|NCT02083250|SCT|sct
4900835|NCT02083250|Thymoglobulin|thymoglobulin
4900836|NCT02083250|ATG|atg
4900837|NCT02083250|Antithymocyte Globulin|antithymocyte globulin
4900838|NCT02083250|Fludarabine|fludarabine
4900839|NCT02083250|Fludarabine Phosphate|fludarabine phosphate
4900840|NCT02083250|Fludara|fludara
4900841|NCT02083250|Clofarabine|clofarabine
4900842|NCT02083250|Clofarex|clofarex
4900843|NCT02083250|Clolar|clolar
4900844|NCT02083250|Busulfan|busulfan
4900845|NCT02083250|Busulfex|busulfex
4900846|NCT02083250|Myleran|myleran
4900847|NCT02083250|SAHA|saha
4900848|NCT02083250|Vorinostat|vorinostat
4900849|NCT02083250|Suberoylanilide Hydroxamic Acid|suberoylanilide hydroxamic acid
4900850|NCT02083250|MSK-390|msk-390
4900851|NCT02083250|Zolinza|zolinza
4900852|NCT02083237|mild cognitive impairment|mild cognitive impairment
4900853|NCT02083237|memory training|memory training
4900855|NCT02083237|psychosocial support|psychosocial support
4900856|NCT02083211|Cervical cancer|cervical cancer
4900857|NCT02083211|Recurrent or persistent tumor|recurrent or persistent tumor
4900858|NCT02083211|Monoclonal antibody|monoclonal antibody
4900859|NCT02083198|hyperchloremic acidosis|hyperchloremic acidosis
4900860|NCT02083198|balanced fluids|balanced fluids
4900861|NCT02083198|plasmalyte|plasmalyte
4900862|NCT02083185|Drug therapy|drug therapy
4900863|NCT02083172|USCOM (UltraSound Cardiac Output Monitor)|uscom (ultrasound cardiac output monitor)
4900864|NCT02083172|2D echocardiography|2d echocardiography
4900865|NCT02083172|agreement|agreement
4900866|NCT02083172|pediatrics|pediatrics
4900867|NCT02083133|Diabetes|diabetes
4900868|NCT02083133|Renal Failure|renal failure
4900869|NCT02083133|Dialysis|dialysis
4900870|NCT02083133|End Stage Renal Disease|end stage renal disease
4900871|NCT02083133|Hypoglycemia|hypoglycemia
4900872|NCT02083120|high flow|high flow
4900873|NCT02083120|COPD|copd
4900874|NCT02083120|AIRVO|airvo
4900875|NCT02083107|Postpartum hemorrhage|postpartum hemorrhage
4900876|NCT02083107|Intrapartum blood loss|intrapartum blood loss
4900877|NCT02083107|Misoprostol|misoprostol
4900878|NCT02083081|tobacco|tobacco
4900879|NCT02083081|smoking|smoking
4900880|NCT02083068|Malaria, vaccine, P. vivax|malaria, vaccine, p. vivax
4900881|NCT02083055|dexmedetomidine|dexmedetomidine
4900882|NCT02083055|controlled hypotensive anesthesia|controlled hypotensive anesthesia
4900883|NCT02083042|CMV|cmv
4900884|NCT02083042|T-Track CMV|t-track cmv
4900885|NCT02083042|kidney transplantation|kidney transplantation
4900886|NCT02083029|Asthma|asthma
4900887|NCT02083029|Death|death
4900888|NCT02083029|Mechanism|mechanism
4900889|NCT02083029|Syncope|syncope
4900890|NCT02083029|Dive reflex|dive reflex
4900891|NCT02083003|Pain|pain
4900892|NCT02083003|Polyamine|polyamine
4900893|NCT02083003|Cholecystectomy|cholecystectomy
4900894|NCT02082990|Alcohol-related disorders|alcohol-related disorders
4900895|NCT02082990|Alcohol Drinking|alcohol drinking
4900896|NCT02082990|e-health|e-health
4900897|NCT02082990|Alcohol Use Disorder Test|alcohol use disorder test
4900898|NCT02082990|Quality of Life|quality of life
4900899|NCT02082977|Refractory|refractory
4900900|NCT02082977|Phase I study, dose escalation study|phase i study, dose escalation study
4900901|NCT02082977|diffuse large B cell lymphoma|diffuse large b cell lymphoma
4900902|NCT02082977|Relapsed|relapsed
4900903|NCT02082977|Solid tumors|solid tumors
4900904|NCT02082977|transformed follicular lymphoma|transformed follicular lymphoma
4900905|NCT02082977|Multiple myeloma|multiple myeloma
4900906|NCT02082977|GSK2816126|gsk2816126
4900907|NCT02082977|Non-Hodgkin's lymphoma|non-hodgkin's lymphoma
4900908|NCT02082938|stroke,|stroke,
4900909|NCT02082938|rehabilitation,|rehabilitation,
4900910|NCT02082938|hemiparesis,|hemiparesis,
4900911|NCT02082938|gait training|gait training
4900912|NCT02082925|Exercise training|exercise training
4900913|NCT02082925|Dyspnea threshold|dyspnea threshold
4900914|NCT02082925|6MWT|6mwt
4900915|NCT02082899|Allergic Conjunctivitis|allergic conjunctivitis
4900916|NCT02082899|Interleukin 1 Receptor Inhibitor|interleukin 1 receptor inhibitor
4900917|NCT02082899|Environmental Exposure Chamber|environmental exposure chamber
4900918|NCT02082899|Conjunctival Allergen Provocation Test|conjunctival allergen provocation test
4900919|NCT02082886|Metastasis|metastasis
4900920|NCT02082886|Carcinomatosis|carcinomatosis
4900921|NCT02082886|Carcinosis|carcinosis
4900922|NCT02082886|Sarcomatosis|sarcomatosis
4900923|NCT02082886|CRS|crs
4900924|NCT02082886|Cytoreductive surgery|cytoreductive surgery
4900925|NCT02082886|HIPEC|hipec
4900926|NCT02082886|Heated Intraperitoneal Chemotherapy|heated intraperitoneal chemotherapy
4900927|NCT02082886|Intra-abdominal|intra-abdominal
4900928|NCT02082886|Sugarbaker technique|sugarbaker technique
4900929|NCT02082886|Mitomycin C|mitomycin c
4900930|NCT02082886|Cisplatin|cisplatin
4900931|NCT02082886|Doxorubicin|doxorubicin
4900932|NCT02082886|Oxaliplatin|oxaliplatin
4900933|NCT02082886|Melphalan|melphalan
4900934|NCT02082873|Quantitative EEG|quantitative eeg
4900935|NCT02082873|Nonconvulsive seizures|nonconvulsive seizures
4900936|NCT02082873|ICU EEG monitoring|icu eeg monitoring
4900937|NCT02082860|Porphyria|porphyria
4900938|NCT02082860|Gene therapy|gene therapy
4900939|NCT02082860|AAV|aav
4900940|NCT02082860|Liver gene transfer|liver gene transfer
4900941|NCT02082834|Endovascular aneurysm repair EVAR|endovascular aneurysm repair evar
4900942|NCT02082834|Endoleak/diagnosis|endoleak/diagnosis
4900943|NCT02082834|VEOTM|veotm
4900944|NCT02082834|Model-based iterative reconstruction (MBIR)|model-based iterative reconstruction (mbir)
4900945|NCT02082834|Adaptive statistical iterative reconstruction (ASIR)|adaptive statistical iterative reconstruction (asir)
4900946|NCT02082834|Aortic Aneurysm|aortic aneurysm
4900947|NCT02082834|Low dose|low dose
4900948|NCT02082834|Prospective|prospective
4900949|NCT02082834|CTA|cta
4900950|NCT02082808|Dolutegravir|dolutegravir
4900951|NCT02082808|healthy volunteer|healthy volunteer
4900952|NCT02082808|pharmacokinetics|pharmacokinetics
4900953|NCT02082808|daclatasvir|daclatasvir
4900954|NCT02082808|drug interaction|drug interaction
4900955|NCT02082795|Breech presentation|breech presentation
4900956|NCT02082795|External cephalic version|external cephalic version
4900957|NCT02082795|Anaesthesia|anaesthesia
4900958|NCT02082795|Qualitative|qualitative
4900959|NCT02082795|Pregnancy|pregnancy
4900960|NCT02082782|Colorectal liver metastases (CRLM)|colorectal liver metastases (crlm)
4900961|NCT02082782|Tumor ablation|tumor ablation
4900962|NCT02082782|Irreversible electroporation (IRE)|irreversible electroporation (ire)
4900963|NCT02082782|Interventional oncology|interventional oncology
4900964|NCT02082782|NanoKnife|nanoknife
4900965|NCT02082782|Colorectal liver metastasis, unresectable and not-thermally ablative due to location near vulnerable structures like vessels or bile ducts|colorectal liver metastasis, unresectable and not-thermally ablative due to location near vulnerable structures like vessels or bile ducts
4900966|NCT02082769|Gout|gout
4900967|NCT02082769|Uric Acid|uric acid
4900968|NCT02082769|Xanthine oxidase|xanthine oxidase
4900969|NCT02082769|Febuxostat|febuxostat
4900970|NCT02082756|Prediabetes|prediabetes
4900971|NCT02082756|Berberine Hydrochloride|berberine hydrochloride
4900972|NCT02082756|Bifidobacterium|bifidobacterium
4900973|NCT02082743|Myopia|myopia
4900974|NCT02082743|Outdoor activity|outdoor activity
4900975|NCT02082743|Recess outside classroom|recess outside classroom
4900976|NCT02082730|CFS/ME, Chronic fatigue syndrome, Pediatric, remote mobile technology|cfs/me, chronic fatigue syndrome, pediatric, remote mobile technology
4900977|NCT02082704|Diabetes|diabetes
4900978|NCT02082704|Education, Patient|education, patient
4900979|NCT02082704|Educational Technology|educational technology
4900980|NCT02082691|G-202|g-202
4900981|NCT02082691|Hepatocellular|hepatocellular
4900982|NCT02082678|Bipolar Disorder|bipolar disorder
4900984|NCT02082678|Alcohol Use Disorder|alcohol use disorder
4900985|NCT02082678|Alcohol Abuse|alcohol abuse
4900986|NCT02082678|Alcohol Dependence|alcohol dependence
4900987|NCT02082678|Ondansetron|ondansetron
4900988|NCT02082678|Cognition|cognition
4900989|NCT02082678|Mood|mood
4900990|NCT02082665|rosuvastatin|rosuvastatin
4900991|NCT02082665|BRAF V600|braf v600
4900992|NCT02082665|Melanoma|melanoma
4900993|NCT02082665|dabrafenib|dabrafenib
4900994|NCT02082665|midazolam|midazolam
4900995|NCT02082652|Etonogestrel|etonogestrel
4900998|NCT02082652|Pharmacokinetics|pharmacokinetics
4900999|NCT02082639|Adolescents|adolescents
4901000|NCT02082639|Havrix|havrix
4901001|NCT02082639|Immunogenicity|immunogenicity
4901002|NCT02082639|Cervarix|cervarix
4901003|NCT02082639|Safety|safety
4901004|NCT02082626|Phase I|phase i
4901005|NCT02082626|Pediatric|pediatric
4901006|NCT02082626|Cancer|cancer
4901007|NCT02082626|Lymphoma|lymphoma
4901008|NCT02082626|Eribulin|eribulin
4901009|NCT02082613|Testicular hydrocele|testicular hydrocele
4901010|NCT02082613|Hydrocele|hydrocele
4901011|NCT02082613|Sclerotherapy|sclerotherapy
4901012|NCT02082613|Surgery|surgery
4901013|NCT02082613|Complications|complications
4901014|NCT02082587|brain metastases|brain metastases
4901015|NCT02082587|brain mets|brain mets
4901016|NCT02082587|WBRT|wbrt
4901017|NCT02082561|transdiagnostic treatment|transdiagnostic treatment
4901018|NCT02082561|cognitive behavior therapy|cognitive behavior therapy
4901019|NCT02082561|anxiety|anxiety
4901020|NCT02082561|panic disorder|panic disorder
4901021|NCT02082561|generalized anxiety disorder|generalized anxiety disorder
4901022|NCT02082561|social anxiety disorder|social anxiety disorder
4901023|NCT02082548|atrial fibrillation|atrial fibrillation
4901024|NCT02082548|anticoagulation|anticoagulation
4901025|NCT02082548|education|education
4901026|NCT02082548|educational intervention|educational intervention
4901027|NCT02082535|Premature Birth|premature birth
4901028|NCT02082535|Brain Injuries|brain injuries
4901029|NCT02082535|Leukomalacia Periventricular|leukomalacia periventricular
4901030|NCT02082535|S100B protein human|s100b protein human
4901031|NCT02082535|Glial Fibrillary Acidic Protein|glial fibrillary acidic protein
4901032|NCT02082535|Magnetic Resonance Imaging|magnetic resonance imaging
4901033|NCT02082535|Developmental Disabilities|developmental disabilities
4901034|NCT02082522|Cholangiocarcinoma|cholangiocarcinoma
4901035|NCT02082522|Unresectable perihilar cholangiocarcinoma|unresectable perihilar cholangiocarcinoma
4901036|NCT02082522|Klatskin tumor|klatskin tumor
4901037|NCT02082522|Photodynamic therapy|photodynamic therapy
4901038|NCT02082522|Porfimer sodium|porfimer sodium
4901039|NCT02082522|Photofrin|photofrin
4901040|NCT02082522|Gemcitabine|gemcitabine
4901041|NCT02082522|Cisplatin|cisplatin
4901042|NCT02082522|Stents|stents
4901043|NCT02082522|CCA|cca
4901044|NCT02082522|PDT|pdt
4901045|NCT02082522|Bile duct cancer|bile duct cancer
4901046|NCT02082522|Bile duct tumor|bile duct tumor
4901047|NCT02082522|Bile duct adenocarcinoma|bile duct adenocarcinoma
4901048|NCT02082522|Chemotherapy|chemotherapy
4901049|NCT02082509|Traumatic Brain Injury|traumatic brain injury
4901050|NCT02082509|Post-Concussive Symptoms|post-concussive symptoms
4901051|NCT02082509|Brain Imaging|brain imaging
4901052|NCT02082509|Cognition|cognition
4901053|NCT02082496|Obesity|obesity
4901054|NCT02082496|Obesity Genetics|obesity genetics
4901055|NCT02082496|GLP-1|glp-1
4901056|NCT02082496|GLP-1 Receptor Agonists|glp-1 receptor agonists
4901057|NCT02082483|Kidney Transplant|kidney transplant
4901058|NCT02082483|Screening|screening
4901059|NCT02082457|Irritable Bowel Syndrome|irritable bowel syndrome
4901060|NCT02082457|Constipation|constipation
4901061|NCT02082457|C-IBS|c-ibs
4901062|NCT02082431|Sensorineural hearing loss|sensorineural hearing loss
4901063|NCT02082431|Long QT Syndrome|long qt syndrome
4901064|NCT02082418|Mild cognitive impairment|mild cognitive impairment
4901065|NCT02082418|Protein digestion|protein digestion
4901066|NCT02082418|Tryptophan digestion|tryptophan digestion
4901067|NCT02082418|Cognitive function|cognitive function
4901068|NCT02082418|Mood|mood
4901069|NCT02082418|Muscle function|muscle function
4901070|NCT02082418|Alpha-lactalbumin|alpha-lactalbumin
4901071|NCT02082379|Interface, aerosol, child, acceptance|interface, aerosol, child, acceptance
4901072|NCT02082366|Atrial fibrillation|atrial fibrillation
4901073|NCT02082366|CPVI|cpvi
4901074|NCT02082366|TCD|tcd
4901075|NCT02082366|nMARQ|nmarq
4901076|NCT02082366|MES|mes
4901077|NCT02082366|microembolic signals|microembolic signals
4901078|NCT02082353|Granulomatous Disease, Chronic|granulomatous disease, chronic
4901079|NCT02082353|Hematopoietic Stem Cell Transplantation (HSCT)|hematopoietic stem cell transplantation (hsct)
4901080|NCT02082353|bone marrow transplant (BMT)|bone marrow transplant (bmt)
4901081|NCT02082353|non-transplant|non-transplant
4901082|NCT02082353|factors associated with best outcomes of transplant in CGD|factors associated with best outcomes of transplant in cgd
4901083|NCT02082340|Tuberculosis|tuberculosis
4901084|NCT02082340|Armenia|armenia
4901085|NCT02082340|Clinical trial|clinical trial
4901086|NCT02082340|Directly Observed Therapy (DOT)|directly observed therapy (dot)
4901087|NCT02082340|Self-administered drug intake|self-administered drug intake
4901088|NCT02082327|Fabry Disease|fabry disease
4901089|NCT02082327|Fabry|fabry
4901090|NCT02082327|Lysosomal storage disorders|lysosomal storage disorders
4901091|NCT02082327|LSD|lsd
4901092|NCT02082327|Amicus|amicus
4901093|NCT02082327|migalastat HCl|migalastat hcl
4901094|NCT02082327|migalastat|migalastat
4901095|NCT02082327|AT1001|at1001
4901096|NCT02082314|radiofrequency ablation|radiofrequency ablation
4901097|NCT02082314|bone metastases|bone metastases
4901098|NCT02082288|ICSI outcome|icsi outcome
4901099|NCT02082275|Prenatal Care|prenatal care
4901100|NCT02082275|Obstetrics|obstetrics
4901101|NCT02082249|Safety|safety
4901102|NCT02082249|Tolerability|tolerability
4901103|NCT02082249|Efficacy|efficacy
4901104|NCT02082249|levodopa-carbidopa intestinal gel|levodopa-carbidopa intestinal gel
4901105|NCT02082249|levodopa|levodopa
4901106|NCT02082249|carbidopa|carbidopa
4901107|NCT02082249|Advanced Parkinson's Disease|advanced parkinson's disease
4901108|NCT02082236|Plasma concentrations|plasma concentrations
4901109|NCT02082223|Quality of life|quality of life
4901110|NCT02082223|Deficits|deficits
4901111|NCT02082223|Complex gastrointestinal surgery|complex gastrointestinal surgery
4901112|NCT02082197|low testosterone|low testosterone
4901113|NCT02082184|Sensing Technology|sensing technology
4901114|NCT02082184|Type 2 Diabetes,|type 2 diabetes,
4901115|NCT02082171|older adults|older adults
4901116|NCT02082171|physical disability|physical disability
4901117|NCT02082171|multidomain intervention|multidomain intervention
4901118|NCT02082171|prevention|prevention
4901119|NCT02082171|pilot study|pilot study
4901120|NCT02082171|frailty|frailty
4901121|NCT02082171|mobility|mobility
4901122|NCT02082171|comprehensive geriatric assessment|comprehensive geriatric assessment
4901123|NCT02082106|alpine skiing|alpine skiing
4901124|NCT02082106|cross country skiing|cross country skiing
4901125|NCT02082106|indoor cycling|indoor cycling
4901126|NCT02082106|physical fitness|physical fitness
4901127|NCT02082106|training status|training status
4901128|NCT02082106|metabolic equivalent|metabolic equivalent
4901129|NCT02082093|Chronic Kidney Disease|chronic kidney disease
4901130|NCT02082093|telemedicine|telemedicine
4901131|NCT02082054|rhinitis|rhinitis
4901132|NCT02082054|seasonal|seasonal
4901133|NCT02082054|allergic|allergic
4901134|NCT02082015|Neuronal plasticity|neuronal plasticity
4901135|NCT02082015|Transcranial magnetic stimulation|transcranial magnetic stimulation
4901136|NCT02082015|Stroke|stroke
4901137|NCT02082015|Upper extremity|upper extremity
4901138|NCT02082015|Function|function
4901139|NCT02082015|Recovery|recovery
4901140|NCT02082002|Multiple scerlosis|multiple scerlosis
4901141|NCT02082002|Fatigue|fatigue
4901142|NCT02082002|Sleep|sleep
4901143|NCT02082002|Somnolence|somnolence
4901144|NCT02082002|Depression|depression
4901145|NCT02082002|Cognitive disorders|cognitive disorders
4901146|NCT02081989|Diabetes|diabetes
4901147|NCT02081989|Renal denervation|renal denervation
4901148|NCT02081963|Nebulized amikacin;|nebulized amikacin;
4901149|NCT02081963|Non-Cystic Fibrosis Bronchiectasis;|non-cystic fibrosis bronchiectasis;
4901150|NCT02081963|Bacterial clearance rate of sputum；|bacterial clearance rate of sputum；
4901151|NCT02081963|Acute exacerbation.|acute exacerbation.
4901152|NCT02081937|chimeric antigen receptor|chimeric antigen receptor
4901153|NCT02081937|immunotherapy|immunotherapy
4901154|NCT02081937|T lymphocyte|t lymphocyte
4901155|NCT02081937|mantle cell lymphoma|mantle cell lymphoma
4901156|NCT02081924|Infertility|infertility
4901157|NCT02081924|Kisspeptin|kisspeptin
4901158|NCT02081924|Reproductive hormones|reproductive hormones
4901159|NCT02081911|adductor canal|adductor canal
4901160|NCT02081911|femoral|femoral
4901161|NCT02081911|quadriceps|quadriceps
4901162|NCT02081898|low calorie diet|low calorie diet
4901163|NCT02081898|BMI|bmi
4901164|NCT02081898|sphingomyelin|sphingomyelin
4901165|NCT02081898|L-leucine|l-leucine
4901166|NCT02081898|L-phenylalanine|l-phenylalanine
4901167|NCT02081885|Tricalcium phosphate|tricalcium phosphate
4901168|NCT02081885|Chitosan|chitosan
4901169|NCT02081885|Grafting, Bone|grafting, bone
4901170|NCT02081885|Mandibular Fractures|mandibular fractures
4901171|NCT02081872|Pharmacogenomics|pharmacogenomics
4901172|NCT02081872|Target Drug Related Adverse Events (TDAE)|target drug related adverse events (tdae)
4901173|NCT02081846|transitions of care|transitions of care
4901174|NCT02081846|reutilization|reutilization
4901175|NCT02081846|home nurse visit|home nurse visit
4901176|NCT02081846|focus groups|focus groups
4901177|NCT02081846|quality improvement|quality improvement
4901178|NCT02081833|acute respiratory infections|acute respiratory infections
4901179|NCT02081833|acute gastrointestinal infections|acute gastrointestinal infections
4901180|NCT02081833|children|children
4901181|NCT02081833|child|child
4901182|NCT02081833|symptom diary|symptom diary
4901183|NCT02081833|nasal swabs|nasal swabs
4901184|NCT02081833|stool samples|stool samples
4901185|NCT02081820|hyperglycemia|hyperglycemia
4901186|NCT02081820|aneurysmal subarachnoid hemorrhage|aneurysmal subarachnoid hemorrhage
4901187|NCT02081820|glycated hemoglobin|glycated hemoglobin
4901188|NCT02081820|outcome|outcome
4901189|NCT02081820|DCI|dci
4901190|NCT02081768|Rathke's cleft cyst|rathke's cleft cyst
4901191|NCT02081768|cystic craniopharyngiomas|cystic craniopharyngiomas
4901192|NCT02081755|Immunosuppressive Agents|immunosuppressive agents
4901193|NCT02081755|Liver Transplantation|liver transplantation
4901194|NCT02081742|Colonoscopy, CT colonography, Colon capsule|colonoscopy, ct colonography, colon capsule
4901195|NCT02081703|Postsurgical pain|postsurgical pain
4901196|NCT02081703|Total knee arthroplasty|total knee arthroplasty
4901197|NCT02081703|Total knee replacement|total knee replacement
4901198|NCT02081690|PAH-SYMPACT|pah-sympact
4901199|NCT02081690|psychometric instrument|psychometric instrument
4901200|NCT02081664|Amalgam attributed health complaints|amalgam attributed health complaints
4901201|NCT02081664|feasibility pilot study|feasibility pilot study
4901202|NCT02081664|integrated medical care program|integrated medical care program
4901203|NCT02081664|lifestyle|lifestyle
4901204|NCT02081638|Immune Activation|immune activation
4901205|NCT02081625|Duchenne muscular dystrophy|duchenne muscular dystrophy
4901206|NCT02081625|NS-065/NCNP-01|ns-065/ncnp-01
4901207|NCT02081625|exon 53 skipping|exon 53 skipping
4901208|NCT02081625|morpholino|morpholino
4901209|NCT02081599|insulin resistance|insulin resistance
4901210|NCT02081586|CBT|cbt
4901211|NCT02081586|Type 2 Diabetes|type 2 diabetes
4901212|NCT02081586|Diabetes Distress|diabetes distress
4901213|NCT02081586|Adherence|adherence
4901214|NCT02081586|Smartphone App|smartphone app
4901215|NCT02081586|Self-management|self-management
4901216|NCT02081573|Brief CBT|brief cbt
4901217|NCT02081573|smartphone app|smartphone app
4901218|NCT02081573|mHealth|mhealth
4901219|NCT02081573|diabetes distress|diabetes distress
4901220|NCT02081573|adherence|adherence
4901221|NCT02081573|cognitive behavioral therapy|cognitive behavioral therapy
4901222|NCT02081560|pharmacokinetics|pharmacokinetics
4901223|NCT02081560|antibiotic|antibiotic
4901224|NCT02081560|Gram negative|gram negative
4901225|NCT02081560|continuous renal replacement therapy|continuous renal replacement therapy
4901226|NCT02081547|rectal carcinoma|rectal carcinoma
4901227|NCT02081547|recurrence|recurrence
4901228|NCT02081547|pathology|pathology
4901229|NCT02081547|cytology|cytology
4901230|NCT02081547|free cancer cells|free cancer cells
4901231|NCT02081547|survival|survival
4901232|NCT02081534|S-phosphate, hyperphosphatemia, hemodialysis, ESRD|s-phosphate, hyperphosphatemia, hemodialysis, esrd
4901233|NCT02081521|behaviour change|behaviour change
4901234|NCT02081521|diarrhoeal disease|diarrhoeal disease
4901235|NCT02081521|handwashing|handwashing
4901236|NCT02081521|breastfeeding|breastfeeding
4901237|NCT02081521|diarrhoea management|diarrhoea management
4901238|NCT02081508|Memory|memory
4901239|NCT02081495|Neoplasms|neoplasms
4901240|NCT02081495|Neoplasms, Ovarian|neoplasms, ovarian
4901241|NCT02081495|Ovarian Cancer|ovarian cancer
4901242|NCT02081495|Advanced or Refractory Solid Malignancies|advanced or refractory solid malignancies
4901243|NCT02081495|Doxorubicin|doxorubicin
4901244|NCT02081495|DOXIL|doxil
4901245|NCT02081495|CAELYX|caelyx
4901246|NCT02081469|Chronic hepatitis B|chronic hepatitis b
4901247|NCT02081469|HBV|hbv
4901248|NCT02081469|Chemotherapy|chemotherapy
4901249|NCT02081469|Reactivation|reactivation
4901250|NCT02081469|Prophylaxis|prophylaxis
4901251|NCT02081443|coronary artery disease|coronary artery disease
4901252|NCT02081443|platelet function|platelet function
4901253|NCT02081443|ticagrelor|ticagrelor
4901254|NCT02081443|cangrelor|cangrelor
4901255|NCT02081417|Trauma|trauma
4901256|NCT02081417|Post traumatic stress disorder|post traumatic stress disorder
4901257|NCT02081417|substance use disorders|substance use disorders
4901258|NCT02081417|peer-delivered trauma treatment|peer-delivered trauma treatment
4901259|NCT02081404|Non-erosive Reflux Disease|non-erosive reflux disease
4901260|NCT02081391|Acute Pain|acute pain
4901261|NCT02081391|Post-operative|post-operative
4901262|NCT02081391|Tapentadol|tapentadol
4901263|NCT02081391|Opioid Treatment|opioid treatment
4901264|NCT02081391|Pediatric Participants|pediatric participants
4901265|NCT02081378|CML|cml
4901266|NCT02081378|Ph+ ALL|ph+ all
4901267|NCT02081352|Dermis|dermis
4901268|NCT02081352|Diabetic foot ulcers|diabetic foot ulcers
4901269|NCT02081352|Skin substitutes|skin substitutes
4901270|NCT02081352|Decellularized|decellularized
4901271|NCT02081326|Diabetes Mellitus, Type One|diabetes mellitus, type one
4901272|NCT02081326|Diabetes Mellitus, Type I|diabetes mellitus, type i
4901273|NCT02081326|Autoimmune Diabetes|autoimmune diabetes
4901274|NCT02081326|Insulin Dependent Diabetes Mellitus 1|insulin dependent diabetes mellitus 1
4901275|NCT02081326|IDDM|iddm
4901276|NCT02081313|Netherton syndrome|netherton syndrome
4901277|NCT02081313|Immune system|immune system
4901278|NCT02081313|Skin barrier|skin barrier
4901279|NCT02081300|Testosterone|testosterone
4901280|NCT02081300|Male hypogonadism|male hypogonadism
4901281|NCT02081300|Low testosterone|low testosterone
4901282|NCT02081300|LPCN 1021|lpcn 1021
4901283|NCT02081300|Androgel|androgel
4901284|NCT02081300|Testim|testim
4901285|NCT02081300|Testopel|testopel
4901286|NCT02081300|Fortesta|fortesta
4901287|NCT02081300|Axiron.|axiron.
4901288|NCT02081300|Hypogonadism|hypogonadism
4901289|NCT02081300|Eunuchism|eunuchism
4901290|NCT02081300|Gonadal Disorders|gonadal disorders
4901291|NCT02081300|Endocrine System Diseases|endocrine system diseases
4901292|NCT02081300|Testosterone enanthate|testosterone enanthate
4901293|NCT02081300|Testosterone undecanoate|testosterone undecanoate
4901294|NCT02081300|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate
4901295|NCT02081300|Methyltestosterone|methyltestosterone
4901296|NCT02081300|Androgens|androgens
4901297|NCT02081300|Hormones|hormones
4901298|NCT02081300|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists
4901299|NCT02081300|Physiological Effects of Drugs|physiological effects of drugs
4901300|NCT02081300|Pharmacologic Actions|pharmacologic actions
4901301|NCT02081300|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal
4901302|NCT02081300|Antineoplastic Agents|antineoplastic agents
4901303|NCT02081300|Anabolic Agents|anabolic agents
4901304|NCT02081287|Bipolar Disorder|bipolar disorder
4901305|NCT02081287|Depression|depression
4901306|NCT02081287|Inositol|inositol
4901307|NCT02081287|Inositol Hexaphosphate|inositol hexaphosphate
4901308|NCT02081287|Phytic Acid|phytic acid
4901309|NCT02081287|IP6|ip6
4901310|NCT02081287|Lithium|lithium
4901311|NCT02081287|Lamotrigine|lamotrigine
4901312|NCT02081274|tidal volume|tidal volume
4901313|NCT02081274|congenital heart disease|congenital heart disease
4901314|NCT02081274|mortality|mortality
4901315|NCT02081261|coronary artery bypass surgery|coronary artery bypass surgery
4901316|NCT02081261|acute kidney injury|acute kidney injury
4901317|NCT02081261|creatinine|creatinine
4901318|NCT02081261|mortality|mortality
4901319|NCT02081235|congenital heart disease|congenital heart disease
4901320|NCT02081235|acute kidney injury|acute kidney injury
4901321|NCT02081235|risk factor|risk factor
4901322|NCT02081235|anesthesia|anesthesia
4901323|NCT02081222|congenital heart disease|congenital heart disease
4901324|NCT02081222|rotational thromboelastometry|rotational thromboelastometry
4901325|NCT02081222|blood loss|blood loss
4901326|NCT02081222|transfusion requirements|transfusion requirements
4901327|NCT02081209|Lipolysis|lipolysis
4901328|NCT02081209|Cryolipolysis|cryolipolysis
4901329|NCT02081209|Fat Reduction|fat reduction
4901330|NCT02081196|Lipolysis|lipolysis
4901331|NCT02081196|Cryolipolysis|cryolipolysis
4901332|NCT02081196|Fat Reduction|fat reduction
4901333|NCT02081144|Standard Care Condition|standard care condition
4901334|NCT02081144|Texting + NRT Condition|texting + nrt condition
4901335|NCT02081131|periampullary cancer|periampullary cancer
4901336|NCT02081131|pancreatic cancer|pancreatic cancer
4901337|NCT02081131|randomized controlled trial|randomized controlled trial
4901338|NCT02081131|Whipple's operation|whipple's operation
4901339|NCT02081131|laparoscopy|laparoscopy
4901340|NCT02081105|ARDS,|ards,
4901341|NCT02081105|PEEP,|peep,
4901342|NCT02081105|lung recruitment,|lung recruitment,
4901343|NCT02081105|lung recruitability,|lung recruitability,
4901344|NCT02081105|Chest-X-Ray,|chest-x-ray,
4901345|NCT02081105|lung imaging,|lung imaging,
4901346|NCT02081105|Pressure/Volume (PV) curve,|pressure/volume (pv) curve,
4901347|NCT02081105|compliance,|compliance,
4901348|NCT02081105|respiratory mechanics|respiratory mechanics
4901349|NCT02081092|PAP|pap
4901350|NCT02081092|Pulmonary Alveolar Proteinosis|pulmonary alveolar proteinosis
4901351|NCT02081092|Pulmonary|pulmonary
4901352|NCT02081092|Patients|patients
4901353|NCT02081079|HCV GT 4|hcv gt 4
4901354|NCT02081079|HCV GT 5|hcv gt 5
4901355|NCT02081053|metastatic lesions|metastatic lesions
4901356|NCT02081053|vertebral body|vertebral body
4901357|NCT02081053|ablation|ablation
4901358|NCT02081053|targeted radio-frequency ablation|targeted radio-frequency ablation
4901359|NCT02081053|radio-frequency targeted vertebral augmentation|radio-frequency targeted vertebral augmentation
4901360|NCT02081053|radiofrequency kyphoplasty|radiofrequency kyphoplasty
4901361|NCT02081053|spine|spine
4901362|NCT02081053|vertebral augmentation|vertebral augmentation
4901363|NCT02081053|kyphoplasty|kyphoplasty
4901364|NCT02081053|spinal ablation|spinal ablation
4901365|NCT02081053|pain|pain
4901366|NCT02081053|quality of life|quality of life
4901367|NCT02081040|brainstem|brainstem
4901368|NCT02081040|diaphragm|diaphragm
4901369|NCT02081040|deglutition disorder|deglutition disorder
4901370|NCT02081040|sonography|sonography
4901371|NCT02081014|Hypoglycemia|hypoglycemia
4901372|NCT02081014|Glucagon|glucagon
4901373|NCT02081014|Diabetes|diabetes
4901374|NCT02081001|Hypoglycemia|hypoglycemia
4901375|NCT02081001|Glucagon|glucagon
4901376|NCT02081001|Artificial Pancreas|artificial pancreas
4901377|NCT02080988|stroke|stroke
4901378|NCT02080988|deglutition disorders|deglutition disorders
4901379|NCT02080988|cough|cough
4901380|NCT02080988|aspiration pneumonia|aspiration pneumonia
4901381|NCT02080988|diaphragm|diaphragm
4901382|NCT02080988|respiratory function|respiratory function
4901383|NCT02080962|non-melanoma skin cancer, radiotherapy, orthovoltage|non-melanoma skin cancer, radiotherapy, orthovoltage
4901384|NCT02080949|brain metastases, hypofractionated stereotactic radiotherapy|brain metastases, hypofractionated stereotactic radiotherapy
4901385|NCT02080936|Experimental approaches|experimental approaches
4901386|NCT02080936|Peripheral muscle Keyword|peripheral muscle keyword
4901387|NCT02080936|Rehabilitation|rehabilitation
4901388|NCT02080923|Adolescent|adolescent
4901389|NCT02080923|Adolescent Behavior|adolescent behavior
4901390|NCT02080923|Age Factors|age factors
4901391|NCT02080923|Courtship|courtship
4901392|NCT02080923|Randomized Control Trial|randomized control trial
4901393|NCT02080923|Female|female
4901394|NCT02080923|Male|male
4901395|NCT02080923|Minority Groups/statistics & numerical data|minority groups/statistics & numerical data
4901396|NCT02080923|Risk-Taking|risk-taking
4901397|NCT02080923|Sex Factors|sex factors
4901603|NCT02079935|purging|purging
4901398|NCT02080923|Sexual Behavior/statistics & numerical data|sexual behavior/statistics & numerical data
4901399|NCT02080923|Substance-Related Disorders/epidemiology|substance-related disorders/epidemiology
4901400|NCT02080923|Urban Population/statistics & numerical data|urban population/statistics & numerical data
4901401|NCT02080923|Violence/statistics & numerical data|violence/statistics & numerical data
4901402|NCT02080923|Dating Violence|dating violence
4901403|NCT02080923|Dating Aggression|dating aggression
4901404|NCT02080923|Perpetration|perpetration
4901405|NCT02080910|Caregiver|caregiver
4901406|NCT02080910|stroke|stroke
4901407|NCT02080910|psychoeducation|psychoeducation
4901408|NCT02080910|problem-solving|problem-solving
4901409|NCT02080897|non-surgical|non-surgical
4901410|NCT02080897|palliative surgery|palliative surgery
4901411|NCT02080871|PAD|pad
4901412|NCT02080871|Stent|stent
4901413|NCT02080871|Claudication|claudication
4901414|NCT02080871|Viabahn|viabahn
4901415|NCT02080871|Gore|gore
4901416|NCT02080871|Endoprosthesis|endoprosthesis
4901417|NCT02080871|Vascular Diseases|vascular diseases
4901418|NCT02080871|Cardiovascular Diseases|cardiovascular diseases
4901419|NCT02080871|Iliac Occlusive Disease|iliac occlusive disease
4901420|NCT02080871|Balloon Expandable|balloon expandable
4901421|NCT02080871|Stent-graft|stent-graft
4901422|NCT02080871|VBX|vbx
4901423|NCT02080858|Apixaban|apixaban
4901424|NCT02080858|Ticagrelor|ticagrelor
4901425|NCT02080858|ASA|asa
4901426|NCT02080858|shed blood|shed blood
4901427|NCT02080858|perfusion chamber|perfusion chamber
4901428|NCT02080845|Caffeine|caffeine
4901429|NCT02080845|MRI|mri
4901430|NCT02080845|Brain blood flow|brain blood flow
4901431|NCT02080845|Cognition|cognition
4901432|NCT02080845|Perfusion|perfusion
4901433|NCT02080845|Resting functional magnetic resonance imaging (fMRI)|resting functional magnetic resonance imaging (fmri)
4901434|NCT02080832|substance abuse|substance abuse
4901435|NCT02080832|cocaine|cocaine
4901436|NCT02080832|impulsivity|impulsivity
4901437|NCT02080832|serotonin|serotonin
4901438|NCT02080832|MRI|mri
4901439|NCT02080819|drug abuse|drug abuse
4901440|NCT02080819|cocaine|cocaine
4901441|NCT02080819|impulsivity|impulsivity
4901442|NCT02080819|dopamine|dopamine
4901443|NCT02080806|stroke, dysphagia, cough, mechanical insufflation exsufflation|stroke, dysphagia, cough, mechanical insufflation exsufflation
4901444|NCT02080754|Crush induction|crush induction
4901445|NCT02080754|Cricoid pressure|cricoid pressure
4901446|NCT02080754|Sellick maneuver|sellick maneuver
4901447|NCT02080754|Lung aspiration|lung aspiration
4901448|NCT02080754|Aspiration pneumonia|aspiration pneumonia
4901449|NCT02080715|Sleep-wake|sleep-wake
4901450|NCT02080715|regulation|regulation
4901451|NCT02080715|volunteers|volunteers
4901452|NCT02080702|GIT, Monosyn, anastomoses leakage|git, monosyn, anastomoses leakage
4901453|NCT02080676|Cannabis|cannabis
4901454|NCT02080676|Intra ocular pressure|intra ocular pressure
4901455|NCT02080676|Ocular perfusion|ocular perfusion
4901456|NCT02080676|Blood pressure|blood pressure
4901457|NCT02080663|carpectomy, proximal row, long-term, wrist, arthritis|carpectomy, proximal row, long-term, wrist, arthritis
4901458|NCT02080637|Single ventricle|single ventricle
4901459|NCT02080585|Inactivity|inactivity
4901460|NCT02080546|Vaginal cuff dehiscence|vaginal cuff dehiscence
4901461|NCT02080546|Thermal Injury|thermal injury
4901462|NCT02080546|Total laparoscopic hysterectomy|total laparoscopic hysterectomy
4901463|NCT02080533|pulmonary arterial hypertension|pulmonary arterial hypertension
4901464|NCT02080533|symptoms|symptoms
4901465|NCT02080533|dyspnea|dyspnea
4901466|NCT02080533|fatigue|fatigue
4901467|NCT02080533|sleep|sleep
4901468|NCT02080520|Prevention|prevention
4901469|NCT02080520|Soy|soy
4901470|NCT02080520|Fermented soy|fermented soy
4901471|NCT02080520|Nattokinase|nattokinase
4901472|NCT02080520|Randomized controlled trial|randomized controlled trial
4901473|NCT02080520|Carotid artery|carotid artery
4901474|NCT02080520|Cognition|cognition
4901475|NCT02080520|Atherothrombosis|atherothrombosis
4901476|NCT02080507|rTMS|rtms
4901477|NCT02080507|depression|depression
4901478|NCT02080507|ECT|ect
4901479|NCT02080494|tranexamic acid|tranexamic acid
4901480|NCT02080494|orthopaedic trauma|orthopaedic trauma
4901481|NCT02080494|pelvic fracture|pelvic fracture
4901482|NCT02080494|hip fracture|hip fracture
4901483|NCT02080494|femur fracture|femur fracture
4901484|NCT02080494|blood loss|blood loss
4901485|NCT02080468|Effect|effect
4901486|NCT02080468|Ethinyl Estradiol/Norgestimate|ethinyl estradiol/norgestimate
4901487|NCT02080468|Pharmacokinetics|pharmacokinetics
4901488|NCT02080468|Lomitapide.|lomitapide.
4901489|NCT02080442|COPD|copd
4901490|NCT02080442|Balance|balance
4901491|NCT02080442|Pulmonary Rehabilitation|pulmonary rehabilitation
4901492|NCT02080416|EBV|ebv
4901493|NCT02080416|KSHV|kshv
4901494|NCT02080416|malignancy|malignancy
4901495|NCT02080416|lymphoma|lymphoma
4901496|NCT02080416|sarcoma|sarcoma
4901497|NCT02080416|virus-associated|virus-associated
4901498|NCT02080403|Peri-Implantitis|peri-implantitis
4901499|NCT02080403|Periodontal Diseases|periodontal diseases
4901500|NCT02080403|Chlorhexidine gluconate|chlorhexidine gluconate
4901501|NCT02080403|PerioChip|periochip
4901502|NCT02080403|Anti-Infective Agents|anti-infective agents
4901503|NCT02080403|Mouth Diseases|mouth diseases
4901504|NCT02080403|Antiseptics|antiseptics
4901505|NCT02080390|Her 2 Positive Breast Cancer|her 2 positive breast cancer
4901506|NCT02080390|Trastuzumab|trastuzumab
4901507|NCT02080390|Herceptin|herceptin
4901508|NCT02080390|Heart Failure|heart failure
4901509|NCT02080390|Echocardiography|echocardiography
4901510|NCT02080377|Pregnancy|pregnancy
4901511|NCT02080377|Gestational diabetes|gestational diabetes
4901512|NCT02080377|Glycaemic control|glycaemic control
4901513|NCT02080377|Metformin|metformin
4901514|NCT02080364|Alzheimer's disease|alzheimer's disease
4901515|NCT02080364|RAGE|rage
4901516|NCT02080364|ADAS-cog|adas-cog
4901517|NCT02080364|CDR-sb|cdr-sb
4901518|NCT02080338|Orthodontic, Bracket slot, Effective, Randomized, Duration|orthodontic, bracket slot, effective, randomized, duration
4901519|NCT02080325|weight loss|weight loss
4901520|NCT02080325|high protein diet|high protein diet
4901521|NCT02080325|plant protein|plant protein
4901522|NCT02080325|satiety|satiety
4901523|NCT02080325|soy|soy
4901524|NCT02080312|Meniere's disease|meniere's disease
4901525|NCT02080312|endolymphatic hydrops|endolymphatic hydrops
4901526|NCT02080286|spatial neglect|spatial neglect
4901527|NCT02080286|rehabilitation|rehabilitation
4901528|NCT02080286|brain stimulation|brain stimulation
4901529|NCT02080286|tDCS|tdcs
4901530|NCT02080286|prism adaptation|prism adaptation
4901531|NCT02080234|Lymphoma, Extranodal NK-T-Cell|lymphoma, extranodal nk-t-cell
4901532|NCT02080234|asparaginase|asparaginase
4901533|NCT02080234|GELOX|gelox
4901534|NCT02080234|concurrent chemoradiotherapy|concurrent chemoradiotherapy
4901535|NCT02080234|sIL-2R|sil-2r
4901536|NCT02080221|metastatic pancreatic cancer|metastatic pancreatic cancer
4901537|NCT02080221|pancreatic cancer|pancreatic cancer
4901538|NCT02080221|metastatic|metastatic
4901539|NCT02080208|hypoxemia|hypoxemia
4901540|NCT02080208|high flow oxygen therapy|high flow oxygen therapy
4901541|NCT02080208|respiratory failure|respiratory failure
4901542|NCT02080182|Acute Pyelonephritis|acute pyelonephritis
4901543|NCT02080182|Acetylcysteine|acetylcysteine
4901544|NCT02080182|Pediatric|pediatric
4901545|NCT02080169|Intensive care unit|intensive care unit
4901546|NCT02080169|Mechanical ventilation|mechanical ventilation
4901547|NCT02080169|Combined sedation|combined sedation
4901548|NCT02080156|Obstructive Sleep Apnea|obstructive sleep apnea
4901549|NCT02080156|Percutaneous Coronary Intervention|percutaneous coronary intervention
4901550|NCT02080156|Coronary Artery Bypass Graft|coronary artery bypass graft
4901551|NCT02080156|Mortality|mortality
4901552|NCT02080156|Questionnaire|questionnaire
4901553|NCT02080156|Biomarker|biomarker
4901554|NCT02080143|Skin temperature measurements|skin temperature measurements
4901555|NCT02080143|Heat patch adhesion|heat patch adhesion
4901556|NCT02080143|Dermal irritation|dermal irritation
4901557|NCT02080130|Gastroenteritis|gastroenteritis
4901558|NCT02080130|diarrhea|diarrhea
4901559|NCT02080117|kidney transplantation|kidney transplantation
4901560|NCT02080117|delayed graft function|delayed graft function
4901561|NCT02080117|creatinine|creatinine
4901562|NCT02080117|graft survival|graft survival
4901563|NCT02080104|postpartum hemorrhage|postpartum hemorrhage
4901564|NCT02080104|oxytocin|oxytocin
4901565|NCT02080104|vaginal delivery|vaginal delivery
4901566|NCT02080104|prophylactic|prophylactic
4901567|NCT02080078|Erlotinib|erlotinib
4901568|NCT02080078|Theophylline|theophylline
4901569|NCT02080078|Diarrhea|diarrhea
4901570|NCT02080065|risk factor|risk factor
4901571|NCT02080065|acute kidney injury|acute kidney injury
4901572|NCT02080065|liver transplantation|liver transplantation
4901573|NCT02080065|postoperative renal function|postoperative renal function
4901574|NCT02080039|Spinal Cord Injury|spinal cord injury
4901575|NCT02080039|Denervation|denervation
4901576|NCT02080039|Electrical Stimulation|electrical stimulation
4901577|NCT02080026|malaria|malaria
4901578|NCT02080026|Plasmodium falciparum|plasmodium falciparum
4901579|NCT02080000|Heart Failure|heart failure
4901580|NCT02080000|Cardiac Resynchronisation Therapy|cardiac resynchronisation therapy
4901581|NCT02080000|Biventricular Pacemaker|biventricular pacemaker
4901582|NCT02080000|Optimisation|optimisation
4901583|NCT02079987|Health Literacy|health literacy
4901584|NCT02079987|Care Transition Intervention|care transition intervention
4901585|NCT02079987|Emergency Department Population|emergency department population
4901586|NCT02079987|Access to Care|access to care
4901587|NCT02079974|endometriosis|endometriosis
4901588|NCT02079974|pain|pain
4901589|NCT02079974|fertility|fertility
4901590|NCT02079961|anemia|anemia
4901591|NCT02079961|children|children
4901592|NCT02079961|iron-fortified product|iron-fortified product
4901593|NCT02079961|value chain|value chain
4901594|NCT02079948|Aging|aging
4901595|NCT02079948|Cognitive Function|cognitive function
4901596|NCT02079948|Physical Function|physical function
4901597|NCT02079948|Systematic Inflammation|systematic inflammation
4901598|NCT02079948|Methotrexate|methotrexate
4901599|NCT02079948|Pain Symptoms|pain symptoms
4901600|NCT02079935|BN|bn
4901601|NCT02079935|Binge|binge
4901602|NCT02079935|overconsumption of food|overconsumption of food
4901605|NCT02079922|Multiple Ascending Dose|multiple ascending dose
4901606|NCT02079922|healthy subjects|healthy subjects
4901607|NCT02079922|Hypercholesterolemia|hypercholesterolemia
4901608|NCT02079922|Hyperlipidemias|hyperlipidemias
4901609|NCT02079922|Dyslipidemias|dyslipidemias
4901610|NCT02079922|Lipid Metabolism Disorders|lipid metabolism disorders
4901611|NCT02079922|Metabolic Diseases|metabolic diseases
4901612|NCT02079909|Alzheimer's Disease|alzheimer's disease
4901613|NCT02079909|Alzheimer's|alzheimer's
4901614|NCT02079896|Dialysis|dialysis
4901615|NCT02079844|Drug therapy|drug therapy
4901616|NCT02079831|Adolescent obesity|adolescent obesity
4901617|NCT02079831|childhood obesity|childhood obesity
4901618|NCT02079831|anthropometry|anthropometry
4901619|NCT02079831|body weights and measures|body weights and measures
4901620|NCT02079818|visceral artery aneurysms|visceral artery aneurysms
4901621|NCT02079818|arteriovenous malformations|arteriovenous malformations
4901622|NCT02079818|Penumbra Ruby Coil System|penumbra ruby coil system
4901623|NCT02079792|Budesonide|budesonide
4901624|NCT02079792|Mucosal Atomization Device|mucosal atomization device
4901625|NCT02079792|Head Position|head position
4901626|NCT02079779|Robotic-assisted therapy|robotic-assisted therapy
4901627|NCT02079779|Acute Stroke|acute stroke
4901628|NCT02079779|International Classification of Functioning, Disability and Health|international classification of functioning, disability and health
4901629|NCT02079753|COPD, portable concentrator, oxygen sources|copd, portable concentrator, oxygen sources
4901630|NCT02079727|Condrosulf|condrosulf
4901631|NCT02079727|Chondroitin sulfate|chondroitin sulfate
4901632|NCT02079727|Celebrex|celebrex
4901633|NCT02079727|Knee OA|knee oa
4901634|NCT02079727|Knee osteoarthritis|knee osteoarthritis
4901635|NCT02079714|Orthopaedic Trauma|orthopaedic trauma
4901636|NCT02079714|Injury|injury
4901637|NCT02079701|pneumonia|pneumonia
4901638|NCT02079701|pneumococcus|pneumococcus
4901639|NCT02079701|vaccine|vaccine
4901640|NCT02079701|23-valent pneumococcal vaccine|23-valent pneumococcal vaccine
4901641|NCT02079701|military recruits|military recruits
4901642|NCT02079688|Antisense oligonucleotide|antisense oligonucleotide
4901643|NCT02079688|atopic eczema|atopic eczema
4901644|NCT02079688|atopic dermatitis|atopic dermatitis
4901645|NCT02079688|Phase II|phase ii
4901646|NCT02079688|Transcription factor GATA-3|transcription factor gata-3
4901647|NCT02079688|dermal application|dermal application
4901648|NCT02079688|Proof-of-Concept|proof-of-concept
4901649|NCT02079662|Breast Cancer|breast cancer
4901650|NCT02079662|Radiation Therapy|radiation therapy
4901651|NCT02079662|Radiotherapy|radiotherapy
4901652|NCT02079662|XRT|xrt
4901653|NCT02079662|Aerobic Activity|aerobic activity
4901654|NCT02079662|Dietician Counseling|dietician counseling
4901655|NCT02079662|Dietary Assessment|dietary assessment
4901656|NCT02079662|Yoga|yoga
4901657|NCT02079662|Cognitive Behavior Therapy|cognitive behavior therapy
4901658|NCT02079662|Smoking Cessation Counseling|smoking cessation counseling
4901659|NCT02079662|Questionnaires|questionnaires
4901660|NCT02079662|Surveys|surveys
4901661|NCT02079662|Saliva Samples|saliva samples
4901662|NCT02079662|Blood Samples|blood samples
4901663|NCT02079649|Allergic conjunctivitis|allergic conjunctivitis
4901664|NCT02079649|Red eyes|red eyes
4901665|NCT02079649|Eyelid swelling|eyelid swelling
4901666|NCT02079649|Ragweed|ragweed
4901667|NCT02079649|Allergies|allergies
4901668|NCT02079649|Itchy eyes|itchy eyes
4901669|NCT02079649|Ocular redness|ocular redness
4901670|NCT02079649|Chemosis|chemosis
4901671|NCT02079649|Tearing|tearing
4901672|NCT02079649|Watery eyes|watery eyes
4901673|NCT02079623|Pancreatic cancer|pancreatic cancer
4901674|NCT02079623|Electroporation|electroporation
4901675|NCT02079623|Nano knife treatment|nano knife treatment
4901676|NCT02079610|Depression|depression
4901677|NCT02079610|Neurofeedback|neurofeedback
4901678|NCT02079610|Amygdala|amygdala
4901679|NCT02079597|SIRS|sirs
4901680|NCT02079597|Ninj1|ninj1
4901681|NCT02079597|Sepsis|sepsis
4901682|NCT02079597|Healthy|healthy
4901683|NCT02079584|Patient Compliance|patient compliance
4901684|NCT02079584|Target Specific Anticoagulant|target specific anticoagulant
4901685|NCT02079584|Quality of Life|quality of life
4901686|NCT02079558|prevention|prevention
4901687|NCT02079558|cesarean section|cesarean section
4901688|NCT02079545|Healthy|healthy
4901689|NCT02079545|Bioavailability|bioavailability
4901690|NCT02079545|Pharmacokinetics|pharmacokinetics
4901691|NCT02079545|Sirukumab|sirukumab
4901692|NCT02079545|Subcutaneous|subcutaneous
4901693|NCT02079545|Male|male
4901694|NCT02079493|osteoarthritis|osteoarthritis
4901695|NCT02079493|knee replacement|knee replacement
4901696|NCT02079493|functional testing|functional testing
4901697|NCT02079467|Arthroplasty, Hip|arthroplasty, hip
4901698|NCT02079467|Replacement, Hip|replacement, hip
4901699|NCT02079467|Postoperative Care|postoperative care
4901700|NCT02079467|Rehabilitation|rehabilitation
4901701|NCT02079441|Anti- TNF|anti- tnf
4901702|NCT02079441|inflammatory bowel disease|inflammatory bowel disease
4901703|NCT02079441|pregnancy|pregnancy
4901704|NCT02079441|infant|infant
4901705|NCT02079441|immunity|immunity
4901706|NCT02079441|Immune function|immune function
4901707|NCT02079428|Heart Failure|heart failure
4901708|NCT02079428|Registry|registry
4901709|NCT02079428|China|china
4901710|NCT02079415|NICU|nicu
4901711|NCT02079402|sepsis|sepsis
4901712|NCT02079402|septic|septic
4901713|NCT02079402|shock|shock
4901714|NCT02079402|ICU|icu
4901715|NCT02079402|intensive|intensive
4901716|NCT02079402|critical|critical
4901717|NCT02079402|resuscitation|resuscitation
4901718|NCT02079402|fluid|fluid
4901719|NCT02079402|IV|iv
4901720|NCT02079402|crystalloid|crystalloid
4901721|NCT02079402|balance|balance
4901722|NCT02079389|colon cancer|colon cancer
4901723|NCT02079389|rectum cancer|rectum cancer
4901724|NCT02079389|laparoscopic ultrasound|laparoscopic ultrasound
4901725|NCT02079389|LUS|lus
4901726|NCT02079389|Contrast enhanced ultrasound|contrast enhanced ultrasound
4901727|NCT02079389|CEUS|ceus
4901728|NCT02079389|Peroperative TNM staging|peroperative tnm staging
4901729|NCT02079389|screening for liver metastases|screening for liver metastases
4901730|NCT02079376|diabetes|diabetes
4901731|NCT02079363|Pancreatic Diseases|pancreatic diseases
4901732|NCT02079363|Pancreatic Neoplasms|pancreatic neoplasms
4901733|NCT02079363|Pancreatitis|pancreatitis
4901734|NCT02079363|DNA promoter hypermethylation|dna promoter hypermethylation
4901735|NCT02079363|DNA methylation|dna methylation
4901736|NCT02079363|Cell-free DNA|cell-free dna
4901737|NCT02079363|Plasma|plasma
4901738|NCT02079324|head and neck cancer|head and neck cancer
4901739|NCT02079324|gene therapy|gene therapy
4901740|NCT02079324|stem cell therapy|stem cell therapy
4901741|NCT02079324|immunotherappy|immunotherappy
4901742|NCT02079311|Patient warming|patient warming
4901743|NCT02079311|Active warming|active warming
4901744|NCT02079311|Forced Air Warming|forced air warming
4901745|NCT02079311|Warming blanket|warming blanket
4901746|NCT02079272|Tomotherapy|tomotherapy
4901747|NCT02079272|Breast Cancer|breast cancer
4901748|NCT02079272|Heart|heart
4901749|NCT02079272|Subclinical cardiac lesions|subclinical cardiac lesions
4901750|NCT02079272|Myocardial lesions|myocardial lesions
4901751|NCT02079272|Coronary lesions|coronary lesions
4901752|NCT02079272|Circulating biomarkers|circulating biomarkers
4901753|NCT02079272|Ionizing radiation|ionizing radiation
4901754|NCT02079272|Heart absorbed doses|heart absorbed doses
4901755|NCT02079233|Basic Science|basic science
4901756|NCT02079233|Safety|safety
4901757|NCT02079233|Tolerability|tolerability
4901758|NCT02079233|Efficacy of CLP|efficacy of clp
4901759|NCT02079220|Colorectal Cancer|colorectal cancer
4901760|NCT02079220|Metastatic Colorectal Cancer|metastatic colorectal cancer
4901761|NCT02079194|Drug-eluting stents|drug-eluting stents
4901762|NCT02079194|aspirin|aspirin
4901763|NCT02079194|P2Y12 antagonist monotherapy|p2y12 antagonist monotherapy
4901764|NCT02079168|Keloid|keloid
4901765|NCT02079168|Cicatrix|cicatrix
4901766|NCT02079168|Keloid prevention|keloid prevention
4901767|NCT02079168|Keloid revision/excision|keloid revision/excision
4901768|NCT02079168|Keloidectomy|keloidectomy
4901769|NCT02079129|agreement between cMRI PVL grading and TTE PVL grading|agreement between cmri pvl grading and tte pvl grading
4901770|NCT02079129|Edwards Sapien TAVR|edwards sapien tavr
4901771|NCT02079116|Obesity|obesity
4901772|NCT02079116|Lipids|lipids
4901773|NCT02079116|Single Photon Emission Computed Tomography|single photon emission computed tomography
4901774|NCT02079116|Functional Neuroimaging|functional neuroimaging
4901775|NCT02079103|Virtual reality|virtual reality
4901776|NCT02079103|Stroke|stroke
4901777|NCT02079103|Arm motor function|arm motor function
4901778|NCT02079103|Neurorehabilitation|neurorehabilitation
4901779|NCT02079090|Propofol|propofol
4901780|NCT02079090|Ketamine|ketamine
4901781|NCT02079090|Fentanyl|fentanyl
4901782|NCT02079090|Procedural sedation|procedural sedation
4901783|NCT02079090|children|children
4901784|NCT02079090|Emergency Department|emergency department
4901785|NCT02079077|HIV, Immune quiescence, ASA, Hydroxychloroquin|hiv, immune quiescence, asa, hydroxychloroquin
4901786|NCT02079064|Splenectomy|splenectomy
4901787|NCT02079064|Desflurane|desflurane
4901788|NCT02079064|Propofol|propofol
4901789|NCT02079064|TCI|tci
4901790|NCT02079064|ROTEM|rotem
4901791|NCT02079051|Obesity Physical Performance Weight loss Optifast|obesity physical performance weight loss optifast
4901792|NCT02079025|Prostate Biopsy|prostate biopsy
4901793|NCT02079025|Ultrasound guided biopsy of the prostate|ultrasound guided biopsy of the prostate
4901794|NCT02079025|High-resolution ultrasound|high-resolution ultrasound
4901795|NCT02079012|Walking Program|walking program
4901796|NCT02079012|Mental Disorders|mental disorders
4901797|NCT02079012|Physical Activity|physical activity
4901798|NCT02079012|Physical Fitness|physical fitness
4901799|NCT02079012|Anxiety|anxiety
4901800|NCT02079012|Depression|depression
4901801|NCT02079012|Self Determination|self determination
4901802|NCT02078999|Mechanical ventilation, procalcitonin, c-reactive protein|mechanical ventilation, procalcitonin, c-reactive protein
4901803|NCT02078986|Whole-Body-Electromyostimulation|whole-body-electromyostimulation
4901804|NCT02078986|High Intensity Resistance Exercise Training (HIT)|high intensity resistance exercise training (hit)
4901805|NCT02078986|Lean Body Mass|lean body mass
4901806|NCT02078986|Muscle Strength|muscle strength
4901809|NCT02078973|Healthy subjects|healthy subjects
4901810|NCT02078973|Nephrology|nephrology
4901811|NCT02078960|Chronic Phase|chronic phase
4901812|NCT02078960|Accelerated Phase|accelerated phase
4901813|NCT02078960|CML|cml
4901814|NCT02078960|Chronic Myeloid Leukemia|chronic myeloid leukemia
4901815|NCT02078947|Diastolic heart failure, Heart failure with preserved ejection fraction, exercise|diastolic heart failure, heart failure with preserved ejection fraction, exercise
4901816|NCT02078934|Surgical Endoscopy|surgical endoscopy
4901817|NCT02078934|Morbid Obesity|morbid obesity
4901818|NCT02078934|Weight Loss|weight loss
4901819|NCT02078934|Bariatrics|bariatrics
4901820|NCT02078934|Complex incisional hernia with mesh|complex incisional hernia with mesh
4901821|NCT02078908|Central blood pressure|central blood pressure
4901822|NCT02078908|Peripheral (brachial) blood pressure|peripheral (brachial) blood pressure
4901823|NCT02078908|Renal variables|renal variables
4901824|NCT02078908|Vasoactive hormones|vasoactive hormones
4901825|NCT02078908|Pharmacology|pharmacology
4901826|NCT02078908|Pharmacokinetics|pharmacokinetics
4901827|NCT02078895|Lower Urinary tract discomfort , ureteral stent pain|lower urinary tract discomfort , ureteral stent pain
4901828|NCT02078882|Primary Biliary Cirrhosis|primary biliary cirrhosis
4901829|NCT02078882|Ursodeoxycholic acid|ursodeoxycholic acid
4901830|NCT02078882|Abatacept|abatacept
4901831|NCT02078882|Cytotoxic T-Lymphocyte Antigen 4 (CTLA-4)|cytotoxic t-lymphocyte antigen 4 (ctla-4)
4901832|NCT02078843|NET|net
4901833|NCT02078843|Gallium-68-DOTATATE|gallium-68-dotatate
4901834|NCT02078843|PET/CT|pet/ct
4901835|NCT02078843|Indium-111-pentetreotide scintigraphy|indium-111-pentetreotide scintigraphy
4901836|NCT02078843|octreoscan|octreoscan
4901837|NCT02078843|GEP-NET|gep-net
4901838|NCT02078843|gastroenteropancreatic neuroendocrine tumors|gastroenteropancreatic neuroendocrine tumors
4901839|NCT02078830|Wound Contamination|wound contamination
4901840|NCT02078817|Treatment-resistant|treatment-resistant
4901841|NCT02078804|Colorectal cancer|colorectal cancer
4901842|NCT02078804|Mortality|mortality
4901843|NCT02078804|Incidence|incidence
4901844|NCT02078804|Screening|screening
4901845|NCT02078804|Health-economy|health-economy
4901846|NCT02078791|Fibromyalgia|fibromyalgia
4901847|NCT02078791|Group Problem Solving Technique|group problem solving technique
4901848|NCT02078791|infiltration|infiltration
4901849|NCT02078778|Continuous airway pressure|continuous airway pressure
4901850|NCT02078778|Hypertension|hypertension
4901851|NCT02078778|Obstructive sleep apnea|obstructive sleep apnea
4901852|NCT02078765|hypertension|hypertension
4901853|NCT02078765|chronic kidneys disease|chronic kidneys disease
4901854|NCT02078765|obstructive sleep apnea|obstructive sleep apnea
4901855|NCT02078765|24-h blood pressure|24-h blood pressure
4901856|NCT02078765|central blood pressure|central blood pressure
4901857|NCT02078765|peripheral blood pressure|peripheral blood pressure
4901858|NCT02078752|ADC|adc
4901859|NCT02078752|PF-06647263|pf-06647263
4901860|NCT02078752|solid tumors|solid tumors
4901861|NCT02078752|tumors|tumors
4901862|NCT02078752|neoplasm metastasis|neoplasm metastasis
4901863|NCT02078752|TNBC|tnbc
4901864|NCT02078752|Triple negative breast cancer|triple negative breast cancer
4901865|NCT02078739|Yoga|yoga
4901866|NCT02078739|COPD|copd
4901867|NCT02078739|Congestive Heart Failure|congestive heart failure
4901868|NCT02078726|glucagon, screening colonoscopy|glucagon, screening colonoscopy
4901869|NCT02078713|contraception|contraception
4901870|NCT02078713|patient decision support|patient decision support
4901871|NCT02078713|patient decision aid|patient decision aid
4901872|NCT02078713|shared decision making|shared decision making
4901873|NCT02078713|Decision Making, Shared|decision making, shared
4901874|NCT02078713|Patient-Centered Outcomes Research|patient-centered outcomes research
4901875|NCT02078700|cancer|cancer
4901876|NCT02078700|early palliative care|early palliative care
4901877|NCT02078700|feasibility|feasibility
4901878|NCT02078687|very preterm|very preterm
4901879|NCT02078687|nutrition|nutrition
4901880|NCT02078687|6 year follow-up|6 year follow-up
4901881|NCT02078687|growth|growth
4901882|NCT02078687|metabolic syndrome|metabolic syndrome
4901883|NCT02078687|allergy|allergy
4901884|NCT02078687|dexa|dexa
4901885|NCT02078674|H7N9|h7n9
4901886|NCT02078661|Keratoconjunctivitis sicca|keratoconjunctivitis sicca
4901887|NCT02078661|Dry eye|dry eye
4901888|NCT02078648|Glioma Associated Antigen|glioma associated antigen
4901889|NCT02078648|Vaccine|vaccine
4901890|NCT02078648|Adult|adult
4901891|NCT02078648|Recurrent Glioblastoma|recurrent glioblastoma
4901892|NCT02078648|Immunotherapy|immunotherapy
4901893|NCT02078635|Arterial plaque|arterial plaque
4901894|NCT02078635|portfolio diet|portfolio diet
4901895|NCT02078635|dietary modification|dietary modification
4901896|NCT02078635|dietary trials|dietary trials
4901897|NCT02078635|Canadian Network|canadian network
4901898|NCT02078635|knowledge synthesis and translation|knowledge synthesis and translation
4901899|NCT02078635|Magnetic resonance imaging|magnetic resonance imaging
4901900|NCT02078622|COPD|copd
4901901|NCT02078622|Respiratory Therapist|respiratory therapist
4901902|NCT02078622|Case Management|case management
4901903|NCT02078622|Education|education
4901904|NCT02078609|AML,|aml,
4901905|NCT02078609|MDS,|mds,
4901908|NCT02078609|acute myelod leukemia,|acute myelod leukemia,
4901909|NCT02078609|myelodysplastic syndrome,|myelodysplastic syndrome,
4901910|NCT02078609|midostaurin,|midostaurin,
4901911|NCT02078609|PKC412|pkc412
4901912|NCT02078596|temper outbursts|temper outbursts
4901913|NCT02078596|pediatric aggression|pediatric aggression
4901914|NCT02078596|irritability|irritability
4901915|NCT02078544|Cancer in Gynaecologic Oncology|cancer in gynaecologic oncology
4901916|NCT02078505|Change in gut microbial population|change in gut microbial population
4901917|NCT02078505|polycystic ovary syndrome|polycystic ovary syndrome
4901918|NCT02078505|gut microbiome|gut microbiome
4901919|NCT02078505|diet|diet
4901920|NCT02078479|Malignancy|malignancy
4901921|NCT02078479|VAS|vas
4901922|NCT02078479|LANSS|lanss
4901923|NCT02078479|VDS|vds
4901924|NCT02078479|Neuropathic pain|neuropathic pain
4901925|NCT02078479|rTMS|rtms
4901926|NCT02078479|motor cortex|motor cortex
4901927|NCT02078479|analgesia|analgesia
4901928|NCT02078466|Functional assessment|functional assessment
4901929|NCT02078466|readmission|readmission
4901930|NCT02078466|acute care|acute care
4901931|NCT02078466|older medical patients|older medical patients
4901932|NCT02078453|Dental caries|dental caries
4901933|NCT02078453|Diagnosis|diagnosis
4901934|NCT02078453|Visual inspection|visual inspection
4901935|NCT02078453|Radiographic examination|radiographic examination
4901936|NCT02078440|Type 2 Diabetes|type 2 diabetes
4901937|NCT02078440|Children|children
4901938|NCT02078440|Adolescents|adolescents
4901939|NCT02078440|Bioavailability|bioavailability
4901940|NCT02078440|Cycloset|cycloset
4901941|NCT02078440|Bromocriptine Mesylate|bromocriptine mesylate
4901942|NCT02078401|Optic pathway glioma|optic pathway glioma
4901943|NCT02078401|Ophthalmological screening|ophthalmological screening
4901944|NCT02078375|Rheumatoid Arthritis|rheumatoid arthritis
4901945|NCT02078323|Irritable Bowel Syndrome with Constipation (IBS-C)|irritable bowel syndrome with constipation (ibs-c)
4901946|NCT02078323|Linaclotide|linaclotide
4901947|NCT02078310|Dementia,|dementia,
4901948|NCT02078310|Healthy|healthy
4901949|NCT02078310|geriatric|geriatric
4901950|NCT02078310|volunteers|volunteers
4901951|NCT02078310|patients|patients
4901952|NCT02078297|IL-23|il-23
4901953|NCT02078297|IL-17A|il-17a
4901954|NCT02078297|Skin biopsies|skin biopsies
4901955|NCT02078284|platelet transfusion|platelet transfusion
4901956|NCT02078258|depression，adolescent，attention bias，modification|depression，adolescent，attention bias，modification
4901957|NCT02078245|Familial pancreatic cancer|familial pancreatic cancer
4901958|NCT02078245|Surveillance|surveillance
4901959|NCT02078245|Screening|screening
4901960|NCT02078232|fine needle aspiration under ultrasound endoscopy|fine needle aspiration under ultrasound endoscopy
4901961|NCT02078232|solid pancreatic tumors|solid pancreatic tumors
4901962|NCT02078232|head of pancreas|head of pancreas
4901963|NCT02078232|19G Flex needle|19g flex needle
4901964|NCT02078232|22G standard needle|22g standard needle
4901965|NCT02078206|Critical illness|critical illness
4901966|NCT02078206|Neurocognition|neurocognition
4901967|NCT02078206|Neurocognitive stimulation|neurocognitive stimulation
4901968|NCT02078206|Delirium|delirium
4901969|NCT02078206|Virtual Reality|virtual reality
4901970|NCT02078206|cognitive|cognitive
4901971|NCT02078206|rehabilitation|rehabilitation
4901972|NCT02078206|ICU|icu
4901973|NCT02078167|ipercholesterolemia not familiarity|ipercholesterolemia not familiarity
4901974|NCT02078154|D-Dimer|d-dimer
4901975|NCT02078154|DVT|dvt
4901976|NCT02078154|Wells score|wells score
4901977|NCT02078141|18F-deoxyglucose (FDG) PET, idiopathic Dilated Cardiomyopathy|18f-deoxyglucose (fdg) pet, idiopathic dilated cardiomyopathy
4901978|NCT02078128|burn, wound healing, skin graft|burn, wound healing, skin graft
4901979|NCT02078089|Refractory cancer pain|refractory cancer pain
4901980|NCT02078076|MRI|mri
4901981|NCT02078076|free-breathing acquisitions|free-breathing acquisitions
4901982|NCT02078076|myopathy|myopathy
4901983|NCT02078076|fibrosis assessment|fibrosis assessment
4901984|NCT02078076|function|function
4901985|NCT02078037|Intracerebral hemorrhage|intracerebral hemorrhage
4901986|NCT02078037|Perihematomal edema|perihematomal edema
4901987|NCT02078037|hemorrhage|hemorrhage
4901988|NCT02078037|normothermia|normothermia
4901989|NCT02078024|Onchocerciasis|onchocerciasis
4901991|NCT02077985|electrodermal activity|electrodermal activity
4901992|NCT02077985|cooperation|cooperation
4901993|NCT02077985|anxiety|anxiety
4901994|NCT02077985|distress|distress
4901995|NCT02077985|stress|stress
4901996|NCT02077985|oral care|oral care
4901997|NCT02077985|sensory processing|sensory processing
4901998|NCT02077985|behavior|behavior
4901999|NCT02077985|occupational therapy|occupational therapy
4902000|NCT02077972|PTSD|ptsd
4902001|NCT02077972|Military service|military service
4902002|NCT02077972|depression|depression
4902003|NCT02077972|Whole Body Hyperthermia (WBH)|whole body hyperthermia (wbh)
4902004|NCT02077959|Relapsed Multiple Myeloma|relapsed multiple myeloma
4902005|NCT02077959|Refractory Multiple Myeloma|refractory multiple myeloma
4902006|NCT02077933|Solid tumors|solid tumors
4902007|NCT02077933|renal cell carcinoma|renal cell carcinoma
4902008|NCT02077933|pancreatic neuroendocrine tumors|pancreatic neuroendocrine tumors
4902009|NCT02077933|breast cancer|breast cancer
4902010|NCT02077933|PI3K inhibitor|pi3k inhibitor
4902011|NCT02077933|BYL719|byl719
4902012|NCT02077933|alpelisib|alpelisib
4902013|NCT02077933|everolimus|everolimus
4902014|NCT02077933|exemestane|exemestane
4902015|NCT02077920|Ventilator-associated pneumonia VAP|ventilator-associated pneumonia vap
4902016|NCT02077920|Chlorhexidine|chlorhexidine
4902017|NCT02077920|Oropharyngeal decontamination|oropharyngeal decontamination
4902018|NCT02077920|Subglottic secretion drainage|subglottic secretion drainage
4902019|NCT02077894|Whole Genome Sequencing|whole genome sequencing
4902020|NCT02077894|Genetic Eye Disease|genetic eye disease
4902021|NCT02077881|metastatic|metastatic
4902022|NCT02077881|metastasis|metastasis
4902023|NCT02077881|Pancreatic|pancreatic
4902024|NCT02077881|Pancreas|pancreas
4902025|NCT02077881|Cancer|cancer
4902026|NCT02077881|adenocarcinoma|adenocarcinoma
4902027|NCT02077868|CRC|crc
4902028|NCT02077868|mCRC|mcrc
4902029|NCT02077868|maintenance treatment|maintenance treatment
4902030|NCT02077868|immune modulation|immune modulation
4902031|NCT02077868|colorectal cancer|colorectal cancer
4902032|NCT02077868|immunotherapy|immunotherapy
4902033|NCT02077868|metastatic|metastatic
4902034|NCT02077855|Sensitivity and Sensitivity|sensitivity and sensitivity
4902035|NCT02077829|Implementation process|implementation process
4902036|NCT02077829|implementation strategy|implementation strategy
4902037|NCT02077829|Implementation research|implementation research
4902038|NCT02077829|evidence based practice|evidence based practice
4902039|NCT02077829|recovery|recovery
4902040|NCT02077829|Illness management and recovery|illness management and recovery
4902041|NCT02077816|body temperature|body temperature
4902042|NCT02077816|Thermometry|thermometry
4902043|NCT02077816|Infrared Rays|infrared rays
4902044|NCT02077816|catheter related infection|catheter related infection
4902045|NCT02077803|Healthy|healthy
4902046|NCT02077803|Canagliflozin|canagliflozin
4902047|NCT02077803|Metformin|metformin
4902048|NCT02077803|Type 2 diabetes mellitus|type 2 diabetes mellitus
4902049|NCT02077803|Bioequivalence|bioequivalence
4902050|NCT02077803|GLUMETZA®|glumetza®
4902051|NCT02077777|mesalazine|mesalazine
4902052|NCT02077777|colon|colon
4902053|NCT02077777|cancer|cancer
4902054|NCT02077764|heart transplantation,|heart transplantation,
4902055|NCT02077764|rejection|rejection
4902056|NCT02077764|cardiac vasculopathy|cardiac vasculopathy
4902057|NCT02077764|optical coherence tomography|optical coherence tomography
4902058|NCT02077764|speckle tracking|speckle tracking
4902059|NCT02077764|Positron Emission Tomography .|positron emission tomography .
4902060|NCT02077764|exercise capacity|exercise capacity
4902061|NCT02077738|effectiveness|effectiveness
4902062|NCT02077738|elderly|elderly
4902063|NCT02077738|high frequency chest wall oscillation|high frequency chest wall oscillation
4902064|NCT02077738|mechanical ventilation|mechanical ventilation
4902065|NCT02077738|pneumonia|pneumonia
4902066|NCT02077738|randomized controlled trial|randomized controlled trial
4902067|NCT02077725|drug related problems|drug related problems
4902068|NCT02077725|comprehensive medication review|comprehensive medication review
4902069|NCT02077725|quality of life|quality of life
4902070|NCT02077699|Lactobacillus casei DG|lactobacillus casei dg
4902071|NCT02077699|Irritable Bowel Syndrome|irritable bowel syndrome
4902072|NCT02077686|diabetes|diabetes
4902073|NCT02077686|education|education
4902074|NCT02077686|randomized|randomized
4902075|NCT02077686|prospective|prospective
4902076|NCT02077673|GEJ-cancer|gej-cancer
4902077|NCT02077673|surgery|surgery
4902078|NCT02077673|gastroesophageal resection|gastroesophageal resection
4902079|NCT02077673|gastroesophageal anastomosis|gastroesophageal anastomosis
4902080|NCT02077673|anastomotic leakage|anastomotic leakage
4902081|NCT02077660|Green tea, aging, oxidation, anthropometrics.|green tea, aging, oxidation, anthropometrics.
4902082|NCT02077647|Knee osteoarthritis|knee osteoarthritis
4902083|NCT02077647|knee osteonecrosis|knee osteonecrosis
4902084|NCT02077647|osteotomy|osteotomy
4902085|NCT02077621|cancer-related fatigue|cancer-related fatigue
4902086|NCT02077621|Palliative Abdominal Surgery|palliative abdominal surgery
4902087|NCT02077621|HRQL|hrql
4902088|NCT02077608|In vitro fertilization|in vitro fertilization
4902089|NCT02077608|Embryotransfer|embryotransfer
4902090|NCT02077608|Hyaluronan|hyaluronan
4902091|NCT02077608|Pregnancy rate|pregnancy rate
4902092|NCT02077608|Implantation rate|implantation rate
4902093|NCT02077595|transcutaneous electrical nerve stimulation|transcutaneous electrical nerve stimulation
4902094|NCT02077595|transcranial magnetic stimulation|transcranial magnetic stimulation
4902095|NCT02077582|acute ischemic stroke|acute ischemic stroke
4902096|NCT02077569|AKT inhibitor|akt inhibitor
4902097|NCT02077569|AZD5363|azd5363
4902098|NCT02077569|Anti-tumour activity|anti-tumour activity
4902099|NCT02077569|Breast cancer|breast cancer
4902100|NCT02077569|ER positive|er positive
4902101|NCT02077569|Oestrogen positive|oestrogen positive
4902102|NCT02077569|post menopausal|post menopausal
4902103|NCT02077569|chemotherapy required|chemotherapy required
4902104|NCT02077569|no prior cancer treatment|no prior cancer treatment
4902105|NCT02077556|tacrolimus, everolimus, pharmacokinetics, drug interaction|tacrolimus, everolimus, pharmacokinetics, drug interaction
4902106|NCT02077530|Patients with metabolic syndrome age between 30 to 64: Central obesity (Men ≥ 90 cm Women ≥ 85 cm), Plasma triglycerides ≥ 150 mg/dL|patients with metabolic syndrome age between 30 to 64: central obesity (men ≥ 90 cm women ≥ 85 cm), plasma triglycerides ≥ 150 mg/dl
4902107|NCT02077530|HDL cholesterol Men < 40 mg/dL, Women < 50 mg/dL, Blood pressure ≥130/85 mm Hg (or treatment for hypertension),|hdl cholesterol men < 40 mg/dl, women < 50 mg/dl, blood pressure ≥130/85 mm hg (or treatment for hypertension),
4902108|NCT02077530|Fasting plasma glucose ≥ 100 mg/dL|fasting plasma glucose ≥ 100 mg/dl
4902109|NCT02077517|Roux en Y Gastric Bypass|roux en y gastric bypass
4902110|NCT02077517|Postoperative complications|postoperative complications
4902111|NCT02077517|Hand sewn anastomosis|hand sewn anastomosis
4902112|NCT02077517|Stapled anastomosis|stapled anastomosis
4902113|NCT02077491|Aged|aged
4902114|NCT02077491|Systemic Inflammatory Response Syndrome|systemic inflammatory response syndrome
4902115|NCT02077491|Body Composition|body composition
4902116|NCT02077491|Dietary Protein|dietary protein
4902117|NCT02077465|COPD, chronic obstructive pulmonary disease; Phase 1b, Safety, Pharmacokinetics|copd, chronic obstructive pulmonary disease; phase 1b, safety, pharmacokinetics
4902118|NCT02077452|Glucokinase activator|glucokinase activator
4902119|NCT02077452|Phase I|phase i
4902120|NCT02077452|Type 2 diabetes mellitus|type 2 diabetes mellitus
4902121|NCT02077439|Stroke|stroke
4902122|NCT02077439|Hand|hand
4902123|NCT02077439|Upper Extremity|upper extremity
4902124|NCT02077439|Robotics|robotics
4902125|NCT02077426|Functional Capacity|functional capacity
4902126|NCT02077426|Exercise Independence|exercise independence
4902127|NCT02077426|Peripheral|peripheral
4902128|NCT02077426|Strength|strength
4902129|NCT02077413|muscle|muscle
4902130|NCT02077413|eccentric exercise|eccentric exercise
4902131|NCT02077413|T2 MRI|t2 mri
4902132|NCT02077387|Inhibitory control|inhibitory control
4902133|NCT02077387|executive functioning|executive functioning
4902134|NCT02077387|childhood obesity|childhood obesity
4902135|NCT02077387|preschool|preschool
4902136|NCT02077387|snack foods|snack foods
4902137|NCT02077387|caloric intake|caloric intake
4902138|NCT02077374|NAFLD|nafld
4902139|NCT02077374|NASH|nash
4902140|NCT02077361|choroideremia|choroideremia
4902141|NCT02077361|gene therapy|gene therapy
4902142|NCT02077361|gene transfer|gene transfer
4902143|NCT02077348|Diabetes Mellitus type I|diabetes mellitus type i
4902144|NCT02077348|Ketoacidosis|ketoacidosis
4902145|NCT02077348|Insulin withdrawal|insulin withdrawal
4902146|NCT02077348|Growth hormone injection|growth hormone injection
4902147|NCT02077348|Lipolysis and ATGL|lipolysis and atgl
4902148|NCT02077335|Brachytherapy|brachytherapy
4902149|NCT02077335|Monotherapy|monotherapy
4902150|NCT02077335|HDR|hdr
4902151|NCT02077322|Merocel Middle Meatus Spacers|merocel middle meatus spacers
4902152|NCT02077322|Silastic Middle Meatus Spacers|silastic middle meatus spacers
4902153|NCT02077322|Functional Endoscopic Sinus Surgery|functional endoscopic sinus surgery
4902154|NCT02077309|T2DM,|t2dm,
4902155|NCT02077309|vascular inflammation,|vascular inflammation,
4902156|NCT02077309|18-FDG-PET,|18-fdg-pet,
4902157|NCT02077309|plaque morphology,|plaque morphology,
4902158|NCT02077309|MRI,|mri,
4902159|NCT02077309|DPP-4 Inhibition|dpp-4 inhibition
4902160|NCT02077296|cytokines|cytokines
4902161|NCT02077296|predictive value|predictive value
4902162|NCT02077296|preoperative chemoradiotherapy|preoperative chemoradiotherapy
4902163|NCT02077296|rectal cancer|rectal cancer
4902164|NCT02077283|NAFLD (non-alcoholic fatty liver disease, NAFLD)|nafld (non-alcoholic fatty liver disease, nafld)
4902165|NCT02077283|urinary metabonomics|urinary metabonomics
4902166|NCT02077283|TCM pattern|tcm pattern
4902167|NCT02077283|"liver depression and spleen deficiency pattern,"|"liver depression and spleen deficiency pattern,"
4902168|NCT02077283|"damp-heat in the interior pattern"|"damp-heat in the interior pattern"
4902169|NCT02077270|colonoscopy|colonoscopy
4902170|NCT02077270|acupuncture|acupuncture
4902171|NCT02077270|pain|pain
4902172|NCT02077244|patient|patient
4902173|NCT02077244|intensive care|intensive care
4902174|NCT02077244|follow up|follow up
4902175|NCT02077244|post traumatic stress symptoms|post traumatic stress symptoms
4902176|NCT02077244|randomized controlled trial|randomized controlled trial
4902177|NCT02077205|Diagnostic and Statistical Manual of Mental Disorders-IV/-5: Anxiety Disorders in children|diagnostic and statistical manual of mental disorders-iv/-5: anxiety disorders in children
4902178|NCT02077179|Postpartum|postpartum
4902179|NCT02077179|Preeclampsia|preeclampsia
4902180|NCT02077179|Gestational Hypertension|gestational hypertension
4902181|NCT02077179|Gestational Diabetes|gestational diabetes
4902182|NCT02077179|Exercise Intervention|exercise intervention
4902183|NCT02077179|Dietary Intervention|dietary intervention
4902184|NCT02077179|Behavioral Intervention|behavioral intervention
4902185|NCT02077179|Mobile Website|mobile website
4902186|NCT02077179|Mobile Application|mobile application
4902187|NCT02077166|DLBCL|dlbcl
4902188|NCT02077101|HIV|hiv
4902189|NCT02077101|Therapeutic vaccine|therapeutic vaccine
4902190|NCT02077101|acceptability|acceptability
4902191|NCT02077101|representations|representations
4902192|NCT02077088|interventional|interventional
4902193|NCT02077088|doubleblind|doubleblind
4902194|NCT02077088|randomised|randomised
4902195|NCT02077088|pediatric|pediatric
4902196|NCT02077088|prebiotic|prebiotic
4902197|NCT02077088|atopic|atopic
4902198|NCT02077088|dermatitis|dermatitis
4902199|NCT02077088|infant|infant
4902200|NCT02077075|weight loss|weight loss
4902201|NCT02077075|healthy weight|healthy weight
4902202|NCT02077075|overweight|overweight
4902203|NCT02077075|body mass index greater that 25 kg/m2|body mass index greater that 25 kg/m2
4902204|NCT02077062|hepatectomy,|hepatectomy,
4902205|NCT02077062|liver regeneration|liver regeneration
4902206|NCT02077062|mediators|mediators
4902207|NCT02077049|elderly|elderly
4902208|NCT02077049|exercise program|exercise program
4902209|NCT02077049|self-training|self-training
4902210|NCT02077049|mobility|mobility
4902211|NCT02077049|computer-based learning games|computer-based learning games
4902212|NCT02077049|serious game|serious game
4902213|NCT02077049|balance|balance
4902214|NCT02077049|training adherence|training adherence
4902215|NCT02077049|training compliance|training compliance
4902216|NCT02077049|Kinect ®|kinect ®
4902217|NCT02077049|Fit Bit ®|fit bit ®
4902218|NCT02077023|Stroke|stroke
4902219|NCT02077023|Heart Attack|heart attack
4902220|NCT02077023|Asymptomatic Carotid Artery Disease|asymptomatic carotid artery disease
4902221|NCT02077023|Atrial Fibrillation|atrial fibrillation
4902222|NCT02077010|milrinone|milrinone
4902223|NCT02077010|heart failure|heart failure
4902224|NCT02077010|cardiomyopathy|cardiomyopathy
4902225|NCT02077010|inhaled|inhaled
4902226|NCT02076997|Cancer|cancer
4902227|NCT02076997|High Dose Methotrexate|high dose methotrexate
4902228|NCT02076984|Ventral hernia|ventral hernia
4902229|NCT02076984|Incisional hernia|incisional hernia
4902230|NCT02076984|Patient affected by ventral or incisional hernias|patient affected by ventral or incisional hernias
4902231|NCT02076971|Lung transplant|lung transplant
4902232|NCT02076971|Quantiferon|quantiferon
4902233|NCT02076971|Immuknow|immuknow
4902234|NCT02076958|Implementation|implementation
4902235|NCT02076958|Cancer|cancer
4902236|NCT02076958|Early detection|early detection
4902237|NCT02076958|Faith-based|faith-based
4902238|NCT02076958|Community health advisor|community health advisor
4902239|NCT02076945|Regional anesthesia|regional anesthesia
4902240|NCT02076945|Diabetic neuropathy|diabetic neuropathy
4902241|NCT02076945|Ultrasound|ultrasound
4902242|NCT02076919|LHA510|lha510
4902243|NCT02076919|First in human|first in human
4902244|NCT02076919|Safety|safety
4902245|NCT02076919|Tolerability|tolerability
4902246|NCT02076919|Pharmacokinetics|pharmacokinetics
4902247|NCT02076919|Elderly|elderly
4902248|NCT02076919|Age-Related Macular Degeneration|age-related macular degeneration
4902249|NCT02076919|AMD|amd
4902250|NCT02076919|Ocular|ocular
4902251|NCT02076919|Eye drop|eye drop
4902252|NCT02076906|relapsed pediatric solid tumors|relapsed pediatric solid tumors
4902253|NCT02076906|refractory pediatric solid tumors|refractory pediatric solid tumors
4902254|NCT02076906|high intensity focused ultrasound|high intensity focused ultrasound
4902255|NCT02076906|rhabdomyosarcoma|rhabdomyosarcoma
4902256|NCT02076906|Ewing's sarcoma|ewing's sarcoma
4902257|NCT02076906|osteosarcoma|osteosarcoma
4902258|NCT02076906|neuroblastoma|neuroblastoma
4902259|NCT02076906|Wilms' tumor|wilms' tumor
4902260|NCT02076906|hepatic tumors|hepatic tumors
4902261|NCT02076906|germ cell tumors|germ cell tumors
4902262|NCT02076906|desmoid tumor|desmoid tumor
4902263|NCT02076893|Tonsillectomy|tonsillectomy
4902264|NCT02076893|Pain management|pain management
4902265|NCT02076893|Pediatrics|pediatrics
4902266|NCT02076880|Type 2 diabetes|type 2 diabetes
4902267|NCT02076880|Obesity|obesity
4902268|NCT02076880|Sleeve gastrectomy|sleeve gastrectomy
4902269|NCT02076880|Insulin|insulin
4902270|NCT02076880|GLP-1|glp-1
4902271|NCT02076867|somatic symptoms and related disorders|somatic symptoms and related disorders
4902272|NCT02076867|somatic symptoms|somatic symptoms
4902273|NCT02076867|psychodynamic psychotherapy|psychodynamic psychotherapy
4902274|NCT02076854|eating disorders|eating disorders
4902275|NCT02076854|anorexia nervosa|anorexia nervosa
4902276|NCT02076854|treatment|treatment
4902277|NCT02076854|technology|technology
4902278|NCT02076828|anemia|anemia
4902279|NCT02076828|iron polymaltose complexes|iron polymaltose complexes
4902280|NCT02076828|iron zinc|iron zinc
4902281|NCT02076815|myeloproliferative neoplasm|myeloproliferative neoplasm
4902282|NCT02076815|essential thrombocythemia|essential thrombocythemia
4902283|NCT02076815|high risk patients|high risk patients
4902284|NCT02076815|anagrelide|anagrelide
4902285|NCT02076802|prehypertension|prehypertension
4902286|NCT02076802|coronary atherosclerosis|coronary atherosclerosis
4902287|NCT02076802|cardiovascular disease|cardiovascular disease
4902288|NCT02076789|Device Replacement|device replacement
4902289|NCT02076789|Device Upgrade|device upgrade
4902290|NCT02076789|Long-term Postoperative Complications|long-term postoperative complications
4902291|NCT02076789|Resource consumption and associated costs after device replacement/upgrade|resource consumption and associated costs after device replacement/upgrade
4902292|NCT02076776|Stroke|stroke
4902293|NCT02076776|Exercise|exercise
4902294|NCT02076776|Rehabilitation|rehabilitation
4902295|NCT02076776|Neuroplasticity|neuroplasticity
4902296|NCT02076776|Task Practice|task practice
4902297|NCT02076763|Observational|observational
4902298|NCT02076763|Porphyria|porphyria
4902299|NCT02076750|Inflammatory Bowel Diseases|inflammatory bowel diseases
4902300|NCT02076750|Vitamin D|vitamin d
4902301|NCT02076750|Cholecalciferol|cholecalciferol
4902302|NCT02076750|Skin Pigmentation|skin pigmentation
4902303|NCT02076737|Model-based iterative reconstruction MB-IR|model-based iterative reconstruction mb-ir
4902304|NCT02076737|VEOTM|veotm
4902305|NCT02076737|Ultra low-dose|ultra low-dose
4902306|NCT02076737|Abdominal CT|abdominal ct
4902307|NCT02076737|Dose reduction|dose reduction
4902308|NCT02076737|Adaptative statistical iterative reconstruction ASIR|adaptative statistical iterative reconstruction asir
4902309|NCT02076737|Acute renal colic|acute renal colic
4902310|NCT02076724|Abdominal donor-site|abdominal donor-site
4902311|NCT02076724|Breast reconstruction|breast reconstruction
4902312|NCT02076724|Synthetic mesh|synthetic mesh
4902313|NCT02076724|Biological mesh|biological mesh
4902314|NCT02076711|Aortic Stenosis|aortic stenosis
4902315|NCT02076711|Myocardial efficiency|myocardial efficiency
4902316|NCT02076698|Deep Brain Stimulation|deep brain stimulation
4902317|NCT02076698|Anterior Nucleus of thalamus|anterior nucleus of thalamus
4902318|NCT02076698|Treatment refractory|treatment refractory
4902319|NCT02076698|Pharmacoresistant partial epilepsy|pharmacoresistant partial epilepsy
4902320|NCT02076698|vagus nerve stimulation therapy|vagus nerve stimulation therapy
4902321|NCT02076685|pharmacogenetics|pharmacogenetics
4902322|NCT02076685|anti-tuberculosis drug|anti-tuberculosis drug
4902323|NCT02076685|genetic polymorphism|genetic polymorphism
4902324|NCT02076685|isoniazid|isoniazid
4902325|NCT02076672|prevention|prevention
4902326|NCT02076672|non-malignant asbestos-related disease|non-malignant asbestos-related disease
4902327|NCT02076672|benign pleural disease|benign pleural disease
4902328|NCT02076672|asbestosis|asbestosis
4902329|NCT02076659|F8|f8
4902330|NCT02076659|IL10|il10
4902331|NCT02076659|Interleukin|interleukin
4902332|NCT02076659|monoclonal|monoclonal
4902333|NCT02076659|antibody|antibody
4902334|NCT02076659|Rheumatoid Arthritis|rheumatoid arthritis
4902335|NCT02076646|Interleukin|interleukin
4902336|NCT02076646|IL2|il2
4902337|NCT02076646|monoclonal|monoclonal
4902338|NCT02076646|antibody|antibody
4902339|NCT02076646|cytokine|cytokine
4902340|NCT02076646|Dacarbazine|dacarbazine
4902341|NCT02076646|metastatic|metastatic
4902342|NCT02076646|melanoma|melanoma
4902343|NCT02076646|tumor targeting|tumor targeting
4902344|NCT02076646|Dose definition|dose definition
4902345|NCT02076646|L19|l19
4902346|NCT02076633|L19|l19
4902347|NCT02076633|monoclonal|monoclonal
4902348|NCT02076633|antibody|antibody
4902349|NCT02076633|IL-2|il-2
4902350|NCT02076633|TNFα|tnfα
4902351|NCT02076633|Interleukin|interleukin
4902352|NCT02076633|Phase II|phase ii
4902353|NCT02076633|metastatic melanoma|metastatic melanoma
4902354|NCT02076633|clinical stage III|clinical stage iii
4902355|NCT02076633|Clinical stage IV M1a|clinical stage iv m1a
4902356|NCT02076620|L19|l19
4902357|NCT02076620|monoclonal|monoclonal
4902358|NCT02076620|antibody|antibody
4902359|NCT02076620|doxorubicin|doxorubicin
4902360|NCT02076620|TNFα|tnfα
4902361|NCT02076620|solid tumour|solid tumour
4902362|NCT02076620|sarcoma, breast cancer, lung carcinomas, gynecological cancer|sarcoma, breast cancer, lung carcinomas, gynecological cancer
4902363|NCT02076620|anthracycline|anthracycline
4902364|NCT02076607|vertebra|vertebra
4902365|NCT02076607|column|column
4902366|NCT02076607|lumbar|lumbar
4902367|NCT02076607|toracica|toracica
4902368|NCT02076607|fracture|fracture
4902369|NCT02076607|burst|burst
4902370|NCT02076568|diabetes|diabetes
4902371|NCT02076568|education|education
4902372|NCT02076568|randomized|randomized
4902373|NCT02076568|prospective|prospective
4902374|NCT02076555|diabetes|diabetes
4902375|NCT02076555|education|education
4902376|NCT02076555|randomized|randomized
4902377|NCT02076555|prospective|prospective
4902378|NCT02076542|diabetes|diabetes
4902379|NCT02076542|education|education
4902380|NCT02076542|randomized|randomized
4902381|NCT02076542|prospective|prospective
4902382|NCT02076529|chemotherapy induced nausea vomiting|chemotherapy induced nausea vomiting
4902383|NCT02076516|Drug-eluting Stent,Coronary Artery Disease|drug-eluting stent,coronary artery disease
4902384|NCT02076503|Neoplasm Staging|neoplasm staging
4902385|NCT02076503|Positron-Emission Tomography|positron-emission tomography
4902386|NCT02076503|Magnetic Resonance Imaging|magnetic resonance imaging
4902387|NCT02076503|1-amino-3-fluorocyclobutane-1-carboxylic acid|1-amino-3-fluorocyclobutane-1-carboxylic acid
4902388|NCT02076490|Telerehabilitation, mirror therapy, phantom limb pain|telerehabilitation, mirror therapy, phantom limb pain
4902389|NCT02076477|intervention time|intervention time
4902390|NCT02076477|radiotherapy|radiotherapy
4902391|NCT02076477|oligometastatic|oligometastatic
4902392|NCT02076477|non-small cell lung cancer|non-small cell lung cancer
4902393|NCT02076438|antibiotics|antibiotics
4902394|NCT02076438|diarrhea|diarrhea
4902395|NCT02076438|c diff|c diff
4902396|NCT02076438|Hospitalized patients|hospitalized patients
4902397|NCT02076425|Depressive Disorder, Major|depressive disorder, major
4902398|NCT02076425|Child Psychiatry|child psychiatry
4902399|NCT02076425|Parent-Child Relationship|parent-child relationship
4902400|NCT02076425|Therapy|therapy
4902401|NCT02076399|Persistent Immune Thrombocytopenic Purpura|persistent immune thrombocytopenic purpura
4902402|NCT02076399|Chronic Immune Thrombocytopenic Purpura|chronic immune thrombocytopenic purpura
4902403|NCT02076360|Preoperative counseling|preoperative counseling
4902404|NCT02076360|Patient satisfaction|patient satisfaction
4902405|NCT02076360|Prolapse|prolapse
4902406|NCT02076360|Sacrocolpopexy|sacrocolpopexy
4902407|NCT02076347|Metformin|metformin
4902408|NCT02076347|Vitamin B12 Deficiency|vitamin b12 deficiency
4902409|NCT02076347|Population Management|population management
4902410|NCT02076347|Pharmacist|pharmacist
4902411|NCT02076334|compression, isokinetic, far-infrared|compression, isokinetic, far-infrared
4902412|NCT02076308|Acupuncture, ultrasound|acupuncture, ultrasound
4902413|NCT02076295|Cognition|cognition
4902414|NCT02076295|Cholinergic nicotinic receptors|cholinergic nicotinic receptors
4902415|NCT02076295|Positron Emission Tomography|positron emission tomography
4902416|NCT02076282|Stage III non-small cell lung cancer|stage iii non-small cell lung cancer
4902417|NCT02076282|Optimization|optimization
4902419|NCT02076282|Radiotherapy|radiotherapy
4902420|NCT02076269|HRCT|hrct
4902421|NCT02076269|Dry Powder Inhaler|dry powder inhaler
4902422|NCT02076269|COPD|copd
4902423|NCT02076269|Pharyngometry|pharyngometry
4902424|NCT02076269|Inhalation Profiles|inhalation profiles
4902425|NCT02076256|helping relationships, healthy lifestyle, quality of life|helping relationships, healthy lifestyle, quality of life
4902426|NCT02076243|cutaneous squamous cell carcinoma|cutaneous squamous cell carcinoma
4902427|NCT02076243|SCC|scc
4902428|NCT02076243|abraxane|abraxane
4902429|NCT02076243|nab-paclitaxel|nab-paclitaxel
4902430|NCT02076243|unresectable|unresectable
4902431|NCT02076243|metastatic|metastatic
4902432|NCT02076230|14C-TH-302|14c-th-302
4902433|NCT02076230|Advanced or Metastatic Solid Tumors|advanced or metastatic solid tumors
4902434|NCT02076230|Evofosfamide|evofosfamide
4902435|NCT02076217|Highly Effective Contraception|highly effective contraception
4902436|NCT02076217|Emergency Contraception|emergency contraception
4902437|NCT02076217|Birth Control|birth control
4902438|NCT02076217|LARC (Long Acting Reversible Contraception)|larc (long acting reversible contraception)
4902439|NCT02076217|HERC (Highly Effective Contraception)|herc (highly effective contraception)
4902440|NCT02076204|Pregnancy|pregnancy
4902441|NCT02076204|Postpartum programs|postpartum programs
4902442|NCT02076204|Infant health services|infant health services
4902443|NCT02076191|Ruxolitinib|ruxolitinib
4902444|NCT02076191|Decitabine|decitabine
4902445|NCT02076191|Myeloproliferative Neoplasms|myeloproliferative neoplasms
4902446|NCT02076191|Combination Therapy|combination therapy
4902447|NCT02076178|Pre-Exposure Prophylaxis|pre-exposure prophylaxis
4902448|NCT02076178|HIV integrase|hiv integrase
4902449|NCT02076178|Intramuscular Injection|intramuscular injection
4902450|NCT02076178|GSK1265744|gsk1265744
4902451|NCT02076165|insomnia|insomnia
4902452|NCT02076165|women|women
4902453|NCT02076152|Recurrent Glioblastoma|recurrent glioblastoma
4902454|NCT02076139|tuberculosis|tuberculosis
4902455|NCT02076139|treg|treg
4902456|NCT02076139|tolerance|tolerance
4902457|NCT02076139|probiotic|probiotic
4902458|NCT02076139|mycobacteria|mycobacteria
4902459|NCT02076126|Lung maturity|lung maturity
4902460|NCT02076126|RDS|rds
4902461|NCT02076126|Prematurity|prematurity
4902462|NCT02076126|Lecithin-sphingomyelin ratio|lecithin-sphingomyelin ratio
4902463|NCT02076126|Spectroscopy|spectroscopy
4902464|NCT02076126|Chemometrics|chemometrics
4902465|NCT02076113|cervical spondylotic myelopathy|cervical spondylotic myelopathy
4902466|NCT02076113|degenerative cervical spondylosis|degenerative cervical spondylosis
4902467|NCT02076113|spinal fusion|spinal fusion
4902468|NCT02076087|Subcutaneous adipose tissue|subcutaneous adipose tissue
4902469|NCT02076087|Lipectomy|lipectomy
4902470|NCT02076061|COPD|copd
4902471|NCT02076061|Primary Care|primary care
4902472|NCT02076061|Smoking|smoking
4902473|NCT02076061|Smokers|smokers
4902474|NCT02076061|ex-Smokers|ex-smokers
4902475|NCT02076061|Lung Cancer|lung cancer
4902476|NCT02076061|Cardiovascular Disease|cardiovascular disease
4902477|NCT02076061|Proteomics|proteomics
4902478|NCT02076061|Biomarkers|biomarkers
4902479|NCT02076061|Biobank|biobank
4902480|NCT02076061|Disease Staging|disease staging
4902481|NCT02076061|Gold Stage|gold stage
4902482|NCT02076048|LCPUFA supplementation|lcpufa supplementation
4902483|NCT02076048|Brain Imaging|brain imaging
4902484|NCT02076048|MRI|mri
4902485|NCT02076048|MEG|meg
4902486|NCT02076035|low back pain|low back pain
4902487|NCT02076035|periduroscopy|periduroscopy
4902488|NCT02076035|genetic|genetic
4902489|NCT02076035|genomic|genomic
4902490|NCT02076035|inflammation|inflammation
4902491|NCT02076022|Fat Grafting|fat grafting
4902492|NCT02076022|Pain at amputation site|pain at amputation site
4902493|NCT02076022|prosthetic|prosthetic
4902494|NCT02076009|Multiple Myeloma|multiple myeloma
4902495|NCT02076009|Relapsed Multiple Myeloma|relapsed multiple myeloma
4902496|NCT02076009|Refractory Multiple Myeloma|refractory multiple myeloma
4902497|NCT02076009|Daratumumab|daratumumab
4902498|NCT02076009|Lenalidomide|lenalidomide
4902499|NCT02076009|Dexamethasone|dexamethasone
4902893|NCT02074371|ICU|icu
4902500|NCT02075996|pomalidomide, Imnovid, dexamethasone, Poseidon, multiple myeloma, daily routine, secondary malignancies, Germany, non-interventional study, safety,|pomalidomide, imnovid, dexamethasone, poseidon, multiple myeloma, daily routine, secondary malignancies, germany, non-interventional study, safety,
4902501|NCT02075983|HIV|hiv
4902502|NCT02075983|Vaccine|vaccine
4902503|NCT02075983|Immunisation|immunisation
4902504|NCT02075983|DNA|dna
4902505|NCT02075983|Adverse events|adverse events
4902506|NCT02075983|Electroporation|electroporation
4902507|NCT02075983|Transcutaneous|transcutaneous
4902508|NCT02075983|GTU MultiHIV B Clade|gtu multihiv b clade
4902509|NCT02075983|Antibody|antibody
4902510|NCT02075983|Intramuscular|intramuscular
4902511|NCT02075983|Immunogenicity|immunogenicity
4902512|NCT02075970|Neonatal|neonatal
4902513|NCT02075970|Anemia|anemia
4902514|NCT02075970|Transfusion|transfusion
4902515|NCT02075970|Erythropoetin|erythropoetin
4902516|NCT02075970|Epoetin Alpha|epoetin alpha
4902517|NCT02075970|Red Blood Cell|red blood cell
4902518|NCT02075970|Survival|survival
4902519|NCT02075970|Pharmacodynamics|pharmacodynamics
4902520|NCT02075970|Model|model
4902521|NCT02075957|Non-small cell lung cancer, adjuvant chemo-therapy, DNA chip|non-small cell lung cancer, adjuvant chemo-therapy, dna chip
4902522|NCT02075944|Aerobic exercise|aerobic exercise
4902523|NCT02075944|Cognitive function|cognitive function
4902524|NCT02075944|Executive function|executive function
4902525|NCT02075944|Brain-derived neurotrophic factor|brain-derived neurotrophic factor
4902526|NCT02075905|Barrett's Esophagus|barrett's esophagus
4902527|NCT02075905|Esophageal Adenocarcinoma|esophageal adenocarcinoma
4902528|NCT02075892|cordyceps, aerobic capacity, exercise performance, fatigue|cordyceps, aerobic capacity, exercise performance, fatigue
4902529|NCT02075853|Cerebral palsy|cerebral palsy
4902530|NCT02075853|Pes planus|pes planus
4902531|NCT02075853|Calcaneal lengthening|calcaneal lengthening
4902532|NCT02075827|Appetite, metabolism, sedentary behaviour, stress response|appetite, metabolism, sedentary behaviour, stress response
4902533|NCT02075801|Sealant, Margins Defect, Amalgam|sealant, margins defect, amalgam
4902534|NCT02075775|instability|instability
4902535|NCT02075749|irradiation|irradiation
4902536|NCT02075749|mucositis|mucositis
4902537|NCT02075749|triamcinolone acetonide|triamcinolone acetonide
4902538|NCT02075749|licorice|licorice
4902539|NCT02075749|mucoadhesive film|mucoadhesive film
4902540|NCT02075710|Diet|diet
4902541|NCT02075710|Sugar|sugar
4902542|NCT02075710|Cardiovascular|cardiovascular
4902543|NCT02075710|Lipid|lipid
4902544|NCT02075697|psoriasis|psoriasis
4902545|NCT02075697|biologic therapy|biologic therapy
4902546|NCT02075697|infliximab|infliximab
4902547|NCT02075697|etanercept|etanercept
4902548|NCT02075697|efalizumab|efalizumab
4902549|NCT02075697|adalimumab|adalimumab
4902550|NCT02075697|ustekinumab|ustekinumab
4902551|NCT02075697|methotrexate|methotrexate
4902552|NCT02075697|cyclosporine|cyclosporine
4902553|NCT02075697|acitretin|acitretin
4902554|NCT02075671|Rosacea|rosacea
4902555|NCT02075671|Photodynamic Therapy|photodynamic therapy
4902556|NCT02075671|Aminolevulinic Acid|aminolevulinic acid
4902557|NCT02075671|Papulopustular Rosacea|papulopustular rosacea
4902558|NCT02075671|Blue Light|blue light
4902559|NCT02075658|renal cell carcinoma|renal cell carcinoma
4902560|NCT02075658|minimally invasive procedures|minimally invasive procedures
4902561|NCT02075658|robotic nephrectomy|robotic nephrectomy
4902562|NCT02075658|laparoscopic nephrectomy|laparoscopic nephrectomy
4902563|NCT02075658|pneumoperitoneum|pneumoperitoneum
4902564|NCT02075658|trocars|trocars
4902565|NCT02075658|AirSeal® IFS|airseal® ifs
4902566|NCT02075632|Alclometasone dipropionate|alclometasone dipropionate
4902567|NCT02075632|Eczema|eczema
4902568|NCT02075632|Psoriasis|psoriasis
4902569|NCT02075632|Itch|itch
4902570|NCT02075619|Amlodipine|amlodipine
4902571|NCT02075619|Healthy volunteers|healthy volunteers
4902572|NCT02075619|Rosuvastatin|rosuvastatin
4902573|NCT02075619|Dyslipidaemia|dyslipidaemia
4902574|NCT02075619|Pharmacokinetics|pharmacokinetics
4902575|NCT02075619|Hypertension|hypertension
4902576|NCT02075606|NET|net
4902577|NCT02075606|Symptomatic response|symptomatic response
4902578|NCT02075606|Functioning NeuroEndocrine Tumours|functioning neuroendocrine tumours
4902579|NCT02075606|midgut region|midgut region
4902580|NCT02075593|dolutegravir/abacavir/lamivudine fixed dose combination|dolutegravir/abacavir/lamivudine fixed dose combination
4902581|NCT02075593|pregnant women|pregnant women
4902582|NCT02075593|once daily|once daily
4902583|NCT02075593|antiretroviral therapy-naive|antiretroviral therapy-naive
4902584|NCT02075593|HIV-1 Infection|hiv-1 infection
4902585|NCT02075593|integrase inhibitor|integrase inhibitor
4902586|NCT02075580|cancer, quality of life, body-image, subcutaneous-implant|cancer, quality of life, body-image, subcutaneous-implant
4902587|NCT02075567|Diabetes Mellitus Type 1|diabetes mellitus type 1
4902588|NCT02075567|Exercise|exercise
4902589|NCT02075567|Insulin Reduction|insulin reduction
4902590|NCT02075567|Glucose|glucose
4902591|NCT02075567|Hypoglycemia|hypoglycemia
4902592|NCT02075567|Continuous Glucose Monitoring System|continuous glucose monitoring system
4902593|NCT02075541|Immunogenicity|immunogenicity
4902594|NCT02075541|Observer-blind|observer-blind
4902595|NCT02075541|Reactogenicity|reactogenicity
4902596|NCT02075541|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
4902597|NCT02075541|Safety|safety
4902598|NCT02075528|Paliperidone|paliperidone
4902599|NCT02075528|Treatment response|treatment response
4902600|NCT02075528|Schizophrenia|schizophrenia
4902601|NCT02075528|Early prediction|early prediction
4902602|NCT02075528|Pharmacokinetics|pharmacokinetics
4902603|NCT02075515|Safety|safety
4902604|NCT02075515|Zoster|zoster
4902605|NCT02075515|Immunogenicity|immunogenicity
4902606|NCT02075515|Adults|adults
4902607|NCT02075515|Consistency|consistency
4902608|NCT02075502|claudication|claudication
4902609|NCT02075502|community walking exercise|community walking exercise
4902610|NCT02075502|community-based participatory research|community-based participatory research
4902611|NCT02075502|exercise adherence|exercise adherence
4902612|NCT02075502|endovascular therapy|endovascular therapy
4902613|NCT02075489|Acupressure|acupressure
4902614|NCT02075489|Reiki|reiki
4902615|NCT02075489|EEG|eeg
4902616|NCT02075489|EMG|emg
4902617|NCT02075489|fatigue relief|fatigue relief
4902618|NCT02075489|veterans|veterans
4902619|NCT02075476|Fracture-luxation|fracture-luxation
4902620|NCT02075476|humeral proximal extremity|humeral proximal extremity
4902621|NCT02075476|Hemiarthroplasty|hemiarthroplasty
4902622|NCT02075476|reverse Arthroplasty|reverse arthroplasty
4902623|NCT02075463|recombinant human erythropoietin|recombinant human erythropoietin
4902624|NCT02075463|GSK1278863|gsk1278863
4902625|NCT02075463|hemodialysis|hemodialysis
4902626|NCT02075463|anemia|anemia
4902627|NCT02075463|Hemoglobin|hemoglobin
4902628|NCT02075463|chronic rhEPO hyporesponsiveness|chronic rhepo hyporesponsiveness
4902629|NCT02075463|chronic kidney disease|chronic kidney disease
4902630|NCT02075463|erythropoiesis stimulating agents|erythropoiesis stimulating agents
4902631|NCT02075463|pharmacokinetics|pharmacokinetics
4902632|NCT02075450|Cardiac|cardiac
4902633|NCT02075450|Arrest|arrest
4902634|NCT02075450|Simulation|simulation
4902635|NCT02075450|Feedback|feedback
4902636|NCT02075437|Functional Abdominal Pain, Children|functional abdominal pain, children
4902637|NCT02075437|Finding a treatment or intervention for children|finding a treatment or intervention for children
4902638|NCT02075424|stress|stress
4902639|NCT02075424|cortisol|cortisol
4902640|NCT02075424|emergency call center|emergency call center
4902641|NCT02075424|hospital staff|hospital staff
4902642|NCT02075411|anterior cruciate ligament reconstruction|anterior cruciate ligament reconstruction
4902643|NCT02075411|transplantation allografts|transplantation allografts
4902644|NCT02075411|adolescent|adolescent
4902645|NCT02075411|nerve block|nerve block
4902646|NCT02075411|pain|pain
4902647|NCT02075398|Portable pulse oximeter|portable pulse oximeter
4902648|NCT02075385|Dysphagia|dysphagia
4902649|NCT02075385|speech language therapy|speech language therapy
4902650|NCT02075385|quality of life|quality of life
4902651|NCT02075385|induction chemotherapy|induction chemotherapy
4902652|NCT02075385|concurrent chemoradiotherapy|concurrent chemoradiotherapy
4902653|NCT02075372|Chronic Total Occlusion of Coronary Artery|chronic total occlusion of coronary artery
4902654|NCT02075372|Percutaneous Coronary Intervention|percutaneous coronary intervention
4902655|NCT02075372|Hybrid|hybrid
4902656|NCT02075372|Angioplasty|angioplasty
4902657|NCT02075359|Total Energy Expenditure|total energy expenditure
4902658|NCT02075359|Physical Activity Levels|physical activity levels
4902659|NCT02075359|Body Mass Index|body mass index
4902660|NCT02075359|Children|children
4902661|NCT02075346|Patient safety monitors|patient safety monitors
4902662|NCT02075320|CT|ct
4902663|NCT02075320|Chest|chest
4902664|NCT02075320|Lung|lung
4902665|NCT02075307|insulin|insulin
4902666|NCT02075307|diabetes|diabetes
4902667|NCT02075307|obesity|obesity
4902668|NCT02075307|DNA damage|dna damage
4902669|NCT02075307|metabolic syndrome|metabolic syndrome
4902670|NCT02075294|Aged|aged
4902671|NCT02075294|Hepatitis B, Chronic|hepatitis b, chronic
4902672|NCT02075294|Antiviral Agents|antiviral agents
4902673|NCT02075268|Korean|korean
4902674|NCT02075268|Healthy|healthy
4902675|NCT02075268|Male|male
4902676|NCT02075255|Asthma, Bronchial Diseases, Respiratory Tract Diseases, Lung Diseases, Obstructive Lung Diseases, OCS, Oral Corticosteroids|asthma, bronchial diseases, respiratory tract diseases, lung diseases, obstructive lung diseases, ocs, oral corticosteroids
4902677|NCT02075242|HBV|hbv
4902678|NCT02075229|Cochlear Implant|cochlear implant
4902679|NCT02075229|Post-lingual onset hearing loss|post-lingual onset hearing loss
4902680|NCT02075229|Profound hearing loss|profound hearing loss
4902681|NCT02075229|Low Frequency hearing loss|low frequency hearing loss
4902682|NCT02075229|Profound sensorineural hearing loss|profound sensorineural hearing loss
4902683|NCT02075229|High frequency hearing loss|high frequency hearing loss
4902684|NCT02075229|CMS-eligible patients|cms-eligible patients
4902685|NCT02075216|Urinary Incontinence|urinary incontinence
4902686|NCT02075216|Children|children
4902687|NCT02075216|Bladder Exstrophy|bladder exstrophy
4902688|NCT02075216|Extrophy -Epispadias complex,|extrophy -epispadias complex,
4902689|NCT02075216|Modern staged repair,|modern staged repair,
4902690|NCT02075216|Bladder neck reconstruction|bladder neck reconstruction
4902691|NCT02075203|BCG Vaccinated|bcg vaccinated
4902692|NCT02075177|neuroblastoma|neuroblastoma
4902693|NCT02075164|Non-alcoholic Fatty Liver Disease|non-alcoholic fatty liver disease
4902694|NCT02075164|Non-alcoholic steatohepatitis|non-alcoholic steatohepatitis
4902695|NCT02075164|NAFLD|nafld
4902696|NCT02075164|NASH|nash
4902697|NCT02075151|Bronchial Thermoplasty|bronchial thermoplasty
4902698|NCT02075125|Korea|korea
4902699|NCT02075125|Platelet inhibition|platelet inhibition
4902700|NCT02075125|Prasugrel|prasugrel
4902701|NCT02075125|Ticagrelor|ticagrelor
4902702|NCT02075125|ST-segment elevation myocardial infarction|st-segment elevation myocardial infarction
4902703|NCT02075112|Soy|soy
4902704|NCT02075112|Isoflavone|isoflavone
4902705|NCT02075112|Radiation Therapy|radiation therapy
4902706|NCT02075112|Cisplatin|cisplatin
4902707|NCT02075099|whole blood donation|whole blood donation
4902708|NCT02075099|donation water drink|donation water drink
4902709|NCT02075099|isotonic drink|isotonic drink
4902710|NCT02075099|presyncopal and syncopal reactions|presyncopal and syncopal reactions
4902711|NCT02075086|angiogenic switch|angiogenic switch
4902712|NCT02075086|plasma cytokines|plasma cytokines
4902713|NCT02075086|Colon cancer|colon cancer
4902714|NCT02075073|Pharmacokinetics|pharmacokinetics
4902715|NCT02075060|low-grade|low-grade
4902716|NCT02075060|NMIBC|nmibc
4902717|NCT02075047|Bipolar I Disorder (current or most recent episode manic). Children and adolescents aged 10 to 17 years.|bipolar i disorder (current or most recent episode manic). children and adolescents aged 10 to 17 years.
4902718|NCT02075034|Myelodysplastic syndrome|myelodysplastic syndrome
4902719|NCT02075034|MDS|mds
4902720|NCT02075034|Low risk|low risk
4902721|NCT02075034|Intermediate-1 risk|intermediate-1 risk
4902722|NCT02075034|Intermediate-2 risk|intermediate-2 risk
4902723|NCT02075034|International Prognostic Scoring System|international prognostic scoring system
4902724|NCT02075034|IPSS|ipss
4902725|NCT02075021|relapsed|relapsed
4902726|NCT02075021|refractory|refractory
4902727|NCT02075021|multiple myeloma|multiple myeloma
4902728|NCT02075021|revlimid|revlimid
4902729|NCT02075021|lenalidomide|lenalidomide
4902730|NCT02075021|abraxane|abraxane
4902731|NCT02075021|n-paclitaxel|n-paclitaxel
4902732|NCT02075008|asthma|asthma
4902733|NCT02075008|allergic asthma|allergic asthma
4902734|NCT02075008|QGE031|qge031
4902735|NCT02075008|open-label|open-label
4902736|NCT02075008|IgE|ige
4902737|NCT02075008|long-term safety|long-term safety
4902738|NCT02074995|Burn, Severe burn, Lean body mass, Cachexia, Hypermetabolism, Catabolism, Wound healing|burn, severe burn, lean body mass, cachexia, hypermetabolism, catabolism, wound healing
4902739|NCT02074982|chronic plaque type psoriasis, secukinumab, ustekinumab, inflammatory skin disease, scaling|chronic plaque type psoriasis, secukinumab, ustekinumab, inflammatory skin disease, scaling
4902740|NCT02074969|re-operation rate|re-operation rate
4902741|NCT02074969|pertrochanteric fractures|pertrochanteric fractures
4902742|NCT02074969|GammaNail|gammanail
4902743|NCT02074969|PFNA|pfna
4902744|NCT02074969|Tip-Apex-Distance|tip-apex-distance
4902745|NCT02074969|Parkers-Ratio|parkers-ratio
4902746|NCT02074956|BCG Vaccinated|bcg vaccinated
4902747|NCT02074956|HIV Negative|hiv negative
4902748|NCT02074943|Androgenetic Alopecia|androgenetic alopecia
4902749|NCT02074917|anterior cruciate ligament|anterior cruciate ligament
4902750|NCT02074917|ACL|acl
4902751|NCT02074917|anterior cruciate ligament reconstruction|anterior cruciate ligament reconstruction
4902752|NCT02074917|outcome assessment|outcome assessment
4902753|NCT02074917|outcome assessment, patient|outcome assessment, patient
4902754|NCT02074917|treatment outcome|treatment outcome
4902755|NCT02074917|exercise test|exercise test
4902756|NCT02074917|anatomic|anatomic
4902757|NCT02074917|anatomical|anatomical
4902758|NCT02074917|single-bundle|single-bundle
4902759|NCT02074917|force platform|force platform
4902760|NCT02074917|postural balance|postural balance
4902761|NCT02074917|biomechanics|biomechanics
4902762|NCT02074917|CT scan|ct scan
4902763|NCT02074917|X-ray computed tomography|x-ray computed tomography
4902764|NCT02074917|tomography|tomography
4902765|NCT02074917|diagnostic imaging|diagnostic imaging
4902766|NCT02074917|knee|knee
4902767|NCT02074917|knee injuries|knee injuries
4902768|NCT02074917|joint instability|joint instability
4902769|NCT02074917|reconstructive surgical procedures|reconstructive surgical procedures
4902770|NCT02074917|knee surgery|knee surgery
4902771|NCT02074917|arthroscopy|arthroscopy
4902772|NCT02074917|athletes|athletes
4902773|NCT02074917|sports medicine|sports medicine
4902774|NCT02074917|humans|humans
4902775|NCT02074917|prospective studies|prospective studies
4902776|NCT02074917|Randomized Controlled Trial|randomized controlled trial
4902777|NCT02074891|preexposure prophylaxis|preexposure prophylaxis
4902778|NCT02074891|PrEP|prep
4902779|NCT02074891|HIV|hiv
4902780|NCT02074878|Breast Cancer|breast cancer
4902781|NCT02074878|Metastatic|metastatic
4902782|NCT02074878|Crizotinib|crizotinib
4902783|NCT02074878|Sunitinib|sunitinib
4902784|NCT02074878|Xalcori|xalcori
4902785|NCT02074878|Sutent|sutent
4902786|NCT02074839|acute myeloid leukemia|acute myeloid leukemia
4902787|NCT02074839|AML|aml
4902788|NCT02074839|myelodysplastic syndrome|myelodysplastic syndrome
4902789|NCT02074839|MDS|mds
4902790|NCT02074839|hematologic malignancies|hematologic malignancies
4902791|NCT02074839|IDH|idh
4902792|NCT02074839|Untreated AML|untreated aml
4902793|NCT02074839|IDH1|idh1
4902794|NCT02074839|relapsed AML|relapsed aml
4902795|NCT02074839|refractory AML|refractory aml
4902796|NCT02074813|Inspiratory muscle training|inspiratory muscle training
4902797|NCT02074813|COPD|copd
4902798|NCT02074813|dyspnea|dyspnea
4902799|NCT02074813|Multidimensional Dyspnea Profile questionnaire (MDP).|multidimensional dyspnea profile questionnaire (mdp).
4902800|NCT02074813|pulmonary rehabilitation|pulmonary rehabilitation
4902801|NCT02074800|Healthy|healthy
4902802|NCT02074800|CNTO 328|cnto 328
4902803|NCT02074800|Sp2/0-derived CNTO 328|sp2/0-derived cnto 328
4902804|NCT02074800|CHO-derived CNTO 328|cho-derived cnto 328
4902805|NCT02074800|Safety|safety
4902806|NCT02074800|Pharmacokinetics|pharmacokinetics
4902807|NCT02074774|nasal cannula, high flow oxygen therapy, pulse oximetry|nasal cannula, high flow oxygen therapy, pulse oximetry
4902808|NCT02074761|sacroiliac joint fusion|sacroiliac joint fusion
4902809|NCT02074761|SIJ fusion|sij fusion
4902810|NCT02074761|SI joint|si joint
4902811|NCT02074761|SIJ|sij
4902812|NCT02074748|Bunion|bunion
4902813|NCT02074748|Foot Arch|foot arch
4902814|NCT02074748|Instability|instability
4902815|NCT02074735|alcohol dependence|alcohol dependence
4902816|NCT02074735|alcohol abuse|alcohol abuse
4902817|NCT02074709|Pain, Liposomal bupivacaine, Wound infiltration|pain, liposomal bupivacaine, wound infiltration
4902818|NCT02074696|brain derived neurotrophic factor|brain derived neurotrophic factor
4902819|NCT02074657|Immunotherapy|immunotherapy
4902820|NCT02074657|NKAEs|nkaes
4902821|NCT02074657|Expanded haploidentical natural killer cells|expanded haploidentical natural killer cells
4902822|NCT02074657|Activated natural killer cells|activated natural killer cells
4902823|NCT02074644|Prostatism|prostatism
4902824|NCT02074644|Randomized Controlled Trial|randomized controlled trial
4902825|NCT02074644|Embolization, Therapeutic|embolization, therapeutic
4902826|NCT02074644|Hyperplasia|hyperplasia
4902827|NCT02074644|Prostatic Diseases|prostatic diseases
4902828|NCT02074644|Genital Diseases, Male|genital diseases, male
4902829|NCT02074631|bone mineral content|bone mineral content
4902830|NCT02074631|bone mineral density|bone mineral density
4902831|NCT02074631|bone formation|bone formation
4902832|NCT02074631|bone resorption|bone resorption
4902833|NCT02074631|pamidronate|pamidronate
4902834|NCT02074631|children|children
4902835|NCT02074631|DXA|dxa
4902836|NCT02074631|bone marrow transplant|bone marrow transplant
4902837|NCT02074618|Physical Therapy.|physical therapy.
4902838|NCT02074618|Exercise.|exercise.
4902839|NCT02074618|Rehabilitation.|rehabilitation.
4902840|NCT02074618|Renal Insufficiency.|renal insufficiency.
4902841|NCT02074618|Quality of life.|quality of life.
4902842|NCT02074605|Melanoma|melanoma
4902843|NCT02074605|Interferon|interferon
4902844|NCT02074605|Cognition|cognition
4902845|NCT02074592|Self assessment|self assessment
4902846|NCT02074592|Audit|audit
4902847|NCT02074592|Feedback|feedback
4902848|NCT02074592|Quality|quality
4902849|NCT02074592|Ultrasound|ultrasound
4902850|NCT02074592|Fetal|fetal
4902851|NCT02074592|Biometry|biometry
4902852|NCT02074579|Irritable Bowel Syndrome|irritable bowel syndrome
4902853|NCT02074579|Rome III criteria|rome iii criteria
4902854|NCT02074579|abdominal bloating|abdominal bloating
4902855|NCT02074579|natural|natural
4902856|NCT02074579|herbal|herbal
4902857|NCT02074579|Kampo|kampo
4902858|NCT02074579|Adult ages 18 to 65|adult ages 18 to 65
4902859|NCT02074579|Female subjects|female subjects
4902860|NCT02074566|Pulmonary Vein Isolation|pulmonary vein isolation
4902861|NCT02074566|Atrial fibrillation|atrial fibrillation
4902862|NCT02074566|Cryoballoon therapy|cryoballoon therapy
4902863|NCT02074566|Duration|duration
4902864|NCT02074527|congenital heart disease|congenital heart disease
4902865|NCT02074527|cardiac catheterization|cardiac catheterization
4902866|NCT02074527|brazilian electronic registration|brazilian electronic registration
4902867|NCT02074501|stroke|stroke
4902868|NCT02074501|elderly|elderly
4902869|NCT02074501|caregivers|caregivers
4902870|NCT02074501|empowerment|empowerment
4902871|NCT02074501|self-care|self-care
4902872|NCT02074501|pilot study|pilot study
4902873|NCT02074488|balance|balance
4902874|NCT02074488|gait|gait
4902875|NCT02074462|Voriconazole|voriconazole
4902876|NCT02074462|CRP|crp
4902877|NCT02074462|Inflammation|inflammation
4902878|NCT02074462|Pharmacokinetics|pharmacokinetics
4902879|NCT02074449|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
4902880|NCT02074449|Right Ventricular Performance|right ventricular performance
4902881|NCT02074449|Treprostinil|treprostinil
4902882|NCT02074449|Remodulin|remodulin
4902883|NCT02074436|hematological malignancies|hematological malignancies
4902884|NCT02074436|thrombocytopenia|thrombocytopenia
4902885|NCT02074436|aminocaproic acid|aminocaproic acid
4902886|NCT02074423|Cinnamon extract|cinnamon extract
4902887|NCT02074423|Postprandial glycemia|postprandial glycemia
4902888|NCT02074423|Glycemic index|glycemic index
4902889|NCT02074423|Pre-diabetes|pre-diabetes
4902890|NCT02074423|Metabolic syndrome|metabolic syndrome
4902891|NCT02074371|coronary artery bypass surgery|coronary artery bypass surgery
4902892|NCT02074371|cardiopulmonary bypass|cardiopulmonary bypass
4902894|NCT02074371|postoperative respiratory depression|postoperative respiratory depression
4902895|NCT02074345|Drug therapy|drug therapy
4902896|NCT02074345|Safety and immunogenicity of Hib vaccine|safety and immunogenicity of hib vaccine
4902897|NCT02074332|Obesity|obesity
4902898|NCT02074332|Physical activity|physical activity
4902899|NCT02074332|Schoolchildren|schoolchildren
4902900|NCT02074332|Intervention Studies|intervention studies
4902901|NCT02074319|Schizophrenia|schizophrenia
4902902|NCT02074319|Anti-Inflammatory|anti-inflammatory
4902903|NCT02074319|Methotrexate|methotrexate
4902904|NCT02074319|Psychosis Not Otherwise Specified|psychosis not otherwise specified
4902905|NCT02074306|endotracheal intubation|endotracheal intubation
4902906|NCT02074306|low energy ultrasound|low energy ultrasound
4902907|NCT02074306|sputum culture|sputum culture
4902908|NCT02074293|Subdermal bloodless space|subdermal bloodless space
4902909|NCT02074293|Subdermal injection|subdermal injection
4902910|NCT02074293|injectable EMG needle|injectable emg needle
4902911|NCT02074293|electrical stimulation|electrical stimulation
4902912|NCT02074293|MRI with Gadolinium|mri with gadolinium
4902913|NCT02074293|Cervical Dystonia|cervical dystonia
4902914|NCT02074293|intramuscular injection|intramuscular injection
4902915|NCT02074293|cervical dystonia,|cervical dystonia,
4902916|NCT02074280|rifaximin|rifaximin
4902917|NCT02074280|endotoxemia|endotoxemia
4902918|NCT02074280|cirrhosis|cirrhosis
4902919|NCT02074280|advanced cirrhosis|advanced cirrhosis
4902920|NCT02074228|Attention-deficit/hyperactivity disorder,|attention-deficit/hyperactivity disorder,
4902921|NCT02074228|symptomatology,|symptomatology,
4902922|NCT02074228|neurocognitive endophenotype,|neurocognitive endophenotype,
4902923|NCT02074228|medication response|medication response
4902924|NCT02074215|Mild Cognitive Impairment|mild cognitive impairment
4902925|NCT02074215|Alzheimer's disease|alzheimer's disease
4902926|NCT02074215|Aerobic exercise|aerobic exercise
4902927|NCT02074202|18F fluorocholine|18f fluorocholine
4902928|NCT02074202|18F fluorodeoxyglucose|18f fluorodeoxyglucose
4902929|NCT02074202|hepatocellular carcinoma|hepatocellular carcinoma
4902930|NCT02074202|PET CT scan|pet ct scan
4902931|NCT02074176|Attention-deficit/hyperactivity disorder|attention-deficit/hyperactivity disorder
4902932|NCT02074176|orexin A|orexin a
4902933|NCT02074176|mRNA|mrna
4902934|NCT02074163|Subdermal bloodless space|subdermal bloodless space
4902935|NCT02074163|Subdermal injection|subdermal injection
4902936|NCT02074163|injectable EMG needle|injectable emg needle
4902937|NCT02074163|electrical stimulation|electrical stimulation
4902938|NCT02074163|MRI with Gadolinium|mri with gadolinium
4902939|NCT02074163|Chronic Migraine|chronic migraine
4902940|NCT02074163|intramuscular injection|intramuscular injection
4902941|NCT02074150|Subdermal bloodless space|subdermal bloodless space
4902942|NCT02074150|Subdermal injection|subdermal injection
4902943|NCT02074150|injectable EMG needle|injectable emg needle
4902944|NCT02074150|electrical stimulation|electrical stimulation
4902945|NCT02074150|MRI with Gadolinium|mri with gadolinium
4902946|NCT02074150|Upper Limb Spasticity|upper limb spasticity
4902947|NCT02074150|intramuscular injection|intramuscular injection
4902948|NCT02074111|Moyamoya disease|moyamoya disease
4902949|NCT02074111|Intracranial atherosclerotic stroke|intracranial atherosclerotic stroke
4902950|NCT02074111|Intracranial steno-occlusive disease|intracranial steno-occlusive disease
4902951|NCT02074111|ring finger 213 (RNF213) gene mutation|ring finger 213 (rnf213) gene mutation
4902952|NCT02074111|high-resolution MRI|high-resolution mri
4902953|NCT02074098|intubation|intubation
4902954|NCT02074098|Cardiopulmonary resuscitation|cardiopulmonary resuscitation
4902955|NCT02074098|Manikin study|manikin study
4902956|NCT02074072|Endotracheal intubation|endotracheal intubation
4902957|NCT02074072|Left lateral tilt wedge|left lateral tilt wedge
4902958|NCT02074072|Maternal Cardiopulmonary Resuscitation|maternal cardiopulmonary resuscitation
4902959|NCT02074072|Manikin Study|manikin study
4902960|NCT02074020|SLE|sle
4902961|NCT02074020|Lupus|lupus
4902962|NCT02074020|Lupus Erythematosus, Systemic|lupus erythematosus, systemic
4902963|NCT02074020|Autoimmune Diseases|autoimmune diseases
4902964|NCT02074020|A-623|a-623
4902965|NCT02074020|Blisibimod|blisibimod
4902966|NCT02074020|Nephritis|nephritis
4902967|NCT02074007|Acute Otitis Media|acute otitis media
4902968|NCT02074007|Pain|pain
4902969|NCT02074007|Ear Pain|ear pain
4902970|NCT02074007|Ear Ache|ear ache
4902971|NCT02074007|Ear infection|ear infection
4902972|NCT02074007|middle ear infection|middle ear infection
4902973|NCT02073994|chondrosarcoma|chondrosarcoma
4902974|NCT02073994|cholangiocarcinoma|cholangiocarcinoma
4902975|NCT02073994|glioma|glioma
4902976|NCT02073994|advanced solid tumors|advanced solid tumors
4902977|NCT02073994|IDH1|idh1
4902978|NCT02073994|AG-120|ag-120
4902979|NCT02073981|Parkinson Disease|parkinson disease
4902980|NCT02073955|Stroke|stroke
4902981|NCT02073955|Validation|validation
4902982|NCT02073955|Community Health workers|community health workers
4902983|NCT02073955|stroke symptom questionnaire|stroke symptom questionnaire
4902984|NCT02073916|Breast Cancer|breast cancer
4902985|NCT02073916|HER2 positive Breast Cancer|her2 positive breast cancer
4902986|NCT02073903|dual handset interpreter phones|dual handset interpreter phones
4902987|NCT02073903|communication|communication
4902988|NCT02073903|14-042|14-042
4902989|NCT02073890|traumatic Subarachnoid Haemorrhage|traumatic subarachnoid haemorrhage
4902990|NCT02073890|Head Trauma|head trauma
4902991|NCT02073890|Computed Tomography|computed tomography
4902992|NCT02073877|Peri-implant dermatitis|peri-implant dermatitis
4902993|NCT02073864|Aortic valve stenosis, stenosis, intervention|aortic valve stenosis, stenosis, intervention
4902994|NCT02073851|TAVR|tavr
4902995|NCT02073825|Computer-assisted interventions|computer-assisted interventions
4902996|NCT02073825|Alcohol use disorders|alcohol use disorders
4902997|NCT02073825|At-risk drinking|at-risk drinking
4902998|NCT02073825|Spouses|spouses
4902999|NCT02073825|Military|military
4903000|NCT02073825|Brief Intervention|brief intervention
4903001|NCT02073773|stroke, virtual reality based therapy|stroke, virtual reality based therapy
4903002|NCT02073760|Healthcare acquired infections|healthcare acquired infections
4903003|NCT02073760|Cardiac Surgery|cardiac surgery
4903004|NCT02073760|Sternal Superficial Wound Infection|sternal superficial wound infection
4903005|NCT02073760|Deep Sternal Infection|deep sternal infection
4903006|NCT02073760|Mediastinitis|mediastinitis
4903007|NCT02073760|Thoracotomy|thoracotomy
4903008|NCT02073760|Conduit harvest or cannulation site|conduit harvest or cannulation site
4903009|NCT02073760|Sepsis|sepsis
4903010|NCT02073760|Pneumonia|pneumonia
4903011|NCT02073747|Albuterol|albuterol
4903012|NCT02073747|Serum Lactate|serum lactate
4903013|NCT02073747|Lactic Acidosis|lactic acidosis
4903014|NCT02073747|Asthma|asthma
4903015|NCT02073734|pelvic organ prolapse surgery|pelvic organ prolapse surgery
4903016|NCT02073734|dexamethasone|dexamethasone
4903017|NCT02073734|postoperative nausea and vomiting|postoperative nausea and vomiting
4903018|NCT02073734|peroperative administration|peroperative administration
4903019|NCT02073695|Proximal humeral fracture|proximal humeral fracture
4903020|NCT02073695|Shoulder|shoulder
4903021|NCT02073695|Orthopaedics|orthopaedics
4903022|NCT02073695|Neutral rotation brace|neutral rotation brace
4903023|NCT02073695|Polysling|polysling
4903024|NCT02073669|latent tuberculosis|latent tuberculosis
4903025|NCT02073669|tuberculin skin test|tuberculin skin test
4903026|NCT02073669|Interferon gamma release assay|interferon gamma release assay
4903027|NCT02073669|immigration|immigration
4903028|NCT02073656|genotype 1|genotype 1
4903029|NCT02073656|genotype 4|genotype 4
4903030|NCT02073656|HIV|hiv
4903031|NCT02073630|magnetoencephalography|magnetoencephalography
4903032|NCT02073630|non invasive brain stimulation|non invasive brain stimulation
4903033|NCT02073630|cerebellum|cerebellum
4903034|NCT02073630|gamma rhythms|gamma rhythms
4903035|NCT02073617|DynaCT|dynact
4903036|NCT02073617|Aortic valve and root measurements|aortic valve and root measurements
4903037|NCT02073617|TAVR|tavr
4903038|NCT02073604|Congenital mirror movements|congenital mirror movements
4903039|NCT02073604|SMA|sma
4903040|NCT02073604|Movement preparation|movement preparation
4903041|NCT02073604|Movement lateralization|movement lateralization
4903042|NCT02073604|MRI|mri
4903043|NCT02073604|Transcranial magnetic stimulation|transcranial magnetic stimulation
4903044|NCT02073591|Children|children
4903045|NCT02073591|Atopic Dermatitis|atopic dermatitis
4903046|NCT02073591|Ceradan|ceradan
4903047|NCT02073591|PEST|pest
4903048|NCT02073591|SCORAD|scorad
4903049|NCT02073578|achalasia|achalasia
4903050|NCT02073578|POEM|poem
4903051|NCT02073578|peroral endoscopic myotomy|peroral endoscopic myotomy
4903052|NCT02073578|myotomy|myotomy
4903053|NCT02073578|Heller myotomy|heller myotomy
4903054|NCT02073565|intracoronary stent|intracoronary stent
4903055|NCT02073565|drug eluting stent|drug eluting stent
4903056|NCT02073565|sirolimus|sirolimus
4903057|NCT02073565|endothelial progenitor cells|endothelial progenitor cells
4903058|NCT02073552|colon cleansing, bowel preparations; polyethyleneglycol|colon cleansing, bowel preparations; polyethyleneglycol
4903059|NCT02073539|Chest compression|chest compression
4903060|NCT02073539|One accelerometer|one accelerometer
4903061|NCT02073539|Manikin Study|manikin study
4903062|NCT02073526|Antibodies, Monoclonal|antibodies, monoclonal
4903063|NCT02073526|Anti-TNF|anti-tnf
4903064|NCT02073526|TNF-alpha|tnf-alpha
4903065|NCT02073526|Trough level|trough level
4903066|NCT02073526|Drug concentration|drug concentration
4903067|NCT02073526|ELISA|elisa
4903068|NCT02073513|Spasticity, Hand Function, Cerebral Palsy, Kinesiotape|spasticity, hand function, cerebral palsy, kinesiotape
4903069|NCT02073500|Peritoneal carcinomatosis|peritoneal carcinomatosis
4903070|NCT02073500|Peritoneal surface malignancy|peritoneal surface malignancy
4903071|NCT02073500|Cytoreductive surgery|cytoreductive surgery
4903072|NCT02073500|Hyperthermic intraperitoneal chemotherapy|hyperthermic intraperitoneal chemotherapy
4903073|NCT02073500|CRS|crs
4903074|NCT02073500|HIPEC|hipec
4903075|NCT02073500|Prognostic biomarker|prognostic biomarker
4903076|NCT02073500|Predictive biomarker|predictive biomarker
4903077|NCT02073487|Neoadjuvant Breast Cancer|neoadjuvant breast cancer
4903078|NCT02073487|HER2 positive Breast Cancer|her2 positive breast cancer
4903079|NCT02073474|cannabinoids|cannabinoids
4903080|NCT02073474|Sativex|sativex
4903081|NCT02073474|THC|thc
4903082|NCT02073474|delta-9-tetrahydrocannabinol|delta-9-tetrahydrocannabinol
4903083|NCT02073474|cannabidiol|cannabidiol
4903084|NCT02073474|CBD|cbd
4903085|NCT02073474|Registry|registry
4903086|NCT02073474|Safety|safety
4903087|NCT02073474|MS|ms
4903088|NCT02073461|Acne Vulgaris|acne vulgaris
4903089|NCT02073448|Acne Vulgaris|acne vulgaris
4903090|NCT02073435|liver transplantation|liver transplantation
4903091|NCT02073435|living donor|living donor
4903092|NCT02073435|Safety|safety
4903093|NCT02073422|Magnetic resonance imaging|magnetic resonance imaging
4903094|NCT02073422|Myocardial stress perfusion magnetic resonance imaging|myocardial stress perfusion magnetic resonance imaging
4903095|NCT02073422|Fractional flow reserve|fractional flow reserve
4903096|NCT02073422|Relaxometry|relaxometry
4903097|NCT02073422|Coronary artery disease|coronary artery disease
4903098|NCT02073409|Nontuberculous Mycobacteria|nontuberculous mycobacteria
4903099|NCT02073383|Axillary brachial plexus block|axillary brachial plexus block
4903100|NCT02073383|Ultrasound|ultrasound
4903101|NCT02073383|Bupivacaine|bupivacaine
4903102|NCT02073344|obstructive sleep apnea|obstructive sleep apnea
4903103|NCT02073344|overhydration|overhydration
4903104|NCT02073344|end stage renal disease|end stage renal disease
4903105|NCT02073344|renal transplantation|renal transplantation
4903106|NCT02073344|polysomnography|polysomnography
4903107|NCT02073344|bioimpedance|bioimpedance
4903108|NCT02073344|leg fluid shift|leg fluid shift
4903109|NCT02073344|neck circumference|neck circumference
4903110|NCT02073331|Open heart surgery, cardiac repair|open heart surgery, cardiac repair
4903111|NCT02073305|obstructive sleep apnea|obstructive sleep apnea
4903112|NCT02073305|end stage renal disease|end stage renal disease
4903113|NCT02073305|cardiovascular events|cardiovascular events
4903114|NCT02073240|Tuberculosis|tuberculosis
4903115|NCT02073240|Infection Control|infection control
4903116|NCT02073227|Healthy Volunteers|healthy volunteers
4903117|NCT02073227|Canagliflozin|canagliflozin
4903118|NCT02073227|Metformin|metformin
4903119|NCT02073227|Type 2 diabetes mellitus|type 2 diabetes mellitus
4903120|NCT02073175|Postpartum|postpartum
4903121|NCT02073175|Dietary Supplements|dietary supplements
4903122|NCT02073175|Mood Symptoms|mood symptoms
4903123|NCT02073149|Iron|iron
4903124|NCT02073149|Anemia|anemia
4903125|NCT02073149|Sodium Fe(III)-ethylenediaminetetraacetic acid (NaFeEDTA)|sodium fe(iii)-ethylenediaminetetraacetic acid (nafeedta)
4903126|NCT02073149|Ferrous compounds|ferrous compounds
4903127|NCT02073149|Child, preschool|child, preschool
4903128|NCT02073149|Kenya|kenya
4903129|NCT02073123|Metastatic melanoma|metastatic melanoma
4903130|NCT02073123|Stage III melanoma|stage iii melanoma
4903131|NCT02073123|Stage IV melanoma|stage iv melanoma
4903132|NCT02073123|unresectable|unresectable
4903133|NCT02073110|Kidney cancer|kidney cancer
4903134|NCT02073110|Renal mass|renal mass
4903135|NCT02073110|Small renal mass|small renal mass
4903136|NCT02073110|Optical Coherence Tomography|optical coherence tomography
4903137|NCT02073110|OCT|oct
4903138|NCT02073110|Diffuse Reflectance Spectroscopy|diffuse reflectance spectroscopy
4903139|NCT02073110|DRS|drs
4903140|NCT02073110|Optical Biopsy|optical biopsy
4903141|NCT02073110|OB|ob
4903142|NCT02073058|Subjects with Type 1 or Type 2 Diabetes Requiring Multiple daily Insulin Injection (MDI) or Continuous Subcutaneous Insulin Infusion (CSII)|subjects with type 1 or type 2 diabetes requiring multiple daily insulin injection (mdi) or continuous subcutaneous insulin infusion (csii)
4903143|NCT02073032|Refeeding syndrome, risk factors, head and neck cancer|refeeding syndrome, risk factors, head and neck cancer
4903144|NCT02073006|Chronic|chronic
4903145|NCT02073006|Functional|functional
4903146|NCT02073006|Constipation|constipation
4903147|NCT02073006|less than 3 bowel movements per week|less than 3 bowel movements per week
4903148|NCT02072993|Phase I, healthy, pharmacokinetics|phase i, healthy, pharmacokinetics
4903149|NCT02072980|DT1|dt1
4903150|NCT02072980|DAILIES TOTAL1®|dailies total1®
4903151|NCT02072980|Lubricity|lubricity
4903152|NCT02072967|Relapsed|relapsed
4903153|NCT02072967|Refractory|refractory
4903154|NCT02072967|Non-Hodgkin Lymphoma|non-hodgkin lymphoma
4903155|NCT02072967|Bendamustine|bendamustine
4903156|NCT02072941|Advance care planning|advance care planning
4903157|NCT02072941|Latino Health|latino health
4903158|NCT02072941|Medical decision making|medical decision making
4903159|NCT02072941|Health Literacy|health literacy
4903160|NCT02072941|Limited English proficiency|limited english proficiency
4903161|NCT02072941|Aging|aging
4903162|NCT02072902|Cohort|cohort
4903163|NCT02072902|Historical|historical
4903164|NCT02072902|Prospective|prospective
4903165|NCT02072902|Medications|medications
4903166|NCT02072902|Observational|observational
4903167|NCT02072902|Glucose|glucose
4903168|NCT02072902|Control|control
4903169|NCT02072889|Cardiac Surgery|cardiac surgery
4903170|NCT02072889|Internal Jugular Cannulation|internal jugular cannulation
4903171|NCT02072889|Optimal Neck Angle|optimal neck angle
4903172|NCT02072876|Stroke|stroke
4903173|NCT02072876|Asymptomatic Intracranial Atherosclerotic Disease|asymptomatic intracranial atherosclerotic disease
4903174|NCT02072876|Lifestyle and socio-economic risk factors|lifestyle and socio-economic risk factors
4903175|NCT02072876|Clinical predictors|clinical predictors
4903176|NCT02072850|Myocardial infarction|myocardial infarction
4903177|NCT02072850|Primary percutaneous coronary intervention (PCI)|primary percutaneous coronary intervention (pci)
4903178|NCT02072850|Thrombolysis|thrombolysis
4903179|NCT02072850|Rescue PCI|rescue pci
4903180|NCT02072850|Electrocardiogram|electrocardiogram
4903181|NCT02072850|Magnetic resonance imaging|magnetic resonance imaging
4903182|NCT02072850|Area-at-risk|area-at-risk
4903183|NCT02072850|Myocardial salvage|myocardial salvage
4903184|NCT02072850|Infarct size|infarct size
4903185|NCT02072850|Pressure wire|pressure wire
4903186|NCT02072850|Coronary thermodilution|coronary thermodilution
4903187|NCT02072850|Coronary microvascular function|coronary microvascular function
4903188|NCT02072850|Index of microvascular resistance|index of microvascular resistance
4903189|NCT02072850|Heart failure|heart failure
4903190|NCT02072850|Prognosis|prognosis
4903191|NCT02072837|hemodialysis, dyslipidemia, cardiovascular disease|hemodialysis, dyslipidemia, cardiovascular disease
4903192|NCT02072824|Partial Onset Seizures|partial onset seizures
4903193|NCT02072824|Epilepsy|epilepsy
4903194|NCT02072824|Safety|safety
4903195|NCT02072824|Efficacy|efficacy
4903196|NCT02072824|Tolerability|tolerability
4903197|NCT02072824|Pregabalin|pregabalin
4903198|NCT02072824|Lyrica|lyrica
4903199|NCT02072824|Adjunctive treatment|adjunctive treatment
4903200|NCT02072824|Placebo controlled|placebo controlled
4903201|NCT02072824|blinded|blinded
4903202|NCT02072824|Eligibility Criteria|eligibility criteria
4903203|NCT02072811|AML|aml
4903204|NCT02072798|Randomized Controlled Trial|randomized controlled trial
4903205|NCT02072798|Caesarean Section|caesarean section
4903206|NCT02072798|Surgical Site Infections|surgical site infections
4903207|NCT02072798|Wound Infections|wound infections
4903208|NCT02072798|Infectious Morbidity|infectious morbidity
4903209|NCT02072785|Adult Acute Lymphoblastic Leukemia|adult acute lymphoblastic leukemia
4903210|NCT02072785|Vincristine Sulfate Liposome|vincristine sulfate liposome
4903211|NCT02072785|Vincristine Sulfate|vincristine sulfate
4903212|NCT02072759|Insulin sensitivity|insulin sensitivity
4903213|NCT02072759|Metabolic flexibility|metabolic flexibility
4903214|NCT02072746|cirrhosis|cirrhosis
4903215|NCT02072746|alcohol|alcohol
4903216|NCT02072733|frailty|frailty
4903217|NCT02072733|oncogeriatrics|oncogeriatrics
4903218|NCT02072733|Multidisciplinary intervention|multidisciplinary intervention
4903219|NCT02072733|multimorbidity|multimorbidity
4903220|NCT02072733|Comprehensive geriatric assessment|comprehensive geriatric assessment
4903221|NCT02072733|patients|patients
4903222|NCT02072720|Radiotherapy|radiotherapy
4903223|NCT02072720|VEGF|vegf
4903224|NCT02072720|esophagus carcinoma|esophagus carcinoma
4903225|NCT02072720|bevacizumab|bevacizumab
4903226|NCT02072707|Ventricular Tachycardia|ventricular tachycardia
4903227|NCT02072707|RF ablation|rf ablation
4903228|NCT02072707|Epicardial Access|epicardial access
4903229|NCT02072707|Contact Sensor Irrigated tip catheter|contact sensor irrigated tip catheter
4903230|NCT02072694|Obesity|obesity
4903231|NCT02072694|Single Photon Emission Computed Tomography|single photon emission computed tomography
4903232|NCT02072694|Functional Neuroimaging|functional neuroimaging
4903233|NCT02072668|sickle cell anemia|sickle cell anemia
4903234|NCT02072668|sickle cell disease|sickle cell disease
4903235|NCT02072668|rivaroxaban|rivaroxaban
4903236|NCT02072668|direct Xa inhibition|direct xa inhibition
4903237|NCT02072668|coagulation|coagulation
4903238|NCT02072668|anticoagulation|anticoagulation
4903239|NCT02072629|Antimalarials|antimalarials
4903240|NCT02072629|Antibiotics|antibiotics
4903241|NCT02072629|ORS Zn|ors zn
4903242|NCT02072629|Village Health Volunteers|village health volunteers
4903243|NCT02072629|Integrated Community Case Management|integrated community case management
4903244|NCT02072616|Circulating Tumor Cells|circulating tumor cells
4903245|NCT02072616|pancreatic adenocarcinoma|pancreatic adenocarcinoma
4903246|NCT02072616|circulating tumor DNA (KRAS)|circulating tumor dna (kras)
4903247|NCT02072616|CA 19.9|ca 19.9
4903248|NCT02072603|Infant HIV|infant hiv
4903249|NCT02072603|Kenya|kenya
4903250|NCT02072603|HITSystem|hitsystem
4903251|NCT02072603|EID care|eid care
4903252|NCT02072603|Early Infant Diagnosis|early infant diagnosis
4903253|NCT02072590|Celiac disease|celiac disease
4903254|NCT02072590|Eosinophilic esophagitis|eosinophilic esophagitis
4903255|NCT02072590|Endomysial antibodies|endomysial antibodies
4903256|NCT02072590|Transglutaminase antibodies|transglutaminase antibodies
4903257|NCT02072590|Small-bowel|small-bowel
4903258|NCT02072577|Nursing care, oral health, educational video, oral hygiene.|nursing care, oral health, educational video, oral hygiene.
4903259|NCT02072538|Stress testing|stress testing
4903260|NCT02072538|Troponin T|troponin t
4903261|NCT02072538|GRACE score|grace score
4903262|NCT02072538|Outcome|outcome
4903263|NCT02072525|Pertussis|pertussis
4903264|NCT02072525|Healthy adults|healthy adults
4903265|NCT02072525|Tetanus|tetanus
4903266|NCT02072525|Human serum samples|human serum samples
4903267|NCT02072525|Streptococcus|streptococcus
4903268|NCT02072525|Diphtheria|diphtheria
4903269|NCT02072525|Plasma|plasma
4903270|NCT02072525|Meningococcus|meningococcus
4903271|NCT02072512|pre- and perimenopausal HR+ advanced breast cancer|pre- and perimenopausal hr+ advanced breast cancer
4903272|NCT02072473|Re-entrant Atrioventricular Node Tachycardia|re-entrant atrioventricular node tachycardia
4903273|NCT02072473|Unsuccessful right-sided slow pathway ablation|unsuccessful right-sided slow pathway ablation
4903376|NCT02072018|Clinical Study|clinical study
4903274|NCT02072473|Coronary sinus / left-sided slow pathway ablation|coronary sinus / left-sided slow pathway ablation
4903275|NCT02072447|absolute bioavailability,|absolute bioavailability,
4903276|NCT02072447|microdose,|microdose,
4903277|NCT02072447|AMS|ams
4903278|NCT02072434|Atrial fibrillation|atrial fibrillation
4903279|NCT02072434|anti-coagulant|anti-coagulant
4903280|NCT02072434|warfarin|warfarin
4903281|NCT02072434|edoxaban|edoxaban
4903282|NCT02072434|electrical cardioversion|electrical cardioversion
4903283|NCT02072395|morbid obesity|morbid obesity
4903284|NCT02072395|bariatric surgery|bariatric surgery
4903285|NCT02072395|gastric banding|gastric banding
4903286|NCT02072395|gastric plication|gastric plication
4903287|NCT02072382|Hypertension|hypertension
4903288|NCT02072382|Metformin|metformin
4903289|NCT02072382|Ambulatory blood pressure monitor|ambulatory blood pressure monitor
4903290|NCT02072369|stroke|stroke
4903291|NCT02072369|hand|hand
4903292|NCT02072369|fingers|fingers
4903293|NCT02072369|rehabilitation|rehabilitation
4903294|NCT02072369|training|training
4903295|NCT02072356|Humanitarian Device|humanitarian device
4903296|NCT02072356|Carcinoma|carcinoma
4903297|NCT02072356|Hepatocellular Carcinoma|hepatocellular carcinoma
4903298|NCT02072356|TheraSphere®|therasphere®
4903299|NCT02072356|HUD|hud
4903300|NCT02072343|Capnography|capnography
4903301|NCT02072343|Catheters|catheters
4903302|NCT02072343|Intubation|intubation
4903303|NCT02072330|Hypertension, Drug therapy|hypertension, drug therapy
4903304|NCT02072317|PFS|pfs
4903305|NCT02072304|mood disorder|mood disorder
4903306|NCT02072304|depressive disorder|depressive disorder
4903307|NCT02072304|mental disorders|mental disorders
4903308|NCT02072304|program acceptability|program acceptability
4903309|NCT02072304|behavioral symptoms|behavioral symptoms
4903310|NCT02072304|suicidal ideation|suicidal ideation
4903311|NCT02072304|patient adherence|patient adherence
4903312|NCT02072265|infrared thermal image|infrared thermal image
4903313|NCT02072265|wound healing|wound healing
4903314|NCT02072265|wound infection|wound infection
4903315|NCT02072252|Depression|depression
4903316|NCT02072252|Anxiety|anxiety
4903317|NCT02072252|Mobile Phone|mobile phone
4903318|NCT02072252|Cellular Phone|cellular phone
4903319|NCT02072252|Mobile Application|mobile application
4903320|NCT02072252|Mobile Intervention|mobile intervention
4903321|NCT02072252|App|app
4903322|NCT02072252|mHealth|mhealth
4903323|NCT02072252|eHealth|ehealth
4903324|NCT02072252|Technology Assisted|technology assisted
4903325|NCT02072252|Internet|internet
4903326|NCT02072252|Cognitive Behavioral Therapy|cognitive behavioral therapy
4903327|NCT02072252|LGBT|lgbt
4903328|NCT02072252|Sexual Minorities|sexual minorities
4903329|NCT02072252|Gay|gay
4903330|NCT02072252|Bisexual|bisexual
4903331|NCT02072252|Same Sex Attraction|same sex attraction
4903332|NCT02072252|Males|males
4903333|NCT02072252|Men|men
4903334|NCT02072252|Youth|youth
4903335|NCT02072252|Adolescents|adolescents
4903336|NCT02072252|Young Adults|young adults
4903337|NCT02072239|CABG|cabg
4903338|NCT02072239|Intimal Hyperplasia|intimal hyperplasia
4903339|NCT02072239|Atherosclerosis|atherosclerosis
4903340|NCT02072239|Myocardial Infarction|myocardial infarction
4903341|NCT02072213|Tamsulosin,controlled release formulation|tamsulosin,controlled release formulation
4903342|NCT02072200|RA, MS, Safety, Efficacy, MR prednisone|ra, ms, safety, efficacy, mr prednisone
4903343|NCT02072187|Depression|depression
4903344|NCT02072187|Vitamin D|vitamin d
4903345|NCT02072187|Complementary and Alternative Medicine|complementary and alternative medicine
4903346|NCT02072187|Supplements|supplements
4903347|NCT02072187|Non Remitted Depression|non remitted depression
4903348|NCT02072161|Statin|statin
4903349|NCT02072161|LDL|ldl
4903350|NCT02072161|Cholesterol|cholesterol
4903351|NCT02072148|Human Papilloma Virus|human papilloma virus
4903352|NCT02072148|Oropharyngeal Squamous Cell Carcinoma|oropharyngeal squamous cell carcinoma
4903353|NCT02072148|Transoral Robotic Surgery|transoral robotic surgery
4903354|NCT02072122|dry eye|dry eye
4903355|NCT02072122|fertility treatment|fertility treatment
4903356|NCT02072122|Meibomian gland dysfunction|meibomian gland dysfunction
4903357|NCT02072122|supra physiologic estrogen level|supra physiologic estrogen level
4903358|NCT02072109|Near infrared spectroscopy|near infrared spectroscopy
4903359|NCT02072109|Bolus nutrition|bolus nutrition
4903360|NCT02072109|Continuous nutrition|continuous nutrition
4903361|NCT02072109|Mesenteric circulation|mesenteric circulation
4903362|NCT02072083|dexmedetomidine|dexmedetomidine
4903363|NCT02072083|intranasal|intranasal
4903364|NCT02072083|strabismus surgery|strabismus surgery
4903365|NCT02072083|premedication|premedication
4903366|NCT02072083|oculocardiac reflex|oculocardiac reflex
4903367|NCT02072070|chondrocyte cells, Osteoarthritis, gene therapy|chondrocyte cells, osteoarthritis, gene therapy
4903368|NCT02072044|Renal Cell Carcinoma（RCC）|renal cell carcinoma（rcc）
4903369|NCT02072044|Anlotinib|anlotinib
4903370|NCT02072031|Anlotinib|anlotinib
4903371|NCT02072031|Sunitinib|sunitinib
4903372|NCT02072031|Renal Cell Carcinoma（RCC）|renal cell carcinoma（rcc）
4903373|NCT02072018|Peyronie's|peyronie's
4903374|NCT02072018|Peyronie's disease|peyronie's disease
4903375|NCT02072018|Treatment|treatment
4903377|NCT02071979|Chronic|chronic
4903378|NCT02071979|Non-healing|non-healing
4903379|NCT02071979|Wounds|wounds
4903380|NCT02071966|Micro-RNA, Microparticles, Ticagrelor, NSTE-ACS|micro-rna, microparticles, ticagrelor, nste-acs
4903381|NCT02071940|Acral Melanoma subtypes|acral melanoma subtypes
4903382|NCT02071940|Mucosal Melanoma subtypes|mucosal melanoma subtypes
4903383|NCT02071927|leukemia|leukemia
4903384|NCT02071927|glutaminase|glutaminase
4903385|NCT02071927|glutamine|glutamine
4903386|NCT02071888|Non-Hodgkin's lymphoma|non-hodgkin's lymphoma
4903387|NCT02071888|Waldenstrom's macroglobulinemia|waldenstrom's macroglobulinemia
4903388|NCT02071888|Multiple myeloma|multiple myeloma
4903389|NCT02071888|glutaminase|glutaminase
4903390|NCT02071888|glutamine|glutamine
4903391|NCT02071875|Vasospasm|vasospasm
4903392|NCT02071875|Aneurysm|aneurysm
4903393|NCT02071875|SAH|sah
4903394|NCT02071875|Nautilus NeuroWave|nautilus neurowave
4903395|NCT02071862|Tumor metabolism|tumor metabolism
4903396|NCT02071862|Glutaminase|glutaminase
4903397|NCT02071862|Glutamine|glutamine
4903398|NCT02071862|Tricarboxylic acid (TCA) cycle|tricarboxylic acid (tca) cycle
4903399|NCT02071849|Aortic Insufficiency|aortic insufficiency
4903400|NCT02071849|Aortic Regurgitation|aortic regurgitation
4903401|NCT02071836|web application|web application
4903402|NCT02071836|DWI intervention|dwi intervention
4903403|NCT02071836|DUI intervention|dui intervention
4903404|NCT02071836|Experimental group: Right Turns + treatment as usual|experimental group: right turns + treatment as usual
4903405|NCT02071836|Control group: Treatment as usual|control group: treatment as usual
4903406|NCT02071823|Opicapone,|opicapone,
4903407|NCT02071823|Parkinson,|parkinson,
4903408|NCT02071823|Bial,|bial,
4903409|NCT02071823|BIA 9-1067|bia 9-1067
4903410|NCT02071810|Parkinson's disease (PD)|parkinson's disease (pd)
4903411|NCT02071810|Opicapone|opicapone
4903412|NCT02071810|Bial|bial
4903413|NCT02071810|BIA 9-1067|bia 9-1067
4903414|NCT02071797|Therapeutic Hypothermia|therapeutic hypothermia
4903415|NCT02071797|Cardiac Arrest|cardiac arrest
4903416|NCT02071797|Randomised Controlled trial|randomised controlled trial
4903417|NCT02071797|Pilot study|pilot study
4903418|NCT02071771|DACP Toric|dacp toric
4903419|NCT02071771|DAILIES® AquaComfort Plus®|dailies® aquacomfort plus®
4903420|NCT02071771|Astigmatism|astigmatism
4903421|NCT02071771|Toric|toric
4903422|NCT02071758|Leishmaniasis|leishmaniasis
4903423|NCT02071758|Visceral leishmaniasis|visceral leishmaniasis
4903424|NCT02071758|Vaccine|vaccine
4903425|NCT02071758|Adjuvant|adjuvant
4903426|NCT02071758|GLA|gla
4903427|NCT02071758|SLA|sla
4903428|NCT02071693|subthalamic nucleus|subthalamic nucleus
4903429|NCT02071693|deep brain stimulation|deep brain stimulation
4903430|NCT02071693|cognition|cognition
4903431|NCT02071693|white matter hyperintensities|white matter hyperintensities
4903432|NCT02071680|atrial fibrillation|atrial fibrillation
4903433|NCT02071680|atrial cardiac innervation|atrial cardiac innervation
4903434|NCT02071680|catheter ablation of atrial fibrillation|catheter ablation of atrial fibrillation
4903435|NCT02071680|High Frequency Stimulation|high frequency stimulation
4903436|NCT02071680|ganglionated plexuses|ganglionated plexuses
4903437|NCT02071680|123I-mIBG|123i-mibg
4903438|NCT02071680|nuclear imaging|nuclear imaging
4903439|NCT02071667|Chronic sinusitis|chronic sinusitis
4903440|NCT02071667|Nasal Polyps|nasal polyps
4903441|NCT02071654|Venus P-valve|venus p-valve
4903442|NCT02071615|Brain Activity|brain activity
4903443|NCT02071602|Heart attack|heart attack
4903444|NCT02071602|Myocardial Infarction|myocardial infarction
4903445|NCT02071602|STEMI|stemi
4903446|NCT02071576|Myopia|myopia
4903447|NCT02071576|Hyperopia|hyperopia
4903448|NCT02071576|Proscan|proscan
4903449|NCT02071576|LASIK|lasik
4903450|NCT02071576|TENEO|teneo
4903451|NCT02071576|Excimer|excimer
4903452|NCT02071550|laparoscopic cholecystectomy, near infrared spectroscopy, positive end expiratory pressure|laparoscopic cholecystectomy, near infrared spectroscopy, positive end expiratory pressure
4903453|NCT02071498|Pillbox|pillbox
4903454|NCT02071498|Non-adherence|non-adherence
4903455|NCT02071498|Applications|applications
4903456|NCT02071498|Patient safety|patient safety
4903457|NCT02071498|Elderly|elderly
4903458|NCT02071459|L-threo DOPS (DroxiDopa)|l-threo dops (droxidopa)
4903459|NCT02071459|Orthostatic Hypotension|orthostatic hypotension
4903460|NCT02071459|Multiple system atrophy|multiple system atrophy
4903461|NCT02071446|Deep Brain Stimulation|deep brain stimulation
4903462|NCT02071446|Local Field Potential|local field potential
4903463|NCT02071446|Subthalamic Nucleus|subthalamic nucleus
4903464|NCT02071433|Saphenous nerve block|saphenous nerve block
4903465|NCT02071433|Adductor canal block|adductor canal block
4903466|NCT02071433|Anterior cruciate ligament|anterior cruciate ligament
4903467|NCT02071433|Pain management|pain management
4903468|NCT02071433|Day care|day care
4903469|NCT02071407|traumatic brain injury|traumatic brain injury
4903470|NCT02071407|sedation|sedation
4903471|NCT02071407|midazolam|midazolam
4903472|NCT02071394|Xenon|xenon
4903473|NCT02071394|Hypothermia|hypothermia
4903474|NCT02071394|Hypoxic Ischemic Encephalopathy|hypoxic ischemic encephalopathy
4903475|NCT02071394|Newborn|newborn
4903476|NCT02071394|Neonate|neonate
4903477|NCT02071394|Term|term
4903478|NCT02071394|Neuroprotection|neuroprotection
4903479|NCT02071394|Cooling|cooling
4903481|NCT02071368|Healthy|healthy
4903482|NCT02071368|Canagliflozin|canagliflozin
4903483|NCT02071368|Metformin|metformin
4903484|NCT02071368|JNJ-28431754|jnj-28431754
4903485|NCT02071368|GLUMETZA®|glumetza®
4903486|NCT02071368|Bioequivalence|bioequivalence
4903487|NCT02071368|Fixed Dose Combination|fixed dose combination
4903488|NCT02071355|Healthy|healthy
4903489|NCT02071355|Chinese participants|chinese participants
4903490|NCT02071355|TMC435|tmc435
4903491|NCT02071355|Multiple oral doses|multiple oral doses
4903492|NCT02071355|Pharmacokinetics|pharmacokinetics
4903493|NCT02071355|Safety|safety
4903494|NCT02071355|Tolerability|tolerability
4903495|NCT02071342|acute myocardial infarction|acute myocardial infarction
4903496|NCT02071342|bioresorbable vascular scaffold|bioresorbable vascular scaffold
4903497|NCT02071342|percutaneous coronary intervention|percutaneous coronary intervention
4903498|NCT02071329|FP-01.1|fp-01.1
4903499|NCT02071329|Influenza A|influenza a
4903500|NCT02071329|Flu|flu
4903501|NCT02071329|Vaccine|vaccine
4903502|NCT02071329|Virus|virus
4903503|NCT02071329|H1N1|h1n1
4903504|NCT02071329|Challenge|challenge
4903505|NCT02071316|upper gastrointestinal bleeding|upper gastrointestinal bleeding
4903506|NCT02071316|Hexacapron|hexacapron
4903507|NCT02071316|hemostasis|hemostasis
4903508|NCT02071303|Pain|pain
4903509|NCT02071303|Hysteroscopy|hysteroscopy
4903510|NCT02071303|Tramadol|tramadol
4903511|NCT02071303|Celecoxib|celecoxib
4903512|NCT02071290|Hemorrhagic Shock|hemorrhagic shock
4903513|NCT02071290|Remote Ischemic Conditioning|remote ischemic conditioning
4903514|NCT02071277|Mechanical ventilation|mechanical ventilation
4903515|NCT02071277|Airway pressure release ventilation|airway pressure release ventilation
4903516|NCT02071277|Biphasic intermittent positive airway pressure|biphasic intermittent positive airway pressure
4903517|NCT02071277|Pressure-controlled ventilation|pressure-controlled ventilation
4903518|NCT02071277|Lung protective ventilation|lung protective ventilation
4903519|NCT02071277|Spontaneous breathing|spontaneous breathing
4903520|NCT02071264|HIV/AIDS|hiv/aids
4903521|NCT02071264|sex work|sex work
4903522|NCT02071264|reproductive health|reproductive health
4903523|NCT02071264|human rights|human rights
4903524|NCT02071264|ethics|ethics
4903525|NCT02071251|Wound complications|wound complications
4903526|NCT02071251|Wound infection|wound infection
4903527|NCT02071251|Wound separation|wound separation
4903528|NCT02071238|Carpal tunnel|carpal tunnel
4903529|NCT02071238|Carpal tunnel release|carpal tunnel release
4903530|NCT02071238|Risk Recall|risk recall
4903531|NCT02071238|Patient satisfaction|patient satisfaction
4903532|NCT02071238|Pamphlet|pamphlet
4903533|NCT02071238|Brochure|brochure
4903534|NCT02071199|Gingivitis|gingivitis
4903535|NCT02071199|Periodontitis|periodontitis
4903536|NCT02071199|ACCS|accs
4903537|NCT02071160|HIE|hie
4903538|NCT02071160|hypothermia|hypothermia
4903539|NCT02071160|encephalopathy|encephalopathy
4903540|NCT02071160|anti oxidants|anti oxidants
4903541|NCT02071160|MRI|mri
4903542|NCT02071147|Follow-up|follow-up
4903543|NCT02071147|No follow-up|no follow-up
4903544|NCT02071147|removal|removal
4903545|NCT02071147|Randomised Controlled Trial|randomised controlled trial
4903546|NCT02071147|6 Weeks|6 weeks
4903547|NCT02071134|Deep brain stimulation|deep brain stimulation
4903548|NCT02071134|Parkinson's disease|parkinson's disease
4903549|NCT02071134|Vercise|vercise
4903550|NCT02071121|BIIB061|biib061
4903551|NCT02071121|Healthy|healthy
4903552|NCT02071095|Human immunodeficiency virus 1|human immunodeficiency virus 1
4903553|NCT02071095|Combined Antiretroviral Therapy|combined antiretroviral therapy
4903554|NCT02071095|Poly-ICLC|poly-iclc
4903555|NCT02071095|Adjuvant|adjuvant
4903556|NCT02071082|HIV|hiv
4903557|NCT02071082|HBV|hbv
4903558|NCT02071082|Coinfection|coinfection
4903559|NCT02071069|Incurable colorectal cancer|incurable colorectal cancer
4903560|NCT02071069|maintenance therapy|maintenance therapy
4903561|NCT02071069|Cetuximab|cetuximab
4903562|NCT02071043|neo-adjuvant chemotherapy|neo-adjuvant chemotherapy
4903563|NCT02071043|advanced gastric cancer patients|advanced gastric cancer patients
4903564|NCT02071043|para-aortic lymph node metastasis|para-aortic lymph node metastasis
4903565|NCT02071030|CBCT|cbct
4903566|NCT02071030|Third molar removal|third molar removal
4903567|NCT02071030|Inferior alveolar nerve injury|inferior alveolar nerve injury
4903568|NCT02071004|acute ischemic stroke|acute ischemic stroke
4903569|NCT02070991|pre- and post-capillary pulmonary hypertension|pre- and post-capillary pulmonary hypertension
4903570|NCT02070991|CpcPH|cpcph
4903571|NCT02070978|Lupus Erythematosus, Systemic|lupus erythematosus, systemic
4903572|NCT02070978|Atacicept 75 and 150 mg|atacicept 75 and 150 mg
4903573|NCT02070978|LTE|lte
4903574|NCT02070952|CyberKnife|cyberknife
4903575|NCT02070952|Stereotactic Body Radiation Therapy|stereotactic body radiation therapy
4903576|NCT02070952|Low and Intermediate Risk Prostate Cancer|low and intermediate risk prostate cancer
4903577|NCT02070939|Phase 1|phase 1
4903578|NCT02070939|Randomized|randomized
4903579|NCT02070939|Double Blind|double blind
4903580|NCT02070939|Placebo-Controlled|placebo-controlled
4903779|NCT02069951|Laparoscopy|laparoscopy
4903581|NCT02070939|Single and Multiple Dose Escalation|single and multiple dose escalation
4903582|NCT02070939|Safety Tolerability|safety tolerability
4903583|NCT02070939|PK|pk
4903584|NCT02070939|PD|pd
4903585|NCT02070939|PF-06460414|pf-06460414
4903586|NCT02070913|Hypothermia|hypothermia
4903587|NCT02070913|Acute Myocardial Infarction|acute myocardial infarction
4903588|NCT02070913|Percutaneous Coronary Intervention|percutaneous coronary intervention
4903589|NCT02070913|AMI|ami
4903590|NCT02070913|PCI|pci
4903591|NCT02070913|Therapeutic Hypothermia|therapeutic hypothermia
4903592|NCT02070900|Prevention of Mother to Child Transmission|prevention of mother to child transmission
4903593|NCT02070900|PMTCT|pmtct
4903594|NCT02070900|Option B+|option b+
4903595|NCT02070900|ART|art
4903596|NCT02070900|Retention|retention
4903597|NCT02070900|Loss to Follow Up|loss to follow up
4903598|NCT02070900|Time to initiation|time to initiation
4903599|NCT02070900|POC CD4|poc cd4
4903600|NCT02070900|Clinical mentoring|clinical mentoring
4903601|NCT02070900|Costing|costing
4903602|NCT02070900|HIV|hiv
4903603|NCT02070900|AIDS|aids
4903604|NCT02070900|Zimbabwe|zimbabwe
4903605|NCT02070874|pain and symptom management|pain and symptom management
4903606|NCT02070861|Cardiac output|cardiac output
4903607|NCT02070861|Exhaled CO2|exhaled co2
4903608|NCT02070861|Nexfin|nexfin
4903609|NCT02070861|Esophageal Doppler|esophageal doppler
4903610|NCT02070848|red blood cell|red blood cell
4903611|NCT02070848|knee extension exercise|knee extension exercise
4903612|NCT02070835|Diabetic Foot Ulcer|diabetic foot ulcer
4903613|NCT02070835|ReCell|recell
4903614|NCT02070822|Hepatocellular carcinoma|hepatocellular carcinoma
4903615|NCT02070822|Transarterial chemoembolization|transarterial chemoembolization
4903616|NCT02070822|Magnetic resonance imaging|magnetic resonance imaging
4903617|NCT02070809|wound|wound
4903618|NCT02070809|tissue-engineered skin|tissue-engineered skin
4903619|NCT02070796|Rotigotine|rotigotine
4903620|NCT02070796|Transdermal Patch|transdermal patch
4903621|NCT02070796|Bioequivalence|bioequivalence
4903622|NCT02070783|depression|depression
4903623|NCT02070783|cognition|cognition
4903624|NCT02070783|emotion perception|emotion perception
4903625|NCT02070783|information processing|information processing
4903626|NCT02070757|Ventilator-associated bacterial pneumonia|ventilator-associated bacterial pneumonia
4903627|NCT02070757|Hospital-acquired bacterial pneumonia|hospital-acquired bacterial pneumonia
4903628|NCT02070757|Pneumonia|pneumonia
4903629|NCT02070757|Lung Diseases|lung diseases
4903630|NCT02070757|Respiratory Tract Diseases|respiratory tract diseases
4903631|NCT02070757|Respiratory Tract Infections|respiratory tract infections
4903632|NCT02070757|Infection|infection
4903633|NCT02070757|Ventilator-Induced Lung Injury|ventilator-induced lung injury
4903634|NCT02070757|Lung Injury|lung injury
4903635|NCT02070744|CF|cf
4903636|NCT02070731|TAVR|tavr
4903637|NCT02070731|TAVI|tavi
4903638|NCT02070731|Aortic Valve Stenosis|aortic valve stenosis
4903639|NCT02070718|hot flashes|hot flashes
4903640|NCT02070718|menopause|menopause
4903641|NCT02070718|kappa agonist|kappa agonist
4903642|NCT02070692|Contraceptive implant|contraceptive implant
4903643|NCT02070692|Irregular vaginal bleeding|irregular vaginal bleeding
4903644|NCT02070692|Etonogestrel implant|etonogestrel implant
4903645|NCT02070679|Alpha-tocopherol|alpha-tocopherol
4903646|NCT02070679|Vitamin E|vitamin e
4903647|NCT02070679|Contrast-Induced Acute Kidney Injury|contrast-induced acute kidney injury
4903648|NCT02070679|Coronary angiography|coronary angiography
4903649|NCT02070666|ARDS|ards
4903650|NCT02070666|Prevention|prevention
4903651|NCT02070666|Protective mechanical ventilation|protective mechanical ventilation
4903652|NCT02070666|low tidal volumes|low tidal volumes
4903653|NCT02070653|Aorta|aorta
4903654|NCT02070653|Aneurysm|aneurysm
4903655|NCT02070653|Antiplatelet|antiplatelet
4903656|NCT02070640|cholecystectomy|cholecystectomy
4903657|NCT02070640|cholecystitis|cholecystitis
4903658|NCT02070627|acute cholecystitis|acute cholecystitis
4903659|NCT02070627|acute cholangitis|acute cholangitis
4903660|NCT02070627|cholecystectomy|cholecystectomy
4903661|NCT02070614|sufentanil|sufentanil
4903662|NCT02070614|metabolism|metabolism
4903663|NCT02070614|cytochrome P450 3A4|cytochrome p450 3a4
4903664|NCT02070614|gene polymorphism|gene polymorphism
4903665|NCT02070588|TBI|tbi
4903666|NCT02070588|mTBI|mtbi
4903667|NCT02070588|MR|mr
4903668|NCT02070588|MRI|mri
4903669|NCT02070588|Pulse Sequences|pulse sequences
4903670|NCT02070588|NFL|nfl
4903671|NCT02070575|PSA|psa
4903672|NCT02070575|Human Kallikrein 2|human kallikrein 2
4903673|NCT02070575|locally resected prostate cancer|locally resected prostate cancer
4903674|NCT02070575|biochemical recurrence|biochemical recurrence
4903675|NCT02070575|14-041|14-041
4903676|NCT02070562|breast milk, dietary survey|breast milk, dietary survey
4903677|NCT02070536|Acute Respiratory Distress Syndrome (ARDS)|acute respiratory distress syndrome (ards)
4903678|NCT02070536|Receptor for advanced glycation end products (RAGE)|receptor for advanced glycation end products (rage)
4903679|NCT02070536|Soluble RAGE (sRAGE)|soluble rage (srage)
4903680|NCT02070536|Gene polymorphisms|gene polymorphisms
4903681|NCT02070536|Biomarker|biomarker
4903682|NCT02070484|NuCel|nucel
4903683|NCT02070484|Lumbar Spine|lumbar spine
4903684|NCT02070484|Degenerative Disease|degenerative disease
4903685|NCT02070484|Efficacy|efficacy
4903686|NCT02070484|Fusion|fusion
4903687|NCT02070445|CABG|cabg
4903688|NCT02070445|pilot|pilot
4903689|NCT02070445|ultrasound|ultrasound
4903690|NCT02070445|perioperative|perioperative
4903691|NCT02070445|low tidal volume ventilation|low tidal volume ventilation
4903692|NCT02070432|LUZ11|luz11
4903693|NCT02070432|head and neck cancer|head and neck cancer
4903694|NCT02070432|photodynamic therapy|photodynamic therapy
4903695|NCT02070432|Redaporfin|redaporfin
4903696|NCT02070393|Hodgkins Disease in Young Females|hodgkins disease in young females
4903697|NCT02070393|Breast Sparing Radiation Treatments|breast sparing radiation treatments
4903698|NCT02070380|confirmed brain disease|confirmed brain disease
4903699|NCT02070380|highly suspected brain disease|highly suspected brain disease
4903700|NCT02070367|allodynia|allodynia
4903701|NCT02070367|complex regional pain syndrome|complex regional pain syndrome
4903702|NCT02070367|peripheral nerve injuries|peripheral nerve injuries
4903703|NCT02070367|clinical measurement properties|clinical measurement properties
4903704|NCT02070354|Obesity|obesity
4903705|NCT02070354|Bariatric surgery|bariatric surgery
4903706|NCT02070354|Physical Activity|physical activity
4903707|NCT02070354|Nutrition|nutrition
4903708|NCT02070354|Weight Loss|weight loss
4903709|NCT02070341|patient tolerability|patient tolerability
4903710|NCT02070341|quality|quality
4903711|NCT02070328|Proton Therapy|proton therapy
4903712|NCT02070328|Registry|registry
4903713|NCT02070315|heart failure|heart failure
4903714|NCT02070315|liver failure|liver failure
4903715|NCT02070315|post liver transplant|post liver transplant
4903716|NCT02070289|Multiple dose|multiple dose
4903717|NCT02070289|safety|safety
4903718|NCT02070289|tolerability|tolerability
4903719|NCT02070289|PK|pk
4903720|NCT02070276|Spinal anesthesia|spinal anesthesia
4903721|NCT02070276|Systemic hypotension|systemic hypotension
4903722|NCT02070276|Total fluid amount|total fluid amount
4903723|NCT02070276|Non-invasive fluid responsiveness|non-invasive fluid responsiveness
4903724|NCT02070276|Passive Leg Raising Test|passive leg raising test
4903725|NCT02070263|Food allergy|food allergy
4903726|NCT02070263|Tree nuts|tree nuts
4903727|NCT02070250|Stress management|stress management
4903728|NCT02070250|Coping skills|coping skills
4903729|NCT02070250|Recently diagnosed cancer patients|recently diagnosed cancer patients
4903730|NCT02070250|Intervention, Psychological|intervention, psychological
4903731|NCT02070237|Obesity|obesity
4903732|NCT02070237|Obesity, Morbid|obesity, morbid
4903733|NCT02070237|Pregnancy|pregnancy
4903734|NCT02070237|Cesarean|cesarean
4903735|NCT02070237|Venous thromboembolism|venous thromboembolism
4903736|NCT02070237|Deep venous thrombosis|deep venous thrombosis
4903737|NCT02070237|Pulmonary embolism|pulmonary embolism
4903738|NCT02070211|Psychotic Disorder|psychotic disorder
4903739|NCT02070211|22q11 Deletion Syndrome|22q11 deletion syndrome
4903740|NCT02070211|Fatty Acids, Omega-3|fatty acids, omega-3
4903741|NCT02070198|Poor responders, IVF, GnRH agonist, GnRH antagonist, recombinant FSH|poor responders, ivf, gnrh agonist, gnrh antagonist, recombinant fsh
4903742|NCT02070185|caloric adjustment,liking, flavour nutrient learning, children|caloric adjustment,liking, flavour nutrient learning, children
4903743|NCT02070172|headache diagnosis|headache diagnosis
4903744|NCT02070172|flexion rotation test|flexion rotation test
4903745|NCT02070172|range of motion|range of motion
4903746|NCT02070172|upper cervical|upper cervical
4903747|NCT02070159|coronary artery disease|coronary artery disease
4903748|NCT02070159|prasugrel|prasugrel
4903749|NCT02070159|platelet function tests|platelet function tests
4903750|NCT02070133|Chronic Bronchitis|chronic bronchitis
4903751|NCT02070133|Statins|statins
4903752|NCT02070133|Endothelial dysfunction|endothelial dysfunction
4903753|NCT02070133|Systemic inflammation|systemic inflammation
4903754|NCT02070133|BODE index|bode index
4903755|NCT02070133|Uric acid|uric acid
4903756|NCT02070133|Vascular growth factors|vascular growth factors
4903757|NCT02070120|Nonmuscle invasive bladder cancer (NMIBC)|nonmuscle invasive bladder cancer (nmibc)
4903758|NCT02070120|Mitomycin C|mitomycin c
4903759|NCT02070120|Chemoresection|chemoresection
4903760|NCT02070081|Obesity|obesity
4903761|NCT02070081|Bariatric surgery|bariatric surgery
4903762|NCT02070055|Maximal Rate of Fat Oxidation|maximal rate of fat oxidation
4903763|NCT02070055|Substrate Oxidation|substrate oxidation
4903764|NCT02070055|Fat oxidation|fat oxidation
4903765|NCT02070055|Respiratory Exchange Ratio (RER)|respiratory exchange ratio (rer)
4903766|NCT02070055|Exercise|exercise
4903767|NCT02070055|indirect calorimetry|indirect calorimetry
4903768|NCT02070055|substrate crossover|substrate crossover
4903769|NCT02070042|Overactive Bladder|overactive bladder
4903770|NCT02070042|Oxybutynin|oxybutynin
4903771|NCT02070042|Omega -3 Fatty Acid|omega -3 fatty acid
4903772|NCT02070029|Female Sexual Dysfunction (FSD)|female sexual dysfunction (fsd)
4903773|NCT02070029|Hypoactive Sexual Desire Disorder (HSDD)|hypoactive sexual desire disorder (hsdd)
4903774|NCT02070029|Low libido|low libido
4903775|NCT02070029|Acupuncture|acupuncture
4903776|NCT02069977|Autism|autism
4903777|NCT02069977|Aripiprazole|aripiprazole
4903778|NCT02069977|Abilify|abilify
4903780|NCT02069951|Training|training
4903781|NCT02069951|Simulator|simulator
4903782|NCT02069938|Subjects|subjects
4903783|NCT02069912|Major Depression|major depression
4903784|NCT02069912|Heart Disease|heart disease
4903785|NCT02069912|Hispanics|hispanics
4903786|NCT02069912|Collaborative Depression Care Management|collaborative depression care management
4903787|NCT02069899|Hemophagocytic lymphohistiocytosis (HLH) previously treated with NI-0501|hemophagocytic lymphohistiocytosis (hlh) previously treated with ni-0501
4903788|NCT02069899|Emapalumab|emapalumab
4903789|NCT02069886|Endocrine complications|endocrine complications
4903790|NCT02069886|transfusion dependent thalassemia|transfusion dependent thalassemia
4903791|NCT02069873|Post Traumatic Stress Disorder|post traumatic stress disorder
4903792|NCT02069873|Group|group
4903793|NCT02069873|Treatment|treatment
4903794|NCT02069873|Cognitive, Exposure, Skills|cognitive, exposure, skills
4903795|NCT02069873|Women|women
4903796|NCT02069873|Veterans|veterans
4903797|NCT02069860|bona anchored|bona anchored
4903798|NCT02069860|haemodialysis|haemodialysis
4903799|NCT02069860|Mastoid bone|mastoid bone
4903800|NCT02069860|nephrology|nephrology
4903801|NCT02069860|retroauricular anchored devices|retroauricular anchored devices
4903802|NCT02069860|permanent central venous access devices.|permanent central venous access devices.
4903803|NCT02069847|Esophageal stricture formation|esophageal stricture formation
4903804|NCT02069847|Endoscopic mucosal resection|endoscopic mucosal resection
4903805|NCT02069847|Endoscopic submucosal dissection|endoscopic submucosal dissection
4903806|NCT02069847|Budesonide|budesonide
4903807|NCT02069847|Radical endoscopic mucosal resection|radical endoscopic mucosal resection
4903809|NCT02069847|ESD|esd
4903810|NCT02069834|Dolutegravir|dolutegravir
4903811|NCT02069834|Rilpivirine|rilpivirine
4903812|NCT02069834|PI- and NRTI- sparing ART regimen|pi- and nrti- sparing art regimen
4903813|NCT02069834|switch study|switch study
4903814|NCT02069795|concussion, athlete, speech analysis|concussion, athlete, speech analysis
4903815|NCT02069782|Pregnancy|pregnancy
4903816|NCT02069782|postpartum programs|postpartum programs
4903817|NCT02069782|infant health services|infant health services
4903818|NCT02069769|Hospice Care|hospice care
4903819|NCT02069769|Head and Neck cancer|head and neck cancer
4903820|NCT02069769|Gynecological Oncology|gynecological oncology
4903821|NCT02069769|Sarcoma|sarcoma
4903822|NCT02069769|Melanoma|melanoma
4903823|NCT02069756|Duchenne|duchenne
4903824|NCT02069756|Becker|becker
4903825|NCT02069756|Muscular Dystrophy|muscular dystrophy
4903826|NCT02069743|cancer pain|cancer pain
4903827|NCT02069730|molecular profiling|molecular profiling
4903828|NCT02069730|selinexor|selinexor
4903829|NCT02069730|tumor tissue|tumor tissue
4903830|NCT02069704|colorectal cancer|colorectal cancer
4903831|NCT02069704|metastatic|metastatic
4903832|NCT02069704|first-line treatment|first-line treatment
4903833|NCT02069704|comparability|comparability
4903834|NCT02069691|stroke,|stroke,
4903835|NCT02069691|rehabilitation,|rehabilitation,
4903836|NCT02069691|leg cycling,|leg cycling,
4903837|NCT02069691|feedback,|feedback,
4903838|NCT02069691|virtual reality|virtual reality
4903839|NCT02069665|pneumonia|pneumonia
4903840|NCT02069665|pediatrics|pediatrics
4903841|NCT02069665|viral|viral
4903842|NCT02069613|Mild traumatic injury to extremity (for controls)|mild traumatic injury to extremity (for controls)
4903843|NCT02069613|mTBI|mtbi
4903844|NCT02069613|concussion|concussion
4903845|NCT02069613|MEG|meg
4903846|NCT02069613|EEG|eeg
4903847|NCT02069613|Blood|blood
4903848|NCT02069613|MRI|mri
4903849|NCT02069613|DTI|dti
4903850|NCT02069613|biomarkers|biomarkers
4903851|NCT02069600|Elderly|elderly
4903852|NCT02069600|CPAP|cpap
4903853|NCT02069600|clinical trial|clinical trial
4903854|NCT02069600|obstructive sleep apnea|obstructive sleep apnea
4903855|NCT02069587|PPROM|pprom
4903856|NCT02069587|PREGNANCY|pregnancy
4903857|NCT02069587|POMEGRANATE|pomegranate
4903858|NCT02069587|OXIDATIVE STRESS|oxidative stress
4903859|NCT02069535|Cupressus arizonica|cupressus arizonica
4903860|NCT02069509|Friedreich's Ataxia|friedreich's ataxia
4903861|NCT02069509|EFACTS|efacts
4903862|NCT02069509|FRDA|frda
4903863|NCT02069483|smoking|smoking
4903864|NCT02069483|smoker|smoker
4903865|NCT02069483|text|text
4903866|NCT02069483|smartphone|smartphone
4903867|NCT02069483|motivation|motivation
4903868|NCT02069483|quitting|quitting
4903869|NCT02069483|cessation|cessation
4903870|NCT02069483|feedback|feedback
4903871|NCT02069483|messages|messages
4903872|NCT02069470|Stepped wedged design|stepped wedged design
4903873|NCT02069470|Early cancer diagnosis|early cancer diagnosis
4903874|NCT02069470|Continuing medical education|continuing medical education
4903875|NCT02069431|inflammation|inflammation
4903876|NCT02069431|physical function|physical function
4903877|NCT02069431|cognitive function|cognitive function
4903878|NCT02069392|schizophrenia|schizophrenia
4903879|NCT02069392|cognition|cognition
4903880|NCT02069392|cognitive remediation|cognitive remediation
4903881|NCT02069392|nicotine|nicotine
4903882|NCT02069379|Metabolic syndrome|metabolic syndrome
4903883|NCT02069379|Insulin resistance|insulin resistance
4903884|NCT02069379|Mu-opioid system|mu-opioid system
4903885|NCT02069379|Depression|depression
4903886|NCT02069379|Emotion regulation|emotion regulation
4903887|NCT02069366|Post-Traumatic Stress Disorders|post-traumatic stress disorders
4903888|NCT02069366|Dronabinol|dronabinol
4903889|NCT02069366|Extinction|extinction
4903890|NCT02069366|fMRI|fmri
4903891|NCT02069353|Cardiac arrest|cardiac arrest
4903892|NCT02069353|Neurological injury|neurological injury
4903893|NCT02069353|Seizures|seizures
4903894|NCT02069353|Spreading depolarizations|spreading depolarizations
4903895|NCT02069353|Cerebral hypoperfusion|cerebral hypoperfusion
4903896|NCT02069353|Brain tissue hypoxia|brain tissue hypoxia
4903897|NCT02069327|Femur|femur
4903898|NCT02069327|Fat|fat
4903899|NCT02069327|Emboli|emboli
4903900|NCT02069327|Bone|bone
4903901|NCT02069327|Marrow|marrow
4903902|NCT02069327|proteomic|proteomic
4903903|NCT02069327|proteomics|proteomics
4903904|NCT02069327|metabolomics|metabolomics
4903905|NCT02069327|metabolomic|metabolomic
4903906|NCT02069327|inflammatory|inflammatory
4903907|NCT02069327|cytokine|cytokine
4903908|NCT02069327|chemokine|chemokine
4903909|NCT02069327|anaphlylatoxin|anaphlylatoxin
4903910|NCT02069327|Thromboelastography|thromboelastography
4903911|NCT02069327|Medical Center of the Rockies|medical center of the rockies
4903912|NCT02069327|Fat Embolism Syndrome|fat embolism syndrome
4903913|NCT02069327|Injury|injury
4903914|NCT02069327|Fracture|fracture
4903915|NCT02069327|Metabolite|metabolite
4903916|NCT02069327|MCR|mcr
4903917|NCT02069327|TEG|teg
4903918|NCT02069327|FES|fes
4903919|NCT02069301|Behavior Activation|behavior activation
4903920|NCT02069301|Problem solving therapy|problem solving therapy
4903921|NCT02069301|Depression Treatment|depression treatment
4903922|NCT02069301|depression care integration|depression care integration
4903923|NCT02069301|microfinance|microfinance
4903924|NCT02069301|livelihood|livelihood
4903925|NCT02069288|fludrocortisone|fludrocortisone
4903926|NCT02069288|pharmacology|pharmacology
4903927|NCT02069288|septic shock|septic shock
4903928|NCT02069275|Immediate mobilization|immediate mobilization
4903929|NCT02069275|Bedrest|bedrest
4903930|NCT02069275|Coronary angiography|coronary angiography
4903931|NCT02069275|Coronary percutaneous intervention|coronary percutaneous intervention
4903932|NCT02069275|Vascular access complications|vascular access complications
4903933|NCT02069275|Patients comfort|patients comfort
4903934|NCT02069262|obscure gastrointestinal bleeding|obscure gastrointestinal bleeding
4903935|NCT02069262|laparoscopy|laparoscopy
4903936|NCT02069262|angiography|angiography
4903937|NCT02069249|Preschool children|preschool children
4903938|NCT02069249|Sleep problems|sleep problems
4903939|NCT02069249|Nutrition problems|nutrition problems
4903940|NCT02069249|Online intervention|online intervention
4903941|NCT02069249|Psychological functioning|psychological functioning
4903942|NCT02069236|Glucose-6 phosphate dehydrogenase deficiency|glucose-6 phosphate dehydrogenase deficiency
4903943|NCT02069236|capillary|capillary
4903944|NCT02069236|venous|venous
4903945|NCT02069236|genotype phenotype correlation|genotype phenotype correlation
4903946|NCT02069223|Biliopancreatic Diversion with Duodenal Switch|biliopancreatic diversion with duodenal switch
4903947|NCT02069223|Gastrectomy|gastrectomy
4903948|NCT02069197|ketogenic diet|ketogenic diet
4903949|NCT02069197|obesity|obesity
4903950|NCT02069197|diabetes|diabetes
4903951|NCT02069197|obstructive sleep apnea|obstructive sleep apnea
4903952|NCT02069184|opioid usage requirements|opioid usage requirements
4903953|NCT02069184|pain|pain
4903954|NCT02069184|IV acetaminophen|iv acetaminophen
4903955|NCT02069184|opioid usage|opioid usage
4903956|NCT02069184|c-section|c-section
4903957|NCT02069171|Lower extremity edema|lower extremity edema
4903958|NCT02069171|Lower leg lymphedema|lower leg lymphedema
4903959|NCT02069171|Lower leg edema|lower leg edema
4903960|NCT02069171|Lymphedema|lymphedema
4903961|NCT02069171|Pelvic lymph node dissection|pelvic lymph node dissection
4903962|NCT02069171|Gynecologic Cancer Lymphedema Questionnaire|gynecologic cancer lymphedema questionnaire
4903963|NCT02069158|Advanced solid tumor|advanced solid tumor
4903964|NCT02069145|Hepatocellular Cancer|hepatocellular cancer
4903965|NCT02069145|Liver Cancer|liver cancer
4903966|NCT02069132|Warfarin|warfarin
4903967|NCT02069132|International Warfarin Pharmacogenetics Consortium algorithm|international warfarin pharmacogenetics consortium algorithm
4903968|NCT02069132|Atrial Fibrillation|atrial fibrillation
4903969|NCT02069132|Heart Valve Prosthesis Implantation|heart valve prosthesis implantation
4903970|NCT02069132|elderly|elderly
4903971|NCT02069132|comorbidity|comorbidity
4903972|NCT02069106|low density lipoprotein cholesterol|low density lipoprotein cholesterol
4903973|NCT02069106|triglycerides|triglycerides
4903974|NCT02069106|mixed hyperlipoproteinemia|mixed hyperlipoproteinemia
4903975|NCT02069106|Dehydroascorbic Acid|dehydroascorbic acid
4903976|NCT02069106|Eicosapentaenoic Acid|eicosapentaenoic acid
4903977|NCT02069106|Fish oil|fish oil
4903978|NCT02069080|Positron Emission Tomograhy|positron emission tomograhy
4903979|NCT02069080|Metastasis|metastasis
4903980|NCT02069067|breakthrough cancer pain|breakthrough cancer pain
4903981|NCT02069067|pain|pain
4903982|NCT02069067|neuropathic pain|neuropathic pain
4903983|NCT02069067|intractable pain|intractable pain
4903984|NCT02069067|cancer|cancer
4903985|NCT02069054|asthma|asthma
4903986|NCT02069054|COPD|copd
4903987|NCT02069054|airway inflammation|airway inflammation
4903988|NCT02069054|remodeling|remodeling
4903989|NCT02069054|cytokines|cytokines
4903990|NCT02069054|airway wall thickness|airway wall thickness
4903991|NCT02069028|surviving sepsis campaign|surviving sepsis campaign
4903992|NCT02069028|sepsis|sepsis
4903993|NCT02069028|septic|septic
4903994|NCT02069028|septicemia|septicemia
4903995|NCT02069028|mortality|mortality
4903996|NCT02069028|compliance|compliance
4903997|NCT02069015|Patient education|patient education
4903998|NCT02069015|Hypertension|hypertension
4903999|NCT02069015|Patient activation|patient activation
4904000|NCT02069002|Indoor Air|indoor air
4904001|NCT02069002|Medically unexplained symptoms|medically unexplained symptoms
4904002|NCT02069002|Randomized controlled trial|randomized controlled trial
4904003|NCT02069002|Cognitive-Behavioral Therapy|cognitive-behavioral therapy
4904004|NCT02069002|Applied relaxation|applied relaxation
4904005|NCT02068950|Head and neck cancer|head and neck cancer
4904006|NCT02068950|Concurrent chemoradiotherapy|concurrent chemoradiotherapy
4904007|NCT02068950|Progressive resistance training|progressive resistance training
4904008|NCT02068950|Exercise|exercise
4904009|NCT02068950|Feasibility|feasibility
4904010|NCT02068950|Weight loss|weight loss
4904011|NCT02068950|LBM|lbm
4904012|NCT02068950|Body composition|body composition
4904013|NCT02068937|Heart Failure|heart failure
4904014|NCT02068937|Therapy|therapy
4904015|NCT02068937|Diuretics|diuretics
4904016|NCT02068937|Algorithms|algorithms
4904017|NCT02068924|Slow freezing|slow freezing
4904018|NCT02068924|Vitrification|vitrification
4904019|NCT02068924|Single embryo transfer|single embryo transfer
4904020|NCT02068911|Neuromuscular disease|neuromuscular disease
4904021|NCT02068911|Home ventilation|home ventilation
4904022|NCT02068911|End tidal CO2|end tidal co2
4904023|NCT02068911|Transcutaneous CO2|transcutaneous co2
4904024|NCT02068911|Monitoring|monitoring
4904025|NCT02068885|Low carbohydrate diet|low carbohydrate diet
4904026|NCT02068885|Low fat diet|low fat diet
4904027|NCT02068885|Glycemic index|glycemic index
4904028|NCT02068885|Weight loss maintenance|weight loss maintenance
4904029|NCT02068872|Obesity|obesity
4904030|NCT02068872|Transplant|transplant
4904031|NCT02068872|Sleeve Gastrectomy|sleeve gastrectomy
4904032|NCT02068872|Liver Transplantation|liver transplantation
4904033|NCT02068872|Weight Loss|weight loss
4904034|NCT02068846|HIV|hiv
4904035|NCT02068846|Salivary Gland Disease|salivary gland disease
4904036|NCT02068846|Benign Lymphoepithelial Lesion|benign lymphoepithelial lesion
4904037|NCT02068846|BK Polyomavirus|bk polyomavirus
4904038|NCT02068833|Microalbuminuria|microalbuminuria
4904039|NCT02068833|Gastrectomy|gastrectomy
4904040|NCT02068833|Biliopancreatic Diversion With Duodenal Switch|biliopancreatic diversion with duodenal switch
4904041|NCT02068820|Sentinel lymph nodes|sentinel lymph nodes
4904042|NCT02068820|da Vinci|da vinci
4904043|NCT02068820|Firefly|firefly
4904044|NCT02068820|Sentinel lymph node mapping|sentinel lymph node mapping
4904045|NCT02068820|Fluorescence Imaging|fluorescence imaging
4904046|NCT02068820|SLN|sln
4904047|NCT02068820|SLN mapping|sln mapping
4904048|NCT02068768|fusion|fusion
4904049|NCT02068768|lateral interbody fusion system|lateral interbody fusion system
4904050|NCT02068768|lumbar spine|lumbar spine
4904051|NCT02068768|degenerative disc disease|degenerative disc disease
4904052|NCT02068755|anemia|anemia
4904053|NCT02068755|renal impairment|renal impairment
4904054|NCT02068755|thrombocytopenia|thrombocytopenia
4904055|NCT02068755|anticoagulation|anticoagulation
4904056|NCT02068755|Coronary bypass|coronary bypass
4904057|NCT02068755|Aortic valve surgery|aortic valve surgery
4904058|NCT02068755|Mitral valve surgery|mitral valve surgery
4904059|NCT02068755|red blood cell|red blood cell
4904060|NCT02068755|platelet|platelet
4904061|NCT02068755|fresh frozen plasma|fresh frozen plasma
4904062|NCT02068755|octaplas|octaplas
4904063|NCT02068742|post-operative cognitive dysfunction|post-operative cognitive dysfunction
4904064|NCT02068742|elderly|elderly
4904065|NCT02068742|Mini Mental State Examination|mini mental state examination
4904066|NCT02068742|Geriatric Index of Comorbidity|geriatric index of comorbidity
4904067|NCT02068742|Geriatric Depression Scale|geriatric depression scale
4904068|NCT02068742|Trail Making Test B-A|trail making test b-a
4904069|NCT02068742|Digit Span|digit span
4904070|NCT02068742|Digit Symbol Substitution Test|digit symbol substitution test
4904071|NCT02068729|degenerative disc disease|degenerative disc disease
4904072|NCT02068729|DDD|ddd
4904073|NCT02068729|Grade 1 spondylolisthesis|grade 1 spondylolisthesis
4904074|NCT02068729|spondylolisthesis|spondylolisthesis
4904075|NCT02068729|L2-S1|l2-s1
4904076|NCT02068716|Healthcare acquired infections|healthcare acquired infections
4904077|NCT02068716|Cardiovascular Surgery|cardiovascular surgery
4904078|NCT02068716|Mediastinitis|mediastinitis
4904079|NCT02068716|Thoracotomy|thoracotomy
4904080|NCT02068716|Conduit harvest or cannulation site|conduit harvest or cannulation site
4904081|NCT02068703|survey|survey
4904082|NCT02068664|spatial neglect|spatial neglect
4904083|NCT02068664|aphasia|aphasia
4904084|NCT02068651|End-of-life care|end-of-life care
4904085|NCT02068651|Treatment decision making|treatment decision making
4904086|NCT02068651|Advance care planning|advance care planning
4904087|NCT02068638|exercise|exercise
4904088|NCT02068638|isotope labeling, stable|isotope labeling, stable
4904089|NCT02068638|spectroscopy, magnetic resonance|spectroscopy, magnetic resonance
4904090|NCT02068638|monitoring, home blood glucose|monitoring, home blood glucose
4904091|NCT02068638|hormones|hormones
4904092|NCT02068625|retinal detachment|retinal detachment
4904093|NCT02068625|rasagiline|rasagiline
4904094|NCT02068625|optical coherence tomography|optical coherence tomography
4904095|NCT02068625|visual acuity|visual acuity
4904096|NCT02068625|neuroprotection|neuroprotection
4904097|NCT02068625|azilect|azilect
4904098|NCT02068612|Executive function,|executive function,
4904099|NCT02068612|cardiovascular fitness,|cardiovascular fitness,
4904100|NCT02068612|cognitive function|cognitive function
4904101|NCT02068599|Osteoarthritis|osteoarthritis
4904102|NCT02068599|OA|oa
4904103|NCT02068599|Arthritis pain|arthritis pain
4904104|NCT02068573|Childhood Asthma|childhood asthma
4904105|NCT02068573|Allergy|allergy
4904106|NCT02068573|House dust mites|house dust mites
4904107|NCT02068573|Indoor air quality|indoor air quality
4904108|NCT02068547|posterior cervical fusion|posterior cervical fusion
4904109|NCT02068547|posterior cervical decompression|posterior cervical decompression
4904110|NCT02068534|in-depth individual interview|in-depth individual interview
4904111|NCT02068534|charcoal-burning suicide|charcoal-burning suicide
4904112|NCT02068521|Growth Hormone Deficiency|growth hormone deficiency
4904113|NCT02068521|Pediatric Growth Hormone Deficiency|pediatric growth hormone deficiency
4904114|NCT02068521|GHD|ghd
4904115|NCT02068521|PGHD|pghd
4904116|NCT02068521|VRS-317|vrs-317
4904117|NCT02068521|Versartis|versartis
4904118|NCT02068521|Growth disorder|growth disorder
4904119|NCT02068521|Long acting growth hormone|long acting growth hormone
4904120|NCT02068521|Growth hormone|growth hormone
4904121|NCT02068521|Weekly growth hormone dosing|weekly growth hormone dosing
4904122|NCT02068521|Semi-monthly growth hormone dosing|semi-monthly growth hormone dosing
4904123|NCT02068521|Monthly growth hormone dosing|monthly growth hormone dosing
4904124|NCT02068521|IGF-I|igf-i
4904125|NCT02068521|Short stature|short stature
4904126|NCT02068521|Height velocity|height velocity
4904127|NCT02068521|Annual height velocity|annual height velocity
4904128|NCT02068521|Growth rate|growth rate
4904129|NCT02068521|Somavaratan|somavaratan
4904130|NCT02068508|Drug therapy|drug therapy
4904131|NCT02068495|Drug therapy|drug therapy
4904132|NCT02068482|Uncomplicated|uncomplicated
4904133|NCT02068482|Symptomatic|symptomatic
4904134|NCT02068456|Drug therapy|drug therapy
4904135|NCT02068443|Drug therapy|drug therapy
4904136|NCT02068430|Corneal Ulcers|corneal ulcers
4904137|NCT02068430|cross-linking|cross-linking
4904138|NCT02068430|UVA|uva
4904139|NCT02068430|Riboflavin|riboflavin
4904140|NCT02068417|IIEF score|iief score
4904141|NCT02068417|ED|ed
4904142|NCT02068404|Tocolysis|tocolysis
4904143|NCT02068404|Preterm labor|preterm labor
4904144|NCT02068404|Nifedipine|nifedipine
4904145|NCT02068404|Pharmacokinetics|pharmacokinetics
4904146|NCT02068391|covert stroke|covert stroke
4904147|NCT02068391|cerebral blood flow|cerebral blood flow
4904148|NCT02068391|grey matter|grey matter
4904149|NCT02068391|attention|attention
4904150|NCT02068391|executive function|executive function
4904151|NCT02068391|aerobic exercise|aerobic exercise
4904152|NCT02068352|Atopic Dermatitis, Eczema|atopic dermatitis, eczema
4904153|NCT02068326|Mentalization-based Treatment|mentalization-based treatment
4904154|NCT02068326|Adolescence|adolescence
4904155|NCT02068326|Borderline Personality Disorder|borderline personality disorder
4904156|NCT02068300|1,5-anhydro-D-glucitol, hypoglycemia, surrogate marker|1,5-anhydro-d-glucitol, hypoglycemia, surrogate marker
4904157|NCT02068287|Septic Shock|septic shock
4904158|NCT02068287|Hemodynamic|hemodynamic
4904159|NCT02068287|Inflammatory status|inflammatory status
4904160|NCT02068287|Beta adrenergic modulation|beta adrenergic modulation
4904161|NCT02068287|Esmolol|esmolol
4904162|NCT02068235|Ponesimod|ponesimod
4904163|NCT02068235|Bioavailability|bioavailability
4904164|NCT02068235|Pharmacokinetics|pharmacokinetics
4904165|NCT02068235|Safety|safety
4904166|NCT02068222|Hepatitis C|hepatitis c
4904167|NCT02068222|HCV|hcv
4904168|NCT02068222|Interferon Free|interferon free
4904169|NCT02068222|Chronic Hepatitis C|chronic hepatitis c
4904170|NCT02068222|Hepatitis C virus|hepatitis c virus
4904171|NCT02068222|Hepatitis C Genotype 3|hepatitis c genotype 3
4904172|NCT02068209|Outpatient hysteroscopy|outpatient hysteroscopy
4904173|NCT02068209|Tramadol|tramadol
4904174|NCT02068196|Cancer|cancer
4904175|NCT02068196|Malignant Melanoma|malignant melanoma
4904176|NCT02068196|Ipilimumab|ipilimumab
4904177|NCT02068183|World Trade Center exposure|world trade center exposure
4904178|NCT02068183|cardiovascular risk|cardiovascular risk
4904179|NCT02068183|insulin resistance|insulin resistance
4904180|NCT02068183|post-traumatic stress|post-traumatic stress
4904181|NCT02068183|pulmonary disease|pulmonary disease
4904182|NCT02068170|QT-prolongation|qt-prolongation
4904183|NCT02068170|Torsade de Pointes|torsade de pointes
4904184|NCT02068170|QT-prolonging drugs|qt-prolonging drugs
4904185|NCT02068144|Cranberry Extract|cranberry extract
4904186|NCT02068131|Metastatic Colorectal Cancer|metastatic colorectal cancer
4904187|NCT02068131|Novaferon|novaferon
4904188|NCT02068131|Recombinant anti-tumor and anti-virus protein for injection|recombinant anti-tumor and anti-virus protein for injection
4904189|NCT02068131|xeloda|xeloda
4904190|NCT02068118|E health|e health
4904191|NCT02068118|Telecardiology program|telecardiology program
4904192|NCT02068118|Heart failure|heart failure
4904193|NCT02068105|ALKS 5461|alks 5461
4904194|NCT02068105|samidorphan|samidorphan
4904195|NCT02068066|Physical work requirements|physical work requirements
4904196|NCT02068066|Energy expenditure|energy expenditure
4904197|NCT02068066|Physical activity|physical activity
4904198|NCT02068066|Different occupational categories|different occupational categories
4904199|NCT02068066|Aerobic capacity|aerobic capacity
4904200|NCT02068040|with preserved ejection fraction of >55%|with preserved ejection fraction of >55%
4904201|NCT02068027|Diabetes Mellitus|diabetes mellitus
4904202|NCT02068027|Pain|pain
4904203|NCT02068027|Foot pain|foot pain
4904204|NCT02068027|Neuropathy|neuropathy
4904205|NCT02068014|stapplers- obesity- stomach|stapplers- obesity- stomach
4904206|NCT02067988|Radioembolization|radioembolization
4904207|NCT02067988|Somatostatin receptor treatment|somatostatin receptor treatment
4904208|NCT02067988|Neuroendocrine tumors|neuroendocrine tumors
4904209|NCT02067988|Liver metastases|liver metastases
4904210|NCT02067975|tryptophan|tryptophan
4904211|NCT02067975|kynurenic acid|kynurenic acid
4904212|NCT02067975|schizophrenia|schizophrenia
4904213|NCT02067962|Juvenile idiopathic arhtritis|juvenile idiopathic arhtritis
4904214|NCT02067962|JIA|jia
4904215|NCT02067962|Gene identification|gene identification
4904216|NCT02067962|Whole exome sequencing|whole exome sequencing
4904217|NCT02067962|Next generation sequencing|next generation sequencing
4904218|NCT02067962|Identification of molecular basis|identification of molecular basis
4904219|NCT02067962|Acceptation of both parents to participate to the study|acceptation of both parents to participate to the study
4904220|NCT02067923|T1D|t1d
4904221|NCT02067923|type 1 diabetes|type 1 diabetes
4904222|NCT02067923|type 1 diabetes mellitus|type 1 diabetes mellitus
4904223|NCT02067923|juvenile diabetes|juvenile diabetes
4904224|NCT02067923|autoimmune diabetes|autoimmune diabetes
4904225|NCT02067923|autoimmune|autoimmune
4904226|NCT02067923|anti-CD3 mAb|anti-cd3 mab
4904227|NCT02067923|mAb hOKT3g1(Ala-Ala)|mab hokt3g1(ala-ala)
4904228|NCT02067923|teplizumab|teplizumab
4904229|NCT02067910|Abatacept|abatacept
4904230|NCT02067910|Subcutaneous|subcutaneous
4904231|NCT02067910|Sjögren's syndrome|sjögren's syndrome
4904232|NCT02067910|Treatment|treatment
4904233|NCT02067910|Safety|safety
4904234|NCT02067910|Efficacy|efficacy
4904235|NCT02067897|Nails, Ingrown|nails, ingrown
4904236|NCT02067897|Children|children
4904237|NCT02067897|Ambulatory Surgical Procedures|ambulatory surgical procedures
4904238|NCT02067871|neuromuscular electrical stimulation|neuromuscular electrical stimulation
4904239|NCT02067871|low-level laser therapy|low-level laser therapy
4904240|NCT02067871|knee osteoarthritis|knee osteoarthritis
4904241|NCT02067871|muscle architecture|muscle architecture
4904242|NCT02067871|functionality|functionality
4904243|NCT02067871|neuromuscular parameters|neuromuscular parameters
4904244|NCT02067845|Lesbian, queer, bisexual women|lesbian, queer, bisexual women
4904245|NCT02067845|HIV and STI prevention|hiv and sti prevention
4904246|NCT02067845|Resilient coping|resilient coping
4904247|NCT02067845|Sexual stigma|sexual stigma
4904248|NCT02067845|Depression|depression
4904249|NCT02067845|Safer-sex practices|safer-sex practices
4904250|NCT02067845|Safer sex self-efficacy|safer sex self-efficacy
4904251|NCT02067845|HIV/STI knowledge and testing|hiv/sti knowledge and testing
4904252|NCT02067845|Pilot-testing|pilot-testing
4904253|NCT02067819|Tourette's|tourette's
4904254|NCT02067819|Tic Disorder|tic disorder
4904255|NCT02067819|Dental Appliance|dental appliance
4904256|NCT02067819|Oral Orthotic|oral orthotic
4904257|NCT02067819|Mouthguard|mouthguard
4904258|NCT02067806|PASS|pass
4904259|NCT02067806|TNS|tns
4904260|NCT02067806|CES|ces
4904261|NCT02067806|CHLOROPROCAINE|chloroprocaine
4904262|NCT02067793|NRX-1074|nrx-1074
4904263|NCT02067793|NMDA Receptor Modulator|nmda receptor modulator
4904264|NCT02067793|Major Depressive Disorder|major depressive disorder
4904265|NCT02067793|Glycine site modulator|glycine site modulator
4904266|NCT02067767|HIV-1 infection|hiv-1 infection
4904267|NCT02067767|Nevirapine|nevirapine
4904268|NCT02067767|Dolutegravir|dolutegravir
4904269|NCT02067767|Anti-retroviral agents|anti-retroviral agents
4904270|NCT02067754|The mutation profiling of circulating free DNA|the mutation profiling of circulating free dna
4904271|NCT02067741|Post-menopausal women|post-menopausal women
4904272|NCT02067741|topical application CR1447|topical application cr1447
4904273|NCT02067741|endocrine responsive-HER2neg breast cancer|endocrine responsive-her2neg breast cancer
4904274|NCT02067741|triple negative-androgen receptor positive breast cancer|triple negative-androgen receptor positive breast cancer
4904275|NCT02067728|obesity prevention|obesity prevention
4904276|NCT02067715|Tooth Discoloration|tooth discoloration
4904277|NCT02067715|Bleaching Agents|bleaching agents
4904879|NCT02064894|analgesia|analgesia
4904278|NCT02067715|Tooth Bleaching|tooth bleaching
4904279|NCT02067689|Normal cognition in healthy adults|normal cognition in healthy adults
4904280|NCT02067689|Cognitive function|cognitive function
4904281|NCT02067689|Transcranial direct current stimulation|transcranial direct current stimulation
4904282|NCT02067689|Structural Magnetic Resonance Imaging|structural magnetic resonance imaging
4904283|NCT02067689|Functional Magnetic Resonance Imaging|functional magnetic resonance imaging
4904284|NCT02067676|Campylobacter jejuni|campylobacter jejuni
4904285|NCT02067663|Postplacental IUD placement|postplacental iud placement
4904286|NCT02067663|LNG-IUS|lng-ius
4904287|NCT02067637|cancer therapy, cancer treatment|cancer therapy, cancer treatment
4904288|NCT02067611|Phase 2, Efficacy, Safety, Osteoarthritis|phase 2, efficacy, safety, osteoarthritis
4904289|NCT02067598|Scapular exercises|scapular exercises
4904290|NCT02067572|oral health|oral health
4904291|NCT02067572|mouthwash|mouthwash
4904292|NCT02067572|salvia|salvia
4904293|NCT02067572|hospice|hospice
4904294|NCT02067572|xerostomia|xerostomia
4904295|NCT02067572|mouth sores|mouth sores
4904296|NCT02067559|Post Traumatic Stress Disorder|post traumatic stress disorder
4904297|NCT02067559|PTSD|ptsd
4904298|NCT02067559|Intensive Care Unit|intensive care unit
4904299|NCT02067559|ICU|icu
4904300|NCT02067546|constipation|constipation
4904301|NCT02067520|Post C/S pain relief|post c/s pain relief
4904302|NCT02067507|Human Papillomavirus|human papillomavirus
4904303|NCT02067507|Immunization|immunization
4904304|NCT02067507|Oncogenic viruses|oncogenic viruses
4904305|NCT02067507|Cervical Cancer|cervical cancer
4904306|NCT02067507|Health Disparities|health disparities
4904307|NCT02067494|Low Back Pain|low back pain
4904308|NCT02067494|Chronic Pain|chronic pain
4904309|NCT02067494|Manual Therapy|manual therapy
4904310|NCT02067494|Randomized Clinical Trial|randomized clinical trial
4904311|NCT02067494|Bandages|bandages
4904312|NCT02067481|Breast cancer|breast cancer
4904313|NCT02067481|Survivors|survivors
4904314|NCT02067481|Weight loss|weight loss
4904315|NCT02067481|Diet|diet
4904316|NCT02067481|Physical activity|physical activity
4904317|NCT02067468|Human Papillomavirus|human papillomavirus
4904318|NCT02067468|cervical cancer|cervical cancer
4904319|NCT02067468|health services research|health services research
4904320|NCT02067468|Colombia|colombia
4904321|NCT02067468|Cervical Intraepithelial Neoplasia|cervical intraepithelial neoplasia
4904322|NCT02067455|Right ventricular function|right ventricular function
4904323|NCT02067455|echocardiography|echocardiography
4904324|NCT02067455|left ventricular assist device|left ventricular assist device
4904325|NCT02067455|exercise|exercise
4904326|NCT02067442|acetaminophen intravenous oral pain scores opioids|acetaminophen intravenous oral pain scores opioids
4904327|NCT02067416|neoadjuvant|neoadjuvant
4904328|NCT02067416|mammostrat|mammostrat
4904329|NCT02067416|TLE3|tle3
4904330|NCT02067416|DDR|ddr
4904331|NCT02067416|breast cancer|breast cancer
4904332|NCT02067403|Pressure-support|pressure-support
4904333|NCT02067403|Asynchrony|asynchrony
4904334|NCT02067377|GOLD, COPD, cachexia, BMI|gold, copd, cachexia, bmi
4904335|NCT02067364|hydrocephalus|hydrocephalus
4904336|NCT02067364|CSF shunt|csf shunt
4904337|NCT02067299|Depressive Disorder, Major|depressive disorder, major
4904338|NCT02067299|Major Depressive Disorder|major depressive disorder
4904339|NCT02067299|Insomnia|insomnia
4904340|NCT02067299|JNJ-42847922|jnj-42847922
4904341|NCT02067299|Placebo|placebo
4904342|NCT02067221|percutaneous nephrolithotomy|percutaneous nephrolithotomy
4904343|NCT02067221|renal calculi|renal calculi
4904344|NCT02067221|ureteroscopy|ureteroscopy
4904345|NCT02067208|Osteoarthritis|osteoarthritis
4904346|NCT02067208|Cartilage|cartilage
4904347|NCT02067208|Musculoskeletal|musculoskeletal
4904348|NCT02067208|Biomechanics|biomechanics
4904349|NCT02067208|Subtype|subtype
4904350|NCT02067208|Footwear|footwear
4904351|NCT02067208|Orthotics|orthotics
4904352|NCT02067208|Joint Loading|joint loading
4904353|NCT02067195|acute myocardial infarction,contrast,coronary intervention|acute myocardial infarction,contrast,coronary intervention
4904354|NCT02067169|Transplantation|transplantation
4904355|NCT02067169|CMV infection|cmv infection
4904356|NCT02067169|antiviral resistance|antiviral resistance
4904357|NCT02067156|glioblastoma|glioblastoma
4904358|NCT02067143|Untreated philadelphia positive acute lymphoblastic leukemia|untreated philadelphia positive acute lymphoblastic leukemia
4904359|NCT02067143|De novo|de novo
4904360|NCT02067143|Secondary|secondary
4904361|NCT02067143|Low-dose corticosteroids pretreatment|low-dose corticosteroids pretreatment
4904362|NCT02067143|Pegylated asparaginase|pegylated asparaginase
4904363|NCT02067143|Lineage-targeted risk and minimal residual disease|lineage-targeted risk and minimal residual disease
4904364|NCT02067130|Beta Thalassemia Major|beta thalassemia major
4904365|NCT02067117|influenza|influenza
4904366|NCT02067091|STEMI|stemi
4904367|NCT02067091|Coronary|coronary
4904368|NCT02067091|Bioresorbable scaffold|bioresorbable scaffold
4904369|NCT02067091|Drug eluting stent|drug eluting stent
4904370|NCT02067091|Optical coherence tomography|optical coherence tomography
4904371|NCT02067091|Multislice computed tomography|multislice computed tomography
4904372|NCT02067078|nerve block|nerve block
4904373|NCT02067078|total knee arthroplasty|total knee arthroplasty
4904374|NCT02067078|saphenous nerve block|saphenous nerve block
4904375|NCT02067078|obturator nerve block|obturator nerve block
4904376|NCT02067078|pain|pain
4904377|NCT02067078|opioid consumption|opioid consumption
4904378|NCT02067065|Colonoscopy|colonoscopy
4904379|NCT02067065|Sedation|sedation
4904380|NCT02067065|Propofol|propofol
4904381|NCT02067065|Non-anesthesiologist propofol administration|non-anesthesiologist propofol administration
4904382|NCT02067052|Vulvar neoplasm|vulvar neoplasm
4904383|NCT02067052|sentinel nodes|sentinel nodes
4904384|NCT02067052|chemotherapy|chemotherapy
4904385|NCT02067052|radiotherapy|radiotherapy
4904386|NCT02067039|HIV testing|hiv testing
4904387|NCT02067039|Rapid HIV test|rapid hiv test
4904388|NCT02067039|HIV self-testing|hiv self-testing
4904389|NCT02067039|Men who have sex with men (MSM)|men who have sex with men (msm)
4904390|NCT02067039|HIV diagnosis|hiv diagnosis
4904391|NCT02067039|Sexual behavior|sexual behavior
4904392|NCT02067026|overweight|overweight
4904393|NCT02067013|Tractional retinal detachment|tractional retinal detachment
4904394|NCT02067013|Exudative retinal detachment|exudative retinal detachment
4904395|NCT02067013|Macular hole|macular hole
4904396|NCT02067013|Neovascular glaucoma|neovascular glaucoma
4904397|NCT02066987|Action planning, Implementation intention|action planning, implementation intention
4904398|NCT02066974|hepatocellular carcinoma|hepatocellular carcinoma
4904399|NCT02066974|genomic expression|genomic expression
4904400|NCT02066974|radiotherapy|radiotherapy
4904401|NCT02066961|metastatic prostate cancer|metastatic prostate cancer
4904402|NCT02066961|castration-resistant prostate cancer|castration-resistant prostate cancer
4904403|NCT02066961|prostate cancer|prostate cancer
4904404|NCT02066948|DXA|dxa
4904405|NCT02066948|MRI|mri
4904406|NCT02066948|Fitness assessment|fitness assessment
4904407|NCT02066948|Meal tolerance test|meal tolerance test
4904408|NCT02066935|immunosuppression|immunosuppression
4904409|NCT02066935|medication nonadherence|medication nonadherence
4904410|NCT02066935|kidney transplantation|kidney transplantation
4904411|NCT02066922|Contact lenses|contact lenses
4904412|NCT02066922|Nearsightedness|nearsightedness
4904413|NCT02066922|Corneal curvature|corneal curvature
4904414|NCT02066922|K-reading|k-reading
4904415|NCT02066922|High minus|high minus
4904416|NCT02066922|Spectacle refraction|spectacle refraction
4904417|NCT02066909|pharmacokinetics|pharmacokinetics
4904418|NCT02066909|safety|safety
4904419|NCT02066909|tolerability|tolerability
4904420|NCT02066909|healthy volunteers|healthy volunteers
4904421|NCT02066909|steady state|steady state
4904422|NCT02066909|multiple doses|multiple doses
4904423|NCT02066909|Japanese subjects|japanese subjects
4904424|NCT02066896|Sjogrens Syndrome|sjogrens syndrome
4904425|NCT02066896|Syndrome, Sjogren's|syndrome, sjogren's
4904426|NCT02066896|Sjogren Syndrome|sjogren syndrome
4904427|NCT02066896|Sicca Syndrome|sicca syndrome
4904428|NCT02066896|Syndrome, Sicca|syndrome, sicca
4904429|NCT02066870|Icotinib|icotinib
4904430|NCT02066870|Arsenic Trioxide|arsenic trioxide
4904431|NCT02066870|Resistance|resistance
4904432|NCT02066870|Non-small cell lung cancer|non-small cell lung cancer
4904433|NCT02066857|Wrist fracture|wrist fracture
4904434|NCT02066857|Radius fracture|radius fracture
4904435|NCT02066857|Elderly|elderly
4904436|NCT02066857|Splint|splint
4904437|NCT02066857|Cast|cast
4904438|NCT02066844|Hip Pain|hip pain
4904439|NCT02066844|Hip Injection|hip injection
4904440|NCT02066844|Hip Fracture|hip fracture
4904441|NCT02066844|Hip Bursitis|hip bursitis
4904442|NCT02066844|Hip Arthritis|hip arthritis
4904443|NCT02066844|Hip Sciatica|hip sciatica
4904444|NCT02066818|local anesthetic|local anesthetic
4904445|NCT02066818|incision and drainage|incision and drainage
4904446|NCT02066818|pain|pain
4904447|NCT02066818|cutaneous abscess|cutaneous abscess
4904448|NCT02066792|Social Phobia|social phobia
4904449|NCT02066753|Cardiac arrest|cardiac arrest
4904450|NCT02066753|Therapeutic Hypothermia|therapeutic hypothermia
4904451|NCT02066753|Cardioprotectiveness|cardioprotectiveness
4904452|NCT02066753|Hemodynamics|hemodynamics
4904453|NCT02066740|Superficial Femoral Artery|superficial femoral artery
4904454|NCT02066740|Proximal Popliteal Artery|proximal popliteal artery
4904455|NCT02066740|Everflex|everflex
4904456|NCT02066740|Entrust|entrust
4904457|NCT02066740|stent|stent
4904458|NCT02066727|Dexmedetomidine|dexmedetomidine
4904459|NCT02066727|obturator nerve block|obturator nerve block
4904460|NCT02066727|lidocaine|lidocaine
4904461|NCT02066727|EC50|ec50
4904462|NCT02066714|Enterovirus Infections|enterovirus infections
4904463|NCT02066714|Hand, Foot and Mouth Disease|hand, foot and mouth disease
4904464|NCT02066714|Coxsackievirus Infections|coxsackievirus infections
4904465|NCT02066714|Herpangina|herpangina
4904466|NCT02066714|Cognition|cognition
4904467|NCT02066714|Neurocognitive|neurocognitive
4904468|NCT02066714|Sequelae|sequelae
4904469|NCT02066714|Outcomes|outcomes
4904470|NCT02066701|Barrett's esophagus|barrett's esophagus
4904471|NCT02066675|Metastatic|metastatic
4904472|NCT02066675|Locally advanced|locally advanced
4904473|NCT02066675|Soft tissue tumors|soft tissue tumors
4904474|NCT02066662|Coronary or Valvular Calcification|coronary or valvular calcification
4904475|NCT02066662|Agatston Score|agatston score
4904476|NCT02066662|Rivaroxaban|rivaroxaban
4904477|NCT02066662|Coumarin|coumarin
4904478|NCT02066662|Oral Anticoagulation Therapy (OAT)|oral anticoagulation therapy (oat)
4904479|NCT02066662|Atrial Fibrillation|atrial fibrillation
4904480|NCT02066662|Pulmonary Embolism|pulmonary embolism
4904481|NCT02066649|portal hypertension|portal hypertension
4904482|NCT02066649|esophageal varices|esophageal varices
4904483|NCT02066649|variceal bleed|variceal bleed
4904484|NCT02066649|carvedilol|carvedilol
4904485|NCT02066649|variceal band ligation|variceal band ligation
4904486|NCT02066623|coronary artery stenosis, vascular scaffold, ABSORB|coronary artery stenosis, vascular scaffold, absorb
4904487|NCT02066597|Deep vein thrombosis|deep vein thrombosis
4904488|NCT02066597|thrombectomy|thrombectomy
4904489|NCT02066597|percutaneuos|percutaneuos
4904490|NCT02066584|sibling oocytes|sibling oocytes
4904491|NCT02066584|glucose|glucose
4904492|NCT02066584|culture media|culture media
4904493|NCT02066571|Parkinson's disease|parkinson's disease
4904494|NCT02066571|Freezing of gait|freezing of gait
4904495|NCT02066571|Gait|gait
4904496|NCT02066558|Carbon monoxide|carbon monoxide
4904497|NCT02066558|Headache|headache
4904498|NCT02066558|Migraine|migraine
4904499|NCT02066532|Breast Neoplasms|breast neoplasms
4904500|NCT02066532|Breast Cancer|breast cancer
4904501|NCT02066532|Breast Carcinoma|breast carcinoma
4904502|NCT02066532|Breast tumors|breast tumors
4904503|NCT02066532|Cancer of the Breast|cancer of the breast
4904504|NCT02066532|Malignant tumor of the breast|malignant tumor of the breast
4904505|NCT02066532|HER2 positive|her2 positive
4904506|NCT02066532|erythroblastosis virus oncogene B-2 (erbB-2)|erythroblastosis virus oncogene b-2 (erbb-2)
4904507|NCT02066532|Metastatic Breast Cancer|metastatic breast cancer
4904508|NCT02066532|Secondary Breast Cancer|secondary breast cancer
4904509|NCT02066519|Myasthenia gravis|myasthenia gravis
4904510|NCT02066519|physical exercise|physical exercise
4904511|NCT02066519|quality of life|quality of life
4904512|NCT02066519|muscular performance|muscular performance
4904513|NCT02066519|fatigability|fatigability
4904514|NCT02066506|systemic right ventricle|systemic right ventricle
4904515|NCT02066506|cardiac magnetic resonance imaging|cardiac magnetic resonance imaging
4904516|NCT02066506|congenital heart disease|congenital heart disease
4904517|NCT02066493|giant intracranial aneurysm|giant intracranial aneurysm
4904518|NCT02066467|Phrenic Nerve Stimulation|phrenic nerve stimulation
4904519|NCT02066467|Heartfailure treatment|heartfailure treatment
4904520|NCT02066467|CRT-D therapy|crt-d therapy
4904521|NCT02066467|Quadripolar lead|quadripolar lead
4904522|NCT02066467|Lead related complication free rate|lead related complication free rate
4904523|NCT02066454|myeloma|myeloma
4904524|NCT02066454|antiXa anticoagulant|antixa anticoagulant
4904525|NCT02066454|venous thromboembolic disease|venous thromboembolic disease
4904526|NCT02066454|iMiDs|imids
4904527|NCT02066441|Vitamin D|vitamin d
4904528|NCT02066441|bone formation|bone formation
4904529|NCT02066441|resorption|resorption
4904530|NCT02066441|mineral density|mineral density
4904531|NCT02066441|inflammation|inflammation
4904532|NCT02066441|flexibility|flexibility
4904533|NCT02066441|balance|balance
4904534|NCT02066441|elderly|elderly
4904535|NCT02066428|BCG Vaccinated|bcg vaccinated
4904536|NCT02066428|HIV Negative|hiv negative
4904537|NCT02066415|Chronic Migraine|chronic migraine
4904538|NCT02066389|anti-inflammatory agents|anti-inflammatory agents
4904539|NCT02066389|Joint Diseases|joint diseases
4904540|NCT02066389|Arthritis|arthritis
4904541|NCT02066389|Musculoskeletal Disease|musculoskeletal disease
4904542|NCT02066389|antirheumatic agents|antirheumatic agents
4904543|NCT02066363|Bioelectrical impedance|bioelectrical impedance
4904544|NCT02066363|Parenteral nutrition|parenteral nutrition
4904545|NCT02066363|Malnutrition|malnutrition
4904546|NCT02066363|Quality of life.|quality of life.
4904547|NCT02066363|Cancer cachexia|cancer cachexia
4904548|NCT02066363|Body composition|body composition
4904549|NCT02066350|Diabetes type 1|diabetes type 1
4904550|NCT02066350|Endothelial dysfunction|endothelial dysfunction
4904551|NCT02066350|Pancreas transplantation|pancreas transplantation
4904552|NCT02066337|Ozone gel|ozone gel
4904553|NCT02066337|Antioxidants|antioxidants
4904554|NCT02066337|Chronic periodontitis|chronic periodontitis
4904555|NCT02066337|Superoxide dismutase|superoxide dismutase
4904556|NCT02066311|lupus|lupus
4904557|NCT02066311|SLE|sle
4904558|NCT02066298|Asthma|asthma
4904559|NCT02066298|Mometasone|mometasone
4904560|NCT02066298|Tiotropium|tiotropium
4904561|NCT02066285|Solitary fibrous tumor|solitary fibrous tumor
4904562|NCT02066285|Extraskeletal myxoid chondrosarcoma|extraskeletal myxoid chondrosarcoma
4904563|NCT02066285|Unresectable|unresectable
4904564|NCT02066285|Locally advanced|locally advanced
4904565|NCT02066285|Metastatic disease|metastatic disease
4904566|NCT02066272|IBD|ibd
4904567|NCT02066272|anti-TNF|anti-tnf
4904568|NCT02066272|biosimilars|biosimilars
4904569|NCT02066272|safety|safety
4904570|NCT02066259|colon cancer|colon cancer
4904571|NCT02066259|cancer associated auto antibodies|cancer associated auto antibodies
4904572|NCT02066259|colon cancer blood test|colon cancer blood test
4905078|NCT02064049|Drug users|drug users
4904573|NCT02066246|laparoscopic robot-assisted surgery|laparoscopic robot-assisted surgery
4904574|NCT02066246|in steep trendelenburg position|in steep trendelenburg position
4904575|NCT02066233|Barrett's|barrett's
4904576|NCT02066233|esophagus|esophagus
4904577|NCT02066233|reflux|reflux
4904578|NCT02066233|heartburn|heartburn
4904579|NCT02066233|screening|screening
4904580|NCT02066220|pediatric brain tumor|pediatric brain tumor
4904581|NCT02066220|medulloblastoma|medulloblastoma
4904582|NCT02066220|event-free survival (EFS)|event-free survival (efs)
4904583|NCT02066220|progression-free survival (PFS)|progression-free survival (pfs)
4904584|NCT02066220|overall survival (OS)|overall survival (os)
4904585|NCT02066220|PNET|pnet
4904586|NCT02066220|posterior fossa|posterior fossa
4904587|NCT02066220|chemotherapy|chemotherapy
4904588|NCT02066220|radiotherapy|radiotherapy
4904589|NCT02066220|biological profile|biological profile
4904590|NCT02066220|ß-catenin|ß-catenin
4904591|NCT02066155|diabetes self-management support|diabetes self-management support
4904592|NCT02066155|diabetes-related distress|diabetes-related distress
4904593|NCT02066155|parish nurses|parish nurses
4904594|NCT02066155|peer support|peer support
4904595|NCT02066129|Asthma|asthma
4904596|NCT02066129|Fluticasone|fluticasone
4904597|NCT02066090|acupuncture|acupuncture
4904598|NCT02066090|obesity|obesity
4904599|NCT02066090|metabolomics|metabolomics
4904600|NCT02066077|Major Depressive Disorder|major depressive disorder
4904601|NCT02066077|Modified Electroconvulsive Therapy|modified electroconvulsive therapy
4904602|NCT02066077|Cognition|cognition
4904603|NCT02066077|Memory|memory
4904604|NCT02066064|Colorectal Cancer|colorectal cancer
4904605|NCT02066064|Adenoma|adenoma
4904606|NCT02066064|Standard Colonoscopy|standard colonoscopy
4904607|NCT02066064|G-EYE(TM) Colonoscopy|g-eye(tm) colonoscopy
4904608|NCT02066038|chemotherapy|chemotherapy
4904609|NCT02066038|maintenance therapy|maintenance therapy
4904610|NCT02066038|erlotinib|erlotinib
4904611|NCT02066025|breast cancer|breast cancer
4904612|NCT02066025|cancer associated auto antibodies|cancer associated auto antibodies
4904613|NCT02066025|breast cancer blood test|breast cancer blood test
4904614|NCT02066012|Dysmetabolic Iron Overload Syndrome|dysmetabolic iron overload syndrome
4904615|NCT02066012|Metabolic Syndrome X|metabolic syndrome x
4904616|NCT02066012|Iron|iron
4904617|NCT02066012|Monocyte|monocyte
4904618|NCT02066012|Macrophage|macrophage
4904619|NCT02066012|Polarization|polarization
4904620|NCT02065999|Hepatitis C, chronic|hepatitis c, chronic
4904621|NCT02065986|HIV|hiv
4904622|NCT02065986|Prevention|prevention
4904623|NCT02065986|Truvada|truvada
4904624|NCT02065960|Feasibility study|feasibility study
4904625|NCT02065960|Early breast cancer|early breast cancer
4904626|NCT02065960|Stereotactic body radiotherapy|stereotactic body radiotherapy
4904627|NCT02065960|Cyberknife|cyberknife
4904628|NCT02065960|Pre-operative radiotherapy|pre-operative radiotherapy
4904629|NCT02065947|paravertebral block, mastectomy, efficiency|paravertebral block, mastectomy, efficiency
4904630|NCT02065934|in hospital cardiac arrest|in hospital cardiac arrest
4904631|NCT02065934|in situ simulation|in situ simulation
4904632|NCT02065934|clinical audit|clinical audit
4904633|NCT02065934|education|education
4904634|NCT02065921|COPD cohort|copd cohort
4904635|NCT02065921|COPD management|copd management
4904636|NCT02065921|exacerbation|exacerbation
4904637|NCT02065908|breast cancer|breast cancer
4904638|NCT02065908|anthracyclines|anthracyclines
4904639|NCT02065908|cardiotoxicity|cardiotoxicity
4904640|NCT02065908|circulating microRNA|circulating microrna
4904641|NCT02065908|biomarker|biomarker
4904642|NCT02065908|serum|serum
4904643|NCT02065908|anthracyclines based chemotherapy|anthracyclines based chemotherapy
4904644|NCT02065895|Physiologic Insulin Delivery (PID)|physiologic insulin delivery (pid)
4904645|NCT02065895|Closed Loop|closed loop
4904646|NCT02065895|Sensor|sensor
4904647|NCT02065895|Insulin sensitivity|insulin sensitivity
4904648|NCT02065882|fibrinogen, bleeding,|fibrinogen, bleeding,
4904649|NCT02065869|ALL|all
4904650|NCT02065869|AML|aml
4904651|NCT02065869|hematologic neoplasms|hematologic neoplasms
4904652|NCT02065869|hematologic malignancies|hematologic malignancies
4904653|NCT02065869|primary immune deficiences|primary immune deficiences
4904654|NCT02065843|Anxiety|anxiety
4904655|NCT02065843|Third molar surgery|third molar surgery
4904656|NCT02065843|Blood pressure|blood pressure
4904657|NCT02065843|Heart rate|heart rate
4904658|NCT02065843|Oxygen saturation|oxygen saturation
4904659|NCT02065830|Robot|robot
4904660|NCT02065830|Spinal Cord Injury|spinal cord injury
4904661|NCT02065830|Gait|gait
4904662|NCT02065830|Quality of life|quality of life
4904663|NCT02065830|Rehabilitation|rehabilitation
4904664|NCT02065830|Lower Limb|lower limb
4904665|NCT02065817|Lipid|lipid
4904666|NCT02065817|Apolipoproteins|apolipoproteins
4904667|NCT02065817|Cardiovascular disease risks|cardiovascular disease risks
4904668|NCT02065804|Herniorrhaphy|herniorrhaphy
4904669|NCT02065804|Surgical Equipment|surgical equipment
4904670|NCT02065804|Chronic Pain|chronic pain
4904671|NCT02065804|Inguinal Herniorrhaphy|inguinal herniorrhaphy
4904672|NCT02065804|Laparoscopy|laparoscopy
4904673|NCT02065804|Surgical Outcome|surgical outcome
4904674|NCT02065791|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
4904675|NCT02065791|Diabetic Nephropathies|diabetic nephropathies
4904676|NCT02065791|Canagliflozin|canagliflozin
4904677|NCT02065791|JNJ-28431754|jnj-28431754
4904678|NCT02065791|End-Stage Kidney Disease|end-stage kidney disease
4904679|NCT02065791|Chronic Kidney Disease|chronic kidney disease
4904680|NCT02065791|Macroalbuminuria|macroalbuminuria
4904681|NCT02065752|Healthy Volunteers|healthy volunteers
4904682|NCT02065752|Canagliflozin|canagliflozin
4904683|NCT02065752|Metformin|metformin
4904684|NCT02065752|Type 2 diabetes mellitus|type 2 diabetes mellitus
4904685|NCT02065739|Healthy|healthy
4904686|NCT02065739|JNJ-42165279|jnj-42165279
4904687|NCT02065739|Itraconazole|itraconazole
4904688|NCT02065739|Pharmacokinetics|pharmacokinetics
4904689|NCT02065713|Psoriatic arthritis, dactylitis, enthesitis|psoriatic arthritis, dactylitis, enthesitis
4904690|NCT02065700|Methotrexate|methotrexate
4904691|NCT02065700|insufficient responders|insufficient responders
4904692|NCT02065674|type II Diabetes mellitus|type ii diabetes mellitus
4904693|NCT02065674|FBS|fbs
4904694|NCT02065674|PPBS|ppbs
4904695|NCT02065674|HbA1c%|hba1c%
4904696|NCT02065648|MRA|mra
4904697|NCT02065648|Syngo Native|syngo native
4904698|NCT02065648|Gadolinium|gadolinium
4904699|NCT02065648|Non contrast|non contrast
4904700|NCT02065622|Ulcerative Colitis|ulcerative colitis
4904701|NCT02065609|Trastuzumab|trastuzumab
4904702|NCT02065596|Sickle Cell Disease|sickle cell disease
4904703|NCT02065596|Sickle Cell Anemia|sickle cell anemia
4904704|NCT02065596|GvHD|gvhd
4904705|NCT02065596|fludarabine|fludarabine
4904706|NCT02065583|Ileus|ileus
4904707|NCT02065583|Equipment and Supplies|equipment and supplies
4904708|NCT02065583|Technology|technology
4904709|NCT02065583|Acoustics|acoustics
4904710|NCT02065570|Crohn's Disease|crohn's disease
4904711|NCT02065557|Ulcerative Colitis|ulcerative colitis
4904712|NCT02065557|adalimumab|adalimumab
4904713|NCT02065544|Type 2 diabetes mellitus|type 2 diabetes mellitus
4904714|NCT02065544|behavioral weight loss|behavioral weight loss
4904715|NCT02065544|exercise training|exercise training
4904716|NCT02065544|hemoglobin A1c|hemoglobin a1c
4904717|NCT02065531|Low Back Pain|low back pain
4904718|NCT02065531|Chronic Pain|chronic pain
4904719|NCT02065531|Manipulation|manipulation
4904720|NCT02065531|Manual Therapy|manual therapy
4904721|NCT02065531|Randomized Controlled Trial|randomized controlled trial
4904722|NCT02065518|Muscle strength|muscle strength
4904723|NCT02065518|Electrical muscle stimulation|electrical muscle stimulation
4904724|NCT02065518|Strength training|strength training
4904725|NCT02065505|Spastic hemiparesis|spastic hemiparesis
4904726|NCT02065505|Posture|posture
4904727|NCT02065505|Pilates|pilates
4904728|NCT02065505|Respiratory Capacity|respiratory capacity
4904729|NCT02065492|Thalassemia|thalassemia
4904730|NCT02065492|Amlodipine|amlodipine
4904731|NCT02065492|Chelation|chelation
4904732|NCT02065492|T2*|t2*
4904733|NCT02065492|MRI|mri
4904734|NCT02065492|Myocardial Iron|myocardial iron
4904735|NCT02065479|Coronary Artery Disease|coronary artery disease
4904736|NCT02065479|Percutaneous Coronary Intervention|percutaneous coronary intervention
4904737|NCT02065479|Genetic Polymorphism|genetic polymorphism
4904738|NCT02065479|Pharmacodynamic|pharmacodynamic
4904739|NCT02065453|lap hysterectomy|lap hysterectomy
4904740|NCT02065453|Women in need of a lap hysterectomy for benign disease.|women in need of a lap hysterectomy for benign disease.
4904741|NCT02065440|Ebastine/Pseudoephedrine|ebastine/pseudoephedrine
4904742|NCT02065440|subacute cough|subacute cough
4904743|NCT02065440|upper airway cough syndrome|upper airway cough syndrome
4904744|NCT02065427|Caregiver|caregiver
4904745|NCT02065427|Burden|burden
4904746|NCT02065427|Social support|social support
4904747|NCT02065427|Primary health Care|primary health care
4904748|NCT02065427|Home Care|home care
4904749|NCT02065427|Intervention|intervention
4904750|NCT02065414|Gums|gums
4904751|NCT02065414|Gingiva|gingiva
4904752|NCT02065414|Gingival Inflammation|gingival inflammation
4904753|NCT02065414|Gingival Bleeding|gingival bleeding
4904754|NCT02065375|RTA 408|rta 408
4904755|NCT02065375|Ocular surgery|ocular surgery
4904756|NCT02065375|Cataract surgery|cataract surgery
4904757|NCT02065375|Ocular inflammation|ocular inflammation
4904758|NCT02065375|Ocular pain|ocular pain
4904759|NCT02065375|Eye inflammation|eye inflammation
4904760|NCT02065362|EBV positive|ebv positive
4904761|NCT02065362|TGFbeta|tgfbeta
4904762|NCT02065362|Nasopharyngeal carcinoma|nasopharyngeal carcinoma
4904763|NCT02065362|cytotoxic T lymphocytes|cytotoxic t lymphocytes
4904764|NCT02065349|peripheral neuropathy|peripheral neuropathy
4904765|NCT02065349|PHN|phn
4904766|NCT02065349|pain|pain
4904767|NCT02065349|PDPN|pdpn
4904768|NCT02065336|HBV|hbv
4904769|NCT02065336|Hepatitis|hepatitis
4904770|NCT02065323|Prostate Cancer|prostate cancer
4904771|NCT02065323|Metastatic|metastatic
4904772|NCT02065323|Hormone-sensitive|hormone-sensitive
4904773|NCT02065323|Androgen Deprivation Therapy (ADT)|androgen deprivation therapy (adt)
4904774|NCT02065323|Castration-Resistant Prostate Cancer (CRPC)|castration-resistant prostate cancer (crpc)
4904775|NCT02065323|Dovitinib|dovitinib
4904776|NCT02065323|TKI258|tki258
4904777|NCT02065323|Circulating Tumor Cells|circulating tumor cells
4904778|NCT02065310|AGE|age
4904779|NCT02065310|Diabetes Biomarkers|diabetes biomarkers
4904780|NCT02065310|CEdG|cedg
4904781|NCT02065284|MS|ms
4904782|NCT02065284|Ambulation|ambulation
4904783|NCT02065258|Asthma, Clinical control, Exercise|asthma, clinical control, exercise
4904784|NCT02065245|Aging Frailty, Frailty, Cardiovascular, stem cells|aging frailty, frailty, cardiovascular, stem cells
4904785|NCT02065219|Chronic Pain|chronic pain
4904786|NCT02065219|Inguinal Hernia|inguinal hernia
4904787|NCT02065219|Outcome|outcome
4904788|NCT02065219|Surgical Procedure, Operative|surgical procedure, operative
4904789|NCT02065206|Focus groups|focus groups
4904790|NCT02065206|Underrepresented Minorities|underrepresented minorities
4904791|NCT02065206|Social Media|social media
4904792|NCT02065206|Clinical Research Careers|clinical research careers
4904793|NCT02065167|avascular necrosis of femoral head|avascular necrosis of femoral head
4904794|NCT02065167|cell therapy|cell therapy
4904795|NCT02065167|Mesenchymal stem cells|mesenchymal stem cells
4904796|NCT02065154|acute myeloid leukemia|acute myeloid leukemia
4904797|NCT02065154|AML|aml
4904798|NCT02065154|acute lymphoblastic leukemia|acute lymphoblastic leukemia
4904799|NCT02065154|ALL|all
4904800|NCT02065154|chronic myeloid leukemia|chronic myeloid leukemia
4904801|NCT02065154|CML|cml
4904802|NCT02065154|chronic lymphocytic leukemia|chronic lymphocytic leukemia
4904803|NCT02065154|CLL|cll
4904804|NCT02065154|non-Hodgkin lymphoma|non-hodgkin lymphoma
4904805|NCT02065154|NHL|nhl
4904806|NCT02065154|Hodgkin lymphoma|hodgkin lymphoma
4904807|NCT02065154|HL|hl
4904808|NCT02065154|myelodysplastic syndrome|myelodysplastic syndrome
4904809|NCT02065154|MDS|mds
4904810|NCT02065154|myelofibrosis|myelofibrosis
4904811|NCT02065154|severe aplastic anemia|severe aplastic anemia
4904812|NCT02065141|digestion|digestion
4904813|NCT02065141|absorption|absorption
4904814|NCT02065141|protein|protein
4904815|NCT02065141|amino acids|amino acids
4904816|NCT02065141|heart failure|heart failure
4904817|NCT02065141|COPD|copd
4904818|NCT02065115|ice|ice
4904819|NCT02065115|cryotherapy|cryotherapy
4904820|NCT02065115|puncture|puncture
4904821|NCT02065115|pain|pain
4904822|NCT02065102|Rotational atherectomy|rotational atherectomy
4904823|NCT02065102|Angina|angina
4904824|NCT02065102|Optical coherence tomography|optical coherence tomography
4904825|NCT02065102|Intravascular ultrasound|intravascular ultrasound
4904826|NCT02065102|Coronary stent|coronary stent
4904827|NCT02065076|Sodium Polystyrene Sulfonate|sodium polystyrene sulfonate
4904828|NCT02065076|Kayexalate|kayexalate
4904829|NCT02065076|Pre-dialysis|pre-dialysis
4904830|NCT02065076|Outpatients|outpatients
4904831|NCT02065076|Hyperkalemia|hyperkalemia
4904832|NCT02065076|Chronic kidney failure|chronic kidney failure
4904833|NCT02065076|Potassium|potassium
4904834|NCT02065063|MEK inhibitor|mek inhibitor
4904835|NCT02065063|PD-0332991|pd-0332991
4904836|NCT02065063|CDK4/6 inhibitor|cdk4/6 inhibitor
4904837|NCT02065063|palbociclib|palbociclib
4904838|NCT02065063|NRAS wild type|nras wild type
4904839|NCT02065063|cutaneous melanoma|cutaneous melanoma
4904840|NCT02065063|GSK1120212|gsk1120212
4904841|NCT02065063|trametinib|trametinib
4904842|NCT02065063|NRAS mutant|nras mutant
4904843|NCT02065063|BRAFV600 wild type|brafv600 wild type
4904844|NCT02065050|Diabetes mellitus|diabetes mellitus
4904845|NCT02065050|Team approach|team approach
4904846|NCT02065037|Insufflation|insufflation
4904847|NCT02065037|Carbon Dioxide|carbon dioxide
4904848|NCT02065037|Colonic Polyps|colonic polyps
4904849|NCT02065037|Colonoscopy|colonoscopy
4904850|NCT02065037|Randomized Controlled Trial|randomized controlled trial
4904851|NCT02065024|b-cryptoxanthin|b-cryptoxanthin
4904852|NCT02065024|plant sterols|plant sterols
4904853|NCT02065024|serum Cholesterol|serum cholesterol
4904854|NCT02065024|bone turnover markers|bone turnover markers
4904855|NCT02064998|Randomized Controlled Trial|randomized controlled trial
4904856|NCT02064998|Alcohol|alcohol
4904857|NCT02064998|Internet|internet
4904858|NCT02064998|Mobile phone|mobile phone
4904859|NCT02064998|Screening|screening
4904860|NCT02064998|Brief intervention|brief intervention
4904861|NCT02064972|Graft vs Host Disease|graft vs host disease
4904862|NCT02064972|Hematopoietic Stem Cell Transplant|hematopoietic stem cell transplant
4904863|NCT02064972|Biological Marker|biological marker
4904864|NCT02064972|Circulating Endothelial Cells|circulating endothelial cells
4904865|NCT02064972|Endothelial Dysfunction|endothelial dysfunction
4904866|NCT02064959|Subdural Hematoma|subdural hematoma
4904867|NCT02064959|Traumatic Brain Injury|traumatic brain injury
4904868|NCT02064959|Hypothermia|hypothermia
4904869|NCT02064946|prostate cancer|prostate cancer
4904870|NCT02064946|bone density|bone density
4904871|NCT02064946|vitamin D|vitamin d
4904872|NCT02064946|micronutrients|micronutrients
4904873|NCT02064946|pharmacologic actions|pharmacologic actions
4904874|NCT02064933|Wiskott-Aldrich Syndrome|wiskott-aldrich syndrome
4904875|NCT02064933|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
4904876|NCT02064933|Genetic Therapy|genetic therapy
4904877|NCT02064907|Drug therapy|drug therapy
4904878|NCT02064894|children|children
4904880|NCT02064894|musculoskeletal injury|musculoskeletal injury
4904881|NCT02064894|emergency|emergency
4904882|NCT02064894|opioids|opioids
4904883|NCT02064881|Postprandial lipemia|postprandial lipemia
4904884|NCT02064881|Diabetes|diabetes
4904885|NCT02064881|Metformin glycinate|metformin glycinate
4904886|NCT02064881|oxidized LDL|oxidized ldl
4904887|NCT02064868|AHF,|ahf,
4904888|NCT02064868|RLX030,|rlx030,
4904889|NCT02064868|SOC,|soc,
4904890|NCT02064868|WHF,|whf,
4904891|NCT02064868|RELAX-AHF-EU|relax-ahf-eu
4904892|NCT02064868|Renal Impairment|renal impairment
4904893|NCT02064855|Spinal stenosis|spinal stenosis
4904894|NCT02064855|Spondylolisthesis|spondylolisthesis
4904895|NCT02064855|Degenerative disc disease|degenerative disc disease
4904896|NCT02064855|Spinal fusion|spinal fusion
4904897|NCT02064855|Allograft|allograft
4904898|NCT02064855|Interbody fusion|interbody fusion
4904899|NCT02064842|Healthy|healthy
4904900|NCT02064842|TMC647055|tmc647055
4904901|NCT02064842|TMC435|tmc435
4904902|NCT02064842|Simeprevir|simeprevir
4904903|NCT02064842|Sovriad|sovriad
4904904|NCT02064842|Ritonavir (RTV)|ritonavir (rtv)
4904905|NCT02064829|Metastatic breast cancer|metastatic breast cancer
4904906|NCT02064829|Locally recurrent breast cancer|locally recurrent breast cancer
4904907|NCT02064829|Bioequivalence|bioequivalence
4904908|NCT02064829|IG-001|ig-001
4904909|NCT02064829|nab-paclitaxel|nab-paclitaxel
4904910|NCT02064829|Paclitaxel|paclitaxel
4904911|NCT02064829|Pharmacokinetics|pharmacokinetics
4904912|NCT02064816|Multiple Sclerosis, Relapsing-Remitting|multiple sclerosis, relapsing-remitting
4904913|NCT02064816|Interferon beta 1a|interferon beta 1a
4904914|NCT02064816|Rebif®|rebif®
4904915|NCT02064790|Gabapentin|gabapentin
4904916|NCT02064790|Pregabalin|pregabalin
4904917|NCT02064790|Lyrica|lyrica
4904918|NCT02064790|Neurontin|neurontin
4904919|NCT02064790|lumbar|lumbar
4904920|NCT02064790|cervical|cervical
4904921|NCT02064738|Omega-3 fatty acids|omega-3 fatty acids
4904922|NCT02064738|Omega-6 fatty acids|omega-6 fatty acids
4904923|NCT02064738|aspirin exacerbated respiratory disease|aspirin exacerbated respiratory disease
4904924|NCT02064738|AERD|aerd
4904925|NCT02064738|Samter's Triad|samter's triad
4904926|NCT02064738|nasal polyp|nasal polyp
4904927|NCT02064738|aspirin|aspirin
4904928|NCT02064738|diet|diet
4904929|NCT02064738|leukotriene|leukotriene
4904930|NCT02064725|Endometrial cancer|endometrial cancer
4904931|NCT02064725|Recurrent or persistent endometrial carcinoma|recurrent or persistent endometrial carcinoma
4904932|NCT02064725|Progesterone Receptor Negative|progesterone receptor negative
4904933|NCT02064725|Sodium cridanimod|sodium cridanimod
4904934|NCT02064725|Virexxa|virexxa
4904935|NCT02064712|Continuous Positive Airway Pressure|continuous positive airway pressure
4904936|NCT02064699|Renal transplant|renal transplant
4904937|NCT02064699|CMV|cmv
4904938|NCT02064699|Test QuantiFERON-CMV|test quantiferon-cmv
4904939|NCT02064673|prostate cancer|prostate cancer
4904940|NCT02064673|radical prostatectomy|radical prostatectomy
4904941|NCT02064660|Myopia|myopia
4904942|NCT02064660|Children|children
4904943|NCT02064660|Acupressure|acupressure
4904944|NCT02064660|Refractive error|refractive error
4904945|NCT02064660|Axial length|axial length
4904946|NCT02064660|Korean medicine|korean medicine
4904947|NCT02064647|Insulin Infusion Systems|insulin infusion systems
4904948|NCT02064647|Blood Glucose|blood glucose
4904949|NCT02064634|Shinbaro Capsule|shinbaro capsule
4904950|NCT02064634|Celecoxib|celecoxib
4904951|NCT02064634|Osteoarthritis|osteoarthritis
4904952|NCT02064634|GCSB-5|gcsb-5
4904953|NCT02064634|Discontinuation rate|discontinuation rate
4904954|NCT02064634|Gastrointestinal adverse event|gastrointestinal adverse event
4904955|NCT02064634|NSAIDs|nsaids
4904956|NCT02064634|OASIS|oasis
4904957|NCT02064608|Prostate|prostate
4904958|NCT02064608|Cancer|cancer
4904959|NCT02064608|Prostate Cancer|prostate cancer
4904960|NCT02064608|High Risk|high risk
4904961|NCT02064608|Intermediate Risk|intermediate risk
4904962|NCT02064608|Early disease|early disease
4904963|NCT02064608|Neoadjuvant treatment|neoadjuvant treatment
4904964|NCT02064608|Radical Prostatectomy|radical prostatectomy
4904965|NCT02064595|Tibial fractures.|tibial fractures.
4904966|NCT02064595|Fracture fixation.|fracture fixation.
4904967|NCT02064595|External fixators.|external fixators.
4904968|NCT02064595|Intramedullary.|intramedullary.
4904969|NCT02064595|Quality of life.|quality of life.
4904970|NCT02064582|prostate cancer, enzalutamide, radiation, hormone therapy|prostate cancer, enzalutamide, radiation, hormone therapy
4904971|NCT02064543|Parkinson's disease|parkinson's disease
4904972|NCT02064543|gait|gait
4904973|NCT02064530|TAP block|tap block
4904974|NCT02064530|dexmedetomidine|dexmedetomidine
4904975|NCT02064530|bupivacaine|bupivacaine
4904976|NCT02064530|postoperative analgesia|postoperative analgesia
4904977|NCT02064517|Necrosed Immature monoradicular Teeth , Revascularisation pulpar, MTA apical barrier, Clinical and radiographic success|necrosed immature monoradicular teeth , revascularisation pulpar, mta apical barrier, clinical and radiographic success
4904978|NCT02064504|Respiratory|respiratory
4904979|NCT02064504|GSK961081 (MABA)|gsk961081 (maba)
4904980|NCT02064504|healthy subjects|healthy subjects
4905184|NCT02063529|Irinotecan|irinotecan
4904981|NCT02064504|pharmacokinetics|pharmacokinetics
4904982|NCT02064504|GW685698 (fluticasone furoate)|gw685698 (fluticasone furoate)
4904983|NCT02064491|Non-small cell lung cancer|non-small cell lung cancer
4904984|NCT02064491|EGFR mutant|egfr mutant
4904985|NCT02064491|Erlotinib|erlotinib
4904986|NCT02064491|Treatment Beyond Progression|treatment beyond progression
4904987|NCT02064478|Bone anchored hearing implant|bone anchored hearing implant
4904988|NCT02064478|Bone anchored hearing device|bone anchored hearing device
4904989|NCT02064452|behavior problems|behavior problems
4904990|NCT02064452|children|children
4904991|NCT02064452|prevention|prevention
4904992|NCT02064452|parenting|parenting
4904993|NCT02064452|online|online
4904994|NCT02064452|pediatric|pediatric
4904995|NCT02064439|deep vein thrombosis|deep vein thrombosis
4904996|NCT02064439|pulmonary embolism|pulmonary embolism
4904997|NCT02064439|long-term prevention of recurrent symptomatic VTE|long-term prevention of recurrent symptomatic vte
4904998|NCT02064426|Anemia of CKD on dialysis|anemia of ckd on dialysis
4904999|NCT02064413|Birth control|birth control
4905000|NCT02064400|Rheumatoid arthritis|rheumatoid arthritis
4905001|NCT02064400|Ultrasound|ultrasound
4905002|NCT02064400|Remission|remission
4905003|NCT02064400|Qualitative|qualitative
4905004|NCT02064387|Multiple Myeloma|multiple myeloma
4905005|NCT02064387|BCMA expressing Lymphomas|bcma expressing lymphomas
4905006|NCT02064374|Dolutegravir|dolutegravir
4905007|NCT02064374|drug interaction|drug interaction
4905008|NCT02064374|metformin|metformin
4905009|NCT02064374|pharmacokinetics|pharmacokinetics
4905010|NCT02064374|healthy volunteers|healthy volunteers
4905011|NCT02064361|SCUBA diving|scuba diving
4905012|NCT02064361|exercise,|exercise,
4905013|NCT02064361|microparticles|microparticles
4905014|NCT02064361|neutrophil activation,|neutrophil activation,
4905015|NCT02064361|high intensity exercise|high intensity exercise
4905016|NCT02064335|physical activity coach, diabetic persons, health, behaviour|physical activity coach, diabetic persons, health, behaviour
4905017|NCT02064322|sacroiliac joint fusion|sacroiliac joint fusion
4905018|NCT02064322|SIJ fusion|sij fusion
4905019|NCT02064322|SI joint|si joint
4905020|NCT02064296|Fibromyalgia Chronic Pain|fibromyalgia chronic pain
4905021|NCT02064270|incision care|incision care
4905022|NCT02064270|Total Hip Arthroplasty|total hip arthroplasty
4905023|NCT02064270|Total Knee Arthroplasty|total knee arthroplasty
4905024|NCT02064270|Knee surgery|knee surgery
4905025|NCT02064270|Hip surgery|hip surgery
4905026|NCT02064257|autonomic nervous system|autonomic nervous system
4905027|NCT02064257|auditory processing disorder|auditory processing disorder
4905028|NCT02064257|social behavior|social behavior
4905029|NCT02064244|renal|renal
4905030|NCT02064244|kidney|kidney
4905031|NCT02064244|creatinine|creatinine
4905032|NCT02064244|Inferior Vena Cava (IVC)|inferior vena cava (ivc)
4905033|NCT02064244|Acute Renal Failure (ARF)|acute renal failure (arf)
4905034|NCT02064244|Acute Kidney Injury (AKI)|acute kidney injury (aki)
4905035|NCT02064205|pre-load|pre-load
4905036|NCT02064205|satiety|satiety
4905037|NCT02064205|energy intake|energy intake
4905038|NCT02064205|appetite|appetite
4905039|NCT02064192|defibrillator, implantable cardioverter|defibrillator, implantable cardioverter
4905040|NCT02064192|sudden cardiac death|sudden cardiac death
4905041|NCT02064192|primary prophylaxis|primary prophylaxis
4905042|NCT02064192|risk stratification|risk stratification
4905043|NCT02064179|Congenital heart disease|congenital heart disease
4905044|NCT02064179|Antiplatelet therapy|antiplatelet therapy
4905045|NCT02064179|Aspirin|aspirin
4905046|NCT02064166|Parkinson disease|parkinson disease
4905047|NCT02064166|Multiple system atrophy|multiple system atrophy
4905048|NCT02064166|Intranasal|intranasal
4905049|NCT02064166|Insulin|insulin
4905050|NCT02064153|Dialysate temperature|dialysate temperature
4905051|NCT02064153|Spent dialysate|spent dialysate
4905052|NCT02064153|Toxin removal|toxin removal
4905053|NCT02064153|Intra-dialytic hypotension|intra-dialytic hypotension
4905054|NCT02064153|Inter-compartmental resistance|inter-compartmental resistance
4905055|NCT02064140|ARDS|ards
4905056|NCT02064140|Mechanical Ventilation|mechanical ventilation
4905057|NCT02064140|Tidal volume|tidal volume
4905058|NCT02064140|NMBA|nmba
4905059|NCT02064114|BMI >40|bmi >40
4905060|NCT02064101|Scoliosis|scoliosis
4905061|NCT02064101|EMG|emg
4905062|NCT02064101|Pedicle screw|pedicle screw
4905063|NCT02064101|Neuromonitoring|neuromonitoring
4905064|NCT02064088|Regional anesthesia|regional anesthesia
4905065|NCT02064088|TAP block|tap block
4905066|NCT02064088|Pediatric anesthesia|pediatric anesthesia
4905067|NCT02064088|analgesic effects|analgesic effects
4905068|NCT02064088|pharmacokinetics|pharmacokinetics
4905069|NCT02064075|Subarachnoid hemorrhage|subarachnoid hemorrhage
4905070|NCT02064075|vasospasm|vasospasm
4905071|NCT02064075|Lactated Ringer's solution|lactated ringer's solution
4905072|NCT02064075|Hydroxyethyl starch solution|hydroxyethyl starch solution
4905073|NCT02064062|Achilles Tendinopathy|achilles tendinopathy
4905074|NCT02064062|Autologous Stem Cells|autologous stem cells
4905075|NCT02064062|Musculoskeletal|musculoskeletal
4905076|NCT02064049|Hepatitis C virus|hepatitis c virus
4905077|NCT02064049|People who inject drugs|people who inject drugs
4905079|NCT02064049|Direct acting antiviral (DAA)|direct acting antiviral (daa)
4905080|NCT02064049|Infectious diseases|infectious diseases
4905081|NCT02064049|Prisoners|prisoners
4905082|NCT02064036|Prostate Cancer|prostate cancer
4905083|NCT02064036|Radiotherapy|radiotherapy
4905084|NCT02064036|Androgen Deprivation|androgen deprivation
4905085|NCT02064023|insulin pump|insulin pump
4905086|NCT02064023|CSII|csii
4905087|NCT02064023|multiple daily injections|multiple daily injections
4905088|NCT02064023|MDI|mdi
4905089|NCT02064023|type 1 diabetes|type 1 diabetes
4905090|NCT02064023|type 2 diabetes|type 2 diabetes
4905091|NCT02064023|pregnancy|pregnancy
4905092|NCT02063971|Skin aging|skin aging
4905093|NCT02063971|Soothing activity|soothing activity
4905094|NCT02063971|Hyaluronic acid injections|hyaluronic acid injections
4905095|NCT02063958|Neuroendocrine tumor|neuroendocrine tumor
4905096|NCT02063958|Hsp90|hsp90
4905097|NCT02063945|ADHA|adha
4905098|NCT02063945|ODD|odd
4905099|NCT02063945|Conduct disorder|conduct disorder
4905100|NCT02063945|Aggression|aggression
4905101|NCT02063945|Treatment|treatment
4905102|NCT02063945|Methylphenidate|methylphenidate
4905103|NCT02063945|Risperidone|risperidone
4905104|NCT02063932|mucosal microbiome|mucosal microbiome
4905105|NCT02063932|H.pylori|h.pylori
4905106|NCT02063932|intestinal metaplasia|intestinal metaplasia
4905107|NCT02063932|gastric neoplasia|gastric neoplasia
4905108|NCT02063932|endomicroscopy|endomicroscopy
4905109|NCT02063880|HIV-1|hiv-1
4905110|NCT02063880|IRIS|iris
4905111|NCT02063867|HAI|hai
4905112|NCT02063867|MRSA|mrsa
4905113|NCT02063867|VRE|vre
4905114|NCT02063854|Drug Therapy|drug therapy
4905115|NCT02063802|pediatric obesity|pediatric obesity
4905116|NCT02063802|conjugated linoleic acid|conjugated linoleic acid
4905117|NCT02063802|CLA|cla
4905118|NCT02063802|metformin|metformin
4905119|NCT02063789|Immune Thrombocytopenia|immune thrombocytopenia
4905120|NCT02063789|Immune Thrombocytopenic Purpura|immune thrombocytopenic purpura
4905121|NCT02063789|Idiopathic Thrombocytopenic Purpura|idiopathic thrombocytopenic purpura
4905122|NCT02063789|Human Immunoglobulin|human immunoglobulin
4905123|NCT02063789|ITP|itp
4905124|NCT02063789|IVIg|ivig
4905125|NCT02063789|IgIV|igiv
4905126|NCT02063789|IV-Globulin SN Inj.|iv-globulin sn inj.
4905127|NCT02063776|Haemodiafiltration (HDF)|haemodiafiltration (hdf)
4905128|NCT02063776|Haemodialysis (HD)|haemodialysis (hd)
4905129|NCT02063776|Children|children
4905130|NCT02063776|Carotid intima media thickness|carotid intima media thickness
4905131|NCT02063776|Pulse wave velocity|pulse wave velocity
4905132|NCT02063776|Height standard deviation score|height standard deviation score
4905133|NCT02063763|Adult patients|adult patients
4905134|NCT02063763|Immune primary thrombocytopenia|immune primary thrombocytopenia
4905135|NCT02063763|Splenectomy|splenectomy
4905136|NCT02063763|TPO-mimetics|tpo-mimetics
4905137|NCT02063763|Eltrombopag|eltrombopag
4905138|NCT02063763|Romiplostim|romiplostim
4905139|NCT02063750|Fibromyalgia|fibromyalgia
4905140|NCT02063750|Muscle strength exercises|muscle strength exercises
4905141|NCT02063750|Pain|pain
4905142|NCT02063750|Quality of life|quality of life
4905143|NCT02063737|Shift work|shift work
4905144|NCT02063737|Fatigue|fatigue
4905145|NCT02063737|Sleepiness|sleepiness
4905146|NCT02063737|Injury|injury
4905147|NCT02063724|Invasive Breast Cancer|invasive breast cancer
4905148|NCT02063724|Breast Cancer|breast cancer
4905149|NCT02063724|Immunotherapy|immunotherapy
4905150|NCT02063724|Vaccine|vaccine
4905151|NCT02063724|Dendritic Cell|dendritic cell
4905152|NCT02063711|Prenatal Yoga|prenatal yoga
4905153|NCT02063711|Yoga, Pregnancy|yoga, pregnancy
4905154|NCT02063711|Yoga, Fetal Response|yoga, fetal response
4905155|NCT02063646|polyphenols|polyphenols
4905156|NCT02063646|memory|memory
4905157|NCT02063646|elderly|elderly
4905158|NCT02063633|Thoracic malignancy, irradiation, respiratory gating system PET|thoracic malignancy, irradiation, respiratory gating system pet
4905159|NCT02063620|IVRA, ketamine, lidocaine, ECG|ivra, ketamine, lidocaine, ecg
4905160|NCT02063607|Hepatitis C naive|hepatitis c naive
4905161|NCT02063594|Iodixanol|iodixanol
4905162|NCT02063594|Iodinated Contrast|iodinated contrast
4905163|NCT02063594|Liposome|liposome
4905164|NCT02063594|Computed Tomography|computed tomography
4905165|NCT02063594|X-ray Imaging|x-ray imaging
4905166|NCT02063594|Blood pool agent|blood pool agent
4905167|NCT02063594|Biomarker|biomarker
4905168|NCT02063555|Tuberculosis|tuberculosis
4905169|NCT02063555|BCG|bcg
4905170|NCT02063555|HIV|hiv
4905171|NCT02063555|TB Vaccines|tb vaccines
4905172|NCT02063542|Postoperative cognitive changes|postoperative cognitive changes
4905173|NCT02063542|Acetylcholine in CSF|acetylcholine in csf
4905174|NCT02063542|Surgery|surgery
4905175|NCT02063529|Colorectal cancer|colorectal cancer
4905176|NCT02063529|Metastatic colorectal cancer|metastatic colorectal cancer
4905177|NCT02063529|Liver metastases|liver metastases
4905178|NCT02063529|Liver resection|liver resection
4905179|NCT02063529|Liver ablation|liver ablation
4905180|NCT02063529|Conversion therapy|conversion therapy
4905181|NCT02063529|FOLFOXIRI|folfoxiri
4905182|NCT02063529|Cetuximab|cetuximab
4905183|NCT02063529|Oxaliplatin|oxaliplatin
4905185|NCT02063529|Leucovorin|leucovorin
4905186|NCT02063516|Airway Cuff|airway cuff
4905187|NCT02063516|Guardian|guardian
4905188|NCT02063516|Proseal|proseal
4905189|NCT02063516|Cuff Pressure|cuff pressure
4905190|NCT02063516|laryngeal Mask Airway|laryngeal mask airway
4905191|NCT02063503|prognostic indicator|prognostic indicator
4905192|NCT02063503|nonspecific|nonspecific
4905193|NCT02063503|chronic|chronic
4905194|NCT02063503|low back pain|low back pain
4905195|NCT02063503|Non specific chronic low back pain|non specific chronic low back pain
4905196|NCT02063490|Adherence|adherence
4905197|NCT02063490|dialysis|dialysis
4905198|NCT02063490|intervention|intervention
4905199|NCT02063490|nurse-led|nurse-led
4905200|NCT02063490|phosphate binders|phosphate binders
4905201|NCT02063490|trial|trial
4905202|NCT02063464|Tumorcidal|tumorcidal
4905203|NCT02063464|Monocytes|monocytes
4905204|NCT02063464|Interferons Alpha and Gamma|interferons alpha and gamma
4905205|NCT02063451|Obesity [C18.654.726.500]|obesity [c18.654.726.500]
4905206|NCT02063451|Receptor, Opioid, mu [D12.776.543.750.100.620.550]|receptor, opioid, mu [d12.776.543.750.100.620.550]
4905207|NCT02063451|Brain [A08.186.211]|brain [a08.186.211]
4905208|NCT02063451|Affect [F01.470.047]|affect [f01.470.047]
4905209|NCT02063438|Thoracotomy|thoracotomy
4905210|NCT02063438|Pain|pain
4905211|NCT02063438|Intracostal Suture|intracostal suture
4905212|NCT02063438|Pericostal Suture|pericostal suture
4905213|NCT02063425|Motor recovery|motor recovery
4905214|NCT02063425|Fluoxetine|fluoxetine
4905215|NCT02063425|Transcranial magnetic stimulation|transcranial magnetic stimulation
4905216|NCT02063425|stroke|stroke
4905217|NCT02063399|NPC|npc
4905218|NCT02063399|Cancer screening|cancer screening
4905219|NCT02063399|Plasma EBV DNA|plasma ebv dna
4905220|NCT02063347|innate collateral supply|innate collateral supply
4905221|NCT02063347|collateral|collateral
4905222|NCT02063347|coronary collateral|coronary collateral
4905223|NCT02063347|renal collateral|renal collateral
4905224|NCT02063347|peripheral collateral|peripheral collateral
4905225|NCT02063347|coronary artery disease|coronary artery disease
4905226|NCT02063334|vitamin D3|vitamin d3
4905227|NCT02063334|cholecalciferol|cholecalciferol
4905228|NCT02063334|calcidiol|calcidiol
4905229|NCT02063334|25-hydroxyvitamin D|25-hydroxyvitamin d
4905230|NCT02063334|gene expression|gene expression
4905231|NCT02063334|vitamin D receptor|vitamin d receptor
4905232|NCT02063334|randomized controlled trial|randomized controlled trial
4905233|NCT02063334|men|men
4905234|NCT02063334|adults|adults
4905235|NCT02063321|DME, diabetic retinopathy, diabetes mellitus, epidemiology|dme, diabetic retinopathy, diabetes mellitus, epidemiology
4905236|NCT02063308|Oxaloacetate|oxaloacetate
4905237|NCT02063308|OAA|oaa
4905238|NCT02063308|AD|ad
4905239|NCT02063308|Alzheimer's Disease|alzheimer's disease
4905240|NCT02063295|Beloranib|beloranib
4905241|NCT02063295|ZGN-440|zgn-440
4905242|NCT02063295|ZGN-440 for injectable suspension|zgn-440 for injectable suspension
4905243|NCT02063295|ZGN-433|zgn-433
4905244|NCT02063282|Asymptomatic|asymptomatic
4905245|NCT02063282|Carriage|carriage
4905246|NCT02063282|Colonization|colonization
4905247|NCT02063282|Clostridium difficile|clostridium difficile
4905248|NCT02063282|Colitis|colitis
4905249|NCT02063282|Rectal swab|rectal swab
4905250|NCT02063269|rivastigmine, butyrylcholinesterase, MRI, PET|rivastigmine, butyrylcholinesterase, mri, pet
4905251|NCT02063256|sperm count|sperm count
4905252|NCT02063256|sperm concentration|sperm concentration
4905253|NCT02063256|mobility|mobility
4905254|NCT02063256|diet|diet
4905255|NCT02063256|PUFA (polyunsaturated fatty acids)|pufa (polyunsaturated fatty acids)
4905256|NCT02063243|Keloid, hypertrophic scar|keloid, hypertrophic scar
4905257|NCT02063230|Phase I, healthy, pharmacokinetic, hepatic impairment|phase i, healthy, pharmacokinetic, hepatic impairment
4905258|NCT02063204|Phase I, healthy, pharmacokinetics, renal impairment|phase i, healthy, pharmacokinetics, renal impairment
4905259|NCT02063191|Atrial Fibrillation|atrial fibrillation
4905260|NCT02063191|Bundle Branch Block|bundle branch block
4905261|NCT02063165|Safflower Oil|safflower oil
4905262|NCT02063165|Linoleic Acid|linoleic acid
4905263|NCT02063165|Dyslipidemia|dyslipidemia
4905264|NCT02063165|Hypertension|hypertension
4905265|NCT02063139|Knemometry|knemometry
4905266|NCT02063126|Coenzyme Q10 plus NADH|coenzyme q10 plus nadh
4905267|NCT02063126|maximum Heart Rate|maximum heart rate
4905268|NCT02063126|Fatigue|fatigue
4905269|NCT02063126|Pain|pain
4905270|NCT02063126|Sleep|sleep
4905271|NCT02063113|Multiple myeloma,|multiple myeloma,
4905272|NCT02063113|Older patient,|older patient,
4905273|NCT02063113|Treatment,|treatment,
4905274|NCT02063113|Geriatric assessment|geriatric assessment
4905275|NCT02063100|Glomerulonephritis|glomerulonephritis
4905276|NCT02063100|proteinuria|proteinuria
4905277|NCT02063100|shenyankangfu tablets|shenyankangfu tablets
4905278|NCT02063100|Losartan Potassium|losartan potassium
4905279|NCT02063100|efficacy|efficacy
4905280|NCT02063100|safety|safety
4905281|NCT02063087|Head CT|head ct
4905282|NCT02063087|Head Injury|head injury
4905283|NCT02063087|Pediatric|pediatric
4905284|NCT02063087|Emergency Department|emergency department
4905285|NCT02063087|Decision Aids|decision aids
4905778|NCT02060929|Nasal Guide|nasal guide
4905286|NCT02063087|Shared Decision Making|shared decision making
4905287|NCT02063061|extracorporeal shock wave therapy ESWT|extracorporeal shock wave therapy eswt
4905288|NCT02063061|erectile dysfunction|erectile dysfunction
4905289|NCT02063048|weight loss|weight loss
4905290|NCT02063048|Text Messaging|text messaging
4905291|NCT02063048|Short Message Service|short message service
4905292|NCT02063048|Text Messages|text messages
4905293|NCT02063035|lumbar spine surgery|lumbar spine surgery
4905294|NCT02063035|thoracic spine surgery|thoracic spine surgery
4905295|NCT02063022|Non metastatic Ewing's Sarcoma|non metastatic ewing's sarcoma
4905296|NCT02062944|Liver Transplant|liver transplant
4905297|NCT02062944|Sirolimus|sirolimus
4905298|NCT02062944|Rapamune|rapamune
4905299|NCT02062944|Immunosuppressant Therapy|immunosuppressant therapy
4905300|NCT02062944|Withdrawal|withdrawal
4905301|NCT02062931|Primary Infertility|primary infertility
4905302|NCT02062931|Primary Amenorrhea|primary amenorrhea
4905303|NCT02062931|Sex Steroid Deficiency|sex steroid deficiency
4905304|NCT02062931|Premature Ovarian Failure (POF)|premature ovarian failure (pof)
4905305|NCT02062918|Abdominal belt|abdominal belt
4905306|NCT02062918|Chronic low back pain|chronic low back pain
4905307|NCT02062918|Pain|pain
4905308|NCT02062918|Functional capacity|functional capacity
4905309|NCT02062892|everolimus|everolimus
4905310|NCT02062892|sirolimus|sirolimus
4905311|NCT02062892|tacrolimus|tacrolimus
4905312|NCT02062892|vascular endothelial function|vascular endothelial function
4905313|NCT02062892|kidney|kidney
4905314|NCT02062892|Transplantation|transplantation
4905315|NCT02062892|biomarkers|biomarkers
4905316|NCT02062879|pain|pain
4905317|NCT02062879|trauma|trauma
4905318|NCT02062840|Whole Body Hyperthermia|whole body hyperthermia
4905319|NCT02062840|Functional Magnetic Resonance Imaging|functional magnetic resonance imaging
4905320|NCT02062840|EEG|eeg
4905321|NCT02062827|Glioma|glioma
4905322|NCT02062827|Virus|virus
4905323|NCT02062827|Oncolytic virus|oncolytic virus
4905324|NCT02062827|Gene therapy|gene therapy
4905325|NCT02062827|Immunotherapy|immunotherapy
4905326|NCT02062801|Combined spinal epidural analgesia, labor, fetal bradycardia|combined spinal epidural analgesia, labor, fetal bradycardia
4905327|NCT02062788|Early Recovery After Surgery|early recovery after surgery
4905328|NCT02062788|Oral rehydration solution|oral rehydration solution
4905329|NCT02062788|Insulin resistance|insulin resistance
4905330|NCT02062788|Postoperative complication|postoperative complication
4905331|NCT02062749|Colorectal cancer|colorectal cancer
4905332|NCT02062749|Colon Cancer|colon cancer
4905333|NCT02062749|Pediatric|pediatric
4905334|NCT02062749|Adolescent|adolescent
4905335|NCT02062749|Hyperthermic Intraperitoneal Chemotherapy|hyperthermic intraperitoneal chemotherapy
4905336|NCT02062749|HIPEC|hipec
4905337|NCT02062749|Oxaliplatin|oxaliplatin
4905338|NCT02062749|Eloxatin|eloxatin
4905339|NCT02062736|methadone|methadone
4905340|NCT02062736|heroin addiction|heroin addiction
4905341|NCT02062736|methadone maintenance treatment|methadone maintenance treatment
4905342|NCT02062736|adequate dosage of methadone|adequate dosage of methadone
4905343|NCT02062723|methadone|methadone
4905344|NCT02062723|heroin addiction|heroin addiction
4905345|NCT02062723|methadone maintenance treatment|methadone maintenance treatment
4905346|NCT02062723|adequate dosage of methadone|adequate dosage of methadone
4905347|NCT02062710|cough|cough
4905348|NCT02062710|cough reflex|cough reflex
4905349|NCT02062710|capsaicin|capsaicin
4905350|NCT02062710|diphenhydramine|diphenhydramine
4905351|NCT02062710|phenylephrine|phenylephrine
4905352|NCT02062710|dextromethorphan|dextromethorphan
4905353|NCT02062710|placebo|placebo
4905354|NCT02062697|Neoplasms|neoplasms
4905355|NCT02062697|Glandular and Epithelial|glandular and epithelial
4905356|NCT02062697|Ovarian Neoplasms|ovarian neoplasms
4905357|NCT02062697|Ovarian cancer|ovarian cancer
4905358|NCT02062684|IgAN|igan
4905359|NCT02062684|IgA Nephropathy|iga nephropathy
4905360|NCT02062684|A-623|a-623
4905361|NCT02062684|Blisibimod|blisibimod
4905362|NCT02062684|Kidney Disease|kidney disease
4905363|NCT02062684|Persistent proteinuria|persistent proteinuria
4905364|NCT02062671|ADPKD|adpkd
4905365|NCT02062671|denervation|denervation
4905366|NCT02062671|renal denervation|renal denervation
4905367|NCT02062658|OCD|ocd
4905368|NCT02062645|essential hypertension|essential hypertension
4905369|NCT02062619|Stroke|stroke
4905370|NCT02062619|Aphasia|aphasia
4905371|NCT02062619|Acquired reading disorders|acquired reading disorders
4905372|NCT02062619|Central alexia|central alexia
4905373|NCT02062619|Computer based rehabilitation|computer based rehabilitation
4905374|NCT02062619|Transcranial direct current stimulation|transcranial direct current stimulation
4905375|NCT02062619|tDCS|tdcs
4905376|NCT02062619|Magnetoencephalography|magnetoencephalography
4905377|NCT02062619|MEG|meg
4905378|NCT02062619|Magnetic Resonance Imaging|magnetic resonance imaging
4905379|NCT02062619|MRI|mri
4905380|NCT02062606|Scoliosis|scoliosis
4905381|NCT02062606|Spinal Curvatures|spinal curvatures
4905382|NCT02062606|Spinal Diseases|spinal diseases
4905383|NCT02062606|Adolescent Idiopathic Scoliosis|adolescent idiopathic scoliosis
4905384|NCT02062606|Spinal Deformity|spinal deformity
4905385|NCT02062593|Stable angina|stable angina
4905386|NCT02062593|Percutaneous coronary intervention|percutaneous coronary intervention
4905387|NCT02062593|Optimal medical therapy|optimal medical therapy
4905388|NCT02062593|Sham-control|sham-control
4905389|NCT02062580|Vaccine immunogenicity|vaccine immunogenicity
4905390|NCT02062580|Immune activation|immune activation
4905391|NCT02062554|Myocardial infarction|myocardial infarction
4905392|NCT02062554|Clinical outcome|clinical outcome
4905393|NCT02062554|Flow-mediated dilation|flow-mediated dilation
4905394|NCT02062554|Inflammation|inflammation
4905395|NCT02062541|functional assessment|functional assessment
4905396|NCT02062541|rehabilitation|rehabilitation
4905397|NCT02062541|cross-sectorial cooperation|cross-sectorial cooperation
4905398|NCT02062528|EPA|epa
4905399|NCT02062489|breast cancer,|breast cancer,
4905400|NCT02062489|tamoxifen,|tamoxifen,
4905401|NCT02062489|ER/PR negative, ER-beta positive|er/pr negative, er-beta positive
4905402|NCT02062463|Asthma|asthma
4905403|NCT02062450|Arthroplasty|arthroplasty
4905404|NCT02062450|Hip Replacement|hip replacement
4905405|NCT02062450|Acetabular cup|acetabular cup
4905406|NCT02062450|Dual mobility|dual mobility
4905407|NCT02062450|Hip revision surgery|hip revision surgery
4905408|NCT02062437|Arthroplasty|arthroplasty
4905409|NCT02062437|Hip Replacement|hip replacement
4905410|NCT02062437|Ceramic|ceramic
4905411|NCT02062437|Acetabular cup|acetabular cup
4905412|NCT02062437|Femoral stem|femoral stem
4905413|NCT02062424|ischemic heart disease, dietary guidelines|ischemic heart disease, dietary guidelines
4905414|NCT02062411|attention deficit disorder (ADHD)|attention deficit disorder (adhd)
4905415|NCT02062411|cognitive behavioral therapy (CBT)|cognitive behavioral therapy (cbt)
4905416|NCT02062411|adult|adult
4905417|NCT02062398|PNP|pnp
4905418|NCT02062398|Stimulation|stimulation
4905419|NCT02062398|Peripheral neurostimulation|peripheral neurostimulation
4905420|NCT02062372|7 T MRI|7 t mri
4905421|NCT02062372|Radiotherapy|radiotherapy
4905422|NCT02062372|Glioblastoma|glioblastoma
4905423|NCT02062372|Biopsy|biopsy
4905424|NCT02062359|Malignant Melanoma|malignant melanoma
4905425|NCT02062359|Metastatic Cancer|metastatic cancer
4905426|NCT02062359|Gene Therapy|gene therapy
4905427|NCT02062359|Immunotherapy|immunotherapy
4905428|NCT02062359|Tumor Regression|tumor regression
4905429|NCT02062346|endothelin;|endothelin;
4905430|NCT02062346|blood pressure;|blood pressure;
4905431|NCT02062346|vasculitis|vasculitis
4905432|NCT02062333|dexmedetomidine|dexmedetomidine
4905433|NCT02062333|esmolol|esmolol
4905434|NCT02062333|stapes reflex|stapes reflex
4905435|NCT02062320|Acute Pain Service|acute pain service
4905436|NCT02062320|postoperative analgesia|postoperative analgesia
4905437|NCT02062320|Caesarean Section|caesarean section
4905438|NCT02062320|non-opioid analgesia|non-opioid analgesia
4905439|NCT02062320|opioid analgesia|opioid analgesia
4905440|NCT02062320|epidural analgesia|epidural analgesia
4905441|NCT02062307|Hypogonadism|hypogonadism
4905442|NCT02062307|Asymmetric Dimethyl Arginine|asymmetric dimethyl arginine
4905443|NCT02062307|Osteoprotegerin|osteoprotegerin
4905444|NCT02062307|Fibroblast Growth Factor|fibroblast growth factor
4905445|NCT02062307|Vitamin D|vitamin d
4905446|NCT02062281|Safety|safety
4905447|NCT02062281|Immunogenicity|immunogenicity
4905448|NCT02062281|vaccine|vaccine
4905449|NCT02062281|pneumococcal|pneumococcal
4905450|NCT02062281|influenza|influenza
4905451|NCT02062268|KAP|kap
4905452|NCT02062268|drink driving|drink driving
4905453|NCT02062268|public|public
4905454|NCT02062268|Jiangsu province|jiangsu province
4905455|NCT02062268|China|china
4905456|NCT02062255|Asprin|asprin
4905457|NCT02062255|Omega-3 Free Fatty Acids|omega-3 free fatty acids
4905458|NCT02062255|Obesity|obesity
4905459|NCT02062255|COX-2 inhibitor|cox-2 inhibitor
4905460|NCT02062242|Pelvic Floor|pelvic floor
4905461|NCT02062242|Physical Therapy Specialty|physical therapy specialty
4905462|NCT02062242|Awareness|awareness
4905463|NCT02062242|Electric Stimulation|electric stimulation
4905464|NCT02062242|Palpation|palpation
4905465|NCT02062229|oxidative stress|oxidative stress
4905466|NCT02062229|oxysterols|oxysterols
4905467|NCT02062229|fatty acids|fatty acids
4905468|NCT02062229|seminal fluid|seminal fluid
4905469|NCT02062216|Coronary artery disease|coronary artery disease
4905470|NCT02062216|Percutaneous coronary intervention|percutaneous coronary intervention
4905471|NCT02062216|Inflammatory receptors|inflammatory receptors
4905472|NCT02062203|Akebia|akebia
4905473|NCT02062203|QT interval|qt interval
4905474|NCT02062203|TQT|tqt
4905475|NCT02062203|pharmacokinetic|pharmacokinetic
4905476|NCT02062203|anemia|anemia
4905477|NCT02062203|chronic kidney disease|chronic kidney disease
4905478|NCT02062203|CKD|ckd
4905479|NCT02062203|chronic renal insufficiency|chronic renal insufficiency
4905480|NCT02062203|renal impairment|renal impairment
4905481|NCT02062203|safety|safety
4905482|NCT02062164|psychosocial, healthcare, co-morbidities, extremely obese adolescents|psychosocial, healthcare, co-morbidities, extremely obese adolescents
4905483|NCT02062138|rehabilitation|rehabilitation
4905484|NCT02062138|total knee arthroplasty|total knee arthroplasty
4905485|NCT02062138|range of motion|range of motion
4905486|NCT02062138|continuous passive motion|continuous passive motion
4905979|NCT02060045|bundle|bundle
4905487|NCT02062138|controlled active motion|controlled active motion
4905488|NCT02062138|postoperative physical therapy|postoperative physical therapy
4905489|NCT02062125|scleroderma|scleroderma
4905490|NCT02062125|calcinosis|calcinosis
4905491|NCT02062112|Bowel preparation solutions|bowel preparation solutions
4905492|NCT02062112|Colonoscopy|colonoscopy
4905493|NCT02062112|Polyethylene glycol|polyethylene glycol
4905494|NCT02062086|Sarcopenia|sarcopenia
4905495|NCT02062086|Mass muscle|mass muscle
4905496|NCT02062086|Quality of life|quality of life
4905497|NCT02062073|head lice|head lice
4905498|NCT02062073|Hatchtech|hatchtech
4905499|NCT02062060|Head Lice|head lice
4905500|NCT02062060|Hatchtech|hatchtech
4905501|NCT02062047|Diabetes Mellitus|diabetes mellitus
4905502|NCT02062047|Chronic Periodontitis|chronic periodontitis
4905503|NCT02062047|Root Planing|root planing
4905504|NCT02062047|Cytokines|cytokines
4905505|NCT02062047|microbiology|microbiology
4905506|NCT02062047|Glycated hemoglobin|glycated hemoglobin
4905507|NCT02062047|diabetic subjects|diabetic subjects
4905508|NCT02062034|Oxidative stress|oxidative stress
4905509|NCT02062034|Mitochondrial dysfunction|mitochondrial dysfunction
4905510|NCT02062034|Ubiquinone|ubiquinone
4905511|NCT02062034|Antioxidant combined therapy|antioxidant combined therapy
4905512|NCT02062034|Diabetic retinopathy|diabetic retinopathy
4905513|NCT02062008|Positron Emission Tomography-Magnetic Resonance Imaging|positron emission tomography-magnetic resonance imaging
4905514|NCT02062008|Cardiac Disease|cardiac disease
4905515|NCT02061995|Bone Diseases|bone diseases
4905516|NCT02061995|Metabolic Bone Diseases|metabolic bone diseases
4905517|NCT02061995|Osteoporosis|osteoporosis
4905518|NCT02061995|Bone Fractures|bone fractures
4905519|NCT02061995|Osteoporotic Fractures|osteoporotic fractures
4905520|NCT02061995|Musculoskeletal Diseases|musculoskeletal diseases
4905521|NCT02061982|Do It Yourself (DIY)|do it yourself (diy)
4905522|NCT02061982|Caffeine|caffeine
4905523|NCT02061982|Cognition|cognition
4905524|NCT02061969|nursing home facility|nursing home facility
4905525|NCT02061969|long-term care facility|long-term care facility
4905526|NCT02061969|older patients|older patients
4905527|NCT02061969|elderly patients|elderly patients
4905528|NCT02061969|hyperglycemia|hyperglycemia
4905529|NCT02061969|type 2 diabetes|type 2 diabetes
4905530|NCT02061943|Spasmodic dysphonia|spasmodic dysphonia
4905531|NCT02061943|Laryngeal dystonia|laryngeal dystonia
4905532|NCT02061943|Dystonia|dystonia
4905533|NCT02061943|Severity|severity
4905534|NCT02061930|single tooth|single tooth
4905535|NCT02061930|dental implant|dental implant
4905536|NCT02061930|aesthetics outcome|aesthetics outcome
4905537|NCT02061930|long term|long term
4905538|NCT02061930|soft tissue recession|soft tissue recession
4905539|NCT02061930|pink esthetic score|pink esthetic score
4905540|NCT02061930|white esthetic score|white esthetic score
4905541|NCT02061917|Biomarkers|biomarkers
4905543|NCT02061917|Tobacco-heating|tobacco-heating
4905544|NCT02061917|Smokeless Tobacco|smokeless tobacco
4905545|NCT02061917|Snus|snus
4905546|NCT02061917|Smoking|smoking
4905547|NCT02061917|Exposure|exposure
4905548|NCT02061917|Quality of Life|quality of life
4905549|NCT02061891|Coronary Stenosis|coronary stenosis
4905550|NCT02061891|Coronary Artery Disease|coronary artery disease
4905551|NCT02061891|Acute coronary syndrome|acute coronary syndrome
4905552|NCT02061891|Percutaneous Coronary Intervention|percutaneous coronary intervention
4905553|NCT02061891|Multidetector Computed Tomography|multidetector computed tomography
4905554|NCT02061878|ApoE|apoe
4905555|NCT02061878|beta-amyloid|beta-amyloid
4905556|NCT02061813|Hatchtech|hatchtech
4905557|NCT02061800|Unrelated donor transplant|unrelated donor transplant
4905558|NCT02061800|Allogenic Stem Cell Transplant|allogenic stem cell transplant
4905559|NCT02061800|Adult Bone Marrow Transplant|adult bone marrow transplant
4905560|NCT02061800|Pediatric Bone Marrow Transplant|pediatric bone marrow transplant
4905561|NCT02061800|Related donor transplant|related donor transplant
4905562|NCT02061800|Haploidentical donor transplant|haploidentical donor transplant
4905563|NCT02061800|Peripheral blood stem cell transplantation|peripheral blood stem cell transplantation
4905564|NCT02061800|Non-malignant disease|non-malignant disease
4905565|NCT02061800|Malignant disease|malignant disease
4905566|NCT02061800|Bone marrow failure syndrome|bone marrow failure syndrome
4905567|NCT02061800|Severe Aplastic Anemia|severe aplastic anemia
4905568|NCT02061800|Severe Congenital Neutropenia|severe congenital neutropenia
4905569|NCT02061800|Amegakaryocytic Thrombocytopenia|amegakaryocytic thrombocytopenia
4905570|NCT02061800|Diamond-Blackfan Anemia|diamond-blackfan anemia
4905571|NCT02061800|Schwachman Diamond Syndrome|schwachman diamond syndrome
4905572|NCT02061800|Primary Immunodeficiency Syndrome|primary immunodeficiency syndrome
4905573|NCT02061800|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
4905574|NCT02061800|Histiocytic Syndrome|histiocytic syndrome
4905575|NCT02061800|Familial Hemophagocytic Lymphocytosis|familial hemophagocytic lymphocytosis
4905576|NCT02061800|Lymphohistiocytosis|lymphohistiocytosis
4905577|NCT02061800|Macrophage Activation Syndrome|macrophage activation syndrome
4905578|NCT02061800|Langerhans Cell Histiocytosis (LCH)|langerhans cell histiocytosis (lch)
4905579|NCT02061800|Hemoglobinopathies|hemoglobinopathies
4905580|NCT02061800|Reduced-Intensity Conditioning|reduced-intensity conditioning
4905581|NCT02061800|Sickle Cell Disease|sickle cell disease
4905582|NCT02061800|Sickle Cell-beta-thalassemia|sickle cell-beta-thalassemia
4905583|NCT02061774|acetaminophen in transforaminal lumbar interbody fusion|acetaminophen in transforaminal lumbar interbody fusion
4905584|NCT02061735|skin imaging|skin imaging
4905585|NCT02061735|image analysis|image analysis
4905586|NCT02061735|infrared thermography|infrared thermography
4905587|NCT02061735|infantile hemangioma|infantile hemangioma
4905588|NCT02061735|three dimensional imaging|three dimensional imaging
4905589|NCT02061735|color imaging and analysis|color imaging and analysis
4905590|NCT02061735|propranolol|propranolol
4905591|NCT02061735|timolol|timolol
4905592|NCT02061735|ontogeny|ontogeny
4905593|NCT02061709|Rhinoconjunctivitis|rhinoconjunctivitis
4905594|NCT02061709|Rhinitis|rhinitis
4905595|NCT02061709|Seasonal|seasonal
4905596|NCT02061709|Ragweed|ragweed
4905597|NCT02061709|Allergy|allergy
4905598|NCT02061696|Coronary Artery Disease|coronary artery disease
4905599|NCT02061696|Coronary Disease|coronary disease
4905600|NCT02061696|Heart disease|heart disease
4905601|NCT02061696|Cardiovascular Diseases|cardiovascular diseases
4905602|NCT02061696|Arteriosclerosis|arteriosclerosis
4905603|NCT02061696|Atherosclerosis|atherosclerosis
4905604|NCT02061696|Manual Compression|manual compression
4905605|NCT02061670|Ragweed|ragweed
4905606|NCT02061670|Allergy|allergy
4905607|NCT02061670|rhinoconjunctivitis|rhinoconjunctivitis
4905608|NCT02061670|rhinitis|rhinitis
4905609|NCT02061670|asthma|asthma
4905610|NCT02061618|South Asian|south asian
4905611|NCT02061605|Laparoscopic partial nephrectomy|laparoscopic partial nephrectomy
4905612|NCT02061605|Surgical hemostasis|surgical hemostasis
4905613|NCT02061605|Laser tissue welding|laser tissue welding
4905614|NCT02061605|Tissue sealant|tissue sealant
4905615|NCT02061579|Physical Activity|physical activity
4905616|NCT02061566|Acute kidney injury|acute kidney injury
4905617|NCT02061553|traumatic brain injury|traumatic brain injury
4905618|NCT02061553|TBI|tbi
4905619|NCT02061553|head injury|head injury
4905620|NCT02061553|brain injury|brain injury
4905621|NCT02061553|depression|depression
4905622|NCT02061553|anxiety|anxiety
4905623|NCT02061527|ADM|adm
4905624|NCT02061527|Strattice|strattice
4905625|NCT02061527|Breast reconstruction|breast reconstruction
4905626|NCT02061527|Immediate breast reconstruction|immediate breast reconstruction
4905627|NCT02061527|IBR|ibr
4905628|NCT02061527|Acellular dermal matrix|acellular dermal matrix
4905629|NCT02061527|Biological mesh|biological mesh
4905630|NCT02061527|Randomized controlled trial|randomized controlled trial
4905631|NCT02061527|RCT|rct
4905632|NCT02061527|Breast cancer|breast cancer
4905633|NCT02061527|Implants|implants
4905634|NCT02061527|Mastectomy|mastectomy
4905635|NCT02061527|Direct-to-implant|direct-to-implant
4905636|NCT02061501|visual cognitive deficits|visual cognitive deficits
4905637|NCT02061488|Artificial pancreas, closed loop glucose control, model predictive control|artificial pancreas, closed loop glucose control, model predictive control
4905638|NCT02061475|Lidocaine patches|lidocaine patches
4905639|NCT02061475|Pain|pain
4905640|NCT02061475|Intravenous cannulation|intravenous cannulation
4905641|NCT02061449|Toll-like receptor agonist|toll-like receptor agonist
4905642|NCT02061449|immunostimulation|immunostimulation
4905643|NCT02061436|chronic total occlusion, percutaneous coronary intervention|chronic total occlusion, percutaneous coronary intervention
4905644|NCT02061423|Invasive Breast Cancer|invasive breast cancer
4905645|NCT02061423|Breast Cancer|breast cancer
4905646|NCT02061423|Immunotherapy|immunotherapy
4905647|NCT02061423|Vaccine|vaccine
4905648|NCT02061423|Dendritic Cell|dendritic cell
4905649|NCT02061423|Neoadjuvant|neoadjuvant
4905650|NCT02061410|Elderly|elderly
4905651|NCT02061397|lymphangioleiomyomatosis (LAM)|lymphangioleiomyomatosis (lam)
4905652|NCT02061397|tuberous sclerosis complex (TSC)|tuberous sclerosis complex (tsc)
4905653|NCT02061397|simvastatin|simvastatin
4905654|NCT02061397|sirolimus|sirolimus
4905655|NCT02061397|everolimus|everolimus
4905656|NCT02061384|Infertility|infertility
4905657|NCT02061371|stroke|stroke
4905658|NCT02061371|spasticity|spasticity
4905659|NCT02061371|physiotherapy|physiotherapy
4905660|NCT02061371|virtual reality|virtual reality
4905661|NCT02061358|Dengue|dengue
4905662|NCT02061358|Arbovirus Infections|arbovirus infections
4905663|NCT02061358|Flaviviridae Infections|flaviviridae infections
4905664|NCT02061358|Flavivirus Infections|flavivirus infections
4905665|NCT02061358|Hemorrhagic Fevers, Viral|hemorrhagic fevers, viral
4905666|NCT02061358|RNA Virus Infections|rna virus infections
4905667|NCT02061358|Virus Diseases|virus diseases
4905668|NCT02061358|Pharmaceutical Solutions|pharmaceutical solutions
4905669|NCT02061358|Pharmacologic Actions|pharmacologic actions
4905670|NCT02061358|Therapeutic Uses|therapeutic uses
4905671|NCT02061345|Prostate cancer|prostate cancer
4905672|NCT02061345|Androgen Deprivation Therapy|androgen deprivation therapy
4905673|NCT02061345|Mild Cognitive Impairment|mild cognitive impairment
4905674|NCT02061332|Breast Cancer|breast cancer
4905675|NCT02061332|DCIS|dcis
4905676|NCT02061332|Immunotherapy|immunotherapy
4905677|NCT02061332|Vaccine|vaccine
4905678|NCT02061332|Dendritic Cell|dendritic cell
4905679|NCT02061306|Celiac disease|celiac disease
4905980|NCT02060045|prevention|prevention
4905680|NCT02061306|coeliac disease|coeliac disease
4905681|NCT02061306|microbiome|microbiome
4905682|NCT02061306|gluten|gluten
4905683|NCT02061306|infants|infants
4905684|NCT02061306|pregnancy|pregnancy
4905685|NCT02061306|genetic|genetic
4905686|NCT02061280|Asthma|asthma
4905687|NCT02061280|Clinical Trial Design|clinical trial design
4905688|NCT02061280|Electronic Data Entry|electronic data entry
4905689|NCT02061280|Mobile Devices|mobile devices
4905690|NCT02061280|Home Spirometry|home spirometry
4905691|NCT02061267|Metabolic Syndrome|metabolic syndrome
4905692|NCT02061267|Olive Oil|olive oil
4905693|NCT02061267|Niacin|niacin
4905694|NCT02061254|Venous insufficiency|venous insufficiency
4905695|NCT02061254|Lymphedema|lymphedema
4905696|NCT02061254|Elastograph|elastograph
4905697|NCT02061254|Ultrasonography|ultrasonography
4905698|NCT02061254|Fibrosis|fibrosis
4905699|NCT02061254|Dermis|dermis
4905700|NCT02061254|Hypodermis|hypodermis
4905701|NCT02061254|Skin|skin
4905702|NCT02061241|Cardiac resynchronisation therapy|cardiac resynchronisation therapy
4905703|NCT02061241|Pacing|pacing
4905704|NCT02061215|CYTOF|cytof
4905705|NCT02061215|CMV|cmv
4905706|NCT02061215|PCR|pcr
4905707|NCT02061215|HLA|hla
4905708|NCT02061202|Sickle Cell Disease|sickle cell disease
4905709|NCT02061202|Pain Crisis|pain crisis
4905710|NCT02061202|Painful Crisis|painful crisis
4905711|NCT02061202|Sickle Pain|sickle pain
4905712|NCT02061189|neuromuscular disease, Spinal Muscular Atrophy, Infantile,|neuromuscular disease, spinal muscular atrophy, infantile,
4905713|NCT02061189|motor function measure, Hammersmith scale,|motor function measure, hammersmith scale,
4905714|NCT02061189|rehabilitation program, physical exercise|rehabilitation program, physical exercise
4905715|NCT02061176|Hemorrhoids|hemorrhoids
4905716|NCT02061176|Haemorrhoids|haemorrhoids
4905717|NCT02061176|Transanal Haemorrhoidal Dearterialization|transanal haemorrhoidal dearterialization
4905718|NCT02061176|Transanal Hemorrhoidal Dearterialisation|transanal hemorrhoidal dearterialisation
4905719|NCT02061176|Open Haemorrhoidectomy|open haemorrhoidectomy
4905720|NCT02061176|Open Hemorrhoidectomy|open hemorrhoidectomy
4905721|NCT02061150|Early onset GBS sepsis|early onset gbs sepsis
4905722|NCT02061150|Prevention|prevention
4905723|NCT02061150|Maternal risk factors|maternal risk factors
4905724|NCT02061137|Rett Syndrome (Mecp2 positive)|rett syndrome (mecp2 positive)
4905725|NCT02061137|Fingolimod (FTY 720)|fingolimod (fty 720)
4905726|NCT02061137|BDNF|bdnf
4905727|NCT02061137|Brain Atrophy|brain atrophy
4905728|NCT02061111|Mitochondria Function|mitochondria function
4905729|NCT02061111|TPO-antibodies|tpo-antibodies
4905730|NCT02061111|Subclinical Thyroid Disease|subclinical thyroid disease
4905731|NCT02061111|Thyroid Disease In Pregnancy|thyroid disease in pregnancy
4905732|NCT02061111|Children´s Development|children´s development
4905733|NCT02061098|Pomegranate|pomegranate
4905734|NCT02061098|Cardiovascular|cardiovascular
4905735|NCT02061098|Urolithins|urolithins
4905736|NCT02061098|Microbiota|microbiota
4905737|NCT02061098|Polyphenols|polyphenols
4905738|NCT02061098|Nutraceutical|nutraceutical
4905739|NCT02061098|Dietary supplement|dietary supplement
4905740|NCT02061085|Breast Neoplasm Metastasis|breast neoplasm metastasis
4905741|NCT02061085|Receptor,HER-2|receptor,her-2
4905742|NCT02061085|Eribulin|eribulin
4905743|NCT02061085|Furans, quetones|furans, quetones
4905744|NCT02061085|Antimitotic agent|antimitotic agent
4905745|NCT02061072|pharmacokinetics|pharmacokinetics
4905746|NCT02061072|population pharmacokinetics|population pharmacokinetics
4905747|NCT02061072|hemophilia|hemophilia
4905748|NCT02061072|factor VIII|factor viii
4905749|NCT02061072|factor IX|factor ix
4905750|NCT02061046|Gait|gait
4905751|NCT02061046|Dual task|dual task
4905752|NCT02061033|Hemophilia A|hemophilia a
4905753|NCT02061033|Hemophilia B|hemophilia b
4905754|NCT02061033|Von Willebrand's Disease|von willebrand's disease
4905755|NCT02061033|Endogen thrombin potential|endogen thrombin potential
4905756|NCT02061033|Overall hemostatic potential|overall hemostatic potential
4905757|NCT02061033|Microparticles|microparticles
4905758|NCT02061033|Fibrin clot|fibrin clot
4905759|NCT02061020|delta-9-tetrahydrocannabinol, volunteers, cannabis users|delta-9-tetrahydrocannabinol, volunteers, cannabis users
4905760|NCT02061007|skin cancer|skin cancer
4905761|NCT02060981|Randomized controlled trial|randomized controlled trial
4905762|NCT02060981|Primary medication adherence|primary medication adherence
4905763|NCT02060981|Decision-support tool|decision-support tool
4905764|NCT02060981|Patient-centered outcomes research|patient-centered outcomes research
4905765|NCT02060981|Antihypertensive medications|antihypertensive medications
4905766|NCT02060981|One-on-one patient interviews|one-on-one patient interviews
4905767|NCT02060968|Promus PREMIER|promus premier
4905768|NCT02060968|Routine Clinical Practice|routine clinical practice
4905769|NCT02060955|Glioblastoma multiforme|glioblastoma multiforme
4905770|NCT02060955|Immunotherapy|immunotherapy
4905771|NCT02060955|Bevacizumab/Irinotecan|bevacizumab/irinotecan
4905772|NCT02060955|ALECSAT|alecsat
4905773|NCT02060955|recurrent|recurrent
4905774|NCT02060942|Volume responsiveness mean systemic filling pressure|volume responsiveness mean systemic filling pressure
4905775|NCT02060929|Healthy|healthy
4905776|NCT02060929|Esketamine|esketamine
4905777|NCT02060929|Intranasal|intranasal
4905779|NCT02060929|Pharmacokinetics|pharmacokinetics
4905780|NCT02060903|Head Lice|head lice
4905781|NCT02060903|Hatchtech|hatchtech
4905782|NCT02060890|Glioblastoma|glioblastoma
4905783|NCT02060877|suspected lung cancer|suspected lung cancer
4905784|NCT02060877|diagnostic work-up|diagnostic work-up
4905785|NCT02060864|enzyme|enzyme
4905786|NCT02060864|gluten|gluten
4905787|NCT02060864|food intolerance|food intolerance
4905788|NCT02060851|EPO|epo
4905789|NCT02060851|Intravenous iron|intravenous iron
4905790|NCT02060851|iron storage|iron storage
4905791|NCT02060851|preterm anemia|preterm anemia
4905792|NCT02060812|ultrasound guided axillary nerve block|ultrasound guided axillary nerve block
4905793|NCT02060812|arthroscopic rotator cuff repair|arthroscopic rotator cuff repair
4905794|NCT02060812|ultrasound guided suprascapular nerve block|ultrasound guided suprascapular nerve block
4905795|NCT02060812|rebound phenomenon of pain|rebound phenomenon of pain
4905796|NCT02060799|Dyspnea|dyspnea
4905797|NCT02060799|Emergency Service, Hospital|emergency service, hospital
4905798|NCT02060799|prognosis|prognosis
4905799|NCT02060799|Fatal Outcome|fatal outcome
4905800|NCT02060799|Epidemiology|epidemiology
4905801|NCT02060786|Antiplatelet; clopidogrel; acute coronary syndrome|antiplatelet; clopidogrel; acute coronary syndrome
4905802|NCT02060773|Septic shock|septic shock
4905803|NCT02060773|Early goal directed therapy|early goal directed therapy
4905804|NCT02060773|Fluid resuscitation|fluid resuscitation
4905805|NCT02060773|Hepatic perfusion|hepatic perfusion
4905806|NCT02060773|Indocyanine Green|indocyanine green
4905807|NCT02060760|Prospective cohort study|prospective cohort study
4905808|NCT02060760|Diagnostic accuracy|diagnostic accuracy
4905809|NCT02060760|High sensitivity versus contemporary troponin I assay|high sensitivity versus contemporary troponin i assay
4905810|NCT02060760|Gender|gender
4905811|NCT02060760|Renal Function|renal function
4905812|NCT02060734|Whiplash,|whiplash,
4905813|NCT02060734|injection,|injection,
4905814|NCT02060734|lidocaine,|lidocaine,
4905815|NCT02060734|sham needling|sham needling
4905816|NCT02060721|Chronic thromboembolic pulmonary hypertension (CTEPH)|chronic thromboembolic pulmonary hypertension (cteph)
4905817|NCT02060695|Parkinson disease|parkinson disease
4905818|NCT02060682|Fractional Flow Reserve|fractional flow reserve
4905819|NCT02060682|Rapid Exchange|rapid exchange
4905820|NCT02060682|Catheter|catheter
4905821|NCT02060656|Relapsed or refractory Diffuse Large B-Cell Lymphoma after R-CHOP chemotherapy|relapsed or refractory diffuse large b-cell lymphoma after r-chop chemotherapy
4905822|NCT02060630|Surgical revascularization|surgical revascularization
4905823|NCT02060630|Endovascular revascularization|endovascular revascularization
4905824|NCT02060630|Amputation|amputation
4905825|NCT02060630|Peripheral artery disease|peripheral artery disease
4905826|NCT02060630|Critical limb ischemia|critical limb ischemia
4905827|NCT02060630|claudication|claudication
4905828|NCT02060630|leg pain|leg pain
4905829|NCT02060630|leg ulcer|leg ulcer
4905830|NCT02060630|gangrene|gangrene
4905831|NCT02060617|low back pain|low back pain
4905832|NCT02060617|physical therapy|physical therapy
4905833|NCT02060617|manual therapy|manual therapy
4905834|NCT02060617|manipulation|manipulation
4905835|NCT02060617|exercise|exercise
4905836|NCT02060617|motor control|motor control
4905837|NCT02060617|regional interdependence|regional interdependence
4905838|NCT02060604|ketorolac|ketorolac
4905839|NCT02060604|NSAIDs|nsaids
4905840|NCT02060604|wet macular degeneration|wet macular degeneration
4905841|NCT02060604|choroidal neovascularization|choroidal neovascularization
4905842|NCT02060578|Cancer palliative care|cancer palliative care
4905843|NCT02060578|Dead child|dead child
4905844|NCT02060565|diagnosis|diagnosis
4905845|NCT02060565|survival|survival
4905846|NCT02060565|non-invasive method|non-invasive method
4905847|NCT02060565|cirrhosis|cirrhosis
4905848|NCT02060565|FibroScan|fibroscan
4905849|NCT02060526|sulfoglucosamine sulfohydrolase (SGSH)|sulfoglucosamine sulfohydrolase (sgsh)
4905850|NCT02060526|recombinant human heparan N-sulfatase (rhHNS)|recombinant human heparan n-sulfatase (rhhns)
4905851|NCT02060526|Hunter's Syndrome|hunter's syndrome
4905852|NCT02060526|Shire HGT|shire hgt
4905853|NCT02060526|Lysosomal Storage Disease (LSD)|lysosomal storage disease (lsd)
4905854|NCT02060526|Sanfilippo Syndrome Type A (Sanfilippo A)|sanfilippo syndrome type a (sanfilippo a)
4905855|NCT02060526|enzyme replacement therapy (ERT)|enzyme replacement therapy (ert)
4905856|NCT02060513|Wounded warriors|wounded warriors
4905857|NCT02060513|Battlefield infection|battlefield infection
4905858|NCT02060513|Acinetobacter|acinetobacter
4905859|NCT02060513|ESBL|esbl
4905860|NCT02060513|MRSA|mrsa
4905861|NCT02060513|KPC|kpc
4905862|NCT02060500|GERD|gerd
4905863|NCT02060500|fundoplication|fundoplication
4905864|NCT02060500|cardiaplication|cardiaplication
4905865|NCT02060500|reflux|reflux
4905866|NCT02060487|pulmonary arterial hypertension|pulmonary arterial hypertension
4905867|NCT02060487|pulmonary hypertension|pulmonary hypertension
4905868|NCT02060487|PAH|pah
4905869|NCT02060487|sildenafil|sildenafil
4905870|NCT02060487|revatio|revatio
4905871|NCT02060474|Allan-Herndon-Dudley Syndrome|allan-herndon-dudley syndrome
4905872|NCT02060474|MCT8|mct8
4905873|NCT02060474|Triac|triac
4905874|NCT02060474|Therapeutic Trial|therapeutic trial
4905875|NCT02060448|Non-suicidal self-injury|non-suicidal self-injury
4905876|NCT02060448|Self-injurious behavior|self-injurious behavior
4905877|NCT02060448|NSSI|nssi
4905878|NCT02060448|Anxiety|anxiety
4905879|NCT02060448|Depression|depression
4905880|NCT02060448|Transdiagnostic|transdiagnostic
4905881|NCT02060448|CBT|cbt
4905882|NCT02060448|Unified Protocol|unified protocol
4905883|NCT02060435|diffuse large B-cell lymphoma|diffuse large b-cell lymphoma
4905884|NCT02060435|Ebstein-Barr Virus|ebstein-barr virus
4905885|NCT02060422|Epilepsy|epilepsy
4905886|NCT02060422|Drug-resistant epilepsy|drug-resistant epilepsy
4905887|NCT02060422|Seizure|seizure
4905888|NCT02060422|Mindfulness|mindfulness
4905889|NCT02060422|Stress|stress
4905890|NCT02060422|Psychotherapy|psychotherapy
4905891|NCT02060409|myelodysplastic syndrome|myelodysplastic syndrome
4905892|NCT02060409|decitabine|decitabine
4905893|NCT02060409|spliceosome mutation|spliceosome mutation
4905894|NCT02060383|Cushing's disease|cushing's disease
4905895|NCT02060383|acromegaly|acromegaly
4905896|NCT02060383|pasireotide|pasireotide
4905897|NCT02060383|hyperglycemia|hyperglycemia
4905898|NCT02060370|Genitourinary Cancer|genitourinary cancer
4905899|NCT02060370|Kidney Cancer|kidney cancer
4905900|NCT02060370|Metastatic Renal Cell Carcinoma|metastatic renal cell carcinoma
4905901|NCT02060370|mRCC|mrcc
4905902|NCT02060370|Sunitinib|sunitinib
4905903|NCT02060370|Sunitinib malate|sunitinib malate
4905904|NCT02060370|SUO11248|suo11248
4905905|NCT02060370|Sutent|sutent
4905906|NCT02060370|Questionnaire|questionnaire
4905907|NCT02060370|Survey|survey
4905908|NCT02060357|Diabetes Mellitus|diabetes mellitus
4905909|NCT02060357|PCI|pci
4905910|NCT02060357|Drug eluting stent|drug eluting stent
4905911|NCT02060357|OCT|oct
4905912|NCT02060344|Cardiovascular Disease|cardiovascular disease
4905913|NCT02060344|Hispanic|hispanic
4905914|NCT02060344|Latinos|latinos
4905915|NCT02060331|Nocturia|nocturia
4905916|NCT02060331|Pelvic Organ Prolapse|pelvic organ prolapse
4905917|NCT02060331|Nocturnal Polyuria|nocturnal polyuria
4905918|NCT02060331|Post-obstructive Diuresis|post-obstructive diuresis
4905919|NCT02060318|Crohn Disease|crohn disease
4905920|NCT02060318|Regulatory T-cells|regulatory t-cells
4905921|NCT02060318|Infliximab|infliximab
4905922|NCT02060292|COPD|copd
4905923|NCT02060292|Cognitive Function|cognitive function
4905924|NCT02060292|MRI Brain|mri brain
4905925|NCT02060292|Aortic Stiffness|aortic stiffness
4905926|NCT02060292|Cerebrovascular disease|cerebrovascular disease
4905927|NCT02060279|Obesity|obesity
4905928|NCT02060279|Diabetes Mellitus|diabetes mellitus
4905929|NCT02060279|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
4905930|NCT02060279|Prevention|prevention
4905931|NCT02060279|Behavioral research|behavioral research
4905932|NCT02060279|Metabolic Syndrome|metabolic syndrome
4905933|NCT02060279|Metabolic Disease|metabolic disease
4905934|NCT02060279|Overnutrition|overnutrition
4905935|NCT02060279|Nutrition Disorders|nutrition disorders
4905936|NCT02060279|Overweight|overweight
4905937|NCT02060279|Body weight|body weight
4905938|NCT02060279|Insulin resistance|insulin resistance
4905939|NCT02060279|Carotenoids|carotenoids
4905940|NCT02060279|Dietary Supplement|dietary supplement
4905941|NCT02060279|Physical fitness|physical fitness
4905942|NCT02060279|Sedentary lifestyle|sedentary lifestyle
4905943|NCT02060240|Obesity|obesity
4905944|NCT02060240|Prediabetic State|prediabetic state
4905945|NCT02060240|Sedentary Lifestyle|sedentary lifestyle
4905946|NCT02060240|Insulin Resistance|insulin resistance
4905947|NCT02060240|Endothelium|endothelium
4905948|NCT02060240|Eicosanoids|eicosanoids
4905949|NCT02060240|Nitric Oxide|nitric oxide
4905950|NCT02060240|Regional Blood Flow|regional blood flow
4905951|NCT02060175|Optical coherence tomography, Drug-eluting stent, Strut coverage|optical coherence tomography, drug-eluting stent, strut coverage
4905952|NCT02060162|antiretroviral therapy|antiretroviral therapy
4905953|NCT02060162|Hepatitis C virus|hepatitis c virus
4905954|NCT02060149|Extensively Drug Resistant A. Baumannii|extensively drug resistant a. baumannii
4905955|NCT02060136|Electronic micturition chart, validation|electronic micturition chart, validation
4905956|NCT02060123|Qigong|qigong
4905957|NCT02060123|Telomerase|telomerase
4905958|NCT02060123|Perceived stress|perceived stress
4905959|NCT02060123|RCT|rct
4905960|NCT02060123|Chinese|chinese
4905961|NCT02060123|Abused women|abused women
4905962|NCT02060123|intervention|intervention
4905963|NCT02060123|Depression|depression
4905964|NCT02060110|CRT|crt
4905965|NCT02060110|HEART FAILURE|heart failure
4905966|NCT02060097|Anti-aging|anti-aging
4905967|NCT02060097|High-flavanol cocoa|high-flavanol cocoa
4905968|NCT02060084|preterm;|preterm;
4905969|NCT02060084|Intestinal flora;|intestinal flora;
4905970|NCT02060084|early Micro-feeding|early micro-feeding
4905971|NCT02060084|Feeding intolerance|feeding intolerance
4905972|NCT02060071|aortic stenosis|aortic stenosis
4905973|NCT02060058|hepatitis C virus|hepatitis c virus
4905974|NCT02060058|hepatitis B virus|hepatitis b virus
4905975|NCT02060058|boceprevir|boceprevir
4905976|NCT02060058|null responder|null responder
4905977|NCT02060058|partial responder|partial responder
4905978|NCT02060058|relapser|relapser
4905981|NCT02060045|Disturbance; Heart, Functional, Postoperative, Cardiac Surgery|disturbance; heart, functional, postoperative, cardiac surgery
4905982|NCT02060032|Chronic periodontitis, Local drug delivery,|chronic periodontitis, local drug delivery,
4905983|NCT02060019|Pharmacokinetics|pharmacokinetics
4905984|NCT02060019|Pharmacodynamics|pharmacodynamics
4905985|NCT02060019|Safety|safety
4905986|NCT02060019|Tolerability|tolerability
4905987|NCT02060006|TB|tb
4905988|NCT02060006|IRIS|iris
4905989|NCT02059993|continuous positive airway pressure|continuous positive airway pressure
4905990|NCT02059993|hypertension|hypertension
4905991|NCT02059993|coronary heart disease|coronary heart disease
4905992|NCT02059993|metabolic disorder|metabolic disorder
4905993|NCT02059993|obstructive sleep apnea|obstructive sleep apnea
4905994|NCT02059980|OCD|ocd
4905995|NCT02059980|Trichotillomania|trichotillomania
4905996|NCT02059980|Response inhibition|response inhibition
4905997|NCT02059980|Cognitive training|cognitive training
4905998|NCT02059967|Lung|lung
4905999|NCT02059954|Hysterectomy|hysterectomy
4906000|NCT02059941|Severe traumatic brain injury, ICP, Latin America, outcomes|severe traumatic brain injury, icp, latin america, outcomes
4906001|NCT02059928|fluid resuscitation|fluid resuscitation
4906002|NCT02059928|invasive pressure monitoring|invasive pressure monitoring
4906003|NCT02059915|pharmacokinetics|pharmacokinetics
4906004|NCT02059915|bioequivalence|bioequivalence
4906005|NCT02059915|bioavailability|bioavailability
4906006|NCT02059915|oxycodone|oxycodone
4906007|NCT02059902|Pain management|pain management
4906008|NCT02059902|Narcotic consumption|narcotic consumption
4906009|NCT02059902|Skin graft|skin graft
4906010|NCT02059889|Lung|lung
4906011|NCT02059876|breast cancer|breast cancer
4906012|NCT02059876|dose dense|dose dense
4906013|NCT02059876|neoadjuvant treatment|neoadjuvant treatment
4906014|NCT02059876|pathologic complete response|pathologic complete response
4906015|NCT02059863|cluster randomised trial|cluster randomised trial
4906016|NCT02059863|low and middle income countries|low and middle income countries
4906017|NCT02059863|community based intervention|community based intervention
4906018|NCT02059863|complex intervention|complex intervention
4906019|NCT02059824|Eyelid sensation, aesthesiometer|eyelid sensation, aesthesiometer
4906020|NCT02059811|Kidney Diseases|kidney diseases
4906021|NCT02059811|Renal Insufficiency, Chronic|renal insufficiency, chronic
4906022|NCT02059811|Diet|diet
4906023|NCT02059811|DASH diet|dash diet
4906024|NCT02059811|Hypertension|hypertension
4906025|NCT02059811|Vascular diseases|vascular diseases
4906026|NCT02059811|Cardiovascular Diseases|cardiovascular diseases
4906027|NCT02059811|Blood pressure|blood pressure
4906028|NCT02059798|Myelopathy|myelopathy
4906029|NCT02059785|Pinocembrin for Injection|pinocembrin for injection
4906030|NCT02059785|Placebo|placebo
4906031|NCT02059785|mRS|mrs
4906032|NCT02059759|low-dose interleukin 2|low-dose interleukin 2
4906033|NCT02059746|cesarean section|cesarean section
4906034|NCT02059746|vaginal birth|vaginal birth
4906035|NCT02059746|twins|twins
4906036|NCT02059746|urinary incontinence|urinary incontinence
4906037|NCT02059746|sexuality|sexuality
4906038|NCT02059746|quality of life|quality of life
4906039|NCT02059733|18F-DTBZ|18f-dtbz
4906040|NCT02059720|acute myeloid leukemia|acute myeloid leukemia
4906041|NCT02059720|allogeneic hematopoietic stem cell transplantation|allogeneic hematopoietic stem cell transplantation
4906042|NCT02059720|autologous hematopoietic stem cell transplantation|autologous hematopoietic stem cell transplantation
4906043|NCT02059720|maintenance treatment|maintenance treatment
4906044|NCT02059720|hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
4906045|NCT02059694|Eyelid surgery|eyelid surgery
4906046|NCT02059694|local block/anesthesia|local block/anesthesia
4906047|NCT02059694|hyaluronidase|hyaluronidase
4906048|NCT02059694|Bilateral upper eyelid surgery|bilateral upper eyelid surgery
4906049|NCT02059694|Duke Eye Centre|duke eye centre
4906050|NCT02059694|Duke Aesthetic Center|duke aesthetic center
4906051|NCT02059668|locally advanced head and neck cancer|locally advanced head and neck cancer
4906052|NCT02059668|biomarkers|biomarkers
4906053|NCT02059668|definitive treatment|definitive treatment
4906054|NCT02059668|adjuvant treatment|adjuvant treatment
4906055|NCT02059668|radiochemotherapy|radiochemotherapy
4906056|NCT02059655|Graves' disease|graves' disease
4906057|NCT02059629|Heart failure|heart failure
4906058|NCT02059629|Eluna pacemaker family|eluna pacemaker family
4906059|NCT02059629|Sentus OTW BP L left ventricular lead|sentus otw bp l left ventricular lead
4906060|NCT02059629|Bradycardia|bradycardia
4906061|NCT02059629|SADE-free rate|sade-free rate
4906062|NCT02059603|Electroacupuncture|electroacupuncture
4906063|NCT02059603|Fast track program|fast track program
4906064|NCT02059603|Postoperative ileus|postoperative ileus
4906065|NCT02059603|Laparoscopic surgery|laparoscopic surgery
4906066|NCT02059603|Colorectal surgery|colorectal surgery
4906067|NCT02059603|Randomized controlled trial|randomized controlled trial
4906068|NCT02059603|Hospital stay|hospital stay
4906069|NCT02059590|14C-labeled isavuconazonium sulfate|14c-labeled isavuconazonium sulfate
4906070|NCT02059590|Pyridinylmethyl-14C-labeled isavuconazonium sulfate|pyridinylmethyl-14c-labeled isavuconazonium sulfate
4906071|NCT02059590|Healthy Subjects|healthy subjects
4906072|NCT02059590|BAL8728|bal8728
4906073|NCT02059590|BAL4815|bal4815
4906074|NCT02059577|vitamins|vitamins
4906075|NCT02059577|minerals|minerals
4906076|NCT02059577|essential fatty acids|essential fatty acids
4906077|NCT02059577|Epsom salts|epsom salts
4906078|NCT02059577|carnitine|carnitine
4906079|NCT02059577|digestive enzymes|digestive enzymes
4906080|NCT02059577|gluten-free casein-free diet|gluten-free casein-free diet
4906081|NCT02059564|Diabetes Mellitus|diabetes mellitus
4906082|NCT02059564|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
4906083|NCT02059564|Glucose Metabolism Disorders|glucose metabolism disorders
4906084|NCT02059564|Metabolic Diseases|metabolic diseases
4906085|NCT02059564|Endocrine System Diseases|endocrine system diseases
4906086|NCT02059564|Exendin-4|exendin-4
4906087|NCT02059551|pulmonary embolism|pulmonary embolism
4906088|NCT02059551|magnetic resonance imaging|magnetic resonance imaging
4906089|NCT02059551|venous ultrasonography of the legs|venous ultrasonography of the legs
4906090|NCT02059551|diagnostic performances|diagnostic performances
4906091|NCT02059538|Obesity|obesity
4906092|NCT02059538|Type 2 diabetes|type 2 diabetes
4906093|NCT02059538|Coronary artery diseases|coronary artery diseases
4906094|NCT02059538|Microbiota|microbiota
4906095|NCT02059538|Omics (ie transcriptomics, metabolomics, metagenomics, lipidomics)|omics (ie transcriptomics, metabolomics, metagenomics, lipidomics)
4906096|NCT02059525|observational|observational
4906097|NCT02059525|Belgium|belgium
4906098|NCT02059512|ischemic heart disease,|ischemic heart disease,
4906099|NCT02059512|autologous bone marrow mononuclear cells|autologous bone marrow mononuclear cells
4906100|NCT02059512|coronary artery bypass grafting|coronary artery bypass grafting
4906101|NCT02059460|Terlipressin|terlipressin
4906102|NCT02059460|Acute kidney injury|acute kidney injury
4906103|NCT02059460|Liver transplantation|liver transplantation
4906104|NCT02059460|NGAL|ngal
4906105|NCT02059447|Controlled trial|controlled trial
4906106|NCT02059447|Active control|active control
4906107|NCT02059447|Waiting, non treatment, period|waiting, non treatment, period
4906108|NCT02059447|Mindfulness Based Cognitive Therapy|mindfulness based cognitive therapy
4906109|NCT02059447|Relaxation Therapy|relaxation therapy
4906110|NCT02059421|Johrei therapy|johrei therapy
4906111|NCT02059421|Sleep|sleep
4906112|NCT02059421|CBT-I|cbt-i
4906113|NCT02059421|Critical illness|critical illness
4906114|NCT02059382|daily physical activity|daily physical activity
4906115|NCT02059382|exercise|exercise
4906116|NCT02059382|social support|social support
4906117|NCT02059382|online social network|online social network
4906118|NCT02059369|Atrial fibrillation|atrial fibrillation
4906119|NCT02059369|Recurrence|recurrence
4906120|NCT02059369|CFAE|cfae
4906121|NCT02059369|linear ablation|linear ablation
4906122|NCT02059356|Dementia|dementia
4906123|NCT02059356|Alzheimer's|alzheimer's
4906124|NCT02059356|Alzheimers|alzheimers
4906125|NCT02059356|Cognitive decline|cognitive decline
4906126|NCT02059356|Cognitive impairment|cognitive impairment
4906127|NCT02059356|Memory loss|memory loss
4906128|NCT02059356|Memory disorder|memory disorder
4906129|NCT02059356|Forgetfulness|forgetfulness
4906130|NCT02059356|Confusion|confusion
4906131|NCT02059356|Senile|senile
4906132|NCT02059356|Demented|demented
4906133|NCT02059356|Developmental delay|developmental delay
4906134|NCT02059356|Portal systemic shunting|portal systemic shunting
4906135|NCT02059356|High ammonia level|high ammonia level
4906136|NCT02059356|Elevated ammonia level|elevated ammonia level
4906137|NCT02059343|pharmacokinetics|pharmacokinetics
4906138|NCT02059343|pharmacodynamics|pharmacodynamics
4906139|NCT02059343|safety|safety
4906140|NCT02059343|dexmedetomidine|dexmedetomidine
4906141|NCT02059343|cardiopulmonary bypass|cardiopulmonary bypass
4906142|NCT02059343|children|children
4906143|NCT02059330|Japanese PK-Bridging Study|japanese pk-bridging study
4906144|NCT02059330|dose-proportionality study|dose-proportionality study
4906145|NCT02059330|Palbociclib|palbociclib
4906146|NCT02059330|PD-0332991|pd-0332991
4906147|NCT02059330|healthy volunteers|healthy volunteers
4906148|NCT02059304|cervical length|cervical length
4906149|NCT02059304|prediction of preterm delivery|prediction of preterm delivery
4906150|NCT02059291|Canakinumab, interleukin-1, Hereditary Periodic Fevers, auto-inflammatory diseases|canakinumab, interleukin-1, hereditary periodic fevers, auto-inflammatory diseases
4906151|NCT02059278|Primary open angle glaucoma|primary open angle glaucoma
4906152|NCT02059278|Ocular hypertension|ocular hypertension
4906153|NCT02059239|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
4906154|NCT02059239|Hodgkin's Lymphoma|hodgkin's lymphoma
4906155|NCT02059239|Lymphoma|lymphoma
4906156|NCT02059239|Transplant|transplant
4906157|NCT02059200|Randomised controlled trial|randomised controlled trial
4906158|NCT02059200|Recurrent depression|recurrent depression
4906159|NCT02059200|Mindfulness training|mindfulness training
4906160|NCT02059200|Compassion training (MBCL)|compassion training (mbcl)
4906161|NCT02059200|Fear of Compassion|fear of compassion
4906162|NCT02059200|Added value Compassion|added value compassion
4906163|NCT02059135|Preeclampsia|preeclampsia
4906164|NCT02059135|Preterm preeclampsia|preterm preeclampsia
4906165|NCT02059135|Pregnancy|pregnancy
4906166|NCT02059109|Belmont|belmont
4906167|NCT02059109|Rapid|rapid
4906168|NCT02059109|Infuser|infuser
4906169|NCT02059109|proficiency|proficiency
4906170|NCT02059109|proficient|proficient
4906171|NCT02059109|training|training
4906172|NCT02059096|Multiple Sclerosis|multiple sclerosis
4906173|NCT02059096|Repetitive transcranial magnetic stimulation (rTMS)|repetitive transcranial magnetic stimulation (rtms)
4906174|NCT02059096|Chronic neuropathic pain|chronic neuropathic pain
4906175|NCT02059096|Cortical excitability|cortical excitability
4906176|NCT02059083|adolescent|adolescent
4906177|NCT02059083|cannabis|cannabis
4906178|NCT02059083|biofeedback|biofeedback
4906179|NCT02059070|Nerve Block/adverse effects|nerve block/adverse effects
4906180|NCT02059070|Phrenic Nerve|phrenic nerve
4906181|NCT02059070|Respiratory function|respiratory function
4906182|NCT02059070|Pain measurement|pain measurement
4906183|NCT02059044|patient safety|patient safety
4906184|NCT02059044|pharmacoepidemiology|pharmacoepidemiology
4906185|NCT02059044|health services research|health services research
4906186|NCT02059044|adherence|adherence
4906187|NCT02059044|information technology|information technology
4906188|NCT02059031|integrase inhibitor|integrase inhibitor
4906189|NCT02059031|pharmacokinetics|pharmacokinetics
4906191|NCT02059031|relative bioavailability|relative bioavailability
4906192|NCT02059031|food|food
4906193|NCT02059031|GSK1265744|gsk1265744
4906194|NCT02059005|Addiction|addiction
4906195|NCT02059005|Substance Use Disorder|substance use disorder
4906196|NCT02059005|Rehospitalization|rehospitalization
4906197|NCT02059005|Community Disease Management|community disease management
4906198|NCT02059005|Behavioral Health|behavioral health
4906199|NCT02059005|Community Health Worker|community health worker
4906200|NCT02058992|Drug therapy|drug therapy
4906201|NCT02058966|Entacapone|entacapone
4906202|NCT02058966|COMT val158met|comt val158met
4906203|NCT02058966|Methamphetamine|methamphetamine
4906204|NCT02058953|Melanoma|melanoma
4906205|NCT02058953|skin cancer|skin cancer
4906206|NCT02058953|brain metastases|brain metastases
4906207|NCT02058953|craniotomy|craniotomy
4906208|NCT02058927|HIV|hiv
4906209|NCT02058927|ART|art
4906210|NCT02058927|children|children
4906211|NCT02058914|Sugar sweetened beverages|sugar sweetened beverages
4906212|NCT02058914|metabolism|metabolism
4906213|NCT02058914|endocrine|endocrine
4906214|NCT02058914|lipids|lipids
4906215|NCT02058914|blood glucose|blood glucose
4906216|NCT02058901|sunitinib|sunitinib
4906217|NCT02058901|solid tumors|solid tumors
4906218|NCT02058888|metagenomics|metagenomics
4906219|NCT02058888|antimicrobial resistance|antimicrobial resistance
4906220|NCT02058888|multidrug resistance|multidrug resistance
4906221|NCT02058849|Mucositis|mucositis
4906222|NCT02058849|Beetroot|beetroot
4906223|NCT02058849|Head and neck cancer|head and neck cancer
4906224|NCT02058836|Chronic testicular pain|chronic testicular pain
4906225|NCT02058836|Orchialgia|orchialgia
4906226|NCT02058836|Botulinum toxin|botulinum toxin
4906227|NCT02058836|Botox|botox
4906228|NCT02058836|Urology|urology
4906229|NCT02058823|Hypoxia|hypoxia
4906230|NCT02058823|Sleep apnea|sleep apnea
4906231|NCT02058823|Valsartan|valsartan
4906232|NCT02058823|Amlodipine|amlodipine
4906233|NCT02058823|Healthy subjects|healthy subjects
4906234|NCT02058823|Randomized|randomized
4906235|NCT02058823|Cross-over|cross-over
4906236|NCT02058823|International|international
4906237|NCT02058823|Sympathetic nervous system|sympathetic nervous system
4906238|NCT02058810|nasal high flow oxygen|nasal high flow oxygen
4906239|NCT02058810|cardio-renal syndrom|cardio-renal syndrom
4906240|NCT02058810|heartfailure|heartfailure
4906241|NCT02058797|Procrastination|procrastination
4906242|NCT02058797|Coherence Therapy|coherence therapy
4906243|NCT02058797|Cognitive Behavioral Therapy|cognitive behavioral therapy
4906244|NCT02058797|Repertory Grid Technique|repertory grid technique
4906245|NCT02058797|Cognitive Conflicts|cognitive conflicts
4906246|NCT02058797|Personal Dilemmas|personal dilemmas
4906247|NCT02058771|Action potential duration restitution|action potential duration restitution
4906248|NCT02058771|Ventricular arrhythmia|ventricular arrhythmia
4906249|NCT02058771|Sudden cardiac death|sudden cardiac death
4906250|NCT02058771|Body-surface potential mapping|body-surface potential mapping
4906251|NCT02058771|Electrocardiogram|electrocardiogram
4906252|NCT02058758|Breast cancer|breast cancer
4906253|NCT02058758|Magnetic resonance spectroscopy|magnetic resonance spectroscopy
4906254|NCT02058758|Diffusion weighted imaging|diffusion weighted imaging
4906255|NCT02058745|Neuro-oncology|neuro-oncology
4906256|NCT02058745|Caregivers|caregivers
4906257|NCT02058745|Intervention Research|intervention research
4906258|NCT02058745|Representational Approach|representational approach
4906259|NCT02058745|Cognitive Behavioral Therapy|cognitive behavioral therapy
4906260|NCT02058745|Family|family
4906261|NCT02058745|Internet|internet
4906262|NCT02058680|prostate specific antigen (PSA)|prostate specific antigen (psa)
4906263|NCT02058667|Breast Cancer|breast cancer
4906264|NCT02058667|Paclitaxel|paclitaxel
4906265|NCT02058667|Helical Tomotherapy|helical tomotherapy
4906266|NCT02058667|Chest wall|chest wall
4906267|NCT02058654|Creatine|creatine
4906268|NCT02058654|Functional magnetic resonance imaging (fMRI)|functional magnetic resonance imaging (fmri)
4906269|NCT02058654|Phosphorus-31 magnetic resonance spectroscopy (31P-MRS)|phosphorus-31 magnetic resonance spectroscopy (31p-mrs)
4906270|NCT02058641|cellular accumulation|cellular accumulation
4906271|NCT02058641|macrophage phenotype|macrophage phenotype
4906272|NCT02058641|cantharidin blister|cantharidin blister
4906273|NCT02058641|M1/M2|m1/m2
4906274|NCT02058641|inflammatory mediators|inflammatory mediators
4906275|NCT02058641|Type 2 diabetes mellitus|type 2 diabetes mellitus
4906276|NCT02058641|darapladib|darapladib
4906277|NCT02058641|cytokines|cytokines
4906278|NCT02058628|azelaic acid|azelaic acid
4906279|NCT02058628|Clindamycin|clindamycin
4906280|NCT02058628|Benzoyl peroxide|benzoyl peroxide
4906281|NCT02058628|Acne vulgaris|acne vulgaris
4906282|NCT02058615|Male caregivers|male caregivers
4906283|NCT02058615|Breast cancer|breast cancer
4906284|NCT02058615|Intervention|intervention
4906285|NCT02058615|Online toolkit|online toolkit
4906286|NCT02058602|HRCT|hrct
4906287|NCT02058602|Airway morphometry|airway morphometry
4906288|NCT02058602|Resistivity|resistivity
4906289|NCT02058602|Inhalation Profiles|inhalation profiles
4906290|NCT02058602|Inhaler|inhaler
4906291|NCT02058602|Pharyngometry|pharyngometry
4906292|NCT02058602|Idiopathic Pulmonary Fibrosis (IPF)|idiopathic pulmonary fibrosis (ipf)
4906293|NCT02058589|Immunocompromised|immunocompromised
4906294|NCT02058589|Safety|safety
4906295|NCT02058589|≥ 18 years of age|≥ 18 years of age
4906296|NCT02058589|Renal transplant|renal transplant
4906297|NCT02058589|Adults|adults
4906298|NCT02058589|Immunosuppressed|immunosuppressed
4906299|NCT02058589|Immunogenicity|immunogenicity
4906300|NCT02058589|Herpes zoster|herpes zoster
4906301|NCT02058576|combination of dutasteride 0.5 mg and tamsulosin HCL 0.4 mg|combination of dutasteride 0.5 mg and tamsulosin hcl 0.4 mg
4906302|NCT02058576|Tamsulosin|tamsulosin
4906303|NCT02058576|healthy subject|healthy subject
4906304|NCT02058576|bioequivalence|bioequivalence
4906305|NCT02058576|GI198745|gi198745
4906306|NCT02058576|dutasteride|dutasteride
4906307|NCT02058576|tamsulosin hydrochloride|tamsulosin hydrochloride
4906308|NCT02058563|Measles, mumps and rubella diseases|measles, mumps and rubella diseases
4906309|NCT02058563|Safety|safety
4906310|NCT02058563|Immunogenicity|immunogenicity
4906311|NCT02058524|Ulcerative Colitis|ulcerative colitis
4906312|NCT02058524|Fecal Microbiota Transplantation|fecal microbiota transplantation
4906313|NCT02058498|Liver transplant|liver transplant
4906314|NCT02058498|Physical Activity|physical activity
4906315|NCT02058498|Quality of Life|quality of life
4906316|NCT02058485|hypertension|hypertension
4906317|NCT02058485|dexmedetomidine|dexmedetomidine
4906318|NCT02058485|midazolam|midazolam
4906319|NCT02058485|premedication|premedication
4906320|NCT02058459|Chronic obstructive pulmonary disease, targeted lung denervation, intervention, device, safety, lung function, Holaira|chronic obstructive pulmonary disease, targeted lung denervation, intervention, device, safety, lung function, holaira
4906321|NCT02058433|Chemotherapy|chemotherapy
4906322|NCT02058433|Individual Paclitaxel dose|individual paclitaxel dose
4906323|NCT02058433|pharmacokinetics|pharmacokinetics
4906324|NCT02058420|bone health|bone health
4906325|NCT02058407|food effect|food effect
4906326|NCT02058407|pharmacokinetics|pharmacokinetics
4906327|NCT02058407|GSK2793660|gsk2793660
4906328|NCT02058407|FTIH|ftih
4906329|NCT02058407|pharmacodynamics|pharmacodynamics
4906330|NCT02058407|safety|safety
4906331|NCT02058394|Retained nuclear lens fragments|retained nuclear lens fragments
4906332|NCT02058394|Phacoemulsification|phacoemulsification
4906333|NCT02058394|Cataract Surgery|cataract surgery
4906334|NCT02058368|Benign Prostatic Hyperplasia|benign prostatic hyperplasia
4906335|NCT02058368|Quality of Life|quality of life
4906336|NCT02058342|Prader Willi syndrome|prader willi syndrome
4906337|NCT02058342|Obesity|obesity
4906338|NCT02058342|Childhood|childhood
4906339|NCT02058342|Family|family
4906340|NCT02058342|Interactive games|interactive games
4906341|NCT02058342|Playground games|playground games
4906342|NCT02058342|Exercise routine|exercise routine
4906343|NCT02058329|Hip fracture|hip fracture
4906344|NCT02058329|postoperative complications|postoperative complications
4906345|NCT02058329|Depression|depression
4906346|NCT02058329|Environmental Hazards|environmental hazards
4906347|NCT02058329|FIM scores|fim scores
4906348|NCT02058329|Falls|falls
4906349|NCT02058303|hand surgery|hand surgery
4906350|NCT02058303|wrist surgery|wrist surgery
4906351|NCT02058303|finger surgery|finger surgery
4906352|NCT02058303|anesthesia|anesthesia
4906353|NCT02058303|regional anesthesia|regional anesthesia
4906354|NCT02058303|postoperative pain|postoperative pain
4906355|NCT02058290|laparoscopic colectomy|laparoscopic colectomy
4906356|NCT02058277|bosutinib|bosutinib
4906357|NCT02058277|aprepitant|aprepitant
4906358|NCT02058277|drug interaction|drug interaction
4906359|NCT02058277|healthy volunteers|healthy volunteers
4906360|NCT02058277|pharmacokinetics|pharmacokinetics
4906361|NCT02058277|chronic myelogenous leukemia|chronic myelogenous leukemia
4906362|NCT02058251|Alcohol|alcohol
4906363|NCT02058251|Oxytocin|oxytocin
4906364|NCT02058251|Stress reactivity|stress reactivity
4906365|NCT02058238|Robotic-guided spinal fusions|robotic-guided spinal fusions
4906366|NCT02058238|Scoliosis|scoliosis
4906367|NCT02058238|Kyphoscoliosis|kyphoscoliosis
4906368|NCT02058238|Spinal deformity|spinal deformity
4906369|NCT02058238|Spondylosis|spondylosis
4906370|NCT02058225|Infant Nutrition|infant nutrition
4906371|NCT02058225|Magnetic resonance spectroscopy|magnetic resonance spectroscopy
4906372|NCT02058225|Infant Brain Development|infant brain development
4906373|NCT02058225|Diffusion weighted Imaging|diffusion weighted imaging
4906374|NCT02058225|Diffusion tensor tractography|diffusion tensor tractography
4906375|NCT02058212|ICSI|icsi
4906376|NCT02058212|antioxidants|antioxidants
4906378|NCT02058212|endometriosis|endometriosis
4906379|NCT02058199|gastric bypass|gastric bypass
4906380|NCT02058199|rivaroxaban|rivaroxaban
4906381|NCT02058199|pharmacodynamics|pharmacodynamics
4906382|NCT02058186|Atopic dermatitis, vitamin D supplementation, cathelicidin, Staphylococcus aureus colonization, SCORAD score|atopic dermatitis, vitamin d supplementation, cathelicidin, staphylococcus aureus colonization, scorad score
4906383|NCT02058121|Eating disorders|eating disorders
4906384|NCT02058121|Acceptance and Commitment Therapy|acceptance and commitment therapy
4906385|NCT02058121|Body image|body image
4906386|NCT02058108|Chronic hepatitis B, pediatrics, antiviral treatment, telbivudine|chronic hepatitis b, pediatrics, antiviral treatment, telbivudine
4906387|NCT02058082|Failure to Conceive Due to Infertility of Male Partner|failure to conceive due to infertility of male partner
4906388|NCT02058082|DNA Damage|dna damage
4906389|NCT02058056|Early prophylactic|early prophylactic
4906390|NCT02058056|cranial irradiation|cranial irradiation
4906391|NCT02058056|hippocampal avoidance|hippocampal avoidance
4906392|NCT02058056|limited disease small-cell lung cancer|limited disease small-cell lung cancer
4906393|NCT02058030|ProSeal laryngeal mask airway|proseal laryngeal mask airway
4906394|NCT02058030|Insertion success|insertion success
4906395|NCT02058030|complication|complication
4906396|NCT02058004|Microaspiration|microaspiration
4906397|NCT02058004|ARDS|ards
4906398|NCT02058004|Hospital acquired pneumonia|hospital acquired pneumonia
4906399|NCT02058004|Cricoid pressure|cricoid pressure
4906400|NCT02057978|Late Lumen Loss|late lumen loss
4906401|NCT02057978|MACE|mace
4906402|NCT02057978|Death|death
4906403|NCT02057978|TLF|tlf
4906404|NCT02057978|Thrombosis(definite or probable )|thrombosis(definite or probable )
4906405|NCT02057965|Mesenchymal Stromal Cells|mesenchymal stromal cells
4906406|NCT02057965|Allograft rejection|allograft rejection
4906407|NCT02057965|Fibrosis|fibrosis
4906408|NCT02057952|Weight Management|weight management
4906409|NCT02057952|Diabetes|diabetes
4906410|NCT02057952|Exercise|exercise
4906411|NCT02057952|Portion Control|portion control
4906412|NCT02057952|Multiple Chronic Conditions|multiple chronic conditions
4906413|NCT02057939|Prostate cancer|prostate cancer
4906414|NCT02057939|enzalutamide|enzalutamide
4906415|NCT02057939|ADT|adt
4906416|NCT02057939|radiation|radiation
4906417|NCT02057926|Membrane degradation|membrane degradation
4906418|NCT02057926|Collagen membrane bio-durability|collagen membrane bio-durability
4906419|NCT02057913|Penile neoplasms|penile neoplasms
4906420|NCT02057913|Chemotherapy|chemotherapy
4906421|NCT02057913|Vinflunine|vinflunine
4906422|NCT02057913|Phase II|phase ii
4906423|NCT02057900|Postinfarction heart failure|postinfarction heart failure
4906424|NCT02057900|Transplantation of human embryonic stem cell-derived cardiac progenitors|transplantation of human embryonic stem cell-derived cardiac progenitors
4906425|NCT02057900|Tissue-engineered cellular graft|tissue-engineered cellular graft
4906426|NCT02057900|Fibrin hydrogel|fibrin hydrogel
4906427|NCT02057861|diabetes mellitus|diabetes mellitus
4906428|NCT02057861|neuromuscular blockade|neuromuscular blockade
4906429|NCT02057861|sugammadex|sugammadex
4906430|NCT02057848|carbohydrate, hypoglycemia|carbohydrate, hypoglycemia
4906431|NCT02057822|Vernal keratoconjunctivitis|vernal keratoconjunctivitis
4906432|NCT02057822|Cytokines|cytokines
4906433|NCT02057822|Mediators|mediators
4906434|NCT02057822|Tears|tears
4906435|NCT02057809|Developmental Disabilities|developmental disabilities
4906436|NCT02057809|Family-centered services|family-centered services
4906437|NCT02057809|Pediatric rehabilitation|pediatric rehabilitation
4906438|NCT02057796|HIV-1|hiv-1
4906439|NCT02057796|Tuberculosis|tuberculosis
4906440|NCT02057796|Systematic empiric TB treatment|systematic empiric tb treatment
4906441|NCT02057796|ART|art
4906442|NCT02057796|TB diagnosis|tb diagnosis
4906443|NCT02057796|Xpert MTB/RIF®|xpert mtb/rif®
4906444|NCT02057796|Urine LAM|urine lam
4906445|NCT02057744|Robotic-guided surgery|robotic-guided surgery
4906446|NCT02057744|Minimally invasive spinal surgery|minimally invasive spinal surgery
4906447|NCT02057744|Spinal fusion|spinal fusion
4906448|NCT02057744|Pedicle screws|pedicle screws
4906449|NCT02057718|Bile duct diseases|bile duct diseases
4906450|NCT02057718|Intrahepatic Cholestasis|intrahepatic cholestasis
4906451|NCT02057718|Cholestasis|cholestasis
4906452|NCT02057718|PFIC|pfic
4906453|NCT02057718|Pruritus|pruritus
4906454|NCT02057718|Cholestatic Liver Disease|cholestatic liver disease
4906455|NCT02057705|MTM|mtm
4906456|NCT02057705|myotubular myopathy|myotubular myopathy
4906457|NCT02057705|X-linked centronuclear myopathy|x-linked centronuclear myopathy
4906458|NCT02057705|inherited myopathies|inherited myopathies
4906459|NCT02057705|neuromuscular diseases|neuromuscular diseases
4906460|NCT02057705|hypotonia|hypotonia
4906461|NCT02057705|genetic mutation|genetic mutation
4906562|NCT02057289|pediatric|pediatric
4906462|NCT02057679|Acute cholecystitis.|acute cholecystitis.
4906463|NCT02057679|Amoxicillin clavulanic|amoxicillin clavulanic
4906464|NCT02057653|Goal-directed fluid management|goal-directed fluid management
4906465|NCT02057601|Local anaesthetic infiltration|local anaesthetic infiltration
4906466|NCT02057601|Fractured neck of femur|fractured neck of femur
4906467|NCT02057601|Postoperative pain|postoperative pain
4906468|NCT02057588|ablation|ablation
4906469|NCT02057575|Open Angle Glaucoma|open angle glaucoma
4906470|NCT02057575|Ocular Hypertension|ocular hypertension
4906471|NCT02057575|Intraocular Pressure|intraocular pressure
4906472|NCT02057575|AR13324|ar13324
4906473|NCT02057575|PG324|pg324
4906474|NCT02057562|Adenoma|adenoma
4906475|NCT02057562|Diverticular disease|diverticular disease
4906476|NCT02057562|Diverticulosis|diverticulosis
4906477|NCT02057562|Colorectal carcinoma|colorectal carcinoma
4906478|NCT02057562|Polyp|polyp
4906479|NCT02057536|estrogen receptor positive, aromatase inhibitors, exercise,|estrogen receptor positive, aromatase inhibitors, exercise,
4906480|NCT02057510|Head and Neck Cancer|head and neck cancer
4906481|NCT02057510|Radiation Therapy|radiation therapy
4906482|NCT02057484|long-term follow-up|long-term follow-up
4906483|NCT02057484|liver transplant|liver transplant
4906484|NCT02057484|kidney transplant|kidney transplant
4906485|NCT02057484|Advagraf|advagraf
4906486|NCT02057484|Tacrolimus|tacrolimus
4906487|NCT02057471|Adenocarcinoma|adenocarcinoma
4906488|NCT02057471|Anemia|anemia
4906489|NCT02057471|Blood Transfusion|blood transfusion
4906490|NCT02057471|Colorectal surgery|colorectal surgery
4906491|NCT02057471|Preoperative care|preoperative care
4906492|NCT02057471|Perioperative care|perioperative care
4906493|NCT02057471|Postoperative care|postoperative care
4906494|NCT02057471|Iron|iron
4906495|NCT02057471|Hematinics|hematinics
4906496|NCT02057471|Hepcidin|hepcidin
4906497|NCT02057471|Quality of life|quality of life
4906498|NCT02057471|Postoperative complications|postoperative complications
4906499|NCT02057458|arterial stiffness|arterial stiffness
4906500|NCT02057458|flow-mediated dilation|flow-mediated dilation
4906501|NCT02057458|endothelial function|endothelial function
4906502|NCT02057458|pulse wave velocity|pulse wave velocity
4906503|NCT02057458|inflammation|inflammation
4906504|NCT02057458|oxidative stress|oxidative stress
4906505|NCT02057458|pulmonary function test|pulmonary function test
4906506|NCT02057458|Cystic Fibrosis|cystic fibrosis
4906507|NCT02057458|Lung Disease|lung disease
4906508|NCT02057458|Nitric Oxide|nitric oxide
4906509|NCT02057458|Exercise Capacity|exercise capacity
4906510|NCT02057458|CF|cf
4906511|NCT02057458|Muscle Function|muscle function
4906512|NCT02057458|Sildenafil|sildenafil
4906513|NCT02057458|Viagra|viagra
4906514|NCT02057458|Revatio|revatio
4906515|NCT02057445|cellular therapy|cellular therapy
4906516|NCT02057445|lymphoma|lymphoma
4906517|NCT02057445|lymphoproliferative disorder|lymphoproliferative disorder
4906518|NCT02057432|I-II Breast Cancer|i-ii breast cancer
4906519|NCT02057419|contraception|contraception
4906520|NCT02057419|contraceptive methods|contraceptive methods
4906521|NCT02057419|sexual lubricant|sexual lubricant
4906522|NCT02057419|user experience|user experience
4906523|NCT02057419|adherence|adherence
4906524|NCT02057419|User experience: impact on use of contraceptive methods|user experience: impact on use of contraceptive methods
4906525|NCT02057419|User experience: impact on use of sexual lubricants|user experience: impact on use of sexual lubricants
4906526|NCT02057393|Melanoma|melanoma
4906527|NCT02057393|Sentinel node biopsy|sentinel node biopsy
4906528|NCT02057393|Indocyanine green|indocyanine green
4906529|NCT02057393|Real time lymphangiography|real time lymphangiography
4906530|NCT02057380|Paclitaxel|paclitaxel
4906531|NCT02057380|Linsitinib|linsitinib
4906532|NCT02057380|OSI-774|osi-774
4906533|NCT02057380|Advanced Solid Tumor|advanced solid tumor
4906534|NCT02057380|Tarceva|tarceva
4906535|NCT02057380|Erlotinib|erlotinib
4906536|NCT02057380|OSI-906|osi-906
4906537|NCT02057367|supratentorial brain tumour|supratentorial brain tumour
4906538|NCT02057367|craniotomy|craniotomy
4906539|NCT02057354|Brain|brain
4906540|NCT02057354|Brain-Derived Neurotrophic Factor|brain-derived neurotrophic factor
4906541|NCT02057354|Brain Mapping|brain mapping
4906542|NCT02057354|Cognition|cognition
4906543|NCT02057354|Exercise|exercise
4906544|NCT02057354|Hippocampus|hippocampus
4906545|NCT02057354|Hydrocortisone|hydrocortisone
4906546|NCT02057354|Learning|learning
4906547|NCT02057354|Memory|memory
4906548|NCT02057354|Magnetic Resonance Imaging|magnetic resonance imaging
4906549|NCT02057354|Nerve Growth Factors|nerve growth factors
4906550|NCT02057354|Neuroimaging|neuroimaging
4906551|NCT02057354|Physical Endurance|physical endurance
4906552|NCT02057354|Physical Fitness|physical fitness
4906553|NCT02057354|Resistance Training|resistance training
4906554|NCT02057354|Walking|walking
4906555|NCT02057341|laminopathy|laminopathy
4906556|NCT02057315|Migraine headache|migraine headache
4906557|NCT02057315|Photophobia|photophobia
4906558|NCT02057315|Phonophobia|phonophobia
4906559|NCT02057315|Aura|aura
4906560|NCT02057315|Topical treatment|topical treatment
4906561|NCT02057302|Xuezhikang Dyslipidemia chinese medicine RCT|xuezhikang dyslipidemia chinese medicine rct
4906563|NCT02057289|antifungal|antifungal
4906564|NCT02057289|bone marrow|bone marrow
4906565|NCT02057289|AML or relapsed ALL|aml or relapsed all
4906566|NCT02057263|Vaccine|vaccine
4906567|NCT02057263|Adjuvant|adjuvant
4906568|NCT02057263|Bisphosphonates|bisphosphonates
4906569|NCT02057263|Alendronate|alendronate
4906570|NCT02057263|Hepatitis B vaccine|hepatitis b vaccine
4906571|NCT02057224|Renal denervation|renal denervation
4906572|NCT02057224|Hypertension|hypertension
4906573|NCT02057224|Insulin resistance|insulin resistance
4906574|NCT02057224|Adipose tissue function|adipose tissue function
4906575|NCT02057185|Chronic Hematological Diseases|chronic hematological diseases
4906576|NCT02057185|work|work
4906577|NCT02057185|job|job
4906578|NCT02057172|glycaemic control|glycaemic control
4906579|NCT02057172|HM11260C|hm11260c
4906580|NCT02057172|placebo|placebo
4906581|NCT02057172|safety|safety
4906582|NCT02057172|tolerability|tolerability
4906583|NCT02057172|type 2 diabetes mellitus|type 2 diabetes mellitus
4906584|NCT02057172|efficacy|efficacy
4906585|NCT02057172|T2DM|t2dm
4906586|NCT02057172|glycated haemoglobin (HbA1c)|glycated haemoglobin (hba1c)
4906587|NCT02057172|glycosylated haemoglobin (HbA1c)|glycosylated haemoglobin (hba1c)
4906588|NCT02057172|Glucagon-Like Peptide-1 (GLP-1) agonists|glucagon-like peptide-1 (glp-1) agonists
4906589|NCT02057172|blood sugar levels|blood sugar levels
4906590|NCT02057172|fasting plasma glucose (FPG)|fasting plasma glucose (fpg)
4906591|NCT02057159|Secondary Progress Multiple Sclerosis|secondary progress multiple sclerosis
4906592|NCT02057159|SPMS|spms
4906593|NCT02057159|Multiple Sclerosis|multiple sclerosis
4906594|NCT02057159|NeuroVax|neurovax
4906595|NCT02057146|PSC|psc
4906596|NCT02057146|mother-baby endoscopy|mother-baby endoscopy
4906597|NCT02057146|ERCP|ercp
4906598|NCT02057146|IPMN|ipmn
4906599|NCT02057120|Kinesio Taping, Soccer, Hop Test, Electromyography, Athletic Performance, Muscle Strength Dynamometer|kinesio taping, soccer, hop test, electromyography, athletic performance, muscle strength dynamometer
4906600|NCT02057081|Stress Disorders, Post-traumatic|stress disorders, post-traumatic
4906601|NCT02057081|Mild Traumatic Brain Injury|mild traumatic brain injury
4906602|NCT02057081|Veterans Health|veterans health
4906603|NCT02057081|Veterans|veterans
4906604|NCT02057081|Spouses|spouses
4906605|NCT02057081|Couples|couples
4906606|NCT02057081|Psychotherapy, Group|psychotherapy, group
4906607|NCT02057081|Depression|depression
4906608|NCT02057081|Couples Therapy|couples therapy
4906609|NCT02057081|Family Therapy|family therapy
4906610|NCT02057081|PTSD|ptsd
4906611|NCT02057081|posttraumatic stress disorder|posttraumatic stress disorder
4906612|NCT02057068|Caregivers|caregivers
4906613|NCT02057068|Telemedicine|telemedicine
4906614|NCT02057068|Sleep Disorders|sleep disorders
4906615|NCT02057068|Meditation|meditation
4906616|NCT02057068|Cognitive Behavioral Therapy|cognitive behavioral therapy
4906617|NCT02057068|Activity Enhancement|activity enhancement
4906618|NCT02057068|Technology|technology
4906619|NCT02057068|Non-pharmacological sleep intervention|non-pharmacological sleep intervention
4906620|NCT02057055|Antibacterial soaps|antibacterial soaps
4906621|NCT02057055|Microbiome|microbiome
4906622|NCT02057055|Commensal bacteria|commensal bacteria
4906623|NCT02057055|Pyrosequencing|pyrosequencing
4906624|NCT02057055|Innate immunity|innate immunity
4906625|NCT02057042|Peer Support|peer support
4906626|NCT02057042|cCBT|ccbt
4906627|NCT02057042|primary care|primary care
4906628|NCT02057029|Estrogen Receptor (ER) Positive|estrogen receptor (er) positive
4906629|NCT02057029|Early Stage Breast Cancer|early stage breast cancer
4906630|NCT02057029|Breast Cancer Index|breast cancer index
4906631|NCT02057003|HIV|hiv
4906632|NCT02057003|hepatitis C virus|hepatitis c virus
4906633|NCT02057003|sustained virologic response|sustained virologic response
4906634|NCT02057003|telaprevir|telaprevir
4906635|NCT02057003|boceprevir|boceprevir
4906636|NCT02057003|simeprevir|simeprevir
4906637|NCT02057003|sofosbuvir|sofosbuvir
4906638|NCT02057003|daclatasvir|daclatasvir
4906639|NCT02057003|paritaprevir|paritaprevir
4906640|NCT02057003|pegylated interferon|pegylated interferon
4906641|NCT02057003|ribavirin|ribavirin
4906642|NCT02057003|direct-acting antivirals|direct-acting antivirals
4906643|NCT02057003|dasabuvir|dasabuvir
4906644|NCT02057003|ombitasvir|ombitasvir
4906645|NCT02057003|ledipasvir|ledipasvir
4906646|NCT02057003|velpatasvir|velpatasvir
4906647|NCT02057003|grazoprevir|grazoprevir
4906648|NCT02057003|elbasvir|elbasvir
4906649|NCT02056990|Athletes|athletes
4906650|NCT02056977|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
4906651|NCT02056977|Cardiac Surgical Procedure|cardiac surgical procedure
4906652|NCT02056977|Mechanical Ventilation|mechanical ventilation
4906653|NCT02056977|Postoperative Complications|postoperative complications
4906654|NCT02056977|Positive End-Expiratory Pressure|positive end-expiratory pressure
4906655|NCT02056977|Lung Collapse|lung collapse
4906656|NCT02056977|Respiratory Failure|respiratory failure
4906657|NCT02056977|Electrical Impedance Tomography|electrical impedance tomography
4906658|NCT02056964|Acute Coronary Syndrome|acute coronary syndrome
4906659|NCT02056964|Chest Pain|chest pain
4906660|NCT02056964|Risk Stratification|risk stratification
4906661|NCT02056964|Clinical Decision Aid|clinical decision aid
4906662|NCT02056964|Emergency Department|emergency department
4906663|NCT02056964|Low Risk Chest Pain|low risk chest pain
4906664|NCT02056964|Non Cardiac Chest Pain|non cardiac chest pain
4906665|NCT02056951|Rehabilitation|rehabilitation
4906666|NCT02056951|Treatment Outcome|treatment outcome
4906667|NCT02056951|Interprofessional Relations|interprofessional relations
4906668|NCT02056951|Interdisciplinary Communication|interdisciplinary communication
4906669|NCT02056951|Behavioural Exercise Therapy|behavioural exercise therapy
4906670|NCT02056951|Cognitive Therapy|cognitive therapy
4906671|NCT02056951|Health Education|health education
4906672|NCT02056951|Workplace related information|workplace related information
4906673|NCT02056951|Multicenter Study|multicenter study
4906674|NCT02056938|Transplantation|transplantation
4906675|NCT02056938|kidney|kidney
4906676|NCT02056938|delayed graft function|delayed graft function
4906677|NCT02056938|induction therapy|induction therapy
4906678|NCT02056938|personalized medicine|personalized medicine
4906679|NCT02056938|First kidney transplantation|first kidney transplantation
4906680|NCT02056938|No anti HLA immunization prior transplantation|no anti hla immunization prior transplantation
4906681|NCT02056938|Risk of DGF higher than 40% calculated byt he score DGFS|risk of dgf higher than 40% calculated byt he score dgfs
4906682|NCT02056912|lipodystrophy|lipodystrophy
4906683|NCT02056912|gene|gene
4906684|NCT02056912|inborn error of metabolism|inborn error of metabolism
4906685|NCT02056899|Preterm labor, premature birth, gabapentin|preterm labor, premature birth, gabapentin
4906686|NCT02056886|breast cancer, sentinel lymph node, extemporaneous, OSNA|breast cancer, sentinel lymph node, extemporaneous, osna
4906687|NCT02056873|deep brain stimulation|deep brain stimulation
4906688|NCT02056873|DBS|dbs
4906689|NCT02056873|tourette|tourette
4906690|NCT02056873|tourette's|tourette's
4906691|NCT02056873|tourette syndrome|tourette syndrome
4906692|NCT02056873|TS|ts
4906693|NCT02056860|cystic fibrosis|cystic fibrosis
4906694|NCT02056847|Livalo, pitavastatin, hyperlipidemia, IFG|livalo, pitavastatin, hyperlipidemia, ifg
4906695|NCT02056821|stroke|stroke
4906696|NCT02056821|transcranial doppler|transcranial doppler
4906697|NCT02056821|cerebral blood flow|cerebral blood flow
4906698|NCT02056821|cardiac output|cardiac output
4906699|NCT02056821|non-invasive hemodynamic monitoring|non-invasive hemodynamic monitoring
4906700|NCT02056782|Acute Myeloid Leukemia|acute myeloid leukemia
4906701|NCT02056782|AML|aml
4906702|NCT02056782|ODSH|odsh
4906703|NCT02056782|ODSH-AML|odsh-aml
4906704|NCT02056782|Cantex|cantex
4906705|NCT02056756|REFRACTORY OR RELAPSED|refractory or relapsed
4906706|NCT02056756|CBD|cbd
4906707|NCT02056730|chronic hemodialysis patients|chronic hemodialysis patients
4906708|NCT02056730|Hyperparathyroidism|hyperparathyroidism
4906709|NCT02056730|Regpara|regpara
4906710|NCT02056730|FGF 23|fgf 23
4906711|NCT02056704|Dialysis Fistula|dialysis fistula
4906712|NCT02056704|Dialysis Graft|dialysis graft
4906713|NCT02056704|Stenosis|stenosis
4906714|NCT02056704|Intravascular Ultrasound|intravascular ultrasound
4906715|NCT02056704|Angiography|angiography
4906716|NCT02056691|Resectable|resectable
4906717|NCT02056691|non-metastatic|non-metastatic
4906718|NCT02056691|colorectal|colorectal
4906719|NCT02056691|carcinoma|carcinoma
4906720|NCT02056691|cancer|cancer
4906721|NCT02056691|neoplasm|neoplasm
4906722|NCT02056691|exercise|exercise
4906723|NCT02056691|effects|effects
4906724|NCT02056691|program|program
4906725|NCT02056691|pre-operative|pre-operative
4906726|NCT02056691|proliferation|proliferation
4906727|NCT02056691|diagnosed|diagnosed
4906728|NCT02056691|surgery|surgery
4906729|NCT02056691|biopsy|biopsy
4906730|NCT02056691|muscle|muscle
4906731|NCT02056691|signalling|signalling
4906732|NCT02056691|IGF1|igf1
4906733|NCT02056691|ki67|ki67
4906734|NCT02056691|p53|p53
4906735|NCT02056691|response|response
4906736|NCT02056691|training|training
4906737|NCT02056691|biochemical|biochemical
4906738|NCT02056691|pathways|pathways
4906739|NCT02056691|glucose|glucose
4906740|NCT02056678|cholecystitis|cholecystitis
4906741|NCT02056678|cholelithiasis|cholelithiasis
4906742|NCT02056678|obstructive sleep apnea|obstructive sleep apnea
4906743|NCT02056678|acetaminophen|acetaminophen
4906744|NCT02056665|Angelman Syndrome|angelman syndrome
4906745|NCT02056665|EFFICACY|efficacy
4906746|NCT02056665|SAFETY|safety
4906747|NCT02056665|MINOCYCLINE|minocycline
4906748|NCT02056665|Pediatrics population|pediatrics population
4906749|NCT02056665|Rare diseases|rare diseases
4906750|NCT02056652|Preterm birth|preterm birth
4906751|NCT02056652|Preterm delivery|preterm delivery
4906752|NCT02056652|short cervix|short cervix
4906753|NCT02056652|pessary|pessary
4906754|NCT02056639|Premature birth|premature birth
4906755|NCT02056639|Premature delivery|premature delivery
4906756|NCT02056639|Short cervix|short cervix
4906757|NCT02056639|Pessary|pessary
4906758|NCT02056626|hypertension|hypertension
4906759|NCT02056613|Blood Donation|blood donation
4906760|NCT02056613|Tissue Procurement|tissue procurement
4906761|NCT02056613|Cellular Therapies|cellular therapies
4906762|NCT02056587|renal cell carcinoma|renal cell carcinoma
4906763|NCT02056587|kidney cancer|kidney cancer
4906764|NCT02056587|bevacizumab failure|bevacizumab failure
4906765|NCT02056587|everolimus|everolimus
4906766|NCT02056574|Endovascular repair|endovascular repair
4906767|NCT02056574|Subarachnoid hemorrhage|subarachnoid hemorrhage
4906768|NCT02056574|Ruptured intracranial aneurysm|ruptured intracranial aneurysm
4906769|NCT02056574|Stroke|stroke
4906770|NCT02056574|Coiling|coiling
4906771|NCT02056574|NA-1|na-1
4906772|NCT02056561|Anesthesia|anesthesia
4906773|NCT02056561|Oxidants|oxidants
4906774|NCT02056561|Antioxidants|antioxidants
4906775|NCT02056548|preemptive antiviral treatment|preemptive antiviral treatment
4906776|NCT02056548|lymphoma|lymphoma
4906777|NCT02056548|chronic hepatitis B|chronic hepatitis b
4906778|NCT02056535|Alcohol|alcohol
4906779|NCT02056535|SBIRT (Screening, Brief Intervention, Referral to Treatment)|sbirt (screening, brief intervention, referral to treatment)
4906780|NCT02056522|Melanoma|melanoma
4906781|NCT02056522|Skin Cancer|skin cancer
4906782|NCT02056509|cardiopulmonary resuscitation,Ventilation|cardiopulmonary resuscitation,ventilation
4906783|NCT02056496|Pomegranate|pomegranate
4906784|NCT02056496|Ellagic acid|ellagic acid
4906785|NCT02056496|Pharmacokinetics|pharmacokinetics
4906786|NCT02056496|Urolithins|urolithins
4906787|NCT02056496|Bioavailability|bioavailability
4906788|NCT02056483|neoplasms|neoplasms
4906789|NCT02056483|rehabilitation|rehabilitation
4906790|NCT02056483|anxiety|anxiety
4906791|NCT02056483|depression|depression
4906792|NCT02056483|adverse effects|adverse effects
4906793|NCT02056483|health behavior|health behavior
4906794|NCT02056457|Responsible fatherhood|responsible fatherhood
4906795|NCT02056457|Healthy marriage|healthy marriage
4906796|NCT02056457|Healthy relationships|healthy relationships
4906797|NCT02056457|Parenting|parenting
4906798|NCT02056457|Economic self-sufficiency|economic self-sufficiency
4906799|NCT02056444|Blood conservation|blood conservation
4906800|NCT02056444|Tranexamic acid|tranexamic acid
4906801|NCT02056444|Total hip arthroplasty|total hip arthroplasty
4906802|NCT02056431|Diabetes|diabetes
4906803|NCT02056431|Neuropathy|neuropathy
4906804|NCT02056431|Patient-Reported Outcomes|patient-reported outcomes
4906805|NCT02056405|Postoperative Ileus|postoperative ileus
4906806|NCT02056405|Mosapride|mosapride
4906807|NCT02056405|Colorectal laparoscopic surgery|colorectal laparoscopic surgery
4906808|NCT02056405|Prolonged postoperative ileus|prolonged postoperative ileus
4906809|NCT02056392|Phase I, healthy, pharmacokinetics|phase i, healthy, pharmacokinetics
4906810|NCT02056379|stridor|stridor
4906811|NCT02056379|laryngitis|laryngitis
4906812|NCT02056379|budesonide|budesonide
4906813|NCT02056379|dexamethasone|dexamethasone
4906814|NCT02056379|children|children
4906815|NCT02056366|Cardiac Autonomic Neuropathy|cardiac autonomic neuropathy
4906816|NCT02056353|Software|software
4906817|NCT02056353|Algorithm|algorithm
4906818|NCT02056353|Cardiac surgery|cardiac surgery
4906819|NCT02056327|Oral Appliance|oral appliance
4906820|NCT02056262|Bacteria|bacteria
4906821|NCT02056262|microbial community|microbial community
4906822|NCT02056262|hygiene|hygiene
4906823|NCT02056249|hypoglycemia|hypoglycemia
4906824|NCT02056249|Positron Emission Tomography|positron emission tomography
4906825|NCT02056249|norepinephrine transporter|norepinephrine transporter
4906826|NCT02056236|Cardiac arrest|cardiac arrest
4906827|NCT02056236|Postanoxic encephalopathy|postanoxic encephalopathy
4906828|NCT02056236|Electroencephalographic status epilepticus|electroencephalographic status epilepticus
4906829|NCT02056236|EEG monitoring|eeg monitoring
4906830|NCT02056236|Anti-epileptic drugs|anti-epileptic drugs
4906831|NCT02056223|Patent ductus arteriosus|patent ductus arteriosus
4906832|NCT02056223|Preterm infant|preterm infant
4906833|NCT02056223|Paracetamol|paracetamol
4906834|NCT02056223|Ibuprofen|ibuprofen
4906835|NCT02056210|Stem cells|stem cells
4906836|NCT02056210|Bone marrow|bone marrow
4906837|NCT02056171|delirium|delirium
4906838|NCT02056171|pediatrics|pediatrics
4906839|NCT02056171|critical care|critical care
4906840|NCT02056171|quetiapine|quetiapine
4906841|NCT02056158|HIV|hiv
4906842|NCT02056158|COPD|copd
4906843|NCT02056158|Emphysema|emphysema
4906844|NCT02056158|Smoking|smoking
4906845|NCT02056119|Ventilators, mechanical|ventilators, mechanical
4906846|NCT02056119|Aerosol Drug Therapy|aerosol drug therapy
4906847|NCT02056119|Nebulizers|nebulizers
4906848|NCT02056119|Equipment Contamination|equipment contamination
4906849|NCT02056119|vibrating mesh nebulizer|vibrating mesh nebulizer
4906850|NCT02056119|jet nebulizer|jet nebulizer
4906851|NCT02056119|mechanical ventilation|mechanical ventilation
4906852|NCT02056119|ventilator associated event|ventilator associated event
4906853|NCT02056119|ventilator associated tracheobronchitis|ventilator associated tracheobronchitis
4906854|NCT02056106|depression, Uganda, HIV, task-shifting, condom use, adherence|depression, uganda, hiv, task-shifting, condom use, adherence
4906855|NCT02056093|NAVA - PAV- Breathing Variability - Asynchrony|nava - pav- breathing variability - asynchrony
4906856|NCT02056080|Breast Neoplasm|breast neoplasm
4906857|NCT02056080|Receptor,HER2|receptor,her2
4906858|NCT02056080|Antineoplastic agent|antineoplastic agent
4906859|NCT02056080|Antibodies, monoclonal|antibodies, monoclonal
4906860|NCT02056080|Trastuzumab, Lapatinib|trastuzumab, lapatinib
4906861|NCT02056080|Protein kinase inhibitors|protein kinase inhibitors
4906862|NCT02056080|quinazolines|quinazolines
4906863|NCT02056054|Autoimmune hepatitis|autoimmune hepatitis
4906864|NCT02056054|Liver transplantation|liver transplantation
4906865|NCT02056054|Hepatitis C|hepatitis c
4906866|NCT02056002|Peer-driven intervention|peer-driven intervention
4906867|NCT02056002|Interactive voice response system|interactive voice response system
4906868|NCT02056002|Continuous Positive Airway Pressure therapy and adherence|continuous positive airway pressure therapy and adherence
4906869|NCT02055976|PF-04950615|pf-04950615
4906870|NCT02055976|Japan|japan
4906871|NCT02055963|Head And Neck Cancer|head and neck cancer
4906872|NCT02055963|Postsurgical symptom reduction|postsurgical symptom reduction
4906873|NCT02055963|Minocycline|minocycline
4906874|NCT02055963|Dynacin|dynacin
4906875|NCT02055963|Minocin|minocin
4906876|NCT02055963|Minocin PAC|minocin pac
4906877|NCT02055963|Myrac|myrac
4906878|NCT02055963|Solodyn|solodyn
4906879|NCT02055963|Placebo|placebo
4906880|NCT02055963|Sugar pill|sugar pill
4906881|NCT02055963|Questionnaires|questionnaires
4906882|NCT02055963|Surveys|surveys
4906883|NCT02055950|Kidney transplant|kidney transplant
4906884|NCT02055950|Marginal donors|marginal donors
4906885|NCT02055950|Pulse perfusion|pulse perfusion
4906886|NCT02055950|Graft function|graft function
4906887|NCT02055937|mastectomy, reconstruction|mastectomy, reconstruction
4906888|NCT02055924|Bruton's tyrosine kinase (BTK) Inhibition in B-cell Lymphomas|bruton's tyrosine kinase (btk) inhibition in b-cell lymphomas
4906889|NCT02055911|diabetic macular edema|diabetic macular edema
4906890|NCT02055911|intravitreal ranibizumab|intravitreal ranibizumab
4906891|NCT02055911|f retinal ganglion cell|f retinal ganglion cell
4906892|NCT02055872|Edema|edema
4906893|NCT02055872|Hypoproteinemia|hypoproteinemia
4906894|NCT02055872|Albumin|albumin
4906895|NCT02055872|Diuresis|diuresis
4906896|NCT02055872|Critical illness|critical illness
4906897|NCT02055859|acoustic neuromas|acoustic neuromas
4906898|NCT02055859|radiosurgery|radiosurgery
4906899|NCT02055859|hearing preservation|hearing preservation
4906900|NCT02055846|Androgen-independent prostate cancer|androgen-independent prostate cancer
4906901|NCT02055807|Atelectasis|atelectasis
4906902|NCT02055807|Ultrasound|ultrasound
4906903|NCT02055807|Recruitment maneuver|recruitment maneuver
4906904|NCT02055807|Positive end-expiratory pressure|positive end-expiratory pressure
4906905|NCT02055794|perineal wound|perineal wound
4906906|NCT02055794|perineal tear|perineal tear
4906907|NCT02055794|perineum|perineum
4906908|NCT02055794|pain|pain
4906909|NCT02055794|childbirth|childbirth
4906910|NCT02055781|Myelofibrosis|myelofibrosis
4906911|NCT02055781|Post-Polycythemia Vera Myelofibrosis|post-polycythemia vera myelofibrosis
4906912|NCT02055781|Post-Essential Thrombocythemia Myelofibrosis|post-essential thrombocythemia myelofibrosis
4906913|NCT02055781|Primary Myelofibrosis|primary myelofibrosis
4906914|NCT02055781|Polycythemia|polycythemia
4906915|NCT02055781|Polycythemia Vera|polycythemia vera
4906916|NCT02055781|Thrombocythemia, Essential|thrombocythemia, essential
4906917|NCT02055781|Thrombocythemia|thrombocythemia
4906918|NCT02055781|Myeloproliferative Disorders|myeloproliferative disorders
4906919|NCT02055781|Bone Marrow Disease|bone marrow disease
4906920|NCT02055781|Hematologic Diseases|hematologic diseases
4906921|NCT02055781|Blood Platelet Disorders|blood platelet disorders
4906922|NCT02055781|Hemorrhagic Disorders|hemorrhagic disorders
4906923|NCT02055781|Splenomegaly|splenomegaly
4906924|NCT02055781|Pacritinib|pacritinib
4906925|NCT02055781|MPN-SAF|mpn-saf
4906926|NCT02055781|MPN-SAF TSS|mpn-saf tss
4906927|NCT02055781|Anemia|anemia
4906928|NCT02055781|Myeloproliferative|myeloproliferative
4906929|NCT02055781|Myeloproliferative Neoplasm|myeloproliferative neoplasm
4906930|NCT02055781|Spleen|spleen
4906931|NCT02055781|Spleen volume|spleen volume
4906932|NCT02055781|Thrombocytopenia|thrombocytopenia
4906933|NCT02055781|SB1518|sb1518
4906934|NCT02055755|Diabetes|diabetes
4906935|NCT02055755|Wounds|wounds
4906936|NCT02055755|Wound Healing|wound healing
4906937|NCT02055755|Diabetic Foot Ulcer|diabetic foot ulcer
4906938|NCT02055755|DFU|dfu
4906939|NCT02055755|Clinical Decision Support|clinical decision support
4906940|NCT02055729|bedsore|bedsore
4906941|NCT02055729|bacteria|bacteria
4906942|NCT02055729|colonization|colonization
4906943|NCT02055729|ecology|ecology
4906944|NCT02055703|Healthy Subjects|healthy subjects
4906945|NCT02055690|Advanced Recurrent Ovarian Cancer|advanced recurrent ovarian cancer
4906946|NCT02055690|Pazopanib|pazopanib
4906947|NCT02055690|Votrient|votrient
4906948|NCT02055690|Fosbretabulin|fosbretabulin
4906949|NCT02055677|personality profiles|personality profiles
4906950|NCT02055677|values|values
4906951|NCT02055677|empathy|empathy
4906952|NCT02055677|quality of life|quality of life
4906953|NCT02055677|vegetarians|vegetarians
4906954|NCT02055677|vegans|vegans
4906955|NCT02055651|Worksite|worksite
4906956|NCT02055651|Cardiovascular|cardiovascular
4906957|NCT02055651|Epidemiology|epidemiology
4906958|NCT02055651|Risk factors|risk factors
4906959|NCT02055638|Intermittent Explosive Disorder|intermittent explosive disorder
4906960|NCT02055638|IED|ied
4906961|NCT02055638|Aggression|aggression
4906962|NCT02055638|SRX246|srx246
4906963|NCT02055638|Vasopressin 1a Receptor Antagonist|vasopressin 1a receptor antagonist
4906964|NCT02055638|V1a|v1a
4906965|NCT02055625|Graft-versus-host-disease|graft-versus-host-disease
4906966|NCT02055625|Immune system diseases|immune system diseases
4906967|NCT02055625|Oral|oral
4906968|NCT02055612|wet AMD|wet amd
4906969|NCT02055612|epidemiology|epidemiology
4906970|NCT02055599|Wound|wound
4906971|NCT02055599|Wound Healing|wound healing
4906972|NCT02055599|Pressure Ulcers|pressure ulcers
4906973|NCT02055599|Chronic Wounds|chronic wounds
4906974|NCT02055599|Clinical Decision Support|clinical decision support
4906975|NCT02055573|Abusive Head Trauma|abusive head trauma
4906976|NCT02055573|Early Literacy|early literacy
4906977|NCT02055573|Parental Education|parental education
4906978|NCT02055573|Low Income|low income
4906979|NCT02055560|colorectal|colorectal
4906980|NCT02055560|OnDose|ondose
4906981|NCT02055560|MyCare|mycare
4906982|NCT02055560|5-FU|5-fu
4906983|NCT02055560|pharmacokinetics|pharmacokinetics
4906984|NCT02055560|exposure|exposure
4906985|NCT02055560|optimization|optimization
4906986|NCT02055560|dose adjustment|dose adjustment
4906987|NCT02055521|Composite tissue allograft|composite tissue allograft
4906988|NCT02055521|operational tolerance|operational tolerance
4906989|NCT02055521|skin rejection|skin rejection
4906990|NCT02055521|Hand and Face allotransplantation|hand and face allotransplantation
4906991|NCT02055508|Exercise|exercise
4906992|NCT02055508|Physical Activity|physical activity
4906993|NCT02055508|Palliative Care|palliative care
4906994|NCT02055508|Lung Cancer|lung cancer
4906995|NCT02055508|NSCLC|nsclc
4906996|NCT02055495|Painful flatfeet|painful flatfeet
4906997|NCT02055495|Planovagus feet|planovagus feet
4906998|NCT02055495|Subtalar arthroeresis|subtalar arthroeresis
4906999|NCT02055495|Lateral column lengthening|lateral column lengthening
4907000|NCT02055495|Kinematic motion analysis|kinematic motion analysis
4907001|NCT02055482|Anemia on CKD|anemia on ckd
4907002|NCT02055469|Achalasia|achalasia
4907003|NCT02055456|Hormones|hormones
4907004|NCT02055456|Androgens|androgens
4907005|NCT02055456|Aplastic Anemia|aplastic anemia
4907006|NCT02055456|Bone Marrow Failure Syndromes|bone marrow failure syndromes
4907007|NCT02055456|Idiopathic Pulmonary Fibrosis|idiopathic pulmonary fibrosis
4907008|NCT02055456|Telomere|telomere
4907009|NCT02055456|Telomere Shortening|telomere shortening
4907010|NCT02055443|nuclear cardiology|nuclear cardiology
4907011|NCT02055443|chest pain|chest pain
4907012|NCT02055443|cardiac ischemia|cardiac ischemia
4907013|NCT02055443|shortness of breath|shortness of breath
4907014|NCT02055443|ECG|ecg
4907015|NCT02055443|EKG|ekg
4907016|NCT02055443|electrocardiogram|electrocardiogram
4907017|NCT02055430|anuria|anuria
4907018|NCT02055430|children|children
4907019|NCT02055430|nephrostomy|nephrostomy
4907020|NCT02055430|stents|stents
4907021|NCT02055430|urinary calculi|urinary calculi
4907022|NCT02055404|astigmatism|astigmatism
4907023|NCT02055404|toric|toric
4907024|NCT02055404|contact lenses|contact lenses
4907025|NCT02055404|daily disposable contact lenses|daily disposable contact lenses
4907026|NCT02055404|molded mark|molded mark
4907027|NCT02055404|rotation mark|rotation mark
4907028|NCT02055378|myopia|myopia
4907029|NCT02055378|atropine|atropine
4907030|NCT02055378|anterior chamber depth|anterior chamber depth
4907031|NCT02055378|auricular acupoint|auricular acupoint
4907032|NCT02055378|axial length|axial length
4907033|NCT02055365|Hepatitis B vaccine|hepatitis b vaccine
4907034|NCT02055326|Smoking|smoking
4907035|NCT02055326|yoga|yoga
4907036|NCT02055326|men|men
4907037|NCT02055326|intervention|intervention
4907038|NCT02055313|Exceptional patient|exceptional patient
4907039|NCT02055313|Cancer care|cancer care
4907040|NCT02055313|Lung cancer|lung cancer
4907041|NCT02055313|Pancreatic cancer|pancreatic cancer
4907042|NCT02055313|Stomach cancer|stomach cancer
4907043|NCT02055313|Unexplained survival|unexplained survival
4907044|NCT02055313|still alive from 2001-2008|still alive from 2001-2008
4907045|NCT02055287|schizophrenia|schizophrenia
4907046|NCT02055287|schizoaffective disorder|schizoaffective disorder
4907047|NCT02055274|Parkinsons|parkinsons
4907048|NCT02055248|Genetic Counseling|genetic counseling
4907049|NCT02055248|Mobius Syndrome|mobius syndrome
4907050|NCT02055248|Birth Defects|birth defects
4907051|NCT02055248|Congenital Malformations|congenital malformations
4907052|NCT02055248|Gene Identification|gene identification
4907053|NCT02055235|Brain|brain
4907054|NCT02055235|Pain|pain
4907055|NCT02055235|Yoga|yoga
4907056|NCT02055222|COPD|copd
4907057|NCT02055222|Smoking|smoking
4907058|NCT02055222|Idiopathic Pulmonary Fibrosis|idiopathic pulmonary fibrosis
4907059|NCT02055209|African American|african american
4907060|NCT02055183|Registry|registry
4907061|NCT02055183|Botulinum toxin|botulinum toxin
4907062|NCT02055183|Botulism Antitoxin Heptavalent- (Equine)|botulism antitoxin heptavalent- (equine)
4907063|NCT02055183|BAT®|bat®
4907064|NCT02055157|Achondroplasia|achondroplasia
4907065|NCT02055157|Dwarfism|dwarfism
4907066|NCT02055157|Bone Diseases, Developmental|bone diseases, developmental
4907067|NCT02055157|Bone Diseases|bone diseases
4907068|NCT02055144|NSCLC|nsclc
4907069|NCT02055144|VeriStrat|veristrat
4907070|NCT02055144|chemotherapy|chemotherapy
4907071|NCT02055144|circulating tumor cells|circulating tumor cells
4907072|NCT02055131|vascular access|vascular access
4907073|NCT02055131|hemodialysis|hemodialysis
4907074|NCT02055131|aspirin resistance|aspirin resistance
4907075|NCT02055131|PFA-100|pfa-100
4907076|NCT02055118|hunters disease|hunters disease
4907077|NCT02055118|MPS II|mps ii
4907078|NCT02055118|lysosomal storage disorder|lysosomal storage disorder
4907079|NCT02055118|hunters syndrome|hunters syndrome
4907080|NCT02055118|ert treatment|ert treatment
4907081|NCT02055118|hunter's disease|hunter's disease
4907082|NCT02055118|iduronate sulfatase|iduronate sulfatase
4907083|NCT02055118|MPS society|mps society
4907084|NCT02055118|mps 2|mps 2
4907085|NCT02055118|enlarged adenoids|enlarged adenoids
4907086|NCT02055118|hunter's syndrome|hunter's syndrome
4907087|NCT02055118|iduronate 2 sulfatase|iduronate 2 sulfatase
4907088|NCT02055118|chronic ear infection|chronic ear infection
4907089|NCT02055118|mucopolysaccharides|mucopolysaccharides
4907090|NCT02055118|hunter syndrome therapy|hunter syndrome therapy
4907091|NCT02055118|hunter's syndrome treatment|hunter's syndrome treatment
4907092|NCT02055118|enzyme replacement therapy|enzyme replacement therapy
4907093|NCT02055118|hunter syndrome treatment|hunter syndrome treatment
4907094|NCT02055118|elaprase|elaprase
4907095|NCT02055118|MPSII|mpsii
4907096|NCT02055118|lysosomal storage disease|lysosomal storage disease
4907097|NCT02055118|mps diagnosis|mps diagnosis
4907098|NCT02055118|mps symptoms|mps symptoms
4907099|NCT02055118|idursulfase|idursulfase
4907100|NCT02055118|hunter disease|hunter disease
4907101|NCT02055118|hunter's disease treatment|hunter's disease treatment
4907102|NCT02055118|MPS2|mps2
4907103|NCT02055105|Pediatric Sepsis|pediatric sepsis
4907104|NCT02055092|Young onset dementia|young onset dementia
4907105|NCT02055092|Quality of life|quality of life
4907106|NCT02055092|Specific needs|specific needs
4907107|NCT02055092|Healthcare resources in dementia|healthcare resources in dementia
4907108|NCT02055092|Frontotemporal dementia|frontotemporal dementia
4907109|NCT02055092|Alzheimer's disease|alzheimer's disease
4907110|NCT02055092|Healthcare services|healthcare services
4907111|NCT02055079|ADPKD|adpkd
4907112|NCT02055079|PKD|pkd
4907113|NCT02055079|Polycystic kidney disease|polycystic kidney disease
4907114|NCT02055079|Mammalian target of rapamycin|mammalian target of rapamycin
4907115|NCT02055079|mTOR-I|mtor-i
4907116|NCT02055079|Sirolimus|sirolimus
4907117|NCT02055066|cancer|cancer
4907118|NCT02055066|c-MET|c-met
4907119|NCT02055053|Post Operative Pain|post operative pain
4907120|NCT02055053|hernia repair|hernia repair
4907121|NCT02055027|Sleep Apnea, Obstructive|sleep apnea, obstructive
4907122|NCT02055027|Continuous Positive Airway Pressure|continuous positive airway pressure
4907123|NCT02055027|Perioperative Period|perioperative period
4907124|NCT02055014|Endobarrier|endobarrier
4907125|NCT02055014|Duodenal-jejunal bypass liner|duodenal-jejunal bypass liner
4907126|NCT02055014|Glucagon-like peptide-1 receptor agonist|glucagon-like peptide-1 receptor agonist
4907127|NCT02055014|Liraglutide|liraglutide
4907128|NCT02055014|Diabesity|diabesity
4907129|NCT02055014|Type 2 diabetes|type 2 diabetes
4907130|NCT02055014|Obesity|obesity
4907131|NCT02055001|gender medicine|gender medicine
4907132|NCT02055001|platelet function|platelet function
4907133|NCT02055001|sex hormones|sex hormones
4907134|NCT02055001|antiplatelet drugs|antiplatelet drugs
4907135|NCT02055001|haemostasis|haemostasis
4907136|NCT02054975|asthma, children, vitamin D deficiency, clinical trial|asthma, children, vitamin d deficiency, clinical trial
4907137|NCT02054962|Pain|pain
4907138|NCT02054949|N-acetyl cysteine|n-acetyl cysteine
4907139|NCT02054949|Refractory Seizures|refractory seizures
4907140|NCT02054923|colonoscopy|colonoscopy
4907141|NCT02054923|videorecording|videorecording
4907142|NCT02054923|quality indicators|quality indicators
4907143|NCT02054923|screening|screening
4907144|NCT02054923|colorectal cancer|colorectal cancer
4907145|NCT02054884|Interleukin, IL2, F16, monoclonal, antibody, cytokine Paclitaxel, Merkel cell carcinoma|interleukin, il2, f16, monoclonal, antibody, cytokine paclitaxel, merkel cell carcinoma
4907146|NCT02054871|Peripheral Angioplasty|peripheral angioplasty
4907147|NCT02054871|Remote Ischaemic Preconditioning|remote ischaemic preconditioning
4907148|NCT02054871|Contrast Induced Nephropathy|contrast induced nephropathy
4907149|NCT02054858|Computerized Tomography|computerized tomography
4907150|NCT02054858|Contrast enhanced|contrast enhanced
4907151|NCT02054858|Acute Kidney Injury|acute kidney injury
4907152|NCT02054858|Remote ischaemic preconditioning|remote ischaemic preconditioning
4907153|NCT02054858|RIPC|ripc
4907154|NCT02054845|Body awareness therapy|body awareness therapy
4907155|NCT02054845|Physical therapy|physical therapy
4907156|NCT02054819|lung cancer|lung cancer
4907157|NCT02054819|NSCLC|nsclc
4907158|NCT02054806|PD1|pd1
4907159|NCT02054806|PD-1|pd-1
4907160|NCT02054806|PDL1|pdl1
4907161|NCT02054806|PD-L1|pd-l1
4907162|NCT02054793|metastatic disease|metastatic disease
4907163|NCT02054793|non-metastatic disease|non-metastatic disease
4907164|NCT02054793|prostate cancer|prostate cancer
4907165|NCT02054793|castration-resistant prostate cancer|castration-resistant prostate cancer
4907166|NCT02054767|articaine|articaine
4907167|NCT02054767|lidocaine|lidocaine
4907168|NCT02054767|mepivacaine|mepivacaine
4907169|NCT02054767|inferior alveolar nerve block|inferior alveolar nerve block
4907170|NCT02054767|irreversible pulpitis|irreversible pulpitis
4907171|NCT02054754|Dexanabinol|dexanabinol
4907172|NCT02054754|Oral|oral
4907173|NCT02054754|Safety|safety
4907174|NCT02054754|Tolerability|tolerability
4907175|NCT02054754|Pharmacokinetics|pharmacokinetics
4907176|NCT02054728|right-heart catheterization|right-heart catheterization
4907177|NCT02054728|respiratory muscle training|respiratory muscle training
4907178|NCT02054728|inspiratory resistance|inspiratory resistance
4907179|NCT02054728|hemodynamics|hemodynamics
4907180|NCT02054702|Schizophrenia|schizophrenia
4907181|NCT02054702|Mental Disorders|mental disorders
4907182|NCT02054702|Psychotic Disorders|psychotic disorders
4907183|NCT02054702|Antipsychotic|antipsychotic
4907184|NCT02054702|Cognitive testing|cognitive testing
4907185|NCT02054676|mandible|mandible
4907186|NCT02054676|alveolar nerve inferior|alveolar nerve inferior
4907187|NCT02054676|anatomy|anatomy
4907188|NCT02054676|cross-sectional|cross-sectional
4907189|NCT02054676|dental implants|dental implants
4907190|NCT02054676|classification|classification
4907191|NCT02054676|reliability|reliability
4907192|NCT02054676|validity|validity
4907193|NCT02054663|Acute coronary syndrome|acute coronary syndrome
4907194|NCT02054663|Coronary artery disease|coronary artery disease
4907195|NCT02054663|Antiplatelet therapy|antiplatelet therapy
4907196|NCT02054663|Ticagrelor|ticagrelor
4907197|NCT02054663|Clopidogrel|clopidogrel
4907198|NCT02054650|Chronic low back pain|chronic low back pain
4907199|NCT02054650|Type 2 diabetes mellitus|type 2 diabetes mellitus
4907200|NCT02054650|Back pain|back pain
4907201|NCT02054650|Diabetes|diabetes
4907202|NCT02054650|Osteopathic manual treatment|osteopathic manual treatment
4907203|NCT02054650|Osteopathic manipulative treatment|osteopathic manipulative treatment
4907204|NCT02054650|OMT|omt
4907205|NCT02054650|Biomarkers|biomarkers
4907206|NCT02054650|Glycemic control|glycemic control
4907207|NCT02054650|Kidney function|kidney function
4907208|NCT02054637|Bile reflux|bile reflux
4907209|NCT02054637|Reflux esophagitis|reflux esophagitis
4907210|NCT02054637|Lanreotide autogel|lanreotide autogel
4907211|NCT02054637|Somatuline|somatuline
4907212|NCT02054637|Endoscopy|endoscopy
4907213|NCT02054637|Impedancemetry|impedancemetry
4907214|NCT02054624|Obesity|obesity
4907215|NCT02054624|Rural Health|rural health
4907216|NCT02054624|Exercise|exercise
4907217|NCT02054624|Weight loss|weight loss
4907218|NCT02054624|Behavior change|behavior change
4907219|NCT02054611|ARDS|ards
4907220|NCT02054611|Chest radiographs|chest radiographs
4907221|NCT02054611|Vignettes|vignettes
4907222|NCT02054611|Online educational video|online educational video
4907223|NCT02054585|dehydration|dehydration
4907224|NCT02054585|pediatric|pediatric
4907225|NCT02054585|glucose|glucose
4907226|NCT02054585|IV fluid|iv fluid
4907227|NCT02054572|AMG 416, ESRD, hemodialysis|amg 416, esrd, hemodialysis
4907228|NCT02054559|localized|localized
4907229|NCT02054559|diffuse large B-cell lymphoma|diffuse large b-cell lymphoma
4907230|NCT02054559|R-CHOP chemotherapy|r-chop chemotherapy
4907231|NCT02054559|radiotherapy|radiotherapy
4907232|NCT02054533|Crohn's disease|crohn's disease
4907233|NCT02054533|Ulcerative colitis|ulcerative colitis
4907234|NCT02054533|Inflammatory bowel disease|inflammatory bowel disease
4907235|NCT02054533|Surgery|surgery
4907236|NCT02054533|Anti-Tumor Necrosis Factor|anti-tumor necrosis factor
4907237|NCT02054533|Infection|infection
4907238|NCT02054520|Stage IV|stage iv
4907239|NCT02054520|metastatic melanoma|metastatic melanoma
4907240|NCT02054507|Children|children
4907241|NCT02054507|Cognitive outcome|cognitive outcome
4907242|NCT02054507|Prematurity|prematurity
4907243|NCT02054507|Care Network|care network
4907244|NCT02054507|Outpatient follow-up of cognitive development|outpatient follow-up of cognitive development
4907245|NCT02054507|Care resources|care resources
4907246|NCT02054468|Muscle relaxant, Rocuronium, TIVA, Propofol|muscle relaxant, rocuronium, tiva, propofol
4907247|NCT02054455|PPI|ppi
4907248|NCT02054455|SIBO|sibo
4907249|NCT02054455|LP-F19|lp-f19
4907250|NCT02054442|cetuximab|cetuximab
4907251|NCT02054442|methotrexate|methotrexate
4907252|NCT02054442|squamous cell carcinoma head neck|squamous cell carcinoma head neck
4907253|NCT02054442|palliative chemotherapy|palliative chemotherapy
4907254|NCT02054416|non-traumatic lower limb amputation|non-traumatic lower limb amputation
4907255|NCT02054416|AKA|aka
4907256|NCT02054416|BKA|bka
4907257|NCT02054390|Angiotensin converting enzyme inhibitor|angiotensin converting enzyme inhibitor
4907258|NCT02054390|inflammation|inflammation
4907259|NCT02054390|metabolic syndrome|metabolic syndrome
4907260|NCT02054390|myonecrosis|myonecrosis
4907261|NCT02054390|percutaneous coronary intervention|percutaneous coronary intervention
4907262|NCT02054390|periprocedural myocardial injury|periprocedural myocardial injury
4907263|NCT02054377|cystic fibrosis|cystic fibrosis
4907264|NCT02054377|tai chi|tai chi
4907265|NCT02054364|Eating Disorder|eating disorder
4907266|NCT02054364|Anorexia Nervosa|anorexia nervosa
4907357|NCT02053883|quadriplegia|quadriplegia
4907267|NCT02054364|Eating Disorder Not Otherwise Specified|eating disorder not otherwise specified
4907268|NCT02054364|Maudsley|maudsley
4907269|NCT02054364|Family-Based Therapy|family-based therapy
4907270|NCT02054364|FBT|fbt
4907271|NCT02054364|Family Therapy|family therapy
4907272|NCT02054364|Cognitive Remediation Therapy|cognitive remediation therapy
4907273|NCT02054364|CRT|crt
4907274|NCT02054351|Advanced ovarian cancer|advanced ovarian cancer
4907275|NCT02054351|CLDN6 positive|cldn6 positive
4907276|NCT02054325|Sclerotherapy|sclerotherapy
4907277|NCT02054325|varicose veins|varicose veins
4907278|NCT02054325|veins|veins
4907279|NCT02054273|Adenoviral conjunctivitis diagnosed with AdenoPlus™ Test|adenoviral conjunctivitis diagnosed with adenoplus™ test
4907280|NCT02054247|Carpal tunnel syndrome,ultrasound,pulsed ultrasound|carpal tunnel syndrome,ultrasound,pulsed ultrasound
4907281|NCT02054234|Adenoviral conjunctivitis diagnosed with AdenoPlus™ Test|adenoviral conjunctivitis diagnosed with adenoplus™ test
4907282|NCT02054221|hypertrophic cardiomyopathy|hypertrophic cardiomyopathy
4907283|NCT02054221|mitral valve|mitral valve
4907284|NCT02054208|human umbilical cord blood derived mesenchymal stem cells|human umbilical cord blood derived mesenchymal stem cells
4907285|NCT02054208|stem cells|stem cells
4907286|NCT02054208|alzheimer's disease|alzheimer's disease
4907287|NCT02054208|cognitive ability|cognitive ability
4907288|NCT02054208|mesenchymal stem cells|mesenchymal stem cells
4907289|NCT02054208|cord blood|cord blood
4907290|NCT02054182|vitamin D supplementation, pneumonia, bronchiolitis|vitamin d supplementation, pneumonia, bronchiolitis
4907291|NCT02054156|Cystic fibrosis (CF)|cystic fibrosis (cf)
4907292|NCT02054156|Azithromycin|azithromycin
4907293|NCT02054156|Tobramycin solution for inhalation (TIS)|tobramycin solution for inhalation (tis)
4907294|NCT02054156|Pseudomonas aeruginosa (Pa)|pseudomonas aeruginosa (pa)
4907295|NCT02054156|Early Pseudomonas aeruginosa infection|early pseudomonas aeruginosa infection
4907296|NCT02054156|Pulmonary exacerbation|pulmonary exacerbation
4907297|NCT02054156|Standardized anti-pseudomonal therapy|standardized anti-pseudomonal therapy
4907298|NCT02054143|sevoflurane|sevoflurane
4907299|NCT02054143|cerebral vasoreactivity|cerebral vasoreactivity
4907300|NCT02054143|arterial stiffness|arterial stiffness
4907301|NCT02054143|Transcranial Doppler|transcranial doppler
4907302|NCT02054143|SphygmoCor|sphygmocor
4907303|NCT02054130|Asthma|asthma
4907304|NCT02054117|Hemorrhage|hemorrhage
4907305|NCT02054117|Intracerebral hemorrhage (ICH)|intracerebral hemorrhage (ich)
4907306|NCT02054104|Minimal Residual Disease|minimal residual disease
4907307|NCT02054104|Cancer Vaccine|cancer vaccine
4907308|NCT02054104|Immunotherapy|immunotherapy
4907309|NCT02054104|No Clinical Evidence of Active Disease|no clinical evidence of active disease
4907310|NCT02054091|Preterm infants|preterm infants
4907311|NCT02054091|Bovine colostrum|bovine colostrum
4907312|NCT02054091|Feeding intolerance|feeding intolerance
4907313|NCT02054091|Postnatal growth|postnatal growth
4907314|NCT02054091|Intestinal maturation|intestinal maturation
4907315|NCT02054091|Necrotizing enterocolitis|necrotizing enterocolitis
4907316|NCT02054065|Urinary Catheter|urinary catheter
4907317|NCT02054065|urinary tract infection|urinary tract infection
4907318|NCT02054052|non-small cell lung cancer|non-small cell lung cancer
4907319|NCT02054052|malignant pleural effusion|malignant pleural effusion
4907320|NCT02054052|bevacizumab|bevacizumab
4907321|NCT02054052|intrapleural injection|intrapleural injection
4907322|NCT02054052|pericardial effusion|pericardial effusion
4907323|NCT02054039|Cardiac surgery|cardiac surgery
4907324|NCT02054039|Spirometry|spirometry
4907325|NCT02054039|Physical Therapy Modalities|physical therapy modalities
4907326|NCT02054039|Postoperative Complications|postoperative complications
4907327|NCT02054000|No-reflow phenomenon, tirofiban, intracoronary|no-reflow phenomenon, tirofiban, intracoronary
4907328|NCT02053974|Anthracycline|anthracycline
4907329|NCT02053974|spironolactone|spironolactone
4907330|NCT02053974|cardiotoxicity|cardiotoxicity
4907331|NCT02053948|Reversal|reversal
4907332|NCT02053948|Surgical technique|surgical technique
4907333|NCT02053948|Pursestring Wound Closure|pursestring wound closure
4907334|NCT02053948|Gunsight Skin Incision and Closure Technique|gunsight skin incision and closure technique
4907335|NCT02053935|Dopamine|dopamine
4907336|NCT02053935|hyperglycemic clamp|hyperglycemic clamp
4907337|NCT02053935|sepsis|sepsis
4907338|NCT02053935|hyperglycemia|hyperglycemia
4907339|NCT02053935|insulin secretion|insulin secretion
4907340|NCT02053922|caesarean section, ecbolics, postpartum hemorrhage|caesarean section, ecbolics, postpartum hemorrhage
4907341|NCT02053909|Saphenous vein graft disease|saphenous vein graft disease
4907342|NCT02053909|Coronary artery bypass graft surgery|coronary artery bypass graft surgery
4907343|NCT02053909|Antiplatelet therapy|antiplatelet therapy
4907344|NCT02053909|Coronary artery disease|coronary artery disease
4907345|NCT02053909|Secondary prevention|secondary prevention
4907346|NCT02053909|Graft patency|graft patency
4907347|NCT02053896|Type I Gaucher|type i gaucher
4907348|NCT02053896|ISU302|isu302
4907349|NCT02053896|Imiglucerase|imiglucerase
4907350|NCT02053883|SCI|sci
4907351|NCT02053883|spinal cord injury|spinal cord injury
4907352|NCT02053883|biologic drug|biologic drug
4907353|NCT02053883|rho|rho
4907354|NCT02053883|paralysis|paralysis
4907355|NCT02053883|paraplegia|paraplegia
4907356|NCT02053883|tetraplegia|tetraplegia
4907358|NCT02053883|trauma|trauma
4907359|NCT02053883|central nervous system|central nervous system
4907360|NCT02053883|fibrin sealant|fibrin sealant
4907361|NCT02053883|neurosurgery|neurosurgery
4907362|NCT02053883|cervical|cervical
4907363|NCT02053883|regeneration|regeneration
4907364|NCT02053883|neurotrauma|neurotrauma
4907365|NCT02053870|Adventitious lung sounds|adventitious lung sounds
4907366|NCT02053870|Crackles|crackles
4907367|NCT02053870|Wheezes|wheezes
4907368|NCT02053870|Sputum location|sputum location
4907369|NCT02053857|severe acute malnutrition|severe acute malnutrition
4907370|NCT02053857|polyunsaturated fatty acids|polyunsaturated fatty acids
4907371|NCT02053857|ready-to-use therapeutic food|ready-to-use therapeutic food
4907372|NCT02053844|health care costs|health care costs
4907373|NCT02053844|quality of health care|quality of health care
4907374|NCT02053831|plastic surgery|plastic surgery
4907375|NCT02053818|Cognitive dysfunction|cognitive dysfunction
4907376|NCT02053818|Cardioprotection|cardioprotection
4907377|NCT02053818|Recovery|recovery
4907378|NCT02053818|Renal function|renal function
4907379|NCT02053818|ICU discharge|icu discharge
4907380|NCT02053805|prostate cancer|prostate cancer
4907381|NCT02053805|BRCA1 Syndrome|brca1 syndrome
4907382|NCT02053805|BRCA germ-line mutation|brca germ-line mutation
4907383|NCT02053805|Lynch syndrome|lynch syndrome
4907384|NCT02053805|BRCA2 Syndrome|brca2 syndrome
4907385|NCT02053779|GnRH agonist|gnrh agonist
4907386|NCT02053779|GnRH antagonist|gnrh antagonist
4907387|NCT02053779|Luteal phase|luteal phase
4907388|NCT02053766|Mitochondrial Diseases|mitochondrial diseases
4907389|NCT02053766|Sevoflurane|sevoflurane
4907390|NCT02053766|Dexmedetomidine (Precedex®)|dexmedetomidine (precedex®)
4907391|NCT02053766|Propofol|propofol
4907392|NCT02053753|denosumab, bioequivalence|denosumab, bioequivalence
4907393|NCT02053727|Rheumatoid Arthritis|rheumatoid arthritis
4907394|NCT02053727|Hepatitis B|hepatitis b
4907395|NCT02053727|Abatacept|abatacept
4907396|NCT02053727|Orencia|orencia
4907397|NCT02053727|entecavir|entecavir
4907398|NCT02053701|magnetic resonance spectroscopy|magnetic resonance spectroscopy
4907399|NCT02053701|quantification precision|quantification precision
4907400|NCT02053701|brain|brain
4907401|NCT02053701|brain metabolites|brain metabolites
4907402|NCT02053675|septic shock|septic shock
4907403|NCT02053675|vasopressin|vasopressin
4907404|NCT02053675|microcirculation|microcirculation
4907405|NCT02053675|tissue oxygenation|tissue oxygenation
4907406|NCT02053675|vasopressors|vasopressors
4907407|NCT02053675|hemodynamics|hemodynamics
4907408|NCT02053662|Bladder Cancer|bladder cancer
4907409|NCT02053649|depression|depression
4907410|NCT02053649|major depressive disorder|major depressive disorder
4907411|NCT02053649|postpartum depression|postpartum depression
4907412|NCT02053649|antenatal depression|antenatal depression
4907413|NCT02053649|sleep|sleep
4907414|NCT02053649|circadian|circadian
4907415|NCT02053649|bright light|bright light
4907416|NCT02053597|Primary breast cancer|primary breast cancer
4907417|NCT02053597|Young women|young women
4907418|NCT02053597|Ovarian function|ovarian function
4907419|NCT02053597|Sexual function|sexual function
4907420|NCT02053597|Eligible for adjuvant or neoadjuvant chemotherapy|eligible for adjuvant or neoadjuvant chemotherapy
4907421|NCT02053597|Negative hormone-receptor status|negative hormone-receptor status
4907422|NCT02053558|Anesthesiology|anesthesiology
4907423|NCT02053558|Pain|pain
4907424|NCT02053558|TAP block|tap block
4907425|NCT02053558|Gynecology|gynecology
4907426|NCT02053558|Postoperative|postoperative
4907427|NCT02053558|Analgesia|analgesia
4907428|NCT02053532|Trauma|trauma
4907429|NCT02053532|Post-traumatic stress disorder (PTSD)|post-traumatic stress disorder (ptsd)
4907430|NCT02053532|Imaging|imaging
4907431|NCT02053532|Neuroimaging|neuroimaging
4907432|NCT02053532|F-18-fluorodeoxyglucose (FDG)|f-18-fluorodeoxyglucose (fdg)
4907433|NCT02053493|Heart Failure|heart failure
4907434|NCT02053493|Preserved Ejection Fraction|preserved ejection fraction
4907435|NCT02053480|pyruvate kinase deficiency|pyruvate kinase deficiency
4907436|NCT02053480|hemolytic anemia|hemolytic anemia
4907437|NCT02053480|anemia|anemia
4907438|NCT02053480|enzymopathy|enzymopathy
4907439|NCT02053480|jaundice|jaundice
4907440|NCT02053480|splenectomy|splenectomy
4907441|NCT02053480|health-related quality of life|health-related quality of life
4907442|NCT02053480|Hematologic diseases|hematologic diseases
4907443|NCT02053467|eConsultation|econsultation
4907444|NCT02053467|Specialist care|specialist care
4907445|NCT02053467|Primary health care|primary health care
4907446|NCT02053467|Reducing wait times for specialist care|reducing wait times for specialist care
4907447|NCT02053467|Reducing referral rates|reducing referral rates
4907448|NCT02053454|RNAi therapeutic|rnai therapeutic
4907449|NCT02053441|Muscle Protein Synthesis|muscle protein synthesis
4907450|NCT02053441|Muscle Protein Breakdown|muscle protein breakdown
4907451|NCT02053428|Head and neck cancer|head and neck cancer
4907452|NCT02053428|Percutaneous image-guided gastrostomy|percutaneous image-guided gastrostomy
4907453|NCT02053428|Pain|pain
4907454|NCT02053428|Quality of life|quality of life
4907455|NCT02053428|Complication|complication
4907456|NCT02053415|krill oil|krill oil
4907457|NCT02053415|omega-3 index|omega-3 index
4907458|NCT02053415|plasma lipid profile|plasma lipid profile
4907459|NCT02053415|tolerance|tolerance
4907460|NCT02053415|young adults|young adults
4907461|NCT02053402|vitamin D supplementation, persistent asthma, control|vitamin d supplementation, persistent asthma, control
4907462|NCT02053389|Patient-Physician communication|patient-physician communication
4907463|NCT02053389|Decision Support Techniques|decision support techniques
4907464|NCT02053389|Health Communication|health communication
4907465|NCT02053389|Physician-Patient Relationship|physician-patient relationship
4907466|NCT02053389|Decision Making|decision making
4907467|NCT02053376|gallbladder cancer, biliary cancer, bile duct cancer, hepatobiliary cancer, Biliary Tract Carcinoma|gallbladder cancer, biliary cancer, bile duct cancer, hepatobiliary cancer, biliary tract carcinoma
4907468|NCT02053376|Cholangiocarcinoma|cholangiocarcinoma
4907469|NCT02053363|tranexamic acid, reconstructive spine surgery|tranexamic acid, reconstructive spine surgery
4907470|NCT02053350|Clostridium difficile|clostridium difficile
4907471|NCT02053350|glutamine|glutamine
4907472|NCT02053350|diarrhea|diarrhea
4907473|NCT02053350|alanyl-glutamine|alanyl-glutamine
4907474|NCT02053324|AvidinOX|avidinox
4907475|NCT02053311|adenocarcinoma of the prostate|adenocarcinoma of the prostate
4907476|NCT02053311|metastatic castration-resistant prostate cancer|metastatic castration-resistant prostate cancer
4907477|NCT02053311|maintenance therapy|maintenance therapy
4907478|NCT02053311|orteronel|orteronel
4907479|NCT02053311|TAK-700|tak-700
4907480|NCT02053298|Glaucoma|glaucoma
4907481|NCT02053272|Diabetes|diabetes
4907482|NCT02053272|Glycaemic control|glycaemic control
4907483|NCT02053272|Delta-9-tetrahydrocannabivarin|delta-9-tetrahydrocannabivarin
4907484|NCT02053272|Cannabinoids|cannabinoids
4907485|NCT02053233|stroke|stroke
4907486|NCT02053233|robot-assisted therapy|robot-assisted therapy
4907487|NCT02053233|conventional therapy|conventional therapy
4907488|NCT02053233|motor function|motor function
4907489|NCT02053207|Cognitive training|cognitive training
4907490|NCT02053207|Brain training|brain training
4907491|NCT02053207|Plasticity-based training|plasticity-based training
4907492|NCT02053207|Cardiac surgery|cardiac surgery
4907493|NCT02053207|Preoperative|preoperative
4907494|NCT02053207|Cognitive function|cognitive function
4907495|NCT02053194|Inappropriate prescribing|inappropriate prescribing
4907496|NCT02053194|Health Education|health education
4907497|NCT02053194|Community Pharmacy Services|community pharmacy services
4907498|NCT02053194|Medication Therapy Management|medication therapy management
4907499|NCT02053194|Preventive Health Services|preventive health services
4907500|NCT02053194|Polypharmacy|polypharmacy
4907501|NCT02053194|Inappropriate prescriptions|inappropriate prescriptions
4907502|NCT02053194|Aged|aged
4907503|NCT02053181|Cadazolid|cadazolid
4907504|NCT02053181|ACT-179811|act-179811
4907505|NCT02053181|Pharmacokinetics|pharmacokinetics
4907506|NCT02053181|Safety|safety
4907507|NCT02053181|Tolerability|tolerability
4907508|NCT02053155|Smoking cessation|smoking cessation
4907509|NCT02053155|perioperative complication|perioperative complication
4907510|NCT02053155|Smokerlyzer|smokerlyzer
4907511|NCT02053155|smokers help line|smokers help line
4907512|NCT02053142|Pharmacokinetics|pharmacokinetics
4907513|NCT02053142|Herpes simplex virus|herpes simplex virus
4907514|NCT02053142|Genital herpes ulcers|genital herpes ulcers
4907515|NCT02053129|tuberculosis|tuberculosis
4907516|NCT02053129|HIV|hiv
4907517|NCT02053129|pregnancy|pregnancy
4907518|NCT02053090|Fibromyalgia|fibromyalgia
4907519|NCT02053090|Group Acupuncture|group acupuncture
4907520|NCT02053090|Group Education with Stretching|group education with stretching
4907521|NCT02053090|Nociceptive Reflex Testing|nociceptive reflex testing
4907522|NCT02053090|Pain|pain
4907523|NCT02053090|Sleep|sleep
4907524|NCT02053090|Fatigue|fatigue
4907525|NCT02053064|Neurodegenerative diseases|neurodegenerative diseases
4907526|NCT02053064|Nervous systems diseases|nervous systems diseases
4907527|NCT02053064|Genetic diseases, Inborn|genetic diseases, inborn
4907528|NCT02053064|Metabolic diseases|metabolic diseases
4907529|NCT02053064|Gene therapy|gene therapy
4907530|NCT02053064|Adeno Associated Virus (AAV)|adeno associated virus (aav)
4907531|NCT02053025|appetite|appetite
4907532|NCT02053025|overweight|overweight
4907533|NCT02053025|energy intake|energy intake
4907534|NCT02053025|obesity|obesity
4907535|NCT02053025|gut hormones|gut hormones
4907536|NCT02052986|Fatty Acids, Omega-3|fatty acids, omega-3
4907537|NCT02052986|Omega-3 fatty acids|omega-3 fatty acids
4907538|NCT02052986|Docosahexaenoic acid (DHA)|docosahexaenoic acid (dha)
4907539|NCT02052986|Eicosapentaenoic acid (EPA)|eicosapentaenoic acid (epa)
4907540|NCT02052986|Docosapentaenoic acid (DPA)|docosapentaenoic acid (dpa)
4907541|NCT02052986|Omega Index|omega index
4907542|NCT02052986|Omega Score|omega score
4907543|NCT02052986|Cardiac Rehab|cardiac rehab
4907544|NCT02052973|Streptococcus mutans|streptococcus mutans
4907545|NCT02052973|Natural products|natural products
4907546|NCT02052947|Alzheimer's disease|alzheimer's disease
4907547|NCT02052947|cerebrovascular disease|cerebrovascular disease
4907548|NCT02052947|Lewy body disease|lewy body disease
4907549|NCT02052947|MRI|mri
4907550|NCT02052947|SPECT|spect
4907551|NCT02052947|CSF|csf
4907552|NCT02052947|biomarkers|biomarkers
4907553|NCT02052947|disability|disability
4907554|NCT02052947|Multicenter and prospective cohort study|multicenter and prospective cohort study
4907555|NCT02052934|Escherichia coli Infections|escherichia coli infections
4907556|NCT02052934|ETEC Candidate Vaccine|etec candidate vaccine
4907557|NCT02052934|Immunogenicity|immunogenicity
4907558|NCT02052921|Observation|observation
4907559|NCT02052921|Rectal Resection|rectal resection
4907560|NCT02052921|complete clinical response|complete clinical response
4907561|NCT02052921|neoadjuvant chemoradiotherapy.|neoadjuvant chemoradiotherapy.
4907562|NCT02052895|Presepsin|presepsin
4907563|NCT02052895|Sepsis|sepsis
4907564|NCT02052895|SIRS|sirs
4907565|NCT02052882|Romiplostim|romiplostim
4907566|NCT02052882|Thrombocytopenia|thrombocytopenia
4907567|NCT02052882|13-132|13-132
4907568|NCT02052869|endotracheal intubation|endotracheal intubation
4907569|NCT02052869|esophageal intubation|esophageal intubation
4907570|NCT02052856|Tunnel Widening|tunnel widening
4907571|NCT02052856|All-Inside Suspensory Method|all-inside suspensory method
4907572|NCT02052856|Biointerference Screw Fixation|biointerference screw fixation
4907573|NCT02052791|Spinal Muscular Atrophy|spinal muscular atrophy
4907574|NCT02052791|SMA|sma
4907575|NCT02052791|SMN|smn
4907576|NCT02052791|SMNRx|smnrx
4907577|NCT02052791|ISIS-SMNRx|isis-smnrx
4907578|NCT02052791|ISIS 396443|isis 396443
4907579|NCT02052791|IONIS-SMNRx|ionis-smnrx
4907580|NCT02052791|IONIS-SMN Rx|ionis-smn rx
4907581|NCT02052791|Spinraza|spinraza
4907582|NCT02052778|Breast Cancer|breast cancer
4907583|NCT02052778|Non Small Cell Lung Cancer|non small cell lung cancer
4907584|NCT02052778|Gastric Cancer|gastric cancer
4907585|NCT02052778|FGF|fgf
4907586|NCT02052778|FGFR|fgfr
4907587|NCT02052778|FGFR abnormality|fgfr abnormality
4907588|NCT02052778|TAS-120|tas-120
4907589|NCT02052778|Dose Escalation|dose escalation
4907590|NCT02052739|Status Epilepticus|status epilepticus
4907591|NCT02052739|Refractory status epilepticus|refractory status epilepticus
4907592|NCT02052739|Super-refractory status epilepticus|super-refractory status epilepticus
4907593|NCT02052739|SAGE-547|sage-547
4907594|NCT02052739|SAGE|sage
4907595|NCT02052739|Sage Therapeutics|sage therapeutics
4907596|NCT02052713|dutasteride|dutasteride
4907597|NCT02052713|tamsulosin|tamsulosin
4907598|NCT02052713|healthy subject|healthy subject
4907599|NCT02052713|dutasteride and tamsulosin combination|dutasteride and tamsulosin combination
4907600|NCT02052713|combination capsule of dutasteride 0.5 mg and tamsulosin HCL 0.4 mg|combination capsule of dutasteride 0.5 mg and tamsulosin hcl 0.4 mg
4907601|NCT02052687|Healthy volunteer|healthy volunteer
4907602|NCT02052674|Precursor to CAUTI|precursor to cauti
4907603|NCT02052661|Infanrix™ hexa|infanrix™ hexa
4907604|NCT02052661|Hepatitis B antibodies|hepatitis b antibodies
4907605|NCT02052661|Immunogenicity|immunogenicity
4907606|NCT02052661|Hepatitis B|hepatitis b
4907607|NCT02052661|Adolescents|adolescents
4907608|NCT02052661|Infancy|infancy
4907609|NCT02052661|Engerix™-B Kinder|engerix™-b kinder
4907610|NCT02052661|Safety|safety
4907611|NCT02052648|glioblastoma multiforme|glioblastoma multiforme
4907612|NCT02052648|glioma|glioma
4907613|NCT02052648|gliosarcoma|gliosarcoma
4907614|NCT02052648|malignant brain tumor|malignant brain tumor
4907615|NCT02052635|Percutaneous Coronary Intervention|percutaneous coronary intervention
4907616|NCT02052622|submental fat reduction|submental fat reduction
4907617|NCT02052596|Boostrix|boostrix
4907618|NCT02052596|Herpes zoster|herpes zoster
4907619|NCT02052596|Immunogenicity|immunogenicity
4907620|NCT02052596|Co-administration|co-administration
4907621|NCT02052596|Adults|adults
4907622|NCT02052596|Safety|safety
4907623|NCT02052583|Cardiac arrest|cardiac arrest
4907624|NCT02052583|Oxymetry|oxymetry
4907625|NCT02052583|Hypothermia|hypothermia
4907626|NCT02052570|School Reentry after pediatric HSCT|school reentry after pediatric hsct
4907627|NCT02052557|Exparel|exparel
4907628|NCT02052557|liposomal bupivicaine|liposomal bupivicaine
4907629|NCT02052557|post operative pain control|post operative pain control
4907630|NCT02052557|local anesthetic after surgery|local anesthetic after surgery
4907631|NCT02052557|colorectal surgery|colorectal surgery
4907632|NCT02052557|marcaine|marcaine
4907633|NCT02052557|long acting local anesthetic|long acting local anesthetic
4907634|NCT02052557|pain medication use after surgery|pain medication use after surgery
4907635|NCT02052544|determination of heparin levels|determination of heparin levels
4907636|NCT02052544|Patients|patients
4907637|NCT02052544|requiring|requiring
4907638|NCT02052544|unfractionated|unfractionated
4907639|NCT02052518|Childhood obesity|childhood obesity
4907640|NCT02052518|Breastfeeding|breastfeeding
4907641|NCT02052518|Introduction of solids|introduction of solids
4907642|NCT02052518|Introduction of juice|introduction of juice
4907643|NCT02052505|inappropriate prescribing|inappropriate prescribing
4907644|NCT02052505|psychiatry|psychiatry
4907645|NCT02052505|medication quality|medication quality
4907646|NCT02052505|patient safety|patient safety
4907647|NCT02052505|medication errors|medication errors
4907648|NCT02052479|Polycystic Ovary Syndrome|polycystic ovary syndrome
4907649|NCT02052479|PCOS|pcos
4907650|NCT02052479|Secondary Amenorrhea|secondary amenorrhea
4907651|NCT02052479|Hirsutism|hirsutism
4907652|NCT02052479|Hyperandrogenism|hyperandrogenism
4907653|NCT02052479|Insulin Resistance|insulin resistance
4907654|NCT02052466|Shoulder Joint|shoulder joint
4907655|NCT02052466|Computed tomography|computed tomography
4907656|NCT02052453|Pacemaker|pacemaker
4907658|NCT02052453|Surgery|surgery
4907659|NCT02052453|Electrocautery|electrocautery
4907660|NCT02052453|Electromagnetic interference|electromagnetic interference
4907661|NCT02052427|Ischemic heart disease|ischemic heart disease
4907662|NCT02052427|Coronary artery disease|coronary artery disease
4907663|NCT02052427|Chronic Heart Failure|chronic heart failure
4907664|NCT02052427|Cardiovascular disease|cardiovascular disease
4907665|NCT02052427|adult stem cells|adult stem cells
4907666|NCT02052427|adipose derived regenerative cells|adipose derived regenerative cells
4907667|NCT02052414|side effects|side effects
4907668|NCT02052414|safety|safety
4907669|NCT02052414|efficacy|efficacy
4907670|NCT02052414|Gralise|gralise
4907671|NCT02052414|Fibromyalgia|fibromyalgia
4907672|NCT02052414|gabapentin|gabapentin
4907673|NCT02052401|OLD AGE|old age
4907674|NCT02052401|Elderly|elderly
4907675|NCT02052401|Domiciliary Intervention|domiciliary intervention
4907676|NCT02052401|Occupational Therapy|occupational therapy
4907677|NCT02052401|Rehospitalization|rehospitalization
4907678|NCT02052388|Skin Infection|skin infection
4907679|NCT02052388|Staph aureus|staph aureus
4907680|NCT02052388|MRSA|mrsa
4907681|NCT02052388|MSSA|mssa
4907682|NCT02052388|Cellulitis/Erysipelas|cellulitis/erysipelas
4907683|NCT02052388|Wound Infection|wound infection
4907684|NCT02052388|Abscess|abscess
4907685|NCT02052375|Rheumatoid Arthritis|rheumatoid arthritis
4907686|NCT02052375|ASP2408|asp2408
4907687|NCT02052375|methotrexate|methotrexate
4907688|NCT02052362|absolute bioavailability|absolute bioavailability
4907689|NCT02052362|healthy volunteers|healthy volunteers
4907690|NCT02052349|relative bioavailability|relative bioavailability
4907691|NCT02052349|healthy volunteers|healthy volunteers
4907692|NCT02052336|Drug-Drug interaction|drug-drug interaction
4907693|NCT02052336|Pharmacokinetics|pharmacokinetics
4907694|NCT02052323|P.f Malaria, Artemisinin resistance, ACT treatment failure|p.f malaria, artemisinin resistance, act treatment failure
4907695|NCT02052310|Anemia|anemia
4907696|NCT02052310|Chronic Kidney Disease|chronic kidney disease
4907697|NCT02052310|Hemoglobin|hemoglobin
4907698|NCT02052310|End-Stage Renal Disease|end-stage renal disease
4907699|NCT02052310|Incident-Dialysis|incident-dialysis
4907700|NCT02052310|Erythropoieitin|erythropoieitin
4907701|NCT02052310|Erythropoieisis stimulating-agent|erythropoieisis stimulating-agent
4907702|NCT02052310|Roxadustat|roxadustat
4907703|NCT02052310|AZD9941|azd9941
4907704|NCT02052310|ASP1517|asp1517
4907705|NCT02052297|Idiopathic Pulmonary Fibrosis (IPF)|idiopathic pulmonary fibrosis (ipf)
4907706|NCT02052297|dosimetry|dosimetry
4907707|NCT02052297|Positron Emission Tomograph (PET)|positron emission tomograph (pet)
4907708|NCT02052284|ELBW|elbw
4907709|NCT02052284|premature|premature
4907710|NCT02052284|neonate|neonate
4907711|NCT02052284|skin|skin
4907712|NCT02052284|water loss|water loss
4907713|NCT02052271|essential tremor|essential tremor
4907714|NCT02052271|cerebellum|cerebellum
4907715|NCT02052271|transcranial direct current stimulation|transcranial direct current stimulation
4907716|NCT02052271|electrophysiology|electrophysiology
4907717|NCT02052258|oxytocin|oxytocin
4907718|NCT02052219|Blisibimod|blisibimod
4907719|NCT02052219|IgA nephropathy|iga nephropathy
4907720|NCT02052219|BAFF|baff
4907721|NCT02052219|BLyS|blys
4907722|NCT02052206|osteoarthritis|osteoarthritis
4907723|NCT02052206|complexe proximal humeral fracture|complexe proximal humeral fracture
4907724|NCT02052206|shoulder|shoulder
4907725|NCT02052206|shoulder replacement|shoulder replacement
4907726|NCT02052206|accuracy|accuracy
4907727|NCT02052206|computer-assisted|computer-assisted
4907728|NCT02052206|3D|3d
4907729|NCT02052180|Carpalmetacarpal arthroplasty|carpalmetacarpal arthroplasty
4907730|NCT02052180|Proximal row carpectomy|proximal row carpectomy
4907731|NCT02052180|Post-operative pain control|post-operative pain control
4907732|NCT02052180|Exparel|exparel
4907733|NCT02052180|Marcaine|marcaine
4907734|NCT02052154|Pneumococcal infection|pneumococcal infection
4907735|NCT02052154|Splenectomized|splenectomized
4907736|NCT02052154|vaccination|vaccination
4907737|NCT02052141|Pediatric|pediatric
4907738|NCT02052141|C1 inhibitor|c1 inhibitor
4907739|NCT02052141|HAE|hae
4907740|NCT02052141|Cinryze|cinryze
4907741|NCT02052141|C1 INH|c1 inh
4907742|NCT02052141|Prevention|prevention
4907743|NCT02052128|endometrial cancer|endometrial cancer
4907744|NCT02052128|ovarian cancer|ovarian cancer
4907745|NCT02052128|breast cancer|breast cancer
4907746|NCT02052128|uterine sarcoma|uterine sarcoma
4907747|NCT02052128|uterine endometrioid adenocarcinoma|uterine endometrioid adenocarcinoma
4907748|NCT02052115|breast cancer|breast cancer
4907749|NCT02052115|exercise|exercise
4907750|NCT02052115|weight loss|weight loss
4907751|NCT02052115|executive function|executive function
4907752|NCT02052115|breast cancer survivor|breast cancer survivor
4907753|NCT02052102|Deep inspiration breath hold|deep inspiration breath hold
4907754|NCT02052102|radiation therapy|radiation therapy
4907755|NCT02052102|Cardiac toxicity|cardiac toxicity
4907756|NCT02052102|Left-sided breast cancer|left-sided breast cancer
4907757|NCT02052089|Tennis Elbow|tennis elbow
4907758|NCT02052089|lateral epicondylosis|lateral epicondylosis
4907759|NCT02052089|lateral epicondylitis|lateral epicondylitis
4907760|NCT02052089|Platelet-Rich Plasma|platelet-rich plasma
4907761|NCT02052089|Extracorporeal Shockwave Therapy|extracorporeal shockwave therapy
4907762|NCT02052089|Prolotherapy|prolotherapy
4907763|NCT02052089|Physiotherapy|physiotherapy
4907764|NCT02052076|Energy balance|energy balance
4907765|NCT02052076|meal pattern|meal pattern
4907766|NCT02052076|metabolic syndrome|metabolic syndrome
4907767|NCT02052063|rectocele|rectocele
4907768|NCT02052063|intussusception|intussusception
4907769|NCT02052063|surgery|surgery
4907770|NCT02052050|colorectal-neoplasms,deep-muscles of the back,rehabilitation|colorectal-neoplasms,deep-muscles of the back,rehabilitation
4907771|NCT02052037|Type 2 Diabetes|type 2 diabetes
4907772|NCT02052037|Egg|egg
4907773|NCT02052037|Glycemic Control|glycemic control
4907774|NCT02052037|Insulin sensitivity|insulin sensitivity
4907775|NCT02052037|Diet quality|diet quality
4907776|NCT02052024|Spasticity|spasticity
4907777|NCT02052024|Modified Ashworth Scale|modified ashworth scale
4907778|NCT02052024|MYOBLOC|myobloc
4907779|NCT02052024|Botox|botox
4907780|NCT02052024|Muscle Atrophy|muscle atrophy
4907781|NCT02052011|Chest Pain|chest pain
4907782|NCT02052011|Microvascular Angina|microvascular angina
4907783|NCT02052011|Ranolazine|ranolazine
4907784|NCT02052011|Emergency department|emergency department
4907785|NCT02052011|PET|pet
4907786|NCT02051998|Geographic atrophy|geographic atrophy
4907787|NCT02051998|Age-related macular degeneration|age-related macular degeneration
4907788|NCT02051998|Retina|retina
4907789|NCT02051998|Retinal pigment epithelium|retinal pigment epithelium
4907790|NCT02051998|Optical coherence tomography|optical coherence tomography
4907791|NCT02051998|Scanning laser ophthalmoscopy|scanning laser ophthalmoscopy
4907792|NCT02051985|Chronic heart failure|chronic heart failure
4907793|NCT02051985|Heart decompensation|heart decompensation
4907794|NCT02051985|Aerobic exercise training|aerobic exercise training
4907795|NCT02051985|Functional capacity|functional capacity
4907796|NCT02051985|Dyspnea|dyspnea
4907797|NCT02051985|Beta-adrenergic receptor signaling|beta-adrenergic receptor signaling
4907798|NCT02051959|Phantom Limb Pain|phantom limb pain
4907799|NCT02051959|Transcranial Direct Current Stimulation|transcranial direct current stimulation
4907800|NCT02051959|Amputation|amputation
4907801|NCT02051959|Diabetes Mellitus|diabetes mellitus
4907802|NCT02051946|novel drug delivery technique for glaucoma patients|novel drug delivery technique for glaucoma patients
4907803|NCT02051933|pilon|pilon
4907804|NCT02051933|tibial plafond|tibial plafond
4907805|NCT02051933|botox|botox
4907806|NCT02051933|ankle dorsiflexion|ankle dorsiflexion
4907807|NCT02051933|ankle functionality|ankle functionality
4907808|NCT02051933|ankle range of motion|ankle range of motion
4907809|NCT02051920|Elastography|elastography
4907810|NCT02051894|Neonates|neonates
4907811|NCT02051894|Dobutamine|dobutamine
4907812|NCT02051894|Superior Vena Cana Flow|superior vena cana flow
4907813|NCT02051894|Hypoxic Ischemic Encephalopathy|hypoxic ischemic encephalopathy
4907814|NCT02051894|Pleth Variability Index|pleth variability index
4907815|NCT02051868|Squamous cell carcinoma of the anus|squamous cell carcinoma of the anus
4907816|NCT02051868|Anal cancer|anal cancer
4907817|NCT02051868|Cancer of the anus|cancer of the anus
4907818|NCT02051868|SCCA|scca
4907819|NCT02051868|Cisplatin-5FU|cisplatin-5fu
4907820|NCT02051868|Carboplatin-Paclitaxel|carboplatin-paclitaxel
4907821|NCT02051868|inoperable|inoperable
4907822|NCT02051868|locally recurrent|locally recurrent
4907823|NCT02051868|metastatic|metastatic
4907824|NCT02051855|Neonates|neonates
4907825|NCT02051855|Superior Vena Cava Flow|superior vena cava flow
4907826|NCT02051855|Pleth Variability Index|pleth variability index
4907827|NCT02051855|Dobutamine|dobutamine
4907828|NCT02051855|Intensive Care|intensive care
4907829|NCT02051842|NAFLD|nafld
4907830|NCT02051842|oxidative stress|oxidative stress
4907831|NCT02051842|malondialdehyde|malondialdehyde
4907832|NCT02051816|Endotracheal Intubation|endotracheal intubation
4907833|NCT02051816|Apneic Oxygenation|apneic oxygenation
4907834|NCT02051816|Respiratory failure|respiratory failure
4907835|NCT02051803|smoking cessation|smoking cessation
4907836|NCT02051803|women|women
4907837|NCT02051751|Solid tumors, Head and neck non squamous cell carcinoma, breast cancer, PI3K inhibitor, BYL719, paclitaxel|solid tumors, head and neck non squamous cell carcinoma, breast cancer, pi3k inhibitor, byl719, paclitaxel
4907838|NCT02051738|Healthy|healthy
4907839|NCT02051738|Mebendazole|mebendazole
4907840|NCT02051738|Fast-Disintegrating Chewable Formulation|fast-disintegrating chewable formulation
4907841|NCT02051738|Bioavailability|bioavailability
4907842|NCT02051712|chronic heart failure|chronic heart failure
4907843|NCT02051712|exercise training|exercise training
4907844|NCT02051712|preferred training|preferred training
4907845|NCT02051712|prevention|prevention
4907846|NCT02051699|Osteoarthritis of the knee|osteoarthritis of the knee
4907847|NCT02051699|Weight bearing radiograph|weight bearing radiograph
4907848|NCT02051699|Kellgren-Lawrence classification|kellgren-lawrence classification
4907849|NCT02051699|Joint space width|joint space width
4907850|NCT02051699|One-leg standing view|one-leg standing view
4907851|NCT02051686|Acetabulum Fractures|acetabulum fractures
4907852|NCT02051686|Pelvic Ring Injuries|pelvic ring injuries
4907853|NCT02051686|Tranexamic Acid|tranexamic acid
4907854|NCT02051673|Kidney Transplantation|kidney transplantation
4907855|NCT02051647|medical students|medical students
4907856|NCT02051647|Basel University|basel university
4907857|NCT02051634|Aging|aging
4907858|NCT02051634|Papaya|papaya
4907859|NCT02051634|Fermented Papaya|fermented papaya
4907860|NCT02051634|Inflammation|inflammation
4907861|NCT02051634|Phytochemicals|phytochemicals
4907862|NCT02051634|Physical function|physical function
4907863|NCT02051634|Quality of life|quality of life
4907864|NCT02051634|Fatigue|fatigue
4907865|NCT02051634|Health|health
4907866|NCT02051621|pulmonary vein isolation|pulmonary vein isolation
4907867|NCT02051621|isthmus ablation|isthmus ablation
4907868|NCT02051621|recurrence|recurrence
4907869|NCT02051595|heart lung machine|heart lung machine
4907870|NCT02051595|blood pump|blood pump
4907871|NCT02051595|cardiac surgery|cardiac surgery
4907872|NCT02051595|cardiopulmonary bypass|cardiopulmonary bypass
4907873|NCT02051595|circulation|circulation
4907874|NCT02051556|Parkinson's disease|parkinson's disease
4907875|NCT02051556|Freezing of gait|freezing of gait
4907876|NCT02051556|Asymmetry|asymmetry
4907877|NCT02051556|Rehabilitation|rehabilitation
4907878|NCT02051556|Physical therapy|physical therapy
4907879|NCT02051530|mood|mood
4907880|NCT02051530|empathy|empathy
4907881|NCT02051530|mimicry|mimicry
4907882|NCT02051530|emotional reactivity|emotional reactivity
4907883|NCT02051530|prosody|prosody
4907884|NCT02051517|Virectomy|virectomy
4907885|NCT02051504|Type 1 diabetes|type 1 diabetes
4907886|NCT02051504|Glycated hemoglobin|glycated hemoglobin
4907887|NCT02051504|Muscle Oxygenation|muscle oxygenation
4907888|NCT02051504|Exercise|exercise
4907889|NCT02051504|Maximal Oxygen uptake|maximal oxygen uptake
4907890|NCT02051504|Mitochondrial respiration|mitochondrial respiration
4907891|NCT02051504|Endocannabinoid system|endocannabinoid system
4907892|NCT02051504|Oxidative stress|oxidative stress
4907893|NCT02051478|manipulation|manipulation
4907894|NCT02051478|mobilization|mobilization
4907895|NCT02051478|spine|spine
4907896|NCT02051478|pressure pain|pressure pain
4907897|NCT02051439|Varicose Veins|varicose veins
4907898|NCT02051439|Venous Insufficiency|venous insufficiency
4907899|NCT02051439|Doppler|doppler
4907900|NCT02051439|Duplex|duplex
4907901|NCT02051439|Valsava|valsava
4907902|NCT02051426|neuropsychiatric effects|neuropsychiatric effects
4907903|NCT02051413|Major depression|major depression
4907904|NCT02051413|Antidepressant drug|antidepressant drug
4907905|NCT02051413|Beta-arrestin|beta-arrestin
4907906|NCT02051413|Biomarker|biomarker
4907907|NCT02051413|Predictive factor|predictive factor
4907908|NCT02051400|Intubation|intubation
4907909|NCT02051400|Laryngoscopes|laryngoscopes
4907910|NCT02051361|DAT = Dual Antiplatelet Treatment|dat = dual antiplatelet treatment
4907911|NCT02051361|Major Cardiac Adverse Events|major cardiac adverse events
4907912|NCT02051348|Helicobacter pylori|helicobacter pylori
4907913|NCT02051348|Mild Indigestion|mild indigestion
4907914|NCT02051335|Drug therapy|drug therapy
4907915|NCT02051309|Smokers|smokers
4907916|NCT02051309|Quit Smoking|quit smoking
4907917|NCT02051309|Treatment|treatment
4907918|NCT02051309|Guanfacine|guanfacine
4907919|NCT02051283|Hepatocellular carcinoma|hepatocellular carcinoma
4907921|NCT02051283|MRI|mri
4907922|NCT02051270|Elderly|elderly
4907923|NCT02051270|Nursing homes|nursing homes
4907924|NCT02051270|Mild cognitive impairment|mild cognitive impairment
4907925|NCT02051244|Alzheimer's Disease|alzheimer's disease
4907926|NCT02051244|Retinal Nerve Fiber Layer|retinal nerve fiber layer
4907927|NCT02051244|Ocular Computerized Tomography|ocular computerized tomography
4907928|NCT02051244|Minimal Cognitive Impairment|minimal cognitive impairment
4907929|NCT02051244|Subjective Memory Loss|subjective memory loss
4907930|NCT02051244|Asymptomatic Preclinical Alzheimer's Disease|asymptomatic preclinical alzheimer's disease
4907931|NCT02051231|Uterine contraction|uterine contraction
4907932|NCT02051231|Oxytocin receptors|oxytocin receptors
4907933|NCT02051231|Oxytocin desensitization|oxytocin desensitization
4907934|NCT02051218|metastatic breast cancer|metastatic breast cancer
4907935|NCT02051218|castration resistant metastatic prostate cancer|castration resistant metastatic prostate cancer
4907936|NCT02051218|bone metastases|bone metastases
4907937|NCT02051218|Denosumab|denosumab
4907938|NCT02051218|XGEVA|xgeva
4907939|NCT02051218|de-escalation|de-escalation
4907940|NCT02051205|Parkinson's disease, risk factors, epidemiology|parkinson's disease, risk factors, epidemiology
4907941|NCT02051192|obsessive-compulsive disorder|obsessive-compulsive disorder
4907942|NCT02051192|Social phobia|social phobia
4907943|NCT02051192|Generalized anxiety disorder|generalized anxiety disorder
4907944|NCT02051192|Specific phobia|specific phobia
4907945|NCT02051192|Separation anxiety disorder|separation anxiety disorder
4907946|NCT02051192|Selective Mutism|selective mutism
4907947|NCT02051192|Anxiety Disorder, Not Otherwise Specified|anxiety disorder, not otherwise specified
4907948|NCT02051192|Counseling|counseling
4907949|NCT02051192|Behavioral therapy|behavioral therapy
4907950|NCT02051192|Psychotherapy|psychotherapy
4907951|NCT02051192|Exposure|exposure
4907952|NCT02051192|Young Children|young children
4907953|NCT02051179|Repair|repair
4907954|NCT02051179|Replacement|replacement
4907955|NCT02051179|Dental Amalgam|dental amalgam
4907956|NCT02051153|Modafinil|modafinil
4907957|NCT02051153|Cognitive|cognitive
4907958|NCT02051153|Performance|performance
4907959|NCT02051140|Postural Balance|postural balance
4907960|NCT02051140|Walking|walking
4907961|NCT02051140|Giat|giat
4907962|NCT02051140|Cognition|cognition
4907963|NCT02051140|Learning|learning
4907964|NCT02051140|Memory|memory
4907965|NCT02051140|Antioxidants|antioxidants
4907966|NCT02051140|Anti-Inflammatory Agents|anti-inflammatory agents
4907967|NCT02051140|Brain|brain
4907968|NCT02051140|Strawberry|strawberry
4907969|NCT02051127|Exercise|exercise
4907970|NCT02051127|Physical Fitness|physical fitness
4907971|NCT02051127|Stress, Psychological|stress, psychological
4907972|NCT02051127|Cognition|cognition
4907973|NCT02051127|Psychophysiology|psychophysiology
4907974|NCT02051127|Ergometry|ergometry
4907975|NCT02051127|Exercise Test|exercise test
4907976|NCT02051127|Sedentary Lifestyle|sedentary lifestyle
4907977|NCT02051114|Rheumatoid arthritis|rheumatoid arthritis
4907978|NCT02051088|Critical limb ischemia|critical limb ischemia
4907979|NCT02051088|Intermittent claudication|intermittent claudication
4907980|NCT02051088|endovascular treatment|endovascular treatment
4907981|NCT02051088|drug-elution|drug-elution
4907982|NCT02051075|IVF|ivf
4907983|NCT02051075|ICSI|icsi
4907984|NCT02051075|Asthenospermia|asthenospermia
4907985|NCT02051075|pentoxyphylline|pentoxyphylline
4907986|NCT02051075|Spermatozoa|spermatozoa
4907987|NCT02051062|Pharmacokinetics|pharmacokinetics
4907988|NCT02051062|BAT|bat
4907989|NCT02051062|Pediatric|pediatric
4907990|NCT02051049|CN|cn
4907991|NCT02051049|UCD|ucd
4907992|NCT02051036|moxibustion|moxibustion
4907993|NCT02051023|keratoconjunctivitis sicca|keratoconjunctivitis sicca
4907994|NCT02051023|dry eye|dry eye
4907995|NCT02051023|dry eye syndrome|dry eye syndrome
4907996|NCT02051023|dry eye disease|dry eye disease
4907997|NCT02051023|steroids|steroids
4907998|NCT02050984|Obesity|obesity
4907999|NCT02050984|Hypertension|hypertension
4908000|NCT02050984|Bariatric Surgery|bariatric surgery
4908001|NCT02050984|Diabetes|diabetes
4908002|NCT02050971|Umbilical Cord Blood|umbilical cord blood
4908003|NCT02050971|Autologous Umbilical Cord Blood Transfusion|autologous umbilical cord blood transfusion
4908004|NCT02050971|Prematurity Complications|prematurity complications
4908005|NCT02050971|Infant, Premature, Diseases|infant, premature, diseases
4908006|NCT02050971|Infant, Newborn, Diseases|infant, newborn, diseases
4908007|NCT02050971|Hematologic Diseases|hematologic diseases
4908008|NCT02050971|Lung Diseases|lung diseases
4908009|NCT02050971|Central Nervous System Diseases|central nervous system diseases
4908010|NCT02050971|Gastrointestinal Tract Diseases|gastrointestinal tract diseases
4908011|NCT02050971|Vascular Diseases|vascular diseases
4908012|NCT02050971|Retinopathies, Neonates|retinopathies, neonates
4908013|NCT02050971|Prevention,Treatment|prevention,treatment
4908014|NCT02050932|hepcidin|hepcidin
4908015|NCT02050932|iron bioavailability|iron bioavailability
4908016|NCT02050932|iron supplementation|iron supplementation
4908017|NCT02050906|IDEA-P|idea-p
4908018|NCT02050906|Androgen Deprivation Therapy|androgen deprivation therapy
4908019|NCT02050893|septic shock|septic shock
4908020|NCT02050893|sepsis|sepsis
4908021|NCT02050893|fluid responsiveness|fluid responsiveness
4908022|NCT02050893|Midazolam|midazolam
4908023|NCT02050893|Propofol|propofol
4908024|NCT02050893|haemodynamics|haemodynamics
4908025|NCT02050880|Normal Eyes|normal eyes
4908026|NCT02050880|Eye; Disorder with Glaucoma|eye; disorder with glaucoma
4908027|NCT02050880|Eye; Disorder with Retinal Disease|eye; disorder with retinal disease
4908028|NCT02050880|Eye; Disorder Corneal Disease incl kerato-refractive group|eye; disorder corneal disease incl kerato-refractive group
4908029|NCT02050867|Youth Suicide|youth suicide
4908030|NCT02050867|Suicide|suicide
4908031|NCT02050854|Aripiprazole|aripiprazole
4908032|NCT02050854|Treatment Adherence|treatment adherence
4908033|NCT02050841|Pediatric|pediatric
4908034|NCT02050841|patients|patients
4908035|NCT02050841|replacement|replacement
4908036|NCT02050841|coagulation factors|coagulation factors
4908037|NCT02050841|plasma|plasma
4908038|NCT02050841|s/d plasma|s/d plasma
4908039|NCT02050841|Octaplas|octaplas
4908040|NCT02050841|plasma replacement|plasma replacement
4908041|NCT02050815|MEK162|mek162
4908042|NCT02050815|Hepatic impairment|hepatic impairment
4908043|NCT02050815|Healthy subjects|healthy subjects
4908044|NCT02050802|Macitentan|macitentan
4908045|NCT02050802|Pharmacokinetics|pharmacokinetics
4908046|NCT02050802|Pharmacodynamics|pharmacodynamics
4908047|NCT02050763|HIV|hiv
4908048|NCT02050763|Intimate partner violence|intimate partner violence
4908049|NCT02050763|Community based prevention intervention|community based prevention intervention
4908050|NCT02050763|Uganda|uganda
4908051|NCT02050763|Cluster randomized trial|cluster randomized trial
4908149|NCT02050360|Raynaud's phenomenon|raynaud's phenomenon
4908052|NCT02050750|Must have registered with the ICORG 06-31 TAILORx trial|must have registered with the icorg 06-31 tailorx trial
4908053|NCT02050737|Curative resection|curative resection
4908054|NCT02050737|Adjuvant chemotherapy|adjuvant chemotherapy
4908055|NCT02050724|Solitary Pulmonary Nodule|solitary pulmonary nodule
4908056|NCT02050724|Thoracoscopy|thoracoscopy
4908057|NCT02050724|Thoracic Surgery|thoracic surgery
4908058|NCT02050724|Video-Assisted|video-assisted
4908059|NCT02050724|Radioactive Tracers|radioactive tracers
4908060|NCT02050724|Radioguided surgery|radioguided surgery
4908061|NCT02050724|Handheld-SPECT|handheld-spect
4908062|NCT02050711|Chronic obstructive pulmonary disease (COPD)|chronic obstructive pulmonary disease (copd)
4908063|NCT02050711|Pulmonary rehabilitation|pulmonary rehabilitation
4908064|NCT02050711|Computerized respiratory sounds|computerized respiratory sounds
4908065|NCT02050698|fift metatarsal avulsion fracture|fift metatarsal avulsion fracture
4908066|NCT02050698|hard-soled shoe|hard-soled shoe
4908067|NCT02050698|short leg walking cast|short leg walking cast
4908068|NCT02050698|protected weightbearing|protected weightbearing
4908069|NCT02050672|Myoinositol|myoinositol
4908070|NCT02050672|ART|art
4908071|NCT02050672|EMBRYO QUALITY|embryo quality
4908072|NCT02050646|Autoimmune hepatitis|autoimmune hepatitis
4908073|NCT02050646|Liver dysfunction|liver dysfunction
4908074|NCT02050646|Elevated serum auto antibodies|elevated serum auto antibodies
4908075|NCT02050633|Craniocerebral Trauma|craniocerebral trauma
4908076|NCT02050633|Long term outcome|long term outcome
4908077|NCT02050633|Activities of Daily Living|activities of daily living
4908078|NCT02050633|Cognitive Deficiency|cognitive deficiency
4908079|NCT02050633|Health Care Quality, Access, and Evaluation|health care quality, access, and evaluation
4908080|NCT02050633|Burden of care|burden of care
4908081|NCT02050620|Breast cancer, exercise and quality of life|breast cancer, exercise and quality of life
4908082|NCT02050581|Platelets are a part of the blood hat helps with clotting|platelets are a part of the blood hat helps with clotting
4908083|NCT02050581|ITP idiopathic thrombocytopenia purpura low platelet count|itp idiopathic thrombocytopenia purpura low platelet count
4908084|NCT02050568|Genital prolapse|genital prolapse
4908085|NCT02050568|Genital prolapse surgery|genital prolapse surgery
4908086|NCT02050568|Stress urinary incontinence|stress urinary incontinence
4908087|NCT02050568|Urethral Pressure Reflectometry|urethral pressure reflectometry
4908088|NCT02050542|cancer|cancer
4908089|NCT02050542|prostate|prostate
4908090|NCT02050542|PSA|psa
4908091|NCT02050542|biopsies|biopsies
4908092|NCT02050542|ultrasound|ultrasound
4908093|NCT02050542|MRI|mri
4908094|NCT02050542|fusion of images|fusion of images
4908095|NCT02050529|Hypertension, Pregnancy induced|hypertension, pregnancy induced
4908096|NCT02050529|Pre-eclampsia|pre-eclampsia
4908097|NCT02050529|Eclampsia|eclampsia
4908098|NCT02050529|Labetalol|labetalol
4908099|NCT02050529|Hydralazine|hydralazine
4908100|NCT02050516|Blastocyst, micro-well group culture dish|blastocyst, micro-well group culture dish
4908101|NCT02050503|Mucositis|mucositis
4908102|NCT02050503|Breakthrough pain|breakthrough pain
4908103|NCT02050503|Head Nad neck cancer|head nad neck cancer
4908104|NCT02050503|Intranasal transmucosal fentanyl in pectin|intranasal transmucosal fentanyl in pectin
4908105|NCT02050477|Obesity|obesity
4908106|NCT02050477|Bariatric|bariatric
4908107|NCT02050477|Surgery|surgery
4908108|NCT02050477|Sleeve|sleeve
4908109|NCT02050477|Gastroplasty|gastroplasty
4908110|NCT02050477|Laparoscopy|laparoscopy
4908111|NCT02050464|Alzheimer Disease|alzheimer disease
4908112|NCT02050464|Frontotemporal Dementia|frontotemporal dementia
4908113|NCT02050464|Dementia, Vascular|dementia, vascular
4908114|NCT02050464|Mild Cognitive Impairment|mild cognitive impairment
4908115|NCT02050464|Diagnosis|diagnosis
4908116|NCT02050464|Risk factors|risk factors
4908117|NCT02050464|Biomarkers|biomarkers
4908118|NCT02050464|AD|ad
4908119|NCT02050464|FTD|ftd
4908120|NCT02050464|VAD|vad
4908121|NCT02050464|MCI|mci
4908122|NCT02050451|radical cystectomy|radical cystectomy
4908123|NCT02050451|urinary diversion|urinary diversion
4908124|NCT02050451|nutrition|nutrition
4908125|NCT02050451|oral supplementation|oral supplementation
4908126|NCT02050451|enteral nutrition|enteral nutrition
4908127|NCT02050438|Osteoarthritis Knee|osteoarthritis knee
4908128|NCT02050438|Total Knee Arthroplasty|total knee arthroplasty
4908129|NCT02050438|Quality of Life|quality of life
4908130|NCT02050425|OSA|osa
4908131|NCT02050425|CPAP|cpap
4908132|NCT02050425|exhaled breath|exhaled breath
4908133|NCT02050399|Isometric Exercise|isometric exercise
4908134|NCT02050399|Arterial Pressure|arterial pressure
4908135|NCT02050399|Autonomic Nervous System|autonomic nervous system
4908136|NCT02050399|Cardiovascular system|cardiovascular system
4908137|NCT02050399|Posture|posture
4908138|NCT02050386|Brain arousal systems|brain arousal systems
4908139|NCT02050386|Aging|aging
4908140|NCT02050386|MRI|mri
4908141|NCT02050386|fMRI|fmri
4908142|NCT02050386|Cognition|cognition
4908143|NCT02050373|Mucositis|mucositis
4908144|NCT02050373|Stomatitis|stomatitis
4908145|NCT02050373|Chemotherapy|chemotherapy
4908146|NCT02050373|Hematopoietic stem cell transplant|hematopoietic stem cell transplant
4908147|NCT02050373|Laser therapy|laser therapy
4908148|NCT02050373|Inflammatory cytokines|inflammatory cytokines
4908150|NCT02050360|Sildenafil|sildenafil
4908151|NCT02050360|Systemic Sclerosis|systemic sclerosis
4908152|NCT02050360|Local cooling|local cooling
4908153|NCT02050360|Microcirculation|microcirculation
4908154|NCT02050347|CD19.CAR-CD28zeta|cd19.car-cd28zeta
4908155|NCT02050347|chimeric antigen receptor|chimeric antigen receptor
4908156|NCT02050347|hematopoietic stem cell transplant|hematopoietic stem cell transplant
4908157|NCT02050334|Phase 1|phase 1
4908158|NCT02050334|Healthy Volunteer|healthy volunteer
4908159|NCT02050334|Safety|safety
4908160|NCT02050334|Healthy Volunteer Safety Study|healthy volunteer safety study
4908161|NCT02050282|Dyspnea|dyspnea
4908162|NCT02050282|Prehospital|prehospital
4908163|NCT02050282|Biomarker|biomarker
4908164|NCT02050282|Heart failure|heart failure
4908165|NCT02050282|Triage|triage
4908166|NCT02050282|Randomized, controlled study|randomized, controlled study
4908167|NCT02050256|Palliative care|palliative care
4908168|NCT02050256|Continuing medical education|continuing medical education
4908169|NCT02050256|General practitioner|general practitioner
4908170|NCT02050256|Electronic decision support|electronic decision support
4908171|NCT02050243|pediatrics|pediatrics
4908172|NCT02050243|brain tumor|brain tumor
4908173|NCT02050243|CNS|cns
4908174|NCT02050243|fluorescence|fluorescence
4908175|NCT02050243|5ALA|5ala
4908176|NCT02050230|transfusion|transfusion
4908177|NCT02050230|pulmonary hypertension|pulmonary hypertension
4908178|NCT02050230|intensive care medicine|intensive care medicine
4908179|NCT02050217|Helmet|helmet
4908180|NCT02050217|Neurally Adjusted Ventilatory Assist|neurally adjusted ventilatory assist
4908181|NCT02050217|Children|children
4908182|NCT02050217|Respiratory Failure|respiratory failure
4908183|NCT02050204|work to family conflict|work to family conflict
4908184|NCT02050204|supervisor support|supervisor support
4908185|NCT02050204|long work hours|long work hours
4908186|NCT02050204|cardiometabolic risk|cardiometabolic risk
4908187|NCT02050204|sleep duration|sleep duration
4908188|NCT02050204|insomnia symptoms|insomnia symptoms
4908189|NCT02050178|Pancreatic Cancer|pancreatic cancer
4908190|NCT02050178|Stage IV Pancreatic Cancer|stage iv pancreatic cancer
4908191|NCT02050165|obesity|obesity
4908192|NCT02050165|snacks|snacks
4908193|NCT02050165|satiety|satiety
4908194|NCT02050165|hunger|hunger
4908195|NCT02050152|Amnesia|amnesia
4908196|NCT02050152|Memory|memory
4908197|NCT02050152|Implicit|implicit
4908198|NCT02050152|Explicit|explicit
4908199|NCT02050152|Nitrous Oxide|nitrous oxide
4908200|NCT02050139|L-Cysteine|l-cysteine
4908201|NCT02050139|Peritoneal dialysis|peritoneal dialysis
4908202|NCT02050139|Diuresis|diuresis
4908203|NCT02050139|Glomerular filtration rate|glomerular filtration rate
4908204|NCT02050139|Peritoneal function|peritoneal function
4908205|NCT02050139|Inflammation|inflammation
4908206|NCT02050113|Complex Aortic Aneurysms|complex aortic aneurysms
4908207|NCT02050113|Thoracoabdominal Aneurysms|thoracoabdominal aneurysms
4908208|NCT02050113|Pararenal Aortic Aneurysms|pararenal aortic aneurysms
4908209|NCT02050113|Juxtarenal Renal Aneurysms|juxtarenal renal aneurysms
4908210|NCT02050113|Endovascular Branch Graft|endovascular branch graft
4908211|NCT02050113|Fenestrated Stent Graft|fenestrated stent graft
4908212|NCT02050113|Abdominal Aortic Aneurysm|abdominal aortic aneurysm
4908213|NCT02050113|Endovascular|endovascular
4908214|NCT02050100|primary lung adenocarcinoma Stages I, II, IIIA, IIIB|primary lung adenocarcinoma stages i, ii, iiia, iiib
4908215|NCT02050100|squamous cell carcinoma Stages I, II, IIIA, IIIB|squamous cell carcinoma stages i, ii, iiia, iiib
4908216|NCT02050100|benign non-calcified pulmonary nodules|benign non-calcified pulmonary nodules
4908217|NCT02050100|early detection|early detection
4908218|NCT02050087|Rotator cuff|rotator cuff
4908219|NCT02050087|Rehabilitation|rehabilitation
4908220|NCT02050048|Pancreatitis|pancreatitis
4908221|NCT02050048|Endoscopic retrograde cholangiopancreatography|endoscopic retrograde cholangiopancreatography
4908222|NCT02050048|Cholangiopancreatography, Endoscopic Retrograde|cholangiopancreatography, endoscopic retrograde
4908223|NCT02050048|ERCP|ercp
4908224|NCT02050048|High Volume|high volume
4908225|NCT02050048|Lactated Ringer|lactated ringer
4908226|NCT02050048|Intravenous Administration|intravenous administration
4908227|NCT02050048|Sphincterotomy, Endoscopic|sphincterotomy, endoscopic
4908228|NCT02050048|Pancreas|pancreas
4908229|NCT02050035|Exercise Therapy|exercise therapy
4908230|NCT02050035|Endothelium, vascular|endothelium, vascular
4908231|NCT02050035|Blood Vessels|blood vessels
4908232|NCT02050022|Biomarkers|biomarkers
4908233|NCT02050022|Genomics|genomics
4908234|NCT02050022|Proteomics|proteomics
4908235|NCT02050022|Diagnostics|diagnostics
4908236|NCT02050022|Prognostics|prognostics
4908237|NCT02049996|Quality of life|quality of life
4908238|NCT02049996|Robotic surgery|robotic surgery
4908239|NCT02049996|Vaginal surgery|vaginal surgery
4908240|NCT02049996|Prolapse repair|prolapse repair
4908241|NCT02049996|Vaginal hysterectomy|vaginal hysterectomy
4908242|NCT02049970|Supraclavicular block|supraclavicular block
4908243|NCT02049957|MLN0128|mln0128
4908244|NCT02049944|Antibiotic Prophylaxis|antibiotic prophylaxis
4908245|NCT02049944|Obesity|obesity
4908246|NCT02049944|Obesity, Morbid|obesity, morbid
4908247|NCT02049944|Pregnancy|pregnancy
4908353|NCT02049437|Tocilizumab|tocilizumab
4908248|NCT02049944|Infection; Cesarean Section|infection; cesarean section
4908249|NCT02049931|osteoporosis, compression fracture, brace|osteoporosis, compression fracture, brace
4908250|NCT02049918|Respiratory viruses|respiratory viruses
4908251|NCT02049905|soft tissue sarcoma|soft tissue sarcoma
4908252|NCT02049905|unresectable|unresectable
4908253|NCT02049905|metastatic|metastatic
4908254|NCT02049905|locally advanced|locally advanced
4908255|NCT02049905|sarcoma|sarcoma
4908256|NCT02049892|Total Hip Replacement|total hip replacement
4908257|NCT02049892|Metal Ion|metal ion
4908258|NCT02049892|2-5 years after surgery|2-5 years after surgery
4908259|NCT02049892|Asymptomatic|asymptomatic
4908260|NCT02049866|osteoporosis|osteoporosis
4908261|NCT02049866|premenopausal|premenopausal
4908262|NCT02049866|denosumab|denosumab
4908263|NCT02049866|idiopathic|idiopathic
4908264|NCT02049866|Idiopathic Osteoporosis in Premenopausal Women|idiopathic osteoporosis in premenopausal women
4908265|NCT02049853|acute dyspnea|acute dyspnea
4908266|NCT02049853|heart failure|heart failure
4908267|NCT02049853|diagnostics|diagnostics
4908268|NCT02049853|POCT analysis|poct analysis
4908269|NCT02049853|preclinical area|preclinical area
4908270|NCT02049840|Female sling|female sling
4908271|NCT02049840|Stress Urinary Incontinence|stress urinary incontinence
4908272|NCT02049840|Urination Disorders|urination disorders
4908273|NCT02049840|Urologic Diseases|urologic diseases
4908274|NCT02049827|Renal transplant, BK virus|renal transplant, bk virus
4908275|NCT02049814|Drug therapy|drug therapy
4908276|NCT02049762|novel P2Y12 inhibitors|novel p2y12 inhibitors
4908277|NCT02049762|aspirin|aspirin
4908278|NCT02049762|platelet reactivity|platelet reactivity
4908279|NCT02049762|acute coronary syndrome|acute coronary syndrome
4908280|NCT02049749|Child Behavior Problems|child behavior problems
4908281|NCT02049749|Parent Training Program|parent training program
4908282|NCT02049723|Gastroesophageal reflux disease|gastroesophageal reflux disease
4908283|NCT02049723|Knowledge|knowledge
4908284|NCT02049697|Healthy|healthy
4908285|NCT02049697|Healthy male participants|healthy male participants
4908286|NCT02049697|14C-JNJ -39823277|14c-jnj -39823277
4908287|NCT02049697|TPI 1062|tpi 1062
4908288|NCT02049697|Tianeptine|tianeptine
4908289|NCT02049697|Absorption|absorption
4908290|NCT02049697|Metabolism|metabolism
4908291|NCT02049697|Excretion|excretion
4908292|NCT02049697|Pharmacokinetics|pharmacokinetics
4908293|NCT02049658|tumor|tumor
4908294|NCT02049658|cancer|cancer
4908295|NCT02049645|lung cancer|lung cancer
4908296|NCT02049645|breast cancer|breast cancer
4908297|NCT02049632|Breast cancer|breast cancer
4908298|NCT02049632|Sentinel Node Biopsy|sentinel node biopsy
4908299|NCT02049632|Micrometastasis|micrometastasis
4908300|NCT02049632|Axillary lymph node dissection|axillary lymph node dissection
4908301|NCT02049619|Pharyngeal pack|pharyngeal pack
4908302|NCT02049619|Nausea|nausea
4908303|NCT02049619|Vomiting|vomiting
4908304|NCT02049619|orthognathic surgery|orthognathic surgery
4908305|NCT02049619|maxillary osteotomy|maxillary osteotomy
4908306|NCT02049606|LAYLA|layla
4908307|NCT02049606|Non-inferiority|non-inferiority
4908308|NCT02049606|100mm pain VAS|100mm pain vas
4908309|NCT02049593|protocol specific|protocol specific
4908310|NCT02049580|lymphoma|lymphoma
4908311|NCT02049567|cataract, presbyopia|cataract, presbyopia
4908312|NCT02049554|preconception care|preconception care
4908313|NCT02049554|women's health|women's health
4908314|NCT02049541|BKM120|bkm120
4908315|NCT02049541|B-Cell Lymphoma|b-cell lymphoma
4908316|NCT02049541|PI3K inhibitor|pi3k inhibitor
4908317|NCT02049528|Food Effect|food effect
4908318|NCT02049528|Pharmacokinetic|pharmacokinetic
4908319|NCT02049528|Healthy|healthy
4908320|NCT02049528|Male|male
4908321|NCT02049515|Phase 3|phase 3
4908322|NCT02049515|CLL/SLL|cll/sll
4908323|NCT02049515|PI3K|pi3k
4908324|NCT02049502|ulcerative colitis|ulcerative colitis
4908325|NCT02049502|fecal microbiota transplantation|fecal microbiota transplantation
4908326|NCT02049489|ICT-121|ict-121
4908327|NCT02049489|glioblastoma|glioblastoma
4908328|NCT02049489|immunotherapy|immunotherapy
4908329|NCT02049489|dendritic cell vaccine|dendritic cell vaccine
4908330|NCT02049489|CD133|cd133
4908331|NCT02049476|Uveitis, Intermediate|uveitis, intermediate
4908332|NCT02049476|Uveitis, Posterior|uveitis, posterior
4908333|NCT02049476|Dexamethasone|dexamethasone
4908334|NCT02049476|Immunosuppressive Agents|immunosuppressive agents
4908335|NCT02049476|Eye Abnormalities|eye abnormalities
4908336|NCT02049476|Eye Diseases|eye diseases
4908337|NCT02049476|Ophthalmology|ophthalmology
4908338|NCT02049476|Ophthalmologic Surgical Procedures|ophthalmologic surgical procedures
4908339|NCT02049476|Vision Disorders|vision disorders
4908340|NCT02049476|Inflammation|inflammation
4908341|NCT02049463|carotid artery|carotid artery
4908342|NCT02049463|sound|sound
4908343|NCT02049463|stenosis|stenosis
4908344|NCT02049463|wall|wall
4908345|NCT02049463|stroke|stroke
4908346|NCT02049450|thalassemia|thalassemia
4908347|NCT02049450|thalassemia major|thalassemia major
4908348|NCT02049450|spleen enlargement|spleen enlargement
4908349|NCT02049450|INC424|inc424
4908350|NCT02049450|ruxolitinib|ruxolitinib
4908352|NCT02049437|Immune failure|immune failure
4908354|NCT02049437|ACTEMRA|actemra
4908355|NCT02049437|Antiretroviral therapy|antiretroviral therapy
4908356|NCT02049437|HAART|haart
4908357|NCT02049411|Ketamine|ketamine
4908358|NCT02049411|acute cognitive dysfunction|acute cognitive dysfunction
4908359|NCT02049411|geriatric patients|geriatric patients
4908360|NCT02049398|Microbiome|microbiome
4908361|NCT02049398|Saliva|saliva
4908362|NCT02049398|Reliability|reliability
4908363|NCT02049398|Oral Cavity|oral cavity
4908364|NCT02049385|Glutamate|glutamate
4908365|NCT02049385|Pathophysiology|pathophysiology
4908366|NCT02049385|Depression|depression
4908367|NCT02049385|Treatment|treatment
4908368|NCT02049372|complications|complications
4908369|NCT02049372|tonsillectomy|tonsillectomy
4908370|NCT02049372|tonsillotomy|tonsillotomy
4908371|NCT02049359|Diabetes|diabetes
4908372|NCT02049346|Anemia|anemia
4908373|NCT02049346|Hemodialysis|hemodialysis
4908374|NCT02049346|Erythropoetin Stimulating Agents|erythropoetin stimulating agents
4908375|NCT02049346|Comparison|comparison
4908376|NCT02049294|Prednisone|prednisone
4908377|NCT02049294|Eosinophils|eosinophils
4908378|NCT02049294|Immunoglobin E (IgE)|immunoglobin e (ige)
4908379|NCT02049294|Asthma|asthma
4908380|NCT02049294|Bronchitis|bronchitis
4908381|NCT02049294|Inflammation|inflammation
4908382|NCT02049294|Allergy|allergy
4908383|NCT02049268|alcohol|alcohol
4908384|NCT02049268|nicotine|nicotine
4908385|NCT02049268|addiction|addiction
4908386|NCT02049268|functional MRI|functional mri
4908387|NCT02049268|functional connectivity|functional connectivity
4908388|NCT02049268|brain circuits|brain circuits
4908389|NCT02049255|All|all
4908390|NCT02049242|Hemorrhage|hemorrhage
4908391|NCT02049242|Leiomyoma|leiomyoma
4908392|NCT02049242|Myofibroma|myofibroma
4908393|NCT02049242|Uterine Myomectomy|uterine myomectomy
4908394|NCT02049242|Tourniquet|tourniquet
4908395|NCT02049229|Stent|stent
4908396|NCT02049229|Titanium|titanium
4908397|NCT02049229|drug eluting stent|drug eluting stent
4908398|NCT02049229|myocardial infarction|myocardial infarction
4908399|NCT02049229|stent thrombosis|stent thrombosis
4908400|NCT02049216|knee|knee
4908401|NCT02049216|osteoarthritis|osteoarthritis
4908402|NCT02049216|tape|tape
4908403|NCT02049216|exercise|exercise
4908404|NCT02049216|rocktape|rocktape
4908405|NCT02049190|Advanced Prostate Cancer|advanced prostate cancer
4908406|NCT02049190|Castration-resistant Prostate Cancer|castration-resistant prostate cancer
4908407|NCT02049190|Prostatic Neoplasms|prostatic neoplasms
4908408|NCT02049190|Genital Neoplasms, Male|genital neoplasms, male
4908409|NCT02049190|Urogenital Neoplasms|urogenital neoplasms
4908410|NCT02049190|Neoplasms by Site|neoplasms by site
4908411|NCT02049190|Neoplasms|neoplasms
4908412|NCT02049190|Genital Diseases, Male|genital diseases, male
4908413|NCT02049190|Prostatic Diseases|prostatic diseases
4908414|NCT02049190|onapristone|onapristone
4908415|NCT02049177|Cancer|cancer
4908416|NCT02049177|Epidemiology|epidemiology
4908417|NCT02049177|Head and Neck|head and neck
4908418|NCT02049177|HPV|hpv
4908419|NCT02049164|AR08, Vasomotor Symptoms|ar08, vasomotor symptoms
4908420|NCT02049151|Carcinoma, Non-Small-Cell Lung|carcinoma, non-small-cell lung
4908421|NCT02049151|Tecemotide|tecemotide
4908422|NCT02049151|Placebo|placebo
4908423|NCT02049151|NSCLC|nsclc
4908424|NCT02049151|L-BLP25|l-blp25
4908425|NCT02049138|Musculoskeletal Disease|musculoskeletal disease
4908426|NCT02049138|Arthritis|arthritis
4908427|NCT02049138|Joint Diseases|joint diseases
4908428|NCT02049138|Anti-inflammatory Agents|anti-inflammatory agents
4908429|NCT02049138|Antirheumatic agents|antirheumatic agents
4908430|NCT02049125|NGAL|ngal
4908431|NCT02049125|Acute kidney injury|acute kidney injury
4908432|NCT02049125|Cirrhosis|cirrhosis
4908433|NCT02049125|Hepatorenal syndrome|hepatorenal syndrome
4908434|NCT02049112|Cross-over|cross-over
4908435|NCT02049112|Salivary equivalent|salivary equivalent
4908436|NCT02049112|Dry mouth|dry mouth
4908437|NCT02049112|Medical device|medical device
4908438|NCT02049086|SBIRT|sbirt
4908439|NCT02049086|Screening|screening
4908440|NCT02049086|Brief Intervention|brief intervention
4908441|NCT02049086|Referral to Treatment|referral to treatment
4908442|NCT02049086|Pain-Management|pain-management
4908443|NCT02049086|Veterans|veterans
4908444|NCT02049073|hearing loss|hearing loss
4908445|NCT02049073|noise induced hearing loss|noise induced hearing loss
4908446|NCT02049073|zonisamide|zonisamide
4908447|NCT02049060|MPM|mpm
4908448|NCT02049060|NSCLC|nsclc
4908449|NCT02049047|thymoma thymic carcinoma|thymoma thymic carcinoma
4908450|NCT02049034|GLP-1 agonist|glp-1 agonist
4908451|NCT02049034|Lixisenatide|lixisenatide
4908452|NCT02049034|Postprandial glucose metabolism|postprandial glucose metabolism
4908453|NCT02049034|Postprandial lipid metabolism|postprandial lipid metabolism
4908454|NCT02049034|Gastric emptying|gastric emptying
4908455|NCT02049034|Lipoprotein lipase activity|lipoprotein lipase activity
4908456|NCT02049021|schizophrenia|schizophrenia
4908457|NCT02049021|electroconvulsive therapy|electroconvulsive therapy
4908458|NCT02049021|refractory Schizophrenia|refractory schizophrenia
4908459|NCT02049021|super refractory schizophrenia|super refractory schizophrenia
4908460|NCT02049021|clozapine|clozapine
4908461|NCT02048995|Bipolar Disorder|bipolar disorder
4908462|NCT02048995|Depression|depression
4908463|NCT02048995|Light Therapy|light therapy
4908464|NCT02048995|Contrast Sensitivity|contrast sensitivity
4908465|NCT02048995|Visual Evoked Potential|visual evoked potential
4908466|NCT02048995|Visual or Neural Responses|visual or neural responses
4908467|NCT02048995|Biomarker|biomarker
4908468|NCT02048982|physician prescribing|physician prescribing
4908469|NCT02048982|behavioral economics|behavioral economics
4908470|NCT02048982|primary care practice|primary care practice
4908471|NCT02048969|hepatic encephalopathy|hepatic encephalopathy
4908472|NCT02048969|flumazenil|flumazenil
4908473|NCT02048969|liver cirrhosis|liver cirrhosis
4908474|NCT02048956|knee osteoarthritis|knee osteoarthritis
4908475|NCT02048956|hydrotherapy|hydrotherapy
4908476|NCT02048930|GPRD|gprd
4908477|NCT02048930|effectiveness|effectiveness
4908478|NCT02048930|cost-effectiveness|cost-effectiveness
4908479|NCT02048930|Easyhaler|easyhaler
4908480|NCT02048930|Primary care|primary care
4908481|NCT02048930|DPI|dpi
4908482|NCT02048917|Smoking|smoking
4908483|NCT02048917|Cessation|cessation
4908484|NCT02048917|Bupropion|bupropion
4908485|NCT02048917|Varenicline|varenicline
4908486|NCT02048917|Nicotine|nicotine
4908487|NCT02048917|Counseling|counseling
4908488|NCT02048917|Tobacco|tobacco
4908489|NCT02048904|microalbuminuria|microalbuminuria
4908490|NCT02048904|type 2 diabetes|type 2 diabetes
4908491|NCT02048878|Insomnia|insomnia
4908492|NCT02048865|VTE Cancer|vte cancer
4908493|NCT02048852|menthol|menthol
4908494|NCT02048852|nicotine|nicotine
4908495|NCT02048826|stroke|stroke
4908496|NCT02048800|Treosulfan pharmacokinetics|treosulfan pharmacokinetics
4908497|NCT02048800|Children|children
4908498|NCT02048800|Any condition that requires an allogeneic HSCT|any condition that requires an allogeneic hsct
4908499|NCT02048787|Renal impairment|renal impairment
4908500|NCT02048787|Healthy volunteers|healthy volunteers
4908501|NCT02048787|Clinical pharmacology study|clinical pharmacology study
4908502|NCT02048748|Home Care Services|home care services
4908503|NCT02048748|Telemedicine|telemedicine
4908504|NCT02048696|Exercise training|exercise training
4908505|NCT02048696|High intensity interval training|high intensity interval training
4908506|NCT02048696|left ventricular systolic function|left ventricular systolic function
4908507|NCT02048696|G-protein related kinase 2|g-protein related kinase 2
4908508|NCT02048696|heart failure|heart failure
4908509|NCT02048696|myocardial infarction|myocardial infarction
4908510|NCT02048696|coronary artery disease|coronary artery disease
4908511|NCT02048696|beta adrenergic receptor|beta adrenergic receptor
4908512|NCT02048683|Pharmacokinetics|pharmacokinetics
4908513|NCT02048683|Sevoflurane|sevoflurane
4908514|NCT02048683|Burn|burn
4908515|NCT02048683|Sedation|sedation
4908516|NCT02048670|Pilot study|pilot study
4908517|NCT02048670|Assessment of sway phase|assessment of sway phase
4908518|NCT02048670|Therapy trial phase|therapy trial phase
4908519|NCT02048657|LMA, Foley Airway Stylet Tool (FAST), introducer-tool (I-Tool)|lma, foley airway stylet tool (fast), introducer-tool (i-tool)
4908520|NCT02048644|Platelets adhesion|platelets adhesion
4908521|NCT02048631|oral cancer,Quality of life,Sensory|oral cancer,quality of life,sensory
4908522|NCT02048618|Active Crohn's Disease|active crohn's disease
4908523|NCT02048618|GLPG0634|glpg0634
4908524|NCT02048592|cystic fibrosis, immunonutrition, oxidative stress|cystic fibrosis, immunonutrition, oxidative stress
4908525|NCT02048566|Echocardiography, Transesophageal|echocardiography, transesophageal
4908526|NCT02048566|Monitoring, Physiologic|monitoring, physiologic
4908527|NCT02048566|Shock|shock
4908528|NCT02048553|ventriculostomy; complications in neurosurgery;catheter accuracy;|ventriculostomy; complications in neurosurgery;catheter accuracy;
4908529|NCT02048514|Aortic Aneurysm, Abdominal|aortic aneurysm, abdominal
4908530|NCT02048514|Endovascular Procedures|endovascular procedures
4908531|NCT02048501|Weight regain|weight regain
4908532|NCT02048501|Sustain weight loss|sustain weight loss
4908533|NCT02048501|Weight loss|weight loss
4908534|NCT02048501|Gut hormones|gut hormones
4908535|NCT02048488|non small cell lung cancer|non small cell lung cancer
4908536|NCT02048488|NSCLC|nsclc
4908537|NCT02048488|Anaplastic lymphoma kinase|anaplastic lymphoma kinase
4908538|NCT02048488|ALK tyrosine kinase receptor|alk tyrosine kinase receptor
4908539|NCT02048488|ALK+|alk+
4908540|NCT02048488|TRK+|trk+
4908541|NCT02048488|ALK inhibitor|alk inhibitor
4908542|NCT02048488|TRK inhibitor|trk inhibitor
4908543|NCT02048488|tropomyosin receptor kinase|tropomyosin receptor kinase
4908544|NCT02048488|TRKA|trka
4908545|NCT02048488|TRKB|trkb
4908546|NCT02048488|TRKC|trkc
4908547|NCT02048488|advanced malignancy|advanced malignancy
4908548|NCT02048475|desflurane|desflurane
4908549|NCT02048475|electroencephalogram|electroencephalogram
4908550|NCT02048449|Reflux finding score, interrater reliability|reflux finding score, interrater reliability
4908551|NCT02048436|Respiratory Rate|respiratory rate
4908552|NCT02048423|suicidal|suicidal
4908553|NCT02048397|Bronchiectasis.|bronchiectasis.
4908554|NCT02048384|rapamycin|rapamycin
4908555|NCT02048384|metformin|metformin
4908556|NCT02048384|pancreatic cancer|pancreatic cancer
4909049|NCT02046447|Dystonia 1|dystonia 1
4908557|NCT02048384|adenocarcinoma|adenocarcinoma
4908558|NCT02048384|metastatic|metastatic
4908559|NCT02048358|Healthy volunteers|healthy volunteers
4908560|NCT02048358|first in human|first in human
4908561|NCT02048358|2B3-201|2b3-201
4908562|NCT02048358|methylprednisolone|methylprednisolone
4908563|NCT02048358|CNS-targeting|cns-targeting
4908564|NCT02048358|liposomal|liposomal
4908565|NCT02048358|crossover|crossover
4908566|NCT02048358|placebo controlled|placebo controlled
4908567|NCT02048358|active controlled|active controlled
4908568|NCT02048358|multiple sclerosis|multiple sclerosis
4908569|NCT02048358|multiple sclerosis relapse|multiple sclerosis relapse
4908570|NCT02048345|ten mL suspension of posaconazol (Noxafil) together with 240mL water will be taken by the volunteer in a fasted state|ten ml suspension of posaconazol (noxafil) together with 240ml water will be taken by the volunteer in a fasted state
4908571|NCT02048345|ten mL suspension of posaconazol (Noxafil) together with 240mL water will be taken by the volunteer in a fed state|ten ml suspension of posaconazol (noxafil) together with 240ml water will be taken by the volunteer in a fed state
4908572|NCT02048345|two point six mL of suspension that is dissolved in 247mL water will be administered to the volunteer by the stomach catheter in a fasted state|two point six ml of suspension that is dissolved in 247ml water will be administered to the volunteer by the stomach catheter in a fasted state
4908573|NCT02048345|two point six mL of suspension that is dissolved in 247mL water will be administered to the volunteer by the stomach catheter in a fed state|two point six ml of suspension that is dissolved in 247ml water will be administered to the volunteer by the stomach catheter in a fed state
4908574|NCT02048332|Epstein-Barr Virus (EBV)|epstein-barr virus (ebv)
4908575|NCT02048332|Adenovirus (ADV)|adenovirus (adv)
4908576|NCT02048332|t-cells|t-cells
4908577|NCT02048332|donor|donor
4908578|NCT02048332|transplant|transplant
4908579|NCT02048332|children|children
4908580|NCT02048332|cytomegalovirus (CMV)|cytomegalovirus (cmv)
4908581|NCT02048332|BK virus (BKV)|bk virus (bkv)
4908582|NCT02048319|Liver cyst|liver cyst
4908583|NCT02048319|Hepatic cyst|hepatic cyst
4908584|NCT02048319|Symptomatic|symptomatic
4908585|NCT02048319|Aspiration sclerotherapy|aspiration sclerotherapy
4908586|NCT02048306|Chronic obstructive pulmonary disease (COPD)|chronic obstructive pulmonary disease (copd)
4908587|NCT02048306|Pulmonary rehabilitation|pulmonary rehabilitation
4908588|NCT02048306|Family|family
4908589|NCT02048306|Integrated care|integrated care
4908590|NCT02048306|Mixed methods|mixed methods
4908591|NCT02048293|remifentanil|remifentanil
4908592|NCT02048293|propofol|propofol
4908593|NCT02048293|pharmacodynamic|pharmacodynamic
4908594|NCT02048293|total intravenous anesthesia|total intravenous anesthesia
4908595|NCT02048293|orotracheal intubation|orotracheal intubation
4908596|NCT02048293|heart rate|heart rate
4908597|NCT02048293|mean arterial pressure|mean arterial pressure
4908598|NCT02048293|Cooper intubation condition score|cooper intubation condition score
4908599|NCT02048267|Alcoholic|alcoholic
4908600|NCT02048267|Non alcoholic|non alcoholic
4908601|NCT02048267|Idiopathic|idiopathic
4908602|NCT02048267|Tropical|tropical
4908603|NCT02048267|Exocrine dysfunction|exocrine dysfunction
4908604|NCT02048267|Endocrine dysfunction|endocrine dysfunction
4908605|NCT02048267|Pain control|pain control
4908606|NCT02048267|Frey's procedure|frey's procedure
4908607|NCT02048267|Duodenum preserving pancreatic head resection|duodenum preserving pancreatic head resection
4908608|NCT02048254|inoperable salivary gland cancer|inoperable salivary gland cancer
4908609|NCT02048254|brachytherapy|brachytherapy
4908610|NCT02048254|intensity-modulated radiation therapy|intensity-modulated radiation therapy
4908611|NCT02048241|childhood|childhood
4908612|NCT02048241|temper|temper
4908613|NCT02048241|explosive|explosive
4908614|NCT02048241|aggression|aggression
4908615|NCT02048241|tantrums|tantrums
4908616|NCT02048241|oppositional|oppositional
4908617|NCT02048241|defiant|defiant
4908618|NCT02048241|conduct|conduct
4908619|NCT02048241|disruptive|disruptive
4908620|NCT02048241|emotional dysregulation|emotional dysregulation
4908621|NCT02048241|special education|special education
4908622|NCT02048228|Clopidogrel,|clopidogrel,
4908623|NCT02048228|Pharmacogenetics,|pharmacogenetics,
4908624|NCT02048228|Platelet reactivity,|platelet reactivity,
4908625|NCT02048228|CYP2C19,|cyp2c19,
4908626|NCT02048228|point-of-care|point-of-care
4908627|NCT02048215|thermogenesis|thermogenesis
4908628|NCT02048215|low-calorie diet|low-calorie diet
4908629|NCT02048215|uncoupling-protein 3|uncoupling-protein 3
4908630|NCT02048215|beta-3 adrenoceptors|beta-3 adrenoceptors
4908631|NCT02048215|thermogenic drugs|thermogenic drugs
4908632|NCT02048202|clown|clown
4908633|NCT02048202|neonate|neonate
4908634|NCT02048202|premature|premature
4908635|NCT02048176|Mutism|mutism
4908636|NCT02048163|Meropenem|meropenem
4908637|NCT02048163|Nausea|nausea
4908638|NCT02048163|Pharmacokinetics|pharmacokinetics
4908639|NCT02048124|25d ProCor needle|25d procor needle
4908640|NCT02048124|22 gauge|22 gauge
4908641|NCT02048124|endoscopic ultrasonography|endoscopic ultrasonography
4908642|NCT02048124|fine needle biopsies|fine needle biopsies
4908643|NCT02048124|Patients|patients
4908644|NCT02048124|presenting|presenting
4908645|NCT02048111|Hemophilia B|hemophilia b
4908646|NCT02048111|Hemophilia A|hemophilia a
4909050|NCT02046447|fMRI|fmri
4908647|NCT02048111|Blood Coagulation Disorders, Inherited|blood coagulation disorders, inherited
4908648|NCT02048111|Blood Coagulation Disorders|blood coagulation disorders
4908649|NCT02048111|Hematologic Diseases|hematologic diseases
4908650|NCT02048111|Coagulation Protein Disorders|coagulation protein disorders
4908651|NCT02048111|Hemorrhagic Disorders|hemorrhagic disorders
4908652|NCT02048111|Genetic Diseases, Inborn|genetic diseases, inborn
4908653|NCT02048111|Genetic Diseases, X-Linked|genetic diseases, x-linked
4908654|NCT02048098|misoprostol|misoprostol
4908655|NCT02048098|Labor, Induced|labor, induced
4908656|NCT02048098|Pregnancy Trimester, Second|pregnancy trimester, second
4908657|NCT02048098|Abortion, Induced|abortion, induced
4908659|NCT02048085|STEMI|stemi
4908660|NCT02048085|Fibrinolysis|fibrinolysis
4908661|NCT02048085|Pharmacodynamics|pharmacodynamics
4908662|NCT02048085|Pharmacokinetics|pharmacokinetics
4908663|NCT02048085|Plavix|plavix
4908664|NCT02048085|Brilinta|brilinta
4908665|NCT02048085|Ticagrelor|ticagrelor
4908666|NCT02048085|Clopidogrel|clopidogrel
4908667|NCT02048072|relapsing remitting|relapsing remitting
4908668|NCT02048072|multiple sclerosis|multiple sclerosis
4908669|NCT02048072|fingolimod|fingolimod
4908670|NCT02048072|Gilenya|gilenya
4908671|NCT02048072|autonomic nervous system|autonomic nervous system
4908672|NCT02048059|ANG1005|ang1005
4908673|NCT02048059|GRN1005|grn1005
4908674|NCT02048059|Low-density lipoprotein receptor-related protein (LRP-1)|low-density lipoprotein receptor-related protein (lrp-1)
4908675|NCT02048059|Targeted therapy|targeted therapy
4908676|NCT02048059|Breast cancer|breast cancer
4908677|NCT02048059|Brain metastases|brain metastases
4908678|NCT02048059|Brain tumor|brain tumor
4908679|NCT02048059|Blood-brain barrier|blood-brain barrier
4908680|NCT02048059|Trastuzumab|trastuzumab
4908681|NCT02048059|Herceptin|herceptin
4908682|NCT02048059|Paclitaxel|paclitaxel
4908683|NCT02048059|Taxol|taxol
4908684|NCT02048059|Breast cancer with brain metastases|breast cancer with brain metastases
4908685|NCT02048059|Triple Negative|triple negative
4908686|NCT02048059|Triple negative breast cancer (TNBC)|triple negative breast cancer (tnbc)
4908687|NCT02048059|Herceptin 2 (HER2)-positive|herceptin 2 (her2)-positive
4908688|NCT02048059|HER2-negative|her2-negative
4908689|NCT02048059|Metastatic brain tumors|metastatic brain tumors
4908690|NCT02048046|ECMO|ecmo
4908691|NCT02048046|Nutrition therapy|nutrition therapy
4908692|NCT02048033|Obesity|obesity
4908693|NCT02048033|Endogastric suturing|endogastric suturing
4908694|NCT02048033|Jujenal anastomosis|jujenal anastomosis
4908695|NCT02048033|weight regain|weight regain
4908696|NCT02048007|Childhood mortality|childhood mortality
4908697|NCT02048007|Azithromycin|azithromycin
4908698|NCT02048007|Mass treatment|mass treatment
4908699|NCT02048007|Infection|infection
4908700|NCT02048007|Bacterial infections|bacterial infections
4908701|NCT02048007|Trachoma|trachoma
4908702|NCT02048007|Chlamydia infections|chlamydia infections
4908703|NCT02048007|Malaria|malaria
4908704|NCT02048007|Diarrhea|diarrhea
4908705|NCT02048007|Respiratory Infections|respiratory infections
4908706|NCT02048007|Antibiotic resistance|antibiotic resistance
4908707|NCT02048007|Verbal Autopsy|verbal autopsy
4908708|NCT02048007|Microbiome|microbiome
4908709|NCT02047994|Gastric cancer|gastric cancer
4908710|NCT02047994|Gastric cancer mortality|gastric cancer mortality
4908711|NCT02047994|Helicobacter pylori treatment|helicobacter pylori treatment
4908712|NCT02047994|Pepsinogen testing|pepsinogen testing
4908713|NCT02047994|Endoscopy|endoscopy
4908714|NCT02047994|Volatile marker|volatile marker
4908715|NCT02047981|Childhood mortality|childhood mortality
4908716|NCT02047981|Azithromycin|azithromycin
4908717|NCT02047981|Mass treatment|mass treatment
4908718|NCT02047981|Infection|infection
4908719|NCT02047981|Verbal Autopsy|verbal autopsy
4908720|NCT02047968|Wake therapy|wake therapy
4908721|NCT02047968|Sleep deprivation|sleep deprivation
4908722|NCT02047968|Light therapy|light therapy
4908723|NCT02047968|Bipolar depression|bipolar depression
4908724|NCT02047968|Sleep-wake cycle|sleep-wake cycle
4908725|NCT02047968|Major depression|major depression
4908726|NCT02047968|Depression|depression
4908727|NCT02047968|Depressive Disorder|depressive disorder
4908728|NCT02047968|Major Behavioural Symptoms|major behavioural symptoms
4908729|NCT02047968|Mood Disorders|mood disorders
4908730|NCT02047968|Mental Disorders|mental disorders
4908731|NCT02047968|Dyssomnias|dyssomnias
4908732|NCT02047968|Sleep Disorders|sleep disorders
4908733|NCT02047968|Affective Disorders|affective disorders
4908734|NCT02047929|Asthma|asthma
4908735|NCT02047929|Shared decision making|shared decision making
4908736|NCT02047929|Participatory methods|participatory methods
4908737|NCT02047929|Practice facilitator|practice facilitator
4908738|NCT02047929|Health coach|health coach
4908739|NCT02047916|Neonates|neonates
4908740|NCT02047916|Superior Vena Cava Flow|superior vena cava flow
4908741|NCT02047916|Pleth variabilty index|pleth variabilty index
4908742|NCT02047890|CDK inhibitor|cdk inhibitor
4908743|NCT02047890|BAY1000394|bay1000394
4908744|NCT02047890|Advanced malignancies|advanced malignancies
4908745|NCT02047890|Japanese|japanese
4908746|NCT02047877|Respiratory Secretions|respiratory secretions
4908747|NCT02047877|Tracheal Secretions|tracheal secretions
4908748|NCT02047877|Bronchial Secretions|bronchial secretions
4908749|NCT02047877|NonBronchoscopic BAL|nonbronchoscopic bal
4908750|NCT02047877|Interleukin 10|interleukin 10
4908751|NCT02047877|Interleukin 12p70|interleukin 12p70
4908752|NCT02047864|Osteoporosis|osteoporosis
4908753|NCT02047864|Sarcopenia|sarcopenia
4908754|NCT02047864|Strength|strength
4908755|NCT02047864|Bone|bone
4908756|NCT02047864|Muscle|muscle
4908757|NCT02047864|Creatine|creatine
4908758|NCT02047825|Multiple sclerosis|multiple sclerosis
4908759|NCT02047825|Dexterity|dexterity
4908760|NCT02047825|Upper limbs|upper limbs
4908761|NCT02047812|Laparotomy|laparotomy
4908762|NCT02047812|General Surgery|general surgery
4908763|NCT02047812|Hospitals,General|hospitals,general
4908764|NCT02047812|Hospitals,High-Volume|hospitals,high-volume
4908765|NCT02047812|Hospitals,Low-Volume|hospitals,low-volume
4908766|NCT02047812|Outcome Assessment (Health Care)|outcome assessment (health care)
4908767|NCT02047799|elderly people, high blood pressure, vitamin D.|elderly people, high blood pressure, vitamin d.
4908768|NCT02047786|Outcome Assessment (Health Care)|outcome assessment (health care)
4908769|NCT02047786|Appendectomy|appendectomy
4908770|NCT02047786|Child|child
4908771|NCT02047786|Hospitals, Pediatric|hospitals, pediatric
4908772|NCT02047786|Hospitals, General|hospitals, general
4908773|NCT02047773|bronchiectasis|bronchiectasis
4908774|NCT02047773|intravenous antibiotics|intravenous antibiotics
4908775|NCT02047773|duration of antibiotic course|duration of antibiotic course
4908776|NCT02047773|side effects|side effects
4908777|NCT02047773|bacterial load|bacterial load
4908778|NCT02047747|Brain|brain
4908779|NCT02047747|Metastasis|metastasis
4908780|NCT02047747|human epidermal receptor (HER)|human epidermal receptor (her)
4908781|NCT02047695|migraine with aura|migraine with aura
4908782|NCT02047695|migraine|migraine
4908783|NCT02047695|case-control study|case-control study
4908784|NCT02047695|magnetic resonance imaging|magnetic resonance imaging
4908785|NCT02047695|brain diseases|brain diseases
4908786|NCT02047656|Healthy volunteers, hypertension|healthy volunteers, hypertension
4908787|NCT02047643|Type 1 diabetes|type 1 diabetes
4908788|NCT02047643|Hypoglycemia|hypoglycemia
4908789|NCT02047643|Accelerometer|accelerometer
4908790|NCT02047630|Primary open angle glaucoma|primary open angle glaucoma
4908791|NCT02047630|Ocular hypertension|ocular hypertension
4908792|NCT02047630|latanoprost|latanoprost
4908793|NCT02047630|generic|generic
4908794|NCT02047630|intraocular pressure|intraocular pressure
4908795|NCT02047617|Muscle Weakness|muscle weakness
4908796|NCT02047617|Exercise therapy|exercise therapy
4908797|NCT02047617|Physiotherapy|physiotherapy
4908798|NCT02047617|Critical illness|critical illness
4908799|NCT02047617|Intensive care|intensive care
4908800|NCT02047617|Mechanical ventilation|mechanical ventilation
4908801|NCT02047617|Rehabilitation|rehabilitation
4908802|NCT02047604|Phase 2a multiple ascending dose, Anti-Very Late Antigen-1|phase 2a multiple ascending dose, anti-very late antigen-1
4908803|NCT02047578|hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
4908804|NCT02047565|punch biopsy|punch biopsy
4908805|NCT02047552|trauma|trauma
4908806|NCT02047552|iron|iron
4908807|NCT02047552|anemia|anemia
4908808|NCT02047552|red blood cell transfusion|red blood cell transfusion
4908809|NCT02047526|Heart Failure|heart failure
4908810|NCT02047526|Cardiovascular disease|cardiovascular disease
4908811|NCT02047526|Congestive Heart Failure|congestive heart failure
4908812|NCT02047500|TH-302|th-302
4908813|NCT02047500|Nab-paclitaxel|nab-paclitaxel
4908814|NCT02047500|Gemcitabine|gemcitabine
4908815|NCT02047500|Evofosfamide|evofosfamide
4908816|NCT02047461|Molybdenum cofactor deficiency (MoCD)|molybdenum cofactor deficiency (mocd)
4908817|NCT02047461|molybdenum cofactor (MoCo) biosynthesis|molybdenum cofactor (moco) biosynthesis
4908818|NCT02047461|sulfite oxidase (SO)|sulfite oxidase (so)
4908819|NCT02047461|xanthine dehydrogenase|xanthine dehydrogenase
4908820|NCT02047461|aldehyde oxidase|aldehyde oxidase
4908821|NCT02047461|S sulfocysteine (SSC)|s sulfocysteine (ssc)
4908822|NCT02047448|transition of care|transition of care
4908823|NCT02047448|care transitions|care transitions
4908824|NCT02047448|readmission|readmission
4908825|NCT02047448|medication|medication
4908826|NCT02047448|adherence|adherence
4908827|NCT02047448|medication management|medication management
4908828|NCT02047448|medication reconciliation|medication reconciliation
4908829|NCT02047448|patient counseling|patient counseling
4908830|NCT02047448|pharmacist|pharmacist
4908831|NCT02047435|Social participation|social participation
4908832|NCT02047435|Loneliness|loneliness
4908833|NCT02047435|General practice|general practice
4908834|NCT02047435|Cultural institutions|cultural institutions
4908835|NCT02047422|Heart failure, diuretics, kidney, glomerular filtration rate|heart failure, diuretics, kidney, glomerular filtration rate
4908836|NCT02047383|respiratory infection|respiratory infection
4908837|NCT02047383|physical variables|physical variables
4908838|NCT02047370|stretching, diaphragm, asthma, manual therapy|stretching, diaphragm, asthma, manual therapy
4908839|NCT02047357|Maternal depression|maternal depression
4908840|NCT02047357|Mother|mother
4908841|NCT02047357|Child|child
4908842|NCT02047357|LTP|ltp
4908843|NCT02047357|Learning Through Play|learning through play
4908844|NCT02047357|Healthy thinking|healthy thinking
4908845|NCT02047344|NSCLC|nsclc
4908846|NCT02047331|periarticular drug injection|periarticular drug injection
4908847|NCT02047331|fascia iliaca block|fascia iliaca block
4908848|NCT02047331|knee arthroplasty|knee arthroplasty
4908849|NCT02047305|ESCN|escn
4908850|NCT02047305|RFA|rfa
4908851|NCT02047292|Gait analysis|gait analysis
4908852|NCT02047292|3D videofluoroscopy|3d videofluoroscopy
4908853|NCT02047292|Femoroacetabular impingement|femoroacetabular impingement
4908854|NCT02047292|Neck-cup impingement|neck-cup impingement
4908855|NCT02047292|Head-neck ratio|head-neck ratio
4908856|NCT02047292|Hip scores|hip scores
4908857|NCT02047292|Functional assessment|functional assessment
4908858|NCT02047292|Cup size|cup size
4908859|NCT02047292|Range of motion|range of motion
4908860|NCT02047292|Unilateral Primary|unilateral primary
4908861|NCT02047292|Secondary|secondary
4908862|NCT02047279|Atrial fibrillation|atrial fibrillation
4908863|NCT02047279|Mitral valve|mitral valve
4908864|NCT02047266|MICS CABG OPCABG ONCABG CAD|mics cabg opcabg oncabg cad
4908865|NCT02047253|carfilzomib|carfilzomib
4908866|NCT02047253|prostate cancer|prostate cancer
4908867|NCT02047253|PSA (prostate-specific antigen)|psa (prostate-specific antigen)
4908868|NCT02047253|CRPC (castration-resistant prostate cancer)|crpc (castration-resistant prostate cancer)
4908869|NCT02047240|liver cirrhosis|liver cirrhosis
4908870|NCT02047240|glomerular filtration|glomerular filtration
4908871|NCT02047240|cystatin C|cystatin c
4908872|NCT02047227|ESPART|espart
4908873|NCT02047227|Reproductive Techniques, Assisted|reproductive techniques, assisted
4908874|NCT02047227|Infertility|infertility
4908875|NCT02047227|Pergoveris®|pergoveris®
4908876|NCT02047227|GONAL-f®|gonal-f®
4908877|NCT02047214|Glioblastoma multiforme|glioblastoma multiforme
4908878|NCT02047214|Glioblastoma|glioblastoma
4908879|NCT02047214|Radiotherapy|radiotherapy
4908880|NCT02047214|Temozolomide|temozolomide
4908881|NCT02047214|TPI 287|tpi 287
4908882|NCT02047214|Taxoid|taxoid
4908883|NCT02047214|Avastin|avastin
4908884|NCT02047214|Bevacizumab|bevacizumab
4908885|NCT02047201|Head and neck cancer|head and neck cancer
4908886|NCT02047201|PET/CT|pet/ct
4908887|NCT02047201|induction chemotherapy|induction chemotherapy
4908888|NCT02047201|IMRT|imrt
4908889|NCT02047188|narrow band imaging,microvessels,matrix metalloproteinase-7|narrow band imaging,microvessels,matrix metalloproteinase-7
4908890|NCT02047162|diarrhea|diarrhea
4908891|NCT02047162|gastroenteritis|gastroenteritis
4908892|NCT02047162|antimicrobial drug resistance|antimicrobial drug resistance
4908893|NCT02047162|antimicrobial agents|antimicrobial agents
4908894|NCT02047162|Pakistan|pakistan
4908895|NCT02047162|ambulatory care|ambulatory care
4908896|NCT02047162|bismuth|bismuth
4908897|NCT02047149|Myelogenous Leukemia|myelogenous leukemia
4908898|NCT02047123|commercial flaxseed|commercial flaxseed
4908899|NCT02047123|cholesterol|cholesterol
4908900|NCT02047123|lipidic profile|lipidic profile
4908901|NCT02047123|yoghurt|yoghurt
4908902|NCT02047123|consumption|consumption
4908903|NCT02047110|ABBV-066|abbv-066
4908904|NCT02047110|BI 655066|bi 655066
4908905|NCT02047110|risankizumab|risankizumab
4908906|NCT02047071|Obstructive sleep apnea|obstructive sleep apnea
4908907|NCT02047071|Female gender|female gender
4908908|NCT02047071|Continuous Positive Airway Pressure|continuous positive airway pressure
4908909|NCT02047058|biomarker|biomarker
4908910|NCT02047058|Q cell|q cell
4908911|NCT02047058|Overall survival|overall survival
4908912|NCT02047058|Progression-free survival|progression-free survival
4908913|NCT02047045|severe chronic constipation|severe chronic constipation
4908914|NCT02047045|randomized controlled|randomized controlled
4908915|NCT02047045|electro-acupuncture|electro-acupuncture
4908916|NCT02047045|prucalopride|prucalopride
4908917|NCT02047032|electroacupuncture|electroacupuncture
4908918|NCT02047032|urinary incontinence|urinary incontinence
4908919|NCT02047032|PFMT|pfmt
4908920|NCT02047032|Solifenacin|solifenacin
4908921|NCT02047019|Drug combination|drug combination
4908922|NCT02047019|Nifedipine GITS|nifedipine gits
4908923|NCT02047019|Candesartan Cilexetil|candesartan cilexetil
4908924|NCT02047019|Hypertension|hypertension
4908925|NCT02047019|Combination therapy|combination therapy
4908926|NCT02047006|Hemodialysis|hemodialysis
4908927|NCT02047006|Rivaroxaban|rivaroxaban
4908928|NCT02047006|AUC|auc
4908929|NCT02046993|Hypertension|hypertension
4908930|NCT02046993|self blood pressure monitoring|self blood pressure monitoring
4908931|NCT02046993|smartphone based telemonitoring|smartphone based telemonitoring
4908932|NCT02046993|primary care|primary care
4908933|NCT02046967|endovenous laser ablation|endovenous laser ablation
4908934|NCT02046967|endovenous steam ablation|endovenous steam ablation
4908935|NCT02046967|great saphenous veins|great saphenous veins
4908936|NCT02046967|quality of life|quality of life
4908937|NCT02046954|transesophageal echocardiography|transesophageal echocardiography
4908938|NCT02046954|tee|tee
4908939|NCT02046954|toe|toe
4908940|NCT02046954|cardiac surgery|cardiac surgery
4908941|NCT02046941|aphasia|aphasia
4908942|NCT02046941|stroke|stroke
4908943|NCT02046941|Magnetic Resonance Imaging|magnetic resonance imaging
4909051|NCT02046447|healthy|healthy
4908944|NCT02046941|Diffusion Magnetic Resonance Imaging|diffusion magnetic resonance imaging
4908945|NCT02046928|Leukemia|leukemia
4908946|NCT02046928|Lymphoma|lymphoma
4908947|NCT02046902|coronary artery disease|coronary artery disease
4908948|NCT02046902|cardiac stent|cardiac stent
4908949|NCT02046902|PCI procedure|pci procedure
4908950|NCT02046902|Patient preference|patient preference
4908951|NCT02046876|neck pain|neck pain
4908952|NCT02046876|physiotherapy|physiotherapy
4908953|NCT02046876|adapted swimming|adapted swimming
4908954|NCT02046876|therapeutic exercises|therapeutic exercises
4908955|NCT02046876|health education|health education
4908956|NCT02046863|Parkinson's disease|parkinson's disease
4908957|NCT02046863|Tremor|tremor
4908958|NCT02046863|Bradykinesia|bradykinesia
4908959|NCT02046863|Deep brain stimulation|deep brain stimulation
4908960|NCT02046863|Kinesia|kinesia
4908961|NCT02046850|Phase I, healthy, pharmacokinetics,|phase i, healthy, pharmacokinetics,
4908962|NCT02046837|Prostate cancer|prostate cancer
4908963|NCT02046837|Exercise|exercise
4908964|NCT02046837|Elderly|elderly
4908965|NCT02046837|Quality of life|quality of life
4908966|NCT02046837|Fatigue|fatigue
4908967|NCT02046837|Physical fitness|physical fitness
4908968|NCT02046837|Adherence|adherence
4908969|NCT02046837|Cost-effectiveness|cost-effectiveness
4908970|NCT02046811|Skin neoplasms|skin neoplasms
4908971|NCT02046811|Radiation|radiation
4908972|NCT02046811|Screening|screening
4908973|NCT02046811|Self-examination|self-examination
4908974|NCT02046811|Comparative effectiveness research|comparative effectiveness research
4908975|NCT02046811|Dermoscopy|dermoscopy
4908976|NCT02046798|Pharmacokinetics|pharmacokinetics
4908977|NCT02046798|ASP3652|asp3652
4908978|NCT02046798|14C radio-labeled|14c radio-labeled
4908979|NCT02046798|Phase 1|phase 1
4908980|NCT02046785|Fluid administration|fluid administration
4908981|NCT02046785|Cardiac output|cardiac output
4908982|NCT02046785|Right atrial pressure|right atrial pressure
4908983|NCT02046785|Resuscitation|resuscitation
4908984|NCT02046772|hemorrhoidectomy|hemorrhoidectomy
4908985|NCT02046772|analgesia|analgesia
4908986|NCT02046772|anaesthetic|anaesthetic
4908987|NCT02046772|bupivacaine|bupivacaine
4908988|NCT02046772|morphine chloride|morphine chloride
4908989|NCT02046733|SCLC|sclc
4908990|NCT02046733|CTLA-4|ctla-4
4908991|NCT02046694|acute lymphoblastic leukemia|acute lymphoblastic leukemia
4908992|NCT02046694|ALL|all
4908993|NCT02046694|pediatric|pediatric
4908994|NCT02046694|maintenance|maintenance
4908995|NCT02046694|allopurinol|allopurinol
4908996|NCT02046694|6-MP|6-mp
4908997|NCT02046694|6-mercaptopurine|6-mercaptopurine
4908998|NCT02046681|Medication Adherence|medication adherence
4908999|NCT02046681|Medication Compliance|medication compliance
4909000|NCT02046681|Medication Therapy Management|medication therapy management
4909001|NCT02046681|Side effects|side effects
4909002|NCT02046681|Analgesics|analgesics
4909003|NCT02046681|Emergency Medicine|emergency medicine
4909004|NCT02046681|Home care|home care
4909005|NCT02046681|Aged|aged
4909006|NCT02046681|Acetaminophen|acetaminophen
4909007|NCT02046681|codeine|codeine
4909008|NCT02046681|ibuprofen|ibuprofen
4909009|NCT02046681|Oxycodone|oxycodone
4909010|NCT02046668|Osteoarthritis of knee|osteoarthritis of knee
4909011|NCT02046642|Amniotic fluid index;|amniotic fluid index;
4909012|NCT02046642|amniotic fluid volume;|amniotic fluid volume;
4909013|NCT02046642|intervention studies;|intervention studies;
4909014|NCT02046642|maternal care patterns;|maternal care patterns;
4909015|NCT02046642|mother-fetus relationships;|mother-fetus relationships;
4909016|NCT02046642|rest;|rest;
4909017|NCT02046642|sonography;|sonography;
4909018|NCT02046642|transplacental exposure|transplacental exposure
4909019|NCT02046590|Propofol|propofol
4909020|NCT02046590|remifentanil|remifentanil
4909021|NCT02046590|safety|safety
4909022|NCT02046590|gastro-intestinal|gastro-intestinal
4909023|NCT02046590|ERCP|ercp
4909024|NCT02046590|minimally invasive|minimally invasive
4909025|NCT02046590|intubation|intubation
4909026|NCT02046590|ventilation|ventilation
4909027|NCT02046577|Acute respiratory tract infections|acute respiratory tract infections
4909028|NCT02046577|vitamin D|vitamin d
4909029|NCT02046577|cholecalciferol|cholecalciferol
4909030|NCT02046577|children|children
4909031|NCT02046577|bronchiolitis|bronchiolitis
4909032|NCT02046577|pneumonia|pneumonia
4909033|NCT02046577|prevention|prevention
4909034|NCT02046551|nicotine|nicotine
4909035|NCT02046551|smoking|smoking
4909036|NCT02046551|atomoxetine|atomoxetine
4909037|NCT02046551|stress|stress
4909038|NCT02046525|Fecal microbiota therapy|fecal microbiota therapy
4909039|NCT02046512|Probiotics|probiotics
4909040|NCT02046499|Prevention, post partum haemorrhage|prevention, post partum haemorrhage
4909041|NCT02046486|ticagrelor|ticagrelor
4909042|NCT02046486|ST elevation myocardial infarction|st elevation myocardial infarction
4909043|NCT02046486|liquid formulation|liquid formulation
4909044|NCT02046447|dystonia|dystonia
4909045|NCT02046447|cervical dystonia|cervical dystonia
4909046|NCT02046447|DYT1|dyt1
4909047|NCT02046447|DYT 1|dyt 1
4909048|NCT02046447|DYT-1|dyt-1
4909052|NCT02046447|trihexyphenidyl|trihexyphenidyl
4909053|NCT02046447|Artane|artane
4909054|NCT02046447|Apo-Trihex|apo-trihex
4909055|NCT02046447|Parkin|parkin
4909056|NCT02046447|Pacitane|pacitane
4909057|NCT02046447|Benzhexol|benzhexol
4909058|NCT02046447|Trihex|trihex
4909059|NCT02046408|Smoking|smoking
4909060|NCT02046408|5A's for smoking cessation|5a's for smoking cessation
4909061|NCT02046408|tailored health messages|tailored health messages
4909062|NCT02046408|Patient-facing information technology|patient-facing information technology
4909063|NCT02046408|Mobile health|mobile health
4909064|NCT02046408|behavioral health|behavioral health
4909065|NCT02046395|Type 2 Diabetes|type 2 diabetes
4909066|NCT02046395|Hypertension|hypertension
4909067|NCT02046382|IV Acetaminophen|iv acetaminophen
4909068|NCT02046382|Cesarean Section|cesarean section
4909069|NCT02046382|Pain, Postoperative|pain, postoperative
4909070|NCT02046369|Lurasidone, Latuda, Bipolar Depression|lurasidone, latuda, bipolar depression
4909071|NCT02046356|hepatocellular carcinoma|hepatocellular carcinoma
4909072|NCT02046356|radiofrequency ablation|radiofrequency ablation
4909073|NCT02046356|Milan Criteria|milan criteria
4909074|NCT02046356|recurrence|recurrence
4909075|NCT02046356|risk factor|risk factor
4909076|NCT02046343|physical activity|physical activity
4909077|NCT02046343|prevention|prevention
4909078|NCT02046343|health disparities|health disparities
4909079|NCT02046343|behavior|behavior
4909080|NCT02046343|community based intervention|community based intervention
4909081|NCT02046330|Deep Brain Stimulation|deep brain stimulation
4909082|NCT02046330|Treatment Resistant Depression|treatment resistant depression
4909083|NCT02046330|Major Depressive Disorder|major depressive disorder
4909084|NCT02046330|Depression|depression
4909085|NCT02046330|ECT|ect
4909086|NCT02046330|TNS|tns
4909087|NCT02046304|Sarcoma|sarcoma
4909088|NCT02046304|Soft Tissue Sarcomas|soft tissue sarcomas
4909089|NCT02046304|STS|sts
4909090|NCT02046304|Extremity and Trunk|extremity and trunk
4909091|NCT02046304|Gemcitabine|gemcitabine
4909092|NCT02046304|Gemcitabine Hydrochloride|gemcitabine hydrochloride
4909093|NCT02046304|Gemzar|gemzar
4909094|NCT02046304|External beam radiation therapy|external beam radiation therapy
4909095|NCT02046304|EBRT|ebrt
4909096|NCT02046304|Radiotherapy|radiotherapy
4909097|NCT02046304|XRT|xrt
4909098|NCT02046291|umbilical cord transplant|umbilical cord transplant
4909099|NCT02046291|acute leukemia|acute leukemia
4909100|NCT02046291|UCBT|ucbt
4909101|NCT02046291|Hodgkin's Lymphoma|hodgkin's lymphoma
4909102|NCT02046291|Lymphoid Leukemia|lymphoid leukemia
4909103|NCT02046291|Multiple Myeloma|multiple myeloma
4909104|NCT02046291|Myeloid and Monocytic Leukemia|myeloid and monocytic leukemia
4909105|NCT02046291|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
4909106|NCT02046291|Hematopoietic malignancies|hematopoietic malignancies
4909107|NCT02046265|Cervical cancer prevention|cervical cancer prevention
4909108|NCT02046226|Critical Limb Ischemia|critical limb ischemia
4909109|NCT02046226|Non Healing Wounds|non healing wounds
4909110|NCT02046226|Diabetic Wounds|diabetic wounds
4909111|NCT02046226|Foot Ulcers|foot ulcers
4909112|NCT02046213|Metabolism and Excretion|metabolism and excretion
4909113|NCT02046200|ivermectin, alcoholism, alcohol use disorder, treatment|ivermectin, alcoholism, alcohol use disorder, treatment
4909114|NCT02046187|Ketogenic Diet|ketogenic diet
4909115|NCT02046187|Brain tumor|brain tumor
4909116|NCT02046187|Glioma|glioma
4909117|NCT02046187|Glioblastoma|glioblastoma
4909118|NCT02046187|Radiation|radiation
4909119|NCT02046187|Chemotherapy|chemotherapy
4909120|NCT02046187|temozolomide|temozolomide
4909121|NCT02046174|colon|colon
4909122|NCT02046174|colorectal|colorectal
4909123|NCT02046174|rectal|rectal
4909124|NCT02046174|cancer|cancer
4909125|NCT02046174|macrobead|macrobead
4909126|NCT02046174|stage IV|stage iv
4909127|NCT02046174|metastatic|metastatic
4909128|NCT02046174|biological|biological
4909129|NCT02046174|mouse cells|mouse cells
4909130|NCT02046174|new york|new york
4909131|NCT02046174|new jersey|new jersey
4909132|NCT02046174|clinical research|clinical research
4909133|NCT02046161|colon preparation|colon preparation
4909134|NCT02046148|Maternal vaccine|maternal vaccine
4909135|NCT02046148|IgG|igg
4909136|NCT02046148|IgA|iga
4909137|NCT02046148|GBS|gbs
4909138|NCT02046148|pregnant women|pregnant women
4909139|NCT02046135|Pediatric|pediatric
4909140|NCT02046135|Sodium bicarbonate|sodium bicarbonate
4909141|NCT02046135|Acute kidney injury|acute kidney injury
4909142|NCT02046135|Cardiac surgery|cardiac surgery
4909143|NCT02046109|Repair|repair
4909144|NCT02046109|Replace|replace
4909145|NCT02046109|Composite|composite
4909146|NCT02046109|restoration|restoration
4909147|NCT02046109|failing dental restoration|failing dental restoration
4909148|NCT02046109|filling|filling
4909149|NCT02046109|dental|dental
4909150|NCT02046109|dentistry|dentistry
4909151|NCT02046096|Venous thrombosis|venous thrombosis
4909152|NCT02046096|pulmonary embolism|pulmonary embolism
4909153|NCT02046096|vena cava, inferior|vena cava, inferior
4909154|NCT02046096|vena cava filters|vena cava filters
4909155|NCT02046096|venous thromboembolism|venous thromboembolism
4909156|NCT02046083|Teenager|teenager
4909157|NCT02046083|Peanut|peanut
4909158|NCT02046083|OIT (Oral Induction Tolerance)|oit (oral induction tolerance)
4909159|NCT02046070|MLN9708|mln9708
4909160|NCT02046070|Newly diagnosed|newly diagnosed
4909161|NCT02046070|NDMM|ndmm
4909162|NCT02046070|IXAZOMIB|ixazomib
4909163|NCT02046070|RRMM|rrmm
4909164|NCT02046057|Sentinel Lymph Node|sentinel lymph node
4909165|NCT02046057|Ultrasound Guided Needle Core Biopsy|ultrasound guided needle core biopsy
4909166|NCT02046044|Heart failure|heart failure
4909167|NCT02046044|Digoxin|digoxin
4909168|NCT02046044|Ivabradine|ivabradine
4909169|NCT02046031|Ischemic stroke|ischemic stroke
4909170|NCT02046031|safety|safety
4909171|NCT02046031|Pharmacokinetics|pharmacokinetics
4909172|NCT02046031|Ginkgolides Meglumine Injection|ginkgolides meglumine injection
4909173|NCT02046018|Maternal and Child Health|maternal and child health
4909174|NCT02046018|Rural Uganda|rural uganda
4909175|NCT02046005|Family History|family history
4909176|NCT02046005|RA|ra
4909177|NCT02046005|Rheumatoid Arthritis|rheumatoid arthritis
4909178|NCT02046005|Genetics|genetics
4909179|NCT02046005|Rheumatoid Factor|rheumatoid factor
4909180|NCT02046005|Shared Epitope|shared epitope
4909181|NCT02046005|Anti-CCP|anti-ccp
4909182|NCT02045953|Healthy Subjects|healthy subjects
4909183|NCT02045953|SERETIDE|seretide
4909184|NCT02045953|Pharmocokinetics|pharmocokinetics
4909185|NCT02045953|FLIXOTIDE|flixotide
4909186|NCT02045953|VENTOLIN Mini-Spacer|ventolin mini-spacer
4909187|NCT02045940|FTIH|ftih
4909188|NCT02045940|pharmacokinetics|pharmacokinetics
4909189|NCT02045940|SARM|sarm
4909190|NCT02045940|safety|safety
4909191|NCT02045927|sedation|sedation
4909192|NCT02045927|BIS|bis
4909193|NCT02045927|monitoring|monitoring
4909194|NCT02045914|calcium ionophore|calcium ionophore
4909195|NCT02045914|fertilization rate|fertilization rate
4909196|NCT02045914|poor ovarian reserve|poor ovarian reserve
4909197|NCT02045901|Nausea|nausea
4909198|NCT02045901|Vomiting|vomiting
4909199|NCT02045901|Pregnancy|pregnancy
4909200|NCT02045901|Adolescent|adolescent
4909201|NCT02045901|Diclegis|diclegis
4909202|NCT02045901|Morning|morning
4909203|NCT02045901|Sickness|sickness
4909204|NCT02045888|Hamstring|hamstring
4909205|NCT02045888|Tear|tear
4909206|NCT02045888|Muscle|muscle
4909207|NCT02045888|Grade|grade
4909208|NCT02045888|adipose|adipose
4909209|NCT02045888|cells|cells
4909210|NCT02045888|regenerative|regenerative
4909211|NCT02045888|Celution|celution
4909212|NCT02045888|stem|stem
4909213|NCT02045888|cell|cell
4909214|NCT02045888|liposuction|liposuction
4909215|NCT02045888|fat|fat
4909216|NCT02045875|Adherence monitoring|adherence monitoring
4909217|NCT02045875|Motivational Interviewing Adherence strategies|motivational interviewing adherence strategies
4909218|NCT02045862|Solifenacin Succinate|solifenacin succinate
4909219|NCT02045862|Mirabegron|mirabegron
4909220|NCT02045862|Urinary Incontinence|urinary incontinence
4909221|NCT02045862|Combination Therapy|combination therapy
4909222|NCT02045862|Urgency|urgency
4909223|NCT02045862|Nocturia|nocturia
4909224|NCT02045862|Overactive Bladder|overactive bladder
4909225|NCT02045849|pharmacokinetics|pharmacokinetics
4909226|NCT02045849|GSK2140944|gsk2140944
4909227|NCT02045849|tolerability|tolerability
4909228|NCT02045849|drug interaction|drug interaction
4909229|NCT02045849|safety|safety
4909230|NCT02045849|itraconazole|itraconazole
4909231|NCT02045849|elderly healthy subjects|elderly healthy subjects
4909232|NCT02045849|food effect|food effect
4909233|NCT02045849|relative bioavailability|relative bioavailability
4909234|NCT02045836|Pneumovax 23|pneumovax 23
4909235|NCT02045836|Co-administration|co-administration
4909236|NCT02045836|Herpes zoster|herpes zoster
4909237|NCT02045836|Immunogenicity|immunogenicity
4909238|NCT02045836|Safety|safety
4909239|NCT02045836|Adults|adults
4909240|NCT02045810|Measurement|measurement
4909241|NCT02045810|nosiseption|nosiseption
4909242|NCT02045797|Dose ranging|dose ranging
4909243|NCT02045797|Intravenous|intravenous
4909244|NCT02045797|Adaptive design|adaptive design
4909245|NCT02045797|suspected or confirmed gram-positive acute bacterial skin and skin structure infection|suspected or confirmed gram-positive acute bacterial skin and skin structure infection
4909246|NCT02045797|Subjects|subjects
4909247|NCT02045797|infection|infection
4909248|NCT02045797|Oral|oral
4909249|NCT02045797|GSK2140944|gsk2140944
4909250|NCT02045771|Depression|depression
4909251|NCT02045771|Behavioral Activation|behavioral activation
4909252|NCT02045745|Postoperative air leaks in risk patients.|postoperative air leaks in risk patients.
4909253|NCT02045732|Multiple Sclerosis|multiple sclerosis
4909254|NCT02045732|MRI|mri
4909255|NCT02045719|cat´s claw|cat´s claw
4909256|NCT02045719|uncaria tomentosa|uncaria tomentosa
4909257|NCT02045719|quality of life|quality of life
4909258|NCT02045719|no further therapeutic options|no further therapeutic options
4909259|NCT02045706|Community Health Workers|community health workers
4909260|NCT02045706|Service|service
4909261|NCT02045706|Volunteerism|volunteerism
4909262|NCT02045706|Health Behaviors|health behaviors
4910556|NCT02039973|Tanzania|tanzania
4909263|NCT02045680|colorectal cancer|colorectal cancer
4909264|NCT02045680|laparoscopy|laparoscopy
4909265|NCT02045680|neuromuscular block|neuromuscular block
4909266|NCT02045680|oxygen delivery|oxygen delivery
4909267|NCT02045667|Becker's myotonia congenita (BMC)|becker's myotonia congenita (bmc)
4909268|NCT02045667|Thomson's myotonia congenita (TMC)|thomson's myotonia congenita (tmc)
4909269|NCT02045667|Paramyotonia Congenita (PMC)|paramyotonia congenita (pmc)
4909270|NCT02045667|Sodium Channel Myotonia (SCM)|sodium channel myotonia (scm)
4909271|NCT02045641|cardiac surgery|cardiac surgery
4909272|NCT02045641|postoperative treatment|postoperative treatment
4909273|NCT02045641|pleural effusion|pleural effusion
4909274|NCT02045641|physical performance|physical performance
4909275|NCT02045628|Bariatric Surgery|bariatric surgery
4909276|NCT02045628|Health Psychology|health psychology
4909277|NCT02045602|Cancer|cancer
4909278|NCT02045602|Solid Tumors|solid tumors
4909279|NCT02045602|Gemcitabine|gemcitabine
4909280|NCT02045602|Oncolytic virus|oncolytic virus
4909281|NCT02045602|Metastatic|metastatic
4909282|NCT02045602|Pancreatic cancer|pancreatic cancer
4909283|NCT02045589|Cancer|cancer
4909284|NCT02045589|Pancreatic adenocarcinoma|pancreatic adenocarcinoma
4909285|NCT02045589|Locally advanced|locally advanced
4909286|NCT02045589|Metastatic|metastatic
4909287|NCT02045589|Gemcitabine|gemcitabine
4909288|NCT02045589|Oncolytic virus|oncolytic virus
4909289|NCT02045589|Abraxane®|abraxane®
4909290|NCT02045576|Obstructive Sleep Apnea|obstructive sleep apnea
4909291|NCT02045576|sleep position trainer|sleep position trainer
4909292|NCT02045576|oral appliance therapy|oral appliance therapy
4909293|NCT02045576|mandibular advancement device or splint|mandibular advancement device or splint
4909294|NCT02045537|HIV|hiv
4909295|NCT02045498|cpr|cpr
4909296|NCT02045498|feedback|feedback
4909297|NCT02045498|capnography|capnography
4909298|NCT02045498|outcome|outcome
4909299|NCT02045498|quality|quality
4909300|NCT02045498|resuscitation|resuscitation
4909301|NCT02045472|Influenza|influenza
4909302|NCT02045472|Monoclonal antibody|monoclonal antibody
4909303|NCT02045459|Microvascular Disease|microvascular disease
4909304|NCT02045459|Exercise|exercise
4909305|NCT02045459|Angina|angina
4909306|NCT02045459|Chest pain|chest pain
4909307|NCT02045420|Idiopathic Parkinson's Disease|idiopathic parkinson's disease
4909308|NCT02045420|Magnetic Resonance Imaging|magnetic resonance imaging
4909309|NCT02045420|MR Venography|mr venography
4909310|NCT02045420|Flow Quantification|flow quantification
4909311|NCT02045420|Susceptibility Weighted Imaging|susceptibility weighted imaging
4909312|NCT02045407|Brain Death|brain death
4909313|NCT02045407|Neurological Death|neurological death
4909314|NCT02045407|Cerebral circulatory arrest|cerebral circulatory arrest
4909315|NCT02045407|Computed Tomography Angiography|computed tomography angiography
4909316|NCT02045394|haemoptysis|haemoptysis
4909317|NCT02045394|hemoptysis|hemoptysis
4909318|NCT02045394|airway bleeding|airway bleeding
4909319|NCT02045381|Cancer|cancer
4909320|NCT02045381|MRI|mri
4909321|NCT02045368|refractory|refractory
4909322|NCT02045368|intolerant|intolerant
4909323|NCT02045368|solid tumors|solid tumors
4909324|NCT02045329|Staphylococcus aureus, mupirocin, decolonization|staphylococcus aureus, mupirocin, decolonization
4909325|NCT02045316|Preeclampsia|preeclampsia
4909326|NCT02045316|Aquaporins|aquaporins
4909327|NCT02045316|Placenta|placenta
4909328|NCT02045303|Sub-acute wound|sub-acute wound
4909329|NCT02045303|Chronic wound|chronic wound
4909330|NCT02045303|wound|wound
4909331|NCT02045303|MIST|mist
4909332|NCT02045303|Soring|soring
4909333|NCT02045303|Contact Ultrasound|contact ultrasound
4909334|NCT02045303|Noncontact ultrasound|noncontact ultrasound
4909335|NCT02045303|Wound Care|wound care
4909336|NCT02045303|VIP Ultrasound Protocol|vip ultrasound protocol
4909337|NCT02045303|Ultrasound|ultrasound
4909338|NCT02045264|Firazyr|firazyr
4909339|NCT02045264|Angioedema|angioedema
4909340|NCT02045264|Angioedemas, Hereditary|angioedemas, hereditary
4909341|NCT02045264|Vascular Diseases|vascular diseases
4909342|NCT02045264|Cardiovascular Diseases|cardiovascular diseases
4909343|NCT02045264|Urticaria|urticaria
4909344|NCT02045264|Skin Diseases, Vascular|skin diseases, vascular
4909345|NCT02045264|Skin Diseases|skin diseases
4909346|NCT02045264|Hypersensitivity, Immediate|hypersensitivity, immediate
4909347|NCT02045264|Hypersensitivity|hypersensitivity
4909348|NCT02045264|Immune System Diseases|immune system diseases
4909349|NCT02045264|Genetic Diseases, Inborn|genetic diseases, inborn
4909350|NCT02045264|Icatibant|icatibant
4909351|NCT02045264|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal
4909352|NCT02045264|Analgesics, Non-Narcotic|analgesics, non-narcotic
4909353|NCT02045264|Analgesics|analgesics
4909354|NCT02045264|Sensory System Agents|sensory system agents
4909355|NCT02045264|Peripheral Nervous System Agents|peripheral nervous system agents
4909356|NCT02045264|Physiological Effects of Drugs|physiological effects of drugs
4909357|NCT02045264|Pharmacologic Actions|pharmacologic actions
4909358|NCT02045264|Anti-Inflammatory Agents|anti-inflammatory agents
4909359|NCT02045264|Therapeutic Uses|therapeutic uses
4909360|NCT02045264|Antirheumatic Agents|antirheumatic agents
4909361|NCT02045264|Adrenergic beta-Antagonists|adrenergic beta-antagonists
4909362|NCT02045264|Adrenergic Antagonists|adrenergic antagonists
4909363|NCT02045264|Adrenergic Agents|adrenergic agents
4909364|NCT02045264|Neurotransmitter Agents|neurotransmitter agents
4909365|NCT02045264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
4909366|NCT02045264|Central Nervous System Agents|central nervous system agents
4909367|NCT02045251|Helicobacter pylori|helicobacter pylori
4909368|NCT02045251|H. pylori|h. pylori
4909369|NCT02045251|Pylera|pylera
4909370|NCT02045238|Bronchiolitis|bronchiolitis
4909371|NCT02045238|Therapeutics|therapeutics
4909372|NCT02045238|Saline Solution, Hypertonic|saline solution, hypertonic
4909373|NCT02045225|social anxiety in sexual situations|social anxiety in sexual situations
4909374|NCT02045212|Ischemic Optic Neuropathy|ischemic optic neuropathy
4909375|NCT02045212|Traumatic Neuropathy|traumatic neuropathy
4909376|NCT02045212|Non Arteritic Ischemic Neuropathy (NAION)|non arteritic ischemic neuropathy (naion)
4909377|NCT02045199|Diabetic Neuropathies|diabetic neuropathies
4909378|NCT02045199|Diabetes Mellitus|diabetes mellitus
4909379|NCT02045199|Diabetic Foot|diabetic foot
4909380|NCT02045199|Diabetes Complications|diabetes complications
4909381|NCT02045186|Human Papilloma Virus|human papilloma virus
4909382|NCT02045186|Oropharynx|oropharynx
4909383|NCT02045186|Oropharyngeal Squamous Cell Carcinoma|oropharyngeal squamous cell carcinoma
4909384|NCT02045186|Squamous Cell Carcinoma|squamous cell carcinoma
4909385|NCT02045186|Radiation Therapy|radiation therapy
4909386|NCT02045186|Chemotherapy|chemotherapy
4909387|NCT02045173|Sleep apnea, Arrhythmias, Heart Failure, ICD, CRT-D, Apneascan|sleep apnea, arrhythmias, heart failure, icd, crt-d, apneascan
4909388|NCT02045147|Home Bound Care Transitions|home bound care transitions
4909389|NCT02045134|Post Operative Atrial Fibrillation after a cardiac surgery|post operative atrial fibrillation after a cardiac surgery
4909390|NCT02045082|Flocked swab|flocked swab
4909391|NCT02045082|Traditional fiber swab|traditional fiber swab
4909392|NCT02045082|Herpes simplex epithelial keratitis|herpes simplex epithelial keratitis
4909393|NCT02045082|Quantitative PCR|quantitative pcr
4909394|NCT02045056|Alzheimer disease|alzheimer disease
4909395|NCT02045056|mild cognitive impairment|mild cognitive impairment
4909396|NCT02045056|normal cognition|normal cognition
4909397|NCT02045043|Sudden Cardiac Death|sudden cardiac death
4909398|NCT02045043|Arrhythmias|arrhythmias
4909399|NCT02045043|Congestive Heart Failure|congestive heart failure
4909400|NCT02045043|Cardiomyopathy|cardiomyopathy
4909401|NCT02045043|Single Nucleotide Polymorphisms|single nucleotide polymorphisms
4909402|NCT02045043|Genomics|genomics
4909403|NCT02045030|metastatic|metastatic
4909404|NCT02045030|colorectal|colorectal
4909405|NCT02045030|cancer|cancer
4909406|NCT02045030|aflibercept|aflibercept
4909407|NCT02045030|FOLFIRI|folfiri
4909408|NCT02045017|Multiple Myeloma|multiple myeloma
4909409|NCT02045017|Relapsed Multiple Myeloma|relapsed multiple myeloma
4909410|NCT02045017|Refactory Multiple Myeloma|refactory multiple myeloma
4909411|NCT02045017|Renal Insufficiency|renal insufficiency
4909412|NCT02045017|Pomalidomide|pomalidomide
4909413|NCT02045017|Dexamethasone|dexamethasone
4909414|NCT02045004|Anesthesia|anesthesia
4909415|NCT02045004|Surgery|surgery
4909416|NCT02045004|Geriatrics|geriatrics
4909417|NCT02045004|Postoperative cognitive dysfunction|postoperative cognitive dysfunction
4909418|NCT02045004|Postoperative delirium|postoperative delirium
4909419|NCT02045004|Dementia|dementia
4909420|NCT02045004|Postoperative complications|postoperative complications
4909421|NCT02045004|Neurological complications|neurological complications
4909422|NCT02045004|Psychological complications|psychological complications
4909423|NCT02044991|Sciatica|sciatica
4909424|NCT02044991|Pelvic girdle pain|pelvic girdle pain
4909425|NCT02044965|urinary tract infection|urinary tract infection
4909426|NCT02044965|antibiotic prophylaxis|antibiotic prophylaxis
4909427|NCT02044965|probiotics|probiotics
4909428|NCT02044965|neurogenic bladder|neurogenic bladder
4909429|NCT02044965|clean intermittent catheterization|clean intermittent catheterization
4909430|NCT02044952|Crohn's Disease|crohn's disease
4909431|NCT02044952|mesalazine|mesalazine
4909432|NCT02044952|Tripterygium Glycosides|tripterygium glycosides
4909433|NCT02044952|induction remission|induction remission
4909434|NCT02044939|Sarcoidosis, pulmonary rehabilitation|sarcoidosis, pulmonary rehabilitation
4909435|NCT02044900|obstructive sleep apnea|obstructive sleep apnea
4909436|NCT02044900|polysomnography|polysomnography
4909437|NCT02044900|heart rate variability|heart rate variability
4909438|NCT02044900|mathematical biomarker|mathematical biomarker
4909439|NCT02044887|Physical activity|physical activity
4909440|NCT02044887|dementia|dementia
4909441|NCT02044887|relative caregivers|relative caregivers
4909442|NCT02044887|podometer|podometer
4909443|NCT02044887|cardiovascular risk|cardiovascular risk
4909444|NCT02044848|type 1 diabetes mellitus|type 1 diabetes mellitus
4909445|NCT02044835|atherosclerotic renal artery stenosis, herbal medicine|atherosclerotic renal artery stenosis, herbal medicine
4909446|NCT02044822|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
4909448|NCT02044783|Adults|adults
4909449|NCT02044783|Elderly|elderly
4909450|NCT02044770|laparoscopic|laparoscopic
4909451|NCT02044770|colectomy|colectomy
4909452|NCT02044770|ENSEAL|enseal
4909453|NCT02044757|Caffeine|caffeine
4909454|NCT02044757|Addiction|addiction
4909455|NCT02044757|Withdrawal symptoms|withdrawal symptoms
4909456|NCT02044757|Pediatric|pediatric
4909457|NCT02044757|Adolescent|adolescent
4909458|NCT02044757|Overweight|overweight
4909459|NCT02044744|Obesity|obesity
4909460|NCT02044744|Pediatric Obesity|pediatric obesity
4909461|NCT02044744|Physical Activity|physical activity
4909462|NCT02044744|Physical Fitness|physical fitness
4909463|NCT02044744|Primary Health Care|primary health care
4909464|NCT02044744|Referral and Consultation|referral and consultation
4909465|NCT02044731|Schools|schools
4909466|NCT02044731|Pediatrics|pediatrics
4909467|NCT02044731|Obesity|obesity
4909468|NCT02044731|Overweight|overweight
4909469|NCT02044731|Intervention Studies|intervention studies
4909470|NCT02044731|African Americans|african americans
4909471|NCT02044731|Family|family
4909472|NCT02044731|Body mass index|body mass index
4909473|NCT02044718|adverse events|adverse events
4909474|NCT02044718|unplanned admission intensive care|unplanned admission intensive care
4909475|NCT02044718|chart review|chart review
4909476|NCT02044705|Primary Health Care|primary health care
4909477|NCT02044705|Pediatrics|pediatrics
4909478|NCT02044705|Obesity|obesity
4909479|NCT02044705|Overweight|overweight
4909480|NCT02044705|Clinical trial|clinical trial
4909481|NCT02044705|Hispanic Americans|hispanic americans
4909482|NCT02044705|Family|family
4909483|NCT02044705|Body mass index|body mass index
4909484|NCT02044692|Hunter syndrome|hunter syndrome
4909485|NCT02044692|Mucopolysaccharidosis II|mucopolysaccharidosis ii
4909486|NCT02044692|Hunterase|hunterase
4909487|NCT02044666|Critical Limb Ischemia|critical limb ischemia
4909488|NCT02044666|Amputation|amputation
4909489|NCT02044653|Phase 2|phase 2
4909490|NCT02044614|Hemodialysis/Peritoneal Dialysis|hemodialysis/peritoneal dialysis
4909491|NCT02044614|functionally anuric|functionally anuric
4909492|NCT02044614|Icodextrin|icodextrin
4909493|NCT02044614|Kidney Disease Quality of Life|kidney disease quality of life
4909494|NCT02044601|Lung Cancer|lung cancer
4909495|NCT02044601|Non-small cell lung cancer|non-small cell lung cancer
4909496|NCT02044601|NSCLC|nsclc
4909497|NCT02044601|Squamous cell carcinoma of the lung|squamous cell carcinoma of the lung
4909498|NCT02044601|Adenocarcinoma of the lung|adenocarcinoma of the lung
4909499|NCT02044601|Radiation therapy|radiation therapy
4909500|NCT02044601|Proton therapy|proton therapy
4909501|NCT02044601|XRT|xrt
4909502|NCT02044601|Carboplatin|carboplatin
4909503|NCT02044601|Paraplatin|paraplatin
4909504|NCT02044601|Paclitaxel|paclitaxel
4909505|NCT02044601|Taxol|taxol
4909506|NCT02044601|Onartuzumab|onartuzumab
4909507|NCT02044601|Erlotinib|erlotinib
4909508|NCT02044601|Erlotinib hydrochloride|erlotinib hydrochloride
4909509|NCT02044601|OSI-774|osi-774
4909510|NCT02044601|CP358774|cp358774
4909511|NCT02044601|Tarceva|tarceva
4909512|NCT02044588|HBsAg(+) donor|hbsag(+) donor
4909513|NCT02044588|HBsAg(-) donor|hbsag(-) donor
4909514|NCT02044588|Anti-hepatitis B antibody|anti-hepatitis b antibody
4909515|NCT02044588|Kidney allograft|kidney allograft
4909516|NCT02044575|Clock genes, circadian regulation|clock genes, circadian regulation
4909517|NCT02044562|dietary nitrate|dietary nitrate
4909518|NCT02044562|radiotherapy|radiotherapy
4909519|NCT02044562|nasopharyngeal carcinoma|nasopharyngeal carcinoma
4909520|NCT02044549|Carbetocin|carbetocin
4909521|NCT02044549|syntometrine|syntometrine
4909522|NCT02044549|postpartum hemorrhage|postpartum hemorrhage
4909523|NCT02044549|cesarean section|cesarean section
4909524|NCT02044536|biopsy; endoscopy; neoplasms|biopsy; endoscopy; neoplasms
4909525|NCT02044523|Chronic liver disease|chronic liver disease
4909526|NCT02044523|Fibrosis|fibrosis
4909527|NCT02044523|Elastography|elastography
4909528|NCT02044523|Ultrasound|ultrasound
4909529|NCT02044523|Magnetic resonance elastography|magnetic resonance elastography
4909530|NCT02044523|Diagnostic performance|diagnostic performance
4909531|NCT02044523|Sensitivity and specificity|sensitivity and specificity
4909532|NCT02044510|Multiple Sclerosis|multiple sclerosis
4909533|NCT02044510|Spinal Cord Injuries|spinal cord injuries
4909534|NCT02044510|mirabegron|mirabegron
4909535|NCT02044510|Urodynamics|urodynamics
4909536|NCT02044497|pharmacokinetics|pharmacokinetics
4909537|NCT02044497|pharmacogenomics|pharmacogenomics
4909538|NCT02044497|oral oxycodone|oral oxycodone
4909539|NCT02044497|pediatric surgical patients|pediatric surgical patients
4909540|NCT02044484|HIV|hiv
4909541|NCT02044484|AIDS|aids
4909542|NCT02044484|Viral load|viral load
4909543|NCT02044484|Primary care|primary care
4909544|NCT02044471|left ventricular assist device|left ventricular assist device
4909545|NCT02044471|continuous flow|continuous flow
4909546|NCT02044471|remote ischemic conditioning|remote ischemic conditioning
4909547|NCT02044471|hypertension|hypertension
4909548|NCT02044471|sympathetic tone|sympathetic tone
4909549|NCT02044471|endothelial dysfunction|endothelial dysfunction
4909550|NCT02044458|Foley Catheterization|foley catheterization
4909551|NCT02044458|Induction of Labor|induction of labor
4909552|NCT02044458|5 French Stylette|5 french stylette
4909553|NCT02044445|IVF, hCG, oocyte retrieval, time interval|ivf, hcg, oocyte retrieval, time interval
4909554|NCT02044419|Comparative|comparative
4909555|NCT02044419|Bioavailability|bioavailability
4909556|NCT02044419|lomitapide|lomitapide
4909557|NCT02044341|Acute Otitis Media|acute otitis media
4909558|NCT02044341|Pain|pain
4909559|NCT02044341|Ear Pain|ear pain
4909560|NCT02044341|Ear Ache|ear ache
4909561|NCT02044341|Ear infection|ear infection
4909562|NCT02044341|middle ear infection|middle ear infection
4909563|NCT02044302|pain|pain
4909564|NCT02044302|breast cancer|breast cancer
4909565|NCT02044302|breast implant|breast implant
4909566|NCT02044302|breast reconstruction|breast reconstruction
4909567|NCT02044289|depression|depression
4909568|NCT02044289|electroconvulsive therapy (ECT)|electroconvulsive therapy (ect)
4909569|NCT02044289|magnetic resonance imaging (MRI)|magnetic resonance imaging (mri)
4909570|NCT02044276|Neutropenia|neutropenia
4909571|NCT02044276|NHL|nhl
4909572|NCT02044276|Non-Hodgkin lymphomas|non-hodgkin lymphomas
4909573|NCT02044276|R-CHOP-21|r-chop-21
4909574|NCT02044263|Cognitive therapy|cognitive therapy
4909575|NCT02044263|Behavior therapy|behavior therapy
4909576|NCT02044263|Waiting lists|waiting lists
4909577|NCT02044263|Therapy, computer-assisted|therapy, computer-assisted
4909578|NCT02044263|Internet|internet
4909579|NCT02044250|Aspirin|aspirin
4909580|NCT02044250|Clopidogrel|clopidogrel
4909581|NCT02044250|Antiplatelet monotherapy|antiplatelet monotherapy
4909582|NCT02044250|Drug-eluting stent|drug-eluting stent
4909583|NCT02044237|trichotillomania|trichotillomania
4909584|NCT02044237|online therapy|online therapy
4909585|NCT02044211|Heart Failure, Systolic|heart failure, systolic
4909586|NCT02044211|Depressive Disorder|depressive disorder
4909587|NCT02044211|Depressive Disorder, Major|depressive disorder, major
4909588|NCT02044211|Mood Disorder|mood disorder
4909589|NCT02044198|Plasmodium Falciparum|plasmodium falciparum
4909590|NCT02044198|Malaria|malaria
4909591|NCT02044198|Vaccine|vaccine
4909592|NCT02044198|Plasmodium|plasmodium
4909593|NCT02044198|Falciparum|falciparum
4909594|NCT02044185|HMGB1 Protein|hmgb1 protein
4909595|NCT02044185|Graft versus Host Disease|graft versus host disease
4909596|NCT02044185|Immunosuppressive Agents|immunosuppressive agents
4909597|NCT02044185|oral mucositis|oral mucositis
4909598|NCT02044172|Prostate cancer|prostate cancer
4909599|NCT02044172|Treatment|treatment
4909600|NCT02044172|Screening|screening
4909601|NCT02044172|Surgery|surgery
4909602|NCT02044172|Radiotherapy|radiotherapy
4909603|NCT02044172|Active monitoring|active monitoring
4909604|NCT02044159|Hydrocortisone|hydrocortisone
4909605|NCT02044159|Pediatrics|pediatrics
4909606|NCT02044159|Adrenal Insufficiency|adrenal insufficiency
4909607|NCT02044107|Diarrhea,|diarrhea,
4909608|NCT02044107|Pneumonia,|pneumonia,
4909609|NCT02044107|Zinc treatment,|zinc treatment,
4909610|NCT02044107|Patient Compliance.|patient compliance.
4909611|NCT02044094|Opioid dependent|opioid dependent
4909612|NCT02044094|Buprenorphine|buprenorphine
4909613|NCT02044094|Suboxone Film|suboxone film
4909614|NCT02044094|Opioid blockade|opioid blockade
4909615|NCT02044094|Hydromorphone challenge|hydromorphone challenge
4909616|NCT02044016|Achilles tendon rupture, lengthening, validity, goniometer.|achilles tendon rupture, lengthening, validity, goniometer.
4909617|NCT02044003|angioplasty|angioplasty
4909618|NCT02044003|dissections|dissections
4909619|NCT02043990|NAVA|nava
4909620|NCT02043990|noninvasive ventilation|noninvasive ventilation
4909621|NCT02043990|infants|infants
4909622|NCT02043977|Propofol|propofol
4909623|NCT02043977|Insomnia|insomnia
4909624|NCT02043977|Sleep disorder|sleep disorder
4909625|NCT02043977|Sleep deprivation|sleep deprivation
4909626|NCT02043977|Chronic insomnia|chronic insomnia
4909627|NCT02043977|Refractory insomnia|refractory insomnia
4909628|NCT02043977|Primary insomnia|primary insomnia
4909629|NCT02043964|Multiple Sclerosis|multiple sclerosis
4909630|NCT02043964|Clinically Isolated Syndrome|clinically isolated syndrome
4909631|NCT02043964|Tears|tears
4909632|NCT02043964|Isoelectric focusing|isoelectric focusing
4909633|NCT02043964|Oligoclonal profile|oligoclonal profile
4909634|NCT02043938|Electroencephalography|electroencephalography
4909635|NCT02043938|pharmacological|pharmacological
4909636|NCT02043925|QT-prolongation|qt-prolongation
4909637|NCT02043925|Torsade de Pointes|torsade de pointes
4909638|NCT02043925|drug interactions|drug interactions
4909639|NCT02043925|psychiatry|psychiatry
4909640|NCT02043912|QT-prolongation|qt-prolongation
4909641|NCT02043912|Torsade de Pointes|torsade de pointes
4909642|NCT02043912|Haloperidol|haloperidol
4909643|NCT02043912|Drug interactions|drug interactions
4909644|NCT02043899|Neuroblastoma|neuroblastoma
4909645|NCT02043899|Positron emission tomography|positron emission tomography
4909646|NCT02043899|124-iodine|124-iodine
4909647|NCT02043899|Meta-Iodobenzylguanidine|meta-iodobenzylguanidine
4909648|NCT02043886|Type 2 Diabetes, Postprandial Hypotension, Acarbose|type 2 diabetes, postprandial hypotension, acarbose
4909649|NCT02043873|Clinical Trial|clinical trial
4909650|NCT02043873|Composite Restorations|composite restorations
4909651|NCT02043873|Restorations Repair|restorations repair
4909652|NCT02043873|Replacement Restorations|replacement restorations
4909653|NCT02043873|Operative Dentistry.|operative dentistry.
4909654|NCT02043860|Multiple Myeloma|multiple myeloma
4909655|NCT02043860|High Risk|high risk
4909656|NCT02043860|Intermediate Risk|intermediate risk
4909657|NCT02043860|Symptomatic|symptomatic
4909658|NCT02043847|Multiple Myeloma|multiple myeloma
4909659|NCT02043847|Relapsed|relapsed
4909660|NCT02043847|Refractory|refractory
4909661|NCT02043847|Progressive Disease|progressive disease
4909662|NCT02043847|Symptomatic|symptomatic
4909663|NCT02043795|Bioresorbable Vascular Scaffold System|bioresorbable vascular scaffold system
4909664|NCT02043795|Percutaneous Transluminal Angioplasty|percutaneous transluminal angioplasty
4909665|NCT02043795|Stent|stent
4909666|NCT02043769|South Africa|south africa
4909667|NCT02043769|Eastern Cape|eastern cape
4909668|NCT02043769|Child ARV|child arv
4909669|NCT02043769|CLWHIV|clwhiv
4909670|NCT02043756|Mitoxantrone Hydrochloride Liposome Injection|mitoxantrone hydrochloride liposome injection
4909671|NCT02043730|pancreatic cancer|pancreatic cancer
4909672|NCT02043730|locally advanced|locally advanced
4909673|NCT02043730|unresectable cancer|unresectable cancer
4909674|NCT02043717|Cystic Fibrosis|cystic fibrosis
4909675|NCT02043717|Vitamin D|vitamin d
4909676|NCT02043717|Lung function|lung function
4909677|NCT02043704|IV Acetaminophen|iv acetaminophen
4909678|NCT02043704|Vaginal Reconstruction|vaginal reconstruction
4909679|NCT02043704|Pain, Postoperative|pain, postoperative
4909680|NCT02043691|Endovascular|endovascular
4909681|NCT02043691|Aortic|aortic
4909682|NCT02043691|Aneurysm|aneurysm
4909683|NCT02043691|Thoracoabdominal|thoracoabdominal
4909684|NCT02043691|Juxtarenal|juxtarenal
4909685|NCT02043691|Suprarenal|suprarenal
4909686|NCT02043691|Endograft|endograft
4909687|NCT02043691|Fenestrated|fenestrated
4909688|NCT02043691|Branched|branched
4909689|NCT02043691|Complex|complex
4909690|NCT02043691|Abdominal|abdominal
4909691|NCT02043691|Thoracic|thoracic
4909692|NCT02043691|Stent|stent
4909693|NCT02043691|Stentgraft|stentgraft
4909694|NCT02043678|Phase III|phase iii
4909695|NCT02043678|Radium-223 dichloride|radium-223 dichloride
4909696|NCT02043678|Abiraterone acetate|abiraterone acetate
4909697|NCT02043678|Combination therapy|combination therapy
4909698|NCT02043678|Chemotherapy-naive|chemotherapy-naive
4909699|NCT02043678|Bone metastasis|bone metastasis
4909700|NCT02043678|Castration-resistant prostate cancer (CRPC)|castration-resistant prostate cancer (crpc)
4909701|NCT02043665|CAVATAK|cavatak
4909702|NCT02043665|KEYNOTE-200|keynote-200
4909703|NCT02043665|pembrolizumab|pembrolizumab
4909704|NCT02043665|lung cancer|lung cancer
4909705|NCT02043665|bladder cancer|bladder cancer
4909706|NCT02043639|rotation|rotation
4909707|NCT02043639|shoulder|shoulder
4909708|NCT02043639|joint|joint
4909709|NCT02043639|ROM|rom
4909710|NCT02043639|abduction,|abduction,
4909711|NCT02043639|internal rotation,|internal rotation,
4909712|NCT02043639|external rotation,|external rotation,
4909713|NCT02043639|flexion|flexion
4909714|NCT02043639|normal|normal
4909715|NCT02043639|joint movement|joint movement
4909716|NCT02043639|physical examination|physical examination
4909717|NCT02043626|childhood nutrition|childhood nutrition
4909718|NCT02043626|physical activity|physical activity
4909719|NCT02043626|school wellness|school wellness
4909720|NCT02043626|school health|school health
4909721|NCT02043626|nutritional policies|nutritional policies
4909722|NCT02043626|childhood obesity|childhood obesity
4909723|NCT02043613|Joint pain|joint pain
4909724|NCT02043613|Context effects|context effects
4909725|NCT02043613|Placebo effect|placebo effect
4909726|NCT02043613|Exercise treatment|exercise treatment
4909727|NCT02043600|Colitis, ulcerative|colitis, ulcerative
4909728|NCT02043600|Yoga|yoga
4909729|NCT02043587|Acute lymphoblastic leukemia|acute lymphoblastic leukemia
4909730|NCT02043587|Lymphoblastic leukemia|lymphoblastic leukemia
4909731|NCT02043587|Lymphoblastic lymphoma|lymphoblastic lymphoma
4909732|NCT02043574|Aerobic Exercise|aerobic exercise
4909733|NCT02043574|Treadmill Test|treadmill test
4909734|NCT02043574|Sedentary Lifestyle|sedentary lifestyle
4909735|NCT02043548|dermatomyositis|dermatomyositis
4909736|NCT02043548|polymyositis|polymyositis
4909737|NCT02043548|tocilizumab|tocilizumab
4909738|NCT02043548|Actemra|actemra
4909739|NCT02043535|myocardial perfusion imaging|myocardial perfusion imaging
4909740|NCT02043535|myocardial blood flow|myocardial blood flow
4909741|NCT02043535|pharmacologic stress agents|pharmacologic stress agents
4909742|NCT02043535|carbon dioxide|carbon dioxide
4909743|NCT02043535|rubidium 82 radioisotope|rubidium 82 radioisotope
4909744|NCT02043535|positron emission tomography|positron emission tomography
4909745|NCT02043522|123I-mIBG|123i-mibg
4909746|NCT02043522|SPECT Imaging|spect imaging
4909747|NCT02043522|Phantom imaging|phantom imaging
4909748|NCT02043522|Heart failure|heart failure
4909749|NCT02043522|Coronary artery disease|coronary artery disease
4909750|NCT02043522|Heart to mediastinum ratios|heart to mediastinum ratios
4909751|NCT02043522|heart to calibration ratios|heart to calibration ratios
4909752|NCT02043522|Myocardial blood flow|myocardial blood flow
4909753|NCT02043522|Myocardial blood flow researve|myocardial blood flow researve
4909754|NCT02043509|smoking cessation|smoking cessation
4909755|NCT02043509|pregnancy|pregnancy
4909756|NCT02043509|cessation support|cessation support
4909757|NCT02043509|tailored text messages|tailored text messages
4909758|NCT02043509|self-help|self-help
4909759|NCT02043509|MiQuit|miquit
4909760|NCT02043496|Binge Eating Disorder|binge eating disorder
4909761|NCT02043496|Binge Eating|binge eating
4909762|NCT02043496|Eating Disorders|eating disorders
4909763|NCT02043496|Obesity|obesity
4909764|NCT02043496|Psychotherapy|psychotherapy
4909765|NCT02043496|Cognitive Behavioral Therapy|cognitive behavioral therapy
4909766|NCT02043483|CPAP|cpap
4909767|NCT02043483|OSAS|osas
4909768|NCT02043483|CEDOC (Centro de Estudos de Doenças Crónicas)|cedoc (centro de estudos de doenças crónicas)
4909769|NCT02043483|FCM (Faculdade de Ciências Médicas)|fcm (faculdade de ciências médicas)
4909770|NCT02043483|UNL (Universidade Nova de Lisboa|unl (universidade nova de lisboa
4909771|NCT02043483|NOVA MEDICAL SCHOOL|nova medical school
4909772|NCT02043483|FCT (Fundação para a Ciência e Tecnologia)|fct (fundação para a ciência e tecnologia)
4909773|NCT02043470|Sinus/nasal cancer|sinus/nasal cancer
4909774|NCT02043431|Heart failure|heart failure
4909775|NCT02043431|Electronic medical records|electronic medical records
4909776|NCT02043431|Genomics|genomics
4909777|NCT02043431|Biobank|biobank
4909778|NCT02043418|HIV|hiv
4909779|NCT02043418|ARV|arv
4909780|NCT02043418|Pediatric|pediatric
4909781|NCT02043418|Cameroon|cameroon
4909782|NCT02043392|intestinal anastomosis|intestinal anastomosis
4909783|NCT02043392|non-emergent|non-emergent
4909784|NCT02043392|intestinal revision|intestinal revision
4909785|NCT02043392|magnetic compression|magnetic compression
4909786|NCT02043392|anastomotic leak|anastomotic leak
4909787|NCT02043379|congenital heart disease|congenital heart disease
4909788|NCT02043379|Cardiopulmonary Bypass|cardiopulmonary bypass
4909789|NCT02043379|Hypogammaglobulinemia|hypogammaglobulinemia
4909790|NCT02043366|Remifentanil|remifentanil
4909791|NCT02043366|Opioid-induced hyperalgesia|opioid-induced hyperalgesia
4909792|NCT02043366|Postoperative pain|postoperative pain
4909793|NCT02043366|Pain Intensity|pain intensity
4909794|NCT02043340|Periodontitis|periodontitis
4909795|NCT02043340|Bacterial viability|bacterial viability
4909796|NCT02043340|Lactate dehydrogenase levels|lactate dehydrogenase levels
4909797|NCT02043340|Indocyanine green|indocyanine green
4909798|NCT02043340|Scaling and root planing|scaling and root planing
4909799|NCT02043340|Antimicrobial photodynamic therapy.|antimicrobial photodynamic therapy.
4909800|NCT02043327|Colonoscopy|colonoscopy
4909801|NCT02043327|assessment|assessment
4909802|NCT02043327|certification,|certification,
4909803|NCT02043327|simulation,|simulation,
4909804|NCT02043327|standard setting|standard setting
4909805|NCT02043301|pharmacokinetics|pharmacokinetics
4909806|NCT02043301|bioavailability|bioavailability
4909807|NCT02043301|PF-04950615|pf-04950615
4909808|NCT02043288|Pancreatic cancer|pancreatic cancer
4909809|NCT02043288|Platinum|platinum
4909810|NCT02043288|Micelle|micelle
4909811|NCT02043275|resistance training|resistance training
4909812|NCT02043262|Elderly|elderly
4909813|NCT02043262|Home-based rehabilitation|home-based rehabilitation
4909814|NCT02043262|Activities of daily living|activities of daily living
4909815|NCT02043262|Restorative care|restorative care
4909816|NCT02043262|Reablement|reablement
4909817|NCT02043262|Everyday rehabilitation|everyday rehabilitation
4909818|NCT02043249|DELAYED CORD CLAMPING|delayed cord clamping
4909819|NCT02043249|MILKING OF CORD|milking of cord
4909820|NCT02043249|PREMATURE INFANTS|premature infants
4909821|NCT02043249|LEVEL OF IgG IN NEONATES|level of igg in neonates
4909822|NCT02043236|Prostate cancer|prostate cancer
4909823|NCT02043236|Androgen deprivation therapy|androgen deprivation therapy
4909824|NCT02043236|Bone health|bone health
4909825|NCT02043236|Bone mineral density|bone mineral density
4909826|NCT02043223|Vitamin A|vitamin a
4909827|NCT02043223|Breast milk|breast milk
4909828|NCT02043223|Postpartum vitamin A supplementation|postpartum vitamin a supplementation
4909829|NCT02043223|Infant vaccine response|infant vaccine response
4909830|NCT02043210|substance use, Spanish speaking, CBT4CBT|substance use, spanish speaking, cbt4cbt
4909831|NCT02043197|Depression,|depression,
4909832|NCT02043197|depressive symptoms,|depressive symptoms,
4909833|NCT02043197|major depressive disorder,|major depressive disorder,
4909834|NCT02043197|Fevarine,|fevarine,
4909835|NCT02043197|fluvoxamine,|fluvoxamine,
4909836|NCT02043197|cognitive function,|cognitive function,
4909837|NCT02043197|neurological disorders,|neurological disorders,
4909838|NCT02043197|sleep state|sleep state
4909839|NCT02043184|Neoplasms|neoplasms
4909840|NCT02043184|Medication Adherence|medication adherence
4909841|NCT02043184|Administration, Oral|administration, oral
4909842|NCT02043184|Symptom Assessment|symptom assessment
4909843|NCT02043184|Neurobehavioral Manifestations|neurobehavioral manifestations
4909844|NCT02043184|Depression|depression
4909845|NCT02043184|Behavioral Symptoms|behavioral symptoms
4909846|NCT02043184|Utilization|utilization
4909847|NCT02043158|Ovarian Cancer|ovarian cancer
4909848|NCT02043158|Short term survivors|short term survivors
4909849|NCT02043158|Long term survivors|long term survivors
4909850|NCT02043158|Biobehavioral characteristics|biobehavioral characteristics
4909851|NCT02043158|Sociodemographic characteristics|sociodemographic characteristics
4909852|NCT02043158|Questionnaire|questionnaire
4909853|NCT02043158|Survey|survey
4909854|NCT02043158|Interview|interview
4909855|NCT02043132|reverse shoulder arthroplasty|reverse shoulder arthroplasty
4909856|NCT02043132|Rotator cuff|rotator cuff
4909857|NCT02043132|Orthopedic joint surgery|orthopedic joint surgery
4909858|NCT02043132|Total shoulder|total shoulder
4909859|NCT02043132|Perioperative bleeding|perioperative bleeding
4909860|NCT02043132|Tranexamic acid|tranexamic acid
4909861|NCT02043132|Orthopedic complications|orthopedic complications
4909862|NCT02043132|Hemorrhage|hemorrhage
4909863|NCT02043132|Postoperative Hemorrhage|postoperative hemorrhage
4909864|NCT02043132|Pathologic Processes|pathologic processes
4909865|NCT02043132|Arthritis|arthritis
4909866|NCT02043132|Joint Diseases|joint diseases
4909867|NCT02043132|Musculoskeletal Diseases|musculoskeletal diseases
4909868|NCT02043132|Postoperative Complications|postoperative complications
4909869|NCT02043132|Antifibrinolytic Agents|antifibrinolytic agents
4909870|NCT02043132|Fibrin Modulating Agents|fibrin modulating agents
4909871|NCT02043132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
4909872|NCT02043132|Pharmacologic Actions|pharmacologic actions
4909873|NCT02043132|Hemostatics|hemostatics
4909874|NCT02043132|Coagulants|coagulants
4909875|NCT02043132|Hematologic Agents|hematologic agents
4909876|NCT02043132|Therapeutic Uses|therapeutic uses
4909877|NCT02043093|Adolescent suicide prevention|adolescent suicide prevention
4909878|NCT02043093|Peer Leader prevention model|peer leader prevention model
4909879|NCT02043093|Universal school-based prevention|universal school-based prevention
4909880|NCT02043080|Tuberculosis|tuberculosis
4909881|NCT02043080|HIV|hiv
4909882|NCT02043080|Xpert MTB/RIF|xpert mtb/rif
4909883|NCT02043080|Determine TB-LAM|determine tb-lam
4909884|NCT02043080|UNC|unc
4909885|NCT02043080|Zambia|zambia
4909886|NCT02043080|Cost Effectiveness Analysis Curve|cost effectiveness analysis curve
4909887|NCT02043080|Centre for Infectious Disease Research in Zambia|centre for infectious disease research in zambia
4909888|NCT02043067|TB|tb
4909889|NCT02043067|HIV|hiv
4909890|NCT02043067|Extensively resistant TB|extensively resistant tb
4909891|NCT02043067|Extra pulmonary TB|extra pulmonary tb
4909892|NCT02043054|Type 2 Diabetes Mellitus (T2DM)|type 2 diabetes mellitus (t2dm)
4909893|NCT02043054|Young Adults|young adults
4909894|NCT02043054|Cardiovascular Disease (CVD)|cardiovascular disease (cvd)
4909895|NCT02043054|GLP1 Analogue|glp1 analogue
4909896|NCT02043054|DPP IV Inhibitor|dpp iv inhibitor
4909897|NCT02043054|Obesity|obesity
4909898|NCT02043054|Cardiometabolic Effects|cardiometabolic effects
4909899|NCT02043054|Cardiac MRI|cardiac mri
4909900|NCT02043028|Cardiopulmonary resuscitation|cardiopulmonary resuscitation
4909901|NCT02043028|Chest compression|chest compression
4909902|NCT02043028|Advanced cardiac life support|advanced cardiac life support
4909903|NCT02043028|Posture|posture
4909904|NCT02043015|voluntary counseling and testing (VCT)|voluntary counseling and testing (vct)
4909905|NCT02043015|couples voluntary counseling and testing (CVCT)|couples voluntary counseling and testing (cvct)
4909906|NCT02043015|pre-exposure prophylaxis (PrEP)|pre-exposure prophylaxis (prep)
4909907|NCT02043015|homosexuality|homosexuality
4909908|NCT02043015|male|male
4909909|NCT02043015|South Africa|south africa
4909910|NCT02042989|Advanced Cancers|advanced cancers
4909911|NCT02042989|Advanced solid tumor|advanced solid tumor
4909912|NCT02042989|Advanced p53 Mutant Malignancies|advanced p53 mutant malignancies
4909913|NCT02042989|MLN9708|mln9708
4909914|NCT02042989|Vorinostat|vorinostat
4909915|NCT02042989|SAHA|saha
4909916|NCT02042989|Suberoylanilide Hydroxamic Acid|suberoylanilide hydroxamic acid
4909917|NCT02042989|MSK-390|msk-390
4909918|NCT02042989|Zolinza|zolinza
4909919|NCT02042976|Chronic obstructive pulmonary disease (COPD)|chronic obstructive pulmonary disease (copd)
4909920|NCT02042976|Mindfulness-based cognitive therapy (MBCT)|mindfulness-based cognitive therapy (mbct)
4909921|NCT02042976|Behavioural intervention|behavioural intervention
4909922|NCT02042976|Quality-of-life|quality-of-life
4909923|NCT02042976|Anxiety|anxiety
4909924|NCT02042976|Depression|depression
4909925|NCT02042976|Physical health status|physical health status
4909926|NCT02042963|The cohort of Asian kidney transplant recipients|the cohort of asian kidney transplant recipients
4909927|NCT02042963|The cohort of metabolic complication after kidney transplant|the cohort of metabolic complication after kidney transplant
4909928|NCT02042963|The biorepository of Asian kidney transplant recipients|the biorepository of asian kidney transplant recipients
4909929|NCT02042950|Lymphoma|lymphoma
4909930|NCT02042950|Mantle Cell Lymphoma|mantle cell lymphoma
4909931|NCT02042950|MCL|mcl
4909932|NCT02042950|Relapsed|relapsed
4909933|NCT02042950|Refractory|refractory
4909934|NCT02042950|Carfilzomib|carfilzomib
4909935|NCT02042937|Knee|knee
4909936|NCT02042937|Hip|hip
4909937|NCT02042937|Muscle Strength|muscle strength
4909938|NCT02042937|Electromyography|electromyography
4909939|NCT02042937|Biomechanical Phenomena|biomechanical phenomena
4909940|NCT02042924|Leukemia|leukemia
4909941|NCT02042924|Lymphoma|lymphoma
4909942|NCT02042924|Myeloma|myeloma
4909943|NCT02042924|Myelodysplastic Syndrome|myelodysplastic syndrome
4909944|NCT02042898|Cardiac Surgery|cardiac surgery
4909945|NCT02042898|Transfusion|transfusion
4909946|NCT02042885|Prostate cancer|prostate cancer
4909947|NCT02042872|Spinal Cord Injury|spinal cord injury
4909948|NCT02042872|Disuse Osteoporosis|disuse osteoporosis
4909949|NCT02042872|Zoledronic acid|zoledronic acid
4909950|NCT02042872|Bisphosphonates|bisphosphonates
4909951|NCT02042872|Dual Energy X-ray Absorptiometry|dual energy x-ray absorptiometry
4909952|NCT02042859|EndoHPB|endohpb
4909953|NCT02042820|Dry Eye|dry eye
4909954|NCT02042781|PG545|pg545
4909955|NCT02042781|Phase I|phase i
4909956|NCT02042781|Progen|progen
4909957|NCT02042781|antimetastatic|antimetastatic
4909958|NCT02042781|antiangiogenic|antiangiogenic
4909959|NCT02042781|advanced cancer patients|advanced cancer patients
4909960|NCT02042781|solid tumors|solid tumors
4909961|NCT02042781|solid tumours|solid tumours
4909962|NCT02042781|tumor microenvironment|tumor microenvironment
4909963|NCT02042768|Glucose|glucose
4909964|NCT02042768|Dialysate|dialysate
4909965|NCT02042768|Peritoneal Dialysis|peritoneal dialysis
4909966|NCT02042768|patients|patients
4909967|NCT02042768|non-diabetic|non-diabetic
4909968|NCT02042755|cataract|cataract
4909969|NCT02042755|IOL|iol
4909970|NCT02042755|trifocal|trifocal
4909971|NCT02042755|FineVision|finevision
4909972|NCT02042742|Cross-over studies|cross-over studies
4909973|NCT02042742|Antioxidants|antioxidants
4909974|NCT02042742|Hydroxytyrosol|hydroxytyrosol
4909975|NCT02042742|Punicalagin|punicalagin
4909976|NCT02042742|Treatment outcome|treatment outcome
4909977|NCT02042742|Inflammatory markers|inflammatory markers
4909978|NCT02042742|Endothelial function|endothelial function
4909979|NCT02042742|Humans|humans
4909980|NCT02042742|Adults|adults
4909981|NCT02042742|volunteers|volunteers
4909982|NCT02042729|volunteer|volunteer
4909983|NCT02042716|preterm and term newborns|preterm and term newborns
4909984|NCT02042716|diagnosis of cerebral white matter damage|diagnosis of cerebral white matter damage
4909985|NCT02042716|quantitative brain elasticity|quantitative brain elasticity
4909986|NCT02042716|Transfontanel ultrafast doppler|transfontanel ultrafast doppler
4909987|NCT02042690|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
4909988|NCT02042690|hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
4909989|NCT02042690|chemotherapy|chemotherapy
4909990|NCT02042677|ileostomy|ileostomy
4909991|NCT02042677|1-piece|1-piece
4909992|NCT02042677|assessment|assessment
4909993|NCT02042677|Nova|nova
4909994|NCT02042677|NovaLife|novalife
4909995|NCT02042677|Dansac|dansac
4909996|NCT02042651|ESWT|eswt
4909997|NCT02042651|Chronic pelvic pain|chronic pelvic pain
4909998|NCT02042651|randomized|randomized
4909999|NCT02042651|sham controlled|sham controlled
4910000|NCT02042612|Pharmacokinetics|pharmacokinetics
4910001|NCT02042612|Sevoflurane|sevoflurane
4910002|NCT02042612|Obesity|obesity
4910003|NCT02042612|Sedation|sedation
4910004|NCT02042612|ICU patients|icu patients
4910005|NCT02042599|Pharmacokinetics|pharmacokinetics
4910006|NCT02042599|Sevoflurane|sevoflurane
4910007|NCT02042599|Acute kidney injury|acute kidney injury
4910008|NCT02042599|Sedation|sedation
4910009|NCT02042599|ICU patients|icu patients
4910010|NCT02042534|stroke|stroke
4910011|NCT02042534|TIA|tia
4910012|NCT02042521|Cigarette|cigarette
4910013|NCT02042521|Withdrawal|withdrawal
4910014|NCT02042521|Nicotine|nicotine
4910015|NCT02042482|Ultra coenzyme Q10|ultra coenzyme q10
4910016|NCT02042482|L-carnitine|l-carnitine
4910017|NCT02042469|awareness, clinical research, Saudi arabia|awareness, clinical research, saudi arabia
4910018|NCT02042456|breast cancer|breast cancer
4910019|NCT02042456|dense breasts|dense breasts
4910020|NCT02042456|mammography screening|mammography screening
4910021|NCT02042456|Screening techniques|screening techniques
4910022|NCT02042456|women|women
4910023|NCT02042404|Hearing impairment|hearing impairment
4910024|NCT02042404|Hearing loss|hearing loss
4910025|NCT02042391|PTLD|ptld
4910026|NCT02042391|CD20-positive|cd20-positive
4910027|NCT02042391|solid organ transplantation|solid organ transplantation
4910028|NCT02042378|BRCA|brca
4910029|NCT02042378|BRCA mutation|brca mutation
4910030|NCT02042378|germline BRCA|germline brca
4910031|NCT02042378|somatic BRCA|somatic brca
4910032|NCT02042378|PARP inhibitor|parp inhibitor
4910033|NCT02042378|rucaparib|rucaparib
4910034|NCT02042378|CO-338|co-338
4910035|NCT02042378|PF 01367338|pf 01367338
4910036|NCT02042378|AG 14699|ag 14699
4910037|NCT02042378|Clovis|clovis
4910038|NCT02042378|Clovis Oncology|clovis oncology
4910039|NCT02042378|RucaPanc|rucapanc
4910040|NCT02042365|Enhanced recovery,|enhanced recovery,
4910041|NCT02042365|sleeve gastrectomy,|sleeve gastrectomy,
4910042|NCT02042339|Hyperbaric Oxygen|hyperbaric oxygen
4910043|NCT02042339|Diabetic ulcer|diabetic ulcer
4910044|NCT02042339|Wound healing|wound healing
4910045|NCT02042339|3-D life-viz- system|3-d life-viz- system
4910046|NCT02042339|Indocyanine green video angiography|indocyanine green video angiography
4910047|NCT02042339|Transcutaneous oxygen pressure|transcutaneous oxygen pressure
4910048|NCT02042339|Endothelial progenitor cells|endothelial progenitor cells
4910049|NCT02042326|Arteriovenous Malformations|arteriovenous malformations
4910050|NCT02042326|Sirolimus|sirolimus
4910051|NCT02042326|Maxillofacial Surgery|maxillofacial surgery
4910052|NCT02042300|XIENCE Xpedition|xience xpedition
4910053|NCT02042300|Routine Clinical Practice|routine clinical practice
4910054|NCT02042300|Alpine|alpine
4910055|NCT02042287|Bacterial Infections and Mycoses|bacterial infections and mycoses
4910056|NCT02042287|Pharmaceutical Preparations|pharmaceutical preparations
4910057|NCT02042287|Health Occupations|health occupations
4910058|NCT02042274|Fish oil|fish oil
4910059|NCT02042274|EPA|epa
4910060|NCT02042274|DHA|dha
4910061|NCT02042274|fatty acids|fatty acids
4910062|NCT02042274|genetic variation|genetic variation
4910063|NCT02042274|gene expression|gene expression
4910064|NCT02042248|HIV|hiv
4910065|NCT02042248|Acute HIV Infection|acute hiv infection
4910066|NCT02042248|Chronic HIV Infection|chronic hiv infection
4910067|NCT02042248|AGS-004|ags-004
4910068|NCT02042248|Phase 1|phase 1
4910069|NCT02042248|Antiretroviral Therapy|antiretroviral therapy
4910070|NCT02042248|ART|art
4910071|NCT02042248|UNC|unc
4910072|NCT02042248|Argos Therapeutics|argos therapeutics
4910073|NCT02042248|The CARE Collaboratory of AIDS|the care collaboratory of aids
4910074|NCT02042248|Immunization|immunization
4910075|NCT02042248|vaccination|vaccination
4910076|NCT02042235|prematurity|prematurity
4910077|NCT02042235|language|language
4910078|NCT02042235|parent-implemented intervention|parent-implemented intervention
4910079|NCT02042235|speech therapy|speech therapy
4910080|NCT02042235|neurodevelopment|neurodevelopment
4910081|NCT02042222|Sickle cell|sickle cell
4910082|NCT02042222|Hydroxyurea|hydroxyurea
4910083|NCT02042222|Dose prediction|dose prediction
4910084|NCT02042222|Maximum tolerated dose|maximum tolerated dose
4910085|NCT02042209|acute coronary syndrome|acute coronary syndrome
4910086|NCT02042209|thoracic pain|thoracic pain
4910087|NCT02042209|prehospital|prehospital
4910088|NCT02042209|diagnostic score|diagnostic score
4910089|NCT02042196|endothelial function|endothelial function
4910090|NCT02042196|women|women
4910091|NCT02042196|estrogen deficiency|estrogen deficiency
4910092|NCT02042196|sex hormones|sex hormones
4910093|NCT02042196|adiposity|adiposity
4910094|NCT02042196|oxidative stress|oxidative stress
4910095|NCT02042196|antioxidants|antioxidants
4910096|NCT02042157|Quality of Life|quality of life
4910097|NCT02042157|Caregivers|caregivers
4910098|NCT02042157|Caregiver burden|caregiver burden
4910099|NCT02042157|Urinary Tract Infections|urinary tract infections
4910100|NCT02042157|Bidet|bidet
4910101|NCT02042157|Women's health|women's health
4910102|NCT02042157|Toileting|toileting
4910103|NCT02042157|Hygiene|hygiene
4910104|NCT02042157|Activities of Daily Living|activities of daily living
4910105|NCT02042157|Functional impairment|functional impairment
4910106|NCT02042157|Geriatrics|geriatrics
4910107|NCT02042144|Neoplasms, Colorectal|neoplasms, colorectal
4910108|NCT02042131|suicide|suicide
4910109|NCT02042131|suicidal ideation|suicidal ideation
4910110|NCT02042131|ambivalence|ambivalence
4910111|NCT02042131|suicide ambivalence|suicide ambivalence
4910112|NCT02042131|reasons for living|reasons for living
4910113|NCT02042131|reasons for dying|reasons for dying
4910114|NCT02042131|military|military
4910115|NCT02042131|veteran|veteran
4910116|NCT02042131|clinical trial|clinical trial
4910117|NCT02042131|cognitive behavioral therapy|cognitive behavioral therapy
4910118|NCT02042131|psychotherapy|psychotherapy
4910119|NCT02042131|crisis|crisis
4910120|NCT02042131|Treatment As Usual (TAU)|treatment as usual (tau)
4910121|NCT02042131|Crisis Response Plan (CRP)|crisis response plan (crp)
4910122|NCT02042131|Enhanced Crisis Response Plan (E-CRP)|enhanced crisis response plan (e-crp)
4910123|NCT02042118|Neonatal resuscitation|neonatal resuscitation
4910124|NCT02042118|Laryngeal Mask Airway (LMA)|laryngeal mask airway (lma)
4910125|NCT02042118|Face mask ventilation (FMV)|face mask ventilation (fmv)
4910126|NCT02042118|Uganda|uganda
4910127|NCT02042118|Africa|africa
4910128|NCT02042105|non-small-cell lung cancer|non-small-cell lung cancer
4910129|NCT02042105|anaplastic lymphoma kinase|anaplastic lymphoma kinase
4910130|NCT02042105|immunohistochemistry|immunohistochemistry
4910131|NCT02042092|Ultrasound|ultrasound
4910132|NCT02042092|MRA|mra
4910133|NCT02042092|Large Vessel Vasculitis|large vessel vasculitis
4910134|NCT02042092|Giant Cell Arteritis|giant cell arteritis
4910135|NCT02042092|Takayasu Arteritis|takayasu arteritis
4910136|NCT02042092|Immunological abnormalities|immunological abnormalities
4910137|NCT02042079|Endoscopic full-thickness resection|endoscopic full-thickness resection
4910138|NCT02042079|gastric subepithelial tumor|gastric subepithelial tumor
4910139|NCT02042079|hybrid-NOTES|hybrid-notes
4910140|NCT02042066|Resistant Hypertension|resistant hypertension
4910141|NCT02042066|RH|rh
4910142|NCT02042066|RHT|rht
4910143|NCT02042066|Blood Pressure|blood pressure
4910144|NCT02042066|Kidney|kidney
4910145|NCT02042066|Shockwave|shockwave
4910146|NCT02042053|imaging|imaging
4910147|NCT02042053|diagnostic|diagnostic
4910148|NCT02042053|castration resistant|castration resistant
4910149|NCT02042053|metastatic prostate cancer|metastatic prostate cancer
4910150|NCT02042053|immunotherapy|immunotherapy
4910151|NCT02042027|corneal neovascularization|corneal neovascularization
4910152|NCT02042027|Gamunex-C|gamunex-c
4910153|NCT02042027|IVI-g|ivi-g
4910154|NCT02042027|anterior segment inflammation|anterior segment inflammation
4910155|NCT02042014|Pulmonary arterial hypertension, QTI571, open label study|pulmonary arterial hypertension, qti571, open label study
4910156|NCT02041988|premedication|premedication
4910157|NCT02041988|oral morphine|oral morphine
4910158|NCT02041988|preemptive analgesia|preemptive analgesia
4910159|NCT02041975|Prebiotics|prebiotics
4910160|NCT02041975|Gut health|gut health
4910161|NCT02041975|Satisfaction|satisfaction
4910162|NCT02041962|Care Management|care management
4910163|NCT02041962|Chronic Care Model|chronic care model
4910164|NCT02041962|Mood Disorders|mood disorders
4910165|NCT02041936|irreversible electroporation|irreversible electroporation
4910166|NCT02041936|Nanoknife|nanoknife
4910167|NCT02041936|pancreatic cancer|pancreatic cancer
4910168|NCT02041923|preterm infant|preterm infant
4910169|NCT02041923|stable infant|stable infant
4910170|NCT02041923|mother-infant interaction|mother-infant interaction
4910171|NCT02041923|health care cost|health care cost
4910172|NCT02041923|H-HOPE intervention|h-hope intervention
4910173|NCT02041923|mother outcomes|mother outcomes
4910174|NCT02041923|infant behavioral organization|infant behavioral organization
4910175|NCT02041923|infant growth|infant growth
4910176|NCT02041897|EUS-FNA|eus-fna
4910177|NCT02041897|Pancreatic cystic lesion|pancreatic cystic lesion
4910178|NCT02041897|Diagnosis|diagnosis
4910179|NCT02041884|Cognitive Behavioral Therapy|cognitive behavioral therapy
4910180|NCT02041884|Dialectical Behavioral Therapy|dialectical behavioral therapy
4910181|NCT02041884|Applied Relaxation|applied relaxation
4910182|NCT02041884|Stress-reduction|stress-reduction
4910183|NCT02041884|Smartphone application|smartphone application
4910184|NCT02041884|ADHD|adhd
4910185|NCT02041884|Randomized controlled trial|randomized controlled trial
4910186|NCT02041884|Psychological treatment|psychological treatment
4910187|NCT02041884|Efficacy|efficacy
4910188|NCT02041871|Liver Surgery|liver surgery
4910189|NCT02041871|Hepatectomy|hepatectomy
4910190|NCT02041871|Immunonutrition|immunonutrition
4910191|NCT02041871|Cancer|cancer
4910192|NCT02041871|Morbidity|morbidity
4910193|NCT02041871|Postoperative complication|postoperative complication
4910194|NCT02041858|Alarms|alarms
4910195|NCT02041858|Physiologic Monitoring|physiologic monitoring
4910196|NCT02041858|Critical Care|critical care
4910197|NCT02041858|Alarm fatigue|alarm fatigue
4910198|NCT02041858|Adverse Events|adverse events
4910199|NCT02041845|Radiotherapy|radiotherapy
4910200|NCT02041845|Radiotherapy dosage|radiotherapy dosage
4910201|NCT02041845|Dose fractionation|dose fractionation
4910202|NCT02041845|Radiotherapy, image-guided|radiotherapy, image-guided
4910203|NCT02041845|Thorax|thorax
4910204|NCT02041819|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
4910205|NCT02041819|Nimotuzumab|nimotuzumab
4910206|NCT02041819|Nab-Paclitaxel|nab-paclitaxel
4910207|NCT02041819|Carcinoma of Esophagus|carcinoma of esophagus
4910208|NCT02041793|Acute pancreatitis|acute pancreatitis
4910209|NCT02041793|Pseudocyst|pseudocyst
4910210|NCT02041780|Diagnostic|diagnostic
4910211|NCT02041780|Liver fibrosis|liver fibrosis
4910212|NCT02041780|Ishak score|ishak score
4910213|NCT02041780|Fibrotest|fibrotest
4910214|NCT02041780|ShearWave elastography|shearwave elastography
4910215|NCT02041780|Liver biopsies|liver biopsies
4910216|NCT02041767|Ertapenem; prostatic diffusion; antibioprophylaxy; pharmacokinetics; benign prostatic hyperplasia|ertapenem; prostatic diffusion; antibioprophylaxy; pharmacokinetics; benign prostatic hyperplasia
4910217|NCT02041741|happiness|happiness
4910218|NCT02041741|well-being|well-being
4910219|NCT02041741|distress|distress
4910220|NCT02041741|positive psychology|positive psychology
4910221|NCT02041715|Virus Diseases|virus diseases
4910222|NCT02041715|Hemorrhagic Fever, Ebola|hemorrhagic fever, ebola
4910223|NCT02041715|Hemorrhagic Fevers, Viral|hemorrhagic fevers, viral
4910224|NCT02041715|RNA Virus Infections|rna virus infections
4910225|NCT02041715|Filoviridae Infections|filoviridae infections
4910226|NCT02041715|Mononegavirales Infections|mononegavirales infections
4910227|NCT02041702|Bradycardia|bradycardia
4910228|NCT02041702|Pacemaker|pacemaker
4910229|NCT02041702|Magnetic|magnetic
4910230|NCT02041702|Conditional|conditional
4910231|NCT02041702|St Jude|st jude
4910232|NCT02041702|Accent|accent
4910233|NCT02041702|Tendril|tendril
4910234|NCT02041689|Children|children
4910235|NCT02041689|Cancer|cancer
4910236|NCT02041689|Learning|learning
4910237|NCT02041689|Education|education
4910238|NCT02041689|Qualitative|qualitative
4910239|NCT02041676|Chest|chest
4910240|NCT02041676|Physiotherapy|physiotherapy
4910241|NCT02041676|Increased Inspiratory Flow Technique|increased inspiratory flow technique
4910242|NCT02041676|Prematurity|prematurity
4910243|NCT02041676|Non Invasive Ventilation|non invasive ventilation
4910244|NCT02041663|brain natriuretic peptide|brain natriuretic peptide
4910245|NCT02041663|cardiac function|cardiac function
4910246|NCT02041663|meningococcal infections|meningococcal infections
4910247|NCT02041663|septic shock|septic shock
4910248|NCT02041663|severe sepsis|severe sepsis
4910249|NCT02041637|liver failure|liver failure
4910250|NCT02041637|etiology|etiology
4910251|NCT02041637|liver transplantation|liver transplantation
4910252|NCT02041624|allergic|allergic
4910253|NCT02041624|rhinitis|rhinitis
4910254|NCT02041624|conjunctivitis|conjunctivitis
4910255|NCT02041624|grass pollen|grass pollen
4910557|NCT02039973|depression|depression
4910256|NCT02041624|Allergen ImmunoTherapy (AIT)|allergen immunotherapy (ait)
4910257|NCT02041624|grass mix|grass mix
4910258|NCT02041611|WHO grade III and IV|who grade iii and iv
4910259|NCT02041585|Hospital Readmission|hospital readmission
4910260|NCT02041585|Social Isolation and Hospital Readmission|social isolation and hospital readmission
4910261|NCT02041585|Age and Hospital Readmission|age and hospital readmission
4910262|NCT02041585|Functional Status and Hospital Readmission|functional status and hospital readmission
4910263|NCT02041585|Charlson Score and Hospital Readmission|charlson score and hospital readmission
4910264|NCT02041585|Length of Stay and Hospital Readmission|length of stay and hospital readmission
4910265|NCT02041546|Lung lavage,|lung lavage,
4910266|NCT02041546|Surfactant,|surfactant,
4910267|NCT02041546|Duration of mechanical|duration of mechanical
4910268|NCT02041546|ventilation|ventilation
4910269|NCT02041520|Seropositive HIV|seropositive hiv
4910270|NCT02041520|Omega 3 fatty acids|omega 3 fatty acids
4910271|NCT02041520|Oxidative stress|oxidative stress
4910272|NCT02041507|Water-aided colonoscopy|water-aided colonoscopy
4910273|NCT02041507|Water Immersion|water immersion
4910274|NCT02041507|Water Exchange|water exchange
4910275|NCT02041507|On-demand sedation|on-demand sedation
4910276|NCT02041507|Unsedated colonoscopy|unsedated colonoscopy
4910277|NCT02041507|Adenoma detection rate|adenoma detection rate
4910278|NCT02041507|Mean adenomas per procedure|mean adenomas per procedure
4910279|NCT02041494|Hernia|hernia
4910280|NCT02041494|Ventral|ventral
4910281|NCT02041494|Incisional|incisional
4910282|NCT02041494|Abdominal|abdominal
4910283|NCT02041494|Herniorrhaphy|herniorrhaphy
4910284|NCT02041494|Recurrence|recurrence
4910285|NCT02041494|Infection|infection
4910286|NCT02041494|Mesh|mesh
4910287|NCT02041494|Biologic|biologic
4910288|NCT02041494|Synthetic|synthetic
4910289|NCT02041468|ALK-positive|alk-positive
4910290|NCT02041455|Fibromyalgia|fibromyalgia
4910291|NCT02041455|Melatonin|melatonin
4910292|NCT02041455|Amitriptylin|amitriptylin
4910293|NCT02041455|Imune-pineal axis|imune-pineal axis
4910294|NCT02041442|overactive bladder|overactive bladder
4910295|NCT02041442|cystoscopy|cystoscopy
4910296|NCT02041429|Recurrent Breast Cancer|recurrent breast cancer
4910297|NCT02041429|Advanced Breast Cancer|advanced breast cancer
4910298|NCT02041429|Metastatic Breast Cancer|metastatic breast cancer
4910299|NCT02041416|Geriatric assessment|geriatric assessment
4910300|NCT02041416|REDCap|redcap
4910301|NCT02041416|touchscreen|touchscreen
4910302|NCT02041416|age 65|age 65
4910303|NCT02041364|Fatigue|fatigue
4910304|NCT02041364|Biomarkers|biomarkers
4910305|NCT02041364|Breast Cancer|breast cancer
4910306|NCT02041351|metastatic breast cancer|metastatic breast cancer
4910307|NCT02041351|taxanes|taxanes
4910308|NCT02041351|heavily pretreated|heavily pretreated
4910309|NCT02041312|Cholesterol|cholesterol
4910310|NCT02041312|Gastric cancer|gastric cancer
4910311|NCT02041312|Stage|stage
4910312|NCT02041299|sickle cell disease|sickle cell disease
4910313|NCT02041299|Iron overload|iron overload
4910314|NCT02041299|Deferiprone|deferiprone
4910315|NCT02041299|Ferriprox|ferriprox
4910316|NCT02041299|deferoxamine|deferoxamine
4910317|NCT02041299|Chelation|chelation
4910318|NCT02041273|bioavailability|bioavailability
4910319|NCT02041273|bioequivalence|bioequivalence
4910320|NCT02041273|AUC|auc
4910321|NCT02041273|Cmax|cmax
4910322|NCT02041260|Adult|adult
4910323|NCT02041260|differentiated thyroid cancer (DTC),|differentiated thyroid cancer (dtc),
4910324|NCT02041260|poorly differentiated thyroid cancer|poorly differentiated thyroid cancer
4910325|NCT02041260|not anaplastic thyroid cancer|not anaplastic thyroid cancer
4910326|NCT02041234|Diabetes|diabetes
4910327|NCT02041234|surgical treatment|surgical treatment
4910328|NCT02041234|medical treatment|medical treatment
4910329|NCT02041221|pharmacokinetics, pharmacodynamics, asthma|pharmacokinetics, pharmacodynamics, asthma
4910330|NCT02041208|Chronic renal anemia|chronic renal anemia
4910331|NCT02041208|Hemoglobin|hemoglobin
4910332|NCT02041208|Kidney transplant|kidney transplant
4910333|NCT02041195|Overweight|overweight
4910334|NCT02041182|youth violence|youth violence
4910335|NCT02041182|doctor-patient communication|doctor-patient communication
4910336|NCT02041182|health risk behaviors|health risk behaviors
4910337|NCT02041182|pre-visit questionnaires|pre-visit questionnaires
4910338|NCT02041130|Heart Failure|heart failure
4910339|NCT02041130|Heart Failure with Preserved Ejection Fraction|heart failure with preserved ejection fraction
4910340|NCT02041104|Metabolic syndrome|metabolic syndrome
4910341|NCT02041104|4 -week intervention|4 -week intervention
4910342|NCT02041104|Randomised placebo controlled parallel study|randomised placebo controlled parallel study
4910343|NCT02041104|Beta-glucans|beta-glucans
4910344|NCT02041104|Abdominal fat|abdominal fat
4910345|NCT02041104|Dyslipidemia|dyslipidemia
4910346|NCT02041104|Insulin resistance|insulin resistance
4910347|NCT02041104|Hypertension|hypertension
4910348|NCT02041104|Gut Microbiota Composition|gut microbiota composition
4910349|NCT02041104|Oral Glucose Tolerance Test|oral glucose tolerance test
4910350|NCT02041104|Lipid Profile|lipid profile
4910351|NCT02041104|Real-Time Polymerase Chain Reaction|real-time polymerase chain reaction
4910452|NCT02040519|Sacral neuromodulation|sacral neuromodulation
4910352|NCT02041104|Denaturating Gradient Gel Electrophoresis|denaturating gradient gel electrophoresis
4910353|NCT02041078|Liver surgery|liver surgery
4910354|NCT02041078|Blood loss|blood loss
4910355|NCT02041078|CUSA|cusa
4910356|NCT02041078|Hepatic transection|hepatic transection
4910357|NCT02041065|Liver transection|liver transection
4910358|NCT02041065|Bloodloss|bloodloss
4910359|NCT02041065|Operation time|operation time
4910360|NCT02041065|Safety|safety
4910361|NCT02041065|feasibility|feasibility
4910362|NCT02041026|probiotic|probiotic
4910363|NCT02041026|Yoghurt|yoghurt
4910364|NCT02041026|NN20|nn20
4910365|NCT02041013|Asthma|asthma
4910366|NCT02041013|Health Literacy|health literacy
4910367|NCT02041000|COPD|copd
4910368|NCT02041000|pulmonary|pulmonary
4910369|NCT02041000|stem cells|stem cells
4910370|NCT02041000|emphysema|emphysema
4910371|NCT02041000|lungs|lungs
4910372|NCT02040987|Thorough QT study|thorough qt study
4910373|NCT02040974|immunotherapy, house dust mites, pollens, allergic rhinitis|immunotherapy, house dust mites, pollens, allergic rhinitis
4910374|NCT02040961|Patients|patients
4910375|NCT02040961|Undergoing|undergoing
4910376|NCT02040961|Elective|elective
4910377|NCT02040961|Thoracic|thoracic
4910378|NCT02040961|Surgery|surgery
4910379|NCT02040922|Antibiotics|antibiotics
4910380|NCT02040922|Campylobacter|campylobacter
4910381|NCT02040922|Diarrhoea|diarrhoea
4910382|NCT02040922|Enteritis|enteritis
4910383|NCT02040922|Microbiota|microbiota
4910384|NCT02040922|Calprotectin|calprotectin
4910385|NCT02040909|sedation|sedation
4910386|NCT02040909|quality of intubation|quality of intubation
4910387|NCT02040909|hypotension|hypotension
4910388|NCT02040909|pharmacodynamics|pharmacodynamics
4910389|NCT02040909|pharmacokinetics|pharmacokinetics
4910390|NCT02040896|computed tomography|computed tomography
4910391|NCT02040896|emergency|emergency
4910392|NCT02040896|CT scan|ct scan
4910393|NCT02040896|ordering behavior|ordering behavior
4910394|NCT02040896|diagnosis|diagnosis
4910395|NCT02040896|radiation|radiation
4910396|NCT02040883|Schizophrenia|schizophrenia
4910397|NCT02040883|Tandospirone|tandospirone
4910398|NCT02040883|Cognitive Therapy|cognitive therapy
4910399|NCT02040870|Non-Small Cell lung Cancer, NSCLC, ALK, LDK378|non-small cell lung cancer, nsclc, alk, ldk378
4910400|NCT02040857|Breast Cancer|breast cancer
4910401|NCT02040805|compulsive hoarding|compulsive hoarding
4910402|NCT02040805|clutter|clutter
4910403|NCT02040805|hoarding disorder|hoarding disorder
4910404|NCT02040792|COPD|copd
4910405|NCT02040792|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
4910406|NCT02040779|asthma|asthma
4910407|NCT02040779|breath-actuated inhaler|breath-actuated inhaler
4910408|NCT02040779|beclomethasone|beclomethasone
4910409|NCT02040766|asthma|asthma
4910410|NCT02040766|breath-actuated inhaler|breath-actuated inhaler
4910411|NCT02040766|metered dose inhaler|metered dose inhaler
4910412|NCT02040753|Lifestyle intervention|lifestyle intervention
4910413|NCT02040753|Change of body composition|change of body composition
4910414|NCT02040753|Physical activity|physical activity
4910415|NCT02040753|Weight loss maintenance|weight loss maintenance
4910416|NCT02040727|Myokines|myokines
4910417|NCT02040727|Osteokines|osteokines
4910418|NCT02040727|Glucose homeostasis|glucose homeostasis
4910419|NCT02040727|Puberty|puberty
4910420|NCT02040714|femur head necrosis|femur head necrosis
4910421|NCT02040714|hip|hip
4910422|NCT02040714|pediatric orthopedics|pediatric orthopedics
4910423|NCT02040714|MRI|mri
4910424|NCT02040714|Osteonecrosis|osteonecrosis
4910425|NCT02040714|Bone diseases|bone diseases
4910426|NCT02040714|Legg Calve Perthes Syndrome|legg calve perthes syndrome
4910427|NCT02040662|paravertebral block|paravertebral block
4910428|NCT02040662|thoracic epidural analgesia|thoracic epidural analgesia
4910429|NCT02040662|videothoracoscopic surgery|videothoracoscopic surgery
4910430|NCT02040662|lung lobectomy|lung lobectomy
4910431|NCT02040649|Critical care|critical care
4910432|NCT02040649|Respiration, artificial|respiration, artificial
4910433|NCT02040636|Pertussis|pertussis
4910434|NCT02040636|Tetanus|tetanus
4910435|NCT02040636|Diphtheria|diphtheria
4910436|NCT02040636|Poliomyelitis|poliomyelitis
4910437|NCT02040636|Hepatitis B|hepatitis b
4910438|NCT02040636|Acellular Pertussis Vaccines|acellular pertussis vaccines
4910439|NCT02040623|Chronic Graft versus Host Disease|chronic graft versus host disease
4910440|NCT02040623|Keratoconjunctivitis Sicca|keratoconjunctivitis sicca
4910441|NCT02040610|Low Risk Prostate Cancer|low risk prostate cancer
4910442|NCT02040610|Intermediate Risk Prostate Cancer|intermediate risk prostate cancer
4910443|NCT02040610|Hypofractionated|hypofractionated
4910444|NCT02040610|Image Guided Proton Therapy|image guided proton therapy
4910445|NCT02040584|De Novo Liver Transplant Recipients, Tacrolimus Minimisation, Everolimus, Renal Function|de novo liver transplant recipients, tacrolimus minimisation, everolimus, renal function
4910446|NCT02040545|Infertility|infertility
4910447|NCT02040545|In Vitro Fertilization (IVF)|in vitro fertilization (ivf)
4910448|NCT02040545|Venopuncture-free treatment|venopuncture-free treatment
4910449|NCT02040545|Needle-free treatment|needle-free treatment
4910450|NCT02040519|Overactive bladder|overactive bladder
4910451|NCT02040519|Non obstructive urinary retention|non obstructive urinary retention
4910453|NCT02040506|Acute Myelogenous Leukemia|acute myelogenous leukemia
4910454|NCT02040506|Acute Myeloid Leukemia|acute myeloid leukemia
4910455|NCT02040506|Drug therapy|drug therapy
4910456|NCT02040506|CD98|cd98
4910457|NCT02040506|Relapsed|relapsed
4910458|NCT02040506|Refractory|refractory
4910459|NCT02040506|Monoclonal antibody|monoclonal antibody
4910460|NCT02040493|breast cancer|breast cancer
4910461|NCT02040493|IORT|iort
4910462|NCT02040493|brachytherapy|brachytherapy
4910463|NCT02040480|bioavailability|bioavailability
4910464|NCT02040480|food effect|food effect
4910465|NCT02040480|formulation|formulation
4910466|NCT02040480|GSK2110183|gsk2110183
4910467|NCT02040480|afuresertib|afuresertib
4910468|NCT02040480|AKT inhibitor|akt inhibitor
4910469|NCT02040441|Proteomics|proteomics
4910470|NCT02040441|Diabetes|diabetes
4910471|NCT02040441|Chronic kidney disease|chronic kidney disease
4910472|NCT02040441|Diabetic nephropathy|diabetic nephropathy
4910473|NCT02040441|Diabetic retinopathy|diabetic retinopathy
4910474|NCT02040441|Mineralocorticoid receptor antagonists|mineralocorticoid receptor antagonists
4910475|NCT02040441|Spironolactone|spironolactone
4910476|NCT02040441|Microalbuminuria|microalbuminuria
4910477|NCT02040428|Cardiovascular Diseases|cardiovascular diseases
4910478|NCT02040428|Fibrin Sealant|fibrin sealant
4910479|NCT02040428|Hemostatics|hemostatics
4910480|NCT02040428|Coagulants|coagulants
4910481|NCT02040402|Comparison of pneumococcal conjugated vaccine regimes|comparison of pneumococcal conjugated vaccine regimes
4910482|NCT02040389|children|children
4910483|NCT02040389|penile|penile
4910484|NCT02040389|inguinal|inguinal
4910485|NCT02040389|kidney parents|kidney parents
4910486|NCT02040389|anxiety|anxiety
4910487|NCT02040376|Paediatrics|paediatrics
4910488|NCT02040376|Medulloblastoma|medulloblastoma
4910489|NCT02040376|Metformin|metformin
4910490|NCT02040363|COPD|copd
4910491|NCT02040363|skeletal muscle|skeletal muscle
4910492|NCT02040363|angiogenesis|angiogenesis
4910493|NCT02040363|exercise training|exercise training
4910494|NCT02040363|intensity|intensity
4910495|NCT02040350|Pralidoxime, atropine, organophosphorous poisoning.|pralidoxime, atropine, organophosphorous poisoning.
4910496|NCT02040285|CT colonography|ct colonography
4910497|NCT02040259|ischemic stroke|ischemic stroke
4910498|NCT02040259|mechanical thrombectomy device|mechanical thrombectomy device
4910499|NCT02040259|Retriever|retriever
4910500|NCT02040220|CRVO, Macular edema, Aflibercept, anti-VEGF|crvo, macular edema, aflibercept, anti-vegf
4910501|NCT02040181|renal function, creatinine clearance|renal function, creatinine clearance
4910502|NCT02040168|Ventilation|ventilation
4910503|NCT02040168|PTSD|ptsd
4910504|NCT02040168|sedation|sedation
4910505|NCT02040142|Hyperthermic Intraperitoneal Mitomycin c|hyperthermic intraperitoneal mitomycin c
4910506|NCT02040142|HIPEC|hipec
4910507|NCT02040142|Cytoreduction|cytoreduction
4910508|NCT02040116|Rapid Infusion Rituximab|rapid infusion rituximab
4910509|NCT02040103|Deep Vein Thrombosis|deep vein thrombosis
4910510|NCT02040103|Pulmonary Embolism|pulmonary embolism
4910511|NCT02040103|Intermittent Pneumatic Compression|intermittent pneumatic compression
4910512|NCT02040103|Pharmacologic DVT|pharmacologic dvt
4910513|NCT02040103|Prophylaxis|prophylaxis
4910514|NCT02040103|Critically Ill Patients.|critically ill patients.
4910515|NCT02040077|opioid|opioid
4910516|NCT02040077|overdose|overdose
4910517|NCT02040077|OD|od
4910518|NCT02040077|opiate|opiate
4910519|NCT02040077|prescription opioids|prescription opioids
4910520|NCT02040077|prescription pain medication|prescription pain medication
4910521|NCT02040077|heroin|heroin
4910522|NCT02040077|detoxification|detoxification
4910523|NCT02040077|prevention|prevention
4910524|NCT02040051|intensive care units|intensive care units
4910525|NCT02040051|mechanical ventilation|mechanical ventilation
4910526|NCT02040051|music therapy|music therapy
4910527|NCT02040038|Diabetes|diabetes
4910528|NCT02040038|Virtual Environment|virtual environment
4910529|NCT02040038|Self-Management|self-management
4910530|NCT02040025|hypertension|hypertension
4910531|NCT02040025|diabetes mellitus|diabetes mellitus
4910532|NCT02040025|hemoglobin A1C|hemoglobin a1c
4910533|NCT02040025|peripheral vascular resistance|peripheral vascular resistance
4910534|NCT02040025|EECP|eecp
4910535|NCT02040025|Blood pressure|blood pressure
4910536|NCT02040025|angiogenesis|angiogenesis
4910537|NCT02040025|Coronary Artery Disease|coronary artery disease
4910538|NCT02040025|Coronary Disease|coronary disease
4910539|NCT02040025|Heart Diseases|heart diseases
4910540|NCT02040025|Cardiovascular Diseases|cardiovascular diseases
4910541|NCT02040012|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
4910542|NCT02039999|chronic|chronic
4910543|NCT02039999|cough|cough
4910544|NCT02039999|challenge|challenge
4910545|NCT02039999|ATP|atp
4910546|NCT02039999|hypersensitivity|hypersensitivity
4910547|NCT02039999|TRPA1|trpa1
4910548|NCT02039986|cystic fibrosis|cystic fibrosis
4910549|NCT02039986|CF|cf
4910550|NCT02039986|cystic fibrosis related diabetes|cystic fibrosis related diabetes
4910551|NCT02039986|CFRD|cfrd
4910552|NCT02039986|kalydeco|kalydeco
4910553|NCT02039986|ivacaftor|ivacaftor
4910554|NCT02039973|HIV|hiv
4910555|NCT02039973|AIDS|aids
4910558|NCT02039973|perinatal|perinatal
4910559|NCT02039973|psychotherapy|psychotherapy
4910560|NCT02039973|task-sharing|task-sharing
4910561|NCT02039973|problem-solving|problem-solving
4910562|NCT02039960|Epidemiology|epidemiology
4910563|NCT02039960|Drug Abuse Warning Network (DAWN)|drug abuse warning network (dawn)
4910564|NCT02039960|bupropion|bupropion
4910565|NCT02039960|abuse|abuse
4910566|NCT02039947|BRAF V600K mutation|braf v600k mutation
4910567|NCT02039947|Metastatic Melanoma|metastatic melanoma
4910568|NCT02039947|BRAF V600R mutation|braf v600r mutation
4910569|NCT02039947|BRAF V600D mutation|braf v600d mutation
4910570|NCT02039947|BRAF V600E mutation|braf v600e mutation
4910571|NCT02039947|Brain metastases BRAF inhibitor|brain metastases braf inhibitor
4910572|NCT02039947|Intracranial|intracranial
4910573|NCT02039934|type 2 diabetes|type 2 diabetes
4910574|NCT02039934|exercise intervention|exercise intervention
4910575|NCT02039934|high intensity interval training|high intensity interval training
4910576|NCT02039908|Tolerance to stimulant medication|tolerance to stimulant medication
4910577|NCT02039895|Cutaneous T-cell lymphoma|cutaneous t-cell lymphoma
4910578|NCT02039895|Helical irradiation of the total skin|helical irradiation of the total skin
4910579|NCT02039895|Refractory|refractory
4910580|NCT02039895|Total skin electron beam therapy|total skin electron beam therapy
4910581|NCT02039882|Acute Coronary Syndrome (ACS)|acute coronary syndrome (acs)
4910582|NCT02039882|Percutaneous Coronary Intervention PCI|percutaneous coronary intervention pci
4910583|NCT02039882|Normals|normals
4910584|NCT02039882|Myocardial Infarction MI|myocardial infarction mi
4910585|NCT02039882|Point of Care POC|point of care poc
4910586|NCT02039882|Hypoxanthine|hypoxanthine
4910587|NCT02039882|Inosine|inosine
4910588|NCT02039882|HPLC High Pressure Liquid Chromatography|hplc high pressure liquid chromatography
4910589|NCT02039869|NERD|nerd
4910590|NCT02039869|Non erosive reflux disease|non erosive reflux disease
4910591|NCT02039869|functional dyspepsia|functional dyspepsia
4910592|NCT02039869|erosive esophagitis|erosive esophagitis
4910593|NCT02039869|confocal endomicroscopy|confocal endomicroscopy
4910594|NCT02039869|cell visio|cell visio
4910595|NCT02039869|proton pump inhibitor|proton pump inhibitor
4910596|NCT02039869|sucralfate|sucralfate
4910597|NCT02039856|Patient-centered medical homes|patient-centered medical homes
4910598|NCT02039856|Primary care|primary care
4910599|NCT02039856|Women's health|women's health
4910600|NCT02039856|Veterans|veterans
4910601|NCT02039830|female|female
4910602|NCT02039830|aging|aging
4910603|NCT02039830|physiotherapy|physiotherapy
4910604|NCT02039830|pelvic floor|pelvic floor
4910605|NCT02039830|rehabilitation|rehabilitation
4910606|NCT02039817|pharmacokinetics|pharmacokinetics
4910607|NCT02039817|pharmacodynamics|pharmacodynamics
4910608|NCT02039817|renal impairment|renal impairment
4910609|NCT02039778|Glioblastoma|glioblastoma
4910610|NCT02039778|High-grade Glioma|high-grade glioma
4910611|NCT02039778|Brain Tums|brain tums
4910612|NCT02039778|Temozolomide|temozolomide
4910613|NCT02039778|Stem cell radiation therapy|stem cell radiation therapy
4910614|NCT02039778|IMRT|imrt
4910615|NCT02039778|Proton beam radiotherapy|proton beam radiotherapy
4910616|NCT02039778|Conventional external beam radiotherapy|conventional external beam radiotherapy
4910617|NCT02039778|Quality of Life|quality of life
4910618|NCT02039778|Neurocognition|neurocognition
4910619|NCT02039765|Ocular Redness|ocular redness
4910620|NCT02039752|Multivessel|multivessel
4910621|NCT02039739|Orsiro|orsiro
4910622|NCT02039739|Drug Eluting Stent|drug eluting stent
4910623|NCT02039739|Routine Clinical Practice|routine clinical practice
4910624|NCT02039739|Angioplasty, Transluminal, Percutaneous Coronary|angioplasty, transluminal, percutaneous coronary
4910625|NCT02039739|Coronary Artery Disease|coronary artery disease
4910626|NCT02039726|Acute Myeloid Leukemia|acute myeloid leukemia
4910627|NCT02039726|AML|aml
4910628|NCT02039726|FMS-like tyrosine kinase 3|fms-like tyrosine kinase 3
4910629|NCT02039726|FLT3-ITD|flt3-itd
4910630|NCT02039726|Quizartinib|quizartinib
4910631|NCT02039726|Leukemia|leukemia
4910632|NCT02039726|Tablets|tablets
4910633|NCT02039713|DeSyne|desyne
4910634|NCT02039713|Angioplasty, Transluminal, Percutaneous Coronary|angioplasty, transluminal, percutaneous coronary
4910635|NCT02039713|Coronary Artery Disease|coronary artery disease
4910636|NCT02039687|neuropathy|neuropathy
4910637|NCT02039687|sarcoidosis|sarcoidosis
4910638|NCT02039674|PD-1|pd-1
4910639|NCT02039674|PD1|pd1
4910640|NCT02039674|Programmed Cell Death-1|programmed cell death-1
4910641|NCT02039674|Programmed Cell Death 1|programmed cell death 1
4910642|NCT02039674|Chemotherapy|chemotherapy
4910643|NCT02039674|Pemetrexed|pemetrexed
4910644|NCT02039674|Paclitaxel|paclitaxel
4910645|NCT02039674|Bevacizumab|bevacizumab
4910646|NCT02039674|Erlotinib|erlotinib
4910647|NCT02039674|Gefitinib|gefitinib
4910648|NCT02039674|Ipilimumab|ipilimumab
4910649|NCT02039674|Carboplatin|carboplatin
4910650|NCT02039661|Curettage;|curettage;
4910651|NCT02039661|Pain Score|pain score
4910652|NCT02039648|Periodontitis|periodontitis
4910653|NCT02039648|Porphyromonas gingivalis|porphyromonas gingivalis
4910654|NCT02039648|Rumex acetosa L.|rumex acetosa l.
4910655|NCT02039648|Proanthocyanidins|proanthocyanidins
4910656|NCT02039635|cancer|cancer
4910657|NCT02039635|cancer related fatigue|cancer related fatigue
4910658|NCT02039635|Korean red ginseng|korean red ginseng
4910659|NCT02039635|chemotherapy|chemotherapy
4910660|NCT02039609|vegetarian|vegetarian
4910661|NCT02039609|vegan|vegan
4910662|NCT02039609|omnivore|omnivore
4910663|NCT02039609|Habitual diet|habitual diet
4910664|NCT02039583|live birth|live birth
4910665|NCT02039583|infant|infant
4910666|NCT02039583|infant, newborn|infant, newborn
4910667|NCT02039583|second-hand smoke|second-hand smoke
4910668|NCT02039583|tobacco smoke pollution|tobacco smoke pollution
4910669|NCT02039583|smoke-free|smoke-free
4910670|NCT02039583|smoke-free policy|smoke-free policy
4910671|NCT02039570|haemorrhoids|haemorrhoids
4910672|NCT02039570|pelvic reflux|pelvic reflux
4910673|NCT02039531|Knee|knee
4910674|NCT02039531|osteoarthritis|osteoarthritis
4910675|NCT02039531|plasma rich in growth factors|plasma rich in growth factors
4910676|NCT02039531|platelet rich plasma|platelet rich plasma
4910677|NCT02039531|hyaluronic acid|hyaluronic acid
4910678|NCT02039518|Progression free Survival|progression free survival
4910679|NCT02039505|Drug therapy|drug therapy
4910680|NCT02039479|anti-suicide|anti-suicide
4910681|NCT02039479|Lithium|lithium
4910682|NCT02039479|Depression|depression
4910683|NCT02039479|suicidal Ideation/behavior|suicidal ideation/behavior
4910684|NCT02039453|Colonoscopy|colonoscopy
4910685|NCT02039453|sedation|sedation
4910686|NCT02039453|propofol|propofol
4910687|NCT02039453|fentanyl|fentanyl
4910688|NCT02039453|pethidine|pethidine
4910689|NCT02039427|Sore throat|sore throat
4910690|NCT02039427|Hoarseness|hoarseness
4910691|NCT02039427|Intubation|intubation
4910692|NCT02039427|Thyroidectomy|thyroidectomy
4910693|NCT02039427|Ketorolac|ketorolac
4910694|NCT02039427|Dexamethasone|dexamethasone
4910695|NCT02039414|Obesity|obesity
4910696|NCT02039414|Physical Inactivity|physical inactivity
4910697|NCT02039414|Lipid Oxidation|lipid oxidation
4910698|NCT02039414|Oxidative stress|oxidative stress
4910699|NCT02039414|pregnancy|pregnancy
4910700|NCT02039414|neonatal adiposity|neonatal adiposity
4910701|NCT02039414|neonatal insulin sensitivity|neonatal insulin sensitivity
4910702|NCT02039401|ALS|als
4910703|NCT02039401|Lou Gehrig's disease|lou gehrig's disease
4910704|NCT02039401|neurodegenerative disease|neurodegenerative disease
4910705|NCT02039388|Ovarian Epithelial Cancer|ovarian epithelial cancer
4910706|NCT02039388|Serous Intraepithelial Carcinoma (STIC)|serous intraepithelial carcinoma (stic)
4910707|NCT02039388|BRCA1 gene|brca1 gene
4910708|NCT02039388|BRCA2 gene|brca2 gene
4910709|NCT02039388|Mutation|mutation
4910710|NCT02039388|Neoplasms|neoplasms
4910711|NCT02039388|Glandular and Epithelial|glandular and epithelial
4910712|NCT02039388|Ovarian Neoplasms|ovarian neoplasms
4910713|NCT02039388|Ovarian cancer|ovarian cancer
4910714|NCT02039388|Carcinoma in situ|carcinoma in situ
4910715|NCT02039388|family history breast cancer|family history breast cancer
4910716|NCT02039388|family history ovarian cancer|family history ovarian cancer
4910717|NCT02039375|IV tPA|iv tpa
4910718|NCT02039375|Thrombolysis|thrombolysis
4910719|NCT02039375|Stroke|stroke
4910720|NCT02039375|Ischemic|ischemic
4910721|NCT02039375|Monitoring|monitoring
4910722|NCT02039349|Alcoholism|alcoholism
4910723|NCT02039349|Ghrelin|ghrelin
4910724|NCT02039349|Ghrelin Antagonism|ghrelin antagonism
4910725|NCT02039323|Tenofovir|tenofovir
4910726|NCT02039323|Tenofovir disoproxil|tenofovir disoproxil
4910727|NCT02039323|Maraviroc|maraviroc
4910728|NCT02039323|Pharmacologic Actions|pharmacologic actions
4910729|NCT02039323|Anti-HIV agents|anti-hiv agents
4910730|NCT02039323|Pharmacodynamics|pharmacodynamics
4910731|NCT02039297|AWARE, Checklist, ICU, Outcome, Adults|aware, checklist, icu, outcome, adults
4910732|NCT02039284|Cerebral palsy|cerebral palsy
4910733|NCT02039284|novel intervention|novel intervention
4910734|NCT02039284|sensory electrical stimulation|sensory electrical stimulation
4910735|NCT02039284|virtual reality|virtual reality
4910736|NCT02039284|cycling training|cycling training
4910737|NCT02039284|constraint-induced therapy|constraint-induced therapy
4910738|NCT02039284|biomechanical|biomechanical
4910739|NCT02039284|physiology|physiology
4910740|NCT02039284|outcome|outcome
4910741|NCT02039271|music|music
4910742|NCT02039271|total knee replacement|total knee replacement
4910743|NCT02039271|Pain management|pain management
4910744|NCT02039258|Healthy Volunteers|healthy volunteers
4910745|NCT02039258|Canagliflozin|canagliflozin
4910746|NCT02039258|Metformin|metformin
4910747|NCT02039258|INVOKANA®|invokana®
4910748|NCT02039258|Type 2 diabetes mellitus|type 2 diabetes mellitus
4910749|NCT02039245|Healthy Volunteers|healthy volunteers
4910750|NCT02039245|Canagliflozin|canagliflozin
4910751|NCT02039245|Metformin|metformin
4910752|NCT02039245|INVOKANA®|invokana®
4910753|NCT02039245|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
4910754|NCT02039206|Machado Joseph disease|machado joseph disease
4910755|NCT02039206|Deep TMS|deep tms
4910756|NCT02039206|TMS|tms
4910757|NCT02039206|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
4910758|NCT02039206|SCA3|sca3
4910759|NCT02039206|Magnetic Stimulation|magnetic stimulation
4910760|NCT02039206|Brainsway|brainsway
4910761|NCT02039193|Generalized anxiety disorder|generalized anxiety disorder
4910762|NCT02039193|cognitive behavior therapy|cognitive behavior therapy
4910763|NCT02039193|adherence|adherence
4910764|NCT02039180|phase I|phase i
4910765|NCT02039180|healthy volunteers|healthy volunteers
4910766|NCT02039180|AZD3293|azd3293
4910767|NCT02039180|bioavailability|bioavailability
4910768|NCT02039180|Pharmacokinetics|pharmacokinetics
4910769|NCT02039154|Exercise|exercise
4910770|NCT02039154|Exercise tolerance|exercise tolerance
4910771|NCT02039154|Aging|aging
4910772|NCT02039154|Physical activity|physical activity
4910773|NCT02039141|diabetes prevention program|diabetes prevention program
4910774|NCT02039141|community based interventions|community based interventions
4910775|NCT02039141|childhood obesity|childhood obesity
4910776|NCT02039141|insulin resistance|insulin resistance
4910777|NCT02039141|glucose tolerance|glucose tolerance
4910778|NCT02039141|quality of life|quality of life
4910779|NCT02039141|Latino youth|latino youth
4910780|NCT02039141|physical activity|physical activity
4910781|NCT02039141|nutrition|nutrition
4910782|NCT02039102|hormonal contraceptives|hormonal contraceptives
4910783|NCT02039102|combined pills|combined pills
4910784|NCT02039102|progesterone-only contraceptives|progesterone-only contraceptives
4910785|NCT02039102|body mass index|body mass index
4910786|NCT02039102|asthma|asthma
4910787|NCT02039102|Scotland|scotland
4910788|NCT02039102|women|women
4910789|NCT02039076|Healthy|healthy
4910790|NCT02039063|Crohn's Disease|crohn's disease
4910791|NCT02039050|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
4910792|NCT02039050|Long-acting muscarinic antagonists|long-acting muscarinic antagonists
4910793|NCT02039050|Impulse oscillometry|impulse oscillometry
4910794|NCT02039024|18F-DTBZ|18f-dtbz
4910795|NCT02039011|Asthma|asthma
4910796|NCT02039011|Long acting beta-agonists|long acting beta-agonists
4910797|NCT02039011|Long acting muscarinic antagonists|long acting muscarinic antagonists
4910798|NCT02039011|Mannitol challenge|mannitol challenge
4910799|NCT02038998|stroke|stroke
4910800|NCT02038998|periodic acceleration|periodic acceleration
4910801|NCT02038998|endothelium release|endothelium release
4910802|NCT02038998|ischemic penumbra|ischemic penumbra
4910803|NCT02038998|shear stress|shear stress
4910804|NCT02038998|adrenomedullin|adrenomedullin
4910805|NCT02038985|Endometriosis|endometriosis
4910806|NCT02038985|Robotic Surgery|robotic surgery
4910807|NCT02038985|Diagnostic Imaging|diagnostic imaging
4910808|NCT02038959|Parkinson disease|parkinson disease
4910809|NCT02038959|Parkinson's|parkinson's
4910810|NCT02038959|Parkinson's disease|parkinson's disease
4910811|NCT02038959|telemedicine|telemedicine
4910812|NCT02038959|virtual visits|virtual visits
4910813|NCT02038959|video calls|video calls
4910814|NCT02038959|video conferencing|video conferencing
4910815|NCT02038959|virtual house calls|virtual house calls
4910816|NCT02038920|Drug Therapy|drug therapy
4910817|NCT02038907|Norovirus, vaccination|norovirus, vaccination
4910818|NCT02038894|Anesthetic|anesthetic
4910819|NCT02038894|Pediatric|pediatric
4910820|NCT02038894|Esophagogastroduodenoscopies|esophagogastroduodenoscopies
4910821|NCT02038894|Eosinophilic esophagitis|eosinophilic esophagitis
4910822|NCT02038894|Gastroesophageal reflux disease (GERD)|gastroesophageal reflux disease (gerd)
4910823|NCT02038894|Abdominal Pain|abdominal pain
4910824|NCT02038894|Vomiting|vomiting
4910825|NCT02038894|Sevofluorane|sevofluorane
4910826|NCT02038894|Propofol|propofol
4910827|NCT02038894|Nasal cannula|nasal cannula
4910828|NCT02038894|Intubation|intubation
4910829|NCT02038894|Endotracheal tube|endotracheal tube
4910830|NCT02038868|BPH|bph
4910831|NCT02038868|ASP4901|asp4901
4910832|NCT02038855|Dual-diagnosis|dual-diagnosis
4910833|NCT02038855|Latino|latino
4910834|NCT02038855|Mental health|mental health
4910835|NCT02038855|Substance use|substance use
4910836|NCT02038855|HIV risk|hiv risk
4910837|NCT02038829|COPD|copd
4910838|NCT02038803|Cystic Fibrosis Medication Adherence|cystic fibrosis medication adherence
4910839|NCT02038790|opioid dependence|opioid dependence
4910840|NCT02038790|buprenorphine/naloxone|buprenorphine/naloxone
4910841|NCT02038790|Opioid-Related Disorders|opioid-related disorders
4910842|NCT02038777|Hematologic Malignancies|hematologic malignancies
4910843|NCT02038764|Phase 1|phase 1
4910844|NCT02038764|RN168|rn168
4910845|NCT02038764|Adults|adults
4910846|NCT02038764|Type 1 Diabetes|type 1 diabetes
4910847|NCT02038764|T1D|t1d
4910848|NCT02038751|Genotyping|genotyping
4910849|NCT02038751|Phenotyping|phenotyping
4910850|NCT02038751|Sleep Apnea|sleep apnea
4910851|NCT02038751|Genetic Association Studies|genetic association studies
4910852|NCT02038751|Phenotype|phenotype
4910853|NCT02038738|gallium|gallium
4910854|NCT02038738|Ga|ga
4910855|NCT02038738|PET Scan|pet scan
4910856|NCT02038725|Risks|risks
4910857|NCT02038725|Risk Factors|risk factors
4910858|NCT02038725|ABCD2 score|abcd2 score
4910859|NCT02038725|Predictive Value of Tests|predictive value of tests
4910860|NCT02038725|Risk Assessment|risk assessment
4910861|NCT02038725|Severity of Illness Index|severity of illness index
4910862|NCT02038725|Decision Support Techniques|decision support techniques
4910863|NCT02038712|Obesity|obesity
4910864|NCT02038712|Binge eating disorder|binge eating disorder
4910865|NCT02038712|fMRI|fmri
4910866|NCT02038712|gut hormones|gut hormones
4910867|NCT02038686|Hip fracture|hip fracture
4910868|NCT02038686|Unstable (31A2 and 31A3)|unstable (31a2 and 31a3)
4910869|NCT02038686|Proximal femoral nail|proximal femoral nail
4910870|NCT02038673|ASP5878|asp5878
4910871|NCT02038673|FGFR 1,2,3 and 4 inhibitor|fgfr 1,2,3 and 4 inhibitor
4910872|NCT02038660|Coronary Artery Disease|coronary artery disease
4910873|NCT02038660|Angioplasty, Balloon|angioplasty, balloon
4910874|NCT02038647|Drug therapy|drug therapy
4910875|NCT02038634|wrist|wrist
4910876|NCT02038634|tendonitis|tendonitis
4910877|NCT02038634|dequervain's|dequervain's
4910878|NCT02038634|tenosynovitis|tenosynovitis
4910879|NCT02038608|Parkinson|parkinson
4910880|NCT02038608|serotonin|serotonin
4910881|NCT02038608|dopamine|dopamine
4910882|NCT02038608|non motor|non motor
4910883|NCT02038608|progression|progression
4910884|NCT02038608|PET|pet
4910885|NCT02038595|brown adipose tissue|brown adipose tissue
4910886|NCT02038582|HIV|hiv
4910887|NCT02038582|HIV Counseling and Testing|hiv counseling and testing
4910888|NCT02038582|Linkages to Care|linkages to care
4910889|NCT02038582|Point of Care CD4|point of care cd4
4910890|NCT02038582|Point of Care Viral Load|point of care viral load
4910891|NCT02038543|Hyperoxaluria|hyperoxaluria
4910892|NCT02038543|Oxalate|oxalate
4910893|NCT02038543|Primary Hyperoxaluria|primary hyperoxaluria
4910894|NCT02038530|Deep Vein Thrombosis|deep vein thrombosis
4910895|NCT02038517|Insulin secretion|insulin secretion
4910896|NCT02038517|Insulin sensitivity|insulin sensitivity
4910897|NCT02038517|Orthotopic liver transplantation|orthotopic liver transplantation
4910898|NCT02038517|Type 2 diabetes|type 2 diabetes
4910899|NCT02038517|Metabolic syndrome|metabolic syndrome
4910900|NCT02038517|Cardiovascular disease|cardiovascular disease
4910901|NCT02038504|gastrointestinal fistula|gastrointestinal fistula
4910902|NCT02038504|enteral nutrition|enteral nutrition
4910903|NCT02038504|thyroid function|thyroid function
4910904|NCT02038491|Epidural anesthesia|epidural anesthesia
4910905|NCT02038491|Spinal anesthesia|spinal anesthesia
4910906|NCT02038491|nerve blocks|nerve blocks
4910907|NCT02038491|complications|complications
4910908|NCT02038478|Sickle Cell Disease|sickle cell disease
4910909|NCT02038478|Thalassemia|thalassemia
4910910|NCT02038452|hand|hand
4910911|NCT02038452|wrist|wrist
4910912|NCT02038452|carpal|carpal
4910913|NCT02038452|tunnel|tunnel
4910914|NCT02038452|syndrome|syndrome
4910915|NCT02038452|pragmatic|pragmatic
4910916|NCT02038452|randomised|randomised
4910917|NCT02038452|steroid|steroid
4910918|NCT02038452|splint|splint
4910919|NCT02038439|Evidence-Based Medicine|evidence-based medicine
4910920|NCT02038439|Evidence Retrieval|evidence retrieval
4910921|NCT02038439|Knowledge Translation|knowledge translation
4910922|NCT02038439|Medical Education|medical education
4910923|NCT02038413|NSCLC|nsclc
4910924|NCT02038413|cT1/cT2aN0M0|ct1/ct2an0m0
4910925|NCT02038413|Stereotactic lung treatment|stereotactic lung treatment
4910926|NCT02038413|MAASTRO|maastro
4910927|NCT02038413|age >18 years|age >18 years
4910928|NCT02038335|immune cells|immune cells
4910929|NCT02038335|contraception|contraception
4910930|NCT02038335|intrauterine device|intrauterine device
4910931|NCT02038335|IUD|iud
4910932|NCT02038335|copper|copper
4910933|NCT02038335|microbiota|microbiota
4910934|NCT02038335|DMPA|dmpa
4910935|NCT02038335|etonogestrel|etonogestrel
4910936|NCT02038335|subdermal implant|subdermal implant
4910937|NCT02038335|NET-EN|net-en
4910938|NCT02038335|Jadelle|jadelle
4910939|NCT02038335|Implanon|implanon
4910940|NCT02038335|Cyclofem|cyclofem
4910941|NCT02038322|OTC Home Use Conception Aid Cervical Cap Insemination|otc home use conception aid cervical cap insemination
4910942|NCT02038309|Acute coronary syndrome|acute coronary syndrome
4910943|NCT02038309|persistent platelet reactivity|persistent platelet reactivity
4910944|NCT02038296|Hepatocellular carcinoma|hepatocellular carcinoma
4910945|NCT02038296|Transarterial chemoembolization|transarterial chemoembolization
4910946|NCT02038296|Gemcitabine|gemcitabine
4910947|NCT02038283|Colorectal Neoplasms|colorectal neoplasms
4910948|NCT02038283|Early Detection of Cancer|early detection of cancer
4910949|NCT02038283|Quality of Life|quality of life
4910950|NCT02038283|Quality-Adjusted Life Years|quality-adjusted life years
4910951|NCT02038283|Direct Service Costs|direct service costs
4910952|NCT02038283|Cost-Benefit Analysis|cost-benefit analysis
4910953|NCT02038231|Adolescence|adolescence
4910954|NCT02038231|Substance abuse|substance abuse
4910955|NCT02038231|Mindfulness|mindfulness
4910956|NCT02038218|DM-CHOC-PEN|dm-choc-pen
4910957|NCT02038218|CNS|cns
4910958|NCT02038218|brain|brain
4910959|NCT02038218|melanoma|melanoma
4910960|NCT02038218|lung cancer|lung cancer
4910961|NCT02038218|breast cancer|breast cancer
4910962|NCT02038218|glioblastoma multiforme|glioblastoma multiforme
4910963|NCT02038218|primary brain tumors|primary brain tumors
4910964|NCT02038192|Caregiver|caregiver
4910965|NCT02038192|Dementia|dementia
4910966|NCT02038192|Long Term Care|long term care
4910967|NCT02038192|Hope|hope
4910968|NCT02038192|Quality of Life|quality of life
4910969|NCT02038192|Intervention|intervention
4910970|NCT02038179|Pre-hypertension|pre-hypertension
4910971|NCT02038179|JNC 7 stage I hypertension|jnc 7 stage i hypertension
4910972|NCT02038140|Primary Ankle Replacement|primary ankle replacement
4910973|NCT02038140|Total Ankle Arthroplasty|total ankle arthroplasty
4910974|NCT02038140|Total Ankle Replacement|total ankle replacement
4910975|NCT02038140|Trabecular Metal Total Ankle|trabecular metal total ankle
4910976|NCT02038114|Odette Cancer Centre at Sunnybrook Health Sciences Centre|odette cancer centre at sunnybrook health sciences centre
4910977|NCT02038114|Toronto|toronto
4910978|NCT02038114|Ontario|ontario
4910979|NCT02038088|Need general anesthesia|need general anesthesia
4910980|NCT02038075|suicide|suicide
4910981|NCT02038075|suicidal ideation|suicidal ideation
4910982|NCT02038075|military|military
4910983|NCT02038075|veteran|veteran
4910984|NCT02038075|cognitive behavioral therapy|cognitive behavioral therapy
4910985|NCT02038075|behavioral therapy|behavioral therapy
4910986|NCT02038075|psychotherapy|psychotherapy
4910987|NCT02038075|Brief Cognitive Behavioral Therapy (BCBT)|brief cognitive behavioral therapy (bcbt)
4910988|NCT02038075|Treatement As Usual (TAU)|treatement as usual (tau)
4910989|NCT02038049|Multiple Sclerosis, Relapsing-Remitting Multiple Sclerosis, Magnetic Resonance Imaging, VAY736, monoclonal antibody, gadolinium [Gd]-enhancing lesions, B-Cell|multiple sclerosis, relapsing-remitting multiple sclerosis, magnetic resonance imaging, vay736, monoclonal antibody, gadolinium [gd]-enhancing lesions, b-cell
4910990|NCT02038036|Polycythemia Vera|polycythemia vera
4910991|NCT02038036|Hematologic Diseases|hematologic diseases
4910992|NCT02038036|Myeloproliferative Disorders|myeloproliferative disorders
4910993|NCT02038036|Bone Marrow Diseases|bone marrow diseases
4910994|NCT02038036|Hydroxyurea|hydroxyurea
4910995|NCT02038036|INC424|inc424
4910996|NCT02038036|Ruxolitinib|ruxolitinib
4910997|NCT02038023|Iv iron in pregnant women|iv iron in pregnant women
4910998|NCT02038023|second and third trimester|second and third trimester
4910999|NCT02037997|PFS|pfs
4911000|NCT02037971|Systemic Lupus Erythematosus|systemic lupus erythematosus
4911001|NCT02037971|Lupus|lupus
4911002|NCT02037971|Sleep disorders|sleep disorders
4911003|NCT02037971|Sleep disturbed|sleep disturbed
4911004|NCT02037971|Physical exercise|physical exercise
4911005|NCT02037971|Aerobic exercise|aerobic exercise
4911006|NCT02037945|18F-Fluorocholine (18F-FCho)|18f-fluorocholine (18f-fcho)
4911007|NCT02037945|Pet Scan|pet scan
4911008|NCT02037945|MRI|mri
4911009|NCT02037945|13-199|13-199
4911010|NCT02037932|Aneurysm|aneurysm
4911011|NCT02037932|Brain Aneurysm|brain aneurysm
4911012|NCT02037906|Renal stones|renal stones
4911013|NCT02037906|SWL|swl
4911014|NCT02037880|Mucopolysaccharidosis|mucopolysaccharidosis
4911015|NCT02037880|MPS|mps
4911016|NCT02037880|Sanfilippo|sanfilippo
4911017|NCT02037867|alcohol|alcohol
4911018|NCT02037867|type 2 diabetes|type 2 diabetes
4911019|NCT02037867|ALT|alt
4911020|NCT02037867|abnormal liver enzymes|abnormal liver enzymes
4911021|NCT02037867|hepatic fibrosis|hepatic fibrosis
4911022|NCT02037867|cirrhosis|cirrhosis
4911023|NCT02037841|Asthma|asthma
4911024|NCT02037841|Nursing|nursing
4911025|NCT02037841|Protocol|protocol
4911026|NCT02037841|PRAM|pram
4911027|NCT02037841|Length of Stay|length of stay
4911028|NCT02037841|Weaning|weaning
4911029|NCT02037841|Clinical pathway|clinical pathway
4911030|NCT02037841|Asthma exacerbation|asthma exacerbation
4911031|NCT02037828|COPD|copd
4911032|NCT02037828|biomarker|biomarker
4911033|NCT02037828|EBC|ebc
4911034|NCT02037828|FEV1|fev1
4911035|NCT02037815|hyperosmolar drugs|hyperosmolar drugs
4911036|NCT02037815|mannitol|mannitol
4911037|NCT02037815|hypertonic saline|hypertonic saline
4911038|NCT02037815|serum osmolality|serum osmolality
4911039|NCT02037815|correlation|correlation
4911040|NCT02037802|caudal|caudal
4911041|NCT02037802|epidural|epidural
4911042|NCT02037802|pediatric|pediatric
4911043|NCT02037802|renal|renal
4911044|NCT02037802|transplant|transplant
4911045|NCT02037802|hemodynamics|hemodynamics
4911046|NCT02037789|pain|pain
4911047|NCT02037789|low back pain|low back pain
4911048|NCT02037789|GWAS|gwas
4911049|NCT02037789|glycomics|glycomics
4911050|NCT02037789|activomics|activomics
4911051|NCT02037776|Rikkunshito|rikkunshito
4911052|NCT02037776|Double blind|double blind
4911053|NCT02037776|Functional dyspepsia (FD)|functional dyspepsia (fd)
4911054|NCT02037763|Low back pain|low back pain
4911055|NCT02037763|GWAS|gwas
4911056|NCT02037763|Glycomics|glycomics
4911057|NCT02037763|Activomics|activomics
4911058|NCT02037763|Epigenetics|epigenetics
4911059|NCT02037750|foster care|foster care
4911060|NCT02037750|school adjustment|school adjustment
4911061|NCT02037711|Laparoscopic|laparoscopic
4911062|NCT02037711|Levobupivacaine|levobupivacaine
4911063|NCT02037711|Pediatric|pediatric
4911064|NCT02037711|Anesthesia|anesthesia
4911065|NCT02037711|Instillation|instillation
4911066|NCT02037711|surgeries|surgeries
4911067|NCT02037698|CTO|cto
4911068|NCT02037698|CT|ct
4911069|NCT02037698|Revascularization|revascularization
4911070|NCT02037685|Statins|statins
4911071|NCT02037685|Cholesterol lowering medications|cholesterol lowering medications
4911072|NCT02037685|Adherence|adherence
4911073|NCT02037685|Motivational interviewing|motivational interviewing
4911074|NCT02037685|Minority populations|minority populations
4911075|NCT02037672|PCOS|pcos
4911076|NCT02037672|PDE-4 inhibitor|pde-4 inhibitor
4911077|NCT02037672|roflumilast|roflumilast
4911078|NCT02037672|metformin|metformin
4911079|NCT02037672|obesity|obesity
4911080|NCT02037646|Colorectal cancer|colorectal cancer
4911081|NCT02037646|Screening|screening
4911082|NCT02037646|Fecal occult blood|fecal occult blood
4911083|NCT02037646|Fecal immunochemical test|fecal immunochemical test
4911084|NCT02037646|Qualitative|qualitative
4911085|NCT02037646|Quantitative|quantitative
4911086|NCT02037620|Epidural Stimulation|epidural stimulation
4911087|NCT02037607|Deep vein thrombosis|deep vein thrombosis
4911088|NCT02037607|Children|children
4911089|NCT02037607|Pediatric|pediatric
4911090|NCT02037607|Anti-coagulant|anti-coagulant
4911091|NCT02037607|Neurosurgical procedures|neurosurgical procedures
4911092|NCT02037607|Blood Clot|blood clot
4911093|NCT02037594|HIV|hiv
4911094|NCT02037594|Pre-exposure prophylaxis|pre-exposure prophylaxis
4911095|NCT02037594|PrEP|prep
4911096|NCT02037594|MSM|msm
4911097|NCT02037594|Demonstration Project|demonstration project
4911098|NCT02037581|integrated care|integrated care
4911099|NCT02037581|hometreatment|hometreatment
4911100|NCT02037581|assertive community treatment (ACT)|assertive community treatment (act)
4911101|NCT02037581|psychosis|psychosis
4911102|NCT02037581|schizophrenia|schizophrenia
4911103|NCT02037581|bipolar disorder|bipolar disorder
4911104|NCT02037581|first episode|first episode
4911105|NCT02037568|depression|depression
4911106|NCT02037568|stress|stress
4911107|NCT02037568|caregiving|caregiving
4911108|NCT02037568|anxiety|anxiety
4911109|NCT02037568|psychoeducation intervention|psychoeducation intervention
4911110|NCT02037568|psycho-oncology|psycho-oncology
4911111|NCT02037568|allogeneic hematopoietic stem cell transplant|allogeneic hematopoietic stem cell transplant
4911112|NCT02037555|Antithrombin|antithrombin
4911113|NCT02037555|Cardiopulmonary bypass|cardiopulmonary bypass
4911114|NCT02037542|BMI, Lipid profile|bmi, lipid profile
4911115|NCT02037516|residual muscle weakness, respiratory events|residual muscle weakness, respiratory events
4911116|NCT02037490|Infants|infants
4911117|NCT02037490|Mothers|mothers
4911118|NCT02037490|Social media|social media
4911119|NCT02037490|Obesity prevention|obesity prevention
4911120|NCT02037464|Prostate Cancer|prostate cancer
4911121|NCT02037464|Active Surveillance|active surveillance
4911122|NCT02037464|Radical Prostatectomy|radical prostatectomy
4911123|NCT02037451|Parkinson's disease|parkinson's disease
4911124|NCT02037451|Auditory Cueing|auditory cueing
4911125|NCT02037438|Clinical sleep medicine|clinical sleep medicine
4911126|NCT02037438|New methodology for healthcare delivery|new methodology for healthcare delivery
4911127|NCT02037438|Diagnosis and treatment of sleep disorders|diagnosis and treatment of sleep disorders
4911128|NCT02037438|Electronic health records|electronic health records
4911129|NCT02037438|Clinical informatics|clinical informatics
4911130|NCT02037438|Evidence-based comparative effectiveness research|evidence-based comparative effectiveness research
4911131|NCT02037438|Sleep specialists|sleep specialists
4911132|NCT02037438|Primary care providers|primary care providers
4911133|NCT02037438|Allied health professionals|allied health professionals
4911134|NCT02037438|Patient-centered care|patient-centered care
4911135|NCT02037425|Chronic Migraine|chronic migraine
4911136|NCT02037425|onabotulinumtoxinA|onabotulinumtoxina
4911137|NCT02037425|Headache|headache
4911138|NCT02037425|Migraine|migraine
4911139|NCT02037425|Neuronal regrowth|neuronal regrowth
4911140|NCT02037425|Botox|botox
4911141|NCT02037412|Ticagrelor|ticagrelor
4911142|NCT02037412|strut coverage|strut coverage
4911143|NCT02037412|DES|des
4911144|NCT02037412|ACS|acs
4911145|NCT02037412|OCT|oct
4911146|NCT02037399|Endoscopic submucosal dissection|endoscopic submucosal dissection
4911147|NCT02037399|early gastric cancer|early gastric cancer
4911148|NCT02037399|pain relief|pain relief
4911149|NCT02037399|intravenous dexamethasone|intravenous dexamethasone
4911150|NCT02037399|present pain intensity|present pain intensity
4911151|NCT02037386|Side branch stent|side branch stent
4911152|NCT02037386|Coronary bifurcation lesion|coronary bifurcation lesion
4911153|NCT02037373|intra and post-op coagulopathy in patients undergoing OLT|intra and post-op coagulopathy in patients undergoing olt
4911154|NCT02037360|Smoking|smoking
4911155|NCT02037360|Cessation|cessation
4911156|NCT02037334|Preterm delivery|preterm delivery
4911157|NCT02037334|Diagnostics|diagnostics
4911158|NCT02037334|Biomechanics|biomechanics
4911159|NCT02037321|Systematic review and meta-analysis|systematic review and meta-analysis
4911160|NCT02037308|Glu298Asp polymorphism|glu298asp polymorphism
4911161|NCT02037308|Blood pressure|blood pressure
4911162|NCT02037308|Plasma NOx|plasma nox
4911163|NCT02037308|Beetroot|beetroot
4911164|NCT02037295|Gut Microbiota|gut microbiota
4911165|NCT02037295|Obesity|obesity
4911166|NCT02037295|Absorption|absorption
4911167|NCT02037295|Overfeeding|overfeeding
4911168|NCT02037282|HAI Titer|hai titer
4911263|NCT02036853|Epilepsy|epilepsy
4911169|NCT02037282|Hemagglutination Inhibition Assays|hemagglutination inhibition assays
4911170|NCT02037282|Immunogenicity|immunogenicity
4911171|NCT02037282|Serum Antibody Response|serum antibody response
4911172|NCT02037269|Cerenkov Luminescence Imaging, CLI, margin status|cerenkov luminescence imaging, cli, margin status
4911173|NCT02037243|behavior change|behavior change
4911174|NCT02037243|handwashing|handwashing
4911175|NCT02037243|water treatment|water treatment
4911176|NCT02037243|disgust|disgust
4911177|NCT02037243|shame|shame
4911178|NCT02037243|neighbour|neighbour
4911179|NCT02037243|willingness to pay|willingness to pay
4911180|NCT02037204|IMPACT|impact
4911181|NCT02037204|Chondrons|chondrons
4911182|NCT02037204|Mesenchymal stem cells|mesenchymal stem cells
4911183|NCT02037204|Allogeneic MSCs|allogeneic mscs
4911184|NCT02037204|single-stage|single-stage
4911185|NCT02037204|Cartilage repair|cartilage repair
4911186|NCT02037204|Safety|safety
4911187|NCT02037204|Efficacy|efficacy
4911188|NCT02037191|ALOPECIA AREATA|alopecia areata
4911189|NCT02037191|TREATMENT METHOTREXATE|treatment methotrexate
4911190|NCT02037178|Peripheral Obliterative Arteriopathy of the legs|peripheral obliterative arteriopathy of the legs
4911191|NCT02037178|Screening by generalists|screening by generalists
4911192|NCT02037178|Ultrasound|ultrasound
4911193|NCT02037152|Chronic pain|chronic pain
4911194|NCT02037152|Mobile applications|mobile applications
4911195|NCT02037152|Mindfulness|mindfulness
4911196|NCT02037152|Meditation|meditation
4911197|NCT02037152|Telemedicine|telemedicine
4911198|NCT02037152|Cellular phone|cellular phone
4911199|NCT02037152|Pain Management|pain management
4911200|NCT02037152|Therapy, computer-assisted|therapy, computer-assisted
4911201|NCT02037139|Hearing loss|hearing loss
4911202|NCT02037139|Screening|screening
4911203|NCT02037139|Primary Care|primary care
4911204|NCT02037113|IVUS|ivus
4911205|NCT02037113|PAD|pad
4911206|NCT02037113|Femoro-popliteal disease|femoro-popliteal disease
4911207|NCT02037113|Intravascular ultrasound|intravascular ultrasound
4911208|NCT02037087|Short Message Service|short message service
4911209|NCT02037087|newborn health|newborn health
4911210|NCT02037087|maternal behavior|maternal behavior
4911211|NCT02037087|good household pregnancy practice|good household pregnancy practice
4911212|NCT02037087|care seeking|care seeking
4911213|NCT02037074|Phosphodiesterase 10 inhibitor|phosphodiesterase 10 inhibitor
4911214|NCT02037022|Autism Spectrum Disorder (ASD)|autism spectrum disorder (asd)
4911215|NCT02037022|Autism|autism
4911216|NCT02036983|Ultrasound guided|ultrasound guided
4911217|NCT02036983|Bilateral Transversus abdominis Plane Block|bilateral transversus abdominis plane block
4911218|NCT02036983|Dexamethasone|dexamethasone
4911219|NCT02036983|Preperitoneal Instillation|preperitoneal instillation
4911220|NCT02036983|Local Analgesic|local analgesic
4911221|NCT02036983|Efficacy|efficacy
4911222|NCT02036983|Total Extraperitoneal Bilateral Inguinal hernia repair|total extraperitoneal bilateral inguinal hernia repair
4911223|NCT02036970|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
4911224|NCT02036970|PAH|pah
4911225|NCT02036970|Bardoxolone methyl|bardoxolone methyl
4911226|NCT02036970|6-minute walk distance|6-minute walk distance
4911227|NCT02036970|CDDO-me|cddo-me
4911228|NCT02036970|RTA 402|rta 402
4911229|NCT02036970|Pulmonary Hypertension|pulmonary hypertension
4911230|NCT02036970|Interstitial Lung Disease|interstitial lung disease
4911231|NCT02036970|Idiopathic Interstitial Pneumonia|idiopathic interstitial pneumonia
4911232|NCT02036970|Idiopathic Pulmonary Fibrosis|idiopathic pulmonary fibrosis
4911233|NCT02036970|Sarcoidosis|sarcoidosis
4911234|NCT02036970|Respiratory Bronchiolitis Associated ILD|respiratory bronchiolitis associated ild
4911235|NCT02036970|Desquamative Interstitial Pneumonia|desquamative interstitial pneumonia
4911236|NCT02036970|Cryptogenic Organizing Pneumonia|cryptogenic organizing pneumonia
4911237|NCT02036970|Acute Interstitial Pneumonitis|acute interstitial pneumonitis
4911238|NCT02036970|Idiopathic Lymphoid Interstitial Pneumonia|idiopathic lymphoid interstitial pneumonia
4911239|NCT02036970|Idiopathic Pleuroparenchymal Fibroelastosis|idiopathic pleuroparenchymal fibroelastosis
4911240|NCT02036957|capecitabine|capecitabine
4911241|NCT02036957|dermatologic toxicity|dermatologic toxicity
4911242|NCT02036944|Celiac Disease|celiac disease
4911243|NCT02036944|Celiac Sprue|celiac sprue
4911244|NCT02036944|Iron-Deficiency Anemia|iron-deficiency anemia
4911245|NCT02036931|Joint|joint
4911246|NCT02036931|Osteoarthritis|osteoarthritis
4911247|NCT02036931|Avascular Necrosis|avascular necrosis
4911248|NCT02036918|castrate resistant prostate cancer|castrate resistant prostate cancer
4911249|NCT02036918|metastatic|metastatic
4911250|NCT02036918|sipuleucel-T|sipuleucel-t
4911251|NCT02036918|lymphadenectomy|lymphadenectomy
4911252|NCT02036918|Excisional lymph node biopsy|excisional lymph node biopsy
4911253|NCT02036905|neck pain, orthopedic manual therapy|neck pain, orthopedic manual therapy
4911254|NCT02036892|Diabetes|diabetes
4911255|NCT02036879|Cystic Fibrosis|cystic fibrosis
4911256|NCT02036879|Loestrin|loestrin
4911257|NCT02036879|Hormone|hormone
4911258|NCT02036866|knee osteoarthritis|knee osteoarthritis
4911259|NCT02036866|grade I and II knee osteoarthritis|grade i and ii knee osteoarthritis
4911260|NCT02036866|arthritis|arthritis
4911261|NCT02036853|Triheptanoin|triheptanoin
4911262|NCT02036853|Glut1 DS|glut1 ds
4911264|NCT02036853|Seizures|seizures
4911265|NCT02036827|Pain, Postoperative|pain, postoperative
4911266|NCT02036827|Neuromuscular Blocking Agents|neuromuscular blocking agents
4911267|NCT02036827|Laparoscopy|laparoscopy
4911268|NCT02036814|Hypertension|hypertension
4911269|NCT02036814|Nursing|nursing
4911270|NCT02036814|Therapeutic compliance|therapeutic compliance
4911271|NCT02036814|Quality of life|quality of life
4911272|NCT02036814|Health education|health education
4911273|NCT02036801|ARDS|ards
4911274|NCT02036801|Lung|lung
4911275|NCT02036801|Specific Elastance|specific elastance
4911276|NCT02036801|Pediatric patients|pediatric patients
4911277|NCT02036788|Esophageal pressure, Mechanical ventilation|esophageal pressure, mechanical ventilation
4911278|NCT02036762|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
4911279|NCT02036762|Thoracoabdominal Mechanics|thoracoabdominal mechanics
4911280|NCT02036762|Functional capacity|functional capacity
4911281|NCT02036762|Quality of life|quality of life
4911282|NCT02036736|Orthopedic Surgery|orthopedic surgery
4911283|NCT02036736|Total hip prosthesis|total hip prosthesis
4911284|NCT02036736|Total knee replacement|total knee replacement
4911285|NCT02036736|Intraoperative anesthetic strategy|intraoperative anesthetic strategy
4911286|NCT02036736|Propofol|propofol
4911287|NCT02036736|Desflurane|desflurane
4911288|NCT02036723|Macular Degeneration|macular degeneration
4911289|NCT02036723|Eye Diseases|eye diseases
4911290|NCT02036723|Neovascular Macular Degeneration|neovascular macular degeneration
4911291|NCT02036723|Choroidal Neovascularization|choroidal neovascularization
4911292|NCT02036723|Geographic Atrophy|geographic atrophy
4911293|NCT02036710|GLP-1|glp-1
4911294|NCT02036710|PYY|pyy
4911295|NCT02036710|Leptin|leptin
4911296|NCT02036710|Duodenal Switch|duodenal switch
4911297|NCT02036697|Cesarean section|cesarean section
4911298|NCT02036697|spinal anesthesia|spinal anesthesia
4911299|NCT02036697|low dose spinal|low dose spinal
4911300|NCT02036697|bupivacaine|bupivacaine
4911301|NCT02036697|hemodynamics|hemodynamics
4911302|NCT02036697|blood pressure|blood pressure
4911303|NCT02036697|cardiac output|cardiac output
4911304|NCT02036684|Prostate cancer|prostate cancer
4911305|NCT02036684|Radical prostatectomy|radical prostatectomy
4911306|NCT02036684|Prehabilitation|prehabilitation
4911307|NCT02036684|Pelvic floor muscle exercises|pelvic floor muscle exercises
4911308|NCT02036671|Arteriovenous fistula|arteriovenous fistula
4911309|NCT02036671|Fistula|fistula
4911310|NCT02036671|Chronic kidney disease|chronic kidney disease
4911311|NCT02036671|Percutaneous|percutaneous
4911312|NCT02036671|Kidney Disease|kidney disease
4911313|NCT02036671|Kidney Failure, Chronic|kidney failure, chronic
4911314|NCT02036671|Urologic Diseases|urologic diseases
4911315|NCT02036671|Renal Insufficiency, Chronic|renal insufficiency, chronic
4911316|NCT02036671|Renal Insufficiency|renal insufficiency
4911317|NCT02036671|CKD|ckd
4911318|NCT02036671|hemodialysis|hemodialysis
4911319|NCT02036658|social anxiety|social anxiety
4911320|NCT02036658|treatment|treatment
4911321|NCT02036658|cognitive-behavioral therapy|cognitive-behavioral therapy
4911322|NCT02036658|mindfulness-based stress reduction|mindfulness-based stress reduction
4911323|NCT02036658|emotion regulation|emotion regulation
4911324|NCT02036658|randomized controlled trial|randomized controlled trial
4911325|NCT02036658|neuroimaging|neuroimaging
4911326|NCT02036658|functional magnetic resonance imaging|functional magnetic resonance imaging
4911327|NCT02036658|mediators|mediators
4911328|NCT02036658|mechanisms|mechanisms
4911329|NCT02036619|gestational diabetes|gestational diabetes
4911330|NCT02036619|pregestational diabetes|pregestational diabetes
4911331|NCT02036619|screening|screening
4911332|NCT02036619|diagnostic criteria|diagnostic criteria
4911333|NCT02036619|IADPSG|iadpsg
4911334|NCT02036593|Cardiovascular Risk Factors|cardiovascular risk factors
4911335|NCT02036580|Japan|japan
4911336|NCT02036580|Phase2|phase2
4911337|NCT02036580|Safety|safety
4911338|NCT02036580|Tolerability|tolerability
4911339|NCT02036580|Idiopathic Pulmonary Fibrosis|idiopathic pulmonary fibrosis
4911340|NCT02036580|IPF|ipf
4911341|NCT02036580|CAT-354|cat-354
4911342|NCT02036580|Tralokinumab|tralokinumab
4911343|NCT02036541|Glaucoma Implant|glaucoma implant
4911344|NCT02036541|Trabeculectomy|trabeculectomy
4911345|NCT02036541|POAG|poag
4911346|NCT02036541|Primary Open Angle Glaucoma|primary open angle glaucoma
4911347|NCT02036541|Pseudoexfoliation Glaucoma|pseudoexfoliation glaucoma
4911348|NCT02036541|Pigmentary Glaucoma|pigmentary glaucoma
4911349|NCT02036528|Foot Ulcer|foot ulcer
4911350|NCT02036528|Diabetic Foot|diabetic foot
4911351|NCT02036528|Gentamicins|gentamicins
4911352|NCT02036528|infection|infection
4911353|NCT02036502|PD1|pd1
4911354|NCT02036502|PD-1|pd-1
4911355|NCT02036502|PDL1|pdl1
4911356|NCT02036502|PD-L1|pd-l1
4911357|NCT02036476|Merkel Cell Carcinoma|merkel cell carcinoma
4911358|NCT02036476|Skin Cancer|skin cancer
4911359|NCT02036463|Duchenne Muscular Dystrophy|duchenne muscular dystrophy
4911360|NCT02036463|Corticosteroids|corticosteroids
4911361|NCT02036450|atrial fibrillation|atrial fibrillation
4911362|NCT02036450|cardiac arrhythmia|cardiac arrhythmia
4911363|NCT02036450|stroke|stroke
4911364|NCT02036450|implantable loop recorder|implantable loop recorder
4911365|NCT02036450|bleeding|bleeding
4911366|NCT02036450|anticoagulation|anticoagulation
4911367|NCT02036450|hypertension|hypertension
4911368|NCT02036450|diabetes|diabetes
4911369|NCT02036450|heart failure|heart failure
4911370|NCT02036450|mortality|mortality
4911371|NCT02036437|Induction of Labor|induction of labor
4911372|NCT02036437|Misoprostol|misoprostol
4911373|NCT02036411|clomiphene citrate|clomiphene citrate
4911374|NCT02036411|amh|amh
4911375|NCT02036411|inhibin b|inhibin b
4911376|NCT02036398|Percutaneous Nephrolithotomy (PCNL)|percutaneous nephrolithotomy (pcnl)
4911377|NCT02036398|Nephrostomy|nephrostomy
4911378|NCT02036398|Double J stent|double j stent
4911379|NCT02036398|PleuraL Effusion|pleural effusion
4911380|NCT02036398|Pain|pain
4911381|NCT02036372|glucose|glucose
4911382|NCT02036372|diabetes mellitus|diabetes mellitus
4911383|NCT02036372|perioperative|perioperative
4911384|NCT02036359|Non-small Cell Lung Cancer(NSCLC)|non-small cell lung cancer(nsclc)
4911385|NCT02036346|ileostomy|ileostomy
4911386|NCT02036346|colorectal resection|colorectal resection
4911387|NCT02036346|dehydration|dehydration
4911388|NCT02036346|nutritional status|nutritional status
4911389|NCT02036333|near infrared spectroscopy|near infrared spectroscopy
4911390|NCT02036333|pediatrics|pediatrics
4911391|NCT02036307|Fish oils|fish oils
4911392|NCT02036307|Triglycerides|triglycerides
4911393|NCT02036307|Blood pressure|blood pressure
4911394|NCT02036294|Patient self-care behaviors|patient self-care behaviors
4911395|NCT02036294|Patient activation|patient activation
4911396|NCT02036294|Family caregiver support|family caregiver support
4911397|NCT02036294|Patient-centered care|patient-centered care
4911398|NCT02036281|Terminally ill , histologically-confirmed advanced cancer|terminally ill , histologically-confirmed advanced cancer
4911399|NCT02036281|Pain unrelieved by opioids|pain unrelieved by opioids
4911400|NCT02036268|Ostomy education|ostomy education
4911401|NCT02036268|Education|education
4911402|NCT02036268|care of ostomy site|care of ostomy site
4911403|NCT02036255|Prevention, Thrombosis, Hemodialysis, Vascular access device|prevention, thrombosis, hemodialysis, vascular access device
4911404|NCT02036242|Opioid|opioid
4911405|NCT02036242|Local anesthetic|local anesthetic
4911406|NCT02036242|Labor delivery|labor delivery
4911407|NCT02036242|Safety|safety
4911408|NCT02036229|demodex|demodex
4911409|NCT02036229|demodicidosis|demodicidosis
4911410|NCT02036229|rosacea|rosacea
4911411|NCT02036229|ivermectin|ivermectin
4911412|NCT02036216|Hepatocellular Carcinoma；cell free tumor DNA; Mutation;|hepatocellular carcinoma；cell free tumor dna; mutation;
4911413|NCT02036190|COPD, chronic obstructive pulmonary disease, emphysema|copd, chronic obstructive pulmonary disease, emphysema
4911415|NCT02036164|Locally advanced cervical cancer|locally advanced cervical cancer
4911416|NCT02036164|Concurrent chemoradiation|concurrent chemoradiation
4911417|NCT02036164|Adjuvant chemotherapy|adjuvant chemotherapy
4911418|NCT02036151|Xylitol|xylitol
4911419|NCT02036151|prevention|prevention
4911420|NCT02036151|Mutans streptococci|mutans streptococci
4911421|NCT02036151|caries|caries
4911422|NCT02036151|plaque|plaque
4911423|NCT02036151|children|children
4911424|NCT02036125|Corticosteroid|corticosteroid
4911425|NCT02036125|Ultrasound|ultrasound
4911426|NCT02036125|Guided injection|guided injection
4911427|NCT02036112|Advanced Lower rectal cancer|advanced lower rectal cancer
4911428|NCT02036112|Extralevator abdominoperineal excision|extralevator abdominoperineal excision
4911429|NCT02036112|Circumferential resection margin|circumferential resection margin
4911430|NCT02036112|Morbidity|morbidity
4911431|NCT02036112|Survival|survival
4911432|NCT02036099|Dementia|dementia
4911433|NCT02036099|Automobile driving|automobile driving
4911434|NCT02036099|Accidents, traffic|accidents, traffic
4911435|NCT02036086|Melanoma stage IIIB or C with BRAF mutation|melanoma stage iiib or c with braf mutation
4911436|NCT02036086|Recurrent regional lymphadenopathy not suitable for surgery|recurrent regional lymphadenopathy not suitable for surgery
4911437|NCT02036086|Eligible for neoadjuvant vemurafenib and cobimetinib|eligible for neoadjuvant vemurafenib and cobimetinib
4911438|NCT02036073|erythropoietin|erythropoietin
4911439|NCT02036073|preterm|preterm
4911440|NCT02036073|brain injury|brain injury
4911441|NCT02036073|cerebral palsy|cerebral palsy
4911442|NCT02036073|PVL|pvl
4911443|NCT02036060|Metastatic prostate cancer|metastatic prostate cancer
4911444|NCT02036060|Abiraterone acetate|abiraterone acetate
4911445|NCT02036021|pediatric anesthesia|pediatric anesthesia
4911446|NCT02036021|perioperative respiratory events|perioperative respiratory events
4911447|NCT02036021|days of hospitalization|days of hospitalization
4911448|NCT02036021|cost of hospitalization|cost of hospitalization
4911449|NCT02036008|Liver metastases|liver metastases
4911450|NCT02036008|MRI|mri
4911451|NCT02036008|Contrast Agents|contrast agents
4911452|NCT02035995|gestational diabetes mellitus; optical coherence tomography; pregnancy; retinal nerve fiber layer.|gestational diabetes mellitus; optical coherence tomography; pregnancy; retinal nerve fiber layer.
4911453|NCT02035956|IVAC MUTANOME|ivac mutanome
4911454|NCT02035956|IVAC|ivac
4911455|NCT02035956|personalized therapy|personalized therapy
4911456|NCT02035956|personalized immuno therapy|personalized immuno therapy
4911457|NCT02035956|RB_0004-01|rb_0004-01
4911458|NCT02035956|Ribological|ribological
4911459|NCT02035956|Melanoma|melanoma
4911460|NCT02035956|cancer vaccine|cancer vaccine
4911461|NCT02035930|Bispectral Index Monitor, Menstrual Cycle, Dexmedetomidine|bispectral index monitor, menstrual cycle, dexmedetomidine
4911462|NCT02035891|colchicine|colchicine
4911463|NCT02035891|urinary albumin-to-creatinine ratio|urinary albumin-to-creatinine ratio
4911464|NCT02035891|carotid Intima-Media Thickness|carotid intima-media thickness
4911465|NCT02035891|overt nephropathy|overt nephropathy
4911466|NCT02035891|Type 2 diabetes|type 2 diabetes
4911467|NCT02035878|anxiety|anxiety
4911468|NCT02035878|depression|depression
4911469|NCT02035878|probiotics|probiotics
4911470|NCT02035878|adult|adult
4911471|NCT02035878|human|human
4911472|NCT02035878|depression anxiety stress scale|depression anxiety stress scale
4911473|NCT02035878|anxiety sensitivity index|anxiety sensitivity index
4911474|NCT02035865|Psychiatric morbidity|psychiatric morbidity
4911475|NCT02035865|Cognitive function|cognitive function
4911476|NCT02035865|Heart transplantation|heart transplantation
4911477|NCT02035865|Mortality|mortality
4911478|NCT02035865|Cardiac allograft vasculopathy|cardiac allograft vasculopathy
4911479|NCT02035839|Target Temperature Management|target temperature management
4911480|NCT02035839|Cooling comatose survivors from OHCA|cooling comatose survivors from ohca
4911481|NCT02035839|Good neurological outcome at modified Rankin Score (mRS) ≤ 3|good neurological outcome at modified rankin score (mrs) ≤ 3
4911482|NCT02035813|metastatic breast cancer|metastatic breast cancer
4911483|NCT02035813|circulating tumor cells|circulating tumor cells
4911484|NCT02035813|everolimus|everolimus
4911485|NCT02035813|eribulin|eribulin
4911486|NCT02035800|Rheumatoid Arthritis|rheumatoid arthritis
4911487|NCT02035800|Adalimumab|adalimumab
4911488|NCT02035800|Humira|humira
4911489|NCT02035787|metformin|metformin
4911490|NCT02035787|endometrial cancer|endometrial cancer
4911491|NCT02035787|Lineberger Comprehensive Cancer Center|lineberger comprehensive cancer center
4911492|NCT02035787|complex atypical hyperplasia|complex atypical hyperplasia
4911493|NCT02035774|Brachial plexus block|brachial plexus block
4911494|NCT02035774|Suprascapular nerve block|suprascapular nerve block
4911495|NCT02035761|MSA|msa
4911496|NCT02035761|Shy-Dragers Syndrome|shy-dragers syndrome
4911497|NCT02035761|Possible or Probable|possible or probable
4911498|NCT02035748|Vitreomacular traction|vitreomacular traction
4911499|NCT02035748|Symptomatic vitreomacular adhesion|symptomatic vitreomacular adhesion
4911500|NCT02035748|Ocriplasmin|ocriplasmin
4911501|NCT02035748|JETREA|jetrea
4911502|NCT02035735|NBI,|nbi,
4911503|NCT02035735|squamous cell carcinoma,|squamous cell carcinoma,
4911504|NCT02035735|pharynx, larynx, surgical margins.|pharynx, larynx, surgical margins.
4911505|NCT02035709|Therapy|therapy
4911506|NCT02035696|influenza|influenza
4911507|NCT02035696|children|children
4911508|NCT02035696|safety|safety
4911509|NCT02035696|tolerability|tolerability
4911510|NCT02035696|immunogenicity|immunogenicity
4911511|NCT02035683|metabolic response|metabolic response
4911512|NCT02035683|chemotherapy|chemotherapy
4911513|NCT02035670|diagnostic strategy|diagnostic strategy
4911514|NCT02035670|effectiveness|effectiveness
4911515|NCT02035670|fever of unknown origin|fever of unknown origin
4911516|NCT02035657|Merkel cell carcinoma|merkel cell carcinoma
4911517|NCT02035657|MCC|mcc
4911518|NCT02035631|Breast Neoplasms|breast neoplasms
4911519|NCT02035631|Recurrence|recurrence
4911520|NCT02035631|Motor Activity|motor activity
4911521|NCT02035631|Diet|diet
4911522|NCT02035631|Quality of Life|quality of life
4911523|NCT02035579|concussion|concussion
4911524|NCT02035579|mild traumatic brain injury|mild traumatic brain injury
4911525|NCT02035579|post-concussion syndrome|post-concussion syndrome
4911526|NCT02035579|adolescents|adolescents
4911527|NCT02035579|sports injury|sports injury
4911528|NCT02035579|aerobic training|aerobic training
4911529|NCT02035579|stretching training|stretching training
4911530|NCT02035566|Minority Health|minority health
4911531|NCT02035566|Health Status Disparities|health status disparities
4911532|NCT02035566|Health Care Disparities|health care disparities
4911533|NCT02035566|Rural Health|rural health
4911534|NCT02035566|Telemedicine|telemedicine
4911535|NCT02035566|Health Services Research|health services research
4911536|NCT02035566|Social Determinants of Health|social determinants of health
4911537|NCT02035566|Ecological Theory of Health|ecological theory of health
4911538|NCT02035527|squamous cell carcinoma|squamous cell carcinoma
4911539|NCT02035527|head and neck|head and neck
4911540|NCT02035514|multiple sclerosis|multiple sclerosis
4911541|NCT02035514|mesenchymal stem cells|mesenchymal stem cells
4911542|NCT02035514|autologous transplantation|autologous transplantation
4911543|NCT02035514|MRI efficacy|mri efficacy
4911544|NCT02035514|clinical safety|clinical safety
4911545|NCT02035488|Dry powder inhalation|dry powder inhalation
4911546|NCT02035488|Bronchiectasis|bronchiectasis
4911547|NCT02035488|Tobramycin|tobramycin
4911548|NCT02035475|Prevention|prevention
4911549|NCT02035475|Pelvic Lymph Node Dissection|pelvic lymph node dissection
4911550|NCT02035475|Lymphoceles|lymphoceles
4911551|NCT02035475|Prostate Malignancies|prostate malignancies
4911552|NCT02035475|daVinci|davinci
4911553|NCT02035475|Vessel Sealer|vessel sealer
4911554|NCT02035475|EndoWrist One|endowrist one
4911555|NCT02035449|Video laryngoscope|video laryngoscope
4911556|NCT02035449|Pre-hospital|pre-hospital
4911557|NCT02035449|Endotracheal intubation|endotracheal intubation
4911558|NCT02035449|Difficult endotracheal intubation|difficult endotracheal intubation
4911559|NCT02035449|Pre hospital Critical care|pre hospital critical care
4911560|NCT02035449|McGrath MAC|mcgrath mac
4911561|NCT02035449|Airway device|airway device
4911562|NCT02035436|Respiration, artificial|respiration, artificial
4911563|NCT02035436|Critcal care|critcal care
4911564|NCT02035423|Vitamin D Deficiency|vitamin d deficiency
4911565|NCT02035423|Compliance|compliance
4911566|NCT02035423|Milk|milk
4911567|NCT02035410|cardiac devices|cardiac devices
4911568|NCT02035410|prevention|prevention
4911569|NCT02035410|infection|infection
4911570|NCT02035397|botulinum toxin|botulinum toxin
4911571|NCT02035397|Endoscopy|endoscopy
4911572|NCT02035397|Satiation|satiation
4911573|NCT02035397|Diet|diet
4911574|NCT02035397|Weight Loss|weight loss
4911575|NCT02035358|Metastatic|metastatic
4911576|NCT02035358|Recurrent|recurrent
4911577|NCT02035358|Refractory|refractory
4911578|NCT02035358|Renal Cell Carcinoma|renal cell carcinoma
4911579|NCT02035358|Kidney|kidney
4911580|NCT02035358|clear-cell renal cancer|clear-cell renal cancer
4911581|NCT02035358|Cancer|cancer
4911582|NCT02035345|Recurrent Ovarian Cancer|recurrent ovarian cancer
4911583|NCT02035345|Platinum Sensitive Ovarian Cancer|platinum sensitive ovarian cancer
4911584|NCT02035332|Excessive Uterine Bleeding|excessive uterine bleeding
4911585|NCT02035332|Menorrhagia|menorrhagia
4911586|NCT02035332|Endometrial Ablation|endometrial ablation
4911587|NCT02035293|COPD Exacerbation|copd exacerbation
4911588|NCT02035293|Pulmonary embolism|pulmonary embolism
4911589|NCT02035293|Standardized and consensus diagnostic strategy|standardized and consensus diagnostic strategy
4911590|NCT02035280|Spine|spine
4911591|NCT02035280|Deformity|deformity
4911592|NCT02035280|Fusion|fusion
4911593|NCT02035280|Elderly|elderly
4911594|NCT02035280|SRS-22r|srs-22r
4911595|NCT02035241|Spices|spices
4911596|NCT02035241|Herbs|herbs
4911597|NCT02035241|Functional food|functional food
4911598|NCT02035241|Cardiometabolic risk|cardiometabolic risk
4911599|NCT02035241|Metabolic syndrome|metabolic syndrome
4911600|NCT02035241|Inflammation|inflammation
4911601|NCT02035241|Appetite|appetite
4911602|NCT02035241|Gut hormone|gut hormone
4911603|NCT02035228|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
4911604|NCT02035228|Lung Hyperinflation|lung hyperinflation
4911605|NCT02035228|Abdominal Muscle|abdominal muscle
4911606|NCT02035228|Functional Electrical Stimulation|functional electrical stimulation
4911607|NCT02035215|Hyperlipidemia, Familial Combined|hyperlipidemia, familial combined
4911608|NCT02035215|Omega 3 acids ethylesters 90|omega 3 acids ethylesters 90
4911609|NCT02035215|Atorvastatin|atorvastatin
4911610|NCT02035176|autism|autism
4911611|NCT02035176|ADHD|adhd
4911612|NCT02035176|attention deficit hyperactivity disorder|attention deficit hyperactivity disorder
4911613|NCT02035176|behavioral assessment|behavioral assessment
4911614|NCT02035176|behavior|behavior
4911615|NCT02035163|Atrial fibrillation|atrial fibrillation
4911616|NCT02035163|coronary artery bypass graft|coronary artery bypass graft
4911617|NCT02035163|cryoablation|cryoablation
4911618|NCT02035163|ganglionic plexi|ganglionic plexi
4911619|NCT02035150|breakfast|breakfast
4911620|NCT02035150|oatmeal|oatmeal
4911621|NCT02035150|appetite|appetite
4911622|NCT02035150|cholesterol|cholesterol
4911623|NCT02035124|Prostate|prostate
4911624|NCT02035124|Metastatic|metastatic
4911625|NCT02035124|Refractory|refractory
4911626|NCT02035124|mCRPC|mcrpc
4911627|NCT02035111|Migraine|migraine
4911628|NCT02035111|Tianshu capsule|tianshu capsule
4911629|NCT02035098|cancer, pain, cluster trial, quality improvement|cancer, pain, cluster trial, quality improvement
4911630|NCT02035085|19F MRI|19f mri
4911631|NCT02035059|Oral Glucose Tolerance Test|oral glucose tolerance test
4911632|NCT02035059|Fibronectin|fibronectin
4911633|NCT02035059|Adiponectin|adiponectin
4911634|NCT02035059|Copeptin|copeptin
4911635|NCT02035059|Cortisol|cortisol
4911636|NCT02035046|Gitelman|gitelman
4911637|NCT02035046|Heterozygous SLC12A3 mutation|heterozygous slc12a3 mutation
4911638|NCT02035046|Blood pressure|blood pressure
4911639|NCT02035046|Hypokalemia|hypokalemia
4911640|NCT02035020|frataxin, gamma interferon, Friedreich ataxia|frataxin, gamma interferon, friedreich ataxia
4911641|NCT02034994|school-based intervention|school-based intervention
4911642|NCT02034994|after school physical activity|after school physical activity
4911643|NCT02034994|sugar sweetened beverages|sugar sweetened beverages
4911644|NCT02034994|sedentary behavior|sedentary behavior
4911645|NCT02034994|schoolchildren|schoolchildren
4911646|NCT02034981|metastatic or unresectable locally advanced malignancies.|metastatic or unresectable locally advanced malignancies.
4911647|NCT02034981|genomic alterations.|genomic alterations.
4911648|NCT02034981|biological crizotinib targets (ALK, MET, ROS1, RON, AXL).|biological crizotinib targets (alk, met, ros1, ron, axl).
4911649|NCT02034968|Nimotuzumab|nimotuzumab
4911650|NCT02034968|Nab-Paclitaxel|nab-paclitaxel
4911651|NCT02034968|Carcinoma of Esophagus|carcinoma of esophagus
4911652|NCT02034955|Prostate Cancer|prostate cancer
4911653|NCT02034955|Adaptive Radiotherapy|adaptive radiotherapy
4911654|NCT02034955|Prostatectomy|prostatectomy
4911655|NCT02034955|Patients who had a prostatectomy|patients who had a prostatectomy
4911656|NCT02034942|non-sedation|non-sedation
4911657|NCT02034929|colon cancer|colon cancer
4911658|NCT02034929|adenoma|adenoma
4911659|NCT02034929|colon polyps|colon polyps
4911660|NCT02034916|Breast cancer|breast cancer
4911661|NCT02034916|BRCA mutation|brca mutation
4911662|NCT02034916|PARP inhibitor|parp inhibitor
4911663|NCT02034916|BRCA 1|brca 1
4911664|NCT02034916|BRCA 2|brca 2
4911665|NCT02034903|Enteral Feeding|enteral feeding
4911666|NCT02034903|Infant, Premature|infant, premature
4911667|NCT02034890|orthotopic neobladder|orthotopic neobladder
4911668|NCT02034890|urinary tract infection|urinary tract infection
4911669|NCT02034890|intravesical instillation|intravesical instillation
4911670|NCT02034890|hyaluronic acid|hyaluronic acid
4911671|NCT02034877|13-valent pneunococcal conjugate vaccine|13-valent pneunococcal conjugate vaccine
4911672|NCT02034877|pneumococcal disease prevention; safety and immunogenicity study|pneumococcal disease prevention; safety and immunogenicity study
4911673|NCT02034864|low back pain|low back pain
4911674|NCT02034864|manual therapy|manual therapy
4911675|NCT02034864|randomizer controlled trial|randomizer controlled trial
4911676|NCT02034851|Acute pyelonephritis|acute pyelonephritis
4911677|NCT02034851|Renal scarring|renal scarring
4911678|NCT02034851|Dexamethasone|dexamethasone
4911679|NCT02034851|Children|children
4911680|NCT02034851|Corticoids|corticoids
4911681|NCT02034851|Complementary treatment|complementary treatment
4911682|NCT02034851|Prevention strategy|prevention strategy
4911684|NCT02034838|pharmacokinetic|pharmacokinetic
4911685|NCT02034838|HIV-infected|hiv-infected
4911686|NCT02034838|atazanavir|atazanavir
4911687|NCT02034838|ritonavir|ritonavir
4911688|NCT02034786|Mesenchymal stem cell|mesenchymal stem cell
4911689|NCT02034786|Hyaluronic acid|hyaluronic acid
4911690|NCT02034786|Adipose Tissue|adipose tissue
4911691|NCT02034786|Filler Agent|filler agent
4911692|NCT02034773|Safety, Pharmacokinetics, Pharmacodynamics, Healthy Subjects|safety, pharmacokinetics, pharmacodynamics, healthy subjects
4911693|NCT02034760|Frailty|frailty
4911694|NCT02034760|Ageing|ageing
4911695|NCT02034760|Protein supplementation|protein supplementation
4911696|NCT02034760|Protein quality|protein quality
4911697|NCT02034760|Gut microbiota|gut microbiota
4911698|NCT02034760|Metabolome|metabolome
4911699|NCT02034760|Exercise training|exercise training
4911700|NCT02034760|Sarcopenia|sarcopenia
4911701|NCT02034747|Advagraf|advagraf
4911702|NCT02034747|kidney transplant|kidney transplant
4911703|NCT02034747|Corticosteroid|corticosteroid
4911704|NCT02034747|Immunosuppressive regimen|immunosuppressive regimen
4911705|NCT02034734|Phase 1|phase 1
4911706|NCT02034734|ASP3652|asp3652
4911707|NCT02034734|Cerebrospinal fluid (CSF)|cerebrospinal fluid (csf)
4911708|NCT02034734|Multiple doses|multiple doses
4911709|NCT02034721|Muscle damage|muscle damage
4911710|NCT02034721|Muscle soreness|muscle soreness
4911711|NCT02034721|Muscle function|muscle function
4911712|NCT02034721|Innate immune function|innate immune function
4911713|NCT02034721|Inflammation|inflammation
4911714|NCT02034708|Primary brain tumor|primary brain tumor
4911715|NCT02034695|Diabetes mellitus|diabetes mellitus
4911716|NCT02034669|Acute Spinal cord Injury, Adipose derived stem cells|acute spinal cord injury, adipose derived stem cells
4911717|NCT02034656|imatinib resistance|imatinib resistance
4911718|NCT02034656|mutation|mutation
4911719|NCT02034630|hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
4911720|NCT02034617|Cognition|cognition
4911721|NCT02034617|Family nursing|family nursing
4911722|NCT02034617|Infant, premature|infant, premature
4911723|NCT02034617|Object attachment|object attachment
4911724|NCT02034617|Stress, physiological|stress, physiological
4911725|NCT02034617|Stress, psychological|stress, psychological
4911726|NCT02034604|Naftopidil|naftopidil
4911727|NCT02034604|safety|safety
4911728|NCT02034539|peripheral artery disease|peripheral artery disease
4911729|NCT02034539|critical limb ischemia|critical limb ischemia
4911730|NCT02034539|VADOplex|vadoplex
4911731|NCT02034539|intermittent foot compression|intermittent foot compression
4911732|NCT02034526|Sinus node disease|sinus node disease
4911733|NCT02034526|Atrial fibrillation|atrial fibrillation
4911734|NCT02034526|Pacing|pacing
4911735|NCT02034500|prevention|prevention
4911736|NCT02034500|Shigella sonnei|shigella sonnei
4911737|NCT02034487|Delayed Puberty|delayed puberty
4911738|NCT02034487|Boys|boys
4911739|NCT02034487|Hormones|hormones
4911740|NCT02034487|Polymorphism, Genetic|polymorphism, genetic
4911741|NCT02034461|Micro-Electrodes|micro-electrodes
4911742|NCT02034461|Peripheral Nerve Injury|peripheral nerve injury
4911743|NCT02034461|Amputation|amputation
4911744|NCT02034461|Spinal Cord Injury|spinal cord injury
4911745|NCT02034448|CRRT|crrt
4911746|NCT02034448|Renal|renal
4911747|NCT02034448|Kidney|kidney
4911748|NCT02034448|adults|adults
4911749|NCT02034448|registry|registry
4911750|NCT02034448|AKI|aki
4911751|NCT02034422|Exercise|exercise
4911752|NCT02034409|Knee Osteoarthritis|knee osteoarthritis
4911753|NCT02034409|Pulsed Low Intensity Ultrasound|pulsed low intensity ultrasound
4911754|NCT02034396|Ulcers, venous, unna's boot|ulcers, venous, unna's boot
4911755|NCT02034370|Interscalene nerve block|interscalene nerve block
4911756|NCT02034370|Shoulder surgery|shoulder surgery
4911757|NCT02034370|Obstructive Sleep Apnea|obstructive sleep apnea
4911758|NCT02034370|Sleep Disordered Breathing|sleep disordered breathing
4911759|NCT02034357|Parkinson Disease|parkinson disease
4911760|NCT02034357|Sleep Disordered Breathing|sleep disordered breathing
4911761|NCT02034357|Sleep Obstructive Apnea|sleep obstructive apnea
4911762|NCT02034357|Polysomnography|polysomnography
4911763|NCT02034357|CPAP (continuous positive airway pressure) titration|cpap (continuous positive airway pressure) titration
4911764|NCT02034357|CPAP (continuous positive airway pressure) treatment|cpap (continuous positive airway pressure) treatment
4911765|NCT02034344|Lupus Erythematosus, Cutaneous|lupus erythematosus, cutaneous
4911766|NCT02034344|Lupus Erythematosus, Systemic|lupus erythematosus, systemic
4911767|NCT02034344|Lupus Erythematosus, Discoid|lupus erythematosus, discoid
4911768|NCT02034344|Healthy|healthy
4911769|NCT02034344|Active Cutaneous Lupus Erythematosus|active cutaneous lupus erythematosus
4911770|NCT02034344|Longitudinal Study|longitudinal study
4911771|NCT02034344|Biomarkers|biomarkers
4911772|NCT02034344|Subacute Cutaneous Lupus Erythematosus|subacute cutaneous lupus erythematosus
4911773|NCT02034344|Skin Biopsy|skin biopsy
4911774|NCT02034331|Insulin Sensitivity|insulin sensitivity
4911775|NCT02034331|Microvascular permeability|microvascular permeability
4911776|NCT02034331|Sympathetic nervous system|sympathetic nervous system
4911777|NCT02034318|Fatigue|fatigue
4911778|NCT02034318|Cardiac Sympathetic Denervation|cardiac sympathetic denervation
4911779|NCT02034318|Parkinson Disease|parkinson disease
4911780|NCT02034305|Airway Clearance|airway clearance
4911781|NCT02034305|Duchenne Muscular Dystrophy|duchenne muscular dystrophy
4911782|NCT02034305|Peak Cough Flow|peak cough flow
4911783|NCT02034279|cirrhosis|cirrhosis
4911784|NCT02034266|Type one diabetes|type one diabetes
4911785|NCT02034266|nerve damage|nerve damage
4911786|NCT02034266|neuropathy|neuropathy
4911787|NCT02034266|omega-3 fatty acid|omega-3 fatty acid
4911788|NCT02034266|supplementation|supplementation
4911789|NCT02034266|nutrition|nutrition
4911790|NCT02034253|duration of untreated psychosis|duration of untreated psychosis
4911791|NCT02034253|glutamate|glutamate
4911792|NCT02034253|functional connectivity|functional connectivity
4911793|NCT02034253|structural connectivity|structural connectivity
4911794|NCT02034253|schizophrenia|schizophrenia
4911795|NCT02034253|psychosis|psychosis
4911796|NCT02034227|leukemia|leukemia
4911797|NCT02034214|HIV|hiv
4911798|NCT02034214|adolescents|adolescents
4911799|NCT02034188|multiple sclerosis|multiple sclerosis
4911800|NCT02034188|umbilical cord|umbilical cord
4911801|NCT02034188|mesenchymal|mesenchymal
4911802|NCT02034188|stem cells|stem cells
4911803|NCT02034175|apnea|apnea
4911804|NCT02034175|hypopnea|hypopnea
4911805|NCT02034175|polysomnography|polysomnography
4911806|NCT02034175|respiratory|respiratory
4911807|NCT02034175|cheyne|cheyne
4911808|NCT02034162|Helminth infections|helminth infections
4911809|NCT02034162|Helminths|helminths
4911810|NCT02034162|Pediatric|pediatric
4911811|NCT02034162|Preschool aged|preschool aged
4911812|NCT02034162|School aged|school aged
4911813|NCT02034162|Mebendazole|mebendazole
4911814|NCT02034162|Vermox|vermox
4911815|NCT02034162|Placebo|placebo
4911816|NCT02034149|chronic kidney disease|chronic kidney disease
4911817|NCT02034149|high risk|high risk
4911818|NCT02034149|intervention|intervention
4911819|NCT02034149|hypertension|hypertension
4911820|NCT02034149|hyperglycemia|hyperglycemia
4911821|NCT02034149|hyperlipidemia|hyperlipidemia
4911822|NCT02034123|First time in humans|first time in humans
4911823|NCT02034123|Small cell lung carcinoma|small cell lung carcinoma
4911824|NCT02034123|Oncology|oncology
4911825|NCT02034123|GSK2879552|gsk2879552
4911826|NCT02034123|LSD1 inhibitor|lsd1 inhibitor
4911827|NCT02034110|solid tumors|solid tumors
4911828|NCT02034110|efficacy|efficacy
4911829|NCT02034110|BRAF V600E mutation|braf v600e mutation
4911830|NCT02034110|trametinib|trametinib
4911831|NCT02034110|safety|safety
4911832|NCT02034110|Dabrafenib|dabrafenib
4911833|NCT02034097|ROS1|ros1
4911834|NCT02034097|erlotinib|erlotinib
4911835|NCT02034097|EGFR|egfr
4911836|NCT02034097|non-small cell lung cancer|non-small cell lung cancer
4911837|NCT02034097|foretinib|foretinib
4911838|NCT02034084|Transradial approach,|transradial approach,
4911839|NCT02034084|Coronary angiography|coronary angiography
4911840|NCT02034071|Prader-Willi syndrome|prader-willi syndrome
4911841|NCT02034058|Wingspan Stent System|wingspan stent system
4911842|NCT02034058|Wingspan Stent|wingspan stent
4911843|NCT02034058|Intracranial Stent|intracranial stent
4911844|NCT02034058|Ischemic Stroke|ischemic stroke
4911845|NCT02034058|Intracranial Atherosclerotic Disease|intracranial atherosclerotic disease
4911846|NCT02034058|Intracranial Stenosis|intracranial stenosis
4911847|NCT02034032|Osteoarthritis|osteoarthritis
4911848|NCT02034032|Knee|knee
4911849|NCT02034032|Arthritis|arthritis
4911850|NCT02034032|TKA|tka
4911851|NCT02034032|Total Knee Arthroplasty|total knee arthroplasty
4911852|NCT02034006|pathological myopia|pathological myopia
4911853|NCT02034006|choroidal neovascularization|choroidal neovascularization
4911854|NCT02034006|ranibizumab|ranibizumab
4911855|NCT02034006|mono-bilateral|mono-bilateral
4911856|NCT02034006|poor visual acuity|poor visual acuity
4911857|NCT02034006|retinal disease|retinal disease
4911858|NCT02034006|eye disease|eye disease
4911859|NCT02034006|Angiogenesis Inhibitors|angiogenesis inhibitors
4911860|NCT02034006|Angiogenesis Modulating Agents|angiogenesis modulating agents
4911861|NCT02033980|narrow band imaging(NBI)|narrow band imaging(nbi)
4911862|NCT02033980|NICE classification|nice classification
4911863|NCT02033980|colorectal lesions|colorectal lesions
4911864|NCT02033980|predicting histology|predicting histology
4911865|NCT02033967|liver donor|liver donor
4911866|NCT02033967|hepatectomy|hepatectomy
4911867|NCT02033967|vasodilator|vasodilator
4911868|NCT02033967|central venous pressure|central venous pressure
4911869|NCT02033967|stroke volume variation|stroke volume variation
4911870|NCT02033954|Embolization|embolization
4911871|NCT02033954|Hemorrhage|hemorrhage
4911872|NCT02033954|TIPS|tips
4911873|NCT02033954|GI Bleeding|gi bleeding
4911874|NCT02033954|AV Fistula|av fistula
4911875|NCT02033954|AV Malformation|av malformation
4911876|NCT02033954|Traumatic Vascular Injury|traumatic vascular injury
4911877|NCT02033941|Alzheimer's Disease|alzheimer's disease
4911878|NCT02033941|Grapeseed Extract|grapeseed extract
4911879|NCT02033941|Clinical Trial|clinical trial
4911880|NCT02033941|Meganatural-AZ|meganatural-az
4911881|NCT02033941|anti-oligomerization|anti-oligomerization
4911882|NCT02033941|Phase 2|phase 2
4911883|NCT02033941|Dietary Supplement|dietary supplement
4911884|NCT02033941|Nutraceutical|nutraceutical
4911885|NCT02033928|Myeloma|myeloma
4911886|NCT02033928|MGUS (monoclonal gammopathy of undetermined significance)|mgus (monoclonal gammopathy of undetermined significance)
4911887|NCT02033928|amyloidosis|amyloidosis
4911888|NCT02033928|stem cell transplant|stem cell transplant
4911889|NCT02033915|Suicide risk assessment|suicide risk assessment
4911890|NCT02033915|interactive discussion group|interactive discussion group
4911891|NCT02033915|suicide attempt|suicide attempt
4911892|NCT02033915|self-harm|self-harm
4911893|NCT02033915|randomized control study|randomized control study
4911894|NCT02033915|identifying high risk group for suicide|identifying high risk group for suicide
4911895|NCT02033902|Epilepsy|epilepsy
4911896|NCT02033863|Varicocele|varicocele
4911897|NCT02033863|Pelvic Congestion Syndrome|pelvic congestion syndrome
4911898|NCT02033863|Pelvic Venous Incompetence|pelvic venous incompetence
4911899|NCT02033863|Ovarian Varices|ovarian varices
4911900|NCT02033850|small vessel disease|small vessel disease
4911901|NCT02033850|cognition|cognition
4911902|NCT02033850|treatment|treatment
4911903|NCT02033850|rehabilitation|rehabilitation
4911904|NCT02033850|attention|attention
4911905|NCT02033850|fMRI|fmri
4911906|NCT02033850|vascular dementia|vascular dementia
4911907|NCT02033837|Coronary artery disease|coronary artery disease
4911908|NCT02033837|Cardiac CT|cardiac ct
4911909|NCT02033837|Appropriate Use Criteria (AUC)|appropriate use criteria (auc)
4911910|NCT02033811|mitral regurgitation|mitral regurgitation
4911911|NCT02033811|MitraClip system|mitraclip system
4911912|NCT02033811|percutaneous mitral valve repair|percutaneous mitral valve repair
4911913|NCT02033798|Urodynamics|urodynamics
4911914|NCT02033798|Glomerular Filtration Rate|glomerular filtration rate
4911915|NCT02033785|Prostatic hyperplasia|prostatic hyperplasia
4911916|NCT02033759|Lymphedema|lymphedema
4911917|NCT02033733|Post cardiac arrest|post cardiac arrest
4911918|NCT02033733|Postcardiac arrest therapeutic hypothermia|postcardiac arrest therapeutic hypothermia
4911919|NCT02033733|Therapeutic hypothermia protocol|therapeutic hypothermia protocol
4911920|NCT02033733|Neuromuscular blocking agents|neuromuscular blocking agents
4911921|NCT02033733|Muscle relaxants|muscle relaxants
4911922|NCT02033733|Hypothermia-induced increased muscle tone|hypothermia-induced increased muscle tone
4911923|NCT02033733|Microshivering|microshivering
4911924|NCT02033720|postcardiac arrest|postcardiac arrest
4911925|NCT02033720|post cardiac arrest syndrome|post cardiac arrest syndrome
4911926|NCT02033720|post cardiac arrest hypothermia|post cardiac arrest hypothermia
4911927|NCT02033720|pulseless electrical activity|pulseless electrical activity
4911928|NCT02033720|asystole|asystole
4911929|NCT02033720|therapeutic hypothermia|therapeutic hypothermia
4911930|NCT02033720|therapeutic hypothermia after cardiac arrest|therapeutic hypothermia after cardiac arrest
4911931|NCT02033720|therapeutic hypothermia neurologic outcome|therapeutic hypothermia neurologic outcome
4911932|NCT02033707|Hallucinogen|hallucinogen
4911933|NCT02033707|Cognitive effects|cognitive effects
4911934|NCT02033707|Subjective effects|subjective effects
4911935|NCT02033694|Lipid|lipid
4911936|NCT02033694|Vulnerable Plaque|vulnerable plaque
4911937|NCT02033694|Plaque|plaque
4911938|NCT02033694|Cholesterol|cholesterol
4911939|NCT02033694|Near Infrared Spectroscopy|near infrared spectroscopy
4911940|NCT02033694|NIRS-IVUS|nirs-ivus
4911941|NCT02033694|Intravascular Ultrasound|intravascular ultrasound
4911942|NCT02033694|Angiography|angiography
4911943|NCT02033694|Coronary Imaging|coronary imaging
4911944|NCT02033681|epinephrine|epinephrine
4911945|NCT02033681|hand|hand
4911946|NCT02033681|ischemia|ischemia
4911947|NCT02033681|lidocaine|lidocaine
4911948|NCT02033681|upper extremity|upper extremity
4911949|NCT02033668|bioavailability|bioavailability
4912831|NCT02029365|Infertility|infertility
4911950|NCT02033668|Pharmacokinetics|pharmacokinetics
4911951|NCT02033668|intravenous|intravenous
4911952|NCT02033668|subcutaneous and intramuscular administration|subcutaneous and intramuscular administration
4911953|NCT02033668|amyloid beta|amyloid beta
4911954|NCT02033668|monoclonal antibody|monoclonal antibody
4911955|NCT02033655|weight loss|weight loss
4911956|NCT02033655|older adults|older adults
4911957|NCT02033655|obesity|obesity
4911958|NCT02033629|Anesthesia|anesthesia
4911959|NCT02033629|remifentanil|remifentanil
4911960|NCT02033629|propofol|propofol
4911961|NCT02033629|target-controlled infusion|target-controlled infusion
4911962|NCT02033629|cardiac surgery|cardiac surgery
4911963|NCT02033603|Total knee arthroplasty|total knee arthroplasty
4911964|NCT02033603|Total knee replacement|total knee replacement
4911965|NCT02033603|Femoral Nerve Block|femoral nerve block
4911966|NCT02033603|Adductor Canal Block|adductor canal block
4911967|NCT02033564|Sore Throat|sore throat
4911968|NCT02033564|Intubation|intubation
4911969|NCT02033564|Laryngoscopy|laryngoscopy
4911970|NCT02033564|Anesthesiology|anesthesiology
4911971|NCT02033564|Perioperative|perioperative
4911972|NCT02033564|Airway Management|airway management
4911973|NCT02033551|Gastric Cancer|gastric cancer
4911974|NCT02033551|Lung Cancer|lung cancer
4911975|NCT02033551|PARP Inhibitor|parp inhibitor
4911976|NCT02033551|Ovarian Cancer|ovarian cancer
4911977|NCT02033551|Solid Tumors|solid tumors
4911978|NCT02033551|Breast Cancer|breast cancer
4911979|NCT02033551|Colon Cancer|colon cancer
4911980|NCT02033538|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
4911981|NCT02033538|Nab-Paclitaxel|nab-paclitaxel
4911982|NCT02033538|Carcinoma of Esophagus|carcinoma of esophagus
4911983|NCT02033525|Chronic Meniscal Injury|chronic meniscal injury
4911984|NCT02033525|Degenerative meniscus|degenerative meniscus
4911985|NCT02033525|Meniscus injury|meniscus injury
4911986|NCT02033525|Meniscal injury|meniscal injury
4911987|NCT02033525|Mesenchymal stromal cells|mesenchymal stromal cells
4911988|NCT02033525|Mesenchymal stem cells|mesenchymal stem cells
4911989|NCT02033525|Advanced Therapy|advanced therapy
4911990|NCT02033525|Bone marrow|bone marrow
4911991|NCT02033512|Post-menopause|post-menopause
4911992|NCT02033512|Hormone Replacement Therapy|hormone replacement therapy
4911993|NCT02033512|Nanotechnology|nanotechnology
4911994|NCT02033512|Biolipid B2|biolipid b2
4911995|NCT02033499|Blood Glucose Self-Monitoring|blood glucose self-monitoring
4911996|NCT02033499|Self-Monitoring, Blood Glucose|self-monitoring, blood glucose
4911997|NCT02033499|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
4911998|NCT02033499|Quality of Life|quality of life
4911999|NCT02033486|diffuse optical tomography|diffuse optical tomography
4912000|NCT02033486|digital breast tomosynthesis|digital breast tomosynthesis
4912001|NCT02033486|breast cancer|breast cancer
4912002|NCT02033486|solid benign lesions|solid benign lesions
4912003|NCT02033486|cysts|cysts
4912004|NCT02033486|malignant lesions|malignant lesions
4912005|NCT02033473|Apelin|apelin
4912006|NCT02033473|insulin|insulin
4912007|NCT02033473|volunteers|volunteers
4912008|NCT02033460|Manual therapy|manual therapy
4912009|NCT02033460|Exercise|exercise
4912010|NCT02033460|Education|education
4912011|NCT02033447|Prostate Cancer|prostate cancer
4912012|NCT02033434|intranasal|intranasal
4912013|NCT02033434|ketamine|ketamine
4912014|NCT02033434|analgesia|analgesia
4912015|NCT02033434|mountain medicine|mountain medicine
4912016|NCT02033434|pre-hospital care|pre-hospital care
4912017|NCT02033434|patient transport|patient transport
4912018|NCT02033434|pilot study|pilot study
4912019|NCT02033434|mountain environment|mountain environment
4912020|NCT02033421|Infective endocarditis|infective endocarditis
4912021|NCT02033421|Therapeutic drug monitoring|therapeutic drug monitoring
4912022|NCT02033408|IBD: Inflammatory Bowel Diseases|ibd: inflammatory bowel diseases
4912023|NCT02033408|CD: Crohn's Disease|cd: crohn's disease
4912024|NCT02033408|UC: Ulcerative Colitis|uc: ulcerative colitis
4912025|NCT02033408|ASC: Acute Severe Colitis|asc: acute severe colitis
4912026|NCT02033408|FMT: Fecal Microbiota Transplantation|fmt: fecal microbiota transplantation
4912027|NCT02033408|PUCAI: Pediatric Ulcerative Colitis Activity Index|pucai: pediatric ulcerative colitis activity index
4912028|NCT02033408|Ciprofloxacin, Doxycycline, Gentamycin, amoxicillin, vancomycin, metronidazole,ciprofloxacin|ciprofloxacin, doxycycline, gentamycin, amoxicillin, vancomycin, metronidazole,ciprofloxacin
4912029|NCT02033369|Major depressive disorder|major depressive disorder
4912030|NCT02033369|MDD|mdd
4912031|NCT02033369|depression|depression
4912032|NCT02033369|pramipexole|pramipexole
4912033|NCT02033356|adductor canal block|adductor canal block
4912034|NCT02033356|volunteers|volunteers
4912035|NCT02033356|US-guided peripheral nerve block|us-guided peripheral nerve block
4912036|NCT02033356|lower limb|lower limb
4912037|NCT02033356|MRI|mri
4912038|NCT02033343|Prostate Cancer|prostate cancer
4912039|NCT02033343|Real-time tracking|real-time tracking
4912040|NCT02033343|Radiotherapy|radiotherapy
4912041|NCT02033343|Dynamic Multileaf Collimator|dynamic multileaf collimator
4912042|NCT02033330|phenolics|phenolics
4912043|NCT02033330|orange peel|orange peel
4912044|NCT02033330|bioavailability|bioavailability
4912045|NCT02033304|Cesarean section|cesarean section
4912046|NCT02033304|Pain|pain
4912047|NCT02033304|Wound hyperalgesia|wound hyperalgesia
4912048|NCT02033291|Cerebral Small Vessel Disease|cerebral small vessel disease
4912049|NCT02033291|Blood-Brain Barrier permeability|blood-brain barrier permeability
4912050|NCT02033291|Dynamic contrast enhanced Magnetic Resonance Imaging|dynamic contrast enhanced magnetic resonance imaging
4912051|NCT02033291|Pharmacokinetic modeling|pharmacokinetic modeling
4912052|NCT02033291|Reproducibility|reproducibility
4912053|NCT02033265|Ultrasound-guided Axillary Brachial Plexus Block|ultrasound-guided axillary brachial plexus block
4912054|NCT02033265|Obesity|obesity
4912055|NCT02033265|Performance time|performance time
4912056|NCT02033265|Failure rate|failure rate
4912057|NCT02033265|Acute complications|acute complications
4912058|NCT02033226|Periodontitis|periodontitis
4912059|NCT02033226|Periodontal Regeneration|periodontal regeneration
4912060|NCT02033226|Amniotic membrane|amniotic membrane
4912061|NCT02033226|Guided tissue regeneration|guided tissue regeneration
4912062|NCT02033226|Anti-inflammatory|anti-inflammatory
4912063|NCT02033226|Periodontal Therapy.|periodontal therapy.
4912064|NCT02033213|intraoperative|intraoperative
4912065|NCT02033213|fluid management|fluid management
4912066|NCT02033213|esophageal carcinoma|esophageal carcinoma
4912067|NCT02033213|surgery|surgery
4912068|NCT02033213|gas exchange|gas exchange
4912069|NCT02033213|tissue perfusion|tissue perfusion
4912070|NCT02033200|vision|vision
4912071|NCT02033200|Stendra|stendra
4912072|NCT02033200|avanafil|avanafil
4912073|NCT02033200|PDE5 inhibitor|pde5 inhibitor
4912074|NCT02033200|visual acuity|visual acuity
4912075|NCT02033200|intraocular pressure|intraocular pressure
4912076|NCT02033200|pupillometry|pupillometry
4912077|NCT02033200|color vision discrimination|color vision discrimination
4912078|NCT02033200|healthy males|healthy males
4912079|NCT02033174|alcohol, inflammation, oxidation.|alcohol, inflammation, oxidation.
4912080|NCT02033161|Functional gastrointestinal disorders|functional gastrointestinal disorders
4912081|NCT02033161|FGID|fgid
4912082|NCT02033161|Recurrent abdominal pain|recurrent abdominal pain
4912083|NCT02033161|Abdominal pain|abdominal pain
4912084|NCT02033161|pain-related functional gastrointestinal disorders|pain-related functional gastrointestinal disorders
4912085|NCT02033135|Atherosclerosis|atherosclerosis
4912086|NCT02033135|Intermittent claudication|intermittent claudication
4912087|NCT02033135|Angioplasty|angioplasty
4912088|NCT02033122|exercise, bronchial hyperresponsiveness, inflammation|exercise, bronchial hyperresponsiveness, inflammation
4912089|NCT02033096|stannsoporfin|stannsoporfin
4912090|NCT02033096|hyperbilirubinemia|hyperbilirubinemia
4912091|NCT02033096|heme oxygenase|heme oxygenase
4912092|NCT02033083|abortion|abortion
4912093|NCT02033083|cervical dilation|cervical dilation
4912094|NCT02033070|RFA|rfa
4912095|NCT02033057|Muscular electrostimulation, mechanically ventilated, critically ill patients, muscular weakness.|muscular electrostimulation, mechanically ventilated, critically ill patients, muscular weakness.
4912096|NCT02033044|borderline personality disorder|borderline personality disorder
4912097|NCT02033044|cognitive rehabilitation|cognitive rehabilitation
4912098|NCT02033044|psychoeducation|psychoeducation
4912099|NCT02033044|psychosocial functioning|psychosocial functioning
4912100|NCT02033031|branch retinal vein occlusion|branch retinal vein occlusion
4912101|NCT02033031|central retinal thickness|central retinal thickness
4912102|NCT02033031|visual acuity|visual acuity
4912103|NCT02033031|central reintal sensitivity|central reintal sensitivity
4912104|NCT02033018|Aflibercept|aflibercept
4912105|NCT02033018|Myopia|myopia
4912106|NCT02033018|Complications|complications
4912107|NCT02033018|Neovascularization|neovascularization
4912108|NCT02033018|OCT|oct
4912109|NCT02033005|Body Composition|body composition
4912110|NCT02033005|Adipose Tissue|adipose tissue
4912111|NCT02033005|Intrahepatocellular Lipid|intrahepatocellular lipid
4912112|NCT02033005|Infant|infant
4912113|NCT02033005|Magnetic Resonance Imaging|magnetic resonance imaging
4912114|NCT02033005|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
4912115|NCT02032966|outcomes|outcomes
4912116|NCT02032966|surgical|surgical
4912117|NCT02032966|non-surgical|non-surgical
4912118|NCT02032966|ankle|ankle
4912119|NCT02032966|malleolus|malleolus
4912120|NCT02032966|fracture|fracture
4912121|NCT02032966|tibia|tibia
4912122|NCT02032966|fibula|fibula
4912123|NCT02032966|bimalleolar|bimalleolar
4912124|NCT02032966|trimalleolar|trimalleolar
4912125|NCT02032953|colorectal cancer|colorectal cancer
4912126|NCT02032953|protein recovery|protein recovery
4912127|NCT02032953|perioperative nutrition|perioperative nutrition
4912128|NCT02032953|hyperinsulinemia|hyperinsulinemia
4912129|NCT02032953|normoglycemia|normoglycemia
4912130|NCT02032953|hyperinsulinemic-normoglycemic clamp|hyperinsulinemic-normoglycemic clamp
4912131|NCT02032953|anabolism|anabolism
4912132|NCT02032940|MRI, Angiography, Pulse Sequence|mri, angiography, pulse sequence
4912133|NCT02032927|osteoarthritis|osteoarthritis
4912134|NCT02032927|pain|pain
4912135|NCT02032927|opioids|opioids
4912136|NCT02032914|pyogenic liver abscess|pyogenic liver abscess
4912137|NCT02032914|colon cancer|colon cancer
4912138|NCT02032862|menopause, hot flushes, hot flashes, salvia, sage, sweating|menopause, hot flushes, hot flashes, salvia, sage, sweating
4912139|NCT02032849|ventilator associated pneumonia|ventilator associated pneumonia
4912140|NCT02032849|subglottic secretion drainage|subglottic secretion drainage
4912141|NCT02032849|manual air-impingement operation|manual air-impingement operation
4912142|NCT02032849|prolonged intubation|prolonged intubation
4912143|NCT02032823|Breast Cancer|breast cancer
4912144|NCT02032823|Adjuvant|adjuvant
4912145|NCT02032823|Olaparib|olaparib
4912146|NCT02032823|BRCA 1/2|brca 1/2
4912147|NCT02032823|HER2|her2
4912148|NCT02032810|Stage III Melanoma|stage iii melanoma
4912149|NCT02032810|Stage IV Melanoma|stage iv melanoma
4912150|NCT02032810|HDAC Inhibitor|hdac inhibitor
4912151|NCT02032758|Occupational; Cramp(s)|occupational; cramp(s)
4912152|NCT02032719|Hypertension, Systolic, Uncontrolled|hypertension, systolic, uncontrolled
4912153|NCT02032706|obstructive sleep apnea|obstructive sleep apnea
4912154|NCT02032706|position therapy|position therapy
4912155|NCT02032706|snoring|snoring
4912156|NCT02032706|positional|positional
4912157|NCT02032693|Everycell|everycell
4912158|NCT02032693|DNA damage|dna damage
4912159|NCT02032693|DNA inflammation|dna inflammation
4912160|NCT02032693|DNA stress|dna stress
4912161|NCT02032667|physical activity|physical activity
4912162|NCT02032667|exergames|exergames
4912163|NCT02032654|antibiotics|antibiotics
4912164|NCT02032654|flucloxacillin|flucloxacillin
4912165|NCT02032654|therapy duration|therapy duration
4912166|NCT02032654|cellulitis|cellulitis
4912167|NCT02032654|erysipelas|erysipelas
4912168|NCT02032654|skin infections|skin infections
4912169|NCT02032654|hospital|hospital
4912170|NCT02032641|Non-ablative laser|non-ablative laser
4912171|NCT02032641|Scar revision|scar revision
4912172|NCT02032641|direct brow lift|direct brow lift
4912173|NCT02032628|epigenetics|epigenetics
4912174|NCT02032628|cancer|cancer
4912175|NCT02032628|exercise|exercise
4912176|NCT02032628|intensity|intensity
4912177|NCT02032628|duration|duration
4912178|NCT02032615|anemia|anemia
4912179|NCT02032602|Myofascial Pain Syndromes|myofascial pain syndromes
4912180|NCT02032602|Trigger Point|trigger point
4912181|NCT02032602|Shoulder Pain|shoulder pain
4912182|NCT02032602|Aged|aged
4912183|NCT02032576|major depressive episode, electroconvulsive therapy|major depressive episode, electroconvulsive therapy
4912184|NCT02032563|neoadjuvant therapy|neoadjuvant therapy
4912185|NCT02032550|Localized prostate cancer|localized prostate cancer
4912186|NCT02032550|Patient preference|patient preference
4912187|NCT02032550|Treatment choice|treatment choice
4912188|NCT02032550|Decision making|decision making
4912189|NCT02032550|Patient centered outcomes|patient centered outcomes
4912190|NCT02032537|callmax cream|callmax cream
4912191|NCT02032537|uremic pruritus|uremic pruritus
4912192|NCT02032498|sentinel lymph nodes|sentinel lymph nodes
4912193|NCT02032498|radiocolloids|radiocolloids
4912194|NCT02032498|Indocyanine Green|indocyanine green
4912195|NCT02032498|complementarity|complementarity
4912196|NCT02032498|axillary lymph node dissection|axillary lymph node dissection
4912197|NCT02032485|colorectal cancer|colorectal cancer
4912198|NCT02032485|Indocyanine Green|indocyanine green
4912199|NCT02032485|visualization of peritoneal metastases|visualization of peritoneal metastases
4912200|NCT02032472|Blood Pressure Monitoring, Ambulatory|blood pressure monitoring, ambulatory
4912201|NCT02032472|Arterial Pressure|arterial pressure
4912202|NCT02032472|Hypertension Controlled|hypertension controlled
4912203|NCT02032472|Pharmacies|pharmacies
4912204|NCT02032459|Pregnancy|pregnancy
4912205|NCT02032459|Minority Women|minority women
4912206|NCT02032459|Preterm delivery|preterm delivery
4912207|NCT02032459|Fetal growth restriction|fetal growth restriction
4912208|NCT02032459|Preeclampsia|preeclampsia
4912209|NCT02032459|Gestational Diabetes|gestational diabetes
4912210|NCT02032459|Vitamin D|vitamin d
4912211|NCT02032433|extended-release naltrexone (Vivitrol)|extended-release naltrexone (vivitrol)
4912212|NCT02032433|buprenorphine-naloxone (Suboxone)|buprenorphine-naloxone (suboxone)
4912213|NCT02032433|comparative effective|comparative effective
4912214|NCT02032433|relapse prevention|relapse prevention
4912215|NCT02032394|Chlorhexidine|chlorhexidine
4912216|NCT02032394|Povidone-iodine|povidone-iodine
4912217|NCT02032394|bacteriuria|bacteriuria
4912218|NCT02032394|Urinary Catheterization|urinary catheterization
4912219|NCT02032394|Urinary tract infection|urinary tract infection
4912220|NCT02032381|non infectious pulmonary complications after hematopoietic cell transplant|non infectious pulmonary complications after hematopoietic cell transplant
4912221|NCT02032381|functional respiratory test and exercise test|functional respiratory test and exercise test
4912222|NCT02032381|thoracic tomodensitometry|thoracic tomodensitometry
4912223|NCT02032368|circulating tumour cell;|circulating tumour cell;
4912224|NCT02032368|transarterial chemoembolization;|transarterial chemoembolization;
4912225|NCT02032368|hepatocellular carcinoma;|hepatocellular carcinoma;
4912226|NCT02032368|recurrence|recurrence
4912227|NCT02032329|Functional Electrical Stimulation (FES)|functional electrical stimulation (fes)
4912228|NCT02032316|Renal Stone|renal stone
4912229|NCT02032316|Ureteroscopy|ureteroscopy
4912230|NCT02032316|Ureteral Stent|ureteral stent
4912231|NCT02032316|post-uncomplicated ureteroscopy|post-uncomplicated ureteroscopy
4912232|NCT02032316|UURS|uurs
4912233|NCT02032277|Oncology|oncology
4912234|NCT02032277|Triple negative breast cancer|triple negative breast cancer
4912235|NCT02032277|German Breast Group - GBG 81|german breast group - gbg 81
4912236|NCT02032277|United States Oncology - 12152|united states oncology - 12152
4912237|NCT02032277|National Surgical Adjuvant Breast and Bowel Project - B-56-I|national surgical adjuvant breast and bowel project - b-56-i
4912238|NCT02032277|Alliance - AFT-04|alliance - aft-04
4912239|NCT02032277|Grupo Español de Investigación en Cáncer de Mama - GEICAM/2014-02|grupo español de investigación en cáncer de mama - geicam/2014-02
4912240|NCT02032264|Next generation sequencing|next generation sequencing
4912241|NCT02032264|Embryonic aneuploidy|embryonic aneuploidy
4912369|NCT02031614|blood withdrawal|blood withdrawal
4912242|NCT02032251|Sperm DNA damage ejaculated spermatozoa Ginger Herbal Drug Herbal medicine|sperm dna damage ejaculated spermatozoa ginger herbal drug herbal medicine
4912243|NCT02032199|Gastric bypass|gastric bypass
4912244|NCT02032199|Health-related quality of life|health-related quality of life
4912245|NCT02032199|SF-36|sf-36
4912246|NCT02032199|Questionnaire|questionnaire
4912247|NCT02032199|Treatment guidelines|treatment guidelines
4912248|NCT02032186|magnesium|magnesium
4912249|NCT02032186|prematurity|prematurity
4912250|NCT02032173|Ranibizumab|ranibizumab
4912251|NCT02032173|Diabetic Macular Edema|diabetic macular edema
4912252|NCT02032160|ADITEC|aditec
4912253|NCT02032160|Immunology|immunology
4912254|NCT02032160|Vaccines|vaccines
4912255|NCT02032160|Hepatitis B|hepatitis b
4912256|NCT02032160|Investigational study|investigational study
4912257|NCT02032160|innate and adaptive immune responses|innate and adaptive immune responses
4912258|NCT02032160|Hepatitis B vaccinations|hepatitis b vaccinations
4912259|NCT02032134|Cryopreserved platelets, thrombocytopenia, DMSO|cryopreserved platelets, thrombocytopenia, dmso
4912260|NCT02032121|Cancer survivors|cancer survivors
4912261|NCT02032121|Long-term cancer survivor|long-term cancer survivor
4912262|NCT02032108|Diabetes lifestyle intervention Rwanda|diabetes lifestyle intervention rwanda
4912263|NCT02032095|IVIG|ivig
4912264|NCT02032095|Renal transplantation|renal transplantation
4912265|NCT02032095|desensitization|desensitization
4912266|NCT02032056|Infections|infections
4912267|NCT02032056|Allergy|allergy
4912268|NCT02032056|Immune function|immune function
4912269|NCT02032056|Microbiota|microbiota
4912270|NCT02032056|infant|infant
4912271|NCT02032043|Filariasis|filariasis
4912272|NCT02032043|Onchocerciasis|onchocerciasis
4912273|NCT02032043|Albendazole|albendazole
4912274|NCT02032043|Ivermectin|ivermectin
4912275|NCT02032043|STH Soil Transmitted Helminth infections|sth soil transmitted helminth infections
4912276|NCT02032043|MDA Mass Drug Administration|mda mass drug administration
4912277|NCT02032030|quality of Life|quality of life
4912278|NCT02032030|pain|pain
4912279|NCT02032030|nausea|nausea
4912280|NCT02032030|falls|falls
4912281|NCT02032030|intraoperative awareness|intraoperative awareness
4912282|NCT02032030|anesthesia awareness|anesthesia awareness
4912283|NCT02032030|cognition|cognition
4912284|NCT02032030|activities of daily living|activities of daily living
4912285|NCT02032030|major morbidity|major morbidity
4912286|NCT02032030|all-cause mortality|all-cause mortality
4912287|NCT02032017|Total Hip Arthroplasty|total hip arthroplasty
4912288|NCT02032017|Gluteus medius|gluteus medius
4912289|NCT02032017|Approach|approach
4912290|NCT02032017|Rehabilitation|rehabilitation
4912291|NCT02032017|Functional outcome|functional outcome
4912292|NCT02032004|Chronic Heart Failure|chronic heart failure
4912293|NCT02032004|CHF|chf
4912294|NCT02032004|Left Ventricular Systolic Dysfunction|left ventricular systolic dysfunction
4912295|NCT02032004|Ischemic Heart Failure|ischemic heart failure
4912296|NCT02032004|Nonischemic Heart Failure|nonischemic heart failure
4912297|NCT02032004|Stem Cells|stem cells
4912298|NCT02032004|Allogeneic Mesenchymal Precursor Cells|allogeneic mesenchymal precursor cells
4912299|NCT02031991|Bioequivalence|bioequivalence
4912300|NCT02031991|Biosimilarity|biosimilarity
4912301|NCT02031991|Similarity|similarity
4912302|NCT02031991|PK|pk
4912303|NCT02031991|Phase 1|phase 1
4912304|NCT02031991|Bevacizumab|bevacizumab
4912305|NCT02031991|Healthy Volunteers|healthy volunteers
4912306|NCT02031991|Single-Dose|single-dose
4912307|NCT02031991|Oncology|oncology
4912308|NCT02031978|Breast Feeding|breast feeding
4912309|NCT02031978|Infant Nutrition|infant nutrition
4912310|NCT02031978|Childhood Obesity|childhood obesity
4912311|NCT02031978|Infant feeding patterns|infant feeding patterns
4912312|NCT02031978|WIC|wic
4912313|NCT02031952|hepatocellular carcinoma|hepatocellular carcinoma
4912314|NCT02031952|hepatectomy|hepatectomy
4912315|NCT02031952|lymphadenectomy|lymphadenectomy
4912316|NCT02031952|complication|complication
4912317|NCT02031952|prognosis|prognosis
4912318|NCT02031939|Rectal cancer|rectal cancer
4912319|NCT02031939|neoadjuvant chemoradiotherapy|neoadjuvant chemoradiotherapy
4912320|NCT02031939|optimization|optimization
4912321|NCT02031913|Chronic hepatitis B|chronic hepatitis b
4912322|NCT02031913|Hepatic fibrosis|hepatic fibrosis
4912323|NCT02031913|Steatosis|steatosis
4912324|NCT02031887|starter formula|starter formula
4912325|NCT02031887|stool microbiota|stool microbiota
4912326|NCT02031887|infants|infants
4912327|NCT02031887|caesarean section delivery|caesarean section delivery
4912328|NCT02031874|H1N1|h1n1
4912329|NCT02031874|HIV|hiv
4913224|NCT02027675|obesity|obesity
4912330|NCT02031874|Immunogenecity|immunogenecity
4912331|NCT02031848|weight loss|weight loss
4912332|NCT02031848|diet|diet
4912333|NCT02031822|Primary Headache|primary headache
4912334|NCT02031822|Greater Occipital Nerve|greater occipital nerve
4912335|NCT02031822|Ultrasound|ultrasound
4912336|NCT02031822|Chronic Pain|chronic pain
4912337|NCT02031822|Cervicogenic|cervicogenic
4912338|NCT02031822|Occipital Neuralgia|occipital neuralgia
4912339|NCT02031822|Migraine|migraine
4912340|NCT02031822|Tension type headache|tension type headache
4912341|NCT02031822|Cluster headache|cluster headache
4912342|NCT02031809|Thoracic Surgery, Video-Assisted|thoracic surgery, video-assisted
4912343|NCT02031770|vascular endothelial cells|vascular endothelial cells
4912344|NCT02031757|Balance control|balance control
4912345|NCT02031757|Aging|aging
4912346|NCT02031757|Balance reactions|balance reactions
4912347|NCT02031757|Perturbation|perturbation
4912348|NCT02031705|Fibrillation|fibrillation
4912349|NCT02031705|Catheter ablation|catheter ablation
4912350|NCT02031692|Benign paroxysmal positional vertigo|benign paroxysmal positional vertigo
4912351|NCT02031692|Vitamin D|vitamin d
4912352|NCT02031692|Calcium|calcium
4912353|NCT02031692|Prevention|prevention
4912354|NCT02031679|Chronic Idiopathic Urticaria|chronic idiopathic urticaria
4912355|NCT02031666|Healthy|healthy
4912356|NCT02031666|JNJ-56021927|jnj-56021927
4912357|NCT02031666|ARN-509|arn-509
4912358|NCT02031666|Bioavailability|bioavailability
4912359|NCT02031653|Penile Cuff Test|penile cuff test
4912360|NCT02031640|asthma|asthma
4912361|NCT02031640|breath-actuated inhaler|breath-actuated inhaler
4912362|NCT02031640|metered-dose inhaler|metered-dose inhaler
4912363|NCT02031627|lymphedema|lymphedema
4912364|NCT02031627|lymphoedema|lymphoedema
4912365|NCT02031627|leg lymphoedema|leg lymphoedema
4912366|NCT02031627|lower extremity lymphoedema|lower extremity lymphoedema
4912367|NCT02031627|pneumatic compression device|pneumatic compression device
4912368|NCT02031614|anemia|anemia
4912370|NCT02031614|phlebotomy|phlebotomy
4912371|NCT02031614|innate immunity|innate immunity
4912372|NCT02031614|Immune reponse|immune reponse
4912373|NCT02031588|Study of commensal flora|study of commensal flora
4912374|NCT02031588|Fluoroquinolones|fluoroquinolones
4912375|NCT02031575|Reproductive Health|reproductive health
4912376|NCT02031575|Contraception|contraception
4912377|NCT02031575|Public Health|public health
4912378|NCT02031575|Sexual Health|sexual health
4912379|NCT02031575|Adolescents|adolescents
4912380|NCT02031575|Mobile Health|mobile health
4912381|NCT02031562|Balance|balance
4912382|NCT02031562|Falls|falls
4912383|NCT02031562|Low back pain|low back pain
4912384|NCT02031562|Geriatric|geriatric
4912385|NCT02031523|endometriosis|endometriosis
4912386|NCT02031523|dysmenorrhea|dysmenorrhea
4912387|NCT02031523|Sanjie analgesic capsule|sanjie analgesic capsule
4912388|NCT02031523|effect/safety|effect/safety
4912389|NCT02031497|Sweetener, insulin, body mass index, physical activity|sweetener, insulin, body mass index, physical activity
4912390|NCT02031432|cancer-related pain|cancer-related pain
4912391|NCT02031432|cebranopadol|cebranopadol
4912392|NCT02031419|CC-122|cc-122
4912393|NCT02031419|CC-223|cc-223
4912394|NCT02031419|CC-292|cc-292
4912395|NCT02031419|Rituximab|rituximab
4912396|NCT02031419|Lymphoma|lymphoma
4912397|NCT02031419|Diffuse Large B-Cell Lymphoma|diffuse large b-cell lymphoma
4912398|NCT02031419|Lenalidomide naïve Follicular Lymphoma|lenalidomide naïve follicular lymphoma
4912399|NCT02031419|Lenalidomide exposed Follicular Lymphoma|lenalidomide exposed follicular lymphoma
4912400|NCT02031380|Glaucoma|glaucoma
4912401|NCT02031380|Open angle glaucoma|open angle glaucoma
4912402|NCT02031380|ocular hypertension|ocular hypertension
4912403|NCT02031380|compliance|compliance
4912404|NCT02031354|Lysine Chloride|lysine chloride
4912405|NCT02031328|prostate|prostate
4912406|NCT02031328|radiation|radiation
4912407|NCT02031328|stereotactic body radiation|stereotactic body radiation
4912408|NCT02031315|sudden death|sudden death
4912409|NCT02031315|sudden cardiac arrest|sudden cardiac arrest
4912410|NCT02031302|Lotus|lotus
4912411|NCT02031302|Valve|valve
4912412|NCT02031302|Real world|real world
4912413|NCT02031302|Aortic stenosis|aortic stenosis
4912414|NCT02031302|High risk|high risk
4912415|NCT02031289|Anemia|anemia
4912416|NCT02031289|Iron deficiency|iron deficiency
4912417|NCT02031289|Cardiac surgery|cardiac surgery
4912418|NCT02031289|Perioperative Care|perioperative care
4912419|NCT02031276|ABBV-066|abbv-066
4912420|NCT02031276|BI 655066|bi 655066
4912421|NCT02031276|risankizumab|risankizumab
4912422|NCT02031224|Chronic Kidney Disease|chronic kidney disease
4912423|NCT02031224|Restricted protein diets|restricted protein diets
4912424|NCT02031224|Nutritional status|nutritional status
4912425|NCT02031198|Alzheimer's disease|alzheimer's disease
4912427|NCT02031198|dementia|dementia
4912428|NCT02031198|elderly|elderly
4912429|NCT02031198|cognitive|cognitive
4912430|NCT02031198|disease modifying|disease modifying
4912431|NCT02031198|treatment|treatment
4912432|NCT02031198|immunization|immunization
4912433|NCT02031198|vaccine|vaccine
4912434|NCT02031172|Dry Eye Disease|dry eye disease
4913225|NCT02027675|asthma|asthma
4912435|NCT02031172|Sjogren's Syndrome|sjogren's syndrome
4912436|NCT02031172|Tear Film|tear film
4912437|NCT02031172|Ocular Surface|ocular surface
4912438|NCT02031172|Aqueous Tear Deficiency|aqueous tear deficiency
4912439|NCT02031159|perioperative hypothermia|perioperative hypothermia
4912440|NCT02031159|zero heat flux|zero heat flux
4912441|NCT02031159|non-invasive measurement of body core temperature|non-invasive measurement of body core temperature
4912442|NCT02031107|stroke|stroke
4912443|NCT02031107|brain stimulation|brain stimulation
4912444|NCT02031107|electroencephalography|electroencephalography
4912445|NCT02031107|functional magnetic resonance imaging|functional magnetic resonance imaging
4912446|NCT02031107|functional connectivity|functional connectivity
4912447|NCT02031068|active rehabilitation|active rehabilitation
4912448|NCT02031068|exercise|exercise
4912449|NCT02031068|concussion|concussion
4912450|NCT02031055|Advanced solid tumors|advanced solid tumors
4912451|NCT02031042|neoadjuvant chemotherapy|neoadjuvant chemotherapy
4912452|NCT02031042|breast cancer|breast cancer
4912453|NCT02031042|sentinel lymph node biopsy|sentinel lymph node biopsy
4912454|NCT02031042|false negative rate|false negative rate
4912455|NCT02031042|identification rate|identification rate
4912456|NCT02031029|personality scores|personality scores
4912457|NCT02031016|Chronic thoracic pain|chronic thoracic pain
4912458|NCT02031016|Remifentanil|remifentanil
4912459|NCT02031016|Fentanyl|fentanyl
4912460|NCT02031016|sternotomy|sternotomy
4912461|NCT02030990|photorefractive keratectomy|photorefractive keratectomy
4912462|NCT02030990|corneal haze|corneal haze
4912463|NCT02030990|mitomycin-C|mitomycin-c
4912464|NCT02030990|postoperative steroids|postoperative steroids
4912465|NCT02030951|preterm infant behavior|preterm infant behavior
4912466|NCT02030951|tube feeding|tube feeding
4912467|NCT02030951|feeding efficiency|feeding efficiency
4912468|NCT02030938|breast implant|breast implant
4912469|NCT02030938|revision augmentation|revision augmentation
4912470|NCT02030938|stretch deformity|stretch deformity
4912471|NCT02030938|fold malposition|fold malposition
4912472|NCT02030938|bottoming out|bottoming out
4912473|NCT02030912|The impact of a number of different types of antibiotics|the impact of a number of different types of antibiotics
4912474|NCT02030912|The emergence and persistence of antibiotic resistance|the emergence and persistence of antibiotic resistance
4912475|NCT02030899|Cervical vertebrae|cervical vertebrae
4912476|NCT02030899|single|single
4912477|NCT02030899|degenerative disease|degenerative disease
4912478|NCT02030899|Fusion|fusion
4912479|NCT02030899|Sagittal angle|sagittal angle
4912480|NCT02030873|virtual simulation|virtual simulation
4912481|NCT02030873|temporal bone|temporal bone
4912482|NCT02030873|surgical training|surgical training
4912483|NCT02030873|medical education|medical education
4912484|NCT02030873|self-directed learning|self-directed learning
4912485|NCT02030873|final product assessment|final product assessment
4912486|NCT02030873|cognitive load|cognitive load
4912487|NCT02030873|reaction time|reaction time
4912488|NCT02030873|skills training|skills training
4912489|NCT02030873|simulator metrics|simulator metrics
4912490|NCT02030808|Thoracic surgery|thoracic surgery
4912491|NCT02030808|non-muscle relaxant|non-muscle relaxant
4912492|NCT02030808|target-controlled infusion|target-controlled infusion
4912493|NCT02030808|remifentanil|remifentanil
4912494|NCT02030808|surgical conditions|surgical conditions
4912495|NCT02030795|Thoracic surgery|thoracic surgery
4912496|NCT02030795|Arndt® blocker|arndt® blocker
4912497|NCT02030795|lung deflation|lung deflation
4912498|NCT02030795|Disconnection technique|disconnection technique
4912499|NCT02030795|Continuous suction|continuous suction
4912500|NCT02030795|Elective video-assisted thoracoscopic|elective video-assisted thoracoscopic
4912501|NCT02030782|depression|depression
4912502|NCT02030782|quality improvement|quality improvement
4912503|NCT02030782|treatment|treatment
4912504|NCT02030782|adolescents|adolescents
4912505|NCT02030769|Esophageal Neoplasms|esophageal neoplasms
4912506|NCT02030769|Lugol's solution|lugol's solution
4912507|NCT02030769|Pronase|pronase
4912508|NCT02030769|Endoscopy, Digestive System|endoscopy, digestive system
4912509|NCT02030769|Pretreatment method|pretreatment method
4912510|NCT02030756|constipation|constipation
4912511|NCT02030743|Falls|falls
4912512|NCT02030743|Older adults|older adults
4912513|NCT02030743|Balance|balance
4912514|NCT02030743|Mobility|mobility
4912515|NCT02030743|Visual attention|visual attention
4912516|NCT02030730|Brief Parenting Training|brief parenting training
4912517|NCT02030730|Early Intervention|early intervention
4912518|NCT02030730|Child Behavior|child behavior
4912519|NCT02030730|Greece|greece
4912520|NCT02030717|Spinal anesthesia|spinal anesthesia
4912521|NCT02030717|Epidural anesthesia|epidural anesthesia
4912522|NCT02030717|Klonidin|klonidin
4912523|NCT02030717|renal cell carcinoma|renal cell carcinoma
4912524|NCT02030691|Neonatal respiratory distress|neonatal respiratory distress
4912525|NCT02030691|nHFPV|nhfpv
4912526|NCT02030691|nCPAP|ncpap
4912527|NCT02030691|cerebral tissue oxygenation|cerebral tissue oxygenation
4912528|NCT02030691|NIRS|nirs
4912529|NCT02030665|Marijuana Dependence|marijuana dependence
4912530|NCT02030665|Individualized treatment|individualized treatment
4913334|NCT02027337|cyproterone|cyproterone
4912531|NCT02030665|Motivational Enhancement Treatment|motivational enhancement treatment
4912532|NCT02030665|Cognitive-Behavioral Treatment|cognitive-behavioral treatment
4912533|NCT02030665|Contingency Management|contingency management
4912534|NCT02030652|premature newborn|premature newborn
4912535|NCT02030652|nasal ventilation|nasal ventilation
4912536|NCT02030652|noninvasive ventilation|noninvasive ventilation
4912537|NCT02030652|continuous positive airway pressure|continuous positive airway pressure
4912538|NCT02030626|Neuropathic pain|neuropathic pain
4912539|NCT02030626|lumbar radiculopathy|lumbar radiculopathy
4912540|NCT02030626|rTMS|rtms
4912541|NCT02030626|tDCS|tdcs
4912542|NCT02030626|placebo controlled study|placebo controlled study
4912543|NCT02030613|juvenile idiopathic arthritis|juvenile idiopathic arthritis
4912544|NCT02030613|etanercept|etanercept
4912545|NCT02030587|Hyperaldosteronism|hyperaldosteronism
4912546|NCT02030587|Adrenocortical adenoma|adrenocortical adenoma
4912547|NCT02030587|Adrenalectomy|adrenalectomy
4912548|NCT02030587|Catheter ablation|catheter ablation
4912549|NCT02030561|NK cells|nk cells
4912550|NCT02030561|trastuzumab|trastuzumab
4912551|NCT02030561|immunotherapy|immunotherapy
4912552|NCT02030548|CABG|cabg
4912553|NCT02030548|dual antiplatelet therapy|dual antiplatelet therapy
4912554|NCT02030548|aspirin|aspirin
4912555|NCT02030548|clopidogrel|clopidogrel
4912556|NCT02030548|prasugrel|prasugrel
4912557|NCT02030548|ticagrelor|ticagrelor
4912558|NCT02030522|Post-traumatic stress disorder|post-traumatic stress disorder
4912559|NCT02030522|PTSD|ptsd
4912560|NCT02030522|Accelerated Resolution Therapy|accelerated resolution therapy
4912561|NCT02030522|Military|military
4912562|NCT02030522|Veterans|veterans
4912563|NCT02030522|Exposure therapy|exposure therapy
4912564|NCT02030522|Eye movements|eye movements
4912565|NCT02030509|cancer diagnosis|cancer diagnosis
4912566|NCT02030496|distal radius fractures|distal radius fractures
4912567|NCT02030496|Closed reduction|closed reduction
4912568|NCT02030496|Open reduction internal fixation|open reduction internal fixation
4912569|NCT02030496|Volar plate|volar plate
4912570|NCT02030496|Redislocation|redislocation
4912571|NCT02030496|Unstable fracture|unstable fracture
4912572|NCT02030496|Extra-articular fracture|extra-articular fracture
4912573|NCT02030496|Colles fracture|colles fracture
4912574|NCT02030496|Barton fracture|barton fracture
4912575|NCT02030470|Periodontitis, treatment, photodynamic, mid-term, bacteria|periodontitis, treatment, photodynamic, mid-term, bacteria
4912576|NCT02030444|Neoplasms Staging|neoplasms staging
4912577|NCT02030444|Bronchoscopy|bronchoscopy
4912578|NCT02030444|Nuclear Medicine|nuclear medicine
4912579|NCT02030444|Radiology|radiology
4912580|NCT02030392|Functional abdominal pain|functional abdominal pain
4912581|NCT02030392|psychological intervention|psychological intervention
4912582|NCT02030392|quality of life|quality of life
4912583|NCT02030392|Randomized controlled trial|randomized controlled trial
4912584|NCT02030392|children|children
4912585|NCT02030379|Cancer|cancer
4912586|NCT02030353|Lifestyle intervention|lifestyle intervention
4912587|NCT02030353|Internet intervention|internet intervention
4912588|NCT02030353|Breast neoplasms|breast neoplasms
4912589|NCT02030353|Body weight|body weight
4912590|NCT02030353|Body weight changes|body weight changes
4912591|NCT02030340|urodynamic investigation|urodynamic investigation
4912592|NCT02030340|lower urinary tract dysfunction|lower urinary tract dysfunction
4912593|NCT02030340|catheter|catheter
4912594|NCT02030340|air-charged|air-charged
4912595|NCT02030340|water filled|water filled
4912596|NCT02030327|proteomics|proteomics
4912597|NCT02030327|multiple trauma|multiple trauma
4912598|NCT02030327|organ dysfunction|organ dysfunction
4912599|NCT02030314|Chlorthalidone|chlorthalidone
4912600|NCT02030314|Resistant Hypertension|resistant hypertension
4912601|NCT02030314|Kidney Transplant Patients|kidney transplant patients
4912602|NCT02030301|Herpes Simplex Virus, Type 2|herpes simplex virus, type 2
4912603|NCT02030301|Herpes|herpes
4912604|NCT02030301|HSV-2|hsv-2
4912605|NCT02030288|alcohol|alcohol
4912606|NCT02030288|substance use|substance use
4912607|NCT02030288|eHealth|ehealth
4912608|NCT02030275|Hypertrophic scar|hypertrophic scar
4912609|NCT02030275|Cicatrix|cicatrix
4912610|NCT02030275|Scar prevention|scar prevention
4912611|NCT02030275|Scar revision|scar revision
4912612|NCT02030249|Pre-diabetes|pre-diabetes
4912613|NCT02030249|Obesity|obesity
4912614|NCT02030249|Low calorie diet|low calorie diet
4912615|NCT02030249|Diet - reducing|diet - reducing
4912616|NCT02030249|Appetite|appetite
4912617|NCT02030249|Visual analogue scale|visual analogue scale
4912618|NCT02030249|Ghrelin|ghrelin
4912619|NCT02030249|Peptide YY|peptide yy
4912620|NCT02030249|Bone mass|bone mass
4912621|NCT02030249|Bone turnover|bone turnover
4912622|NCT02030249|Muscle strength|muscle strength
4912623|NCT02030236|hypothermia, induced|hypothermia, induced
4912624|NCT02030236|rewarming|rewarming
4912625|NCT02030236|therapeutic|therapeutic
4912626|NCT02030236|heart arrest|heart arrest
4912627|NCT02030236|asystole|asystole
4912628|NCT02030236|frostbite|frostbite
4912629|NCT02030223|transversus abdominis plane block|transversus abdominis plane block
4912630|NCT02030223|inguinal hernia repair|inguinal hernia repair
4912631|NCT02030223|acute postoperative pain|acute postoperative pain
4912632|NCT02030223|neuropathic pain|neuropathic pain
4912633|NCT02030210|Quality improvement|quality improvement
4912634|NCT02030210|STEMI|stemi
4912635|NCT02030210|Belgium|belgium
4912636|NCT02030184|Lung cancer|lung cancer
4912637|NCT02030184|Small cell lung cancer|small cell lung cancer
4912638|NCT02030184|Neuroendocrine tumor|neuroendocrine tumor
4912639|NCT02030184|Rhenium|rhenium
4912640|NCT02030184|Re 188-P2045|re 188-p2045
4912641|NCT02030171|Chronic low back pain|chronic low back pain
4912642|NCT02030158|Severe sepsis|severe sepsis
4912643|NCT02030158|Septic shock|septic shock
4912644|NCT02030158|Early goal directed therapy|early goal directed therapy
4912645|NCT02030158|Individual patient data meta-analysis|individual patient data meta-analysis
4912646|NCT02030145|COPD|copd
4912647|NCT02030145|Pulmonary|pulmonary
4912648|NCT02030132|Physical activity|physical activity
4912649|NCT02030132|Sedentary lifestyle|sedentary lifestyle
4912650|NCT02030132|Pedometers|pedometers
4912651|NCT02030132|Walking|walking
4912652|NCT02030132|Financial Incentives|financial incentives
4912653|NCT02030132|Behavioral Economics|behavioral economics
4912654|NCT02030119|Sedentary lifestyle|sedentary lifestyle
4912655|NCT02030119|Pedometers|pedometers
4912656|NCT02030119|Obesity|obesity
4912657|NCT02030119|Physical Activity|physical activity
4912658|NCT02030119|Financial Incentives|financial incentives
4912659|NCT02030119|Behavioral Economics|behavioral economics
4912660|NCT02030106|Cervicovaginal microbiome|cervicovaginal microbiome
4912661|NCT02030106|Microbiome|microbiome
4912662|NCT02030106|Preterm Birth|preterm birth
4912663|NCT02030106|Cervical Remodeling|cervical remodeling
4912664|NCT02030106|Preterm delivery|preterm delivery
4912665|NCT02030106|Microbiota|microbiota
4912666|NCT02030093|Alcohol dependence|alcohol dependence
4912667|NCT02030093|Telephone-based continuing care|telephone-based continuing care
4912668|NCT02030093|Outcome monitoring|outcome monitoring
4912669|NCT02030080|Pedometers|pedometers
4912670|NCT02030080|Walking|walking
4912671|NCT02030080|Financial incentives|financial incentives
4912672|NCT02030080|Sedentary lifestyle|sedentary lifestyle
4912673|NCT02030080|Behavioral economics|behavioral economics
4912674|NCT02030067|oncology|oncology
4912675|NCT02030067|tumor|tumor
4912676|NCT02030067|metastatic|metastatic
4912677|NCT02030067|bladder|bladder
4912678|NCT02030041|simvastatin|simvastatin
4912679|NCT02030041|cardiorespiratory fitness|cardiorespiratory fitness
4912680|NCT02030041|vitamin D|vitamin d
4912681|NCT02030041|exercise|exercise
4912682|NCT02030041|mitochondria|mitochondria
4912683|NCT02030028|Rheumatoid Arthritis|rheumatoid arthritis
4912684|NCT02030028|ACTH gel|acth gel
4912685|NCT02030015|infantile Tay-Sachs disease|infantile tay-sachs disease
4912686|NCT02030015|juvenile Tay-Sachs disease|juvenile tay-sachs disease
4912687|NCT02030015|infantile GM1 gangliosidosis|infantile gm1 gangliosidosis
4912688|NCT02030015|juvenile GM1 gangliosidosis|juvenile gm1 gangliosidosis
4912689|NCT02030015|infantile GM2 gangliosidosis|infantile gm2 gangliosidosis
4912690|NCT02030015|juvenile GM2 gangliosidosis|juvenile gm2 gangliosidosis
4912691|NCT02030015|Sandhoff disease|sandhoff disease
4912692|NCT02030015|gangliosidoses|gangliosidoses
4912693|NCT02030015|miglustat|miglustat
4912694|NCT02030015|ketogenic diet|ketogenic diet
4912695|NCT02030015|SYNER-G regimen|syner-g regimen
4912696|NCT02030015|Syner-G|syner-g
4912697|NCT02030015|Zavesca|zavesca
4912698|NCT02030015|Tay-Sachs disease|tay-sachs disease
4912699|NCT02030015|Tay Sachs disease|tay sachs disease
4912700|NCT02029989|Metabolic Syndrome|metabolic syndrome
4912701|NCT02029989|Antipsychotics|antipsychotics
4912702|NCT02029989|Schizophrenia|schizophrenia
4912703|NCT02029989|Bipolar Disorder|bipolar disorder
4912704|NCT02029989|Diabetes|diabetes
4912705|NCT02029989|Dyslipidemia|dyslipidemia
4912706|NCT02029989|Hyperlipidemia|hyperlipidemia
4912707|NCT02029989|Hypertension|hypertension
4912708|NCT02029989|Obesity|obesity
4912709|NCT02029989|Medication Therapy Management|medication therapy management
4912710|NCT02029989|MTM|mtm
4912711|NCT02029989|Pharmacist|pharmacist
4912712|NCT02029989|Comprehensive Medication Management|comprehensive medication management
4912713|NCT02029989|CMM|cmm
4912714|NCT02029989|Health Disparity|health disparity
4912715|NCT02029989|Monitoring|monitoring
4912716|NCT02029989|Point of Care Testing|point of care testing
4912717|NCT02029989|Chronic Persistent Mental Illness|chronic persistent mental illness
4912718|NCT02029937|Squamous cell neoplasia|squamous cell neoplasia
4912719|NCT02029937|Proflavine|proflavine
4912720|NCT02029937|Lugol's chromoendoscopy|lugol's chromoendoscopy
4912721|NCT02029911|Menorrhagia|menorrhagia
4912722|NCT02029911|Excessive uterine bleeding|excessive uterine bleeding
4912723|NCT02029911|Endometrial Ablation|endometrial ablation
4912724|NCT02029898|cesarean section|cesarean section
4912725|NCT02029898|anesthesia|anesthesia
4912726|NCT02029898|children|children
4912727|NCT02029885|Hypertension|hypertension
4912728|NCT02029885|Renal Denervation|renal denervation
4912729|NCT02029872|MRSA|mrsa
4912730|NCT02029872|colonization|colonization
4912731|NCT02029872|decolonization|decolonization
4913335|NCT02027337|hemostasis|hemostasis
4912732|NCT02029859|pregnancy (after 30 weeks of amenorhea)|pregnancy (after 30 weeks of amenorhea)
4912733|NCT02029859|obesity (BMI>35)|obesity (bmi>35)
4912734|NCT02029859|sleep apnea syndrom|sleep apnea syndrom
4912735|NCT02029859|preeclampsy|preeclampsy
4912736|NCT02029859|intrauterine growth restriction|intrauterine growth restriction
4912737|NCT02029820|Contrast Nephropathy|contrast nephropathy
4912738|NCT02029820|Prevention|prevention
4912739|NCT02029820|Renalguard|renalguard
4912740|NCT02029794|Cervical Cancer|cervical cancer
4912741|NCT02029794|Cervical Cancer Screening|cervical cancer screening
4912742|NCT02029794|Low Resource setting|low resource setting
4912743|NCT02029794|HPV|hpv
4912744|NCT02029794|Self-Collection|self-collection
4912745|NCT02029794|VIA|via
4912746|NCT02029781|Appendicitis|appendicitis
4912747|NCT02029781|Laparoscopy|laparoscopy
4912748|NCT02029781|Appendectomy|appendectomy
4912749|NCT02029781|Negative appendectomy|negative appendectomy
4912750|NCT02029781|Morbidity|morbidity
4912751|NCT02029768|outcome|outcome
4912752|NCT02029755|transversus abdominis plane block|transversus abdominis plane block
4912753|NCT02029755|local infiltration|local infiltration
4912754|NCT02029755|ropivacaine|ropivacaine
4912755|NCT02029755|heart rate variability|heart rate variability
4912756|NCT02029755|postoperative analgesia|postoperative analgesia
4912757|NCT02029742|Sickle cell disease|sickle cell disease
4912758|NCT02029742|Medication adherence|medication adherence
4912759|NCT02029742|Hydroxyurea|hydroxyurea
4912760|NCT02029742|Community health worker intervention|community health worker intervention
4912761|NCT02029742|Sickle Cell Treatment|sickle cell treatment
4912762|NCT02029729|RTA 408|rta 408
4912763|NCT02029729|RTA 408 Capsules|rta 408 capsules
4912764|NCT02029729|Non-small cell lung cancer|non-small cell lung cancer
4912765|NCT02029729|Metastatic non-small cell lung cancer|metastatic non-small cell lung cancer
4912766|NCT02029729|Incurable non-small cell lung cancer|incurable non-small cell lung cancer
4912767|NCT02029729|Refractory melanoma|refractory melanoma
4912768|NCT02029729|Relapsed melanoma|relapsed melanoma
4912769|NCT02029716|RTA 408|rta 408
4912770|NCT02029716|RTA 408 Lotion|rta 408 lotion
4912771|NCT02029716|Oxidative stress|oxidative stress
4912772|NCT02029716|Inflammation|inflammation
4912773|NCT02029716|Volunteers|volunteers
4912774|NCT02029703|Knee Osteoarthritis|knee osteoarthritis
4912775|NCT02029703|Knee Pain|knee pain
4912776|NCT02029703|Synvisc-One|synvisc-one
4912777|NCT02029690|argininosuccinate synthetase|argininosuccinate synthetase
4912778|NCT02029690|arginine|arginine
4912779|NCT02029690|arginine deiminase|arginine deiminase
4912780|NCT02029651|Stroke|stroke
4912781|NCT02029651|Hand|hand
4912782|NCT02029651|Rehabilitation|rehabilitation
4912783|NCT02029651|Game|game
4912784|NCT02029638|Kidney Transplantation|kidney transplantation
4912785|NCT02029638|Renal Transplantation|renal transplantation
4912786|NCT02029612|Tobacco Use Cessation|tobacco use cessation
4912787|NCT02029612|Cancer Prevention|cancer prevention
4912788|NCT02029612|HIV/AIDS|hiv/aids
4912789|NCT02029612|Questionnaires|questionnaires
4912790|NCT02029612|Surveys|surveys
4912791|NCT02029612|Nicotine patch|nicotine patch
4912792|NCT02029612|Breath test|breath test
4912793|NCT02029612|Cell Phone Calls for Smoking Cessation Counseling|cell phone calls for smoking cessation counseling
4912794|NCT02029612|Text Message Smoking Cessation Support|text message smoking cessation support
4912795|NCT02029573|Phase II|phase ii
4912796|NCT02029573|Atorvastatin|atorvastatin
4912797|NCT02029573|Temozolomide|temozolomide
4912798|NCT02029573|Radiotherapy|radiotherapy
4912799|NCT02029573|Glioblastoma Multiforme (GBM)|glioblastoma multiforme (gbm)
4912800|NCT02029534|post-operative atrial fibrillation|post-operative atrial fibrillation
4912801|NCT02029534|POAF|poaf
4912802|NCT02029534|A-Fib|a-fib
4912803|NCT02029521|cystic fibrosis|cystic fibrosis
4912804|NCT02029521|growth Failure|growth failure
4912805|NCT02029521|glutathione|glutathione
4912806|NCT02029508|PSCC(Posterior semicircular canal)|pscc(posterior semicircular canal)
4912807|NCT02029508|BPPV(Bening paroxysmal positional vertigo)|bppv(bening paroxysmal positional vertigo)
4912808|NCT02029508|Vertigo|vertigo
4912809|NCT02029508|Otorhinolaryngologic Diseases|otorhinolaryngologic diseases
4912810|NCT02029495|Psoriatic Arthritis|psoriatic arthritis
4912811|NCT02029495|Brodalumab|brodalumab
4912812|NCT02029495|AMG 827|amg 827
4912813|NCT02029482|ACT-128800|act-128800
4912814|NCT02029469|Humeral Resurfacing|humeral resurfacing
4912815|NCT02029469|Humeral Resurfacing Arthroplasty|humeral resurfacing arthroplasty
4912816|NCT02029456|Massive Pulmonary embolism|massive pulmonary embolism
4912817|NCT02029456|thrombolytic therapy|thrombolytic therapy
4912818|NCT02029456|high risk|high risk
4912819|NCT02029456|elderly|elderly
4912820|NCT02029443|Bruton's tyrosine kinase inhibitor|bruton's tyrosine kinase inhibitor
4912821|NCT02029430|HIV +|hiv +
4912822|NCT02029430|HIV positive|hiv positive
4912823|NCT02029430|AIDS|aids
4912824|NCT02029430|Kaposi's sarcoma|kaposi's sarcoma
4912825|NCT02029430|Sarcoma|sarcoma
4912826|NCT02029430|tumor|tumor
4912827|NCT02029430|cancer|cancer
4912828|NCT02029391|Myofascial pain syndrome|myofascial pain syndrome
4912829|NCT02029391|taping|taping
4912830|NCT02029391|manual therapies|manual therapies
4912832|NCT02029365|desire for children|desire for children
4912833|NCT02029365|eating disorder|eating disorder
4912834|NCT02029365|anorexia nervosa|anorexia nervosa
4912835|NCT02029365|bulimia nervosa|bulimia nervosa
4912836|NCT02029365|eating disorders not otherwise specified|eating disorders not otherwise specified
4912837|NCT02029352|Treatment|treatment
4912838|NCT02029352|Sinecatechins|sinecatechins
4912839|NCT02029339|Negative pressure wound therapy|negative pressure wound therapy
4912840|NCT02029339|Acute wound infection|acute wound infection
4912841|NCT02029339|complicated abdominal infection|complicated abdominal infection
4912842|NCT02029339|Cytokines|cytokines
4912843|NCT02029339|Matrix metalloproteinase|matrix metalloproteinase
4912844|NCT02029326|colorectal cancer, cetuximab, biomarker, prometheus|colorectal cancer, cetuximab, biomarker, prometheus
4912845|NCT02029300|pediatrics|pediatrics
4912846|NCT02029300|fiberoptic intubation|fiberoptic intubation
4912847|NCT02029300|oral intubation|oral intubation
4912848|NCT02029300|nasal intubation|nasal intubation
4912849|NCT02029300|children under the age of 2|children under the age of 2
4912850|NCT02029287|Chronic heart failure|chronic heart failure
4912851|NCT02029287|telemedicine|telemedicine
4912852|NCT02029287|health service platform|health service platform
4912853|NCT02029274|Dermatomyositis|dermatomyositis
4912854|NCT02029261|Burn|burn
4912855|NCT02029248|Anorectal malformation|anorectal malformation
4912856|NCT02029248|fecal incontinence|fecal incontinence
4912857|NCT02029248|quality of life|quality of life
4912858|NCT02029248|child|child
4912859|NCT02029235|Adult|adult
4912860|NCT02029235|soft-tissue hand surgery|soft-tissue hand surgery
4912861|NCT02029183|stroke, SAHS, BiPAP|stroke, sahs, bipap
4912862|NCT02029170|ankle fracture|ankle fracture
4912863|NCT02029170|weightbearing|weightbearing
4912864|NCT02029170|cast|cast
4912865|NCT02029118|Acupoint Application,Stable Angina Pectoris,herbal medicine|acupoint application,stable angina pectoris,herbal medicine
4912866|NCT02029105|Mesothelioma,|mesothelioma,
4912867|NCT02029105|Pleural diseases,|pleural diseases,
4912868|NCT02029105|Mesothelin,|mesothelin,
4912869|NCT02029105|Osteopontin,|osteopontin,
4912870|NCT02029105|Hyaluronan,|hyaluronan,
4912871|NCT02029105|Syndecan-1|syndecan-1
4912872|NCT02029092|International|international
4912873|NCT02029092|Multicenter|multicenter
4912874|NCT02029092|Observational registry|observational registry
4912875|NCT02029092|Orsiro Drug Eluting Stent (DES)|orsiro drug eluting stent (des)
4912876|NCT02029092|Stenting|stenting
4912877|NCT02029092|Treatment of coronary artery disease|treatment of coronary artery disease
4912878|NCT02029092|Coronary revascularization|coronary revascularization
4912879|NCT02029092|Percutaneous Coronary Intervention (PCI)|percutaneous coronary intervention (pci)
4912880|NCT02029092|STEMI|stemi
4912881|NCT02029092|NSTEMI|nstemi
4912882|NCT02029092|Ischemia|ischemia
4912883|NCT02029092|Angina|angina
4912884|NCT02029092|Acute Myocardial Infarction (AMI)|acute myocardial infarction (ami)
4912885|NCT02029092|Small Vessels|small vessels
4912886|NCT02029092|Chronical Total Occlusion (CTO)|chronical total occlusion (cto)
4912887|NCT02029079|Malnutrition|malnutrition
4912888|NCT02029066|actinic keratosis|actinic keratosis
4912889|NCT02029066|SR-T100|sr-t100
4912890|NCT02029066|pharmacokinetics|pharmacokinetics
4912891|NCT02029053|Vaginal dryness|vaginal dryness
4912892|NCT02029053|Vaginal lubrication|vaginal lubrication
4912893|NCT02029053|Post-menopausal symptoms|post-menopausal symptoms
4912894|NCT02029053|Peri-menopausal symptoms|peri-menopausal symptoms
4912895|NCT02029053|Urogenital atrophy|urogenital atrophy
4912896|NCT02029053|Dyspareunia|dyspareunia
4912897|NCT02029053|Painful intercourse|painful intercourse
4912898|NCT02029040|Bronchiolitis|bronchiolitis
4912899|NCT02029040|Hypertonic saline|hypertonic saline
4912900|NCT02029040|Emergency Department|emergency department
4912901|NCT02029027|Urinary Stress Incontinence|urinary stress incontinence
4912902|NCT02029027|Urinary Mixed Incontinence|urinary mixed incontinence
4912903|NCT02029014|LAmbre|lambre
4912904|NCT02029001|Solid tumor|solid tumor
4912905|NCT02029001|Recurrent/metastatic|recurrent/metastatic
4912906|NCT02029001|Personalized medicine|personalized medicine
4912907|NCT02029001|Genomic alteration|genomic alteration
4912908|NCT02029001|Targeted therapy|targeted therapy
4912909|NCT02029001|Nilotinib|nilotinib
4912910|NCT02029001|Everolimus|everolimus
4912911|NCT02029001|Sorafenib|sorafenib
4912912|NCT02029001|Lapatinib|lapatinib
4912913|NCT02029001|Pazopanib|pazopanib
4912914|NCT02029001|Olaparib|olaparib
4912915|NCT02029001|Immunotherapy|immunotherapy
4912916|NCT02029001|Durvalumab|durvalumab
4912917|NCT02029001|Tremelimumab|tremelimumab
4912918|NCT02028988|Intermediate Risk Prostate Cancer|intermediate risk prostate cancer
4912919|NCT02028962|Smoking cessation|smoking cessation
4912920|NCT02028962|Romanian adults|romanian adults
4912921|NCT02028923|topical morphine|topical morphine
4912922|NCT02028910|gastroenteritis|gastroenteritis
4912923|NCT02028910|pediatrics|pediatrics
4912924|NCT02028910|vomiting|vomiting
4912925|NCT02028897|In vitro fertilization|in vitro fertilization
4912926|NCT02028897|IVF|ivf
4912927|NCT02028897|Embryo culture|embryo culture
4912928|NCT02028897|Blastocyst transfer|blastocyst transfer
4912929|NCT02028832|pain|pain
4912930|NCT02028832|nausea/vomiting|nausea/vomiting
4912931|NCT02028832|anxiety|anxiety
4912932|NCT02028832|complementary and alternative medicine|complementary and alternative medicine
4912933|NCT02028832|pediatric|pediatric
4912934|NCT02028832|oncology|oncology
4912935|NCT02028832|cost-effectiveness|cost-effectiveness
4912936|NCT02028793|Pharmaceutical Care, Taiwan, pharmacist, Workload, pressure|pharmaceutical care, taiwan, pharmacist, workload, pressure
4912937|NCT02028741|neck pain|neck pain
4912938|NCT02028741|transverse vertebral pressures|transverse vertebral pressures
4912939|NCT02028741|thoracic mobilization|thoracic mobilization
4912940|NCT02028728|International|international
4912941|NCT02028728|Multicenter|multicenter
4912942|NCT02028728|Observational registry|observational registry
4912943|NCT02028728|Orsiro Drug Eluting Stent (DES)|orsiro drug eluting stent (des)
4912944|NCT02028728|Stenting|stenting
4912945|NCT02028728|Treatment of coronary artery disease|treatment of coronary artery disease
4912946|NCT02028728|Coronary revascularization|coronary revascularization
4912947|NCT02028728|Percutaneous Coronary Intervention (PCI)|percutaneous coronary intervention (pci)
4912948|NCT02028728|STEMI|stemi
4912949|NCT02028728|NSTEMI|nstemi
4912950|NCT02028728|Ischemia|ischemia
4912951|NCT02028728|Angina|angina
4912952|NCT02028728|Acute Myocardial Infarction (AMI)|acute myocardial infarction (ami)
4912953|NCT02028728|Small Vessels|small vessels
4912954|NCT02028728|Chronic Total Occlusion (CTO)|chronic total occlusion (cto)
4912955|NCT02028715|IV Acetaminophen|iv acetaminophen
4912956|NCT02028715|Ofirmev|ofirmev
4912957|NCT02028715|Post-operative pain|post-operative pain
4912958|NCT02028702|red clover|red clover
4912959|NCT02028702|menopause|menopause
4912960|NCT02028702|bioactive compounds|bioactive compounds
4912961|NCT02028702|isoflavones|isoflavones
4912962|NCT02028702|phytoestrogen|phytoestrogen
4912963|NCT02028676|HIV|hiv
4912964|NCT02028676|Africa|africa
4912965|NCT02028676|children|children
4912966|NCT02028676|antiretroviral therapy|antiretroviral therapy
4912967|NCT02028676|laboratory monitoring|laboratory monitoring
4912968|NCT02028676|toxicity|toxicity
4912969|NCT02028676|CD4|cd4
4912970|NCT02028676|induction maintenance|induction maintenance
4912971|NCT02028676|cotrimoxazole|cotrimoxazole
4912972|NCT02028676|prophylaxis|prophylaxis
4912973|NCT02028676|abacavir|abacavir
4912974|NCT02028676|lamivudine|lamivudine
4912975|NCT02028676|once daily|once daily
4912976|NCT02028663|P-CAB|p-cab
4912977|NCT02028663|APA(Acid Pump Antagonist)|apa(acid pump antagonist)
4912978|NCT02028650|relapse leukemia|relapse leukemia
4912979|NCT02028650|DSI|dsi
4912980|NCT02028637|asthma|asthma
4912981|NCT02028637|toll like receptor|toll like receptor
4912982|NCT02028637|innate immunity|innate immunity
4912983|NCT02028624|Rheumatoid arthritis|rheumatoid arthritis
4912984|NCT02028624|Mediterranean diet|mediterranean diet
4912985|NCT02028624|Lifestyle intervention|lifestyle intervention
4912986|NCT02028624|Adiponectin|adiponectin
4912987|NCT02028624|Telephone counseling|telephone counseling
4912988|NCT02028611|Rib fracture|rib fracture
4912989|NCT02028611|Inverted grayscale|inverted grayscale
4912990|NCT02028598|Clomipramine|clomipramine
4912991|NCT02028598|Premature ejaculation|premature ejaculation
4912992|NCT02028585|low-fat milk|low-fat milk
4912993|NCT02028585|metabolic syndrome|metabolic syndrome
4912994|NCT02028585|lipid profile|lipid profile
4912995|NCT02028585|inflammation|inflammation
4912996|NCT02028585|oxidative stress|oxidative stress
4912997|NCT02028585|endothelial function|endothelial function
4912998|NCT02028572|Structure function correlation|structure function correlation
4912999|NCT02028572|Optical coherence tomography|optical coherence tomography
4913000|NCT02028572|Retinal Nerve fibre layer thickness|retinal nerve fibre layer thickness
4913001|NCT02028572|Visual fields|visual fields
4913002|NCT02028572|Primary open angle glaucoma|primary open angle glaucoma
4913003|NCT02028559|stones|stones
4913004|NCT02028559|kidney|kidney
4913005|NCT02028559|stone fragments|stone fragments
4913006|NCT02028559|lithotripsy|lithotripsy
4913007|NCT02028546|atopic dermatitis, skin cleansing, cleanser, moisturizer, skin hydration|atopic dermatitis, skin cleansing, cleanser, moisturizer, skin hydration
4913008|NCT02028533|addiction|addiction
4913009|NCT02028533|oxytocin|oxytocin
4913010|NCT02028533|tolerability|tolerability
4913011|NCT02028507|Palbociclib|palbociclib
4913012|NCT02028507|Capecitabine|capecitabine
4913013|NCT02028507|Hormonal Receptor positive|hormonal receptor positive
4913014|NCT02028507|HER2 negative|her2 negative
4913015|NCT02028507|Metastatic Breast Cancer|metastatic breast cancer
4913016|NCT02028507|Resistance to non-steroidal Aromatase inhibitors|resistance to non-steroidal aromatase inhibitors
4913017|NCT02028507|Fulvestrant|fulvestrant
4913018|NCT02028507|Exemestane|exemestane
4913019|NCT02028507|Aromatase inhibitor|aromatase inhibitor
4913020|NCT02028481|Macular hole|macular hole
4913021|NCT02028481|Vitreoretinal surgery|vitreoretinal surgery
4913022|NCT02028481|Macular surgery|macular surgery
4913023|NCT02028481|Air tamponade|air tamponade
4913024|NCT02028468|Femoral Neck Fracture|femoral neck fracture
4913025|NCT02028468|Anterolateral approach|anterolateral approach
4913026|NCT02028468|Trans-gluteal approach|trans-gluteal approach
4913027|NCT02028468|Watson Jones approach|watson jones approach
4913028|NCT02028468|Hardinge approach|hardinge approach
4913029|NCT02028455|pediatric|pediatric
4913030|NCT02028455|young adult|young adult
4913031|NCT02028455|acute lymphoblastic leukemia|acute lymphoblastic leukemia
4913032|NCT02028455|CD19|cd19
4913033|NCT02028455|leukemia|leukemia
4913034|NCT02028455|Chimeric Antigen Receptor|chimeric antigen receptor
4913035|NCT02028455|T cell|t cell
4913036|NCT02028429|Minimal Hepatic Encephalopathy (MHE)|minimal hepatic encephalopathy (mhe)
4913037|NCT02028429|Psychometric Hepatic Encephalopathy Score (PHES)|psychometric hepatic encephalopathy score (phes)
4913038|NCT02028429|Sickness Impact Profile (SIP)|sickness impact profile (sip)
4913039|NCT02028429|Model for End-stage Liver Disease (MELD)|model for end-stage liver disease (meld)
4913040|NCT02028429|Child-Turcotte-Pugh score (CTP)|child-turcotte-pugh score (ctp)
4913041|NCT02028416|pancytopenia|pancytopenia
4913042|NCT02028416|aplastic anemia|aplastic anemia
4913043|NCT02028416|ATG|atg
4913044|NCT02028416|Cyclosporin|cyclosporin
4913045|NCT02028390|wounds|wounds
4913046|NCT02028390|thermal|thermal
4913047|NCT02028390|temperature|temperature
4913048|NCT02028390|periwound|periwound
4913049|NCT02028390|camera|camera
4913050|NCT02028390|imaging|imaging
4913051|NCT02028377|Adenocarcinoma|adenocarcinoma
4913052|NCT02028377|imaging|imaging
4913053|NCT02028377|PET|pet
4913054|NCT02028377|MRI|mri
4913055|NCT02028364|Locally advanced breast cancer|locally advanced breast cancer
4913056|NCT02028364|HER2 negative|her2 negative
4913057|NCT02028364|NSAI refractory|nsai refractory
4913058|NCT02028364|Metastatic breast cancer|metastatic breast cancer
4913059|NCT02028364|Estrogen-receptor positive (ER+)|estrogen-receptor positive (er+)
4913060|NCT02028351|visual acuity|visual acuity
4913061|NCT02028351|contrast sensitivity|contrast sensitivity
4913062|NCT02028351|cataract|cataract
4913063|NCT02028351|maculopathy|maculopathy
4913064|NCT02028312|Dry Eye|dry eye
4913065|NCT02028299|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
4913066|NCT02028299|Pulmonary Vascular Resistance|pulmonary vascular resistance
4913067|NCT02028299|Right Heart Catheterization|right heart catheterization
4913068|NCT02028286|Rosacea|rosacea
4913069|NCT02028273|Neurogenesis|neurogenesis
4913070|NCT02028273|Addiction|addiction
4913071|NCT02028273|Cocaine|cocaine
4913072|NCT02028273|MRI|mri
4913073|NCT02028273|MRS|mrs
4913074|NCT02028247|Autism spectrum disorders|autism spectrum disorders
4913075|NCT02028247|Autism|autism
4913076|NCT02028247|Asperger's syndrome|asperger's syndrome
4913077|NCT02028247|Pervasive developmental disability - not otherwise specified|pervasive developmental disability - not otherwise specified
4913078|NCT02028247|obsessive-compulsive disorder|obsessive-compulsive disorder
4913079|NCT02028247|Social phobia|social phobia
4913080|NCT02028247|Generalized anxiety disorder|generalized anxiety disorder
4913081|NCT02028247|Specific phobia|specific phobia
4913082|NCT02028247|Separation anxiety disorder|separation anxiety disorder
4913083|NCT02028247|Counseling|counseling
4913084|NCT02028247|Cognitive-behavioral therapy|cognitive-behavioral therapy
4913085|NCT02028247|Psychotherapy|psychotherapy
4913086|NCT02028221|Breast cancer prevention|breast cancer prevention
4913087|NCT02028221|metformin|metformin
4913088|NCT02028221|Breast cancer risk reduction|breast cancer risk reduction
4913089|NCT02028208|Patch Test|patch test
4913090|NCT02028208|Allergy Testing|allergy testing
4913091|NCT02028208|Contact Dermatitis|contact dermatitis
4913092|NCT02028208|Mercury, Aluminum or Palladium skin allergy|mercury, aluminum or palladium skin allergy
4913093|NCT02028195|Health check|health check
4913094|NCT02028195|Health promotion|health promotion
4913095|NCT02028195|prevention diabetes|prevention diabetes
4913096|NCT02028195|prevention cardiovascular disease|prevention cardiovascular disease
4913097|NCT02028195|mental health|mental health
4913098|NCT02028182|Patch Test|patch test
4913099|NCT02028182|Allergy Testing|allergy testing
4913100|NCT02028182|Contact dermatitis|contact dermatitis
4913101|NCT02028182|Lyral allergen|lyral allergen
4913102|NCT02028182|Fragrance Mix allergen|fragrance mix allergen
4913103|NCT02028169|Work Productivity|work productivity
4913104|NCT02028169|Anti-TNFs|anti-tnfs
4913105|NCT02028169|Psoriatic Arthritis|psoriatic arthritis
4913106|NCT02028143|Atrial Fibrillation|atrial fibrillation
4913107|NCT02028130|Atrial fibrillation|atrial fibrillation
4913108|NCT02028130|Ablation|ablation
4913109|NCT02028130|Left atrial appendage occlusion|left atrial appendage occlusion
4913110|NCT02028130|Stroke prevention|stroke prevention
4913111|NCT02028091|Pulse walve arrival time differences|pulse walve arrival time differences
4913112|NCT02028078|Endogenous glucose production|endogenous glucose production
4913113|NCT02028078|Type 1 diabetes mellitus|type 1 diabetes mellitus
4913114|NCT02028078|hypoglycaemic clamp|hypoglycaemic clamp
4913115|NCT02028078|tracer to technique|tracer to technique
4913116|NCT02028078|pharmacodynamics|pharmacodynamics
4913117|NCT02028078|pharmacokinetics|pharmacokinetics
4913118|NCT02028065|reversal of neuromuscular blockade|reversal of neuromuscular blockade
4913119|NCT02028052|enlarged mediastinal nodes|enlarged mediastinal nodes
4913120|NCT02028052|enlarged hilar lymph nodes|enlarged hilar lymph nodes
4913121|NCT02028039|Leukemia|leukemia
4913122|NCT02028039|Refractory Acute Lymphoblastic Leukemia|refractory acute lymphoblastic leukemia
4913123|NCT02028039|ALL|all
4913124|NCT02028039|Burkitt's lymphoma|burkitt's lymphoma
4913125|NCT02028039|Lymphoblastic lymphoma|lymphoblastic lymphoma
4913126|NCT02028039|IPI-145|ipi-145
4913127|NCT02028026|Depressive Disorder|depressive disorder
4913128|NCT02028026|Anxiety|anxiety
4913129|NCT02028026|Comorbidity|comorbidity
4913130|NCT02028026|Magnetic Resonance Imaging|magnetic resonance imaging
4913131|NCT02028026|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
4913132|NCT02028026|Citalopram|citalopram
4913133|NCT02028026|Vilazodone|vilazodone
4913134|NCT02028026|Serotonin Uptake Inhibitors|serotonin uptake inhibitors
4913135|NCT02028026|Receptor, Serotonin, 5-HT1A|receptor, serotonin, 5-ht1a
4913136|NCT02028013|Erectile dysfunction, sexual dysfunction, bioresonance|erectile dysfunction, sexual dysfunction, bioresonance
4913137|NCT02028000|Pregnancy|pregnancy
4913138|NCT02028000|Pregnant|pregnant
4913139|NCT02028000|Cesarean Section Delivery|cesarean section delivery
4913140|NCT02027987|valproate acid|valproate acid
4913141|NCT02027987|traumatic brain injury|traumatic brain injury
4913142|NCT02027987|brain protection|brain protection
4913143|NCT02027987|epilepsy|epilepsy
4913144|NCT02027974|Hip|hip
4913145|NCT02027974|Arthroplasty|arthroplasty
4913146|NCT02027974|Arthroplasties|arthroplasties
4913147|NCT02027974|Prosthesis|prosthesis
4913148|NCT02027974|Iconacy|iconacy
4913149|NCT02027974|Osteoarthritis|osteoarthritis
4913150|NCT02027974|Arthritis|arthritis
4913151|NCT02027974|THA|tha
4913152|NCT02027974|THR|thr
4913153|NCT02027974|DJD|djd
4913154|NCT02027961|Metastatic or Unresectable Melanoma, MEDI4736, dafrafenib, trametinib, BRAF-mutation positive, wild-type BRAF, PD-L1, PD-1|metastatic or unresectable melanoma, medi4736, dafrafenib, trametinib, braf-mutation positive, wild-type braf, pd-l1, pd-1
4913155|NCT02027948|nutritional management algorithm|nutritional management algorithm
4913156|NCT02027948|nutritional and functional assessments|nutritional and functional assessments
4913157|NCT02027948|13-264|13-264
4913158|NCT02027935|Melanoma|melanoma
4913159|NCT02027935|Metastatic|metastatic
4913160|NCT02027935|CD8+ T cells|cd8+ t cells
4913161|NCT02027935|White blood cell|white blood cell
4913162|NCT02027935|Leukapheresis|leukapheresis
4913163|NCT02027935|Cyclophosphamide|cyclophosphamide
4913164|NCT02027935|Cytoxan|cytoxan
4913165|NCT02027935|Neosar|neosar
4913166|NCT02027935|Interleukin-2|interleukin-2
4913167|NCT02027935|Aldesleukin|aldesleukin
4913168|NCT02027935|IL-2|il-2
4913169|NCT02027935|Proleukin|proleukin
4913170|NCT02027935|Ipilimumab|ipilimumab
4913171|NCT02027935|Yervoy|yervoy
4913172|NCT02027935|BMS-734016|bms-734016
4913173|NCT02027935|MDX010|mdx010
4913174|NCT02027922|white spot lesion|white spot lesion
4913175|NCT02027922|caries|caries
4913176|NCT02027909|Sinus Node Dysfunction|sinus node dysfunction
4913177|NCT02027896|Perioperative outcomes|perioperative outcomes
4913178|NCT02027883|Defibrillators|defibrillators
4913179|NCT02027883|Ventricular Fibrillation Induction Testing|ventricular fibrillation induction testing
4913180|NCT02027870|DES|des
4913181|NCT02027870|CAD|cad
4913182|NCT02027870|EXCEL-II|excel-ii
4913183|NCT02027870|JWMS|jwms
4913184|NCT02027870|PCI|pci
4913185|NCT02027857|brain electrical impedance;|brain electrical impedance;
4913186|NCT02027857|traumatic brain injury;|traumatic brain injury;
4913187|NCT02027857|brain edema;|brain edema;
4913188|NCT02027857|intracranial pressure|intracranial pressure
4913189|NCT02027831|lymph nodes|lymph nodes
4913190|NCT02027818|margins|margins
4913191|NCT02027818|tumorectomy|tumorectomy
4913192|NCT02027805|Steroid-resistant|steroid-resistant
4913193|NCT02027805|Graft vs Host Disease|graft vs host disease
4913194|NCT02027805|Refractory acute Graft vs Host Disease|refractory acute graft vs host disease
4913195|NCT02027805|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
4913196|NCT02027805|Stem Cell Transplantation|stem cell transplantation
4913197|NCT02027805|Allogeneic Stem Cell Transplantation|allogeneic stem cell transplantation
4913198|NCT02027805|Immune System Diseases|immune system diseases
4913199|NCT02027805|Antibodies, monoclonal|antibodies, monoclonal
4913200|NCT02027805|Immunotoxins|immunotoxins
4913201|NCT02027805|Immunosuppressive agents|immunosuppressive agents
4913202|NCT02027779|GreenGene™ F, Previously Treated Patients|greengene™ f, previously treated patients
4913203|NCT02027727|inflammatory bowel disease|inflammatory bowel disease
4913204|NCT02027727|infliximab|infliximab
4913205|NCT02027727|trough level|trough level
4913206|NCT02027727|crohn's disease|crohn's disease
4913207|NCT02027727|ulcerative colitis|ulcerative colitis
4913208|NCT02027714|Discordant|discordant
4913209|NCT02027714|Lesotho|lesotho
4913210|NCT02027714|Couples|couples
4913211|NCT02027714|Enhanced Prevention Package (EPP)|enhanced prevention package (epp)
4913212|NCT02027714|ART|art
4913213|NCT02027714|Counseling|counseling
4913214|NCT02027714|Male Circumcision|male circumcision
4913215|NCT02027688|Oral feeding|oral feeding
4913216|NCT02027688|Premature|premature
4913217|NCT02027688|Infants|infants
4913218|NCT02027688|Neonatal Intensive Care Unit|neonatal intensive care unit
4913219|NCT02027675|exercise|exercise
4913220|NCT02027675|immune function|immune function
4913221|NCT02027675|inflammation|inflammation
4913222|NCT02027675|immunity|immunity
4913223|NCT02027675|diet|diet
4913226|NCT02027649|Bladder cancer|bladder cancer
4913227|NCT02027649|Keratin 14|keratin 14
4913228|NCT02027649|Pronostic marker|pronostic marker
4913229|NCT02027649|Diagnostic marker|diagnostic marker
4913230|NCT02027649|Noninvasive technique|noninvasive technique
4913231|NCT02027636|Depression|depression
4913232|NCT02027636|Latinos|latinos
4913233|NCT02027636|Mental Health|mental health
4913234|NCT02027636|Disparities|disparities
4913235|NCT02027623|Mechanical low back pain|mechanical low back pain
4913236|NCT02027623|Non-specific low back pain|non-specific low back pain
4913237|NCT02027623|Exercise|exercise
4913238|NCT02027623|Motor skill training|motor skill training
4913239|NCT02027610|Infant|infant
4913240|NCT02027610|Bangladesh|bangladesh
4913241|NCT02027610|vitamin A|vitamin a
4913242|NCT02027610|microbiota|microbiota
4913243|NCT02027610|vaccine|vaccine
4913244|NCT02027610|immunity|immunity
4913245|NCT02027597|video games|video games
4913246|NCT02027597|oral health|oral health
4913247|NCT02027597|social cognitive theory|social cognitive theory
4913248|NCT02027597|behavior change|behavior change
4913249|NCT02027597|randomized trial|randomized trial
4913250|NCT02027597|growth modeling|growth modeling
4913251|NCT02027597|minority|minority
4913252|NCT02027597|gender|gender
4913253|NCT02027584|infant, premature|infant, premature
4913254|NCT02027584|infant, newborn|infant, newborn
4913255|NCT02027584|choline|choline
4913256|NCT02027571|Diabetes|diabetes
4913257|NCT02027571|Race/Ethnicity|race/ethnicity
4913258|NCT02027571|Offspring Cohort|offspring cohort
4913259|NCT02027571|African Americans|african americans
4913260|NCT02027571|Prediabetes Reversal|prediabetes reversal
4913261|NCT02027571|Lifestyle Intervention|lifestyle intervention
4913262|NCT02027571|Insulin Sensitivity|insulin sensitivity
4913263|NCT02027571|Beta-cell Function|beta-cell function
4913264|NCT02027571|Diabetes Prevention|diabetes prevention
4913265|NCT02027558|cognitive behavioral therapy|cognitive behavioral therapy
4913266|NCT02027558|insomnia|insomnia
4913267|NCT02027558|apnea|apnea
4913268|NCT02027545|cancer screening|cancer screening
4913269|NCT02027545|decision making|decision making
4913270|NCT02027519|Self-testing|self-testing
4913271|NCT02027519|Home-based testing|home-based testing
4913272|NCT02027519|Lesotho|lesotho
4913273|NCT02027519|Discordant|discordant
4913275|NCT02027506|aVL|avl
4913276|NCT02027506|CHRONIC STABLE ANGINA|chronic stable angina
4913277|NCT02027506|T WAVE|t wave
4913278|NCT02027493|Children|children
4913279|NCT02027493|Chronic hepatitis C|chronic hepatitis c
4913280|NCT02027493|Hansenula polymorpha|hansenula polymorpha
4913281|NCT02027493|Pegylated interferon|pegylated interferon
4913282|NCT02027493|Response rate|response rate
4913283|NCT02027493|Ribavirin|ribavirin
4913284|NCT02027493|Treatment|treatment
4913285|NCT02027480|Antiretroviral Therapy (ART)|antiretroviral therapy (art)
4913286|NCT02027480|Biomarkers|biomarkers
4913287|NCT02027480|Nyanza Province|nyanza province
4913288|NCT02027480|Kenya|kenya
4913289|NCT02027467|Hematopoietic stem cells|hematopoietic stem cells
4913290|NCT02027467|Herbal|herbal
4913291|NCT02027467|Dietary|dietary
4913292|NCT02027467|CD cells|cd cells
4913293|NCT02027467|Basic research|basic research
4913294|NCT02027454|GSK1265744|gsk1265744
4913295|NCT02027454|HIV|hiv
4913296|NCT02027454|placebo|placebo
4913297|NCT02027454|cardiac repolarization|cardiac repolarization
4913298|NCT02027454|12-lead ECG|12-lead ecg
4913299|NCT02027454|moxifloxacin|moxifloxacin
4913300|NCT02027454|QTc|qtc
4913301|NCT02027441|Serodiscordant|serodiscordant
4913302|NCT02027441|Lesotho|lesotho
4913303|NCT02027441|Home-based testing|home-based testing
4913304|NCT02027428|Nab-paclitaxel|nab-paclitaxel
4913305|NCT02027428|Albumin bound paclitaxel|albumin bound paclitaxel
4913306|NCT02027428|Taxanes|taxanes
4913307|NCT02027428|Maintenance trials|maintenance trials
4913308|NCT02027428|Celgene|celgene
4913309|NCT02027428|Abraxane|abraxane
4913310|NCT02027428|ABI-007|abi-007
4913311|NCT02027428|NSCLC|nsclc
4913312|NCT02027428|Non-Small Cell Lung Cancer|non-small cell lung cancer
4913313|NCT02027428|Cancer of the Lung|cancer of the lung
4913314|NCT02027428|Carcinoma, Squamous Cell|carcinoma, squamous cell
4913315|NCT02027428|Lung Neoplasms|lung neoplasms
4913316|NCT02027428|Abound.sqm|abound.sqm
4913317|NCT02027415|air pollution|air pollution
4913318|NCT02027415|food|food
4913319|NCT02027415|nitrites|nitrites
4913320|NCT02027415|nitrates|nitrates
4913321|NCT02027415|breath tests/methods|breath tests/methods
4913322|NCT02027389|MSSA, MRSA|mssa, mrsa
4913323|NCT02027376|Advanced Breast Cancer|advanced breast cancer
4913324|NCT02027376|LDE225|lde225
4913325|NCT02027376|Triple Negative|triple negative
4913326|NCT02027376|Hormonal Receptor negative|hormonal receptor negative
4913327|NCT02027376|Her2 negative|her2 negative
4913328|NCT02027363|Metastasis colorectal cancer|metastasis colorectal cancer
4913329|NCT02027363|Maintenance|maintenance
4913330|NCT02027363|First-line treatment|first-line treatment
4913331|NCT02027363|Capecitabine|capecitabine
4913332|NCT02027337|combined oral contraceptives|combined oral contraceptives
4913333|NCT02027337|drospirenone|drospirenone
4913336|NCT02027337|antioxidants|antioxidants
4913337|NCT02027324|Surgical site infection|surgical site infection
4913338|NCT02027324|Cesarean delivery|cesarean delivery
4913339|NCT02027324|Antisepsis|antisepsis
4913340|NCT02027324|Povidone iodine|povidone iodine
4913341|NCT02027324|Chlorhexidine alcohol|chlorhexidine alcohol
4913342|NCT02027324|Endometritis|endometritis
4913343|NCT02027311|Endoscopic Retrograde Cholangiopancreatography (ERCP)|endoscopic retrograde cholangiopancreatography (ercp)
4913344|NCT02027311|Conscious Sedation|conscious sedation
4913345|NCT02027311|etomidate|etomidate
4913346|NCT02027311|midazolam|midazolam
4913347|NCT02027298|Abatacept|abatacept
4913348|NCT02027298|Sjogren's Syndrome|sjogren's syndrome
4913349|NCT02027298|Rheumatoid Arthritis|rheumatoid arthritis
4913350|NCT02027285|fortified milk, aging, health status|fortified milk, aging, health status
4913351|NCT02027272|Eclampsia|eclampsia
4913352|NCT02027259|Diabetes|diabetes
4913353|NCT02027259|Depression|depression
4913354|NCT02027259|Group|group
4913355|NCT02027246|spinal cord injury|spinal cord injury
4913356|NCT02027246|autologous bone marrow mononuclear cells|autologous bone marrow mononuclear cells
4913357|NCT02027246|stem cell therapy|stem cell therapy
4913358|NCT02027233|Prevention|prevention
4913359|NCT02027233|Influenza|influenza
4913360|NCT02027233|Adults hospitalized|adults hospitalized
4913361|NCT02027233|Vaccines|vaccines
4913362|NCT02027233|Effectiveness|effectiveness
4913363|NCT02027207|Cholera|cholera
4913364|NCT02027207|Oral cholera vaccine|oral cholera vaccine
4913365|NCT02027207|Shanchol|shanchol
4913366|NCT02027207|Protective efficacy|protective efficacy
4913367|NCT02027207|Bangladesh|bangladesh
4913368|NCT02027194|Allergic Rhinitis|allergic rhinitis
4913369|NCT02027194|Chinese herbal medicine|chinese herbal medicine
4913370|NCT02027194|Adolescents|adolescents
4913371|NCT02027194|Double-blinded|double-blinded
4913372|NCT02027194|Randomized controlled trial|randomized controlled trial
4913373|NCT02027168|infertility|infertility
4913374|NCT02027168|elevated FSH|elevated fsh
4913375|NCT02027168|alternative treatment|alternative treatment
4913376|NCT02027168|Clear Passage Approach|clear passage approach
4913377|NCT02027168|Clear Passage Physical Therapy|clear passage physical therapy
4913378|NCT02027155|healthy volunteers|healthy volunteers
4913379|NCT02027129|Respiratory Distress Syndrome, Adult|respiratory distress syndrome, adult
4913380|NCT02027129|Cor Pulmonale|cor pulmonale
4913381|NCT02027129|High Frequency Ventilaiton|high frequency ventilaiton
4913382|NCT02027116|chronic hepatitis C|chronic hepatitis c
4913383|NCT02027116|DNA Vaccine|dna vaccine
4913384|NCT02027116|Electroporation|electroporation
4913385|NCT02027116|Intramuscular (IM) Injection|intramuscular (im) injection
4913386|NCT02027103|Fetuin-A|fetuin-a
4913387|NCT02027103|OPG|opg
4913388|NCT02027103|Metformin|metformin
4913389|NCT02027103|Pioglitazone|pioglitazone
4913390|NCT02027077|physical activity|physical activity
4913391|NCT02027077|diet|diet
4913392|NCT02027077|small change|small change
4913393|NCT02027077|behavior change|behavior change
4913394|NCT02027051|population genetics|population genetics
4913395|NCT02027025|Spasticity, Multiple sclerosis|spasticity, multiple sclerosis
4913396|NCT02026934|Graft-Versus-Host Disease(GVHD)|graft-versus-host disease(gvhd)
4913397|NCT02026934|Hematopoietic Stem Cell Transplantation.|hematopoietic stem cell transplantation.
4913398|NCT02026934|Graft failure|graft failure
4913399|NCT02026934|Graft exhaustion|graft exhaustion
4913400|NCT02026921|Phase II study,|phase ii study,
4913401|NCT02026921|Recurrent platinum-sensitive ovarian cancer|recurrent platinum-sensitive ovarian cancer
4913402|NCT02026921|docetaxel|docetaxel
4913403|NCT02026921|Carboplatin|carboplatin
4913404|NCT02026921|Toxicity|toxicity
4913405|NCT02026908|Prostate Artery Embolization|prostate artery embolization
4913406|NCT02026908|PAE|pae
4913407|NCT02026908|Benign Prostatic Hyperplasia|benign prostatic hyperplasia
4913408|NCT02026908|BPH|bph
4913409|NCT02026908|Lower Urinary Tract Symptoms|lower urinary tract symptoms
4913410|NCT02026908|LUTS|luts
4913411|NCT02026882|Airway, Caesarean|airway, caesarean
4913412|NCT02026869|Vaginal administration, PCOS, Metformin|vaginal administration, pcos, metformin
4913413|NCT02026856|oxidative stress, sepsis, selenium|oxidative stress, sepsis, selenium
4913414|NCT02026830|Diabetic foot infections|diabetic foot infections
4913415|NCT02026830|microorganisms|microorganisms
4913416|NCT02026791|Supraglottic airway device|supraglottic airway device
4913417|NCT02026791|I-gel|i-gel
4913418|NCT02026791|SupremeLMA|supremelma
4913419|NCT02026791|Elderly patient|elderly patient
4913420|NCT02026739|minimally invasive esophagectomy; pulmonary function|minimally invasive esophagectomy; pulmonary function
4913421|NCT02026674|urineflow|urineflow
4913422|NCT02026674|luts|luts
4913423|NCT02026674|urine flow|urine flow
4913424|NCT02026674|uroflometry|uroflometry
4913425|NCT02026674|bph|bph
4913426|NCT02026635|heart failure|heart failure
4913427|NCT02026635|Optivol® cardiac device|optivol® cardiac device
4913428|NCT02026635|Medtronic CareLink|medtronic carelink
4913429|NCT02026622|major depressive disorder|major depressive disorder
4913430|NCT02026622|cerebrovascular reactivity|cerebrovascular reactivity
4913431|NCT02026622|emotional reactivity|emotional reactivity
4913432|NCT02026609|TIPS|tips
4913433|NCT02026609|Hepatic encephalopathy|hepatic encephalopathy
4913434|NCT02026609|Oral glutamine challenge|oral glutamine challenge
4913435|NCT02026609|Psychometric tests|psychometric tests
4913436|NCT02026609|Portal hypertension|portal hypertension
4913437|NCT02026609|Cirrhosis|cirrhosis
4913438|NCT02026596|subrachnoid hemorrhage|subrachnoid hemorrhage
4913439|NCT02026596|secondary brain injury|secondary brain injury
4913440|NCT02026570|Prosthesis|prosthesis
4913441|NCT02026570|Falls|falls
4913442|NCT02026570|Training|training
4913443|NCT02026544|low frequency ultrasound|low frequency ultrasound
4913444|NCT02026544|glomerular filtration rate|glomerular filtration rate
4913445|NCT02026492|exercise-induced bronchoconstriction|exercise-induced bronchoconstriction
4913446|NCT02026492|exercise-induced asthma|exercise-induced asthma
4913447|NCT02026492|cold chamber|cold chamber
4913448|NCT02026492|exercise challenge|exercise challenge
4913449|NCT02026492|cold air challenge|cold air challenge
4913450|NCT02026492|combined exercise- and cold-air challenge|combined exercise- and cold-air challenge
4913451|NCT02026492|methacholine challenge|methacholine challenge
4913452|NCT02026479|full-frequency sudden hearing loss|full-frequency sudden hearing loss
4913453|NCT02026479|post auricular injection|post auricular injection
4913454|NCT02026479|glucocorticoid|glucocorticoid
4913455|NCT02026479|multi-center|multi-center
4913456|NCT02026466|Coronary Artery Disease|coronary artery disease
4913457|NCT02026466|Chronic Total Occlusion|chronic total occlusion
4913458|NCT02026453|Adverse drug events|adverse drug events
4913459|NCT02026440|oral fluid collection device cotinine detection|oral fluid collection device cotinine detection
4913460|NCT02026414|PrimaVie|primavie
4913461|NCT02026414|Herbal Supplement|herbal supplement
4913462|NCT02026414|Muscle biopsy|muscle biopsy
4913463|NCT02026414|Energy|energy
4913464|NCT02026414|Exercise|exercise
4913465|NCT02026414|Human skeletal muscle adaptation|human skeletal muscle adaptation
4913466|NCT02026414|Muscle function|muscle function
4913467|NCT02026388|PH|ph
4913468|NCT02026388|primary hyperoxaluria|primary hyperoxaluria
4913469|NCT02026388|hyperoxaluria|hyperoxaluria
4913470|NCT02026388|primary oxalosis|primary oxalosis
4913471|NCT02026388|Primary Hyperoxaluria Type 1|primary hyperoxaluria type 1
4913472|NCT02026388|Primary Hyperoxaluria Type 2|primary hyperoxaluria type 2
4913473|NCT02026388|Primary Hyperoxaluria Type 3|primary hyperoxaluria type 3
4913474|NCT02026388|Dent|dent
4913475|NCT02026388|Dents|dents
4913476|NCT02026388|Dent Disease|dent disease
4913477|NCT02026388|Dent 1|dent 1
4913478|NCT02026388|Dent 2|dent 2
4913479|NCT02026388|Cystinuria|cystinuria
4913480|NCT02026388|APRT|aprt
4913481|NCT02026388|APRT deficiency|aprt deficiency
4913482|NCT02026388|Biobank|biobank
4913483|NCT02026362|HCC|hcc
4913484|NCT02026362|DC|dc
4913485|NCT02026362|CTL|ctl
4913486|NCT02026349|influenza|influenza
4913487|NCT02026349|flu|flu
4913488|NCT02026349|fever|fever
4913489|NCT02026349|cough|cough
4913490|NCT02026349|body aches|body aches
4913491|NCT02026349|headache|headache
4913492|NCT02026349|nasal congestion|nasal congestion
4913493|NCT02026349|body pains|body pains
4913494|NCT02026349|sore throat|sore throat
4913495|NCT02026349|fatigue|fatigue
4913496|NCT02026349|T-705|t-705
4913497|NCT02026349|favipiravir|favipiravir
4913498|NCT02026349|favor|favor
4913499|NCT02026349|flu symptoms|flu symptoms
4913500|NCT02026336|asthma; inflammation; electronic nose|asthma; inflammation; electronic nose
4913501|NCT02026310|glimepiride|glimepiride
4913502|NCT02026310|metformin|metformin
4913503|NCT02026310|basal insulin|basal insulin
4913504|NCT02026310|Hemoglobin A, Glycosylated|hemoglobin a, glycosylated
4913505|NCT02026310|glucose fluctuation|glucose fluctuation
4913506|NCT02026310|hypoglycemia|hypoglycemia
4913507|NCT02026297|postpartum hemorrhage|postpartum hemorrhage
4913508|NCT02026297|estimated blood loss|estimated blood loss
4913509|NCT02026297|coagulation|coagulation
4913510|NCT02026297|thromboelastography|thromboelastography
4913511|NCT02026297|tranexamic acid|tranexamic acid
4913512|NCT02026284|Caesarean section|caesarean section
4913513|NCT02026284|Anaesthesia|anaesthesia
4913514|NCT02026284|Questionnaires|questionnaires
4913515|NCT02026245|Arthritis|arthritis
4913516|NCT02026245|rheumatoid|rheumatoid
4913517|NCT02026245|joints|joints
4913518|NCT02026245|swelling|swelling
4913519|NCT02026245|measurement|measurement
4913520|NCT02026245|movement|movement
4913521|NCT02026245|electronic|electronic
4913522|NCT02026245|data|data
4913523|NCT02026245|glove|glove
4913524|NCT02026245|goniometry|goniometry
4913525|NCT02026245|outcome|outcome
4913526|NCT02026245|stiffness|stiffness
4913527|NCT02026232|Type 2 Diabetes|type 2 diabetes
4913528|NCT02026232|Overweight|overweight
4913529|NCT02026206|Primary Dysmenorrhea|primary dysmenorrhea
4913530|NCT02026206|Pain|pain
4913531|NCT02026167|Chronic Pain|chronic pain
4913532|NCT02026167|Mood|mood
4913533|NCT02026167|Physical Activity|physical activity
4913534|NCT02026154|hypertension, biomarkers, echocardiography, heart failure|hypertension, biomarkers, echocardiography, heart failure
4913535|NCT02026128|Uveitis|uveitis
4913536|NCT02026128|Inflammation|inflammation
4913537|NCT02026128|OCT|oct
4913538|NCT02026128|Grading|grading
4913539|NCT02026115|cancer|cancer
4913540|NCT02026115|hospice|hospice
4913541|NCT02026115|pain|pain
4913542|NCT02026102|decision aid|decision aid
4913543|NCT02026102|patient decision making|patient decision making
4913544|NCT02026102|heart failure|heart failure
4913545|NCT02026102|ejection fraction|ejection fraction
4913546|NCT02026102|primary prevention|primary prevention
4913547|NCT02026102|implantable cardioverter defibrillator|implantable cardioverter defibrillator
4913548|NCT02026102|ICD|icd
4913549|NCT02026102|pilot trial|pilot trial
4913550|NCT02026102|patient centered health care|patient centered health care
4913551|NCT02026076|low back pain|low back pain
4913552|NCT02026076|traction|traction
4913553|NCT02026076|unloading|unloading
4913554|NCT02026050|dexamethasone|dexamethasone
4913555|NCT02026050|intraarticular injection|intraarticular injection
4913556|NCT02026050|interscalene brachial plexus block|interscalene brachial plexus block
4913557|NCT02026037|Stress Disorders|stress disorders
4913558|NCT02026037|Post-Traumatic|post-traumatic
4913559|NCT02026037|Burns|burns
4913560|NCT02026037|Brief Psychotherapy|brief psychotherapy
4913561|NCT02026037|Cognitive Behavior Therapy|cognitive behavior therapy
4913562|NCT02026011|alcohol use disorder|alcohol use disorder
4913563|NCT02026011|naltrexone|naltrexone
4913564|NCT02026011|Asian American|asian american
4913565|NCT02026011|pharmacogenetics|pharmacogenetics
4913566|NCT02026011|OPRM1 gene|oprm1 gene
4913567|NCT02025998|ibudilast, alcoholism|ibudilast, alcoholism
4913568|NCT02025985|Karyopharm|karyopharm
4913569|NCT02025985|KPT-330|kpt-330
4913570|NCT02025985|Selinexor|selinexor
4913571|NCT02025985|SIGN|sign
4913572|NCT02025985|ovarian cancer|ovarian cancer
4913573|NCT02025985|endometrial cancer|endometrial cancer
4913574|NCT02025985|cervical cancer|cervical cancer
4913575|NCT02025985|SINE™|sine™
4913576|NCT02025985|breast cancer|breast cancer
4913577|NCT02025985|HER2 negative|her2 negative
4913578|NCT02025972|Cerebral palsy|cerebral palsy
4913579|NCT02025972|Umbilical cord blood|umbilical cord blood
4913580|NCT02025972|Rehabilitation|rehabilitation
4913581|NCT02025972|Cytokine|cytokine
4913582|NCT02025972|Outcome|outcome
4913583|NCT02025959|staff empowerment|staff empowerment
4913584|NCT02025959|Sleep Apnea|sleep apnea
4913585|NCT02025959|educational intervention|educational intervention
4913586|NCT02025933|Children|children
4913587|NCT02025933|Age 9-12 years|age 9-12 years
4913588|NCT02025933|Overweight (iso-BMI > 25)|overweight (iso-bmi > 25)
4913589|NCT02025907|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
4913590|NCT02025907|Canagliflozin|canagliflozin
4913591|NCT02025907|Hemoglobin A1c|hemoglobin a1c
4913592|NCT02025907|Metformin|metformin
4913593|NCT02025907|Sitagliptin|sitagliptin
4913594|NCT02025907|T2DM|t2dm
4913595|NCT02025907|JNJ-28431754|jnj-28431754
4913596|NCT02025894|neoplastic solid tumour|neoplastic solid tumour
4913597|NCT02025894|PCVC|pcvc
4913598|NCT02025894|thromboembolic complications|thromboembolic complications
4913599|NCT02025894|infectious complications|infectious complications
4913600|NCT02025894|risk factors|risk factors
4913601|NCT02025868|Africa|africa
4913602|NCT02025868|Antiretroviral Treatment|antiretroviral treatment
4913603|NCT02025868|Adherence reinforcement|adherence reinforcement
4913604|NCT02025868|Third line ART|third line art
4913605|NCT02025868|Second line ART|second line art
4913606|NCT02025868|Virologic failure|virologic failure
4913607|NCT02025868|Adults|adults
4913608|NCT02025855|Iatrogenic opioid abstinence syndrome|iatrogenic opioid abstinence syndrome
4913609|NCT02025855|Methadone|methadone
4913610|NCT02025855|Mechanical ventilation|mechanical ventilation
4913611|NCT02025855|ICU delirium|icu delirium
4913612|NCT02025855|Continuous sedation|continuous sedation
4913613|NCT02025842|Hepatocellular carcinoma|hepatocellular carcinoma
4913614|NCT02025842|Hepatitis B|hepatitis b
4913615|NCT02025829|cystic fibrosis|cystic fibrosis
4913616|NCT02025829|IL-17 neutrophils|il-17 neutrophils
4913617|NCT02025803|Advanced solid tumors|advanced solid tumors
4913618|NCT02025790|Achalasia|achalasia
4913619|NCT02025790|POEM|poem
4913620|NCT02025790|Pneumatic dilatation|pneumatic dilatation
4913621|NCT02025790|Eckardt score|eckardt score
4913622|NCT02025777|Ulcerative Colitis|ulcerative colitis
4913623|NCT02025777|PillCam|pillcam
4913624|NCT02025777|IBD|ibd
4913625|NCT02025751|Diabetes|diabetes
4913626|NCT02025751|Gastroparesis|gastroparesis
4913627|NCT02025751|Delayed gastric emptying|delayed gastric emptying
4913628|NCT02025751|Nausea|nausea
4913629|NCT02025751|Vomiting|vomiting
4913630|NCT02025751|Bloating|bloating
4913631|NCT02025751|Abdominal pain|abdominal pain
4913632|NCT02025751|Early Satiety|early satiety
4913633|NCT02025751|Gastric stasis|gastric stasis
4913634|NCT02025751|Gastropathy|gastropathy
4913635|NCT02025725|Gastroparesis|gastroparesis
4913636|NCT02025725|Diabetic|diabetic
4913637|NCT02025725|Delayed gastric emptying|delayed gastric emptying
4913638|NCT02025725|Gastric stasis|gastric stasis
4913639|NCT02025725|Nausea|nausea
4913640|NCT02025725|Vomiting|vomiting
4913641|NCT02025725|Bloating|bloating
4913642|NCT02025725|Abdominal pain|abdominal pain
4913643|NCT02025725|Early satiety|early satiety
4913644|NCT02025725|Gastropathy|gastropathy
4913645|NCT02025686|Pain|pain
4913646|NCT02025686|Inflammation|inflammation
4913647|NCT02025686|Hyperalgesia|hyperalgesia
4913648|NCT02025686|burn injury|burn injury
4913649|NCT02025686|Hyperbaric Oxygen|hyperbaric oxygen
4913650|NCT02025660|Mw|mw
4913651|NCT02025660|Mycobacterium indicum prannii|mycobacterium indicum prannii
4913652|NCT02025660|Mycobacterium w|mycobacterium w
4913653|NCT02025660|Severe sepsis|severe sepsis
4913654|NCT02025660|Septic shock|septic shock
4913655|NCT02025647|Mood disorders|mood disorders
4913656|NCT02025647|Anxiety disorders|anxiety disorders
4913657|NCT02025647|Eating concerns|eating concerns
4913658|NCT02025647|Pain concerns|pain concerns
4913659|NCT02025647|Alcohol abuse|alcohol abuse
4913660|NCT02025647|Self harm|self harm
4913661|NCT02025647|Mental health|mental health
4913662|NCT02025647|Clinical Decision Support|clinical decision support
4913663|NCT02025634|Pain, Postoperative|pain, postoperative
4913664|NCT02025634|Ofirmev|ofirmev
4913665|NCT02025634|Acetaminophen|acetaminophen
4913666|NCT02025634|Analgesics, Non-Narcotic|analgesics, non-narcotic
4913667|NCT02025634|Arthroscopy|arthroscopy
4913668|NCT02025621|coronary artery bypass grafting|coronary artery bypass grafting
4913669|NCT02025621|CABG|cabg
4913670|NCT02025621|mitral valve|mitral valve
4913671|NCT02025621|LCOS|lcos
4913672|NCT02025621|low cardiac output syndrome|low cardiac output syndrome
4913673|NCT02025621|levosimendan|levosimendan
4913674|NCT02025608|Restless legs syndrome|restless legs syndrome
4913675|NCT02025595|Brain|brain
4913676|NCT02025595|Genes|genes
4913677|NCT02025595|Environment|environment
4913678|NCT02025595|Etiology|etiology
4913679|NCT02025595|Reward|reward
4913680|NCT02025595|Satiety Response|satiety response
4913681|NCT02025595|Central Nervous System|central nervous system
4913682|NCT02025595|Magnetic Resonance Imaging|magnetic resonance imaging
4913683|NCT02025595|Twins, Monozygotic|twins, monozygotic
4913684|NCT02025595|Overweight|overweight
4913685|NCT02025595|Obesity|obesity
4913686|NCT02025582|idiopathic toe walking|idiopathic toe walking
4913687|NCT02025582|gait disorder|gait disorder
4913688|NCT02025582|gait analysis|gait analysis
4913689|NCT02025582|kinesio taping|kinesio taping
4913690|NCT02025582|ultrasound elastography|ultrasound elastography
4913691|NCT02025582|pediatric|pediatric
4913692|NCT02025582|children|children
4913693|NCT02025582|muscle stiffness|muscle stiffness
4913694|NCT02025582|muscle elasticity|muscle elasticity
4913695|NCT02025569|chronic ankle instability|chronic ankle instability
4913696|NCT02025569|lateral ankle sprain|lateral ankle sprain
4913697|NCT02025569|manual therapy|manual therapy
4913698|NCT02025569|star excursion balance test|star excursion balance test
4913699|NCT02025569|strain and counterstrain|strain and counterstrain
4913700|NCT02025556|High Frequency Episodic Migraine Headache|high frequency episodic migraine headache
4913701|NCT02025556|Episodic Migraine Headache|episodic migraine headache
4913702|NCT02025556|Migraine Headache|migraine headache
4913703|NCT02025543|MRI|mri
4913704|NCT02025543|Iron overload|iron overload
4913705|NCT02025530|Stillbirth|stillbirth
4913706|NCT02025530|Modifiable risk factors|modifiable risk factors
4913707|NCT02025517|Parkinson's disease|parkinson's disease
4913708|NCT02025517|rehabilitation|rehabilitation
4913709|NCT02025517|kinematics|kinematics
4913710|NCT02025517|cognition|cognition
4913711|NCT02025504|Colonoscopy, Looping, Sigmoid Looping, ColoWrap, Binder, Patient Satisfaction|colonoscopy, looping, sigmoid looping, colowrap, binder, patient satisfaction
4913712|NCT02025491|Disseminated leishmaniasis|disseminated leishmaniasis
4913713|NCT02025491|Liposomal Amphotericin B|liposomal amphotericin b
4913714|NCT02025491|Leishmania braziliensis|leishmania braziliensis
4913715|NCT02025478|children|children
4913716|NCT02025478|bone marrow transplant|bone marrow transplant
4913717|NCT02025478|autologous|autologous
4913718|NCT02025478|allogeneic|allogeneic
4913719|NCT02025478|breastmilk|breastmilk
4913720|NCT02025478|hematopoietic stem cell transplantation (HSCT)|hematopoietic stem cell transplantation (hsct)
4913721|NCT02025465|Atrial Fibrillation|atrial fibrillation
4913722|NCT02025465|Atrial Flutter|atrial flutter
4913723|NCT02025465|Metoprolol|metoprolol
4913724|NCT02025465|Diltiazem|diltiazem
4913725|NCT02025452|diarrhoea|diarrhoea
4913726|NCT02025452|gastroenteritis|gastroenteritis
4913727|NCT02025452|rapid diagnostics|rapid diagnostics
4913728|NCT02025452|probiotics|probiotics
4913729|NCT02025452|sub-Saharan Africa|sub-saharan africa
4913730|NCT02025439|Traumatic Brain Injury|traumatic brain injury
4913731|NCT02025439|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
4913732|NCT02025439|Amantadine|amantadine
4913733|NCT02025439|Vegetative State|vegetative state
4913734|NCT02025439|Minimally Conscious State|minimally conscious state
4913735|NCT02025426|Cesarean delivery|cesarean delivery
4913736|NCT02025426|Spinal Anesthesia|spinal anesthesia
4913737|NCT02025400|Rehabilitation|rehabilitation
4913738|NCT02025400|eRehab|erehab
4913739|NCT02025400|Physical Therapy|physical therapy
4913740|NCT02025400|e-Health|e-health
4913741|NCT02025400|Telemedicine|telemedicine
4913742|NCT02025400|Telerehabilitation|telerehabilitation
4913743|NCT02025400|Patient-Centered|patient-centered
4913744|NCT02025374|spinal anesthesia|spinal anesthesia
4913745|NCT02025374|cesarean section|cesarean section
4913746|NCT02025374|hyperbaric levobupivacaine|hyperbaric levobupivacaine
4913747|NCT02025361|prostate biopsy, local anesthesia, cancer detection rate.|prostate biopsy, local anesthesia, cancer detection rate.
4913748|NCT02025322|HIV/AIDS|hiv/aids
4913749|NCT02025322|Peer Mentoring|peer mentoring
4913750|NCT02025322|Medication Adherence|medication adherence
4913751|NCT02025322|Medication Non-adherent|medication non-adherent
4913752|NCT02025322|Newly diagnosed|newly diagnosed
4913753|NCT02025322|HIV-positive individuals|hiv-positive individuals
4913754|NCT02025322|HIV viral load|hiv viral load
4913755|NCT02025322|CD4 lymphocyte cell counts|cd4 lymphocyte cell counts
4913756|NCT02025322|Treatment adherence|treatment adherence
4913757|NCT02025322|Health literacy|health literacy
4913758|NCT02025322|Self-efficacy|self-efficacy
4913759|NCT02025309|train of four|train of four
4913760|NCT02025309|neuromuscular recovery|neuromuscular recovery
4913761|NCT02025309|sugammadex|sugammadex
4913762|NCT02025296|Telemedicine|telemedicine
4913763|NCT02025296|Clinical decision support system|clinical decision support system
4913764|NCT02025296|Ubiquitous healthcare|ubiquitous healthcare
4913765|NCT02025296|Diabetes Care|diabetes care
4913766|NCT02025296|Multifactorial Intervention|multifactorial intervention
4913767|NCT02025283|Intervertebral disc disease|intervertebral disc disease
4913768|NCT02025283|Radiculopathy|radiculopathy
4913769|NCT02025283|Chronic pain|chronic pain
4913770|NCT02025283|Thermocoagulation|thermocoagulation
4913771|NCT02025270|Azoospermia, Spermatogonial Arrest, Maturation Arrest.|azoospermia, spermatogonial arrest, maturation arrest.
4913772|NCT02025257|coronary artery disease|coronary artery disease
4913773|NCT02025257|elderly|elderly
4913774|NCT02025257|exercise|exercise
4913775|NCT02025257|exercise-based cardiac rehabilitation|exercise-based cardiac rehabilitation
4913776|NCT02025244|Key hole biopsy|key hole biopsy
4913777|NCT02025244|Upper Gastrointestinal Submucosal Tumors|upper gastrointestinal submucosal tumors
4913778|NCT02025244|EUS-FNA|eus-fna
4913779|NCT02025244|Mitototic Activity|mitototic activity
4913780|NCT02025244|GIST|gist
4913781|NCT02025231|reirradiation|reirradiation
4913782|NCT02025231|recurrent glioma|recurrent glioma
4913783|NCT02025231|positron emission tomography|positron emission tomography
4913784|NCT02025231|amino acid tracer|amino acid tracer
4913785|NCT02025218|NSCLC|nsclc
4913786|NCT02025218|EGFR|egfr
4913788|NCT02025218|Re-challenge|re-challenge
4913789|NCT02025218|Lung Cancer|lung cancer
4913790|NCT02025218|Resistance|resistance
4913791|NCT02025192|ONT-380|ont-380
4913792|NCT02025192|Capecitabine|capecitabine
4913793|NCT02025192|Trastuzumab|trastuzumab
4913794|NCT02025192|Xeloda|xeloda
4913795|NCT02025192|Herceptin|herceptin
4913796|NCT02025192|HER2 positive breast cancer|her2 positive breast cancer
4913797|NCT02025192|Breast cancer|breast cancer
4913798|NCT02025192|ARRY-380|arry-380
4913799|NCT02025192|Tucatinib|tucatinib
4913800|NCT02025179|Teriparatide|teriparatide
4913801|NCT02025179|Osteoporosis|osteoporosis
4913802|NCT02025179|Spinal Cord Injury|spinal cord injury
4913803|NCT02025179|Bone Diseases|bone diseases
4913804|NCT02025179|Metabolic Bone Diseases|metabolic bone diseases
4913805|NCT02025179|Musculoskeletal Diseases|musculoskeletal diseases
4913806|NCT02025179|Spinal Cord Diseases|spinal cord diseases
4913807|NCT02025179|Central Nervous System Diseases|central nervous system diseases
4913808|NCT02025179|Nervous System Diseases|nervous system diseases
4913809|NCT02025179|Nervous System|nervous system
4913810|NCT02025179|Wounds and Injuries|wounds and injuries
4913811|NCT02025179|Bone Density Conservation Agents|bone density conservation agents
4913812|NCT02025179|Physiological Effects of Drugs|physiological effects of drugs
4913813|NCT02025179|Pharmacologic Actions|pharmacologic actions
4913814|NCT02025179|Vibration|vibration
4913815|NCT02025166|Pain|pain
4913816|NCT02025166|abortion|abortion
4913817|NCT02025166|paracetamol|paracetamol
4913818|NCT02025166|lornoxicam|lornoxicam
4913819|NCT02025140|Computer controlled anesthesia (CCLAD)|computer controlled anesthesia (cclad)
4913820|NCT02025140|pain perception|pain perception
4913821|NCT02025140|Effectiveness|effectiveness
4913822|NCT02025140|primary molars|primary molars
4913823|NCT02025140|Behavior|behavior
4913824|NCT02025127|septic shock|septic shock
4913825|NCT02025127|mechanical ventilation|mechanical ventilation
4913826|NCT02025127|enteral nutrition|enteral nutrition
4913827|NCT02025127|trophic feeding|trophic feeding
4913828|NCT02025114|NSCLC, EGFR mutation|nsclc, egfr mutation
4913829|NCT02025101|Slow Coronary Flow|slow coronary flow
4913830|NCT02025075|Tomography|tomography
4913831|NCT02025075|Oximetry|oximetry
4913832|NCT02025075|Echocardiography|echocardiography
4913833|NCT02025062|head and neck squamous cell carcinomas (HNSCCs)|head and neck squamous cell carcinomas (hnsccs)
4913834|NCT02025062|elderly|elderly
4913835|NCT02025062|cancer|cancer
4913836|NCT02025062|comprehensive geriatric assessment|comprehensive geriatric assessment
4913837|NCT02025062|functional status|functional status
4913838|NCT02025062|malnutrition|malnutrition
4913839|NCT02025062|survival|survival
4913840|NCT02025049|pancreatitis|pancreatitis
4913841|NCT02025036|Chemoradiotherapy， Esophageal Squamous Cancer|chemoradiotherapy， esophageal squamous cancer
4913842|NCT02025023|Size|size
4913843|NCT02025023|Pain|pain
4913844|NCT02025023|Resolution|resolution
4913845|NCT02025023|Complications|complications
4913846|NCT02025023|Swelling|swelling
4913847|NCT02025010|castration-resistant prostate cancer|castration-resistant prostate cancer
4913848|NCT02024997|Pancreatic malignancy|pancreatic malignancy
4913849|NCT02024997|Radiation Therapy|radiation therapy
4913850|NCT02024984|LPFPCCPCOS|lpfpccpcos
4913851|NCT02024971|Drug therapy|drug therapy
4913852|NCT02024958|Adult ICU patients|adult icu patients
4913853|NCT02024958|spontaneous breathing|spontaneous breathing
4913854|NCT02024958|invasive ventilation|invasive ventilation
4913855|NCT02024958|non-invasive ventilation|non-invasive ventilation
4913856|NCT02024945|Drug therapy|drug therapy
4913857|NCT02024906|isoflavone|isoflavone
4913858|NCT02024906|CVD|cvd
4913859|NCT02024906|soy intake|soy intake
4913860|NCT02024906|subclinical hypothyroid|subclinical hypothyroid
4913861|NCT02024893|Humeral retroversion|humeral retroversion
4913862|NCT02024893|dynamic control ratio|dynamic control ratio
4913863|NCT02024893|GIRD|gird
4913864|NCT02024880|in vitro fertilization|in vitro fertilization
4913865|NCT02024880|embryo transfer|embryo transfer
4913866|NCT02024880|transfer catheter|transfer catheter
4913867|NCT02024867|Methicillin resistent Staphylococcus aureus|methicillin resistent staphylococcus aureus
4913868|NCT02024867|Staphylococcus aureus|staphylococcus aureus
4913869|NCT02024854|Kangaroo-Mother Care Method|kangaroo-mother care method
4913870|NCT02024854|Stress, Physiological|stress, physiological
4913871|NCT02024841|Gastric cancer|gastric cancer
4913872|NCT02024841|Peritoneal carcinomatosis|peritoneal carcinomatosis
4913873|NCT02024841|Intraperitoneal docetaxel|intraperitoneal docetaxel
4913874|NCT02024841|Cisplatin|cisplatin
4913875|NCT02024841|TS-ONE|ts-one
4913876|NCT02024828|Infant feeding|infant feeding
4913877|NCT02024802|Pain|pain
4913878|NCT02024802|Pain Cream|pain cream
4913879|NCT02024802|Nociceptive pain|nociceptive pain
4913880|NCT02024802|neurologic pain|neurologic pain
4913881|NCT02024802|transdermal|transdermal
4913882|NCT02024802|compounding|compounding
4913883|NCT02024802|compound|compound
4913884|NCT02024776|Training|training
4913885|NCT02024776|Wellness|wellness
4913886|NCT02024776|Aerobic capacity|aerobic capacity
4913887|NCT02024776|Information and communication technology, surgical risk|information and communication technology, surgical risk
4913888|NCT02024776|Abdominal surgery|abdominal surgery
4913889|NCT02024763|Energy Expenditure|energy expenditure
4913890|NCT02024763|Physical Education|physical education
4913891|NCT02024763|Children|children
4913892|NCT02024763|Randomized Controlled Trial|randomized controlled trial
4913893|NCT02024750|Family centered care|family centered care
4913894|NCT02024750|Patient centered care|patient centered care
4913895|NCT02024750|Diabetes Mellitus, Type 1|diabetes mellitus, type 1
4913896|NCT02024750|Problem Recognition in Illness Self-Management (PRISM)|problem recognition in illness self-management (prism)
4913897|NCT02024711|Cataract|cataract
4913898|NCT02024711|Intraocular Lens|intraocular lens
4913899|NCT02024711|IOL|iol
4913900|NCT02024711|Aphakia|aphakia
4913901|NCT02024685|Prostate|prostate
4913902|NCT02024685|Localized Prostate Cancer|localized prostate cancer
4913903|NCT02024685|Decision making|decision making
4913904|NCT02024672|Intrauterine devices|intrauterine devices
4913905|NCT02024672|IUDs|iuds
4913906|NCT02024672|postpartum|postpartum
4913907|NCT02024672|contraception|contraception
4913908|NCT02024659|nasal polyps|nasal polyps
4913909|NCT02024659|remodeling|remodeling
4913910|NCT02024659|inflammatory cells|inflammatory cells
4913911|NCT02024659|budesonide|budesonide
4913912|NCT02024646|Psoriatic Arthritis|psoriatic arthritis
4913913|NCT02024646|Brodalumab|brodalumab
4913914|NCT02024646|AMG 827|amg 827
4913915|NCT02024620|depression|depression
4913916|NCT02024620|technology|technology
4913917|NCT02024620|psychotherapy|psychotherapy
4913918|NCT02024620|behavioral activation|behavioral activation
4913919|NCT02024594|Nitrous Oxide-Oxygen conscious sedation|nitrous oxide-oxygen conscious sedation
4913920|NCT02024594|Cognitive Behavioral Therapy|cognitive behavioral therapy
4913921|NCT02024594|Children, Preschool|children, preschool
4913922|NCT02024594|dental anxiety|dental anxiety
4913923|NCT02024594|Patient Cooperation|patient cooperation
4913924|NCT02024581|pediatric|pediatric
4913925|NCT02024581|dermatology|dermatology
4913926|NCT02024581|East Indian sandalwood oil|east indian sandalwood oil
4913927|NCT02024581|pox virus|pox virus
4913928|NCT02024568|Pregabalin|pregabalin
4913929|NCT02024568|Arthralgia Myalgia Syndrome|arthralgia myalgia syndrome
4913930|NCT02024568|Paclitaxel|paclitaxel
4913931|NCT02024568|Pain management|pain management
4913932|NCT02024568|Breast cancer|breast cancer
4913933|NCT02024542|Bariatric Surgery|bariatric surgery
4913934|NCT02024542|Obesity|obesity
4913935|NCT02024542|Metabolic syndrome|metabolic syndrome
4913936|NCT02024542|Diabetes|diabetes
4913937|NCT02024516|Type 2 diabetes|type 2 diabetes
4913938|NCT02024516|Pomegranate|pomegranate
4913939|NCT02024516|Inflammation|inflammation
4913940|NCT02024516|lipid profiles|lipid profiles
4913941|NCT02024503|stroke|stroke
4913942|NCT02024503|fMRI|fmri
4913943|NCT02024503|DTI|dti
4913944|NCT02024490|vitamin D, prematurity, RDS, BPD, maternal, neonatal|vitamin d, prematurity, rds, bpd, maternal, neonatal
4913945|NCT02024477|endothelial cells|endothelial cells
4913946|NCT02024477|cellular biomarker|cellular biomarker
4913947|NCT02024477|endothelial dysfunction|endothelial dysfunction
4913948|NCT02024464|Primary open angle glaucoma|primary open angle glaucoma
4913949|NCT02024464|POAG|poag
4913950|NCT02024464|Pseudoexfoliative glaucoma|pseudoexfoliative glaucoma
4913951|NCT02024464|PXG|pxg
4913952|NCT02024464|Pigmentary dispersion glaucoma|pigmentary dispersion glaucoma
4913953|NCT02024464|PDG|pdg
4913954|NCT02024464|Hydrus|hydrus
4913955|NCT02024451|Radial shock wave|radial shock wave
4913956|NCT02024451|Acupuncture|acupuncture
4913957|NCT02024438|metastatic gastric cancer|metastatic gastric cancer
4913958|NCT02024438|neurotoxicity|neurotoxicity
4913959|NCT02024438|mFOLFOX6|mfolfox6
4913960|NCT02024438|monosialotetrahexosylganglioside Sodium Injection|monosialotetrahexosylganglioside sodium injection
4913961|NCT02024425|Clinical trials|clinical trials
4913962|NCT02024425|Adult|adult
4913963|NCT02024425|Women|women
4913964|NCT02024425|Functional food|functional food
4913965|NCT02024425|Dietary Supplements|dietary supplements
4913966|NCT02024425|Overweight|overweight
4913967|NCT02024425|Obese|obese
4913968|NCT02024425|Absorptiometry, Dual X-Ray|absorptiometry, dual x-ray
4913969|NCT02024425|Rosmarinus|rosmarinus
4913970|NCT02024425|Oligosaccharides|oligosaccharides
4913971|NCT02024425|Lactulose|lactulose
4913972|NCT02024425|Bioactive peptide|bioactive peptide
4913973|NCT02024412|metastatic colorectal cancer|metastatic colorectal cancer
4913974|NCT02024412|neurotoxicity|neurotoxicity
4913975|NCT02024412|mFOLFOX6|mfolfox6
4913976|NCT02024412|monosialotetrahexosylganglioside Sodium Injection|monosialotetrahexosylganglioside sodium injection
4913977|NCT02024399|Pediatric Overweight/Obesity, DEXA, Fitness|pediatric overweight/obesity, dexa, fitness
4913978|NCT02024386|Guanylate Cyclase|guanylate cyclase
4913979|NCT02024386|Pulmonary Edema of Mountaineers|pulmonary edema of mountaineers
4913980|NCT02024386|Mountaineering|mountaineering
4913981|NCT02024386|Performance-Enhancing Substances|performance-enhancing substances
4913982|NCT02024386|Athletic Performance|athletic performance
4913983|NCT02024373|chronic subdural hematoma|chronic subdural hematoma
4913984|NCT02024373|Atorvastatin|atorvastatin
4913985|NCT02024373|oral administration therapy|oral administration therapy
4913986|NCT02024360|obesity|obesity
4913987|NCT02024360|overweight|overweight
4913988|NCT02024360|children|children
4913989|NCT02024360|prevention|prevention
4913990|NCT02024334|JIA|jia
4913991|NCT02024334|LEFLUNOMIDE|leflunomide
4913992|NCT02024334|EFFICACY|efficacy
4913993|NCT02024321|abdominal surgery|abdominal surgery
4913994|NCT02024321|TPN|tpn
4913995|NCT02024321|blood glucose|blood glucose
4913996|NCT02024308|acute myeloid leukemia,|acute myeloid leukemia,
4913997|NCT02024308|AML1-ETO fusion protein,|aml1-eto fusion protein,
4913998|NCT02024308|Fludarabine,|fludarabine,
4913999|NCT02024308|recurrence|recurrence
4914000|NCT02024269|macular degeneration|macular degeneration
4914001|NCT02024269|stem cells|stem cells
4914002|NCT02024269|adipose stem cells|adipose stem cells
4914003|NCT02024256|Vaginal delivery|vaginal delivery
4914004|NCT02024256|Perineal swelling|perineal swelling
4914005|NCT02024256|Perineal pain|perineal pain
4914006|NCT02024256|MgSo4|mgso4
4914007|NCT02024256|Magnesium sulfate|magnesium sulfate
4914008|NCT02024256|Cold water|cold water
4914009|NCT02024243|Micro RNA|micro rna
4914010|NCT02024243|Wound|wound
4914011|NCT02024243|Chronic Venous Leg Ulcer|chronic venous leg ulcer
4914012|NCT02024243|VLU|vlu
4914013|NCT02024243|miR210|mir210
4914014|NCT02024243|OSU Comprehensive Wound Center|osu comprehensive wound center
4914015|NCT02024204|World Trade Center Disaster|world trade center disaster
4914016|NCT02024204|Environmental Exposure|environmental exposure
4914017|NCT02024204|Respiratory Physiology|respiratory physiology
4914018|NCT02024204|Inflammation|inflammation
4914019|NCT02024204|Gastrointestinal Diseases|gastrointestinal diseases
4914020|NCT02024204|Sinus Symptoms|sinus symptoms
4914021|NCT02024204|PTSD|ptsd
4914022|NCT02024204|Anxiety|anxiety
4914023|NCT02024204|Depression|depression
4914024|NCT02024204|Hypersensitivity|hypersensitivity
4914025|NCT02024204|Spirometry|spirometry
4914026|NCT02024204|Oscillometry|oscillometry
4914027|NCT02024191|glutamine|glutamine
4914028|NCT02024191|oxaliplatin|oxaliplatin
4914029|NCT02024191|peripheral neuropathy|peripheral neuropathy
4914030|NCT02024178|Prostate Cancer|prostate cancer
4914031|NCT02024178|Radical Prostatectomy|radical prostatectomy
4914032|NCT02024178|Ultrasound Imaging|ultrasound imaging
4914033|NCT02024165|Ultrasound|ultrasound
4914034|NCT02024165|FSE|fse
4914035|NCT02024165|IUPC|iupc
4914036|NCT02024139|Orthodontic pain|orthodontic pain
4914037|NCT02024139|Chewing gum|chewing gum
4914038|NCT02024126|Knee osteoarthritis|knee osteoarthritis
4914039|NCT02024126|Exercise therapy|exercise therapy
4914040|NCT02024126|RCT|rct
4914041|NCT02024126|Intervention|intervention
4914042|NCT02024126|Knee pain|knee pain
4914043|NCT02024126|Muticenter|muticenter
4914044|NCT02024126|Knee function|knee function
4914045|NCT02024113|validation|validation
4914046|NCT02024113|model|model
4914047|NCT02024113|metabolic profile|metabolic profile
4914048|NCT02024113|positron emission tomography|positron emission tomography
4914049|NCT02024061|Adolescents|adolescents
4914050|NCT02024061|Obesity|obesity
4914051|NCT02024061|Physical activity|physical activity
4914052|NCT02024061|Sedentary behavior|sedentary behavior
4914053|NCT02024061|Psychosocial health|psychosocial health
4914054|NCT02024048|Pregnancy|pregnancy
4914055|NCT02024048|OCT|oct
4914056|NCT02024048|Enhanced depth imaging|enhanced depth imaging
4914057|NCT02024048|Choroid|choroid
4914058|NCT02024035|Tomotherapy|tomotherapy
4914059|NCT02024035|Head and neck squamous celle carcinoma|head and neck squamous celle carcinoma
4914060|NCT02024035|Health economic evaluation|health economic evaluation
4914061|NCT02024022|colonoscopy|colonoscopy
4914062|NCT02024022|bowel cleansing|bowel cleansing
4914063|NCT02024022|polyethylene glycol|polyethylene glycol
4914064|NCT02024022|sodium picosulphate / magnesium citrate|sodium picosulphate / magnesium citrate
4914065|NCT02024009|chemoradiotherapy|chemoradiotherapy
4914066|NCT02024009|nelfinavir|nelfinavir
4914067|NCT02024009|abraxane|abraxane
4914068|NCT02024009|gemcitabine|gemcitabine
4914069|NCT02024009|radiotherapy|radiotherapy
4914070|NCT02024009|capecitabine|capecitabine
4914071|NCT02023996|HER2 positive|her2 positive
4914072|NCT02023996|PET Imaging|pet imaging
4914073|NCT02023996|89Zr-DFO-trastuzumab|89zr-dfo-trastuzumab
4914074|NCT02023996|13-165|13-165
4914075|NCT02023983|ST-segment elevation myocardial infarction|st-segment elevation myocardial infarction
4914076|NCT02023983|Primary percutaneous coronary intervention|primary percutaneous coronary intervention
4914077|NCT02023983|Low risk|low risk
4914078|NCT02023983|Early discharge|early discharge
4914079|NCT02023970|Bioprosthetic heart valves, immune response, structural valve deterioration, valvular disease.|bioprosthetic heart valves, immune response, structural valve deterioration, valvular disease.
4914080|NCT02023957|Interactive Health-risk assessment|interactive health-risk assessment
4914081|NCT02023957|Primary Care|primary care
4914082|NCT02023957|Randomized|randomized
4914083|NCT02023957|Open Label|open label
4914084|NCT02023957|Efficacy Study|efficacy study
4914085|NCT02023944|Memory|memory
4914086|NCT02023944|Aging|aging
4914087|NCT02023944|Healthy People|healthy people
4914088|NCT02023944|Intervention|intervention
4914089|NCT02023931|Oral mucosa|oral mucosa
4914090|NCT02023931|Nrf2 pathway|nrf2 pathway
4914091|NCT02023931|Broccoli Sprout Extract|broccoli sprout extract
4914092|NCT02023931|Head and Neck Cancer|head and neck cancer
4914093|NCT02023918|Growth hormone antagonism|growth hormone antagonism
4914094|NCT02023866|Leigh Syndrome|leigh syndrome
4914095|NCT02023866|Leber's hereditary optic neuropathy|leber's hereditary optic neuropathy
4914096|NCT02023866|myoclonic epilepsy|myoclonic epilepsy
4914097|NCT02023866|mitochondrial encephalomyopathy|mitochondrial encephalomyopathy
4914098|NCT02023866|Kearn-Sayre syndrome|kearn-sayre syndrome
4914099|NCT02023866|POLG-related disorders|polg-related disorders
4914100|NCT02023866|Neurogastrointestinal encephalopathy|neurogastrointestinal encephalopathy
4914101|NCT02023840|periodontitis|periodontitis
4914102|NCT02023840|pockets|pockets
4914103|NCT02023827|Transtheoretical Model|transtheoretical model
4914104|NCT02023827|Stages of change|stages of change
4914105|NCT02023827|Computer-tailored intervention|computer-tailored intervention
4914106|NCT02023827|Delinquency|delinquency
4914107|NCT02023827|Substance abuse|substance abuse
4914108|NCT02023827|Juvenile offender|juvenile offender
4914109|NCT02023827|Juvenile justice|juvenile justice
4914110|NCT02023827|Rise Above Your Situation (RAYS) program|rise above your situation (rays) program
4914111|NCT02023801|Menorrhagia|menorrhagia
4914112|NCT02023801|Dysfunctional Uterine Bleeding|dysfunctional uterine bleeding
4914113|NCT02023801|Endometrial Ablation|endometrial ablation
4914114|NCT02023788|human umbilical cord blood-derived mesenchymal stem cells|human umbilical cord blood-derived mesenchymal stem cells
4914115|NCT02023788|bronchopulmonary dysplasia|bronchopulmonary dysplasia
4914116|NCT02023788|respiratory tract infection|respiratory tract infection
4914117|NCT02023788|Premature infants|premature infants
4914118|NCT02023762|mitral regurgitation|mitral regurgitation
4914119|NCT02023762|local anaesthesia|local anaesthesia
4914120|NCT02023762|percutaneous repair|percutaneous repair
4914121|NCT02023749|nuts|nuts
4914122|NCT02023749|metabolic syndrome|metabolic syndrome
4914123|NCT02023749|lipid profile|lipid profile
4914124|NCT02023749|inflammation|inflammation
4914125|NCT02023749|oxidative stress|oxidative stress
4914126|NCT02023749|endothelial function|endothelial function
4914127|NCT02023723|Energy Drink|energy drink
4914128|NCT02023723|Electrocardiograph|electrocardiograph
4914129|NCT02023723|Hemodynamic|hemodynamic
4914130|NCT02023710|mucosal melanoma|mucosal melanoma
4914131|NCT02023710|Bevacizumab|bevacizumab
4914132|NCT02023710|Carboplatin|carboplatin
4914133|NCT02023710|Paclitaxel|paclitaxel
4914134|NCT02023684|Sleeve Gastrectomy|sleeve gastrectomy
4914135|NCT02023684|Lidocaine|lidocaine
4914136|NCT02023684|ropivacaine|ropivacaine
4914137|NCT02023658|HIV|hiv
4914138|NCT02023658|pMTCT|pmtct
4914139|NCT02023645|lutein|lutein
4914140|NCT02023645|cognition|cognition
4914141|NCT02023645|neural efficiency|neural efficiency
4914142|NCT02023645|aging|aging
4914143|NCT02023632|older adults|older adults
4914144|NCT02023632|physical activity|physical activity
4914145|NCT02023632|self-categorization|self-categorization
4914146|NCT02023632|group dynamics|group dynamics
4914147|NCT02023632|self-identity|self-identity
4914148|NCT02023619|Keratoconus|keratoconus
4914149|NCT02023619|Astigmatism|astigmatism
4914150|NCT02023619|Cornea|cornea
4914151|NCT02023619|SD-OCT|sd-oct
4914152|NCT02023606|Impulsive Aggression|impulsive aggression
4914153|NCT02023606|ADHD|adhd
4914154|NCT02023580|Viral suppression|viral suppression
4914155|NCT02023580|Sexual risk|sexual risk
4914156|NCT02023554|azithromycin|azithromycin
4914157|NCT02023554|theophylline|theophylline
4914158|NCT02023554|CYP3A4|cyp3a4
4914159|NCT02023515|weight loss|weight loss
4914160|NCT02023515|metabolic syndrome|metabolic syndrome
4914161|NCT02023515|stress|stress
4914162|NCT02023515|obesity|obesity
4914163|NCT02023502|female stress urinary incontinence|female stress urinary incontinence
4914164|NCT02023502|proteomics|proteomics
4914165|NCT02023502|biomarker|biomarker
4914166|NCT02023424|BDNF|bdnf
4914167|NCT02023424|GLATIRAMER ACETATE|glatiramer acetate
4914168|NCT02023424|RETT SYNDROME|rett syndrome
4914169|NCT02023424|COPAXONE|copaxone
4914170|NCT02023424|Bruria Ben-Zeev|bruria ben-zeev
4914171|NCT02023411|Teriparatide|teriparatide
4914172|NCT02023411|Inactive Charcot's neuroarthropathy|inactive charcot's neuroarthropathy
4914173|NCT02023398|High Frequency|high frequency
4914174|NCT02023398|Waist circumferential reduction|waist circumferential reduction
4914175|NCT02023385|Low Level Laser Therapy|low level laser therapy
4914176|NCT02023385|LLLT|lllt
4914177|NCT02023385|Waist circumferential reduction|waist circumferential reduction
4914178|NCT02023372|NuCel|nucel
4914179|NCT02023372|Lumbar Spine|lumbar spine
4914180|NCT02023372|Degenerative Disease|degenerative disease
4914181|NCT02023372|Efficacy|efficacy
4914182|NCT02023372|Fusion|fusion
4914183|NCT02023359|Advanced breast cancer|advanced breast cancer
4914184|NCT02023359|Everolimus|everolimus
4914185|NCT02023346|Patient-Physician Communication|patient-physician communication
4914186|NCT02023346|Brain cancer|brain cancer
4914187|NCT02023346|13-253|13-253
4914188|NCT02023333|Regorafenib|regorafenib
4914189|NCT02023333|Performance Status|performance status
4914190|NCT02023333|13-211|13-211
4914191|NCT02023281|Depression|depression
4914192|NCT02023281|Exercise|exercise
4914193|NCT02023281|Neurotransmitters|neurotransmitters
4914194|NCT02023281|Catecholimines|catecholimines
4914195|NCT02023281|EEG|eeg
4914196|NCT02023255|Healthy|healthy
4914197|NCT02023255|JNJ-39393406|jnj-39393406
4914198|NCT02023255|Safety|safety
4914199|NCT02023255|Tolerability|tolerability
4914200|NCT02023255|Pharmacokinetics|pharmacokinetics
4914201|NCT02023242|Primary open angle glaucoma|primary open angle glaucoma
4914202|NCT02023242|POAG|poag
4914203|NCT02023242|Pseudoexfoliative glaucoma|pseudoexfoliative glaucoma
4914204|NCT02023242|PXG|pxg
4914205|NCT02023242|Pigmentary glaucoma|pigmentary glaucoma
4914206|NCT02023242|PG|pg
4914207|NCT02023242|Hydrus|hydrus
4914208|NCT02023229|Branched chain aminoacids|branched chain aminoacids
4914209|NCT02023229|Nutritional status|nutritional status
4914210|NCT02023229|Hepatic encephalopathy|hepatic encephalopathy
4914211|NCT02023216|Preterm infants|preterm infants
4914212|NCT02023216|Non-nutritive sucking|non-nutritive sucking
4914213|NCT02023216|Pacifier|pacifier
4914214|NCT02023216|Gastro-esophageal reflux|gastro-esophageal reflux
4914215|NCT02023216|pH-multiple intraluminal impedance|ph-multiple intraluminal impedance
4914216|NCT02023216|Apneas|apneas
4914217|NCT02023216|Bradycardias|bradycardias
4914218|NCT02023216|Hypoxic episodes|hypoxic episodes
4914219|NCT02023216|Polysomnographic monitoring|polysomnographic monitoring
4914220|NCT02023190|liver cirrhosis|liver cirrhosis
4914221|NCT02023190|liver transplant|liver transplant
4914222|NCT02023190|nutritional status|nutritional status
4914223|NCT02023190|bioelectrical impedance vector analysis|bioelectrical impedance vector analysis
4914224|NCT02023177|phase angle|phase angle
4914225|NCT02023177|liver cirrhosis|liver cirrhosis
4914226|NCT02023177|mortality|mortality
4914227|NCT02023177|malnutrition|malnutrition
4914228|NCT02023138|Clinical practice guideline|clinical practice guideline
4914229|NCT02023138|Brain injury|brain injury
4914230|NCT02023138|Acceptability|acceptability
4914231|NCT02023138|Feasibility|feasibility
4914232|NCT02023138|Effectiveness|effectiveness
4914233|NCT02023112|Japanese|japanese
4914234|NCT02023112|Hepatitis C|hepatitis c
4914235|NCT02023112|Treatment naive|treatment naive
4914236|NCT02023112|Treatment experienced|treatment experienced
4914237|NCT02023112|Genotype 2|genotype 2
4914238|NCT02023112|Ombitasvir|ombitasvir
4914239|NCT02023112|Paritaprevir|paritaprevir
4914240|NCT02023112|Ritonavir|ritonavir
4914241|NCT02023112|Ribavirin|ribavirin
4914242|NCT02023112|VIEKIRAX Combination Tablets|viekirax combination tablets
4914243|NCT02023099|Hepatitis C|hepatitis c
4914244|NCT02023099|Genotype 1b|genotype 1b
4914245|NCT02023099|Cirrhotic|cirrhotic
4914246|NCT02023099|Treatment Experienced|treatment experienced
4914247|NCT02023099|Treatment Naive|treatment naive
4914248|NCT02023099|Japanese|japanese
4914249|NCT02023099|ombitasvir|ombitasvir
4914250|NCT02023099|paritaprevir|paritaprevir
4914251|NCT02023099|ritonavir|ritonavir
4914252|NCT02023099|VIEKIRAX Combination Tablets|viekirax combination tablets
4914253|NCT02023086|Visual field defect|visual field defect
4914254|NCT02023086|Blood oxygenation|blood oxygenation
4914255|NCT02023086|Optic nerve Head|optic nerve head
4914256|NCT02023047|Anal Fissure|anal fissure
4914257|NCT02023047|Nifedipine|nifedipine
4914258|NCT02023034|Parkinson's disease, Physical Therapy, Fatigue, Quality of Life|parkinson's disease, physical therapy, fatigue, quality of life
4914382|NCT02022410|TKA|tka
4914259|NCT02023021|Pancreatic Cancer; Pancreatic Adenocarcinoma; Nab-paclitaxel; Gemcitabine; Adjuvant Therapy|pancreatic cancer; pancreatic adenocarcinoma; nab-paclitaxel; gemcitabine; adjuvant therapy
4914260|NCT02022995|EGFR|egfr
4914261|NCT02022995|cetuximab|cetuximab
4914262|NCT02022995|colon cancer|colon cancer
4914263|NCT02022982|KRAS mutant Non-Small Cell Lung Cancer|kras mutant non-small cell lung cancer
4914264|NCT02022982|Solid Tumors|solid tumors
4914265|NCT02022969|atelectasis|atelectasis
4914266|NCT02022969|SPO2 - oscillations|spo2 - oscillations
4914267|NCT02022943|Alzheimer's|alzheimer's
4914268|NCT02022943|prevention|prevention
4914269|NCT02022930|Osteoarthritis|osteoarthritis
4914270|NCT02022930|Knee|knee
4914271|NCT02022917|ovarian cancer.|ovarian cancer.
4914272|NCT02022917|tubal cancer|tubal cancer
4914273|NCT02022917|peritoneal cancer|peritoneal cancer
4914274|NCT02022904|prostate cancer|prostate cancer
4914275|NCT02022904|metastatic|metastatic
4914276|NCT02022904|castrate resistant|castrate resistant
4914277|NCT02022891|Sickle cell disease|sickle cell disease
4914278|NCT02022891|psychological support|psychological support
4914279|NCT02022891|quality of life|quality of life
4914280|NCT02022878|Chronic total occlusion|chronic total occlusion
4914281|NCT02022878|Percutaneous coronary intervention|percutaneous coronary intervention
4914282|NCT02022878|Coronary computed tomography angiography|coronary computed tomography angiography
4914283|NCT02022878|Coronary angiography|coronary angiography
4914284|NCT02022865|periodontitis|periodontitis
4914285|NCT02022865|cytokines|cytokines
4914286|NCT02022865|adverse pregnancy outcome|adverse pregnancy outcome
4914287|NCT02022852|Rectal Cancer|rectal cancer
4914288|NCT02022852|Concurrent Chemoradiotherapy|concurrent chemoradiotherapy
4914289|NCT02022852|Sequential Therapy|sequential therapy
4914290|NCT02022839|mechanical ventilation, weaning|mechanical ventilation, weaning
4914291|NCT02022839|ultrasonography|ultrasonography
4914292|NCT02022826|Gastroparesis|gastroparesis
4914293|NCT02022826|SmartPill Monitoring System (SPM)|smartpill monitoring system (spm)
4914294|NCT02022826|Gastric Emptying Scintigraphy (GES)|gastric emptying scintigraphy (ges)
4914295|NCT02022813|Energy requirements, Glucose turnover, Protein turnover|energy requirements, glucose turnover, protein turnover
4914296|NCT02022787|RCC|rcc
4914297|NCT02022787|Chemokines|chemokines
4914298|NCT02022787|nephrectomy|nephrectomy
4914299|NCT02022787|partial nephrectomy|partial nephrectomy
4914300|NCT02022761|Mild or moderate asthmatics|mild or moderate asthmatics
4914301|NCT02022761|Adults|adults
4914302|NCT02022761|Laninamivir|laninamivir
4914303|NCT02022735|Deep Brain Stimulation|deep brain stimulation
4914304|NCT02022722|Pelvic Floor Myalgia|pelvic floor myalgia
4914305|NCT02022722|Trigger Point Injections|trigger point injections
4914306|NCT02022722|Pelvic Rehabilitation|pelvic rehabilitation
4914307|NCT02022722|Dyspareunia|dyspareunia
4914308|NCT02022709|Cognitive Behavior Therapy|cognitive behavior therapy
4914309|NCT02022709|Exposure and Response/Ritual Prevention|exposure and response/ritual prevention
4914310|NCT02022709|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors
4914311|NCT02022709|Psychotherapy|psychotherapy
4914312|NCT02022709|Pharmacotherapy|pharmacotherapy
4914313|NCT02022709|Citalopram|citalopram
4914314|NCT02022709|Fluoxetine|fluoxetine
4914315|NCT02022709|Paroxetine|paroxetine
4914316|NCT02022709|Sertraline|sertraline
4914317|NCT02022709|Fluvoxamine|fluvoxamine
4914318|NCT02022709|fMRI|fmri
4914319|NCT02022709|Stop Signal Task|stop signal task
4914320|NCT02022696|Adenosine Deaminase Deficiency|adenosine deaminase deficiency
4914321|NCT02022696|Gene Therapy|gene therapy
4914322|NCT02022696|Lentiviral Vectors|lentiviral vectors
4914323|NCT02022683|Endoscopic lung volume reduction|endoscopic lung volume reduction
4914324|NCT02022683|Endobronchial valves|endobronchial valves
4914325|NCT02022670|endothelial function|endothelial function
4914326|NCT02022670|arterial stiffness|arterial stiffness
4914327|NCT02022670|flow-mediated dilation|flow-mediated dilation
4914328|NCT02022670|pulse wave velocity|pulse wave velocity
4914329|NCT02022670|sodium nitrite|sodium nitrite
4914330|NCT02022670|aging|aging
4914331|NCT02022670|vascular diseases|vascular diseases
4914332|NCT02022657|Pre exposure prophylaxis|pre exposure prophylaxis
4914333|NCT02022657|Dried blood spots|dried blood spots
4914334|NCT02022618|Hypertension|hypertension
4914335|NCT02022618|Target organ damage|target organ damage
4914336|NCT02022618|polymorphism|polymorphism
4914337|NCT02022618|Hypertensive patients|hypertensive patients
4914536|NCT02021682|Alzheimer's|alzheimer's
4914338|NCT02022605|ERCP, trainning, trainees, EMS|ercp, trainning, trainees, ems
4914339|NCT02022579|Breast Cancer|breast cancer
4914340|NCT02022579|Diagnosis|diagnosis
4914341|NCT02022579|Malignant|malignant
4914342|NCT02022579|Benign|benign
4914343|NCT02022579|Biopsy|biopsy
4914344|NCT02022566|Osteoarthritis knee|osteoarthritis knee
4914345|NCT02022566|Osteoarthritis hip|osteoarthritis hip
4914346|NCT02022566|Physical activity|physical activity
4914347|NCT02022566|accelerometer|accelerometer
4914348|NCT02022553|rectal cancer|rectal cancer
4914349|NCT02022553|RACHEL|rachel
4914350|NCT02022553|oil chemoembolization|oil chemoembolization
4914351|NCT02022540|Neovascular Age-Related Macular Degeneration|neovascular age-related macular degeneration
4914352|NCT02022540|AMD|amd
4914353|NCT02022540|Macular Degeneration|macular degeneration
4914354|NCT02022540|Age-Related Macular Degeneration|age-related macular degeneration
4914355|NCT02022540|wet AMD|wet amd
4914356|NCT02022540|neovascular AMD|neovascular amd
4914357|NCT02022540|exudative AMD|exudative amd
4914358|NCT02022527|Cost-Effectiveness,|cost-effectiveness,
4914359|NCT02022527|Heart valve prosthesis|heart valve prosthesis
4914360|NCT02022527|Warfarin,|warfarin,
4914361|NCT02022527|Aspirin,|aspirin,
4914362|NCT02022527|Egypt|egypt
4914363|NCT02022501|Macular Degeneration|macular degeneration
4914364|NCT02022488|Child|child
4914365|NCT02022488|Sevoflurane|sevoflurane
4914366|NCT02022488|Emergence delirium|emergence delirium
4914367|NCT02022488|General anesthesia|general anesthesia
4914368|NCT02022488|Premedication.|premedication.
4914369|NCT02022475|vitamin D|vitamin d
4914370|NCT02022475|fatigue|fatigue
4914371|NCT02022462|Serious mental illnesses|serious mental illnesses
4914372|NCT02022462|peer navigator|peer navigator
4914373|NCT02022462|integrated health care|integrated health care
4914374|NCT02022449|Maternal depression|maternal depression
4914375|NCT02022449|Maternal psychosocial stress and distress|maternal psychosocial stress and distress
4914376|NCT02022449|Maternal health outcomes|maternal health outcomes
4914377|NCT02022449|Social support|social support
4914378|NCT02022449|Pediatric cancer|pediatric cancer
4914379|NCT02022410|CAS|cas
4914380|NCT02022410|Length of stay|length of stay
4914381|NCT02022410|Rehabilitation localisation|rehabilitation localisation
4914383|NCT02022397|tracheal intubation|tracheal intubation
4914384|NCT02022397|predicting difficult intubation|predicting difficult intubation
4914385|NCT02022397|general anesthesia|general anesthesia
4914386|NCT02022397|difficult ventilation|difficult ventilation
4914387|NCT02022384|Malignant glioma|malignant glioma
4914388|NCT02022384|Anaplastic astrocytoma|anaplastic astrocytoma
4914389|NCT02022384|Glioblastoma multiforme|glioblastoma multiforme
4914390|NCT02022384|Immune|immune
4914391|NCT02022384|Immunophenotyping|immunophenotyping
4914392|NCT02022384|Immune cells|immune cells
4914393|NCT02022384|activation state|activation state
4914394|NCT02022384|Quality of live|quality of live
4914395|NCT02022384|translational research|translational research
4914396|NCT02022358|Osteosarcoma|osteosarcoma
4914397|NCT02022358|Methotrexate|methotrexate
4914398|NCT02022358|Glucarpidase|glucarpidase
4914399|NCT02022358|Mucositis|mucositis
4914400|NCT02022345|Percutaneous Coronary Intervention|percutaneous coronary intervention
4914401|NCT02022345|Coronary Artery Disease|coronary artery disease
4914402|NCT02022345|Angioplasty|angioplasty
4914403|NCT02022345|Offsite cardiac surgery|offsite cardiac surgery
4914404|NCT02022345|Heart disease|heart disease
4914405|NCT02022345|Ischemic Heart Disease|ischemic heart disease
4914406|NCT02022306|Hepatitis C|hepatitis c
4914407|NCT02022293|Nasopharyngeal Carcinoma|nasopharyngeal carcinoma
4914408|NCT02022293|Radiotherapy|radiotherapy
4914409|NCT02022293|Carotid Stenosis|carotid stenosis
4914410|NCT02022293|Atorvastatin|atorvastatin
4914411|NCT02022267|clubfoot|clubfoot
4914412|NCT02022267|gait analysis|gait analysis
4914413|NCT02022267|outcome questionaire|outcome questionaire
4914414|NCT02022267|Ponseti method|ponseti method
4914415|NCT02022241|Ovarian Hyperstimulation Syndrome|ovarian hyperstimulation syndrome
4914416|NCT02022241|Luteinizing Hormone|luteinizing hormone
4914417|NCT02022241|Polycystic Ovarian Syndrome|polycystic ovarian syndrome
4914418|NCT02022241|Ovarian Yield|ovarian yield
4914419|NCT02022241|Ovarian Maturity|ovarian maturity
4914420|NCT02022228|Ovarian Hyperstimulation Syndrome|ovarian hyperstimulation syndrome
4914421|NCT02022228|Luteinizing Hormone|luteinizing hormone
4914422|NCT02022228|Polycystic Ovarian Syndrome|polycystic ovarian syndrome
4914423|NCT02022228|Ovarian Yield|ovarian yield
4914424|NCT02022228|Ovarian Maturity|ovarian maturity
4914425|NCT02022228|Gonadotropin Releasing Hormone Agonist|gonadotropin releasing hormone agonist
4914426|NCT02022228|Human Chorionic Gonadotropin|human chorionic gonadotropin
4914427|NCT02022189|Dent|dent
4914428|NCT02022189|Dents|dents
4914429|NCT02022189|Dent Disease|dent disease
4914430|NCT02022189|Renal Biopsy|renal biopsy
4914431|NCT02022189|Kidney Biopsy|kidney biopsy
4914432|NCT02022189|Clinical Biopsy|clinical biopsy
4914433|NCT02022176|Nitrate|nitrate
4914434|NCT02022176|Nitrite|nitrite
4914435|NCT02022176|Nitric oxide|nitric oxide
4914436|NCT02022176|Resting metabolic rate|resting metabolic rate
4914437|NCT02022176|Glucose uptake|glucose uptake
4914438|NCT02022176|Insulin sensitivity|insulin sensitivity
4914439|NCT02022176|Reactive oxygen species production|reactive oxygen species production
4914440|NCT02022176|inorganic nitrate|inorganic nitrate
4914441|NCT02022176|Sodium nitrite infusion|sodium nitrite infusion
4914442|NCT02022163|Influenza, Human|influenza, human
4914443|NCT02022163|RNA Virus Infections|rna virus infections
4914444|NCT02022163|Respiratory Tract Diseases|respiratory tract diseases
4914445|NCT02022163|Respiratory Tract Infections|respiratory tract infections
4914446|NCT02022163|Aluminum Hydroxide|aluminum hydroxide
4914447|NCT02022163|Adjuvants, Immunologic|adjuvants, immunologic
4914448|NCT02022163|Immunogenic Factors|immunogenic factors
4914449|NCT02022163|Physiological Effects of Drugs|physiological effects of drugs
4914450|NCT02022163|Virus Diseases|virus diseases
4914451|NCT02022163|Orthomyxoviridae Infections|orthomyxoviridae infections
4914452|NCT02022163|Infection|infection
4914453|NCT02022150|Paracentesis|paracentesis
4914454|NCT02022150|Liver Cirrhosis|liver cirrhosis
4914455|NCT02022150|ascites|ascites
4914456|NCT02022150|body composition|body composition
4914457|NCT02022137|Minimal hepatic encephalopathy|minimal hepatic encephalopathy
4914458|NCT02022137|Hepatic encephalopathy|hepatic encephalopathy
4914459|NCT02022124|chronic low back pain|chronic low back pain
4914460|NCT02022124|open-label placebo|open-label placebo
4914461|NCT02022046|chronic kidney disease|chronic kidney disease
4914462|NCT02022046|cardiovascular disease|cardiovascular disease
4914463|NCT02022046|nitric oxide|nitric oxide
4914464|NCT02022046|homocysteine|homocysteine
4914465|NCT02022046|asymmetric dimethylarginine|asymmetric dimethylarginine
4914466|NCT02022046|methylation|methylation
4914467|NCT02022033|Pancreatic Cancer|pancreatic cancer
4914468|NCT02022033|Adjuvant|adjuvant
4914469|NCT02022033|Pancreas|pancreas
4914470|NCT02022033|Resected|resected
4914471|NCT02022033|Invasive adenocarcinoma|invasive adenocarcinoma
4914472|NCT02022033|adenosquamous cancer|adenosquamous cancer
4914473|NCT02022033|Intraductal papillary mucinous neoplasm|intraductal papillary mucinous neoplasm
4914474|NCT02022007|PCOS|pcos
4914475|NCT02022007|IGT|igt
4914476|NCT02022007|DPP-4 inhibitor|dpp-4 inhibitor
4914477|NCT02021981|Quality Improvement|quality improvement
4914478|NCT02021981|Primary Care|primary care
4914479|NCT02021981|Blood Pressure, High|blood pressure, high
4914480|NCT02021981|Feedback|feedback
4914481|NCT02021981|Knowledge|knowledge
4914482|NCT02021955|randomized controlled trial|randomized controlled trial
4914483|NCT02021955|quality of life|quality of life
4914484|NCT02021955|patient readmission|patient readmission
4914485|NCT02021955|mortality|mortality
4914486|NCT02021955|patient satisfaction|patient satisfaction
4914487|NCT02021955|intervention studies|intervention studies
4914488|NCT02021955|multicenter study|multicenter study
4914489|NCT02021942|primary inoperable thymoma|primary inoperable thymoma
4914490|NCT02021942|local recurrent thymoma|local recurrent thymoma
4914491|NCT02021942|reduction of tumor size|reduction of tumor size
4914492|NCT02021942|SOM230 LAR|som230 lar
4914493|NCT02021929|Randomized Controlled Trial|randomized controlled trial
4914494|NCT02021929|Clinical Trial|clinical trial
4914495|NCT02021929|sorafenib|sorafenib
4914496|NCT02021929|Hepatopulmonary Syndrome|hepatopulmonary syndrome
4914497|NCT02021903|arterial hypotension|arterial hypotension
4914498|NCT02021903|postprandial sleepiness|postprandial sleepiness
4914499|NCT02021903|orthostatic hypotension|orthostatic hypotension
4914500|NCT02021903|synucleinopathies|synucleinopathies
4914501|NCT02021903|hyperglycemia|hyperglycemia
4914502|NCT02021890|Dance|dance
4914503|NCT02021890|Physical activity|physical activity
4914504|NCT02021890|Physical fitness|physical fitness
4914505|NCT02021890|Weight loss|weight loss
4914506|NCT02021877|Brain trauma|brain trauma
4914507|NCT02021877|ICP measurement|icp measurement
4914508|NCT02021877|cranial CT / MRI|cranial ct / mri
4914509|NCT02021877|Glasgow Coma Score|glasgow coma score
4914510|NCT02021877|acute TBI|acute tbi
4914511|NCT02021877|EEG|eeg
4914512|NCT02021877|metabolic, proteomic, and genetic biomarkers of TBIs|metabolic, proteomic, and genetic biomarkers of tbis
4914513|NCT02021877|injury mechanism|injury mechanism
4914514|NCT02021864|hypocalcemia, pregnancy, vitamin D|hypocalcemia, pregnancy, vitamin d
4914515|NCT02021851|Dexamethasone,|dexamethasone,
4914516|NCT02021851|Ondansetron|ondansetron
4914517|NCT02021851|Aprepitant|aprepitant
4914518|NCT02021851|PONV|ponv
4914519|NCT02021851|Laparoscopic surgery|laparoscopic surgery
4914520|NCT02021838|domestic violence homicide prevention|domestic violence homicide prevention
4914521|NCT02021825|mitoxantrone|mitoxantrone
4914522|NCT02021825|neuromyelitis optica|neuromyelitis optica
4914523|NCT02021825|relapse|relapse
4914524|NCT02021799|Gut microbiome|gut microbiome
4914525|NCT02021799|Vaginal microbiome|vaginal microbiome
4914526|NCT02021799|Oral microbiome|oral microbiome
4914527|NCT02021799|Human milk microbiome|human milk microbiome
4914528|NCT02021799|Nutritional Status|nutritional status
4914529|NCT02021773|Headache|headache
4914530|NCT02021773|Migraine|migraine
4914531|NCT02021773|Chronic Migraine|chronic migraine
4914532|NCT02021682|Aβ|aβ
4914533|NCT02021682|ABeta|abeta
4914534|NCT02021682|ABeta kinetics|abeta kinetics
4914535|NCT02021682|Alzheimer's Disease|alzheimer's disease
4914537|NCT02021682|amyloid beta|amyloid beta
4914538|NCT02021682|biomarker|biomarker
4914539|NCT02021682|dementia|dementia
4914540|NCT02021682|PET/PIB|pet/pib
4914541|NCT02021669|Antidepressive agents|antidepressive agents
4914542|NCT02021669|Coronary disease|coronary disease
4914543|NCT02021669|Depression|depression
4914544|NCT02021669|Depressive disorder|depressive disorder
4914545|NCT02021669|Fatty Acids, Omega-3|fatty acids, omega-3
4914546|NCT02021630|Obesity|obesity
4914547|NCT02021630|Bariatric Surgery|bariatric surgery
4914548|NCT02021630|Weight Loss|weight loss
4914549|NCT02021630|Physical Activity|physical activity
4914550|NCT02021630|Body Composition|body composition
4914551|NCT02021617|Intraosseous Access|intraosseous access
4914552|NCT02021617|EZ-IO|ez-io
4914553|NCT02021604|Congenital Hyperinsulinism|congenital hyperinsulinism
4914554|NCT02021604|HI|hi
4914555|NCT02021604|Hypoglycemia|hypoglycemia
4914556|NCT02021604|FDOPA|fdopa
4914557|NCT02021604|18F-DOPA|18f-dopa
4914558|NCT02021604|Hyperinsulinism|hyperinsulinism
4914559|NCT02021591|Diabetes|diabetes
4914560|NCT02021591|Chronic disease|chronic disease
4914561|NCT02021591|problem solving|problem solving
4914562|NCT02021591|self management|self management
4914563|NCT02021578|Depression|depression
4914564|NCT02021578|Mood disorder|mood disorder
4914565|NCT02021565|Caregivers|caregivers
4914566|NCT02021565|Activities of Daily Living|activities of daily living
4914567|NCT02021565|Dementia|dementia
4914568|NCT02021565|Veterans|veterans
4914569|NCT02021565|Self-Help Devices|self-help devices
4914570|NCT02021565|Telemedicine|telemedicine
4914571|NCT02021552|Trauma|trauma
4914572|NCT02021552|Sepsis|sepsis
4914573|NCT02021539|Elastography of the cervix|elastography of the cervix
4914574|NCT02021539|Cervical elastography|cervical elastography
4914575|NCT02021539|Predicting delivery|predicting delivery
4914576|NCT02021526|G1D|g1d
4914577|NCT02021526|Glut1 Deficiency|glut1 deficiency
4914578|NCT02021526|Glucose Transporter Type 1 Deficiency|glucose transporter type 1 deficiency
4914579|NCT02021526|Glucose Transporter Type I Deficiency|glucose transporter type i deficiency
4914580|NCT02021513|SLE|sle
4914581|NCT02021513|Fish Oil|fish oil
4914582|NCT02021513|Omega-3|omega-3
4914583|NCT02021448|OHS|ohs
4914584|NCT02021422|metastatic pancreatic ductal adenocarcinoma (PDAC)|metastatic pancreatic ductal adenocarcinoma (pdac)
4914585|NCT02021422|pancreatic cancer|pancreatic cancer
4914586|NCT02021422|pancreas cancer|pancreas cancer
4914587|NCT02021422|pancreatic adenocarcinoma|pancreatic adenocarcinoma
4914588|NCT02021422|metastatic pancreas cancer|metastatic pancreas cancer
4914589|NCT02021422|metastatic pancreatic cancer|metastatic pancreatic cancer
4914590|NCT02021409|Anemia on CKD|anemia on ckd
4914591|NCT02021396|splenic rescue; splenectomy|splenic rescue; splenectomy
4914592|NCT02021383|Weight loss|weight loss
4914593|NCT02021383|Weight maintenance|weight maintenance
4914594|NCT02021383|Contingency Management|contingency management
4914595|NCT02021383|College students|college students
4914596|NCT02021383|Financial incentives|financial incentives
4914597|NCT02021370|Anemia of CKD|anemia of ckd
4914598|NCT02021357|Facial Pain|facial pain
4914599|NCT02021357|Physical Therapy Modalities|physical therapy modalities
4914600|NCT02021357|Temporomandibular Joint Disorders|temporomandibular joint disorders
4914601|NCT02021357|Exercise Therapy|exercise therapy
4914602|NCT02021331|jaw, edentulous, partially|jaw, edentulous, partially
4914603|NCT02021318|Non-dialysis|non-dialysis
4914604|NCT02021318|Roxadustat|roxadustat
4914605|NCT02021318|ASP1517|asp1517
4914606|NCT02021318|Chronic Kidney Disease (CKD)|chronic kidney disease (ckd)
4914607|NCT02021318|Anemia|anemia
4914608|NCT02021318|Hemoglobin|hemoglobin
4914609|NCT02021305|Toll like Receptors|toll like receptors
4914610|NCT02021305|TLR 4|tlr 4
4914611|NCT02021305|Urinary track infections in children|urinary track infections in children
4914612|NCT02021305|TLR 4 polymorphisms|tlr 4 polymorphisms
4914613|NCT02021305|Innate immunity|innate immunity
4914614|NCT02021305|Defence mechanisms|defence mechanisms
4914615|NCT02021305|Immune responses|immune responses
4914616|NCT02021292|Chronic thromboembolic pulmonary hypertension (CTEPH)|chronic thromboembolic pulmonary hypertension (cteph)
4914617|NCT02021279|pelvic organ prolapse|pelvic organ prolapse
4914618|NCT02021279|MatriStem|matristem
4914619|NCT02021279|pelvic floor matrix|pelvic floor matrix
4914620|NCT02021279|ACell|acell
4914621|NCT02021279|native tissue repair|native tissue repair
4914622|NCT02021253|Endotoxemia|endotoxemia
4914623|NCT02021253|Probiotic|probiotic
4914624|NCT02021253|Leaky gut|leaky gut
4914625|NCT02021253|Gut permeability|gut permeability
4914626|NCT02021253|Liver cirrhosis|liver cirrhosis
4914627|NCT02021253|Liver fibrosis|liver fibrosis
4914628|NCT02021253|Hepatocellular carcinoma|hepatocellular carcinoma
4914629|NCT02021227|Acute respiratory failure|acute respiratory failure
4914630|NCT02021227|Mechanical ventilation|mechanical ventilation
4914631|NCT02021227|Rehabilitation|rehabilitation
4914632|NCT02021227|Exercise chair sitting|exercise chair sitting
4914633|NCT02021227|Weaning|weaning
4914634|NCT02021227|Chronic respiratory failure|chronic respiratory failure
4914635|NCT02021214|Methylphenidate|methylphenidate
4914636|NCT02021214|Fear extinction|fear extinction
4914637|NCT02021214|fMRI|fmri
4914638|NCT02021214|mPFC|mpfc
4914639|NCT02021188|Vascular inflammation|vascular inflammation
4914640|NCT02021188|Atherosclerosis|atherosclerosis
4914641|NCT02021188|Positron Emission Tomography|positron emission tomography
4914642|NCT02021188|Molecular Imaging|molecular imaging
4914643|NCT02021188|68Ga-DOTATATE|68ga-dotatate
4914644|NCT02021175|Smoking Cessation|smoking cessation
4914645|NCT02021175|Korean|korean
4914646|NCT02021175|Youth|youth
4914647|NCT02021175|Adolescent|adolescent
4914648|NCT02021175|Dependence|dependence
4914649|NCT02021175|Teen Smoking|teen smoking
4914650|NCT02021175|Smoking and Youth|smoking and youth
4914651|NCT02021175|Youth and Tobacco|youth and tobacco
4914652|NCT02021175|Cognitive-Behavioral Motivational Enhancement|cognitive-behavioral motivational enhancement
4914653|NCT02021175|Technology|technology
4914654|NCT02021175|Nicotine Dependence|nicotine dependence
4914655|NCT02021175|Cell Phone|cell phone
4914656|NCT02021175|Smart Phone|smart phone
4914657|NCT02021175|Internet|internet
4914658|NCT02021175|Web|web
4914659|NCT02021162|Multiple sclerosis|multiple sclerosis
4914660|NCT02021162|Gilenya|gilenya
4914661|NCT02021162|Healthy controls|healthy controls
4914662|NCT02021162|Thalamic atrophy|thalamic atrophy
4914663|NCT02021162|MRI|mri
4914664|NCT02021149|Major Depressive Disorder|major depressive disorder
4914665|NCT02021149|Whole Body Hyperthermia|whole body hyperthermia
4914666|NCT02021149|Psychotherapy|psychotherapy
4914667|NCT02021149|Therapist and patient alliance|therapist and patient alliance
4914668|NCT02021123|Anidulafungin|anidulafungin
4914669|NCT02021123|Gastric bypass|gastric bypass
4914670|NCT02021123|Morbidly obese|morbidly obese
4914671|NCT02021123|Pharmacokinetics|pharmacokinetics
4914672|NCT02021123|Prophylaxis|prophylaxis
4914673|NCT02021123|Yeast infection|yeast infection
4914674|NCT02021097|Levonorgestrel；|levonorgestrel；
4914675|NCT02021097|Ethinyl Estradiol；|ethinyl estradiol；
4914676|NCT02021097|Oral Contraceptive|oral contraceptive
4914677|NCT02021084|Familial Mediterranean Fever (FMF), probiotics|familial mediterranean fever (fmf), probiotics
4914678|NCT02021032|BPH|bph
4914679|NCT02021006|antibiotic prophylaxis|antibiotic prophylaxis
4914680|NCT02021006|vesicoureteral reflux|vesicoureteral reflux
4914681|NCT02021006|congenital abnormalities of kidney|congenital abnormalities of kidney
4914682|NCT02021006|renal hypodysplasia|renal hypodysplasia
4914683|NCT02021006|chronic kidney disease|chronic kidney disease
4914684|NCT02020993|Nt-proBNP, newborn, preterm|nt-probnp, newborn, preterm
4914685|NCT02020928|Oral Mucositis|oral mucositis
4914686|NCT02020928|chemotherapy|chemotherapy
4914687|NCT02020928|Bone Marrow Transplantation|bone marrow transplantation
4914688|NCT02020889|eosinophils|eosinophils
4914689|NCT02020889|SB 240563|sb 240563
4914690|NCT02020889|Churg-Strauss Syndrome|churg-strauss syndrome
4914691|NCT02020889|quality of life|quality of life
4914692|NCT02020889|mepolizumab|mepolizumab
4914693|NCT02020889|safety|safety
4914694|NCT02020889|biomarkers|biomarkers
4914695|NCT02020889|efficacy|efficacy
4914696|NCT02020889|corticosteroids|corticosteroids
4914697|NCT02020889|Eosinophilic granulomatosis with polyangiitis|eosinophilic granulomatosis with polyangiitis
4914698|NCT02020850|Toe-Brachial Index|toe-brachial index
4914699|NCT02020850|Ankle-Brachial Index|ankle-brachial index
4914700|NCT02020850|Systolic blood pressure|systolic blood pressure
4914701|NCT02020824|Acrophobia|acrophobia
4914702|NCT02020785|proteinuria|proteinuria
4914703|NCT02020772|primary health care|primary health care
4914704|NCT02020772|Physical Therapy Specialty|physical therapy specialty
4914705|NCT02020772|General Practitioners|general practitioners
4914706|NCT02020772|General Practice|general practice
4914707|NCT02020733|Hysterosalpingography|hysterosalpingography
4914708|NCT02020733|balloon catheter|balloon catheter
4914709|NCT02020733|metal cannula|metal cannula
4914710|NCT02020733|pain assessment|pain assessment
4914711|NCT02020694|Obesity|obesity
4914712|NCT02020694|Insulin resistance|insulin resistance
4914713|NCT02020694|Vitamin D|vitamin d
4914714|NCT02020694|Cardiovascular risk factors|cardiovascular risk factors
4914715|NCT02020681|Dental caries|dental caries
4914716|NCT02020681|Curodont Repair|curodont repair
4914717|NCT02020681|P11-4|p11-4
4914718|NCT02020668|Pain|pain
4914719|NCT02020668|Functional capacity|functional capacity
4914720|NCT02020668|Quality of Life|quality of life
4914721|NCT02020655|IL-1 alpha, Sebutape, shear- force|il-1 alpha, sebutape, shear- force
4914722|NCT02020642|polysomnography|polysomnography
4914723|NCT02020642|bioimpedance|bioimpedance
4914724|NCT02020642|leg fluid shift|leg fluid shift
4914725|NCT02020642|neck circumference|neck circumference
4914726|NCT02020642|Sleep Apnea Syndromes|sleep apnea syndromes
4914727|NCT02020642|Sleep Apnea, Obstructive|sleep apnea, obstructive
4914728|NCT02020642|Sleep Disorders, Intrinsic|sleep disorders, intrinsic
4914729|NCT02020642|Sleep Disorders|sleep disorders
4914730|NCT02020642|Apnea|apnea
4914731|NCT02020642|Kidney Diseases|kidney diseases
4914732|NCT02020642|Kidney Failure, Chronic|kidney failure, chronic
4914733|NCT02020642|Renal Insufficiency, Chronic|renal insufficiency, chronic
4914734|NCT02020642|Renal Insufficiency|renal insufficiency
4914735|NCT02020642|Dyssomnias|dyssomnias
4914736|NCT02020629|Glucagon|glucagon
4914737|NCT02020629|Hypoglycemia|hypoglycemia
4914738|NCT02020629|Counterregulation|counterregulation
4914739|NCT02020603|peptic ulcer bleeding|peptic ulcer bleeding
4914740|NCT02020603|hemostatic forceps|hemostatic forceps
4914741|NCT02020603|soft coagulation|soft coagulation
4914742|NCT02020603|argon plasma coagulation|argon plasma coagulation
4914743|NCT02020590|Delayed-Union Fractures|delayed-union fractures
4914744|NCT02020590|Impaired Healing|impaired healing
4914745|NCT02020590|Fractures|fractures
4914746|NCT02020590|Orthopedics|orthopedics
4914747|NCT02020590|Bone|bone
4914748|NCT02020590|Musculoskeletal Disorders|musculoskeletal disorders
4914749|NCT02020564|Processing Speed|processing speed
4914750|NCT02020564|Cognition|cognition
4914751|NCT02020564|Intervention|intervention
4914752|NCT02020564|Traumatic Brain Injury|traumatic brain injury
4914753|NCT02020564|Mild Cognitive Impairment|mild cognitive impairment
4914754|NCT02020551|Scores During IUD insertion.|scores during iud insertion.
4914755|NCT02020538|Thoracic surgery|thoracic surgery
4914756|NCT02020538|cardiac surgery|cardiac surgery
4914757|NCT02020538|acute kidney injury|acute kidney injury
4914758|NCT02020538|hyperchloremia|hyperchloremia
4914759|NCT02020538|intravenous fluid|intravenous fluid
4914760|NCT02020486|Healthy|healthy
4914761|NCT02020473|Informed consents|informed consents
4914762|NCT02020473|Withholding/withdrawing life support (WLS)|withholding/withdrawing life support (wls)
4914763|NCT02020473|Intensive care unit (ICU)|intensive care unit (icu)
4914764|NCT02020460|post-laminectomy pain syndrome,|post-laminectomy pain syndrome,
4914765|NCT02020460|refractory,|refractory,
4914766|NCT02020460|refractory chronic neuropathic pain,|refractory chronic neuropathic pain,
4914767|NCT02020460|failed back surgery syndrome.|failed back surgery syndrome.
4914768|NCT02020421|ischemic stroke|ischemic stroke
4914769|NCT02020421|rehabilitation|rehabilitation
4914770|NCT02020421|aphasia|aphasia
4914771|NCT02020421|non-invasive brain stimulation|non-invasive brain stimulation
4914772|NCT02020382|microRNAs|micrornas
4914774|NCT02020382|Crohn's disease|crohn's disease
4914775|NCT02020382|Ulcerative colitis|ulcerative colitis
4914776|NCT02020382|colonic polyps screening|colonic polyps screening
4914777|NCT02020382|controls|controls
4914778|NCT02020356|Alzheimer's disease|alzheimer's disease
4914779|NCT02020356|Neuroleptics|neuroleptics
4914780|NCT02020356|Music therapy|music therapy
4914781|NCT02020330|falciparum, malaria|falciparum, malaria
4914782|NCT02020317|drug interactions|drug interactions
4914783|NCT02020317|Drug Monitoring|drug monitoring
4914784|NCT02020317|Potassium|potassium
4914785|NCT02020317|Hyperkalemia|hyperkalemia
4914786|NCT02020304|Combined spinal epidural duration|combined spinal epidural duration
4914787|NCT02020304|labor pain|labor pain
4914788|NCT02020291|Foxy-5|foxy-5
4914789|NCT02020291|Wnt-5A|wnt-5a
4914790|NCT02020278|Hyponatremia|hyponatremia
4914791|NCT02020278|Euvolemic|euvolemic
4914792|NCT02020278|Hypervolemic|hypervolemic
4914793|NCT02020278|Serum sodium|serum sodium
4914794|NCT02020278|Dilutional hyponatremia|dilutional hyponatremia
4914795|NCT02020278|Electrolyte abnormality|electrolyte abnormality
4914796|NCT02020278|Electrolyte imbalance|electrolyte imbalance
4914797|NCT02020278|Metabolic disease|metabolic disease
4914798|NCT02020278|Water-Electrolyte Imbalance|water-electrolyte imbalance
4914799|NCT02020265|stress and depression related symptoms|stress and depression related symptoms
4914800|NCT02020239|physical activity|physical activity
4914801|NCT02020239|females|females
4914802|NCT02020239|body composition|body composition
4914803|NCT02020226|TH-302|th-302
4914804|NCT02020226|Solid Tumors|solid tumors
4914805|NCT02020226|QTc|qtc
4914806|NCT02020226|Cardiac|cardiac
4914807|NCT02020226|Evofosfamide|evofosfamide
4914808|NCT02020213|successful percentage|successful percentage
4914809|NCT02020200|Bipolar Disorder|bipolar disorder
4914810|NCT02020200|Methylphenidate|methylphenidate
4914811|NCT02020200|Cognitive Function|cognitive function
4914812|NCT02020187|Congenital myopathy|congenital myopathy
4914813|NCT02020187|Exercise|exercise
4914814|NCT02020174|Preeclampsia|preeclampsia
4914815|NCT02020174|Eclampsia|eclampsia
4914816|NCT02020174|HELLP|hellp
4914817|NCT02020174|HELLP Syndrome|hellp syndrome
4914818|NCT02020174|Toxemia|toxemia
4914819|NCT02020174|Hypertensive Disorder of Pregnancy|hypertensive disorder of pregnancy
4914820|NCT02020174|Registry|registry
4914821|NCT02020174|Pregnancy Complication|pregnancy complication
4914822|NCT02020174|Pregnancy|pregnancy
4914823|NCT02020174|Maternal Death|maternal death
4914824|NCT02020174|Premature|premature
4914825|NCT02020174|High Blood Pressure|high blood pressure
4914826|NCT02020174|Hypertension|hypertension
4914827|NCT02020148|pregnancy|pregnancy
4914828|NCT02020148|oxytocin|oxytocin
4914829|NCT02020148|postpartum depression|postpartum depression
4914830|NCT02020148|depression|depression
4914831|NCT02020148|pregnant women|pregnant women
4914832|NCT02020148|mood|mood
4914833|NCT02020148|anxiety|anxiety
4914834|NCT02020148|hormones|hormones
4914835|NCT02020148|women's health|women's health
4914836|NCT02020148|mental health|mental health
4914837|NCT02020148|baby blues|baby blues
4914838|NCT02020148|mood disorders|mood disorders
4914839|NCT02020122|endogenous pain modulation|endogenous pain modulation
4914840|NCT02020122|coronary artery bypass grafting|coronary artery bypass grafting
4914841|NCT02020122|quantitative sensory testings|quantitative sensory testings
4914842|NCT02020122|duloxetine|duloxetine
4914843|NCT02020122|pregabalin|pregabalin
4914844|NCT02020122|preemptive treatment|preemptive treatment
4914845|NCT02020096|Lumbar plexus block|lumbar plexus block
4914846|NCT02020096|Ultrasound guidance|ultrasound guidance
4914847|NCT02020096|Nerve stimulator|nerve stimulator
4914848|NCT02020083|VIH ; Placental transfer ; Tenofovir ; Emtricitabine ; Membrane transporter|vih ; placental transfer ; tenofovir ; emtricitabine ; membrane transporter
4914849|NCT02020070|Ipilimumab|ipilimumab
4914850|NCT02020070|Degarelix|degarelix
4914851|NCT02020070|Radical Prostatectomy|radical prostatectomy
4914852|NCT02020070|13-134|13-134
4914853|NCT02020031|Revision knee joint|revision knee joint
4914854|NCT02020005|menthol cigarettes|menthol cigarettes
4914855|NCT02020005|smoking cessation|smoking cessation
4914856|NCT02019992|sepsis|sepsis
4914857|NCT02019992|mitochondrial DNA|mitochondrial dna
4914858|NCT02019992|systemic inflammation|systemic inflammation
4914859|NCT02019992|outcome|outcome
4914860|NCT02019979|non squamous|non squamous
4914861|NCT02019979|non small cell|non small cell
4914862|NCT02019979|lung cancer|lung cancer
4914863|NCT02019979|metformin|metformin
4914864|NCT02019927|NAION|naion
4914865|NCT02019927|Decreased vision|decreased vision
4914866|NCT02019927|Eye trauma|eye trauma
4914867|NCT02019927|TES|tes
4914868|NCT02019927|Electrical stimulation|electrical stimulation
4914869|NCT02019927|Multiple Sclerosis|multiple sclerosis
4914870|NCT02019927|Optic Neuritis|optic neuritis
4914871|NCT02019914|PTSD|ptsd
4914872|NCT02019914|CPAP|cpap
4914873|NCT02019914|OSA|osa
4914874|NCT02019901|Rheumatoid arthritis|rheumatoid arthritis
4914875|NCT02019901|Person-centered care|person-centered care
4914876|NCT02019901|Tight control|tight control
4914877|NCT02019888|Ear, Middle|ear, middle
4914878|NCT02019888|Ear, Inner|ear, inner
4914879|NCT02019888|Audiometry|audiometry
4914880|NCT02019888|Acoustic impedance tests|acoustic impedance tests
4914881|NCT02019875|Vitamin D|vitamin d
4914882|NCT02019875|CYP3A4|cyp3a4
4914883|NCT02019875|Calcium|calcium
4914884|NCT02019862|Total hip arthroplasty|total hip arthroplasty
4914885|NCT02019862|TRJ|trj
4914886|NCT02019862|PMCF|pmcf
4914887|NCT02019862|Hip stem|hip stem
4914888|NCT02019849|THA, Plasmafit®|tha, plasmafit®
4914889|NCT02019836|vit D; sepsis; newborn; maternal; neonatal|vit d; sepsis; newborn; maternal; neonatal
4914890|NCT02019823|SMS-text|sms-text
4914891|NCT02019823|mobile health|mobile health
4914892|NCT02019823|mHealth|mhealth
4914893|NCT02019823|treatment|treatment
4914894|NCT02019823|adherence|adherence
4914895|NCT02019797|aortic valve replacement|aortic valve replacement
4914896|NCT02019784|Cirrhosis|cirrhosis
4914897|NCT02019784|Hepatic encephalopathy|hepatic encephalopathy
4914898|NCT02019771|HIV Infection|hiv infection
4914899|NCT02019771|Men who have sex with men|men who have sex with men
4914900|NCT02019771|Chlamydia|chlamydia
4914901|NCT02019771|Gonorrhea|gonorrhea
4914902|NCT02019745|Live attenuated influenza virus (LAIV)|live attenuated influenza virus (laiv)
4914903|NCT02019745|Flu vaccine|flu vaccine
4914904|NCT02019745|FluMist|flumist
4914905|NCT02019745|Smokers|smokers
4914906|NCT02019745|New and emerging tobacco products|new and emerging tobacco products
4914907|NCT02019732|Mild outcomes|mild outcomes
4914908|NCT02019732|Database|database
4914909|NCT02019732|Influenza-attributable|influenza-attributable
4914910|NCT02019732|Retrospective|retrospective
4914911|NCT02019732|Influenza|influenza
4914912|NCT02019732|United States of America (USA)|united states of america (usa)
4914913|NCT02019719|Hemodialysis|hemodialysis
4914914|NCT02019719|GSK1278863|gsk1278863
4914915|NCT02019719|Pharmacokinetics|pharmacokinetics
4914916|NCT02019719|Erythropoiesis Stimulating Agents|erythropoiesis stimulating agents
4914917|NCT02019719|Chronic Kidney Disease|chronic kidney disease
4914918|NCT02019719|Hemoglobin|hemoglobin
4914919|NCT02019719|Recombinant Erythropoietin|recombinant erythropoietin
4914920|NCT02019719|Prolyl Hydroxylase Inhibitor|prolyl hydroxylase inhibitor
4914921|NCT02019719|Anemia|anemia
4914922|NCT02019706|Cushing Syndrome|cushing syndrome
4914923|NCT02019706|Ectopic ACTH Secretion|ectopic acth secretion
4914924|NCT02019706|Imaging|imaging
4914925|NCT02019693|MET Inhibitor|met inhibitor
4914926|NCT02019693|Sporadic|sporadic
4914927|NCT02019693|Hereditary|hereditary
4914928|NCT02019693|Multifocal|multifocal
4914929|NCT02019693|HGF/MET Pathway|hgf/met pathway
4914930|NCT02019680|Endothelial Function|endothelial function
4914931|NCT02019680|Biomarkers|biomarkers
4914932|NCT02019680|Atherosclerosis|atherosclerosis
4914933|NCT02019680|Blood Flow|blood flow
4914934|NCT02019680|Blood Pressure|blood pressure
4914935|NCT02019667|GABA|gaba
4914936|NCT02019667|Seizures|seizures
4914937|NCT02019667|Neurotransmitters|neurotransmitters
4914938|NCT02019654|Concussion|concussion
4914939|NCT02019654|Mild Traumatic Brain Injury|mild traumatic brain injury
4914940|NCT02019654|Traumatic Brain Injury|traumatic brain injury
4914941|NCT02019654|Mild TBI|mild tbi
4914942|NCT02019654|mTBI|mtbi
4914943|NCT02019641|Exercise|exercise
4914944|NCT02019641|Interstitial Lung Disease|interstitial lung disease
4914945|NCT02019641|Pulmonary Rehabilitation|pulmonary rehabilitation
4914946|NCT02019628|NK cells cytotoxicity, dietary supplementation|nk cells cytotoxicity, dietary supplementation
4914947|NCT02019615|disorders of consciousness|disorders of consciousness
4914948|NCT02019615|minimally conscious state|minimally conscious state
4914949|NCT02019615|traumatic brain injury|traumatic brain injury
4914950|NCT02019615|stroke|stroke
4914951|NCT02019615|transcranial direct current stimulation|transcranial direct current stimulation
4914952|NCT02019602|Cimzia®|cimzia®
4914953|NCT02019602|CZP|czp
4914954|NCT02019602|Placental transfer|placental transfer
4914955|NCT02019602|Autoimmune diseases and pregnancy|autoimmune diseases and pregnancy
4914956|NCT02019589|Secondary Amenorrhea|secondary amenorrhea
4914957|NCT02019589|SPRY Trial|spry trial
4914958|NCT02019576|Metastatic renal cell carcinoma|metastatic renal cell carcinoma
4914959|NCT02019576|mRCC|mrcc
4914960|NCT02019576|Clear cell|clear cell
4914961|NCT02019563|pediatrics|pediatrics
4914962|NCT02019563|dental caries|dental caries
4914963|NCT02019563|dental pulp exposure|dental pulp exposure
4914964|NCT02019563|incisor|incisor
4914965|NCT02019550|Multiple Sclerosis, Relapsing-Remitting|multiple sclerosis, relapsing-remitting
4914966|NCT02019550|Rebif®Rebidose®|rebif®rebidose®
4914967|NCT02019550|Rebiject II®|rebiject ii®
4914968|NCT02019524|Stage I breast cancer|stage i breast cancer
4914969|NCT02019524|Stage II breast cancer|stage ii breast cancer
4914970|NCT02019524|Stage IIIA, IIIB, and IIIC breast cancer|stage iiia, iiib, and iiic breast cancer
4914971|NCT02019524|Male breast cancer|male breast cancer
4914972|NCT02019524|Ovarian cancer|ovarian cancer
4914973|NCT02019511|Orthopedic surgery|orthopedic surgery
4914974|NCT02019511|Infections|infections
4914975|NCT02019511|Steroid|steroid
4914976|NCT02019511|Fast-track|fast-track
4914977|NCT02019511|Total knee arthroplasty|total knee arthroplasty
4914978|NCT02019511|Safety|safety
4914979|NCT02019498|low back pain|low back pain
4914980|NCT02019498|relaxation|relaxation
4914981|NCT02019485|Healthy|healthy
4914982|NCT02019485|Tapentadol|tapentadol
4914983|NCT02019485|Tapentadol extended-release tamper-resistant formulation|tapentadol extended-release tamper-resistant formulation
4914984|NCT02019485|Tapentadol extended-release prolonged-release formulation|tapentadol extended-release prolonged-release formulation
4914985|NCT02019485|Bioequivalence|bioequivalence
4914986|NCT02019485|Fasted Conditions|fasted conditions
4914987|NCT02019472|Rheumatoid arthritis|rheumatoid arthritis
4914988|NCT02019472|CNTO 136|cnto 136
4914989|NCT02019472|Sirukumab|sirukumab
4914990|NCT02019472|Adalimumab|adalimumab
4914991|NCT02019472|HUMIRA®|humira®
4914992|NCT02019446|type 2 diabetes mellitus|type 2 diabetes mellitus
4914993|NCT02019446|onychomycosis|onychomycosis
4914994|NCT02019446|laser treatment|laser treatment
4914995|NCT02019446|antifungal|antifungal
4914996|NCT02019433|THA, augment, revision, pelvis|tha, augment, revision, pelvis
4914997|NCT02019420|Pneumonia|pneumonia
4914998|NCT02019420|Tedizolid Phosphate|tedizolid phosphate
4914999|NCT02019420|TR-701|tr-701
4915000|NCT02019407|atrial fibrillation|atrial fibrillation
4915001|NCT02019407|atrial flutter|atrial flutter
4915002|NCT02019407|catheter ablation|catheter ablation
4915003|NCT02019407|cavo-tricuspid isthmus block|cavo-tricuspid isthmus block
4915004|NCT02019342|blood pressure|blood pressure
4915005|NCT02019342|mean arterial pressure|mean arterial pressure
4915006|NCT02019342|MAP|map
4915007|NCT02019342|intraoperative|intraoperative
4915008|NCT02019342|postoperative|postoperative
4915009|NCT02019342|anesthesia|anesthesia
4915010|NCT02019316|Supplementation|supplementation
4915011|NCT02019316|Performance|performance
4915012|NCT02019316|Cognitive Function|cognitive function
4915013|NCT02019316|Muscular Endurance|muscular endurance
4915014|NCT02019316|BioSteel|biosteel
4915015|NCT02019316|BCAA|bcaa
4915016|NCT02019316|Branched Chain Amino Acids|branched chain amino acids
4915017|NCT02019316|Sprint Interval Exercise|sprint interval exercise
4915018|NCT02019264|Diabetes|diabetes
4915019|NCT02019264|Cardiovascular Disease|cardiovascular disease
4915020|NCT02019264|Multiple Cardiovascular Risk Factors|multiple cardiovascular risk factors
4915021|NCT02019264|Obesity|obesity
4915022|NCT02019264|Overweight|overweight
4915023|NCT02019264|MACE|mace
4915024|NCT02019264|Conversion to Diabetes|conversion to diabetes
4915025|NCT02019225|dialysis|dialysis
4915026|NCT02019225|hemodialysis|hemodialysis
4915027|NCT02019225|pragmatic trial|pragmatic trial
4915028|NCT02019225|end stage renal disease|end stage renal disease
4915029|NCT02019225|randomized clinical trial|randomized clinical trial
4915030|NCT02019212|99mTc-tetrofosmin|99mtc-tetrofosmin
4915031|NCT02019212|myocardial perfusion imaging|myocardial perfusion imaging
4915032|NCT02019212|SPECT|spect
4915033|NCT02019212|radiation|radiation
4915034|NCT02019186|type 1 diabetes|type 1 diabetes
4915035|NCT02019186|endothelial function|endothelial function
4915036|NCT02019186|adolescents|adolescents
4915037|NCT02019186|vitamin C|vitamin c
4915038|NCT02019186|vitamin E|vitamin e
4915039|NCT02019173|exercise therapy|exercise therapy
4915137|NCT02018653|Placebo|placebo
4915040|NCT02019173|brain injury|brain injury
4915041|NCT02019173|postural balance|postural balance
4915042|NCT02019160|silver nitrate|silver nitrate
4915043|NCT02019160|sodium fluoride|sodium fluoride
4915044|NCT02019160|silver diamine fluoride|silver diamine fluoride
4915045|NCT02019160|caries|caries
4915046|NCT02019160|non-inferiority trial|non-inferiority trial
4915048|NCT02019147|Biomarker|biomarker
4915049|NCT02019134|chronic neck pain|chronic neck pain
4915050|NCT02019134|relaxation technique|relaxation technique
4915051|NCT02019134|comparative effectiveness research|comparative effectiveness research
4915052|NCT02019108|osteoarthritis|osteoarthritis
4915053|NCT02019108|knee|knee
4915054|NCT02019108|walking|walking
4915055|NCT02019108|toeout|toeout
4915056|NCT02019108|gait modification|gait modification
4915057|NCT02019095|Pneumonia, Ventilator-Associated|pneumonia, ventilator-associated
4915058|NCT02019095|Respiratory Distress Syndrome, Adult|respiratory distress syndrome, adult
4915059|NCT02019095|Pulmonary Surfactant-Associated Proteins|pulmonary surfactant-associated proteins
4915060|NCT02019095|activin A|activin a
4915061|NCT02019030|benign prostatic hyperplasia|benign prostatic hyperplasia
4915062|NCT02019030|Transurethral vaporization of prostate|transurethral vaporization of prostate
4915063|NCT02019017|Cluster Headache|cluster headache
4915064|NCT02019017|Botulinum Toxin Type A|botulinum toxin type a
4915065|NCT02019017|Sphenopalatine Ganglion Block|sphenopalatine ganglion block
4915066|NCT02019017|Autonomic Nerve Block|autonomic nerve block
4915067|NCT02018978|HIV prevention|hiv prevention
4915068|NCT02018978|Behavioral intervention|behavioral intervention
4915069|NCT02018978|Community-randomized trial|community-randomized trial
4915070|NCT02018965|HIV|hiv
4915071|NCT02018965|Extended-release Niacin|extended-release niacin
4915072|NCT02018965|Immune activation|immune activation
4915073|NCT02018952|Septic arthritis|septic arthritis
4915074|NCT02018952|Ultrasonography|ultrasonography
4915075|NCT02018952|Prognosis parameters|prognosis parameters
4915076|NCT02018939|pharmacokinetics, doripenem, renal replacement therapy, MARS, organ replacement therapy|pharmacokinetics, doripenem, renal replacement therapy, mars, organ replacement therapy
4915077|NCT02018926|Mocetinostat|mocetinostat
4915078|NCT02018926|Azacitidine|azacitidine
4915079|NCT02018926|Vidaza|vidaza
4915080|NCT02018926|Myelodysplastic syndrome|myelodysplastic syndrome
4915081|NCT02018926|HDAC|hdac
4915082|NCT02018926|HMA|hma
4915083|NCT02018926|MDS|mds
4915084|NCT02018900|Synbiotics|synbiotics
4915085|NCT02018900|Intestinal permeability|intestinal permeability
4915086|NCT02018900|Microbiota|microbiota
4915087|NCT02018900|Immune response|immune response
4915088|NCT02018848|Obsessive-Compulsive Disorder|obsessive-compulsive disorder
4915089|NCT02018848|Attention Training|attention training
4915090|NCT02018848|Attention Bias Modification|attention bias modification
4915091|NCT02018848|Dot-Probe Task|dot-probe task
4915092|NCT02018848|Randomized Controlled Trial|randomized controlled trial
4915093|NCT02018848|Online Treatment|online treatment
4915094|NCT02018848|Washing|washing
4915095|NCT02018848|Checking|checking
4915096|NCT02018822|restorative material|restorative material
4915097|NCT02018809|Medication Adherence|medication adherence
4915098|NCT02018809|High Blood Pressure|high blood pressure
4915099|NCT02018809|Diabetes|diabetes
4915100|NCT02018809|Statins|statins
4915101|NCT02018770|Temporomandibular Disorders, Electromyogram,|temporomandibular disorders, electromyogram,
4915102|NCT02018770|Modalities of physiotherapy,|modalities of physiotherapy,
4915103|NCT02018770|Temporomandibular dysfunction syndrome,|temporomandibular dysfunction syndrome,
4915104|NCT02018770|Lasers.|lasers.
4915105|NCT02018757|Carcinoma, Hepatocellular|carcinoma, hepatocellular
4915106|NCT02018757|primary liver cancer|primary liver cancer
4915107|NCT02018757|primary hepatocellular carcinoma|primary hepatocellular carcinoma
4915108|NCT02018757|transarterial chemoembolization|transarterial chemoembolization
4915109|NCT02018757|Chemoembolization, Therapeutic|chemoembolization, therapeutic
4915110|NCT02018757|arsenic trioxide|arsenic trioxide
4915111|NCT02018757|arsenous anhydride|arsenous anhydride
4915112|NCT02018757|diarsenic trioxide|diarsenic trioxide
4915113|NCT02018757|randomized controlled trial|randomized controlled trial
4915114|NCT02018757|multicenter study|multicenter study
4915115|NCT02018757|HCC|hcc
4915116|NCT02018757|TACE|tace
4915117|NCT02018731|Becker's Muscular dystrophy|becker's muscular dystrophy
4915118|NCT02018731|BMD|bmd
4915119|NCT02018731|Metformin|metformin
4915120|NCT02018731|L-citrulline|l-citrulline
4915121|NCT02018718|Skeletal muscle|skeletal muscle
4915122|NCT02018718|Marathon|marathon
4915123|NCT02018718|MRI|mri
4915124|NCT02018705|POEM|poem
4915125|NCT02018705|LHM|lhm
4915126|NCT02018705|Achalasia treatment|achalasia treatment
4915127|NCT02018705|LES sphincter myotomy|les sphincter myotomy
4915128|NCT02018679|Nodular basal cell carcinoma|nodular basal cell carcinoma
4915129|NCT02018679|Er:YAG|er:yag
4915130|NCT02018679|AFL-assisted|afl-assisted
4915131|NCT02018679|MAL-PDT|mal-pdt
4915132|NCT02018653|Cancer|cancer
4915133|NCT02018653|Diarrhea|diarrhea
4915134|NCT02018653|Calcium Alumina-Silicate|calcium alumina-silicate
4915135|NCT02018653|CASAD|casad
4915136|NCT02018653|Calcium Aluminosilicate anti-diarrheal|calcium aluminosilicate anti-diarrheal
4915138|NCT02018653|Sugar pill|sugar pill
4915139|NCT02018653|Questionnaire|questionnaire
4915140|NCT02018653|Survey|survey
4915141|NCT02018640|cancer|cancer
4915142|NCT02018640|tobacco use|tobacco use
4915143|NCT02018640|pregnancy|pregnancy
4915144|NCT02018627|bionic pancreas|bionic pancreas
4915145|NCT02018627|artificial pancreas|artificial pancreas
4915146|NCT02018627|insulin|insulin
4915147|NCT02018627|glucagon|glucagon
4915148|NCT02018627|clamp|clamp
4915149|NCT02018614|Pain|pain
4915150|NCT02018614|elderly|elderly
4915151|NCT02018614|aged 65 or above 65|aged 65 or above 65
4915152|NCT02018614|communication disorders|communication disorders
4915153|NCT02018614|Algoplus® scale|algoplus® scale
4915154|NCT02018588|requirements|requirements
4915155|NCT02018588|amino acid|amino acid
4915156|NCT02018588|tryptophan|tryptophan
4915157|NCT02018575|lysine|lysine
4915158|NCT02018575|bioavailability|bioavailability
4915159|NCT02018575|amino acids|amino acids
4915160|NCT02018575|corn|corn
4915161|NCT02018562|Quality of Life|quality of life
4915162|NCT02018562|Talking Tracheostomy Tube|talking tracheostomy tube
4915163|NCT02018562|Speech|speech
4915164|NCT02018562|Mechanically ventilated patients|mechanically ventilated patients
4915165|NCT02018549|COPD|copd
4915166|NCT02018549|placebo|placebo
4915167|NCT02018549|inhalatory profile|inhalatory profile
4915168|NCT02018536|Healthy|healthy
4915169|NCT02018536|TMC435|tmc435
4915170|NCT02018536|GSK2336805|gsk2336805
4915171|NCT02018536|Pharmacokinetic|pharmacokinetic
4915172|NCT02018536|Safety|safety
4915173|NCT02018536|Tolerability|tolerability
4915174|NCT02018523|Carcinoma, Non-Small-Cell Lung|carcinoma, non-small-cell lung
4915175|NCT02018523|Stage 3B/4|stage 3b/4
4915176|NCT02018523|Maintenance Therapy|maintenance therapy
4915177|NCT02018523|Lenalidomide|lenalidomide
4915178|NCT02018510|Healthy Volunteers|healthy volunteers
4915179|NCT02018510|HIV|hiv
4915180|NCT02018497|Essential arterial hypotension|essential arterial hypotension
4915181|NCT02018497|Arterial hypotension|arterial hypotension
4915182|NCT02018497|Low blood pressure|low blood pressure
4915183|NCT02018497|Hypotension|hypotension
4915184|NCT02018497|Essential arterial hypertension|essential arterial hypertension
4915185|NCT02018497|Syncope|syncope
4915186|NCT02018497|Dysautonomia|dysautonomia
4915187|NCT02018497|Stress|stress
4915188|NCT02018497|Adaptability|adaptability
4915189|NCT02018497|Reactivity|reactivity
4915190|NCT02018497|Homeostasis|homeostasis
4915191|NCT02018497|Allostasis|allostasis
4915192|NCT02018497|Allostatic load|allostatic load
4915193|NCT02018497|Distress|distress
4915194|NCT02018497|Epigenetic|epigenetic
4915195|NCT02018497|Plasticity|plasticity
4915196|NCT02018484|Surgery / Knee / Replacement / MRI / Specific cutting guides|surgery / knee / replacement / mri / specific cutting guides
4915197|NCT02018471|anxiety|anxiety
4915198|NCT02018471|psychoeducational training|psychoeducational training
4915199|NCT02018471|coping|coping
4915200|NCT02018471|relaxation|relaxation
4915201|NCT02018458|Dendritic cell vaccine|dendritic cell vaccine
4915202|NCT02018458|Breast Cancer|breast cancer
4915203|NCT02018458|Doxorubicin|doxorubicin
4915204|NCT02018458|Paclitaxel|paclitaxel
4915205|NCT02018458|Cyclophosphamide|cyclophosphamide
4915206|NCT02018458|Carboplatin|carboplatin
4915207|NCT02018406|Hematopoietic Growth Factors (EPO, G-CSF),|hematopoietic growth factors (epo, g-csf),
4915208|NCT02018406|Neurological Diseases,|neurological diseases,
4915209|NCT02018406|Neurorehabilitation,|neurorehabilitation,
4915210|NCT02018406|Neurotrophic and Neuroprotective Effects|neurotrophic and neuroprotective effects
4915211|NCT02018393|FEIBA®|feiba®
4915212|NCT02018367|Barrett's esophagus|barrett's esophagus
4915213|NCT02018367|proflavine|proflavine
4915214|NCT02018367|Microscopic imaging|microscopic imaging
4915215|NCT02018354|Orthopaedics|orthopaedics
4915216|NCT02018354|Anterior cruciate ligament (ACL) reconstruction|anterior cruciate ligament (acl) reconstruction
4915217|NCT02018354|Anterolateral ligament|anterolateral ligament
4915218|NCT02018354|Lateral Extra-articular Tenodesis (LET)|lateral extra-articular tenodesis (let)
4915219|NCT02018341|Assessment of biologic activity of a homeopathic remedy|assessment of biologic activity of a homeopathic remedy
4915220|NCT02018315|G1D|g1d
4915221|NCT02018315|Glut1 Disorder|glut1 disorder
4915222|NCT02018315|Glucose Transporter Type 1 Disorder|glucose transporter type 1 disorder
4915223|NCT02018315|Glucose Transporter Type I Disorder|glucose transporter type i disorder
4915224|NCT02018302|G1D|g1d
4915225|NCT02018302|Glut1 Deficiency|glut1 deficiency
4915226|NCT02018302|Glucose Transporter Type 1 Deficiency|glucose transporter type 1 deficiency
4915227|NCT02018302|Glucose Transporter Type I Deficiency|glucose transporter type i deficiency
4915228|NCT02018289|Triclosan coated suture|triclosan coated suture
4915229|NCT02018289|Surgical site infection|surgical site infection
4915230|NCT02018289|Fecal peritonitis|fecal peritonitis
4915231|NCT02018289|Superficial|superficial
4915232|NCT02018289|incisional|incisional
4915233|NCT02018276|Lidocaine|lidocaine
4915234|NCT02018276|Magnesium|magnesium
4915235|NCT02018276|Functional recovery|functional recovery
4915236|NCT02018237|Obesity|obesity
4915237|NCT02018237|Nonalcoholic fatty liver disease|nonalcoholic fatty liver disease
4915238|NCT02018237|High fructose corn syrup|high fructose corn syrup
4915239|NCT02018224|Achilles tendon rupture, operative treatment, elongation, long-term follow up.|achilles tendon rupture, operative treatment, elongation, long-term follow up.
4915240|NCT02018211|delayed onset muscle soreness|delayed onset muscle soreness
4915241|NCT02018211|muscle damage|muscle damage
4915242|NCT02018211|muscle function|muscle function
4915243|NCT02018211|inflammation|inflammation
4915244|NCT02018146|Laryngeal Masks|laryngeal masks
4915245|NCT02018146|Airway Management|airway management
4915246|NCT02018133|CKD|ckd
4915247|NCT02018133|chronic|chronic
4915248|NCT02018133|kidney|kidney
4915249|NCT02018133|vitamin D|vitamin d
4915250|NCT02018120|multiple gingival recession|multiple gingival recession
4915251|NCT02018120|platelet rich fibrin|platelet rich fibrin
4915252|NCT02018120|connective tissue graft|connective tissue graft
4915253|NCT02018120|microsurgery|microsurgery
4915254|NCT02018120|periodontal diseases|periodontal diseases
4915255|NCT02018120|gingival recession|gingival recession
4915256|NCT02018107|Liver Tumor Ablation|liver tumor ablation
4915257|NCT02018107|Liver Neoplasms|liver neoplasms
4915258|NCT02018107|Positron Emission Tomography|positron emission tomography
4915259|NCT02018107|Computed Tomography|computed tomography
4915260|NCT02018094|Amputation|amputation
4915261|NCT02018094|Infection|infection
4915262|NCT02018094|Skin Preparation|skin preparation
4915263|NCT02018094|SSI|ssi
4915264|NCT02018094|Stump|stump
4915265|NCT02018094|Wound|wound
4915266|NCT02018081|pharmacokinetic study : open, prospective, monocentric|pharmacokinetic study : open, prospective, monocentric
4915267|NCT02018068|Patient-controlled Perineural analgesia|patient-controlled perineural analgesia
4915268|NCT02018068|Postoperative|postoperative
4915269|NCT02018068|Orthopedic surgery|orthopedic surgery
4915270|NCT02018068|"Remote Control versus at bedside care"|"remote control versus at bedside care"
4915271|NCT02018068|Comparative medico-economic evaluation|comparative medico-economic evaluation
4915272|NCT02018042|Alopecia Areata|alopecia areata
4915273|NCT02018042|AA|aa
4915274|NCT02018029|Heart failure|heart failure
4915275|NCT02018029|Cardiac Resynchronisation Therapy|cardiac resynchronisation therapy
4915276|NCT02018029|collagen peptides|collagen peptides
4915277|NCT02018029|MIBG scintigraphy|mibg scintigraphy
4915278|NCT02018016|Appendectomy|appendectomy
4915279|NCT02018016|Hospitals,General|hospitals,general
4915280|NCT02018016|Hospitals,High-Volume|hospitals,high-volume
4915281|NCT02018016|Hospitals,Low-Volume|hospitals,low-volume
4915282|NCT02018016|Outcome Assessment (Health Care)|outcome assessment (health care)
4915283|NCT02017990|Renal transplantation|renal transplantation
4915284|NCT02017990|n-3 polyunsaturated fatty acids|n-3 polyunsaturated fatty acids
4915285|NCT02017990|Mortality|mortality
4915286|NCT02017990|Graft loss|graft loss
4915287|NCT02017990|Rejection|rejection
4915288|NCT02017977|Laparotomy|laparotomy
4915289|NCT02017977|General Surgery|general surgery
4915290|NCT02017977|Hospitals,General|hospitals,general
4915291|NCT02017977|Hospitals,Rural|hospitals,rural
4915292|NCT02017977|Hospitals,Urban|hospitals,urban
4915293|NCT02017977|Rural Health Services|rural health services
4915294|NCT02017977|Geography, Medical|geography, medical
4915295|NCT02017977|Outcome Assessment (Health Care)|outcome assessment (health care)
4915296|NCT02017951|Appendectomy|appendectomy
4915297|NCT02017951|Hospitals,General|hospitals,general
4915298|NCT02017951|Hospitals,Rural|hospitals,rural
4915299|NCT02017951|Hospitals,Urban|hospitals,urban
4915300|NCT02017951|Rural Health Services|rural health services
4915301|NCT02017951|Geography, Medical|geography, medical
4915302|NCT02017951|Outcome Assessment (Health Care)|outcome assessment (health care)
4915303|NCT02017938|Fatigue|fatigue
4915304|NCT02017938|electromyography (EMG)|electromyography (emg)
4915305|NCT02017938|central fatigue|central fatigue
4915306|NCT02017938|cycling training|cycling training
4915307|NCT02017925|Pulmonary Rehabilitation|pulmonary rehabilitation
4915308|NCT02017925|Non-Small Cell Lung Cancer|non-small cell lung cancer
4915309|NCT02017925|NSCLC|nsclc
4915310|NCT02017912|Mesenchymal Stromal cells|mesenchymal stromal cells
4915311|NCT02017912|MSC-NTF|msc-ntf
4915312|NCT02017912|Cell therapy|cell therapy
4915313|NCT02017912|ALS|als
4915314|NCT02017899|prevention|prevention
4915315|NCT02017899|Shigella sonnei|shigella sonnei
4915316|NCT02017886|Probiotics|probiotics
4915317|NCT02017886|Oral health|oral health
4915318|NCT02017886|Innate immunity|innate immunity
4915319|NCT02017873|bleaching|bleaching
4915320|NCT02017873|smokers|smokers
4915321|NCT02017873|effectiveness|effectiveness
4915322|NCT02017873|pain|pain
4915323|NCT02017860|RAD001, everolimus, roll-over|rad001, everolimus, roll-over
4915324|NCT02017847|oxygen consumption|oxygen consumption
4915325|NCT02017847|activity monitors|activity monitors
4915326|NCT02017847|METs|mets
4915327|NCT02017847|intensity|intensity
4915328|NCT02017834|oral cavity squamous cell carcinoma|oral cavity squamous cell carcinoma
4915329|NCT02017834|head and neck cancer|head and neck cancer
4915330|NCT02017834|oral cancer|oral cancer
4915331|NCT02017821|Exercise|exercise
4915332|NCT02017821|Oxygen Consumption|oxygen consumption
4915333|NCT02017821|mental health|mental health
4915334|NCT02017808|OCT|oct
4915335|NCT02017808|Copaxone|copaxone
4915336|NCT02017808|Multiple sclerosis|multiple sclerosis
4915337|NCT02017808|relapsing-remitting|relapsing-remitting
4915338|NCT02017795|asthma, mixed asthma, telehealth, action plan, exacerbation|asthma, mixed asthma, telehealth, action plan, exacerbation
4915339|NCT02017782|Dust|dust
4915340|NCT02017782|Ozone|ozone
4915341|NCT02017782|Indoor air quality|indoor air quality
4915342|NCT02017782|Indoor environment|indoor environment
4915343|NCT02017782|Indoor climate|indoor climate
4915344|NCT02017782|Cardiovascular diseases|cardiovascular diseases
4915345|NCT02017782|Full body exposure|full body exposure
4915346|NCT02017782|Exposure experiment with dust and ozone|exposure experiment with dust and ozone
4915347|NCT02017782|Acute exposure to ozone and dust|acute exposure to ozone and dust
4915348|NCT02017782|Respiratory outcomes|respiratory outcomes
4915349|NCT02017782|Cardiovascular outcomes|cardiovascular outcomes
4915350|NCT02017782|Acoustic rhinometry|acoustic rhinometry
4915351|NCT02017782|Body inflammatory markers|body inflammatory markers
4915352|NCT02017782|Cytokines|cytokines
4915353|NCT02017782|Exhaled FeNO|exhaled feno
4915354|NCT02017782|Nasal Lavage|nasal lavage
4915355|NCT02017782|Heart rate variability|heart rate variability
4915356|NCT02017782|Blood biomarkers|blood biomarkers
4915357|NCT02017782|Subjective discomfort|subjective discomfort
4915358|NCT02017782|General mucosal irritation|general mucosal irritation
4915359|NCT02017769|Subcutaneous immunoglobulin|subcutaneous immunoglobulin
4915360|NCT02017769|Magnetic resonance imaging|magnetic resonance imaging
4915361|NCT02017756|Carotid artery|carotid artery
4915362|NCT02017756|Atherosclerosis|atherosclerosis
4915363|NCT02017756|Vulnerable plaque|vulnerable plaque
4915364|NCT02017756|Magnetic resonance imaging|magnetic resonance imaging
4915365|NCT02017756|Arterial wall|arterial wall
4915366|NCT02017704|Endorectal Brachytherapy Radiation Therapy|endorectal brachytherapy radiation therapy
4915367|NCT02017704|Intensity Modulated Radiation Therapy and Capecitabine|intensity modulated radiation therapy and capecitabine
4915368|NCT02017678|JX-594|jx-594
4915369|NCT02017678|Ovarian cancer|ovarian cancer
4915370|NCT02017678|Peritoneal|peritoneal
4915371|NCT02017678|Carcinomatosis|carcinomatosis
4915372|NCT02017678|Vaccinia virus|vaccinia virus
4915373|NCT02017678|Oncolytic virus|oncolytic virus
4915374|NCT02017665|encephalitis|encephalitis
4915375|NCT02017665|viral infections|viral infections
4915376|NCT02017665|central nervous system|central nervous system
4915377|NCT02017652|bowel motility|bowel motility
4915378|NCT02017652|cerebral perfusion|cerebral perfusion
4915379|NCT02017652|intestinal perfusion|intestinal perfusion
4915380|NCT02017626|Fish allergy|fish allergy
4915381|NCT02017626|immunotherapy|immunotherapy
4915382|NCT02017626|hypoallergen|hypoallergen
4915383|NCT02017613|CLL, SLL, NHL, SLL, PTCL, CTCL, MM, AML|cll, sll, nhl, sll, ptcl, ctcl, mm, aml
4915384|NCT02017574|Stroke|stroke
4915385|NCT02017574|Cerebral Infarction|cerebral infarction
4915386|NCT02017561|Diastolic dysfunction|diastolic dysfunction
4915387|NCT02017561|Metabolic syndrome|metabolic syndrome
4915388|NCT02017561|Metformin|metformin
4915389|NCT02017548|advance directives, advance care planning|advance directives, advance care planning
4915390|NCT02017522|PET|pet
4915391|NCT02017522|Cardiac sarcoidosis|cardiac sarcoidosis
4915392|NCT02017522|FDG|fdg
4915393|NCT02017522|Cardiac MRI|cardiac mri
4915394|NCT02017509|Immunophenotype|immunophenotype
4915395|NCT02017509|Immunoscore|immunoscore
4915396|NCT02017509|MRI|mri
4915397|NCT02017509|RNA Later|rna later
4915398|NCT02017496|Breast cancer|breast cancer
4915399|NCT02017496|locally advanced|locally advanced
4915400|NCT02017496|neoadjuvant treatment|neoadjuvant treatment
4915401|NCT02017496|breast conserving surgery|breast conserving surgery
4915402|NCT02017483|ADHD,|adhd,
4915403|NCT02017483|emotion recognition|emotion recognition
4915404|NCT02017483|attention|attention
4915405|NCT02017470|Women Heart Health|women heart health
4915406|NCT02017470|Cardiovascular Disease|cardiovascular disease
4915407|NCT02017470|focus group|focus group
4915408|NCT02017470|advisory board|advisory board
4915409|NCT02017470|one-on-one interview|one-on-one interview
4915410|NCT02017457|Hematology|hematology
4915411|NCT02017457|Acute Myelogenous Leukemia|acute myelogenous leukemia
4915412|NCT02017457|Myelodysplasic syndrome|myelodysplasic syndrome
4915413|NCT02017457|Allogeneic stem cell transplantation|allogeneic stem cell transplantation
4915414|NCT02017457|Donor lymphocyte infusion|donor lymphocyte infusion
4915415|NCT02017457|DLI|dli
4915416|NCT02017457|Azacytidine|azacytidine
4915417|NCT02017457|Vidaza|vidaza
4915418|NCT02017457|Overall response rate|overall response rate
4915419|NCT02017457|Relapse|relapse
4915420|NCT02017444|Pseudotumor Cerebri|pseudotumor cerebri
4915421|NCT02017444|Benign Intracranial Hypertension|benign intracranial hypertension
4915422|NCT02017444|Headaches|headaches
4915423|NCT02017444|Tinnitus|tinnitus
4915424|NCT02017444|Papilledema|papilledema
4915425|NCT02017444|Blindness|blindness
4915426|NCT02017444|Optic Disk|optic disk
4915427|NCT02017444|Intracranial Hypertension|intracranial hypertension
4915428|NCT02017444|Clinical Trial, Phase 2|clinical trial, phase 2
4915429|NCT02017444|11beta-Hydroxysteroid Dehydrogenase Type 1|11beta-hydroxysteroid dehydrogenase type 1
4915430|NCT02017444|Obesity|obesity
4915431|NCT02017431|Diesel exhaust|diesel exhaust
4915432|NCT02017431|Particle depleted diesel exhaust|particle depleted diesel exhaust
4915433|NCT02017431|Air pollution|air pollution
4915434|NCT02017431|Airway responsiveness|airway responsiveness
4915435|NCT02017431|Allergies|allergies
4915436|NCT02017418|zeaxanthin|zeaxanthin
4915437|NCT02017418|visual function|visual function
4915438|NCT02017418|reaction time|reaction time
4915439|NCT02017418|processing speed|processing speed
4915440|NCT02017405|Digestibility|digestibility
4915441|NCT02017405|Healthy volunteers|healthy volunteers
4915442|NCT02017405|serum-derived bovine immunoglobulin protein isolate|serum-derived bovine immunoglobulin protein isolate
4915443|NCT02017405|bovine IgG|bovine igg
4915444|NCT02017405|adults|adults
4915445|NCT02017392|postoperative agitation|postoperative agitation
4915446|NCT02017392|endotracheal intubation|endotracheal intubation
4915447|NCT02017392|general anesthesia|general anesthesia
4915448|NCT02017379|upper gastrointestinal bleeding|upper gastrointestinal bleeding
4915449|NCT02017379|melena|melena
4915450|NCT02017379|hematemesis|hematemesis
4915451|NCT02017366|Surgery|surgery
4915452|NCT02017366|Malnutrition|malnutrition
4915453|NCT02017366|Nutrition, Enteral|nutrition, enteral
4915454|NCT02017340|Alzheimer's Disease|alzheimer's disease
4915455|NCT02017340|Investigator-driven clinical trial|investigator-driven clinical trial
4915456|NCT02017340|Nilvadipine|nilvadipine
4915457|NCT02017340|Calcium Channel blocker|calcium channel blocker
4915458|NCT02017340|Elderly|elderly
4915459|NCT02017340|Therapeutic Intervention|therapeutic intervention
4915460|NCT02017314|morbid obesity|morbid obesity
4915461|NCT02017314|postoperative pain|postoperative pain
4915462|NCT02017301|Liver Cirrhosis,Infection, Impedance, Body Composition|liver cirrhosis,infection, impedance, body composition
4915463|NCT02017288|Head and Neck Cancers|head and neck cancers
4915464|NCT02017288|Larynx|larynx
4915465|NCT02017288|Oropharynx|oropharynx
4915466|NCT02017288|Oral Cavity|oral cavity
4915467|NCT02017262|Self-care|self-care
4915468|NCT02017262|Patient education|patient education
4915469|NCT02017236|Food Effect|food effect
4915470|NCT02017236|Health subjects|health subjects
4915471|NCT02017223|Physical activity|physical activity
4915472|NCT02017197|Therapeutic Equivalency|therapeutic equivalency
4915473|NCT02017197|Warfarin|warfarin
4915474|NCT02017197|Drugs, Generic|drugs, generic
4915475|NCT02017197|Anticoagulants|anticoagulants
4915476|NCT02017197|Anticoagulants [Pharmacological Action]|anticoagulants [pharmacological action]
4915477|NCT02017197|Coumarins|coumarins
4915478|NCT02017184|Body Temperature Regulation Sensor Noninvasive|body temperature regulation sensor noninvasive
4915479|NCT02017171|Kidney Diseases|kidney diseases
4915480|NCT02017171|Diabetic Nephropathies|diabetic nephropathies
4915481|NCT02017171|Diabetes Mellitus|diabetes mellitus
4915482|NCT02017171|Diabetes Complications|diabetes complications
4915483|NCT02017171|Uric acid|uric acid
4915484|NCT02017171|Allopurinol|allopurinol
4915485|NCT02017171|Glomerular filtration rate|glomerular filtration rate
4915486|NCT02017171|Coronary artery disease|coronary artery disease
4915487|NCT02017158|Obesity|obesity
4915488|NCT02017158|Nutrition|nutrition
4915489|NCT02017158|Children|children
4915490|NCT02017145|infection|infection
4915491|NCT02017145|chloraprep|chloraprep
4915492|NCT02017145|chlorhexidine|chlorhexidine
4915493|NCT02017145|lower extremity surgery|lower extremity surgery
4915494|NCT02017145|antiseptic|antiseptic
4915495|NCT02017145|bacterial colonization|bacterial colonization
4915496|NCT02017132|Pomegranate|pomegranate
4915497|NCT02017132|Blood pressure|blood pressure
4915498|NCT02017132|Body composition|body composition
4915499|NCT02017132|Weight-loss|weight-loss
4915500|NCT02017132|Fat mass|fat mass
4915501|NCT02017132|Polyphenols|polyphenols
4915502|NCT02017132|Quality of Life|quality of life
4915503|NCT02017106|Varicose Veins|varicose veins
4915504|NCT02017093|CVA, rehabilitation|cva, rehabilitation
4915505|NCT02017080|fetal thyroid ultrasound|fetal thyroid ultrasound
4915506|NCT02017080|fetal fT4|fetal ft4
4915507|NCT02017080|antithyroid antibodies|antithyroid antibodies
4915508|NCT02017080|pregnancy|pregnancy
4915509|NCT02017080|autoimmune thyroid disease|autoimmune thyroid disease
4915510|NCT02017067|Resistance training|resistance training
4915511|NCT02017067|musculoskeletal conditions|musculoskeletal conditions
4915512|NCT02017067|RFD|rfd
4915513|NCT02017041|opioid dependence, buprenorphine, smartphone, suboxone|opioid dependence, buprenorphine, smartphone, suboxone
4915514|NCT02017015|Pancreatic cancer|pancreatic cancer
4915515|NCT02017015|Metastatic pancreatic cancer|metastatic pancreatic cancer
4915516|NCT02017015|treatment for pancreatic cancer|treatment for pancreatic cancer
4915517|NCT02017015|Abraxane clinical research trials|abraxane clinical research trials
4915518|NCT02017015|Celgene clinical research trials|celgene clinical research trials
4915519|NCT02017002|Esophageal cancer|esophageal cancer
4915520|NCT02017002|minimally invasive|minimally invasive
4915521|NCT02017002|Surgical Procedures|surgical procedures
4915522|NCT02017002|Esophagectomy|esophagectomy
4915523|NCT02016989|Bacterial keratitis|bacterial keratitis
4915524|NCT02016989|OTR4120|otr4120
4915525|NCT02016989|Matrix therapy|matrix therapy
4915526|NCT02016963|Monoclonal Antibody|monoclonal antibody
4915527|NCT02016963|Safety|safety
4915528|NCT02016963|Raxibacumab|raxibacumab
4915529|NCT02016963|HGS1021|hgs1021
4915530|NCT02016963|Immunogenicity|immunogenicity
4915737|NCT02016066|Healthy|healthy
4915531|NCT02016937|Anesthesia , lactation, birth|anesthesia , lactation, birth
4915532|NCT02016924|Pediatrics|pediatrics
4915533|NCT02016924|Adolescents|adolescents
4915534|NCT02016924|HIV|hiv
4915535|NCT02016924|HIV-1|hiv-1
4915536|NCT02016924|Treatment experienced|treatment experienced
4915537|NCT02016898|Primary open angle glaucoma|primary open angle glaucoma
4915538|NCT02016898|trabeculectomy|trabeculectomy
4915539|NCT02016898|mitomycin-C|mitomycin-c
4915540|NCT02016898|express mini-shunt|express mini-shunt
4915541|NCT02016872|PET/CT|pet/ct
4915542|NCT02016872|18F-FMISO|18f-fmiso
4915543|NCT02016872|tumor hypoxia|tumor hypoxia
4915544|NCT02016872|13-186|13-186
4915545|NCT02016859|IPF Immature platelet fraction|ipf immature platelet fraction
4915546|NCT02016859|ICU neutropenic fever|icu neutropenic fever
4915547|NCT02016859|hip fracture|hip fracture
4915548|NCT02016859|critically ill|critically ill
4915549|NCT02016833|Ovarian Cancer|ovarian cancer
4915550|NCT02016833|Cervical Cancer|cervical cancer
4915551|NCT02016833|Leukemia|leukemia
4915552|NCT02016833|Immunity|immunity
4915553|NCT02016833|WT-1|wt-1
4915554|NCT02016833|Survivin|survivin
4915555|NCT02016833|HPV|hpv
4915556|NCT02016820|Clostridium Difficile Infection|clostridium difficile infection
4915557|NCT02016820|Proton Pump Inhibitors|proton pump inhibitors
4915558|NCT02016820|Histamine-2 Receptor Antagonists|histamine-2 receptor antagonists
4915559|NCT02016820|Gastroesophageal Reflux Disease|gastroesophageal reflux disease
4915560|NCT02016807|Mucositis|mucositis
4915561|NCT02016807|Sucralfate|sucralfate
4915562|NCT02016807|Prothelial|prothelial
4915563|NCT02016807|High potency sucralfate|high potency sucralfate
4915564|NCT02016807|Ulcerations|ulcerations
4915565|NCT02016807|Chemotherapy induced diarrhea|chemotherapy induced diarrhea
4915566|NCT02016807|Radiation induced mucositis|radiation induced mucositis
4915567|NCT02016807|Chemotherapy colitis|chemotherapy colitis
4915568|NCT02016807|Radiation colitis|radiation colitis
4915569|NCT02016807|Mucosal erosions|mucosal erosions
4915570|NCT02016794|cervical|cervical
4915571|NCT02016794|interbody|interbody
4915572|NCT02016794|spacer|spacer
4915573|NCT02016794|degenerative|degenerative
4915574|NCT02016794|pain|pain
4915575|NCT02016794|neck|neck
4915576|NCT02016794|decompression|decompression
4915577|NCT02016794|fusion|fusion
4915578|NCT02016794|implant|implant
4915579|NCT02016781|Myelodysplastic Syndrome|myelodysplastic syndrome
4915580|NCT02016755|Peripheral Arterial Disease|peripheral arterial disease
4915581|NCT02016755|Vascular Disease|vascular disease
4915582|NCT02016755|CLI|cli
4915583|NCT02016755|Critical Limb Ischemia|critical limb ischemia
4915584|NCT02016755|PAD|pad
4915585|NCT02016755|AnGes|anges
4915586|NCT02016755|HGF Plasmid|hgf plasmid
4915587|NCT02016755|HGF|hgf
4915588|NCT02016755|Hepatocyte Growth Factor Plasmid|hepatocyte growth factor plasmid
4915589|NCT02016755|gene therapy|gene therapy
4915590|NCT02016742|Pharmacokinetics|pharmacokinetics
4915591|NCT02016729|AML|aml
4915592|NCT02016716|Postmenopausal Osteoporosis|postmenopausal osteoporosis
4915593|NCT02016703|erythritol|erythritol
4915594|NCT02016703|polyol|polyol
4915595|NCT02016703|laxation|laxation
4915596|NCT02016703|gastrointestinal|gastrointestinal
4915597|NCT02016703|tolerance|tolerance
4915598|NCT02016703|soft drinks|soft drinks
4915599|NCT02016703|child|child
4915600|NCT02016703|diarrhoea|diarrhoea
4915601|NCT02016690|Prevention of severe RSV infection|prevention of severe rsv infection
4915602|NCT02016690|Respiratory syncytial virus (RSV) infection|respiratory syncytial virus (rsv) infection
4915603|NCT02016690|Down Syndrome|down syndrome
4915604|NCT02016690|Immunocompromised|immunocompromised
4915605|NCT02016690|Effectiveness of palivizumab|effectiveness of palivizumab
4915606|NCT02016677|Breast reduction|breast reduction
4915607|NCT02016677|Mastopexy|mastopexy
4915608|NCT02016677|Sagging|sagging
4915609|NCT02016664|Chronic Pain, Ketamine, Safety|chronic pain, ketamine, safety
4915610|NCT02016638|Obstructive Sleep Apnea in pregnancy|obstructive sleep apnea in pregnancy
4915611|NCT02016638|Pregnancy induced hypertension|pregnancy induced hypertension
4915612|NCT02016638|Restless leg syndrome|restless leg syndrome
4915613|NCT02016638|Sleep|sleep
4915614|NCT02016612|Recurrent|recurrent
4915615|NCT02016612|Ptosis|ptosis
4915616|NCT02016612|Reduction|reduction
4915617|NCT02016612|Mammoplasty|mammoplasty
4915618|NCT02016612|Mastopexy|mastopexy
4915619|NCT02016599|Hypotension|hypotension
4915620|NCT02016599|Low blood pressure|low blood pressure
4915621|NCT02016599|Neonate|neonate
4915622|NCT02016599|Extremely Low Birth Weight Infant|extremely low birth weight infant
4915623|NCT02016573|renal denervation|renal denervation
4915624|NCT02016573|blood pressure|blood pressure
4915625|NCT02016573|cardiovascular risk|cardiovascular risk
4915626|NCT02016573|target organ damage|target organ damage
4915627|NCT02016573|sympathetic activity|sympathetic activity
4915628|NCT02016547|Stroke|stroke
4915629|NCT02016547|Middle Cerebral Artery|middle cerebral artery
4915630|NCT02016547|Thrombectomy|thrombectomy
4915631|NCT02016547|Mechanical Thrombolysis|mechanical thrombolysis
4915632|NCT02016547|Abciximab|abciximab
4915738|NCT02016066|CR6261|cr6261
4915739|NCT02016066|Japanese|japanese
4915633|NCT02016534|MET Amplified Gastric / Gastroesophageal Junction / Esophageal Adenocarcinoma, or other solid tumors.|met amplified gastric / gastroesophageal junction / esophageal adenocarcinoma, or other solid tumors.
4915634|NCT02016521|Exercise|exercise
4915635|NCT02016521|Clothing|clothing
4915636|NCT02016521|Core body temperature|core body temperature
4915637|NCT02016521|Skin Temperature|skin temperature
4915638|NCT02016521|Performance|performance
4915639|NCT02016508|Adult bone marrow stem cells|adult bone marrow stem cells
4915640|NCT02016508|AMD|amd
4915641|NCT02016482|Nail Psoriasis|nail psoriasis
4915642|NCT02016482|Plaque Psoriasis|plaque psoriasis
4915643|NCT02016456|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
4915644|NCT02016456|Neuronavigation|neuronavigation
4915645|NCT02016456|Magnetic Resonance Imaging|magnetic resonance imaging
4915646|NCT02016443|inguinal hernia|inguinal hernia
4915647|NCT02016430|TMAO|tmao
4915648|NCT02016430|Gut Flora|gut flora
4915649|NCT02016430|Dietary Intervention|dietary intervention
4915650|NCT02016430|Choline|choline
4915651|NCT02016430|Carnitine|carnitine
4915652|NCT02016417|Nasopharyngeal carcinoma|nasopharyngeal carcinoma
4915653|NCT02016417|Induction chemotherapy|induction chemotherapy
4915654|NCT02016417|Concurrent chemoradiotherapy|concurrent chemoradiotherapy
4915655|NCT02016417|Gemcitabine|gemcitabine
4915656|NCT02016417|Docetaxel|docetaxel
4915657|NCT02016404|blood pressure|blood pressure
4915658|NCT02016404|sodium|sodium
4915659|NCT02016404|salt|salt
4915660|NCT02016404|low sodium high potassium salt|low sodium high potassium salt
4915661|NCT02016404|potassium|potassium
4915662|NCT02016404|Vietnam|vietnam
4915663|NCT02016404|randomized controlled trial|randomized controlled trial
4915664|NCT02016365|Transthyretin amyloidosis|transthyretin amyloidosis
4915665|NCT02016365|Cardiomyopathy|cardiomyopathy
4915666|NCT02016365|ATTR|attr
4915667|NCT02016365|neuropathy|neuropathy
4915668|NCT02016352|hydrocephalus|hydrocephalus
4915669|NCT02016352|proteomic|proteomic
4915670|NCT02016352|cerebrospinal fluid|cerebrospinal fluid
4915671|NCT02016326|Colonoscopy|colonoscopy
4915672|NCT02016326|High Definition White Light|high definition white light
4915673|NCT02016326|I-Scan|i-scan
4915674|NCT02016326|Adenomas|adenomas
4915675|NCT02016300|cartilage|cartilage
4915676|NCT02016300|microfracture|microfracture
4915677|NCT02016300|knee|knee
4915678|NCT02016300|bracing|bracing
4915679|NCT02016261|Cognitive function|cognitive function
4915680|NCT02016248|CyberKnife|cyberknife
4915681|NCT02016248|Prostate Cancer|prostate cancer
4915682|NCT02016248|Stereotactic Body Radiation|stereotactic body radiation
4915683|NCT02016248|SBRT|sbrt
4915684|NCT02016248|Radiosurgery|radiosurgery
4915685|NCT02016248|SABR|sabr
4915686|NCT02016248|Stereotactic Ablative Body Radiotherapy|stereotactic ablative body radiotherapy
4915687|NCT02016248|Boost|boost
4915688|NCT02016235|Dent|dent
4915689|NCT02016235|Dents|dents
4915690|NCT02016235|Dent Disease|dent disease
4915691|NCT02016235|Phosphorus Supplements|phosphorus supplements
4915692|NCT02016235|FGF 23|fgf 23
4915693|NCT02016222|primary progressive multiple sclerosis|primary progressive multiple sclerosis
4915694|NCT02016222|diagnosis|diagnosis
4915695|NCT02016222|tears|tears
4915696|NCT02016222|isoelectric focusing|isoelectric focusing
4915697|NCT02016222|oligoclonal bands|oligoclonal bands
4915698|NCT02016196|TIPS|tips
4915699|NCT02016196|portal pressure|portal pressure
4915700|NCT02016196|rifaximin|rifaximin
4915701|NCT02016196|overt hepatic encephalopathy|overt hepatic encephalopathy
4915702|NCT02016196|microbiota|microbiota
4915703|NCT02016183|Drug Therapy|drug therapy
4915704|NCT02016170|platelet reactivity|platelet reactivity
4915705|NCT02016170|ticagrelor|ticagrelor
4915706|NCT02016170|prasugrel|prasugrel
4915707|NCT02016157|Moxifloxacin|moxifloxacin
4915708|NCT02016157|Chlorhexidine|chlorhexidine
4915709|NCT02016157|In situ gel|in situ gel
4915710|NCT02016157|Chronic periodontitis|chronic periodontitis
4915711|NCT02016144|Airway management; Fiber optic technology; Intubation|airway management; fiber optic technology; intubation
4915712|NCT02016131|endoleak|endoleak
4915713|NCT02016131|EVAR|evar
4915714|NCT02016131|AAA|aaa
4915715|NCT02016131|CQDSA|cqdsa
4915716|NCT02016118|RUTI|ruti
4915717|NCT02016105|plaque type psoriasis|plaque type psoriasis
4915718|NCT02016105|equivalent efficacy|equivalent efficacy
4915719|NCT02016105|safety and immunogenicity|safety and immunogenicity
4915720|NCT02016105|GP2017|gp2017
4915721|NCT02016105|Humira®|humira®
4915722|NCT02016092|Parkinson's disease|parkinson's disease
4915723|NCT02016092|biomarkers|biomarkers
4915724|NCT02016092|blood|blood
4915725|NCT02016092|urine,|urine,
4915726|NCT02016092|proteomics|proteomics
4915727|NCT02016092|lipidomics|lipidomics
4915728|NCT02016092|metabolomics|metabolomics
4915729|NCT02016079|randomized controlled trial|randomized controlled trial
4915730|NCT02016079|omega-3|omega-3
4915731|NCT02016079|nutrition|nutrition
4915732|NCT02016079|behavior problems|behavior problems
4915733|NCT02016079|externalizing|externalizing
4915734|NCT02016079|internalizing|internalizing
4915735|NCT02016079|antisocial|antisocial
4915736|NCT02016079|aggressive|aggressive
4915740|NCT02016066|Safety|safety
4915741|NCT02016066|Pharmacokinetics|pharmacokinetics
4915742|NCT02016066|Immunogenicity|immunogenicity
4915743|NCT02016040|Prostate cancer|prostate cancer
4915744|NCT02016040|HIFU Hemi-ablation|hifu hemi-ablation
4915745|NCT02016040|Prostate biopsies|prostate biopsies
4915746|NCT02016014|Physical activity|physical activity
4915747|NCT02016014|Alimentation|alimentation
4915748|NCT02016014|Information and communication Technology|information and communication technology
4915749|NCT02016014|Arterial aging|arterial aging
4915750|NCT02016001|fluoride|fluoride
4915751|NCT02016001|dental caries|dental caries
4915752|NCT02016001|prevention|prevention
4915753|NCT02015988|Acute coronary syndrome|acute coronary syndrome
4915754|NCT02015988|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
4915755|NCT02015988|Hypertriglyceridemia|hypertriglyceridemia
4915756|NCT02015988|Simvastatin|simvastatin
4915757|NCT02015988|Fenofibrate|fenofibrate
4915758|NCT02015975|patellar fracture|patellar fracture
4915759|NCT02015975|fracture of patella|fracture of patella
4915760|NCT02015975|patella|patella
4915761|NCT02015975|locking plate osteosynthesis|locking plate osteosynthesis
4915762|NCT02015975|osteosynthesis|osteosynthesis
4915763|NCT02015975|star-plate|star-plate
4915764|NCT02015975|arrow-plate|arrow-plate
4915765|NCT02015962|Hypokalemia|hypokalemia
4915766|NCT02015962|Intravenous|intravenous
4915767|NCT02015962|Enteral|enteral
4915768|NCT02015962|post-cardiac surgery|post-cardiac surgery
4915769|NCT02015936|stage III cancer|stage iii cancer
4915770|NCT02015936|stage IV cancer|stage iv cancer
4915771|NCT02015936|cancer|cancer
4915772|NCT02015936|advanced stage cancer|advanced stage cancer
4915773|NCT02015936|Nintendo Wii training|nintendo wii training
4915774|NCT02015936|exercise|exercise
4915775|NCT02015936|physical training|physical training
4915776|NCT02015936|physical function|physical function
4915777|NCT02015936|physical fitness test|physical fitness test
4915778|NCT02015923|Colonic cancer|colonic cancer
4915779|NCT02015923|Metastasis|metastasis
4915780|NCT02015884|Incivility|incivility
4915781|NCT02015884|Rudeness|rudeness
4915782|NCT02015884|Aggression|aggression
4915783|NCT02015884|Violent act|violent act
4915784|NCT02015884|Healthcare workers|healthcare workers
4915785|NCT02015884|Emergency unit|emergency unit
4915786|NCT02015832|SYNTAX II Score|syntax ii score
4915787|NCT02015832|Pressure wires|pressure wires
4915788|NCT02015832|instantaneous wave-free ratio|instantaneous wave-free ratio
4915789|NCT02015832|fractional flow reserve|fractional flow reserve
4915790|NCT02015832|intravascular ultrasound|intravascular ultrasound
4915791|NCT02015832|Drug eluting stents|drug eluting stents
4915792|NCT02015832|Stents|stents
4915793|NCT02015832|Angioplasty|angioplasty
4915794|NCT02015832|multi slice computed tomography|multi slice computed tomography
4915795|NCT02015806|Quality improvement|quality improvement
4915796|NCT02015806|Randomized controlled trial|randomized controlled trial
4915797|NCT02015806|Medication adherence|medication adherence
4915798|NCT02015806|RxTimer Cap|rxtimer cap
4915799|NCT02015806|PillMinder|pillminder
4915800|NCT02015806|Take-N-Slide|take-n-slide
4915801|NCT02015806|Low-touch devices|low-touch devices
4915802|NCT02015806|Medication management|medication management
4915803|NCT02015793|Crohn's Disease|crohn's disease
4915804|NCT02015793|Pharmacokinetics|pharmacokinetics
4915805|NCT02015780|Drug therapy|drug therapy
4915806|NCT02015767|Drug therapy|drug therapy
4915807|NCT02015728|Refractory|refractory
4915808|NCT02015728|Recurrent|recurrent
4915809|NCT02015728|Brain|brain
4915810|NCT02015728|Tumor|tumor
4915811|NCT02015728|Pediatric|pediatric
4915812|NCT02015728|Biologically Targeted Therapy|biologically targeted therapy
4915813|NCT02015728|Sorafenib|sorafenib
4915814|NCT02015728|Everolimus|everolimus
4915815|NCT02015728|Erlotinib|erlotinib
4915816|NCT02015728|Dasatinib|dasatinib
4915817|NCT02015728|Temozolomide|temozolomide
4915818|NCT02015728|Etoposide|etoposide
4915819|NCT02015702|Physicians|physicians
4915820|NCT02015702|Electronic Health Record|electronic health record
4915821|NCT02015702|Education|education
4915822|NCT02015663|Cystic Fibrosis|cystic fibrosis
4915823|NCT02015663|CF|cf
4915824|NCT02015650|Locally advanced squamous cell carcinomas of head and neck|locally advanced squamous cell carcinomas of head and neck
4915825|NCT02015637|Gonorrhea|gonorrhea
4915826|NCT02015637|N. gonorrhoeae|n. gonorrhoeae
4915827|NCT02015637|bacterial infection|bacterial infection
4915828|NCT02015637|Anti-Infective Agents|anti-infective agents
4915829|NCT02015637|Anti-Bacterial Agents|anti-bacterial agents
4915830|NCT02015624|Acute coronary syndromes|acute coronary syndromes
4915831|NCT02015624|Intensive Care Unit|intensive care unit
4915832|NCT02015611|Vitamin D|vitamin d
4915833|NCT02015611|Muscle power|muscle power
4915834|NCT02015611|Muscle fiber|muscle fiber
4915835|NCT02015611|Falls|falls
4915836|NCT02015611|Aging|aging
4915837|NCT02015598|Obstructive sleep apnoea|obstructive sleep apnoea
4915838|NCT02015598|Antioxidant|antioxidant
4915839|NCT02015598|drug treatment|drug treatment
4915840|NCT02015598|oxidative stress|oxidative stress
4915841|NCT02015598|Continuous Positive Airway Pressure|continuous positive airway pressure
4915842|NCT02015572|Low back pain|low back pain
4915843|NCT02015572|Return to work|return to work
4915844|NCT02015572|Sickness absence|sickness absence
4915845|NCT02015572|Rehabilitation|rehabilitation
4915846|NCT02015572|Occupational intervention|occupational intervention
4915847|NCT02015546|Major Depressive Disorder|major depressive disorder
4915848|NCT02015546|Vilazodone|vilazodone
4915849|NCT02015533|Healthy|healthy
4915850|NCT02015533|CR8020|cr8020
4915851|NCT02015533|Japanese|japanese
4915852|NCT02015533|Safety|safety
4915853|NCT02015533|Pharmacokinetics|pharmacokinetics
4915854|NCT02015533|Immunogenicity|immunogenicity
4915855|NCT02015494|Safety|safety
4915856|NCT02015494|Immunogenicity|immunogenicity
4915857|NCT02015481|Case control, safety, tolerability, efficacy.|case control, safety, tolerability, efficacy.
4915858|NCT02015468|Distal radius fracture|distal radius fracture
4915859|NCT02015468|Wrist fracture|wrist fracture
4915860|NCT02015468|Physiotherapy|physiotherapy
4915861|NCT02015468|Immobilization|immobilization
4915862|NCT02015468|Volar locking plates|volar locking plates
4915863|NCT02015468|Mobilization|mobilization
4915864|NCT02015455|pragmatic trial|pragmatic trial
4915865|NCT02015455|stepped-wedge design|stepped-wedge design
4915866|NCT02015455|cluster-randomized trial|cluster-randomized trial
4915867|NCT02015442|Sucrose in diet|sucrose in diet
4915868|NCT02015429|Food intake|food intake
4915869|NCT02015429|satiety|satiety
4915870|NCT02015429|glycemia|glycemia
4915871|NCT02015429|appetite|appetite
4915872|NCT02015429|blood glucose|blood glucose
4915873|NCT02015429|yellow peas|yellow peas
4915874|NCT02015429|fibre|fibre
4915875|NCT02015429|protein|protein
4915876|NCT02015429|mixed meal|mixed meal
4915877|NCT02015416|Melanoma|melanoma
4915878|NCT02015416|Ovarian cancer|ovarian cancer
4915879|NCT02015416|Sarcoma|sarcoma
4915880|NCT02015416|Non-small cell lung cancer|non-small cell lung cancer
4915881|NCT02015416|NSCLC|nsclc
4915882|NCT02015416|Breast cancer|breast cancer
4915883|NCT02015390|bone defects|bone defects
4915884|NCT02015390|iatrogenic resection|iatrogenic resection
4915885|NCT02015390|titanium mesh cage|titanium mesh cage
4915886|NCT02015390|biomembrane|biomembrane
4915887|NCT02015390|Masquelet technique|masquelet technique
4915888|NCT02015364|Achilles tendon|achilles tendon
4915889|NCT02015364|Rupture|rupture
4915890|NCT02015364|Rehabilitation|rehabilitation
4915891|NCT02015364|Dynamic rehabilitation|dynamic rehabilitation
4915892|NCT02015351|Choroidal neovascularization|choroidal neovascularization
4915893|NCT02015351|Vogt Koyanagi Harada Disease|vogt koyanagi harada disease
4916022|NCT02014896|Cryptogenic Stroke|cryptogenic stroke
4915894|NCT02015351|Inflammatory choroidal neovascularization|inflammatory choroidal neovascularization
4915895|NCT02015351|Anti-VEGF|anti-vegf
4915896|NCT02015338|Hemiparesis|hemiparesis
4915897|NCT02015338|Cerebral Palsy|cerebral palsy
4915898|NCT02015338|Congenital Stroke|congenital stroke
4915899|NCT02015338|Congenital Infarct|congenital infarct
4915900|NCT02015325|Water|water
4915901|NCT02015325|Sanitation|sanitation
4915902|NCT02015325|Hygiene|hygiene
4915903|NCT02015325|Education|education
4915904|NCT02015325|Evaluation|evaluation
4915905|NCT02015312|Amyloidosis|amyloidosis
4915906|NCT02015299|Diabetes|diabetes
4915907|NCT02015299|Pulse Wave Velocity|pulse wave velocity
4915908|NCT02015299|Dipeptidyl peptidase (DPP)-4 inhibitors|dipeptidyl peptidase (dpp)-4 inhibitors
4915909|NCT02015299|Linagliptin|linagliptin
4915910|NCT02015299|Arterial Stiffness|arterial stiffness
4915911|NCT02015299|Subclinical arterial inflammation|subclinical arterial inflammation
4915912|NCT02015286|Growth disorders|growth disorders
4915913|NCT02015286|Saizen|saizen
4915914|NCT02015286|Easypod|easypod
4915915|NCT02015286|Growth hormone|growth hormone
4915916|NCT02015286|Pediatric subject|pediatric subject
4915917|NCT02015273|easypod™|easypod™
4915918|NCT02015273|SAIZEN®|saizen®
4915919|NCT02015260|human papilloma virus infection|human papilloma virus infection
4915920|NCT02015260|Anogenital warts|anogenital warts
4915921|NCT02015260|condylomata acuminata|condylomata acuminata
4915922|NCT02015234|TNX-102 SL|tnx-102 sl
4915923|NCT02015234|bedtime|bedtime
4915924|NCT02015234|sublingual|sublingual
4915925|NCT02015234|12-month|12-month
4915926|NCT02015234|long term safety|long term safety
4915927|NCT02015234|long term efficacy|long term efficacy
4915928|NCT02015234|Fibromyalgia|fibromyalgia
4915929|NCT02015221|chronic venous insufficiency|chronic venous insufficiency
4915930|NCT02015221|venous leg ulcers|venous leg ulcers
4915931|NCT02015221|pneumatic compression|pneumatic compression
4915933|NCT02015208|cytokine signaling|cytokine signaling
4915934|NCT02015208|signal transduction inhibitors|signal transduction inhibitors
4915935|NCT02015208|elderly|elderly
4915936|NCT02015208|p53|p53
4915937|NCT02015195|Jellyfish stings|jellyfish stings
4915938|NCT02015195|Treatment|treatment
4915939|NCT02015195|Humans|humans
4915940|NCT02015195|Topical Treatments|topical treatments
4915941|NCT02015195|Pain|pain
4915942|NCT02015195|Erythema|erythema
4915943|NCT02015182|Bupivacaine|bupivacaine
4915944|NCT02015182|Sensorcaine|sensorcaine
4915945|NCT02015182|Population pharmacokinetics|population pharmacokinetics
4915946|NCT02015182|Children|children
4915947|NCT02015182|Pediatrics|pediatrics
4915948|NCT02015182|Transversus abdominis plane (TAP) block|transversus abdominis plane (tap) block
4915949|NCT02015182|Regional Anesthesia|regional anesthesia
4915950|NCT02015169|gastric cancer|gastric cancer
4915951|NCT02015169|neoadjuvant chemotherapy|neoadjuvant chemotherapy
4915952|NCT02015169|capecitabine|capecitabine
4915953|NCT02015169|oxaliplatin|oxaliplatin
4915954|NCT02015169|lapatinib|lapatinib
4915955|NCT02015156|Trastuzumab|trastuzumab
4915956|NCT02015156|Healthy Male Volunteers|healthy male volunteers
4915957|NCT02015156|Single-Dose|single-dose
4915958|NCT02015156|Phase 1|phase 1
4915959|NCT02015156|Biosimilarity|biosimilarity
4915960|NCT02015130|Type 2 diabetes|type 2 diabetes
4915961|NCT02015130|hypertension|hypertension
4915962|NCT02015130|individual|individual
4915963|NCT02015104|Urothelial Cancinoma|urothelial cancinoma
4915964|NCT02015104|Vaccines|vaccines
4915965|NCT02015104|Immunotherapy|immunotherapy
4915966|NCT02015104|TICE BCG|tice bcg
4915967|NCT02015104|Intravesical Treatment|intravesical treatment
4915968|NCT02015091|Healthy Subjects|healthy subjects
4915969|NCT02015091|Vaccine-Mediated Protection|vaccine-mediated protection
4915970|NCT02015091|Immunogenicity|immunogenicity
4915971|NCT02015091|Sporozoites|sporozoites
4915972|NCT02015091|Parasitemia|parasitemia
4915973|NCT02015078|Eating Behavior|eating behavior
4915974|NCT02015078|Cancer|cancer
4915975|NCT02015078|Chronic Diseases|chronic diseases
4915976|NCT02015078|Obesity|obesity
4915977|NCT02015065|GIST|gist
4915978|NCT02015065|Toxicity|toxicity
4915979|NCT02015065|Mesenchymal Tumor|mesenchymal tumor
4915980|NCT02015065|Clinical Activity|clinical activity
4915981|NCT02015065|Survival|survival
4915982|NCT02015039|Occupational Therapy|occupational therapy
4915983|NCT02015039|Botulinum Toxin|botulinum toxin
4915984|NCT02015039|Writer's Cramp|writer's cramp
4915985|NCT02015026|Biospecimen Repository|biospecimen repository
4915986|NCT02015026|Disease Progression Pattern|disease progression pattern
4915987|NCT02015026|Specimen Analysis|specimen analysis
4915988|NCT02015026|Genetic Analysis|genetic analysis
4915989|NCT02015013|Leukapheresis|leukapheresis
4915990|NCT02015013|Progenitor Cells|progenitor cells
4915991|NCT02015000|Pterygium|pterygium
4915992|NCT02015000|Recurrence|recurrence
4915993|NCT02014987|Running related injury|running related injury
4915994|NCT02014987|Overuse injury|overuse injury
4915995|NCT02014987|Running pattern|running pattern
4915996|NCT02014974|Fractures|fractures
4915997|NCT02014974|burden of fractures|burden of fractures
4915998|NCT02014974|orthopaedic fractures|orthopaedic fractures
4915999|NCT02014974|orthopaedic injuries|orthopaedic injuries
4916000|NCT02014974|orthopaedic trauma|orthopaedic trauma
4916001|NCT02014974|fractures India|fractures india
4916002|NCT02014974|observational study|observational study
4916003|NCT02014974|outcomes of fracture care|outcomes of fracture care
4916004|NCT02014974|wait times India|wait times india
4916005|NCT02014974|epidemiology|epidemiology
4916006|NCT02014948|Low Back Pain|low back pain
4916007|NCT02014948|Physiotherapy|physiotherapy
4916008|NCT02014935|Low-intensity Laser|low-intensity laser
4916009|NCT02014935|Spasticity|spasticity
4916010|NCT02014935|pain,|pain,
4916011|NCT02014935|Fatigue|fatigue
4916012|NCT02014909|KTN3379|ktn3379
4916013|NCT02014909|Advanced cancer|advanced cancer
4916014|NCT02014909|Phase 1|phase 1
4916015|NCT02014909|Monoclonal antibody|monoclonal antibody
4916016|NCT02014909|Safety and pharmacokinetics|safety and pharmacokinetics
4916017|NCT02014909|CDX3379|cdx3379
4916018|NCT02014896|Ischemic Stroke|ischemic stroke
4916019|NCT02014896|Transient Ischemic Attack|transient ischemic attack
4916020|NCT02014896|Transient Neurological Event|transient neurological event
4916021|NCT02014896|Atrial Fibrillation|atrial fibrillation
4916023|NCT02014896|Gene Expression|gene expression
4916024|NCT02014896|RNA|rna
4916025|NCT02014896|Anticoagulant|anticoagulant
4916026|NCT02014896|NOAC|noac
4916027|NCT02014896|Antiplatelet|antiplatelet
4916028|NCT02014896|Cardiac monitoring|cardiac monitoring
4916029|NCT02014896|Point of Care|point of care
4916030|NCT02014896|tPA|tpa
4916031|NCT02014896|Atheroembolic|atheroembolic
4916032|NCT02014870|Influenza|influenza
4916033|NCT02014870|Vaccine|vaccine
4916034|NCT02014870|Virus|virus
4916035|NCT02014870|H1N1|h1n1
4916036|NCT02014870|Challenge|challenge
4916037|NCT02014870|Vismederi|vismederi
4916038|NCT02014857|Smoking, gingival crevicular fluid, matrix metalloproteinases, intercellular signaling peptides and proteins, healthy volunteers|smoking, gingival crevicular fluid, matrix metalloproteinases, intercellular signaling peptides and proteins, healthy volunteers
4916039|NCT02014844|glioblastoma|glioblastoma
4916040|NCT02014844|aldoxorubicin|aldoxorubicin
4916041|NCT02014844|temozolomide|temozolomide
4916042|NCT02014844|brain cancer|brain cancer
4916043|NCT02014844|brain tumor|brain tumor
4916044|NCT02014831|Squamous Cell Carcinoma of the penis|squamous cell carcinoma of the penis
4916045|NCT02014831|Stage N3|stage n3
4916046|NCT02014831|Metastasis|metastasis
4916047|NCT02014831|TIP|tip
4916048|NCT02014831|Cetuximab|cetuximab
4916049|NCT02014831|Objective Response Rate|objective response rate
4916050|NCT02014831|Safety profile|safety profile
4916051|NCT02014831|Overall Survival|overall survival
4916052|NCT02014831|Progression Free Survival|progression free survival
4916053|NCT02014831|Quality of Life|quality of life
4916054|NCT02014805|postoperative|postoperative
4916055|NCT02014805|conformal|conformal
4916056|NCT02014805|radiotherapy|radiotherapy
4916057|NCT02014805|thymoma|thymoma
4916058|NCT02014792|Haemodialysis|haemodialysis
4916059|NCT02014792|Heart rate variability|heart rate variability
4916060|NCT02014792|n-3 PUFA|n-3 pufa
4916061|NCT02014779|Randomized Controlled Trial|randomized controlled trial
4916062|NCT02014779|Alcohol|alcohol
4916063|NCT02014779|Internet|internet
4916064|NCT02014779|Internet based therapy|internet based therapy
4916065|NCT02014779|Cognitive behavioral therapy|cognitive behavioral therapy
4916066|NCT02014753|AMI|ami
4916067|NCT02014753|STEMI|stemi
4916068|NCT02014753|ACS|acs
4916069|NCT02014740|Epicardial fat|epicardial fat
4916070|NCT02014740|Type 2 diabetes|type 2 diabetes
4916071|NCT02014740|Obesity|obesity
4916072|NCT02014740|GLP-1 analogs|glp-1 analogs
4916073|NCT02014727|Malaria vaccine|malaria vaccine
4916074|NCT02014727|phase 1,|phase 1,
4916075|NCT02014727|AMA1-DiCO|ama1-dico
4916076|NCT02014701|echocardiogram|echocardiogram
4916077|NCT02014701|regional wall motion abnormalities|regional wall motion abnormalities
4916078|NCT02014701|myocardial contrast|myocardial contrast
4916079|NCT02014688|Normal subjects|normal subjects
4916080|NCT02014675|ICD|icd
4916081|NCT02014675|CRT-D|crt-d
4916082|NCT02014675|Lead|lead
4916083|NCT02014662|Muscle function, Muscle damage and recovery, Eccentric exercise, Muscle soreness, Protein synthesis|muscle function, muscle damage and recovery, eccentric exercise, muscle soreness, protein synthesis
4916084|NCT02014649|Influenza treatment|influenza treatment
4916085|NCT02014649|pediatric|pediatric
4916086|NCT02014649|laninamivir|laninamivir
4916087|NCT02014636|Pazopanib (GW786034)|pazopanib (gw786034)
4916088|NCT02014636|MK 3475|mk 3475
4916089|NCT02014636|Renal cell carcinoma|renal cell carcinoma
4916090|NCT02014623|Allergic rhinitis|allergic rhinitis
4916091|NCT02014623|Asthma|asthma
4916092|NCT02014623|Regulatory T cells|regulatory t cells
4916093|NCT02014623|IgE|ige
4916094|NCT02014623|IgG4|igg4
4916095|NCT02014610|Neutrophil|neutrophil
4916096|NCT02014610|Lymphocyte|lymphocyte
4916097|NCT02014610|Eosinophil|eosinophil
4916098|NCT02014610|Leukocyte count|leukocyte count
4916099|NCT02014610|Cardiovascular disease|cardiovascular disease
4916100|NCT02014610|Atherosclerosis|atherosclerosis
4916101|NCT02014610|Monocyte|monocyte
4916102|NCT02014610|Basophil|basophil
4916103|NCT02014597|Glaucoma|glaucoma
4916104|NCT02014584|quality of life|quality of life
4916105|NCT02014584|safety|safety
4916106|NCT02014584|sexual function|sexual function
4916107|NCT02014584|male pattern hair loss (MPHL)|male pattern hair loss (mphl)
4916108|NCT02014584|Androgenic alopecia (AGA)|androgenic alopecia (aga)
4916109|NCT02014584|dutasteride|dutasteride
4916110|NCT02014584|satisfaction with hair growth|satisfaction with hair growth
4916111|NCT02014571|NS5B|ns5b
4916112|NCT02014571|chronic hepatitis C (CHC)|chronic hepatitis c (chc)
4916113|NCT02014571|antiviral activity|antiviral activity
4916114|NCT02014571|pharmacokinetics (PK)|pharmacokinetics (pk)
4916115|NCT02014571|Safety|safety
4916116|NCT02014571|hepatitis C virus (HCV)|hepatitis c virus (hcv)
4916117|NCT02014571|GSK2878175|gsk2878175
4916118|NCT02014558|Acute Myeloid Leukemia|acute myeloid leukemia
4916119|NCT02014558|Gilteritinib|gilteritinib
4916120|NCT02014558|ASP2215|asp2215
4916121|NCT02014545|brain metastases|brain metastases
4916122|NCT02014545|non-small cell lung cancer|non-small cell lung cancer
4916123|NCT02014545|whole brain radiation therapy|whole brain radiation therapy
4916124|NCT02014545|lucanthone|lucanthone
4916125|NCT02014532|Leukotriene receptor antagonist|leukotriene receptor antagonist
4916126|NCT02014532|Chronic periodontitis|chronic periodontitis
4916127|NCT02014532|Scaling and root planing|scaling and root planing
4916128|NCT02014532|C- reactive protein|c- reactive protein
4916129|NCT02014519|Adults|adults
4916130|NCT02014519|Hungary|hungary
4916131|NCT02014519|Bordetella pertussis|bordetella pertussis
4916132|NCT02014519|Seroprevalence|seroprevalence
4916133|NCT02014519|Pertussis antibodies|pertussis antibodies
4916134|NCT02014506|Children and adolescents|children and adolescents
4916135|NCT02014506|Malignant disease|malignant disease
4916136|NCT02014506|Non-malignant disease|non-malignant disease
4916137|NCT02014506|TCRαβ depletion|tcrαβ depletion
4916138|NCT02014506|Haploidentical hematopoietic stem cell transplantation|haploidentical hematopoietic stem cell transplantation
4916139|NCT02014493|Respiration|respiration
4916140|NCT02014493|Noninvasive Ventilation|noninvasive ventilation
4916141|NCT02014493|Work of breathing|work of breathing
4916142|NCT02014493|Infant, premature|infant, premature
4916143|NCT02014493|Electromyography|electromyography
4916144|NCT02014493|Diaphragm|diaphragm
4916145|NCT02014480|Long-acting beta-agonist|long-acting beta-agonist
4916146|NCT02014480|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
4916147|NCT02014480|Umeclidinium|umeclidinium
4916148|NCT02014480|Long-acting muscarinic antagonist|long-acting muscarinic antagonist
4916149|NCT02014480|Vilanterol|vilanterol
4916150|NCT02014454|Retinopathy of prematurity|retinopathy of prematurity
4916151|NCT02014454|Propranolol|propranolol
4916152|NCT02014454|Eye drops|eye drops
4916153|NCT02014454|Newborns|newborns
4916154|NCT02014454|Retinal angiogenesis|retinal angiogenesis
4916155|NCT02014454|Retinal neovascularization|retinal neovascularization
4916156|NCT02014415|Alpha-1|alpha-1
4916157|NCT02014415|AAT Deficiency|aat deficiency
4916158|NCT02014415|AATD|aatd
4916159|NCT02014415|Liver|liver
4916160|NCT02014415|Fibrosis|fibrosis
4916161|NCT02014415|Liver Transplant|liver transplant
4916162|NCT02014415|Cirrhosis|cirrhosis
4916163|NCT02014402|Vascular surgery|vascular surgery
4916164|NCT02014402|Hepatic surgery|hepatic surgery
4916165|NCT02014402|Soft tissue surgery|soft tissue surgery
4916166|NCT02014402|Spinal surgery|spinal surgery
4916167|NCT02014389|Retinal Dystrophies|retinal dystrophies
4916168|NCT02014389|Retinitis Pigmentosa|retinitis pigmentosa
4916169|NCT02014389|Glaucoma|glaucoma
4916170|NCT02014389|Visual Field|visual field
4916171|NCT02014376|Epidermolysis Bullosa|epidermolysis bullosa
4916172|NCT02014376|Simplex|simplex
4916173|NCT02014376|Recessive Dystrophic|recessive dystrophic
4916174|NCT02014376|Junctional non-Herlitz|junctional non-herlitz
4916175|NCT02014337|Mifepristone|mifepristone
4916176|NCT02014337|Eribulin Mesylate|eribulin mesylate
4916177|NCT02014337|Breast Cancer|breast cancer
4916178|NCT02014337|Ovarian Cancer|ovarian cancer
4916179|NCT02014337|Sarcoma|sarcoma
4916180|NCT02014337|Non-small cell lung cancer|non-small cell lung cancer
4916181|NCT02014337|Carcinoma, transitional cell|carcinoma, transitional cell
4916182|NCT02014337|Prostate cancer|prostate cancer
4916183|NCT02014337|Prostatic neoplasms|prostatic neoplasms
4916184|NCT02014311|Multidetector Computed Tomography|multidetector computed tomography
4916185|NCT02014311|Myocardial Perfusion Imaging|myocardial perfusion imaging
4916186|NCT02014311|Coronary Stenosis|coronary stenosis
4916187|NCT02014311|Coronary Artery Disease|coronary artery disease
4916188|NCT02014311|Angina Pectoris|angina pectoris
4916189|NCT02014298|Burns|burns
4916190|NCT02014298|Non-ablative fractional laser|non-ablative fractional laser
4916191|NCT02014298|scar texture|scar texture
4916192|NCT02014298|histology|histology
4916193|NCT02014298|laser treatment|laser treatment
4916194|NCT02014298|erbium:glass laser|erbium:glass laser
4916195|NCT02014298|meshed skin-grafts|meshed skin-grafts
4916196|NCT02014298|photothermolysis|photothermolysis
4916197|NCT02014298|skin|skin
4916198|NCT02014285|Acute Respiratory Failure|acute respiratory failure
4916199|NCT02014285|Critical Illness|critical illness
4916200|NCT02014285|Mechanical Ventilation|mechanical ventilation
4916201|NCT02014285|Muscle Architecture|muscle architecture
4916202|NCT02014285|Muscle Ultrasound|muscle ultrasound
4916203|NCT02014272|Bioequivalence|bioequivalence
4916204|NCT02014272|RIN 150|rin 150
4916205|NCT02014272|Healthy volunteers|healthy volunteers
4916206|NCT02014246|Movement Disorders|movement disorders
4916207|NCT02014246|Polymorphisms|polymorphisms
4916209|NCT02014246|Lymphoblast Cell Lines|lymphoblast cell lines
4916210|NCT02014233|Randomized clinical trial|randomized clinical trial
4916211|NCT02014233|Humans|humans
4916212|NCT02014233|Omega-3 fatty acids|omega-3 fatty acids
4916213|NCT02014233|Essential fatty acid|essential fatty acid
4916214|NCT02014233|Neuromuscular function|neuromuscular function
4916215|NCT02014233|Wingate|wingate
4916216|NCT02014233|Maximum voluntary contraction|maximum voluntary contraction
4916217|NCT02014233|Electromyography|electromyography
4916218|NCT02014233|Seal oil|seal oil
4916219|NCT02014233|Cycling time trial|cycling time trial
4916220|NCT02014233|Placebo controlled|placebo controlled
4916221|NCT02014194|Attentional Bias|attentional bias
4916222|NCT02014194|Attentional Bias modification treatment|attentional bias modification treatment
4916223|NCT02014181|cystic fibrosis|cystic fibrosis
4916224|NCT02014181|isoprostanes|isoprostanes
4916225|NCT02014181|8-oxo-dGuo|8-oxo-dguo
4916226|NCT02014181|oxidative stress|oxidative stress
4916227|NCT02014181|inflammation|inflammation
4916228|NCT02014181|flaxseed|flaxseed
4916229|NCT02014181|enterodiol|enterodiol
4916230|NCT02014181|enterolactone|enterolactone
4916231|NCT02014155|Chronic Obstructive Pulmonary Disease,|chronic obstructive pulmonary disease,
4916232|NCT02014103|bioequivalence|bioequivalence
4916233|NCT02014103|tacrolimus|tacrolimus
4916234|NCT02014103|transplant|transplant
4916235|NCT02014103|CYP3A5 expressors/non expressors|cyp3a5 expressors/non expressors
4916236|NCT02014090|ECP|ecp
4916237|NCT02014090|Endurance exercise|endurance exercise
4916238|NCT02014090|myocardial perfusion|myocardial perfusion
4916239|NCT02014077|VATS( Video-Assisted Thoracoscopy )|vats( video-assisted thoracoscopy )
4916240|NCT02014077|Thoracostomy Tube|thoracostomy tube
4916241|NCT02014077|Empyema|empyema
4916242|NCT02014077|Thoracotomy|thoracotomy
4916243|NCT02014064|Methamphetamine, Atomoxetine, Clinical Pharmacology|methamphetamine, atomoxetine, clinical pharmacology
4916244|NCT02014038|Ultrarunners|ultrarunners
4916245|NCT02014038|ultramarathon runners|ultramarathon runners
4916246|NCT02014038|ULTRA|ultra
4916247|NCT02014038|Physical activity|physical activity
4916248|NCT02014038|Health Risks|health risks
4916249|NCT02014038|sedentary|sedentary
4916250|NCT02014038|moderately active|moderately active
4916251|NCT02014025|Laparoscope hepatectomy|laparoscope hepatectomy
4916252|NCT02014025|Open hepatectomy|open hepatectomy
4916253|NCT02014025|large PHC|large phc
4916254|NCT02014025|safety and sensibility|safety and sensibility
4916255|NCT02013986|salivary cortisol|salivary cortisol
4916256|NCT02013986|circadian rhythm|circadian rhythm
4916257|NCT02013986|children|children
4916258|NCT02013986|etomidate|etomidate
4916259|NCT02013973|Anti mullerian hormone|anti mullerian hormone
4916260|NCT02013973|In vitro fertilization|in vitro fertilization
4916261|NCT02013973|Optimal treatment|optimal treatment
4916262|NCT02013973|Randomized controlled trial|randomized controlled trial
4916263|NCT02013947|Exercise, moderate altitude, hypoxia, metabolic syndrome|exercise, moderate altitude, hypoxia, metabolic syndrome
4916264|NCT02013921|Physical activity|physical activity
4916265|NCT02013921|Cancer|cancer
4916266|NCT02013908|acupuncture|acupuncture
4916267|NCT02013908|emergency department|emergency department
4916268|NCT02013908|acute pain|acute pain
4916269|NCT02013908|ankle sprain|ankle sprain
4916270|NCT02013908|neck pain|neck pain
4916271|NCT02013908|primary headache|primary headache
4916272|NCT02013895|liver|liver
4916273|NCT02013895|surgery|surgery
4916274|NCT02013895|liver function|liver function
4916275|NCT02013895|GSA|gsa
4916276|NCT02013895|ICG|icg
4916277|NCT02013882|low flow anesthesia|low flow anesthesia
4916278|NCT02013882|wash-in|wash-in
4916279|NCT02013882|desflurane|desflurane
4916280|NCT02013869|fresh gas flow|fresh gas flow
4916281|NCT02013869|quality of anaesthesia|quality of anaesthesia
4916282|NCT02013869|minimal alveolar concentration|minimal alveolar concentration
4916283|NCT02013856|Blood pressure|blood pressure
4916284|NCT02013856|Flavanols|flavanols
4916285|NCT02013856|Cardiovascular disease|cardiovascular disease
4916286|NCT02013843|Pediatric obesity|pediatric obesity
4916287|NCT02013843|Community-based treatment|community-based treatment
4916288|NCT02013843|dyslipidemia|dyslipidemia
4916289|NCT02013843|hypertension|hypertension
4916290|NCT02013843|diabetes|diabetes
4916291|NCT02013778|outside of transplant criteria|outside of transplant criteria
4916292|NCT02013752|Delivery tears|delivery tears
4916293|NCT02013752|Birth injuries|birth injuries
4916294|NCT02013752|Perineal protection device|perineal protection device
4916295|NCT02013713|Cardiology|cardiology
4916296|NCT02013713|Family Hypercholesterolemia|family hypercholesterolemia
4916297|NCT02013700|IPF|ipf
4916298|NCT02013700|Pulmonary fibrosis|pulmonary fibrosis
4916299|NCT02013674|Cardiovascular, Chronic Ischemic Left Ventricular Dysfunction|cardiovascular, chronic ischemic left ventricular dysfunction
4916300|NCT02013661|periodontal debridement|periodontal debridement
4916301|NCT02013661|sutures|sutures
4916302|NCT02013661|tissue reaction|tissue reaction
4916303|NCT02013648|AML|aml
4916304|NCT02013648|Dasatinib|dasatinib
4916305|NCT02013648|Core Binding Factor (CBF)|core binding factor (cbf)
4916306|NCT02013635|cerebral venous thrombosis|cerebral venous thrombosis
4916307|NCT02013635|thrombin generation|thrombin generation
4916308|NCT02013635|d-dimers|d-dimers
4916309|NCT02013635|clinical evolution|clinical evolution
4916310|NCT02013622|schizophrenia|schizophrenia
4916311|NCT02013622|Mental Disorders|mental disorders
4916312|NCT02013622|Psychotic Disorders|psychotic disorders
4916313|NCT02013622|social avoidance|social avoidance
4916314|NCT02013622|emotional withdrawal|emotional withdrawal
4916315|NCT02013622|passive/apathetic|passive/apathetic
4916316|NCT02013622|social withdrawal|social withdrawal
4916317|NCT02013622|antipsychotic|antipsychotic
4916318|NCT02013609|schizophrenia|schizophrenia
4916319|NCT02013609|Major depressive disorder|major depressive disorder
4916320|NCT02013609|Anxiety Symptoms|anxiety symptoms
4916321|NCT02013609|School, Work environment|school, work environment
4916322|NCT02013609|Mental Disorders|mental disorders
4916323|NCT02013609|Psychotic Disorders|psychotic disorders
4916324|NCT02013609|antipsychotic|antipsychotic
4916325|NCT02013596|hepatic dysfunction|hepatic dysfunction
4916326|NCT02013596|renal dysfunction|renal dysfunction
4916327|NCT02013596|pneumoperitoneum|pneumoperitoneum
4916328|NCT02013596|Transcutaneous electric stimulation|transcutaneous electric stimulation
4916329|NCT02013583|Glucose Transporter Type I Deficiency|glucose transporter type i deficiency
4916330|NCT02013583|Glucose Transporter Type 1 Deficiency|glucose transporter type 1 deficiency
4916331|NCT02013583|G1D|g1d
4916332|NCT02013583|Glut1 Deficiency|glut1 deficiency
4916333|NCT02013570|postoperative pain; dexmedetomidine; adenotonsillectomy|postoperative pain; dexmedetomidine; adenotonsillectomy
4916334|NCT02013557|Gestational Diabetes|gestational diabetes
4916335|NCT02013557|Postpartum screening|postpartum screening
4916336|NCT02013557|Text-messages|text-messages
4916337|NCT02013557|75-g oral glucose tolerance test|75-g oral glucose tolerance test
4916338|NCT02013544|Vulvovaginal atrophy (VVA)|vulvovaginal atrophy (vva)
4916339|NCT02013544|Vaginal atrophy|vaginal atrophy
4916340|NCT02013544|Atrophic vaginitis|atrophic vaginitis
4916341|NCT02013544|prasterone|prasterone
4916342|NCT02013544|DHEA|dhea
4916343|NCT02013544|Intrarosa|intrarosa
4916344|NCT02013531|schizophrenia|schizophrenia
4916345|NCT02013531|Major depressive disorder|major depressive disorder
4916440|NCT02013037|Eculizumab|eculizumab
4916346|NCT02013531|Anxiety Symptoms|anxiety symptoms
4916347|NCT02013531|Mental Disorders|mental disorders
4916348|NCT02013531|Psychotic Disorders|psychotic disorders
4916349|NCT02013531|emotional withdrawal|emotional withdrawal
4916350|NCT02013531|antipsychotic|antipsychotic
4916351|NCT02013518|Alzheimers' disease|alzheimers' disease
4916352|NCT02013518|Cognitive behavioral therapy|cognitive behavioral therapy
4916353|NCT02013518|Depression|depression
4916354|NCT02013518|Self-efficacy|self-efficacy
4916355|NCT02013518|Quality of Life|quality of life
4916356|NCT02013505|Colonoscopy|colonoscopy
4916357|NCT02013492|Beta-Blocker|beta-blocker
4916358|NCT02013492|metastatic melanoma|metastatic melanoma
4916359|NCT02013492|hepatocellular carcinoma|hepatocellular carcinoma
4916360|NCT02013466|Bioavailability|bioavailability
4916361|NCT02013466|Amino Acids|amino acids
4916362|NCT02013466|Elderly|elderly
4916363|NCT02013466|Supplement|supplement
4916364|NCT02013427|chronic|chronic
4916365|NCT02013427|back|back
4916366|NCT02013427|pain|pain
4916367|NCT02013427|brain|brain
4916368|NCT02013427|MRI|mri
4916369|NCT02013401|mother-infant dyadic regulation|mother-infant dyadic regulation
4916370|NCT02013401|stress|stress
4916371|NCT02013401|psychophysiology|psychophysiology
4916372|NCT02013401|emotion regulation|emotion regulation
4916373|NCT02013388|N91115|n91115
4916374|NCT02013388|GSNORi|gsnori
4916375|NCT02013388|SNO|sno
4916376|NCT02013388|Cavosonstat|cavosonstat
4916377|NCT02013336|pediatric|pediatric
4916378|NCT02013336|MM-398|mm-398
4916379|NCT02013336|cyclophosphamide|cyclophosphamide
4916380|NCT02013336|irinotecan|irinotecan
4916381|NCT02013323|Septiline, chronic periodontitis, Immunomodulator, microbiology|septiline, chronic periodontitis, immunomodulator, microbiology
4916382|NCT02013297|Pediatrics|pediatrics
4916383|NCT02013297|SBRT|sbrt
4916384|NCT02013297|Brain metastasis|brain metastasis
4916385|NCT02013297|Pulmonary metastasis|pulmonary metastasis
4916386|NCT02013297|Spinal metastasis|spinal metastasis
4916387|NCT02013297|Pulmonary primary tumor|pulmonary primary tumor
4916388|NCT02013297|Spinal primary tumor|spinal primary tumor
4916389|NCT02013297|Relapsed ependymoma|relapsed ependymoma
4916390|NCT02013297|Relapsed irradiated tumors|relapsed irradiated tumors
4916391|NCT02013297|Local control rate|local control rate
4916392|NCT02013297|Safety|safety
4916393|NCT02013297|Overall survival|overall survival
4916394|NCT02013297|Progression Free Survival|progression free survival
4916395|NCT02013258|Prader Willi syndrome|prader willi syndrome
4916396|NCT02013258|Oxytocin|oxytocin
4916397|NCT02013232|Risperidone;|risperidone;
4916398|NCT02013232|Aripiprazole;|aripiprazole;
4916399|NCT02013232|Hyperprolactinemia;|hyperprolactinemia;
4916400|NCT02013232|dose effects|dose effects
4916401|NCT02013193|drug-coated balloon|drug-coated balloon
4916402|NCT02013193|drug-eluting balloon|drug-eluting balloon
4916403|NCT02013193|peripheral artery disease|peripheral artery disease
4916404|NCT02013193|claudication|claudication
4916405|NCT02013180|Prostate cancer, PSA, zinc, zinc/PSA|prostate cancer, psa, zinc, zinc/psa
4916406|NCT02013167|Relapsed; Refractory; B-precursor; Acute Lymphoblastic Leukemia; Philadelphia Negative; ALL; Blinatumomab; Leukemia; Standard of Care; SOC|relapsed; refractory; b-precursor; acute lymphoblastic leukemia; philadelphia negative; all; blinatumomab; leukemia; standard of care; soc
4916407|NCT02013141|Gram positive bacteria|gram positive bacteria
4916408|NCT02013141|Telavancin|telavancin
4916409|NCT02013141|VIBATIV|vibativ
4916410|NCT02013141|Pediatric|pediatric
4916411|NCT02013141|Pharmacokinetics|pharmacokinetics
4916412|NCT02013115|infant|infant
4916413|NCT02013115|respiratory distress syndrome|respiratory distress syndrome
4916414|NCT02013089|genomic sequencing, Integrated genomic network analysis|genomic sequencing, integrated genomic network analysis
4916415|NCT02013076|Asthma; Children; Cohort study; Corticosteroids|asthma; children; cohort study; corticosteroids
4916416|NCT02013063|Single Pulmonary Nodule|single pulmonary nodule
4916417|NCT02013063|SPN|spn
4916418|NCT02013063|Lung cancer|lung cancer
4916419|NCT02013063|Diagnostic|diagnostic
4916420|NCT02013063|Computed Tomography|computed tomography
4916421|NCT02013063|CT scan|ct scan
4916422|NCT02013063|FDG-PET scan|fdg-pet scan
4916423|NCT02013063|Dynamic CT scan|dynamic ct scan
4916424|NCT02013063|DCE-CT scan|dce-ct scan
4916425|NCT02013063|Dynamic contrast enhanced CT scan|dynamic contrast enhanced ct scan
4916426|NCT02013063|soft tissue solitary dominant|soft tissue solitary dominant
4916427|NCT02013063|≥ 8mm and ≤30mm|≥ 8mm and ≤30mm
4916428|NCT02013037|cardiac transplantation|cardiac transplantation
4916429|NCT02013037|immunosuppression|immunosuppression
4916430|NCT02013037|acute cellular rejection|acute cellular rejection
4916431|NCT02013037|antibody mediated rejection|antibody mediated rejection
4916432|NCT02013037|sensitization|sensitization
4916433|NCT02013037|antibody production in cardiac patients|antibody production in cardiac patients
4916434|NCT02013037|panel reactive antibodies|panel reactive antibodies
4916435|NCT02013037|desensitization strategies in heart transplant patients|desensitization strategies in heart transplant patients
4916436|NCT02013037|complement activation|complement activation
4916437|NCT02013037|complement c3d and c4d deposition|complement c3d and c4d deposition
4916438|NCT02013037|terminal complement inhibition|terminal complement inhibition
4916439|NCT02013037|complement C5 binding|complement c5 binding
4916441|NCT02013037|monoclonal antibody|monoclonal antibody
4916442|NCT02013037|donor specific antibodies|donor specific antibodies
4916443|NCT02012985|hyperoxaluria|hyperoxaluria
4916444|NCT02012985|oxalate|oxalate
4916445|NCT02012985|PH|ph
4916446|NCT02012972|Antiretroviral therapy|antiretroviral therapy
4916447|NCT02012972|HIV/AIDS|hiv/aids
4916448|NCT02012972|Non-communicable diseases|non-communicable diseases
4916449|NCT02012972|South Africa|south africa
4916450|NCT02012959|Hyponatremia|hyponatremia
4916451|NCT02012959|Euvolemic|euvolemic
4916452|NCT02012959|Hypervolemic|hypervolemic
4916453|NCT02012959|Serum sodium|serum sodium
4916454|NCT02012959|Dilutional hyponatremia|dilutional hyponatremia
4916455|NCT02012959|Electrolyte abnormality|electrolyte abnormality
4916456|NCT02012959|Electrolyte imbalance|electrolyte imbalance
4916457|NCT02012959|Metabolic disease|metabolic disease
4916458|NCT02012933|3,4DAP, LEMS, CM|3,4dap, lems, cm
4916459|NCT02012920|castration-resistant prostate cancer|castration-resistant prostate cancer
4916460|NCT02012920|CYP17|cyp17
4916461|NCT02012920|P450c17a|p450c17a
4916462|NCT02012920|lyase|lyase
4916463|NCT02012920|Prostate Cancer|prostate cancer
4916464|NCT02012894|Obesity|obesity
4916465|NCT02012894|Gastroesophageal reflux|gastroesophageal reflux
4916466|NCT02012894|sleeve gastrectomy|sleeve gastrectomy
4916467|NCT02012894|pH-monitoring|ph-monitoring
4916468|NCT02012894|manometry|manometry
4916469|NCT02012868|obstructive sleep apnoea|obstructive sleep apnoea
4916470|NCT02012868|weight loss|weight loss
4916471|NCT02012868|bariatric surgery|bariatric surgery
4916472|NCT02012842|Metabolic Syndrome|metabolic syndrome
4916473|NCT02012842|Periodontal Disease|periodontal disease
4916474|NCT02012842|Periodontal therapy|periodontal therapy
4916475|NCT02012842|inflammatory markers|inflammatory markers
4916476|NCT02012842|C reactive protein|c reactive protein
4916477|NCT02012842|serum fibrinogen|serum fibrinogen
4916478|NCT02012842|glycated hemoglobin|glycated hemoglobin
4916479|NCT02012829|cancer, CRC screening, communication|cancer, crc screening, communication
4916480|NCT02012816|Uncircumcised men|uncircumcised men
4916481|NCT02012816|Voluntary Medical Male circumcision|voluntary medical male circumcision
4916482|NCT02012816|Peer-referral incentive|peer-referral incentive
4916483|NCT02012803|Achilles tendon rupture|achilles tendon rupture
4916484|NCT02012803|treatment, elongation|treatment, elongation
4916485|NCT02012803|operative treatment of achilles tendon rupture|operative treatment of achilles tendon rupture
4916486|NCT02012803|conservative treatment of achilles tendon rupture|conservative treatment of achilles tendon rupture
4916487|NCT02012790|Migraine disorders|migraine disorders
4916488|NCT02012777|sickle cell disease|sickle cell disease
4916489|NCT02012777|propanolol|propanolol
4916490|NCT02012777|red blood cell adhesion|red blood cell adhesion
4916491|NCT02012764|Anti-CCP antibody|anti-ccp antibody
4916492|NCT02012764|Inflammatory arthritis|inflammatory arthritis
4916493|NCT02012764|Rheumatoid arthritis|rheumatoid arthritis
4916494|NCT02012764|Musculoskeletal symptom|musculoskeletal symptom
4916495|NCT02012751|Computer-assisted diagnosis|computer-assisted diagnosis
4916496|NCT02012751|General practice|general practice
4916497|NCT02012751|Dermatoscopy|dermatoscopy
4916498|NCT02012751|Melanoma|melanoma
4916499|NCT02012751|Nevus|nevus
4916500|NCT02012725|Healthy|healthy
4916501|NCT02012725|Myocardial fibrosis|myocardial fibrosis
4916502|NCT02012725|Chronic kidney disease|chronic kidney disease
4916503|NCT02012712|Personal health record|personal health record
4916504|NCT02012712|medication management|medication management
4916505|NCT02012712|patient safety|patient safety
4916506|NCT02012699|Pancreatic Cancer|pancreatic cancer
4916507|NCT02012699|Thyroid Cancer|thyroid cancer
4916508|NCT02012699|Esophageal cancer|esophageal cancer
4916509|NCT02012699|Thymus cancer|thymus cancer
4916510|NCT02012699|Pancreatic tumor|pancreatic tumor
4916511|NCT02012699|Esophageal tumor|esophageal tumor
4916512|NCT02012699|Thymus tumor|thymus tumor
4916513|NCT02012699|Thyroid Tumor|thyroid tumor
4916514|NCT02012699|Thyroid Nodule|thyroid nodule
4916515|NCT02012699|Lung Tumor|lung tumor
4916516|NCT02012686|transcutaneous electric nerve stimulation|transcutaneous electric nerve stimulation
4916517|NCT02012686|thyroidectomy|thyroidectomy
4916518|NCT02012686|neck pain|neck pain
4916519|NCT02012686|pain management|pain management
4916520|NCT02012673|COPD|copd
4916521|NCT02012673|Emphysema|emphysema
4916522|NCT02012673|Bronchoscopy|bronchoscopy
4916523|NCT02012673|Lung Volume Reduction|lung volume reduction
4916524|NCT02012647|parkinson|parkinson
4916525|NCT02012647|PD|pd
4916526|NCT02012647|parkinson disease|parkinson disease
4916527|NCT02012647|parkinson's|parkinson's
4916528|NCT02012647|parkinson's disease|parkinson's disease
4916529|NCT02012647|parkinsons|parkinsons
4916530|NCT02012647|parkinsons disease|parkinsons disease
4916531|NCT02012647|TMS|tms
4916532|NCT02012647|DBS|dbs
4916533|NCT02012647|transcranial magnetic stimulation|transcranial magnetic stimulation
4916534|NCT02012647|deep brain stimulation|deep brain stimulation
4916535|NCT02012634|Breast Cancer|breast cancer
4916536|NCT02012634|Capecitabine|capecitabine
4916537|NCT02012634|Triple Negative Breast CancerTNBC（TNBC）|triple negative breast cancertnbc（tnbc）
4916538|NCT02012621|HIV/AIDS|hiv/aids
4916539|NCT02012621|Adherence|adherence
4916540|NCT02012621|Tenofovir|tenofovir
4916541|NCT02012621|Dried Blood Spots|dried blood spots
4916542|NCT02012608|breast|breast
4916543|NCT02012569|skin grafting|skin grafting
4916544|NCT02012569|elective treatment|elective treatment
4916545|NCT02012543|constipation, agar|constipation, agar
4916546|NCT02012530|Articular cartilage|articular cartilage
4916547|NCT02012530|Hyaluronic Acid (HA)|hyaluronic acid (ha)
4916548|NCT02012530|Platelet rich plasma (PRP)|platelet rich plasma (prp)
4916549|NCT02012517|surgical site infection|surgical site infection
4916550|NCT02012517|breast reconstruction|breast reconstruction
4916551|NCT02012517|drains|drains
4916552|NCT02012517|prophylaxis|prophylaxis
4916553|NCT02012491|Spontaneous abortion|spontaneous abortion
4916554|NCT02012491|Early Pregnancy Failure|early pregnancy failure
4916555|NCT02012491|Mifepristone|mifepristone
4916556|NCT02012491|Misoprostol|misoprostol
4916557|NCT02012465|Steroid induced hyperglycemia|steroid induced hyperglycemia
4916558|NCT02012465|Glucocorticoid induced hyperglycemia|glucocorticoid induced hyperglycemia
4916559|NCT02012452|posttraumatic stress disorder|posttraumatic stress disorder
4916560|NCT02012452|tobacco dependence|tobacco dependence
4916561|NCT02012452|cognitive behavioral therapy|cognitive behavioral therapy
4916562|NCT02012439|multiple sclerosis|multiple sclerosis
4916563|NCT02012439|chronic pain|chronic pain
4916564|NCT02012439|treatment|treatment
4916565|NCT02012439|nonpharmacological|nonpharmacological
4916566|NCT02012439|mindfulness|mindfulness
4916567|NCT02012439|cognitive therapy|cognitive therapy
4916568|NCT02012413|knee|knee
4916569|NCT02012413|chondromalacia|chondromalacia
4916570|NCT02012413|patella|patella
4916571|NCT02012413|pulsed signal therapy|pulsed signal therapy
4916572|NCT02012413|PST|pst
4916573|NCT02012400|Asthma|asthma
4916574|NCT02012400|Exercise|exercise
4916575|NCT02012400|Asthma control|asthma control
4916576|NCT02012400|Physical fitness|physical fitness
4916577|NCT02012400|Quality of life|quality of life
4916578|NCT02012387|Cholinergic urticaria|cholinergic urticaria
4916579|NCT02012387|Omalizumab|omalizumab
4916580|NCT02012374|aphasia|aphasia
4916581|NCT02012374|anomia|anomia
4916582|NCT02012374|speech therapy|speech therapy
4916583|NCT02012374|rehabilitation|rehabilitation
4916584|NCT02012374|neuroplasticity|neuroplasticity
4916585|NCT02012374|fMRI|fmri
4916586|NCT02012374|quality of life|quality of life
4916587|NCT02012361|Ischemic preconditioning|ischemic preconditioning
4916588|NCT02012361|Human limb ischemia|human limb ischemia
4916589|NCT02012361|Total knee arthroplasty|total knee arthroplasty
4916590|NCT02012361|Supplemental inspired helium|supplemental inspired helium
4916591|NCT02012348|bacteria survival, surfactants|bacteria survival, surfactants
4916592|NCT02012322|Aging|aging
4916593|NCT02012322|Coenzyme Q10|coenzyme q10
4916594|NCT02012322|Q10|q10
4916595|NCT02012322|Quality of Life|quality of life
4916596|NCT02012322|Oxidative Stress|oxidative stress
4916597|NCT02012322|Mitochondrial Function|mitochondrial function
4916598|NCT02012322|Cell Energetics|cell energetics
4916599|NCT02012322|Fatigue|fatigue
4916600|NCT02012322|Ubiquinone|ubiquinone
4916601|NCT02012309|HIV|hiv
4916602|NCT02012309|Streptococcus pneumoniae infection|streptococcus pneumoniae infection
4916603|NCT02012309|Streptococcus pneumoniae colonization|streptococcus pneumoniae colonization
4916604|NCT02012309|Pneumococcal vaccines|pneumococcal vaccines
4916605|NCT02012309|Prevnar|prevnar
4916606|NCT02012309|Pneumovax|pneumovax
4916607|NCT02012309|Nasopharyngeal microbiome|nasopharyngeal microbiome
4916608|NCT02012283|spices and vegetables|spices and vegetables
4916609|NCT02012270|Aortic Aneurysm|aortic aneurysm
4916610|NCT02012270|Hernia|hernia
4916611|NCT02012270|Abdominal Wound Closure Techniques|abdominal wound closure techniques
4916612|NCT02012257|anterior middle superior alveolar nerve|anterior middle superior alveolar nerve
4916613|NCT02012257|electric pulp tester|electric pulp tester
4916614|NCT02012257|local anesthesia|local anesthesia
4916615|NCT02012244|analgesia; colorectal surgery; immunity; local anesthetics; opioids|analgesia; colorectal surgery; immunity; local anesthetics; opioids
4916616|NCT02012231|melanoma|melanoma
4916617|NCT02012231|anaplastic thyroid cancer|anaplastic thyroid cancer
4916618|NCT02012231|advanced papillary thyroid cancer|advanced papillary thyroid cancer
4916619|NCT02012231|colorectal cancer|colorectal cancer
4916620|NCT02012231|non-small cell lung cancer|non-small cell lung cancer
4916621|NCT02012231|cholangiocarcinoma|cholangiocarcinoma
4916622|NCT02012231|histiocytosis|histiocytosis
4916623|NCT02012231|hairy cell leukemia|hairy cell leukemia
4916624|NCT02012218|Major Depressive Disorder, Depression|major depressive disorder, depression
4916625|NCT02012205|wet cupping - back pain - NSLBP - Saudi|wet cupping - back pain - nslbp - saudi
4916626|NCT02012192|High-grade serous|high-grade serous
4916627|NCT02012192|high-grade endometrioid|high-grade endometrioid
4916628|NCT02012192|undifferentiated|undifferentiated
4916629|NCT02012179|Diet|diet
4916630|NCT02012179|Dietary sodium reduction|dietary sodium reduction
4916631|NCT02012179|Salt restriction|salt restriction
4916632|NCT02012179|Nutrition|nutrition
4916633|NCT02012166|Diabetes Mellitus|diabetes mellitus
4916634|NCT02012166|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
4916833|NCT02011191|Dialysis|dialysis
4916635|NCT02012166|Glucose Metabolism Disorders|glucose metabolism disorders
4916636|NCT02012166|Metabolic Diseases|metabolic diseases
4916637|NCT02012166|Endocrine System Diseases|endocrine system diseases
4916638|NCT02012166|Therapeutic Uses|therapeutic uses
4916639|NCT02012166|Pharmacologic Actions|pharmacologic actions
4916640|NCT02012166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
4916892|NCT02010853|resting state|resting state
4916641|NCT02012166|Physiological Effects of Drugs|physiological effects of drugs
4916642|NCT02012153|Mesenchymal stromal cells|mesenchymal stromal cells
4916643|NCT02012153|Kidney transplantation|kidney transplantation
4916644|NCT02012153|Tolerance|tolerance
4916645|NCT02012114|Cystinosis, compliance, cysteamine, neurological assessments|cystinosis, compliance, cysteamine, neurological assessments
4916646|NCT02012101|COPD|copd
4916647|NCT02012101|dyspnea|dyspnea
4916648|NCT02012101|exercise|exercise
4916649|NCT02012101|Noninvasive Ventilation|noninvasive ventilation
4916650|NCT02012088|Follicular lymphoma, large B-cell lymphoma|follicular lymphoma, large b-cell lymphoma
4916651|NCT02012062|Nasopharyngeal carcinoma|nasopharyngeal carcinoma
4916652|NCT02012062|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
4916653|NCT02012062|Concurrent chemotherapy|concurrent chemotherapy
4916654|NCT02012062|Nimotuzumab|nimotuzumab
4916655|NCT02012049|Healthy|healthy
4916656|NCT02012049|Risperdal OD|risperdal od
4916657|NCT02012049|Risperdal Quicklet|risperdal quicklet
4916658|NCT02012049|Korea|korea
4916659|NCT02012023|Low anterior resection|low anterior resection
4916660|NCT02012023|Anastomotic leakage|anastomotic leakage
4916661|NCT02012023|Defunctioning stoma|defunctioning stoma
4916662|NCT02012023|Controllable tube ileostomy|controllable tube ileostomy
4916663|NCT02012023|Loop ileostomy|loop ileostomy
4916664|NCT02012010|hysteroscopy, water intoxication, hyponatremia|hysteroscopy, water intoxication, hyponatremia
4916665|NCT02011971|epilepsy|epilepsy
4916666|NCT02011971|cognition|cognition
4916667|NCT02011971|memory|memory
4916668|NCT02011958|Visceral Leishmaniasis|visceral leishmaniasis
4916669|NCT02011958|HIV positive patients|hiv positive patients
4916670|NCT02011958|Phase III trial|phase iii trial
4916671|NCT02011958|Randomised|randomised
4916672|NCT02011958|Liposomal amphotericin B|liposomal amphotericin b
4916673|NCT02011958|Ambisome|ambisome
4916674|NCT02011958|Miltefosine|miltefosine
4916675|NCT02011958|Pentamidine|pentamidine
4916676|NCT02011958|Efficacy|efficacy
4916677|NCT02011958|Safety|safety
4916678|NCT02011906|antioxidant enzymes|antioxidant enzymes
4916679|NCT02011906|omega 3|omega 3
4916680|NCT02011906|vitamin E|vitamin e
4916681|NCT02011906|CAD|cad
4916682|NCT02011906|Sirtuins|sirtuins
4916683|NCT02011906|FOXOs|foxos
4916684|NCT02011880|breast cancer|breast cancer
4916685|NCT02011880|bone metastasis|bone metastasis
4916686|NCT02011880|traditional Chinese medicine(TCM)|traditional chinese medicine(tcm)
4916687|NCT02011867|Inner Ear Malformations|inner ear malformations
4916688|NCT02011867|Gusher|gusher
4916689|NCT02011867|Cochlear Implantation|cochlear implantation
4916690|NCT02011854|acupuncture，rehabilitation,Shoulder-hand Syndrome|acupuncture，rehabilitation,shoulder-hand syndrome
4916691|NCT02011841|liver cirrhosis|liver cirrhosis
4916692|NCT02011841|ascites|ascites
4916693|NCT02011841|spontaneous bacterial peritonitis|spontaneous bacterial peritonitis
4916694|NCT02011841|recurrence|recurrence
4916695|NCT02011828|Hemodialysis, paricalcitol|hemodialysis, paricalcitol
4916696|NCT02011815|Breast neoplasms|breast neoplasms
4916697|NCT02011815|Circadian rhythm|circadian rhythm
4916698|NCT02011815|sleep|sleep
4916699|NCT02011815|survival|survival
4916700|NCT02011815|distress|distress
4916701|NCT02011815|anxiety|anxiety
4916702|NCT02011815|depression|depression
4916703|NCT02011815|quality of life|quality of life
4916704|NCT02011815|actigraph|actigraph
4916705|NCT02011815|fatigue|fatigue
4916706|NCT02011802|Sorbact TM|sorbact tm
4916707|NCT02011802|Alginates|alginates
4916708|NCT02011802|Dressing|dressing
4916709|NCT02011802|Wound healing|wound healing
4916710|NCT02011789|hypercholesterolemia|hypercholesterolemia
4916711|NCT02011789|inflammation|inflammation
4916712|NCT02011789|citrus limonoids|citrus limonoids
4916713|NCT02011776|Corticosteroids Dry Eye Sjögren syndrome inflammation treatment|corticosteroids dry eye sjögren syndrome inflammation treatment
4916714|NCT02011763|Hepatitis A|hepatitis a
4916715|NCT02011763|hepatitis A virus|hepatitis a virus
4916716|NCT02011763|Avaxim® 80U Pediatric|avaxim® 80u pediatric
4916717|NCT02011750|schizophrenia|schizophrenia
4916718|NCT02011750|toxoplasmosis|toxoplasmosis
4916719|NCT02011737|Medical Expulsive therapy|medical expulsive therapy
4916720|NCT02011698|Groin hernia|groin hernia
4916721|NCT02011698|lichtenstein herniorrhaphy|lichtenstein herniorrhaphy
4916722|NCT02011672|dairy|dairy
4916723|NCT02011672|glucose|glucose
4916724|NCT02011672|inflammation|inflammation
4916725|NCT02011659|Ramosetron, postoperative nausea and vomiting, laparoscopy|ramosetron, postoperative nausea and vomiting, laparoscopy
4916726|NCT02011646|diet|diet
4916727|NCT02011646|body weight|body weight
4916728|NCT02011646|eating|eating
4916729|NCT02011646|eating disorder|eating disorder
4916730|NCT02011646|exercise|exercise
4916731|NCT02011581|Overweight|overweight
4916732|NCT02011568|Therapeutic Hypothermia|therapeutic hypothermia
4916733|NCT02011568|Out of hospital cardiac arrest|out of hospital cardiac arrest
4916734|NCT02011568|Mild hypothermia|mild hypothermia
4916735|NCT02011568|Moderate hypothermia|moderate hypothermia
4916736|NCT02011542|Irritable Bowel Syndrome|irritable bowel syndrome
4916737|NCT02011542|Gulf War Illness|gulf war illness
4916738|NCT02011516|Marijuana|marijuana
4916739|NCT02011516|Addiction|addiction
4916740|NCT02011516|fMRI|fmri
4916741|NCT02011516|Baclofen|baclofen
4916742|NCT02011516|Treatment|treatment
4916743|NCT02011477|Neural mobilization|neural mobilization
4916744|NCT02011477|Physical therapy|physical therapy
4916745|NCT02011477|Asymptomatic subjects|asymptomatic subjects
4916746|NCT02011451|Multiple Sclerosis|multiple sclerosis
4916747|NCT02011451|Green Tea|green tea
4916748|NCT02011451|ECGC|ecgc
4916749|NCT02011451|Theaphenon|theaphenon
4916750|NCT02011451|Randomized placebo controlled trial|randomized placebo controlled trial
4916751|NCT02011451|NAA|naa
4916752|NCT02011451|Spectroscopy|spectroscopy
4916753|NCT02011451|Brain Atrophy|brain atrophy
4916754|NCT02011451|SIENA|siena
4916755|NCT02011438|Social Anxiety|social anxiety
4916756|NCT02011438|Prevention|prevention
4916757|NCT02011438|Peer Relations|peer relations
4916758|NCT02011438|Depression|depression
4916759|NCT02011438|Adolescent|adolescent
4916760|NCT02011438|High School|high school
4916761|NCT02011438|Interpersonal|interpersonal
4916762|NCT02011438|Peer Victimization|peer victimization
4916763|NCT02011425|obstructive sleep apnea|obstructive sleep apnea
4916764|NCT02011425|oral appliance|oral appliance
4916765|NCT02011425|therapy|therapy
4916766|NCT02011425|masseter muscle activity|masseter muscle activity
4916767|NCT02011425|randomized controlled trial|randomized controlled trial
4916768|NCT02011425|mandibular advancement device|mandibular advancement device
4916769|NCT02011425|mandibular advancement appliance|mandibular advancement appliance
4916770|NCT02011425|arousals|arousals
4916771|NCT02011412|Trauma|trauma
4916772|NCT02011412|Scoring Systems|scoring systems
4916773|NCT02011412|Intermountain Risk Score|intermountain risk score
4916774|NCT02011399|brain|brain
4916775|NCT02011399|computer|computer
4916776|NCT02011399|interfaces|interfaces
4916777|NCT02011399|mobility impairments|mobility impairments
4916778|NCT02011373|prolapse, laparoscopic sacrocolpopexy, IFABONDTM glue|prolapse, laparoscopic sacrocolpopexy, ifabondtm glue
4916779|NCT02011360|Prader Willi syndrome|prader willi syndrome
4916780|NCT02011360|childhood obesity|childhood obesity
4916781|NCT02011360|ghrelin|ghrelin
4916782|NCT02011360|appetite regulation|appetite regulation
4916783|NCT02011321|subarachnoid hemorrhage|subarachnoid hemorrhage
4916784|NCT02011321|aneurysm|aneurysm
4916785|NCT02011321|vasospasm|vasospasm
4916786|NCT02011321|clevidipine|clevidipine
4916787|NCT02011321|transcranial dopplers|transcranial dopplers
4916788|NCT02011295|OLT|olt
4916789|NCT02011295|Surgical Intervention|surgical intervention
4916790|NCT02011295|BMAC|bmac
4916791|NCT02011282|ICU,|icu,
4916792|NCT02011282|MYOPATHY,|myopathy,
4916793|NCT02011282|NEUROPATHY,|neuropathy,
4916794|NCT02011282|PNEUMONIA|pneumonia
4916795|NCT02011269|TSO|tso
4916796|NCT02011269|Ova|ova
4916797|NCT02011269|Psoriasis|psoriasis
4916798|NCT02011269|plaque psoriasis|plaque psoriasis
4916799|NCT02011269|plaque-type|plaque-type
4916800|NCT02011269|Coronado|coronado
4916801|NCT02011269|Moderate to severe plaque psoriasis|moderate to severe plaque psoriasis
4916802|NCT02011256|Transient Ischemic Attack|transient ischemic attack
4916803|NCT02011256|Atrial Fibrillation|atrial fibrillation
4916804|NCT02011256|NOTICE|notice
4916805|NCT02011256|Implantable loop-recorder|implantable loop-recorder
4916806|NCT02011256|Holter-monitoring|holter-monitoring
4916807|NCT02011243|deficit|deficit
4916808|NCT02011243|internal rotation|internal rotation
4916809|NCT02011243|gleno humeral articulation|gleno humeral articulation
4916810|NCT02011243|hand ball|hand ball
4916811|NCT02011230|Dehydration|dehydration
4916812|NCT02011230|Hoist|hoist
4916813|NCT02011230|pain control|pain control
4916814|NCT02011230|The intervention is to provide a commercially available isotonic hydration solution (Hoist®) to the patients.|the intervention is to provide a commercially available isotonic hydration solution (hoist®) to the patients.
4916815|NCT02011230|Patients will drink this solution post procedure as needed.|patients will drink this solution post procedure as needed.
4916816|NCT02011230|Patients in the control group will use their discretion to drink any solution they feel suitable|patients in the control group will use their discretion to drink any solution they feel suitable
4916817|NCT02011217|Rye|rye
4916818|NCT02011217|Dietary Fibre|dietary fibre
4916819|NCT02011217|Bread|bread
4916820|NCT02011217|Crisp bread|crisp bread
4916821|NCT02011217|Appetite|appetite
4916822|NCT02011217|Satiety|satiety
4916823|NCT02011217|Hunger|hunger
4916824|NCT02011217|Desire to eat|desire to eat
4916825|NCT02011217|Metabolism|metabolism
4916826|NCT02011217|Glucose|glucose
4916827|NCT02011217|Insulin|insulin
4916828|NCT02011217|Gut hormones|gut hormones
4916829|NCT02011217|Gastric emptying rate|gastric emptying rate
4916830|NCT02011191|Biotin|biotin
4916831|NCT02011191|Restless|restless
4916832|NCT02011191|Kidney|kidney
4916834|NCT02011191|Renal|renal
4916835|NCT02011165|Macular hole|macular hole
4916836|NCT02011165|Vitrectomy|vitrectomy
4916837|NCT02011165|Gas tamponade|gas tamponade
4916838|NCT02011165|Vitreomacular traction in danger of macular hole formation|vitreomacular traction in danger of macular hole formation
4916839|NCT02011165|Epiretinal membrane in danger of macular hole formation|epiretinal membrane in danger of macular hole formation
4916840|NCT02011113|Pomalidomide,|pomalidomide,
4916841|NCT02011113|CC-4047,|cc-4047,
4916842|NCT02011113|Dexamethasone,|dexamethasone,
4916843|NCT02011113|Relapsed and refractory multiple myeloma,|relapsed and refractory multiple myeloma,
4916844|NCT02011113|phase 2|phase 2
4916845|NCT02011061|Multidetector Computed Tomography|multidetector computed tomography
4916846|NCT02011061|Coronary Stenosis|coronary stenosis
4916847|NCT02011061|Coronary Artery Disease|coronary artery disease
4916848|NCT02011061|Angina Pectoris|angina pectoris
4916849|NCT02011035|Oral health|oral health
4916850|NCT02011035|Mouth health|mouth health
4916851|NCT02011035|Halitosis|halitosis
4916852|NCT02011035|Oral bacteria|oral bacteria
4916853|NCT02011035|Sore throat|sore throat
4916854|NCT02011035|Colds|colds
4916855|NCT02011022|Methotrexate,|methotrexate,
4916856|NCT02011022|Pharmacokinetic|pharmacokinetic
4916857|NCT02011022|Acute lymphoblastic leukemia|acute lymphoblastic leukemia
4916858|NCT02011022|Model|model
4916859|NCT02010970|phase I|phase i
4916860|NCT02010970|healthy volunteers|healthy volunteers
4916861|NCT02010970|AZD3293|azd3293
4916862|NCT02010970|itraconazole|itraconazole
4916863|NCT02010970|diltiazem|diltiazem
4916864|NCT02010970|medazolam|medazolam
4916865|NCT02010970|drug interactions|drug interactions
4916866|NCT02010970|Pharmacokinetics|pharmacokinetics
4916867|NCT02010957|123I Iodometomidate imaging|123i iodometomidate imaging
4916868|NCT02010957|18F FDG positron emission tomography|18f fdg positron emission tomography
4916869|NCT02010957|Adrenal tumour|adrenal tumour
4916870|NCT02010944|Solifenacin|solifenacin
4916871|NCT02010944|Mirabegron|mirabegron
4916872|NCT02010944|Fixed-dose combination (FDC)|fixed-dose combination (fdc)
4916873|NCT02010944|Single Entity Tablet (SET)|single entity tablet (set)
4916874|NCT02010944|Pharmacokinetics|pharmacokinetics
4916875|NCT02010944|Bioavailability|bioavailability
4916876|NCT02010918|Knee Osteoarthritis;|knee osteoarthritis;
4916877|NCT02010918|Glucosamine;|glucosamine;
4916878|NCT02010918|Chondroitin.|chondroitin.
4916879|NCT02010905|Losartan|losartan
4916880|NCT02010879|patent ductus arterioses|patent ductus arterioses
4916881|NCT02010879|ductal closure|ductal closure
4916882|NCT02010879|thrombocyte|thrombocyte
4916883|NCT02010866|internship and residency|internship and residency
4916884|NCT02010866|physicians|physicians
4916885|NCT02010866|prevention|prevention
4916886|NCT02010866|counseling|counseling
4916887|NCT02010866|suicide|suicide
4916888|NCT02010866|depression|depression
4916889|NCT02010866|burnout|burnout
4916890|NCT02010853|Transient Global amnesia|transient global amnesia
4916891|NCT02010853|fMRI|fmri
4916893|NCT02010840|Depressive symptoms, marital relationship, quality of life|depressive symptoms, marital relationship, quality of life
4916894|NCT02010827|Diabetes mellitus|diabetes mellitus
4916895|NCT02010827|Glucagon|glucagon
4916896|NCT02010827|Endogenous glucose production|endogenous glucose production
4916897|NCT02010827|Incretin hormones|incretin hormones
4916898|NCT02010814|PCOS|pcos
4916899|NCT02010814|Inflammation|inflammation
4916900|NCT02010814|Body Composition|body composition
4916901|NCT02010801|hepatocellular carcinoma|hepatocellular carcinoma
4916902|NCT02010801|irreversible electroporation|irreversible electroporation
4916903|NCT02010801|liver cancer|liver cancer
4916904|NCT02010762|Crohn's disease|crohn's disease
4916905|NCT02010762|Vitamin D|vitamin d
4916906|NCT02010762|Postoperative|postoperative
4916907|NCT02010762|Recurrence|recurrence
4916908|NCT02010762|Inflammatory bowel disease|inflammatory bowel disease
4916909|NCT02010762|Gastroenteritis|gastroenteritis
4916910|NCT02010762|Gastrointestinal Diseases|gastrointestinal diseases
4916911|NCT02010762|Digestive System Diseases|digestive system diseases
4916912|NCT02010762|Colonic Diseases|colonic diseases
4916913|NCT02010762|Intestinal Diseases|intestinal diseases
4916914|NCT02010762|Pathologic Processes|pathologic processes
4916915|NCT02010736|Cerebral palsy|cerebral palsy
4916916|NCT02010736|Gait|gait
4916917|NCT02010736|Weight Bearing|weight bearing
4916918|NCT02010736|Rehabilitation|rehabilitation
4916919|NCT02010723|varicosis|varicosis
4916920|NCT02010723|foam sclerotherapy|foam sclerotherapy
4916921|NCT02010723|surgery|surgery
4916922|NCT02010710|continuous electronic fetal monitoring|continuous electronic fetal monitoring
4916923|NCT02010710|labour|labour
4916924|NCT02010710|pregnancy|pregnancy
4916925|NCT02010710|fetal distress|fetal distress
4916926|NCT02010697|smoking cessation|smoking cessation
4916927|NCT02010697|nonsmokers|nonsmokers
4916928|NCT02010697|proxy|proxy
4916929|NCT02010697|mail intervention|mail intervention
4916930|NCT02010697|self-help|self-help
4916931|NCT02010697|behavioral intervention|behavioral intervention
4916932|NCT02010684|Diabetes|diabetes
4916933|NCT02010684|Depression|depression
4916934|NCT02010684|Self care|self care
4916935|NCT02010684|Empowerment|empowerment
4916936|NCT02010684|Behavioral intervention|behavioral intervention
4916937|NCT02010684|Cognitive behavioral therapy|cognitive behavioral therapy
4916938|NCT02010684|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
4916939|NCT02010671|Pregnancy|pregnancy
4916940|NCT02010671|Cesarean Section|cesarean section
4916941|NCT02010671|Survey|survey
4916942|NCT02010671|Delivery|delivery
4916943|NCT02010645|Leukemia|leukemia
4916944|NCT02010645|Advanced Myelodysplastic Syndrome|advanced myelodysplastic syndrome
4916945|NCT02010645|MDS|mds
4916946|NCT02010645|Intermediate-2 Myelodysplastic Syndrome|intermediate-2 myelodysplastic syndrome
4916947|NCT02010645|High-Risk Myelodysplastic Syndrome|high-risk myelodysplastic syndrome
4916948|NCT02010645|Chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
4916949|NCT02010645|CMML|cmml
4916950|NCT02010645|Eltrombopag|eltrombopag
4916951|NCT02010645|Promacta|promacta
4916952|NCT02010645|Decitabine|decitabine
4916953|NCT02010645|Dacogen|dacogen
4916954|NCT02010632|Clopidogrel|clopidogrel
4916955|NCT02010632|Platelet inhibition|platelet inhibition
4916956|NCT02010632|Platelet aggregation|platelet aggregation
4916957|NCT02010606|Newly diagnosed glioblastoma|newly diagnosed glioblastoma
4916958|NCT02010606|Recurrent glioblastoma|recurrent glioblastoma
4916959|NCT02010606|Dendritic cell vaccine|dendritic cell vaccine
4916960|NCT02010606|Immunotherapy|immunotherapy
4916961|NCT02010606|Cancer stem cells|cancer stem cells
4916962|NCT02010606|Glioma stem cells|glioma stem cells
4916963|NCT02010606|Glioma stem-like cells|glioma stem-like cells
4916964|NCT02010606|Cancer stem-like cells|cancer stem-like cells
4916965|NCT02010606|Neurosphere|neurosphere
4916966|NCT02010606|Therapeutic Uses|therapeutic uses
4916967|NCT02010606|Antineoplastic Agents|antineoplastic agents
4916968|NCT02010606|Neoplasms|neoplasms
4916969|NCT02010606|Immunologic Factors|immunologic factors
4916970|NCT02010606|Interferon Inducers|interferon inducers
4916971|NCT02010606|Physiological Effects of Drugs|physiological effects of drugs
4916972|NCT02010606|Pharmacologic Actions|pharmacologic actions
4916973|NCT02010567|rectal cancer|rectal cancer
4916974|NCT02010567|colorectal cancer|colorectal cancer
4916975|NCT02010567|locally advanced rectal cancer|locally advanced rectal cancer
4916976|NCT02010567|locally advanced rectal cancer (resectable)|locally advanced rectal cancer (resectable)
4916977|NCT02010567|locally advanced rectal cancer (non-resectable)|locally advanced rectal cancer (non-resectable)
4916978|NCT02010567|chemoradiotherapy|chemoradiotherapy
4916979|NCT02010567|nanopharmaceutical|nanopharmaceutical
4916980|NCT02010567|CLRX101|clrx101
4916981|NCT02010567|camptothecin|camptothecin
4916982|NCT02010567|capecitabine|capecitabine
4916983|NCT02010554|Multiple Sclerosis|multiple sclerosis
4916984|NCT02010554|Disease modifying medication|disease modifying medication
4916985|NCT02010554|Relapsing-Remitting MS|relapsing-remitting ms
4916986|NCT02010554|Motivational Interviewing|motivational interviewing
4916987|NCT02010554|Telephone Counseling|telephone counseling
4916988|NCT02010541|type 1 diabetes among young children, sensor, insulin pump, education, psychological support|type 1 diabetes among young children, sensor, insulin pump, education, psychological support
4916989|NCT02010528|Diabetes related distress, children, T1D, family hardiness, psychological well-being|diabetes related distress, children, t1d, family hardiness, psychological well-being
4916990|NCT02010515|sudden cardiac death|sudden cardiac death
4916991|NCT02010515|risk stratification|risk stratification
4916992|NCT02010515|t-wave alternans|t-wave alternans
4916993|NCT02010515|Holter electrocardiography|holter electrocardiography
4916994|NCT02010515|heart rate turbulence|heart rate turbulence
4916995|NCT02010502|Beet root|beet root
4916996|NCT02010502|exercise performance|exercise performance
4916997|NCT02010502|cyclists|cyclists
4916998|NCT02010489|Bariatric Surgery|bariatric surgery
4916999|NCT02010489|Exercise|exercise
4917000|NCT02010489|Physical Fitness|physical fitness
4917001|NCT02010476|Alzheimer's disease, CSF biomarkers, Insulin resistance|alzheimer's disease, csf biomarkers, insulin resistance
4917002|NCT02010463|reward processing|reward processing
4917003|NCT02010463|impulse control|impulse control
4917004|NCT02010463|obese|obese
4917005|NCT02010463|clinically obese|clinically obese
4917006|NCT02010450|Sudden Infant Death Syndrome|sudden infant death syndrome
4917007|NCT02010450|SIDS|sids
4917008|NCT02010450|safe sleep|safe sleep
4917009|NCT02010450|safe sleep message|safe sleep message
4917010|NCT02010437|Superficial Venous Insufficiency|superficial venous insufficiency
4917011|NCT02010424|reduced fertility|reduced fertility
4917012|NCT02010398|Resistance training/methods|resistance training/methods
4917013|NCT02010398|contralateral strength training|contralateral strength training
4917014|NCT02010398|ipsilateral strength training|ipsilateral strength training
4917015|NCT02010398|Isokinetic contraction|isokinetic contraction
4917016|NCT02010398|Adaptation, Physiological/physiology|adaptation, physiological/physiology
4917017|NCT02010398|Electromyography/methods|electromyography/methods
4917018|NCT02010398|Transcranial Magnetic Stimulation/methods|transcranial magnetic stimulation/methods
4917019|NCT02010398|Evoked Potentials, Motor|evoked potentials, motor
4917020|NCT02010385|RYGB|rygb
4917021|NCT02010385|Bariatric surgery|bariatric surgery
4917022|NCT02010385|Taste|taste
4917023|NCT02010385|Reward|reward
4917024|NCT02010385|Food behaviour|food behaviour
4917025|NCT02010385|Gut hormones|gut hormones
4917026|NCT02010372|Immunization Registry|immunization registry
4917027|NCT02010372|Human Papillomavirus|human papillomavirus
4917028|NCT02010346|Early orthodontic treatment|early orthodontic treatment
4917029|NCT02010346|Class II treatment|class ii treatment
4917030|NCT02010346|Orthodontic treatment outcome|orthodontic treatment outcome
4917031|NCT02010320|population model|population model
4917032|NCT02010320|pharmacokinetic|pharmacokinetic
4917033|NCT02010320|tacrolimus|tacrolimus
4917034|NCT02010320|therapeutic drug monitoring|therapeutic drug monitoring
4917035|NCT02010320|individualized dosing|individualized dosing
4917036|NCT02010294|Invasive GAS infection|invasive gas infection
4917037|NCT02010294|emm genotypes|emm genotypes
4917038|NCT02010294|Bacterial virulence factors|bacterial virulence factors
4917039|NCT02010294|Mendelian susceptibility to infections|mendelian susceptibility to infections
4917040|NCT02010281|rTMS|rtms
4917041|NCT02010281|peripheral neuropathic pain|peripheral neuropathic pain
4917042|NCT02010281|randomized controlled trial|randomized controlled trial
4917043|NCT02010268|Faecal calprotectin|faecal calprotectin
4917044|NCT02010268|Feces|feces
4917045|NCT02010268|Preterm neonates|preterm neonates
4917046|NCT02010268|Enterocolitis|enterocolitis
4917047|NCT02010268|Enteropathy|enteropathy
4917048|NCT02010268|Necrotizing|necrotizing
4917049|NCT02010242|Type 2 diabetes|type 2 diabetes
4917050|NCT02010242|Proteinuria|proteinuria
4917051|NCT02010242|Albuminuria|albuminuria
4917052|NCT02010229|Placenta accreta|placenta accreta
4917053|NCT02010229|previous caesarean|previous caesarean
4917054|NCT02010229|placenta praevia|placenta praevia
4917055|NCT02010229|severe obstetric haemorrhage|severe obstetric haemorrhage
4917056|NCT02010229|population-based study|population-based study
4917057|NCT02010203|TURBT|turbt
4917058|NCT02010203|Bladder|bladder
4917059|NCT02010203|Cancer|cancer
4917060|NCT02010203|GP96|gp96
4917061|NCT02010203|Vaccine|vaccine
4917062|NCT02010203|Immunotherapy|immunotherapy
4917063|NCT02010203|Heat Biologics|heat biologics
4917064|NCT02010203|BCG|bcg
4917065|NCT02010203|Bacillus Calmette-Guerin|bacillus calmette-guerin
4917066|NCT02010203|Bacillus Calmette-Guérin|bacillus calmette-guérin
4917067|NCT02010190|Pediatric malignancies|pediatric malignancies
4917068|NCT02010190|Cancer survivors|cancer survivors
4917069|NCT02010190|Coronary artery risk|coronary artery risk
4917070|NCT02010190|Vascular function|vascular function
4917071|NCT02010190|Cardiovascular risk in survivors of pediatric cancer|cardiovascular risk in survivors of pediatric cancer
4917072|NCT02010164|Reproductive aging|reproductive aging
4917073|NCT02010164|Mitochondria|mitochondria
4917074|NCT02010151|Out of Hospital Cardiac Arrest|out of hospital cardiac arrest
4917075|NCT02010151|Cardiopulmonary Resuscitation|cardiopulmonary resuscitation
4917076|NCT02010151|dispatch|dispatch
4917077|NCT02010151|emergency medicine|emergency medicine
4917078|NCT02010138|Internal Limiting Membrane|internal limiting membrane
4917079|NCT02010138|Metamorphopsia|metamorphopsia
4917080|NCT02010125|Anterior Cruciate Ligament (ACL)|anterior cruciate ligament (acl)
4917081|NCT02010125|Magnetic Resonance Imaging (MRI)|magnetic resonance imaging (mri)
4917082|NCT02010125|Osteoarthritis (OA)|osteoarthritis (oa)
4917083|NCT02010125|Bio-specimens|bio-specimens
4917084|NCT02010125|Acute ACL Injury|acute acl injury
4917085|NCT02010125|Arthritis Foundation (AF)|arthritis foundation (af)
4917086|NCT02010112|H.Pylori|h.pylori
4917087|NCT02010086|Intervention|intervention
4917088|NCT02010086|Autism|autism
4917089|NCT02010086|Treatment sensitivity|treatment sensitivity
4917090|NCT02010086|School aged|school aged
4917091|NCT02010086|Cognitive behavioral therapy|cognitive behavioral therapy
4917092|NCT02010086|Social Skills Intervention|social skills intervention
4917093|NCT02010073|Lung|lung
4917094|NCT02010073|ARDS|ards
4917095|NCT02010073|acute|acute
4917096|NCT02010073|respiratory|respiratory
4917097|NCT02010073|syndrome|syndrome
4917098|NCT02010073|prognosis|prognosis
4917099|NCT02010073|outcome research|outcome research
4917100|NCT02010073|respiratory infection|respiratory infection
4917101|NCT02010073|sepsis|sepsis
4917102|NCT02010073|organ failure|organ failure
4917103|NCT02010073|hypoxaemia|hypoxaemia
4917104|NCT02010060|Exercise training|exercise training
4917105|NCT02010060|Non-exercise physical activity|non-exercise physical activity
4917106|NCT02010060|pedometers|pedometers
4917107|NCT02010047|Anaplastic lymphoma kinase gene|anaplastic lymphoma kinase gene
4917108|NCT02010047|Polymerase chain reaction|polymerase chain reaction
4917109|NCT02010047|Immunohistochemistry|immunohistochemistry
4917110|NCT02010047|Fluorescence in situ hybridization|fluorescence in situ hybridization
4917111|NCT02010034|TPN|tpn
4917112|NCT02010034|Liver Function|liver function
4917113|NCT02010034|parenteral nutritional fat emulsions|parenteral nutritional fat emulsions
4917114|NCT02010021|breast cancer|breast cancer
4917115|NCT02010021|postmenopausal|postmenopausal
4917116|NCT02010021|letrozole|letrozole
4917117|NCT02010021|RAD001|rad001
4917118|NCT02010021|Everolimus|everolimus
4917119|NCT02010008|breast cancer|breast cancer
4917120|NCT02010008|cancer disparities|cancer disparities
4917121|NCT02010008|Latino women|latino women
4917122|NCT02010008|Hispanic women|hispanic women
4917123|NCT02010008|mammography|mammography
4917124|NCT02010008|multi-level intervention|multi-level intervention
4917125|NCT02009995|Diabetes Mellitus|diabetes mellitus
4917126|NCT02009995|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
4917127|NCT02009995|Resistance Training|resistance training
4917128|NCT02009995|Resistance Exercise|resistance exercise
4917129|NCT02009995|Resistance Band|resistance band
4917130|NCT02009995|Thera-band|thera-band
4917131|NCT02009995|elastic band|elastic band
4917132|NCT02009995|exercise band|exercise band
4917133|NCT02009982|Fainting|fainting
4917134|NCT02009982|Ablation|ablation
4917135|NCT02009982|Cardiology|cardiology
4917136|NCT02009982|Cardiac Electrophysiology|cardiac electrophysiology
4917137|NCT02009969|Psychosis|psychosis
4917138|NCT02009969|Adverse effects|adverse effects
4917139|NCT02009969|Symptom Severity|symptom severity
4917140|NCT02009969|Magnetic Resonance Imaging|magnetic resonance imaging
4917141|NCT02009943|critical illness|critical illness
4917142|NCT02009943|iron supplementation|iron supplementation
4917143|NCT02009943|functional iron deficiency|functional iron deficiency
4917144|NCT02009943|ICU anemia|icu anemia
4917145|NCT02009943|red blood cell transfusion|red blood cell transfusion
4917146|NCT02009930|Enlisted military members|enlisted military members
4917147|NCT02009930|CAC|cac
4917148|NCT02009930|Coronary Artery Calcium|coronary artery calcium
4917149|NCT02009930|Cardiovascular|cardiovascular
4917150|NCT02009917|Indicator Amino Acid Oxidation|indicator amino acid oxidation
4917151|NCT02009917|Non essential Amino acids|non essential amino acids
4917152|NCT02009917|Protein|protein
4917153|NCT02009917|Amino acid|amino acid
4917154|NCT02009904|PKU|pku
4917155|NCT02009904|Phenylketonuria|phenylketonuria
4917156|NCT02009904|Phenylalanine|phenylalanine
4917157|NCT02009904|Children|children
4917158|NCT02009904|Stable isotopes|stable isotopes
4917159|NCT02009904|Sapropterin dihydrochloride responsiveness|sapropterin dihydrochloride responsiveness
4917160|NCT02009891|predictive model|predictive model
4917161|NCT02009891|in vitro fertilization|in vitro fertilization
4917162|NCT02009891|elective single embryo transfer|elective single embryo transfer
4917163|NCT02009878|SIADH|siadh
4917164|NCT02009865|Hypertriglyceridemia|hypertriglyceridemia
4917165|NCT02009865|Dyslipidemia|dyslipidemia
4917166|NCT02009865|Eicosapentaenoic acid|eicosapentaenoic acid
4917167|NCT02009865|EPA|epa
4917168|NCT02009865|Docosahexaenoic acid|docosahexaenoic acid
4917169|NCT02009865|DHA|dha
4917170|NCT02009852|microRNA-29b|microrna-29b
4917171|NCT02009852|Oral squamous cell carcinoma|oral squamous cell carcinoma
4917172|NCT02009852|migration|migration
4917173|NCT02009852|prognosis|prognosis
4917174|NCT02009839|anxiety|anxiety
4917175|NCT02009839|frequency of speech|frequency of speech
4917176|NCT02009839|selective mutism|selective mutism
4917177|NCT02009826|Schizophrenia|schizophrenia
4917178|NCT02009826|Psychosis|psychosis
4917179|NCT02009826|Neuroinflammation|neuroinflammation
4917180|NCT02009826|Microglial activation|microglial activation
4917181|NCT02009813|Insulin resistance|insulin resistance
4917182|NCT02009813|Inflammation|inflammation
4917183|NCT02009813|Hypoxia|hypoxia
4917184|NCT02009787|hypercholesterolemia; vitamin D; adjuvant therapy|hypercholesterolemia; vitamin d; adjuvant therapy
4917185|NCT02009774|Colonoscopy|colonoscopy
4917186|NCT02009774|Adenoma detection rate|adenoma detection rate
4917187|NCT02009774|Narrow band imaging|narrow band imaging
4917188|NCT02009774|Optical biopsy|optical biopsy
4917189|NCT02009774|Accuracy|accuracy
4917190|NCT02009735|Enterovirus 71 and Influenza Virus|enterovirus 71 and influenza virus
4917191|NCT02009722|Cesarean Delivery|cesarean delivery
4917192|NCT02009722|Intrathecal Morphine|intrathecal morphine
4917193|NCT02009722|Intrathecal Hydromorphone|intrathecal hydromorphone
4917194|NCT02009722|Obstetrical Analgesia|obstetrical analgesia
4917195|NCT02009722|Spinal Anesthesia|spinal anesthesia
4917196|NCT02009709|keratoconus|keratoconus
4917197|NCT02009709|collagen crosslinking|collagen crosslinking
4917198|NCT02009709|crosslinking|crosslinking
4917199|NCT02009709|ectasia|ectasia
4917200|NCT02009644|Abdominal Aortic Aneurysm|abdominal aortic aneurysm
4917201|NCT02009644|AAA|aaa
4917202|NCT02009644|Aneurysm|aneurysm
4917203|NCT02009631|Solid Tumors|solid tumors
4917204|NCT02009631|Ovarian Cancer|ovarian cancer
4917205|NCT02009631|Colon Cancer|colon cancer
4917206|NCT02009631|Lung Cancer|lung cancer
4917207|NCT02009631|Breast Cancer|breast cancer
4917208|NCT02009631|Gastric Cancer|gastric cancer
4917209|NCT02009618|IBS|ibs
4917210|NCT02009618|Rifaximin|rifaximin
4917211|NCT02009605|icotinib, SCC|icotinib, scc
4917212|NCT02009592|Hepatosteatosis|hepatosteatosis
4917213|NCT02009592|Steatohepatitis|steatohepatitis
4917214|NCT02009592|Rifaximin|rifaximin
4917215|NCT02009592|Inflammatory cytokines|inflammatory cytokines
4917216|NCT02009579|Uterine Cervical Cancer|uterine cervical cancer
4917217|NCT02009579|Paclitaxel|paclitaxel
4917218|NCT02009579|Carboplatin|carboplatin
4917219|NCT02009579|Nintedanib|nintedanib
4917220|NCT02009553|Anxiety|anxiety
4917221|NCT02009553|Urodynamics|urodynamics
4917222|NCT02009514|Hemodialysis|hemodialysis
4917223|NCT02009514|Continuous glucose monitoring|continuous glucose monitoring
4918216|NCT02005237|Cognition|cognition
4917224|NCT02009514|Hypoglycemia|hypoglycemia
4917225|NCT02009514|Hyperglycemia|hyperglycemia
4917226|NCT02009501|Infected wounds|infected wounds
4917227|NCT02009501|NPWTi|npwti
4917228|NCT02009501|VAC Instill|vac instill
4917229|NCT02009501|Biofilm|biofilm
4917230|NCT02009488|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
4917231|NCT02009488|Metformin|metformin
4917232|NCT02009488|Canagliflozin|canagliflozin
4917233|NCT02009488|INVOKANA®|invokana®
4917234|NCT02009488|Insulin sensitivity|insulin sensitivity
4917235|NCT02009488|DPP-4 inhibitor|dpp-4 inhibitor
4917236|NCT02009488|dipeptidyl peptidase-4|dipeptidyl peptidase-4
4917237|NCT02009475|Rehabilitation|rehabilitation
4917238|NCT02009475|Exercise Training|exercise training
4917239|NCT02009475|Interval training|interval training
4917240|NCT02009462|HIV|hiv
4917241|NCT02009462|Facial lipoatrophy|facial lipoatrophy
4917242|NCT02009449|Phase 1/Phase 1b|phase 1/phase 1b
4917243|NCT02009449|Oncology|oncology
4917244|NCT02009449|Cancer|cancer
4917245|NCT02009449|Solid Tumors|solid tumors
4917246|NCT02009423|Gastro-Intestinal Stromal Tumour, GIST, localized primary tumor, complete surgery, adjuvant therapy.|gastro-intestinal stromal tumour, gist, localized primary tumor, complete surgery, adjuvant therapy.
4917247|NCT02009410|Exocrine Pancreatic Insufficiency|exocrine pancreatic insufficiency
4917248|NCT02009358|mental health promotion|mental health promotion
4917249|NCT02009358|depression|depression
4917250|NCT02009358|migrant workers|migrant workers
4917251|NCT02009358|China|china
4917252|NCT02009345|Familial hypercholesterolemia,|familial hypercholesterolemia,
4917253|NCT02009345|High LDL-cholesterol|high ldl-cholesterol
4917254|NCT02009345|Registry|registry
4917255|NCT02009345|Coronary artery disease|coronary artery disease
4917256|NCT02009319|endobronchial ultrasound|endobronchial ultrasound
4917257|NCT02009319|EBUS - TBNA|ebus - tbna
4917258|NCT02009319|elastography|elastography
4917259|NCT02009319|strain ratio|strain ratio
4917260|NCT02009319|lung cancer staging|lung cancer staging
4917261|NCT02009306|Palliative|palliative
4917262|NCT02009306|Symptom control|symptom control
4917263|NCT02009306|Hospice|hospice
4917264|NCT02009306|Opioid|opioid
4917265|NCT02009306|Benzodiazepine|benzodiazepine
4917266|NCT02009293|idiopathic pulmonary fibrosis|idiopathic pulmonary fibrosis
4917267|NCT02009293|cough|cough
4917268|NCT02009293|quality of life|quality of life
4917269|NCT02009280|Propofol|propofol
4917270|NCT02009280|Lung transplantation|lung transplantation
4917271|NCT02009280|Extracorporeal membrane oxygenation|extracorporeal membrane oxygenation
4917272|NCT02009280|Acute kidney injury|acute kidney injury
4917273|NCT02009241|Lymphangioleiomyomatosis|lymphangioleiomyomatosis
4917274|NCT02009241|Rehabilitation|rehabilitation
4917275|NCT02009241|Exercise|exercise
4917276|NCT02009228|Single-port laparoscopy|single-port laparoscopy
4917277|NCT02009228|Abdominal pain|abdominal pain
4917278|NCT02009228|Ovarian spillage|ovarian spillage
4917279|NCT02009228|Endobag rupture|endobag rupture
4917280|NCT02009228|Ovarian reserve|ovarian reserve
4917281|NCT02009215|Uganda|uganda
4917282|NCT02009215|intermittent preventive treatment|intermittent preventive treatment
4917283|NCT02009215|dihydroartemisinin-piperaquine|dihydroartemisinin-piperaquine
4917284|NCT02009215|schoolchildren|schoolchildren
4917285|NCT02009215|malaria|malaria
4917286|NCT02009202|Colon preparation|colon preparation
4917287|NCT02009202|Child|child
4917288|NCT02009189|home parenteral nutrition|home parenteral nutrition
4917289|NCT02009189|central venous catheter|central venous catheter
4917290|NCT02009176|Hepatocellular Carcinoma|hepatocellular carcinoma
4917291|NCT02009176|Laparoscopic|laparoscopic
4917292|NCT02009176|Aon-anatomical hepatectomy|aon-anatomical hepatectomy
4917293|NCT02009176|Anatomical hepatectomy|anatomical hepatectomy
4917294|NCT02009176|Micrometastases|micrometastases
4917295|NCT02009137|small breast|small breast
4917296|NCT02009137|augmentation|augmentation
4917297|NCT02009137|breast volume|breast volume
4917298|NCT02009137|External Soft Tissue Expansion System(ESTES)|external soft tissue expansion system(estes)
4917299|NCT02009124|spinal cord injury|spinal cord injury
4917300|NCT02009124|stem cell therapy|stem cell therapy
4917301|NCT02009124|bone marrow|bone marrow
4917302|NCT02009124|mononuclear cells|mononuclear cells
4917303|NCT02009124|autologous|autologous
4917304|NCT02009111|Transition to parenthood|transition to parenthood
4917305|NCT02009111|Relationship intervention|relationship intervention
4917306|NCT02009098|Randomized Controlled Trial|randomized controlled trial
4917307|NCT02009098|Caesarean Section|caesarean section
4917308|NCT02009098|preoperative|preoperative
4917309|NCT02009098|intraoperative|intraoperative
4917310|NCT02009098|prophylactic antibiotics|prophylactic antibiotics
4917311|NCT02009098|antibiotics|antibiotics
4917312|NCT02009098|timing|timing
4917313|NCT02009098|surgical site infections|surgical site infections
4917314|NCT02009098|endometritis|endometritis
4917315|NCT02009098|wound infections|wound infections
4917316|NCT02009098|urinary tract infections|urinary tract infections
4917317|NCT02009098|infectious morbidity|infectious morbidity
4917318|NCT02009098|neonatal antibiotics exposure|neonatal antibiotics exposure
4917319|NCT02009098|Antibiotic Prophylaxis|antibiotic prophylaxis
4917320|NCT02009072|Pterygium surgery|pterygium surgery
4917321|NCT02009072|Sutureless glue free conjunctival autograft|sutureless glue free conjunctival autograft
4917322|NCT02009072|Amniotic membrane graft.|amniotic membrane graft.
4917323|NCT02009059|hypothermia|hypothermia
4917324|NCT02009059|Temperature|temperature
4917325|NCT02009059|epitympanic|epitympanic
4917326|NCT02009059|pre-hospital|pre-hospital
4917327|NCT02009046|Adolescent|adolescent
4917328|NCT02009046|Sex education|sex education
4917329|NCT02009046|Sexuality education|sexuality education
4917330|NCT02009046|Sexually transmitted diseases|sexually transmitted diseases
4917331|NCT02009046|Pregnancy|pregnancy
4917332|NCT02009046|Sexual behavior|sexual behavior
4917333|NCT02009046|Sexuality|sexuality
4917334|NCT02009046|Relationship rights|relationship rights
4917335|NCT02009046|Gender norms|gender norms
4917336|NCT02009046|Human rights|human rights
4917337|NCT02009046|Intervention studies|intervention studies
4917338|NCT02009046|Parent intervention|parent intervention
4917339|NCT02009046|Peer intervention|peer intervention
4917340|NCT02009007|cerebral oximeter|cerebral oximeter
4917341|NCT02009007|one lung ventilation|one lung ventilation
4917342|NCT02009007|dopamine|dopamine
4917343|NCT02009007|phenylephrine|phenylephrine
4917344|NCT02008994|metastatic breast cancer|metastatic breast cancer
4917345|NCT02008994|breast cancer|breast cancer
4917346|NCT02008994|genomics|genomics
4917347|NCT02008994|personalized medicine|personalized medicine
4917348|NCT02008994|precision oncology|precision oncology
4917349|NCT02008994|breast cancer treatment|breast cancer treatment
4917350|NCT02008994|metastatic breast cancer treatment|metastatic breast cancer treatment
4917351|NCT02008994|genetic testing and breast cancer treatment|genetic testing and breast cancer treatment
4917352|NCT02008994|breast cancer trial|breast cancer trial
4917353|NCT02008994|metastatic breast cancer trial|metastatic breast cancer trial
4917354|NCT02008955|lysine, indicator amino acid oxidation, elderly females|lysine, indicator amino acid oxidation, elderly females
4917355|NCT02008929|NKCELL|nkcell
4917356|NCT02008916|AIN457, ankylosing spondylitis, chronic inflammatory disease, inflammatory back pain, secukinumab, self-injection|ain457, ankylosing spondylitis, chronic inflammatory disease, inflammatory back pain, secukinumab, self-injection
4917357|NCT02008890|palmoplantar, pustular, psoriasis|palmoplantar, pustular, psoriasis
4917358|NCT02008877|Malignant Peripheral Nerve Sheath Tumors|malignant peripheral nerve sheath tumors
4917359|NCT02008877|MPNST|mpnst
4917360|NCT02008877|Sarcoma|sarcoma
4917361|NCT02008877|Ganetespib|ganetespib
4917362|NCT02008877|Sirolimus|sirolimus
4917363|NCT02008877|mTOR inhibitor|mtor inhibitor
4917364|NCT02008877|Heat shock protein|heat shock protein
4917365|NCT02008877|Hsp90|hsp90
4917366|NCT02008864|End stage renal diseases|end stage renal diseases
4917367|NCT02008864|Hemodialysis|hemodialysis
4917368|NCT02008864|Uremic pruritus|uremic pruritus
4917369|NCT02008864|Iranian traditional medicine|iranian traditional medicine
4917370|NCT02008864|Cassia angustifolia|cassia angustifolia
4917371|NCT02008851|Chronic kidney disease|chronic kidney disease
4917372|NCT02008851|Type 2 Diabetes|type 2 diabetes
4917373|NCT02008851|Neo-kidney augment|neo-kidney augment
4917374|NCT02008851|Regenerative medicine|regenerative medicine
4917375|NCT02008825|ViSiGi|visigi
4917376|NCT02008825|Calibration tube|calibration tube
4917377|NCT02008825|Sleeve gastrectomy|sleeve gastrectomy
4917378|NCT02008812|Adenovirus|adenovirus
4917379|NCT02008799|Stem cell, infertility, Azoospermia|stem cell, infertility, azoospermia
4917380|NCT02008786|Coronary Artery Dissection, Spontaneous|coronary artery dissection, spontaneous
4917381|NCT02008786|Angina|angina
4917382|NCT02008773|schizophrenia|schizophrenia
4917383|NCT02008773|schizoaffective|schizoaffective
4917384|NCT02008773|schizophreniform|schizophreniform
4917385|NCT02008773|inflammatory markers|inflammatory markers
4917386|NCT02008773|HSV1|hsv1
4917387|NCT02008773|cognition|cognition
4917388|NCT02008773|early psychosis|early psychosis
4917389|NCT02008773|valacyclovir|valacyclovir
4917390|NCT02008760|pain|pain
4917391|NCT02008760|quality of life|quality of life
4917392|NCT02008760|ADL|adl
4917393|NCT02008760|DOLO test|dolo test
4917394|NCT02008760|compliance|compliance
4917395|NCT02008760|D3|d3
4917396|NCT02008747|Atrial fibrillation|atrial fibrillation
4917397|NCT02008747|Neuropathic pain|neuropathic pain
4917398|NCT02008747|Posterolateral thoracotomy|posterolateral thoracotomy
4917399|NCT02008747|Lung resection|lung resection
4917400|NCT02008721|Multiple System Atrophy|multiple system atrophy
4917401|NCT02008721|epigallocatechin gallate|epigallocatechin gallate
4917402|NCT02008708|Health|health
4917403|NCT02008708|Microfinance|microfinance
4917404|NCT02008695|Health|health
4917405|NCT02008695|Youth|youth
4917406|NCT02008695|Microfinance|microfinance
4917407|NCT02008669|Multiple Sclerosis, Fatigue, Nutritional Status, Disability.|multiple sclerosis, fatigue, nutritional status, disability.
4917408|NCT02008656|CAPECITABINE (ORAL)|capecitabine (oral)
4917409|NCT02008656|FLUOROURACIL|fluorouracil
4917410|NCT02008656|LEUCOVORIN|leucovorin
4917411|NCT02008656|OXALIPLATIN|oxaliplatin
4917412|NCT02008656|Total mesorectal excision|total mesorectal excision
4917413|NCT02008656|Chemoradiation therapy|chemoradiation therapy
4917414|NCT02008656|Total neoadjuvant therapy|total neoadjuvant therapy
4917415|NCT02008656|13-213|13-213
4918314|NCT02004756|pediatric|pediatric
4917416|NCT02008643|Health related quality of life, food allergy, children, chronic diseases|health related quality of life, food allergy, children, chronic diseases
4917417|NCT02008617|Anterior cruciate ligament reconstruction|anterior cruciate ligament reconstruction
4917418|NCT02008604|ischemia|ischemia
4917419|NCT02008604|stroke|stroke
4917420|NCT02008604|transient ischemic attack (TIA)|transient ischemic attack (tia)
4917421|NCT02008604|microbiome|microbiome
4917422|NCT02008604|microbiota|microbiota
4917423|NCT02008604|gut|gut
4917424|NCT02008591|Neuraxial Technique|neuraxial technique
4917425|NCT02008591|Epidural Technique|epidural technique
4917426|NCT02008591|Dural Puncture Epidural Technique|dural puncture epidural technique
4917427|NCT02008591|Combined Spinal Epidural Technique|combined spinal epidural technique
4917428|NCT02008591|Labor Analgesia|labor analgesia
4917429|NCT02008591|Obstetric|obstetric
4917430|NCT02008578|Antiviral|antiviral
4917431|NCT02008578|Adjunctive Therapy|adjunctive therapy
4917432|NCT02008578|Antibody|antibody
4917433|NCT02008565|Fecal incontinence|fecal incontinence
4917434|NCT02008565|Loperamide|loperamide
4917435|NCT02008565|anal exercises|anal exercises
4917436|NCT02008565|biofeedback|biofeedback
4917437|NCT02008552|Genetic factor|genetic factor
4917438|NCT02008552|Valvulopathy|valvulopathy
4917439|NCT02008552|Mediator|mediator
4917440|NCT02008526|Text Messaging|text messaging
4917441|NCT02008526|mHealth|mhealth
4917442|NCT02008526|Methamphetamine|methamphetamine
4917443|NCT02008526|HIV|hiv
4917444|NCT02008526|AIDS|aids
4917445|NCT02008513|AFFITOPE® AD02|affitope® ad02
4917446|NCT02008513|Alzheimer Disease|alzheimer disease
4917447|NCT02008513|Dementia|dementia
4917448|NCT02008513|Brain Disease|brain disease
4917449|NCT02008513|Nervous System Diseases|nervous system diseases
4917450|NCT02008513|Tauopathies|tauopathies
4917451|NCT02008513|Neurodegenerative Diseases|neurodegenerative diseases
4917452|NCT02008513|Mental Disorders|mental disorders
4917453|NCT02008500|Dentinal Hypersensitivity|dentinal hypersensitivity
4917454|NCT02008500|Gingival Recession|gingival recession
4917455|NCT02008500|Visual Analogue Score|visual analogue score
4917456|NCT02008487|wound|wound
4917457|NCT02008487|palliative care|palliative care
4917458|NCT02008487|hospice|hospice
4917459|NCT02008487|pressure ulcers|pressure ulcers
4917460|NCT02008435|Group-delivered Diabetes Prevention Program|group-delivered diabetes prevention program
4917461|NCT02008435|Obesity|obesity
4917462|NCT02008435|Overweight|overweight
4917463|NCT02008435|Lifestyle change|lifestyle change
4917464|NCT02008435|Healthy eating|healthy eating
4917465|NCT02008435|Weight loss|weight loss
4917466|NCT02008435|Exercise|exercise
4917467|NCT02008435|Cognitive-behavioral intervention|cognitive-behavioral intervention
4917468|NCT02008435|Implementation intentions|implementation intentions
4917469|NCT02008435|Mental imagery|mental imagery
4917470|NCT02008435|Mental practice|mental practice
4917471|NCT02008435|If-then plans|if-then plans
4917472|NCT02008409|Minimally Invasive Surgery|minimally invasive surgery
4917473|NCT02008409|EndoLift Liver Retractor|endolift liver retractor
4917474|NCT02008396|MDMA|mdma
4917475|NCT02008396|autism|autism
4917476|NCT02008396|social anxiety|social anxiety
4917477|NCT02008383|Colorectal cancer|colorectal cancer
4917478|NCT02008383|Panitumumab|panitumumab
4917479|NCT02008383|Cabozantinib|cabozantinib
4917480|NCT02008370|minimally invasive cardiac surgery|minimally invasive cardiac surgery
4917481|NCT02008370|Exparel|exparel
4917482|NCT02008357|Cognition|cognition
4917483|NCT02008357|Prevention|prevention
4917484|NCT02008344|influenza|influenza
4917485|NCT02008344|flu|flu
4917486|NCT02008344|fever|fever
4917487|NCT02008344|cough|cough
4917488|NCT02008344|body aches|body aches
4917489|NCT02008344|headache|headache
4917490|NCT02008344|nasal congestion|nasal congestion
4917491|NCT02008344|body pains|body pains
4917492|NCT02008344|sore throat|sore throat
4917493|NCT02008344|fatigue|fatigue
4917494|NCT02008344|T-705|t-705
4917495|NCT02008344|favipiravir|favipiravir
4917496|NCT02008344|favor|favor
4917497|NCT02008344|flu symptoms|flu symptoms
4917498|NCT02008331|chronic kidney disease|chronic kidney disease
4917499|NCT02008331|p-cresol|p-cresol
4917500|NCT02008331|synbiotic|synbiotic
4917501|NCT02008292|smoking|smoking
4917502|NCT02008292|schizophrenia|schizophrenia
4917503|NCT02008292|acetylcholine|acetylcholine
4917504|NCT02008279|Healthy|healthy
4917505|NCT02008279|CNTO 3157|cnto 3157
4917506|NCT02008279|Pharmacokinetics|pharmacokinetics
4917507|NCT02008253|INTRASTROMAL CORNEAL RING|intrastromal corneal ring
4917508|NCT02008253|ASTIGMATISM|astigmatism
4917509|NCT02008240|Infertility|infertility
4917510|NCT02008240|Hydrosalpinx|hydrosalpinx
4917511|NCT02008240|IVF-ET|ivf-et
4917512|NCT02008240|Salpingectomy|salpingectomy
4917513|NCT02008214|Pentoxifylline|pentoxifylline
4917514|NCT02008214|Sustained virologic response|sustained virologic response
4917515|NCT02008214|Hepatic fibrosis|hepatic fibrosis
4917516|NCT02008201|dose-response study|dose-response study
4917517|NCT02008188|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
4917518|NCT02008188|Artificial Pancreas|artificial pancreas
4917519|NCT02008188|Closed Loop Control|closed loop control
4917520|NCT02008188|Diabetes Assistant (DiAs)|diabetes assistant (dias)
4917521|NCT02008188|Continuous Glucose Monitor (CGM)|continuous glucose monitor (cgm)
4917522|NCT02008188|Insulin Pump|insulin pump
4917523|NCT02008188|Metabolic Diseases|metabolic diseases
4917524|NCT02008188|Endocrine System Diseases|endocrine system diseases
4917525|NCT02008188|Autoimmune Diseases|autoimmune diseases
4917526|NCT02008175|paediatric, keratoconus, collagen cross linking|paediatric, keratoconus, collagen cross linking
4917527|NCT02008162|Emphysema, COPD, bronchoreversibility, ventilatory obstruction, lung volume reduction surgery, LVRS|emphysema, copd, bronchoreversibility, ventilatory obstruction, lung volume reduction surgery, lvrs
4917528|NCT02008149|Osteoporosis|osteoporosis
4917529|NCT02008136|myofascial pain|myofascial pain
4917530|NCT02008136|muscle spasm|muscle spasm
4917531|NCT02008136|botulinum toxin|botulinum toxin
4917532|NCT02008136|cervicalgia|cervicalgia
4917533|NCT02008136|lumbago|lumbago
4917534|NCT02008136|low back pain|low back pain
4917535|NCT02008123|Clopidogrel|clopidogrel
4917536|NCT02008123|Clopidogrel Resistance|clopidogrel resistance
4917537|NCT02008123|Primidone|primidone
4917538|NCT02008123|Secondary Stroke Prevention|secondary stroke prevention
4917539|NCT02008110|Heart failure|heart failure
4917540|NCT02008110|Biomarker guided-therapy|biomarker guided-therapy
4917541|NCT02008110|Carbohydrate antigen 125|carbohydrate antigen 125
4917542|NCT02008110|Clinical outcomes.|clinical outcomes.
4917543|NCT02008097|Ultrasound|ultrasound
4917544|NCT02008097|Ultrasonography|ultrasonography
4917545|NCT02008097|Liver transplantation|liver transplantation
4917546|NCT02008097|Arterial Occlusive Diseases|arterial occlusive diseases
4917547|NCT02008097|Hypertension|hypertension
4917548|NCT02008097|Pregnancy, High Risk|pregnancy, high risk
4917549|NCT02008097|Pregnancy|pregnancy
4917550|NCT02008084|hypertriglyceridemia|hypertriglyceridemia
4917551|NCT02008084|mixed hyperlipidemia|mixed hyperlipidemia
4917552|NCT02008058|Metastatic Castrate-Resistant Prostate Cancer|metastatic castrate-resistant prostate cancer
4917553|NCT02008058|LCCC 1231|lccc 1231
4917554|NCT02008058|Lineberger Comprehensive Cancer Center|lineberger comprehensive cancer center
4917555|NCT02008058|UNC Lineberger|unc lineberger
4917556|NCT02008058|Prostate Cancer|prostate cancer
4917557|NCT02008058|Pain|pain
4917558|NCT02008045|MRI|mri
4917559|NCT02008045|Imaging|imaging
4917560|NCT02008045|Neurocognitive|neurocognitive
4917561|NCT02008045|White matter injury|white matter injury
4917562|NCT02008032|Mammography|mammography
4917563|NCT02008032|Breast|breast
4917564|NCT02008032|Implants|implants
4917565|NCT02008019|Chondrosarcoma|chondrosarcoma
4917566|NCT02008019|Neoadjuvant therapy|neoadjuvant therapy
4917567|NCT02008019|Phase II|phase ii
4917568|NCT02008019|Everolimus|everolimus
4917569|NCT02008019|Success Rate|success rate
4917570|NCT02008019|Progression Free Survival|progression free survival
4917571|NCT02008019|Overall Survival|overall survival
4917572|NCT02008019|Safety|safety
4917573|NCT02008019|Quality of Life|quality of life
4917574|NCT02008019|Molecular study (ancillary study)|molecular study (ancillary study)
4917575|NCT02008006|Follicular Lymphoma|follicular lymphoma
4917576|NCT02008006|Chemosensitive relapse|chemosensitive relapse
4917577|NCT02008006|High Dose Chemotherapy|high dose chemotherapy
4917578|NCT02008006|Bendamustine|bendamustine
4917579|NCT02008006|BeEAM|beeam
4917580|NCT02008006|Autologous Stem Cell Transplantation|autologous stem cell transplantation
4917581|NCT02008006|Safety|safety
4917582|NCT02008006|Event Free Survival|event free survival
4917583|NCT02008006|Overall Response Rate|overall response rate
4917584|NCT02008006|Progression Free Survival|progression free survival
4917585|NCT02008006|Overall Survival|overall survival
4917586|NCT02008006|Phase II|phase ii
4917587|NCT02008006|World Health Organization (WHO) 1 grade|world health organization (who) 1 grade
4917588|NCT02008006|WHO 2 grade|who 2 grade
4917589|NCT02008006|WHO 3a grade|who 3a grade
4917590|NCT02007993|Halitosis,|halitosis,
4917591|NCT02007993|Photodynamic Therapy,|photodynamic therapy,
4917592|NCT02007993|Adolescent|adolescent
4917593|NCT02007980|urological problems|urological problems
4917594|NCT02007980|indwelling urologic stent|indwelling urologic stent
4917595|NCT02007980|kidney stone disease|kidney stone disease
4917596|NCT02007980|urinary system obstruction|urinary system obstruction
4917597|NCT02007980|hydronephrosis|hydronephrosis
4917598|NCT02007980|ureteral damage|ureteral damage
4917599|NCT02007954|HCC|hcc
4917600|NCT02007915|Adolescent|adolescent
4917601|NCT02007915|Avascular Necrosis|avascular necrosis
4917602|NCT02007915|Bisphosphonates|bisphosphonates
4917603|NCT02007915|Pamidronate|pamidronate
4917604|NCT02007902|Preterm baby|preterm baby
4917605|NCT02007902|Total plasma protein|total plasma protein
4917606|NCT02007902|Albumin|albumin
4917607|NCT02007902|Hemodynamic disturbances|hemodynamic disturbances
4917608|NCT02007902|Perfusion|perfusion
4917609|NCT02007902|Near Infra Red Spectroscopy (NIRS)|near infra red spectroscopy (nirs)
4917610|NCT02007902|Ultrasound|ultrasound
4917611|NCT02007876|Mobility|mobility
4917612|NCT02007876|Activity|activity
4917613|NCT02007876|Training|training
4917614|NCT02007876|Abdominal|abdominal
4917615|NCT02007876|Surgery|surgery
4917616|NCT02007876|Adult|adult
4917617|NCT02007863|Leukemia|leukemia
4917618|NCT02007863|Myelodysplasia|myelodysplasia
4917619|NCT02007863|Acute lymphocytic leukemia|acute lymphocytic leukemia
4917620|NCT02007863|ALL|all
4917621|NCT02007863|Acute myelogenous leukemia|acute myelogenous leukemia
4917622|NCT02007863|AML|aml
4917623|NCT02007863|Pediatric|pediatric
4917624|NCT02007850|continuous femoral nerve block|continuous femoral nerve block
4917625|NCT02007850|knee arthroplasty|knee arthroplasty
4917626|NCT02007850|quadriceps muscle strength|quadriceps muscle strength
4917627|NCT02007837|pregnancy induced hypertension|pregnancy induced hypertension
4917628|NCT02007837|gestational hypertension|gestational hypertension
4917629|NCT02007837|pre-eclampsia|pre-eclampsia
4917630|NCT02007837|preeclampsia|preeclampsia
4917631|NCT02007837|hypertensive disorders in pregnancy|hypertensive disorders in pregnancy
4917632|NCT02007824|pressure ulcer|pressure ulcer
4917633|NCT02007824|chronic wound|chronic wound
4917634|NCT02007824|tissue necrosis|tissue necrosis
4917635|NCT02007824|slough|slough
4917636|NCT02007824|ultra sound|ultra sound
4917637|NCT02007798|dexmedetomidine|dexmedetomidine
4917638|NCT02007798|supratentorial tumors|supratentorial tumors
4917639|NCT02007785|Cognitive Orientation to daily Occupational Performance|cognitive orientation to daily occupational performance
4917640|NCT02007785|CO-OP|co-op
4917641|NCT02007772|COPD, nHF, BiPAP|copd, nhf, bipap
4917642|NCT02007759|Dysphagia|dysphagia
4917643|NCT02007759|neuromuscular electrical stimulation|neuromuscular electrical stimulation
4917644|NCT02007759|NMES|nmes
4917645|NCT02007759|Neonates|neonates
4917646|NCT02007759|Vitalstim|vitalstim
4917647|NCT02007746|sickle cell disease|sickle cell disease
4917648|NCT02007746|hemochromatosis|hemochromatosis
4917649|NCT02007746|liver fibrosis|liver fibrosis
4917650|NCT02007746|liver cirrhosis|liver cirrhosis
4917651|NCT02007746|FibroScan|fibroscan
4917652|NCT02007746|Ferriscan|ferriscan
4917653|NCT02007746|liver iron|liver iron
4917654|NCT02007733|Diarrhea|diarrhea
4917655|NCT02007733|Dehydration|dehydration
4917656|NCT02007733|Children|children
4917657|NCT02007733|Resuscitation|resuscitation
4917658|NCT02007733|Clinical Prediction Rule|clinical prediction rule
4917659|NCT02007733|Low Income Country|low income country
4917660|NCT02007733|Bangladesh|bangladesh
4917661|NCT02007720|Serelaxin,|serelaxin,
4917662|NCT02007720|WHF,|whf,
4917663|NCT02007720|Likert Scale,|likert scale,
4917664|NCT02007720|RELAX-AHF-ASIA,|relax-ahf-asia,
4917665|NCT02007720|RLX030,|rlx030,
4917666|NCT02007720|AHF,|ahf,
4917667|NCT02007720|acute heart failure|acute heart failure
4917668|NCT02007707|Asian American|asian american
4917669|NCT02007707|Vietnamese American|vietnamese american
4917670|NCT02007707|Smoking cessation|smoking cessation
4917671|NCT02007707|Community Health Worker|community health worker
4917672|NCT02007707|Lay Health Worker Outreach|lay health worker outreach
4917673|NCT02007707|Family Intervention|family intervention
4917674|NCT02007694|Phobic Disorders (Fear of Flying and acrophobia)|phobic disorders (fear of flying and acrophobia)
4917675|NCT02007694|Virtual Reality Exposure Therapy|virtual reality exposure therapy
4917676|NCT02007694|Fear extinction|fear extinction
4917677|NCT02007694|propranolol|propranolol
4917678|NCT02007694|Yohimbine|yohimbine
4917679|NCT02007681|Sedentary Behavior; Breaks; Workplace; Energy Expenditure; Physical activity; doubly labeled water|sedentary behavior; breaks; workplace; energy expenditure; physical activity; doubly labeled water
4917680|NCT02007668|low back pain|low back pain
4917681|NCT02007668|kinesio taping|kinesio taping
4917682|NCT02007655|Cardiovascular|cardiovascular
4917683|NCT02007616|Cognitive aging|cognitive aging
4917684|NCT02007616|Video games training|video games training
4917685|NCT02007616|Attention|attention
4917686|NCT02007616|Memory|memory
4917687|NCT02007616|Wellbeing|wellbeing
4917688|NCT02007616|Speed of processing|speed of processing
4917689|NCT02007616|Executive functions|executive functions
4917690|NCT02007603|chronic hemodialysis|chronic hemodialysis
4917691|NCT02007603|ampicillin|ampicillin
4917692|NCT02007603|sulbactam|sulbactam
4917693|NCT02007603|amoxicillin|amoxicillin
4917694|NCT02007603|clavulanic acid|clavulanic acid
4917695|NCT02007603|pharmacokinetics|pharmacokinetics
4917696|NCT02007577|insulin resistant|insulin resistant
4917697|NCT02007564|Palliative care dyads|palliative care dyads
4917698|NCT02007564|Volunteers|volunteers
4917699|NCT02007564|Community-based|community-based
4917700|NCT02007564|Mixed methods|mixed methods
4917701|NCT02007551|Social Isolation|social isolation
4917702|NCT02007551|Nutrition Assessments|nutrition assessments
4917703|NCT02007551|Food Habits|food habits
4917704|NCT02007551|Meals|meals
4917705|NCT02007551|Self Efficacy|self efficacy
4917706|NCT02007551|Quality of Life|quality of life
4917707|NCT02007551|Peer Group|peer group
4917708|NCT02007538|Lung Cancer|lung cancer
4917709|NCT02007538|Bronchoscopy|bronchoscopy
4917710|NCT02007538|Fine Need Aspiration|fine need aspiration
4917711|NCT02007538|Cytochemical Assays|cytochemical assays
4917712|NCT02007512|advanced breast cancer|advanced breast cancer
4917713|NCT02007512|enzalutamide|enzalutamide
4917714|NCT02007512|MDV3100|mdv3100
4917715|NCT02007512|Estrogen receptor positive (ER +)|estrogen receptor positive (er +)
4917716|NCT02007512|Progesterone receptor positive (PgR +)|progesterone receptor positive (pgr +)
4917717|NCT02007512|HER-2 normal|her-2 normal
4917718|NCT02007499|Prehospital emergency care|prehospital emergency care
4917719|NCT02007499|Out of hospital cardiac arrest|out of hospital cardiac arrest
4917720|NCT02007499|Cardiopulmonary resuscitation|cardiopulmonary resuscitation
4917721|NCT02007499|CPR|cpr
4917722|NCT02007499|Heart arrest|heart arrest
4917723|NCT02007499|Outcome|outcome
4917724|NCT02007499|Bystander|bystander
4917725|NCT02007486|Heart Failure|heart failure
4917726|NCT02007486|Exercise|exercise
4917727|NCT02007486|Dyspnea|dyspnea
4917728|NCT02007486|Diaphragm electromyogram|diaphragm electromyogram
4917729|NCT02007486|Respiratory mechanics|respiratory mechanics
4917730|NCT02007473|Haemovigilance|haemovigilance
4917731|NCT02007473|Plasma|plasma
4917732|NCT02007473|Pathogen reduction|pathogen reduction
4917733|NCT02007473|Methylene Blue|methylene blue
4917734|NCT02007447|autism, oxytocin, autism spectrum disorder, social skills.|autism, oxytocin, autism spectrum disorder, social skills.
4917735|NCT02007421|Human Papillomavirus,|human papillomavirus,
4917736|NCT02007421|Anal High Grade Squamous intraepithelial lesions,|anal high grade squamous intraepithelial lesions,
4917737|NCT02007421|Homosexual Men|homosexual men
4917738|NCT02007421|High resolution anoscopy,|high resolution anoscopy,
4917739|NCT02007421|Cancer Screening|cancer screening
4917740|NCT02007421|HIV|hiv
4917741|NCT02007408|abortion|abortion
4917742|NCT02007408|analgesia|analgesia
4917743|NCT02007408|paracervical block|paracervical block
4917744|NCT02007408|lidocaine spray|lidocaine spray
4917745|NCT02007343|Enterobacteriaceae|enterobacteriaceae
4917746|NCT02007343|Pseudomonas|pseudomonas
4917747|NCT02007343|Acinetobacter|acinetobacter
4917748|NCT02007343|Stenotrophomonas|stenotrophomonas
4917749|NCT02007343|Mortality|mortality
4917750|NCT02007343|Morbidity|morbidity
4917751|NCT02007343|Cost of Illness|cost of illness
4917752|NCT02007343|Causality|causality
4917753|NCT02007343|Multicenter Study|multicenter study
4917754|NCT02007343|Cohort Studies|cohort studies
4917755|NCT02007343|Case-Control Studies|case-control studies
4917756|NCT02007343|Prospective Studies|prospective studies
4917757|NCT02007343|Follow-up Studies|follow-up studies
4917758|NCT02007330|systemic lidocaine|systemic lidocaine
4917759|NCT02007330|postoperative pain|postoperative pain
4917760|NCT02007330|recovery, pediatric|recovery, pediatric
4917761|NCT02007330|inguinal hernia|inguinal hernia
4917762|NCT02007330|laparoscopy|laparoscopy
4917764|NCT02007291|Alzheimer, MMSE, response, colinesterase inhibitors (ChEI)|alzheimer, mmse, response, colinesterase inhibitors (chei)
4917765|NCT02007278|diabetes|diabetes
4917766|NCT02007278|hypoglycemia|hypoglycemia
4917767|NCT02007278|glycemic variability|glycemic variability
4917768|NCT02007278|vildagliptin|vildagliptin
4917769|NCT02007278|glimepiride|glimepiride
4917770|NCT02007252|Abdominal Aortic Aneurysm|abdominal aortic aneurysm
4917771|NCT02007252|AAA|aaa
4917772|NCT02007252|IL-1b|il-1b
4917773|NCT02007252|Abdominal ultrasound|abdominal ultrasound
4917774|NCT02007239|tocilizumab|tocilizumab
4917775|NCT02007239|hemophagocytic lymphohistiocytosis (HLH)|hemophagocytic lymphohistiocytosis (hlh)
4917776|NCT02007239|cytokine|cytokine
4917777|NCT02007239|cytokine release syndrome|cytokine release syndrome
4917778|NCT02007226|Coronary Heart Disease|coronary heart disease
4917779|NCT02007226|spinal cord injury|spinal cord injury
4917780|NCT02007226|risk factor|risk factor
4917781|NCT02007226|postprandial lipemia|postprandial lipemia
4917782|NCT02007213|Neuromuscular Disease|neuromuscular disease
4917783|NCT02007213|Motor Function|motor function
4917784|NCT02007213|Proxy Reported Outcome|proxy reported outcome
4917785|NCT02007213|Young Children|young children
4917786|NCT02007187|Unstable Angina Pectoris|unstable angina pectoris
4917787|NCT02007187|Randomized Controlled Trial|randomized controlled trial
4917788|NCT02007187|Traditional Chinese Medicine|traditional chinese medicine
4917789|NCT02007174|recurrent pterygium|recurrent pterygium
4917790|NCT02007174|bevacizumab|bevacizumab
4917791|NCT02007174|triple dose|triple dose
4917792|NCT02007148|gastric adenocarcinoma,|gastric adenocarcinoma,
4917793|NCT02007148|capecitabine,|capecitabine,
4917794|NCT02007148|second line treatment,|second line treatment,
4917795|NCT02007148|recurrent or metastatic disease,|recurrent or metastatic disease,
4917796|NCT02007148|overall survival,|overall survival,
4917797|NCT02007148|tumor response,|tumor response,
4917798|NCT02007148|quality of life|quality of life
4917799|NCT02007122|HD|hd
4917800|NCT02007122|CVVH|cvvh
4917801|NCT02007122|renal replacement therapy|renal replacement therapy
4917802|NCT02007122|ceftaroline|ceftaroline
4917803|NCT02007122|pharmacokinetics|pharmacokinetics
4917804|NCT02007096|Transabdominal plane block|transabdominal plane block
4917805|NCT02007096|ventral hernia|ventral hernia
4917806|NCT02007096|umbilical hernia|umbilical hernia
4917807|NCT02007096|incisional hernia|incisional hernia
4917808|NCT02007096|hernia repair|hernia repair
4917809|NCT02007083|Lumbar Spinal stenosis|lumbar spinal stenosis
4917810|NCT02007083|Surgical treatment of LSS.|surgical treatment of lss.
4917811|NCT02007070|PD1|pd1
4917812|NCT02007070|PD-1|pd-1
4917813|NCT02007070|PDL1|pdl1
4917814|NCT02007070|PD-L1|pd-l1
4917815|NCT02007057|Suprascapular nerve block|suprascapular nerve block
4918315|NCT02004756|fontan|fontan
4917816|NCT02007057|Interscalene nerve block|interscalene nerve block
4917817|NCT02007044|Leukemia|leukemia
4917818|NCT02007044|Chronic lymphocytic leukemia|chronic lymphocytic leukemia
4917819|NCT02007044|CLL|cll
4917820|NCT02007044|Relapsed|relapsed
4917821|NCT02007044|Ibrutinib|ibrutinib
4917822|NCT02007044|PCI-32765|pci-32765
4917823|NCT02007044|Rituximab|rituximab
4917824|NCT02007044|Rituxan|rituxan
4917825|NCT02007031|Hypertension|hypertension
4917826|NCT02007031|Cold temperature|cold temperature
4917827|NCT02007031|Blood pressure|blood pressure
4917828|NCT02007031|Electrocardiography|electrocardiography
4917829|NCT02007018|Surgical Site Infections|surgical site infections
4917830|NCT02007018|Colorectal Resection|colorectal resection
4917831|NCT02007018|Negative Pressure Wound Therapy|negative pressure wound therapy
4917832|NCT02007005|superficial bladder cancer|superficial bladder cancer
4917833|NCT02007005|mistletoe extract|mistletoe extract
4917834|NCT02007005|maximum tolerated dose|maximum tolerated dose
4917835|NCT02007005|marker tumor|marker tumor
4917836|NCT02007005|remission|remission
4917837|NCT02007005|recurrence rate|recurrence rate
4917838|NCT02006979|cardiotoxicity|cardiotoxicity
4917839|NCT02006979|Chemotherapy, Adjuvant|chemotherapy, adjuvant
4917840|NCT02006979|Breast Neoplasms|breast neoplasms
4917841|NCT02006979|Exercise|exercise
4917842|NCT02006979|Cardiotoxins|cardiotoxins
4917843|NCT02006979|Echocardiography|echocardiography
4917844|NCT02006979|Speckle tracking|speckle tracking
4917845|NCT02006979|Biological Markers|biological markers
4917846|NCT02006979|Electrocardiography|electrocardiography
4917847|NCT02006966|Systemic lidocaine|systemic lidocaine
4917848|NCT02006966|postoperative pain|postoperative pain
4917849|NCT02006966|Video-assisted thoracic surgery|video-assisted thoracic surgery
4917850|NCT02006966|VATS|vats
4917851|NCT02006953|gastrostomy|gastrostomy
4917852|NCT02006953|enteral|enteral
4917853|NCT02006940|alveoflex|alveoflex
4917854|NCT02006940|probe-based confocal laser endomicroscopy|probe-based confocal laser endomicroscopy
4917855|NCT02006940|pCLE|pcle
4917856|NCT02006940|alveoscopy|alveoscopy
4917857|NCT02006940|morphology|morphology
4917858|NCT02006940|high resolution computed tomography|high resolution computed tomography
4917859|NCT02006927|Prostate Cancer|prostate cancer
4917860|NCT02006914|Insulin resistance|insulin resistance
4917861|NCT02006914|HIV disease|hiv disease
4917862|NCT02006914|chromium picolinate|chromium picolinate
4917863|NCT02006901|surgical procedures, operative|surgical procedures, operative
4917864|NCT02006901|lumbar vertebrae|lumbar vertebrae
4917865|NCT02006901|decompression, surgical|decompression, surgical
4917866|NCT02006901|microdecompression|microdecompression
4917867|NCT02006901|laminectomy|laminectomy
4917868|NCT02006901|registries|registries
4917869|NCT02006888|Inflammation|inflammation
4917870|NCT02006888|cataract surgery|cataract surgery
4917871|NCT02006875|repetitive transcranial magnetic stimulation|repetitive transcranial magnetic stimulation
4917872|NCT02006875|postural|postural
4917873|NCT02006875|balance|balance
4917874|NCT02006875|mobility|mobility
4917875|NCT02006875|leg|leg
4917876|NCT02006875|stroke|stroke
4917877|NCT02006862|olanzapine|olanzapine
4917878|NCT02006862|olanzapine treatment efficacy|olanzapine treatment efficacy
4917879|NCT02006849|AfricanAmericans|africanamericans
4917880|NCT02006849|Hypertension|hypertension
4917881|NCT02006849|Proteinuria|proteinuria
4917882|NCT02006849|ApoL1 gene|apol1 gene
4917883|NCT02006836|glycemic index|glycemic index
4917884|NCT02006836|glycemic response|glycemic response
4917885|NCT02006836|diabetes|diabetes
4917886|NCT02006836|pomelo|pomelo
4917887|NCT02006823|Chronic Hepatitis C|chronic hepatitis c
4917888|NCT02006810|Endothelium biomarkers|endothelium biomarkers
4917889|NCT02006810|Atherosclerotic disease|atherosclerotic disease
4917890|NCT02006810|Endothelial function|endothelial function
4917891|NCT02006810|Nutritional stimuli|nutritional stimuli
4917892|NCT02006797|reconciliation|reconciliation
4917893|NCT02006797|discharge|discharge
4917894|NCT02006797|pharmacist|pharmacist
4917895|NCT02006797|drug related problems|drug related problems
4917896|NCT02006771|Meal|meal
4917897|NCT02006771|Postprandial oxidative stress|postprandial oxidative stress
4917898|NCT02006719|Adhesive Capsulitis|adhesive capsulitis
4917899|NCT02006719|Frozen Shoulder|frozen shoulder
4917900|NCT02006719|Shoulder Range of Motion limitation|shoulder range of motion limitation
4917901|NCT02006719|Shoulder Pain|shoulder pain
4917902|NCT02006693|XEN|xen
4917903|NCT02006693|Primary Open Angle Glaucoma|primary open angle glaucoma
4917904|NCT02006693|Filtration Device|filtration device
4917905|NCT02006693|Ab interno|ab interno
4917906|NCT02006680|Central Precocious Puberty|central precocious puberty
4917907|NCT02006680|Suppression|suppression
4917908|NCT02006680|Alpha Subunit|alpha subunit
4917909|NCT02006680|Leuprolide Stimulation Test|leuprolide stimulation test
4917910|NCT02006628|GWP42003|gwp42003
4917911|NCT02006628|Cannabinoids|cannabinoids
4917912|NCT02006628|Schizophrenia|schizophrenia
4917913|NCT02006602|Candesartan cilexetil|candesartan cilexetil
4917914|NCT02006602|Healthy adult human subjects|healthy adult human subjects
4917915|NCT02006602|Bioequivalence|bioequivalence
4917916|NCT02006589|Bioequivalence|bioequivalence
4917917|NCT02006589|Candesartan cilexetil|candesartan cilexetil
4917918|NCT02006589|Healthy adult human subjects|healthy adult human subjects
4917919|NCT02006576|Emphysema|emphysema
4917920|NCT02006576|Prostaglandin E|prostaglandin e
4917921|NCT02006576|Bronchoalveolar lavage|bronchoalveolar lavage
4917922|NCT02006563|Brain Tumor|brain tumor
4917923|NCT02006563|Glioblastoma multiforme|glioblastoma multiforme
4917924|NCT02006563|GBM|gbm
4917925|NCT02006563|Metabolic Tumor Volume|metabolic tumor volume
4917926|NCT02006563|MTV|mtv
4917927|NCT02006563|Clinical Tumor Volume|clinical tumor volume
4917928|NCT02006563|CTV|ctv
4917929|NCT02006550|Wnt|wnt
4917930|NCT02006550|Notch|notch
4917931|NCT02006550|Hedgehog|hedgehog
4917932|NCT02006550|Tumor Sample|tumor sample
4917933|NCT02006537|soluble epoxide hydrolase inhibitor|soluble epoxide hydrolase inhibitor
4917934|NCT02006537|Entero-Test|entero-test
4917935|NCT02006537|pharmacokinetics|pharmacokinetics
4917936|NCT02006537|COPD|copd
4917937|NCT02006537|safety|safety
4917938|NCT02006524|Silent atrial fibrillation|silent atrial fibrillation
4917939|NCT02006524|primary care|primary care
4917940|NCT02006524|screening|screening
4917941|NCT02006524|influenza vaccination|influenza vaccination
4917942|NCT02006511|incisional negative pressure wound therapy|incisional negative pressure wound therapy
4917943|NCT02006511|groin incision|groin incision
4917944|NCT02006511|incisional VAC|incisional vac
4917945|NCT02006511|Prevena|prevena
4917946|NCT02006511|groin wound|groin wound
4917947|NCT02006498|non-alcoholic fatty liver disease|non-alcoholic fatty liver disease
4917948|NCT02006498|sillymarin|sillymarin
4917949|NCT02006498|randomised trial|randomised trial
4917950|NCT02006498|non-alcoholic steatohepatitis|non-alcoholic steatohepatitis
4917951|NCT02006472|Huntington's Disease|huntington's disease
4917952|NCT02006472|Pridopidine|pridopidine
4917953|NCT02006472|Pride-HD|pride-hd
4917954|NCT02006459|Gastrointestinal-mediated glucose disposal|gastrointestinal-mediated glucose disposal
4917955|NCT02006459|Total pancreatectomy|total pancreatectomy
4917956|NCT02006459|Incretin hormones|incretin hormones
4917957|NCT02006459|Glucagon|glucagon
4917958|NCT02006446|Male infertility|male infertility
4917959|NCT02006446|sperm head vacuoles|sperm head vacuoles
4917960|NCT02006446|sperm morphology|sperm morphology
4917961|NCT02006446|aneuploidy|aneuploidy
4917962|NCT02006446|DNA fragmentation|dna fragmentation
4917963|NCT02006446|abnormal chromatin condensation|abnormal chromatin condensation
4917964|NCT02006446|telomere abnormalities|telomere abnormalities
4917965|NCT02006394|Inflammation|inflammation
4917966|NCT02006394|Monocytes|monocytes
4917967|NCT02006381|healthy boys|healthy boys
4917968|NCT02006381|plasma oxytocin|plasma oxytocin
4917969|NCT02006381|pediatric|pediatric
4917970|NCT02006368|Volunteers|volunteers
4917971|NCT02006368|Blood Platelets|blood platelets
4917972|NCT02006368|Platelet Transfusion|platelet transfusion
4917973|NCT02006342|Diabetes Mellitus|diabetes mellitus
4917974|NCT02006342|Diabetic Ketoacidosis|diabetic ketoacidosis
4917975|NCT02006342|Insulin Glargine|insulin glargine
4917976|NCT02006342|Anion gap|anion gap
4917977|NCT02006342|Metabolic acidosis|metabolic acidosis
4917978|NCT02006303|Benign Prostate Hyperplasia|benign prostate hyperplasia
4917979|NCT02006303|Green light|green light
4917980|NCT02006303|Photoselective vaporization of the prostate|photoselective vaporization of the prostate
4917981|NCT02006303|Prostatic artery embolization|prostatic artery embolization
4917982|NCT02006303|Outcome|outcome
4917983|NCT02006277|healthy volunteers|healthy volunteers
4917984|NCT02006277|taste|taste
4917985|NCT02006277|bioavailability|bioavailability
4917986|NCT02006238|Hot flash|hot flash
4917987|NCT02006238|Farabloc|farabloc
4917988|NCT02006238|menopausal women|menopausal women
4917989|NCT02006225|autologous|autologous
4917990|NCT02006225|stem cell|stem cell
4917991|NCT02006225|transplantation|transplantation
4917992|NCT02006199|obsessive-compulsive disorder|obsessive-compulsive disorder
4917993|NCT02006199|mindfulness|mindfulness
4917994|NCT02006199|meditation|meditation
4917995|NCT02006186|Bicycling|bicycling
4917996|NCT02006173|Hya-Dermis mixed with lidocaine on reducing pain|hya-dermis mixed with lidocaine on reducing pain
4917997|NCT02006147|Macular Edema|macular edema
4917998|NCT02006147|RVO|rvo
4917999|NCT02006134|Vasculitis|vasculitis
4918000|NCT02006134|Primary CNS Vasculitis|primary cns vasculitis
4918001|NCT02006134|Systemic vasculitis|systemic vasculitis
4918002|NCT02006134|Churg-Strauss Syndrome|churg-strauss syndrome
4918003|NCT02006134|Polyarteritis Nodosa|polyarteritis nodosa
4918004|NCT02006134|Wegener Granulomatosis|wegener granulomatosis
4918005|NCT02006134|Pediatric vasculitis|pediatric vasculitis
4918006|NCT02006134|Childhood vasculitis|childhood vasculitis
4918007|NCT02006134|Granulomatosis with polyangiitis|granulomatosis with polyangiitis
4918008|NCT02006134|Microscopic Polyangiitis|microscopic polyangiitis
4918009|NCT02006134|Takayasu Arteritis|takayasu arteritis
4918010|NCT02006134|Autoimmune|autoimmune
4918136|NCT02005588|iron salt|iron salt
4918011|NCT02006134|ANCA-associated vasculitis|anca-associated vasculitis
4918012|NCT02006121|Parkinson's disease|parkinson's disease
4918013|NCT02006121|motor fluctuations|motor fluctuations
4918014|NCT02006121|not well controlled|not well controlled
4918015|NCT02006121|medical treatment|medical treatment
4918016|NCT02006108|kidney|kidney
4918017|NCT02006108|transplant|transplant
4918018|NCT02006108|rejection|rejection
4918019|NCT02006108|Feraheme|feraheme
4918020|NCT02006108|ferumoxytol|ferumoxytol
4918021|NCT02006095|carotid artery stenting|carotid artery stenting
4918022|NCT02006095|carotid endarterectomy|carotid endarterectomy
4918023|NCT02006095|magnetic resonance imaging (MRI)|magnetic resonance imaging (mri)
4918024|NCT02006095|neuropsychological testing|neuropsychological testing
4918025|NCT02006095|microemboli|microemboli
4918026|NCT02006082|Telemedicine video-consultation (TVC)|telemedicine video-consultation (tvc)
4918027|NCT02006082|Re-admission to hospital|re-admission to hospital
4918028|NCT02006082|Time to re-admission|time to re-admission
4918029|NCT02006082|Length if hospital stay|length if hospital stay
4918030|NCT02006082|Patient satisfaction|patient satisfaction
4918031|NCT02006082|Chronic obstructive pulmonary disease (COPD)|chronic obstructive pulmonary disease (copd)
4918032|NCT02006069|CRT, non responders, MultiPoint Pacing (MPP)|crt, non responders, multipoint pacing (mpp)
4918033|NCT02006030|Unresectable Hepatocellular Carcinoma|unresectable hepatocellular carcinoma
4918034|NCT02006030|Liver Cancer|liver cancer
4918035|NCT02006030|ADI|adi
4918036|NCT02006030|ADI-PEG 20|adi-peg 20
4918037|NCT02006004|AML|aml
4918038|NCT02005991|PF-05212377|pf-05212377
4918039|NCT02005991|phase 1|phase 1
4918040|NCT02005991|open-label|open-label
4918041|NCT02005991|5-HT2a receptor occupancy|5-ht2a receptor occupancy
4918042|NCT02005991|positron emission tomography|positron emission tomography
4918043|NCT02005991|healthy subjects|healthy subjects
4918044|NCT02005991|brain|brain
4918045|NCT02005991|cortex|cortex
4918046|NCT02005991|alzheimers disease|alzheimers disease
4918047|NCT02005965|Rectal Cancer|rectal cancer
4918048|NCT02005965|Low Rectal Cancer|low rectal cancer
4918049|NCT02005965|MERCURY|mercury
4918050|NCT02005965|Cancer|cancer
4918051|NCT02005965|CRM|crm
4918052|NCT02005965|Circumferential Margin|circumferential margin
4918053|NCT02005965|Quality of Life|quality of life
4918054|NCT02005965|MRI|mri
4918055|NCT02005965|Radiology|radiology
4918056|NCT02005965|Abdominoperineal Excision|abdominoperineal excision
4918057|NCT02005965|Anterior Resection|anterior resection
4918058|NCT02005965|Surgery|surgery
4918059|NCT02005965|Pathology|pathology
4918060|NCT02005939|Pomegranate|pomegranate
4918061|NCT02005939|Blood pressure|blood pressure
4918062|NCT02005939|Insulin sensitivity|insulin sensitivity
4918063|NCT02005939|Cortisol|cortisol
4918064|NCT02005939|Quality of life|quality of life
4918065|NCT02005939|Body composition|body composition
4918066|NCT02005926|Breast cancer|breast cancer
4918067|NCT02005926|Sentinel lymph node biopsy|sentinel lymph node biopsy
4918068|NCT02005926|Ultrasonography|ultrasonography
4918069|NCT02005926|Fine needle aspiration|fine needle aspiration
4918070|NCT02005900|DHA|dha
4918071|NCT02005900|Omega 3|omega 3
4918072|NCT02005900|Polyunsaturated Fatty Acids|polyunsaturated fatty acids
4918073|NCT02005900|Dyslipidemia induced by HAART|dyslipidemia induced by haart
4918074|NCT02005900|Lipid metabolic alterations|lipid metabolic alterations
4918075|NCT02005900|HIV|hiv
4918076|NCT02005887|Premenopausal patients|premenopausal patients
4918077|NCT02005887|ER-positive|er-positive
4918078|NCT02005887|PgR+ (>50%)|pgr+ (>50%)
4918079|NCT02005887|HER2-negative or not amplified|her2-negative or not amplified
4918080|NCT02005861|osteochondral lesion|osteochondral lesion
4918081|NCT02005861|talus|talus
4918082|NCT02005861|ankle|ankle
4918083|NCT02005861|cartilage repair|cartilage repair
4918084|NCT02005848|Type-1 Diabetes|type-1 diabetes
4918085|NCT02005848|T1D|t1d
4918086|NCT02005848|Diabetes Mellitus|diabetes mellitus
4918087|NCT02005835|HIV|hiv
4918088|NCT02005835|Option B+|option b+
4918089|NCT02005835|Prevention of Mother to Child Transmission|prevention of mother to child transmission
4918090|NCT02005822|Cytomegalovirus|cytomegalovirus
4918091|NCT02005822|Congenital infection|congenital infection
4918092|NCT02005822|Sensorineural hearing loss|sensorineural hearing loss
4918093|NCT02005822|Valganciclovir|valganciclovir
4918094|NCT02005809|Endoscopic submucosal dissection|endoscopic submucosal dissection
4918095|NCT02005809|gastric neoplasm|gastric neoplasm
4918096|NCT02005809|second look endoscopy|second look endoscopy
4918097|NCT02005783|incidence of grade 3/4 neutropenia|incidence of grade 3/4 neutropenia
4918098|NCT02005783|incidence of febrile neutropenia|incidence of febrile neutropenia
4918099|NCT02005783|time to neutropenia recovery|time to neutropenia recovery
4918100|NCT02005783|safety|safety
4918101|NCT02005757|rheumatoid arthritis|rheumatoid arthritis
4918102|NCT02005757|RA|ra
4918103|NCT02005757|Mizoribine|mizoribine
4918104|NCT02005757|DAS28|das28
4918105|NCT02005757|European League Against Rheumatism|european league against rheumatism
4918106|NCT02005744|CKD-501|ckd-501
4918107|NCT02005731|Low Intensity Shockwave|low intensity shockwave
4918108|NCT02005731|Extracorporeal shockwave therapy|extracorporeal shockwave therapy
4918109|NCT02005731|Erectile dysfunction|erectile dysfunction
4918110|NCT02005692|pressure ulcers|pressure ulcers
4918111|NCT02005692|bed sores|bed sores
4918112|NCT02005692|patient turn protocol|patient turn protocol
4918113|NCT02005692|patient movement|patient movement
4918114|NCT02005692|patient monitoring|patient monitoring
4918115|NCT02005679|Prelingual Deafness|prelingual deafness
4918116|NCT02005679|Retention Disorders, Cognitive|retention disorders, cognitive
4918117|NCT02005679|Sign language|sign language
4918118|NCT02005679|Mini-Mental State|mini-mental state
4918119|NCT02005666|Acne Vulgaris|acne vulgaris
4918120|NCT02005666|DUAC|duac
4918121|NCT02005666|CADILA|cadila
4918122|NCT02005666|CLIANTHA|cliantha
4918123|NCT02005653|Lymphatic filariasis|lymphatic filariasis
4918124|NCT02005653|W. bancrofti|w. bancrofti
4918125|NCT02005653|DEC|dec
4918126|NCT02005653|Albendazole|albendazole
4918127|NCT02005653|Doxycycline|doxycycline
4918128|NCT02005627|grass pollen allergy|grass pollen allergy
4918129|NCT02005627|hayfever|hayfever
4918130|NCT02005627|atopy|atopy
4918131|NCT02005627|allergic rhinitis|allergic rhinitis
4918132|NCT02005627|sublingual immunotherapy tablets|sublingual immunotherapy tablets
4918133|NCT02005614|Rational dose selection|rational dose selection
4918134|NCT02005614|gamma knife radiosurgery|gamma knife radiosurgery
4918135|NCT02005588|amino acid chelated iron|amino acid chelated iron
4918137|NCT02005588|iron deficiency anemia|iron deficiency anemia
4918138|NCT02005536|Poliomyelitis|poliomyelitis
4918139|NCT02005536|Poliovirus|poliovirus
4918140|NCT02005536|Polio|polio
4918141|NCT02005536|IMOVAX POLIO®|imovax polio®
4918142|NCT02005536|Inactivated polio vaccine|inactivated polio vaccine
4918143|NCT02005510|cervical cancer|cervical cancer
4918144|NCT02005510|screening|screening
4918145|NCT02005510|human papillomavirus|human papillomavirus
4918146|NCT02005510|cervical intraepithelial neoplasia|cervical intraepithelial neoplasia
4918147|NCT02005497|Cancer prevention and control|cancer prevention and control
4918148|NCT02005497|Health promotion|health promotion
4918149|NCT02005497|Workplace|workplace
4918150|NCT02005497|Dissemination|dissemination
4918151|NCT02005497|Implementation|implementation
4918152|NCT02005458|Neutropenia|neutropenia
4918153|NCT02005458|Febrile neutropenia|febrile neutropenia
4918154|NCT02005458|PEG-rhG-CSF|peg-rhg-csf
4918155|NCT02005458|Myelosuppressive chemotherapy|myelosuppressive chemotherapy
4918156|NCT02005445|Obstructive sleep apnea|obstructive sleep apnea
4918157|NCT02005445|Coronary heart disease|coronary heart disease
4918158|NCT02005445|Cardiac rehabilitation|cardiac rehabilitation
4918159|NCT02005445|Cardiopulmonary exercise testing|cardiopulmonary exercise testing
4918160|NCT02005432|Diabetis|diabetis
4918161|NCT02005432|Retinal Neovascularization|retinal neovascularization
4918162|NCT02005432|laser treatment|laser treatment
4918163|NCT02005419|Pancreatic Cancer|pancreatic cancer
4918164|NCT02005419|Pancreatic Adenocarcinoma|pancreatic adenocarcinoma
4918165|NCT02005419|Metformin|metformin
4918166|NCT02005419|Gemcitabine|gemcitabine
4918167|NCT02005419|Adjuvant Therapy|adjuvant therapy
4918168|NCT02005406|Wei JET|wei jet
4918169|NCT02005393|FICE|fice
4918170|NCT02005393|NBI|nbi
4918171|NCT02005380|Alzheimer's Disease Rehabilitation|alzheimer's disease rehabilitation
4918172|NCT02005367|substance use treatment|substance use treatment
4918173|NCT02005367|person-centered treatment|person-centered treatment
4918174|NCT02005367|residential treatment outcomes|residential treatment outcomes
4918175|NCT02005367|dual diagnosis|dual diagnosis
4918176|NCT02005367|recovery model|recovery model
4918177|NCT02005367|psychosocial treatment|psychosocial treatment
4918178|NCT02005354|Pain|pain
4918179|NCT02005354|Bone marrow aspiration|bone marrow aspiration
4918180|NCT02005354|trephine biopsy|trephine biopsy
4918181|NCT02005341|Lumbar|lumbar
4918182|NCT02005341|fusion|fusion
4918183|NCT02005328|Xerostomia|xerostomia
4918184|NCT02005328|hyposialia|hyposialia
4918185|NCT02005328|hyposalivation|hyposalivation
4918186|NCT02005328|saliva substitute|saliva substitute
4918187|NCT02005328|Salivary Gland|salivary gland
4918188|NCT02005328|Mouth Diseases|mouth diseases
4918189|NCT02005328|Dry mouth|dry mouth
4918190|NCT02005315|Pancreatic Cancer|pancreatic cancer
4918191|NCT02005315|Stage IV Pancreatic Cancer|stage iv pancreatic cancer
4918192|NCT02005302|chronic kidney disease|chronic kidney disease
4918193|NCT02005302|mineral and bone disease|mineral and bone disease
4918194|NCT02005302|Malnutrition|malnutrition
4918195|NCT02005302|Vitamin D|vitamin d
4918196|NCT02005302|low protein diet|low protein diet
4918197|NCT02005289|CLL|cll
4918198|NCT02005289|SLL|sll
4918199|NCT02005289|PLL|pll
4918200|NCT02005289|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
4918201|NCT02005289|Small Lymphocytic Lymphoma|small lymphocytic lymphoma
4918202|NCT02005289|Prolymphocytic Leukemia|prolymphocytic leukemia
4918203|NCT02005289|MOR00208|mor00208
4918204|NCT02005289|MOR208|mor208
4918205|NCT02005276|Sedentary|sedentary
4918206|NCT02005276|Behavioral Economic Intervention|behavioral economic intervention
4918207|NCT02005276|Team Studies|team studies
4918208|NCT02005276|Financial Incentives|financial incentives
4918209|NCT02005276|Workplace Wellness|workplace wellness
4918210|NCT02005276|Team Incentives|team incentives
4918211|NCT02005263|Hysteroscopy|hysteroscopy
4918212|NCT02005250|osteoporosis|osteoporosis
4918213|NCT02005250|hyperthyroidism|hyperthyroidism
4918214|NCT02005250|hypothyroidism|hypothyroidism
4918215|NCT02005237|Exercise|exercise
4918217|NCT02005237|Neuroimaging|neuroimaging
4918218|NCT02005237|Rehabilitation|rehabilitation
4918219|NCT02005237|Connectivity|connectivity
4918220|NCT02005224|Insulin sensitivity|insulin sensitivity
4918221|NCT02005224|Lipid profile|lipid profile
4918222|NCT02005224|Body composition|body composition
4918223|NCT02005224|Weight|weight
4918224|NCT02005211|AZD3293|azd3293
4918225|NCT02005211|Healthy volunteers|healthy volunteers
4918226|NCT02005211|Young volunteers|young volunteers
4918227|NCT02005211|Elderly volunteers|elderly volunteers
4918228|NCT02005211|Japanese volunteers|japanese volunteers
4918229|NCT02005211|Phase 1|phase 1
4918230|NCT02005211|Single and multiple ascending dose study|single and multiple ascending dose study
4918231|NCT02005172|arrhythmia, palpitations, lightheadedness|arrhythmia, palpitations, lightheadedness
4918232|NCT02005159|Enterobacteria|enterobacteria
4918233|NCT02005159|Bacteremia|bacteremia
4918234|NCT02005159|Minimum inhibitory concentration|minimum inhibitory concentration
4918235|NCT02005159|Susceptible|susceptible
4918236|NCT02005159|Prognosis|prognosis
4918237|NCT02005146|Hepatitis B|hepatitis b
4918238|NCT02005146|Nucleoside/nucleotide|nucleoside/nucleotide
4918239|NCT02005146|HBsAg loss|hbsag loss
4918240|NCT02005133|Wet age-related macular degeneration|wet age-related macular degeneration
4918241|NCT02005068|Osteoarticular infections|osteoarticular infections
4918242|NCT02005068|Osteomyelitis|osteomyelitis
4918243|NCT02005068|Joint infections|joint infections
4918244|NCT02005068|MRSA (Methicillin- Resistant Staphylococcus Aureus)|mrsa (methicillin- resistant staphylococcus aureus)
4918245|NCT02005068|MSSA (Methicillin- Susceptible Staphylococcus Aureus)|mssa (methicillin- susceptible staphylococcus aureus)
4918246|NCT02005055|Brachytherapy|brachytherapy
4918247|NCT02005055|Radiotherapy|radiotherapy
4918248|NCT02005055|Scar treatment|scar treatment
4918249|NCT02005042|Physical activity|physical activity
4918250|NCT02005042|Ecological Momentary Assessment|ecological momentary assessment
4918251|NCT02005042|Ecological Momentary Intervention|ecological momentary intervention
4918252|NCT02005042|Accelerometer|accelerometer
4918253|NCT02005042|Smartphone|smartphone
4918254|NCT02005029|Parkinson's Disease|parkinson's disease
4918255|NCT02005029|Levodopa|levodopa
4918256|NCT02005029|motor fluctuations|motor fluctuations
4918257|NCT02005029|gastroparesis|gastroparesis
4918258|NCT02005016|Aphasia|aphasia
4918259|NCT02005016|Language Therapy|language therapy
4918260|NCT02005016|Acquired Language Disorders|acquired language disorders
4918261|NCT02005016|Semantics|semantics
4918262|NCT02005016|Stroke|stroke
4918263|NCT02004990|Children, Plaque|children, plaque
4918264|NCT02004951|Superficial femoral artery|superficial femoral artery
4918265|NCT02004951|paclitaxel|paclitaxel
4918266|NCT02004951|stent|stent
4918267|NCT02004951|self expandable|self expandable
4918268|NCT02004951|restenosis|restenosis
4918269|NCT02004951|endovascular|endovascular
4918270|NCT02004951|above-the-knee intermediate length|above-the-knee intermediate length
4918271|NCT02004938|measurements|measurements
4918272|NCT02004938|jugular|jugular
4918273|NCT02004938|ultrasound|ultrasound
4918274|NCT02004938|pediatric|pediatric
4918275|NCT02004938|respiratory|respiratory
4918276|NCT02004938|diameter|diameter
4918277|NCT02004925|pneumoperitoneum|pneumoperitoneum
4918278|NCT02004925|free peritoneal air|free peritoneal air
4918279|NCT02004925|ultrasonography|ultrasonography
4918280|NCT02004912|maternal|maternal
4918281|NCT02004912|neonatal|neonatal
4918282|NCT02004912|child|child
4918283|NCT02004912|health services|health services
4918284|NCT02004912|health care|health care
4918285|NCT02004912|Karnataka|karnataka
4918286|NCT02004912|India|india
4918287|NCT02004899|Labor epidural analgesia|labor epidural analgesia
4918288|NCT02004899|Fentanyl|fentanyl
4918289|NCT02004899|Bupivacaine|bupivacaine
4918290|NCT02004899|Onset|onset
4918291|NCT02004886|Diabetes Mellitus|diabetes mellitus
4918292|NCT02004886|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
4918293|NCT02004886|Glucose Metabolism Disorders|glucose metabolism disorders
4918294|NCT02004886|Metabolic Diseases|metabolic diseases
4918295|NCT02004886|Endocrine System Diseases|endocrine system diseases
4918296|NCT02004886|Therapeutic Uses|therapeutic uses
4918297|NCT02004886|Pharmacologic Actions|pharmacologic actions
4918298|NCT02004886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
4918299|NCT02004886|Physiological Effects of Drugs|physiological effects of drugs
4918300|NCT02004886|Metformin|metformin
4918301|NCT02004873|pacemaker|pacemaker
4918302|NCT02004873|leadless|leadless
4918303|NCT02004873|single chamber|single chamber
4918304|NCT02004860|local immunosuppressive|local immunosuppressive
4918305|NCT02004860|Maintenance therapy|maintenance therapy
4918306|NCT02004795|Boron Neutron Capture Therapy|boron neutron capture therapy
4918307|NCT02004795|Image-guided intensity modulation radiotherapy|image-guided intensity modulation radiotherapy
4918308|NCT02004769|Metastatic gastric or gastro-esophageal junction cancer|metastatic gastric or gastro-esophageal junction cancer
4918309|NCT02004769|Trastuzumab|trastuzumab
4918310|NCT02004769|HER2-positive|her2-positive
4918311|NCT02004769|Capecitabine|capecitabine
4918312|NCT02004769|Docetaxel|docetaxel
4918313|NCT02004769|First-line therapy|first-line therapy
4918316|NCT02004756|congenital heart disease|congenital heart disease
4918317|NCT02004756|cardiac and musculoskeletal funion|cardiac and musculoskeletal funion
4918318|NCT02004756|cardiac and/or musculoskeletal metabolism|cardiac and/or musculoskeletal metabolism
4918319|NCT02004756|exercise training intervention|exercise training intervention
4918320|NCT02004743|Early Intervention|early intervention
4918321|NCT02004743|Prevention|prevention
4918322|NCT02004743|Risk Factors|risk factors
4918323|NCT02004743|Exposure Therapy|exposure therapy
4918324|NCT02004743|Psychoeducation|psychoeducation
4918325|NCT02004717|advanced solid tumor|advanced solid tumor
4918326|NCT02004717|Phase 1|phase 1
4918327|NCT02004717|Oncology|oncology
4918328|NCT02004652|Prucalopride|prucalopride
4918329|NCT02004652|Gastrointestinal Diseases|gastrointestinal diseases
4918330|NCT02004652|Postoperative ileus|postoperative ileus
4918331|NCT02004652|Randomised trial|randomised trial
4918332|NCT02004639|IMRT or HT with chemotherapy|imrt or ht with chemotherapy
4918333|NCT02004626|Collagenase|collagenase
4918334|NCT02004626|Phase III|phase iii
4918335|NCT02004626|National|national
4918336|NCT02004626|Noninferiority|noninferiority
4918337|NCT02004626|Double-blind|double-blind
4918338|NCT02004626|Multicenter|multicenter
4918339|NCT02004626|Prospective.|prospective.
4918340|NCT02004587|Hepatic impairment|hepatic impairment
4918341|NCT02004587|Pharmacokinetics|pharmacokinetics
4918342|NCT02004587|Pharmacodynamics|pharmacodynamics
4918343|NCT02004587|Gemigliptin|gemigliptin
4918344|NCT02004561|bariatric_surgery|bariatric_surgery
4918345|NCT02004561|pediatric obesity|pediatric obesity
4918346|NCT02004561|diabetes|diabetes
4918347|NCT02004535|Hearing loss|hearing loss
4918348|NCT02004535|Asymmetric hearing loss|asymmetric hearing loss
4918349|NCT02004535|Cochlear implantation|cochlear implantation
4918350|NCT02004522|Phase 3|phase 3
4918351|NCT02004522|CLL/SLL|cll/sll
4918352|NCT02004522|Pi3K|pi3k
4918353|NCT02004509|atrial fibrillation|atrial fibrillation
4918354|NCT02004509|stroke|stroke
4918355|NCT02004509|pacemaker|pacemaker
4918356|NCT02004509|anticoagulant|anticoagulant
4918357|NCT02004483|percutaneous coronary intervention|percutaneous coronary intervention
4918358|NCT02004483|ischemia|ischemia
4918359|NCT02004483|strain|strain
4918360|NCT02004483|coronary stenosis|coronary stenosis
4918361|NCT02004470|post laparoscopic shoulder pain|post laparoscopic shoulder pain
4918362|NCT02004470|active suction|active suction
4918363|NCT02004470|lavage and suction|lavage and suction
4918364|NCT02004470|right shoulder pain|right shoulder pain
4918365|NCT02004470|post operative shoulder pain|post operative shoulder pain
4918366|NCT02004457|HIV|hiv
4918367|NCT02004457|Primary care|primary care
4918368|NCT02004457|Engagement|engagement
4918369|NCT02004457|Acceptance|acceptance
4918370|NCT02004457|Disclosure|disclosure
4918371|NCT02004457|Stigma|stigma
4918372|NCT02004444|JC Virus|jc virus
4918373|NCT02004444|Natalizumab|natalizumab
4918374|NCT02004431|Chronic post surgical pain|chronic post surgical pain
4918375|NCT02004431|Orthopaedic|orthopaedic
4918376|NCT02004431|Anxiety|anxiety
4918377|NCT02004431|depression|depression
4918378|NCT02004418|C-Choline PET scans|c-choline pet scans
4918379|NCT02004418|external beam radiotherapy|external beam radiotherapy
4918380|NCT02004405|autonomic nervous system|autonomic nervous system
4918381|NCT02004405|fibromyalgia|fibromyalgia
4918382|NCT02004405|autonomic dysfunction|autonomic dysfunction
4918383|NCT02004405|strengthening|strengthening
4918384|NCT02004405|flexibility|flexibility
4918385|NCT02004405|exercise|exercise
4918386|NCT02004405|heart rate variability|heart rate variability
4918387|NCT02004392|Alzheimer's disease|alzheimer's disease
4918388|NCT02004392|Cognition|cognition
4918389|NCT02004392|Alpha-7 nAChR|alpha-7 nachr
4918390|NCT02004379|HCV|hcv
4918391|NCT02004379|Hepatitis C|hepatitis c
4918392|NCT02004379|telaprevir|telaprevir
4918393|NCT02004379|boceprevir|boceprevir
4918394|NCT02004379|clinical practice|clinical practice
4918395|NCT02004366|Diabetes|diabetes
4918396|NCT02004366|Linagliptin|linagliptin
4918397|NCT02004366|hospital hyperglycemia|hospital hyperglycemia
4918398|NCT02004366|inpatient diabetes|inpatient diabetes
4918399|NCT02004353|Cochlear® Hearing Implants|cochlear® hearing implants
4918400|NCT02004340|pediatric epilepsy|pediatric epilepsy
4918401|NCT02004340|transcutaneous vagus nerve stimulation|transcutaneous vagus nerve stimulation
4918402|NCT02004314|Chloroquine|chloroquine
4918403|NCT02004314|T cell immune activation|t cell immune activation
4918404|NCT02004314|CD4 recovery|cd4 recovery
4918405|NCT02004314|HIV|hiv
4918406|NCT02004301|Formulation behaviour|formulation behaviour
4918407|NCT02004301|Drug absorption profile|drug absorption profile
4918408|NCT02004288|Probiotics|probiotics
4918409|NCT02004288|Anorexia nervosa|anorexia nervosa
4918410|NCT02004288|Constipation|constipation
4918411|NCT02004288|Body weight|body weight
4918412|NCT02004262|cancer|cancer
4918413|NCT02004262|cancer vaccine|cancer vaccine
4918414|NCT02004262|Listeria monocytogenes|listeria monocytogenes
4918415|NCT02004262|Listeria-based vaccine|listeria-based vaccine
4918416|NCT02004262|GVAX|gvax
4918417|NCT02004262|cyclophosphamide|cyclophosphamide
4918418|NCT02004262|Cytoxan|cytoxan
4918419|NCT02004262|immunotherapy|immunotherapy
4918420|NCT02004262|mesothelin|mesothelin
4918421|NCT02004236|tRNS|trns
4918422|NCT02004236|QEEG|qeeg
4918423|NCT02004236|ERP|erp
4918424|NCT02004236|ASD|asd
4918425|NCT02004236|Autism|autism
4918426|NCT02004236|verbal fluency|verbal fluency
4918427|NCT02004236|empathy|empathy
4918428|NCT02004236|noninvasive brain stimulation|noninvasive brain stimulation
4918429|NCT02004236|tDCS|tdcs
4918430|NCT02004223|Prostate Cancer|prostate cancer
4918431|NCT02004223|Dose escalation|dose escalation
4918432|NCT02004223|Stereotactic|stereotactic
4918433|NCT02004223|SBRT|sbrt
4918434|NCT02004223|Hypofractionation|hypofractionation
4918435|NCT02004210|transarterial chemoembolization|transarterial chemoembolization
4918436|NCT02004210|transarterial radioembolization|transarterial radioembolization
4918437|NCT02004210|advanced hepatocellular carcinoma|advanced hepatocellular carcinoma
4918438|NCT02004184|Pemetrexed|pemetrexed
4918439|NCT02004184|drug therapy|drug therapy
4918440|NCT02004171|electronic cigarette|electronic cigarette
4918441|NCT02004171|nicotine inhaler|nicotine inhaler
4918442|NCT02004171|smoking cessation|smoking cessation
4918443|NCT02004158|Acute coronary syndrome|acute coronary syndrome
4918444|NCT02004158|Health behavior|health behavior
4918445|NCT02004158|Mental health|mental health
4918446|NCT02004145|MDD|mdd
4918447|NCT02004145|Positive Psychology|positive psychology
4918448|NCT02004145|Suicidality|suicidality
4918449|NCT02004080|TBI|tbi
4918450|NCT02004080|ICU|icu
4918451|NCT02004080|Comparative Effectiveness Research|comparative effectiveness research
4918452|NCT02004067|Evaporative|evaporative
4918453|NCT02004067|Aqueous deficient|aqueous deficient
4918454|NCT02004067|Dry eye disease|dry eye disease
4918455|NCT02004054|multiple sclerosis|multiple sclerosis
4918456|NCT02004054|diameter pupil|diameter pupil
4918457|NCT02004041|pruritus|pruritus
4918458|NCT02004041|atopic dermatitis|atopic dermatitis
4918459|NCT02004041|VLY-686|vly-686
4918460|NCT02004028|Mesothelioma|mesothelioma
4918461|NCT02004028|adenoma|adenoma
4918462|NCT02004028|Neoplasms, Mesothelial|neoplasms, mesothelial
4918463|NCT02004028|Focal Adhesion Kinase Inhibitor|focal adhesion kinase inhibitor
4918464|NCT02004015|Analytical|analytical
4918465|NCT02004015|Diagnostic|diagnostic
4918466|NCT02004015|Anesthesia|anesthesia
4918467|NCT02004015|Analgesia|analgesia
4918468|NCT02003976|knee osteoarthritis|knee osteoarthritis
4918469|NCT02003976|high tibial osteotomy|high tibial osteotomy
4918470|NCT02003976|gait analysis|gait analysis
4918471|NCT02003976|muscular strength|muscular strength
4918472|NCT02003976|body composition|body composition
4918473|NCT02003976|magnetic resonance imaging|magnetic resonance imaging
4918474|NCT02003976|biological markers|biological markers
4918475|NCT02003963|Physical Activity|physical activity
4918476|NCT02003963|Sedentary Behavior|sedentary behavior
4918477|NCT02003963|Video Games|video games
4918478|NCT02003963|Exergames|exergames
4918479|NCT02003911|Asthma|asthma
4918480|NCT02003911|Acute asthma exacerbation|acute asthma exacerbation
4918481|NCT02003911|Pediatric|pediatric
4918482|NCT02003911|Azithromycin|azithromycin
4918483|NCT02003911|Macrolide|macrolide
4918484|NCT02003911|Length of Stay|length of stay
4918485|NCT02003911|Hospital Medicine|hospital medicine
4918486|NCT02003898|Diabetes|diabetes
4918487|NCT02003898|Insulin pump|insulin pump
4918488|NCT02003898|Threshold Suspend|threshold suspend
4918489|NCT02003885|Desflurane, mitral annular velocity, tissue Doppler imaging|desflurane, mitral annular velocity, tissue doppler imaging
4918490|NCT02003859|IBD|ibd
4918491|NCT02003859|Pediatrics|pediatrics
4918492|NCT02003859|pCLE|pcle
4918493|NCT02003833|Poly-L-lactic acid|poly-l-lactic acid
4918494|NCT02003833|Sculptra Aesthetic|sculptra aesthetic
4918495|NCT02003833|Skin Quality|skin quality
4918496|NCT02003833|Wrinkles|wrinkles
4918497|NCT02003833|Filler|filler
4918498|NCT02003820|Autism|autism
4918499|NCT02003820|Dental Caries|dental caries
4918500|NCT02003820|Prevention|prevention
4918501|NCT02003820|Oral Hygiene|oral hygiene
4918502|NCT02003794|acute ischemic stroke|acute ischemic stroke
4918503|NCT02003794|intravenous fluid|intravenous fluid
4918504|NCT02003794|้hydration|้hydration
4918505|NCT02003781|cardiovascular disease|cardiovascular disease
4918506|NCT02003781|metabolic disease|metabolic disease
4918507|NCT02003781|high risk|high risk
4918508|NCT02003781|prospective cohort|prospective cohort
4918509|NCT02003768|pneumoperitoneum|pneumoperitoneum
4918510|NCT02003768|optic nerve sheath diameter|optic nerve sheath diameter
4918511|NCT02003768|laparoscopy|laparoscopy
4918512|NCT02003768|Patients|patients
4918513|NCT02003768|general anesthesia|general anesthesia
4918514|NCT02003768|diameter|diameter
4918515|NCT02003755|Cerebral palsy|cerebral palsy
4918516|NCT02003755|Continuous passive motion|continuous passive motion
4918517|NCT02003755|Hypertonia|hypertonia
4918518|NCT02003742|LUTS|luts
4918519|NCT02003742|BPH|bph
4918520|NCT02003729|obstructive sleep apnea|obstructive sleep apnea
4918521|NCT02003729|Portable Monitor|portable monitor
4918522|NCT02003729|AHI|ahi
4918523|NCT02003729|ESS|ess
4918524|NCT02003729|Cost effectiveness|cost effectiveness
4918525|NCT02003703|Vaccine|vaccine
4918526|NCT02003703|Primary Prevention|primary prevention
4918527|NCT02003703|Immunogenicity|immunogenicity
4918528|NCT02003690|Bipolar disorder|bipolar disorder
4918529|NCT02003690|Adolescent suicidal behavior|adolescent suicidal behavior
4918530|NCT02003690|Psychotherapy|psychotherapy
4918531|NCT02003664|Cocaine|cocaine
4918532|NCT02003664|Treatment|treatment
4918533|NCT02003664|fMRI|fmri
4918534|NCT02003664|Outcomes|outcomes
4918535|NCT02003651|Common cold|common cold
4918536|NCT02003625|Non-Hodgkin's lymphoma|non-hodgkin's lymphoma
4918537|NCT02003625|Hodgkin's lymphoma|hodgkin's lymphoma
4918538|NCT02003625|Multiple myeloma|multiple myeloma
4918539|NCT02003625|Hematopoietic stem cells|hematopoietic stem cells
4918540|NCT02003599|Radiodermatitis|radiodermatitis
4918541|NCT02003599|Breast neoplasms|breast neoplasms
4918542|NCT02003599|Laser Therapy, Low- Level|laser therapy, low- level
4918543|NCT02003586|subjects|subjects
4918544|NCT02003560|breast cancer|breast cancer
4918545|NCT02003560|breast conserving therapy|breast conserving therapy
4918546|NCT02003560|accelerated partial breast irradiation|accelerated partial breast irradiation
4918547|NCT02003560|3D conformal radiotherapy|3d conformal radiotherapy
4918548|NCT02003560|intensity modulated radiotherapy|intensity modulated radiotherapy
4918549|NCT02003521|Lung Flute|lung flute
4918550|NCT02003508|Prevalence|prevalence
4918551|NCT02003508|HPV|hpv
4918552|NCT02003508|Human papillomavirus|human papillomavirus
4918553|NCT02003508|Vaccination|vaccination
4918554|NCT02003495|Immunogenicity, Safety, Meningococcal Conjugate Vaccine|immunogenicity, safety, meningococcal conjugate vaccine
4918555|NCT02003482|Head and Neck Cancer|head and neck cancer
4918556|NCT02003482|Head and Neck Squamous Cell Carcinoma|head and neck squamous cell carcinoma
4918557|NCT02003482|Intensity modulated radiation therapy|intensity modulated radiation therapy
4918558|NCT02003482|IMRT|imrt
4918559|NCT02003482|Anatomic Changes|anatomic changes
4918560|NCT02003482|Postoperative|postoperative
4918561|NCT02003482|Unresectable|unresectable
4918562|NCT02003469|hypertension|hypertension
4918563|NCT02003469|kidney disease|kidney disease
4918564|NCT02003469|cardiovascular disease|cardiovascular disease
4918565|NCT02003456|positron emission tomography|positron emission tomography
4918566|NCT02003456|rubidium|rubidium
4918567|NCT02003456|myocardial perfusion imaging|myocardial perfusion imaging
4918568|NCT02003456|viability|viability
4918569|NCT02003456|FDG|fdg
4918570|NCT02003443|Acupressure|acupressure
4918571|NCT02003443|Older Adults|older adults
4918572|NCT02003443|Knee pain|knee pain
4918573|NCT02003443|Pain Treatment|pain treatment
4918574|NCT02003430|gynecologic malignancy|gynecologic malignancy
4918575|NCT02003430|non-ovarian gynecological cancer|non-ovarian gynecological cancer
4918576|NCT02003430|cervical cancer|cervical cancer
4918577|NCT02003430|vaginal cancer|vaginal cancer
4918578|NCT02003430|vulvar cancer|vulvar cancer
4918579|NCT02003430|endometrial cancer|endometrial cancer
4918580|NCT02003417|Prostate cancer|prostate cancer
4918581|NCT02003417|External beam radiation treatment|external beam radiation treatment
4918582|NCT02003417|Androgen deprivation therapy|androgen deprivation therapy
4918583|NCT02003417|Definitive treatment|definitive treatment
4918584|NCT02003417|Cardiovascular risk factors|cardiovascular risk factors
4918585|NCT02003417|Quality of life|quality of life
4918586|NCT02003404|ostomy appliance|ostomy appliance
4918587|NCT02003391|Open Angle Glaucoma|open angle glaucoma
4918588|NCT02003391|Ocular Hypertension|ocular hypertension
4918589|NCT02003391|Intraocular Pressure|intraocular pressure
4918590|NCT02003378|Chronotropic incompetence|chronotropic incompetence
4918591|NCT02003365|osteoarthritis|osteoarthritis
4918592|NCT02003365|knee|knee
4918593|NCT02003365|corticosteroids|corticosteroids
4918594|NCT02003365|triamcinolone acetonide|triamcinolone acetonide
4918595|NCT02003365|synovial fluid|synovial fluid
4918596|NCT02003352|TBI|tbi
4918597|NCT02003352|PTSD|ptsd
4918598|NCT02003352|Functional Neurology|functional neurology
4918599|NCT02003352|Vestibular Rehabilitation|vestibular rehabilitation
4918600|NCT02003352|Dynamic Computerized Posturography|dynamic computerized posturography
4918601|NCT02003352|Saccadometry|saccadometry
4918602|NCT02003313|safety, immunogenicity, Meningococcal Polysaccharide Vaccine|safety, immunogenicity, meningococcal polysaccharide vaccine
4918603|NCT02003300|Oxygen uptake|oxygen uptake
4918604|NCT02003300|Anesthetic gas uptake|anesthetic gas uptake
4918605|NCT02003287|Deglutition Disorders|deglutition disorders
4918606|NCT02003287|Intensive Care Units, Neonatal|intensive care units, neonatal
4918607|NCT02003274|Mixed Meal Test|mixed meal test
4918608|NCT02003274|Insulin Pump|insulin pump
4918609|NCT02003274|Continuous Glucose Monitoring|continuous glucose monitoring
4918610|NCT02003274|Metabolic Control Analysis|metabolic control analysis
4918611|NCT02003274|Closed Loop Control|closed loop control
4918612|NCT02003274|Artificial Pancreas|artificial pancreas
4918613|NCT02003248|Parkinson's disease|parkinson's disease
4918614|NCT02003248|ultrasound|ultrasound
4918615|NCT02003248|dyskinesia|dyskinesia
4918616|NCT02003248|magnetic resonance|magnetic resonance
4918617|NCT02003235|Amblyopia|amblyopia
4918618|NCT02003196|Brain injury|brain injury
4918619|NCT02003196|virus|virus
4918620|NCT02003196|immunosuppression|immunosuppression
4918621|NCT02003196|mechanical ventilation|mechanical ventilation
4918622|NCT02003183|CTE|cte
4918623|NCT02003183|TBI|tbi
4918624|NCT02003183|Cognitive Impairment|cognitive impairment
4918625|NCT02003183|Brain Imaging|brain imaging
4918626|NCT02003183|PET|pet
4918627|NCT02003170|Autism|autism
4918628|NCT02003170|Autism Spectrum Disorder (ASD)|autism spectrum disorder (asd)
4918629|NCT02003170|Pervasive Developmental Disorder (PDD)|pervasive developmental disorder (pdd)
4918630|NCT02003170|Developmental delays|developmental delays
4918631|NCT02003170|Genetic disorder|genetic disorder
4918632|NCT02003170|Mitochondrial disorder|mitochondrial disorder
4918633|NCT02003157|hypnosis embryo transfer IVF ICSI|hypnosis embryo transfer ivf icsi
4918634|NCT02003144|Long-term safety study|long-term safety study
4918635|NCT02003144|Extension trial|extension trial
4918636|NCT02003144|Eculizumab|eculizumab
4918637|NCT02003144|Neuromyelitis Optica Spectrum Disorder|neuromyelitis optica spectrum disorder
4918638|NCT02003144|Devic's disease|devic's disease
4918639|NCT02003144|Transverse Myelitis|transverse myelitis
4918640|NCT02003144|Optic Neuritis|optic neuritis
4918641|NCT02003144|Relapse|relapse
4918642|NCT02003144|NMO-IgG|nmo-igg
4918643|NCT02003144|CNS Autoimmune Disorders|cns autoimmune disorders
4918644|NCT02003144|Demyelinating Disorders|demyelinating disorders
4918645|NCT02003131|osteoarthritis|osteoarthritis
4918646|NCT02003131|umbilical cord|umbilical cord
4918647|NCT02003131|mesenchymal|mesenchymal
4918648|NCT02003131|stem cells|stem cells
4918649|NCT02003131|trophic factors|trophic factors
4918650|NCT02003092|Metastatic|metastatic
4918651|NCT02003092|Rexahn|rexahn
4918652|NCT02003092|Phase 1|phase 1
4918653|NCT02003092|Triple Negative Breast Cancer|triple negative breast cancer
4918654|NCT02003092|Phase 2|phase 2
4918655|NCT02003092|Relapsed|relapsed
4918656|NCT02003066|Fluid Therapy|fluid therapy
4918657|NCT02003066|Head and Neck Neoplasms|head and neck neoplasms
4918658|NCT02003066|Surgical Flaps|surgical flaps
4918659|NCT02003053|Critically ill|critically ill
4918660|NCT02003053|intubated|intubated
4918661|NCT02003053|safety|safety
4918662|NCT02003053|feasibility|feasibility
4918663|NCT02003053|inspiratory muscle training|inspiratory muscle training
4918664|NCT02003014|Drug Therapy|drug therapy
4918665|NCT02002975|Drug Therapy|drug therapy
4918666|NCT02002949|Hemodialysis|hemodialysis
4918667|NCT02002910|iFR|ifr
4918668|NCT02002910|FFR|ffr
4918669|NCT02002910|Medical Economy|medical economy
4918670|NCT02002910|physiological assessment|physiological assessment
4918671|NCT02002910|SYNTAX score|syntax score
4918672|NCT02002897|Localized scleroderma UVA1 fractional carbon dioxide laser|localized scleroderma uva1 fractional carbon dioxide laser
4918673|NCT02002884|Upper limb spasticity|upper limb spasticity
4918674|NCT02002884|lower limb spasticity|lower limb spasticity
4918675|NCT02002884|combined upper and lower limb spasticity|combined upper and lower limb spasticity
4918676|NCT02002858|smoking|smoking
4918677|NCT02002858|cessation|cessation
4918678|NCT02002858|anxiety|anxiety
4918679|NCT02002858|anxious|anxious
4918680|NCT02002858|depression|depression
4918681|NCT02002858|depressed|depressed
4918682|NCT02002858|smoker|smoker
4918683|NCT02002858|stress|stress
4918684|NCT02002845|Tongue base resection, partial glossectomy|tongue base resection, partial glossectomy
4918685|NCT02002819|Alzheimer's disease|alzheimer's disease
4918686|NCT02002819|AD|ad
4918687|NCT02002819|Early-onset AD|early-onset ad
4918688|NCT02002819|EOAD|eoad
4918689|NCT02002819|Early-onset Alzheimer's|early-onset alzheimer's
4918690|NCT02002819|Early-onset Alzheimer's disease|early-onset alzheimer's disease
4918691|NCT02002806|Pancreatic cancer|pancreatic cancer
4918692|NCT02002806|Pain|pain
4918693|NCT02002793|pancreatitis|pancreatitis
4918694|NCT02002793|early stage|early stage
4918695|NCT02002793|mini-invasive abdominal drainage|mini-invasive abdominal drainage
4918696|NCT02002780|pediatrics|pediatrics
4918697|NCT02002780|stress|stress
4918698|NCT02002780|cardiac surgery|cardiac surgery
4918699|NCT02002754|eosinophilic bronchitis|eosinophilic bronchitis
4918700|NCT02002754|cough variant asthma|cough variant asthma
4918701|NCT02002754|bronchodilator|bronchodilator
4918702|NCT02002741|patent ductus arteriosus|patent ductus arteriosus
4918703|NCT02002741|PDA|pda
4918704|NCT02002741|Preterm|preterm
4918705|NCT02002741|Infant|infant
4918706|NCT02002741|Electrocardiography|electrocardiography
4918707|NCT02002741|Paracetamol|paracetamol
4918708|NCT02002741|Acamol|acamol
4918709|NCT02002741|ibuprofen|ibuprofen
4918710|NCT02002741|Placebo|placebo
4918711|NCT02002715|eosinophilic bronchitis|eosinophilic bronchitis
4918712|NCT02002715|inhaled corticosteroids|inhaled corticosteroids
4918713|NCT02002715|therapeutic effect|therapeutic effect
4918714|NCT02002702|Acute heart failure (AHF),|acute heart failure (ahf),
4918715|NCT02002702|Japanese,|japanese,
4918716|NCT02002702|Safety and tolerability, Pharmacokinetics,|safety and tolerability, pharmacokinetics,
4918717|NCT02002702|Renal Impairment|renal impairment
4918718|NCT02002689|Solid tumor malignancy,|solid tumor malignancy,
4918719|NCT02002689|hematologic malignancy,|hematologic malignancy,
4918720|NCT02002689|mutation, translocations,|mutation, translocations,
4918721|NCT02002689|signature,|signature,
4918722|NCT02002689|PTCH1,|ptch1,
4918723|NCT02002689|SMO,|smo,
4918724|NCT02002689|LDE225,|lde225,
4918725|NCT02002689|endometrial cancer,|endometrial cancer,
4918726|NCT02002689|colon cancer,|colon cancer,
4918727|NCT02002689|bladder,|bladder,
4918728|NCT02002689|NSCLC|nsclc
4918729|NCT02002676|rest energy expenditure,critical ill, outcome|rest energy expenditure,critical ill, outcome
4918730|NCT02002650|Indomethacin, pancreatitis, ERCP|indomethacin, pancreatitis, ercp
4918731|NCT02002611|Lobeglitazone|lobeglitazone
4918732|NCT02002611|Warfarin|warfarin
4918733|NCT02002611|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
4918734|NCT02002611|Drug-Drug interaction|drug-drug interaction
4918735|NCT02002611|Phase 1|phase 1
4918736|NCT02002598|Newly diagnosed|newly diagnosed
4918737|NCT02002598|multiple myeloma|multiple myeloma
4918738|NCT02002598|myeloma|myeloma
4918739|NCT02002598|bendamustine|bendamustine
4918740|NCT02002598|treanda|treanda
4918741|NCT02002598|carfilzomib|carfilzomib
4918742|NCT02002598|dexamethasone|dexamethasone
4918743|NCT02002598|phase I|phase i
4918744|NCT02002598|phase II|phase ii
4918745|NCT02002598|dose escalation|dose escalation
4918746|NCT02002598|transplant|transplant
4918747|NCT02002598|non-transplant, plasma cells|non-transplant, plasma cells
4918748|NCT02002585|Renal protection|renal protection
4918749|NCT02002585|Renal sympathetic denervation|renal sympathetic denervation
4918750|NCT02002572|Facial Mimic Muscle|facial mimic muscle
4918751|NCT02002572|MRI|mri
4918752|NCT02002572|Segmentation|segmentation
4918753|NCT02002572|Three dimensional assessment|three dimensional assessment
4918754|NCT02002572|Motion capture|motion capture
4918755|NCT02002572|Movement analysis|movement analysis
4918756|NCT02002572|Digital Image Correlation|digital image correlation
4918757|NCT02002546|Heart Attack|heart attack
4918758|NCT02002546|Myocardial Infarction|myocardial infarction
4918759|NCT02002546|Angina|angina
4918760|NCT02002546|Chest Pain|chest pain
4918761|NCT02002520|Acute pain|acute pain
4918762|NCT02002520|Epigenetic|epigenetic
4918763|NCT02002520|Dental pain|dental pain
4918764|NCT02002468|Risk Communication|risk communication
4918765|NCT02002468|Follow-up|follow-up
4918766|NCT02002468|Organisation of screening|organisation of screening
4918767|NCT02002455|FACBC|facbc
4918768|NCT02002455|PET/CT|pet/ct
4918769|NCT02002455|PET/MRI|pet/mri
4918770|NCT02002455|Radical prostatectomy|radical prostatectomy
4918771|NCT02002455|Radiotherapy|radiotherapy
4918772|NCT02002442|Mouthwash|mouthwash
4918773|NCT02002442|Chlorhexidine|chlorhexidine
4918774|NCT02002442|cetylpyridinium chloride|cetylpyridinium chloride
4918775|NCT02002442|Saline|saline
4918776|NCT02002442|Implants|implants
4918777|NCT02002442|Saliva Collection|saliva collection
4918778|NCT02002429|Facet joint|facet joint
4918779|NCT02002429|Medial branch block|medial branch block
4918780|NCT02002429|Radiofrequency denervation|radiofrequency denervation
4918781|NCT02002429|Zygapophysial joint|zygapophysial joint
4918782|NCT02002429|Low back pain|low back pain
4918783|NCT02002416|C-met expression, gastric cancer, overall survival|c-met expression, gastric cancer, overall survival
4918784|NCT02002403|Edema|edema
4918785|NCT02002403|Macular Edema|macular edema
4918786|NCT02002403|Retinal Diseases|retinal diseases
4918787|NCT02002403|Eye Diseases|eye diseases
4918788|NCT02002403|Danazol|danazol
4918789|NCT02002403|Estrogen Antagonists|estrogen antagonists
4918790|NCT02002403|Estrogen Receptor Modulators|estrogen receptor modulators
4918791|NCT02002403|Hormone Antagonists|hormone antagonists
4918792|NCT02002403|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists
4918793|NCT02002403|Physiological Effects of Drugs|physiological effects of drugs
4918794|NCT02002403|Pharmacologic Actions|pharmacologic actions
4918795|NCT02002390|Stroke,Fingolimod(FTY 720), treatment|stroke,fingolimod(fty 720), treatment
4918796|NCT02002377|Age Related Macular Degeneration, wet|age related macular degeneration, wet
4918797|NCT02002377|aflibercept|aflibercept
4918798|NCT02002364|tracheal intubation|tracheal intubation
4918799|NCT02002338|pterygium surgery|pterygium surgery
4918800|NCT02002338|refractive changes|refractive changes
4918801|NCT02002338|surgical technique|surgical technique
4918802|NCT02002312|Advanced Renal Cell Carcinoma|advanced renal cell carcinoma
4918803|NCT02002312|Clear Cell Renal Cell Carcinoma (ccRCC)|clear cell renal cell carcinoma (ccrcc)
4918804|NCT02002312|Lutetium-177|lutetium-177
4918805|NCT02002312|Lu-177|lu-177
4918806|NCT02002312|girentuximab|girentuximab
4918807|NCT02002312|cG250|cg250
4918808|NCT02002312|Monoclonal Antibody|monoclonal antibody
4918809|NCT02002299|colorectal cancer|colorectal cancer
4918810|NCT02002299|surface|surface
4918811|NCT02002299|invasive front|invasive front
4918812|NCT02002299|tumor budding|tumor budding
4918813|NCT02002286|HIV-infected immunological non-responders|hiv-infected immunological non-responders
4918814|NCT02002286|Tripterygium Wilfordii Hook F|tripterygium wilfordii hook f
4918815|NCT02002286|Immune activation|immune activation
4918816|NCT02002247|antioxidants|antioxidants
4918817|NCT02002247|selenium|selenium
4918818|NCT02002247|heart disease|heart disease
4918819|NCT02002247|cardiac surgery|cardiac surgery
4918820|NCT02002247|perioperative|perioperative
4918916|NCT02001857|patients,|patients,
4918821|NCT02002234|Hemicraniectomy, stroke, decompressive surgery, HeMMI|hemicraniectomy, stroke, decompressive surgery, hemmi
4918822|NCT02002221|Diabetes Mellitus (DM) ,|diabetes mellitus (dm) ,
4918823|NCT02002221|diabetes,|diabetes,
4918824|NCT02002221|noninsulin-dependent diabetes mellitus (NIDDM),|noninsulin-dependent diabetes mellitus (niddm),
4918825|NCT02002221|adult-onset diabetes,|adult-onset diabetes,
4918826|NCT02002221|high blood sugar,|high blood sugar,
4918827|NCT02002221|T2DM|t2dm
4918828|NCT02002195|metastatic gastric cancer,|metastatic gastric cancer,
4918829|NCT02002195|elderly,|elderly,
4918830|NCT02002195|folinic acid,|folinic acid,
4918831|NCT02002195|fluorouracil,|fluorouracil,
4918832|NCT02002195|oxaliplatin,|oxaliplatin,
4918833|NCT02002195|capecitabine,|capecitabine,
4918834|NCT02002195|overall survival,|overall survival,
4918835|NCT02002195|progression free survival|progression free survival
4918836|NCT02002182|HPV|hpv
4918837|NCT02002182|oropharynx|oropharynx
4918838|NCT02002182|squamous cell carcinoma|squamous cell carcinoma
4918839|NCT02002182|head and neck cancer|head and neck cancer
4918840|NCT02002182|transoral robotic surgery|transoral robotic surgery
4918841|NCT02002169|Catheter Related Bacteremia|catheter related bacteremia
4918842|NCT02002143|Diabetes|diabetes
4918843|NCT02002143|Older People|older people
4918844|NCT02002143|Seniors|seniors
4918845|NCT02002143|Group Appointments|group appointments
4918846|NCT02002143|Group Medical Visits|group medical visits
4918847|NCT02002143|Shared Appointments|shared appointments
4918848|NCT02002143|Quality of Life|quality of life
4918849|NCT02002143|Physical Activity|physical activity
4918850|NCT02002143|Health care Utilization|health care utilization
4918851|NCT02002143|Depression|depression
4918852|NCT02002143|Anxiety|anxiety
4918853|NCT02002130|Diabetes|diabetes
4918854|NCT02002104|Expanded polytetrafluoroethylene( ePTFE)|expanded polytetrafluoroethylene( eptfe)
4918855|NCT02002091|Type2 diabetes mellitus|type2 diabetes mellitus
4918856|NCT02002091|Microangiopathy|microangiopathy
4918857|NCT02002091|Chronic Kidney disease|chronic kidney disease
4918858|NCT02002091|Cardiovascular disease|cardiovascular disease
4918859|NCT02002078|caustic|caustic
4918860|NCT02002078|corticosteroid therapy|corticosteroid therapy
4918861|NCT02002078|stricture|stricture
4918862|NCT02002078|children|children
4918863|NCT02002065|hepatitis A|hepatitis a
4918864|NCT02002065|inactivated hepatitis A vaccine|inactivated hepatitis a vaccine
4918865|NCT02002065|attenuated alive hepatitis A vaccine|attenuated alive hepatitis a vaccine
4918866|NCT02002065|immune persistence|immune persistence
4918867|NCT02002052|non-small cell lung cancer, radiotherapy, chemotherapy, pneumonitis, functional lung avoidance|non-small cell lung cancer, radiotherapy, chemotherapy, pneumonitis, functional lung avoidance
4918868|NCT02002039|Perinatal asphyxia|perinatal asphyxia
4918869|NCT02002039|erythropoietin|erythropoietin
4918870|NCT02002026|placenta previa, uterine artery ligation|placenta previa, uterine artery ligation
4918871|NCT02002013|Adult|adult
4918872|NCT02002013|ICU patient|icu patient
4918873|NCT02002013|Fluid resuscitation|fluid resuscitation
4918874|NCT02002013|observational study|observational study
4918875|NCT02002000|Vitamin D deficiency|vitamin d deficiency
4918876|NCT02002000|Musculoskeletal pain|musculoskeletal pain
4918877|NCT02002000|Vitamin D supplementation|vitamin d supplementation
4918878|NCT02001974|HER 2 negative|her 2 negative
4918879|NCT02001974|metastatic breast cancer|metastatic breast cancer
4918880|NCT02001974|Cancer Stem Cells|cancer stem cells
4918881|NCT02001961|Fibrosis|fibrosis
4918882|NCT02001961|collagen metabolism|collagen metabolism
4918883|NCT02001961|paediatric, dilated cardiomyopathy|paediatric, dilated cardiomyopathy
4918884|NCT02001961|biomarkers|biomarkers
4918885|NCT02001961|T1 mapping|t1 mapping
4918886|NCT02001961|MRI|mri
4918887|NCT02001948|Spinal anaesthesia|spinal anaesthesia
4918888|NCT02001948|morphine|morphine
4918889|NCT02001948|postoperative analgesia|postoperative analgesia
4918890|NCT02001948|vomiting|vomiting
4918891|NCT02001935|COPD|copd
4918892|NCT02001935|theophylline|theophylline
4918893|NCT02001935|CYP1A2|cyp1a2
4918894|NCT02001935|CYP2E1|cyp2e1
4918895|NCT02001922|COPD|copd
4918896|NCT02001922|Pulmonary disease, chronic obstructive|pulmonary disease, chronic obstructive
4918897|NCT02001922|Integrated care|integrated care
4918898|NCT02001922|Outcome and process assessment|outcome and process assessment
4918899|NCT02001922|Quality indicators, Health care|quality indicators, health care
4918900|NCT02001922|Self-management,|self-management,
4918901|NCT02001922|Patient empowerment|patient empowerment
4918902|NCT02001922|Quantitative and qualitative methods|quantitative and qualitative methods
4918903|NCT02001909|Regorafenib|regorafenib
4918904|NCT02001909|Neomycin|neomycin
4918905|NCT02001909|Cancer|cancer
4918906|NCT02001909|Pharmacokinetics|pharmacokinetics
4918907|NCT02001909|Safety|safety
4918908|NCT02001896|NSCLC|nsclc
4918909|NCT02001896|EGFR-TKI|egfr-tki
4918910|NCT02001883|Coronary artery disease, nutraceuticals, statins|coronary artery disease, nutraceuticals, statins
4918911|NCT02001870|Infertility|infertility
4918912|NCT02001870|female age|female age
4918913|NCT02001870|intra-uterine insemination|intra-uterine insemination
4918914|NCT02001870|in vitro fecundation|in vitro fecundation
4918915|NCT02001870|assisted reproductive technology center|assisted reproductive technology center
4918917|NCT02001857|undergoing|undergoing
4918918|NCT02001857|pelvic|pelvic
4918919|NCT02001857|lymph|lymph
4918920|NCT02001857|node|node
4918921|NCT02001857|dissection.|dissection.
4918922|NCT02001831|Sarcopenia|sarcopenia
4918923|NCT02001831|Frailty|frailty
4918924|NCT02001831|Aging|aging
4918925|NCT02001831|Skeletal muscle|skeletal muscle
4918926|NCT02001831|Nutrition|nutrition
4918927|NCT02001792|sedation|sedation
4918928|NCT02001792|endoscopy|endoscopy
4918929|NCT02001792|patient positioning|patient positioning
4918930|NCT02001792|hypoxemia|hypoxemia
4918931|NCT02001779|Malignant biliary obstruction|malignant biliary obstruction
4918932|NCT02001779|Obstruction/stricture|obstruction/stricture
4918933|NCT02001779|Stent|stent
4918934|NCT02001779|Brachytherapy|brachytherapy
4918935|NCT02001779|Bile duct|bile duct
4918936|NCT02001766|High intensity exercise|high intensity exercise
4918937|NCT02001766|Glycemic control|glycemic control
4918938|NCT02001766|Exercise|exercise
4918939|NCT02001740|shoulder|shoulder
4918940|NCT02001701|vitreomacular adhesion|vitreomacular adhesion
4918941|NCT02001701|vitreomacular traction|vitreomacular traction
4918942|NCT02001701|macular hole|macular hole
4918943|NCT02001701|epiretinal membrane|epiretinal membrane
4918944|NCT02001701|intravitreal gas|intravitreal gas
4918945|NCT02001701|sulfahexafluoride gas|sulfahexafluoride gas
4918946|NCT02001701|perfluoropropane gas|perfluoropropane gas
4918947|NCT02001701|ocriplasmin|ocriplasmin
4918948|NCT02001701|vitrectomy|vitrectomy
4918949|NCT02001675|Neuromuscular electrical stimulation (NMES)|neuromuscular electrical stimulation (nmes)
4918950|NCT02001662|Minor arthroscopic knee surgery including ACL-reconstruction (hamstrins graft)|minor arthroscopic knee surgery including acl-reconstruction (hamstrins graft)
4918951|NCT02001662|High pain responders|high pain responders
4918952|NCT02001662|Adductore Canal Block|adductore canal block
4918953|NCT02001662|Analgesics|analgesics
4918954|NCT02001662|Ultrasound guided nerve block|ultrasound guided nerve block
4918955|NCT02001649|suicide|suicide
4918956|NCT02001649|adolescent|adolescent
4918957|NCT02001649|genetic|genetic
4918959|NCT02001636|Bariatric surgery|bariatric surgery
4918960|NCT02001636|Protein malnutrition|protein malnutrition
4918961|NCT02001636|Protein supplementation|protein supplementation
4918962|NCT02001636|Body composition|body composition
4918963|NCT02001636|Body fat mass|body fat mass
4918964|NCT02001636|Protein intake|protein intake
4918965|NCT02001623|ovary cancer|ovary cancer
4918966|NCT02001623|cervix cancer|cervix cancer
4918967|NCT02001623|endometrium cancer|endometrium cancer
4918968|NCT02001623|bladder cancer|bladder cancer
4918969|NCT02001623|prostate cancer (CRPC)|prostate cancer (crpc)
4918970|NCT02001623|esophagus cancer|esophagus cancer
4918971|NCT02001623|lung cancer(NSCLC)|lung cancer(nsclc)
4918972|NCT02001623|Squamous cell carcinoma of the head and neck (SCCHN)|squamous cell carcinoma of the head and neck (scchn)
4918973|NCT02001610|microbiota|microbiota
4918974|NCT02001610|probiotics|probiotics
4918975|NCT02001610|fecal markers|fecal markers
4918976|NCT02001597|surgery|surgery
4918977|NCT02001597|robotic|robotic
4918978|NCT02001597|ultrasound|ultrasound
4918979|NCT02001597|guidance|guidance
4918980|NCT02001597|endorectal|endorectal
4918981|NCT02001571|Prostate Cancer|prostate cancer
4918982|NCT02001571|Abiraterone acetate|abiraterone acetate
4918983|NCT02001571|Pharmacokinetics|pharmacokinetics
4918984|NCT02001558|Spinal cord injuries|spinal cord injuries
4918985|NCT02001558|Pressure ulcer|pressure ulcer
4918986|NCT02001545|acute coronary syndrome, antithrombotic management patterns,quality of life, acute clinical management strategies|acute coronary syndrome, antithrombotic management patterns,quality of life, acute clinical management strategies
4918987|NCT02001532|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
4918988|NCT02001532|Diabetes Complications|diabetes complications
4918989|NCT02001532|Diabetic Angiopathies|diabetic angiopathies
4918990|NCT02001532|Diabetic Nephropathies|diabetic nephropathies
4918991|NCT02001532|Myocardial Infarction|myocardial infarction
4918992|NCT02001532|Stroke|stroke
4918993|NCT02001532|Vascular Stiffness|vascular stiffness
4918994|NCT02001532|Pulse Wave Analysis|pulse wave analysis
4918995|NCT02001506|breast cancer|breast cancer
4918996|NCT02001506|neoadjuvant|neoadjuvant
4918997|NCT02001506|different number of chemotherapy cycles|different number of chemotherapy cycles
4918998|NCT02001441|Physical Activity, Aging, Memory, Cognitive Impairment, MRI, Neuroscience|physical activity, aging, memory, cognitive impairment, mri, neuroscience
4918999|NCT02001428|malaria|malaria
4919000|NCT02001428|vivax|vivax
4919001|NCT02001428|falciparum|falciparum
4919002|NCT02001428|infants|infants
4919003|NCT02001415|Progressive Myopia|progressive myopia
4919004|NCT02001415|Contact Lenses|contact lenses
4919005|NCT02001415|Spectacles|spectacles
4919006|NCT02001402|climacteric symptoms ; nurse ;|climacteric symptoms ; nurse ;
4919007|NCT02001402|intervention;follow-up|intervention;follow-up
4919008|NCT02001389|Enzyme occupancy|enzyme occupancy
4919009|NCT02001389|Positron emission tomography (PET)|positron emission tomography (pet)
4919010|NCT02001389|Phosphodiesterase 10 inhibitor|phosphodiesterase 10 inhibitor
4919011|NCT02001363|Reperfusion injury|reperfusion injury
4919012|NCT02001363|Liraglutide|liraglutide
4919013|NCT02001337|pancreatic cancer|pancreatic cancer
4919014|NCT02001337|new-onset diabetic|new-onset diabetic
4919015|NCT02001337|diabetes|diabetes
4919016|NCT02001324|quality of life, heavy menstrual bleeding, electronic data collection|quality of life, heavy menstrual bleeding, electronic data collection
4919017|NCT02001311|chlorhexidine gel|chlorhexidine gel
4919018|NCT02001311|orthodontic brackets|orthodontic brackets
4919019|NCT02001311|orthodontic patients|orthodontic patients
4919020|NCT02001311|bacterial count|bacterial count
4919021|NCT02001311|friction|friction
4919022|NCT02001298|remifentanil|remifentanil
4919023|NCT02001298|nitroprusside|nitroprusside
4919024|NCT02001298|hypotension|hypotension
4919025|NCT02001285|remifentanil|remifentanil
4919026|NCT02001272|Elderly|elderly
4919027|NCT02001272|Vulnerable|vulnerable
4919028|NCT02001272|Ovarian cancer|ovarian cancer
4919029|NCT02001272|Chemotherapy|chemotherapy
4919030|NCT02001259|post-operative pain control|post-operative pain control
4919031|NCT02001259|total knee arthroplasty|total knee arthroplasty
4919032|NCT02001259|epidural steroid injection|epidural steroid injection
4919033|NCT02001246|mindfulness|mindfulness
4919034|NCT02001246|cognitive behavior therapy|cognitive behavior therapy
4919035|NCT02001246|awareness|awareness
4919036|NCT02001246|anger|anger
4919037|NCT02001246|aggression|aggression
4919038|NCT02001233|EV71 vaccine|ev71 vaccine
4919039|NCT02001233|EV71-associated HFMD|ev71-associated hfmd
4919040|NCT02001233|efficacy|efficacy
4919041|NCT02001233|safety|safety
4919042|NCT02001233|immune persistence|immune persistence
4919043|NCT02001220|screening|screening
4919044|NCT02001220|invasive ventilation|invasive ventilation
4919045|NCT02001220|mechanical ventilation|mechanical ventilation
4919046|NCT02001220|weaning|weaning
4919047|NCT02001220|spontaneous breathing trials|spontaneous breathing trials
4919048|NCT02001194|Sedentary|sedentary
4919049|NCT02001194|Behavioral Economic Intervention|behavioral economic intervention
4919050|NCT02001194|Team Studies|team studies
4919051|NCT02001194|Financial Incentives|financial incentives
4919052|NCT02001194|Workplace Wellness|workplace wellness
4919053|NCT02001194|Team Incentives|team incentives
4919054|NCT02001181|Atopic Dermatitis|atopic dermatitis
4919055|NCT02001181|Atopic Eczema|atopic eczema
4919056|NCT02001181|Eczema|eczema
4919057|NCT02001181|topical treatment|topical treatment
4919058|NCT02001181|skin diseases|skin diseases
4919059|NCT02001181|tofacitinib|tofacitinib
4919060|NCT02001181|CP-690|cp-690
4919061|NCT02001181|550|550
4919062|NCT02001181|Janus Kinase inhibitor|janus kinase inhibitor
4919063|NCT02001155|Water drinking test|water drinking test
4919064|NCT02001155|trabeculectomy|trabeculectomy
4919065|NCT02001155|tube shunt|tube shunt
4919066|NCT02001142|Insulin Sensitivity|insulin sensitivity
4919067|NCT02001142|Exercise|exercise
4919068|NCT02001142|Metabolism|metabolism
4919069|NCT02001129|Eye care adherence|eye care adherence
4919070|NCT02001129|health care utilization|health care utilization
4919071|NCT02001116|Quality of care|quality of care
4919072|NCT02001116|Hospital|hospital
4919073|NCT02001116|Children|children
4919074|NCT02001116|WHO guideline|who guideline
4919075|NCT02001103|adjuvant therapy|adjuvant therapy
4919076|NCT02001103|cognitive deficits|cognitive deficits
4919077|NCT02001103|first episode schizophrenia|first episode schizophrenia
4919078|NCT02001103|glutamate hypothesis|glutamate hypothesis
4919079|NCT02001103|memantine|memantine
4919080|NCT02001103|negative symptoms|negative symptoms
4919081|NCT02001090|Cardiac Surgical Procedures|cardiac surgical procedures
4919082|NCT02001090|Heart-Lung Machine|heart-lung machine
4919083|NCT02001090|Coronary Artery Bypass|coronary artery bypass
4919084|NCT02001090|Brachial Artery|brachial artery
4919085|NCT02001090|Vasodilation|vasodilation
4919086|NCT02001090|Regional Blood Flow|regional blood flow
4919087|NCT02001090|Ultrasonography|ultrasonography
4919088|NCT02001064|interventions|interventions
4919089|NCT02001064|technology|technology
4919090|NCT02001064|adherence|adherence
4919091|NCT02001064|ARV|arv
4919092|NCT02001051|Diabetes, Hypertension, Hypercholesterolemia, Obesity, and Osteoporosis.|diabetes, hypertension, hypercholesterolemia, obesity, and osteoporosis.
4919093|NCT02001051|Nonoperative and Operative Management|nonoperative and operative management
4919094|NCT02001051|Adrenal Incidentalomas|adrenal incidentalomas
4919095|NCT02001051|Excess of Cortisol|excess of cortisol
4919096|NCT02001025|coronary vessels|coronary vessels
4919097|NCT02001025|coronary stenosis|coronary stenosis
4919098|NCT02001025|percutaneous transluminal angioplasty|percutaneous transluminal angioplasty
4919099|NCT02001025|stents|stents
4919100|NCT02001025|drug-eluting stents|drug-eluting stents
4919101|NCT02001025|bioresorbable scaffolds|bioresorbable scaffolds
4919102|NCT02001025|optical coherence tomography|optical coherence tomography
4919103|NCT02001012|uncomplicated|uncomplicated
4919104|NCT02001012|plasmodium|plasmodium
4919105|NCT02001012|knowlesi|knowlesi
4919106|NCT02001012|malaria|malaria
4919107|NCT02001012|infection|infection
4919108|NCT02000999|Bile duct stricture|bile duct stricture
4919109|NCT02000999|Cholangiocarcinoma|cholangiocarcinoma
4919110|NCT02000999|Pancreatic cancer|pancreatic cancer
4919111|NCT02000999|Chronic pancreatitis|chronic pancreatitis
4919112|NCT02000986|Hodgkin's Lymphoma|hodgkin's lymphoma
4919113|NCT02000986|Brain and Nervous System|brain and nervous system
4919114|NCT02000986|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
4919115|NCT02000986|Leukemia, not otherwise specified|leukemia, not otherwise specified
4919116|NCT02000960|Glut1 DS|glut1 ds
4919117|NCT02000947|anti-CTLA-4|anti-ctla-4
4919118|NCT02000947|anti-PD-L1|anti-pd-l1
4919119|NCT02000947|immunotherapy|immunotherapy
4919120|NCT02000947|IMTC|imtc
4919121|NCT02000934|TAK-659|tak-659
4919122|NCT02000934|Solid Tumors|solid tumors
4919123|NCT02000934|CLL|cll
4919124|NCT02000934|DLBCL|dlbcl
4919125|NCT02000921|Cigarette Smoking|cigarette smoking
4919126|NCT02000921|Very Low Nicotine Content cigarettes (VLNC)|very low nicotine content cigarettes (vlnc)
4919127|NCT02000921|Dual Tobacco Use|dual tobacco use
4919128|NCT02000908|gynecological cancer|gynecological cancer
4919129|NCT02000908|ovarian cancer|ovarian cancer
4919130|NCT02000908|primary peritoneal cancer|primary peritoneal cancer
4919131|NCT02000908|cervical caner|cervical caner
4919132|NCT02000908|peripheral neuropathy|peripheral neuropathy
4919133|NCT02000882|Breast Cancer|breast cancer
4919134|NCT02000882|Triple Negative Breast Cancer|triple negative breast cancer
4919135|NCT02000882|Brain Metastases|brain metastases
4919136|NCT02000882|Capecitabine|capecitabine
4919137|NCT02000882|Metastatic Breast Cancer|metastatic breast cancer
4919138|NCT02000843|perforation|perforation
4919139|NCT02000843|tympanoplasty|tympanoplasty
4919140|NCT02000843|conchal cavum approach|conchal cavum approach
4919141|NCT02000843|perichondrium/ cartilage|perichondrium/ cartilage
4919142|NCT02000843|scar|scar
4919143|NCT02000830|stannsoporfin|stannsoporfin
4919144|NCT02000817|Beta Cell|beta cell
4919145|NCT02000817|Monoclonal Antibody|monoclonal antibody
4919146|NCT02000817|Otelixizumab|otelixizumab
4919147|NCT02000817|Cytokine Release Syndrome|cytokine release syndrome
4919148|NCT02000817|Epstein-Barr Virus|epstein-barr virus
4919149|NCT02000817|Diabetes Mellitus|diabetes mellitus
4919150|NCT02000804|Darapladib, Safety, Pharmacokinetics, Pharmacodynamics, Healthy Chinese Subjects|darapladib, safety, pharmacokinetics, pharmacodynamics, healthy chinese subjects
4919151|NCT02000791|cLMA|clma
4919152|NCT02000791|laryngoscopy|laryngoscopy
4919153|NCT02000791|fiberoptic|fiberoptic
4919154|NCT02000778|Occult Ovarian Carcinoma|occult ovarian carcinoma
4919155|NCT02000765|oral|oral
4919156|NCT02000765|ADME|adme
4919157|NCT02000765|IV|iv
4919158|NCT02000765|antibiotic|antibiotic
4919159|NCT02000765|healthy volunteer|healthy volunteer
4919160|NCT02000765|[14C]-GSK2140944|[14c]-gsk2140944
4919161|NCT02000765|mass balance|mass balance
4919162|NCT02000765|radiolabel|radiolabel
4919163|NCT02000752|Labor|labor
4919164|NCT02000752|Acupuncture|acupuncture
4919165|NCT02000752|Placental expulsion time|placental expulsion time
4919166|NCT02000752|Postpartum hemorrhage|postpartum hemorrhage
4919167|NCT02000739|Breast cancer|breast cancer
4919168|NCT02000739|melanoma|melanoma
4919169|NCT02000739|GI cancer|gi cancer
4919170|NCT02000739|ovarian cancer|ovarian cancer
4919171|NCT02000739|lung cancer|lung cancer
4919172|NCT02000739|metastatic cancer|metastatic cancer
4919173|NCT02000739|brain cancer|brain cancer
4919174|NCT02000739|head and neck cancer|head and neck cancer
4919175|NCT02000700|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
4919176|NCT02000700|Canagliflozin|canagliflozin
4919177|NCT02000700|JNJ-28431754|jnj-28431754
4919178|NCT02000700|Pharmacokinetics|pharmacokinetics
4919179|NCT02000700|Pharmacodynamics|pharmacodynamics
4919180|NCT02000700|Children|children
4919181|NCT02000700|Adolescents|adolescents
4919182|NCT02000674|tracheal intubation|tracheal intubation
4919183|NCT02000674|pre hospital emergency|pre hospital emergency
4919184|NCT02000661|Fractional Flow Reserve (FFR)|fractional flow reserve (ffr)
4919185|NCT02000661|FFR guided coronary interventions|ffr guided coronary interventions
4919186|NCT02000661|Percutaneous Coronary Intervention|percutaneous coronary intervention
4919187|NCT02000648|Allergic Rhinitis|allergic rhinitis
4919188|NCT02000648|Non-allergic Rhinitis|non-allergic rhinitis
4919189|NCT02000648|Chronic urticaria|chronic urticaria
4919190|NCT02000622|Breast Cancer|breast cancer
4919191|NCT02000622|Metastatic|metastatic
4919192|NCT02000622|Olaparib|olaparib
4919193|NCT02000622|BRCA|brca
4919194|NCT02000622|PARP inhibitor|parp inhibitor
4919195|NCT02000622|HER2|her2
4919196|NCT02000622|chemotherapy|chemotherapy
4919197|NCT02000609|pharmacodynamics COPD|pharmacodynamics copd
4919198|NCT02000596|HER2 overexpressed|her2 overexpressed
4919199|NCT02000596|Metastatic Breast Cancer|metastatic breast cancer
4919200|NCT02000596|Elderly|elderly
4919201|NCT02000583|Alzheimer's Disease|alzheimer's disease
4919202|NCT02000583|AD|ad
4919203|NCT02000583|Aerobic Exercise|aerobic exercise
4919204|NCT02000583|Exercise|exercise
4919205|NCT02000570|sitting position|sitting position
4919206|NCT02000570|PPV|ppv
4919207|NCT02000570|SVV|svv
4919208|NCT02000570|PVI|pvi
4919209|NCT02000570|fluid challenge|fluid challenge
4919210|NCT02000570|preload indicators|preload indicators
4919211|NCT02000557|Photographic analysis|photographic analysis
4919212|NCT02000557|Cephalometric analysis|cephalometric analysis
4919213|NCT02000557|Standardized photographs|standardized photographs
4919214|NCT02000557|Angular measurements|angular measurements
4919215|NCT02000557|Linear measurements|linear measurements
4919216|NCT02000557|Malocclusion|malocclusion
4919217|NCT02000557|Facial Profile|facial profile
4919218|NCT02000544|Extracorporeal Circulation|extracorporeal circulation
4919219|NCT02000544|Cardiopulmonary Bypass|cardiopulmonary bypass
4919220|NCT02000544|Cardiac surgery|cardiac surgery
4919221|NCT02000531|Non-small-cell lung cancer (NSCLC)|non-small-cell lung cancer (nsclc)
4919222|NCT02000518|emergency radiotherapy|emergency radiotherapy
4919223|NCT02000518|MSCC|mscc
4919224|NCT02000518|spine|spine
4919225|NCT02000518|neurological outcome|neurological outcome
4919226|NCT02000466|Women|women
4919227|NCT02000466|Pregnancy exposure|pregnancy exposure
4919228|NCT02000466|FluLaval Quadrivalent|flulaval quadrivalent
4919229|NCT02000466|Pregnancy outcome|pregnancy outcome
4919230|NCT02000466|Pregnancy Registry|pregnancy registry
4919231|NCT02000453|Quality of Life|quality of life
4919232|NCT02000453|Infection|infection
4919233|NCT02000453|GSK2586184|gsk2586184
4919234|NCT02000453|ulcerative colitis|ulcerative colitis
4919235|NCT02000440|GW856553|gw856553
4919236|NCT02000440|Focal segmental glomerulosclerosis (FSGS)|focal segmental glomerulosclerosis (fsgs)
4919237|NCT02000440|p38 mitogen-activated protein kinase (MAPK) inhibitor|p38 mitogen-activated protein kinase (mapk) inhibitor
4919238|NCT02000440|losmapimod|losmapimod
4919239|NCT02000440|nephrotic syndrome|nephrotic syndrome
4919240|NCT02000427|Relapsed; Refractory; Philadelphia Positive; B-precursor; Acute Lymphoblastic Leukemia; ALL; Blinatumomab; Leukemia;|relapsed; refractory; philadelphia positive; b-precursor; acute lymphoblastic leukemia; all; blinatumomab; leukemia;
4919241|NCT02000414|intraperitoneal|intraperitoneal
4919242|NCT02000414|peritoneal dialysis|peritoneal dialysis
4919243|NCT02000414|daptomycin|daptomycin
4919244|NCT02000414|pharmacokinetics|pharmacokinetics
4919245|NCT02000414|peritonitis|peritonitis
4919246|NCT02000375|metastatic breastcancer|metastatic breastcancer
4919247|NCT02000375|ER/PgR-negative/AR-positive|er/pgr-negative/ar-positive
4919248|NCT02000375|ER and/or PgR-positive/AR-positive|er and/or pgr-positive/ar-positive
4919249|NCT02000375|Androgen Receptor positve|androgen receptor positve
4919250|NCT02000362|Crohn's Disease|crohn's disease
4919251|NCT02000362|Stem cell|stem cell
4919252|NCT02000362|Cell therapy|cell therapy
4919253|NCT02000362|Auto-immune disease|auto-immune disease
4919254|NCT02000362|furestem|furestem
4919255|NCT02000362|CD|cd
4919256|NCT02000362|inflammatory bowel disease|inflammatory bowel disease
4919257|NCT02000362|MSCs|mscs
4919258|NCT02000362|Mesenchymal Stem Cells|mesenchymal stem cells
4919259|NCT02000362|hUCB-MSC|hucb-msc
4919260|NCT02000362|UCB-MSC|ucb-msc
4919261|NCT02000362|Umbilical cord Blood|umbilical cord blood
4919262|NCT02000349|infertility|infertility
4919263|NCT02000349|next generation sequencing|next generation sequencing
4919264|NCT02000336|radiographic damage|radiographic damage
4919265|NCT02000336|rheumatoid arthritis|rheumatoid arthritis
4919266|NCT02000323|pancreatitis|pancreatitis
4919267|NCT02000323|enteral nutrition|enteral nutrition
4919268|NCT02000310|Gaucher disease|gaucher disease
4919269|NCT02000310|Fabry disease|fabry disease
4919270|NCT02000310|Pompe disease|pompe disease
4919271|NCT02000310|Niemann-Pick disease|niemann-pick disease
4919272|NCT02000297|Osteoarthritis|osteoarthritis
4919273|NCT02000297|Knee|knee
4919274|NCT02000297|High tibial osteotomy|high tibial osteotomy
4919275|NCT02000297|Calcium phosphate|calcium phosphate
4919276|NCT02000297|Calcium sulfate|calcium sulfate
4919277|NCT02000284|Autism Spectrum Disorder|autism spectrum disorder
4919279|NCT02000284|Autism|autism
4919280|NCT02000284|Pervasive developmental disorder - Not Otherwise Specified|pervasive developmental disorder - not otherwise specified
4919281|NCT02000284|PDD-NOS|pdd-nos
4919282|NCT02000284|Asperger's Syndrome|asperger's syndrome
4919283|NCT02000284|Mitochondrial Disease|mitochondrial disease
4919284|NCT02000284|Developmental Delay|developmental delay
4919285|NCT02000284|Typical Development|typical development
4919286|NCT02000258|Anterior cruciate ligament reconstruction|anterior cruciate ligament reconstruction
4919287|NCT02000258|Double-bundle|double-bundle
4919288|NCT02000258|MRI|mri
4919289|NCT02000258|Graft location|graft location
4919290|NCT02000245|bronchoscopy|bronchoscopy
4919291|NCT02000245|anxiety|anxiety
4919292|NCT02000245|touch|touch
4919293|NCT02000245|sympathy|sympathy
4919294|NCT02000232|gout|gout
4919295|NCT02000232|colchicine|colchicine
4919296|NCT02000219|hyperoxaluria|hyperoxaluria
4919297|NCT02000219|oxalate|oxalate
4919298|NCT02000219|PH|ph
4919299|NCT02000219|dialysis|dialysis
4919300|NCT02000206|Ketamine|ketamine
4919301|NCT02000206|Alfentanil|alfentanil
4919302|NCT02000206|Propofol|propofol
4919303|NCT02000206|Oxygen saturation|oxygen saturation
4919304|NCT02000206|Percutaneous carbon dioxide|percutaneous carbon dioxide
4919305|NCT02000206|Bronchoscopy|bronchoscopy
4919306|NCT02000167|Electron Transport Chain|electron transport chain
4919307|NCT02000167|Mitochondrial Disease|mitochondrial disease
4919308|NCT02000167|Chromosomal Deletion|chromosomal deletion
4919309|NCT02000128|Peritoneal Dialysis|peritoneal dialysis
4919310|NCT02000128|fluid overload|fluid overload
4919311|NCT02000128|bioimpedance analysis|bioimpedance analysis
4919312|NCT02000128|Randomized Controlled Trial|randomized controlled trial
4919313|NCT02000089|familial pancreas cancer|familial pancreas cancer
4919314|NCT02000089|(Peutz-Jeghers Syndrome) PJS|(peutz-jeghers syndrome) pjs
4919315|NCT02000089|Breast cancer (BRCA) 2|breast cancer (brca) 2
4919316|NCT02000089|Partner and Locator of BRCA2 (PALB2)|partner and locator of brca2 (palb2)
4919317|NCT02000089|Familial Atypical Multiple Mole- Melanoma (FAMMM)|familial atypical multiple mole- melanoma (fammm)
4919318|NCT02000089|p16|p16
4919319|NCT02000089|Breast Cancer (BRCA)1|breast cancer (brca)1
4919320|NCT02000089|(hereditary non-polyposis colorectal cancer or Lynch syndrome) HNPCC|(hereditary non-polyposis colorectal cancer or lynch syndrome) hnpcc
4919321|NCT02000089|Lynch Syndrome|lynch syndrome
4919322|NCT02000089|hereditary pancreatitis|hereditary pancreatitis
4919323|NCT02000089|Protease Serine (PRSS)|protease serine (prss)
4919324|NCT02000089|Chymotrypsin C (CTRC)|chymotrypsin c (ctrc)
4919325|NCT02000089|Ataxia Telangiectasia Mutated(ATM)|ataxia telangiectasia mutated(atm)
4919326|NCT02000076|Sleep|sleep
4919327|NCT02000076|resting state|resting state
4919328|NCT02000076|functional connectivity|functional connectivity
4919329|NCT02000076|emotional contagion|emotional contagion
4919330|NCT02000076|empathy|empathy
4919331|NCT02000076|emotional regulation|emotional regulation
4919332|NCT02000063|Hepatitis C|hepatitis c
4919333|NCT02000063|acute|acute
4919334|NCT02000063|early chronic|early chronic
4919335|NCT02000050|resectable rectal cancer|resectable rectal cancer
4919336|NCT02000050|up-front chemotherapy|up-front chemotherapy
4919337|NCT02000050|neo-adjuvant short course radiotherapy|neo-adjuvant short course radiotherapy
4919338|NCT02000050|short course radiotherapy|short course radiotherapy
4919339|NCT02000011|patients|patients
4919340|NCT02000011|aged 70 years old|aged 70 years old
4919341|NCT02000011|thoracic,|thoracic,
4919342|NCT02000011|digestive or|digestive or
4919343|NCT02000011|urological|urological
4919344|NCT02000011|resectable|resectable
4919345|NCT01999985|Epidermal Growth Factor Receptor (EGFR)|epidermal growth factor receptor (egfr)
4919346|NCT01999985|Tyrosine kinase inhibitors|tyrosine kinase inhibitors
4919347|NCT01999985|Neoplasms|neoplasms
4919348|NCT01999985|Lung Diseases|lung diseases
4919349|NCT01999985|Respiratory Tract Diseases|respiratory tract diseases
4919350|NCT01999985|Pleural Diseases|pleural diseases
4919351|NCT01999985|Pleural Neoplasms|pleural neoplasms
4919352|NCT01999985|Lung Neoplasms|lung neoplasms
4919353|NCT01999985|Pleural Effusion|pleural effusion
4919354|NCT01999985|Pleural Effusion, Malignant|pleural effusion, malignant
4919355|NCT01999985|Respiratory Tract Neoplasms|respiratory tract neoplasms
4919356|NCT01999985|Thoracic Neoplasms|thoracic neoplasms
4919357|NCT01999985|Neoplasms by Site|neoplasms by site
4919358|NCT01999985|EGFR mutation|egfr mutation
4919359|NCT01999985|Afatinib|afatinib
4919360|NCT01999985|Dasatinib|dasatinib
4919361|NCT01999985|Carcinoma, Bronchogenic|carcinoma, bronchogenic
4919362|NCT01999985|Gene Mutation|gene mutation
4919363|NCT01999985|T790M mutation.|t790m mutation.
4919364|NCT01999985|Non-small cell lung cancer|non-small cell lung cancer
4919365|NCT01999972|Carcinoma|carcinoma
4919366|NCT01999972|Renal Cell|renal cell
4919367|NCT01999959|Unexplained Infertility, Pertubation, Gonadotrophin, Ovulation Induction, Intrauterine Insemination|unexplained infertility, pertubation, gonadotrophin, ovulation induction, intrauterine insemination
4919368|NCT01999946|Heroin Dependence|heroin dependence
4919369|NCT01999946|Opioid-Related Disorders|opioid-related disorders
4919370|NCT01999933|Cervical cancer|cervical cancer
4919371|NCT01999933|postoperative risk factor|postoperative risk factor
4919372|NCT01999933|treatment|treatment
4919373|NCT01999920|Adult separation anxiety disorder|adult separation anxiety disorder
4919374|NCT01999920|ASAD|asad
4919375|NCT01999907|asthma|asthma
4919376|NCT01999907|virus diseases|virus diseases
4919377|NCT01999907|pediatric|pediatric
4919378|NCT01999907|RCT|rct
4919379|NCT01999907|steroid|steroid
4919380|NCT01999894|Namenda|namenda
4919381|NCT01999894|Autism|autism
4919382|NCT01999894|Memantine|memantine
4919383|NCT01999894|Pediatric|pediatric
4919384|NCT01999894|Forest Laboratories|forest laboratories
4919385|NCT01999868|psoriasis vulgaris|psoriasis vulgaris
4919386|NCT01999868|ustekinumab|ustekinumab
4919387|NCT01999868|abatacept|abatacept
4919388|NCT01999842|H7N9|h7n9
4919389|NCT01999842|Influenza|influenza
4919390|NCT01999842|Safety|safety
4919391|NCT01999842|Adults|adults
4919392|NCT01999842|Adjuvant|adjuvant
4919393|NCT01999842|Immunogenicity|immunogenicity
4919394|NCT01999816|pressure ulcer|pressure ulcer
4919395|NCT01999816|lifestyle redesign|lifestyle redesign
4919396|NCT01999816|spinal cord injury|spinal cord injury
4919397|NCT01999790|upper lid|upper lid
4919398|NCT01999790|exophthalmos|exophthalmos
4919399|NCT01999790|grave's orbitopathy|grave's orbitopathy
4919400|NCT01999777|Epilepsy|epilepsy
4919401|NCT01999777|seizure clusters|seizure clusters
4919402|NCT01999777|acute repetitive seizures|acute repetitive seizures
4919403|NCT01999777|rescue treatment|rescue treatment
4919404|NCT01999751|Magnetic Resonance Imaging|magnetic resonance imaging
4919405|NCT01999751|Pacemaker, Artificial|pacemaker, artificial
4919406|NCT01999751|Defibrillators, Implantable|defibrillators, implantable
4919511|NCT01999179|cancer|cancer
4919407|NCT01999725|Normal Volunteers, Safety, Pharmacokinetics|normal volunteers, safety, pharmacokinetics
4919408|NCT01999712|heart failure|heart failure
4919409|NCT01999712|left ventricular assist device|left ventricular assist device
4919410|NCT01999712|right ventricular failure|right ventricular failure
4919411|NCT01999699|Heplisav|heplisav
4919412|NCT01999686|Polycystic ovarium syndrome|polycystic ovarium syndrome
4919413|NCT01999686|DLBS3233|dlbs3233
4919414|NCT01999686|metformin|metformin
4919415|NCT01999686|insulin resistance|insulin resistance
4919416|NCT01999686|Female|female
4919417|NCT01999673|SUNRISE|sunrise
4919418|NCT01999673|PPHM 1202|pphm 1202
4919419|NCT01999673|Bavituximab|bavituximab
4919420|NCT01999673|Peregrine|peregrine
4919421|NCT01999660|Prostatic Neoplasms|prostatic neoplasms
4919422|NCT01999660|Radiotherapy|radiotherapy
4919423|NCT01999660|rectal toxicity|rectal toxicity
4919424|NCT01999647|Lower Extremity|lower extremity
4919425|NCT01999647|Sciatic Nerve|sciatic nerve
4919426|NCT01999647|Anesthetics, Local|anesthetics, local
4919427|NCT01999647|Ropivacaine|ropivacaine
4919428|NCT01999647|Ultrasonography|ultrasonography
4919429|NCT01999634|rectum|rectum
4919430|NCT01999634|microdialysis|microdialysis
4919431|NCT01999634|anastomotic leaks|anastomotic leaks
4919432|NCT01999621|organ failure|organ failure
4919433|NCT01999621|intensive care|intensive care
4919434|NCT01999621|palliative care|palliative care
4919435|NCT01999621|patient's wishes|patient's wishes
4919436|NCT01999608|Infertility|infertility
4919437|NCT01999595|transcutaneous electrical nerve stimulation|transcutaneous electrical nerve stimulation
4919438|NCT01999595|pad size|pad size
4919439|NCT01999595|pulse frequency|pulse frequency
4919440|NCT01999595|blunt pressure pain|blunt pressure pain
4919441|NCT01999595|healthy humans.|healthy humans.
4919442|NCT01999582|Anemia|anemia
4919443|NCT01999582|End Stage Kidney Disease|end stage kidney disease
4919444|NCT01999582|Chronic Kidney Disease|chronic kidney disease
4919445|NCT01999582|Dialysis|dialysis
4919446|NCT01999582|Erythrpoietin Stimulating Agent (ESA)|erythrpoietin stimulating agent (esa)
4919447|NCT01999543|Blood glucose|blood glucose
4919448|NCT01999530|prazosin|prazosin
4919449|NCT01999530|dopamine|dopamine
4919450|NCT01999530|healthy|healthy
4919451|NCT01999530|Positron Emission Tomography|positron emission tomography
4919452|NCT01999530|PHNO|phno
4919453|NCT01999530|scan|scan
4919454|NCT01999530|effect|effect
4919455|NCT01999504|Glucagon-like peptide-1|glucagon-like peptide-1
4919456|NCT01999504|Glucose-dependent Insulinotropic Peptide|glucose-dependent insulinotropic peptide
4919457|NCT01999504|Peptide YY|peptide yy
4919458|NCT01999504|Glucagon|glucagon
4919459|NCT01999504|Satiety|satiety
4919460|NCT01999504|Meal|meal
4919461|NCT01999504|palaeolithic|palaeolithic
4919462|NCT01999465|Brachial plexus injury|brachial plexus injury
4919463|NCT01999465|Brachial plexus palsy|brachial plexus palsy
4919464|NCT01999465|Neonate|neonate
4919465|NCT01999452|Paleolithic diet|paleolithic diet
4919466|NCT01999426|Physical Therapy Modalities|physical therapy modalities
4919467|NCT01999426|Pediatrics|pediatrics
4919468|NCT01999426|Critical Care|critical care
4919469|NCT01999426|Respiration, Artificial|respiration, artificial
4919470|NCT01999413|AML|aml
4919471|NCT01999413|high-risk cytogenetics|high-risk cytogenetics
4919472|NCT01999413|younger patients|younger patients
4919473|NCT01999413|Induction treatment|induction treatment
4919474|NCT01999413|OMEGAVEN|omegaven
4919475|NCT01999387|food|food
4919476|NCT01999387|consumption|consumption
4919477|NCT01999309|Schizophrenia spectrum disorders|schizophrenia spectrum disorders
4919478|NCT01999283|Cervical pain|cervical pain
4919479|NCT01999283|yoga|yoga
4919480|NCT01999283|pilates|pilates
4919481|NCT01999283|exercise|exercise
4919482|NCT01999257|Genetic Counseling|genetic counseling
4919483|NCT01999257|Technology|technology
4919484|NCT01999257|Ashkenazi Jewish|ashkenazi jewish
4919485|NCT01999257|Carrier screening|carrier screening
4919486|NCT01999244|Overweight|overweight
4919487|NCT01999244|Obesity|obesity
4919488|NCT01999244|Weight Loss|weight loss
4919489|NCT01999244|Self-monitoring|self-monitoring
4919490|NCT01999244|Food Records|food records
4919491|NCT01999244|Self-weighing|self-weighing
4919492|NCT01999244|Technology|technology
4919493|NCT01999231|Safety|safety
4919494|NCT01999231|Tolerability|tolerability
4919495|NCT01999231|ESAT6|esat6
4919496|NCT01999231|CFP10|cfp10
4919497|NCT01999231|skin test|skin test
4919498|NCT01999231|diagnostic test|diagnostic test
4919499|NCT01999205|workplace|workplace
4919500|NCT01999205|intervention|intervention
4919501|NCT01999205|physical activity|physical activity
4919502|NCT01999205|sedentary behavior|sedentary behavior
4919503|NCT01999205|evaluation|evaluation
4919504|NCT01999192|inadequate response to MTX|inadequate response to mtx
4919505|NCT01999192|Methotrexate|methotrexate
4919506|NCT01999192|rheumatoid Arthritis|rheumatoid arthritis
4919507|NCT01999192|Phase 2b|phase 2b
4919508|NCT01999179|catheter related thrombosis|catheter related thrombosis
4919509|NCT01999179|upper extremity deep venous thrombosis|upper extremity deep venous thrombosis
4919510|NCT01999179|central venous catheters|central venous catheters
4919512|NCT01999179|Catheters|catheters
4919513|NCT01999153|skin graft|skin graft
4919514|NCT01999153|donor site|donor site
4919515|NCT01999114|Healthy subjects|healthy subjects
4919516|NCT01999114|Opioid|opioid
4919517|NCT01999114|Transdermal|transdermal
4919518|NCT01999114|ECG|ecg
4919519|NCT01999088|Fatty Acids, Omega-3|fatty acids, omega-3
4919520|NCT01999088|Rosemary extract|rosemary extract
4919521|NCT01999088|Functional meat|functional meat
4919522|NCT01999088|Cardiovascular disease|cardiovascular disease
4919523|NCT01999075|Duchenne Muscular Dystrophy|duchenne muscular dystrophy
4919524|NCT01999075|Pulmonary complications|pulmonary complications
4919525|NCT01999075|Lung volume recruitment,|lung volume recruitment,
4919526|NCT01999075|Breath-stacking,|breath-stacking,
4919527|NCT01999075|Cough efficacy,|cough efficacy,
4919528|NCT01999075|Maximal insufflation capacity|maximal insufflation capacity
4919529|NCT01999062|Breast RT|breast rt
4919530|NCT01999062|Breast radiation therapy|breast radiation therapy
4919531|NCT01999036|cardiac arrest, CPR, resuscitation|cardiac arrest, cpr, resuscitation
4919532|NCT01999010|psychiatry|psychiatry
4919533|NCT01999010|mental health|mental health
4919534|NCT01999010|major depressive disorder|major depressive disorder
4919535|NCT01999010|self-management|self-management
4919536|NCT01999010|data visualization|data visualization
4919537|NCT01999010|mood diaries|mood diaries
4919538|NCT01999010|electronic diaries|electronic diaries
4919539|NCT01999010|cell phones|cell phones
4919540|NCT01999010|software|software
4919541|NCT01999010|mental health telemetry|mental health telemetry
4919542|NCT01999010|ecological momentary assessment|ecological momentary assessment
4919543|NCT01998997|Delirium|delirium
4919544|NCT01998997|Hospitalized elderly|hospitalized elderly
4919545|NCT01998971|Multiple myeloma|multiple myeloma
4919546|NCT01998971|Daratumumab|daratumumab
4919547|NCT01998971|JNJ-54767414|jnj-54767414
4919548|NCT01998971|Velcade-dexamethasone|velcade-dexamethasone
4919549|NCT01998971|Velcade-melphalan-prednisone|velcade-melphalan-prednisone
4919550|NCT01998971|Velcade-thalidomide-dexamethasone|velcade-thalidomide-dexamethasone
4919551|NCT01998971|Pomalidomide-dexamethasone|pomalidomide-dexamethasone
4919552|NCT01998971|Carfilzomib-dexamethasone|carfilzomib-dexamethasone
4919553|NCT01998971|Carfilzomib-lenalidomide-dexamethasone|carfilzomib-lenalidomide-dexamethasone
4919554|NCT01998971|Anti-CD38 Monoclonal Antibody|anti-cd38 monoclonal antibody
4919555|NCT01998971|Immunomodulatory drug|immunomodulatory drug
4919556|NCT01998971|IMiD|imid
4919557|NCT01998958|Treatment resistant depressive disorder|treatment resistant depressive disorder
4919558|NCT01998958|Intranasal esketamine|intranasal esketamine
4919559|NCT01998958|Efficacy|efficacy
4919560|NCT01998958|SYNAPSE|synapse
4919561|NCT01998958|JNJ-54135419|jnj-54135419
4919562|NCT01998945|Exposure therapy|exposure therapy
4919563|NCT01998945|Cognitive behavioral therapy|cognitive behavioral therapy
4919564|NCT01998945|Relaxation Training|relaxation training
4919565|NCT01998945|Older Adults|older adults
4919566|NCT01998945|Fall Injury|fall injury
4919567|NCT01998945|Anxiety|anxiety
4919568|NCT01998945|Posttraumatic Stress|posttraumatic stress
4919569|NCT01998932|Venous Ulcer|venous ulcer
4919570|NCT01998932|Leg Ulcer|leg ulcer
4919571|NCT01998932|Metabonomics|metabonomics
4919572|NCT01998932|Ulcer Fluid|ulcer fluid
4919573|NCT01998854|Menorrhagia|menorrhagia
4919574|NCT01998854|Leiomyoma|leiomyoma
4919575|NCT01998854|Uterine Fibroids|uterine fibroids
4919576|NCT01998828|Polycythemia|polycythemia
4919577|NCT01998828|Polycythemia Vera|polycythemia vera
4919578|NCT01998828|Essential Thrombocythemia|essential thrombocythemia
4919579|NCT01998828|Thrombocytosis|thrombocytosis
4919580|NCT01998828|Myeloproliferative Disorders|myeloproliferative disorders
4919581|NCT01998828|Bone Marrow Diseases|bone marrow diseases
4919582|NCT01998828|Hematologic Diseases|hematologic diseases
4919583|NCT01998828|Blood Coagulation Disorders|blood coagulation disorders
4919584|NCT01998828|Blood Platelet Disorders|blood platelet disorders
4919585|NCT01998828|Hemorrhagic Disorders|hemorrhagic disorders
4919586|NCT01998789|Liver Transplantation|liver transplantation
4919587|NCT01998789|Everolimus|everolimus
4919588|NCT01998789|Immunosuppression|immunosuppression
4919589|NCT01998776|ulcer|ulcer
4919590|NCT01998763|Vitamin D3 supplementation|vitamin d3 supplementation
4919591|NCT01998763|metabolite profile|metabolite profile
4919592|NCT01998763|SNPs|snps
4919593|NCT01998763|bone-turnover marker|bone-turnover marker
4919594|NCT01998750|obesity|obesity
4919595|NCT01998750|genetics|genetics
4919596|NCT01998750|early-onset|early-onset
4919597|NCT01998750|childhood|childhood
4919598|NCT01998737|Osteoporosis, diagnostics, ultrasound|osteoporosis, diagnostics, ultrasound
4919599|NCT01998724|Chronic bronchitis|chronic bronchitis
4919600|NCT01998724|Emphysema|emphysema
4919601|NCT01998724|Pulmonary|pulmonary
4919602|NCT01998724|COPD|copd
4919603|NCT01998711|Alzheimer's disease|alzheimer's disease
4919604|NCT01998711|Mild cognitive impairment|mild cognitive impairment
4919605|NCT01998711|Memory intervention|memory intervention
4919606|NCT01998711|Strategy use|strategy use
4919607|NCT01998711|Memory group|memory group
4919608|NCT01998698|cataract|cataract
4919609|NCT01998698|phacoemulsification|phacoemulsification
4919610|NCT01998698|monovision|monovision
4919611|NCT01998698|multifocal lens|multifocal lens
4919612|NCT01998685|Prostatectomy|prostatectomy
4919613|NCT01998685|Coagulation Factor|coagulation factor
4919614|NCT01998685|Balanced Anesthesia|balanced anesthesia
4919615|NCT01998685|Intravenous Anesthesia,|intravenous anesthesia,
4919616|NCT01998646|ASP4058|asp4058
4919617|NCT01998646|healthy subjects|healthy subjects
4919618|NCT01998633|Hemophagocytic lymphohistiocytosis|hemophagocytic lymphohistiocytosis
4919619|NCT01998633|Chronic Active EBV|chronic active ebv
4919620|NCT01998633|Chronic Granulomatous Disease|chronic granulomatous disease
4919621|NCT01998633|Hyperimmunoglobulin M Syndrome (Hyper IGM)|hyperimmunoglobulin m syndrome (hyper igm)
4919622|NCT01998633|Leukocyte Adhesion Deficiency|leukocyte adhesion deficiency
4919623|NCT01998633|IPEX|ipex
4919624|NCT01998633|Hematopoietic Stem Cell Transplant (HSCT)|hematopoietic stem cell transplant (hsct)
4919625|NCT01998633|Non-Myeloablative Transplant (NST)|non-myeloablative transplant (nst)
4919626|NCT01998633|Reduced-Intensity Conditioning (RIC)|reduced-intensity conditioning (ric)
4919627|NCT01998620|Hepatitis B|hepatitis b
4919628|NCT01998620|Cholestasis|cholestasis
4919629|NCT01998607|Solid tumours|solid tumours
4919630|NCT01998607|Bone Metastasis|bone metastasis
4919631|NCT01998594|Thumb arthritis|thumb arthritis
4919632|NCT01998594|CMC arthritis|cmc arthritis
4919633|NCT01998594|Arthroplasty|arthroplasty
4919634|NCT01998568|Intraocular pressure|intraocular pressure
4919635|NCT01998568|Corneal edema|corneal edema
4919636|NCT01998568|Tonometer|tonometer
4919637|NCT01998568|Dynamic contour tonometer|dynamic contour tonometer
4919638|NCT01998568|Tonopen|tonopen
4919639|NCT01998568|iCare|icare
4919640|NCT01998568|Goldmann applanation|goldmann applanation
4919641|NCT01998542|Head and neck cancers|head and neck cancers
4919642|NCT01998542|tumor vaccine|tumor vaccine
4919643|NCT01998542|immunotherapy|immunotherapy
4919644|NCT01998542|personalized anti-cancer vaccine|personalized anti-cancer vaccine
4919645|NCT01998529|Lung Cancer|lung cancer
4919646|NCT01998529|Unilateral Pleural Malignancy|unilateral pleural malignancy
4919647|NCT01998529|Metastatic active pleural malignancy|metastatic active pleural malignancy
4919648|NCT01998529|Lung tumors|lung tumors
4919649|NCT01998529|Sarcomas|sarcomas
4919650|NCT01998529|Cytoreductive Surgery|cytoreductive surgery
4919651|NCT01998529|Hyperthermic Intrathoracic Pleural Chemotherapy|hyperthermic intrathoracic pleural chemotherapy
4919652|NCT01998529|HITC|hitc
4919653|NCT01998529|Cisplatin|cisplatin
4919654|NCT01998529|Platinol-AQ|platinol-aq
4919655|NCT01998529|Platinol|platinol
4919656|NCT01998529|CDDP|cddp
4919657|NCT01998529|Amifostine|amifostine
4919658|NCT01998529|Ethyol|ethyol
4919659|NCT01998529|Ethiofos|ethiofos
4919660|NCT01998529|Gammaphos|gammaphos
4919661|NCT01998516|Emotional Intelligence|emotional intelligence
4919662|NCT01998503|AL amyloidosis|al amyloidosis
4919663|NCT01998503|bortezomib|bortezomib
4919664|NCT01998503|autologous stem cell transplantation|autologous stem cell transplantation
4919665|NCT01998477|Influenza|influenza
4919666|NCT01998477|Vaccine|vaccine
4919667|NCT01998477|Flu|flu
4919668|NCT01998477|Children|children
4919669|NCT01998477|Adolescents|adolescents
4919670|NCT01998464|Retinal Vasculitis|retinal vasculitis
4919671|NCT01998464|Optical coherence tomography|optical coherence tomography
4919672|NCT01998464|OCT|oct
4919673|NCT01998464|Imaging|imaging
4919674|NCT01998451|double sphincter in gallbladder|double sphincter in gallbladder
4919675|NCT01998451|recurrence rate of gallstones|recurrence rate of gallstones
4919676|NCT01998438|tranexamic acid|tranexamic acid
4919677|NCT01998438|cardiac surgery|cardiac surgery
4919678|NCT01998438|cardiopulmonary bypass|cardiopulmonary bypass
4919679|NCT01998425|circulating fibrocytes|circulating fibrocytes
4919680|NCT01998425|fibrocyte|fibrocyte
4919681|NCT01998425|NSCLC|nsclc
4919682|NCT01998425|treatment response|treatment response
4919683|NCT01998425|survival|survival
4919684|NCT01998425|stage|stage
4919685|NCT01998399|CAP|cap
4919686|NCT01998399|Pneumonia|pneumonia
4919687|NCT01998399|Intensive Care Unit|intensive care unit
4919688|NCT01998399|Mechanical Ventilation|mechanical ventilation
4919689|NCT01998386|Tooth Whitening|tooth whitening
4919690|NCT01998386|Adolescent|adolescent
4919691|NCT01998386|Clinical Trial|clinical trial
4919692|NCT01998373|Patient training|patient training
4919693|NCT01998373|Rheumatoid arthritis|rheumatoid arthritis
4919694|NCT01998373|Quality of life|quality of life
4919695|NCT01998360|Circumcision|circumcision
4919696|NCT01998360|Voluntary medical male circumcision|voluntary medical male circumcision
4919697|NCT01998360|Minimally-invasive|minimally-invasive
4919698|NCT01998360|HIV prevention|hiv prevention
4919699|NCT01998334|Systemic Inflammatory Response Syndrome|systemic inflammatory response syndrome
4919700|NCT01998334|Continuous Blood Purification|continuous blood purification
4919701|NCT01998321|PSI: Patient Specific Instrument|psi: patient specific instrument
4919702|NCT01998321|TKA: Total Knee Arthroplasty|tka: total knee arthroplasty
4919703|NCT01998321|Articular Deformity|articular deformity
4919704|NCT01998321|Varus|varus
4919705|NCT01998295|Clearance time|clearance time
4919706|NCT01998295|Recurrence time|recurrence time
4919707|NCT01998295|Artemether/lumefantrine|artemether/lumefantrine
4919708|NCT01998295|P. falciparum|p. falciparum
4919709|NCT01998295|Uncomplicated malaria|uncomplicated malaria
4919710|NCT01998295|Children|children
4919711|NCT01998282|Focus of study is to assess filter/stove use and efficacy in reducing exposure to waterborne and airborne pathogens.|focus of study is to assess filter/stove use and efficacy in reducing exposure to waterborne and airborne pathogens.
4919712|NCT01998256|AV optimization|av optimization
4919713|NCT01998256|Interatrial conduction delay|interatrial conduction delay
4919714|NCT01998243|morbid obesity|morbid obesity
4919715|NCT01998243|bioenterics intragastric balloon|bioenterics intragastric balloon
4919716|NCT01998243|bariatric surgery|bariatric surgery
4919717|NCT01998230|esophageal cancer|esophageal cancer
4919718|NCT01998230|esophagectomy|esophagectomy
4919719|NCT01998230|oral feeding|oral feeding
4919720|NCT01998217|extracorporeal shock wave lithotripsy|extracorporeal shock wave lithotripsy
4919721|NCT01998217|remifentanil|remifentanil
4919722|NCT01998217|flurbiprofen|flurbiprofen
4919723|NCT01998217|pancreatic stone|pancreatic stone
4919724|NCT01998204|Parkinson's disease|parkinson's disease
4919725|NCT01998204|propofol|propofol
4919726|NCT01998204|deep brain stimulator|deep brain stimulator
4919727|NCT01998191|mortality|mortality
4919728|NCT01998191|adverse events|adverse events
4919729|NCT01998165|Anesthesia|anesthesia
4919730|NCT01998165|Remifentanil|remifentanil
4919731|NCT01998165|Ultiva|ultiva
4919732|NCT01998113|gestational diabetes mellitus|gestational diabetes mellitus
4919733|NCT01998113|glyburide|glyburide
4919734|NCT01998113|metformin|metformin
4919735|NCT01998113|oral agents|oral agents
4919736|NCT01998113|insulin|insulin
4919737|NCT01998113|outcomes|outcomes
4919738|NCT01998100|PTSD|ptsd
4919739|NCT01998100|Anxiety|anxiety
4919740|NCT01998100|Behavior Therapy|behavior therapy
4919741|NCT01998100|Prolonged Exposure|prolonged exposure
4919742|NCT01998100|Exercise|exercise
4919743|NCT01998100|Wellness|wellness
4919744|NCT01998100|Post-traumatic|post-traumatic
4919745|NCT01998100|Stress|stress
4919746|NCT01998087|Exclusive breastfeeding|exclusive breastfeeding
4919747|NCT01998087|Breastfeeding|breastfeeding
4919748|NCT01998087|Proactive breastfeeding support|proactive breastfeeding support
4919749|NCT01998087|Telephone breastfeeding support|telephone breastfeeding support
4919750|NCT01998087|Infant feeding attitudes|infant feeding attitudes
4919751|NCT01998087|Breastfeeding self-efficacy|breastfeeding self-efficacy
4919752|NCT01998087|Breastfeeding difficulties|breastfeeding difficulties
4919753|NCT01998074|Cow's Milk protein Allergy|cow's milk protein allergy
4919754|NCT01998048|surgical treatment|surgical treatment
4919755|NCT01998048|Bankart|bankart
4919756|NCT01998048|Latarjet|latarjet
4919757|NCT01998048|redislocation|redislocation
4919758|NCT01998035|Lymphoid Malignancies|lymphoid malignancies
4919759|NCT01998035|Lymphoma|lymphoma
4919760|NCT01998035|Hodgkin Lymphoma|hodgkin lymphoma
4919761|NCT01998035|Non-hodgkin Lymphoma|non-hodgkin lymphoma
4919762|NCT01998035|Follicular Lymphoma|follicular lymphoma
4919763|NCT01998035|Diffuse Large B-Cell Lymphoma|diffuse large b-cell lymphoma
4919764|NCT01998035|Anaplastic Large Cell Lymphoma|anaplastic large cell lymphoma
4919765|NCT01998035|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
4919766|NCT01998035|Small Lymphocytic Lymphoma|small lymphocytic lymphoma
4919767|NCT01998035|Mantle Cell Lymphoma|mantle cell lymphoma
4919768|NCT01998035|Marginal Zone Lymphoma|marginal zone lymphoma
4919769|NCT01998035|Burkitt Lymphoma|burkitt lymphoma
4919770|NCT01998035|Waldenstrom Macroglobulinemia|waldenstrom macroglobulinemia
4919771|NCT01998035|Peripheral T-cell Lymphoma|peripheral t-cell lymphoma
4919772|NCT01998035|Cutaneous T-cell Lymphoma|cutaneous t-cell lymphoma
4919773|NCT01998022|hypertension|hypertension
4919774|NCT01998022|knowledge|knowledge
4919775|NCT01998022|blood pressure control|blood pressure control
4919776|NCT01998009|colorectal cancer|colorectal cancer
4919777|NCT01998009|mass screening|mass screening
4919778|NCT01998009|fecal occult blood|fecal occult blood
4919779|NCT01997996|Pelvic Organ Prolapse|pelvic organ prolapse
4919780|NCT01997996|PROLIFT+M|prolift+m
4919781|NCT01997996|Vita sexualis|vita sexualis
4919782|NCT01997983|interstitial cystitis|interstitial cystitis
4919783|NCT01997983|PBS/IC|pbs/ic
4919784|NCT01997983|IC|ic
4919785|NCT01997983|Botox|botox
4919786|NCT01997983|Botulinum toxin|botulinum toxin
4919787|NCT01997983|TC-3 Gel|tc-3 gel
4919788|NCT01997983|TCGel|tcgel
4919789|NCT01997983|TheraCoat|theracoat
4919790|NCT01997970|NEAT|neat
4919791|NCT01997970|Treadmill desk|treadmill desk
4919792|NCT01997957|Hepatocellular Carcinoma|hepatocellular carcinoma
4919793|NCT01997957|Transarterial Chemoembolization|transarterial chemoembolization
4919794|NCT01997957|Hepatic Arterial Infusion Chemotherapy|hepatic arterial infusion chemotherapy
4919795|NCT01997957|Efficacy|efficacy
4919796|NCT01997931|bispectral index|bispectral index
4919797|NCT01997931|sedation|sedation
4919798|NCT01997931|intensive care|intensive care
4919799|NCT01997931|mechanical ventilation|mechanical ventilation
4919800|NCT01997918|Secondary allogeneic HSCT|secondary allogeneic hsct
4919801|NCT01997918|Haploidentical HSCT|haploidentical hsct
4919802|NCT01997905|Left Atrial Appendage|left atrial appendage
4919803|NCT01997905|LAA|laa
4920991|NCT01992458|death|death
4919804|NCT01997905|Atrial Fibrillation|atrial fibrillation
4919805|NCT01997905|AFib|afib
4919806|NCT01997905|AF|af
4919807|NCT01997905|IRB approved|irb approved
4919808|NCT01997905|clinical|clinical
4919809|NCT01997905|Stroke|stroke
4919810|NCT01997905|TIA|tia
4919811|NCT01997905|contraindication to oral anticoagulation therapy|contraindication to oral anticoagulation therapy
4919812|NCT01997905|Arrhythmias, Cardiac|arrhythmias, cardiac
4919813|NCT01997905|OAC|oac
4919814|NCT01997905|trial|trial
4919815|NCT01997905|study|study
4919816|NCT01997905|LAA occlusion|laa occlusion
4919817|NCT01997905|occluded|occluded
4919818|NCT01997905|prevent|prevent
4919819|NCT01997892|CKD|ckd
4919820|NCT01997892|Darbepoetin Alfa|darbepoetin alfa
4919821|NCT01997892|Dialysis|dialysis
4919822|NCT01997892|Hemodialysis|hemodialysis
4919823|NCT01997892|Anemia|anemia
4919824|NCT01997892|Peg epoetin beta|peg epoetin beta
4919825|NCT01997866|Obstructive Sleep Apnea|obstructive sleep apnea
4919826|NCT01997866|Sleep Apnea|sleep apnea
4919827|NCT01997866|Congestive Heart Failure|congestive heart failure
4919828|NCT01997866|Heart Failure|heart failure
4919829|NCT01997853|Omega 3 fatty acids|omega 3 fatty acids
4919830|NCT01997853|C Reactive Protein|c reactive protein
4919831|NCT01997853|Host Modulation|host modulation
4919832|NCT01997853|Chronic Periodontitis|chronic periodontitis
4919833|NCT01997840|Multiple Myeloma|multiple myeloma
4919834|NCT01997840|Neoplasms, Plasma Cell|neoplasms, plasma cell
4919835|NCT01997840|Neoplasms by Histologic Type|neoplasms by histologic type
4919836|NCT01997840|Neoplasms|neoplasms
4919837|NCT01997840|Blood Protein Disorders|blood protein disorders
4919838|NCT01997840|Hematologic Diseases|hematologic diseases
4919839|NCT01997840|Dexamethasone|dexamethasone
4919840|NCT01997840|Dexamethasone acetate|dexamethasone acetate
4919841|NCT01997840|Pomalidomide|pomalidomide
4919842|NCT01997814|Herbal medicine,|herbal medicine,
4919843|NCT01997814|Host modulation therapy,|host modulation therapy,
4919844|NCT01997814|Periodontitis,|periodontitis,
4919845|NCT01997814|Meta-analysis,|meta-analysis,
4919846|NCT01997814|Scaling and root planing.|scaling and root planing.
4919847|NCT01997801|Thyroidectomy|thyroidectomy
4919848|NCT01997801|Endoscopy|endoscopy
4919849|NCT01997801|Ketamine|ketamine
4919850|NCT01997801|Acute Pain|acute pain
4919851|NCT01997801|Chronic Pain|chronic pain
4919852|NCT01997801|Postoperative period|postoperative period
4919853|NCT01997788|Injection, Spinal|injection, spinal
4919854|NCT01997788|Morphine|morphine
4919855|NCT01997788|Analgesia|analgesia
4919856|NCT01997788|Patient-Controlled|patient-controlled
4919857|NCT01997788|Pain|pain
4919858|NCT01997788|Postoperative|postoperative
4919859|NCT01997788|Combined Modality Therapy|combined modality therapy
4919860|NCT01997788|Nephrectomy|nephrectomy
4919861|NCT01997775|IL-6|il-6
4919862|NCT01997775|Metformin|metformin
4919863|NCT01997775|Non-small cell lung cancer|non-small cell lung cancer
4919864|NCT01997775|Lung adenocarcinoma|lung adenocarcinoma
4919865|NCT01997762|resveratrol,|resveratrol,
4919866|NCT01997762|gestational diabetes,|gestational diabetes,
4919867|NCT01997762|beta cell function|beta cell function
4919868|NCT01997762|history|history
4919869|NCT01997749|stroke, ketogenic diet, ketosis, ischemia, brain, ketones, hyperglycemia, neuroprotection|stroke, ketogenic diet, ketosis, ischemia, brain, ketones, hyperglycemia, neuroprotection
4919870|NCT01997736|Paroxysmal Atrial Fibrillation|paroxysmal atrial fibrillation
4919871|NCT01997736|Catheter Ablation|catheter ablation
4919872|NCT01997736|Ablation Techniques|ablation techniques
4919873|NCT01997723|OSA, portable monitoring, home diagnosis|osa, portable monitoring, home diagnosis
4919874|NCT01997684|Colorectal Cancer|colorectal cancer
4919875|NCT01997684|Colonic Obstruction|colonic obstruction
4919876|NCT01997671|Primary Care|primary care
4919877|NCT01997671|Lipid-lowering therapy|lipid-lowering therapy
4919878|NCT01997671|Prescription|prescription
4919879|NCT01997671|Adequacy|adequacy
4919880|NCT01997671|Primary prevention|primary prevention
4919881|NCT01997671|Cardiovascular diseases|cardiovascular diseases
4919882|NCT01997671|Electronic Medical records|electronic medical records
4919883|NCT01997671|Clinical Practice Guideline|clinical practice guideline
4919884|NCT01997658|Glucocorticoids|glucocorticoids
4919885|NCT01997658|Total complication rate|total complication rate
4919886|NCT01997658|Hepatectomy.|hepatectomy.
4919887|NCT01997645|Anal fistula|anal fistula
4919888|NCT01997645|Rectal fistula|rectal fistula
4919889|NCT01997645|Intersphincteric fistula|intersphincteric fistula
4919890|NCT01997645|Perianal fistula|perianal fistula
4919891|NCT01997632|Poliomyelitis|poliomyelitis
4919892|NCT01997632|Vaccine|vaccine
4919893|NCT01997619|biological mesh|biological mesh
4919894|NCT01997619|contaminated hernia|contaminated hernia
4919895|NCT01997619|abdominal wall reconstruction|abdominal wall reconstruction
4919896|NCT01997593|analgesia|analgesia
4919897|NCT01997593|pediatric|pediatric
4919898|NCT01997593|pain|pain
4919899|NCT01997593|laparoscopy|laparoscopy
4919900|NCT01997593|ropivacaine|ropivacaine
4919901|NCT01997580|depression|depression
4919902|NCT01997580|treatment|treatment
4919903|NCT01997580|electrophysiology|electrophysiology
4919904|NCT01997580|biomarker|biomarker
4919905|NCT01997567|Hip Arthroscopy|hip arthroscopy
4919906|NCT01997567|Regional Anesthesia|regional anesthesia
4919907|NCT01997567|Peripheral Nerve block|peripheral nerve block
4919908|NCT01997554|TSH Testing|tsh testing
4919909|NCT01997554|sub-clinical hypothyroidism|sub-clinical hypothyroidism
4919910|NCT01997515|QOR-40|qor-40
4919911|NCT01997515|Pain|pain
4919912|NCT01997515|Hypoxia|hypoxia
4919913|NCT01997515|Gastric Surgery|gastric surgery
4919914|NCT01997515|Obesity|obesity
4919915|NCT01997515|Ketamine|ketamine
4919916|NCT01997502|Hemoglobin|hemoglobin
4919917|NCT01997502|Non-invasive|non-invasive
4919918|NCT01997489|Eye|eye
4919919|NCT01997489|Fabry|fabry
4919920|NCT01997489|vessels|vessels
4919921|NCT01997476|Combined Endoscopic Ultrasound Morphologic Evaluation.|combined endoscopic ultrasound morphologic evaluation.
4919922|NCT01997450|Q/LAIV/FluMist® Quadrivalent Vaccine|q/laiv/flumist® quadrivalent vaccine
4919923|NCT01997450|Inactivated Influenza Vaccine (IIV)|inactivated influenza vaccine (iiv)
4919924|NCT01997450|Effectiveness|effectiveness
4919925|NCT01997450|Influenza|influenza
4919926|NCT01997437|Tissue-engineered tracheal transplantation|tissue-engineered tracheal transplantation
4919927|NCT01997398|Deep brain stimulation surgery under general anesthesia|deep brain stimulation surgery under general anesthesia
4919928|NCT01997398|Deep brain stimulation target accuracy|deep brain stimulation target accuracy
4919929|NCT01997398|Deep brain stimulation for Parkinsons's disease|deep brain stimulation for parkinsons's disease
4919930|NCT01997398|Deep brain stimulation functional outcomes|deep brain stimulation functional outcomes
4919931|NCT01997398|Deep brain stimulation quality of life outcomes|deep brain stimulation quality of life outcomes
4919932|NCT01997385|adapted APD|adapted apd
4919933|NCT01997385|dwell time|dwell time
4919934|NCT01997385|fill volume|fill volume
4919935|NCT01997372|ATG|atg
4919936|NCT01997372|SAA|saa
4919937|NCT01997372|immunosuppressive treatment|immunosuppressive treatment
4919938|NCT01997372|cyclosporine|cyclosporine
4919939|NCT01997359|ART initiation|art initiation
4919940|NCT01997359|HIV|hiv
4919941|NCT01997359|AIDS|aids
4919942|NCT01997359|Ethiopia|ethiopia
4919943|NCT01997346|ART initiation|art initiation
4919944|NCT01997346|Ethiopia|ethiopia
4919945|NCT01997346|Clinic observation|clinic observation
4919946|NCT01997346|VCT observation|vct observation
4919947|NCT01997333|Metastatic Breast Cancer|metastatic breast cancer
4919948|NCT01997333|Locally advanced breast cancer|locally advanced breast cancer
4919949|NCT01997333|Breast cancer|breast cancer
4919950|NCT01997333|Triple negative|triple negative
4919951|NCT01997333|Estrogen|estrogen
4919952|NCT01997333|Progesterone|progesterone
4919953|NCT01997333|HER2 receptors|her2 receptors
4919954|NCT01997333|Targeted treatment for breast cancer|targeted treatment for breast cancer
4919955|NCT01997333|Antibody-drug-conjugate|antibody-drug-conjugate
4919956|NCT01997333|Breast Neoplasms|breast neoplasms
4919957|NCT01997333|CDX-011|cdx-011
4919958|NCT01997333|gpNMB|gpnmb
4919959|NCT01997333|METRIC|metric
4919960|NCT01997333|Glembatumumab vedotin|glembatumumab vedotin
4919961|NCT01997333|Triple Negative Breast Cancer|triple negative breast cancer
4919962|NCT01997333|TNBC|tnbc
4919963|NCT01997320|Sarcopenia|sarcopenia
4919964|NCT01997320|Frailty|frailty
4919965|NCT01997320|Strength|strength
4919966|NCT01997320|Protein supplementation|protein supplementation
4919967|NCT01997320|Ageing|ageing
4919968|NCT01997307|acute coronary syndrome, coronary arteriography, menopause|acute coronary syndrome, coronary arteriography, menopause
4919969|NCT01997294|sequential therapy|sequential therapy
4919970|NCT01997294|atorvastatin|atorvastatin
4919971|NCT01997294|acute myocardial infarction|acute myocardial infarction
4919972|NCT01997281|dietary fiber|dietary fiber
4919973|NCT01997281|diabetes mellitus|diabetes mellitus
4919974|NCT01997281|gut hormone|gut hormone
4919975|NCT01997268|Dyslipidemia|dyslipidemia
4919976|NCT01997268|Hyperlipidemia|hyperlipidemia
4919977|NCT01997268|Omega-3 Fatty Acids|omega-3 fatty acids
4919978|NCT01997268|Metabolic Diseases|metabolic diseases
4919979|NCT01997268|TG ≥500 mg/dL and ≤ 2,000 mg/dL|tg ≥500 mg/dl and ≤ 2,000 mg/dl
4919980|NCT01997255|Everolimus|everolimus
4919981|NCT01997255|Epilepsy|epilepsy
4919982|NCT01997255|Sturge Weber Syndrome|sturge weber syndrome
4919983|NCT01997255|Port wine stain|port wine stain
4919984|NCT01997255|Glaucoma|glaucoma
4919985|NCT01997242|CORONARY STENT|coronary stent
4919986|NCT01997242|CARDIAC SURGERY|cardiac surgery
4919987|NCT01997242|NON CARDIAC SURGEY|non cardiac surgey
4919988|NCT01997229|Myasthenia Gravis|myasthenia gravis
4919989|NCT01997229|Eculizumab|eculizumab
4919990|NCT01997229|safety|safety
4919991|NCT01997229|efficacy|efficacy
4919992|NCT01997216|contact lenses|contact lenses
4919993|NCT01997216|multifocal|multifocal
4919994|NCT01997203|hepatitis C infection|hepatitis c infection
4919995|NCT01997203|vitamin D|vitamin d
4919996|NCT01997190|Immunotherapy|immunotherapy
4919997|NCT01997190|Gene therapy|gene therapy
4919998|NCT01997190|Tumor vaccine|tumor vaccine
4919999|NCT01997177|simulation|simulation
4920000|NCT01997177|training|training
4920001|NCT01997177|colonoscopy|colonoscopy
4920002|NCT01997177|standard setting|standard setting
4920003|NCT01997138|pain, inflammation, surgery|pain, inflammation, surgery
4920004|NCT01997112|Blood pressure|blood pressure
4920005|NCT01997112|Hypertension|hypertension
4920006|NCT01997112|Paracetamol|paracetamol
4920007|NCT01997112|Acetaminophen|acetaminophen
4920008|NCT01997099|Drug Library|drug library
4920009|NCT01997099|Ambulatory Infusion Pump|ambulatory infusion pump
4920010|NCT01997099|Medication Safety Software|medication safety software
4920011|NCT01997099|CADD®-Solis VIP|cadd®-solis vip
4920012|NCT01997099|Pump Programming|pump programming
4920013|NCT01997099|Home Infusion Workflow|home infusion workflow
4920014|NCT01997073|Respiratory enthalpy|respiratory enthalpy
4920015|NCT01997073|One Lung Ventilation|one lung ventilation
4920016|NCT01997060|Lifestyle intervention|lifestyle intervention
4920017|NCT01997060|Body weight|body weight
4920018|NCT01997060|Body composition|body composition
4920019|NCT01997060|Weight loss maintenance|weight loss maintenance
4920020|NCT01997060|Physical activity|physical activity
4920021|NCT01997047|Pneumonia|pneumonia
4920022|NCT01997047|bronchiolitis|bronchiolitis
4920023|NCT01997047|asthma|asthma
4920024|NCT01997047|children|children
4920025|NCT01997047|tachypnea|tachypnea
4920026|NCT01997047|developing countries|developing countries
4920027|NCT01997047|diagnostic criteria|diagnostic criteria
4920028|NCT01997034|Weight loss maintenance|weight loss maintenance
4920029|NCT01997034|Body composition|body composition
4920030|NCT01997034|Physical activity|physical activity
4920031|NCT01997034|Lifestyle intervention|lifestyle intervention
4920032|NCT01997021|Sedentary behavior|sedentary behavior
4920033|NCT01997021|physical activity|physical activity
4920034|NCT01997021|older adults|older adults
4920035|NCT01996982|Induced therapeutic hypothermia|induced therapeutic hypothermia
4920036|NCT01996969|metastatic colorectal cancer|metastatic colorectal cancer
4920037|NCT01996969|refractory|refractory
4920038|NCT01996969|regorafenib|regorafenib
4920039|NCT01996969|biomarker|biomarker
4920040|NCT01996969|gene sequencing|gene sequencing
4920041|NCT01996956|stroke volume variation,|stroke volume variation,
4920042|NCT01996956|cardiac output,|cardiac output,
4920043|NCT01996956|fluid responsiveness,|fluid responsiveness,
4920044|NCT01996956|noninvasive cardiac output monitor|noninvasive cardiac output monitor
4920045|NCT01996943|Atrial Fibrillation|atrial fibrillation
4920046|NCT01996943|Alcohol|alcohol
4920047|NCT01996943|Electrophysiologic properties of the atria|electrophysiologic properties of the atria
4920048|NCT01996943|Randomized Clinical Study|randomized clinical study
4920049|NCT01996917|wound closure|wound closure
4920050|NCT01996917|prineo|prineo
4920051|NCT01996917|scar|scar
4920052|NCT01996904|subscapularis tear|subscapularis tear
4920053|NCT01996904|arthroscopic tendon repair|arthroscopic tendon repair
4920054|NCT01996904|arthroscopic tendon debridement|arthroscopic tendon debridement
4920055|NCT01996904|ASES|ases
4920056|NCT01996891|Asthma|asthma
4920057|NCT01996891|Nutrition|nutrition
4920058|NCT01996891|Anti-inflammatory diet|anti-inflammatory diet
4920059|NCT01996878|Parkinson's disease|parkinson's disease
4920060|NCT01996878|Genetic Polymorphism|genetic polymorphism
4920061|NCT01996865|Lymphoma, Mantle cell Lymphoma, Follicular Lymphoma, Marginal zone Lymphoma, Lenalidomide treatment, rituximab treatment, Non Hodgkins Lymphoma|lymphoma, mantle cell lymphoma, follicular lymphoma, marginal zone lymphoma, lenalidomide treatment, rituximab treatment, non hodgkins lymphoma
4920062|NCT01996852|Erectile dysfunction|erectile dysfunction
4920063|NCT01996852|ED|ed
4920064|NCT01996852|Prostate|prostate
4920065|NCT01996852|Prostatectomy|prostatectomy
4920066|NCT01996826|Corneal Neovascularization|corneal neovascularization
4920067|NCT01996826|Cornea Blood Vessels|cornea blood vessels
4920068|NCT01996826|Corneal Graft Failure|corneal graft failure
4920069|NCT01996826|High-Risk Penetrating Keratoplasty|high-risk penetrating keratoplasty
4920070|NCT01996826|Corneal Transplant|corneal transplant
4920071|NCT01996813|arthroscopy|arthroscopy
4920072|NCT01996813|shoulder|shoulder
4920073|NCT01996813|obesity|obesity
4920074|NCT01996813|beach chair|beach chair
4920075|NCT01996813|compression hose|compression hose
4920076|NCT01996787|visibility tinted silicone hydrogel contact lenses for daily wear|visibility tinted silicone hydrogel contact lenses for daily wear
4920077|NCT01996735|Endothelial function|endothelial function
4920078|NCT01996735|Adenosine receptor stimulation|adenosine receptor stimulation
4920079|NCT01996709|Silicone hydrogel contact lenses|silicone hydrogel contact lenses
4920080|NCT01996709|Multi-purpose solution|multi-purpose solution
4920081|NCT01996709|Lid Papillae|lid papillae
4920082|NCT01996709|Palpebral Roughness|palpebral roughness
4920083|NCT01996696|metformin|metformin
4920084|NCT01996696|metabolic syndrome|metabolic syndrome
4920085|NCT01996696|weight gain|weight gain
4920086|NCT01996683|B-thalassemia|b-thalassemia
4920087|NCT01996683|ferritin|ferritin
4920088|NCT01996657|mechanical valves replacement|mechanical valves replacement
4920089|NCT01996657|INR|inr
4920090|NCT01996657|D-dimer|d-dimer
4920091|NCT01996657|thromboembolic events|thromboembolic events
4920092|NCT01996644|Anorexia, Bulimia, Anxiety, Exposure|anorexia, bulimia, anxiety, exposure
4920093|NCT01996618|Premature Ventricular Beats|premature ventricular beats
4920094|NCT01996618|Premature Heart Beats|premature heart beats
4920095|NCT01996618|Ranolazine|ranolazine
4920096|NCT01996592|chronic pain|chronic pain
4920097|NCT01996592|cesarean section pain|cesarean section pain
4920098|NCT01996579|Critically Ill|critically ill
4920099|NCT01996579|Intensive care|intensive care
4920100|NCT01996579|Nasogastric tube|nasogastric tube
4920101|NCT01996579|Orogastric tube|orogastric tube
4920102|NCT01996579|mechanically ventilated|mechanically ventilated
4920103|NCT01996579|nosocomially acquired infections|nosocomially acquired infections
4920104|NCT01996579|length of stay|length of stay
4920105|NCT01996579|lactoferrin|lactoferrin
4920106|NCT01996579|placebo controlled|placebo controlled
4920107|NCT01996579|antibiotic free days|antibiotic free days
4920108|NCT01996566|taste|taste
4920109|NCT01996566|non-esterified fatty acids|non-esterified fatty acids
4920110|NCT01996566|threshold|threshold
4920111|NCT01996566|sensitivity|sensitivity
4920112|NCT01996566|human|human
4920113|NCT01996553|blood flow, regional|blood flow, regional
4920114|NCT01996553|complications|complications
4920115|NCT01996553|disease, arterial obstructive|disease, arterial obstructive
4920116|NCT01996553|cardiac catheterization|cardiac catheterization
4920117|NCT01996553|radial artery|radial artery
4920118|NCT01996540|gastric neoplasm|gastric neoplasm
4920119|NCT01996540|pancreatic neoplasm|pancreatic neoplasm
4920120|NCT01996540|advanced|advanced
4920121|NCT01996540|palliative care|palliative care
4920122|NCT01996514|Children|children
4920123|NCT01996514|Food advertisement|food advertisement
4920124|NCT01996514|Obesity|obesity
4920125|NCT01996514|Television viewing|television viewing
4920126|NCT01996514|Food intake|food intake
4920127|NCT01996449|Hypertension|hypertension
4920128|NCT01996449|blood pressure|blood pressure
4920129|NCT01996449|Aldosterone|aldosterone
4920130|NCT01996449|Eplerenone|eplerenone
4920131|NCT01996449|Amlodipine|amlodipine
4920132|NCT01996449|Primary aldosteronism|primary aldosteronism
4920133|NCT01996449|Exercise pressor reflex|exercise pressor reflex
4920134|NCT01996449|handgrip exercise|handgrip exercise
4920135|NCT01996449|passive arm cycling|passive arm cycling
4920136|NCT01996449|active arm cycling|active arm cycling
4920137|NCT01996436|cerebral vasospasm|cerebral vasospasm
4920138|NCT01996436|aneurysmal subarachnoid hemorrhage|aneurysmal subarachnoid hemorrhage
4920139|NCT01996436|intra arterial drug treatment for cerebral vasospasm|intra arterial drug treatment for cerebral vasospasm
4920140|NCT01996436|nicardipine milrinone nitroglycerin verapamil|nicardipine milrinone nitroglycerin verapamil
4920141|NCT01996423|Atopic dermatitis|atopic dermatitis
4920142|NCT01996423|vitamin D|vitamin d
4920143|NCT01996410|Breast Cancer|breast cancer
4920144|NCT01996410|Acupuncture|acupuncture
4920145|NCT01996410|Taxol|taxol
4920146|NCT01996410|Cytoxan|cytoxan
4920147|NCT01996410|Adriamycin|adriamycin
4920148|NCT01996410|Taxotere|taxotere
4920149|NCT01996410|Carboplatin|carboplatin
4920150|NCT01996410|Perjeta|perjeta
4920151|NCT01996410|Chemotherapy|chemotherapy
4920152|NCT01996410|Chemotherapy-induced nausea, vomiting|chemotherapy-induced nausea, vomiting
4920153|NCT01996410|Chemotherapy-induced peripheral neuropathy|chemotherapy-induced peripheral neuropathy
4920154|NCT01996410|Adriamycin (60 mg/m2), Cytoxan (600 mg/m2), Taxol (175 mg/m2)|adriamycin (60 mg/m2), cytoxan (600 mg/m2), taxol (175 mg/m2)
4920155|NCT01996410|Adriamycin (60 mg/m2), Cytoxan (600 mg/m2), Taxol (80 g/m2)|adriamycin (60 mg/m2), cytoxan (600 mg/m2), taxol (80 g/m2)
4920156|NCT01996410|Taxotere (75mg/m2), Cytoxan (600 mg/m2)|taxotere (75mg/m2), cytoxan (600 mg/m2)
4920157|NCT01996410|Taxotere (75 mg/m2), Carboplatin (AUC 6), Perjeta (840 mg loading fixed dose)|taxotere (75 mg/m2), carboplatin (auc 6), perjeta (840 mg loading fixed dose)
4920158|NCT01996397|Heart failure|heart failure
4920159|NCT01996397|Bundle branch block|bundle branch block
4920160|NCT01996397|CRT response|crt response
4920161|NCT01996384|Vulvodynia|vulvodynia
4920162|NCT01996384|Provoked, localized vulvodynia|provoked, localized vulvodynia
4920163|NCT01996384|vulvar vestibulitis|vulvar vestibulitis
4920164|NCT01996384|provoked vestibulodynia|provoked vestibulodynia
4920165|NCT01996384|vulvovaginal pain|vulvovaginal pain
4920166|NCT01996384|vulvar pain|vulvar pain
4920167|NCT01996384|vaginal pain|vaginal pain
4920168|NCT01996384|chronic pain|chronic pain
4920169|NCT01996384|lidocaine|lidocaine
4920170|NCT01996384|numbing agent|numbing agent
4920171|NCT01996384|anesthetic cream|anesthetic cream
4920172|NCT01996384|acupuncture|acupuncture
4920173|NCT01996384|electroacupuncture|electroacupuncture
4920174|NCT01996384|electrical stimulated acupuncture|electrical stimulated acupuncture
4920175|NCT01996384|manual acupuncture|manual acupuncture
4920176|NCT01996384|classical acupuncture|classical acupuncture
4920177|NCT01996384|non-classical acupuncture|non-classical acupuncture
4920178|NCT01996384|Traditional Chinese Medicine|traditional chinese medicine
4920179|NCT01996384|TCM|tcm
4920180|NCT01996384|Chinese medicine|chinese medicine
4920181|NCT01996384|Acupuncture and Oriental Medicine|acupuncture and oriental medicine
4920182|NCT01996384|AOM|aom
4920183|NCT01996384|treatment|treatment
4920184|NCT01996384|feasibility|feasibility
4920185|NCT01996384|pilot study|pilot study
4920186|NCT01996384|Patient Reported Outcomes Measure Information System|patient reported outcomes measure information system
4920187|NCT01996384|Tampon Test|tampon test
4920188|NCT01996384|cotton swab test|cotton swab test
4920189|NCT01996384|pain diary|pain diary
4920190|NCT01996384|Research Electronic Data Capture|research electronic data capture
4920191|NCT01996384|REDCap|redcap
4920192|NCT01996358|Succinylcholine|succinylcholine
4920193|NCT01996358|Rocuronium|rocuronium
4920194|NCT01996358|Rigid Bronchoscopy|rigid bronchoscopy
4920195|NCT01996345|Placenta Previa|placenta previa
4920196|NCT01996345|Vaginal Pessary|vaginal pessary
4920197|NCT01996345|Premature Birth|premature birth
4920198|NCT01996319|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
4920199|NCT01996319|COPD|copd
4920200|NCT01996306|AXEPT|axept
4920201|NCT01996306|Fluorouracil|fluorouracil
4920202|NCT01996306|CPT-11|cpt-11
4920203|NCT01996306|XELIRI|xeliri
4920204|NCT01996306|Bevacizumab|bevacizumab
4920205|NCT01996306|FOLFIRI|folfiri
4920206|NCT01996306|Capecitabine|capecitabine
4920207|NCT01996306|2nd-line metastatic colorectal cancer|2nd-line metastatic colorectal cancer
4920208|NCT01996293|pregnant|pregnant
4920209|NCT01996293|bipolar|bipolar
4920210|NCT01996293|lamotrigine|lamotrigine
4920211|NCT01996293|lamictal|lamictal
4920212|NCT01996293|women|women
4920213|NCT01996293|female|female
4920214|NCT01996267|neoadjuvant|neoadjuvant
4920215|NCT01996267|breast cancer|breast cancer
4920216|NCT01996267|HER2 positive|her2 positive
4920217|NCT01996254|electrical stimulation|electrical stimulation
4920218|NCT01996254|neurostimulation|neurostimulation
4920219|NCT01996254|neuromodulation|neuromodulation
4920220|NCT01996254|post-amputation pain|post-amputation pain
4920221|NCT01996254|phantom limb pain|phantom limb pain
4920222|NCT01996254|residual limb pain|residual limb pain
4920223|NCT01996254|neuropathic pain|neuropathic pain
4920224|NCT01996254|amputee pain|amputee pain
4920225|NCT01996241|adolescent girls|adolescent girls
4920226|NCT01996241|female sex work|female sex work
4920227|NCT01996241|age at marriage|age at marriage
4920228|NCT01996241|retention in school|retention in school
4920229|NCT01996241|sexual debut|sexual debut
4920230|NCT01996241|India|india
4920231|NCT01996241|Karnataka|karnataka
4920232|NCT01996228|Type 1 diabetes|type 1 diabetes
4920233|NCT01996228|autoimmune|autoimmune
4920234|NCT01996228|cord blood stem cell|cord blood stem cell
4920235|NCT01996228|stem cell educator|stem cell educator
4920236|NCT01996228|immune modulation|immune modulation
4920237|NCT01996228|children|children
4920238|NCT01996228|Control autoimmunity|control autoimmunity
4920239|NCT01996228|stimulate the regeneration of islet beta cells|stimulate the regeneration of islet beta cells
4920240|NCT01996202|Melanoma|melanoma
4920241|NCT01996176|Sedentary Lifestyle|sedentary lifestyle
4920242|NCT01996176|Sedentary work|sedentary work
4920243|NCT01996176|Office workers|office workers
4920244|NCT01996176|Work|work
4920245|NCT01996176|Workplace intervention|workplace intervention
4920246|NCT01996176|Sitting time|sitting time
4920247|NCT01996150|atopic dermatitis|atopic dermatitis
4920248|NCT01996150|eczema|eczema
4920249|NCT01996150|bleach bath|bleach bath
4920250|NCT01996150|itch|itch
4920251|NCT01996150|skin barrier|skin barrier
4920252|NCT01996150|staphylococcus aureus|staphylococcus aureus
4920253|NCT01996137|Stroke|stroke
4920254|NCT01996137|Treadmill|treadmill
4920255|NCT01996137|Gait Speed|gait speed
4920256|NCT01996124|COPD|copd
4920257|NCT01996124|Pulmonary Hyperinflation|pulmonary hyperinflation
4920258|NCT01996124|Ultra Long Acting Beta 2 Agonists|ultra long acting beta 2 agonists
4920259|NCT01996124|Cor Pulmonale|cor pulmonale
4920260|NCT01996124|Cardiac performance|cardiac performance
4920261|NCT01996111|plantar fasciitis|plantar fasciitis
4920262|NCT01996085|arterial hypertension|arterial hypertension
4920263|NCT01996085|hemodynamics|hemodynamics
4920264|NCT01996085|impedance cardiography|impedance cardiography
4920265|NCT01996085|hypotensive therapy|hypotensive therapy
4920266|NCT01996072|Primary hyperparathyroidism|primary hyperparathyroidism
4920267|NCT01996072|Parathyroid|parathyroid
4920268|NCT01996059|nutritional status|nutritional status
4920269|NCT01996059|functional jejunal interposition|functional jejunal interposition
4920270|NCT01996059|Roux-en-Y|roux-en-y
4920271|NCT01996059|gastrectomy|gastrectomy
4920272|NCT01996033|uncontrolled hypertension|uncontrolled hypertension
4920273|NCT01996033|Renal Denervation|renal denervation
4920274|NCT01996007|Pneumococcus|pneumococcus
4920275|NCT01996007|Carriage|carriage
4920276|NCT01996007|Children|children
4920277|NCT01996007|Parents|parents
4920278|NCT01996007|Immunogenicity|immunogenicity
4920279|NCT01996007|PCV13|pcv13
4920280|NCT01995981|Sarcoma, Soft Tissue|sarcoma, soft tissue
4920281|NCT01995981|Pazopanib|pazopanib
4920282|NCT01995981|Positron-Emission Tomography|positron-emission tomography
4920283|NCT01995981|Pharmacokinetics|pharmacokinetics
4920284|NCT01995981|Biomarker|biomarker
4920285|NCT01995968|Stillbirth|stillbirth
4920286|NCT01995968|Fetal growth restriction|fetal growth restriction
4920287|NCT01995968|Small for gestational age|small for gestational age
4920288|NCT01995968|Antenatal detection|antenatal detection
4920289|NCT01995968|Prenatal Care|prenatal care
4920290|NCT01995968|Mass Screening|mass screening
4920291|NCT01995955|Coronary Microvascular Dysfunction|coronary microvascular dysfunction
4920292|NCT01995955|coronary artery disease|coronary artery disease
4920293|NCT01995955|index of myocardial resistance|index of myocardial resistance
4920992|NCT01992458|shock|shock
4920294|NCT01995942|Rectal Cancer|rectal cancer
4920295|NCT01995942|EMVI|emvi
4920296|NCT01995942|Extramural Venous Invasion|extramural venous invasion
4920297|NCT01995942|Microarray|microarray
4920298|NCT01995942|Biomarker|biomarker
4920299|NCT01995942|mrEMVI|mremvi
4920300|NCT01995942|Tumour Regression Grade|tumour regression grade
4920301|NCT01995942|Cancer|cancer
4920302|NCT01995942|Circumferential Resection Margin|circumferential resection margin
4920303|NCT01995942|CRM|crm
4920304|NCT01995942|MRI|mri
4920305|NCT01995942|Radiology|radiology
4920306|NCT01995942|Surgery|surgery
4920307|NCT01995942|Pathology|pathology
4920308|NCT01995929|neurogenic dysphagia|neurogenic dysphagia
4920309|NCT01995929|transnasal endoscopy|transnasal endoscopy
4920310|NCT01995929|functional endoscopy|functional endoscopy
4920311|NCT01995890|nepafenac eye drops|nepafenac eye drops
4920312|NCT01995890|intraocular pressure|intraocular pressure
4920313|NCT01995864|Schizophrenia and Disorders with Psychotic Features|schizophrenia and disorders with psychotic features
4920314|NCT01995864|Community Psychiatry|community psychiatry
4920315|NCT01995851|Influenza|influenza
4920316|NCT01995851|Vaccine|vaccine
4920317|NCT01995838|Chronic Insomnia|chronic insomnia
4920318|NCT01995838|Adults|adults
4920319|NCT01995838|Elderly|elderly
4920320|NCT01995825|bioequivalence|bioequivalence
4920321|NCT01995825|lamotrigine|lamotrigine
4920322|NCT01995825|epilepsy|epilepsy
4920323|NCT01995799|Myocardial Infarction (and related inflammation)|myocardial infarction (and related inflammation)
4920324|NCT01995786|Fluid Therapy|fluid therapy
4920325|NCT01995786|Cost-Benefit Analysis|cost-benefit analysis
4920326|NCT01995786|Hemodynamics|hemodynamics
4920327|NCT01995786|Cost Control|cost control
4920328|NCT01995773|Healthy women|healthy women
4920329|NCT01995773|Quality of life|quality of life
4920330|NCT01995773|Glucose metabolism|glucose metabolism
4920331|NCT01995773|Adrenal reactivity|adrenal reactivity
4920332|NCT01995773|Physical activity|physical activity
4920333|NCT01995773|Body Composition|body composition
4920334|NCT01995760|vancomycin|vancomycin
4920335|NCT01995760|therapeutic response monitoring|therapeutic response monitoring
4920336|NCT01995760|AUC/MIC|auc/mic
4920337|NCT01995747|IgE|ige
4920338|NCT01995747|Atopic Dermatitis|atopic dermatitis
4920339|NCT01995747|antibody|antibody
4920340|NCT01995747|allergy|allergy
4920341|NCT01995734|Acromegaly, Pituitary diseases|acromegaly, pituitary diseases
4920342|NCT01995721|recurrent respiratory papillomatosis|recurrent respiratory papillomatosis
4920343|NCT01995721|human papillomavirus|human papillomavirus
4920344|NCT01995721|vaccine|vaccine
4920345|NCT01995721|treatment|treatment
4920346|NCT01995721|immunology|immunology
4920347|NCT01995721|relapse|relapse
4920348|NCT01995708|CT7|ct7
4920349|NCT01995708|MAGE-A3|mage-a3
4920350|NCT01995708|WT1 mRNA-electroporated Autologous Langerhans|wt1 mrna-electroporated autologous langerhans
4920351|NCT01995708|vaccine|vaccine
4920352|NCT01995708|Autologous Stem Cell Transplantation|autologous stem cell transplantation
4920353|NCT01995708|13-009|13-009
4920354|NCT01995682|Independent living|independent living
4920355|NCT01995682|walk with or without walking aids|walk with or without walking aids
4920356|NCT01995669|Lymphoma|lymphoma
4920357|NCT01995669|Relapsed Indolent Non-Hodgkin's Lymphoma|relapsed indolent non-hodgkin's lymphoma
4920358|NCT01995669|non-Hodgkin's lymphoma|non-hodgkin's lymphoma
4920359|NCT01995669|NHL|nhl
4920360|NCT01995669|Relapsed/refractory indolent lymphoma|relapsed/refractory indolent lymphoma
4920361|NCT01995669|Small lymphocytic lymphoma|small lymphocytic lymphoma
4920362|NCT01995669|SLL|sll
4920363|NCT01995669|Follicular lymphoma|follicular lymphoma
4920364|NCT01995669|Marginal zone lymphoma|marginal zone lymphoma
4920365|NCT01995669|Lenalidomide|lenalidomide
4920366|NCT01995669|CC-5013|cc-5013
4920367|NCT01995669|Revlimid|revlimid
4920368|NCT01995669|Obinutuzumab|obinutuzumab
4920369|NCT01995669|GA101|ga101
4920370|NCT01995643|Grape seed extract|grape seed extract
4920371|NCT01995643|Polyphenols|polyphenols
4920372|NCT01995643|Insulin|insulin
4920373|NCT01995643|Oxidative stress Marker|oxidative stress marker
4920374|NCT01995643|Inflammatory marker|inflammatory marker
4920375|NCT01995643|Healthy human|healthy human
4920376|NCT01995617|vaccine|vaccine
4920377|NCT01995617|Streptococcus pneumoniae|streptococcus pneumoniae
4920378|NCT01995617|Strep pneumo|strep pneumo
4920379|NCT01995591|colon cancer|colon cancer
4920380|NCT01995591|sentinel lymph node|sentinel lymph node
4920381|NCT01995591|Indocyanine Green|indocyanine green
4920382|NCT01995578|5'-Azacitidine|5'-azacitidine
4920383|NCT01995578|Stem cell transplant|stem cell transplant
4920384|NCT01995578|13-192|13-192
4920385|NCT01995552|Post myocardial infarction patients with low EF.|post myocardial infarction patients with low ef.
4920386|NCT01995539|Type 2|type 2
4920387|NCT01995500|CAD|cad
4920388|NCT01995500|PCI|pci
4920389|NCT01995500|ACS|acs
4920390|NCT01995500|non ACS|non acs
4920391|NCT01995500|BioNIR|bionir
4920392|NCT01995500|DES|des
4920393|NCT01995487|more comers|more comers
4920394|NCT01995487|DES|des
4920395|NCT01995487|BioNIR|bionir
4920396|NCT01995487|ACS|acs
4920397|NCT01995487|non ACS|non acs
4920398|NCT01995487|complex lesions|complex lesions
4920399|NCT01995474|EUS|eus
4920400|NCT01995474|pancreatic cancer|pancreatic cancer
4920401|NCT01995474|cytology|cytology
4920402|NCT01995474|fine needle aspiration|fine needle aspiration
4920403|NCT01995448|The acute phase of Sepsis|the acute phase of sepsis
4920404|NCT01995448|multiparameter 8-color flow cytometry|multiparameter 8-color flow cytometry
4920405|NCT01995422|Major depressive disorder|major depressive disorder
4920406|NCT01995422|Follow-up study|follow-up study
4920407|NCT01995422|Ecological momentary assessment|ecological momentary assessment
4920408|NCT01995422|Physical activity|physical activity
4920409|NCT01995422|Depression|depression
4920410|NCT01995422|Self-esteem|self-esteem
4920411|NCT01995422|Anxiety|anxiety
4920412|NCT01995422|Rumination|rumination
4920413|NCT01995422|Quality of life|quality of life
4920414|NCT01995396|rectal cancer,|rectal cancer,
4920415|NCT01995396|fecal incontinence,|fecal incontinence,
4920416|NCT01995396|severe co-morbidity,|severe co-morbidity,
4920417|NCT01995396|Hartmann´s procedure,|hartmann´s procedure,
4920418|NCT01995396|abdominoperineal excision with intersphincteric dissection,|abdominoperineal excision with intersphincteric dissection,
4920419|NCT01995396|postoperative complications,|postoperative complications,
4920420|NCT01995396|pelvic abscess,|pelvic abscess,
4920421|NCT01995396|perineal infections|perineal infections
4920422|NCT01995370|Noncardioembolic cerebral infarction|noncardioembolic cerebral infarction
4920423|NCT01995370|Dual antiplatelet therapy (DAPT)|dual antiplatelet therapy (dapt)
4920424|NCT01995370|Cilostazol|cilostazol
4920425|NCT01995370|Aspirin|aspirin
4920426|NCT01995370|Clopidogrel|clopidogrel
4920427|NCT01995331|aplastic anemia;|aplastic anemia;
4920428|NCT01995331|cyclophosphamide;|cyclophosphamide;
4920429|NCT01995331|immunosuppressive therapy;|immunosuppressive therapy;
4920430|NCT01995331|cyclosporine A|cyclosporine a
4920431|NCT01995318|Kinesiotaping|kinesiotaping
4920432|NCT01995305|fanconi anemia|fanconi anemia
4920433|NCT01995305|hematopoiesis maintainance|hematopoiesis maintainance
4920434|NCT01995292|awake fiberoptic intubation|awake fiberoptic intubation
4920435|NCT01995292|spray as you go technique|spray as you go technique
4920436|NCT01995292|anesthesia|anesthesia
4920437|NCT01995292|Enk Fiberoptic Atomizer Set|enk fiberoptic atomizer set
4920438|NCT01995279|low back pain|low back pain
4920439|NCT01995279|French Auriculotherapy|french auriculotherapy
4920440|NCT01995279|postural control|postural control
4920441|NCT01995279|balance|balance
4920442|NCT01995279|posture|posture
4920443|NCT01995240|pancreatic cancer|pancreatic cancer
4920444|NCT01995240|MRI|mri
4920445|NCT01995240|reproducibility|reproducibility
4920446|NCT01995240|optimalization|optimalization
4920447|NCT01995227|liver cancer|liver cancer
4920448|NCT01995227|HCC|hcc
4920449|NCT01995227|tumor vaccine|tumor vaccine
4920450|NCT01995227|immunotherapy|immunotherapy
4920451|NCT01995227|personalized anti-cancer vaccine|personalized anti-cancer vaccine
4920452|NCT01995214|Postoperative delirium|postoperative delirium
4920453|NCT01995214|Geriatric|geriatric
4920454|NCT01995214|General anesthesia|general anesthesia
4920455|NCT01995214|Propofol|propofol
4920456|NCT01995214|Sevoflurane|sevoflurane
4920457|NCT01995175|Asthma|asthma
4920458|NCT01995175|Respiratory Syncytial virus|respiratory syncytial virus
4920459|NCT01995175|Cohort study|cohort study
4920460|NCT01995175|Quarterly phone contacts|quarterly phone contacts
4920461|NCT01995175|Wheeze|wheeze
4920462|NCT01995175|New born|new born
4920463|NCT01995175|Lower Respiratory Tract Infection|lower respiratory tract infection
4920464|NCT01995149|Familial Hypercholesterolemia|familial hypercholesterolemia
4920465|NCT01995149|Familial Combined Hypercholesterolemia|familial combined hypercholesterolemia
4920466|NCT01995149|Weight loss; Lipids; Phytosterols|weight loss; lipids; phytosterols
4920467|NCT01995149|Obesity|obesity
4920468|NCT01995149|Overweight.|overweight.
4920469|NCT01995149|Lipids|lipids
4920470|NCT01995136|Glaucoma|glaucoma
4920471|NCT01995136|Ocular hypertension|ocular hypertension
4920472|NCT01995123|Tobacco dependence|tobacco dependence
4920473|NCT01995123|PTSD|ptsd
4920474|NCT01995123|Behavioral Activation Therapy|behavioral activation therapy
4920475|NCT01995097|smoking cessation|smoking cessation
4920476|NCT01995097|smoking reduction|smoking reduction
4920477|NCT01995097|scheduled gradual reduction|scheduled gradual reduction
4920478|NCT01995097|pregnancy|pregnancy
4920479|NCT01995097|text message intervention|text message intervention
4920480|NCT01995084|hypoxia|hypoxia
4920481|NCT01995084|HX4|hx4
4920482|NCT01995084|PET|pet
4920483|NCT01995084|cancer|cancer
4920484|NCT01995071|Chronic Hepatitis C|chronic hepatitis c
4920485|NCT01995071|Cirrhosis|cirrhosis
4920486|NCT01995071|Child Pugh A|child pugh a
4920487|NCT01995071|Hepatitis C virus|hepatitis c virus
4920488|NCT01995071|Compensated Cirrhosis|compensated cirrhosis
4920489|NCT01995071|Hepatitis C Genotype 1|hepatitis c genotype 1
4920490|NCT01995071|Hepatitis C|hepatitis c
4920491|NCT01995071|Interferon-Free|interferon-free
4920492|NCT01995071|Cirrhotic|cirrhotic
4920493|NCT01995058|CRPC|crpc
4920494|NCT01995058|castration resistant prostate cancer|castration resistant prostate cancer
4920495|NCT01995058|prostate cancer|prostate cancer
4920496|NCT01995045|Retina|retina
4920497|NCT01995045|Vitreoretinal|vitreoretinal
4920498|NCT01995045|Surgery|surgery
4920499|NCT01995032|Duchenne's muscular dystrophy|duchenne's muscular dystrophy
4920500|NCT01995032|DMD|dmd
4920501|NCT01995019|Arthralgia|arthralgia
4920502|NCT01995019|Temporomandibular joint|temporomandibular joint
4920503|NCT01995019|corticosteroids|corticosteroids
4920504|NCT01995019|injection|injection
4920505|NCT01995019|intra-articular|intra-articular
4920506|NCT01995006|Effect|effect
4920507|NCT01995006|metamizole|metamizole
4920508|NCT01995006|salt-depleted|salt-depleted
4920509|NCT01995006|subjects|subjects
4920510|NCT01994993|Antibiotics|antibiotics
4920511|NCT01994993|ampicillin|ampicillin
4920512|NCT01994993|metronidazole|metronidazole
4920513|NCT01994993|clindamycin|clindamycin
4920514|NCT01994993|piperacillin-tazobactam|piperacillin-tazobactam
4920515|NCT01994993|Safety|safety
4920516|NCT01994993|Infants|infants
4920517|NCT01994993|Intra abdominal infections|intra abdominal infections
4920518|NCT01994967|Phase III|phase iii
4920519|NCT01994967|Noninferiority|noninferiority
4920520|NCT01994967|Controlled|controlled
4920521|NCT01994967|Double-blind|double-blind
4920522|NCT01994967|Randomized|randomized
4920523|NCT01994967|Spinal|spinal
4920524|NCT01994967|Anesthetic|anesthetic
4920525|NCT01994967|Lower limb|lower limb
4920526|NCT01994954|newborn intensive care unit|newborn intensive care unit
4920527|NCT01994954|NICU|nicu
4920528|NCT01994954|supplemental oxygen|supplemental oxygen
4920529|NCT01994941|Acute Coronary Syndrome|acute coronary syndrome
4920530|NCT01994941|Platelet Reactivity|platelet reactivity
4920531|NCT01994941|P2Y12 Receptor Blocker|p2y12 receptor blocker
4920532|NCT01994941|CYP2C19 Genotyping|cyp2c19 genotyping
4920533|NCT01994915|exacerbation|exacerbation
4920534|NCT01994915|functionality|functionality
4920535|NCT01994915|occupational therapy|occupational therapy
4920536|NCT01994915|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
4920537|NCT01994889|amyloidosis|amyloidosis
4920538|NCT01994889|amyloid|amyloid
4920539|NCT01994889|transthyretin|transthyretin
4920540|NCT01994889|TTR|ttr
4920541|NCT01994837|GDC-0199|gdc-0199
4920542|NCT01994837|Acute Myelogenous Leukemia|acute myelogenous leukemia
4920543|NCT01994837|AML|aml
4920544|NCT01994837|ABT-199|abt-199
4920545|NCT01994837|Acute Myeloid Leukemia|acute myeloid leukemia
4920546|NCT01994837|Myeloid Leukemia|myeloid leukemia
4920547|NCT01994811|cancer|cancer
4920548|NCT01994811|cardiovascular disease|cardiovascular disease
4920549|NCT01994811|diabetes|diabetes
4920550|NCT01994785|Sedation|sedation
4920551|NCT01994785|Endoscopy|endoscopy
4920552|NCT01994785|Capnography|capnography
4920553|NCT01994772|Therapeutic hypothermia|therapeutic hypothermia
4920554|NCT01994772|Targeted controlled temperature|targeted controlled temperature
4920555|NCT01994772|Cardiac arrest|cardiac arrest
4920556|NCT01994772|Non shockable rhythm|non shockable rhythm
4920557|NCT01994772|successful resuscitation|successful resuscitation
4920558|NCT01994759|Plantar fasciitis|plantar fasciitis
4920559|NCT01994759|Treatment|treatment
4920560|NCT01994759|Training|training
4920561|NCT01994759|Glucocorticosteroid injection|glucocorticosteroid injection
4920562|NCT01994733|end-stage renal disease|end-stage renal disease
4920563|NCT01994733|hemodialysis|hemodialysis
4920564|NCT01994733|mineral metabolism|mineral metabolism
4920565|NCT01994733|serum phosphate|serum phosphate
4920566|NCT01994733|phosphate binders|phosphate binders
4920567|NCT01994720|Acute ischaemic stroke.|acute ischaemic stroke.
4920568|NCT01994720|Transient ischaemic attack.|transient ischaemic attack.
4920569|NCT01994707|Remote ischemic preconditioning|remote ischemic preconditioning
4920570|NCT01994707|Coronary artery bypass graft surgery|coronary artery bypass graft surgery
4920571|NCT01994707|Troponin T|troponin t
4920572|NCT01994707|Apoptosis|apoptosis
4920573|NCT01994707|Experimental|experimental
4920574|NCT01994707|Cardioprotection|cardioprotection
4920575|NCT01994668|lorazepam|lorazepam
4920576|NCT01994668|intravenous|intravenous
4920577|NCT01994668|pharmacolinetics|pharmacolinetics
4920578|NCT01994668|healthy|healthy
4920579|NCT01994668|Japanese|japanese
4920580|NCT01994655|climacteric symptoms|climacteric symptoms
4920581|NCT01994655|menopause|menopause
4920582|NCT01994655|nurses|nurses
4920583|NCT01994629|meningococcal disease|meningococcal disease
4920584|NCT01994629|children|children
4920585|NCT01994629|vaccination|vaccination
4920586|NCT01994616|Keloid, hypertrophic scar|keloid, hypertrophic scar
4920587|NCT01994603|Prevention|prevention
4920588|NCT01994603|HIV|hiv
4920589|NCT01994603|AIDS|aids
4920590|NCT01994603|Fetal Alcohol Syndrome (FAS)|fetal alcohol syndrome (fas)
4920591|NCT01994603|Alcohol Related Neurodevelopmental Disorder (ARND)|alcohol related neurodevelopmental disorder (arnd)
4920592|NCT01994590|Prostate Cancer|prostate cancer
4920593|NCT01994590|Metastatic Castrate-Resistant Prostate Cancer|metastatic castrate-resistant prostate cancer
4920594|NCT01994590|mCRPC|mcrpc
4920595|NCT01994590|Dovitinib|dovitinib
4920596|NCT01994590|TKI258|tki258
4920597|NCT01994590|Abiraterone Acetate|abiraterone acetate
4920598|NCT01994590|Zytiga|zytiga
4920599|NCT01994590|Prednisone|prednisone
4920600|NCT01994577|Emergency Department|emergency department
4920601|NCT01994577|Cardiac troponin|cardiac troponin
4920602|NCT01994577|Myocardial infarction|myocardial infarction
4920603|NCT01994564|OAG|oag
4920604|NCT01994538|Urinary Tract Infections|urinary tract infections
4920605|NCT01994538|Urinary antiinfective agents|urinary antiinfective agents
4920606|NCT01994512|Spinal stenosis|spinal stenosis
4920607|NCT01994512|Decompression|decompression
4920608|NCT01994512|Fusion|fusion
4920609|NCT01994512|Olisthesis|olisthesis
4920610|NCT01994486|HCV Genotype 1|hcv genotype 1
4920611|NCT01994486|Hepatitis C Virus Genotype 1|hepatitis c virus genotype 1
4920612|NCT01994486|HCV|hcv
4920613|NCT01994486|TVR|tvr
4920614|NCT01994473|Schizophrenia|schizophrenia
4920615|NCT01994460|Tuberculosis|tuberculosis
4920616|NCT01994447|Informed Consent|informed consent
4920617|NCT01994447|Instructional Films and Video|instructional films and video
4920618|NCT01994447|Consent Comprehension|consent comprehension
4920619|NCT01994447|Multimedia Consent|multimedia consent
4920620|NCT01994447|Parent|parent
4920621|NCT01994434|Deep branch of the ulnar nerve|deep branch of the ulnar nerve
4920622|NCT01994434|Distal ulnar nerve compression|distal ulnar nerve compression
4920623|NCT01994421|Facilitating kinesiotape|facilitating kinesiotape
4920624|NCT01994421|Inhibiting kinesiotape|inhibiting kinesiotape
4920625|NCT01994421|Classical tape|classical tape
4920626|NCT01994421|No tape|no tape
4920627|NCT01994408|physician inertia|physician inertia
4920628|NCT01994408|hypertension|hypertension
4920629|NCT01994408|telemedicine|telemedicine
4920630|NCT01994408|mobile technology|mobile technology
4920631|NCT01994395|Stroke|stroke
4920632|NCT01994395|Gait|gait
4920633|NCT01994395|Stride Management Assist|stride management assist
4920634|NCT01994395|Mild-moderate Stroke, post 30 days or longer|mild-moderate stroke, post 30 days or longer
4920635|NCT01994382|Leukemia|leukemia
4920636|NCT01994382|Lymphocytic|lymphocytic
4920637|NCT01994382|Chronic|chronic
4920638|NCT01994382|B Cell|b cell
4920639|NCT01994369|Breast Cancer|breast cancer
4920640|NCT01994356|Contraceptive counseling|contraceptive counseling
4920641|NCT01994356|Physician self disclosure|physician self disclosure
4920642|NCT01994356|Satisfaction|satisfaction
4920643|NCT01994356|Intrauterine contraceptive use|intrauterine contraceptive use
4920644|NCT01994343|Chronic pelvic pain, women, pain, posture.|chronic pelvic pain, women, pain, posture.
4920645|NCT01994330|acquired von Willebrand disease|acquired von willebrand disease
4920646|NCT01994330|severe aortic stenosis|severe aortic stenosis
4920647|NCT01994330|Heye´s syndrome|heye´s syndrome
4920648|NCT01994330|desmopressin|desmopressin
4920649|NCT01994330|von Willebrand multimers|von willebrand multimers
4920650|NCT01994304|Safe Childbirth Checklist|safe childbirth checklist
4920651|NCT01994304|Intrapartum mortality, Quality of Institutional delivery care|intrapartum mortality, quality of institutional delivery care
4920652|NCT01994304|Maternal & newborn care practices|maternal & newborn care practices
4920653|NCT01994291|Chemokine Antagonist|chemokine antagonist
4920654|NCT01994291|Diabetic Macular Edema|diabetic macular edema
4920655|NCT01994291|Diabetes|diabetes
4920656|NCT01994291|Diabetes Mellitus|diabetes mellitus
4920657|NCT01994291|Macular Edema|macular edema
4920658|NCT01994291|Diabetic Retinopathy|diabetic retinopathy
4920659|NCT01994291|Anti-VEGF|anti-vegf
4920660|NCT01994265|Atrial fibrillation|atrial fibrillation
4920661|NCT01994265|Cognition|cognition
4920662|NCT01994265|Cognitive impairment|cognitive impairment
4920663|NCT01994265|Anticoagulation|anticoagulation
4920664|NCT01994265|Dabigatran|dabigatran
4920665|NCT01994265|Warfarin|warfarin
4920666|NCT01994265|Efficacy|efficacy
4920667|NCT01994252|defibrillator|defibrillator
4920668|NCT01994252|cardiac resynchronization|cardiac resynchronization
4920669|NCT01994239|Prostate-Specific Antigen|prostate-specific antigen
4920670|NCT01994239|LHRH antagonist|lhrh antagonist
4920671|NCT01994239|Radiotherapy|radiotherapy
4920672|NCT01994213|Famitinib|famitinib
4920673|NCT01994213|Gastroenteropancreatic Neuroendocrine Tumor|gastroenteropancreatic neuroendocrine tumor
4920674|NCT01994213|GEPNET|gepnet
4920675|NCT01994200|Thyroid cancer|thyroid cancer
4920676|NCT01994200|New diagnosis|new diagnosis
4920677|NCT01994200|Dedicated Nurse|dedicated nurse
4920678|NCT01994200|Interdisciplinary team|interdisciplinary team
4920679|NCT01994200|Randomized Controlled Trial|randomized controlled trial
4920680|NCT01994200|Intervention|intervention
4920681|NCT01994200|Supportive care|supportive care
4920682|NCT01994187|Carotid stenosis|carotid stenosis
4920683|NCT01994187|Angioplasty|angioplasty
4920684|NCT01994187|Carotid endarterectomy|carotid endarterectomy
4920685|NCT01994187|Stroke|stroke
4920686|NCT01994174|vascular|vascular
4920687|NCT01994174|retina|retina
4920688|NCT01994174|Anti-VEGF|anti-vegf
4920689|NCT01994174|Aqueous humor dynamics|aqueous humor dynamics
4920690|NCT01994161|ischemic stroke|ischemic stroke
4920691|NCT01994161|intracranial stenting|intracranial stenting
4920692|NCT01994161|vascular risk factor management|vascular risk factor management
4920693|NCT01994148|Trauma|trauma
4920694|NCT01994148|Gastrointestinal injury|gastrointestinal injury
4920695|NCT01994148|Laparoscopy|laparoscopy
4920696|NCT01994109|Sialorrhea|sialorrhea
4920697|NCT01994109|Parkinson's disease|parkinson's disease
4920993|NCT01992458|mortality|mortality
4920698|NCT01994109|Amyotrophic lateral sclerosis (ALS)|amyotrophic lateral sclerosis (als)
4920699|NCT01994109|stroke|stroke
4920700|NCT01994109|neuroleptics|neuroleptics
4920701|NCT01994057|Non-small cell lung cancer (NSCLC);|non-small cell lung cancer (nsclc);
4920702|NCT01994057|EGFR-TKI;|egfr-tki;
4920703|NCT01994057|Pharmacogenetics;|pharmacogenetics;
4920704|NCT01994057|Precision medicine|precision medicine
4920705|NCT01994057|somatic mutations ,germline mutations;|somatic mutations ,germline mutations;
4920706|NCT01994044|Whiplash, surgery, multimodal rehabilitation, independent examiners|whiplash, surgery, multimodal rehabilitation, independent examiners
4920707|NCT01994031|paclitaxel liposome injection|paclitaxel liposome injection
4920708|NCT01994031|paclitaxel|paclitaxel
4920709|NCT01994018|Vitamin D|vitamin d
4920710|NCT01994018|Interferon Beta|interferon beta
4920711|NCT01994018|Glatiramer Acetate|glatiramer acetate
4920712|NCT01994018|Relapse rates|relapse rates
4920713|NCT01993992|Anesthesia|anesthesia
4920714|NCT01993979|Adjuvant chemotherapy|adjuvant chemotherapy
4920715|NCT01993979|Surveillance|surveillance
4920716|NCT01993979|Nephro-ureterectomy|nephro-ureterectomy
4920717|NCT01993966|Urothelial carcinoma (UC),|urothelial carcinoma (uc),
4920718|NCT01993966|(-)-epigallocatechin-3-gallate(EGCG),|(-)-epigallocatechin-3-gallate(egcg),
4920719|NCT01993966|chemotherapy,|chemotherapy,
4920720|NCT01993966|cytotoxicity,|cytotoxicity,
4920721|NCT01993966|drug resistance,|drug resistance,
4920722|NCT01993966|xenograft.|xenograft.
4920723|NCT01993953|Muscle strength|muscle strength
4920724|NCT01993953|Body composition|body composition
4920725|NCT01993953|Body weight|body weight
4920726|NCT01993953|Resistance training|resistance training
4920727|NCT01993953|Personal training|personal training
4920728|NCT01993953|BodyPump|bodypump
4920729|NCT01993940|Opioid-induced Constipation|opioid-induced constipation
4920730|NCT01993927|Drug Therapy|drug therapy
4920731|NCT01993901|lung SBRT, ESAS, anxiety|lung sbrt, esas, anxiety
4920732|NCT01993888|Hepatobiliary Surgery|hepatobiliary surgery
4920733|NCT01993849|Anxiety|anxiety
4920734|NCT01993849|Impulse control|impulse control
4920735|NCT01993849|Depression|depression
4920736|NCT01993849|ADHD|adhd
4920737|NCT01993849|Fingernail Biting|fingernail biting
4920738|NCT01993849|N-Acetylcysteine|n-acetylcysteine
4920739|NCT01993849|NAC|nac
4920740|NCT01993836|isoflurane|isoflurane
4920741|NCT01993836|propofol|propofol
4920742|NCT01993836|total intravenous anesthesia|total intravenous anesthesia
4920743|NCT01993836|inhaled anesthetic|inhaled anesthetic
4920744|NCT01993836|volatile anesthetic|volatile anesthetic
4920745|NCT01993836|anesthesia|anesthesia
4920746|NCT01993836|delirium|delirium
4920747|NCT01993836|Post Operative Cognitive Dysfunction|post operative cognitive dysfunction
4920748|NCT01993836|Alzheimer's Disease|alzheimer's disease
4920749|NCT01993836|Mild Cognitive Impairment|mild cognitive impairment
4920750|NCT01993810|Non small cell lung cancer|non small cell lung cancer
4920751|NCT01993810|NSCLC|nsclc
4920752|NCT01993810|proton radiotherapy|proton radiotherapy
4920753|NCT01993797|Bronchiolitis|bronchiolitis
4920754|NCT01993758|tourniquet pressure|tourniquet pressure
4920755|NCT01993758|total knee arthroplasty|total knee arthroplasty
4920756|NCT01993745|ECMO|ecmo
4920757|NCT01993745|APACH II score|apach ii score
4920758|NCT01993732|Cancer|cancer
4920759|NCT01993732|Cryopreservation|cryopreservation
4920760|NCT01993732|Ovarian Function|ovarian function
4920761|NCT01993732|In Vitro|in vitro
4920762|NCT01993719|Metastatic|metastatic
4920763|NCT01993719|Melanoma|melanoma
4920764|NCT01993719|Adoptive Cell Therapy|adoptive cell therapy
4920765|NCT01993706|Broadly HIV-1 Neutralizing Activity|broadly hiv-1 neutralizing activity
4920766|NCT01993706|Healthy Adults|healthy adults
4920767|NCT01993706|Placebo|placebo
4920768|NCT01993706|HIV Prevention|hiv prevention
4920769|NCT01993706|Monoclonal Antibodies|monoclonal antibodies
4920770|NCT01993706|Antibodies|antibodies
4920771|NCT01993693|knee|knee
4920772|NCT01993693|pain|pain
4920773|NCT01993693|osteoarthritis|osteoarthritis
4920774|NCT01993693|ultrasound|ultrasound
4920775|NCT01993654|Pigmented Lesions|pigmented lesions
4920776|NCT01993654|PAM|pam
4920777|NCT01993654|Ocular lesion|ocular lesion
4920778|NCT01993641|Myelodysplastic Syndrome|myelodysplastic syndrome
4920779|NCT01993641|MDS|mds
4920780|NCT01993641|pracinostat|pracinostat
4920781|NCT01993641|Hypomethylating Agent|hypomethylating agent
4920782|NCT01993641|HMA|hma
4920783|NCT01993641|azacitadine|azacitadine
4920784|NCT01993641|Vidaza|vidaza
4920785|NCT01993641|decitabine|decitabine
4920786|NCT01993641|dacogen|dacogen
4920787|NCT01993615|FAI|fai
4920788|NCT01993615|femoroacetabular impingement|femoroacetabular impingement
4920789|NCT01993615|hip pain|hip pain
4920790|NCT01993615|hip arthroscopy|hip arthroscopy
4920791|NCT01993615|physical therapy|physical therapy
4920792|NCT01993602|general surgery|general surgery
4920793|NCT01993602|postoperative care|postoperative care
4920794|NCT01993602|breathing exercises|breathing exercises
4920795|NCT01993602|respiratory muscle|respiratory muscle
4920796|NCT01993602|postoperative complications|postoperative complications
4920797|NCT01993602|lung volume measurements|lung volume measurements
4920798|NCT01993602|pulmonary ventilations|pulmonary ventilations
4920799|NCT01993602|thoracic wall|thoracic wall
4920800|NCT01993589|Curettage; analgesia; paracetamol; lidocaine; Dexketoprofen trometamol; pethidine; diclofenac.|curettage; analgesia; paracetamol; lidocaine; dexketoprofen trometamol; pethidine; diclofenac.
4920801|NCT01993563|Stroke|stroke
4920802|NCT01993563|Rehabilitation|rehabilitation
4920803|NCT01993563|Motor Imagery|motor imagery
4920804|NCT01993563|Upper Extremity|upper extremity
4920805|NCT01993563|Mirror Therapy|mirror therapy
4920806|NCT01993550|lung cancer|lung cancer
4920807|NCT01993550|family caregiving|family caregiving
4920808|NCT01993550|behavioral intervention|behavioral intervention
4920809|NCT01993550|counseling|counseling
4920810|NCT01993550|symptom management|symptom management
4920811|NCT01993498|cancer toxicities|cancer toxicities
4920812|NCT01993498|cohort|cohort
4920813|NCT01993498|breast cancer|breast cancer
4920814|NCT01993485|transaortic valve replacement (TAVI)|transaortic valve replacement (tavi)
4920815|NCT01993485|endothelial function|endothelial function
4920816|NCT01993485|circulating microparticles|circulating microparticles
4920817|NCT01993459|Quality of Recovery|quality of recovery
4920818|NCT01993394|human centrifuge, oxygen, imaging, stroke volume, lung|human centrifuge, oxygen, imaging, stroke volume, lung
4920819|NCT01993381|chemotherapy-induced nausea and vomiting|chemotherapy-induced nausea and vomiting
4920820|NCT01993368|wisdom teeth extraction|wisdom teeth extraction
4920821|NCT01993355|non-specific chronic low back pain,|non-specific chronic low back pain,
4920822|NCT01993355|health-related quality of life,|health-related quality of life,
4920823|NCT01993355|physioterapy,|physioterapy,
4920824|NCT01993355|sophrology,|sophrology,
4920825|NCT01993355|cognitive-behavioral therapy,|cognitive-behavioral therapy,
4920826|NCT01993355|motivational interviewing|motivational interviewing
4920827|NCT01993342|adipocytokines|adipocytokines
4920828|NCT01993342|osteoarthritis|osteoarthritis
4920829|NCT01993342|inflammation|inflammation
4920830|NCT01993342|ultrasonography|ultrasonography
4920831|NCT01993316|neurofeedback|neurofeedback
4920832|NCT01993316|EEG|eeg
4920833|NCT01993316|transcranial magnetic stimulation|transcranial magnetic stimulation
4920834|NCT01993303|Myocardial Perfusion Imaging|myocardial perfusion imaging
4920835|NCT01993303|PET|pet
4920836|NCT01993303|Rb-82|rb-82
4920837|NCT01993264|Heart disease|heart disease
4920838|NCT01993264|Echocardiogram|echocardiogram
4920839|NCT01993264|Ultrasound|ultrasound
4920840|NCT01993264|Heart defect|heart defect
4920841|NCT01993264|Heart Dysfunction|heart dysfunction
4920842|NCT01993264|Pediatric Cardiologists|pediatric cardiologists
4920843|NCT01993264|Prenatal|prenatal
4920844|NCT01993251|sleep,melatonin,autism,children|sleep,melatonin,autism,children
4920845|NCT01993225|Low Testosterone|low testosterone
4920846|NCT01993212|Low Testosterone|low testosterone
4920847|NCT01993186|Glucose Transporter Type 1 Deficiency Syndrome Glut1|glucose transporter type 1 deficiency syndrome glut1
4920848|NCT01993173|Diphtheria|diphtheria
4920849|NCT01993173|Tetanus|tetanus
4920850|NCT01993173|Pertussis|pertussis
4920851|NCT01993173|ADACEL®|adacel®
4920852|NCT01993173|Tdap vaccine|tdap vaccine
4920853|NCT01993160|Fluorocholine (FCH)|fluorocholine (fch)
4920854|NCT01993160|Positron emission tomography (PET)|positron emission tomography (pet)
4920855|NCT01993160|Magnetic resonance imaging (MRI)|magnetic resonance imaging (mri)
4920856|NCT01993147|Methylphenidate|methylphenidate
4920857|NCT01993147|Placebo|placebo
4920858|NCT01993147|functional Magnetic Resonance Imaging (fMRI)|functional magnetic resonance imaging (fmri)
4920859|NCT01993147|Attention Control|attention control
4920860|NCT01993134|Postoperative infection|postoperative infection
4920861|NCT01993134|Antibiotic prophylaxis|antibiotic prophylaxis
4920862|NCT01993134|Cefazolin|cefazolin
4920863|NCT01993121|diabetes|diabetes
4920864|NCT01993121|exercise|exercise
4920865|NCT01993121|heart|heart
4920866|NCT01993121|cardiovascular|cardiovascular
4920867|NCT01993108|Methylphenidate|methylphenidate
4920868|NCT01993108|Naltrexone|naltrexone
4920869|NCT01993108|Placebo|placebo
4920870|NCT01993108|Neuroimaging|neuroimaging
4920871|NCT01993108|Prefrontal Control Circuits|prefrontal control circuits
4920872|NCT01993108|Attention Control|attention control
4920873|NCT01993108|Motor Control|motor control
4920874|NCT01993108|Appetitive Control|appetitive control
4920875|NCT01993095|Multiple Sclerosis|multiple sclerosis
4920876|NCT01993095|Quality of Life|quality of life
4920877|NCT01993095|Functional Fitness|functional fitness
4920878|NCT01993082|Caregivers|caregivers
4920879|NCT01993082|Telomerase|telomerase
4920880|NCT01993082|Telomere Length|telomere length
4920881|NCT01993082|Psychological Stress|psychological stress
4920882|NCT01993082|Cardiovascular Risk|cardiovascular risk
4920883|NCT01993082|Exercise|exercise
4920884|NCT01993056|injury incidence, male veteran soccer, 11+, Functional Movement Screen, FMS, warm-up|injury incidence, male veteran soccer, 11+, functional movement screen, fms, warm-up
4920885|NCT01993043|ROP|rop
4920886|NCT01993043|Bevacizumab|bevacizumab
4920887|NCT01993043|Laser|laser
4920888|NCT01993043|Development|development
4920889|NCT01993017|Acute Coronary Syndrome|acute coronary syndrome
4920890|NCT01993017|Depressive Symptoms|depressive symptoms
4920891|NCT01992991|transcranial stimulation|transcranial stimulation
4920892|NCT01992991|Intracranial hemorrhage|intracranial hemorrhage
4920893|NCT01992991|Home training|home training
4920894|NCT01992991|Occupational Therapy|occupational therapy
4920895|NCT01992991|Jebsen Taylor Hand Function Test|jebsen taylor hand function test
4920896|NCT01992978|radiofrequency-assisted（RF）|radiofrequency-assisted（rf）
4920897|NCT01992978|hepatectomy|hepatectomy
4920898|NCT01992978|postoperative liver injury|postoperative liver injury
4920899|NCT01992965|continuous glucose monitoring；|continuous glucose monitoring；
4920900|NCT01992965|critically ill;|critically ill;
4920901|NCT01992939|pulse|pulse
4920902|NCT01992939|heat|heat
4920903|NCT01992939|blood circulation|blood circulation
4920904|NCT01992926|health literacy|health literacy
4920905|NCT01992926|health numeracy|health numeracy
4920906|NCT01992913|Schizophrenia|schizophrenia
4920907|NCT01992913|Cognitive Behavioral Therapy|cognitive behavioral therapy
4920908|NCT01992913|Cognition|cognition
4920909|NCT01992913|Vocational Rehabilitation|vocational rehabilitation
4920910|NCT01992913|Supported Employment|supported employment
4920911|NCT01992913|Schizoaffective Disorder|schizoaffective disorder
4920912|NCT01992900|Plasmodium falciparum Malaria|plasmodium falciparum malaria
4920913|NCT01992900|Eurartesim|eurartesim
4920914|NCT01992900|ACT|act
4920915|NCT01992887|HIV/AIDS|hiv/aids
4920916|NCT01992887|Retention|retention
4920917|NCT01992887|ART (anti-retroviral therapy) ineligible|art (anti-retroviral therapy) ineligible
4920918|NCT01992874|Neoplasms|neoplasms
4920919|NCT01992874|Pimasertib|pimasertib
4920920|NCT01992874|Cancer|cancer
4920921|NCT01992822|rTMS|rtms
4920922|NCT01992822|fibromyalgia|fibromyalgia
4920923|NCT01992822|experimental pain|experimental pain
4920924|NCT01992809|Nonalcoholic fatty liver|nonalcoholic fatty liver
4920925|NCT01992809|omega 3|omega 3
4920926|NCT01992796|irbesartan, angiotensin, sepsis|irbesartan, angiotensin, sepsis
4920927|NCT01992783|Resistant Starch|resistant starch
4920928|NCT01992783|Antioxidant Status|antioxidant status
4920929|NCT01992783|Insulin Resistance|insulin resistance
4920930|NCT01992783|Overweight|overweight
4920931|NCT01992783|Obesity|obesity
4920932|NCT01992770|behavioural medicine|behavioural medicine
4920933|NCT01992770|pain|pain
4920934|NCT01992770|physical therapy|physical therapy
4920935|NCT01992770|physical exercise|physical exercise
4920936|NCT01992770|primary care|primary care
4920937|NCT01992757|functional fibrinogen assay|functional fibrinogen assay
4920938|NCT01992757|cardiac surgery|cardiac surgery
4920939|NCT01992744|pregnancy|pregnancy
4920940|NCT01992744|brain-derived neurotrophic factor|brain-derived neurotrophic factor
4920941|NCT01992744|birth outcomes|birth outcomes
4920942|NCT01992731|Age (38-42 years)|age (38-42 years)
4920943|NCT01992731|pregnancy rates|pregnancy rates
4920944|NCT01992731|3 IUI cycles|3 iui cycles
4920945|NCT01992731|1 IVF/ICSI cycle|1 ivf/icsi cycle
4920946|NCT01992705|pancreatic cancer|pancreatic cancer
4920947|NCT01992692|Parkinson's disease|parkinson's disease
4920948|NCT01992692|remifentanil|remifentanil
4920949|NCT01992692|deep brain stimulator|deep brain stimulator
4920950|NCT01992692|cardiovascular response|cardiovascular response
4920951|NCT01992666|Systemic lupus erythematosus|systemic lupus erythematosus
4920952|NCT01992666|genetic|genetic
4920953|NCT01992666|immunological|immunological
4920954|NCT01992666|pediatric|pediatric
4920955|NCT01992666|mutation|mutation
4920956|NCT01992666|lupus|lupus
4920957|NCT01992627|High Intensity Laser Therapy|high intensity laser therapy
4920958|NCT01992627|elbow epicondylosis|elbow epicondylosis
4920959|NCT01992614|Single Ascending Dose|single ascending dose
4920960|NCT01992614|healthy subjects|healthy subjects
4920961|NCT01992614|Hypercholesterolemia|hypercholesterolemia
4920962|NCT01992614|Hyperlipidemias|hyperlipidemias
4920963|NCT01992614|Dyslipidemias|dyslipidemias
4920964|NCT01992614|Lipid Metabolism Disorders|lipid metabolism disorders
4920965|NCT01992614|Metabolic Diseases|metabolic diseases
4920966|NCT01992601|Drug interaction|drug interaction
4920967|NCT01992601|Rosuvastatin|rosuvastatin
4920968|NCT01992601|Telmisartan|telmisartan
4920969|NCT01992601|Pharmacokinetic|pharmacokinetic
4920970|NCT01992601|(Pharmacokinetics and Drug Interaction)|(pharmacokinetics and drug interaction)
4920971|NCT01992575|Retinal vein occlusion|retinal vein occlusion
4920972|NCT01992575|OCT|oct
4920973|NCT01992575|Optical coherence tomography|optical coherence tomography
4920974|NCT01992575|Imaging|imaging
4920975|NCT01992536|Meningococcal|meningococcal
4920976|NCT01992536|Booster|booster
4920977|NCT01992536|MenABCWY|menabcwy
4920978|NCT01992536|Menveo|menveo
4920979|NCT01992536|Vaccine Adolescents|vaccine adolescents
4920980|NCT01992536|Immune Response|immune response
4920981|NCT01992536|N. Meningitidis|n. meningitidis
4920982|NCT01992523|Ticagrelor|ticagrelor
4920983|NCT01992523|antiplatelet|antiplatelet
4920984|NCT01992523|Acute Coronary Syndrome|acute coronary syndrome
4920985|NCT01992497|Cesarean section, probiotic, formula fed, gut microbiota|cesarean section, probiotic, formula fed, gut microbiota
4920986|NCT01992484|platelets, Acute coronary Syndrome (ACS), prasugrel, ticagrelor, aspirin|platelets, acute coronary syndrome (acs), prasugrel, ticagrelor, aspirin
4920987|NCT01992471|BRCA1 testing|brca1 testing
4920988|NCT01992471|BRCA2 testing|brca2 testing
4920989|NCT01992471|13-215|13-215
4920990|NCT01992458|implantable cardioverter defibrillator|implantable cardioverter defibrillator
4920994|NCT01992458|complication|complication
4920995|NCT01992458|sudden death|sudden death
4920996|NCT01992445|suicide|suicide
4920997|NCT01992445|suicidal intent|suicidal intent
4920998|NCT01992445|thought markers|thought markers
4920999|NCT01992432|Brain magnetic resonance imaging|brain magnetic resonance imaging
4921000|NCT01992432|chemotherapy toxicity|chemotherapy toxicity
4921001|NCT01992432|older woman|older woman
4921002|NCT01992432|breast cancer|breast cancer
4921003|NCT01992419|Out-of-hospital Cardiac arrest|out-of-hospital cardiac arrest
4921004|NCT01992419|telephone dispatch assisted resuscitation|telephone dispatch assisted resuscitation
4921005|NCT01992419|cardiac arrest phone detection|cardiac arrest phone detection
4921006|NCT01992393|Epilepsy|epilepsy
4921007|NCT01992393|Schizophrenia|schizophrenia
4921008|NCT01992393|Schizoaffective Disorder|schizoaffective disorder
4921009|NCT01992393|Bipolar Disorder|bipolar disorder
4921010|NCT01992393|Depression|depression
4921011|NCT01992393|Intervention|intervention
4921012|NCT01992393|Treatment|treatment
4921013|NCT01992393|Adherence|adherence
4921014|NCT01992341|sarcomas|sarcomas
4921015|NCT01992341|carcinomas|carcinomas
4921016|NCT01992328|Immunoglobulin G Deficiency|immunoglobulin g deficiency
4921017|NCT01992315|Scar|scar
4921018|NCT01992315|Soft tissue defect|soft tissue defect
4921019|NCT01992302|Rapid cycling|rapid cycling
4921020|NCT01992289|XLHED|xlhed
4921022|NCT01992289|Hypohidrotic ectodermal dysplasia|hypohidrotic ectodermal dysplasia
4921023|NCT01992289|Christ-Siemens-Touraine Syndrome|christ-siemens-touraine syndrome
4921024|NCT01992276|Influenza|influenza
4921025|NCT01992276|Virus|virus
4921026|NCT01992276|Monoclonal Antibody|monoclonal antibody
4921027|NCT01992276|Immunization|immunization
4921028|NCT01992276|Treatment|treatment
4921029|NCT01992263|tuberculosis|tuberculosis
4921030|NCT01992263|vitamin D|vitamin d
4921031|NCT01992263|immunity|immunity
4921032|NCT01992250|Cryoablation|cryoablation
4921033|NCT01992237|ALI,|ali,
4921034|NCT01992237|ARDS,|ards,
4921035|NCT01992237|ECMO,|ecmo,
4921036|NCT01992237|energy expenditure,|energy expenditure,
4921037|NCT01992237|mechanical ventilation,|mechanical ventilation,
4921038|NCT01992237|Extracorporeal Membrane Oxygenation|extracorporeal membrane oxygenation
4921039|NCT01992237|Nutrition Assessment|nutrition assessment
4921040|NCT01992237|Pulmonary Ventilation|pulmonary ventilation
4921041|NCT01992224|severe acute pancreatitis|severe acute pancreatitis
4921042|NCT01992224|mechanical ventilation|mechanical ventilation
4921043|NCT01992198|antibiothearpy strategy|antibiothearpy strategy
4921044|NCT01992198|cefoperazone|cefoperazone
4921045|NCT01992198|metronidazole|metronidazole
4921046|NCT01992198|meropenem|meropenem
4921047|NCT01992159|Osteoporosis, Osteoporosis-Postmenopausal, Bone Diseases-Metabolic, Bone Diseases, Musculoskeletal Diseases|osteoporosis, osteoporosis-postmenopausal, bone diseases-metabolic, bone diseases, musculoskeletal diseases
4921048|NCT01992146|central sensitization|central sensitization
4921049|NCT01992146|endogenous opioids|endogenous opioids
4921050|NCT01992146|humans|humans
4921051|NCT01992146|latent sensitization|latent sensitization
4921052|NCT01992146|naloxone|naloxone
4921053|NCT01992146|open groin hernia repair|open groin hernia repair
4921054|NCT01992146|pain|pain
4921055|NCT01992146|randomized controlled trial|randomized controlled trial
4921056|NCT01992146|secondary hyperalgesia|secondary hyperalgesia
4921057|NCT01992146|target-controlled infusion|target-controlled infusion
4921058|NCT01992133|Former gestational Diabetes|former gestational diabetes
4921059|NCT01992133|Vitamin D deficiency|vitamin d deficiency
4921060|NCT01992133|insulin resistance|insulin resistance
4921061|NCT01992133|beta cell function|beta cell function
4921062|NCT01992120|Simulation|simulation
4921063|NCT01992120|Sepsis|sepsis
4921064|NCT01992120|High-fidelity|high-fidelity
4921065|NCT01992120|Severe Sepsis|severe sepsis
4921066|NCT01992120|Septic Shock|septic shock
4921067|NCT01992120|Education|education
4921068|NCT01992107|Influenza|influenza
4921069|NCT01992107|Influenza vaccine|influenza vaccine
4921070|NCT01992107|Novartis|novartis
4921071|NCT01992107|children|children
4921072|NCT01992094|Influenza|influenza
4921073|NCT01992094|Influenza vaccine|influenza vaccine
4921074|NCT01992094|Novartis|novartis
4921075|NCT01992094|Adults|adults
4921076|NCT01992081|COPD, Physical Activity, Telecoaching, PROactive|copd, physical activity, telecoaching, proactive
4921077|NCT01992068|lung cancer|lung cancer
4921078|NCT01992055|Executive dysfunction|executive dysfunction
4921079|NCT01992055|Neuropsychological rehabilitation|neuropsychological rehabilitation
4921080|NCT01992055|Goal Management Training|goal management training
4921081|NCT01992029|ALS|als
4921082|NCT01992029|miRNA|mirna
4921083|NCT01992029|biomarker|biomarker
4921084|NCT01992029|monocentric observational study|monocentric observational study
4921085|NCT01992016|Prostate cancer|prostate cancer
4921086|NCT01992016|F18 FDG-PET|f18 fdg-pet
4921087|NCT01992016|Imaging|imaging
4921088|NCT01992016|Ranolazine|ranolazine
4921089|NCT01992016|Bone metastases|bone metastases
4921090|NCT01992016|Soft tissue metastases|soft tissue metastases
4921091|NCT01991964|stridor|stridor
4921092|NCT01991964|laryngomalacia|laryngomalacia
4921093|NCT01991964|ultrasound|ultrasound
4921094|NCT01991938|PI3K Inhibitor|pi3k inhibitor
4921095|NCT01991938|mTOR Inhibitor|mtor inhibitor
4921096|NCT01991938|Dual PI3K/mTOR Inhibitor|dual pi3k/mtor inhibitor
4921097|NCT01991938|CSC|csc
4921098|NCT01991938|Cancer Stem Cells|cancer stem cells
4921099|NCT01991912|irrigation endoscopic decompression|irrigation endoscopic decompression
4921100|NCT01991912|minimally invasive surgery|minimally invasive surgery
4921101|NCT01991912|spinal stenosis|spinal stenosis
4921102|NCT01991899|Measles, mumps and rubella vaccine|measles, mumps and rubella vaccine
4921103|NCT01991899|Tetraviral vaccine|tetraviral vaccine
4921104|NCT01991899|Immunogenicity, Reactogenicity and Safety|immunogenicity, reactogenicity and safety
4921105|NCT01991899|Consistency of production|consistency of production
4921106|NCT01991886|nasal High Flow|nasal high flow
4921107|NCT01991886|premature baby|premature baby
4921108|NCT01991886|CPAP (Continuous positive airways pressure)|cpap (continuous positive airways pressure)
4921109|NCT01991873|metastatic colorectal cancer|metastatic colorectal cancer
4921110|NCT01991873|maintenance therapy|maintenance therapy
4921111|NCT01991873|Panitumumab|panitumumab
4921112|NCT01991873|Vectibix®|vectibix®
4921113|NCT01991847|colon|colon
4921114|NCT01991847|cancer|cancer
4921115|NCT01991847|prevention|prevention
4921116|NCT01991847|exercise|exercise
4921117|NCT01991847|physical activity|physical activity
4921118|NCT01991847|rectal|rectal
4921119|NCT01991834|laparoscopy|laparoscopy
4921120|NCT01991834|surgical wound infection|surgical wound infection
4921121|NCT01991834|antibiotic prophylaxis|antibiotic prophylaxis
4921122|NCT01991834|gynecologic surgical procedures|gynecologic surgical procedures
4921123|NCT01991795|Diabetes|diabetes
4921124|NCT01991795|Coronary artery disease|coronary artery disease
4921125|NCT01991795|Outcome|outcome
4921126|NCT01991795|Prevention|prevention
4921127|NCT01991795|Antiplatelet|antiplatelet
4921128|NCT01991782|Telemedicine|telemedicine
4921129|NCT01991782|Fracture|fracture
4921130|NCT01991782|Orthopaedics|orthopaedics
4921131|NCT01991769|exercise|exercise
4921132|NCT01991769|endothelium|endothelium
4921133|NCT01991769|postprandial period|postprandial period
4921134|NCT01991756|Abdominal Aortic Aneurysms|abdominal aortic aneurysms
4921135|NCT01991756|AAA|aaa
4921136|NCT01991743|Version|version
4921137|NCT01991743|Pregnancy|pregnancy
4921138|NCT01991743|Vaginal Delivery|vaginal delivery
4921139|NCT01991743|Pain Control|pain control
4921140|NCT01991743|Combined Spinal Epidural|combined spinal epidural
4921141|NCT01991717|Victus|victus
4921142|NCT01991717|lensfragmentation|lensfragmentation
4921143|NCT01991717|femtosecond laser assisted|femtosecond laser assisted
4921144|NCT01991717|capsulotomy,|capsulotomy,
4921145|NCT01991717|manual, continuous curvilinear capsulorhexis (CCC)|manual, continuous curvilinear capsulorhexis (ccc)
4921146|NCT01991717|effective phaco time, phaco|effective phaco time, phaco
4921147|NCT01991704|incubation|incubation
4921148|NCT01991704|Craving|craving
4921149|NCT01991704|alcohol dependence|alcohol dependence
4921150|NCT01991691|Antineoplastic Agents|antineoplastic agents
4921151|NCT01991665|Intrapartum Ultrasound|intrapartum ultrasound
4921152|NCT01991665|Vacuum|vacuum
4921153|NCT01991665|Occiput position|occiput position
4921154|NCT01991652|Wilms tumour|wilms tumour
4921155|NCT01991652|Childhood cancer|childhood cancer
4921156|NCT01991652|Africa|africa
4921157|NCT01991639|frailty|frailty
4921158|NCT01991639|community-dwelling|community-dwelling
4921159|NCT01991639|malnutrition|malnutrition
4921160|NCT01991639|physical activity|physical activity
4921161|NCT01991639|nutritional intervention|nutritional intervention
4921162|NCT01991600|iron absorption|iron absorption
4921163|NCT01991600|bioavailability|bioavailability
4921164|NCT01991600|anaemia|anaemia
4921165|NCT01991600|iron deficiency|iron deficiency
4921166|NCT01991600|ferrous sulphate|ferrous sulphate
4921167|NCT01991587|Influenza|influenza
4921168|NCT01991587|Human|human
4921169|NCT01991587|RNA Virus Infections|rna virus infections
4921170|NCT01991587|Immunologic|immunologic
4921171|NCT01991587|Immunogenic Factors|immunogenic factors
4921172|NCT01991587|Physiological Effects of Drugs|physiological effects of drugs
4921173|NCT01991587|Virus diseases|virus diseases
4921174|NCT01991587|Orthomyxoviridae Infections|orthomyxoviridae infections
4921175|NCT01991587|Infection|infection
4921176|NCT01991574|urinary phosphate|urinary phosphate
4921177|NCT01991574|iron hydroxide|iron hydroxide
4921178|NCT01991574|hypophosphatemia|hypophosphatemia
4921179|NCT01991574|phosphate binder|phosphate binder
4921180|NCT01991574|ferric hydroxide adipate|ferric hydroxide adipate
4921181|NCT01991561|Influenza, Human|influenza, human
4921182|NCT01991561|RNA Virus Infections|rna virus infections
4921183|NCT01991561|Respiratory Tract Diseases|respiratory tract diseases
4921184|NCT01991561|Respiratory Tract Infections|respiratory tract infections
4921185|NCT01991561|Aluminum Hydroxide|aluminum hydroxide
4921186|NCT01991561|Adjuvants, Immunologic|adjuvants, immunologic
4921187|NCT01991561|Immunogenic Factors|immunogenic factors
4921188|NCT01991561|GLA-SE|gla-se
4921189|NCT01991561|Physiological Effects of Drugs|physiological effects of drugs
4921190|NCT01991561|Virus Diseases|virus diseases
4921191|NCT01991561|Orthomyxoviridae Infections|orthomyxoviridae infections
4921192|NCT01991561|Infection|infection
4921193|NCT01991548|Insulin pump|insulin pump
4921194|NCT01991470|Insulin requiring diabetes|insulin requiring diabetes
4921195|NCT01991470|Children|children
4921196|NCT01991470|Sensor|sensor
4921197|NCT01991470|Accuracy|accuracy
4921198|NCT01991457|ALL|all
4921199|NCT01991418|non-small cell lung cancer|non-small cell lung cancer
4921200|NCT01991418|thioredoxin reductase|thioredoxin reductase
4921201|NCT01991418|carcina embryonic antigen|carcina embryonic antigen
4921202|NCT01991405|Mild Cognitive Impairment|mild cognitive impairment
4921203|NCT01991405|Working Memory Training|working memory training
4921204|NCT01991405|Neuropsychological function in MCI|neuropsychological function in mci
4921205|NCT01991392|Pancreaticoduodenectomy|pancreaticoduodenectomy
4921206|NCT01991392|nasogastric tube|nasogastric tube
4921207|NCT01991379|MEK162|mek162
4921208|NCT01991379|Imatinib|imatinib
4921209|NCT01991379|13-162|13-162
4921210|NCT01991366|Major adverse microvascular integrity|major adverse microvascular integrity
4921211|NCT01991366|all cause mortality|all cause mortality
4921212|NCT01991366|Q Wave MI|q wave mi
4921213|NCT01991353|Knee|knee
4921214|NCT01991353|meniscus|meniscus
4921215|NCT01991353|platelet rich plasma|platelet rich plasma
4921216|NCT01991301|graft-versus-host disease|graft-versus-host disease
4921217|NCT01991301|stem cell transplantation|stem cell transplantation
4921218|NCT01991301|matched unrelated donors|matched unrelated donors
4921219|NCT01991301|proteosmoe inhibitor|proteosmoe inhibitor
4921220|NCT01991301|carfilzumib|carfilzumib
4921221|NCT01991288|Total Knee Replacement|total knee replacement
4921222|NCT01991288|Bupivacaine|bupivacaine
4921223|NCT01991288|Levobupivacaine|levobupivacaine
4921224|NCT01991288|Saphenous Nerve Block|saphenous nerve block
4921225|NCT01991288|Local Infiltration Analgesia|local infiltration analgesia
4921226|NCT01991275|Prostatic Neoplasms|prostatic neoplasms
4921227|NCT01991275|Laparoscopy|laparoscopy
4921228|NCT01991275|Injections, Spinal|injections, spinal
4921229|NCT01991275|Morphine|morphine
4921230|NCT01991249|pediatric acute leukemia|pediatric acute leukemia
4921231|NCT01991249|Targeted high throughput sequencing|targeted high throughput sequencing
4921232|NCT01991249|messenger RNA|messenger rna
4921233|NCT01991197|Psoriasis|psoriasis
4921234|NCT01991197|Type 2 Diabetes|type 2 diabetes
4921235|NCT01991197|Dipeptidyl peptidase-4 inhibition|dipeptidyl peptidase-4 inhibition
4921236|NCT01991197|Sitagliptin|sitagliptin
4921237|NCT01991197|Gliclazide|gliclazide
4921238|NCT01991197|Psoriasis area and severity index|psoriasis area and severity index
4921239|NCT01991171|kinesio taping|kinesio taping
4921240|NCT01991171|Muscle activation|muscle activation
4921241|NCT01991171|Muscle inhibition|muscle inhibition
4921242|NCT01991158|GAD-M regimen|gad-m regimen
4921243|NCT01991158|first line chemotherapy|first line chemotherapy
4921244|NCT01991158|NK/T-cell Lymphoma|nk/t-cell lymphoma
4921245|NCT01991145|Cerebral Palsy|cerebral palsy
4921246|NCT01991145|Umbilical Cord Blood|umbilical cord blood
4921247|NCT01991145|Erythropoietin|erythropoietin
4921248|NCT01991145|Rehabilitation|rehabilitation
4921249|NCT01991132|Dry Eyes|dry eyes
4921250|NCT01991132|Meibomian glands|meibomian glands
4921251|NCT01991132|Algorithm|algorithm
4921252|NCT01991132|MediView software|mediview software
4921253|NCT01991119|Atrial fibrillation|atrial fibrillation
4921254|NCT01991119|Propafenone|propafenone
4921255|NCT01991119|Dronedarone|dronedarone
4921256|NCT01991106|Exercise|exercise
4921257|NCT01991106|Myocardial function|myocardial function
4921258|NCT01991106|Vascular function|vascular function
4921259|NCT01991106|Cardiovascular disease/prevention & control|cardiovascular disease/prevention & control
4921260|NCT01991106|Paediatric obesity|paediatric obesity
4921261|NCT01991106|Visceral adipose tissue|visceral adipose tissue
4921262|NCT01991093|light transmittance aggregometry (LTA),multiple electrode aggregometry, clopidogrel-resistance|light transmittance aggregometry (lta),multiple electrode aggregometry, clopidogrel-resistance
4921263|NCT01991080|biofeedback|biofeedback
4921264|NCT01991080|relaxation|relaxation
4921265|NCT01991080|Wheat germ juice|wheat germ juice
4921266|NCT01991067|Marrow transplant recipients|marrow transplant recipients
4921267|NCT01991054|Diabetes mellitus|diabetes mellitus
4921268|NCT01991054|HgA1C|hga1c
4921269|NCT01991054|25(OH) vitamin D|25(oh) vitamin d
4921270|NCT01991054|HgA1C levels above 7.5%|hga1c levels above 7.5%
4921271|NCT01991041|Lennox-Gastaut Syndrome|lennox-gastaut syndrome
4921272|NCT01991002|14/21 diet|14/21 diet
4921273|NCT01991002|BMI|bmi
4921274|NCT01991002|biochemical blood markers|biochemical blood markers
4921275|NCT01991002|quality of life|quality of life
4921276|NCT01990989|clopidogrel|clopidogrel
4921277|NCT01990989|pharmacogenomics|pharmacogenomics
4921278|NCT01990989|CYP2C19|cyp2c19
4921279|NCT01990989|platelet aggregation|platelet aggregation
4921280|NCT01990989|score system|score system
4921281|NCT01990989|ischemic cardiovascular outcomes|ischemic cardiovascular outcomes
4921282|NCT01990989|hemorrhage complications|hemorrhage complications
4921283|NCT01990976|Muscular Dystrophy|muscular dystrophy
4921284|NCT01990976|Facioscapulohumeral|facioscapulohumeral
4921285|NCT01990976|Physical training|physical training
4921286|NCT01990976|Magnetic Resonance Imaging|magnetic resonance imaging
4921287|NCT01990976|Muscle Biopsy|muscle biopsy
4921288|NCT01990963|Brain trauma;|brain trauma;
4921289|NCT01990963|MALUNA;|maluna;
4921290|NCT01990963|densitometric data|densitometric data
4921291|NCT01990963|CT|ct
4921292|NCT01990950|Aneurysm|aneurysm
4921293|NCT01990950|Aortic Aneurysm|aortic aneurysm
4921294|NCT01990950|Iliac Aneurysm|iliac aneurysm
4921295|NCT01990950|Aortic Aneurysm, Abdominal|aortic aneurysm, abdominal
4921296|NCT01990950|Vascular Diseases|vascular diseases
4921297|NCT01990950|Cardiovascular Diseases|cardiovascular diseases
4921298|NCT01990950|Aortic Diseases|aortic diseases
4921299|NCT01990937|oral midazolam|oral midazolam
4921300|NCT01990937|sedation|sedation
4921301|NCT01990937|premedication|premedication
4921302|NCT01990937|upper gastrointestinal endoscopy|upper gastrointestinal endoscopy
4921303|NCT01990937|EGD|egd
4921304|NCT01990924|fluoroscopy|fluoroscopy
4921305|NCT01990924|radiation|radiation
4921306|NCT01990924|transradial|transradial
4921307|NCT01990924|diagnostic|diagnostic
4921308|NCT01990924|angiography|angiography
4921309|NCT01990924|cardiac|cardiac
4921310|NCT01990924|coronary|coronary
4921311|NCT01990924|angioplasty|angioplasty
4921312|NCT01990911|hypertension|hypertension
4921313|NCT01990911|hypertensive heart disease|hypertensive heart disease
4921314|NCT01990911|atrial fibrillation|atrial fibrillation
4921315|NCT01990911|autonomic imbalance|autonomic imbalance
4921316|NCT01990872|Vitamin D status|vitamin d status
4921317|NCT01990872|25-hydroxyvitamin D|25-hydroxyvitamin d
4921318|NCT01990872|Vitamin D3|vitamin d3
4921319|NCT01990872|RCT|rct
4921320|NCT01990872|Calcium intake|calcium intake
4921321|NCT01990872|Dietary requirement|dietary requirement
4921322|NCT01990846|antiviral, influenza|antiviral, influenza
4921323|NCT01990820|Pediatric Chronic Rhinosinusitis|pediatric chronic rhinosinusitis
4921324|NCT01990807|high risk|high risk
4921325|NCT01990807|Philadelphia Chromosome absent|philadelphia chromosome absent
4921326|NCT01990807|Childhood acute lymphoblastic leukemia|childhood acute lymphoblastic leukemia
4921327|NCT01990794|Cobalt|cobalt
4921328|NCT01990794|Dietary Supplements|dietary supplements
4921329|NCT01990794|Hematological|hematological
4921330|NCT01990794|Thyroid|thyroid
4921331|NCT01990781|Lidocaine, Dexamethasone, Postoperative sore throat|lidocaine, dexamethasone, postoperative sore throat
4921332|NCT01990768|tranexamic acid|tranexamic acid
4921333|NCT01990768|traumatic brain injury|traumatic brain injury
4921334|NCT01990768|intracranial hemorrhage|intracranial hemorrhage
4921335|NCT01990768|prehospital|prehospital
4921336|NCT01990768|neurologic outcome|neurologic outcome
4921337|NCT01990768|glasgow outcome scale extended|glasgow outcome scale extended
4921338|NCT01990768|disability rating scale|disability rating scale
4921339|NCT01990716|Adult|adult
4921340|NCT01990716|Colonoscopy|colonoscopy
4921341|NCT01990703|Contraception|contraception
4921342|NCT01990703|Birth Control|birth control
4921343|NCT01990703|Levonorgestrel IUD|levonorgestrel iud
4921344|NCT01990703|Mirena IUD|mirena iud
4921345|NCT01990690|oligohydramnios,antioxidant,oxidative stress and pregnancy outcomes|oligohydramnios,antioxidant,oxidative stress and pregnancy outcomes
4921346|NCT01990677|Central Serous Chorioretinopathy|central serous chorioretinopathy
4921347|NCT01990677|csr|csr
4921348|NCT01990677|cscr|cscr
4921349|NCT01990677|eplerenone|eplerenone
4921350|NCT01990677|vision|vision
4921351|NCT01990677|choroid|choroid
4921352|NCT01990677|retina|retina
4921353|NCT01990677|acute|acute
4921354|NCT01990677|chronic|chronic
4921355|NCT01990638|coronary artery bypass graft|coronary artery bypass graft
4921356|NCT01990638|Diabetes mellitus, type 2|diabetes mellitus, type 2
4921357|NCT01990625|Maternal Near Miss Morbidity|maternal near miss morbidity
4921358|NCT01990625|Maternal Mortality|maternal mortality
4921359|NCT01990625|Neonatal Mortality|neonatal mortality
4921360|NCT01990625|Gestational Age Dating|gestational age dating
4921361|NCT01990625|Pregnancy Complications|pregnancy complications
4921362|NCT01990625|Ultrasound|ultrasound
4921363|NCT01990625|Stillbirth|stillbirth
4921364|NCT01990612|Induction of labor|induction of labor
4921365|NCT01990612|Expectant management of labor|expectant management of labor
4921366|NCT01990612|39 weeks gestation|39 weeks gestation
4921367|NCT01990599|nasopharyngeal tube|nasopharyngeal tube
4921368|NCT01990599|airway management|airway management
4921369|NCT01990599|thermal coagulation of the Gasserian ganglion|thermal coagulation of the gasserian ganglion
4921370|NCT01990573|spinal surgery|spinal surgery
4921371|NCT01990573|Methadone|methadone
4921372|NCT01990560|mild hypercortisolism|mild hypercortisolism
4921373|NCT01990560|Subclinical Cushing's Syndrome|subclinical cushing's syndrome
4921374|NCT01990560|Preclinical Cushing's Syndrome|preclinical cushing's syndrome
4921375|NCT01990547|Virtual Reality Exposure Therapy|virtual reality exposure therapy
4921376|NCT01990547|functional Magnetic Resonance Imaging|functional magnetic resonance imaging
4921377|NCT01990547|Traumatic Event|traumatic event
4921378|NCT01990547|Trauma Survivor|trauma survivor
4921379|NCT01990547|Combat-related PTSD|combat-related ptsd
4921380|NCT01990547|mTBI|mtbi
4921381|NCT01990547|mild TBI|mild tbi
4921382|NCT01990547|PTSD|ptsd
4921383|NCT01990547|Veteran|veteran
4921384|NCT01990534|Lymphoma|lymphoma
4921385|NCT01990534|Hodgkin|hodgkin
4921386|NCT01990534|Relapsed|relapsed
4921387|NCT01990534|Refractory|refractory
4921388|NCT01990534|Antigens, CD30|antigens, cd30
4921389|NCT01990534|Antibody-Drug Conjugate|antibody-drug conjugate
4921390|NCT01990534|Antibodies, Monoclonal|antibodies, monoclonal
4921391|NCT01990534|Monomethyl auristatin E|monomethyl auristatin e
4921392|NCT01990534|Drug Therapy|drug therapy
4921393|NCT01990534|Immunotherapy|immunotherapy
4921394|NCT01990534|Hematologic Diseases|hematologic diseases
4921395|NCT01990534|Additional Relevant MeSH terms:|additional relevant mesh terms:
4921396|NCT01990534|Lymphoma, Large B-Cell, Diffuse|lymphoma, large b-cell, diffuse
4921397|NCT01990534|Lymphoma, Hodgkin|lymphoma, hodgkin
4921398|NCT01990534|Neoplasms by Histologic Type|neoplasms by histologic type
4921399|NCT01990534|Neoplasms|neoplasms
4921400|NCT01990534|Lymphoproliferative Disorders|lymphoproliferative disorders
4921401|NCT01990534|Lymphatic Diseases|lymphatic diseases
4921402|NCT01990534|Immunoproliferative Disorders|immunoproliferative disorders
4921403|NCT01990534|Immune System Diseases|immune system diseases
4921404|NCT01990534|Lymphoma, B-Cell|lymphoma, b-cell
4921405|NCT01990534|Lymphoma, T-Cell|lymphoma, t-cell
4921406|NCT01990534|Immunologic Factors|immunologic factors
4921407|NCT01990534|Physiological Effects of Drugs|physiological effects of drugs
4921408|NCT01990534|Pharmacologic Actions|pharmacologic actions
4921409|NCT01990508|sugar-sweetened beverages|sugar-sweetened beverages
4921410|NCT01990508|traffic-light labels|traffic-light labels
4921411|NCT01990508|financial incentives|financial incentives
4921412|NCT01990508|low-income community|low-income community
4921413|NCT01990508|obesity prevention|obesity prevention
4921414|NCT01990495|Renal failure|renal failure
4921415|NCT01990495|Exercise testing|exercise testing
4921416|NCT01990495|Exercise training|exercise training
4921417|NCT01990495|Protein signaling|protein signaling
4921418|NCT01990495|Skeletal muscle|skeletal muscle
4921419|NCT01990469|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
4921420|NCT01990456|Extracorporeal Membrane Oxygenation|extracorporeal membrane oxygenation
4921421|NCT01990456|Ventilator-Induced Lung Injury|ventilator-induced lung injury
4921422|NCT01990456|Ventilators, Mechanical|ventilators, mechanical
4921423|NCT01990456|Pulmonary Heart Disease|pulmonary heart disease
4921424|NCT01990456|Ultrasonography|ultrasonography
4921425|NCT01990443|Reslizumab|reslizumab
4921426|NCT01990443|monoclonal antibody|monoclonal antibody
4921427|NCT01990417|Muscle Stretching Exercises|muscle stretching exercises
4921428|NCT01990417|Joint range of motion|joint range of motion
4921429|NCT01990417|Resistance Training|resistance training
4921430|NCT01990417|Physical Therapy|physical therapy
4921431|NCT01990404|Premixed nitrous oxide and oxygen|premixed nitrous oxide and oxygen
4921432|NCT01990404|Severe acute pain|severe acute pain
4921433|NCT01990404|Prehospital setting|prehospital setting
4921434|NCT01990365|Vertebral fracture, low back pain, gips, mobility|vertebral fracture, low back pain, gips, mobility
4921435|NCT01990313|Parkinson's Disease|parkinson's disease
4921436|NCT01990313|DBS|dbs
4921437|NCT01990313|Deep Brain Stimulation|deep brain stimulation
4921438|NCT01990313|Subthalamic Nucleus|subthalamic nucleus
4921439|NCT01990300|Drug Therapy|drug therapy
4921440|NCT01990287|Low Back Pain|low back pain
4921441|NCT01990287|Failed Back surgery Syndrome|failed back surgery syndrome
4921442|NCT01990287|Post-Laminectomy Syndrome|post-laminectomy syndrome
4921443|NCT01990287|Spinal Cord Stimulation|spinal cord stimulation
4921444|NCT01990287|Peripheral Nerve field Stimulation|peripheral nerve field stimulation
4921445|NCT01990287|Pain|pain
4921446|NCT01990274|Tuberculosis|tuberculosis
4921447|NCT01990274|Diagnosis|diagnosis
4921448|NCT01990274|GeneXpert MTB/RIF|genexpert mtb/rif
4921449|NCT01990274|Point-of-treatment|point-of-treatment
4921450|NCT01990274|Mobile unit|mobile unit
4921451|NCT01990235|Advance care planning|advance care planning
4921452|NCT01990235|Aging|aging
4921453|NCT01990235|Health communication|health communication
4921454|NCT01990235|Health literacy|health literacy
4921455|NCT01990235|Medical decision making|medical decision making
4921456|NCT01990235|primary care|primary care
4921457|NCT01990235|vulnerable population|vulnerable population
4921458|NCT01990235|chronic illness|chronic illness
4921459|NCT01990222|ADHD|adhd
4921460|NCT01990209|triple-negative breast cancer|triple-negative breast cancer
4921461|NCT01990209|orteronel|orteronel
4921462|NCT01990209|TAK-700|tak-700
4921463|NCT01990209|metastatic breast cancer|metastatic breast cancer
4921464|NCT01990196|prostate cancer|prostate cancer
4921465|NCT01990196|hormone therapy|hormone therapy
4921466|NCT01990196|radical prostatectomy|radical prostatectomy
4921467|NCT01990183|preterm infants|preterm infants
4921468|NCT01990183|early intervention|early intervention
4921469|NCT01990183|enrichment|enrichment
4921470|NCT01990183|cognitive, motor, visual development|cognitive, motor, visual development
4921471|NCT01990183|tele-rehabilitation|tele-rehabilitation
4921472|NCT01990131|computerized intervention|computerized intervention
4921473|NCT01990131|cognitive bias modification|cognitive bias modification
4921474|NCT01990131|anxiety|anxiety
4921475|NCT01990131|suicide|suicide
4921476|NCT01990118|Renal transplant|renal transplant
4921477|NCT01990118|Renal allograft rejection|renal allograft rejection
4921478|NCT01990118|Cyclosporine|cyclosporine
4921479|NCT01990118|Gengraf|gengraf
4921480|NCT01990105|atrial fibrillation|atrial fibrillation
4921481|NCT01990105|anticoagulation|anticoagulation
4921579|NCT01989468|PsA|psa
4921482|NCT01990105|antiarrhythmic medication|antiarrhythmic medication
4921483|NCT01990105|CHA2DS2VASc score|cha2ds2vasc score
4921484|NCT01990105|HAS-BLED score|has-bled score
4921485|NCT01990105|CHADS2 score|chads2 score
4921486|NCT01990092|Metanx|metanx
4921487|NCT01990092|B vitamins|b vitamins
4921488|NCT01990092|neuropathy|neuropathy
4921489|NCT01990092|nutrition|nutrition
4921490|NCT01990079|PTSD|ptsd
4921491|NCT01990079|smoking|smoking
4921492|NCT01990066|Quality of Life|quality of life
4921493|NCT01990066|Physical Function|physical function
4921494|NCT01990040|Short Bowel Syndrome|short bowel syndrome
4921495|NCT01990040|SBS|sbs
4921496|NCT01990040|teduglutide|teduglutide
4921497|NCT01990040|Gattex|gattex
4921498|NCT01990027|kidney stone|kidney stone
4921499|NCT01990001|contraception, adherence, medication reminder|contraception, adherence, medication reminder
4921500|NCT01989988|Type 2 Diabetes Mellitus (T2DM)|type 2 diabetes mellitus (t2dm)
4921501|NCT01989988|Obesity|obesity
4921502|NCT01989988|Laparoscopic gastric bypass|laparoscopic gastric bypass
4921503|NCT01989988|Duodenum exclusion|duodenum exclusion
4921504|NCT01989975|Sensor-Augmented Pump Therapy|sensor-augmented pump therapy
4921505|NCT01989975|Connected Care|connected care
4921506|NCT01989962|Aboriginal Health|aboriginal health
4921507|NCT01989962|Diabetes Mellitus Type 2|diabetes mellitus type 2
4921508|NCT01989962|Cultural Competency|cultural competency
4921509|NCT01989962|Continuing Medical Education|continuing medical education
4921510|NCT01989923|Smoking cessation|smoking cessation
4921511|NCT01989923|Traditional nicotine replacement therapy|traditional nicotine replacement therapy
4921512|NCT01989923|Electronic nicotine delivery devices|electronic nicotine delivery devices
4921513|NCT01989923|electronic cigarettes|electronic cigarettes
4921514|NCT01989923|cervical dysplasia|cervical dysplasia
4921515|NCT01989910|Efavirenz|efavirenz
4921516|NCT01989910|Raltegravir|raltegravir
4921517|NCT01989910|Combination antiretroviral therapy|combination antiretroviral therapy
4921518|NCT01989897|diluent|diluent
4921519|NCT01989897|rhinitis|rhinitis
4921520|NCT01989897|allergic|allergic
4921521|NCT01989871|preterm|preterm
4921522|NCT01989871|oral feeding|oral feeding
4921523|NCT01989871|outcome|outcome
4921524|NCT01989858|localized gastric adenocarcinoma, operable considered.|localized gastric adenocarcinoma, operable considered.
4921525|NCT01989832|cohort|cohort
4921526|NCT01989832|pharmaco-economic|pharmaco-economic
4921527|NCT01989832|kidney|kidney
4921528|NCT01989832|transplantation|transplantation
4921529|NCT01989832|quality of life|quality of life
4921530|NCT01989806|Spinal cord injury|spinal cord injury
4921531|NCT01989806|robotic|robotic
4921532|NCT01989806|locomotion|locomotion
4921533|NCT01989793|sarcopenia|sarcopenia
4921534|NCT01989793|frailty|frailty
4921535|NCT01989793|losartan|losartan
4921536|NCT01989767|sickness absence|sickness absence
4921537|NCT01989767|rehabilitation|rehabilitation
4921538|NCT01989767|mental disorders|mental disorders
4921539|NCT01989767|screening|screening
4921540|NCT01989754|Albuminuria|albuminuria
4921541|NCT01989754|Canagliflozin|canagliflozin
4921542|NCT01989754|Cardiovascular outcomes|cardiovascular outcomes
4921543|NCT01989754|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
4921544|NCT01989754|T2DM|t2dm
4921545|NCT01989754|JNJ-28431754|jnj-28431754
4921546|NCT01989754|Antihyperglycemic Agent|antihyperglycemic agent
4921547|NCT01989741|sleep restriction, decision making, wakefullness|sleep restriction, decision making, wakefullness
4921548|NCT01989728|sickness absence, return to work, psychiatric examination, feedback, psychological distress, quality of life, attrition analysis, multiple imputation|sickness absence, return to work, psychiatric examination, feedback, psychological distress, quality of life, attrition analysis, multiple imputation
4921549|NCT01989689|PSORIASIS|psoriasis
4921550|NCT01989676|Phase 3|phase 3
4921551|NCT01989676|trastuzumab|trastuzumab
4921552|NCT01989676|Breast Neoplasms|breast neoplasms
4921553|NCT01989663|Healthy Women|healthy women
4921554|NCT01989624|Pancreatic adenocarcinoma|pancreatic adenocarcinoma
4921555|NCT01989624|diagnosis|diagnosis
4921556|NCT01989624|treatment|treatment
4921557|NCT01989572|locally advanced or stage IV melanoma|locally advanced or stage iv melanoma
4921558|NCT01989572|GM-CSF|gm-csf
4921559|NCT01989572|peptide vaccine|peptide vaccine
4921560|NCT01989546|DNA Damage|dna damage
4921561|NCT01989546|Advanced Solid Tumors|advanced solid tumors
4921562|NCT01989546|BRCA Mutations|brca mutations
4921563|NCT01989546|PARP Inhibitor|parp inhibitor
4921564|NCT01989546|Pharmacodynamics|pharmacodynamics
4921565|NCT01989533|HIV Vaccine|hiv vaccine
4921566|NCT01989533|Adenovirus|adenovirus
4921567|NCT01989520|Relative bioavailability, Healthy volunteers, Neutrophils|relative bioavailability, healthy volunteers, neutrophils
4921568|NCT01989507|tobacco smoking|tobacco smoking
4921569|NCT01989507|smoking cessation|smoking cessation
4921570|NCT01989507|nicotine dependence|nicotine dependence
4921571|NCT01989507|tobacco use disorder|tobacco use disorder
4921572|NCT01989494|anesthesiologists|anesthesiologists
4921573|NCT01989494|physical activity|physical activity
4921574|NCT01989494|pedometer|pedometer
4921575|NCT01989494|wellness|wellness
4921576|NCT01989494|exercise|exercise
4921577|NCT01989468|Psoriatic arthritis|psoriatic arthritis
4921578|NCT01989468|AIN457|ain457
4921580|NCT01989468|ACR|acr
4921581|NCT01989468|CASPAR|caspar
4921582|NCT01989468|PASDAS|pasdas
4921583|NCT01989468|secukinumab|secukinumab
4921584|NCT01989468|autoinjector|autoinjector
4921585|NCT01989455|Healthy|healthy
4921586|NCT01989455|Deferiprone|deferiprone
4921587|NCT01989455|DFP|dfp
4921588|NCT01989455|L1|l1
4921589|NCT01989442|cpap failure|cpap failure
4921590|NCT01989442|bronchopulmonary dysplasia|bronchopulmonary dysplasia
4921591|NCT01989442|nasal trauma|nasal trauma
4921592|NCT01989442|ventilation duration|ventilation duration
4921593|NCT01989442|non-invasive ventilation|non-invasive ventilation
4921594|NCT01989429|psoriasis|psoriasis
4921595|NCT01989429|Vitamin D3|vitamin d3
4921596|NCT01989429|topical|topical
4921597|NCT01989429|ointments|ointments
4921598|NCT01989416|colonization|colonization
4921599|NCT01989338|hallux valgus|hallux valgus
4921600|NCT01989338|pain|pain
4921601|NCT01989338|functional status|functional status
4921602|NCT01989338|quality of life|quality of life
4921603|NCT01989312|ultrasound|ultrasound
4921604|NCT01989312|peripheral nerves|peripheral nerves
4921605|NCT01989312|anesthetics|anesthetics
4921606|NCT01989312|local|local
4921607|NCT01989299|Heart failure with preserved ejection fraction (HFpEF)|heart failure with preserved ejection fraction (hfpef)
4921608|NCT01989299|ILR|ilr
4921609|NCT01989299|ventricular tachyarrhythmias|ventricular tachyarrhythmias
4921610|NCT01989299|Safety|safety
4921611|NCT01989286|Plagiocephaly|plagiocephaly
4921612|NCT01989286|Posture|posture
4921613|NCT01989286|Spine|spine
4921614|NCT01989273|Trauma|trauma
4921615|NCT01989273|Ultrasound|ultrasound
4921616|NCT01989273|Shock|shock
4921617|NCT01989273|Resuscitation|resuscitation
4921618|NCT01989260|Endometriosis|endometriosis
4921619|NCT01989247|Depression|depression
4921620|NCT01989247|Anxiety|anxiety
4921621|NCT01989247|Randomized Controlled Trial|randomized controlled trial
4921622|NCT01989247|Self Care|self care
4921623|NCT01989247|Intervention Studies|intervention studies
4921624|NCT01989247|Health Education|health education
4921625|NCT01989208|Heart Failure|heart failure
4921626|NCT01989208|Congestive Heart Failure|congestive heart failure
4921627|NCT01989208|Oxidative Stress|oxidative stress
4921628|NCT01989208|Hydrogen Sulfide|hydrogen sulfide
4921629|NCT01989195|ISCHEMIC OR CORONARY HEART DISEASE|ischemic or coronary heart disease
4921630|NCT01989195|MYOCARDIAL INFARCTION|myocardial infarction
4921631|NCT01989195|MAGNETIC RESONANCE IMAGING|magnetic resonance imaging
4921632|NCT01989195|DELAYED GADOLINIUM ENHANCEMENT MRI|delayed gadolinium enhancement mri
4921633|NCT01989195|MANGANESE-ENHANCED MRI|manganese-enhanced mri
4921634|NCT01989195|INFARCT VOLUME/SIZE|infarct volume/size
4921635|NCT01989195|ALL CAUSE MORTALITY|all cause mortality
4921636|NCT01989195|VENTRICULAR ARRHYTHMIAS|ventricular arrhythmias
4921637|NCT01989182|Endobronchial Valves|endobronchial valves
4921638|NCT01989182|Intrabronchial Valves|intrabronchial valves
4921639|NCT01989182|Bronchial Valve|bronchial valve
4921640|NCT01989182|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
4921641|NCT01989182|COPD|copd
4921642|NCT01989182|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
4921643|NCT01989182|Bronchoscopic Lung Volume Reduction|bronchoscopic lung volume reduction
4921644|NCT01989182|BLVR|blvr
4921645|NCT01989182|TLVR|tlvr
4921646|NCT01989182|Emphysema|emphysema
4921647|NCT01989182|Pulmonary Emphysema|pulmonary emphysema
4921648|NCT01989182|Pathologic Process|pathologic process
4921649|NCT01989182|Lung Diseases|lung diseases
4921650|NCT01989182|Respiratory Tract Disease|respiratory tract disease
4921651|NCT01989182|China|china
4921652|NCT01989182|Spiration Valve System (SVS)|spiration valve system (svs)
4921653|NCT01989156|Smoking|smoking
4921654|NCT01989156|Candidate modified risk tobacco product|candidate modified risk tobacco product
4921655|NCT01989156|Menthol conventional cigarettes|menthol conventional cigarettes
4921656|NCT01989156|Reduced exposure|reduced exposure
4921657|NCT01989156|HPHCs|hphcs
4921658|NCT01989156|Ambulatory|ambulatory
4921659|NCT01989143|Phase 1|phase 1
4921660|NCT01989143|Randomized|randomized
4921661|NCT01989143|Double-blind|double-blind
4921662|NCT01989143|Placebo-controlled|placebo-controlled
4921663|NCT01989143|Dose escalating|dose escalating
4921664|NCT01989143|Single and Multiple doses|single and multiple doses
4921665|NCT01989143|Safety|safety
4921666|NCT01989143|Tolerability|tolerability
4921667|NCT01989143|PK/PD|pk/pd
4921668|NCT01989143|PF-06480605|pf-06480605
4921669|NCT01989130|antimicrobial stewardship|antimicrobial stewardship
4921670|NCT01989130|Cepheid Xpert CT/NG|cepheid xpert ct/ng
4921671|NCT01989130|chlamydia|chlamydia
4921672|NCT01989130|gonorrhea|gonorrhea
4921673|NCT01989130|emergency department|emergency department
4921674|NCT01989130|Diagnostic Techniques, Obstetrical and Gynecological|diagnostic techniques, obstetrical and gynecological
4921675|NCT01989130|Diagnostic Techniques, Urological|diagnostic techniques, urological
4921676|NCT01989104|Indirect calorimetry|indirect calorimetry
4921677|NCT01989091|kidney dialysis|kidney dialysis
4921678|NCT01989091|hemodialysis|hemodialysis
4921679|NCT01989091|locking solution|locking solution
4921680|NCT01989091|antimicrobial|antimicrobial
4921681|NCT01989091|thrombolytic|thrombolytic
4921682|NCT01989078|Kidney disorder|kidney disorder
4921683|NCT01989078|Blood disorder|blood disorder
4921684|NCT01989078|Pediatrics|pediatrics
4921685|NCT01989065|Child obesity|child obesity
4921686|NCT01989065|childhood obesity|childhood obesity
4921687|NCT01989065|obesity treatment|obesity treatment
4921688|NCT01989065|text messaging|text messaging
4921689|NCT01989065|Lifestyle|lifestyle
4921690|NCT01989052|Carboxyamidotriazole Orotate|carboxyamidotriazole orotate
4921691|NCT01989052|CTO|cto
4921692|NCT01989052|Lomustine|lomustine
4921693|NCT01989052|N-(2-chloroethyl)-N'-cyclo-hexyl-N-nitrosourea (CCNU)|n-(2-chloroethyl)-n'-cyclo-hexyl-n-nitrosourea (ccnu)
4921694|NCT01989052|CeeNU|ceenu
4921695|NCT01989052|Malignant Glioma|malignant glioma
4921696|NCT01989052|Pro00047969|pro00047969
4921697|NCT01989052|Desjardins|desjardins
4921698|NCT01989052|Duke|duke
4921699|NCT01989052|The Preston Robert Tisch Brain Tumor Center|the preston robert tisch brain tumor center
4921700|NCT01989026|BCG|bcg
4921701|NCT01989026|non-specific effects|non-specific effects
4921702|NCT01989026|neonatal mortality|neonatal mortality
4921703|NCT01989026|vaccines|vaccines
4921704|NCT01989013|Parkinson's disease|parkinson's disease
4921705|NCT01989013|Craniosacral therapy|craniosacral therapy
4921706|NCT01989013|cranial osteopathy|cranial osteopathy
4921707|NCT01989000|Pancreatic cancer|pancreatic cancer
4921708|NCT01989000|Hypoxia|hypoxia
4921709|NCT01989000|Vasculature|vasculature
4921710|NCT01989000|Stroma|stroma
4921711|NCT01988987|Gestational diabetes|gestational diabetes
4921712|NCT01988987|Postpartum glucose testing|postpartum glucose testing
4921713|NCT01988987|Impaired glucose metabolism|impaired glucose metabolism
4921714|NCT01988987|Diabetes mellitus|diabetes mellitus
4921715|NCT01988961|Colitis, Ulcerative|colitis, ulcerative
4921716|NCT01988961|Golimumab|golimumab
4921717|NCT01988961|CNTO148|cnto148
4921718|NCT01988961|SIMPONI|simponi
4921719|NCT01988961|Length-109 Probe Set Panel|length-109 probe set panel
4921720|NCT01988948|Human papilloma virus|human papilloma virus
4921721|NCT01988948|Young women|young women
4921722|NCT01988948|I-Share|i-share
4921723|NCT01988922|ketamine polymorphisms|ketamine polymorphisms
4921724|NCT01988909|Cutaneous leishmaniasis|cutaneous leishmaniasis
4921725|NCT01988909|Paromomycin + Gentamicin Topical Cream|paromomycin + gentamicin topical cream
4921726|NCT01988909|Safety|safety
4921727|NCT01988909|Efficacy|efficacy
4921728|NCT01988883|Postural Tachycardia Syndrome|postural tachycardia syndrome
4921729|NCT01988883|Tachycardia|tachycardia
4921730|NCT01988883|Orthostatic Intolerance|orthostatic intolerance
4921731|NCT01988883|Autonomic Nervous System Diseases|autonomic nervous system diseases
4921732|NCT01988883|Primary Dysautonomias|primary dysautonomias
4921733|NCT01988883|Nervous System Diseases|nervous system diseases
4921734|NCT01988883|Cardiovascular Diseases|cardiovascular diseases
4921735|NCT01988883|Modafinil|modafinil
4921736|NCT01988883|Propranolol|propranolol
4921737|NCT01988883|Neurobehavioral Manifestations|neurobehavioral manifestations
4921738|NCT01988883|Neurologic Manifestations|neurologic manifestations
4921739|NCT01988883|Cognitive Symptoms|cognitive symptoms
4921740|NCT01988883|Neuropsychological Tests|neuropsychological tests
4921741|NCT01988857|Vietnam|vietnam
4921742|NCT01988857|Children|children
4921743|NCT01988857|Reactogenicity|reactogenicity
4921744|NCT01988857|BoostrixTM|boostrixtm
4921745|NCT01988857|Safety|safety
4921746|NCT01988857|dTpa|dtpa
4921747|NCT01988857|Booster|booster
4921748|NCT01988857|Healthy|healthy
4921749|NCT01988844|functionality|functionality
4921750|NCT01988844|Cerebral palsy|cerebral palsy
4921751|NCT01988844|Handwriting|handwriting
4921752|NCT01988831|Malignant melanoma|malignant melanoma
4921753|NCT01988831|betablocker|betablocker
4921754|NCT01988831|propranolol|propranolol
4921755|NCT01988831|interventional|interventional
4921756|NCT01988831|prospective|prospective
4921757|NCT01988831|adjuvant|adjuvant
4921758|NCT01988831|recurrence|recurrence
4921759|NCT01988818|wound dressing|wound dressing
4921760|NCT01988818|silicone|silicone
4921761|NCT01988818|standard wound dressing|standard wound dressing
4921762|NCT01988766|Thrombosis|thrombosis
4921763|NCT01988766|Central Venosis Catheter|central venosis catheter
4921764|NCT01988766|Renal Disease|renal disease
4921765|NCT01988766|Vascular Access|vascular access
4921766|NCT01988753|Serum Biomarkers|serum biomarkers
4921767|NCT01988753|Sheer-wave Elastography|sheer-wave elastography
4921768|NCT01988753|Ultrasound imaging|ultrasound imaging
4921769|NCT01988753|Viral hepatitis|viral hepatitis
4921770|NCT01988753|Liver Fibrosis|liver fibrosis
4921771|NCT01988753|Liver disease|liver disease
4921772|NCT01988753|Hepatitis B|hepatitis b
4921773|NCT01988753|Hepatitis C|hepatitis c
4921774|NCT01988740|Ischemia-modified albumin|ischemia-modified albumin
4921775|NCT01988740|Recurrent pregnancy loss|recurrent pregnancy loss
4921776|NCT01988740|Abnormal placenta|abnormal placenta
4921777|NCT01988714|Targeted cognitive training (TCT) plus evidence-based SE|targeted cognitive training (tct) plus evidence-based se
4921778|NCT01988714|Computer games (CG) plus evidence-based SE|computer games (cg) plus evidence-based se
4921779|NCT01988701|GVHD|gvhd
4921780|NCT01988701|chronic Graft versus Host Disease|chronic graft versus host disease
4921781|NCT01988688|deep brain stimulation|deep brain stimulation
4921782|NCT01988662|nAMD, VEGF, VEGF agent, BCVA, CRT, Ranibizumab, Lucentis, Aflibercept, Eylea|namd, vegf, vegf agent, bcva, crt, ranibizumab, lucentis, aflibercept, eylea
4921783|NCT01988649|Pain|pain
4921784|NCT01988649|Oxytocin|oxytocin
4921785|NCT01988636|Randomized|randomized
4921786|NCT01988636|Double Blinded|double blinded
4921787|NCT01988636|Mali|mali
4921788|NCT01988636|Malaria|malaria
4921789|NCT01988636|Transmission|transmission
4921790|NCT01988623|Intellectual Disabilities|intellectual disabilities
4921791|NCT01988623|Speech Delay|speech delay
4921792|NCT01988623|Language Disorder|language disorder
4921793|NCT01988610|cognition|cognition
4921794|NCT01988610|prediabetes|prediabetes
4921795|NCT01988610|mood|mood
4921796|NCT01988597|Dry Eyes|dry eyes
4921797|NCT01988597|Quality of life|quality of life
4921798|NCT01988597|Utility assessment|utility assessment
4921799|NCT01988584|Cerebral Palsy|cerebral palsy
4921800|NCT01988584|Brain Injury|brain injury
4921801|NCT01988584|Stem Cells|stem cells
4921802|NCT01988584|Mononuclear Cells|mononuclear cells
4921803|NCT01988584|Bone Morrow|bone morrow
4921804|NCT01988584|Umbilical Cord Blood|umbilical cord blood
4921805|NCT01988571|Stage I breast cancer|stage i breast cancer
4921806|NCT01988571|Stage II breast cancer|stage ii breast cancer
4921807|NCT01988571|Stage III breast cancer|stage iii breast cancer
4921808|NCT01988558|Recurrent Tonsillitis|recurrent tonsillitis
4921809|NCT01988558|Streptococcus A|streptococcus a
4921810|NCT01988545|GLP-1|glp-1
4921811|NCT01988545|blood flow|blood flow
4921812|NCT01988545|cardiac out put|cardiac out put
4921813|NCT01988545|stroke volume|stroke volume
4921814|NCT01988545|beat to beat|beat to beat
4921815|NCT01988545|effect of GLP-1 on cardiac parameters and blood flow|effect of glp-1 on cardiac parameters and blood flow
4921816|NCT01988506|IL2,|il2,
4921817|NCT01988506|Interleukin 2,|interleukin 2,
4921818|NCT01988506|ILT101|ilt101
4921819|NCT01988506|Proleukin®, RhIL-2|proleukin®, rhil-2
4921820|NCT01988506|Auto-immune disease|auto-immune disease
4921821|NCT01988506|Inflammatory disease|inflammatory disease
4921822|NCT01988506|Inflammation|inflammation
4921823|NCT01988506|Regulatory T cells,|regulatory t cells,
4921824|NCT01988506|Treg|treg
4921825|NCT01988506|Immunoregulation|immunoregulation
4921826|NCT01988506|Immune tolerance|immune tolerance
4921827|NCT01988493|Carcinoma, Hepatocellular|carcinoma, hepatocellular
4921828|NCT01988493|MSC2156119J|msc2156119j
4921829|NCT01988493|Sorafenib|sorafenib
4921830|NCT01988493|Recommended Phase 2 dose|recommended phase 2 dose
4921831|NCT01988480|Guided surgery|guided surgery
4921832|NCT01988480|Sinus graft|sinus graft
4921833|NCT01988467|nasal breathing, oral breathing, secondhand smoking,|nasal breathing, oral breathing, secondhand smoking,
4921834|NCT01988441|autophagy|autophagy
4921835|NCT01988441|children|children
4921836|NCT01988441|polymorphism|polymorphism
4921837|NCT01988428|sepsis|sepsis
4921838|NCT01988428|severe sepsis|severe sepsis
4921839|NCT01988428|septic shock|septic shock
4921840|NCT01988402|gout|gout
4921841|NCT01988402|allopurinol|allopurinol
4921842|NCT01988363|greater occipital nerve|greater occipital nerve
4921843|NCT01988363|occipital neuralgia|occipital neuralgia
4921844|NCT01988363|cervicogenic headache|cervicogenic headache
4921845|NCT01988350|pancreatic insufficiency|pancreatic insufficiency
4921846|NCT01988350|pancreatic elastase|pancreatic elastase
4921847|NCT01988350|fecal elastase|fecal elastase
4921848|NCT01988350|smoking|smoking
4921849|NCT01988350|tobacco|tobacco
4921850|NCT01988311|Psilocybin|psilocybin
4921851|NCT01988311|Hallucinogens|hallucinogens
4921852|NCT01988311|Pharmacologic Actions|pharmacologic actions
4921853|NCT01988311|Central Nervous System Agents|central nervous system agents
4921854|NCT01988311|Therapeutic Uses|therapeutic uses
4921855|NCT01988311|Psychotropic Drugs|psychotropic drugs
4921856|NCT01988285|Esophagitis|esophagitis
4921857|NCT01988285|Eosinophilic Esophagitis|eosinophilic esophagitis
4921858|NCT01988285|Esophageal Diseases|esophageal diseases
4921859|NCT01988285|Gastrointestinal Diseases|gastrointestinal diseases
4921860|NCT01988285|Digestive System Diseases|digestive system diseases
4921861|NCT01988272|SPECT/CT|spect/ct
4921862|NCT01988272|Dosimetry|dosimetry
4921863|NCT01988272|Radiation absorbed dose|radiation absorbed dose
4921864|NCT01988272|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
4921865|NCT01988272|I-131 tositumomab radioimmunotherapy|i-131 tositumomab radioimmunotherapy
4921866|NCT01988246|Diabetes|diabetes
4921867|NCT01988246|Diabetic Retinopathy|diabetic retinopathy
4921868|NCT01988233|Physical activity|physical activity
4921869|NCT01988233|Dance|dance
4921870|NCT01988233|Latinos|latinos
4921871|NCT01988233|Aging|aging
4921872|NCT01988233|Older adults|older adults
4921873|NCT01988233|Health disparities|health disparities
4921874|NCT01988220|stroke|stroke
4921875|NCT01988220|sensory deficit|sensory deficit
4921876|NCT01988220|sensory retraining|sensory retraining
4921877|NCT01988220|perceptual learning|perceptual learning
4921878|NCT01988220|lower extremity|lower extremity
4921879|NCT01988207|Muscle Tension Dysphonia|muscle tension dysphonia
4921880|NCT01988207|Voice|voice
4921881|NCT01988207|Hyperfunction|hyperfunction
4921882|NCT01988194|acupuncture|acupuncture
4921883|NCT01988194|postoperative pain|postoperative pain
4921884|NCT01988194|nausea|nausea
4921885|NCT01988194|vomiting|vomiting
4921886|NCT01988194|anxiety|anxiety
4921887|NCT01988194|depression|depression
4921888|NCT01988194|hospitalization|hospitalization
4921889|NCT01988194|inpatient|inpatient
4921890|NCT01988181|Intradialytic Hypotension|intradialytic hypotension
4921891|NCT01988181|Renal Dialysis|renal dialysis
4921892|NCT01988181|Blood Volume Determination|blood volume determination
4921893|NCT01988181|Clinical Trials, Randomized|clinical trials, randomized
4921894|NCT01988181|Crossover Studies|crossover studies
4921895|NCT01988168|Suture Techniques|suture techniques
4921896|NCT01988168|Sutures|sutures
4921897|NCT01988168|Surgical Staplers|surgical staplers
4921898|NCT01988142|Spinal Cord Injury|spinal cord injury
4921899|NCT01988142|Passive motion|passive motion
4921900|NCT01988142|Fatigue index|fatigue index
4921901|NCT01988142|Hypertonia|hypertonia
4921902|NCT01988129|sleep|sleep
4921903|NCT01988129|firefighter|firefighter
4921904|NCT01988129|fire|fire
4921905|NCT01988129|apnea|apnea
4921906|NCT01988129|insomnia|insomnia
4921907|NCT01988129|shift|shift
4921908|NCT01988129|narcolepsy|narcolepsy
4921909|NCT01988129|restless leg|restless leg
4921910|NCT01988129|rls|rls
4921911|NCT01988129|fatigue|fatigue
4921912|NCT01988129|actigraph|actigraph
4921913|NCT01988129|actigraphy|actigraphy
4921914|NCT01988129|actiwatch|actiwatch
4921915|NCT01988129|safety|safety
4921916|NCT01988129|sleepiness|sleepiness
4921917|NCT01988129|sleepy|sleepy
4921918|NCT01988129|work|work
4921919|NCT01988129|hours|hours
4921920|NCT01988129|Federal Emergency Management Agency|federal emergency management agency
4921921|NCT01988129|drowsy|drowsy
4921922|NCT01988116|Chronic kidney disease|chronic kidney disease
4921923|NCT01988116|Anemia of chronic disease|anemia of chronic disease
4921924|NCT01988116|Iron Metabolism|iron metabolism
4921925|NCT01988116|Iron Homeostasis|iron homeostasis
4921926|NCT01988116|Vitamin D|vitamin d
4921927|NCT01988116|Calcitriol|calcitriol
4921928|NCT01988116|hemojuvelin|hemojuvelin
4921929|NCT01988116|hepcidin|hepcidin
4921930|NCT01988116|anemia|anemia
4921931|NCT01988116|ferroportin|ferroportin
4921932|NCT01988103|Psoriasis; Psoriatic Arthritis|psoriasis; psoriatic arthritis
4921933|NCT01988090|Breast Cancer|breast cancer
4921934|NCT01988090|Hormone Receptor Positive|hormone receptor positive
4921935|NCT01988090|Vitamin D|vitamin d
4921936|NCT01988064|pulse rate|pulse rate
4921937|NCT01988064|patient education|patient education
4921938|NCT01988064|training|training
4921939|NCT01988038|Polycystic Kidney Disease|polycystic kidney disease
4921940|NCT01988038|Autosomal Dominant Polycystic Kidney Disease|autosomal dominant polycystic kidney disease
4921941|NCT01988038|Disease Progression|disease progression
4921942|NCT01987986|cellulite|cellulite
4921943|NCT01987986|dimple|dimple
4921944|NCT01987986|orange peel|orange peel
4921945|NCT01987986|cottage cheese|cottage cheese
4921946|NCT01987986|mattress texture|mattress texture
4921947|NCT01987947|MEMP1972A|memp1972a
4921948|NCT01987934|Squamous Cell Carcinoma of the Head and Neck|squamous cell carcinoma of the head and neck
4921949|NCT01987934|Methyl Green Pyronin Staining|methyl green pyronin staining
4921950|NCT01987934|AgNORs|agnors
4921951|NCT01987934|Morphometry|morphometry
4921952|NCT01987921|Acute kidney injury|acute kidney injury
4921953|NCT01987921|Pediatrics|pediatrics
4921954|NCT01987921|Critical Care|critical care
4921955|NCT01987908|Pain|pain
4921956|NCT01987908|Biomarkers|biomarkers
4921957|NCT01987908|6 minute walk test|6 minute walk test
4921958|NCT01987908|5-HMF|5-hmf
4921959|NCT01987908|Pharmacokinetics|pharmacokinetics
4921960|NCT01987908|Analgesic use|analgesic use
4921961|NCT01987908|Sickle cell disease|sickle cell disease
4921962|NCT01987908|Aes-103|aes-103
4921963|NCT01987908|SpO2|spo2
4921964|NCT01987908|Anemia|anemia
4921965|NCT01987908|Hemoglobin|hemoglobin
4921966|NCT01987895|Post-antibiotic diarrhea|post-antibiotic diarrhea
4921967|NCT01987895|Clostridium difficile infection|clostridium difficile infection
4921968|NCT01987882|Outcomes research, treatment effectiveness, quality of life|outcomes research, treatment effectiveness, quality of life
4921969|NCT01987869|hiperemesis gravidarum,vomiting,serotonin levels,ketonuria|hiperemesis gravidarum,vomiting,serotonin levels,ketonuria
4921970|NCT01987856|aCGH|acgh
4921971|NCT01987856|chromosome|chromosome
4921972|NCT01987856|blastocyst|blastocyst
4921973|NCT01987856|trophectoderm|trophectoderm
4921974|NCT01987856|vitrification|vitrification
4921975|NCT01987856|natural cycle|natural cycle
4921976|NCT01987856|pregnancy|pregnancy
4921977|NCT01987856|live birth|live birth
4921978|NCT01987843|Psoriasis|psoriasis
4921979|NCT01987843|Plaque Psoriasis|plaque psoriasis
4921980|NCT01987830|Recurrent glioblastoma|recurrent glioblastoma
4921981|NCT01987817|Characterized Peanut Allergen|characterized peanut allergen
4921982|NCT01987817|Peanut|peanut
4921983|NCT01987817|OIT|oit
4921984|NCT01987817|Oral Desensitization|oral desensitization
4921985|NCT01987817|Peanut Allergen|peanut allergen
4921986|NCT01987817|Allergy|allergy
4921987|NCT01987817|Peanut Allergy|peanut allergy
4921988|NCT01987817|Peanut-Allergic Children|peanut-allergic children
4921989|NCT01987817|Children|children
4921990|NCT01987817|Peanut-Allergic Adults|peanut-allergic adults
4921991|NCT01987778|Hot flashes|hot flashes
4921992|NCT01987778|Menopause|menopause
4921993|NCT01987778|HRQoL|hrqol
4921994|NCT01987778|Resistance training|resistance training
4921995|NCT01987778|Physical activity|physical activity
4921996|NCT01987778|Adipose tissue|adipose tissue
4921997|NCT01987739|Almorexant|almorexant
4921998|NCT01987739|Zolpidem|zolpidem
4921999|NCT01987726|Solid Tumor Malignancies|solid tumor malignancies
4922000|NCT01987700|Abdominal Hernia Repair|abdominal hernia repair
4922001|NCT01987700|Dermal Allograft|dermal allograft
4922002|NCT01987700|Mesh|mesh
4922003|NCT01987700|Component Separation|component separation
4922004|NCT01987661|COPD|copd
4922005|NCT01987661|NIV|niv
4922006|NCT01987661|Airtrapping|airtrapping
4922007|NCT01987661|Ventimotion2|ventimotion2
4922008|NCT01987648|Craniotomy|craniotomy
4922009|NCT01987648|Postoperative complications|postoperative complications
4922010|NCT01987648|Perioperative care|perioperative care
4922011|NCT01987648|Postoperative intracerebral hemorrhage|postoperative intracerebral hemorrhage
4922012|NCT01987648|Postoperative seizure|postoperative seizure
4922013|NCT01987635|Mitral valve disease|mitral valve disease
4922014|NCT01987635|primarily regurgitation|primarily regurgitation
4922015|NCT01987635|necessitating surgical repair|necessitating surgical repair
4922016|NCT01987622|lumbar spinal stenosis|lumbar spinal stenosis
4922017|NCT01987622|claudication|claudication
4922018|NCT01987622|low back pain|low back pain
4922019|NCT01987622|radiculopathy|radiculopathy
4922020|NCT01987622|acupuncture|acupuncture
4922021|NCT01987622|Korean medicine|korean medicine
4922022|NCT01987622|randomized controlled trial|randomized controlled trial
4922023|NCT01987609|Psoriasis|psoriasis
4922024|NCT01987609|Dendritic cells|dendritic cells
4922025|NCT01987609|Hyaluronidase|hyaluronidase
4922026|NCT01987609|Hylenex|hylenex
4922027|NCT01987570|Xanthine oxidase|xanthine oxidase
4922028|NCT01987570|Magnetic resonance|magnetic resonance
4922029|NCT01987570|Oxidative stress|oxidative stress
4922030|NCT01987570|Inflammation|inflammation
4922031|NCT01987557|treadmill|treadmill
4922032|NCT01987557|parkinson's|parkinson's
4922033|NCT01987557|proprioception|proprioception
4922034|NCT01987557|cadence|cadence
4922035|NCT01987557|step length|step length
4922036|NCT01987557|intrinsic feedback|intrinsic feedback
4922037|NCT01987544|COPD|copd
4922038|NCT01987544|telemonitoring|telemonitoring
4922039|NCT01987544|training|training
4922040|NCT01987544|ergometer|ergometer
4922041|NCT01987544|telemedicine|telemedicine
4922042|NCT01987531|after open cardiac chamber cardiac surgery|after open cardiac chamber cardiac surgery
4922043|NCT01987466|Neutrophil Gelatinase-associated Lipocalin(NGAL)|neutrophil gelatinase-associated lipocalin(ngal)
4922044|NCT01987466|Acute renal failure|acute renal failure
4922045|NCT01987466|Cardiac arrest|cardiac arrest
4922046|NCT01987466|Hypothermia|hypothermia
4922047|NCT01987453|genotype 1|genotype 1
4922048|NCT01987427|Overweight|overweight
4922049|NCT01987427|Obese|obese
4922050|NCT01987427|Weight Management|weight management
4922051|NCT01987414|Stroke|stroke
4922052|NCT01987414|Cardiovascular Accident|cardiovascular accident
4922053|NCT01987414|Task-oriented approach|task-oriented approach
4922054|NCT01987414|Orthosis|orthosis
4922055|NCT01987414|occupational therapy|occupational therapy
4922056|NCT01987401|pulmonary|pulmonary
4922057|NCT01987401|lung|lung
4922058|NCT01987401|military and environmental exposures|military and environmental exposures
4922059|NCT01987401|epidemiologic|epidemiologic
4922060|NCT01987401|observational|observational
4922061|NCT01987401|interview or questionnaire|interview or questionnaire
4922062|NCT01987401|deployment related|deployment related
4922063|NCT01987401|Enduring Freedom|enduring freedom
4922064|NCT01987401|Iraqi Freedom|iraqi freedom
4922065|NCT01987375|HNSCC|hnscc
4922066|NCT01987375|Imaging|imaging
4922067|NCT01987349|Influenza vaccines|influenza vaccines
4922068|NCT01987349|healthy participants|healthy participants
4922069|NCT01987349|immunity to influenza|immunity to influenza
4922070|NCT01987349|identical twins|identical twins
4922071|NCT01987349|fraternal twins|fraternal twins
4922072|NCT01987349|non-twins|non-twins
4922073|NCT01987336|Standard Foley Catheter|standard foley catheter
4922074|NCT01987323|glaucoma|glaucoma
4922075|NCT01987323|raised intraocular pressure|raised intraocular pressure
4922076|NCT01987310|non alcoholic fatty liver disease|non alcoholic fatty liver disease
4922077|NCT01987310|endothelial function|endothelial function
4922078|NCT01987310|liver steatosis|liver steatosis
4922079|NCT01987310|liver fibrosis|liver fibrosis
4922080|NCT01987310|statin treatment|statin treatment
4922081|NCT01987297|arsenic|arsenic
4922082|NCT01987297|acute promyelocytic leukemia|acute promyelocytic leukemia
4922083|NCT01987297|outcome|outcome
4922084|NCT01987271|exercise tolerance|exercise tolerance
4922085|NCT01987271|exercise test|exercise test
4922086|NCT01987271|noninvasive ventilation|noninvasive ventilation
4922087|NCT01987258|Glycemic control|glycemic control
4922088|NCT01987258|excess post-exercise oxygen consumption|excess post-exercise oxygen consumption
4922089|NCT01987219|familial dysautonomia|familial dysautonomia
4922090|NCT01987206|artificial pancreas|artificial pancreas
4922091|NCT01987193|Proton radiation|proton radiation
4922092|NCT01987193|tumor blood flow|tumor blood flow
4922093|NCT01987180|self-efficacy|self-efficacy
4922094|NCT01987167|acute optic neuritis|acute optic neuritis
4922095|NCT01987115|Trigger Finger|trigger finger
4922096|NCT01987115|Physiotherapy|physiotherapy
4922097|NCT01987115|Fascial Manipulation|fascial manipulation
4922098|NCT01987102|Methotrexate|methotrexate
4922099|NCT01987102|rescue treatment|rescue treatment
4922100|NCT01987089|Insomnia|insomnia
4922101|NCT01987089|Sleep initiation and maintenance disorder|sleep initiation and maintenance disorder
4922102|NCT01987089|Alcoholism|alcoholism
4922103|NCT01987089|Cognitive behavioral therapy for insomnia|cognitive behavioral therapy for insomnia
4922104|NCT01987076|DRESS|dress
4922105|NCT01987076|Systemic steroid|systemic steroid
4922106|NCT01987076|Topical steroid|topical steroid
4922107|NCT01987076|Treatment|treatment
4922108|NCT01987063|Twin delivery|twin delivery
4922109|NCT01987063|Planned vaginal delivery|planned vaginal delivery
4922110|NCT01987063|Planned cesarean delivery|planned cesarean delivery
4922111|NCT01987063|Total breech extraction|total breech extraction
4922112|NCT01987063|Internal cephalic version|internal cephalic version
4922113|NCT01987063|External cephalic version|external cephalic version
4922114|NCT01987037|autism spectrum disorder|autism spectrum disorder
4922115|NCT01987037|neuropsychomotor assessment|neuropsychomotor assessment
4922116|NCT01987037|NP-MOT|np-mot
4922117|NCT01987037|motor skills|motor skills
4922118|NCT01987037|gross motor|gross motor
4922119|NCT01987011|Avian influenza|avian influenza
4922120|NCT01986998|Multiple sclerosis relapse|multiple sclerosis relapse
4922121|NCT01986998|oral methylprednisolone|oral methylprednisolone
4922122|NCT01986998|EDSS|edss
4922123|NCT01986998|gadolinium|gadolinium
4922124|NCT01986972|Toothbrushing|toothbrushing
4922125|NCT01986972|Dental plaque|dental plaque
4922126|NCT01986972|Dentifrice|dentifrice
4922127|NCT01986972|Oral hygiene|oral hygiene
4922128|NCT01986959|Periodontal Dressings|periodontal dressings
4922129|NCT01986959|Surgical crown lengthening|surgical crown lengthening
4922130|NCT01986959|Periodontal surgery|periodontal surgery
4922131|NCT01986920|SK|sk
4922132|NCT01986907|wet AMD|wet amd
4922133|NCT01986907|macular degeneration|macular degeneration
4922134|NCT01986907|ranibizumab|ranibizumab
4922135|NCT01986907|mono-bilateral|mono-bilateral
4922136|NCT01986907|poor visual acuity|poor visual acuity
4922137|NCT01986907|retinal disease|retinal disease
4922138|NCT01986907|eye disease|eye disease
4922139|NCT01986907|Angiogenesis Inhibitors|angiogenesis inhibitors
4922140|NCT01986907|Angiogenesis Modulating Agents|angiogenesis modulating agents
4922141|NCT01986894|TQT|tqt
4922142|NCT01986894|Pharmacokinetic|pharmacokinetic
4922143|NCT01986894|Healthy|healthy
4922144|NCT01986868|Coronary Magnetic Resonance Angiography|coronary magnetic resonance angiography
4922145|NCT01986868|CMRA|cmra
4922146|NCT01986868|MRI with contrast|mri with contrast
4922147|NCT01986868|MultiHance|multihance
4922148|NCT01986868|Optimark|optimark
4922149|NCT01986868|Gadolinium-based contrast|gadolinium-based contrast
4922150|NCT01986868|MRA|mra
4922151|NCT01986868|MR angiography|mr angiography
4922152|NCT01986842|Muscle protein synthesis|muscle protein synthesis
4922153|NCT01986842|Digestion and absorption kinetics|digestion and absorption kinetics
4922154|NCT01986842|Leucine|leucine
4922155|NCT01986842|Whey protein|whey protein
4922156|NCT01986816|Obesity|obesity
4922157|NCT01986816|Bariatric surgery|bariatric surgery
4922158|NCT01986816|Laparoscopic gastric bypass|laparoscopic gastric bypass
4922159|NCT01986816|Quality of life|quality of life
4922160|NCT01986816|QALY|qaly
4922161|NCT01986803|ST-elevation Myocardial Infarction (STEMI)|st-elevation myocardial infarction (stemi)
4922162|NCT01986803|Primary Percutaneous Coronary Intervention within 24 hrs|primary percutaneous coronary intervention within 24 hrs
4922163|NCT01986803|Healing score|healing score
4922164|NCT01986803|OFDI|ofdi
4922165|NCT01986790|Health insurance|health insurance
4922166|NCT01986790|Health services accessibility|health services accessibility
4922167|NCT01986790|Decision making|decision making
4922168|NCT01986790|Health literacy|health literacy
4922169|NCT01986777|cognitive complains|cognitive complains
4922170|NCT01986777|RRSO|rrso
4922171|NCT01986777|oophorectomy|oophorectomy
4922172|NCT01986777|memory|memory
4922173|NCT01986777|cognition|cognition
4922174|NCT01986777|early menopause|early menopause
4922175|NCT01986764|oophorectomy|oophorectomy
4922176|NCT01986764|RRSO|rrso
4922177|NCT01986764|menopause|menopause
4922178|NCT01986764|early menopause|early menopause
4922179|NCT01986764|cognition|cognition
4922180|NCT01986764|memory|memory
4922181|NCT01986764|brain-imaging|brain-imaging
4922182|NCT01986751|nerve|nerve
4922183|NCT01986751|block|block
4922184|NCT01986751|motor blockade|motor blockade
4922185|NCT01986751|lower extremity pain|lower extremity pain
4922186|NCT01986751|nerve block|nerve block
4922187|NCT01986725|vulvar neoplasia|vulvar neoplasia
4922188|NCT01986725|vulvar cancer|vulvar cancer
4922289|NCT01986335|Infants|infants
4922189|NCT01986725|vulvar intraepithelial neoplasia|vulvar intraepithelial neoplasia
4922190|NCT01986725|self management|self management
4922191|NCT01986725|symptom management|symptom management
4922192|NCT01986712|Melanoma, Stage III, adjuvant, Quality of Life|melanoma, stage iii, adjuvant, quality of life
4922193|NCT01986699|polypectomy|polypectomy
4922194|NCT01986699|laparoscopic|laparoscopic
4922195|NCT01986673|Pharmacokinetic Characterization|pharmacokinetic characterization
4922196|NCT01986660|Pharmacokinetic Study|pharmacokinetic study
4922197|NCT01986647|exercise|exercise
4922198|NCT01986647|older adults|older adults
4922199|NCT01986647|mobility disability|mobility disability
4922200|NCT01986634|Laser Resurfacing|laser resurfacing
4922201|NCT01986634|Rhytids|rhytids
4922202|NCT01986634|Perioral|perioral
4922203|NCT01986621|Percutaneous Coronary Intervention|percutaneous coronary intervention
4922204|NCT01986621|Cardiac troponin|cardiac troponin
4922205|NCT01986621|Antiplatelet therapy|antiplatelet therapy
4922206|NCT01986608|Lacosamide|lacosamide
4922207|NCT01986608|Vimpat|vimpat
4922208|NCT01986608|Bioequivalence|bioequivalence
4922209|NCT01986608|Bioavailability|bioavailability
4922210|NCT01986608|Japanese|japanese
4922211|NCT01986595|Neuroblastoma|neuroblastoma
4922212|NCT01986595|anaplastic lymphoma kinase|anaplastic lymphoma kinase
4922213|NCT01986595|cancer genetics|cancer genetics
4922214|NCT01986595|target therapy|target therapy
4922215|NCT01986595|RNA and genomic DNA extraction|rna and genomic dna extraction
4922216|NCT01986595|complementary DNA(cDNA) preparation|complementary dna(cdna) preparation
4922217|NCT01986595|Array-comparative genomic hybridization|array-comparative genomic hybridization
4922218|NCT01986595|Multiplex ligation-dependent probe amplification (MLPA)|multiplex ligation-dependent probe amplification (mlpa)
4922219|NCT01986595|Sequencing of cDNA prepared from NB|sequencing of cdna prepared from nb
4922220|NCT01986595|Pyrosequencing|pyrosequencing
4922221|NCT01986595|Quantitative real-time polymerase chain reaction(RT-PCR)|quantitative real-time polymerase chain reaction(rt-pcr)
4922222|NCT01986595|Immunohistochemistry|immunohistochemistry
4922223|NCT01986582|Allergic Rhinitis|allergic rhinitis
4922224|NCT01986582|Congestion|congestion
4922225|NCT01986582|Mucoadhesive Treatment|mucoadhesive treatment
4922226|NCT01986582|Nasal Decongestant|nasal decongestant
4922227|NCT01986569|Fluoroestradiol (FES)|fluoroestradiol (fes)
4922228|NCT01986569|PET/CT scan|pet/ct scan
4922229|NCT01986569|Estrogen Receptor|estrogen receptor
4922230|NCT01986569|Recurrent breast cancer|recurrent breast cancer
4922231|NCT01986569|Stage IV breast cancer|stage iv breast cancer
4922232|NCT01986543|Pharmacokinetic|pharmacokinetic
4922233|NCT01986530|irisin|irisin
4922234|NCT01986530|adiponectin|adiponectin
4922235|NCT01986530|leptin|leptin
4922236|NCT01986530|lean body mass|lean body mass
4922237|NCT01986530|fat mass|fat mass
4922238|NCT01986517|Feedback|feedback
4922239|NCT01986517|Therapeutic competencies|therapeutic competencies
4922240|NCT01986517|Training|training
4922241|NCT01986504|Infection|infection
4922242|NCT01986504|Cohort|cohort
4922243|NCT01986504|Prospective|prospective
4922244|NCT01986504|Epidemiology|epidemiology
4922245|NCT01986504|Outcome|outcome
4922246|NCT01986491|Healthy|healthy
4922247|NCT01986491|JNJ-39393406|jnj-39393406
4922248|NCT01986491|Relative Bioavailability|relative bioavailability
4922249|NCT01986491|Solid Formulation|solid formulation
4922250|NCT01986465|lateral epicondylitis|lateral epicondylitis
4922251|NCT01986465|treatment|treatment
4922252|NCT01986465|steroid|steroid
4922253|NCT01986465|immobilization|immobilization
4922254|NCT01986452|OSA|osa
4922255|NCT01986452|Apoplexy|apoplexy
4922256|NCT01986452|CPAP|cpap
4922257|NCT01986452|adherence|adherence
4922258|NCT01986452|telemonitoring|telemonitoring
4922259|NCT01986426|Transdermal accessible tumours|transdermal accessible tumours
4922260|NCT01986413|COPD|copd
4922261|NCT01986413|chronic hypercapnic respiratory failure|chronic hypercapnic respiratory failure
4922262|NCT01986413|NIV|niv
4922263|NCT01986413|respiratory events|respiratory events
4922264|NCT01986413|IVAPS|ivaps
4922265|NCT01986400|Adolescent|adolescent
4922266|NCT01986400|Skype|skype
4922267|NCT01986400|Peer Mentorship|peer mentorship
4922268|NCT01986400|Internet Self-Management|internet self-management
4922269|NCT01986387|adolescent|adolescent
4922270|NCT01986387|Skype|skype
4922271|NCT01986387|peer mentorship|peer mentorship
4922272|NCT01986387|internet self-management|internet self-management
4922273|NCT01986374|IVF , embryo implantation, HCG|ivf , embryo implantation, hcg
4922274|NCT01986361|Pharyngitis|pharyngitis
4922275|NCT01986361|Sore Throat|sore throat
4922276|NCT01986361|acute upper respiratory tract infection (URTI)|acute upper respiratory tract infection (urti)
4922278|NCT01986348|Glioblastoma|glioblastoma
4922279|NCT01986348|selinexor|selinexor
4922280|NCT01986348|KPT-330|kpt-330
4922281|NCT01986348|Karyopharm|karyopharm
4922282|NCT01986348|brain tumor|brain tumor
4922283|NCT01986348|brain cancer|brain cancer
4922284|NCT01986348|Glioma|glioma
4922285|NCT01986348|Astrocytoma|astrocytoma
4922286|NCT01986348|Oligodendrogliomas|oligodendrogliomas
4922287|NCT01986348|Oligo-astrocytomas|oligo-astrocytomas
4922288|NCT01986335|Combined pentavalent DTP/HB/Hib vaccine|combined pentavalent dtp/hb/hib vaccine
4922290|NCT01986335|Primary vaccination|primary vaccination
4922291|NCT01986322|DTP/HB/Hib vaccine|dtp/hb/hib vaccine
4922292|NCT01986322|Immunogenicity|immunogenicity
4922293|NCT01986322|Infants|infants
4922294|NCT01986322|Safety|safety
4922295|NCT01986309|Postoperative|postoperative
4922296|NCT01986309|Nausea|nausea
4922297|NCT01986309|Vomiting|vomiting
4922298|NCT01986309|Pain|pain
4922299|NCT01986309|Surgery|surgery
4922300|NCT01986283|Abuse potential|abuse potential
4922301|NCT01986283|PF-00345439|pf-00345439
4922302|NCT01986283|drug abuse|drug abuse
4922303|NCT01986244|Osteoarthritis|osteoarthritis
4922304|NCT01986244|Arthritis|arthritis
4922305|NCT01986244|Joint Diseases|joint diseases
4922306|NCT01986231|diabetes|diabetes
4922307|NCT01986231|insulin|insulin
4922308|NCT01986231|glucagon|glucagon
4922309|NCT01986231|glycogen|glycogen
4922310|NCT01986231|MRS|mrs
4922311|NCT01986205|Concussion|concussion
4922312|NCT01986205|Traumatic brain injury|traumatic brain injury
4922313|NCT01986205|Hyperbaric oxygenation|hyperbaric oxygenation
4922314|NCT01986205|Post-concussion symptoms|post-concussion symptoms
4922315|NCT01986205|Headache|headache
4922316|NCT01986205|Carbon monoxide|carbon monoxide
4922317|NCT01986192|anticoagulation|anticoagulation
4922318|NCT01986192|pharmacomechanical thrombolysis|pharmacomechanical thrombolysis
4922319|NCT01986192|aspiration thrombectomy|aspiration thrombectomy
4922320|NCT01986153|Fatty acid, essential|fatty acid, essential
4922321|NCT01986153|Immune system|immune system
4922322|NCT01986153|Home parenteral nutrition|home parenteral nutrition
4922323|NCT01986140|Breast Cancer|breast cancer
4922324|NCT01986140|Alopecia|alopecia
4922325|NCT01986140|Scalp|scalp
4922326|NCT01986140|Cooling|cooling
4922327|NCT01986127|Crohn disease|crohn disease
4922328|NCT01986075|Cocaine Dependence Treatment|cocaine dependence treatment
4922329|NCT01986075|Computer-assisted therapy|computer-assisted therapy
4922330|NCT01986075|Pharmacotherapy|pharmacotherapy
4922331|NCT01986062|ADHD|adhd
4922332|NCT01986062|AR11|ar11
4922333|NCT01986062|classroom design|classroom design
4922334|NCT01986062|amphetamine sulfate|amphetamine sulfate
4922335|NCT01986023|Stroke|stroke
4922336|NCT01986023|Medication Adherence|medication adherence
4922337|NCT01986023|SMS|sms
4922338|NCT01986023|Randomised|randomised
4922339|NCT01985997|FluMist, Quadrivalent, Vaccine|flumist, quadrivalent, vaccine
4922340|NCT01985984|Head and neck cancer|head and neck cancer
4922341|NCT01985906|Aorta|aorta
4922342|NCT01985906|Aneurysm|aneurysm
4922343|NCT01985906|Stents|stents
4922344|NCT01985906|Collateral Circulation|collateral circulation
4922345|NCT01985893|Metastatic|metastatic
4922346|NCT01985893|breast|breast
4922347|NCT01985893|cancer|cancer
4922348|NCT01985880|Biomarkers|biomarkers
4922349|NCT01985854|Desflurane|desflurane
4922350|NCT01985854|Propofol|propofol
4922351|NCT01985854|Total intravenous anesthesia|total intravenous anesthesia
4922352|NCT01985854|Neurosurgery|neurosurgery
4922353|NCT01985841|Early breast cancer|early breast cancer
4922354|NCT01985841|Primary operable breast cancer|primary operable breast cancer
4922355|NCT01985841|HER2- negative|her2- negative
4922356|NCT01985841|bevacizumab|bevacizumab
4922357|NCT01985828|Prostate neoplasm|prostate neoplasm
4922358|NCT01985828|Prostate Cancer|prostate cancer
4922359|NCT01985815|obsessive-compulsive disorder|obsessive-compulsive disorder
4922360|NCT01985815|Deep Brain Stimulation|deep brain stimulation
4922361|NCT01985815|Psychosurgery|psychosurgery
4922362|NCT01985789|airway hyperresponsiveness|airway hyperresponsiveness
4922363|NCT01985776|Exercise|exercise
4922364|NCT01985776|Electric Stimulation|electric stimulation
4922365|NCT01985763|Genistein|genistein
4922366|NCT01985763|soy supplements|soy supplements
4922367|NCT01985763|phytoestrogens|phytoestrogens
4922368|NCT01985763|colon cancer|colon cancer
4922369|NCT01985763|rectal cancer|rectal cancer
4922370|NCT01985763|colorectal cancer|colorectal cancer
4922371|NCT01985763|metastatic|metastatic
4922372|NCT01985763|stage IV|stage iv
4922373|NCT01985763|FOLFOX|folfox
4922374|NCT01985763|FOLFOX-Avastin|folfox-avastin
4922375|NCT01985763|Chemotherapy|chemotherapy
4922376|NCT01985750|dyspnea|dyspnea
4922377|NCT01985750|fmri|fmri
4922378|NCT01985750|d-cycloserine|d-cycloserine
4922379|NCT01985737|Neonatal Intensive Care Units (NICUs)|neonatal intensive care units (nicus)
4922380|NCT01985737|NICUs|nicus
4922381|NCT01985737|Neonates|neonates
4922382|NCT01985737|CLABSI|clabsi
4922383|NCT01985737|Microbiome|microbiome
4922384|NCT01985737|DNA signature|dna signature
4922385|NCT01985737|Catheter infections|catheter infections
4922386|NCT01985724|Early breast cancer|early breast cancer
4922387|NCT01985724|Axillary node positive|axillary node positive
4922388|NCT01985724|HER-2 negative|her-2 negative
4922389|NCT01985724|Adjuvant chemotherapy|adjuvant chemotherapy
4922390|NCT01985724|Dose dense|dose dense
4922391|NCT01985724|Docetaxel|docetaxel
4922392|NCT01985724|FEC|fec
4922393|NCT01985711|Motivational Interviewing|motivational interviewing
4922394|NCT01985711|Cognitive Behavioral Therapy|cognitive behavioral therapy
4922395|NCT01985711|Transtheoretical Model of behavior change|transtheoretical model of behavior change
4922396|NCT01985711|Questionnaires|questionnaires
4922397|NCT01985711|Telemedicine/*methods|telemedicine/*methods
4922398|NCT01985711|Comorbidity|comorbidity
4922399|NCT01985711|Diabetes|diabetes
4922400|NCT01985711|Glucose/metabolism|glucose/metabolism
4922401|NCT01985711|Hemoglobin A, Glycosylated|hemoglobin a, glycosylated
4922402|NCT01985711|Blood Pressure|blood pressure
4922403|NCT01985711|Cholesterol, LDL/blood|cholesterol, ldl/blood
4922404|NCT01985711|Quality of life|quality of life
4922405|NCT01985711|Depressive Disorder/psychology/*therapy|depressive disorder/psychology/*therapy
4922406|NCT01985711|Randomized Controlled Trials|randomized controlled trials
4922407|NCT01985698|Low rectal cancer|low rectal cancer
4922408|NCT01985698|Robotic|robotic
4922409|NCT01985698|Laparoscopic|laparoscopic
4922410|NCT01985698|Abdominoperineal resection|abdominoperineal resection
4922411|NCT01985685|VO2, critically ill, oxygen consumption|vo2, critically ill, oxygen consumption
4922412|NCT01985672|Infertility|infertility
4922413|NCT01985659|Lymph Node Excision|lymph node excision
4922414|NCT01985659|Thoracic Surgical Procedures|thoracic surgical procedures
4922415|NCT01985659|Thoracic Surgery, Video-Assisted|thoracic surgery, video-assisted
4922416|NCT01985659|Thoracotomy|thoracotomy
4922417|NCT01985646|Hirschsprung disease|hirschsprung disease
4922418|NCT01985646|conservative treatment|conservative treatment
4922419|NCT01985646|surgery treatment|surgery treatment
4922420|NCT01985646|infants|infants
4922421|NCT01985633|Osteoarthritis|osteoarthritis
4922422|NCT01985633|stem cells|stem cells
4922423|NCT01985633|Platelet gel|platelet gel
4922424|NCT01985633|Functional outcome|functional outcome
4922425|NCT01985620|Vaccination|vaccination
4922426|NCT01985620|RSV|rsv
4922427|NCT01985620|Influenza|influenza
4922428|NCT01985620|Prematurity|prematurity
4922429|NCT01985594|preterm labor|preterm labor
4922430|NCT01985581|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
4922431|NCT01985581|Intuniv extended release|intuniv extended release
4922432|NCT01985581|Executive Function|executive function
4922433|NCT01985581|Quality of Life|quality of life
4922434|NCT01985568|Obesity|obesity
4922435|NCT01985568|weight-loss|weight-loss
4922436|NCT01985568|Physical activity|physical activity
4922437|NCT01985555|Phase I|phase i
4922438|NCT01985555|Safety|safety
4922439|NCT01985555|Pharmacokinetics|pharmacokinetics
4922440|NCT01985516|Pain|pain
4922441|NCT01985516|Urethra|urethra
4922442|NCT01985516|Catheter|catheter
4922443|NCT01985503|positron emission tomography|positron emission tomography
4922444|NCT01985503|magnetic resonance imaging|magnetic resonance imaging
4922445|NCT01985503|brown adipose tissue|brown adipose tissue
4922446|NCT01985503|obesity|obesity
4922447|NCT01985503|cardiovascular disease|cardiovascular disease
4922448|NCT01985503|subclinical atherosclerosis|subclinical atherosclerosis
4922449|NCT01985490|epiretinal membrane|epiretinal membrane
4922450|NCT01985490|foveal avascular zone|foveal avascular zone
4922451|NCT01985490|internal limiting membrane|internal limiting membrane
4922452|NCT01985477|Myeloma|myeloma
4922453|NCT01985477|Multiple myeloma|multiple myeloma
4922454|NCT01985477|MM|mm
4922455|NCT01985477|Relapsed/Refractory Multiple Myeloma|relapsed/refractory multiple myeloma
4922456|NCT01985477|RR MM|rr mm
4922457|NCT01985477|Lenalidomide|lenalidomide
4922458|NCT01985477|CC-5013|cc-5013
4922459|NCT01985477|Revlimid|revlimid
4922460|NCT01985477|Dexamethasone|dexamethasone
4922461|NCT01985477|Decadron|decadron
4922462|NCT01985477|All-Trans Retinoic Acid|all-trans retinoic acid
4922463|NCT01985477|ATRA|atra
4922464|NCT01985477|Tretinoin (Oral)|tretinoin (oral)
4922465|NCT01985477|Vesanoid|vesanoid
4922466|NCT01985464|rheumatoid arthritis|rheumatoid arthritis
4922467|NCT01985464|umbilical cord|umbilical cord
4922468|NCT01985464|mesenchymal|mesenchymal
4922469|NCT01985464|stem cells|stem cells
4922470|NCT01985451|Lymphoma|lymphoma
4922471|NCT01985438|Head and Neck Neoplasms|head and neck neoplasms
4922472|NCT01985438|Nutritional Support|nutritional support
4922473|NCT01985438|Randomized Controlled Trial|randomized controlled trial
4922474|NCT01985438|Percutaneous Endoscopic Gastrostomy tube|percutaneous endoscopic gastrostomy tube
4922475|NCT01985438|Nasogastric tube|nasogastric tube
4922476|NCT01985438|Radiation Effects|radiation effects
4922477|NCT01985438|Pakistan|pakistan
4922478|NCT01985412|Rejection|rejection
4922479|NCT01985412|Transplant|transplant
4922480|NCT01985412|Cardiac|cardiac
4922481|NCT01985412|Pulmonary|pulmonary
4922482|NCT01985412|Heart|heart
4922483|NCT01985412|Lung|lung
4922484|NCT01985412|Cell-Free DNA|cell-free dna
4922485|NCT01985412|cfDNA|cfdna
4922486|NCT01985412|Cell|cell
4922487|NCT01985412|Free|free
4922488|NCT01985412|DNA|dna
4922489|NCT01985412|Biopsy|biopsy
4922490|NCT01985412|Non-Invasive|non-invasive
4922491|NCT01985399|HIV|hiv
4922492|NCT01985399|AIDS|aids
4922493|NCT01985399|Aging|aging
4922494|NCT01985386|Iron absorption|iron absorption
4922495|NCT01985386|Slow release iron|slow release iron
4922496|NCT01985386|Gastric delivery system|gastric delivery system
4922497|NCT01985386|Iron deficiency|iron deficiency
4922498|NCT01985373|intravenous immunoglobulin|intravenous immunoglobulin
4922499|NCT01985373|pharmacokinetics|pharmacokinetics
4922500|NCT01985373|10% IVIG|10% ivig
4922501|NCT01985334|Moderate COPD, glycopyrronium bromide, indacaterol maleate and glycopyrronium bromide FDC, NVA237, QVA149|moderate copd, glycopyrronium bromide, indacaterol maleate and glycopyrronium bromide fdc, nva237, qva149
4922502|NCT01985321|herpes labialis|herpes labialis
4922503|NCT01985321|cold sore|cold sore
4922504|NCT01985269|High risk|high risk
4922505|NCT01985269|ART naive|art naive
4922506|NCT01985256|glioma|glioma
4922507|NCT01985256|glioblastoma|glioblastoma
4922508|NCT01985256|glioblastoma multiforme|glioblastoma multiforme
4922509|NCT01985256|Grade IV astrocytoma|grade iv astrocytoma
4922510|NCT01985256|brain cancer|brain cancer
4922511|NCT01985256|recurrent glioblastoma|recurrent glioblastoma
4922512|NCT01985256|GBM|gbm
4922513|NCT01985256|AA|aa
4922514|NCT01985256|AOD|aod
4922515|NCT01985256|anaplastic astrocytoma|anaplastic astrocytoma
4922516|NCT01985256|anaplastic oligodendroglioma|anaplastic oligodendroglioma
4922517|NCT01985256|anaplastic oligoastrocytoma|anaplastic oligoastrocytoma
4922518|NCT01985256|malignant glioma|malignant glioma
4922519|NCT01985256|high grade glioma|high grade glioma
4922520|NCT01985243|Dietary diversity|dietary diversity
4922521|NCT01985243|Infant and young child|infant and young child
4922522|NCT01985243|Adolescents|adolescents
4922523|NCT01985243|Anemia|anemia
4922524|NCT01985243|Rural health|rural health
4922525|NCT01985204|iodine|iodine
4922526|NCT01985204|thyroid hormones|thyroid hormones
4922527|NCT01985204|obesity|obesity
4922528|NCT01985204|TSH|tsh
4922529|NCT01985204|dyslipidemia|dyslipidemia
4922530|NCT01985204|insulin resistance|insulin resistance
4922531|NCT01985139|Obesity, food pleasure, behavioral tasks, endocannabinoids|obesity, food pleasure, behavioral tasks, endocannabinoids
4922532|NCT01985126|Multiple myeloma|multiple myeloma
4922533|NCT01985126|Daratumumab|daratumumab
4922534|NCT01985126|Proteasome inhibitor|proteasome inhibitor
4922535|NCT01985126|Immunomodulatory drug|immunomodulatory drug
4922536|NCT01985126|IMiD|imid
4922537|NCT01985113|thioredoxin reductase|thioredoxin reductase
4922538|NCT01985113|non-small cell lung cancer|non-small cell lung cancer
4922539|NCT01985074|case management, disease management, emergency|case management, disease management, emergency
4922540|NCT01985074|department|department
4922541|NCT01985061|Myelodysplasic syndrome|myelodysplasic syndrome
4922542|NCT01985061|Acute Myeloid leukemia|acute myeloid leukemia
4922543|NCT01985035|Obstructive sleep apnea|obstructive sleep apnea
4922544|NCT01985035|obesity|obesity
4922545|NCT01985035|diet|diet
4922546|NCT01985035|energy expenditure|energy expenditure
4922547|NCT01985022|autism|autism
4922548|NCT01985022|autism spectrum disorders|autism spectrum disorders
4922549|NCT01985022|pervasive developmental disorders|pervasive developmental disorders
4922550|NCT01985022|toddlers|toddlers
4922551|NCT01985022|intervention|intervention
4922552|NCT01984983|Venezuelan equine encephalitis virus|venezuelan equine encephalitis virus
4922553|NCT01984983|DNA vaccine|dna vaccine
4922554|NCT01984983|electroporation|electroporation
4922555|NCT01984983|intradermal|intradermal
4922556|NCT01984983|intramuscular|intramuscular
4922557|NCT01984970|McGrath Videolaryngoscope|mcgrath videolaryngoscope
4922558|NCT01984970|double-lumen tube intubation|double-lumen tube intubation
4922559|NCT01984970|Thoracic surgery|thoracic surgery
4922560|NCT01984957|ALS|als
4922561|NCT01984957|Motor neuron diseases|motor neuron diseases
4922562|NCT01984957|Transcriptome|transcriptome
4922563|NCT01984944|circadian rhythm|circadian rhythm
4922564|NCT01984931|post operative nausea and vomiting|post operative nausea and vomiting
4922565|NCT01984931|Trimebutine Maleate|trimebutine maleate
4922566|NCT01984905|18 FDG PET-scan|18 fdg pet-scan
4922567|NCT01984905|angioscan|angioscan
4922568|NCT01984905|aortic dissection|aortic dissection
4922569|NCT01984892|Autologous Vaccination|autologous vaccination
4922570|NCT01984892|Intratumoral Injections|intratumoral injections
4922571|NCT01984892|Intramuscular Injections|intramuscular injections
4922572|NCT01984892|Advanced Accessible Solid Tumors|advanced accessible solid tumors
4922573|NCT01984892|Poly-ICLC|poly-iclc
4922574|NCT01984892|Phase II Clinical Trial|phase ii clinical trial
4922575|NCT01984892|Safety|safety
4922576|NCT01984892|Efficacy|efficacy
4922577|NCT01984892|Autovaccination|autovaccination
4922578|NCT01984892|In Situ|in situ
4922579|NCT01984892|Host Targeted Strategy|host targeted strategy
4922580|NCT01984892|Overall Survival|overall survival
4922581|NCT01984892|Immunotherapy|immunotherapy
4922582|NCT01984892|Adjuvant|adjuvant
4922583|NCT01984866|CPR: Complete Pathological Response|cpr: complete pathological response
4922584|NCT01984853|ACS|acs
4922585|NCT01984853|repository|repository
4922586|NCT01984853|Observational|observational
4922587|NCT01984827|Hyperglycaemia|hyperglycaemia
4922588|NCT01984827|Moxifloxacin|moxifloxacin
4922589|NCT01984827|QTc prolongation|qtc prolongation
4922590|NCT01984827|C-peptide|c-peptide
4922591|NCT01984827|Dead in bed syndrome|dead in bed syndrome
4922592|NCT01984801|SCD1|scd1
4922593|NCT01984801|Gel|gel
4922594|NCT01984801|Topical Administration|topical administration
4922595|NCT01984801|Acne|acne
4922596|NCT01984788|Oral Prophylaxis|oral prophylaxis
4922597|NCT01984775|safety|safety
4922598|NCT01984775|dermal|dermal
4922599|NCT01984775|GSK2894512|gsk2894512
4922600|NCT01984775|Cumulative irritation|cumulative irritation
4922601|NCT01984736|Pharmacokinetic|pharmacokinetic
4922602|NCT01984736|Safety|safety
4922603|NCT01984723|Pharmacokinetic|pharmacokinetic
4922604|NCT01984723|Safety|safety
4922605|NCT01984710|Treatment Resistant Depression|treatment resistant depression
4922606|NCT01984710|Deep Brain Stimulation|deep brain stimulation
4922607|NCT01984710|Psychiatry|psychiatry
4922608|NCT01984710|Neuro Surgery|neuro surgery
4922609|NCT01984684|Bacterial skin infection|bacterial skin infection
4922610|NCT01984684|infection|infection
4922611|NCT01984684|skin|skin
4922612|NCT01984684|delafloxacin|delafloxacin
4922613|NCT01984684|vancomycin|vancomycin
4922614|NCT01984684|aztreonam|aztreonam
4922615|NCT01984684|methicillin-resistant Staphylococcus aureus (MRSA) bacteria|methicillin-resistant staphylococcus aureus (mrsa) bacteria
4922616|NCT01984684|bacterial infection|bacterial infection
4922617|NCT01984684|Anti-Infective Agents|anti-infective agents
4922618|NCT01984658|pancreatic cancer|pancreatic cancer
4922619|NCT01984645|Emergency Visit|emergency visit
4922620|NCT01984645|Secure Health messaging|secure health messaging
4922621|NCT01984645|Inpatient|inpatient
4922622|NCT01984593|Yoga|yoga
4922623|NCT01984593|Hypertension|hypertension
4922624|NCT01984593|Quality of Life|quality of life
4922625|NCT01984593|Primary Health Care|primary health care
4922626|NCT01984593|Stress|stress
4922627|NCT01984593|Anxiety|anxiety
4922628|NCT01984593|Depression|depression
4922629|NCT01984580|Barrett's esophagus|barrett's esophagus
4922630|NCT01984580|Esophagus|esophagus
4922631|NCT01984580|Adenocarcinoma|adenocarcinoma
4922632|NCT01984567|Oxyphytosterols|oxyphytosterols
4922633|NCT01984567|Oxidative stress|oxidative stress
4922634|NCT01984567|Vitamin E|vitamin e
4922635|NCT01984567|Lipoic acid|lipoic acid
4922636|NCT01984541|Pollen|pollen
4922637|NCT01984528|Immunotherapy|immunotherapy
4922638|NCT01984528|Skin prick test|skin prick test
4922639|NCT01984528|Standardization|standardization
4922640|NCT01984528|Alternaria alternata|alternaria alternata
4922641|NCT01984515|Post-traumatic Stress Disorder|post-traumatic stress disorder
4922642|NCT01984515|Evidence-Based Psychotherapy|evidence-based psychotherapy
4922643|NCT01984515|Treatment Engagement|treatment engagement
4922644|NCT01984515|Cognitive Behavioral Therapy|cognitive behavioral therapy
4922645|NCT01984515|Implementation Science|implementation science
4922646|NCT01984502|Larynx Cancer|larynx cancer
4922647|NCT01984489|SHR117887, Metformin,combination,PhaseII|shr117887, metformin,combination,phaseii
4922648|NCT01984476|spinal cord injury|spinal cord injury
4922649|NCT01984476|autonomic dysreflexia|autonomic dysreflexia
4922650|NCT01984476|baroreceptor integrity|baroreceptor integrity
4922651|NCT01984476|sympathetic integrity|sympathetic integrity
4922652|NCT01984476|vagal integrity|vagal integrity
4922653|NCT01984476|autonomic integrity|autonomic integrity
4922654|NCT01984476|arterial stiffness|arterial stiffness
4922655|NCT01984476|cognitive function|cognitive function
4922656|NCT01984476|traumatic brain injury|traumatic brain injury
4922657|NCT01984476|cerebral blood flow|cerebral blood flow
4922658|NCT01984476|white matter hyperintensities|white matter hyperintensities
4922659|NCT01984476|cerebral vascular resistance index|cerebral vascular resistance index
4922660|NCT01984463|Postoperative pain|postoperative pain
4922661|NCT01984463|Shoulder pain|shoulder pain
4922662|NCT01984463|Thoracotomy|thoracotomy
4922663|NCT01984450|Articular cartilage|articular cartilage
4922664|NCT01984450|Autologous collagen|autologous collagen
4922665|NCT01984450|BMAC|bmac
4922666|NCT01984437|Vascular disease|vascular disease
4922667|NCT01984437|Minimally invasive treatment|minimally invasive treatment
4922668|NCT01984437|Endovascular treatment|endovascular treatment
4922669|NCT01984437|Magellan|magellan
4922670|NCT01984437|Robotic|robotic
4922671|NCT01984424|High Cholesterol, Treatment for high cholesterol, Lowering cholesterol, Lowering high cholesterol, Hypercholesterolemia|high cholesterol, treatment for high cholesterol, lowering cholesterol, lowering high cholesterol, hypercholesterolemia
4922672|NCT01984346|Atrial Fibrillation|atrial fibrillation
4922673|NCT01984346|Convergent Procedure|convergent procedure
4922674|NCT01984346|Combined Epicardial/ Endocardial Ablation|combined epicardial/ endocardial ablation
4922675|NCT01984346|Hybrid Procedure|hybrid procedure
4922676|NCT01984346|Radiofrequency Ablation|radiofrequency ablation
4922677|NCT01984346|Arrhythmia|arrhythmia
4922678|NCT01984346|RF Ablation|rf ablation
4922679|NCT01984333|trichotillomania|trichotillomania
4922680|NCT01984333|response inhibition|response inhibition
4922681|NCT01984333|cognitive retraining|cognitive retraining
4922682|NCT01984320|OHSS|ohss
4922683|NCT01984320|ICSI|icsi
4922684|NCT01984320|Coasting|coasting
4922685|NCT01984320|Cabergoline|cabergoline
4922686|NCT01984307|Acute coronary syndrome|acute coronary syndrome
4922687|NCT01984307|Myocardial infarction|myocardial infarction
4922688|NCT01984307|retrospective|retrospective
4922689|NCT01984307|cohort study|cohort study
4922690|NCT01984307|Healthcare resources utilization|healthcare resources utilization
4922691|NCT01984294|HCV genotype 1|hcv genotype 1
4922693|NCT01984294|Sustained Virologic Response|sustained virologic response
4922694|NCT01984294|Direct-Acting Antiviral|direct-acting antiviral
4922695|NCT01984294|Combination Therapy|combination therapy
4922696|NCT01984294|GS-7977|gs-7977
4922697|NCT01984294|GS-5885|gs-5885
4922698|NCT01984294|Ribavirin|ribavirin
4922699|NCT01984294|Open Label|open label
4922700|NCT01984294|Sofosbuvir|sofosbuvir
4922701|NCT01984294|Treatment-Naive|treatment-naive
4922702|NCT01984294|Protease Inhibitors|protease inhibitors
4922703|NCT01984294|PI|pi
4922704|NCT01984294|Treatment experienced|treatment experienced
4922705|NCT01984294|Cirrhotic|cirrhotic
4922706|NCT01984281|Physical Activity|physical activity
4922707|NCT01984281|Pedometers|pedometers
4922708|NCT01984281|Quality of Life|quality of life
4922709|NCT01984268|Rheumatoid arthritis|rheumatoid arthritis
4922710|NCT01984268|ACTHAR|acthar
4922711|NCT01984268|Methotrexate|methotrexate
4922712|NCT01984268|Inadequate response|inadequate response
4922713|NCT01984203|Shoulder|shoulder
4922714|NCT01984203|Impingement|impingement
4922715|NCT01984203|Rotator Cuff Syndrome|rotator cuff syndrome
4922716|NCT01984203|Subacromial Impingement Syndrome|subacromial impingement syndrome
4922717|NCT01984203|Exercise|exercise
4922718|NCT01984203|Physiotherapy|physiotherapy
4922719|NCT01984190|venous thromboembolism|venous thromboembolism
4922720|NCT01984190|deep vein thrombosis|deep vein thrombosis
4922721|NCT01984190|pulmonary emboli|pulmonary emboli
4922722|NCT01984190|hip arthroplasty|hip arthroplasty
4922723|NCT01984190|knee arthroplasty|knee arthroplasty
4922724|NCT01984190|efficacy|efficacy
4922725|NCT01984190|mobile compression device|mobile compression device
4922726|NCT01984190|mechanical device|mechanical device
4922727|NCT01984190|prophylaxis.|prophylaxis.
4922728|NCT01984177|Cocaine|cocaine
4922729|NCT01984177|Substance-Related Disorders|substance-related disorders
4922730|NCT01984177|Drug Addiction|drug addiction
4922731|NCT01984177|Substance Addiction|substance addiction
4922732|NCT01984177|Dopamine|dopamine
4922733|NCT01984177|Receptors, Dopamine D2|receptors, dopamine d2
4922734|NCT01984177|Receptors, Dopamine D3|receptors, dopamine d3
4922735|NCT01984177|Stress, Psychological|stress, psychological
4922736|NCT01984177|Corticorelin|corticorelin
4922737|NCT01984177|Neuroendocrine System|neuroendocrine system
4922738|NCT01984177|Cortisol|cortisol
4922739|NCT01984177|Adrenocorticotropic Hormone|adrenocorticotropic hormone
4922740|NCT01984177|Positron-Emission Tomography|positron-emission tomography
4922741|NCT01984177|11C-PHNO|11c-phno
4922742|NCT01984164|cerebrovascular function|cerebrovascular function
4922743|NCT01984138|estrogen receptor positive breast cancer|estrogen receptor positive breast cancer
4922744|NCT01984138|breast cancer|breast cancer
4922745|NCT01984125|Adolescent Immunization Rates|adolescent immunization rates
4922746|NCT01984125|Provider prompts|provider prompts
4922747|NCT01984112|Humerus|humerus
4922748|NCT01984112|fracture|fracture
4922749|NCT01984112|nail|nail
4922750|NCT01984112|plate|plate
4922751|NCT01984112|tuberosity|tuberosity
4922752|NCT01984099|Postmolar Gestational Trophoblastic Disease, Hydatidiform Mole|postmolar gestational trophoblastic disease, hydatidiform mole
4922753|NCT01984086|COPD|copd
4922754|NCT01984086|Asthma|asthma
4922755|NCT01984086|Respiratory|respiratory
4922756|NCT01984073|Atherogenic dyslipidemia phenotype|atherogenic dyslipidemia phenotype
4922757|NCT01984060|Aging|aging
4922758|NCT01984060|Physical Activity|physical activity
4922759|NCT01984060|Physical Function|physical function
4922760|NCT01984060|HIV|hiv
4922761|NCT01984060|Frailty|frailty
4922762|NCT01984060|Autonomous Motivation|autonomous motivation
4922763|NCT01984060|Depression|depression
4922764|NCT01984047|safety|safety
4922765|NCT01984047|GSK3050002|gsk3050002
4922766|NCT01984047|CCR6 receptor|ccr6 receptor
4922767|NCT01984047|single dose escalation|single dose escalation
4922768|NCT01984047|Phase 1|phase 1
4922769|NCT01984047|CCL20|ccl20
4922770|NCT01984034|Educational outreach|educational outreach
4922771|NCT01984034|Academic detailing|academic detailing
4922772|NCT01984034|Guideline adherence|guideline adherence
4922773|NCT01984034|Family Practice|family practice
4922774|NCT01984034|Drug utilization|drug utilization
4922775|NCT01984034|Program evaluation|program evaluation
4922776|NCT01984034|Cost effectiveness|cost effectiveness
4922777|NCT01984021|Physical Therapy Modalities|physical therapy modalities
4922778|NCT01984021|Neck pain|neck pain
4922779|NCT01984021|Acupuncture|acupuncture
4922780|NCT01983995|Breast Cancer|breast cancer
4922781|NCT01983995|Aromatase Inhibitors|aromatase inhibitors
4922782|NCT01983995|Actigraphy|actigraphy
4922783|NCT01983995|Pain|pain
4922784|NCT01983995|Fatigue|fatigue
4922785|NCT01983995|Sleep quality|sleep quality
4922786|NCT01983982|Breast Cancer|breast cancer
4922787|NCT01983982|Chemotherapy|chemotherapy
4922788|NCT01983982|Chronic Pain|chronic pain
4922789|NCT01983982|Survivorship|survivorship
4922790|NCT01983969|Advanced Cancers|advanced cancers
4922791|NCT01983969|Lymphoma|lymphoma
4922792|NCT01983969|Recurrent Hodgkin's|recurrent hodgkin's
4922793|NCT01983969|non-Hodgkin's lymphoma|non-hodgkin's lymphoma
4922794|NCT01983969|Stem cell transplant|stem cell transplant
4922795|NCT01983969|Azacitidine|azacitidine
4922796|NCT01983969|5-azacytidine|5-azacytidine
4922797|NCT01983969|5-aza|5-aza
4922798|NCT01983969|Vidaza|vidaza
4922799|NCT01983969|5-AZC|5-azc
4922800|NCT01983969|AZA-CR|aza-cr
4922801|NCT01983969|Ladakamycin|ladakamycin
4922802|NCT01983969|NSC-102816|nsc-102816
4922803|NCT01983969|Azacytidine|azacytidine
4922804|NCT01983969|Vorinostat|vorinostat
4922805|NCT01983969|SAHA|saha
4922806|NCT01983969|Suberoylanilide Hydroxamic Acid|suberoylanilide hydroxamic acid
4922807|NCT01983969|MSK-390|msk-390
4922808|NCT01983969|Zolinza|zolinza
4922809|NCT01983969|Gemcitabine|gemcitabine
4922810|NCT01983969|Gemcitabine Hydrochloride|gemcitabine hydrochloride
4922811|NCT01983969|Gemzar|gemzar
4922812|NCT01983969|Busulfan|busulfan
4922813|NCT01983969|Busulfex|busulfex
4922814|NCT01983969|Myleran|myleran
4922815|NCT01983969|Melphalan|melphalan
4922816|NCT01983969|Alkeran|alkeran
4922817|NCT01983969|Dexamethasone|dexamethasone
4922818|NCT01983969|Decadron|decadron
4922819|NCT01983969|Caphosol|caphosol
4922820|NCT01983969|Glutamine|glutamine
4922821|NCT01983969|Enterex|enterex
4922822|NCT01983969|Glutapak-10|glutapak-10
4922823|NCT01983969|NutreStore|nutrestore
4922824|NCT01983969|Resource|resource
4922825|NCT01983969|GlutaSolve|glutasolve
4922826|NCT01983969|Sympt-X G.I.|sympt-x g.i.
4922827|NCT01983969|Sympt-X|sympt-x
4922828|NCT01983969|Pyridoxine|pyridoxine
4922829|NCT01983969|Rituximab|rituximab
4922830|NCT01983969|Rituxan|rituxan
4922831|NCT01983956|early palliative care|early palliative care
4922832|NCT01983956|patient empowerment|patient empowerment
4922833|NCT01983956|cancer|cancer
4922834|NCT01983956|assessment|assessment
4922835|NCT01983956|end of life|end of life
4922836|NCT01983930|Memory impairment|memory impairment
4922837|NCT01983930|Meditation|meditation
4922838|NCT01983930|Yoga|yoga
4922839|NCT01983930|memory training|memory training
4922840|NCT01983930|Mild cognitive impairment|mild cognitive impairment
4922841|NCT01983930|MCI|mci
4922842|NCT01983930|geriatric|geriatric
4922843|NCT01983930|fMRI|fmri
4922844|NCT01983917|diabetes|diabetes
4922845|NCT01983917|mobile application|mobile application
4922846|NCT01983917|diabetic retinopathy|diabetic retinopathy
4922847|NCT01983904|Major depressive disorder (MDD)|major depressive disorder (mdd)
4922848|NCT01983904|Bi-polar disorder (BP)|bi-polar disorder (bp)
4922849|NCT01983891|food shelf|food shelf
4922850|NCT01983891|nutrition education|nutrition education
4922851|NCT01983891|cooking course|cooking course
4922852|NCT01983852|End of Life Care|end of life care
4922853|NCT01983852|Paediatric|paediatric
4922854|NCT01983852|Experiences|experiences
4922855|NCT01983852|Needs|needs
4922856|NCT01983852|Current Practices|current practices
4922857|NCT01983839|Moxifloxacin|moxifloxacin
4922858|NCT01983839|Pneumonia|pneumonia
4922859|NCT01983839|Pharmacokinetics|pharmacokinetics
4922860|NCT01983826|nitrates|nitrates
4922861|NCT01983826|blood flow|blood flow
4922862|NCT01983826|vascular function|vascular function
4922863|NCT01983826|exercise|exercise
4922864|NCT01983813|Diabetes|diabetes
4922865|NCT01983813|High Blood Pressure|high blood pressure
4922866|NCT01983813|High Cholesterol|high cholesterol
4922867|NCT01983813|Heart Irregularity|heart irregularity
4922868|NCT01983813|Stroke|stroke
4922869|NCT01983800|Mechanical Ventilation|mechanical ventilation
4922870|NCT01983800|Volatile Sedation|volatile sedation
4922871|NCT01983800|Intravenous Sedation|intravenous sedation
4922872|NCT01983800|Delirium|delirium
4922873|NCT01983787|Cystic Fibrosis|cystic fibrosis
4922874|NCT01983787|Continuous infusion|continuous infusion
4922875|NCT01983787|Pharmacokinetics|pharmacokinetics
4922876|NCT01983774|CF|cf
4922877|NCT01983748|Uveal Melanoma, Monosomy 3|uveal melanoma, monosomy 3
4922878|NCT01983735|TELMINUVO Tab.|telminuvo tab.
4922879|NCT01983735|CKD-828|ckd-828
4922880|NCT01983735|Hypertension|hypertension
4922881|NCT01983735|Stage 2 Hypertension|stage 2 hypertension
4922882|NCT01983735|S-Amlodipine|s-amlodipine
4922883|NCT01983735|Telmisartan|telmisartan
4922884|NCT01983696|low oxygen tension|low oxygen tension
4922885|NCT01983696|embryo quality|embryo quality
4922886|NCT01983683|Clostridium difficile infection|clostridium difficile infection
4922887|NCT01983683|Post-antibiotic diarrhea|post-antibiotic diarrhea
4922888|NCT01983670|Pre-movement facilitation|pre-movement facilitation
4922889|NCT01983670|Fast goal directed movement|fast goal directed movement
4922890|NCT01983670|Triphasic EMG pattern|triphasic emg pattern
4922891|NCT01983670|Temporal electrical stimulation,|temporal electrical stimulation,
4922892|NCT01983670|Spinocerebellar Ataxia|spinocerebellar ataxia
4922893|NCT01983657|Pulmonary|pulmonary
4922894|NCT01983657|Pulmonary Alveolar Proteinosis|pulmonary alveolar proteinosis
4922895|NCT01983657|PAP|pap
4922896|NCT01983644|acute ischemic stroke,endovascular recanalization|acute ischemic stroke,endovascular recanalization
4922897|NCT01983644|mechanical thrombectomy|mechanical thrombectomy
4922898|NCT01983631|Whole body vibration|whole body vibration
4922899|NCT01983631|Reciprocal inhibition|reciprocal inhibition
4922900|NCT01983631|Spinocerebellar ataxia|spinocerebellar ataxia
4922901|NCT01983631|voluntary activation level|voluntary activation level
4922902|NCT01983618|Cerebral ischemia|cerebral ischemia
4922903|NCT01983618|Beachchair position|beachchair position
4922904|NCT01983618|Interscalene nerve block|interscalene nerve block
4922905|NCT01983592|Homeopathy|homeopathy
4922906|NCT01983592|Fatigue|fatigue
4922907|NCT01983592|Chemotherapy|chemotherapy
4922908|NCT01983592|Cancer|cancer
4922909|NCT01983553|Dengue Virus|dengue virus
4922910|NCT01983553|Dengue Fever|dengue fever
4922911|NCT01983553|Dengue Hemorrhagic Fever|dengue hemorrhagic fever
4922912|NCT01983553|CYD Dengue Vaccine|cyd dengue vaccine
4922913|NCT01983540|Diphtheria|diphtheria
4922914|NCT01983540|Tetanus|tetanus
4922915|NCT01983540|Whooping Cough|whooping cough
4922916|NCT01983540|Hepatitis B|hepatitis b
4922917|NCT01983540|Poliomyelitis|poliomyelitis
4922918|NCT01983540|Pediatric combined vaccine|pediatric combined vaccine
4922919|NCT01983527|Arthrographic distention|arthrographic distention
4922920|NCT01983527|Hydrodilatation|hydrodilatation
4922921|NCT01983527|Intra-articular corticosteroid injection|intra-articular corticosteroid injection
4922922|NCT01983514|oxytocin|oxytocin
4922923|NCT01983514|fMRI|fmri
4922924|NCT01983514|social cognition|social cognition
4922925|NCT01983514|heart rate variability|heart rate variability
4922926|NCT01983514|pupillometry|pupillometry
4922927|NCT01983514|eye tracking|eye tracking
4922928|NCT01983501|ONT-380|ont-380
4922929|NCT01983501|T-DM1|t-dm1
4922930|NCT01983501|Kadcyla|kadcyla
4922931|NCT01983501|HER2 positive breast cancer|her2 positive breast cancer
4922932|NCT01983501|Breast cancer|breast cancer
4922933|NCT01983501|ARRY-380|arry-380
4922934|NCT01983501|Tucatinib|tucatinib
4922935|NCT01983501|Tucatinib (ONT-380)|tucatinib (ont-380)
4922936|NCT01983488|Uveitis|uveitis
4922937|NCT01983488|Vision Loss|vision loss
4922938|NCT01983475|Spinal Cord Injury|spinal cord injury
4922939|NCT01983475|Denosumab|denosumab
4922940|NCT01983475|Osteoporosis|osteoporosis
4922941|NCT01983475|Dual Energy X-ray Absorptiometry|dual energy x-ray absorptiometry
4922942|NCT01983462|Prehypertension|prehypertension
4922943|NCT01983462|Hypertension|hypertension
4922944|NCT01983462|Obese|obese
4922945|NCT01983462|Sympathetic Nervous System|sympathetic nervous system
4922946|NCT01983462|renin-angiotensin system|renin-angiotensin system
4922947|NCT01983462|Endothelial function|endothelial function
4922948|NCT01983449|Adventitia|adventitia
4922949|NCT01983449|Peripheral Artery Disease|peripheral artery disease
4922950|NCT01983449|Restenosis|restenosis
4922951|NCT01983449|Inflammation|inflammation
4922952|NCT01983449|Anti-Inflammatory|anti-inflammatory
4922953|NCT01983449|Dexamethasone|dexamethasone
4922954|NCT01983436|Maxillofacial Orthognathic Surgery|maxillofacial orthognathic surgery
4922955|NCT01983436|Manual lymphatic drainage|manual lymphatic drainage
4922956|NCT01983423|Endometrial Biopsy|endometrial biopsy
4922957|NCT01983423|Endometrial Sampling|endometrial sampling
4922958|NCT01983423|In Vitro Fertilization|in vitro fertilization
4922959|NCT01983423|Pregnancy|pregnancy
4922960|NCT01983423|Implantation|implantation
4922961|NCT01983410|BRCA Mutation Carriers|brca mutation carriers
4922962|NCT01983410|PDAC carriers|pdac carriers
4922963|NCT01983410|BRCAmut carriers|brcamut carriers
4922964|NCT01983410|Registry|registry
4922965|NCT01983410|13-217|13-217
4922966|NCT01983397|aged, 80 and over|aged, 80 and over
4922967|NCT01983397|Exercise|exercise
4922968|NCT01983397|Cognition|cognition
4922969|NCT01983397|Balance|balance
4922970|NCT01983397|Randomized controlled trial|randomized controlled trial
4922971|NCT01983384|Delirium|delirium
4922972|NCT01983384|Cognition|cognition
4922973|NCT01983384|Surgery|surgery
4922974|NCT01983384|Anesthesia|anesthesia
4922975|NCT01983384|Aging|aging
4922976|NCT01983358|PARP-1 inhibitor|parp-1 inhibitor
4922977|NCT01983345|Myelomeningocele|myelomeningocele
4922978|NCT01983345|Arnold Chiari malformation|arnold chiari malformation
4922979|NCT01983345|Spina bifida|spina bifida
4922980|NCT01983332|MDACC|mdacc
4922981|NCT01983332|MOHO|moho
4922982|NCT01983306|Constipation|constipation
4922983|NCT01983306|Opioid|opioid
4922984|NCT01983306|GC C Agonist|gc c agonist
4922985|NCT01983306|Pain|pain
4922986|NCT01983293|Non-left bundle branch block|non-left bundle branch block
4922988|NCT01983293|LV lead pacing location|lv lead pacing location
4922989|NCT01983293|CRT-D|crt-d
4922990|NCT01983280|polysomnography|polysomnography
4922991|NCT01983280|sleep|sleep
4922992|NCT01983280|healing touch|healing touch
4922993|NCT01983280|pediatric burn|pediatric burn
4922994|NCT01983254|coping|coping
4922995|NCT01983254|acute respiratory failure|acute respiratory failure
4922996|NCT01983254|critical illness|critical illness
4922997|NCT01983254|depression|depression
4922998|NCT01983254|anxiety|anxiety
4922999|NCT01983254|post-traumatic stress|post-traumatic stress
4923000|NCT01983254|intensive care unit|intensive care unit
4923001|NCT01983241|Pulmonary Emphysema|pulmonary emphysema
4923002|NCT01983241|Alpha-1 Antitrypsin Deficiency|alpha-1 antitrypsin deficiency
4923003|NCT01983241|AATD|aatd
4923004|NCT01983241|Alpha-1 PI Deficiency|alpha-1 pi deficiency
4923005|NCT01983241|Alpha-1 Protienase Inhibitor|alpha-1 protienase inhibitor
4923006|NCT01983228|Musculoskeletal Pain|musculoskeletal pain
4923007|NCT01983228|Walking|walking
4923008|NCT01983228|African American|african american
4923009|NCT01983228|Telephone Coaching|telephone coaching
4923010|NCT01983228|Pedometer|pedometer
4923011|NCT01983215|groin incisions|groin incisions
4923012|NCT01983202|PCOS|pcos
4923013|NCT01983202|Pregnancy|pregnancy
4923014|NCT01983202|Obstetric|obstetric
4923015|NCT01983189|TMS|tms
4923016|NCT01983189|transcranial magnetic stimulation|transcranial magnetic stimulation
4923017|NCT01983189|rTMS|rtms
4923018|NCT01983189|recurrent transcranial magnetic stimulation|recurrent transcranial magnetic stimulation
4923019|NCT01983189|fMRI|fmri
4923020|NCT01983189|functional magnetic resonance imaging.|functional magnetic resonance imaging.
4923021|NCT01983176|Parotid tumor|parotid tumor
4923022|NCT01983176|Partial superficial parotidectomy|partial superficial parotidectomy
4923023|NCT01983176|Facial palsy|facial palsy
4923024|NCT01983150|Population Health|population health
4923025|NCT01983150|Smoking cessation|smoking cessation
4923026|NCT01983150|Young adults|young adults
4923027|NCT01983150|Cancer prevention|cancer prevention
4923028|NCT01983150|Tobacco control strategies|tobacco control strategies
4923029|NCT01983150|Behaviour modification|behaviour modification
4923030|NCT01983150|Social Media|social media
4923031|NCT01983150|Smartphone technology|smartphone technology
4923032|NCT01983137|Chronic pain|chronic pain
4923033|NCT01983137|Severe pain|severe pain
4923034|NCT01983137|oxycodon|oxycodon
4923035|NCT01983137|naloxon|naloxon
4923036|NCT01983137|opioid-induced constipation|opioid-induced constipation
4923037|NCT01983137|opioid|opioid
4923038|NCT01983137|quality of life|quality of life
4923039|NCT01983137|laxative|laxative
4923040|NCT01983137|analgesic rescue medication|analgesic rescue medication
4923041|NCT01983124|Advanced Melanoma|advanced melanoma
4923042|NCT01983098|Colorectal cancer|colorectal cancer
4923043|NCT01983098|Metastatic|metastatic
4923044|NCT01983098|Circulating tumor DNA|circulating tumor dna
4923045|NCT01983098|Biomaker|biomaker
4923046|NCT01983085|Nitric Oxide Dressing|nitric oxide dressing
4923047|NCT01983085|Nitric oxide|nitric oxide
4923048|NCT01983085|Superficial partial thickness wound|superficial partial thickness wound
4923049|NCT01983085|Burns|burns
4923050|NCT01983085|Skin graft donor sites|skin graft donor sites
4923051|NCT01983085|Improved healing|improved healing
4923052|NCT01983085|Vasodilation|vasodilation
4923053|NCT01983085|Angiogenesis|angiogenesis
4923054|NCT01983085|Anti-microbial|anti-microbial
4923055|NCT01983072|colonization of the gastrointestinal tract with bacteria|colonization of the gastrointestinal tract with bacteria
4923056|NCT01983007|Diabetes Mellitus.|diabetes mellitus.
4923057|NCT01982994|Physical Activity Education|physical activity education
4923058|NCT01982994|Caregivers|caregivers
4923059|NCT01982981|perception|perception
4923060|NCT01982981|wellbeing|wellbeing
4923061|NCT01982981|plain water|plain water
4923062|NCT01982968|Idiopathic pulmonary fibrosis|idiopathic pulmonary fibrosis
4923063|NCT01982968|IPF|ipf
4923064|NCT01982968|Gastroesophageal reflux|gastroesophageal reflux
4923065|NCT01982968|GER|ger
4923066|NCT01982968|GERD|gerd
4923067|NCT01982955|MSC2156119J|msc2156119j
4923068|NCT01982955|Gefitinib|gefitinib
4923069|NCT01982955|Pemetrexed|pemetrexed
4923070|NCT01982955|Cisplatin|cisplatin
4923071|NCT01982955|MET positive|met positive
4923072|NCT01982955|Tepotinib|tepotinib
4923073|NCT01982955|Carboplatin|carboplatin
4923074|NCT01982955|INSIGHT|insight
4923075|NCT01982916|Allergic Rhinitis|allergic rhinitis
4923076|NCT01982916|Perennial Allergic Rhinitis|perennial allergic rhinitis
4923077|NCT01982916|Non-seasonal Allergic Rhinitis|non-seasonal allergic rhinitis
4923078|NCT01982916|PAR|par
4923079|NCT01982903|kidney transplantation|kidney transplantation
4923080|NCT01982903|connective tissue growth factor|connective tissue growth factor
4923081|NCT01982903|fibrosis|fibrosis
4923082|NCT01982890|Telomere length|telomere length
4923083|NCT01982890|Longitudinal observation|longitudinal observation
4923084|NCT01982877|decision making|decision making
4923085|NCT01982877|values elicitation|values elicitation
4923086|NCT01982877|patient centered care|patient centered care
4923087|NCT01982877|Four Supports|four supports
4923088|NCT01982877|Family Support|family support
4923089|NCT01982864|Aminoglycosides|aminoglycosides
4923090|NCT01982864|hemodialysis|hemodialysis
4923091|NCT01982864|clinical pharmacokinetics|clinical pharmacokinetics
4923092|NCT01982864|pharmacokinetic modelling|pharmacokinetic modelling
4923093|NCT01982864|Bayesian estimation|bayesian estimation
4923094|NCT01982864|Necessity|necessity
4923095|NCT01982864|of the treatment|of the treatment
4923096|NCT01982864|gentamicin|gentamicin
4923097|NCT01982851|pain|pain
4923098|NCT01982851|epidural|epidural
4923099|NCT01982851|combined spinal epidural|combined spinal epidural
4923100|NCT01982838|pain|pain
4923101|NCT01982838|epidural|epidural
4923102|NCT01982838|combined spinal epidural|combined spinal epidural
4923103|NCT01982825|Tobacco use cessation|tobacco use cessation
4923104|NCT01982825|Cigarette smoking|cigarette smoking
4923105|NCT01982799|Endodontic treatment, analgesics, anesthesia, post-operative pain|endodontic treatment, analgesics, anesthesia, post-operative pain
4923106|NCT01982773|Virtual Hope Box|virtual hope box
4923107|NCT01982760|Rhinoplasty|rhinoplasty
4923108|NCT01982760|Ecchymosis|ecchymosis
4923109|NCT01982760|Edema|edema
4923110|NCT01982747|Cardiac Safety|cardiac safety
4923111|NCT01982747|General Safety|general safety
4923112|NCT01982747|Pharmacokinetics|pharmacokinetics
4923113|NCT01982734|bioavailability|bioavailability
4923114|NCT01982734|curcumin|curcumin
4923115|NCT01982734|pharmacokinetic|pharmacokinetic
4923116|NCT01982734|curcuma longa|curcuma longa
4923117|NCT01982734|age differences|age differences
4923118|NCT01982734|sex differences|sex differences
4923119|NCT01982708|Evaluation|evaluation
4923120|NCT01982695|Duchenne muscular Dystrophy (DMD)|duchenne muscular dystrophy (dmd)
4923121|NCT01982695|Cardiomyopathy|cardiomyopathy
4923122|NCT01982695|Losartan|losartan
4923123|NCT01982695|Lisinopril|lisinopril
4923124|NCT01982669|Salty taste|salty taste
4923125|NCT01982669|Urinary sodium excretion|urinary sodium excretion
4923126|NCT01982669|Spicy hedonic|spicy hedonic
4923127|NCT01982669|Blood pressure|blood pressure
4923128|NCT01982617|Transtheoretical Model|transtheoretical model
4923129|NCT01982617|Stages of Change|stages of change
4923130|NCT01982617|Nicotine Dependence|nicotine dependence
4923131|NCT01982617|Severe Mental Illness|severe mental illness
4923132|NCT01982578|Treatment|treatment
4923133|NCT01982578|Genistein|genistein
4923134|NCT01982578|Alzheimer's disease|alzheimer's disease
4923135|NCT01982578|Cerebrospinal fluid|cerebrospinal fluid
4923136|NCT01982578|Amyloid beta|amyloid beta
4923137|NCT01982565|Nitric oxide|nitric oxide
4923138|NCT01982565|Nitric oxide dressing|nitric oxide dressing
4923139|NCT01982565|NOx|nox
4923140|NCT01982565|NOx dressing|nox dressing
4923141|NCT01982565|Diabetic|diabetic
4923142|NCT01982565|Foot|foot
4923143|NCT01982565|Ulcers|ulcers
4923144|NCT01982565|Chronic|chronic
4923145|NCT01982552|Plaque psoriasis|plaque psoriasis
4923146|NCT01982552|calcipotriene|calcipotriene
4923147|NCT01982552|betamethasone dipropionate|betamethasone dipropionate
4923148|NCT01982552|topical|topical
4923149|NCT01982539|pain|pain
4923150|NCT01982539|NSAID|nsaid
4923151|NCT01982539|moderate pain|moderate pain
4923152|NCT01982539|mild pain|mild pain
4923153|NCT01982539|acute pain|acute pain
4923154|NCT01982539|mild acute pain|mild acute pain
4923155|NCT01982539|moderate acute pain|moderate acute pain
4923156|NCT01982539|mild or moderate acute pain|mild or moderate acute pain
4923157|NCT01982526|Ovarian reserve|ovarian reserve
4923158|NCT01982526|Antimullerian hormone|antimullerian hormone
4923159|NCT01982513|Cardiopulmonary Resuscitation|cardiopulmonary resuscitation
4923160|NCT01982513|Pregnancy|pregnancy
4923161|NCT01982513|Ultrasound|ultrasound
4923162|NCT01982513|Inferior Vena Cava|inferior vena cava
4923163|NCT01982500|Ovarian Cancer|ovarian cancer
4923164|NCT01982500|Chemotherapy|chemotherapy
4923165|NCT01982500|Anti-angiogenic agent|anti-angiogenic agent
4923166|NCT01982500|Bevacizumab|bevacizumab
4923167|NCT01982500|Front Line|front line
4923168|NCT01982474|allergic rhinitis|allergic rhinitis
4923169|NCT01982448|TRIPLE NEGATIVE BREAST CANCER WITHOUT GERMLINE BRCA MUTATIONS|triple negative breast cancer without germline brca mutations
4923170|NCT01982448|CISPLATIN|cisplatin
4923171|NCT01982448|PACLITAXEL|paclitaxel
4923172|NCT01982435|Diabetes|diabetes
4923173|NCT01982435|Macular Edema|macular edema
4923174|NCT01982422|Attention Deficit and Hyperactivity Disorder|attention deficit and hyperactivity disorder
4923175|NCT01982422|Nutrition|nutrition
4923176|NCT01982422|Diet|diet
4923177|NCT01982422|Developmental Origins of Disease|developmental origins of disease
4923178|NCT01982396|HIV|hiv
4923179|NCT01982396|paediatric|paediatric
4923180|NCT01982396|Abacavir|abacavir
4923181|NCT01982396|lamivudine|lamivudine
4923182|NCT01982383|CSC|csc
4923183|NCT01982383|Edema|edema
4923184|NCT01982383|Retinopathy|retinopathy
4923185|NCT01982344|mini-exchange-room|mini-exchange-room
4923186|NCT01982344|physical activity|physical activity
4923187|NCT01982344|quality of life|quality of life
4923188|NCT01982344|peritoneal dialysis|peritoneal dialysis
4923189|NCT01982331|H2N2|h2n2
4923190|NCT01982331|vaccine|vaccine
4923191|NCT01982318|Venous Leg Ulcer|venous leg ulcer
4923192|NCT01982318|Leg Ulcer|leg ulcer
4923193|NCT01982318|Venous Hypertension|venous hypertension
4923194|NCT01982318|Venous Reflux|venous reflux
4923195|NCT01982318|Deep Venous System|deep venous system
4923196|NCT01982318|Chronic leg ulceration|chronic leg ulceration
4923197|NCT01982318|Calf perforator|calf perforator
4923198|NCT01982292|Chronic Heart Failure, CHF, Heart Failure, HF, Immunogenicity, Anti-bodies, Hypersensitivity, Serelaxin, RELAX-REPEAT|chronic heart failure, chf, heart failure, hf, immunogenicity, anti-bodies, hypersensitivity, serelaxin, relax-repeat
4923199|NCT01982279|Caloric compensation|caloric compensation
4923200|NCT01982279|Eating in the absence of hunger|eating in the absence of hunger
4923201|NCT01982279|Preschool children|preschool children
4923202|NCT01982279|Maternal feeding practices|maternal feeding practices
4923203|NCT01982279|Maternal eating behavior|maternal eating behavior
4923204|NCT01982279|one year|one year
4923205|NCT01982279|children|children
4923206|NCT01982253|Drug therapy|drug therapy
4923207|NCT01982240|CIC|cic
4923208|NCT01982240|Constipation|constipation
4923209|NCT01982240|Chronic Constipation|chronic constipation
4923210|NCT01982240|Synergy|synergy
4923211|NCT01982240|Plecanatide|plecanatide
4923212|NCT01982227|colorectal cancer metastatic|colorectal cancer metastatic
4923213|NCT01982227|indocyanine green|indocyanine green
4923214|NCT01982214|osteopenia|osteopenia
4923215|NCT01982214|whole body vibration|whole body vibration
4923216|NCT01982214|women|women
4923217|NCT01982214|bone microarchitecture|bone microarchitecture
4923218|NCT01982214|bone density|bone density
4923219|NCT01982188|single incision sling|single incision sling
4923220|NCT01982188|cough stress test|cough stress test
4923221|NCT01982188|MiniArc|miniarc
4923222|NCT01982188|UDI-6|udi-6
4923223|NCT01982188|UIQ-7|uiq-7
4923224|NCT01982188|Sandvick Severity Index (SSI)|sandvick severity index (ssi)
4923225|NCT01982175|Alemtuzumab|alemtuzumab
4923226|NCT01982175|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
4923227|NCT01982175|CD52|cd52
4923228|NCT01982162|Sputum|sputum
4923229|NCT01982162|Clinical cohorts|clinical cohorts
4923230|NCT01982162|Smokers|smokers
4923231|NCT01982162|Asthma|asthma
4923232|NCT01982162|Biopsies|biopsies
4923233|NCT01982162|Severe asthma|severe asthma
4923234|NCT01982162|Collaborative research|collaborative research
4923235|NCT01982162|Phenotyping|phenotyping
4923236|NCT01982162|Lipidomics|lipidomics
4923237|NCT01982162|Transcriptomics|transcriptomics
4923238|NCT01982162|Proteomics|proteomics
4923239|NCT01982162|Paediatric cohort|paediatric cohort
4923240|NCT01982162|Systems Biology|systems biology
4923241|NCT01982149|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
4923242|NCT01982149|COPD|copd
4923243|NCT01982149|Smokers|smokers
4923244|NCT01982149|Nonsmokers|nonsmokers
4923245|NCT01982110|smoking cessation|smoking cessation
4923246|NCT01982110|mindfulness|mindfulness
4923247|NCT01982110|behavioral intervention|behavioral intervention
4923248|NCT01982097|Non-interventional|non-interventional
4923249|NCT01982097|Nexavar|nexavar
4923250|NCT01982097|Sorafenib|sorafenib
4923251|NCT01982097|Carcinoma, renal cell|carcinoma, renal cell
4923252|NCT01982097|Neoadjuvant|neoadjuvant
4923253|NCT01982097|Nephrectomy|nephrectomy
4923254|NCT01982097|Russian Federation|russian federation
4923255|NCT01982084|Group B streptococcus|group b streptococcus
4923256|NCT01982084|Immunisation|immunisation
4923257|NCT01982084|Pregnancy|pregnancy
4923258|NCT01982084|Attitudes|attitudes
4923259|NCT01982071|Micafungin|micafungin
4923260|NCT01982071|candidiasis|candidiasis
4923261|NCT01982071|candidemia|candidemia
4923262|NCT01982071|Open-label design|open-label design
4923263|NCT01982045|Bone graft|bone graft
4923264|NCT01982045|Ceramic|ceramic
4923265|NCT01982045|Spinal fusion|spinal fusion
4923266|NCT01982045|RCT|rct
4923267|NCT01982045|Thoracolumbar region|thoracolumbar region
4923268|NCT01982032|Periprosthetic aortic valve regurgitation|periprosthetic aortic valve regurgitation
4923269|NCT01982032|3D transesophageal echocardiography|3d transesophageal echocardiography
4923270|NCT01982032|Cardiac MRI|cardiac mri
4923271|NCT01982019|26RFa|26rfa
4923272|NCT01982019|sleeve gastrectomy|sleeve gastrectomy
4923273|NCT01982019|diabetes|diabetes
4923274|NCT01982019|obesity|obesity
4923275|NCT01982006|cataract surgery|cataract surgery
4923276|NCT01982006|femtosecond laser cataract surgery|femtosecond laser cataract surgery
4923277|NCT01982006|phacoemulsification|phacoemulsification
4923278|NCT01982006|Cost-Benefit Analysis|cost-benefit analysis
4923279|NCT01982006|Cost Effectiveness|cost effectiveness
4923280|NCT01982006|Hospital Costs|hospital costs
4923281|NCT01981980|Carbon dioxide|carbon dioxide
4923282|NCT01981980|Carboxytherapy|carboxytherapy
4923283|NCT01981980|Radiofrequency|radiofrequency
4923284|NCT01981967|Japanese encephalitis|japanese encephalitis
4923285|NCT01981967|IMOJEV®|imojev®
4923286|NCT01981967|Japanese encephalitis chimeric virus vaccine|japanese encephalitis chimeric virus vaccine
4923287|NCT01981954|Solifenacin succinate suspension|solifenacin succinate suspension
4923288|NCT01981954|Efficacy|efficacy
4923289|NCT01981954|Safety|safety
4923290|NCT01981941|Gabapentin|gabapentin
4923291|NCT01981941|Restless legs syndrome (RLS)|restless legs syndrome (rls)
4923292|NCT01981928|Phase 1|phase 1
4923293|NCT01981928|Healthy Subjects|healthy subjects
4923294|NCT01981928|Safety|safety
4923295|NCT01981928|Tolerability|tolerability
4923296|NCT01981928|Pharmacokinetics|pharmacokinetics
4923297|NCT01981928|Single Ascending Oral Dose|single ascending oral dose
4923298|NCT01981928|Food Effect|food effect
4923299|NCT01981915|Cough augmentation|cough augmentation
4923300|NCT01981915|Peak cough flow|peak cough flow
4923301|NCT01981915|hyperinsufflation|hyperinsufflation
4923302|NCT01981902|Dehydration|dehydration
4923303|NCT01981889|steroid, inflammatory bowel diseases|steroid, inflammatory bowel diseases
4923304|NCT01981876|Dysplasia|dysplasia
4923305|NCT01981876|Esophageal Squamous Cell Carcinoma|esophageal squamous cell carcinoma
4923306|NCT01981863|cardiac surgery|cardiac surgery
4923307|NCT01981863|cardiopulmonary bypass|cardiopulmonary bypass
4923308|NCT01981863|fibrinolysis|fibrinolysis
4923309|NCT01981863|thromboelastography|thromboelastography
4923310|NCT01981863|D-Dimers|d-dimers
4923311|NCT01981863|antifibrinolytic agents|antifibrinolytic agents
4923312|NCT01981850|fibrosis|fibrosis
4923414|NCT01981486|PF-05180999|pf-05180999
4923313|NCT01981837|RNAi therapeutic|rnai therapeutic
4923314|NCT01981824|prediction IUGR FL/MTC|prediction iugr fl/mtc
4923315|NCT01981811|OPC-14597 Digital|opc-14597 digital
4923316|NCT01981811|Aripiprazole|aripiprazole
4923317|NCT01981811|Medical Information Device #1 System (MIND1)|medical information device #1 system (mind1)
4923318|NCT01981811|Treatment Adherence|treatment adherence
4923319|NCT01981811|Ingestible Event Marker|ingestible event marker
4923320|NCT01981798|outpatient intervention program|outpatient intervention program
4923321|NCT01981798|behavioral therapy approach|behavioral therapy approach
4923322|NCT01981798|unspecific back pain|unspecific back pain
4923323|NCT01981798|unspecific neck pain|unspecific neck pain
4923324|NCT01981798|chronic pain|chronic pain
4923325|NCT01981798|physiotherapy|physiotherapy
4923326|NCT01981798|occupational therapy|occupational therapy
4923327|NCT01981798|psychosocial aspects|psychosocial aspects
4923328|NCT01981798|fear avoidance beliefs|fear avoidance beliefs
4923329|NCT01981798|health-related quality of life|health-related quality of life
4923330|NCT01981785|Primary immune deficiencies|primary immune deficiencies
4923331|NCT01981785|Autoimmune diseases|autoimmune diseases
4923332|NCT01981785|Inflammatory diseases|inflammatory diseases
4923333|NCT01981785|Common variable immune deficiencies|common variable immune deficiencies
4923334|NCT01981785|Primary Immunodeficiencies|primary immunodeficiencies
4923335|NCT01981785|Immunoglobulin|immunoglobulin
4923336|NCT01981785|IgG|igg
4923337|NCT01981785|IVIG|ivig
4923338|NCT01981785|Recurrent Infections|recurrent infections
4923339|NCT01981759|Schizophrenia|schizophrenia
4923340|NCT01981759|Delusions|delusions
4923341|NCT01981759|D-Cycloserine|d-cycloserine
4923342|NCT01981759|CBT|cbt
4923343|NCT01981746|adductor canal block|adductor canal block
4923344|NCT01981746|healthy volunteers|healthy volunteers
4923345|NCT01981746|US-guided peripheral nerve block|us-guided peripheral nerve block
4923346|NCT01981746|lower limb|lower limb
4923347|NCT01981733|Deep Vein Thrombosis|deep vein thrombosis
4923348|NCT01981720|PRX-102|prx-102
4923349|NCT01981720|pegunigalsidase alfa|pegunigalsidase alfa
4923350|NCT01981720|Fabry Disease|fabry disease
4923351|NCT01981707|castration-resistant prostate cancer|castration-resistant prostate cancer
4923352|NCT01981707|abiraterone acetate|abiraterone acetate
4923353|NCT01981707|enzalutamide|enzalutamide
4923354|NCT01981707|choline pet|choline pet
4923355|NCT01981694|Phase 1|phase 1
4923356|NCT01981694|Randomized|randomized
4923357|NCT01981694|Double Blind|double blind
4923358|NCT01981694|Placebo-Controlled|placebo-controlled
4923359|NCT01981694|Single-Dose Escalation|single-dose escalation
4923360|NCT01981694|Safety|safety
4923361|NCT01981694|Tolerability|tolerability
4923362|NCT01981694|PK|pk
4923363|NCT01981694|PD|pd
4923364|NCT01981694|PF-06649751|pf-06649751
4923365|NCT01981681|Phase 1|phase 1
4923366|NCT01981681|Randomized|randomized
4923367|NCT01981681|Placebo-Controlled|placebo-controlled
4923368|NCT01981681|Multiple Dose Escalation|multiple dose escalation
4923369|NCT01981681|Tolerability|tolerability
4923370|NCT01981681|Safety|safety
4923371|NCT01981681|PK|pk
4923372|NCT01981681|Topical|topical
4923373|NCT01981681|Healthy|healthy
4923374|NCT01981681|PF-06263276|pf-06263276
4923375|NCT01981655|Sodium Lactate|sodium lactate
4923376|NCT01981655|Acute|acute
4923377|NCT01981655|Heart|heart
4923378|NCT01981655|Failure|failure
4923379|NCT01981655|Perfusion|perfusion
4923380|NCT01981629|Shock|shock
4923381|NCT01981629|USCOM|uscom
4923382|NCT01981629|Cardiac Ultrasound|cardiac ultrasound
4923383|NCT01981629|Emergency Department|emergency department
4923384|NCT01981616|Drug therapy|drug therapy
4923385|NCT01981603|Navigators|navigators
4923386|NCT01981603|Kidney Transplant|kidney transplant
4923387|NCT01981603|Hemodialysis|hemodialysis
4923388|NCT01981590|breathing, heart failure, sleep apnea|breathing, heart failure, sleep apnea
4923389|NCT01981577|Parkinson Disease|parkinson disease
4923390|NCT01981577|Subthalamic Nucleus|subthalamic nucleus
4923391|NCT01981577|Ultrahigh field Magnetic Resonance imaging|ultrahigh field magnetic resonance imaging
4923392|NCT01981577|Functional connectivity|functional connectivity
4923393|NCT01981577|Structural connectivity|structural connectivity
4923394|NCT01981564|Pediatric|pediatric
4923395|NCT01981564|Emergency department visit|emergency department visit
4923396|NCT01981551|Desmoid Tumor|desmoid tumor
4923397|NCT01981551|Aggressive Fibromatosis|aggressive fibromatosis
4923398|NCT01981551|Gamma-secretase Inhibitor|gamma-secretase inhibitor
4923399|NCT01981551|Notch Pathway|notch pathway
4923400|NCT01981538|Web-Based Survey|web-based survey
4923401|NCT01981538|Cancer Caregivers|cancer caregivers
4923402|NCT01981525|TP53 Mutation|tp53 mutation
4923403|NCT01981525|Autosomal Dominant Hereditary Disorder|autosomal dominant hereditary disorder
4923404|NCT01981525|Chemoprevention|chemoprevention
4923405|NCT01981499|PF-05180999|pf-05180999
4923406|NCT01981499|safety|safety
4923407|NCT01981499|tolerability|tolerability
4923408|NCT01981499|pharmacokinetics|pharmacokinetics
4923409|NCT01981499|histamine|histamine
4923410|NCT01981499|wheal|wheal
4923411|NCT01981499|flare|flare
4923412|NCT01981499|migraine|migraine
4923413|NCT01981499|PDE2|pde2
4923416|NCT01981486|tolerability|tolerability
4923417|NCT01981486|pharmacokinetics|pharmacokinetics
4923418|NCT01981486|migraine|migraine
4923419|NCT01981486|PDE2|pde2
4923420|NCT01981486|cAMP|camp
4923421|NCT01981486|cGMP|cgmp
4923422|NCT01981486|cantharidin|cantharidin
4923423|NCT01981486|blister|blister
4923424|NCT01981486|CYP3A induction|cyp3a induction
4923425|NCT01981473|rheumatoid arthritis|rheumatoid arthritis
4923426|NCT01981473|etanercept|etanercept
4923427|NCT01981473|adalimumab|adalimumab
4923428|NCT01981473|infliximab|infliximab
4923429|NCT01981473|anti-drug antibody|anti-drug antibody
4923430|NCT01981473|immunogenicity|immunogenicity
4923431|NCT01981473|drug concentration|drug concentration
4923432|NCT01981447|epilepsy|epilepsy
4923433|NCT01981421|Liver fibrosis|liver fibrosis
4923434|NCT01981421|Elastography|elastography
4923435|NCT01981421|MR Elastography|mr elastography
4923436|NCT01981421|Quantitative imaging|quantitative imaging
4923437|NCT01981395|fenobam|fenobam
4923438|NCT01981395|heat|heat
4923439|NCT01981395|capsaicin|capsaicin
4923440|NCT01981395|hyperalgesia|hyperalgesia
4923441|NCT01981395|allodynia|allodynia
4923442|NCT01981395|mood|mood
4923443|NCT01981395|cognitive function|cognitive function
4923444|NCT01981382|low back pain|low back pain
4923445|NCT01981382|pain sensitivity|pain sensitivity
4923446|NCT01981382|genes|genes
4923447|NCT01981382|gene expression,|gene expression,
4923448|NCT01981382|quantitative sensory testing|quantitative sensory testing
4923449|NCT01981369|Dexmedetomidine sedation|dexmedetomidine sedation
4923450|NCT01981369|Regional Anesthesia|regional anesthesia
4923451|NCT01981369|Infraclavicular block|infraclavicular block
4923452|NCT01981356|Psychotic Disorders|psychotic disorders
4923453|NCT01981356|Acceptance and Commitment Therapy|acceptance and commitment therapy
4923454|NCT01981356|Inpatient psychiatry|inpatient psychiatry
4923455|NCT01981356|Schizophrenia|schizophrenia
4923456|NCT01981356|Acute psychiatric disorder|acute psychiatric disorder
4923457|NCT01981343|Gallbladder motility|gallbladder motility
4923458|NCT01981343|A-F Betafood|a-f betafood
4923459|NCT01981343|Betaine|betaine
4923460|NCT01981343|Ejection fraction|ejection fraction
4923461|NCT01981343|Ejection rate|ejection rate
4923462|NCT01981343|Ultrasound|ultrasound
4923463|NCT01981330|vocal fold scarring|vocal fold scarring
4923464|NCT01981330|mesenchymal stem cells|mesenchymal stem cells
4923465|NCT01981317|Obsessive Compulsive Disorder|obsessive compulsive disorder
4923466|NCT01981317|Cognitive Behavioral Therapy|cognitive behavioral therapy
4923467|NCT01981317|Stepped Care CBT|stepped care cbt
4923468|NCT01981317|Exposure and Response Prevention|exposure and response prevention
4923469|NCT01981317|Psychotherapy|psychotherapy
4923470|NCT01981317|Counseling|counseling
4923471|NCT01981304|Coronary artery disease|coronary artery disease
4923472|NCT01981304|Percutaneous coronary intervention|percutaneous coronary intervention
4923473|NCT01981291|Lower Extremity|lower extremity
4923474|NCT01981291|Sciatic Nerve|sciatic nerve
4923475|NCT01981291|Anesthesia, Regional|anesthesia, regional
4923476|NCT01981291|Anesthetics, Local|anesthetics, local
4923477|NCT01981291|Mepivacaine|mepivacaine
4923478|NCT01981291|Ultrasonography|ultrasonography
4923479|NCT01981278|Healthy|healthy
4923480|NCT01981278|Tapentadol|tapentadol
4923481|NCT01981278|Bioequivalence|bioequivalence
4923482|NCT01981278|Fasted|fasted
4923483|NCT01981252|Ulthera® System|ulthera® system
4923484|NCT01981252|Ultherapy™ Treatment|ultherapy™ treatment
4923485|NCT01981252|Ulthera, Inc.|ulthera, inc.
4923486|NCT01981252|Micro-focused Ultrasound with Visualization (MFU-V)|micro-focused ultrasound with visualization (mfu-v)
4923487|NCT01981239|voice analysis aspiration prediction|voice analysis aspiration prediction
4923488|NCT01981213|Acetaminophen|acetaminophen
4923489|NCT01981213|Suicide|suicide
4923490|NCT01981213|Attempts|attempts
4923491|NCT01981213|Early Predictors of Hepatic Injury|early predictors of hepatic injury
4923492|NCT01981213|Childhood Suicidal Behaviour|childhood suicidal behaviour
4923493|NCT01981200|COPD acute exacerbation|copd acute exacerbation
4923494|NCT01981200|Physiotherapy|physiotherapy
4923495|NCT01981200|Resistance training|resistance training
4923496|NCT01981200|Muscle strength|muscle strength
4923497|NCT01981200|Handheld dynamometer|handheld dynamometer
4923498|NCT01981161|progressive multifocal leucoencephalopathy|progressive multifocal leucoencephalopathy
4923499|NCT01981161|JC virus|jc virus
4923500|NCT01981161|Zoster infection|zoster infection
4923501|NCT01981135|Controlled Human exposure study|controlled human exposure study
4923502|NCT01981135|Air Pollution|air pollution
4923503|NCT01981135|Temperature|temperature
4923504|NCT01981135|Lung Function|lung function
4923505|NCT01981135|Cardiovascular|cardiovascular
4923506|NCT01981096|juvenile fibromyalgia|juvenile fibromyalgia
4923507|NCT01981096|pain in children|pain in children
4923508|NCT01981096|musculoskeletal pain|musculoskeletal pain
4923509|NCT01981096|cognitive behavioral therapy|cognitive behavioral therapy
4923510|NCT01981096|coping skills training|coping skills training
4923511|NCT01981083|Protein-Energy Malnutrition|protein-energy malnutrition
4923512|NCT01981083|Chronic Kidney Disease|chronic kidney disease
4923513|NCT01981083|Malnutrition-Inflammation Score|malnutrition-inflammation score
4923514|NCT01981083|Subjective Global Assessment|subjective global assessment
4923515|NCT01981083|Hemodialysis|hemodialysis
4923516|NCT01981083|Egg albumin|egg albumin
4923517|NCT01981070|parent support|parent support
4923518|NCT01981070|mindfulness|mindfulness
4923519|NCT01981070|intellectual disability|intellectual disability
4923520|NCT01981070|developmental disability|developmental disability
4923521|NCT01981070|empowerment|empowerment
4923522|NCT01981070|psychological acceptance|psychological acceptance
4923523|NCT01981070|parental stress|parental stress
4923524|NCT01981070|parental depression|parental depression
4923525|NCT01981057|parenteral nutrition|parenteral nutrition
4923526|NCT01981057|Numeta|numeta
4923527|NCT01981057|prescription software Cato Pan|prescription software cato pan
4923528|NCT01981018|Mental imagery, CBT, anxiety, mood instability|mental imagery, cbt, anxiety, mood instability
4923529|NCT01980992|Food Allergy|food allergy
4923530|NCT01980992|Wheat Allergy|wheat allergy
4923531|NCT01980992|Oral Immunotherapy|oral immunotherapy
4923532|NCT01980979|congenital heart disease,pulmonary hypertension,prostacyclin|congenital heart disease,pulmonary hypertension,prostacyclin
4923533|NCT01980927|Migraine|migraine
4923534|NCT01980927|National Upper Cervical Chiropractic Association atlas correction|national upper cervical chiropractic association atlas correction
4923535|NCT01980914|hypoglycemia|hypoglycemia
4923536|NCT01980914|type 2 diabetes|type 2 diabetes
4923537|NCT01980914|insulin glargine|insulin glargine
4923538|NCT01980914|cardiac function|cardiac function
4923539|NCT01980914|myocardial ischemia|myocardial ischemia
4923540|NCT01980914|cardiac rhythm|cardiac rhythm
4923541|NCT01980914|autonomic cardiovascular function|autonomic cardiovascular function
4923542|NCT01980901|AAA|aaa
4923543|NCT01980849|Nadroparin|nadroparin
4923544|NCT01980849|venous thromboembolism prophylaxis|venous thromboembolism prophylaxis
4923545|NCT01980836|Rheumatoid arthritis|rheumatoid arthritis
4923546|NCT01980836|Tocilizumab|tocilizumab
4923547|NCT01980836|Seasonal influenza vaccine|seasonal influenza vaccine
4923548|NCT01980823|Breast Cancer|breast cancer
4923549|NCT01980823|Metformin|metformin
4923550|NCT01980823|Atorvastatin|atorvastatin
4923551|NCT01980823|Ki-67|ki-67
4923552|NCT01980797|Bicuspid aortic valve disease|bicuspid aortic valve disease
4923553|NCT01980797|Thoracic aortic disease|thoracic aortic disease
4923554|NCT01980797|Genetics|genetics
4923555|NCT01980797|Echocardiography|echocardiography
4923556|NCT01980797|Cardiac CT|cardiac ct
4923557|NCT01980797|Cardiac MRI|cardiac mri
4923558|NCT01980784|Spinal Cord Injury|spinal cord injury
4923559|NCT01980771|HIV|hiv
4923560|NCT01980771|prevention|prevention
4923561|NCT01980771|men|men
4923562|NCT01980771|African American|african american
4923563|NCT01980758|obesity, pediatric obesity, bariatric, bariatric surgery|obesity, pediatric obesity, bariatric, bariatric surgery
4923564|NCT01980745|autoimmune hepatitis|autoimmune hepatitis
4923565|NCT01980745|recurrence|recurrence
4923566|NCT01980745|treatment withdrawal|treatment withdrawal
4923567|NCT01980745|chloroquine|chloroquine
4923568|NCT01980745|maintenance of remission|maintenance of remission
4923569|NCT01980706|Baclofen|baclofen
4923570|NCT01980706|Alcohol Dependence|alcohol dependence
4923571|NCT01980667|lurbinectedin|lurbinectedin
4923572|NCT01980667|PM01183|pm01183
4923573|NCT01980667|tumors|tumors
4923574|NCT01980667|cancer|cancer
4923575|NCT01980667|Pharma Mar|pharma mar
4923576|NCT01980654|Pharmacyclics|pharmacyclics
4923577|NCT01980654|PCYC|pcyc
4923578|NCT01980654|Lymphoma|lymphoma
4923579|NCT01980654|Follicular Lymphoma|follicular lymphoma
4923580|NCT01980654|FL|fl
4923581|NCT01980654|Rituximab|rituximab
4923582|NCT01980654|Ibrutinib|ibrutinib
4923583|NCT01980654|Rituxan|rituxan
4923584|NCT01980654|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
4923585|NCT01980654|NHL|nhl
4923586|NCT01980654|B-cell Lymphoma|b-cell lymphoma
4923587|NCT01980641|Stroke|stroke
4923588|NCT01980641|ADL|adl
4923589|NCT01980641|mHealth|mhealth
4923590|NCT01980641|App|app
4923591|NCT01980641|Adherence|adherence
4923592|NCT01980641|Home|home
4923593|NCT01980641|Environment|environment
4923594|NCT01980641|Tool|tool
4923595|NCT01980641|Advice|advice
4923596|NCT01980641|Smartphone|smartphone
4923597|NCT01980628|MZL|mzl
4923598|NCT01980628|NHL|nhl
4923599|NCT01980628|SMZL|smzl
4923600|NCT01980628|NMZL|nmzl
4923601|NCT01980628|MALT|malt
4923602|NCT01980602|Intermittent claudication|intermittent claudication
4923603|NCT01980602|endothelial function|endothelial function
4923604|NCT01980602|cardiopulmonary testing|cardiopulmonary testing
4923605|NCT01980602|inflammation|inflammation
4923606|NCT01980602|muscle architecture|muscle architecture
4923607|NCT01980589|multiple myeloma|multiple myeloma
4923608|NCT01980576|Pain|pain
4923609|NCT01980576|Sensitization|sensitization
4923610|NCT01980576|Spondylitis|spondylitis
4923611|NCT01980485|smoker|smoker
4923612|NCT01980459|Hypomagnesemia, Cellular Mg, Inflammation, Diabetes Mellitus|hypomagnesemia, cellular mg, inflammation, diabetes mellitus
4923613|NCT01980446|Coma|coma
4923614|NCT01980446|Cardiac arrest|cardiac arrest
4923615|NCT01980446|Neurophysiology|neurophysiology
4923616|NCT01980446|Auditory evoked potential|auditory evoked potential
4923617|NCT01980433|Wilson disease|wilson disease
4923618|NCT01980433|Dystonia|dystonia
4923619|NCT01980433|Movement Disorders|movement disorders
4923620|NCT01980433|Handwriting|handwriting
4923621|NCT01980433|Repetitive Transcranial Magnetic Stimulation|repetitive transcranial magnetic stimulation
4923622|NCT01980420|Sleeve gastrectomy|sleeve gastrectomy
4923623|NCT01980420|Oesogastric junction - GEJ|oesogastric junction - gej
4923624|NCT01980420|Dynamic MRI Imaging|dynamic mri imaging
4923625|NCT01980407|S-1|s-1
4923626|NCT01980407|Oxaliplatin|oxaliplatin
4923627|NCT01980407|Leucovorin|leucovorin
4923628|NCT01980407|Gastric Cancer|gastric cancer
4923629|NCT01980394|esophagus|esophagus
4923630|NCT01980394|gastro-esophegeal junction|gastro-esophegeal junction
4923631|NCT01980394|cancer|cancer
4923632|NCT01980394|tumor seeding|tumor seeding
4923633|NCT01980394|free viable tumor cells|free viable tumor cells
4923634|NCT01980394|surgery|surgery
4923635|NCT01980394|intraluminal tumor cells|intraluminal tumor cells
4923636|NCT01980394|stump washout|stump washout
4923637|NCT01980355|cancer|cancer
4923638|NCT01980355|surgery|surgery
4923639|NCT01980355|oncology|oncology
4923640|NCT01980355|major|major
4923641|NCT01980355|surgical oncology|surgical oncology
4923642|NCT01980355|tranexamic acid|tranexamic acid
4923643|NCT01980342|Long acting reversible contraception|long acting reversible contraception
4923644|NCT01980342|HIV|hiv
4923645|NCT01980329|CYP3A5|cyp3a5
4923646|NCT01980329|maraviroc|maraviroc
4923647|NCT01980329|polymorphism|polymorphism
4923648|NCT01980316|Argatroban|argatroban
4923649|NCT01980316|Extracranial vertebral Artery Stenting|extracranial vertebral artery stenting
4923650|NCT01980316|restenosis|restenosis
4923651|NCT01980303|Healthy|healthy
4923652|NCT01980303|Japanese|japanese
4923653|NCT01980303|Caucasian|caucasian
4923654|NCT01980303|Anesthetics|anesthetics
4923655|NCT01980303|Intranasal|intranasal
4923656|NCT01980303|Esketamine|esketamine
4923657|NCT01980303|Pharmacokinetics|pharmacokinetics
4923658|NCT01980290|HCV genotype 1|hcv genotype 1
4923659|NCT01980290|Liver Fibrosis|liver fibrosis
4923660|NCT01980290|ex-People who INject Drugs (ex-PWIDs)|ex-people who inject drugs (ex-pwids)
4923661|NCT01980264|Melanoma|melanoma
4923662|NCT01980264|Basal Cell Carcinoma|basal cell carcinoma
4923663|NCT01980264|Squamous Cell Carcinoma|squamous cell carcinoma
4923664|NCT01980264|BD, AK|bd, ak
4923665|NCT01980264|melanin|melanin
4923666|NCT01980251|Delirium, electroencephalography, CSD|delirium, electroencephalography, csd
4923667|NCT01980238|LAR|lar
4923668|NCT01980238|anastomotic leakage|anastomotic leakage
4923669|NCT01980238|Cannula ileostomy|cannula ileostomy
4923670|NCT01980238|loop ileostomy|loop ileostomy
4923671|NCT01980225|vitrification, blastocyst, artificial shrinkage, collapse|vitrification, blastocyst, artificial shrinkage, collapse
4923672|NCT01980212|non-small cell lung cancer|non-small cell lung cancer
4923673|NCT01980212|thioredoxin reductase|thioredoxin reductase
4923674|NCT01980199|visceral leishmaniasis|visceral leishmaniasis
4923675|NCT01980199|fexinidazole|fexinidazole
4923676|NCT01980199|adults|adults
4923677|NCT01980199|proof of concept|proof of concept
4923678|NCT01980199|efficacy|efficacy
4923679|NCT01980199|safety|safety
4923680|NCT01980199|pharmacokinetic|pharmacokinetic
4923681|NCT01980199|pharmacodynamic|pharmacodynamic
4923682|NCT01980186|transcranial ultrasound|transcranial ultrasound
4923683|NCT01980186|autism|autism
4923684|NCT01980186|cortical dysplasia|cortical dysplasia
4923685|NCT01980186|extra-axial fluid|extra-axial fluid
4923686|NCT01980173|Bakri balloon|bakri balloon
4923687|NCT01980147|Severe Mental Illness|severe mental illness
4923688|NCT01980134|adenomatous colorectal lesions|adenomatous colorectal lesions
4923689|NCT01980134|colorectal polyps|colorectal polyps
4923690|NCT01980134|polyps|polyps
4923691|NCT01980121|Respiratory Aspiration|respiratory aspiration
4923692|NCT01980121|Pregnancy|pregnancy
4923693|NCT01980121|Ultrasound|ultrasound
4923694|NCT01980121|Gastric Contents|gastric contents
4923695|NCT01980108|Pregnancy|pregnancy
4923696|NCT01980108|Respiratory Aspiration|respiratory aspiration
4923697|NCT01980108|Gastric Contents|gastric contents
4923698|NCT01980108|Ultrasound|ultrasound
4923699|NCT01980095|Helicobacter pylori|helicobacter pylori
4923700|NCT01980095|H. pylori|h. pylori
4923701|NCT01980095|Dyspepsia|dyspepsia
4923702|NCT01980082|head and neck surgery|head and neck surgery
4923703|NCT01980082|surgical wound infection|surgical wound infection
4923704|NCT01980082|antibiotic prophylaxis|antibiotic prophylaxis
4923705|NCT01980069|Sugammadex|sugammadex
4923706|NCT01980069|Neostigmine|neostigmine
4923707|NCT01980069|Surgery|surgery
4923708|NCT01980056|INT-2 or high-risk MDS|int-2 or high-risk mds
4923709|NCT01980017|Diabetes Type 2 Mellitus|diabetes type 2 mellitus
4923710|NCT01980017|Ottawa Model for Smoking Cessation|ottawa model for smoking cessation
4923711|NCT01980017|Diabetes Education Programs|diabetes education programs
4923712|NCT01979965|Mitral Regurgitation|mitral regurgitation
4923713|NCT01979965|cardiac resynchronization therapy|cardiac resynchronization therapy
4923714|NCT01979965|ranolazine|ranolazine
4923715|NCT01979965|maximal medical therapy|maximal medical therapy
4923716|NCT01979965|ischemic cardiomyopathy|ischemic cardiomyopathy
4924305|NCT01977417|Prediabetes|prediabetes
4923717|NCT01979913|Primary Open Angle Glaucoma|primary open angle glaucoma
4923718|NCT01979913|Ocular Hypertension|ocular hypertension
4923719|NCT01979913|Tafluprost|tafluprost
4923720|NCT01979913|Saflutan|saflutan
4923721|NCT01979913|Intraocular pressure|intraocular pressure
4923722|NCT01979913|Preservative free|preservative free
4923723|NCT01979913|Single dose unit|single dose unit
4923724|NCT01979900|TB Infection|tb infection
4923725|NCT01979900|Lesion Degree|lesion degree
4923726|NCT01979900|Bacteriology Indicators|bacteriology indicators
4923727|NCT01979900|Cavity|cavity
4923728|NCT01979900|Humoral Immunity|humoral immunity
4923729|NCT01979900|Cellular Immunologic Response|cellular immunologic response
4923730|NCT01979861|Endometrial ablation with vapor|endometrial ablation with vapor
4923731|NCT01979848|continence outcomes|continence outcomes
4923732|NCT01979848|sexual function|sexual function
4923733|NCT01979848|Robotic Assisted Radical Prostatectomy|robotic assisted radical prostatectomy
4923734|NCT01979848|thermal imaging|thermal imaging
4923735|NCT01979848|localized hypothermia|localized hypothermia
4923736|NCT01979835|intrauterine device, contraception|intrauterine device, contraception
4923737|NCT01979822|medication pump, complications, safety observation|medication pump, complications, safety observation
4923738|NCT01979809|Dietary change|dietary change
4923739|NCT01979809|Young adult|young adult
4923740|NCT01979809|Prevention|prevention
4923741|NCT01979809|Web-based intervention|web-based intervention
4923742|NCT01979809|eCoaching|ecoaching
4923743|NCT01979796|Addiction, Schizophrenia, Electronic cigarettes|addiction, schizophrenia, electronic cigarettes
4923744|NCT01979770|Adolescent|adolescent
4923745|NCT01979770|Nutritional status|nutritional status
4923746|NCT01979770|Body composition|body composition
4923747|NCT01979770|Biochemical status|biochemical status
4923748|NCT01979744|Intravenous ultrasound,|intravenous ultrasound,
4923749|NCT01979744|third generation drug-eluting stent|third generation drug-eluting stent
4923750|NCT01979731|Occupational health|occupational health
4923751|NCT01979731|Ergonomics|ergonomics
4923752|NCT01979731|Environments|environments
4923753|NCT01979731|Prevention and Control|prevention and control
4923755|NCT01979692|The study will|the study will
4923756|NCT01979692|focus on using|focus on using
4923757|NCT01979692|CLM to|clm to
4923758|NCT01979692|distinguish between|distinguish between
4923759|NCT01979692|viable and|viable and
4923760|NCT01979692|necrotic tissue|necrotic tissue
4923761|NCT01979692|at TTNB in real time|at ttnb in real time
4923762|NCT01979666|Knee AVN, Nitrates|knee avn, nitrates
4923763|NCT01979640|bronchial cuff|bronchial cuff
4923764|NCT01979640|double lumen tube|double lumen tube
4923765|NCT01979640|blood tight seal|blood tight seal
4923766|NCT01979627|transulnar approach|transulnar approach
4923767|NCT01979627|transradial approach|transradial approach
4923768|NCT01979627|angiography|angiography
4923769|NCT01979627|angioplasty|angioplasty
4923770|NCT01979614|coronary artery disease|coronary artery disease
4923771|NCT01979601|hypercholesterolemia,|hypercholesterolemia,
4923772|NCT01979601|LGT209,|lgt209,
4923773|NCT01979601|PCSK9,|pcsk9,
4923774|NCT01979601|LDL-C|ldl-c
4923775|NCT01979575|Nexfin|nexfin
4923776|NCT01979575|Flotrac|flotrac
4923777|NCT01979575|Esophageal|esophageal
4923778|NCT01979575|Cardiac output|cardiac output
4923779|NCT01979562|Overuse injury|overuse injury
4923780|NCT01979562|Femur|femur
4923781|NCT01979562|Tibia|tibia
4923782|NCT01979562|Running|running
4923783|NCT01979562|Prevention|prevention
4923784|NCT01979549|Adverse events|adverse events
4923785|NCT01979549|Upper gastrointestinal endoscopy|upper gastrointestinal endoscopy
4923786|NCT01979549|Sedation|sedation
4923787|NCT01979484|bioavailability|bioavailability
4923788|NCT01979471|Cardiovascular risk reduction|cardiovascular risk reduction
4923789|NCT01979471|Diabetes|diabetes
4923790|NCT01979471|Chronic Kidney Disease|chronic kidney disease
4923791|NCT01979471|Atherosclerotic vascular disease|atherosclerotic vascular disease
4923792|NCT01979471|Community Pharmacist|community pharmacist
4923793|NCT01979471|Randomized controlled trial|randomized controlled trial
4923794|NCT01979471|[eGFR <60 ml/min/1.73m2 and/or (ACR >= 30 mg/mmol or two consecutive ACR tests which are >= 3 mg/mmol)]|[egfr <60 ml/min/1.73m2 and/or (acr >= 30 mg/mmol or two consecutive acr tests which are >= 3 mg/mmol)]
4923795|NCT01979458|Colonoscopy|colonoscopy
4923796|NCT01979445|CAD|cad
4923797|NCT01979432|Alzheimer, cognitive diseases, Ankle-to-brachial index|alzheimer, cognitive diseases, ankle-to-brachial index
4923798|NCT01979419|mild cognitive impairment|mild cognitive impairment
4923799|NCT01979419|Alzheimer's disease|alzheimer's disease
4923800|NCT01979419|subcortical Vascular Dementia|subcortical vascular dementia
4923801|NCT01979419|amyloid|amyloid
4923802|NCT01979419|plaques|plaques
4923803|NCT01979419|neuroimaging|neuroimaging
4923804|NCT01979419|biomarkers|biomarkers
4923805|NCT01979419|cognition disorder|cognition disorder
4923806|NCT01979419|early detection|early detection
4923807|NCT01979419|pre-dementia|pre-dementia
4923808|NCT01979419|dementia|dementia
4923809|NCT01979419|vascular MCI|vascular mci
4923810|NCT01979406|Anthrax vaccine|anthrax vaccine
4923811|NCT01979393|Locally advanced|locally advanced
4923812|NCT01979393|stage III|stage iii
4923813|NCT01979393|stage IV|stage iv
4923909|NCT01978782|drug-drug interaction|drug-drug interaction
4923814|NCT01979393|residual disease after primary surgery|residual disease after primary surgery
4923815|NCT01979393|newly diagnosed HGUS|newly diagnosed hgus
4923816|NCT01979393|Metastatic|metastatic
4923817|NCT01979380|KD101|kd101
4923818|NCT01979380|Anti-obesity Agents|anti-obesity agents
4923819|NCT01979354|spinal morphine|spinal morphine
4923820|NCT01979354|VATs lobectomy|vats lobectomy
4923821|NCT01979341|dual trigger|dual trigger
4923822|NCT01979341|hCG|hcg
4923823|NCT01979341|GnRH agonist|gnrh agonist
4923824|NCT01979341|ICSI|icsi
4923825|NCT01979341|pregnancy|pregnancy
4923826|NCT01979341|OHSS|ohss
4923827|NCT01979328|Deep Vein Thrombosis|deep vein thrombosis
4923828|NCT01979302|Geriatric Depression|geriatric depression
4923829|NCT01979302|Depression Care Management|depression care management
4923830|NCT01979302|home healthcare|home healthcare
4923831|NCT01979302|nurse training intervention|nurse training intervention
4923832|NCT01979289|Executive Dysfunction|executive dysfunction
4923833|NCT01979289|Cognitive Remediation|cognitive remediation
4923834|NCT01979289|Geriatric|geriatric
4923835|NCT01979289|Depression|depression
4923836|NCT01979250|endothelial keratoplasty|endothelial keratoplasty
4923837|NCT01979250|Descemet's stripping automated endothelial keratoplasty|descemet's stripping automated endothelial keratoplasty
4923838|NCT01979250|lamellar keratoplasty|lamellar keratoplasty
4923839|NCT01979224|educational intervention, Asthma control, asthma knowledge|educational intervention, asthma control, asthma knowledge
4923840|NCT01979211|head and neck cancer|head and neck cancer
4923841|NCT01979198|burst fracture, kyphotic angle, surgical outcome|burst fracture, kyphotic angle, surgical outcome
4923842|NCT01979172|LASIK|lasik
4923843|NCT01979172|Intraocular lens|intraocular lens
4923844|NCT01979172|Biometry|biometry
4923845|NCT01979172|IOL master|iol master
4923846|NCT01979159|aphasia|aphasia
4923847|NCT01979159|apraxia of speech|apraxia of speech
4923848|NCT01979159|outcomes|outcomes
4923849|NCT01979146|Cancer|cancer
4923850|NCT01979120|Sleep-disordered breathing|sleep-disordered breathing
4923851|NCT01979120|Chronic heart failure|chronic heart failure
4923852|NCT01979120|Implantable cardioverter-defibrillator|implantable cardioverter-defibrillator
4923853|NCT01979120|Apnea-Hypopnea-Index|apnea-hypopnea-index
4923854|NCT01979120|Portable Polygraphy Monitoring|portable polygraphy monitoring
4923855|NCT01979120|Polysomnography|polysomnography
4923856|NCT01979107|Health behavior|health behavior
4923857|NCT01979107|Chronic disease|chronic disease
4923858|NCT01979107|Proactive action|proactive action
4923859|NCT01979107|General practitioner|general practitioner
4923860|NCT01979107|Preventive health check|preventive health check
4923861|NCT01979107|Social inequality in health|social inequality in health
4923862|NCT01979107|Randomised controlled trial|randomised controlled trial
4923863|NCT01979055|asthma|asthma
4923864|NCT01979055|older adults|older adults
4923865|NCT01979055|elderly|elderly
4923866|NCT01979055|behavior|behavior
4923867|NCT01979042|renal colic|renal colic
4923868|NCT01979042|acute renal failure|acute renal failure
4923869|NCT01979042|Neutrophil gelatinase associated lipocalin|neutrophil gelatinase associated lipocalin
4923870|NCT01978977|mBC|mbc
4923871|NCT01978977|HER2 negative|her2 negative
4923872|NCT01978977|Chemotherapy|chemotherapy
4923873|NCT01978977|Anti-angiogenic agent|anti-angiogenic agent
4923874|NCT01978977|Bevacizumab|bevacizumab
4923875|NCT01978977|1st Line|1st line
4923876|NCT01978964|ONT-10|ont-10
4923877|NCT01978964|MUC1|muc1
4923878|NCT01978964|Vaccine|vaccine
4923879|NCT01978964|Phase 1b|phase 1b
4923880|NCT01978964|Solid tumors|solid tumors
4923881|NCT01978964|Maintenance therapy|maintenance therapy
4923882|NCT01978951|Chronic Kidney Disease|chronic kidney disease
4923883|NCT01978951|Integrated Chronic Kidney Disease Care|integrated chronic kidney disease care
4923884|NCT01978951|Village Health Volunteers|village health volunteers
4923885|NCT01978925|Pharmaceutical care|pharmaceutical care
4923886|NCT01978925|Medication Adherence|medication adherence
4923887|NCT01978925|Blood Pressure|blood pressure
4923888|NCT01978925|Diabetes|diabetes
4923889|NCT01978925|Emergency|emergency
4923890|NCT01978886|Diabetes Mellitus|diabetes mellitus
4923891|NCT01978886|frozen shoulder|frozen shoulder
4923892|NCT01978886|adhesive capsulitis|adhesive capsulitis
4923893|NCT01978860|CABG Coronary artery bypass grafting|cabg coronary artery bypass grafting
4923894|NCT01978860|CTO Chronic Total Occlusion|cto chronic total occlusion
4923895|NCT01978860|PCI Percutaneous coronary intervention|pci percutaneous coronary intervention
4923896|NCT01978860|MACE Major adverse cardiovascular event(s)|mace major adverse cardiovascular event(s)
4923897|NCT01978860|MI Myocardial infarction|mi myocardial infarction
4923898|NCT01978834|Osteoporosis, diagnosis, ultrasound|osteoporosis, diagnosis, ultrasound
4923899|NCT01978821|Cerebral Palsy|cerebral palsy
4923900|NCT01978821|autologous bone marrow mononuclear cells|autologous bone marrow mononuclear cells
4923901|NCT01978821|stem cell therapy|stem cell therapy
4923902|NCT01978795|concussion|concussion
4923903|NCT01978795|high school|high school
4923904|NCT01978795|web-based training|web-based training
4923905|NCT01978795|school-based health care|school-based health care
4923906|NCT01978782|raltegravir|raltegravir
4923907|NCT01978782|citalopram|citalopram
4923908|NCT01978782|pharmacokinetics|pharmacokinetics
4923910|NCT01978756|Outpatient clinic|outpatient clinic
4923911|NCT01978756|Breast cancer|breast cancer
4923912|NCT01978756|Late toxicity|late toxicity
4923913|NCT01978743|HIV|hiv
4924041|NCT01978301|patient|patient
4923914|NCT01978743|HIV-associated neurocognitive disorder|hiv-associated neurocognitive disorder
4923915|NCT01978743|neurotoxicity|neurotoxicity
4923916|NCT01978730|vascular dementia|vascular dementia
4923917|NCT01978730|cognition|cognition
4923918|NCT01978730|stroke|stroke
4923919|NCT01978717|Anesthesia|anesthesia
4923920|NCT01978717|T-helper|t-helper
4923921|NCT01978717|MDSCs|mdscs
4923922|NCT01978717|Colorectal cancer|colorectal cancer
4923923|NCT01978717|Fast track|fast track
4923924|NCT01978691|Obesity|obesity
4923925|NCT01978691|Blood glucose|blood glucose
4923926|NCT01978691|Waist circumference|waist circumference
4923927|NCT01978691|Lipid metabolism|lipid metabolism
4923928|NCT01978691|Probiotics|probiotics
4923929|NCT01978691|Prebiotics|prebiotics
4923930|NCT01978691|Dietary supplements|dietary supplements
4923931|NCT01978691|Endotoxemia|endotoxemia
4923932|NCT01978665|COPD exercise inflammation prednisone|copd exercise inflammation prednisone
4923933|NCT01978626|Insomnia|insomnia
4923934|NCT01978626|Comorbid insomnia|comorbid insomnia
4923935|NCT01978626|Cognitive Behavioral Therapy|cognitive behavioral therapy
4923936|NCT01978600|Open-Angle Glaucoma|open-angle glaucoma
4923937|NCT01978600|Ocular Hypertension|ocular hypertension
4923938|NCT01978600|Simbrinza™|simbrinza™
4923939|NCT01978600|Intraocular Pressure|intraocular pressure
4923940|NCT01978587|End-stage Renal Disease|end-stage renal disease
4923941|NCT01978587|Hemodialysis|hemodialysis
4923942|NCT01978587|Pharmacokinetics|pharmacokinetics
4923943|NCT01978574|Cognitive reserve|cognitive reserve
4923944|NCT01978574|intellectual enrichment|intellectual enrichment
4923945|NCT01978548|Alzheimer Disease|alzheimer disease
4923946|NCT01978548|Prodromal Alzheimer Disease|prodromal alzheimer disease
4923947|NCT01978548|Safety|safety
4923948|NCT01978548|Tolerability|tolerability
4923949|NCT01978548|Pharmacokinetic|pharmacokinetic
4923950|NCT01978548|Proof of Mechanism|proof of mechanism
4923951|NCT01978548|JNJ-54861911|jnj-54861911
4923952|NCT01978535|POTS|pots
4923953|NCT01978522|Randomised trial|randomised trial
4923954|NCT01978522|postal questionnaires|postal questionnaires
4923955|NCT01978522|return rates|return rates
4923956|NCT01978509|Colonoscopy|colonoscopy
4923957|NCT01978483|Humans|humans
4923958|NCT01978483|Adult|adult
4923959|NCT01978483|skin|skin
4923960|NCT01978483|metabolism|metabolism
4923961|NCT01978483|radiation effects|radiation effects
4923962|NCT01978483|Ultraviolet Rays|ultraviolet rays
4923963|NCT01978483|RANKL|rankl
4923964|NCT01978483|RANK Ligand|rank ligand
4923965|NCT01978483|denosumab|denosumab
4923966|NCT01978483|diphenylcyclopropenone|diphenylcyclopropenone
4923967|NCT01978483|diphencyprone|diphencyprone
4923968|NCT01978483|immunology|immunology
4923969|NCT01978483|immunosuppression|immunosuppression
4923970|NCT01978483|Antibodies, Monoclonal|antibodies, monoclonal
4923971|NCT01978483|Dermatitis, Allergic Contact|dermatitis, allergic contact
4923972|NCT01978483|Hypersensitivity, Delayed|hypersensitivity, delayed
4923973|NCT01978470|epilepsy|epilepsy
4923974|NCT01978470|drug resistent epilepsy|drug resistent epilepsy
4923975|NCT01978470|partial onset seizures|partial onset seizures
4923976|NCT01978470|trigeminal nerve stimulation|trigeminal nerve stimulation
4923977|NCT01978470|neuromodulation|neuromodulation
4923978|NCT01978444|D2 lymphadenectomy|d2 lymphadenectomy
4923979|NCT01978444|Complete Mesogastrium Excision|complete mesogastrium excision
4923980|NCT01978418|Lung fluid|lung fluid
4923981|NCT01978418|Postnatal adaptation|postnatal adaptation
4923982|NCT01978418|Salbutamol|salbutamol
4923983|NCT01978418|Albuterol|albuterol
4923984|NCT01978418|Epithelial Sodium Channel|epithelial sodium channel
4923985|NCT01978405|Type 2 diabetes|type 2 diabetes
4923986|NCT01978405|Nephropathy|nephropathy
4923987|NCT01978405|Contrast medium|contrast medium
4923988|NCT01978405|Alpha lipoic acid|alpha lipoic acid
4923989|NCT01978392|disability|disability
4923990|NCT01978392|self-management|self-management
4923991|NCT01978392|chronic illness|chronic illness
4923992|NCT01978392|chronic pain|chronic pain
4923993|NCT01978392|occupation|occupation
4923994|NCT01978392|> 6 months|> 6 months
4923995|NCT01978379|General Anesthesia|general anesthesia
4923996|NCT01978379|Nociception Level|nociception level
4923997|NCT01978366|Duchenne muscular dystrophy|duchenne muscular dystrophy
4923998|NCT01978366|halofuginone hydrobromide|halofuginone hydrobromide
4923999|NCT01978366|anti-fibrotic|anti-fibrotic
4924000|NCT01978366|anti-inflammatory|anti-inflammatory
4924001|NCT01978366|muscle regeneration|muscle regeneration
4924002|NCT01978366|protein synthesis inhibitor|protein synthesis inhibitor
4924003|NCT01978353|Mild cognitive impairment|mild cognitive impairment
4924004|NCT01978353|Dementia|dementia
4924005|NCT01978353|Alzheimer's disease|alzheimer's disease
4924006|NCT01978353|Memory Training|memory training
4924007|NCT01978353|Cognitive Training|cognitive training
4924008|NCT01978353|Cognitive Rehabilitation|cognitive rehabilitation
4924009|NCT01978353|Neuropsychological Rehabilitation|neuropsychological rehabilitation
4924010|NCT01978327|Alzheimer's disease|alzheimer's disease
4924011|NCT01978327|GSK2647544|gsk2647544
4924012|NCT01978327|drug-drug interaction|drug-drug interaction
4924013|NCT01978327|healthy subjects|healthy subjects
4924014|NCT01978327|Lp-PLA2|lp-pla2
4924015|NCT01978327|simvastatin|simvastatin
4924016|NCT01978314|Chronic Kidney Disease|chronic kidney disease
4924017|NCT01978314|Acute Kidney Injury|acute kidney injury
4924018|NCT01978314|AKI|aki
4924019|NCT01978314|CKD|ckd
4924020|NCT01978314|Plasma Volume|plasma volume
4924021|NCT01978314|GFR|gfr
4924022|NCT01978314|Glomerular Filtration Rate|glomerular filtration rate
4924023|NCT01978314|Blood volume|blood volume
4924024|NCT01978314|mGFR|mgfr
4924025|NCT01978314|measured GFR|measured gfr
4924026|NCT01978314|kidney biomarker|kidney biomarker
4924027|NCT01978314|renal disease|renal disease
4924028|NCT01978314|renal biomarker|renal biomarker
4924029|NCT01978314|Renal function|renal function
4924030|NCT01978314|kidney function|kidney function
4924031|NCT01978314|organ function|organ function
4924032|NCT01978314|kidney monitor|kidney monitor
4924033|NCT01978314|kidney device|kidney device
4924034|NCT01978301|triamcinolone acetonide (TAC)|triamcinolone acetonide (tac)
4924035|NCT01978301|heavy water|heavy water
4924036|NCT01978301|fibrosis|fibrosis
4924037|NCT01978301|deuterium|deuterium
4924038|NCT01978301|collagen degradation|collagen degradation
4924039|NCT01978301|collagen synthesis|collagen synthesis
4924040|NCT01978301|Keloid|keloid
4924042|NCT01978275|total knee arthroplasty|total knee arthroplasty
4924043|NCT01978275|lumbar plexus block|lumbar plexus block
4924044|NCT01978275|stimulating catheters|stimulating catheters
4924045|NCT01978275|peripheral nerve blocks|peripheral nerve blocks
4924046|NCT01978262|influenza vaccine|influenza vaccine
4924047|NCT01978262|cytokines|cytokines
4924048|NCT01978262|hormones|hormones
4924049|NCT01978262|progesterone|progesterone
4924050|NCT01978249|Colorectal cancer|colorectal cancer
4924051|NCT01978249|Primary tumor resection|primary tumor resection
4924052|NCT01978249|Chemotherapy|chemotherapy
4924053|NCT01978249|Overall survival|overall survival
4924054|NCT01978249|Quality of life|quality of life
4924055|NCT01978236|BRAF V600E mutation|braf v600e mutation
4924056|NCT01978236|brain metastases|brain metastases
4924057|NCT01978236|BRAF V600K mutation|braf v600k mutation
4924058|NCT01978236|Metastatic melanoma|metastatic melanoma
4924059|NCT01978236|BRAF inhibitor|braf inhibitor
4924060|NCT01978236|brain neoplasms|brain neoplasms
4924061|NCT01978236|GSK2118436|gsk2118436
4924062|NCT01978223|Rotarix™|rotarix™
4924063|NCT01978223|Case-control|case-control
4924064|NCT01978223|Venezuela|venezuela
4924065|NCT01978223|Vaccine effectiveness|vaccine effectiveness
4924066|NCT01978223|Rotavirus Severe Gastroenteritis|rotavirus severe gastroenteritis
4924067|NCT01978223|Children|children
4924068|NCT01978223|Hospitalised|hospitalised
4924069|NCT01978210|autism|autism
4924070|NCT01978210|enuresis|enuresis
4924071|NCT01978210|toilet-training|toilet-training
4924072|NCT01978184|Pancreatic Cancer, resectable adenocarcinoma of the pancreas|pancreatic cancer, resectable adenocarcinoma of the pancreas
4924073|NCT01978171|breast neoplasms|breast neoplasms
4924074|NCT01978171|everolimus|everolimus
4924075|NCT01978171|interstitial lung disease|interstitial lung disease
4924076|NCT01978171|pneumonitis|pneumonitis
4924077|NCT01978158|Oxygen|oxygen
4924078|NCT01978158|Hypoxia|hypoxia
4924079|NCT01978158|Hyperoxia|hyperoxia
4924080|NCT01978158|Inflammation|inflammation
4924081|NCT01978158|Innate immunity|innate immunity
4924082|NCT01978145|efficacy|efficacy
4924083|NCT01978145|tolerability|tolerability
4924084|NCT01978145|capsule-based inhaler|capsule-based inhaler
4924085|NCT01978145|quality of life|quality of life
4924086|NCT01978145|safety|safety
4924087|NCT01978145|multi-dose inhaler|multi-dose inhaler
4924088|NCT01978145|fluticasone propionate/salmeterol (FSC) 250/50 mcg|fluticasone propionate/salmeterol (fsc) 250/50 mcg
4924089|NCT01978145|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
4924090|NCT01978132|primary hyperaldosteronism|primary hyperaldosteronism
4924091|NCT01978132|primary hypertension|primary hypertension
4924092|NCT01978132|forearm ischemia-reperfusion|forearm ischemia-reperfusion
4924093|NCT01978132|(reduction) in brachial artery FMD|(reduction) in brachial artery fmd
4924094|NCT01978132|endothelial ischemia-reperfusion injury|endothelial ischemia-reperfusion injury
4924095|NCT01978119|Multi-Dose Inhaler|multi-dose inhaler
4924096|NCT01978119|safety|safety
4924097|NCT01978119|Asthma|asthma
4924098|NCT01978119|efficacy|efficacy
4924099|NCT01978119|pharmacodynamics|pharmacodynamics
4924100|NCT01978119|fluticasone propionate/salmeterol (FSC) 250/50 mcg|fluticasone propionate/salmeterol (fsc) 250/50 mcg
4924101|NCT01978119|tolerability|tolerability
4924102|NCT01978119|Capsule-Based Inhaler|capsule-based inhaler
4924103|NCT01978106|toric calculator|toric calculator
4924104|NCT01978106|toric intraocular lens power|toric intraocular lens power
4924105|NCT01978106|Acrysof|acrysof
4924106|NCT01978106|Tecnis|tecnis
4924107|NCT01978106|iTrace|itrace
4924108|NCT01978093|Conjugate|conjugate
4924109|NCT01978093|Immunogenicity|immunogenicity
4924110|NCT01978093|Hib-MenCY-TT vaccine|hib-mency-tt vaccine
4924111|NCT01978093|Haemophilus type b|haemophilus type b
4924112|NCT01978093|Safety|safety
4924113|NCT01978093|Reactogenicity|reactogenicity
4924114|NCT01978067|Uterine Scar From Previous Cesarean Delivery|uterine scar from previous cesarean delivery
4924115|NCT01978067|previous caesarean scar deficiency|previous caesarean scar deficiency
4924116|NCT01978067|transvaginal resection|transvaginal resection
4924117|NCT01978067|quality of life|quality of life
4924118|NCT01978067|sexual activity|sexual activity
4924119|NCT01978054|Information Dissemination|information dissemination
4924120|NCT01978054|Information Sharing|information sharing
4924121|NCT01978054|Innovation Diffusion|innovation diffusion
4924122|NCT01978054|Public Health Practice|public health practice
4924123|NCT01978054|Evidence-Based Public Health|evidence-based public health
4924124|NCT01978054|Chronic Disease Prevention|chronic disease prevention
4924125|NCT01978054|Cancer Prevention and Control|cancer prevention and control
4924126|NCT01978041|pharmacokinetics, saliva, plasma, fluoride, dental fluorosis, dental caries|pharmacokinetics, saliva, plasma, fluoride, dental fluorosis, dental caries
4924127|NCT01978028|heart failure|heart failure
4924128|NCT01978015|primary open angle glaucoma|primary open angle glaucoma
4924129|NCT01978015|timolol|timolol
4924130|NCT01978015|prostaglandin analogues|prostaglandin analogues
4924131|NCT01977976|Endometrial injury|endometrial injury
4924132|NCT01977976|Pipelle|pipelle
4924133|NCT01977976|Implantation|implantation
4924134|NCT01977976|Ongoing pregnancy rate|ongoing pregnancy rate
4924135|NCT01977976|IVF|ivf
4924136|NCT01977950|Undernutrition, Nutritional risk, NRS2002, nutritional care practices, hospital, elderly patients, nursing students|undernutrition, nutritional risk, nrs2002, nutritional care practices, hospital, elderly patients, nursing students
4924137|NCT01977937|gabapentin|gabapentin
4924138|NCT01977937|Analgesic Drugs|analgesic drugs
4924139|NCT01977937|Analgesics, Nonopioid|analgesics, nonopioid
4924140|NCT01977924|sleep apnea|sleep apnea
4924141|NCT01977924|polyphenols|polyphenols
4924142|NCT01977924|endothelial function|endothelial function
4924143|NCT01977911|Airway reconstruction|airway reconstruction
4924144|NCT01977911|Regenerative medicine|regenerative medicine
4924145|NCT01977898|Postdural puncture headache|postdural puncture headache
4924146|NCT01977898|Intrathecal morphine|intrathecal morphine
4924147|NCT01977898|Intrathecal catheter|intrathecal catheter
4924148|NCT01977898|Headache|headache
4924149|NCT01977898|Labor and delivery|labor and delivery
4924150|NCT01977898|Unintentional dural puncture|unintentional dural puncture
4924151|NCT01977885|epigenetics|epigenetics
4924152|NCT01977885|obesity|obesity
4924153|NCT01977885|overweight|overweight
4924154|NCT01977885|high protein diet|high protein diet
4924155|NCT01977885|exercise|exercise
4924156|NCT01977885|post menopausal women|post menopausal women
4924157|NCT01977872|Arthritis|arthritis
4924158|NCT01977872|Physical Activity|physical activity
4924159|NCT01977872|Diet|diet
4924160|NCT01977859|B-type Natriuretic Peptide|b-type natriuretic peptide
4924161|NCT01977859|Metabolism|metabolism
4924162|NCT01977859|Insulin infusion|insulin infusion
4924163|NCT01977846|genetic testing|genetic testing
4924164|NCT01977846|ABCA4|abca4
4924165|NCT01977846|Stargardt|stargardt
4924166|NCT01977846|retina|retina
4924167|NCT01977846|retinal degeneration|retinal degeneration
4924168|NCT01977833|BTdiet|btdiet
4924169|NCT01977833|Dtdiet|dtdiet
4924170|NCT01977833|High Calorie Breakfast diet (BTdiet)|high calorie breakfast diet (btdiet)
4924171|NCT01977833|High Calorie Dinner diet (DTdiet)|high calorie dinner diet (dtdiet)
4924172|NCT01977820|Phenylketonuria|phenylketonuria
4924173|NCT01977820|Sapropterin|sapropterin
4924174|NCT01977820|Placebo|placebo
4924175|NCT01977820|Cognitive Abilities|cognitive abilities
4924176|NCT01977820|Kuvan®|kuvan®
4924177|NCT01977807|Myopia|myopia
4924178|NCT01977807|Hyperopia|hyperopia
4924179|NCT01977807|Presbyopia|presbyopia
4924180|NCT01977807|Supracor|supracor
4924181|NCT01977807|Zyoptix|zyoptix
4924182|NCT01977807|Proscan|proscan
4924183|NCT01977807|LASIK|lasik
4924184|NCT01977794|Bisoprolol|bisoprolol
4924185|NCT01977794|Amlodipine|amlodipine
4924186|NCT01977794|Fixed dose combination (FDC)|fixed dose combination (fdc)
4924187|NCT01977794|Systolic Blood Pressure (SBP)|systolic blood pressure (sbp)
4924188|NCT01977794|Diastolic Blood Pressure (DBP)|diastolic blood pressure (dbp)
4924189|NCT01977781|GVHD|gvhd
4924190|NCT01977781|Ocular GVHD|ocular gvhd
4924191|NCT01977781|Tacrolimus|tacrolimus
4924192|NCT01977781|Methylprednisolone|methylprednisolone
4924193|NCT01977768|M. vaccae|m. vaccae
4924194|NCT01977768|TB|tb
4924195|NCT01977768|MDR-TB|mdr-tb
4924196|NCT01977768|V7-immunitor|v7-immunitor
4924197|NCT01977729|anxiety|anxiety
4924198|NCT01977716|Peritonitis|peritonitis
4924199|NCT01977716|loss of residual renal function|loss of residual renal function
4924200|NCT01977716|technique survival|technique survival
4924201|NCT01977703|Heart Failure|heart failure
4924202|NCT01977703|Advanced Heart Failure|advanced heart failure
4924203|NCT01977703|LVAD|lvad
4924204|NCT01977703|Left Ventricular Assist Device|left ventricular assist device
4924205|NCT01977703|Heart-Assist Devices|heart-assist devices
4924206|NCT01977664|oocyte maturation failure|oocyte maturation failure
4924207|NCT01977664|Maturation induction in vitro|maturation induction in vitro
4924208|NCT01977651|enzalutamide|enzalutamide
4924209|NCT01977651|Xtandi|xtandi
4924210|NCT01977651|seizure|seizure
4924211|NCT01977651|Central Nervous System|central nervous system
4924212|NCT01977651|MDV3100|mdv3100
4924213|NCT01977651|metastatic castration-resistant prostate cancer (mCRPC)|metastatic castration-resistant prostate cancer (mcrpc)
4924214|NCT01977638|Advanced solid tumours|advanced solid tumours
4924215|NCT01977638|Lymphoma|lymphoma
4924216|NCT01977638|Myeloma|myeloma
4924217|NCT01977625|Menopause|menopause
4924218|NCT01977625|fMRI|fmri
4924219|NCT01977625|Vyvanse|vyvanse
4924220|NCT01977612|Wound infection|wound infection
4924221|NCT01977612|Wound separation|wound separation
4924222|NCT01977612|Skin staples|skin staples
4924223|NCT01977612|Subcuticular suture|subcuticular suture
4924224|NCT01977599|Text message reminders|text message reminders
4924225|NCT01977599|Short Message Service (SMS) Reminders|short message service (sms) reminders
4924226|NCT01977599|Social Health Inequalities|social health inequalities
4924227|NCT01977599|Breast Screening|breast screening
4924228|NCT01977599|Screening|screening
4924229|NCT01977599|Public Health Intervention|public health intervention
4924230|NCT01977599|Missed Appointments|missed appointments
4924231|NCT01977599|Non-attendance|non-attendance
4924232|NCT01977586|Clear cell renal cell carcinoma|clear cell renal cell carcinoma
4924233|NCT01977586|Stage IV renal cell carcinoma|stage iv renal cell carcinoma
4924234|NCT01977586|Anti-angiogenic therapy|anti-angiogenic therapy
4924235|NCT01977586|Response assessment|response assessment
4924236|NCT01977586|Magnetic resonance imaging|magnetic resonance imaging
4924237|NCT01977573|Prolyl hydroxylase inhibitor|prolyl hydroxylase inhibitor
4924238|NCT01977573|pharmacokinetics|pharmacokinetics
4924239|NCT01977573|GSK1278863|gsk1278863
4924240|NCT01977573|Anemia|anemia
4924241|NCT01977573|hemoglobin|hemoglobin
4924242|NCT01977573|erythropoiesis stimulating agents|erythropoiesis stimulating agents
4924243|NCT01977573|Chronic kidney disease|chronic kidney disease
4924244|NCT01977560|Type 2 diabetes|type 2 diabetes
4924245|NCT01977560|Exercise|exercise
4924246|NCT01977560|High protein|high protein
4924247|NCT01977547|Red blood cell transfusions|red blood cell transfusions
4924248|NCT01977547|Red blood cell storage age|red blood cell storage age
4924249|NCT01977547|Pediatrics|pediatrics
4924250|NCT01977547|Critical Care|critical care
4924251|NCT01977534|Bioabsorbable|bioabsorbable
4924252|NCT01977534|Coronary Stent|coronary stent
4924253|NCT01977534|Everolimus|everolimus
4924254|NCT01977534|drug eluting stents|drug eluting stents
4924255|NCT01977534|stents|stents
4924256|NCT01977534|angioplasty|angioplasty
4924257|NCT01977534|coronary artery disease|coronary artery disease
4924258|NCT01977534|total coronary occlusion|total coronary occlusion
4924259|NCT01977534|coronary artery restenosis|coronary artery restenosis
4924260|NCT01977534|stent thrombosis|stent thrombosis
4924261|NCT01977534|vascular disease|vascular disease
4924262|NCT01977534|myocardial ischemia|myocardial ischemia
4924263|NCT01977534|coronary artery stenosis|coronary artery stenosis
4924264|NCT01977534|CAD|cad
4924265|NCT01977534|CAOD|caod
4924266|NCT01977508|Vascular access grafts|vascular access grafts
4924267|NCT01977508|Haemodialysis|haemodialysis
4924268|NCT01977495|Diabetes|diabetes
4924269|NCT01977495|Enrollment methods|enrollment methods
4924270|NCT01977495|Behavioral Economic Intervention|behavioral economic intervention
4924271|NCT01977495|Opt-in Enrollment|opt-in enrollment
4924272|NCT01977495|Opt-out Enrollment|opt-out enrollment
4924273|NCT01977495|lottery|lottery
4924274|NCT01977495|financial incentives|financial incentives
4924275|NCT01977482|hemoglobin|hemoglobin
4924276|NCT01977482|recombinant human erythropoietin|recombinant human erythropoietin
4924277|NCT01977482|Chronic kidney disease|chronic kidney disease
4924278|NCT01977482|hemodialysis|hemodialysis
4924279|NCT01977482|pharmacokinetics|pharmacokinetics
4924280|NCT01977482|erythropoiesis stimulating agents|erythropoiesis stimulating agents
4924281|NCT01977482|Anemia|anemia
4924282|NCT01977482|GSK1278863|gsk1278863
4924283|NCT01977469|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
4924284|NCT01977469|Activities of Daily Living|activities of daily living
4924285|NCT01977469|Mortality|mortality
4924286|NCT01977469|Strength Training|strength training
4924287|NCT01977456|acute ischemic stroke|acute ischemic stroke
4924288|NCT01977456|stroke|stroke
4924289|NCT01977456|rt-PA, thrombolytic|rt-pa, thrombolytic
4924290|NCT01977456|t-PA|t-pa
4924291|NCT01977456|recombinant tissue plasminogen activator|recombinant tissue plasminogen activator
4924292|NCT01977456|Activase|activase
4924293|NCT01977456|eptifibatide|eptifibatide
4924294|NCT01977456|Integrilin|integrilin
4924295|NCT01977456|fibrinolytic agents|fibrinolytic agents
4924296|NCT01977456|clot dissolving|clot dissolving
4924297|NCT01977456|blood clot|blood clot
4924298|NCT01977430|Residual renal function|residual renal function
4924299|NCT01977430|Combined thiazide-furosemide therapy|combined thiazide-furosemide therapy
4924300|NCT01977430|Haemodialysis|haemodialysis
4924301|NCT01977417|Endothelial Function|endothelial function
4924302|NCT01977417|Arterial Stiffness|arterial stiffness
4924303|NCT01977417|Inflammation|inflammation
4924304|NCT01977417|Muscle Sympathetic Nervous System|muscle sympathetic nervous system
4924306|NCT01977417|Autonomic function|autonomic function
4924307|NCT01977404|Congestive heart failure|congestive heart failure
4924308|NCT01977404|Energy expenditure|energy expenditure
4924309|NCT01977404|Body composition|body composition
4924310|NCT01977404|Caloric intake|caloric intake
4924311|NCT01977365|Cluster Randomized Trial,|cluster randomized trial,
4924312|NCT01977365|Nutrition counseling,|nutrition counseling,
4924313|NCT01977365|Caretaker's knowledge|caretaker's knowledge
4924314|NCT01977365|Child growth,|child growth,
4924315|NCT01977365|Prevention,|prevention,
4924316|NCT01977365|Acute malnutrition|acute malnutrition
4924317|NCT01977352|Exparel|exparel
4924318|NCT01977352|Liposomal Bupivacaine|liposomal bupivacaine
4924319|NCT01977352|Arthroscopic Shoulder Surgery|arthroscopic shoulder surgery
4924320|NCT01977339|Femoral Nerve Block|femoral nerve block
4924321|NCT01977339|Liposomal Bupivacaine|liposomal bupivacaine
4924322|NCT01977326|task sharing|task sharing
4924323|NCT01977326|task shifting|task shifting
4924324|NCT01977326|prenatal depression|prenatal depression
4924325|NCT01977326|counselling|counselling
4924326|NCT01977326|lay health workers|lay health workers
4924327|NCT01977287|Multiple Sclerosis|multiple sclerosis
4924328|NCT01977287|Functional Electrical Stimulation|functional electrical stimulation
4924329|NCT01977287|Ankle Foot Orthosis|ankle foot orthosis
4924330|NCT01977287|Walking performance|walking performance
4924331|NCT01977287|gait analysis|gait analysis
4924332|NCT01977287|fatigue|fatigue
4924333|NCT01977287|activity monitoring|activity monitoring
4924334|NCT01977274|ovarian, endometrium, cervix cancer|ovarian, endometrium, cervix cancer
4924335|NCT01977235|Irinotecan; Cisplatin; Small-cell lung cancer; UGT1A1|irinotecan; cisplatin; small-cell lung cancer; ugt1a1
4924336|NCT01977209|NSCLC; Gossypol; APE1; Chemotherapy|nsclc; gossypol; ape1; chemotherapy
4924337|NCT01977196|DTB/HB/Hib vaccine|dtb/hb/hib vaccine
4924338|NCT01977196|Infants|infants
4924339|NCT01977196|Phase I|phase i
4924340|NCT01977183|gastrointestinal|gastrointestinal
4924341|NCT01977183|microbiome|microbiome
4924342|NCT01977183|prebiotic|prebiotic
4924343|NCT01977183|starch|starch
4924344|NCT01977170|Adults|adults
4924345|NCT01977170|Hib vaccines|hib vaccines
4924346|NCT01977170|Immunogenicity|immunogenicity
4924347|NCT01977170|Safety|safety
4924348|NCT01977157|Impedance cardiography|impedance cardiography
4924349|NCT01977157|bioimpedance|bioimpedance
4924350|NCT01977157|spectroscopy|spectroscopy
4924351|NCT01977157|extracellular resistance|extracellular resistance
4924352|NCT01977157|body composition|body composition
4924353|NCT01977157|hemodynamics|hemodynamics
4924354|NCT01977157|alcohol|alcohol
4924355|NCT01977144|Single Embryo Transfer|single embryo transfer
4924356|NCT01977144|Double Embryo Transfer|double embryo transfer
4924357|NCT01977144|CCS (Comprehensive Chromosome Screening)|ccs (comprehensive chromosome screening)
4924358|NCT01977144|Aneuploidy|aneuploidy
4924359|NCT01977144|Low Responders|low responders
4924360|NCT01977118|Streptokinase|streptokinase
4924361|NCT01977118|Percutaneous catheter drainage|percutaneous catheter drainage
4924362|NCT01977118|Pancreatic necrosis|pancreatic necrosis
4924363|NCT01977118|peripancreatic necrosis|peripancreatic necrosis
4924364|NCT01977105|Infants|infants
4924365|NCT01977105|Mothers|mothers
4924366|NCT01977105|Social media|social media
4924367|NCT01977105|Obesity prevention|obesity prevention
4924368|NCT01977092|sober living houses|sober living houses
4924370|NCT01977092|alcohol and drugs|alcohol and drugs
4924371|NCT01977079|pregnancy|pregnancy
4924372|NCT01977079|premature birth|premature birth
4924373|NCT01977079|procalcitonin|procalcitonin
4924374|NCT01977066|pancreatic cancer|pancreatic cancer
4924375|NCT01977066|exercise training|exercise training
4924376|NCT01977066|quality of life|quality of life
4924377|NCT01977066|physical functioning|physical functioning
4924378|NCT01977053|breast cancer|breast cancer
4924379|NCT01977053|colon cancer|colon cancer
4924380|NCT01977053|rectal cancer|rectal cancer
4924381|NCT01977053|adjuvant chemotherapy|adjuvant chemotherapy
4924382|NCT01977053|phone calls|phone calls
4924383|NCT01977053|emotional states|emotional states
4924384|NCT01977053|quality of life|quality of life
4924385|NCT01977040|Vasa Previa|vasa previa
4924386|NCT01977027|Rehabilitation|rehabilitation
4924387|NCT01977027|Fingers|fingers
4924388|NCT01977027|Grasp|grasp
4924389|NCT01977027|Strength|strength
4924390|NCT01977027|Hand Function|hand function
4924391|NCT01977027|Motor Function|motor function
4924392|NCT01977027|Post Stroke|post stroke
4924393|NCT01977027|Brain Infraction|brain infraction
4924394|NCT01977027|Biomechanis|biomechanis
4924395|NCT01977027|Neuronal Plasticity|neuronal plasticity
4924396|NCT01977027|Weight-Bearing|weight-bearing
4924397|NCT01977001|Primary headache|primary headache
4924398|NCT01977001|Headache|headache
4924399|NCT01977001|MigraineBox|migrainebox
4924400|NCT01976975|Depression|depression
4924401|NCT01976975|Major Depressive Disorder|major depressive disorder
4924402|NCT01976975|Bipolar Disorder|bipolar disorder
4924403|NCT01976975|Mania|mania
4924404|NCT01976975|Hypomania|hypomania
4924405|NCT01976975|EEG|eeg
4924406|NCT01976975|MRI|mri
4924407|NCT01976975|Reward|reward
4924408|NCT01976962|Prostatic neoplasms|prostatic neoplasms
4924409|NCT01976962|Radiotherapy|radiotherapy
4924410|NCT01976962|Dose fractionation|dose fractionation
4924411|NCT01976962|Magnetic resonance imaging|magnetic resonance imaging
4924412|NCT01976949|Cancer, social-networking intervention, cancer-related distress, internet health services, intervention delivery|cancer, social-networking intervention, cancer-related distress, internet health services, intervention delivery
4924413|NCT01976936|Stroke|stroke
4924414|NCT01976936|Rhabdomyolysis|rhabdomyolysis
4924415|NCT01976936|Jaundice|jaundice
4924416|NCT01976923|Intravitreal Bevacizumab|intravitreal bevacizumab
4924417|NCT01976923|Tractional Retinal Detachment|tractional retinal detachment
4924418|NCT01976923|Proliferative Diabetic Retinopathy|proliferative diabetic retinopathy
4924419|NCT01976923|Small gauge pars plana vitrectomy|small gauge pars plana vitrectomy
4924420|NCT01976923|Intraoperative bleeding|intraoperative bleeding
4924421|NCT01976923|Post-operative vitreous hemorrhage|post-operative vitreous hemorrhage
4924422|NCT01976923|Visual acuity|visual acuity
4924423|NCT01976910|Glioblastoma multiforme|glioblastoma multiforme
4924424|NCT01976910|Advanced cancers|advanced cancers
4924425|NCT01976910|Brain Neoplasms, Malignant, Primary|brain neoplasms, malignant, primary
4924426|NCT01976910|Brain Tumor, Recurrent|brain tumor, recurrent
4924427|NCT01976910|Advanced cancer|advanced cancer
4924428|NCT01976897|heel - mattress pressure interface|heel - mattress pressure interface
4924429|NCT01976897|flexion|flexion
4924430|NCT01976897|knee angular position|knee angular position
4924431|NCT01976884|sepsis|sepsis
4924432|NCT01976884|immunosuppression|immunosuppression
4924433|NCT01976884|PD-L1|pd-l1
4924434|NCT01976871|Restless Legs Syndrome|restless legs syndrome
4924435|NCT01976871|Ekbom Syndrome|ekbom syndrome
4924436|NCT01976871|Willis-Ekbom Disease|willis-ekbom disease
4924437|NCT01976871|Rotigotine|rotigotine
4924438|NCT01976871|Neupro|neupro
4924439|NCT01976871|Dopamine Agonist|dopamine agonist
4924440|NCT01976858|PEX168, diabetes, phase I|pex168, diabetes, phase i
4924441|NCT01976845|propofol|propofol
4924442|NCT01976845|midazolam|midazolam
4924443|NCT01976845|sedative|sedative
4924444|NCT01976845|anxiolytic|anxiolytic
4924445|NCT01976845|amnesic|amnesic
4924446|NCT01976845|recall|recall
4924447|NCT01976845|Memory|memory
4924448|NCT01976845|Perioperative outcomes|perioperative outcomes
4924449|NCT01976819|Tracheotomy|tracheotomy
4924450|NCT01976819|Tracheostomy|tracheostomy
4924451|NCT01976819|Speaking valve|speaking valve
4924452|NCT01976819|HME|hme
4924453|NCT01976819|patients|patients
4924454|NCT01976806|Docosahexaenoic acid|docosahexaenoic acid
4924455|NCT01976806|DHA|dha
4924456|NCT01976806|Periodontitis|periodontitis
4924457|NCT01976806|Gingivitis|gingivitis
4924458|NCT01976806|Omega-3 fatty acid|omega-3 fatty acid
4924459|NCT01976806|Fish oil|fish oil
4924460|NCT01976793|Recurrent depressive disorder|recurrent depressive disorder
4924461|NCT01976793|Depression|depression
4924462|NCT01976793|Depressive episode|depressive episode
4924463|NCT01976793|Atypical antipsychotics|atypical antipsychotics
4924464|NCT01976780|Malaria|malaria
4924465|NCT01976780|P. falciparum mono infection|p. falciparum mono infection
4924466|NCT01976780|Early Treatment Failure|early treatment failure
4924467|NCT01976780|Late Treatment Failure|late treatment failure
4924468|NCT01976767|Sputum|sputum
4924469|NCT01976767|Clinical cohorts|clinical cohorts
4924470|NCT01976767|Smokers|smokers
4924471|NCT01976767|Asthma|asthma
4924472|NCT01976767|Biopsies|biopsies
4924473|NCT01976767|Severe asthma|severe asthma
4924474|NCT01976767|Collaborative research|collaborative research
4924475|NCT01976767|Phenotyping|phenotyping
4924476|NCT01976767|Lipidomics|lipidomics
4924477|NCT01976767|Transcriptomics|transcriptomics
4924478|NCT01976767|Proteomics|proteomics
4924479|NCT01976767|Paediatric cohort|paediatric cohort
4924480|NCT01976767|Systems Biology|systems biology
4924481|NCT01976741|Phase I|phase i
4924482|NCT01976741|Dose escalation|dose escalation
4924483|NCT01976741|refractory, locally advanced or metastatic solid tumor|refractory, locally advanced or metastatic solid tumor
4924484|NCT01976741|Bladder cancer|bladder cancer
4924485|NCT01976741|squamous non-small cell lung cancer|squamous non-small cell lung cancer
4924486|NCT01976741|pan-FGFR inhibitor|pan-fgfr inhibitor
4924487|NCT01976741|lung adenocarcinoma|lung adenocarcinoma
4924488|NCT01976741|head and neck cancer|head and neck cancer
4924489|NCT01976715|HIV|hiv
4924490|NCT01976715|Treatment Failure|treatment failure
4924491|NCT01976715|Drug Resistance|drug resistance
4924492|NCT01976702|HIV risk behaviors|hiv risk behaviors
4924493|NCT01976702|Pregnant drug abusers|pregnant drug abusers
4924494|NCT01976689|Glucose Regulation|glucose regulation
4924495|NCT01976689|Left Ventricular Hypertrophy|left ventricular hypertrophy
4924496|NCT01976689|New-onset Diabetes|new-onset diabetes
4924497|NCT01976689|Renal Transplantation|renal transplantation
4924498|NCT01976598|chronic|chronic
4924499|NCT01976598|back|back
4924500|NCT01976598|leg|leg
4924501|NCT01976598|pain|pain
4924502|NCT01976598|sub-sensory|sub-sensory
4924503|NCT01976598|stimulation|stimulation
4924504|NCT01976598|Neuromodulation|neuromodulation
4924505|NCT01976598|Yearwood|yearwood
4924506|NCT01976585|Intratumoral injections|intratumoral injections
4924507|NCT01976585|rhuFlt3L|rhuflt3l
4924508|NCT01976585|Flt3L|flt3l
4924509|NCT01976585|CDX-301|cdx-301
4924510|NCT01976585|Vaccine|vaccine
4924511|NCT01976585|Poly-ICLC|poly-iclc
4924512|NCT01976585|iNHL|inhl
4924513|NCT01976585|TLR3|tlr3
4924514|NCT01976585|Low-Grade B-cell Lymphoma|low-grade b-cell lymphoma
4924515|NCT01976585|Follicular|follicular
4924516|NCT01976585|Marginal Zone|marginal zone
4924517|NCT01976585|SLL|sll
4924518|NCT01976585|Small lymphocytic|small lymphocytic
4924519|NCT01976572|CKD Stage V|ckd stage v
4924520|NCT01976572|dialysis|dialysis
4924521|NCT01976559|ICP|icp
4924522|NCT01976559|Intracranial pressure|intracranial pressure
4924523|NCT01976559|Hydrocephalus|hydrocephalus
4924524|NCT01976559|Idiopathic normal pressure hydrocephalus|idiopathic normal pressure hydrocephalus
4924525|NCT01976559|CSF|csf
4924526|NCT01976559|Cerebrospinal fluid|cerebrospinal fluid
4924527|NCT01976559|Noninvasive ICP|noninvasive icp
4924528|NCT01976520|Cancer vaccine|cancer vaccine
4924529|NCT01976520|Chronic lymphocytic leukemia|chronic lymphocytic leukemia
4924530|NCT01976520|CLL|cll
4924531|NCT01976520|Autologous vaccine|autologous vaccine
4924532|NCT01976520|B cell leukemia|b cell leukemia
4924533|NCT01976494|Patient controlled analgesia equipment|patient controlled analgesia equipment
4924534|NCT01976494|efficacy|efficacy
4924535|NCT01976494|safety|safety
4924536|NCT01976494|Accufuser Omnibus®|accufuser omnibus®
4924537|NCT01976494|Upper abdominal surgery|upper abdominal surgery
4924538|NCT01976494|laparotomy|laparotomy
4924539|NCT01976455|obesity|obesity
4924540|NCT01976455|carbon13|carbon13
4924541|NCT01976455|over-eating|over-eating
4924542|NCT01976455|metabolic chamber|metabolic chamber
4924543|NCT01976455|room calorimeter|room calorimeter
4924544|NCT01976442|Leukemia|leukemia
4924545|NCT01976442|Transfusion|transfusion
4924546|NCT01976429|barotrauma|barotrauma
4924547|NCT01976429|barotitis|barotitis
4924548|NCT01976429|middle ear|middle ear
4924550|NCT01976429|diving|diving
4924551|NCT01976429|Eustachian tube|eustachian tube
4924552|NCT01976416|Hydroxyurea|hydroxyurea
4924553|NCT01976390|Kidney|kidney
4924554|NCT01976390|Kidney transplant|kidney transplant
4924555|NCT01976390|Renal failure|renal failure
4924556|NCT01976390|End Stage Renal Disease|end stage renal disease
4924557|NCT01976390|kidney transplant recipient|kidney transplant recipient
4924558|NCT01976364|Tofacitinib|tofacitinib
4924559|NCT01976364|Psoriatic Arthritis|psoriatic arthritis
4924560|NCT01976364|Xeljanz|xeljanz
4924561|NCT01976364|CP-690550|cp-690550
4924562|NCT01976364|Jak-inhibitor|jak-inhibitor
4924563|NCT01976364|oral treatment|oral treatment
4924564|NCT01976364|psoriasis|psoriasis
4924565|NCT01976364|OPAL BALANCE|opal balance
4924566|NCT01976364|methotrexate|methotrexate
4924567|NCT01976364|pruritus|pruritus
4924568|NCT01976364|itch|itch
4924569|NCT01976364|DLQI|dlqi
4924570|NCT01976351|Barrett's esophagus|barrett's esophagus
4924571|NCT01976351|image-enhanced endoscopy|image-enhanced endoscopy
4924572|NCT01976338|BRVO|brvo
4924573|NCT01976338|macular edema|macular edema
4924574|NCT01976338|vision impairment|vision impairment
4924575|NCT01976338|retinal vein occlusion|retinal vein occlusion
4924576|NCT01976338|ranibizumab|ranibizumab
4924577|NCT01976338|branch retinal vein occlusion|branch retinal vein occlusion
4924578|NCT01976338|anti-VEGF therapy|anti-vegf therapy
4924579|NCT01976338|RFB002|rfb002
4924580|NCT01976325|decision aid|decision aid
4924581|NCT01976325|imported malaria|imported malaria
4924582|NCT01976325|malaria prevention and control|malaria prevention and control
4924583|NCT01976325|malaria chemoprophylaxis|malaria chemoprophylaxis
4924584|NCT01976325|mefloquine|mefloquine
4924585|NCT01976325|lariam|lariam
4924586|NCT01976325|atovaquone-proguanil|atovaquone-proguanil
4924587|NCT01976325|malarone|malarone
4924588|NCT01976325|doxycycline|doxycycline
4924589|NCT01976325|vibramycin|vibramycin
4924590|NCT01976312|CRVO, macular edema, vision impairment, retinal vein occlusion, ranibizumab|crvo, macular edema, vision impairment, retinal vein occlusion, ranibizumab
4924591|NCT01976221|Comprehensive referrals|comprehensive referrals
4924592|NCT01976221|Appropriate referring|appropriate referring
4924593|NCT01976221|Priority setting|priority setting
4924594|NCT01976221|Waiting time in hospital|waiting time in hospital
4924595|NCT01976208|Omalizumab|omalizumab
4924596|NCT01976208|IgE|ige
4924597|NCT01976208|Asthma|asthma
4924598|NCT01976195|Thalidomide|thalidomide
4924599|NCT01976195|Dexamethasone|dexamethasone
4924600|NCT01976195|ITP|itp
4924601|NCT01976182|large granular lymphocytes leukemia|large granular lymphocytes leukemia
4924602|NCT01976182|immunosuppressive drugs|immunosuppressive drugs
4924603|NCT01976182|methotrexate|methotrexate
4924604|NCT01976182|cyclophosphamide|cyclophosphamide
4924605|NCT01976182|efficiency|efficiency
4924606|NCT01976182|phase II randomized controlled trial|phase ii randomized controlled trial
4924607|NCT01976169|Breast Cancer|breast cancer
4924608|NCT01976169|Advanced Breast Cancer|advanced breast cancer
4924609|NCT01976104|Thrombocytopenia|thrombocytopenia
4924610|NCT01976104|Chronic Liver Disease|chronic liver disease
4924611|NCT01976091|limb girdle muscular dystrophy|limb girdle muscular dystrophy
4924612|NCT01976091|LGMD2D|lgmd2d
4924613|NCT01976091|alpha-sarcoglycan|alpha-sarcoglycan
4924614|NCT01976091|gene transfer|gene transfer
4924615|NCT01976091|adeno-associated virus|adeno-associated virus
4924616|NCT01976078|Voriconazole|voriconazole
4924617|NCT01976078|Pharmacokinetics|pharmacokinetics
4924618|NCT01976078|Ontogeny|ontogeny
4924619|NCT01976078|Modeling|modeling
4924620|NCT01976078|Bayesian|bayesian
4924621|NCT01976065|Necrotic tooth pulp|necrotic tooth pulp
4924622|NCT01976065|Immature permanent teeth|immature permanent teeth
4924623|NCT01976065|Regeneration|regeneration
4924624|NCT01976052|Biomarkers|biomarkers
4924625|NCT01976052|Genomics|genomics
4924626|NCT01976039|motorcyclist|motorcyclist
4924627|NCT01976039|nasal mucociliary clearance|nasal mucociliary clearance
4924628|NCT01976039|physical therapy|physical therapy
4924629|NCT01976026|Flow Diversion|flow diversion
4924630|NCT01976026|Aneurysm|aneurysm
4924631|NCT01976026|Intracranial|intracranial
4924632|NCT01976026|Cerebral|cerebral
4924633|NCT01976026|Vertebral|vertebral
4924634|NCT01976026|blood blister-like|blood blister-like
4924635|NCT01976026|ruptured aneurysm|ruptured aneurysm
4924636|NCT01976026|Pipeline Flow Diversion|pipeline flow diversion
4924637|NCT01976026|Pipeline Flow Diverter|pipeline flow diverter
4924638|NCT01976026|Best-Standard Treatment|best-standard treatment
4924639|NCT01976013|PT|pt
4924640|NCT01976013|INR|inr
4924641|NCT01976013|intraventricular haemorrhage|intraventricular haemorrhage
4924642|NCT01976013|pulmonary haemorrhage|pulmonary haemorrhage
4924643|NCT01976013|ELBW infants|elbw infants
4924644|NCT01975987|Intubation|intubation
4924645|NCT01975987|Bonfils fiberscope|bonfils fiberscope
4924646|NCT01975974|vascular|vascular
4924647|NCT01975974|access|access
4924648|NCT01975974|ultrasound|ultrasound
4924649|NCT01975948|Mental Health|mental health
4924650|NCT01975948|Education and Practice Support Program|education and practice support program
4924651|NCT01975948|Depression|depression
4924652|NCT01975948|Primary Care|primary care
4924653|NCT01975948|Skill-based training|skill-based training
4924654|NCT01975948|Patient centered outcomes|patient centered outcomes
4924655|NCT01975935|diabetes mellitus type 2|diabetes mellitus type 2
4924656|NCT01975935|non-alcoholic fatt liver disease|non-alcoholic fatt liver disease
4924657|NCT01975935|obesity|obesity
4924658|NCT01975922|language impairment|language impairment
4924659|NCT01975922|language disorder|language disorder
4924660|NCT01975922|language delay|language delay
4924661|NCT01975922|late talkers|late talkers
4924662|NCT01975922|late talking|late talking
4924663|NCT01975909|Spinocerebellar Ataxia|spinocerebellar ataxia
4924664|NCT01975909|SCA|sca
4924665|NCT01975909|Ataxia|ataxia
4924666|NCT01975909|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
4924667|NCT01975909|TMS|tms
4924668|NCT01975883|Blood Glucose|blood glucose
4924669|NCT01975883|Postoperative Complications|postoperative complications
4924670|NCT01975883|Spine|spine
4924671|NCT01975883|Orthopedic surgery|orthopedic surgery
4924672|NCT01975870|Sedentary behavior, smartphone, application|sedentary behavior, smartphone, application
4924673|NCT01975857|mild traumatic brain injury|mild traumatic brain injury
4924674|NCT01975857|sleep|sleep
4924675|NCT01975857|mind body intervention|mind body intervention
4924676|NCT01975857|mind body bridging|mind body bridging
4924677|NCT01975844|Anemia|anemia
4924678|NCT01975844|End Stage Renal Disease|end stage renal disease
4924679|NCT01975831|Non Triple Negative Breast Cancer|non triple negative breast cancer
4924680|NCT01975818|Anemia of CKD on dialysis|anemia of ckd on dialysis
4924681|NCT01975805|cesarean delivery|cesarean delivery
4924682|NCT01975805|chlorhexidine|chlorhexidine
4924683|NCT01975805|iodine|iodine
4924684|NCT01975805|skin disinfectant|skin disinfectant
4924685|NCT01975792|PPROM|pprom
4924686|NCT01975792|Pregnant|pregnant
4924687|NCT01975792|Preterm|preterm
4924688|NCT01975792|Premature, labor|premature, labor
4924689|NCT01975766|Carcinoma, squamous cell of head and neck|carcinoma, squamous cell of head and neck
4924690|NCT01975766|Head and neck cancer|head and neck cancer
4924691|NCT01975766|ketogenic diet|ketogenic diet
4924692|NCT01975766|radiotherapy|radiotherapy
4924693|NCT01975766|cisplatin|cisplatin
4924694|NCT01975753|pain|pain
4924695|NCT01975727|PONV|ponv
4924696|NCT01975727|Dexamethasone|dexamethasone
4924697|NCT01975727|Treatment|treatment
4924698|NCT01975714|Glaucoma|glaucoma
4924699|NCT01975714|Ocular hypertension|ocular hypertension
4924700|NCT01975714|Preservative-free prostaglandins|preservative-free prostaglandins
4924701|NCT01975701|BGJ398,|bgj398,
4924702|NCT01975701|recurrent glioblastoma'|recurrent glioblastoma'
4924703|NCT01975701|recurrent GBM,|recurrent gbm,
4924704|NCT01975701|FGFR,|fgfr,
4924705|NCT01975662|MRSA|mrsa
4924706|NCT01975662|bacteremia|bacteremia
4924707|NCT01975662|vancomycin|vancomycin
4924708|NCT01975662|daptomycin|daptomycin
4924709|NCT01975649|postmenopausal|postmenopausal
4924710|NCT01975649|hypoactive|hypoactive
4924711|NCT01975649|sexual disorder|sexual disorder
4924712|NCT01975649|androgen|androgen
4924713|NCT01975636|Metabolism and Elimination|metabolism and elimination
4924714|NCT01975623|Video assisted thoracoscopic surgery (VATS)|video assisted thoracoscopic surgery (vats)
4925015|NCT01973972|Diabetes|diabetes
4924715|NCT01975610|Arthritis, Rheumatoid, Autoimmune, Inflammatory, Synovial, Bruton's tyrosine kinase (Btk), CC-292, Joint Disease|arthritis, rheumatoid, autoimmune, inflammatory, synovial, bruton's tyrosine kinase (btk), cc-292, joint disease
4924716|NCT01975571|residual hearing|residual hearing
4924717|NCT01975571|hybrid|hybrid
4924718|NCT01975571|hearing preservation|hearing preservation
4924719|NCT01975545|Down syndrome|down syndrome
4924720|NCT01975545|Caries|caries
4924721|NCT01975545|Dental varnish|dental varnish
4924722|NCT01975519|TRC105|trc105
4924723|NCT01975519|CD105|cd105
4924724|NCT01975519|Endoglin|endoglin
4924725|NCT01975519|Angiogenesis Inhibitor|angiogenesis inhibitor
4924726|NCT01975519|STS|sts
4924727|NCT01975519|Soft Tissue Sarcoma|soft tissue sarcoma
4924728|NCT01975519|TKI|tki
4924729|NCT01975519|Tyrosine Kinase Inhibitor|tyrosine kinase inhibitor
4924730|NCT01975519|Pazopanib|pazopanib
4924731|NCT01975519|Votrient|votrient
4924732|NCT01975519|Advanced Soft Tissue Sarcoma|advanced soft tissue sarcoma
4924733|NCT01975519|Angiosarcoma|angiosarcoma
4924734|NCT01975506|Head Start|head start
4924735|NCT01975506|Occupational Therapy|occupational therapy
4924736|NCT01975493|Infectious Diseases|infectious diseases
4924737|NCT01975493|Paediatrics|paediatrics
4924738|NCT01975493|Neonatology|neonatology
4924739|NCT01975493|Pharmacokinetics|pharmacokinetics
4924740|NCT01975493|Antimicrobials|antimicrobials
4924741|NCT01975467|midshaft clavicle fracture|midshaft clavicle fracture
4924742|NCT01975467|intramedullary nail|intramedullary nail
4924743|NCT01975467|sling|sling
4924744|NCT01975454|Metastatic colorectal cancer|metastatic colorectal cancer
4924745|NCT01975454|Chemotherapy|chemotherapy
4924746|NCT01975454|Traditional Chinese Medicine (TCM)|traditional chinese medicine (tcm)
4924747|NCT01975454|Teng-Long-Bu-Zhong-Tang|teng-long-bu-zhong-tang
4924748|NCT01975441|Diethycarbamazine|diethycarbamazine
4924749|NCT01975441|Albendazole|albendazole
4924750|NCT01975441|Ivermectin|ivermectin
4924751|NCT01975441|Lymphatic filariasis|lymphatic filariasis
4924752|NCT01975415|Meditation|meditation
4924753|NCT01975415|Sensors|sensors
4924754|NCT01975415|Digital medicine|digital medicine
4924755|NCT01975402|Congestive Heart Failure|congestive heart failure
4924756|NCT01975389|myocardial infarction|myocardial infarction
4924757|NCT01975389|stroke|stroke
4924758|NCT01975389|hyperlipidemia|hyperlipidemia
4924759|NCT01975376|myocardial infarction|myocardial infarction
4924760|NCT01975376|stroke|stroke
4924761|NCT01975376|hyperlipidemia|hyperlipidemia
4924762|NCT01975363|Breast Cancer|breast cancer
4924763|NCT01975350|Colistimethate sodium inhalation|colistimethate sodium inhalation
4924764|NCT01975324|Ampyra|ampyra
4924765|NCT01975324|NAION|naion
4924766|NCT01975324|Dalfampridine|dalfampridine
4924767|NCT01975298|RRMS|rrms
4924768|NCT01975285|Pain management|pain management
4924769|NCT01975285|Postoperative opioid requirements|postoperative opioid requirements
4924770|NCT01975285|Perioperative outcomes|perioperative outcomes
4924771|NCT01975285|Dexamethasone|dexamethasone
4924772|NCT01975285|Anesthetic adjuvant|anesthetic adjuvant
4924773|NCT01975285|Analgesic adjuvant|analgesic adjuvant
4924774|NCT01975272|postoperative|postoperative
4924775|NCT01975272|anemia|anemia
4924776|NCT01975272|gynaecologic|gynaecologic
4924777|NCT01975272|surgery|surgery
4924778|NCT01975233|Endovascular|endovascular
4924779|NCT01975233|Brain Aneurysm|brain aneurysm
4924780|NCT01975181|cardiovascular health|cardiovascular health
4924781|NCT01975181|lifestyle modification|lifestyle modification
4924782|NCT01975181|patient reported outcomes|patient reported outcomes
4924783|NCT01975181|risk assessment|risk assessment
4924784|NCT01975168|laser acupuncture|laser acupuncture
4924785|NCT01975168|obesity|obesity
4924786|NCT01975155|Celiac disease|celiac disease
4924787|NCT01975155|Gluten free diet nutrient content|gluten free diet nutrient content
4924788|NCT01975155|mycotoxins|mycotoxins
4924789|NCT01975155|Gluten free diet|gluten free diet
4924790|NCT01975142|Metastatic breast cancer|metastatic breast cancer
4924791|NCT01975142|Primary tumor HER2 negative|primary tumor her2 negative
4924792|NCT01975142|CTC HER2 positive|ctc her2 positive
4924793|NCT01975077|patients with mCRC who failed 2nd therapy or more|patients with mcrc who failed 2nd therapy or more
4924794|NCT01975064|Breast neoplasms|breast neoplasms
4924795|NCT01975064|Colonic neoplasms|colonic neoplasms
4924796|NCT01975064|Rectal neoplasms|rectal neoplasms
4924797|NCT01975051|Kala- azar|kala- azar
4924798|NCT01975051|PKDL|pkdl
4924799|NCT01975051|Treatment|treatment
4924800|NCT01975051|Pathogenesis|pathogenesis
4924801|NCT01975051|Bangladesh|bangladesh
4924802|NCT01975038|Melanin Index|melanin index
4924803|NCT01975038|Fitzpatrick Skin Phototype|fitzpatrick skin phototype
4924804|NCT01975038|Spectrophotometry|spectrophotometry
4924805|NCT01975038|Skin Diseases|skin diseases
4924806|NCT01975025|Renal Dialysis|renal dialysis
4924807|NCT01974999|Kidney|kidney
4924808|NCT01974999|Transplant|transplant
4924809|NCT01974999|Rejection|rejection
4924810|NCT01974986|dehydration|dehydration
4924811|NCT01974986|exercise|exercise
4924812|NCT01974986|rehydration|rehydration
4924813|NCT01974986|sodium|sodium
4924814|NCT01974986|water|water
4924815|NCT01974986|carbohydrate|carbohydrate
4924816|NCT01974973|autism spectrum disorders|autism spectrum disorders
4924817|NCT01974973|stem cells|stem cells
4924818|NCT01974947|Metabolic syndrome|metabolic syndrome
4924819|NCT01974947|Epigenetic|epigenetic
4924820|NCT01974947|Male infertility|male infertility
4924821|NCT01974947|Sperm parameters|sperm parameters
4924822|NCT01974947|Biomarkers|biomarkers
4924823|NCT01974921|Asthma|asthma
4924824|NCT01974921|Bronchial Thermoplasty|bronchial thermoplasty
4924825|NCT01974921|Bronchial smooth muscle|bronchial smooth muscle
4924826|NCT01974908|Ventricular Tachycardia|ventricular tachycardia
4924827|NCT01974895|Children|children
4924828|NCT01974895|Immunogenicity|immunogenicity
4924829|NCT01974895|Fluzone®|fluzone®
4924830|NCT01974895|6 to 35 months of age|6 to 35 months of age
4924831|NCT01974895|Seasonal influenza|seasonal influenza
4924832|NCT01974895|Safety|safety
4924833|NCT01974882|abdominal surgery|abdominal surgery
4924834|NCT01974882|cryotherapy|cryotherapy
4924835|NCT01974882|pain score|pain score
4924836|NCT01974882|narcotic utilization|narcotic utilization
4924837|NCT01974869|Surgery,Crohn's disease,Ulcerative colitis|surgery,crohn's disease,ulcerative colitis
4924838|NCT01974830|alpha-1|alpha-1
4924839|NCT01974830|anti-trypsin|anti-trypsin
4924840|NCT01974830|pulmonary function|pulmonary function
4924841|NCT01974830|augmentation therayp|augmentation therayp
4924842|NCT01974830|home care|home care
4924843|NCT01974817|pneumococcal vaccine|pneumococcal vaccine
4924844|NCT01974817|end stage renal disease|end stage renal disease
4924845|NCT01974817|dialysis|dialysis
4924846|NCT01974804|MRI|mri
4924847|NCT01974804|Brain metastases|brain metastases
4924848|NCT01974804|13-094|13-094
4924849|NCT01974765|Enzalutamide|enzalutamide
4924850|NCT01974765|Androgen Receptor Positive (AR+)|androgen receptor positive (ar+)
4924851|NCT01974765|13-119|13-119
4924852|NCT01974752|uveal melanoma|uveal melanoma
4924853|NCT01974739|intensive care|intensive care
4924854|NCT01974739|diuretics|diuretics
4924855|NCT01974726|ear|ear
4924856|NCT01974726|middle ear|middle ear
4924857|NCT01974726|Eustachian tube|eustachian tube
4924858|NCT01974726|Eustachian tube dysfunction|eustachian tube dysfunction
4924859|NCT01974726|Eustachian tube function|eustachian tube function
4924860|NCT01974713|CKD progression|ckd progression
4924861|NCT01974713|Inflammation|inflammation
4924862|NCT01974713|FGF23|fgf23
4924863|NCT01974713|Genetic biomarkers|genetic biomarkers
4924864|NCT01974687|Hepatitis C virus|hepatitis c virus
4924865|NCT01974687|HCV|hcv
4924866|NCT01974674|diabetes|diabetes
4924867|NCT01974674|transplantation|transplantation
4924868|NCT01974648|Laryngeal Mask Airway Supreme|laryngeal mask airway supreme
4924869|NCT01974648|propofol|propofol
4924870|NCT01974648|remifentanil|remifentanil
4924871|NCT01974648|effective dose of intravenous propofol|effective dose of intravenous propofol
4924872|NCT01974648|ED50|ed50
4924873|NCT01974635|Spinal Cord Injury|spinal cord injury
4924874|NCT01974635|Robotic therapy|robotic therapy
4924875|NCT01974635|Rehabilitation|rehabilitation
4924876|NCT01974635|Sensation|sensation
4924877|NCT01974635|Movement|movement
4924878|NCT01974635|Proprioception|proprioception
4924879|NCT01974635|Stroke|stroke
4924880|NCT01974635|Acquired Brain Injury|acquired brain injury
4924881|NCT01974609|pain relief|pain relief
4924882|NCT01974609|narcotic pain relief|narcotic pain relief
4924883|NCT01974609|non-narcotic pain relief|non-narcotic pain relief
4924884|NCT01974609|post-operative pain relief|post-operative pain relief
4924885|NCT01974609|carpal tunnel|carpal tunnel
4924886|NCT01974596|Dental implants|dental implants
4924887|NCT01974596|Probiotics|probiotics
4924888|NCT01974596|Lactobacillus reuteri|lactobacillus reuteri
4924889|NCT01974596|Periimplant mucositis|periimplant mucositis
4924890|NCT01974596|Cytokines|cytokines
4924891|NCT01974596|Bacterial load|bacterial load
4924892|NCT01974583|the split-thickness skin graft （STSG） donor site|the split-thickness skin graft （stsg） donor site
4924893|NCT01974583|regraft|regraft
4924894|NCT01974583|wound healing|wound healing
4924895|NCT01974570|Prehypertension|prehypertension
4924896|NCT01974570|Hypertension|hypertension
4924897|NCT01974570|Shrimp protein hydrolysate|shrimp protein hydrolysate
4924898|NCT01974570|Marine protein hydrolysate|marine protein hydrolysate
4924899|NCT01974570|Ambulatory blood pressure|ambulatory blood pressure
4924900|NCT01974570|Blood pressure|blood pressure
4924901|NCT01974557|Cardiac physiology|cardiac physiology
4924902|NCT01974557|ageing|ageing
4924903|NCT01974557|gender differences|gender differences
4924904|NCT01974557|diastole|diastole
4924905|NCT01974557|fluid challenge|fluid challenge
4924906|NCT01974544|diabetes complications|diabetes complications
4924907|NCT01974544|metabolic surgery|metabolic surgery
4924908|NCT01974544|Intensive medicines|intensive medicines
4924909|NCT01974518|Pemphigus|pemphigus
4924910|NCT01974518|Rituximab|rituximab
4924911|NCT01974518|Rituximab and IV cyclophosphamide combination|rituximab and iv cyclophosphamide combination
4924912|NCT01974518|B cell re-population characteristics following Rituximab|b cell re-population characteristics following rituximab
4924913|NCT01974492|saphenous vein graft|saphenous vein graft
4924914|NCT01974492|composite graft|composite graft
4924915|NCT01974492|coronary artery bypass grafting|coronary artery bypass grafting
4924916|NCT01974492|graft remodeling|graft remodeling
4924917|NCT01974479|Redirected Natural Killer Cells|redirected natural killer cells
4924918|NCT01974479|Haploidentical Cell Therapy|haploidentical cell therapy
4924919|NCT01974466|pancreatitis|pancreatitis
4924920|NCT01974466|resuscitation goal|resuscitation goal
4924921|NCT01974453|Radiation dose, transradial approach, percutaneous coronary interventions, coronary angiography|radiation dose, transradial approach, percutaneous coronary interventions, coronary angiography
4924922|NCT01974440|Lymphoma|lymphoma
4924923|NCT01974440|Follicular lymphoma|follicular lymphoma
4924924|NCT01974440|Marginal zone lymphoma|marginal zone lymphoma
4924925|NCT01974440|Indolent Non-Hodgkin lymphoma|indolent non-hodgkin lymphoma
4924926|NCT01974440|PCI-32765|pci-32765
4924927|NCT01974440|Ibrutinib|ibrutinib
4924928|NCT01974440|Bendamustine|bendamustine
4924929|NCT01974440|Rituximab|rituximab
4924930|NCT01974440|Cyclophosphamide|cyclophosphamide
4924931|NCT01974440|Doxorubicin|doxorubicin
4924932|NCT01974440|Vincristine|vincristine
4924933|NCT01974440|Prednisone|prednisone
4924934|NCT01974440|R-CHOP|r-chop
4924935|NCT01974427|Magnetic Resonance Imaging (MRI)|magnetic resonance imaging (mri)
4924936|NCT01974427|Functional Imaging|functional imaging
4924937|NCT01974427|BOLD Effect|bold effect
4924938|NCT01974427|EEG|eeg
4924939|NCT01974427|MEG|meg
4924940|NCT01974414|oral lichen planus|oral lichen planus
4924941|NCT01974414|cedar honey|cedar honey
4924942|NCT01974414|atrophic|atrophic
4924943|NCT01974414|erosive|erosive
4924944|NCT01974414|pain|pain
4924945|NCT01974414|treatment|treatment
4924946|NCT01974414|clinical trial|clinical trial
4924947|NCT01974401|oral irrigator|oral irrigator
4924948|NCT01974401|leukemia|leukemia
4924949|NCT01974401|blood dyscrasia|blood dyscrasia
4924950|NCT01974401|Oral Health Index Simplified (OHI-S)|oral health index simplified (ohi-s)
4924951|NCT01974401|supra gingival irrigator|supra gingival irrigator
4924952|NCT01974388|Bariatric surgery, sleeve gastrectomy, gastric leak|bariatric surgery, sleeve gastrectomy, gastric leak
4924953|NCT01974375|Living donor|living donor
4924954|NCT01974375|Liver transplant|liver transplant
4924955|NCT01974375|antifungal prevention|antifungal prevention
4924956|NCT01974362|Monolithic Zirconia|monolithic zirconia
4924957|NCT01974362|Zirconia-Feldspathic zirconia|zirconia-feldspathic zirconia
4924958|NCT01974362|Dental Implants|dental implants
4924959|NCT01974362|Fracture|fracture
4924960|NCT01974362|Chipping|chipping
4924961|NCT01974349|Phase I, healthy, pharmacokinetics, food effect.|phase i, healthy, pharmacokinetics, food effect.
4924962|NCT01974310|Macular Holes|macular holes
4924963|NCT01974310|Non face down positioning|non face down positioning
4924964|NCT01974310|Face down positioning|face down positioning
4924965|NCT01974297|Hyperlipidemia|hyperlipidemia
4924966|NCT01974297|Atorvastatin|atorvastatin
4924967|NCT01974297|Fenofibric acid|fenofibric acid
4924968|NCT01974297|combination|combination
4924969|NCT01974297|monotherapy|monotherapy
4924970|NCT01974245|Cholecalciferol|cholecalciferol
4924971|NCT01974245|Kidney diseases|kidney diseases
4924972|NCT01974232|Immune Thrombocytopenia (ITP), Thrombopoietin (TPO) agents, children, romiplostim and eltrombopag|immune thrombocytopenia (itp), thrombopoietin (tpo) agents, children, romiplostim and eltrombopag
4924973|NCT01974219|HIV|hiv
4924974|NCT01974219|COPD|copd
4924975|NCT01974219|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
4924976|NCT01974219|Smoking|smoking
4924977|NCT01974206|ASP0113|asp0113
4924978|NCT01974206|Cytomegalovirus (CMV)|cytomegalovirus (cmv)
4924979|NCT01974206|Kidney Transplantation|kidney transplantation
4924980|NCT01974180|Smoking|smoking
4924981|NCT01974180|COPD|copd
4924982|NCT01974180|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
4924983|NCT01974180|Healthy Smoker|healthy smoker
4924984|NCT01974180|Non-smoker|non-smoker
4924985|NCT01974167|glucocorticoid-induced osteoporosis|glucocorticoid-induced osteoporosis
4924986|NCT01974154|COPD|copd
4924987|NCT01974154|Smoking|smoking
4924988|NCT01974154|Non-smoker|non-smoker
4924989|NCT01974128|MI|mi
4924990|NCT01974115|Cellulite|cellulite
4924991|NCT01974115|Extracorporeal shock wave therapy|extracorporeal shock wave therapy
4924992|NCT01974115|ESWT|eswt
4924993|NCT01974115|Radial shock wave therapy|radial shock wave therapy
4924994|NCT01974115|RSWT|rswt
4924995|NCT01974089|Dysphagia|dysphagia
4924996|NCT01974089|Modified diet|modified diet
4924997|NCT01974089|Community acquired pneumonia|community acquired pneumonia
4924998|NCT01974089|Mortality|mortality
4924999|NCT01974089|Rehospitalization|rehospitalization
4925000|NCT01974063|Smoking|smoking
4925001|NCT01974063|Smoking Cessation|smoking cessation
4925002|NCT01974063|Healthy Smoker|healthy smoker
4925003|NCT01974063|Shisha Smoker|shisha smoker
4925004|NCT01974063|Non-smoker|non-smoker
4925005|NCT01974050|Influenza vaccination|influenza vaccination
4925006|NCT01974024|Dexamethasone|dexamethasone
4925007|NCT01974024|Hiccup|hiccup
4925008|NCT01974024|Chemotherapy|chemotherapy
4925009|NCT01974024|Methylprednisolone|methylprednisolone
4925010|NCT01973998|COPD|copd
4925011|NCT01973998|Emphysema|emphysema
4925012|NCT01973998|Roflumilast|roflumilast
4925013|NCT01973998|readmission|readmission
4925014|NCT01973985|Pleural Effusion|pleural effusion
4925016|NCT01973972|Obesity|obesity
4925017|NCT01973972|Complex Care|complex care
4925018|NCT01973972|Primary Care|primary care
4925019|NCT01973972|Chronic Disease|chronic disease
4925020|NCT01973946|Cancer|cancer
4925021|NCT01973933|Metformin|metformin
4925022|NCT01973933|Pyrimethamine|pyrimethamine
4925023|NCT01973933|Drug interaction|drug interaction
4925024|NCT01973920|Diabetes Mellitus|diabetes mellitus
4925025|NCT01973920|Oral Insulin|oral insulin
4925026|NCT01973907|Sepsis|sepsis
4925027|NCT01973907|Septic Shock|septic shock
4925028|NCT01973907|Fluid Therapy|fluid therapy
4925029|NCT01973907|Pediatrics|pediatrics
4925030|NCT01973907|Resuscitation|resuscitation
4925031|NCT01973907|Emergency Medicine|emergency medicine
4925032|NCT01973907|Critical Care|critical care
4925033|NCT01973894|PBPK|pbpk
4925034|NCT01973894|Midazolam|midazolam
4925035|NCT01973894|Pharmacokinetics|pharmacokinetics
4925036|NCT01973894|Critically ill patients|critically ill patients
4925037|NCT01973868|Regorafenib|regorafenib
4925038|NCT01973868|Cetuximab|cetuximab
4925039|NCT01973868|Solid tumors|solid tumors
4925040|NCT01973868|Cancer|cancer
4925041|NCT01973868|Safety|safety
4925042|NCT01973868|Tolerability|tolerability
4925043|NCT01973868|Pharmacokinetics|pharmacokinetics
4925044|NCT01973842|GnRH agonist|gnrh agonist
4925045|NCT01973842|OHSS|ohss
4925046|NCT01973842|Triggering final oocyte maturation|triggering final oocyte maturation
4925047|NCT01973829|CERTAIN, Checklist, ICU, Outcome, Adults|certain, checklist, icu, outcome, adults
4925048|NCT01973816|deep endometriosis;|deep endometriosis;
4925049|NCT01973816|rectal endometriosis;|rectal endometriosis;
4925050|NCT01973816|rectal shaving;|rectal shaving;
4925051|NCT01973816|colorectal resection;|colorectal resection;
4925052|NCT01973816|bowel endometriosis|bowel endometriosis
4925053|NCT01973803|Carpometacarpal joint|carpometacarpal joint
4925054|NCT01973803|Osteoarthritis of CMC-1 joint|osteoarthritis of cmc-1 joint
4925055|NCT01973790|Z-338|z-338
4925056|NCT01973790|Functional Dyspepsia|functional dyspepsia
4925057|NCT01973790|Postprandial Distress Syndrome|postprandial distress syndrome
4925058|NCT01973777|intrauterine device, contraception|intrauterine device, contraception
4925059|NCT01973764|Intraoperative ultrasound|intraoperative ultrasound
4925060|NCT01973764|Ventricular System|ventricular system
4925061|NCT01973764|Puncture|puncture
4925062|NCT01973764|Ventricular catheter|ventricular catheter
4925063|NCT01973764|Ventriculostomy|ventriculostomy
4925064|NCT01973764|Hydrocephalus|hydrocephalus
4925065|NCT01973764|Excessive accumulation of cerebrospinal fluids within the cranium. Often associated with dilatation of cerebral ventricles|excessive accumulation of cerebrospinal fluids within the cranium. often associated with dilatation of cerebral ventricles
4925066|NCT01973764|Intracranial Hypertension|intracranial hypertension
4925067|NCT01973764|increased pressure within the cranial vault. This may result from several conditions, including hydrocephalus, brain edema.|increased pressure within the cranial vault. this may result from several conditions, including hydrocephalus, brain edema.
4925068|NCT01973738|raloxifene|raloxifene
4925069|NCT01973738|bazedoxifene|bazedoxifene
4925070|NCT01973738|bone mineral density|bone mineral density
4925071|NCT01973738|bone turnover markers|bone turnover markers
4925072|NCT01973738|bone quality|bone quality
4925073|NCT01973699|shoulder arthroscopy, epinephrine, visualization|shoulder arthroscopy, epinephrine, visualization
4925074|NCT01973673|prostate cancer|prostate cancer
4925075|NCT01973673|ADT|adt
4925076|NCT01973673|bone health|bone health
4925077|NCT01973660|Human Epidermal Growth Factor Receptor 2|human epidermal growth factor receptor 2
4925078|NCT01973660|HER2|her2
4925079|NCT01973660|HER2 positive|her2 positive
4925080|NCT01973660|PAM50|pam50
4925081|NCT01973660|lapatinib|lapatinib
4925082|NCT01973660|trastuzumab|trastuzumab
4925083|NCT01973660|dual HER2 blockade|dual her2 blockade
4925084|NCT01973660|neoadjuvant|neoadjuvant
4925085|NCT01973647|insomnia|insomnia
4925086|NCT01973647|cognitive behavioral therapy|cognitive behavioral therapy
4925087|NCT01973647|COPD|copd
4925088|NCT01973647|fatigue|fatigue
4925089|NCT01973634|Radiotherapy|radiotherapy
4925090|NCT01973608|Melanoma|melanoma
4925091|NCT01973608|MSB0010445|msb0010445
4925092|NCT01973608|Dose limiting toxicity|dose limiting toxicity
4925093|NCT01973608|Stereotactic body radiation therapy|stereotactic body radiation therapy
4925094|NCT01973595|almonds|almonds
4925095|NCT01973595|inflammation|inflammation
4925096|NCT01973595|immunity|immunity
4925097|NCT01973595|gut microbiota|gut microbiota
4925098|NCT01973595|stress|stress
4925099|NCT01973595|diet quality|diet quality
4925100|NCT01973582|Hepatitis B|hepatitis b
4925101|NCT01973582|epidemiology|epidemiology
4925102|NCT01973582|youth|youth
4925103|NCT01973582|vaccine|vaccine
4925104|NCT01973569|Rheumatoid Arthritis|rheumatoid arthritis
4925105|NCT01973569|Denosumab|denosumab
4925106|NCT01973569|RANKL|rankl
4925107|NCT01973569|RANK|rank
4925108|NCT01973569|AMG 162|amg 162
4925109|NCT01973569|joint damage|joint damage
4925110|NCT01973569|Developmental Phase III|developmental phase iii
4925111|NCT01973543|PD|pd
4925112|NCT01973543|Parkinson's disease|parkinson's disease
4925113|NCT01973543|Aromatic Amino Acid Decarboxylase|aromatic amino acid decarboxylase
4925114|NCT01973543|AADC|aadc
4925115|NCT01973543|AAV2-AADC|aav2-aadc
4925116|NCT01973543|AAV2|aav2
4925117|NCT01973543|Viral Vector|viral vector
4925118|NCT01973543|Gene Therapy|gene therapy
4925119|NCT01973543|Gene Transfer|gene transfer
4925120|NCT01973543|MRI|mri
4925121|NCT01973543|PET|pet
4925122|NCT01973543|VY-AADC01|vy-aadc01
4925123|NCT01973530|femoral nerve block|femoral nerve block
4925124|NCT01973530|adductor canal block|adductor canal block
4925125|NCT01973530|steroid|steroid
4925126|NCT01973530|total knee replacement|total knee replacement
4925127|NCT01973517|Multiple sclerosis|multiple sclerosis
4925128|NCT01973517|MRI|mri
4925129|NCT01973517|USPIO|uspio
4925130|NCT01973517|Ferumoxytol|ferumoxytol
4925131|NCT01973517|Feraheme|feraheme
4925132|NCT01973504|Trauma|trauma
4925133|NCT01973504|Hemorrhagic shock|hemorrhagic shock
4925134|NCT01973504|Hemorrhage|hemorrhage
4925135|NCT01973504|Lactic acidosis|lactic acidosis
4925136|NCT01973504|Oxygen therapeutics|oxygen therapeutics
4925137|NCT01973504|Oxygen carriers|oxygen carriers
4925138|NCT01973504|Ischemic rescue therapy|ischemic rescue therapy
4925139|NCT01973504|Hemoglobin solutions|hemoglobin solutions
4925140|NCT01973504|PEGylated hemoglobin|pegylated hemoglobin
4925141|NCT01973491|ATX-MS-1467 (MSC2358825A)|atx-ms-1467 (msc2358825a)
4925142|NCT01973491|Relapsing Multiple Sclerosis|relapsing multiple sclerosis
4925143|NCT01973491|Magnetic resonance imaging (MRI)|magnetic resonance imaging (mri)
4925144|NCT01973491|M2736|m2736
4925145|NCT01973478|Major depressive disorder|major depressive disorder
4925146|NCT01973478|Recurrent depressive disorder|recurrent depressive disorder
4925147|NCT01973478|Bipolar disorder|bipolar disorder
4925148|NCT01973478|Deep brain stimulation|deep brain stimulation
4925149|NCT01973478|Accumbens|accumbens
4925150|NCT01973465|C-Diff|c-diff
4925151|NCT01973465|Diarrhea|diarrhea
4925152|NCT01973452|Dexmedetomidine|dexmedetomidine
4925153|NCT01973452|Opioid|opioid
4925154|NCT01973452|Thoracic Surgery|thoracic surgery
4925155|NCT01973439|HIV|hiv
4925156|NCT01973439|Abacavir|abacavir
4925157|NCT01973439|Lamivudine|lamivudine
4925158|NCT01973439|Pharmacokinetics|pharmacokinetics
4925159|NCT01973426|Robot|robot
4925160|NCT01973426|Thumb|thumb
4925161|NCT01973426|Orthosis|orthosis
4925162|NCT01973426|Hemiplegia|hemiplegia
4925163|NCT01973426|Hemiplegic Stroke|hemiplegic stroke
4925164|NCT01973426|Hemiplegic Cerebral Palsy|hemiplegic cerebral palsy
4925165|NCT01973426|Stroke|stroke
4925166|NCT01973426|Cerebral Palsy|cerebral palsy
4925167|NCT01973426|Grasp assistance|grasp assistance
4925168|NCT01973413|Artificial Pancreas Project|artificial pancreas project
4925169|NCT01973413|Diabetes Mellitus, Type 1|diabetes mellitus, type 1
4925170|NCT01973413|Insulin pump therapy|insulin pump therapy
4925171|NCT01973413|Continuous Glucose Monitors (CGM)|continuous glucose monitors (cgm)
4925172|NCT01973413|Juvenile-Onset Diabetes|juvenile-onset diabetes
4925173|NCT01973413|Autoimmune Diabetes|autoimmune diabetes
4925174|NCT01973413|Closed-to-Range|closed-to-range
4925175|NCT01973413|Diabetes Assistant (DiAs)|diabetes assistant (dias)
4925176|NCT01973387|Chronic lymphocytic leukemia|chronic lymphocytic leukemia
4925177|NCT01973387|Small lymphocytic lymphoma|small lymphocytic lymphoma
4925178|NCT01973387|Relapsed or refractory chronic lymphocytic leukemia|relapsed or refractory chronic lymphocytic leukemia
4925179|NCT01973387|Relapsed or refractory small lymphocytic lymphoma|relapsed or refractory small lymphocytic lymphoma
4925180|NCT01973387|Ibrutinib|ibrutinib
4925181|NCT01973387|PCI-32765|pci-32765
4925182|NCT01973387|Bruton's tyrosine kinase inhibitor|bruton's tyrosine kinase inhibitor
4925183|NCT01973387|Rituximab|rituximab
4925184|NCT01973387|Asia Pacific region participants|asia pacific region participants
4925185|NCT01973361|Wounds|wounds
4925186|NCT01973361|Lower extremity|lower extremity
4925187|NCT01973361|Diabetes|diabetes
4925188|NCT01973361|Arterial Insufficiency|arterial insufficiency
4925189|NCT01973361|Debridement|debridement
4925190|NCT01973361|Low frequency ultrasound|low frequency ultrasound
4925191|NCT01973361|Contact ultrasound|contact ultrasound
4925192|NCT01973361|Wound clinic|wound clinic
4925193|NCT01973361|Wound bed preparation|wound bed preparation
4925194|NCT01973361|Wound infection|wound infection
4925195|NCT01973361|Chronic wound inflammation|chronic wound inflammation
4925196|NCT01973348|amblyopia|amblyopia
4925197|NCT01973335|acetazolamide|acetazolamide
4925198|NCT01973335|bumetanide|bumetanide
4925199|NCT01973335|cardio-renal syndrome|cardio-renal syndrome
4925200|NCT01973335|diuretics|diuretics
4925201|NCT01973335|heart failure|heart failure
4925202|NCT01973335|natriuresis|natriuresis
4925203|NCT01973335|spironolactone|spironolactone
4925204|NCT01973322|Malignant melanoma stage III or IV|malignant melanoma stage iii or iv
4925205|NCT01973322|pretreated melanoma|pretreated melanoma
4925206|NCT01973322|vaccination|vaccination
4925207|NCT01973322|autologous dendritic cells|autologous dendritic cells
4925208|NCT01973322|autologous tumor lysate or homogenate|autologous tumor lysate or homogenate
4925209|NCT01973322|immunomodulating radiotherapy|immunomodulating radiotherapy
4925210|NCT01973309|Locally Recurrent|locally recurrent
4925211|NCT01973309|Metastatic Breast Cancer|metastatic breast cancer
4925212|NCT01973296|Health Literacy|health literacy
4925213|NCT01973296|Care Transition Intervention|care transition intervention
4925214|NCT01973296|Emergency Department Population|emergency department population
4925215|NCT01973296|Access to Care|access to care
4925216|NCT01973218|Meningitis, adolescents, Meningococcal B|meningitis, adolescents, meningococcal b
4925217|NCT01973205|Migraine|migraine
4925218|NCT01973205|acetaminophen|acetaminophen
4925219|NCT01973205|aspirin|aspirin
4925220|NCT01973166|Tattoo Removal|tattoo removal
4925221|NCT01973166|Q-switched laser|q-switched laser
4925222|NCT01973166|Nd:YAG laser|nd:yag laser
4925223|NCT01973166|Nanosecond laser|nanosecond laser
4925224|NCT01973166|Picosecond laser|picosecond laser
4925225|NCT01973166|Laser therapy|laser therapy
4925226|NCT01973166|Tattoo|tattoo
4925227|NCT01973166|pulsed-laser|pulsed-laser
4925228|NCT01973166|laser treatment|laser treatment
4925229|NCT01973166|remove tattoo|remove tattoo
4925230|NCT01973166|tattoo clearing|tattoo clearing
4925231|NCT01973166|tattoo lightening|tattoo lightening
4925232|NCT01973166|tattoo lighten|tattoo lighten
4925233|NCT01973153|Obesity prevention|obesity prevention
4925234|NCT01973153|Weight management|weight management
4925235|NCT01973153|Motivational Interviewing|motivational interviewing
4925236|NCT01973140|Tolvaptan|tolvaptan
4925237|NCT01973140|Aquaretic Efficacy|aquaretic efficacy
4925238|NCT01973127|alcohol|alcohol
4925239|NCT01973127|addiction|addiction
4925240|NCT01973127|TMS|tms
4925241|NCT01973127|craving|craving
4925242|NCT01973127|use|use
4925243|NCT01973127|rTMS|rtms
4925244|NCT01973127|EEG|eeg
4925245|NCT01973127|LPP|lpp
4925246|NCT01973127|p300|p300
4925247|NCT01973127|ERN|ern
4925248|NCT01973127|SST|sst
4925249|NCT01973127|CCT|cct
4925250|NCT01973127|AAAT|aaat
4925251|NCT01973114|Menière's disease|menière's disease
4925252|NCT01973114|Vertigo|vertigo
4925253|NCT01973114|Hearing loss|hearing loss
4925254|NCT01973114|Tinnitus|tinnitus
4925255|NCT01973101|Advanced carcinomas of uterine cervix|advanced carcinomas of uterine cervix
4925256|NCT01973101|Chemoradiation|chemoradiation
4925257|NCT01973101|Chemo-induction|chemo-induction
4925258|NCT01973101|Cisplatin|cisplatin
4925259|NCT01973101|Gemcitabine|gemcitabine
4925260|NCT01973075|Premature Ovarian Insufficiency (POI)|premature ovarian insufficiency (poi)
4925261|NCT01973036|foley catheter|foley catheter
4925262|NCT01973036|foley bulb|foley bulb
4925263|NCT01973036|oxytocin|oxytocin
4925264|NCT01973023|botulinum toxin injection|botulinum toxin injection
4925265|NCT01973023|stroke|stroke
4925266|NCT01973023|3D motion analysis|3d motion analysis
4925267|NCT01973023|gait pattern|gait pattern
4925268|NCT01973010|massage|massage
4925269|NCT01973010|low back pain|low back pain
4925270|NCT01972984|Estrogen receptor positive|estrogen receptor positive
4925271|NCT01972971|warfarin|warfarin
4925272|NCT01972971|pharmacist|pharmacist
4925273|NCT01972971|anticoagulation|anticoagulation
4925274|NCT01972945|vaginoscopy|vaginoscopy
4925275|NCT01972945|hysteroscopy|hysteroscopy
4925276|NCT01972945|office hysteroscopy|office hysteroscopy
4925277|NCT01972945|outpatient hysteroscopy|outpatient hysteroscopy
4925278|NCT01972932|Bio-K+®|bio-k+®
4925279|NCT01972932|Placebo|placebo
4925280|NCT01972932|AAD|aad
4925281|NCT01972932|CDI|cdi
4925282|NCT01972932|hospitalized subjects|hospitalized subjects
4925283|NCT01972906|moxibustion|moxibustion
4925284|NCT01972906|primary dysmenorrhea|primary dysmenorrhea
4925285|NCT01972893|Selective GLP-1 agonist|selective glp-1 agonist
4925286|NCT01972880|Open-label design|open-label design
4925287|NCT01972880|Bioequivalence|bioequivalence
4925288|NCT01972880|ASP1941|asp1941
4925289|NCT01972867|Focal|focal
4925290|NCT01972867|Prostate|prostate
4925291|NCT01972867|Cancer|cancer
4925292|NCT01972867|Irreversible|irreversible
4925293|NCT01972867|Electroporation|electroporation
4925294|NCT01972867|NanoKnife|nanoknife
4925295|NCT01972854|keratoconus|keratoconus
4925296|NCT01972854|cross-linking|cross-linking
4925297|NCT01972854|KXL|kxl
4925298|NCT01972841|Combination Therapy|combination therapy
4925299|NCT01972841|Mirabegron|mirabegron
4925300|NCT01972841|Overactive Bladder|overactive bladder
4925301|NCT01972841|Urgency|urgency
4925302|NCT01972841|Urinary Incontinence|urinary incontinence
4925303|NCT01972841|Nocturia|nocturia
4925304|NCT01972841|Solifenacin Succinate|solifenacin succinate
4925305|NCT01972828|Septic shock|septic shock
4925306|NCT01972828|Randomized controlled trial|randomized controlled trial
4925307|NCT01972828|Preload dependence|preload dependence
4925308|NCT01972828|Pulmonary thermodilution|pulmonary thermodilution
4925309|NCT01972802|HEAD AND NECK|head and neck
4925310|NCT01972789|Subfoveal choroidal neovascularization (CNV)|subfoveal choroidal neovascularization (cnv)
4925311|NCT01972789|wet age-related macular degeneration(AMD)|wet age-related macular degeneration(amd)
4925312|NCT01972789|inject and extend|inject and extend
4925313|NCT01972789|retinal fluid|retinal fluid
4925314|NCT01972776|COPD, inflammation, small airways, LCI, PFTs, lung heterogeneity|copd, inflammation, small airways, lci, pfts, lung heterogeneity
4925315|NCT01972750|glioblastoma|glioblastoma
4925316|NCT01972750|recurrence|recurrence
4925317|NCT01972737|Vaccine|vaccine
4925318|NCT01972737|Colon cancer|colon cancer
4925319|NCT01972737|safety|safety
4925320|NCT01972737|tolerability|tolerability
4925321|NCT01972737|antibody responses|antibody responses
4925322|NCT01972737|T cell responses|t cell responses
4925323|NCT01972724|Drug therapy|drug therapy
4925324|NCT01972711|Schizophrenia|schizophrenia
4925325|NCT01972698|Focused Cardiac Ultrasound|focused cardiac ultrasound
4925326|NCT01972698|Lung Ultrasound|lung ultrasound
4925327|NCT01972698|Simulation|simulation
4925328|NCT01972698|Education|education
4925329|NCT01972698|Web-based learning|web-based learning
4925330|NCT01972685|ILD, transbronchial, cryoprobe, VATS|ild, transbronchial, cryoprobe, vats
4925331|NCT01972659|sugammadex|sugammadex
4925332|NCT01972659|rocuronium|rocuronium
4925333|NCT01972659|magnesium|magnesium
4925334|NCT01972659|female|female
4925335|NCT01972646|Cellulitis, treatment failure, skin and soft tissue infections, risk factors.|cellulitis, treatment failure, skin and soft tissue infections, risk factors.
4925336|NCT01972633|endovenous treatment|endovenous treatment
4925337|NCT01972633|Laser, Vnus Closure Fast|laser, vnus closure fast
4925338|NCT01972633|Varicosis|varicosis
4925339|NCT01972633|great saphenous vein|great saphenous vein
4925340|NCT01972633|small saphenous vein|small saphenous vein
4925341|NCT01972633|Venous Insufficiency|venous insufficiency
4925342|NCT01972620|gallstones|gallstones
4925343|NCT01972620|cholelithiasis|cholelithiasis
4925344|NCT01972620|cholecystectomy, laparoscopic|cholecystectomy, laparoscopic
4925345|NCT01972620|pain|pain
4925346|NCT01972607|Migraine, aerobic exercise, prevention|migraine, aerobic exercise, prevention
4925347|NCT01972581|neurocognitive visual reaction training|neurocognitive visual reaction training
4925348|NCT01972581|baseball|baseball
4925349|NCT01972568|Atacicept|atacicept
4925350|NCT01972568|Placebo|placebo
4925351|NCT01972542|Postprandial period|postprandial period
4925352|NCT01972542|triglyceride|triglyceride
4925353|NCT01972542|Diabetes mellitus, type 2|diabetes mellitus, type 2
4925354|NCT01972542|Prediabetic state|prediabetic state
4925355|NCT01972529|Thrombocytopenia|thrombocytopenia
4925356|NCT01972529|Chronic Liver Disease|chronic liver disease
4925357|NCT01972516|Platinum-Sensitive|platinum-sensitive
4925358|NCT01972516|Ovarian Cancer|ovarian cancer
4925359|NCT01972516|Fallopian Tube Cancer|fallopian tube cancer
4925360|NCT01972516|Primary Peritoneal Cancer|primary peritoneal cancer
4925361|NCT01972516|High-grade Serous|high-grade serous
4925362|NCT01972503|Colorectal Neoplasms|colorectal neoplasms
4925363|NCT01972503|Liver|liver
4925364|NCT01972503|Neoplasm Metastasis|neoplasm metastasis
4925365|NCT01972503|Tegafur|tegafur
4925366|NCT01972503|oxaliplatin|oxaliplatin
4925367|NCT01972490|colorectal neoplasms|colorectal neoplasms
4925368|NCT01972490|liver metastasis|liver metastasis
4925369|NCT01972490|chemotherapy|chemotherapy
4925370|NCT01972490|avastin|avastin
4925371|NCT01972477|DLBS1449|dlbs1449
4925372|NCT01972477|diabetes mellitus|diabetes mellitus
4925373|NCT01972477|HDL-cholesterol|hdl-cholesterol
4925374|NCT01972464|Progesterone|progesterone
4925375|NCT01972464|Placebo|placebo
4925376|NCT01972464|Postpartum|postpartum
4925377|NCT01972464|Tobacco|tobacco
4925378|NCT01972464|Pregnancy|pregnancy
4925379|NCT01972438|Graft Versus Host Disease|graft versus host disease
4925380|NCT01972438|Hematopoietic Stem Cell Transplant|hematopoietic stem cell transplant
4925381|NCT01972412|nursing care|nursing care
4925382|NCT01972412|diabetes mellitus|diabetes mellitus
4925383|NCT01972412|phone support|phone support
4925384|NCT01972412|chronic care model|chronic care model
4925385|NCT01972373|VEGF|vegf
4925386|NCT01972373|Fluorescence|fluorescence
4925387|NCT01972373|Endoscopy|endoscopy
4925388|NCT01972373|Rectal cancer|rectal cancer
4925389|NCT01972360|SPECT|spect
4925390|NCT01972360|CMR|cmr
4925391|NCT01972360|High risk for ischemic cardiovascular events|high risk for ischemic cardiovascular events
4925392|NCT01972347|Melanoma|melanoma
4925393|NCT01972347|Cutaneous melanoma|cutaneous melanoma
4925394|NCT01972347|Malignant melanoma|malignant melanoma
4925395|NCT01972347|Stage III B / C melanoma|stage iii b / c melanoma
4925396|NCT01972347|Neoadjuvant treatment|neoadjuvant treatment
4925397|NCT01972347|Pyrexia|pyrexia
4925398|NCT01972347|Biomarkers|biomarkers
4925399|NCT01972347|Dabrafenib|dabrafenib
4925400|NCT01972347|Trametinib|trametinib
4925401|NCT01972334|clostridium difficile|clostridium difficile
4925402|NCT01972334|children|children
4925403|NCT01972334|fecal transplant|fecal transplant
4925404|NCT01972321|Community health worker|community health worker
4925405|NCT01972321|Motivation|motivation
4925406|NCT01972321|Performance|performance
4925407|NCT01972321|Quality of care|quality of care
4925408|NCT01972321|Africa|africa
4925409|NCT01972308|asthma|asthma
4925410|NCT01972308|patient advocate|patient advocate
4925411|NCT01972308|health disparity|health disparity
4925412|NCT01972308|patient-provider communication|patient-provider communication
4925413|NCT01972282|Atrial fibrillation|atrial fibrillation
4925414|NCT01972282|Stroke|stroke
4925415|NCT01972282|Thrombus|thrombus
4925416|NCT01972282|Thromboembolism|thromboembolism
4925417|NCT01972282|Left atrial appendage|left atrial appendage
4925418|NCT01972269|Epidural|epidural
4925419|NCT01972269|Labor Analgesia|labor analgesia
4925420|NCT01972269|Bupivacaine|bupivacaine
4925421|NCT01972269|Minimum effective volume|minimum effective volume
4925422|NCT01972243|risk of recurrent|risk of recurrent
4925423|NCT01972217|Olaparib|olaparib
4925424|NCT01972217|castration-resistant, metastatic prostate cancer|castration-resistant, metastatic prostate cancer
4925425|NCT01972217|Prior Docetaxel Chemotherapy|prior docetaxel chemotherapy
4925426|NCT01972191|Toric marking, Corneal horizontal marking|toric marking, corneal horizontal marking
4925427|NCT01972165|Carpal tunnel syndrome|carpal tunnel syndrome
4925428|NCT01972152|Hypoglycemia|hypoglycemia
4925429|NCT01972152|Glucagon|glucagon
4925430|NCT01972139|Uncontrolled hypertension|uncontrolled hypertension
4925431|NCT01972139|blood pressure|blood pressure
4925432|NCT01972139|renal denervation|renal denervation
4925433|NCT01972139|HTN-4|htn-4
4925434|NCT01972139|SYMPLICITY|symplicity
4925435|NCT01972113|Vitamin K|vitamin k
4925436|NCT01972113|Vitamin K2|vitamin k2
4925437|NCT01972113|Menaquinone-7|menaquinone-7
4925438|NCT01972113|Osteocalcin|osteocalcin
4925439|NCT01972113|Children|children
4925440|NCT01972113|Obesity|obesity
4925441|NCT01972113|Insulin resistance|insulin resistance
4925442|NCT01972113|Insulin sensitivity|insulin sensitivity
4925443|NCT01972113|Beta-cell function|beta-cell function
4925444|NCT01972113|Prediabetes|prediabetes
4925445|NCT01972113|Matrix Gla protein|matrix gla protein
4925446|NCT01972113|Arterial stiffness|arterial stiffness
4925447|NCT01972113|Endothelial function|endothelial function
4925448|NCT01972100|Low-level laser therapy|low-level laser therapy
4925449|NCT01972100|Muscle fatigue resistance|muscle fatigue resistance
4925450|NCT01972074|Autism spectrum disorder|autism spectrum disorder
4925451|NCT01972074|Treatment|treatment
4925452|NCT01972074|Adolescents|adolescents
4925453|NCT01972074|Memantine|memantine
4925454|NCT01972074|functional Magnetic Resonance Imaging|functional magnetic resonance imaging
4925455|NCT01972074|MRS|mrs
4925456|NCT01972074|Neuroimaging|neuroimaging
4925457|NCT01972048|breast cancer|breast cancer
4925458|NCT01972048|breast cancer screening|breast cancer screening
4925459|NCT01972048|mammogram|mammogram
4925460|NCT01972035|EBV|ebv
4925461|NCT01972035|CMV|cmv
4925462|NCT01972035|Kidney transplant|kidney transplant
4925463|NCT01972035|valganciclovir|valganciclovir
4925464|NCT01972035|valacyclovir|valacyclovir
4925465|NCT01972022|Drug Eluting Stents|drug eluting stents
4925466|NCT01972022|Bioabsorbale Polymer Coating|bioabsorbale polymer coating
4925467|NCT01972022|Neoatherosclerosis|neoatherosclerosis
4925468|NCT01972022|Stent Coverage|stent coverage
4925469|NCT01972022|Stent Failure|stent failure
4925470|NCT01971996|Near infrared Spectroscopy|near infrared spectroscopy
4925471|NCT01971983|Low back pain|low back pain
4925472|NCT01971983|Spinal manipulation|spinal manipulation
4925473|NCT01971983|Osteopathy|osteopathy
4925474|NCT01971983|Muscle energy technique|muscle energy technique
4925475|NCT01971983|Muscle thickness|muscle thickness
4925476|NCT01971970|Inflammatory bowel disease|inflammatory bowel disease
4925477|NCT01971970|Pediatric|pediatric
4925478|NCT01971970|Adult|adult
4925479|NCT01971970|Biomarker|biomarker
4925480|NCT01971970|Anti-TNF response|anti-tnf response
4925481|NCT01971970|Infliximab|infliximab
4925482|NCT01971970|Adalimumab|adalimumab
4925483|NCT01971957|ichthyosis|ichthyosis
4925484|NCT01971957|spasticity|spasticity
4925485|NCT01971957|spastic diplegia|spastic diplegia
4925486|NCT01971957|intellectual disability|intellectual disability
4925487|NCT01971944|Beta Blocker|beta blocker
4925488|NCT01971944|Inotrope|inotrope
4925489|NCT01971918|spondyloarthritis|spondyloarthritis
4925490|NCT01971918|monoclonal antibodies anti-TNF|monoclonal antibodies anti-tnf
4925491|NCT01971918|secondary treatment failure|secondary treatment failure
4925492|NCT01971892|Abdominal surgery;|abdominal surgery;
4925493|NCT01971892|Postoperative complication;|postoperative complication;
4925494|NCT01971892|Acute respiratory failure;|acute respiratory failure;
4925495|NCT01971892|Hypoxemia;|hypoxemia;
4925496|NCT01971892|Intubation;|intubation;
4925497|NCT01971892|Non-invasive ventilation|non-invasive ventilation
4925498|NCT01971879|Remote ischemic preconditioning|remote ischemic preconditioning
4925499|NCT01971879|Obliterating Arteriopathy of the Lower Limbs|obliterating arteriopathy of the lower limbs
4925500|NCT01971866|Proton radiation|proton radiation
4925501|NCT01971866|AlignRT|alignrt
4925502|NCT01971853|Analgesia|analgesia
4925503|NCT01971840|Physical activity|physical activity
4925504|NCT01971840|Physical fitness|physical fitness
4925505|NCT01971840|Obesity|obesity
4925506|NCT01971840|Adiposity|adiposity
4925507|NCT01971840|Adiposity rebound period|adiposity rebound period
4925508|NCT01971840|Children|children
4925509|NCT01971840|Blood pressure|blood pressure
4925510|NCT01971840|Randomized controlled trials|randomized controlled trials
4925511|NCT01971840|Barriers and facilitators of the environment|barriers and facilitators of the environment
4925512|NCT01971827|Physical activity|physical activity
4925513|NCT01971827|Obesity|obesity
4925514|NCT01971827|Adiposity rebound period|adiposity rebound period
4925515|NCT01971827|Children with ADHD|children with adhd
4925516|NCT01971827|Children without ADHD|children without adhd
4925517|NCT01971827|Academic performance|academic performance
4925518|NCT01971827|Motor skills|motor skills
4925519|NCT01971827|Health related-quality of life|health related-quality of life
4925520|NCT01971827|Sleep|sleep
4925521|NCT01971801|urinary incontinence|urinary incontinence
4925522|NCT01971801|bowel incontinence|bowel incontinence
4925523|NCT01971801|vitamin D|vitamin d
4925524|NCT01971801|overactive bladder|overactive bladder
4925525|NCT01971801|lower urinary tract symptoms|lower urinary tract symptoms
4925526|NCT01971801|quality of life|quality of life
4925527|NCT01971775|Ultrasonically Activated Shear|ultrasonically activated shear
4925528|NCT01971775|Conventional Monopolar Electrocautery|conventional monopolar electrocautery
4925529|NCT01971775|Gastric Cancer|gastric cancer
4925530|NCT01971762|multiresistant bacteremia|multiresistant bacteremia
4925531|NCT01971762|bacteremia management|bacteremia management
4925532|NCT01971762|blood culture|blood culture
4925533|NCT01971749|Coronary stent procedure (CSP|coronary stent procedure (csp
4925534|NCT01971749|Coronary-artery bypass grafting (CABG)|coronary-artery bypass grafting (cabg)
4925535|NCT01971736|1064nm YAG laser|1064nm yag laser
4925536|NCT01971736|laxity|laxity
4925537|NCT01971736|rhytides|rhytides
4925538|NCT01971736|asian|asian
4925539|NCT01971723|Testosterone|testosterone
4925540|NCT01971723|Estrogen|estrogen
4925541|NCT01971723|Insulin|insulin
4925542|NCT01971723|Blood Lipid|blood lipid
4925543|NCT01971723|Glucose|glucose
4925544|NCT01971723|Creatine Kinase|creatine kinase
4925545|NCT01971723|Strength|strength
4925546|NCT01971723|Power Athlete|power athlete
4925547|NCT01971710|HIV|hiv
4925548|NCT01971710|AIDS|aids
4925549|NCT01971710|PMTCT|pmtct
4925550|NCT01971684|ITP|itp
4925551|NCT01971684|idiopathic thrombocytopenic purpura|idiopathic thrombocytopenic purpura
4925552|NCT01971684|bleeding score|bleeding score
4925553|NCT01971684|platelet count|platelet count
4925554|NCT01971684|health-related quality of life|health-related quality of life
4925555|NCT01971684|HRQL|hrql
4925556|NCT01971684|Purpura|purpura
4925557|NCT01971684|Purpura, Thrombocytopenic|purpura, thrombocytopenic
4925558|NCT01971684|Purpura, Thrombocytopenic, Idiopathic|purpura, thrombocytopenic, idiopathic
4925559|NCT01971684|Blood Coagulation Disorders|blood coagulation disorders
4925560|NCT01971684|Hematologic Diseases|hematologic diseases
4925561|NCT01971684|Hemorrhage|hemorrhage
4925562|NCT01971684|Skin Manifestations|skin manifestations
4925563|NCT01971684|Thrombocytopenia|thrombocytopenia
4925564|NCT01971684|Blood Platelet Disorders|blood platelet disorders
4925565|NCT01971684|Immune System Diseases|immune system diseases
4925566|NCT01971684|Hemorrhagic Disorders|hemorrhagic disorders
4925567|NCT01971684|Autoimmune Diseases|autoimmune diseases
4925568|NCT01971684|Therapeutic Uses|therapeutic uses
4925569|NCT01971658|Multiple myeloma|multiple myeloma
4925570|NCT01971658|Newly Diagnosed|newly diagnosed
4925571|NCT01971645|Dexamethasone|dexamethasone
4925572|NCT01971645|Ropivacaine|ropivacaine
4925573|NCT01971645|Knee arthroscopy|knee arthroscopy
4925574|NCT01971645|Femoral nerve blocks|femoral nerve blocks
4925575|NCT01971645|Peripheral nerve blocks|peripheral nerve blocks
4925576|NCT01971645|Adjuvant|adjuvant
4925577|NCT01971645|Pediatrics|pediatrics
4925578|NCT01971606|Statin, coronary artery bypass grafting, off-pump surgery, acute coronary syndrome|statin, coronary artery bypass grafting, off-pump surgery, acute coronary syndrome
4925579|NCT01971567|Insomnia|insomnia
4925580|NCT01971567|Electroencephalic|electroencephalic
4925581|NCT01971567|Biofeedback|biofeedback
4925582|NCT01971567|Neural oscillations|neural oscillations
4925583|NCT01971567|Auto calibration|auto calibration
4925584|NCT01971567|Relaxation|relaxation
4925585|NCT01971541|mindfulness|mindfulness
4925586|NCT01971541|behavior therapies, cognitive|behavior therapies, cognitive
4925587|NCT01971541|posttraumatic stress disorder|posttraumatic stress disorder
4925588|NCT01971541|group therapy|group therapy
4925589|NCT01971528|Muscle strength, fatigue, electromyography (EMG), central fatigue, strength straining|muscle strength, fatigue, electromyography (emg), central fatigue, strength straining
4925590|NCT01971515|MSC2363318A|msc2363318a
4925591|NCT01971515|Maximum tolerated dose|maximum tolerated dose
4925592|NCT01971515|Dose limiting toxicities|dose limiting toxicities
4925593|NCT01971515|Recommended phase 2 dose|recommended phase 2 dose
4925594|NCT01971515|M2698|m2698
4925595|NCT01971515|Metastatic Breast Cancer|metastatic breast cancer
4925596|NCT01971515|HER2+ Metastatic Breast Cancer|her2+ metastatic breast cancer
4925597|NCT01971515|Hormone refractory ER/PR+ breast cancer|hormone refractory er/pr+ breast cancer
4925598|NCT01971515|Tamoxifen|tamoxifen
4925599|NCT01971515|PAM Pathway Alteration(s)|pam pathway alteration(s)
4925600|NCT01971515|PAM Pathway|pam pathway
4925601|NCT01971515|Targeted Therapy|targeted therapy
4925602|NCT01971515|P70S6K|p70s6k
4925603|NCT01971515|AKT Inhibition|akt inhibition
4925604|NCT01971515|PI3K Pathway|pi3k pathway
4925605|NCT01971515|HER2+ Trastuzumab Resistance|her2+ trastuzumab resistance
4925606|NCT01971450|Non-interventional|non-interventional
4925607|NCT01971450|Ventavis|ventavis
4925608|NCT01971450|Iloprost|iloprost
4925609|NCT01971450|Pulmonary hypertension|pulmonary hypertension
4925610|NCT01971450|Compliance|compliance
4925611|NCT01971450|Russian Federation|russian federation
4925612|NCT01971437|Overactive Bladder|overactive bladder
4925613|NCT01971437|OAB|oab
4925614|NCT01971437|Cystoscopy|cystoscopy
4925615|NCT01971437|Cystodistension|cystodistension
4925616|NCT01971437|UTI|uti
4925617|NCT01971437|Cytokines|cytokines
4925618|NCT01971424|magnesium|magnesium
4925619|NCT01971424|SPPB|sppb
4925620|NCT01971424|strength|strength
4925621|NCT01971424|physical performance|physical performance
4925622|NCT01971424|24 hour magnesuria|24 hour magnesuria
4925623|NCT01971411|Hyperparathyroidism|hyperparathyroidism
4925624|NCT01971411|Hypoparathyroidism|hypoparathyroidism
4925625|NCT01971411|Calcium|calcium
4925626|NCT01971411|Vitamin D|vitamin d
4925627|NCT01971411|Bone mineral density|bone mineral density
4925628|NCT01971411|African American|african american
4925629|NCT01971411|Female|female
4925630|NCT01971411|Elderly|elderly
4925631|NCT01971398|Fetal Alcohol Spectrum Disorders (FASD)|fetal alcohol spectrum disorders (fasd)
4925632|NCT01971398|Prevention|prevention
4925633|NCT01971398|Alcohol-Exposed Pregnancy|alcohol-exposed pregnancy
4925634|NCT01971398|Knowledge|knowledge
4925635|NCT01971398|Attitudes|attitudes
4925636|NCT01971359|Stroke, Intracerebral Hemorrhage, ICH|stroke, intracerebral hemorrhage, ich
4925637|NCT01971346|Psoriasis|psoriasis
4925638|NCT01971346|ENBREL|enbrel
4925639|NCT01971346|etanercept|etanercept
4925640|NCT01971346|anti-TNF|anti-tnf
4925641|NCT01971333|pulse pressure variation|pulse pressure variation
4925642|NCT01971333|stroke volume variation|stroke volume variation
4925643|NCT01971333|plethysmographic variation index|plethysmographic variation index
4925644|NCT01971333|fluid responsiveness|fluid responsiveness
4925645|NCT01971294|Urinary symptoms|urinary symptoms
4925646|NCT01971294|Systemic sclerosis|systemic sclerosis
4925647|NCT01971294|Severity index|severity index
4925648|NCT01971294|Urinary tract infection|urinary tract infection
4925649|NCT01971294|mortality|mortality
4925650|NCT01971294|Quality of life|quality of life
4925651|NCT01971281|Pancreatic adenocarcinoma|pancreatic adenocarcinoma
4925652|NCT01971281|Pancreas tumor|pancreas tumor
4925653|NCT01971281|Treatment|treatment
4925654|NCT01971281|Minimal toxicity|minimal toxicity
4925655|NCT01971281|TTFields|ttfields
4925656|NCT01971281|Tumor Treating Fields|tumor treating fields
4925657|NCT01971281|Novocure|novocure
4925658|NCT01971268|T3 dental implants|t3 dental implants
4925659|NCT01971268|Marginal bone loss|marginal bone loss
4925660|NCT01971268|Survival rate|survival rate
4925661|NCT01971255|Influenza A|influenza a
4925662|NCT01971255|HAI|hai
4925663|NCT01971255|H1N1|h1n1
4925664|NCT01971255|Challenge Study|challenge study
4925665|NCT01971255|Correlates of Protection|correlates of protection
4925666|NCT01971242|Parkinson's|parkinson's
4925667|NCT01971242|Parkinson's Disease|parkinson's disease
4925668|NCT01971242|Exenatide|exenatide
4925669|NCT01971242|Bydureon|bydureon
4925670|NCT01971216|Breastfeeding, relaxation, anxiety, infant growth|breastfeeding, relaxation, anxiety, infant growth
4925671|NCT01971203|seroquel XR|seroquel xr
4925672|NCT01971203|quetiapine XR|quetiapine xr
4925673|NCT01971203|major depression|major depression
4925674|NCT01971203|generalized anxiety disorder|generalized anxiety disorder
4925675|NCT01971203|CBT|cbt
4925676|NCT01971203|co-morbid MDD|co-morbid mdd
4925677|NCT01971164|anemia|anemia
4925678|NCT01971164|chronic kidney disease|chronic kidney disease
4925679|NCT01971164|hemodialysis|hemodialysis
4925680|NCT01971151|Chronic|chronic
4925681|NCT01971151|Back pain|back pain
4925682|NCT01971151|Low back|low back
4925683|NCT01971125|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
4925684|NCT01971125|Heart Diseases|heart diseases
4925685|NCT01971125|Left Ventricular Dysfunction|left ventricular dysfunction
4925686|NCT01971112|Multi-vitamins|multi-vitamins
4925687|NCT01971112|Minerals|minerals
4925688|NCT01971112|Respiratory infections|respiratory infections
4925689|NCT01971112|DTH|dth
4925690|NCT01971112|CRP|crp
4925691|NCT01971112|Cathelicidin|cathelicidin
4925692|NCT01971099|sexual function|sexual function
4925693|NCT01971099|hypoactive|hypoactive
4925694|NCT01971099|desire|desire
4925695|NCT01971099|androgens|androgens
4925696|NCT01971073|schizophrenic patients|schizophrenic patients
4925697|NCT01971073|tDCS|tdcs
4925698|NCT01971073|Executive functions|executive functions
4925699|NCT01971073|Dorsolateral prefrontal cortex|dorsolateral prefrontal cortex
4925700|NCT01971060|uterine fibroids|uterine fibroids
4925701|NCT01971060|barbed suture|barbed suture
4925702|NCT01971060|infertility|infertility
4925703|NCT01971060|adhesions|adhesions
4925704|NCT01971047|Diabetes|diabetes
4925705|NCT01971047|Surgery|surgery
4925706|NCT01971047|anesthesiology|anesthesiology
4925707|NCT01971047|endocrinology|endocrinology
4925708|NCT01970995|Candidate modified risk tobacco product|candidate modified risk tobacco product
4925709|NCT01970995|Conventional cigarettes|conventional cigarettes
4925710|NCT01970995|Reduced exposure|reduced exposure
4925711|NCT01970995|HPHCs|hphcs
4925712|NCT01970995|Ambulatory|ambulatory
4925713|NCT01970982|Candidate modified risk tobacco product|candidate modified risk tobacco product
4925714|NCT01970982|Conventional cigarette|conventional cigarette
4925715|NCT01970982|Reduced exposure|reduced exposure
4925716|NCT01970982|HPHCs|hphcs
4925717|NCT01970982|Confinement|confinement
4925718|NCT01970969|Atrial Fibrillation|atrial fibrillation
4925719|NCT01970969|Cardiac monitoring|cardiac monitoring
4925720|NCT01970969|Genomics|genomics
4925721|NCT01970943|migraine, headache, episodic, chronic, pain|migraine, headache, episodic, chronic, pain
4925722|NCT01970930|Tissue banking|tissue banking
4925723|NCT01970917|tear film thickness|tear film thickness
4925724|NCT01970917|optical coherence tomography|optical coherence tomography
4925725|NCT01970917|topical lubricants|topical lubricants
4925726|NCT01970917|tear film thickness in healthy subjects|tear film thickness in healthy subjects
4925727|NCT01970904|Chronic hepatitis C|chronic hepatitis c
4925728|NCT01970904|DEB025|deb025
4925729|NCT01970904|Alisporivir|alisporivir
4925730|NCT01970904|ribavirin therapy|ribavirin therapy
4925731|NCT01970904|genotype 2/3 treatment naive patients|genotype 2/3 treatment naive patients
4925732|NCT01970891|Freezing of Gait|freezing of gait
4925733|NCT01970891|Gait|gait
4925734|NCT01970891|Comfort|comfort
4925735|NCT01970891|Pain tolerance|pain tolerance
4925736|NCT01970891|Pain|pain
4925737|NCT01970891|Sensory threshold|sensory threshold
4925738|NCT01970891|Motor threshold|motor threshold
4925739|NCT01970891|Pain threshold|pain threshold
4925740|NCT01970865|Phase 1|phase 1
4925741|NCT01970865|Phase 2|phase 2
4925742|NCT01970865|safety|safety
4925743|NCT01970865|pharmacokinetic|pharmacokinetic
4925744|NCT01970865|pharmacodynamic|pharmacodynamic
4925745|NCT01970865|efficacy|efficacy
4925746|NCT01970852|Inpatient|inpatient
4925747|NCT01970852|PHR Portal|phr portal
4925748|NCT01970852|Information Technology|information technology
4925749|NCT01970839|Tourniquet|tourniquet
4925750|NCT01970839|Endoneural|endoneural
4925751|NCT01970839|Ischemia|ischemia
4925752|NCT01970826|aseptic sterilized field|aseptic sterilized field
4925753|NCT01970826|clean sterilized field|clean sterilized field
4925754|NCT01970826|dental implants|dental implants
4925755|NCT01970826|Surgery|surgery
4925756|NCT01970813|Parkinson's disease|parkinson's disease
4925757|NCT01970813|Idiopathic Parkinson's disease|idiopathic parkinson's disease
4925758|NCT01970813|acupuncture|acupuncture
4925759|NCT01970813|bee venom acupuncture|bee venom acupuncture
4925760|NCT01970800|IGF-1|igf-1
4925761|NCT01970800|Short Stature|short stature
4925762|NCT01970800|GH|gh
4925763|NCT01970748|Variceal bleeding|variceal bleeding
4925764|NCT01970748|Portal hypertension|portal hypertension
4925765|NCT01970748|Hepatocellular carcinoma|hepatocellular carcinoma
4925766|NCT01970748|Endoscopic variceal ligation|endoscopic variceal ligation
4925767|NCT01970748|Non-selective beta-blocker|non-selective beta-blocker
4925768|NCT01970709|Adverse Drug Reactions|adverse drug reactions
4925769|NCT01970709|Emergency Department Visits|emergency department visits
4925770|NCT01970709|Hospitalizations|hospitalizations
4925771|NCT01970709|Pharmacogenomic|pharmacogenomic
4925772|NCT01970696|ovarian|ovarian
4925773|NCT01970696|testicular|testicular
4925774|NCT01970696|stromal|stromal
4925775|NCT01970696|Sertoli|sertoli
4925776|NCT01970696|Leydig|leydig
4925777|NCT01970696|gynandroblastoma|gynandroblastoma
4925778|NCT01970696|juvenile granulosa cell tumor|juvenile granulosa cell tumor
4925779|NCT01970696|DICER1|dicer1
4925780|NCT01970657|Venous Stasis Ulcer|venous stasis ulcer
4925781|NCT01970657|VLU|vlu
4925782|NCT01970644|Neoplasm metastasis|neoplasm metastasis
4925783|NCT01970644|Brain neoplasms|brain neoplasms
4925784|NCT01970644|Radiosurgery|radiosurgery
4925785|NCT01970644|Cognition disorders|cognition disorders
4925786|NCT01970644|Cranial irradiation|cranial irradiation
4925787|NCT01970631|Osteoarthritis|osteoarthritis
4925788|NCT01970631|Total Knee Replacement|total knee replacement
4925789|NCT01970631|total Knee Arthroplasty|total knee arthroplasty
4925790|NCT01970631|Post-operative recovery TKR|post-operative recovery tkr
4925791|NCT01970631|Physical Activity|physical activity
4925792|NCT01970631|Motivational Interviewing|motivational interviewing
4925793|NCT01970631|Financial Incentives|financial incentives
4925794|NCT01970592|exercise|exercise
4925795|NCT01970592|rehabilitation|rehabilitation
4925796|NCT01970592|walking|walking
4925797|NCT01970566|Intense Exercise/Moderate Calorie Restriction|intense exercise/moderate calorie restriction
4925798|NCT01970566|Topiramate-Phentermine|topiramate-phentermine
4925799|NCT01970553|lurbinectedin|lurbinectedin
4925800|NCT01970553|PM01183|pm01183
4925801|NCT01970553|tumors|tumors
4925802|NCT01970553|cancer|cancer
4925803|NCT01970553|Pharma Mar|pharma mar
4925804|NCT01970540|lurbinectedin|lurbinectedin
4925805|NCT01970540|PM01183|pm01183
4925806|NCT01970540|tumors|tumors
4925807|NCT01970540|cancer|cancer
4925808|NCT01970540|Pharma Mar|pharma mar
4925809|NCT01970501|atrial fibrillation|atrial fibrillation
4925810|NCT01970501|atrial flutter|atrial flutter
4925811|NCT01970501|heart failure|heart failure
4925812|NCT01970501|reduced left ventricle ejection fraction|reduced left ventricle ejection fraction
4925813|NCT01970501|electrical cardioversion|electrical cardioversion
4925814|NCT01970501|GENETIC-AF|genetic-af
4925815|NCT01970501|Medtronic|medtronic
4925816|NCT01970501|bucindolol|bucindolol
4925817|NCT01970501|pharmacogenetic|pharmacogenetic
4925818|NCT01970501|ARCA|arca
4925819|NCT01970501|Toprol|toprol
4925820|NCT01970501|Toprol-XL|toprol-xl
4925821|NCT01970501|Metoprolol|metoprolol
4925822|NCT01970501|Metoprolol succinate|metoprolol succinate
4925823|NCT01970488|Plaque Psoriasis|plaque psoriasis
4925824|NCT01970475|Arthritis|arthritis
4925825|NCT01970475|Rheumatoid|rheumatoid
4925826|NCT01970436|Prenatal care|prenatal care
4925827|NCT01970436|Pregnancy|pregnancy
4925828|NCT01970436|Obstetrics|obstetrics
4925829|NCT01970436|Telemedicine|telemedicine
4925830|NCT01970423|Patients with pacemaker or ICD therapy|patients with pacemaker or icd therapy
4925831|NCT01970410|teriflunomide|teriflunomide
4925832|NCT01970410|natalizumab|natalizumab
4925833|NCT01970410|relapsing multiple sclerosis|relapsing multiple sclerosis
4925834|NCT01970384|transcranial direct current stimulation|transcranial direct current stimulation
4925835|NCT01970384|stroke-related dysphagia|stroke-related dysphagia
4925836|NCT01970384|cortical plasticity|cortical plasticity
4925837|NCT01970371|Gram-negative|gram-negative
4925838|NCT01970371|bacterial infection|bacterial infection
4925839|NCT01970371|antibacterial|antibacterial
4925840|NCT01970371|antimicrobial|antimicrobial
4925841|NCT01970371|CRE|cre
4925842|NCT01970371|CPE|cpe
4925843|NCT01970371|BSI|bsi
4925844|NCT01970371|pneumonia|pneumonia
4925845|NCT01970371|HABP|habp
4925846|NCT01970371|VABP|vabp
4925847|NCT01970371|AP|ap
4925848|NCT01970371|cUTI|cuti
4925849|NCT01970371|UTI|uti
4925850|NCT01970358|melanoma|melanoma
4925851|NCT01970358|melanoma vaccine|melanoma vaccine
4925852|NCT01970358|adjuvant therapy|adjuvant therapy
4925853|NCT01970345|Autism Spectrum Disorder|autism spectrum disorder
4925854|NCT01970345|IGF-1|igf-1
4925855|NCT01970332|Peripheral Arterial Disease|peripheral arterial disease
4925856|NCT01970332|Peripheral Vascular Disease|peripheral vascular disease
4925857|NCT01970332|Claudication|claudication
4925858|NCT01970332|Myopathy|myopathy
4925859|NCT01970332|Oxidative stress|oxidative stress
4925860|NCT01970332|Mitochondrial dysfunction|mitochondrial dysfunction
4925861|NCT01970332|Biomechanics|biomechanics
4925862|NCT01970332|Inflammation|inflammation
4925863|NCT01970306|Esophageal Reinforcement|esophageal reinforcement
4925864|NCT01970306|ACell MatriStem|acell matristem
4925865|NCT01970306|13-178|13-178
4925866|NCT01970293|Alcohol use|alcohol use
4925867|NCT01970293|STI|sti
4925868|NCT01970293|Incarcerated women|incarcerated women
4925869|NCT01970293|AA|aa
4925870|NCT01970254|hepatitis B virus infection|hepatitis b virus infection
4925871|NCT01970254|HBV|hbv
4925872|NCT01970254|Cancer Patients|cancer patients
4925873|NCT01970254|chemotherapy|chemotherapy
4925874|NCT01970254|HBV screening strategy|hbv screening strategy
4925875|NCT01970254|HBV care|hbv care
4925876|NCT01970254|chronic HBV|chronic hbv
4925877|NCT01970254|concomitant HBV infection|concomitant hbv infection
4925878|NCT01970254|viral infections|viral infections
4925879|NCT01970241|corticosteroid|corticosteroid
4925880|NCT01970241|diabetes|diabetes
4925881|NCT01970241|insulin|insulin
4925882|NCT01970202|obesity|obesity
4925883|NCT01970202|overweight|overweight
4925884|NCT01970202|sleeve gastrectomy|sleeve gastrectomy
4925885|NCT01970189|Immune Thrombocytopenia|immune thrombocytopenia
4925886|NCT01970189|Primary Immune Thrombocytopenia|primary immune thrombocytopenia
4925887|NCT01970189|Purpura, Thrombocytopenic, Idiopathic|purpura, thrombocytopenic, idiopathic
4925888|NCT01970189|Autoimmune Thrombocytopenia|autoimmune thrombocytopenia
4925889|NCT01970189|Thrombocytopenia|thrombocytopenia
4925890|NCT01970163|Diabetic foot ulcer|diabetic foot ulcer
4925891|NCT01970163|Venous stasis ulcer|venous stasis ulcer
4925892|NCT01970163|Wound of the lower extremity|wound of the lower extremity
4925893|NCT01970163|Skin substitute|skin substitute
4925894|NCT01970163|Acellular Dermal Matrix|acellular dermal matrix
4925895|NCT01970150|rTMS|rtms
4925896|NCT01970150|Alzheimer Disease|alzheimer disease
4925897|NCT01970150|Memory|memory
4925898|NCT01970150|attention|attention
4925899|NCT01970150|EEG|eeg
4925900|NCT01970137|Spinocerebellar degeneration (SCD)|spinocerebellar degeneration (scd)
4925901|NCT01970137|Thyrotropin-Releasing Hormone (TRH)|thyrotropin-releasing hormone (trh)
4925902|NCT01970137|Spinocerebellar Ataxia (SCA)|spinocerebellar ataxia (sca)
4925903|NCT01970124|Spinocerebellar degeneration (SCD)|spinocerebellar degeneration (scd)
4925904|NCT01970124|Thyrotropin-Releasing Hormone (TRH)|thyrotropin-releasing hormone (trh)
4925905|NCT01970124|Spinocerebellar Ataxia (SCA)|spinocerebellar ataxia (sca)
4925906|NCT01970111|Spinocerebellar degeneration (SCD)|spinocerebellar degeneration (scd)
4925907|NCT01970111|Thyrotropin-Releasing Hormone (TRH)|thyrotropin-releasing hormone (trh)
4925908|NCT01970111|Spinocerebellar Ataxia (SCA)|spinocerebellar ataxia (sca)
4925909|NCT01970111|Cortical Cerebellar Atrophy (CCA)|cortical cerebellar atrophy (cca)
4925910|NCT01970098|Spinocerebellar degeneration (SCD)|spinocerebellar degeneration (scd)
4925911|NCT01970098|Thyrotropin-Releasing Hormone (TRH)|thyrotropin-releasing hormone (trh)
4925912|NCT01970098|Spinocerebellar Ataxia (SCA)|spinocerebellar ataxia (sca)
4925913|NCT01970098|Cortical Cerebellar Atrophy (CCA)|cortical cerebellar atrophy (cca)
4925914|NCT01970072|Remimazolam Tosylate|remimazolam tosylate
4925915|NCT01970072|Phase Ⅰ study|phase ⅰ study
4925916|NCT01970072|Health|health
4926119|NCT01969240|Chest Pain|chest pain
4925917|NCT01970059|Hypertension|hypertension
4925918|NCT01970046|SP2086|sp2086
4925919|NCT01970046|Phase III|phase iii
4925920|NCT01970046|combination therapy|combination therapy
4925921|NCT01970033|SP2086|sp2086
4925922|NCT01970033|Phase III|phase iii
4925923|NCT01970033|Monotherapy|monotherapy
4925924|NCT01970020|Healthy|healthy
4925925|NCT01970020|JNJ-38518168|jnj-38518168
4925926|NCT01970020|14C-JNJ-38518168|14c-jnj-38518168
4925927|NCT01970020|Absorption|absorption
4925928|NCT01970020|Metabolism|metabolism
4925929|NCT01970020|Excretion|excretion
4925930|NCT01970007|venous|venous
4925931|NCT01970007|outflow obstruction|outflow obstruction
4925932|NCT01970007|iliofemoral vein|iliofemoral vein
4925933|NCT01969994|Epicatechin|epicatechin
4925934|NCT01969994|Flavanols|flavanols
4925935|NCT01969994|Procyanidins|procyanidins
4925936|NCT01969994|Polyphenols|polyphenols
4925937|NCT01969994|Phytonutrients|phytonutrients
4925938|NCT01969994|AMDE|amde
4925939|NCT01969994|Antioxidants|antioxidants
4925940|NCT01969981|Peripheral Inserted Central Catheter|peripheral inserted central catheter
4925941|NCT01969955|nanoparticle albumin-bound paclitaxel|nanoparticle albumin-bound paclitaxel
4925942|NCT01969955|Squamous Cell Carcinoma of Lung|squamous cell carcinoma of lung
4925943|NCT01969942|Ewings sarcoma|ewings sarcoma
4925944|NCT01969916|Cardiac CT imaging|cardiac ct imaging
4925945|NCT01969916|Myocardial ischemia|myocardial ischemia
4925946|NCT01969916|Myocardial perfusion|myocardial perfusion
4925947|NCT01969916|Vasodilator stress testing|vasodilator stress testing
4925948|NCT01969916|Regadenoson|regadenoson
4925949|NCT01969903|brachial plexus block|brachial plexus block
4925950|NCT01969903|lidocaine|lidocaine
4925951|NCT01969903|dexmedetomidine|dexmedetomidine
4925952|NCT01969903|bradycardia|bradycardia
4925953|NCT01969903|hypotension|hypotension
4925954|NCT01969877|Head and neck cancer|head and neck cancer
4925955|NCT01969877|Cetuximab|cetuximab
4925956|NCT01969877|Cisplatin|cisplatin
4925957|NCT01969877|Radiotherapy|radiotherapy
4925958|NCT01969877|Quality of life|quality of life
4925959|NCT01969877|Human papilloma virus|human papilloma virus
4925960|NCT01969877|Health economy|health economy
4925961|NCT01969877|Biomarker investigations|biomarker investigations
4925962|NCT01969864|Randomized Controlled Trial|randomized controlled trial
4925963|NCT01969864|Healthcare Disparities|healthcare disparities
4925964|NCT01969851|Lacosamide|lacosamide
4925965|NCT01969851|Vimpat|vimpat
4925966|NCT01969851|Epilepsy|epilepsy
4925967|NCT01969851|Children|children
4925968|NCT01969825|Infertility|infertility
4925969|NCT01969825|Intrauterine insemination|intrauterine insemination
4925970|NCT01969825|Male factor infertility|male factor infertility
4925971|NCT01969825|Massage|massage
4925972|NCT01969825|Total motile sperm count|total motile sperm count
4925973|NCT01969812|Infertility|infertility
4925974|NCT01969812|Intrauterine Insemination|intrauterine insemination
4925975|NCT01969812|Slow-release Insemination|slow-release insemination
4925976|NCT01969812|Evie|evie
4925977|NCT01969799|Gram-negative pneumonia|gram-negative pneumonia
4925978|NCT01969799|Aerosol antibiotics|aerosol antibiotics
4925979|NCT01969799|Mechanical ventilation|mechanical ventilation
4925980|NCT01969799|Amikacin|amikacin
4925981|NCT01969799|Fosfomycin|fosfomycin
4925982|NCT01969799|Pneumonia, Bacterial|pneumonia, bacterial
4925983|NCT01969799|Pneumonia|pneumonia
4925984|NCT01969799|Bacterial Infections|bacterial infections
4925985|NCT01969799|Lung Diseases|lung diseases
4925986|NCT01969799|Respiratory Tract Diseases|respiratory tract diseases
4925987|NCT01969799|Respiratory Tract Infections|respiratory tract infections
4925988|NCT01969799|Anti-Bacterial Agents|anti-bacterial agents
4925989|NCT01969799|Anti-Infective Agents|anti-infective agents
4925990|NCT01969799|Therapeutic Uses|therapeutic uses
4925991|NCT01969799|Pharmacologic Actions|pharmacologic actions
4925992|NCT01969773|Botulinum Toxin A (BoNT-A)|botulinum toxin a (bont-a)
4925993|NCT01969773|Interstitial Cystitis|interstitial cystitis
4925994|NCT01969734|Emphysema|emphysema
4925995|NCT01969734|Moderate COPD|moderate copd
4925996|NCT01969734|Hyperinflation|hyperinflation
4925997|NCT01969734|Endobronchial valves|endobronchial valves
4925998|NCT01969695|ABT-199|abt-199
4925999|NCT01969695|Cancer|cancer
4926000|NCT01969695|GDC-0199|gdc-0199
4926001|NCT01969695|non-Hodgkin's lymphoma|non-hodgkin's lymphoma
4926002|NCT01969695|Relapsed|relapsed
4926003|NCT01969695|Refractory|refractory
4926004|NCT01969695|Safety|safety
4926005|NCT01969682|non-Hodgkin's lymphoma|non-hodgkin's lymphoma
4926006|NCT01969682|GDC-0199|gdc-0199
4926007|NCT01969682|Safety|safety
4926008|NCT01969682|Relapsed|relapsed
4926009|NCT01969682|Refractory|refractory
4926010|NCT01969682|ABT-199|abt-199
4926011|NCT01969682|Pharmacokinetics|pharmacokinetics
4926012|NCT01969682|Cancer|cancer
4926013|NCT01969669|non-Hodgkin's lymphoma|non-hodgkin's lymphoma
4926014|NCT01969669|GDC-0199|gdc-0199
4926015|NCT01969669|Safety|safety
4926016|NCT01969669|Relapsed|relapsed
4926017|NCT01969669|Refractory|refractory
4926018|NCT01969669|ABT-199|abt-199
4926019|NCT01969669|Pharmacokinetics|pharmacokinetics
4926020|NCT01969669|Cancer|cancer
4926021|NCT01969656|vitamin D analog|vitamin d analog
4926022|NCT01969643|Breast cancer|breast cancer
4926023|NCT01969643|Monomethyl auristatin E|monomethyl auristatin e
4926024|NCT01969643|Antibody-drug conjugate|antibody-drug conjugate
4926025|NCT01969643|Drug therapy|drug therapy
4926026|NCT01969643|Metastatic|metastatic
4926027|NCT01969643|LIV-1 protein, human|liv-1 protein, human
4926028|NCT01969643|Trastuzumab|trastuzumab
4926029|NCT01969630|femoropopliteal lesions|femoropopliteal lesions
4926030|NCT01969604|Rheumatoid Arthritis|rheumatoid arthritis
4926031|NCT01969604|Sedentary Behaviour|sedentary behaviour
4926032|NCT01969604|Motivational Counselling|motivational counselling
4926033|NCT01969604|Short Text Message Service|short text message service
4926034|NCT01969604|Fatigue|fatigue
4926035|NCT01969604|Pain|pain
4926036|NCT01969604|Self-efficacy|self-efficacy
4926037|NCT01969604|ActivPAL|activpal
4926038|NCT01969591|Fast track surgery, Laparoscopic surgery, colorectal cancer|fast track surgery, laparoscopic surgery, colorectal cancer
4926039|NCT01969578|salivary duct cancer|salivary duct cancer
4926040|NCT01969578|adenocarcinoma, NOS|adenocarcinoma, nos
4926041|NCT01969578|androgen deprivation|androgen deprivation
4926042|NCT01969578|androgen receptor|androgen receptor
4926043|NCT01969552|TSH, thyroid hormones, thyroid tresting, levothyroxine|tsh, thyroid hormones, thyroid tresting, levothyroxine
4926044|NCT01969526|Frail elderly|frail elderly
4926045|NCT01969513|Vestibular Diseases|vestibular diseases
4926046|NCT01969513|Vertigo|vertigo
4926047|NCT01969513|Primary care|primary care
4926048|NCT01969513|Epley maneuver|epley maneuver
4926049|NCT01969500|Schizophrenia|schizophrenia
4926050|NCT01969500|Schizoaffective Disorder|schizoaffective disorder
4926051|NCT01969500|Self Management of Schizophrenia|self management of schizophrenia
4926052|NCT01969500|SOS|sos
4926053|NCT01969500|SMI|smi
4926054|NCT01969500|Psychosis|psychosis
4926055|NCT01969500|Social Dysfunction|social dysfunction
4926056|NCT01969500|Medication Adherence|medication adherence
4926057|NCT01969500|Mobile Application|mobile application
4926058|NCT01969500|EHealth|ehealth
4926059|NCT01969500|E-Health|e-health
4926060|NCT01969500|Health Technology|health technology
4926061|NCT01969500|mHealth|mhealth
4926062|NCT01969500|m-Health|m-health
4926063|NCT01969474|Tinnitus Cannabis|tinnitus cannabis
4926064|NCT01969461|HIV positive|hiv positive
4926065|NCT01969461|Adolescents|adolescents
4926066|NCT01969461|Adolescent Trials Network|adolescent trials network
4926067|NCT01969461|Comparative Effectiveness Trial|comparative effectiveness trial
4926068|NCT01969461|Implementation|implementation
4926069|NCT01969461|Adherence Intervention|adherence intervention
4926070|NCT01969461|Alcohol Intervention|alcohol intervention
4926071|NCT01969448|Nipple-areola skin sparing mastectomy|nipple-areola skin sparing mastectomy
4926072|NCT01969448|Immediate reconstruction|immediate reconstruction
4926073|NCT01969448|Prophylactic Mastectomy|prophylactic mastectomy
4926074|NCT01969448|Breast-Q|breast-q
4926075|NCT01969448|Breast Cancer|breast cancer
4926076|NCT01969448|Ductal Carcinoma in Situ - Category|ductal carcinoma in situ - category
4926077|NCT01969409|Lung|lung
4926078|NCT01969409|Fibrosis|fibrosis
4926079|NCT01969396|Biopsy|biopsy
4926080|NCT01969396|Endometrial biopsy|endometrial biopsy
4926081|NCT01969396|Endometrial sampling|endometrial sampling
4926082|NCT01969396|sonohysterography|sonohysterography
4926083|NCT01969383|healthy|healthy
4926084|NCT01969370|Cancer|cancer
4926085|NCT01969370|Cardiovascular disease|cardiovascular disease
4926086|NCT01969370|Neurodegenerative disease|neurodegenerative disease
4926087|NCT01969370|Neurodevelopmental disease|neurodevelopmental disease
4926088|NCT01969370|Dysmorphology|dysmorphology
4926089|NCT01969370|Hearing loss|hearing loss
4926090|NCT01969370|Other conditions, including ophthalmic conditions|other conditions, including ophthalmic conditions
4926091|NCT01969357|Sp2086|sp2086
4926092|NCT01969357|Phase II|phase ii
4926093|NCT01969357|monotherapy|monotherapy
4926094|NCT01969331|Gastritis|gastritis
4926095|NCT01969331|Helicobacter pylori|helicobacter pylori
4926096|NCT01969318|SP2086|sp2086
4926097|NCT01969318|Phase II|phase ii
4926098|NCT01969318|combination therapy|combination therapy
4926099|NCT01969305|Kazakhstan|kazakhstan
4926100|NCT01969305|Central Asia|central asia
4926101|NCT01969305|HIV prevention|hiv prevention
4926102|NCT01969305|Adolescents|adolescents
4926103|NCT01969305|Sexual risk behaviors|sexual risk behaviors
4926104|NCT01969305|Drug abuse prevention|drug abuse prevention
4926105|NCT01969305|Multi-media intervention|multi-media intervention
4926106|NCT01969305|Drug use|drug use
4926107|NCT01969292|colonoscopy|colonoscopy
4926108|NCT01969292|quality assurance|quality assurance
4926109|NCT01969279|Osteoporosis|osteoporosis
4926110|NCT01969279|Bisphosphonate|bisphosphonate
4926111|NCT01969279|Atypical femoral fracture|atypical femoral fracture
4926112|NCT01969279|Side effect|side effect
4926113|NCT01969266|Healthy volunteer|healthy volunteer
4926114|NCT01969266|PCI-32765|pci-32765
4926115|NCT01969266|PCI 45227|pci 45227
4926116|NCT01969266|JNJ-54179060|jnj-54179060
4926117|NCT01969266|Pharmacokinetic|pharmacokinetic
4926118|NCT01969253|Breast Cancer, Axillary Lymph Node Dissection, Lymphedema|breast cancer, axillary lymph node dissection, lymphedema
4926120|NCT01969240|Decision Aid|decision aid
4926121|NCT01969240|Acute Coronary Syndrome|acute coronary syndrome
4926122|NCT01969240|Cardiac|cardiac
4926123|NCT01969240|Emergency Department|emergency department
4926124|NCT01969240|Cardiac Testing|cardiac testing
4926125|NCT01969240|Healthcare Utilization|healthcare utilization
4926126|NCT01969240|Patient Centered Outcomes|patient centered outcomes
4926127|NCT01969240|Shared Decision Making|shared decision making
4926128|NCT01969240|Unnecessary hospital admissions|unnecessary hospital admissions
4926129|NCT01969201|In vitro fertilization (IVF)|in vitro fertilization (ivf)
4926130|NCT01969201|Assisted reproduction technologies (ART)|assisted reproduction technologies (art)
4926131|NCT01969201|GnRH-antagonist|gnrh-antagonist
4926132|NCT01969201|Follicle stimulating hormone (FSH)|follicle stimulating hormone (fsh)
4926133|NCT01969188|spondyloarthritis|spondyloarthritis
4926134|NCT01969188|ankylosing spondylitis|ankylosing spondylitis
4926135|NCT01969188|psoriatic arthritis|psoriatic arthritis
4926136|NCT01969149|Stress Hyperglycemia|stress hyperglycemia
4926137|NCT01969149|Perioperative glycemic control|perioperative glycemic control
4926138|NCT01969149|Cardiac surgery|cardiac surgery
4926139|NCT01969149|Coronary artery bypass surgery|coronary artery bypass surgery
4926140|NCT01969136|Alzheimer's disease|alzheimer's disease
4926141|NCT01969136|Cognition|cognition
4926142|NCT01969136|Alpha-7 nAChR|alpha-7 nachr
4926143|NCT01969123|Alzheimer's disease|alzheimer's disease
4926144|NCT01969123|Cognition|cognition
4926145|NCT01969123|Alpha-7 nAChR|alpha-7 nachr
4926146|NCT01969110|Immunonutrition|immunonutrition
4926147|NCT01969097|Stroke|stroke
4926148|NCT01969097|Hemiparesis|hemiparesis
4926149|NCT01969097|tDCS|tdcs
4926150|NCT01969097|Motor cortex|motor cortex
4926151|NCT01969084|Type II Diabetes Mellitus|type ii diabetes mellitus
4926152|NCT01969084|Diabetes|diabetes
4926153|NCT01969084|Metabolism|metabolism
4926154|NCT01969084|Linagliptin|linagliptin
4926155|NCT01969084|Tradjenta|tradjenta
4926156|NCT01969084|Glucose|glucose
4926157|NCT01969071|levosimendan|levosimendan
4926158|NCT01969071|mitral valve surgery|mitral valve surgery
4926159|NCT01969071|cardiopulmonary bypass|cardiopulmonary bypass
4926160|NCT01969071|serum creatinine|serum creatinine
4926161|NCT01969071|estimated glomerular filtration rate|estimated glomerular filtration rate
4926162|NCT01969071|ejection fraction|ejection fraction
4926163|NCT01969058|Isotretinoin|isotretinoin
4926164|NCT01969058|HIV-1|hiv-1
4926165|NCT01969058|immunology markers|immunology markers
4926166|NCT01969058|immune activation|immune activation
4926167|NCT01969058|viral suppression|viral suppression
4926168|NCT01969045|felxible bronchoscopy|felxible bronchoscopy
4926169|NCT01969045|anaesthetics|anaesthetics
4926170|NCT01969045|transcutaneous pCO2|transcutaneous pco2
4926171|NCT01969045|capillary pCO2|capillary pco2
4926172|NCT01969006|inguinal hernia, postoperative pain, localanesthesia, nerve blockage|inguinal hernia, postoperative pain, localanesthesia, nerve blockage
4926173|NCT01968993|Degenerative Disc Disease|degenerative disc disease
4926174|NCT01968980|High Risk of cardiovascular events|high risk of cardiovascular events
4926175|NCT01968980|Heterozygous familial hypercholesterolemia|heterozygous familial hypercholesterolemia
4926176|NCT01968967|mixed dyslipidemia|mixed dyslipidemia
4926177|NCT01968967|high risk of cardiovascular events|high risk of cardiovascular events
4926178|NCT01968967|multiple cardiovascular disease risk factors|multiple cardiovascular disease risk factors
4926179|NCT01968954|mixed dyslipidemia|mixed dyslipidemia
4926180|NCT01968954|high risk of cardiovascular events|high risk of cardiovascular events
4926181|NCT01968941|stereotactic body radiotherapy|stereotactic body radiotherapy
4926182|NCT01968941|conventional radiotherapy|conventional radiotherapy
4926183|NCT01968941|inoperable patients|inoperable patients
4926184|NCT01968941|local control|local control
4926185|NCT01968941|cancer recurrence|cancer recurrence
4926186|NCT01968941|toxicity|toxicity
4926187|NCT01968941|survival|survival
4926188|NCT01968928|Bladder urothelial carcinoma (UC)|bladder urothelial carcinoma (uc)
4926189|NCT01968928|pyruvate kinase|pyruvate kinase
4926190|NCT01968928|drug resistance|drug resistance
4926191|NCT01968928|shikonin|shikonin
4926192|NCT01968915|LCL161, Paclitaxel, Japanese patient, Neoplasms|lcl161, paclitaxel, japanese patient, neoplasms
4926193|NCT01968902|spasticity|spasticity
4926194|NCT01968902|lower limb|lower limb
4926195|NCT01968902|multiple sclerosis|multiple sclerosis
4926196|NCT01968902|toxin|toxin
4926197|NCT01968889|Critical illness neuromyopathy|critical illness neuromyopathy
4926198|NCT01968889|Diaphragm dysfunction|diaphragm dysfunction
4926199|NCT01968889|Mechanical ventilation|mechanical ventilation
4926200|NCT01968889|Weaning|weaning
4926201|NCT01968889|Ultrasound|ultrasound
4926202|NCT01968850|osteoporosis|osteoporosis
4926203|NCT01968850|HIV|hiv
4926204|NCT01968850|bone Mineral Density|bone mineral density
4926205|NCT01968850|alendronate|alendronate
4926206|NCT01968850|vitamin D|vitamin d
4926207|NCT01968824|pain|pain
4926208|NCT01968798|ACES|aces
4926209|NCT01968798|ASPREE Cancer Endpoints Study|aspree cancer endpoints study
4926210|NCT01968798|Cancer|cancer
4926211|NCT01968798|Aspirin|aspirin
4926212|NCT01968798|Tumor|tumor
4926213|NCT01968772|Fibromyalgia|fibromyalgia
4926214|NCT01968772|Fibromyalgia Syndrome|fibromyalgia syndrome
4926215|NCT01968772|Magnesium Chloride|magnesium chloride
4926216|NCT01968772|Transdermal Magnesium Chloride|transdermal magnesium chloride
4926217|NCT01968759|Chronic kidney disease|chronic kidney disease
4926218|NCT01968759|Sevelamer carbonate|sevelamer carbonate
4926219|NCT01968759|Proteinuria|proteinuria
4926220|NCT01968759|Phosphate binders|phosphate binders
4926221|NCT01968746|Sepsis|sepsis
4926222|NCT01968746|Shock|shock
4926223|NCT01968733|Pneumonia|pneumonia
4926224|NCT01968733|CABP|cabp
4926225|NCT01968733|CAP|cap
4926226|NCT01968733|Macrolide|macrolide
4926227|NCT01968707|surgical prep|surgical prep
4926228|NCT01968707|CHG|chg
4926229|NCT01968707|IPA|ipa
4926230|NCT01968694|endometriosis|endometriosis
4926231|NCT01968694|chronic pain|chronic pain
4926232|NCT01968694|intravenous lidocaine|intravenous lidocaine
4926233|NCT01968668|BAY94-8862|bay94-8862
4926234|NCT01968668|MR antagonist|mr antagonist
4926235|NCT01968668|Diabetic nephropathy|diabetic nephropathy
4926236|NCT01968668|Japanese patients|japanese patients
4926237|NCT01968655|Factor VIII Inhibitory Auto-antibodies|factor viii inhibitory auto-antibodies
4926238|NCT01968642|Transthoracic echocardiograms|transthoracic echocardiograms
4926239|NCT01968642|Appropriate Use Criteria|appropriate use criteria
4926240|NCT01968642|Medical Education|medical education
4926241|NCT01968629|Hepatocellular Carcinoma|hepatocellular carcinoma
4926242|NCT01968590|Vitamin D|vitamin d
4926243|NCT01968590|Cholecalciferol|cholecalciferol
4926244|NCT01968590|Bone density|bone density
4926245|NCT01968577|Coronary angioplasty|coronary angioplasty
4926246|NCT01968577|Myocardial infarction|myocardial infarction
4926247|NCT01968551|HIV-1|hiv-1
4926248|NCT01968551|HIV|hiv
4926249|NCT01968551|Treatment-Experienced|treatment-experienced
4926250|NCT01968525|anemia|anemia
4926251|NCT01968525|non-hypoxic apnoea|non-hypoxic apnoea
4926252|NCT01968525|tracheal intubation|tracheal intubation
4926253|NCT01968525|anesthesia|anesthesia
4926254|NCT01968512|Attention Deficit Hyperactivity Disorder (ADHD);|attention deficit hyperactivity disorder (adhd);
4926255|NCT01968512|Transcranial Direct Current Stimulation (tDCS);|transcranial direct current stimulation (tdcs);
4926256|NCT01968512|Control Inhibitory;|control inhibitory;
4926257|NCT01968512|Quantitative electroencephalography;|quantitative electroencephalography;
4926258|NCT01968512|Functional Brain Network;|functional brain network;
4926259|NCT01968512|Go/No Go test.|go/no go test.
4926260|NCT01968499|coronary stent implantation; clopidogrel low response|coronary stent implantation; clopidogrel low response
4926261|NCT01968473|Parkinson's disease|parkinson's disease
4926262|NCT01968473|Freezing of Gait|freezing of gait
4926263|NCT01968473|Neuromuscular Electrical Stimulation|neuromuscular electrical stimulation
4926264|NCT01968473|Comfort|comfort
4926265|NCT01968473|Pain tolerance|pain tolerance
4926266|NCT01968473|Pain|pain
4926267|NCT01968473|Sensory threshold|sensory threshold
4926268|NCT01968473|Motor threshold|motor threshold
4926269|NCT01968473|Pain threshold|pain threshold
4926270|NCT01968460|Parkinson's Disease, Rasagiline, Pramipexole|parkinson's disease, rasagiline, pramipexole
4926271|NCT01968434|cough|cough
4926272|NCT01968434|common cold|common cold
4926273|NCT01968434|antitussive agents|antitussive agents
4926274|NCT01968434|mucosal protection|mucosal protection
4926275|NCT01968434|medical device|medical device
4926276|NCT01968421|OM-85, bronchiectasis, placebo, acute exacerbation|om-85, bronchiectasis, placebo, acute exacerbation
4926277|NCT01968408|nosocomial diarrhea|nosocomial diarrhea
4926278|NCT01968408|Lactobacillus reuteri DSM 17938|lactobacillus reuteri dsm 17938
4926279|NCT01968408|rotavirus diarrhea|rotavirus diarrhea
4926280|NCT01968408|probiotics|probiotics
4926281|NCT01968382|IMM 124-E|imm 124-e
4926282|NCT01968382|Bovine Colostrum|bovine colostrum
4926283|NCT01968382|Alcoholic|alcoholic
4926284|NCT01968382|Hepatitis|hepatitis
4926285|NCT01968382|LPS|lps
4926286|NCT01968382|Hyper-immune|hyper-immune
4926287|NCT01968369|flow mediated vasodilatation|flow mediated vasodilatation
4926288|NCT01968369|tomato|tomato
4926289|NCT01968369|arterial stiffness|arterial stiffness
4926290|NCT01968369|lycopene|lycopene
4926291|NCT01968356|surgical skin prep|surgical skin prep
4926292|NCT01968356|CHG|chg
4926293|NCT01968356|IPA|ipa
4926294|NCT01968317|Endometrial Atypical Hyperplasia|endometrial atypical hyperplasia
4926295|NCT01968317|Endometrial Adenocarcinoma|endometrial adenocarcinoma
4926296|NCT01968317|Conservative Medication|conservative medication
4926297|NCT01968304|Iron Status, Cancer|iron status, cancer
4926298|NCT01968291|Health Literacy|health literacy
4926299|NCT01968291|Teach-back|teach-back
4926300|NCT01968291|Emergency|emergency
4926301|NCT01968265|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
4926302|NCT01968265|T2DM|t2dm
4926303|NCT01968252|Speckle-tracking echocardiography|speckle-tracking echocardiography
4926304|NCT01968252|Transthoracic echocardiography|transthoracic echocardiography
4926305|NCT01968252|Transesophageal echocardiography|transesophageal echocardiography
4926306|NCT01968239|BRVO|brvo
4926307|NCT01968239|Macular edema|macular edema
4926308|NCT01968239|Ranibizumab|ranibizumab
4926309|NCT01968239|re-treatment|re-treatment
4926310|NCT01968226|carotid artery disease|carotid artery disease
4926311|NCT01968226|carotid stenosis|carotid stenosis
4927883|NCT01961973|BMAC|bmac
4926312|NCT01968226|carotid endarterectomy|carotid endarterectomy
4926313|NCT01968226|RDG-K5|rdg-k5
4926314|NCT01968226|PET imaging|pet imaging
4926315|NCT01968213|ARIEL3|ariel3
4926316|NCT01968213|ARIEL 3|ariel 3
4926317|NCT01968213|platinum sensitive|platinum sensitive
4926318|NCT01968213|PARP Inhibitor|parp inhibitor
4926319|NCT01968213|rucaparib|rucaparib
4926320|NCT01968213|homologous recombination|homologous recombination
4926321|NCT01968213|homologous recombination deficiency|homologous recombination deficiency
4926322|NCT01968213|CO-338|co-338
4926323|NCT01968213|PF 01367338|pf 01367338
4926324|NCT01968213|AG 14699|ag 14699
4926325|NCT01968213|platinum sensitive ovarian cancer|platinum sensitive ovarian cancer
4926326|NCT01968213|platinum sensitive fallopian tube cancer|platinum sensitive fallopian tube cancer
4926327|NCT01968213|platinum sensitive primary peritoneal cancer|platinum sensitive primary peritoneal cancer
4926328|NCT01968213|platinum sensitive peritoneal cancer|platinum sensitive peritoneal cancer
4926329|NCT01968213|gynecological cancer|gynecological cancer
4926330|NCT01968213|Clovis|clovis
4926331|NCT01968213|Clovis Oncology|clovis oncology
4926332|NCT01968200|cancer|cancer
4926333|NCT01968200|chemotherapy|chemotherapy
4926334|NCT01968200|anthracyclines|anthracyclines
4926335|NCT01968174|astigmatism|astigmatism
4926336|NCT01968174|lid surgery|lid surgery
4926337|NCT01968174|older than 40 years|older than 40 years
4926338|NCT01968174|can sign an acceptance form|can sign an acceptance form
4926339|NCT01968174|uper lid surgery|uper lid surgery
4926340|NCT01968148|glucose|glucose
4926341|NCT01968148|cardiac arrest|cardiac arrest
4926342|NCT01968148|resuscitation|resuscitation
4926343|NCT01968148|insulin|insulin
4926344|NCT01968148|GLP-1|glp-1
4926345|NCT01968122|symptomatic Intracranial artery stenosis|symptomatic intracranial artery stenosis
4926346|NCT01968122|conventional treatment|conventional treatment
4926347|NCT01968122|stenting|stenting
4926348|NCT01968122|stroke prevention|stroke prevention
4926349|NCT01968122|medical treatment|medical treatment
4926350|NCT01968122|endovascular treatment|endovascular treatment
4926351|NCT01968096|Reflex|reflex
4926352|NCT01968096|Post activation|post activation
4926353|NCT01968096|Spinal cord injury|spinal cord injury
4926354|NCT01968096|Pre-synaptic inhibition|pre-synaptic inhibition
4926355|NCT01968096|Machine driven passive strech|machine driven passive strech
4926356|NCT01968044|renal impairment|renal impairment
4926357|NCT01968031|Parkinson's disease|parkinson's disease
4926358|NCT01968031|Moderate to Severe Parkinson's Disease|moderate to severe parkinson's disease
4926359|NCT01968018|Cancer|cancer
4926360|NCT01968018|Chronic Cancer Pain|chronic cancer pain
4926361|NCT01968018|Tramadol HCI|tramadol hci
4926362|NCT01968018|Acetaminophen|acetaminophen
4926363|NCT01968018|Analgesics|analgesics
4926364|NCT01968018|Pain assessment|pain assessment
4926365|NCT01967992|diabetes|diabetes
4926366|NCT01967992|obesity|obesity
4926367|NCT01967992|mindful eating|mindful eating
4926368|NCT01967992|positive affect|positive affect
4926369|NCT01967992|low carbohydrate|low carbohydrate
4926370|NCT01967992|ketogenic|ketogenic
4926371|NCT01967992|diet|diet
4926372|NCT01967940|HIV-1|hiv-1
4926373|NCT01967940|HIV|hiv
4926374|NCT01967940|Treatment-Experienced|treatment-experienced
4926375|NCT01967927|carcinoma|carcinoma
4926376|NCT01967927|cancer|cancer
4926377|NCT01967927|head|head
4926378|NCT01967927|neck|neck
4926379|NCT01967927|otolaryngology|otolaryngology
4926380|NCT01967901|Diabetic nephropathies|diabetic nephropathies
4926381|NCT01967901|Nursing|nursing
4926382|NCT01967901|Multidisciplinary|multidisciplinary
4926383|NCT01967901|Self-care|self-care
4926384|NCT01967901|Quality of Life|quality of life
4926385|NCT01967888|Pancreatic islet auto-transplantation|pancreatic islet auto-transplantation
4926386|NCT01967875|Gastric Cancer|gastric cancer
4926387|NCT01967875|ERCC1|ercc1
4926388|NCT01967875|Platinum|platinum
4926389|NCT01967875|Chemotherapy|chemotherapy
4926390|NCT01967849|obesity|obesity
4926391|NCT01967849|type 2 diabetes|type 2 diabetes
4926392|NCT01967836|Invasive Line|invasive line
4926393|NCT01967836|IV Dressing protection|iv dressing protection
4926394|NCT01967836|Hygiene|hygiene
4926395|NCT01967836|Oncology|oncology
4926396|NCT01967836|Ambulatory Care|ambulatory care
4926397|NCT01967823|Metastatic Cancer|metastatic cancer
4926398|NCT01967823|Gene Therapy|gene therapy
4926399|NCT01967823|Immunotherapy|immunotherapy
4926400|NCT01967823|Tumor Regression|tumor regression
4926401|NCT01967823|Melanoma|melanoma
4926402|NCT01967810|glioma|glioma
4926403|NCT01967810|glioblastoma|glioblastoma
4926404|NCT01967810|brain cancer|brain cancer
4926405|NCT01967810|brain tumor|brain tumor
4926406|NCT01967810|recurrent|recurrent
4926407|NCT01967797|Obesity|obesity
4926408|NCT01967784|Influenza|influenza
4926409|NCT01967784|Quadrivalent Inactivated Influenza Vaccine|quadrivalent inactivated influenza vaccine
4926410|NCT01967771|healthy volunteers|healthy volunteers
4926411|NCT01967771|drug interaction|drug interaction
4926412|NCT01967771|carbamazepine|carbamazepine
4926413|NCT01967771|Dolutegravir|dolutegravir
4926414|NCT01967771|pharmacokinetics|pharmacokinetics
4926415|NCT01967758|Astrocytic Tumors|astrocytic tumors
4926416|NCT01967758|Glioblastoma Multiforme|glioblastoma multiforme
4926417|NCT01967758|Anaplastic Astrocytoma|anaplastic astrocytoma
4926418|NCT01967758|Brain Tumor|brain tumor
4926419|NCT01967758|Brain Cancer|brain cancer
4926420|NCT01967758|Immunotherapy|immunotherapy
4926421|NCT01967745|open appendectomy|open appendectomy
4926422|NCT01967745|laparoscopic appendectomy|laparoscopic appendectomy
4926423|NCT01967745|appendicitis|appendicitis
4926424|NCT01967732|Smoking|smoking
4926425|NCT01967732|Nicotine absorption|nicotine absorption
4926426|NCT01967732|Modified risk tobacco product|modified risk tobacco product
4926427|NCT01967732|Conventional cigarette|conventional cigarette
4926428|NCT01967732|Nicotine replacement therapy|nicotine replacement therapy
4926429|NCT01967732|Nicotine nasal spray|nicotine nasal spray
4926430|NCT01967719|Smoking|smoking
4926431|NCT01967719|Nicotine absorption|nicotine absorption
4926432|NCT01967719|Candidate modified risk tobacco product|candidate modified risk tobacco product
4926433|NCT01967719|Conventional cigarette|conventional cigarette
4926434|NCT01967719|Nicotine replacement therapy: nasal spray|nicotine replacement therapy: nasal spray
4926435|NCT01967706|Smoking|smoking
4926436|NCT01967706|Nicotine absorption|nicotine absorption
4926437|NCT01967706|Candidate modified risk tobacco product|candidate modified risk tobacco product
4926438|NCT01967706|Cigarette|cigarette
4926439|NCT01967706|Nicotine replacement therapy|nicotine replacement therapy
4926440|NCT01967706|Nicotine gum|nicotine gum
4926441|NCT01967693|Laryngeal contact granuloma|laryngeal contact granuloma
4926442|NCT01967693|Treatment type|treatment type
4926443|NCT01967693|Outcome|outcome
4926444|NCT01967641|opioid dependence|opioid dependence
4926445|NCT01967641|opioid abuse|opioid abuse
4926446|NCT01967641|suboxone|suboxone
4926447|NCT01967641|prescription pain medications|prescription pain medications
4926448|NCT01967628|Vitamin D|vitamin d
4926449|NCT01967628|Respiratory infection|respiratory infection
4926450|NCT01967628|Innate immunity|innate immunity
4926451|NCT01967615|PCI,|pci,
4926452|NCT01967615|CTO,|cto,
4926453|NCT01967615|bifurcation,|bifurcation,
4926454|NCT01967615|clopidogrel,|clopidogrel,
4926455|NCT01967615|prasugrel,|prasugrel,
4926456|NCT01967615|ticagrelor|ticagrelor
4926457|NCT01967602|Acute respiratory distress syndrome (ARDS)|acute respiratory distress syndrome (ards)
4926458|NCT01967602|Extracorporeal membrane oxygenation (ECMO)|extracorporeal membrane oxygenation (ecmo)
4926459|NCT01967602|biomarker|biomarker
4926460|NCT01967576|Mutation in SDHB gene|mutation in sdhb gene
4926461|NCT01967576|Mutation in SDHV gene|mutation in sdhv gene
4926462|NCT01967576|Mutation in VHL gene|mutation in vhl gene
4926463|NCT01967576|Pharmacogenomics analyses|pharmacogenomics analyses
4926464|NCT01967576|Germline DNA examination|germline dna examination
4926465|NCT01967563|Energy Expenditure|energy expenditure
4926466|NCT01967563|Obesity|obesity
4926467|NCT01967563|Carbohydrate|carbohydrate
4926468|NCT01967563|Fat|fat
4926469|NCT01967563|Ketones|ketones
4926470|NCT01967550|Symptomatic knee OA Kellgren-Lawrence grade 1-3|symptomatic knee oa kellgren-lawrence grade 1-3
4926471|NCT01967537|NET|net
4926472|NCT01967537|MEN1|men1
4926473|NCT01967537|Von Hippel Lindau (VHL)|von hippel lindau (vhl)
4926474|NCT01967537|Surgical Resection|surgical resection
4926475|NCT01967537|Somatostatin Receptor Status|somatostatin receptor status
4926476|NCT01967524|Myofascial pain|myofascial pain
4926477|NCT01967524|Perineal pain|perineal pain
4926478|NCT01967524|Chronic pelvic pain|chronic pelvic pain
4926479|NCT01967524|Botulinum toxin type A|botulinum toxin type a
4926480|NCT01967524|Ropivacaïne|ropivacaïne
4926481|NCT01967511|Cross-sectional study|cross-sectional study
4926482|NCT01967511|Fibromuscular dysplasia|fibromuscular dysplasia
4926483|NCT01967511|Fibroblast|fibroblast
4926484|NCT01967511|Spontaneous Coronary Artery Dissection|spontaneous coronary artery dissection
4926485|NCT01967511|Cervical Artery Dissection|cervical artery dissection
4926486|NCT01967498|chronic otitis media with effusion|chronic otitis media with effusion
4926487|NCT01967498|conductive hearing loss|conductive hearing loss
4926488|NCT01967485|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
4926489|NCT01967485|Medication adherence|medication adherence
4926490|NCT01967485|Disease management|disease management
4926491|NCT01967485|Text message|text message
4926492|NCT01967485|ADHD|adhd
4926493|NCT01967485|Children|children
4926494|NCT01967485|Reminder systems|reminder systems
4926495|NCT01967485|Text Messaging|text messaging
4926496|NCT01967485|Telemedicine|telemedicine
4926497|NCT01967433|Fentanyl|fentanyl
4926498|NCT01967433|Midazolam|midazolam
4926499|NCT01967433|Sedation|sedation
4926500|NCT01967433|Patient tolerance|patient tolerance
4926501|NCT01967433|Duration of colonoscopy|duration of colonoscopy
4926502|NCT01967420|Cognitive remediation|cognitive remediation
4926503|NCT01967420|Social cognition training|social cognition training
4926504|NCT01967420|First episode psychosis|first episode psychosis
4926505|NCT01967420|Schizophrenia|schizophrenia
4926506|NCT01967407|kidney tumor|kidney tumor
4926507|NCT01967407|renal cell cancer|renal cell cancer
4926508|NCT01967407|RCC|rcc
4926509|NCT01967407|irreversible electroporation|irreversible electroporation
4926510|NCT01967407|IRE|ire
4926511|NCT01967407|partial kidney resection|partial kidney resection
4926512|NCT01967407|percutaneous|percutaneous
4926513|NCT01967407|ablation|ablation
4926514|NCT01967407|IRENE|irene
4926515|NCT01967394|Health Care Quality|health care quality
4926516|NCT01967394|Access|access
4926517|NCT01967394|Evaluation|evaluation
4926518|NCT01967368|Influenza vaccine|influenza vaccine
4926519|NCT01967368|intradermal|intradermal
4926520|NCT01967368|intramuscular|intramuscular
4926521|NCT01967368|efficacy|efficacy
4926522|NCT01967368|safety|safety
4926523|NCT01967355|preeclampsia|preeclampsia
4926524|NCT01967355|lipid apheresis|lipid apheresis
4926525|NCT01967355|apheresis|apheresis
4926526|NCT01967342|chronic pain|chronic pain
4926527|NCT01967342|pain|pain
4926528|NCT01967342|chronic pain syndrome|chronic pain syndrome
4926529|NCT01967342|widespread chronic pain|widespread chronic pain
4926530|NCT01967342|back pain|back pain
4926531|NCT01967342|literacy|literacy
4926532|NCT01967342|health literacy|health literacy
4926533|NCT01967342|group therapy|group therapy
4926534|NCT01967342|psychosocial treatment|psychosocial treatment
4926535|NCT01967342|cognitive-behavioral therapy|cognitive-behavioral therapy
4926536|NCT01967342|pain education|pain education
4926537|NCT01967342|health disparities|health disparities
4926538|NCT01967342|patient-centered outcomes|patient-centered outcomes
4926539|NCT01967303|Restless legs syndrome|restless legs syndrome
4926540|NCT01967303|Stroke|stroke
4926541|NCT01967303|Transient ischemic attack|transient ischemic attack
4926542|NCT01967303|Cerebrovascular risk factors|cerebrovascular risk factors
4926543|NCT01967290|stroke|stroke
4926544|NCT01967290|motor deficits|motor deficits
4926545|NCT01967290|motor rehabilitation|motor rehabilitation
4926546|NCT01967290|neurorehabilitation|neurorehabilitation
4926547|NCT01967290|medical devices|medical devices
4926548|NCT01967290|wearable devices|wearable devices
4926549|NCT01967290|e-health systems|e-health systems
4926550|NCT01967264|Drug therapy|drug therapy
4926551|NCT01967251|Prostatic Hyperplasia|prostatic hyperplasia
4926552|NCT01967251|Phosphodiesterase 5 inhibitors|phosphodiesterase 5 inhibitors
4926553|NCT01967251|Erectile DysfunctionDrug Therapy|erectile dysfunctiondrug therapy
4926554|NCT01967238|immune response|immune response
4926555|NCT01967225|Methicillin Resistant Staphylococcus Aureus,|methicillin resistant staphylococcus aureus,
4926556|NCT01967225|Skin and soft tissue infection,|skin and soft tissue infection,
4926557|NCT01967225|Bacteremia,|bacteremia,
4926558|NCT01967225|Tedizolid|tedizolid
4926559|NCT01967212|stroke|stroke
4926560|NCT01967212|swallowing training|swallowing training
4926561|NCT01967212|game-based|game-based
4926562|NCT01967212|biofeedback|biofeedback
4926563|NCT01967199|drug-eluting stent|drug-eluting stent
4926564|NCT01967199|drug-coated Balloon|drug-coated balloon
4926565|NCT01967199|recurrent In-Stent restenosis|recurrent in-stent restenosis
4926566|NCT01967186|Type 1 diabetes|type 1 diabetes
4926567|NCT01967186|islets|islets
4926568|NCT01967186|transplantation|transplantation
4926569|NCT01967186|nephropathy|nephropathy
4926570|NCT01967186|intramuscular|intramuscular
4926571|NCT01967173|Asthma|asthma
4926572|NCT01967173|Fluticasone|fluticasone
4926573|NCT01967173|Salmeterol|salmeterol
4926574|NCT01967147|Dry eye|dry eye
4926575|NCT01967147|Lipid deficiency|lipid deficiency
4926576|NCT01967147|Tear film break-up time|tear film break-up time
4926577|NCT01967134|HIV Negative|hiv negative
4926578|NCT01967121|Compex, ice|compex, ice
4926579|NCT01967095|Erlotinib|erlotinib
4926580|NCT01967095|12-278|12-278
4926581|NCT01967095|CNS involvement|cns involvement
4926582|NCT01967082|Cancer Prevention|cancer prevention
4926583|NCT01967082|Tobacco Control Program for Youth|tobacco control program for youth
4926584|NCT01967082|Smoking cessation|smoking cessation
4926585|NCT01967082|Smoking prevention|smoking prevention
4926586|NCT01967082|Smokers|smokers
4926587|NCT01967082|Non smokers|non smokers
4926588|NCT01967082|Students|students
4926589|NCT01967082|University of Houston|university of houston
4926590|NCT01967082|Survey|survey
4926591|NCT01967082|Questionnaire|questionnaire
4926592|NCT01967082|Telephone survey|telephone survey
4926593|NCT01967082|Smart phone application|smart phone application
4926594|NCT01967056|Muscle strength|muscle strength
4926595|NCT01967056|respiratory failure|respiratory failure
4926596|NCT01967056|extubation failure|extubation failure
4926597|NCT01967056|intensive care unit|intensive care unit
4926598|NCT01967056|outcome prediction|outcome prediction
4926599|NCT01967030|gestational diabetes mellitus|gestational diabetes mellitus
4926600|NCT01967030|breastfeeding|breastfeeding
4926601|NCT01967030|obesity|obesity
4926602|NCT01967030|diabetes|diabetes
4926603|NCT01967030|lactation|lactation
4926604|NCT01967030|prospective|prospective
4926605|NCT01967030|women|women
4926606|NCT01967030|postpartum|postpartum
4926607|NCT01967017|Intrauterine device|intrauterine device
4926608|NCT01967017|Paracervical block|paracervical block
4926609|NCT01966991|Down syndrome|down syndrome
4926610|NCT01966991|prenatal screening|prenatal screening
4926611|NCT01966991|trisomy 21|trisomy 21
4926612|NCT01966991|patient satisfaction|patient satisfaction
4926613|NCT01966978|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
4926614|NCT01966978|Insulin|insulin
4926615|NCT01966978|Insulin, Long-Acting|insulin, long-acting
4926616|NCT01966978|Insulin, Short Acting|insulin, short acting
4926617|NCT01966978|Detemir|detemir
4926618|NCT01966978|Liraglutide|liraglutide
4926619|NCT01966978|GLP-1|glp-1
4926620|NCT01966978|Glucagon Like Peptide|glucagon like peptide
4926621|NCT01966978|Metformin|metformin
4926622|NCT01966978|Uncontrolled Diabetes|uncontrolled diabetes
4926623|NCT01966978|Elevated A1c|elevated a1c
4926624|NCT01966978|Incretins|incretins
4926625|NCT01966965|PIOLIN®, PEDICULOSIS, EFFICACY, SAFETY, PHYTOMEDICINE,|piolin®, pediculosis, efficacy, safety, phytomedicine,
4926626|NCT01966965|ARRUDA, RUTA|arruda, ruta
4926627|NCT01966952|Hypertension|hypertension
4926628|NCT01966939|craniotomy|craniotomy
4926629|NCT01966939|craniectomy|craniectomy
4926630|NCT01966939|temporalis|temporalis
4926631|NCT01966939|TMJ|tmj
4926632|NCT01966939|mastication|mastication
4926633|NCT01966939|QoL|qol
4926634|NCT01966926|self monitoring|self monitoring
4926635|NCT01966926|self weighing|self weighing
4926636|NCT01966926|weight tracking|weight tracking
4926637|NCT01966926|psychosocial outcomes|psychosocial outcomes
4926638|NCT01966926|feasibility|feasibility
4926639|NCT01966913|Germ Cell Tumors|germ cell tumors
4926640|NCT01966913|Bevacizumab|bevacizumab
4926641|NCT01966913|salvage therapy|salvage therapy
4926642|NCT01966900|Human immunodeficiency disease|human immunodeficiency disease
4926643|NCT01966900|HIV|hiv
4926644|NCT01966900|Vaccine|vaccine
4926645|NCT01966900|CN54gp140|cn54gp140
4926646|NCT01966900|Glucopyranosyl lipid adjuvant|glucopyranosyl lipid adjuvant
4926647|NCT01966900|GLA|gla
4926648|NCT01966900|GLA-AF|gla-af
4926649|NCT01966887|Heart failure|heart failure
4926650|NCT01966887|Gene therapy|gene therapy
4926651|NCT01966887|Serca2a|serca2a
4926652|NCT01966887|Cardiomyopathy|cardiomyopathy
4926653|NCT01966874|Medical abortion|medical abortion
4926654|NCT01966874|Mifepristone|mifepristone
4926655|NCT01966874|Misoprostol|misoprostol
4926656|NCT01966874|Zacafemyl|zacafemyl
4926657|NCT01966874|Mexico|mexico
4926658|NCT01966861|mechanical ventilation|mechanical ventilation
4926659|NCT01966861|weaning|weaning
4926660|NCT01966861|acute respiratory failure|acute respiratory failure
4926661|NCT01966861|weaning failure|weaning failure
4926662|NCT01966861|lung ultrasound|lung ultrasound
4926663|NCT01966848|Knee|knee
4926664|NCT01966848|osteoarthritis|osteoarthritis
4926665|NCT01966848|arthroplasty|arthroplasty
4926666|NCT01966848|tka|tka
4926667|NCT01966848|rsa|rsa
4926668|NCT01966835|sleep quality|sleep quality
4926669|NCT01966835|sleep disturbances|sleep disturbances
4926670|NCT01966835|high intensity aerobic interval training|high intensity aerobic interval training
4926671|NCT01966835|rheumatoid arthritis|rheumatoid arthritis
4926672|NCT01966835|fatigue|fatigue
4926673|NCT01966835|pain|pain
4926674|NCT01966835|polysomnography|polysomnography
4926675|NCT01966835|watt max|watt max
4926676|NCT01966822|Osteoporosis|osteoporosis
4926677|NCT01966822|Bone mineral density|bone mineral density
4926678|NCT01966822|Dual-energy X-ray absorptiometry|dual-energy x-ray absorptiometry
4926679|NCT01966822|HIV infection|hiv infection
4926680|NCT01966822|Dolutegravir|dolutegravir
4926681|NCT01966822|Integrase inhibitor|integrase inhibitor
4926682|NCT01966809|Brain Tumor|brain tumor
4926683|NCT01966809|Photodynamic Therapy|photodynamic therapy
4926684|NCT01966809|Photochemotherapy|photochemotherapy
4926685|NCT01966809|Astrocytoma|astrocytoma
4926686|NCT01966809|Pilocytic Astrocytoma|pilocytic astrocytoma
4926687|NCT01966809|Low grade Astrocytoma|low grade astrocytoma
4926688|NCT01966809|Anaplastic Astrocytoma|anaplastic astrocytoma
4926689|NCT01966809|Glioblastoma|glioblastoma
4926690|NCT01966809|GBM|gbm
4926691|NCT01966809|Chordoma|chordoma
4926692|NCT01966809|Germinoma|germinoma
4926693|NCT01966809|Germ Cell Tumor|germ cell tumor
4926694|NCT01966809|Non-germinoma|non-germinoma
4926695|NCT01966809|CNS Lymphoma|cns lymphoma
4926696|NCT01966809|Craniopharyngioma|craniopharyngioma
4926697|NCT01966809|Mixed Glioma|mixed glioma
4926698|NCT01966809|Optic Nerve Glioma|optic nerve glioma
4926699|NCT01966809|Meningioma|meningioma
4926700|NCT01966809|Oligodendroglioma|oligodendroglioma
4926701|NCT01966809|Pituitary Tumors|pituitary tumors
4926702|NCT01966809|Desmoplastic Neuroepithelial Tumor|desmoplastic neuroepithelial tumor
4926703|NCT01966809|DNET|dnet
4926704|NCT01966809|glioblastoma multiforme|glioblastoma multiforme
4926705|NCT01966809|glioma|glioma
4926706|NCT01966809|glioblastoma survivors|glioblastoma survivors
4926707|NCT01966809|what is glioblastoma|what is glioblastoma
4926708|NCT01966809|gbm cancer|gbm cancer
4926709|NCT01966809|oligoastrocytoma|oligoastrocytoma
4926710|NCT01966809|gbm tumor|gbm tumor
4926711|NCT01966809|anaplastic oligodendroglioma|anaplastic oligodendroglioma
4926712|NCT01966809|High-Grade Glioma|high-grade glioma
4926713|NCT01966809|high grade glioma|high grade glioma
4926714|NCT01966809|glioblastomas|glioblastomas
4926715|NCT01966809|glioblastoma cancer|glioblastoma cancer
4926716|NCT01966809|anaplastic oligoastrocytoma|anaplastic oligoastrocytoma
4926717|NCT01966809|astrocytoma glioma|astrocytoma glioma
4926718|NCT01966809|glioblastoma clinical trials|glioblastoma clinical trials
4926719|NCT01966809|photodynamic therapy for cancer|photodynamic therapy for cancer
4926720|NCT01966809|glioblastoma multiforme clinical trials|glioblastoma multiforme clinical trials
4926721|NCT01966809|astrocytoma glioblastoma|astrocytoma glioblastoma
4926722|NCT01966809|gbm grade 4|gbm grade 4
4926723|NCT01966809|clinical trials for glioblastoma|clinical trials for glioblastoma
4926724|NCT01966809|photodynamic therapy cancer|photodynamic therapy cancer
4926725|NCT01966809|clinical trials glioblastoma|clinical trials glioblastoma
4926726|NCT01966809|glioblastoma clinical trials 2015|glioblastoma clinical trials 2015
4926727|NCT01966809|glioblastoma clinical trials 2014 not open in 2014|glioblastoma clinical trials 2014 not open in 2014
4926728|NCT01966809|glioblastoma trials|glioblastoma trials
4926729|NCT01966809|gbm clinical trials|gbm clinical trials
4926730|NCT01966809|glioblastoma immunotherapy|glioblastoma immunotherapy
4926731|NCT01966809|malignant gliomas|malignant gliomas
4926732|NCT01966809|anaplastic astrocytomas|anaplastic astrocytomas
4926733|NCT01966809|immunotherapy for glioblastoma|immunotherapy for glioblastoma
4926734|NCT01966809|immunotherapy glioblastoma|immunotherapy glioblastoma
4926735|NCT01966809|High Grade Glioblastoma Multiforme|high grade glioblastoma multiforme
4926736|NCT01966809|clinical trial glioblastoma|clinical trial glioblastoma
4926737|NCT01966809|glioblastoma clinical trial|glioblastoma clinical trial
4926738|NCT01966809|glioblastoma trial|glioblastoma trial
4926739|NCT01966809|brain tumors|brain tumors
4926740|NCT01966809|recurrent brain tumors|recurrent brain tumors
4926741|NCT01966809|glioma grade 3|glioma grade 3
4926742|NCT01966809|grade 3 brain tumor|grade 3 brain tumor
4926743|NCT01966809|grade 4 brain tumor|grade 4 brain tumor
4926744|NCT01966796|healthcare associated pneumonia|healthcare associated pneumonia
4926745|NCT01966796|drug-resistant bacteria|drug-resistant bacteria
4926746|NCT01966796|pneumonia severity index|pneumonia severity index
4926747|NCT01966757|Neuronal Ceroid Lipofuscinosis|neuronal ceroid lipofuscinosis
4926748|NCT01966757|NCL|ncl
4926749|NCT01966757|Batten's Disease|batten's disease
4926750|NCT01966757|Children's Sleep Habits Questionnaire|children's sleep habits questionnaire
4926751|NCT01966757|Restless Leg Syndrome|restless leg syndrome
4926752|NCT01966731|Africa|africa
4926753|NCT01966718|Rheumatoid arthritis|rheumatoid arthritis
4926754|NCT01966718|Joint pain|joint pain
4926755|NCT01966718|Repository corticotropin injection|repository corticotropin injection
4926756|NCT01966705|severe health anxiety|severe health anxiety
4926757|NCT01966705|somatic symptom disorder|somatic symptom disorder
4926758|NCT01966705|illness anxiety disorder|illness anxiety disorder
4926759|NCT01966705|cognitive behavior therapy|cognitive behavior therapy
4926760|NCT01966705|bibliotherapy|bibliotherapy
4926761|NCT01966705|internet|internet
4926762|NCT01966705|exposure|exposure
4926763|NCT01966692|Bioequivalence|bioequivalence
4926764|NCT01966692|Fluticasone Propionate|fluticasone propionate
4926765|NCT01966666|Alzheimer's disease|alzheimer's disease
4926766|NCT01966666|mild to moderate|mild to moderate
4926767|NCT01966653|nitrofurantoin|nitrofurantoin
4926768|NCT01966653|fosfomycin|fosfomycin
4926769|NCT01966653|urinary tract infection|urinary tract infection
4926770|NCT01966653|clinical efficacy|clinical efficacy
4926771|NCT01966653|bacteriologic response|bacteriologic response
4926772|NCT01966640|diagnosis of allergy|diagnosis of allergy
4926773|NCT01966640|Basophil Activation Test|basophil activation test
4926774|NCT01966627|non alcoholic fatty liver|non alcoholic fatty liver
4926775|NCT01966627|childhood obesity|childhood obesity
4926776|NCT01966627|genetic variants|genetic variants
4926777|NCT01966614|Benign prostatic hyperplasia|benign prostatic hyperplasia
4926778|NCT01966614|BPH|bph
4926779|NCT01966614|Enlarged prostate|enlarged prostate
4926780|NCT01966614|Lower urinary tract symptoms (LUTS)|lower urinary tract symptoms (luts)
4926781|NCT01966588|Antipsychotic agents|antipsychotic agents
4926782|NCT01966588|Adverse effects|adverse effects
4926783|NCT01966588|Genomics|genomics
4926784|NCT01966588|Transcriptome|transcriptome
4926785|NCT01966575|Polycystic ovary syndrome|polycystic ovary syndrome
4926786|NCT01966575|Progestin|progestin
4926787|NCT01966575|Endometrial shedding|endometrial shedding
4926788|NCT01966575|Ovulation induction cycles|ovulation induction cycles
4926789|NCT01966575|Clomiphene citrate|clomiphene citrate
4926790|NCT01966575|Clinical pregnancy rate|clinical pregnancy rate
4926791|NCT01966549|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
4926792|NCT01966549|Moderate to Severe Chronic Obstructive Pulmonary Disease|moderate to severe chronic obstructive pulmonary disease
4926793|NCT01966549|CNTO 6785|cnto 6785
4926794|NCT01966549|Placebo|placebo
4926795|NCT01966510|cord blood transplant|cord blood transplant
4926796|NCT01966510|advanced lymphoid malignancies|advanced lymphoid malignancies
4926797|NCT01966497|AML|aml
4926798|NCT01966484|Succinylcholine|succinylcholine
4926799|NCT01966484|Mivacurium|mivacurium
4926800|NCT01966484|Rigid Bronchoscopy|rigid bronchoscopy
4926801|NCT01966484|Intubating conditions|intubating conditions
4926802|NCT01966484|Short Procedure|short procedure
4926803|NCT01966445|GSK2849330|gsk2849330
4926804|NCT01966445|Oncology|oncology
4926805|NCT01966445|First Time in Human|first time in human
4926806|NCT01966445|HER3|her3
4926807|NCT01966432|Substance abuse|substance abuse
4926808|NCT01966432|Alcohol use|alcohol use
4926809|NCT01966432|Tobacco use|tobacco use
4926810|NCT01966432|Brief intervention|brief intervention
4926811|NCT01966432|Referral to treatment|referral to treatment
4926812|NCT01966419|hepatic encephalopathy|hepatic encephalopathy
4926813|NCT01966419|hyperammonemia|hyperammonemia
4926814|NCT01966419|cirrhosis|cirrhosis
4926815|NCT01966419|ornithine phenylacetate|ornithine phenylacetate
4926816|NCT01966419|OCR-002|ocr-002
4926817|NCT01966406|Pancreaticoduodenectomy|pancreaticoduodenectomy
4926818|NCT01966406|nasogastric tube|nasogastric tube
4926819|NCT01966393|Type 1 diabetes|type 1 diabetes
4926820|NCT01966393|Hypoglycemia|hypoglycemia
4926821|NCT01966393|Insulin|insulin
4926822|NCT01966393|Glucagon|glucagon
4926823|NCT01966393|Closed-loop strategy|closed-loop strategy
4926824|NCT01966393|Artificial pancreas|artificial pancreas
4926825|NCT01966367|Unrelated donor transplant|unrelated donor transplant
4926826|NCT01966367|Haploidentical donor transplant|haploidentical donor transplant
4926827|NCT01966367|Peripheral blood stem cell transplantation|peripheral blood stem cell transplantation
4926828|NCT01966367|CD34+ selection|cd34+ selection
4926829|NCT01966367|Non-malignant disease|non-malignant disease
4926830|NCT01966367|Bone marrow failure syndrome|bone marrow failure syndrome
4926831|NCT01966367|Severe Aplastic Anemia|severe aplastic anemia
4926832|NCT01966367|Severe Congenital Neutropenia|severe congenital neutropenia
4926833|NCT01966367|Amegakaryocytic Thrombocytopenia|amegakaryocytic thrombocytopenia
4926834|NCT01966367|Diamond-Blackfan Anemia|diamond-blackfan anemia
4926835|NCT01966367|Schwachman Diamond Syndrome|schwachman diamond syndrome
4926836|NCT01966367|Primary Immunodeficiency Syndrome|primary immunodeficiency syndrome
4926837|NCT01966367|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
4926838|NCT01966367|Histiocytic Syndrome|histiocytic syndrome
4926839|NCT01966367|Familial Hemophagocytic Lymphocytosis|familial hemophagocytic lymphocytosis
4926840|NCT01966367|Lymphohistiocytosis|lymphohistiocytosis
4926841|NCT01966367|Macrophage Activation Syndrome|macrophage activation syndrome
4926842|NCT01966367|Langerhans Cell Histiocytosis (LCH)|langerhans cell histiocytosis (lch)
4926843|NCT01966367|Hemoglobinopathies|hemoglobinopathies
4926844|NCT01966367|Sickle Cell Disease|sickle cell disease
4926845|NCT01966367|Sickle Cell-beta-thalassemia|sickle cell-beta-thalassemia
4926846|NCT01966354|adult|adult
4926847|NCT01966354|catheterization, central venous|catheterization, central venous
4926848|NCT01966354|ultrasonography, interventional|ultrasonography, interventional
4926849|NCT01966354|evidence-based medicine|evidence-based medicine
4926850|NCT01966354|cost-benefit analysis|cost-benefit analysis
4926851|NCT01966302|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
4926852|NCT01966302|prostacyclin|prostacyclin
4926853|NCT01966302|oral|oral
4926854|NCT01966289|Colorectal Neoplasms|colorectal neoplasms
4926855|NCT01966289|Intestinal Neoplasms|intestinal neoplasms
4926856|NCT01966289|Gastrointestinal Neoplasms|gastrointestinal neoplasms
4926857|NCT01966289|Digestive System Neoplasms|digestive system neoplasms
4926858|NCT01966289|Neoplasms by Site|neoplasms by site
4926859|NCT01966289|Neoplasms|neoplasms
4926860|NCT01966289|Digestive System Diseases|digestive system diseases
4926861|NCT01966289|Gastrointestinal Diseases|gastrointestinal diseases
4926862|NCT01966289|Colonic Diseases|colonic diseases
4926863|NCT01966289|Intestinal Diseases|intestinal diseases
4926864|NCT01966289|Rectal Diseases|rectal diseases
4926865|NCT01966276|Chronic Fatigue Syndrome (CFS)|chronic fatigue syndrome (cfs)
4926866|NCT01966276|Myalgic Encephalomyelitis (ME)|myalgic encephalomyelitis (me)
4926867|NCT01966276|central nervous system (CNS)|central nervous system (cns)
4926868|NCT01966276|fatigue|fatigue
4926869|NCT01966276|alertness|alertness
4926870|NCT01966276|brain fog|brain fog
4926871|NCT01966276|mitochondria|mitochondria
4926872|NCT01966276|methylphenidate|methylphenidate
4926873|NCT01966276|Ritalin|ritalin
4926874|NCT01966276|stimulant|stimulant
4926875|NCT01966276|multivitamin|multivitamin
4926876|NCT01966276|multimineral|multimineral
4926877|NCT01966276|micronutrients|micronutrients
4926878|NCT01966276|supplements|supplements
4926879|NCT01966263|total knee arthroplasty|total knee arthroplasty
4926880|NCT01966263|femoral nerve block|femoral nerve block
4926881|NCT01966263|local infiltration analgesia|local infiltration analgesia
4926882|NCT01966263|fast track|fast track
4926883|NCT01966198|pulse plethysmography, autonomic nervous system, heart rate variability, baro-reflex|pulse plethysmography, autonomic nervous system, heart rate variability, baro-reflex
4926884|NCT01966185|virtual simulation|virtual simulation
4926885|NCT01966185|temporal bone|temporal bone
4926886|NCT01966185|surgical training|surgical training
4926887|NCT01966185|medical education|medical education
4926888|NCT01966185|self-directed learning|self-directed learning
4926889|NCT01966185|final product assessment|final product assessment
4926890|NCT01966185|cognitive load|cognitive load
4926891|NCT01966185|reaction time|reaction time
4926892|NCT01966185|skills training|skills training
4926893|NCT01966185|simulator metrics|simulator metrics
4926894|NCT01966172|NSAID, gabapentin, multimodal, morphine, dexamethasone, cardiac surgery, postoperative pain, analgesia.|nsaid, gabapentin, multimodal, morphine, dexamethasone, cardiac surgery, postoperative pain, analgesia.
4926895|NCT01966133|HCC|hcc
4926896|NCT01966133|Randomised controlled trial|randomised controlled trial
4926897|NCT01966133|TACE|tace
4926898|NCT01966133|Resection|resection
4926899|NCT01966120|Photodynamic Therapy|photodynamic therapy
4926900|NCT01966120|Field-directed Treatment|field-directed treatment
4926901|NCT01966068|Asthma|asthma
4926902|NCT01966068|Pediatrics|pediatrics
4926903|NCT01966068|Health Technology|health technology
4926904|NCT01966068|Meaningful Use Stage-3|meaningful use stage-3
4926905|NCT01966068|Web Portal|web portal
4926906|NCT01966042|Refractory angina|refractory angina
4926907|NCT01966042|Cell Therapy|cell therapy
4926908|NCT01966042|Bone Marrow|bone marrow
4926909|NCT01966042|Mononuclear Cells|mononuclear cells
4926910|NCT01966016|LV- Left Ventricular|lv- left ventricular
4926911|NCT01966016|CRT- Cardiac resynchronization therapy|crt- cardiac resynchronization therapy
4926912|NCT01966016|MSCRT- Multisite Cardiac resynchronization therapy (P-pacemaker; D-defibrillator)|mscrt- multisite cardiac resynchronization therapy (p-pacemaker; d-defibrillator)
4926913|NCT01966016|BBB -bundle branch block|bbb -bundle branch block
4926914|NCT01965990|Enteral nutrition|enteral nutrition
4926915|NCT01965990|very low-calorie diet|very low-calorie diet
4926916|NCT01965990|severe obesity|severe obesity
4926917|NCT01965990|weight loss|weight loss
4926918|NCT01965990|ketosis|ketosis
4926919|NCT01965964|Dysphagia, Swallowing functions, Questionnaire in German|dysphagia, swallowing functions, questionnaire in german
4926920|NCT01965925|Cognition|cognition
4926921|NCT01965925|Sleep problems|sleep problems
4926922|NCT01965925|Bipolar Disorder|bipolar disorder
4926923|NCT01965912|Phenylketonuria|phenylketonuria
4926924|NCT01965912|Kuvan|kuvan
4926925|NCT01965912|Sapropterin dihydrochloride|sapropterin dihydrochloride
4926926|NCT01965886|osteoarthritis|osteoarthritis
4926927|NCT01965886|knee|knee
4926928|NCT01965886|arthroplasty|arthroplasty
4926929|NCT01965886|replacement|replacement
4926930|NCT01965873|Pancreatitis, Acute necrotizing|pancreatitis, acute necrotizing
4926931|NCT01965873|Enteral nutrition|enteral nutrition
4926932|NCT01965873|Fasting|fasting
4926933|NCT01965873|Complications|complications
4926934|NCT01965873|Mortality|mortality
4926935|NCT01965834|Multiple Myeloma|multiple myeloma
4926936|NCT01965834|Fenofibrate|fenofibrate
4926937|NCT01965821|tracheal cuff pressure|tracheal cuff pressure
4926938|NCT01965821|continuous control|continuous control
4926939|NCT01965821|microaspiration|microaspiration
4926940|NCT01965795|Brain-derived neurotrophic factor|brain-derived neurotrophic factor
4926941|NCT01965795|Cognitive function|cognitive function
4926942|NCT01965795|Dietary supplement|dietary supplement
4926943|NCT01965795|Coffee plant extract|coffee plant extract
4926944|NCT01965769|Very low birth weight infants|very low birth weight infants
4926945|NCT01965769|premature|premature
4926946|NCT01965769|nutrition|nutrition
4926947|NCT01965769|gastric residual|gastric residual
4926948|NCT01965756|Alzheimer's Disease|alzheimer's disease
4926949|NCT01965756|Vascular Dementia|vascular dementia
4926950|NCT01965756|Dementia|dementia
4926951|NCT01965756|Memory Impairment|memory impairment
4926952|NCT01965743|intrauterine contraception (IUC)|intrauterine contraception (iuc)
4926953|NCT01965743|social networks|social networks
4926954|NCT01965743|social influence|social influence
4926955|NCT01965743|diffusion of innovation|diffusion of innovation
4926956|NCT01965743|intrauterine device (IUD)|intrauterine device (iud)
4926957|NCT01965743|LARC|larc
4926958|NCT01965730|dilated ascending aorta|dilated ascending aorta
4926959|NCT01965717|endoleak|endoleak
4926960|NCT01965717|MMP- 9|mmp- 9
4926961|NCT01965717|biomarker|biomarker
4926962|NCT01965704|Narcotic addiction during pregnancy|narcotic addiction during pregnancy
4926963|NCT01965704|Neonatal abstinence syndrome|neonatal abstinence syndrome
4926964|NCT01965704|NAS|nas
4926965|NCT01965691|Phenylketonuria|phenylketonuria
4926966|NCT01965691|PKU|pku
4926967|NCT01965691|Phenylalanine metabolism|phenylalanine metabolism
4926968|NCT01965691|Protein requirements|protein requirements
4926969|NCT01965691|Indicator Amino acid Oxidation|indicator amino acid oxidation
4926970|NCT01965691|Stable isotopes|stable isotopes
4926971|NCT01965678|Osteopathic manipulative treatment|osteopathic manipulative treatment
4926972|NCT01965678|muscle-skeletal disorder|muscle-skeletal disorder
4926973|NCT01965678|quality of life|quality of life
4926974|NCT01965665|Diabetes|diabetes
4926975|NCT01965665|Surgical Intervention|surgical intervention
4926976|NCT01965665|Honey|honey
4926977|NCT01965652|Opioid Induced Constipation|opioid induced constipation
4926978|NCT01965639|Diabetes Mellitus Type 2|diabetes mellitus type 2
4926979|NCT01965639|Standard of care|standard of care
4926980|NCT01965639|Quality of life|quality of life
4926981|NCT01965639|Disease management|disease management
4926982|NCT01965626|Oseltamivir|oseltamivir
4926983|NCT01965626|Dexamethasone|dexamethasone
4926984|NCT01965626|ITP|itp
4926985|NCT01965613|Pyoderma Gangrenosum|pyoderma gangrenosum
4926986|NCT01965600|Endotoxin challenge|endotoxin challenge
4926987|NCT01965587|novasure|novasure
4926988|NCT01965587|Mirena IUS|mirena ius
4926989|NCT01965587|menorrhagia|menorrhagia
4926990|NCT01965587|pelvic pain|pelvic pain
4926991|NCT01965587|ashermanns|ashermanns
4926992|NCT01965574|ARDS - FLUID LOADING - PRELOAD DEPENDENCE|ards - fluid loading - preload dependence
4926993|NCT01965548|spleen|spleen
4926994|NCT01965548|injury|injury
4926995|NCT01965548|patient transfer|patient transfer
4926996|NCT01965548|splenectomy|splenectomy
4927884|NCT01961960|ASP7374|asp7374
4926997|NCT01965548|embolization, theurapeutic|embolization, theurapeutic
4926998|NCT01965535|Hepatitis C|hepatitis c
4926999|NCT01965535|HCV|hcv
4927000|NCT01965535|Cirrhosis|cirrhosis
4927001|NCT01965522|Breast cancer|breast cancer
4927002|NCT01965522|melatonin|melatonin
4927003|NCT01965522|vitamin d|vitamin d
4927004|NCT01965522|ki67|ki67
4927005|NCT01965509|PEX168|pex168
4927006|NCT01965509|Phase I/II|phase i/ii
4927007|NCT01965509|add on to metformin|add on to metformin
4927008|NCT01965496|PEX168|pex168
4927009|NCT01965496|Phase I|phase i
4927010|NCT01965496|titration|titration
4927011|NCT01965483|radiotherapy|radiotherapy
4927012|NCT01965483|adjuvant|adjuvant
4927013|NCT01965483|weekly hypofractionation|weekly hypofractionation
4927014|NCT01965457|obstructive sleep apnea|obstructive sleep apnea
4927015|NCT01965457|pediatric|pediatric
4927016|NCT01965457|adenoid hypertrophy|adenoid hypertrophy
4927017|NCT01965444|Sub-epidermal moisture|sub-epidermal moisture
4927018|NCT01965444|Pressure Ulcers|pressure ulcers
4927019|NCT01965405|HIV|hiv
4927020|NCT01965405|AIDS|aids
4927021|NCT01965405|Nicotine Dependence|nicotine dependence
4927022|NCT01965405|Smoking|smoking
4927023|NCT01965405|Smoking cessation|smoking cessation
4927024|NCT01965405|Contingency Management|contingency management
4927025|NCT01965379|Dialysis|dialysis
4927026|NCT01965379|Phosphorus|phosphorus
4927027|NCT01965379|Diet|diet
4927028|NCT01965366|Dexamethasone|dexamethasone
4927029|NCT01965366|Virtual Reality|virtual reality
4927030|NCT01965366|Military|military
4927031|NCT01965366|PTSD|ptsd
4927032|NCT01965353|Relapsed Multiple Myeloma|relapsed multiple myeloma
4927033|NCT01965353|Relapse-Refractory Multiple Myeloma|relapse-refractory multiple myeloma
4927034|NCT01965340|patients|patients
4927035|NCT01965327|Friedreich ataxia|friedreich ataxia
4927036|NCT01965327|Interferon gamma-1b|interferon gamma-1b
4927037|NCT01965327|FRDA|frda
4927038|NCT01965314|ultrasound guided regional anaesthesia|ultrasound guided regional anaesthesia
4927039|NCT01965314|upper limb surgery|upper limb surgery
4927040|NCT01965314|ultrasound guided axillary brachial plexus blockade|ultrasound guided axillary brachial plexus blockade
4927041|NCT01965275|Advanced non-small cell lung cancer|advanced non-small cell lung cancer
4927042|NCT01965275|High-dose|high-dose
4927043|NCT01965275|Pulsatile|pulsatile
4927044|NCT01965275|EGFR-TKIs|egfr-tkis
4927045|NCT01965249|Laparotomy|laparotomy
4927046|NCT01965249|short stitch|short stitch
4927047|NCT01965249|long stitch|long stitch
4927048|NCT01965249|MonoMax|monomax
4927049|NCT01965236|hypertension, sodium intake, left ventricular function|hypertension, sodium intake, left ventricular function
4927050|NCT01965223|Oligometastatic|oligometastatic
4927051|NCT01965223|Neoplasia|neoplasia
4927052|NCT01965223|Radiosurgery|radiosurgery
4927053|NCT01965223|Stereotactic Ablative Body Radiotherapy|stereotactic ablative body radiotherapy
4927054|NCT01965223|SABR|sabr
4927055|NCT01965223|Metastases to the Lung|metastases to the lung
4927056|NCT01965223|Non Haematological|non haematological
4927057|NCT01965210|Rye|rye
4927058|NCT01965210|Fermentable dietary fibre|fermentable dietary fibre
4927059|NCT01965210|Inulin|inulin
4927060|NCT01965210|Plant protein|plant protein
4927061|NCT01965210|Gluten|gluten
4927062|NCT01965210|Porridge|porridge
4927063|NCT01965210|Bread|bread
4927064|NCT01965210|Appetite|appetite
4927065|NCT01965210|Satiety|satiety
4927066|NCT01965210|Hunger|hunger
4927067|NCT01965210|Desire to eat|desire to eat
4927068|NCT01965210|Metabolism|metabolism
4927069|NCT01965210|Glucose|glucose
4927070|NCT01965210|Insulin|insulin
4927071|NCT01965210|Gut hormones|gut hormones
4927072|NCT01965210|Metabolomics|metabolomics
4927073|NCT01965210|Gastric emptying rate|gastric emptying rate
4927074|NCT01965210|Breath hydrogen and methane excretion|breath hydrogen and methane excretion
4927075|NCT01965184|child|child
4927076|NCT01965184|cognitive behavioral therapy|cognitive behavioral therapy
4927077|NCT01965184|CBT|cbt
4927078|NCT01965184|aggression|aggression
4927079|NCT01965184|disruptive behavior|disruptive behavior
4927080|NCT01965184|treatment|treatment
4927081|NCT01965184|frustrative non-reward|frustrative non-reward
4927082|NCT01965171|hematologic malignancy|hematologic malignancy
4927083|NCT01965171|iron overload|iron overload
4927084|NCT01965171|magnetic resonance imaging|magnetic resonance imaging
4927085|NCT01965171|childhood cancer survivors|childhood cancer survivors
4927086|NCT01965158|Opioid-induced Constipation|opioid-induced constipation
4927087|NCT01965132|Rheumatiod Arhthritis|rheumatiod arhthritis
4927088|NCT01965132|Ankylosing spondylitis|ankylosing spondylitis
4927089|NCT01965132|Psoriatic arthritis|psoriatic arthritis
4927090|NCT01965132|Biologic agents|biologic agents
4927091|NCT01965132|Cohort studies|cohort studies
4927092|NCT01965106|Glaucoma, Angle-Closure|glaucoma, angle-closure
4927093|NCT01965106|Glaucoma, Closed-Angle|glaucoma, closed-angle
4927094|NCT01965106|Primary angle closure|primary angle closure
4927095|NCT01965106|Acute angle closure|acute angle closure
4927096|NCT01965106|Acute angle-closure glaucoma|acute angle-closure glaucoma
4927097|NCT01965093|perioperative|perioperative
4927098|NCT01965093|desaturation|desaturation
4927099|NCT01965093|growth development|growth development
4927100|NCT01965093|intelligence outcome|intelligence outcome
4927101|NCT01965080|Endometrial cancer|endometrial cancer
4927102|NCT01965054|Intrahepatic cholestasis of pregnancy|intrahepatic cholestasis of pregnancy
4927103|NCT01965054|fish oil|fish oil
4927104|NCT01965054|omega-3|omega-3
4927105|NCT01965054|Docosahexaenoic acid,|docosahexaenoic acid,
4927106|NCT01965054|eicosapentaenoic acid|eicosapentaenoic acid
4927107|NCT01965041|AVA Study|ava study
4927108|NCT01965028|tinnitus|tinnitus
4927109|NCT01965028|transcranial random noise stimulation|transcranial random noise stimulation
4927110|NCT01965028|tRNS|trns
4927111|NCT01965028|auditory cortex|auditory cortex
4927112|NCT01965028|non-invasive brain stimulation|non-invasive brain stimulation
4927113|NCT01965015|Heart Failure (HF)|heart failure (hf)
4927114|NCT01965015|Left Atrial Pressure|left atrial pressure
4927115|NCT01964989|Influenza|influenza
4927116|NCT01964989|children|children
4927117|NCT01964950|drug therapy|drug therapy
4927118|NCT01964911|Martorell ulcer|martorell ulcer
4927119|NCT01964911|Hypertensive leg ulcer|hypertensive leg ulcer
4927120|NCT01964911|Pain|pain
4927121|NCT01964911|Continuous nerve block|continuous nerve block
4927122|NCT01964911|Ropivacaïne|ropivacaïne
4927123|NCT01964911|Local anesthesic|local anesthesic
4927124|NCT01964898|Smoking|smoking
4927125|NCT01964898|Mood Management|mood management
4927126|NCT01964898|Depression|depression
4927127|NCT01964898|Behavioral Activation|behavioral activation
4927128|NCT01964898|Acute Coronary Syndrome|acute coronary syndrome
4927129|NCT01964898|Myocardial Infarction|myocardial infarction
4927130|NCT01964872|Healthy volunteers|healthy volunteers
4927131|NCT01964872|JNJ-38877618|jnj-38877618
4927132|NCT01964872|Pharmacokinetic|pharmacokinetic
4927133|NCT01964872|Safety|safety
4927134|NCT01964872|Single-ascending dose|single-ascending dose
4927135|NCT01964872|Multiple-ascending dose|multiple-ascending dose
4927136|NCT01964859|healthy skin|healthy skin
4927137|NCT01964859|wounds and injuries|wounds and injuries
4927138|NCT01964859|prosthetics|prosthetics
4927139|NCT01964859|amputations|amputations
4927140|NCT01964859|dermal fibroblasts|dermal fibroblasts
4927141|NCT01964846|inflammation|inflammation
4927142|NCT01964846|high fat meal|high fat meal
4927143|NCT01964846|resveratrol|resveratrol
4927144|NCT01964846|curcumin|curcumin
4927145|NCT01964846|gene expression|gene expression
4927146|NCT01964833|clinical trial|clinical trial
4927147|NCT01964833|DMT2|dmt2
4927148|NCT01964833|periodontitis|periodontitis
4927149|NCT01964833|PDT|pdt
4927150|NCT01964807|Cardiovascular|cardiovascular
4927151|NCT01964807|tobacco|tobacco
4927152|NCT01964807|cigarettes|cigarettes
4927153|NCT01964807|secondhand cigarette smoke|secondhand cigarette smoke
4927154|NCT01964807|SHS|shs
4927155|NCT01964807|smokeless tobacco|smokeless tobacco
4927156|NCT01964807|chewing tobacco|chewing tobacco
4927157|NCT01964807|snus|snus
4927158|NCT01964807|electronic cigarettes|electronic cigarettes
4927159|NCT01964807|vapor|vapor
4927160|NCT01964807|particles|particles
4927161|NCT01964807|oxidative stress|oxidative stress
4927162|NCT01964807|flow-mediated dilation|flow-mediated dilation
4927163|NCT01964807|FMD|fmd
4927164|NCT01964794|Warfarin|warfarin
4927165|NCT01964781|Administration, topical|administration, topical
4927166|NCT01964781|tranexamic acid|tranexamic acid
4927167|NCT01964781|adrenaline|adrenaline
4927168|NCT01964781|bupivacaine|bupivacaine
4927169|NCT01964781|surgery|surgery
4927170|NCT01964755|EBV+|ebv+
4927171|NCT01964755|NHL|nhl
4927172|NCT01964755|HL|hl
4927173|NCT01964755|Non Hodgkin's Lymphoma|non hodgkin's lymphoma
4927174|NCT01964755|Hodgkin's Lymphoma|hodgkin's lymphoma
4927175|NCT01964755|Epstein Barr Virus|epstein barr virus
4927176|NCT01964755|Epstein Barr Virus Associated Non Hodgkin's Lymphoma|epstein barr virus associated non hodgkin's lymphoma
4927177|NCT01964755|Epstein Barr Virus Associated Hodgkin's Lymphoma|epstein barr virus associated hodgkin's lymphoma
4927178|NCT01964755|Post-Transplant Lymphoproliferative Disease|post-transplant lymphoproliferative disease
4927179|NCT01964729|rTMS|rtms
4927180|NCT01964729|Pain threshold|pain threshold
4927181|NCT01964729|Neuromodulation|neuromodulation
4927182|NCT01964729|Myofascial|myofascial
4927183|NCT01964716|Prevenar 13|prevenar 13
4927184|NCT01964716|13vPnC|13vpnc
4927185|NCT01964716|Healthy Subjects|healthy subjects
4927186|NCT01964690|Lactate|lactate
4927187|NCT01964690|Sepsis|sepsis
4927188|NCT01964690|Capillary lactate|capillary lactate
4927189|NCT01964690|Venous lactate|venous lactate
4927190|NCT01964690|Quick test|quick test
4927191|NCT01964677|Magnetic Resonance Imaging (MRI)|magnetic resonance imaging (mri)
4927192|NCT01964677|High Intensity Focused Ultrasound (HIFU)|high intensity focused ultrasound (hifu)
4927193|NCT01964664|Mindfulness|mindfulness
4927194|NCT01964664|Meditation|meditation
4927195|NCT01964664|acute lateral sclerosis|acute lateral sclerosis
4927196|NCT01964664|Cerebral Palsy|cerebral palsy
4927197|NCT01964664|Cerebral Ataxia|cerebral ataxia
4927198|NCT01964664|Locked-in Syndrome|locked-in syndrome
4927199|NCT01964651|Healthy|healthy
4927200|NCT01964651|JNJ-42165279|jnj-42165279
4927201|NCT01964651|Pharmacokinetics|pharmacokinetics
4927202|NCT01964651|Elderly|elderly
4927203|NCT01964651|Young|young
4927204|NCT01964638|Prostate Cancer|prostate cancer
4927205|NCT01964638|Prostate Biopsy|prostate biopsy
4927206|NCT01964638|Targeted Biopsy|targeted biopsy
4927207|NCT01964625|Chronic GvHD|chronic gvhd
4927208|NCT01964599|Fiber|fiber
4927209|NCT01964599|Gastrointestinal|gastrointestinal
4927210|NCT01964586|Septoplasty, Dexmedetomidine, Surgical Conditions|septoplasty, dexmedetomidine, surgical conditions
4927211|NCT01964573|Parkinson's Disease|parkinson's disease
4927212|NCT01964573|Rotigotine|rotigotine
4927213|NCT01964573|Pharmacokinetics|pharmacokinetics
4927214|NCT01964573|Healthy subjects|healthy subjects
4927215|NCT01964560|Lacosamide|lacosamide
4927216|NCT01964560|Vimpat|vimpat
4927217|NCT01964560|UCB|ucb
4927218|NCT01964560|Epilepsy|epilepsy
4927219|NCT01964560|Partial Onset Seizures|partial onset seizures
4927220|NCT01964560|Pediatric|pediatric
4927221|NCT01964547|Cognition|cognition
4927222|NCT01964547|Mood|mood
4927223|NCT01964534|Metastatic|metastatic
4927224|NCT01964534|Pancreatic|pancreatic
4927225|NCT01964534|Cancer|cancer
4927226|NCT01964534|Pancreas|pancreas
4927227|NCT01964534|GERCOR|gercor
4927228|NCT01964534|Gemcitabine|gemcitabine
4927229|NCT01964534|LV5FU2|lv5fu2
4927230|NCT01964534|ABI-007|abi-007
4927231|NCT01964534|PACLITAXEL ALBUMIN-BOUND PARTICLES|paclitaxel albumin-bound particles
4927232|NCT01964482|Hospitalization|hospitalization
4927233|NCT01964482|Older|older
4927234|NCT01964482|Medical patient|medical patient
4927235|NCT01964482|Strength training|strength training
4927236|NCT01964456|Bodily self-consciousness|bodily self-consciousness
4927237|NCT01964456|intersubjective body|intersubjective body
4927238|NCT01964456|Anorexia Nervosa|anorexia nervosa
4927239|NCT01964456|Joint perception task|joint perception task
4927240|NCT01964456|Interoceptive awareness|interoceptive awareness
4927241|NCT01964443|Plaque Psoriasis|plaque psoriasis
4927242|NCT01964443|Alexithymia|alexithymia
4927243|NCT01964443|Quality of life|quality of life
4927244|NCT01964430|Resectable pancreatic cancer|resectable pancreatic cancer
4927245|NCT01964430|resected|resected
4927246|NCT01964430|resectable PDA|resectable pda
4927247|NCT01964430|adenocarcinoma|adenocarcinoma
4927248|NCT01964430|surgically resected|surgically resected
4927249|NCT01964430|adjuvant|adjuvant
4927250|NCT01964430|Abraxane|abraxane
4927251|NCT01964430|nab-paclitaxel|nab-paclitaxel
4927252|NCT01964430|ABI-007|abi-007
4927253|NCT01964430|gemcitabine|gemcitabine
4927254|NCT01964430|Gemzar|gemzar
4927255|NCT01964430|Phase 3|phase 3
4927256|NCT01964417|BOWEL PREPARATION|bowel preparation
4927257|NCT01964417|PEG|peg
4927258|NCT01964417|Low-volume PEG Plus Ascorbic Acid|low-volume peg plus ascorbic acid
4927259|NCT01964404|Dronabinol|dronabinol
4927260|NCT01964404|Schizophrenia|schizophrenia
4927261|NCT01964404|Dual Diagnosis|dual diagnosis
4927262|NCT01964404|Substance Abuse|substance abuse
4927263|NCT01964404|Cannabis Use Disorder|cannabis use disorder
4927264|NCT01964378|cancer-related pain|cancer-related pain
4927265|NCT01964378|neuropathic related cancer pain|neuropathic related cancer pain
4927266|NCT01964378|morphine|morphine
4927267|NCT01964378|cebranopadol (GRT6005)|cebranopadol (grt6005)
4927268|NCT01964378|Numerical Rating Scale|numerical rating scale
4927269|NCT01964326|atorvastatin|atorvastatin
4927270|NCT01964326|Hypercholesterolemia|hypercholesterolemia
4927271|NCT01964313|Acute coronary syndrome|acute coronary syndrome
4927272|NCT01964313|treatment strategy|treatment strategy
4927273|NCT01964313|genetics|genetics
4927274|NCT01964274|Nursing Delirium Screening Scale,|nursing delirium screening scale,
4927275|NCT01964274|Acetylcholinesterase Activity|acetylcholinesterase activity
4927276|NCT01964261|Neural|neural
4927277|NCT01964261|Prosthetic|prosthetic
4927278|NCT01964261|Brain machine interface|brain machine interface
4927279|NCT01964261|brain computer interface|brain computer interface
4927280|NCT01964261|brain control|brain control
4927281|NCT01964261|paralysis|paralysis
4927282|NCT01964261|tetraplegia|tetraplegia
4927283|NCT01964261|quadriplegia|quadriplegia
4927284|NCT01964261|spinal cord injury|spinal cord injury
4927285|NCT01964261|stimulation|stimulation
4927286|NCT01964261|sensory feedback|sensory feedback
4927287|NCT01964248|Blood gas analysis|blood gas analysis
4927288|NCT01964248|Arterial puncture|arterial puncture
4927289|NCT01964248|Local anesthesia|local anesthesia
4927290|NCT01964248|Eutectic mixture|eutectic mixture
4927291|NCT01964248|Lidocaïne/prilocaïne cream (5%)|lidocaïne/prilocaïne cream (5%)
4927292|NCT01964248|Placebo|placebo
4927293|NCT01964248|Pain Intensity Scale|pain intensity scale
4927294|NCT01964248|Numerical Rating Scale|numerical rating scale
4927295|NCT01964235|INC280, advanced hepatocellular carcinoma, c-MET pathway dysregulation.|inc280, advanced hepatocellular carcinoma, c-met pathway dysregulation.
4927296|NCT01964222|Cancer|cancer
4927297|NCT01964222|Clinical trials|clinical trials
4927298|NCT01964222|Informed consent|informed consent
4927299|NCT01964222|Health literacy|health literacy
4927300|NCT01964209|ADHD|adhd
4927301|NCT01964209|Validation|validation
4927302|NCT01964209|Quality Improvement|quality improvement
4927303|NCT01964209|Vanderbilt|vanderbilt
4927304|NCT01964209|Conners 3rd Edition|conners 3rd edition
4927305|NCT01964209|ADHD Measures|adhd measures
4927306|NCT01964209|ADHD Adolescent|adhd adolescent
4927307|NCT01964209|ADHD Questionnaire|adhd questionnaire
4927308|NCT01964209|ICISS|iciss
4927309|NCT01964209|Integrated Clinical Information Sharing System|integrated clinical information sharing system
4927310|NCT01964196|Renal anemia|renal anemia
4927311|NCT01964196|Chronic Renal Failure|chronic renal failure
4927312|NCT01964196|ASP1517|asp1517
4927313|NCT01964183|Open-label design|open-label design
4927314|NCT01964183|Pharmacokinetics|pharmacokinetics
4927315|NCT01964183|Drug-Drug Interaction|drug-drug interaction
4927316|NCT01964183|Mirabegron|mirabegron
4927317|NCT01964170|ASP3550|asp3550
4927318|NCT01964170|Prostate cancer|prostate cancer
4927319|NCT01964157|non-small cell lung cancer (NSCLC)|non-small cell lung cancer (nsclc)
4927320|NCT01964144|thyroid cancer, dovitinib|thyroid cancer, dovitinib
4927321|NCT01964131|Bioequivalence|bioequivalence
4927322|NCT01964131|pharmacodynamics|pharmacodynamics
4927323|NCT01964131|pharmacokinetics|pharmacokinetics
4927324|NCT01964131|safety|safety
4927325|NCT01964131|tolerability|tolerability
4927326|NCT01964131|D961H|d961h
4927327|NCT01964131|Japanese|japanese
4927328|NCT01964118|intermittent fasting|intermittent fasting
4927329|NCT01964118|obesity|obesity
4927330|NCT01964118|calorie restriction|calorie restriction
4927331|NCT01964105|Hypomastia|hypomastia
4927332|NCT01964105|Augmentation|augmentation
4927333|NCT01964105|Breast|breast
4927334|NCT01964105|3D|3d
4927335|NCT01964105|Breast Q|breast q
4927336|NCT01964092|Disability|disability
4927337|NCT01964092|Individual placement and support|individual placement and support
4927338|NCT01964092|Mental health|mental health
4927339|NCT01964092|Quality of life|quality of life
4927340|NCT01964092|Randomized controlled trial|randomized controlled trial
4927341|NCT01964092|Rehabilitation|rehabilitation
4927342|NCT01964092|Return to work|return to work
4927343|NCT01964092|Supported employment|supported employment
4927344|NCT01964066|therapeutic ERCP|therapeutic ercp
4927345|NCT01964066|prevention of post-ERCP pancreatitis|prevention of post-ercp pancreatitis
4927346|NCT01964066|thoracic epidural analgesia|thoracic epidural analgesia
4927347|NCT01964053|Self-management adherence|self-management adherence
4927348|NCT01964053|post acute care|post acute care
4927349|NCT01964053|critical access hospitals|critical access hospitals
4927350|NCT01964053|patient activation|patient activation
4927351|NCT01964053|hospital readmission|hospital readmission
4927352|NCT01964040|femoral nerve block|femoral nerve block
4927353|NCT01964040|peri-neural dexmedetomidine|peri-neural dexmedetomidine
4927354|NCT01964027|second line chemoregime|second line chemoregime
4927355|NCT01964027|gastric cancer|gastric cancer
4927356|NCT01964014|once|once
4927357|NCT01963988|Bladder Pain Syndrome|bladder pain syndrome
4927358|NCT01963988|Transurethral Resection of Ulcer|transurethral resection of ulcer
4927359|NCT01963988|Transurethral Coagulation of Ulcer|transurethral coagulation of ulcer
4927360|NCT01963962|Emergency contraception|emergency contraception
4927361|NCT01963962|Levonorgestrel IUD|levonorgestrel iud
4927362|NCT01963962|Copper IUD|copper iud
4927363|NCT01963962|Oral Levonorgestrel|oral levonorgestrel
4927364|NCT01963936|Infant newborn|infant newborn
4927365|NCT01963936|Laryngeal mask airway|laryngeal mask airway
4927366|NCT01963936|Positive pressure ventilation|positive pressure ventilation
4927367|NCT01963936|Resuscitation|resuscitation
4927368|NCT01963923|Pulmonary Rehabilitation|pulmonary rehabilitation
4927369|NCT01963923|Lung Cancer Resection|lung cancer resection
4927370|NCT01963923|Video-assisted thoracic surgery|video-assisted thoracic surgery
4927371|NCT01963923|Exercise tolerance|exercise tolerance
4927372|NCT01963923|Quality of life|quality of life
4927373|NCT01963910|Mannitol|mannitol
4927374|NCT01963910|TRPV1 receptor|trpv1 receptor
4927375|NCT01963910|Pain|pain
4927376|NCT01963910|Burning pain|burning pain
4927377|NCT01963910|neuropathy|neuropathy
4927378|NCT01963910|neuropathic pain|neuropathic pain
4927379|NCT01963897|Genotype/phenotype correlations|genotype/phenotype correlations
4927380|NCT01963897|Growth|growth
4927381|NCT01963897|Bone health|bone health
4927382|NCT01963897|Puberty|puberty
4927383|NCT01963897|Quality of life|quality of life
4927384|NCT01963884|Extraction Sockets|extraction sockets
4927385|NCT01963884|Ridge dimensions|ridge dimensions
4927386|NCT01963884|Dental Alveolar Anatomy|dental alveolar anatomy
4927387|NCT01963884|Dental Implants|dental implants
4927388|NCT01963884|Bone Physiology|bone physiology
4927389|NCT01963871|chronic low back pain|chronic low back pain
4927390|NCT01963871|low back pain|low back pain
4927391|NCT01963871|yoga|yoga
4927392|NCT01963832|stroke|stroke
4927393|NCT01963832|Fluoxetine (FLX)|fluoxetine (flx)
4927394|NCT01963832|eCIMT|ecimt
4927395|NCT01963832|Central Nervous System|central nervous system
4927396|NCT01963793|Pruritus|pruritus
4927397|NCT01963780|lung transplantation|lung transplantation
4927398|NCT01963780|lung preservation|lung preservation
4927399|NCT01963780|breathing lung transplant|breathing lung transplant
4927400|NCT01963767|memory|memory
4927401|NCT01963767|cognition|cognition
4927402|NCT01963767|dietary supplements|dietary supplements
4927403|NCT01963754|Articaine 1:100.000|articaine 1:100.000
4927404|NCT01963754|Dental Implants|dental implants
4927405|NCT01963754|Posterior mandible|posterior mandible
4927406|NCT01963754|Loco-regional Anesthesia|loco-regional anesthesia
4927407|NCT01963754|Subperiosteal Anesthesia|subperiosteal anesthesia
4927408|NCT01963741|Leukotriene D4|leukotriene d4
4927409|NCT01963741|allergic rhinitis|allergic rhinitis
4927410|NCT01963741|nasal airway resistance|nasal airway resistance
4927411|NCT01963741|nasal provocation test|nasal provocation test
4927412|NCT01963741|nasal hyperreactivity|nasal hyperreactivity
4927413|NCT01963741|airway inflammation|airway inflammation
4927414|NCT01963741|asthma|asthma
4927415|NCT01963728|post-transplant|post-transplant
4927416|NCT01963728|diabetes mellitus|diabetes mellitus
4927417|NCT01963728|renal transplant|renal transplant
4927418|NCT01963728|kidney transplant|kidney transplant
4927419|NCT01963728|lung transplant|lung transplant
4927420|NCT01963728|heart transplant|heart transplant
4927421|NCT01963728|insulin|insulin
4927422|NCT01963715|IMGN289|imgn289
4927423|NCT01963715|Antibody Drug Conjugate|antibody drug conjugate
4927424|NCT01963715|antibody|antibody
4927425|NCT01963715|EGFR|egfr
4927426|NCT01963715|NSCLC|nsclc
4927427|NCT01963715|SCCHN|scchn
4927428|NCT01963715|Head and neck|head and neck
4927429|NCT01963715|Squamous cell carcinoma|squamous cell carcinoma
4927430|NCT01963715|Solid tumor|solid tumor
4927431|NCT01963715|Immunogen|immunogen
4927432|NCT01963715|Lung|lung
4927433|NCT01963715|Phase 1|phase 1
4927434|NCT01963702|predictive factor|predictive factor
4927435|NCT01963702|response|response
4927436|NCT01963702|gastric neoplasm|gastric neoplasm
4927437|NCT01963702|oxaliplatin|oxaliplatin
4927438|NCT01963702|docetaxol|docetaxol
4927439|NCT01963702|capecitabine|capecitabine
4927440|NCT01963689|Anxiety|anxiety
4927441|NCT01963689|Self-Esteem|self-esteem
4927442|NCT01963676|schizophrenia|schizophrenia
4927443|NCT01963676|auditory hallucinations|auditory hallucinations
4927444|NCT01963676|transcranial stimulation|transcranial stimulation
4927445|NCT01963676|tDCS|tdcs
4927446|NCT01963676|tACS|tacs
4927447|NCT01963663|YKL-40|ykl-40
4927448|NCT01963663|Chronic low grade inflammation|chronic low grade inflammation
4927449|NCT01963663|type 2 diabetes mellitus|type 2 diabetes mellitus
4927450|NCT01963663|metformin|metformin
4927451|NCT01963663|pioglitazone|pioglitazone
4927452|NCT01963637|obesity, sleeve gastrectomy, gastric bypass, gastric tomodensitometry, gastric pouch size, weight regain|obesity, sleeve gastrectomy, gastric bypass, gastric tomodensitometry, gastric pouch size, weight regain
4927453|NCT01963624|Breast|breast
4927454|NCT01963624|Screening|screening
4927455|NCT01963624|Ultrasound|ultrasound
4927456|NCT01963624|Elastography|elastography
4927457|NCT01963624|Doppler ultrasonography|doppler ultrasonography
4927458|NCT01963611|Multiple Sclerosis|multiple sclerosis
4927459|NCT01963611|Relapsing Remitting|relapsing remitting
4927460|NCT01963611|Plovamer acetate|plovamer acetate
4927461|NCT01963611|Copaxone|copaxone
4927462|NCT01963585|C reactive protein|c reactive protein
4927463|NCT01963585|Airway hyperreactivity|airway hyperreactivity
4927464|NCT01963585|Body mass index|body mass index
4927465|NCT01963572|Breast cancer|breast cancer
4927466|NCT01963572|Care model|care model
4927467|NCT01963572|Physical Therapy|physical therapy
4927468|NCT01963546|diabetic|diabetic
4927469|NCT01963546|laparoscopic gastric bypass surgery|laparoscopic gastric bypass surgery
4927470|NCT01963546|stress response|stress response
4927471|NCT01963546|anesthesia|anesthesia
4927472|NCT01963546|dexmedetomidine|dexmedetomidine
4927473|NCT01963533|lung cancer|lung cancer
4927474|NCT01963533|telomere length|telomere length
4927475|NCT01963533|comorbidity|comorbidity
4927476|NCT01963533|Eastern Cooperation Oncology Group (ECOG)|eastern cooperation oncology group (ecog)
4927477|NCT01963533|chemotherapy|chemotherapy
4927478|NCT01963520|Hip prosthesis infection|hip prosthesis infection
4927479|NCT01963520|Reinfection|reinfection
4927480|NCT01963520|Excision-synovectomy|excision-synovectomy
4927481|NCT01963520|One stage/two stage revision|one stage/two stage revision
4927482|NCT01963520|Antibiotherapy|antibiotherapy
4927483|NCT01963494|Physical activity|physical activity
4927484|NCT01963494|Health-behavior-change|health-behavior-change
4927485|NCT01963494|Dyadic Planning|dyadic planning
4927486|NCT01963494|Individual Planning|individual planning
4927487|NCT01963481|hormonal therapy|hormonal therapy
4927488|NCT01963481|immunotherapy|immunotherapy
4927489|NCT01963468|Hearing Loss|hearing loss
4927490|NCT01963468|Cochlear Implant|cochlear implant
4927491|NCT01963468|Deaf|deaf
4927492|NCT01963468|Hearing Impairment|hearing impairment
4927493|NCT01963468|Hard of Hearing|hard of hearing
4927494|NCT01963455|transplantation autologous stress urinary incontinence|transplantation autologous stress urinary incontinence
4927495|NCT01963455|muscle derived cells|muscle derived cells
4927496|NCT01963429|hepatocellular|hepatocellular
4927497|NCT01963429|Proton|proton
4927498|NCT01963429|RFA|rfa
4927499|NCT01963403|etonogestrel implant|etonogestrel implant
4927500|NCT01963403|birth control|birth control
4927501|NCT01963403|irregular bleeding|irregular bleeding
4927502|NCT01963403|heavy bleeding|heavy bleeding
4927503|NCT01963390|Hypogonadism|hypogonadism
4927504|NCT01963390|Testosterone Deficiency|testosterone deficiency
4927505|NCT01963377|bronchoscopy|bronchoscopy
4927506|NCT01963377|O2-supplementation|o2-supplementation
4927507|NCT01963364|fructans|fructans
4927508|NCT01963364|inulin|inulin
4927509|NCT01963364|oligofructose|oligofructose
4927510|NCT01963364|colonic fermentation|colonic fermentation
4927511|NCT01963364|microbiota|microbiota
4927512|NCT01963364|whoe gut transit|whoe gut transit
4927513|NCT01963351|NSCLC|nsclc
4927514|NCT01963351|Non-squamous|non-squamous
4927515|NCT01963286|ICD|icd
4927516|NCT01963286|CRT-D|crt-d
4927517|NCT01963286|Sudden cardiac death|sudden cardiac death
4927518|NCT01963286|Device settings|device settings
4927519|NCT01963286|Optimized programming strategy|optimized programming strategy
4927520|NCT01963221|elderly|elderly
4927521|NCT01963221|aorta|aorta
4927522|NCT01963221|inflammation|inflammation
4927523|NCT01963221|arterial stiffness|arterial stiffness
4927524|NCT01963221|PET/CT Imaging|pet/ct imaging
4927525|NCT01963221|hypertension|hypertension
4927526|NCT01963221|MRI|mri
4927527|NCT01963208|partial onset seizures|partial onset seizures
4927528|NCT01963208|complex partial seizures|complex partial seizures
4927529|NCT01963208|simple partial seizures|simple partial seizures
4927530|NCT01963208|anticonvulsant|anticonvulsant
4927531|NCT01963208|ganaxolone|ganaxolone
4927532|NCT01963208|neurosteroid|neurosteroid
4927533|NCT01963208|Marinus|marinus
4927534|NCT01963208|epilepsy|epilepsy
4927535|NCT01963195|Adverse Reaction to Drug|adverse reaction to drug
4927536|NCT01963195|Self Efficacy|self efficacy
4927537|NCT01963169|Bone Health|bone health
4927538|NCT01963169|Online intervention|online intervention
4927539|NCT01963169|Dissemination|dissemination
4927540|NCT01963169|Theory-based intervention|theory-based intervention
4927541|NCT01963156|Prescription synchronization|prescription synchronization
4927542|NCT01963156|Cardiovascular disease|cardiovascular disease
4927543|NCT01963156|Medication adherence|medication adherence
4927544|NCT01963156|Randomized controlled trial|randomized controlled trial
4927545|NCT01963156|Chronic disease|chronic disease
4927546|NCT01963156|Pharmacy benefit design|pharmacy benefit design
4927547|NCT01963156|Quality improvement|quality improvement
4927548|NCT01963130|Vildagliptin|vildagliptin
4927549|NCT01963130|Portal Vein Pressure|portal vein pressure
4927550|NCT01963130|Hepatosteatosis|hepatosteatosis
4927551|NCT01963104|hearing test, audiology, healthcare utilization,|hearing test, audiology, healthcare utilization,
4927552|NCT01963104|patient education, hearing screening|patient education, hearing screening
4927553|NCT01963065|Children's environmental health|children's environmental health
4927554|NCT01963065|preterm birth|preterm birth
4927555|NCT01963065|newborns|newborns
4927556|NCT01963065|bisphenol A|bisphenol a
4927557|NCT01963065|BPA|bpa
4927558|NCT01963065|phthalates|phthalates
4927559|NCT01963065|metals exposure|metals exposure
4927560|NCT01963065|very low birth weight|very low birth weight
4927561|NCT01963065|NICU|nicu
4927562|NCT01963052|Metastatic Urothelial Cancer|metastatic urothelial cancer
4927563|NCT01963052|AGS15E|ags15e
4927564|NCT01963052|AGS15E-13-1|ags15e-13-1
4927565|NCT01963052|ASG-15ME|asg-15me
4927566|NCT01963052|Pharmacokinetics of AGS15E|pharmacokinetics of ags15e
4927567|NCT01963026|spinal cord injury|spinal cord injury
4927568|NCT01963026|upper extremity|upper extremity
4927569|NCT01963026|skill performance|skill performance
4927570|NCT01963026|motor learning|motor learning
4927571|NCT01963013|Non-returning catheter valve|non-returning catheter valve
4927572|NCT01963013|Catheter associated urinary tract infection|catheter associated urinary tract infection
4927573|NCT01963013|Critically ill patients|critically ill patients
4927574|NCT01963013|Prevention|prevention
4927575|NCT01963000|Community Acquired Pneumonia|community acquired pneumonia
4927576|NCT01963000|Emergency Department|emergency department
4927577|NCT01963000|Standardized Care|standardized care
4927578|NCT01963000|Reduced Mortality|reduced mortality
4927579|NCT01963000|CRB-65 Risk Classes|crb-65 risk classes
4927580|NCT01963000|Antibiotic Therapy|antibiotic therapy
4927581|NCT01962974|Arthritis, Rheumatoid|arthritis, rheumatoid
4927582|NCT01962961|HIV|hiv
4927583|NCT01962961|Endothelial function|endothelial function
4927584|NCT01962961|Oxidative stress|oxidative stress
4927585|NCT01962961|Cardiovascular disease|cardiovascular disease
4927586|NCT01962961|N-acetylcysteine|n-acetylcysteine
4927587|NCT01962935|Healthy volunteer|healthy volunteer
4927588|NCT01962935|Multiple ascending dose|multiple ascending dose
4927589|NCT01962909|Pancreatic Resection|pancreatic resection
4927590|NCT01962883|Post Concussion Syndrome|post concussion syndrome
4927591|NCT01962883|Vestibular disturbance|vestibular disturbance
4927592|NCT01962883|Balance|balance
4927593|NCT01962883|Dizziness|dizziness
4927594|NCT01962883|Dizziness handicap inventory|dizziness handicap inventory
4927595|NCT01962883|Balance Error Scoring System|balance error scoring system
4927596|NCT01962857|Physical activity|physical activity
4927597|NCT01962857|Exercise|exercise
4927598|NCT01962857|Insulin resistance|insulin resistance
4927599|NCT01962857|High intensity interval training|high intensity interval training
4927600|NCT01962857|Fat oxidation|fat oxidation
4927601|NCT01962857|Fitness|fitness
4927602|NCT01962857|Lipids|lipids
4927603|NCT01962857|Blood pressure|blood pressure
4927604|NCT01962844|chronic coronary artery disease|chronic coronary artery disease
4927605|NCT01962844|coconut oil extra virgin|coconut oil extra virgin
4927606|NCT01962844|index of diet quality|index of diet quality
4927607|NCT01962844|nutritional treatment|nutritional treatment
4927608|NCT01962831|obesity|obesity
4927609|NCT01962831|labor, induced|labor, induced
4927610|NCT01962831|pregnancy|pregnancy
4927611|NCT01962831|cervical ripening|cervical ripening
4927612|NCT01962831|dinoprostone|dinoprostone
4927613|NCT01962818|Respiratory Distress Syndrome In Premature Infants|respiratory distress syndrome in premature infants
4927614|NCT01962818|Bronchopulmonary Dysplasia|bronchopulmonary dysplasia
4927615|NCT01962818|Ventilator-Induced Lung Injury|ventilator-induced lung injury
4927616|NCT01962818|Functional Residual Capacity|functional residual capacity
4927617|NCT01962818|Electric impedance tomography|electric impedance tomography
4927618|NCT01962792|PCI-32765|pci-32765
4927619|NCT01962792|Multiple Myeloma|multiple myeloma
4927620|NCT01962792|Relapsed Refractory Multiple Myeloma|relapsed refractory multiple myeloma
4927621|NCT01962792|Bruton's Tyrosine Kinase|bruton's tyrosine kinase
4927622|NCT01962792|Carfilzomib|carfilzomib
4927623|NCT01962792|Dexamethasone|dexamethasone
4927624|NCT01962792|Ibrutinib|ibrutinib
4927625|NCT01962779|Sleep Disordered Breathing|sleep disordered breathing
4927626|NCT01962779|Cognitively normal elderly|cognitively normal elderly
4927627|NCT01962779|Alzheimer's disease|alzheimer's disease
4927628|NCT01962779|Prevention|prevention
4927629|NCT01962779|Continuous positive airway pressure (CPAP)|continuous positive airway pressure (cpap)
4927630|NCT01962753|Affective symptoms as prodromal stage of Alzheimer|affective symptoms as prodromal stage of alzheimer
4927631|NCT01962727|scapular dyskinesis, kinematics, muscular activities|scapular dyskinesis, kinematics, muscular activities
4927632|NCT01962714|Behavior therapies, cognitive|behavior therapies, cognitive
4927633|NCT01962714|Mindfulness|mindfulness
4927634|NCT01962714|Emotion|emotion
4927635|NCT01962714|Group therapy|group therapy
4927636|NCT01962701|C-section|c-section
4927637|NCT01962688|Heart Failure|heart failure
4927638|NCT01962688|Handheld ultrasound|handheld ultrasound
4927639|NCT01962688|Inferior Vena Cava|inferior vena cava
4927640|NCT01962675|tDCS|tdcs
4927641|NCT01962675|motor training|motor training
4927642|NCT01962675|SCI|sci
4927643|NCT01962662|stroke|stroke
4927644|NCT01962662|transcranial magnetic stimulation|transcranial magnetic stimulation
4927645|NCT01962662|EMG biofeedback|emg biofeedback
4927646|NCT01962662|motor function|motor function
4927647|NCT01962662|neural plasticity|neural plasticity
4927648|NCT01962662|force|force
4927649|NCT01962649|Hepatocellular carcinoma|hepatocellular carcinoma
4927650|NCT01962636|Umbilical Cord Transplant|umbilical cord transplant
4927651|NCT01962636|Acute Myeloid Leukemia (AML)|acute myeloid leukemia (aml)
4927652|NCT01962636|Acute Lymphocytic Leukemia (ALL)|acute lymphocytic leukemia (all)
4927653|NCT01962636|Chronic Myelogenous Leukemia|chronic myelogenous leukemia
4927654|NCT01962636|Plasma Cell Leukemia|plasma cell leukemia
4927655|NCT01962636|Myelofibrosis|myelofibrosis
4927656|NCT01962636|Myelodysplasia|myelodysplasia
4927657|NCT01962636|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
4927658|NCT01962636|Small Lymphocytic Lymphoma|small lymphocytic lymphoma
4927659|NCT01962636|Marginal Zone B-Cell Lymphoma|marginal zone b-cell lymphoma
4927660|NCT01962636|Follicular Lymphoma|follicular lymphoma
4927661|NCT01962636|Lymphoplasmacytic Lymphoma|lymphoplasmacytic lymphoma
4927662|NCT01962636|Mantle-Cell Lymphoma|mantle-cell lymphoma
4927663|NCT01962636|Prolymphocytic Leukemia|prolymphocytic leukemia
4927664|NCT01962636|Large Cell Non-Hodgkin Lymphoma|large cell non-hodgkin lymphoma
4927665|NCT01962636|Lymphoblastic Lymphoma|lymphoblastic lymphoma
4927666|NCT01962636|Burkitt's Lymphoma|burkitt's lymphoma
4927667|NCT01962636|Non-Hodgkin Lymphoma|non-hodgkin lymphoma
4927668|NCT01962636|Multiple Myeloma|multiple myeloma
4927669|NCT01962623|Severe Mood Dysregulation|severe mood dysregulation
4927670|NCT01962623|Mood Disorders|mood disorders
4927671|NCT01962623|Irritability|irritability
4927672|NCT01962623|Disruptive Mood Dysregulation Disorder|disruptive mood dysregulation disorder
4927673|NCT01962623|Interpersonal Psychotherapy|interpersonal psychotherapy
4927674|NCT01962610|Pain care|pain care
4927675|NCT01962610|emergency|emergency
4927676|NCT01962610|clinical decision support|clinical decision support
4927677|NCT01962610|abdominal pain|abdominal pain
4927678|NCT01962597|hemodialysis|hemodialysis
4927679|NCT01962597|aerobic exercise|aerobic exercise
4927680|NCT01962597|resistance training|resistance training
4927681|NCT01962597|walking speed|walking speed
4927682|NCT01962597|randomized controlled trial|randomized controlled trial
4927683|NCT01962571|Optic neuritis|optic neuritis
4927684|NCT01962571|Multiple Sclerosis|multiple sclerosis
4927685|NCT01962571|Clinically isolated syndrome|clinically isolated syndrome
4927686|NCT01962571|Erythropoietin|erythropoietin
4927687|NCT01962558|Tinnitus|tinnitus
4927688|NCT01962558|Medical Device|medical device
4927689|NCT01962558|Randomized|randomized
4927690|NCT01962558|Vagus Nerve Stimulation|vagus nerve stimulation
4927691|NCT01962545|Atrial Fibrillation|atrial fibrillation
4927692|NCT01962545|Percutaneous coronary intervention|percutaneous coronary intervention
4927693|NCT01962545|Stent|stent
4927694|NCT01962545|Anticoagulant therapy|anticoagulant therapy
4927695|NCT01962545|Antiplatelet therapy|antiplatelet therapy
4927696|NCT01962545|Warfarin|warfarin
4927697|NCT01962545|NOAC|noac
4927698|NCT01962545|Aspirin|aspirin
4927699|NCT01962545|Clopidogrel|clopidogrel
4927700|NCT01962532|Neoplasms|neoplasms
4927701|NCT01962532|Lymphoma|lymphoma
4927702|NCT01962532|Advanced or refractory solid tumors|advanced or refractory solid tumors
4927703|NCT01962532|Advanced or refractory lymphoma|advanced or refractory lymphoma
4927704|NCT01962532|Gastric adenocarcinoma|gastric adenocarcinoma
4927705|NCT01962532|Gastroesophageal junctions|gastroesophageal junctions
4927706|NCT01962532|JNJ-42756493|jnj-42756493
4927707|NCT01962532|Pharmacokinetics|pharmacokinetics
4927708|NCT01962532|Japanese|japanese
4927709|NCT01962532|Asian|asian
4927710|NCT01962532|Pharmacodynamics|pharmacodynamics
4927711|NCT01962519|gastrectomy|gastrectomy
4927712|NCT01962519|gastric cancer|gastric cancer
4927713|NCT01962519|oral feeding|oral feeding
4927714|NCT01962519|complications|complications
4927715|NCT01962506|Chest pain|chest pain
4927716|NCT01962506|Copeptin|copeptin
4927717|NCT01962506|High-sensitivity cardiac troponin|high-sensitivity cardiac troponin
4927718|NCT01962506|Non-ST-Elevation (NSTE) - ACS|non-st-elevation (nste) - acs
4927719|NCT01962467|Allergic rhinitis|allergic rhinitis
4927720|NCT01962467|healthy volunteers|healthy volunteers
4927721|NCT01962467|fluticasone furoate|fluticasone furoate
4927722|NCT01962467|levocabastine|levocabastine
4927723|NCT01962467|fixed dose combination|fixed dose combination
4927724|NCT01962467|pharmacokinetics|pharmacokinetics
4927725|NCT01962454|muscle mass|muscle mass
4927726|NCT01962454|dynamic proteomics|dynamic proteomics
4927727|NCT01962454|Duke University|duke university
4927728|NCT01962454|Microbiopsy|microbiopsy
4927729|NCT01962454|D2O|d2o
4927730|NCT01962454|testosterone|testosterone
4927731|NCT01962454|skeletal muscle|skeletal muscle
4927732|NCT01962441|7977|7977
4927733|NCT01962441|GS-7977|gs-7977
4927734|NCT01962441|PSI-7977|psi-7977
4927735|NCT01962441|Sofosbuvir (SOF)|sofosbuvir (sof)
4927736|NCT01962441|Pegylated Interferon (Peg-IFN)|pegylated interferon (peg-ifn)
4927737|NCT01962441|Ribavirin (RBV)|ribavirin (rbv)
4927738|NCT01962428|ticagrelor|ticagrelor
4927739|NCT01962428|loading dose|loading dose
4927740|NCT01962428|non-ST-segment elevation acute coronary syndromes|non-st-segment elevation acute coronary syndromes
4927741|NCT01962428|percutaneous coronary intervention|percutaneous coronary intervention
4927742|NCT01962428|the antiplatelet effects|the antiplatelet effects
4927743|NCT01962428|bleeding events|bleeding events
4927744|NCT01962428|major adverse cardiac events|major adverse cardiac events
4927745|NCT01962415|Severe Combined Immune Deficiency (SCID)|severe combined immune deficiency (scid)
4927746|NCT01962415|Omenn Syndrome|omenn syndrome
4927747|NCT01962415|Bare Lymphocyte Syndrome (BLS)|bare lymphocyte syndrome (bls)
4927748|NCT01962415|Combined Immune Deficiency (CID) syndromes|combined immune deficiency (cid) syndromes
4927749|NCT01962415|Combined Variable Immune Deficiency (CVID) syndrome|combined variable immune deficiency (cvid) syndrome
4927750|NCT01962415|Wiskott-Aldrich Syndrome|wiskott-aldrich syndrome
4927751|NCT01962415|Leukocyte adhesion deficiency|leukocyte adhesion deficiency
4927752|NCT01962415|Chronic granulomatous disease (CGD)|chronic granulomatous disease (cgd)
4927753|NCT01962415|X-linked Hyper IgM (XHIM) syndrome|x-linked hyper igm (xhim) syndrome
4927754|NCT01962415|IPEX syndrome|ipex syndrome
4927755|NCT01962415|Chediak - Higashi Syndrome|chediak - higashi syndrome
4927756|NCT01962415|Autoimmune Lymphoproliferative Syndrome (ALPS)|autoimmune lymphoproliferative syndrome (alps)
4927757|NCT01962415|Hemophagocytic Lymphohistiocytosis (HLH) syndromes|hemophagocytic lymphohistiocytosis (hlh) syndromes
4927758|NCT01962415|Lymphocyte Signaling defects|lymphocyte signaling defects
4927759|NCT01962415|Dyskeratosis Congenita (DC)|dyskeratosis congenita (dc)
4927760|NCT01962415|Congenital Amegakaryocytic Thrombocytopenia (CAMT)|congenital amegakaryocytic thrombocytopenia (camt)
4927761|NCT01962415|Osteopetrosis|osteopetrosis
4927762|NCT01962415|Mucopolysaccharidoses|mucopolysaccharidoses
4927763|NCT01962415|Hurler syndrome (MPS I)|hurler syndrome (mps i)
4927764|NCT01962415|Hunter syndrome (MPS II)|hunter syndrome (mps ii)
4927765|NCT01962415|Sanfilippo syndrome (MPS II)|sanfilippo syndrome (mps ii)
4927766|NCT01962415|Leukodystrophies|leukodystrophies
4927767|NCT01962415|Krabbe Disease|krabbe disease
4927768|NCT01962415|Metachromatic leukodystrophy (MLD)|metachromatic leukodystrophy (mld)
4927769|NCT01962415|X-linked adrenoleukodystrophy (ALD)|x-linked adrenoleukodystrophy (ald)
4927770|NCT01962415|Alpha mannosidosis|alpha mannosidosis
4927771|NCT01962415|Gaucher Disease|gaucher disease
4927772|NCT01962415|Thalassemia major|thalassemia major
4927773|NCT01962415|Sickle cell disease (SCD)|sickle cell disease (scd)
4927774|NCT01962415|Diamond Blackfan Anemia (DBA)|diamond blackfan anemia (dba)
4927775|NCT01962415|Crohn's Disease|crohn's disease
4927776|NCT01962415|Inflammatory Bowel Disease|inflammatory bowel disease
4927777|NCT01962415|Hematopoietic Stem Cell Transplant (HSCT)|hematopoietic stem cell transplant (hsct)
4927778|NCT01962415|Congenital transfusion dependent anemias|congenital transfusion dependent anemias
4927779|NCT01962415|Globoid cell leukodystrophy|globoid cell leukodystrophy
4927780|NCT01962389|ISR, Laser, SFA, PAD|isr, laser, sfa, pad
4927781|NCT01962376|Capecitabine|capecitabine
4927782|NCT01962376|Oxaliplatin|oxaliplatin
4927783|NCT01962376|Bevacizumab|bevacizumab
4928271|NCT01959945|Prevention|prevention
4927784|NCT01962376|Potentially Resectable Gastric Cancer Liver Metastasis|potentially resectable gastric cancer liver metastasis
4927785|NCT01962363|Friedreich's ataxia point mutation|friedreich's ataxia point mutation
4927786|NCT01962350|Deep Brain Transcranial Magnetic Stimulation;|deep brain transcranial magnetic stimulation;
4927787|NCT01962350|H1-Coil deep brain rTMS;|h1-coil deep brain rtms;
4927788|NCT01962350|H1-Coil;|h1-coil;
4927789|NCT01962350|Bipolar Depression;|bipolar depression;
4927790|NCT01962350|Cognition.|cognition.
4927791|NCT01962324|Quality of Life|quality of life
4927792|NCT01962324|Radiotherapy|radiotherapy
4927793|NCT01962324|Radiotherapy, dose-escalation|radiotherapy, dose-escalation
4927794|NCT01962311|ALS|als
4927795|NCT01962311|Spinal Cerebrospinal Fluid|spinal cerebrospinal fluid
4927796|NCT01962311|Urine|urine
4927797|NCT01962311|SERUM|serum
4927798|NCT01962311|Diagnosis|diagnosis
4927799|NCT01962285|neuronal inertia|neuronal inertia
4927800|NCT01962285|loss of consciousness|loss of consciousness
4927801|NCT01962285|propofol pharmacodynamics|propofol pharmacodynamics
4927802|NCT01962285|Bispectral index|bispectral index
4927803|NCT01962285|anesthesia, general/pharmacology|anesthesia, general/pharmacology
4927805|NCT01962272|radiotherapy|radiotherapy
4927806|NCT01962272|chemotherapy|chemotherapy
4927807|NCT01962272|nutrition|nutrition
4927808|NCT01962272|dietary counseling|dietary counseling
4927809|NCT01962272|quality of life|quality of life
4927810|NCT01962246|Capecitabine|capecitabine
4927811|NCT01962246|Oxaliplatin|oxaliplatin
4927812|NCT01962246|Preoperative Concurrent Chemoradiotherapy|preoperative concurrent chemoradiotherapy
4927813|NCT01962246|Gastroesophageal Junction Adenocarcinoma|gastroesophageal junction adenocarcinoma
4927814|NCT01962220|HIV/AIDS|hiv/aids
4927815|NCT01962220|PMTCT|pmtct
4927816|NCT01962220|Pregnant Women|pregnant women
4927817|NCT01962220|Kenya|kenya
4927818|NCT01962220|Maternal Health|maternal health
4927819|NCT01962207|10 years Meningitec|10 years meningitec
4927820|NCT01962207|Safety|safety
4927821|NCT01962207|booster response|booster response
4927822|NCT01962207|Adolescents|adolescents
4927823|NCT01962207|Adults|adults
4927824|NCT01962207|Immunogenicity|immunogenicity
4927825|NCT01962207|Mencevax ACWY|mencevax acwy
4927826|NCT01962181|EEG Attention Deficit / Hyperactivity Disorder (ADHD) Ritalin machine learning|eeg attention deficit / hyperactivity disorder (adhd) ritalin machine learning
4927827|NCT01962168|Biliary Tract Neoplasms|biliary tract neoplasms
4927828|NCT01962168|Neoplasms|neoplasms
4927829|NCT01962168|Gastrointestinal Diseases|gastrointestinal diseases
4927830|NCT01962168|Digestive System Diseases|digestive system diseases
4927831|NCT01962168|Biliary Tract|biliary tract
4927832|NCT01962168|Stents|stents
4927833|NCT01962155|Fibrosis|fibrosis
4927834|NCT01962155|Liver Cirrhosis|liver cirrhosis
4927835|NCT01962155|non-invasive|non-invasive
4927836|NCT01962155|biopsy|biopsy
4927837|NCT01962155|hepatitis B virus|hepatitis b virus
4927838|NCT01962103|Neuroblastoma|neuroblastoma
4927839|NCT01962103|Rhabdomyosarcoma|rhabdomyosarcoma
4927840|NCT01962103|Soft Tissue|soft tissue
4927841|NCT01962103|Pediatric Oncology|pediatric oncology
4927842|NCT01962103|Abraxane|abraxane
4927843|NCT01962103|albumin-bound paclitaxel|albumin-bound paclitaxel
4927844|NCT01962103|nab-paclitaxel|nab-paclitaxel
4927845|NCT01962103|ABI-007|abi-007
4927846|NCT01962103|taxane|taxane
4927847|NCT01962103|solid tumors|solid tumors
4927848|NCT01962090|Neck Pain|neck pain
4927849|NCT01962090|Thoracic spine thrust manipulation|thoracic spine thrust manipulation
4927850|NCT01962090|Osteopathic Manipulation|osteopathic manipulation
4927851|NCT01962090|Dentistry|dentistry
4927852|NCT01962090|Range of Motion|range of motion
4927853|NCT01962077|pulpotomy|pulpotomy
4927854|NCT01962077|MTA|mta
4927855|NCT01962077|primary teeth|primary teeth
4927856|NCT01962077|formocresol|formocresol
4927857|NCT01962038|Mild Cognitive Impairment|mild cognitive impairment
4927858|NCT01962038|Aging|aging
4927859|NCT01962025|Renal failure|renal failure
4927860|NCT01962025|Hemodialysis|hemodialysis
4927861|NCT01962025|Canulation technique|canulation technique
4927862|NCT01962025|Training time|training time
4927863|NCT01962025|Cost|cost
4927864|NCT01962025|Patient discomfort with cannulation technique|patient discomfort with cannulation technique
4927865|NCT01962012|Orthodontic|orthodontic
4927866|NCT01962012|Orthodontic Treatment|orthodontic treatment
4927867|NCT01962012|Accelerated Tooth Movement|accelerated tooth movement
4927868|NCT01962012|Malocclusion|malocclusion
4927869|NCT01962012|Device|device
4927870|NCT01962012|AcceleDent Aura|acceledent aura
4927871|NCT01962012|Clear Aligners|clear aligners
4927872|NCT01961999|Acute kidney injury|acute kidney injury
4927873|NCT01961999|Cardiac surgery|cardiac surgery
4927874|NCT01961999|Renal replacement therapy|renal replacement therapy
4927875|NCT01961986|Rotator Cuff|rotator cuff
4927876|NCT01961986|Rotator Cuff Sparing|rotator cuff sparing
4927877|NCT01961986|Shoulder Replacement|shoulder replacement
4927878|NCT01961986|Total Shoulder Replacement|total shoulder replacement
4927879|NCT01961986|Total Shoulder Arthroplasty|total shoulder arthroplasty
4927880|NCT01961986|Arthritis|arthritis
4927881|NCT01961973|Articular cartilage|articular cartilage
4927882|NCT01961973|Chondrocytes|chondrocytes
4927885|NCT01961960|Prevention of seasonal influenza|prevention of seasonal influenza
4927886|NCT01961947|ASP7374|asp7374
4927887|NCT01961947|Approved egg-derived vaccine|approved egg-derived vaccine
4927888|NCT01961947|Prevention of seasonal influenza|prevention of seasonal influenza
4927889|NCT01961934|glioblastoma|glioblastoma
4927890|NCT01961934|high grade brain tumors|high grade brain tumors
4927891|NCT01961934|recurrent|recurrent
4927892|NCT01961934|pseudo-progression|pseudo-progression
4927893|NCT01961934|radionecrosis|radionecrosis
4927894|NCT01961934|carbon acetate|carbon acetate
4927895|NCT01961934|C11 aceate|c11 aceate
4927896|NCT01961934|PET|pet
4927897|NCT01961934|positron emission tomography|positron emission tomography
4927898|NCT01961921|RNAi therapeutic|rnai therapeutic
4927899|NCT01961895|Continuous lumbar plexus (LP) block analgesia|continuous lumbar plexus (lp) block analgesia
4927900|NCT01961882|OCV-501|ocv-501
4927901|NCT01961882|Acute Myeloid Leukemia|acute myeloid leukemia
4927902|NCT01961882|Antigen specific cancer immunotherapeutic|antigen specific cancer immunotherapeutic
4927903|NCT01961869|black raspberry|black raspberry
4927904|NCT01961869|chemoprevention|chemoprevention
4927905|NCT01961869|oral delivery|oral delivery
4927906|NCT01961856|platelet reactivity|platelet reactivity
4927907|NCT01961856|ticagrelor loading dose|ticagrelor loading dose
4927908|NCT01961856|clopidogrel loading dose|clopidogrel loading dose
4927909|NCT01961843|Castration Resistant|castration resistant
4927910|NCT01961817|Retromolar|retromolar
4927911|NCT01961817|Difficult Intubation|difficult intubation
4927912|NCT01961791|gastric cancer, staging system, prognosis|gastric cancer, staging system, prognosis
4927913|NCT01961765|Relapsed acute myeloid leukemia|relapsed acute myeloid leukemia
4927914|NCT01961765|Refractory acute myeloid leukemia|refractory acute myeloid leukemia
4927915|NCT01961752|bupivacaine,|bupivacaine,
4927916|NCT01961752|triamcinolone acetonide,|triamcinolone acetonide,
4927917|NCT01961752|endoscopic|endoscopic
4927918|NCT01961752|submucosal|submucosal
4927919|NCT01961752|dissection|dissection
4927920|NCT01961752|Patients|patients
4927921|NCT01961739|Hemorrhoids|hemorrhoids
4927922|NCT01961739|Lidocaine|lidocaine
4927923|NCT01961713|circulating tumor cells|circulating tumor cells
4927924|NCT01961713|CTC-Chip|ctc-chip
4927925|NCT01961661|intestinal inflammation|intestinal inflammation
4927926|NCT01961661|intestinal microflora|intestinal microflora
4927927|NCT01961661|children|children
4927928|NCT01961648|Apnea|apnea
4927929|NCT01961648|Sleep Apnea Disorder|sleep apnea disorder
4927930|NCT01961648|Respiratory chemical drive|respiratory chemical drive
4927931|NCT01961648|CO2|co2
4927932|NCT01961635|Dental Implants|dental implants
4927933|NCT01961635|Zirconia Abutments|zirconia abutments
4927934|NCT01961635|Titanium abutments|titanium abutments
4927935|NCT01961635|Acrylic abutments|acrylic abutments
4927936|NCT01961635|Gingival Healing|gingival healing
4927937|NCT01961635|Inflammation|inflammation
4927938|NCT01961635|Bone loss|bone loss
4927939|NCT01961622|Type 1 diabetes|type 1 diabetes
4927940|NCT01961622|Closed loop insulin delivery|closed loop insulin delivery
4927941|NCT01961622|Continuous subcutaneous glucose monitoring|continuous subcutaneous glucose monitoring
4927942|NCT01961622|Continuous subcutaneous insulin infusion|continuous subcutaneous insulin infusion
4927943|NCT01961609|Chronic plaque psoriasis|chronic plaque psoriasis
4927944|NCT01961596|Cooling ice spray|cooling ice spray
4927945|NCT01961596|Time to stability|time to stability
4927946|NCT01961596|Jump|jump
4927947|NCT01961570|Early stage hand osteoarthritis|early stage hand osteoarthritis
4927948|NCT01961570|Carpometacarpal osteoarthritis|carpometacarpal osteoarthritis
4927949|NCT01961557|EEG|eeg
4927950|NCT01961557|Cerebral Palsy|cerebral palsy
4927951|NCT01961557|Knee|knee
4927952|NCT01961544|Breast Cancer|breast cancer
4927953|NCT01961544|Metastatic|metastatic
4927954|NCT01961531|DCIS|dcis
4927955|NCT01961531|IDC|idc
4927956|NCT01961531|Invasive breast carcinoma|invasive breast carcinoma
4927957|NCT01961479|Premenstrual syndrome (PMS)|premenstrual syndrome (pms)
4927958|NCT01961479|Premenstrual Dysphoric Disorder (PMDD)|premenstrual dysphoric disorder (pmdd)
4927959|NCT01961479|Internet-based Therapy|internet-based therapy
4927960|NCT01961479|Cognitive Behavioural Therapy (CBT)|cognitive behavioural therapy (cbt)
4927961|NCT01961453|Hypertension|hypertension
4927962|NCT01961453|Isosorbide Mononitrate|isosorbide mononitrate
4927963|NCT01961453|Myocardial fibrosis|myocardial fibrosis
4927964|NCT01961427|dietary nitrate|dietary nitrate
4927965|NCT01961427|beetroot juice|beetroot juice
4927966|NCT01961427|exercise performance|exercise performance
4927967|NCT01961427|oxygen consumption|oxygen consumption
4927968|NCT01961414|Exudative|exudative
4927969|NCT01961414|AMD|amd
4927970|NCT01961414|Macular|macular
4927971|NCT01961414|Degeneration|degeneration
4927972|NCT01961414|Aflibercept|aflibercept
4927973|NCT01961414|Eylea|eylea
4927974|NCT01961414|Intravitreal|intravitreal
4927975|NCT01961401|exercise|exercise
4927976|NCT01961401|exercise therapy|exercise therapy
4927977|NCT01961401|insulin resistance|insulin resistance
4927978|NCT01961388|Type 2 Diabetes|type 2 diabetes
4927979|NCT01961362|Pulmonary fibrosis|pulmonary fibrosis
4927980|NCT01961362|Interstitial lung disease|interstitial lung disease
4928272|NCT01959932|Smoking|smoking
4927981|NCT01961362|Connective tissue disease|connective tissue disease
4927982|NCT01961362|Chronic hypersensitivity pneumonitis|chronic hypersensitivity pneumonitis
4927983|NCT01961362|Idiopathic pulmonary fibrosis|idiopathic pulmonary fibrosis
4927984|NCT01961362|Pulmonary fibrosis of any cause|pulmonary fibrosis of any cause
4927985|NCT01961362|Primary supporters/caregivers|primary supporters/caregivers
4927986|NCT01961349|sedation, propofol, gastrointestinal endoscopy|sedation, propofol, gastrointestinal endoscopy
4927987|NCT01961336|IVF, poor responder, testosterone|ivf, poor responder, testosterone
4927988|NCT01961323|Hypertension|hypertension
4927989|NCT01961323|high blood pressure|high blood pressure
4927990|NCT01961323|stress echocardiogram|stress echocardiogram
4927991|NCT01961323|nebivolol|nebivolol
4927992|NCT01961323|left ventricular diastolic dysfunction|left ventricular diastolic dysfunction
4927993|NCT01961310|bacterial translocation|bacterial translocation
4927994|NCT01961310|intestinal microbiota|intestinal microbiota
4927995|NCT01961297|dystonia|dystonia
4927996|NCT01961297|tremor|tremor
4927997|NCT01961297|treatment|treatment
4927998|NCT01961297|sodium oxybate|sodium oxybate
4927999|NCT01961297|brain activity|brain activity
4928000|NCT01961271|Norspan|norspan
4928001|NCT01961271|buprenorphine|buprenorphine
4928002|NCT01961271|transdermal|transdermal
4928003|NCT01961271|patch|patch
4928004|NCT01961271|chronic pain|chronic pain
4928005|NCT01961271|non-malignant|non-malignant
4928006|NCT01961271|osteoarthritis|osteoarthritis
4928007|NCT01961271|rheumatoid arthritis|rheumatoid arthritis
4928008|NCT01961271|lower back pain|lower back pain
4928009|NCT01961271|joint pain|joint pain
4928010|NCT01961271|muscle pain|muscle pain
4928011|NCT01961271|opioid|opioid
4928012|NCT01961271|analgesic|analgesic
4928013|NCT01961271|painkiller|painkiller
4928014|NCT01961271|Mundipharma|mundipharma
4928015|NCT01961258|Severe Asthma, Community, comorbidities, patient compliance,PFT, anti-IgE therapy|severe asthma, community, comorbidities, patient compliance,pft, anti-ige therapy
4928016|NCT01961232|Pulmonary Hypertension|pulmonary hypertension
4928017|NCT01961232|biomarker|biomarker
4928018|NCT01961232|cardiac|cardiac
4928019|NCT01961232|circulation|circulation
4928020|NCT01961232|heart disease|heart disease
4928021|NCT01961232|lung disease|lung disease
4928022|NCT01961193|critically ill patients|critically ill patients
4928023|NCT01961193|punctal plug|punctal plug
4928024|NCT01961193|corneal injuries|corneal injuries
4928025|NCT01961180|Quality of Life|quality of life
4928026|NCT01961180|Adrenal hyper activity|adrenal hyper activity
4928027|NCT01961180|Glucose metabolism|glucose metabolism
4928028|NCT01961154|Asthma|asthma
4928029|NCT01961154|medication reduction|medication reduction
4928030|NCT01961154|asthma exacerbation|asthma exacerbation
4928031|NCT01961141|Ultrasound Doppler|ultrasound doppler
4928032|NCT01961141|Pulmonary diseases|pulmonary diseases
4928033|NCT01961141|Cardiopulmonary conditions|cardiopulmonary conditions
4928034|NCT01961128|High risk|high risk
4928035|NCT01961102|postmenopausal bleeding|postmenopausal bleeding
4928036|NCT01961102|postmenopausal hyperplasia|postmenopausal hyperplasia
4928037|NCT01961102|endometrial cancer|endometrial cancer
4928038|NCT01961102|atypical hyperplasia|atypical hyperplasia
4928039|NCT01961102|curettage|curettage
4928040|NCT01961102|intraoperative rapid section|intraoperative rapid section
4928041|NCT01961050|alcohol|alcohol
4928042|NCT01961050|pregnancy|pregnancy
4928043|NCT01961050|fetal exposure|fetal exposure
4928044|NCT01961050|prevention|prevention
4928045|NCT01961050|FAS|fas
4928046|NCT01961050|Alcohol-Related Neurodevelopmental Disorder (ARND)|alcohol-related neurodevelopmental disorder (arnd)
4928047|NCT01961037|Accidental Falls|accidental falls
4928048|NCT01961037|Tai Chi|tai chi
4928049|NCT01961037|Older Adults|older adults
4928050|NCT01961037|Balance|balance
4928051|NCT01961037|Moving for Better Balance|moving for better balance
4928052|NCT01961037|Church|church
4928053|NCT01961037|Congregational Intervention|congregational intervention
4928054|NCT01961037|Rural|rural
4928055|NCT01961037|West Virginia|west virginia
4928056|NCT01961024|VLDL-TG kinetics|vldl-tg kinetics
4928057|NCT01961024|Postprandial state|postprandial state
4928058|NCT01961024|Obesity|obesity
4928059|NCT01961011|nerve compression, carpal tunnel, clinical decision making|nerve compression, carpal tunnel, clinical decision making
4928060|NCT01960998|radical prostatectomy|radical prostatectomy
4928061|NCT01960998|urinary incontinence|urinary incontinence
4928062|NCT01960998|prostate cancer|prostate cancer
4928063|NCT01960998|telehealth|telehealth
4928064|NCT01960998|pelvic floor muscle training|pelvic floor muscle training
4928065|NCT01960985|Balance, Postural|balance, postural
4928066|NCT01960985|Parkinson´s Disease|parkinson´s disease
4928067|NCT01960985|H&Y 1-3|h&y 1-3
4928068|NCT01960985|Exrecice|exrecice
4928069|NCT01960985|Postural adjustments|postural adjustments
4928070|NCT01960985|antecipatory postural|antecipatory postural
4928071|NCT01960985|compensatory postural adjustments|compensatory postural adjustments
4928072|NCT01960972|Blood pressure|blood pressure
4928073|NCT01960972|Hypertension|hypertension
4928074|NCT01960972|Stepped wedge trial design|stepped wedge trial design
4928075|NCT01960946|Hypertension|hypertension
4928076|NCT01960946|Galectin 3|galectin 3
4928077|NCT01960946|Fibrosis|fibrosis
4928078|NCT01960946|Vascular Stiffness|vascular stiffness
4928079|NCT01960946|Echocardiography|echocardiography
4928080|NCT01960933|STEMI|stemi
4928081|NCT01960933|MVD|mvd
4928082|NCT01960933|Full revascularization|full revascularization
4928083|NCT01960933|Culprit lesion revascularization only|culprit lesion revascularization only
4928084|NCT01960933|Primary PCI|primary pci
4928085|NCT01960920|Air Pollution|air pollution
4928086|NCT01960920|Heart Failure|heart failure
4928087|NCT01960920|Endothelium|endothelium
4928088|NCT01960920|Autonomic Dysfunction|autonomic dysfunction
4928089|NCT01960920|Cardiopulmonary Exercise Test|cardiopulmonary exercise test
4928090|NCT01960907|COPD|copd
4928091|NCT01960907|CHF|chf
4928092|NCT01960907|SDB|sdb
4928093|NCT01960881|Prostate cancer|prostate cancer
4928094|NCT01960855|anti-inflammatory agents|anti-inflammatory agents
4928095|NCT01960855|Joint Diseases|joint diseases
4928096|NCT01960855|Arthritis|arthritis
4928097|NCT01960855|Musculoskeletal Disease|musculoskeletal disease
4928098|NCT01960855|antirheumatic agents|antirheumatic agents
4928099|NCT01960842|levodopa|levodopa
4928100|NCT01960842|Advanced Parkinson's Disease|advanced parkinson's disease
4928101|NCT01960842|carbidopa|carbidopa
4928102|NCT01960842|levodopa-carbidopa intestinal gel|levodopa-carbidopa intestinal gel
4928103|NCT01960842|Safety and Efficacy|safety and efficacy
4928104|NCT01960829|melanoma|melanoma
4928105|NCT01960829|TOR Serine-Threonine Kinases|tor serine-threonine kinases
4928106|NCT01960816|nasal obstruction|nasal obstruction
4928107|NCT01960803|Stage I Breast Carcinoma|stage i breast carcinoma
4928108|NCT01960790|Humira®|humira®
4928109|NCT01960790|Behcet's Disease|behcet's disease
4928110|NCT01960790|Adalimumab|adalimumab
4928111|NCT01960777|Hernia, Inguinal|hernia, inguinal
4928112|NCT01960777|Laparoscopy|laparoscopy
4928113|NCT01960777|Onstep|onstep
4928114|NCT01960764|Autologous microbiome transplant|autologous microbiome transplant
4928115|NCT01960764|Bacteria transplant|bacteria transplant
4928116|NCT01960764|Treatment for atopic dermatitis|treatment for atopic dermatitis
4928117|NCT01960738|Diving|diving
4928118|NCT01960738|Water|water
4928119|NCT01960738|Recreation|recreation
4928120|NCT01960738|Precursor|precursor
4928121|NCT01960725|Gastroenteritis|gastroenteritis
4928122|NCT01960725|Diarrhea|diarrhea
4928123|NCT01960725|Rotavirus|rotavirus
4928124|NCT01960725|Vaccine|vaccine
4928125|NCT01960725|Dehydration|dehydration
4928126|NCT01960699|Prognosis|prognosis
4928127|NCT01960699|Neurological outcome|neurological outcome
4928128|NCT01960699|Resuscitation|resuscitation
4928129|NCT01960699|Biomarker|biomarker
4928130|NCT01960673|supraglottic airway,igel-LMA, ambu-LMA, changing position, head and neck position, oropharyngeal leak pressure,degree of rotation|supraglottic airway,igel-lma, ambu-lma, changing position, head and neck position, oropharyngeal leak pressure,degree of rotation
4928131|NCT01960660|Fish Oil|fish oil
4928132|NCT01960660|EPA|epa
4928133|NCT01960660|DHA|dha
4928134|NCT01960660|Omega-Score|omega-score
4928135|NCT01960660|Lipemic Index|lipemic index
4928136|NCT01960660|ethyl esters|ethyl esters
4928137|NCT01960660|triglycerides|triglycerides
4928138|NCT01960660|phospholipids|phospholipids
4928139|NCT01960595|PCA,Nerve block,Hullax Valgus|pca,nerve block,hullax valgus
4928140|NCT01960582|Housing adaptation|housing adaptation
4928141|NCT01960582|Independence|independence
4928142|NCT01960582|Costs|costs
4928143|NCT01960569|Thrombexx|thrombexx
4928144|NCT01960569|Topical r-Hirudin|topical r-hirudin
4928145|NCT01960569|Efficacy|efficacy
4928146|NCT01960569|haematoma|haematoma
4928147|NCT01960556|simulation|simulation
4928148|NCT01960543|Intrathecal anesthesia|intrathecal anesthesia
4928149|NCT01960543|Levobupivacaine|levobupivacaine
4928150|NCT01960543|Bupivacaine|bupivacaine
4928151|NCT01960543|Hip fracture|hip fracture
4928152|NCT01960517|Urinary|urinary
4928153|NCT01960517|Incontinence|incontinence
4928154|NCT01960517|Catheter|catheter
4928155|NCT01960504|DREAMS|dreams
4928156|NCT01960504|Drug Eluting Absorbable Metal Scaffold|drug eluting absorbable metal scaffold
4928157|NCT01960504|Scaffold|scaffold
4928158|NCT01960504|Coronary Artery Disease|coronary artery disease
4928159|NCT01960504|Myocardial Ischemia|myocardial ischemia
4928160|NCT01960504|Atherosclerosis|atherosclerosis
4928161|NCT01960465|CPAP treatment|cpap treatment
4928162|NCT01960465|hypertension|hypertension
4928163|NCT01960452|Insomnia|insomnia
4928164|NCT01960452|Primary insomnia|primary insomnia
4928165|NCT01960452|High density EEG|high density eeg
4928166|NCT01960452|Polysomnography|polysomnography
4928167|NCT01960452|Healthy sleeping controls|healthy sleeping controls
4928168|NCT01960439|disease activity|disease activity
4928169|NCT01960439|central reader|central reader
4928170|NCT01960439|endoscopic indices|endoscopic indices
4928171|NCT01960426|Harvey Bradshaw score|harvey bradshaw score
4928172|NCT01960426|Partial Mayo Clinical Score|partial mayo clinical score
4928173|NCT01960426|Infliximab|infliximab
4928174|NCT01960426|Adalimumab|adalimumab
4928175|NCT01960400|Complex regional pain syndrome type 1 (CRPS)|complex regional pain syndrome type 1 (crps)
4928176|NCT01960400|Transcranial direct current stimulation (tDCS)|transcranial direct current stimulation (tdcs)
4928462|NCT01958944|inhalation|inhalation
4928177|NCT01960400|Graded motor imagery (GMI)|graded motor imagery (gmi)
4928178|NCT01960400|Magnetic resonance imaging (MRI)|magnetic resonance imaging (mri)
4928179|NCT01960400|Functional magnetic resonance imaging (fMRI)|functional magnetic resonance imaging (fmri)
4928180|NCT01960387|AML|aml
4928181|NCT01960387|clofarabine|clofarabine
4928182|NCT01960387|cytarabine|cytarabine
4928183|NCT01960387|persistent AML|persistent aml
4928184|NCT01960387|induction therapy|induction therapy
4928185|NCT01960374|RAS or RAF oncogenes, Inhibition of MEK pathway, inhibition cancer cell proliferation promising anti-cancer therapeutic strategy.|ras or raf oncogenes, inhibition of mek pathway, inhibition cancer cell proliferation promising anti-cancer therapeutic strategy.
4928186|NCT01960348|RNAi therapeutic|rnai therapeutic
4928187|NCT01960348|FAP|fap
4928188|NCT01960348|Familial Amyloid Polyneuropathy|familial amyloid polyneuropathy
4928189|NCT01960348|TTR|ttr
4928190|NCT01960348|Transthyretin|transthyretin
4928191|NCT01960348|Amyloidosis|amyloidosis
4928192|NCT01960335|whey protein intake|whey protein intake
4928193|NCT01960335|obesity|obesity
4928194|NCT01960335|visceral fat|visceral fat
4928195|NCT01960335|resistance exercise training|resistance exercise training
4928196|NCT01960335|sprint interval training|sprint interval training
4928197|NCT01960335|endurance exercise training|endurance exercise training
4928198|NCT01960335|yoga training|yoga training
4928199|NCT01960335|healthy eating|healthy eating
4928200|NCT01960335|healthy lifestyle strategies|healthy lifestyle strategies
4928201|NCT01960335|leptin|leptin
4928202|NCT01960335|hunger|hunger
4928203|NCT01960322|adherence|adherence
4928204|NCT01960322|nonadherence|nonadherence
4928205|NCT01960322|compliance|compliance
4928206|NCT01960322|noncompliance|noncompliance
4928207|NCT01960322|liver transplantation|liver transplantation
4928208|NCT01960296|clopidogrel|clopidogrel
4928209|NCT01960296|general surgery|general surgery
4928210|NCT01960270|relapse after an initial clinical response|relapse after an initial clinical response
4928211|NCT01960257|tuberculosis|tuberculosis
4928212|NCT01960257|tuberculosis treatment|tuberculosis treatment
4928213|NCT01960257|wirelessly observed therapy|wirelessly observed therapy
4928214|NCT01960257|proteus digital health|proteus digital health
4928215|NCT01960257|digital health feedback system|digital health feedback system
4928216|NCT01960244|familial|familial
4928217|NCT01960244|hypercholesterolemia|hypercholesterolemia
4928218|NCT01960244|FH|fh
4928219|NCT01960218|acute decompensated heart failure|acute decompensated heart failure
4928220|NCT01960218|gas exchange|gas exchange
4928221|NCT01960218|cardiopulmonary|cardiopulmonary
4928222|NCT01960218|dyspnea|dyspnea
4928223|NCT01960218|cardiopulmonary analyzer|cardiopulmonary analyzer
4928224|NCT01960218|heart disease|heart disease
4928225|NCT01960218|cardiovascular disease|cardiovascular disease
4928226|NCT01960218|cardiopulmonary exercise|cardiopulmonary exercise
4928227|NCT01960205|Saxagliptin, prediabetes, glucose intolerance,obesity|saxagliptin, prediabetes, glucose intolerance,obesity
4928228|NCT01960192|primary CNS lymphoma;chemotherapy;|primary cns lymphoma;chemotherapy;
4928229|NCT01960192|RR;PFS;OS|rr;pfs;os
4928230|NCT01960153|Heart failure|heart failure
4928231|NCT01960153|Pulmonary hypertension|pulmonary hypertension
4928232|NCT01960153|tadalafil|tadalafil
4928233|NCT01960153|Phosphodiesterase Type 5 Inhibition|phosphodiesterase type 5 inhibition
4928234|NCT01960114|Acetaminophen|acetaminophen
4928235|NCT01960114|Paracetamol Analgesics|paracetamol analgesics
4928236|NCT01960114|Analgesics|analgesics
4928237|NCT01960114|Non-Narcotic Pain|non-narcotic pain
4928238|NCT01960114|Postoperative Pain|postoperative pain
4928239|NCT01960114|Antipyretics Dental Surgery|antipyretics dental surgery
4928240|NCT01960114|Third molar extraction|third molar extraction
4928241|NCT01960101|xerostomia|xerostomia
4928242|NCT01960101|Saliva|saliva
4928243|NCT01960101|iatrogenic oral dryness|iatrogenic oral dryness
4928244|NCT01960101|antidepressants|antidepressants
4928245|NCT01960101|mouth dryness|mouth dryness
4928246|NCT01960101|milk product|milk product
4928247|NCT01960088|Adolescent vaccines|adolescent vaccines
4928248|NCT01960088|HPV vaccine|hpv vaccine
4928249|NCT01960088|Pharmacies|pharmacies
4928250|NCT01960075|status epilepticus, refractory, benzodiazepine, fosphenytoin, levetiracetam, valproic acid|status epilepticus, refractory, benzodiazepine, fosphenytoin, levetiracetam, valproic acid
4928251|NCT01960062|diabetes|diabetes
4928252|NCT01960062|web-based|web-based
4928253|NCT01960062|software|software
4928254|NCT01960062|device|device
4928255|NCT01960049|Postoperative pain|postoperative pain
4928256|NCT01960049|Liver resection|liver resection
4928257|NCT01960049|Medial Open Transversus Abdominis Plane catheter|medial open transversus abdominis plane catheter
4928258|NCT01960036|Substance Use Disorders|substance use disorders
4928259|NCT01960036|Complementary Therapies|complementary therapies
4928260|NCT01960036|Women|women
4928261|NCT01960036|Mind-Body Therapies|mind-body therapies
4928262|NCT01960036|Behavior and Behavior Mechanisms|behavior and behavior mechanisms
4928263|NCT01960023|Colorectal cancer|colorectal cancer
4928264|NCT01960023|KRAS|kras
4928265|NCT01960023|BRAF|braf
4928266|NCT01960023|NRAS|nras
4928267|NCT01960023|PIK3CA|pik3ca
4928268|NCT01960023|NSABP|nsabp
4928269|NCT01959958|Nocturnal enuresis|nocturnal enuresis
4928270|NCT01959958|Barriers to treatment|barriers to treatment
4928273|NCT01959932|Candidate Modified Risk Tobacco Product|candidate modified risk tobacco product
4928274|NCT01959932|Conventional cigarettes|conventional cigarettes
4928275|NCT01959932|Reduced exposure|reduced exposure
4928276|NCT01959932|Confinement|confinement
4928277|NCT01959906|Esophagectomy|esophagectomy
4928278|NCT01959880|Breast Augmentation|breast augmentation
4928279|NCT01959880|Breast Reconstruction|breast reconstruction
4928280|NCT01959880|Breast Revision|breast revision
4928281|NCT01959880|Silicone Gel|silicone gel
4928282|NCT01959880|Contour Profile Gel|contour profile gel
4928283|NCT01959880|Siltex|siltex
4928284|NCT01959880|CPG Styles|cpg styles
4928285|NCT01959867|mastectomy|mastectomy
4928286|NCT01959867|breast reconstruction|breast reconstruction
4928287|NCT01959867|bovine|bovine
4928288|NCT01959867|ADM|adm
4928289|NCT01959867|breast cancer|breast cancer
4928290|NCT01959867|breast implants|breast implants
4928291|NCT01959867|breast expanders|breast expanders
4928292|NCT01959867|radiation therapy|radiation therapy
4928293|NCT01959828|pulmonary hypertension|pulmonary hypertension
4928294|NCT01959828|cardiac surgery|cardiac surgery
4928295|NCT01959828|Glenn surgery|glenn surgery
4928296|NCT01959828|fontan surgery|fontan surgery
4928297|NCT01959828|left ventricular assist device|left ventricular assist device
4928298|NCT01959828|LVAD|lvad
4928299|NCT01959802|Macular pseudohole|macular pseudohole
4928300|NCT01959802|Cone outer segment tips line|cone outer segment tips line
4928301|NCT01959789|Randomized Controlled Clinical Trial|randomized controlled clinical trial
4928302|NCT01959789|Tooth Bleaching|tooth bleaching
4928303|NCT01959776|cone outer segment tips line, foveal displacement|cone outer segment tips line, foveal displacement
4928304|NCT01959763|Metabolic syndrome|metabolic syndrome
4928305|NCT01959763|obesity|obesity
4928306|NCT01959763|overweight|overweight
4928307|NCT01959763|weight loss intervention|weight loss intervention
4928308|NCT01959763|cognitive behavioral therapy|cognitive behavioral therapy
4928309|NCT01959763|ICT intervention|ict intervention
4928310|NCT01959763|cardiovascular disease|cardiovascular disease
4928311|NCT01959763|persuasive systems design|persuasive systems design
4928312|NCT01959737|reactivity of HPA axis|reactivity of hpa axis
4928313|NCT01959724|Macular detachment|macular detachment
4928314|NCT01959724|Macular retinoschisis|macular retinoschisis
4928315|NCT01959724|Vitrectomy|vitrectomy
4928316|NCT01959711|Lateral transperitoneal laparoscopic adrenalectomy|lateral transperitoneal laparoscopic adrenalectomy
4928317|NCT01959711|Posterior retroperitoneoscopic adrenalectomy|posterior retroperitoneoscopic adrenalectomy
4928318|NCT01959646|Immune Function|immune function
4928319|NCT01959646|Aged Garlic Extract|aged garlic extract
4928320|NCT01959646|Supplementation|supplementation
4928321|NCT01959646|Inflammation|inflammation
4928322|NCT01959620|PTSD|ptsd
4928323|NCT01959607|Smoking|smoking
4928324|NCT01959607|Nicotine absorption|nicotine absorption
4928325|NCT01959607|Candidate modified risk tobacco product|candidate modified risk tobacco product
4928326|NCT01959607|Cigarettes|cigarettes
4928327|NCT01959607|Nicotine Replacement Therapy gum (NRT gum)|nicotine replacement therapy gum (nrt gum)
4928328|NCT01959594|multiple doses|multiple doses
4928329|NCT01959594|pharmacokinetics|pharmacokinetics
4928330|NCT01959594|safety|safety
4928331|NCT01959594|tolerability|tolerability
4928332|NCT01959594|healthy volunteers|healthy volunteers
4928333|NCT01959594|steady state|steady state
4928334|NCT01959594|cognitive impairment associated with schizophrenia|cognitive impairment associated with schizophrenia
4928335|NCT01959581|Wilmington Robotic Exoskeleton|wilmington robotic exoskeleton
4928336|NCT01959581|Reaching|reaching
4928337|NCT01959581|Upper extremity function|upper extremity function
4928338|NCT01959581|Preterm Infants|preterm infants
4928339|NCT01959581|Brain injury|brain injury
4928340|NCT01959581|Pediatrics|pediatrics
4928341|NCT01959581|Early Intervention|early intervention
4928342|NCT01959581|Arthrogryposis|arthrogryposis
4928343|NCT01959568|Retinal Detachment|retinal detachment
4928344|NCT01959568|Double Tamponade|double tamponade
4928345|NCT01959568|Perfluorocarbon liquids|perfluorocarbon liquids
4928346|NCT01959568|Vitrectomy|vitrectomy
4928347|NCT01959542|Prostate Cancer|prostate cancer
4928348|NCT01959516|COPD, early morning symptoms|copd, early morning symptoms
4928349|NCT01959503|Aorta|aorta
4928350|NCT01959503|Aortic|aortic
4928351|NCT01959503|Reconstruction|reconstruction
4928352|NCT01959503|CABG|cabg
4928353|NCT01959503|Bypass|bypass
4928354|NCT01959464|Assisted reproductive technology|assisted reproductive technology
4928355|NCT01959464|Infertility|infertility
4928356|NCT01959464|Progesterone|progesterone
4928357|NCT01959464|Vaginal gel|vaginal gel
4928358|NCT01959464|Luteal-phase support|luteal-phase support
4928359|NCT01959451|Prasugrel|prasugrel
4928360|NCT01959451|Clopidogrel|clopidogrel
4928361|NCT01959438|Phase I study for safety|phase i study for safety
4928362|NCT01959438|Later Phase II study for responses|later phase ii study for responses
4928363|NCT01959425|Anticoagulation|anticoagulation
4928364|NCT01959425|Oral|oral
4928365|NCT01959425|Paroxysmal atrial fibrillation|paroxysmal atrial fibrillation
4928366|NCT01959425|Patients post successful cardiac ablation|patients post successful cardiac ablation
4928367|NCT01959425|Symptomatic high-burden paroxysmal AF|symptomatic high-burden paroxysmal af
4928368|NCT01959425|3 months post procedure|3 months post procedure
4928369|NCT01959425|Remain free from AF recurrence|remain free from af recurrence
4928370|NCT01959412|wheezing, short of breath, laba, inhaler|wheezing, short of breath, laba, inhaler
4928371|NCT01959399|ASP015K|asp015k
4928372|NCT01959399|healthy subjects|healthy subjects
4928373|NCT01959360|Arthroplasty, Total Hip Replacement, Hip|arthroplasty, total hip replacement, hip
4928374|NCT01959360|Surgical Procedures, Operative|surgical procedures, operative
4928375|NCT01959360|Surgical Procedures, Minimally Invasive|surgical procedures, minimally invasive
4928376|NCT01959347|urinary incontinence|urinary incontinence
4928377|NCT01959347|midurethral sling|midurethral sling
4928378|NCT01959347|pelvic floor therapy|pelvic floor therapy
4928379|NCT01959334|Diabetes Mellitus|diabetes mellitus
4928380|NCT01959334|Hypoglycemia|hypoglycemia
4928381|NCT01959334|Glucagon|glucagon
4928382|NCT01959334|Anti-glucagon Antibody|anti-glucagon antibody
4928383|NCT01959334|Immunogenicity|immunogenicity
4928384|NCT01959308|Adherence|adherence
4928385|NCT01959308|Compliance|compliance
4928386|NCT01959308|Immunosuppressive Therapy|immunosuppressive therapy
4928387|NCT01959308|Liver Transplant|liver transplant
4928388|NCT01959308|Liver Recipients|liver recipients
4928389|NCT01959308|Adult|adult
4928390|NCT01959308|Adolescent|adolescent
4928391|NCT01959282|Colitis, Ulcerative|colitis, ulcerative
4928392|NCT01959282|JNJ-54781532|jnj-54781532
4928393|NCT01959282|Moderate|moderate
4928394|NCT01959282|Severe|severe
4928395|NCT01959282|Active|active
4928396|NCT01959256|Stroke|stroke
4928397|NCT01959256|Visual Field Defect|visual field defect
4928398|NCT01959256|Visual perceptual learning|visual perceptual learning
4928399|NCT01959256|Brain connectivity|brain connectivity
4928400|NCT01959243|Ocular redness|ocular redness
4928401|NCT01959230|Ocular redness|ocular redness
4928402|NCT01959217|HIV|hiv
4928403|NCT01959217|Substance Abuse|substance abuse
4928404|NCT01959217|Prospective Memory|prospective memory
4928405|NCT01959204|pharmacokinetics|pharmacokinetics
4928406|NCT01959204|safety|safety
4928407|NCT01959191|Platelet activity, CABG, off-pump surgery|platelet activity, cabg, off-pump surgery
4928408|NCT01959165|Ulcerative Colitis, Japanese, subcutaneously|ulcerative colitis, japanese, subcutaneously
4928409|NCT01959152|Cochlear Implant|cochlear implant
4928410|NCT01959152|HiRes™ 90K Advantage implant|hires™ 90k advantage implant
4928411|NCT01959152|Cochlear Implantation|cochlear implantation
4928412|NCT01959152|HiFocus™ Mid-Scala electrode|hifocus™ mid-scala electrode
4928413|NCT01959152|Listening Benefits|listening benefits
4928414|NCT01959152|Adults|adults
4928415|NCT01959152|Cochlear Implant Benefit|cochlear implant benefit
4928416|NCT01959152|HiRes Fidelity 120™|hires fidelity 120™
4928417|NCT01959152|Electrical Stimulation|electrical stimulation
4928418|NCT01959126|Telomerase|telomerase
4928419|NCT01959126|Telomere length|telomere length
4928420|NCT01959126|Psychological Sress|psychological sress
4928421|NCT01959126|Mindfulness|mindfulness
4928422|NCT01959113|Microbiome|microbiome
4928423|NCT01959113|Bacteria transplant|bacteria transplant
4928424|NCT01959113|Atopic dermatitis treatments|atopic dermatitis treatments
4928425|NCT01959100|hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
4928426|NCT01959100|pulmonary non-infectious complications|pulmonary non-infectious complications
4928427|NCT01959100|bronchiolitis obliterans syndrome|bronchiolitis obliterans syndrome
4928428|NCT01959087|Single port surgery|single port surgery
4928429|NCT01959087|Colonic surgery|colonic surgery
4928430|NCT01959087|Postoperative morbidity|postoperative morbidity
4928431|NCT01959087|Postoperative outcomes|postoperative outcomes
4928432|NCT01959061|Advanced colorectal cancer of liver metastatic|advanced colorectal cancer of liver metastatic
4928433|NCT01959048|Clostridium difficile associated disease|clostridium difficile associated disease
4928434|NCT01959048|fecal microbiota transplantation|fecal microbiota transplantation
4928435|NCT01959022|Posttramatic Stress Disorder|posttramatic stress disorder
4928436|NCT01959022|Post-traumatic Stress Disorder|post-traumatic stress disorder
4928437|NCT01959022|PTSD|ptsd
4928438|NCT01959022|Doxazosin|doxazosin
4928439|NCT01959022|Nightmares|nightmares
4928440|NCT01959022|Sleep Disturbance|sleep disturbance
4928441|NCT01959009|newborn, lung disease, mechanical ventilation, lung recruitment, high frequency ventilation|newborn, lung disease, mechanical ventilation, lung recruitment, high frequency ventilation
4928442|NCT01958983|dementia|dementia
4928443|NCT01958983|drumming|drumming
4928444|NCT01958983|emotion|emotion
4928445|NCT01958983|cognition|cognition
4928446|NCT01958983|functional MRI|functional mri
4928447|NCT01958970|End Stage Renal Disease|end stage renal disease
4928448|NCT01958970|ESRD|esrd
4928449|NCT01958970|Maintenance Hemodialysis|maintenance hemodialysis
4928450|NCT01958970|Hemodialysis|hemodialysis
4928451|NCT01958970|Dialysis|dialysis
4928452|NCT01958970|MHD|mhd
4928453|NCT01958970|Protein Energy Wasting|protein energy wasting
4928454|NCT01958970|PEW|pew
4928455|NCT01958957|ischemic stroke|ischemic stroke
4928456|NCT01958957|safety|safety
4928457|NCT01958957|Ginkgolides Meglumine Injection|ginkgolides meglumine injection
4928458|NCT01958944|CF|cf
4928459|NCT01958944|Cystic Fibrosis|cystic fibrosis
4928460|NCT01958944|NO|no
4928461|NCT01958944|nitric oxide|nitric oxide
4928463|NCT01958918|neovascular AMD|neovascular amd
4928464|NCT01958918|ranibizumab|ranibizumab
4928465|NCT01958918|aflibercept|aflibercept
4928466|NCT01958918|BCVA|bcva
4928467|NCT01958918|SD OCT|sd oct
4928468|NCT01958892|BPH|bph
4928469|NCT01958879|internal derangement,arthrocentesis,corticosteroid|internal derangement,arthrocentesis,corticosteroid
4928470|NCT01958866|Fever|fever
4928471|NCT01958866|Body temperature|body temperature
4928472|NCT01958853|Pain|pain
4928473|NCT01958840|Behavioral|behavioral
4928474|NCT01958840|Activation|activation
4928475|NCT01958840|Treatment|treatment
4928476|NCT01958827|Dose Escalation|dose escalation
4928477|NCT01958827|Crohn's Disease|crohn's disease
4928478|NCT01958801|Supraclavicular brachial plexus block|supraclavicular brachial plexus block
4928479|NCT01958801|Interscalene brachial plexus block|interscalene brachial plexus block
4928480|NCT01958801|Arthroscopic shoulder surgery|arthroscopic shoulder surgery
4928481|NCT01958788|Cognitive-behavioral treatment|cognitive-behavioral treatment
4928482|NCT01958788|Generalized anxiety disorder|generalized anxiety disorder
4928483|NCT01958788|Worry|worry
4928484|NCT01958788|Behavioral experiments|behavioral experiments
4928485|NCT01958788|Safety behaviors|safety behaviors
4928486|NCT01958788|Anxiety|anxiety
4928487|NCT01958775|Lipoproteins, apoB, GLP-2|lipoproteins, apob, glp-2
4928488|NCT01958762|Screening|screening
4928489|NCT01958762|Cancer|cancer
4928490|NCT01958762|Tobacco|tobacco
4928491|NCT01958762|General Practitioner|general practitioner
4928492|NCT01958762|Precancerous Lesion|precancerous lesion
4928493|NCT01958762|Dysplasia|dysplasia
4928494|NCT01958762|Tobacco vendor|tobacco vendor
4928495|NCT01958723|Problem Specific Template|problem specific template
4928496|NCT01958723|Physician Documentation|physician documentation
4928497|NCT01958723|Electronic Medical Record Documentation|electronic medical record documentation
4928498|NCT01958710|Catheterization, Bronchial|catheterization, bronchial
4928499|NCT01958710|Pneumonectomy|pneumonectomy
4928500|NCT01958710|Lobectomy|lobectomy
4928501|NCT01958710|Thoracoplasty|thoracoplasty
4928502|NCT01958697|Nutritional Disorders|nutritional disorders
4928503|NCT01958697|Feeding Behavior|feeding behavior
4928504|NCT01958684|Bleeding pattern|bleeding pattern
4928505|NCT01958684|LNG-IUS|lng-ius
4928506|NCT01958684|Cu-IUD|cu-iud
4928507|NCT01958684|postabortion|postabortion
4928508|NCT01958645|Phase 1, healthy male subjects, safety and tolerability, pharmacodynamic, pharmacokinetic|phase 1, healthy male subjects, safety and tolerability, pharmacodynamic, pharmacokinetic
4928509|NCT01958619|open label|open label
4928510|NCT01958619|healthy volunteers|healthy volunteers
4928511|NCT01958619|pharmacokinetic|pharmacokinetic
4928512|NCT01958619|parallel group|parallel group
4928513|NCT01958606|Stroke|stroke
4928514|NCT01958606|Rehabilitation|rehabilitation
4928515|NCT01958606|Exercise|exercise
4928516|NCT01958606|Intensity|intensity
4928517|NCT01958606|Gait|gait
4928518|NCT01958593|PTSD|ptsd
4928519|NCT01958593|Posttraumatic stress disorder|posttraumatic stress disorder
4928520|NCT01958593|MDMA|mdma
4928521|NCT01958593|psychotherapy|psychotherapy
4928522|NCT01958567|Scleritis|scleritis
4928523|NCT01958567|Episcleritis|episcleritis
4928524|NCT01958567|Optical coherence Tomography|optical coherence tomography
4928525|NCT01958541|Sleep|sleep
4928526|NCT01958541|Insomnia|insomnia
4928527|NCT01958541|Suicidal Symptoms|suicidal symptoms
4928528|NCT01958541|Suicidal Ideation|suicidal ideation
4928529|NCT01958541|Military Veteran|military veteran
4928530|NCT01958541|Service Member|service member
4928531|NCT01958541|Depression|depression
4928532|NCT01958515|Radiation Therapy|radiation therapy
4928533|NCT01958515|Chemotherapy|chemotherapy
4928534|NCT01958515|Chemoradiation Therapy|chemoradiation therapy
4928535|NCT01958502|nonunion|nonunion
4928536|NCT01958502|mesenchymal stem cell|mesenchymal stem cell
4928537|NCT01958502|scaffold|scaffold
4928538|NCT01958502|BMP2|bmp2
4928539|NCT01958502|long bone|long bone
4928540|NCT01958476|Neonatal Abstinence Syndrome|neonatal abstinence syndrome
4928541|NCT01958476|Opioids|opioids
4928542|NCT01958463|Clostridium Difficile Infection|clostridium difficile infection
4928543|NCT01958463|Fecal Microbiota Transplantation|fecal microbiota transplantation
4928544|NCT01958450|acne scar|acne scar
4928545|NCT01958450|Laser therapy|laser therapy
4928546|NCT01958450|wound healing|wound healing
4928547|NCT01958437|Aging|aging
4928548|NCT01958437|Alzheimer's Disease/Dementia|alzheimer's disease/dementia
4928549|NCT01958437|Cognitive Disorders|cognitive disorders
4928550|NCT01958437|Imaging|imaging
4928551|NCT01958437|Magnetic Resonance Imaging (MRI)|magnetic resonance imaging (mri)
4928552|NCT01958437|Neurology|neurology
4928553|NCT01958437|Physical Medicine & Rehabilitation|physical medicine & rehabilitation
4928554|NCT01958437|transcranial direct current stimulation|transcranial direct current stimulation
4928555|NCT01958424|metabolic syndrome|metabolic syndrome
4928556|NCT01958424|in vitro fertilization|in vitro fertilization
4928557|NCT01958424|c reactive protein|c reactive protein
4928558|NCT01958424|over-weight women|over-weight women
4928559|NCT01958424|ovarian stimulation|ovarian stimulation
4928560|NCT01958398|Randomized Controlled Trial|randomized controlled trial
4928561|NCT01958398|Alcohol|alcohol
4928562|NCT01958398|Internet|internet
4928563|NCT01958398|Mobile phone|mobile phone
4928564|NCT01958398|Screening|screening
4928565|NCT01958398|Brief intervention|brief intervention
4928566|NCT01958385|Total Body Weight Loss|total body weight loss
4928567|NCT01958359|Randomized Controlled Trial|randomized controlled trial
4928568|NCT01958359|Alcohol|alcohol
4928569|NCT01958359|Telephone|telephone
4928570|NCT01958359|Mobile phone|mobile phone
4928571|NCT01958359|Screening|screening
4928572|NCT01958359|Brief intervention|brief intervention
4928573|NCT01958359|IVR-based conversation menu with exercises and vignettes|ivr-based conversation menu with exercises and vignettes
4928574|NCT01958333|Health-Related Physical Fitness|health-related physical fitness
4928575|NCT01958333|Aerobic Endurance|aerobic endurance
4928576|NCT01958333|Muscular Endurance|muscular endurance
4928577|NCT01958333|Flexibility|flexibility
4928578|NCT01958320|patent ductus arteriosus|patent ductus arteriosus
4928579|NCT01958320|patent ductus arteriosus ligation|patent ductus arteriosus ligation
4928580|NCT01958320|necrotizing enterocolitis|necrotizing enterocolitis
4928581|NCT01958320|spontaneous intestinal perforation|spontaneous intestinal perforation
4928582|NCT01958255|tobacco quit rates|tobacco quit rates
4928583|NCT01958242|Cardiopulmonary bypass|cardiopulmonary bypass
4928584|NCT01958242|pediatric|pediatric
4928585|NCT01958242|blood products|blood products
4928586|NCT01958242|conservation|conservation
4928587|NCT01958216|TICE-human-stable isotopes|tice-human-stable isotopes
4928588|NCT01958190|Liver transplantation long term renal function|liver transplantation long term renal function
4928589|NCT01958190|tacrolimus sirolimus|tacrolimus sirolimus
4928590|NCT01958177|stem cell|stem cell
4928591|NCT01958177|cerebellar ataxia|cerebellar ataxia
4928592|NCT01958177|BMMNC|bmmnc
4928593|NCT01958151|colonoscopy|colonoscopy
4928594|NCT01958151|deep sedation|deep sedation
4928595|NCT01958151|anxiety|anxiety
4928596|NCT01958138|Laryngeal Mask Airway|laryngeal mask airway
4928597|NCT01958138|Propofol|propofol
4928598|NCT01958138|Isoflurane|isoflurane
4928599|NCT01958138|Pediatric patients|pediatric patients
4928600|NCT01958138|Emergence|emergence
4928601|NCT01958125|vagus nerve stimulation|vagus nerve stimulation
4928602|NCT01958125|vagal nerve stimulation|vagal nerve stimulation
4928603|NCT01958125|nVNS|nvns
4928604|NCT01958125|VNS|vns
4928605|NCT01958125|cluster headache|cluster headache
4928606|NCT01958125|non invasive|non invasive
4928607|NCT01958125|gammacore|gammacore
4928608|NCT01958112|Cervical Cancer|cervical cancer
4928609|NCT01958112|Cervical|cervical
4928610|NCT01958112|Cervix|cervix
4928611|NCT01958099|Injury Prevention|injury prevention
4928612|NCT01958086|Neural|neural
4928613|NCT01958086|Prosthetic|prosthetic
4928614|NCT01958086|brain machine interface|brain machine interface
4928615|NCT01958086|brain computer interface|brain computer interface
4928616|NCT01958086|brain control|brain control
4928617|NCT01958086|paralysis|paralysis
4928618|NCT01958086|tetraplegia|tetraplegia
4928619|NCT01958086|quadriplegia|quadriplegia
4928620|NCT01958086|spinal cord injury|spinal cord injury
4928621|NCT01958073|Recurrent Urinary Tract Infection|recurrent urinary tract infection
4928622|NCT01958073|Postmenopausal|postmenopausal
4928623|NCT01958073|Vaginal Estrogen|vaginal estrogen
4928624|NCT01958047|Phase I|phase i
4928625|NCT01958047|ASP3652|asp3652
4928626|NCT01958047|Single dose|single dose
4928627|NCT01958047|Dietary intake|dietary intake
4928628|NCT01958021|HR-positive|hr-positive
4928629|NCT01958021|HER2-negative|her2-negative
4928630|NCT01958021|Advanced breast cancer|advanced breast cancer
4928631|NCT01958021|LEE011|lee011
4928632|NCT01958021|Letrozole|letrozole
4928633|NCT01958021|CDK|cdk
4928634|NCT01958021|CDK4|cdk4
4928635|NCT01958021|CDK6|cdk6
4928636|NCT01958021|CDK4/6|cdk4/6
4928637|NCT01958021|Phase III|phase iii
4928638|NCT01958021|ER-positive|er-positive
4928639|NCT01958021|PR-positive|pr-positive
4928640|NCT01958021|Postmenopausal|postmenopausal
4928641|NCT01957943|Omega 3 lipid emulsions|omega 3 lipid emulsions
4928642|NCT01957943|Liver transplantation|liver transplantation
4928643|NCT01957943|Ischemia reperfusion injury|ischemia reperfusion injury
4928644|NCT01957943|graft function|graft function
4928645|NCT01957930|HbA1c|hba1c
4928646|NCT01957930|Iontophoresis|iontophoresis
4928647|NCT01957930|Intensified insulin treatment|intensified insulin treatment
4928648|NCT01957930|Ischemic foot ulcer|ischemic foot ulcer
4928649|NCT01957930|Type 1 diabetes|type 1 diabetes
4928650|NCT01957917|HIV|hiv
4928651|NCT01957917|Food Insecurity|food insecurity
4928652|NCT01957917|Antiretroviral Therapy|antiretroviral therapy
4928653|NCT01957904|ArterX, surgical sealant|arterx, surgical sealant
4928654|NCT01957891|Hypoxia|hypoxia
4928655|NCT01957891|Multiple wavelengths|multiple wavelengths
4928656|NCT01957865|HIV/AIDS|hiv/aids
4928657|NCT01957865|adherence|adherence
4928658|NCT01957865|real time monitoring|real time monitoring
4928659|NCT01957865|SMS|sms
4928660|NCT01957865|mHealth|mhealth
4928661|NCT01957865|social support|social support
4928662|NCT01957826|mesenchymal|mesenchymal
4928663|NCT01957826|stem cells|stem cells
4928664|NCT01957826|transendocardial injection|transendocardial injection
4928665|NCT01957826|dilated idiopathic cardiomyopathy|dilated idiopathic cardiomyopathy
4928666|NCT01957826|idiopathic cardiomyopathy|idiopathic cardiomyopathy
4928667|NCT01957813|APHIA AIDS, Population and Health Integrated Assistance|aphia aids, population and health integrated assistance
4928668|NCT01957813|DIC Drop-in center|dic drop-in center
4928669|NCT01957813|DMPA depot medroxyprogesterone acetate|dmpa depot medroxyprogesterone acetate
4928670|NCT01957813|DRH Division of Reproductive Health|drh division of reproductive health
4928671|NCT01957813|FAIR Family AIDS Initiative Response|fair family aids initiative response
4928672|NCT01957813|FHOK Family Health Options Kenya|fhok family health options kenya
4928673|NCT01957813|FP Family planning|fp family planning
4928674|NCT01957813|FGD Focus group discussion|fgd focus group discussion
4928675|NCT01957813|FSW Female sex worker|fsw female sex worker
4928676|NCT01957813|GSKenya Gold Star Kenya|gskenya gold star kenya
4928677|NCT01957813|HTC HIV testing and counseling|htc hiv testing and counseling
4928678|NCT01957813|HIV Human Immunodeficiency Virus|hiv human immunodeficiency virus
4928679|NCT01957813|KNASP Kenya National AIDS Strategic Plan|knasp kenya national aids strategic plan
4928680|NCT01957813|MARPS Most at-risk populations|marps most at-risk populations
4928681|NCT01957813|MoPHS Ministry of Public Health and Sanitation|mophs ministry of public health and sanitation
4928682|NCT01957813|MMS Ministry of Medical Services|mms ministry of medical services
4928683|NCT01957813|NASCOP National AIDS and STI Control Program|nascop national aids and sti control program
4928684|NCT01957813|RH Reproductive health|rh reproductive health
4928685|NCT01957813|SRH Sexual and reproductive health|srh sexual and reproductive health
4928686|NCT01957813|STI Sexually transmitted infection|sti sexually transmitted infection
4928687|NCT01957813|USAID United States Agency for International Development|usaid united states agency for international development
4928688|NCT01957800|weight loss|weight loss
4928689|NCT01957800|healthy diet|healthy diet
4928690|NCT01957800|website|website
4928691|NCT01957800|action planning|action planning
4928692|NCT01957800|phone|phone
4928693|NCT01957800|social|social
4928694|NCT01957787|Metastatic lung tumors|metastatic lung tumors
4928695|NCT01957787|Pulmonary metastatic disease|pulmonary metastatic disease
4928696|NCT01957748|Retention|retention
4928697|NCT01957748|Care|care
4928698|NCT01957748|Engagement|engagement
4928699|NCT01957735|metastatic cancer|metastatic cancer
4928700|NCT01957735|solid tumor|solid tumor
4928701|NCT01957735|unresectable tumor|unresectable tumor
4928702|NCT01957735|brain cancer|brain cancer
4928703|NCT01957735|lymphoma|lymphoma
4928704|NCT01957696|Diabetes mellitus|diabetes mellitus
4928705|NCT01957696|Pancreas transplantation|pancreas transplantation
4928706|NCT01957696|Rejection|rejection
4928707|NCT01957696|Surgical complications|surgical complications
4928708|NCT01957696|Allograft biopsies|allograft biopsies
4928709|NCT01957696|Immunological analyses|immunological analyses
4928710|NCT01957696|Pancreas graft survival|pancreas graft survival
4928711|NCT01957683|intracranial aneurysm|intracranial aneurysm
4928712|NCT01957683|bifurcation|bifurcation
4928713|NCT01957683|wide-neck|wide-neck
4928714|NCT01957683|saccular|saccular
4928715|NCT01957683|endovascular treatment|endovascular treatment
4928716|NCT01957683|coil embolization|coil embolization
4928717|NCT01957683|stent|stent
4928718|NCT01957683|bare platinum|bare platinum
4928719|NCT01957670|Keratoconjunctivitis Sicca|keratoconjunctivitis sicca
4928720|NCT01957670|Dry Eye Syndromes|dry eye syndromes
4928721|NCT01957631|Plantar Fasciitis|plantar fasciitis
4928722|NCT01957631|Steroid|steroid
4928723|NCT01957631|Platelet rich plasma|platelet rich plasma
4928724|NCT01957631|Injection|injection
4928725|NCT01957631|Ultrasound|ultrasound
4928726|NCT01957605|prone position|prone position
4928727|NCT01957605|hemodynamic variation|hemodynamic variation
4928728|NCT01957605|mean systemic pressure|mean systemic pressure
4928729|NCT01957579|Phase I|phase i
4928730|NCT01957579|advanced|advanced
4928731|NCT01957579|B cell malignancies|b cell malignancies
4928732|NCT01957579|dose escalation|dose escalation
4928733|NCT01957579|CD19|cd19
4928734|NCT01957579|Japanese|japanese
4928735|NCT01957566|propofol sedation|propofol sedation
4928736|NCT01957566|children|children
4928737|NCT01957566|procedure sedation|procedure sedation
4928738|NCT01957540|ticagrelor|ticagrelor
4928739|NCT01957540|prasugrel|prasugrel
4928740|NCT01957540|endothelial function|endothelial function
4928741|NCT01957527|ticagrelor|ticagrelor
4928742|NCT01957527|endothelial function|endothelial function
4928743|NCT01957527|peripheral arterial tonometry|peripheral arterial tonometry
4928744|NCT01957501|Major Depressive Disorder|major depressive disorder
4928745|NCT01957501|Bipolar Disorder|bipolar disorder
4928746|NCT01957501|Adolescents|adolescents
4928747|NCT01957501|Biomarker|biomarker
4928748|NCT01957436|prostate|prostate
4928749|NCT01957436|cancer|cancer
4928750|NCT01957436|metastatic hormone-naive|metastatic hormone-naive
4928751|NCT01957436|radiotherapy|radiotherapy
4928752|NCT01957436|abiraterone acetate|abiraterone acetate
4928753|NCT01957436|docetaxel|docetaxel
4928754|NCT01957423|Crohn's disease|crohn's disease
4928755|NCT01957423|whey protein|whey protein
4928756|NCT01957423|soy protein|soy protein
4928757|NCT01957423|nutritional status|nutritional status
4928953|NCT01956383|Zimbabwe|zimbabwe
4928758|NCT01957423|activity of disease|activity of disease
4928759|NCT01957410|Major Depressive Disorder|major depressive disorder
4928760|NCT01957410|Ketamine|ketamine
4928761|NCT01957410|Evoked potentials|evoked potentials
4928762|NCT01957410|Somatosensory evoked potentials|somatosensory evoked potentials
4928763|NCT01957410|Motor evoked potentials|motor evoked potentials
4928764|NCT01957410|Cortical plasticity|cortical plasticity
4928765|NCT01957371|PTSD|ptsd
4928766|NCT01957371|Yoga|yoga
4928767|NCT01957371|Complementary and Alternative Medicine (CAM)|complementary and alternative medicine (cam)
4928768|NCT01957371|Chronic Pain|chronic pain
4928769|NCT01957345|constitutional functional disorders of platelets|constitutional functional disorders of platelets
4928770|NCT01957345|platelet signalling defects|platelet signalling defects
4928771|NCT01957332|molecular imaging|molecular imaging
4928772|NCT01957332|HER2-PET|her2-pet
4928773|NCT01957332|89Zr-trastuzumab|89zr-trastuzumab
4928774|NCT01957332|FES-PET|fes-pet
4928775|NCT01957332|metastatic breast cancer|metastatic breast cancer
4928776|NCT01957332|clinical utility|clinical utility
4928777|NCT01957306|hot flashes, night sweats|hot flashes, night sweats
4928778|NCT01957280|HER3|her3
4928779|NCT01957267|Glaucoma|glaucoma
4928780|NCT01957267|Optical Coherence Tomography|optical coherence tomography
4928781|NCT01957267|Intraocular pressure|intraocular pressure
4928782|NCT01957267|Optic nervehead|optic nervehead
4928783|NCT01957267|Nerve fiber layer|nerve fiber layer
4928784|NCT01957202|levocabastine fixed dose combination, Rhinitis, Allergic, Perennial and Seasonal, Allergic Rhinitis, fluticasone furoate|levocabastine fixed dose combination, rhinitis, allergic, perennial and seasonal, allergic rhinitis, fluticasone furoate
4928785|NCT01957189|pharmacokinetics, Chinese|pharmacokinetics, chinese
4928786|NCT01957189|Avodart, Duodart, dutasteride, tamsulosin, drug-drug interaction,|avodart, duodart, dutasteride, tamsulosin, drug-drug interaction,
4928787|NCT01957176|myelodysplastic syndromes|myelodysplastic syndromes
4928788|NCT01957176|thrombocytopenia|thrombocytopenia
4928789|NCT01957176|acute myeloid leukemia|acute myeloid leukemia
4928790|NCT01957176|, idiopathic thrombocytopenic purpura|, idiopathic thrombocytopenic purpura
4928791|NCT01957176|Eltrombopag|eltrombopag
4928792|NCT01957176|pediatrics|pediatrics
4928793|NCT01957163|dry powder inhaler|dry powder inhaler
4928794|NCT01957163|fluticasone furoate/vilanterol|fluticasone furoate/vilanterol
4928795|NCT01957163|umeclidinium bromide|umeclidinium bromide
4928796|NCT01957163|safety|safety
4928797|NCT01957163|long acting beta2- receptor agonist|long acting beta2- receptor agonist
4928798|NCT01957163|long acting muscarininc receptor antagonist|long acting muscarininc receptor antagonist
4928799|NCT01957163|efficacy|efficacy
4928800|NCT01957163|COPD|copd
4928801|NCT01957163|inhaled corticosteroid|inhaled corticosteroid
4928802|NCT01957137|Urinary|urinary
4928803|NCT01957137|Urge|urge
4928804|NCT01957137|Incontinence|incontinence
4928805|NCT01957098|L-arabinose|l-arabinose
4928806|NCT01957098|D-xylose|d-xylose
4928807|NCT01957098|sucrose|sucrose
4928808|NCT01957098|glucose|glucose
4928809|NCT01957098|insulin|insulin
4928810|NCT01957098|C-peptide|c-peptide
4928811|NCT01957098|GLP-1|glp-1
4928812|NCT01957085|Hepatitis C|hepatitis c
4928813|NCT01957072|Cystic fibrosis|cystic fibrosis
4928814|NCT01957072|Nutrition|nutrition
4928815|NCT01957072|Weight|weight
4928816|NCT01957072|BMI|bmi
4928817|NCT01957072|Behaviour change|behaviour change
4928818|NCT01957059|DMD|dmd
4928819|NCT01957059|Duchenne muscular dystrophy|duchenne muscular dystrophy
4928820|NCT01957059|Duchenne|duchenne
4928821|NCT01957059|BMN053|bmn053
4928822|NCT01957059|BioMarin|biomarin
4928823|NCT01957046|Opioid induced constipation|opioid induced constipation
4928824|NCT01957046|Laxatives|laxatives
4928825|NCT01957033|whiplash|whiplash
4928826|NCT01957033|neck pain|neck pain
4928827|NCT01957033|manual therapy|manual therapy
4928828|NCT01957033|exercise|exercise
4928829|NCT01957033|dosage|dosage
4928830|NCT01957007|Phase 1|phase 1
4928831|NCT01957007|dose escalation|dose escalation
4928832|NCT01957007|histologically confirmed|histologically confirmed
4928833|NCT01957007|malignancy metastatic|malignancy metastatic
4928834|NCT01956994|Whey Protein|whey protein
4928835|NCT01956994|Arterial Stiffness|arterial stiffness
4928836|NCT01956994|Neurovascular Coupling|neurovascular coupling
4928837|NCT01956994|Cerebrovascular Reactivity|cerebrovascular reactivity
4928838|NCT01956994|Hemodynamics|hemodynamics
4928839|NCT01956994|Blood Flow|blood flow
4928840|NCT01956994|Pulsatility|pulsatility
4928841|NCT01956981|controlled hypotension, dexmedetomidine, magnesium sulfate.|controlled hypotension, dexmedetomidine, magnesium sulfate.
4928842|NCT01956968|Shoulder pain, Scapular dyskinesia, Physical examination|shoulder pain, scapular dyskinesia, physical examination
4928843|NCT01956942|GLAUCOMA|glaucoma
4928844|NCT01956942|MICROPULSE|micropulse
4928845|NCT01956942|LASER|laser
4928846|NCT01956942|TRABECULOPLASTY|trabeculoplasty
4928847|NCT01956942|OPEN ANGLE|open angle
4928848|NCT01956942|INTRAOCULAR PRESSURE|intraocular pressure
4928849|NCT01956929|Insulin Resistance|insulin resistance
4928850|NCT01956929|Prediabetic State|prediabetic state
4928851|NCT01956929|Metformin|metformin
4928852|NCT01956916|Pulmonary exacerbation|pulmonary exacerbation
4928853|NCT01956916|Inflammation|inflammation
4928854|NCT01956916|Intestinal microbiota|intestinal microbiota
4928855|NCT01956903|mesenchymal stem cell transplantation|mesenchymal stem cell transplantation
4928856|NCT01956890|Breast neoplasms|breast neoplasms
4928857|NCT01956890|PET|pet
4928858|NCT01956890|MRI|mri
4928859|NCT01956864|Vitamin D|vitamin d
4928860|NCT01956851|insulin, kisspeptin, GLP 1|insulin, kisspeptin, glp 1
4928861|NCT01956838|food intake|food intake
4928862|NCT01956838|tastants|tastants
4928863|NCT01956838|obesity|obesity
4928864|NCT01956825|non alcoholic fatty liver disease|non alcoholic fatty liver disease
4928865|NCT01956825|LCARNITINE amino acid|lcarnitine amino acid
4928866|NCT01956825|magnesium|magnesium
4928867|NCT01956825|fat content|fat content
4928868|NCT01956812|clivatuzumab tetraxetan|clivatuzumab tetraxetan
4928869|NCT01956812|90Y-clivatuzumab tetraxetan|90y-clivatuzumab tetraxetan
4928870|NCT01956812|IMMU-107|immu-107
4928871|NCT01956799|MDS|mds
4928872|NCT01956799|PMF|pmf
4928873|NCT01956799|CMML|cmml
4928874|NCT01956799|AA|aa
4928875|NCT01956786|Amlodipine|amlodipine
4928876|NCT01956786|Folic Acid|folic acid
4928877|NCT01956786|Homocysteine|homocysteine
4928878|NCT01956786|Blood Pressure|blood pressure
4928879|NCT01956773|family health history|family health history
4928880|NCT01956773|prevention|prevention
4928881|NCT01956773|genetic risk|genetic risk
4928882|NCT01956773|clinical decision support|clinical decision support
4928883|NCT01956760|Insomnia|insomnia
4928884|NCT01956734|glioblastoma|glioblastoma
4928885|NCT01956734|first recurrence|first recurrence
4928886|NCT01956734|temozolomide|temozolomide
4928887|NCT01956721|Heart Failure , Skeletal muscle,Calcium,Ryanodine Receptor, Mitochondria, Exercise training, Muscle biopsy, Healthy volunteers|heart failure , skeletal muscle,calcium,ryanodine receptor, mitochondria, exercise training, muscle biopsy, healthy volunteers
4928888|NCT01956669|VEGF|vegf
4928889|NCT01956669|Pazopanib|pazopanib
4928890|NCT01956669|Sarcoma|sarcoma
4928891|NCT01956669|GW786034|gw786034
4928892|NCT01956669|Refractory Solid Tumors|refractory solid tumors
4928893|NCT01956656|lotus leaf, mouthwash, gingivitis|lotus leaf, mouthwash, gingivitis
4928894|NCT01956643|sham feeding|sham feeding
4928895|NCT01956643|postoperative ileus|postoperative ileus
4928896|NCT01956643|liver transplantation|liver transplantation
4928897|NCT01956591|Treatment efficacy|treatment efficacy
4928898|NCT01956591|Long-term effects|long-term effects
4928899|NCT01956591|Tachyphylaxis|tachyphylaxis
4928900|NCT01956591|Undesirable effects|undesirable effects
4928901|NCT01956591|Side effects|side effects
4928902|NCT01956591|Self-assessment|self-assessment
4928903|NCT01956591|Hyperhidrosis|hyperhidrosis
4928904|NCT01956591|Quality of life|quality of life
4928905|NCT01956565|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
4928906|NCT01956565|Rehabilitation|rehabilitation
4928907|NCT01956565|Physiotherapy|physiotherapy
4928908|NCT01956565|Patient Compliance|patient compliance
4928909|NCT01956565|Inspiratory Muscle Training|inspiratory muscle training
4928910|NCT01956565|Respiratory Muscle Training|respiratory muscle training
4928911|NCT01956552|Metastatic breast cancer|metastatic breast cancer
4928912|NCT01956552|Tumor biopsy|tumor biopsy
4928913|NCT01956552|Phenotype and genotype characterization|phenotype and genotype characterization
4928914|NCT01956526|Heart Failure with Preserved Ejection Fraction (HFpEF)|heart failure with preserved ejection fraction (hfpef)
4928915|NCT01956526|Diastolic Heart Failure (DHF)|diastolic heart failure (dhf)
4928916|NCT01956526|Diastolic Dysfunction (DD)|diastolic dysfunction (dd)
4928918|NCT01956513|breast cancer|breast cancer
4928919|NCT01956513|complete pathological response|complete pathological response
4928920|NCT01956500|glucosamine|glucosamine
4928921|NCT01956500|inflammation|inflammation
4928922|NCT01956500|quality of life|quality of life
4928923|NCT01956500|physical function|physical function
4928924|NCT01956487|Bioequivalence|bioequivalence
4928925|NCT01956487|RYTHMOL SR®|rythmol sr®
4928926|NCT01956487|Atrial fibrillation|atrial fibrillation
4928927|NCT01956487|Propafenone|propafenone
4928928|NCT01956487|Pharmavokinetics|pharmavokinetics
4928929|NCT01956474|keratoconus|keratoconus
4928930|NCT01956474|cross-linking|cross-linking
4928931|NCT01956474|Post-LASIK ectasia|post-lasik ectasia
4928932|NCT01956474|Pellucid marginal degeneration|pellucid marginal degeneration
4928933|NCT01956474|Forme fruste pellucid marginal degeneration|forme fruste pellucid marginal degeneration
4928934|NCT01956474|FFKC|ffkc
4928935|NCT01956474|Radial Keratotomy|radial keratotomy
4928936|NCT01956474|Terrien's Marginal Degeneration|terrien's marginal degeneration
4928937|NCT01956461|osteoporosis|osteoporosis
4928938|NCT01956461|BMD|bmd
4928939|NCT01956461|teriparatide|teriparatide
4928940|NCT01956461|nursing home|nursing home
4928941|NCT01956448|Percutaneous coronary intervention|percutaneous coronary intervention
4928942|NCT01956448|DES|des
4928943|NCT01956448|Angina pectoris|angina pectoris
4928944|NCT01956448|Stent|stent
4928945|NCT01956409|breast neoplasms|breast neoplasms
4928946|NCT01956409|18F-FCH PET|18f-fch pet
4928947|NCT01956409|MRI|mri
4928948|NCT01956396|male circumcision|male circumcision
4928949|NCT01956396|HIV|hiv
4928950|NCT01956396|Zimbabwe|zimbabwe
4928951|NCT01956383|male circumcision|male circumcision
4928952|NCT01956383|HIV|hiv
4928954|NCT01956370|Male Circumcision|male circumcision
4928955|NCT01956370|HIV Prevention|hiv prevention
4928956|NCT01956370|Medical Device|medical device
4928957|NCT01956357|aquatic exercises;|aquatic exercises;
4928958|NCT01956357|deep water running;|deep water running;
4928959|NCT01956357|diabetes;|diabetes;
4928960|NCT01956357|blood glucose;|blood glucose;
4928961|NCT01956357|inflammation.|inflammation.
4928962|NCT01956344|Hoarding Disorder|hoarding disorder
4928963|NCT01956344|Clutter|clutter
4928964|NCT01956344|CBT|cbt
4928965|NCT01956344|Cognitive behavior therapy|cognitive behavior therapy
4928966|NCT01956344|fMRI|fmri
4928967|NCT01956344|Obsessive compulsive disorder (OCD)|obsessive compulsive disorder (ocd)
4928968|NCT01956344|Healthy control|healthy control
4928969|NCT01956331|NSC lung Cancer,Elderly patients,post operative,|nsc lung cancer,elderly patients,post operative,
4928970|NCT01956318|Chronic venous insufficiency|chronic venous insufficiency
4928971|NCT01956318|Varicose vein|varicose vein
4928972|NCT01956318|Crenobalneotherapy|crenobalneotherapy
4928973|NCT01956318|Balneotherapy|balneotherapy
4928974|NCT01956318|Spa therapy|spa therapy
4928975|NCT01956279|Pregnenolone|pregnenolone
4928976|NCT01956279|Gulf War Veteran|gulf war veteran
4928977|NCT01956279|Fatigue|fatigue
4928978|NCT01956279|Musculoskeletal Pain|musculoskeletal pain
4928979|NCT01956279|Cognitive Decline|cognitive decline
4928980|NCT01956279|Placebo Control|placebo control
4928981|NCT01956266|Prosody|prosody
4928982|NCT01956266|Communication|communication
4928983|NCT01956266|Dysarthria|dysarthria
4928984|NCT01956253|Bladder Cancer|bladder cancer
4928985|NCT01956253|Neratinib|neratinib
4928986|NCT01956253|13-2526|13-2526
4928987|NCT01956240|shoulder|shoulder
4928988|NCT01956240|pectoralis minor|pectoralis minor
4928989|NCT01956240|stretching|stretching
4928990|NCT01956240|scapular kinematics|scapular kinematics
4928991|NCT01956214|hemodialysis|hemodialysis
4928992|NCT01956214|exercise|exercise
4928993|NCT01956214|electrical stimulation|electrical stimulation
4928994|NCT01956175|electrical pharyngeal stimulation|electrical pharyngeal stimulation
4928995|NCT01956175|stroke-related dysphagia|stroke-related dysphagia
4928996|NCT01956175|tracheostomy|tracheostomy
4928997|NCT01956175|decannulation|decannulation
4928998|NCT01956149|gastric cancer|gastric cancer
4928999|NCT01956149|second-line treatment|second-line treatment
4929000|NCT01956149|Cabazitaxel|cabazitaxel
4929001|NCT01956149|response|response
4929002|NCT01956045|Intensive Care Units|intensive care units
4929003|NCT01956045|Judgment|judgment
4929004|NCT01956045|Disability Evaluation|disability evaluation
4929005|NCT01956045|Autonomy|autonomy
4929006|NCT01956032|LCIG|lcig
4929007|NCT01956032|Parkinson's disease|parkinson's disease
4929008|NCT01956032|levodopa carbidopa intestinal gel|levodopa carbidopa intestinal gel
4929009|NCT01956032|Telemedicine|telemedicine
4929010|NCT01955993|Obesity, adolescence,pharmacokinetics,fentanyl|obesity, adolescence,pharmacokinetics,fentanyl
4929011|NCT01955980|CRS|crs
4929012|NCT01955980|without polyposis|without polyposis
4929013|NCT01955967|Effect|effect
4929014|NCT01955967|Lidocaine|lidocaine
4929015|NCT01955954|carbon dioxide monitoring|carbon dioxide monitoring
4929016|NCT01955954|panic disorder|panic disorder
4929017|NCT01955954|biofeedback|biofeedback
4929018|NCT01955954|breathing training|breathing training
4929019|NCT01955954|Primary diagnosis|primary diagnosis
4929020|NCT01955954|panic attacks|panic attacks
4929021|NCT01955941|Uveal melanoma|uveal melanoma
4929022|NCT01955941|brachytherapy|brachytherapy
4929023|NCT01955941|radiation|radiation
4929024|NCT01955941|ciliary body|ciliary body
4929025|NCT01955941|choroid|choroid
4929026|NCT01955941|I-125 plaque brachytherapy|i-125 plaque brachytherapy
4929027|NCT01955915|choroid|choroid
4929028|NCT01955915|tumor|tumor
4929029|NCT01955915|OCT|oct
4929030|NCT01955915|malignant melanoma|malignant melanoma
4929031|NCT01955902|Opioid dependence|opioid dependence
4929032|NCT01955902|Buprenorphine|buprenorphine
4929033|NCT01955902|Adherence|adherence
4929034|NCT01955902|Substance use|substance use
4929035|NCT01955902|Suboxone|suboxone
4929036|NCT01955889|Exercise|exercise
4929037|NCT01955889|Rehabilitation|rehabilitation
4929038|NCT01955889|Telemedicine|telemedicine
4929039|NCT01955876|Fosrenol|fosrenol
4929040|NCT01955876|hyperphosphatemia|hyperphosphatemia
4929041|NCT01955876|chronic kidney disease not on dialysis|chronic kidney disease not on dialysis
4929042|NCT01955863|Prostatic Neoplasms|prostatic neoplasms
4929043|NCT01955863|Prostatectomy, Retropubic|prostatectomy, retropubic
4929044|NCT01955863|Patient Discharge|patient discharge
4929045|NCT01955824|bronchoscopy|bronchoscopy
4929046|NCT01955824|lignocaine|lignocaine
4929047|NCT01955824|cough|cough
4929048|NCT01955811|platelet transfusion|platelet transfusion
4929049|NCT01955811|Fibrinogen|fibrinogen
4929050|NCT01955811|blood coagulation|blood coagulation
4929051|NCT01955811|Thrombocytopenia|thrombocytopenia
4929052|NCT01955811|in-vitro experiments|in-vitro experiments
4929053|NCT01955811|FGTW|fgtw
4929054|NCT01955811|Fit2012|fit2012
4929055|NCT01955811|factor I|factor i
4929056|NCT01955811|Fibrin|fibrin
4929057|NCT01955798|Laparoscopy|laparoscopy
4929058|NCT01955798|Gyneacological|gyneacological
4929059|NCT01955798|Entry techniques|entry techniques
4929060|NCT01955785|Traumatic brain injury|traumatic brain injury
4929061|NCT01955785|Intracranial pressure|intracranial pressure
4929062|NCT01955785|Ventilation|ventilation
4929063|NCT01955785|Respiratory therapy|respiratory therapy
4929064|NCT01955772|Haematopoietic stem cell transplantation|haematopoietic stem cell transplantation
4929065|NCT01955772|Malignant hemopathy|malignant hemopathy
4929066|NCT01955772|Artificial nutrition|artificial nutrition
4929067|NCT01955694|BAY94-8862|bay94-8862
4929068|NCT01955694|MR antagonist|mr antagonist
4929069|NCT01955694|Heart failure|heart failure
4929070|NCT01955694|Japanese patients|japanese patients
4929071|NCT01955681|Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor retrement.|epidermal growth factor receptor tyrosine kinase inhibitor retrement.
4929072|NCT01955668|11q-deleted relapsed/refractory chronic lymphocytic leukaemia|11q-deleted relapsed/refractory chronic lymphocytic leukaemia
4929073|NCT01955668|Prolymphocytic leukaemia|prolymphocytic leukaemia
4929074|NCT01955668|B cell lymphomas|b cell lymphomas
4929075|NCT01955655|Baclofen|baclofen
4929076|NCT01955655|cerebral palsy|cerebral palsy
4929077|NCT01955655|colic|colic
4929078|NCT01955655|crying infant|crying infant
4929079|NCT01955655|recurrent crying spells|recurrent crying spells
4929080|NCT01955655|spasticity|spasticity
4929081|NCT01955655|therapy|therapy
4929082|NCT01955642|Clopidogrel|clopidogrel
4929083|NCT01955642|Brain Ischemia|brain ischemia
4929084|NCT01955642|Ischemic attack|ischemic attack
4929085|NCT01955642|Biological response to clopidogrel|biological response to clopidogrel
4929086|NCT01955616|Parkinson's disease, chronic constipation|parkinson's disease, chronic constipation
4929087|NCT01955590|Metacognitive therapy|metacognitive therapy
4929088|NCT01955590|Eye Movement Desensitization Reprocessing (EMDR)|eye movement desensitization reprocessing (emdr)
4929089|NCT01955590|Cognitive therapy|cognitive therapy
4929090|NCT01955577|Vitamin D deficiency|vitamin d deficiency
4929091|NCT01955577|Ring fixator|ring fixator
4929092|NCT01955577|Tibial fracture|tibial fracture
4929093|NCT01955525|Acute coronary syndrome|acute coronary syndrome
4929094|NCT01955525|health related quality of life|health related quality of life
4929095|NCT01955525|mortality|mortality
4929096|NCT01955486|flight simulation|flight simulation
4929097|NCT01955486|middle ear|middle ear
4929098|NCT01955486|Eustachian tube function|eustachian tube function
4929099|NCT01955473|Solid tumors|solid tumors
4929100|NCT01955473|Sym004|sym004
4929101|NCT01955473|Phase 1|phase 1
4929102|NCT01955460|Melanoma|melanoma
4929103|NCT01955460|Metastatic|metastatic
4929104|NCT01955460|T-cells|t-cells
4929105|NCT01955460|Autologous tumor infiltrating lymphocytes|autologous tumor infiltrating lymphocytes
4929106|NCT01955460|TIL|til
4929107|NCT01955460|DNRII|dnrii
4929108|NCT01955460|NGFR|ngfr
4929109|NCT01955460|Cyclophosphamide|cyclophosphamide
4929110|NCT01955460|Cytoxan|cytoxan
4929111|NCT01955460|Neosar|neosar
4929112|NCT01955460|Mesna|mesna
4929113|NCT01955460|Mesnex|mesnex
4929114|NCT01955460|Fludarabine|fludarabine
4929115|NCT01955460|Fludarabine phosphate|fludarabine phosphate
4929116|NCT01955460|Fludara|fludara
4929117|NCT01955460|Interleukin-2|interleukin-2
4929118|NCT01955460|IL-2|il-2
4929119|NCT01955460|Aldesleukin|aldesleukin
4929120|NCT01955460|Proleukin|proleukin
4929121|NCT01955447|Blood glucose|blood glucose
4929122|NCT01955421|NSCLC|nsclc
4929123|NCT01955421|stage IIIB|stage iiib
4929124|NCT01955421|stage IV)|stage iv)
4929125|NCT01955421|confirmed by histology or cytology methods|confirmed by histology or cytology methods
4929126|NCT01955421|Harboring a PCR-confirmed activating mutation of EGFR, including an exon 19 deletion or an exon 21 L858R point mutation|harboring a pcr-confirmed activating mutation of egfr, including an exon 19 deletion or an exon 21 l858r point mutation
4929127|NCT01955408|overactive bladder|overactive bladder
4929128|NCT01955408|bladder cancer|bladder cancer
4929129|NCT01955408|Synergo|synergo
4929130|NCT01955408|urodynamic study|urodynamic study
4929131|NCT01955395|Relaxation Response Resiliency Program (3RP)|relaxation response resiliency program (3rp)
4929132|NCT01955395|monoclonal gammopathy of undetermined significance|monoclonal gammopathy of undetermined significance
4929133|NCT01955395|smoldering multiple myeloma|smoldering multiple myeloma
4929134|NCT01955382|Parasite Clearance Rate|parasite clearance rate
4929135|NCT01955382|Parasite Half Life|parasite half life
4929136|NCT01955382|Actidose Aqua|actidose aqua
4929137|NCT01955382|Severe Malaria|severe malaria
4929138|NCT01955369|incidence|incidence
4929139|NCT01955369|phenotype|phenotype
4929140|NCT01955369|mortality|mortality
4929141|NCT01955356|Scratching|scratching
4929142|NCT01955356|Endometrial biopsy|endometrial biopsy
4929143|NCT01955356|Ongoing embryo implantation|ongoing embryo implantation
4929144|NCT01955356|Assisted reproductive techniques|assisted reproductive techniques
4929145|NCT01955343|Immune response|immune response
4929146|NCT01955343|Cancer|cancer
4929147|NCT01955330|CABG, Hybrid, Robotic surgery|cabg, hybrid, robotic surgery
4929148|NCT01955317|Neonate|neonate
4929149|NCT01955317|Bangladesh|bangladesh
4929150|NCT01955317|Health behavior|health behavior
4929151|NCT01955317|Handwashing|handwashing
4929152|NCT01955317|Developing countries|developing countries
4929153|NCT01955317|Infectious disease|infectious disease
4929154|NCT01955291|Virtual Reality, Motor Learning, Rehabilitation, Upper Limb|virtual reality, motor learning, rehabilitation, upper limb
4929155|NCT01955278|Laparoscopic colorectal surgery|laparoscopic colorectal surgery
4929156|NCT01955278|Parastomal hernia|parastomal hernia
4929157|NCT01955278|Prophylactic|prophylactic
4929158|NCT01955278|Mesh|mesh
4929159|NCT01955265|Positive youth development|positive youth development
4929282|NCT01954797|MRI|mri
4929160|NCT01955265|Sports / physical activity|sports / physical activity
4929161|NCT01955252|Endemic treponematoses|endemic treponematoses
4929162|NCT01955252|Azithromycin|azithromycin
4929163|NCT01955252|Mass drug administration|mass drug administration
4929164|NCT01955252|Eradication|eradication
4929165|NCT01955239|Head and Neck Cancer|head and neck cancer
4929166|NCT01955239|Radiotherapy|radiotherapy
4929167|NCT01955239|IMRT|imrt
4929168|NCT01955239|Stem cell|stem cell
4929169|NCT01955239|Parotid gland|parotid gland
4929170|NCT01955213|constipation, methylnaltrexone, opoid|constipation, methylnaltrexone, opoid
4929171|NCT01955200|Stent implantation|stent implantation
4929172|NCT01955200|Clopidogrel low response|clopidogrel low response
4929173|NCT01955200|Ticagrelor|ticagrelor
4929174|NCT01955200|Cilostazol|cilostazol
4929175|NCT01955200|Clopidogrel|clopidogrel
4929176|NCT01955187|SEQUENTIAL THERAPY|sequential therapy
4929177|NCT01955187|PRIMARY MEMBRANOUS NEPHROPATHY|primary membranous nephropathy
4929178|NCT01955187|TACROLIMUS|tacrolimus
4929179|NCT01955187|RITUXIMAB|rituximab
4929180|NCT01955174|Botulinum toxin|botulinum toxin
4929181|NCT01955174|Esophageal motility disorder|esophageal motility disorder
4929182|NCT01955174|Distal esophageal spasm|distal esophageal spasm
4929183|NCT01955148|PTB|ptb
4929184|NCT01955148|sPTB|sptb
4929185|NCT01955148|cervical cerclage|cervical cerclage
4929186|NCT01955148|LEEP|leep
4929187|NCT01955148|PROM|prom
4929188|NCT01955148|short cervix|short cervix
4929189|NCT01955135|Prematurity, Retinopathy, propofol, ketamine, sedation|prematurity, retinopathy, propofol, ketamine, sedation
4929190|NCT01955122|polyp/adenoma miss rate|polyp/adenoma miss rate
4929191|NCT01955122|colonoscopy add-on device|colonoscopy add-on device
4929192|NCT01955122|enhanced screening|enhanced screening
4929193|NCT01955109|Food allergy|food allergy
4929194|NCT01955109|Immediate hypersensitivity|immediate hypersensitivity
4929195|NCT01955109|Whole peanut extract|whole peanut extract
4929196|NCT01955109|Allergenic product|allergenic product
4929197|NCT01955109|Specific Immunotherapy|specific immunotherapy
4929198|NCT01955109|Epicutaneous Immunotherapy (EPIT)|epicutaneous immunotherapy (epit)
4929199|NCT01955096|fast-track surgery, laparoscopic gastrectomy|fast-track surgery, laparoscopic gastrectomy
4929200|NCT01955083|Obstructive sleep apnea|obstructive sleep apnea
4929201|NCT01955083|snoring|snoring
4929202|NCT01955083|radiofrequency|radiofrequency
4929203|NCT01955083|pillar implant|pillar implant
4929204|NCT01955083|snore sound analysis|snore sound analysis
4929205|NCT01955070|Informed consent|informed consent
4929206|NCT01955070|Ethics|ethics
4929207|NCT01955044|neonatal prematurity|neonatal prematurity
4929208|NCT01955044|infant, extremely low birth weight|infant, extremely low birth weight
4929209|NCT01955044|fatty acids, polyunsaturated|fatty acids, polyunsaturated
4929210|NCT01955031|Telemedicine|telemedicine
4929211|NCT01955031|Telemonitoring|telemonitoring
4929212|NCT01955031|Education|education
4929213|NCT01955031|Nutrition|nutrition
4929214|NCT01955031|Food behaviour|food behaviour
4929215|NCT01955031|Weight|weight
4929216|NCT01955031|Physical activity|physical activity
4929217|NCT01955031|Glycaemia|glycaemia
4929218|NCT01955031|Self-monitoring blood glucose|self-monitoring blood glucose
4929219|NCT01955018|computed tomography|computed tomography
4929220|NCT01955018|radiation|radiation
4929221|NCT01955018|screening|screening
4929222|NCT01955018|asbestos|asbestos
4929223|NCT01955018|workers|workers
4929224|NCT01955018|cancer|cancer
4929225|NCT01955005|Health Records, Personal|health records, personal
4929226|NCT01955005|Delivery of healthcare|delivery of healthcare
4929227|NCT01955005|Consumer Participation|consumer participation
4929228|NCT01955005|Internet|internet
4929229|NCT01954992|glufosfamide|glufosfamide
4929230|NCT01954992|5-FU|5-fu
4929231|NCT01954992|metastatic pancreatic adenocarcinoma|metastatic pancreatic adenocarcinoma
4929232|NCT01954979|Graft versus Host Disease|graft versus host disease
4929233|NCT01954979|ABATACEPT|abatacept
4929234|NCT01954966|Nicotine|nicotine
4929235|NCT01954966|Smoking|smoking
4929236|NCT01954953|Retinitis Pigmentosa Syndromic|retinitis pigmentosa syndromic
4929237|NCT01954953|Congenital Deafness|congenital deafness
4929238|NCT01954953|Usher Syndrome Retinitis Pigmentosa and Deafness|usher syndrome retinitis pigmentosa and deafness
4929239|NCT01954953|Progressive Hearing Loss|progressive hearing loss
4929240|NCT01954953|Retinitis Pigmentosa|retinitis pigmentosa
4929241|NCT01954940|Whole body vibration therapy, muscle strength testing, bone health, ambulatory, endurance.|whole body vibration therapy, muscle strength testing, bone health, ambulatory, endurance.
4929242|NCT01954927|Pain control|pain control
4929243|NCT01954914|Plerixafor|plerixafor
4929244|NCT01954914|donor|donor
4929245|NCT01954914|allogeneic peripheral stam cell donation|allogeneic peripheral stam cell donation
4929246|NCT01954914|PBSC|pbsc
4929247|NCT01954914|poor donors|poor donors
4929248|NCT01954875|neurodegenerative diseases|neurodegenerative diseases
4929249|NCT01954875|amyotrophic lateral sclerosis|amyotrophic lateral sclerosis
4929250|NCT01954875|multiple sclerosis|multiple sclerosis
4929251|NCT01954875|Parkinson's Disease|parkinson's disease
4929252|NCT01954862|Water-aided colonoscopy|water-aided colonoscopy
4929253|NCT01954862|Water Immersion colonoscopy|water immersion colonoscopy
4929254|NCT01954862|Water Exchange colonoscopy|water exchange colonoscopy
4929255|NCT01954862|Carbon-dioxide colonoscopy|carbon-dioxide colonoscopy
4929256|NCT01954862|Painless unsedated colonoscopy|painless unsedated colonoscopy
4929257|NCT01954862|Adenoma detection rate|adenoma detection rate
4929258|NCT01954862|Mean Adenomas per Procedure|mean adenomas per procedure
4929259|NCT01954849|gingivitis|gingivitis
4929260|NCT01954849|inflammation|inflammation
4929261|NCT01954849|plaque|plaque
4929262|NCT01954849|orthodontics|orthodontics
4929263|NCT01954836|short-term fasting|short-term fasting
4929264|NCT01954836|adjuvant chemotherapy|adjuvant chemotherapy
4929265|NCT01954836|toxicity|toxicity
4929266|NCT01954836|side-effects|side-effects
4929267|NCT01954836|ovarial carinoma|ovarial carinoma
4929268|NCT01954836|breast cancer|breast cancer
4929269|NCT01954823|Multiple sclerosis, Patient-reported outcomes, patient diary|multiple sclerosis, patient-reported outcomes, patient diary
4929270|NCT01954810|JECV|jecv
4929271|NCT01954810|IMOJEV|imojev
4929272|NCT01954810|Booster response|booster response
4929273|NCT01954810|Children|children
4929274|NCT01954810|antibody response|antibody response
4929275|NCT01954810|Duration|duration
4929276|NCT01954797|Physical fitness|physical fitness
4929277|NCT01954797|relaxation|relaxation
4929278|NCT01954797|stroke|stroke
4929279|NCT01954797|cerebral ischemia|cerebral ischemia
4929280|NCT01954797|cerebral perfusion|cerebral perfusion
4929281|NCT01954797|biomarkers|biomarkers
4929283|NCT01954771|Diabetes mellitus|diabetes mellitus
4929284|NCT01954771|Coronary artery disease|coronary artery disease
4929285|NCT01954771|SMBG|smbg
4929286|NCT01954771|Elderly|elderly
4929287|NCT01954758|Window of implantation|window of implantation
4929288|NCT01954758|Personalized embryo transfer|personalized embryo transfer
4929289|NCT01954758|Fresh embryo transfer|fresh embryo transfer
4929290|NCT01954758|Delayed embryo transfer|delayed embryo transfer
4929291|NCT01954758|Elective deferred embryo transfer|elective deferred embryo transfer
4929292|NCT01954758|Endometrial receptivity array|endometrial receptivity array
4929293|NCT01954758|Endometrial receptivity analysis|endometrial receptivity analysis
4929294|NCT01954758|Endometrial receptivity test|endometrial receptivity test
4929295|NCT01954745|Bile Duct Cancer|bile duct cancer
4929296|NCT01954745|intrahepatic cholangiocarcinoma|intrahepatic cholangiocarcinoma
4929297|NCT01954745|extrahepatic cholangiocarcinoma|extrahepatic cholangiocarcinoma
4929298|NCT01954745|Cabozantinib|cabozantinib
4929299|NCT01954719|Cervix Uteri, Cesarean Section, Infection, Dilatation|cervix uteri, cesarean section, infection, dilatation
4929300|NCT01954693|Tuberous Sclerosis|tuberous sclerosis
4929301|NCT01954693|Everolimus|everolimus
4929302|NCT01954693|Neurocognitive functioning|neurocognitive functioning
4929303|NCT01954680|bipolar disorder|bipolar disorder
4929304|NCT01954680|child|child
4929305|NCT01954680|adolescent|adolescent
4929306|NCT01954667|Gastroesophageal Reflux Disease; Anthropometric Measures; Leptin|gastroesophageal reflux disease; anthropometric measures; leptin
4929307|NCT01954641|breast cancer|breast cancer
4929308|NCT01954641|lung cancer|lung cancer
4929309|NCT01954641|cancer treatments|cancer treatments
4929310|NCT01954641|racial inequity|racial inequity
4929311|NCT01954641|health systems change|health systems change
4929312|NCT01954641|transparency|transparency
4929313|NCT01954641|accountability|accountability
4929314|NCT01954628|Exacerbation of COPD|exacerbation of copd
4929315|NCT01954628|Unstable COPD|unstable copd
4929316|NCT01954615|ACT-281959|act-281959
4929317|NCT01954615|ACT-246475|act-246475
4929318|NCT01954602|Biliary cannulation|biliary cannulation
4929319|NCT01954602|Endoscopic retrograde cholangiopancreatography|endoscopic retrograde cholangiopancreatography
4929320|NCT01954602|Touch guide-wire techniques|touch guide-wire techniques
4929321|NCT01954602|No touch guide-wire techniques|no touch guide-wire techniques
4929322|NCT01954589|ACT-462206|act-462206
4929323|NCT01954589|Selective dual orexin receptor antagonist|selective dual orexin receptor antagonist
4929324|NCT01954576|bevacizumab-naïve recurrent GBM|bevacizumab-naïve recurrent gbm
4929325|NCT01954576|bevacizumab-refractory GBM|bevacizumab-refractory gbm
4929326|NCT01954563|Tuberculosis|tuberculosis
4929327|NCT01954563|Vaccine|vaccine
4929328|NCT01954563|Immunogenicity|immunogenicity
4929329|NCT01954550|Exercise|exercise
4929330|NCT01954550|Dementia|dementia
4929331|NCT01954550|Cognition|cognition
4929332|NCT01954550|Brain Volume|brain volume
4929333|NCT01954550|Aging|aging
4929334|NCT01954537|Exertional heat illness|exertional heat illness
4929335|NCT01954537|Hydration Status|hydration status
4929336|NCT01954537|Preseason football|preseason football
4929337|NCT01954537|heat stroke|heat stroke
4929338|NCT01954511|Stomatognathic diseases;|stomatognathic diseases;
4929339|NCT01954511|Temporomandibular Joint Dysfunction Syndrome|temporomandibular joint dysfunction syndrome
4929340|NCT01954498|Randomized controlled trial|randomized controlled trial
4929341|NCT01954498|Spermatozoa|spermatozoa
4929342|NCT01954498|Sperm|sperm
4929343|NCT01954498|Male Infertility|male infertility
4929344|NCT01954498|Walnuts|walnuts
4929345|NCT01954498|Nutrition|nutrition
4929346|NCT01954498|Male Reproduction|male reproduction
4929347|NCT01954485|LaserLok, connective tissue, adhesion|laserlok, connective tissue, adhesion
4929348|NCT01954472|Portfolio diet|portfolio diet
4929349|NCT01954472|dietary modification|dietary modification
4929350|NCT01954472|hypercholesterolemia|hypercholesterolemia
4929351|NCT01954472|diabetes|diabetes
4929352|NCT01954472|Exercise|exercise
4929353|NCT01954472|CVD risk|cvd risk
4929354|NCT01954472|glycemic index|glycemic index
4929355|NCT01954472|inflammatory biomarkers|inflammatory biomarkers
4929356|NCT01954472|monounsaturated fat|monounsaturated fat
4929357|NCT01954472|saturated fat|saturated fat
4929358|NCT01954472|nuts|nuts
4929359|NCT01954472|plant sterols|plant sterols
4929360|NCT01954472|vegetable protein|vegetable protein
4929361|NCT01954472|viscous fiber|viscous fiber
4929362|NCT01954472|soy|soy
4929363|NCT01954459|Type 1 diabetes|type 1 diabetes
4929364|NCT01954459|Continuous glucose sensor|continuous glucose sensor
4929365|NCT01954459|Insupatch|insupatch
4929366|NCT01954433|Cost-effectiveness analyses|cost-effectiveness analyses
4929367|NCT01954433|Cost-utility analyses|cost-utility analyses
4929368|NCT01954433|Upper extremity|upper extremity
4929369|NCT01954433|Orthopedic|orthopedic
4929370|NCT01954433|Shoulder arthroplasty|shoulder arthroplasty
4929371|NCT01954433|Rotator cuff tear repair|rotator cuff tear repair
4929372|NCT01954433|Resection interposition suspension arthroplasty|resection interposition suspension arthroplasty
4929373|NCT01954420|Pain|pain
4929374|NCT01954420|Fatigue|fatigue
4929375|NCT01954420|Sleep|sleep
4929376|NCT01954420|Cancer|cancer
4929377|NCT01954420|Relaxation|relaxation
4929378|NCT01954420|Distraction|distraction
4929379|NCT01954420|Symptoms|symptoms
4929380|NCT01954407|smoking-related messages|smoking-related messages
4929381|NCT01954407|anti-smoking messages|anti-smoking messages
4929382|NCT01954407|smoking-related beliefs|smoking-related beliefs
4929383|NCT01954407|anti-smoking intentions|anti-smoking intentions
4929384|NCT01954355|advanced solid tumor|advanced solid tumor
4929385|NCT01954355|ovarian cancer|ovarian cancer
4929386|NCT01954355|LDE225|lde225
4929387|NCT01954355|Paclitaxel|paclitaxel
4929388|NCT01954355|Hedgehog inhibitor|hedgehog inhibitor
4929389|NCT01954342|Pregnancy|pregnancy
4929390|NCT01954342|Postpartum|postpartum
4929391|NCT01954329|Biomarkers|biomarkers
4929392|NCT01954329|TIA|tia
4929393|NCT01954329|Diagnosis|diagnosis
4929394|NCT01954316|advanced cancer|advanced cancer
4929395|NCT01954316|CFI-400945 fumarate|cfi-400945 fumarate
4929396|NCT01954316|polo-like kinase 4|polo-like kinase 4
4929397|NCT01954316|PLK4|plk4
4929398|NCT01954316|tablet|tablet
4929399|NCT01954316|dose escalation|dose escalation
4929400|NCT01954316|genetic testing|genetic testing
4929401|NCT01954290|Stroke|stroke
4929402|NCT01954290|Brain Edema|brain edema
4929403|NCT01954290|Brain Herniation|brain herniation
4929404|NCT01954290|Conivaptan|conivaptan
4929405|NCT01954277|Chronic Tension-Type Headache|chronic tension-type headache
4929406|NCT01954277|Electroacupuncture|electroacupuncture
4929407|NCT01954277|Headache Impact|headache impact
4929408|NCT01954277|BDNF|bdnf
4929410|NCT01954264|Saharan Western Africa|saharan western africa
4929411|NCT01954264|Epidemiology|epidemiology
4929412|NCT01954264|Post-Approval Programme study|post-approval programme study
4929413|NCT01954264|Malaria|malaria
4929414|NCT01954264|Burden of Disease Study|burden of disease study
4929415|NCT01954251|FLU-D-QIV|flu-d-qiv
4929416|NCT01954251|Adults|adults
4929417|NCT01954251|Safety|safety
4929418|NCT01954251|Immunogenicity|immunogenicity
4929419|NCT01954251|co-administration|co-administration
4929420|NCT01954251|Herpes zoster|herpes zoster
4929421|NCT01954238|Anti-coagulant|anti-coagulant
4929422|NCT01954238|Coagulation factor Xa inhibitor|coagulation factor xa inhibitor
4929423|NCT01954225|Fistula in ano|fistula in ano
4929424|NCT01954225|Bhagandara|bhagandara
4929425|NCT01954225|Udumbara sutra|udumbara sutra
4929426|NCT01954212|Oral health|oral health
4929427|NCT01954199|Sciatica|sciatica
4929428|NCT01954199|Nerve pain|nerve pain
4929429|NCT01954199|Low back pain|low back pain
4929430|NCT01954186|Oxytocin|oxytocin
4929431|NCT01954186|Active Management of Third Stage of Labour|active management of third stage of labour
4929432|NCT01954134|Tumor Suppressor Protein p53,|tumor suppressor protein p53,
4929433|NCT01954134|Iodine Radioisotopes|iodine radioisotopes
4929434|NCT01954121|Levetiracetam|levetiracetam
4929435|NCT01954121|Keppra|keppra
4929436|NCT01954121|Monotherapy|monotherapy
4929437|NCT01954121|China|china
4929438|NCT01954121|Epilepsy|epilepsy
4929439|NCT01954121|Partial-onset Seizures|partial-onset seizures
4929440|NCT01954108|tendinopathy|tendinopathy
4929441|NCT01954108|hyaluronan|hyaluronan
4929442|NCT01954108|tendon|tendon
4929443|NCT01954108|hyaluronic acid|hyaluronic acid
4929444|NCT01954108|extracorporeal shock wave|extracorporeal shock wave
4930048|NCT01951209|Human|human
4929445|NCT01954095|17-OHPC, Prometrium, Cerclage, Pre-term birth, Short cervix|17-ohpc, prometrium, cerclage, pre-term birth, short cervix
4929446|NCT01954082|Retinopathy|retinopathy
4929447|NCT01954082|Prematurity|prematurity
4929448|NCT01954082|Infant, Newborn, Diseases|infant, newborn, diseases
4929449|NCT01954056|NICHD Neonatal Research Network|nichd neonatal research network
4929450|NCT01954056|Mechanical ventilation|mechanical ventilation
4929451|NCT01954056|Intubation|intubation
4929452|NCT01954056|Neurodevelopmental impairment|neurodevelopmental impairment
4929453|NCT01954043|melanoma|melanoma
4929454|NCT01954043|dabrafenib|dabrafenib
4929455|NCT01954043|BRAF V600|braf v600
4929456|NCT01954043|rabeprazole|rabeprazole
4929457|NCT01954043|rifampin|rifampin
4929458|NCT01954030|Carboxyamidotriazole Orotate|carboxyamidotriazole orotate
4929459|NCT01954030|CTO|cto
4929460|NCT01954030|Bevacizumab|bevacizumab
4929461|NCT01954030|Avastin|avastin
4929462|NCT01954030|Malignant Glioma|malignant glioma
4929463|NCT01954030|Pro00044274|pro00044274
4929464|NCT01954030|Desjardins|desjardins
4929465|NCT01954030|Duke|duke
4929466|NCT01954030|The Preston Robert Tisch Brain Tumor Center|the preston robert tisch brain tumor center
4929467|NCT01953978|Pain|pain
4929468|NCT01953978|Analgesia|analgesia
4929469|NCT01953978|Postoperative|postoperative
4929470|NCT01953978|Dexamethasone|dexamethasone
4929471|NCT01953978|Spine surgery|spine surgery
4929472|NCT01953926|Neratinib|neratinib
4929473|NCT01953926|Nerlynx|nerlynx
4929474|NCT01953926|Breast|breast
4929475|NCT01953926|Gastroesophageal|gastroesophageal
4929476|NCT01953926|Endometrial|endometrial
4929477|NCT01953926|Ovarian|ovarian
4929478|NCT01953926|Biliary Tract|biliary tract
4929479|NCT01953926|Solid Tumors|solid tumors
4929480|NCT01953926|Cancer|cancer
4929481|NCT01953926|HER2|her2
4929482|NCT01953926|HER4|her4
4929483|NCT01953926|EGFR|egfr
4929484|NCT01953926|Bladder/Urinary Tract|bladder/urinary tract
4929485|NCT01953926|Paclitaxel|paclitaxel
4929486|NCT01953926|Fulvestrant|fulvestrant
4929487|NCT01953926|Trastuzumab|trastuzumab
4929488|NCT01953926|Fibrolamellar Carcinoma|fibrolamellar carcinoma
4929489|NCT01953900|Sarcoma|sarcoma
4929490|NCT01953900|T-Cells|t-cells
4929491|NCT01953900|varicella zoster virus (VZV)|varicella zoster virus (vzv)
4929492|NCT01953900|GD2|gd2
4929493|NCT01953887|Phase I|phase i
4929494|NCT01953887|Final formulation EC905|final formulation ec905
4929495|NCT01953887|Solifenacin succinate|solifenacin succinate
4929496|NCT01953887|Tamsulosin HCl|tamsulosin hcl
4929497|NCT01953887|Marketed drugs|marketed drugs
4929498|NCT01953874|heart failure|heart failure
4929499|NCT01953874|congestive heart failure|congestive heart failure
4929500|NCT01953874|acute decompensated heart failure|acute decompensated heart failure
4929501|NCT01953874|chronic heart failure|chronic heart failure
4929502|NCT01953874|left-sided heart failure|left-sided heart failure
4929503|NCT01953874|heart failure decompensation|heart failure decompensation
4929504|NCT01953874|sleep apnea|sleep apnea
4929505|NCT01953874|sleep disordered breathing|sleep disordered breathing
4929506|NCT01953874|central sleep apnea|central sleep apnea
4929507|NCT01953874|obstructive sleep apnea|obstructive sleep apnea
4929508|NCT01953874|cheyne-stokes respiration|cheyne-stokes respiration
4929509|NCT01953861|Phase I|phase i
4929510|NCT01953861|Combination tablet EC905|combination tablet ec905
4929511|NCT01953861|Omnic OCAS®|omnic ocas®
4929512|NCT01953861|Vesicare®|vesicare®
4929513|NCT01953861|Food effect|food effect
4929514|NCT01953861|Vesomni|vesomni
4929515|NCT01953861|VesiFlow|vesiflow
4929516|NCT01953861|Urizia|urizia
4929517|NCT01953848|Phase I|phase i
4929518|NCT01953848|Combination tablet EC905|combination tablet ec905
4929519|NCT01953848|Steady-state|steady-state
4929520|NCT01953848|Vesomni|vesomni
4929521|NCT01953848|VesiFlow|vesiflow
4929522|NCT01953848|Urizia|urizia
4929523|NCT01953835|Pharmacokinetics|pharmacokinetics
4929524|NCT01953835|GSK2586184|gsk2586184
4929525|NCT01953835|Simvastatin|simvastatin
4929526|NCT01953835|Rosuvastatin|rosuvastatin
4929527|NCT01953835|Poloxamer|poloxamer
4929528|NCT01953822|Observational|observational
4929529|NCT01953822|Cohort|cohort
4929530|NCT01953822|Autoimmune disease|autoimmune disease
4929531|NCT01953822|Cervarix®|cervarix®
4929532|NCT01953822|Women aged 9 to 25 years|women aged 9 to 25 years
4929533|NCT01953822|United Kingdom|united kingdom
4929534|NCT01953809|oral|oral
4929535|NCT01953809|oral contraceptive|oral contraceptive
4929536|NCT01953809|pharmacokinetics|pharmacokinetics
4929537|NCT01953809|drug interaction|drug interaction
4929538|NCT01953809|pharmacodynamics|pharmacodynamics
4929539|NCT01953809|GSK1322322|gsk1322322
4929540|NCT01953809|antibiotic|antibiotic
4929541|NCT01953809|safety|safety
4929542|NCT01953796|Polycystic Ovarian Syndrome stair step traditional protocol|polycystic ovarian syndrome stair step traditional protocol
4929543|NCT01953770|Acute lymphoblastic leukemia, children, adolescents, L-asparaginase, methotrexate|acute lymphoblastic leukemia, children, adolescents, l-asparaginase, methotrexate
4929544|NCT01953757|diabetic neuropathy, diet, vegan, vegetarian|diabetic neuropathy, diet, vegan, vegetarian
4929545|NCT01953744|Fluconazole; Meglumine antimoniate;L.Braziliensis;|fluconazole; meglumine antimoniate;l.braziliensis;
4929546|NCT01953744|L.Guyanensis|l.guyanensis
4929547|NCT01953731|palbociclib|palbociclib
4929548|NCT01953731|PD-0332991|pd-0332991
4929549|NCT01953731|rifampin|rifampin
4929550|NCT01953731|drug-drug interaction study|drug-drug interaction study
4929551|NCT01953705|omega 3 fatty acids|omega 3 fatty acids
4929552|NCT01953705|cognitive decline|cognitive decline
4929553|NCT01953705|MRI|mri
4929554|NCT01953705|endothelial function|endothelial function
4929555|NCT01953705|white matter|white matter
4929556|NCT01953705|executive function|executive function
4929557|NCT01953705|prevention|prevention
4929558|NCT01953705|DTI|dti
4929559|NCT01953705|ASL|asl
4929560|NCT01953692|PD1|pd1
4929561|NCT01953692|PD-1|pd-1
4929562|NCT01953692|PDL1|pdl1
4929563|NCT01953692|PD-L1|pd-l1
4929564|NCT01953666|word prediction software, text input speed, copm, occupational therapist, rehabilitation, spinal cord injury|word prediction software, text input speed, copm, occupational therapist, rehabilitation, spinal cord injury
4929565|NCT01953614|quantitative encephalography|quantitative encephalography
4929566|NCT01953614|brain computer interface|brain computer interface
4929567|NCT01953614|chiropractic|chiropractic
4929568|NCT01953614|sacro-occipital technique|sacro-occipital technique
4929569|NCT01953575|Mucosal Impedance|mucosal impedance
4929570|NCT01953575|Eosinophilic Esophagitis|eosinophilic esophagitis
4929571|NCT01953575|EoE|eoe
4929572|NCT01953562|infants|infants
4929573|NCT01953562|NICU|nicu
4929574|NCT01953562|intubated|intubated
4929575|NCT01953562|ventilator|ventilator
4929576|NCT01953549|physical activity, relaxation, activities of daily living, motor functions, cognitive functions|physical activity, relaxation, activities of daily living, motor functions, cognitive functions
4929577|NCT01953523|erectile dysfunction|erectile dysfunction
4929578|NCT01953523|peyronies|peyronies
4929579|NCT01953523|interstitial cystitis|interstitial cystitis
4929580|NCT01953523|cardiomyopathy|cardiomyopathy
4929581|NCT01953523|emphysema|emphysema
4929582|NCT01953523|copd|copd
4929583|NCT01953523|arthritis|arthritis
4929584|NCT01953523|multiple sclerosis|multiple sclerosis
4929585|NCT01953523|parkinson's|parkinson's
4929586|NCT01953510|Pneumococcal vaccines|pneumococcal vaccines
4929587|NCT01953510|10-valent pneumococcal vaccine|10-valent pneumococcal vaccine
4929588|NCT01953510|13-valent pneumococcal vaccine|13-valent pneumococcal vaccine
4929589|NCT01953510|Immunization Schedule|immunization schedule
4929590|NCT01953510|Public Health|public health
4929591|NCT01953458|Hepatitis B and C|hepatitis b and c
4929592|NCT01953458|ANRS HEPATHER French Cohort|anrs hepather french cohort
4929593|NCT01953432|Cocaine-Related Disorders|cocaine-related disorders
4929594|NCT01953432|Cocaine|cocaine
4929595|NCT01953432|Doxazosin|doxazosin
4929596|NCT01953432|Cardiovascular Agents|cardiovascular agents
4929597|NCT01953432|Antihypertensive Agents|antihypertensive agents
4929598|NCT01953432|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists
4929599|NCT01953432|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists
4929600|NCT01953432|Adrenergic Antagonists|adrenergic antagonists
4929601|NCT01953432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
4929602|NCT01953432|Neurotransmitter Agents|neurotransmitter agents
4929603|NCT01953432|Therapeutic Uses|therapeutic uses
4929604|NCT01953432|Pharmacologic Actions|pharmacologic actions
4929605|NCT01953432|Substance-Related Disorders|substance-related disorders
4929606|NCT01953406|hepatocellular carcinoma|hepatocellular carcinoma
4929607|NCT01953406|lung metastasis|lung metastasis
4929608|NCT01953406|5-fluorouracil/mitomycin|5-fluorouracil/mitomycin
4929609|NCT01953380|Intervention Studies|intervention studies
4929610|NCT01953380|Eczema|eczema
4929611|NCT01953380|Randomized Controlled Trial|randomized controlled trial
4929612|NCT01953380|Knowledge|knowledge
4929613|NCT01953380|Quality of Life|quality of life
4929614|NCT01953367|Bioequivalence|bioequivalence
4929615|NCT01953367|AUC|auc
4929616|NCT01953367|Cmax|cmax
4929617|NCT01953354|Ulcerative colitis (UC)|ulcerative colitis (uc)
4929618|NCT01953354|Inflammatory Bowel Disease (IBD)|inflammatory bowel disease (ibd)
4929619|NCT01953354|Trichuris suis ova (TSO)|trichuris suis ova (tso)
4929620|NCT01953341|Migraine|migraine
4929621|NCT01953328|Japanese, high cholesterol, LDL-C, High Cardiovascular Risk|japanese, high cholesterol, ldl-c, high cardiovascular risk
4929622|NCT01953315|urinary incontinence, muscle progenitor cells, MPCs|urinary incontinence, muscle progenitor cells, mpcs
4929623|NCT01953302|ventral hernia|ventral hernia
4929624|NCT01953302|infection|infection
4929625|NCT01953302|hematoma|hematoma
4929626|NCT01953302|seroma|seroma
4929627|NCT01953302|recurrence|recurrence
4929628|NCT01953302|mesh technique|mesh technique
4929629|NCT01953289|Appendicitis|appendicitis
4929630|NCT01953289|Free fluid|free fluid
4929631|NCT01953276|Acute Coronary Syndrome|acute coronary syndrome
4929632|NCT01953276|Chest pain|chest pain
4929633|NCT01953276|Electrocardiograms|electrocardiograms
4929634|NCT01953276|Risk Stratification|risk stratification
4929635|NCT01953276|Emergency Department|emergency department
4929636|NCT01953263|urinary incontinence, muscle fibers|urinary incontinence, muscle fibers
4929637|NCT01953250|Deep infiltrating endometriosis|deep infiltrating endometriosis
4929638|NCT01953250|Laparoscopic sigmoid resection|laparoscopic sigmoid resection
4930049|NCT01951209|Hepatitis C|hepatitis c
4929639|NCT01953250|laparoscopic rectum resection|laparoscopic rectum resection
4929640|NCT01953250|Colorectal surgery|colorectal surgery
4929641|NCT01953237|Schizophrenia|schizophrenia
4929642|NCT01953237|antipsychotic medication adherence|antipsychotic medication adherence
4929643|NCT01953237|mobile phones|mobile phones
4929644|NCT01953224|Physical activity|physical activity
4929645|NCT01953224|Video game|video game
4929646|NCT01953224|Mobile|mobile
4929647|NCT01953224|Technology|technology
4929648|NCT01953224|Obesity|obesity
4929649|NCT01953198|hypoxia hypobaric|hypoxia hypobaric
4929650|NCT01953185|elderly|elderly
4929651|NCT01953185|subjects|subjects
4929652|NCT01953146|PCOS|pcos
4929653|NCT01953107|Anemia|anemia
4929654|NCT01953107|Ovarian cancer|ovarian cancer
4929655|NCT01953107|Uterine cancer|uterine cancer
4929656|NCT01953107|Cervical cancer|cervical cancer
4929657|NCT01953107|Oral iron|oral iron
4929658|NCT01953094|Cervical|cervical
4929659|NCT01953081|Enteral feeding|enteral feeding
4929661|NCT01953068|Executive Reaction Time Test|executive reaction time test
4929662|NCT01953068|Aortic valve surgery|aortic valve surgery
4929663|NCT01953068|Cognitive functions|cognitive functions
4929664|NCT01953068|Transcatheter Aortic Valve Implantation|transcatheter aortic valve implantation
4929665|NCT01953055|stereotactic ablative radiotherapy|stereotactic ablative radiotherapy
4929666|NCT01953055|androgen deprivation therapy|androgen deprivation therapy
4929667|NCT01953042|Obsessive-Compulsive Disorder|obsessive-compulsive disorder
4929668|NCT01953042|Health Education|health education
4929669|NCT01953016|ADA-SCID/SCID all forms|ada-scid/scid all forms
4929670|NCT01953016|Wiskott-Aldrich Syndrome|wiskott-aldrich syndrome
4929671|NCT01953016|GATA2|gata2
4929672|NCT01953016|Primary Immunodeficiencies|primary immunodeficiencies
4929673|NCT01953016|CGD (Chronic Granulomatous Disease)|cgd (chronic granulomatous disease)
4929674|NCT01952990|Pharmacokinetic|pharmacokinetic
4929675|NCT01952964|exit site infection|exit site infection
4929676|NCT01952964|skin allergy|skin allergy
4929677|NCT01952964|physical damage|physical damage
4929678|NCT01952951|rectal neoplasms|rectal neoplasms
4929679|NCT01952951|radiotherapy|radiotherapy
4929680|NCT01952951|Antineoplastic Agents|antineoplastic agents
4929681|NCT01952938|knee revision surgery,|knee revision surgery,
4929682|NCT01952938|rotating hinge prosthesis|rotating hinge prosthesis
4929683|NCT01952899|Intensive Care Unit|intensive care unit
4929684|NCT01952899|Delirium|delirium
4929685|NCT01952899|Implementation|implementation
4929686|NCT01952899|Guideline|guideline
4929687|NCT01952886|malignant glioma|malignant glioma
4929688|NCT01952886|antiemetic|antiemetic
4929689|NCT01952886|ondansetron|ondansetron
4929690|NCT01952886|granisetron|granisetron
4929691|NCT01952886|Preston Robert Tisch Brain Tumor Center|preston robert tisch brain tumor center
4929692|NCT01952886|Pro00041233|pro00041233
4929693|NCT01952886|Duke|duke
4929694|NCT01952873|stents|stents
4929695|NCT01952873|angioplasty, balloon, coronary|angioplasty, balloon, coronary
4929696|NCT01952873|coronary artery stenosis|coronary artery stenosis
4929697|NCT01952873|optical coherence tomography|optical coherence tomography
4929698|NCT01952860|Lung Cancer|lung cancer
4929699|NCT01952860|Non-small cell lung cancer|non-small cell lung cancer
4929700|NCT01952860|NSCLC|nsclc
4929701|NCT01952860|Caregiving partner|caregiving partner
4929702|NCT01952860|Hatha Yoga|hatha yoga
4929703|NCT01952860|Radiation therapy|radiation therapy
4929704|NCT01952860|XRT|xrt
4929705|NCT01952860|Questionnaires|questionnaires
4929706|NCT01952860|Surveys|surveys
4929707|NCT01952847|Advanced Cancers|advanced cancers
4929708|NCT01952847|Mucositis|mucositis
4929709|NCT01952847|Esophagitis|esophagitis
4929710|NCT01952847|mTOR Inhibitor-based Regimen|mtor inhibitor-based regimen
4929711|NCT01952847|Radiation to the Esophagus|radiation to the esophagus
4929712|NCT01952847|Thoracic malignancies|thoracic malignancies
4929713|NCT01952847|Placebo|placebo
4929714|NCT01952847|Glutamine|glutamine
4929715|NCT01952847|Enterex|enterex
4929716|NCT01952847|Glutapak-10|glutapak-10
4929717|NCT01952847|NutreStore|nutrestore
4929718|NCT01952847|Resource|resource
4929719|NCT01952847|GlutaSolve|glutasolve
4929720|NCT01952847|Sympt-X G.I.|sympt-x g.i.
4929721|NCT01952847|Sympt-X|sympt-x
4929722|NCT01952847|Questionnaires|questionnaires
4929723|NCT01952847|Surveys|surveys
4929724|NCT01952834|coronary artery disease|coronary artery disease
4929725|NCT01952834|probiotic|probiotic
4929726|NCT01952834|endothelial function|endothelial function
4929727|NCT01952834|brachial artery|brachial artery
4929728|NCT01952834|ntric oxide|ntric oxide
4929729|NCT01952821|Head and Neck Cancer|head and neck cancer
4929730|NCT01952821|Physical function|physical function
4929731|NCT01952821|Cancer Related Fatigue|cancer related fatigue
4929732|NCT01952821|Gait Speed|gait speed
4929733|NCT01952821|6MWT|6mwt
4929734|NCT01952821|10-Meter Walk Test|10-meter walk test
4929735|NCT01952821|30-Second Chair Stand|30-second chair stand
4929736|NCT01952821|Linear Analog Scale of Function|linear analog scale of function
4929737|NCT01952821|Modified Brief Fatigue Inventory|modified brief fatigue inventory
4929738|NCT01952769|anti PD1,diffuse pontine glioma|anti pd1,diffuse pontine glioma
4929739|NCT01952756|cilostazol|cilostazol
4929740|NCT01952756|endothelial progenitor cells|endothelial progenitor cells
4929741|NCT01952756|vasculogenesis|vasculogenesis
4929742|NCT01952756|angiogenesis|angiogenesis
4929743|NCT01952756|peripheral arterial disease|peripheral arterial disease
4929744|NCT01952756|biomarkers|biomarkers
4929745|NCT01952743|Atrial Fibrillation|atrial fibrillation
4929746|NCT01952743|Hypertension|hypertension
4929747|NCT01952743|Renal Denervation|renal denervation
4929748|NCT01952730|Stage IV|stage iv
4929749|NCT01952730|Hepatic Lesions|hepatic lesions
4929750|NCT01952691|hallux valgus|hallux valgus
4929751|NCT01952691|pain|pain
4929752|NCT01952691|conservative|conservative
4929753|NCT01952691|treatment|treatment
4929754|NCT01952678|DaTscan|datscan
4929755|NCT01952678|Parkinson's Disease|parkinson's disease
4929756|NCT01952652|Naproxen-codeine|naproxen-codeine
4929757|NCT01952652|preemptive analgesia|preemptive analgesia
4929758|NCT01952652|day case surgery|day case surgery
4929759|NCT01952626|intrathecal|intrathecal
4929760|NCT01952626|morphine|morphine
4929761|NCT01952626|ondansetron|ondansetron
4929762|NCT01952626|palonosetron|palonosetron
4929763|NCT01952626|pruritus|pruritus
4929764|NCT01952613|Foot drop|foot drop
4929765|NCT01952613|Functional Electrical Stimulation|functional electrical stimulation
4929766|NCT01952600|Chronic Kidney Disease|chronic kidney disease
4929767|NCT01952600|Hemodialysis|hemodialysis
4929768|NCT01952600|Peritoneal Dialysis|peritoneal dialysis
4929769|NCT01952574|migraine, headache, prevention, prophylaxis|migraine, headache, prevention, prophylaxis
4929770|NCT01952561|pharmacokinetics|pharmacokinetics
4929771|NCT01952561|vaginal ring|vaginal ring
4929772|NCT01952522|Resistance training|resistance training
4929773|NCT01952522|Walking|walking
4929774|NCT01952522|Weight bearing|weight bearing
4929775|NCT01952496|Cerebral Palsy|cerebral palsy
4929776|NCT01952496|Non ambulatory|non ambulatory
4929777|NCT01952496|Neuromuscular disability|neuromuscular disability
4929778|NCT01952496|Children|children
4929779|NCT01952483|Multiple Sclerosis (MS)|multiple sclerosis (ms)
4929780|NCT01952470|Lung transplantation|lung transplantation
4929781|NCT01952470|Respiratory Tract Infections|respiratory tract infections
4929782|NCT01952470|Respiratory Therapy|respiratory therapy
4929783|NCT01952470|Isotonic Solutions|isotonic solutions
4929784|NCT01952470|Sodium Chloride|sodium chloride
4929785|NCT01952470|Postoperative complications|postoperative complications
4929786|NCT01952470|Postoperative care|postoperative care
4929787|NCT01952470|dornase alpha|dornase alpha
4929788|NCT01952431|Total Lung Capacity|total lung capacity
4929789|NCT01952392|Effectiveness study|effectiveness study
4929790|NCT01952392|Acute coronary Syndrome|acute coronary syndrome
4929791|NCT01952392|Real-life|real-life
4929792|NCT01952392|France|france
4929793|NCT01952379|Melasma|melasma
4929794|NCT01952379|Lymphocytes|lymphocytes
4929795|NCT01952379|Macrophages|macrophages
4929796|NCT01952379|Mast cells|mast cells
4929797|NCT01952379|Interleukin 17|interleukin 17
4929798|NCT01952379|COX-2|cox-2
4929799|NCT01952379|Inflammation|inflammation
4929800|NCT01952366|Aged|aged
4929801|NCT01952366|Depression|depression
4929802|NCT01952366|Cognition|cognition
4929803|NCT01952366|Longitudinal study|longitudinal study
4929804|NCT01952353|Hepatocellular Carcinoma; Transarterial Chemoembolization; Hepatic Resection; Portal Vein Tumor Thrombosis|hepatocellular carcinoma; transarterial chemoembolization; hepatic resection; portal vein tumor thrombosis
4929805|NCT01952301|Autologous; Collagen Matrix; Keratinized Tissue|autologous; collagen matrix; keratinized tissue
4929806|NCT01952262|ultrasound|ultrasound
4929807|NCT01952262|diaphragm|diaphragm
4929808|NCT01952262|intensive care|intensive care
4929809|NCT01952262|critical care|critical care
4929810|NCT01952249|Ovarian|ovarian
4929811|NCT01952249|Primary Peritoneal|primary peritoneal
4929812|NCT01952249|Fallopian Tube Cancer|fallopian tube cancer
4929813|NCT01952236|Smoking|smoking
4929814|NCT01952236|Quit|quit
4929815|NCT01952236|Tobacco|tobacco
4929816|NCT01952236|Abstinence|abstinence
4929817|NCT01952236|Adult|adult
4929818|NCT01952236|Text Messaging|text messaging
4929819|NCT01952236|Web-based|web-based
4929820|NCT01952236|Mobile phone|mobile phone
4929821|NCT01952236|smartphone|smartphone
4929822|NCT01952236|internet|internet
4929823|NCT01952236|web|web
4929824|NCT01952223|adenocarcinome|adenocarcinome
4929825|NCT01952223|prostate|prostate
4929826|NCT01952223|relapse|relapse
4929827|NCT01952223|Radiotherapy|radiotherapy
4929828|NCT01952223|Androgen Deprivation Therapy|androgen deprivation therapy
4929829|NCT01952223|Cabazitaxel|cabazitaxel
4929830|NCT01952197|Passive Leg Raise|passive leg raise
4929831|NCT01952197|Cardiac arrest|cardiac arrest
4929832|NCT01952197|Survival after CPR|survival after cpr
4929833|NCT01952184|vitrification|vitrification
4929834|NCT01952184|oocyte|oocyte
4929835|NCT01952184|donor|donor
4929836|NCT01952184|open|open
4929837|NCT01952184|closed|closed
4929838|NCT01952171|Genomics|genomics
4929839|NCT01952171|Birth Defects|birth defects
4929840|NCT01952171|Congenital Heart Disease|congenital heart disease
4929841|NCT01952158|Multidrug-Resistant Organisms|multidrug-resistant organisms
4929842|NCT01952158|Hospital Infection|hospital infection
4929843|NCT01952158|Colonization|colonization
4929844|NCT01952158|Healthcare Personnel|healthcare personnel
4929845|NCT01952132|Schizophrenia|schizophrenia
4929846|NCT01952119|hypertension|hypertension
4929847|NCT01952106|venepuncture|venepuncture
4929848|NCT01952106|distraction|distraction
4929849|NCT01952106|distress|distress
4929850|NCT01952093|Early intervention|early intervention
4929851|NCT01952093|Mother-child interaction|mother-child interaction
4929852|NCT01952093|Neurodevelopment|neurodevelopment
4929853|NCT01952093|Parenting|parenting
4929854|NCT01952093|Prematurity|prematurity
4929855|NCT01952093|School age|school age
4929856|NCT01952080|Short Bowel Syndrome|short bowel syndrome
4929857|NCT01952080|SBS|sbs
4929858|NCT01952080|Pediatric SBS|pediatric sbs
4929859|NCT01952067|Hip Prosthesis|hip prosthesis
4929860|NCT01952067|surgery|surgery
4929861|NCT01952067|cements|cements
4929862|NCT01952067|Radiostereometric Analysis|radiostereometric analysis
4929863|NCT01952054|Breast cancer|breast cancer
4929864|NCT01952054|Breast carcinoma|breast carcinoma
4929865|NCT01952054|Bone metastasis|bone metastasis
4929866|NCT01952054|Cancer that has spread to the bone|cancer that has spread to the bone
4929867|NCT01952054|Denosumab|denosumab
4929868|NCT01952054|AMG 162|amg 162
4929869|NCT01952054|Prolia|prolia
4929870|NCT01952054|Hormonal agent|hormonal agent
4929871|NCT01952041|Schizophrenia|schizophrenia
4929872|NCT01952041|Schizoaffective Disorder|schizoaffective disorder
4929873|NCT01952041|Mobile Application|mobile application
4929874|NCT01952041|Relapse Signature|relapse signature
4929875|NCT01952041|Relapse|relapse
4929876|NCT01952041|SMI|smi
4929877|NCT01952041|EHealth|ehealth
4929878|NCT01952041|E-Health|e-health
4929879|NCT01952041|Health Technology|health technology
4929880|NCT01952041|mHealth|mhealth
4929881|NCT01952041|m-Health|m-health
4929882|NCT01952028|MDC1A|mdc1a
4929883|NCT01952028|Congenital Muscular Dystrophy|congenital muscular dystrophy
4929884|NCT01952028|Merosin Deficient|merosin deficient
4929885|NCT01952028|LAMA2|lama2
4929886|NCT01952028|brain white matter abnormalities|brain white matter abnormalities
4929887|NCT01952028|Seizure|seizure
4929888|NCT01952015|generalized pustular psoriasis|generalized pustular psoriasis
4929889|NCT01952002|Blood Pressure|blood pressure
4929890|NCT01952002|heart rate|heart rate
4929891|NCT01952002|electrocardiogram|electrocardiogram
4929892|NCT01952002|Cardiac arrhythmias|cardiac arrhythmias
4929893|NCT01952002|respiratory exercise|respiratory exercise
4929894|NCT01951989|Gaucher disease|gaucher disease
4929895|NCT01951989|Imiglucerase|imiglucerase
4929896|NCT01951989|Pharmacokinetics|pharmacokinetics
4929897|NCT01951976|breast|breast
4929898|NCT01951976|carcinoma|carcinoma
4929899|NCT01951976|stage 0-III breast cancer|stage 0-iii breast cancer
4929900|NCT01951976|post-menopausal|post-menopausal
4929901|NCT01951976|aromatase inhibitor (AI)|aromatase inhibitor (ai)
4929902|NCT01951976|joint pain|joint pain
4929903|NCT01951976|AI-associated joint pain|ai-associated joint pain
4929904|NCT01951963|pain management|pain management
4929905|NCT01951963|ketamine|ketamine
4929906|NCT01951963|morphine|morphine
4929907|NCT01951963|pediatrics|pediatrics
4929908|NCT01951963|emergency medicine|emergency medicine
4929909|NCT01951937|Cognitive Test|cognitive test
4929910|NCT01951937|Omega-3 Fatty acids|omega-3 fatty acids
4930039|NCT01951261|Telemonitoring|telemonitoring
4929911|NCT01951924|Multifocal Motor Neuropathy|multifocal motor neuropathy
4929912|NCT01951911|Pain Management|pain management
4929913|NCT01951911|Ketamine|ketamine
4929914|NCT01951911|Palliative care|palliative care
4929915|NCT01951898|asthma|asthma
4929916|NCT01951898|regulatory T cells|regulatory t cells
4929917|NCT01951898|leukotriene antagonist|leukotriene antagonist
4929918|NCT01951872|caffeine dependence|caffeine dependence
4929919|NCT01951872|caffeine withdrawal|caffeine withdrawal
4929920|NCT01951872|caffeine use disorder|caffeine use disorder
4929921|NCT01951833|Lung clearance index (LCI)|lung clearance index (lci)
4929922|NCT01951807|Psychosocial Effects of Cancer and Treatment|psychosocial effects of cancer and treatment
4929923|NCT01951807|Coping|coping
4929924|NCT01951794|HIV infected|hiv infected
4929925|NCT01951794|HIV exposed|hiv exposed
4929926|NCT01951794|HIV-free|hiv-free
4929927|NCT01951781|marker CD64|marker cd64
4929928|NCT01951781|blood sample|blood sample
4929929|NCT01951781|nosocomial infection|nosocomial infection
4929930|NCT01951781|preterm newborn|preterm newborn
4929931|NCT01951755|Inoperable NSCLC|inoperable nsclc
4929932|NCT01951755|TKIs|tkis
4929933|NCT01951742|wrinkles|wrinkles
4929934|NCT01951729|Blood sugar|blood sugar
4929935|NCT01951729|GIP|gip
4929936|NCT01951729|Xenin-25|xenin-25
4929937|NCT01951729|Cholinergic Signaling|cholinergic signaling
4929938|NCT01951729|Atropine|atropine
4929939|NCT01951729|Insulin|insulin
4929940|NCT01951729|Glucagon|glucagon
4929941|NCT01951729|Pancreatic polypeptide|pancreatic polypeptide
4929942|NCT01951716|Vagotomy|vagotomy
4929943|NCT01951716|Vagus Nerve|vagus nerve
4929944|NCT01951716|Xenin-25|xenin-25
4929945|NCT01951716|GIP|gip
4929946|NCT01951716|Insulin Secretion|insulin secretion
4930050|NCT01951209|Cirrhosis|cirrhosis
4929947|NCT01951716|Glucagon Secretion|glucagon secretion
4929948|NCT01951716|Gastric Emptying|gastric emptying
4929949|NCT01951690|Focal Adhesion Kinase inhibitor|focal adhesion kinase inhibitor
4929950|NCT01951690|FAK inhibitor|fak inhibitor
4929951|NCT01951690|Cancer Stem Cells|cancer stem cells
4929952|NCT01951690|CSC|csc
4929953|NCT01951690|KRAS mutation|kras mutation
4929954|NCT01951677|hepatitis B virus|hepatitis b virus
4929955|NCT01951677|vaccine|vaccine
4929956|NCT01951677|adjuvant|adjuvant
4929957|NCT01951677|prophylaxis|prophylaxis
4929958|NCT01951651|Diabetes|diabetes
4929959|NCT01951638|Worsening Heart Failure|worsening heart failure
4929960|NCT01951638|Heart Failure with Preserved Ejection Fraction|heart failure with preserved ejection fraction
4929961|NCT01951625|Worsening Heart Failure|worsening heart failure
4929962|NCT01951625|Heart Failure with Reduced Ejection Fraction|heart failure with reduced ejection fraction
4929963|NCT01951612|cognitive impairment|cognitive impairment
4929964|NCT01951612|ischemic white matter disease|ischemic white matter disease
4929965|NCT01951612|small vessel disease|small vessel disease
4929966|NCT01951612|transient ischemic attack|transient ischemic attack
4929967|NCT01951612|mild stroke|mild stroke
4929968|NCT01951612|stroke risk|stroke risk
4929969|NCT01951599|Phase I, healthy, bioavailability, pharmacokinetics, safety, tolerability.|phase i, healthy, bioavailability, pharmacokinetics, safety, tolerability.
4929970|NCT01951573|contact lenses|contact lenses
4929971|NCT01951573|multifocal|multifocal
4929972|NCT01951573|daily disposable|daily disposable
4929973|NCT01951573|silicone hydrogel|silicone hydrogel
4929974|NCT01951573|presbyopia|presbyopia
4929975|NCT01951547|HbA1c|hba1c
4929976|NCT01951547|hs-CRP|hs-crp
4929977|NCT01951547|non-surgical periodontal therapy|non-surgical periodontal therapy
4929978|NCT01951547|oral health education|oral health education
4929979|NCT01951547|probing pocket depth|probing pocket depth
4929980|NCT01951547|plaque index|plaque index
4929981|NCT01951547|gingival bleeding index.|gingival bleeding index.
4929982|NCT01951534|breast reconstruction|breast reconstruction
4929983|NCT01951521|Rectal cancer|rectal cancer
4929984|NCT01951521|Locally advanced rectal cancer|locally advanced rectal cancer
4929985|NCT01951521|Radiotherapy|radiotherapy
4929986|NCT01951521|Boost|boost
4929987|NCT01951521|Dose-escalation|dose-escalation
4929988|NCT01951521|Pathological complete response|pathological complete response
4929989|NCT01951521|Response|response
4929990|NCT01951508|Methylphenidate|methylphenidate
4929991|NCT01951508|Modafinil|modafinil
4929992|NCT01951508|MDMA|mdma
4929993|NCT01951508|fMRI|fmri
4929994|NCT01951508|emotion-processing|emotion-processing
4929995|NCT01951508|social cognition|social cognition
4929996|NCT01951456|Smoking cessation|smoking cessation
4929997|NCT01951456|resistance training|resistance training
4929998|NCT01951443|ginseng|ginseng
4929999|NCT01951443|clinical trial|clinical trial
4930000|NCT01951443|vascular|vascular
4930001|NCT01951443|ginsenosides|ginsenosides
4930002|NCT01951443|blood pressure|blood pressure
4930003|NCT01951430|Adult patients|adult patients
4930004|NCT01951430|Infective events|infective events
4930005|NCT01951430|Antibiotic|antibiotic
4930006|NCT01951430|Antifungal|antifungal
4930007|NCT01951430|Myelodysplastic syndrome|myelodysplastic syndrome
4930008|NCT01951404|Left Ventricular Hypertrophy|left ventricular hypertrophy
4930009|NCT01951404|Allopurinol|allopurinol
4930010|NCT01951404|End Stage Renal Disease|end stage renal disease
4930011|NCT01951404|Haemodialysis|haemodialysis
4930012|NCT01951404|Renal Replacement Therapy|renal replacement therapy
4930013|NCT01951404|MRI|mri
4930014|NCT01951391|study|study
4930015|NCT01951391|subjects|subjects
4930016|NCT01951378|Asthma|asthma
4930017|NCT01951378|Asthma exacerbation|asthma exacerbation
4930018|NCT01951365|Schwannoma|schwannoma
4930019|NCT01951365|Growth|growth
4930020|NCT01951365|intradural|intradural
4930021|NCT01951365|natural history|natural history
4930022|NCT01951352|study|study
4930023|NCT01951352|meant|meant
4930024|NCT01951352|individuals|individuals
4930025|NCT01951339|diabetes|diabetes
4930026|NCT01951339|type 2 diabetes|type 2 diabetes
4930027|NCT01951339|exercise|exercise
4930028|NCT01951339|echo|echo
4930029|NCT01951339|heart|heart
4930030|NCT01951339|sitagliptin|sitagliptin
4930031|NCT01951339|glimepiride|glimepiride
4930032|NCT01951339|cardiovascular|cardiovascular
4930033|NCT01951326|Crohn's Disease|crohn's disease
4930034|NCT01951326|moderate to severe|moderate to severe
4930035|NCT01951326|remission|remission
4930036|NCT01951326|MAP|map
4930037|NCT01951326|antibiotic|antibiotic
4930038|NCT01951313|Meal tolerance test focusing on carotenoids absorption|meal tolerance test focusing on carotenoids absorption
4930040|NCT01951261|COPD|copd
4930041|NCT01951261|Home care|home care
4930042|NCT01951248|chronic kidney disease|chronic kidney disease
4930043|NCT01951248|obstructive sleep apnea|obstructive sleep apnea
4930044|NCT01951248|24-h blood pressure|24-h blood pressure
4930045|NCT01951248|central blood pressure|central blood pressure
4930046|NCT01951248|peripheral blood pressure|peripheral blood pressure
4930047|NCT01951222|Asthma, COPD, broncodilator, airway, lung, inhalation, antimuscarinic|asthma, copd, broncodilator, airway, lung, inhalation, antimuscarinic
4930051|NCT01951209|B-cell|b-cell
4930052|NCT01951209|Rifaximin|rifaximin
4930053|NCT01951196|Chronic kidney disease|chronic kidney disease
4930054|NCT01951196|24 hour blood pressure|24 hour blood pressure
4930055|NCT01951196|central blood pressure|central blood pressure
4930056|NCT01951196|peripheral blood pressure|peripheral blood pressure
4930057|NCT01951196|obstructive sleep apnea|obstructive sleep apnea
4930058|NCT01951144|Phase 1|phase 1
4930059|NCT01951144|Single Dose|single dose
4930060|NCT01951144|Pharmacokinetics|pharmacokinetics
4930061|NCT01951144|Safety|safety
4930062|NCT01951144|Toleration|toleration
4930063|NCT01951144|Pharmacodynamics|pharmacodynamics
4930064|NCT01951118|Smell|smell
4930065|NCT01951118|Olfaction Disorders|olfaction disorders
4930066|NCT01951118|Atropine|atropine
4930067|NCT01951118|Donepezil|donepezil
4930068|NCT01951118|Cholinesterase Inhibitors|cholinesterase inhibitors
4930069|NCT01951118|Cognition Disorders|cognition disorders
4930070|NCT01951105|Subacute|subacute
4930071|NCT01951105|Back|back
4930072|NCT01951105|Pain|pain
4930073|NCT01951105|Brain|brain
4930074|NCT01951105|MRI|mri
4930075|NCT01951092|HIV|hiv
4930076|NCT01951092|adherence|adherence
4930077|NCT01951092|retention|retention
4930078|NCT01951092|texting|texting
4930079|NCT01951079|Digoxin|digoxin
4930080|NCT01951079|Intra-amniotic injection|intra-amniotic injection
4930081|NCT01951079|feticide|feticide
4930082|NCT01951079|second trimester abortion|second trimester abortion
4930083|NCT01951053|Healthy|healthy
4930084|NCT01951053|Safety|safety
4930085|NCT01951053|Tolerability|tolerability
4930086|NCT01951053|Pharmacokinetics|pharmacokinetics
4930087|NCT01951053|Pharmacodynamics|pharmacodynamics
4930088|NCT01951053|JNJ-40411813|jnj-40411813
4930089|NCT01951053|Positive allosteric modulator|positive allosteric modulator
4930090|NCT01951040|Oxytocin, breastfeeding|oxytocin, breastfeeding
4930091|NCT01951027|Safety|safety
4930092|NCT01951027|Pharmacokinetics|pharmacokinetics
4930093|NCT01951027|Pharmacodynamics|pharmacodynamics
4930094|NCT01951027|DLT|dlt
4930095|NCT01951027|Immunogenecity|immunogenecity
4930096|NCT01951014|Adolescence|adolescence
4930097|NCT01951014|Pregnancy|pregnancy
4930098|NCT01951014|Telemedicine|telemedicine
4930099|NCT01951001|Acute Coronary Syndrome, Asians, platelet, prasugrel|acute coronary syndrome, asians, platelet, prasugrel
4930100|NCT01950936|Infection|infection
4930101|NCT01950936|Antibiotics|antibiotics
4930102|NCT01950936|COLD|cold
4930103|NCT01950910|Amyotrophic lateral sclerosis|amyotrophic lateral sclerosis
4930104|NCT01950910|motor neuron disease|motor neuron disease
4930105|NCT01950910|biological markers|biological markers
4930106|NCT01950910|biomarkers|biomarkers
4930107|NCT01950897|muscular dystrophies|muscular dystrophies
4930108|NCT01950897|muscular dystrophy|muscular dystrophy
4930109|NCT01950884|•Non-alcoholic Steatohepatitis (NASH)|•non-alcoholic steatohepatitis (nash)
4930110|NCT01950871|HistoScanning|histoscanning
4930111|NCT01950871|TRUS|trus
4930112|NCT01950871|Prostate cancer|prostate cancer
4930113|NCT01950871|Biopsy guidance|biopsy guidance
4930114|NCT01950845|anesthesiology, Closed-Loop system, automated fluid management, cardiac output optimization, high risk surgical patient, major abdominal surgery|anesthesiology, closed-loop system, automated fluid management, cardiac output optimization, high risk surgical patient, major abdominal surgery
4930115|NCT01950832|Structure of Retina|structure of retina
4930116|NCT01950832|Macular Thickness|macular thickness
4930117|NCT01950832|Retinal Nerve Fiber Layer|retinal nerve fiber layer
4930118|NCT01950832|Choroidal Thickness|choroidal thickness
4930119|NCT01950832|PCOS|pcos
4930120|NCT01950832|Optical Coherence Tomography|optical coherence tomography
4930121|NCT01950819|kidney failure|kidney failure
4930122|NCT01950819|dialysis|dialysis
4930123|NCT01950819|renal failure|renal failure
4930124|NCT01950819|transplantation|transplantation
4930125|NCT01950793|Hyaluronic acid, trigger finger|hyaluronic acid, trigger finger
4930126|NCT01950780|Alopecia Areata|alopecia areata
4930127|NCT01950780|Ruxolitinib|ruxolitinib
4930128|NCT01950728|volunteers|volunteers
4930129|NCT01950728|18 to 65 years|18 to 65 years
4930130|NCT01950728|Males and Females|males and females
4930131|NCT01950715|Irritable Bowel Syndrome|irritable bowel syndrome
4930132|NCT01950715|Sacral Nerve Stimulation|sacral nerve stimulation
4930133|NCT01950715|Gastro-colic response|gastro-colic response
4930134|NCT01950715|Multimodal Stimulation|multimodal stimulation
4930135|NCT01950663|Diagnostic Equipment|diagnostic equipment
4930136|NCT01950663|Validation Studies|validation studies
4930137|NCT01950624|Patient Registry|patient registry
4930138|NCT01950624|Down Syndrome|down syndrome
4930139|NCT01950611|acute promyelocytic leukemia|acute promyelocytic leukemia
4930140|NCT01950611|arsenic trioxide|arsenic trioxide
4930141|NCT01950611|proteasome inhibition|proteasome inhibition
4930142|NCT01950611|bortezomib|bortezomib
4930143|NCT01950598|Boston Keratoprosthesis type I surgery, frozen corneal graft|boston keratoprosthesis type i surgery, frozen corneal graft
4930144|NCT01950585|Hydroxyurea|hydroxyurea
4930145|NCT01950585|Pulmonary Hypertension|pulmonary hypertension
4930146|NCT01950585|Idiopathic Pulmonary Arterial Hypertension|idiopathic pulmonary arterial hypertension
4930147|NCT01950585|Familial Pulmonary Arterial Hypertension|familial pulmonary arterial hypertension
4930148|NCT01950585|CD34 + Cells|cd34 + cells
4930149|NCT01950572|Samples|samples
4930150|NCT01950572|Biobank|biobank
4930151|NCT01950572|Lung Neoplasms|lung neoplasms
4930152|NCT01950572|Ovarian Neoplasms|ovarian neoplasms
4930153|NCT01950559|soy allergy|soy allergy
4930154|NCT01950559|food allergy|food allergy
4930155|NCT01950559|pediatric|pediatric
4930156|NCT01950559|adult|adult
4930157|NCT01950546|silver nanoparticles|silver nanoparticles
4930158|NCT01950546|antimicrobial activity|antimicrobial activity
4930159|NCT01950546|toxicity|toxicity
4930160|NCT01950546|biofilm|biofilm
4930161|NCT01950546|cariostatic agents|cariostatic agents
4930162|NCT01950533|Peanut allergy|peanut allergy
4930163|NCT01950533|Milk allergy|milk allergy
4930164|NCT01950533|Egg allergy|egg allergy
4930165|NCT01950533|Pediatric|pediatric
4930166|NCT01950533|Adult|adult
4930167|NCT01950533|Food allergy|food allergy
4930168|NCT01950520|Adipose Tissue|adipose tissue
4930169|NCT01950520|Adult|adult
4930170|NCT01950520|Body Composition|body composition
4930171|NCT01950520|Brown Adipose Tissue|brown adipose tissue
4930172|NCT01950520|Non-Shivering Thermogenesis|non-shivering thermogenesis
4930173|NCT01950507|Fluconazole|fluconazole
4930174|NCT01950507|Graft Versus Host Disease|graft versus host disease
4930175|NCT01950507|Voriconazole|voriconazole
4930176|NCT01950507|Azoles|azoles
4930177|NCT01950494|hand dermatitis|hand dermatitis
4930178|NCT01950494|health care workers|health care workers
4930179|NCT01950494|hand sanitizer|hand sanitizer
4930180|NCT01950481|LDK378|ldk378
4930181|NCT01950481|pharmacokinetics|pharmacokinetics
4930182|NCT01950481|hepatic impairment|hepatic impairment
4930183|NCT01950468|Parkinson's Disease|parkinson's disease
4930184|NCT01950455|Parkinson's Disease|parkinson's disease
4930185|NCT01950442|malignant strictures|malignant strictures
4930186|NCT01950442|esophageal staging|esophageal staging
4930187|NCT01950429|Microbiome|microbiome
4930188|NCT01950429|Sickle Cell Disease|sickle cell disease
4930189|NCT01950429|Bone Marrow Transplant|bone marrow transplant
4930190|NCT01950416|ST elevation myocardial infarction|st elevation myocardial infarction
4930191|NCT01950416|Fibrinolysis|fibrinolysis
4930192|NCT01950416|Ticagrelor|ticagrelor
4930193|NCT01950416|Clopidogrel|clopidogrel
4930194|NCT01950416|Platelet reactivity|platelet reactivity
4930195|NCT01950377|Dopamine Transporter|dopamine transporter
4930196|NCT01950377|D2 Dopamine Receptor Subtype|d2 dopamine receptor subtype
4930197|NCT01950377|Dopamine|dopamine
4930198|NCT01950377|Dopamine Genes|dopamine genes
4930199|NCT01950377|Dopaminergic Mechanisms|dopaminergic mechanisms
4930200|NCT01950364|Lymphoma|lymphoma
4930201|NCT01950364|Hodgkin|hodgkin
4930202|NCT01950364|Anaplastic Large-cell|anaplastic large-cell
4930203|NCT01950364|Relapsed|relapsed
4930204|NCT01950364|Refractory|refractory
4930205|NCT01950364|Antigens, CD30|antigens, cd30
4930206|NCT01950364|Antibody-Drug Conjugate|antibody-drug conjugate
4930207|NCT01950364|Antibodies, Monoclonal|antibodies, monoclonal
4930208|NCT01950364|Lymphoma, Non-Hodgkin|lymphoma, non-hodgkin
4930209|NCT01950364|Lymphoma, Large-Cell, Anaplastic|lymphoma, large-cell, anaplastic
4930210|NCT01950364|Monomethyl auristatin E|monomethyl auristatin e
4930211|NCT01950364|Drug Therapy|drug therapy
4930212|NCT01950364|Immunotherapy|immunotherapy
4930213|NCT01950364|Hematologic Diseases|hematologic diseases
4930214|NCT01950351|Prostate Cancer|prostate cancer
4930215|NCT01950351|Localized prostate cancer|localized prostate cancer
4930216|NCT01950351|Adenocarcinoma of the prostate|adenocarcinoma of the prostate
4930217|NCT01950351|Proton therapy|proton therapy
4930218|NCT01950351|Radiation therapy|radiation therapy
4930219|NCT01950351|XRT|xrt
4930220|NCT01950351|Gray|gray
4930221|NCT01950351|Gy|gy
4930222|NCT01950351|Questionnaire|questionnaire
4930223|NCT01950351|Survey|survey
4930224|NCT01950325|HIV-1 Viral Load|hiv-1 viral load
4930225|NCT01950325|CD4 Count|cd4 count
4930226|NCT01950325|Antiviral|antiviral
4930227|NCT01950325|HIV-1 Infection|hiv-1 infection
4930228|NCT01950325|Broadly Neutralizing Antibody|broadly neutralizing antibody
4930229|NCT01950312|Autoimmune Inner Ear Disease|autoimmune inner ear disease
4930230|NCT01950312|Inner Ear Disease|inner ear disease
4930231|NCT01950312|Meniere's Disease|meniere's disease
4930232|NCT01950312|Sudden Sensorineural Hearing Loss|sudden sensorineural hearing loss
4930233|NCT01950286|T-cell Acute Lymphoblastic Leukemia|t-cell acute lymphoblastic leukemia
4930234|NCT01950286|chemotherapy|chemotherapy
4930235|NCT01950286|allogeneic stem cell transplantation|allogeneic stem cell transplantation
4930236|NCT01950260|Graves' disease|graves' disease
4930237|NCT01950260|Radioactive iodine|radioactive iodine
4930238|NCT01950260|Hypothyroidism|hypothyroidism
4930239|NCT01950221|Double-blind Trial|double-blind trial
4930240|NCT01950221|Placebo-controlled|placebo-controlled
4930241|NCT01950221|Pomegranate|pomegranate
4930242|NCT01950221|Memory|memory
4930243|NCT01950221|Memory Impairment|memory impairment
4930244|NCT01950221|Cognition|cognition
4930245|NCT01950221|Ages 50-75|ages 50-75
4930246|NCT01950208|Assessment|assessment
4930247|NCT01950195|Melanoma|melanoma
4930248|NCT01950195|Metastases|metastases
4930249|NCT01950195|Brain|brain
4930250|NCT01950195|Spine|spine
4930251|NCT01950195|SRS(Stereotactic Radiosurgery))|srs(stereotactic radiosurgery))
4930252|NCT01950195|Ipilimumab|ipilimumab
4930253|NCT01950182|Luminal B2 subtype|luminal b2 subtype
4930254|NCT01950182|First line treatment|first line treatment
4930255|NCT01950169|Hip fracture|hip fracture
4930256|NCT01950169|Nutritional supplement|nutritional supplement
4930257|NCT01950169|Bisphosphonates|bisphosphonates
4930258|NCT01950169|Bone mineral density|bone mineral density
4930259|NCT01950169|Body composition|body composition
4930260|NCT01950143|prostate cancer prevention|prostate cancer prevention
4930261|NCT01950143|diet|diet
4930262|NCT01950143|global gene expression|global gene expression
4930263|NCT01950143|metabolic changes|metabolic changes
4930264|NCT01950130|IABP|iabp
4930265|NCT01950130|IABC|iabc
4930266|NCT01950130|coronary artery disease|coronary artery disease
4930267|NCT01950130|prophylactic|prophylactic
4930268|NCT01950130|cardiac assist|cardiac assist
4930269|NCT01950117|nonpedunculated|nonpedunculated
4930270|NCT01950117|neoplastic|neoplastic
4930271|NCT01950117|colorectal|colorectal
4930272|NCT01950117|polyps|polyps
4930273|NCT01950104|Embryo biopsy|embryo biopsy
4930274|NCT01950104|Blastocyst stage|blastocyst stage
4930275|NCT01950104|Day 3|day 3
4930276|NCT01950104|Preimplantation genetic screening|preimplantation genetic screening
4930277|NCT01950091|low back pain|low back pain
4930278|NCT01950091|internet|internet
4930279|NCT01950091|app|app
4930280|NCT01950091|prevention|prevention
4930281|NCT01950091|treatment|treatment
4930282|NCT01950078|gene polymorphism|gene polymorphism
4930283|NCT01950078|pain perception|pain perception
4930284|NCT01950078|postoperative pain|postoperative pain
4930285|NCT01950052|VLCD|vlcd
4930286|NCT01950052|Low calorie diet|low calorie diet
4930287|NCT01950052|very low calorie diet|very low calorie diet
4930288|NCT01950052|pre-operative diet|pre-operative diet
4930289|NCT01950052|liver shrinking diet|liver shrinking diet
4930290|NCT01950052|bariatric surgery|bariatric surgery
4930291|NCT01950052|gastric bypass|gastric bypass
4930292|NCT01950039|Obesity|obesity
4930293|NCT01950039|Glucose Intolerance|glucose intolerance
4930294|NCT01950026|skin temperature|skin temperature
4930295|NCT01950026|ethnic groups|ethnic groups
4930296|NCT01950026|cryotherapy|cryotherapy
4930297|NCT01950013|Presbycusis|presbycusis
4930298|NCT01950013|Aging|aging
4930299|NCT01950013|hearing aids|hearing aids
4930300|NCT01950013|hearing training|hearing training
4930301|NCT01950000|Pain. Analgesia. Prevention|pain. analgesia. prevention
4930302|NCT01949974|Palliative Chemotherapy|palliative chemotherapy
4930303|NCT01949974|Integral Attention Program|integral attention program
4930304|NCT01949974|Advanced cancer|advanced cancer
4930305|NCT01949974|Randomized Clinical Trial|randomized clinical trial
4930306|NCT01949961|intervention|intervention
4930307|NCT01949961|sonothrombolysis|sonothrombolysis
4930308|NCT01949961|Ultrasound treatment|ultrasound treatment
4930309|NCT01949948|treatment, intervention, thrombolysis|treatment, intervention, thrombolysis
4930310|NCT01949935|Mupirocin|mupirocin
4930311|NCT01949935|Surgical Site Infections|surgical site infections
4930312|NCT01949935|Coronary Artery Bypass Grafting|coronary artery bypass grafting
4930313|NCT01949922|regenerative medicine|regenerative medicine
4930314|NCT01949922|fecal incontinence|fecal incontinence
4930315|NCT01949922|muscle fiber injection|muscle fiber injection
4930316|NCT01949909|plasmodium falciparum|plasmodium falciparum
4930317|NCT01949909|long synthetic peptide|long synthetic peptide
4930318|NCT01949909|antibody|antibody
4930319|NCT01949909|T cell|t cell
4930320|NCT01949909|cytokine|cytokine
4930321|NCT01949909|vaccine|vaccine
4930322|NCT01949909|safety|safety
4930323|NCT01949909|phase 1|phase 1
4930324|NCT01949896|Pro inflammatory cytokine|pro inflammatory cytokine
4930325|NCT01949896|Necrotizing enterocolitis|necrotizing enterocolitis
4930326|NCT01949896|Packed red blood cell transfusion|packed red blood cell transfusion
4930327|NCT01949883|Phase 1|phase 1
4930328|NCT01949883|Oncology|oncology
4930329|NCT01949883|BET Inhibitor|bet inhibitor
4930330|NCT01949857|Hepatitis A|hepatitis a
4930331|NCT01949857|Vaccine|vaccine
4930332|NCT01949857|Safety|safety
4930333|NCT01949857|efficacy|efficacy
4930334|NCT01949844|MRI|mri
4930335|NCT01949844|Magnetic Resonance Imaging|magnetic resonance imaging
4930336|NCT01949844|myocardial perfusion|myocardial perfusion
4930337|NCT01949844|myocardial perfusion imaging|myocardial perfusion imaging
4930338|NCT01949844|Novel MRI Techniques|novel mri techniques
4930339|NCT01949831|functional assessment|functional assessment
4930340|NCT01949831|acute care|acute care
4930341|NCT01949831|older medical patients|older medical patients
4930342|NCT01949753|Obsessive-compulsive disorder (OCD)|obsessive-compulsive disorder (ocd)
4930343|NCT01949753|Exposure therapy|exposure therapy
4930344|NCT01949753|Extinction learning|extinction learning
4930345|NCT01949753|Pregnenolone|pregnenolone
4930346|NCT01949727|AECOPD|aecopd
4930347|NCT01949727|COPD|copd
4930348|NCT01949727|Emphysema|emphysema
4930349|NCT01949727|Chronic bronchitis|chronic bronchitis
4930350|NCT01949675|Cholera|cholera
4930351|NCT01949675|Shanchol™|shanchol™
4930352|NCT01949675|Cholera Vaccine|cholera vaccine
4930353|NCT01949662|Advanced Cancers|advanced cancers
4930354|NCT01949662|Locally advanced cancer|locally advanced cancer
4930355|NCT01949662|Metastatic cancer|metastatic cancer
4930356|NCT01949662|Recurrent cancer|recurrent cancer
4930357|NCT01949662|Incurable cancer|incurable cancer
4930358|NCT01949662|Delirium|delirium
4930359|NCT01949662|Agitation|agitation
4930360|NCT01949662|Lorazepam|lorazepam
4930361|NCT01949662|Haloperidol|haloperidol
4930362|NCT01949662|Placebo|placebo
4930363|NCT01949662|Questionnaires|questionnaires
4930364|NCT01949662|Surveys|surveys
4930365|NCT01949662|Acute palliative care unit|acute palliative care unit
4930366|NCT01949649|body image|body image
4930367|NCT01949649|body dissatisfaction|body dissatisfaction
4930368|NCT01949623|RP|rp
4930369|NCT01949610|Healthy Participants|healthy participants
4930370|NCT01949610|JNJ26489112|jnj26489112
4930371|NCT01949610|14C-JNJ26489112|14c-jnj26489112
4930372|NCT01949610|Absorption|absorption
4930373|NCT01949610|Metabolism|metabolism
4930374|NCT01949610|Excretion|excretion
4930375|NCT01949571|Mirtazapine.|mirtazapine.
4930376|NCT01949571|Addiction.|addiction.
4930377|NCT01949571|Cocaine.|cocaine.
4930378|NCT01949571|Cocaine-craving.|cocaine-craving.
4930379|NCT01949571|Cocaine-withdrawal|cocaine-withdrawal
4930380|NCT01949558|diet|diet
4930381|NCT01949558|lifestyle|lifestyle
4930382|NCT01949519|prostate cancer|prostate cancer
4930383|NCT01949519|lycopene|lycopene
4930384|NCT01949519|docetaxel|docetaxel
4930385|NCT01949519|metastatic|metastatic
4930386|NCT01949519|castration resistant|castration resistant
4930387|NCT01949506|Lung metastases|lung metastases
4930388|NCT01949506|Radiation Therapy|radiation therapy
4930389|NCT01949506|Stereotactic Body Radiation Therapy|stereotactic body radiation therapy
4930390|NCT01949493|carpal tunnel syndrome|carpal tunnel syndrome
4930391|NCT01949493|traction|traction
4930392|NCT01949493|mechanical traction|mechanical traction
4930393|NCT01949493|Phystrac|phystrac
4930394|NCT01949480|Peripheral nerve block|peripheral nerve block
4930395|NCT01949480|Ultrasound guidance|ultrasound guidance
4930396|NCT01949480|Postoperative pain management post status thoracotomy|postoperative pain management post status thoracotomy
4930397|NCT01949480|Postoperative pain management post status VATS|postoperative pain management post status vats
4930398|NCT01949467|ferroportin disease|ferroportin disease
4930399|NCT01949467|dysmetabolic hepatosiderosis|dysmetabolic hepatosiderosis
4930400|NCT01949467|genetic hemochromatosis|genetic hemochromatosis
4930401|NCT01949467|hyperferritinemia|hyperferritinemia
4930402|NCT01949467|hepcidin|hepcidin
4930403|NCT01949467|iron fumarate|iron fumarate
4930404|NCT01949467|physiopathological study|physiopathological study
4930405|NCT01949467|diagnosis|diagnosis
4930406|NCT01949467|HFE gene|hfe gene
4930407|NCT01949467|TRF2 gene|trf2 gene
4930408|NCT01949467|iron parameters|iron parameters
4930409|NCT01949467|divalent cations|divalent cations
4930410|NCT01949454|trachoma|trachoma
4930411|NCT01949454|trichiasis|trichiasis
4930412|NCT01949454|trachomatous trichiasis|trachomatous trichiasis
4930413|NCT01949454|bilamellar tarsal rotation|bilamellar tarsal rotation
4930414|NCT01949454|fluorometholone|fluorometholone
4930415|NCT01949454|placebo controlled|placebo controlled
4930416|NCT01949441|HDM Allergy|hdm allergy
4930417|NCT01949441|Rhinoconjunctivitis|rhinoconjunctivitis
4930418|NCT01949441|Immunotherapy|immunotherapy
4930419|NCT01949441|ToleroMune HDM|toleromune hdm
4930420|NCT01949428|HDM Allergy|hdm allergy
4930421|NCT01949428|Rhinoconjunctivitis|rhinoconjunctivitis
4930422|NCT01949415|House Dust Mite|house dust mite
4930423|NCT01949415|Rhinoconjunctivitis|rhinoconjunctivitis
4930424|NCT01949415|ToleroMune|toleromune
4930425|NCT01949376|breast cancer|breast cancer
4930426|NCT01949376|invasive ductal carcinoma|invasive ductal carcinoma
4930427|NCT01949376|cognitive impairment|cognitive impairment
4930428|NCT01949376|adjuvant therapy|adjuvant therapy
4930429|NCT01949376|hormone therapy|hormone therapy
4930430|NCT01949376|hormonal therapy|hormonal therapy
4930431|NCT01949376|chemotherapy|chemotherapy
4930432|NCT01949376|chemo brain|chemo brain
4930433|NCT01949376|MRI|mri
4930434|NCT01949363|Gonococcal Infections, Cefixime, Neisseria gonorrhoeae, Azithromycin, antibiotic, cephalosporin|gonococcal infections, cefixime, neisseria gonorrhoeae, azithromycin, antibiotic, cephalosporin
4930435|NCT01949324|MacTel|mactel
4930436|NCT01949298|immediate loading of dental implant|immediate loading of dental implant
4930437|NCT01949298|implant supported over denture|implant supported over denture
4930438|NCT01949285|Spinal cord injury|spinal cord injury
4930439|NCT01949285|Paralysis|paralysis
4930440|NCT01949285|Rehabilitation|rehabilitation
4930441|NCT01949285|Assessment|assessment
4930442|NCT01949285|Theranostics|theranostics
4930443|NCT01949272|ARDS|ards
4930444|NCT01949259|Retrospective|retrospective
4930445|NCT01949259|Lung cancer|lung cancer
4930446|NCT01949246|Biomarkers|biomarkers
4930447|NCT01949220|Inherited|inherited
4930448|NCT01949220|Von Willebrand disease|von willebrand disease
4930449|NCT01949220|Von Willebrand factor|von willebrand factor
4930450|NCT01949220|Deficiency|deficiency
4930451|NCT01949220|safety|safety
4930452|NCT01949207|Incompetent perforating veins|incompetent perforating veins
4930453|NCT01949207|EVLA|evla
4930454|NCT01949207|Phlebectomies|phlebectomies
4930455|NCT01949207|TRansluminal Occlusion of Perforators (TRLOP) closure of incompetent perforators.|transluminal occlusion of perforators (trlop) closure of incompetent perforators.
4930456|NCT01949194|liver metastases|liver metastases
4930457|NCT01949181|Metals|metals
4930458|NCT01949181|Metalloids|metalloids
4930459|NCT01949181|Blood|blood
4930460|NCT01949181|Hair|hair
4930461|NCT01949181|Lung|lung
4930462|NCT01949181|Lung cancer|lung cancer
4930463|NCT01949181|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
4930464|NCT01949155|otitis media|otitis media
4930465|NCT01949155|otorrhea|otorrhea
4930466|NCT01949155|middle ear effusion|middle ear effusion
4930467|NCT01949155|tympanostomy tubes|tympanostomy tubes
4930468|NCT01949142|otitis media|otitis media
4930469|NCT01949142|otorrhea|otorrhea
4930470|NCT01949142|middle ear effusion|middle ear effusion
4930471|NCT01949142|tympanostomy tubes|tympanostomy tubes
4930472|NCT01949129|stem cell transplantation|stem cell transplantation
4930473|NCT01949129|children and adolescents|children and adolescents
4930474|NCT01949129|high risk acute lymphoblastic leukaemia|high risk acute lymphoblastic leukaemia
4930475|NCT01949103|Gram-positive|gram-positive
4930476|NCT01949090|H7N1|h7n1
4930477|NCT01949090|AS03 adjuvant|as03 adjuvant
4930478|NCT01949090|Safety|safety
4930479|NCT01949090|Immunogenicity|immunogenicity
4930480|NCT01949090|Influenza|influenza
4930481|NCT01949090|Adults|adults
4930482|NCT01949090|Elderly adults|elderly adults
4930483|NCT01949077|Hepatitis|hepatitis
4930484|NCT01949077|Hepatitis C|hepatitis c
4930485|NCT01949077|Observational study|observational study
4930486|NCT01949077|Biomarkers of treatment response|biomarkers of treatment response
4930487|NCT01949051|Allergic rhinitis|allergic rhinitis
4930488|NCT01949051|levocabastine|levocabastine
4930489|NCT01949051|allergen challenge|allergen challenge
4930490|NCT01949038|Pain|pain
4930491|NCT01949038|Discomfort|discomfort
4930492|NCT01949038|Anxiety|anxiety
4930493|NCT01949038|Satisfaction|satisfaction
4930494|NCT01949038|Compliance|compliance
4930495|NCT01949012|Midazolam|midazolam
4930496|NCT01949012|Endtidal carbon dioxide|endtidal carbon dioxide
4930497|NCT01949012|Desaturation|desaturation
4930498|NCT01948999|electroconvulsive therapy|electroconvulsive therapy
4930499|NCT01948999|treatment-refractory schizophrenia|treatment-refractory schizophrenia
4930500|NCT01948973|Irritable Bowel Syndrome|irritable bowel syndrome
4930501|NCT01948973|Sacral Nerve Stimulation|sacral nerve stimulation
4930502|NCT01948973|Symptoms|symptoms
4930503|NCT01948973|Quality of Life|quality of life
4930504|NCT01948973|Bowel habits|bowel habits
4930505|NCT01948960|Breast Neoplasms|breast neoplasms
4930506|NCT01948960|everolimus|everolimus
4930507|NCT01948960|pharmacokinetics|pharmacokinetics
4930508|NCT01948960|elderly patients|elderly patients
4930509|NCT01948960|obese patients|obese patients
4930510|NCT01948934|Skin|skin
4930511|NCT01948934|Injury|injury
4930512|NCT01948934|Membrane amniotic|membrane amniotic
4930513|NCT01948934|Wound|wound
4930514|NCT01948921|EGD|egd
4930515|NCT01948921|tolerance|tolerance
4930516|NCT01948921|discomfort|discomfort
4930517|NCT01948908|Sedation|sedation
4930518|NCT01948908|Laceration repair|laceration repair
4930519|NCT01948908|Children|children
4930520|NCT01948908|Intranasal|intranasal
4930521|NCT01948908|Midazolam|midazolam
4930522|NCT01948895|Desvenlafaxine|desvenlafaxine
4930523|NCT01948895|Open-label|open-label
4930524|NCT01948895|Flexible-dose|flexible-dose
4930525|NCT01948895|Dysthymic disorder|dysthymic disorder
4930526|NCT01948895|Anxiety disorders|anxiety disorders
4930527|NCT01948895|Generalized anxiety disorder|generalized anxiety disorder
4930528|NCT01948895|Social anxiety disorder|social anxiety disorder
4930529|NCT01948895|Post-traumatic stress disorder|post-traumatic stress disorder
4930530|NCT01948882|Birth control|birth control
4930531|NCT01948869|Phoenix|phoenix
4930532|NCT01948869|Mild atopic dermatitis|mild atopic dermatitis
4930533|NCT01948869|efficacy|efficacy
4930534|NCT01948869|safety|safety
4930535|NCT01948856|Recurrent common cold|recurrent common cold
4930536|NCT01948856|laryngitis|laryngitis
4930537|NCT01948856|pharyngitis/tonsillitis|pharyngitis/tonsillitis
4930538|NCT01948856|acute rhinitis|acute rhinitis
4930539|NCT01948856|acute rhinosinusitis|acute rhinosinusitis
4930540|NCT01948856|acute otitis media|acute otitis media
4930541|NCT01948843|HER2 Negative Metastatic Breast Cancer|her2 negative metastatic breast cancer
4930542|NCT01948830|Ranibizumab, Lucentis, choroidal neovascularization, age-related macular degeneration, treat and extend regimen|ranibizumab, lucentis, choroidal neovascularization, age-related macular degeneration, treat and extend regimen
4930543|NCT01948817|Thalassemia|thalassemia
4930544|NCT01948791|Alzheimer's disease|alzheimer's disease
4930545|NCT01948791|ENA713|ena713
4930546|NCT01948791|Chinese patients|chinese patients
4930547|NCT01948791|INSTINCT|instinct
4930548|NCT01948765|xenon anesthesia|xenon anesthesia
4930549|NCT01948765|Off-pump coronary artery bypass graft surgery|off-pump coronary artery bypass graft surgery
4930550|NCT01948752|Nutrition policy|nutrition policy
4930551|NCT01948752|food labelling|food labelling
4930552|NCT01948752|diet|diet
4930553|NCT01948752|obesity|obesity
4930554|NCT01948752|health behavior|health behavior
4930555|NCT01948739|Brain machine interface|brain machine interface
4930556|NCT01948739|Rehabilitation robotics|rehabilitation robotics
4930557|NCT01948739|Stroke|stroke
4930558|NCT01948739|Hemiparesis|hemiparesis
4930559|NCT01948726|Breast cancer|breast cancer
4930560|NCT01948726|Hypofractionation|hypofractionation
4930561|NCT01948726|Simultaneous integrated boost|simultaneous integrated boost
4930562|NCT01948726|Toxicity|toxicity
4930563|NCT01948700|Motivational Interviewing|motivational interviewing
4930564|NCT01948700|Problem Drinking|problem drinking
4930565|NCT01948700|Adolescents|adolescents
4930566|NCT01948700|Minority Health|minority health
4930567|NCT01948687|real time elastography|real time elastography
4930568|NCT01948687|hepatitis|hepatitis
4930569|NCT01948648|plant sterols|plant sterols
4930570|NCT01948648|cholesterol|cholesterol
4930571|NCT01948648|colesevelam|colesevelam
4930572|NCT01948648|phytosterolemia|phytosterolemia
4930573|NCT01948648|fish oil|fish oil
4930574|NCT01948635|tracheal cuff shape|tracheal cuff shape
4930575|NCT01948635|microaspiration|microaspiration
4930576|NCT01948635|pepsin|pepsin
4930577|NCT01948635|ventilator-associated pneumonia|ventilator-associated pneumonia
4930578|NCT01948622|Anxiety|anxiety
4930579|NCT01948622|Third molar surgery|third molar surgery
4930580|NCT01948622|Blood pressure|blood pressure
4930581|NCT01948622|Heart rate|heart rate
4930582|NCT01948622|Oxygen saturation|oxygen saturation
4930583|NCT01948596|pregnant women|pregnant women
4930584|NCT01948596|depression|depression
4930585|NCT01948596|depressive symptoms|depressive symptoms
4930586|NCT01948596|omega-3 fatty acids|omega-3 fatty acids
4930587|NCT01948583|vaginal dryness|vaginal dryness
4930588|NCT01948583|hyaluronic acid|hyaluronic acid
4930589|NCT01948583|menopause|menopause
4930590|NCT01948570|acne,comedones, oily skin|acne,comedones, oily skin
4930591|NCT01948557|Breastfeeding|breastfeeding
4930592|NCT01948557|Infants|infants
4930593|NCT01948557|Mother to child transmission of HIV|mother to child transmission of hiv
4930594|NCT01948557|Survival|survival
4930595|NCT01948544|COPD|copd
4930596|NCT01948544|LTOT|ltot
4930597|NCT01948544|Long-Term Oxygen Therapy|long-term oxygen therapy
4930598|NCT01948544|Portable Oxygen Concentrator|portable oxygen concentrator
4930599|NCT01948544|Quality of Life|quality of life
4930600|NCT01948544|Six Minute Walk Distance Test|six minute walk distance test
4930601|NCT01948531|Antiage|antiage
4930602|NCT01948518|Pulmonary hypertension|pulmonary hypertension
4930603|NCT01948518|Parenchymal Lung Disease|parenchymal lung disease
4930604|NCT01948518|Diffusion Capacity|diffusion capacity
4930605|NCT01948505|Craniotomy|craniotomy
4930606|NCT01948466|Nutrition|nutrition
4930607|NCT01948466|Commercials|commercials
4930608|NCT01948466|Elementary|elementary
4930609|NCT01948466|Lunchroom|lunchroom
4930610|NCT01948466|Fruits|fruits
4930611|NCT01948466|Vegetables|vegetables
4930612|NCT01948453|CAD|cad
4930613|NCT01948453|CIMT|cimt
4930614|NCT01948453|FMD|fmd
4930615|NCT01948440|Substance abuse, early recovery, relapse prevention|substance abuse, early recovery, relapse prevention
4930616|NCT01948427|UCD|ucd
4930617|NCT01948427|BUPHENYL|buphenyl
4930618|NCT01948427|RAVICTI|ravicti
4930619|NCT01948427|Urea|urea
4930620|NCT01948427|Urea cycle disorder|urea cycle disorder
4930621|NCT01948427|Glycerol phenylbutyrate|glycerol phenylbutyrate
4930622|NCT01948427|Benzoate|benzoate
4930623|NCT01948427|Sodium phenylbutyrate|sodium phenylbutyrate
4930624|NCT01948427|Ornithine transcarbamylase (OTC)|ornithine transcarbamylase (otc)
4930625|NCT01948427|Argininosuccinate synthetase (ASS)|argininosuccinate synthetase (ass)
4930626|NCT01948427|Argininosuccinate lyase (ASL)|argininosuccinate lyase (asl)
4930627|NCT01948427|Carbamyl phosphate synthetase (CPS)|carbamyl phosphate synthetase (cps)
4930628|NCT01948427|Arginine|arginine
4930629|NCT01948427|Citrulline|citrulline
4930630|NCT01948427|Ammonia|ammonia
4930631|NCT01948414|Obesity|obesity
4930632|NCT01948414|Hyperalimentation|hyperalimentation
4930633|NCT01948414|Event-Related Potential|event-related potential
4930634|NCT01948414|P300|p300
4930635|NCT01948388|Rheumatoid arthritis|rheumatoid arthritis
4930636|NCT01948375|subject blinding|subject blinding
4930637|NCT01948375|placebo needle|placebo needle
4930638|NCT01948336|Contrast-induced nephropathy, Dexmedetomidine, Endothelin-1|contrast-induced nephropathy, dexmedetomidine, endothelin-1
4930639|NCT01948323|Pregnancy|pregnancy
4930640|NCT01948323|Maternal health|maternal health
4930641|NCT01948323|Newborn health|newborn health
4930642|NCT01948323|Information technology|information technology
4930643|NCT01948323|Health education|health education
4930644|NCT01948323|Cellphone|cellphone
4930645|NCT01948323|Touch screen technology|touch screen technology
4930646|NCT01948323|Pregnancy outcome|pregnancy outcome
4930647|NCT01948323|Low-Middle income|low-middle income
4930648|NCT01948323|Nurse-led|nurse-led
4930649|NCT01948323|Nutrition|nutrition
4930650|NCT01948323|Exercise|exercise
4930651|NCT01948284|cecal intubation time|cecal intubation time
4930652|NCT01948284|water exchange|water exchange
4930653|NCT01948284|pain|pain
4930654|NCT01948271|Psoriasis|psoriasis
4930655|NCT01948271|Trichuris suis ova|trichuris suis ova
4930656|NCT01948271|T-lymphocytes|t-lymphocytes
4930657|NCT01948258|Pregnancy|pregnancy
4930658|NCT01948245|Catheter Related Blood Stream Infection|catheter related blood stream infection
4930659|NCT01948245|Long-term intestinal Failure|long-term intestinal failure
4930660|NCT01948245|Taurolidine|taurolidine
4930661|NCT01948245|Catheter lock solution|catheter lock solution
4930662|NCT01948245|Antimicrobial agent|antimicrobial agent
4930663|NCT01948245|Home Parenteral Nutrition|home parenteral nutrition
4930664|NCT01948245|Anti-infective agents|anti-infective agents
4930665|NCT01948206|Sudden Cardiac Death|sudden cardiac death
4930666|NCT01948206|Implantable Cardioverter-Defibrillator|implantable cardioverter-defibrillator
4930667|NCT01948206|Cardiomyopathy|cardiomyopathy
4930668|NCT01948206|Prolonged Paced QRS Duration|prolonged paced qrs duration
4930669|NCT01948193|Diphtheria|diphtheria
4930670|NCT01948193|Tetanus|tetanus
4930671|NCT01948193|Whooping Cough|whooping cough
4930672|NCT01948193|Hepatitis B|hepatitis b
4930673|NCT01948193|Poliomyelitis|poliomyelitis
4930674|NCT01948193|DTaP IPV-Hep B-PRP~T combined vaccine (Hexaxim™)|dtap ipv-hep b-prp~t combined vaccine (hexaxim™)
4930675|NCT01948180|NKTCL|nktcl
4930676|NCT01948180|T cell|t cell
4930677|NCT01948180|CITADEL|citadel
4930678|NCT01948180|Epstein-Barr Virus|epstein-barr virus
4930679|NCT01948180|Natural Killer|natural killer
4930680|NCT01948167|Depression|depression
4930681|NCT01948167|Prevention|prevention
4930682|NCT01948167|Adolescents|adolescents
4930683|NCT01948154|Cerebral Palsy|cerebral palsy
4930684|NCT01948154|Early Intervention|early intervention
4930685|NCT01948154|Speech Function|speech function
4930686|NCT01948154|Quality of Life|quality of life
4930687|NCT01948128|Breast|breast
4930688|NCT01948115|Breech presentation|breech presentation
4930689|NCT01948115|equimolar mixture of oxygen and nitrous oxide|equimolar mixture of oxygen and nitrous oxide
4930690|NCT01948115|external cephalic version|external cephalic version
4930691|NCT01948102|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
4930692|NCT01948102|motor neuron disease|motor neuron disease
4930693|NCT01948102|biological markers|biological markers
4930694|NCT01948102|biomarkers|biomarkers
4930695|NCT01948089|Chronic Stroke|chronic stroke
4930696|NCT01948089|near transfer|near transfer
4930697|NCT01948089|far transfer|far transfer
4930698|NCT01948089|working memory|working memory
4930699|NCT01948089|fluid intelligence|fluid intelligence
4930700|NCT01948089|cognitive training|cognitive training
4930701|NCT01948089|dual n-back|dual n-back
4930702|NCT01948076|splenomegaly|splenomegaly
4930703|NCT01948076|pleural effusion|pleural effusion
4930704|NCT01948037|hydrotherapy|hydrotherapy
4930705|NCT01948037|randomized controlled trial|randomized controlled trial
4930706|NCT01948037|lower extremity arterial disease|lower extremity arterial disease
4930707|NCT01948037|diabetes|diabetes
4930708|NCT01947998|Rivaroxaban|rivaroxaban
4930709|NCT01947998|Stroke Prevention in Atrial Fibrillation,|stroke prevention in atrial fibrillation,
4930710|NCT01947998|Anticoagulants|anticoagulants
4930711|NCT01947998|Hematologic Agents|hematologic agents
4930712|NCT01947998|Therapeutic Uses|therapeutic uses
4930713|NCT01947998|Observational|observational
4930714|NCT01947998|Venous Thromboembolism|venous thromboembolism
4930715|NCT01947998|Secondary Prevention of Acute Coronary Syndrome|secondary prevention of acute coronary syndrome
4930716|NCT01947998|Intracranial Hemorrhages|intracranial hemorrhages
4930717|NCT01947998|Gastrointestinal Hemorrhage,|gastrointestinal hemorrhage,
4930718|NCT01947985|Rivaroxaban|rivaroxaban
4930719|NCT01947985|Stroke Prevention in Atrial Fibrillation,|stroke prevention in atrial fibrillation,
4930720|NCT01947985|Anticoagulants|anticoagulants
4930721|NCT01947985|Hematologic Agents|hematologic agents
4930722|NCT01947985|Therapeutic Uses|therapeutic uses
4930723|NCT01947985|Observational|observational
4930724|NCT01947985|Venous Thromboembolism|venous thromboembolism
4930725|NCT01947985|Secondary Prevention of Acute Coronary Syndrome|secondary prevention of acute coronary syndrome
4930726|NCT01947985|Intracranial Hemorrhages|intracranial hemorrhages
4930727|NCT01947985|Gastrointestinal Hemorrhage|gastrointestinal hemorrhage
4930728|NCT01947972|preterm neonate|preterm neonate
4930729|NCT01947972|tailored fortification|tailored fortification
4930730|NCT01947972|nutrition|nutrition
4930731|NCT01947972|maternal breast milk composition|maternal breast milk composition
4930732|NCT01947959|Rivaroxaban|rivaroxaban
4930733|NCT01947959|Stroke Prevention in Atrial Fibrillation,|stroke prevention in atrial fibrillation,
4930734|NCT01947959|Anticoagulants|anticoagulants
4930735|NCT01947959|Hematologic Agents|hematologic agents
4930736|NCT01947959|Therapeutic Uses|therapeutic uses
4930737|NCT01947959|Observational|observational
4930738|NCT01947959|Venous Thromboembolism|venous thromboembolism
4930739|NCT01947959|Secondary Prevention of Acute Coronary Syndrome|secondary prevention of acute coronary syndrome
4930740|NCT01947959|Intracranial Hemorrhages|intracranial hemorrhages
4930741|NCT01947959|Gastrointestinal Hemorrhage,|gastrointestinal hemorrhage,
4930742|NCT01947946|Asthma, Bronchial Diseases, Respiratory Tract Diseases, Lung Diseases, Obstructive Lung Diseases|asthma, bronchial diseases, respiratory tract diseases, lung diseases, obstructive lung diseases
4930743|NCT01947920|Healthy|healthy
4930744|NCT01947920|Pain|pain
4930745|NCT01947920|Tramadol hydrochloride|tramadol hydrochloride
4930746|NCT01947920|Tramadol HCl|tramadol hcl
4930747|NCT01947920|Analgesic|analgesic
4930748|NCT01947920|QT prolongation|qt prolongation
4930749|NCT01947920|RWJ-26898-002|rwj-26898-002
4930750|NCT01947907|Human Growth Hormone|human growth hormone
4930751|NCT01947907|rhGH|rhgh
4930752|NCT01947907|hGH|hgh
4930753|NCT01947907|GHD|ghd
4930754|NCT01947881|Diabetic Macular Edema|diabetic macular edema
4930755|NCT01947881|anti-VEGF|anti-vegf
4930756|NCT01947881|Treatment Response|treatment response
4930757|NCT01947842|Smartphone|smartphone
4930758|NCT01947842|adherence|adherence
4930759|NCT01947842|contraceptives|contraceptives
4930760|NCT01947842|college|college
4930761|NCT01947842|females|females
4930762|NCT01947829|hemodialysis|hemodialysis
4930763|NCT01947829|dialysis dose|dialysis dose
4930764|NCT01947816|Ulcerative Colitis|ulcerative colitis
4930765|NCT01947803|Schizophrenia|schizophrenia
4930766|NCT01947803|Paliperidone|paliperidone
4930767|NCT01947803|Safety|safety
4930768|NCT01947803|Effectiveness|effectiveness
4930769|NCT01947803|Chinese|chinese
4930770|NCT01947790|Type 2 diabetes|type 2 diabetes
4930771|NCT01947790|left ventricular mass|left ventricular mass
4930772|NCT01947790|pioglitazone|pioglitazone
4930773|NCT01947777|Phase 1|phase 1
4930774|NCT01947777|Healthy subjects|healthy subjects
4930775|NCT01947777|DDI|ddi
4930776|NCT01947777|CYP3A|cyp3a
4930777|NCT01947764|HIV|hiv
4930778|NCT01947764|Disclosure|disclosure
4930779|NCT01947764|Pediatrics|pediatrics
4930780|NCT01947751|Catheter related infection|catheter related infection
4930781|NCT01947751|Central venous catheter|central venous catheter
4930782|NCT01947751|CVC infection|cvc infection
4930783|NCT01947738|Healthy|healthy
4930784|NCT01947738|Subjects|subjects
4930785|NCT01947738|Safety|safety
4930786|NCT01947738|Tolerability|tolerability
4930787|NCT01947738|VBY891|vby891
4930788|NCT01947738|Maximum|maximum
4930789|NCT01947738|Pharmacodynamic|pharmacodynamic
4930790|NCT01947738|Pharmacokinetic|pharmacokinetic
4930791|NCT01947712|Peripheral arterial disease|peripheral arterial disease
4930792|NCT01947712|Oxidative stress|oxidative stress
4930793|NCT01947712|Cocoa|cocoa
4930794|NCT01947712|polyphenols|polyphenols
4930795|NCT01947712|NADPH oxidase|nadph oxidase
4930796|NCT01947686|osteoarthritis, patellofemoral|osteoarthritis, patellofemoral
4930797|NCT01947647|behavior therapy|behavior therapy
4930798|NCT01947647|Randomized Controlled Trials|randomized controlled trials
4930799|NCT01947647|Depressive Disorder|depressive disorder
4930800|NCT01947647|Anxiety Disorders|anxiety disorders
4930801|NCT01947647|comorbidity|comorbidity
4930802|NCT01947621|Broken heart syndrome, stress cardiomyopathy|broken heart syndrome, stress cardiomyopathy
4930803|NCT01947595|diabetes mellitus type 2|diabetes mellitus type 2
4930804|NCT01947595|impaired glucose tolerance|impaired glucose tolerance
4930805|NCT01947595|lifestyle intervention|lifestyle intervention
4930806|NCT01947595|body fat distribution|body fat distribution
4930807|NCT01947595|prevention|prevention
4930808|NCT01947582|multiple sclerosis|multiple sclerosis
4930809|NCT01947582|gait|gait
4930810|NCT01947582|ankle foot orthosis (AFO)|ankle foot orthosis (afo)
4930811|NCT01947556|diabetes|diabetes
4930812|NCT01947556|insulin administration|insulin administration
4930813|NCT01947556|hyperglycaemia|hyperglycaemia
4930814|NCT01947556|insulin aspart|insulin aspart
4930815|NCT01947478|Drug-Eluting Angioplasty Balloon|drug-eluting angioplasty balloon
4930816|NCT01947478|Drug Coated Angioplasty Balloon|drug coated angioplasty balloon
4930817|NCT01947478|Peripheral Artery Disease|peripheral artery disease
4930818|NCT01947478|Experimental|experimental
4930819|NCT01947478|Percutaneous Transluminal Angioplasty (PTA)|percutaneous transluminal angioplasty (pta)
4930820|NCT01947452|Youth violence reduction|youth violence reduction
4930821|NCT01947452|Youth crime reduction|youth crime reduction
4930822|NCT01947452|School engagement|school engagement
4930823|NCT01947452|Employment|employment
4930824|NCT01947452|Social-emotional learning|social-emotional learning
4930825|NCT01947439|multivessel stenting|multivessel stenting
4930826|NCT01947426|DHA, term neonates, mother milk|dha, term neonates, mother milk
4930827|NCT01947413|repetitive transcranial magnetic stimulation|repetitive transcranial magnetic stimulation
4930828|NCT01947413|BoNTA|bonta
4930829|NCT01947413|stroke|stroke
4930830|NCT01947413|optimal treatment protocol|optimal treatment protocol
4930831|NCT01947413|randomized controlled trial|randomized controlled trial
4930832|NCT01947413|motor control|motor control
4930833|NCT01947413|clinical predictors|clinical predictors
4930834|NCT01947400|Physician and Patient Communication|physician and patient communication
4930835|NCT01947400|Acknowledge Introduce Duration Explanation Thank|acknowledge introduce duration explanation thank
4930836|NCT01947400|Hospital Consumer Assessment of Health Plans Survey|hospital consumer assessment of health plans survey
4930837|NCT01947374|Cartilage|cartilage
4930838|NCT01947374|Articular|articular
4930839|NCT01947335|Coronary|coronary
4930840|NCT01947335|Angioplasty|angioplasty
4930841|NCT01947335|Percutaneous coronary intervention|percutaneous coronary intervention
4930842|NCT01947335|Stent|stent
4930843|NCT01947335|Contrast|contrast
4930844|NCT01947335|Acute Renal failure|acute renal failure
4930845|NCT01947335|Intravascular ultrasound|intravascular ultrasound
4930846|NCT01947335|Prevention|prevention
4930847|NCT01947322|Natural killer cell|natural killer cell
4930848|NCT01947322|Haploidentical|haploidentical
4930849|NCT01947322|Acute myeloid leukemia|acute myeloid leukemia
4930850|NCT01947322|Chemotherapy|chemotherapy
4930851|NCT01947309|Revlimid, lenalidomide, multiple myeloma, PFS, Response Rates|revlimid, lenalidomide, multiple myeloma, pfs, response rates
4930852|NCT01947296|Oral antineoplastic agent|oral antineoplastic agent
4930853|NCT01947296|Adverse Effects|adverse effects
4930854|NCT01947296|Cancer Networks|cancer networks
4930855|NCT01947296|Continuity of care|continuity of care
4930856|NCT01947296|Coordination of patient's care|coordination of patient's care
4930857|NCT01947283|Patient-Provider Relationship|patient-provider relationship
4930858|NCT01947283|Shared Decision Making|shared decision making
4930859|NCT01947283|Therapeutic Alliance|therapeutic alliance
4930860|NCT01947283|Mental Health|mental health
4930861|NCT01947283|Minority Health|minority health
4930862|NCT01947283|Patient Activation|patient activation
4930863|NCT01947283|Communication|communication
4930864|NCT01947270|Potentially inappropriate medications|potentially inappropriate medications
4930865|NCT01947270|Elderly|elderly
4930866|NCT01947270|Prevention|prevention
4930867|NCT01947270|Multidisciplinary program|multidisciplinary program
4930868|NCT01947270|Checklist|checklist
4930869|NCT01947270|Stepped wedge design|stepped wedge design
4930870|NCT01947270|AGED, 75 AND OVER|aged, 75 and over
4930871|NCT01947244|Doulas|doulas
4930872|NCT01947244|Parenting|parenting
4930873|NCT01947244|Breast Feeding|breast feeding
4930874|NCT01947244|Pregnancy in Adolescence|pregnancy in adolescence
4930875|NCT01947244|Child Development|child development
4930876|NCT01947231|neck pain|neck pain
4930877|NCT01947231|chronic|chronic
4930878|NCT01947231|Global Postural Re-education|global postural re-education
4930879|NCT01947231|manual therapy|manual therapy
4930880|NCT01947231|physical therapy|physical therapy
4930881|NCT01947205|Curettage|curettage
4930882|NCT01947205|analgesia|analgesia
4930883|NCT01947205|paracervical block|paracervical block
4930884|NCT01947205|paracetamol|paracetamol
4930885|NCT01947205|lidocaine|lidocaine
4930886|NCT01947205|Dexketoprofen trometamol|dexketoprofen trometamol
4930887|NCT01947192|Chlorhexidine|chlorhexidine
4930888|NCT01947192|Matrix metalloproteinases (MMP) inhibitor|matrix metalloproteinases (mmp) inhibitor
4930889|NCT01947192|Adhesive system|adhesive system
4930890|NCT01947192|Controlled clinical trial|controlled clinical trial
4930891|NCT01947192|Dental restoration|dental restoration
4930892|NCT01947192|Noncarious cervical lesions|noncarious cervical lesions
4930893|NCT01947192|Dental restoration failure|dental restoration failure
4930894|NCT01947166|Whipple|whipple
4930895|NCT01947140|Lymphoid Malignancies|lymphoid malignancies
4930896|NCT01947140|Multiple Myeloma|multiple myeloma
4930897|NCT01947140|Lymphoma|lymphoma
4930898|NCT01947140|Hodgkin Lymphoma|hodgkin lymphoma
4930899|NCT01947140|Non-hodgkin Lymphoma|non-hodgkin lymphoma
4930900|NCT01947140|Follicular Lymphoma|follicular lymphoma
4930901|NCT01947140|Diffuse Large B-Cell Lymphoma|diffuse large b-cell lymphoma
4930902|NCT01947140|Anaplastic Large Cell Lymphoma|anaplastic large cell lymphoma
4930903|NCT01947140|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
4930904|NCT01947140|Small Lymphocytic Lymphoma|small lymphocytic lymphoma
4930905|NCT01947140|Mantle Cell Lymphoma|mantle cell lymphoma
4930906|NCT01947140|Marginal Zone Lymphoma|marginal zone lymphoma
4930907|NCT01947140|Burkitt Lymphoma|burkitt lymphoma
4930908|NCT01947140|Waldenstrom Macroglobulinemia|waldenstrom macroglobulinemia
4930909|NCT01947140|Peripheral T-cell Lymphoma|peripheral t-cell lymphoma
4930910|NCT01947140|Cutaneous T-cell Lymphoma|cutaneous t-cell lymphoma
4930911|NCT01947127|Lactate|lactate
4930912|NCT01947127|Sepsis|sepsis
4930913|NCT01947127|Septic shock|septic shock
4930914|NCT01947127|Disease progression|disease progression
4930915|NCT01947127|Prognosis|prognosis
4930916|NCT01947114|General anesthesia,|general anesthesia,
4930917|NCT01947114|Children,|children,
4930918|NCT01947114|Rigid Bronchoscopy,|rigid bronchoscopy,
4930919|NCT01947114|Remifentanil,|remifentanil,
4930920|NCT01947114|Propofol,|propofol,
4930921|NCT01947114|Ketamine.|ketamine.
4930922|NCT01947101|Stool transplant|stool transplant
4930923|NCT01947101|Ulcerative Colitis|ulcerative colitis
4930924|NCT01947101|Fecal transplant|fecal transplant
4930925|NCT01947101|Inflammatory Bowel Disease|inflammatory bowel disease
4930926|NCT01947088|Epilepsy, seizure disorder|epilepsy, seizure disorder
4930927|NCT01947075|Fever|fever
4930928|NCT01947075|Tanzania|tanzania
4930929|NCT01947075|Pneumonia|pneumonia
4930930|NCT01947075|HIV|hiv
4930931|NCT01947075|Diabetes|diabetes
4930932|NCT01947075|Indoor Air Pollution|indoor air pollution
4930933|NCT01947062|NSCLC|nsclc
4930934|NCT01947062|Metronomic chemotherapy|metronomic chemotherapy
4930935|NCT01947062|Metronomic cyclophosphamide|metronomic cyclophosphamide
4930936|NCT01947049|Influenza|influenza
4930937|NCT01947049|diagnostic testing|diagnostic testing
4930938|NCT01947049|antiviral treatment|antiviral treatment
4930939|NCT01947049|rapid influenza testing|rapid influenza testing
4930940|NCT01947036|autoimmune disease|autoimmune disease
4930941|NCT01947036|immune-mediated disease|immune-mediated disease
4931135|NCT01946152|MM|mm
4930942|NCT01947036|T and B cells immunophenotype|t and b cells immunophenotype
4930943|NCT01947036|IL23 signaling|il23 signaling
4930944|NCT01947036|genetic risk variants|genetic risk variants
4930945|NCT01947010|antibodies|antibodies
4930946|NCT01946984|diclofenac, ERCP and pancreatitis|diclofenac, ercp and pancreatitis
4930947|NCT01946958|Triple P|triple p
4930948|NCT01946945|infertility|infertility
4930949|NCT01946945|recurrent pregnancy loss|recurrent pregnancy loss
4930950|NCT01946945|miscarriage|miscarriage
4930951|NCT01946945|Next Generation Sequencing|next generation sequencing
4930952|NCT01946932|Induced hypothermia|induced hypothermia
4930953|NCT01946932|Mild induced hypothermia|mild induced hypothermia
4930954|NCT01946932|Resuscitation|resuscitation
4930955|NCT01946932|Therapeutic hypothermia|therapeutic hypothermia
4930956|NCT01946932|Neurological function|neurological function
4930957|NCT01946932|Cardiovascular diseases|cardiovascular diseases
4930958|NCT01946932|Rehabilitation|rehabilitation
4930959|NCT01946932|Quality of life|quality of life
4930960|NCT01946932|Cognition|cognition
4930961|NCT01946919|Cinepazide|cinepazide
4930962|NCT01946919|Adverse Drug Reaction|adverse drug reaction
4930963|NCT01946919|Safety|safety
4930964|NCT01946919|Real World Study|real world study
4930965|NCT01946893|meditation|meditation
4930966|NCT01946893|education|education
4930967|NCT01946893|stress, psychological|stress, psychological
4930968|NCT01946893|aged|aged
4930969|NCT01946880|Systemic Lupus Erythematosus|systemic lupus erythematosus
4930970|NCT01946880|Mycophenolate Mofetil (MMF)|mycophenolate mofetil (mmf)
4930971|NCT01946867|Oral cavity Cancer|oral cavity cancer
4930972|NCT01946867|Oropharynx Cancer|oropharynx cancer
4930973|NCT01946854|Gastrointestinal|gastrointestinal
4930974|NCT01946854|Metastatic Well-differentiated Mucinous Appendiceal Adenocarcinomas with Pseudomyxoma Peritonea|metastatic well-differentiated mucinous appendiceal adenocarcinomas with pseudomyxoma peritonea
4930975|NCT01946854|Appendiceal cancer|appendiceal cancer
4930976|NCT01946854|Surgically unresectable|surgically unresectable
4930977|NCT01946854|Chemotherapy|chemotherapy
4930978|NCT01946854|Observation|observation
4930979|NCT01946854|Questionnaires|questionnaires
4930980|NCT01946841|Chronic kidney disease|chronic kidney disease
4930981|NCT01946841|Hemodialysis|hemodialysis
4930982|NCT01946841|Severe malnutrition|severe malnutrition
4930983|NCT01946841|Enteral nutrition|enteral nutrition
4930984|NCT01946828|Field Induced Mydriasis|field induced mydriasis
4930985|NCT01946828|FIM|fim
4930986|NCT01946828|ATI|ati
4930987|NCT01946802|Heart arrest|heart arrest
4930988|NCT01946802|Cardiopulmonary resuscitation|cardiopulmonary resuscitation
4930989|NCT01946802|Hypothermia induced|hypothermia induced
4930990|NCT01946802|Seizures|seizures
4930991|NCT01946802|Electroencephalography|electroencephalography
4930992|NCT01946789|cancer|cancer
4930993|NCT01946789|IL-15|il-15
4930994|NCT01946789|melanoma|melanoma
4930995|NCT01946789|metastatic|metastatic
4930996|NCT01946789|unresectable|unresectable
4930997|NCT01946789|solid tumors|solid tumors
4930998|NCT01946789|renal cell|renal cell
4930999|NCT01946789|non-small cell lung|non-small cell lung
4931000|NCT01946789|squamous cell head and neck|squamous cell head and neck
4931001|NCT01946737|Coronary|coronary
4931002|NCT01946737|Artery|artery
4931003|NCT01946737|Disease|disease
4931004|NCT01946737|Diagnostic|diagnostic
4931005|NCT01946737|Performance|performance
4931006|NCT01946737|Angiography|angiography
4931007|NCT01946711|CRS|crs
4931008|NCT01946711|polyposis|polyposis
4931009|NCT01946672|gynaecological malignancy|gynaecological malignancy
4931010|NCT01946672|pelvic lymphadenectomy|pelvic lymphadenectomy
4931011|NCT01946672|lymphedema|lymphedema
4931012|NCT01946672|sentinel node|sentinel node
4931013|NCT01946672|reverse mapping|reverse mapping
4931014|NCT01946659|Tailored Telephone Intervention|tailored telephone intervention
4931015|NCT01946620|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
4931016|NCT01946620|Exacerbations|exacerbations
4931017|NCT01946620|FEV1 ≤ 50%|fev1 ≤ 50%
4931018|NCT01946607|Neuroticism|neuroticism
4931019|NCT01946607|Emotion processing|emotion processing
4931020|NCT01946607|Eye gaze movements|eye gaze movements
4931021|NCT01946607|Heart Rate Variability|heart rate variability
4931022|NCT01946594|fever|fever
4931023|NCT01946594|antipyretics|antipyretics
4931024|NCT01946594|acetaminophen|acetaminophen
4931025|NCT01946594|influenza vaccine|influenza vaccine
4931026|NCT01946594|influenza, human|influenza, human
4931027|NCT01946594|body temperature changes|body temperature changes
4931028|NCT01946594|Orthomyxoviridae Infections|orthomyxoviridae infections
4931029|NCT01946594|RNA virus infections|rna virus infections
4931030|NCT01946594|Virus Diseases|virus diseases
4931031|NCT01946594|Respiratory Tract Infections|respiratory tract infections
4931032|NCT01946594|Respiratory Tract Diseases|respiratory tract diseases
4931033|NCT01946555|Breakthrough cancer pain|breakthrough cancer pain
4931034|NCT01946555|Neuropathic pain|neuropathic pain
4931035|NCT01946555|Major opioid|major opioid
4931036|NCT01946555|Analgesics|analgesics
4931037|NCT01946542|exercise|exercise
4931038|NCT01946542|heart failure|heart failure
4931039|NCT01946542|fatigue|fatigue
4931040|NCT01946542|physical endurance|physical endurance
4931041|NCT01946542|functional food|functional food
4931042|NCT01946516|viral screening|viral screening
4931043|NCT01946503|Short Gut|short gut
4931044|NCT01946503|Short Bowel Syndrome|short bowel syndrome
4931045|NCT01946503|Intestinal Failure|intestinal failure
4931046|NCT01946503|Home parenteral nutrition|home parenteral nutrition
4931047|NCT01946503|Feeding Behavior|feeding behavior
4931048|NCT01946503|Enteral Nutrition|enteral nutrition
4931049|NCT01946503|Parent-Child Relations|parent-child relations
4931050|NCT01946503|Parenteral Nutrition|parenteral nutrition
4931051|NCT01946503|Digestive System Diseases|digestive system diseases
4931052|NCT01946477|Multiple Myeloma, MM, cancer, oncology, hematology, plasma, neoplasm, plasmacytoma|multiple myeloma, mm, cancer, oncology, hematology, plasma, neoplasm, plasmacytoma
4931053|NCT01946464|edentulous|edentulous
4931054|NCT01946464|bearded|bearded
4931055|NCT01946464|patients|patients
4931056|NCT01946464|requiring|requiring
4931057|NCT01946464|general anesthesia|general anesthesia
4931058|NCT01946464|Mallampati Class II or IV|mallampati class ii or iv
4931059|NCT01946451|idiopathic epiretinal membranes|idiopathic epiretinal membranes
4931060|NCT01946451|secondary epiretinal membranes|secondary epiretinal membranes
4931061|NCT01946438|Influenza|influenza
4931062|NCT01946438|Fluzone® Quadrivalent, Influenza Virus Vaccine (2013-2014 formulation),|fluzone® quadrivalent, influenza virus vaccine (2013-2014 formulation),
4931063|NCT01946438|Fluzone® Intradermal, Influenza Virus Vaccine (2013-2014 formulation),|fluzone® intradermal, influenza virus vaccine (2013-2014 formulation),
4931064|NCT01946438|Fluzone® High-Dose, Influenza Virus Vaccine (2013-2014 formulation)|fluzone® high-dose, influenza virus vaccine (2013-2014 formulation)
4931065|NCT01946425|Influenza|influenza
4931066|NCT01946425|Influenza virus vaccine|influenza virus vaccine
4931067|NCT01946425|Fluzone® Quadrivalent Influenza Vaccine (No Preservative)|fluzone® quadrivalent influenza vaccine (no preservative)
4931068|NCT01946412|Cystic Fibrosis|cystic fibrosis
4931069|NCT01946373|Melanoma|melanoma
4931070|NCT01946373|Dendritic cell vaccination|dendritic cell vaccination
4931071|NCT01946373|Lymphodepletion|lymphodepletion
4931072|NCT01946373|Adoptive cell transfer|adoptive cell transfer
4931073|NCT01946373|T cells|t cells
4931074|NCT01946373|Tumor infiltrating lymphocytes|tumor infiltrating lymphocytes
4931075|NCT01946373|Fludarabine|fludarabine
4931076|NCT01946373|IL-2|il-2
4931077|NCT01946373|Interleukin-2|interleukin-2
4931078|NCT01946373|Cyclophosphamide|cyclophosphamide
4931079|NCT01946373|Phase I study|phase i study
4931080|NCT01946373|Monocytes|monocytes
4931081|NCT01946373|Autologous|autologous
4931082|NCT01946373|NY-ESO-1|ny-eso-1
4931083|NCT01946347|Insulin Resistance|insulin resistance
4931084|NCT01946347|Hyperglycemia|hyperglycemia
4931085|NCT01946347|Endothelial function|endothelial function
4931086|NCT01946347|Oxidative stress|oxidative stress
4931087|NCT01946308|sleep|sleep
4931088|NCT01946308|sleep efficiency|sleep efficiency
4931089|NCT01946308|active sleep|active sleep
4931090|NCT01946308|quiet sleep|quiet sleep
4931091|NCT01946308|arousals|arousals
4931092|NCT01946308|premature infant|premature infant
4931093|NCT01946308|conformational positioning|conformational positioning
4931094|NCT01946308|mattress|mattress
4931095|NCT01946308|feeding difficulty|feeding difficulty
4931096|NCT01946308|neonatal intensive care unit|neonatal intensive care unit
4931097|NCT01946308|sleep state|sleep state
4931098|NCT01946308|behavioral observation|behavioral observation
4931099|NCT01946308|stress behavior|stress behavior
4931100|NCT01946308|self-regulatory behavior|self-regulatory behavior
4931101|NCT01946308|surgery|surgery
4931102|NCT01946308|gastrointestinal|gastrointestinal
4931103|NCT01946282|neoplasm|neoplasm
4931104|NCT01946282|colorectal|colorectal
4931105|NCT01946282|cancer|cancer
4931106|NCT01946282|uninsured|uninsured
4931107|NCT01946282|FIT|fit
4931108|NCT01946282|Fecal Immunochemical Test|fecal immunochemical test
4931109|NCT01946204|Prostate neoplasms|prostate neoplasms
4931110|NCT01946204|Prostate cancer|prostate cancer
4931111|NCT01946204|Castration-resistant prostate cancer|castration-resistant prostate cancer
4931112|NCT01946204|Non-metastatic castration-resistant prostate cancer|non-metastatic castration-resistant prostate cancer
4931113|NCT01946204|ARN-509|arn-509
4931114|NCT01946204|Apalutamide|apalutamide
4931115|NCT01946191|Weight maintenance|weight maintenance
4931116|NCT01946191|Electronic health record|electronic health record
4931117|NCT01946191|Primary care|primary care
4931118|NCT01946178|Uterine Fibroids|uterine fibroids
4931119|NCT01946178|Leiomyomas|leiomyomas
4931120|NCT01946178|High-Intensity Focused Ultrasound Ablation|high-intensity focused ultrasound ablation
4931121|NCT01946178|Ultrasonography|ultrasonography
4931122|NCT01946165|Prostate Cancer|prostate cancer
4931123|NCT01946165|High risk prostate cancer|high risk prostate cancer
4931124|NCT01946165|Abiraterone acetate|abiraterone acetate
4931125|NCT01946165|Zytiga|zytiga
4931126|NCT01946165|Prednisone|prednisone
4931127|NCT01946165|Enzalutamide|enzalutamide
4931128|NCT01946165|MDV3100|mdv3100
4931129|NCT01946165|XTANDI|xtandi
4931130|NCT01946165|Androgen ablation|androgen ablation
4931131|NCT01946165|LHRHa|lhrha
4931132|NCT01946165|Hormonal therapy|hormonal therapy
4931133|NCT01946152|Myeloma|myeloma
4931134|NCT01946152|Relapsed/Refractory Multiple Myeloma|relapsed/refractory multiple myeloma
4931136|NCT01946152|Pomalidomide|pomalidomide
4931137|NCT01946152|CC-4047|cc-4047
4931138|NCT01946152|Dexamethasone|dexamethasone
4931139|NCT01946152|Decadron|decadron
4931140|NCT01946152|C-CSF|c-csf
4931141|NCT01946152|Filgrastim|filgrastim
4931142|NCT01946152|Neupogen|neupogen
4931143|NCT01946152|Granulocyte colony stimulating factor|granulocyte colony stimulating factor
4931144|NCT01946100|multifocal|multifocal
4931145|NCT01946100|genetic|genetic
4931146|NCT01946100|bronchoalveolar carcinoma|bronchoalveolar carcinoma
4931147|NCT01946100|adenocarcinoma in situ|adenocarcinoma in situ
4931148|NCT01946100|ground glass opacity|ground glass opacity
4931149|NCT01946100|next generation sequencing|next generation sequencing
4931150|NCT01946087|Remote ischemic preconditioning|remote ischemic preconditioning
4931151|NCT01946087|cardiac surgery|cardiac surgery
4931152|NCT01946087|left ventricular hypertrophy|left ventricular hypertrophy
4931153|NCT01946087|reperfusion injury salvage kinase|reperfusion injury salvage kinase
4931154|NCT01946074|ABBV-181|abbv-181
4931155|NCT01946074|ABT-165|abt-165
4931156|NCT01946074|cancer|cancer
4931157|NCT01946074|neoplasm|neoplasm
4931158|NCT01946074|advanced solid tumor|advanced solid tumor
4931159|NCT01946074|colorectal cancer|colorectal cancer
4931160|NCT01946061|Oxaliplatin, S-1, Gastric cancer, Adjuvant chemotherapy|oxaliplatin, s-1, gastric cancer, adjuvant chemotherapy
4931161|NCT01946022|infertility|infertility
4931162|NCT01946022|ovulation induction|ovulation induction
4931163|NCT01946022|luteal phase|luteal phase
4931164|NCT01946022|granulosa cells function|granulosa cells function
4931165|NCT01946022|GnRH agonist and antagonist|gnrh agonist and antagonist
4931166|NCT01946022|HMG|hmg
4931167|NCT01946022|FSHr|fshr
4931168|NCT01945996|Hispanic Americans|hispanic americans
4931169|NCT01945996|Cellular Phone|cellular phone
4931170|NCT01945996|Behavior|behavior
4931171|NCT01945983|Septic shock|septic shock
4931172|NCT01945983|Severe sepsis|severe sepsis
4931173|NCT01945983|Norepinephrine|norepinephrine
4931174|NCT01945970|Vascular function|vascular function
4931175|NCT01945970|Flow mediated dilation|flow mediated dilation
4931176|NCT01945970|Tea|tea
4931177|NCT01945957|autism|autism
4931178|NCT01945957|brain|brain
4931179|NCT01945957|functional magnetic resonance imaging|functional magnetic resonance imaging
4931180|NCT01945957|oxytocin|oxytocin
4931181|NCT01945944|pediatric|pediatric
4931182|NCT01945944|mucolytic|mucolytic
4931183|NCT01945944|respiratory failure|respiratory failure
4931184|NCT01945944|atelectasis|atelectasis
4931185|NCT01945944|hypertonic saline|hypertonic saline
4931186|NCT01945931|Maternal health|maternal health
4931187|NCT01945931|perinatal health|perinatal health
4931188|NCT01945931|mHealth|mhealth
4931189|NCT01945931|smartphone|smartphone
4931190|NCT01945931|mobile phone|mobile phone
4931191|NCT01945931|Ethiopia|ethiopia
4931192|NCT01945918|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
4931193|NCT01945918|Diabetes Mellitus|diabetes mellitus
4931194|NCT01945918|Primary Health Care|primary health care
4931195|NCT01945918|Self care|self care
4931196|NCT01945905|Tuberculosis|tuberculosis
4931197|NCT01945905|Adherence, medication|adherence, medication
4931198|NCT01945905|Patient compliance|patient compliance
4931199|NCT01945892|macular edema, irvine gass syndrome, ozurdex|macular edema, irvine gass syndrome, ozurdex
4931200|NCT01945879|pancreatic cancer|pancreatic cancer
4931201|NCT01945879|heparin|heparin
4931202|NCT01945879|thromboembolic events|thromboembolic events
4931203|NCT01945879|bleedings|bleedings
4931204|NCT01945866|Diabetic Macular Edema|diabetic macular edema
4931205|NCT01945866|Anti-vascular endothelial growth factor|anti-vascular endothelial growth factor
4931206|NCT01945866|Dexamethasone Intravitreal implant|dexamethasone intravitreal implant
4931207|NCT01945866|Ranibizumab intravitreal injection|ranibizumab intravitreal injection
4931208|NCT01945801|Sleep apnea|sleep apnea
4931209|NCT01945801|Treatment|treatment
4931210|NCT01945801|Sodium-Restricted Diet|sodium-restricted diet
4931211|NCT01945801|Diuretic|diuretic
4931212|NCT01945801|Lasilactone|lasilactone
4931213|NCT01945775|Breast cancer|breast cancer
4931214|NCT01945775|BRCA mutation|brca mutation
4931215|NCT01945775|PARP inhibitor|parp inhibitor
4931216|NCT01945775|BRCA 1|brca 1
4931217|NCT01945775|BRCA 2|brca 2
4931218|NCT01945762|RET Mutation|ret mutation
4931219|NCT01945762|DIagnostics|diagnostics
4931220|NCT01945762|Medullary Thyroid Cancer|medullary thyroid cancer
4931221|NCT01945762|MTC|mtc
4931222|NCT01945736|Opiate withdrawal in children|opiate withdrawal in children
4931223|NCT01945723|Endoscopy|endoscopy
4931224|NCT01945723|Gastrointestinal tract|gastrointestinal tract
4931225|NCT01945723|Bacterial markers|bacterial markers
4931226|NCT01945723|volunteers|volunteers
4931227|NCT01945710|Tumors|tumors
4931228|NCT01945697|DNA methylation, biomarkers, oral cancer|dna methylation, biomarkers, oral cancer
4931229|NCT01945645|Prevention|prevention
4931230|NCT01945645|Screening|screening
4931231|NCT01945645|Type 2 diabetes|type 2 diabetes
4931232|NCT01945645|Action Competence|action competence
4931233|NCT01945645|Family practice|family practice
4931234|NCT01945645|Health Services Research|health services research
4931235|NCT01945619|CMV|cmv
4931236|NCT01945619|Adenovirus|adenovirus
4931237|NCT01945619|EBV|ebv
4931238|NCT01945619|Stem cell transplant|stem cell transplant
4931239|NCT01945619|cytotoxic T-lymphocytes|cytotoxic t-lymphocytes
4931240|NCT01945580|POP|pop
4931241|NCT01945580|Transvaginal|transvaginal
4931242|NCT01945580|Native Tissue Repair|native tissue repair
4931243|NCT01945580|Repair Augmented with Mesh|repair augmented with mesh
4931244|NCT01945580|Biologic Graft|biologic graft
4931245|NCT01945580|Pelvic Organ Prolapse|pelvic organ prolapse
4931246|NCT01945567|Parkinson's disease|parkinson's disease
4931247|NCT01945567|Essential tremor|essential tremor
4931248|NCT01945567|Tremor|tremor
4931249|NCT01945567|Deep brain stimulation|deep brain stimulation
4931250|NCT01945567|Posterior subthalamic area|posterior subthalamic area
4931251|NCT01945567|Zona incerta|zona incerta
4931252|NCT01945554|infiltrative therapy|infiltrative therapy
4931253|NCT01945554|cervical disc herniation|cervical disc herniation
4931254|NCT01945554|lumbar disc herniation|lumbar disc herniation
4931255|NCT01945541|Intraoperative Fluid Administration|intraoperative fluid administration
4931256|NCT01945541|Body Composition Measurement|body composition measurement
4931257|NCT01945528|Platelet Rich Plasma|platelet rich plasma
4931258|NCT01945528|tendinopathy|tendinopathy
4931259|NCT01945528|epicondylitis|epicondylitis
4931260|NCT01945528|ultrasound|ultrasound
4931261|NCT01945528|injection therapy|injection therapy
4931262|NCT01945528|needle tenotomy|needle tenotomy
4931263|NCT01945515|Stroke|stroke
4931264|NCT01945515|transcranial direct current stimulation|transcranial direct current stimulation
4931265|NCT01945515|robotic rehabilitation|robotic rehabilitation
4931266|NCT01945515|gait|gait
4931267|NCT01945476|midazolam|midazolam
4931268|NCT01945476|premedication|premedication
4931269|NCT01945476|functional recovery|functional recovery
4931270|NCT01945476|breast cancer|breast cancer
4931271|NCT01945424|Quadrivalent Influenza Vaccine|quadrivalent influenza vaccine
4931272|NCT01945424|Pregnancy Registry|pregnancy registry
4931273|NCT01945424|Influenza|influenza
4931274|NCT01945411|Airway Management|airway management
4931275|NCT01945411|Ventilation|ventilation
4931276|NCT01945398|Pulmonary Rehabilitation|pulmonary rehabilitation
4931277|NCT01945398|Inspiratory Muscle Training|inspiratory muscle training
4931278|NCT01945398|Inspiratory Muscle Strength|inspiratory muscle strength
4931279|NCT01945398|Vascular Resistance|vascular resistance
4931280|NCT01945398|Exercise|exercise
4931281|NCT01945398|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
4931282|NCT01945385|Abortion|abortion
4931283|NCT01945385|LARC|larc
4931284|NCT01945385|Contraception|contraception
4931285|NCT01945385|IUD|iud
4931286|NCT01945385|Contraceptive implant|contraceptive implant
4931287|NCT01945385|behavioral change|behavioral change
4931288|NCT01945385|video intervention|video intervention
4931289|NCT01945359|Relapsing Multiple Sclerosis|relapsing multiple sclerosis
4931290|NCT01945359|Dimethyl Fumarate|dimethyl fumarate
4931291|NCT01945359|Natalizumab|natalizumab
4931292|NCT01945346|PRX167700|prx167700
4931293|NCT01945346|Osteoarthritis|osteoarthritis
4931294|NCT01945333|Cognitive remediation|cognitive remediation
4931295|NCT01945333|Schizophrenia|schizophrenia
4931296|NCT01945333|Schizoaffective disorder|schizoaffective disorder
4931297|NCT01945320|hemodialysis|hemodialysis
4931298|NCT01945320|wasting and malnutrition|wasting and malnutrition
4931299|NCT01945320|nutrition status|nutrition status
4931300|NCT01945320|bioelectrical impedance analysis|bioelectrical impedance analysis
4931301|NCT01945320|body composition|body composition
4931302|NCT01945307|Complement|complement
4931303|NCT01945307|Serum Bactericidal Assay|serum bactericidal assay
4931304|NCT01945268|vascular, influenza, vaccine, heart failure|vascular, influenza, vaccine, heart failure
4931305|NCT01945255|Calcification|calcification
4931306|NCT01945255|aortic pulse wave velocity|aortic pulse wave velocity
4931307|NCT01945255|peripheral artery occlusion disease|peripheral artery occlusion disease
4931308|NCT01945255|hemodialysis|hemodialysis
4931309|NCT01945255|metabolic syndrome|metabolic syndrome
4931310|NCT01945242|Drug Therapy|drug therapy
4931311|NCT01945216|Drug therapy|drug therapy
4931312|NCT01945203|Calcification|calcification
4931313|NCT01945203|aortic pulse wave velocity|aortic pulse wave velocity
4931314|NCT01945203|peripheral artery occlusion disease|peripheral artery occlusion disease
4931315|NCT01945203|peritoneal dialysis|peritoneal dialysis
4931316|NCT01945203|metabolic syndrome|metabolic syndrome
4931317|NCT01945177|endoscopy|endoscopy
4931318|NCT01945177|gastric intestinal metaplasia|gastric intestinal metaplasia
4931319|NCT01945177|gastric cancer|gastric cancer
4931320|NCT01945164|XL999|xl999
4931321|NCT01945164|Advanced Malignancy|advanced malignancy
4931322|NCT01945151|spastic hemiparesis|spastic hemiparesis
4931323|NCT01945138|Total Pancreatectomy|total pancreatectomy
4931324|NCT01945138|Islet Auto-Transplantation|islet auto-transplantation
4931325|NCT01945138|Closed Loop Insulin Pump|closed loop insulin pump
4931326|NCT01945099|diabetes, insulin,post prandial, closed loop, artificial pancreas, hyperglycemia|diabetes, insulin,post prandial, closed loop, artificial pancreas, hyperglycemia
4931327|NCT01945086|Dermatitis, Atopic|dermatitis, atopic
4931328|NCT01945086|Eczema|eczema
4931329|NCT01945086|Ustekinumab|ustekinumab
4931330|NCT01945086|CNTO1275|cnto1275
4931331|NCT01945086|STELARA|stelara
4931332|NCT01945073|Educational intervention|educational intervention
4931333|NCT01945073|Formal Counselling|formal counselling
4931334|NCT01945073|Knowledge|knowledge
4931335|NCT01945073|Illness Perception|illness perception
4931336|NCT01945060|Artificial Pancreas Project|artificial pancreas project
4931337|NCT01945060|Diabetes Assistant (DiAs) Medical Platform System|diabetes assistant (dias) medical platform system
4931338|NCT01945060|Artificial Pancreas Platform|artificial pancreas platform
4931339|NCT01945060|Insulin Pump|insulin pump
4931340|NCT01945060|Continuous Glucose Monitor|continuous glucose monitor
4931341|NCT01945060|Closed-Loop Control|closed-loop control
4931342|NCT01945060|heart rate Control to Range System (hrCTR)|heart rate control to range system (hrctr)
4931343|NCT01945047|depression|depression
4931344|NCT01945047|treatment|treatment
4931345|NCT01945047|ketamine|ketamine
4931346|NCT01945047|ottawa|ottawa
4931347|NCT01945047|treatment-resistant|treatment-resistant
4931348|NCT01945047|infusion|infusion
4931349|NCT01945034|topical ibuprofen|topical ibuprofen
4931350|NCT01945034|ankle sprain|ankle sprain
4931351|NCT01945021|Non small cell lung cancer|non small cell lung cancer
4931352|NCT01945021|NSCLC|nsclc
4931353|NCT01945021|ROS1|ros1
4931354|NCT01945021|ROS1 positive|ros1 positive
4931355|NCT01945021|ROS1 proto oncogene|ros1 proto oncogene
4931356|NCT01945021|c ros tyrosine kinases|c ros tyrosine kinases
4931357|NCT01945021|ROS1 positive NSCLC|ros1 positive nsclc
4931358|NCT01945021|ROS1 lung cancer|ros1 lung cancer
4931359|NCT01945021|ALK negative|alk negative
4931360|NCT01945021|Lung Carcinoma|lung carcinoma
4931361|NCT01945021|Neoplasm|neoplasm
4931362|NCT01945021|Crizotinib|crizotinib
4931363|NCT01945021|Xalkori|xalkori
4931364|NCT01945021|Previously treated or untreated|previously treated or untreated
4931365|NCT01945021|North East Asian|north east asian
4931366|NCT01945008|HCV|hcv
4931367|NCT01945008|observational study|observational study
4931368|NCT01945008|HCV direct-acting antiviral agents|hcv direct-acting antiviral agents
4931369|NCT01944982|Immunotherapy|immunotherapy
4931370|NCT01944982|NKAEs|nkaes
4931371|NCT01944982|Expanded haploidentical natural killer cells|expanded haploidentical natural killer cells
4931372|NCT01944982|Activated natural killer cells|activated natural killer cells
4931373|NCT01944956|Maturation|maturation
4931374|NCT01944956|preterm infants|preterm infants
4931375|NCT01944956|sucking and swallowing|sucking and swallowing
4931376|NCT01944943|refractory/relapsed|refractory/relapsed
4931377|NCT01944943|diffuse large B-cell lymphoma|diffuse large b-cell lymphoma
4931378|NCT01944943|indolent non-hodgkin lymphoma|indolent non-hodgkin lymphoma
4931379|NCT01944943|Primary central nervous system lymphoma|primary central nervous system lymphoma
4931380|NCT01944943|chronic lymphocytic leukemia|chronic lymphocytic leukemia
4931381|NCT01944917|Electromagnetic field|electromagnetic field
4931382|NCT01944917|VAS score|vas score
4931383|NCT01944917|Heart Rate Variability|heart rate variability
4931384|NCT01944904|XOS|xos
4931385|NCT01944904|pre-diabetic|pre-diabetic
4931386|NCT01944904|abnormal glucose levels|abnormal glucose levels
4931387|NCT01944891|Adolescent girls|adolescent girls
4931388|NCT01944891|Mozambique|mozambique
4931389|NCT01944891|Diet|diet
4931390|NCT01944891|Anthropometrics|anthropometrics
4931391|NCT01944891|Serum biomarkers|serum biomarkers
4931392|NCT01944878|Peptic ulcer|peptic ulcer
4931393|NCT01944878|Liver cirrhosis|liver cirrhosis
4931394|NCT01944878|Portal hypertension|portal hypertension
4931395|NCT01944865|Aerobic Interval Training|aerobic interval training
4931396|NCT01944865|Supramaximal Training|supramaximal training
4931397|NCT01944852|icodextrin|icodextrin
4931398|NCT01944852|double dose|double dose
4931399|NCT01944852|elderly incident CAPD patients|elderly incident capd patients
4931400|NCT01944852|DIDo study|dido study
4931401|NCT01944839|Wet AMD|wet amd
4931402|NCT01944839|choroidal neovascularization|choroidal neovascularization
4931403|NCT01944839|Fovista®|fovista®
4931404|NCT01944839|E10030|e10030
4931405|NCT01944839|Lucentis®|lucentis®
4931406|NCT01944826|Dyspnea|dyspnea
4931407|NCT01944826|Angina pectoris|angina pectoris
4931408|NCT01944813|Advance Care planning|advance care planning
4931409|NCT01944813|End-of-life Discussions|end-of-life discussions
4931410|NCT01944813|Questionaires|questionaires
4931411|NCT01944813|Palliative Care|palliative care
4931412|NCT01944800|Ticagrelor|ticagrelor
4931413|NCT01944800|Prasugrel|prasugrel
4931414|NCT01944800|Acute coronary syndrome|acute coronary syndrome
4931415|NCT01944800|Percutaneous coronary intervention|percutaneous coronary intervention
4931416|NCT01944774|Moxifloxacin|moxifloxacin
4931417|NCT01944761|pediatrics|pediatrics
4931418|NCT01944761|Brain Tumor|brain tumor
4931419|NCT01944761|Neuro-radiation|neuro-radiation
4931420|NCT01944761|Exercise|exercise
4931421|NCT01944709|melanoma|melanoma
4931422|NCT01944709|dendritic cells|dendritic cells
4931423|NCT01944709|peptide|peptide
4931424|NCT01944709|Melan-A|melan-a
4931425|NCT01944696|hyperbilirubinemia|hyperbilirubinemia
4931426|NCT01944696|prematurity|prematurity
4931427|NCT01944696|extremely low birth weight (ELBW)|extremely low birth weight (elbw)
4931428|NCT01944696|phototherapy|phototherapy
4931429|NCT01944696|cycled phototherapy|cycled phototherapy
4931430|NCT01944696|intermittent phototherapy|intermittent phototherapy
4931431|NCT01944657|Major Depressive Disorder Clinical Outcomes|major depressive disorder clinical outcomes
4931432|NCT01944657|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
4931433|NCT01944657|Standard Medication Monotherapy|standard medication monotherapy
4931434|NCT01944657|Exploratory Field Study|exploratory field study
4931435|NCT01944605|Endotoxin|endotoxin
4931436|NCT01944605|Cytokine|cytokine
4931437|NCT01944605|Metabolism|metabolism
4931438|NCT01944592|Gynaecology Teaching Associate|gynaecology teaching associate
4931439|NCT01944592|Pelvic examination|pelvic examination
4931440|NCT01944592|Students|students
4931441|NCT01944553|Spine|spine
4931442|NCT01944553|Accurancy|accurancy
4931443|NCT01944553|Robotic|robotic
4931444|NCT01944553|Screw placement|screw placement
4931445|NCT01944553|Degenerative|degenerative
4931446|NCT01944514|Action potential duration restitution|action potential duration restitution
4931447|NCT01944514|Ventricular arrhythmia|ventricular arrhythmia
4931448|NCT01944514|Sudden cardiac death|sudden cardiac death
4931449|NCT01944514|Peri-infarct zone|peri-infarct zone
4931450|NCT01944514|Electrocardiogram|electrocardiogram
4931451|NCT01944501|tinnitus|tinnitus
4931452|NCT01944501|hearing loss|hearing loss
4931453|NCT01944501|Transcranial magnetic stimulation|transcranial magnetic stimulation
4931454|NCT01944501|Transcranial direct current stimulation|transcranial direct current stimulation
4931455|NCT01944488|Precocious puberty|precocious puberty
4931456|NCT01944488|GnRH-test|gnrh-test
4931457|NCT01944475|Precocious puberty|precocious puberty
4931458|NCT01944475|Premature thelarche|premature thelarche
4931459|NCT01944475|Tanner-stage|tanner-stage
4931460|NCT01944475|GnRH-test|gnrh-test
4931461|NCT01944462|pneumococcal vaccine|pneumococcal vaccine
4931462|NCT01944462|pharmacist vaccination|pharmacist vaccination
4931463|NCT01944462|Pneumovax 23|pneumovax 23
4931464|NCT01944462|pneumococcal vaccine polyvalent|pneumococcal vaccine polyvalent
4931465|NCT01944449|Type 2 diabetes (T2D)|type 2 diabetes (t2d)
4931466|NCT01944449|Whey Protein Concentrate (WPC)|whey protein concentrate (wpc)
4931467|NCT01944436|Pharmacogenomics|pharmacogenomics
4931468|NCT01944436|Dementia with Lewy bodies|dementia with lewy bodies
4931469|NCT01944436|Adverse events|adverse events
4931470|NCT01944436|Polymorphisms|polymorphisms
4931471|NCT01944436|Acetylcholinesterase|acetylcholinesterase
4931472|NCT01944436|Parkinson's Disease Dementia|parkinson's disease dementia
4931473|NCT01944436|Cognitive enhancers|cognitive enhancers
4931474|NCT01944436|Clinical efficacy|clinical efficacy
4931475|NCT01944436|Cytochrome P450|cytochrome p450
4931476|NCT01944436|Butyrylcholinesterase|butyrylcholinesterase
4931477|NCT01944410|PRP|prp
4931478|NCT01944410|TBC|tbc
4931479|NCT01944410|Treatment|treatment
4931480|NCT01944397|Atrial fibrillation|atrial fibrillation
4931481|NCT01944397|Heart failure|heart failure
4931482|NCT01944397|Stroke|stroke
4931483|NCT01944397|Myocardial infarction|myocardial infarction
4931484|NCT01944371|Latent reservoir|latent reservoir
4931485|NCT01944358|Syphilis; human immunodeficiency virus; penicillin|syphilis; human immunodeficiency virus; penicillin
4931486|NCT01944332|gamete treatment|gamete treatment
4931487|NCT01944332|ICSI|icsi
4931488|NCT01944332|IVF|ivf
4931489|NCT01944332|infertility|infertility
4931490|NCT01944332|oocyte activation|oocyte activation
4931491|NCT01944319|Infection; Meropenem; Pharmacokinetics; Pharmacodynamics|infection; meropenem; pharmacokinetics; pharmacodynamics
4931492|NCT01944306|Pharmacokinetics|pharmacokinetics
4931493|NCT01944306|Pharmacology, Clinical|pharmacology, clinical
4931494|NCT01944306|Drug Efficacy|drug efficacy
4931495|NCT01944306|Drug Failure|drug failure
4931496|NCT01944306|Contraceptive Agents|contraceptive agents
4931497|NCT01944293|Ketamine|ketamine
4931498|NCT01944293|Midazolam|midazolam
4931499|NCT01944293|Bipolar Disorder|bipolar disorder
4931500|NCT01944293|Major Depressive Episode|major depressive episode
4931501|NCT01944293|Suicidal Ideation|suicidal ideation
4931502|NCT01944293|Suicide|suicide
4931503|NCT01944293|Depression|depression
4931504|NCT01944293|Treatment|treatment
4931505|NCT01944293|Ketamine Treatment|ketamine treatment
4931506|NCT01944254|Cardiac surgical procedures|cardiac surgical procedures
4931507|NCT01944254|Pulmonary Artery Catheterizations|pulmonary artery catheterizations
4931508|NCT01944254|Cardiac output|cardiac output
4931509|NCT01944254|Swan Ganz Catheterization|swan ganz catheterization
4931510|NCT01944241|cervical surgery|cervical surgery
4931511|NCT01944241|LLETZ|lletz
4931512|NCT01944241|LEEP|leep
4931513|NCT01944241|Cone biopsy|cone biopsy
4931514|NCT01944241|Fertility|fertility
4931515|NCT01944228|inflammation|inflammation
4931516|NCT01944228|vagus nerve stimulation|vagus nerve stimulation
4931517|NCT01944228|chronic heart failure|chronic heart failure
4931518|NCT01944228|Systemic Inflammatory Response Syndrome|systemic inflammatory response syndrome
4931519|NCT01944228|sepsis|sepsis
4931520|NCT01944228|auto-immune diseases|auto-immune diseases
4931521|NCT01944215|Normal subjects|normal subjects
4931522|NCT01944215|Female|female
4931523|NCT01944215|Molecular Breast Imaging|molecular breast imaging
4931524|NCT01944215|Fasting|fasting
4931525|NCT01944215|Exercise|exercise
4931526|NCT01944215|Tracer Uptake|tracer uptake
4931527|NCT01944215|Tc-99m Sestamibi|tc-99m sestamibi
4931528|NCT01944215|Prandial status|prandial status
4931529|NCT01944215|metabolic status|metabolic status
4931530|NCT01944215|negative mammogram|negative mammogram
4931531|NCT01944215|Caffeine|caffeine
4931532|NCT01944215|External Warming|external warming
4931533|NCT01944202|Echocardiography|echocardiography
4931534|NCT01944202|Appropriate Use Criteria|appropriate use criteria
4931535|NCT01944202|Educational Intervention|educational intervention
4931536|NCT01944189|lumefantrine pharmacokinetics & bioavailability|lumefantrine pharmacokinetics & bioavailability
4931537|NCT01944176|COPD|copd
4931538|NCT01944176|Statins|statins
4931539|NCT01944176|Cytokines|cytokines
4931540|NCT01944163|Low back pain|low back pain
4931541|NCT01944163|Impact analysis|impact analysis
4931542|NCT01944163|Cluster randomized trial|cluster randomized trial
4931543|NCT01944163|Referral rule|referral rule
4931544|NCT01944163|Axial spondyloarthritis|axial spondyloarthritis
4931545|NCT01944150|Hypnosis|hypnosis
4931546|NCT01944150|chronic pain|chronic pain
4931547|NCT01944150|transcutaneous electrical nerve stimulation|transcutaneous electrical nerve stimulation
4931548|NCT01944150|nociceptive pain|nociceptive pain
4931549|NCT01944150|neuropathic pain|neuropathic pain
4931550|NCT01944150|complementary therapies|complementary therapies
4931551|NCT01944137|colonic neoplasms|colonic neoplasms
4931552|NCT01944137|Lung neoplasms|lung neoplasms
4931553|NCT01944137|patient-centered nursing|patient-centered nursing
4931554|NCT01944137|breast neoplasms|breast neoplasms
4931555|NCT01944124|Mobile health|mobile health
4931556|NCT01944124|Metabolic syndrome|metabolic syndrome
4931557|NCT01944124|Exercise prescription|exercise prescription
4931558|NCT01944124|Exercise intervention|exercise intervention
4931559|NCT01944124|Disease prevention|disease prevention
4931560|NCT01944124|Rural health|rural health
4931561|NCT01944111|Gastric plication|gastric plication
4931562|NCT01944085|children|children
4931563|NCT01944085|supracondylar fracture|supracondylar fracture
4931564|NCT01944085|pin removal|pin removal
4931565|NCT01944085|analgesia|analgesia
4931566|NCT01944085|pain score|pain score
4931567|NCT01944072|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
4931568|NCT01944072|COPD|copd
4931569|NCT01944072|Pulmonary rehabilitation|pulmonary rehabilitation
4931570|NCT01944072|Aerobic exercise|aerobic exercise
4931571|NCT01944072|CEDOC|cedoc
4931572|NCT01944072|FCM|fcm
4931573|NCT01944072|UNL|unl
4931574|NCT01944072|NOVA MEDICAL SCHOOL|nova medical school
4931575|NCT01944046|autism, ASD, autistic, Asperger's, PDD-NOS, oxytocin|autism, asd, autistic, asperger's, pdd-nos, oxytocin
4931576|NCT01944033|β2-agonist|β2-agonist
4931577|NCT01944033|Ipratropium Bromide|ipratropium bromide
4931578|NCT01944033|Chronic Obstructive Pulmonary Disease Exacerbation|chronic obstructive pulmonary disease exacerbation
4931579|NCT01944033|Emergency departement|emergency departement
4931580|NCT01944020|Sleep Apnea, Obstructive|sleep apnea, obstructive
4931581|NCT01944020|Energy Balance|energy balance
4931582|NCT01944020|Food Intake|food intake
4931583|NCT01944020|Energy Expenditure|energy expenditure
4931584|NCT01944020|Sleep|sleep
4931585|NCT01944020|Obesity|obesity
4931586|NCT01944007|CLP|clp
4931587|NCT01943994|Psilocybin|psilocybin
4931588|NCT01943994|Smoking cessation|smoking cessation
4931589|NCT01943955|dizziness|dizziness
4931590|NCT01943955|vertigo|vertigo
4931591|NCT01943955|unsteadiness|unsteadiness
4931592|NCT01943955|unbalance|unbalance
4931593|NCT01943955|falls|falls
4931594|NCT01943942|Mexico|mexico
4931595|NCT01943942|Montelukast|montelukast
4931596|NCT01943942|Pharmacokinetics|pharmacokinetics
4931597|NCT01943942|Bioequivalence|bioequivalence
4931598|NCT01943929|Nasal septum|nasal septum
4931599|NCT01943929|Headache|headache
4931600|NCT01943929|Mucosa contact point headache|mucosa contact point headache
4931601|NCT01943916|breast imaging diagnosis|breast imaging diagnosis
4931602|NCT01943916|breast ultrasound|breast ultrasound
4931603|NCT01943916|Imagio|imagio
4931604|NCT01943916|Seno Medical Instruments, Inc.|seno medical instruments, inc.
4931605|NCT01943916|Seno|seno
4931606|NCT01943916|opto-acoustics|opto-acoustics
4931607|NCT01943916|OA|oa
4931608|NCT01943916|angiogenesis|angiogenesis
4931609|NCT01943916|blood map|blood map
4931610|NCT01943890|Hypertonic saline|hypertonic saline
4931611|NCT01943890|Lung physiotherapy|lung physiotherapy
4931612|NCT01943864|pharmacokinetics|pharmacokinetics
4931613|NCT01943864|second line monotherapy|second line monotherapy
4931614|NCT01943864|GSK1120212 (trametinib)|gsk1120212 (trametinib)
4931615|NCT01943864|MEK inhibitor|mek inhibitor
4931616|NCT01943864|locally advanced or metastatic biliary tract cancers|locally advanced or metastatic biliary tract cancers
4931617|NCT01943851|leukemia|leukemia
4931618|NCT01943851|Acute myeloid leukemia|acute myeloid leukemia
4931619|NCT01943851|BET inhibitor|bet inhibitor
4931620|NCT01943851|lymphoma|lymphoma
4931621|NCT01943851|Myelodysplastic syndromes|myelodysplastic syndromes
4931622|NCT01943851|Oncology|oncology
4931623|NCT01943851|multiple myeloma|multiple myeloma
4931624|NCT01943851|GSK525762|gsk525762
4931625|NCT01943825|Dengue|dengue
4931626|NCT01943825|Dengue fever|dengue fever
4931627|NCT01943825|CYD dengue vaccine|cyd dengue vaccine
4931628|NCT01943825|IXIARO JE vaccine|ixiaro je vaccine
4931629|NCT01943825|Flavivirus|flavivirus
4931630|NCT01943799|Hepatitis B (HBV)|hepatitis b (hbv)
4931631|NCT01943799|Oral antiviral (OAV)|oral antiviral (oav)
4931632|NCT01943799|GS-4774|gs-4774
4931633|NCT01943786|Wild type KRAS|wild type kras
4931634|NCT01943773|delirium|delirium
4931635|NCT01943773|surgery|surgery
4931636|NCT01943773|operation|operation
4931637|NCT01943773|geriatric|geriatric
4931638|NCT01943773|complication|complication
4931639|NCT01943760|Tramadol|tramadol
4931640|NCT01943760|Children|children
4931641|NCT01943760|Hernioplasty|hernioplasty
4931642|NCT01943760|Wound infiltration|wound infiltration
4931643|NCT01943747|sepsis|sepsis
4931644|NCT01943747|severe sepsis|severe sepsis
4931645|NCT01943747|septic shock|septic shock
4931646|NCT01943747|infection|infection
4931647|NCT01943747|organ dysfunction|organ dysfunction
4931648|NCT01943747|quality improvement|quality improvement
4931649|NCT01943734|Information|information
4931650|NCT01943734|Lifestyle|lifestyle
4931651|NCT01943734|Occupational Health|occupational health
4931652|NCT01943695|Breast Cancer|breast cancer
4931653|NCT01943695|Exercise|exercise
4931654|NCT01943695|Chemotherapy|chemotherapy
4931655|NCT01943695|15-178|15-178
4931656|NCT01943682|Relapsed acute myeloid leukemia|relapsed acute myeloid leukemia
4931657|NCT01943682|non-therapy related acute myeloid leukemia|non-therapy related acute myeloid leukemia
4931658|NCT01943682|Refractory acute myeloid leukemia|refractory acute myeloid leukemia
4931659|NCT01943682|Untreated acute myeloid leukemia|untreated acute myeloid leukemia
4931660|NCT01943682|Lymphoma|lymphoma
4931661|NCT01943682|Leukemia|leukemia
4931662|NCT01943669|Spinal Cord Injury|spinal cord injury
4931663|NCT01943656|Spinal Cord Injury|spinal cord injury
4931664|NCT01943643|angiography, bifurcation, stenting, CT|angiography, bifurcation, stenting, ct
4931665|NCT01943630|HPV condyloma acuminata|hpv condyloma acuminata
4931666|NCT01943617|Liver Cirrhosis|liver cirrhosis
4931667|NCT01943617|Hepatitis B|hepatitis b
4931668|NCT01943617|Compensation|compensation
4931669|NCT01943617|Efficacy|efficacy
4931670|NCT01943604|Neuropsychology|neuropsychology
4931671|NCT01943604|Breakfast eating patters|breakfast eating patters
4931672|NCT01943604|Glucose|glucose
4931673|NCT01943604|Child Psychology|child psychology
4931674|NCT01943591|treatment trial|treatment trial
4931675|NCT01943591|cerebral aneurysm|cerebral aneurysm
4931676|NCT01943591|randomized|randomized
4931677|NCT01943591|coils|coils
4931678|NCT01943591|endovascular|endovascular
4931679|NCT01943591|Aneurysm|aneurysm
4931680|NCT01943591|Intracranial Aneurysm|intracranial aneurysm
4931681|NCT01943591|Vascular Diseases|vascular diseases
4931682|NCT01943591|Cardiovascular Diseases|cardiovascular diseases
4931683|NCT01943591|Intracranial Arterial Diseases|intracranial arterial diseases
4931684|NCT01943591|Cerebrovascular Disorders|cerebrovascular disorders
4931685|NCT01943591|Brain Diseases|brain diseases
4931686|NCT01943591|Central Nervous System Diseases|central nervous system diseases
4931687|NCT01943591|Nervous System Diseases|nervous system diseases
4931688|NCT01943565|Pregnancy|pregnancy
4931689|NCT01943565|Healthy|healthy
4931690|NCT01943565|Intrathecal|intrathecal
4931691|NCT01943565|Opioids|opioids
4931692|NCT01943565|Spinal|spinal
4931693|NCT01943565|Anesthesia|anesthesia
4931694|NCT01943565|Pain|pain
4931695|NCT01943565|Cesarean|cesarean
4931696|NCT01943565|Delivery|delivery
4931697|NCT01943565|Human|human
4931698|NCT01943526|Ireland|ireland
4931699|NCT01943526|Natalizumab|natalizumab
4931700|NCT01943513|Muscle Disuse Atrophy|muscle disuse atrophy
4931701|NCT01943500|Breast cancer|breast cancer
4931702|NCT01943500|Prostate cancer|prostate cancer
4931703|NCT01943500|Colorectal cancer|colorectal cancer
4931704|NCT01943500|Circulating tumor cell (CTC)|circulating tumor cell (ctc)
4931705|NCT01943487|Phase I|phase i
4931706|NCT01943487|Verapamil|verapamil
4931707|NCT01943487|Tamsulosin OCAS|tamsulosin ocas
4931708|NCT01943487|Solifenacin|solifenacin
4931709|NCT01943487|Pharmacokinetics|pharmacokinetics
4931710|NCT01943487|EC905|ec905
4931711|NCT01943474|IV Catheter comparison|iv catheter comparison
4931712|NCT01943474|AccuCath versus Conventional IV Catheters|accucath versus conventional iv catheters
4931713|NCT01943474|IV Catheter Study|iv catheter study
4931714|NCT01943474|IV Catheter User Preference Comparison|iv catheter user preference comparison
4931715|NCT01943474|First Attempt Success Rate for IV Catheters|first attempt success rate for iv catheters
4931716|NCT01943474|AccuCath Device Performance|accucath device performance
4931717|NCT01943474|Complication Rates for IV Catheters|complication rates for iv catheters
4931718|NCT01943474|Average Dwell Time for IV Catheters|average dwell time for iv catheters
4931719|NCT01943474|Patient Satisfaction with IV Catheters|patient satisfaction with iv catheters
4931720|NCT01943474|Clinician Satisfaction with AccuCath Device Performance|clinician satisfaction with accucath device performance
4931721|NCT01943461|Solid Tumors|solid tumors
4931722|NCT01943461|MSB0010718C|msb0010718c
4931723|NCT01943461|anti PD-L1|anti pd-l1
4931724|NCT01943461|avelumab|avelumab
4931725|NCT01943461|Phase 1|phase 1
4931726|NCT01943448|Macula Lutea Hemorrhage|macula lutea hemorrhage
4931727|NCT01943448|High Myopia|high myopia
4931728|NCT01943448|Optical Coherence Tomography|optical coherence tomography
4931729|NCT01943435|Spinal Stenosis|spinal stenosis
4931730|NCT01943435|Spinal manipulation|spinal manipulation
4931731|NCT01943435|Exercise|exercise
4931732|NCT01943435|Epidural injection|epidural injection
4931733|NCT01943422|advanced|advanced
4931734|NCT01943422|melanoma|melanoma
4931735|NCT01943422|Vemurafenib|vemurafenib
4931736|NCT01943422|High-dose Interferon alfa-2b|high-dose interferon alfa-2b
4931737|NCT01943409|Parenteral nutrition|parenteral nutrition
4931738|NCT01943409|lipid emulsion|lipid emulsion
4931739|NCT01943409|Intralipid|intralipid
4931740|NCT01943409|ClinOleic|clinoleic
4931741|NCT01943409|Inflammation|inflammation
4931742|NCT01943409|Infection|infection
4931743|NCT01943409|Bloodstream Infection|bloodstream infection
4931744|NCT01943409|length of stay|length of stay
4931745|NCT01943409|mortality|mortality
4931746|NCT01943396|age-related macular degeneration|age-related macular degeneration
4931747|NCT01943396|AMD|amd
4931748|NCT01943396|rheohemapheresis|rheohemapheresis
4931749|NCT01943396|plasma filtration|plasma filtration
4931750|NCT01943396|electroretinography|electroretinography
4931751|NCT01943396|ERG|erg
4931752|NCT01943396|multifocal ERG|multifocal erg
4931753|NCT01943396|double plasma filtration|double plasma filtration
4931754|NCT01943383|Hypertension|hypertension
4931755|NCT01943370|endoscopic sinus surgery|endoscopic sinus surgery
4931756|NCT01943370|post-operative irrigation|post-operative irrigation
4931757|NCT01943370|pain|pain
4931758|NCT01943370|debridement|debridement
4931759|NCT01943357|diabetes|diabetes
4931760|NCT01943357|patient education|patient education
4931761|NCT01943357|self management|self management
4931762|NCT01943357|health improvement|health improvement
4931763|NCT01943344|vascular large hole closure|vascular large hole closure
4931764|NCT01943344|arteriotomy closure|arteriotomy closure
4931765|NCT01943344|Large hole vascular closure device|large hole vascular closure device
4931766|NCT01943344|vascular closure device|vascular closure device
4931767|NCT01943344|percutaneous vascular closure device|percutaneous vascular closure device
4931768|NCT01943318|Liver Cirrhosis|liver cirrhosis
4931769|NCT01943318|Hepatocellular carcinoma|hepatocellular carcinoma
4931770|NCT01943305|Yellow Fever|yellow fever
4931771|NCT01943305|vaccination|vaccination
4931772|NCT01943305|Japanese encephalitis|japanese encephalitis
4931773|NCT01943305|antibodies|antibodies
4931774|NCT01943292|Focal Adhesion Kinase inhibitor|focal adhesion kinase inhibitor
4931775|NCT01943292|FAK inhibitor|fak inhibitor
4931776|NCT01943292|Cancer Stem Cells|cancer stem cells
4931777|NCT01943292|CSC|csc
4931778|NCT01943279|medical abortion|medical abortion
4931779|NCT01943279|telephone follow-up|telephone follow-up
4931780|NCT01943279|ultrasound|ultrasound
4931781|NCT01943279|serum hCG|serum hcg
4931782|NCT01943279|methotrexate|methotrexate
4931783|NCT01943279|misoprostol|misoprostol
4931784|NCT01943253|Early gastric cancer,|early gastric cancer,
4931785|NCT01943253|endoscopic submucosal dissection (ESD)|endoscopic submucosal dissection (esd)
4931786|NCT01943253|water-jet assisted ESD|water-jet assisted esd
4931787|NCT01943227|humidity|humidity
4931788|NCT01943227|enthalpy|enthalpy
4931789|NCT01943227|mechanical ventilation|mechanical ventilation
4931790|NCT01943214|Diabetes Mellitus|diabetes mellitus
4931791|NCT01943214|Body constitution|body constitution
4931792|NCT01943175|schizophrenia|schizophrenia
4931793|NCT01943175|stem cells|stem cells
4931794|NCT01943175|neurons|neurons
4931795|NCT01943175|genetic hish risk for schizophrenia|genetic hish risk for schizophrenia
4931796|NCT01943136|impetigo|impetigo
4931797|NCT01943136|papaya extract ointment|papaya extract ointment
4931798|NCT01943123|probiotics,|probiotics,
4931799|NCT01943123|streptococcus mutans,|streptococcus mutans,
4931800|NCT01943123|lactobacilli,|lactobacilli,
4931801|NCT01943123|plaque index,|plaque index,
4931802|NCT01943123|gingival index|gingival index
4931803|NCT01943110|Intradermal injections|intradermal injections
4931804|NCT01943110|Vaccine delivery devices|vaccine delivery devices
4931805|NCT01943071|dementia|dementia
4931806|NCT01943071|day care centre programs|day care centre programs
4931807|NCT01943071|patients|patients
4931808|NCT01943071|family carers|family carers
4931809|NCT01943071|cost-consequence analysis|cost-consequence analysis
4931810|NCT01943006|Mucopolysaccaride polysulfate (MPS)|mucopolysaccaride polysulfate (mps)
4931812|NCT01943006|Heparinoide|heparinoide
4931813|NCT01943006|Infusionphlebitis|infusionphlebitis
4931814|NCT01943006|Prevention|prevention
4931815|NCT01943006|Superficial thrombophlebitis|superficial thrombophlebitis
4931816|NCT01943006|Treatment|treatment
4931817|NCT01942993|melanoma|melanoma
4931818|NCT01942993|unresectable|unresectable
4931819|NCT01942993|mutation|mutation
4931820|NCT01942993|BRAF protein|braf protein
4931821|NCT01942980|Breast cancer|breast cancer
4931822|NCT01942980|one brain metastasis|one brain metastasis
4931823|NCT01942967|Neonate|neonate
4931824|NCT01942967|Hemodynamic|hemodynamic
4931825|NCT01942967|Tissue oxygenation|tissue oxygenation
4931826|NCT01942967|Non invasive ventilation|non invasive ventilation
4931827|NCT01942954|Alcohol Dependence|alcohol dependence
4931828|NCT01942954|Cognitive Therapy|cognitive therapy
4931829|NCT01942954|Executive Function|executive function
4931830|NCT01942954|Mobile Health|mobile health
4931831|NCT01942954|Recovery of Function|recovery of function
4931832|NCT01942954|Rehabilitation|rehabilitation
4931833|NCT01942889|COPD|copd
4931834|NCT01942889|exercise training|exercise training
4931835|NCT01942889|pulmonary rehabilitation|pulmonary rehabilitation
4931836|NCT01942889|antioxidant|antioxidant
4931837|NCT01942889|muscle|muscle
4931838|NCT01942876|Drugs|drugs
4931839|NCT01942876|at risk|at risk
4931840|NCT01942876|community health center patients|community health center patients
4931841|NCT01942837|Enzalutamid|enzalutamid
4931842|NCT01942837|Prostate Cancer|prostate cancer
4931843|NCT01942811|DRUG PREVENTION|drug prevention
4931844|NCT01942811|BINATIONAL|binational
4931845|NCT01942811|CASUAL USE OF ILLICIT DRUGS|casual use of illicit drugs
4931846|NCT01942811|BRIEF INTERVENTION|brief intervention
4931847|NCT01942811|SBIRT|sbirt
4931848|NCT01942798|Rehabilitation|rehabilitation
4931849|NCT01942798|Lower Limb Amputation|lower limb amputation
4931850|NCT01942798|Prosthetic|prosthetic
4931851|NCT01942798|Walking|walking
4931852|NCT01942798|unilateral transtibial amputation|unilateral transtibial amputation
4931853|NCT01942798|unilateral transfemoral amputation|unilateral transfemoral amputation
4931854|NCT01942798|older adults|older adults
4931855|NCT01942798|cognitive computer games|cognitive computer games
4931856|NCT01942798|home-based training|home-based training
4931857|NCT01942798|Nintendo Wii|nintendo wii
4931858|NCT01942798|virtual reality|virtual reality
4931859|NCT01942772|powered ankle-foot orthosis|powered ankle-foot orthosis
4931860|NCT01942772|mechanical structure|mechanical structure
4931861|NCT01942772|optimization|optimization
4931862|NCT01942772|dorsiflexion|dorsiflexion
4931863|NCT01942772|plantar flexion|plantar flexion
4931864|NCT01942772|gait|gait
4931865|NCT01942772|servomotor|servomotor
4931866|NCT01942772|ankle rehabilitation|ankle rehabilitation
4931867|NCT01942759|Breast Neoplasms|breast neoplasms
4931868|NCT01942759|Positron-Emission Tomography|positron-emission tomography
4931869|NCT01942759|Diffusion Magnetic Resonance Imaging|diffusion magnetic resonance imaging
4931870|NCT01942746|blueberry|blueberry
4931871|NCT01942746|anthocyanin|anthocyanin
4931872|NCT01942746|dark vision|dark vision
4931873|NCT01942746|photo bleaching|photo bleaching
4931874|NCT01942746|Visual Perception|visual perception
4931875|NCT01942746|Photic Stimulation|photic stimulation
4931876|NCT01942707|Abdominoplasty,Seroma,Bariatric surgery|abdominoplasty,seroma,bariatric surgery
4931877|NCT01942694|Prediabetes|prediabetes
4931878|NCT01942694|Vitamin D|vitamin d
4931879|NCT01942681|female|female
4931880|NCT01942681|mixed urinary incontinence|mixed urinary incontinence
4931881|NCT01942668|Vasomotor symptoms|vasomotor symptoms
4931882|NCT01942668|Hot flashes|hot flashes
4931883|NCT01942668|Endometrial protection|endometrial protection
4931884|NCT01942655|HIV|hiv
4931885|NCT01942655|Chronic inflammatory bowel disease|chronic inflammatory bowel disease
4931886|NCT01942655|Reservoirs|reservoirs
4931887|NCT01942655|IL-17|il-17
4931888|NCT01942655|IL-23|il-23
4931889|NCT01942655|Intestinal biopsies|intestinal biopsies
4931890|NCT01942642|cataract surgery, meibomian gland dysfunction, meibum expressibility, meibography|cataract surgery, meibomian gland dysfunction, meibum expressibility, meibography
4931891|NCT01942629|prognostic markers,Pancreatic ductal adenocarcinoma|prognostic markers,pancreatic ductal adenocarcinoma
4931892|NCT01942616|IPV|ipv
4931893|NCT01942603|Minimal (SN) tumor burden|minimal (sn) tumor burden
4931894|NCT01942603|Stage III|stage iii
4931895|NCT01942603|Patients|patients
4931896|NCT01942603|Lymphnode Dissections|lymphnode dissections
4931897|NCT01942590|Pompe disease|pompe disease
4931898|NCT01942577|NoSting|nosting
4931899|NCT01942577|Skin protectants|skin protectants
4931900|NCT01942577|Emollients|emollients
4931901|NCT01942577|Skin microbiome|skin microbiome
4931902|NCT01942564|traumatic brain injury|traumatic brain injury
4931903|NCT01942564|photophobia|photophobia
4931904|NCT01942564|photosensitivity|photosensitivity
4931905|NCT01942564|pupil|pupil
4931906|NCT01942538|rTMS|rtms
4931907|NCT01942538|fibromyalgia|fibromyalgia
4931908|NCT01942538|sham|sham
4931909|NCT01942538|maintenance session|maintenance session
4931910|NCT01942538|pain|pain
4931911|NCT01942525|IUGR|iugr
4931912|NCT01942525|aEEG|aeeg
4931913|NCT01942525|preterm infants|preterm infants
4931914|NCT01942525|neurodevelopmental outcome|neurodevelopmental outcome
4931915|NCT01942512|Intracranial Aneurysm - Endovascular treatment -|intracranial aneurysm - endovascular treatment -
4931916|NCT01942512|Coiling - Stenting - Flow diversion - Flow disruption -|coiling - stenting - flow diversion - flow disruption -
4931917|NCT01942512|Recanalization - Risk factors|recanalization - risk factors
4931918|NCT01942499|COPD, exercise, community|copd, exercise, community
4931919|NCT01942486|migraine|migraine
4931920|NCT01942486|photophobia|photophobia
4931921|NCT01942486|light sensitivity|light sensitivity
4931922|NCT01942486|melanopsin cells|melanopsin cells
4931923|NCT01942486|intrinsically photosensitive retinal ganglion cells|intrinsically photosensitive retinal ganglion cells
4931924|NCT01942460|Iron|iron
4931925|NCT01942460|Anemia|anemia
4931926|NCT01942460|Chronic Kidney Disease|chronic kidney disease
4931927|NCT01942460|Peritoneal Dialysis|peritoneal dialysis
4931928|NCT01942460|Inflammation|inflammation
4931929|NCT01942460|Oxidative stress|oxidative stress
4931930|NCT01942447|Fecal microbiota transplantation|fecal microbiota transplantation
4931931|NCT01942447|microbiota|microbiota
4931932|NCT01942447|clostridium difficile|clostridium difficile
4931933|NCT01942447|clostridium difficile infection|clostridium difficile infection
4931934|NCT01942447|Efficacy of FMT|efficacy of fmt
4931935|NCT01942434|Fatty acids|fatty acids
4931936|NCT01942434|Breast milk nutrients|breast milk nutrients
4931937|NCT01942434|Cognitive development|cognitive development
4931938|NCT01942434|Electrophysiology|electrophysiology
4931939|NCT01942434|Long-term assessment|long-term assessment
4931940|NCT01942421|Limbal deficiency|limbal deficiency
4931941|NCT01942421|Cultivated limbal transplantation|cultivated limbal transplantation
4931942|NCT01942421|Ex vivo limbal transplantation|ex vivo limbal transplantation
4931943|NCT01942421|Cultivated autologous mucosal epithelial transplantation|cultivated autologous mucosal epithelial transplantation
4931944|NCT01942408|Atrial fibrillation|atrial fibrillation
4931945|NCT01942408|Pulmonary vein isolation|pulmonary vein isolation
4931946|NCT01942408|Pulmonary vein reconnection|pulmonary vein reconnection
4931947|NCT01942395|Diet|diet
4931948|NCT01942395|Sodium|sodium
4931949|NCT01942395|Hypertension|hypertension
4931950|NCT01942395|Potassium|potassium
4931951|NCT01942395|Antioxidants|antioxidants
4931952|NCT01942395|Congestive Heart Failure|congestive heart failure
4931953|NCT01942395|Heart failure with normal ejection fraction|heart failure with normal ejection fraction
4931954|NCT01942395|Heart failure with preserved ejection fraction|heart failure with preserved ejection fraction
4931955|NCT01942382|Schizophrenia|schizophrenia
4931956|NCT01942382|JNS010|jns010
4931957|NCT01942382|Paliperidone Palmitate|paliperidone palmitate
4931958|NCT01942382|Clinical Pharmacology|clinical pharmacology
4931959|NCT01942369|Endometriosis|endometriosis
4931960|NCT01942304|Sinus Floor Augmentation|sinus floor augmentation
4931961|NCT01942304|Maxillary Sinus|maxillary sinus
4931962|NCT01942304|Bone Substitutes|bone substitutes
4931963|NCT01942304|Bone Regeneration|bone regeneration
4931964|NCT01942291|Niacin|niacin
4931965|NCT01942291|Endothelial function|endothelial function
4931966|NCT01942291|Laropiprant|laropiprant
4931967|NCT01942291|HDL|hdl
4931968|NCT01942278|Healthcare|healthcare
4931969|NCT01942278|Patients|patients
4931970|NCT01942265|Influenza, Immunogenicity, Monovalent, A/H7N9, Vaccine, AS03, Adjuvant|influenza, immunogenicity, monovalent, a/h7n9, vaccine, as03, adjuvant
4931971|NCT01942252|Secondhand smoking, pain, postoperative complications|secondhand smoking, pain, postoperative complications
4931972|NCT01942239|hypoglycemia|hypoglycemia
4931973|NCT01942239|very low birth weight neonate|very low birth weight neonate
4931974|NCT01942239|continuous glucose monitoring|continuous glucose monitoring
4931975|NCT01942226|Dry eye syndrome|dry eye syndrome
4931976|NCT01942213|Macular|macular
4931977|NCT01942213|Degeneration|degeneration
4931978|NCT01942213|Age related|age related
4931979|NCT01942213|Neovascular|neovascular
4931980|NCT01942200|carcinoma|carcinoma
4931981|NCT01942200|colon cancer|colon cancer
4931982|NCT01942200|colorectal cancer|colorectal cancer
4931983|NCT01942200|ambulant chemotherapy|ambulant chemotherapy
4931984|NCT01942200|treatment cycles|treatment cycles
4931985|NCT01942200|Oxaliplatin|oxaliplatin
4931986|NCT01942200|Oxaliplatin onkovis|oxaliplatin onkovis
4931987|NCT01942200|Quantity of Oxaliplatin|quantity of oxaliplatin
4931988|NCT01942200|Packaging Sizes|packaging sizes
4931989|NCT01942174|Antipneumococcal vaccination|antipneumococcal vaccination
4931990|NCT01942174|Methotrexate treatment|methotrexate treatment
4931991|NCT01942161|Schyzophrenia, pediatric patients|schyzophrenia, pediatric patients
4931992|NCT01942148|Schizophrenia, Pediatric patients|schizophrenia, pediatric patients
4931993|NCT01942135|Palbociclib (PD-0332991)|palbociclib (pd-0332991)
4931994|NCT01942135|Fulvestrant|fulvestrant
4931995|NCT01942135|Goserelin|goserelin
4931996|NCT01942135|Hormone receptor-+|hormone receptor-+
4931997|NCT01942135|HER2-negative|her2-negative
4931998|NCT01942135|Prior Endocrine treatment|prior endocrine treatment
4931999|NCT01942135|any menopausal status|any menopausal status
4932000|NCT01942135|PALOMA-3|paloma-3
4932001|NCT01942122|DLBS1442|dlbs1442
4932002|NCT01942122|Endometriosis|endometriosis
4932003|NCT01942122|Pain|pain
4932004|NCT01942122|Visual Analogue Scale|visual analogue scale
4932005|NCT01942122|Endometriosis Health Profile (EHP-30TM)|endometriosis health profile (ehp-30tm)
4932006|NCT01942109|heart failure|heart failure
4932007|NCT01942109|diuretics|diuretics
4932008|NCT01942109|furosemide|furosemide
4932009|NCT01942109|torasemide|torasemide
4932010|NCT01942070|Cardiovascular Disease|cardiovascular disease
4932011|NCT01942070|Myocardial Infarction|myocardial infarction
4932012|NCT01942070|Bioresorbable vascular scaffold|bioresorbable vascular scaffold
4932013|NCT01942070|Durable polymer everolimus-eluting stent|durable polymer everolimus-eluting stent
4932014|NCT01942070|Primary angioplasty|primary angioplasty
4932015|NCT01942070|Stent|stent
4932016|NCT01942044|Shear stress|shear stress
4932017|NCT01942044|Optical coherence tomography|optical coherence tomography
4932018|NCT01942044|Drug-eluting stents|drug-eluting stents
4932019|NCT01942031|Ischemic stroke|ischemic stroke
4932020|NCT01942031|Hemorrhagic stroke|hemorrhagic stroke
4932021|NCT01942031|TIA|tia
4932022|NCT01942031|Atrial fibrillation|atrial fibrillation
4932023|NCT01942031|prevention|prevention
4932024|NCT01942031|primary care|primary care
4932025|NCT01942018|esophagogastric junction outflow obstruction|esophagogastric junction outflow obstruction
4932026|NCT01942018|EGOO|egoo
4932027|NCT01942018|Per oral endoscopic myotomy|per oral endoscopic myotomy
4932028|NCT01942018|POEM|poem
4932029|NCT01942018|Gastroesophageal reflux disease|gastroesophageal reflux disease
4932030|NCT01942018|GERD|gerd
4932031|NCT01941992|head and neck|head and neck
4932032|NCT01941992|Squamous Cell Carcinoma|squamous cell carcinoma
4932033|NCT01941992|oral mucositis|oral mucositis
4932034|NCT01941992|Chemo-radiotherapy|chemo-radiotherapy
4932035|NCT01941966|Anal canal cancer;capecitabine; mitomycin; radiotherapy.|anal canal cancer;capecitabine; mitomycin; radiotherapy.
4932036|NCT01941953|Metformin|metformin
4932037|NCT01941953|Metastatic Colorectal Cancer|metastatic colorectal cancer
4932038|NCT01941953|Fluorouracil|fluorouracil
4932039|NCT01941927|Melanoma|melanoma
4932040|NCT01941927|Wild-type|wild-type
4932041|NCT01941927|BRAF|braf
4932042|NCT01941914|Calcium electroporation|calcium electroporation
4932043|NCT01941914|calcium|calcium
4932044|NCT01941914|electroporation|electroporation
4932045|NCT01941914|electrotransfer|electrotransfer
4932046|NCT01941914|keloid|keloid
4932047|NCT01941901|Cutaneous metastases|cutaneous metastases
4932048|NCT01941875|controlled ovarian hyperstimulation|controlled ovarian hyperstimulation
4932049|NCT01941875|gonadotropins|gonadotropins
4932050|NCT01941875|intrauterine insemination|intrauterine insemination
4932051|NCT01941875|infertility|infertility
4932052|NCT01941875|luteal progesterone|luteal progesterone
4932053|NCT01941862|computerized intervention|computerized intervention
4932054|NCT01941862|cognitive bias modification|cognitive bias modification
4932055|NCT01941862|anxiety|anxiety
4932056|NCT01941862|mood|mood
4932057|NCT01941862|perceived burdensomeness|perceived burdensomeness
4932058|NCT01941862|thwarted belongingness|thwarted belongingness
4932059|NCT01941862|suicide|suicide
4932060|NCT01941862|post-traumatic stress disorder|post-traumatic stress disorder
4932061|NCT01941849|Phaeochromocytoma|phaeochromocytoma
4932062|NCT01941849|Paraganglioma|paraganglioma
4932063|NCT01941849|Neuroendocrine Tumour|neuroendocrine tumour
4932064|NCT01941849|Vandetanib|vandetanib
4932065|NCT01941849|131I-mIBG|131i-mibg
4932066|NCT01941849|Radionucleotide Therapy|radionucleotide therapy
4932067|NCT01941849|Vascular Endothelial Growth Factor (VEGF)|vascular endothelial growth factor (vegf)
4932068|NCT01941849|Epidermal Growth Factor Receptor (EGFR)|epidermal growth factor receptor (egfr)
4932070|NCT01941849|Tyrosine Kinase|tyrosine kinase
4932071|NCT01941836|Statin intolerant|statin intolerant
4932072|NCT01941836|Statin tolerant|statin tolerant
4932073|NCT01941836|LDL|ldl
4932074|NCT01941836|Cholesterol|cholesterol
4932075|NCT01941823|acute renal failure|acute renal failure
4932076|NCT01941823|CRRT|crrt
4932077|NCT01941823|continuous dialysis|continuous dialysis
4932078|NCT01941823|carnitine|carnitine
4932079|NCT01941823|cardiac strain|cardiac strain
4932080|NCT01941771|Breast cancer|breast cancer
4932081|NCT01941771|Metronomic chemotherapy|metronomic chemotherapy
4932082|NCT01941771|Vinorelbine|vinorelbine
4932083|NCT01941771|Navelbine|navelbine
4932084|NCT01941771|Capecitabine|capecitabine
4932085|NCT01941771|Xeloda|xeloda
4932086|NCT01941771|Antineoplastic Agents|antineoplastic agents
4932087|NCT01941719|Diabetes Mellitus|diabetes mellitus
4932088|NCT01941719|Diabetic Foot|diabetic foot
4932089|NCT01941719|Diabetic Peripheral Neuropathy|diabetic peripheral neuropathy
4932090|NCT01941719|Diabetic Foot Education|diabetic foot education
4932091|NCT01941706|Epilepsy|epilepsy
4932092|NCT01941706|Seizure|seizure
4932093|NCT01941706|Cognitive Behavioral Therapy|cognitive behavioral therapy
4932094|NCT01941706|Mindfulness|mindfulness
4932095|NCT01941706|Depression|depression
4932096|NCT01941706|Depressive symptoms|depressive symptoms
4932097|NCT01941706|prevention|prevention
4932098|NCT01941706|Coping skills|coping skills
4932099|NCT01941706|Quality of life|quality of life
4932100|NCT01941706|Telehealth|telehealth
4932101|NCT01941706|Phone intervention|phone intervention
4932102|NCT01941706|Internet-based intervention|internet-based intervention
4932103|NCT01941693|alcohol|alcohol
4932104|NCT01941693|anxiety|anxiety
4932105|NCT01941693|depression|depression
4932106|NCT01941693|comorbidity|comorbidity
4932107|NCT01941693|CBT|cbt
4932108|NCT01941667|Congenital Heart Disease|congenital heart disease
4932109|NCT01941667|Neonates and infants|neonates and infants
4932110|NCT01941667|Telehealth|telehealth
4932111|NCT01941667|Virtual Home Visits|virtual home visits
4932112|NCT01941628|Cesarean section|cesarean section
4932113|NCT01941628|General anesthesia|general anesthesia
4932114|NCT01941628|neuromuscular blockade|neuromuscular blockade
4932115|NCT01941628|Surgical conditions|surgical conditions
4932116|NCT01941602|surgery|surgery
4932117|NCT01941602|enoxaparin|enoxaparin
4932118|NCT01941602|venous thromboembolism|venous thromboembolism
4932119|NCT01941602|perioperative care|perioperative care
4932120|NCT01941576|Heart defects, Congenital|heart defects, congenital
4932121|NCT01941576|rhBNP|rhbnp
4932122|NCT01941576|heart failure|heart failure
4932123|NCT01941550|untreated, high risk prostate cancer|untreated, high risk prostate cancer
4932124|NCT01941537|Atopic Dermatitis|atopic dermatitis
4932125|NCT01941524|Brain oxygenation|brain oxygenation
4932126|NCT01941524|NIRS|nirs
4932127|NCT01941524|aEEG|aeeg
4932128|NCT01941524|surfactant|surfactant
4932129|NCT01941511|QTc|qtc
4932130|NCT01941511|African-American|african-american
4932131|NCT01941511|GMI-1070|gmi-1070
4932132|NCT01941511|QT/QTc interval prolongation|qt/qtc interval prolongation
4932133|NCT01941498|nearsighted|nearsighted
4932134|NCT01941498|farsighted|farsighted
4932135|NCT01941498|astigmatism|astigmatism
4932136|NCT01941498|LASIK|lasik
4932137|NCT01941498|refractive surgery|refractive surgery
4932138|NCT01941498|WaveLight|wavelight
4932139|NCT01941485|nearsighted|nearsighted
4932140|NCT01941485|astigmatism|astigmatism
4932141|NCT01941485|LASIK|lasik
4932142|NCT01941485|refractive surgery|refractive surgery
4932143|NCT01941485|WaveLight|wavelight
4932144|NCT01941459|CK-MB|ck-mb
4932145|NCT01941459|troponin-T|troponin-t
4932146|NCT01941433|rheumatoid arthritis|rheumatoid arthritis
4932147|NCT01941433|self-management|self-management
4932148|NCT01941433|online|online
4932149|NCT01941433|patient passport|patient passport
4932150|NCT01941420|CK-MB|ck-mb
4932151|NCT01941420|troponin-T|troponin-t
4932152|NCT01941420|Cytokines under ischemia|cytokines under ischemia
4932153|NCT01941394|GVHD|gvhd
4932154|NCT01941394|Relapse|relapse
4932155|NCT01941394|Overall Survival|overall survival
4932156|NCT01941381|Otitis Media|otitis media
4932157|NCT01941381|Tympanometry|tympanometry
4932158|NCT01941368|Performance|performance
4932159|NCT01941368|Aerobic Exercise|aerobic exercise
4932160|NCT01941342|Obstructive Jaundice|obstructive jaundice
4932161|NCT01941342|Preoperative Biliary Drainage|preoperative biliary drainage
4932162|NCT01941342|Pancreatoduodenectomy|pancreatoduodenectomy
4932163|NCT01941329|Diabetes|diabetes
4932164|NCT01941329|Proliferative Retinopathy|proliferative retinopathy
4932165|NCT01941329|Ranibizumab|ranibizumab
4932166|NCT01941329|Panretinal Photocoagulation|panretinal photocoagulation
4932167|NCT01941316|Carfilzomib|carfilzomib
4932168|NCT01941316|Irinotecan|irinotecan
4932169|NCT01941316|Small Cell Lung Cancer|small cell lung cancer
4932170|NCT01941316|Non Small Cell Lung Cancer|non small cell lung cancer
4932171|NCT01941316|Ovarian Cancer|ovarian cancer
4932172|NCT01941316|Gastric Cancer|gastric cancer
4932173|NCT01941316|Esophageal Cancer|esophageal cancer
4932174|NCT01941316|Cervical Cancer|cervical cancer
4932175|NCT01941303|Non-small cell lung cancer|non-small cell lung cancer
4932176|NCT01941290|International|international
4932177|NCT01941290|Multicenter|multicenter
4932178|NCT01941290|Observational registry|observational registry
4932179|NCT01941290|Orsiro Drug Eluting Stents (DES)|orsiro drug eluting stents (des)
4932180|NCT01941290|Stenting|stenting
4932181|NCT01941290|Treatment of Coronary Artery Disease|treatment of coronary artery disease
4932182|NCT01941290|Coronary Revascularization|coronary revascularization
4932183|NCT01941290|Percutaneous Coronary Intervention (PCI)|percutaneous coronary intervention (pci)
4932184|NCT01941290|Diabetes Mellitus Type 1|diabetes mellitus type 1
4932185|NCT01941290|Diabetes Mellitus Type 2|diabetes mellitus type 2
4932186|NCT01941290|STEMI|stemi
4932187|NCT01941290|NSTEMI|nstemi
4932188|NCT01941290|Ischemia|ischemia
4932189|NCT01941290|Angina|angina
4932190|NCT01941290|Subgroups|subgroups
4932191|NCT01941290|Acute Myocardial Infarction|acute myocardial infarction
4932192|NCT01941290|Small Vessels|small vessels
4932193|NCT01941290|Chronic Total Occlusion|chronic total occlusion
4932194|NCT01941264|malaria|malaria
4932195|NCT01941264|placenta|placenta
4932196|NCT01941264|pregnancy|pregnancy
4932197|NCT01941264|plasmodium falciparum|plasmodium falciparum
4932198|NCT01941264|screening and treatment|screening and treatment
4932199|NCT01941264|rapid diagnostic test|rapid diagnostic test
4932200|NCT01941264|coartem|coartem
4932201|NCT01941264|artemether-lumefantrine|artemether-lumefantrine
4932202|NCT01941264|community health worker|community health worker
4932203|NCT01941251|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
4932204|NCT01941251|Repetitive Transcranial Magnetic Stimulation|repetitive transcranial magnetic stimulation
4932205|NCT01941251|Schizophrenia|schizophrenia
4932206|NCT01941251|Schizoaffective Disorder|schizoaffective disorder
4932207|NCT01941251|Treatment|treatment
4932208|NCT01941251|Negative Symptoms|negative symptoms
4932209|NCT01941251|Positive Symptoms|positive symptoms
4932210|NCT01941251|TMS|tms
4932211|NCT01941251|rTMS|rtms
4932212|NCT01941238|Ramadan|ramadan
4932213|NCT01941238|Fasting|fasting
4932214|NCT01941238|Diabetes|diabetes
4932215|NCT01941238|Type1|type1
4932216|NCT01941238|Insulin|insulin
4932217|NCT01941238|Pump|pump
4932218|NCT01941225|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
4932219|NCT01941225|Pulmonary vasculature|pulmonary vasculature
4932220|NCT01941225|Inhaled iloprost|inhaled iloprost
4932221|NCT01941225|Inhaled prostacyclin|inhaled prostacyclin
4932222|NCT01941225|Dynamic hyperinflation|dynamic hyperinflation
4932223|NCT01941225|Oxidative stress|oxidative stress
4932224|NCT01941225|Cardiopulmonary exercise testing|cardiopulmonary exercise testing
4932225|NCT01941225|B-type natriuretic peptide|b-type natriuretic peptide
4932226|NCT01941212|Music therapy|music therapy
4932227|NCT01941212|pain|pain
4932228|NCT01941212|gynecological surgeries|gynecological surgeries
4932229|NCT01941186|Children|children
4932230|NCT01941186|Developmental Delays|developmental delays
4932231|NCT01941186|Early Intervention (EI)|early intervention (ei)
4932232|NCT01941186|Patient Decision Aid (PDA)|patient decision aid (pda)
4932233|NCT01941147|Acute Stroke|acute stroke
4932234|NCT01941147|Brain Ischemia|brain ischemia
4932235|NCT01941147|Extremely Low Frequency Magnetic Fields|extremely low frequency magnetic fields
4932236|NCT01941121|HIV Screening|hiv screening
4932237|NCT01941121|Linkage to PrEP|linkage to prep
4932238|NCT01941121|Linkage to Care|linkage to care
4932239|NCT01941121|CCTG|cctg
4932240|NCT01941121|593|593
4932241|NCT01941108|AIDS|aids
4932242|NCT01941108|peer navigation|peer navigation
4932243|NCT01941108|ecological momentary assessment|ecological momentary assessment
4932244|NCT01941108|eMOCHA|emocha
4932245|NCT01941108|Baltimore|baltimore
4932246|NCT01941108|IDU|idu
4932247|NCT01941030|Peripheral Artery Disease|peripheral artery disease
4932248|NCT01941030|Critical Limb Ischemia|critical limb ischemia
4932249|NCT01941030|Orbital Atherectomy|orbital atherectomy
4932250|NCT01941030|Balloon Angioplasty|balloon angioplasty
4932251|NCT01941030|Intravascular Ultrasound (IVUS)|intravascular ultrasound (ivus)
4932252|NCT01941030|Fractional Flow Reserve (FFR)|fractional flow reserve (ffr)
4932253|NCT01941004|multiple sclerosis (MS)|multiple sclerosis (ms)
4932254|NCT01941004|relapsing remitting multiple sclerosis (RRMS)|relapsing remitting multiple sclerosis (rrms)
4932255|NCT01941004|fingolimod|fingolimod
4932256|NCT01940978|Methamphetamine|methamphetamine
4932257|NCT01940978|Methylphenidate|methylphenidate
4932258|NCT01940978|ADHD|adhd
4932259|NCT01940939|schizophrenia|schizophrenia
4932260|NCT01940926|rheumatoid arthritis|rheumatoid arthritis
4932261|NCT01940926|angiogenesis|angiogenesis
4932262|NCT01940926|68Ga-PRGD2|68ga-prgd2
4932263|NCT01940926|18F-FDG|18f-fdg
4932264|NCT01940926|positron emission tomography/computed tomography|positron emission tomography/computed tomography
4932265|NCT01940900|Wet AMD|wet amd
4932266|NCT01940900|choroidal neovascularization|choroidal neovascularization
4932267|NCT01940900|Fovista®|fovista®
4932268|NCT01940900|E10030|e10030
4932269|NCT01940900|Lucentis®|lucentis®
4932270|NCT01940887|Wet AMD|wet amd
4932271|NCT01940887|choroidal neovascularization|choroidal neovascularization
4932272|NCT01940887|Fovista®|fovista®
4932273|NCT01940887|E10030|e10030
4932274|NCT01940887|Avastin®|avastin®
4932275|NCT01940887|Eylea®|eylea®
4932276|NCT01940874|Cerebral Oximetry.|cerebral oximetry.
4932277|NCT01940874|Aortic valve stenosis.|aortic valve stenosis.
4932278|NCT01940874|Aortic valve regurgitation.|aortic valve regurgitation.
4932279|NCT01940874|Coronary artery disease.|coronary artery disease.
4932280|NCT01940848|Iberogast|iberogast
4932281|NCT01940848|efficacy|efficacy
4932283|NCT01940796|Brentuximab Vedotin|brentuximab vedotin
4932284|NCT01940796|GVHD|gvhd
4932285|NCT01940796|Refractory Chronic Graft vs Host Disease|refractory chronic graft vs host disease
4932286|NCT01940770|Diabetes Mellitus(DM)|diabetes mellitus(dm)
4932287|NCT01940770|Bydureon|bydureon
4932288|NCT01940770|Exenatide|exenatide
4932289|NCT01940757|Necator americanus|necator americanus
4932290|NCT01940757|Hookworm Infection|hookworm infection
4932291|NCT01940757|Experimental challenge infection|experimental challenge infection
4932292|NCT01940744|Low back pain|low back pain
4932293|NCT01940744|Non-specific Low back pain|non-specific low back pain
4932294|NCT01940718|Priapism|priapism
4932295|NCT01940718|Sickle cell disease|sickle cell disease
4932296|NCT01940718|Testosterone|testosterone
4932297|NCT01940718|Androgen deficiency|androgen deficiency
4932298|NCT01940705|hearing aids|hearing aids
4932299|NCT01940705|counseling|counseling
4932300|NCT01940705|outcomes assessment (health care)|outcomes assessment (health care)
4932301|NCT01940705|rehabilitation|rehabilitation
4932302|NCT01940666|Hyperandrogenism/|hyperandrogenism/
4932303|NCT01940666|FAI/|fai/
4932304|NCT01940666|Metabolic syndrome/|metabolic syndrome/
4932305|NCT01940666|Adipocytokines/|adipocytokines/
4932306|NCT01940666|Insulin resistance.|insulin resistance.
4932307|NCT01940640|neonates, DHA|neonates, dha
4932308|NCT01940627|Ubiquinol, exercise|ubiquinol, exercise
4932309|NCT01940614|Copeptin|copeptin
4932310|NCT01940614|differential diagnosis of polyuria polydipsia syndrome|differential diagnosis of polyuria polydipsia syndrome
4932311|NCT01940614|diabetes insipidus|diabetes insipidus
4932312|NCT01940614|compulsive water drinking|compulsive water drinking
4932313|NCT01940614|water deprivation test|water deprivation test
4932314|NCT01940614|Diabetes insipidus (central and nephrogenic)|diabetes insipidus (central and nephrogenic)
4932315|NCT01940601|solid tumors|solid tumors
4932316|NCT01940601|balugrastim|balugrastim
4932317|NCT01940575|Tissue restorative biomaterial|tissue restorative biomaterial
4932318|NCT01940575|Hyaluronic acid|hyaluronic acid
4932319|NCT01940575|Restylane®|restylane®
4932320|NCT01940575|Wrinkle Severity Rating Scale (WSRS)|wrinkle severity rating scale (wsrs)
4932417|NCT01940120|Mitral Insufficiency|mitral insufficiency
4932321|NCT01940575|Global Aesthetic Improvement Scale (GAIS)|global aesthetic improvement scale (gais)
4932322|NCT01940575|Nasolabial fold(NLF)|nasolabial fold(nlf)
4932323|NCT01940562|cord blood transplantation|cord blood transplantation
4932324|NCT01940562|platelets|platelets
4932325|NCT01940562|eltrombopag|eltrombopag
4932326|NCT01940549|PTSD|ptsd
4932327|NCT01940549|tDCS|tdcs
4932328|NCT01940549|Trauma|trauma
4932329|NCT01940536|Hip Fracture|hip fracture
4932330|NCT01940536|Blood Transfusion|blood transfusion
4932331|NCT01940536|Blood Loss|blood loss
4932332|NCT01940536|Tranexamic Acid|tranexamic acid
4932333|NCT01940523|total knee arthroplasty|total knee arthroplasty
4932334|NCT01940523|total knee replacement|total knee replacement
4932335|NCT01940523|tranexamic acid|tranexamic acid
4932336|NCT01940523|osteoarthritis|osteoarthritis
4932337|NCT01940523|degenerative joint disease|degenerative joint disease
4932338|NCT01940471|Hepatitis|hepatitis
4932339|NCT01940471|Tenofovir|tenofovir
4932340|NCT01940471|Viread|viread
4932341|NCT01940432|simple stress urinary incontinence|simple stress urinary incontinence
4932342|NCT01940419|Reduction of blood loss|reduction of blood loss
4932343|NCT01940419|Surgical complication|surgical complication
4932344|NCT01940419|Hysterectomy|hysterectomy
4932345|NCT01940419|Antifibrinolytic Agents|antifibrinolytic agents
4932346|NCT01940419|Randomized Controlled Trials|randomized controlled trials
4932347|NCT01940406|Essential Tremor|essential tremor
4932348|NCT01940406|Parkinson Disease|parkinson disease
4932349|NCT01940406|Electrical Stimulation|electrical stimulation
4932350|NCT01940406|Tremor|tremor
4932351|NCT01940393|urticaria|urticaria
4932352|NCT01940393|bilastine|bilastine
4932353|NCT01940393|fexofenadine|fexofenadine
4932354|NCT01940393|cetirizine|cetirizine
4932355|NCT01940393|ebastine|ebastine
4932356|NCT01940393|desloratadine|desloratadine
4932357|NCT01940367|Overactive Bladder|overactive bladder
4932358|NCT01940367|TENS|tens
4932359|NCT01940367|PTNS|ptns
4932360|NCT01940367|Electrical Nerve Stimulation|electrical nerve stimulation
4932361|NCT01940367|Urge Urinary Incontinence|urge urinary incontinence
4932362|NCT01940354|IV Catheter comparison|iv catheter comparison
4932363|NCT01940354|AccuCath versus Conventional IV Catheters|accucath versus conventional iv catheters
4932364|NCT01940354|IV Catheter Study|iv catheter study
4932365|NCT01940354|IV Catheter User Preference Comparison|iv catheter user preference comparison
4932366|NCT01940354|First Attempt Success Rate for IV Catheters|first attempt success rate for iv catheters
4932367|NCT01940354|AccuCath Device Performance|accucath device performance
4932368|NCT01940354|Patient Satisfaction with IV Catheters|patient satisfaction with iv catheters
4932369|NCT01940354|Clinician Satisfaction with AccuCath Device Performance|clinician satisfaction with accucath device performance
4932370|NCT01940341|Hepatitis|hepatitis
4932371|NCT01940341|Tenofovir|tenofovir
4932372|NCT01940341|Viread|viread
4932373|NCT01940328|Ultrasound Doppler|ultrasound doppler
4932374|NCT01940328|Congestive heart failure|congestive heart failure
4932375|NCT01940328|Pulmonary Edema|pulmonary edema
4932376|NCT01940315|Defender Study|defender study
4932377|NCT01940315|experimental vaccine|experimental vaccine
4932378|NCT01940315|inhalational intoxication|inhalational intoxication
4932379|NCT01940302|Malnutrition; Metabolic disorders|malnutrition; metabolic disorders
4932380|NCT01940289|algometry|algometry
4932381|NCT01940289|pain|pain
4932382|NCT01940289|VAS|vas
4932383|NCT01940276|Prostate cancer|prostate cancer
4932384|NCT01940276|metastatic|metastatic
4932385|NCT01940276|castrate resistant|castrate resistant
4932386|NCT01940276|abiraterone acetate|abiraterone acetate
4932387|NCT01940276|prednisone|prednisone
4932388|NCT01940276|metastatic prostate cancer|metastatic prostate cancer
4932389|NCT01940263|oxidative stress|oxidative stress
4932390|NCT01940263|dyslipidemia|dyslipidemia
4932391|NCT01940263|inflammation|inflammation
4932392|NCT01940263|apoptosis|apoptosis
4932393|NCT01940250|Hand, foot and mouth disease|hand, foot and mouth disease
4932394|NCT01940250|Autonomic nervous system dysregulation|autonomic nervous system dysregulation
4932395|NCT01940250|Magnesium sulphate|magnesium sulphate
4932396|NCT01940237|Depression|depression
4932397|NCT01940237|Psychotherapy|psychotherapy
4932398|NCT01940237|Cancer|cancer
4932399|NCT01940237|Pancreatic Cancer|pancreatic cancer
4932400|NCT01940237|Lung Cancer|lung cancer
4932401|NCT01940237|Colon Cancer|colon cancer
4932402|NCT01940237|Prostate Cancer|prostate cancer
4932403|NCT01940224|Pregabalin|pregabalin
4932404|NCT01940224|Laparoscopic colorectal surgery|laparoscopic colorectal surgery
4932405|NCT01940224|Postoperative pain|postoperative pain
4932406|NCT01940224|Opioid consumption|opioid consumption
4932407|NCT01940198|Atazanavir|atazanavir
4932408|NCT01940198|long-term|long-term
4932409|NCT01940198|primary care setting|primary care setting
4932410|NCT01940198|sydney|sydney
4932411|NCT01940159|Schizophrenia|schizophrenia
4932412|NCT01940159|Schizoaffective disorders|schizoaffective disorders
4932413|NCT01940120|Mitral Valve Insufficiency|mitral valve insufficiency
4932414|NCT01940120|Mitral Valve Regurgitation|mitral valve regurgitation
4932415|NCT01940120|Mitral Valve Incompetence|mitral valve incompetence
4932416|NCT01940120|Mitral Regurgitation|mitral regurgitation
4932512|NCT01939821|attitudes|attitudes
4932418|NCT01940120|Mitral Valve|mitral valve
4932419|NCT01940120|MR|mr
4932420|NCT01940120|Mitral Valve Prolapse|mitral valve prolapse
4932421|NCT01940120|Edge to Edge (E2E)|edge to edge (e2e)
4932422|NCT01940120|Alfieri Technique|alfieri technique
4932423|NCT01940120|MitraClip|mitraclip
4932424|NCT01940120|Functional MR|functional mr
4932425|NCT01940120|Degenerative MR|degenerative mr
4932426|NCT01940120|Echocardiogram|echocardiogram
4932427|NCT01940120|Coronary Artery Disease (CAD)|coronary artery disease (cad)
4932428|NCT01940120|Heart Failure|heart failure
4932429|NCT01940120|Heart Attack|heart attack
4932430|NCT01940120|EVEREST|everest
4932431|NCT01940120|EVEREST I|everest i
4932432|NCT01940120|EVEREST II|everest ii
4932433|NCT01940120|REALISM|realism
4932434|NCT01940107|breast cancer,|breast cancer,
4932435|NCT01940107|radiotherapy,|radiotherapy,
4932436|NCT01940107|physical therapy,|physical therapy,
4932437|NCT01940107|upper limb|upper limb
4932438|NCT01940094|Granulomatosis with polyangiitis|granulomatosis with polyangiitis
4932439|NCT01940094|Wegener's granulomatosis|wegener's granulomatosis
4932440|NCT01940094|WG|wg
4932441|NCT01940094|GPA|gpa
4932442|NCT01940094|ANCA-Associated Vasculitis|anca-associated vasculitis
4932443|NCT01940094|AAV|aav
4932444|NCT01940094|Vasculitis|vasculitis
4932445|NCT01940094|Prednisone|prednisone
4932446|NCT01940094|Glucocorticoid|glucocorticoid
4932447|NCT01940094|Taper|taper
4932448|NCT01940081|Cardiomyopathy, Dilated|cardiomyopathy, dilated
4932449|NCT01940081|Tachycardia, Ventricular|tachycardia, ventricular
4932450|NCT01940081|Ventricular Fibrillation|ventricular fibrillation
4932451|NCT01940081|Arrhythmias, Cardiac/etiology|arrhythmias, cardiac/etiology
4932452|NCT01940081|Arrhythmias, Cardiac/physiopathology|arrhythmias, cardiac/physiopathology
4932453|NCT01940081|Magnetic Resonance Imaging|magnetic resonance imaging
4932454|NCT01940081|3-Iodobenzylguanidine/diagnostic use|3-iodobenzylguanidine/diagnostic use
4932455|NCT01940081|Sympathetic Nervous System/radionuclide imaging|sympathetic nervous system/radionuclide imaging
4932456|NCT01940081|Electrophysiologic Techniques, Cardiac|electrophysiologic techniques, cardiac
4932457|NCT01940081|Biopsy|biopsy
4932458|NCT01940081|Genetic Testing|genetic testing
4932459|NCT01940081|Echocardiography|echocardiography
4932460|NCT01940081|Electrocardiography, Ambulatory|electrocardiography, ambulatory
4932461|NCT01940081|Exercise Test|exercise test
4932462|NCT01940068|Hypersensitivity|hypersensitivity
4932463|NCT01940068|Milk Hypersensitivity|milk hypersensitivity
4932464|NCT01940068|Immune System Diseases|immune system diseases
4932465|NCT01940068|Food Hypersensitivity|food hypersensitivity
4932466|NCT01940055|Balance|balance
4932467|NCT01940055|Gait|gait
4932468|NCT01940055|Instrumented Treadmill|instrumented treadmill
4932469|NCT01940055|Recumbent cycle|recumbent cycle
4932470|NCT01940055|Cognitive games|cognitive games
4932471|NCT01940029|vancomycin, neurosurgery, critical ill, pharmacokinetics|vancomycin, neurosurgery, critical ill, pharmacokinetics
4932472|NCT01940016|Feasibility study|feasibility study
4932473|NCT01940016|Interactive voice response system (IVR)|interactive voice response system (ivr)
4932474|NCT01940016|health coach|health coach
4932475|NCT01940016|no evidence of disease|no evidence of disease
4932476|NCT01940003|Diabetes, Gestational|diabetes, gestational
4932477|NCT01940003|Pregnancy Outcome|pregnancy outcome
4932478|NCT01940003|Exercise|exercise
4932479|NCT01940003|glycemic control|glycemic control
4932480|NCT01939990|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
4932481|NCT01939977|Hyperparathyroidism|hyperparathyroidism
4932482|NCT01939977|Hyperparathyroidism Secondary|hyperparathyroidism secondary
4932483|NCT01939977|Paricalcitol|paricalcitol
4932484|NCT01939977|Calcifediol|calcifediol
4932485|NCT01939977|Parathyroid hormone|parathyroid hormone
4932486|NCT01939977|Renal transplantation|renal transplantation
4932487|NCT01939964|Wrinkles|wrinkles
4932488|NCT01939964|Activation Mist|activation mist
4932489|NCT01939951|Asthma|asthma
4932490|NCT01939951|Persistent|persistent
4932491|NCT01939925|patient education|patient education
4932492|NCT01939925|Health Knowledge, Attitudes, Practice|health knowledge, attitudes, practice
4932493|NCT01939925|comprehension|comprehension
4932494|NCT01939925|consumer health information|consumer health information
4932495|NCT01939899|MLN9708|mln9708
4932496|NCT01939899|Lymphoma|lymphoma
4932497|NCT01939899|IXAZOMIB|ixazomib
4932498|NCT01939886|Malaria treatment efficacy|malaria treatment efficacy
4932499|NCT01939886|Malaria transmission|malaria transmission
4932500|NCT01939873|Kristeller maneuver; Second stage of labor;|kristeller maneuver; second stage of labor;
4932501|NCT01939873|Perineal laceration; Obstetrical outcome;|perineal laceration; obstetrical outcome;
4932502|NCT01939873|Neonatal outcome|neonatal outcome
4932503|NCT01939847|Metastatic breast cancer|metastatic breast cancer
4932504|NCT01939847|Breast cancer|breast cancer
4932505|NCT01939847|Molecular profiling|molecular profiling
4932506|NCT01939847|Personalized medicine|personalized medicine
4932507|NCT01939834|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
4932508|NCT01939834|Artificial Pancreas|artificial pancreas
4932509|NCT01939834|Diabetes Assistant (DiAs)|diabetes assistant (dias)
4932510|NCT01939834|Continuous Glucose Monitor|continuous glucose monitor
4932511|NCT01939821|Fecal incontinence|fecal incontinence
4932513|NCT01939821|knowledge|knowledge
4932514|NCT01939821|quality of care|quality of care
4932515|NCT01939795|cardiac resynchronization therapy (CRT)|cardiac resynchronization therapy (crt)
4932516|NCT01939782|Metabolic CLock Genes (MCG)|metabolic clock genes (mcg)
4932517|NCT01939782|Type 2 Diabetes (T2D)|type 2 diabetes (t2d)
4932518|NCT01939769|fMRI|fmri
4932519|NCT01939769|Catecholamines|catecholamines
4932520|NCT01939769|Stress|stress
4932521|NCT01939769|Exercise|exercise
4932522|NCT01939769|Memory|memory
4932523|NCT01939756|High risk non-muscle invasive urothelial bladder cancer|high risk non-muscle invasive urothelial bladder cancer
4932524|NCT01939756|Intravesical BCG|intravesical bcg
4932525|NCT01939756|Local toxicity|local toxicity
4932526|NCT01939756|Natural baobab oil|natural baobab oil
4932527|NCT01939730|Lymphoma|lymphoma
4932528|NCT01939730|Follicular B-Cell Lymphoma|follicular b-cell lymphoma
4932529|NCT01939730|Rituximab|rituximab
4932530|NCT01939730|Rituxan|rituxan
4932531|NCT01939730|GM-CSF|gm-csf
4932532|NCT01939730|Sargramostim|sargramostim
4932533|NCT01939730|Leukine|leukine
4932534|NCT01939717|Parkinson's disease|parkinson's disease
4932535|NCT01939717|Irish set dancing|irish set dancing
4932536|NCT01939691|difluprednate|difluprednate
4932537|NCT01939691|prednisolone acetate|prednisolone acetate
4932538|NCT01939691|nepafenac|nepafenac
4932539|NCT01939665|Locally advanced pancreatic carcinoma|locally advanced pancreatic carcinoma
4932540|NCT01939665|LAPC|lapc
4932541|NCT01939665|Irreversible electroporation|irreversible electroporation
4932542|NCT01939665|NanoKnife|nanoknife
4932544|NCT01939665|Safety|safety
4932545|NCT01939665|Efficacy|efficacy
4932546|NCT01939665|Non-thermal ablation|non-thermal ablation
4932547|NCT01939665|Percutaneous ablation|percutaneous ablation
4932548|NCT01939665|Low Energy Direct Current|low energy direct current
4932549|NCT01939652|minilaparotomy|minilaparotomy
4932550|NCT01939652|AAA|aaa
4932551|NCT01939652|fluid regime|fluid regime
4932552|NCT01939639|Oxytocin|oxytocin
4932553|NCT01939639|fMRI|fmri
4932554|NCT01939626|embryo|embryo
4932555|NCT01939626|culture|culture
4932556|NCT01939613|fluid resuscitation|fluid resuscitation
4932557|NCT01939613|burn|burn
4932558|NCT01939613|colloid,|colloid,
4932559|NCT01939613|multiple organ dysfunction|multiple organ dysfunction
4932560|NCT01939613|intra-abdominal pressure|intra-abdominal pressure
4932561|NCT01939600|Resistant starch|resistant starch
4932562|NCT01939600|Ileostomy|ileostomy
4932563|NCT01939600|In vivo|in vivo
4932564|NCT01939600|Carbohydrate digestibility|carbohydrate digestibility
4932565|NCT01939587|Adenosine A1 receptor antagonist|adenosine a1 receptor antagonist
4932566|NCT01939587|Asthma|asthma
4932567|NCT01939587|adenosine receptor modulator|adenosine receptor modulator
4932568|NCT01939587|COPD|copd
4932569|NCT01939574|Glioblastoma|glioblastoma
4932570|NCT01939574|Potential Image Biomarkers|potential image biomarkers
4932571|NCT01939574|PFS|pfs
4932572|NCT01939574|Bevacizumab|bevacizumab
4932573|NCT01939574|Conventional Therapy|conventional therapy
4932574|NCT01939561|Myotonia|myotonia
4932575|NCT01939561|Lamotrigine|lamotrigine
4932576|NCT01939561|RCT|rct
4932577|NCT01939561|treatment|treatment
4932578|NCT01939548|PF-02545920|pf-02545920
4932579|NCT01939548|schizophrenia|schizophrenia
4932580|NCT01939548|outpatient|outpatient
4932581|NCT01939548|safety|safety
4932582|NCT01939548|efficacy|efficacy
4932583|NCT01939548|suboptimal response|suboptimal response
4932584|NCT01939535|Endometriosis|endometriosis
4932585|NCT01939535|Magnetic resonance imaging|magnetic resonance imaging
4932586|NCT01939522|diabetes|diabetes
4932587|NCT01939522|pneumococcal|pneumococcal
4932588|NCT01939496|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
4932589|NCT01939496|Hypertension|hypertension
4932590|NCT01939496|Canagliflozin|canagliflozin
4932591|NCT01939496|JNJ 28431754|jnj 28431754
4932592|NCT01939496|Sodium-Glucose Transporter 2|sodium-glucose transporter 2
4932593|NCT01939496|Blood Glucose|blood glucose
4932594|NCT01939496|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
4932595|NCT01939483|Irinotecan hydrochloride|irinotecan hydrochloride
4932596|NCT01939483|Irinotecan|irinotecan
4932597|NCT01939483|CAMPTOSAR|camptosar
4932598|NCT01939470|osteoporosis|osteoporosis
4932599|NCT01939470|bone|bone
4932600|NCT01939470|inflammation|inflammation
4932601|NCT01939470|diabetes|diabetes
4932602|NCT01939470|vitamin D|vitamin d
4932603|NCT01939444|Antidotes|antidotes
4932604|NCT01939444|naloxone|naloxone
4932605|NCT01939444|administration, intravenous|administration, intravenous
4932606|NCT01939444|administration, intranasal|administration, intranasal
4932607|NCT01939444|pharmacology|pharmacology
4932608|NCT01939431|Podoconiosis|podoconiosis
4932609|NCT01939431|Gene Expression|gene expression
4932610|NCT01939431|Genomics|genomics
4932611|NCT01939431|Pathogenesis|pathogenesis
4932612|NCT01939418|metastatic breast cancer|metastatic breast cancer
4932613|NCT01939418|triple negative breast cancer|triple negative breast cancer
4932614|NCT01939418|gemcitabine|gemcitabine
4932615|NCT01939418|RAD001|rad001
4932616|NCT01939405|Obesity|obesity
4932617|NCT01939405|Overweight|overweight
4932618|NCT01939405|Physical Activity|physical activity
4932619|NCT01939405|Built Environment|built environment
4932620|NCT01939405|counseling|counseling
4932621|NCT01939392|Resistant hypertension|resistant hypertension
4932622|NCT01939392|Uncontrolled hypertension|uncontrolled hypertension
4932623|NCT01939392|Renal artery ablation|renal artery ablation
4932624|NCT01939379|Total knee arthroplasty|total knee arthroplasty
4932625|NCT01939379|nerve block|nerve block
4932626|NCT01939379|Pain control after surgery|pain control after surgery
4932627|NCT01939366|Painful Diabetic Peripheral Neuropathy|painful diabetic peripheral neuropathy
4932628|NCT01939353|Adult ADHD|adult adhd
4932629|NCT01939327|diffuse large B cell|diffuse large b cell
4932630|NCT01939327|non-Hodgkin lymphoma|non-hodgkin lymphoma
4932631|NCT01939314|Headache|headache
4932632|NCT01939314|Migraine|migraine
4932633|NCT01939301|Pulmonary embolism clot|pulmonary embolism clot
4932634|NCT01939262|Arthritis|arthritis
4932635|NCT01939262|Pain|pain
4932636|NCT01939262|Function|function
4932637|NCT01939262|Diet|diet
4932638|NCT01939262|Vegan|vegan
4932639|NCT01939262|Vegetarian|vegetarian
4932640|NCT01939262|Restriction|restriction
4932641|NCT01939236|chronic heart failure|chronic heart failure
4932642|NCT01939236|traditional Chinese medicine|traditional chinese medicine
4932643|NCT01939236|syndrome differentiation|syndrome differentiation
4932644|NCT01939223|Stage IV colorectal cancer / Liver Metastasis|stage iv colorectal cancer / liver metastasis
4932645|NCT01939197|HCV Genotype 4|hcv genotype 4
4932646|NCT01939197|Interferon-Free|interferon-free
4932647|NCT01939197|Hepatitis C Genotype 1|hepatitis c genotype 1
4932648|NCT01939197|Compensated Cirrhosis|compensated cirrhosis
4932649|NCT01939197|Hepatitis C Genotype 4|hepatitis c genotype 4
4932650|NCT01939197|HCV / HIV coinfection|hcv / hiv coinfection
4932651|NCT01939197|Cirrhotic|cirrhotic
4932652|NCT01939197|Hepatitis C|hepatitis c
4932653|NCT01939197|HIV-1|hiv-1
4932654|NCT01939197|HCV Genotype 1|hcv genotype 1
4932655|NCT01939171|Thymoglobulin|thymoglobulin
4932656|NCT01939171|Cadaver donor|cadaver donor
4932657|NCT01939171|Kidney injury brain death related|kidney injury brain death related
4932658|NCT01939158|Co-administration|co-administration
4932659|NCT01939158|Safety|safety
4932660|NCT01939158|Persistence|persistence
4932661|NCT01939158|Immunogenicity|immunogenicity
4932662|NCT01939158|Prevenar 13|prevenar 13
4932663|NCT01939158|Meningococcal vaccine|meningococcal vaccine
4932664|NCT01939158|Toddlers|toddlers
4932665|NCT01939158|5 years|5 years
4932666|NCT01939145|hospital admission|hospital admission
4932667|NCT01939132|Psoriatic Arthritis|psoriatic arthritis
4932668|NCT01939132|ACTH|acth
4932669|NCT01939132|Acthar|acthar
4932670|NCT01939119|retinal vascular occlusion|retinal vascular occlusion
4932671|NCT01939119|drinking habits|drinking habits
4932672|NCT01939119|body hydration|body hydration
4932673|NCT01939119|body-fluid balance|body-fluid balance
4932674|NCT01939106|Stoma|stoma
4932675|NCT01939106|Ileostomy|ileostomy
4932676|NCT01939106|pouch|pouch
4932677|NCT01939106|Drainable Pouch for collection of stool|drainable pouch for collection of stool
4932678|NCT01939093|Quetiapine|quetiapine
4932679|NCT01939093|Haloperidol|haloperidol
4932680|NCT01939093|Methamphetamine|methamphetamine
4932681|NCT01939093|Psychosis|psychosis
4932682|NCT01939080|moderate risk|moderate risk
4932683|NCT01939080|high risk|high risk
4932684|NCT01939067|respiratory distress|respiratory distress
4932685|NCT01939067|Heated Humidified High Flow Nasal Cannula (HHHFNC)|heated humidified high flow nasal cannula (hhhfnc)
4932686|NCT01939067|HHHFNC|hhhfnc
4932687|NCT01939067|noninvasive nasal continuous positive airway pressure (NCPAP)|noninvasive nasal continuous positive airway pressure (ncpap)
4932688|NCT01939067|NCPAP|ncpap
4932689|NCT01939041|Subacute Stroke|subacute stroke
4932690|NCT01939041|Unilateral Robot-Assisted Training|unilateral robot-assisted training
4932691|NCT01939041|Bilateral Robot-Assisted Training|bilateral robot-assisted training
4932692|NCT01939041|Motor control|motor control
4932693|NCT01939041|Physiological Response|physiological response
4932694|NCT01939015|3D miniplate|3d miniplate
4932695|NCT01939015|angle mandibular fracture|angle mandibular fracture
4932696|NCT01939015|champy technique|champy technique
4932697|NCT01939015|internal rigid fixation|internal rigid fixation
4932698|NCT01939002|flu-like symptoms|flu-like symptoms
4932699|NCT01938989|cataract|cataract
4932700|NCT01938989|intraocular lens|intraocular lens
4932701|NCT01938989|IOL|iol
4932702|NCT01938989|blue light filter|blue light filter
4932703|NCT01938976|Asthma|asthma
4932704|NCT01938976|Tobacco|tobacco
4932705|NCT01938976|Waterpipe|waterpipe
4932706|NCT01938976|Cigarettes|cigarettes
4932707|NCT01938976|Adolescents|adolescents
4932708|NCT01938976|Peer education|peer education
4932709|NCT01938976|Jordan|jordan
4932710|NCT01938963|Depression|depression
4932711|NCT01938963|Hypertension|hypertension
4932712|NCT01938963|Older Adults|older adults
4932713|NCT01938911|Trier social stress test|trier social stress test
4932714|NCT01938911|Oxytocin|oxytocin
4932715|NCT01938911|Hypertension|hypertension
4932716|NCT01938898|Randomized trial|randomized trial
4932717|NCT01938898|Invitation letter|invitation letter
4932718|NCT01938898|Recruitment|recruitment
4932719|NCT01938898|Retention|retention
4932720|NCT01938872|critical limb ischemia|critical limb ischemia
4932721|NCT01938872|drug-eluting balloon|drug-eluting balloon
4932722|NCT01938872|restenosis|restenosis
4932723|NCT01938859|bipolar disorder|bipolar disorder
4932724|NCT01938859|lithium|lithium
4932725|NCT01938859|quetiapine|quetiapine
4932726|NCT01938859|Medicine, Chinese Traditional|medicine, chinese traditional
4932727|NCT01938859|efficacy|efficacy
4932728|NCT01938859|safety|safety
4932729|NCT01938859|Recurrence|recurrence
4932730|NCT01938820|Hepatitis B|hepatitis b
4932731|NCT01938820|Liver Cirrhosis|liver cirrhosis
4932732|NCT01938820|Regression|regression
4932733|NCT01938820|Efficacy|efficacy
4932734|NCT01938807|type 1 diabetes|type 1 diabetes
4932735|NCT01938807|parents|parents
4932736|NCT01938807|mobile application|mobile application
4932737|NCT01938807|diabetes management|diabetes management
4932738|NCT01938781|Hepatitis B|hepatitis b
4932739|NCT01938781|Liver fibrosis|liver fibrosis
4932740|NCT01938781|Regression|regression
4932741|NCT01938781|Efficacy|efficacy
4932742|NCT01938768|Multiple trauma|multiple trauma
4932743|NCT01938768|Polytrauma|polytrauma
4932744|NCT01938768|Hyperfibrinolysis|hyperfibrinolysis
4932745|NCT01938768|Tranexamic acid|tranexamic acid
4932746|NCT01938768|Thrombelastometry|thrombelastometry
4932747|NCT01938742|A/H7N9,Adjuvant,Immunogenicity,Influenza,MF59,Monovalent,Vaccine|a/h7n9,adjuvant,immunogenicity,influenza,mf59,monovalent,vaccine
4932748|NCT01938729|HEPATIC ARTERIAL INFUSION|hepatic arterial infusion
4932749|NCT01938729|FLOXURIDINE|floxuridine
4932750|NCT01938729|DEXAMETHASONE|dexamethasone
4932751|NCT01938729|GEMCITABINE|gemcitabine
4932752|NCT01938729|Pump|pump
4932753|NCT01938729|13-148|13-148
4932754|NCT01938716|Pancreatic Cancer|pancreatic cancer
4932755|NCT01938716|Adenocarcinoma of the Pancreas|adenocarcinoma of the pancreas
4932756|NCT01938716|Intratumoral gemcitabine levels|intratumoral gemcitabine levels
4932757|NCT01938716|Pancreatic surgery|pancreatic surgery
4932758|NCT01938716|Pharmacokinetic testing|pharmacokinetic testing
4932759|NCT01938716|PK|pk
4932760|NCT01938716|Gemcitabine|gemcitabine
4932761|NCT01938716|Gemcitabine Hydrochloride|gemcitabine hydrochloride
4932762|NCT01938716|Gemzar|gemzar
4932763|NCT01938690|stroke, transcranial magnetic stimulation, rehabilitation|stroke, transcranial magnetic stimulation, rehabilitation
4932764|NCT01938677|Vestibular schwannoma|vestibular schwannoma
4932765|NCT01938677|Gamma knife radiosurgery|gamma knife radiosurgery
4932766|NCT01938677|Hearing preservation|hearing preservation
4932767|NCT01938664|cocaine|cocaine
4932768|NCT01938664|dependence|dependence
4932769|NCT01938664|pharmacotherapy|pharmacotherapy
4932770|NCT01938638|Advanced malignancies|advanced malignancies
4932771|NCT01938638|TNBC|tnbc
4932772|NCT01938638|DLBCL|dlbcl
4932773|NCT01938638|Gastric cancer|gastric cancer
4932774|NCT01938625|Hepatitis C, Chronic|hepatitis c, chronic
4932775|NCT01938625|Recurrent Chronic Hepatitis C|recurrent chronic hepatitis c
4932776|NCT01938625|Pharmacokinetics|pharmacokinetics
4932777|NCT01938625|Simeprevir|simeprevir
4932778|NCT01938625|Daclatasvir|daclatasvir
4932779|NCT01938625|Ribavirin|ribavirin
4932780|NCT01938625|Orthotopic Liver Transplantation|orthotopic liver transplantation
4932781|NCT01938625|TMC435|tmc435
4932782|NCT01938625|BMS-790052|bms-790052
4932783|NCT01938625|RBV|rbv
4932784|NCT01938612|MEDI4736|medi4736
4932785|NCT01938612|Advanced solid tumors|advanced solid tumors
4932786|NCT01938612|squamous cell carcinoma of the head and Neck|squamous cell carcinoma of the head and neck
4932787|NCT01938612|biliary tract cancer|biliary tract cancer
4932788|NCT01938612|squamous cell carcinoma of esophagus cancer|squamous cell carcinoma of esophagus cancer
4932789|NCT01938612|B7-H1|b7-h1
4932790|NCT01938612|PD-L1|pd-l1
4932791|NCT01938599|Plaque Psoriasis|plaque psoriasis
4932792|NCT01938586|Scar|scar
4932793|NCT01938586|Appearance|appearance
4932794|NCT01938547|perioperative|perioperative
4932795|NCT01938547|blood pressure|blood pressure
4932796|NCT01938547|pediatrics|pediatrics
4932797|NCT01938547|pediatric surgery|pediatric surgery
4932798|NCT01938521|Red Grape Cells powder (RGC)|red grape cells powder (rgc)
4932799|NCT01938521|Placebo (PLA)|placebo (pla)
4932800|NCT01938508|dermatitis|dermatitis
4932801|NCT01938508|Minocycline|minocycline
4932802|NCT01938508|bioavailability|bioavailability
4932803|NCT01938495|ALS|als
4932804|NCT01938495|DPS|dps
4932805|NCT01938495|Diaphragm Pacing|diaphragm pacing
4932806|NCT01938482|SCD1|scd1
4932807|NCT01938482|Topical Administration|topical administration
4932808|NCT01938482|Acne|acne
4932809|NCT01938482|Gel|gel
4932810|NCT01938469|Bariatric|bariatric
4932811|NCT01938469|Gastric Bypass|gastric bypass
4932812|NCT01938469|Gastric Banding,|gastric banding,
4932813|NCT01938469|Incretins|incretins
4932814|NCT01938469|glucagon-like peptide-1(GLP-1)|glucagon-like peptide-1(glp-1)
4932815|NCT01938469|gastric inhibitory peptide (GIP)|gastric inhibitory peptide (gip)
4932816|NCT01938456|Non-small cell lung cancer|non-small cell lung cancer
4932817|NCT01938456|GSK1120212 (trametinib)|gsk1120212 (trametinib)
4932818|NCT01938456|Japanese|japanese
4932819|NCT01938456|Phase Ib|phase ib
4932820|NCT01938456|combination therapy|combination therapy
4932821|NCT01938456|docetaxel|docetaxel
4932822|NCT01938456|MEK inhibitor|mek inhibitor
4932823|NCT01938443|pharmacodynamics|pharmacodynamics
4932824|NCT01938443|MEK inhibitor|mek inhibitor
4932825|NCT01938443|Focal adhesion kinase inhibitor|focal adhesion kinase inhibitor
4932826|NCT01938443|cancer|cancer
4932827|NCT01938443|pharmacokinetic|pharmacokinetic
4932828|NCT01938443|mesothelioma|mesothelioma
4932829|NCT01938443|Phase 1|phase 1
4932830|NCT01938417|tobramycin|tobramycin
4932831|NCT01938417|bone graft substitute|bone graft substitute
4932832|NCT01938417|pharmacokinetics|pharmacokinetics
4932833|NCT01938417|renal failure|renal failure
4932834|NCT01938404|Plasma exchange|plasma exchange
4932835|NCT01938404|Thrombotic Thrombocytopenic Purpura|thrombotic thrombocytopenic purpura
4932836|NCT01938404|TTP|ttp
4932837|NCT01938391|Peripheral Artery Disease|peripheral artery disease
4932838|NCT01938391|PAD|pad
4932839|NCT01938391|Claudication|claudication
4932840|NCT01938391|Peripheral Vascular Disease|peripheral vascular disease
4932841|NCT01938391|PVD|pvd
4932842|NCT01938391|Orbital Atherectomy|orbital atherectomy
4932843|NCT01938391|Balloon Angioplasty|balloon angioplasty
4932844|NCT01938391|Intravascular Ultrasound (IVUS)|intravascular ultrasound (ivus)
4932845|NCT01938378|Octaplas|octaplas
4932846|NCT01938352|Influenza|influenza
4932847|NCT01938352|Virus|virus
4932848|NCT01938352|Monoclonal Antibody|monoclonal antibody
4932849|NCT01938352|Immunization|immunization
4932850|NCT01938352|Treatment|treatment
4932851|NCT01938339|prostate cancer|prostate cancer
4932852|NCT01938339|MRI|mri
4932853|NCT01938339|PET|pet
4932854|NCT01938326|Stomach neoplasm|stomach neoplasm
4932855|NCT01938326|TLDG|tldg
4932856|NCT01938326|SIDG|sidg
4932857|NCT01938326|single-port|single-port
4932858|NCT01938326|inflammatory response|inflammatory response
4932859|NCT01938313|gastric cancer|gastric cancer
4932860|NCT01938313|ERAS (early recovery after surgery)|eras (early recovery after surgery)
4932861|NCT01938313|fast track|fast track
4932862|NCT01938313|laparoscopic gastrectomy|laparoscopic gastrectomy
4932863|NCT01938274|Hip|hip
4932864|NCT01938274|Knee|knee
4932865|NCT01938274|Osteoarthritis|osteoarthritis
4932866|NCT01938274|Arthroplasty|arthroplasty
4932867|NCT01938274|Physical Activity|physical activity
4932868|NCT01938274|Expectations|expectations
4932869|NCT01938274|Leisure Activity|leisure activity
4932870|NCT01938248|Pacemaker, Artificial|pacemaker, artificial
4932871|NCT01938248|Defibrillators, Implantable|defibrillators, implantable
4932872|NCT01938248|Atrial Fibrillation|atrial fibrillation
4932873|NCT01938248|Stroke Risk|stroke risk
4932874|NCT01938235|Myocardial infarction|myocardial infarction
4932875|NCT01938235|Percutaneous coronary intervention|percutaneous coronary intervention
4932876|NCT01938235|Reperfusion injury|reperfusion injury
4932877|NCT01938235|Exenatide|exenatide
4932878|NCT01938235|Magnetic resonance imaging|magnetic resonance imaging
4932879|NCT01938222|abdominal wall closure|abdominal wall closure
4932880|NCT01938222|short stitch technique|short stitch technique
4932881|NCT01938196|Chronic Constipation|chronic constipation
4932882|NCT01938196|Constipation|constipation
4932883|NCT01938196|Functional gastrointestinal disorders|functional gastrointestinal disorders
4932884|NCT01938183|chronic periodontitis|chronic periodontitis
4932885|NCT01938183|metronidazole|metronidazole
4932886|NCT01938157|High Risk of Breast Cancer|high risk of breast cancer
4932887|NCT01938157|Diffusion Magnetic Resonance Imaging|diffusion magnetic resonance imaging
4932888|NCT01938144|Common cold|common cold
4932889|NCT01938144|efficacy|efficacy
4932890|NCT01938144|symptoms|symptoms
4932891|NCT01938144|Wisconsin Upper Respiratory Symptom Survey - 21|wisconsin upper respiratory symptom survey - 21
4932892|NCT01938144|ibuprofen|ibuprofen
4932893|NCT01938144|phenylephrine|phenylephrine
4932894|NCT01938144|pseudoephedrine|pseudoephedrine
4932895|NCT01938131|knee, osteoarthritis, muscle vibration|knee, osteoarthritis, muscle vibration
4932896|NCT01938118|Infant diet|infant diet
4932897|NCT01938118|Family diet|family diet
4932898|NCT01938118|Responsive feeding|responsive feeding
4932899|NCT01938118|Infant temperament|infant temperament
4932900|NCT01938118|Physical activity|physical activity
4932901|NCT01938118|Television|television
4932902|NCT01938105|Cervical cancer|cervical cancer
4932903|NCT01938105|Nimotuzumab|nimotuzumab
4932904|NCT01938105|Intensity-modulated radiation therapy|intensity-modulated radiation therapy
4932905|NCT01938105|Concurrent chemoradiotherapy|concurrent chemoradiotherapy
4932906|NCT01938092|High-tone pelvic floor dysfunction|high-tone pelvic floor dysfunction
4932907|NCT01938092|Spasm|spasm
4932908|NCT01938092|Pelvic pain|pelvic pain
4932909|NCT01938092|Diazepam|diazepam
4932910|NCT01938092|Female|female
4932911|NCT01938092|Randomized trial|randomized trial
4932912|NCT01938079|ECMO|ecmo
4932913|NCT01938079|Ketamine|ketamine
4932914|NCT01938079|Opiates|opiates
4932915|NCT01938079|Lung failure|lung failure
4932916|NCT01938079|Extracorporeal membrane oxygenation|extracorporeal membrane oxygenation
4932917|NCT01938079|Mechanical ventilation|mechanical ventilation
4932918|NCT01938079|Sedation|sedation
4932919|NCT01938066|procellera|procellera
4932920|NCT01938053|STI, STD|sti, std
4933108|NCT01936948|Colon cancer screening|colon cancer screening
4932921|NCT01938040|laparoscopic cholecystectomy|laparoscopic cholecystectomy
4932922|NCT01938027|Rectal Neoplasms|rectal neoplasms
4932923|NCT01938027|Colorectal Neoplasms|colorectal neoplasms
4932924|NCT01938027|transanal surgery|transanal surgery
4932925|NCT01938014|MPS I|mps i
4932926|NCT01938014|MPS II|mps ii
4932927|NCT01938014|MPS III|mps iii
4932928|NCT01938014|MPS VI|mps vi
4932929|NCT01938014|Krabbe disease|krabbe disease
4932930|NCT01938014|globoid cell leukodystrophy|globoid cell leukodystrophy
4932931|NCT01938014|galactosylceramide lipidosis|galactosylceramide lipidosis
4932932|NCT01938014|mucopolysaccharidoses|mucopolysaccharidoses
4932933|NCT01938014|mucopolysaccharidosis|mucopolysaccharidosis
4932934|NCT01938014|Rare Diseases Clinical Research Network|rare diseases clinical research network
4932935|NCT01938014|Lysosomal Disease Network|lysosomal disease network
4932936|NCT01938014|enzyme replacement therapy|enzyme replacement therapy
4932937|NCT01938014|hematopoietic stem cell transplant|hematopoietic stem cell transplant
4932938|NCT01938014|telephone-based surveillance|telephone-based surveillance
4932939|NCT01938014|Hurler syndrome|hurler syndrome
4932940|NCT01938014|Hunter syndrome|hunter syndrome
4932941|NCT01938014|Scheie syndrome|scheie syndrome
4932942|NCT01938014|Hurler-Scheie syndrome|hurler-scheie syndrome
4932943|NCT01938014|Sanfilippo syndrome|sanfilippo syndrome
4932944|NCT01938014|Maroteaux-Lamy syndrome|maroteaux-lamy syndrome
4932945|NCT01938001|Non-Hodgkins Follicular lymphoma, Non-Hodgkins Marginal zone lymphoma, treatment for follicular lymphoma, treatment for Marginal zone lymphoma|non-hodgkins follicular lymphoma, non-hodgkins marginal zone lymphoma, treatment for follicular lymphoma, treatment for marginal zone lymphoma
4932946|NCT01937988|Doula|doula
4932947|NCT01937988|Abortion|abortion
4932948|NCT01937988|Pain|pain
4932949|NCT01937988|support|support
4932950|NCT01937949|Aortic aneurysm|aortic aneurysm
4932951|NCT01937936|caregiver stress|caregiver stress
4932952|NCT01937936|depression|depression
4932953|NCT01937936|quality of life|quality of life
4932954|NCT01937936|cognitive behavioral therapy|cognitive behavioral therapy
4932955|NCT01937910|neuroplastic change|neuroplastic change
4932956|NCT01937910|myelin|myelin
4932957|NCT01937897|Unilateral Massage|unilateral massage
4932958|NCT01937897|Depression|depression
4932959|NCT01937858|HbA1c|hba1c
4932960|NCT01937858|glycated hemoglobin|glycated hemoglobin
4932961|NCT01937858|correlation|correlation
4932962|NCT01937858|diabetes|diabetes
4932963|NCT01937858|renal failure|renal failure
4932964|NCT01937819|BOWEL PREPARATION|bowel preparation
4932965|NCT01937819|SMARTPHONE APPLICATION|smartphone application
4932966|NCT01937806|Chronic hepatitis B|chronic hepatitis b
4932967|NCT01937793|radiation|radiation
4932968|NCT01937793|speech-language pathology|speech-language pathology
4932969|NCT01937754|Prehypertension|prehypertension
4932970|NCT01937754|Nitric Oxide|nitric oxide
4932971|NCT01937754|Blood Pressure|blood pressure
4932972|NCT01937754|Functional Capacity|functional capacity
4932973|NCT01937754|Quality of Life|quality of life
4932974|NCT01937728|Hepatitis C|hepatitis c
4932975|NCT01937728|Genotype 1|genotype 1
4932976|NCT01937728|Peg interferon|peg interferon
4932977|NCT01937728|alfa 1a|alfa 1a
4932978|NCT01937728|Ribavirin|ribavirin
4932979|NCT01937689|Breast cancer|breast cancer
4932980|NCT01937689|advanced|advanced
4932981|NCT01937689|Pyrotinib|pyrotinib
4932982|NCT01937689|Phase I|phase i
4932983|NCT01937689|HER2 positive advanced breast cancer|her2 positive advanced breast cancer
4932984|NCT01937663|Chronic Constipation|chronic constipation
4932985|NCT01937663|Constipation|constipation
4932986|NCT01937663|Functional gastrointestinal disorders|functional gastrointestinal disorders
4932987|NCT01937650|Radiotherapy, metronidazole, cervical cancer, Mulago|radiotherapy, metronidazole, cervical cancer, mulago
4932988|NCT01937637|Cognitive Behavioral Intervention for Breathlessness|cognitive behavioral intervention for breathlessness
4932989|NCT01937624|Diagnostic ultrasound|diagnostic ultrasound
4932990|NCT01937611|dexmedetomidine|dexmedetomidine
4932991|NCT01937611|intramuscular premedication|intramuscular premedication
4932992|NCT01937611|bradycardiac|bradycardiac
4932993|NCT01937598|Incretin, DPP-4 inhibitor|incretin, dpp-4 inhibitor
4932994|NCT01937585|prostate cancer|prostate cancer
4932995|NCT01937585|partner|partner
4932996|NCT01937585|communication messages|communication messages
4932997|NCT01937585|monitoring style|monitoring style
4932998|NCT01937585|AA men|aa men
4932999|NCT01937572|Total knee arthroplasty (TKA)|total knee arthroplasty (tka)
4933000|NCT01937572|Computer aided systems|computer aided systems
4933001|NCT01937559|tranexaminic acid (TXA)|tranexaminic acid (txa)
4933002|NCT01937546|Anal Canal/injuries|anal canal/injuries
4933003|NCT01937546|Delivery, Obstetric/methods|delivery, obstetric/methods
4933004|NCT01937546|Labour Stage, Second|labour stage, second
4933005|NCT01937546|Lacerations/prevention & control|lacerations/prevention & control
4933006|NCT01937546|Obstetric Labour Complications/prevention & control|obstetric labour complications/prevention & control
4933007|NCT01937546|perineum/injuries|perineum/injuries
4933008|NCT01937533|Magnetic Resonance Imaging|magnetic resonance imaging
4933009|NCT01937520|acupuncture|acupuncture
4933010|NCT01937520|inflammation|inflammation
4933011|NCT01937520|thyroid|thyroid
4933012|NCT01937520|parathyroid|parathyroid
4933013|NCT01937494|asthma|asthma
4933109|NCT01936948|Colonoscopy|colonoscopy
4933014|NCT01937494|bronchial hyperresponsiveness|bronchial hyperresponsiveness
4933015|NCT01937494|histamine challenge test|histamine challenge test
4933016|NCT01937494|spirometry|spirometry
4933017|NCT01937481|Child, Preschool|child, preschool
4933018|NCT01937481|Parents|parents
4933019|NCT01937481|Family|family
4933020|NCT01937481|Obesity|obesity
4933021|NCT01937481|Overweight|overweight
4933022|NCT01937481|Diet|diet
4933023|NCT01937481|Overnutrition|overnutrition
4933024|NCT01937481|Motor Activity|motor activity
4933025|NCT01937481|Child Care|child care
4933026|NCT01937481|Schools|schools
4933027|NCT01937468|Chronic GVHD|chronic gvhd
4933028|NCT01937468|Chronic graft versus host disease|chronic graft versus host disease
4933029|NCT01937468|Allogeneic stem cell transplant|allogeneic stem cell transplant
4933030|NCT01937455|HIV|hiv
4933031|NCT01937455|AIDS|aids
4933032|NCT01937455|HIV vaccine|hiv vaccine
4933033|NCT01937455|HIV prevention|hiv prevention
4933034|NCT01937455|AAV|aav
4933035|NCT01937455|PG9|pg9
4933036|NCT01937442|Multiple myeloma|multiple myeloma
4933037|NCT01937442|Pharmacokinetics|pharmacokinetics
4933038|NCT01937442|Thalidomide|thalidomide
4933039|NCT01937429|Colonoscopy - Chromoendoscopy - Indigo Carmin® - Adenoma detection - Tepid water|colonoscopy - chromoendoscopy - indigo carmin® - adenoma detection - tepid water
4933040|NCT01937403|Physical Therapy|physical therapy
4933041|NCT01937403|Return to sport|return to sport
4933042|NCT01937351|Atherectomy|atherectomy
4933043|NCT01937351|Optical Coherence Tomography|optical coherence tomography
4933044|NCT01937351|Lumivascular|lumivascular
4933045|NCT01937338|Healthy volunteers, Phase 1|healthy volunteers, phase 1
4933046|NCT01937325|Eligible CF patients with G551D gene mutation|eligible cf patients with g551d gene mutation
4933047|NCT01937312|glaucoma|glaucoma
4933048|NCT01937312|prostaglandin analogue|prostaglandin analogue
4933049|NCT01937312|brinzolamide|brinzolamide
4933050|NCT01937312|brimonidine|brimonidine
4933051|NCT01937299|glaucoma|glaucoma
4933052|NCT01937299|prostaglandin analogue|prostaglandin analogue
4933053|NCT01937299|brinzolamide|brinzolamide
4933054|NCT01937299|brimonidine|brimonidine
4933055|NCT01937286|LDLT,HCC, Microvascular invasion|ldlt,hcc, microvascular invasion
4933056|NCT01937273|Nutritional status, malnutrition, chemo-radiotherapy|nutritional status, malnutrition, chemo-radiotherapy
4933057|NCT01937247|Operative Time|operative time
4933058|NCT01937247|Operating Rooms|operating rooms
4933059|NCT01937247|Efficiency|efficiency
4933060|NCT01937221|mild cognitive impairment|mild cognitive impairment
4933061|NCT01937221|mild to moderate cognitive impairment|mild to moderate cognitive impairment
4933062|NCT01937208|Esophageal Carcinoma|esophageal carcinoma
4933063|NCT01937208|chemoradiation|chemoradiation
4933064|NCT01937208|radiation dose|radiation dose
4933065|NCT01937195|IV Catheter comparison|iv catheter comparison
4933066|NCT01937195|AccuCath versus Conventional IV Catheters|accucath versus conventional iv catheters
4933067|NCT01937195|IV Catheter Study|iv catheter study
4933068|NCT01937195|IV Catheter User Preference Comparison|iv catheter user preference comparison
4933069|NCT01937195|First Attempt Success Rate for IV Catheters|first attempt success rate for iv catheters
4933070|NCT01937195|AccuCath Device Performance|accucath device performance
4933071|NCT01937195|Complication Rates for IV Catheters|complication rates for iv catheters
4933072|NCT01937195|Average Dwell Time for IV Catheters|average dwell time for iv catheters
4933073|NCT01937195|Patient Satisfaction with IV Catheters|patient satisfaction with iv catheters
4933074|NCT01937195|Clinician Satisfaction with AccuCath Device Performance|clinician satisfaction with accucath device performance
4933075|NCT01937182|Stroke|stroke
4933076|NCT01937182|SSRI (Selective Serotonin Reuptake Inhibitors)|ssri (selective serotonin reuptake inhibitors)
4933077|NCT01937182|Serotonin|serotonin
4933078|NCT01937182|5-HT (5-Hydroxytryptamine)|5-ht (5-hydroxytryptamine)
4933079|NCT01937182|Neuroprotection|neuroprotection
4933080|NCT01937182|MRI (Magnetic Resonance Imaging)|mri (magnetic resonance imaging)
4933081|NCT01937182|Platelet|platelet
4933082|NCT01937182|CT (computerized tomography)|ct (computerized tomography)
4933083|NCT01937182|Post Stroke Depression|post stroke depression
4933084|NCT01937143|parent education|parent education
4933085|NCT01937143|immunization|immunization
4933086|NCT01937143|vaccination|vaccination
4933087|NCT01937143|infant|infant
4933088|NCT01937143|pain management|pain management
4933089|NCT01937130|Liver Failure|liver failure
4933090|NCT01937130|Cirrhosis|cirrhosis
4933091|NCT01937130|Alcoholic Hepatitis|alcoholic hepatitis
4933092|NCT01937117|Breast cancer|breast cancer
4933093|NCT01937117|Preoperative treatment|preoperative treatment
4933094|NCT01937117|Neoadjuvant treatment|neoadjuvant treatment
4933095|NCT01937104|Intracranial pressure|intracranial pressure
4933096|NCT01937104|Laparoscopy|laparoscopy
4933097|NCT01937104|Optic nerve sheath diameter|optic nerve sheath diameter
4933098|NCT01937104|Position|position
4933099|NCT01937091|HIV|hiv
4933100|NCT01937091|clinical trials|clinical trials
4933101|NCT01937013|Frontotemporal Dementia|frontotemporal dementia
4933102|NCT01937013|emotion|emotion
4933103|NCT01937013|oxytocin|oxytocin
4933104|NCT01937013|fMRI|fmri
4933105|NCT01936961|Cancer|cancer
4933106|NCT01936948|Large colon polyps|large colon polyps
4933107|NCT01936948|Polyp resection|polyp resection
4933510|NCT01935050|Depression|depression
4933110|NCT01936948|Endoscopic mucosal resection|endoscopic mucosal resection
4933111|NCT01936935|Insulin sensitivity|insulin sensitivity
4933112|NCT01936922|Fall accidents|fall accidents
4933113|NCT01936922|Gait|gait
4933114|NCT01936922|Balance|balance
4933115|NCT01936922|Fear of falling|fear of falling
4933116|NCT01936922|Virtual reality|virtual reality
4933117|NCT01936896|Acute myocardial infarction|acute myocardial infarction
4933118|NCT01936896|Heart Failure|heart failure
4933119|NCT01936896|Inflammation|inflammation
4933120|NCT01936883|prostatic neoplasm|prostatic neoplasm
4933121|NCT01936883|brachytherapy|brachytherapy
4933122|NCT01936883|quality of life|quality of life
4933123|NCT01936883|high dose rate|high dose rate
4933124|NCT01936883|low dose rate|low dose rate
4933125|NCT01936870|Toviaz|toviaz
4933126|NCT01936870|Fesoterodine|fesoterodine
4933127|NCT01936870|Post marketing surveillance|post marketing surveillance
4933128|NCT01936870|Japanese|japanese
4933129|NCT01936870|Overactive Bladder|overactive bladder
4933130|NCT01936870|OAB|oab
4933131|NCT01936870|Good post marketing practice|good post marketing practice
4933132|NCT01936870|Regulatory Post Marketing Commitment Plan|regulatory post marketing commitment plan
4933133|NCT01936792|Concussion|concussion
4933134|NCT01936792|Mild Traumatic Brain Injury|mild traumatic brain injury
4933135|NCT01936792|Traumatic Brain Injury|traumatic brain injury
4933136|NCT01936779|plasma triglycerides|plasma triglycerides
4933137|NCT01936779|dietary fat|dietary fat
4933138|NCT01936779|liver fat metabolism|liver fat metabolism
4933139|NCT01936779|human|human
4933140|NCT01936766|malaria, falciparum|malaria, falciparum
4933141|NCT01936766|sepsis|sepsis
4933142|NCT01936766|fluid therapy|fluid therapy
4933143|NCT01936766|thermodilution|thermodilution
4933144|NCT01936766|extravascular lung water|extravascular lung water
4933145|NCT01936766|acute kidney injury|acute kidney injury
4933146|NCT01936753|PMTCT|pmtct
4933147|NCT01936753|HIV|hiv
4933148|NCT01936753|Mentor Mothers|mentor mothers
4933149|NCT01936753|Nigeria|nigeria
4933150|NCT01936753|Retention|retention
4933151|NCT01936753|Adherence|adherence
4933152|NCT01936740|Efficacy and Safety|efficacy and safety
4933153|NCT01936727|efficiency and safety|efficiency and safety
4933154|NCT01936714|Efficacy and Safety|efficacy and safety
4933155|NCT01936675|Coronary Artery Disease|coronary artery disease
4933156|NCT01936675|Myocardial Infarction|myocardial infarction
4933157|NCT01936675|Genomic Risk Communication|genomic risk communication
4933158|NCT01936675|Risk Stratification|risk stratification
4933159|NCT01936662|Airway management comparison|airway management comparison
4933160|NCT01936649|Nuclear imaging|nuclear imaging
4933161|NCT01936649|Radiopharmaceutical|radiopharmaceutical
4933162|NCT01936649|Iobenguane|iobenguane
4933163|NCT01936649|I-123|i-123
4933164|NCT01936649|reproducibility|reproducibility
4933165|NCT01936649|Quantitative measurements|quantitative measurements
4933166|NCT01936649|myocardial uptake|myocardial uptake
4933167|NCT01936649|SPECT imaging|spect imaging
4933168|NCT01936649|planar imaging|planar imaging
4933169|NCT01936649|AdreView™|adreview™
4933170|NCT01936636|Breakthrough cancer pain|breakthrough cancer pain
4933171|NCT01936636|diary|diary
4933172|NCT01936636|quality of life|quality of life
4933173|NCT01936636|Abstral|abstral
4933174|NCT01936636|BTcP|btcp
4933175|NCT01936623|brief intervention|brief intervention
4933176|NCT01936623|computerized brief intervention|computerized brief intervention
4933177|NCT01936610|Lecture|lecture
4933178|NCT01936610|Role-playing|role-playing
4933179|NCT01936610|Knowledge|knowledge
4933180|NCT01936610|Attitude|attitude
4933181|NCT01936610|Decision making|decision making
4933182|NCT01936610|Type of delivery|type of delivery
4933183|NCT01936597|external cardiac massage, medical hotline,|external cardiac massage, medical hotline,
4933184|NCT01936545|Liver transplantation, reactive oxygen species, antioxidant|liver transplantation, reactive oxygen species, antioxidant
4933185|NCT01936532|multiple myeloma|multiple myeloma
4933186|NCT01936519|Everolimus|everolimus
4933187|NCT01936519|Zortress|zortress
4933188|NCT01936519|Renal Function|renal function
4933189|NCT01936519|Tacrolimus|tacrolimus
4933190|NCT01936519|Cyclosporine|cyclosporine
4933191|NCT01936519|Myfortic|myfortic
4933192|NCT01936519|Mycophenolic Acid|mycophenolic acid
4933193|NCT01936519|Liver Transplantation|liver transplantation
4933194|NCT01936506|Cognitive training|cognitive training
4933195|NCT01936506|Depression|depression
4933196|NCT01936493|Uterine leiomyomas (fibroids or myomas)|uterine leiomyomas (fibroids or myomas)
4933197|NCT01936493|Uterine fibroids|uterine fibroids
4933198|NCT01936493|Fibroids|fibroids
4933199|NCT01936493|Uterine leiomyomas|uterine leiomyomas
4933200|NCT01936467|Pancreatic solid lesions|pancreatic solid lesions
4933201|NCT01936467|Pancreatic mass|pancreatic mass
4933202|NCT01936467|Pancreatic cancer|pancreatic cancer
4933203|NCT01936467|Endoscopic Ultrasound|endoscopic ultrasound
4933204|NCT01936467|EUS|eus
4933205|NCT01936467|Fine needle aspiration|fine needle aspiration
4933206|NCT01936467|FNA|fna
4933207|NCT01936467|EUS-FNA|eus-fna
4933208|NCT01936441|Menopause|menopause
4933209|NCT01936441|Vasomotor|vasomotor
4933210|NCT01936441|Symptoms|symptoms
4933211|NCT01936441|Sleep|sleep
4933212|NCT01936441|Cognitive Behavioral Therapy|cognitive behavioral therapy
4933213|NCT01936415|Knee prosthesis|knee prosthesis
4933214|NCT01936402|Cardiopulmonary Resuscitation|cardiopulmonary resuscitation
4933215|NCT01936376|kidney safety|kidney safety
4933216|NCT01936376|biomarkers|biomarkers
4933217|NCT01936376|serum creatinine|serum creatinine
4933218|NCT01936376|BUN|bun
4933219|NCT01936376|cystic fibrosis|cystic fibrosis
4933220|NCT01936376|head and neck cancer|head and neck cancer
4933221|NCT01936376|renal injury|renal injury
4933222|NCT01936376|drug induced acute kidney injury|drug induced acute kidney injury
4933223|NCT01936376|aminoglycoside|aminoglycoside
4933224|NCT01936376|cisplatin|cisplatin
4933225|NCT01936376|nephrotoxicity|nephrotoxicity
4933226|NCT01936376|biomarker qualification|biomarker qualification
4933227|NCT01936363|Ovarian Cancer|ovarian cancer
4933228|NCT01936363|Pimasertib|pimasertib
4933229|NCT01936363|Placebo|placebo
4933230|NCT01936363|SAR245409|sar245409
4933231|NCT01936350|Heart failure|heart failure
4933232|NCT01936324|acne vulgaris|acne vulgaris
4933233|NCT01936311|Health Behavior|health behavior
4933234|NCT01936311|Behavior change|behavior change
4933235|NCT01936311|self-management goal|self-management goal
4933236|NCT01936311|health goal|health goal
4933237|NCT01936298|Hand Edema|hand edema
4933238|NCT01936298|Exercise Therapy|exercise therapy
4933239|NCT01936233|Hepatocellular Carcinoma|hepatocellular carcinoma
4933240|NCT01936233|Aspirin|aspirin
4933241|NCT01936233|antiviral treatment|antiviral treatment
4933242|NCT01936233|recurrence free survival|recurrence free survival
4933243|NCT01936233|radical therapy|radical therapy
4933244|NCT01936220|Schizophrenia|schizophrenia
4933245|NCT01936220|First-psychotic episode|first-psychotic episode
4933246|NCT01936220|Initial phase|initial phase
4933247|NCT01936220|Relapse prevention|relapse prevention
4933248|NCT01936220|Specialized treatment|specialized treatment
4933249|NCT01936220|Parent groups|parent groups
4933250|NCT01936220|Social functioning|social functioning
4933251|NCT01936207|acute|acute
4933252|NCT01936207|respiratory|respiratory
4933253|NCT01936207|syndrome|syndrome
4933254|NCT01936207|prognosis|prognosis
4933255|NCT01936207|outcome research|outcome research
4933256|NCT01936207|respiratory infection|respiratory infection
4933257|NCT01936207|sepsis|sepsis
4933258|NCT01936207|organ failure|organ failure
4933259|NCT01936181|Rheumatoid Arthritis|rheumatoid arthritis
4933260|NCT01936181|Infliximab|infliximab
4933261|NCT01936181|Biosimilar|biosimilar
4933262|NCT01936168|GSV|gsv
4933263|NCT01936168|Primary Varicose Veins|primary varicose veins
4933264|NCT01936168|Great Saphenous Vein|great saphenous vein
4933265|NCT01936168|Treatment|treatment
4933266|NCT01936155|Joint Mobility|joint mobility
4933267|NCT01936155|Skin Tissue Oxygenation|skin tissue oxygenation
4933268|NCT01936155|Neuromuscular Electrical Stimulation|neuromuscular electrical stimulation
4933269|NCT01936155|Goniometry|goniometry
4933270|NCT01936155|Transcutaneous Oxygen Measurements (tcpO2)|transcutaneous oxygen measurements (tcpo2)
4933271|NCT01936155|Water Displacement|water displacement
4933272|NCT01936142|Resynchroniztion therapy|resynchroniztion therapy
4933273|NCT01936142|Kidney|kidney
4933274|NCT01936142|Contrast media|contrast media
4933275|NCT01936142|Prevention|prevention
4933276|NCT01936116|Sonohysterography|sonohysterography
4933277|NCT01936116|catheter placement|catheter placement
4933278|NCT01936116|pain magnitude|pain magnitude
4933279|NCT01936116|vasovagal reaction|vasovagal reaction
4933404|NCT01935401|Neuroimaging|neuroimaging
4933280|NCT01936103|Acute anterior myocardial infarction|acute anterior myocardial infarction
4933281|NCT01936103|Percutaneous coronary stent implantation|percutaneous coronary stent implantation
4933282|NCT01936103|Intensive statin therapy|intensive statin therapy
4933283|NCT01936103|Left ventricular function|left ventricular function
4933284|NCT01936077|Infertility, IVF, ovarian stimulation, rec LH, GnRH antagonist|infertility, ivf, ovarian stimulation, rec lh, gnrh antagonist
4933285|NCT01936064|Breast Cancer|breast cancer
4933286|NCT01936064|Jobelyn|jobelyn
4933287|NCT01936064|Sorghum bicolor|sorghum bicolor
4933288|NCT01936038|CPAP|cpap
4933289|NCT01936038|Upper Airway Toning|upper airway toning
4933290|NCT01936038|Obstructive Sleep Apnoea|obstructive sleep apnoea
4933291|NCT01936025|Diabetes mellitus|diabetes mellitus
4933292|NCT01936012|Lisinopril|lisinopril
4933293|NCT01936012|Bioequivalence|bioequivalence
4933294|NCT01936012|Bioavailability|bioavailability
4933295|NCT01936012|Pharmacokinetic|pharmacokinetic
4933296|NCT01936012|Angiotensin-converting enzyme inhibitor|angiotensin-converting enzyme inhibitor
4933297|NCT01935999|Colostomy|colostomy
4933298|NCT01935999|peristomal skin|peristomal skin
4933299|NCT01935999|stoma|stoma
4933300|NCT01935999|pouch|pouch
4933301|NCT01935908|Subarachnoid Hemorrhage|subarachnoid hemorrhage
4933302|NCT01935908|Seizures|seizures
4933303|NCT01935908|Prophylaxis|prophylaxis
4933304|NCT01935908|Levetiracetam|levetiracetam
4933305|NCT01935895|blood pressure reduction|blood pressure reduction
4933306|NCT01935895|vascular reactivity|vascular reactivity
4933307|NCT01935895|combined exercise session|combined exercise session
4933308|NCT01935856|patients|patients
4933309|NCT01935856|receiving|receiving
4933613|NCT01934439|AMES|ames
4933310|NCT01935856|hemodialysis|hemodialysis
4933311|NCT01935856|Secondary|secondary
4933312|NCT01935843|CART-HER-2|cart-her-2
4933313|NCT01935843|HER-2 positive|her-2 positive
4933314|NCT01935843|Advanced|advanced
4933315|NCT01935843|Refactory|refactory
4933316|NCT01935843|Solid tumors|solid tumors
4933317|NCT01935830|PET Imaging|pet imaging
4933318|NCT01935830|Efavirenz|efavirenz
4933319|NCT01935830|Ritonavior [11C] LAAM|ritonavior [11c] laam
4933320|NCT01935830|Healthy volunteers|healthy volunteers
4933321|NCT01935804|pioglitazone|pioglitazone
4933322|NCT01935804|metformin|metformin
4933323|NCT01935804|hyperglycemic agents|hyperglycemic agents
4933324|NCT01935804|physiological effects of drugs|physiological effects of drugs
4933325|NCT01935804|bone health|bone health
4933326|NCT01935765|Type 1 diabetes, sleep apnea, polysomnography,|type 1 diabetes, sleep apnea, polysomnography,
4933327|NCT01935765|autonomic neuropathy, intima media thickness|autonomic neuropathy, intima media thickness
4933328|NCT01935752|fibromuscular|fibromuscular
4933329|NCT01935752|dysplasia|dysplasia
4933330|NCT01935752|endothelium|endothelium
4933331|NCT01935752|microparticles|microparticles
4933332|NCT01935752|microRNA|microrna
4933333|NCT01935726|Pulmonary fibrosis|pulmonary fibrosis
4933334|NCT01935726|Interstitial lung disease|interstitial lung disease
4933335|NCT01935726|Connective tissue disease|connective tissue disease
4933336|NCT01935726|Chronic hypersensitivity pneumonitis|chronic hypersensitivity pneumonitis
4933337|NCT01935726|Idiopathic pulmonary fibrosis|idiopathic pulmonary fibrosis
4933338|NCT01935700|hepatocellular carcinoma|hepatocellular carcinoma
4933339|NCT01935700|colchicine|colchicine
4933340|NCT01935687|Instrumented Wheel|instrumented wheel
4933341|NCT01935687|Manual Wheelchair|manual wheelchair
4933342|NCT01935687|Spinal Cord Injury (SCI)|spinal cord injury (sci)
4933343|NCT01935687|Manual wheelchair Users|manual wheelchair users
4933344|NCT01935687|Aged between 18-70 years|aged between 18-70 years
4933345|NCT01935674|Hypercholesterolaemia|hypercholesterolaemia
4933346|NCT01935674|HIV|hiv
4933347|NCT01935674|Rosuvastatin|rosuvastatin
4933348|NCT01935674|Protease inhibitor switching|protease inhibitor switching
4933349|NCT01935661|Blood transfusion|blood transfusion
4933350|NCT01935661|Hemosiderosis|hemosiderosis
4933351|NCT01935661|ERP|erp
4933352|NCT01935648|Knee arthroplasty|knee arthroplasty
4933353|NCT01935635|CHB|chb
4933354|NCT01935635|Antiviral|antiviral
4933355|NCT01935635|Dentritic cells|dentritic cells
4933356|NCT01935635|Immune Therapy|immune therapy
4933357|NCT01935622|heart failure|heart failure
4933358|NCT01935622|non-ischemic cardiomyopathy|non-ischemic cardiomyopathy
4933359|NCT01935609|traumatic brain injury|traumatic brain injury
4933360|NCT01935609|acquired brain injury|acquired brain injury
4933361|NCT01935596|Anesthesia|anesthesia
4933362|NCT01935596|Randomized study|randomized study
4933363|NCT01935596|Lower limbs surgery|lower limbs surgery
4933364|NCT01935583|traumatic brain injury|traumatic brain injury
4933365|NCT01935570|Bioavailability of magnesium|bioavailability of magnesium
4933366|NCT01935570|Digestive and general tolerance|digestive and general tolerance
4933367|NCT01935557|Continuous heparin infusion|continuous heparin infusion
4933368|NCT01935557|Intermittent heparin infusion|intermittent heparin infusion
4933369|NCT01935557|during catheter ablation|during catheter ablation
4933370|NCT01935544|Botulinum Toxin|botulinum toxin
4933371|NCT01935544|Ultrasound-guidance|ultrasound-guidance
4933372|NCT01935544|Stroke|stroke
4933373|NCT01935544|Spasticity|spasticity
4933374|NCT01935544|Ultrasonography|ultrasonography
4933375|NCT01935544|Hemiplegia|hemiplegia
4933376|NCT01935531|actinic keratoses|actinic keratoses
4933377|NCT01935531|tumor metabolism|tumor metabolism
4933378|NCT01935531|glycolysis|glycolysis
4933379|NCT01935531|diclofenac|diclofenac
4933380|NCT01935531|warburg effect|warburg effect
4933381|NCT01935505|smoking cessation|smoking cessation
4933382|NCT01935505|intervention model|intervention model
4933383|NCT01935505|Chinese|chinese
4933384|NCT01935505|quitting rate|quitting rate
4933385|NCT01935492|metastatic breast cancer|metastatic breast cancer
4933386|NCT01935492|HER2/neu negative|her2/neu negative
4933387|NCT01935492|paclitaxel|paclitaxel
4933388|NCT01935492|bevacizumab|bevacizumab
4933389|NCT01935492|liposomal doxorubicine|liposomal doxorubicine
4933390|NCT01935492|capecitabine|capecitabine
4933391|NCT01935479|AK159, teriparatide acetate|ak159, teriparatide acetate
4933392|NCT01935466|Pioglitazone|pioglitazone
4933393|NCT01935466|Bladder cancer|bladder cancer
4933394|NCT01935466|Type 2 Diabetes|type 2 diabetes
4933395|NCT01935440|HIV, drug use|hiv, drug use
4933396|NCT01935427|Pulse Oximeter|pulse oximeter
4933397|NCT01935427|Stroke Volume|stroke volume
4933398|NCT01935427|Hemorrhagic shock|hemorrhagic shock
4933399|NCT01935427|Compensatory Reserve Index|compensatory reserve index
4933400|NCT01935401|Bulimia Nervosa|bulimia nervosa
4933401|NCT01935401|Bulimia|bulimia
4933402|NCT01935401|Response Inhibition|response inhibition
4933403|NCT01935401|fNIR|fnir
4933405|NCT01935388|Mechanical ventilation|mechanical ventilation
4933406|NCT01935388|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
4933407|NCT01935388|asthma|asthma
4933408|NCT01935388|common canister|common canister
4933409|NCT01935388|MDI|mdi
4933410|NCT01935388|ventilator associated pneumonia|ventilator associated pneumonia
4933411|NCT01935375|Postpartum Depression|postpartum depression
4933412|NCT01935375|Nurse Midwife|nurse midwife
4933413|NCT01935375|Interpersonal Psychotherapy|interpersonal psychotherapy
4933414|NCT01935362|Flavanones|flavanones
4933415|NCT01935362|Bioavailability|bioavailability
4933416|NCT01935362|Blood vessel health|blood vessel health
4933417|NCT01935362|Blood glucose|blood glucose
4933418|NCT01935349|Diabetes mellitus (DM)|diabetes mellitus (dm)
4933419|NCT01935349|hypertension (HT)|hypertension (ht)
4933420|NCT01935349|Hong Kong|hong kong
4933421|NCT01935336|Lung Cancer|lung cancer
4933422|NCT01935336|Malignancy|malignancy
4933423|NCT01935336|Predictive biomarkers|predictive biomarkers
4933424|NCT01935323|high intensity interval training|high intensity interval training
4933425|NCT01935323|aerobic exercise|aerobic exercise
4933426|NCT01935323|insulin sensitivity|insulin sensitivity
4933427|NCT01935323|obesity|obesity
4933428|NCT01935323|cardiovascular fitness|cardiovascular fitness
4933429|NCT01935310|Photoaging|photoaging
4933430|NCT01935310|imiquimod|imiquimod
4933431|NCT01935310|wrinkles|wrinkles
4933432|NCT01935310|elastosis|elastosis
4933433|NCT01935271|immunosenescence|immunosenescence
4933434|NCT01935271|sarcopenia|sarcopenia
4933435|NCT01935258|Medically unexplained symptoms|medically unexplained symptoms
4933436|NCT01935258|Somatization|somatization
4933437|NCT01935258|Psychosomatic therapy|psychosomatic therapy
4933438|NCT01935245|Coronary artery bypass grafting|coronary artery bypass grafting
4933439|NCT01935245|Extracorporeal circulation|extracorporeal circulation
4933440|NCT01935245|Minimal extracorporeal circulation|minimal extracorporeal circulation
4933441|NCT01935245|Coagulopathy|coagulopathy
4933442|NCT01935245|Thrombocytopathy|thrombocytopathy
4933443|NCT01935245|Platelet dysfunction|platelet dysfunction
4933444|NCT01935232|Osteoporosis, diagnostics, ultrasound|osteoporosis, diagnostics, ultrasound
4933445|NCT01935219|mild cognitive impairment|mild cognitive impairment
4933446|NCT01935219|seniors|seniors
4933447|NCT01935219|cognitive training|cognitive training
4933448|NCT01935219|driving|driving
4933449|NCT01935219|driving simulation|driving simulation
4933450|NCT01935219|intervention|intervention
4933451|NCT01935219|goal management training|goal management training
4933452|NCT01935219|process speed training|process speed training
4933453|NCT01935206|secondary hyperalgesia|secondary hyperalgesia
4933454|NCT01935206|allodynia|allodynia
4933455|NCT01935206|mechanical pain threshold|mechanical pain threshold
4933456|NCT01935206|naloxone|naloxone
4933457|NCT01935206|endogenous opioids|endogenous opioids
4933458|NCT01935206|pain|pain
4933459|NCT01935193|platelets aggregation|platelets aggregation
4933460|NCT01935193|asa resistance|asa resistance
4933461|NCT01935180|colon polyps|colon polyps
4933462|NCT01935180|adenoma resection|adenoma resection
4933463|NCT01935180|colon cancer screening|colon cancer screening
4933464|NCT01935180|colonoscopy|colonoscopy
4933465|NCT01935180|polyp detection|polyp detection
4933466|NCT01935167|Microalbuminuria|microalbuminuria
4933467|NCT01935154|NSCLC|nsclc
4933468|NCT01935154|Vaccine|vaccine
4933469|NCT01935141|Pulmonary Embolus|pulmonary embolus
4933470|NCT01935141|Radio Contrast Material|radio contrast material
4933471|NCT01935141|Computed Tomography|computed tomography
4933472|NCT01935128|Renal Transplant|renal transplant
4933473|NCT01935128|Immunosuppression|immunosuppression
4933474|NCT01935128|Steroid Avoidance|steroid avoidance
4933475|NCT01935128|Calcineurin Avoidance|calcineurin avoidance
4933476|NCT01935128|Mammalian Target of Rapamycin (mTOR)|mammalian target of rapamycin (mtor)
4933477|NCT01935128|Kidney|kidney
4933478|NCT01935115|Depression|depression
4933479|NCT01935115|MDD|mdd
4933480|NCT01935115|Treatment Resistant Depression|treatment resistant depression
4933481|NCT01935115|Electroconvulsive Therapy|electroconvulsive therapy
4933482|NCT01935115|ECT|ect
4933483|NCT01935115|Ketamine|ketamine
4933484|NCT01935115|Propofol|propofol
4933485|NCT01935115|NMDA|nmda
4933486|NCT01935102|metastatic breast cancer|metastatic breast cancer
4933487|NCT01935102|bevacizumab|bevacizumab
4933488|NCT01935102|single nucleotide polymorphism|single nucleotide polymorphism
4933489|NCT01935102|VEGF-A|vegf-a
4933490|NCT01935102|VEGFR-2|vegfr-2
4933491|NCT01935102|IL-8|il-8
4933492|NCT01935089|HIV-1|hiv-1
4933493|NCT01935089|Interferon alpha|interferon alpha
4933494|NCT01935089|Integrated DNA|integrated dna
4933495|NCT01935089|Latent reservoir|latent reservoir
4933496|NCT01935076|Maternal obesity|maternal obesity
4933497|NCT01935076|Macrosomic|macrosomic
4933498|NCT01935076|miRNA|mirna
4933499|NCT01935076|Fetal overgrowth|fetal overgrowth
4933500|NCT01935063|Vulvodynia|vulvodynia
4933501|NCT01935063|Provoked vestibulodynia|provoked vestibulodynia
4933502|NCT01935063|Vulvar pain|vulvar pain
4933503|NCT01935063|Dyspareunia|dyspareunia
4933504|NCT01935063|Couples therapy|couples therapy
4933505|NCT01935063|Lidocaine|lidocaine
4933506|NCT01935063|Cognitive behavioral couple therapy|cognitive behavioral couple therapy
4933507|NCT01935063|Cognitive behavioral therapy|cognitive behavioral therapy
4933508|NCT01935063|Pain|pain
4933509|NCT01935063|Pain during sexual intercourse|pain during sexual intercourse
4933511|NCT01935050|Parkinson's disease|parkinson's disease
4933512|NCT01935050|Cognitive-Behavioral Treatment|cognitive-behavioral treatment
4933513|NCT01935024|Alzheimer's disease|alzheimer's disease
4933514|NCT01935024|dementia|dementia
4933515|NCT01935024|aerobic exercise|aerobic exercise
4933516|NCT01934998|SCA6, parkinsonism, Datscan|sca6, parkinsonism, datscan
4933517|NCT01934985|Single-Photon Emission-Computed Tomography|single-photon emission-computed tomography
4933518|NCT01934985|Myocardial Perfusion Imaging|myocardial perfusion imaging
4933519|NCT01934985|Ischemia|ischemia
4933520|NCT01934985|Stress test|stress test
4933521|NCT01934985|Coronary Artery Disease (CAD)|coronary artery disease (cad)
4933522|NCT01934985|Coronary Flow Reserve (CFR)|coronary flow reserve (cfr)
4933523|NCT01934985|Coronary Angiography|coronary angiography
4933524|NCT01934972|Bipolar disorder|bipolar disorder
4933525|NCT01934946|hip fracture|hip fracture
4933526|NCT01934933|inflammation|inflammation
4933527|NCT01934933|etanercept|etanercept
4933528|NCT01934933|celecoxib|celecoxib
4933529|NCT01934933|ankylsoing spondylitis|ankylsoing spondylitis
4933530|NCT01934894|HER2-positive breast cancer|her2-positive breast cancer
4933531|NCT01934894|intracranial metastases|intracranial metastases
4933532|NCT01934894|lapatinib|lapatinib
4933533|NCT01934894|cabazitaxel|cabazitaxel
4933534|NCT01934868|low back pain|low back pain
4933535|NCT01934868|sciatica|sciatica
4933536|NCT01934868|spinal stenosis|spinal stenosis
4933537|NCT01934868|epidural injections|epidural injections
4933538|NCT01934868|prolotherapy|prolotherapy
4933539|NCT01934868|sacroiliac pain or dysfunction.|sacroiliac pain or dysfunction.
4933540|NCT01934855|cancer|cancer
4933541|NCT01934855|radiotherapy|radiotherapy
4933542|NCT01934855|4D-MRI|4d-mri
4933543|NCT01934855|4D-CT|4d-ct
4933544|NCT01934855|MRI|mri
4933545|NCT01934816|Incretins, KATP channels, intradermal injection|incretins, katp channels, intradermal injection
4933546|NCT01934803|Alcohol Use|alcohol use
4933547|NCT01934803|Microbial Translocation|microbial translocation
4933548|NCT01934803|Inflammation|inflammation
4933549|NCT01934803|Altered Coagulation|altered coagulation
4933550|NCT01934803|Russia|russia
4933551|NCT01934803|Zinc|zinc
4933552|NCT01934803|AMI|ami
4933553|NCT01934803|VACS index|vacs index
4933554|NCT01934803|Reynolds risk score|reynolds risk score
4933555|NCT01934777|NAFLD|nafld
4933556|NCT01934777|NASH|nash
4933557|NCT01934777|fibrosis|fibrosis
4933558|NCT01934738|Multiple dose|multiple dose
4933559|NCT01934738|safety|safety
4933560|NCT01934738|tolerability|tolerability
4933561|NCT01934738|PK|pk
4933562|NCT01934725|Ischemic Stroke|ischemic stroke
4933563|NCT01934725|Brain Infarction|brain infarction
4933564|NCT01934725|Patent Foramen Ovale|patent foramen ovale
4933565|NCT01934725|Stroke in the Young|stroke in the young
4933566|NCT01934725|Myocardial Infarction|myocardial infarction
4933567|NCT01934725|Cerebral Venous Thrombosis|cerebral venous thrombosis
4933568|NCT01934725|Pulmonary Embolism|pulmonary embolism
4933569|NCT01934725|Deep Vein Thrombosis|deep vein thrombosis
4933570|NCT01934725|Subarachnoid Hemorrhage|subarachnoid hemorrhage
4933571|NCT01934725|Prognosis|prognosis
4933572|NCT01934725|Databases, Genetic|databases, genetic
4933573|NCT01934699|Coronary stenosis|coronary stenosis
4933574|NCT01934699|Angina pectoris|angina pectoris
4933575|NCT01934699|Left ventricular wall motion abnormalities|left ventricular wall motion abnormalities
4933576|NCT01934699|2D-Strain|2d-strain
4933577|NCT01934660|Cardiovascular Disease|cardiovascular disease
4933578|NCT01934660|Diabetes Mellitus|diabetes mellitus
4933579|NCT01934660|Inflammation|inflammation
4933580|NCT01934634|Pancreatic Cancer|pancreatic cancer
4933581|NCT01934634|Stage IV Pancreatic Cancer|stage iv pancreatic cancer
4933582|NCT01934634|Stage IV metastatic pancreatic ductal adenocarcinoma|stage iv metastatic pancreatic ductal adenocarcinoma
4933583|NCT01934621|Stroke|stroke
4933584|NCT01934621|Rehabilitation|rehabilitation
4933585|NCT01934621|Cognition|cognition
4933586|NCT01934621|Disability|disability
4933587|NCT01934595|Critically ill|critically ill
4933588|NCT01934595|Protein|protein
4933589|NCT01934595|Supplement|supplement
4933590|NCT01934595|ICU|icu
4933591|NCT01934595|Protein synthesis|protein synthesis
4933592|NCT01934530|implant complications|implant complications
4933593|NCT01934530|esthetics|esthetics
4933594|NCT01934530|soft tissue grafting|soft tissue grafting
4933595|NCT01934504|clinical tolerance|clinical tolerance
4933596|NCT01934504|biomarker(s) identification|biomarker(s) identification
4933597|NCT01934491|Cognitive training|cognitive training
4933598|NCT01934491|Depression|depression
4933599|NCT01934478|Breast|breast
4933600|NCT01934478|Cancer|cancer
4933601|NCT01934478|Human Epidermal Growth Factor 2 (Her2)|human epidermal growth factor 2 (her2)
4933602|NCT01934478|irradiation|irradiation
4933603|NCT01934465|NSCLC|nsclc
4933604|NCT01934465|Chemotherapy|chemotherapy
4933605|NCT01934465|Anti-angiogenic agent|anti-angiogenic agent
4933606|NCT01934465|Bevacizumab|bevacizumab
4933607|NCT01934465|1st Line|1st line
4933608|NCT01934452|complete remission|complete remission
4933609|NCT01934439|Stroke|stroke
4933610|NCT01934439|Rehabilitation|rehabilitation
4933611|NCT01934439|Dyssynergia|dyssynergia
4933612|NCT01934439|Robotics|robotics
4933614|NCT01934439|Cerebrovascular Accident|cerebrovascular accident
4933615|NCT01934426|Admission High Risk Elderly|admission high risk elderly
4933616|NCT01934413|Palliative Care|palliative care
4933617|NCT01934413|Technology|technology
4933618|NCT01934413|Rural|rural
4933619|NCT01934413|Transitional Care|transitional care
4933620|NCT01934400|Osteoporosis|osteoporosis
4933621|NCT01934400|fall prevention|fall prevention
4933622|NCT01934400|high risk population|high risk population
4933623|NCT01934387|World Health Organization Fracture Risk Assessment Tool|world health organization fracture risk assessment tool
4933624|NCT01934387|Osteoporosis|osteoporosis
4933625|NCT01934387|Aged|aged
4933626|NCT01934387|Prevention|prevention
4933627|NCT01934387|Fracture|fracture
4933628|NCT01934387|FRAX|frax
4933629|NCT01934374|task-oriented training, long-term effects, plasticity|task-oriented training, long-term effects, plasticity
4933630|NCT01934361|BKM120|bkm120
4933631|NCT01934361|Recurrent glioblastoma multiforme|recurrent glioblastoma multiforme
4933632|NCT01934361|rGBM|rgbm
4933633|NCT01934361|buparlisib|buparlisib
4933634|NCT01934335|breast cancer, TKI, tyrosine kinase inhibitor, vandetanib, Ki-67|breast cancer, tki, tyrosine kinase inhibitor, vandetanib, ki-67
4933635|NCT01934322|frequent users of the emergency department|frequent users of the emergency department
4933636|NCT01934322|vulnerable populations|vulnerable populations
4933637|NCT01934322|case management|case management
4933638|NCT01934322|cost savings intervention|cost savings intervention
4933639|NCT01934322|quality of life|quality of life
4933640|NCT01934322|number of emergency department visits|number of emergency department visits
4933641|NCT01934309|tuberculosis|tuberculosis
4933642|NCT01934309|isoniazid preventative therapy|isoniazid preventative therapy
4933643|NCT01934309|clinical decision support|clinical decision support
4933644|NCT01934309|HIV|hiv
4933645|NCT01934309|Kenya|kenya
4933646|NCT01934309|eHealth|ehealth
4933647|NCT01934296|deep brain stimulation|deep brain stimulation
4933648|NCT01934296|cortical recording|cortical recording
4933649|NCT01934296|neuroprosthesis|neuroprosthesis
4933650|NCT01934231|Acute bacterial rhinosinusitis|acute bacterial rhinosinusitis
4933651|NCT01934231|Amoxicilin|amoxicilin
4933652|NCT01934231|Infection|infection
4933653|NCT01934231|Potassium clavulanate|potassium clavulanate
4933654|NCT01934218|Knee|knee
4933655|NCT01934218|Osteoarthritis|osteoarthritis
4933781|NCT01933737|postural balance;|postural balance;
4933656|NCT01934218|Intra-articular injection|intra-articular injection
4933657|NCT01934205|GSK2140944|gsk2140944
4933658|NCT01934205|pharmacokinetics|pharmacokinetics
4933659|NCT01934205|bronchoalveolar lavage|bronchoalveolar lavage
4933660|NCT01934205|pulmonary|pulmonary
4933661|NCT01934205|antimicrobial|antimicrobial
4933662|NCT01934205|healthy volunteer|healthy volunteer
4933663|NCT01934192|tolerability|tolerability
4933664|NCT01934192|camicinal|camicinal
4933665|NCT01934192|single dose|single dose
4933666|NCT01934192|acetaminophen|acetaminophen
4933667|NCT01934192|gastric emptying|gastric emptying
4933668|NCT01934192|critically ill|critically ill
4933669|NCT01934192|GSK962040|gsk962040
4933670|NCT01934192|pharmacokinetics|pharmacokinetics
4933671|NCT01934192|pharmacodynamics|pharmacodynamics
4933672|NCT01934192|gut motility|gut motility
4933673|NCT01934153|hyperhidrosis|hyperhidrosis
4933674|NCT01934153|topical|topical
4933675|NCT01934153|[14C] radiolabel|[14c] radiolabel
4933676|NCT01934153|palm|palm
4933677|NCT01934153|GSK573719|gsk573719
4933678|NCT01934153|axilla|axilla
4933679|NCT01934153|Umeclidinium|umeclidinium
4933680|NCT01934140|Healthy|healthy
4933681|NCT01934140|Adults|adults
4933682|NCT01934140|Safety|safety
4933683|NCT01934140|Neisseria meningitidis|neisseria meningitidis
4933684|NCT01934140|Booster response|booster response
4933685|NCT01934140|Immunogenicity|immunogenicity
4933686|NCT01934140|Adolescents|adolescents
4933687|NCT01934140|Serogroups A, C, W-135, and Y|serogroups a, c, w-135, and y
4933688|NCT01934140|long-term antibody persistence|long-term antibody persistence
4933689|NCT01934127|Immunogenicity|immunogenicity
4933690|NCT01934127|H7N1|h7n1
4933691|NCT01934127|Influenza|influenza
4933692|NCT01934127|Safety|safety
4933693|NCT01934127|AS03 adjuvant|as03 adjuvant
4933694|NCT01934127|Adults|adults
4933695|NCT01934088|Inflammatory Bowel disease|inflammatory bowel disease
4933696|NCT01934088|IBD|ibd
4933697|NCT01934088|Sedation|sedation
4933698|NCT01934088|NAPS|naps
4933699|NCT01934088|Propofol|propofol
4933700|NCT01934088|Midazolam|midazolam
4933701|NCT01934088|Satisfaction|satisfaction
4933702|NCT01934088|Feasibility|feasibility
4933703|NCT01934075|Obstetric fistula|obstetric fistula
4933704|NCT01934075|Mental health|mental health
4933705|NCT01934075|Tanzania|tanzania
4933706|NCT01934036|Weight loss|weight loss
4933707|NCT01934036|Nutritional supplement|nutritional supplement
4933708|NCT01934036|Waist|waist
4933709|NCT01934036|Body composition|body composition
4933710|NCT01934036|Skinfolds|skinfolds
4933711|NCT01934023|plasticity, schizophrenia, varenicline, non smokers,|plasticity, schizophrenia, varenicline, non smokers,
4933712|NCT01933997|pharmacokinetics|pharmacokinetics
4933713|NCT01933997|metadoxine|metadoxine
4933714|NCT01933984|Bronchodilator agents,|bronchodilator agents,
4933715|NCT01933984|chronic obstructive pulmonary disease,|chronic obstructive pulmonary disease,
4933716|NCT01933984|endotracheal intubation,|endotracheal intubation,
4933717|NCT01933984|mechanical ventilator|mechanical ventilator
4933718|NCT01933958|Regorafenib|regorafenib
4933719|NCT01933958|Gastrointestinal stromal tumors|gastrointestinal stromal tumors
4933720|NCT01933932|Mitogen-Activated Protein Kinase Kinase inhibitor; Non Small Cell Lung Cancer; metastatic; second line treatment for Non Small Cell Lung Cancer; KRAS mutation|mitogen-activated protein kinase kinase inhibitor; non small cell lung cancer; metastatic; second line treatment for non small cell lung cancer; kras mutation
4933721|NCT01933919|Obsessive Compulsive Disorder|obsessive compulsive disorder
4933722|NCT01933919|Adolescent Subjects|adolescent subjects
4933723|NCT01933919|Pediatric Subjects|pediatric subjects
4933724|NCT01933906|CML|cml
4933725|NCT01933906|Chronic myeloid leukemia|chronic myeloid leukemia
4933726|NCT01933906|Chronic myeloid leukaemia|chronic myeloid leukaemia
4933727|NCT01933906|PEG-Proline-Interferon-alpha 2b|peg-proline-interferon-alpha 2b
4933728|NCT01933906|Interferon|interferon
4933729|NCT01933906|P1101|p1101
4933730|NCT01933906|Imatinib|imatinib
4933731|NCT01933893|Pipelle, luteal, follicular, implantation|pipelle, luteal, follicular, implantation
4933732|NCT01933880|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
4933733|NCT01933880|Methylphenidate Hydrochloride|methylphenidate hydrochloride
4933734|NCT01933880|CONCERTA|concerta
4933735|NCT01933867|water|water
4933736|NCT01933867|colonoscopy|colonoscopy
4933737|NCT01933867|Crohn´s disease|crohn´s disease
4933738|NCT01933867|ulcerative colitis|ulcerative colitis
4933739|NCT01933854|Urinary incontinence|urinary incontinence
4933740|NCT01933854|riverside|riverside
4933741|NCT01933854|women|women
4933742|NCT01933854|Amapa|amapa
4933743|NCT01933841|Post operative residual curarization|post operative residual curarization
4933744|NCT01933841|Neuromuscular blocking drugs|neuromuscular blocking drugs
4933745|NCT01933828|Lung cancer|lung cancer
4933746|NCT01933828|surgery video-assisted|surgery video-assisted
4933747|NCT01933828|robot|robot
4933748|NCT01933828|surgical treatment|surgical treatment
4933749|NCT01933815|Glioblastoma multiforme|glioblastoma multiforme
4933750|NCT01933815|Glioblastoma|glioblastoma
4933751|NCT01933815|Radiotherapy|radiotherapy
4933752|NCT01933815|Temozolomide|temozolomide
4933753|NCT01933815|TPI 287|tpi 287
4933754|NCT01933815|Taxoid|taxoid
4933755|NCT01933815|Avastin|avastin
4933756|NCT01933815|Bevacizumab|bevacizumab
4933757|NCT01933802|mesenchymal stem cells|mesenchymal stem cells
4933758|NCT01933802|neural progenitors|neural progenitors
4933759|NCT01933802|autologous|autologous
4933760|NCT01933802|bone marrow|bone marrow
4933761|NCT01933802|multiple sclerosis|multiple sclerosis
4933762|NCT01933789|Palliative Care|palliative care
4933763|NCT01933789|End-of-Life Issues|end-of-life issues
4933764|NCT01933789|Patient/Clinician Communication|patient/clinician communication
4933765|NCT01933789|Patient/Family Communication|patient/family communication
4933766|NCT01933789|Concordance|concordance
4933767|NCT01933789|Treatment Preferences|treatment preferences
4933768|NCT01933789|Anxiety|anxiety
4933769|NCT01933789|Depressive Symptoms|depressive symptoms
4933770|NCT01933789|Talking with Your Doctor|talking with your doctor
4933771|NCT01933789|Coping with Serious Illness|coping with serious illness
4933772|NCT01933789|Outpatient Collaboration|outpatient collaboration
4933773|NCT01933776|Diphtheria|diphtheria
4933774|NCT01933776|Tetanus|tetanus
4933775|NCT01933776|Pertussis|pertussis
4933776|NCT01933776|ADACEL®|adacel®
4933777|NCT01933776|Tdap vaccine|tdap vaccine
4933778|NCT01933750|Presbyopia|presbyopia
4933779|NCT01933750|Reading Glasses|reading glasses
4933780|NCT01933750|Near Vision|near vision
4933782|NCT01933737|elderly;|elderly;
4933783|NCT01933737|proprioception;|proprioception;
4933784|NCT01933737|prevention;|prevention;
4933785|NCT01933737|fall|fall
4933786|NCT01933724|granulomatosis with polyangiitis|granulomatosis with polyangiitis
4933787|NCT01933724|GPA|gpa
4933788|NCT01933724|Wegeners'|wegeners'
4933789|NCT01933724|WG|wg
4933790|NCT01933724|vasculitis|vasculitis
4933791|NCT01933724|taper|taper
4933792|NCT01933724|prednisone|prednisone
4933793|NCT01933724|glucocorticoid|glucocorticoid
4933794|NCT01933724|ANCA-associated vasculitis|anca-associated vasculitis
4933795|NCT01933724|AAV|aav
4933796|NCT01933724|Wegener Granulomatosis|wegener granulomatosis
4933797|NCT01933724|Systemic Vasculitis|systemic vasculitis
4933798|NCT01933724|Lung diseases, interstitial|lung diseases, interstitial
4933799|NCT01933724|Lung diseases|lung diseases
4933800|NCT01933724|Respiratory Tract Diseases|respiratory tract diseases
4933801|NCT01933724|Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis|anti-neutrophil cytoplasmic antibody-associated vasculitis
4933802|NCT01933724|Vascular Diseases|vascular diseases
4933803|NCT01933724|Cardiovascular Diseases|cardiovascular diseases
4933804|NCT01933724|Glucocorticoids|glucocorticoids
4933805|NCT01933724|Hormones|hormones
4933806|NCT01933724|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists
4933807|NCT01933724|Physiological Effects of Drugs|physiological effects of drugs
4933808|NCT01933724|Pharmacologic Actions|pharmacologic actions
4933809|NCT01933724|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal
4933810|NCT01933724|Antineoplastic Agents|antineoplastic agents
4933811|NCT01933724|Therapeutic Uses|therapeutic uses
4933812|NCT01933724|Anti-Inflammatory Agents|anti-inflammatory agents
4933813|NCT01933711|CD20+ aggressive lymphoma|cd20+ aggressive lymphoma
4933814|NCT01933711|mantle cell lymphoma|mantle cell lymphoma
4933815|NCT01933711|rituximab|rituximab
4933816|NCT01933711|maintenance|maintenance
4933817|NCT01933698|Bioequivalence|bioequivalence
4933818|NCT01933698|Amoxicillin|amoxicillin
4933819|NCT01933698|Human|human
4933820|NCT01933672|Phase 1b|phase 1b
4933821|NCT01933672|type 2 diabetes|type 2 diabetes
4933822|NCT01933672|metformin background|metformin background
4933823|NCT01933672|PF-04937319|pf-04937319
4933824|NCT01933659|Helicobacter pylori|helicobacter pylori
4933825|NCT01933659|deep see water|deep see water
4933826|NCT01933646|Group B streptococcus|group b streptococcus
4933827|NCT01933646|Incidence|incidence
4933828|NCT01933646|Case fatality rate|case fatality rate
4933829|NCT01933646|Serotype distribution|serotype distribution
4933830|NCT01933633|Pregnancy|pregnancy
4933831|NCT01933633|Fertility|fertility
4933832|NCT01933633|exercise|exercise
4933833|NCT01933633|Fertilization in vitro|fertilization in vitro
4933834|NCT01933620|Microbiome|microbiome
4933835|NCT01933620|Nosocomial Infection|nosocomial infection
4933836|NCT01933620|Multidrug Resistance|multidrug resistance
4933837|NCT01933542|Chlorzoxazone|chlorzoxazone
4933838|NCT01933542|Postoperative pain|postoperative pain
4933839|NCT01933542|Spine surgery|spine surgery
4933840|NCT01933542|Opioid consumption|opioid consumption
4933841|NCT01933529|diabetes|diabetes
4933842|NCT01933529|glucose tolerance|glucose tolerance
4933843|NCT01933529|insulin secretion|insulin secretion
4933844|NCT01933529|insulin sensitivity|insulin sensitivity
4933845|NCT01933529|erythropoietin|erythropoietin
4933846|NCT01933529|inflammation|inflammation
4933847|NCT01933529|cytokines|cytokines
4933848|NCT01933516|GP2013|gp2013
4933849|NCT01933516|Japanese|japanese
4933850|NCT01933516|indolent B-cell non-Hodgkin's lymphoma|indolent b-cell non-hodgkin's lymphoma
4933851|NCT01933516|biosimilar|biosimilar
4933852|NCT01933516|CD20|cd20
4933853|NCT01933516|GP13-101|gp13-101
4933854|NCT01933503|MAD|mad
4933855|NCT01933503|SAD|sad
4933856|NCT01933503|Obeticholic Acid (OCA)|obeticholic acid (oca)
4933857|NCT01933490|hyperinsulinemic hypoglycemia|hyperinsulinemic hypoglycemia
4933858|NCT01933477|Maternal Health|maternal health
4933859|NCT01933477|Child Health|child health
4933860|NCT01933477|HIV infection|hiv infection
4933861|NCT01933477|Antenatal care|antenatal care
4933862|NCT01933477|Postpartum care|postpartum care
4933863|NCT01933477|Prevention of mother to child transmission (PMTCT)|prevention of mother to child transmission (pmtct)
4933864|NCT01933477|Breast feeding|breast feeding
4933865|NCT01933477|Antiretrovirals|antiretrovirals
4933866|NCT01933464|Rosacea|rosacea
4933867|NCT01933464|Cromolyn sodium|cromolyn sodium
4933868|NCT01933451|fluid therapy|fluid therapy
4933869|NCT01933451|Intraoperative care|intraoperative care
4933870|NCT01933451|Patient Outcome Assessment|patient outcome assessment
4933871|NCT01933451|pulse pressure variation|pulse pressure variation
4933872|NCT01933451|restrictive fluid therapy|restrictive fluid therapy
4933873|NCT01933451|goal-directed fluid therapy|goal-directed fluid therapy
4933874|NCT01933451|esophagectomy|esophagectomy
4933875|NCT01933438|birth related brachial plexus injury|birth related brachial plexus injury
4933876|NCT01933438|brachial plexus|brachial plexus
4933877|NCT01933438|splint|splint
4933878|NCT01933425|surgical conditions|surgical conditions
4933879|NCT01933425|laparoscopy|laparoscopy
4933880|NCT01933412|Dialysis|dialysis
4933881|NCT01933412|Hepatitis B|hepatitis b
4933882|NCT01933399|Low back pain|low back pain
4933883|NCT01933399|Back brace|back brace
4933884|NCT01933399|Lumbar orthoses|lumbar orthoses
4933885|NCT01933399|Lumbosacral orthoses|lumbosacral orthoses
4933886|NCT01933399|Low back pain treatment|low back pain treatment
4933887|NCT01933386|Single Sided Deafness|single sided deafness
4933888|NCT01933386|SSD|ssd
4933889|NCT01933386|Unilateral hearing loss|unilateral hearing loss
4933890|NCT01933373|Randomized|randomized
4933891|NCT01933373|Toupet|toupet
4933892|NCT01933373|Dor|dor
4933893|NCT01933373|Achalasia|achalasia
4933894|NCT01933360|Misoprostol|misoprostol
4933895|NCT01933360|First trimester pregnancy|first trimester pregnancy
4933896|NCT01933360|Surgical abortion|surgical abortion
4933897|NCT01933360|Cervical priming|cervical priming
4933898|NCT01933334|pirfenidone|pirfenidone
4933899|NCT01933334|SSc-ILD|ssc-ild
4933900|NCT01933334|scleroderma|scleroderma
4933901|NCT01933334|systemic sclerosis|systemic sclerosis
4933902|NCT01933334|interstitial lung disease|interstitial lung disease
4933903|NCT01933321|ALS, stem cells|als, stem cells
4933904|NCT01933308|Pulmonary Rehabilitation|pulmonary rehabilitation
4933905|NCT01933308|Comparison of exercise training protocol|comparison of exercise training protocol
4933906|NCT01933308|Exercise tolerance|exercise tolerance
4934027|NCT01932645|urinary symptoms|urinary symptoms
4933907|NCT01933308|Functional and quality of life status|functional and quality of life status
4934101|NCT01932281|SierraSil|sierrasil
4933908|NCT01933308|Cognitive and psychological status|cognitive and psychological status
4933909|NCT01933308|Compliance to exercise recommendations|compliance to exercise recommendations
4933910|NCT01933308|Long term adherence to exercise recommendations|long term adherence to exercise recommendations
4933911|NCT01933295|treatment|treatment
4933912|NCT01933282|MESA, chemotherapy,NK/T cell lymphoma|mesa, chemotherapy,nk/t cell lymphoma
4933913|NCT01933256|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
4933915|NCT01933256|Placebo|placebo
4933916|NCT01933256|islet β cell|islet β cell
4933917|NCT01933243|Anxiety|anxiety
4933918|NCT01933243|Anorexia nervosa|anorexia nervosa
4933919|NCT01933243|Adolescents|adolescents
4933920|NCT01933243|Fish oil|fish oil
4933921|NCT01933217|TBI|tbi
4933922|NCT01933217|traumatic brain injury|traumatic brain injury
4933923|NCT01933217|ADHD|adhd
4933924|NCT01933217|methylphenidate|methylphenidate
4933925|NCT01933217|Concerta|concerta
4933926|NCT01933217|attention problems|attention problems
4933927|NCT01933204|perimenopause|perimenopause
4933928|NCT01933204|hot flash|hot flash
4933929|NCT01933204|palpitation|palpitation
4933930|NCT01933191|Dental Anxiety, Physical Activity, Dental Phobia|dental anxiety, physical activity, dental phobia
4933931|NCT01933191|Cortisol, Amylase|cortisol, amylase
4933932|NCT01933178|Dry eyes|dry eyes
4933933|NCT01933178|Cirrus AS-OCT|cirrus as-oct
4933934|NCT01933178|Excess folds of the conjunctiva|excess folds of the conjunctiva
4933935|NCT01933165|Dry Eyes|dry eyes
4933936|NCT01933165|LipiView|lipiview
4933937|NCT01933165|Lipid thickness|lipid thickness
4933938|NCT01933152|wAMD|wamd
4933939|NCT01933152|anti-VEGF|anti-vegf
4933940|NCT01933139|Informed consent|informed consent
4933941|NCT01933139|preoperative counseling|preoperative counseling
4933942|NCT01933139|hysterectomy|hysterectomy
4933943|NCT01933113|Obesity|obesity
4933944|NCT01933113|Deep Brain Stimulation|deep brain stimulation
4933945|NCT01933113|LHA|lha
4933946|NCT01933100|Functional constipation|functional constipation
4933947|NCT01933100|Brown rice based-meal|brown rice based-meal
4933948|NCT01933100|Polished rice based-meal|polished rice based-meal
4933949|NCT01933100|Wheat based-meal|wheat based-meal
4933950|NCT01933087|Hand hygiene,|hand hygiene,
4933951|NCT01933087|Randonmised Controlled Trials,|randonmised controlled trials,
4933952|NCT01933087|Hospital|hospital
4933953|NCT01933074|Urinary Urgency|urinary urgency
4933954|NCT01933061|Skin cancer, Melanoma|skin cancer, melanoma
4933955|NCT01933048|influenza|influenza
4933956|NCT01933035|ITP|itp
4933957|NCT01933035|Thrombocytopenia|thrombocytopenia
4933958|NCT01933035|mean platelet mass|mean platelet mass
4933959|NCT01933035|mean platelet component|mean platelet component
4933960|NCT01933022|Exploratory|exploratory
4933961|NCT01933022|Biomarkers|biomarkers
4933962|NCT01933022|Eligard|eligard
4933963|NCT01933022|Metastatic prostate cancer|metastatic prostate cancer
4933964|NCT01932996|Smoking Cessation|smoking cessation
4933965|NCT01932996|Smoking Cessation Products|smoking cessation products
4933966|NCT01932996|Tobacco Use Cessation Products|tobacco use cessation products
4933967|NCT01932983|Neuromuscular blockade|neuromuscular blockade
4933968|NCT01932983|TOF test|tof test
4933969|NCT01932983|Quantitative TOF method|quantitative tof method
4933970|NCT01932983|Visual interpretation of TOF|visual interpretation of tof
4933971|NCT01932970|Secondary Hyperparathyroidism (SHPT), chronic kidney disease (CKD), hemodialysis, parathyroid hormone (PTH), hypocalcemia, bone and mineral metabolism|secondary hyperparathyroidism (shpt), chronic kidney disease (ckd), hemodialysis, parathyroid hormone (pth), hypocalcemia, bone and mineral metabolism
4933972|NCT01932957|Laparoscopy|laparoscopy
4933973|NCT01932957|Ruptured ectopic pregnancy|ruptured ectopic pregnancy
4933974|NCT01932931|Vitamin D|vitamin d
4933975|NCT01932931|Major depression|major depression
4933976|NCT01932931|SSRIs|ssris
4933977|NCT01932931|Osteoporosis|osteoporosis
4933978|NCT01932918|reactive oxygen species|reactive oxygen species
4933979|NCT01932918|ischemia reperfusion injury|ischemia reperfusion injury
4933980|NCT01932905|deep repetitive transcranial magnetic stimulation|deep repetitive transcranial magnetic stimulation
4933981|NCT01932905|chronic pain|chronic pain
4933982|NCT01932905|assessment|assessment
4933983|NCT01932905|neuropathic pain|neuropathic pain
4933984|NCT01932905|central pain|central pain
4933985|NCT01932905|treatment|treatment
4933986|NCT01932892|transhumeral|transhumeral
4933987|NCT01932866|pre-diabetes|pre-diabetes
4933988|NCT01932866|diabetes risk score|diabetes risk score
4933989|NCT01932866|motivation|motivation
4933990|NCT01932866|Air Force|air force
4933991|NCT01932866|Military|military
4933992|NCT01932866|Lifestyle change|lifestyle change
4933993|NCT01932840|attitudes and understanding of plant sterol claims|attitudes and understanding of plant sterol claims
4933994|NCT01932840|general Canadian population|general canadian population
4933995|NCT01932827|Attitudes and understanding of oat fibre claims|attitudes and understanding of oat fibre claims
4933996|NCT01932827|Food labels|food labels
4933997|NCT01932827|General Canadian population|general canadian population
4933998|NCT01932814|Aminoglycosides|aminoglycosides
4933999|NCT01932814|Acute kidney injury|acute kidney injury
4934000|NCT01932814|Severe sepsis|severe sepsis
4934001|NCT01932814|Critically ill patient|critically ill patient
4934194|NCT01931956|EVEREST II|everest ii
4934002|NCT01932801|harm reduction, naltrexone, alcohol dependence, homelessness|harm reduction, naltrexone, alcohol dependence, homelessness
4934003|NCT01932788|pregnancy|pregnancy
4934004|NCT01932788|Vitamin D status|vitamin d status
4934005|NCT01932736|middle ear|middle ear
4934006|NCT01932736|Eustachian tube|eustachian tube
4934007|NCT01932736|fMRI|fmri
4934008|NCT01932723|Stabilization exercises, Pain, Disability, Menstruation|stabilization exercises, pain, disability, menstruation
4934009|NCT01932710|Leukemia|leukemia
4934010|NCT01932710|Acute myelogenous leukemia|acute myelogenous leukemia
4934011|NCT01932710|AML|aml
4934012|NCT01932710|High-risk myelodysplastic leukemia|high-risk myelodysplastic leukemia
4934013|NCT01932710|MDS|mds
4934014|NCT01932710|Infection risk|infection risk
4934015|NCT01932710|White Blood Cell transfusion|white blood cell transfusion
4934016|NCT01932710|Prophylactic therapy|prophylactic therapy
4934017|NCT01932671|Cardiovascular diseases|cardiovascular diseases
4934018|NCT01932671|Atherosclerosis|atherosclerosis
4934019|NCT01932671|Multidetector Computed Tomography|multidetector computed tomography
4934020|NCT01932671|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
4934021|NCT01932658|autologous|autologous
4934022|NCT01932658|Lymphoablation|lymphoablation
4934023|NCT01932658|hematopoietic|hematopoietic
4934024|NCT01932658|immune system|immune system
4934025|NCT01932645|prostatitis|prostatitis
4934026|NCT01932645|pelvic pain|pelvic pain
4934028|NCT01932645|sexual dysfunction|sexual dysfunction
4934029|NCT01932632|Polypharmacy|polypharmacy
4934030|NCT01932632|De-prescribing|de-prescribing
4934031|NCT01932632|Frailty|frailty
4934032|NCT01932593|multiple sclerosis|multiple sclerosis
4934033|NCT01932593|bone marrow|bone marrow
4934034|NCT01932593|stem cell therapy|stem cell therapy
4934035|NCT01932580|gastric|gastric
4934036|NCT01932580|esophageal|esophageal
4934037|NCT01932580|adenocarcinoma|adenocarcinoma
4934038|NCT01932554|Sickle Cell Pain Crisis|sickle cell pain crisis
4934039|NCT01932554|Abciximab|abciximab
4934040|NCT01932554|Integrins|integrins
4934041|NCT01932554|Cell Adhesion Molecules|cell adhesion molecules
4934042|NCT01932541|Bipolar Disorder|bipolar disorder
4934043|NCT01932541|Mania|mania
4934044|NCT01932541|Bipolar I|bipolar i
4934045|NCT01932541|Bipolar II|bipolar ii
4934046|NCT01932541|Bipolar Spectrum Disorder|bipolar spectrum disorder
4934047|NCT01932541|Pediatric|pediatric
4934048|NCT01932528|Absorption|absorption
4934049|NCT01932528|Metabolism|metabolism
4934050|NCT01932528|Excretion|excretion
4934051|NCT01932502|epilepsy|epilepsy
4934052|NCT01932502|Onfi|onfi
4934053|NCT01932502|clonazepam|clonazepam
4934054|NCT01932463|Tremor|tremor
4934055|NCT01932463|Essential Tremor|essential tremor
4934056|NCT01932463|Medication-refractory Essential Tremor|medication-refractory essential tremor
4934057|NCT01932450|hypertension|hypertension
4934058|NCT01932450|radiofrequency ablation|radiofrequency ablation
4934059|NCT01932450|autosomal dominant polycystic kidney disease|autosomal dominant polycystic kidney disease
4934060|NCT01932424|Children|children
4934061|NCT01932398|Alpha|alpha
4934062|NCT01932398|Lateralization|lateralization
4934063|NCT01932398|Attention|attention
4934064|NCT01932398|ADHD|adhd
4934065|NCT01932398|Oscillation|oscillation
4934066|NCT01932385|Sorafenib|sorafenib
4934067|NCT01932385|Hepatocellular carcinoma|hepatocellular carcinoma
4934068|NCT01932385|Best supportive care|best supportive care
4934069|NCT01932385|Survival|survival
4934070|NCT01932372|Rheumatoid Arthritis|rheumatoid arthritis
4934071|NCT01932372|Good Post Marketing Study Practice|good post marketing study practice
4934072|NCT01932372|Tofacitinib|tofacitinib
4934073|NCT01932372|Xeljanz|xeljanz
4934074|NCT01932372|Regulatory Post Marketing Commitment Plan|regulatory post marketing commitment plan
4934075|NCT01932359|Scar outcome|scar outcome
4934076|NCT01932359|Mohs surgery|mohs surgery
4934077|NCT01932359|face|face
4934078|NCT01932346|near infra-red spectroscopy, coronary artery bypass grafting|near infra-red spectroscopy, coronary artery bypass grafting
4934079|NCT01932333|Healthy|healthy
4934080|NCT01932333|Safety|safety
4934081|NCT01932333|Tolerability|tolerability
4934082|NCT01932333|Pharmacokinetics|pharmacokinetics
4934083|NCT01932333|Pharmacodynamics|pharmacodynamics
4934084|NCT01932333|JNJ-40411813|jnj-40411813
4934085|NCT01932333|Positive allosteric modulator|positive allosteric modulator
4934086|NCT01932320|Healthy|healthy
4934087|NCT01932320|Relative Bioavailability|relative bioavailability
4934088|NCT01932320|Food effect|food effect
4934089|NCT01932320|JNJ-40411813|jnj-40411813
4934090|NCT01932320|Positive allosteric modulator|positive allosteric modulator
4934091|NCT01932320|Solid Dosage Formulation of JNJ-40411813|solid dosage formulation of jnj-40411813
4934092|NCT01932320|Ketoconazole|ketoconazole
4934093|NCT01932307|Surgeon neck health|surgeon neck health
4934094|NCT01932294|Advanced Heart Failure|advanced heart failure
4934095|NCT01932294|Refractory Heart Failure|refractory heart failure
4934096|NCT01932294|Mechanical Circulatory Support Device|mechanical circulatory support device
4934097|NCT01932294|Ventricular Assist Device|ventricular assist device
4934098|NCT01932294|Medamacs|medamacs
4934099|NCT01932281|muscle power|muscle power
4934100|NCT01932281|muscle fatigue|muscle fatigue
4934102|NCT01932255|microvascular decompression surgery|microvascular decompression surgery
4934103|NCT01932255|cerebrospinal fluid leakage|cerebrospinal fluid leakage
4934104|NCT01932255|postoperative complications|postoperative complications
4934105|NCT01932229|Advanced NSCLC|advanced nsclc
4934106|NCT01932229|EGFR mutation|egfr mutation
4934107|NCT01932229|TKIs|tkis
4934108|NCT01932229|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors
4934109|NCT01932216|robotic single-site cholecystectomy|robotic single-site cholecystectomy
4934110|NCT01932216|laparoscopic cholecystectomy|laparoscopic cholecystectomy
4934111|NCT01932216|cosmesis|cosmesis
4934112|NCT01932216|quality of life|quality of life
4934113|NCT01932203|Cerebral small vessel disease|cerebral small vessel disease
4934114|NCT01932203|Leukoaraiosis|leukoaraiosis
4934115|NCT01932203|Magnetic Resonance Imaging|magnetic resonance imaging
4934116|NCT01932203|Diffusion Tensor Imaging|diffusion tensor imaging
4934117|NCT01932190|Acute Kidney Injury|acute kidney injury
4934118|NCT01932190|Critical Care|critical care
4934119|NCT01932190|Renal Replacement Therapy|renal replacement therapy
4934120|NCT01932190|Treatment Outcome|treatment outcome
4934121|NCT01932177|Everolimus ; Sorafenib ; Phase 1 trial ; Solid tumor|everolimus ; sorafenib ; phase 1 trial ; solid tumor
4934122|NCT01932164|Cleft lip and palate|cleft lip and palate
4934123|NCT01932164|Deciduous dental pulp stem cells|deciduous dental pulp stem cells
4934124|NCT01932164|mesenchymal stem cells|mesenchymal stem cells
4934125|NCT01932164|tissue engineering|tissue engineering
4934126|NCT01932164|bone tissue engineering|bone tissue engineering
4934127|NCT01932164|bioengineering|bioengineering
4934128|NCT01932151|type-1 HRS|type-1 hrs
4934129|NCT01932151|active bacterial infections|active bacterial infections
4934130|NCT01932151|terlipressin and albumin|terlipressin and albumin
4934131|NCT01932151|kidney function|kidney function
4934132|NCT01932138|Community-based intervention|community-based intervention
4934133|NCT01932138|Community health workers|community health workers
4934134|NCT01932138|Antenatal care|antenatal care
4934135|NCT01932138|HIV|hiv
4934136|NCT01932138|PMTCT|pmtct
4934137|NCT01932138|HIV vertical transmission|hiv vertical transmission
4934138|NCT01932138|Public-sector health systems|public-sector health systems
4934139|NCT01932112|Pulmonary Vein Isolation|pulmonary vein isolation
4934140|NCT01932112|Adenosin effect|adenosin effect
4934141|NCT01932112|Atrial fibrillation ablation|atrial fibrillation ablation
4934142|NCT01932099|pathological constriction; restricted outflow, stenosis|pathological constriction; restricted outflow, stenosis
4934143|NCT01932086|male|male
4934144|NCT01932086|Glucose|glucose
4934145|NCT01932086|Triglyceride|triglyceride
4934146|NCT01932086|Glycemic index|glycemic index
4934147|NCT01932086|White rice|white rice
4934148|NCT01932086|Brown rice|brown rice
4934149|NCT01932086|Black rice|black rice
4934150|NCT01932086|Bread|bread
4934151|NCT01932073|Radiation|radiation
4934152|NCT01932073|dermatitis|dermatitis
4934153|NCT01932073|radiodermatitis|radiodermatitis
4934154|NCT01932073|radiotherapy induced|radiotherapy induced
4934155|NCT01932073|skin reactions|skin reactions
4934156|NCT01932073|low level laser therapy|low level laser therapy
4934157|NCT01932073|breast cancer|breast cancer
4934158|NCT01932060|Oxytocin|oxytocin
4934159|NCT01932060|blood loss|blood loss
4934160|NCT01932060|Cesarean delivery|cesarean delivery
4934161|NCT01932034|Vancomycin|vancomycin
4934162|NCT01932034|Pharmacokinetics|pharmacokinetics
4934163|NCT01932034|Pharmacodynamics|pharmacodynamics
4934164|NCT01932034|Decision support|decision support
4934165|NCT01932021|necrotitis angiodermatitis|necrotitis angiodermatitis
4934166|NCT01932021|autologous fat transplantation|autologous fat transplantation
4934167|NCT01932021|mesenchymal stem cells|mesenchymal stem cells
4934168|NCT01932008|Coronary artery bypass grafting|coronary artery bypass grafting
4934169|NCT01932008|Chronic kidney disease|chronic kidney disease
4934170|NCT01932008|Body composition|body composition
4934171|NCT01932008|Physical activity|physical activity
4934172|NCT01932008|Physical function|physical function
4934173|NCT01931982|diabetes, GLP-1, Victoza, CFR, microvascular dysfunction|diabetes, glp-1, victoza, cfr, microvascular dysfunction
4934174|NCT01931969|Vein catheterization; Ultrasound; Landmark; Complication|vein catheterization; ultrasound; landmark; complication
4934175|NCT01931956|Mitral Valve Insufficiency|mitral valve insufficiency
4934176|NCT01931956|Mitral Valve Regurgitation|mitral valve regurgitation
4934177|NCT01931956|Mitral Valve Incompetence|mitral valve incompetence
4934178|NCT01931956|Mitral Regurgitation|mitral regurgitation
4934179|NCT01931956|Mitral Insufficiency|mitral insufficiency
4934180|NCT01931956|Mitral Valve|mitral valve
4934181|NCT01931956|Mitral Regurgitation (MR)|mitral regurgitation (mr)
4934182|NCT01931956|Mitral Valve Prolapse|mitral valve prolapse
4934183|NCT01931956|Edge to Edge (E2E)|edge to edge (e2e)
4934184|NCT01931956|Alfieri Technique|alfieri technique
4934185|NCT01931956|MitraClip|mitraclip
4934186|NCT01931956|Functional MR|functional mr
4934187|NCT01931956|Degenerative MR|degenerative mr
4934188|NCT01931956|Echocardiogram|echocardiogram
4934189|NCT01931956|Coronary Artery Disease (CAD)|coronary artery disease (cad)
4934190|NCT01931956|Heart Failure|heart failure
4934191|NCT01931956|Heart Attack|heart attack
4934192|NCT01931956|EVEREST|everest
4934193|NCT01931956|EVEREST I|everest i
4934195|NCT01931956|REALISM|realism
4934196|NCT01931930|Gastrointestinal discomfort|gastrointestinal discomfort
4934197|NCT01931930|Perilla frutescens|perilla frutescens
4934198|NCT01931930|bloating|bloating
4934199|NCT01931930|abdominal discomfort|abdominal discomfort
4934200|NCT01931930|human study|human study
4934201|NCT01931930|healthy subjects|healthy subjects
4934202|NCT01931917|Prevention|prevention
4934203|NCT01931917|Parenting|parenting
4934204|NCT01931917|Infants|infants
4934205|NCT01931917|Family programs|family programs
4934206|NCT01931917|Early intervention|early intervention
4934207|NCT01931904|IOP|iop
4934208|NCT01931904|Glaucoma|glaucoma
4934209|NCT01931904|Trabeculectomy|trabeculectomy
4934210|NCT01931891|preeclampsia, ADAMTS , wharton jelly, extracellüler matrix, placenta|preeclampsia, adamts , wharton jelly, extracellüler matrix, placenta
4934211|NCT01931878|Restless Legs Syndrome|restless legs syndrome
4934212|NCT01931878|Leg pain|leg pain
4934213|NCT01931878|Sleep|sleep
4934214|NCT01931878|Dysesthesias|dysesthesias
4934215|NCT01931878|incobotulinumtoxin|incobotulinumtoxin
4934216|NCT01931865|cancer pain, radiation therapy, surgery, incobotulinum toxin|cancer pain, radiation therapy, surgery, incobotulinum toxin
4934217|NCT01931852|Acute Coronary Syndrome|acute coronary syndrome
4934218|NCT01931852|Chest pain|chest pain
4934219|NCT01931852|Cardiac MRI|cardiac mri
4934220|NCT01931852|Risk Stratification|risk stratification
4934221|NCT01931852|Emergency Department|emergency department
4934222|NCT01931852|Elevated Troponin|elevated troponin
4934223|NCT01931852|Troponin|troponin
4934224|NCT01931852|Non-ST Elevation Myocardial Infarction|non-st elevation myocardial infarction
4934225|NCT01931826|Schistosomiasis|schistosomiasis
4934226|NCT01931826|Surgical treatment|surgical treatment
4934227|NCT01931826|Endoscopic treatment|endoscopic treatment
4934228|NCT01931774|acne vulgaris cognitive functions|acne vulgaris cognitive functions
4934229|NCT01931761|Pharmacokinetics, mass balance, AZD6244|pharmacokinetics, mass balance, azd6244
4934230|NCT01931735|menisci|menisci
4934231|NCT01931735|tibial|tibial
4934232|NCT01931722|branched chain amino acid requirement|branched chain amino acid requirement
4934233|NCT01931722|older men|older men
4934234|NCT01931722|strength training|strength training
4934235|NCT01931722|sarcopenia|sarcopenia
4934236|NCT01931696|Efficacy|efficacy
4934237|NCT01931696|Acupuncture|acupuncture
4934238|NCT01931696|Asthma|asthma
4934239|NCT01931683|LMA removal|lma removal
4934240|NCT01931683|remifentanil|remifentanil
4934241|NCT01931683|propofol|propofol
4934242|NCT01931670|Dysmenorrhea (DYS)|dysmenorrhea (dys)
4934243|NCT01931670|Elagolix|elagolix
4934244|NCT01931670|Gonadotropin-Releasing Hormone Antagonist|gonadotropin-releasing hormone antagonist
4934245|NCT01931670|Non-Menstrual Pelvic Pain (NMPP)|non-menstrual pelvic pain (nmpp)
4934246|NCT01931670|Endometriosis Associated Pain|endometriosis associated pain
4934247|NCT01931657|LNG-IUS|lng-ius
4934248|NCT01931657|Mirena|mirena
4934249|NCT01931657|Contraception|contraception
4934250|NCT01931657|Bleeding|bleeding
4934251|NCT01931657|Hormonal effects in the breast|hormonal effects in the breast
4934252|NCT01931644|Graft-versus-Host Disease (GVHD)|graft-versus-host disease (gvhd)
4934253|NCT01931644|Amyotrophic Lateral Sclerosis (ALS)|amyotrophic lateral sclerosis (als)
4934254|NCT01931644|Cancer|cancer
4934255|NCT01931644|Diabetes|diabetes
4934256|NCT01931644|Melanoma|melanoma
4934257|NCT01931644|Hepatitis B|hepatitis b
4934258|NCT01931644|Lupus|lupus
4934259|NCT01931644|Multiple Sclerosis|multiple sclerosis
4934260|NCT01931644|Asthma|asthma
4934261|NCT01931644|Crohn's Disease|crohn's disease
4934262|NCT01931644|Ulcerative Colitis|ulcerative colitis
4934263|NCT01931644|Kidney Disease|kidney disease
4934264|NCT01931644|Alzheimer's Disease|alzheimer's disease
4934265|NCT01931644|Parkinson's Disease|parkinson's disease
4934266|NCT01931644|Huntington's Disease|huntington's disease
4934267|NCT01931644|Rheumatoid Arthritis|rheumatoid arthritis
4934268|NCT01931644|Sjogren's Syndrome|sjogren's syndrome
4934269|NCT01931644|Leukemia|leukemia
4934270|NCT01931644|Lymphoma|lymphoma
4934271|NCT01931644|Myeloma|myeloma
4934272|NCT01931644|CIDP|cidp
4934273|NCT01931644|COPD|copd
4934274|NCT01931644|Idiopathic Thrombocytopenia Purpura|idiopathic thrombocytopenia purpura
4934275|NCT01931644|Cystic Fibrosis|cystic fibrosis
4934276|NCT01931644|Primary Biliary Cirrhosis|primary biliary cirrhosis
4934277|NCT01931631|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
4934278|NCT01931631|Diet, Vegetarian|diet, vegetarian
4934279|NCT01931631|Diet, Fat-Restricted|diet, fat-restricted
4934280|NCT01931631|Glycemic Index|glycemic index
4934281|NCT01931618|alcohol|alcohol
4934282|NCT01931618|online intervention|online intervention
4934283|NCT01931618|hazardous drinking|hazardous drinking
4934284|NCT01931618|harmful drinking|harmful drinking
4934285|NCT01931618|early intervention|early intervention
4934286|NCT01931618|behavior change intervention|behavior change intervention
4934287|NCT01931592|ESBL|esbl
4934288|NCT01931592|neutropenia|neutropenia
4934289|NCT01931592|eradication|eradication
4934290|NCT01931592|bloodstream infection|bloodstream infection
4934291|NCT01931592|immunosuppression|immunosuppression
4934292|NCT01931579|confocal endo-microscopy, lung nodule, respiratory neoplasms|confocal endo-microscopy, lung nodule, respiratory neoplasms
4934293|NCT01931566|Drug therapy|drug therapy
4934294|NCT01931540|Obesity|obesity
4934295|NCT01931540|Epigenesis, Genetic|epigenesis, genetic
4934296|NCT01931540|Exercise Therapy|exercise therapy
4934297|NCT01931527|Obesity|obesity
4934298|NCT01931527|Metabolic syndrome|metabolic syndrome
4934299|NCT01931527|Hyperuricemia|hyperuricemia
4934300|NCT01931462|Cancer of the Kidney|cancer of the kidney
4934301|NCT01931462|Renal Cancer|renal cancer
4934302|NCT01931462|Renal Neoplasms|renal neoplasms
4934303|NCT01931462|Neoplasms, Kidney|neoplasms, kidney
4934304|NCT01931449|Pancreatoduodenectomy|pancreatoduodenectomy
4934305|NCT01931449|Digestive Tract Reconstruction|digestive tract reconstruction
4934306|NCT01931449|Pancreas|pancreas
4934307|NCT01931436|Menopause, pharmacokinetic|menopause, pharmacokinetic
4934308|NCT01931397|Dried blood spots|dried blood spots
4934309|NCT01931397|kidney transplant|kidney transplant
4934310|NCT01931397|Children|children
4934311|NCT01931384|Luteal phase support|luteal phase support
4934312|NCT01931384|Human chorionic gonadotrophin|human chorionic gonadotrophin
4934313|NCT01931384|frozen-thawed embryo transfer cycle|frozen-thawed embryo transfer cycle
4934314|NCT01931371|fistula in ano|fistula in ano
4934315|NCT01931371|anal fistula|anal fistula
4934316|NCT01931371|recurrence|recurrence
4934317|NCT01931371|costs|costs
4934318|NCT01931345|Rapid HIV testing|rapid hiv testing
4934319|NCT01931345|MSM|msm
4934320|NCT01931345|Motivational Interviewing|motivational interviewing
4934321|NCT01931345|HIV prevention|hiv prevention
4934322|NCT01931345|HIV/AIDS|hiv/aids
4934323|NCT01931345|At-risk anal intercourse|at-risk anal intercourse
4934324|NCT01931345|Randomized trial|randomized trial
4934325|NCT01931332|Arthroplasty|arthroplasty
4934326|NCT01931332|Analgesia|analgesia
4934327|NCT01931319|baclofen withdrawal|baclofen withdrawal
4934328|NCT01931319|interruption|interruption
4934329|NCT01931319|spasticity|spasticity
4934330|NCT01931319|pharmacokinetics|pharmacokinetics
4934331|NCT01931319|tolerability|tolerability
4934332|NCT01931319|intravenous|intravenous
4934333|NCT01931293|atrophic glossitis, burning mouth syndrome, gastric parietal cell antibody, thyroglobulin antibody, thyroid microsomal antibody, HLA-DR, HLA-DQ|atrophic glossitis, burning mouth syndrome, gastric parietal cell antibody, thyroglobulin antibody, thyroid microsomal antibody, hla-dr, hla-dq
4934334|NCT01931280|Gestational diabetes|gestational diabetes
4934335|NCT01931241|atherosclerosis|atherosclerosis
4934336|NCT01931241|atherosclerotic heart disease|atherosclerotic heart disease
4934337|NCT01931241|hypercholesteremia|hypercholesteremia
4934338|NCT01931241|atherosclerotic plaque|atherosclerotic plaque
4934339|NCT01931241|hyperlipidemia|hyperlipidemia
4934340|NCT01931228|Intensive care unit|intensive care unit
4934341|NCT01931228|acute respiratory insufficiency|acute respiratory insufficiency
4934342|NCT01931228|Respiratory failure|respiratory failure
4934343|NCT01931228|Mechanical Insufflation-Exsufflation|mechanical insufflation-exsufflation
4934344|NCT01931150|Topical Dapsone 5% Gel|topical dapsone 5% gel
4934345|NCT01931150|Moisturizer|moisturizer
4934346|NCT01931150|rash|rash
4934347|NCT01931150|13-012|13-012
4934348|NCT01931124|maximal oxygen uptake, activity levels, elderly|maximal oxygen uptake, activity levels, elderly
4934349|NCT01931111|physical activity|physical activity
4934350|NCT01931111|maximal oxygen uptake|maximal oxygen uptake
4934351|NCT01931098|Brain Tumors|brain tumors
4934352|NCT01931072|Exercise|exercise
4934353|NCT01931072|High-intensity interval training|high-intensity interval training
4934354|NCT01931072|Moderate training|moderate training
4934355|NCT01931072|Healthy elderly|healthy elderly
4934356|NCT01931072|Skeletal muscle|skeletal muscle
4934357|NCT01931072|DNA-methylation|dna-methylation
4934358|NCT01931072|Gene expression|gene expression
4934359|NCT01931072|subjects|subjects
4934360|NCT01931059|Imaging|imaging
4934361|NCT01931059|Risperidone|risperidone
4934362|NCT01931059|Placebo|placebo
4934363|NCT01931059|antipsychotic|antipsychotic
4934364|NCT01931046|prostate cancer|prostate cancer
4934365|NCT01931046|adenocarcinoma of the prostate|adenocarcinoma of the prostate
4934366|NCT01931033|Autism Spectrum Disorders|autism spectrum disorders
4934367|NCT01931033|Pervasive Developmental Disorders|pervasive developmental disorders
4934368|NCT01931033|ASD|asd
4934369|NCT01931033|PDD|pdd
4934370|NCT01931033|Oxytocin|oxytocin
4934371|NCT01931033|Syntocinon|syntocinon
4934372|NCT01931033|treatment|treatment
4934373|NCT01931020|Pain|pain
4934374|NCT01931020|Preterm|preterm
4934375|NCT01931020|Neonates|neonates
4934376|NCT01931020|24% Sucrose|24% sucrose
4934377|NCT01931020|25% Dextrose|25% dextrose
4934378|NCT01931007|osteoarthritis|osteoarthritis
4934379|NCT01930994|LNG: Levonorgestrel|lng: levonorgestrel
4934380|NCT01930994|MSI: Marie Stopes International|msi: marie stopes international
4934381|NCT01930994|MSK: Marie Stopes Kenya|msk: marie stopes kenya
4934382|NCT01930994|PK: Pharmacokinetic|pk: pharmacokinetic
4934383|NCT01930981|quality of life|quality of life
4934384|NCT01930981|toxicities|toxicities
4934385|NCT01930981|hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
4934386|NCT01930968|Uveal melanoma, ocular melanoma|uveal melanoma, ocular melanoma
4934387|NCT01930955|Non-antibiotic prescribing|non-antibiotic prescribing
4934388|NCT01930955|acute upper respiratory tract infection|acute upper respiratory tract infection
4934389|NCT01930955|white cell count|white cell count
4934390|NCT01930955|vomiting|vomiting
4934391|NCT01930942|rectal carcinoma|rectal carcinoma
4934392|NCT01930942|preoperative concurrent chemoradiotherapy|preoperative concurrent chemoradiotherapy
4934393|NCT01930929|Bariatric surgery|bariatric surgery
4934394|NCT01930929|Complications|complications
4934395|NCT01930929|Drugs|drugs
4934396|NCT01930916|Prothrombin Time/instrumentation|prothrombin time/instrumentation
4934397|NCT01930916|Prothrombin Time/utilization|prothrombin time/utilization
4934398|NCT01930916|Blood Coagulation Disorders/blood|blood coagulation disorders/blood
4934399|NCT01930916|Blood Coagulation Disorders/complications|blood coagulation disorders/complications
4934400|NCT01930916|Blood Coagulation Disorders/diagnosis|blood coagulation disorders/diagnosis
4934401|NCT01930916|Prospective Studies|prospective studies
4934402|NCT01930916|Adult|adult
4934403|NCT01930916|Reproducibility of Results|reproducibility of results
4934404|NCT01930916|Point-of-Care Systems/utilization|point-of-care systems/utilization
4934405|NCT01930916|Aged|aged
4934406|NCT01930916|Elderly|elderly
4934407|NCT01930903|PRO-Kinetic Energy BMS + Pantera Lux DEB combination|pro-kinetic energy bms + pantera lux deb combination
4934408|NCT01930877|quality of recovery|quality of recovery
4934409|NCT01930877|spine surgery|spine surgery
4934410|NCT01930877|intravenous lidocaine|intravenous lidocaine
4934411|NCT01930864|metformin|metformin
4934412|NCT01930864|colorectal cancer|colorectal cancer
4934413|NCT01930864|chemotherapy|chemotherapy
4934414|NCT01930851|Bariatric surgery|bariatric surgery
4934415|NCT01930851|Quality of life|quality of life
4934416|NCT01930851|Complications|complications
4934417|NCT01930838|Bariatric surgery|bariatric surgery
4934418|NCT01930838|Complications|complications
4934419|NCT01930838|Osteoporosis|osteoporosis
4934420|NCT01930838|Neuropathy|neuropathy
4934421|NCT01930838|Vitamine deficiency|vitamine deficiency
4934422|NCT01930812|18F-NaF PET/CT|18f-naf pet/ct
4934423|NCT01930812|Bone imaging|bone imaging
4934424|NCT01930773|clopidogrel|clopidogrel
4934425|NCT01930773|prasugrel|prasugrel
4934426|NCT01930773|platelet function testing|platelet function testing
4934427|NCT01930773|genotyping|genotyping
4934428|NCT01930773|peri-procedural MI|peri-procedural mi
4934429|NCT01930760|pediatric|pediatric
4934430|NCT01930760|Childhood Obesity|childhood obesity
4934431|NCT01930760|motivational interviewing|motivational interviewing
4934432|NCT01930760|pediatric primary care physicians|pediatric primary care physicians
4934433|NCT01930747|pneumoperitoneum|pneumoperitoneum
4934434|NCT01930747|laparoscopy|laparoscopy
4934435|NCT01930734|Heart Failure|heart failure
4934436|NCT01930734|Dobutamine|dobutamine
4934437|NCT01930708|BG-12|bg-12
4934438|NCT01930695|DX functionality|dx functionality
4934439|NCT01930695|Atrial fibrillation|atrial fibrillation
4934440|NCT01930695|CRT-D indication|crt-d indication
4934441|NCT01930682|Myocardial Infarction|myocardial infarction
4934442|NCT01930682|Catheterization|catheterization
4934443|NCT01930682|Fibrinolysis|fibrinolysis
4934444|NCT01930669|Heart Rate Variability|heart rate variability
4934445|NCT01930669|Multiple Organ Dysfunction Syndrome|multiple organ dysfunction syndrome
4934446|NCT01930669|Critically Ill|critically ill
4934447|NCT01930656|osteoporisis|osteoporisis
4934448|NCT01930656|fracture|fracture
4934449|NCT01930656|risk|risk
4934450|NCT01930656|cost effectiveness|cost effectiveness
4934451|NCT01930656|FRAX|frax
4934452|NCT01930656|mobile device|mobile device
4934453|NCT01930643|Electric muscle stimulation|electric muscle stimulation
4934454|NCT01930643|mechanical ventilation|mechanical ventilation
4934455|NCT01930643|chronic respiratory failure|chronic respiratory failure
4934456|NCT01930630|extraesophageal saline injection (ESI);|extraesophageal saline injection (esi);
4934457|NCT01930630|esophageal squamous cell carcinoma (ESCC);|esophageal squamous cell carcinoma (escc);
4934458|NCT01930630|esophageal cancer;|esophageal cancer;
4934459|NCT01930630|endoscopic ultrasonography (EUS)|endoscopic ultrasonography (eus)
4934460|NCT01930617|surgery|surgery
4934461|NCT01930617|trephining|trephining
4934462|NCT01930617|drainage|drainage
4934463|NCT01930617|therapeutic irrigation|therapeutic irrigation
4934464|NCT01930617|subdural space|subdural space
4934465|NCT01930617|postoperative complications|postoperative complications
4934466|NCT01930617|mortality|mortality
4934467|NCT01930604|Palmar hyperhidrosis.|palmar hyperhidrosis.
4934468|NCT01930604|Plantar hyperhidrosis.|plantar hyperhidrosis.
4934469|NCT01930604|Inguinal (groins and buttocks) hyperhidrosis.|inguinal (groins and buttocks) hyperhidrosis.
4934470|NCT01930604|Craniofacial hyperhidrosis.|craniofacial hyperhidrosis.
4934471|NCT01930604|Truncal hyperhidrosis.|truncal hyperhidrosis.
4934472|NCT01930591|fibrinolytic therapy|fibrinolytic therapy
4934473|NCT01930591|stenting|stenting
4934474|NCT01930591|platelet activity|platelet activity
4934475|NCT01930578|bioimpedance analysis|bioimpedance analysis
4934476|NCT01930578|spectroscopy|spectroscopy
4934477|NCT01930578|electrolyte sodium bromide|electrolyte sodium bromide
4934478|NCT01930578|extracellular water|extracellular water
4934479|NCT01930565|acne|acne
4934480|NCT01930565|therapeutics|therapeutics
4934481|NCT01930565|clinical trial|clinical trial
4934482|NCT01930565|natural compound|natural compound
4935992|NCT01923701|ARMS|arms
4934483|NCT01930565|Lactobacillus fermented Chamaecypris obtuse|lactobacillus fermented chamaecypris obtuse
4934484|NCT01930565|tea tree oil|tea tree oil
4934485|NCT01930526|COPD|copd
4934486|NCT01930526|Exercise|exercise
4934487|NCT01930526|Cycling|cycling
4934488|NCT01930526|Single leg|single leg
4934489|NCT01930526|Pulmonary Rehabilitation|pulmonary rehabilitation
4934490|NCT01930513|Obesity|obesity
4934491|NCT01930513|Obstructive Sleep Apnea|obstructive sleep apnea
4934492|NCT01930513|Exercise|exercise
4934493|NCT01930513|Walking tests|walking tests
4934494|NCT01930513|Cardiopulmonary exercise tests|cardiopulmonary exercise tests
4934495|NCT01930513|Physical activity|physical activity
4934496|NCT01930487|Primary open angle glaucoma|primary open angle glaucoma
4934497|NCT01930487|intraocular pressure|intraocular pressure
4934498|NCT01930487|ocular perfusion pressure|ocular perfusion pressure
4934499|NCT01930487|retrobulbar blood flow|retrobulbar blood flow
4934500|NCT01930487|retinal capillary blood flow|retinal capillary blood flow
4934501|NCT01930487|choroidal blood flow|choroidal blood flow
4934502|NCT01930474|lung cancer, plasma DNA, free DNA, EGFR, ALK|lung cancer, plasma dna, free dna, egfr, alk
4934503|NCT01930448|Bariatric|bariatric
4934504|NCT01930448|Gastric Bypass|gastric bypass
4934505|NCT01930448|Gastric Banding,|gastric banding,
4934506|NCT01930448|Type 2 Diabetes|type 2 diabetes
4934507|NCT01930448|Incretins|incretins
4934508|NCT01930448|GLP-1|glp-1
4934509|NCT01930448|GIP|gip
4934510|NCT01930448|Insulin secretion|insulin secretion
4934511|NCT01930448|insulin sensitivity|insulin sensitivity
4934512|NCT01930435|Quality of Life|quality of life
4934513|NCT01930422|Direct transcranial electrical stimulation (tDCS)|direct transcranial electrical stimulation (tdcs)
4934514|NCT01930422|Sham procedure|sham procedure
4934515|NCT01930422|Tobacco consumption|tobacco consumption
4934516|NCT01930422|Craving|craving
4934517|NCT01930409|Femoral Fractures|femoral fractures
4934518|NCT01930409|Hip Fractures|hip fractures
4934519|NCT01930409|Frail older adults|frail older adults
4934520|NCT01930409|Quality of Life|quality of life
4934521|NCT01930409|Feasibility Studies|feasibility studies
4934522|NCT01930396|Hemodialysis|hemodialysis
4934523|NCT01930396|Anticoagulation|anticoagulation
4934524|NCT01930396|Tinzaparin|tinzaparin
4934525|NCT01930396|Unfractionated Heparin|unfractionated heparin
4934526|NCT01930396|Randomized Controlled Trial|randomized controlled trial
4934527|NCT01930383|biomarkers|biomarkers
4934528|NCT01930370|pediatrics|pediatrics
4934529|NCT01930370|phosphate and postassium revmoval|phosphate and postassium revmoval
4934530|NCT01930370|dialysate bicarbonate modeling|dialysate bicarbonate modeling
4934531|NCT01930357|Rabies|rabies
4934532|NCT01930357|Purified Vero Rabies Vaccine - Serum Free (VRVg)|purified vero rabies vaccine - serum free (vrvg)
4934533|NCT01930357|Imovax® rabies|imovax® rabies
4934534|NCT01930357|Human Diploid Cell Vaccine|human diploid cell vaccine
4934535|NCT01930344|stereopsis|stereopsis
4934536|NCT01930344|3D laparoscopy|3d laparoscopy
4934537|NCT01930344|OCHRA|ochra
4934538|NCT01930331|Uncomplicated Plasmodium falciparum Malaria|uncomplicated plasmodium falciparum malaria
4934539|NCT01930305|Heating transfusion|heating transfusion
4934540|NCT01930279|T cell markers|t cell markers
4934541|NCT01930227|hypotension|hypotension
4934542|NCT01930227|spinal anesthesia|spinal anesthesia
4934543|NCT01930227|cesarean|cesarean
4934544|NCT01930175|Pemphigus vulgaris|pemphigus vulgaris
4934545|NCT01930175|pemphigus|pemphigus
4934546|NCT01930175|blistering disease|blistering disease
4934547|NCT01930162|HSC835|hsc835
4934548|NCT01930162|single umbilical cord blood transplantation|single umbilical cord blood transplantation
4934549|NCT01930162|non-myeloablative conditioning regimen|non-myeloablative conditioning regimen
4934550|NCT01930162|Umbilical cord blood|umbilical cord blood
4934551|NCT01930162|UCB transplantation|ucb transplantation
4934552|NCT01930149|Cholesterol screening|cholesterol screening
4934553|NCT01930149|High cholesterol|high cholesterol
4934554|NCT01930149|Cardiovascular disease|cardiovascular disease
4934555|NCT01930149|Statin treatment|statin treatment
4934556|NCT01930136|Calorie restriction|calorie restriction
4934557|NCT01930136|Type 2 diabetes|type 2 diabetes
4934558|NCT01930136|Obesity|obesity
4934559|NCT01930136|Diabetic nephropathy prevention|diabetic nephropathy prevention
4934560|NCT01930123|Fructose|fructose
4934561|NCT01930123|NASH|nash
4934562|NCT01930123|advanced fibrosis|advanced fibrosis
4934563|NCT01930123|biomarker|biomarker
4934564|NCT01930123|magnetic resonance|magnetic resonance
4934565|NCT01930110|Type 1 diabetes|type 1 diabetes
4934566|NCT01930110|Hypoglycemia|hypoglycemia
4934567|NCT01930110|Insulin|insulin
4934568|NCT01930110|Glucagon|glucagon
4934569|NCT01930110|Closed-loop system|closed-loop system
4934570|NCT01930110|Artificial pancreas|artificial pancreas
4934571|NCT01930097|Type 1 diabetes|type 1 diabetes
4934572|NCT01930097|Hypoglycemia|hypoglycemia
4934573|NCT01930097|Insulin|insulin
4934574|NCT01930097|Glucagon|glucagon
4934575|NCT01930097|Closed-loop system|closed-loop system
4934576|NCT01930097|Artificial pancreas|artificial pancreas
4934577|NCT01930097|Carbohydrate counting|carbohydrate counting
4934578|NCT01930084|HIV|hiv
4934579|NCT01930084|linkage|linkage
4934580|NCT01930084|retention|retention
4936091|NCT01923311|HIV|hiv
4934581|NCT01930032|Clostridium difficile infection|clostridium difficile infection
4934582|NCT01930019|etomidate,|etomidate,
4934583|NCT01930019|thiopental,|thiopental,
4934584|NCT01930019|serum cortisol concentration,|serum cortisol concentration,
4934585|NCT01930006|c-Met|c-met
4934586|NCT01930006|VEGFR|vegfr
4934587|NCT01930006|Ron|ron
4934588|NCT01930006|Cancer|cancer
4934589|NCT01930006|Tumor|tumor
4934590|NCT01930006|Safety|safety
4934591|NCT01930006|Phase 1|phase 1
4934592|NCT01929993|Conization|conization
4934593|NCT01929993|Cervical Intraepithelial Neoplasia|cervical intraepithelial neoplasia
4934594|NCT01929993|Cervix Dysplasia|cervix dysplasia
4934595|NCT01929993|Therapy|therapy
4934596|NCT01929993|Electrosurgery|electrosurgery
4934597|NCT01929980|HSCT|hsct
4934598|NCT01929980|cytopenia|cytopenia
4934599|NCT01929980|immune suppression|immune suppression
4934600|NCT01929980|proteasome inhibitor|proteasome inhibitor
4934601|NCT01929967|Heterotaxy syndrome|heterotaxy syndrome
4934602|NCT01929967|Asplenia|asplenia
4934603|NCT01929967|Polysplenia|polysplenia
4934604|NCT01929889|schizophrenia|schizophrenia
4934605|NCT01929889|schizoaffective disorder|schizoaffective disorder
4934606|NCT01929889|iloperidone|iloperidone
4934607|NCT01929889|Fanapt|fanapt
4934608|NCT01929889|social cognition|social cognition
4934609|NCT01929889|cognition|cognition
4934610|NCT01929863|Metformin|metformin
4934611|NCT01929863|Diabetes|diabetes
4934612|NCT01929837|Tinnitus|tinnitus
4934613|NCT01929837|Transcranial magnetic stimulation|transcranial magnetic stimulation
4934614|NCT01929824|dysphagia, trouble swallowing, chest pain|dysphagia, trouble swallowing, chest pain
4934615|NCT01929798|artificial pancreas|artificial pancreas
4934616|NCT01929785|post tranplant heart allograft|post tranplant heart allograft
4934617|NCT01929759|HIV|hiv
4934618|NCT01929759|neurocognitive symptoms|neurocognitive symptoms
4934619|NCT01929759|efavirenz|efavirenz
4934620|NCT01929759|elvitegravir|elvitegravir
4934621|NCT01929759|neurometabolites|neurometabolites
4934622|NCT01929733|Patent Ductus Arteriosus|patent ductus arteriosus
4934623|NCT01929720|cancer|cancer
4934624|NCT01929720|cancer survivors|cancer survivors
4934625|NCT01929720|worry|worry
4934626|NCT01929720|insomnia|insomnia
4934627|NCT01929720|symptoms|symptoms
4934628|NCT01929720|fatigue|fatigue
4934629|NCT01929720|depression|depression
4934630|NCT01929720|anxiety|anxiety
4934631|NCT01929681|Low Field Magnetic Stimulation|low field magnetic stimulation
4934632|NCT01929681|bipolar|bipolar
4934633|NCT01929681|depression|depression
4934634|NCT01929681|alternative treatment|alternative treatment
4934635|NCT01929668|ulcerative colitis|ulcerative colitis
4934636|NCT01929668|bowel preparation|bowel preparation
4934637|NCT01929655|Phase II|phase ii
4934638|NCT01929655|symptomatic castration-resistant prostate cancer|symptomatic castration-resistant prostate cancer
4934639|NCT01929655|bone metastases|bone metastases
4934640|NCT01929642|Tuberous Sclerosis Complex (TSC)|tuberous sclerosis complex (tsc)
4934641|NCT01929642|self-injury|self-injury
4934642|NCT01929642|Autism|autism
4934643|NCT01929629|Phase 1|phase 1
4934644|NCT01929629|Healthy Volunteers|healthy volunteers
4934645|NCT01929629|First Time in Man|first time in man
4934646|NCT01929629|Pharmacokinetics|pharmacokinetics
4934647|NCT01929616|adenocarcinoma, colorectal,regorafenib|adenocarcinoma, colorectal,regorafenib
4934648|NCT01929603|oncology, cancer, tumour, anticancer drug, pharmacokinetics, olaparib, rifampicin, neoplasm, CYP P450 inducer|oncology, cancer, tumour, anticancer drug, pharmacokinetics, olaparib, rifampicin, neoplasm, cyp p450 inducer
4934649|NCT01929590|Colonoscopy|colonoscopy
4934650|NCT01929590|Preparation|preparation
4934651|NCT01929590|Polyp|polyp
4934652|NCT01929590|Polyethylene glycol|polyethylene glycol
4934653|NCT01929577|ASP015K|asp015k
4934654|NCT01929577|healthy subjects|healthy subjects
4934655|NCT01929564|cardiovascular disease|cardiovascular disease
4934656|NCT01929564|risk factor|risk factor
4934657|NCT01929564|broccoli|broccoli
4934658|NCT01929564|GST|gst
4934659|NCT01929564|blood pressure|blood pressure
4934660|NCT01929564|Total cholesterol|total cholesterol
4934661|NCT01929551|glycemic index|glycemic index
4934662|NCT01929538|Chronic pancreatitis|chronic pancreatitis
4934663|NCT01929538|Biliary stricture|biliary stricture
4934664|NCT01929538|Endoscopic treatment|endoscopic treatment
4934665|NCT01929538|cSEMS|csems
4934666|NCT01929499|Colon cancer|colon cancer
4934667|NCT01929499|Cytokine-induced killer cells|cytokine-induced killer cells
4934668|NCT01929499|Adjuvant immunotherapy|adjuvant immunotherapy
4934669|NCT01929499|Adjuvant chemotherapy|adjuvant chemotherapy
4934670|NCT01929473|Pertussis infection|pertussis infection
4934671|NCT01929473|Risk factors|risk factors
4934672|NCT01929447|sleep disorders|sleep disorders
4934673|NCT01929447|sleep apnea|sleep apnea
4934674|NCT01929447|ambulatory device|ambulatory device
4934675|NCT01929447|WatchPAT|watchpat
4934676|NCT01929434|cerebral palsy|cerebral palsy
4934677|NCT01929434|cell transplantation|cell transplantation
4934678|NCT01929434|rehabilitation|rehabilitation
4934679|NCT01929421|colorectal cancer|colorectal cancer
4934680|NCT01929421|gemcitabine|gemcitabine
4934681|NCT01929421|S-1|s-1
4934682|NCT01929395|Breast Cancer|breast cancer
4934683|NCT01929395|Breast Conserving Surgery|breast conserving surgery
4934684|NCT01929395|Breast diagnostics|breast diagnostics
4934685|NCT01929395|Breast imaging|breast imaging
4934686|NCT01929382|dose titration|dose titration
4934687|NCT01929382|FLS|fls
4934688|NCT01929382|flu like symptoms|flu like symptoms
4934689|NCT01929382|Actimmune|actimmune
4934690|NCT01929369|ESRD|esrd
4934691|NCT01929369|CKD|ckd
4934692|NCT01929369|AV GRAFTS|av grafts
4934693|NCT01929369|THROMBOSED AV GRAFTS|thrombosed av grafts
4934694|NCT01929356|lung function tests|lung function tests
4934695|NCT01929356|chest physiotherapy|chest physiotherapy
4934696|NCT01929343|cocaine|cocaine
4934697|NCT01929343|addiction|addiction
4934698|NCT01929343|lidocaine|lidocaine
4934699|NCT01929343|memory|memory
4934700|NCT01929343|drug abuse|drug abuse
4934701|NCT01929330|Bioequivalence|bioequivalence
4934702|NCT01929330|Healthy Male Volunteers|healthy male volunteers
4934703|NCT01929330|Androgenetic Alopecia|androgenetic alopecia
4934704|NCT01929330|Dutasteride|dutasteride
4934705|NCT01929330|Safety|safety
4934706|NCT01929330|Tolerability|tolerability
4934707|NCT01929317|Ropinirole|ropinirole
4934708|NCT01929317|Parkinson's disease|parkinson's disease
4934709|NCT01929291|Korea|korea
4934710|NCT01929291|Post-marketing surveillance|post-marketing surveillance
4934711|NCT01929291|Boostrix|boostrix
4934712|NCT01929291|Prescribing information|prescribing information
4934713|NCT01929291|Safety|safety
4934714|NCT01929265|INFL|infl
4934715|NCT01929265|Indolent non-follicular|indolent non-follicular
4934716|NCT01929265|untreated INFL|untreated infl
4934717|NCT01929252|dexmedetomidine|dexmedetomidine
4934718|NCT01929252|wound infiltration|wound infiltration
4934719|NCT01929252|postoperative analgesia|postoperative analgesia
4934720|NCT01929187|Onychomycosis, BioEqual carrier system, amorolfine.|onychomycosis, bioequal carrier system, amorolfine.
4934721|NCT01929174|Congenital heart disease|congenital heart disease
4934722|NCT01929174|Myocardial fibrosis|myocardial fibrosis
4934723|NCT01929174|Diastolic dysfunction|diastolic dysfunction
4934724|NCT01929161|positive emotions|positive emotions
4934725|NCT01929161|meditation|meditation
4934726|NCT01929161|oxytocin|oxytocin
4934727|NCT01929148|risk-reducing salpingectomy|risk-reducing salpingectomy
4934728|NCT01929148|prophylactic bilateral salpingectomy|prophylactic bilateral salpingectomy
4934729|NCT01929148|ovarian cancer prevention|ovarian cancer prevention
4934730|NCT01929148|ovarian reserve|ovarian reserve
4934731|NCT01929135|Periodontal Disease|periodontal disease
4934732|NCT01929135|Chronic Periodontitis|chronic periodontitis
4934733|NCT01929135|Atorvastatin|atorvastatin
4934734|NCT01929135|Statins|statins
4934735|NCT01929135|Hydroxymethylglutaryl-coenzyme A Reductase Inhibitors|hydroxymethylglutaryl-coenzyme a reductase inhibitors
4934736|NCT01929135|Dentifrice|dentifrice
4934737|NCT01929122|Prevention & control|prevention & control
4934738|NCT01929122|Diet|diet
4934739|NCT01929122|Functional food|functional food
4934740|NCT01929122|Nutrition Assessment|nutrition assessment
4934741|NCT01929122|Oryza sativa|oryza sativa
4934742|NCT01929122|Rice Bran|rice bran
4934743|NCT01929122|Phaseolus vulgaris L.|phaseolus vulgaris l.
4934744|NCT01929122|Legumes|legumes
4934745|NCT01929122|Microbiome|microbiome
4934746|NCT01929122|Metabolomics|metabolomics
4934747|NCT01929122|Prebiotics|prebiotics
4934748|NCT01929083|Torsades de pointes|torsades de pointes
4934749|NCT01929083|Progesterone|progesterone
4934750|NCT01929083|Clinical trial|clinical trial
4934751|NCT01929083|Risk reduction|risk reduction
4934752|NCT01929083|Electrocardiography|electrocardiography
4934753|NCT01929070|HCP1007|hcp1007
4934754|NCT01929070|Rosuvastatin|rosuvastatin
4934755|NCT01929070|Omega-3|omega-3
4934756|NCT01929018|Amputation|amputation
4934757|NCT01929018|Rehabilitation|rehabilitation
4934758|NCT01929018|Exercise|exercise
4934759|NCT01929018|Movement|movement
4934760|NCT01929005|Comprehensive care|comprehensive care
4934761|NCT01929005|Medicare|medicare
4934762|NCT01929005|Cost-sharing|cost-sharing
4934763|NCT01929005|Quality of care|quality of care
4934764|NCT01928992|Mammography|mammography
4934765|NCT01928992|3D|3d
4934766|NCT01928992|Breast Cancer Detection|breast cancer detection
4934767|NCT01928979|LA/LAA Thrombus|la/laa thrombus
4934768|NCT01928979|Atrial Fibrillation|atrial fibrillation
4934769|NCT01928979|Observation|observation
4934770|NCT01928966|dietary fat|dietary fat
4934771|NCT01928966|fat intake|fat intake
4934772|NCT01928966|blood pressure|blood pressure
4934774|NCT01928966|phytoestrogen|phytoestrogen
4934775|NCT01928966|pumpkin seeds|pumpkin seeds
4934776|NCT01928966|cardiovascular disease|cardiovascular disease
4934777|NCT01928966|heart disease|heart disease
4934778|NCT01928966|secoisolariciresinol|secoisolariciresinol
4934779|NCT01928966|monounsaturated fat|monounsaturated fat
4934780|NCT01928966|polyunsaturated fat|polyunsaturated fat
4934781|NCT01928966|feeding study|feeding study
4934782|NCT01928953|opioid induced constipation in patients without cancer and with cancer|opioid induced constipation in patients without cancer and with cancer
4934783|NCT01928940|Advanced solid tumors|advanced solid tumors
4934784|NCT01928940|BRAF|braf
4934785|NCT01928940|Melanoma|melanoma
4936092|NCT01923311|HIV-1|hiv-1
4934786|NCT01928888|Acute heartburn episodes|acute heartburn episodes
4934787|NCT01928849|Amputation|amputation
4934788|NCT01928849|Post-amputation Pain|post-amputation pain
4934789|NCT01928849|Neuropathic pain|neuropathic pain
4934790|NCT01928849|Valproic Acid|valproic acid
4934791|NCT01928849|Anesthesia, Conduction|anesthesia, conduction
4934792|NCT01928849|Neuralgia, stump|neuralgia, stump
4934793|NCT01928836|Carcinoma, Non-Small-Cell Lung|carcinoma, non-small-cell lung
4934794|NCT01928836|Small Cell Lung Carcinoma|small cell lung carcinoma
4934795|NCT01928836|Biological Markers|biological markers
4934796|NCT01928836|ROC Curve|roc curve
4934797|NCT01928836|Delayed Diagnosis|delayed diagnosis
4934798|NCT01928823|agoraphobia|agoraphobia
4934799|NCT01928823|panic disorder|panic disorder
4934800|NCT01928823|D-Cycloserine|d-cycloserine
4934801|NCT01928823|DCS|dcs
4934802|NCT01928823|exposure|exposure
4934803|NCT01928823|cognitive behavioral therapy|cognitive behavioral therapy
4934804|NCT01928823|CBT|cbt
4934805|NCT01928823|augmentation|augmentation
4934806|NCT01928810|Panic Disorder|panic disorder
4934807|NCT01928810|Agoraphobia|agoraphobia
4934808|NCT01928810|Physical Activity|physical activity
4934809|NCT01928797|cardiac output pregnancy spinal anesthesia|cardiac output pregnancy spinal anesthesia
4934810|NCT01928784|Low back pain|low back pain
4934811|NCT01928784|extracorporeal shock wave therapy|extracorporeal shock wave therapy
4934812|NCT01928784|Trigger Points|trigger points
4934813|NCT01928771|Asthma,|asthma,
4934814|NCT01928771|Bronchial Diseases,|bronchial diseases,
4934815|NCT01928771|Respiratory Tract Diseases,|respiratory tract diseases,
4934816|NCT01928771|Lung Diseases,|lung diseases,
4934817|NCT01928771|Obstructive Lung Diseases|obstructive lung diseases
4934818|NCT01928758|Smoking|smoking
4934819|NCT01928758|Nicotine|nicotine
4934820|NCT01928745|Stewart approach|stewart approach
4934821|NCT01928745|sepsis|sepsis
4934822|NCT01928745|SIRS|sirs
4934823|NCT01928745|cardiothoracic surgery|cardiothoracic surgery
4934824|NCT01928745|CABG|cabg
4934825|NCT01928719|Smoking|smoking
4934826|NCT01928719|Nicotine|nicotine
4934827|NCT01928706|edentulism|edentulism
4934828|NCT01928706|denture liner|denture liner
4934829|NCT01928706|prosthodontics|prosthodontics
4934830|NCT01928706|OHIP EDENT|ohip edent
4934831|NCT01928693|infectious corneal ulcers|infectious corneal ulcers
4934832|NCT01928680|Triple Negative Breast Cancer, Cisplatin, Capecitabine|triple negative breast cancer, cisplatin, capecitabine
4934833|NCT01928654|Edema|edema
4934834|NCT01928654|Diabetic|diabetic
4934835|NCT01928654|Laser|laser
4934836|NCT01928654|Treatment|treatment
4934837|NCT01928602|Crossover|crossover
4934838|NCT01928602|Chronic stroke|chronic stroke
4934839|NCT01928602|Stroke|stroke
4934840|NCT01928602|Rehabilitation|rehabilitation
4934841|NCT01928602|Language Therapy|language therapy
4934842|NCT01928602|Aphasia|aphasia
4934843|NCT01928602|Aphasia Therapy|aphasia therapy
4934844|NCT01928602|Computerised Therapy|computerised therapy
4934845|NCT01928602|Computerised Rehabilitation|computerised rehabilitation
4934846|NCT01928602|Tablet|tablet
4934847|NCT01928602|Apps|apps
4934848|NCT01928602|Aphasia Rehabilitation|aphasia rehabilitation
4934849|NCT01928602|Rehabilitation on Portable Tablets|rehabilitation on portable tablets
4934850|NCT01928589|Cyclophosphamide|cyclophosphamide
4934851|NCT01928589|Doxorubicin|doxorubicin
4934852|NCT01928589|Docetaxel|docetaxel
4934853|NCT01928589|Carboplatin|carboplatin
4934854|NCT01928589|Herceptin|herceptin
4934855|NCT01928589|Partial Breast Irradiation|partial breast irradiation
4934856|NCT01928589|Concurrent Chemotherapy|concurrent chemotherapy
4934857|NCT01928550|Diabetes|diabetes
4934858|NCT01928550|OCT|oct
4934859|NCT01928550|PDR|pdr
4934860|NCT01928537|International Working Group|international working group
4934861|NCT01928537|azacitidine|azacitidine
4934862|NCT01928537|decitabine|decitabine
4934863|NCT01928524|Gastric cancer|gastric cancer
4934864|NCT01928524|Cancer of the esophagus|cancer of the esophagus
4934865|NCT01928524|Oxaliplatin|oxaliplatin
4934866|NCT01928524|Docetaxel|docetaxel
4934867|NCT01928524|S1|s1
4934868|NCT01928511|Hepatitis B virus|hepatitis b virus
4934869|NCT01928511|HBeAg positive|hbeag positive
4934870|NCT01928511|HBeAg negative|hbeag negative
4934871|NCT01928511|antiviral therapy|antiviral therapy
4934872|NCT01928511|nucleoside analogues|nucleoside analogues
4934873|NCT01928498|arteriovenous fistulae|arteriovenous fistulae
4934874|NCT01928498|arteriovenous graft|arteriovenous graft
4934875|NCT01928498|restenosis|restenosis
4934876|NCT01928498|angioplasty|angioplasty
4934877|NCT01928498|drug eluting balloon|drug eluting balloon
4934878|NCT01928472|Influenza, H7N9, Vaccine|influenza, h7n9, vaccine
4934879|NCT01928459|BGJ398|bgj398
4934880|NCT01928459|BYL719|byl719
4934881|NCT01928459|advanced solid tumor|advanced solid tumor
4934882|NCT01928459|metastatic breast cancer|metastatic breast cancer
4934883|NCT01928459|PK3CA|pk3ca
4934884|NCT01928459|FGFR|fgfr
4934885|NCT01928459|fibroblast growth factor receptor|fibroblast growth factor receptor
4934886|NCT01928446|Lithium|lithium
4934887|NCT01928446|Placebo|placebo
4934888|NCT01928446|Double-blind methods|double-blind methods
4936297|NCT01922167|Leucine|leucine
4934889|NCT01928446|Clinical Trials, Randomized|clinical trials, randomized
4934890|NCT01928446|Veterans|veterans
4934891|NCT01928433|Urinary Tract Infection|urinary tract infection
4934892|NCT01928433|Pyelonephritis|pyelonephritis
4934893|NCT01928420|Alzheimer Disease|alzheimer disease
4934894|NCT01928420|Alzheimer Type Senile Dementia|alzheimer type senile dementia
4934895|NCT01928420|Alzheimer's Disease|alzheimer's disease
4934896|NCT01928420|clinical trial|clinical trial
4934897|NCT01928420|dementia|dementia
4934898|NCT01928420|diabetes|diabetes
4934899|NCT01928420|dietary supplements|dietary supplements
4934900|NCT01928420|Senile Dementia, Alzheimer|senile dementia, alzheimer
4934901|NCT01928420|Therapeutics|therapeutics
4934902|NCT01928420|Brain Diseases|brain diseases
4934903|NCT01928420|Central Nervous System Diseases|central nervous system diseases
4934904|NCT01928420|Nervous System Diseases|nervous system diseases
4934905|NCT01928420|Neurodegenerative Diseases|neurodegenerative diseases
4934906|NCT01928420|Delirium, Dementia, Amnestic, Cognitive|delirium, dementia, amnestic, cognitive
4934907|NCT01928420|Disorders|disorders
4934908|NCT01928420|Mental Disorders|mental disorders
4934909|NCT01928407|naives, CD4 < 200 cell/mm3, Atazanavir, Darunavir|naives, cd4 < 200 cell/mm3, atazanavir, darunavir
4934910|NCT01928368|Mild asthma|mild asthma
4934911|NCT01928368|Atopic asthma|atopic asthma
4934912|NCT01928368|Healthy volunteers|healthy volunteers
4934913|NCT01928368|First-in-human|first-in-human
4934914|NCT01928316|Healthy|healthy
4934915|NCT01928316|Bioequivalence|bioequivalence
4934916|NCT01928316|Mizolastine|mizolastine
4934917|NCT01928316|Domestic|domestic
4934918|NCT01928316|Imported|imported
4934919|NCT01928303|opioids|opioids
4934920|NCT01928303|chronic pain|chronic pain
4934921|NCT01928303|oxycodone|oxycodone
4934922|NCT01928303|oxymorphone|oxymorphone
4934923|NCT01928303|patients using opioid pain medication|patients using opioid pain medication
4934924|NCT01928277|Symptom assessment agreement|symptom assessment agreement
4934925|NCT01928277|Work of breathing|work of breathing
4934926|NCT01928264|Mental disorders|mental disorders
4934927|NCT01928264|Physical activity|physical activity
4934928|NCT01928264|Disability pension|disability pension
4934929|NCT01928264|Disability pension due to mental illness|disability pension due to mental illness
4934930|NCT01928264|Ability to work|ability to work
4934931|NCT01928264|Mental toughness|mental toughness
4934933|NCT01928238|NAVA|nava
4934934|NCT01928238|noninvasive neurally adjusted ventilatory|noninvasive neurally adjusted ventilatory
4934935|NCT01928238|noninvasive pressure support ventilation|noninvasive pressure support ventilation
4934936|NCT01928225|HSIL|hsil
4934937|NCT01928225|CIN|cin
4934938|NCT01928225|HPV|hpv
4934939|NCT01928225|HPV vaccination|hpv vaccination
4934940|NCT01928225|gardasil|gardasil
4934941|NCT01928225|HIV|hiv
4934942|NCT01928225|cervical dysplasia|cervical dysplasia
4934943|NCT01928225|LEEP|leep
4934944|NCT01928225|cervical cancer|cervical cancer
4934945|NCT01928212|retinal nerve fiber layer thickness|retinal nerve fiber layer thickness
4934946|NCT01928212|optical coherence tomography|optical coherence tomography
4934947|NCT01928212|Parkinson disease|parkinson disease
4934948|NCT01928199|diabetes|diabetes
4934949|NCT01928199|transplant|transplant
4934950|NCT01928199|kidney|kidney
4934951|NCT01928173|Sleep Initiation and Maintenance Disorders|sleep initiation and maintenance disorders
4934952|NCT01928173|Cognitive Therapy|cognitive therapy
4934953|NCT01928160|Non-small cell lung cancer, EGFR mutation, erlotinib acquired resistance|non-small cell lung cancer, egfr mutation, erlotinib acquired resistance
4934954|NCT01928147|NS5B polymerase inhibitor|ns5b polymerase inhibitor
4934955|NCT01928147|Phase 1|phase 1
4934956|NCT01928147|Genotype 1|genotype 1
4934957|NCT01928134|Vitamin K2|vitamin k2
4934958|NCT01928134|Vitamin D3|vitamin d3
4934959|NCT01928134|Bioavailability of calcium|bioavailability of calcium
4934960|NCT01928134|volunteers|volunteers
4934961|NCT01928134|Men|men
4934962|NCT01928134|non-pregnant women|non-pregnant women
4934963|NCT01928134|twenty years of age|twenty years of age
4934964|NCT01928121|nurse|nurse
4934965|NCT01928121|expert program|expert program
4934966|NCT01928121|primary care|primary care
4934967|NCT01928121|implementation|implementation
4934968|NCT01928121|interdisciplinary|interdisciplinary
4934969|NCT01928121|effectiveness|effectiveness
4934970|NCT01928121|disease management system|disease management system
4934971|NCT01928095|atherosclerosis|atherosclerosis
4934972|NCT01928095|carotid endartherectomy|carotid endartherectomy
4934973|NCT01928082|Hypercalciuria, Familial Idiopathic|hypercalciuria, familial idiopathic
4934974|NCT01928082|Hypercalciuria|hypercalciuria
4934975|NCT01928082|Osteopenia|osteopenia
4934976|NCT01928082|Osteoporosis|osteoporosis
4934977|NCT01928082|Postmenopausal women|postmenopausal women
4934978|NCT01928004|edentulous|edentulous
4934979|NCT01928004|complete denture|complete denture
4934980|NCT01927991|tinnitus|tinnitus
4934981|NCT01927991|cognitive behavioural therapy|cognitive behavioural therapy
4934982|NCT01927991|internet treatment|internet treatment
4934983|NCT01927978|Esophageal cancer|esophageal cancer
4934984|NCT01927978|18F-FDG PET|18f-fdg pet
4934985|NCT01927978|staging|staging
4934986|NCT01927978|therapy planning|therapy planning
4936991|NCT01919255|Picolight|picolight
4934987|NCT01927978|therapy response monitoring|therapy response monitoring
4934988|NCT01927978|prognosis|prognosis
4934989|NCT01927965|gastrointestinal tract|gastrointestinal tract
4934990|NCT01927965|GI tract|gi tract
4934991|NCT01927965|advanced gastrointestinal tumors|advanced gastrointestinal tumors
4934992|NCT01927965|gastrointestinal tumors|gastrointestinal tumors
4934993|NCT01927965|GI tumors|gi tumors
4934994|NCT01927965|biliary|biliary
4934995|NCT01927965|gallbladder,|gallbladder,
4934996|NCT01927965|colorectal,|colorectal,
4934997|NCT01927965|gastric,|gastric,
4934998|NCT01927965|hepatocellular|hepatocellular
4934999|NCT01927965|esophageal|esophageal
4935000|NCT01927965|pancreatic|pancreatic
4935001|NCT01927952|hammertoe|hammertoe
4935002|NCT01927939|Breast cancer; bone metastases; 18F-FDG PET; 99mTc bone scintigraphy; therapy response monitoring; prognosis|breast cancer; bone metastases; 18f-fdg pet; 99mtc bone scintigraphy; therapy response monitoring; prognosis
4935003|NCT01927926|Energy intake|energy intake
4935004|NCT01927926|appetite|appetite
4935005|NCT01927926|satiety|satiety
4935006|NCT01927926|gut hormones|gut hormones
4935007|NCT01927900|Human milk oligosaccharides|human milk oligosaccharides
4935008|NCT01927900|Microbiota|microbiota
4935009|NCT01927900|Prebiotics|prebiotics
4935010|NCT01927887|Papillary Carcinoma of Thyroid|papillary carcinoma of thyroid
4935011|NCT01927887|Follicular thyroid cancer lymph node metastasis|follicular thyroid cancer lymph node metastasis
4935012|NCT01927887|Metastatic medullary thyroid cancer|metastatic medullary thyroid cancer
4935013|NCT01927874|infiltration|infiltration
4935014|NCT01927874|hemorrhoidectomy|hemorrhoidectomy
4935015|NCT01927874|Postoperative pain|postoperative pain
4935016|NCT01927822|termination of pregnancy, abortion|termination of pregnancy, abortion
4935017|NCT01927809|Hereditary Diseases|hereditary diseases
4935018|NCT01927809|Colon|colon
4935019|NCT01927783|Cardiovascular Disease|cardiovascular disease
4935020|NCT01927783|Obesity|obesity
4935021|NCT01927770|Whole Genome Sequencing|whole genome sequencing
4935022|NCT01927770|Informed Choice|informed choice
4935023|NCT01927757|rheumatoid arthritis|rheumatoid arthritis
4935024|NCT01927757|etanercept|etanercept
4935025|NCT01927757|arthritis|arthritis
4935026|NCT01927757|adalimumab failure to respond|adalimumab failure to respond
4935027|NCT01927757|loss of response to adalimumab|loss of response to adalimumab
4935028|NCT01927757|ACR20|acr20
4935029|NCT01927757|methotrexate|methotrexate
4935030|NCT01927757|Swollen joints|swollen joints
4935031|NCT01927757|tender joints|tender joints
4935032|NCT01927744|Head and Neck Cancer|head and neck cancer
4935033|NCT01927744|Squamous cell carcinoma of the head and neck|squamous cell carcinoma of the head and neck
4935034|NCT01927744|SCCHN|scchn
4935035|NCT01927744|Oral cavity squamous cell carcinomas|oral cavity squamous cell carcinomas
4935036|NCT01927744|Docetaxel|docetaxel
4935037|NCT01927744|Taxotere|taxotere
4935038|NCT01927744|Erlotinib|erlotinib
4935039|NCT01927744|Erlotinib Hydrochloride|erlotinib hydrochloride
4935040|NCT01927744|OSI-774|osi-774
4935041|NCT01927744|CP358774|cp358774
4935042|NCT01927744|Tarceva|tarceva
4935043|NCT01927744|Questionnaire|questionnaire
4935044|NCT01927744|Survey|survey
4935045|NCT01927744|Phone call|phone call
4935046|NCT01927731|Blood And Marrow Transplantation|blood and marrow transplantation
4935047|NCT01927731|Cord blood transplantation|cord blood transplantation
4935048|NCT01927731|CBT|cbt
4935049|NCT01927731|Platelet count|platelet count
4935050|NCT01927731|Haploidentical donor stem cell transplant|haploidentical donor stem cell transplant
4935051|NCT01927731|Eltrombopag|eltrombopag
4935052|NCT01927731|Promacta|promacta
4935053|NCT01927718|Blood And Marrow Transplantation|blood and marrow transplantation
4935054|NCT01927718|Myeloma|myeloma
4935055|NCT01927718|Multiple myeloma|multiple myeloma
4935056|NCT01927718|MM|mm
4935057|NCT01927718|Autologous stem cell transplantation|autologous stem cell transplantation
4935058|NCT01927718|ASCT|asct
4935059|NCT01927718|Thalidomide|thalidomide
4935060|NCT01927718|Thalomid|thalomid
4935061|NCT01927718|Lenalidomide|lenalidomide
4935062|NCT01927718|CC-5013|cc-5013
4935063|NCT01927718|Revlimid|revlimid
4935064|NCT01927718|Questionnaires|questionnaires
4935065|NCT01927718|Surveys|surveys
4935066|NCT01927705|Atopic dermatitis|atopic dermatitis
4935067|NCT01927705|Stem cell|stem cell
4935068|NCT01927705|Cell therapy|cell therapy
4935069|NCT01927705|skin disease|skin disease
4935070|NCT01927705|furestem|furestem
4935071|NCT01927705|AD|ad
4935072|NCT01927705|hUCB-MSC|hucb-msc
4935073|NCT01927705|UCB-MSC|ucb-msc
4935074|NCT01927705|Umbilical cord Blood|umbilical cord blood
4935075|NCT01927692|MG|mg
4935076|NCT01927666|glucoraphanin|glucoraphanin
4935077|NCT01927666|broccoli|broccoli
4935078|NCT01927666|gut microbiota|gut microbiota
4935079|NCT01927653|Amnestic mild cognitive impairment|amnestic mild cognitive impairment
4935080|NCT01927653|Dysexecutive mild cognitive impairment|dysexecutive mild cognitive impairment
4935081|NCT01927653|Diffusion MRI|diffusion mri
4935082|NCT01927640|Cocaine|cocaine
4935083|NCT01927640|Dexmedetomidine|dexmedetomidine
4935084|NCT01927640|Myocardial Contrast Echocardiography|myocardial contrast echocardiography
4935085|NCT01927627|Prostate cancer|prostate cancer
4935086|NCT01927627|adenocarcinoma of the prostate|adenocarcinoma of the prostate
4935087|NCT01927627|Enzalutamide|enzalutamide
4935088|NCT01927614|Cardiac Allograft Vasculopathy|cardiac allograft vasculopathy
4935089|NCT01927614|Cardiac MRI|cardiac mri
4935090|NCT01927614|Cardiac CT|cardiac ct
4935091|NCT01927614|Observational study|observational study
4935092|NCT01927601|TAVR|tavr
4935093|NCT01927601|aortic disease|aortic disease
4935094|NCT01927588|Certican|certican
4935095|NCT01927588|Renal Transplant|renal transplant
4935096|NCT01927588|Cytomegalovirus Infection|cytomegalovirus infection
4935097|NCT01927575|TOMOSYNTHESIS|tomosynthesis
4935098|NCT01927549|cardiogenic shock|cardiogenic shock
4935099|NCT01927549|infarction|infarction
4935100|NCT01927549|multivessel coronary artery disease|multivessel coronary artery disease
4935101|NCT01927549|angioplasty|angioplasty
4935102|NCT01927523|Youth violence|youth violence
4935103|NCT01927523|Crime|crime
4935104|NCT01927523|Educational achievement|educational achievement
4935105|NCT01927510|Early mobilization, rehabilitation, intensive care|early mobilization, rehabilitation, intensive care
4935106|NCT01927497|Rectal cancer|rectal cancer
4935107|NCT01927497|Extralevator abdominoperineal resection|extralevator abdominoperineal resection
4935108|NCT01927497|Biological Mesh|biological mesh
4935109|NCT01927497|Primary closure|primary closure
4935110|NCT01927484|methotrexate,|methotrexate,
4935111|NCT01927484|osteoarthritis,|osteoarthritis,
4935112|NCT01927484|pain,|pain,
4935113|NCT01927484|function,|function,
4935114|NCT01927484|synovitis|synovitis
4935115|NCT01927471|Menstrual cycles|menstrual cycles
4935116|NCT01927471|Ultrasound|ultrasound
4935117|NCT01927471|Ovary|ovary
4935118|NCT01927471|Polycystic Ovary Syndrome (PCOS)|polycystic ovary syndrome (pcos)
4935119|NCT01927471|Physical activity|physical activity
4935120|NCT01927471|Diet|diet
4935121|NCT01927432|Polycystic Ovary Syndrome (PCOS)|polycystic ovary syndrome (pcos)
4935122|NCT01927432|Nutrition|nutrition
4935123|NCT01927432|Metabolism|metabolism
4935124|NCT01927432|Antral follicle growth|antral follicle growth
4935125|NCT01927432|Menstrual Cyclicity|menstrual cyclicity
4935126|NCT01927406|Thyroid Eye Disease|thyroid eye disease
4935127|NCT01927406|Graves' Disease|graves' disease
4935128|NCT01927406|Prostaglandin Analogues|prostaglandin analogues
4935129|NCT01927380|autonomic nervous system modulation|autonomic nervous system modulation
4935130|NCT01927380|heart rate variability|heart rate variability
4935131|NCT01927380|prostatectomy|prostatectomy
4935132|NCT01927380|steep trendelenburg|steep trendelenburg
4935133|NCT01927380|pneumoperitoneum|pneumoperitoneum
4935134|NCT01927367|Clinical Decision Support System|clinical decision support system
4935135|NCT01927367|Primary Health Care|primary health care
4935136|NCT01927367|Clinical Practice Guidelines|clinical practice guidelines
4935137|NCT01927354|Head-and-Neck squamous cell carcinoma (HNSCC)|head-and-neck squamous cell carcinoma (hnscc)
4935138|NCT01927354|epithelial-mesenchymal transition (EMT)|epithelial-mesenchymal transition (emt)
4935139|NCT01927354|microRNA29|microrna29
4935140|NCT01927354|Twist1|twist1
4935141|NCT01927341|MEK162,|mek162,
4935142|NCT01927341|panitumumab,|panitumumab,
4935143|NCT01927341|mutant RAS,|mutant ras,
4935144|NCT01927341|wild-type RAS,|wild-type ras,
4935145|NCT01927341|metastatic colorectal cancer,|metastatic colorectal cancer,
4935146|NCT01927341|adult mCRC patient|adult mcrc patient
4935147|NCT01927328|Adenocarcinoma|adenocarcinoma
4935148|NCT01927328|Anemia|anemia
4935149|NCT01927328|Palliative therapy|palliative therapy
4935150|NCT01927328|Palliative care|palliative care
4935151|NCT01927328|Palliative treatments|palliative treatments
4935152|NCT01927328|Chemotherapy|chemotherapy
4935153|NCT01927328|Esophageal Cancer|esophageal cancer
4935154|NCT01927328|Gastric Cancer|gastric cancer
4935155|NCT01927315|Stem cells|stem cells
4935156|NCT01927315|Regeneration|regeneration
4935157|NCT01927315|Angiogenesis|angiogenesis
4935158|NCT01927315|Prevention|prevention
4935159|NCT01927302|Aphasia|aphasia
4935160|NCT01927302|Dysgraphia|dysgraphia
4935161|NCT01927302|Anomia|anomia
4935162|NCT01927302|Agrammatism|agrammatism
4935163|NCT01927302|Stroke|stroke
4935164|NCT01927302|Language Recovery|language recovery
4935165|NCT01927302|Treatment|treatment
4935166|NCT01927302|Biomarkers of Recovery|biomarkers of recovery
4935167|NCT01927289|Ultrasound|ultrasound
4935168|NCT01927289|supraclavicular block|supraclavicular block
4935169|NCT01927289|distal forearm block|distal forearm block
4935170|NCT01927289|Grip Strength|grip strength
4935171|NCT01927289|Satisfaction|satisfaction
4935172|NCT01927276|Schizophrenia|schizophrenia
4935173|NCT01927276|Gluten|gluten
4935174|NCT01927250|cohort study|cohort study
4935175|NCT01927250|diet program|diet program
4935176|NCT01927250|art therapy|art therapy
4935177|NCT01927250|laying-on-of-hands|laying-on-of-hands
4935178|NCT01927250|quality of life|quality of life
4935179|NCT01927237|pulmonary artery pressure|pulmonary artery pressure
4935180|NCT01927237|ARDS|ards
4935181|NCT01927237|alveolar hypoventilation|alveolar hypoventilation
4935182|NCT01927237|hypercapnic acidosis|hypercapnic acidosis
4935183|NCT01927237|permissive hypercapnia|permissive hypercapnia
4935184|NCT01927237|myocardial strain|myocardial strain
4936992|NCT01919255|Clicolon|clicolon
4935185|NCT01927185|central venous access|central venous access
4935186|NCT01927185|ultrasonography|ultrasonography
4935187|NCT01927185|subclavian vein|subclavian vein
4935188|NCT01927185|pneumothorax|pneumothorax
4935189|NCT01927185|vessel view|vessel view
4935190|NCT01927159|Tuberculosis|tuberculosis
4935192|NCT01927159|Pulmonary|pulmonary
4935193|NCT01927159|Vaccine|vaccine
4935194|NCT01927159|Adjuvant|adjuvant
4935195|NCT01927146|Lauren classification|lauren classification
4935196|NCT01927146|HER2 status|her2 status
4935197|NCT01927146|Resectable gastric cancer|resectable gastric cancer
4935198|NCT01927133|Fibrosis, HBV, HCV, ALD, NAFLD|fibrosis, hbv, hcv, ald, nafld
4935199|NCT01927120|GVHD|gvhd
4935200|NCT01927120|Allogeneic|allogeneic
4935201|NCT01927120|Hematopoietic Cell Transplant|hematopoietic cell transplant
4935202|NCT01927107|probiotics|probiotics
4935203|NCT01927107|obesity|obesity
4935204|NCT01927107|oxidative stress|oxidative stress
4935205|NCT01927094|probiotics, diarrhea|probiotics, diarrhea
4935206|NCT01927055|NOH|noh
4935207|NCT01927055|OH|oh
4935208|NCT01927055|PD|pd
4935209|NCT01927055|MSA|msa
4935210|NCT01927055|PAF|paf
4935211|NCT01927055|DBH|dbh
4935212|NCT01927042|Eating Disorders|eating disorders
4935213|NCT01927042|Carers|carers
4935214|NCT01927029|twin pregnancy|twin pregnancy
4935215|NCT01927029|progesterone|progesterone
4935216|NCT01927029|preterm delivery|preterm delivery
4935217|NCT01927029|>14 years|>14 years
4935218|NCT01927029|Abscense of cerclage,|abscense of cerclage,
4935219|NCT01927029|TTTS, hemorrage,|ttts, hemorrage,
4935220|NCT01927029|history of thrombosis.|history of thrombosis.
4935221|NCT01927029|cervix >15mm|cervix >15mm
4935222|NCT01927016|Esophageal Neoplasm|esophageal neoplasm
4935223|NCT01927016|Esophagus|esophagus
4935224|NCT01927016|Surgery|surgery
4935225|NCT01927016|Outcome assessment|outcome assessment
4935226|NCT01927003|defect,|defect,
4935227|NCT01927003|dorsal branch of the digital artery,|dorsal branch of the digital artery,
4935228|NCT01927003|dorsal digital flap,|dorsal digital flap,
4935229|NCT01927003|dorsal metacarpal artery flap.|dorsal metacarpal artery flap.
4935230|NCT01926964|Adjuvant treatment recommendation|adjuvant treatment recommendation
4935231|NCT01926964|Early breast cancer|early breast cancer
4935232|NCT01926964|Oncotype DX|oncotype dx
4935233|NCT01926964|Genetic profiling|genetic profiling
4935234|NCT01926951|hypertension|hypertension
4935235|NCT01926925|Type 2 diabetes, Endothelium, children/adolescents|type 2 diabetes, endothelium, children/adolescents
4935236|NCT01926912|Schizophrenia|schizophrenia
4935237|NCT01926912|Paliperidone Palmitate|paliperidone palmitate
4935238|NCT01926912|Hospital setting|hospital setting
4935239|NCT01926912|Schizophrenic Disorders|schizophrenic disorders
4935240|NCT01926860|Prevenar13|prevenar13
4935241|NCT01926860|pneumococcal conjugate vaccine|pneumococcal conjugate vaccine
4935242|NCT01926860|Epaxal|epaxal
4935243|NCT01926860|hepatitis A vaccine|hepatitis a vaccine
4935244|NCT01926847|Digital ischemia|digital ischemia
4935245|NCT01926847|Raynaud's phenomenon|raynaud's phenomenon
4935246|NCT01926834|promoting angiogenesis in multiple targets|promoting angiogenesis in multiple targets
4935247|NCT01926834|herbal medicine|herbal medicine
4935248|NCT01926834|traditional chinese medicine|traditional chinese medicine
4935249|NCT01926834|random clinical trial|random clinical trial
4935250|NCT01926795|toddler's fracture|toddler's fracture
4935251|NCT01926795|tibial fracture|tibial fracture
4935252|NCT01926795|children|children
4935253|NCT01926769|Colorectal cancer|colorectal cancer
4935254|NCT01926769|Metformin|metformin
4935255|NCT01926769|FOLFOX6|folfox6
4935256|NCT01926769|FOFIRI|fofiri
4935257|NCT01926769|5FU|5fu
4935258|NCT01926769|irinotecan|irinotecan
4935259|NCT01926769|oxaliplatin|oxaliplatin
4935260|NCT01926756|bacteriuria|bacteriuria
4935261|NCT01926756|straight catheterization|straight catheterization
4935262|NCT01926756|urinary tract infections|urinary tract infections
4935263|NCT01926756|iatrogenic|iatrogenic
4935264|NCT01926743|near infrared|near infrared
4935265|NCT01926743|fluorescence imaging|fluorescence imaging
4935266|NCT01926743|indocyanine green|indocyanine green
4935267|NCT01926743|gastrectomy|gastrectomy
4935268|NCT01926717|Single Roux-y of Pancreaticojejunostomy-choledochojejunostomy|single roux-y of pancreaticojejunostomy-choledochojejunostomy
4935269|NCT01926691|dementia|dementia
4935270|NCT01926691|poststroke cognitive impairment|poststroke cognitive impairment
4935271|NCT01926691|inflammation|inflammation
4935272|NCT01926691|stress|stress
4935273|NCT01926678|swedish massage|swedish massage
4935274|NCT01926678|fatigue|fatigue
4935275|NCT01926678|light touch|light touch
4935276|NCT01926678|inflammation|inflammation
4935277|NCT01926665|Blood And Marrow Transplantation|blood and marrow transplantation
4935278|NCT01926665|Mantle cell lymphoma|mantle cell lymphoma
4935279|NCT01926665|MCL|mcl
4935280|NCT01926665|T-cell lymphoma|t-cell lymphoma
4935281|NCT01926665|TCL|tcl
4935282|NCT01926665|Diffuse large b-cell lymphoma|diffuse large b-cell lymphoma
4935283|NCT01926665|DLBCL|dlbcl
4935284|NCT01926665|Autologous stem cell transplantation|autologous stem cell transplantation
4935285|NCT01926665|ASCT|asct
4935286|NCT01926665|Carfilzomib|carfilzomib
4935287|NCT01926665|CFZ|cfz
4935288|NCT01926665|Dexamethasone|dexamethasone
4935289|NCT01926665|Decadron|decadron
4935290|NCT01926639|Follicular lymphoma|follicular lymphoma
4935291|NCT01926639|Rituximab|rituximab
4935292|NCT01926639|Autologous dendritic cells|autologous dendritic cells
4935293|NCT01926639|Cancer vaccine|cancer vaccine
4935294|NCT01926626|Nicotine addiction|nicotine addiction
4935295|NCT01926626|Smoking Cessation|smoking cessation
4935296|NCT01926626|Quit Smoking|quit smoking
4935297|NCT01926626|moclobemide|moclobemide
4935298|NCT01926626|Nicotine Patch|nicotine patch
4935299|NCT01926613|Schizophrenia|schizophrenia
4935300|NCT01926613|Chronic Mental Disorder|chronic mental disorder
4935301|NCT01926613|Employment|employment
4935302|NCT01926613|Cognitive remediation|cognitive remediation
4935303|NCT01926613|Vocational rehabilitation|vocational rehabilitation
4935304|NCT01926600|gastric ulcer|gastric ulcer
4935305|NCT01926600|duodenal ulcer|duodenal ulcer
4935306|NCT01926600|re-bleeding rate|re-bleeding rate
4935307|NCT01926600|intragastric pH|intragastric ph
4935308|NCT01926600|proton pump inhibitor|proton pump inhibitor
4935309|NCT01926587|rigosertib|rigosertib
4935310|NCT01926587|ON 01910.Na|on 01910.na
4935311|NCT01926587|azacitidine|azacitidine
4935312|NCT01926587|Vidaza|vidaza
4935313|NCT01926574|absenteeism|absenteeism
4935314|NCT01926574|rehabilitation|rehabilitation
4935315|NCT01926574|return to work|return to work
4935316|NCT01926561|Hypotensive bradycardic event|hypotensive bradycardic event
4935317|NCT01926561|Interscalene brachial plexus block|interscalene brachial plexus block
4935318|NCT01926561|Sitting position|sitting position
4935319|NCT01926561|Shoulder arthroscopic surgery|shoulder arthroscopic surgery
4935320|NCT01926548|Pharmacokinetics|pharmacokinetics
4935321|NCT01926548|Safety|safety
4935322|NCT01926535|amniotic membrane|amniotic membrane
4935323|NCT01926535|contact lens|contact lens
4935324|NCT01926535|bullous keratopathy|bullous keratopathy
4935325|NCT01926522|Exercise Therapy|exercise therapy
4935326|NCT01926483|Stage IIIA-N2 NSCLC|stage iiia-n2 nsclc
4935327|NCT01926470|epidural injections, intravascular injection|epidural injections, intravascular injection
4935328|NCT01926457|First trimester treatment of prediabetes|first trimester treatment of prediabetes
4935329|NCT01926457|First trimester treatment of gestational diabetes|first trimester treatment of gestational diabetes
4935330|NCT01926457|Umbilical cord C-Peptide|umbilical cord c-peptide
4935331|NCT01926457|Neonatal fat mass|neonatal fat mass
4935332|NCT01926457|Gestational weight gain|gestational weight gain
4935333|NCT01926457|Infant obesity|infant obesity
4935334|NCT01926444|colonoscopy|colonoscopy
4935335|NCT01926444|sedation-free|sedation-free
4935336|NCT01926444|colorectal cancer|colorectal cancer
4935337|NCT01926444|CRC screening|crc screening
4935338|NCT01926444|prevention|prevention
4935339|NCT01926444|analgesia|analgesia
4935340|NCT01926444|colonic|colonic
4935341|NCT01926444|kappa|kappa
4935342|NCT01926444|opioid agonist|opioid agonist
4935343|NCT01926444|pain management|pain management
4935344|NCT01926444|oral|oral
4935345|NCT01926444|hydrogen sulfide|hydrogen sulfide
4935346|NCT01926444|peripheral|peripheral
4935347|NCT01926418|HIV|hiv
4935348|NCT01926418|Condoms|condoms
4935349|NCT01926418|Men who have sex with men|men who have sex with men
4935350|NCT01926418|implementation intentions|implementation intentions
4935351|NCT01926418|executive function|executive function
4935352|NCT01926405|hypersomnia|hypersomnia
4935353|NCT01926405|narcolepsy|narcolepsy
4935354|NCT01926405|amylase|amylase
4935355|NCT01926405|salivary sampling|salivary sampling
4935356|NCT01926379|Ethiopia|ethiopia
4935357|NCT01926379|TB|tb
4935358|NCT01926379|tuberculosis|tuberculosis
4935359|NCT01926379|HIV|hiv
4935360|NCT01926379|IPT|ipt
4935361|NCT01926379|isoniazid|isoniazid
4935362|NCT01926379|adherence|adherence
4935363|NCT01926379|combination intervention package|combination intervention package
4935364|NCT01926379|retention|retention
4935365|NCT01926353|Vesicoureteral Reflux (VUR)|vesicoureteral reflux (vur)
4935366|NCT01926353|Complicated Urinary Tract Infection|complicated urinary tract infection
4935367|NCT01926353|Vantris|vantris
4935368|NCT01926353|Polyacrylate Polyalcohol Copolymer|polyacrylate polyalcohol copolymer
4935369|NCT01926327|PRP PRGF Osteoarthritis|prp prgf osteoarthritis
4935370|NCT01926301|sepsis|sepsis
4935371|NCT01926301|cerebrovascular autoregulation|cerebrovascular autoregulation
4935372|NCT01926301|delirium|delirium
4935373|NCT01926275|COPD|copd
4935374|NCT01926275|Noninvasive Positive Pressure Ventilation|noninvasive positive pressure ventilation
4935375|NCT01926275|Respiratory Muscle Training|respiratory muscle training
4935376|NCT01926262|Pain, Neck, Exercise, Pilots, Crewmembers,|pain, neck, exercise, pilots, crewmembers,
4935377|NCT01926249|Alzheimer's disease|alzheimer's disease
4935378|NCT01926249|Mild Cognitive Impairment|mild cognitive impairment
4935379|NCT01926210|Poor ovarian response|poor ovarian response
4935380|NCT01926210|in vitro fertilization|in vitro fertilization
4935381|NCT01926210|mild ovarian stimulation|mild ovarian stimulation
4935382|NCT01926210|controlled ovarian stimulation|controlled ovarian stimulation
4935383|NCT01926184|HIV/AIDS|hiv/aids
4935384|NCT01926184|Treatment as Prevention|treatment as prevention
4935385|NCT01926184|Methamphetamine|methamphetamine
4935386|NCT01926184|Cocaine|cocaine
4935387|NCT01926184|HIV viral Load|hiv viral load
4935388|NCT01926158|Denosumab|denosumab
4935389|NCT01926158|Osteoporosis|osteoporosis
4935390|NCT01926158|Hip replacement|hip replacement
4935391|NCT01926158|Osteoarthritis|osteoarthritis
4935392|NCT01926158|Radiostereometric analysis (RSA)|radiostereometric analysis (rsa)
4935393|NCT01926158|Dual energy X-ray absorptiometry (DXA)|dual energy x-ray absorptiometry (dxa)
4935394|NCT01926132|ascorbic acid|ascorbic acid
4935395|NCT01926132|fatigue|fatigue
4935396|NCT01926132|mitochondrial DNA|mitochondrial dna
4935397|NCT01926132|patient for more than 6 months|patient for more than 6 months
4935398|NCT01926106|Nasal Intermittent Positive-Pressure Ventilation|nasal intermittent positive-pressure ventilation
4935399|NCT01926106|Nasal Continuous Positive Airway Pressure|nasal continuous positive airway pressure
4935400|NCT01926106|twin|twin
4935401|NCT01926106|respiratory distress syndrome|respiratory distress syndrome
4935402|NCT01926093|Acute Respiratory Distress Syndrome (ARDS)|acute respiratory distress syndrome (ards)
4935403|NCT01926080|Depression|depression
4935404|NCT01926080|Spirituality|spirituality
4935405|NCT01926080|Neonatal death|neonatal death
4935406|NCT01926080|Bereavement|bereavement
4935407|NCT01926080|Randomized controlled trial|randomized controlled trial
4935408|NCT01926067|Accelerometer|accelerometer
4935409|NCT01926067|Cardiopulmonary by pass|cardiopulmonary by pass
4935410|NCT01926041|community|community
4935411|NCT01926041|preventive medicine|preventive medicine
4935412|NCT01926041|prediabetes|prediabetes
4935413|NCT01926041|smoking cessation|smoking cessation
4935414|NCT01926028|recurrent vulvovaginal candidiasis|recurrent vulvovaginal candidiasis
4935415|NCT01926028|candida|candida
4935416|NCT01926028|NDV3|ndv3
4935417|NCT01926028|vaginal thrush|vaginal thrush
4935418|NCT01926028|chronic yeast infection|chronic yeast infection
4935419|NCT01925976|obesity|obesity
4935420|NCT01925976|dietetic intervention|dietetic intervention
4935421|NCT01925976|eating behaviors|eating behaviors
4935422|NCT01925976|children|children
4935423|NCT01925976|healthy eating|healthy eating
4935424|NCT01925976|energy dense foods|energy dense foods
4935425|NCT01925963|Normal|normal
4935426|NCT01925963|Traumatic brain injury|traumatic brain injury
4935427|NCT01925963|Neuroimaging|neuroimaging
4935428|NCT01925963|Hyperbaric oxygen|hyperbaric oxygen
4935429|NCT01925963|Neurobehavioral symptom inventory|neurobehavioral symptom inventory
4935430|NCT01925950|BDP|bdp
4935431|NCT01925950|orBec|orbec
4935432|NCT01925950|GVHD|gvhd
4935433|NCT01925950|beclomethasone dipropionate|beclomethasone dipropionate
4935434|NCT01925950|bone marrow transplant|bone marrow transplant
4935435|NCT01925950|hematopoietic cell transplant|hematopoietic cell transplant
4935436|NCT01925950|HCT|hct
4935437|NCT01925950|stem cell transplant|stem cell transplant
4935438|NCT01925950|marrow transplant|marrow transplant
4935439|NCT01925950|SCT|sct
4935440|NCT01925950|beclomethasone 17,21-dipropionate|beclomethasone 17,21-dipropionate
4935441|NCT01925937|Coenzyme Q10|coenzyme q10
4935442|NCT01925937|Atorvastatin|atorvastatin
4935443|NCT01925937|clinical trial|clinical trial
4935444|NCT01925937|congestive heart failure|congestive heart failure
4935445|NCT01925924|Dental cements|dental cements
4935446|NCT01925924|Orthodontic adhesives|orthodontic adhesives
4935447|NCT01925924|Glass ionomer cement|glass ionomer cement
4935448|NCT01925924|Tooth demineralization|tooth demineralization
4935449|NCT01925911|Phase 1|phase 1
4935450|NCT01925911|Healthy subjects|healthy subjects
4935451|NCT01925911|DDI|ddi
4935452|NCT01925911|CYP3A|cyp3a
4935453|NCT01925898|Laceration|laceration
4935454|NCT01925898|Sedation|sedation
4935455|NCT01925898|Pediatrics|pediatrics
4935456|NCT01925885|Atrial Arrhythmia|atrial arrhythmia
4935457|NCT01925872|ischemic cerebrovascular disease|ischemic cerebrovascular disease
4935458|NCT01925872|Percutaneous transluminal angioplasty and stenting|percutaneous transluminal angioplasty and stenting
4935459|NCT01925872|Clopidogrel resistance|clopidogrel resistance
4935460|NCT01925859|Pharmacokinetic analysis|pharmacokinetic analysis
4935461|NCT01925859|EryDex|erydex
4935462|NCT01925846|Pseudomonas aeruginosa|pseudomonas aeruginosa
4935463|NCT01925846|type three secretory system|type three secretory system
4935464|NCT01925846|contact lens associated microbial keratitis|contact lens associated microbial keratitis
4935465|NCT01925820|Hepatitis B,Entecavir,Pegylated IFN|hepatitis b,entecavir,pegylated ifn
4935466|NCT01925807|Adolescent|adolescent
4935467|NCT01925807|Suicidal Ideation|suicidal ideation
4935468|NCT01925807|Emergency Department|emergency department
4935469|NCT01925807|Crisis|crisis
4935470|NCT01925807|Attachment|attachment
4935471|NCT01925807|Coping|coping
4935472|NCT01925794|Stent, Coronary Arteries for Early healing|stent, coronary arteries for early healing
4935473|NCT01925781|Smoking Cessation|smoking cessation
4935474|NCT01925781|Nicotine Addiction|nicotine addiction
4935475|NCT01925781|e-Cigarette|e-cigarette
4935476|NCT01925781|electronic nicotine delivery device|electronic nicotine delivery device
4935477|NCT01925781|electronic cigarette|electronic cigarette
4935478|NCT01925781|nicotine replacement therapy|nicotine replacement therapy
4935479|NCT01925768|Apremilast, Psoriatic Arthritis, PDE4 inhibitor|apremilast, psoriatic arthritis, pde4 inhibitor
4935480|NCT01925755|Non-interventional|non-interventional
4935481|NCT01925755|Rivaroxaban|rivaroxaban
4935482|NCT01925755|Prevention in prior stroke or TIA|prevention in prior stroke or tia
4935483|NCT01925755|Russian Federation|russian federation
4935484|NCT01925742|Fetal aneuploidy|fetal aneuploidy
4935485|NCT01925729|middle ear|middle ear
4935486|NCT01925729|allergy|allergy
4935487|NCT01925729|nose|nose
4935488|NCT01925716|cholesterol,LDL|cholesterol,ldl
4935489|NCT01925716|vegetable oils|vegetable oils
4935490|NCT01925716|heart diseases|heart diseases
4935491|NCT01925690|Multiple Sclerosis|multiple sclerosis
4935492|NCT01925690|Disease modifying medication|disease modifying medication
4935493|NCT01925690|Relapsing-Remitting MS|relapsing-remitting ms
4935494|NCT01925690|Motivational Interviewing|motivational interviewing
4935495|NCT01925690|Telephone Counseling|telephone counseling
4935496|NCT01925677|Transplant|transplant
4935497|NCT01925677|donor|donor
4935498|NCT01925677|nephrectomy|nephrectomy
4935499|NCT01925677|robotic|robotic
4935500|NCT01925677|laparoscopy|laparoscopy
4935501|NCT01925677|single-port|single-port
4935502|NCT01925664|Doulas|doulas
4935503|NCT01925664|Parenting|parenting
4935504|NCT01925664|Breastfeeding|breastfeeding
4935505|NCT01925664|Pregnancy in Adolescence|pregnancy in adolescence
4935506|NCT01925651|Post Mastectomy Radiotherapy|post mastectomy radiotherapy
4935507|NCT01925651|Breast Cancer|breast cancer
4935508|NCT01925651|Bolus|bolus
4935509|NCT01925651|Radiodermatitis|radiodermatitis
4935510|NCT01925638|Healthy Volunteers|healthy volunteers
4935511|NCT01925638|Refametinib|refametinib
4935512|NCT01925638|Ketoconazole|ketoconazole
4935513|NCT01925638|Pharmacokinetics|pharmacokinetics
4935514|NCT01925612|Antibodies, Monoclonal|antibodies, monoclonal
4935515|NCT01925612|Antibody-Drug Conjugate|antibody-drug conjugate
4935516|NCT01925612|Antigens, CD30|antigens, cd30
4935517|NCT01925612|Drug Therapy|drug therapy
4935518|NCT01925612|Hematologic Diseases|hematologic diseases
4935519|NCT01925612|Lymphoma, B-cell|lymphoma, b-cell
4935520|NCT01925612|Lymphoma, Large B-cell, Diffuse|lymphoma, large b-cell, diffuse
4935521|NCT01925612|Monomethyl auristatin E|monomethyl auristatin e
4935522|NCT01925599|Nevus|nevus
4935523|NCT01925599|Choroidal Melanoma|choroidal melanoma
4935524|NCT01925599|BAP1 mutation|bap1 mutation
4935525|NCT01925573|RECURRENT GLIOBLASTOMA|recurrent glioblastoma
4935526|NCT01925573|Brain Tumor|brain tumor
4935527|NCT01925534|Optiflow|optiflow
4935528|NCT01925534|Humidified high-flow oxygen therapy|humidified high-flow oxygen therapy
4935529|NCT01925534|Noninvasive ventilation|noninvasive ventilation
4935530|NCT01925534|Acute respiratory failure|acute respiratory failure
4935531|NCT01925534|Standard oxygen therapy|standard oxygen therapy
4935532|NCT01925521|Intestinal Infection|intestinal infection
4935533|NCT01925495|otitis media|otitis media
4935534|NCT01925495|middle ear|middle ear
4935535|NCT01925495|feedback pathways|feedback pathways
4935536|NCT01925495|middle-ear pressure|middle-ear pressure
4935537|NCT01925482|middle ear|middle ear
4935538|NCT01925482|otitis|otitis
4935539|NCT01925482|gas exchange|gas exchange
4935540|NCT01925469|Hysterosalpingogram|hysterosalpingogram
4935542|NCT01925469|Pain relief|pain relief
4935543|NCT01925469|Analgesia|analgesia
4935544|NCT01925469|Benzocaine|benzocaine
4935545|NCT01925456|urge urinary incontinence|urge urinary incontinence
4935546|NCT01925443|diabetes mellitus non-insulin-dependent|diabetes mellitus non-insulin-dependent
4935547|NCT01925443|low level laser therapy|low level laser therapy
4935548|NCT01925430|Observational|observational
4935549|NCT01925430|Sleep|sleep
4935550|NCT01925430|Algorithm|algorithm
4935551|NCT01925417|Clostridium difficile|clostridium difficile
4935552|NCT01925417|C diff|c diff
4935553|NCT01925417|Microbiota Restoration Therapy|microbiota restoration therapy
4935554|NCT01925417|MRT|mrt
4935555|NCT01925417|microbiota suspension|microbiota suspension
4935556|NCT01925417|CDI|cdi
4935557|NCT01925417|CDAD|cdad
4935558|NCT01925417|Fecal transplant|fecal transplant
4935559|NCT01925417|Fecal Microbiota Transplant|fecal microbiota transplant
4935560|NCT01925417|FMT|fmt
4935561|NCT01925417|Diarrhea|diarrhea
4935562|NCT01925417|Fecal bacteriotherapy|fecal bacteriotherapy
4935563|NCT01925404|Physical activity|physical activity
4935564|NCT01925404|parks|parks
4935565|NCT01925404|programming|programming
4935566|NCT01925404|public health|public health
4935567|NCT01925391|Pediatric glaucoma|pediatric glaucoma
4935568|NCT01925391|Intraocular pressure|intraocular pressure
4935569|NCT01925391|pediatric glaucoma diagnosis|pediatric glaucoma diagnosis
4935570|NCT01925391|Volatiles and intraocular pressure|volatiles and intraocular pressure
4935571|NCT01925391|nitrous oxide|nitrous oxide
4935572|NCT01925391|Tetracaine|tetracaine
4935573|NCT01925378|Cervical Dysplasia|cervical dysplasia
4935574|NCT01925352|ischemic heart disease|ischemic heart disease
4935575|NCT01925352|adenovirus|adenovirus
4935576|NCT01925352|hepatocyte growth factor|hepatocyte growth factor
4935577|NCT01925313|Safety|safety
4935578|NCT01925313|Pharmacokinetics|pharmacokinetics
4935579|NCT01925300|Pharmacokinetics|pharmacokinetics
4935580|NCT01925300|Pharmacodynamics|pharmacodynamics
4935581|NCT01925300|Safety|safety
4935582|NCT01925300|Tolerability|tolerability
4935583|NCT01925287|bioavailability|bioavailability
4935584|NCT01925287|curcumin|curcumin
4935585|NCT01925287|curcuma longa|curcuma longa
4935586|NCT01925287|healthy humans|healthy humans
4935587|NCT01925287|safety|safety
4935588|NCT01925287|sex differences|sex differences
4935589|NCT01925274|metastatic colorectal cancer|metastatic colorectal cancer
4935590|NCT01925274|colorectal cancer|colorectal cancer
4935591|NCT01925274|KRAS|kras
4935592|NCT01925274|colon cancer|colon cancer
4935593|NCT01925274|mCRC|mcrc
4935594|NCT01925274|CRC|crc
4935595|NCT01925274|PF-05212384|pf-05212384
4935596|NCT01925274|KRAS wild type colorectal cancer|kras wild type colorectal cancer
4935597|NCT01925274|irinotecan|irinotecan
4935598|NCT01925274|cetuximab|cetuximab
4935599|NCT01925274|NRAS|nras
4935600|NCT01925261|knee osteoarthritis|knee osteoarthritis
4935601|NCT01925261|bilateral|bilateral
4935602|NCT01925261|osteoarthritis|osteoarthritis
4935603|NCT01925248|Whey protein|whey protein
4935604|NCT01925248|protein supplement|protein supplement
4935605|NCT01925248|Diabetes|diabetes
4935606|NCT01925248|Type 2 DM|type 2 dm
4935607|NCT01925248|Hyperglycemia|hyperglycemia
4935608|NCT01925248|Insulin secretagogue|insulin secretagogue
4935609|NCT01925235|remote ischemic preconditioning|remote ischemic preconditioning
4935610|NCT01925235|acute kidney injury|acute kidney injury
4935611|NCT01925235|TAVI|tavi
4935612|NCT01925235|RenPRO trial|renpro trial
4935613|NCT01925235|parameters|parameters
4935614|NCT01925209|sporadic inclusion body myositis,|sporadic inclusion body myositis,
4935615|NCT01925209|myositis,|myositis,
4935616|NCT01925209|muscle wasting,|muscle wasting,
4935617|NCT01925209|controlled clinical trial,|controlled clinical trial,
4935618|NCT01925209|randomized,|randomized,
4935619|NCT01925209|body mass,|body mass,
4935620|NCT01925209|muscle function,|muscle function,
4935621|NCT01925209|strength,|strength,
4935622|NCT01925209|performance,|performance,
4935623|NCT01925209|physical function|physical function
4935624|NCT01925196|Motor Neuron Disease|motor neuron disease
4935625|NCT01925196|Frontotemporal Dementia|frontotemporal dementia
4935626|NCT01925196|Cognitive Testing|cognitive testing
4935627|NCT01925196|Magnetic Resonance Imaging (MRI)|magnetic resonance imaging (mri)
4935628|NCT01925196|Transcranial Magnetic Stimulation (TMS)|transcranial magnetic stimulation (tms)
4935629|NCT01925183|Boceprevir|boceprevir
4935630|NCT01925183|HIV/HCV-coinfection|hiv/hcv-coinfection
4935631|NCT01925183|HIV/HCV coinfection|hiv/hcv coinfection
4935632|NCT01925183|HIV/HCV|hiv/hcv
4935633|NCT01925183|Response-guided therapy|response-guided therapy
4935634|NCT01925170|Dense breast tissue|dense breast tissue
4935635|NCT01925170|Breast Cancer Screening|breast cancer screening
4935636|NCT01925170|Molecular Breast Imaging|molecular breast imaging
4935637|NCT01925170|Breast Cancer|breast cancer
4935638|NCT01925170|Breast|breast
4935639|NCT01925105|Polypharmacy|polypharmacy
4935640|NCT01925092|Cushing's disease|cushing's disease
4935641|NCT01925092|Mifepristone|mifepristone
4935642|NCT01925092|Cushing's syndrome|cushing's syndrome
4935643|NCT01925092|Pharmacokinetic-pharmacodynamic|pharmacokinetic-pharmacodynamic
4935644|NCT01925092|Child/pediatric population|child/pediatric population
4935645|NCT01925092|Safety-efficacy|safety-efficacy
4935646|NCT01925079|acute coronary syndrome|acute coronary syndrome
4935647|NCT01925079|statins|statins
4935648|NCT01925079|LDL-C|ldl-c
4935649|NCT01925079|intensive education|intensive education
4935650|NCT01925027|Nano+ DES|nano+ des
4935651|NCT01925027|OCT|oct
4935652|NCT01925027|Neointimal hyperplasia|neointimal hyperplasia
4935653|NCT01925027|DAPT|dapt
4935654|NCT01925027|3 month|3 month
4935655|NCT01925014|Appendectomy|appendectomy
4935656|NCT01925014|Appendicitis|appendicitis
4935657|NCT01925014|False Positive Reactions|false positive reactions
4935658|NCT01925014|Humans|humans
4935659|NCT01925014|Radiation Dosage|radiation dosage
4935660|NCT01925014|Tomography, X-Ray Computed|tomography, x-ray computed
4935661|NCT01925014|Young Adult|young adult
4935662|NCT01925001|Sickle cell anemia|sickle cell anemia
4935663|NCT01925001|Sickle cell disease|sickle cell disease
4935664|NCT01925001|Sickling crisis|sickling crisis
4935665|NCT01925001|Vaso-occlusive crisis|vaso-occlusive crisis
4935666|NCT01925001|Carboxyhemoglobin|carboxyhemoglobin
4935667|NCT01925001|Oxygen therapeutic|oxygen therapeutic
4935668|NCT01925001|Ischemic rescue therapy|ischemic rescue therapy
4935669|NCT01925001|Hemoglobin solution|hemoglobin solution
4935670|NCT01925001|Pegylated hemoglobin|pegylated hemoglobin
4935671|NCT01924988|BPH, benign prostatic hyperplasia|bph, benign prostatic hyperplasia
4935672|NCT01924962|chronic occlusion of coronary artery|chronic occlusion of coronary artery
4935673|NCT01924962|left ventricular function|left ventricular function
4935674|NCT01924962|revascularisation|revascularisation
4935675|NCT01924949|7977|7977
4935676|NCT01924949|5885|5885
4935677|NCT01924949|GS-7977|gs-7977
4935678|NCT01924949|GS-5885|gs-5885
4935679|NCT01924949|SOF|sof
4935680|NCT01924949|LDV|ldv
4935681|NCT01924949|Sofosbuvir|sofosbuvir
4935682|NCT01924949|Ledipasvir|ledipasvir
4935683|NCT01924949|FDC|fdc
4935684|NCT01924923|uveal melanoma|uveal melanoma
4935685|NCT01924923|biopsy|biopsy
4935686|NCT01924923|enucleation|enucleation
4935687|NCT01924923|ocular cancer|ocular cancer
4935688|NCT01924910|Healthy, by self report|healthy, by self report
4935689|NCT01924897|CPET test|cpet test
4935690|NCT01924897|Exercise training|exercise training
4935691|NCT01924897|Prehabilitation|prehabilitation
4935692|NCT01924897|Exercise Test|exercise test
4935693|NCT01924884|Vacuum-Assisted Closure|vacuum-assisted closure
4935694|NCT01924884|Topical Negative-Pressure Therapy|topical negative-pressure therapy
4935695|NCT01924884|Negative-Pressure Dressings|negative-pressure dressings
4935696|NCT01924858|PET, healthy subjects|pet, healthy subjects
4935697|NCT01924858|Lp-PLA2|lp-pla2
4935698|NCT01924858|positron emission tomography|positron emission tomography
4935699|NCT01924858|Alzheimer's disease|alzheimer's disease
4935700|NCT01924858|brain exposure|brain exposure
4935701|NCT01924858|GSK2647544|gsk2647544
4935702|NCT01924819|Gastric cancer|gastric cancer
4935703|NCT01924819|Stomach cancer|stomach cancer
4935704|NCT01924819|Chemoradiotherapy|chemoradiotherapy
4935705|NCT01924819|Surgery|surgery
4935706|NCT01924819|Chemotherapy|chemotherapy
4935707|NCT01924819|Neoadjuvant|neoadjuvant
4935708|NCT01924806|debridement|debridement
4935709|NCT01924806|post-debridement|post-debridement
4935710|NCT01924806|infection|infection
4935711|NCT01924806|prevention|prevention
4935712|NCT01924806|wound|wound
4935713|NCT01924806|wound tissue|wound tissue
4935714|NCT01924806|wound management|wound management
4935715|NCT01924806|WoundWand|woundwand
4935716|NCT01924806|wound size reduction|wound size reduction
4935717|NCT01924806|wound bed debridement|wound bed debridement
4935718|NCT01924806|WoundWand Debridement Device|woundwand debridement device
4935719|NCT01924806|chronic wound|chronic wound
4935720|NCT01924806|delayed healing|delayed healing
4935721|NCT01924806|cellular senescence|cellular senescence
4935722|NCT01924806|acute wound|acute wound
4935723|NCT01924806|diabetic foot ulcer|diabetic foot ulcer
4935724|NCT01924806|venous leg ulcers|venous leg ulcers
4935725|NCT01924806|radiofrequency debridement|radiofrequency debridement
4935726|NCT01924806|necrotic tissue|necrotic tissue
4935727|NCT01924806|wound healing|wound healing
4935728|NCT01924806|skin|skin
4935729|NCT01924780|Dose-Response Relationship, Immunologic|dose-response relationship, immunologic
4935730|NCT01924754|HPV|hpv
4935731|NCT01924754|Gardasil|gardasil
4935732|NCT01924754|seroconversion|seroconversion
4935733|NCT01924741|Liver neoplasms|liver neoplasms
4935734|NCT01924741|Liver regeneration|liver regeneration
4935735|NCT01924715|somatoform disorder|somatoform disorder
4935736|NCT01924715|psychotherapy|psychotherapy
4935737|NCT01924715|depression|depression
4935738|NCT01924715|anxiety|anxiety
4935739|NCT01924715|personality disorder|personality disorder
4935740|NCT01924689|Phase 1|phase 1
4935741|NCT01924689|Metastatic Disease|metastatic disease
4935742|NCT01924689|Solid Tumor|solid tumor
4935743|NCT01924689|Malignancy|malignancy
4935744|NCT01924689|Metastases|metastases
4935745|NCT01924689|Clinical Trial|clinical trial
4935746|NCT01924689|Hypoxia|hypoxia
4935747|NCT01924689|Necrosis|necrosis
4935748|NCT01924689|Intratumoral|intratumoral
4935749|NCT01924689|Locally advanced cancer|locally advanced cancer
4935750|NCT01924689|Immunotherapy|immunotherapy
4935751|NCT01924689|Sarcoma|sarcoma
4935752|NCT01924689|Chordoma|chordoma
4935753|NCT01924689|Bacteriolytic|bacteriolytic
4935754|NCT01924676|food effect|food effect
4935755|NCT01924676|pharmacokinetics|pharmacokinetics
4935756|NCT01924676|bioavailability|bioavailability
4935757|NCT01924676|oxycodone|oxycodone
4935758|NCT01924676|management of moderate to severe pain|management of moderate to severe pain
4935759|NCT01924663|Heart Failure|heart failure
4935760|NCT01924663|Acute Kidney Injury|acute kidney injury
4935761|NCT01924663|Myocardial Dysfunction|myocardial dysfunction
4935762|NCT01924663|Pediatric Critical Care|pediatric critical care
4935763|NCT01924663|Pediatric Intensive Care Units|pediatric intensive care units
4935764|NCT01924663|Respiratory Virus|respiratory virus
4935765|NCT01924611|Dental caries|dental caries
4935766|NCT01924611|Atraumatic Restorative Technique|atraumatic restorative technique
4935767|NCT01924598|Anorexia Nervosa|anorexia nervosa
4935768|NCT01924598|Treatment Development|treatment development
4935769|NCT01924598|Capacity|capacity
4935770|NCT01924598|Neuroimaging|neuroimaging
4935771|NCT01924598|Magnetoencephalography|magnetoencephalography
4935772|NCT01924598|functional MRI|functional mri
4935773|NCT01924598|Reward processing|reward processing
4935774|NCT01924598|Habit formation|habit formation
4935775|NCT01924585|Colorectal|colorectal
4935776|NCT01924585|Surgery|surgery
4935777|NCT01924585|Frailty|frailty
4935778|NCT01924585|Elderly|elderly
4935779|NCT01924585|Quality of Life|quality of life
4935780|NCT01924572|umbilical cord clamping|umbilical cord clamping
4935781|NCT01924572|Placental residual blood volume|placental residual blood volume
4935782|NCT01924572|hematocrit|hematocrit
4935783|NCT01924572|hemoglobin|hemoglobin
4935784|NCT01924572|bilirubin|bilirubin
4935785|NCT01924559|Airway|airway
4935786|NCT01924546|cognition|cognition
4935787|NCT01924546|hydration|hydration
4935788|NCT01924546|schoolchildren|schoolchildren
4935789|NCT01924520|Antipsychotic|antipsychotic
4935790|NCT01924520|FK949E|fk949e
4935791|NCT01924520|Quetiapine|quetiapine
4935792|NCT01924507|Sleep medicine|sleep medicine
4935793|NCT01924507|Sleep apnea|sleep apnea
4935794|NCT01924507|Acute myocardial infarction|acute myocardial infarction
4935795|NCT01924507|Heart failure|heart failure
4935796|NCT01924507|CPAP|cpap
4935797|NCT01924494|telemedicine, tele-endoscopy|telemedicine, tele-endoscopy
4935798|NCT01924481|Caffeine|caffeine
4935799|NCT01924481|Flavonoids|flavonoids
4935800|NCT01924481|MRI|mri
4935801|NCT01924481|Brain blood flow|brain blood flow
4935802|NCT01924481|Cognition|cognition
4935803|NCT01924481|Perfusion|perfusion
4935804|NCT01924481|Resting functional magnetic resonance imaging (fMRI)|resting functional magnetic resonance imaging (fmri)
4935805|NCT01924468|Cognitive Control|cognitive control
4935806|NCT01924468|fMRI|fmri
4935807|NCT01924468|Genetics|genetics
4935808|NCT01924468|Dopamine|dopamine
4935809|NCT01924455|HIV|hiv
4935810|NCT01924455|HBV|hbv
4935811|NCT01924442|Coronary Artery Disease|coronary artery disease
4935812|NCT01924442|Off-Pump|off-pump
4935813|NCT01924442|Myocardial Ischemia|myocardial ischemia
4935814|NCT01924442|Heart Disease|heart disease
4935815|NCT01924429|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
4935816|NCT01924429|ADHD|adhd
4935817|NCT01924429|fMRI|fmri
4935818|NCT01924429|Imaging|imaging
4935819|NCT01924429|Vyvanse|vyvanse
4935820|NCT01924429|Stimulant Medication|stimulant medication
4935821|NCT01924429|Treatment|treatment
4935822|NCT01924429|Clinical Trial|clinical trial
4935823|NCT01924429|Adult|adult
4935824|NCT01924403|TKA|tka
4935825|NCT01924403|Wound Closure|wound closure
4935826|NCT01924403|Wound Perfusion|wound perfusion
4935827|NCT01924390|Tooth extraction|tooth extraction
4935828|NCT01924377|AF|af
4935829|NCT01924364|Craniomaxillofacial (CMF) Battle-injured (BI)|craniomaxillofacial (cmf) battle-injured (bi)
4935830|NCT01924364|Facial Trauma|facial trauma
4935831|NCT01924364|Fat Grafts|fat grafts
4935832|NCT01924364|Autogenous Fat Transfers (AFT)|autogenous fat transfers (aft)
4935833|NCT01924364|Wounded warriors|wounded warriors
4935834|NCT01924351|Breast Cancer with Brain Metastasis|breast cancer with brain metastasis
4935835|NCT01924351|HER2-positive|her2-positive
4935836|NCT01924351|HER-2 therapy|her-2 therapy
4935837|NCT01924338|Patient|patient
4935838|NCT01924338|localisation|localisation
4935839|NCT01924338|in cranial|in cranial
4935840|NCT01924338|radiation|radiation
4935841|NCT01924338|therapy|therapy
4935842|NCT01924338|thickness of|thickness of
4935843|NCT01924325|apixaban|apixaban
4935844|NCT01924325|clopidogrel|clopidogrel
4935845|NCT01924325|aspirin|aspirin
4935846|NCT01924325|new oral anticoagulant|new oral anticoagulant
4935847|NCT01924325|TIA|tia
4935848|NCT01924325|acute minor ischemic stroke|acute minor ischemic stroke
4935849|NCT01924312|stroke, dementia, hypertension, diabetes, hyperlipidemia, smoking, obesity|stroke, dementia, hypertension, diabetes, hyperlipidemia, smoking, obesity
4935850|NCT01924286|HIV|hiv
4935851|NCT01924286|Tuberculosis|tuberculosis
4935852|NCT01924286|Immune reconstitution inflammatory syndrome|immune reconstitution inflammatory syndrome
4935853|NCT01924286|Highly active antiretroviral therapy|highly active antiretroviral therapy
4935854|NCT01924286|Glucocorticoids|glucocorticoids
4935855|NCT01924286|Prednisone|prednisone
4935856|NCT01924286|Preventive therapy|preventive therapy
4935857|NCT01924273|Port Wine Stain Birthmarks|port wine stain birthmarks
4935858|NCT01924234|Remifentanil|remifentanil
4935859|NCT01924234|Pharyngeal dysfunction|pharyngeal dysfunction
4935860|NCT01924234|Subjective swallowing difficulties|subjective swallowing difficulties
4935861|NCT01924234|Pulmonary aspiration|pulmonary aspiration
4935862|NCT01924208|Timothy|timothy
4935863|NCT01924208|Influenza|influenza
4935864|NCT01924208|Interferon|interferon
4935865|NCT01924208|T cell|t cell
4935866|NCT01924208|Tonsil|tonsil
4935867|NCT01924195|lung|lung
4935868|NCT01924195|Anlotinib|anlotinib
4935869|NCT01924195|AL3818|al3818
4935870|NCT01924195|NSCLC|nsclc
4935871|NCT01924195|Cancer|cancer
4935872|NCT01924182|chronic pain|chronic pain
4935873|NCT01924182|inadequate pain relief|inadequate pain relief
4935874|NCT01924182|intolerable side effects|intolerable side effects
4935875|NCT01924169|Hematologic Disorder|hematologic disorder
4935876|NCT01924169|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
4935877|NCT01924169|CLL|cll
4935878|NCT01924169|Hypogammaglobulinemia|hypogammaglobulinemia
4935879|NCT01924169|Impaired Response to Vaccinations|impaired response to vaccinations
4935880|NCT01924169|Immunoglobulins|immunoglobulins
4935881|NCT01924169|Immune system's function|immune system's function
4935882|NCT01924169|Lenalidomide|lenalidomide
4935883|NCT01924169|CC-5013|cc-5013
4935884|NCT01924169|Revlimid|revlimid
4935885|NCT01924169|Flu vaccine|flu vaccine
4935886|NCT01924169|TIV|tiv
4935887|NCT01924169|Pneumonia vaccine|pneumonia vaccine
4935888|NCT01924143|ADHD|adhd
4935889|NCT01924143|Fibromyalgia|fibromyalgia
4935890|NCT01924117|cervical intraepithelial neoplasia, HPV, Cancer|cervical intraepithelial neoplasia, hpv, cancer
4935891|NCT01924104|IVF failure, implantation rate, heparin & aspirin|ivf failure, implantation rate, heparin & aspirin
4935892|NCT01924078|breast cancer|breast cancer
4935893|NCT01924078|metronomic chemotherapy|metronomic chemotherapy
4935894|NCT01924078|aromatase inhibitors|aromatase inhibitors
4935895|NCT01924065|Atrial fibrillation, conversion, stroke|atrial fibrillation, conversion, stroke
4935896|NCT01924039|Psychosis|psychosis
4935897|NCT01924039|Substance Use|substance use
4935898|NCT01924039|Motivational Enhancement Therapy|motivational enhancement therapy
4935899|NCT01924026|Phenylketonuria|phenylketonuria
4935900|NCT01924026|Mild Hyperphenylalaninemia|mild hyperphenylalaninemia
4935901|NCT01924026|PKU|pku
4935902|NCT01924026|MHP|mhp
4935903|NCT01924013|Pregnancy|pregnancy
4935904|NCT01924013|Infant Growth|infant growth
4935905|NCT01924013|Vitamin D|vitamin d
4935906|NCT01924013|Bangladesh|bangladesh
4935907|NCT01923987|Short course radiotherapy|short course radiotherapy
4935908|NCT01923987|Modified FOLFOX6|modified folfox6
4935909|NCT01923987|Delayed surgery|delayed surgery
4935910|NCT01923987|Rectal cancer|rectal cancer
4935911|NCT01923987|Synchronous metastasis|synchronous metastasis
4935912|NCT01923987|Liver metastasis|liver metastasis
4935913|NCT01923987|Lung metastasis|lung metastasis
4935914|NCT01923961|Maintenance hemodialysis or hemodiafiltration|maintenance hemodialysis or hemodiafiltration
4935915|NCT01923961|>18 years|>18 years
4935916|NCT01923961|Stable condition|stable condition
4935917|NCT01923948|Hepatocellular carcinoma|hepatocellular carcinoma
4935918|NCT01923948|Hepatectomy|hepatectomy
4935919|NCT01923948|randomized controlled trials(RCTs)|randomized controlled trials(rcts)
4935920|NCT01923948|Postoperative Pain|postoperative pain
4935921|NCT01923935|Multiple myeloma, busulfan, melphalan,transplantation|multiple myeloma, busulfan, melphalan,transplantation
4935922|NCT01923922|glioblastoma multiforme|glioblastoma multiforme
4935923|NCT01923922|CT Perfusion|ct perfusion
4935924|NCT01923922|Survival|survival
4935925|NCT01923909|Knee|knee
4935926|NCT01923909|Osteoarthritis|osteoarthritis
4935927|NCT01923909|Bahrain|bahrain
4935928|NCT01923909|PRP|prp
4935929|NCT01923909|Steroid|steroid
4935930|NCT01923909|WOMAC|womac
4935931|NCT01923909|Oxford Knee Score|oxford knee score
4935932|NCT01923909|Platelet-rich plasma|platelet-rich plasma
4935933|NCT01923896|food refusal|food refusal
4935934|NCT01923896|behavioral intervention|behavioral intervention
4935935|NCT01923896|D-cycloserine|d-cycloserine
4935936|NCT01923844|Newborn|newborn
4935937|NCT01923844|perfusion index|perfusion index
4935938|NCT01923844|pulsatility index|pulsatility index
4935939|NCT01923844|respiratory distress syndrome|respiratory distress syndrome
4935940|NCT01923844|surfactant|surfactant
4935941|NCT01923844|transcutaneous carbon monoxide|transcutaneous carbon monoxide
4935942|NCT01923831|Magnesium, Post operative sore throat, Prone position, Tracheal intubation|magnesium, post operative sore throat, prone position, tracheal intubation
4935943|NCT01923818|rivaroxaban|rivaroxaban
4935944|NCT01923818|aspirin|aspirin
4935945|NCT01923818|new oral anticoagulant|new oral anticoagulant
4935946|NCT01923818|TIA|tia
4935947|NCT01923818|acute minor ischemic stroke|acute minor ischemic stroke
4935948|NCT01923792|House Dust Mite Allergy|house dust mite allergy
4935949|NCT01923792|Rhinoconjunctivitis|rhinoconjunctivitis
4935950|NCT01923792|Environmental Exposure Unit|environmental exposure unit
4935951|NCT01923792|Immunotherapy|immunotherapy
4935952|NCT01923792|ToleroMune HDM|toleromune hdm
4935953|NCT01923779|Grass allergy|grass allergy
4935954|NCT01923779|Rhinoconjunctivitis|rhinoconjunctivitis
4935955|NCT01923779|Environmental Exposure Unit|environmental exposure unit
4935956|NCT01923779|Immunotherapy|immunotherapy
4935957|NCT01923779|ToleroMune Grass|toleromune grass
4935958|NCT01923766|Transplantation|transplantation
4935959|NCT01923753|Cystic Fibrosis|cystic fibrosis
4935960|NCT01923753|Neural respiratory drive|neural respiratory drive
4935961|NCT01923753|Airway clearance technique|airway clearance technique
4935962|NCT01923753|Expectoration|expectoration
4935963|NCT01923753|Positive expiratory pressure device|positive expiratory pressure device
4935964|NCT01923740|Absorb™ BVS|absorb™ bvs
4935965|NCT01923740|Angioplasty|angioplasty
4935966|NCT01923740|Bioabsorbable|bioabsorbable
4935967|NCT01923740|BVS|bvs
4935968|NCT01923740|Bioresorbable|bioresorbable
4935969|NCT01923740|Coronary Artery Disease|coronary artery disease
4935970|NCT01923740|Coronary Artery Endothelial Responsiveness|coronary artery endothelial responsiveness
4935971|NCT01923740|Coronary artery restenosis|coronary artery restenosis
4935972|NCT01923740|Coronary artery stenosis|coronary artery stenosis
4935973|NCT01923740|Coronary scaffold|coronary scaffold
4935974|NCT01923740|Coronary Stent|coronary stent
4935975|NCT01923740|Drug eluting stents|drug eluting stents
4935976|NCT01923740|Everolimus|everolimus
4935977|NCT01923740|Myocardial ischemia|myocardial ischemia
4935978|NCT01923740|Stent thrombosis|stent thrombosis
4935979|NCT01923740|Stents|stents
4935980|NCT01923727|[89Zr]Df-IAB2M|[89zr]df-iab2m
4935981|NCT01923727|Prostate|prostate
4935982|NCT01923727|PET Scan|pet scan
4935983|NCT01923714|Glaucoma|glaucoma
4935984|NCT01923701|At Risk Mental State|at risk mental state
4935985|NCT01923701|Attenuated Psychosis Syndrome|attenuated psychosis syndrome
4935986|NCT01923701|Prodrom|prodrom
4935987|NCT01923701|Paranoia|paranoia
4935988|NCT01923701|Psychosis|psychosis
4935989|NCT01923701|Cognitive Behavioral Therapy|cognitive behavioral therapy
4935990|NCT01923701|Group|group
4935991|NCT01923701|Family|family
4935993|NCT01923688|Prediction Prevention Severe Hypoglycemia RealTime Alert|prediction prevention severe hypoglycemia realtime alert
4935994|NCT01923675|myopia|myopia
4935995|NCT01923675|nearsightedness|nearsightedness
4935996|NCT01923675|axial elongation of the eye|axial elongation of the eye
4935997|NCT01923675|refractive error|refractive error
4935998|NCT01923662|Paraplegia|paraplegia
4935999|NCT01923662|Tetraplegia|tetraplegia
4936000|NCT01923662|Spinal Cord Injury|spinal cord injury
4936001|NCT01923662|FES|fes
4936002|NCT01923649|postoperative dumping|postoperative dumping
4936003|NCT01923649|somatostatin analogues|somatostatin analogues
4936004|NCT01923649|somatulin|somatulin
4936005|NCT01923649|lanreotide|lanreotide
4936006|NCT01923649|dumping syndrome|dumping syndrome
4936007|NCT01923636|Cytomegalovirus, congenital, handicap|cytomegalovirus, congenital, handicap
4936008|NCT01923610|Low risk HIV infection|low risk hiv infection
4936009|NCT01923610|HIV Seronegativity|hiv seronegativity
4936010|NCT01923610|HIV Preventive Vaccine|hiv preventive vaccine
4936011|NCT01923597|Proteinuria|proteinuria
4936012|NCT01923597|Oxidative stress|oxidative stress
4936013|NCT01923597|Epigallocatechin gallate|epigallocatechin gallate
4936014|NCT01923545|PEG-G-CSF|peg-g-csf
4936015|NCT01923493|neck pain|neck pain
4936016|NCT01923493|tuina|tuina
4936017|NCT01923467|smoking|smoking
4936018|NCT01923467|nicotine replacement|nicotine replacement
4936019|NCT01923467|internet|internet
4936020|NCT01923454|paracentesis|paracentesis
4936021|NCT01923454|primary acute angle closure|primary acute angle closure
4936022|NCT01923454|iridotomy|iridotomy
4936023|NCT01923454|filtration|filtration
4936024|NCT01923454|glaucoma|glaucoma
4936025|NCT01923415|Lupus Erythematosus, Subacute, Cutaneous|lupus erythematosus, subacute, cutaneous
4936026|NCT01923415|Lupus Erythematosus, Systemic|lupus erythematosus, systemic
4936027|NCT01923415|Lupus Erythematosus, Discoid|lupus erythematosus, discoid
4936028|NCT01923415|Active Cutaneous Lupus Erythematosus|active cutaneous lupus erythematosus
4936029|NCT01923415|Systemic Cutaneous Lupus Erythematosus|systemic cutaneous lupus erythematosus
4936030|NCT01923415|Skin Biopsy|skin biopsy
4936031|NCT01923415|Lesions|lesions
4936032|NCT01923402|Biomarkers|biomarkers
4936033|NCT01923402|Metabolic Profiling|metabolic profiling
4936034|NCT01923402|Metabolomics|metabolomics
4936036|NCT01923402|Smokeless Tobacco|smokeless tobacco
4936037|NCT01923402|Moist Snuff|moist snuff
4936038|NCT01923389|T2DM|t2dm
4936039|NCT01923389|obesity|obesity
4936040|NCT01923389|safety|safety
4936041|NCT01923389|multiple dose|multiple dose
4936042|NCT01923389|intravenous|intravenous
4936043|NCT01923376|hepatic encephalopathy|hepatic encephalopathy
4936044|NCT01923376|hepatic coma|hepatic coma
4936045|NCT01923376|HE|he
4936046|NCT01923376|PSE|pse
4936047|NCT01923376|lactulose|lactulose
4936048|NCT01923376|golytely|golytely
4936049|NCT01923376|cirrhosis|cirrhosis
4936050|NCT01923376|Hepatic Insufficiency|hepatic insufficiency
4936051|NCT01923376|Liver Cirrhosis|liver cirrhosis
4936052|NCT01923376|Fibrosis|fibrosis
4936053|NCT01923376|Brain Damage, Chronic|brain damage, chronic
4936054|NCT01923376|Delirium|delirium
4936055|NCT01923376|Encephalitis|encephalitis
4936056|NCT01923376|Neurotoxicity Syndromes|neurotoxicity syndromes
4936057|NCT01923376|Liver Failure|liver failure
4936058|NCT01923376|Liver Diseases|liver diseases
4936059|NCT01923376|Digestive System Diseases|digestive system diseases
4936060|NCT01923376|Brain Diseases, Metabolic|brain diseases, metabolic
4936061|NCT01923376|Brain Diseases|brain diseases
4936062|NCT01923376|Central Nervous System Diseases|central nervous system diseases
4936063|NCT01923376|Nervous System Diseases|nervous system diseases
4936064|NCT01923376|Metabolic Diseases|metabolic diseases
4936065|NCT01923376|Pathologic Processes|pathologic processes
4936066|NCT01923376|Confusion|confusion
4936067|NCT01923376|Neurobehavioral Manifestations|neurobehavioral manifestations
4936068|NCT01923376|Neurologic Manifestations|neurologic manifestations
4936069|NCT01923376|Signs and Symptoms|signs and symptoms
4936070|NCT01923376|Delirium, Dementia, Amnestic, Cognitive Disorders|delirium, dementia, amnestic, cognitive disorders
4936071|NCT01923376|Mental Disorders|mental disorders
4936072|NCT01923376|Central Nervous System Viral Diseases|central nervous system viral diseases
4936073|NCT01923376|Virus Diseases|virus diseases
4936074|NCT01923376|Central Nervous System Infections|central nervous system infections
4936075|NCT01923376|Poisoning|poisoning
4936076|NCT01923376|Substance-Related Disorders|substance-related disorders
4936077|NCT01923376|Citric Acid|citric acid
4936078|NCT01923363|pharmacokinetics|pharmacokinetics
4936079|NCT01923363|obesity|obesity
4936080|NCT01923363|piperacillin-tazobactam combination product|piperacillin-tazobactam combination product
4936081|NCT01923363|pharmacodynamics|pharmacodynamics
4936082|NCT01923363|piperacillin/tazobactam|piperacillin/tazobactam
4936083|NCT01923350|Weight reduction|weight reduction
4936084|NCT01923350|Behavioral intervention|behavioral intervention
4936085|NCT01923350|Gestational diabetes mellitus|gestational diabetes mellitus
4936086|NCT01923350|Type 2 diabetes|type 2 diabetes
4936087|NCT01923350|Diabetes testing|diabetes testing
4936088|NCT01923337|Colorectal cancer|colorectal cancer
4936089|NCT01923311|Pediatrics|pediatrics
4936090|NCT01923311|Adolescents|adolescents
4936093|NCT01923311|Treatment-experienced|treatment-experienced
4936094|NCT01923246|Alcohol consumption|alcohol consumption
4936095|NCT01923246|Brief intervention|brief intervention
4936096|NCT01923246|Automated techniques|automated techniques
4936097|NCT01923233|liver cancer|liver cancer
4936098|NCT01923233|HCC|hcc
4936099|NCT01923233|tumor vaccine|tumor vaccine
4936100|NCT01923233|immunotherapy|immunotherapy
4936101|NCT01923220|Breast Cancer|breast cancer
4936102|NCT01923220|Radiation Therapy|radiation therapy
4936103|NCT01923220|Radiation Dermatitis|radiation dermatitis
4936104|NCT01923168|Breast Cancer, Pathological Complete Response, neoadjuvant, hormone receptor-positive|breast cancer, pathological complete response, neoadjuvant, hormone receptor-positive
4936105|NCT01923142|Vitiligo|vitiligo
4936106|NCT01923142|Outer-Root-Sheath|outer-root-sheath
4936107|NCT01923142|Melanocytes|melanocytes
4936108|NCT01923142|Hair Follicles|hair follicles
4936109|NCT01923129|indwelling catheter|indwelling catheter
4936110|NCT01923129|foley|foley
4936111|NCT01923129|duration|duration
4936112|NCT01923116|Anal intraepithelial neoplasia|anal intraepithelial neoplasia
4936113|NCT01923116|HIV|hiv
4936114|NCT01923116|HPV|hpv
4936115|NCT01923116|Vaccination|vaccination
4936116|NCT01923116|Treatment|treatment
4936117|NCT01923077|acute myocardial infarction|acute myocardial infarction
4936118|NCT01923077|Statin|statin
4936119|NCT01923077|speckle tracking echocardiography|speckle tracking echocardiography
4936120|NCT01923077|Strain|strain
4936121|NCT01923077|MSCT|msct
4936122|NCT01923077|plaque|plaque
4936123|NCT01923077|vulnerable plaque|vulnerable plaque
4936124|NCT01923051|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
4936125|NCT01923051|COPD|copd
4936126|NCT01923051|national database|national database
4936127|NCT01923051|observational|observational
4936128|NCT01923038|atelectasis|atelectasis
4936129|NCT01923038|laparoscopic surgery|laparoscopic surgery
4936130|NCT01923038|anesthesia|anesthesia
4936131|NCT01923038|mechanical ventilation|mechanical ventilation
4936132|NCT01923038|Prevent|prevent
4936133|NCT01923038|shape of the airway|shape of the airway
4936134|NCT01923038|pressure-time curve|pressure-time curve
4936135|NCT01922986|stroke|stroke
4936136|NCT01922986|rehabilitation|rehabilitation
4936137|NCT01922986|hemiplegia|hemiplegia
4936138|NCT01922986|repetitive transcranial magnetic stimulation|repetitive transcranial magnetic stimulation
4936139|NCT01922973|ghrelin|ghrelin
4936140|NCT01922973|growth hormone|growth hormone
4936141|NCT01922973|aging|aging
4936142|NCT01922973|normal volunteers|normal volunteers
4936143|NCT01922960|trauma|trauma
4936144|NCT01922960|multiple organ dysfunction syndrome|multiple organ dysfunction syndrome
4936145|NCT01922908|Ischemic|ischemic
4936146|NCT01922908|Stroke|stroke
4936147|NCT01922908|Stem Cells|stem cells
4936148|NCT01922908|MSC|msc
4936149|NCT01922908|Allogeneic|allogeneic
4936150|NCT01922908|Bone Marrow|bone marrow
4936151|NCT01922895|Alcoholic Hepatitis|alcoholic hepatitis
4936152|NCT01922895|MELD < 20|meld < 20
4936153|NCT01922895|Probiotic|probiotic
4936154|NCT01922895|Nutritional Supplement|nutritional supplement
4936155|NCT01922895|Lactobacillus Rhamnosus GG|lactobacillus rhamnosus gg
4936156|NCT01922882|HIV|hiv
4936157|NCT01922882|Maternal disclosure|maternal disclosure
4936158|NCT01922882|Health promotion|health promotion
4936159|NCT01922882|Maternal mental health|maternal mental health
4936160|NCT01922882|Child behavior|child behavior
4936161|NCT01922869|Absorption|absorption
4936162|NCT01922869|Metabolism|metabolism
4936163|NCT01922869|Excretion|excretion
4936164|NCT01922869|Flavonoids|flavonoids
4936165|NCT01922869|Polyphenols|polyphenols
4936166|NCT01922869|Genes|genes
4936167|NCT01922869|Gut-microflora|gut-microflora
4936168|NCT01922843|Hemodialysis|hemodialysis
4936169|NCT01922830|Sleeve Gastrectomy|sleeve gastrectomy
4936170|NCT01922830|NAFLD|nafld
4936171|NCT01922830|gut microbiot|gut microbiot
4936172|NCT01922830|Bariatric surgery|bariatric surgery
4936173|NCT01922791|Nutrition|nutrition
4936174|NCT01922791|Probiotics|probiotics
4936175|NCT01922791|Fish oil|fish oil
4936176|NCT01922765|Helicobacter|helicobacter
4936177|NCT01922765|Eradication|eradication
4936178|NCT01922752|CEP-37440|cep-37440
4936179|NCT01922752|Advanced solid tumors|advanced solid tumors
4936180|NCT01922752|Metastatic solid tumors|metastatic solid tumors
4936181|NCT01922739|low back pain|low back pain
4936182|NCT01922739|hydrocodone bitartrate|hydrocodone bitartrate
4936183|NCT01922739|opioids|opioids
4936184|NCT01922713|biofortification|biofortification
4936185|NCT01922713|vitamin A|vitamin a
4936186|NCT01922713|maize|maize
4936187|NCT01922713|beta-carotene|beta-carotene
4936188|NCT01922713|breastmilk|breastmilk
4936189|NCT01922713|Zambia|zambia
4936190|NCT01922700|Pepper spray|pepper spray
4936191|NCT01922700|bronchospasm|bronchospasm
4936192|NCT01922700|lacrimation|lacrimation
4936193|NCT01922648|RSV|rsv
4936194|NCT01922648|Immune response|immune response
4936195|NCT01922648|Paediatric|paediatric
4936196|NCT01922635|Primary lymphedema quality of life, genetic research|primary lymphedema quality of life, genetic research
4936298|NCT01922167|Resistance Exercise|resistance exercise
4936197|NCT01922622|minimum effective dose of local anaesthetic|minimum effective dose of local anaesthetic
4936198|NCT01922622|spinal catheter|spinal catheter
4936199|NCT01922622|fractured neck of femur|fractured neck of femur
4936200|NCT01922622|a step up, step down methodology|a step up, step down methodology
4936201|NCT01922609|Carotid stenting|carotid stenting
4936202|NCT01922609|Proximal protection system|proximal protection system
4936203|NCT01922609|Transcranial Doppler ultrasound|transcranial doppler ultrasound
4936204|NCT01922609|Cerebrovascular reserve|cerebrovascular reserve
4936205|NCT01922596|Total Knee Arthroplasty|total knee arthroplasty
4936206|NCT01922596|Adductor Canal Blockade|adductor canal blockade
4936207|NCT01922596|Us-guided nerve blockade|us-guided nerve blockade
4936208|NCT01922583|NSCLC, EGFR mutation|nsclc, egfr mutation
4936209|NCT01922570|Enteral nutrition|enteral nutrition
4936210|NCT01922570|Supplemental parenteral nutrition|supplemental parenteral nutrition
4936211|NCT01922570|Critical illness|critical illness
4936212|NCT01922570|ICU patients|icu patients
4936213|NCT01922570|diarrhea|diarrhea
4936214|NCT01922544|heart failure|heart failure
4936215|NCT01922544|cardiac resynchronization therapy|cardiac resynchronization therapy
4936216|NCT01922544|coronary sinus lead|coronary sinus lead
4936217|NCT01922531|mTBI|mtbi
4936218|NCT01922531|Mild Traumatic Brain Injury|mild traumatic brain injury
4936219|NCT01922531|Axonal Injury|axonal injury
4936220|NCT01922518|atrioventricular block, cardiomyopathy|atrioventricular block, cardiomyopathy
4936221|NCT01922492|autologous islet transplantation|autologous islet transplantation
4936222|NCT01922492|partial pancreatectomy|partial pancreatectomy
4936223|NCT01922492|pancreatogenic diabetes|pancreatogenic diabetes
4936224|NCT01922479|Heart Failure|heart failure
4936225|NCT01922479|Anemia|anemia
4936226|NCT01922479|Iron Deficiency|iron deficiency
4936227|NCT01922479|Ferric Carboxymaltose|ferric carboxymaltose
4936228|NCT01922479|Asian|asian
4936229|NCT01922466|chronic neck pain|chronic neck pain
4936230|NCT01922466|combined treatment between conventional and complementary alternative medical treatment|combined treatment between conventional and complementary alternative medical treatment
4936231|NCT01922466|bee venom acupuncture|bee venom acupuncture
4936232|NCT01922466|NSAIDs|nsaids
4936233|NCT01922453|breech presentation|breech presentation
4936234|NCT01922453|vertex presentation|vertex presentation
4936235|NCT01922440|Chronic Hypoparathyroidism|chronic hypoparathyroidism
4936236|NCT01922440|rhPTH(1-84)|rhpth(1-84)
4936237|NCT01922440|Observational study|observational study
4936238|NCT01922440|parathyroid hormone (PTH)|parathyroid hormone (pth)
4936239|NCT01922440|Drug registry|drug registry
4936240|NCT01922414|Staghorn stones|staghorn stones
4936241|NCT01922414|Percutaneous nephrolithotomy|percutaneous nephrolithotomy
4936242|NCT01922414|Laser|laser
4936243|NCT01922414|Randomized trial|randomized trial
4936244|NCT01922414|Lithotripsy|lithotripsy
4936245|NCT01922388|Parkinson disease|parkinson disease
4936246|NCT01922388|deep brain stimulation|deep brain stimulation
4936247|NCT01922388|subthalamic nucleus|subthalamic nucleus
4936248|NCT01922388|motor complication|motor complication
4936249|NCT01922388|quality of life|quality of life
4936250|NCT01922362|STSG|stsg
4936251|NCT01922362|wound healing|wound healing
4936252|NCT01922336|Pharmacokinetics|pharmacokinetics
4936253|NCT01922323|Living liver donor|living liver donor
4936254|NCT01922297|Delinquency|delinquency
4936255|NCT01922297|HIV Associated Risk Behavior|hiv associated risk behavior
4936256|NCT01922297|Juveniles|juveniles
4936257|NCT01922297|Family based treatment|family based treatment
4936258|NCT01922297|Multidimensional Family Therapy|multidimensional family therapy
4936259|NCT01922284|HIV|hiv
4936260|NCT01922284|Vaccine|vaccine
4936261|NCT01922284|Immunisation|immunisation
4936262|NCT01922284|DNA|dna
4936263|NCT01922284|Adverse events|adverse events
4936264|NCT01922284|MVA-C|mva-c
4936265|NCT01922284|GLA-AF|gla-af
4936266|NCT01922284|Antibody|antibody
4936267|NCT01922271|COPD|copd
4936268|NCT01922258|OPC-34712|opc-34712
4936269|NCT01922258|brexpiprazole|brexpiprazole
4936270|NCT01922258|Dementia|dementia
4936271|NCT01922258|Alzheimer's Disease|alzheimer's disease
4936272|NCT01922258|Cognitive Disorders|cognitive disorders
4936273|NCT01922258|Memory|memory
4936274|NCT01922258|Agitation|agitation
4936275|NCT01922245|aphasia|aphasia
4936276|NCT01922245|therapy|therapy
4936277|NCT01922245|stroke|stroke
4936278|NCT01922245|language|language
4936279|NCT01922245|naming|naming
4936280|NCT01922245|quality of life|quality of life
4936281|NCT01922245|tDCS|tdcs
4936282|NCT01922245|treatment|treatment
4936283|NCT01922219|depression|depression
4936284|NCT01922219|cognitive therapy|cognitive therapy
4936285|NCT01922219|cognitive behavioral therapy|cognitive behavioral therapy
4936286|NCT01922219|CBT|cbt
4936287|NCT01922219|psychotherapy|psychotherapy
4936288|NCT01922219|MDD|mdd
4936289|NCT01922219|major depressive disorder|major depressive disorder
4936290|NCT01922219|MRI|mri
4936291|NCT01922219|fMRI|fmri
4936292|NCT01922206|HIV|hiv
4936293|NCT01922206|Maternal Disclosure|maternal disclosure
4936294|NCT01922180|Chest Computed Tomography|chest computed tomography
4936295|NCT01922167|Aging|aging
4936296|NCT01922167|Frailty|frailty
4936299|NCT01922154|Angiogenesis inhibitors|angiogenesis inhibitors
4936300|NCT01922154|Neovascular|neovascular
4936301|NCT01922154|Intraocular pressure|intraocular pressure
4936302|NCT01922154|Retinal Vein Occlusion|retinal vein occlusion
4936303|NCT01922154|Vascular Endothelial Growth Factor|vascular endothelial growth factor
4936304|NCT01922141|High blood pressure, stage 1 and 2 hypertension|high blood pressure, stage 1 and 2 hypertension
4936305|NCT01922128|Non-exudative, dry AMD|non-exudative, dry amd
4936306|NCT01922115|COGNITIVE FUNCTION|cognitive function
4936307|NCT01922115|OVERACTIVE BLADDER|overactive bladder
4936308|NCT01922115|[C23.888.942.343.780]|[c23.888.942.343.780]
4936309|NCT01922102|Pathologic myopia (PM), choroidal neovascularization (CNV), ranibizumab, verteporfin PDT, Brilliance|pathologic myopia (pm), choroidal neovascularization (cnv), ranibizumab, verteporfin pdt, brilliance
4936310|NCT01922089|Heart failure, reduced ejection fraction, LCZ696, titration, safety, tolerability|heart failure, reduced ejection fraction, lcz696, titration, safety, tolerability
4936311|NCT01922063|disc herniation surgery|disc herniation surgery
4936312|NCT01922063|physiotherapy, exercise therapy|physiotherapy, exercise therapy
4936313|NCT01922063|randomized|randomized
4936314|NCT01922063|long term|long term
4936315|NCT01922063|follow up|follow up
4936316|NCT01921972|AD, Dementia|ad, dementia
4936317|NCT01921946|Fimasartan|fimasartan
4936318|NCT01921933|End-stage renal disease|end-stage renal disease
4936319|NCT01921933|ESRD|esrd
4936320|NCT01921933|AVF|avf
4936321|NCT01921933|Fistulas|fistulas
4936322|NCT01921920|Omeprazole, Prilosec, Phase I, Healthy Subjects, Pharmacokinetics, Bioequivalence|omeprazole, prilosec, phase i, healthy subjects, pharmacokinetics, bioequivalence
4936323|NCT01921907|Actinic keratosis|actinic keratosis
4936324|NCT01921907|topical|topical
4936325|NCT01921907|dermatology|dermatology
4936326|NCT01921907|treatment|treatment
4936327|NCT01921907|clinical study|clinical study
4936328|NCT01921907|double blinded|double blinded
4936329|NCT01921894|asthma|asthma
4936330|NCT01921894|vitamin D|vitamin d
4936331|NCT01921881|Glucose tolerance|glucose tolerance
4936332|NCT01921829|Cardiorenal failure|cardiorenal failure
4936333|NCT01921829|Cardiorenal syndrome|cardiorenal syndrome
4936334|NCT01921829|Diuretic resistance|diuretic resistance
4936335|NCT01921829|Volume overload|volume overload
4936336|NCT01921829|Edema|edema
4936337|NCT01921829|Health-related quality of life|health-related quality of life
4936338|NCT01921829|Outcomes|outcomes
4936339|NCT01921829|Treatment protocol|treatment protocol
4936340|NCT01921790|Avastin+ GemAOD|avastin+ gemaod
4936341|NCT01921790|first line chemotherapy|first line chemotherapy
4936342|NCT01921790|NK/T-cell Lymphoma|nk/t-cell lymphoma
4936343|NCT01921777|Muscle|muscle
4936344|NCT01921777|exercise|exercise
4936345|NCT01921777|soreness|soreness
4936346|NCT01921777|Damage|damage
4936347|NCT01921777|Traumeel|traumeel
4936348|NCT01921777|homeopathy|homeopathy
4936349|NCT01921751|SMAD4|smad4
4936350|NCT01921751|IMRT|imrt
4936351|NCT01921751|gemcitabine|gemcitabine
4936352|NCT01921751|high-dose radiotherapy|high-dose radiotherapy
4936353|NCT01921738|Chronic Periodontitis, Azithromycin, SRP|chronic periodontitis, azithromycin, srp
4936354|NCT01921725|wound healing|wound healing
4936355|NCT01921725|carbon|carbon
4936356|NCT01921712|COPD|copd
4936357|NCT01921712|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
4936358|NCT01921699|macrophages|macrophages
4936359|NCT01921699|adenocarcinoma|adenocarcinoma
4936360|NCT01921699|chemoresistance|chemoresistance
4936361|NCT01921686|Eosinophil|eosinophil
4936362|NCT01921686|Reflux|reflux
4936363|NCT01921686|Esophagus|esophagus
4936364|NCT01921686|Food allergy|food allergy
4936365|NCT01921686|Trouble Swallowing|trouble swallowing
4936366|NCT01921686|Pediatrics|pediatrics
4936367|NCT01921686|Healthy Volunteers|healthy volunteers
4936368|NCT01921673|Gastric cancer|gastric cancer
4936369|NCT01921673|Phase I/II|phase i/ii
4936370|NCT01921673|Second-line chemotherapy|second-line chemotherapy
4936371|NCT01921673|Dovitinib|dovitinib
4936372|NCT01921673|Docetaxel|docetaxel
4936373|NCT01921673|Refractory to first-line chemotherapy|refractory to first-line chemotherapy
4936374|NCT01921647|safety/tolerability and pharmacokinetics/pharmacodynamics|safety/tolerability and pharmacokinetics/pharmacodynamics
4936375|NCT01921621|proficiency based progression|proficiency based progression
4936376|NCT01921621|surgical skill|surgical skill
4936377|NCT01921621|metric validation|metric validation
4936378|NCT01921621|formative feedback|formative feedback
4936379|NCT01921621|simulator model|simulator model
4936380|NCT01921608|Male Circumcision|male circumcision
4936381|NCT01921608|HIV Prevention|hiv prevention
4936382|NCT01921608|HIV Infections|hiv infections
4936383|NCT01921595|balanced salt colloid, coagulation profiles, spinal cord tumor|balanced salt colloid, coagulation profiles, spinal cord tumor
4936384|NCT01921543|Deep Brain Stimulation|deep brain stimulation
4936385|NCT01921543|Major Depressive Disorder|major depressive disorder
4936386|NCT01921543|Psychosurgery|psychosurgery
4936387|NCT01921543|Electrical stimulation|electrical stimulation
4936388|NCT01921530|Posterolateral Fusion|posterolateral fusion
4936389|NCT01921530|Interbody Fusion|interbody fusion
4936390|NCT01921530|Lumbar|lumbar
4936391|NCT01921530|Spinal Stenosis|spinal stenosis
4936392|NCT01921530|Degenerative Spondylolisthesis|degenerative spondylolisthesis
4936393|NCT01921517|Biomechanics|biomechanics
4936394|NCT01921517|Osteogenesis|osteogenesis
4936395|NCT01921504|Functional Dyspepsia|functional dyspepsia
4936396|NCT01921504|Acupuncture|acupuncture
4936397|NCT01921504|Genotype|genotype
4936398|NCT01921504|Ghrelin|ghrelin
4936399|NCT01921465|outpatient care|outpatient care
4936400|NCT01921465|videoconferencing|videoconferencing
4936401|NCT01921465|elective cesarean section|elective cesarean section
4936402|NCT01921452|Hypothyroidism|hypothyroidism
4936403|NCT01921452|Third generation TSH kit|third generation tsh kit
4936404|NCT01921452|Quantitative POC TSH kit|quantitative poc tsh kit
4936405|NCT01921452|Qualitative POC TSH kit|qualitative poc tsh kit
4936406|NCT01921439|smoking|smoking
4936407|NCT01921439|quit smoking|quit smoking
4936408|NCT01921439|smoking cessation|smoking cessation
4936409|NCT01921439|smoking study|smoking study
4936410|NCT01921439|secondhand smoke|secondhand smoke
4936411|NCT01921439|smokers|smokers
4936412|NCT01921426|Squamous Cell Carcinoma of the Head and Neck|squamous cell carcinoma of the head and neck
4936413|NCT01921426|Oral Cavity|oral cavity
4936414|NCT01921426|Oropharynx|oropharynx
4936415|NCT01921426|Radiation|radiation
4936416|NCT01921426|Chemotherapy|chemotherapy
4936417|NCT01921426|Cisplatin|cisplatin
4936418|NCT01921426|Oral Mucositis|oral mucositis
4936419|NCT01921426|Superoxide Dismutase|superoxide dismutase
4936420|NCT01921413|Plasmodium falciparum|plasmodium falciparum
4936421|NCT01921413|Clinical Malaria|clinical malaria
4936422|NCT01921413|Fever|fever
4936423|NCT01921413|Schistosoma hematobium|schistosoma hematobium
4936424|NCT01921413|Rheumatoid arthritis|rheumatoid arthritis
4936425|NCT01921400|Hepatitis C (HCV)|hepatitis c (hcv)
4936426|NCT01921400|Infection Transmission, Maternal-Fetal|infection transmission, maternal-fetal
4936427|NCT01921400|Placenta|placenta
4936428|NCT01921400|Trophoblast|trophoblast
4936429|NCT01921374|Duchenne;|duchenne;
4936430|NCT01921374|mothers caregivers;|mothers caregivers;
4936431|NCT01921374|sleep;|sleep;
4936432|NCT01921374|hormonal profile;|hormonal profile;
4936433|NCT01921374|cardiac profile;|cardiac profile;
4936434|NCT01921374|biochemical profile;|biochemical profile;
4936435|NCT01921374|inflammatory profile.|inflammatory profile.
4936436|NCT01921361|Shivering|shivering
4936437|NCT01921361|Dexmedetomidine|dexmedetomidine
4936438|NCT01921361|Spinal anesthesia|spinal anesthesia
4936439|NCT01921348|Hay Fever|hay fever
4936440|NCT01921348|Hayfever|hayfever
4936441|NCT01921348|Pollen Allergy|pollen allergy
4936442|NCT01921348|Pollinosis|pollinosis
4936443|NCT01921348|Seasonal Allergic Rhinitis|seasonal allergic rhinitis
4936444|NCT01921335|ARRY-380|arry-380
4936445|NCT01921335|Trastuzumab|trastuzumab
4936446|NCT01921335|Advanced HER2-positive breast cancer|advanced her2-positive breast cancer
4936447|NCT01921309|osteoarthritis|osteoarthritis
4936448|NCT01921309|avascular necrosis|avascular necrosis
4936449|NCT01921309|rheumatoid arthritis|rheumatoid arthritis
4936450|NCT01921309|correction of functional deformity|correction of functional deformity
4936451|NCT01921309|dysplasia of the hip|dysplasia of the hip
4936452|NCT01921296|Breast cancer|breast cancer
4936453|NCT01921296|Aromatase inhibitor|aromatase inhibitor
4936454|NCT01921283|propofol, endoscopy, bispectral index|propofol, endoscopy, bispectral index
4936455|NCT01921270|Oromandibular Dystonia|oromandibular dystonia
4936456|NCT01921270|Oral Dystonia|oral dystonia
4936457|NCT01921270|Tardive Dystonia|tardive dystonia
4936458|NCT01921270|botulinum toxin|botulinum toxin
4936459|NCT01921270|abobotulinumtoxinA|abobotulinumtoxina
4936460|NCT01921257|Cat Allergy|cat allergy
4936461|NCT01921257|Rhinoconjunctivitis|rhinoconjunctivitis
4936462|NCT01921244|Autistic Disorder|autistic disorder
4936463|NCT01921244|Decision Making|decision making
4936464|NCT01921244|Medication Therapy Management|medication therapy management
4936465|NCT01921218|Kidney transplant|kidney transplant
4936466|NCT01921205|Lacosamide|lacosamide
4936467|NCT01921205|Vimpat|vimpat
4936468|NCT01921205|UCB|ucb
4936469|NCT01921205|Epilepsy|epilepsy
4936470|NCT01921205|Partial Onset Seizures|partial onset seizures
4936471|NCT01921205|Pediatric|pediatric
4936472|NCT01921179|Post Traumatic Stress Disorder,|post traumatic stress disorder,
4936473|NCT01921179|Mild Traumatic Brain Injury|mild traumatic brain injury
4936474|NCT01921179|Concussion|concussion
4936475|NCT01921179|Cognitive Rehabilitation|cognitive rehabilitation
4936476|NCT01921166|infertility|infertility
4936477|NCT01921166|diminished ovarian reserve|diminished ovarian reserve
4936478|NCT01921166|fertilization in vitro|fertilization in vitro
4936479|NCT01921166|ovulation inducion|ovulation inducion
4936480|NCT01921166|vitrification|vitrification
4936481|NCT01921140|Oncology, cancer, tumour, neoplasm, anticancer drug, food, area under the curve, pharmacokinetics, olaparib, neoplasm, metabolites, QT interval effects|oncology, cancer, tumour, neoplasm, anticancer drug, food, area under the curve, pharmacokinetics, olaparib, neoplasm, metabolites, qt interval effects
4936482|NCT01921127|COPD, Comparative effectiveness, Symbicort|copd, comparative effectiveness, symbicort
4936483|NCT01921101|nutrition|nutrition
4936484|NCT01921101|enteral feeding|enteral feeding
4936485|NCT01921101|parenteral feeding|parenteral feeding
4936486|NCT01921101|hospital malnutrition|hospital malnutrition
4936487|NCT01921088|fMRI|fmri
4936488|NCT01921088|Neurofeedback|neurofeedback
4936489|NCT01921088|Blood pressure|blood pressure
4936490|NCT01921088|Psychophysiology|psychophysiology
4936491|NCT01921075|physiology, normal function|physiology, normal function
4936492|NCT01921062|Distal radius fracture|distal radius fracture
4936493|NCT01921062|Motor imagery|motor imagery
4936494|NCT01921062|Immobilisation|immobilisation
4936495|NCT01921062|Effectivity|effectivity
4936496|NCT01921023|Blood Gas analysis|blood gas analysis
4936497|NCT01920997|Healthy|healthy
4936498|NCT01920997|normal menstrual cycles|normal menstrual cycles
4936499|NCT01920971|chronic low back pain|chronic low back pain
4936500|NCT01920971|infrared energy|infrared energy
4936501|NCT01920971|effects|effects
4936502|NCT01920932|Pediatric cancer|pediatric cancer
4936503|NCT01920932|Hodgkin lymphoma|hodgkin lymphoma
4936504|NCT01920932|Targeted therapy|targeted therapy
4936505|NCT01920932|Frontline therapy|frontline therapy
4936506|NCT01920932|Brentuximab vedotin|brentuximab vedotin
4936507|NCT01920932|Quality of Life|quality of life
4936508|NCT01920932|OEPA/COPDac|oepa/copdac
4936509|NCT01920906|Psoriasis|psoriasis
4936510|NCT01920906|Korean|korean
4936511|NCT01920906|Healthy Volunteers|healthy volunteers
4936512|NCT01920880|Anterior cutaneous nerve entrapment syndrome|anterior cutaneous nerve entrapment syndrome
4936513|NCT01920880|ACNES|acnes
4936514|NCT01920880|chronic abdominal wall pain|chronic abdominal wall pain
4936515|NCT01920880|CAWP|cawp
4936516|NCT01920867|Stem Cells|stem cells
4936517|NCT01920867|Bone Marrow Derived Stem Cells|bone marrow derived stem cells
4936518|NCT01920867|BMSC|bmsc
4936519|NCT01920867|BMC (Bone Marrow Cell)|bmc (bone marrow cell)
4936520|NCT01920867|Mesenchymal Stem Cells|mesenchymal stem cells
4936521|NCT01920867|MSC|msc
4936522|NCT01920867|Eye Disease|eye disease
4936523|NCT01920867|Eye Stem Cells|eye stem cells
4936524|NCT01920867|Ophthalmology|ophthalmology
4936525|NCT01920867|Ophthalmic Disease|ophthalmic disease
4936526|NCT01920867|Retina|retina
4936527|NCT01920867|Retinal Disease|retinal disease
4936528|NCT01920867|Macular Degeneration|macular degeneration
4936529|NCT01920867|Age Related Macular Degeneration|age related macular degeneration
4936530|NCT01920867|Myopic Macular Degeneration|myopic macular degeneration
4936531|NCT01920867|Geographic Atrophy|geographic atrophy
4936532|NCT01920867|Dry Macular Degeneration|dry macular degeneration
4936533|NCT01920867|Wet Macular Degeneration|wet macular degeneration
4936534|NCT01920867|Retinal Atrophy|retinal atrophy
4936535|NCT01920867|Retinal Dystrophy|retinal dystrophy
4936536|NCT01920867|Hereditary Retinal Dystrophy|hereditary retinal dystrophy
4936537|NCT01920867|Retinitis Pigmentosa|retinitis pigmentosa
4936538|NCT01920867|Stargardt Disease|stargardt disease
4936539|NCT01920867|Cone Dystrophy|cone dystrophy
4936540|NCT01920867|Cone Rod Dystrophy|cone rod dystrophy
4936541|NCT01920867|Maculopathy|maculopathy
4936542|NCT01920867|Optic Nerve Disease|optic nerve disease
4936543|NCT01920867|Optic Nerve Atrophy|optic nerve atrophy
4936544|NCT01920867|Optic Atrophy|optic atrophy
4936545|NCT01920867|Ischemic Optic Neuropathy|ischemic optic neuropathy
4936546|NCT01920867|Optic Nerve Damage|optic nerve damage
4936547|NCT01920867|Optic Nerve Compression|optic nerve compression
4936548|NCT01920867|Compressive Optic Neuropathy|compressive optic neuropathy
4936549|NCT01920867|Devics Syndrome|devics syndrome
4936550|NCT01920854|Soluble Ferric Pyrophosphate, Pharmacokinetics, Iron, Hemodialysis|soluble ferric pyrophosphate, pharmacokinetics, iron, hemodialysis
4936551|NCT01920841|lipolytic|lipolytic
4936552|NCT01920841|herbal extracts|herbal extracts
4936553|NCT01920841|thigh girth|thigh girth
4936554|NCT01920841|thigh smoothness|thigh smoothness
4936555|NCT01920789|Non-small call lung cancer|non-small call lung cancer
4936556|NCT01920789|Medically inoperable|medically inoperable
4936557|NCT01920789|Stage one|stage one
4936558|NCT01920789|Radiotherapy|radiotherapy
4936559|NCT01920789|SBRT|sbrt
4936560|NCT01920789|Hypofractionation|hypofractionation
4936561|NCT01920789|Conventional fractionation|conventional fractionation
4936562|NCT01920776|critical ultrasound|critical ultrasound
4936563|NCT01920763|Intracerebral hemorrhage|intracerebral hemorrhage
4936564|NCT01920763|Surgical evacuation|surgical evacuation
4936565|NCT01920763|Minimally-invasive surgery|minimally-invasive surgery
4936566|NCT01920750|Leprosy, skin test, MLSA-LAM, MLCwA, diagnosis, Protocol 98-202|leprosy, skin test, mlsa-lam, mlcwa, diagnosis, protocol 98-202
4936567|NCT01920737|ALL|all
4936568|NCT01920737|Bone Marrow|bone marrow
4936569|NCT01920737|Ph Negative|ph negative
4936570|NCT01920737|Daunorubicin|daunorubicin
4936571|NCT01920737|Vincristine|vincristine
4936572|NCT01920737|Prednisone|prednisone
4936573|NCT01920737|PEG-Asparaginase|peg-asparaginase
4936574|NCT01920737|Methotrexate|methotrexate
4936575|NCT01920737|16-MP (6-Mercaptopurine)|16-mp (6-mercaptopurine)
4936576|NCT01920737|Cyclophosphamide|cyclophosphamide
4936577|NCT01920737|Cytarabine|cytarabine
4936578|NCT01920737|Leucovorin|leucovorin
4936579|NCT01920737|Dexamethasone|dexamethasone
4936580|NCT01920737|12-266|12-266
4936581|NCT01920724|Preschool children|preschool children
4936582|NCT01920724|Body composition|body composition
4936583|NCT01920711|Heart failure|heart failure
4936584|NCT01920711|preserved ejection fraction|preserved ejection fraction
4936585|NCT01920711|diastolic heart failure|diastolic heart failure
4936688|NCT01920321|COPD|copd
4936586|NCT01920698|Heart Valve Diseases|heart valve diseases
4936587|NCT01920698|Heart failure|heart failure
4936588|NCT01920698|Heart diseases|heart diseases
4936589|NCT01920698|Mitral valve insufficiency|mitral valve insufficiency
4936590|NCT01920685|Paranoia|paranoia
4936591|NCT01920685|CBT|cbt
4936592|NCT01920685|Reasoning|reasoning
4936593|NCT01920685|Anxiety|anxiety
4936594|NCT01920659|High Intensity Training|high intensity training
4936595|NCT01920659|Insulin sensitivity|insulin sensitivity
4936596|NCT01920659|Fitness|fitness
4936597|NCT01920620|obesity, inpatient, intervention, weight loss|obesity, inpatient, intervention, weight loss
4936598|NCT01920607|Fecal Incontinence.|fecal incontinence.
4936599|NCT01920607|Anal Incontinence.|anal incontinence.
4936600|NCT01920607|Functional Bowel Disorders.|functional bowel disorders.
4936601|NCT01920607|SNS.|sns.
4936602|NCT01920607|Artificial Sphincters.|artificial sphincters.
4936603|NCT01920607|Magnetic Anal Sphincter.|magnetic anal sphincter.
4936604|NCT01920594|GSK1278863|gsk1278863
4936605|NCT01920594|Thoracic Aortic Aneurysm Repair|thoracic aortic aneurysm repair
4936606|NCT01920581|CEIP|ceip
4936607|NCT01920581|pharmacodependance|pharmacodependance
4936608|NCT01920581|addictovigilance|addictovigilance
4936609|NCT01920581|benzodiazepines and benzodiazepines related drugs|benzodiazepines and benzodiazepines related drugs
4936610|NCT01920581|elderly|elderly
4936611|NCT01920568|GSK2371746|gsk2371746
4936612|NCT01920568|Denosumab|denosumab
4936613|NCT01920568|China|china
4936614|NCT01920568|skeletal-related events|skeletal-related events
4936615|NCT01920568|bone metastases|bone metastases
4936616|NCT01920568|bridging study|bridging study
4936617|NCT01920568|solid tumors|solid tumors
4936618|NCT01920555|Depression|depression
4936619|NCT01920555|Treatment Resistant Depression|treatment resistant depression
4936620|NCT01920555|Ketamine|ketamine
4936621|NCT01920555|Antidepressant|antidepressant
4936622|NCT01920555|MDD|mdd
4936623|NCT01920555|Major Depression|major depression
4936624|NCT01920529|asthma, aerobic exercise, child, cytokines|asthma, aerobic exercise, child, cytokines
4936625|NCT01920516|Isolated limb infusion|isolated limb infusion
4936626|NCT01920516|Melphalan|melphalan
4936627|NCT01920516|Limb Melanoma|limb melanoma
4936628|NCT01920516|Tumor response|tumor response
4936629|NCT01920503|cholangiocarcinoma|cholangiocarcinoma
4936630|NCT01920503|transarterial chemoembolization|transarterial chemoembolization
4936631|NCT01920503|doxorubicin|doxorubicin
4936632|NCT01920503|tumor response|tumor response
4936633|NCT01920477|Pemphigus|pemphigus
4936634|NCT01920477|(MAB)|(mab)
4936635|NCT01920477|autoimmune disorder|autoimmune disorder
4936636|NCT01920477|human CD20 antigen|human cd20 antigen
4936637|NCT01920477|subcutaneous|subcutaneous
4936638|NCT01920477|Pemphigus vulgaris|pemphigus vulgaris
4936639|NCT01920477|Phase 3|phase 3
4936640|NCT01920477|monoclonal antibody|monoclonal antibody
4936641|NCT01920477|ofatumumab|ofatumumab
4936642|NCT01920477|PV|pv
4936643|NCT01920477|rare disease|rare disease
4936644|NCT01920451|sleep|sleep
4936645|NCT01920451|insomnia|insomnia
4936646|NCT01920451|posttraumatic stress disorder|posttraumatic stress disorder
4936647|NCT01920451|hypertension|hypertension
4936648|NCT01920451|cardiovascular disease|cardiovascular disease
4936649|NCT01920438|Percutaneous endoscopic gastrostomy,|percutaneous endoscopic gastrostomy,
4936650|NCT01920438|Radiologically inserted gastrostomy,|radiologically inserted gastrostomy,
4936651|NCT01920438|Complications|complications
4936652|NCT01920425|Parkinson's disease|parkinson's disease
4936653|NCT01920425|dyskinesia|dyskinesia
4936654|NCT01920425|fluctuations|fluctuations
4936655|NCT01920425|tremor|tremor
4936656|NCT01920425|bradykinesia|bradykinesia
4936657|NCT01920425|levodopa|levodopa
4936658|NCT01920412|Atrial fibrillation|atrial fibrillation
4936659|NCT01920412|Thrombosis|thrombosis
4936660|NCT01920412|Ischemic stroke|ischemic stroke
4936661|NCT01920412|Left atrial appendage occluder|left atrial appendage occluder
4936662|NCT01920412|Intervention method|intervention method
4936663|NCT01920399|CAZ-AVI China phase I PK study|caz-avi china phase i pk study
4936664|NCT01920386|Acute Toothache|acute toothache
4936665|NCT01920386|Wontran|wontran
4936666|NCT01920386|Wontran SR Tab.|wontran sr tab.
4936667|NCT01920386|Tramadol Hydrochloride/Acetaminophen|tramadol hydrochloride/acetaminophen
4936668|NCT01920373|degenerative joint disease|degenerative joint disease
4936669|NCT01920373|temporomandibular joint|temporomandibular joint
4936670|NCT01920360|KNEE OSTEOARTHRITIS|knee osteoarthritis
4936671|NCT01920360|BALNEOTHERAPY|balneotherapy
4936672|NCT01920360|SULPHUROUS WATERS|sulphurous waters
4936673|NCT01920360|WOMAC|womac
4936674|NCT01920360|LEQUESNE|lequesne
4936675|NCT01920360|HEALTH ASSESSMENT QUESTIONNAIRE|health assessment questionnaire
4936676|NCT01920360|SHORT FORM - 36|short form - 36
4936678|NCT01920347|hypoxic encephalopathy|hypoxic encephalopathy
4936679|NCT01920347|cardiac arrest|cardiac arrest
4936680|NCT01920347|outcome|outcome
4936681|NCT01920347|pupillary reflex|pupillary reflex
4936682|NCT01920334|coronary disease|coronary disease
4936683|NCT01920334|heart diseases|heart diseases
4936684|NCT01920334|enzymes|enzymes
4936685|NCT01920334|sleep|sleep
4936686|NCT01920334|troponin|troponin
4936687|NCT01920334|zolpidem|zolpidem
4936689|NCT01920321|Bronchoscopic LVR|bronchoscopic lvr
4936690|NCT01920321|Emphysema|emphysema
4936691|NCT01920321|Hot injury|hot injury
4936692|NCT01920269|non-muscle invasive bladder cancer|non-muscle invasive bladder cancer
4936693|NCT01920269|intravesical chemotherapy|intravesical chemotherapy
4936694|NCT01920269|mitomycin|mitomycin
4936695|NCT01920269|passive diffusion|passive diffusion
4936696|NCT01920269|electromotive drug administration|electromotive drug administration
4936697|NCT01920256|Insulin therapy|insulin therapy
4936698|NCT01920256|Type 2 diabetes|type 2 diabetes
4936699|NCT01920243|Telemedicine|telemedicine
4936700|NCT01920243|self-management|self-management
4936701|NCT01920243|Medical psychology|medical psychology
4936702|NCT01920243|Health psychology|health psychology
4936703|NCT01920243|Rehabilitation|rehabilitation
4936704|NCT01920243|Education, Health|education, health
4936705|NCT01920230|Burnout|burnout
4936706|NCT01920230|Stress|stress
4936707|NCT01920230|Mindfulness|mindfulness
4936708|NCT01920230|Acceptance-commitment therapy (ACT)|acceptance-commitment therapy (act)
4936709|NCT01920230|Intervention|intervention
4936710|NCT01920230|Effectiveness|effectiveness
4936711|NCT01920230|Working conditions|working conditions
4936712|NCT01920230|Work engagement|work engagement
4936713|NCT01920230|Psychological well-being|psychological well-being
4936714|NCT01920230|Life situation|life situation
4936715|NCT01920217|sepsis|sepsis
4936716|NCT01920217|SNP|snp
4936717|NCT01920217|mortality|mortality
4936718|NCT01920204|Mastocytosis|mastocytosis
4936719|NCT01920204|ISM|ism
4936720|NCT01920204|SSM|ssm
4936721|NCT01920191|Glioblastoma|glioblastoma
4936722|NCT01920165|respiratory tract infections|respiratory tract infections
4936723|NCT01920165|upper respiratory tract infections|upper respiratory tract infections
4936724|NCT01920165|lower respiratory tract infections|lower respiratory tract infections
4936725|NCT01920165|hospitalisation|hospitalisation
4936726|NCT01920165|child|child
4936727|NCT01920165|children|children
4936728|NCT01920165|minors|minors
4936729|NCT01920165|infants|infants
4936730|NCT01920165|second-hand smoke|second-hand smoke
4936731|NCT01920165|tobacco smoke pollution|tobacco smoke pollution
4936732|NCT01920165|smoke-free|smoke-free
4936733|NCT01920165|smoke-free policy|smoke-free policy
4936734|NCT01920165|smoke-free legislation|smoke-free legislation
4936735|NCT01920165|public places|public places
4936736|NCT01920152|Hip, Chondropenia, Osteoarthritis.|hip, chondropenia, osteoarthritis.
4936737|NCT01920126|sodium bicarbonate, renal function, infective endocarditis, open heart surgery|sodium bicarbonate, renal function, infective endocarditis, open heart surgery
4936738|NCT01920113|Endoscopic submucosal dissection|endoscopic submucosal dissection
4936739|NCT01920113|propofol|propofol
4936740|NCT01920113|remifentanil|remifentanil
4936741|NCT01920113|dexmedetomidine|dexmedetomidine
4936742|NCT01920113|efficacy|efficacy
4936743|NCT01920113|safeness|safeness
4936744|NCT01920100|Health Care Costs|health care costs
4936745|NCT01920100|Genetic Polymorphism|genetic polymorphism
4936746|NCT01920087|Atypical Facial Pain|atypical facial pain
4936747|NCT01920087|Persistent Idiopathic Facial Pain|persistent idiopathic facial pain
4936748|NCT01920087|Atypical Trigeminal Neuralgia|atypical trigeminal neuralgia
4936749|NCT01920087|Orofacial Pain|orofacial pain
4936750|NCT01920087|Orofacial neuropathic pain|orofacial neuropathic pain
4936751|NCT01920087|Fothergill Disease|fothergill disease
4936752|NCT01920087|Tic Douloureux|tic douloureux
4936753|NCT01920087|Prosopalgia|prosopalgia
4936754|NCT01920074|Anal Fissure|anal fissure
4936755|NCT01920074|Nitroglycerin|nitroglycerin
4936756|NCT01920074|Pediatrics|pediatrics
4936757|NCT01920074|RECTIV®|rectiv®
4936758|NCT01920074|Pediatric Research Equity Act|pediatric research equity act
4936759|NCT01920061|Advanced cancer|advanced cancer
4936760|NCT01920061|solid tumors|solid tumors
4936761|NCT01920061|PI3K|pi3k
4936762|NCT01920061|mTOR|mtor
4936763|NCT01920061|PI3K/mTOR|pi3k/mtor
4936764|NCT01920061|metastatic|metastatic
4936765|NCT01920061|Triple Negative Breast Cancer (TNBC)|triple negative breast cancer (tnbc)
4936766|NCT01920048|Heart Failure|heart failure
4936767|NCT01920048|Ventricular Dysfunction|ventricular dysfunction
4936768|NCT01920048|Ischemic Cardiomyopathy|ischemic cardiomyopathy
4936769|NCT01920048|Ischemic Heart Disease|ischemic heart disease
4936770|NCT01920048|Revascularization|revascularization
4936771|NCT01920048|Percutaneous Coronary Intervention|percutaneous coronary intervention
4936772|NCT01920048|Randomized Control Trial|randomized control trial
4936773|NCT01920048|Implantable Cardioverter Defibrillator|implantable cardioverter defibrillator
4936774|NCT01920035|Incontinence post RARP|incontinence post rarp
4936775|NCT01920035|Surgery induced incontinence|surgery induced incontinence
4936776|NCT01920035|Incontinence after prostatectomy|incontinence after prostatectomy
4936777|NCT01920035|Neuropathy-induced incontinence|neuropathy-induced incontinence
4936778|NCT01920022|medical abortion|medical abortion
4936779|NCT01920022|postabortion contraception|postabortion contraception
4936780|NCT01920022|LARC|larc
4936781|NCT01920022|Nexplanon|nexplanon
4936782|NCT01920022|subdermal contraceptive implant|subdermal contraceptive implant
4936783|NCT01920009|pharmacy care|pharmacy care
4936784|NCT01920009|adherence|adherence
4936785|NCT01920009|coronary heart disease|coronary heart disease
4936786|NCT01919996|Ocular safety|ocular safety
4936787|NCT01919996|azithromycin|azithromycin
4936788|NCT01919996|pharyngitis|pharyngitis
4936789|NCT01919996|tonsillitis|tonsillitis
4936790|NCT01919983|cardiac|cardiac
4936791|NCT01919983|innervation|innervation
4936792|NCT01919983|inflammation|inflammation
4936793|NCT01919983|sudden|sudden
4936794|NCT01919983|death|death
4936795|NCT01919970|Autism|autism
4936796|NCT01919970|Asperger's Syndrome|asperger's syndrome
4936797|NCT01919970|Pervasive Developmental Disorder Not Otherwise Specified|pervasive developmental disorder not otherwise specified
4936798|NCT01919970|Treatment|treatment
4936799|NCT01919970|Cognitive-behavioral therapy|cognitive-behavioral therapy
4936800|NCT01919970|Anxiety|anxiety
4936801|NCT01919970|Children|children
4936802|NCT01919970|Therapy|therapy
4936803|NCT01919970|Generalized Anxiety Disorder|generalized anxiety disorder
4936804|NCT01919970|Social Phobia|social phobia
4936805|NCT01919970|Separation Anxiety Disorder|separation anxiety disorder
4936806|NCT01919970|Obsessive-compulsive Disorder|obsessive-compulsive disorder
4936807|NCT01919970|Specific Phobia|specific phobia
4936808|NCT01919957|epilepsy|epilepsy
4936809|NCT01919957|surgery|surgery
4936810|NCT01919957|functional MRI|functional mri
4936811|NCT01919957|memory outcome|memory outcome
4936812|NCT01919944|itch|itch
4936813|NCT01919931|Candida albicans|candida albicans
4936814|NCT01919931|Candidiasis|candidiasis
4936815|NCT01919931|Biofilm|biofilm
4936816|NCT01919931|Flow cytometry|flow cytometry
4936817|NCT01919931|Mannose Binding Lectin|mannose binding lectin
4936818|NCT01919905|Mozzarella cheese fortification|mozzarella cheese fortification
4936819|NCT01919905|Bioavailability of Vitamin D|bioavailability of vitamin d
4936820|NCT01919892|predictors of response|predictors of response
4936821|NCT01919892|bipolar disorder|bipolar disorder
4936822|NCT01919892|depression|depression
4936823|NCT01919892|lithium treatment|lithium treatment
4936824|NCT01919892|biomarkers|biomarkers
4936825|NCT01919879|Chemotherapy refractory|chemotherapy refractory
4936826|NCT01919879|wtKRAS metastatic colorectal cancer|wtkras metastatic colorectal cancer
4936827|NCT01919879|cross over|cross over
4936828|NCT01919853|Cancer|cancer
4936829|NCT01919853|Fatigue|fatigue
4936830|NCT01919853|Mindfulness|mindfulness
4936831|NCT01919853|Meditation|meditation
4936832|NCT01919853|Neoplasms|neoplasms
4936833|NCT01919853|Signs and symptoms|signs and symptoms
4936834|NCT01919840|hemostatic disorders|hemostatic disorders
4936835|NCT01919840|ardiac surgery|ardiac surgery
4936836|NCT01919840|cardiopulmonary bypass|cardiopulmonary bypass
4936837|NCT01919827|Idiopathic pulmonary fibrosis|idiopathic pulmonary fibrosis
4936838|NCT01919827|Stem cells|stem cells
4936839|NCT01919827|Mesenchymal stem cells|mesenchymal stem cells
4936840|NCT01919801|ACE-I|ace-i
4936841|NCT01919801|Firazyr|firazyr
4936842|NCT01919801|icatibant|icatibant
4936843|NCT01919788|Diabetes Mellitus Type I|diabetes mellitus type i
4936844|NCT01919788|Hypoglycemia|hypoglycemia
4936845|NCT01919788|Counter-regulatory mechanisms|counter-regulatory mechanisms
4936846|NCT01919762|Bacteremia|bacteremia
4936847|NCT01919762|Sepsis|sepsis
4936848|NCT01919762|Acinetobacter baumannii|acinetobacter baumannii
4936849|NCT01919762|Staphylococcus aureus|staphylococcus aureus
4936850|NCT01919762|Klebsiella pneumonia|klebsiella pneumonia
4936851|NCT01919762|Pseudomonas aeruginosa|pseudomonas aeruginosa
4936852|NCT01919762|Enterococcus faecalis|enterococcus faecalis
4936853|NCT01919762|Magnetic Relaxation Detection|magnetic relaxation detection
4936854|NCT01919762|Nuclear Magnetic Resonance Detection|nuclear magnetic resonance detection
4936855|NCT01919762|Blood culture|blood culture
4936856|NCT01919749|breast cancer metastatic|breast cancer metastatic
4936857|NCT01919749|molecular profiling|molecular profiling
4936858|NCT01919749|sequencing|sequencing
4936859|NCT01919749|profiling|profiling
4936860|NCT01919749|breast cancer|breast cancer
4936861|NCT01919736|knee OA|knee oa
4936863|NCT01919723|Ticagrelor|ticagrelor
4936864|NCT01919723|Eptifibatide|eptifibatide
4936865|NCT01919710|Neutropenia|neutropenia
4936866|NCT01919710|chemotherapy|chemotherapy
4936867|NCT01919710|rHSA/GCSF|rhsa/gcsf
4936868|NCT01919697|Plecantaide|plecantaide
4936869|NCT01919697|Chronic Idiopathic Constipation|chronic idiopathic constipation
4936870|NCT01919697|Chronic|chronic
4936871|NCT01919697|Idiopathic|idiopathic
4936872|NCT01919697|Constipation|constipation
4936873|NCT01919697|Synergy|synergy
4936874|NCT01919697|CIC|cic
4936875|NCT01919697|CIC study|cic study
4936876|NCT01919697|CIC OLE|cic ole
4936877|NCT01919697|CIC OLE study|cic ole study
4936878|NCT01919697|OLE|ole
4936879|NCT01919697|OLE CIC|ole cic
4936880|NCT01919697|OLE CIC3|ole cic3
4936881|NCT01919697|Open label|open label
4936882|NCT01919697|Open label study|open label study
4936883|NCT01919697|Long term|long term
4936884|NCT01919697|Long term study|long term study
4936885|NCT01919697|Extension|extension
4936886|NCT01919697|Extension study|extension study
4936887|NCT01919684|Glucagon receptor antagonist|glucagon receptor antagonist
4936888|NCT01919671|Ischemic Stroke|ischemic stroke
4936889|NCT01919671|Tongxinluo capsule|tongxinluo capsule
4936890|NCT01919658|nerve blocks in Anterior cruciate ligament surgery|nerve blocks in anterior cruciate ligament surgery
4936891|NCT01919645|Rheumatoid Arthritis|rheumatoid arthritis
4936892|NCT01919645|Sleep Disorders|sleep disorders
4936893|NCT01919645|Polysomnography|polysomnography
4936894|NCT01919645|Sleep Stages|sleep stages
4936895|NCT01919645|Physical Exercise|physical exercise
4936896|NCT01919632|lifestyle|lifestyle
4936897|NCT01919632|physical activity|physical activity
4936898|NCT01919632|endothelial function|endothelial function
4936899|NCT01919632|cardiovascular|cardiovascular
4936900|NCT01919632|occupational|occupational
4936901|NCT01919632|prevention|prevention
4936902|NCT01919619|Blood And Marrow Transplantation|blood and marrow transplantation
4936903|NCT01919619|Leukemia|leukemia
4936904|NCT01919619|Lymphoma|lymphoma
4936905|NCT01919619|Allogeneic stem cell transplant|allogeneic stem cell transplant
4936906|NCT01919619|Autologous stem cell transplant|autologous stem cell transplant
4936907|NCT01919619|SCT|sct
4936908|NCT01919619|Lenalidomide CC-5013|lenalidomide cc-5013
4936909|NCT01919619|Revlimid|revlimid
4936910|NCT01919619|Ipilimumab|ipilimumab
4936911|NCT01919619|Yervoy|yervoy
4936912|NCT01919619|BMS-734016|bms-734016
4936913|NCT01919619|MDX010|mdx010
4936914|NCT01919606|hysterectomy|hysterectomy
4936915|NCT01919606|analgesia|analgesia
4936916|NCT01919593|Blood culture|blood culture
4936917|NCT01919593|Contamination|contamination
4936918|NCT01919593|Chlorhexidine gluconate|chlorhexidine gluconate
4936919|NCT01919593|Povidone iodine|povidone iodine
4936920|NCT01919580|Gα12|gα12
4936921|NCT01919580|Oral cancer|oral cancer
4936922|NCT01919567|SOX-9|sox-9
4936923|NCT01919567|Oral cancer|oral cancer
4936924|NCT01919567|arecoline|arecoline
4936925|NCT01919554|House Dust Mite Allergic Rhinitis|house dust mite allergic rhinitis
4936926|NCT01919554|Phase I|phase i
4936927|NCT01919554|House Dust Mite Allergen Extract|house dust mite allergen extract
4936928|NCT01919541|Colorectal Surgery|colorectal surgery
4936929|NCT01919528|ultrasonography|ultrasonography
4936930|NCT01919528|catheterization|catheterization
4936931|NCT01919528|central line|central line
4936932|NCT01919528|mechanical ventilation|mechanical ventilation
4936933|NCT01919528|intensive care|intensive care
4936934|NCT01919528|axillary vein|axillary vein
4936935|NCT01919515|pediatric|pediatric
4936936|NCT01919515|primary molars|primary molars
4936937|NCT01919515|stainless steel crowns|stainless steel crowns
4936938|NCT01919489|Incretins|incretins
4936939|NCT01919489|Liraglutide|liraglutide
4936940|NCT01919489|Glargine|glargine
4936941|NCT01919489|Randomized controlled trial|randomized controlled trial
4936942|NCT01919489|basal insulin|basal insulin
4936943|NCT01919489|hospital discharge|hospital discharge
4936944|NCT01919489|inpatient diabetes|inpatient diabetes
4936945|NCT01919476|Postprandial|postprandial
4936946|NCT01919476|Insulin resistance|insulin resistance
4936947|NCT01919476|Lipids|lipids
4936948|NCT01919476|Satiety|satiety
4936949|NCT01919476|Almonds|almonds
4936950|NCT01919463|Colonoscopy|colonoscopy
4936951|NCT01919463|Lower Gastrointestinal Tract|lower gastrointestinal tract
4936952|NCT01919463|Magnetic Endoscopic Imaging|magnetic endoscopic imaging
4936953|NCT01919463|Abdominal Compression|abdominal compression
4936954|NCT01919450|PET|pet
4936955|NCT01919450|Lexiscan|lexiscan
4936956|NCT01919450|Regadenoson|regadenoson
4936957|NCT01919450|Rubidium|rubidium
4936958|NCT01919450|Blood Flow Reserve|blood flow reserve
4936959|NCT01919450|Myocardial Perfusion|myocardial perfusion
4936960|NCT01919450|Quantitated Myocardial Perfusion|quantitated myocardial perfusion
4936961|NCT01919411|Chronic rhinosinusitis|chronic rhinosinusitis
4936962|NCT01919411|Sinus surgery|sinus surgery
4936963|NCT01919411|Antibiotics|antibiotics
4936964|NCT01919385|Type 1 diabetes|type 1 diabetes
4936965|NCT01919385|Insulin Pump|insulin pump
4936966|NCT01919359|ablative laser|ablative laser
4936967|NCT01919359|soft tissue filler|soft tissue filler
4936968|NCT01919346|Kidney Transplantation|kidney transplantation
4936969|NCT01919346|Delayed Graft Function|delayed graft function
4936970|NCT01919320|SynCardia|syncardia
4936971|NCT01919320|Total Artificial Heart|total artificial heart
4936972|NCT01919320|TAH-t|tah-t
4936973|NCT01919307|Seizures|seizures
4936974|NCT01919307|Convulsions|convulsions
4936975|NCT01919307|Anticonvulsants|anticonvulsants
4936976|NCT01919307|Epilepsy|epilepsy
4936977|NCT01919307|Neurologic|neurologic
4936978|NCT01919294|nonalcoholic fatty liver disease|nonalcoholic fatty liver disease
4936979|NCT01919294|nonalcoholic steatohepatitis|nonalcoholic steatohepatitis
4936980|NCT01919294|hypogonadism|hypogonadism
4936981|NCT01919294|testosterone replacement therapy|testosterone replacement therapy
4936982|NCT01919281|exercise|exercise
4936983|NCT01919281|resistance training|resistance training
4936984|NCT01919281|insulin resistance|insulin resistance
4936985|NCT01919281|high intensity interval training|high intensity interval training
4936986|NCT01919268|Pilates-based exercises|pilates-based exercises
4936987|NCT01919268|Electrotherapy|electrotherapy
4936988|NCT01919268|Interferencial current|interferencial current
4936989|NCT01919255|Colonoscopy|colonoscopy
4936990|NCT01919255|Bowel preparation|bowel preparation
4936993|NCT01919255|Coolprep|coolprep
4936994|NCT01919229|HR-positive|hr-positive
4936995|NCT01919229|HER2-negative|her2-negative
4936996|NCT01919229|Breast cancer|breast cancer
4936997|NCT01919229|LEE011|lee011
4936998|NCT01919229|Letrozole|letrozole
4936999|NCT01919229|CDK|cdk
4937000|NCT01919229|CDK4|cdk4
4937001|NCT01919229|CDK6|cdk6
4937002|NCT01919229|CDK4/6|cdk4/6
4937003|NCT01919229|Pharmacodynamics|pharmacodynamics
4937004|NCT01919229|Pre-surgical|pre-surgical
4937005|NCT01919229|Postmenopausal|postmenopausal
4937006|NCT01919177|Heart Failure|heart failure
4937007|NCT01919177|Arterial hemodynamics|arterial hemodynamics
4937008|NCT01919177|Exercise capacity|exercise capacity
4937009|NCT01919177|Mitochondrial oxidative capacity|mitochondrial oxidative capacity
4937010|NCT01919164|Osteoarthritis of knee|osteoarthritis of knee
4937011|NCT01919164|AS902330|as902330
4937012|NCT01919164|Recombinant Human Fibroblast Growth Factor-18 (rhFGF-18)|recombinant human fibroblast growth factor-18 (rhfgf-18)
4937013|NCT01919164|Sprifermin|sprifermin
4937014|NCT01919164|Placebo|placebo
4937015|NCT01919151|survival|survival
4937016|NCT01919125|Chronic hepatitis C|chronic hepatitis c
4937017|NCT01919125|Hepatitis C virus|hepatitis c virus
4937018|NCT01919125|HCV|hcv
4937019|NCT01919112|Brain stimulation|brain stimulation
4937020|NCT01919099|Transplantation Costs|transplantation costs
4937021|NCT01919099|Risk Factors|risk factors
4937022|NCT01919099|Transplant Infections|transplant infections
4937023|NCT01919086|Bortezomib|bortezomib
4937024|NCT01919086|Dexamethasone|dexamethasone
4937025|NCT01919086|Lenalidomide|lenalidomide
4937026|NCT01919086|13-064|13-064
4937027|NCT01919073|Attention Deficit, ADD, ADHD, ODD, Oppositional Behavior, Disruptive Behavior, Behavior Modification, Parent Management Training, Pre-School|attention deficit, add, adhd, odd, oppositional behavior, disruptive behavior, behavior modification, parent management training, pre-school
4937028|NCT01919047|overactive bladder|overactive bladder
4937029|NCT01919047|mirabegron|mirabegron
4937030|NCT01919047|occurrence of adverse events|occurrence of adverse events
4937031|NCT01919047|Overactive Bladder Symptom Score|overactive bladder symptom score
4937032|NCT01919034|Interleukin-20, Thrombomodulin, Huntington disease, patient control analgesic|interleukin-20, thrombomodulin, huntington disease, patient control analgesic
4937033|NCT01919008|FK949E|fk949e
4937034|NCT01919008|Pharmacokinetics|pharmacokinetics
4937035|NCT01919008|Major Depressive Disorder|major depressive disorder
4937036|NCT01918995|CVT3146|cvt3146
4937037|NCT01918995|Regadenoson|regadenoson
4937038|NCT01918982|Aortic aneurysm|aortic aneurysm
4937039|NCT01918982|circulating endothelial progenitor cells|circulating endothelial progenitor cells
4937040|NCT01918969|Endothelial progenitor cells|endothelial progenitor cells
4937041|NCT01918969|Healthy blood donors|healthy blood donors
4937042|NCT01918956|immunotherapy|immunotherapy
4937043|NCT01918956|birch pollen|birch pollen
4937044|NCT01918956|seasonal allergy|seasonal allergy
4937045|NCT01918956|up-dosing|up-dosing
4937046|NCT01918943|Spine|spine
4937047|NCT01918943|Aspen device|aspen device
4937048|NCT01918943|PLIF|plif
4937049|NCT01918943|Low back pain|low back pain
4937050|NCT01918930|Melanoma|melanoma
4937051|NCT01918930|Accessible tumors|accessible tumors
4937052|NCT01918930|B7-H3 positive tumors|b7-h3 positive tumors
4937053|NCT01918917|Arthroscopic knee surgery|arthroscopic knee surgery
4937054|NCT01918917|Dexmedetomidine|dexmedetomidine
4937055|NCT01918917|Analgesia|analgesia
4937056|NCT01918904|calcinosis|calcinosis
4937057|NCT01918904|sodium thiosulfate|sodium thiosulfate
4937058|NCT01918904|topical treatment|topical treatment
4937059|NCT01918904|connective tissue disease|connective tissue disease
4937060|NCT01918891|stroke|stroke
4937061|NCT01918891|transient ischemic attack|transient ischemic attack
4937062|NCT01918891|High blood pressure|high blood pressure
4937063|NCT01918891|Hypertension|hypertension
4937064|NCT01918878|age-related macular degeneration|age-related macular degeneration
4937065|NCT01918878|intravitreal injections|intravitreal injections
4937066|NCT01918878|Aflibercept|aflibercept
4937067|NCT01918878|EYLEA|eylea
4937068|NCT01918865|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
4937069|NCT01918865|T2DM|t2dm
4937070|NCT01918852|Hand-foot syndrome|hand-foot syndrome
4937071|NCT01918852|Toxicity|toxicity
4937072|NCT01918852|Fluoropyrimidine|fluoropyrimidine
4937073|NCT01918852|Capecitabine|capecitabine
4937074|NCT01918852|Teysuno|teysuno
4937075|NCT01918852|S1|s1
4937076|NCT01918839|Investigational Device (VINCI Plus)|investigational device (vinci plus)
4937077|NCT01918839|Correction of nasolabial fold|correction of nasolabial fold
4937078|NCT01918839|Wrinkle improvement|wrinkle improvement
4937079|NCT01918839|Wrinkle correction|wrinkle correction
4937080|NCT01918800|fatigue|fatigue
4937081|NCT01918800|quality of life|quality of life
4937082|NCT01918800|rehabilitation|rehabilitation
4937083|NCT01918800|self management|self management
4937084|NCT01918800|energy effectiveness|energy effectiveness
4937085|NCT01918774|Unemployment|unemployment
4937086|NCT01918774|Cognitive Behavioral Therapy|cognitive behavioral therapy
4937087|NCT01918774|Mental Disorders|mental disorders
4937088|NCT01918761|NSCLC|nsclc
4937089|NCT01918761|Stage IV|stage iv
4937090|NCT01918761|Pemetrexed|pemetrexed
4937091|NCT01918761|Dacomitinib|dacomitinib
4937092|NCT01918735|Safety|safety
4937093|NCT01918735|Tolerability|tolerability
4937094|NCT01918735|Assessment of potential adverse events|assessment of potential adverse events
4937095|NCT01918735|Assessment of potential laboratory abnormalities|assessment of potential laboratory abnormalities
4937096|NCT01918722|Activating blood stagnation and expelling blood stasis|activating blood stagnation and expelling blood stasis
4937097|NCT01918722|Hematoma enlargement|hematoma enlargement
4937098|NCT01918722|herbal medicine|herbal medicine
4937099|NCT01918722|traditional chinese medicine|traditional chinese medicine
4937100|NCT01918722|random clinical trial|random clinical trial
4937101|NCT01918696|suicide|suicide
4937102|NCT01918696|anger|anger
4937103|NCT01918696|interpretation modification|interpretation modification
4937104|NCT01918696|computerized treatment|computerized treatment
4937105|NCT01918670|atrial fibrillation; catheter ablation; relapse; stroke; death|atrial fibrillation; catheter ablation; relapse; stroke; death
4937106|NCT01918657|Interventional|interventional
4937107|NCT01918657|Randomized|randomized
4937108|NCT01918657|Double blind|double blind
4937109|NCT01918657|Placebo controlled|placebo controlled
4937110|NCT01918657|Pediatric|pediatric
4937111|NCT01918618|levosimendan|levosimendan
4937112|NCT01918618|renal effects|renal effects
4937113|NCT01918618|cardiac surgery|cardiac surgery
4937114|NCT01918618|left heart insufficiency|left heart insufficiency
4937115|NCT01918605|prostate cancer|prostate cancer
4937116|NCT01918605|brachytherapy|brachytherapy
4937117|NCT01918605|spacer|spacer
4937118|NCT01918605|side effect|side effect
4937119|NCT01918592|bladder cancer|bladder cancer
4937120|NCT01918592|neoadjuvant chemotherapy|neoadjuvant chemotherapy
4937121|NCT01918592|radical cystectomy|radical cystectomy
4937122|NCT01918592|lymphadenectomy|lymphadenectomy
4937123|NCT01918592|biomarker|biomarker
4937124|NCT01918553|AMD|amd
4937125|NCT01918553|epidemiology|epidemiology
4937126|NCT01918553|risk factors|risk factors
4937127|NCT01918553|cohort study|cohort study
4937128|NCT01918540|Radiostereometry|radiostereometry
4937129|NCT01918540|Total Hip Arthroplasty|total hip arthroplasty
4937130|NCT01918540|Stem design|stem design
4937131|NCT01918527|Locally advanced colon cancer|locally advanced colon cancer
4937132|NCT01918527|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
4937133|NCT01918514|Magnesium sulfate|magnesium sulfate
4937134|NCT01918514|epidural|epidural
4937135|NCT01918514|interscalene|interscalene
4937136|NCT01918514|NMDA receptor|nmda receptor
4937137|NCT01918501|multiple sclerosis|multiple sclerosis
4937138|NCT01918501|Remyelination|remyelination
4937139|NCT01918501|Mitochondria|mitochondria
4937140|NCT01918501|fatty acids|fatty acids
4937141|NCT01918488|Diabetic Nephropathies|diabetic nephropathies
4937142|NCT01918488|Hypertension|hypertension
4937143|NCT01918488|Proteinuria|proteinuria
4937144|NCT01918488|Albuminuria|albuminuria
4937145|NCT01918488|Epithelial Sodium Channels|epithelial sodium channels
4937146|NCT01918488|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers
4937147|NCT01918488|Amiloride|amiloride
4937148|NCT01918475|randomized controlled trial|randomized controlled trial
4937149|NCT01918475|placebo controlled trial|placebo controlled trial
4937150|NCT01918475|cross over trial|cross over trial
4937151|NCT01918462|Alcoholic hepatitis|alcoholic hepatitis
4937152|NCT01918462|IL-22|il-22
4937153|NCT01918462|Kupffer cells|kupffer cells
4937154|NCT01918449|OSA|osa
4937155|NCT01918449|CPAP treatment|cpap treatment
4937156|NCT01918449|primary care|primary care
4937157|NCT01918449|efficacy|efficacy
4937158|NCT01918436|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
4937282|NCT01917903|attention|attention
4937159|NCT01918436|Neurocognitive training for preschool children with ADHD|neurocognitive training for preschool children with adhd
4937160|NCT01918436|Play intervention for children with ADHD|play intervention for children with adhd
4937161|NCT01918423|Childhood adiposity|childhood adiposity
4937162|NCT01918423|Metabolic risk factors|metabolic risk factors
4937163|NCT01918423|Bone mineralization|bone mineralization
4937164|NCT01918410|contact lens|contact lens
4937165|NCT01918410|alginic|alginic
4937166|NCT01918410|dry eyes|dry eyes
4937167|NCT01918384|Duchenne muscular dystrophy|duchenne muscular dystrophy
4937168|NCT01918384|NPC-14|npc-14
4937169|NCT01918384|Arbekacin|arbekacin
4937170|NCT01918384|nonsense|nonsense
4937171|NCT01918384|readthrough|readthrough
4937172|NCT01918345|Diabetes|diabetes
4937173|NCT01918345|Diabetes Mellitus|diabetes mellitus
4937174|NCT01918345|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
4937175|NCT01918345|Diabetes, gestational|diabetes, gestational
4937176|NCT01918345|Prevention & control|prevention & control
4937177|NCT01918345|Postpartum Period|postpartum period
4937178|NCT01918345|Mothers|mothers
4937179|NCT01918345|Diet|diet
4937180|NCT01918345|Diabetic Diet|diabetic diet
4937181|NCT01918345|Exercise|exercise
4937182|NCT01918345|Life Style|life style
4937183|NCT01918345|Motivation|motivation
4937184|NCT01918345|Health Behavior|health behavior
4937185|NCT01918345|Insulin-Secreting Cells|insulin-secreting cells
4937186|NCT01918345|Randomized Controlled Trial|randomized controlled trial
4937187|NCT01918345|Clinical Trial|clinical trial
4937188|NCT01918345|Pilot Projects|pilot projects
4937189|NCT01918345|Feasibility Studies|feasibility studies
4937190|NCT01918306|Triple Negative Breast Cancer|triple negative breast cancer
4937191|NCT01918306|Estrogen receptor negative breast cancer|estrogen receptor negative breast cancer
4937192|NCT01918306|Metastatic breast cancer|metastatic breast cancer
4937193|NCT01918306|Stage IV breast cancer|stage iv breast cancer
4937194|NCT01918306|HER2 negative breast cancer|her2 negative breast cancer
4937195|NCT01918293|ASTHMA|asthma
4937196|NCT01918293|SMARTPHONE APPLICATION|smartphone application
4937197|NCT01918280|Klinefelter Syndrome|klinefelter syndrome
4937198|NCT01918280|Azoospermia|azoospermia
4937199|NCT01918280|Seminal analyses|seminal analyses
4937200|NCT01918280|Testicular biopsy|testicular biopsy
4937201|NCT01918241|Pegylation|pegylation
4937202|NCT01918241|G-CSF|g-csf
4937203|NCT01918241|Efficacy|efficacy
4937204|NCT01918241|Satety|satety
4937205|NCT01918202|Enzyme occupancy|enzyme occupancy
4937206|NCT01918202|PET|pet
4937207|NCT01918202|Phosphodiesterase 10 inhibitor|phosphodiesterase 10 inhibitor
4937208|NCT01918189|back pain|back pain
4937209|NCT01918189|low back pain|low back pain
4937210|NCT01918189|chronic pain|chronic pain
4937211|NCT01918189|cognitive behavior therapy|cognitive behavior therapy
4937212|NCT01918189|behavior therapy|behavior therapy
4937213|NCT01918176|Palbociclib|palbociclib
4937214|NCT01918176|PD-0332991|pd-0332991
4937215|NCT01918176|Proton Pump Inhibitor|proton pump inhibitor
4937216|NCT01918176|DDI|ddi
4937217|NCT01918176|Healthy Volunteers|healthy volunteers
4937218|NCT01918176|Pharmacokinetics|pharmacokinetics
4937219|NCT01918176|Rabeprazole|rabeprazole
4937220|NCT01918163|pomegranate pills, male infertility, pregnancy rate, semen analysis, ROS, oxidative stress|pomegranate pills, male infertility, pregnancy rate, semen analysis, ros, oxidative stress
4937221|NCT01918124|disease free survival, overall survival|disease free survival, overall survival
4937222|NCT01918111|Renal denervation, Exercise diastolic function, Atherosclerosis, New methods|renal denervation, exercise diastolic function, atherosclerosis, new methods
4937223|NCT01918072|Women's Health|women's health
4937224|NCT01918072|Hospitals, Veterans|hospitals, veterans
4937225|NCT01918072|Education|education
4937226|NCT01918072|Remote consultation|remote consultation
4937227|NCT01918072|Videoconferencing|videoconferencing
4937228|NCT01918059|Trauma|trauma
4937229|NCT01918059|Eyelid|eyelid
4937230|NCT01918059|Laceration|laceration
4937231|NCT01918059|Tissue adhesive|tissue adhesive
4937232|NCT01918059|suture|suture
4937233|NCT01918059|cosmetic|cosmetic
4937234|NCT01918059|octyl-2-cyanoacrylate|octyl-2-cyanoacrylate
4937235|NCT01918046|biomarker|biomarker
4937236|NCT01918046|MIOX|miox
4937237|NCT01918033|Rhinitis|rhinitis
4937238|NCT01918033|Allergic Rhinitis|allergic rhinitis
4937239|NCT01918033|Nose Diseases|nose diseases
4937240|NCT01918033|Respiratory Tract Diseases|respiratory tract diseases
4937241|NCT01918033|Immune System Diseases|immune system diseases
4937242|NCT01918033|Cholinergic Antagonists|cholinergic antagonists
4937243|NCT01918033|Cholinergic Agents|cholinergic agents
4937244|NCT01918033|Neurotransmitter Agents|neurotransmitter agents
4937245|NCT01918033|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating
4937246|NCT01918033|Histamine H1 Antagonists|histamine h1 antagonists
4937247|NCT01918033|Histamine Antagonists|histamine antagonists
4937248|NCT01918033|Histamine Agents|histamine agents
4937249|NCT01918020|Fruit|fruit
4937250|NCT01918020|Vegetables|vegetables
4937251|NCT01918020|Motor Activity|motor activity
4937252|NCT01918007|Apnea|apnea
4937253|NCT01918007|Sleep Apnea Syndromes|sleep apnea syndromes
4937254|NCT01918007|Snoring|snoring
4937255|NCT01918007|Sleep Apnea, Obstructive|sleep apnea, obstructive
4937256|NCT01918007|Respiration Disorders|respiration disorders
4937257|NCT01918007|Respiratory Tract Diseases|respiratory tract diseases
4937258|NCT01918007|Signs and Symptoms, Respiratory Signs and Symptoms|signs and symptoms, respiratory signs and symptoms
4937259|NCT01918007|Sleep Disorders, Intrinsic|sleep disorders, intrinsic
4937260|NCT01918007|Dyssomnias|dyssomnias
4937261|NCT01918007|Sleep Disorders|sleep disorders
4937262|NCT01918007|Respiratory Sounds|respiratory sounds
4937263|NCT01917981|Intermittent cardiac monitoring|intermittent cardiac monitoring
4937264|NCT01917981|Implantable device|implantable device
4937265|NCT01917968|POP|pop
4937266|NCT01917968|Transvaginal|transvaginal
4937267|NCT01917968|Native Tissue Repair|native tissue repair
4937268|NCT01917968|Repair Augmented with Mesh|repair augmented with mesh
4937269|NCT01917968|Pelvic Organ Prolapse|pelvic organ prolapse
4937270|NCT01917955|MRI|mri
4937271|NCT01917942|Radiotherapy|radiotherapy
4937272|NCT01917942|Humidification|humidification
4937273|NCT01917942|Mucositis|mucositis
4937274|NCT01917929|[E04.555.110.110.110]|[e04.555.110.110.110]
4937275|NCT01917903|walking|walking
4937276|NCT01917903|Parkinson's disease|parkinson's disease
4937277|NCT01917903|traumatic brain injury|traumatic brain injury
4937278|NCT01917903|multiple sclerosis|multiple sclerosis
4937279|NCT01917903|physical therapy|physical therapy
4937280|NCT01917903|falls|falls
4937281|NCT01917903|memory|memory
4937283|NCT01917903|multitasking|multitasking
4937284|NCT01917903|exercise|exercise
4937285|NCT01917890|curcumin|curcumin
4937286|NCT01917890|radioprotective|radioprotective
4937287|NCT01917890|radiosensitizer|radiosensitizer
4937288|NCT01917877|Becacizumab|becacizumab
4937289|NCT01917877|pulmonary fibrosis|pulmonary fibrosis
4937290|NCT01917877|irradiation|irradiation
4937291|NCT01917877|chemotherapy|chemotherapy
4937292|NCT01917864|Autism|autism
4937293|NCT01917864|Autism Spectrum Disorders|autism spectrum disorders
4937294|NCT01917864|Prosody|prosody
4937295|NCT01917864|Speech treatment|speech treatment
4937296|NCT01917851|Accurate|accurate
4937297|NCT01917851|Hb|hb
4937298|NCT01917851|noninvasive measurement|noninvasive measurement
4937299|NCT01917838|Mental Health Services|mental health services
4937300|NCT01917825|radicular pain|radicular pain
4937301|NCT01917812|physical activity|physical activity
4937302|NCT01917812|exercise|exercise
4937303|NCT01917812|mHealth|mhealth
4937304|NCT01917812|smartphone|smartphone
4937305|NCT01917812|activity tracker|activity tracker
4937306|NCT01917812|pedometer|pedometer
4937307|NCT01917812|text messaging|text messaging
4937308|NCT01917812|SMS|sms
4937309|NCT01917799|Aspirin|aspirin
4937310|NCT01917799|Heparin|heparin
4937311|NCT01917799|pregnancy|pregnancy
4937312|NCT01917799|miscarriage|miscarriage
4937313|NCT01917760|Gamma-aminobutyric acid|gamma-aminobutyric acid
4937314|NCT01917760|Pharmacokinetics|pharmacokinetics
4937315|NCT01917760|Pharmacodynamics|pharmacodynamics
4937316|NCT01917760|Insulin|insulin
4937317|NCT01917760|C-peptide|c-peptide
4937318|NCT01917760|Glucagon|glucagon
4937319|NCT01917747|Infant hearing screening|infant hearing screening
4937320|NCT01917747|Patient Navigator|patient navigator
4937321|NCT01917734|severe acute malnutrition|severe acute malnutrition
4937322|NCT01917734|severe wasting|severe wasting
4937323|NCT01917734|facility-based care|facility-based care
4937324|NCT01917734|community-based care|community-based care
4937325|NCT01917734|Madhya Pradesh|madhya pradesh
4937326|NCT01917734|India|india
4937327|NCT01917721|Kawasaki disease|kawasaki disease
4937328|NCT01917721|doxycycline|doxycycline
4937329|NCT01917721|coronary artery aneurysm|coronary artery aneurysm
4937330|NCT01917708|non malignant conditions|non malignant conditions
4937331|NCT01917708|blood and marrow transplant|blood and marrow transplant
4937332|NCT01917695|Bulky cervical cancers|bulky cervical cancers
4937333|NCT01917695|Neoadjuvant Chemotherapy|neoadjuvant chemotherapy
4937334|NCT01917695|Neoadjuvant Chemoradiotherapy|neoadjuvant chemoradiotherapy
4937335|NCT01917682|robotic-assisted PCI|robotic-assisted pci
4937336|NCT01917682|coronary intervention|coronary intervention
4937337|NCT01917682|CorPath PRECISION Registry|corpath precision registry
4937338|NCT01917682|PCI|pci
4937339|NCT01917682|angioplasty|angioplasty
4937340|NCT01917643|COPD, Comparative Effectiveness, Symbicort|copd, comparative effectiveness, symbicort
4937341|NCT01917630|Celiac disease|celiac disease
4937342|NCT01917630|Gluten-free diet|gluten-free diet
4937343|NCT01917630|Coeliac disease|coeliac disease
4937344|NCT01917630|Celiac sprue|celiac sprue
4937345|NCT01917604|open versus closed surgical technique|open versus closed surgical technique
4937346|NCT01917604|impacted maxillary canine|impacted maxillary canine
4937347|NCT01917604|orthodontic disimpaction|orthodontic disimpaction
4937348|NCT01917591|Bandages|bandages
4937349|NCT01917591|Biological Dressings|biological dressings
4937350|NCT01917591|Chronic Disease|chronic disease
4937351|NCT01917591|Collagen|collagen
4937352|NCT01917591|Epithelium|epithelium
4937353|NCT01917591|Extracellular Matrix|extracellular matrix
4937354|NCT01917591|Extra Cellular Matrix|extra cellular matrix
4937355|NCT01917591|Fibroblasts|fibroblasts
4937356|NCT01917591|Granulation Tissue|granulation tissue
4937357|NCT01917591|Leg Ulcer|leg ulcer
4937358|NCT01917591|Middle Aged|middle aged
4937359|NCT01917591|Prospective Studies|prospective studies
4937360|NCT01917591|Soft Tissue Injuries|soft tissue injuries
4937361|NCT01917591|Treatment Outcome|treatment outcome
4937362|NCT01917591|Varicose Ulcer|varicose ulcer
4937363|NCT01917591|Wound Healing|wound healing
4937364|NCT01917591|Wounds and Injuries|wounds and injuries
4937365|NCT01917591|biopsy|biopsy
4937366|NCT01917591|autoimmunity|autoimmunity
4937367|NCT01917578|Breast Cancer|breast cancer
4937368|NCT01917578|shrinkage modes|shrinkage modes
4937369|NCT01917578|three-dimensional reconstruction|three-dimensional reconstruction
4937370|NCT01917578|neoadjuvant chemotherapy|neoadjuvant chemotherapy
4937371|NCT01917578|Magnetic Resonance Imaging|magnetic resonance imaging
4937372|NCT01917565|airway management|airway management
4937373|NCT01917565|laryngoscope|laryngoscope
4937374|NCT01917565|Airtraq|airtraq
4937375|NCT01917565|Macintosh laryngoscope|macintosh laryngoscope
4937376|NCT01917565|fiberoptic bronchoscope|fiberoptic bronchoscope
4937377|NCT01917565|intubation|intubation
4937378|NCT01917552|Gastric adenocarcinoma, gastroesophageal junction adenocarcinoma, adjuvant, capecitabine, gastric cancer, stage 1b|gastric adenocarcinoma, gastroesophageal junction adenocarcinoma, adjuvant, capecitabine, gastric cancer, stage 1b
4937379|NCT01917526|Oxygen|oxygen
4937380|NCT01917526|PACU|pacu
4937381|NCT01917526|Hypoxemia|hypoxemia
4937382|NCT01917513|Adenoma|adenoma
4937383|NCT01917513|Polyps|polyps
4937384|NCT01917513|CRC|crc
4937385|NCT01917513|Colonoscopy|colonoscopy
4937386|NCT01917513|Detection Yield|detection yield
4937387|NCT01917500|Continues non-invasive Blood pressure measurement|continues non-invasive blood pressure measurement
4937388|NCT01917500|Continues non-invasive Cardiac Output measurement|continues non-invasive cardiac output measurement
4937389|NCT01917474|low-lipid diet|low-lipid diet
4937390|NCT01917474|normal lipid intake|normal lipid intake
4937391|NCT01917474|saturated fats reduction|saturated fats reduction
4937392|NCT01917474|headache attacks|headache attacks
4937393|NCT01917448|postoperative pain|postoperative pain
4937394|NCT01917448|spinal morphine|spinal morphine
4937395|NCT01917448|video-assisted thoracoscopic surgery|video-assisted thoracoscopic surgery
4937396|NCT01917435|fiberoptic bronchoscopy,|fiberoptic bronchoscopy,
4937397|NCT01917435|Video-stylet,|video-stylet,
4937398|NCT01917435|Nasotracheal Intubation|nasotracheal intubation
4937399|NCT01917409|Conventional Laryngoscopy ,|conventional laryngoscopy ,
4937400|NCT01917409|Video-stylet ,|video-stylet ,
4937401|NCT01917409|Nasotracheal Intubation|nasotracheal intubation
4937402|NCT01917396|caesarean, bowel, gass|caesarean, bowel, gass
4937403|NCT01917383|glaucoma|glaucoma
4937404|NCT01917383|primary open angle glaucoma|primary open angle glaucoma
4937405|NCT01917383|ocular hypertension|ocular hypertension
4937406|NCT01917383|adenosine agonist|adenosine agonist
4937407|NCT01917383|eye drop|eye drop
4937408|NCT01917383|trabodenoson|trabodenoson
4937409|NCT01917383|trabecular meshwork|trabecular meshwork
4937410|NCT01917370|intrahepatic cholangiocarcinoma|intrahepatic cholangiocarcinoma
4937411|NCT01917370|icc|icc
4937412|NCT01917370|vegf signal pathway|vegf signal pathway
4937413|NCT01917357|Vaccination|vaccination
4937414|NCT01917357|Immunisation|immunisation
4937415|NCT01917357|Virus|virus
4937416|NCT01917357|Diphtheria|diphtheria
4937417|NCT01917357|Pertussis|pertussis
4937418|NCT01917357|Tetanus|tetanus
4937419|NCT01917357|Hepatitis B|hepatitis b
4937420|NCT01917357|Haemophilus Influenzae|haemophilus influenzae
4937421|NCT01917357|Immunity|immunity
4937422|NCT01917344|Phenylketonuria|phenylketonuria
4937423|NCT01917344|MRI|mri
4937424|NCT01917344|Neuropsychological functioning|neuropsychological functioning
4937425|NCT01917344|Neurological functioning|neurological functioning
4937426|NCT01917344|EEG|eeg
4937427|NCT01917331|spirometry|spirometry
4937428|NCT01917331|severe COPD|severe copd
4937429|NCT01917331|lung disease|lung disease
4937430|NCT01917331|fixed combination|fixed combination
4937431|NCT01917318|Post traumatic stress disorder|post traumatic stress disorder
4937432|NCT01917318|Treatment of post traumatic stress disorder|treatment of post traumatic stress disorder
4937433|NCT01917318|Symptoms of arousal in post traumatic stress disorder|symptoms of arousal in post traumatic stress disorder
4937434|NCT01917318|Iloperidone in post traumatic stress disorder|iloperidone in post traumatic stress disorder
4937435|NCT01917305|Bacteria|bacteria
4937436|NCT01917305|bone level|bone level
4937437|NCT01917305|bone loss|bone loss
4937438|NCT01917305|dental implants|dental implants
4937439|NCT01917305|implant design|implant design
4937440|NCT01917305|platform-shifting|platform-shifting
4937441|NCT01917305|platform-matching|platform-matching
4937442|NCT01917292|Periodontitis|periodontitis
4937443|NCT01917292|Prehypertension|prehypertension
4937444|NCT01917292|Periodontal Intervention|periodontal intervention
4937445|NCT01917279|Metastatic Breast Cancer|metastatic breast cancer
4937446|NCT01917279|Antineoplastic Agents|antineoplastic agents
4937447|NCT01917279|Therapeutic Uses|therapeutic uses
4937448|NCT01917279|Antimetabolites|antimetabolites
4937449|NCT01917279|Tubulin Modulators|tubulin modulators
4937450|NCT01917279|Maintenance chemotherapy|maintenance chemotherapy
4937451|NCT01917279|Metronomic chemotherapy|metronomic chemotherapy
4937452|NCT01917279|Capecitabine|capecitabine
4937453|NCT01917279|Docetaxel|docetaxel
4937454|NCT01917253|infiltration, phlebitis, occlusion, thrombosis|infiltration, phlebitis, occlusion, thrombosis
4937455|NCT01917240|Monophasic|monophasic
4937456|NCT01917240|Sequential|sequential
4937457|NCT01917240|Media|media
4937458|NCT01917201|Coronary Artery Disease|coronary artery disease
4937459|NCT01917201|Drug Eluting Stents|drug eluting stents
4937460|NCT01917201|Intravascular Ultrasound|intravascular ultrasound
4937461|NCT01917201|Optical Coherence Tomography|optical coherence tomography
4937462|NCT01917201|Intravascular Visualization|intravascular visualization
4937463|NCT01917175|HIV|hiv
4937464|NCT01917175|Cohort|cohort
4937465|NCT01917175|Early HIV infection|early hiv infection
4937466|NCT01917175|Côte d'Ivoire|côte d'ivoire
4937467|NCT01917175|Disease progression|disease progression
4937468|NCT01917162|contact lenses|contact lenses
4937469|NCT01917162|daily disposable contact lenses|daily disposable contact lenses
4937470|NCT01917162|silicone hydrogel|silicone hydrogel
4937471|NCT01917162|contact lens comfort|contact lens comfort
4937472|NCT01917162|near-sighted|near-sighted
4937473|NCT01917149|Dilated cardiomyopathy|dilated cardiomyopathy
4937474|NCT01917149|High dose ACEI/ARB|high dose acei/arb
4937475|NCT01917136|pulmonary hypertension|pulmonary hypertension
4937476|NCT01917136|right ventricular function|right ventricular function
4937477|NCT01917136|11C acetate|11c acetate
4937478|NCT01917136|FDG|fdg
4937479|NCT01917136|ranolazine|ranolazine
4937675|NCT01916148|Hypoglycemia|hypoglycemia
4937480|NCT01917123|L-Citrulline malate,Coronary Heart Disease, Brachial Index|l-citrulline malate,coronary heart disease, brachial index
4937481|NCT01917084|Passive range of motion|passive range of motion
4937482|NCT01917084|Single ventricle|single ventricle
4937483|NCT01917084|Infants|infants
4937484|NCT01917084|Congenital heart disease|congenital heart disease
4937485|NCT01917058|Alopecia Areata|alopecia areata
4937486|NCT01917058|Abatacept|abatacept
4937487|NCT01917045|sufentanil|sufentanil
4937488|NCT01917045|morphine|morphine
4937489|NCT01917045|postoperative pain control|postoperative pain control
4937490|NCT01917045|body fat percentage|body fat percentage
4937491|NCT01917045|gynecology laparoscopic surgery|gynecology laparoscopic surgery
4937492|NCT01917045|lipid solubility|lipid solubility
4937493|NCT01917032|Trace Elements|trace elements
4937494|NCT01917032|Preschool|preschool
4937495|NCT01917032|Malnutrition|malnutrition
4937496|NCT01917032|Fortified Food|fortified food
4937497|NCT01917019|Japan|japan
4937498|NCT01916980|Dermatitis|dermatitis
4937499|NCT01916980|Dermatitis, Atopic|dermatitis, atopic
4937500|NCT01916980|Skin Diseases|skin diseases
4937501|NCT01916980|Skin Diseases, Genetic|skin diseases, genetic
4937502|NCT01916980|Genetic Diseases, Inborn|genetic diseases, inborn
4937503|NCT01916980|Skin Diseases, Eczematous|skin diseases, eczematous
4937504|NCT01916980|Hypersensitivity, Immediate|hypersensitivity, immediate
4937505|NCT01916980|Hypersensitivity|hypersensitivity
4937506|NCT01916980|Immune System Diseases|immune system diseases
4937507|NCT01916967|Urticaria|urticaria
4937508|NCT01916967|Skin Diseases, Vascular|skin diseases, vascular
4937509|NCT01916967|Skin Diseases|skin diseases
4937510|NCT01916967|Hypersensitivity, Immediate|hypersensitivity, immediate
4937511|NCT01916967|Hypersensitivity|hypersensitivity
4937512|NCT01916967|Immune System Diseases|immune system diseases
4937513|NCT01916967|Cholinergic Antagonists|cholinergic antagonists
4937514|NCT01916967|Cholinergic Agents|cholinergic agents
4937515|NCT01916967|Neurotransmitter Agents|neurotransmitter agents
4937516|NCT01916967|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating
4937517|NCT01916967|Histamine H1 Antagonists|histamine h1 antagonists
4937518|NCT01916967|Histamine Antagonists|histamine antagonists
4937519|NCT01916967|Histamine Agents|histamine agents
4937520|NCT01916954|Malaria|malaria
4937521|NCT01916954|Pregnancy|pregnancy
4937522|NCT01916954|Plasmodium falciparum|plasmodium falciparum
4937523|NCT01916928|Circulating cell free fetal DNA|circulating cell free fetal dna
4937524|NCT01916928|Intrauterine fetal demise|intrauterine fetal demise
4937525|NCT01916928|Miscarriage|miscarriage
4937526|NCT01916902|Optical Coherence Tomography|optical coherence tomography
4937527|NCT01916902|Ticagrelor|ticagrelor
4937528|NCT01916889|Delirium|delirium
4937529|NCT01916876|medical in-patients|medical in-patients
4937530|NCT01916876|follow-up care|follow-up care
4937531|NCT01916876|developing country|developing country
4937532|NCT01916837|Breast cancer|breast cancer
4937533|NCT01916837|Feasibility|feasibility
4937534|NCT01916837|Genomic grade index|genomic grade index
4937535|NCT01916824|depression|depression
4937536|NCT01916824|melancholia|melancholia
4937537|NCT01916824|treatment|treatment
4937538|NCT01916811|Low Back Pain|low back pain
4937539|NCT01916811|Load quantitative MRI|load quantitative mri
4937540|NCT01916798|Infertility|infertility
4937541|NCT01916798|intralipid|intralipid
4937542|NCT01916798|invitro fertilization|invitro fertilization
4937543|NCT01916798|repeated implantation failure|repeated implantation failure
4937544|NCT01916798|repeated miscarriage|repeated miscarriage
4937545|NCT01916772|cherubism|cherubism
4937546|NCT01916772|bone tumors|bone tumors
4937547|NCT01916759|immunization|immunization
4937548|NCT01916746|Caesarean Scar Pregnancy|caesarean scar pregnancy
4937549|NCT01916746|Transvaginal Resection|transvaginal resection
4937550|NCT01916746|treatment|treatment
4937551|NCT01916707|trauma|trauma
4937552|NCT01916707|enoxaparin|enoxaparin
4937553|NCT01916707|weight based|weight based
4937554|NCT01916707|prophylaxis|prophylaxis
4937555|NCT01916694|Gestational diabetes mellitus|gestational diabetes mellitus
4937556|NCT01916694|m Health|m health
4937557|NCT01916694|Smartphone|smartphone
4937558|NCT01916694|Blood glucose monitoring|blood glucose monitoring
4937559|NCT01916681|Induction|induction
4937560|NCT01916681|Labor|labor
4937561|NCT01916681|Cervical foley|cervical foley
4937562|NCT01916681|Misoprostol|misoprostol
4937563|NCT01916681|Pitocin|pitocin
4937564|NCT01916681|Oxytocin|oxytocin
4937565|NCT01916681|Cytotec|cytotec
4937566|NCT01916681|Delivery|delivery
4937567|NCT01916681|IOL|iol
4937568|NCT01916655|Obstructive Sleep Apnea|obstructive sleep apnea
4937569|NCT01916655|Adherence|adherence
4937570|NCT01916655|Chronic Disease|chronic disease
4937571|NCT01916655|Telemedicine|telemedicine
4937572|NCT01916655|Continuous Positive Airway Pressure|continuous positive airway pressure
4937573|NCT01916655|Mobile Health|mobile health
4937574|NCT01916642|iv lidocaine|iv lidocaine
4937575|NCT01916642|inducing dose|inducing dose
4937576|NCT01916642|etomidate|etomidate
4937577|NCT01916642|dose response|dose response
4937578|NCT01916616|paradoxical vocal fold motion|paradoxical vocal fold motion
4938572|NCT01911689|APACHEⅡ|apacheⅱ
4937579|NCT01916616|cognitive-behavioral therapy|cognitive-behavioral therapy
4937580|NCT01916590|Post-operative pain|post-operative pain
4937581|NCT01916590|Anterior Cruciate Ligament repair|anterior cruciate ligament repair
4937582|NCT01916577|Stem Cell Mobilization|stem cell mobilization
4937583|NCT01916577|Stem Cells|stem cells
4937584|NCT01916577|Transplantation|transplantation
4937585|NCT01916577|Autologous|autologous
4937586|NCT01916564|Bowel preparation|bowel preparation
4937587|NCT01916564|Morning colonoscopy|morning colonoscopy
4937588|NCT01916564|Split-dose|split-dose
4937589|NCT01916564|Same-morning whole-dose|same-morning whole-dose
4937590|NCT01916564|Reduced-volume PEG-ELS|reduced-volume peg-els
4937591|NCT01916538|anorexia nervosa|anorexia nervosa
4937592|NCT01916538|genetics|genetics
4937593|NCT01916538|gene|gene
4937594|NCT01916538|eating disorder|eating disorder
4937595|NCT01916525|Acute coronary syndrome|acute coronary syndrome
4937596|NCT01916525|Cost-effectiveness|cost-effectiveness
4937597|NCT01916525|Cardiac rehabilitation|cardiac rehabilitation
4937598|NCT01916525|Exercise|exercise
4937599|NCT01916525|Physical activity|physical activity
4937600|NCT01916525|Home monitoring|home monitoring
4937601|NCT01916512|CETP, HDL, LDL, apoB-100, apoB-48, remnants|cetp, hdl, ldl, apob-100, apob-48, remnants
4937602|NCT01916499|Child, adolescent|child, adolescent
4937603|NCT01916499|Coronary artery disease|coronary artery disease
4937604|NCT01916499|Magnetic resonance imaging|magnetic resonance imaging
4937605|NCT01916473|Epidural analgesia|epidural analgesia
4937606|NCT01916473|continuous wound infusion|continuous wound infusion
4937607|NCT01916473|ropivacaine|ropivacaine
4937608|NCT01916473|total abdominal hysterectomy|total abdominal hysterectomy
4937609|NCT01916460|Gastroparesis|gastroparesis
4937610|NCT01916460|Endoscopic ultrasound|endoscopic ultrasound
4937611|NCT01916460|Interstitial cell of Cajal|interstitial cell of cajal
4937612|NCT01916447|Angiogenesis Inhibitor|angiogenesis inhibitor
4937613|NCT01916447|Monoclonal Antibody|monoclonal antibody
4937614|NCT01916447|Vascular Endothelial Growth Factor A (VEGF-A)|vascular endothelial growth factor a (vegf-a)
4937615|NCT01916434|Farmed fish|farmed fish
4937616|NCT01916434|Dietary intervention|dietary intervention
4937617|NCT01916434|Long-term intervention|long-term intervention
4937618|NCT01916434|Omega-3 index|omega-3 index
4937619|NCT01916434|Cardiovascular risk markers|cardiovascular risk markers
4937620|NCT01916434|Coagulation and endothelial activation|coagulation and endothelial activation
4937621|NCT01916434|Bleeding time|bleeding time
4937622|NCT01916434|Inflammation|inflammation
4937623|NCT01916434|Oxidative stress|oxidative stress
4937624|NCT01916434|Gut health|gut health
4937625|NCT01916434|Micronutrient availability|micronutrient availability
4937626|NCT01916421|Pancreatic adenocarcinoma|pancreatic adenocarcinoma
4937627|NCT01916421|lymphadenopathy|lymphadenopathy
4937628|NCT01916421|Endoscopic ultrasound|endoscopic ultrasound
4937629|NCT01916408|Exercise|exercise
4937630|NCT01916408|Inflammation|inflammation
4937631|NCT01916408|Upper Respiratory Tract Illness|upper respiratory tract illness
4937632|NCT01916408|Oral Proteolytic and Hydrolytic Enzymes|oral proteolytic and hydrolytic enzymes
4937633|NCT01916408|Flavinoids|flavinoids
4937634|NCT01916395|Migraine|migraine
4937635|NCT01916382|Alkaptonuria, nitisinone,Ochronosis, Homogentisic acid|alkaptonuria, nitisinone,ochronosis, homogentisic acid
4937636|NCT01916369|Peripheral Arterial Disease|peripheral arterial disease
4937637|NCT01916369|Fontaine Stage II, III or IV|fontaine stage ii, iii or iv
4937638|NCT01916369|Vascular disease|vascular disease
4937639|NCT01916369|Cardiovascular diseases|cardiovascular diseases
4937640|NCT01916369|Neural stem cell|neural stem cell
4937641|NCT01916356|Infertility|infertility
4937642|NCT01916356|Education|education
4937643|NCT01916356|Risk Factors|risk factors
4937644|NCT01916356|Fertility knowledge|fertility knowledge
4937645|NCT01916356|Fertility myths|fertility myths
4937646|NCT01916343|Laparoscopy|laparoscopy
4937647|NCT01916343|Surgical skills|surgical skills
4937648|NCT01916343|Team training|team training
4937649|NCT01916343|Obstetrics and Gynecology|obstetrics and gynecology
4937650|NCT01916343|Curriculum|curriculum
4937651|NCT01916304|Drug Therapy|drug therapy
4937652|NCT01916252|Multiple Myeloma|multiple myeloma
4937653|NCT01916252|MEL200|mel200
4937654|NCT01916252|BUMEL|bumel
4937655|NCT01916239|Pomegranate|pomegranate
4937656|NCT01916239|Urolithins|urolithins
4937657|NCT01916239|Colorectal cancer|colorectal cancer
4937658|NCT01916239|Colon cancer|colon cancer
4937659|NCT01916239|Metabolite|metabolite
4937660|NCT01916239|Gene expression|gene expression
4937661|NCT01916239|microRNA|microrna
4937662|NCT01916239|Nutraceutical|nutraceutical
4937663|NCT01916239|Food supplement|food supplement
4937664|NCT01916239|Polyphenol|polyphenol
4937665|NCT01916239|Gut microbiota|gut microbiota
4937666|NCT01916226|cetirizine|cetirizine
4937667|NCT01916226|seasonal allergic rhinitis|seasonal allergic rhinitis
4937668|NCT01916226|Quality of Life|quality of life
4937669|NCT01916226|fluticasone propionate nasal spray|fluticasone propionate nasal spray
4937670|NCT01916161|Crohn's disease|crohn's disease
4937671|NCT01916161|ulcerative colitis|ulcerative colitis
4937672|NCT01916161|anxiety|anxiety
4937673|NCT01916161|patient knowledge|patient knowledge
4937674|NCT01916161|information sources|information sources
4937676|NCT01916148|Hyperinsulinism|hyperinsulinism
4937677|NCT01916135|[18F]-SKI-249380|[18f]-ski-249380
4937678|NCT01916135|PET Imaging|pet imaging
4937679|NCT01916135|CT Imaging|ct imaging
4937680|NCT01916135|12-182|12-182
4937681|NCT01916122|Fluorestradiol (FES)|fluorestradiol (fes)
4937682|NCT01916122|PET/CT scan|pet/ct scan
4937683|NCT01916122|Estrogen Receptor|estrogen receptor
4937684|NCT01916122|13-071|13-071
4937685|NCT01916109|Gemcitabine|gemcitabine
4937686|NCT01916109|Carboplatin|carboplatin
4937687|NCT01916109|Panitumumab|panitumumab
4937688|NCT01916109|(GCaP)|(gcap)
4937689|NCT01916109|radical cystectomy|radical cystectomy
4937690|NCT01916109|10-103|10-103
4937691|NCT01916070|syncope|syncope
4937692|NCT01916070|near syncope|near syncope
4937693|NCT01916070|prognosis|prognosis
4937694|NCT01916070|emergency department|emergency department
4937695|NCT01916057|Positron-Emission Tomography Scan|positron-emission tomography scan
4937696|NCT01916057|Fluorodeoxyglucose F18|fluorodeoxyglucose f18
4937697|NCT01916057|Magnetic Resonance Imaging|magnetic resonance imaging
4937698|NCT01916057|Enzyme-Linked Immunospot Assay|enzyme-linked immunospot assay
4937699|NCT01916057|Immune Reconstitution Inflammatory Syndrome|immune reconstitution inflammatory syndrome
4937700|NCT01916057|Real-Time Polymerase Chain Reaction|real-time polymerase chain reaction
4937701|NCT01916057|beta-1,3-D-glucan|beta-1,3-d-glucan
4937702|NCT01916057|Candida spp.|candida spp.
4937703|NCT01916057|Genetic Susceptibility|genetic susceptibility
4937704|NCT01916057|Genotype|genotype
4937705|NCT01916044|caesarean,|caesarean,
4937706|NCT01916044|trial of labor,|trial of labor,
4937707|NCT01916044|ultrasound|ultrasound
4937708|NCT01916018|Congenital hypothyroidism|congenital hypothyroidism
4937709|NCT01916018|Thyroid dysgenesis|thyroid dysgenesis
4937710|NCT01916018|Genetics|genetics
4937711|NCT01916018|Associated malformations|associated malformations
4937712|NCT01916018|Psychomotor delay|psychomotor delay
4937713|NCT01916018|Mental retardation|mental retardation
4937714|NCT01915979|plasma rich in growth factors, tendinopathy, traumatology|plasma rich in growth factors, tendinopathy, traumatology
4937715|NCT01915979|,rotator cuff, effectiveness, plasma rich in platelets|,rotator cuff, effectiveness, plasma rich in platelets
4937716|NCT01915953|Accurte Hb noninvasive measurement|accurte hb noninvasive measurement
4937717|NCT01915940|Glaucoma|glaucoma
4937718|NCT01915940|Primary Open-Angle Glaucoma|primary open-angle glaucoma
4937719|NCT01915940|Ocular Hypertension|ocular hypertension
4937720|NCT01915888|Clinical|clinical
4937721|NCT01915888|Children|children
4937722|NCT01915888|Rotavirus|rotavirus
4937723|NCT01915888|Cost|cost
4937724|NCT01915888|Rotarix vaccination|rotarix vaccination
4937725|NCT01915875|Cystic fibrosis-pain-sophrology|cystic fibrosis-pain-sophrology
4937726|NCT01915862|Acute ischemic stroke|acute ischemic stroke
4937727|NCT01915862|Blood pressure variability|blood pressure variability
4937728|NCT01915862|Ambulatory arterial stiffness index|ambulatory arterial stiffness index
4937729|NCT01915862|Ambulatory blood pressure monitoring|ambulatory blood pressure monitoring
4937730|NCT01915862|Outcome|outcome
4937731|NCT01915836|11-043|11-043
4937732|NCT01915836|MSKCC Tobacco Cessation Program|mskcc tobacco cessation program
4937733|NCT01915810|Tobacco Use Cessation|tobacco use cessation
4937734|NCT01915810|Smoking Cessation with Physical Activity|smoking cessation with physical activity
4937735|NCT01915810|SCwPA|scwpa
4937736|NCT01915810|Cancer Prevention|cancer prevention
4937737|NCT01915810|African American cigarette smoker|african american cigarette smoker
4937738|NCT01915810|Questionnaires|questionnaires
4937739|NCT01915810|Surveys|surveys
4937740|NCT01915810|Phone Counseling|phone counseling
4937741|NCT01915810|Breath Test|breath test
4937742|NCT01915810|Walking Program|walking program
4937743|NCT01915810|Nicotine Patch|nicotine patch
4937744|NCT01915810|Audio Recorded Focus Group|audio recorded focus group
4937745|NCT01915797|Pediatric patients, tumor, developmental abnormalities|pediatric patients, tumor, developmental abnormalities
4937746|NCT01915745|Osteoporosis|osteoporosis
4937747|NCT01915745|Bone densitometry|bone densitometry
4937748|NCT01915745|Fracture|fracture
4937749|NCT01915745|Anti-osteoporotic treatment|anti-osteoporotic treatment
4937750|NCT01915745|Short message service|short message service
4937751|NCT01915706|Glaucoma drainage device|glaucoma drainage device
4937752|NCT01915706|Baerveldt 350|baerveldt 350
4937753|NCT01915706|Ripcord|ripcord
4937754|NCT01915706|Complications|complications
4937755|NCT01915693|Radiotherapy|radiotherapy
4937756|NCT01915693|stent|stent
4937757|NCT01915693|quality of life|quality of life
4937758|NCT01915654|Cardiac surgery|cardiac surgery
4937759|NCT01915654|Transfusion|transfusion
4937760|NCT01915641|walking capacity|walking capacity
4937761|NCT01915641|COPD|copd
4937762|NCT01915641|OSA|osa
4937763|NCT01915641|CPAP|cpap
4937764|NCT01915628|MACE|mace
4937765|NCT01915628|Safety|safety
4937766|NCT01915628|Efficacy|efficacy
4937767|NCT01915628|On label|on label
4937768|NCT01915628|Myocardial Infarction|myocardial infarction
4937769|NCT01915628|Cardiac death|cardiac death
4937770|NCT01915628|TVR|tvr
4937771|NCT01915628|stent thrombosis|stent thrombosis
4937772|NCT01915615|Hypertrophic cardiomyopathy|hypertrophic cardiomyopathy
4937962|NCT01914900|beta tubulin II|beta tubulin ii
4937773|NCT01915615|Cardiac magnetic resonance imaging|cardiac magnetic resonance imaging
4937774|NCT01915615|CMR|cmr
4937775|NCT01915615|Genetics|genetics
4937776|NCT01915615|Biomarkers|biomarkers
4937777|NCT01915615|Late gadolinium enhancement|late gadolinium enhancement
4937778|NCT01915615|T1 mapping|t1 mapping
4937779|NCT01915602|Hepatocellular Carcinoma|hepatocellular carcinoma
4937780|NCT01915602|Mitogen-activated Extracellular-signal-regulated kinase (MEK) inhibitor|mitogen-activated extracellular-signal-regulated kinase (mek) inhibitor
4937781|NCT01915602|Sorafenib|sorafenib
4937782|NCT01915602|Objective tumor response rate (ORR)|objective tumor response rate (orr)
4937783|NCT01915602|modified RECIST criteria|modified recist criteria
4937784|NCT01915589|Hepatocellular Carcinoma|hepatocellular carcinoma
4937785|NCT01915589|Mitogen-activated Extracellular-signal-regulated kinase (MEK) inhibitor|mitogen-activated extracellular-signal-regulated kinase (mek) inhibitor
4937786|NCT01915589|Objective tumor response rate (ORR)|objective tumor response rate (orr)
4937787|NCT01915589|modified RECIST criteria|modified recist criteria
4937788|NCT01915563|Mechanical ventilation|mechanical ventilation
4937790|NCT01915563|Extubation failure|extubation failure
4937791|NCT01915550|Diabetes mellitus|diabetes mellitus
4937792|NCT01915550|Pregnancy|pregnancy
4937793|NCT01915550|Insulin|insulin
4937794|NCT01915550|Metformin|metformin
4937795|NCT01915537|poor prognosis|poor prognosis
4937796|NCT01915537|severe RA|severe ra
4937797|NCT01915537|infliximab|infliximab
4937798|NCT01915511|Idiopathic pulmonary fibrosis|idiopathic pulmonary fibrosis
4937799|NCT01915511|Pulmonary fibrosis|pulmonary fibrosis
4937800|NCT01915511|IPF|ipf
4937801|NCT01915511|Registry|registry
4937802|NCT01915511|1199.174|1199.174
4937803|NCT01915498|acute myeloid leukemia|acute myeloid leukemia
4937804|NCT01915498|AML|aml
4937805|NCT01915498|myelodysplastic syndrome|myelodysplastic syndrome
4937806|NCT01915498|MDS|mds
4937807|NCT01915498|hematologic malignancies|hematologic malignancies
4937808|NCT01915498|IDH2|idh2
4937809|NCT01915498|Phase I|phase i
4937810|NCT01915498|Phase II|phase ii
4937811|NCT01915498|AG-221|ag-221
4937812|NCT01915498|relapse AML|relapse aml
4937813|NCT01915498|refractory AML|refractory aml
4937814|NCT01915472|Metastatic Colorectal Cancer|metastatic colorectal cancer
4937815|NCT01915472|Colorectal Cancer|colorectal cancer
4937816|NCT01915472|Rectal Cancer|rectal cancer
4937817|NCT01915472|previously treated|previously treated
4937818|NCT01915459|Stroke|stroke
4937819|NCT01915459|Spasticity|spasticity
4937820|NCT01915446|EVAR|evar
4937821|NCT01915446|endovascular aortic repair|endovascular aortic repair
4937822|NCT01915446|acute kidney failure|acute kidney failure
4937823|NCT01915446|mesenteric ischemia|mesenteric ischemia
4937824|NCT01915433|Secondary Progressive Multiple Sclerosis|secondary progressive multiple sclerosis
4937825|NCT01915433|Primary Progressive Multiple Sclerosis|primary progressive multiple sclerosis
4937826|NCT01915433|Relapsing progressive multiple sclerosis|relapsing progressive multiple sclerosis
4937827|NCT01915433|relapsing remitting multiple sclerosis|relapsing remitting multiple sclerosis
4937828|NCT01915433|Fatigue|fatigue
4937829|NCT01915433|Quality of life|quality of life
4937830|NCT01915433|Paleo|paleo
4937831|NCT01915433|Nutrition|nutrition
4937832|NCT01915433|Ketogenic|ketogenic
4937833|NCT01915420|Drug eluting stent|drug eluting stent
4937834|NCT01915420|Bioabsorbable|bioabsorbable
4937835|NCT01915420|Bioresorbable|bioresorbable
4937836|NCT01915420|Coronary Stent|coronary stent
4937837|NCT01915420|Scaffold|scaffold
4937838|NCT01915420|Stents|stents
4937839|NCT01915420|Angioplasty|angioplasty
4937840|NCT01915420|Coronary Artery Disease|coronary artery disease
4937841|NCT01915420|Stentthrombosis|stentthrombosis
4937842|NCT01915420|Rotational atherectomy|rotational atherectomy
4937843|NCT01915394|Respiratory Syncytial Virus Infections|respiratory syncytial virus infections
4937844|NCT01915394|Epidemics|epidemics
4937845|NCT01915394|Neonatal Intensive Care Unit|neonatal intensive care unit
4937846|NCT01915394|Newborn infants|newborn infants
4937847|NCT01915381|Intellectual disability|intellectual disability
4937848|NCT01915381|mHealth|mhealth
4937849|NCT01915381|App|app
4937850|NCT01915381|Physical activity|physical activity
4937851|NCT01915381|Adherence|adherence
4937852|NCT01915368|Exercise|exercise
4937853|NCT01915368|Rehabilitation|rehabilitation
4937854|NCT01915368|Dose|dose
4937855|NCT01915368|Randomized controlled trial|randomized controlled trial
4937856|NCT01915368|Stroke|stroke
4937857|NCT01915355|onychomycosis|onychomycosis
4937858|NCT01915355|nail|nail
4937859|NCT01915355|fungus|fungus
4937860|NCT01915342|Monosynaptic reflex|monosynaptic reflex
4937861|NCT01915342|H-reflex|h-reflex
4937862|NCT01915329|CRPS|crps
4937863|NCT01915329|repetitive sensory stimulation|repetitive sensory stimulation
4937864|NCT01915329|cortical reorganization|cortical reorganization
4937865|NCT01915329|2-point-discrimination|2-point-discrimination
4937866|NCT01915303|Cushing's disease, pituitary tumors, pasireotide, cabergoline, combination treatment, UFC, hormone disorder, cortisol, adrenocorticotropic hormone|cushing's disease, pituitary tumors, pasireotide, cabergoline, combination treatment, ufc, hormone disorder, cortisol, adrenocorticotropic hormone
4937867|NCT01915290|physical activity|physical activity
4937868|NCT01915290|maximal oxygen uptake|maximal oxygen uptake
4937869|NCT01915277|Pediatric corrective cardiac surgery|pediatric corrective cardiac surgery
4937870|NCT01915264|Diabetes Mellitus|diabetes mellitus
4937871|NCT01915264|Type 2 Diabetes|type 2 diabetes
4937872|NCT01915264|Acarbose (25/50mg) and Metformin (500mg) in fixed dose combination|acarbose (25/50mg) and metformin (500mg) in fixed dose combination
4937873|NCT01915251|Vulvovaginal Candidiasis|vulvovaginal candidiasis
4937874|NCT01915251|Amoxicilin|amoxicilin
4937875|NCT01915251|Microbiome|microbiome
4937876|NCT01915238|Age-Related Macular Degeneration (AMD)|age-related macular degeneration (amd)
4937877|NCT01915238|AMD|amd
4937878|NCT01915225|Tissue Procurement|tissue procurement
4937879|NCT01915225|Surgery|surgery
4937880|NCT01915225|Metastasectomy|metastasectomy
4937881|NCT01915212|Vaccination|vaccination
4937882|NCT01915212|Replication-Defective|replication-defective
4937883|NCT01915212|Genital Herpes|genital herpes
4937884|NCT01915212|Safety|safety
4937885|NCT01915212|Immune Responses|immune responses
4937886|NCT01915186|DHEA|dhea
4937887|NCT01915186|Poor ovarian reserve|poor ovarian reserve
4937888|NCT01915186|Normal ovarian reserve|normal ovarian reserve
4937889|NCT01915186|In vitro fertilization treatment|in vitro fertilization treatment
4937890|NCT01915186|Ovarian response|ovarian response
4937891|NCT01915186|Pregnancy outcomes|pregnancy outcomes
4937892|NCT01915173|Gastroesophageal reflux disease (GERD)|gastroesophageal reflux disease (gerd)
4937893|NCT01915173|Heartburn|heartburn
4937894|NCT01915173|Dyspepsia|dyspepsia
4937895|NCT01915147|oxycodone naloxone combination|oxycodone naloxone combination
4937896|NCT01915147|severe chronic pain|severe chronic pain
4937897|NCT01915147|non-malignant pain|non-malignant pain
4937898|NCT01915147|Non-malignant pain that requires around-the-clock opioid therapy|non-malignant pain that requires around-the-clock opioid therapy
4937899|NCT01915134|nasopharyngeal carcinoma|nasopharyngeal carcinoma
4937900|NCT01915134|Recombinant Human Endostatin|recombinant human endostatin
4937901|NCT01915134|chemotherapy|chemotherapy
4937902|NCT01915134|gemcitabine and cisplatin|gemcitabine and cisplatin
4937903|NCT01915121|Bladder Cancer|bladder cancer
4937904|NCT01915121|Intervention|intervention
4937905|NCT01915121|Education|education
4937906|NCT01915121|Randomized Controlled Trials|randomized controlled trials
4937907|NCT01915095|spinal cord injury|spinal cord injury
4937908|NCT01915095|neural control|neural control
4937909|NCT01915095|motor function|motor function
4937910|NCT01915095|hand movement|hand movement
4937911|NCT01915082|Lung Function|lung function
4937912|NCT01915082|Allograft Outcome|allograft outcome
4937913|NCT01915069|contraception|contraception
4937914|NCT01915069|Cilostazol|cilostazol
4937915|NCT01915069|phosphodiesterase inhibitors|phosphodiesterase inhibitors
4937916|NCT01915069|To assess the ability of Cilostazol to act as a contraceptive agent|to assess the ability of cilostazol to act as a contraceptive agent
4937917|NCT01915056|Comprehensive Geriatric Assessment (CGA)|comprehensive geriatric assessment (cga)
4937918|NCT01915056|GA-driven interventions|ga-driven interventions
4937919|NCT01915056|Toxicity|toxicity
4937920|NCT01915056|Outcomes|outcomes
4937921|NCT01915056|providing information|providing information
4937922|NCT01915056|older cancer patients|older cancer patients
4937923|NCT01915056|first-line chemotherapy|first-line chemotherapy
4937924|NCT01915056|second-line chemotherapy|second-line chemotherapy
4937925|NCT01915043|lymphedema, prevention, ehealth, cancer|lymphedema, prevention, ehealth, cancer
4937926|NCT01915030|Muscle|muscle
4937927|NCT01915030|Physical performance|physical performance
4937928|NCT01915030|Protein|protein
4937929|NCT01915030|Diet|diet
4937930|NCT01915030|Caloric restriction|caloric restriction
4937931|NCT01915017|Cognitive Adaptation Training|cognitive adaptation training
4937932|NCT01915017|Cognitive Behavior Therapy for Psychosis|cognitive behavior therapy for psychosis
4937933|NCT01915017|Schizophrenia|schizophrenia
4937934|NCT01915004|Pediatric Urology|pediatric urology
4937935|NCT01915004|Urotherapy|urotherapy
4937936|NCT01915004|Nonneurogenic Lower Urinary Tract Dysfunction|nonneurogenic lower urinary tract dysfunction
4937937|NCT01915004|Dysfunctional Elimination Syndrome|dysfunctional elimination syndrome
4937938|NCT01915004|Randomized Controlled Trial|randomized controlled trial
4937939|NCT01914991|proximal interphalangeal joint|proximal interphalangeal joint
4937940|NCT01914991|Orthoses|orthoses
4937941|NCT01914965|Huntington's disease|huntington's disease
4937942|NCT01914965|Apathy|apathy
4937943|NCT01914965|Bupropion|bupropion
4937944|NCT01914952|CaHMB|cahmb
4937945|NCT01914952|HMB free acid|hmb free acid
4937946|NCT01914952|HMB|hmb
4937947|NCT01914939|autism spectrum disorder|autism spectrum disorder
4937948|NCT01914939|social skills deficits|social skills deficits
4937949|NCT01914939|cognitive behavioral therapy|cognitive behavioral therapy
4937950|NCT01914939|oxytocin|oxytocin
4937951|NCT01914939|young adult|young adult
4937952|NCT01914926|metoprolol|metoprolol
4937953|NCT01914926|diltiazem|diltiazem
4937954|NCT01914926|heart rate|heart rate
4937955|NCT01914913|retinitis pigmentosa|retinitis pigmentosa
4937956|NCT01914913|Bone marrow|bone marrow
4937957|NCT01914913|stem cell|stem cell
4937958|NCT01914913|BMMNC|bmmnc
4937959|NCT01914900|oral cavity cancer|oral cavity cancer
4937960|NCT01914900|induction chemotherapy|induction chemotherapy
4937961|NCT01914900|TP53|tp53
4937963|NCT01914887|Ulcerative Colitis|ulcerative colitis
4937964|NCT01914887|Inflammatory Bowel Disease|inflammatory bowel disease
4937965|NCT01914887|Mesenchymal stem cells|mesenchymal stem cells
4937966|NCT01914874|Community Sample|community sample
4937967|NCT01914835|cocaine dependence|cocaine dependence
4937968|NCT01914835|neuropsychological rehabilitation|neuropsychological rehabilitation
4937969|NCT01914835|executive functions|executive functions
4937970|NCT01914822|Ritalin|ritalin
4937971|NCT01914822|methylphenidate hydrochloride|methylphenidate hydrochloride
4937972|NCT01914822|experimental pain|experimental pain
4937973|NCT01914796|Phase 1|phase 1
4937974|NCT01914796|Randomized|randomized
4937975|NCT01914796|Double Blind|double blind
4937976|NCT01914796|Placebo-Controlled|placebo-controlled
4937977|NCT01914796|Single-Dose Escalation|single-dose escalation
4937978|NCT01914796|Safety|safety
4937979|NCT01914796|Tolerability|tolerability
4937980|NCT01914796|PK|pk
4937981|NCT01914796|PD|pd
4937982|NCT01914796|PF-06412562|pf-06412562
4937983|NCT01914783|air pollution|air pollution
4937984|NCT01914783|ozone|ozone
4937985|NCT01914783|fine particle|fine particle
4937986|NCT01914783|cytokine|cytokine
4937987|NCT01914783|chemokine|chemokine
4937988|NCT01914783|oxidative stress|oxidative stress
4937989|NCT01914783|inflammation|inflammation
4937990|NCT01914783|heart rate variability|heart rate variability
4937991|NCT01914783|autonomic nervous system|autonomic nervous system
4937992|NCT01914783|sympathetic nerve activity|sympathetic nerve activity
4937993|NCT01914783|plasma catecholamine|plasma catecholamine
4937994|NCT01914770|pooled analyses|pooled analyses
4937995|NCT01914770|quality of life|quality of life
4937996|NCT01914770|SELENA SLEDAI|selena sledai
4937997|NCT01914770|SLE|sle
4937998|NCT01914770|steroid use|steroid use
4937999|NCT01914770|responder rate|responder rate
4938000|NCT01914770|flares|flares
4938001|NCT01914770|belimumab|belimumab
4938002|NCT01914770|BILAG|bilag
4938003|NCT01914757|Asthma, Bronchial Diseases, Respiratory Tract Diseases, Lung Diseases, Obstructive Lung Diseases|asthma, bronchial diseases, respiratory tract diseases, lung diseases, obstructive lung diseases
4938004|NCT01914744|NHL|nhl
4938005|NCT01914744|HBV|hbv
4938006|NCT01914744|entecavir|entecavir
4938007|NCT01914744|lamivudine|lamivudine
4938008|NCT01914731|Fecal Microbiota Transplant|fecal microbiota transplant
4938009|NCT01914731|Clostridium difficile|clostridium difficile
4938010|NCT01914731|Diarrhea|diarrhea
4938011|NCT01914718|DLBCL|dlbcl
4938012|NCT01914718|DA-EPOCH-R|da-epoch-r
4938013|NCT01914705|Landmark|landmark
4938014|NCT01914705|Ultrasound|ultrasound
4938015|NCT01914705|central venous catheter|central venous catheter
4938016|NCT01914679|Fibromyalgia|fibromyalgia
4938017|NCT01914679|Pain|pain
4938018|NCT01914679|Brain|brain
4938019|NCT01914679|Stimulation|stimulation
4938020|NCT01914679|Device|device
4938021|NCT01914679|Treatment|treatment
4938022|NCT01914666|Chronic Low Back Pain|chronic low back pain
4938023|NCT01914666|CLBP|clbp
4938152|NCT01914042|Neuropathic pain|neuropathic pain
4938024|NCT01914640|Waist circumference, Metabolic Syndrome, Cardiovascular risk|waist circumference, metabolic syndrome, cardiovascular risk
4938025|NCT01914627|Psoriasis capitis|psoriasis capitis
4938026|NCT01914627|Scaling|scaling
4938027|NCT01914627|Salicylic acid|salicylic acid
4938028|NCT01914627|Dimethicone|dimethicone
4938029|NCT01914627|Plaque removal|plaque removal
4938030|NCT01914614|Breast Cancer|breast cancer
4938031|NCT01914614|Working Women|working women
4938032|NCT01914601|Laryngoscope|laryngoscope
4938033|NCT01914601|Macintosh|macintosh
4938034|NCT01914601|King Vision|king vision
4938035|NCT01914601|tracheal intubation|tracheal intubation
4938036|NCT01914601|cervical spines|cervical spines
4938037|NCT01914536|POMPE|pompe
4938038|NCT01914536|Glycogenosis type II|glycogenosis type ii
4938039|NCT01914536|Acid maltase deficiency|acid maltase deficiency
4938040|NCT01914523|Laryngoscope|laryngoscope
4938041|NCT01914523|Macintosh|macintosh
4938042|NCT01914523|Glidescope|glidescope
4938043|NCT01914523|King Vision|king vision
4938044|NCT01914523|AirTraq|airtraq
4938045|NCT01914523|tracheal intubation|tracheal intubation
4938046|NCT01914510|ovarian|ovarian
4938047|NCT01914510|cancer|cancer
4938048|NCT01914510|clear cell|clear cell
4938049|NCT01914510|ENMD-2076|enmd-2076
4938050|NCT01914510|oral|oral
4938051|NCT01914510|capsule|capsule
4938052|NCT01914484|tyrosine kinase inhibitor resistance|tyrosine kinase inhibitor resistance
4938053|NCT01914484|chronic myeloid leukemia|chronic myeloid leukemia
4938054|NCT01914484|acute lymphoblastic leukemia|acute lymphoblastic leukemia
4938055|NCT01914484|nilotinib|nilotinib
4938056|NCT01914484|ruxolitinib|ruxolitinib
4938057|NCT01914458|Lung cancer|lung cancer
4938058|NCT01914458|Low-dose computed tomography scan|low-dose computed tomography scan
4938059|NCT01914419|Postpartum hemorrhage|postpartum hemorrhage
4938060|NCT01914419|Oxytocin|oxytocin
4938061|NCT01914419|Prevention|prevention
4938062|NCT01914419|Third stage of labor|third stage of labor
4938063|NCT01914419|Hemoglobin|hemoglobin
4938064|NCT01914419|Intravenous|intravenous
4938065|NCT01914419|Intramuscular|intramuscular
4938066|NCT01914419|Bolus|bolus
4938067|NCT01914406|Heart transplant recipients|heart transplant recipients
4938068|NCT01914406|Exercise capacity|exercise capacity
4938069|NCT01914406|endothelial function|endothelial function
4938070|NCT01914406|Quality of life|quality of life
4938071|NCT01914393|Schizophrenia|schizophrenia
4938072|NCT01914393|Autism|autism
4938073|NCT01914393|Lurasidone|lurasidone
4938074|NCT01914393|Latuda|latuda
4938075|NCT01914380|Wet age-related macular degeneration|wet age-related macular degeneration
4938076|NCT01914380|Anti-VEGF-Therapy|anti-vegf-therapy
4938077|NCT01914380|Observational study|observational study
4938078|NCT01914354|T cells|t cells
4938079|NCT01914354|Human Alloimmune Reactivity|human alloimmune reactivity
4938080|NCT01914354|immunosuppression|immunosuppression
4938081|NCT01914341|Infant|infant
4938082|NCT01914341|Newborn|newborn
4938083|NCT01914341|Music|music
4938084|NCT01914328|Postoperative Pulmonary Complications|postoperative pulmonary complications
4938085|NCT01914328|PORC|porc
4938086|NCT01914328|Surgical Related Outcome|surgical related outcome
4938087|NCT01914328|Surgical Related Mortality|surgical related mortality
4938088|NCT01914328|Postoperative ICU length of stay|postoperative icu length of stay
4938089|NCT01914315|Rehabilitation|rehabilitation
4938090|NCT01914315|Heart failure|heart failure
4938091|NCT01914315|HFPEF|hfpef
4938092|NCT01914315|Exercise training|exercise training
4938093|NCT01914289|Intrahepatic Cholangiocarcinoma|intrahepatic cholangiocarcinoma
4938094|NCT01914289|Prognosis|prognosis
4938095|NCT01914289|Resection|resection
4938096|NCT01914289|Radiotherapy|radiotherapy
4938097|NCT01914263|Cord blood-Derived cytokine induced killer cells,|cord blood-derived cytokine induced killer cells,
4938098|NCT01914263|Radical resection|radical resection
4938099|NCT01914250|Frenotomy|frenotomy
4938100|NCT01914250|Pain|pain
4938101|NCT01914237|Single-Branched Stent Graft System|single-branched stent graft system
4938102|NCT01914237|Aortic Dissection|aortic dissection
4938103|NCT01914237|Endovascular Repair|endovascular repair
4938104|NCT01914224|Prehypertension|prehypertension
4938105|NCT01914224|Hypertension|hypertension
4938106|NCT01914224|Sodium|sodium
4938107|NCT01914224|Potassium|potassium
4938108|NCT01914224|renin|renin
4938109|NCT01914224|aldosterone|aldosterone
4938110|NCT01914198|sleep study|sleep study
4938111|NCT01914198|NCH|nch
4938112|NCT01914185|Childhood|childhood
4938113|NCT01914185|Physical activity|physical activity
4938114|NCT01914185|Nutrition|nutrition
4938115|NCT01914185|Health Promotion|health promotion
4938116|NCT01914172|rare disease|rare disease
4938117|NCT01914172|community-based participatory research|community-based participatory research
4938118|NCT01914172|health promotion|health promotion
4938119|NCT01914172|quantitative research|quantitative research
4938120|NCT01914172|qualitative research|qualitative research
4938121|NCT01914172|focus group|focus group
4938122|NCT01914146|Diabetes|diabetes
4938123|NCT01914146|Insulin|insulin
4938124|NCT01914146|Orthostatic Hypotension|orthostatic hypotension
4938125|NCT01914146|Falls|falls
4938126|NCT01914146|Syncope|syncope
4938127|NCT01914133|Acarbose|acarbose
4938128|NCT01914133|PPH (Post Prandial Hypotension)|pph (post prandial hypotension)
4938129|NCT01914133|Falls|falls
4938130|NCT01914133|Syncope|syncope
4938131|NCT01914133|Elderly|elderly
4938132|NCT01914120|lung cancer|lung cancer
4938133|NCT01914120|quality of life|quality of life
4938134|NCT01914120|FACT-L|fact-l
4938135|NCT01914107|malignancy|malignancy
4938136|NCT01914107|solid tumor|solid tumor
4938137|NCT01914107|cancer pain|cancer pain
4938138|NCT01914094|Preoperative care|preoperative care
4938139|NCT01914094|Exercise therapy|exercise therapy
4938140|NCT01914094|Cardiac surgery|cardiac surgery
4938141|NCT01914081|Non-ischemic cardiomyopathy|non-ischemic cardiomyopathy
4938142|NCT01914081|Resveratrol|resveratrol
4938143|NCT01914068|Neoadjuvant chemoradiotherapy (NACRT)|neoadjuvant chemoradiotherapy (nacrt)
4938144|NCT01914068|Rectal cancer|rectal cancer
4938145|NCT01914068|Physical fitness|physical fitness
4938146|NCT01914068|Exercise programme|exercise programme
4938147|NCT01914068|Surgery|surgery
4938148|NCT01914068|Stage III/IV|stage iii/iv
4938149|NCT01914068|Locally advanced operable|locally advanced operable
4938150|NCT01914068|patients|patients
4938151|NCT01914042|Opioid induced hyperalgesia|opioid induced hyperalgesia
4938153|NCT01914042|Opioids|opioids
4938154|NCT01914042|Sciatica|sciatica
4938155|NCT01914042|Serotonin-norepinephrine reuptake inhibitor (SNRI)|serotonin-norepinephrine reuptake inhibitor (snri)
4938156|NCT01913990|Nausea|nausea
4938157|NCT01913990|Vomiting|vomiting
4938158|NCT01913938|Hemophagocytosis, adults, rhG-CSF|hemophagocytosis, adults, rhg-csf
4938159|NCT01913899|phantom limb pain|phantom limb pain
4938160|NCT01913899|mirror therapy|mirror therapy
4938161|NCT01913899|amputees|amputees
4938162|NCT01913899|phantom limb|phantom limb
4938163|NCT01913899|occupational therapy|occupational therapy
4938164|NCT01913886|Cardiovascular Diseases|cardiovascular diseases
4938165|NCT01913886|Myocardial Ischemia|myocardial ischemia
4938166|NCT01913886|Coronary Artery Disease|coronary artery disease
4938167|NCT01913886|Heart Diseases|heart diseases
4938168|NCT01913886|Coronary Disease|coronary disease
4938364|NCT01912716|ERCP|ercp
4938169|NCT01913886|Ventricular Dysfunction|ventricular dysfunction
4938170|NCT01913886|Arteriosclerosis|arteriosclerosis
4938171|NCT01913873|High-sensitivity Cardiac Troponin|high-sensitivity cardiac troponin
4938172|NCT01913873|Creatinin Kinase MB|creatinin kinase mb
4938173|NCT01913873|Cardiac Surgery|cardiac surgery
4938174|NCT01913873|Myocardial injury|myocardial injury
4938175|NCT01913873|Myocardial infarction|myocardial infarction
4938176|NCT01913873|Concentration change|concentration change
4938177|NCT01913860|UTI|uti
4938178|NCT01913860|antibiotics|antibiotics
4938179|NCT01913860|prescribing|prescribing
4938180|NCT01913860|primary care|primary care
4938181|NCT01913834|Parathyroid hormone 1-34|parathyroid hormone 1-34
4938182|NCT01913808|Postoperative anemia|postoperative anemia
4938183|NCT01913808|Total knee arthroplasty|total knee arthroplasty
4938184|NCT01913808|Iron therapy|iron therapy
4938185|NCT01913782|Chronic low back pain, CLBC, fMRI|chronic low back pain, clbc, fmri
4938186|NCT01913769|post-RT|post-rt
4938187|NCT01913769|myocardial perfusion images|myocardial perfusion images
4938188|NCT01913743|fMRI|fmri
4938189|NCT01913743|cognitive strategies|cognitive strategies
4938190|NCT01913743|obesity|obesity
4938191|NCT01913743|weight loss|weight loss
4938192|NCT01913743|mindsets|mindsets
4938193|NCT01913730|Multiple Myeloma|multiple myeloma
4938194|NCT01913730|Refractory|refractory
4938195|NCT01913730|Relapsed|relapsed
4938196|NCT01913717|Prostate cancer|prostate cancer
4938197|NCT01913717|Radiotherapy|radiotherapy
4938198|NCT01913717|hypofractionated radiotherapy|hypofractionated radiotherapy
4938199|NCT01913704|venous leg ulcer|venous leg ulcer
4938200|NCT01913704|mixed aetiology leg ulcers|mixed aetiology leg ulcers
4938201|NCT01913691|Neuroendocrine Skin Cancer|neuroendocrine skin cancer
4938202|NCT01913691|Merkel Cell Polyomavirus|merkel cell polyomavirus
4938203|NCT01913691|Immunotherapy|immunotherapy
4938204|NCT01913652|dedifferentiated liposarcoma|dedifferentiated liposarcoma
4938205|NCT01913652|cabazitaxel|cabazitaxel
4938206|NCT01913639|BAY 73-4506 (REGORAFENIB)|bay 73-4506 (regorafenib)
4938207|NCT01913639|FLUOROURACIL|fluorouracil
4938208|NCT01913639|LEUCOVORIN|leucovorin
4938209|NCT01913639|OXALIPLATIN|oxaliplatin
4938210|NCT01913626|subjective memory complains|subjective memory complains
4938211|NCT01913600|TARGET LESION REVASCULARIZATION (TLR)|target lesion revascularization (tlr)
4938212|NCT01913600|TARGET VESSEL REVASCULARIZATION (TVR)|target vessel revascularization (tvr)
4938213|NCT01913600|Coronary Artery Disease|coronary artery disease
4938214|NCT01913600|MYOCARDIAL INFARCTION (MI)|myocardial infarction (mi)
4938215|NCT01913600|PERCUTANEOUS CORONARY INTERVENTION (PCI)|percutaneous coronary intervention (pci)
4938216|NCT01913600|STENT THROMBOSIS|stent thrombosis
4938217|NCT01913600|TARGET LESION FAILURE (TLF)|target lesion failure (tlf)
4938218|NCT01913561|Electrocardiogram|electrocardiogram
4938219|NCT01913561|gel electrodes|gel electrodes
4938220|NCT01913561|textile electrodes|textile electrodes
4938221|NCT01913535|Depression|depression
4938222|NCT01913535|Treatment Resistant Depression|treatment resistant depression
4938223|NCT01913535|Antidepressant|antidepressant
4938224|NCT01913535|Major Depression|major depression
4938225|NCT01913535|MDD|mdd
4938226|NCT01913509|hemiplegic shoulder pain|hemiplegic shoulder pain
4938227|NCT01913509|poststroke fatigue|poststroke fatigue
4938228|NCT01913509|functional electrical stimulation|functional electrical stimulation
4938229|NCT01913509|stroke rehabilitation|stroke rehabilitation
4938230|NCT01913496|web application|web application
4938231|NCT01913496|nutrition knowledge|nutrition knowledge
4938232|NCT01913496|physical activity|physical activity
4938233|NCT01913470|NAFLD|nafld
4938234|NCT01913470|Non-alcoholic Fatty Liver Disease|non-alcoholic fatty liver disease
4938235|NCT01913470|Obesity|obesity
4938236|NCT01913470|Pediatrics|pediatrics
4938237|NCT01913470|Children|children
4938238|NCT01913470|Losartan|losartan
4938239|NCT01913470|Cozaar|cozaar
4938240|NCT01913457|Ultrasound Doppler|ultrasound doppler
4938241|NCT01913457|Lungs|lungs
4938242|NCT01913457|Pulmonary artery hypertension|pulmonary artery hypertension
4938243|NCT01913444|Recombinant Antithrombin|recombinant antithrombin
4938244|NCT01913444|ATryn|atryn
4938245|NCT01913444|Pharmacokinetics|pharmacokinetics
4938246|NCT01913444|ECMO|ecmo
4938247|NCT01913444|Neonates|neonates
4938248|NCT01913418|Traditional Chinese Medicine|traditional chinese medicine
4938249|NCT01913418|Suan-Zao-Ren Tang|suan-zao-ren tang
4938250|NCT01913418|Methadone|methadone
4938251|NCT01913418|Opiate dependence|opiate dependence
4938252|NCT01913418|Sleep|sleep
4938253|NCT01913379|Phase 1|phase 1
4938254|NCT01913379|MDV3100|mdv3100
4938255|NCT01913379|Gemfibrozil|gemfibrozil
4938256|NCT01913379|Itraconazole|itraconazole
4938257|NCT01913379|Xtandi|xtandi
4938258|NCT01913379|enzalutamide|enzalutamide
4938259|NCT01913340|erythropoietin|erythropoietin
4938260|NCT01913340|therapeutic hypothermia|therapeutic hypothermia
4938261|NCT01913327|cognition|cognition
4938262|NCT01913327|executive function|executive function
4938263|NCT01913327|prefrontal cortex|prefrontal cortex
4938264|NCT01913327|locus coeruleus|locus coeruleus
4938265|NCT01913288|neonatal care, preterm, maternal sounds, auditory stimulation|neonatal care, preterm, maternal sounds, auditory stimulation
4938470|NCT01912183|pilot|pilot
4938266|NCT01913275|cholecystojejunostomy|cholecystojejunostomy
4938267|NCT01913275|whipple's pancreaticoduodenectomy|whipple's pancreaticoduodenectomy
4938268|NCT01913275|endoscopic stenting|endoscopic stenting
4938269|NCT01913275|hyperbilirubinemia|hyperbilirubinemia
4938270|NCT01913262|depression|depression
4938271|NCT01913262|phq9|phq9
4938272|NCT01913262|phq-9|phq-9
4938273|NCT01913262|standard treatment|standard treatment
4938274|NCT01913249|Anorectal fistula|anorectal fistula
4938275|NCT01913249|LIFT|lift
4938276|NCT01913249|Seton|seton
4938277|NCT01913236|Tailored implementation interventions|tailored implementation interventions
4938278|NCT01913236|Primary care|primary care
4938279|NCT01913236|Depression in the elderly|depression in the elderly
4938280|NCT01913223|Endoscopic submucosal dissection|endoscopic submucosal dissection
4938281|NCT01913223|jet injector|jet injector
4938282|NCT01913223|saline solution|saline solution
4938283|NCT01913223|safety|safety
4938284|NCT01913223|effectiveness|effectiveness
4938285|NCT01913197|Prostate Brachytherapy|prostate brachytherapy
4938286|NCT01913119|extranodal NKTcell lymphoma|extranodal nktcell lymphoma
4938287|NCT01913093|Childhood leukemia survivors|childhood leukemia survivors
4938288|NCT01913093|Acute lymphoblastic leukemia|acute lymphoblastic leukemia
4938289|NCT01913093|Leukemia|leukemia
4938290|NCT01913093|Late effects|late effects
4938291|NCT01913093|Folate|folate
4938292|NCT01913093|Blood folate|blood folate
4938293|NCT01913093|Neurotoxicity|neurotoxicity
4938294|NCT01913093|Methotrexate|methotrexate
4938295|NCT01913093|Pharmacogenetics|pharmacogenetics
4938296|NCT01913093|Cognitive|cognitive
4938297|NCT01913093|Cognitive late effects|cognitive late effects
4938298|NCT01913093|N-PhenoGENICS|n-phenogenics
4938299|NCT01913080|health management|health management
4938300|NCT01913067|brain metastasis|brain metastasis
4938301|NCT01913067|breast cancer|breast cancer
4938302|NCT01913067|HER2 negative|her2 negative
4938303|NCT01913067|NSCLC|nsclc
4938304|NCT01913054|Etomidate|etomidate
4938305|NCT01913054|Propofol|propofol
4938306|NCT01913054|Painless gastroscopy|painless gastroscopy
4938307|NCT01913041|perioperative hypothermia|perioperative hypothermia
4938308|NCT01913041|Epidemiology|epidemiology
4938309|NCT01913041|Tympanic temperature|tympanic temperature
4938310|NCT01913028|safety, tolerability, pharmacokinetics,immunogenicity, MEDI9929, Japanese|safety, tolerability, pharmacokinetics,immunogenicity, medi9929, japanese
4938311|NCT01912989|motivational interviewing|motivational interviewing
4938312|NCT01912989|obesity|obesity
4938313|NCT01912989|parent|parent
4938314|NCT01912976|Bowen's disease|bowen's disease
4938315|NCT01912976|Er:YAG|er:yag
4938316|NCT01912976|AFL-assisted|afl-assisted
4938317|NCT01912976|MAL-PDT|mal-pdt
4938318|NCT01912963|HER-2 Positive Breast Cancer|her-2 positive breast cancer
4938319|NCT01912950|intense pulsed light|intense pulsed light
4938320|NCT01912950|IPL|ipl
4938321|NCT01912950|healthy volunteer|healthy volunteer
4938322|NCT01912950|light-based hair removal|light-based hair removal
4938323|NCT01912950|hair removal|hair removal
4938324|NCT01912950|epilation|epilation
4938325|NCT01912950|laser hair removal|laser hair removal
4938326|NCT01912950|permanent hair reduction|permanent hair reduction
4938327|NCT01912937|Paclitaxel|paclitaxel
4938328|NCT01912937|Percutaneous Transluminal Angioplasty|percutaneous transluminal angioplasty
4938329|NCT01912937|Balloon Catheter|balloon catheter
4938330|NCT01912937|Pharmacokinetic|pharmacokinetic
4938331|NCT01912937|Peripheral Artery Disease|peripheral artery disease
4938332|NCT01912937|PAD|pad
4938333|NCT01912924|chronic pain from failed knee surgery|chronic pain from failed knee surgery
4938334|NCT01912846|End-of-life care|end-of-life care
4938335|NCT01912846|Preference of end-of-life care|preference of end-of-life care
4938336|NCT01912846|RCT|rct
4938337|NCT01912846|Terminally ill cancer patients|terminally ill cancer patients
4938338|NCT01912833|postpartum depression|postpartum depression
4938339|NCT01912807|Postoperative vomiting|postoperative vomiting
4938340|NCT01912807|Children|children
4938341|NCT01912794|Cerebrovascular Accident|cerebrovascular accident
4938342|NCT01912794|Rehabilitation|rehabilitation
4938343|NCT01912794|Sensory System|sensory system
4938344|NCT01912781|contact lenses|contact lenses
4938345|NCT01912781|contact lens solution|contact lens solution
4938346|NCT01912781|gas permeable contact lenses|gas permeable contact lenses
4938347|NCT01912768|contact lenses|contact lenses
4938348|NCT01912768|contact lens solution|contact lens solution
4938349|NCT01912768|soft contact lenses|soft contact lenses
4938350|NCT01912755|Pulpitis|pulpitis
4938351|NCT01912755|Hot tooth|hot tooth
4938352|NCT01912755|Articaine|articaine
4938353|NCT01912755|Lidocaine|lidocaine
4938354|NCT01912755|Local anesthetics|local anesthetics
4938355|NCT01912742|Weight loss|weight loss
4938356|NCT01912742|Speed of weight loss|speed of weight loss
4938357|NCT01912742|Metabolic compensation|metabolic compensation
4938358|NCT01912742|Diet therapy|diet therapy
4938359|NCT01912729|Depression prevention|depression prevention
4938360|NCT01912729|Technology Assisted|technology assisted
4938361|NCT01912729|Adolescents|adolescents
4938362|NCT01912729|Peer networked|peer networked
4938363|NCT01912716|pancreatitis|pancreatitis
4938365|NCT01912677|hypertension in pregnancy|hypertension in pregnancy
4938366|NCT01912677|preeclampsia|preeclampsia
4938367|NCT01912677|anti-hypertension|anti-hypertension
4938368|NCT01912677|labetalol|labetalol
4938369|NCT01912677|nifedipine|nifedipine
4938370|NCT01912677|methyldopa|methyldopa
4938371|NCT01912651|facial skin wound|facial skin wound
4938372|NCT01912651|facial wound|facial wound
4938373|NCT01912651|skin wound|skin wound
4938374|NCT01912651|facial defect|facial defect
4938375|NCT01912651|reconstructive skin graft|reconstructive skin graft
4938376|NCT01912638|Trabeculectomy|trabeculectomy
4938377|NCT01912638|Glaucoma|glaucoma
4938378|NCT01912638|Steroids|steroids
4938379|NCT01912638|Ologen|ologen
4938380|NCT01912638|Viscoelastic|viscoelastic
4938381|NCT01912612|Breast cancer|breast cancer
4938382|NCT01912612|Pain sensitivity|pain sensitivity
4938383|NCT01912599|Glaucoma|glaucoma
4938384|NCT01912599|Intraocular Pressure|intraocular pressure
4938385|NCT01912599|Blood Pressure|blood pressure
4938386|NCT01912586|erectile dysfunction|erectile dysfunction
4938387|NCT01912586|laparoscopic surgery|laparoscopic surgery
4938388|NCT01912586|rectal cancer|rectal cancer
4938389|NCT01912586|sildenafil|sildenafil
4938390|NCT01912586|vacuum erection device|vacuum erection device
4938391|NCT01912573|heroin|heroin
4938392|NCT01912573|prescription pain killers|prescription pain killers
4938393|NCT01912573|narcotics|narcotics
4938394|NCT01912534|Sarcomere Mutations|sarcomere mutations
4938395|NCT01912521|HIV|hiv
4938396|NCT01912521|Stigma|stigma
4938397|NCT01912521|Social support|social support
4938398|NCT01912521|Social network|social network
4938399|NCT01912521|Kenya|kenya
4938400|NCT01912508|cervical length|cervical length
4938401|NCT01912508|cervical curvature|cervical curvature
4938402|NCT01912469|Muscle|muscle
4938403|NCT01912469|exercise|exercise
4938404|NCT01912469|soreness|soreness
4938405|NCT01912469|Damage|damage
4938406|NCT01912469|Traumeel|traumeel
4938407|NCT01912456|Hereditary Angioedema|hereditary angioedema
4938408|NCT01912430|Integrated Care Coaching|integrated care coaching
4938409|NCT01912430|Chronic Care Coaching|chronic care coaching
4938410|NCT01912430|Care Coaching|care coaching
4938411|NCT01912417|HEMODIALYSIS|hemodialysis
4938412|NCT01912417|Kidney Failure, Chronic|kidney failure, chronic
4938413|NCT01912417|AEROBIC EXERCISE|aerobic exercise
4938414|NCT01912404|alcoholic hepatitis|alcoholic hepatitis
4938415|NCT01912391|Depression|depression
4938416|NCT01912391|Anxiety|anxiety
4938417|NCT01912391|Headaches|headaches
4938418|NCT01912391|Migraines|migraines
4938419|NCT01912391|Irritable Bowel Syndrome IBS|irritable bowel syndrome ibs
4938420|NCT01912391|Neurodermatitis|neurodermatitis
4938421|NCT01912391|Fibromyalgia|fibromyalgia
4938422|NCT01912391|Premenstrual Syndrome PMS|premenstrual syndrome pms
4938423|NCT01912391|Temporomandibular Joint Dysfunction TMJ|temporomandibular joint dysfunction tmj
4938424|NCT01912365|Fracture|fracture
4938425|NCT01912365|Supracondylar|supracondylar
4938426|NCT01912365|Pediatric|pediatric
4938427|NCT01912365|Orthopedic|orthopedic
4938428|NCT01912352|ADHD|adhd
4938429|NCT01912352|ADRA2A|adra2a
4938430|NCT01912352|Methylphenidate|methylphenidate
4938431|NCT01912352|Response|response
4938432|NCT01912339|Hyperlasia|hyperlasia
4938433|NCT01912339|Retention|retention
4938434|NCT01912339|Prostate|prostate
4938435|NCT01912326|pacemaker|pacemaker
4938436|NCT01912326|atrial fibrillation|atrial fibrillation
4938437|NCT01912313|IBS patients|ibs patients
4938438|NCT01912313|healthy subjects|healthy subjects
4938439|NCT01912287|Generalized Anxiety Disorder|generalized anxiety disorder
4938440|NCT01912287|GAD|gad
4938441|NCT01912287|Yoga|yoga
4938442|NCT01912287|CBT|cbt
4938443|NCT01912274|AML|aml
4938444|NCT01912274|open label|open label
4938445|NCT01912274|nonrandomized|nonrandomized
4938446|NCT01912274|single arm|single arm
4938447|NCT01912274|elderly patients|elderly patients
4938448|NCT01912274|HMA|hma
4938449|NCT01912274|newly diagnosed|newly diagnosed
4938450|NCT01912261|Coronary artery bypass gafting|coronary artery bypass gafting
4938451|NCT01912261|Anemia|anemia
4938452|NCT01912261|Postoperative fatigue|postoperative fatigue
4938453|NCT01912261|Functional Capacity|functional capacity
4938454|NCT01912261|Iron|iron
4938455|NCT01912261|Adherence|adherence
4938456|NCT01912248|acute rise of systolic and diastolic bloodpressure|acute rise of systolic and diastolic bloodpressure
4938457|NCT01912235|Arginine synthesis|arginine synthesis
4938458|NCT01912235|15N2 arginine, 1-13C Glutamine, 2-15N Glutamine, 15N Proline|15n2 arginine, 1-13c glutamine, 2-15n glutamine, 15n proline
4938459|NCT01912209|employees|employees
4938460|NCT01912209|metabolic syndrome|metabolic syndrome
4938461|NCT01912209|obesity|obesity
4938462|NCT01912209|sub-clinical cardiovascular disease|sub-clinical cardiovascular disease
4938463|NCT01912209|weight loss|weight loss
4938464|NCT01912209|diet|diet
4938465|NCT01912196|Depressive Disorder|depressive disorder
4938466|NCT01912183|pediatric obesity|pediatric obesity
4938467|NCT01912183|e-learning|e-learning
4938468|NCT01912183|personal health record|personal health record
4938469|NCT01912183|personal electronic device|personal electronic device
4938471|NCT01912170|omega-3 fatty acid|omega-3 fatty acid
4938472|NCT01912170|gestational diabetes|gestational diabetes
4938473|NCT01912170|insulin sensitivity|insulin sensitivity
4938474|NCT01912131|13-120|13-120
4938475|NCT01912118|Nociception|nociception
4938476|NCT01912118|General anesthesia|general anesthesia
4938477|NCT01912105|endotracheal tube|endotracheal tube
4938478|NCT01912105|ct scan|ct scan
4938479|NCT01912105|cleaning device|cleaning device
4938480|NCT01912105|biofilm|biofilm
4938481|NCT01912105|mechanical ventilation|mechanical ventilation
4938482|NCT01912053|Intra-hepatic Cholangiocarcinoma treatment|intra-hepatic cholangiocarcinoma treatment
4938483|NCT01912040|Safety profile|safety profile
4938484|NCT01912040|locally produced 123 Iodine MIBG|locally produced 123 iodine mibg
4938485|NCT01912014|stroke|stroke
4938486|NCT01912014|psychosocial|psychosocial
4938487|NCT01912014|intervention|intervention
4938488|NCT01912014|quality of life|quality of life
4938489|NCT01912001|end stage renal disease|end stage renal disease
4938490|NCT01912001|kidney failure|kidney failure
4938491|NCT01912001|home dialysis|home dialysis
4938492|NCT01912001|hemodialysis|hemodialysis
4938493|NCT01912001|peritoneal dialysis|peritoneal dialysis
4938494|NCT01912001|gaps in care|gaps in care
4938495|NCT01912001|co-morbidity|co-morbidity
4938496|NCT01912001|transitions of care settings|transitions of care settings
4938497|NCT01911988|Peripheral immune cells|peripheral immune cells
4938498|NCT01911988|Colorectal Cancers|colorectal cancers
4938499|NCT01911988|Stage II/ Stage III|stage ii/ stage iii
4938500|NCT01911988|Recurrence|recurrence
4938501|NCT01911988|Metastasis|metastasis
4938502|NCT01911975|Small Fiber Neuropathy|small fiber neuropathy
4938503|NCT01911975|Painful Neuropathy|painful neuropathy
4938504|NCT01911975|NAV1.7 Voltage-Gated Sodium Channel|nav1.7 voltage-gated sodium channel
4938505|NCT01911975|SCN9A|scn9a
4938506|NCT01911949|femoral nerve block|femoral nerve block
4938507|NCT01911949|ultrasound guided|ultrasound guided
4938508|NCT01911949|total hip arthroplasty|total hip arthroplasty
4938509|NCT01911936|CLJM716,|cljm716,
4938510|NCT01911936|Japanese patients,|japanese patients,
4938511|NCT01911936|Neoplasms|neoplasms
4938512|NCT01911910|primary prevention|primary prevention
4938513|NCT01911910|Cardiovascular disease|cardiovascular disease
4938514|NCT01911910|Cardiovascular magnetic resonance (CMR)|cardiovascular magnetic resonance (cmr)
4938515|NCT01911910|Electronic coaching (e-coaching)|electronic coaching (e-coaching)
4938516|NCT01911897|Hypertension|hypertension
4938517|NCT01911884|Rokitansky syndrome|rokitansky syndrome
4938518|NCT01911884|surgical or vaginal dilatation of vaginal aplasia|surgical or vaginal dilatation of vaginal aplasia
4938519|NCT01911884|quality of global and sexual life|quality of global and sexual life
4938520|NCT01911871|Thalassemia|thalassemia
4938521|NCT01911871|sickle cell disease|sickle cell disease
4938522|NCT01911871|myelodysplasia|myelodysplasia
4938523|NCT01911871|transfusion|transfusion
4938524|NCT01911871|chelation|chelation
4938525|NCT01911845|HCV Genotype 1|hcv genotype 1
4938526|NCT01911845|Hepatitis Genotype 1|hepatitis genotype 1
4938527|NCT01911845|Interferon Free|interferon free
4938528|NCT01911845|methadone|methadone
4938529|NCT01911845|HCV|hcv
4938530|NCT01911845|Buprenorphine|buprenorphine
4938531|NCT01911845|Hepatitis C|hepatitis c
4938532|NCT01911845|Viekira Pak|viekira pak
4938533|NCT01911845|paritaprevir|paritaprevir
4938534|NCT01911845|Viekira|viekira
4938535|NCT01911845|ombitasvir|ombitasvir
4938536|NCT01911845|dasabuvir|dasabuvir
4938537|NCT01911832|Cancer of the esophagogastric junction|cancer of the esophagogastric junction
4938538|NCT01911832|Reconstruction of gastric tube|reconstruction of gastric tube
4938539|NCT01911832|Quality of life|quality of life
4938540|NCT01911832|Width|width
4938541|NCT01911832|Regurgitation|regurgitation
4938542|NCT01911819|Histomorphometric Analysis|histomorphometric analysis
4938543|NCT01911819|New bone Formation|new bone formation
4938544|NCT01911819|Sinus Augmentation|sinus augmentation
4938545|NCT01911819|Bone Graft Materials|bone graft materials
4938546|NCT01911806|Back care pillow|back care pillow
4938547|NCT01911806|chronic non-specific low back pain|chronic non-specific low back pain
4938548|NCT01911806|randomized controlled trial|randomized controlled trial
4938549|NCT01911793|stoma|stoma
4938550|NCT01911793|ileus|ileus
4938551|NCT01911793|postoperative|postoperative
4938552|NCT01911793|stoma tube|stoma tube
4938553|NCT01911741|Phase I|phase i
4938554|NCT01911741|Enzalutamide|enzalutamide
4938555|NCT01911741|Relative bioavailability of MDV3100|relative bioavailability of mdv3100
4938556|NCT01911741|Immediate release oral formulation|immediate release oral formulation
4938557|NCT01911741|Xtandi|xtandi
4938558|NCT01911728|Drug-Drug Interaction|drug-drug interaction
4938559|NCT01911728|Phase 1|phase 1
4938560|NCT01911728|MDV3100|mdv3100
4938561|NCT01911728|Xtandi|xtandi
4938562|NCT01911728|Enzalutamide|enzalutamide
4938563|NCT01911715|Phase 1|phase 1
4938564|NCT01911715|Mass Balance|mass balance
4938565|NCT01911715|MDV3100|mdv3100
4938566|NCT01911715|Xtandi|xtandi
4938567|NCT01911715|Enzalutamide|enzalutamide
4938568|NCT01911715|Metabolism|metabolism
4938569|NCT01911715|Excretion|excretion
4938570|NCT01911689|pancreatitis|pancreatitis
4938571|NCT01911689|MRI|mri
4938573|NCT01911689|T2*|t2*
4938574|NCT01911689|T2 star|t2 star
4938575|NCT01911650|Achilles|achilles
4938576|NCT01911650|tendinopathy|tendinopathy
4938577|NCT01911637|Healthy|healthy
4938578|NCT01911637|Subjects|subjects
4938579|NCT01911637|Safety|safety
4938580|NCT01911637|Tolerability|tolerability
4938581|NCT01911637|VBY-036|vby-036
4938582|NCT01911637|Maximum|maximum
4938583|NCT01911637|Pharmacodynamic|pharmacodynamic
4938584|NCT01911637|Pharmacokinetic|pharmacokinetic
4938585|NCT01911585|Posttraumatic Stress Disorder|posttraumatic stress disorder
4938586|NCT01911585|PTSD|ptsd
4938587|NCT01911585|Prolonged Exposure Therapy|prolonged exposure therapy
4938588|NCT01911585|Cognitive Behavioral Therapy|cognitive behavioral therapy
4938589|NCT01911572|Streptococcus species|streptococcus species
4938590|NCT01911572|Streptococcus pyogenes|streptococcus pyogenes
4938591|NCT01911572|Streptococcus agalactiae|streptococcus agalactiae
4938592|NCT01911572|Necrotising fasciitis|necrotising fasciitis
4938593|NCT01911572|Sepsis|sepsis
4938594|NCT01911559|Standing-frame|standing-frame
4938595|NCT01911559|Chronic constipation|chronic constipation
4938596|NCT01911559|Cerebral palsy|cerebral palsy
4938597|NCT01911559|Quadriplegia|quadriplegia
4938598|NCT01911559|Severe diplegia|severe diplegia
4938599|NCT01911494|cluster randomized controlled trial|cluster randomized controlled trial
4938600|NCT01911494|pre-eclampsia|pre-eclampsia
4938601|NCT01911494|eclampsia|eclampsia
4938602|NCT01911494|maternal mortality|maternal mortality
4938603|NCT01911468|PCOS|pcos
4938604|NCT01911468|obesity|obesity
4938605|NCT01911468|GLP-1 receptor agonist|glp-1 receptor agonist
4938606|NCT01911468|liraglutide|liraglutide
4938607|NCT01911468|metformin|metformin
4938608|NCT01911455|Fragile X Syndrome|fragile x syndrome
4938609|NCT01911442|Autism, Lurasidone, Latuda|autism, lurasidone, latuda
4938610|NCT01911429|schizophrenia|schizophrenia
4938611|NCT01911429|Lurasidone|lurasidone
4938612|NCT01911429|Latuda|latuda
4938613|NCT01911403|Femoral Artery puncture|femoral artery puncture
4938614|NCT01911390|High cholesterol.|high cholesterol.
4938615|NCT01911364|Frequent exacerbators|frequent exacerbators
4938616|NCT01911351|nitrous oxide|nitrous oxide
4938617|NCT01911351|pediatric pain and anxiety|pediatric pain and anxiety
4938618|NCT01911338|Spinal Manipulation|spinal manipulation
4938619|NCT01911338|Teaching|teaching
4938620|NCT01911338|Thoracic Vertebrae|thoracic vertebrae
4938621|NCT01911338|Feedback|feedback
4938622|NCT01911325|Squamous non-small cell lung cancer|squamous non-small cell lung cancer
4938623|NCT01911325|NSCLC|nsclc
4938624|NCT01911325|Docetaxel|docetaxel
4938625|NCT01911325|Buparlisib|buparlisib
4938626|NCT01911325|BKM120|bkm120
4938627|NCT01911325|Metastatic|metastatic
4938628|NCT01911325|Stage IIIb|stage iiib
4938629|NCT01911325|Stage IV|stage iv
4938630|NCT01911325|PI3K inhibitor|pi3k inhibitor
4938631|NCT01911299|Choline|choline
4938632|NCT01911299|Glycerophosphocholine|glycerophosphocholine
4938633|NCT01911299|Choline alphoscerate|choline alphoscerate
4938634|NCT01911299|Fetal alcohol spectrum disorders|fetal alcohol spectrum disorders
4938635|NCT01911299|Fetal alcohol syndrome|fetal alcohol syndrome
4938636|NCT01911299|Partial fetal alcohol syndrome|partial fetal alcohol syndrome
4938637|NCT01911299|Alcohol-related neurodevelopmental disorder|alcohol-related neurodevelopmental disorder
4938638|NCT01911299|Prenatal alcohol exposure|prenatal alcohol exposure
4938639|NCT01911299|Fetal Alcohol Effects|fetal alcohol effects
4938640|NCT01911299|Pregnancy Complications|pregnancy complications
4938641|NCT01911299|Alcohol-Induced Disorders|alcohol-induced disorders
4938642|NCT01911299|Alcohol-Related Disorders|alcohol-related disorders
4938643|NCT01911299|Central Nervous System Agents|central nervous system agents
4938644|NCT01911299|Therapeutic Uses|therapeutic uses
4938645|NCT01911273|Hepatocellular carcinoma|hepatocellular carcinoma
4938646|NCT01911273|monoclonal antibody|monoclonal antibody
4938647|NCT01911273|ALK-1|alk-1
4938648|NCT01911273|best supportive care|best supportive care
4938649|NCT01911260|Zinc|zinc
4938650|NCT01911260|Growth|growth
4938651|NCT01911260|Child|child
4938652|NCT01911260|Dietary Supplements|dietary supplements
4938653|NCT01911260|Randomized Controlled Trial|randomized controlled trial
4938654|NCT01911221|Meningococcal disease,|meningococcal disease,
4938655|NCT01911221|Adults|adults
4938656|NCT01911208|Minority|minority
4938657|NCT01911208|Recruitment|recruitment
4938658|NCT01911195|General anesthesia|general anesthesia
4938659|NCT01911195|cognition|cognition
4938660|NCT01911195|consciousness|consciousness
4938661|NCT01911182|apnea of prematurity|apnea of prematurity
4938662|NCT01911182|control of breathing|control of breathing
4938663|NCT01911182|newborn|newborn
4938664|NCT01911182|CO2 inhalation|co2 inhalation
4938665|NCT01911169|atherosclerosis|atherosclerosis
4938666|NCT01911169|systemic lupus erythematosus|systemic lupus erythematosus
4938667|NCT01911169|flow mediated dilation|flow mediated dilation
4938668|NCT01911169|interferon gene signature|interferon gene signature
4938669|NCT01911156|Chronic Hepatitis B|chronic hepatitis b
4938670|NCT01911130|outcomes measures|outcomes measures
4938671|NCT01911130|strength measurement|strength measurement
4938672|NCT01911130|disease progression|disease progression
4938673|NCT01911104|muscle|muscle
4938674|NCT01911104|mitochondrial function|mitochondrial function
4938675|NCT01911104|exercise resistance|exercise resistance
4938676|NCT01911104|human|human
4938677|NCT01911104|myotubes|myotubes
4938678|NCT01911104|epigenetics|epigenetics
4938679|NCT01911091|skeletal muscle|skeletal muscle
4938680|NCT01911091|adipose tissue|adipose tissue
4938681|NCT01911091|metabolism|metabolism
4938682|NCT01911091|oxidation|oxidation
4938683|NCT01911091|mitochondrial capacity|mitochondrial capacity
4938684|NCT01911078|Metabolic syndrome|metabolic syndrome
4938685|NCT01911078|Renal denervation|renal denervation
4938686|NCT01911078|Renal artery|renal artery
4938687|NCT01911078|Muscle sympathetic nerve activity|muscle sympathetic nerve activity
4938688|NCT01911065|Herpes zoster|herpes zoster
4938689|NCT01911065|immune response|immune response
4938690|NCT01911065|Zostavax|zostavax
4938691|NCT01911065|twins|twins
4938692|NCT01911065|non-twins|non-twins
4938693|NCT01911052|Bowel preparation|bowel preparation
4938694|NCT01911039|GVHD|gvhd
4938695|NCT01911039|cGVHD|cgvhd
4938696|NCT01911026|Bowel preparation|bowel preparation
4938697|NCT01911013|degenerative cervical disease|degenerative cervical disease
4938698|NCT01911013|anterior cervical discectomy and fusion|anterior cervical discectomy and fusion
4938699|NCT01911013|plate and cage|plate and cage
4938700|NCT01911013|cage alone|cage alone
4938701|NCT01910987|Multiple Myeloma|multiple myeloma
4938702|NCT01910987|bortezomib|bortezomib
4938703|NCT01910987|Velcade|velcade
4938704|NCT01910987|First or Second Relapse|first or second relapse
4938705|NCT01910987|retreatment|retreatment
4938706|NCT01910987|Prolonged therapy|prolonged therapy
4938707|NCT01910974|oesophagus|oesophagus
4938708|NCT01910974|stomach|stomach
4938709|NCT01910974|intestine|intestine
4938710|NCT01910974|rectum|rectum
4938711|NCT01910948|omega-3 gastric cancer perioperation|omega-3 gastric cancer perioperation
4938712|NCT01910935|Physical activity|physical activity
4938713|NCT01910935|Hypertension|hypertension
4938714|NCT01910935|Scheme reference|scheme reference
4938715|NCT01910935|Primary care|primary care
4938716|NCT01910922|vegetable acceptance|vegetable acceptance
4938717|NCT01910922|vegetable intake|vegetable intake
4938718|NCT01910922|vegetable liking|vegetable liking
4938719|NCT01910922|learning mechanisms|learning mechanisms
4938720|NCT01910922|repeated exposure to flavor|repeated exposure to flavor
4938721|NCT01910922|flavor learning|flavor learning
4938722|NCT01910922|replace salt with spice|replace salt with spice
4938723|NCT01910909|Hepatocellular carcinoma|hepatocellular carcinoma
4938724|NCT01910909|unresectable|unresectable
4938725|NCT01910909|small size|small size
4938726|NCT01910909|Stereotactic body radiotherapy|stereotactic body radiotherapy
4938727|NCT01910883|Safety|safety
4938728|NCT01910883|Tolerability|tolerability
4938729|NCT01910883|Pharmacokinetic|pharmacokinetic
4938730|NCT01910870|Early-relapse|early-relapse
4938731|NCT01910844|triple negative breast cancer|triple negative breast cancer
4938732|NCT01910844|late-relapse|late-relapse
4938733|NCT01910831|bruising, reduction, older age, aging|bruising, reduction, older age, aging
4938734|NCT01910818|radiation|radiation
4938735|NCT01910818|dermatitis|dermatitis
4938736|NCT01910818|laser|laser
4938737|NCT01910818|fractional|fractional
4938738|NCT01910818|CO2|co2
4938739|NCT01910818|chronic|chronic
4938740|NCT01910818|fibrosis|fibrosis
4938741|NCT01910818|scar|scar
4938742|NCT01910805|Gestational diabetes|gestational diabetes
4938743|NCT01910805|Diabetes mellitus|diabetes mellitus
4938744|NCT01910805|diabetes in pregnancy|diabetes in pregnancy
4938745|NCT01910805|diabetes risk|diabetes risk
4938746|NCT01910805|diabetes risk awareness|diabetes risk awareness
4938747|NCT01910805|African-American|african-american
4938748|NCT01910805|Women|women
4938749|NCT01910779|Atrial Fibrillation|atrial fibrillation
4938750|NCT01910779|Cardioversion|cardioversion
4938751|NCT01910779|Biphasic Shock|biphasic shock
4938752|NCT01910766|pcos|pcos
4938753|NCT01910766|coenzymeQ10|coenzymeq10
4938754|NCT01910766|clomiphene citrate|clomiphene citrate
4938755|NCT01910753|Head and neck cancer,|head and neck cancer,
4938756|NCT01910753|physical activity,|physical activity,
4938757|NCT01910753|nutrition therapeutic education|nutrition therapeutic education
4938758|NCT01910740|Randomized Controlled Trial|randomized controlled trial
4938759|NCT01910740|Exercise Movement Techniques|exercise movement techniques
4938760|NCT01910740|Frail Elderly|frail elderly
4938761|NCT01910740|Gait|gait
4938762|NCT01910727|American Indian|american indian
4938763|NCT01910727|Diabetes|diabetes
4938764|NCT01910727|Pre-diabetes|pre-diabetes
4938765|NCT01910727|Family health Coach|family health coach
4938766|NCT01910714|HIV/AIDS|hiv/aids
4938767|NCT01910714|Prevention|prevention
4938768|NCT01910714|American Indian|american indian
4938769|NCT01910714|Substance use|substance use
4938770|NCT01910714|CBPR|cbpr
4938771|NCT01910701|Home visiting interventions|home visiting interventions
4938772|NCT01910701|American Indian|american indian
4938773|NCT01910701|Community based participatory research|community based participatory research
4938774|NCT01910688|RGB Salvage, RFA|rgb salvage, rfa
4938775|NCT01910662|Suction Skin Blister|suction skin blister
4938776|NCT01910662|Induration|induration
4938777|NCT01910662|Tuberculin Purified Protein Derivative|tuberculin purified protein derivative
4938778|NCT01910662|Erythema|erythema
4938779|NCT01910662|Biopsy|biopsy
4938780|NCT01910662|Keyhole Limpet Hemocyanin|keyhole limpet hemocyanin
4938781|NCT01910662|Delayed Type Hypersensitivity|delayed type hypersensitivity
4938782|NCT01910649|drisapersen|drisapersen
4938783|NCT01910636|HCV genotype 2 (GT-2)|hcv genotype 2 (gt-2)
4938784|NCT01910623|Quality of life|quality of life
4938785|NCT01910623|Health related quality of life outcomes|health related quality of life outcomes
4938786|NCT01910623|Long-term|long-term
4938787|NCT01910623|Aida 0493|aida 0493
4938788|NCT01910623|AIDA 2000|aida 2000
4938789|NCT01910610|wild-type RAS metastatic colorectal cancer|wild-type ras metastatic colorectal cancer
4938790|NCT01910584|quality of life|quality of life
4938791|NCT01910584|sexual activity|sexual activity
4938792|NCT01910584|Novasure endometrial ablation|novasure endometrial ablation
4938793|NCT01910584|menorrhagia|menorrhagia
4938794|NCT01910558|Alpha-cyclodextrin|alpha-cyclodextrin
4938795|NCT01910558|Dietary fiber|dietary fiber
4938796|NCT01910558|Fecal fat|fecal fat
4938797|NCT01910558|Saturated fat|saturated fat
4938798|NCT01910519|influenza A (H5N1) virus|influenza a (h5n1) virus
4938799|NCT01910519|H5N1 influenza|h5n1 influenza
4938800|NCT01910519|influenza A/H5/N1|influenza a/h5/n1
4938801|NCT01910519|monovalent H5N1 influenza vaccine|monovalent h5n1 influenza vaccine
4938802|NCT01910519|systems biology|systems biology
4938803|NCT01910519|AS03 adjuvant|as03 adjuvant
4938804|NCT01910519|unadjuvanted|unadjuvanted
4938805|NCT01910493|mhealth|mhealth
4938806|NCT01910493|mobile health|mobile health
4938807|NCT01910493|SMS|sms
4938808|NCT01910493|SMS reminders|sms reminders
4938809|NCT01910493|ART retention in care|art retention in care
4938810|NCT01910493|PMTCT|pmtct
4938811|NCT01910493|PMTCT cascade|pmtct cascade
4938812|NCT01910493|retention in care|retention in care
4938813|NCT01910454|Stroke|stroke
4938814|NCT01910454|Occupational Therapy|occupational therapy
4938815|NCT01910454|Cognition|cognition
4938816|NCT01910441|Type 2 Diabetes Mellitus, Glycemic variability|type 2 diabetes mellitus, glycemic variability
4938817|NCT01910428|L-asparaginase encapsulated in RBCs, leukemia, lymphoma|l-asparaginase encapsulated in rbcs, leukemia, lymphoma
4938818|NCT01910402|antiretroviral therapy naïve|antiretroviral therapy naïve
4938819|NCT01910402|women|women
4938820|NCT01910402|once daily|once daily
4938821|NCT01910402|HIV infection|hiv infection
4938822|NCT01910402|atazanavir|atazanavir
4938823|NCT01910402|tenofovir/emtricitabine|tenofovir/emtricitabine
4938824|NCT01910402|dolutegravir/abacavir/lamivudine fixed dose combination|dolutegravir/abacavir/lamivudine fixed dose combination
4938825|NCT01910402|integrase inhibitor|integrase inhibitor
4938826|NCT01910402|ritonavir|ritonavir
4938827|NCT01910389|Heart failure|heart failure
4938828|NCT01910389|Pulmonary hypertension|pulmonary hypertension
4938829|NCT01910389|tadalafil|tadalafil
4938830|NCT01910389|Phosphodiesterase Type 5 Inhibition|phosphodiesterase type 5 inhibition
4938831|NCT01910363|poststroke spasticity|poststroke spasticity
4938832|NCT01910363|lower limb|lower limb
4938833|NCT01910363|botulinum toxin|botulinum toxin
4938834|NCT01910363|A2|a2
4938835|NCT01910350|Breast & cervical cancer prevention & screening|breast & cervical cancer prevention & screening
4938836|NCT01910337|ASA I patients|asa i patients
4938837|NCT01910324|Juvenile Offenders|juvenile offenders
4938838|NCT01910324|HIV/STD Prevention|hiv/std prevention
4938839|NCT01910324|Adolescent Substance Abuse|adolescent substance abuse
4938840|NCT01910324|Multidimensional Family Therapy|multidimensional family therapy
4938841|NCT01910298|Breast reconstruction|breast reconstruction
4938842|NCT01910298|Breast implant|breast implant
4938843|NCT01910298|Breast cancer|breast cancer
4938844|NCT01910298|Mastectomy|mastectomy
4938845|NCT01910285|Anesthetic induction|anesthetic induction
4938846|NCT01910285|Intubation conditions|intubation conditions
4938847|NCT01910285|Tooth extraction|tooth extraction
4938848|NCT01910285|Propofol|propofol
4938849|NCT01910285|Sufentanil|sufentanil
4938850|NCT01910285|Remifentanil|remifentanil
4938851|NCT01910272|Radiation attenuation|radiation attenuation
4938852|NCT01910272|Fluoroscopy|fluoroscopy
4938853|NCT01910272|Invasive cardiac procedures|invasive cardiac procedures
4938854|NCT01910272|Cardiac Catheterization|cardiac catheterization
4938855|NCT01910259|Secondary Progressive Multiple Sclerosis|secondary progressive multiple sclerosis
4938856|NCT01910259|Neuroprotective|neuroprotective
4938857|NCT01910259|Repurposed drugs|repurposed drugs
4938858|NCT01910259|Brain atrophy|brain atrophy
4938859|NCT01910259|Percentage Brain Volume Change|percentage brain volume change
4938860|NCT01910259|Magnetic Resonance Imaging|magnetic resonance imaging
4938861|NCT01910259|Optical Coherence Tomography|optical coherence tomography
4938862|NCT01910259|Cerebrospinal fluid|cerebrospinal fluid
4938863|NCT01910259|Amiloride|amiloride
4938864|NCT01910259|Riluzole|riluzole
4938865|NCT01910259|Double blind|double blind
4938866|NCT01910259|Placebo|placebo
4938867|NCT01910259|Fluoxetine|fluoxetine
4938868|NCT01910246|Metformin|metformin
4938869|NCT01910246|Insulin Resistance|insulin resistance
4938870|NCT01910246|Cardiac Function|cardiac function
4938871|NCT01910233|dyspnea|dyspnea
4938872|NCT01910233|registry|registry
4938873|NCT01910233|baseline characteristics|baseline characteristics
4938874|NCT01910233|mortality|mortality
4938875|NCT01910233|risk assessment|risk assessment
4938876|NCT01910233|emergency department|emergency department
4938877|NCT01910142|bone metabolism|bone metabolism
4938878|NCT01910129|vagus nerve stimulation|vagus nerve stimulation
4938879|NCT01910129|vagal nerve stimulation|vagal nerve stimulation
4938880|NCT01910129|nVNS|nvns
4938881|NCT01910129|VNS|vns
4938882|NCT01910129|epilepsy|epilepsy
4938883|NCT01910129|non invasive|non invasive
4938884|NCT01910129|gammacore|gammacore
4938885|NCT01910116|osteoarthritis|osteoarthritis
4938886|NCT01910116|hand|hand
4938887|NCT01910116|Shinbaro|shinbaro
4938888|NCT01910116|GCSB-5|gcsb-5
4938889|NCT01910103|Breast Neoplasms/radiography|breast neoplasms/radiography
4938890|NCT01910103|Mammography/methods|mammography/methods
4938891|NCT01910103|Mass Screening|mass screening
4938892|NCT01910103|Tomography, X-Ray Computed/methods|tomography, x-ray computed/methods
4938893|NCT01910103|Predictive Value of Tests|predictive value of tests
4938894|NCT01910103|False Positive Reactions|false positive reactions
4938895|NCT01910090|fasting condition|fasting condition
4938896|NCT01910077|tacrolimus|tacrolimus
4938897|NCT01910077|tacrobell capsule|tacrobell capsule
4938898|NCT01910077|prograf capsule|prograf capsule
4938899|NCT01910077|bioequivalence|bioequivalence
4938900|NCT01910064|Acne Vulgaris|acne vulgaris
4938901|NCT01910025|Argininosuccinate Synthetase|argininosuccinate synthetase
4938902|NCT01910025|Arginine|arginine
4938903|NCT01910025|Arginine deiminase|arginine deiminase
4938904|NCT01910012|Argininosuccinate Synthetase|argininosuccinate synthetase
4938905|NCT01910012|Arginine|arginine
4938906|NCT01910012|Arginine deiminase|arginine deiminase
4938907|NCT01909999|Dental Implants|dental implants
4938908|NCT01909999|Osseointegration|osseointegration
4938909|NCT01909999|Immediate Dental Implant Loading|immediate dental implant loading
4938910|NCT01909999|Bone formation|bone formation
4938911|NCT01909986|ONO-4053|ono-4053
4938912|NCT01909986|Healthy adult male subjects|healthy adult male subjects
4938913|NCT01909986|pharmacokinetics|pharmacokinetics
4938914|NCT01909986|metabolism|metabolism
4938915|NCT01909986|excretion|excretion
4938916|NCT01909986|mass balance|mass balance
4938917|NCT01909973|Depression|depression
4938918|NCT01909973|Antidepressant Medication|antidepressant medication
4938919|NCT01909973|Adherence|adherence
4938920|NCT01909973|Mobile Smartphone Intervention|mobile smartphone intervention
4938921|NCT01909973|Telemedicine|telemedicine
4938922|NCT01909973|Primary Care|primary care
4938923|NCT01909960|Normal pressure hydrocephalus|normal pressure hydrocephalus
4938924|NCT01909960|Flow MRI|flow mri
4938925|NCT01909960|Dementia|dementia
4938926|NCT01909960|Cerebrospinal fluid|cerebrospinal fluid
4938927|NCT01909960|Shunt|shunt
4938928|NCT01909947|Respiratory rate variability|respiratory rate variability
4938929|NCT01909947|Heart rate variability|heart rate variability
4938930|NCT01909947|Extubation readiness|extubation readiness
4938931|NCT01909947|Extubation failure|extubation failure
4938932|NCT01909947|Clinical predictors|clinical predictors
4938933|NCT01909934|Lymphoma|lymphoma
4938934|NCT01909934|Anaplastic Large-cell|anaplastic large-cell
4938935|NCT01909934|Relapsed|relapsed
4938936|NCT01909934|Refractory|refractory
4938937|NCT01909934|Antigens, CD30|antigens, cd30
4938938|NCT01909934|Antibody-Drug Conjugate|antibody-drug conjugate
4938939|NCT01909934|Antibodies, Monoclonal|antibodies, monoclonal
4938940|NCT01909934|Lymphoma, Non-Hodgkin|lymphoma, non-hodgkin
4938941|NCT01909934|Lymphoma, Large-Cell, Anaplastic|lymphoma, large-cell, anaplastic
4938942|NCT01909934|monomethyl auristatin E|monomethyl auristatin e
4938943|NCT01909934|Drug Therapy|drug therapy
4938944|NCT01909934|Immunotherapy|immunotherapy
4938945|NCT01909934|Hematologic Diseases|hematologic diseases
4938946|NCT01909908|Wounds and injuries|wounds and injuries
4938947|NCT01909908|Ulcer|ulcer
4938948|NCT01909908|Diabetic angiopathies|diabetic angiopathies
4938949|NCT01909908|Diabetic foot|diabetic foot
4938950|NCT01909908|Venous insufficiency|venous insufficiency
4938951|NCT01909908|Extracellular matrix|extracellular matrix
4938952|NCT01909882|Family member's massage therapy|family member's massage therapy
4938953|NCT01909882|Vital signs|vital signs
4938954|NCT01909882|Glasgow coma scale|glasgow coma scale
4938955|NCT01909882|Intensive care unit|intensive care unit
4938956|NCT01909882|Randomized controlled Clinical Trial|randomized controlled clinical trial
4938957|NCT01909882|Iran|iran
4938958|NCT01909869|MACE|mace
4938960|NCT01909869|MI|mi
4938961|NCT01909869|TLF|tlf
4938962|NCT01909869|Death|death
4938963|NCT01909830|Colorectal Cancer Metastatic|colorectal cancer metastatic
4938964|NCT01909830|pretreated|pretreated
4938965|NCT01909804|Hepatitis|hepatitis
4938966|NCT01909804|Genotype 1|genotype 1
4938967|NCT01909804|Genotype 3|genotype 3
4938968|NCT01909804|Treatment experienced|treatment experienced
4938969|NCT01909791|Diabetic Macular Edema|diabetic macular edema
4938970|NCT01909791|anti-vascular endothelial growth factor|anti-vascular endothelial growth factor
4938971|NCT01909765|Circumcision|circumcision
4939074|NCT01909349|eHealth|ehealth
4938972|NCT01909765|postoperative pain|postoperative pain
4938973|NCT01909752|Lung cancer|lung cancer
4938974|NCT01909752|DRibble Vaccine|dribble vaccine
4938975|NCT01909752|Imiquimod|imiquimod
4938976|NCT01909752|GM-CSF|gm-csf
4938977|NCT01909752|HPV vaccine (Ceravix)|hpv vaccine (ceravix)
4938978|NCT01909752|Cyclophosphamide|cyclophosphamide
4938979|NCT01909739|AKI, atrovastatin, Valvular heart surgery|aki, atrovastatin, valvular heart surgery
4938980|NCT01909726|Hospital Design|hospital design
4938981|NCT01909726|Technology|technology
4938982|NCT01909726|Anxiety|anxiety
4938983|NCT01909713|acne, pediatric|acne, pediatric
4938984|NCT01909700|Single Incision, Mesh, Complications|single incision, mesh, complications
4938985|NCT01909687|blood glucose monitoring systems|blood glucose monitoring systems
4938986|NCT01909687|ISO 15197|iso 15197
4938987|NCT01909687|system accuracy|system accuracy
4938988|NCT01909661|allergy|allergy
4938989|NCT01909661|Cow's milk protein|cow's milk protein
4938990|NCT01909661|Tolerance|tolerance
4938991|NCT01909661|Efficacy|efficacy
4938992|NCT01909661|Infants' growth|infants' growth
4938993|NCT01909622|Vitamin D|vitamin d
4938994|NCT01909622|Milk fortification|milk fortification
4938995|NCT01909622|Children|children
4938996|NCT01909622|Colombia|colombia
4938997|NCT01909609|male|male
4938998|NCT01909583|congenital|congenital
4938999|NCT01909583|surgery|surgery
4939000|NCT01909583|peri-operative|peri-operative
4939001|NCT01909583|counselling|counselling
4939002|NCT01909557|Acetyl-L-carnitine|acetyl-l-carnitine
4939003|NCT01909557|Interferons|interferons
4939004|NCT01909557|Ribavirin|ribavirin
4939005|NCT01909557|Hepatitis C|hepatitis c
4939006|NCT01909557|Fatigue|fatigue
4939007|NCT01909544|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
4939008|NCT01909544|Muscle fatigue|muscle fatigue
4939009|NCT01909544|Energy metabolism|energy metabolism
4939010|NCT01909544|Muscle oxygenation|muscle oxygenation
4939011|NCT01909531|Deep Brain Stimulation|deep brain stimulation
4939012|NCT01909531|Parkinsons Disease|parkinsons disease
4939013|NCT01909531|Essential Tremor|essential tremor
4939014|NCT01909531|Asleep DBS|asleep dbs
4939015|NCT01909518|Esophageal Squamous Intraepithelial Neoplasia|esophageal squamous intraepithelial neoplasia
4939016|NCT01909518|surface maturation scoring|surface maturation scoring
4939017|NCT01909518|probe-based confocal laser endomicroscopy|probe-based confocal laser endomicroscopy
4939018|NCT01909518|virtual chromoendoscopy|virtual chromoendoscopy
4939019|NCT01909492|Multiple Sclerosis|multiple sclerosis
4939020|NCT01909492|MS|ms
4939021|NCT01909492|Relaxin|relaxin
4939022|NCT01909466|OPC-14597|opc-14597
4939023|NCT01909466|Aripiprazole|aripiprazole
4939024|NCT01909466|Schizophrenia|schizophrenia
4939025|NCT01909453|Melanoma|melanoma
4939026|NCT01909453|Cutaneous melanoma|cutaneous melanoma
4939027|NCT01909453|Skin disease|skin disease
4939028|NCT01909453|Skin cancer|skin cancer
4939029|NCT01909453|Skin Neoplasms|skin neoplasms
4939030|NCT01909453|Neoplasm Metastasis|neoplasm metastasis
4939031|NCT01909453|BRAF mutant|braf mutant
4939032|NCT01909453|BRAF V600E|braf v600e
4939033|NCT01909453|BRAF V600K|braf v600k
4939034|NCT01909453|Cancer|cancer
4939035|NCT01909453|LGX818|lgx818
4939036|NCT01909453|MEK162|mek162
4939037|NCT01909453|vemurafenib|vemurafenib
4939038|NCT01909453|combination|combination
4939039|NCT01909453|BRAF inhibitor|braf inhibitor
4939040|NCT01909453|resistance|resistance
4939041|NCT01909453|The combination of a selective BRAF- and a MEK1/2-inhibitor|the combination of a selective braf- and a mek1/2-inhibitor
4939042|NCT01909453|Prior immunotherapy|prior immunotherapy
4939043|NCT01909453|MEK inhibitor|mek inhibitor
4939044|NCT01909453|Phase III|phase iii
4939045|NCT01909453|Combo 300, Combo 450|combo 300, combo 450
4939046|NCT01909427|Active rheumatoid arthritis despite methotrexate therapy|active rheumatoid arthritis despite methotrexate therapy
4939047|NCT01909427|CNTO 6785|cnto 6785
4939048|NCT01909427|Methotrexate|methotrexate
4939049|NCT01909401|Liver Transplantation|liver transplantation
4939050|NCT01909388|Cancer|cancer
4939051|NCT01909388|Prostate Cancer|prostate cancer
4939052|NCT01909388|Brachytherapy|brachytherapy
4939053|NCT01909388|Dose escalation|dose escalation
4939054|NCT01909388|High Dose Rate|high dose rate
4939055|NCT01909388|MRI-TRUS fusion|mri-trus fusion
4939056|NCT01909388|Detection of DILs by MRI|detection of dils by mri
4939057|NCT01909362|advanced metastatic colorectal cancer|advanced metastatic colorectal cancer
4939058|NCT01909362|mCRC|mcrc
4939059|NCT01909362|Colorectal Cancer|colorectal cancer
4939060|NCT01909362|Colorectal Carcinoma|colorectal carcinoma
4939061|NCT01909362|Colorectal Tumors|colorectal tumors
4939062|NCT01909362|Genetic mutation testing|genetic mutation testing
4939063|NCT01909362|Tumor tissue sampling|tumor tissue sampling
4939064|NCT01909349|medical rehabilitation|medical rehabilitation
4939065|NCT01909349|aftercare|aftercare
4939066|NCT01909349|multiple health behavior change|multiple health behavior change
4939067|NCT01909349|diet|diet
4939068|NCT01909349|physical activity|physical activity
4939069|NCT01909349|computer|computer
4939070|NCT01909349|international study|international study
4939071|NCT01909349|ETHNOPSYCHOLOGY|ethnopsychology
4939072|NCT01909349|HABIT|habit
4939073|NCT01909349|HEALTH|health
4939075|NCT01909349|eLearning|elearning
4939076|NCT01909310|anesthesia, cardiac arrest, resuscitation, ventilation|anesthesia, cardiac arrest, resuscitation, ventilation
4939077|NCT01909297|airway management|airway management
4939078|NCT01909271|Stroke|stroke
4939079|NCT01909271|Community Health Education|community health education
4939080|NCT01909271|Minority Health|minority health
4939081|NCT01909271|healthcare disparities|healthcare disparities
4939082|NCT01909245|Islet cells|islet cells
4939083|NCT01909245|hypoglycemia|hypoglycemia
4939084|NCT01909245|hypoglycemia unawareness|hypoglycemia unawareness
4939085|NCT01909245|islet after kidney transplantation|islet after kidney transplantation
4939086|NCT01909245|islet transplant|islet transplant
4939087|NCT01909245|insulin independence|insulin independence
4939088|NCT01909245|insulin dependence|insulin dependence
4939089|NCT01909232|Depression|depression
4939090|NCT01909232|Depressive Disorder|depressive disorder
4939091|NCT01909232|Major depression|major depression
4939092|NCT01909232|Major depressive disorder|major depressive disorder
4939093|NCT01909232|MDD|mdd
4939094|NCT01909232|Treatment resistant depression|treatment resistant depression
4939095|NCT01909232|Treatment intolerant depression|treatment intolerant depression
4939096|NCT01909232|TRMD|trmd
4939097|NCT01909232|TIMD|timd
4939098|NCT01909232|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
4939099|NCT01909232|TMS|tms
4939100|NCT01909219|preparation, cleansing, colon|preparation, cleansing, colon
4939101|NCT01909167|Pregnancy|pregnancy
4939102|NCT01909167|symptoms of depression|symptoms of depression
4939103|NCT01909167|anxiety|anxiety
4939104|NCT01909167|online CBT therapy|online cbt therapy
4939105|NCT01909167|treatment as usual|treatment as usual
4939106|NCT01909167|maternal bonding|maternal bonding
4939107|NCT01909167|postnatal period|postnatal period
4939108|NCT01909154|neurophysiological parameters improvement|neurophysiological parameters improvement
4939109|NCT01909154|spinal cord injury|spinal cord injury
4939110|NCT01909154|biology therapy|biology therapy
4939111|NCT01909141|letrozole|letrozole
4939112|NCT01909141|clomiphene citrate|clomiphene citrate
4939113|NCT01909141|pioglitazone|pioglitazone
4939114|NCT01909141|metformin|metformin
4939115|NCT01909141|ovulation induction|ovulation induction
4939116|NCT01909141|PCOS|pcos
4939117|NCT01909128|children, fermented milk fermented rice, gastrointestinal infections, respiratory infections|children, fermented milk fermented rice, gastrointestinal infections, respiratory infections
4939118|NCT01909102|Acceptance and Commitment Therapy|acceptance and commitment therapy
4939119|NCT01909102|Cardiac rehabilitation|cardiac rehabilitation
4939120|NCT01909050|celiac disease|celiac disease
4939121|NCT01909050|refractory celiac disease|refractory celiac disease
4939122|NCT01909050|gluten sensitivity|gluten sensitivity
4939123|NCT01909037|osteoarthritis|osteoarthritis
4939124|NCT01909037|curcumin|curcumin
4939125|NCT01909037|biomarker|biomarker
4939126|NCT01909037|pain|pain
4939127|NCT01909024|Randomised controlled trial|randomised controlled trial
4939128|NCT01909024|Endovenous laser treatment|endovenous laser treatment
4939129|NCT01909024|Transjugular coil embolisation|transjugular coil embolisation
4939130|NCT01908998|Y-Balance test|y-balance test
4939131|NCT01908985|glaucoma|glaucoma
4939132|NCT01908985|high intensity focused ultrasound|high intensity focused ultrasound
4939133|NCT01908985|aqueous humor|aqueous humor
4939134|NCT01908985|fluorophotometry|fluorophotometry
4939135|NCT01908972|Hemangioma|hemangioma
4939136|NCT01908972|Propranolol|propranolol
4939137|NCT01908972|prednisolone|prednisolone
4939138|NCT01908972|steroid|steroid
4939139|NCT01908959|Hispanic Women|hispanic women
4939140|NCT01908959|Postpartum|postpartum
4939141|NCT01908959|Overweight Hispanic Women|overweight hispanic women
4939142|NCT01908959|Low-income|low-income
4939143|NCT01908959|Physical Activity|physical activity
4939144|NCT01908959|Walking|walking
4939145|NCT01908946|Polio|polio
4939146|NCT01908933|Advanced Emphysema|advanced emphysema
4939147|NCT01908933|Heterogeneous Lower Lobe Predominant Emphysema|heterogeneous lower lobe predominant emphysema
4939148|NCT01908933|Heterogeneous Upper and Lower Lobe Predominant|heterogeneous upper and lower lobe predominant
4939149|NCT01908907|Premature Infants|premature infants
4939150|NCT01908907|DHA(docosahexaenoic acid)|dha(docosahexaenoic acid)
4939151|NCT01908907|DHA deficit|dha deficit
4939152|NCT01908881|Child Development|child development
4939153|NCT01908881|Mother-Child relations|mother-child relations
4939154|NCT01908881|Primary Health Care|primary health care
4939155|NCT01908881|Public Policy|public policy
4939156|NCT01908855|somatoform symptoms|somatoform symptoms
4939157|NCT01908855|somatic symptoms|somatic symptoms
4939158|NCT01908855|somatoform disorder|somatoform disorder
4939159|NCT01908855|somatic symptom disorder|somatic symptom disorder
4939160|NCT01908855|cognitive-behavioral therapy|cognitive-behavioral therapy
4939161|NCT01908855|emotion regulation training|emotion regulation training
4939162|NCT01908842|Opioid|opioid
4939163|NCT01908842|Dependence|dependence
4939164|NCT01908842|agonist|agonist
4939165|NCT01908842|buprenorphine|buprenorphine
4939166|NCT01908842|naloxone|naloxone
4939167|NCT01908842|BUP/NAL|bup/nal
4939168|NCT01908829|Vesitrim|vesitrim
4939169|NCT01908829|Betanis|betanis
4939170|NCT01908829|Urgency|urgency
4939171|NCT01908829|Frequency|frequency
4939172|NCT01908829|Mirabegron|mirabegron
4939173|NCT01908829|YM178|ym178
4939174|NCT01908829|Betmiga|betmiga
4939175|NCT01908829|Vesicare|vesicare
4939176|NCT01908829|Micturition|micturition
4939177|NCT01908829|YM905|ym905
4939178|NCT01908829|Solifenacin|solifenacin
4939179|NCT01908829|Urinary incontinence|urinary incontinence
4939180|NCT01908829|Overactive Bladder (OAB)|overactive bladder (oab)
4939181|NCT01908829|Myrbetriq|myrbetriq
4939182|NCT01908829|Vesikur|vesikur
4939183|NCT01908829|Urgency incontinence|urgency incontinence
4939184|NCT01908803|AOMT|aomt
4939185|NCT01908803|tympanostomy tubes|tympanostomy tubes
4939186|NCT01908803|Otorrhea|otorrhea
4939187|NCT01908803|anti-infective|anti-infective
4939188|NCT01908790|venous oximeter|venous oximeter
4939189|NCT01908790|non-invasive monitor|non-invasive monitor
4939190|NCT01908790|heart failure (HF)|heart failure (hf)
4939191|NCT01908764|ear tubes|ear tubes
4939192|NCT01908764|tympanostomy tubes|tympanostomy tubes
4939193|NCT01908764|Otitis Media at the time of Tympanostomy Tube surgery|otitis media at the time of tympanostomy tube surgery
4939194|NCT01908764|OMTT|omtt
4939195|NCT01908738|Endometrial biopsy|endometrial biopsy
4939196|NCT01908738|paracervical block|paracervical block
4939197|NCT01908738|Lidocaine spray|lidocaine spray
4939198|NCT01908738|women|women
4939199|NCT01908738|abnormal uterine bleeding|abnormal uterine bleeding
4939200|NCT01908686|ASD|asd
4939201|NCT01908673|heart rate variability biofeedback|heart rate variability biofeedback
4939202|NCT01908673|automatic self transcedental meditation|automatic self transcedental meditation
4939203|NCT01908660|HIV|hiv
4939204|NCT01908660|hepatitis C virus|hepatitis c virus
4939205|NCT01908660|hepatitis B virus|hepatitis b virus
4939206|NCT01908660|antiretroviral drugs|antiretroviral drugs
4939207|NCT01908660|nucleos(t)ide reverse transcriptase inhibitors|nucleos(t)ide reverse transcriptase inhibitors
4939208|NCT01908660|non-nucleos(t)ide reverse transcriptase inhibitors|non-nucleos(t)ide reverse transcriptase inhibitors
4939209|NCT01908660|protease inhibitors|protease inhibitors
4939210|NCT01908660|integrase inhibitors|integrase inhibitors
4939211|NCT01908660|entry inhibitors|entry inhibitors
4939212|NCT01908660|transaminase elevations|transaminase elevations
4939213|NCT01908660|alanine aminotransferase|alanine aminotransferase
4939214|NCT01908660|aspartate aminotransferase|aspartate aminotransferase
4939215|NCT01908660|bilirubin elevations|bilirubin elevations
4939216|NCT01908660|hepatic fibrosis|hepatic fibrosis
4939217|NCT01908647|mTBI|mtbi
4939218|NCT01908647|PTSD|ptsd
4939219|NCT01908634|Bioavailability|bioavailability
4939220|NCT01908634|Strawberry polyphenols|strawberry polyphenols
4939221|NCT01908634|Fruit Beverage Matrix|fruit beverage matrix
4939222|NCT01908621|multiple myeloma|multiple myeloma
4939223|NCT01908621|mobilization|mobilization
4939224|NCT01908621|G-CSF|g-csf
4939225|NCT01908621|filgrastim|filgrastim
4939226|NCT01908621|cytosine arabinoside|cytosine arabinoside
4939227|NCT01908621|autologous stem cell transplantation|autologous stem cell transplantation
4939228|NCT01908569|MACS, time-lapse, embryo, spermatozoid, sperm|macs, time-lapse, embryo, spermatozoid, sperm
4939229|NCT01908543|Iron deficiency|iron deficiency
4939230|NCT01908543|Nosebleeds|nosebleeds
4939231|NCT01908530|Diabetes,Continuous Glucose Monitoring,Microprobes|diabetes,continuous glucose monitoring,microprobes
4939232|NCT01908517|HPV Vaccine Adherence|hpv vaccine adherence
4939233|NCT01908517|Electronic Reminders|electronic reminders
4939234|NCT01908491|patient controlled analgesia|patient controlled analgesia
4939235|NCT01908491|wound catheter infusion|wound catheter infusion
4939236|NCT01908491|postoperative pain control|postoperative pain control
4939237|NCT01908491|pectus excavatum|pectus excavatum
4939238|NCT01908491|pain score|pain score
4939239|NCT01908478|locally advanced|locally advanced
4939240|NCT01908478|unresectable|unresectable
4939241|NCT01908478|pancreatic|pancreatic
4939242|NCT01908478|pancreas|pancreas
4939243|NCT01908478|pancreatic adenocarcinoma|pancreatic adenocarcinoma
4939244|NCT01908452|Schizophrenia|schizophrenia
4939245|NCT01908452|pyridoxal kinase activity|pyridoxal kinase activity
4939246|NCT01908452|plasma pyridoxal level|plasma pyridoxal level
4939247|NCT01908439|muscle electrical activity|muscle electrical activity
4939248|NCT01908439|whole-body vibration|whole-body vibration
4939249|NCT01908439|latency|latency
4939250|NCT01908426|cabozantinib|cabozantinib
4939251|NCT01908426|XL184|xl184
4939252|NCT01908426|liver cancer|liver cancer
4939253|NCT01908426|hepatocellular carcinoma|hepatocellular carcinoma
4939254|NCT01908426|tyrosine kinase inhibitor|tyrosine kinase inhibitor
4939255|NCT01908426|MET|met
4939256|NCT01908426|vascular endothelial growth factor receptor 2 (VEGFR2)|vascular endothelial growth factor receptor 2 (vegfr2)
4939257|NCT01908413|Advanced Solid Tumors|advanced solid tumors
4939258|NCT01908413|Lymphoma|lymphoma
4939259|NCT01908413|Open-Label|open-label
4939260|NCT01908413|Dose-Escalation|dose-escalation
4939261|NCT01908413|IAP|iap
4939262|NCT01908400|Mental retardation , stem cell,BMMNC|mental retardation , stem cell,bmmnc
4939263|NCT01908387|Oral azacitidine|oral azacitidine
4939264|NCT01908387|CC-486|cc-486
4939265|NCT01908387|Hematological neoplasms|hematological neoplasms
4939266|NCT01908387|Phase 1|phase 1
4939267|NCT01908374|Active-placebo controlled double blind cross over|active-placebo controlled double blind cross over
4939268|NCT01908361|comparative efficacy research|comparative efficacy research
4939269|NCT01908361|combination therapy|combination therapy
4939270|NCT01908361|neurorehabilitation|neurorehabilitation
4939271|NCT01908361|robotic rehabilitation|robotic rehabilitation
4939272|NCT01908361|restraint therapy|restraint therapy
4939273|NCT01908348|Erythritol|erythritol
4939274|NCT01908348|Endothelial function|endothelial function
4939275|NCT01908335|interferon|interferon
4939276|NCT01908335|ribavirin|ribavirin
4939277|NCT01908335|virological response|virological response
4939278|NCT01908322|Hepatocellular carcinoma|hepatocellular carcinoma
4939279|NCT01908322|Intermediate stage|intermediate stage
4939280|NCT01908322|Observational study|observational study
4939281|NCT01908309|acute kidney injury|acute kidney injury
4939282|NCT01908309|contrast media|contrast media
4939283|NCT01908309|cystatin-C|cystatin-c
4939284|NCT01908296|FK949E|fk949e
4939285|NCT01908296|fluvoxamine|fluvoxamine
4939286|NCT01908296|Antipsychotic|antipsychotic
4939287|NCT01908296|Quetiapine|quetiapine
4939288|NCT01908244|Preterm infants, music, Neonatal Intensive Care Unit (NICU)|preterm infants, music, neonatal intensive care unit (nicu)
4939289|NCT01908231|Pulmonary embolism, plasma lactate, right ventricular dysfunction|pulmonary embolism, plasma lactate, right ventricular dysfunction
4939290|NCT01908218|ULBT, diffficult laryngoscopy, Predictive Value of Tests|ulbt, diffficult laryngoscopy, predictive value of tests
4939291|NCT01908205|Autism|autism
4939292|NCT01908205|Social|social
4939293|NCT01908205|Functioning|functioning
4939294|NCT01908205|Cognition|cognition
4939295|NCT01908205|Repetitive Behaviors|repetitive behaviors
4939296|NCT01908205|Anxiety|anxiety
4939297|NCT01908205|Quality of Life|quality of life
4939298|NCT01908192|Sodium Benzoate|sodium benzoate
4939299|NCT01908192|Schizophrenia|schizophrenia
4939300|NCT01908192|Adolescent|adolescent
4939301|NCT01908192|Antipsychotic|antipsychotic
4939302|NCT01908192|Anti-psychotic|anti-psychotic
4939303|NCT01908192|NMDA|nmda
4939304|NCT01908192|NaBen|naben
4939305|NCT01908192|pediatric|pediatric
4939306|NCT01908179|Sterotactic Radiosurgery|sterotactic radiosurgery
4939307|NCT01908153|Picture food type|picture food type
4939308|NCT01908153|Taste type|taste type
4939309|NCT01908127|film modelling|film modelling
4939310|NCT01908127|dental anxiety|dental anxiety
4939311|NCT01908127|cooperative behaviour|cooperative behaviour
4939312|NCT01908127|children|children
4939313|NCT01908114|Polio disease|polio disease
4939314|NCT01908114|Intervention Package|intervention package
4939315|NCT01908114|Polio sero prevalence and sero conversion|polio sero prevalence and sero conversion
4939316|NCT01908114|Polio high risk areas of Pakistan|polio high risk areas of pakistan
4939317|NCT01908088|Epidermolysis Bullosa mitten hand deformity autologous cultured fibroblast|epidermolysis bullosa mitten hand deformity autologous cultured fibroblast
4939318|NCT01908088|amniotic membrane|amniotic membrane
4939319|NCT01908075|Primary care|primary care
4939320|NCT01908075|Asthma management|asthma management
4939321|NCT01908075|Real-world|real-world
4939322|NCT01908075|Observational|observational
4939323|NCT01908075|Fostair|fostair
4939324|NCT01908075|Seretide|seretide
4939325|NCT01908062|Substance related disorders|substance related disorders
4939326|NCT01908062|HIV|hiv
4939327|NCT01908062|naltrexone|naltrexone
4939328|NCT01908049|Probiotic|probiotic
4939329|NCT01908049|HIV|hiv
4939330|NCT01908049|Microbial translocation|microbial translocation
4939331|NCT01908049|inflammation|inflammation
4939332|NCT01908049|microbiota composition|microbiota composition
4939333|NCT01908036|Chronic fatigue syndrome|chronic fatigue syndrome
4939334|NCT01908036|CFS|cfs
4939335|NCT01908036|myalgic encephalomyelitis|myalgic encephalomyelitis
4939336|NCT01908036|M.E.|m.e.
4939337|NCT01908036|activity monitor|activity monitor
4939338|NCT01908023|exercise therapy|exercise therapy
4939339|NCT01908023|oxygen consumption|oxygen consumption
4939340|NCT01908010|Alzheimer's disease|alzheimer's disease
4939341|NCT01907997|Systemic lidocaine, Intravenous lidocaine infusion, postoperative pain, quality of recovery, Robot-assisted thyroidectomy, thyroid cancer|systemic lidocaine, intravenous lidocaine infusion, postoperative pain, quality of recovery, robot-assisted thyroidectomy, thyroid cancer
4939342|NCT01907984|premedication|premedication
4939343|NCT01907984|diclofenac|diclofenac
4939344|NCT01907984|postoperative headache|postoperative headache
4939345|NCT01907984|Visual Analog Scale|visual analog scale
4939346|NCT01907958|Microalbuminuria|microalbuminuria
4939347|NCT01907958|Hypertensive|hypertensive
4939348|NCT01907958|Diabetics|diabetics
4939349|NCT01907958|urine albumin|urine albumin
4939350|NCT01907945|Household water treatment|household water treatment
4939351|NCT01907945|Waterborne illness|waterborne illness
4939352|NCT01907945|ceramic filters|ceramic filters
4939353|NCT01907945|social network|social network
4939354|NCT01907932|splenomegaly|splenomegaly
4939355|NCT01907932|ultrasound|ultrasound
4939356|NCT01907932|VScan|vscan
4939357|NCT01907919|Pulp capping, Diode laser 808 nm, Tertiary dentin, RM-GIC|pulp capping, diode laser 808 nm, tertiary dentin, rm-gic
4939358|NCT01907906|Pathogen reduction technology|pathogen reduction technology
4939359|NCT01907880|breast|breast
4939360|NCT01907880|bone|bone
4939361|NCT01907880|pain|pain
4939362|NCT01907841|Investigate IPC on EIMD|investigate ipc on eimd
4939363|NCT01907789|Ovarian Carcinoma|ovarian carcinoma
4939364|NCT01907789|Ovary|ovary
4939365|NCT01907789|BRCA Mutation Carriers|brca mutation carriers
4939366|NCT01907789|BRCA1 or BRCA2 mutation|brca1 or brca2 mutation
4939367|NCT01907789|High risk for developing ovarian cancer|high risk for developing ovarian cancer
4939368|NCT01907789|Ovarian cancer screening|ovarian cancer screening
4939369|NCT01907789|Risk-reducing salpingo-oophorectomy|risk-reducing salpingo-oophorectomy
4939370|NCT01907789|RRSO|rrso
4939371|NCT01907789|Prophylactic salpingectomy with delayed oophorectomy|prophylactic salpingectomy with delayed oophorectomy
4939372|NCT01907789|PSDO|psdo
4939373|NCT01907789|Questionnaire|questionnaire
4939374|NCT01907789|Quality of life|quality of life
4939375|NCT01907789|QOL|qol
4939376|NCT01907789|Survey|survey
4939377|NCT01907789|Transvaginal ultrasound|transvaginal ultrasound
4939378|NCT01907789|Phone call|phone call
4939379|NCT01907763|asthma|asthma
4939380|NCT01907763|SOTB07|sotb07
4939381|NCT01907750|biliary fistula|biliary fistula
4939382|NCT01907750|biliary stricture|biliary stricture
4939383|NCT01907750|biliary drainage tube|biliary drainage tube
4939384|NCT01907724|Chronic hepatitis C|chronic hepatitis c
4939385|NCT01907724|Hepatitis C virus|hepatitis c virus
4939386|NCT01907724|HCV|hcv
4939387|NCT01907711|Acupuncture.|acupuncture.
4939388|NCT01907711|Fatigue syndrome chronic.|fatigue syndrome chronic.
4939389|NCT01907711|Sleep disturbances.|sleep disturbances.
4939390|NCT01907711|Pain.|pain.
4939391|NCT01907711|Cognitive impairment.|cognitive impairment.
4939392|NCT01907698|vaginal intercourse|vaginal intercourse
4939393|NCT01907698|labour|labour
4939394|NCT01907698|term pregnancy|term pregnancy
4939395|NCT01907672|Malaria|malaria
4939396|NCT01907672|Rapid Diagnostic Tests for Malaria|rapid diagnostic tests for malaria
4939397|NCT01907672|Chemical Shops|chemical shops
4939398|NCT01907672|Drug Shops|drug shops
4939399|NCT01907672|Diagnostics|diagnostics
4939400|NCT01907672|Testing for Malaria|testing for malaria
4939401|NCT01907659|Respiratory|respiratory
4939402|NCT01907659|Viruses|viruses
4939403|NCT01907659|Bacterial|bacterial
4939404|NCT01907659|Antibiotics|antibiotics
4939405|NCT01907659|Procalcitonin|procalcitonin
4939406|NCT01907646|bladder training, radical hysterectomy,gynaecologic cancer|bladder training, radical hysterectomy,gynaecologic cancer
4939407|NCT01907633|Death, Sudden, Cardiac|death, sudden, cardiac
4939408|NCT01907633|Risk of Sudden Cardiac Death|risk of sudden cardiac death
4939409|NCT01907633|Domperidone|domperidone
4939410|NCT01907633|Proton Pump Inhibitors (PPI)|proton pump inhibitors (ppi)
4939411|NCT01907633|Metoclopramide|metoclopramide
4939412|NCT01907633|Observational Study|observational study
4939413|NCT01907607|Advanced Gastrointestinal Stromal Tumor Refractory to Imatinib and Sunitinib|advanced gastrointestinal stromal tumor refractory to imatinib and sunitinib
4939414|NCT01907607|PD-0332991|pd-0332991
4939415|NCT01907607|Orally|orally
4939416|NCT01907607|Efficacy and safety|efficacy and safety
4939417|NCT01907607|Adult patients|adult patients
4939418|NCT01907607|Refractory|refractory
4939419|NCT01907607|Imatinib|imatinib
4939420|NCT01907607|Sunitinib|sunitinib
4939421|NCT01907490|Topical treatment of Head Lice Infestation|topical treatment of head lice infestation
4939422|NCT01907464|Anorexia nervosa|anorexia nervosa
4939423|NCT01907464|Bone mineral density|bone mineral density
4939424|NCT01907464|Teenagers or young women|teenagers or young women
4939425|NCT01907464|Bone remodelling markers|bone remodelling markers
4939426|NCT01907438|BRCA|brca
4939427|NCT01907438|estrogen|estrogen
4939428|NCT01907438|epithelial breast cells|epithelial breast cells
4939429|NCT01907438|genome profile|genome profile
4939430|NCT01907412|First time parents|first time parents
4939431|NCT01907412|Coparenting|coparenting
4939432|NCT01907412|Family Foundations|family foundations
4939433|NCT01907399|obese patients|obese patients
4939434|NCT01907399|obese patients with type 2 diabetes|obese patients with type 2 diabetes
4939435|NCT01907399|healthy volunteers|healthy volunteers
4939436|NCT01907386|Endoleaks|endoleaks
4939437|NCT01907386|Non-invasive vascular elastography|non-invasive vascular elastography
4939438|NCT01907373|olmesartan|olmesartan
4939439|NCT01907373|probenecid|probenecid
4939440|NCT01907373|pharmacokinetics|pharmacokinetics
4939441|NCT01907373|tolerability|tolerability
4939442|NCT01907347|intensive care unit (ICU)|intensive care unit (icu)
4939443|NCT01907347|body composition|body composition
4939444|NCT01907347|phase angle|phase angle
4939445|NCT01907347|mortality|mortality
4939446|NCT01907347|nosocomial infection|nosocomial infection
4939447|NCT01907347|bioimpedance analysis|bioimpedance analysis
4939448|NCT01907347|nutrition|nutrition
4939449|NCT01907334|oscillometry|oscillometry
4939450|NCT01907334|asthma|asthma
4939451|NCT01907334|methacholine|methacholine
4939452|NCT01907321|stroke|stroke
4939453|NCT01907321|dysphagia|dysphagia
4939454|NCT01907321|dystussia|dystussia
4939455|NCT01907321|cough|cough
4939456|NCT01907321|maximum expiratory pressure|maximum expiratory pressure
4939457|NCT01907308|Bladder cancer|bladder cancer
4939458|NCT01907308|Urothelial cancer|urothelial cancer
4939459|NCT01907308|Urothelial carcinoma|urothelial carcinoma
4939460|NCT01907295|idiopathic|idiopathic
4939461|NCT01907295|heritable|heritable
4939462|NCT01907295|anorexigen|anorexigen
4939463|NCT01907282|Schizophrenia|schizophrenia
4939464|NCT01907282|psychosis|psychosis
4939465|NCT01907230|Rheumatoid arthritis|rheumatoid arthritis
4939466|NCT01907230|Inactive HBV carrier|inactive hbv carrier
4939467|NCT01907230|Resolved Hepatitis B|resolved hepatitis b
4939468|NCT01907230|HBV reactivation|hbv reactivation
4939469|NCT01907230|Anti-tumor necrotic factor-alfa|anti-tumor necrotic factor-alfa
4939470|NCT01907217|Electroconvulsive therapy|electroconvulsive therapy
4939471|NCT01907217|ECT|ect
4939472|NCT01907217|electrode placement|electrode placement
4939473|NCT01907217|effectiveness|effectiveness
4939474|NCT01907217|cognition|cognition
4939475|NCT01907217|autobiographical memory|autobiographical memory
4939476|NCT01907191|Hip Arthroscopy|hip arthroscopy
4939477|NCT01907191|Liposomal Bupivacaine|liposomal bupivacaine
4939478|NCT01907191|Bupivacaine|bupivacaine
4939479|NCT01907178|total knee arthroplasty|total knee arthroplasty
4939480|NCT01907152|malnutrition|malnutrition
4939481|NCT01907152|undernourishment|undernourishment
4939482|NCT01907152|loss of muscle mass|loss of muscle mass
4939483|NCT01907139|comparative efficacy research|comparative efficacy research
4939484|NCT01907139|combination therapy|combination therapy
4939485|NCT01907139|neurorehabilitation|neurorehabilitation
4939486|NCT01907139|robot-assisted therapy|robot-assisted therapy
4939487|NCT01907139|constraint-induced therapy|constraint-induced therapy
4939488|NCT01907126|HIV|hiv
4939489|NCT01907126|Sexually transmitted infections|sexually transmitted infections
4939490|NCT01907126|Sexual abuse|sexual abuse
4939491|NCT01907126|Physical abuse|physical abuse
4939492|NCT01907126|Women|women
4939493|NCT01907126|Prison|prison
4939494|NCT01907087|Late infantile Neuronal Ceroid Lipofuscinosis Type 2|late infantile neuronal ceroid lipofuscinosis type 2
4939495|NCT01907087|LINCL|lincl
4939496|NCT01907087|NCL2|ncl2
4939497|NCT01907087|CLN2|cln2
4939498|NCT01907087|Jansky-Bielschowsky disease|jansky-bielschowsky disease
4939499|NCT01907074|liver function tests|liver function tests
4939500|NCT01907074|end stage liver disease|end stage liver disease
4939501|NCT01907074|cirrhosis|cirrhosis
4939502|NCT01907074|living liver donor|living liver donor
4939503|NCT01907061|acute renal failure|acute renal failure
4939504|NCT01907061|post liver transplant|post liver transplant
4939505|NCT01907048|Survey|survey
4939506|NCT01907048|Effectiveness of risk minimization measures|effectiveness of risk minimization measures
4939507|NCT01907048|Rivaroxaban|rivaroxaban
4939508|NCT01907048|Anticoagulants|anticoagulants
4939509|NCT01907022|repetitive transcranial magnetic stimulation|repetitive transcranial magnetic stimulation
4939510|NCT01907022|chronic tinnitus|chronic tinnitus
4939511|NCT01907022|relaxation|relaxation
4939512|NCT01906944|trigger point injection|trigger point injection
4939513|NCT01906944|transversus abdominis plane|transversus abdominis plane
4939514|NCT01906944|abdominal wall pain|abdominal wall pain
4939515|NCT01906931|Interstitial lung disease|interstitial lung disease
4939516|NCT01906931|Oxygen therapy|oxygen therapy
4939517|NCT01906931|Walk|walk
4939518|NCT01906918|ischemia|ischemia
4939519|NCT01906918|reperfusion|reperfusion
4939520|NCT01906918|myocardial ischemia|myocardial ischemia
4939521|NCT01906918|myocardial reperfusion|myocardial reperfusion
4939522|NCT01906866|Sleep disturbance|sleep disturbance
4939523|NCT01906866|Circadian|circadian
4939524|NCT01906866|Prolong release melatonin|prolong release melatonin
4939525|NCT01906866|Autism Spectrum Disorder|autism spectrum disorder
4939526|NCT01906866|Smith-Magenis Syndrome|smith-magenis syndrome
4939527|NCT01906866|Angelman Syndrome|angelman syndrome
4939528|NCT01906866|tuberous sclerosis|tuberous sclerosis
4939529|NCT01906853|BCG|bcg
4939530|NCT01906853|Bacille Calmette Guérin|bacille calmette guérin
4939531|NCT01906853|Allergy|allergy
4939532|NCT01906853|Immunity|immunity
4939533|NCT01906853|Immune response|immune response
4939534|NCT01906853|Vaccine|vaccine
4939535|NCT01906853|Infants|infants
4939536|NCT01906853|Children|children
4939537|NCT01906853|Infection|infection
4939538|NCT01906840|Chronic renal failure|chronic renal failure
4939539|NCT01906840|Hemodialysis|hemodialysis
4939540|NCT01906840|Oxidative stress|oxidative stress
4939541|NCT01906840|Turmeric|turmeric
4939542|NCT01906827|cholestasis|cholestasis
4939543|NCT01906827|pregnancy|pregnancy
4939544|NCT01906827|p wave dispersion|p wave dispersion
4939545|NCT01906827|arrhythmia|arrhythmia
4939546|NCT01906801|Osteoarthritis|osteoarthritis
4939547|NCT01906801|Glucosamine sulfate|glucosamine sulfate
4939548|NCT01906801|Diacerein|diacerein
4939549|NCT01906801|Randomized controlled trial|randomized controlled trial
4939550|NCT01906775|ICD|icd
4939551|NCT01906775|ventricular tachyarrhythmia|ventricular tachyarrhythmia
4939552|NCT01906775|shock|shock
4939553|NCT01906775|sub-threshold pacing|sub-threshold pacing
4939554|NCT01906762|Morphine, Acetaminophen, Renal colic, Emergency treatment|morphine, acetaminophen, renal colic, emergency treatment
4939555|NCT01906749|Acute coronary syndrome|acute coronary syndrome
4939556|NCT01906749|Colchicine|colchicine
4939557|NCT01906710|Adverse Drug Events|adverse drug events
4939558|NCT01906710|Drug related problems|drug related problems
4939559|NCT01906710|Medication Reconciliation|medication reconciliation
4939560|NCT01906710|Medication review|medication review
4939561|NCT01906710|discharge counseling|discharge counseling
4939562|NCT01906710|Hospital Pharmacy based|hospital pharmacy based
4939563|NCT01906710|integrated medicines management|integrated medicines management
4939564|NCT01906710|patient safety|patient safety
4939565|NCT01906684|Acthar Gel|acthar gel
4939566|NCT01906684|MS relapse|ms relapse
4939567|NCT01906684|7T MRI imaging|7t mri imaging
4939568|NCT01906684|Quality of Life|quality of life
4939569|NCT01906671|6-mercaptopurine|6-mercaptopurine
4939570|NCT01906671|Drug formulation|drug formulation
4939571|NCT01906658|H.P. Acthar Gel|h.p. acthar gel
4939572|NCT01906658|Acthar|acthar
4939573|NCT01906658|amyotrophic lateral sclerosis|amyotrophic lateral sclerosis
4939574|NCT01906658|ALS|als
4939575|NCT01906645|Patient Readmission|patient readmission
4939576|NCT01906645|Continuity of Patient Care|continuity of patient care
4939577|NCT01906619|Febrile Seizure|febrile seizure
4939578|NCT01906619|Respiratory physiology|respiratory physiology
4939579|NCT01906619|Respiratory drive|respiratory drive
4939580|NCT01906619|Respiratory alkalosis|respiratory alkalosis
4939581|NCT01906606|child nutritional status|child nutritional status
4939582|NCT01906606|child development|child development
4939583|NCT01906606|maternal depression|maternal depression
4939584|NCT01906593|safety|safety
4939585|NCT01906593|influenza vaccine|influenza vaccine
4939586|NCT01906593|post-marketing|post-marketing
4939587|NCT01906580|HBV|hbv
4939588|NCT01906580|entecavir|entecavir
4939589|NCT01906580|peginterferon|peginterferon
4939590|NCT01906567|cadmium|cadmium
4939591|NCT01906567|lead|lead
4939592|NCT01906567|mercury|mercury
4939593|NCT01906567|preeclampsia|preeclampsia
4939594|NCT01906567|pregnancy|pregnancy
4939595|NCT01906541|X-CGD|x-cgd
4939596|NCT01906541|chronic granulomatous disease|chronic granulomatous disease
4939597|NCT01906541|gene-therapy|gene-therapy
4939598|NCT01906528|Nondepolarizing neuromuscular blocking drug|nondepolarizing neuromuscular blocking drug
4939599|NCT01906528|Mivacurium|mivacurium
4939600|NCT01906528|Sensitivity|sensitivity
4939601|NCT01906528|Sex|sex
4939602|NCT01906515|Anemia|anemia
4939603|NCT01906515|Blood transfusion|blood transfusion
4939604|NCT01906515|non invasive hemoglobin monitoring|non invasive hemoglobin monitoring
4939605|NCT01906515|patient safety|patient safety
4939606|NCT01906489|anemia|anemia
4939607|NCT01906489|chronic kidney disease|chronic kidney disease
4939608|NCT01906489|CKD|ckd
4939609|NCT01906489|chronic renal insufficiency|chronic renal insufficiency
4939610|NCT01906489|renal impairment|renal impairment
4939611|NCT01906489|erythropoietin|erythropoietin
4939612|NCT01906489|kidney|kidney
4939613|NCT01906489|oral anemia treatment|oral anemia treatment
4939614|NCT01906489|hemoglobin|hemoglobin
4939615|NCT01906489|hypoxia-inducible factor|hypoxia-inducible factor
4939616|NCT01906489|HIF|hif
4939617|NCT01906489|hypoxia-inducible factor prolyl-hydroxylase inhibitor|hypoxia-inducible factor prolyl-hydroxylase inhibitor
4939618|NCT01906489|HIF-PHI|hif-phi
4939619|NCT01906489|efficacy|efficacy
4939620|NCT01906489|safety|safety
4939621|NCT01906489|pharmacokinetics|pharmacokinetics
4939622|NCT01906476|Depression|depression
4939623|NCT01906476|Telephone Cognitive Behavior Therapy|telephone cognitive behavior therapy
4939624|NCT01906476|Internet Cognitive Behavioral Therapy|internet cognitive behavioral therapy
4939625|NCT01906437|Cardiac fibrosis and Lymphoma|cardiac fibrosis and lymphoma
4939626|NCT01906424|spinal cord injury|spinal cord injury
4939627|NCT01906424|quadriplegia|quadriplegia
4939628|NCT01906424|tetraplegia|tetraplegia
4939629|NCT01906424|stimulation|stimulation
4939630|NCT01906398|Refractory epilepsy|refractory epilepsy
4939631|NCT01906398|ketogenic diet|ketogenic diet
4939632|NCT01906398|efficacy|efficacy
4939633|NCT01906385|Glioblastoma|glioblastoma
4939634|NCT01906385|Astrocytoma|astrocytoma
4939635|NCT01906385|Brain Tumor|brain tumor
4939636|NCT01906385|Radiotherapy|radiotherapy
4939637|NCT01906372|dermatomyositis|dermatomyositis
4939638|NCT01906372|polymyositis|polymyositis
4939639|NCT01906359|Interesterified fat|interesterified fat
4939640|NCT01906359|Stereospecific number 2|stereospecific number 2
4939641|NCT01906359|Gut hormones|gut hormones
4939642|NCT01906359|GIP|gip
4939643|NCT01906359|Insulin sensitivity|insulin sensitivity
4939644|NCT01906359|Postprandial lipaemia|postprandial lipaemia
4939645|NCT01906359|Haemostatic markers|haemostatic markers
4939646|NCT01906333|Exercise|exercise
4939647|NCT01906333|Ectopic fat accumulation|ectopic fat accumulation
4939648|NCT01906320|anorexia nervosa|anorexia nervosa
4939649|NCT01906320|restricting type|restricting type
4939650|NCT01906320|muscle strength|muscle strength
4939651|NCT01906320|exercise|exercise
4939652|NCT01906320|body composition|body composition
4939653|NCT01906320|physical activity|physical activity
4939654|NCT01906307|hepatorenal syndrome|hepatorenal syndrome
4939655|NCT01906294|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
4939656|NCT01906281|adipocytokines|adipocytokines
4939657|NCT01906281|osteoarthritis|osteoarthritis
4939658|NCT01906281|cardiovascular risk|cardiovascular risk
4939659|NCT01906268|Generalized Anxiety Disorder|generalized anxiety disorder
4939660|NCT01906268|Social Anxiety Disorder|social anxiety disorder
4939661|NCT01906268|Panic Disorder|panic disorder
4939662|NCT01906268|Antidepressants Resistant|antidepressants resistant
4939663|NCT01906268|Attentional Bias Modification Treatment (ABMT)|attentional bias modification treatment (abmt)
4939664|NCT01906268|Attentional Retraining|attentional retraining
4939665|NCT01906268|Adjuvant Therapy|adjuvant therapy
4939666|NCT01906255|HIV-1|hiv-1
4939667|NCT01906255|Truvada|truvada
4939668|NCT01906255|FTC/TDF|ftc/tdf
4939669|NCT01906255|Pre-exposure prophylaxy|pre-exposure prophylaxy
4939670|NCT01906255|PrEP|prep
4939671|NCT01906255|Adherence|adherence
4939672|NCT01906255|Resistance|resistance
4939673|NCT01906216|Hepatocellular carcinoma|hepatocellular carcinoma
4939674|NCT01906216|sorafenib|sorafenib
4939675|NCT01906216|transarterial chemoembolization|transarterial chemoembolization
4939676|NCT01906203|Ultramarathon|ultramarathon
4939677|NCT01906203|bioelectrical impedance|bioelectrical impedance
4939678|NCT01906203|Phase-Angle|phase-angle
4939679|NCT01906190|influenza vaccine|influenza vaccine
4939680|NCT01906190|immune response|immune response
4939681|NCT01906190|persistence|persistence
4939682|NCT01906164|RSV|rsv
4939683|NCT01906125|Bioequivalence|bioequivalence
4939684|NCT01906125|Cmax|cmax
4939685|NCT01906125|AUC|auc
4939686|NCT01906073|fentanyl|fentanyl
4939687|NCT01906073|administration, intranasal|administration, intranasal
4939688|NCT01906073|morphine|morphine
4939689|NCT01906073|patient satisfaction|patient satisfaction
4939690|NCT01906073|patient preference|patient preference
4939691|NCT01906047|Non-cystic fibrosis bronchiectasis|non-cystic fibrosis bronchiectasis
4939692|NCT01906021|Thermomap|thermomap
4939693|NCT01906021|Hepatic Lesions|hepatic lesions
4939694|NCT01906021|Radiofrequency Ablation|radiofrequency ablation
4939695|NCT01906021|Microwave|microwave
4939696|NCT01906021|Non-Invasive Technique|non-invasive technique
4939697|NCT01906008|Colorectal cancer|colorectal cancer
4939698|NCT01906008|CRC|crc
4939699|NCT01906008|Acute peripheral neuropathy|acute peripheral neuropathy
4939700|NCT01906008|Numbness|numbness
4939701|NCT01906008|Pain|pain
4939702|NCT01906008|Loss of motor function|loss of motor function
4939703|NCT01906008|Minocycline|minocycline
4939704|NCT01906008|Dynacin|dynacin
4939705|NCT01906008|Minocin|minocin
4939706|NCT01906008|Minocin PAC|minocin pac
4939707|NCT01906008|Myrac|myrac
4939708|NCT01906008|Solodyn|solodyn
4939709|NCT01906008|Placebo|placebo
4939710|NCT01906008|Questionnaires|questionnaires
4939711|NCT01906008|Surveys|surveys
4939712|NCT01906008|Sensory tests|sensory tests
4939713|NCT01905995|deep brain sitimulation|deep brain sitimulation
4939714|NCT01905995|local field potentials|local field potentials
4939715|NCT01905969|Gastric caner, adjuvant chemotherapy|gastric caner, adjuvant chemotherapy
4939716|NCT01905917|Stroke|stroke
4939717|NCT01905904|electroconvulsive therapy|electroconvulsive therapy
4939718|NCT01905904|seizures|seizures
4939719|NCT01905904|sevoflurane|sevoflurane
4939720|NCT01905891|Non melanoma skin cancer|non melanoma skin cancer
4939721|NCT01905891|Field of cancerization|field of cancerization
4939722|NCT01905891|Skin carcinogenesis|skin carcinogenesis
4939723|NCT01905865|Uncertainty|uncertainty
4939724|NCT01905865|Undiagnosed Disease|undiagnosed disease
4939725|NCT01905865|Coping|coping
4939726|NCT01905852|Transcatheter Aortic Valve Replacement|transcatheter aortic valve replacement
4939727|NCT01905852|Ejection Fraction|ejection fraction
4939728|NCT01905852|Fractional Flow Reserve|fractional flow reserve
4939729|NCT01905852|Myocardial Fibrosis|myocardial fibrosis
4939730|NCT01905839|Rigidity|rigidity
4939731|NCT01905839|Assessment|assessment
4939732|NCT01905839|Parkinson's Disease|parkinson's disease
4939733|NCT01905839|Physiological Measures|physiological measures
4939734|NCT01905826|Hematopoiesis|hematopoiesis
4939735|NCT01905826|Immunodeficiency|immunodeficiency
4939736|NCT01905826|Myelodysplasia/Leukemia|myelodysplasia/leukemia
4939737|NCT01905826|Lymphedema|lymphedema
4939738|NCT01905826|Pulmonary Alveolar Proteinosis|pulmonary alveolar proteinosis
4939739|NCT01905800|Vertigo and dizziness.|vertigo and dizziness.
4939740|NCT01905800|semicircular canals|semicircular canals
4939741|NCT01905774|Renal Function|renal function
4939742|NCT01905761|obesity|obesity
4939743|NCT01905748|Coagulation|coagulation
4939744|NCT01905735|RA|ra
4939745|NCT01905722|MRI|mri
4939746|NCT01905722|metabolism|metabolism
4939747|NCT01905722|healthy|healthy
4939748|NCT01905722|7 Tesla|7 tesla
4939749|NCT01905709|C diff|c diff
4939750|NCT01905709|CDI|cdi
4939751|NCT01905709|clostridium difficile associated diarrhea|clostridium difficile associated diarrhea
4939752|NCT01905670|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
4939753|NCT01905670|cardiac pacing|cardiac pacing
4939754|NCT01905670|electrical stimulation|electrical stimulation
4939755|NCT01905670|bi-ventricular pacing|bi-ventricular pacing
4939756|NCT01905657|PD1|pd1
4939757|NCT01905657|PD-1|pd-1
4939758|NCT01905657|PDL1|pdl1
4939759|NCT01905657|PD-L1|pd-l1
4939760|NCT01905644|Vaginal delivery|vaginal delivery
4939761|NCT01905644|Perineal lesions|perineal lesions
4939762|NCT01905644|Anal sphincter rupture|anal sphincter rupture
4939763|NCT01905644|Ultrasound|ultrasound
4939764|NCT01905618|Medical Education|medical education
4939765|NCT01905618|Tobacco Dependence Treatment|tobacco dependence treatment
4939766|NCT01905618|Physician Delivered Intervention|physician delivered intervention
4939767|NCT01905592|Human Epidermal Growth Factor 2 Negative Carcinoma of Breast|human epidermal growth factor 2 negative carcinoma of breast
4939768|NCT01905592|BRCA1 Gene Mutation|brca1 gene mutation
4939769|NCT01905592|BRCA2 Gene Mutation|brca2 gene mutation
4939770|NCT01905592|Parp Inhibitor|parp inhibitor
4939771|NCT01905592|BRCA|brca
4939772|NCT01905579|flaremetry|flaremetry
4939773|NCT01905579|aqueous proteins|aqueous proteins
4939774|NCT01905579|clinical grading|clinical grading
4939775|NCT01905579|Compare flaremetry readings with the protein content of the aqueous|compare flaremetry readings with the protein content of the aqueous
4939776|NCT01905579|Compare flaremetry readings with clinical grading of flare|compare flaremetry readings with clinical grading of flare
4939777|NCT01905566|Plaque, Atherosclerotic|plaque, atherosclerotic
4939778|NCT01905566|clopidogrel|clopidogrel
4939779|NCT01905566|ticagrelor|ticagrelor
4939780|NCT01905566|Fluorodeoxyglucose F18|fluorodeoxyglucose f18
4939903|NCT01904890|Filipinos Americans|filipinos americans
4939781|NCT01905566|Positron-Emission Tomography and Computed Tomography|positron-emission tomography and computed tomography
4939782|NCT01905527|Multiple Sclerosis|multiple sclerosis
4939783|NCT01905527|Relapsing-Remitting|relapsing-remitting
4939784|NCT01905527|Rebif|rebif
4939785|NCT01905527|Quintiles Geographic Area Group|quintiles geographic area group
4939786|NCT01905527|Standard Subgroup|standard subgroup
4939787|NCT01905527|Custom Subgroup|custom subgroup
4939788|NCT01905527|RxCrossroads Geographic Area Group|rxcrossroads geographic area group
4939789|NCT01905501|Balanced anesthesia|balanced anesthesia
4939790|NCT01905501|Inhalation anesthesia|inhalation anesthesia
4939791|NCT01905501|Reperfusion injury|reperfusion injury
4939792|NCT01905501|Microsurgical Free flap|microsurgical free flap
4939793|NCT01905475|STEMI|stemi
4939795|NCT01905475|repair|repair
4939796|NCT01905462|Cervarix|cervarix
4939797|NCT01905462|Spontaneous abortion|spontaneous abortion
4939798|NCT01905462|Vaccine|vaccine
4939799|NCT01905462|Human Papillomavirus|human papillomavirus
4939800|NCT01905436|Filariasis|filariasis
4939801|NCT01905436|Onchocerciasis|onchocerciasis
4939802|NCT01905436|Albendazole|albendazole
4939803|NCT01905436|Ivermectin|ivermectin
4939804|NCT01905436|STH Soil Transmitted Helminth infections|sth soil transmitted helminth infections
4939805|NCT01905436|MDA Mass Drug Administration|mda mass drug administration
4939806|NCT01905423|Filariasis|filariasis
4939807|NCT01905423|Albendazole|albendazole
4939808|NCT01905423|Diethylcarbamazine|diethylcarbamazine
4939809|NCT01905423|STH Soil Transmitted Helminths|sth soil transmitted helminths
4939810|NCT01905423|MDA Mass Drug Administration|mda mass drug administration
4939811|NCT01905384|pancreatic cancer|pancreatic cancer
4939812|NCT01905384|cholangiocarcinoma|cholangiocarcinoma
4939813|NCT01905384|metastatic malignancy|metastatic malignancy
4939814|NCT01905384|jaundice|jaundice
4939815|NCT01905371|amphetamine|amphetamine
4939816|NCT01905371|stroke recovery|stroke recovery
4939817|NCT01905319|juvenile idiopathic arthritis|juvenile idiopathic arthritis
4939818|NCT01905319|incidence rate|incidence rate
4939819|NCT01905306|dental implants|dental implants
4939820|NCT01905306|immediate loading|immediate loading
4939821|NCT01905306|full-arch|full-arch
4939822|NCT01905306|computer guided implant surgery|computer guided implant surgery
4939823|NCT01905280|allograft|allograft
4939824|NCT01905280|acellular dermal matrix|acellular dermal matrix
4939825|NCT01905280|alveolar ridge|alveolar ridge
4939826|NCT01905267|mindfulness|mindfulness
4939827|NCT01905267|relapse prevention|relapse prevention
4939828|NCT01905267|recovery|recovery
4939829|NCT01905267|depression|depression
4939830|NCT01905267|adolescents|adolescents
4939831|NCT01905254|Transient elastography|transient elastography
4939832|NCT01905254|mini-laparoscopy|mini-laparoscopy
4939833|NCT01905254|liver biopsy|liver biopsy
4939834|NCT01905254|liver cirrhosis|liver cirrhosis
4939835|NCT01905254|autoimmune hepatitis|autoimmune hepatitis
4939836|NCT01905228|Metastatic Advance Solid Neoplasms|metastatic advance solid neoplasms
4939837|NCT01905228|Unresectable Advance Solid Neoplasms|unresectable advance solid neoplasms
4939838|NCT01905215|Immunogenicity|immunogenicity
4939839|NCT01905215|Respiratory Syncytial Virus|respiratory syncytial virus
4939840|NCT01905215|Reactogenicity|reactogenicity
4939841|NCT01905215|Vaccination|vaccination
4939842|NCT01905215|Safety|safety
4939843|NCT01905202|Proton Pump Inhibitor|proton pump inhibitor
4939844|NCT01905202|Safety|safety
4939845|NCT01905202|Tolerability|tolerability
4939846|NCT01905202|pH control|ph control
4939847|NCT01905202|Bile Acid|bile acid
4939848|NCT01905189|pulmonary arterial hypertension|pulmonary arterial hypertension
4939849|NCT01905189|cardiac resynchronization therapy|cardiac resynchronization therapy
4939850|NCT01905176|Heart Failure|heart failure
4939851|NCT01905176|Randomized Control Trial|randomized control trial
4939852|NCT01905176|Disease management|disease management
4939853|NCT01905176|Self-care|self-care
4939854|NCT01905176|Nursing|nursing
4939855|NCT01905176|Patient education as topic|patient education as topic
4939856|NCT01905163|Laparoscopy, interval debulking surgery|laparoscopy, interval debulking surgery
4939953|NCT01904669|Fertility|fertility
4939857|NCT01905150|pancreatic Cancer|pancreatic cancer
4939858|NCT01905150|G-FLIP, Gemcitabine 5FU Leucovorin Irinotecan Oxaliplatin|g-flip, gemcitabine 5fu leucovorin irinotecan oxaliplatin
4939859|NCT01905150|G-FLIP-DM (G-FLIP + Low doses Docetaxel and Mitomycin C)|g-flip-dm (g-flip + low doses docetaxel and mitomycin c)
4939860|NCT01905150|Vitamin C (ascorbic acid)|vitamin c (ascorbic acid)
4939861|NCT01905137|Myofascial pelvic pain|myofascial pelvic pain
4939862|NCT01905124|Uveitis|uveitis
4939863|NCT01905124|Intermediate uveitis|intermediate uveitis
4939864|NCT01905124|Posterior uveitis|posterior uveitis
4939865|NCT01905098|Detoxification|detoxification
4939866|NCT01905098|Sauna|sauna
4939867|NCT01905098|Hyperthermia|hyperthermia
4939868|NCT01905072|Obesity|obesity
4939869|NCT01905072|Breastfeeding|breastfeeding
4939870|NCT01905072|Educational Intervention|educational intervention
4939871|NCT01905059|HIV infection|hiv infection
4939872|NCT01905059|second line ART|second line art
4939873|NCT01905059|maintenance strategies|maintenance strategies
4939874|NCT01905059|Protease inhibitors|protease inhibitors
4939875|NCT01905059|mono or bi-therapy|mono or bi-therapy
4939876|NCT01905033|Sepsis|sepsis
4939877|NCT01905033|Pneumonia|pneumonia
4939878|NCT01905033|Peritonitis|peritonitis
4939879|NCT01905033|Biomarkers|biomarkers
4939880|NCT01905033|Transcriptomics|transcriptomics
4939881|NCT01905033|Pathogen detection|pathogen detection
4939882|NCT01905020|Type 1 diabetes|type 1 diabetes
4939883|NCT01905020|Hypoglycemia|hypoglycemia
4939884|NCT01905020|Insulin|insulin
4939885|NCT01905020|Glucagon|glucagon
4939886|NCT01905020|Closed-loop system|closed-loop system
4939887|NCT01905020|Artificial pancreas|artificial pancreas
4939888|NCT01905007|Implantable cardioverter defibrillator|implantable cardioverter defibrillator
4939889|NCT01905007|Defibrillation threshold testing|defibrillation threshold testing
4939890|NCT01904994|HIV (Human Immunodeficiency Virus)|hiv (human immunodeficiency virus)
4939891|NCT01904994|ART (antiretroviral therapy)|art (antiretroviral therapy)
4939892|NCT01904994|financial incentive|financial incentive
4939893|NCT01904994|linkage|linkage
4939894|NCT01904994|retention|retention
4939895|NCT01904994|SMS (Short Message Service) appointment reminder|sms (short message service) appointment reminder
4939896|NCT01904994|accelerated ART|accelerated art
4939897|NCT01904994|CD4+ count|cd4+ count
4939898|NCT01904903|Breast Cancer HER2 Positive|breast cancer her2 positive
4939899|NCT01904903|Cardiac Safety|cardiac safety
4939900|NCT01904890|Asian Americans|asian americans
4939901|NCT01904890|colorectal cancer screening|colorectal cancer screening
4939902|NCT01904890|cancer prevention|cancer prevention
4939904|NCT01904890|Hmong Americans|hmong americans
4939905|NCT01904890|Korean Americans|korean americans
4939906|NCT01904890|Randomized Controlled Trials|randomized controlled trials
4939907|NCT01904877|HIV testing|hiv testing
4939908|NCT01904877|linkage|linkage
4939909|NCT01904877|care|care
4939910|NCT01904864|randomized controlled trial|randomized controlled trial
4939911|NCT01904864|iron medication|iron medication
4939912|NCT01904864|Anemia|anemia
4939913|NCT01904864|Hematologic Disease|hematologic disease
4939914|NCT01904864|Anemia, Iron deficiency|anemia, iron deficiency
4939915|NCT01904864|anemia, nutritional|anemia, nutritional
4939916|NCT01904864|ferrous sulfate|ferrous sulfate
4939917|NCT01904864|NovaFerrum®|novaferrum®
4939918|NCT01904851|Peripheral Arterial Disease|peripheral arterial disease
4939919|NCT01904851|Stents|stents
4939920|NCT01904851|Registry|registry
4939921|NCT01904851|Angioplasty|angioplasty
4939922|NCT01904851|Endovascular Procedures|endovascular procedures
4939923|NCT01904786|Hypoxic Ischemic Encephalopathy|hypoxic ischemic encephalopathy
4939924|NCT01904786|Newborn|newborn
4939925|NCT01904786|Outcomes|outcomes
4939926|NCT01904786|Melatonin|melatonin
4939927|NCT01904773|Combined Multiple Motor and Vocal Tic Disorder; Tourette Disorder; Gilles de la Tourette Syndrome; Tourette Disease|combined multiple motor and vocal tic disorder; tourette disorder; gilles de la tourette syndrome; tourette disease
4939928|NCT01904760|agitation|agitation
4939929|NCT01904760|delirium|delirium
4939930|NCT01904760|dexmedetomidine|dexmedetomidine
4939931|NCT01904760|head and neck surgery|head and neck surgery
4939932|NCT01904760|microvascular free tissue transfer|microvascular free tissue transfer
4939933|NCT01904760|flap|flap
4939934|NCT01904747|Food|food
4939935|NCT01904747|Bioavailability|bioavailability
4939936|NCT01904747|Fasted|fasted
4939937|NCT01904747|Fed|fed
4939938|NCT01904734|testosterone|testosterone
4939939|NCT01904734|hypogonadism|hypogonadism
4939940|NCT01904734|pituitary|pituitary
4939941|NCT01904708|Phenylketonuria|phenylketonuria
4939942|NCT01904708|PKU|pku
4939943|NCT01904708|Exercise|exercise
4939944|NCT01904708|Muscle Protein Synthesis|muscle protein synthesis
4939945|NCT01904708|Plasma Phenylalanine concentration|plasma phenylalanine concentration
4939946|NCT01904695|resistant hypertension|resistant hypertension
4939947|NCT01904695|causal inference|causal inference
4939948|NCT01904695|a chorot study|a chorot study
4939949|NCT01904695|recipe of removing both phlegm and blood stasis|recipe of removing both phlegm and blood stasis
4939950|NCT01904682|Erythrocyte transfusion|erythrocyte transfusion
4939951|NCT01904682|Erythropoiesis-stimulating agent|erythropoiesis-stimulating agent
4939952|NCT01904682|International Prognostic Scoring System|international prognostic scoring system
4939954|NCT01904669|Infertility|infertility
4939955|NCT01904669|Pregnancy|pregnancy
4939956|NCT01904669|Conception|conception
4939957|NCT01904669|Behavioral|behavioral
4939958|NCT01904669|Lifestyle|lifestyle
4939959|NCT01904669|Preconception Care|preconception care
4939960|NCT01904669|Women's Health|women's health
4939961|NCT01904669|Abortion, Spontaneous|abortion, spontaneous
4939962|NCT01904669|Cohort Studies|cohort studies
4939963|NCT01904669|Epidemiology|epidemiology
4939964|NCT01904669|Internet|internet
4939965|NCT01904656|Colorectal Cancer Screening|colorectal cancer screening
4939966|NCT01904656|Ohio Appalachia|ohio appalachia
4939967|NCT01904630|gene sequencing|gene sequencing
4939968|NCT01904630|familial|familial
4939969|NCT01904630|risk factors|risk factors
4939970|NCT01904617|Length of labor|length of labor
4939971|NCT01904617|second stage of labor|second stage of labor
4939972|NCT01904617|intravenous hydration of labor|intravenous hydration of labor
4939973|NCT01904617|intravenous glucose|intravenous glucose
4939974|NCT01904604|Peanut Allergy|peanut allergy
4939975|NCT01904604|Food Allergy|food allergy
4939976|NCT01904604|Viaskin peanut patch|viaskin peanut patch
4939977|NCT01904604|Allergen Immunotherapy|allergen immunotherapy
4939978|NCT01904604|Epicutaneous Immunotherapy|epicutaneous immunotherapy
4939979|NCT01904604|Whole peanut extract|whole peanut extract
4939980|NCT01904604|Allergenic product|allergenic product
4939981|NCT01904604|Immediate hypersensitivity|immediate hypersensitivity
4939982|NCT01904591|Spinal Cord Injury|spinal cord injury
4939983|NCT01904591|Antioxidants|antioxidants
4939984|NCT01904591|tractography|tractography
4939985|NCT01904591|ASIA assessment|asia assessment
4939986|NCT01904578|Menopause|menopause
4939987|NCT01904578|Sleep quality|sleep quality
4939988|NCT01904578|Acupressure|acupressure
4939989|NCT01904565|Hyperthermia,|hyperthermia,
4939990|NCT01904565|Proton beam therapy|proton beam therapy
4939991|NCT01904565|Soft Tissue Sarcoma|soft tissue sarcoma
4939992|NCT01904565|Radiotherapy|radiotherapy
4939993|NCT01904565|Phase I/II trial|phase i/ii trial
4939994|NCT01904552|Apical periodontitis|apical periodontitis
4939995|NCT01904552|Dentaport ZX|dentaport zx
4939996|NCT01904552|electronic apex locators|electronic apex locators
4939997|NCT01904552|i-Root|i-root
4939998|NCT01904552|Raypex 5|raypex 5
4939999|NCT01904552|working length|working length
4940000|NCT01904526|Guanfacine|guanfacine
4940001|NCT01904526|PK/PD|pk/pd
4940002|NCT01904526|Smokers|smokers
4940003|NCT01904513|Metals|metals
4940004|NCT01904513|Pesticides|pesticides
4940005|NCT01904513|Toxicity|toxicity
4940006|NCT01904500|Cesarean delivery|cesarean delivery
4940007|NCT01904474|obesity|obesity
4940008|NCT01904474|overweight|overweight
4940009|NCT01904474|technology|technology
4940010|NCT01904474|internet|internet
4940011|NCT01904474|intervention|intervention
4940012|NCT01904474|adolescents|adolescents
4940013|NCT01904461|tonsillectomy|tonsillectomy
4940014|NCT01904461|children|children
4940015|NCT01904461|vacuum|vacuum
4940016|NCT01904461|medical device|medical device
4940017|NCT01904461|pain|pain
4940018|NCT01904461|hemorrhage|hemorrhage
4940019|NCT01904461|post-surgical complications|post-surgical complications
4940020|NCT01904448|pediatric|pediatric
4940021|NCT01904448|profound hearing loss|profound hearing loss
4940022|NCT01904448|auditory brainstem implant|auditory brainstem implant
4940023|NCT01904448|cochlear implant|cochlear implant
4940024|NCT01904448|developmental or acquired cochlear nerve deficiency (CND)|developmental or acquired cochlear nerve deficiency (cnd)
4940025|NCT01904448|cochlear aplasia (Michel)|cochlear aplasia (michel)
4940026|NCT01904448|post-meningitis cochlear ossification|post-meningitis cochlear ossification
4940027|NCT01904448|cochlear malformation|cochlear malformation
4940028|NCT01904448|CND|cnd
4940029|NCT01904422|Diabetes mellitus.|diabetes mellitus.
4940030|NCT01904422|Periodontitis|periodontitis
4940031|NCT01904422|Periodontal treatment.|periodontal treatment.
4940032|NCT01904357|Cefazolin, Pediatric|cefazolin, pediatric
4940033|NCT01904344|Sleep|sleep
4940034|NCT01904344|Sleep- related breathing disorders|sleep- related breathing disorders
4940035|NCT01904344|Respiratory pathology|respiratory pathology
4940036|NCT01904331|Cardiotoxicity|cardiotoxicity
4940037|NCT01904331|long-term effects|long-term effects
4940038|NCT01904331|chemotherapy|chemotherapy
4940039|NCT01904331|radiotherapy|radiotherapy
4940040|NCT01904318|male|male
4940041|NCT01904318|Phase I|phase i
4940042|NCT01904318|A dose block-randomized|a dose block-randomized
4940043|NCT01904318|Double-blinded|double-blinded
4940044|NCT01904318|Placebo controlled|placebo controlled
4940045|NCT01904318|Single Dose|single dose
4940046|NCT01904318|dose Escalation|dose escalation
4940047|NCT01904318|IDP-73152 mesylate|idp-73152 mesylate
4940048|NCT01904318|Food Effect|food effect
4940049|NCT01904318|Pharmacokinetics|pharmacokinetics
4940050|NCT01904318|health male volunteer|health male volunteer
4940051|NCT01904318|PDF inhibitor|pdf inhibitor
4940052|NCT01904305|Pneumonia|pneumonia
4940053|NCT01904253|Second line Small Cell Lung Cancer, (SCLC), Refractory or Sensitive to First line Platinum based chemotherapy|second line small cell lung cancer, (sclc), refractory or sensitive to first line platinum based chemotherapy
4940054|NCT01904240|Parkinson's disease|parkinson's disease
4940055|NCT01904240|GI tract|gi tract
4940056|NCT01904240|Lipopolysaccharide binding protein|lipopolysaccharide binding protein
4940057|NCT01904227|Borderline Personality Disorder|borderline personality disorder
4940058|NCT01904227|Dialectical Behavior Therapy|dialectical behavior therapy
4940059|NCT01904214|renal impairement|renal impairement
4940060|NCT01904214|pharmacokinetics|pharmacokinetics
4940061|NCT01904201|Immune function|immune function
4940062|NCT01904201|Interferon-gamma release assays|interferon-gamma release assays
4940063|NCT01904201|Active HIV cell Reservoirs|active hiv cell reservoirs
4940064|NCT01904188|microbial identification|microbial identification
4940065|NCT01904188|antibiotic resistance|antibiotic resistance
4940066|NCT01904188|GeneZ and other techniques as developed|genez and other techniques as developed
4940067|NCT01904188|sepsis|sepsis
4940068|NCT01904188|Systemic Inflammatory Response Syndrome|systemic inflammatory response syndrome
4940069|NCT01904175|Stem cell transplantation, non-myeloablative|stem cell transplantation, non-myeloablative
4940070|NCT01904149|Moderate to severe acute pain|moderate to severe acute pain
4940071|NCT01904149|Postoperative pain|postoperative pain
4940072|NCT01904149|Abdominal hysterectomy|abdominal hysterectomy
4940073|NCT01904149|Analgesics|analgesics
4940074|NCT01904149|Dexketoprofen|dexketoprofen
4940075|NCT01904149|Tramadol|tramadol
4940076|NCT01904136|Leukemia|leukemia
4940077|NCT01904136|Myeloproliferative Diseases|myeloproliferative diseases
4940078|NCT01904136|Blood And Marrow Transplantation|blood and marrow transplantation
4940079|NCT01904136|High Risk Myeloid Malignancies|high risk myeloid malignancies
4940080|NCT01904136|Acute myeloid leukemia|acute myeloid leukemia
4940081|NCT01904136|AML|aml
4940082|NCT01904136|Myelodysplastic syndrome|myelodysplastic syndrome
4940083|NCT01904136|MDS|mds
4940084|NCT01904136|Chronic myeloid leukemia|chronic myeloid leukemia
4940085|NCT01904136|CML|cml
4940086|NCT01904136|Haploidentical Stem-cell Transplantation|haploidentical stem-cell transplantation
4940087|NCT01904136|HaploSCT|haplosct
4940088|NCT01904136|Expanded natural killer cells|expanded natural killer cells
4940089|NCT01904136|NK|nk
4940090|NCT01904136|Melphalan|melphalan
4940091|NCT01904136|Alkeran|alkeran
4940092|NCT01904136|Mesna|mesna
4940093|NCT01904136|Mesnex|mesnex
4940094|NCT01904136|Cyclophosphamide|cyclophosphamide
4940095|NCT01904136|Cytoxan|cytoxan
4940096|NCT01904136|Neosar|neosar
4940097|NCT01904136|Tacrolimus|tacrolimus
4940098|NCT01904136|Prograf|prograf
4940099|NCT01904136|Mycophenolate mofetil|mycophenolate mofetil
4940100|NCT01904136|MMF|mmf
4940101|NCT01904136|CellCept|cellcept
4940102|NCT01904136|G-CSF|g-csf
4940103|NCT01904136|Filgrastim|filgrastim
4940104|NCT01904136|Neupogen|neupogen
4940105|NCT01904136|Fludarabine|fludarabine
4940106|NCT01904136|Fludarabine phosphate|fludarabine phosphate
4940107|NCT01904136|Fludara|fludara
4940108|NCT01904123|Brain cancer|brain cancer
4940109|NCT01904123|Central nervous system neoplasms|central nervous system neoplasms
4940110|NCT01904123|CNS|cns
4940111|NCT01904123|Melanoma|melanoma
4940112|NCT01904123|Glioblastoma Multiforme|glioblastoma multiforme
4940113|NCT01904123|GBM|gbm
4940114|NCT01904123|Solid tumors|solid tumors
4940115|NCT01904123|Metastatic to the brain|metastatic to the brain
4940116|NCT01904123|WP1066|wp1066
4940117|NCT01904123|Recurrent malignant glioma|recurrent malignant glioma
4940118|NCT01904123|Glioblastoma|glioblastoma
4940119|NCT01904123|Anaplastic glioma|anaplastic glioma
4940120|NCT01904123|Advanced Brain Tumor Imaging|advanced brain tumor imaging
4940121|NCT01904123|ABTI|abti
4940122|NCT01904110|Risedronate,cholecalciferol,BMD,montly,weekly,compliance|risedronate,cholecalciferol,bmd,montly,weekly,compliance
4940123|NCT01904097|Fibromyalgia|fibromyalgia
4940124|NCT01904097|Transcranial Direct Current Stimulation|transcranial direct current stimulation
4940125|NCT01904097|tDCS|tdcs
4940126|NCT01904097|Pregabalin|pregabalin
4940127|NCT01904097|Functional Neuroimaging|functional neuroimaging
4940128|NCT01904097|Near Infrared Spectroscopy|near infrared spectroscopy
4940129|NCT01904097|NIRS|nirs
4940130|NCT01904097|Chronic Pain|chronic pain
4940131|NCT01904097|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
4940132|NCT01904097|TMS|tms
4940133|NCT01904084|Distal radius fracture|distal radius fracture
4940134|NCT01904071|Hip Fracture|hip fracture
4940135|NCT01904071|Ultrasound|ultrasound
4940136|NCT01904071|Nerve Block|nerve block
4940137|NCT01904058|PBC|pbc
4940138|NCT01904032|Vitamin D|vitamin d
4940139|NCT01904032|Diabetes|diabetes
4940140|NCT01904032|Self-Management|self-management
4940141|NCT01904032|Depression|depression
4940142|NCT01904032|Women|women
4940143|NCT01904019|arthroplasty|arthroplasty
4940144|NCT01904019|trapezio-metacarpial|trapezio-metacarpial
4940145|NCT01904006|grouped embryo culture|grouped embryo culture
4940146|NCT01904006|embryo density|embryo density
4940147|NCT01904006|low oxygen|low oxygen
4940148|NCT01904006|benchtop incubator|benchtop incubator
4940149|NCT01904006|culture condition|culture condition
4940150|NCT01903980|Epipericardial Fat Necrosis|epipericardial fat necrosis
4940151|NCT01903980|Fat Necrosis|fat necrosis
4940152|NCT01903980|Chest Pain|chest pain
4940238|NCT01903707|Psychosis|psychosis
4940153|NCT01903980|Pericardial Necrosis|pericardial necrosis
4940154|NCT01903980|Pleuritic pain|pleuritic pain
4940155|NCT01903967|Pituitary|pituitary
4940156|NCT01903967|CGH array|cgh array
4940157|NCT01903967|Tumor|tumor
4940158|NCT01903941|exercise|exercise
4940159|NCT01903928|cytomegalovirus|cytomegalovirus
4940160|NCT01903928|DNA vaccine|dna vaccine
4940161|NCT01903928|transplantation|transplantation
4940162|NCT01903928|HCT|hct
4940163|NCT01903902|Coronary artery disease|coronary artery disease
4940164|NCT01903902|Balloon angioplasty|balloon angioplasty
4940165|NCT01903902|Drug-eluting balloon|drug-eluting balloon
4940166|NCT01903889|AE adverse event|ae adverse event
4940167|NCT01903889|AIDS acquired immunodeficiency syndrome|aids acquired immunodeficiency syndrome
4940168|NCT01903889|ALT (SGPT) alanine aminotransferase|alt (sgpt) alanine aminotransferase
4940169|NCT01903889|ART antiretroviral therapy|art antiretroviral therapy
4940170|NCT01903889|AST (SGOT) aspartate aminotransferase|ast (sgot) aspartate aminotransferase
4940171|NCT01903889|DCF data collection forms|dcf data collection forms
4940172|NCT01903889|DMC Data Monitoring Committee|dmc data monitoring committee
4940173|NCT01903889|FDA (U.S.) Food and Drug Administration|fda (u.s.) food and drug administration
4940174|NCT01903889|GCP Good Clinical Practice guidelines|gcp good clinical practice guidelines
4940175|NCT01903889|HB sAg Hepatitis B surface antigen|hb sag hepatitis b surface antigen
4940176|NCT01903889|ICH International Conference of Harmonization|ich international conference of harmonization
4940177|NCT01903889|IND Investigational New Drug Application|ind investigational new drug application
4940178|NCT01903889|IRB Institutional Review Board|irb institutional review board
4940179|NCT01903889|IU International units|iu international units
4940180|NCT01903889|mg milligram(s)|mg milligram(s)
4940181|NCT01903889|mm3 cubic millimeter(s)|mm3 cubic millimeter(s)
4940182|NCT01903889|PCR polymerase chain reaction|pcr polymerase chain reaction
4940183|NCT01903889|SAE serious adverse event|sae serious adverse event
4940184|NCT01903889|µg microgram|µg microgram
4940185|NCT01903889|ULN upper limit of the normal range|uln upper limit of the normal range
4940186|NCT01903889|WB Western Blot|wb western blot
4940187|NCT01903889|ANC Antenatal care|anc antenatal care
4940188|NCT01903889|ARV Antiretroviral|arv antiretroviral
4940189|NCT01903889|C&T Care and treatment|c&t care and treatment
4940190|NCT01903889|CPR Contraceptive prevalence rate|cpr contraceptive prevalence rate
4940191|NCT01903889|DHS Demographic and Health Survey|dhs demographic and health survey
4940192|NCT01903889|EGPAF Elizabeth Glaser Pediatric AIDS Foundation|egpaf elizabeth glaser pediatric aids foundation
4940193|NCT01903889|FP Family planning|fp family planning
4940194|NCT01903889|HIV Human immunodeficiency virus|hiv human immunodeficiency virus
4940195|NCT01903889|HTC HIV testing and counseling|htc hiv testing and counseling
4940196|NCT01903889|IUCD Intrauterine contraceptive device|iucd intrauterine contraceptive device
4940197|NCT01903889|MCH Maternal/child health|mch maternal/child health
4940198|NCT01903889|PDA Personal digital assistant|pda personal digital assistant
4940199|NCT01903889|PEPFAR President's Emergency Plan for AIDS Relief|pepfar president's emergency plan for aids relief
4940200|NCT01903889|PHSC Protection of Human Subjects Committee|phsc protection of human subjects committee
4940201|NCT01903889|PMTCT Prevention of maternal to child transmission|pmtct prevention of maternal to child transmission
4940202|NCT01903889|STAR-SW Strengthening TB and HIV/AIDS Response in the South Western Region of Uganda|star-sw strengthening tb and hiv/aids response in the south western region of uganda
4940203|NCT01903889|STI Sexually transmitted infection|sti sexually transmitted infection
4940204|NCT01903889|TM Technical monitor|tm technical monitor
4940205|NCT01903889|USAID United States Agency for International Development|usaid united states agency for international development
4940206|NCT01903889|WHO World Health Organization|who world health organization
4940207|NCT01903863|FFP|ffp
4940208|NCT01903863|fresh frozen plasma|fresh frozen plasma
4940209|NCT01903863|ECMO|ecmo
4940210|NCT01903863|extracorporeal membrane oxygenation|extracorporeal membrane oxygenation
4940211|NCT01903863|anticoagulation|anticoagulation
4940212|NCT01903863|transfusion|transfusion
4940213|NCT01903850|Benign central airway obstruction|benign central airway obstruction
4940214|NCT01903850|Malignant central airway obstruction|malignant central airway obstruction
4940215|NCT01903850|Spray cryotherapy|spray cryotherapy
4940216|NCT01903850|Endoluminal tumors|endoluminal tumors
4940217|NCT01903850|Airway granulation tissue|airway granulation tissue
4940218|NCT01903837|Schizophrenia|schizophrenia
4940219|NCT01903837|Olanzapine|olanzapine
4940220|NCT01903837|Samidorphan|samidorphan
4940221|NCT01903837|Alkermes|alkermes
4940222|NCT01903824|Irdabisant|irdabisant
4940223|NCT01903824|cognitive impairment|cognitive impairment
4940224|NCT01903811|carfilzomib|carfilzomib
4940225|NCT01903811|relapsed|relapsed
4940226|NCT01903811|refractory|refractory
4940227|NCT01903811|multiple myeloma|multiple myeloma
4940228|NCT01903785|exercise-induced bronchoconstriction (EIB)|exercise-induced bronchoconstriction (eib)
4940229|NCT01903785|inhaled salbutamol|inhaled salbutamol
4940230|NCT01903785|performance enhancing|performance enhancing
4940231|NCT01903785|cycling|cycling
4940232|NCT01903733|Subjects|subjects
4940233|NCT01903733|Chronic Myeloid Leukemia|chronic myeloid leukemia
4940234|NCT01903733|CML|cml
4940235|NCT01903733|Bosutinib|bosutinib
4940236|NCT01903733|Extension|extension
4940237|NCT01903707|Schizophrenia|schizophrenia
4940239|NCT01903707|Cognitive deficits|cognitive deficits
4940240|NCT01903681|Sleep problems, autism spectrum disorder, prolonged-release melatonin, Circadin, endogenous saliva melatonin|sleep problems, autism spectrum disorder, prolonged-release melatonin, circadin, endogenous saliva melatonin
4940241|NCT01903681|Smith-Magenis syndrome, Angelman syndrome, Tuberous Sclerosis|smith-magenis syndrome, angelman syndrome, tuberous sclerosis
4940242|NCT01903603|cerebral palsy|cerebral palsy
4940243|NCT01903603|multi-modal brain techniques|multi-modal brain techniques
4940244|NCT01903603|MRI|mri
4940245|NCT01903603|Kinematic|kinematic
4940246|NCT01903603|motor control|motor control
4940247|NCT01903590|TVT,TOT,Randomized|tvt,tot,randomized
4940248|NCT01903577|Ergonomics|ergonomics
4940249|NCT01903577|Robotic Surgery|robotic surgery
4940250|NCT01903577|Laparoscopic Surgery|laparoscopic surgery
4940251|NCT01903564|fetus|fetus
4940252|NCT01903564|fetal arrhythmia|fetal arrhythmia
4940253|NCT01903564|fetal heart rate|fetal heart rate
4940254|NCT01903564|long QT syndrome|long qt syndrome
4940255|NCT01903551|post-operative pain|post-operative pain
4940256|NCT01903551|loco-regional analgesia|loco-regional analgesia
4940257|NCT01903551|minimally invasive surgery|minimally invasive surgery
4940258|NCT01903512|TMJ arthrocentesis|tmj arthrocentesis
4940259|NCT01903512|internal derangement|internal derangement
4940260|NCT01903512|conservative treatment|conservative treatment
4940261|NCT01903486|Trouble swallowing|trouble swallowing
4940262|NCT01903486|dysphagia|dysphagia
4940263|NCT01903486|disorder of the esophagus|disorder of the esophagus
4940264|NCT01903473|Allogeneic hematopoietic cell transplantation|allogeneic hematopoietic cell transplantation
4940265|NCT01903473|GVHD|gvhd
4940266|NCT01903473|Regulatory T cells|regulatory t cells
4940267|NCT01903473|Steroid refractory|steroid refractory
4940268|NCT01903473|Rapamycin|rapamycin
4940269|NCT01903473|Immune recovery|immune recovery
4940270|NCT01903473|Infusion|infusion
4940271|NCT01903473|HLA-identical sibling|hla-identical sibling
4940272|NCT01903473|HLA-matched unrelated donor|hla-matched unrelated donor
4940273|NCT01903447|Internalizing psychopathologies|internalizing psychopathologies
4940274|NCT01903447|Depression|depression
4940275|NCT01903447|Anxiety|anxiety
4940277|NCT01903447|medication treatment|medication treatment
4940278|NCT01903447|psychotherapy|psychotherapy
4940279|NCT01903447|brain function|brain function
4940280|NCT01903421|Elderly surgical patients|elderly surgical patients
4940281|NCT01903421|Alzheimer's disease|alzheimer's disease
4940282|NCT01903421|Dementia|dementia
4940283|NCT01903421|Elderly|elderly
4940284|NCT01903421|Surgery|surgery
4940285|NCT01903395|Colorectal Neoplasms/*drug therapy/*secondary|colorectal neoplasms/*drug therapy/*secondary
4940286|NCT01903395|Health Services Accessibility|health services accessibility
4940287|NCT01903395|Humans|humans
4940288|NCT01903395|Supportive Care Needs|supportive care needs
4940289|NCT01903395|Psychooncology|psychooncology
4940290|NCT01903395|Primary Health Care/*methods|primary health care/*methods
4940291|NCT01903395|Treatment Outcome|treatment outcome
4940292|NCT01903395|Socioeconomic Factors|socioeconomic factors
4940293|NCT01903395|Quality Assurance, Health Care|quality assurance, health care
4940294|NCT01903395|Adult|adult
4940295|NCT01903395|Aged|aged
4940296|NCT01903395|Aged, 80 and over|aged, 80 and over
4940297|NCT01903369|Shear wave|shear wave
4940298|NCT01903369|Elastography|elastography
4940299|NCT01903369|Repeatability and Reproducibility|repeatability and reproducibility
4940300|NCT01903343|Shear wave|shear wave
4940301|NCT01903343|Elastography|elastography
4940302|NCT01903343|Repeatability and Reproducibility|repeatability and reproducibility
4940303|NCT01903330|ERC1671|erc1671
4940304|NCT01903330|GM-CSF|gm-csf
4940305|NCT01903330|Cyclophosphamide|cyclophosphamide
4940306|NCT01903330|Bevacizumab|bevacizumab
4940307|NCT01903304|Olive oil|olive oil
4940308|NCT01903304|DTH|dth
4940309|NCT01903304|elderly|elderly
4940310|NCT01903278|interferon|interferon
4940311|NCT01903278|ribavirin|ribavirin
4940312|NCT01903278|sustained virological response|sustained virological response
4940313|NCT01903265|pain|pain
4940314|NCT01903265|sleep|sleep
4940315|NCT01903252|UC|uc
4940316|NCT01903226|spinal cord injury|spinal cord injury
4940317|NCT01903226|physical capacity|physical capacity
4940318|NCT01903226|energy expenditure|energy expenditure
4940319|NCT01903226|training|training
4940320|NCT01903213|Peritoneal dialysis|peritoneal dialysis
4940321|NCT01903213|Bixalomer|bixalomer
4940322|NCT01903213|Chronic renal failure patients with Hyperphosphatemia|chronic renal failure patients with hyperphosphatemia
4940323|NCT01903213|Kiklin®|kiklin®
4940324|NCT01903200|Antipsychotic|antipsychotic
4940325|NCT01903200|FK949E|fk949e
4940326|NCT01903200|Quetiapine|quetiapine
4940327|NCT01903200|Elderly|elderly
4940328|NCT01903187|hypertension|hypertension
4940329|NCT01903187|resistant hypertension|resistant hypertension
4940330|NCT01903187|renal denervation|renal denervation
4940331|NCT01903174|Breast Cancer|breast cancer
4940332|NCT01903174|Breast Reconstruction|breast reconstruction
4940333|NCT01903174|Breast Tissue Expansion|breast tissue expansion
4940334|NCT01903174|Breast Tissue Expander|breast tissue expander
4940335|NCT01903174|Two Stage Breast Reconstruction|two stage breast reconstruction
4940537|NCT01902186|DEXA|dexa
4940336|NCT01903161|delayed remote ischemic preconditioning|delayed remote ischemic preconditioning
4940337|NCT01903161|troponin|troponin
4940338|NCT01903161|valve replacement surgery|valve replacement surgery
4940339|NCT01903148|ANEMIA IN CHRONIC KIDNEY DISEASE PATIENTS NOT ON DIALYSIS|anemia in chronic kidney disease patients not on dialysis
4940340|NCT01903135|Obesity Hypoventilation Syndrome|obesity hypoventilation syndrome
4940341|NCT01903135|Prevalence|prevalence
4940342|NCT01903135|Bicarbonate|bicarbonate
4940343|NCT01903096|Panic disorder|panic disorder
4940344|NCT01903096|Generalized anxiety disorder|generalized anxiety disorder
4940345|NCT01903096|Social phobia|social phobia
4940346|NCT01903096|Specific phobia|specific phobia
4940347|NCT01903096|Major depressive disorder|major depressive disorder
4940348|NCT01903096|Dysthymia|dysthymia
4940349|NCT01903096|Somatizations disorder|somatizations disorder
4940350|NCT01903096|Pain disorder|pain disorder
4940351|NCT01903083|Pancreas|pancreas
4940352|NCT01903083|Pancreatic cancer|pancreatic cancer
4940353|NCT01903083|Immunotherapy|immunotherapy
4940354|NCT01903083|Chemotherapy|chemotherapy
4940355|NCT01903083|Radiation|radiation
4940356|NCT01903083|Surgery|surgery
4940357|NCT01903083|Pancreaticoduodenectomy|pancreaticoduodenectomy
4940358|NCT01903057|Mass Drug Administration|mass drug administration
4940359|NCT01903057|Neglected Tropical Diseases|neglected tropical diseases
4940360|NCT01903057|Preventive Chemotherapy and Transmission Control|preventive chemotherapy and transmission control
4940361|NCT01903057|Preventive Chemotherapy|preventive chemotherapy
4940362|NCT01903044|Lowe extremity ischemia|lowe extremity ischemia
4940363|NCT01903044|Bone marrow|bone marrow
4940364|NCT01903044|Neoangiogenesis|neoangiogenesis
4940365|NCT01903005|Opioid, Dependence, agonist, Buprenorphine, Naloxone|opioid, dependence, agonist, buprenorphine, naloxone
4940366|NCT01902966|Cervical Cancer|cervical cancer
4940367|NCT01902966|Propranolol|propranolol
4940368|NCT01902966|Betachron|betachron
4940369|NCT01902966|Inderal|inderal
4940370|NCT01902966|Beta blocker|beta blocker
4940371|NCT01902966|Questionnaires|questionnaires
4940372|NCT01902966|Surveys|surveys
4940373|NCT01902966|Symptom inventory|symptom inventory
4940374|NCT01902966|Anxiety and depression survey|anxiety and depression survey
4940375|NCT01902966|Pain inventory|pain inventory
4940376|NCT01902966|Quality of life survey|quality of life survey
4940377|NCT01902966|Relaxation audio recording|relaxation audio recording
4940378|NCT01902966|MP3 player|mp3 player
4940379|NCT01902966|Diary|diary
4940380|NCT01902953|Sentinel lymph nodes|sentinel lymph nodes
4940381|NCT01902953|colon cancer|colon cancer
4940382|NCT01902953|rectal cancer|rectal cancer
4940383|NCT01902953|immunohistochemistry|immunohistochemistry
4940384|NCT01902927|Exercise tolerance|exercise tolerance
4940385|NCT01902927|Dyspnea|dyspnea
4940386|NCT01902927|Affective distraction|affective distraction
4940387|NCT01902914|hearing aids|hearing aids
4940388|NCT01902914|hearing disability|hearing disability
4940389|NCT01902914|community|community
4940390|NCT01902914|hearing aids service|hearing aids service
4940391|NCT01902901|Whole Genome Sequencing|whole genome sequencing
4940392|NCT01902901|Carrier status|carrier status
4940393|NCT01902901|Genetics|genetics
4940394|NCT01902888|popliteal artery|popliteal artery
4940395|NCT01902888|aneurysm|aneurysm
4940396|NCT01902888|popliteal artery aneurysm|popliteal artery aneurysm
4940397|NCT01902888|asymptomatic aneurysm|asymptomatic aneurysm
4940398|NCT01902888|mural thrombus|mural thrombus
4940399|NCT01902888|Viabahn|viabahn
4940400|NCT01902888|Gore|gore
4940401|NCT01902888|Endoprosthesis|endoprosthesis
4940402|NCT01902862|Lymphoma, follicular|lymphoma, follicular
4940403|NCT01902862|Bortezomib|bortezomib
4940404|NCT01902862|Rituximab|rituximab
4940405|NCT01902849|intravenous anesthesia|intravenous anesthesia
4940406|NCT01902849|inhalational anesthesia|inhalational anesthesia
4940407|NCT01902849|interleukins|interleukins
4940408|NCT01902849|colorectal surgery|colorectal surgery
4940409|NCT01902836|Dialyzable Leukocyte Extracts|dialyzable leukocyte extracts
4940410|NCT01902836|Transferon|transferon
4940411|NCT01902836|atopic dermatitis|atopic dermatitis
4940412|NCT01902823|Nurse Navigator|nurse navigator
4940413|NCT01902823|Satisfaction with Care|satisfaction with care
4940414|NCT01902823|Quality of Life|quality of life
4940415|NCT01902823|Symptom Distress|symptom distress
4940416|NCT01902797|Refugee camps|refugee camps
4940417|NCT01902797|Household residence|household residence
4940418|NCT01902797|Treated bednets|treated bednets
4940419|NCT01902797|PCR|pcr
4940420|NCT01902784|Intensive Care Unit patients and families|intensive care unit patients and families
4940421|NCT01902784|Surrogate decision making|surrogate decision making
4940422|NCT01902784|Life Sustaining Treatments (LST)|life sustaining treatments (lst)
4940423|NCT01902771|Dendritic Cell Vaccine|dendritic cell vaccine
4940424|NCT01902771|DCV|dcv
4940425|NCT01902771|Pediatric|pediatric
4940426|NCT01902771|Brain Tumor|brain tumor
4940427|NCT01902771|In Situ|in situ
4940428|NCT01902771|Lysate|lysate
4940429|NCT01902771|Tumor Lysate|tumor lysate
4940430|NCT01902771|Glioblastoma Multiforme|glioblastoma multiforme
4940431|NCT01902771|GBM|gbm
4940432|NCT01902771|Pheresis|pheresis
4940433|NCT01902771|Leukapheresis|leukapheresis
4940434|NCT01902771|High Grade Glioma|high grade glioma
4940435|NCT01902771|HGG|hgg
4940436|NCT01902758|exercise performance|exercise performance
4940437|NCT01902693|HIV|hiv
4940438|NCT01902693|Chemotherapy|chemotherapy
4940439|NCT01902693|Cohort|cohort
4940440|NCT01902693|Cancer|cancer
4940441|NCT01902693|HAART|haart
4940442|NCT01902693|Malignancy|malignancy
4940443|NCT01902680|Prostate cancer, permanent implant brachytherapy, image fusion, focal therapy, active surveillance|prostate cancer, permanent implant brachytherapy, image fusion, focal therapy, active surveillance
4940444|NCT01902667|Retroperitoneal Sarcoma|retroperitoneal sarcoma
4940445|NCT01902667|Magnetic Resonance Imaging|magnetic resonance imaging
4940446|NCT01902654|Osteoarthritis|osteoarthritis
4940447|NCT01902654|cardiovascular disease|cardiovascular disease
4940448|NCT01902641|succinylcholine|succinylcholine
4940449|NCT01902641|rocuronium|rocuronium
4940450|NCT01902641|sugammadex|sugammadex
4940451|NCT01902641|Intubating Conditions|intubating conditions
4940452|NCT01902641|short Procedures|short procedures
4940453|NCT01902563|osteopathic manipulative treatment|osteopathic manipulative treatment
4940454|NCT01902563|newborns|newborns
4940455|NCT01902563|preterm infants|preterm infants
4940456|NCT01902563|procedures|procedures
4940457|NCT01902550|Healthy|healthy
4940458|NCT01902550|JNJ-54452840|jnj-54452840
4940459|NCT01902550|Metoprolol Tartrate Immediate-Release|metoprolol tartrate immediate-release
4940460|NCT01902550|Placebo|placebo
4940461|NCT01902550|Male|male
4940462|NCT01902537|Constipation|constipation
4940463|NCT01902537|Prucalopride|prucalopride
4940464|NCT01902524|Chronic Pain|chronic pain
4940465|NCT01902524|Fentanyl-TTS|fentanyl-tts
4940466|NCT01902524|Fentanyl Patch|fentanyl patch
4940467|NCT01902524|Transdermal|transdermal
4940468|NCT01902524|Non-cancer Pain|non-cancer pain
4940469|NCT01902498|aspirin|aspirin
4940470|NCT01902485|Contraception|contraception
4940471|NCT01902485|Medical Abortion|medical abortion
4940472|NCT01902485|Implant|implant
4940473|NCT01902485|Injectable|injectable
4940474|NCT01902485|Quickstart|quickstart
4940475|NCT01902472|HIV-1|hiv-1
4940476|NCT01902472|Truvada|truvada
4940477|NCT01902472|FTC/TDF|ftc/tdf
4940478|NCT01902472|Pre-exposure prophylaxy|pre-exposure prophylaxy
4940479|NCT01902472|PrEP|prep
4940480|NCT01902472|Resistance|resistance
4940481|NCT01902459|Hemostasis|hemostasis
4940482|NCT01902446|Chlorhexidine|chlorhexidine
4940483|NCT01902446|Randomized Controlled Trial|randomized controlled trial
4940484|NCT01902446|Emergency Medical Services|emergency medical services
4940485|NCT01902446|Intubation, Endotracheal|intubation, endotracheal
4940486|NCT01902407|Pcrit|pcrit
4940487|NCT01902407|Critical closing pressure|critical closing pressure
4940488|NCT01902407|Down syndrome|down syndrome
4940489|NCT01902407|Obstructive Sleep Apnea|obstructive sleep apnea
4940490|NCT01902407|Sleep MRI|sleep mri
4940491|NCT01902394|digestive health and natural defenses|digestive health and natural defenses
4940492|NCT01902368|Gluten free diet|gluten free diet
4940493|NCT01902355|Central Venous Catheterization|central venous catheterization
4940494|NCT01902329|Acute Myeloid Leukemia|acute myeloid leukemia
4940495|NCT01902329|Antibody-Drug Conjugate|antibody-drug conjugate
4940496|NCT01902329|CD33 Antigen|cd33 antigen
4940497|NCT01902329|Immunotherapy|immunotherapy
4940498|NCT01902329|Drug Therapy|drug therapy
4940499|NCT01902329|Acute Myelogenous Leukemia|acute myelogenous leukemia
4940500|NCT01902329|Acute Promyelocytic Leukemia|acute promyelocytic leukemia
4940501|NCT01902329|APL|apl
4940502|NCT01902316|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
4940503|NCT01902316|peptide biomarker|peptide biomarker
4940504|NCT01902316|early diagnosis|early diagnosis
4940505|NCT01902316|label free|label free
4940506|NCT01902303|Herpes Labialis|herpes labialis
4940507|NCT01902303|Herpes Simplex|herpes simplex
4940508|NCT01902303|Herpes|herpes
4940509|NCT01902303|Ultra Violet (UV) Induced|ultra violet (uv) induced
4940510|NCT01902290|Inadequately controlled asthma, brodalumab, AMG 827|inadequately controlled asthma, brodalumab, amg 827
4940511|NCT01902277|Delirium|delirium
4940512|NCT01902277|Intensive Care Unit|intensive care unit
4940513|NCT01902277|Critical illness|critical illness
4940514|NCT01902264|Levomefolate calcium|levomefolate calcium
4940515|NCT01902264|Contraceptives, oral, combined|contraceptives, oral, combined
4940516|NCT01902264|Neural tube defects|neural tube defects
4940517|NCT01902251|Phase 1|phase 1
4940518|NCT01902251|Prostate cancer|prostate cancer
4940519|NCT01902251|Bioavailability|bioavailability
4940520|NCT01902251|Food effect|food effect
4940521|NCT01902251|Pharmacokinetics|pharmacokinetics
4940522|NCT01902251|Xtandi|xtandi
4940523|NCT01902251|Enzalutamide|enzalutamide
4940524|NCT01902251|MDV3100|mdv3100
4940525|NCT01902238|neuroendocrine tumor|neuroendocrine tumor
4940526|NCT01902238|ethanol|ethanol
4940527|NCT01902238|endoscopic ultrasonography|endoscopic ultrasonography
4940528|NCT01902225|Lymphoma|lymphoma
4940529|NCT01902225|T-Cell|t-cell
4940530|NCT01902225|Cutaneous|cutaneous
4940531|NCT01902225|Doxil|doxil
4940532|NCT01902225|romidepsin|romidepsin
4940533|NCT01902225|skin|skin
4940534|NCT01902186|HIV|hiv
4940535|NCT01902186|osteopenia|osteopenia
4940536|NCT01902186|t-score|t-score
4940538|NCT01902186|tenofovir|tenofovir
4940539|NCT01902186|raltegravir|raltegravir
4940540|NCT01902147|abdominal|abdominal
4940541|NCT01902147|thoracic|thoracic
4940542|NCT01902147|arthroplasty|arthroplasty
4940543|NCT01902134|Moderate to severe acute pain|moderate to severe acute pain
4940544|NCT01902134|Postoperative pain|postoperative pain
4940545|NCT01902134|Hip arthroplasty|hip arthroplasty
4940546|NCT01902134|Analgesics|analgesics
4940547|NCT01902134|Dexketoprofen|dexketoprofen
4940548|NCT01902134|Tramadol|tramadol
4940549|NCT01902108|clonidine|clonidine
4940550|NCT01902108|bupivacaine|bupivacaine
4940551|NCT01902108|post-operative pain|post-operative pain
4940552|NCT01902108|arthrodesis|arthrodesis
4940553|NCT01902108|discectomy|discectomy
4940554|NCT01902108|local infiltration|local infiltration
4940555|NCT01902095|tooth pastes|tooth pastes
4940556|NCT01902095|tooth powders|tooth powders
4940557|NCT01902095|Stain Index|stain index
4940558|NCT01902082|ARDS|ards
4940559|NCT01902082|mesenchymal stem cells|mesenchymal stem cells
4940560|NCT01902082|Safety|safety
4940561|NCT01902082|Cytokines|cytokines
4940562|NCT01902069|sweet and fat preference|sweet and fat preference
4940563|NCT01902056|allograft|allograft
4940564|NCT01902056|acellular dermal matrix|acellular dermal matrix
4940565|NCT01902056|Alloderm|alloderm
4940566|NCT01902043|diabetes mellitus|diabetes mellitus
4940567|NCT01902043|cohort study|cohort study
4940568|NCT01902043|quality of care|quality of care
4940569|NCT01902043|quality indicators, Health care|quality indicators, health care
4940570|NCT01902043|quality of Health Care|quality of health care
4940571|NCT01902043|outcome and process assessment|outcome and process assessment
4940572|NCT01902043|health services research|health services research
4940573|NCT01902043|chronic diseases prevention and management|chronic diseases prevention and management
4940574|NCT01902017|Joint|joint
4940575|NCT01902017|Contracture|contracture
4940576|NCT01902017|Elbow|elbow
4940577|NCT01902017|Fracture|fracture
4940578|NCT01902017|Dislocation|dislocation
4940579|NCT01902004|Major Depression|major depression
4940580|NCT01902004|Geriatric Major Depression|geriatric major depression
4940581|NCT01902004|Executive Cognitive Dysfunction|executive cognitive dysfunction
4940582|NCT01902004|Mild Cognitive Impairment|mild cognitive impairment
4940583|NCT01902004|Older Adults|older adults
4940584|NCT01902004|Geriatric|geriatric
4940585|NCT01902004|Executive Cognitive Impairment|executive cognitive impairment
4940586|NCT01902004|Quality of Life|quality of life
4940587|NCT01902004|Disability|disability
4940588|NCT01902004|Comorbidity|comorbidity
4940589|NCT01902004|Medical Burden|medical burden
4940590|NCT01902004|Safety|safety
4940591|NCT01902004|Candidate Genes|candidate genes
4940592|NCT01901991|Nonpalpable breast lesions|nonpalpable breast lesions
4940593|NCT01901991|Breast Cancer and carcinoma in situ|breast cancer and carcinoma in situ
4940594|NCT01901991|Radioactive seed localization|radioactive seed localization
4940595|NCT01901991|Wire-guided localization|wire-guided localization
4940596|NCT01901991|Randomized study|randomized study
4940597|NCT01901978|Obesity|obesity
4940598|NCT01901978|Insulin Resistance|insulin resistance
4940599|NCT01901978|Weight loss|weight loss
4940600|NCT01901978|Women|women
4940601|NCT01901952|Self management diabetes intervention|self management diabetes intervention
4940602|NCT01901939|exercise|exercise
4940603|NCT01901939|elderly|elderly
4940604|NCT01901939|activities of daily living|activities of daily living
4940605|NCT01901939|disability|disability
4940606|NCT01901913|Type 1 Diabetes|type 1 diabetes
4940607|NCT01901913|Artificial pancreas|artificial pancreas
4940608|NCT01901913|Closed loop|closed loop
4940609|NCT01901887|Adults|adults
4940610|NCT01901887|Suicidality|suicidality
4940611|NCT01901861|GLP-1, GIP, DPP-4 inhibition, iset function|glp-1, gip, dpp-4 inhibition, iset function
4940612|NCT01901848|Smoking Cessation|smoking cessation
4940613|NCT01901848|Stress Disorders, Post-Traumatic|stress disorders, post-traumatic
4940614|NCT01901848|Psychotherapy|psychotherapy
4940615|NCT01901822|acellular dermal matrix|acellular dermal matrix
4940616|NCT01901809|Heart failure, diastolic|heart failure, diastolic
4940617|NCT01901809|HFpEF|hfpef
4940618|NCT01901809|Diuretics|diuretics
4940619|NCT01901809|Dopamine|dopamine
4940620|NCT01901796|Anxiety|anxiety
4940621|NCT01901796|Depression|depression
4940622|NCT01901796|CBT|cbt
4940623|NCT01901783|allograft|allograft
4940624|NCT01901783|regeneration|regeneration
4940625|NCT01901783|alveolar ridge|alveolar ridge
4940626|NCT01901770|HPV|hpv
4940627|NCT01901770|Ohio Appalachia|ohio appalachia
4940628|NCT01901770|HPV vaccine|hpv vaccine
4940629|NCT01901770|No evidence of disease|no evidence of disease
4940630|NCT01901744|Contrast Sensitivity , Pediatric Cataract Surgery,|contrast sensitivity , pediatric cataract surgery,
4940631|NCT01901731|transjugular coil embolisation|transjugular coil embolisation
4940632|NCT01901731|endovenous treatment of varicose veins|endovenous treatment of varicose veins
4940633|NCT01901731|pelvic venous reflux|pelvic venous reflux
4940634|NCT01901731|recurrent varicose veins|recurrent varicose veins
4940635|NCT01901718|Breakthrough Pain|breakthrough pain
4940636|NCT01901718|Subsys|subsys
4940637|NCT01901718|Fentanyl|fentanyl
4940638|NCT01901718|Opioid|opioid
4940639|NCT01901718|Persistent Pain|persistent pain
4940640|NCT01901705|Psoriasis|psoriasis
4940641|NCT01901705|Indigo Naturalis|indigo naturalis
4940642|NCT01901705|chinese medicine|chinese medicine
4940643|NCT01901692|liver cancer|liver cancer
4940644|NCT01901692|first-line|first-line
4940645|NCT01901692|tumor thrombus|tumor thrombus
4940646|NCT01901692|vascular invasion|vascular invasion
4940647|NCT01901679|Obesity|obesity
4940648|NCT01901679|Post-menopausal|post-menopausal
4940649|NCT01901666|growth hormone, Chronic Myelogenous Leukemia, Imatinib,serum IGF-1|growth hormone, chronic myelogenous leukemia, imatinib,serum igf-1
4940650|NCT01901653|Small cell lung cancer|small cell lung cancer
4940651|NCT01901627|Spondylitis, Ankylosing|spondylitis, ankylosing
4940652|NCT01901627|adalimumab|adalimumab
4940653|NCT01901627|Prospective Studies|prospective studies
4940654|NCT01901614|Keratoconus|keratoconus
4940655|NCT01901614|Corneal Opacity|corneal opacity
4940656|NCT01901614|Keratoplasty|keratoplasty
4940657|NCT01901601|KERATOPLASTY|keratoplasty
4940658|NCT01901601|STROMAL OPACITIES|stromal opacities
4940659|NCT01901588|strabismus|strabismus
4940660|NCT01901588|pediatric|pediatric
4940661|NCT01901588|emergence delirium|emergence delirium
4940662|NCT01901588|precedex/dexmedetomidine|precedex/dexmedetomidine
4940663|NCT01901575|idiopathic ventricular tachycardia|idiopathic ventricular tachycardia
4940664|NCT01901562|ductoscopy|ductoscopy
4940665|NCT01901562|nipple discharge|nipple discharge
4940666|NCT01901562|breast|breast
4940667|NCT01901562|papilloma|papilloma
4940668|NCT01901536|First time parents|first time parents
4940669|NCT01901536|Coparenting|coparenting
4940670|NCT01901536|Family Foundations|family foundations
4940671|NCT01901523|Discrepancy|discrepancy
4940672|NCT01901523|Committee on Publication Ethics|committee on publication ethics
4940673|NCT01901523|Correction|correction
4940674|NCT01901523|Erratum|erratum
4940675|NCT01901523|Retraction|retraction
4940676|NCT01901510|polyp|polyp
4940677|NCT01901497|non invasive ventilation|non invasive ventilation
4940678|NCT01901497|single limb circuit ventilator|single limb circuit ventilator
4940679|NCT01901497|bilevel|bilevel
4940680|NCT01901497|nebulization|nebulization
4940681|NCT01901497|nebulizer|nebulizer
4940682|NCT01901497|vibrating mesh nebulizer|vibrating mesh nebulizer
4940683|NCT01901497|amikacin|amikacin
4940684|NCT01901484|Schistosoma mansoni|schistosoma mansoni
4940685|NCT01901484|morbidity|morbidity
4940686|NCT01901484|chemotherapy|chemotherapy
4940687|NCT01901471|Cyclosporine, cardiogenic shock, SOFA score,|cyclosporine, cardiogenic shock, sofa score,
4940688|NCT01901458|apheresis|apheresis
4940689|NCT01901458|peripheral blood progenitor cells|peripheral blood progenitor cells
4940690|NCT01901458|peripheral blood stem cells|peripheral blood stem cells
4940691|NCT01901445|Quality of life|quality of life
4940692|NCT01901445|Constipation|constipation
4940693|NCT01901445|Focus groups|focus groups
4940694|NCT01901445|Health education|health education
4940695|NCT01901445|Problem-based learning|problem-based learning
4940696|NCT01901432|chronic myeloproliferative neoplasms|chronic myeloproliferative neoplasms
4940697|NCT01901432|Polycythemia Vera|polycythemia vera
4940698|NCT01901432|Essential Thrombocythemia|essential thrombocythemia
4940699|NCT01901432|Primary Myelofibrosis|primary myelofibrosis
4940700|NCT01901432|Post-Polycythemia Vera Myelofibrosis|post-polycythemia vera myelofibrosis
4940701|NCT01901432|Post-Essential Thrombocythemia Myelofibrosis|post-essential thrombocythemia myelofibrosis
4940702|NCT01901432|Givinostat|givinostat
4940703|NCT01901419|nitroglycerin|nitroglycerin
4940704|NCT01901419|cardiopulmonary bypass|cardiopulmonary bypass
4940705|NCT01901419|cardiac surgery|cardiac surgery
4940706|NCT01901406|epiretinal membrane, stereopsis, aniseikonia|epiretinal membrane, stereopsis, aniseikonia
4940707|NCT01901393|Post Operative Pain,|post operative pain,
4940708|NCT01901393|Pail relief|pail relief
4940709|NCT01901367|Adiponectin, Glucose, Insulin, Leptin|adiponectin, glucose, insulin, leptin
4940710|NCT01901354|Acute lung injury (ALI)|acute lung injury (ali)
4940711|NCT01901354|Adult respiratory distress syndrome (ARDS)|adult respiratory distress syndrome (ards)
4940712|NCT01901354|Low-tidal-volume strategy|low-tidal-volume strategy
4940713|NCT01901354|ARDSNet|ardsnet
4940714|NCT01901354|airway pressure release ventilation (APRV)|airway pressure release ventilation (aprv)
4940715|NCT01901354|biomarkers of lung injury|biomarkers of lung injury
4940716|NCT01901341|Opioid|opioid
4940717|NCT01901341|Constipation|constipation
4940718|NCT01901341|Chronic|chronic
4940719|NCT01901341|Pain|pain
4940720|NCT01901328|Opioid|opioid
4940721|NCT01901328|Constipation|constipation
4940722|NCT01901328|Chronic|chronic
4940723|NCT01901328|Pain|pain
4940724|NCT01901315|telepsychiatry|telepsychiatry
4940725|NCT01901315|telemental health|telemental health
4940726|NCT01901315|teleassistance|teleassistance
4940727|NCT01901315|health care delivery|health care delivery
4940728|NCT01901315|depression|depression
4940729|NCT01901315|Telemedicine|telemedicine
4940730|NCT01901315|Remote Consultation|remote consultation
4940731|NCT01901315|Videoconferencing|videoconferencing
4940732|NCT01901315|Community Mental Health Services|community mental health services
4940733|NCT01901302|Opioid|opioid
4940734|NCT01901302|Constipation|constipation
4940735|NCT01901302|Chronic|chronic
4940736|NCT01901302|Pain|pain
4940737|NCT01901289|Peripheral Vascular Disease|peripheral vascular disease
4940738|NCT01901289|Femoral Artery|femoral artery
4940739|NCT01901289|Popliteal Artery|popliteal artery
4940740|NCT01901289|Drug-Eluting Stent|drug-eluting stent
4940741|NCT01901276|Proton Pump Inhibitors|proton pump inhibitors
4940742|NCT01901276|Microbiome|microbiome
4940743|NCT01901276|Clostridium difficile|clostridium difficile
4940744|NCT01901263|Cognitive and behavioral units|cognitive and behavioral units
4940745|NCT01901263|Alzheimer Disease|alzheimer disease
4940746|NCT01901263|Dementia|dementia
4940747|NCT01901250|Dental Caries|dental caries
4940748|NCT01901250|Xylitol|xylitol
4940749|NCT01901250|Prevention|prevention
4940750|NCT01901237|Cancer|cancer
4940751|NCT01901237|Adolescent and Young Adult|adolescent and young adult
4940752|NCT01901237|Exercise|exercise
4940753|NCT01901237|Physical Activity|physical activity
4940754|NCT01901237|Quality of Life|quality of life
4940755|NCT01901237|End-of-Life|end-of-life
4940756|NCT01901237|Palliative|palliative
4940757|NCT01901237|Terminal|terminal
4940758|NCT01901237|Yoga|yoga
4940759|NCT01901237|Alternative Therapies|alternative therapies
4940760|NCT01901237|Fitness|fitness
4940761|NCT01901237|Fatigue|fatigue
4940762|NCT01901211|Cerebral palsy|cerebral palsy
4940763|NCT01901211|Interactive computer play|interactive computer play
4940764|NCT01901211|Multi-player gaming|multi-player gaming
4940765|NCT01901211|Exercise|exercise
4940766|NCT01901146|Human Epidermal Growth Factor Receptor 2 (HER2)|human epidermal growth factor receptor 2 (her2)
4940767|NCT01901146|Positive Early Breast Cancer|positive early breast cancer
4940768|NCT01901133|Phase 1|phase 1
4940769|NCT01901133|MDV3100|mdv3100
4940770|NCT01901133|Hepatic Impairment|hepatic impairment
4940771|NCT01901133|Kidney Diseases|kidney diseases
4940772|NCT01901133|Xtandi|xtandi
4940773|NCT01901133|enzalutamide|enzalutamide
4940774|NCT01901120|Betanis®|betanis®
4940775|NCT01901120|mirabegron|mirabegron
4940776|NCT01901120|Overactive Bladder|overactive bladder
4940777|NCT01901107|Hemodialysis|hemodialysis
4940778|NCT01901107|CKD (chronic kidney disease)|ckd (chronic kidney disease)
4940779|NCT01901107|ASP1585|asp1585
4940780|NCT01901107|Hyperphosphatemia|hyperphosphatemia
4940781|NCT01901081|Implantable Myoelectric Sensor|implantable myoelectric sensor
4940782|NCT01901081|IMES|imes
4940783|NCT01901081|transradial|transradial
4940784|NCT01901081|amputation|amputation
4940785|NCT01901081|myoelectric|myoelectric
4940786|NCT01901081|prosthesis|prosthesis
4940787|NCT01901081|prosthetic control|prosthetic control
4940788|NCT01901068|Laparotomy|laparotomy
4940789|NCT01901068|Surgical Procedures, Elective|surgical procedures, elective
4940790|NCT01901068|Sutures|sutures
4940791|NCT01901068|Abdominal Wound Closure Techniques|abdominal wound closure techniques
4940792|NCT01901055|sleep apnea|sleep apnea
4940793|NCT01901055|diabetes|diabetes
4940794|NCT01901042|Quality of life|quality of life
4940795|NCT01901042|Symbiotic|symbiotic
4940796|NCT01901042|Proctitis/Radiotherapy|proctitis/radiotherapy
4940797|NCT01901029|Male Reproductive Health|male reproductive health
4940798|NCT01901029|Floating Population|floating population
4940799|NCT01901029|Sexual Behavior|sexual behavior
4940800|NCT01901029|Erectile Dysfunction|erectile dysfunction
4940801|NCT01901029|Premature Ejaculation|premature ejaculation
4940802|NCT01901016|HIV|hiv
4940803|NCT01901016|depressive symptoms|depressive symptoms
4940804|NCT01901016|quality of life|quality of life
4940805|NCT01901016|relaxation|relaxation
4940806|NCT01901016|viral load|viral load
4940807|NCT01901016|CD4+ T cell count|cd4+ t cell count
4940808|NCT01900990|Noninvasive Positive Pressure Ventilation|noninvasive positive pressure ventilation
4940809|NCT01900990|Invasive Positive Pressure Ventilation|invasive positive pressure ventilation
4940810|NCT01900990|tracheotomy|tracheotomy
4940811|NCT01900977|Universal Test and Treat (UTT)|universal test and treat (utt)
4940812|NCT01900977|Combination Prevention|combination prevention
4940813|NCT01900964|Regeneration|regeneration
4940814|NCT01900964|Bone regeneration|bone regeneration
4940815|NCT01900964|Grafting, Bone|grafting, bone
4940816|NCT01900964|Allograft|allograft
4940817|NCT01900964|Xenograft|xenograft
4940818|NCT01900951|Small cell lung cancer|small cell lung cancer
4940819|NCT01900951|temozolomide|temozolomide
4940820|NCT01900951|Maintenance chemotherapy|maintenance chemotherapy
4940821|NCT01900938|Cholangiopancreatography|cholangiopancreatography
4940822|NCT01900938|Endoscopic Retrograde|endoscopic retrograde
4940823|NCT01900925|Low back pain, non-specific low back pain|low back pain, non-specific low back pain
4940824|NCT01900912|sanitation|sanitation
4940825|NCT01900912|diarrhea prevalence|diarrhea prevalence
4940826|NCT01900912|health|health
4940827|NCT01900912|social networks|social networks
4940828|NCT01900912|cooperation|cooperation
4940829|NCT01900899|Healthy|healthy
4940830|NCT01900899|Immunogenicity|immunogenicity
4940831|NCT01900899|Children|children
4940832|NCT01900899|Neisseria meningitidis|neisseria meningitidis
4940833|NCT01900899|Long-term antibody persistence|long-term antibody persistence
4940834|NCT01900899|Safety|safety
4940835|NCT01900899|Serogroups A, C, W-135, and Y|serogroups a, c, w-135, and y
4940936|NCT01900379|Heart failure|heart failure
4940836|NCT01900886|prison, disorder, hepatitis c|prison, disorder, hepatitis c
4940837|NCT01900873|Inspiratory Muscle Training|inspiratory muscle training
4940838|NCT01900873|COPD|copd
4940839|NCT01900873|Inspiratory Muscle Function|inspiratory muscle function
4940840|NCT01900873|Dyspnea|dyspnea
4940841|NCT01900860|Vitamin D|vitamin d
4940842|NCT01900860|Bone quality|bone quality
4940843|NCT01900860|Bone density|bone density
4940844|NCT01900860|calcium metabolism|calcium metabolism
4940845|NCT01900860|High resolution peripheral quantitative computed tomography|high resolution peripheral quantitative computed tomography
4940846|NCT01900860|Dual X-ray absorptiometry|dual x-ray absorptiometry
4940847|NCT01900860|Quality of life|quality of life
4940848|NCT01900847|Ketamine|ketamine
4940849|NCT01900847|Acute Pain|acute pain
4940850|NCT01900795|Postsurgical pain|postsurgical pain
4940851|NCT01900743|Sarcoma|sarcoma
4940852|NCT01900743|Metastatic|metastatic
4940853|NCT01900743|Regorafenib|regorafenib
4940854|NCT01900730|Breast cancer|breast cancer
4940855|NCT01900730|Metastatic|metastatic
4940856|NCT01900730|Indwelling pleural catheter|indwelling pleural catheter
4940857|NCT01900730|Valproic acid|valproic acid
4940858|NCT01900730|VPA|vpa
4940859|NCT01900730|Depakene|depakene
4940860|NCT01900730|Placebo|placebo
4940861|NCT01900730|Pill diary|pill diary
4940862|NCT01900730|Drainage diary|drainage diary
4940863|NCT01900730|Questionnaires|questionnaires
4940864|NCT01900730|Surveys|surveys
4940865|NCT01900691|Esophageal Fistula|esophageal fistula
4940866|NCT01900691|Esophageal Neoplasms|esophageal neoplasms
4940867|NCT01900691|Esophageal Perforation|esophageal perforation
4940868|NCT01900691|Esophageal Stenosis|esophageal stenosis
4940869|NCT01900691|Stents|stents
4940870|NCT01900639|aspirin|aspirin
4940871|NCT01900639|circadian rhythm|circadian rhythm
4940872|NCT01900639|platelet reactivity|platelet reactivity
4940873|NCT01900639|platelet activation|platelet activation
4940874|NCT01900639|time dependent|time dependent
4940875|NCT01900613|child obesity|child obesity
4940876|NCT01900613|Mexican-American|mexican-american
4940877|NCT01900613|Nutrition education|nutrition education
4940878|NCT01900613|Intervention|intervention
4940879|NCT01900587|Healthy|healthy
4940880|NCT01900587|Bio-equivalence|bio-equivalence
4940881|NCT01900587|Tapentadol extended release|tapentadol extended release
4940882|NCT01900587|Tamper-resistant formulation|tamper-resistant formulation
4940883|NCT01900574|Colitis, Ulcerative|colitis, ulcerative
4940884|NCT01900574|Ulcerative Colitis|ulcerative colitis
4940885|NCT01900574|Moderately to Severely Active Ulcerative Colitis|moderately to severely active ulcerative colitis
4940886|NCT01900574|Golimumab|golimumab
4940887|NCT01900574|Simponi|simponi
4940888|NCT01900574|Human anti-TNFα Antibody|human anti-tnfα antibody
4940889|NCT01900574|Pediatric participants|pediatric participants
4940890|NCT01900574|Safety and Pharmacokinetics|safety and pharmacokinetics
4940891|NCT01900561|prostate cancer|prostate cancer
4940892|NCT01900561|survivorship|survivorship
4940893|NCT01900561|intervention|intervention
4940894|NCT01900561|telemedicine|telemedicine
4940895|NCT01900548|Osteopenia|osteopenia
4940896|NCT01900548|Sarcopenia|sarcopenia
4940897|NCT01900548|Osteoporosis|osteoporosis
4940898|NCT01900548|Physical function|physical function
4940899|NCT01900548|Body composition|body composition
4940900|NCT01900548|Muscle protein|muscle protein
4940901|NCT01900548|Leucine|leucine
4940902|NCT01900548|Ketogenic amino acids|ketogenic amino acids
4940903|NCT01900548|Resistance Training|resistance training
4940904|NCT01900548|Whey protein|whey protein
4940905|NCT01900548|Soy protein|soy protein
4940906|NCT01900548|Bone turnover|bone turnover
4940907|NCT01900535|chlorhexidine|chlorhexidine
4940908|NCT01900535|gingivitis|gingivitis
4940909|NCT01900535|periodontitis|periodontitis
4940910|NCT01900522|Drug therapy|drug therapy
4940911|NCT01900509|Childhood leukemia|childhood leukemia
4940912|NCT01900509|Childhood lymphoma|childhood lymphoma
4940913|NCT01900509|Bendamustine|bendamustine
4940914|NCT01900496|cHL|chl
4940915|NCT01900496|Hodgkin lymphoma|hodgkin lymphoma
4940916|NCT01900496|Lymphoma|lymphoma
4940917|NCT01900496|relapsed Lymphoma|relapsed lymphoma
4940918|NCT01900496|SGN-35|sgn-35
4940919|NCT01900496|Brentuximab Vedotin|brentuximab vedotin
4940920|NCT01900496|Rituxan|rituxan
4940921|NCT01900496|Rituximab|rituximab
4940922|NCT01900470|Multiple chronic conditions|multiple chronic conditions
4940923|NCT01900444|Japanese encephalitis|japanese encephalitis
4940924|NCT01900444|Japanese encephalitis chimeric virus vaccine|japanese encephalitis chimeric virus vaccine
4940925|NCT01900444|IMOJEV®|imojev®
4940926|NCT01900418|breast cancer|breast cancer
4940927|NCT01900418|aromatase inhibitors|aromatase inhibitors
4940928|NCT01900418|physical activity|physical activity
4940929|NCT01900418|joint pain|joint pain
4940930|NCT01900405|Dexmedetomidine|dexmedetomidine
4940931|NCT01900405|Administration, Intranasal|administration, intranasal
4940932|NCT01900405|Children|children
4940933|NCT01900405|Computerized Tomography|computerized tomography
4940934|NCT01900379|Obstructive sleep apneas syndrome|obstructive sleep apneas syndrome
4940935|NCT01900379|Continuous positive airway pressure treatment|continuous positive airway pressure treatment
4941136|NCT01899521|alveolar|alveolar
4940937|NCT01900379|Coronary reperfusion surgery|coronary reperfusion surgery
4940938|NCT01900366|Obesity|obesity
4940939|NCT01900366|Healthy Volunteers|healthy volunteers
4940940|NCT01900340|GLP-1|glp-1
4940941|NCT01900340|satiation peptides|satiation peptides
4940942|NCT01900340|food intake|food intake
4940943|NCT01900327|pancreatic cancer|pancreatic cancer
4940944|NCT01900327|surgery|surgery
4940945|NCT01900327|chemoradiation|chemoradiation
4940946|NCT01900327|neoadjuvant treatment|neoadjuvant treatment
4940947|NCT01900327|overall survival|overall survival
4940948|NCT01900314|Major Depression|major depression
4940949|NCT01900314|Major Depressive Disorder|major depressive disorder
4940950|NCT01900314|TMS|tms
4940951|NCT01900314|rTMS|rtms
4940952|NCT01900301|exposure|exposure
4940953|NCT01900301|scopolamine|scopolamine
4940954|NCT01900301|extinction learning|extinction learning
4940955|NCT01900301|social anxiety|social anxiety
4940956|NCT01900288|short bowel disorder|short bowel disorder
4940957|NCT01900288|short bowel syndrome|short bowel syndrome
4940958|NCT01900288|home parenteral nutrition|home parenteral nutrition
4940959|NCT01900288|HPN|hpn
4940960|NCT01900288|total parenteral nutrition|total parenteral nutrition
4940961|NCT01900288|TPN|tpn
4940962|NCT01900288|telehealth|telehealth
4940963|NCT01900288|telemedicine|telemedicine
4940964|NCT01900275|Sepsis|sepsis
4940965|NCT01900275|Trauma|trauma
4940966|NCT01900275|Shock|shock
4940967|NCT01900275|Acute kidney injury|acute kidney injury
4940968|NCT01900275|Heparanase|heparanase
4940969|NCT01900262|Biomechanics|biomechanics
4940970|NCT01900262|Ankle Strength|ankle strength
4940971|NCT01900262|Postural Control|postural control
4940972|NCT01900262|Running Mechanics|running mechanics
4940973|NCT01900236|Patients newly initiating outpatient HIV medical care|patients newly initiating outpatient hiv medical care
4940974|NCT01900210|Criminal justice|criminal justice
4940975|NCT01900210|substance abuse treatment|substance abuse treatment
4940976|NCT01900210|HIV risk behaviors|hiv risk behaviors
4940977|NCT01900158|Phase I, Phase II, Dose Escalation, Safety, Tolerability,|phase i, phase ii, dose escalation, safety, tolerability,
4940978|NCT01900158|Efficacy, Amphinex induced Photochemical Internalisation, PCI, Amphinex, Gemcitabine, Cisplatin,|efficacy, amphinex induced photochemical internalisation, pci, amphinex, gemcitabine, cisplatin,
4940979|NCT01900158|Inoperable Cholangiocarcinomas, CCA, Cholangiocarcinoma, bile duct cancer, photodynamic therapy|inoperable cholangiocarcinomas, cca, cholangiocarcinoma, bile duct cancer, photodynamic therapy
4940980|NCT01900132|Electrophysiology|electrophysiology
4940981|NCT01900132|Neuromuscular Disease|neuromuscular disease
4940982|NCT01900119|Oral Microbiome|oral microbiome
4940983|NCT01900119|Next Generation Sequencing|next generation sequencing
4940984|NCT01900106|late presenter|late presenter
4940985|NCT01900106|naïve|naïve
4940986|NCT01900106|advanced HIV disease|advanced hiv disease
4940987|NCT01900080|HIV|hiv
4940988|NCT01900080|AIDS|aids
4940989|NCT01900080|Antiretroviral therapy|antiretroviral therapy
4940990|NCT01900080|Retention in care|retention in care
4940991|NCT01900080|Adherence|adherence
4940992|NCT01900080|Cost-effectiveness|cost-effectiveness
4940993|NCT01900054|TAU-284|tau-284
4940994|NCT01900054|Bepotastine besilate|bepotastine besilate
4940995|NCT01900054|Histamine H1 receptor antagonists|histamine h1 receptor antagonists
4940996|NCT01900054|children|children
4940997|NCT01900028|oncology,|oncology,
4940998|NCT01900028|cancer,|cancer,
4940999|NCT01900028|tumour,|tumour,
4941000|NCT01900028|anticancer drug,|anticancer drug,
4941001|NCT01900028|pharmacokinetics,|pharmacokinetics,
4941002|NCT01900028|olaparib,itraconazole,|olaparib,itraconazole,
4941003|NCT01900028|neoplasm,|neoplasm,
4941004|NCT01900028|QT interval|qt interval
4941005|NCT01900002|Liver Cancer|liver cancer
4941006|NCT01900002|Advanced Hepatocellular Carcinoma|advanced hepatocellular carcinoma
4941007|NCT01900002|HCC|hcc
4941008|NCT01900002|Sorafenib|sorafenib
4941009|NCT01900002|Nexavar|nexavar
4941010|NCT01900002|BAY 43-9006|bay 43-9006
4941011|NCT01900002|Yttrium-90|yttrium-90
4941012|NCT01900002|Microspheres|microspheres
4941013|NCT01900002|Phone calls|phone calls
4941014|NCT01899989|Stereotactic Body Radiation Therapy (SBRT)|stereotactic body radiation therapy (sbrt)
4941015|NCT01899989|Chemotherapy|chemotherapy
4941016|NCT01899989|13-113|13-113
4941017|NCT01899976|covered biliary stent|covered biliary stent
4941018|NCT01899976|X-Suit NIR Covered Biliary Stent|x-suit nir covered biliary stent
4941019|NCT01899976|malignant strictures in biliary tree|malignant strictures in biliary tree
4941020|NCT01899963|wet Age Related Macular Degeneration|wet age related macular degeneration
4941021|NCT01899963|Diabetic Macular Edema|diabetic macular edema
4941022|NCT01899963|Telemedicine|telemedicine
4941023|NCT01899963|Teleophthalmology|teleophthalmology
4941024|NCT01899963|Time to Treatment|time to treatment
4941025|NCT01899950|Niemann-Pick disease type C|niemann-pick disease type c
4941026|NCT01899950|Lysosomal disease|lysosomal disease
4941027|NCT01899937|Endothelial dysfunction|endothelial dysfunction
4941028|NCT01899937|Flow mediated dilation|flow mediated dilation
4941029|NCT01899937|Brachial artery flow mediated dilation|brachial artery flow mediated dilation
4941030|NCT01899937|FMD|fmd
4941031|NCT01899898|Refractory epilepsy|refractory epilepsy
4941032|NCT01899898|Dietary therapy|dietary therapy
4941033|NCT01899898|Non-Pharmacological therapy|non-pharmacological therapy
4941034|NCT01899898|Simplified Modified Atkins Diet|simplified modified atkins diet
4941035|NCT01899885|Emergency laparotomy|emergency laparotomy
4941036|NCT01899885|Emergency laparoscopy|emergency laparoscopy
4941037|NCT01899872|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
4941038|NCT01899872|Endothelial progenitor cell|endothelial progenitor cell
4941039|NCT01899872|Endothelial function|endothelial function
4941040|NCT01899872|Exercise|exercise
4941041|NCT01899859|Non-Alcoholic Steatohepatitis (NASH)|non-alcoholic steatohepatitis (nash)
4941042|NCT01899846|Makena|makena
4941043|NCT01899846|Pharmacokinetics|pharmacokinetics
4941044|NCT01899846|Prior preterm delivery|prior preterm delivery
4941045|NCT01899846|Hydroxyprogesterone Caproate|hydroxyprogesterone caproate
4941046|NCT01899846|17P|17p
4941047|NCT01899833|Coronary Artery Disease|coronary artery disease
4941048|NCT01899833|CAD|cad
4941049|NCT01899781|Lacerations|lacerations
4941050|NCT01899781|Tendons|tendons
4941051|NCT01899781|Antobiotic|antobiotic
4941052|NCT01899768|efficacy|efficacy
4941053|NCT01899768|hypertussive challenge|hypertussive challenge
4941054|NCT01899768|voltage gated sodium channels (VGSC)|voltage gated sodium channels (vgsc)
4941055|NCT01899768|anaesthesia|anaesthesia
4941056|NCT01899768|Safety and tolerability|safety and tolerability
4941057|NCT01899768|capsaicin challenge|capsaicin challenge
4941058|NCT01899768|cough|cough
4941059|NCT01899768|citric acid challenge|citric acid challenge
4941060|NCT01899768|pharmacokinetics|pharmacokinetics
4941061|NCT01899755|monoclonal antibody|monoclonal antibody
4941062|NCT01899755|healthy volunteer|healthy volunteer
4941063|NCT01899755|TNF alpha|tnf alpha
4941064|NCT01899729|plaque psoriasis|plaque psoriasis
4941065|NCT01899729|autoimmune disease|autoimmune disease
4941066|NCT01899729|Toll like receptor|toll like receptor
4941067|NCT01899716|Severe Depression|severe depression
4941068|NCT01899716|Quality of life|quality of life
4941069|NCT01899716|Exercise|exercise
4941070|NCT01899716|BDNF|bdnf
4941071|NCT01899716|TBARS|tbars
4941072|NCT01899703|Intestinal bile acid transport inhibitor|intestinal bile acid transport inhibitor
4941073|NCT01899703|Pruritus|pruritus
4941074|NCT01899703|Primary biliary cirrhosis|primary biliary cirrhosis
4941075|NCT01899703|Ursodeoxycholic acid|ursodeoxycholic acid
4941076|NCT01899703|GSK2330672|gsk2330672
4941077|NCT01899703|Pharmacokinetics|pharmacokinetics
4941078|NCT01899690|breast reconstruction|breast reconstruction
4941079|NCT01899690|cancer|cancer
4941080|NCT01899690|expander|expander
4941081|NCT01899690|antibiotics|antibiotics
4941082|NCT01899690|infection|infection
4941083|NCT01899690|surgical site infection|surgical site infection
4941084|NCT01899690|surgery|surgery
4941085|NCT01899690|oncology|oncology
4941086|NCT01899690|plastic surgery|plastic surgery
4941087|NCT01899677|Symbiotic,cytokines, necrotising enterocolitis|symbiotic,cytokines, necrotising enterocolitis
4941088|NCT01899664|peripheral nerves|peripheral nerves
4941089|NCT01899664|quadriplegia|quadriplegia
4941090|NCT01899664|nerve transfer|nerve transfer
4941091|NCT01899664|surgical procedures, operative|surgical procedures, operative
4941092|NCT01899664|hand|hand
4941093|NCT01899664|upper extremity|upper extremity
4941094|NCT01899664|quality of life|quality of life
4941095|NCT01899651|EEG|eeg
4941096|NCT01899651|Brain|brain
4941097|NCT01899651|Infants|infants
4941098|NCT01899651|Preterm|preterm
4941099|NCT01899651|Hemorrhage|hemorrhage
4941100|NCT01899651|Bleeding|bleeding
4941101|NCT01899625|Obesity|obesity
4941102|NCT01899625|weight loss|weight loss
4941103|NCT01899625|young adults|young adults
4941104|NCT01899612|menopause|menopause
4941105|NCT01899612|vaginal atrophy|vaginal atrophy
4941106|NCT01899612|cytokine|cytokine
4941107|NCT01899612|IL-1beta|il-1beta
4941108|NCT01899612|IL-6|il-6
4941109|NCT01899612|IL-8|il-8
4941110|NCT01899612|TNF-alpha|tnf-alpha
4941111|NCT01899586|Aging|aging
4941112|NCT01899586|Functional Capacity|functional capacity
4941113|NCT01899586|Exercise Independence|exercise independence
4941114|NCT01899586|Peripheral Adaptations|peripheral adaptations
4941115|NCT01899586|Vascular|vascular
4941116|NCT01899573|Heart failure|heart failure
4941117|NCT01899573|mitral regurgitation|mitral regurgitation
4941118|NCT01899573|mitral valve|mitral valve
4941119|NCT01899560|Acute respiratory distress syndrome (ARDS)|acute respiratory distress syndrome (ards)
4941120|NCT01899560|positive end expiratory pressure (PEEP)|positive end expiratory pressure (peep)
4941121|NCT01899560|Staircase recruitment maneuver (SRM)|staircase recruitment maneuver (srm)
4941122|NCT01899560|Lung elastance|lung elastance
4941123|NCT01899560|chest wall elastance|chest wall elastance
4941124|NCT01899534|Pregnancy|pregnancy
4941125|NCT01899534|Mental Health|mental health
4941126|NCT01899534|Screening|screening
4941127|NCT01899534|Computer|computer
4941128|NCT01899534|Feasibility|feasibility
4941129|NCT01899521|alcoholism|alcoholism
4941130|NCT01899521|lung health|lung health
4941131|NCT01899521|pulmonary|pulmonary
4941132|NCT01899521|macrophage|macrophage
4941133|NCT01899521|zinc|zinc
4941134|NCT01899521|SAMe|same
4941135|NCT01899521|S-adenosylmethionine|s-adenosylmethionine
4941137|NCT01899495|blood pressure|blood pressure
4941138|NCT01899495|hypertension|hypertension
4941139|NCT01899495|salt sensitivity|salt sensitivity
4941140|NCT01899482|Venous Insufficiency|venous insufficiency
4941141|NCT01899482|Physical Therapy Techniques|physical therapy techniques
4941142|NCT01899482|Manual Lymphatic Drainage|manual lymphatic drainage
4941143|NCT01899443|total hip replacement|total hip replacement
4941144|NCT01899443|total knee replacement|total knee replacement
4941145|NCT01899443|patient outcomes|patient outcomes
4941146|NCT01899443|health services research|health services research
4941147|NCT01899430|PCOS|pcos
4941148|NCT01899430|obesity|obesity
4941149|NCT01899430|GLP-1 receptor agonist|glp-1 receptor agonist
4941150|NCT01899430|liraglutide|liraglutide
4941151|NCT01899430|metformin|metformin
4941152|NCT01899417|osteoarthritis|osteoarthritis
4941153|NCT01899417|knee replacement|knee replacement
4941154|NCT01899417|patient-specific|patient-specific
4941155|NCT01899417|economics|economics
4941156|NCT01899404|Cervical Cancer|cervical cancer
4941157|NCT01899404|PET Scan for cervix|pet scan for cervix
4941158|NCT01899404|MRI for cervix|mri for cervix
4941159|NCT01899391|Prostate cancer|prostate cancer
4941160|NCT01899378|probiotics|probiotics
4941161|NCT01899365|anti-pneumococcal vaccination|anti-pneumococcal vaccination
4941162|NCT01899365|information|information
4941163|NCT01899365|emergency department|emergency department
4941164|NCT01899339|submassive pulmonary embolism|submassive pulmonary embolism
4941165|NCT01899339|Ultrasonic energy|ultrasonic energy
4941166|NCT01899339|Ekosonic Endovascular Device|ekosonic endovascular device
4941167|NCT01899339|RV:LV function after Pulmonary Embolism|rv:lv function after pulmonary embolism
4941168|NCT01899313|methamphetamine dependence|methamphetamine dependence
4941169|NCT01899313|texting|texting
4941170|NCT01899313|short message service|short message service
4941171|NCT01899313|addiction|addiction
4941172|NCT01899313|amphetamine|amphetamine
4941173|NCT01899313|outpatient|outpatient
4941174|NCT01899300|Refractory Benign Esophageal Strictures caused by Caustic Ingestion|refractory benign esophageal strictures caused by caustic ingestion
4941175|NCT01899287|workers education|workers education
4941176|NCT01899287|occupational|occupational
4941177|NCT01899209|Obstructed Defecation|obstructed defecation
4941178|NCT01899209|Rectal rectocele|rectal rectocele
4941179|NCT01899209|Intussusception|intussusception
4941180|NCT01899209|STARR|starr
4941181|NCT01899209|Ventral Rectopexy|ventral rectopexy
4941182|NCT01899196|Cardiac surgery|cardiac surgery
4941183|NCT01899183|Chronic cough|chronic cough
4941184|NCT01899183|Esophagus|esophagus
4941185|NCT01899183|Gastro-esophageal reflux disease|gastro-esophageal reflux disease
4941186|NCT01899183|Esophageal surgery|esophageal surgery
4941187|NCT01899183|Minimally invasive surgery|minimally invasive surgery
4941188|NCT01899183|Extra-esophageal reflux symptoms.|extra-esophageal reflux symptoms.
4941189|NCT01899170|deep brain stimulation|deep brain stimulation
4941190|NCT01899170|multi-coil transcranial magnetic stimulation|multi-coil transcranial magnetic stimulation
4941191|NCT01899170|PET-imaging|pet-imaging
4941192|NCT01899170|personalized treatment|personalized treatment
4941193|NCT01899157|Nutritional status|nutritional status
4941194|NCT01899157|Nutritional situation|nutritional situation
4941195|NCT01899144|Albuterol Spiromax|albuterol spiromax
4941196|NCT01899144|ProAir HFA|proair hfa
4941197|NCT01899144|albuterol sulfate|albuterol sulfate
4941198|NCT01899131|dental implants|dental implants
4941199|NCT01899131|crestal bone|crestal bone
4941200|NCT01899131|gingival margin|gingival margin
4941201|NCT01899118|locally advanced rectal cancer|locally advanced rectal cancer
4941202|NCT01899118|Neoadjuvant chemoradiotherapy|neoadjuvant chemoradiotherapy
4941203|NCT01899118|Nimotuzumab|nimotuzumab
4941204|NCT01899092|Genotype 1|genotype 1
4941205|NCT01899092|Chronic Hepatitis C|chronic hepatitis c
4941206|NCT01899092|CHC|chc
4941207|NCT01899092|HCV|hcv
4941208|NCT01899092|Hepatitis|hepatitis
4941209|NCT01899092|RNAi|rnai
4941210|NCT01899092|shRNA|shrna
4941211|NCT01899092|ddRNAi|ddrnai
4941212|NCT01899092|AAV8|aav8
4941213|NCT01899092|AAV|aav
4941214|NCT01899092|Adeno-associated virus|adeno-associated virus
4941215|NCT01899092|Adeno-associated viral vectors|adeno-associated viral vectors
4941216|NCT01899079|Breast Cancer|breast cancer
4941217|NCT01899079|Prosigna|prosigna
4941218|NCT01899079|FFPE|ffpe
4941219|NCT01899079|node negative|node negative
4941220|NCT01899079|estrogen receptor positive|estrogen receptor positive
4941221|NCT01899079|HER2 negative|her2 negative
4941222|NCT01899066|Efficacy|efficacy
4941223|NCT01899053|Solid tumors|solid tumors
4941224|NCT01899053|MLN0128|mln0128
4941225|NCT01899053|MLN1117|mln1117
4941226|NCT01899040|neuromodulation|neuromodulation
4941227|NCT01899040|migraine headache|migraine headache
4941228|NCT01899027|Arterial hypertension|arterial hypertension
4941229|NCT01899027|Radiofrequency ablation|radiofrequency ablation
4941230|NCT01899027|Renal function|renal function
4941231|NCT01899001|Polycystic Ovary Syndrome|polycystic ovary syndrome
4941232|NCT01899001|PCOS|pcos
4941233|NCT01899001|Depression|depression
4941234|NCT01899001|Anxiety|anxiety
4941235|NCT01899001|Weight loss|weight loss
4941236|NCT01899001|Exercise|exercise
4941237|NCT01899001|Nutrition|nutrition
4941238|NCT01899001|Therapy|therapy
4941239|NCT01899001|Mood symptoms|mood symptoms
4941240|NCT01899001|Stress|stress
4941241|NCT01898975|Neurosurgical patients|neurosurgical patients
4941242|NCT01898975|Fluid loading|fluid loading
4941243|NCT01898975|Fluid responsiveness|fluid responsiveness
4941244|NCT01898975|NICOM|nicom
4941245|NCT01898975|Stroke volume variation|stroke volume variation
4941246|NCT01898975|Pulse pressure variation|pulse pressure variation
4941247|NCT01898975|Total peripheral resistance|total peripheral resistance
4941248|NCT01898975|Gray zone approach|gray zone approach
4941249|NCT01898962|Oligometastases|oligometastases
4941250|NCT01898962|Metastatic cancer|metastatic cancer
4941251|NCT01898962|Stereotactic radiosurgery|stereotactic radiosurgery
4941252|NCT01898949|Diet-induced thermogenesis|diet-induced thermogenesis
4941253|NCT01898949|Cold-induced thermogenesis|cold-induced thermogenesis
4941254|NCT01898949|Brown adipose tissue|brown adipose tissue
4941255|NCT01898949|Brown fat|brown fat
4941256|NCT01898923|WH-1,Diabetic Foot,Ulcer|wh-1,diabetic foot,ulcer
4941257|NCT01898845|Neoplasms|neoplasms
4941258|NCT01898832|Cholestasis, pregnant, interleukin 17|cholestasis, pregnant, interleukin 17
4941259|NCT01898819|DEXMEDETOMIDINE|dexmedetomidine
4941260|NCT01898819|intraocular pressure|intraocular pressure
4941261|NCT01898806|Alopecia Areata|alopecia areata
4941262|NCT01898806|Kenalog|kenalog
4941263|NCT01898806|Triamcinolone|triamcinolone
4941264|NCT01898767|mild|mild
4941265|NCT01898767|asthma|asthma
4941266|NCT01898767|allergic|allergic
4941267|NCT01898754|Transmitted Drug Resistance|transmitted drug resistance
4941268|NCT01898741|Pancreatic cancer|pancreatic cancer
4941269|NCT01898741|Radiotherapy|radiotherapy
4941270|NCT01898741|SBRT|sbrt
4941271|NCT01898715|Adrenocortical carcinoma|adrenocortical carcinoma
4941272|NCT01898715|Adrenal cancer|adrenal cancer
4941273|NCT01898715|ACC|acc
4941274|NCT01898676|Extended-release divalproex sodium|extended-release divalproex sodium
4941275|NCT01898676|Depakote ER|depakote er
4941276|NCT01898650|craniosynostosis|craniosynostosis
4941277|NCT01898650|sagittal synostosis|sagittal synostosis
4941278|NCT01898650|metopic synostosis|metopic synostosis
4941279|NCT01898650|coronal synostosis|coronal synostosis
4941280|NCT01898650|lambdoid synostosis|lambdoid synostosis
4941281|NCT01898637|pulmonary embolism|pulmonary embolism
4941282|NCT01898637|pulse oximetry|pulse oximetry
4941283|NCT01898637|change in oxygen saturation|change in oxygen saturation
4941284|NCT01898637|hypoxemia|hypoxemia
4941285|NCT01898637|emergency department|emergency department
4941286|NCT01898637|deep inspiration|deep inspiration
4941287|NCT01898637|vital capacity|vital capacity
4941288|NCT01898637|clinical diagnosis|clinical diagnosis
4941289|NCT01898624|mirabegron|mirabegron
4941290|NCT01898624|Overactive Bladder|overactive bladder
4941291|NCT01898624|Betanis®|betanis®
4941292|NCT01898624|glaucoma|glaucoma
4941293|NCT01898611|Frailty|frailty
4941294|NCT01898611|Sarcopenia|sarcopenia
4941295|NCT01898611|Weight Loss|weight loss
4941296|NCT01898611|Exercise|exercise
4941297|NCT01898611|Aging|aging
4941298|NCT01898611|Ghrelin|ghrelin
4941299|NCT01898611|Elderly|elderly
4941300|NCT01898572|Newly Diagnosed Type II Diabetes Mellitus|newly diagnosed type ii diabetes mellitus
4941301|NCT01898572|Carotid Intimae-media Thickness|carotid intimae-media thickness
4941302|NCT01898572|Carotid Plaque|carotid plaque
4941303|NCT01898572|Cardiovascular Disease|cardiovascular disease
4941304|NCT01898559|little cigars|little cigars
4941305|NCT01898559|cigarettes|cigarettes
4941306|NCT01898559|smoking|smoking
4941307|NCT01898546|Ischemic postconditioning|ischemic postconditioning
4941308|NCT01898546|Myocardial Infarction|myocardial infarction
4941309|NCT01898546|Microvascular Obstruction|microvascular obstruction
4941310|NCT01898520|Spasticity|spasticity
4941311|NCT01898507|low nicotine|low nicotine
4941312|NCT01898507|cigarettes|cigarettes
4941313|NCT01898507|NMR|nmr
4941314|NCT01898481|Health care decision making|health care decision making
4941315|NCT01898468|Neuropathic pain symptoms|neuropathic pain symptoms
4941316|NCT01898468|Intracostal Closure Technique|intracostal closure technique
4941317|NCT01898468|Pericostal Suture Closure Technique|pericostal suture closure technique
4941318|NCT01898468|Post surgical pain|post surgical pain
4941319|NCT01898468|Post thoracotomy pain|post thoracotomy pain
4941320|NCT01898455|Migraine|migraine
4941321|NCT01898455|Cluster headache|cluster headache
4941322|NCT01898455|headache|headache
4941323|NCT01898442|platelet function|platelet function
4941324|NCT01898442|ticagrelor|ticagrelor
4941325|NCT01898442|STEMI|stemi
4941326|NCT01898429|Treatment Resistant Depression|treatment resistant depression
4941327|NCT01898429|Treatment Refractory Depression|treatment refractory depression
4941328|NCT01898429|Treatment Resistant Bipolar Disorder|treatment resistant bipolar disorder
4941329|NCT01898429|Treatment Refractory Bipolar Disorder|treatment refractory bipolar disorder
4941330|NCT01898429|Deep brain stimulation|deep brain stimulation
4941331|NCT01898429|DBS|dbs
4941332|NCT01898390|Parkinson's Disease|parkinson's disease
4941333|NCT01898390|Allo-Transplantation|allo-transplantation
4941334|NCT01898390|Fetal Ventral Mesencephalic Tissue|fetal ventral mesencephalic tissue
4941335|NCT01898377|Children|children
4941336|NCT01898377|Chronic graft-versus-host disease|chronic graft-versus-host disease
4941337|NCT01898351|Alternative sources of plant proteins|alternative sources of plant proteins
4941338|NCT01898351|High protein diets|high protein diets
4941339|NCT01898351|Satiety|satiety
4941340|NCT01898351|Postprandial effects|postprandial effects
4941341|NCT01898351|Bioactive phytochemicals|bioactive phytochemicals
4941342|NCT01898351|Phytochemicals bioactivity and metabolism|phytochemicals bioactivity and metabolism
4941343|NCT01898351|Macronutrients metabolism|macronutrients metabolism
4941344|NCT01898351|Health effects of plant proteins vs. meat proteins|health effects of plant proteins vs. meat proteins
4941345|NCT01898351|Partial meat proteins replacement with plant proteins|partial meat proteins replacement with plant proteins
4941346|NCT01898351|Satiety of meals rich in plant proteins|satiety of meals rich in plant proteins
4941347|NCT01898351|Postprandial effects of meals rich in plant proteins|postprandial effects of meals rich in plant proteins
4941348|NCT01898351|Plant phytochemicals and macronutrients bioavailability and metabolism|plant phytochemicals and macronutrients bioavailability and metabolism
4941349|NCT01898338|MRSA|mrsa
4941350|NCT01898338|bacteremia|bacteremia
4941351|NCT01898338|therapy|therapy
4941352|NCT01898325|Fibrosis|fibrosis
4941353|NCT01898325|Gaucher disease|gaucher disease
4941354|NCT01898299|Schizophrenia|schizophrenia
4941355|NCT01898286|C peptide|c peptide
4941356|NCT01898286|beta cell function|beta cell function
4941357|NCT01898286|immune modulation of type 1 diabetes|immune modulation of type 1 diabetes
4941358|NCT01898286|immune intervention in type 1 diabetes|immune intervention in type 1 diabetes
4941359|NCT01898273|Glioma|glioma
4941360|NCT01898273|Glioblastoma Multiforme|glioblastoma multiforme
4941361|NCT01898273|PET|pet
4941362|NCT01898273|Imaging|imaging
4941363|NCT01898273|Radiopharmaceutical|radiopharmaceutical
4941364|NCT01898273|Diagnostic|diagnostic
4941365|NCT01898260|contact lenses|contact lenses
4941366|NCT01898260|daily disposable contact lenses|daily disposable contact lenses
4941367|NCT01898260|silicone hydrogel|silicone hydrogel
4941368|NCT01898260|contact lens comfort|contact lens comfort
4941369|NCT01898260|near-sighted|near-sighted
4941370|NCT01898247|Thoracentesis|thoracentesis
4941371|NCT01898247|Simulation Based Mastery Learning|simulation based mastery learning
4941372|NCT01898247|Medical Education|medical education
4941373|NCT01898247|Length of Stay|length of stay
4941374|NCT01898247|Cost of Care|cost of care
4941375|NCT01898234|Hemodynamics|hemodynamics
4941376|NCT01898234|intradialytic hypotension|intradialytic hypotension
4941377|NCT01898234|subjective tolerance|subjective tolerance
4941378|NCT01898234|dialysis membranes|dialysis membranes
4941379|NCT01898234|high flux|high flux
4941380|NCT01898234|low flux|low flux
4941381|NCT01898234|hemodialysis|hemodialysis
4941382|NCT01898208|Bacteremia|bacteremia
4941383|NCT01898208|Fungemia|fungemia
4941384|NCT01898208|Bloodstream infection|bloodstream infection
4941385|NCT01898208|susceptibility|susceptibility
4941386|NCT01898208|MRSA|mrsa
4941387|NCT01898208|VRE|vre
4941388|NCT01898143|Whole body vibration, cardiorespiratory response|whole body vibration, cardiorespiratory response
4941389|NCT01898117|Triple negative|triple negative
4941390|NCT01898117|Metastatic|metastatic
4941391|NCT01898104|rectal|rectal
4941392|NCT01898104|low risk|low risk
4941393|NCT01898104|moderate risk|moderate risk
4941394|NCT01898091|Oral|oral
4941395|NCT01898091|Mucositis|mucositis
4941396|NCT01898091|Stomatitis|stomatitis
4941397|NCT01898091|Radiotherapy|radiotherapy
4941398|NCT01898078|MLN8237|mln8237
4941399|NCT01898078|alisertib|alisertib
4941400|NCT01898078|food effects|food effects
4941401|NCT01898065|Hypoxia|hypoxia
4941402|NCT01898065|radiotherapy|radiotherapy
4941403|NCT01898065|PET with 18-F-MISO|pet with 18-f-miso
4941405|NCT01898052|pain control|pain control
4941406|NCT01898052|periarticular injection|periarticular injection
4941407|NCT01898052|Total knee arthroplasty|total knee arthroplasty
4941408|NCT01898052|levobupivacaine|levobupivacaine
4941409|NCT01898052|multimodal drug injection|multimodal drug injection
4941410|NCT01898039|malignant melanoma|malignant melanoma
4941411|NCT01898039|vaccine|vaccine
4941412|NCT01898039|cell line|cell line
4941413|NCT01898039|high risk|high risk
4941414|NCT01898039|residual disease|residual disease
4941415|NCT01898026|PGX|pgx
4941416|NCT01898026|fibre|fibre
4941417|NCT01898026|postprandial glycemia|postprandial glycemia
4941418|NCT01898013|pain|pain
4941419|NCT01898013|pregnenolone|pregnenolone
4941420|NCT01898013|Veterans|veterans
4941421|NCT01898013|clinical trial|clinical trial
4941422|NCT01898013|neurosteroid|neurosteroid
4941423|NCT01898013|allopregnanolone|allopregnanolone
4941424|NCT01898013|low back|low back
4941425|NCT01898013|placebo controlled|placebo controlled
4941426|NCT01898013|randomized|randomized
4941427|NCT01898013|musculoskeletal|musculoskeletal
4941428|NCT01898000|Gingivitis|gingivitis
4941429|NCT01898000|Herbal medicine|herbal medicine
4941430|NCT01898000|Plaque control|plaque control
4941431|NCT01897987|Human Umbilical Cord Blood Derived Mesenchymal Stem Cells|human umbilical cord blood derived mesenchymal stem cells
4941432|NCT01897987|Bronchopulmonary dysplasia|bronchopulmonary dysplasia
4941433|NCT01897987|Premature infants|premature infants
4941434|NCT01897935|Uveitis|uveitis
4941435|NCT01897896|Chorea|chorea
4941436|NCT01897896|Huntington Disease|huntington disease
4941437|NCT01897870|continuity of care|continuity of care
4941438|NCT01897870|medicines management|medicines management
4941439|NCT01897870|home visit|home visit
4941440|NCT01897870|drug-related problems|drug-related problems
4941441|NCT01897857|diabetes mellitus(DM)|diabetes mellitus(dm)
4941442|NCT01897857|radial artery cannulation|radial artery cannulation
4941443|NCT01897857|artery blood flow|artery blood flow
4941444|NCT01897857|complication|complication
4941445|NCT01897857|End stage renal disease undergoing kidney transplantation|end stage renal disease undergoing kidney transplantation
4941446|NCT01897844|volunteers|volunteers
4941447|NCT01897831|Piperacillin Sodium and sulbactam sodium|piperacillin sodium and sulbactam sodium
4941448|NCT01897831|Phase IV clinical studies|phase iv clinical studies
4941449|NCT01897831|Respiratory and urinary tract infections|respiratory and urinary tract infections
4941450|NCT01897805|Coronary artery disease|coronary artery disease
4941451|NCT01897766|Genotropin|genotropin
4941452|NCT01897766|Somatropin|somatropin
4941453|NCT01897766|Long Term Follow-Up|long term follow-up
4941454|NCT01897766|Special Investigation|special investigation
4941455|NCT01897766|Small for Gestational Age|small for gestational age
4941456|NCT01897766|SGA|sga
4941457|NCT01897753|SGA|sga
4941458|NCT01897753|Growth hormone|growth hormone
4941459|NCT01897740|sildenafil|sildenafil
4941460|NCT01897740|pulmonary arterial hypertension|pulmonary arterial hypertension
4941461|NCT01897740|PAH|pah
4941462|NCT01897727|sleep apnea|sleep apnea
4941463|NCT01897727|hypertension|hypertension
4941464|NCT01897727|aldosterone|aldosterone
4941465|NCT01897727|hyperaldosteronism|hyperaldosteronism
4941466|NCT01897727|spironolactone|spironolactone
4941467|NCT01897727|blood pressure|blood pressure
4941468|NCT01897727|resistant|resistant
4941469|NCT01897701|H7N9|h7n9
4941470|NCT01897688|Diabetes|diabetes
4941471|NCT01897688|Islet|islet
4941472|NCT01897688|Pancreas|pancreas
4941473|NCT01897688|Hypoglycemia|hypoglycemia
4941474|NCT01897688|T1D|t1d
4941475|NCT01897688|Transplant|transplant
4941476|NCT01897675|Cutaneous Abscess|cutaneous abscess
4941477|NCT01897675|Emergency Department|emergency department
4941478|NCT01897662|overweight|overweight
4941479|NCT01897662|satiety|satiety
4941480|NCT01897662|functional food|functional food
4941481|NCT01897662|food intake|food intake
4941482|NCT01897662|digestive tolerance|digestive tolerance
4941483|NCT01897649|functional food|functional food
4941484|NCT01897649|digestive tolerance|digestive tolerance
4941485|NCT01897649|microbiota|microbiota
4941486|NCT01897649|bifidogenic effect|bifidogenic effect
4941487|NCT01897636|endoscopic ultrasound-guided fine-needle injection|endoscopic ultrasound-guided fine-needle injection
4941488|NCT01897636|dendritic cell|dendritic cell
4941489|NCT01897636|vaccination|vaccination
4941490|NCT01897610|Immuncell-LC, advanced hepatocellular carcinoma|immuncell-lc, advanced hepatocellular carcinoma
4941491|NCT01897584|laparoscopy, Trendelenburg Position, ventilation|laparoscopy, trendelenburg position, ventilation
4941492|NCT01897545|Arterial hypertension|arterial hypertension
4941493|NCT01897545|Atrial Fibrillation|atrial fibrillation
4941494|NCT01897545|Percutaneous renal denervation|percutaneous renal denervation
4941495|NCT01897519|High risk surgery|high risk surgery
4941496|NCT01897519|Acute Kidney Injury|acute kidney injury
4941497|NCT01897506|Food insecurity|food insecurity
4941498|NCT01897506|Health literacy|health literacy
4941499|NCT01897506|Quality of life|quality of life
4941500|NCT01897402|Central Nervous System Infections|central nervous system infections
4941501|NCT01897402|Meningitis|meningitis
4941502|NCT01897402|toxoid|toxoid
4941503|NCT01897402|Meningococcal vaccine|meningococcal vaccine
4941504|NCT01897402|conjugate vaccines|conjugate vaccines
4941505|NCT01897389|Healthy volunteers|healthy volunteers
4941506|NCT01897389|Bioavailability|bioavailability
4941507|NCT01897389|Abiraterone acetate|abiraterone acetate
4941508|NCT01897389|ZYTIGA|zytiga
4941509|NCT01897376|wound|wound
4941510|NCT01897376|infection|infection
4941511|NCT01897376|cesarean delivery|cesarean delivery
4941512|NCT01897376|obesity|obesity
4941513|NCT01897363|Prader Willi Syndrome|prader willi syndrome
4941514|NCT01897363|Hypoglycemia|hypoglycemia
4941515|NCT01897363|Fasting study|fasting study
4941516|NCT01897350|STEMI|stemi
4941517|NCT01897350|Myocardial edema|myocardial edema
4941518|NCT01897350|Cardiovascular magnetic resonance|cardiovascular magnetic resonance
4941519|NCT01897324|Poor Ovarian Response|poor ovarian response
4941520|NCT01897324|Poor Responders|poor responders
4941521|NCT01897324|IVF/ICSI|ivf/icsi
4941522|NCT01897324|Growth Hormone|growth hormone
4941523|NCT01897311|cesarean section|cesarean section
4941524|NCT01897311|pain|pain
4941525|NCT01897311|transcutaneous electrical nerve stimulation|transcutaneous electrical nerve stimulation
4941526|NCT01897311|postpartum period|postpartum period
4941527|NCT01897298|chronic obstructive pulmonary disease (COPD)|chronic obstructive pulmonary disease (copd)
4941528|NCT01897298|urban training|urban training
4941529|NCT01897298|physical activity|physical activity
4941530|NCT01897298|active aging|active aging
4941627|NCT01896739|over than 2.5Kg at at birth weight.|over than 2.5kg at at birth weight.
4941531|NCT01897285|Performance and safety of the AQUACEL® foam adhesive dressing|performance and safety of the aquacel® foam adhesive dressing
4941532|NCT01897272|carpal tunnel syndrome|carpal tunnel syndrome
4941533|NCT01897272|splinting|splinting
4941534|NCT01897272|nerve decompression|nerve decompression
4941535|NCT01897259|tennis elbow|tennis elbow
4941536|NCT01897259|lateral epicondylitis|lateral epicondylitis
4941537|NCT01897246|distal radius malunion|distal radius malunion
4941538|NCT01897246|extra-articular|extra-articular
4941539|NCT01897220|Noncardiac surgery;|noncardiac surgery;
4941540|NCT01897220|Perioperative ischemic complications;|perioperative ischemic complications;
4941541|NCT01897220|Perioperative bleeding complications;|perioperative bleeding complications;
4941542|NCT01897220|Antithrombotic therapy;|antithrombotic therapy;
4941543|NCT01897220|Coronary artery disease;|coronary artery disease;
4941544|NCT01897220|Stent thrombosis;|stent thrombosis;
4941545|NCT01897220|Perioperative infarction.|perioperative infarction.
4941546|NCT01897207|prostate cancer|prostate cancer
4941547|NCT01897207|dendritic cells|dendritic cells
4941548|NCT01897207|vaccination|vaccination
4941549|NCT01897181|Central auditory processing|central auditory processing
4941550|NCT01897181|Bilateral sensorineural hearing loss|bilateral sensorineural hearing loss
4941551|NCT01897181|Hearing aids|hearing aids
4941552|NCT01897155|analgesia, postoperative;|analgesia, postoperative;
4941553|NCT01897155|analgesics opioid;|analgesics opioid;
4941554|NCT01897155|hyperalgesia;|hyperalgesia;
4941555|NCT01897155|remifentanil;|remifentanil;
4941556|NCT01897155|hypertension.|hypertension.
4941557|NCT01897103|Peripheral Artery Disease|peripheral artery disease
4941558|NCT01897103|Endarterectomy (Carotid)|endarterectomy (carotid)
4941559|NCT01897103|Aortic Aneurysm, Abdominal|aortic aneurysm, abdominal
4941560|NCT01897103|Aortic Aneurysm, Thoracic|aortic aneurysm, thoracic
4941561|NCT01897103|Amputation|amputation
4941562|NCT01897103|Platelet Activity|platelet activity
4941563|NCT01897103|Thrombin|thrombin
4941564|NCT01897103|Transcriptomics|transcriptomics
4941565|NCT01897090|Elimination Diet|elimination diet
4941566|NCT01897090|Crohn's disease|crohn's disease
4941567|NCT01897077|Food Allergy|food allergy
4941568|NCT01897077|Peanut|peanut
4941569|NCT01897077|Sublingual Immunotherapy|sublingual immunotherapy
4941570|NCT01897064|Schizophrenia|schizophrenia
4941571|NCT01897064|Cognition|cognition
4941572|NCT01897064|Aerobic Exercise|aerobic exercise
4941573|NCT01897051|Liver cirrhosis|liver cirrhosis
4941574|NCT01897051|Portal hypertension|portal hypertension
4941575|NCT01897051|Hepatic Venous Pressure Gradient|hepatic venous pressure gradient
4941576|NCT01897051|Rifaximin|rifaximin
4941577|NCT01897025|Stroke|stroke
4941578|NCT01897025|Noninvasive brain stimulation|noninvasive brain stimulation
4941579|NCT01897025|Brain-computer interface|brain-computer interface
4941580|NCT01897025|Motor imagery|motor imagery
4941581|NCT01897025|Rehabilitation|rehabilitation
4941582|NCT01896986|Special risk patients|special risk patients
4941583|NCT01896986|Immunosuppressive biologic treatments|immunosuppressive biologic treatments
4941584|NCT01896986|PRD (Paediatric Rheumatological Disease)|prd (paediatric rheumatological disease)
4941585|NCT01896986|IBD (Inflammatory Bowel Disease)|ibd (inflammatory bowel disease)
4941586|NCT01896973|Benign Prostatic Hyperplasia|benign prostatic hyperplasia
4941588|NCT01896973|LUTS|luts
4941589|NCT01896973|Vortx Rx|vortx rx
4941590|NCT01896973|Histotripsy|histotripsy
4941591|NCT01896960|Post spinal hypotension|post spinal hypotension
4941592|NCT01896960|Cesarian Section|cesarian section
4941593|NCT01896960|ET50|et50
4941594|NCT01896960|Bupivacaine|bupivacaine
4941595|NCT01896960|Fentanyl|fentanyl
4941596|NCT01896934|Depression|depression
4941597|NCT01896934|Antidepressants|antidepressants
4941598|NCT01896934|Elderly|elderly
4941599|NCT01896934|Geriatrics|geriatrics
4941600|NCT01896921|HIV|hiv
4941601|NCT01896908|diastolic dysfunction|diastolic dysfunction
4941602|NCT01896908|Sodium restriction|sodium restriction
4941603|NCT01896908|Randomized clinical trial|randomized clinical trial
4941604|NCT01896882|Diet, Sodium-Restricted|diet, sodium-restricted
4941605|NCT01896882|Food and Nutrition Education|food and nutrition education
4941606|NCT01896882|Renal Dialyisis|renal dialyisis
4941607|NCT01896869|Pancreatic Cancer|pancreatic cancer
4941608|NCT01896869|Vaccine|vaccine
4941609|NCT01896869|Immunotherapy|immunotherapy
4941610|NCT01896869|Ipilimumab|ipilimumab
4941611|NCT01896869|CTLA-4|ctla-4
4941612|NCT01896869|antibody|antibody
4941613|NCT01896869|FOLFIRINOX|folfirinox
4941614|NCT01896856|SGI-110|sgi-110
4941615|NCT01896856|irinotecan|irinotecan
4941616|NCT01896856|regorafenib|regorafenib
4941617|NCT01896856|methylation|methylation
4941618|NCT01896856|colorectal|colorectal
4941619|NCT01896856|metastatic|metastatic
4941620|NCT01896856|TAS-102|tas-102
4941621|NCT01896856|lonsurf|lonsurf
4941622|NCT01896843|Positron Emission Tomography (PET)|positron emission tomography (pet)
4941623|NCT01896843|Metabotropic Glutamate Receptors|metabotropic glutamate receptors
4941624|NCT01896830|Clostridium difficile infection|clostridium difficile infection
4941625|NCT01896830|Clostridium difficile Toxoid Vaccine|clostridium difficile toxoid vaccine
4941626|NCT01896739|Healthy infants with over than 37 weeks gestation periods.|healthy infants with over than 37 weeks gestation periods.
4941628|NCT01896713|Prostate Cancer|prostate cancer
4941629|NCT01896713|MRI|mri
4941630|NCT01896713|TRUSBx|trusbx
4941631|NCT01896700|Multiple sclerosis|multiple sclerosis
4941632|NCT01896700|postural balance|postural balance
4941633|NCT01896700|walking|walking
4941634|NCT01896687|nonspecific low back pain|nonspecific low back pain
4941635|NCT01896687|chronic low back pain|chronic low back pain
4941636|NCT01896674|Computed tomography|computed tomography
4941637|NCT01896661|Sleep apnea|sleep apnea
4941638|NCT01896661|Hypertension|hypertension
4941639|NCT01896661|Treatment|treatment
4941640|NCT01896661|Diuretics|diuretics
4941641|NCT01896661|Chlorthalidone|chlorthalidone
4941642|NCT01896661|Amlodipine|amlodipine
4941643|NCT01896635|Ulcerative Colitis|ulcerative colitis
4941644|NCT01896635|Inflammatory Bowel Disease|inflammatory bowel disease
4941645|NCT01896635|Fecal Transplantation|fecal transplantation
4941646|NCT01896635|Fecal Microbiota Transplantation|fecal microbiota transplantation
4941647|NCT01896622|Dabigatran Etexilate|dabigatran etexilate
4941648|NCT01896622|Ritonavir|ritonavir
4941649|NCT01896622|Cobicistat|cobicistat
4941650|NCT01896622|P-Glycoprotein|p-glycoprotein
4941651|NCT01896609|Chronic hepatitis c|chronic hepatitis c
4941652|NCT01896609|Egyptian population|egyptian population
4941653|NCT01896609|Reiferon Retard|reiferon retard
4941654|NCT01896609|Ribavirin|ribavirin
4941655|NCT01896609|Nitazoxanide|nitazoxanide
4941656|NCT01896609|Bon one|bon one
4941657|NCT01896596|vaccines|vaccines
4941658|NCT01896596|immunogenicity|immunogenicity
4941659|NCT01896596|adverse reactions|adverse reactions
4941660|NCT01896570|atrial fibrillation|atrial fibrillation
4941661|NCT01896570|catheter ablation|catheter ablation
4941662|NCT01896570|subsequent atrial tachycardia|subsequent atrial tachycardia
4941663|NCT01896570|mechanisms|mechanisms
4941664|NCT01896557|clopidogrel|clopidogrel
4941665|NCT01896557|omeprazole|omeprazole
4941666|NCT01896557|ranitidin|ranitidin
4941667|NCT01896557|interaction|interaction
4941668|NCT01896557|aggregability|aggregability
4941669|NCT01896544|cholecalciferol|cholecalciferol
4941670|NCT01896544|vitamin D|vitamin d
4941671|NCT01896544|sepsis|sepsis
4941672|NCT01896544|infection|infection
4941673|NCT01896518|second hand smoke exposure; children|second hand smoke exposure; children
4941674|NCT01896505|bone|bone
4941675|NCT01896505|soft-tissue|soft-tissue
4941676|NCT01896505|sarcoma|sarcoma
4941677|NCT01896505|KPT-330|kpt-330
4941678|NCT01896505|food|food
4941679|NCT01896505|effects|effects
4941680|NCT01896505|Selinexor|selinexor
4941681|NCT01896492|PCOS,|pcos,
4941682|NCT01896492|NAC,|nac,
4941683|NCT01896492|OVULATION INDUCTION,|ovulation induction,
4941684|NCT01896492|CLOMOPHEN CITRATE|clomophen citrate
4941685|NCT01896479|thyroid cancer|thyroid cancer
4941686|NCT01896479|medullary thyroid cancer|medullary thyroid cancer
4941687|NCT01896466|Fall Risk|fall risk
4941688|NCT01896466|Gait|gait
4941689|NCT01896466|Dynamic Balance|dynamic balance
4941690|NCT01896466|Static Balance|static balance
4941691|NCT01896466|Neuromodulation|neuromodulation
4941692|NCT01896440|Pediatric|pediatric
4941693|NCT01896440|Ondansetron|ondansetron
4941694|NCT01896440|Cardiac repolarization|cardiac repolarization
4941695|NCT01896440|QTc interval|qtc interval
4941696|NCT01896427|Third Molar|third molar
4941697|NCT01896427|Edema|edema
4941698|NCT01896427|pain|pain
4941699|NCT01896427|trismus|trismus
4941700|NCT01896414|Metabolic Syndrome|metabolic syndrome
4941701|NCT01896414|Omega 3 Fish Oil|omega 3 fish oil
4941702|NCT01896401|large bore endovascular catheterization procedures|large bore endovascular catheterization procedures
4941703|NCT01896401|Vascular Closure Device|vascular closure device
4941704|NCT01896388|PTSD/ifenprodil|ptsd/ifenprodil
4941705|NCT01896375|Gutkha|gutkha
4941706|NCT01896375|Pan masala ban|pan masala ban
4941707|NCT01896375|Legislation|legislation
4941708|NCT01896375|Smokeless tobacco|smokeless tobacco
4941709|NCT01896349|Psychotherapy, Treatment Resistant Depression, depression|psychotherapy, treatment resistant depression, depression
4941710|NCT01896271|kidney cancer|kidney cancer
4941711|NCT01896271|metastatic cancer|metastatic cancer
4941712|NCT01896245|hoarseness|hoarseness
4941713|NCT01896245|sore throat|sore throat
4941714|NCT01896245|intubating conditions|intubating conditions
4941715|NCT01896245|vocal cord injuries|vocal cord injuries
4941716|NCT01896245|sevoflurane|sevoflurane
4941717|NCT01896232|Secondary Hyperparathyroidism, renal, kidney, kidneys, dialysis, hemodialysis, chronic kidney disease, CKD, SHPT|secondary hyperparathyroidism, renal, kidney, kidneys, dialysis, hemodialysis, chronic kidney disease, ckd, shpt
4941718|NCT01896219|Medical device|medical device
4941719|NCT01896219|CT|ct
4941720|NCT01896219|Needle|needle
4941721|NCT01896219|Navigation|navigation
4941722|NCT01896219|IMACTIS-CT®|imactis-ct®
4941723|NCT01896219|Thoraco-abdominal level|thoraco-abdominal level
4941724|NCT01896219|anesthesia needles|anesthesia needles
4941725|NCT01896180|POAG|poag
4941726|NCT01896180|OHT|oht
4941727|NCT01896180|OHTN|ohtn
4941728|NCT01896180|IOP|iop
4941729|NCT01896167|Headache|headache
4941730|NCT01896167|Migraine|migraine
4941731|NCT01896167|Aura|aura
4941732|NCT01896167|Cerebral hemodynamics|cerebral hemodynamics
4941733|NCT01896154|dietary fibers, influenza vaccination, HI titres|dietary fibers, influenza vaccination, hi titres
4941734|NCT01896128|stroke|stroke
4941735|NCT01896128|CVA|cva
4941736|NCT01896128|cerebrovascular accident|cerebrovascular accident
4941737|NCT01896128|hemiparesis|hemiparesis
4941738|NCT01896128|impairment|impairment
4941739|NCT01896128|motor recovery|motor recovery
4941740|NCT01896128|neuroplasticity|neuroplasticity
4941741|NCT01896128|nuvigil|nuvigil
4941742|NCT01896128|armodafinil|armodafinil
4941743|NCT01896115|Stimulation, implantable pulse generator, deep brain stimulation|stimulation, implantable pulse generator, deep brain stimulation
4941744|NCT01896102|Adrenoleukodystrophy|adrenoleukodystrophy
4941745|NCT01896102|X-linked adrenoleukodystrophy|x-linked adrenoleukodystrophy
4941746|NCT01896102|Gene therapy|gene therapy
4941747|NCT01896102|Hematopoietic stem cell|hematopoietic stem cell
4941748|NCT01896076|caudal space|caudal space
4941749|NCT01896076|children|children
4941750|NCT01896076|ultrasound evaluation|ultrasound evaluation
4941751|NCT01896063|Electroacupuncture, Sedation|electroacupuncture, sedation
4941752|NCT01896050|Joint pain|joint pain
4941753|NCT01896050|Grip strength|grip strength
4941754|NCT01896050|Hormone receptor positive breast cancer|hormone receptor positive breast cancer
4941755|NCT01896037|Spinal cord injury|spinal cord injury
4941756|NCT01896037|Tetraplegia|tetraplegia
4941757|NCT01896037|Quadraplegia|quadraplegia
4941758|NCT01896037|Cholesterol|cholesterol
4941759|NCT01896037|HDL-c|hdl-c
4941760|NCT01896037|LDL-c|ldl-c
4941761|NCT01896037|Omega-3 fatty acids|omega-3 fatty acids
4941762|NCT01895998|sickle cell disease|sickle cell disease
4941763|NCT01895998|pulmonary hypertension|pulmonary hypertension
4941764|NCT01895998|airway hyperreactivity|airway hyperreactivity
4941765|NCT01895998|acute chest syndrome|acute chest syndrome
4941766|NCT01895959|knee osteoarthritis (OA)|knee osteoarthritis (oa)
4941767|NCT01895959|hyaluronic acid injection|hyaluronic acid injection
4941768|NCT01895946|Advanced solid malignancy, AZD5363,|advanced solid malignancy, azd5363,
4941769|NCT01895946|food effect,|food effect,
4941770|NCT01895946|formulation comparison|formulation comparison
4941895|NCT01895595|intuitive eating|intuitive eating
4941771|NCT01895933|Investigational device (chitosan gel)|investigational device (chitosan gel)
4941772|NCT01895933|Wound healing|wound healing
4941773|NCT01895933|Endoscopic sinus surgery|endoscopic sinus surgery
4941774|NCT01895933|SurgiShield|surgishield
4941776|NCT01895920|Biofilm|biofilm
4941777|NCT01895920|Transmission|transmission
4941778|NCT01895907|Special Olympics|special olympics
4941779|NCT01895907|occupational therapy|occupational therapy
4941780|NCT01895907|SCOPE|scope
4941781|NCT01895907|life participation improvement|life participation improvement
4941782|NCT01895894|Mycophenolate mofetil|mycophenolate mofetil
4941783|NCT01895894|Immunosuppressive Agents|immunosuppressive agents
4941784|NCT01895894|Nephrosis|nephrosis
4941785|NCT01895881|Intracranial Aneurysm|intracranial aneurysm
4941786|NCT01895881|Estradiol|estradiol
4941787|NCT01895868|Ultrasound training|ultrasound training
4941788|NCT01895868|Ultrasound simulation|ultrasound simulation
4941789|NCT01895868|Ultrasound assessment|ultrasound assessment
4941790|NCT01895868|Technology-enhanced learning|technology-enhanced learning
4941791|NCT01895868|virtual reality simulation|virtual reality simulation
4941792|NCT01895842|Leukemia|leukemia
4941793|NCT01895842|Myelodysplastic syndrome|myelodysplastic syndrome
4941794|NCT01895842|MDS|mds
4941795|NCT01895842|Low or intermediate-1 risk|low or intermediate-1 risk
4941796|NCT01895842|Maximum tolerated dose|maximum tolerated dose
4941797|NCT01895842|MTD|mtd
4941798|NCT01895842|Ruxolitinib|ruxolitinib
4941799|NCT01895842|Jakafi|jakafi
4941800|NCT01895842|INCB018424|incb018424
4941801|NCT01895842|INC424|inc424
4941802|NCT01895829|Head and Neck Cancer|head and neck cancer
4941803|NCT01895829|Squamous cell carcinomas of the head and neck|squamous cell carcinomas of the head and neck
4941804|NCT01895829|HNSCC|hnscc
4941805|NCT01895829|Magnetic resonance imaging|magnetic resonance imaging
4941806|NCT01895829|MRI|mri
4941807|NCT01895829|Ferumoxytol|ferumoxytol
4941808|NCT01895829|Ultra-small superparamagnetic iron oxide nanoparticle|ultra-small superparamagnetic iron oxide nanoparticle
4941809|NCT01895829|USPIO|uspio
4941810|NCT01895829|Contrast agent|contrast agent
4941811|NCT01895829|Dynamic contrast imaging|dynamic contrast imaging
4941812|NCT01895829|DCI|dci
4941813|NCT01895816|male infertility,oligo spermia|male infertility,oligo spermia
4941814|NCT01895803|smoking woman|smoking woman
4941815|NCT01895790|Pancreatic Cancer|pancreatic cancer
4941816|NCT01895790|Pancreatic Duct|pancreatic duct
4941817|NCT01895790|Stent|stent
4941818|NCT01895790|Pancreatic Duct Stent|pancreatic duct stent
4941819|NCT01895790|Cancer|cancer
4941820|NCT01895790|Pain|pain
4941821|NCT01895790|Obstructive Pain|obstructive pain
4941822|NCT01895790|Palliative|palliative
4941823|NCT01895764|ankylosing spondylitis|ankylosing spondylitis
4941824|NCT01895751|Non-ST elevation myocardial infarction (NSTEMI)|non-st elevation myocardial infarction (nstemi)
4941825|NCT01895751|Non-ST elevation acute coronary syndrome (NSTE-ACS)|non-st elevation acute coronary syndrome (nste-acs)
4941826|NCT01895751|Unstable Angina|unstable angina
4941827|NCT01895751|Medical therapy|medical therapy
4941828|NCT01895751|Coronary angiogram|coronary angiogram
4941829|NCT01895751|Percutaneous coronary intervention|percutaneous coronary intervention
4941830|NCT01895751|Coronary artery bypass surgery|coronary artery bypass surgery
4941831|NCT01895751|Coronary revascularization|coronary revascularization
4941832|NCT01895751|Health economics|health economics
4941833|NCT01895738|Trauma|trauma
4941834|NCT01895738|Injuries|injuries
4941835|NCT01895738|Violence|violence
4941836|NCT01895738|Adolescent|adolescent
4941837|NCT01895738|WrapAround care|wraparound care
4941838|NCT01895712|International|international
4941839|NCT01895712|Multicenter|multicenter
4941840|NCT01895712|Observational registry|observational registry
4941841|NCT01895712|Orsiro Drug Eluting Stents (DES)|orsiro drug eluting stents (des)
4941842|NCT01895712|Stenting|stenting
4941843|NCT01895712|Treatment of Coronary Artery Disease|treatment of coronary artery disease
4941844|NCT01895712|Coronary revascularization|coronary revascularization
4941845|NCT01895712|Percutaneous Coronary Intervention (PCI)|percutaneous coronary intervention (pci)
4941846|NCT01895712|Diabetes Mellitus Type 1|diabetes mellitus type 1
4941847|NCT01895712|Diabetes Mellitus Type 2|diabetes mellitus type 2
4941848|NCT01895712|STEMI|stemi
4941849|NCT01895712|NSTEMI|nstemi
4941850|NCT01895712|Ischemia|ischemia
4941851|NCT01895712|Angina|angina
4941852|NCT01895712|Subgroups|subgroups
4941853|NCT01895712|Acute Myocardial Infarction|acute myocardial infarction
4941854|NCT01895712|Small vessels|small vessels
4941855|NCT01895712|Chronic Total Occlusion|chronic total occlusion
4941856|NCT01895699|Contrast agent|contrast agent
4941857|NCT01895699|endothelium|endothelium
4941858|NCT01895699|Free radical|free radical
4941859|NCT01895699|Alpha lipoic acid|alpha lipoic acid
4941860|NCT01895686|open angle glaucoma|open angle glaucoma
4941861|NCT01895686|narrow angles|narrow angles
4941862|NCT01895686|angle closure glaucoma|angle closure glaucoma
4941863|NCT01895686|gonioscopy|gonioscopy
4941864|NCT01895686|anterior segment OCT|anterior segment oct
4941865|NCT01895673|FDG-PET|fdg-pet
4941866|NCT01895673|Radiofrequency Ablation|radiofrequency ablation
4941867|NCT01895673|Magnetic Resonance Imaging|magnetic resonance imaging
4941868|NCT01895660|P-CIMT|p-cimt
4941869|NCT01895660|Pediatric Constraint Induced Movement Therapy|pediatric constraint induced movement therapy
4941870|NCT01895660|Hemiparesis|hemiparesis
4941871|NCT01895660|Cerebral Palsy|cerebral palsy
4941872|NCT01895660|Children|children
4941873|NCT01895647|electric muscle stimulation|electric muscle stimulation
4941874|NCT01895647|respiratory failure|respiratory failure
4941875|NCT01895647|sepsis|sepsis
4941876|NCT01895647|interleukin 6|interleukin 6
4941877|NCT01895647|interleukin 15|interleukin 15
4941878|NCT01895634|Ischemia|ischemia
4941879|NCT01895634|Stroke|stroke
4941880|NCT01895634|Ischemic Stroke|ischemic stroke
4941881|NCT01895634|Thrombectomy|thrombectomy
4941882|NCT01895634|Brain clot|brain clot
4941883|NCT01895634|Cerebrovascular disease|cerebrovascular disease
4941884|NCT01895634|Recanalization|recanalization
4941885|NCT01895634|Revascularization|revascularization
4941886|NCT01895634|Clot Retriever|clot retriever
4941887|NCT01895634|Neurovascular Intervention|neurovascular intervention
4941888|NCT01895634|Interventional Neuroradiology|interventional neuroradiology
4941889|NCT01895634|neurovascular clinical trial|neurovascular clinical trial
4941890|NCT01895608|aged or aged 80 and over|aged or aged 80 and over
4941891|NCT01895608|gait disorder|gait disorder
4941892|NCT01895608|attention|attention
4941893|NCT01895595|obesity|obesity
4941894|NCT01895595|stress|stress
4941896|NCT01895595|guided imagery|guided imagery
4941897|NCT01895595|latinos|latinos
4941898|NCT01895595|adolescents|adolescents
4941899|NCT01895595|insulin resistance|insulin resistance
4941900|NCT01895582|Ageing|ageing
4941901|NCT01895582|Tuberculosis|tuberculosis
4941902|NCT01895582|Interferon gamma releasing tests|interferon gamma releasing tests
4941903|NCT01895556|Malawi|malawi
4941904|NCT01895556|Risk Compensation|risk compensation
4941905|NCT01895556|Male Circumcision|male circumcision
4941906|NCT01895556|Demand|demand
4941907|NCT01895530|Probiotics|probiotics
4941908|NCT01895530|colorectal cancer|colorectal cancer
4941909|NCT01895530|postoperative infection|postoperative infection
4941910|NCT01895530|immune function|immune function
4941911|NCT01895530|bacterial translocation|bacterial translocation
4941912|NCT01895530|gastrointestinal surgery|gastrointestinal surgery
4941913|NCT01895504|Colonoscopy|colonoscopy
4941914|NCT01895504|Colorectal cancer|colorectal cancer
4941915|NCT01895504|Adenoma|adenoma
4941916|NCT01895478|asthma|asthma
4941917|NCT01895478|pediatrics|pediatrics
4941918|NCT01895478|control|control
4941919|NCT01895478|medication adherence|medication adherence
4941920|NCT01895465|urine collection, contamination|urine collection, contamination
4941921|NCT01895452|Schizophrenia|schizophrenia
4941922|NCT01895439|Bone marrow derived Mesenchymal Stem Cells|bone marrow derived mesenchymal stem cells
4941923|NCT01895439|Multiple Sclerosis|multiple sclerosis
4941924|NCT01895439|Oligodendrocytes|oligodendrocytes
4941925|NCT01895439|Neuroimmunology|neuroimmunology
4941926|NCT01895439|Autoimmune disease|autoimmune disease
4941927|NCT01895413|Cartilage injury|cartilage injury
4941928|NCT01895413|Osteoarthritis|osteoarthritis
4941929|NCT01895413|Mesenchymal stem cells|mesenchymal stem cells
4941930|NCT01895400|Renexin for Recurrent Vestibulopathy|renexin for recurrent vestibulopathy
4941931|NCT01895374|Laser therapy|laser therapy
4941932|NCT01895374|Biological dressing|biological dressing
4941933|NCT01895374|Amniotic membrane|amniotic membrane
4941934|NCT01895374|Hydrocolloid bandages|hydrocolloid bandages
4941935|NCT01895374|wound healing|wound healing
4941936|NCT01895361|SelG1|selg1
4941937|NCT01895361|P-selectin|p-selectin
4941938|NCT01895361|monoclonal antibody|monoclonal antibody
4941939|NCT01895361|sickle cell disease|sickle cell disease
4941940|NCT01895361|sickle cell anemia|sickle cell anemia
4941941|NCT01895361|sickle cell|sickle cell
4941942|NCT01895361|pain crisis|pain crisis
4941943|NCT01895361|pain crises|pain crises
4941944|NCT01895361|vasoocclusion|vasoocclusion
4941945|NCT01895361|vaso-occlusion|vaso-occlusion
4941946|NCT01895361|priapism|priapism
4941947|NCT01895361|hepatic sequestration|hepatic sequestration
4941948|NCT01895361|splenic sequestration|splenic sequestration
4941949|NCT01895361|chest syndrome|chest syndrome
4941950|NCT01895322|Tolvaptan|tolvaptan
4941951|NCT01895322|dialysis|dialysis
4941952|NCT01895309|Rheumatoid Arthritis|rheumatoid arthritis
4941953|NCT01895309|Etanercept|etanercept
4941954|NCT01895309|Biosimilar|biosimilar
4941955|NCT01895296|dumping syndrome|dumping syndrome
4941956|NCT01895296|OGTT|ogtt
4941957|NCT01895296|hypoglycemia|hypoglycemia
4941958|NCT01895283|Aerobic training|aerobic training
4941959|NCT01895283|VO2max|vo2max
4941960|NCT01895283|Bethlem myopathy|bethlem myopathy
4941961|NCT01895270|opioid dependence|opioid dependence
4941962|NCT01895270|buprenorphine|buprenorphine
4941963|NCT01895270|isradipine|isradipine
4941964|NCT01895270|opioid withdrawal|opioid withdrawal
4941965|NCT01895270|opioid detoxification|opioid detoxification
4941966|NCT01895257|TTP1|ttp1
4941967|NCT01895257|TTP2|ttp2
4941968|NCT01895257|PFS|pfs
4941969|NCT01895257|Safety|safety
4941970|NCT01895257|R0 resection rate|r0 resection rate
4941971|NCT01895257|Quality of life|quality of life
4941972|NCT01895257|Overall Survival|overall survival
4941973|NCT01895244|scleroderma|scleroderma
4941974|NCT01895244|autologous stem cell transplantation|autologous stem cell transplantation
4941975|NCT01895244|thiotepa|thiotepa
4941976|NCT01895244|cluster of differentiation (CD) 34 selection|cluster of differentiation (cd) 34 selection
4941977|NCT01895192|sperm morphology|sperm morphology
4941978|NCT01895192|vacuoles|vacuoles
4941979|NCT01895192|fertile|fertile
4941980|NCT01895192|Motile Sperm Organellar Morphology Examination|motile sperm organellar morphology examination
4941981|NCT01895192|high magnification|high magnification
4941982|NCT01895192|reference values|reference values
4941983|NCT01895179|Time-restricted feeding|time-restricted feeding
4941984|NCT01895179|Intermittent fasting|intermittent fasting
4941985|NCT01895179|Prediabetes|prediabetes
4941986|NCT01895179|Insulin resistance|insulin resistance
4941987|NCT01895179|Glucose tolerance|glucose tolerance
4941988|NCT01895179|Insulin sensitivity|insulin sensitivity
4941989|NCT01895179|Circadian rhythms|circadian rhythms
4941990|NCT01895179|Diurnal|diurnal
4941991|NCT01895166|Endobronchial ultrasonography with a guide sheath|endobronchial ultrasonography with a guide sheath
4941992|NCT01895166|Peripheral pulmonary lesions|peripheral pulmonary lesions
4941993|NCT01895166|Transbronchial biopsy|transbronchial biopsy
4941994|NCT01895153|bladder pain syndrome|bladder pain syndrome
4941995|NCT01895153|pentosan polysulfate|pentosan polysulfate
4941996|NCT01895153|hydrodistension|hydrodistension
4941997|NCT01895140|Treatment-resistant hypertension|treatment-resistant hypertension
4941998|NCT01895140|Renal denervation|renal denervation
4941999|NCT01895140|Ambulatory blood pressure|ambulatory blood pressure
4942000|NCT01895127|Kidney Transplant|kidney transplant
4942001|NCT01895127|Renal Transplant|renal transplant
4942002|NCT01895127|Rejection|rejection
4942003|NCT01895127|Antibody mediated|antibody mediated
4942004|NCT01895127|Humoral|humoral
4942005|NCT01895127|Eculizumab|eculizumab
4942006|NCT01895114|Renal function|renal function
4942007|NCT01895114|cirrhotic patients|cirrhotic patients
4942008|NCT01895114|transplant evaluation|transplant evaluation
4942009|NCT01895101|blood loss|blood loss
4942010|NCT01895101|tranexamix acid|tranexamix acid
4942011|NCT01895101|cardiac surgery|cardiac surgery
4942012|NCT01895088|presbyopia|presbyopia
4942013|NCT01895075|Budesonide|budesonide
4942014|NCT01895075|Inhalation|inhalation
4942015|NCT01895075|Premature infants|premature infants
4942016|NCT01895062|colonoscopy|colonoscopy
4942017|NCT01895062|oxygen desaturation|oxygen desaturation
4942018|NCT01895049|Tacrolimus|tacrolimus
4942019|NCT01895049|Everolimus|everolimus
4942020|NCT01895049|Cytomegalovirus|cytomegalovirus
4942021|NCT01895049|Thymoglobulin|thymoglobulin
4942022|NCT01895049|Deceased donors|deceased donors
4942023|NCT01895049|Expanded criteria|expanded criteria
4942024|NCT01895036|maintained on 2 mg or less of buprenorphine, in which discontinuation of agonist treatment is clinically feasible but difficult|maintained on 2 mg or less of buprenorphine, in which discontinuation of agonist treatment is clinically feasible but difficult
4942025|NCT01895010|prevention and treatment|prevention and treatment
4942026|NCT01895010|improvement of the patient's appetite|improvement of the patient's appetite
4942027|NCT01895010|TACE|tace
4942028|NCT01894997|Deep Vein Thrombosis|deep vein thrombosis
4942029|NCT01894997|Neuromuscular Electrical Stimulation|neuromuscular electrical stimulation
4942030|NCT01894997|Intermittent Pneumatic Compression|intermittent pneumatic compression
4942031|NCT01894997|Doppler Ultrasound|doppler ultrasound
4942032|NCT01894984|Schizophrenia|schizophrenia
4942033|NCT01894984|Risperidone|risperidone
4942034|NCT01894984|Risperdal Consta|risperdal consta
4942035|NCT01894984|Oral antipsychotic|oral antipsychotic
4942036|NCT01894958|Fragile X disorder|fragile x disorder
4942037|NCT01894958|Autism|autism
4942038|NCT01894932|Psychotherapy, Group|psychotherapy, group
4942039|NCT01894919|Meningococcal B disease,|meningococcal b disease,
4942040|NCT01894919|Antibody persistence|antibody persistence
4942041|NCT01894906|Soluble Ferric Pyrophosphate,|soluble ferric pyrophosphate,
4942042|NCT01894906|Pharmacokinetics,|pharmacokinetics,
4942043|NCT01894906|Iron, Mass Transfer,|iron, mass transfer,
4942044|NCT01894906|Hemodialysis|hemodialysis
4942045|NCT01894906|chronic therapy;|chronic therapy;
4942046|NCT01894867|LIVER CIRRHOSIS|liver cirrhosis
4942047|NCT01894867|MAGNESIUM|magnesium
4942048|NCT01894867|MINIMAL ENCEPHALOPATHY|minimal encephalopathy
4942049|NCT01894867|MUSCLE WEAKNESS|muscle weakness
4942050|NCT01894854|Radiostereometry|radiostereometry
4942051|NCT01894854|Total Hip Arthroplasty|total hip arthroplasty
4942052|NCT01894854|Stem design|stem design
4942053|NCT01894841|depression|depression
4942054|NCT01894841|prevention|prevention
4942055|NCT01894841|Veterans health|veterans health
4942056|NCT01894828|Nutritional support|nutritional support
4942057|NCT01894828|Gastrointestinal cancer|gastrointestinal cancer
4942058|NCT01894828|Malnutrition|malnutrition
4942059|NCT01894815|major depressive disorder|major depressive disorder
4942060|NCT01894815|major depression|major depression
4942061|NCT01894815|depressive disorder|depressive disorder
4942062|NCT01894815|major depressive episode|major depressive episode
4942063|NCT01894802|Tetraplegia|tetraplegia
4942064|NCT01894802|Quadriplegia|quadriplegia
4942065|NCT01894802|Spinal cord injury|spinal cord injury
4942066|NCT01894802|Brainstem or spinal stroke|brainstem or spinal stroke
4942067|NCT01894802|Neuroprosthetic|neuroprosthetic
4942068|NCT01894802|Brain-machine interface|brain-machine interface
4942069|NCT01894802|Brain-computer interface|brain-computer interface
4942070|NCT01894802|Neural activity|neural activity
4942071|NCT01894802|Sensory stimulation|sensory stimulation
4942072|NCT01894802|Microstimulation|microstimulation
4942073|NCT01894789|myocardial blood flow|myocardial blood flow
4942074|NCT01894789|myocardial perfusion imaging|myocardial perfusion imaging
4942075|NCT01894789|myocardial blood flow reserve|myocardial blood flow reserve
4942076|NCT01894789|positron emission tomography|positron emission tomography
4942077|NCT01894789|adenosine|adenosine
4942078|NCT01894789|ticagrelor|ticagrelor
4942079|NCT01894789|clopidogrel|clopidogrel
4942080|NCT01894776|healthy volunteers|healthy volunteers
4942081|NCT01894763|esophagus|esophagus
4942082|NCT01894763|cancer|cancer
4942083|NCT01894750|Heart Failure|heart failure
4942084|NCT01894750|Self-Care|self-care
4942085|NCT01894685|Colorectal|colorectal
4942086|NCT01894685|Adenoma|adenoma
4942087|NCT01894685|Recurrence|recurrence
4942088|NCT01894685|Mesalazine|mesalazine
4942089|NCT01894685|Chemoprevention|chemoprevention
4942090|NCT01894672|LGX818|lgx818
4942091|NCT01894672|BRAF Inhibitor|braf inhibitor
4942092|NCT01894672|Stage IV melanoma|stage iv melanoma
4942093|NCT01894672|unresectable stage III melanoma|unresectable stage iii melanoma
4942094|NCT01894672|BRAFV600 mutation|brafv600 mutation
4942095|NCT01894672|13-053|13-053
4942096|NCT01894633|Prophylactic Cranial Irradiation|prophylactic cranial irradiation
4942097|NCT01894633|Metastasis|metastasis
4942098|NCT01894633|Cloroquine|cloroquine
4942099|NCT01894620|Alzheimer's|alzheimer's
4942100|NCT01894620|rTMS|rtms
4942101|NCT01894620|sleep quality|sleep quality
4942102|NCT01894620|dementia|dementia
4942103|NCT01894620|memory|memory
4942104|NCT01894607|Kidney Cancer|kidney cancer
4942105|NCT01894607|Renal Mass|renal mass
4942106|NCT01894607|Open partial nephrectomy|open partial nephrectomy
4942107|NCT01894607|Ultrasound-guided surgery|ultrasound-guided surgery
4942108|NCT01894607|DEFINITY|definity
4942109|NCT01894607|Contrast agent|contrast agent
4942110|NCT01894607|Phone call|phone call
4942111|NCT01894594|Sickle cell disease|sickle cell disease
4942112|NCT01894594|Chronic kidney disease|chronic kidney disease
4942113|NCT01894594|Bicarbonate therapy|bicarbonate therapy
4942114|NCT01894555|Platelet Transcriptome|platelet transcriptome
4942115|NCT01894555|Coronary Artery Disease|coronary artery disease
4942116|NCT01894555|Myocardial Ischemia|myocardial ischemia
4942117|NCT01894555|Coronary Disease|coronary disease
4942118|NCT01894555|Heart Diseases|heart diseases
4942119|NCT01894555|Cardiovascular Diseases|cardiovascular diseases
4942120|NCT01894555|Arteriosclerosis|arteriosclerosis
4942121|NCT01894555|Arterial Occlusive Diseases|arterial occlusive diseases
4942122|NCT01894555|Vascular Diseases|vascular diseases
4942123|NCT01894555|Aspirin|aspirin
4942124|NCT01894529|ischemic stroke|ischemic stroke
4942125|NCT01894529|immune biomarkers|immune biomarkers
4942126|NCT01894529|stroke-associated infection|stroke-associated infection
4942127|NCT01894529|functional outcome|functional outcome
4942128|NCT01894529|prediction|prediction
4942129|NCT01894490|Gastrointestinal surgery, complications, length of hospital stay, mortality|gastrointestinal surgery, complications, length of hospital stay, mortality
4942130|NCT01894464|truancy|truancy
4942131|NCT01894464|attendance|attendance
4942132|NCT01894464|education|education
4942133|NCT01894464|primary school|primary school
4942134|NCT01894464|elementary school|elementary school
4942135|NCT01894451|Inflammatory Breast Carcinoma|inflammatory breast carcinoma
4942136|NCT01894451|89Zr-bevacizumab|89zr-bevacizumab
4942137|NCT01894438|NAFLD|nafld
4942138|NCT01894438|NASH|nash
4942139|NCT01894438|Mediterranean diet|mediterranean diet
4942140|NCT01894438|Mediterranean lifestyle|mediterranean lifestyle
4942141|NCT01894425|Medically assisted procreation|medically assisted procreation
4942142|NCT01894425|Assisted reproductive technology|assisted reproductive technology
4942143|NCT01894425|Human papilloma virus|human papilloma virus
4942144|NCT01894399|HM61713|hm61713
4942145|NCT01894399|pharmacokinetics|pharmacokinetics
4942146|NCT01894399|Phase I|phase i
4942147|NCT01894399|healthy|healthy
4942148|NCT01894399|olmutinib|olmutinib
4942149|NCT01894386|GW642444 (Vilanterol)|gw642444 (vilanterol)
4942150|NCT01894386|GSK573719 (Umeclidinium)|gsk573719 (umeclidinium)
4942151|NCT01894386|GW685698 (Fluticasone Furoate)|gw685698 (fluticasone furoate)
4942152|NCT01894386|pharmacokinetics|pharmacokinetics
4942153|NCT01894386|Healthy subjects|healthy subjects
4942154|NCT01894360|Pharmacokinetics|pharmacokinetics
4942155|NCT01894360|Phase 1|phase 1
4942156|NCT01894360|Healthy Subjects|healthy subjects
4942157|NCT01894360|Comparability|comparability
4942158|NCT01894360|Belimumab|belimumab
4942159|NCT01894347|Colistin, MDR, inhalative therapy|colistin, mdr, inhalative therapy
4942160|NCT01894334|Aortic dissection|aortic dissection
4942161|NCT01894334|acute lung injury|acute lung injury
4942162|NCT01894334|injury mechanism|injury mechanism
4942163|NCT01894334|early intervention|early intervention
4942164|NCT01894321|Acute cholecystitis|acute cholecystitis
4942165|NCT01894321|Elderly|elderly
4942166|NCT01894321|Critically ill patients|critically ill patients
4942167|NCT01894321|Surgical high risk|surgical high risk
4942168|NCT01894321|Percutaneous cholecystostomy|percutaneous cholecystostomy
4942169|NCT01894321|Cholecystectomy|cholecystectomy
4942170|NCT01894308|Male Hormone Replacement|male hormone replacement
4942171|NCT01894308|Multiple Dose|multiple dose
4942172|NCT01894308|Single Period|single period
4942173|NCT01894308|Phase II|phase ii
4942174|NCT01894308|Dose Ranging|dose ranging
4942175|NCT01894308|Adult Male Subjects|adult male subjects
4942176|NCT01894308|Testosterone Replacement|testosterone replacement
4942177|NCT01894295|Vitamin D analogues|vitamin d analogues
4942178|NCT01894295|Resting Metabolic rate|resting metabolic rate
4942179|NCT01894295|obesity|obesity
4942180|NCT01894282|Chronic Lower Back Pain|chronic lower back pain
4942181|NCT01894282|Manual Therapy|manual therapy
4942182|NCT01894282|Cognitive Behavioral Therapy|cognitive behavioral therapy
4942183|NCT01894256|oncology,|oncology,
4942184|NCT01894256|cancer,|cancer,
4942185|NCT01894256|neoplasm,|neoplasm,
4942186|NCT01894256|anticancer drug,|anticancer drug,
4942187|NCT01894256|pharmacokinetics,|pharmacokinetics,
4942188|NCT01894256|area under curve,|area under curve,
4942189|NCT01894256|olaparib,|olaparib,
4942190|NCT01894256|solid tumour,|solid tumour,
4942191|NCT01894256|mild renal impairment,|mild renal impairment,
4942192|NCT01894256|moderate renal impairment|moderate renal impairment
4942193|NCT01894243|oncology,|oncology,
4942194|NCT01894243|cancer,|cancer,
4942195|NCT01894243|neoplasm,|neoplasm,
4942196|NCT01894243|anticancer drug,|anticancer drug,
4942197|NCT01894243|pharmacokinetics,|pharmacokinetics,
4942198|NCT01894243|area under curve,|area under curve,
4942199|NCT01894243|olaparib,|olaparib,
4942200|NCT01894243|solid tumour,|solid tumour,
4942201|NCT01894243|mild hepatic impairment,|mild hepatic impairment,
4942202|NCT01894243|moderate hepatic impairment|moderate hepatic impairment
4942203|NCT01894230|high cholesterol|high cholesterol
4942204|NCT01894230|genetic testing|genetic testing
4942205|NCT01894230|medication adherence|medication adherence
4942206|NCT01894230|statins|statins
4942207|NCT01894230|Adverse Effects|adverse effects
4942208|NCT01894230|pharmacogenetics|pharmacogenetics
4942209|NCT01894217|high cholesterol|high cholesterol
4942210|NCT01894217|genetic testing|genetic testing
4942211|NCT01894217|medication adherence|medication adherence
4942212|NCT01894217|statins|statins
4942213|NCT01894217|Adverse Effects|adverse effects
4942214|NCT01894217|Pharmacogenetic|pharmacogenetic
4942215|NCT01894204|HTTPE|httpe
4942216|NCT01894204|Idiopathic Pulmonary embolism|idiopathic pulmonary embolism
4942217|NCT01894191|adenoma detection rate|adenoma detection rate
4942218|NCT01894191|colonoscopy|colonoscopy
4942219|NCT01894191|water exchange|water exchange
4942220|NCT01894165|molybdenum cofactor deficiency (MoCD)|molybdenum cofactor deficiency (mocd)
4942221|NCT01894165|deficiency of activity of molybdenum-dependent enzymes|deficiency of activity of molybdenum-dependent enzymes
4942222|NCT01894152|XIENCE PRIME EECSS|xience prime eecss
4942223|NCT01894152|XIENCE V EECSS|xience v eecss
4942224|NCT01894152|XIENCE PRIME|xience prime
4942225|NCT01894152|SPIRIT PRIME|spirit prime
4942226|NCT01894152|XIENCE PRIME SV (Small Vessel)|xience prime sv (small vessel)
4942227|NCT01894152|XIENCE PRIME LL (Long Lesion)|xience prime ll (long lesion)
4942228|NCT01894152|Coronary Artery Disease|coronary artery disease
4942229|NCT01894152|Coronary Heart Disease|coronary heart disease
4942230|NCT01894152|Cardiovascular Disease|cardiovascular disease
4942231|NCT01894152|Myocardial Infarction|myocardial infarction
4942232|NCT01894152|Stent Thrombosis|stent thrombosis
4942233|NCT01894139|Gestational weight gain|gestational weight gain
4942234|NCT01894139|Obese women|obese women
4942235|NCT01894139|Fetal programming|fetal programming
4942236|NCT01894139|Metabolic disorders|metabolic disorders
4942237|NCT01894139|Development of obesity|development of obesity
4942238|NCT01894139|Development og overweight|development og overweight
4942239|NCT01894139|Complications during pregnancy and birth|complications during pregnancy and birth
4942240|NCT01894113|interstitial lung disease|interstitial lung disease
4942241|NCT01894113|transbronchial biopsy|transbronchial biopsy
4942242|NCT01894113|cryobiopsy|cryobiopsy
4942243|NCT01894074|Subfertility|subfertility
4942244|NCT01894074|Anovulatory|anovulatory
4942245|NCT01894074|Obese|obese
4942246|NCT01894074|Women|women
4942247|NCT01894061|adult giant cell glioblastoma|adult giant cell glioblastoma
4942248|NCT01894061|adult glioblastoma|adult glioblastoma
4942249|NCT01894061|adult gliosarcoma|adult gliosarcoma
4942250|NCT01894061|recurrent adult brain tumor|recurrent adult brain tumor
4942251|NCT01894061|Bevacizumab-naive|bevacizumab-naive
4942252|NCT01894061|NovoTTF-100A|novottf-100a
4942253|NCT01894048|asthma control|asthma control
4942254|NCT01894048|small airways|small airways
4942255|NCT01894048|extra-fine particle inhaled corticosteroids|extra-fine particle inhaled corticosteroids
4942256|NCT01894035|Pulmonary Hypertension|pulmonary hypertension
4942257|NCT01894035|Ventavis|ventavis
4942258|NCT01894035|Patient compliance|patient compliance
4942259|NCT01894022|Inoperable chronic thromboembolic pulmonary hypertension, endothelin receptor antagonist|inoperable chronic thromboembolic pulmonary hypertension, endothelin receptor antagonist
4942260|NCT01894009|Osteopathic manipulation|osteopathic manipulation
4942261|NCT01894009|Exercise therapy|exercise therapy
4942262|NCT01894009|Pregnancy pelvic girdle pain|pregnancy pelvic girdle pain
4942263|NCT01893996|rheumatoid|rheumatoid
4942264|NCT01893996|arthritis|arthritis
4942265|NCT01893996|cardiovascular|cardiovascular
4942266|NCT01893996|adalimumab|adalimumab
4942268|NCT01893996|biologic|biologic
4942269|NCT01893983|Mental Health|mental health
4942270|NCT01893983|Veterans Health|veterans health
4942271|NCT01893983|Rural|rural
4942272|NCT01893983|Motivational Interviewing|motivational interviewing
4942273|NCT01893957|breast cancer|breast cancer
4942274|NCT01893957|physical therapy|physical therapy
4942275|NCT01893957|electrical stimulation|electrical stimulation
4942276|NCT01893957|tactile sensitivity|tactile sensitivity
4942277|NCT01893957|flow blood|flow blood
4942278|NCT01893944|Breast cancer|breast cancer
4942279|NCT01893944|vibratory therapy|vibratory therapy
4942280|NCT01893944|virtual reality|virtual reality
4942281|NCT01893931|Geriatrics|geriatrics
4942282|NCT01893931|Emergency Medicine|emergency medicine
4942283|NCT01893931|Care Transitions|care transitions
4942284|NCT01893918|Smoking|smoking
4942285|NCT01893918|Dyspnea|dyspnea
4942286|NCT01893892|Basal Cell Carcinoma|basal cell carcinoma
4942287|NCT01893892|Gorlin syndrome|gorlin syndrome
4942288|NCT01893892|Erivedge|erivedge
4942289|NCT01893892|Basal Cell Nevus Syndrome|basal cell nevus syndrome
4942290|NCT01893853|dehydration|dehydration
4942291|NCT01893853|fluid balance|fluid balance
4942292|NCT01893853|exercise|exercise
4942293|NCT01893853|heat|heat
4942294|NCT01893853|body weight|body weight
4942295|NCT01893853|performance|performance
4942296|NCT01893827|Naltrexone|naltrexone
4942297|NCT01893827|Extended-release naltrexone|extended-release naltrexone
4942298|NCT01893827|Oral naltrexone|oral naltrexone
4942299|NCT01893827|Vivitrol|vivitrol
4942300|NCT01893827|XR-NTX|xr-ntx
4942301|NCT01893827|alcohol dependence|alcohol dependence
4942302|NCT01893827|primary care|primary care
4942303|NCT01893827|Medical Management|medical management
4942304|NCT01893801|pancreatic cancer|pancreatic cancer
4942305|NCT01893801|pancreatic adenocarcinoma|pancreatic adenocarcinoma
4942306|NCT01893801|Stage IV pancreatic cancer|stage iv pancreatic cancer
4942307|NCT01893801|pancreas|pancreas
4942308|NCT01893801|pancreatic|pancreatic
4942309|NCT01893788|hypertension|hypertension
4942310|NCT01893788|left ventricular hypertrophy|left ventricular hypertrophy
4942311|NCT01893788|renin angiotensin system|renin angiotensin system
4942312|NCT01893788|aldosterone|aldosterone
4942313|NCT01893788|aliskiren|aliskiren
4942314|NCT01893788|eplerenone|eplerenone
4942315|NCT01893788|P3NP|p3np
4942316|NCT01893775|Anti CD 122|anti cd 122
4942317|NCT01893775|Monoclonal Antibody Therapy|monoclonal antibody therapy
4942318|NCT01893775|Autoimmune Inflammatory Enteropathy|autoimmune inflammatory enteropathy
4942319|NCT01893762|neutrophil|neutrophil
4942320|NCT01893762|exercise|exercise
4942321|NCT01893762|URTI|urti
4942322|NCT01893762|Innate|innate
4942323|NCT01893762|Immune|immune
4942324|NCT01893749|depression|depression
4942325|NCT01893749|prevention|prevention
4942326|NCT01893749|teen|teen
4942327|NCT01893749|at risk|at risk
4942328|NCT01893749|internet|internet
4942329|NCT01893736|Breastfeeding|breastfeeding
4942330|NCT01893736|professional support|professional support
4942331|NCT01893736|postnatal|postnatal
4942332|NCT01893736|interventions|interventions
4942333|NCT01893736|exclusive breastfeeding|exclusive breastfeeding
4942334|NCT01893736|randomized controlled trial|randomized controlled trial
4942335|NCT01893723|autonomous nervous system monitoring|autonomous nervous system monitoring
4942336|NCT01893723|analgesia nociception balance|analgesia nociception balance
4942337|NCT01893723|remifentanil|remifentanil
4942338|NCT01893723|analgesia nociception index|analgesia nociception index
4942339|NCT01893723|hemodynamic reactivity|hemodynamic reactivity
4942340|NCT01893710|peritoneal dialysis|peritoneal dialysis
4942341|NCT01893710|parietal peritoneum|parietal peritoneum
4942342|NCT01893710|omentum|omentum
4942343|NCT01893710|children|children
4942344|NCT01893684|protein|protein
4942345|NCT01893684|physical function|physical function
4942346|NCT01893684|muscle quality|muscle quality
4942347|NCT01893684|fatigue|fatigue
4942348|NCT01893684|weight loss|weight loss
4942349|NCT01893671|LASIK|lasik
4942350|NCT01893671|corneal power|corneal power
4942351|NCT01893671|astigmatism|astigmatism
4942352|NCT01893671|HOA|hoa
4942353|NCT01893671|Optical Coherence Tomography|optical coherence tomography
4942354|NCT01893658|Interstitial Nephritis|interstitial nephritis
4942355|NCT01893658|Nephritis|nephritis
4942356|NCT01893658|Tubulointerstitial|tubulointerstitial
4942357|NCT01893658|Renal disease|renal disease
4942358|NCT01893658|Kidney|kidney
4942359|NCT01893645|Pronto-7|pronto-7
4942360|NCT01893645|SpHb|sphb
4942361|NCT01893645|Obstetric patients|obstetric patients
4942362|NCT01893632|Benzodiazepines|benzodiazepines
4942363|NCT01893632|clonazepam|clonazepam
4942364|NCT01893632|alprazolam|alprazolam
4942365|NCT01893632|Klonopin|klonopin
4942366|NCT01893632|Xanax|xanax
4942367|NCT01893632|diazepam|diazepam
4942368|NCT01893632|Valium|valium
4942369|NCT01893632|lorazepam|lorazepam
4942370|NCT01893632|Ativan|ativan
4942371|NCT01893619|Chronic fatigue syndrome|chronic fatigue syndrome
4942372|NCT01893619|Karnofsky score|karnofsky score
4942373|NCT01893619|supplements|supplements
4942374|NCT01893606|diarrhea|diarrhea
4942375|NCT01893606|abdominal pain|abdominal pain
4942376|NCT01893593|Cardiovascular risk|cardiovascular risk
4942377|NCT01893593|lifestyle change|lifestyle change
4942378|NCT01893593|blood pressure|blood pressure
4942379|NCT01893593|body mass index|body mass index
4942380|NCT01893593|tobacco|tobacco
4942381|NCT01893580|Cancer|cancer
4942382|NCT01893580|Rehabilitation|rehabilitation
4942383|NCT01893580|Exercise|exercise
4942384|NCT01893580|Lung cancer|lung cancer
4942385|NCT01893580|NSCLC|nsclc
4942386|NCT01893541|CIRRHOTIC|cirrhotic
4942387|NCT01893541|VARICEAL BLEEDING|variceal bleeding
4942388|NCT01893541|PRIMARY PROPHYLAXIS|primary prophylaxis
4942389|NCT01893489|positron emission tomography|positron emission tomography
4942390|NCT01893489|macrophage|macrophage
4942391|NCT01893489|neomannosyl human serum albumin|neomannosyl human serum albumin
4942392|NCT01893476|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
4942393|NCT01893476|implementation|implementation
4942394|NCT01893463|hemorrhage control|hemorrhage control
4942395|NCT01893463|wound closure|wound closure
4942396|NCT01893450|Graves ophthalmopathy|graves ophthalmopathy
4942397|NCT01893450|Exophthalmos|exophthalmos
4942398|NCT01893450|Proptosis|proptosis
4942399|NCT01893450|Quality of life|quality of life
4942400|NCT01893424|Biological Availability|biological availability
4942401|NCT01893424|Pharmacokinetics|pharmacokinetics
4942402|NCT01893385|vitamin D|vitamin d
4942403|NCT01893385|supplementation|supplementation
4942404|NCT01893385|immunocompetente cells, immune system|immunocompetente cells, immune system
4942405|NCT01893385|influenza vaccine|influenza vaccine
4942406|NCT01893385|elderly|elderly
4942407|NCT01893372|Leukemia|leukemia
4942408|NCT01893372|Myelodysplastic syndrome|myelodysplastic syndrome
4942409|NCT01893372|MDS|mds
4942410|NCT01893372|Overall response rate|overall response rate
4942411|NCT01893372|ORR|orr
4942412|NCT01893372|Eltrombopag|eltrombopag
4942413|NCT01893372|Promacta|promacta
4942414|NCT01893372|Hypomethylating Agent|hypomethylating agent
4942415|NCT01893359|hyperopia|hyperopia
4942416|NCT01893359|hyperopic astigmatism|hyperopic astigmatism
4942417|NCT01893359|cross-linking|cross-linking
4942418|NCT01893346|Ceftazidime, Avibactam, Anti-Infectives|ceftazidime, avibactam, anti-infectives
4942419|NCT01893333|cervical cancer|cervical cancer
4942420|NCT01893333|nerve sparing radical hysterectomy|nerve sparing radical hysterectomy
4942421|NCT01893320|Leukemia|leukemia
4942422|NCT01893320|Acute Myeloid Leukemia|acute myeloid leukemia
4942423|NCT01893320|AML|aml
4942424|NCT01893320|High-risk Myelodysplastic Syndrome|high-risk myelodysplastic syndrome
4942425|NCT01893320|MDS|mds
4942426|NCT01893320|Chronic Myelomonocytic Leukemia|chronic myelomonocytic leukemia
4942427|NCT01893320|CMM|cmm
4942428|NCT01893320|Maximum tolerated dose|maximum tolerated dose
4942429|NCT01893320|MTD|mtd
4942430|NCT01893320|Vosaroxin|vosaroxin
4942431|NCT01893320|Decitabine|decitabine
4942432|NCT01893320|Dacogen|dacogen
4942433|NCT01893307|Head And Neck Cancer|head and neck cancer
4942434|NCT01893307|Oropharyngeal Cancer|oropharyngeal cancer
4942435|NCT01893307|Squamous cell carcinoma of the oropharynx|squamous cell carcinoma of the oropharynx
4942436|NCT01893307|Acute and late toxicity|acute and late toxicity
4942437|NCT01893307|Intensity modulated photon therapy|intensity modulated photon therapy
4942438|NCT01893307|IMRT|imrt
4942439|NCT01893307|Intensity modulated proton therapy|intensity modulated proton therapy
4942440|NCT01893307|IMPT|impt
4942441|NCT01893307|Modified barium swallow|modified barium swallow
4942442|NCT01893307|MBS|mbs
4942443|NCT01893307|Questionnaires|questionnaires
4942444|NCT01893307|Surveys|surveys
4942445|NCT01893229|Bipolar disorder|bipolar disorder
4942446|NCT01893229|Comparative Effectiveness Research|comparative effectiveness research
4942447|NCT01893229|Therapeutics|therapeutics
4942448|NCT01893229|Patient Dropouts|patient dropouts
4942449|NCT01893216|anxiety|anxiety
4942450|NCT01893216|depression|depression
4942451|NCT01893216|sexual dysfunction|sexual dysfunction
4942452|NCT01893216|infertility|infertility
4942453|NCT01893190|Ruptured saccular aneurysm|ruptured saccular aneurysm
4942454|NCT01893190|nimodipine|nimodipine
4942455|NCT01893190|safety|safety
4942456|NCT01893190|tolerability|tolerability
4942457|NCT01893190|Subarachnoid hemorrhage|subarachnoid hemorrhage
4942458|NCT01893177|Influenza|influenza
4942459|NCT01893177|Virus|virus
4942460|NCT01893177|Vaccination|vaccination
4942461|NCT01893177|Inflexal V|inflexal v
4942462|NCT01893164|cubital tunnel syndrome|cubital tunnel syndrome
4942463|NCT01893164|simple decompression|simple decompression
4942464|NCT01893164|anterior subcutaneous transposition of ulnar nerve|anterior subcutaneous transposition of ulnar nerve
4942465|NCT01893164|anterior intramuscular transposition of ulnar nerve|anterior intramuscular transposition of ulnar nerve
4942466|NCT01893164|severity scale|severity scale
4942467|NCT01893151|Iguratimod|iguratimod
4942468|NCT01893151|MRI|mri
4942469|NCT01893151|Rheumatoid Arthritis|rheumatoid arthritis
4942470|NCT01893138|Urinary Incontinence, Stress|urinary incontinence, stress
4942471|NCT01893138|Tissue Therapy (Cell Therapy)|tissue therapy (cell therapy)
4942472|NCT01893138|Transplantation, Autologous|transplantation, autologous
4942473|NCT01893060|Prematurity|prematurity
4942474|NCT01893060|Central line care|central line care
4942475|NCT01893060|Umbilical line colonization|umbilical line colonization
4942476|NCT01893060|Colonization|colonization
4942477|NCT01893060|Newborn Intensive Care Unit|newborn intensive care unit
4942478|NCT01893060|Neonatal Intensive Care Unit|neonatal intensive care unit
4942479|NCT01893047|breast milk production|breast milk production
4942480|NCT01893034|Femoroacetabular Impingement|femoroacetabular impingement
4942481|NCT01893034|Arthroscopy|arthroscopy
4942482|NCT01893034|Physiotherapy|physiotherapy
4942483|NCT01893034|Randomised Controlled Trial|randomised controlled trial
4942484|NCT01893008|Esophageal cancer|esophageal cancer
4942485|NCT01893008|Surgery|surgery
4942486|NCT01892995|suicide|suicide
4942487|NCT01892995|ketamine|ketamine
4942488|NCT01892995|low-dose ketamine|low-dose ketamine
4942489|NCT01892995|suicidal ideations|suicidal ideations
4942490|NCT01892995|emergency department|emergency department
4942491|NCT01892982|Maternal Depression|maternal depression
4942492|NCT01892982|Preterm Birth|preterm birth
4942493|NCT01892982|Preterm Outcomes|preterm outcomes
4942494|NCT01892982|Child Development|child development
4942495|NCT01892917|International|international
4942496|NCT01892917|Multicenter|multicenter
4942497|NCT01892917|Observational registry|observational registry
4942498|NCT01892917|Orsiro Drug Eluting Stent (DES)|orsiro drug eluting stent (des)
4942499|NCT01892917|Stenting|stenting
4942500|NCT01892917|Treatment of Coronary Artery Disease|treatment of coronary artery disease
4942501|NCT01892917|Coronary revascularization|coronary revascularization
4942502|NCT01892917|Percutaneous Coronary Intervention|percutaneous coronary intervention
4942503|NCT01892917|STEMI|stemi
4942504|NCT01892917|NSTEMI|nstemi
4942505|NCT01892917|Ischemia|ischemia
4942506|NCT01892917|Subgroups|subgroups
4942507|NCT01892917|Acute Myocardial Infarction|acute myocardial infarction
4942508|NCT01892917|Diabetes|diabetes
4942509|NCT01892917|Small Vessels|small vessels
4942510|NCT01892917|Chronic Total Occlusion (CTO)|chronic total occlusion (cto)
4942511|NCT01892904|YAZ|yaz
4942512|NCT01892904|Flexible regimen|flexible regimen
4942513|NCT01892904|Drospirenone|drospirenone
4942514|NCT01892904|Ethinylestradiol Betadex|ethinylestradiol betadex
4942515|NCT01892904|Dysmenorrhea|dysmenorrhea
4942516|NCT01892904|Japanese patients|japanese patients
4942517|NCT01892891|Healthy|healthy
4942518|NCT01892891|Subjects|subjects
4942519|NCT01892891|Safety|safety
4942520|NCT01892891|Tolerability|tolerability
4942521|NCT01892891|VBY036|vby036
4942522|NCT01892891|maximum|maximum
4942523|NCT01892891|pharmacodynamic|pharmacodynamic
4942524|NCT01892891|pharmacokinetic|pharmacokinetic
4942525|NCT01892865|Operating room utilization|operating room utilization
4942526|NCT01892852|Acupuncture|acupuncture
4942527|NCT01892852|Traditional Korean Medicine|traditional korean medicine
4942528|NCT01892826|FET|fet
4942529|NCT01892826|Blastocyst|blastocyst
4942530|NCT01892826|natural cycle|natural cycle
4942531|NCT01892826|hCG|hcg
4942532|NCT01892826|Spontaneous LH pic|spontaneous lh pic
4942533|NCT01892813|Nicotine dependence|nicotine dependence
4942534|NCT01892813|Smoking cessation|smoking cessation
4942535|NCT01892813|Telehealth|telehealth
4942536|NCT01892813|Alcohol use|alcohol use
4942537|NCT01892813|Depression|depression
4942538|NCT01892813|Body weight|body weight
4942539|NCT01892800|Lung Cancer|lung cancer
4942540|NCT01892800|Ventricular function, Right|ventricular function, right
4942541|NCT01892787|Asthma|asthma
4942542|NCT01892787|Small airways|small airways
4942543|NCT01892787|Extra fine particle long-acting beta agonists|extra fine particle long-acting beta agonists
4942544|NCT01892774|LSPAF|lspaf
4942545|NCT01892774|asymptomatic|asymptomatic
4942546|NCT01892774|exercise tolerance|exercise tolerance
4942547|NCT01892761|mycophenolate mofetil|mycophenolate mofetil
4942548|NCT01892761|mycophenolic acid|mycophenolic acid
4942549|NCT01892761|MPA|mpa
4942550|NCT01892761|MMF|mmf
4942551|NCT01892761|Pharmacokinetics|pharmacokinetics
4942552|NCT01892761|renal transplantation|renal transplantation
4942553|NCT01892748|Lupus|lupus
4942554|NCT01892748|Juvenile|juvenile
4942555|NCT01892748|Cholecalciferol|cholecalciferol
4942556|NCT01892748|Disease activity|disease activity
4942557|NCT01892748|Bone Mass|bone mass
4942558|NCT01892748|Fatigue|fatigue
4942559|NCT01892748|Safety|safety
4942560|NCT01892722|pediatric|pediatric
4942561|NCT01892722|multiple sclerosis|multiple sclerosis
4942562|NCT01892709|acute|acute
4942563|NCT01892709|pain|pain
4942564|NCT01892709|emergency department|emergency department
4942565|NCT01892709|hydromorphone|hydromorphone
4942566|NCT01892709|in ER|in er
4942567|NCT01892696|inspiratory flow pattern|inspiratory flow pattern
4942568|NCT01892696|mechanical ventilation|mechanical ventilation
4942569|NCT01892696|cardiac preload|cardiac preload
4942570|NCT01892696|arterial pulse pressure variation|arterial pulse pressure variation
4942571|NCT01892696|inferior vena cava collapsibility|inferior vena cava collapsibility
4942572|NCT01892683|propofol|propofol
4942573|NCT01892683|exhaled|exhaled
4942574|NCT01892683|monitoring|monitoring
4942575|NCT01892683|anesthesia|anesthesia
4942576|NCT01892670|Blood|blood
4942577|NCT01892670|Whole blood|whole blood
4942578|NCT01892670|Cold-storage|cold-storage
4942579|NCT01892670|Filtration|filtration
4942580|NCT01892670|Transfusion|transfusion
4942581|NCT01892670|Platelet-function|platelet-function
4942582|NCT01892657|Cetaphil Daily Facial Moisturizer with SPF 50+|cetaphil daily facial moisturizer with spf 50+
4942583|NCT01892657|Hypoallergenicity|hypoallergenicity
4942584|NCT01892657|Skin Irritation|skin irritation
4942585|NCT01892644|Hemochromatosis|hemochromatosis
4942586|NCT01892644|Myelodysplastic syndromes|myelodysplastic syndromes
4942587|NCT01892644|Iron overload|iron overload
4942588|NCT01892644|Deferasirox|deferasirox
4942589|NCT01892644|Chelation therapy|chelation therapy
4942590|NCT01892644|Venesection|venesection
4942591|NCT01892644|Phlebotomy|phlebotomy
4942592|NCT01892644|Ferritin|ferritin
4942593|NCT01892644|Transfusional siderosis|transfusional siderosis
4942594|NCT01892631|Text messaging|text messaging
4942595|NCT01892605|Mozart K.448|mozart k.448
4942596|NCT01892605|first unprovoked seizure|first unprovoked seizure
4942597|NCT01892605|epileptiform discharges|epileptiform discharges
4942598|NCT01892605|music therapy|music therapy
4942599|NCT01892605|children|children
4942600|NCT01892592|Hypertension|hypertension
4942601|NCT01892592|African American|african american
4942602|NCT01892592|Health Disparities|health disparities
4942603|NCT01892592|Stroke|stroke
4942604|NCT01892592|Cardiovascular Disease|cardiovascular disease
4942605|NCT01892579|Agitation|agitation
4942606|NCT01892579|Dementia|dementia
4942607|NCT01892579|Alzheimer's Disease|alzheimer's disease
4942608|NCT01892579|Neuropsychiatric Behaviors|neuropsychiatric behaviors
4942609|NCT01892566|HIV|hiv
4942610|NCT01892566|mobile health|mobile health
4942611|NCT01892566|spirometry|spirometry
4942612|NCT01892553|Dyspnea|dyspnea
4942613|NCT01892553|Transcranial direct current stimulation (tDCS)|transcranial direct current stimulation (tdcs)
4942614|NCT01892553|Perception|perception
4942615|NCT01892527|Colorectal Cancer Metastatic|colorectal cancer metastatic
4942616|NCT01892527|wild type KRAS|wild type kras
4942617|NCT01892527|C-met overexpression|c-met overexpression
4942618|NCT01892527|Tivantinib|tivantinib
4942619|NCT01892527|Cetuximab|cetuximab
4942620|NCT01892514|osteonecrosis|osteonecrosis
4942621|NCT01892514|bone marrow concentrate|bone marrow concentrate
4942622|NCT01892514|demineralized bone matrix|demineralized bone matrix
4942623|NCT01892514|homologous lyophilized bone chips|homologous lyophilized bone chips
4942624|NCT01892514|autologous platelet rich fibrin|autologous platelet rich fibrin
4942625|NCT01892514|mesenchymal stromal cells|mesenchymal stromal cells
4942626|NCT01892501|Mediastinal lymphadenopathy|mediastinal lymphadenopathy
4942627|NCT01892501|PET CT to 18FDG|pet ct to 18fdg
4942628|NCT01892501|EUS|eus
4942629|NCT01892488|COPD|copd
4942630|NCT01892488|AE-COPD|ae-copd
4942631|NCT01892488|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
4942632|NCT01892488|acute exacerbations of Chronic obstructive pulmonary disease|acute exacerbations of chronic obstructive pulmonary disease
4942633|NCT01892475|Physical Activity|physical activity
4942634|NCT01892475|Incentives|incentives
4942635|NCT01892475|Mental Accounting|mental accounting
4942636|NCT01892475|Older adults|older adults
4942637|NCT01892436|Extension study, psoriatic arthritis, pre-filled syringe|extension study, psoriatic arthritis, pre-filled syringe
4942638|NCT01892397|intracranial supratentorial meningioma|intracranial supratentorial meningioma
4942639|NCT01892397|Atypical and Anaplastic Meningioma|atypical and anaplastic meningioma
4942640|NCT01892397|Optune (NovoTTF-100A)|optune (novottf-100a)
4942641|NCT01892397|13-067|13-067
4942642|NCT01892371|Leukemia|leukemia
4942643|NCT01892371|Acute Myeloid Leukemia|acute myeloid leukemia
4942644|NCT01892371|AML|aml
4942645|NCT01892371|Myelodysplastic Syndrome|myelodysplastic syndrome
4942646|NCT01892371|MDS|mds
4942647|NCT01892371|Quizartinib|quizartinib
4942648|NCT01892371|AC220|ac220
4942649|NCT01892371|ASP2689|asp2689
4942650|NCT01892371|Cytarabine|cytarabine
4942651|NCT01892371|Ara-C|ara-c
4942652|NCT01892371|Cytosar|cytosar
4942653|NCT01892371|DepoCyt|depocyt
4942654|NCT01892371|Cytosine arabinosine hydrochloride|cytosine arabinosine hydrochloride
4942655|NCT01892371|AZA|aza
4942656|NCT01892371|Vidaza|vidaza
4942657|NCT01892371|Azacitidine|azacitidine
4942658|NCT01892371|5-Azacytidine|5-azacytidine
4942659|NCT01892371|5-AZA|5-aza
4942660|NCT01892371|5-AZC|5-azc
4942661|NCT01892371|AZA-CR|aza-cr
4942662|NCT01892371|Ladakamycin|ladakamycin
4942663|NCT01892371|NSC-102816|nsc-102816
4942664|NCT01892371|Azacytidine|azacytidine
4942665|NCT01892371|Maximum tolerated dose|maximum tolerated dose
4942666|NCT01892371|MTD|mtd
4942667|NCT01892371|Overall response|overall response
4942668|NCT01892371|Complete remission|complete remission
4942669|NCT01892371|CR|cr
4942670|NCT01892371|Complete remission with incomplete blood count recovery|complete remission with incomplete blood count recovery
4942671|NCT01892371|Cri|cri
4942672|NCT01892371|Partial remission|partial remission
4942673|NCT01892371|PR|pr
4942674|NCT01892371|Hematologic improvement|hematologic improvement
4942675|NCT01892371|HI|hi
4942676|NCT01892358|injection drug use|injection drug use
4942677|NCT01892345|Neuromyelitis Optica|neuromyelitis optica
4942678|NCT01892345|Neuromyelitis Optica Spectrum Disorder|neuromyelitis optica spectrum disorder
4942679|NCT01892345|Devic's disease, Transverse Myelitis|devic's disease, transverse myelitis
4942680|NCT01892345|Optic Neuritis|optic neuritis
4942681|NCT01892345|relapse|relapse
4942682|NCT01892345|eculizumab|eculizumab
4942683|NCT01892345|soliris|soliris
4942684|NCT01892345|NMO-IgG|nmo-igg
4942685|NCT01892345|CNS Autoimmune Disorders|cns autoimmune disorders
4942686|NCT01892345|Demyelinating Disorders|demyelinating disorders
4942687|NCT01892345|NMO|nmo
4942688|NCT01892345|NMOSD|nmosd
4942689|NCT01892293|Multiple Myeloma|multiple myeloma
4942690|NCT01892293|Autologous stem cell transplantation|autologous stem cell transplantation
4942691|NCT01892293|Received initial treatment previously|received initial treatment previously
4942692|NCT01892267|PEGJ|pegj
4942693|NCT01892267|PEG-J|peg-j
4942694|NCT01892267|Percutaneous Endoscopic Gastrostomy|percutaneous endoscopic gastrostomy
4942695|NCT01892267|Feeding tube|feeding tube
4942696|NCT01892267|Gastroparesis|gastroparesis
4942697|NCT01892267|Acute pancreatitis|acute pancreatitis
4942698|NCT01892267|Stroke|stroke
4942699|NCT01892267|Respiratory failure|respiratory failure
4942700|NCT01892267|GERD|gerd
4942701|NCT01892267|Balloon|balloon
4942702|NCT01892267|Self-propelled|self-propelled
4942703|NCT01892254|incretin effect|incretin effect
4942704|NCT01892254|PCOS|pcos
4942705|NCT01892254|insulin resistance|insulin resistance
4942706|NCT01892254|OGTT|ogtt
4942707|NCT01892254|IIGI|iigi
4942708|NCT01892241|Chronic hepatitis B,Spontaneous Decline of HBV DNA,Peginterferon a-2a, entecavir|chronic hepatitis b,spontaneous decline of hbv dna,peginterferon a-2a, entecavir
4942709|NCT01892228|antiretroviral therapy|antiretroviral therapy
4942710|NCT01892228|education|education
4942711|NCT01892228|mortality|mortality
4942712|NCT01892215|Uterine incision.|uterine incision.
4942713|NCT01892215|Blunt transversal expansion.|blunt transversal expansion.
4942714|NCT01892215|Blunt cephalad-caudad expansion.|blunt cephalad-caudad expansion.
4942715|NCT01892189|Drug therapy|drug therapy
4942716|NCT01892176|coenzyme Q10, Parkinson disease, oxidative damage|coenzyme q10, parkinson disease, oxidative damage
4942717|NCT01892163|Diabetic macular edema, Ozurdex|diabetic macular edema, ozurdex
4942718|NCT01892137|Actinic Keratosis|actinic keratosis
4942719|NCT01892137|Histopathology|histopathology
4942720|NCT01892137|Reflectance Confocal Microscopy|reflectance confocal microscopy
4942721|NCT01892137|Local Skin Reaction|local skin reaction
4942722|NCT01892124|Motivational Interviewing|motivational interviewing
4942723|NCT01892124|Cognitive Therapy|cognitive therapy
4942724|NCT01892124|Community-Based Participatory Research|community-based participatory research
4942725|NCT01892124|Indians, North American|indians, north american
4942726|NCT01892111|SET|set
4942727|NCT01892111|infertility|infertility
4942728|NCT01892111|IVF/ICSI|ivf/icsi
4942729|NCT01892111|pregnancy|pregnancy
4942730|NCT01892098|Zinc|zinc
4942731|NCT01892098|Bone|bone
4942732|NCT01892098|Adolescents|adolescents
4942733|NCT01892098|Growth|growth
4942734|NCT01892085|Breast milk|breast milk
4942735|NCT01892085|lactogenesis stage two|lactogenesis stage two
4942736|NCT01892085|premature infant|premature infant
4942737|NCT01892085|insufficient milk supply|insufficient milk supply
4942738|NCT01892085|breast milk expression|breast milk expression
4942739|NCT01892072|hepatocellular carcinoma|hepatocellular carcinoma
4942740|NCT01892072|HCC|hcc
4942741|NCT01892072|VEGF signaling pathway|vegf signaling pathway
4942742|NCT01892059|renal tumour|renal tumour
4942743|NCT01892059|partial nephrectomy|partial nephrectomy
4942744|NCT01892059|laparoscope|laparoscope
4942745|NCT01892059|segmental renal artery clamping|segmental renal artery clamping
4942746|NCT01892046|Small Cell Lung Cancer|small cell lung cancer
4942747|NCT01892046|Non Small Cell Lung Cancer|non small cell lung cancer
4942748|NCT01892046|Hsp90|hsp90
4942749|NCT01892033|Posttraumatic Stress Disorder|posttraumatic stress disorder
4942750|NCT01892033|PTSD|ptsd
4942751|NCT01892033|Aerobic Exercise|aerobic exercise
4942752|NCT01892033|Women|women
4942753|NCT01892033|Veteran|veteran
4942754|NCT01892007|Hearing loss|hearing loss
4942755|NCT01892007|Hearing aid|hearing aid
4942756|NCT01892007|Speech intelligibility|speech intelligibility
4942757|NCT01892007|Speech perception|speech perception
4942758|NCT01892007|Cognitive training|cognitive training
4942759|NCT01892007|Working memory|working memory
4942760|NCT01892007|Working memory training|working memory training
4942761|NCT01891994|Cytokine|cytokine
4942762|NCT01891994|Hematopoiesis|hematopoiesis
4942763|NCT01891994|Autoimmunity|autoimmunity
4942764|NCT01891994|Thrombocytopenia|thrombocytopenia
4942765|NCT01891994|Neutropenia|neutropenia
4942766|NCT01891981|Leukemia|leukemia
4942767|NCT01891981|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
4942768|NCT01891981|ALL|all
4942769|NCT01891981|Relapsed and/or refractory|relapsed and/or refractory
4942770|NCT01891981|Moxetumomab Pasudotox|moxetumomab pasudotox
4942771|NCT01891981|Maximum tolerated dose|maximum tolerated dose
4942772|NCT01891981|MTD|mtd
4942773|NCT01891968|Leukemia|leukemia
4943024|NCT01891045|Clinical trial|clinical trial
4942774|NCT01891968|Myelodysplastic syndrome|myelodysplastic syndrome
4942775|NCT01891968|MDS|mds
4942776|NCT01891968|Low or intermediate-1|low or intermediate-1
4942777|NCT01891968|Bortezomib|bortezomib
4942778|NCT01891968|Velcade|velcade
4942779|NCT01891968|LDP-341|ldp-341
4942780|NCT01891968|MLN341|mln341
4942781|NCT01891968|PS-341|ps-341
4942782|NCT01891955|Diabetes mellitus type 2|diabetes mellitus type 2
4942783|NCT01891955|Cereals|cereals
4942784|NCT01891955|Dairy|dairy
4942785|NCT01891955|Dietary carbohydrates|dietary carbohydrates
4942786|NCT01891955|Dietary fiber|dietary fiber
4942787|NCT01891955|Food|food
4942788|NCT01891955|Metabolic syndrome|metabolic syndrome
4942789|NCT01891955|Satiety|satiety
4942790|NCT01891942|Normal|normal
4942791|NCT01891942|subjects|subjects
4942792|NCT01891929|Schizophrenia|schizophrenia
4942793|NCT01891929|Cognitive Remediation|cognitive remediation
4942794|NCT01891929|Working abilities and social functioning|working abilities and social functioning
4942795|NCT01891890|Pediatrics|pediatrics
4942796|NCT01891877|Sickle Cell Trait|sickle cell trait
4942797|NCT01891877|Football|football
4942798|NCT01891877|Sickling|sickling
4942799|NCT01891877|Heat Illness|heat illness
4942800|NCT01891877|SCT|sct
4942801|NCT01891851|Healthy|healthy
4942802|NCT01891851|Hepatitis C|hepatitis c
4942803|NCT01891851|TMC435350|tmc435350
4942804|NCT01891851|Ritonavir|ritonavir
4942805|NCT01891851|Pharmacokinetics|pharmacokinetics
4942806|NCT01891838|surgery|surgery
4942807|NCT01891838|transsphenoidal surgery|transsphenoidal surgery
4942808|NCT01891838|pituitary adenoma|pituitary adenoma
4942809|NCT01891838|mechanical ventilation|mechanical ventilation
4942810|NCT01891838|bleeding|bleeding
4942811|NCT01891825|Atrial fibrillation|atrial fibrillation
4942812|NCT01891825|Persistent atrial fibrillation|persistent atrial fibrillation
4942813|NCT01891825|Atrial fibrillation ablation|atrial fibrillation ablation
4942814|NCT01891812|Sickle cell disease|sickle cell disease
4942815|NCT01891812|Vaso-occlusive crisis|vaso-occlusive crisis
4942816|NCT01891812|Nitrous oxide|nitrous oxide
4942817|NCT01891812|Emergency department|emergency department
4942818|NCT01891799|HIV/AIDS|hiv/aids
4942819|NCT01891799|PMTCT|pmtct
4942820|NCT01891799|Option B+|option b+
4942821|NCT01891799|Swaziland|swaziland
4942822|NCT01891773|Asthma|asthma
4942823|NCT01891773|Inhaled Corticosteroids|inhaled corticosteroids
4942824|NCT01891773|School Nurses|school nurses
4942825|NCT01891747|gliomas|gliomas
4942826|NCT01891734|Veterans|veterans
4942827|NCT01891734|Health Services|health services
4942828|NCT01891734|Mental Health|mental health
4942829|NCT01891734|Technology|technology
4942830|NCT01891734|Primary Health Care|primary health care
4942831|NCT01891734|Psychotherapy|psychotherapy
4942832|NCT01891721|cognitive training|cognitive training
4942833|NCT01891721|schizophrenia|schizophrenia
4942834|NCT01891721|mismatch negativity|mismatch negativity
4942835|NCT01891721|cognition|cognition
4942836|NCT01891721|functional capacity|functional capacity
4942837|NCT01891721|EEG|eeg
4942838|NCT01891682|Methionine Metabolism|methionine metabolism
4942839|NCT01891682|Parenteral Nutrition|parenteral nutrition
4942840|NCT01891682|Pediatric|pediatric
4942841|NCT01891682|Pediatrics|pediatrics
4942842|NCT01891682|Sepsis|sepsis
4942843|NCT01891682|Observational Study|observational study
4942844|NCT01891669|ADC 5T4|adc 5t4
4942845|NCT01891669|PF-06263507|pf-06263507
4942846|NCT01891669|solid tumors|solid tumors
4942847|NCT01891669|lung cancer|lung cancer
4942848|NCT01891669|breast cancer|breast cancer
4942849|NCT01891669|ovarian cancer|ovarian cancer
4942850|NCT01891669|cancer|cancer
4942851|NCT01891669|tumors|tumors
4942852|NCT01891669|neoplasm metastasis|neoplasm metastasis
4942853|NCT01891656|Motivational Interviewing|motivational interviewing
4942854|NCT01891656|Internet|internet
4942855|NCT01891656|Treatment|treatment
4942856|NCT01891656|Substance-Related Disorders|substance-related disorders
4942857|NCT01891656|Criminal Justice|criminal justice
4942858|NCT01891630|African American|african american
4942859|NCT01891630|Asthma|asthma
4942860|NCT01891617|exercise|exercise
4942861|NCT01891617|high carbohydrate and high fat diets|high carbohydrate and high fat diets
4942862|NCT01891617|insulin|insulin
4942863|NCT01891617|gut peptides|gut peptides
4942864|NCT01891617|appetite|appetite
4942865|NCT01891617|metabolism|metabolism
4942866|NCT01891617|glucose|glucose
4942867|NCT01891591|Obesity|obesity
4942868|NCT01891591|Gastric bypass|gastric bypass
4942869|NCT01891591|Energy balance|energy balance
4942870|NCT01891591|Nutritional status|nutritional status
4942871|NCT01891591|Protein balance|protein balance
4942872|NCT01891552|Colon Cancer, Liver Metastasis, DEBIRI, cetuximab, efficacy|colon cancer, liver metastasis, debiri, cetuximab, efficacy
4942873|NCT01891539|Hepatocellular carcinoma, doxorubicin, chemoembolization|hepatocellular carcinoma, doxorubicin, chemoembolization
4942874|NCT01891526|Metabolisation of 9-cis-retinoic acid|metabolisation of 9-cis-retinoic acid
4942875|NCT01891526|hepatic patients|hepatic patients
4942876|NCT01891526|investigation of urine and blood samples|investigation of urine and blood samples
4942877|NCT01891513|Physical activity|physical activity
4942878|NCT01891513|Hypertension|hypertension
4942879|NCT01891513|Physical function|physical function
4942880|NCT01891513|Aging|aging
4942881|NCT01891500|Persistent Fetal Circulation Syndrome|persistent fetal circulation syndrome
4942882|NCT01891500|Infant, Newborn|infant, newborn
4942883|NCT01891500|Nitric Oxide|nitric oxide
4942884|NCT01891500|Oxidative Stress|oxidative stress
4942885|NCT01891500|Endothelin 1|endothelin 1
4942886|NCT01891500|Vascular Endothelial Growth Factor|vascular endothelial growth factor
4942887|NCT01891487|Eyebrow|eyebrow
4942888|NCT01891487|Hypotrichosis|hypotrichosis
4942889|NCT01891487|Thinning|thinning
4942890|NCT01891487|Bimatoprost|bimatoprost
4942891|NCT01891461|total knee arthroplasty|total knee arthroplasty
4942892|NCT01891461|post-operative bleeding|post-operative bleeding
4942893|NCT01891461|floseal|floseal
4942894|NCT01891435|antipyretics|antipyretics
4942895|NCT01891435|oral paracetamol|oral paracetamol
4942896|NCT01891435|intravenous paracetamol|intravenous paracetamol
4942897|NCT01891435|intramuscular diclofenac|intramuscular diclofenac
4942898|NCT01891435|emergency department|emergency department
4942899|NCT01891422|Glycoprotein Storage Disease|glycoprotein storage disease
4942900|NCT01891422|Lysosomal Storage Disease|lysosomal storage disease
4942901|NCT01891422|mannosidase deficiency disorders|mannosidase deficiency disorders
4942902|NCT01891422|Neuraminidase deficiency with beta-galactosidase deficiency|neuraminidase deficiency with beta-galactosidase deficiency
4942903|NCT01891422|mucolipidoses|mucolipidoses
4942904|NCT01891422|Oligosaccharidoses|oligosaccharidoses
4942905|NCT01891422|Lysosomal Disease|lysosomal disease
4942906|NCT01891422|Metabolic Disease, Inborn|metabolic disease, inborn
4942907|NCT01891422|aspartylglucosaminuria|aspartylglucosaminuria
4942908|NCT01891422|fucosidosis|fucosidosis
4942909|NCT01891422|galactosialidosis|galactosialidosis
4942910|NCT01891422|alpha mannosidosis|alpha mannosidosis
4942911|NCT01891422|beta mannosidosis|beta mannosidosis
4942912|NCT01891422|mucolipidosis II|mucolipidosis ii
4942913|NCT01891422|mucolipidosis III|mucolipidosis iii
4942914|NCT01891422|Schindler disease|schindler disease
4942915|NCT01891422|sialidosis|sialidosis
4942916|NCT01891409|HIV prevention|hiv prevention
4942917|NCT01891409|Male Circumcision|male circumcision
4942918|NCT01891409|Children|children
4942919|NCT01891409|Childhood|childhood
4942920|NCT01891409|Shang Ring|shang ring
4942921|NCT01891396|Knee osteoarthritis|knee osteoarthritis
4942922|NCT01891396|Hyaluronic acid|hyaluronic acid
4942923|NCT01891396|HA Injection|ha injection
4942924|NCT01891396|Steroid Injection|steroid injection
4942925|NCT01891396|Knee injection|knee injection
4942926|NCT01891383|Dementia|dementia
4942927|NCT01891383|Traumatic brain injury (TBI)|traumatic brain injury (tbi)
4942928|NCT01891383|Mild cognitive impairment (MCI)|mild cognitive impairment (mci)
4942929|NCT01891383|Chronic traumatic encephalopathy (CTE)|chronic traumatic encephalopathy (cte)
4942930|NCT01891383|Remote effects of TBI|remote effects of tbi
4942931|NCT01891383|Post-traumatic stress disorder (PTSD_|post-traumatic stress disorder (ptsd_
4942932|NCT01891357|Unilateral primary invasive carcinoma of the breast|unilateral primary invasive carcinoma of the breast
4942933|NCT01891344|ovarian cancer|ovarian cancer
4942934|NCT01891344|fallopian tube cancer|fallopian tube cancer
4942935|NCT01891344|primary peritoneal cancer|primary peritoneal cancer
4942936|NCT01891344|peritoneal cancer|peritoneal cancer
4942937|NCT01891344|platinum sensitive|platinum sensitive
4942938|NCT01891344|relapsed disease|relapsed disease
4942939|NCT01891344|PARP Inhibitor|parp inhibitor
4942940|NCT01891344|rucaparib|rucaparib
4942941|NCT01891344|homologous recombination|homologous recombination
4942942|NCT01891344|homologous recombination deficiency|homologous recombination deficiency
4942943|NCT01891344|genomic scarring|genomic scarring
4942944|NCT01891344|loss of heterozygosity|loss of heterozygosity
4942945|NCT01891344|CO-338|co-338
4942946|NCT01891344|PF 01367338|pf 01367338
4942947|NCT01891344|AG 14699|ag 14699
4942948|NCT01891344|platinum sensitive ovarian cancer|platinum sensitive ovarian cancer
4942949|NCT01891344|platinum sensitive fallopian tube cancer|platinum sensitive fallopian tube cancer
4942950|NCT01891344|platinum sensitive primary peritoneal cancer|platinum sensitive primary peritoneal cancer
4942951|NCT01891344|platinum sensitive peritoneal cancer|platinum sensitive peritoneal cancer
4942952|NCT01891344|gynecological cancer|gynecological cancer
4942953|NCT01891344|Clovis|clovis
4942954|NCT01891344|Clovis Oncology|clovis oncology
4942955|NCT01891344|ARIEL2|ariel2
4942956|NCT01891344|ARIEL 2|ariel 2
4942957|NCT01891344|ARIEL3|ariel3
4942958|NCT01891344|ARIEL 3|ariel 3
4942959|NCT01891279|short bowel syndrome|short bowel syndrome
4942960|NCT01891279|Elemental formula|elemental formula
4942961|NCT01891279|partially hydrolyzed formula|partially hydrolyzed formula
4942962|NCT01891279|Enteral feeding|enteral feeding
4942963|NCT01891279|TPN dependency|tpn dependency
4942964|NCT01891279|Intestinal adaptation|intestinal adaptation
4942965|NCT01891279|TPN cholestasis|tpn cholestasis
4942966|NCT01891253|cardiac output|cardiac output
4942967|NCT01891253|mechanical ventilation|mechanical ventilation
4942968|NCT01891253|inert gas rebreathing|inert gas rebreathing
4942969|NCT01891253|pulse contour analysis|pulse contour analysis
4942970|NCT01891240|Diagnostic|diagnostic
4942971|NCT01891240|Pre-eclampsia|pre-eclampsia
4942972|NCT01891240|Pregnancy outcome|pregnancy outcome
4942973|NCT01891240|Mass screening|mass screening
4942974|NCT01891240|Diagnostic Techniques and Procedures|diagnostic techniques and procedures
4942975|NCT01891227|Bendamustine|bendamustine
4942976|NCT01891227|Capecitabine|capecitabine
4942977|NCT01891227|Pretreated|pretreated
4942978|NCT01891227|Her2 negative|her2 negative
4942979|NCT01891227|Advanced breast cancer|advanced breast cancer
4942980|NCT01891227|Metastatic breast cancer|metastatic breast cancer
4942981|NCT01891227|Anthracycline pretreatment|anthracycline pretreatment
4942982|NCT01891227|Taxane pretreatment|taxane pretreatment
4942983|NCT01891214|Inflammatory bowel diseases|inflammatory bowel diseases
4942984|NCT01891214|Inflammatory Bowel Disease Questionnaire (IBDQ)|inflammatory bowel disease questionnaire (ibdq)
4942985|NCT01891201|Bonding|bonding
4942986|NCT01891201|Oxytocin|oxytocin
4942987|NCT01891201|Breastfeeding|breastfeeding
4942988|NCT01891201|Newborn|newborn
4942989|NCT01891201|Delivery|delivery
4942990|NCT01891188|hepatic blood,|hepatic blood,
4942991|NCT01891188|cardiac cath,|cardiac cath,
4942992|NCT01891188|hepatic oxygenation,|hepatic oxygenation,
4942993|NCT01891188|pediatrics|pediatrics
4942994|NCT01891175|Caesarean|caesarean
4942995|NCT01891175|hypotension|hypotension
4942996|NCT01891175|Spinal Anaesthesia|spinal anaesthesia
4942997|NCT01891175|intermittent pneumatic compression|intermittent pneumatic compression
4942998|NCT01891175|lower extremities|lower extremities
4942999|NCT01891162|quality of life, incontinence urinary, socioeconomic|quality of life, incontinence urinary, socioeconomic
4943000|NCT01891136|Peanut allergy|peanut allergy
4943001|NCT01891123|Non-small Cell Lung Cancer|non-small cell lung cancer
4943002|NCT01891123|Breast cancer|breast cancer
4943003|NCT01891123|plasma drug concentration|plasma drug concentration
4943004|NCT01891123|Nasopharygeal carcinoma|nasopharygeal carcinoma
4943005|NCT01891110|electric stimulation|electric stimulation
4943006|NCT01891110|tilt-table|tilt-table
4943007|NCT01891097|Insomnia|insomnia
4943008|NCT01891097|Acupuncture|acupuncture
4943009|NCT01891097|Electroacupuncture|electroacupuncture
4943010|NCT01891097|Aricular acupuncture|aricular acupuncture
4943011|NCT01891097|Randomized Clinical Trial|randomized clinical trial
4943012|NCT01891097|Traditional Chinese Medicine|traditional chinese medicine
4943013|NCT01891084|Influenza|influenza
4943014|NCT01891084|Antipyretics|antipyretics
4943015|NCT01891084|Fever|fever
4943016|NCT01891071|Multiple sclerosis|multiple sclerosis
4943017|NCT01891071|Lung volume recruitment|lung volume recruitment
4943018|NCT01891071|Pulmonary function impairment|pulmonary function impairment
4943019|NCT01891071|Cough impairment|cough impairment
4943020|NCT01891045|Psychotherapy|psychotherapy
4943021|NCT01891045|Drug addiction|drug addiction
4943022|NCT01891045|Drop-out|drop-out
4943023|NCT01891045|OQ-45.2|oq-45.2
4943025|NCT01891045|Randomized Controlled Trail|randomized controlled trail
4943026|NCT01891032|acute kidney injury, partial nephrectomy, biomarker|acute kidney injury, partial nephrectomy, biomarker
4943027|NCT01891006|Randomized Controlled Trial|randomized controlled trial
4943028|NCT01891006|Economical Evaluation|economical evaluation
4943029|NCT01891006|Caesarean Section|caesarean section
4943030|NCT01891006|Cesarean Section|cesarean section
4943031|NCT01891006|Postoperative Wound Treatment|postoperative wound treatment
4943032|NCT01891006|Surgical Site Infections|surgical site infections
4943033|NCT01891006|Wound Infections|wound infections
4943034|NCT01891006|Infectious Morbidity|infectious morbidity
4943035|NCT01891006|Negative Pressure Wound Therapy|negative pressure wound therapy
4943036|NCT01890980|WT-1-vaccine Montanide|wt-1-vaccine montanide
4943037|NCT01890980|GM-CSF|gm-csf
4943038|NCT01890980|Wilms Tumor-1 vaccine|wilms tumor-1 vaccine
4943039|NCT01890980|immunotherapy|immunotherapy
4943040|NCT01890980|Montanide|montanide
4943041|NCT01890980|Sargramostim|sargramostim
4943042|NCT01890980|Granulocyte Macrophage Colony Stimulating Factor|granulocyte macrophage colony stimulating factor
4943043|NCT01890980|Malignant Pleural Mesothelioma|malignant pleural mesothelioma
4943044|NCT01890980|MPM|mpm
4943045|NCT01890980|soluble mesothelin related protein|soluble mesothelin related protein
4943046|NCT01890980|SMRP|smrp
4943047|NCT01890967|low density lipoprotein, heterozygous familial hypercholesterolemia, polygenic hypercholesterolemia|low density lipoprotein, heterozygous familial hypercholesterolemia, polygenic hypercholesterolemia
4943048|NCT01890954|Type 1 Diabetes Mellitus (T1DM)|type 1 diabetes mellitus (t1dm)
4943049|NCT01890954|Closed Loop Control (CLC)|closed loop control (clc)
4943050|NCT01890954|Diabetes Assistant (DiAs)|diabetes assistant (dias)
4943051|NCT01890954|Continuous Glucose Monitor (CGM)|continuous glucose monitor (cgm)
4943052|NCT01890941|Dry eye syndromes|dry eye syndromes
4943053|NCT01890941|Corneal diseases|corneal diseases
4943054|NCT01890941|Conjunctival diseases|conjunctival diseases
4943055|NCT01890928|Gluconeogenesis|gluconeogenesis
4943056|NCT01890928|Glycogenolysis|glycogenolysis
4943057|NCT01890928|Pyruvate cycling|pyruvate cycling
4943058|NCT01890928|Glucose production rates|glucose production rates
4943059|NCT01890928|Mitochondria|mitochondria
4943060|NCT01890928|Acylcarnitines|acylcarnitines
4943061|NCT01890915|Spinal cord injury|spinal cord injury
4943062|NCT01890915|Body temperature|body temperature
4943063|NCT01890915|Executive function|executive function
4943064|NCT01890915|Sweat|sweat
4943065|NCT01890889|Total Cholesterol|total cholesterol
4943066|NCT01890889|LDL|ldl
4943067|NCT01890876|glucose tolerance, hypoxia, myokines, exercise|glucose tolerance, hypoxia, myokines, exercise
4943068|NCT01890863|asthma|asthma
4943069|NCT01890863|fluticasone propionate/salmeterol|fluticasone propionate/salmeterol
4943070|NCT01890863|PK equivalence|pk equivalence
4943071|NCT01890863|COPD|copd
4943072|NCT01890863|pharmacokinetics|pharmacokinetics
4943073|NCT01890863|fluticasone propionate/salmeterol in a capsule-based inhaler|fluticasone propionate/salmeterol in a capsule-based inhaler
4943074|NCT01890863|fluticasone propionate/salmeterol in a multi-dose dry powder inhaler|fluticasone propionate/salmeterol in a multi-dose dry powder inhaler
4943075|NCT01890863|Respiratory|respiratory
4943076|NCT01890850|Risk factors|risk factors
4943077|NCT01890850|U.S. commercially insured population|u.s. commercially insured population
4943078|NCT01890850|Pertussis/whooping cough infection|pertussis/whooping cough infection
4943079|NCT01890850|Retrospective database study|retrospective database study
4943080|NCT01890837|Rectal Compliance|rectal compliance
4943081|NCT01890837|Rectal Sensation|rectal sensation
4943082|NCT01890837|Rectal Tone|rectal tone
4943083|NCT01890824|Breast Cancer|breast cancer
4943084|NCT01890824|Fat metabolism|fat metabolism
4943085|NCT01890824|Fat digestion|fat digestion
4943086|NCT01890824|physical activity|physical activity
4943087|NCT01890824|muscle function|muscle function
4943088|NCT01890811|CKD|ckd
4943089|NCT01890811|Hemodialysis|hemodialysis
4943090|NCT01890811|Protein Digestion|protein digestion
4943091|NCT01890811|Fat Digestion|fat digestion
4943092|NCT01890811|Gut Function|gut function
4943093|NCT01890811|Glucose Absorption|glucose absorption
4943094|NCT01890811|Muscle Function|muscle function
4943095|NCT01890798|Duchenne Muscular Dystrophy|duchenne muscular dystrophy
4943096|NCT01890798|GSK2402968|gsk2402968
4943097|NCT01890798|drisapersen|drisapersen
4943098|NCT01890772|Hepatitis C Genotype 1|hepatitis c genotype 1
4943099|NCT01890772|Vitamin D|vitamin d
4943100|NCT01890772|treatment-naive|treatment-naive
4943101|NCT01890759|Meningitis|meningitis
4943102|NCT01890759|Meningococcal Infection|meningococcal infection
4943103|NCT01890759|Menactra®|menactra®
4943104|NCT01890746|de novo AML|de novo aml
4943105|NCT01890746|Eltrombopag|eltrombopag
4943106|NCT01890746|leukemia|leukemia
4943107|NCT01890746|sAML/MDS|saml/mds
4943108|NCT01890746|acute myeloid leukemia|acute myeloid leukemia
4943109|NCT01890746|secondary acute myeloid|secondary acute myeloid
4943110|NCT01890746|thrombocytopenia|thrombocytopenia
4943111|NCT01890733|Massive Rotator Cuff Tear, Sub-acromial spacer, Best repair of rotator cuff,|massive rotator cuff tear, sub-acromial spacer, best repair of rotator cuff,
4943112|NCT01890720|Randomized Controlled Trial|randomized controlled trial
4943113|NCT01890720|Economical Evaluation|economical evaluation
4943114|NCT01890720|Caesarean Section|caesarean section
4943115|NCT01890720|postoperative wound treatment|postoperative wound treatment
4943116|NCT01890720|surgical site infections|surgical site infections
4943117|NCT01890720|wound infections|wound infections
4943118|NCT01890720|infectious morbidity|infectious morbidity
4943119|NCT01890720|Negative Pressure Wound Therapy|negative pressure wound therapy
4943120|NCT01890720|Incisional Negative Pressure Wound Therapy|incisional negative pressure wound therapy
4943121|NCT01890720|Obesity|obesity
4943122|NCT01890707|Gynecology|gynecology
4943123|NCT01890707|Pain|pain
4943124|NCT01890707|Anesthesia|anesthesia
4943125|NCT01890707|Quality of Recovery 40|quality of recovery 40
4943126|NCT01890694|Hyponatremia|hyponatremia
4943127|NCT01890694|Dilutional Hyponatremia|dilutional hyponatremia
4943128|NCT01890694|Euvolemic Hyponatremia|euvolemic hyponatremia
4943129|NCT01890694|Hypervolemic Hyponatremia|hypervolemic hyponatremia
4943130|NCT01890694|Fluid Restriction|fluid restriction
4943131|NCT01890694|Tolvaptan|tolvaptan
4943132|NCT01890681|childhood obesity|childhood obesity
4943133|NCT01890681|child care|child care
4943134|NCT01890681|infant|infant
4943135|NCT01890681|toddler|toddler
4943136|NCT01890668|Breastfeeding behaviour|breastfeeding behaviour
4943137|NCT01890668|OMT (Osteopathic Manipulative Treatment)|omt (osteopathic manipulative treatment)
4943138|NCT01890668|suboptimal infant breastfeeding behaviour|suboptimal infant breastfeeding behaviour
4943139|NCT01890668|healthy newborns|healthy newborns
4943140|NCT01890655|relapsing-remitting multiple sclerosis|relapsing-remitting multiple sclerosis
4943141|NCT01890655|RRMS|rrms
4943142|NCT01890642|Pain|pain
4943143|NCT01890642|Children|children
4943144|NCT01890642|Venipuncture|venipuncture
4943145|NCT01890642|J tip|j tip
4943146|NCT01890642|Lidocaine|lidocaine
4943147|NCT01890642|video observation|video observation
4943148|NCT01890629|diabetes mellitus|diabetes mellitus
4943149|NCT01890603|Care coordination, primary care|care coordination, primary care
4943150|NCT01890603|nurse care management|nurse care management
4943151|NCT01890603|practice facilitation|practice facilitation
4943152|NCT01890590|Renal Cell Carcinoma|renal cell carcinoma
4943153|NCT01890590|Cyberknife|cyberknife
4943154|NCT01890577|Chronic kidney disease|chronic kidney disease
4943155|NCT01890577|Dialysis|dialysis
4943156|NCT01890577|Erythropoiesis stimulating agent|erythropoiesis stimulating agent
4943157|NCT01890577|South Africa|south africa
4943158|NCT01890551|Adoloescent, patellofemoral, instability,biomechanics, magnetic resonance imaging|adoloescent, patellofemoral, instability,biomechanics, magnetic resonance imaging
4943159|NCT01890538|vertigo|vertigo
4943160|NCT01890538|dimenhydrinate|dimenhydrinate
4943161|NCT01890538|piracetam|piracetam
4943162|NCT01890525|radiation|radiation
4943163|NCT01890499|tolerability|tolerability
4943164|NCT01890499|diet after operation|diet after operation
4943165|NCT01890447|Cocooning|cocooning
4943166|NCT01890447|Web-based questionnaire|web-based questionnaire
4943167|NCT01890447|Italy|italy
4943168|NCT01890447|Pertussis|pertussis
4943169|NCT01890447|Spain|spain
4943170|NCT01890447|Survey|survey
4943171|NCT01890434|Myocardial Perfusion Imaging|myocardial perfusion imaging
4943172|NCT01890421|Myocardial Perfusion Imaging|myocardial perfusion imaging
4943173|NCT01890408|Laparotomy|laparotomy
4943174|NCT01890408|Hepatic resection|hepatic resection
4943175|NCT01890408|continuous wound catheter analgesia|continuous wound catheter analgesia
4943176|NCT01890408|morphine|morphine
4943177|NCT01890408|post operative recovery|post operative recovery
4943178|NCT01890395|mitochondrial DAMPS|mitochondrial damps
4943179|NCT01890382|resistance exercise|resistance exercise
4943180|NCT01890382|protein|protein
4943181|NCT01890382|creatine|creatine
4943182|NCT01890382|leucine|leucine
4943183|NCT01890382|aging|aging
4943184|NCT01890369|Old Age|old age
4943185|NCT01890369|Sarcopenia|sarcopenia
4943186|NCT01890369|Amino Acid|amino acid
4943187|NCT01890369|Muscle|muscle
4943188|NCT01890356|Depression|depression
4943189|NCT01890356|Treatment|treatment
4943190|NCT01890356|Transcranial electrical stimulation|transcranial electrical stimulation
4943191|NCT01890356|Maintenance|maintenance
4943192|NCT01890330|Canola Oil|canola oil
4943193|NCT01890330|Metabolic Syndrome|metabolic syndrome
4943194|NCT01890330|Serum LDL cholesterol|serum ldl cholesterol
4943195|NCT01890317|Cardiogenic shock|cardiogenic shock
4943196|NCT01890317|acute myocardial infarction|acute myocardial infarction
4943197|NCT01890317|mild hypothermia|mild hypothermia
4943198|NCT01890304|Traumatic Brain Injury|traumatic brain injury
4943199|NCT01890304|TBI|tbi
4943200|NCT01890304|Concussion|concussion
4943201|NCT01890304|Sports related injury|sports related injury
4943202|NCT01890291|Immuncell-LC, Hepatocellular carcinoma|immuncell-lc, hepatocellular carcinoma
4943203|NCT01890278|Brain Cancer|brain cancer
4943204|NCT01890278|Metastatic Brain Cancer|metastatic brain cancer
4943205|NCT01890278|IMRT|imrt
4943206|NCT01890265|Idiopathic Pulmonary Fibrosis, IPF, Idiopathic Interstitial Pneumonia, Interstitial Lung Disease, Lung Fibrosis|idiopathic pulmonary fibrosis, ipf, idiopathic interstitial pneumonia, interstitial lung disease, lung fibrosis
4943207|NCT01890213|alphavirus|alphavirus
4943208|NCT01890213|colon cancer|colon cancer
4943209|NCT01890213|immune response|immune response
4943210|NCT01890213|CEA|cea
4943211|NCT01890200|add-on treatment|add-on treatment
4943212|NCT01890200|botanical drug|botanical drug
4943213|NCT01890200|HCV genotype 1|hcv genotype 1
4943214|NCT01890200|TCM-700C|tcm-700c
4943215|NCT01890161|asthma|asthma
4943216|NCT01890148|Asthma|asthma
4943217|NCT01890135|randomized|randomized
4943218|NCT01890135|double blind|double blind
4943219|NCT01890135|blood flow|blood flow
4943220|NCT01890135|muscle perfusion|muscle perfusion
4943221|NCT01890135|safety|safety
4943222|NCT01890122|Drug therapy|drug therapy
4943223|NCT01890109|Vasomotor symptoms; Hot Flashes; Menopause|vasomotor symptoms; hot flashes; menopause
4943224|NCT01890096|HDR|hdr
4943225|NCT01890096|monotherapy|monotherapy
4943226|NCT01890096|low|low
4943227|NCT01890096|intermediate|intermediate
4943228|NCT01890096|prostate cancer|prostate cancer
4943229|NCT01890083|Hepatitis C|hepatitis c
4943230|NCT01890083|Interferon-alpha|interferon-alpha
4943231|NCT01890083|Depression|depression
4943232|NCT01890083|Major Depressive Disorder|major depressive disorder
4943233|NCT01890083|Exercise|exercise
4943234|NCT01890083|Physical Activity|physical activity
4943235|NCT01890070|mediterranean diet, nutrigenomics, body composition, inflammation, oxidative stress|mediterranean diet, nutrigenomics, body composition, inflammation, oxidative stress
4943236|NCT01890044|VTE|vte
4943237|NCT01890044|DVT|dvt
4943238|NCT01890044|Venous Thromboembolism|venous thromboembolism
4943239|NCT01890044|Deep Vein Thrombosis|deep vein thrombosis
4943240|NCT01890044|Pulmonary embolus|pulmonary embolus
4943241|NCT01890044|Trauma|trauma
4943242|NCT01890031|cardiovascular disease|cardiovascular disease
4943243|NCT01890031|cholesterol|cholesterol
4943244|NCT01890018|Acute Myocardial Infarction (AMI)|acute myocardial infarction (ami)
4943245|NCT01890018|taking a statin medication|taking a statin medication
4943246|NCT01890018|also have a medication adherence ratio (MPR)|also have a medication adherence ratio (mpr)
4943247|NCT01890005|Preeclampsia|preeclampsia
4943248|NCT01890005|Low dose aspirin|low dose aspirin
4943249|NCT01890005|Fetal growth restriction|fetal growth restriction
4943250|NCT01890005|Neonatal death|neonatal death
4943251|NCT01890005|Stillbirth|stillbirth
4943252|NCT01890005|Abruptio placenta|abruptio placenta
4943253|NCT01889992|Heart transplantation|heart transplantation
4943254|NCT01889992|Cardiac allograft remodeling|cardiac allograft remodeling
4943255|NCT01889992|Immunosuppression|immunosuppression
4943256|NCT01889992|Cardiac MRI|cardiac mri
4943257|NCT01889992|M-TOR inhibitor|m-tor inhibitor
4943258|NCT01889979|Pain during labour|pain during labour
4943259|NCT01889979|Duration of labour|duration of labour
4943260|NCT01889979|Apgar score|apgar score
4943261|NCT01889979|Umbilical cord pH|umbilical cord ph
4943262|NCT01889966|vasoreactivity testing|vasoreactivity testing
4943263|NCT01889966|Sildenafil|sildenafil
4943264|NCT01889966|precapillary pulmonary hypertension|precapillary pulmonary hypertension
4943265|NCT01889966|connective tissue disease|connective tissue disease
4943391|NCT01889420|everolimus|everolimus
4943266|NCT01889966|mean pressure in the pulmonary artery 25 mmHg or more|mean pressure in the pulmonary artery 25 mmhg or more
4943267|NCT01889966|mean pulmonary capillary wedge pressure below 16 mmHg|mean pulmonary capillary wedge pressure below 16 mmhg
4943268|NCT01889953|EUS-Guided Biliary Drainage|eus-guided biliary drainage
4943269|NCT01889953|Endoscopic retrograde cholangiopancreatography|endoscopic retrograde cholangiopancreatography
4943270|NCT01889953|Malignant Biliary Obstruction|malignant biliary obstruction
4943271|NCT01889940|Acute Spinal Cord Injury|acute spinal cord injury
4943272|NCT01889940|Patient Satisfaction|patient satisfaction
4943273|NCT01889940|Psychological Distress|psychological distress
4943274|NCT01889940|Rehabilitation|rehabilitation
4943275|NCT01889940|Training Professionals|training professionals
4943276|NCT01889940|Burnout|burnout
4943277|NCT01889940|Job Content|job content
4943278|NCT01889927|exercise|exercise
4943279|NCT01889927|physiotherapy|physiotherapy
4943280|NCT01889927|lung function|lung function
4943281|NCT01889927|quality of life|quality of life
4943282|NCT01889901|Physical Activity|physical activity
4943283|NCT01889901|Epilepsy|epilepsy
4943284|NCT01889901|Seizures|seizures
4943285|NCT01889901|Quality of Life|quality of life
4943286|NCT01889888|Male urethral stricture|male urethral stricture
4943287|NCT01889888|ADRC|adrc
4943288|NCT01889888|Adipose-derived regenerative cells|adipose-derived regenerative cells
4943289|NCT01889888|Fat tissue|fat tissue
4943290|NCT01889888|Stem cells|stem cells
4943292|NCT01889862|PEG-PAL|peg-pal
4943293|NCT01889862|Prism|prism
4943294|NCT01889862|BioMarin|biomarin
4943295|NCT01889862|rAvPAL-PEG|ravpal-peg
4943296|NCT01889862|Pegvaliase|pegvaliase
4943297|NCT01889836|meningococcal conjugate vaccine serogroup C|meningococcal conjugate vaccine serogroup c
4943298|NCT01889836|Prevention|prevention
4943299|NCT01889823|Oxygen|oxygen
4943300|NCT01889823|Hypoxia|hypoxia
4943301|NCT01889823|Hyperoxia|hyperoxia
4943302|NCT01889823|Inflammation|inflammation
4943303|NCT01889823|Innate immunity|innate immunity
4943304|NCT01889810|Vitamin D, Pre-diabetes, Insulin Resistance|vitamin d, pre-diabetes, insulin resistance
4943305|NCT01889797|Untreated Non-Hodgkin's Lymphoma|untreated non-hodgkin's lymphoma
4943306|NCT01889797|Low Tumor Burden Non-Hodgkin's Lymphoma|low tumor burden non-hodgkin's lymphoma
4943307|NCT01889797|NHL|nhl
4943308|NCT01889797|Indolent|indolent
4943309|NCT01889797|Rituximab|rituximab
4943310|NCT01889797|Rituxan|rituxan
4943311|NCT01889797|GA101|ga101
4943312|NCT01889797|Obinutuzumab|obinutuzumab
4943313|NCT01889784|diabetes mellitus, type 2|diabetes mellitus, type 2
4943314|NCT01889784|phototherapy|phototherapy
4943315|NCT01889784|physical exercise|physical exercise
4943316|NCT01889784|oxygen consumption|oxygen consumption
4943317|NCT01889784|arterial blood pressure|arterial blood pressure
4943318|NCT01889784|heart rate|heart rate
4943319|NCT01889784|baroreflex sensitivity|baroreflex sensitivity
4943320|NCT01889784|cardiovascular autonomic control|cardiovascular autonomic control
4943321|NCT01889758|bioequivalence|bioequivalence
4943322|NCT01889758|tacrolimus|tacrolimus
4943323|NCT01889758|kidney|kidney
4943324|NCT01889758|liver|liver
4943325|NCT01889758|transplant|transplant
4943326|NCT01889719|HIV Prevention|hiv prevention
4943327|NCT01889706|Type 1 diabetes mellitus,|type 1 diabetes mellitus,
4943328|NCT01889706|metformin,|metformin,
4943329|NCT01889706|insulin resistance,|insulin resistance,
4943330|NCT01889706|obesity|obesity
4943331|NCT01889693|positron emission tomography|positron emission tomography
4943332|NCT01889693|macrophage|macrophage
4943333|NCT01889693|neomannosyl human serum albumin|neomannosyl human serum albumin
4943334|NCT01889680|colorectal cancer|colorectal cancer
4943335|NCT01889680|metastatic colorectal cancer|metastatic colorectal cancer
4943336|NCT01889680|ziv-aflibercept|ziv-aflibercept
4943337|NCT01889680|NSABP|nsabp
4943338|NCT01889667|Oral Insulin|oral insulin
4943339|NCT01889667|Diabetes Mellitus Type 2|diabetes mellitus type 2
4943340|NCT01889667|Safety|safety
4943341|NCT01889667|Pharmacodynamics|pharmacodynamics
4943342|NCT01889667|Pharmacokinetics|pharmacokinetics
4943343|NCT01889628|Glycaemic response|glycaemic response
4943344|NCT01889628|Glycaemic Index|glycaemic index
4943345|NCT01889628|Nutritional formula|nutritional formula
4943346|NCT01889628|Asia|asia
4943347|NCT01889628|Ethnic differences|ethnic differences
4943348|NCT01889628|Chinese|chinese
4943349|NCT01889628|Malay|malay
4943350|NCT01889628|Indian|indian
4943351|NCT01889615|Ovarian cancer|ovarian cancer
4943352|NCT01889615|PET/CT|pet/ct
4943353|NCT01889615|glucose 6 phosphatase|glucose 6 phosphatase
4943354|NCT01889602|Healthy volunteers|healthy volunteers
4943355|NCT01889602|Topiramate|topiramate
4943356|NCT01889602|Neurocognition|neurocognition
4943357|NCT01889602|Drug-induced cognitive deficits|drug-induced cognitive deficits
4943358|NCT01889576|glucose|glucose
4943359|NCT01889563|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
4943360|NCT01889563|heart rate variability|heart rate variability
4943361|NCT01889563|physical training|physical training
4943362|NCT01889550|Screening|screening
4943363|NCT01889550|Downs syndrome|downs syndrome
4943364|NCT01889550|Informed choice|informed choice
4943365|NCT01889550|eHealth|ehealth
4943366|NCT01889537|Virtual Reality Ketamine|virtual reality ketamine
4943367|NCT01889511|Text Messaging|text messaging
4943368|NCT01889511|Medication Adherence|medication adherence
4943369|NCT01889511|Oral Agents|oral agents
4943370|NCT01889498|Acetazolamide, intracranial/cerebrospinal fluid pressure, paraplegia, thoracoabdominal aortic surgery|acetazolamide, intracranial/cerebrospinal fluid pressure, paraplegia, thoracoabdominal aortic surgery
4943371|NCT01889485|Aortic Aneurysm, Abdominal|aortic aneurysm, abdominal
4943372|NCT01889485|Carotid Stenosis|carotid stenosis
4943373|NCT01889485|Peripheral Arterial Disease|peripheral arterial disease
4943374|NCT01889485|Health Services Accessibility|health services accessibility
4943375|NCT01889472|CPAP compliance|cpap compliance
4943376|NCT01889472|leaks|leaks
4943377|NCT01889472|Respiratory disturbances index|respiratory disturbances index
4943378|NCT01889472|quality of life|quality of life
4943379|NCT01889446|Propionic acid|propionic acid
4943380|NCT01889446|Food preservatives|food preservatives
4943381|NCT01889433|Hepatitis C|hepatitis c
4943382|NCT01889433|Cepeginterferon alfa|cepeginterferon alfa
4943383|NCT01889433|Peginterferon|peginterferon
4943384|NCT01889433|Treatment|treatment
4943385|NCT01889420|myeloma|myeloma
4943386|NCT01889420|relapse|relapse
4943387|NCT01889420|refractory|refractory
4943388|NCT01889420|relapsed|relapsed
4943389|NCT01889420|pomalidomide|pomalidomide
4943390|NCT01889420|pomalyst|pomalyst
4943392|NCT01889420|afinitor|afinitor
4943393|NCT01889420|dexamethasone|dexamethasone
4943394|NCT01889407|Acute Myeloid Leukemia|acute myeloid leukemia
4943395|NCT01889394|pilonidal sinus|pilonidal sinus
4943396|NCT01889394|excision|excision
4943397|NCT01889394|primary wound closure|primary wound closure
4943398|NCT01889394|limberg flap|limberg flap
4943399|NCT01889368|Insulin resistance|insulin resistance
4943400|NCT01889368|Central adiposity|central adiposity
4943401|NCT01889368|Elevated blood pressure|elevated blood pressure
4943402|NCT01889368|Vascular reactivity|vascular reactivity
4943403|NCT01889368|Elevated triglycerides|elevated triglycerides
4943404|NCT01889368|Low high-density lipoprotein (HDL)|low high-density lipoprotein (hdl)
4943405|NCT01889355|diabetes|diabetes
4943406|NCT01889355|glucose|glucose
4943407|NCT01889355|glucometer|glucometer
4943408|NCT01889342|MCT|mct
4943409|NCT01889342|Metacognitive therapy|metacognitive therapy
4943410|NCT01889342|Anxiety disorders|anxiety disorders
4943411|NCT01889342|Transdiagnostic|transdiagnostic
4943412|NCT01889316|Fetal monitoring|fetal monitoring
4943413|NCT01889316|ECG|ecg
4943414|NCT01889303|concurrent chemoradiotherapy|concurrent chemoradiotherapy
4943415|NCT01889303|FOLFOX6|folfox6
4943416|NCT01889303|chemotherapy|chemotherapy
4943417|NCT01889303|docetaxel|docetaxel
4943418|NCT01889303|cisplatin|cisplatin
4943419|NCT01889303|gastric cancer|gastric cancer
4943420|NCT01889290|methylnaltrexone|methylnaltrexone
4943421|NCT01889290|opioid-antagonist|opioid-antagonist
4943422|NCT01889290|Obstipation|obstipation
4943423|NCT01889290|pharmacokinetics|pharmacokinetics
4943424|NCT01889277|Diabetic Nephropathy|diabetic nephropathy
4943425|NCT01889264|Methionine Metabolism|methionine metabolism
4943426|NCT01889264|Enteral Nutrition|enteral nutrition
4943427|NCT01889264|Pediatric|pediatric
4943428|NCT01889264|Pediatrics|pediatrics
4943429|NCT01889264|Sepsis|sepsis
4943430|NCT01889264|Observational Study|observational study
4943431|NCT01889251|Vitreomacular Adhesion|vitreomacular adhesion
4943432|NCT01889251|Vitreomacular Traction|vitreomacular traction
4943433|NCT01889251|Vitreomacular Traction Syndrome|vitreomacular traction syndrome
4943434|NCT01889251|Vitrectomy|vitrectomy
4943435|NCT01889251|Central Visual Field Defect|central visual field defect
4943436|NCT01889251|Blind Spot|blind spot
4943437|NCT01889251|Intravitreal Injection|intravitreal injection
4943438|NCT01889251|Macula|macula
4943439|NCT01889251|Retina|retina
4943440|NCT01889251|Decreased Visual Acuity|decreased visual acuity
4943441|NCT01889251|Visual Complaint|visual complaint
4943442|NCT01889251|SD-OCT|sd-oct
4943443|NCT01889251|Macular Hole|macular hole
4943444|NCT01889238|breast cancer|breast cancer
4943445|NCT01889238|triple negative|triple negative
4943446|NCT01889238|androgen receptor positive|androgen receptor positive
4943447|NCT01889199|polycystic ovary syndrome|polycystic ovary syndrome
4943448|NCT01889199|hirsutism|hirsutism
4943449|NCT01889199|anovulation|anovulation
4943450|NCT01889199|oligomenorrhea|oligomenorrhea
4943451|NCT01889199|amenorrhea|amenorrhea
4943452|NCT01889199|hyperandrogenism|hyperandrogenism
4943453|NCT01889199|antiandrogen effect|antiandrogen effect
4943454|NCT01889186|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
4943455|NCT01889186|17 p Deletion|17 p deletion
4943456|NCT01889160|Healthy volunteers, Phase 1|healthy volunteers, phase 1
4943457|NCT01889147|Peak plasma concentration|peak plasma concentration
4943458|NCT01889147|safety and efficacy|safety and efficacy
4943459|NCT01889147|therapeutic agent|therapeutic agent
4943460|NCT01889147|LPS-mediated diseases|lps-mediated diseases
4943461|NCT01889147|Pharmacokinetics of administered hRESCAP|pharmacokinetics of administered hrescap
4943462|NCT01889147|Determine half-time|determine half-time
4943463|NCT01889134|primary hyperparathyroidism|primary hyperparathyroidism
4943464|NCT01889134|RANKL|rankl
4943465|NCT01889134|osteoprotegerin|osteoprotegerin
4943466|NCT01889134|bone mineral density|bone mineral density
4943467|NCT01889134|alendronate|alendronate
4943468|NCT01889134|parathyroidectomy|parathyroidectomy
4943469|NCT01889108|Premature|premature
4943470|NCT01889108|Development|development
4943471|NCT01889108|Motor|motor
4943472|NCT01889108|Cognitive|cognitive
4943473|NCT01889108|Parent|parent
4943474|NCT01889082|Obesity|obesity
4943475|NCT01889082|weight loss|weight loss
4943476|NCT01889082|young adults|young adults
4943477|NCT01889056|Erythropoietin|erythropoietin
4943478|NCT01889056|Cognition|cognition
4943479|NCT01889056|Exercise|exercise
4943480|NCT01889043|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
4943481|NCT01889043|Noninvasive Ventilation|noninvasive ventilation
4943482|NCT01889043|Polysomnography|polysomnography
4943483|NCT01889030|Cardiovascular primary prevention|cardiovascular primary prevention
4943484|NCT01889030|Cardiovascular risk strtification|cardiovascular risk strtification
4943485|NCT01889017|generic immunosuppressive|generic immunosuppressive
4943486|NCT01889004|Cerebral blood flow|cerebral blood flow
4943487|NCT01889004|Consciousness|consciousness
4943488|NCT01889004|Dexmedetomidine|dexmedetomidine
4943489|NCT01889004|EEG|eeg
4943490|NCT01889004|Event related potentials|event related potentials
4943491|NCT01889004|Functional magnetic resonance imaging|functional magnetic resonance imaging
4943492|NCT01889004|General anesthesia|general anesthesia
4943493|NCT01889004|Positron emission tomography|positron emission tomography
4943494|NCT01889004|Propofol|propofol
4943495|NCT01888991|Glucose|glucose
4943496|NCT01888991|Exercise|exercise
4943497|NCT01888991|Metabolic flexibility|metabolic flexibility
4943498|NCT01888991|Substrate Oxidation|substrate oxidation
4943499|NCT01888991|Food intake|food intake
4943500|NCT01888978|Pancreas|pancreas
4943501|NCT01888978|cancer|cancer
4943502|NCT01888978|metastatic|metastatic
4943503|NCT01888978|chemotherapy|chemotherapy
4943504|NCT01888965|Maintenance therapy|maintenance therapy
4943505|NCT01888965|Adjuvant Therapy|adjuvant therapy
4943506|NCT01888939|Executive Function|executive function
4943507|NCT01888939|Child|child
4943508|NCT01888939|Obesity|obesity
4943509|NCT01888939|Exercise|exercise
4943510|NCT01888939|Insulin Sensitivity|insulin sensitivity
4943511|NCT01888926|rPAS|rpas
4943512|NCT01888926|Dystonia|dystonia
4943513|NCT01888913|Body Weight|body weight
4943514|NCT01888913|Virtual Reality Technology|virtual reality technology
4943515|NCT01888900|Hepatitis C|hepatitis c
4943516|NCT01888900|Non-Responders|non-responders
4943517|NCT01888900|Direct Acting Antivirals|direct acting antivirals
4943518|NCT01888900|Interferon Free|interferon free
4943519|NCT01888900|Cirrhosis|cirrhosis
4943520|NCT01888874|Methotrexate insufficient responders|methotrexate insufficient responders
4943521|NCT01888861|length of stay in ICU|length of stay in icu
4943522|NCT01888861|ventilator free days|ventilator free days
4943523|NCT01888848|Postural Balance|postural balance
4943524|NCT01888848|Walking|walking
4943525|NCT01888848|Gait|gait
4943526|NCT01888848|Cognition|cognition
4943527|NCT01888848|Learning|learning
4943528|NCT01888848|Memory|memory
4943529|NCT01888848|Blueberry|blueberry
4943530|NCT01888848|Antioxidants|antioxidants
4943531|NCT01888848|Anti-Inflammatory Agents|anti-inflammatory agents
4943532|NCT01888848|Brain|brain
4943533|NCT01888835|HIV|hiv
4943534|NCT01888835|sexual behavior|sexual behavior
4943535|NCT01888822|Laparoscopic cholecystectomy|laparoscopic cholecystectomy
4943536|NCT01888822|Prophylactic antibiotics|prophylactic antibiotics
4943537|NCT01888809|teen parents|teen parents
4943538|NCT01888809|early childhood development|early childhood development
4943539|NCT01888809|home visitation|home visitation
4943540|NCT01888809|evidence-based treatment|evidence-based treatment
4943541|NCT01888796|T2DM|t2dm
4943542|NCT01888796|diastolic dysfunction|diastolic dysfunction
4943543|NCT01888783|CRPS Type I|crps type i
4943544|NCT01888783|tactile acuity|tactile acuity
4943545|NCT01888783|2-point-discrimination|2-point-discrimination
4943546|NCT01888783|Grating Orientation Task|grating orientation task
4943547|NCT01888783|sensory signs|sensory signs
4943548|NCT01888757|Bioequivalence|bioequivalence
4943549|NCT01888757|Lamotrigine Extended Release|lamotrigine extended release
4943550|NCT01888757|crossover|crossover
4943551|NCT01888744|Intracytoplasmic sperm injection (ICSI)|intracytoplasmic sperm injection (icsi)
4943552|NCT01888744|PGD|pgd
4943553|NCT01888744|GnrH agonist|gnrh agonist
4943554|NCT01888744|GnRH antagonist|gnrh antagonist
4943555|NCT01888731|Bioequivalence|bioequivalence
4943556|NCT01888731|Lamotrigine Extended Release|lamotrigine extended release
4943557|NCT01888731|crossover|crossover
4943558|NCT01888705|COPD|copd
4943559|NCT01888705|Complexity|complexity
4943560|NCT01888705|Entropy Sampling|entropy sampling
4943561|NCT01888705|Variability|variability
4943562|NCT01888705|Respiratory Mechanics|respiratory mechanics
4943563|NCT01888705|FOT|fot
4943564|NCT01888692|PET/CT|pet/ct
4943565|NCT01888692|Radiotherapy|radiotherapy
4943566|NCT01888692|Lung Cancer|lung cancer
4943567|NCT01888679|Airway|airway
4943568|NCT01888679|Endotracheal intubation|endotracheal intubation
4943569|NCT01888679|selective intubation|selective intubation
4943570|NCT01888653|PTSD|ptsd
4943571|NCT01888653|Attention Bias to threat|attention bias to threat
4943572|NCT01888653|Attention Bias Modification Treatment|attention bias modification treatment
4943573|NCT01888640|TENS|tens
4943574|NCT01888640|Fibromyalgia|fibromyalgia
4943575|NCT01888640|Accelerometer|accelerometer
4943576|NCT01888627|Schizophrenia|schizophrenia
4943577|NCT01888627|Bipolar disorder|bipolar disorder
4943578|NCT01888627|Assertive community treatment|assertive community treatment
4943579|NCT01888627|Integrated care|integrated care
4943580|NCT01888627|Severe and persistent mental disorder|severe and persistent mental disorder
4943581|NCT01888614|carbon mono oxide|carbon mono oxide
4943582|NCT01888614|sickle cell|sickle cell
4943583|NCT01888614|hemolysis|hemolysis
4943584|NCT01888588|Uncomplicated peptic ulcer|uncomplicated peptic ulcer
4943585|NCT01888588|Low dose aspirin (ASA)|low dose aspirin (asa)
4943586|NCT01888588|Acid-suppressing drugs|acid-suppressing drugs
4943587|NCT01888588|Epidemiology|epidemiology
4943588|NCT01888575|Discontinuation of low dose ASA,|discontinuation of low dose asa,
4943589|NCT01888575|Secondary cardiovascular prevention,|secondary cardiovascular prevention,
4943590|NCT01888575|Acid-suppressing drugs,|acid-suppressing drugs,
4943591|NCT01888575|Gastrointestinal risk,|gastrointestinal risk,
4943592|NCT01888575|Epidemiology|epidemiology
4943593|NCT01888549|Chronic cough, proton pump inhibitor, GERD, nonacid reflux,|chronic cough, proton pump inhibitor, gerd, nonacid reflux,
4943594|NCT01888497|Sleeplessness|sleeplessness
4943595|NCT01888484|PID|pid
4943596|NCT01888471|Streptococcal disease|streptococcal disease
4943597|NCT01888471|Feasibility|feasibility
4943598|NCT01888471|Infants|infants
4943599|NCT01888458|Adult|adult
4943600|NCT01888458|allo-Stem Cell Transplantation|allo-stem cell transplantation
4943601|NCT01888458|Cord Blood|cord blood
4943602|NCT01888445|Renal anemia|renal anemia
4943603|NCT01888445|Chronic Renal Failure|chronic renal failure
4943604|NCT01888445|ASP1517|asp1517
4943605|NCT01888432|liver transplantation|liver transplantation
4943606|NCT01888432|everolimus|everolimus
4943607|NCT01888432|tacrolimus|tacrolimus
4943608|NCT01888432|reduced calcineuron inhibitor|reduced calcineuron inhibitor
4943609|NCT01888432|renal function|renal function
4943610|NCT01888432|living donor|living donor
4943611|NCT01888432|RAD001H2307|rad001h2307
4943612|NCT01888432|RAD001H|rad001h
4943613|NCT01888419|Post Breast Therapy Pain Syndrome|post breast therapy pain syndrome
4943614|NCT01888419|Lipotransplantation|lipotransplantation
4943615|NCT01888419|Breast Cancer|breast cancer
4943616|NCT01888419|Pain|pain
4943617|NCT01888406|Obesity|obesity
4943618|NCT01888406|Weight gain prevention|weight gain prevention
4943619|NCT01888406|Eating disorder|eating disorder
4943620|NCT01888406|Binge eating|binge eating
4943621|NCT01888393|pharmacokinetics, hepatic impairment|pharmacokinetics, hepatic impairment
4943622|NCT01888380|Autopsy|autopsy
4943623|NCT01888380|Minimally invasive|minimally invasive
4943624|NCT01888380|Foetuses|foetuses
4943625|NCT01888380|Newborns|newborns
4943626|NCT01888380|Children|children
4943627|NCT01888380|Adolescents|adolescents
4943628|NCT01888354|MS|ms
4943629|NCT01888354|Multiple Sclerosis|multiple sclerosis
4943630|NCT01888315|Hypertension|hypertension
4943631|NCT01888315|Heart Failure|heart failure
4943632|NCT01888315|Sympathetic activity|sympathetic activity
4943633|NCT01888276|Words generation, compulsive gamblers|words generation, compulsive gamblers
4943634|NCT01888263|Bioequivalence|bioequivalence
4943635|NCT01888263|Lamotrigine Extended Release|lamotrigine extended release
4943636|NCT01888263|crossover|crossover
4943637|NCT01888250|Bioequivalence|bioequivalence
4943638|NCT01888250|Lamotrigine Extended Release|lamotrigine extended release
4943639|NCT01888250|crossover|crossover
4943640|NCT01888237|Dyspepsia|dyspepsia
4943641|NCT01888237|Helicobacter pylori|helicobacter pylori
4943642|NCT01888237|Clarithromycin resistance|clarithromycin resistance
4943643|NCT01888237|Other Specified Disorders of Function of Stomach|other specified disorders of function of stomach
4943644|NCT01888198|ablation|ablation
4943645|NCT01888198|quality of Life (QOL)|quality of life (qol)
4943646|NCT01888198|kidney|kidney
4943647|NCT01888198|registry|registry
4943648|NCT01888198|Ablation of Renal Masses Outcomes Registry (ARMOR)|ablation of renal masses outcomes registry (armor)
4943649|NCT01888198|13-116|13-116
4943650|NCT01888185|Parkinson's|parkinson's
4943651|NCT01888185|PD|pd
4943652|NCT01888185|nigrostriatal|nigrostriatal
4943653|NCT01888185|substantia nigra|substantia nigra
4943654|NCT01888185|MRI|mri
4943655|NCT01888185|DTI|dti
4943656|NCT01888185|FA|fa
4943657|NCT01888185|R2*|r2*
4943658|NCT01888185|Parkinson's Disease Biomarkers Program|parkinson's disease biomarkers program
4943659|NCT01888185|PDBP|pdbp
4943660|NCT01888185|ferritin|ferritin
4943661|NCT01888185|transferrin|transferrin
4943662|NCT01888185|Fe|fe
4943663|NCT01888185|iron protein|iron protein
4943664|NCT01888185|PSP|psp
4943665|NCT01888185|MSA|msa
4943666|NCT01888146|Pain management|pain management
4943667|NCT01888146|Opioid use|opioid use
4943668|NCT01888146|Pragmatic|pragmatic
4943669|NCT01888146|Collaborative care|collaborative care
4943670|NCT01888146|Primary care|primary care
4943671|NCT01888107|Schizophrenia|schizophrenia
4943672|NCT01888107|Schizoaffective Disorder|schizoaffective disorder
4943673|NCT01888107|Antipsychotics|antipsychotics
4943674|NCT01888107|Risperidone|risperidone
4943675|NCT01888107|Long-acting injectable|long-acting injectable
4943676|NCT01888094|Central venous catheter|central venous catheter
4943677|NCT01888094|Complications|complications
4943678|NCT01888094|Ultrasound|ultrasound
4943679|NCT01888094|Subclavian vein cannulation|subclavian vein cannulation
4943680|NCT01888094|Critical care|critical care
4943681|NCT01888094|Echocardiography|echocardiography
4943682|NCT01888094|Chest radiographyiography|chest radiographyiography
4943683|NCT01888055|Healthy older adults Cortical Plasticity|healthy older adults cortical plasticity
4943684|NCT01888055|Transcranial Direct Current Stimulation|transcranial direct current stimulation
4943685|NCT01888029|mild cognitive impairment|mild cognitive impairment
4943686|NCT01888029|Transcranial Direct Current Stimulation|transcranial direct current stimulation
4943687|NCT01888029|Cortical Plasticity|cortical plasticity
4943688|NCT01888003|anemia|anemia
4943689|NCT01887977|Orthognathic surgery|orthognathic surgery
4943690|NCT01887977|Speech production|speech production
4943691|NCT01887977|MRI|mri
4943692|NCT01887964|Diabetes|diabetes
4943693|NCT01887964|Obesity|obesity
4943694|NCT01887964|Cardiovascular disease|cardiovascular disease
4943695|NCT01887964|Metabolic syndrome|metabolic syndrome
4943696|NCT01887925|breast neoplasms|breast neoplasms
4943697|NCT01887925|sleep|sleep
4943698|NCT01887925|anxiety|anxiety
4943699|NCT01887925|depression|depression
4943700|NCT01887925|life quality|life quality
4943701|NCT01887912|Clostridium difficile Toxoid Vaccine|clostridium difficile toxoid vaccine
4943702|NCT01887912|Clostridium difficile infection|clostridium difficile infection
4943703|NCT01887912|Cdiffense|cdiffense
4943704|NCT01887899|cortical plasticity|cortical plasticity
4943705|NCT01887899|transcranial direct current stimulation|transcranial direct current stimulation
4943706|NCT01887873|open angle glaucoma|open angle glaucoma
4943707|NCT01887873|cataract|cataract
4943708|NCT01887860|Cetaphil Daily Facial Moisturizer SPF 50|cetaphil daily facial moisturizer spf 50
4943709|NCT01887847|nicotine|nicotine
4943710|NCT01887847|pharmacokinetics|pharmacokinetics
4943711|NCT01887834|bloating|bloating
4943712|NCT01887834|constipation|constipation
4943713|NCT01887834|diarrhea|diarrhea
4943714|NCT01887834|gas|gas
4943715|NCT01887834|mucous|mucous
4943716|NCT01887834|cramping|cramping
4943717|NCT01887808|Determine|determine
4943718|NCT01887808|Hypoallergenicity|hypoallergenicity
4943719|NCT01887808|Cetaphil DermaControl Oil Control Moisturizer SPF 30|cetaphil dermacontrol oil control moisturizer spf 30
4943720|NCT01887795|Informed Consent;|informed consent;
4943721|NCT01887795|Ethical Principles;|ethical principles;
4943722|NCT01887795|Data collection|data collection
4943723|NCT01887782|depression|depression
4943724|NCT01887782|magnetic|magnetic
4943725|NCT01887782|brain stimulation|brain stimulation
4943726|NCT01887782|treatment-resistant|treatment-resistant
4943727|NCT01887769|Lung cancer|lung cancer
4943728|NCT01887769|Body composition analysis|body composition analysis
4943729|NCT01887769|Ct-Scan|ct-scan
4943730|NCT01887769|Muscle mass|muscle mass
4943731|NCT01887769|Cachexia|cachexia
4943732|NCT01887756|telerehabilitation stroke virtual reatlity|telerehabilitation stroke virtual reatlity
4943733|NCT01887743|GERD|gerd
4943734|NCT01887743|Obesity|obesity
4943735|NCT01887743|Pediatric|pediatric
4943736|NCT01887743|Pantoprazole|pantoprazole
4943737|NCT01887743|CYP2C19|cyp2c19
4943738|NCT01887743|Pharmacokinetic|pharmacokinetic
4943739|NCT01887730|Hand Hygiene|hand hygiene
4943740|NCT01887730|Communicable Diseases|communicable diseases
4943741|NCT01887730|Prevention|prevention
4943742|NCT01887717|hepatocellular carcinoma|hepatocellular carcinoma
4943743|NCT01887717|portal vein thrombosis|portal vein thrombosis
4943744|NCT01887691|Diabetes|diabetes
4943745|NCT01887691|Prediabetic|prediabetic
4943746|NCT01887691|Prediabetes|prediabetes
4943747|NCT01887691|Glucose intolerance|glucose intolerance
4943748|NCT01887691|Sleep quality|sleep quality
4943749|NCT01887691|Continuous glucose monitoring|continuous glucose monitoring
4943750|NCT01887691|Diabetes risk|diabetes risk
4943751|NCT01887691|eszopiclone|eszopiclone
4943752|NCT01887665|substance use disorders|substance use disorders
4943753|NCT01887665|substance abuse|substance abuse
4943754|NCT01887665|substance abuse treatment|substance abuse treatment
4943755|NCT01887665|contingency management|contingency management
4943756|NCT01887652|In Vitro Fertilization|in vitro fertilization
4943757|NCT01887652|ovulation induction|ovulation induction
4943758|NCT01887652|anti-mullerian hormone|anti-mullerian hormone
4943759|NCT01887639|Non-psychotic unipolar major depression|non-psychotic unipolar major depression
4943760|NCT01887639|Resistant depression|resistant depression
4943761|NCT01887626|Phase 1, pharmacokinetic, safety, Ticagrelor|phase 1, pharmacokinetic, safety, ticagrelor
4943762|NCT01887613|Gabapentin|gabapentin
4943763|NCT01887600|anemia|anemia
4943764|NCT01887600|chronic kidney disease (CKD)|chronic kidney disease (ckd)
4943765|NCT01887600|Hemoglobin (Hb)|hemoglobin (hb)
4943766|NCT01887600|non-dialysis|non-dialysis
4943767|NCT01887548|Crohn's disease|crohn's disease
4943768|NCT01887548|inflammatory bowel disease|inflammatory bowel disease
4943769|NCT01887548|quality of life|quality of life
4943770|NCT01887548|personality|personality
4943771|NCT01887548|neuroticism|neuroticism
4943772|NCT01887535|Healthy|healthy
4943773|NCT01887535|Elderly|elderly
4943774|NCT01887535|Safety|safety
4943775|NCT01887535|Tolerability|tolerability
4943776|NCT01887535|Pharmacokinetic|pharmacokinetic
4943777|NCT01887535|Alzheimer's Disease|alzheimer's disease
4943778|NCT01887535|JNJ-54861911|jnj-54861911
4943779|NCT01887522|Children|children
4943780|NCT01887522|Adolescents|adolescents
4943781|NCT01887522|Young Adults|young adults
4943782|NCT01887509|Rectal cancer|rectal cancer
4943783|NCT01887509|Tumor margin|tumor margin
4943784|NCT01887509|Confocal endomicroscopy|confocal endomicroscopy
4943785|NCT01887509|Virtual biopsy|virtual biopsy
4943786|NCT01887509|Fluorescein|fluorescein
4943787|NCT01887496|Varicella|varicella
4943788|NCT01887496|Turkey|turkey
4943789|NCT01887496|hospitalization|hospitalization
4943790|NCT01887496|varicella vaccine|varicella vaccine
4943791|NCT01887483|IBS|ibs
4943792|NCT01887483|bowel function|bowel function
4943793|NCT01887483|probiotic|probiotic
4943794|NCT01887470|Bowel Evacuation|bowel evacuation
4943795|NCT01887470|Colonoscopy Preparation|colonoscopy preparation
4943796|NCT01887457|voriconazole|voriconazole
4943797|NCT01887457|VFEND|vfend
4943798|NCT01887457|individualised|individualised
4943799|NCT01887457|personalised|personalised
4943800|NCT01887444|Pediatric Gastroenterology|pediatric gastroenterology
4943801|NCT01887444|Probiotics|probiotics
4943802|NCT01887444|Lactobacillus reuteri|lactobacillus reuteri
4943803|NCT01887431|Diabetes Mellitus, Type 1|diabetes mellitus, type 1
4943804|NCT01887431|Adult|adult
4943805|NCT01887431|Insulin Infusion Systems|insulin infusion systems
4943806|NCT01887431|Telecare|telecare
4943807|NCT01887418|Hypogonadism|hypogonadism
4943808|NCT01887418|Testosterone enanthate|testosterone enanthate
4943809|NCT01887405|Adrenaline|adrenaline
4943810|NCT01887405|Auto-injector|auto-injector
4943811|NCT01887405|Jext|jext
4943812|NCT01887405|Epipen|epipen
4943813|NCT01887392|Long-term Care|long-term care
4943814|NCT01887392|Knowledge Translation|knowledge translation
4943815|NCT01887379|Gastroretentive drug formulation|gastroretentive drug formulation
4943816|NCT01887379|Furosemide|furosemide
4943817|NCT01887379|Magnetic Marker Monitoring|magnetic marker monitoring
4943818|NCT01887379|Magnetic marker|magnetic marker
4943819|NCT01887379|Oedema|oedema
4943820|NCT01887366|Cocaine addiction|cocaine addiction
4943821|NCT01887366|TV-1380|tv-1380
4943822|NCT01887366|Recombinant human serum albumin (HSA) mutated butyrylcholinesterase (AlbuBChE)|recombinant human serum albumin (hsa) mutated butyrylcholinesterase (albubche)
4943823|NCT01887353|atrial fibrillation|atrial fibrillation
4943824|NCT01887353|heart failure|heart failure
4943825|NCT01887353|ranolazine|ranolazine
4943826|NCT01887353|cardioversion|cardioversion
4943827|NCT01887353|persistent AF|persistent af
4943828|NCT01887353|paroxysmal AF|paroxysmal af
4943829|NCT01887327|G6PD deficiency|g6pd deficiency
4943830|NCT01887327|ABO incompatibility|abo incompatibility
4943831|NCT01887327|Coombs positive ABO/RH incompatibility|coombs positive abo/rh incompatibility
4943832|NCT01887327|intensive phototherapy in neonates|intensive phototherapy in neonates
4943833|NCT01887327|Hyperbilirubinemia|hyperbilirubinemia
4943834|NCT01887327|Neonatal Jaundice|neonatal jaundice
4943835|NCT01887314|Cancer|cancer
4943836|NCT01887314|Cisplatin|cisplatin
4943837|NCT01887314|Nausea|nausea
4943838|NCT01887314|Ginger|ginger
4943839|NCT01887314|Zingiber officinale|zingiber officinale
4943840|NCT01887314|5HT3|5ht3
4943841|NCT01887314|Dexamethasone|dexamethasone
4943842|NCT01887314|Neurokinin-1 (NK-1)|neurokinin-1 (nk-1)
4943843|NCT01887314|Interleukin-6 (IL-6)|interleukin-6 (il-6)
4943844|NCT01887314|Tumor necrosis factor-alpha (TNF-alpha)|tumor necrosis factor-alpha (tnf-alpha)
4943845|NCT01887314|Insulin like growth factor-1 (IGF-1)|insulin like growth factor-1 (igf-1)
4943846|NCT01887314|Placebo|placebo
4943847|NCT01887314|FLIE|flie
4943848|NCT01887314|BFI|bfi
4943849|NCT01887275|Chronic hepatitis B|chronic hepatitis b
4943850|NCT01887275|Medical Ozone|medical ozone
4943851|NCT01887275|Interferon-α|interferon-α
4943852|NCT01887275|Efficacy|efficacy
4943853|NCT01887262|fluid|fluid
4943854|NCT01887262|edema|edema
4943855|NCT01887223|Encapsulated blebs|encapsulated blebs
4943856|NCT01887223|trabeculectomy failure|trabeculectomy failure
4943857|NCT01887223|glaucoma|glaucoma
4943858|NCT01887210|HIV|hiv
4943859|NCT01887210|youth|youth
4943860|NCT01887210|medical adherence|medical adherence
4943861|NCT01887197|cystic fibrosis|cystic fibrosis
4943862|NCT01887197|mucociliary clearance|mucociliary clearance
4943863|NCT01887197|airway surface liquid|airway surface liquid
4943864|NCT01887197|nuclear medicine|nuclear medicine
4943865|NCT01887197|mannitol|mannitol
4943866|NCT01887171|Liver transplantation|liver transplantation
4943867|NCT01887171|Early allograft dysfunction|early allograft dysfunction
4943868|NCT01887171|Ischemic reperfusion injury|ischemic reperfusion injury
4943869|NCT01887171|Portal and arterial ex vivo HTK flush|portal and arterial ex vivo htk flush
4943870|NCT01887145|Carpal tunnel syndrome|carpal tunnel syndrome
4943871|NCT01887145|Surgery|surgery
4943872|NCT01887145|Outcomes|outcomes
4943873|NCT01887132|Sleep Architecture|sleep architecture
4943874|NCT01887132|Autism|autism
4943875|NCT01887132|Language Development|language development
4943876|NCT01887093|coronary artery disease|coronary artery disease
4943877|NCT01887093|walking|walking
4943878|NCT01887093|lipids|lipids
4943879|NCT01887093|inflammatory markers|inflammatory markers
4943880|NCT01887093|time of day|time of day
4943881|NCT01887080|Cardiovascular rehabilitation home-based|cardiovascular rehabilitation home-based
4943882|NCT01887080|Acute myocardial infarction|acute myocardial infarction
4943883|NCT01887080|Obesity|obesity
4943884|NCT01887080|Microcurrent|microcurrent
4943885|NCT01887067|Hypertension|hypertension
4943886|NCT01887067|Diabetes Mellitus|diabetes mellitus
4943887|NCT01887041|Advanced, metastasising pancreatic head carcinoma|advanced, metastasising pancreatic head carcinoma
4943888|NCT01887041|Jaundice|jaundice
4943889|NCT01887041|Biliodigestive anastomosis|biliodigestive anastomosis
4943890|NCT01887041|Endoscopically inserted biliary tract drainage|endoscopically inserted biliary tract drainage
4943891|NCT01887041|Quality of Life|quality of life
4943892|NCT01887028|Carbon deoxide pneumoperitoneum|carbon deoxide pneumoperitoneum
4943893|NCT01887028|Intraperitoneal pressure|intraperitoneal pressure
4943894|NCT01887028|Peritoneum|peritoneum
4943895|NCT01887028|Gene expression|gene expression
4943896|NCT01887028|Post-operative recovery|post-operative recovery
4943897|NCT01887028|Laparoscopic Humidification System|laparoscopic humidification system
4943898|NCT01887015|Postoperative pulmonary complications|postoperative pulmonary complications
4943899|NCT01887015|Oxygen therapy|oxygen therapy
4943900|NCT01887015|Nasal high flow oxygen therapy|nasal high flow oxygen therapy
4943901|NCT01887015|Nasal high flow cannula|nasal high flow cannula
4943902|NCT01887002|Irritable Bowel Syndrome|irritable bowel syndrome
4943903|NCT01887002|IBS|ibs
4943904|NCT01887002|ONO-2952|ono-2952
4943905|NCT01886989|diabetes|diabetes
4943906|NCT01886989|cocoa polyphenols|cocoa polyphenols
4943907|NCT01886989|postprandial glycemia|postprandial glycemia
4943908|NCT01886989|postprandial lipemia|postprandial lipemia
4943909|NCT01886976|multiple myeloma|multiple myeloma
4943910|NCT01886950|CKD stage 5|ckd stage 5
4943911|NCT01886950|Bone histomorphometry|bone histomorphometry
4943912|NCT01886950|Renal transplantation|renal transplantation
4943913|NCT01886924|Tobacco|tobacco
4943914|NCT01886924|Nicotine|nicotine
4943915|NCT01886924|Dependence|dependence
4943916|NCT01886924|Quitline|quitline
4943917|NCT01886911|prosocial behavior|prosocial behavior
4943918|NCT01886911|prosocial|prosocial
4943919|NCT01886911|attention training|attention training
4943920|NCT01886911|attention|attention
4943921|NCT01886911|empathy|empathy
4943922|NCT01886911|emotion recognition|emotion recognition
4943923|NCT01886885|Mindfulness|mindfulness
4943924|NCT01886885|Meditation|meditation
4943925|NCT01886885|Chronic Pain|chronic pain
4943926|NCT01886833|Rotavirus|rotavirus
4943927|NCT01886833|Diarrhoea|diarrhoea
4943928|NCT01886833|Immunisation|immunisation
4943929|NCT01886833|Seroconversion|seroconversion
4943930|NCT01886833|Breastmilk|breastmilk
4943931|NCT01886833|HIV|hiv
4943932|NCT01886833|Zinc|zinc
4943933|NCT01886833|Vitamin A|vitamin a
4943934|NCT01886833|Failure|failure
4943935|NCT01886820|Dementia|dementia
4943936|NCT01886820|Alzheimer's Disease|alzheimer's disease
4943937|NCT01886820|Terminally Ill|terminally ill
4943938|NCT01886794|pelvic floor dysfunction|pelvic floor dysfunction
4943939|NCT01886794|pelvic organ prolapse|pelvic organ prolapse
4943940|NCT01886794|vaginal estrogen effects|vaginal estrogen effects
4943941|NCT01886781|only constipation and diarrhea predominant|only constipation and diarrhea predominant
4943942|NCT01886781|no mixed or alternating types|no mixed or alternating types
4943943|NCT01886768|Nasal anesthesia|nasal anesthesia
4943944|NCT01886768|endoscopes|endoscopes
4943945|NCT01886768|transnasal endoscopy|transnasal endoscopy
4943946|NCT01886755|Acute gastroenteritis|acute gastroenteritis
4943947|NCT01886755|Probiotics|probiotics
4943948|NCT01886755|Lactobacillus reuteri|lactobacillus reuteri
4943949|NCT01886755|Zinc supplementation|zinc supplementation
4943950|NCT01886755|Infants|infants
4943951|NCT01886755|Age 6 months to 36 months|age 6 months to 36 months
4943952|NCT01886742|Perioperative antibiotic prophylaxis|perioperative antibiotic prophylaxis
4943953|NCT01886742|Morbidly Obese|morbidly obese
4943954|NCT01886729|transcranial direct current stimulation|transcranial direct current stimulation
4943955|NCT01886729|time shift|time shift
4943956|NCT01886716|Alcohol Abuse|alcohol abuse
4943957|NCT01886716|Alcohol Dependence|alcohol dependence
4943958|NCT01886716|Alcohol Drinking|alcohol drinking
4943959|NCT01886716|Social Anxiety|social anxiety
4943960|NCT01886716|Social Phobia|social phobia
4943961|NCT01886716|Anxiety Disorders|anxiety disorders
4943962|NCT01886703|Physical activity|physical activity
4943963|NCT01886703|Exercise|exercise
4943964|NCT01886703|Quality of Life|quality of life
4943965|NCT01886703|Radiation Therapy|radiation therapy
4943966|NCT01886703|Breast Cancer|breast cancer
4943967|NCT01886703|Head and Neck Cancer|head and neck cancer
4943968|NCT01886677|prostate cancer|prostate cancer
4943969|NCT01886677|intervention|intervention
4943970|NCT01886677|diet|diet
4943971|NCT01886677|physical activity|physical activity
4943972|NCT01886677|exercise|exercise
4943973|NCT01886677|weight loss|weight loss
4943974|NCT01886677|biomarkers|biomarkers
4943975|NCT01886677|cancer progression|cancer progression
4943976|NCT01886651|acute lymphoblastic leukemia|acute lymphoblastic leukemia
4943977|NCT01886651|child|child
4943978|NCT01886651|6-mercaptopurine|6-mercaptopurine
4943979|NCT01886651|methotrexate|methotrexate
4943980|NCT01886638|Platelets|platelets
4943981|NCT01886638|HIV|hiv
4943982|NCT01886638|Cardiovascular disease|cardiovascular disease
4943983|NCT01886638|Acute myocardial infarction|acute myocardial infarction
4943984|NCT01886638|Abacavir|abacavir
4943985|NCT01886638|Antiretrovirals|antiretrovirals
4943986|NCT01886612|Deep Vein Thrombosis|deep vein thrombosis
4943987|NCT01886612|Neuromuscular Electrical Stimulation|neuromuscular electrical stimulation
4943988|NCT01886612|Intermittent Pneumatic Compression|intermittent pneumatic compression
4943989|NCT01886612|Doppler Ultrasound|doppler ultrasound
4943990|NCT01886586|Mild Cognitive Impairment|mild cognitive impairment
4943991|NCT01886586|memory impairment|memory impairment
4943992|NCT01886586|problem-solving therapy|problem-solving therapy
4943993|NCT01886586|depression prevention|depression prevention
4943994|NCT01886586|caregiver stress|caregiver stress
4943995|NCT01886586|exercise|exercise
4943996|NCT01886534|Heart failure|heart failure
4943997|NCT01886534|Heart diseases|heart diseases
4943998|NCT01886534|Cardiovascular diseases|cardiovascular diseases
4943999|NCT01886534|Health information technology|health information technology
4944000|NCT01886534|Disease management|disease management
4944001|NCT01886534|Patient care management|patient care management
4944002|NCT01886534|Self care|self care
4944003|NCT01886534|Informal caregiver|informal caregiver
4944004|NCT01886534|Care partner|care partner
4944005|NCT01886534|Peer support|peer support
4944006|NCT01886534|Transitional care|transitional care
4944007|NCT01886534|Patient education|patient education
4944008|NCT01886534|Teach-back|teach-back
4944009|NCT01886534|Clinical decision aid|clinical decision aid
4944010|NCT01886443|Liver|liver
4944011|NCT01886443|Transplantation|transplantation
4944012|NCT01886443|Ischemia-reperfusion|ischemia-reperfusion
4944013|NCT01886443|Safety|safety
4944014|NCT01886404|HIV|hiv
4944015|NCT01886404|efavirenz|efavirenz
4944016|NCT01886404|Sustiva|sustiva
4944017|NCT01886404|pharmacokinetics|pharmacokinetics
4944018|NCT01886404|Pharmacogenomics|pharmacogenomics
4944019|NCT01886391|Heart Failure|heart failure
4944020|NCT01886391|Dyspnea|dyspnea
4944021|NCT01886391|Diaphragmatic breathing retraining|diaphragmatic breathing retraining
4944022|NCT01886391|Fatigue|fatigue
4944023|NCT01886391|Health-related Outcomes|health-related outcomes
4944024|NCT01886378|FAOD|faod
4944025|NCT01886378|VLCAD|vlcad
4944026|NCT01886378|CPT II|cpt ii
4944027|NCT01886378|CPT2|cpt2
4944028|NCT01886378|CPT 2|cpt 2
4944029|NCT01886378|LCHAD|lchad
4944030|NCT01886378|UX007|ux007
4944031|NCT01886378|Triheptanoin|triheptanoin
4944033|NCT01886378|C7|c7
4944034|NCT01886365|Computer based glycemic control, insulin, blood glucose|computer based glycemic control, insulin, blood glucose
4944035|NCT01886352|laparoscopic|laparoscopic
4944036|NCT01886352|pain|pain
4944037|NCT01886326|Obesity|obesity
4944038|NCT01886326|energy balance|energy balance
4944039|NCT01886326|variety|variety
4944040|NCT01886326|nut intake|nut intake
4944041|NCT01886313|Herpes Zoster|herpes zoster
4944042|NCT01886313|Postherpetic Neuralgia|postherpetic neuralgia
4944043|NCT01886313|Shingles|shingles
4944044|NCT01886313|Civamide|civamide
4944045|NCT01886313|Zucapsaicin|zucapsaicin
4944046|NCT01886313|Neuropeptides|neuropeptides
4944047|NCT01886313|TRPV-1|trpv-1
4944048|NCT01886287|endocrine system|endocrine system
4944049|NCT01886287|neuroendocrine tumors|neuroendocrine tumors
4944050|NCT01886287|neuroendocrine cancer|neuroendocrine cancer
4944051|NCT01886287|metastatic|metastatic
4944052|NCT01886287|neuroendocrine|neuroendocrine
4944053|NCT01886287|gastrointestinal (GI)|gastrointestinal (gi)
4944054|NCT01886287|high-dose octreotide|high-dose octreotide
4944055|NCT01886287|flushing|flushing
4944056|NCT01886287|diarrhea|diarrhea
4944057|NCT01886287|quality of life in patients|quality of life in patients
4944058|NCT01886287|disease-related symptoms|disease-related symptoms
4944059|NCT01886274|EEG|eeg
4944060|NCT01886274|migraine|migraine
4944061|NCT01886274|pain|pain
4944062|NCT01886274|phosphene|phosphene
4944063|NCT01886274|tDCs|tdcs
4944064|NCT01886274|TMS|tms
4944065|NCT01886261|validation|validation
4944066|NCT01886261|physical activity|physical activity
4944067|NCT01886261|place-based interventions|place-based interventions
4944068|NCT01886261|construct validity|construct validity
4944069|NCT01886261|divergent validity|divergent validity
4944070|NCT01886261|usability|usability
4944071|NCT01886261|gps|gps
4944072|NCT01886261|PALMS|palms
4944073|NCT01886248|hepatic veno-occlusive disease after hematopoietic stem cell transplantation|hepatic veno-occlusive disease after hematopoietic stem cell transplantation
4944074|NCT01886222|Traumatic brain injury|traumatic brain injury
4944075|NCT01886196|elderly|elderly
4944076|NCT01886196|women|women
4944077|NCT01886196|exercise|exercise
4944078|NCT01886196|pQCT|pqct
4944079|NCT01886196|ibuprofen|ibuprofen
4944080|NCT01886183|Postural Balance|postural balance
4944081|NCT01886183|Virtual Reality Exposure Therapy|virtual reality exposure therapy
4944082|NCT01886183|Gait|gait
4944083|NCT01886183|Stroke|stroke
4944084|NCT01886170|Adults with self-reported diagnosis of diabetes recruited from waiting rooms at outpatient primary care sites at the University of Pennsylvania|adults with self-reported diagnosis of diabetes recruited from waiting rooms at outpatient primary care sites at the university of pennsylvania
4944085|NCT01886157|trigger finger|trigger finger
4944086|NCT01886157|orthotic intervention|orthotic intervention
4944087|NCT01886144|OA|oa
4944088|NCT01886144|arthritis|arthritis
4944089|NCT01886144|knee OA|knee oa
4944090|NCT01886131|REM behaviour disorder|rem behaviour disorder
4944091|NCT01886131|Subthalamic nucleus|subthalamic nucleus
4944092|NCT01886131|Local field potential|local field potential
4944093|NCT01886131|Motor control|motor control
4944094|NCT01886118|In vitro fertilization|in vitro fertilization
4944095|NCT01886118|Autologous Endometrial Co-Culture|autologous endometrial co-culture
4944096|NCT01886105|Osteosarcoma|osteosarcoma
4944097|NCT01886105|Osteogenic Sarcoma|osteogenic sarcoma
4944098|NCT01886105|Sarcoma|sarcoma
4944099|NCT01886105|Bone Cancer|bone cancer
4944100|NCT01886092|tinnitus|tinnitus
4944101|NCT01886027|IBS|ibs
4944102|NCT01886027|Relaxation|relaxation
4944103|NCT01886027|Emotional exposure|emotional exposure
4944104|NCT01886027|Emotional Processing|emotional processing
4944105|NCT01886014|pain|pain
4944106|NCT01886014|pain modulation|pain modulation
4944107|NCT01886014|placebo analgesia|placebo analgesia
4944108|NCT01886001|Newborn Intensive Care Unit|newborn intensive care unit
4944109|NCT01886001|Neonatal Intensive Care Unit|neonatal intensive care unit
4944110|NCT01886001|Colonization|colonization
4944111|NCT01886001|Line Colonization|line colonization
4944112|NCT01886001|Umbilical line|umbilical line
4944113|NCT01886001|Umbilical Cord Care|umbilical cord care
4944114|NCT01885988|Erectile dysfunction|erectile dysfunction
4944115|NCT01885975|Apical Ballooning syndrome|apical ballooning syndrome
4944116|NCT01885975|Personality|personality
4944117|NCT01885962|pressure ulcer prevention|pressure ulcer prevention
4944118|NCT01885962|spinal cord injury|spinal cord injury
4944119|NCT01885962|internet delivered pressure ulcer intervention|internet delivered pressure ulcer intervention
4944120|NCT01885949|Metastatic|metastatic
4944121|NCT01885936|LOPD|lopd
4944122|NCT01885936|Pompe Disease|pompe disease
4944123|NCT01885923|schizophrenia; relapse prevention; information technology|schizophrenia; relapse prevention; information technology
4944124|NCT01885897|Acute myelogenous leukemia (AML)|acute myelogenous leukemia (aml)
4944125|NCT01885897|Acute lymphoblastic leukemia (ALL)|acute lymphoblastic leukemia (all)
4944126|NCT01885897|Myelodysplastic syndromes (MDS)|myelodysplastic syndromes (mds)
4944127|NCT01885897|Lymphoma|lymphoma
4944128|NCT01885897|Myeloma|myeloma
4944129|NCT01885897|Chronic Lymphocytic Leukemia (CLL)|chronic lymphocytic leukemia (cll)
4944130|NCT01885897|Chronic myelogenous leukemia (CML)|chronic myelogenous leukemia (cml)
4944131|NCT01885884|Supportive Care|supportive care
4944132|NCT01885884|Palliative Care|palliative care
4944133|NCT01885884|Pancreatic Cancer|pancreatic cancer
4944134|NCT01885884|Embedded, coordinated model of supportive care within oncology care|embedded, coordinated model of supportive care within oncology care
4944135|NCT01885884|Patient and Caregiver support|patient and caregiver support
4944136|NCT01885871|Sun|sun
4944137|NCT01885871|Age|age
4944138|NCT01885871|Spot|spot
4944139|NCT01885858|health services research|health services research
4944140|NCT01885858|family planning|family planning
4944141|NCT01885858|ethnicity|ethnicity
4944142|NCT01885858|healthcare disparities|healthcare disparities
4944143|NCT01885845|postpartum blood loss measurement|postpartum blood loss measurement
4944144|NCT01885845|BRASSS-V drape|brasss-v drape
4944145|NCT01885832|autologous adipose stem cells|autologous adipose stem cells
4944146|NCT01885832|stromal vascular fraction|stromal vascular fraction
4944147|NCT01885832|osteoarthritis|osteoarthritis
4944148|NCT01885819|Adipose stromal vascular fraction|adipose stromal vascular fraction
4944149|NCT01885819|Rheumatoid arthritis|rheumatoid arthritis
4944150|NCT01885819|adult stem cells|adult stem cells
4944151|NCT01885806|Apathy; Alzheimer's disease; Cognition; Burden of Care|apathy; alzheimer's disease; cognition; burden of care
4944152|NCT01885780|Astigmatism, arcuate incisions, astigmatic keratotomy|astigmatism, arcuate incisions, astigmatic keratotomy
4944153|NCT01885767|Neurofibromatosis|neurofibromatosis
4944155|NCT01885767|Neurofibromatosis 1|neurofibromatosis 1
4944156|NCT01885767|NF1|nf1
4944157|NCT01885767|Neurofibromatosis 2|neurofibromatosis 2
4944158|NCT01885767|NF2|nf2
4944159|NCT01885767|Schwannomatosis|schwannomatosis
4944160|NCT01885754|Biopsy|biopsy
4944161|NCT01885754|Maximal incremental cardiopulmonary test|maximal incremental cardiopulmonary test
4944162|NCT01885754|Muscle strength test|muscle strength test
4944163|NCT01885754|magnetic stimulation|magnetic stimulation
4944164|NCT01885702|Dendritic cell vaccination|dendritic cell vaccination
4944165|NCT01885702|MSI-high colorectal cancer (CRC)|msi-high colorectal cancer (crc)
4944166|NCT01885702|Vaccines|vaccines
4944167|NCT01885702|Immunotherapy|immunotherapy
4944168|NCT01885702|CRC|crc
4944169|NCT01885702|Germline MMR-gene mutation without disease criteria of CRC|germline mmr-gene mutation without disease criteria of crc
4944170|NCT01885663|Umbilical cord blood|umbilical cord blood
4944171|NCT01885663|Acquired brain injury|acquired brain injury
4944172|NCT01885650|Non invasive ventilation|non invasive ventilation
4944173|NCT01885650|Chest physiotherapy|chest physiotherapy
4944174|NCT01885650|Airway clearance|airway clearance
4944175|NCT01885637|Palliative|palliative
4944176|NCT01885637|Palliation|palliation
4944177|NCT01885637|Cancer|cancer
4944178|NCT01885637|Care|care
4944179|NCT01885637|SPC|spc
4944180|NCT01885637|Caregivers|caregivers
4944181|NCT01885637|Home Care Services, Hospital-Based|home care services, hospital-based
4944182|NCT01885637|Psychological|psychological
4944183|NCT01885637|From Oncological Treatment to Palliative Care at Home|from oncological treatment to palliative care at home
4944184|NCT01885637|Place of death|place of death
4944185|NCT01885624|TAB08|tab08
4944186|NCT01885624|healthy volunteers|healthy volunteers
4944187|NCT01885611|Leprosy|leprosy
4944188|NCT01885572|breast reconstruction|breast reconstruction
4944189|NCT01885572|mastectomy|mastectomy
4944190|NCT01885572|mesh|mesh
4944191|NCT01885572|breast cancer|breast cancer
4944192|NCT01885559|polycystic kidney disease|polycystic kidney disease
4944193|NCT01885559|polycystic|polycystic
4944194|NCT01885559|kidney|kidney
4944195|NCT01885559|disease|disease
4944196|NCT01885559|adpkd|adpkd
4944197|NCT01885559|halt|halt
4944198|NCT01885559|pkd|pkd
4944199|NCT01885559|blood pressure|blood pressure
4944200|NCT01885559|bp|bp
4944201|NCT01885559|hypertension|hypertension
4944202|NCT01885559|renal|renal
4944203|NCT01885559|renin-angiotensin-aldosterone-system|renin-angiotensin-aldosterone-system
4944204|NCT01885559|RAAS|raas
4944205|NCT01885546|diabetes|diabetes
4944206|NCT01885546|glucose|glucose
4944207|NCT01885546|glucometer|glucometer
4944208|NCT01885533|Graves' disease|graves' disease
4944209|NCT01885533|radioiodine|radioiodine
4944210|NCT01885533|thyroid|thyroid
4944211|NCT01885533|hypothyroidism|hypothyroidism
4944212|NCT01885533|Graves' orbitopathy|graves' orbitopathy
4944213|NCT01885520|low back pain|low back pain
4944214|NCT01885481|dexamethasone|dexamethasone
4944215|NCT01885481|betamethasone|betamethasone
4944216|NCT01885481|epidural steroid injection|epidural steroid injection
4944217|NCT01885481|comparative effectiveness research|comparative effectiveness research
4944218|NCT01885468|Hydrocephalus shunt|hydrocephalus shunt
4944219|NCT01885468|proGAV|progav
4944220|NCT01885455|non-small cell lung cancer (NSCLC)|non-small cell lung cancer (nsclc)
4944221|NCT01885442|mechanical ventilation|mechanical ventilation
4944222|NCT01885442|cycle ergometry|cycle ergometry
4944223|NCT01885442|intensive care unit|intensive care unit
4944224|NCT01885442|rehabilitation|rehabilitation
4944225|NCT01885429|Protein Turnover|protein turnover
4944226|NCT01885429|Resistance Exercise|resistance exercise
4944227|NCT01885429|Whey Protein|whey protein
4944228|NCT01885429|Leucine|leucine
4944229|NCT01885403|Acute Cardiogenic Pulmonary Edema,|acute cardiogenic pulmonary edema,
4944230|NCT01885403|Acute Decompensated Heart Failure,|acute decompensated heart failure,
4944231|NCT01885403|BiLevel Positive Airway Pressure,|bilevel positive airway pressure,
4944232|NCT01885403|Continuous Positive Airway Pressure|continuous positive airway pressure
4944233|NCT01885390|Hypertension|hypertension
4944234|NCT01885390|High blood pressure|high blood pressure
4944235|NCT01885390|Resistant blood pressure|resistant blood pressure
4944236|NCT01885390|Uncontrolled blood pressure|uncontrolled blood pressure
4944237|NCT01885377|Subacromial pain|subacromial pain
4944238|NCT01885377|Impingement|impingement
4944239|NCT01885377|Exercises|exercises
4944240|NCT01885377|Physical therapy|physical therapy
4944241|NCT01885377|Primary care|primary care
4944242|NCT01885364|esmolol|esmolol
4944243|NCT01885364|pain|pain
4944244|NCT01885364|propofol|propofol
4944245|NCT01885364|remifentanil|remifentanil
4944246|NCT01885351|Colorectal Cancer Screening|colorectal cancer screening
4944247|NCT01885351|Ambulatory Care|ambulatory care
4944248|NCT01885351|Patient-Centered Care|patient-centered care
4944249|NCT01885351|Intervention Studies|intervention studies
4944250|NCT01885351|Longitudinal Studies|longitudinal studies
4944251|NCT01885338|Schizophrenia|schizophrenia
4944252|NCT01885338|Cognition|cognition
4944253|NCT01885338|Neurocognition|neurocognition
4944254|NCT01885338|N-Acetylcysteine|n-acetylcysteine
4944255|NCT01885338|NAC|nac
4944256|NCT01885338|EEG|eeg
4944257|NCT01885325|Physical Activity|physical activity
4944258|NCT01885325|Sedentary Behavior|sedentary behavior
4944259|NCT01885325|Preschool Children|preschool children
4944260|NCT01885312|Drinking|drinking
4944261|NCT01885312|Heavy Drinking|heavy drinking
4944262|NCT01885312|Technology|technology
4944263|NCT01885312|Mobile Phone|mobile phone
4944264|NCT01885312|Text Message|text message
4944265|NCT01885312|Problem Drinking|problem drinking
4944266|NCT01885312|Alcohol Problems|alcohol problems
4944267|NCT01885312|Alcoholism|alcoholism
4944268|NCT01885312|Moderation-Oriented Treatment|moderation-oriented treatment
4944269|NCT01885312|Controlled Drinking|controlled drinking
4944270|NCT01885312|Reduced Drinking|reduced drinking
4944271|NCT01885299|Radiosurgery|radiosurgery
4944272|NCT01885299|CyberKnife|cyberknife
4944273|NCT01885299|Benign tumors|benign tumors
4944274|NCT01885299|Malignant tumors|malignant tumors
4944275|NCT01885299|Cranial tumors|cranial tumors
4944276|NCT01885299|Extracranial tumors|extracranial tumors
4944278|NCT01885299|Liver|liver
4944279|NCT01885299|Pancreas|pancreas
4944280|NCT01885299|Prostate|prostate
4944281|NCT01885299|Stereotactic radiosurgery|stereotactic radiosurgery
4944282|NCT01885299|Stereotactic body radiotherapy|stereotactic body radiotherapy
4944283|NCT01885286|circumcision|circumcision
4944284|NCT01885286|HIV prevention|hiv prevention
4944285|NCT01885273|pressurized irrigation|pressurized irrigation
4944286|NCT01885273|wound cleansing method|wound cleansing method
4944287|NCT01885273|irrigation|irrigation
4944288|NCT01885273|swabbing|swabbing
4944289|NCT01885273|appropriate pressure for irrigation|appropriate pressure for irrigation
4944290|NCT01885260|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
4944291|NCT01885260|T2DM|t2dm
4944292|NCT01885234|Glycated hemoglobin|glycated hemoglobin
4944293|NCT01885234|HOMA|homa
4944294|NCT01885234|Pregnancy|pregnancy
4944295|NCT01885234|aerobic exercise|aerobic exercise
4944296|NCT01885221|smokeless tobacco cessation|smokeless tobacco cessation
4944297|NCT01885221|social support|social support
4944298|NCT01885221|partner support|partner support
4944299|NCT01885195|RAS, RAF, MEK, NF1, MEK162, signature, papillary thyroid, small intestine, bladder, esophagus, lung cancer, NSCLC, acute myelogenous leukemia, AML|ras, raf, mek, nf1, mek162, signature, papillary thyroid, small intestine, bladder, esophagus, lung cancer, nsclc, acute myelogenous leukemia, aml
4944300|NCT01885169|Cystic fibrosis|cystic fibrosis
4944301|NCT01885169|Influenza|influenza
4944302|NCT01885169|Vaccine|vaccine
4944303|NCT01885143|Mammography|mammography
4944304|NCT01885117|Influenza,|influenza,
4944305|NCT01885117|Adults,|adults,
4944306|NCT01885117|Elderly,|elderly,
4944307|NCT01885117|Immunology,|immunology,
4944308|NCT01885117|Safety|safety
4944309|NCT01885052|Smoking Cessation Clinical Trial|smoking cessation clinical trial
4944310|NCT01885052|Text Messaging Program|text messaging program
4944311|NCT01885052|Smoking Cessation Aid|smoking cessation aid
4944312|NCT01885039|Cancer|cancer
4944313|NCT01885039|Breast Cancer|breast cancer
4944314|NCT01885039|Molecular Subtypes|molecular subtypes
4944315|NCT01885039|Asian Breast Cancer|asian breast cancer
4944316|NCT01885026|Randomized Controlled Trial|randomized controlled trial
4944317|NCT01885026|Alcohol|alcohol
4944318|NCT01885026|Drugs|drugs
4944319|NCT01885026|Internet|internet
4944320|NCT01885026|Screening|screening
4944321|NCT01885026|Brief intervention|brief intervention
4944322|NCT01885013|HER2 negative|her2 negative
4944323|NCT01885013|metastatic breast cancer|metastatic breast cancer
4944324|NCT01885013|non endocrine responsive disease|non endocrine responsive disease
4944325|NCT01884974|Myeloproliferative disease|myeloproliferative disease
4944326|NCT01884974|Pulmonary Hypertension|pulmonary hypertension
4944327|NCT01884948|at least 1 segment|at least 1 segment
4944328|NCT01884948|multiple wedge resections (≥3)|multiple wedge resections (≥3)
4944329|NCT01884935|Pediatric|pediatric
4944330|NCT01884922|Children|children
4944331|NCT01884922|adolescents|adolescents
4944332|NCT01884922|young adults|young adults
4944333|NCT01884870|Asymptomatic|asymptomatic
4944334|NCT01884870|ureteral|ureteral
4944335|NCT01884870|calculi|calculi
4944336|NCT01884870|renal function|renal function
4944337|NCT01884870|treatment|treatment
4944338|NCT01884831|damage to the skin, the skin equivalent, cell therapy|damage to the skin, the skin equivalent, cell therapy
4944339|NCT01884818|Thoracic spine, pain, manipulation|thoracic spine, pain, manipulation
4944340|NCT01884805|Adaptive Optics Visual Simulator|adaptive optics visual simulator
4944341|NCT01884805|Wavefront aberrometer|wavefront aberrometer
4944342|NCT01884805|Optical Aberrations|optical aberrations
4944343|NCT01884805|Hyperopia|hyperopia
4944344|NCT01884792|prediabetes|prediabetes
4944345|NCT01884792|physical inactivity|physical inactivity
4944346|NCT01884792|sedentary|sedentary
4944347|NCT01884792|standing|standing
4944348|NCT01884779|HIV|hiv
4944349|NCT01884779|Histoplasmosis|histoplasmosis
4944350|NCT01884779|Histoplasma capsulatum var.capsulatum|histoplasma capsulatum var.capsulatum
4944351|NCT01884779|ELISA test|elisa test
4944352|NCT01884753|lower urinary tract symptoms|lower urinary tract symptoms
4944353|NCT01884753|overactive bladder syndrome|overactive bladder syndrome
4944354|NCT01884753|antimuscarinic drug|antimuscarinic drug
4944355|NCT01884753|three-dimensional power Doppler ultrasound|three-dimensional power doppler ultrasound
4944356|NCT01884753|sexual dysfunction|sexual dysfunction
4944357|NCT01884740|GBM|gbm
4944358|NCT01884740|AA|aa
4944359|NCT01884740|FA|fa
4944360|NCT01884740|PXA|pxa
4944361|NCT01884740|AOA|aoa
4944362|NCT01884740|High grade glioma|high grade glioma
4944363|NCT01884727|Obesity|obesity
4944364|NCT01884727|Overweight|overweight
4944365|NCT01884727|Over nutrition|over nutrition
4944366|NCT01884727|nutrition disorders|nutrition disorders
4944367|NCT01884727|energy expenditure|energy expenditure
4944368|NCT01884727|metabolic rate|metabolic rate
4944369|NCT01884714|diabetes|diabetes
4944370|NCT01884714|obesity|obesity
4944371|NCT01884714|metabolism|metabolism
4944372|NCT01884714|clinical study|clinical study
4944373|NCT01884701|Chronic Total Occlusion CTO|chronic total occlusion cto
4944374|NCT01884688|Asymptomatic Multiple Myeloma|asymptomatic multiple myeloma
4944375|NCT01884688|Auto-ENK Cell Therapy|auto-enk cell therapy
4944376|NCT01884688|Natural Killer Cells|natural killer cells
4944377|NCT01884675|Endothelin Receptor Antagonist|endothelin receptor antagonist
4944378|NCT01884675|Inoperable Chronic Thromboembolic Pulmonary Hypertension|inoperable chronic thromboembolic pulmonary hypertension
4944379|NCT01884662|spinal cord injury|spinal cord injury
4944380|NCT01884662|neuropathic pain|neuropathic pain
4944381|NCT01884649|Acute phase reactant, fetuin A, Hashimoto thyroiditis|acute phase reactant, fetuin a, hashimoto thyroiditis
4944382|NCT01884636|Isavuconazole|isavuconazole
4944383|NCT01884636|Pharmacokinetics|pharmacokinetics
4944384|NCT01884636|Healthy Subjects|healthy subjects
4944385|NCT01884636|BAL8557|bal8557
4944386|NCT01884636|BAL4815|bal4815
4944387|NCT01884636|methotrexate|methotrexate
4944388|NCT01884597|PEARL2|pearl2
4944389|NCT01884597|PCV|pcv
4944390|NCT01884597|Polypoidal Choroidal Vasculopathy|polypoidal choroidal vasculopathy
4944391|NCT01884571|Immunosuppression|immunosuppression
4944392|NCT01884571|ALS|als
4944393|NCT01884571|Neuromuscular Disorders|neuromuscular disorders
4944394|NCT01884558|Isavuconazole|isavuconazole
4944395|NCT01884558|Pharmacokinetics|pharmacokinetics
4944396|NCT01884558|Healthy Subjects|healthy subjects
4944397|NCT01884558|BAL8557|bal8557
4944398|NCT01884558|BAL4815|bal4815
4944399|NCT01884558|metformin|metformin
4944400|NCT01884545|heart disease|heart disease
4944401|NCT01884545|type 2 diabetes|type 2 diabetes
4944402|NCT01884545|genetic testing|genetic testing
4944403|NCT01884545|health coaching|health coaching
4944404|NCT01884545|risk assessment|risk assessment
4944405|NCT01884532|Adverse Local Tissue Reaction|adverse local tissue reaction
4944406|NCT01884532|Metal Ions|metal ions
4944407|NCT01884532|Serum|serum
4944408|NCT01884532|Whole Blood|whole blood
4944409|NCT01884532|Metal-on-Metal|metal-on-metal
4944410|NCT01884532|Total Hip Arthroplasty|total hip arthroplasty
4944411|NCT01884532|ASR-XL Metal-on-Metal|asr-xl metal-on-metal
4944412|NCT01884532|Revised ASR-XL Metal-on-Metal|revised asr-xl metal-on-metal
4944413|NCT01884519|Elderly|elderly
4944414|NCT01884519|Influenza|influenza
4944415|NCT01884519|Safety|safety
4944416|NCT01884519|Adults|adults
4944417|NCT01884519|Immunogenicity|immunogenicity
4944418|NCT01884493|Parkinson's Disease|parkinson's disease
4944419|NCT01884493|Freezing of Gait|freezing of gait
4944420|NCT01884493|movement-related cortical potential|movement-related cortical potential
4944421|NCT01884493|repetitive transcranial magnetic stimulation|repetitive transcranial magnetic stimulation
4944422|NCT01884480|Advagraf, pharmacogenetics, Cyp3A5|advagraf, pharmacogenetics, cyp3a5
4944423|NCT01884467|Urinary Tract Infections|urinary tract infections
4944424|NCT01884467|Gentamicin|gentamicin
4944425|NCT01884454|sleep|sleep
4944426|NCT01884454|obstructive sleep apnea|obstructive sleep apnea
4944427|NCT01884454|reproduction|reproduction
4944428|NCT01884454|sperm|sperm
4944429|NCT01884454|hormones|hormones
4944430|NCT01884454|men|men
4944431|NCT01884441|Hodgkin|hodgkin
4944432|NCT01884441|Lymphoma|lymphoma
4944433|NCT01884441|refractory|refractory
4944434|NCT01884441|relapsed|relapsed
4944435|NCT01884428|Hodgkin|hodgkin
4944436|NCT01884428|Lymphoma|lymphoma
4944437|NCT01884389|HIV|hiv
4944438|NCT01884389|Chronic disease|chronic disease
4944439|NCT01884389|Early palliative care|early palliative care
4944440|NCT01884389|Patient navigation|patient navigation
4944441|NCT01884376|nerve biopsy|nerve biopsy
4944442|NCT01884376|nerve regeneration|nerve regeneration
4944443|NCT01884376|neuroma pain|neuroma pain
4944444|NCT01884376|loss of sensation|loss of sensation
4944445|NCT01884363|Endothelial function|endothelial function
4944446|NCT01884363|walnuts|walnuts
4944447|NCT01884363|clinical trial|clinical trial
4944448|NCT01884363|Nutrition|nutrition
4944449|NCT01884363|cardiovascular disease|cardiovascular disease
4944450|NCT01884324|Gastroschisis|gastroschisis
4944451|NCT01884324|Cesarean delivery|cesarean delivery
4944452|NCT01884324|Neonatal outcomes|neonatal outcomes
4944453|NCT01884311|Primary Immune Deficiency Disorders|primary immune deficiency disorders
4944454|NCT01884311|Common Variable Immunodeficiency|common variable immunodeficiency
4944455|NCT01884311|X-linked agammaglobulinaemia|x-linked agammaglobulinaemia
4944456|NCT01884311|Hyper-IgM Syndrome|hyper-igm syndrome
4944457|NCT01884311|Subcutaneous|subcutaneous
4944458|NCT01884311|Immunoglobulins|immunoglobulins
4944459|NCT01884298|remifentanil|remifentanil
4944460|NCT01884298|isolated systolic hypertension|isolated systolic hypertension
4944461|NCT01884298|morbidity|morbidity
4944462|NCT01884298|epidural combined general anesthesia|epidural combined general anesthesia
4944463|NCT01884285|Advanced Castrate-resistant Prostate Cancer(CRPC)|advanced castrate-resistant prostate cancer(crpc)
4944464|NCT01884285|Squamous Non-Small Cell Lung Cancer(sqNSCLC)|squamous non-small cell lung cancer(sqnsclc)
4944465|NCT01884285|Triple Negative Breast Cancer(TNBC)|triple negative breast cancer(tnbc)
4944466|NCT01884285|PTEN-deficient/mutated Advanced Solid Malignancies|pten-deficient/mutated advanced solid malignancies
4944467|NCT01884285|PIK3CB mutated/amplified advanced solid malignancies|pik3cb mutated/amplified advanced solid malignancies
4944468|NCT01884259|local advanced squamous cell carcinoma|local advanced squamous cell carcinoma
4944469|NCT01884259|Larynx|larynx
4944470|NCT01884259|Hypopharynx|hypopharynx
4944471|NCT01884259|Oropharynx|oropharynx
4944472|NCT01884259|Cavum oris|cavum oris
4944473|NCT01884259|docetaxel|docetaxel
4944474|NCT01884259|cisplatin|cisplatin
4944475|NCT01884259|5-fluorouracil|5-fluorouracil
4944476|NCT01884259|Cetuximab|cetuximab
4944477|NCT01884246|lifestyle change|lifestyle change
4944478|NCT01884246|behavior change|behavior change
4944479|NCT01884246|obesity|obesity
4944480|NCT01884246|hypertension|hypertension
4944481|NCT01884246|hyperlipidemia|hyperlipidemia
4944482|NCT01884246|physical inactivity|physical inactivity
4944483|NCT01884246|depression|depression
4944484|NCT01884233|HIV|hiv
4944485|NCT01884233|Opioid Abuse|opioid abuse
4944486|NCT01884233|Mobile technology|mobile technology
4944487|NCT01884220|Wolman Disease|wolman disease
4944488|NCT01884220|Cholesteryl Ester Storage Disease|cholesteryl ester storage disease
4944489|NCT01884220|Enzyme deficiency|enzyme deficiency
4944490|NCT01884220|Natural History|natural history
4944491|NCT01884220|Medical Records Review|medical records review
4944492|NCT01884194|retinoblastoma|retinoblastoma
4944493|NCT01884194|pineoblastoma|pineoblastoma
4944494|NCT01884181|Huntington Disease, diffusion MRI, diagnosis, fast imaging|huntington disease, diffusion mri, diagnosis, fast imaging
4944495|NCT01884129|Circulating tumor cells|circulating tumor cells
4944496|NCT01884129|Head and neck cancer|head and neck cancer
4944497|NCT01884129|Squamous cell carcinoma|squamous cell carcinoma
4944498|NCT01884129|Survival|survival
4944499|NCT01884129|Prognosis|prognosis
4944500|NCT01884116|Capsaicin|capsaicin
4944501|NCT01884116|myofascial pain syndrome|myofascial pain syndrome
4944502|NCT01884116|non-steroidal anti-inflammatory agents|non-steroidal anti-inflammatory agents
4944503|NCT01884116|transcutaneous electric nerve stimulation|transcutaneous electric nerve stimulation
4944504|NCT01884103|TBI|tbi
4944505|NCT01884103|Trauma|trauma
4944506|NCT01884103|Traumatic Brain Injury|traumatic brain injury
4944507|NCT01884090|Empowerment|empowerment
4944508|NCT01884090|Youth|youth
4944509|NCT01884090|Violence|violence
4944510|NCT01884090|Community|community
4944511|NCT01884090|Prevention|prevention
4944512|NCT01884077|patient outcomes two years after shoulder replacement|patient outcomes two years after shoulder replacement
4944513|NCT01884077|seventy years of age and older|seventy years of age and older
4944514|NCT01884064|focal hand dystonia|focal hand dystonia
4944515|NCT01884064|rehabilitation|rehabilitation
4944516|NCT01884064|rTMS|rtms
4944517|NCT01884064|writer's cramp|writer's cramp
4944518|NCT01884064|clinical|clinical
4944519|NCT01884051|Pulmonary arterial hypertension|pulmonary arterial hypertension
4944520|NCT01884038|Liver Transplant|liver transplant
4944521|NCT01884038|Prostacyclin|prostacyclin
4944522|NCT01884038|Treprostinil sodium|treprostinil sodium
4944523|NCT01884038|Remodulin|remodulin
4944524|NCT01884038|Reperfusion Injury|reperfusion injury
4944525|NCT01884038|Primary Nonfunction|primary nonfunction
4944526|NCT01884025|patient centered care|patient centered care
4944527|NCT01884025|physical activity|physical activity
4944528|NCT01884025|behavioral activation|behavioral activation
4944529|NCT01884025|self efficacy|self efficacy
4944530|NCT01884025|serious mental illness|serious mental illness
4944531|NCT01883986|palliative care|palliative care
4944532|NCT01883973|PD|pd
4944533|NCT01883973|DBS|dbs
4944534|NCT01883960|cerebral palsy|cerebral palsy
4944535|NCT01883960|cerebral vascular accident|cerebral vascular accident
4944536|NCT01883960|multi-modal brain techniques|multi-modal brain techniques
4944537|NCT01883960|MRI|mri
4944538|NCT01883960|motor control|motor control
4944539|NCT01883947|Stroke|stroke
4944540|NCT01883947|Massage|massage
4944541|NCT01883947|General Health|general health
4944542|NCT01883947|Independence|independence
4944543|NCT01883934|In Vitro Fertilization (IVF)|in vitro fertilization (ivf)
4944544|NCT01883934|Embryo donation|embryo donation
4944545|NCT01883921|Primary Immunodeficiency|primary immunodeficiency
4944546|NCT01883921|Immunodeficiencies|immunodeficiencies
4944547|NCT01883921|Primary Immunodeficiency Diseases|primary immunodeficiency diseases
4944548|NCT01883921|PIDD|pidd
4944549|NCT01883921|CVID|cvid
4944550|NCT01883921|PI|pi
4944551|NCT01883921|Common Variable Immunodeficiency|common variable immunodeficiency
4944552|NCT01883921|Hypogammaglobulinemia|hypogammaglobulinemia
4944553|NCT01883921|Acquired Hypogammaglobulinemia|acquired hypogammaglobulinemia
4944554|NCT01883921|Immunology|immunology
4944555|NCT01883921|Autoimmune Deficiency|autoimmune deficiency
4944556|NCT01883921|Intravenous Immunoglobulin|intravenous immunoglobulin
4944557|NCT01883921|Subcutaneous Immunoglobulin|subcutaneous immunoglobulin
4944558|NCT01883921|IVIg|ivig
4944559|NCT01883921|SCIg|scig
4944560|NCT01883921|Immune Globulin|immune globulin
4944561|NCT01883921|Outcomes Research|outcomes research
4944562|NCT01883921|Immunodeficiency|immunodeficiency
4944563|NCT01883908|Acupuncture therapy|acupuncture therapy
4944564|NCT01883908|Mucositis|mucositis
4944565|NCT01883908|oropharyngeal cancer|oropharyngeal cancer
4944566|NCT01883895|Pain|pain
4944567|NCT01883895|exercise-induced hypoalgesia|exercise-induced hypoalgesia
4944568|NCT01883882|chronic non-cancer pain|chronic non-cancer pain
4944569|NCT01883882|opioid taper|opioid taper
4944570|NCT01883882|chronic pain self-management|chronic pain self-management
4944571|NCT01883882|motivational interviewing|motivational interviewing
4944572|NCT01883869|Platelet inhibition|platelet inhibition
4944573|NCT01883869|Platelet-leukocyte aggregates|platelet-leukocyte aggregates
4944574|NCT01883869|Platelet-neutrophil aggregates|platelet-neutrophil aggregates
4944575|NCT01883869|CAP|cap
4944576|NCT01883869|HAP|hap
4944577|NCT01883869|ALI|ali
4944578|NCT01883869|Blood Platelets|blood platelets
4944579|NCT01883856|Refractory Glaucoma|refractory glaucoma
4944580|NCT01883856|Intractable Glaucoma|intractable glaucoma
4944581|NCT01883856|Primary Open Angle Glaucoma|primary open angle glaucoma
4944582|NCT01883856|Neovascular Glaucoma|neovascular glaucoma
4944583|NCT01883843|Chronic Stroke|chronic stroke
4944584|NCT01883843|tDCS|tdcs
4944585|NCT01883843|transcranial direct current stimulation|transcranial direct current stimulation
4944586|NCT01883843|task oriented circuit training|task oriented circuit training
4944587|NCT01883843|TOCT|toct
4944588|NCT01883843|gait training|gait training
4944589|NCT01883830|traumatic brain injury (TBI)|traumatic brain injury (tbi)
4944590|NCT01883830|balance disorders|balance disorders
4944591|NCT01883830|attention deficits|attention deficits
4944592|NCT01883830|x-box|x-box
4944593|NCT01883830|gaming|gaming
4944594|NCT01883830|virtual reality|virtual reality
4944595|NCT01883817|ADHD|adhd
4944596|NCT01883804|Diabetes|diabetes
4944597|NCT01883804|Diabetes Mellitus|diabetes mellitus
4944598|NCT01883804|Type 1 Diabetes|type 1 diabetes
4944599|NCT01883791|substance abuse prevention and treatment|substance abuse prevention and treatment
4944600|NCT01883791|comorbidity|comorbidity
4944601|NCT01883791|SBIRT|sbirt
4944602|NCT01883778|Attitudes of health personnel|attitudes of health personnel
4944603|NCT01883778|Attitudes of patients|attitudes of patients
4944604|NCT01883778|Medical compliance|medical compliance
4944605|NCT01883778|Cost awareness|cost awareness
4944606|NCT01883778|Cost analysis|cost analysis
4944607|NCT01883778|Patient knowledge|patient knowledge
4944608|NCT01883778|Physician knowledge|physician knowledge
4944707|NCT01883375|Family|family
4944609|NCT01883778|Medical economics|medical economics
4944610|NCT01883778|Policy|policy
4944611|NCT01883778|Questionnaires|questionnaires
4944612|NCT01883778|Health literacy|health literacy
4944613|NCT01883765|ADHD, Neurofeedback, CBT|adhd, neurofeedback, cbt
4944614|NCT01883752|Goal-directed fluid therapy|goal-directed fluid therapy
4944615|NCT01883739|Parental anxiety|parental anxiety
4944616|NCT01883739|Children's safety|children's safety
4944617|NCT01883739|Family Centered Care|family centered care
4944618|NCT01883739|Bedside Transfer Rounds|bedside transfer rounds
4944619|NCT01883739|Pediatric Cardiac Intensive Care|pediatric cardiac intensive care
4944620|NCT01883726|Unilateral complete cleft lip, Nasoalveolar molding|unilateral complete cleft lip, nasoalveolar molding
4944621|NCT01883713|anemia|anemia
4944622|NCT01883713|CPB|cpb
4944623|NCT01883713|methemoglobin|methemoglobin
4944624|NCT01883713|hypoxia|hypoxia
4944625|NCT01883700|Healthy|healthy
4944626|NCT01883700|Glycemic Index|glycemic index
4944627|NCT01883700|Glycemic Load|glycemic load
4944628|NCT01883700|Blood Glucose|blood glucose
4944629|NCT01883700|Arterial Stiffness|arterial stiffness
4944630|NCT01883674|Sarcopenia|sarcopenia
4944631|NCT01883674|Physical capacity|physical capacity
4944632|NCT01883674|Muscle force|muscle force
4944633|NCT01883674|Muscle quality|muscle quality
4944634|NCT01883674|Milk proteins|milk proteins
4944635|NCT01883674|Essential amino acids|essential amino acids
4944636|NCT01883674|Proteins|proteins
4944637|NCT01883674|Resistance training|resistance training
4944638|NCT01883674|Exercise|exercise
4944639|NCT01883661|stem cell|stem cell
4944640|NCT01883661|Multiple Sclerosis|multiple sclerosis
4944641|NCT01883661|BMMNC|bmmnc
4944642|NCT01883648|Mild to Moderate Alzheimer's disease|mild to moderate alzheimer's disease
4944643|NCT01883622|diabetes|diabetes
4944644|NCT01883622|pregnancy|pregnancy
4944645|NCT01883622|glucose variability|glucose variability
4944646|NCT01883622|continuous glucose monitoring (CGM)|continuous glucose monitoring (cgm)
4944647|NCT01883622|gestational diabetes mellitus (GDM)|gestational diabetes mellitus (gdm)
4944648|NCT01883609|Plasmodium Falciparum|plasmodium falciparum
4944649|NCT01883609|Malaria|malaria
4944650|NCT01883609|Vaccine|vaccine
4944651|NCT01883609|Plasmodium|plasmodium
4944652|NCT01883609|Falciparum|falciparum
4944653|NCT01883583|Ultrasound|ultrasound
4944654|NCT01883583|Perfusion Imaging|perfusion imaging
4944655|NCT01883583|Elasticity Imaging Techniques|elasticity imaging techniques
4944656|NCT01883583|Kidney Transplantation|kidney transplantation
4944657|NCT01883583|Graft Rejection|graft rejection
4944658|NCT01883583|Chronic allograft nephropathy|chronic allograft nephropathy
4944659|NCT01883570|visual search strategy, training, chest x-ray|visual search strategy, training, chest x-ray
4944660|NCT01883544|Safety|safety
4944661|NCT01883544|Tolerability|tolerability
4944662|NCT01883544|Pharmacokinetics|pharmacokinetics
4944663|NCT01883544|Pharmacodynamics|pharmacodynamics
4944664|NCT01883544|ALXN1007|alxn1007
4944665|NCT01883544|Healthy Male and Female Subjects|healthy male and female subjects
4944666|NCT01883531|improving lung function|improving lung function
4944667|NCT01883531|paediatric and adolescent|paediatric and adolescent
4944668|NCT01883531|FEV1|fev1
4944669|NCT01883518|Fibrosarcoma|fibrosarcoma
4944670|NCT01883518|Neurofibrosarcoma|neurofibrosarcoma
4944671|NCT01883518|Histiocytoma|histiocytoma
4944672|NCT01883518|Histiocytoma, Malignant Fibrous|histiocytoma, malignant fibrous
4944673|NCT01883518|Chondrosarcoma|chondrosarcoma
4944674|NCT01883518|Synovial Sarcoma|synovial sarcoma
4944675|NCT01883518|Leiomyosarcoma|leiomyosarcoma
4944676|NCT01883518|Liposarcoma|liposarcoma
4944677|NCT01883518|Myosarcoma|myosarcoma
4944678|NCT01883518|Rhabdomyosarcoma|rhabdomyosarcoma
4944679|NCT01883518|Sarcoma, Alveolar Soft Part|sarcoma, alveolar soft part
4944680|NCT01883518|NY-ESO-1|ny-eso-1
4944681|NCT01883518|MAGE|mage
4944682|NCT01883518|MAGE A3|mage a3
4944683|NCT01883518|Vaccine|vaccine
4944684|NCT01883518|Immunotherapy|immunotherapy
4944685|NCT01883505|Motor fluctuations|motor fluctuations
4944686|NCT01883505|levodopa pharmacokinetics|levodopa pharmacokinetics
4944687|NCT01883505|levodopa and carbidopa solution|levodopa and carbidopa solution
4944688|NCT01883505|continuous subcutaneous delivery|continuous subcutaneous delivery
4944689|NCT01883505|Patch-pump|patch-pump
4944690|NCT01883492|Only Female|only female
4944691|NCT01883492|Age between 20 - 75 at the time of operation|age between 20 - 75 at the time of operation
4944692|NCT01883466|Air Pollution|air pollution
4944693|NCT01883466|Biodiesel exhaust|biodiesel exhaust
4944694|NCT01883466|Diesel exhaust|diesel exhaust
4944695|NCT01883466|Vascular function|vascular function
4944696|NCT01883466|Fibrinolysis|fibrinolysis
4944697|NCT01883466|Acute endothelial responses|acute endothelial responses
4944698|NCT01883440|Duration|duration
4944699|NCT01883427|Days with URTI symptoms|days with urti symptoms
4944700|NCT01883414|Ulthera, Ultherapy, Surgical scar, scar,|ulthera, ultherapy, surgical scar, scar,
4944701|NCT01883401|Strawberries|strawberries
4944702|NCT01883401|Heart health|heart health
4944703|NCT01883401|Anthocyanins|anthocyanins
4944704|NCT01883388|Lung Cancer|lung cancer
4944705|NCT01883388|blood sample|blood sample
4944706|NCT01883375|Palliative Care|palliative care
4944708|NCT01883375|adaptation, psychological|adaptation, psychological
4944709|NCT01883362|acute myeloid leukemia|acute myeloid leukemia
4944710|NCT01883362|AML|aml
4944711|NCT01883362|FLT3-ITD|flt3-itd
4944712|NCT01883362|midostaurin|midostaurin
4944713|NCT01883362|PKC412|pkc412
4944714|NCT01883362|allogeneic hematopoeitic stem cell tranplant|allogeneic hematopoeitic stem cell tranplant
4944715|NCT01883362|SCT|sct
4944716|NCT01883362|HSCT|hsct
4944717|NCT01883362|CR1|cr1
4944718|NCT01883336|Incidental pancreatic cysts|incidental pancreatic cysts
4944719|NCT01883323|Measurable|measurable
4944720|NCT01883323|Unresectable|unresectable
4944721|NCT01883323|Stage III|stage iii
4944722|NCT01883323|Stage IV|stage iv
4944723|NCT01883323|Metastatic|metastatic
4944724|NCT01883323|Melanoma|melanoma
4944725|NCT01883323|Tumor-Infiltrating Lymphocytes|tumor-infiltrating lymphocytes
4944726|NCT01883323|Low-Dose Interleukin-2|low-dose interleukin-2
4944727|NCT01883323|Cyclophosphamide|cyclophosphamide
4944728|NCT01883323|Fludarabine|fludarabine
4944729|NCT01883310|Multiple Sclerosis|multiple sclerosis
4944730|NCT01883310|transcranial direct current stimulation|transcranial direct current stimulation
4944731|NCT01883310|TOCT|toct
4944732|NCT01883310|task-oriented circuit training|task-oriented circuit training
4944733|NCT01883310|locomotor function|locomotor function
4944734|NCT01883310|mobility|mobility
4944735|NCT01883310|balance|balance
4944736|NCT01883297|Measurable|measurable
4944737|NCT01883297|Recurrent|recurrent
4944738|NCT01883297|Platinum resistant|platinum resistant
4944739|NCT01883297|Tumor-Infiltrating Lymphocytes|tumor-infiltrating lymphocytes
4944740|NCT01883297|Low-Dose Interleukin-2|low-dose interleukin-2
4944741|NCT01883297|Autologous dendritic cells|autologous dendritic cells
4944742|NCT01883297|Anti-CD3 monoclonal antibody|anti-cd3 monoclonal antibody
4944743|NCT01883297|High grade serous ovarian, fallopian tube, or primary peritoneal cancer|high grade serous ovarian, fallopian tube, or primary peritoneal cancer
4944744|NCT01883297|Cyclophosphamide|cyclophosphamide
4944745|NCT01883284|Cystic Fibrosis|cystic fibrosis
4944746|NCT01883284|nasal epithelia|nasal epithelia
4944747|NCT01883284|mucins|mucins
4944748|NCT01883245|Orofacial chronic pain|orofacial chronic pain
4944749|NCT01883245|tDCS|tdcs
4944750|NCT01883245|Transcranial direct current stimulation|transcranial direct current stimulation
4944751|NCT01883245|Brain stimulation|brain stimulation
4944752|NCT01883219|Philadelphia chromosome|philadelphia chromosome
4944753|NCT01883219|Acute lymphoblastic leukemia|acute lymphoblastic leukemia
4944754|NCT01883219|Allogeneic hematopoietic cell transplantation|allogeneic hematopoietic cell transplantation
4944755|NCT01883219|Minimal residual disease|minimal residual disease
4944756|NCT01883219|Tyrosine kinase inhibitor|tyrosine kinase inhibitor
4944757|NCT01883206|Cytomegalovirus|cytomegalovirus
4944758|NCT01883193|preconception maternal nutrition|preconception maternal nutrition
4944759|NCT01883193|LBW|lbw
4944760|NCT01883193|Length-for-age|length-for-age
4944761|NCT01883193|maternal nutrition supplement|maternal nutrition supplement
4944762|NCT01883193|multi-micronutrient fortified lipid-based supplement|multi-micronutrient fortified lipid-based supplement
4944763|NCT01883193|infant growth|infant growth
4944764|NCT01883193|low-resource settings|low-resource settings
4944765|NCT01883180|haploidentical hematopoietic Stem Cell Transplantation|haploidentical hematopoietic stem cell transplantation
4944766|NCT01883180|Antithymocyte globulin|antithymocyte globulin
4944767|NCT01883180|viral infection|viral infection
4944768|NCT01883128|Biochemical Failure|biochemical failure
4944769|NCT01883128|Radiotherapy|radiotherapy
4944770|NCT01883128|Radiorecurrent Prostate Cancer|radiorecurrent prostate cancer
4944771|NCT01883128|MRI Prostate|mri prostate
4944772|NCT01883128|Whole Body MRI|whole body mri
4944773|NCT01883128|Bone Scan|bone scan
4944774|NCT01883128|Choline PET|choline pet
4944775|NCT01883128|Focal Salvage Treatment|focal salvage treatment
4944776|NCT01883128|HIFU|hifu
4944777|NCT01883128|Cryotherapy|cryotherapy
4944778|NCT01883115|Telescopic extraperitoneal dissection|telescopic extraperitoneal dissection
4944779|NCT01883115|Single incision laparosocpic surgery|single incision laparosocpic surgery
4944780|NCT01883115|Inguinal hernia|inguinal hernia
4944781|NCT01883115|Triport system|triport system
4944782|NCT01883076|Hypoplastic Left Heart Syndrome|hypoplastic left heart syndrome
4944783|NCT01883076|HLHS|hlhs
4944784|NCT01883076|Congenital Heart Disease|congenital heart disease
4944785|NCT01883076|Umbilical cord blood|umbilical cord blood
4944786|NCT01883076|UCB|ucb
4944787|NCT01883076|Cord blood|cord blood
4944788|NCT01883076|Stem cells|stem cells
4944789|NCT01883076|Regenerative therapy|regenerative therapy
4944790|NCT01883076|Stage II Glenn|stage ii glenn
4944791|NCT01883076|Glenn Surgery|glenn surgery
4944792|NCT01883050|Coronary artery disease|coronary artery disease
4944793|NCT01883050|Percutaneous Intervention|percutaneous intervention
4944794|NCT01883050|Stent|stent
4944795|NCT01883050|Balloon angioplasty|balloon angioplasty
4944796|NCT01883050|Angiogram|angiogram
4944797|NCT01883050|Coronary angiogram|coronary angiogram
4944798|NCT01883037|Cystic Fibrosis|cystic fibrosis
4944799|NCT01883037|Cystic Fibrosis related diabetes|cystic fibrosis related diabetes
4944800|NCT01883037|Oral glucose tolerance test|oral glucose tolerance test
4944902|NCT01882491|Osteoarthritis of the Hand|osteoarthritis of the hand
4944801|NCT01883024|Real time continuous glucose monitoring, decision support software, smartphone application.|real time continuous glucose monitoring, decision support software, smartphone application.
4944802|NCT01883011|Piracetam|piracetam
4944803|NCT01883011|Stroke|stroke
4944804|NCT01883011|Aphasia|aphasia
4944805|NCT01883011|Acute|acute
4944806|NCT01883011|Cerebral|cerebral
4944807|NCT01883011|Ischemic|ischemic
4944808|NCT01883011|Nootropil|nootropil
4944809|NCT01882998|HIV and pregnancy|hiv and pregnancy
4944810|NCT01882998|HIV and breastfeeding|hiv and breastfeeding
4944811|NCT01882998|Mother-to-child transmission of HIV|mother-to-child transmission of hiv
4944812|NCT01882998|Africa|africa
4944813|NCT01882998|Uganda|uganda
4944814|NCT01882985|docetaxel|docetaxel
4944815|NCT01882985|lycopene|lycopene
4944816|NCT01882985|prostate cancer|prostate cancer
4944817|NCT01882933|Gastric adenocarcinoma|gastric adenocarcinoma
4944818|NCT01882933|HIPEC|hipec
4944819|NCT01882933|Oxaliplatin|oxaliplatin
4944820|NCT01882933|Signet ring cell|signet ring cell
4944821|NCT01882920|Cytoreductive surgery|cytoreductive surgery
4944822|NCT01882920|hyperthermic intraperitoneal chemotherapy|hyperthermic intraperitoneal chemotherapy
4944823|NCT01882920|Goal directed fluid therapy|goal directed fluid therapy
4944824|NCT01882907|vildagliptin|vildagliptin
4944825|NCT01882907|metformin|metformin
4944826|NCT01882894|Plantar fasciitis, orthotic, functional outcome|plantar fasciitis, orthotic, functional outcome
4944827|NCT01882842|Infertility|infertility
4944828|NCT01882842|Endometrium|endometrium
4944829|NCT01882842|Live birth|live birth
4944830|NCT01882829|depression|depression
4944831|NCT01882829|major depressive disorder|major depressive disorder
4944832|NCT01882829|treatment resistant|treatment resistant
4944833|NCT01882829|Nuedexta|nuedexta
4944834|NCT01882829|dextromethorphan|dextromethorphan
4944835|NCT01882829|antidepressant|antidepressant
4944836|NCT01882829|glutamate|glutamate
4944837|NCT01882829|NMDA receptor|nmda receptor
4944838|NCT01882816|non-anaplastic|non-anaplastic
4944839|NCT01882816|non-medullary|non-medullary
4944840|NCT01882816|radiation|radiation
4944841|NCT01882816|IMRT|imrt
4944842|NCT01882816|Doxorubicin|doxorubicin
4944843|NCT01882816|13-070|13-070
4944844|NCT01882803|PI3K Inhibitor|pi3k inhibitor
4944845|NCT01882790|coronary artery spasm|coronary artery spasm
4944846|NCT01882790|hypertension|hypertension
4944847|NCT01882790|Pathophysiology|pathophysiology
4944848|NCT01882790|atrioventricular block|atrioventricular block
4944849|NCT01882790|blood pressure|blood pressure
4944850|NCT01882790|autonomic nervous function|autonomic nervous function
4944851|NCT01882751|kinematics|kinematics
4944852|NCT01882751|knee joint|knee joint
4944853|NCT01882738|Cervical length|cervical length
4944854|NCT01882738|BMI|bmi
4944855|NCT01882699|Insomnia|insomnia
4944856|NCT01882686|Pain|pain
4944857|NCT01882686|Back Pain|back pain
4944858|NCT01882686|Low Back Pain|low back pain
4944859|NCT01882686|Chronic Low Back Pain|chronic low back pain
4944860|NCT01882686|Cognitive Functional Therapy|cognitive functional therapy
4944861|NCT01882686|Intervention|intervention
4944862|NCT01882686|Subclassification|subclassification
4944863|NCT01882686|Multidimensional|multidimensional
4944864|NCT01882673|Tobacco|tobacco
4944865|NCT01882673|nicotine|nicotine
4944866|NCT01882673|dependence|dependence
4944867|NCT01882673|quitline|quitline
4944868|NCT01882647|psoriasis|psoriasis
4944869|NCT01882647|lotion|lotion
4944870|NCT01882647|investigator's global assessment|investigator's global assessment
4944871|NCT01882621|NSCLC|nsclc
4944872|NCT01882621|Monosialoganglioside(GM1)|monosialoganglioside(gm1)
4944873|NCT01882621|neurotoxicity|neurotoxicity
4944874|NCT01882608|psychiatry|psychiatry
4944875|NCT01882608|mental health|mental health
4944876|NCT01882608|mood disorders|mood disorders
4944877|NCT01882608|mood diaries|mood diaries
4944878|NCT01882608|electronic diaries|electronic diaries
4944879|NCT01882608|cell phones|cell phones
4944880|NCT01882608|software|software
4944881|NCT01882608|mental health telemetry|mental health telemetry
4944882|NCT01882608|ecological momentary assessment|ecological momentary assessment
4944883|NCT01882595|Nebulization aerosol nebulizer tracheostomy|nebulization aerosol nebulizer tracheostomy
4944884|NCT01882556|Early treatment of spasticity.|early treatment of spasticity.
4944885|NCT01882556|Post stroke spasticity.|post stroke spasticity.
4944886|NCT01882543|Interstitial cystitis|interstitial cystitis
4944887|NCT01882543|Bladder pain syndrome|bladder pain syndrome
4944888|NCT01882543|IC/BPS|ic/bps
4944889|NCT01882543|AQX-1125|aqx-1125
4944890|NCT01882543|SHIP1|ship1
4944891|NCT01882530|Post operative analgesia ;|post operative analgesia ;
4944892|NCT01882530|Paracetamol ;|paracetamol ;
4944893|NCT01882530|Ketoprofen ;|ketoprofen ;
4944894|NCT01882530|Nefopam ;|nefopam ;
4944895|NCT01882530|Morphine|morphine
4944896|NCT01882504|Pyoderma Gangrenosum|pyoderma gangrenosum
4944897|NCT01882504|Classic Pyoderma Gangrenosum|classic pyoderma gangrenosum
4944898|NCT01882504|Atypical Pyoderma Gangrenosum|atypical pyoderma gangrenosum
4944899|NCT01882504|Peristomal Pyoderma Gangrenosum|peristomal pyoderma gangrenosum
4944900|NCT01882491|Erosive Osteoarthritis|erosive osteoarthritis
4944901|NCT01882491|Osteoarthritis|osteoarthritis
4944903|NCT01882478|Barrett's esophagus|barrett's esophagus
4944904|NCT01882478|Early esophageal adenocarcinoma|early esophageal adenocarcinoma
4944905|NCT01882478|Radio Frequency Ablation|radio frequency ablation
4944906|NCT01882478|Cryotherapy|cryotherapy
4944907|NCT01882452|Memory specificity training|memory specificity training
4944908|NCT01882452|Autobiographical memory|autobiographical memory
4944909|NCT01882452|Major depressive disorder|major depressive disorder
4944910|NCT01882439|psoriatic arthritis|psoriatic arthritis
4944911|NCT01882439|tofacitinib|tofacitinib
4944912|NCT01882439|ACR20|acr20
4944913|NCT01882439|HAQ-DI|haq-di
4944914|NCT01882439|TNF inhibitor failure|tnf inhibitor failure
4944915|NCT01882426|CONSTRUCT|construct
4944916|NCT01882426|Cluster randomization controlled trial|cluster randomization controlled trial
4944917|NCT01882426|Gastroenterology practices in North America|gastroenterology practices in north america
4944918|NCT01882400|Osteoporosis|osteoporosis
4944919|NCT01882400|Severe muscular dystrophy|severe muscular dystrophy
4944920|NCT01882400|Cystic fibrosis|cystic fibrosis
4944921|NCT01882387|Allogeneic Peripheral Blood Stem Cell Transplantation|allogeneic peripheral blood stem cell transplantation
4944922|NCT01882387|Graft-vs-Host Disease|graft-vs-host disease
4944923|NCT01882387|Neutrophil Engraftment|neutrophil engraftment
4944924|NCT01882387|Platelet Engraftment|platelet engraftment
4944925|NCT01882387|Immune Reconstitution|immune reconstitution
4944926|NCT01882387|Mucositis|mucositis
4944927|NCT01882374|Double Umbilical Cord Blood Transplantation|double umbilical cord blood transplantation
4944928|NCT01882374|Acute Graft versus Host Disease|acute graft versus host disease
4944929|NCT01882374|Neutrophil Engraftment|neutrophil engraftment
4944930|NCT01882374|Platelet Recovery|platelet recovery
4944931|NCT01882374|Immune Reconstitution|immune reconstitution
4944932|NCT01882374|Mucositis|mucositis
4944933|NCT01882361|opioid addiction|opioid addiction
4944934|NCT01882361|opioid treatment|opioid treatment
4944935|NCT01882361|naloxone|naloxone
4944936|NCT01882348|tobacco control, tobacco treatment, pediatrics, parents|tobacco control, tobacco treatment, pediatrics, parents
4944937|NCT01882335|Human capital formation|human capital formation
4944938|NCT01882322|FK506|fk506
4944939|NCT01882322|tacrolimus|tacrolimus
4944940|NCT01882322|immunosuppressant|immunosuppressant
4944941|NCT01882283|serum lipids|serum lipids
4944942|NCT01882283|cholesterol|cholesterol
4944943|NCT01882283|serum cholesterol|serum cholesterol
4944944|NCT01882283|black tea|black tea
4944945|NCT01882283|flavonoids|flavonoids
4944946|NCT01882283|crossover trial|crossover trial
4944947|NCT01882283|randomized control trial|randomized control trial
4944948|NCT01882283|diet controlled|diet controlled
4944949|NCT01882270|pericoronitis|pericoronitis
4944950|NCT01882270|periodontal|periodontal
4944951|NCT01882257|obstructive sleep apnea|obstructive sleep apnea
4944952|NCT01882257|sleep-disordered breathing|sleep-disordered breathing
4944953|NCT01882257|hypercapnia|hypercapnia
4944954|NCT01882257|spinal cord injury|spinal cord injury
4944955|NCT01882244|traumatic brain injury|traumatic brain injury
4944956|NCT01882244|cognition|cognition
4944957|NCT01882244|rehabilitation|rehabilitation
4944958|NCT01882244|attentional regulation|attentional regulation
4944959|NCT01882244|working memory|working memory
4944960|NCT01882231|Osteosarcoma|osteosarcoma
4944961|NCT01882231|Ewing sarcoma|ewing sarcoma
4944962|NCT01882231|Paget's disease|paget's disease
4944963|NCT01882231|bone cancer|bone cancer
4944964|NCT01882231|childhood cancers|childhood cancers
4944965|NCT01882231|DCE MRI|dce mri
4944966|NCT01882231|DW MRI|dw mri
4944967|NCT01882231|CEST MRI|cest mri
4944968|NCT01882231|MT MRI|mt mri
4944969|NCT01882218|Liver cancer|liver cancer
4944970|NCT01882205|Ulcerative colitis|ulcerative colitis
4944971|NCT01882205|DALM|dalm
4944972|NCT01882205|chromoendoscopy|chromoendoscopy
4944973|NCT01882205|dysplasia|dysplasia
4944974|NCT01882205|virtual chromoendoscopy|virtual chromoendoscopy
4944975|NCT01882205|FICE|fice
4944976|NCT01882205|NBI|nbi
4944977|NCT01882205|I-scan|i-scan
4944978|NCT01882192|family|family
4944979|NCT01882192|physical activity|physical activity
4944980|NCT01882192|planning|planning
4944981|NCT01882179|Reperfusion injury|reperfusion injury
4944982|NCT01882179|myocardial infarct size|myocardial infarct size
4944983|NCT01882179|MRI|mri
4944984|NCT01882179|spironolactone|spironolactone
4944985|NCT01882166|Fertilization in Vitro|fertilization in vitro
4944986|NCT01882166|Sperm Injections, Intracytoplasmic|sperm injections, intracytoplasmic
4944987|NCT01882166|Follicle Stimulating Hormone|follicle stimulating hormone
4944988|NCT01882166|Embryonic Development|embryonic development
4944989|NCT01882140|burns|burns
4944990|NCT01882140|wound healing|wound healing
4944991|NCT01882140|magnetic field therapy|magnetic field therapy
4944992|NCT01882127|Purpura|purpura
4944993|NCT01882127|Idiopathic Thrombocytopenic Purpura|idiopathic thrombocytopenic purpura
4944994|NCT01882114|atherosclerosis|atherosclerosis
4944995|NCT01882114|cardiovascular events|cardiovascular events
4944996|NCT01882114|ankle-brachial index|ankle-brachial index
4944997|NCT01882114|carotid disease|carotid disease
4944998|NCT01882114|echocardiography|echocardiography
4944999|NCT01882114|mediterranean diet|mediterranean diet
4945000|NCT01882114|platelet activation|platelet activation
4945001|NCT01882101|Fecal incontinence|fecal incontinence
4945002|NCT01882101|posterior tibial nerve stimulation|posterior tibial nerve stimulation
4945003|NCT01882101|biofeedback|biofeedback
4945004|NCT01882101|quality of life|quality of life
4945005|NCT01882075|Anesthesia|anesthesia
4945006|NCT01882075|Fluid administration|fluid administration
4945007|NCT01882075|Closed-loop|closed-loop
4945008|NCT01882023|EDNOS|ednos
4945009|NCT01882023|adolescents|adolescents
4945010|NCT01882010|Parkinson's disease|parkinson's disease
4945011|NCT01882010|motor function|motor function
4945012|NCT01882010|immune activation|immune activation
4945013|NCT01882010|T cells|t cells
4945014|NCT01882010|CD4|cd4
4945015|NCT01882010|GMCSF|gmcsf
4945016|NCT01882010|leukine|leukine
4945017|NCT01882010|sargramostim|sargramostim
4945018|NCT01882010|magnetoencephalography|magnetoencephalography
4945019|NCT01881997|Procedure|procedure
4945020|NCT01881997|Abscess|abscess
4945021|NCT01881997|Emergency Department|emergency department
4945022|NCT01881997|Opioid|opioid
4945023|NCT01881997|Fentanyl|fentanyl
4945024|NCT01881984|Medium-chain acyl-CoA dehydrogenase deficiency|medium-chain acyl-coa dehydrogenase deficiency
4945025|NCT01881984|MCAD deficiency|mcad deficiency
4945026|NCT01881984|MCADD|mcadd
4945027|NCT01881984|ACADM deficiency|acadm deficiency
4945028|NCT01881984|MCADH deficiency|mcadh deficiency
4945029|NCT01881984|985A>G mutation|985a>g mutation
4945030|NCT01881984|K304E mutation|k304e mutation
4945031|NCT01881984|Ravicti|ravicti
4945032|NCT01881984|glycerol phenylbutyrate|glycerol phenylbutyrate
4945033|NCT01881971|HIV|hiv
4945034|NCT01881971|lung|lung
4945035|NCT01881971|lipids|lipids
4945036|NCT01881971|no lipid lowering medication|no lipid lowering medication
4945037|NCT01881971|normal liver and kidney function|normal liver and kidney function
4945038|NCT01881971|on stable ART regimen|on stable art regimen
4945039|NCT01881971|not pregnant|not pregnant
4945040|NCT01881945|Swallowing|swallowing
4945041|NCT01881945|Hyperventilation|hyperventilation
4945042|NCT01881932|acupuncture therapy|acupuncture therapy
4945043|NCT01881932|sham acupuncture therapy|sham acupuncture therapy
4945044|NCT01881932|chemotherapy-induced peripheral neuropathy (CIPN)|chemotherapy-induced peripheral neuropathy (cipn)
4945045|NCT01881919|Functional Food|functional food
4945046|NCT01881906|aerobic exercise|aerobic exercise
4945047|NCT01881906|Lung cancer|lung cancer
4945048|NCT01881906|psyco-social|psyco-social
4945049|NCT01881893|Quality of life|quality of life
4945050|NCT01881893|Psychosocial Support Systems|psychosocial support systems
4945051|NCT01881893|Randomized Controls as Topic|randomized controls as topic
4945052|NCT01881893|Cognitive Therapy|cognitive therapy
4945053|NCT01881893|Feasibility Studies|feasibility studies
4945054|NCT01881880|Tomosynthesis|tomosynthesis
4945055|NCT01881880|Mammography|mammography
4945056|NCT01881880|Breast cancer|breast cancer
4945057|NCT01881841|Alcohol abuse|alcohol abuse
4945058|NCT01881841|Substance use|substance use
4945059|NCT01881841|Tobacco use disorder|tobacco use disorder
4945060|NCT01881841|Motivational Enhancement Therapy|motivational enhancement therapy
4945061|NCT01881841|Adolescents|adolescents
4945062|NCT01881815|Chronic wounds with different etiologies|chronic wounds with different etiologies
4945063|NCT01881815|Diabetic foot ulcers|diabetic foot ulcers
4945064|NCT01881815|venous leg ulcers|venous leg ulcers
4945065|NCT01881815|pressure sores|pressure sores
4945066|NCT01881815|acute wounds|acute wounds
4945067|NCT01881802|Opioid drug Abuse|opioid drug abuse
4945068|NCT01881802|Morphine|morphine
4945069|NCT01881802|Immune Function|immune function
4945070|NCT01881789|multiple myeloma|multiple myeloma
4945071|NCT01881789|proteasome inhibitor|proteasome inhibitor
4945072|NCT01881789|oprozomib|oprozomib
4945073|NCT01881789|orpozomib tablets|orpozomib tablets
4945074|NCT01881776|Single injection interscalene brachial plexus block|single injection interscalene brachial plexus block
4945075|NCT01881776|Continuous interscalene brachial plexus block|continuous interscalene brachial plexus block
4945076|NCT01881776|General anesthesia|general anesthesia
4945077|NCT01881776|Postoperative pain|postoperative pain
4945078|NCT01881776|Recovery profile|recovery profile
4945079|NCT01881763|Electroconvulsive Therapy|electroconvulsive therapy
4945080|NCT01881763|Ketamine|ketamine
4945081|NCT01881763|anesthesia|anesthesia
4945082|NCT01881763|depression|depression
4945083|NCT01881763|unipolar|unipolar
4945084|NCT01881763|bipolar|bipolar
4945085|NCT01881750|Autism PRT|autism prt
4945086|NCT01881737|autism|autism
4945087|NCT01881711|hydrocephalus|hydrocephalus
4945088|NCT01881711|CSF shunt|csf shunt
4945089|NCT01881711|shunt malfunction|shunt malfunction
4945090|NCT01881711|shunt obstruction|shunt obstruction
4945091|NCT01881711|ShuntCheck|shuntcheck
4945092|NCT01881711|ShuntCheck-Micro-Pumper|shuntcheck-micro-pumper
4945093|NCT01881698|pregnancy|pregnancy
4945094|NCT01881698|platelet function|platelet function
4945095|NCT01881698|monitoring|monitoring
4945096|NCT01881698|multiple electrode aggregometry|multiple electrode aggregometry
4945097|NCT01881672|Aspiration pneumonia|aspiration pneumonia
4945098|NCT01881672|Coma|coma
4945099|NCT01881672|Mechanical ventilation|mechanical ventilation
4945100|NCT01881659|cervical cancer|cervical cancer
4945101|NCT01881659|cancer prevention|cancer prevention
4945102|NCT01881659|cervical screening|cervical screening
4945103|NCT01881659|HPV testing|hpv testing
4945104|NCT01881659|triage techniques|triage techniques
4945105|NCT01881646|Neuroinflammation|neuroinflammation
4945106|NCT01881646|Postoperative cognitive dysfunction|postoperative cognitive dysfunction
4945107|NCT01881633|gaucher disease, imiglucerase, ISU302|gaucher disease, imiglucerase, isu302
4945108|NCT01881620|PET scan|pet scan
4945109|NCT01881620|CT scan|ct scan
4945110|NCT01881620|Diagnostic performance|diagnostic performance
4945111|NCT01881607|tobacco smoke pollution|tobacco smoke pollution
4945112|NCT01881607|Tobacco use|tobacco use
4945113|NCT01881594|ileostomy closure,postoperative ileus,stimulation ileostomy|ileostomy closure,postoperative ileus,stimulation ileostomy
4945114|NCT01881581|Therapeutic|therapeutic
4945115|NCT01881581|Vaccine|vaccine
4945116|NCT01881581|HIV|hiv
4945117|NCT01881581|MVA|mva
4945118|NCT01881581|DNA|dna
4945119|NCT01881568|Total Knee Arthroplasty, TKA, blood loss|total knee arthroplasty, tka, blood loss
4945120|NCT01881555|fractional flow reserve|fractional flow reserve
4945121|NCT01881555|multivessel coronary artery disease|multivessel coronary artery disease
4945122|NCT01881555|angiography|angiography
4945123|NCT01881542|preeclampsia|preeclampsia
4945124|NCT01881542|proteinuria|proteinuria
4945125|NCT01881542|urine collection|urine collection
4945126|NCT01881529|limited scleroderma|limited scleroderma
4945127|NCT01881529|diffuse scleroderma|diffuse scleroderma
4945128|NCT01881529|Sclerosis|sclerosis
4945129|NCT01881529|Progressive|progressive
4945130|NCT01881529|Limited|limited
4945131|NCT01881503|life-threatening anemia|life-threatening anemia
4945132|NCT01881503|blood alternative|blood alternative
4945133|NCT01881503|HBOC|hboc
4945134|NCT01881490|Crohn's Disease|crohn's disease
4945135|NCT01881490|MRE|mre
4945136|NCT01881490|Pelvic MRI|pelvic mri
4945137|NCT01881490|P-MRI|p-mri
4945138|NCT01881490|colonoscopy|colonoscopy
4945139|NCT01881490|gastroscopy|gastroscopy
4945140|NCT01881477|immobilization|immobilization
4945141|NCT01881477|physical therapy|physical therapy
4945142|NCT01881477|intensive care|intensive care
4945143|NCT01881477|bed rest|bed rest
4945144|NCT01881477|movement|movement
4945145|NCT01881451|Tumour hypoxia|tumour hypoxia
4945146|NCT01881451|Clear Cell Ovarian Cancer|clear cell ovarian cancer
4945147|NCT01881451|Recurrent|recurrent
4945148|NCT01881451|Metastatic|metastatic
4945149|NCT01881438|Retinal Detachment|retinal detachment
4945150|NCT01881438|Fluoroquinolones|fluoroquinolones
4945151|NCT01881438|Ciprofloxacin|ciprofloxacin
4945152|NCT01881438|Levofloxacin|levofloxacin
4945153|NCT01881438|Gatifloxacin|gatifloxacin
4945154|NCT01881438|Gemifloxacin|gemifloxacin
4945155|NCT01881438|Moxifloxacin|moxifloxacin
4945156|NCT01881438|Norfloxacin|norfloxacin
4945157|NCT01881438|Ofloxacin|ofloxacin
4945158|NCT01881438|Beta-Lactam|beta-lactam
4945159|NCT01881425|POAG|poag
4945160|NCT01881412|Asthma|asthma
4945161|NCT01881412|Children|children
4945162|NCT01881412|Inhaled Corticosteroids|inhaled corticosteroids
4945163|NCT01881412|Emergency Department|emergency department
4945164|NCT01881399|Cholelithiasis|cholelithiasis
4945165|NCT01881399|Gallbladder polyps|gallbladder polyps
4945166|NCT01881399|Fluorescence|fluorescence
4945167|NCT01881399|Indocyanine green (ICG)|indocyanine green (icg)
4945168|NCT01881399|Intraoperative cholangiography (IOC)|intraoperative cholangiography (ioc)
4945169|NCT01881399|da Vinci surgical system|da vinci surgical system
4945170|NCT01881386|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
4945171|NCT01881386|Lactate|lactate
4945172|NCT01881373|Obesity|obesity
4945173|NCT01881373|Child|child
4945174|NCT01881373|Food|food
4945175|NCT01881373|Physical Activity|physical activity
4945176|NCT01881373|Pacific|pacific
4945177|NCT01881360|fibromyalgia|fibromyalgia
4945178|NCT01881360|celiac-type symptoms|celiac-type symptoms
4945179|NCT01881360|gluten-free diet|gluten-free diet
4945180|NCT01881360|hypocaloric diet|hypocaloric diet
4945181|NCT01881347|endothelium|endothelium
4945182|NCT01881347|mitochondria|mitochondria
4945183|NCT01881347|reactive oxygen species|reactive oxygen species
4945184|NCT01881347|vascular biology|vascular biology
4945185|NCT01881347|arterial stiffness|arterial stiffness
4945186|NCT01881347|nitric oxide|nitric oxide
4945187|NCT01881334|Haploidentical Donor|haploidentical donor
4945188|NCT01881334|T-cell depleted Stem Cells|t-cell depleted stem cells
4945189|NCT01881334|Allogeneic Transplant|allogeneic transplant
4945190|NCT01881334|Umbilical Cord Blood Donor|umbilical cord blood donor
4945191|NCT01881334|High Risk Malignancies|high risk malignancies
4945192|NCT01881334|Metabolic Disorders|metabolic disorders
4945193|NCT01881334|Immune Deficiency|immune deficiency
4945194|NCT01881334|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
4945195|NCT01881334|Acute Myelogenous Leukemia|acute myelogenous leukemia
4945196|NCT01881334|Myelodysplastic Syndrome|myelodysplastic syndrome
4945197|NCT01881334|ALL|all
4945198|NCT01881334|AML|aml
4945199|NCT01881334|MDS|mds
4945200|NCT01881334|CGD|cgd
4945201|NCT01881334|SCID|scid
4945202|NCT01881334|Adrenoleukodystrophy|adrenoleukodystrophy
4945405|NCT01880593|lithium|lithium
4945203|NCT01881334|Metachromaticleukodystrophy|metachromaticleukodystrophy
4945204|NCT01881334|Krabbe|krabbe
4945205|NCT01881334|PMD|pmd
4945206|NCT01881334|Hunter's|hunter's
4945207|NCT01881334|Hurler's|hurler's
4945208|NCT01881334|Severe Aplastic Anemia|severe aplastic anemia
4945209|NCT01881334|Lymphoma|lymphoma
4945210|NCT01881334|Sickle Cell Disease|sickle cell disease
4945211|NCT01881334|Thalassemia|thalassemia
4945212|NCT01881321|Contraception|contraception
4945213|NCT01881321|Counseling|counseling
4945214|NCT01881295|Potassium|potassium
4945215|NCT01881295|Potato|potato
4945216|NCT01881295|French Fries|french fries
4945217|NCT01881295|Bioavailability|bioavailability
4945218|NCT01881295|Blood Pressure|blood pressure
4945219|NCT01881282|Hemorrhoids|hemorrhoids
4945220|NCT01881282|Carraghenates|carraghenates
4945221|NCT01881282|Mayinglong Musk|mayinglong musk
4945222|NCT01881282|Titanoreine|titanoreine
4945223|NCT01881256|Preterm birth|preterm birth
4945224|NCT01881256|Parenteral and enteral nutrition|parenteral and enteral nutrition
4945225|NCT01881256|Body composition in preterm infants|body composition in preterm infants
4945226|NCT01881243|Cardiac Arrest, Hyperoxia, Ischemia-reperfusion Injury, Reactive Oxygen Species, Oxidative Stress, Neuropsychological Tests|cardiac arrest, hyperoxia, ischemia-reperfusion injury, reactive oxygen species, oxidative stress, neuropsychological tests
4945227|NCT01881230|Breast Cancer|breast cancer
4945228|NCT01881230|Cancer of the Breast|cancer of the breast
4945229|NCT01881230|Metastatic Breast Cancer|metastatic breast cancer
4945230|NCT01881230|Metastatic Triple Negative Breast Cancer|metastatic triple negative breast cancer
4945231|NCT01881230|Triple Negative Breast Cancer|triple negative breast cancer
4945232|NCT01881230|Triple Negative Metastatic Breast Cancer|triple negative metastatic breast cancer
4945233|NCT01881230|Basal-like breast cancer|basal-like breast cancer
4945234|NCT01881230|Hormone receptor negative breast cancer|hormone receptor negative breast cancer
4945235|NCT01881230|Estrogen receptor negative breast cancer|estrogen receptor negative breast cancer
4945236|NCT01881230|Progesterone negative receptor breast cancer|progesterone negative receptor breast cancer
4945237|NCT01881230|HER2 Negative Breast Cancer|her2 negative breast cancer
4945238|NCT01881230|Abraxane|abraxane
4945239|NCT01881230|nab-Paclitaxel|nab-paclitaxel
4945240|NCT01881230|ABI-007|abi-007
4945241|NCT01881230|gemcitabine|gemcitabine
4945242|NCT01881230|Gemzar|gemzar
4945243|NCT01881230|carboplatin|carboplatin
4945244|NCT01881230|Paraplatin|paraplatin
4945245|NCT01881230|Paraplatin AQ|paraplatin aq
4945246|NCT01881230|Phase 2|phase 2
4945247|NCT01881230|Phase 3|phase 3
4945248|NCT01881217|Phase I|phase i
4945249|NCT01881217|Dose escalation|dose escalation
4945250|NCT01881217|Advanced, refractory solid tumors|advanced, refractory solid tumors
4945251|NCT01881217|FGFR2|fgfr2
4945252|NCT01881204|Hesperidin|hesperidin
4945253|NCT01881204|Osteoporosis|osteoporosis
4945254|NCT01881204|Bone Loss|bone loss
4945255|NCT01881191|multiple sclerosis|multiple sclerosis
4945256|NCT01881191|relapsing remitting|relapsing remitting
4945257|NCT01881191|MRI|mri
4945258|NCT01881191|teriflunomide|teriflunomide
4945259|NCT01881191|aubagio|aubagio
4945260|NCT01881191|gray matter atrophy|gray matter atrophy
4945261|NCT01881191|gray matter pathology|gray matter pathology
4945262|NCT01881178|CRP|crp
4945263|NCT01881178|Nopalea|nopalea
4945264|NCT01881178|Fruit|fruit
4945265|NCT01881178|Juice|juice
4945266|NCT01881152|Stroke|stroke
4945267|NCT01881152|Community education|community education
4945268|NCT01881152|Awareness|awareness
4945269|NCT01881152|Prehospital delay|prehospital delay
4945270|NCT01881139|Exercise|exercise
4945271|NCT01881139|Lipid|lipid
4945272|NCT01881139|Left ventricular|left ventricular
4945273|NCT01881139|heart function|heart function
4945274|NCT01881100|resin infiltration|resin infiltration
4945275|NCT01881100|randomized clinical trial|randomized clinical trial
4945276|NCT01881100|fluoride varnish|fluoride varnish
4945277|NCT01881100|caries lesion|caries lesion
4945278|NCT01881100|deciduous teeth|deciduous teeth
4945279|NCT01881087|Knee Arthroscopy|knee arthroscopy
4945280|NCT01881087|Levobupivacaine|levobupivacaine
4945281|NCT01881087|Spinal Anesthesia|spinal anesthesia
4945282|NCT01881087|Motor Block|motor block
4945283|NCT01881074|Type II Diabetes|type ii diabetes
4945284|NCT01881074|Periodontal Disease|periodontal disease
4945285|NCT01881074|Periodontitis|periodontitis
4945286|NCT01881074|Gum Disease|gum disease
4945287|NCT01881074|Gingivitis|gingivitis
4945288|NCT01881074|Triclosan|triclosan
4945289|NCT01881074|Inflammatory Markers|inflammatory markers
4945290|NCT01881074|Immune Response|immune response
4945291|NCT01881061|Sonography|sonography
4945292|NCT01881061|ICU|icu
4945293|NCT01881061|PEEP|peep
4945294|NCT01881048|Breast cancer|breast cancer
4945295|NCT01881048|Omega-3 Fatty Acid|omega-3 fatty acid
4945296|NCT01881048|Celecoxib|celecoxib
4945297|NCT01881048|Celebrex|celebrex
4945298|NCT01881048|Surgery|surgery
4945299|NCT01881035|Hypertension|hypertension
4945300|NCT01881035|End stage renal disease|end stage renal disease
4945301|NCT01881022|Breast Cancer|breast cancer
4945302|NCT01881022|Couples|couples
4945303|NCT01881022|Sexual Dysfunction|sexual dysfunction
4945406|NCT01880567|Lymphoma|lymphoma
4945304|NCT01881022|Psychosexual Intervention|psychosexual intervention
4945305|NCT01881022|Sex Therapy|sex therapy
4945306|NCT01881022|Online Support|online support
4945307|NCT01881022|e-health|e-health
4945308|NCT01881009|Diabetes|diabetes
4945309|NCT01881009|Insulin|insulin
4945310|NCT01881009|Closed loop|closed loop
4945311|NCT01881009|Nocturnal glucose control|nocturnal glucose control
4945312|NCT01880996|Ovarian Cancer|ovarian cancer
4945313|NCT01880996|Gynecological Malignancies|gynecological malignancies
4945314|NCT01880996|Chemotherapy|chemotherapy
4945315|NCT01880996|Tai-chi|tai-chi
4945316|NCT01880996|Qigong|qigong
4945317|NCT01880996|Fatigue|fatigue
4945318|NCT01880996|Quality of life|quality of life
4945319|NCT01880996|Sleep disturbance|sleep disturbance
4945320|NCT01880983|EPP|epp
4945321|NCT01880983|Bloomer|bloomer
4945322|NCT01880983|Porphyria|porphyria
4945323|NCT01880957|bipolar disorder|bipolar disorder
4945324|NCT01880957|bipolar depression|bipolar depression
4945325|NCT01880957|serotonin transporter|serotonin transporter
4945326|NCT01880957|serotonin receptors|serotonin receptors
4945327|NCT01880957|binding potential|binding potential
4945328|NCT01880957|brain imaging|brain imaging
4945329|NCT01880957|unipolar depression|unipolar depression
4945330|NCT01880944|spine|spine
4945331|NCT01880944|trauma|trauma
4945332|NCT01880944|MRI|mri
4945333|NCT01880944|contrast|contrast
4945334|NCT01880918|Compression Anastomosis|compression anastomosis
4945335|NCT01880905|the length of uterine ovarian ligament|the length of uterine ovarian ligament
4945336|NCT01880879|coronary artery disease|coronary artery disease
4945337|NCT01880879|PCI|pci
4945338|NCT01880879|stent|stent
4945339|NCT01880866|PAH|pah
4945340|NCT01880853|breast cancer|breast cancer
4945341|NCT01880853|screening|screening
4945342|NCT01880853|mammography|mammography
4945343|NCT01880853|ultrasound|ultrasound
4945344|NCT01880827|GIP|gip
4945345|NCT01880827|GLP-1|glp-1
4945346|NCT01880827|type 2 diabetes|type 2 diabetes
4945347|NCT01880827|obesity|obesity
4945348|NCT01880827|splanchnic blood flow|splanchnic blood flow
4945349|NCT01880827|incretin hormones|incretin hormones
4945350|NCT01880814|Depression, child, cognitive behavioral treatment, parent training, personalized treatment|depression, child, cognitive behavioral treatment, parent training, personalized treatment
4945351|NCT01880801|ITP|itp
4945352|NCT01880788|Age Related Macular Degeneration|age related macular degeneration
4945353|NCT01880788|Choroidal Neovascularization|choroidal neovascularization
4945354|NCT01880788|Central Serous Chorioretinopathy|central serous chorioretinopathy
4945355|NCT01880762|PET MR development and validation|pet mr development and validation
4945356|NCT01880723|exhaled breath condensate|exhaled breath condensate
4945357|NCT01880723|diffusion capacity of the lungs for carbon monoxide and nitric oxide|diffusion capacity of the lungs for carbon monoxide and nitric oxide
4945358|NCT01880723|albuterol|albuterol
4945359|NCT01880723|peripheral oxygen saturation|peripheral oxygen saturation
4945360|NCT01880723|ion regulation|ion regulation
4945361|NCT01880710|long term follow-up|long term follow-up
4945362|NCT01880710|urinary incontinence|urinary incontinence
4945363|NCT01880710|pelvic organ prolapse|pelvic organ prolapse
4945364|NCT01880710|total versus subtotal hysterectomy|total versus subtotal hysterectomy
4945365|NCT01880697|Influenza|influenza
4945366|NCT01880697|adults|adults
4945367|NCT01880697|elderly|elderly
4945368|NCT01880697|immunology|immunology
4945369|NCT01880697|safety|safety
4945370|NCT01880684|Thermodilution|thermodilution
4945371|NCT01880684|Blood Volume|blood volume
4945372|NCT01880684|Cardiac Output|cardiac output
4945373|NCT01880684|Leg|leg
4945374|NCT01880684|Capnography|capnography
4945375|NCT01880684|Blood Pressure|blood pressure
4945376|NCT01880658|Maintenance therapy|maintenance therapy
4945377|NCT01880658|Capecitabine|capecitabine
4945378|NCT01880658|Adjuvant chemotherapy|adjuvant chemotherapy
4945379|NCT01880658|Post-operation|post-operation
4945380|NCT01880645|Breast Cancer|breast cancer
4945381|NCT01880645|Invasive breast cancer|invasive breast cancer
4945382|NCT01880645|Axillary lymph node metastases|axillary lymph node metastases
4945383|NCT01880645|Ultrasound|ultrasound
4945384|NCT01880645|Fine needle aspiration|fine needle aspiration
4945385|NCT01880645|FNA|fna
4945386|NCT01880645|Lymph node surgery|lymph node surgery
4945387|NCT01880645|Partial mastectomy|partial mastectomy
4945388|NCT01880645|Total mastectomy|total mastectomy
4945389|NCT01880632|XELOX|xelox
4945390|NCT01880632|perioperative treatment|perioperative treatment
4945391|NCT01880632|locally advanced gastric adenocarcinoma|locally advanced gastric adenocarcinoma
4945392|NCT01880632|D2 resection|d2 resection
4945393|NCT01880619|Double J|double j
4945394|NCT01880619|Ureteral stents|ureteral stents
4945395|NCT01880619|Symptoms|symptoms
4945396|NCT01880619|Alpha blockers|alpha blockers
4945397|NCT01880619|Anticholinergic|anticholinergic
4945398|NCT01880593|Ketamine|ketamine
4945399|NCT01880593|glutamate|glutamate
4945400|NCT01880593|N-methyl-D-aspartate|n-methyl-d-aspartate
4945401|NCT01880593|depression|depression
4945402|NCT01880593|major depressive disorder|major depressive disorder
4945403|NCT01880593|treatment resistant|treatment resistant
4945404|NCT01880593|antidepressant|antidepressant
4945407|NCT01880567|Relapsed/Refractory Mantle Cell Lymphoma|relapsed/refractory mantle cell lymphoma
4945408|NCT01880567|R/R MCL|r/r mcl
4945409|NCT01880567|Ibrutinib|ibrutinib
4945410|NCT01880567|PCI-32765|pci-32765
4945411|NCT01880567|Rituximab|rituximab
4945412|NCT01880567|Rituxan|rituxan
4945413|NCT01880567|Newly-Diagnosed Untreated Mantle Cell Lymphoma|newly-diagnosed untreated mantle cell lymphoma
4945414|NCT01880567|MCL|mcl
4945415|NCT01880554|Liver metastases|liver metastases
4945416|NCT01880554|Colorectal primary cancer|colorectal primary cancer
4945417|NCT01880554|Contrast-enhanced ultrasound|contrast-enhanced ultrasound
4945418|NCT01880554|Sonovue®|sonovue®
4945419|NCT01880541|Patients with breast cancer and breast surgery requiring|patients with breast cancer and breast surgery requiring
4945420|NCT01880515|Lung cancer|lung cancer
4945421|NCT01880515|BIBW 2992|bibw 2992
4945422|NCT01880515|Skin Rash|skin rash
4945423|NCT01880515|Tetracycline|tetracycline
4945424|NCT01880515|Afatinib|afatinib
4945425|NCT01880502|Healthy, Volunteers|healthy, volunteers
4945426|NCT01880489|transgender women|transgender women
4945427|NCT01880489|sexual risk|sexual risk
4945428|NCT01880489|substance use|substance use
4945429|NCT01880489|HIV prevention|hiv prevention
4945430|NCT01880489|behavioral intervention|behavioral intervention
4945431|NCT01880476|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
4945432|NCT01880476|Comorbidity|comorbidity
4945433|NCT01880476|Aged|aged
4945434|NCT01880476|Health Services|health services
4945435|NCT01880463|Dry eye disease|dry eye disease
4945436|NCT01880463|incidence|incidence
4945437|NCT01880463|progression|progression
4945438|NCT01880411|PEK fusion protein Healthbanks|pek fusion protein healthbanks
4945439|NCT01880398|FIstula in ano; Bhagandar|fistula in ano; bhagandar
4945440|NCT01880385|bevacizumab|bevacizumab
4945441|NCT01880385|inflammatory breast cancer|inflammatory breast cancer
4945442|NCT01880385|non metastatic|non metastatic
4945443|NCT01880385|Avastin|avastin
4945444|NCT01880372|Diabetes|diabetes
4945445|NCT01880372|Diabetic Retinopathy|diabetic retinopathy
4945446|NCT01880372|Retinopathy|retinopathy
4945447|NCT01880372|Free radical|free radical
4945448|NCT01880372|Retinal diseases|retinal diseases
4945449|NCT01880372|Antioxidants|antioxidants
4945450|NCT01880372|Protective agents|protective agents
4945451|NCT01880372|Thioctic acid|thioctic acid
4945452|NCT01880346|Cystic Fibrosis|cystic fibrosis
4945453|NCT01880346|Vitamin D|vitamin d
4945454|NCT01880346|absorption|absorption
4945455|NCT01880346|vitamin Deficiency|vitamin deficiency
4945456|NCT01880346|fat soluble|fat soluble
4945457|NCT01880333|Refractory epilepsy|refractory epilepsy
4945458|NCT01880333|dietary therapy|dietary therapy
4945459|NCT01880333|non-pharmacological therapy|non-pharmacological therapy
4945460|NCT01880333|Modified Atkin Diet|modified atkin diet
4945461|NCT01880307|Crohn's disease|crohn's disease
4945462|NCT01880307|pediatric|pediatric
4945463|NCT01880307|infliximab|infliximab
4945464|NCT01880307|top-down|top-down
4945465|NCT01880307|ITSKids|itskids
4945466|NCT01880294|Constipation|constipation
4945467|NCT01880294|Chronic constipation|chronic constipation
4945468|NCT01880294|Asia-Pacific|asia-pacific
4945469|NCT01880294|Gastroentrology|gastroentrology
4945470|NCT01880294|Asian participants|asian participants
4945471|NCT01880281|G protein-coupled receptor 99 (GPR99)|g protein-coupled receptor 99 (gpr99)
4945472|NCT01880281|2-oxoglutarate receptor 1 (OXGR1)|2-oxoglutarate receptor 1 (oxgr1)
4945473|NCT01880281|alpha-ketoglutarate|alpha-ketoglutarate
4945474|NCT01880281|urine|urine
4945475|NCT01880281|pH|ph
4945476|NCT01880281|acidosis|acidosis
4945477|NCT01880281|alkalosis|alkalosis
4945478|NCT01880281|Healthy volunteers|healthy volunteers
4945479|NCT01880255|Repetitive Transcranial Magnetic Stimulation|repetitive transcranial magnetic stimulation
4945480|NCT01880255|Schizophrenia|schizophrenia
4945481|NCT01880255|Cognition|cognition
4945482|NCT01880255|Working Memory|working memory
4945483|NCT01880242|International|international
4945484|NCT01880242|Multicenter|multicenter
4945485|NCT01880242|Observational registry|observational registry
4945486|NCT01880242|Orsiro Drug Eluting Stent (DES)|orsiro drug eluting stent (des)
4945487|NCT01880242|Stenting|stenting
4945488|NCT01880242|Treatment of Coronary Artery Disease|treatment of coronary artery disease
4945489|NCT01880242|Coronary revascularization|coronary revascularization
4945490|NCT01880242|Percutaneous Coronary Intervention (PCI)|percutaneous coronary intervention (pci)
4945491|NCT01880242|STEMI|stemi
4945492|NCT01880242|NSTEMI|nstemi
4945493|NCT01880242|Ischemia|ischemia
4945494|NCT01880242|Angina|angina
4945495|NCT01880242|Subgroups|subgroups
4945496|NCT01880242|Acute Myocardial Infarction|acute myocardial infarction
4945497|NCT01880242|Diabetes|diabetes
4945498|NCT01880242|Small Vessels|small vessels
4945499|NCT01880242|Chronic Total Occlusion (CTO)|chronic total occlusion (cto)
4945500|NCT01880216|Deep vein thrombosis|deep vein thrombosis
4945501|NCT01880216|DVT|dvt
4945502|NCT01880216|Treatment|treatment
4945503|NCT01880216|Low molecular weight heparin|low molecular weight heparin
4945504|NCT01880216|Bemiparin|bemiparin
4945505|NCT01880216|Enoxaparin|enoxaparin
4945506|NCT01880203|thyroid|thyroid
4945507|NCT01880203|elastography SWE|elastography swe
4945508|NCT01880203|indeterminate cytology|indeterminate cytology
4945509|NCT01880164|Scoliosis|scoliosis
4945510|NCT01880164|Kyphosis|kyphosis
4945511|NCT01880164|Sagittal plane deformity|sagittal plane deformity
4945512|NCT01880151|Alzheimer's disease|alzheimer's disease
4945513|NCT01880151|Dementia|dementia
4945514|NCT01880151|Prodromal|prodromal
4945515|NCT01880151|EEG|eeg
4945516|NCT01880151|ERP|erp
4945517|NCT01880151|Biomarkers|biomarkers
4945518|NCT01880138|Animated cartoon, Emergence agitation|animated cartoon, emergence agitation
4945519|NCT01880125|Tramadol|tramadol
4945520|NCT01880125|Acetaminophen|acetaminophen
4945521|NCT01880125|Pharmacokinetics|pharmacokinetics
4945522|NCT01880125|Sustained release|sustained release
4945523|NCT01880125|Immediate release|immediate release
4945524|NCT01880112|Infection|infection
4945525|NCT01880112|Cesarean delivery|cesarean delivery
4945526|NCT01880112|Antibiotic prophylaxis|antibiotic prophylaxis
4945527|NCT01880112|Cefazolin dosing|cefazolin dosing
4945528|NCT01880099|addiction|addiction
4945529|NCT01880099|smoking|smoking
4945530|NCT01880099|tobacco|tobacco
4945531|NCT01880099|cigarettes|cigarettes
4945532|NCT01880086|Chronic pain|chronic pain
4945533|NCT01880086|Low testosterone|low testosterone
4945534|NCT01880086|Hypogonadism|hypogonadism
4945535|NCT01880086|Opioid analgesics|opioid analgesics
4945536|NCT01880086|Narcotics|narcotics
4945537|NCT01880086|Opioid-induced androgen deficiency|opioid-induced androgen deficiency
4945538|NCT01880086|OPIAD|opiad
4945539|NCT01880086|Male infertility|male infertility
4945540|NCT01880086|Clomiphene citrate|clomiphene citrate
4945541|NCT01880086|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators
4945542|NCT01880086|Testosterone replacement therapy|testosterone replacement therapy
4945543|NCT01880060|Worksite|worksite
4945544|NCT01880060|weight loss|weight loss
4945545|NCT01880060|obesity|obesity
4945546|NCT01880047|Immune Thrombocytopenia|immune thrombocytopenia
4945547|NCT01880047|ITP|itp
4945548|NCT01880047|Eltrombopag|eltrombopag
4945549|NCT01880047|Promacta|promacta
4945550|NCT01880008|positron emission tomography|positron emission tomography
4945551|NCT01880008|magnetic resonance imaging|magnetic resonance imaging
4945552|NCT01880008|diffusion magnetic resonance imaging|diffusion magnetic resonance imaging
4945553|NCT01880008|radionuclide imaging|radionuclide imaging
4945554|NCT01880008|disease management|disease management
4945555|NCT01880008|radiation therapy|radiation therapy
4945556|NCT01879982|Bipolar disorder|bipolar disorder
4945557|NCT01879982|subtypes|subtypes
4945558|NCT01879969|computer-assisted orthognathic surgery; facial asymmetry|computer-assisted orthognathic surgery; facial asymmetry
4945559|NCT01879956|Executive Functions|executive functions
4945560|NCT01879956|Schizophrenia|schizophrenia
4945561|NCT01879956|Occupational Therapy|occupational therapy
4945562|NCT01879943|Colorectal cancer|colorectal cancer
4945563|NCT01879943|Follow up|follow up
4945564|NCT01879943|Colonoscopy|colonoscopy
4945565|NCT01879943|Videocapsule|videocapsule
4945566|NCT01879930|randomized|randomized
4945567|NCT01879930|placebo-controlled|placebo-controlled
4945568|NCT01879930|double-blind study|double-blind study
4945569|NCT01879930|doxycycline|doxycycline
4945570|NCT01879917|c-peptide|c-peptide
4945571|NCT01879917|insulin|insulin
4945572|NCT01879917|hypoglycemia|hypoglycemia
4945573|NCT01879917|Newly onset|newly onset
4945574|NCT01879917|Diabetes|diabetes
4945575|NCT01879917|Type 1|type 1
4945576|NCT01879917|Beta cell|beta cell
4945577|NCT01879917|Autoimmune|autoimmune
4945578|NCT01879917|Glucagon|glucagon
4945579|NCT01879917|Meal test|meal test
4945580|NCT01879904|Colorectal Neoplasms|colorectal neoplasms
4945581|NCT01879891|Exercise Intensity|exercise intensity
4945582|NCT01879891|Metabolism|metabolism
4945583|NCT01879891|Insulin|insulin
4945584|NCT01879878|pancreatic adenocarcinoma|pancreatic adenocarcinoma
4945585|NCT01879878|broccoli sprouts|broccoli sprouts
4945586|NCT01879878|sulforaphane|sulforaphane
4945587|NCT01879878|palliative chemotherapy|palliative chemotherapy
4945588|NCT01879878|cancer stem cells|cancer stem cells
4945589|NCT01879865|PKPD|pkpd
4945590|NCT01879865|Dexmedetomidine|dexmedetomidine
4945591|NCT01879865|Auditory Stimulation|auditory stimulation
4945592|NCT01879865|Cardiac Output|cardiac output
4945593|NCT01879852|Quadriceps strength|quadriceps strength
4945594|NCT01879852|Knee|knee
4945595|NCT01879852|Rehabilitation|rehabilitation
4945596|NCT01879826|Aculaser|aculaser
4945597|NCT01879826|Microlight ML830|microlight ml830
4945598|NCT01879826|Kidney biopsy|kidney biopsy
4945599|NCT01879826|Pain|pain
4945600|NCT01879826|Anxiety|anxiety
4945601|NCT01879826|Sedation|sedation
4945602|NCT01879813|Memory|memory
4945603|NCT01879813|Attention|attention
4945604|NCT01879787|Stroke|stroke
4945605|NCT01879787|transcranial direct current stimulation|transcranial direct current stimulation
4945606|NCT01879787|constraint-induced movement therapy|constraint-induced movement therapy
4945607|NCT01879787|mental practice|mental practice
4945608|NCT01879774|Hyponatremia|hyponatremia
4945609|NCT01879761|Immunosuppressed|immunosuppressed
4945610|NCT01879761|Sepsis|sepsis
4945611|NCT01879761|Staphylococcus Aureus|staphylococcus aureus
4945612|NCT01879761|Bacteremia|bacteremia
4945613|NCT01879761|HLA-DR|hla-dr
4945614|NCT01879748|Parkinson's disease|parkinson's disease
4945615|NCT01879748|Azilect|azilect
4945616|NCT01879748|rasagiline mesylate|rasagiline mesylate
4945617|NCT01879722|Drug therapy|drug therapy
4945618|NCT01879709|schizophrenia|schizophrenia
4945619|NCT01879709|Cognition|cognition
4945620|NCT01879709|Independent living skills|independent living skills
4945621|NCT01879683|Hunner's lesion|hunner's lesion
4945622|NCT01879644|ADHD|adhd
4945623|NCT01879644|Neurofeedback|neurofeedback
4945624|NCT01879644|Self-Management|self-management
4945625|NCT01879644|Parental Psychoeducation|parental psychoeducation
4945626|NCT01879644|Social Support|social support
4945627|NCT01879631|radial keratotomy; keratoconus; optical rehabilitation|radial keratotomy; keratoconus; optical rehabilitation
4945628|NCT01879618|Fragmin|fragmin
4945629|NCT01879618|dalteparin|dalteparin
4945630|NCT01879618|hemodialysis|hemodialysis
4945631|NCT01879618|anticoagulation|anticoagulation
4945632|NCT01879618|Renal Failure|renal failure
4945633|NCT01879605|Spinal surgery|spinal surgery
4945634|NCT01879605|Bowel preparation|bowel preparation
4945635|NCT01879605|Ileus|ileus
4945636|NCT01879605|Constipation|constipation
4945637|NCT01879605|Well-being|well-being
4945638|NCT01879592|Sickle cell disease|sickle cell disease
4945639|NCT01879592|Asthma|asthma
4945640|NCT01879592|Metabolomics|metabolomics
4945641|NCT01879592|Gene expression|gene expression
4945642|NCT01879579|Insulin|insulin
4945643|NCT01879579|Telemedicine|telemedicine
4945644|NCT01879553|Influenza,|influenza,
4945645|NCT01879553|Adults,|adults,
4945646|NCT01879553|Elderly,|elderly,
4945647|NCT01879553|Immunology,|immunology,
4945648|NCT01879553|Safety|safety
4945649|NCT01879540|Influenza,|influenza,
4945650|NCT01879540|Elderly,|elderly,
4945651|NCT01879540|Immunology,|immunology,
4945652|NCT01879540|Safety|safety
4945653|NCT01879514|IgA nephropathy|iga nephropathy
4945780|NCT01878942|Psychedelic|psychedelic
4945654|NCT01879514|Therapy of Chinese medicine|therapy of chinese medicine
4945655|NCT01879501|Low vision|low vision
4945656|NCT01879501|Self management|self management
4945657|NCT01879501|Randomized controlled trial|randomized controlled trial
4945658|NCT01879501|Quality of life|quality of life
4945659|NCT01879501|Self efficacy|self efficacy
4945660|NCT01879501|Effectiveness|effectiveness
4945661|NCT01879501|Chronic eye diseases management|chronic eye diseases management
4945662|NCT01879488|Aerosol|aerosol
4945663|NCT01879488|Lung deposition|lung deposition
4945664|NCT01879488|Mechanical ventilation|mechanical ventilation
4945665|NCT01879462|chronic hepatitis C (CHC)|chronic hepatitis c (chc)
4945666|NCT01879462|Hepatitis C virus (HCV)|hepatitis c virus (hcv)
4945667|NCT01879462|NS5B|ns5b
4945668|NCT01879462|pharmacokinetics|pharmacokinetics
4945669|NCT01879462|GSK2878175|gsk2878175
4945670|NCT01879462|safety|safety
4945671|NCT01879462|FTIH|ftih
4945672|NCT01879462|healthy subjects|healthy subjects
4945673|NCT01879449|Spasticity|spasticity
4945674|NCT01879449|Veterans|veterans
4945675|NCT01879449|Prevalence|prevalence
4945676|NCT01879436|Pregnancy, Placenta, Cancer|pregnancy, placenta, cancer
4945677|NCT01879410|GSK573719|gsk573719
4945678|NCT01879410|lung function|lung function
4945679|NCT01879410|salmeterol (SAL)|salmeterol (sal)
4945680|NCT01879410|umeclidinium bromide (UMEC)|umeclidinium bromide (umec)
4945681|NCT01879410|GW642444|gw642444
4945682|NCT01879410|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
4945683|NCT01879410|Novel Dry Powder Inhaler (NDPI)|novel dry powder inhaler (ndpi)
4945684|NCT01879410|fluticasone propionate (FP)|fluticasone propionate (fp)
4945685|NCT01879410|vilanterol (VI)|vilanterol (vi)
4945686|NCT01879397|atherosclerosis|atherosclerosis
4945687|NCT01879397|arteriosclerosis|arteriosclerosis
4945688|NCT01879397|carotid stenosis|carotid stenosis
4945689|NCT01879397|carotid endarterectomy|carotid endarterectomy
4945690|NCT01879397|Stroke|stroke
4945691|NCT01879384|microdialysis|microdialysis
4945692|NCT01879384|bone free flap|bone free flap
4945693|NCT01879384|head and neck|head and neck
4945694|NCT01879384|monitoring free flap|monitoring free flap
4945695|NCT01879384|reconstructive surgery|reconstructive surgery
4945696|NCT01879358|Drug-eluting stent|drug-eluting stent
4945697|NCT01879358|Safety|safety
4945698|NCT01879358|Efficacy|efficacy
4945699|NCT01879345|Anticonvulsant|anticonvulsant
4945700|NCT01879332|Anticonvulsant|anticonvulsant
4945701|NCT01879319|LDL-C, triglycerides, high cholesterol|ldl-c, triglycerides, high cholesterol
4945702|NCT01879293|Metformin|metformin
4945703|NCT01879293|Left ventricular mass|left ventricular mass
4945704|NCT01879293|Endothelial dysfunction|endothelial dysfunction
4945705|NCT01879293|cardiac magnetic resonance|cardiac magnetic resonance
4945706|NCT01879293|aortic pulse wave|aortic pulse wave
4945707|NCT01879280|pterional craniotomy|pterional craniotomy
4945708|NCT01879280|osteoplastic craniotomy|osteoplastic craniotomy
4945709|NCT01879280|temporalis|temporalis
4945710|NCT01879280|minimally-invasive|minimally-invasive
4945711|NCT01879254|obsessive compulsive disorder (OCD)|obsessive compulsive disorder (ocd)
4945909|NCT01878526|omeprazole|omeprazole
4945712|NCT01879254|deep brain stimulation (DBS)|deep brain stimulation (dbs)
4945713|NCT01879254|psychosurgery|psychosurgery
4945714|NCT01879254|long-term follow-up|long-term follow-up
4945715|NCT01879241|amyotrophic lateral sclerosis|amyotrophic lateral sclerosis
4945716|NCT01879241|survival time|survival time
4945717|NCT01879241|ALS functioning Rating Scale|als functioning rating scale
4945718|NCT01879241|quality of life|quality of life
4945719|NCT01879241|survival|survival
4945720|NCT01879228|Cystic Fibrosis|cystic fibrosis
4945721|NCT01879228|Diabetes|diabetes
4945722|NCT01879228|Pancreatic Insufficiency|pancreatic insufficiency
4945723|NCT01879202|multiple sclerosis|multiple sclerosis
4945724|NCT01879202|fatigue|fatigue
4945725|NCT01879202|fatigue severity scale|fatigue severity scale
4945726|NCT01879202|fatigue impact scale|fatigue impact scale
4945727|NCT01879202|quality of life|quality of life
4945728|NCT01879163|Vaccine|vaccine
4945729|NCT01879163|Immunogenicity|immunogenicity
4945730|NCT01879137|Copeptin|copeptin
4945731|NCT01879137|Arginin stimulation test|arginin stimulation test
4945732|NCT01879111|Depressive episode|depressive episode
4945733|NCT01879111|Chronic ischaemic heart disease|chronic ischaemic heart disease
4945734|NCT01879111|Hypertension|hypertension
4945735|NCT01879098|probiotics|probiotics
4945736|NCT01879098|inflammation|inflammation
4945737|NCT01879098|bile|bile
4945738|NCT01879098|hunger|hunger
4945739|NCT01879098|satiety|satiety
4945740|NCT01879085|advanced|advanced
4945741|NCT01879085|metastatic|metastatic
4945742|NCT01879085|unresectable|unresectable
4945743|NCT01879085|soft|soft
4945744|NCT01879085|tissue|tissue
4945745|NCT01879085|sarcomas|sarcomas
4945746|NCT01879072|Biomarkers|biomarkers
4945747|NCT01879072|Hematopoietic stem cell transplant|hematopoietic stem cell transplant
4945748|NCT01879059|insulin resistance|insulin resistance
4945749|NCT01879059|exercise|exercise
4945750|NCT01879059|continuous glucose monitoring|continuous glucose monitoring
4945751|NCT01879059|blood flow|blood flow
4945752|NCT01879059|endothelial function|endothelial function
4945753|NCT01879046|Mesenchymal stem cells|mesenchymal stem cells
4945754|NCT01879046|articular cartilage|articular cartilage
4945755|NCT01879046|tissue engineering|tissue engineering
4945756|NCT01879046|immunomodulation|immunomodulation
4945757|NCT01879046|osteo-arthritis|osteo-arthritis
4945758|NCT01879033|Obesity|obesity
4945759|NCT01879033|endothelial function|endothelial function
4945760|NCT01879033|Rh-PAT|rh-pat
4945761|NCT01879033|adipocytokines|adipocytokines
4945762|NCT01879020|MT-8995|mt-8995
4945763|NCT01879020|Dyslipidemia|dyslipidemia
4945764|NCT01879020|Cholesteryl ester transfer proteins|cholesteryl ester transfer proteins
4945765|NCT01878994|Overweight|overweight
4945766|NCT01878994|Obesity|obesity
4945767|NCT01878994|Children|children
4945768|NCT01878994|Behaviour|behaviour
4945769|NCT01878994|Physical Activity|physical activity
4945770|NCT01878994|Nutrition|nutrition
4945771|NCT01878981|Catheter Ablation versus Drug Therapy in AF in China|catheter ablation versus drug therapy in af in china
4945772|NCT01878955|Antimullarian hormone(AMH)|antimullarian hormone(amh)
4945773|NCT01878955|Polycystic Ovary|polycystic ovary
4945774|NCT01878955|Multicystic Ovary|multicystic ovary
4945775|NCT01878942|LSD|lsd
4945776|NCT01878942|Pharmacology|pharmacology
4945777|NCT01878942|Pharmacokinetics|pharmacokinetics
4945778|NCT01878942|Pharmacodynamics|pharmacodynamics
4945779|NCT01878942|Mechanism of action|mechanism of action
4945781|NCT01878942|Serotonin|serotonin
4945782|NCT01878942|Prepulse inhibition|prepulse inhibition
4945783|NCT01878942|LSD-induced neuroendocrine effects|lsd-induced neuroendocrine effects
4945784|NCT01878942|Long-term psychological effects|long-term psychological effects
4945785|NCT01878929|pollen|pollen
4945786|NCT01878929|allergen immunotherapy|allergen immunotherapy
4945787|NCT01878929|subcutaneous allergen immunotherapy|subcutaneous allergen immunotherapy
4945788|NCT01878929|SCIT|scit
4945789|NCT01878916|the incidence of thrombosis,|the incidence of thrombosis,
4945790|NCT01878916|the effect of Hcy on thrombosis formation,|the effect of hcy on thrombosis formation,
4945791|NCT01878916|the relation between Hcy and plasma vitamin levels,|the relation between hcy and plasma vitamin levels,
4945792|NCT01878916|to compare these results with the control group|to compare these results with the control group
4945793|NCT01878890|Solid tumors (other than pancreas)|solid tumors (other than pancreas)
4945794|NCT01878877|Chronic pain|chronic pain
4945795|NCT01878877|neuropathic pain|neuropathic pain
4945796|NCT01878864|Pain, Discomfort, Periodontitis, Scaling and Root Planning, Visual Analogue Scale, McGills Pain Questionnaire|pain, discomfort, periodontitis, scaling and root planning, visual analogue scale, mcgills pain questionnaire
4945797|NCT01878825|Immunogenicity|immunogenicity
4945798|NCT01878825|Trivalent|trivalent
4945799|NCT01878825|Safety|safety
4945800|NCT01878825|Adults|adults
4945801|NCT01878825|Elderly|elderly
4945802|NCT01878825|Influenza|influenza
4945803|NCT01878812|Immunogenicity|immunogenicity
4945804|NCT01878812|Influenza|influenza
4945805|NCT01878812|Adults|adults
4945806|NCT01878812|Safety|safety
4945807|NCT01878812|Elderly|elderly
4945808|NCT01878799|Direct Acting Antiviral|direct acting antiviral
4945809|NCT01878799|Treatment Naive|treatment naive
4945910|NCT01878526|prokinetic|prokinetic
4945810|NCT01878799|Interferon Sparing|interferon sparing
4945811|NCT01878799|Ribavirin Sparing|ribavirin sparing
4945812|NCT01878786|kidney failure|kidney failure
4945813|NCT01878773|Prostate Cancer|prostate cancer
4945814|NCT01878773|MRI scan|mri scan
4945815|NCT01878773|External beam radiotherapy|external beam radiotherapy
4945816|NCT01878760|APRICOT|apricot
4945817|NCT01878760|Anaesthesia|anaesthesia
4945818|NCT01878760|Children|children
4945819|NCT01878760|kids|kids
4945820|NCT01878760|Paediatric Anaesthesia|paediatric anaesthesia
4945821|NCT01878760|Observational Trial|observational trial
4945822|NCT01878760|epidemiology|epidemiology
4945823|NCT01878760|severe critical events in|severe critical events in
4945824|NCT01878760|European Society of Anaesthesiology|european society of anaesthesiology
4945825|NCT01878760|Europe|europe
4945826|NCT01878747|Pediatric|pediatric
4945827|NCT01878747|Pain|pain
4945828|NCT01878747|Postoperative|postoperative
4945829|NCT01878747|General Anesthesia|general anesthesia
4945830|NCT01878747|Anesthesia Recovery Period|anesthesia recovery period
4945831|NCT01878747|Infant Behavior|infant behavior
4945832|NCT01878747|Adolescent Behavior|adolescent behavior
4945833|NCT01878747|Patient Satisfaction|patient satisfaction
4945834|NCT01878721|PET/CT|pet/ct
4945835|NCT01878721|infection|infection
4945836|NCT01878721|vasculitis|vasculitis
4945837|NCT01878708|T-Cell Lymphoma|t-cell lymphoma
4945838|NCT01878708|Relapsed T-Cell Lymphoma|relapsed t-cell lymphoma
4945839|NCT01878708|Refractory T-Cell Lymphoma|refractory t-cell lymphoma
4945840|NCT01878708|Oncaspar®|oncaspar®
4945841|NCT01878708|PEG-L-asparaginase and dexamethasone|peg-l-asparaginase and dexamethasone
4945842|NCT01878695|Integrative Medicine|integrative medicine
4945843|NCT01878695|Breast Cancer|breast cancer
4945844|NCT01878695|Stage 0|stage 0
4945845|NCT01878695|Stage 1|stage 1
4945846|NCT01878669|n-acetyl cysteine|n-acetyl cysteine
4945847|NCT01878669|percutaneous coronary intervention|percutaneous coronary intervention
4945848|NCT01878643|aerosolized antibiotic|aerosolized antibiotic
4945849|NCT01878643|ventilator-associated pneumonia|ventilator-associated pneumonia
4945850|NCT01878643|bacterial resistance|bacterial resistance
4945851|NCT01878643|ventilator -associated tracheobronchitis|ventilator -associated tracheobronchitis
4945852|NCT01878643|clinical pulmonary infection score|clinical pulmonary infection score
4945853|NCT01878630|Chronic Heart Failure|chronic heart failure
4945854|NCT01878630|CHF|chf
4945855|NCT01878617|SJMB12|sjmb12
4945856|NCT01878617|Brain Cancer|brain cancer
4945857|NCT01878617|Brain Tumors in Children|brain tumors in children
4945858|NCT01878617|Cisplatin|cisplatin
4945859|NCT01878617|Cyclophosphamide|cyclophosphamide
4945860|NCT01878617|Embryonal Tumors of CNS|embryonal tumors of cns
4945861|NCT01878617|GDC-0449|gdc-0449
4945862|NCT01878617|Gemcitabine|gemcitabine
4945863|NCT01878617|Hedgehog Pathway Inhibitor|hedgehog pathway inhibitor
4945864|NCT01878617|Infratentorial|infratentorial
4945865|NCT01878617|Mass in Brain|mass in brain
4945866|NCT01878617|Medulloblastoma|medulloblastoma
4945867|NCT01878617|Medulloblastoma Brain Tumor|medulloblastoma brain tumor
4945868|NCT01878617|Medulloblastoma Tumor|medulloblastoma tumor
4945869|NCT01878617|Molecular|molecular
4945870|NCT01878617|Neuroectodermal Tumor, Primitive|neuroectodermal tumor, primitive
4945871|NCT01878617|Newly Diagnosed Childhood Medulloblastoma|newly diagnosed childhood medulloblastoma
4945872|NCT01878617|Non-SHH Non-WNT|non-shh non-wnt
4945873|NCT01878617|Pediatric Brain Tumor|pediatric brain tumor
4945874|NCT01878617|Pemetrexed|pemetrexed
4945875|NCT01878617|Posterior Fossa Tumor|posterior fossa tumor
4945876|NCT01878617|Proton Beam Therapy|proton beam therapy
4945877|NCT01878617|Radiation Therapy|radiation therapy
4945878|NCT01878617|Rare Brain Tumor|rare brain tumor
4945879|NCT01878617|Risk|risk
4945880|NCT01878617|SHH|shh
4945881|NCT01878617|Sonic Hedgehog Pathway|sonic hedgehog pathway
4945882|NCT01878617|St Jude Medullo|st jude medullo
4945883|NCT01878617|St. Jude Brain Tumor Studies|st. jude brain tumor studies
4945884|NCT01878617|St. Jude Medullo|st. jude medullo
4945885|NCT01878617|St. Jude Studies|st. jude studies
4945886|NCT01878617|St. Jude Treatment|st. jude treatment
4945887|NCT01878617|Treatment for Brain Tumors in Children|treatment for brain tumors in children
4945888|NCT01878617|Untreated Childhood Medulloblastoma|untreated childhood medulloblastoma
4945889|NCT01878617|Vincristine|vincristine
4945890|NCT01878617|Vismodegib|vismodegib
4945891|NCT01878617|WNT|wnt
4945892|NCT01878591|labour|labour
4945893|NCT01878591|dystocia|dystocia
4945894|NCT01878591|operative delivery|operative delivery
4945895|NCT01878591|vacuum|vacuum
4945896|NCT01878591|ultrasound|ultrasound
4945897|NCT01878578|Anticonvulsant, BIA 2-093|anticonvulsant, bia 2-093
4945898|NCT01878565|HBIg|hbig
4945899|NCT01878565|GM-CSF|gm-csf
4945900|NCT01878565|HBV vaccine|hbv vaccine
4945901|NCT01878565|immune regulatory therapy|immune regulatory therapy
4945902|NCT01878526|gastroesophageal reflux disease|gastroesophageal reflux disease
4945903|NCT01878526|heart burn|heart burn
4945904|NCT01878526|regurgitation|regurgitation
4945905|NCT01878526|systemic sclerosis|systemic sclerosis
4945906|NCT01878526|scleroderma|scleroderma
4945907|NCT01878526|proton pump inhibitor|proton pump inhibitor
4945908|NCT01878526|alginic acid|alginic acid
4945911|NCT01878500|Bladder exstrophy epispadias complex|bladder exstrophy epispadias complex
4945912|NCT01878500|Pelvic floor musculature|pelvic floor musculature
4945913|NCT01878500|Intraoperative stereotactic imaging|intraoperative stereotactic imaging
4945914|NCT01878487|Acute MI|acute mi
4945915|NCT01878487|Primary percutaneous coronary intervention|primary percutaneous coronary intervention
4945916|NCT01878487|thrombus aspiration, IVUS|thrombus aspiration, ivus
4945918|NCT01878474|Dyslipidemia|dyslipidemia
4945919|NCT01878474|Cholesteryl ester transfer proteins|cholesteryl ester transfer proteins
4945920|NCT01878435|Short Message System|short message system
4945921|NCT01878435|SMS reminder|sms reminder
4945922|NCT01878435|mobile phone|mobile phone
4945923|NCT01878435|cell phone|cell phone
4945924|NCT01878435|vaccination|vaccination
4945925|NCT01878435|immunization|immunization
4945926|NCT01878435|mHealth|mhealth
4945927|NCT01878409|Sexuality|sexuality
4945928|NCT01878409|Parkinson Disease|parkinson disease
4945929|NCT01878409|BISF|bisf
4945930|NCT01878409|IIEF|iief
4945931|NCT01878409|FSFI|fsfi
4945932|NCT01878396|Circulating Melanoma cells in metastatic melanoma|circulating melanoma cells in metastatic melanoma
4945933|NCT01878383|(HSV)|(hsv)
4945934|NCT01878357|MST|mst
4945935|NCT01878357|Malaria|malaria
4945936|NCT01878357|Indonesia|indonesia
4945937|NCT01878357|Transmission|transmission
4945938|NCT01878305|hepatic encephalopathy|hepatic encephalopathy
4945939|NCT01878305|brain waves|brain waves
4945940|NCT01878305|electroencephalogram|electroencephalogram
4945941|NCT01878305|transcranial Doppler ultrasonography|transcranial doppler ultrasonography
4945942|NCT01878305|physiological monitoring|physiological monitoring
4945943|NCT01878305|intensive care|intensive care
4945944|NCT01878266|Diffuse Intrinsic Pontine Glioma (DIPG)|diffuse intrinsic pontine glioma (dipg)
4945945|NCT01878266|Hypofractionated Radiotherapy|hypofractionated radiotherapy
4945946|NCT01878266|Radiotherapy|radiotherapy
4945947|NCT01878266|Median survival|median survival
4945948|NCT01878253|Total Shoulder Arthoplasty|total shoulder arthoplasty
4945949|NCT01878240|Vascular surgery|vascular surgery
4945950|NCT01878240|Abdominal Aortic aneurysm|abdominal aortic aneurysm
4945951|NCT01878240|endovascular|endovascular
4945952|NCT01878214|Health communication|health communication
4945953|NCT01878214|Smoking cessation|smoking cessation
4945954|NCT01878214|Health behavior|health behavior
4945955|NCT01878214|Construction industry|construction industry
4945956|NCT01878214|Audience segmentation|audience segmentation
4945957|NCT01878201|Fimasartan|fimasartan
4945958|NCT01878201|24 hours ABP monitoring(ABPM)|24 hours abp monitoring(abpm)
4945959|NCT01878201|antihypertension|antihypertension
4945960|NCT01878175|Arthroplasty, Replacement, Hip|arthroplasty, replacement, hip
4945961|NCT01878175|Veterans|veterans
4945962|NCT01878175|Exercise|exercise
4945963|NCT01878162|Prevention|prevention
4945964|NCT01878162|Wellness|wellness
4945965|NCT01878162|Occupation|occupation
4945966|NCT01878162|Work|work
4945967|NCT01878162|Law Enforcement|law enforcement
4945968|NCT01878162|Exercise|exercise
4945969|NCT01878123|Arthritis|arthritis
4945970|NCT01878123|Rheumatoid Arthritis|rheumatoid arthritis
4945971|NCT01878123|Joint Diseases|joint diseases
4945972|NCT01878123|Musculoskeletal Diseases|musculoskeletal diseases
4945973|NCT01878123|Rheumatic Diseases|rheumatic diseases
4945974|NCT01878123|Connective Tissue Diseases|connective tissue diseases
4945975|NCT01878123|Autoimmune Diseases|autoimmune diseases
4945976|NCT01878123|Immune System Diseases|immune system diseases
4945977|NCT01878123|Antirheumatic agents|antirheumatic agents
4945978|NCT01878110|Trichotillomania|trichotillomania
4945979|NCT01878110|Hair pulling|hair pulling
4945980|NCT01878110|Behavior therapy|behavior therapy
4945981|NCT01878084|Tissue regeneration|tissue regeneration
4945982|NCT01878084|sol gel bioglass|sol gel bioglass
4945983|NCT01878084|alveolar ridge preservation|alveolar ridge preservation
4945984|NCT01878084|children|children
4945985|NCT01878084|Egyptian|egyptian
4945986|NCT01878084|class II orthodontic cases|class ii orthodontic cases
4945987|NCT01878058|Prostate cancer|prostate cancer
4945988|NCT01878058|Brachytherapy|brachytherapy
4945989|NCT01878058|Seed implant|seed implant
4945990|NCT01878045|American Indians|american indians
4945991|NCT01878045|Diabetic Nephropathy|diabetic nephropathy
4945992|NCT01878045|Kidney Biopsy|kidney biopsy
4945993|NCT01878045|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
4945994|NCT01878045|Retinopathy|retinopathy
4945995|NCT01878032|Retinal Disease|retinal disease
4945996|NCT01878032|Inherited Retinal Degeneration|inherited retinal degeneration
4945997|NCT01878019|Pain|pain
4945998|NCT01878019|Placebo|placebo
4945999|NCT01878019|Opiate Antagonist|opiate antagonist
4946000|NCT01878006|Opiate Receptor|opiate receptor
4946001|NCT01878006|Genotype|genotype
4946002|NCT01878006|PET Imaging|pet imaging
4946003|NCT01877993|coronary artery spasm|coronary artery spasm
4946004|NCT01877993|pathophysiology|pathophysiology
4946005|NCT01877993|atrioventricular block|atrioventricular block
4946006|NCT01877993|blood pressure|blood pressure
4946007|NCT01877993|autonomic nervous function|autonomic nervous function
4946008|NCT01877954|hydrofluoroalkane beclomethasone|hydrofluoroalkane beclomethasone
4946009|NCT01877954|fluticasone|fluticasone
4946010|NCT01877954|paediatrics|paediatrics
4946011|NCT01877954|real-life|real-life
4946012|NCT01877954|observational|observational
4946013|NCT01877954|primary care|primary care
4946014|NCT01877941|cardiac output|cardiac output
4946015|NCT01877941|pulse oximetry|pulse oximetry
4946016|NCT01877941|hemodynamics|hemodynamics
4946017|NCT01877928|Obstructive sleep apnea, CPAP, Boussignac|obstructive sleep apnea, cpap, boussignac
4946018|NCT01877915|Heart Failure|heart failure
4946019|NCT01877915|Coronary Artery Disease|coronary artery disease
4946020|NCT01877915|Stroke|stroke
4946021|NCT01877915|Myocardial Infarction|myocardial infarction
4946022|NCT01877915|Anticoagulation|anticoagulation
4946023|NCT01877889|Healthy|healthy
4946024|NCT01877889|Canagliflozin|canagliflozin
4946025|NCT01877889|INVOKANA|invokana
4946026|NCT01877889|Dapagliflozin|dapagliflozin
4946027|NCT01877889|FORXIGA|forxiga
4946028|NCT01877889|Pharmacodynamics|pharmacodynamics
4946029|NCT01877863|intradialytic exercise|intradialytic exercise
4946030|NCT01877863|hemodialysis|hemodialysis
4946031|NCT01877837|Stem cell transplant|stem cell transplant
4946032|NCT01877837|Sickle cell|sickle cell
4946033|NCT01877837|Stem cell transplantation|stem cell transplantation
4946034|NCT01877837|Related|related
4946035|NCT01877837|Unrelated|unrelated
4946036|NCT01877824|Surgery|surgery
4946037|NCT01877824|Training|training
4946038|NCT01877811|Lung Cancer|lung cancer
4946039|NCT01877811|RET Inhibitor|ret inhibitor
4946040|NCT01877811|Solid Tumors|solid tumors
4946041|NCT01877811|RET mutations or rearrangements|ret mutations or rearrangements
4946042|NCT01877811|BRAF mutations or rearrangements|braf mutations or rearrangements
4946043|NCT01877811|Squamous NSCLC|squamous nsclc
4946044|NCT01877811|KRAS mutation|kras mutation
4946045|NCT01877811|Other Lung adenocarcinomas|other lung adenocarcinomas
4946046|NCT01877772|cuff repair|cuff repair
4946047|NCT01877772|arthroscopic|arthroscopic
4946048|NCT01877772|Trephination|trephination
4946049|NCT01877772|Bone|bone
4946050|NCT01877772|cuff tear|cuff tear
4946051|NCT01877759|Stem cell ,liver cirrhosis|stem cell ,liver cirrhosis
4946052|NCT01877746|ICM|icm
4946053|NCT01877746|myocarditis|myocarditis
4946054|NCT01877746|cardiomyopathy|cardiomyopathy
4946055|NCT01877746|endomyocardial biopsy|endomyocardial biopsy
4946056|NCT01877746|immunosuppression|immunosuppression
4946057|NCT01877733|Resistance training|resistance training
4946058|NCT01877720|Preterm infant less than 32 weeks of gestation age|preterm infant less than 32 weeks of gestation age
4946059|NCT01877720|intubated more than 48 hours after birth|intubated more than 48 hours after birth
4946060|NCT01877720|postextubation|postextubation
4946061|NCT01877694|pink eye|pink eye
4946062|NCT01877668|psoriatic arthritis|psoriatic arthritis
4946063|NCT01877668|radiographic changes|radiographic changes
4946064|NCT01877668|active comparator|active comparator
4946065|NCT01877668|tofacitinib|tofacitinib
4946066|NCT01877655|ASP0113|asp0113
4946067|NCT01877655|Cytomegalovirus (CMV)|cytomegalovirus (cmv)
4946068|NCT01877655|Hematopoietic Cell Transplant (HCT)|hematopoietic cell transplant (hct)
4946069|NCT01877642|ADASUVE|adasuve
4946070|NCT01877642|inhaled loxapine|inhaled loxapine
4946071|NCT01877642|drug drug interaction|drug drug interaction
4946072|NCT01877642|lorazepam|lorazepam
4946073|NCT01877642|acute treatment of agitation|acute treatment of agitation
4946074|NCT01877629|Pharmacokinetics|pharmacokinetics
4946075|NCT01877629|Tolerability|tolerability
4946076|NCT01877629|Safety|safety
4946077|NCT01877629|ACT-129968|act-129968
4946078|NCT01877616|sleep disorders|sleep disorders
4946079|NCT01877616|insomnia|insomnia
4946080|NCT01877616|hypersomnia|hypersomnia
4946081|NCT01877616|sleep-disordered breathing|sleep-disordered breathing
4946082|NCT01877616|cardiovascular health|cardiovascular health
4946083|NCT01877616|stroke|stroke
4946084|NCT01877616|ischemic heart disease|ischemic heart disease
4946085|NCT01877616|Atahualpa|atahualpa
4946086|NCT01877551|HIV|hiv
4946087|NCT01877551|Protease inhibitor|protease inhibitor
4946088|NCT01877551|insulin resistance|insulin resistance
4946089|NCT01877551|Tauroursodeoxycholic acid|tauroursodeoxycholic acid
4946090|NCT01877525|colorectal polyps|colorectal polyps
4946091|NCT01877525|resect and discard|resect and discard
4946092|NCT01877525|endoscopic prediction|endoscopic prediction
4946093|NCT01877525|histological diagnosis|histological diagnosis
4946094|NCT01877525|narrow band imaging|narrow band imaging
4946095|NCT01877499|Hemodiafiltration|hemodiafiltration
4946096|NCT01877499|Convection volume|convection volume
4946097|NCT01877499|Filtration fraction|filtration fraction
4946098|NCT01877499|Blood flow|blood flow
4946099|NCT01877499|Treatment time|treatment time
4946100|NCT01877486|atrial fibrillation|atrial fibrillation
4946101|NCT01877486|cryoballoon ablation|cryoballoon ablation
4946102|NCT01877486|persistent AF|persistent af
4946103|NCT01877486|paroxysmal AF|paroxysmal af
4946104|NCT01877486|dofetilide|dofetilide
4946105|NCT01877473|atrial fibrillation|atrial fibrillation
4946106|NCT01877473|persistent AF|persistent af
4946107|NCT01877473|catheter ablation|catheter ablation
4946108|NCT01877473|duration of 7 days to one year|duration of 7 days to one year
4946205|NCT01877044|Immunity|immunity
4946109|NCT01877473|with symptoms and failure of at least one antiarrhythmic drug|with symptoms and failure of at least one antiarrhythmic drug
4946110|NCT01877460|sodium alginate|sodium alginate
4946111|NCT01877460|chocolate milk|chocolate milk
4946112|NCT01877460|satiety|satiety
4946113|NCT01877460|energy intake|energy intake
4946114|NCT01877460|glycemia|glycemia
4946115|NCT01877460|insulinemia|insulinemia
4946116|NCT01877447|tDCS|tdcs
4946117|NCT01877447|Brain stimulation|brain stimulation
4946118|NCT01877447|depressive disorder|depressive disorder
4946119|NCT01877434|Reversed shoulder arthroplasty|reversed shoulder arthroplasty
4946120|NCT01877434|Treatment|treatment
4946121|NCT01877434|TESS|tess
4946122|NCT01877421|Reducing plaque|reducing plaque
4946123|NCT01877421|Reducing gingivitis|reducing gingivitis
4946124|NCT01877421|safety|safety
4946125|NCT01877421|proof of concept|proof of concept
4946126|NCT01877421|antiplaque chewing gum|antiplaque chewing gum
4946127|NCT01877408|disposable circumcision device|disposable circumcision device
4946128|NCT01877408|Tissue adhesive|tissue adhesive
4946129|NCT01877408|Open surgical circumcision|open surgical circumcision
4946130|NCT01877408|Minimally-invasive circumcision|minimally-invasive circumcision
4946131|NCT01877395|Rabies|rabies
4946132|NCT01877395|Purified Vero Rabies Vaccine - Serum Free|purified vero rabies vaccine - serum free
4946133|NCT01877395|Human Diploid Cell Vaccine|human diploid cell vaccine
4946134|NCT01877395|Imovax® Rabies|imovax® rabies
4946135|NCT01877356|ambulatory surgery|ambulatory surgery
4946136|NCT01877356|spinal anesthesia|spinal anesthesia
4946137|NCT01877356|micturition|micturition
4946138|NCT01877356|bladder retention|bladder retention
4946139|NCT01877356|unilateral block|unilateral block
4946140|NCT01877356|prilocaine hyperbaric|prilocaine hyperbaric
4946141|NCT01877356|prilocaine plain|prilocaine plain
4946142|NCT01877356|local anaesthetic dose|local anaesthetic dose
4946143|NCT01877343|cardiac functional health classification|cardiac functional health classification
4946144|NCT01877343|Congenital heart failure|congenital heart failure
4946145|NCT01877343|chronic heart failure|chronic heart failure
4946146|NCT01877330|shoulder arthroscopy|shoulder arthroscopy
4946147|NCT01877330|ultrasound guided nerve block|ultrasound guided nerve block
4946148|NCT01877330|interscalene nerve block|interscalene nerve block
4946149|NCT01877317|Audiology|audiology
4946150|NCT01877317|hearing loss|hearing loss
4946151|NCT01877317|hearing healthcare|hearing healthcare
4946152|NCT01877317|mobile app|mobile app
4946153|NCT01877317|hearing aid fitting|hearing aid fitting
4946154|NCT01877317|audiometry|audiometry
4946155|NCT01877317|audiogram|audiogram
4946156|NCT01877291|smoking, nasal lavage, exhaled breath condensate, mucociliary transport|smoking, nasal lavage, exhaled breath condensate, mucociliary transport
4946157|NCT01877278|Osteoarthritis|osteoarthritis
4946158|NCT01877278|Pulsed electromagnetic fields|pulsed electromagnetic fields
4946159|NCT01877278|Device|device
4946160|NCT01877278|Pain|pain
4946161|NCT01877278|Pressure algometry|pressure algometry
4946162|NCT01877252|critical limb ischemia|critical limb ischemia
4946163|NCT01877252|endovascular treatment|endovascular treatment
4946164|NCT01877252|open surgical repair|open surgical repair
4946165|NCT01877252|diabetic foot|diabetic foot
4946166|NCT01877226|Healthy|healthy
4946167|NCT01877226|Tapentadol|tapentadol
4946168|NCT01877213|coaching|coaching
4946169|NCT01877213|therapeutic education|therapeutic education
4946170|NCT01877213|hospital admission|hospital admission
4946171|NCT01877213|quality improvement strategies|quality improvement strategies
4946172|NCT01877213|management program|management program
4946173|NCT01877213|nurse follow up|nurse follow up
4946174|NCT01877213|discharge planning|discharge planning
4946175|NCT01877213|rehospitalization|rehospitalization
4946176|NCT01877187|Primary liver cancer|primary liver cancer
4946177|NCT01877187|Metastatic liver cancer|metastatic liver cancer
4946178|NCT01877174|Internal Carotid Stenosis|internal carotid stenosis
4946179|NCT01877174|Reverse Flow|reverse flow
4946180|NCT01877174|Carotid stenting|carotid stenting
4946181|NCT01877174|MICHI(TM) NPS+f|michi(tm) nps+f
4946182|NCT01877148|Parkinson, rehabilitation, tDCS|parkinson, rehabilitation, tdcs
4946183|NCT01877135|anal carcinoma|anal carcinoma
4946184|NCT01877135|AIN3|ain3
4946185|NCT01877135|cohort study|cohort study
4946186|NCT01877109|Lymphoma|lymphoma
4946187|NCT01877109|Prognosis|prognosis
4946188|NCT01877109|Biomarker|biomarker
4946189|NCT01877109|Quality of life|quality of life
4946190|NCT01877096|Motivational Interviewing|motivational interviewing
4946191|NCT01877096|Screening Colonoscopy|screening colonoscopy
4946192|NCT01877096|Cancer Prevention|cancer prevention
4946193|NCT01877083|KIF5B-RET-Positive Adenocarcinoma|kif5b-ret-positive adenocarcinoma
4946194|NCT01877083|Lung Cancer|lung cancer
4946195|NCT01877083|NSCLC|nsclc
4946196|NCT01877083|Non-Small Cell Lung Cancer|non-small cell lung cancer
4946197|NCT01877070|assessments|assessments
4946198|NCT01877070|13-076|13-076
4946199|NCT01877057|Pea protein|pea protein
4946200|NCT01877057|Satiety hormone|satiety hormone
4946201|NCT01877057|Ussing Chamber|ussing chamber
4946202|NCT01877044|Prebiotics|prebiotics
4946203|NCT01877044|Intestinal permeability|intestinal permeability
4946204|NCT01877044|Gut barrier function|gut barrier function
4946206|NCT01877031|central line|central line
4946207|NCT01877031|ultrasound guided central line insertion|ultrasound guided central line insertion
4946208|NCT01877031|virtual reality|virtual reality
4946209|NCT01877031|augmented reality|augmented reality
4946210|NCT01877018|Comparative Effectiveness Research|comparative effectiveness research
4946211|NCT01877018|Reminder Systems|reminder systems
4946212|NCT01877018|Patient Participation|patient participation
4946213|NCT01877018|Primary Health Care|primary health care
4946214|NCT01877018|Early Detection of Cancer|early detection of cancer
4946215|NCT01877018|Colorectal Neoplasms|colorectal neoplasms
4946216|NCT01877005|Multicenter, single arm and opened label phase II study|multicenter, single arm and opened label phase ii study
4946217|NCT01876992|diabetes|diabetes
4946218|NCT01876992|pediatrics|pediatrics
4946219|NCT01876992|obesity|obesity
4946220|NCT01876992|healthy volunteers|healthy volunteers
4946221|NCT01876992|metformin|metformin
4946222|NCT01876992|nutrition|nutrition
4946223|NCT01876992|healthy controls|healthy controls
4946224|NCT01876992|bmi|bmi
4946225|NCT01876966|HIV|hiv
4946226|NCT01876966|pharmacokinetic interaction|pharmacokinetic interaction
4946227|NCT01876966|healthy HIV-negative person|healthy hiv-negative person
4946228|NCT01876940|supraglottic airway|supraglottic airway
4946229|NCT01876940|children|children
4946230|NCT01876940|tracheal intubation|tracheal intubation
4946231|NCT01876940|fiberoptic bronchoscopy|fiberoptic bronchoscopy
4946232|NCT01876927|Locally|locally
4946233|NCT01876927|Advanced|advanced
4946234|NCT01876927|Resectable|resectable
4946235|NCT01876927|Gastric Cancer|gastric cancer
4946236|NCT01876914|Diabetes|diabetes
4946237|NCT01876914|Edema|edema
4946238|NCT01876914|DME|dme
4946239|NCT01876914|OCT|oct
4946240|NCT01876901|Rectal cancer|rectal cancer
4946241|NCT01876901|Coloanal anastomosis|coloanal anastomosis
4946242|NCT01876901|Phase 2 clinical trial|phase 2 clinical trial
4946243|NCT01876888|patient satisfaction|patient satisfaction
4946244|NCT01876888|physical therapy|physical therapy
4946245|NCT01876888|MedRisk instrument|medrisk instrument
4946246|NCT01876875|psoriasis|psoriasis
4946247|NCT01876875|obesity|obesity
4946248|NCT01876862|HIV-1|hiv-1
4946249|NCT01876862|chronic infection|chronic infection
4946250|NCT01876862|cure|cure
4946251|NCT01876862|remission|remission
4946252|NCT01876849|diabetes|diabetes
4946253|NCT01876849|exenatide|exenatide
4946254|NCT01876849|Byetta|byetta
4946255|NCT01876849|Amylin|amylin
4946256|NCT01876849|Lilly|lilly
4946257|NCT01876836|i-gel|i-gel
4946258|NCT01876836|C-LMA|c-lma
4946259|NCT01876836|gastroeosephageal reflux|gastroeosephageal reflux
4946260|NCT01876836|sore troat|sore troat
4946261|NCT01876823|Memory Decline|memory decline
4946262|NCT01876823|Depression|depression
4946263|NCT01876823|Elderly|elderly
4946264|NCT01876823|Antidepressants|antidepressants
4946265|NCT01876823|Treatment|treatment
4946266|NCT01876823|memantine|memantine
4946267|NCT01876810|Gemfibrozil|gemfibrozil
4946268|NCT01876810|Nicotine Dependence|nicotine dependence
4946269|NCT01876810|Smoking|smoking
4946270|NCT01876810|Cigarettes|cigarettes
4946271|NCT01876784|vandetanib, AZD 6474, Differentiated Thyroid Cancer|vandetanib, azd 6474, differentiated thyroid cancer
4946272|NCT01876771|177lutetium-DOTA(O)Tyr3)octreotate|177lutetium-dota(o)tyr3)octreotate
4946273|NCT01876758|ECT|ect
4946274|NCT01876758|Memory Training|memory training
4946275|NCT01876758|Cognitive Remediation|cognitive remediation
4946276|NCT01876758|Electroconvulsive Therapy|electroconvulsive therapy
4946277|NCT01876758|Treatment Resistant Depression|treatment resistant depression
4946278|NCT01876758|Depression|depression
4946279|NCT01876758|Geriatric Depression|geriatric depression
4946280|NCT01876758|Memory Loss|memory loss
4946281|NCT01876758|Cognitive Training|cognitive training
4946282|NCT01876732|hemodialysis|hemodialysis
4946283|NCT01876732|viatmin B12 deficiency|viatmin b12 deficiency
4946284|NCT01876732|Epogen|epogen
4946285|NCT01876719|ADHD|adhd
4946286|NCT01876719|AR08|ar08
4946287|NCT01876719|adrenergic receptor agonists|adrenergic receptor agonists
4946288|NCT01876719|randomized, placebo-controlled clinical trial|randomized, placebo-controlled clinical trial
4946289|NCT01876706|UroLift System|urolift system
4946290|NCT01876680|chronic|chronic
4946291|NCT01876680|neck|neck
4946292|NCT01876680|shoulder|shoulder
4946293|NCT01876680|exercise|exercise
4946294|NCT01876654|Total Knee Replacement|total knee replacement
4946295|NCT01876654|Patient specific instrumentation|patient specific instrumentation
4946296|NCT01876641|Metastatic melanoma|metastatic melanoma
4946297|NCT01876641|melanoma|melanoma
4946298|NCT01876641|BRAF-mutated Metastatic Melanoma|braf-mutated metastatic melanoma
4946299|NCT01876641|V600EBRAF-mutated metastatic melanoma|v600ebraf-mutated metastatic melanoma
4946300|NCT01876641|Decitabine|decitabine
4946301|NCT01876641|Vemurafenib|vemurafenib
4946302|NCT01876628|Clindamycin|clindamycin
4946303|NCT01876628|Cellulitis|cellulitis
4946304|NCT01876628|Flucloxacillin|flucloxacillin
4946305|NCT01876628|Group A streptococcus|group a streptococcus
4946306|NCT01876628|Staphylococcus aureus|staphylococcus aureus
4946408|NCT01876147|Visual acuity|visual acuity
4946409|NCT01876147|Poor vision|poor vision
4946307|NCT01876615|safety/tolerability and pharmacokinetics/pharmacodynamics|safety/tolerability and pharmacokinetics/pharmacodynamics
4946308|NCT01876602|adolescents|adolescents
4946309|NCT01876602|exercise|exercise
4946310|NCT01876602|fitness|fitness
4946311|NCT01876602|school-based|school-based
4946312|NCT01876589|Coronary Artery Disease (CAD)|coronary artery disease (cad)
4946313|NCT01876589|Invasive coronary angiography (ICA)|invasive coronary angiography (ica)
4946314|NCT01876589|Positron Emission Tomography (PET)|positron emission tomography (pet)
4946315|NCT01876576|colonoscopy|colonoscopy
4946316|NCT01876563|thioredoxin|thioredoxin
4946317|NCT01876563|TBP-2|tbp-2
4946318|NCT01876563|thioredoxin reductase|thioredoxin reductase
4946319|NCT01876563|vitamin D|vitamin d
4946320|NCT01876563|DIABETES|diabetes
4946321|NCT01876550|Mupirocin Calcium Cream 2%|mupirocin calcium cream 2%
4946322|NCT01876550|Bactroban® Cream|bactroban® cream
4946323|NCT01876550|Secondarily infected traumatic skin lesions|secondarily infected traumatic skin lesions
4946324|NCT01876524|Substance Use Disorder|substance use disorder
4946325|NCT01876524|Attention Deficit Disorder With Hyperactivity|attention deficit disorder with hyperactivity
4946326|NCT01876524|Schizophrenia|schizophrenia
4946327|NCT01876524|Bipolar disorder|bipolar disorder
4946328|NCT01876524|Personality disorder|personality disorder
4946329|NCT01876511|MSI|msi
4946330|NCT01876511|MSS|mss
4946331|NCT01876511|MLH 1|mlh 1
4946332|NCT01876511|MSH 2|msh 2
4946333|NCT01876511|MSH 6|msh 6
4946334|NCT01876511|PMS2|pms2
4946335|NCT01876511|BRAF pV600E|braf pv600e
4946336|NCT01876511|TGFBR2|tgfbr2
4946337|NCT01876511|Mutation load|mutation load
4946338|NCT01876511|tumor mutation load|tumor mutation load
4946339|NCT01876511|mutation burden|mutation burden
4946340|NCT01876511|tumor mutation burden|tumor mutation burden
4946341|NCT01876511|hypermutation|hypermutation
4946342|NCT01876511|POLE|pole
4946343|NCT01876511|MSI Negative with Mutator Phenotype (High Tumor Mutation Burden)|msi negative with mutator phenotype (high tumor mutation burden)
4946344|NCT01876485|Diabetes Mellitus|diabetes mellitus
4946345|NCT01876485|health literacy|health literacy
4946346|NCT01876485|patient activation|patient activation
4946347|NCT01876485|goals of care|goals of care
4946348|NCT01876394|Healthy|healthy
4946349|NCT01876394|Arterial Stiffness|arterial stiffness
4946350|NCT01876394|Blood Pressure|blood pressure
4946351|NCT01876394|Blood Glucose|blood glucose
4946352|NCT01876394|Vascular Function|vascular function
4946353|NCT01876368|hypertension,|hypertension,
4946354|NCT01876368|LCZ696,|lcz696,
4946355|NCT01876368|olmesartan|olmesartan
4946356|NCT01876355|Delirium, clonidine, ICU, sedation|delirium, clonidine, icu, sedation
4946357|NCT01876342|sports hernia|sports hernia
4946358|NCT01876342|sportsman's hernia|sportsman's hernia
4946359|NCT01876342|chronic groin pain|chronic groin pain
4946360|NCT01876342|open minimal repair|open minimal repair
4946361|NCT01876342|totally extraperitoneal endoscopic technique|totally extraperitoneal endoscopic technique
4946362|NCT01876329|Rheumatoid Arthritis|rheumatoid arthritis
4946363|NCT01876329|Vitamin B12 deficiency|vitamin b12 deficiency
4946364|NCT01876329|Autoimmune Thyroid Disease|autoimmune thyroid disease
4946365|NCT01876329|Autoantibodies|autoantibodies
4946366|NCT01876316|Moxifloxacin|moxifloxacin
4946367|NCT01876316|QT interval prolongation|qt interval prolongation
4946368|NCT01876316|Korean|korean
4946369|NCT01876316|Japanese|japanese
4946370|NCT01876290|Anesthesiology|anesthesiology
4946371|NCT01876290|Complications|complications
4946372|NCT01876290|Closed-loop|closed-loop
4946373|NCT01876277|Cancer|cancer
4946374|NCT01876277|Body image|body image
4946375|NCT01876277|Adolescent|adolescent
4946376|NCT01876264|Colorectal surgery|colorectal surgery
4946377|NCT01876264|Colonoscopy|colonoscopy
4946378|NCT01876264|Randomized controlled trial|randomized controlled trial
4946379|NCT01876251|Breast cancer metastatic|breast cancer metastatic
4946380|NCT01876251|docetaxel|docetaxel
4946381|NCT01876251|PF-03084014|pf-03084014
4946382|NCT01876238|Breast Cancer|breast cancer
4946383|NCT01876238|Patient-Doctor Communication|patient-doctor communication
4946384|NCT01876238|Supportive Care|supportive care
4946385|NCT01876225|cervical biopsy|cervical biopsy
4946386|NCT01876225|forced cough|forced cough
4946387|NCT01876225|pain|pain
4946388|NCT01876225|VAS scale|vas scale
4946389|NCT01876212|melanoma|melanoma
4946390|NCT01876212|metastatic|metastatic
4946391|NCT01876212|vaccine|vaccine
4946392|NCT01876212|BRAF|braf
4946393|NCT01876199|HIV-1|hiv-1
4946394|NCT01876199|acute|acute
4946395|NCT01876199|diagnosis|diagnosis
4946396|NCT01876199|pharmacies|pharmacies
4946397|NCT01876199|healthcare facilities|healthcare facilities
4946398|NCT01876186|antimuscarinic treatment|antimuscarinic treatment
4946399|NCT01876186|urodynamic studies|urodynamic studies
4946400|NCT01876186|nerve growth factor|nerve growth factor
4946401|NCT01876173|Sudden cardiac death|sudden cardiac death
4946402|NCT01876173|implantable cardioverter defibrillator|implantable cardioverter defibrillator
4946403|NCT01876173|decision aid|decision aid
4946404|NCT01876147|Low vision|low vision
4946405|NCT01876147|Vision testing|vision testing
4946406|NCT01876147|Retinitis Pigmentosa|retinitis pigmentosa
4946407|NCT01876147|AMD|amd
4946410|NCT01876147|Quantification|quantification
4946411|NCT01876134|Cardiac surgery|cardiac surgery
4946412|NCT01876134|Acute kidney injury|acute kidney injury
4946413|NCT01876134|Cyr-61|cyr-61
4946414|NCT01876134|Pulse wave analysis|pulse wave analysis
4946415|NCT01876121|NSAIDs|nsaids
4946416|NCT01876121|Acute pain|acute pain
4946417|NCT01876108|Steatohepatitis|steatohepatitis
4946418|NCT01876108|Helicobacter pylori|helicobacter pylori
4946419|NCT01876108|Alanine aminotransferase|alanine aminotransferase
4946420|NCT01876108|Aspartate aminotransferase|aspartate aminotransferase
4946421|NCT01876108|Fatty Liver|fatty liver
4946422|NCT01876108|Liver Diseases|liver diseases
4946423|NCT01876108|Digestive System Diseases|digestive system diseases
4946424|NCT01876082|Desmoids tumors|desmoids tumors
4946425|NCT01876082|Pazopanib|pazopanib
4946426|NCT01876082|Phase 2 clinical trial|phase 2 clinical trial
4946427|NCT01876082|Cross over|cross over
4946428|NCT01876056|Psychosis|psychosis
4946429|NCT01876056|Culture|culture
4946430|NCT01876056|CBT|cbt
4946431|NCT01876030|Functional electrical stimulation (FES)|functional electrical stimulation (fes)
4946432|NCT01876030|Sub acute stroke|sub acute stroke
4946433|NCT01876030|Gait analysis|gait analysis
4946434|NCT01876017|CRF|crf
4946435|NCT01876017|STEM CELL|stem cell
4946436|NCT01876017|CKD|ckd
4946437|NCT01876004|ectopic pregnancy|ectopic pregnancy
4946438|NCT01876004|methotrexate|methotrexate
4946439|NCT01876004|human chorionic gonadotropin beta subunit|human chorionic gonadotropin beta subunit
4946440|NCT01876004|expectant management|expectant management
4946441|NCT01875978|Phytosterols|phytosterols
4946442|NCT01875978|Endothelial progenitor cells|endothelial progenitor cells
4946443|NCT01875952|Latent tuberculosis infection|latent tuberculosis infection
4946444|NCT01875952|Human immunodeficiency virus (HIV)|human immunodeficiency virus (hiv)
4946445|NCT01875952|Treatment|treatment
4946446|NCT01875952|Isoniazid|isoniazid
4946447|NCT01875939|healthy volunteers|healthy volunteers
4946448|NCT01875913|Curiosity|curiosity
4946449|NCT01875913|Intention|intention
4946450|NCT01875913|Follow Through|follow through
4946451|NCT01875900|neonatal resuscitation|neonatal resuscitation
4946452|NCT01875900|video-assisted learning|video-assisted learning
4946453|NCT01875900|self-directed training|self-directed training
4946454|NCT01875900|simulation|simulation
4946455|NCT01875900|simulation-based training|simulation-based training
4946456|NCT01875900|simulation-based medical education|simulation-based medical education
4946457|NCT01875900|objective structured clinical examination|objective structured clinical examination
4946458|NCT01875874|liver failure|liver failure
4946459|NCT01875874|acute liver failure|acute liver failure
4946460|NCT01875874|fulminant hepatic failure|fulminant hepatic failure
4946461|NCT01875874|primary graft non-function|primary graft non-function
4946462|NCT01875874|surgically-induced liver failure|surgically-induced liver failure
4946463|NCT01875874|ELAD|elad
4946464|NCT01875874|ALF|alf
4946465|NCT01875874|FHF|fhf
4946466|NCT01875874|PNF|pnf
4946467|NCT01875861|Antipsychotic Agents|antipsychotic agents
4946468|NCT01875861|Metabolic Syndrome|metabolic syndrome
4946469|NCT01875861|Quality Improvement|quality improvement
4946470|NCT01875848|pain management|pain management
4946471|NCT01875835|Acute myocardiac infarction|acute myocardiac infarction
4946472|NCT01875835|Bare-metal stent|bare-metal stent
4946473|NCT01875835|Everolimus-eluting stent|everolimus-eluting stent
4946474|NCT01875835|Optical coherence tomography|optical coherence tomography
4946475|NCT01875822|Curcumin|curcumin
4946476|NCT01875822|Epigenetics|epigenetics
4946477|NCT01875822|Schizophrenia|schizophrenia
4946478|NCT01875822|Nitric Oxide synthetase|nitric oxide synthetase
4946479|NCT01875822|cognition|cognition
4946480|NCT01875822|negative symptoms|negative symptoms
4946481|NCT01875809|RDN|rdn
4946482|NCT01875809|renal denervation|renal denervation
4946483|NCT01875809|catecholamine|catecholamine
4946484|NCT01875809|spill-over|spill-over
4946485|NCT01875809|blood pressure|blood pressure
4946486|NCT01875809|electrophysiology|electrophysiology
4946487|NCT01875809|ablation|ablation
4946488|NCT01875796|cannabis|cannabis
4946489|NCT01875796|marijuana|marijuana
4946490|NCT01875796|anxiety|anxiety
4946491|NCT01875796|transdiagnostic|transdiagnostic
4946492|NCT01875796|dual diagnosis|dual diagnosis
4946493|NCT01875796|cannabis abuse|cannabis abuse
4946494|NCT01875796|cannabis dependence|cannabis dependence
4946495|NCT01875796|cannabis use disorder|cannabis use disorder
4946496|NCT01875783|diabetes|diabetes
4946497|NCT01875783|diabetic macular edema|diabetic macular edema
4946498|NCT01875783|diabetic retinopathy|diabetic retinopathy
4946499|NCT01875783|optical coherence tomography|optical coherence tomography
4946500|NCT01875770|Retinal Vein Occlusion|retinal vein occlusion
4946501|NCT01875757|Vitamin D|vitamin d
4946502|NCT01875757|Acute bronchitis|acute bronchitis
4946503|NCT01875757|Upper respiratory tract infection|upper respiratory tract infection
4946504|NCT01875757|Recurrent bronchitis|recurrent bronchitis
4946505|NCT01875757|Acute bronchiolitis|acute bronchiolitis
4946506|NCT01875757|Infants|infants
4946507|NCT01875744|constipation|constipation
4946508|NCT01875744|children|children
4946509|NCT01875744|polyethylene glycol|polyethylene glycol
4946510|NCT01875731|Pneumonia|pneumonia
4946511|NCT01875731|Acute respiratory infection|acute respiratory infection
4946512|NCT01875731|Decision-support techniques|decision-support techniques
4946513|NCT01875692|Metagenomic|metagenomic
4946514|NCT01875692|Ventilator-Associated Pneumonia (VAP)|ventilator-associated pneumonia (vap)
4946515|NCT01875679|Surgical education|surgical education
4946516|NCT01875679|Deliberate practice|deliberate practice
4946517|NCT01875679|Debriefing|debriefing
4946518|NCT01875679|Behaviour modelling|behaviour modelling
4946519|NCT01875666|breast cancer|breast cancer
4946520|NCT01875666|Kinome|kinome
4946521|NCT01875666|HER two positive|her two positive
4946522|NCT01875653|metastatic melanoma|metastatic melanoma
4946523|NCT01875653|dendritic cells|dendritic cells
4946524|NCT01875653|immunotherapy|immunotherapy
4946525|NCT01875653|Granulocyte-Macrophage Colony Stimulating Factor|granulocyte-macrophage colony stimulating factor
4946526|NCT01875653|overall survival|overall survival
4946527|NCT01875653|autologous|autologous
4946528|NCT01875653|peripheral blood mononuclear cells|peripheral blood mononuclear cells
4946529|NCT01875653|treatment|treatment
4946530|NCT01875653|phase 3|phase 3
4946531|NCT01875653|tumor cells|tumor cells
4946532|NCT01875640|disorder of sex development|disorder of sex development
4946533|NCT01875640|intersex|intersex
4946534|NCT01875640|46,XX congenital adrenal hyperplasia|46,xx congenital adrenal hyperplasia
4946535|NCT01875640|hypospadias|hypospadias
4946536|NCT01875640|decision support tool|decision support tool
4946537|NCT01875601|NK Cells|nk cells
4946538|NCT01875601|Cytokine|cytokine
4946539|NCT01875601|Lymphodepleting Chemotherapy|lymphodepleting chemotherapy
4946540|NCT01875601|Immunotherapy|immunotherapy
4946541|NCT01875601|Pediatric|pediatric
4946542|NCT01875588|Healthy Controls|healthy controls
4946543|NCT01875588|HIV-positive|hiv-positive
4946544|NCT01875588|Neurophyschological Testing|neurophyschological testing
4946545|NCT01875588|PET/CT Scan|pet/ct scan
4946546|NCT01875588|Lumbar Drain/Puncture|lumbar drain/puncture
4946547|NCT01875575|glucagon-like peptide-1|glucagon-like peptide-1
4946548|NCT01875575|peptide tyrosine tyrosine|peptide tyrosine tyrosine
4946549|NCT01875575|ghrelin|ghrelin
4946550|NCT01875575|stomach|stomach
4946551|NCT01875575|small intestine|small intestine
4946552|NCT01875575|gastric emptying|gastric emptying
4946553|NCT01875562|Neck pain|neck pain
4946554|NCT01875562|Cervical radiculopathy|cervical radiculopathy
4946555|NCT01875562|Qishe Pill|qishe pill
4946556|NCT01875562|Traditional Chinese Medicine|traditional chinese medicine
4946557|NCT01875536|transcranial magnetic stimulation|transcranial magnetic stimulation
4946558|NCT01875536|spasticity|spasticity
4946559|NCT01875536|physiotherapy|physiotherapy
4946560|NCT01875536|Rehabilitation|rehabilitation
4946561|NCT01875523|Renal disease|renal disease
4946562|NCT01875523|renal impairment|renal impairment
4946563|NCT01875523|End stage renal disease|end stage renal disease
4946564|NCT01875523|Healthy volunteer|healthy volunteer
4946565|NCT01875523|Pharmacokinetics|pharmacokinetics
4946566|NCT01875497|athletes, polyphenols, nutrition, oxidative stress|athletes, polyphenols, nutrition, oxidative stress
4946567|NCT01875484|miR-126|mir-126
4946568|NCT01875484|Left Ventricular Remodeling|left ventricular remodeling
4946569|NCT01875484|Myocardial Infarction|myocardial infarction
4946570|NCT01875484|primary percutaneous coronary intervention|primary percutaneous coronary intervention
4946571|NCT01875484|left ventricular end diastolic volume|left ventricular end diastolic volume
4946572|NCT01875484|left ventricular ejection fraction|left ventricular ejection fraction
4946573|NCT01875484|major adverse cardiovascular events|major adverse cardiovascular events
4946574|NCT01875458|Aclasta|aclasta
4946575|NCT01875458|Actonel|actonel
4946576|NCT01875458|alendronate|alendronate
4946577|NCT01875458|alendronate/cholecalciferol|alendronate/cholecalciferol
4946578|NCT01875458|Aredia|aredia
4946579|NCT01875458|Atelvia|atelvia
4946580|NCT01875458|Boniva|boniva
4946581|NCT01875458|Didronel|didronel
4946582|NCT01875458|etidronate|etidronate
4946583|NCT01875458|Fosamax|fosamax
4946584|NCT01875458|Fosamax Plus D|fosamax plus d
4946585|NCT01875458|ibandronate|ibandronate
4946586|NCT01875458|pamidronate|pamidronate
4946587|NCT01875458|Reclast|reclast
4946588|NCT01875458|risedronate|risedronate
4946589|NCT01875458|Skelid|skelid
4946590|NCT01875458|tiludronate|tiludronate
4946591|NCT01875458|zoledronic acid|zoledronic acid
4946592|NCT01875458|Zometa|zometa
4946593|NCT01875458|Bisphosphonate|bisphosphonate
4946594|NCT01875458|Atypical Femur Fracture (AFF)|atypical femur fracture (aff)
4946595|NCT01875458|Osteoporosis|osteoporosis
4946596|NCT01875458|Bisphosphonate Related Osteonecrosis of the Jaw (BRONJ)|bisphosphonate related osteonecrosis of the jaw (bronj)
4946597|NCT01875445|Inositol|inositol
4946598|NCT01875445|Trichotillomania|trichotillomania
4946599|NCT01875445|Hair Pulling|hair pulling
4946600|NCT01875445|Impulse Control Disorder|impulse control disorder
4946601|NCT01875393|Prostatic Disease|prostatic disease
4946602|NCT01875393|Genital Neoplasm,male|genital neoplasm,male
4946603|NCT01875393|Urogenital neoplasm|urogenital neoplasm
4946604|NCT01875393|Genital disease,male|genital disease,male
4946605|NCT01875393|Male urogenital disease|male urogenital disease
4946606|NCT01875393|Neoplasms|neoplasms
4946607|NCT01875393|Neoplasms by site|neoplasms by site
4946608|NCT01875393|Prostatic neoplasm|prostatic neoplasm
4946609|NCT01875393|Carcinoma|carcinoma
4946610|NCT01875380|metastatic colorectal cancer|metastatic colorectal cancer
4946611|NCT01875380|frail and unfit patient|frail and unfit patient
4946612|NCT01875380|regorafenib|regorafenib
4946613|NCT01875367|Subcutaneous trastuzumab|subcutaneous trastuzumab
4946614|NCT01875367|Intravenous trastuzumab|intravenous trastuzumab
4946615|NCT01875367|HER2 positive|her2 positive
4946616|NCT01875367|Advanced Breast Cancer|advanced breast cancer
4946617|NCT01875341|type 2 diabetes|type 2 diabetes
4946618|NCT01875341|diabetic nephropathy|diabetic nephropathy
4946619|NCT01875341|hypertension|hypertension
4946620|NCT01875341|sleep apnea|sleep apnea
4946621|NCT01875341|sympathetic hyperactivity|sympathetic hyperactivity
4946622|NCT01875328|stroke|stroke
4946623|NCT01875328|blood pressure|blood pressure
4946624|NCT01875328|telemedicine|telemedicine
4946625|NCT01875302|COPD PRO Instraments equivalency|copd pro instraments equivalency
4946626|NCT01875276|Rhinitis|rhinitis
4946627|NCT01875276|Antihistamine|antihistamine
4946628|NCT01875276|Nasal Steroid Therapy|nasal steroid therapy
4946629|NCT01875263|catheter-related bacteremia, SAMS|catheter-related bacteremia, sams
4946630|NCT01875263|catheter related bacteremia|catheter related bacteremia
4946631|NCT01875263|susceptible|susceptible
4946632|NCT01875263|aureus meticillin|aureus meticillin
4946633|NCT01875250|Gene Transfer|gene transfer
4946634|NCT01875250|Androgen Receptor Antagonist|androgen receptor antagonist
4946635|NCT01875250|PSA|psa
4946636|NCT01875250|Immune Response|immune response
4946637|NCT01875250|Immunotherapy|immunotherapy
4946638|NCT01875237|Leukemia|leukemia
4946639|NCT01875237|Myeloma|myeloma
4946640|NCT01875237|Myeloproliferative Diseases|myeloproliferative diseases
4946641|NCT01875237|Myelodysplastic syndrome|myelodysplastic syndrome
4946642|NCT01875237|MDS|mds
4946643|NCT01875237|Lymphoma|lymphoma
4946644|NCT01875237|Hodgkin disease|hodgkin disease
4946645|NCT01875237|Multiple myeloma|multiple myeloma
4946646|NCT01875237|MM|mm
4946647|NCT01875237|Transplant donor|transplant donor
4946648|NCT01875237|T-cells|t-cells
4946649|NCT01875237|G-versus-host disease|g-versus-host disease
4946650|NCT01875237|GvHD|gvhd
4946651|NCT01875237|G-CSF|g-csf
4946652|NCT01875237|Filgrastim|filgrastim
4946653|NCT01875237|Neupogen|neupogen
4946654|NCT01875237|Fludarabine|fludarabine
4946655|NCT01875237|Fludarabine phosphate|fludarabine phosphate
4946656|NCT01875237|Fludara|fludara
4946657|NCT01875237|Melphalan|melphalan
4946658|NCT01875237|Alkeran|alkeran
4946659|NCT01875237|Alemtuzumab|alemtuzumab
4946660|NCT01875237|CAMPATH-1H|campath-1h
4946661|NCT01875237|Campath|campath
4946662|NCT01875237|Tacrolimus|tacrolimus
4946663|NCT01875237|Prograf|prograf
4946664|NCT01875237|Mini-methotrexate|mini-methotrexate
4946665|NCT01875237|AP 1903|ap 1903
4946666|NCT01875237|Methylprednisolone|methylprednisolone
4946667|NCT01875237|Depo-Medrol|depo-medrol
4946668|NCT01875237|Medrol|medrol
4946669|NCT01875237|Solu-Medrol|solu-medrol
4946670|NCT01875237|Stem cell infusion|stem cell infusion
4946671|NCT01875237|Donor lymphocyte infusion|donor lymphocyte infusion
4946672|NCT01875237|DLI|dli
4946673|NCT01875237|Questionnaire|questionnaire
4946674|NCT01875237|Survey|survey
4946675|NCT01875224|kidney transplant|kidney transplant
4946676|NCT01875224|diabetes after transplant|diabetes after transplant
4946677|NCT01875224|belatacept|belatacept
4946678|NCT01875198|Splenectomy;|splenectomy;
4946679|NCT01875198|Spleen-preserving|spleen-preserving
4946680|NCT01875185|acute coronary syndrome|acute coronary syndrome
4946681|NCT01875185|clotting|clotting
4946682|NCT01875185|hormones|hormones
4946683|NCT01875185|women|women
4946684|NCT01875172|bupropion SR|bupropion sr
4946685|NCT01875172|randomized controlled trial|randomized controlled trial
4946686|NCT01875172|pregnancy|pregnancy
4946687|NCT01875159|Prematurity|prematurity
4946688|NCT01875159|Apnea of prematurity|apnea of prematurity
4946689|NCT01875159|Intermittent hypoxia|intermittent hypoxia
4946690|NCT01875133|airway disease|airway disease
4946691|NCT01875133|bronchitis|bronchitis
4946692|NCT01875133|emphysema|emphysema
4946693|NCT01875133|lung|lung
4946694|NCT01875120|Anxiety|anxiety
4946695|NCT01875120|Somatoform Disorders|somatoform disorders
4946696|NCT01875068|referrals|referrals
4946697|NCT01875068|nurse practitioners|nurse practitioners
4946698|NCT01875068|physician assistants|physician assistants
4946699|NCT01875068|consultative general internal medicine|consultative general internal medicine
4946700|NCT01875055|Cerebral|cerebral
4946701|NCT01875055|desaturation|desaturation
4946702|NCT01875029|Low back pain|low back pain
4946703|NCT01875029|chronic pain|chronic pain
4946704|NCT01875029|tDCS|tdcs
4946705|NCT01875029|transcranial direct current stimulation|transcranial direct current stimulation
4946706|NCT01875016|Cryo ablation|cryo ablation
4946707|NCT01875016|Cardiomyopathy|cardiomyopathy
4946708|NCT01874977|rheumatoid arthritis|rheumatoid arthritis
4946709|NCT01874977|fatigue|fatigue
4946710|NCT01874977|physical activity|physical activity
4946711|NCT01874964|HIV Prevention|hiv prevention
4946712|NCT01874964|Opioid-Related Disorders|opioid-related disorders
4946713|NCT01874964|Medication Assisted Treatment|medication assisted treatment
4946714|NCT01874964|Methadone|methadone
4946715|NCT01874951|Depression|depression
4946716|NCT01874951|Recurrence|recurrence
4946717|NCT01874951|Relapse|relapse
4946718|NCT01874951|Antidepressants|antidepressants
4946719|NCT01874951|Naltrexone|naltrexone
4946720|NCT01874951|Drug augmentation|drug augmentation
4946721|NCT01874886|Magnetic resonance imaging|magnetic resonance imaging
4946722|NCT01874886|Diffusion tensor imaging|diffusion tensor imaging
4946723|NCT01874886|Hippocampus|hippocampus
4946724|NCT01874886|Cannabis|cannabis
4946725|NCT01874886|Geriatrics|geriatrics
4946726|NCT01874886|Neuropsychology|neuropsychology
4946727|NCT01874886|Apolipoprotein E|apolipoprotein e
4946728|NCT01874847|melatonin|melatonin
4946729|NCT01874847|placebo|placebo
4946730|NCT01874847|post-concussion syndrome|post-concussion syndrome
4946731|NCT01874847|mild traumatic brain injury|mild traumatic brain injury
4946732|NCT01874847|concussion|concussion
4946733|NCT01874847|treatment|treatment
4946734|NCT01874847|outcome|outcome
4946735|NCT01874847|children|children
4946736|NCT01874847|functional magnetic resonance imaging|functional magnetic resonance imaging
4946737|NCT01874847|transcranial magnetic stimulation|transcranial magnetic stimulation
4946738|NCT01874847|sleep|sleep
4946739|NCT01874834|ozone|ozone
4946740|NCT01874834|diesel|diesel
4946741|NCT01874834|lung function|lung function
4946742|NCT01874834|cardiac electrophysiology|cardiac electrophysiology
4946743|NCT01874834|mediators of inflammation and clotting|mediators of inflammation and clotting
4946744|NCT01874821|Frozen Shoulder|frozen shoulder
4946745|NCT01874821|Adhesive Capsulitis|adhesive capsulitis
4946746|NCT01874821|ROM|rom
4946747|NCT01874821|Dynasplint|dynasplint
4946748|NCT01874808|movement preparation|movement preparation
4946749|NCT01874808|gait|gait
4946750|NCT01874808|gait initiation|gait initiation
4946751|NCT01874808|postural control|postural control
4946752|NCT01874808|neuroimaging|neuroimaging
4946753|NCT01874795|Autonomic Nervous System|autonomic nervous system
4946754|NCT01874795|Neuromodulation|neuromodulation
4946755|NCT01874795|Exercise|exercise
4946756|NCT01874795|Pulmonary oxygen kinetics|pulmonary oxygen kinetics
4946757|NCT01874795|Oxygen uptake|oxygen uptake
4946758|NCT01874782|spinal cord injury|spinal cord injury
4946759|NCT01874782|cardiovascular|cardiovascular
4946760|NCT01874782|orthostatic hypotension|orthostatic hypotension
4946761|NCT01874782|transcranial electrical stimulation|transcranial electrical stimulation
4946762|NCT01874782|electrotherapy|electrotherapy
4946763|NCT01874769|RDEB|rdeb
4946764|NCT01874769|COL7A1|col7a1
4946765|NCT01874769|Collagen VII|collagen vii
4946766|NCT01874756|schizophrenia|schizophrenia
4946767|NCT01874756|Estrogen receptor agonist|estrogen receptor agonist
4946768|NCT01874756|cognitive impairment|cognitive impairment
4946769|NCT01874756|negative symptoms|negative symptoms
4946770|NCT01874743|HIV,|hiv,
4946771|NCT01874743|Rosuvastatine,|rosuvastatine,
4946772|NCT01874743|Antiretroviral therapy|antiretroviral therapy
4946773|NCT01874730|colorectal surgery|colorectal surgery
4946774|NCT01874730|fluid therapy|fluid therapy
4946775|NCT01874717|Conscious sedation|conscious sedation
4946776|NCT01874717|Dental anxiety|dental anxiety
4946777|NCT01874717|Oral midazolam|oral midazolam
4946778|NCT01874717|Intravenous midazolam|intravenous midazolam
4946779|NCT01874717|Behaviour|behaviour
4946780|NCT01874704|Stress, occupation, biomarkers, emergency, physicians|stress, occupation, biomarkers, emergency, physicians
4946781|NCT01874691|acute myocardial infarction|acute myocardial infarction
4946782|NCT01874691|China|china
4946783|NCT01874691|Registry|registry
4946784|NCT01874665|Gastrointestinal Neoplasms|gastrointestinal neoplasms
4946785|NCT01874665|Gastrointestinal stromal tumor|gastrointestinal stromal tumor
4946786|NCT01874665|mesenchymal tumor|mesenchymal tumor
4946787|NCT01874639|Hepatectomy|hepatectomy
4946788|NCT01874639|blood loss|blood loss
4946789|NCT01874639|hemostasis|hemostasis
4946790|NCT01874639|coagulation|coagulation
4946791|NCT01874639|Liver surgery (benign or malign)|liver surgery (benign or malign)
4946792|NCT01874639|Resection of 2 or more segments|resection of 2 or more segments
4946793|NCT01874626|acute ankle sprain|acute ankle sprain
4946794|NCT01874626|Grade I or Grade II|grade i or grade ii
4946795|NCT01874613|Craniofacial bone reconstruction|craniofacial bone reconstruction
4946796|NCT01874613|Fibre-reinforced composite|fibre-reinforced composite
4946797|NCT01874613|Bioactive glass|bioactive glass
4946798|NCT01874613|Craniotomy|craniotomy
4946799|NCT01874613|Skull bone defect|skull bone defect
4946800|NCT01874587|Adaptative radiotherapy|adaptative radiotherapy
4946801|NCT01874587|oropharynx carcinoma|oropharynx carcinoma
4946802|NCT01874587|xerostomia|xerostomia
4946803|NCT01874574|Knee Osteoarthritis|knee osteoarthritis
4946804|NCT01874574|Corticosteroid|corticosteroid
4946805|NCT01874574|Hyaluronic acid|hyaluronic acid
4946806|NCT01874574|Intra-articular injection|intra-articular injection
4946807|NCT01874561|Custirsen sodium|custirsen sodium
4946808|NCT01874561|TV1011|tv1011
4946809|NCT01874561|OGX-011|ogx-011
4946810|NCT01874561|Thorough QT study|thorough qt study
4946811|NCT01874561|cancer|cancer
4946812|NCT01874548|Autophagy|autophagy
4946813|NCT01874548|Cancer metabolism|cancer metabolism
4946814|NCT01874548|Cervical cancer|cervical cancer
4946815|NCT01874548|Diffusion weighted imaging|diffusion weighted imaging
4946816|NCT01874548|Human papillomavirus|human papillomavirus
4946817|NCT01874548|Magnetic resonance spectroscopy.|magnetic resonance spectroscopy.
4946818|NCT01874522|Advanced solid tumors (excluding breast cancer) for which no standard therapy exists|advanced solid tumors (excluding breast cancer) for which no standard therapy exists
4946819|NCT01874405|Iron overload|iron overload
4946820|NCT01874405|thalassaemia|thalassaemia
4946821|NCT01874405|deferasirox|deferasirox
4946822|NCT01874405|magnetic resonance|magnetic resonance
4946823|NCT01874405|endocrine function|endocrine function
4946824|NCT01874379|Joint Replacement|joint replacement
4946825|NCT01874379|Hip Replacement|hip replacement
4946826|NCT01874379|Knee Replacement|knee replacement
4946827|NCT01874379|Complementary Medicine Intervention|complementary medicine intervention
4946828|NCT01874353|BRCA|brca
4946829|NCT01874353|Ovarian cancer|ovarian cancer
4946830|NCT01874353|Chemotherapy|chemotherapy
4946831|NCT01874353|PARP Inhibitor|parp inhibitor
4946832|NCT01874353|Platinum sensitive|platinum sensitive
4946833|NCT01874340|Multiple Sclerosis|multiple sclerosis
4946834|NCT01874340|Relapsing Multiple Sclerosis|relapsing multiple sclerosis
4946835|NCT01874340|AIN457|ain457
4946836|NCT01874340|Secukinumab|secukinumab
4946837|NCT01874340|Magnetic Resonance Imaging|magnetic resonance imaging
4946838|NCT01874340|Relapsing Remitting Multiple Sclerosis|relapsing remitting multiple sclerosis
4946839|NCT01874340|Autoimmune Diseases|autoimmune diseases
4946840|NCT01874340|Nervous System Diseases|nervous system diseases
4946841|NCT01874340|Immune System Diseases|immune system diseases
4946842|NCT01874340|Demyelinating Diseases|demyelinating diseases
4946843|NCT01874314|tuberculosis, SQ109, QTc, moxifloxacin, crossover, placebo, pharmacokinetic, randomized, single-center|tuberculosis, sq109, qtc, moxifloxacin, crossover, placebo, pharmacokinetic, randomized, single-center
4946844|NCT01874288|NHL|nhl
4946845|NCT01874288|Immunocytokine|immunocytokine
4946846|NCT01874288|Lymphoma|lymphoma
4946847|NCT01874288|Non-Hodgkin|non-hodgkin
4946848|NCT01874288|B-cell|b-cell
4946849|NCT01874288|IL (interleukin)|il (interleukin)
4946850|NCT01874249|Hepatic fibrosis|hepatic fibrosis
4946851|NCT01874249|Steatosis|steatosis
4946852|NCT01874249|Noninvasive markers.|noninvasive markers.
4946853|NCT01874236|SI joint pain, SI joint dysfunction, degenerative sacroiliitis, sacroiliac joint disruption|si joint pain, si joint dysfunction, degenerative sacroiliitis, sacroiliac joint disruption
4946854|NCT01874223|Interstitial Lung Disease (ILD)|interstitial lung disease (ild)
4946855|NCT01874223|Idiopathic Pulmonary Fibrosis (IPF)|idiopathic pulmonary fibrosis (ipf)
4946856|NCT01874197|Thoracoabdominal Aortic Aneurysm|thoracoabdominal aortic aneurysm
4946857|NCT01874197|Branched vessels|branched vessels
4946858|NCT01874158|Trichomonas vaginalis|trichomonas vaginalis
4946859|NCT01874145|Multiple Sclerosis|multiple sclerosis
4946860|NCT01874145|Relapsing-Remitting Multiple Sclerosis|relapsing-remitting multiple sclerosis
4946861|NCT01874145|Glatiramer Acetate|glatiramer acetate
4946862|NCT01874145|Glatiramer|glatiramer
4946863|NCT01874132|Exercise|exercise
4946864|NCT01874132|Blood pressure|blood pressure
4946865|NCT01874132|Lipids|lipids
4946866|NCT01874132|Body composition|body composition
4946867|NCT01874132|Fitness|fitness
4946868|NCT01874132|Bone density|bone density
4946869|NCT01874132|Quality of life|quality of life
4946870|NCT01874119|melanoma|melanoma
4946871|NCT01874119|renal cell carcinoma|renal cell carcinoma
4946872|NCT01874119|interleukin-2|interleukin-2
4946873|NCT01874106|Hemodialysis|hemodialysis
4946874|NCT01874106|Diet|diet
4946875|NCT01874106|Inflammation|inflammation
4946876|NCT01874106|Malnutrition|malnutrition
4946877|NCT01874054|Antibody-Drug Conjugate|antibody-drug conjugate
4946878|NCT01874054|Antibodies, Monoclonal|antibodies, monoclonal
4946879|NCT01874054|Hodgkin Disease|hodgkin disease
4946880|NCT01874054|Hematologic Diseases|hematologic diseases
4946881|NCT01874054|Drug Therapy|drug therapy
4946882|NCT01874054|Immunotherapy|immunotherapy
4946883|NCT01874054|Antigens, CD30|antigens, cd30
4946884|NCT01874054|Lymphoma|lymphoma
4946885|NCT01874054|monomethylauristatin E|monomethylauristatin e
4946886|NCT01874041|Physical Therapy Modalities|physical therapy modalities
4946887|NCT01874041|Facial Pain|facial pain
4946888|NCT01874041|Orthodontic Appliances|orthodontic appliances
4946889|NCT01874028|Trientine|trientine
4946890|NCT01874028|Pharmacokinetics|pharmacokinetics
4946891|NCT01874015|Crohn's disease|crohn's disease
4946892|NCT01874015|mesenchymal stem cell|mesenchymal stem cell
4946893|NCT01874015|fistula|fistula
4946894|NCT01874002|Stents|stents
4946895|NCT01874002|Stent|stent
4946896|NCT01874002|Drug eluting|drug eluting
4946897|NCT01874002|Drug eluting stent|drug eluting stent
4946898|NCT01874002|Drug eluting stents|drug eluting stents
4946899|NCT01874002|Endothelial progenitor cell|endothelial progenitor cell
4946900|NCT01874002|Endothelial progenitor cell capturing|endothelial progenitor cell capturing
4946901|NCT01874002|Sirolimus|sirolimus
4946902|NCT01874002|Sirolimus eluting|sirolimus eluting
4946903|NCT01874002|Percutaneous Coronary Intervention|percutaneous coronary intervention
4946904|NCT01874002|PCI|pci
4946905|NCT01874002|Registry|registry
4946906|NCT01874002|Registries|registries
4946907|NCT01874002|Multi center|multi center
4946908|NCT01874002|Multi centre|multi centre
4946909|NCT01873989|Chronic pain|chronic pain
4946910|NCT01873989|Opioid addiction|opioid addiction
4946911|NCT01873989|Symptomatic hypogonadism|symptomatic hypogonadism
4946912|NCT01873989|Testosterone replacement|testosterone replacement
4946913|NCT01873989|Opioid agonist maintenance|opioid agonist maintenance
4946914|NCT01873989|Methadone|methadone
4946915|NCT01873989|Buprenorphine|buprenorphine
4946916|NCT01873937|Lasertherapy|lasertherapy
4946917|NCT01873937|Ledtherapy|ledtherapy
4946918|NCT01873937|TMJs|tmjs
4946919|NCT01873937|pain relief|pain relief
4946920|NCT01873937|oral aperture|oral aperture
4946921|NCT01873924|Batten disease|batten disease
4946922|NCT01873924|NCL|ncl
4946923|NCT01873924|Neuronal Ceroid Lipofuscinosis|neuronal ceroid lipofuscinosis
4946924|NCT01873911|MPS IIIA|mps iiia
4946925|NCT01873911|MPS IIIB|mps iiib
4946926|NCT01873911|Sanfilippo syndrome type A|sanfilippo syndrome type a
4946927|NCT01873911|Sanfilippo syndrome type B|sanfilippo syndrome type b
4946928|NCT01873911|Hurler syndrome|hurler syndrome
4946929|NCT01873911|cognitive decline|cognitive decline
4946930|NCT01873911|MPS IH|mps ih
4946931|NCT01873898|femoral artery|femoral artery
4946932|NCT01873898|access site|access site
4946933|NCT01873898|hemostasis|hemostasis
4946934|NCT01873885|PB1046, VIP, Essential Hypertension, Vasomera|pb1046, vip, essential hypertension, vasomera
4946935|NCT01873859|Lactic acidosis|lactic acidosis
4946936|NCT01873859|Contrast media|contrast media
4946937|NCT01873859|Angiography|angiography
4946938|NCT01873859|Diabetic|diabetic
4946939|NCT01873859|Metformin|metformin
4946940|NCT01873820|Vitamin C|vitamin c
4946941|NCT01873820|calcium ascorbate|calcium ascorbate
4946942|NCT01873820|ascorbic acid|ascorbic acid
4946943|NCT01873807|Idarubicin|idarubicin
4946944|NCT01873807|Etoposide|etoposide
4946945|NCT01873807|HSCT|hsct
4946946|NCT01873807|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
4946947|NCT01873794|Fatigue|fatigue
4946948|NCT01873794|Sleep|sleep
4946949|NCT01873794|Quality of life|quality of life
4946950|NCT01873794|Cancer|cancer
4946951|NCT01873794|Light|light
4946952|NCT01873768|Tranexamic acid|tranexamic acid
4946953|NCT01873768|6-Aminocaproic Acid|6-aminocaproic acid
4946954|NCT01873768|Arthroplasty|arthroplasty
4946955|NCT01873768|Osteoarthritis|osteoarthritis
4946956|NCT01873768|Arthritis|arthritis
4946957|NCT01873768|Joint Diseases|joint diseases
4946958|NCT01873768|Musculoskeletal Diseases|musculoskeletal diseases
4946959|NCT01873768|Rheumatic Diseases|rheumatic diseases
4946960|NCT01873768|Antifibrinolytic Agents|antifibrinolytic agents
4946961|NCT01873768|Fibrin Modulating Agents|fibrin modulating agents
4946962|NCT01873768|Pharmacologic Actions|pharmacologic actions
4946963|NCT01873768|Coagulants|coagulants
4946964|NCT01873768|Therapeutic Uses|therapeutic uses
4946965|NCT01873755|asthma|asthma
4946966|NCT01873755|children|children
4946967|NCT01873755|physical activity|physical activity
4946968|NCT01873755|school|school
4946969|NCT01873742|Psychotherapy feedback|psychotherapy feedback
4946970|NCT01873729|ADHD|adhd
4946971|NCT01873729|Naltrexone|naltrexone
4946972|NCT01873729|Adults|adults
4946973|NCT01873716|Atherosclerosis|atherosclerosis
4946974|NCT01873716|Molecular Imaging|molecular imaging
4946975|NCT01873716|Vascular Biology|vascular biology
4946976|NCT01873716|Inflammation|inflammation
4946977|NCT01873716|Fluorescence|fluorescence
4946978|NCT01873703|MDS|mds
4946979|NCT01873703|High risk myelodysplastic syndrome|high risk myelodysplastic syndrome
4946980|NCT01873703|Intermediate-2 Myelodysplastic syndrome|intermediate-2 myelodysplastic syndrome
4946981|NCT01873703|Untreated|untreated
4946982|NCT01873690|Antibiotics|antibiotics
4946983|NCT01873690|Shock Wave Lithotripsy|shock wave lithotripsy
4946984|NCT01873690|Urinary Tract Infection|urinary tract infection
4946985|NCT01873664|fMRI|fmri
4946986|NCT01873664|Jaw tapping|jaw tapping
4946987|NCT01873664|Memory disorder|memory disorder
4946988|NCT01873664|Mild cognitive impairment|mild cognitive impairment
4946989|NCT01873664|MCI|mci
4946990|NCT01873664|Working memory|working memory
4946991|NCT01873638|5-year outcome after cholecystectomy|5-year outcome after cholecystectomy
4946992|NCT01873625|mesenchymal stem cells|mesenchymal stem cells
4946993|NCT01873625|osteoarthritis|osteoarthritis
4946994|NCT01873625|arthritis rheumatoid|arthritis rheumatoid
4946995|NCT01873612|Dexmedetomidine|dexmedetomidine
4946996|NCT01873612|Propofol|propofol
4946997|NCT01873612|Hypoxic ventilatory response|hypoxic ventilatory response
4946998|NCT01873612|Hypercapnic ventilatory response|hypercapnic ventilatory response
4946999|NCT01873573|radiation-induced stricture|radiation-induced stricture
4947000|NCT01873573|anastomotic stricture|anastomotic stricture
4947001|NCT01873573|esophagogastroduodenoscopy (EGD)|esophagogastroduodenoscopy (egd)
4947002|NCT01873573|dilation|dilation
4947003|NCT01873573|steroid injection|steroid injection
4947004|NCT01873573|triamcinolone|triamcinolone
4947005|NCT01873573|difficulty swallowing|difficulty swallowing
4947006|NCT01873560|fractional flow reserve|fractional flow reserve
4947007|NCT01873560|drug eluting stent|drug eluting stent
4948475|NCT01866488|Misoprostol|misoprostol
4947008|NCT01873560|coronary atherosclerosis|coronary atherosclerosis
4947009|NCT01873547|spinal cord injury|spinal cord injury
4947010|NCT01873547|cell transplantation|cell transplantation
4947011|NCT01873547|rehabilitation|rehabilitation
4947012|NCT01873534|Anemia|anemia
4947013|NCT01873521|Positive Pressure Ventilation|positive pressure ventilation
4947014|NCT01873521|Neurally Adjusted Ventilatory Assist|neurally adjusted ventilatory assist
4947015|NCT01873521|Patient/ventilator Asynchrony|patient/ventilator asynchrony
4947016|NCT01873521|Pediatric patient|pediatric patient
4947017|NCT01873521|Infant|infant
4947018|NCT01873469|glioblastoma multiforme|glioblastoma multiforme
4947019|NCT01873469|radiotherapy|radiotherapy
4947020|NCT01873430|Melatonin|melatonin
4947021|NCT01873430|Sunburn|sunburn
4947022|NCT01873430|Erythema|erythema
4947023|NCT01873430|Sunlight|sunlight
4947024|NCT01873430|Ultraviolet rays|ultraviolet rays
4947025|NCT01873391|Diagnostic hysteroscopy|diagnostic hysteroscopy
4947026|NCT01873391|Pain|pain
4947027|NCT01873391|VAS|vas
4947028|NCT01873391|Multivariate analysis|multivariate analysis
4947029|NCT01873391|Normal saline|normal saline
4947030|NCT01873391|Carbon dioxide|carbon dioxide
4947031|NCT01873378|Uterine myoma|uterine myoma
4947032|NCT01873378|GnRHa|gnrha
4947033|NCT01873378|Hysteroscopy|hysteroscopy
4947034|NCT01873378|Cold loop|cold loop
4947035|NCT01873365|Quality of life|quality of life
4947036|NCT01873365|Herpes zoster|herpes zoster
4947037|NCT01873365|Postherpetic neuralgia|postherpetic neuralgia
4947038|NCT01873365|Japan|japan
4947039|NCT01873365|Physician-practice|physician-practice
4947040|NCT01873365|Adults|adults
4947041|NCT01873365|Health economics|health economics
4947042|NCT01873339|Drug interaction, healthy volunteer, SB-480848, Lp-PLA2, darapladib, atherosclerosis, midazolam|drug interaction, healthy volunteer, sb-480848, lp-pla2, darapladib, atherosclerosis, midazolam
4947043|NCT01873326|newly diagnosed GCT|newly diagnosed gct
4947044|NCT01873326|Intermediate|intermediate
4947045|NCT01873326|Poor-Risk|poor-risk
4947046|NCT01873326|BLEOMYCIN|bleomycin
4947047|NCT01873326|CISPLATIN|cisplatin
4947048|NCT01873326|ETOPOSIDE (VP-16)|etoposide (vp-16)
4947049|NCT01873326|IFOSFAMIDE|ifosfamide
4947050|NCT01873326|TAXOL (PACLITAXEL)|taxol (paclitaxel)
4947051|NCT01873326|13-074|13-074
4947052|NCT01873300|Achalasia|achalasia
4947053|NCT01873300|Dysphagia|dysphagia
4947054|NCT01873300|Endoscopic|endoscopic
4947055|NCT01873300|Myotomy|myotomy
4947056|NCT01873300|Heller|heller
4947057|NCT01873300|NOTES|notes
4947058|NCT01873300|POEM|poem
4947059|NCT01873287|Concussions|concussions
4947060|NCT01873287|Persistent post-concussion symptoms|persistent post-concussion symptoms
4947061|NCT01873287|PCS|pcs
4947062|NCT01873287|Clinical Prediction Rule|clinical prediction rule
4947063|NCT01873261|Neurally Adjusted Ventilatory Assist|neurally adjusted ventilatory assist
4947064|NCT01873261|Pediatric Acute Respiratory Failure|pediatric acute respiratory failure
4947065|NCT01873261|non-invasive ventilation|non-invasive ventilation
4947066|NCT01873248|Neuroendocrine Carcinoma|neuroendocrine carcinoma
4947067|NCT01873222|Coronary Artery Disease|coronary artery disease
4947068|NCT01873222|Percutaneous Coronary Intervention|percutaneous coronary intervention
4947069|NCT01873222|Optical Frequency Domain Imaging|optical frequency domain imaging
4947070|NCT01873222|Intravascular Ultrasound|intravascular ultrasound
4947071|NCT01873183|echocardiography|echocardiography
4947072|NCT01873183|morbid obesity|morbid obesity
4947073|NCT01873183|bariatric surgery|bariatric surgery
4947074|NCT01873183|venous return|venous return
4947075|NCT01873183|mean arterial blood pressure|mean arterial blood pressure
4947076|NCT01873170|immune cells|immune cells
4947077|NCT01873170|contraception|contraception
4947078|NCT01873170|intrauterine device|intrauterine device
4947079|NCT01873170|IUD|iud
4947080|NCT01873170|copper|copper
4947081|NCT01873170|microflora|microflora
4947082|NCT01873170|DMPA|dmpa
4947083|NCT01873170|etonogestrel|etonogestrel
4947084|NCT01873170|subdermal implant|subdermal implant
4947085|NCT01873157|Kidney transplantation|kidney transplantation
4947086|NCT01873157|Antibody formation|antibody formation
4947087|NCT01873157|Graft rejection|graft rejection
4947088|NCT01873157|Proteasome inhibitors|proteasome inhibitors
4947089|NCT01873157|Randomized controlled trial|randomized controlled trial
4947090|NCT01873144|Bronchiolitis|bronchiolitis
4947091|NCT01873144|Hypertonic saline solution|hypertonic saline solution
4947092|NCT01873144|High-flow oxygen therapy|high-flow oxygen therapy
4947093|NCT01873144|Respiratory distress|respiratory distress
4947094|NCT01873144|Comfort|comfort
4947095|NCT01873131|hemangioma|hemangioma
4947096|NCT01873131|infantile hemangioma|infantile hemangioma
4947097|NCT01873131|pulsed dye laser|pulsed dye laser
4947098|NCT01873131|PDL|pdl
4947099|NCT01873131|topical beta blocker|topical beta blocker
4947100|NCT01873131|timolol maleate|timolol maleate
4947101|NCT01873131|timolol|timolol
4947102|NCT01873118|hospital discharge|hospital discharge
4947103|NCT01873118|discharge readiness|discharge readiness
4947104|NCT01873118|readmission|readmission
4947105|NCT01873118|Emergency Department visits|emergency department visits
4947106|NCT01873118|Nurse assessment|nurse assessment
4947107|NCT01873092|Oximetry|oximetry
4947108|NCT01873092|Physical Activity|physical activity
4947109|NCT01873079|ERCP|ercp
4947110|NCT01873079|sphincterotomy|sphincterotomy
4947111|NCT01873079|proton pump inhibitor|proton pump inhibitor
4947112|NCT01873066|Type 1 diabetes|type 1 diabetes
4947113|NCT01873066|Closed-loop glucose control|closed-loop glucose control
4947114|NCT01873066|Artificial Pancreas|artificial pancreas
4947115|NCT01873066|Continuous subcutaneous insulin infusion|continuous subcutaneous insulin infusion
4947116|NCT01873066|Continuous glucose monitoring|continuous glucose monitoring
4947117|NCT01873053|Osteoarthritis, Knee|osteoarthritis, knee
4947118|NCT01873053|WIN-34B|win-34b
4947119|NCT01873040|Social Media|social media
4947120|NCT01873040|Vaccine|vaccine
4947121|NCT01873040|Immunization|immunization
4947122|NCT01873027|Coronary Artery Disease|coronary artery disease
4947123|NCT01873027|Percutaneous Coronary Intervention|percutaneous coronary intervention
4947124|NCT01873027|Optical Frequency Domain Imaging|optical frequency domain imaging
4947125|NCT01873027|Intravascular Ultrasound|intravascular ultrasound
4947126|NCT01873001|Healthy volunteers|healthy volunteers
4947127|NCT01873001|Drug-drug Interaction|drug-drug interaction
4947128|NCT01873001|Pharmacokinetics|pharmacokinetics
4947129|NCT01873001|Abiraterone|abiraterone
4947130|NCT01873001|JNJ-589485|jnj-589485
4947131|NCT01873001|Abiraterone acetate|abiraterone acetate
4947132|NCT01873001|JNJ-212082|jnj-212082
4947133|NCT01873001|Pioglitazone HCl|pioglitazone hcl
4947134|NCT01872988|antiviral therapy|antiviral therapy
4947135|NCT01872988|intermediate stage|intermediate stage
4947136|NCT01872988|hepatitis B virus|hepatitis b virus
4947137|NCT01872962|Nasopharyngeal carcinoma|nasopharyngeal carcinoma
4947138|NCT01872962|Induction chemotherapy|induction chemotherapy
4947139|NCT01872962|Concurrent chemoradiotherapy|concurrent chemoradiotherapy
4947140|NCT01872962|Clinical trial|clinical trial
4947141|NCT01872949|Heart Failure|heart failure
4947142|NCT01872949|NYHA Class III|nyha class iii
4947143|NCT01872949|NYHA Class IV|nyha class iv
4947144|NCT01872923|Amphinex|amphinex
4947145|NCT01872923|PCI|pci
4947146|NCT01872923|Bleomycin|bleomycin
4947147|NCT01872923|Cutaneous malignancies|cutaneous malignancies
4947148|NCT01872923|Sub-cutaneous malignancies|sub-cutaneous malignancies
4947149|NCT01872923|Safety|safety
4947150|NCT01872923|Phase I|phase i
4947151|NCT01872923|Photochemical Internalisation|photochemical internalisation
4947152|NCT01872923|Squamous Cell Carcinoma|squamous cell carcinoma
4947153|NCT01872923|Head and Neck cancer|head and neck cancer
4947154|NCT01872923|Breast Cancer|breast cancer
4947155|NCT01872923|HNSCC|hnscc
4947156|NCT01872923|SCCHN|scchn
4947157|NCT01872923|Advanced or metastatic cancer|advanced or metastatic cancer
4947158|NCT01872923|Dose finding|dose finding
4947159|NCT01872910|Wisdom tooth extraction|wisdom tooth extraction
4947160|NCT01872897|Gastroesophageal Reflux Disease|gastroesophageal reflux disease
4947161|NCT01872897|GERD|gerd
4947162|NCT01872897|Acid reflux|acid reflux
4947163|NCT01872897|Compound Sodium Alginate Double Action Chewable Tablet|compound sodium alginate double action chewable tablet
4947164|NCT01872897|Gaviscon Double Action Tablets|gaviscon double action tablets
4947165|NCT01872884|Stroke|stroke
4947166|NCT01872884|Ischemic stroke|ischemic stroke
4947167|NCT01872884|Acute stroke|acute stroke
4947168|NCT01872884|Embolectomy|embolectomy
4947169|NCT01872884|Endovascular therapy|endovascular therapy
4947170|NCT01872884|Intra-arterial therapy|intra-arterial therapy
4947171|NCT01872884|Sedation|sedation
4947172|NCT01872884|Anesthesia|anesthesia
4947173|NCT01872845|Statin|statin
4947174|NCT01872845|CIMT|cimt
4947175|NCT01872845|BES|bes
4947176|NCT01872793|bioelectrical impedance vector analysis|bioelectrical impedance vector analysis
4947177|NCT01872793|nutritional assessment|nutritional assessment
4947178|NCT01872793|nutritional status|nutritional status
4947179|NCT01872793|mortality|mortality
4947180|NCT01872793|complications|complications
4947181|NCT01872780|CYP2C8|cyp2c8
4947182|NCT01872780|genetic polymorphism|genetic polymorphism
4947183|NCT01872780|rosiglitazone|rosiglitazone
4947184|NCT01872780|Korean|korean
4947185|NCT01872767|Acute on Chronic Liver Failure (ACLF),Cirrhosis,|acute on chronic liver failure (aclf),cirrhosis,
4947186|NCT01872767|Institute of Liver & Biliary Sciences (ILBS)|institute of liver & biliary sciences (ilbs)
4947187|NCT01872754|Bronchial fibroscopy|bronchial fibroscopy
4947188|NCT01872754|Remifentanil|remifentanil
4947189|NCT01872754|Propofol|propofol
4947190|NCT01872754|Sedation|sedation
4947191|NCT01872754|Target Controlled Infusion|target controlled infusion
4947192|NCT01872741|craniotomy,|craniotomy,
4947193|NCT01872741|intracerebral aneurysms,|intracerebral aneurysms,
4947194|NCT01872741|atrophy,|atrophy,
4947195|NCT01872741|temporal muscle,|temporal muscle,
4947196|NCT01872741|outcome|outcome
4947197|NCT01872728|facial block|facial block
4947198|NCT01872728|levobupivacaine|levobupivacaine
4947199|NCT01872728|regional anesthesia|regional anesthesia
4947200|NCT01872728|rhinoplasty|rhinoplasty
4947201|NCT01872728|outpatient|outpatient
4947202|NCT01872715|Papulopustular Rosacea|papulopustular rosacea
4947203|NCT01872715|Oracea|oracea
4947204|NCT01872715|anti inflammatory doxycycline|anti inflammatory doxycycline
4947205|NCT01872702|Malaria elimination|malaria elimination
4947206|NCT01872702|Chemotherapy|chemotherapy
4947207|NCT01872702|Epidemiology|epidemiology
4947208|NCT01872702|South East Asia|south east asia
4947209|NCT01872702|Artemisinin resistance|artemisinin resistance
4947210|NCT01872702|Dihydroartemisinin piperaquine|dihydroartemisinin piperaquine
4947211|NCT01872702|Primaquine|primaquine
4947212|NCT01872676|Thermography|thermography
4947213|NCT01872676|Skin Temperature|skin temperature
4947214|NCT01872676|Manipulation, Spinal|manipulation, spinal
4947215|NCT01872676|Physical Therapy Modalities|physical therapy modalities
4947216|NCT01872663|Morbid obesity|morbid obesity
4947217|NCT01872663|Bariatric surgery|bariatric surgery
4947218|NCT01872663|Pulmonary atelectasis|pulmonary atelectasis
4947219|NCT01872663|Spirometry|spirometry
4947220|NCT01872663|Continuos Positive Airway Pressure|continuos positive airway pressure
4947221|NCT01872663|Physical therapy speciality|physical therapy speciality
4947222|NCT01872650|postoperative adhesions|postoperative adhesions
4947223|NCT01872650|adhesion prevention|adhesion prevention
4947224|NCT01872650|colorectal surgery|colorectal surgery
4947225|NCT01872650|temporary ostomy|temporary ostomy
4947226|NCT01872611|Diabetes Type I|diabetes type i
4947227|NCT01872611|Diabetes Type II|diabetes type ii
4947228|NCT01872611|Non-proliferative diabetic retinopathy|non-proliferative diabetic retinopathy
4947229|NCT01872611|Macular edema|macular edema
4947230|NCT01872611|Cataract|cataract
4947231|NCT01872598|Alzheimer|alzheimer
4947232|NCT01872598|dementia|dementia
4947233|NCT01872598|cognitive disease|cognitive disease
4947234|NCT01872598|memory loss|memory loss
4947235|NCT01872598|cerebrovascular disease|cerebrovascular disease
4947236|NCT01872585|Parenting|parenting
4947237|NCT01872585|Mental Illness|mental illness
4947238|NCT01872585|Maternal sensitivity|maternal sensitivity
4947239|NCT01872585|Parent-child relationship|parent-child relationship
4947240|NCT01872533|obesity|obesity
4947241|NCT01872533|hypoxia|hypoxia
4947242|NCT01872533|insulin sensitivity|insulin sensitivity
4947243|NCT01872533|altitude|altitude
4947244|NCT01872520|the Injection of DanShenDuoFenSuanYan|the injection of danshenduofensuanyan
4947245|NCT01872520|Magnesium Lithospermate B|magnesium lithospermate b
4947246|NCT01872520|Safety|safety
4947247|NCT01872520|Real World Study|real world study
4947248|NCT01872507|cerebral palsy|cerebral palsy
4947249|NCT01872507|autonomic nerveus system|autonomic nerveus system
4947250|NCT01872507|heart rate variability|heart rate variability
4947251|NCT01872494|Local analgesia system|local analgesia system
4947252|NCT01872494|Ropivacaine|ropivacaine
4947253|NCT01872494|Analgesic efficacy after operation|analgesic efficacy after operation
4947254|NCT01872494|Postoperative|postoperative
4947255|NCT01872481|Phantom limb pain syndrome|phantom limb pain syndrome
4947256|NCT01872481|Neuropathic pain|neuropathic pain
4947257|NCT01872481|Antipersonnel landmines|antipersonnel landmines
4947258|NCT01872481|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
4947259|NCT01872468|Glomerular filtration Rate.|glomerular filtration rate.
4947260|NCT01872468|Primary Health Care.|primary health care.
4947261|NCT01872468|Cluster Clinical Trial.|cluster clinical trial.
4947262|NCT01872429|subtotal parathyroidectomy|subtotal parathyroidectomy
4947263|NCT01872429|calcium|calcium
4947264|NCT01872429|phosphorus|phosphorus
4947265|NCT01872429|parathyroid hormone|parathyroid hormone
4947266|NCT01872429|hyperparathyroidism|hyperparathyroidism
4947267|NCT01872416|Refractory and relapsed small cell lung cancer|refractory and relapsed small cell lung cancer
4947268|NCT01872416|Liposomal Doxorubicin|liposomal doxorubicin
4947269|NCT01872416|ifosfamide|ifosfamide
4947270|NCT01872403|Squamous Cell Carcinoma of the lung|squamous cell carcinoma of the lung
4947271|NCT01872390|Lesotho|lesotho
4947272|NCT01872390|TB|tb
4947273|NCT01872390|tuberculosis|tuberculosis
4947274|NCT01872390|HIV|hiv
4947275|NCT01872390|antiretroviral therapy|antiretroviral therapy
4947276|NCT01872390|ART|art
4947277|NCT01872390|adherence|adherence
4947278|NCT01872390|combination intervention package|combination intervention package
4947279|NCT01872390|retention|retention
4947280|NCT01872377|pancreas|pancreas
4947281|NCT01872377|pancreatic|pancreatic
4947282|NCT01872377|unresectable|unresectable
4947283|NCT01872377|CyberKnife|cyberknife
4947284|NCT01872377|SBRT|sbrt
4947285|NCT01872364|Hernia repair|hernia repair
4947286|NCT01872364|Hydrocelectomy|hydrocelectomy
4947287|NCT01872364|Global Health|global health
4947288|NCT01872364|Global Disease Burden|global disease burden
4947289|NCT01872364|Surgical Mission|surgical mission
4947290|NCT01872364|Dominican Republic|dominican republic
4947291|NCT01872364|Cost-minimization|cost-minimization
4947292|NCT01872364|Procedural cost|procedural cost
4947293|NCT01872364|Material cost|material cost
4947294|NCT01872364|Item utilization|item utilization
4947295|NCT01872364|Excision of benign cutaneous mass|excision of benign cutaneous mass
4947296|NCT01872364|Minor procedure|minor procedure
4947297|NCT01872351|chronic fatigue syndrome|chronic fatigue syndrome
4947298|NCT01872351|mitochondrial disorder|mitochondrial disorder
4947299|NCT01872351|conditioning exercise|conditioning exercise
4947300|NCT01872351|nutraceutical supplements|nutraceutical supplements
4947301|NCT01872351|high protein diet|high protein diet
4947302|NCT01872338|suicide prevention|suicide prevention
4947303|NCT01872338|minfulness-based cognitive therapy|minfulness-based cognitive therapy
4947304|NCT01872338|mindfulness meditation|mindfulness meditation
4947305|NCT01872338|Veterans|veterans
4947306|NCT01872338|safety planning|safety planning
4947307|NCT01872325|cardiac arrest|cardiac arrest
4947308|NCT01872325|bystander cardiopulmonary resuscitation CPR|bystander cardiopulmonary resuscitation cpr
4947309|NCT01872325|dispatch-assisted CPR instructions|dispatch-assisted cpr instructions
4947310|NCT01872325|agonal breathing|agonal breathing
4947311|NCT01872312|BPF(Bronchopleural fistulae)|bpf(bronchopleural fistulae)
4947312|NCT01872286|Capsule Endoscopy|capsule endoscopy
4947313|NCT01872273|Metabolic Syndrome|metabolic syndrome
4947314|NCT01872273|Obese|obese
4947315|NCT01872273|Overweight|overweight
4947316|NCT01872273|Hypertension|hypertension
4947317|NCT01872273|Hyperlipidemia|hyperlipidemia
4947318|NCT01872273|Glucose Intolerant|glucose intolerant
4947319|NCT01872273|High blood sugar|high blood sugar
4947320|NCT01872273|Exercise in obesity|exercise in obesity
4947321|NCT01872273|Platelets|platelets
4947322|NCT01872260|Hormone-receptor positive|hormone-receptor positive
4947323|NCT01872234|Heart Failure|heart failure
4947324|NCT01872234|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
4947325|NCT01872234|Mild systolic dysfunction|mild systolic dysfunction
4947326|NCT01872234|Left Bundle Branch Block|left bundle branch block
4947327|NCT01872221|Glioblastoma|glioblastoma
4947328|NCT01872221|Spectroscopy|spectroscopy
4947329|NCT01872221|MRI|mri
4947330|NCT01872221|Glioma stem cells|glioma stem cells
4947331|NCT01872221|Surgery|surgery
4947332|NCT01872221|Radioresistance|radioresistance
4947333|NCT01872208|PAD|pad
4947334|NCT01872208|Atherosclerosis|atherosclerosis
4947335|NCT01872208|Peripheral circulation|peripheral circulation
4947336|NCT01872208|Blood Vessel Prosthesis|blood vessel prosthesis
4947337|NCT01872208|Tissue-Engineered Vascular Graft|tissue-engineered vascular graft
4947338|NCT01872208|Vascular Prosthesis Implantation|vascular prosthesis implantation
4947339|NCT01872208|Femoro-Popliteal Bypass|femoro-popliteal bypass
4947340|NCT01872195|Checklist|checklist
4947341|NCT01872195|In-Hospital Mortality|in-hospital mortality
4947342|NCT01872195|In-Hospital Morbidity|in-hospital morbidity
4947343|NCT01872156|Smoking|smoking
4947344|NCT01872156|Primary care|primary care
4947345|NCT01872130|Moh's Surgery|moh's surgery
4947346|NCT01872130|mosaicing algorithm|mosaicing algorithm
4947347|NCT01872130|intraoperative imaging|intraoperative imaging
4947348|NCT01872130|12-239|12-239
4947349|NCT01872104|rectal cancer|rectal cancer
4947350|NCT01872104|rectal adenocarcinoma|rectal adenocarcinoma
4947351|NCT01872104|photodynamic therapy|photodynamic therapy
4947352|NCT01872104|chemothrapy|chemothrapy
4947353|NCT01872078|Pharmacokinetics, Pharmacodynamics, endocrinopathies, PCOS, female, hormone, LH|pharmacokinetics, pharmacodynamics, endocrinopathies, pcos, female, hormone, lh
4947354|NCT01872039|Nicardipine|nicardipine
4947355|NCT01872039|Hypertension|hypertension
4947356|NCT01872039|Calcium blocker|calcium blocker
4947357|NCT01872026|Plasma concentration|plasma concentration
4947358|NCT01872026|Pharmacokinetics|pharmacokinetics
4947359|NCT01872026|Pharmacodynamics|pharmacodynamics
4947360|NCT01872026|ASP7991|asp7991
4947361|NCT01872013|Plasma concentration|plasma concentration
4947362|NCT01872013|Urinary concentration|urinary concentration
4947363|NCT01872013|ASP7991|asp7991
4947364|NCT01872000|Intraocular lens|intraocular lens
4947365|NCT01872000|Phacoemulsification|phacoemulsification
4947366|NCT01871987|FK949E|fk949e
4947367|NCT01871987|Quetiapine|quetiapine
4947368|NCT01871987|Antipsychotic|antipsychotic
4947369|NCT01871974|FK949E|fk949e
4947370|NCT01871974|Antipsychotic|antipsychotic
4947371|NCT01871974|Quetiapine|quetiapine
4947372|NCT01871909|Physical trauma|physical trauma
4947373|NCT01871896|Surgical Endoscopy|surgical endoscopy
4947374|NCT01871896|Morbid Obesity|morbid obesity
4947375|NCT01871896|Weight Loss|weight loss
4947376|NCT01871896|Bariatrics|bariatrics
4947377|NCT01871896|Surgical Revision|surgical revision
4947378|NCT01871883|Sensitive skin|sensitive skin
4947379|NCT01871883|Transient potential receptor vanilloid 1|transient potential receptor vanilloid 1
4947380|NCT01871883|TRPV1|trpv1
4947381|NCT01871883|Transepidermal water loss|transepidermal water loss
4947382|NCT01871883|Skin Phototype|skin phototype
4947383|NCT01871883|Lactic acid test|lactic acid test
4947384|NCT01871883|Skin irritancy tests|skin irritancy tests
4947385|NCT01871818|Multiple sclerosis|multiple sclerosis
4947386|NCT01871818|Rehabilitation|rehabilitation
4947387|NCT01871818|Chronic evolutive disease|chronic evolutive disease
4947388|NCT01871818|Physiotherapy|physiotherapy
4947389|NCT01871818|Resistance training|resistance training
4947390|NCT01871818|Endurance training|endurance training
4947391|NCT01871792|Contrast-induced nephropathy|contrast-induced nephropathy
4947392|NCT01871792|Prevention|prevention
4947393|NCT01871792|Statin|statin
4947394|NCT01871792|Pitavastatin|pitavastatin
4947395|NCT01871766|Rhabdomyosarcoma|rhabdomyosarcoma
4947396|NCT01871766|Radiation therapy|radiation therapy
4947397|NCT01871766|Proton beam|proton beam
4947398|NCT01871740|Folic acid|folic acid
4947399|NCT01871740|Renal function decline|renal function decline
4947400|NCT01871740|Hypertension|hypertension
4947401|NCT01871740|Hyperhomocysteinemia|hyperhomocysteinemia
4947402|NCT01871740|Chronic kidney disease|chronic kidney disease
4947403|NCT01871740|MTHFR C677T genotype|mthfr c677t genotype
4947404|NCT01871740|Randomized controlled trial|randomized controlled trial
4947405|NCT01871727|Persistent or Recurrent Cutaneous T-Cell Lymphoma|persistent or recurrent cutaneous t-cell lymphoma
4947406|NCT01871727|E7777|e7777
4947407|NCT01871714|XLHED|xlhed
4947408|NCT01871714|HED|hed
4947409|NCT01871714|Hypohidrotic Ectodermal Dysplasia|hypohidrotic ectodermal dysplasia
4947410|NCT01871714|X Linked Hypohidrotic Ectodermal Dysplasia|x linked hypohidrotic ectodermal dysplasia
4947411|NCT01871701|Corrected QT interval prolongation|corrected qt interval prolongation
4947412|NCT01871701|Psychotropic drugs|psychotropic drugs
4947413|NCT01871688|pelvic floor dysfunction|pelvic floor dysfunction
4947414|NCT01871688|neuromodulation|neuromodulation
4947415|NCT01871688|rehabilitation|rehabilitation
4947416|NCT01871675|Lymphoma|lymphoma
4947417|NCT01871675|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
4947418|NCT01871675|Non-Hodgkin Lymphoma|non-hodgkin lymphoma
4947419|NCT01871675|T-cell Lymphoma|t-cell lymphoma
4947420|NCT01871675|Rituxan|rituxan
4947421|NCT01871675|Bendamustine|bendamustine
4947422|NCT01871675|Hematologic Malignancy|hematologic malignancy
4947423|NCT01871675|Relapsed|relapsed
4947424|NCT01871675|Refractory|refractory
4947425|NCT01871662|HCV|hcv
4947426|NCT01871662|Hepatitis C|hepatitis c
4947427|NCT01871649|psoriatic arthritis|psoriatic arthritis
4947428|NCT01871649|golimumab|golimumab
4947429|NCT01871649|methotrexate|methotrexate
4947430|NCT01871649|minimal disease activity|minimal disease activity
4947431|NCT01871649|safety|safety
4947432|NCT01871649|withdrawal|withdrawal
4947433|NCT01871636|endoscopy|endoscopy
4947434|NCT01871636|WESD|wesd
4947435|NCT01871636|EMR|emr
4947436|NCT01871623|Cleft lip and palate|cleft lip and palate
4947437|NCT01871623|Cone-Beam Computed Tomography|cone-beam computed tomography
4947438|NCT01871623|Le Fort I Osteotomy|le fort i osteotomy
4947439|NCT01871623|Segmental Osteotomy|segmental osteotomy
4947440|NCT01871623|Stability|stability
4947441|NCT01871610|Traumatic brain injury|traumatic brain injury
4947442|NCT01871610|mild TBI|mild tbi
4947443|NCT01871610|Alzheimer's disease|alzheimer's disease
4947444|NCT01871610|[18F]AV-45 PET amyloid binding imaging|[18f]av-45 pet amyloid binding imaging
4947445|NCT01871597|Lung cancer|lung cancer
4947446|NCT01871597|VATS procedure|vats procedure
4947447|NCT01871597|Pulmonary Artery Sealing|pulmonary artery sealing
4947448|NCT01871584|A colon hydrotherapy system|a colon hydrotherapy system
4947449|NCT01871584|Hydrocolonic preparation|hydrocolonic preparation
4947450|NCT01871584|Preparation for colonoscopy|preparation for colonoscopy
4947451|NCT01871558|type 2 diabetes|type 2 diabetes
4947452|NCT01871558|basal insulin|basal insulin
4947453|NCT01871558|vildagliptin|vildagliptin
4947454|NCT01871545|hepatocellular carcinoma|hepatocellular carcinoma
4947455|NCT01871545|HCC|hcc
4947456|NCT01871545|liver cancer|liver cancer
4947457|NCT01871545|liver disease|liver disease
4947458|NCT01871545|magnetic resonance imaging|magnetic resonance imaging
4947459|NCT01871545|MRI|mri
4947460|NCT01871532|Monofollicular Development|monofollicular development
4947461|NCT01871532|Gonal-f®|gonal-f®
4947462|NCT01871532|Recombinant Follicle Stimulating Hormone|recombinant follicle stimulating hormone
4947463|NCT01871532|Ovarian hyperstimulation syndrome (OHSS)|ovarian hyperstimulation syndrome (ohss)
4947464|NCT01871519|vertebral body compression fracture|vertebral body compression fracture
4947465|NCT01871480|NSCLC|nsclc
4947466|NCT01871480|CIK|cik
4947467|NCT01871480|Gefitinib|gefitinib
4947468|NCT01871480|Adenocarcinoma|adenocarcinoma
4947469|NCT01871402|psoriasis|psoriasis
4947470|NCT01871402|lotion|lotion
4947471|NCT01871402|investigator's global assessment|investigator's global assessment
4947472|NCT01871376|PCV|pcv
4947473|NCT01871363|Preoperative Chemoradiotherapy|preoperative chemoradiotherapy
4947474|NCT01871363|Bevacizumab|bevacizumab
4947475|NCT01871363|Locally Advanced Rectal Cancer|locally advanced rectal cancer
4947476|NCT01871350|Cancer|cancer
4947477|NCT01871350|Chemotherapy|chemotherapy
4947478|NCT01871350|Chemo related toxicity|chemo related toxicity
4947479|NCT01871350|Protein digestion|protein digestion
4947480|NCT01871350|Fat digestion|fat digestion
4947481|NCT01871350|Gut function|gut function
4947482|NCT01871350|Glucose absorption|glucose absorption
4947483|NCT01871350|Muscle function|muscle function
4947484|NCT01871337|Multiple Sclerosis|multiple sclerosis
4947485|NCT01871337|urinary incontinence|urinary incontinence
4947486|NCT01871311|metastatic Kras wildtype|metastatic kras wildtype
4947487|NCT01871311|squamous cell carcinoma|squamous cell carcinoma
4947488|NCT01871311|cetuximab|cetuximab
4947489|NCT01871311|nilotinib|nilotinib
4947490|NCT01871298|internet and mobile technology use|internet and mobile technology use
4947491|NCT01871298|history of drug use|history of drug use
4947492|NCT01871298|injection drug user (IDU) syringe customers|injection drug user (idu) syringe customers
4947493|NCT01871285|ATC, Opioid, withdrawal, switch|atc, opioid, withdrawal, switch
4947494|NCT01871259|Sedation, sleep apnea, propofol|sedation, sleep apnea, propofol
4947495|NCT01871233|anti-epileptic drug|anti-epileptic drug
4947496|NCT01871233|Extended Access Program|extended access program
4947497|NCT01871233|partial onset seizures|partial onset seizures
4947498|NCT01871233|Perampanel|perampanel
4947499|NCT01871220|Implant Abutments|implant abutments
4947500|NCT01871220|Oral Mucosa Changes|oral mucosa changes
4947501|NCT01871220|Implant Esthetics|implant esthetics
4947502|NCT01871207|Erythropoietin (EPO)|erythropoietin (epo)
4947503|NCT01871207|Diabetes|diabetes
4947504|NCT01871207|Diabetic Retinopathy|diabetic retinopathy
4947505|NCT01871207|Vascular Endothelial Growth Factor (VEGF)|vascular endothelial growth factor (vegf)
4947506|NCT01871207|Erythropoiesis Stimulating Agents (ESA)|erythropoiesis stimulating agents (esa)
4947507|NCT01871142|5 Hydroxymethyl 2 Furfural|5 hydroxymethyl 2 furfural
4947508|NCT01871142|AES103|aes103
4947509|NCT01871142|Exercise|exercise
4947510|NCT01871129|Dexmedetomidine|dexmedetomidine
4947511|NCT01871129|Postoperative Period|postoperative period
4947512|NCT01871129|Airway extubation|airway extubation
4947513|NCT01871129|Systolic Pressure|systolic pressure
4947514|NCT01871116|breast cancer|breast cancer
4947515|NCT01871116|early stage|early stage
4947516|NCT01871116|weight loss|weight loss
4947517|NCT01871103|Soft tissue defect|soft tissue defect
4947518|NCT01871103|dorsal branch of the digital artery|dorsal branch of the digital artery
4947519|NCT01871103|dorsal branch of the digital nerve|dorsal branch of the digital nerve
4947520|NCT01871103|dorsal homodigital island flap|dorsal homodigital island flap
4947521|NCT01871090|Remote Monitoring|remote monitoring
4947522|NCT01871090|Remote Care|remote care
4947523|NCT01871090|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
4947524|NCT01871090|Pacemaker|pacemaker
4947525|NCT01871090|Implantable Cardioverter Defibrillator|implantable cardioverter defibrillator
4947526|NCT01871064|Laparotomy|laparotomy
4947527|NCT01871064|laparoscopic surgery|laparoscopic surgery
4947528|NCT01871064|general anesthesia|general anesthesia
4947529|NCT01871064|Neuromuscular Block|neuromuscular block
4947530|NCT01871038|vaccine effectiveness|vaccine effectiveness
4947531|NCT01871038|rotavirus|rotavirus
4947532|NCT01871038|acute gastroenteritis|acute gastroenteritis
4947533|NCT01871025|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
4947534|NCT01871012|Nerve Block|nerve block
4947535|NCT01871012|Intraoperative Care|intraoperative care
4947536|NCT01871012|Postoperative Recovery and Complications|postoperative recovery and complications
4947537|NCT01871012|Stress and Inflammation|stress and inflammation
4947538|NCT01870986|Healthy Volunteers|healthy volunteers
4947539|NCT01870986|Phase 1|phase 1
4947540|NCT01870986|PK|pk
4947541|NCT01870986|adalimumab|adalimumab
4947542|NCT01870986|Single-dose|single-dose
4947543|NCT01870986|Immunology|immunology
4947544|NCT01870986|Bioequivalence|bioequivalence
4947545|NCT01870986|Biosimilarity|biosimilarity
4947546|NCT01870986|Similarity.|similarity.
4947547|NCT01870973|postoperative pain|postoperative pain
4947548|NCT01870973|root canal treatment|root canal treatment
4947549|NCT01870947|Stage I endometrial adenocarcinoma|stage i endometrial adenocarcinoma
4947550|NCT01870947|Obesity|obesity
4947551|NCT01870947|Exercise and Physical Fitness|exercise and physical fitness
4947552|NCT01870947|Diet|diet
4947553|NCT01870947|Cancer|cancer
4947554|NCT01870934|Telemedicine|telemedicine
4947555|NCT01870934|Diabetes|diabetes
4947556|NCT01870934|Foot Ulcers|foot ulcers
4947557|NCT01870895|YM060|ym060
4947558|NCT01870895|Ramosetron|ramosetron
4947559|NCT01870895|Diarrhea-predominant Irritable Bowel Syndrome|diarrhea-predominant irritable bowel syndrome
4947560|NCT01870882|Opioid-Related Disorders|opioid-related disorders
4947561|NCT01870882|Cocaine-Related Disorders|cocaine-related disorders
4947562|NCT01870882|Substance-Related Disorders|substance-related disorders
4947563|NCT01870882|Mental Disorders|mental disorders
4947564|NCT01870882|Cocaine|cocaine
4947565|NCT01870882|Methadone|methadone
4947566|NCT01870882|Therapeutic Uses|therapeutic uses
4947567|NCT01870856|Ocular discomfort|ocular discomfort
4947568|NCT01870856|Contact lenses|contact lenses
4947569|NCT01870856|Myopia|myopia
4947570|NCT01870843|Depressive Disorder, Major|depressive disorder, major
4947571|NCT01870843|Depressive Disorder|depressive disorder
4947572|NCT01870843|Depression|depression
4947573|NCT01870843|Anxiety|anxiety
4947574|NCT01870843|Escitalopram|escitalopram
4947575|NCT01870843|Quality of life|quality of life
4947576|NCT01870843|Social functionality|social functionality
4947577|NCT01870817|Randomized|randomized
4947578|NCT01870817|Jejunostomy|jejunostomy
4947579|NCT01870817|Enteral|enteral
4947580|NCT01870817|Nutrition|nutrition
4947581|NCT01870817|Esophagectomy|esophagectomy
4947582|NCT01870817|Gastrectomy|gastrectomy
4947583|NCT01870804|Statins|statins
4947584|NCT01870804|Contrast-Induced Acute Kidney Injury|contrast-induced acute kidney injury
4947585|NCT01870804|Periprocedural Myocardial Damage|periprocedural myocardial damage
4947586|NCT01870791|Esophageal adenocarcinoma|esophageal adenocarcinoma
4947587|NCT01870791|Gastric adenocarcinoma|gastric adenocarcinoma
4947588|NCT01870778|acute heart failure,|acute heart failure,
4947589|NCT01870778|AHF,|ahf,
4947590|NCT01870778|multi-center,|multi-center,
4947591|NCT01870778|randomized,|randomized,
4947592|NCT01870778|double-blind|double-blind
4947593|NCT01870739|LCZ696,|lcz696,
4947594|NCT01870739|Hypertension,|hypertension,
4947595|NCT01870739|Aortic stiffness,|aortic stiffness,
4947596|NCT01870739|Central blood pressure,|central blood pressure,
4947597|NCT01870739|Cardiovascular MRI|cardiovascular mri
4947598|NCT01870726|Glioblastoma multiforme (GBM), glioblastoma, Grade IV Astrocytoma, brain tumor, brain cancer, giant cell glioblastoma, gliosarcoma|glioblastoma multiforme (gbm), glioblastoma, grade iv astrocytoma, brain tumor, brain cancer, giant cell glioblastoma, gliosarcoma
4947599|NCT01870713|gastric bypass surgery|gastric bypass surgery
4947600|NCT01870713|proteomics|proteomics
4947601|NCT01870687|vitex agnus castus|vitex agnus castus
4947602|NCT01870687|clinical trial|clinical trial
4947603|NCT01870687|cyclic mastodynia|cyclic mastodynia
4947604|NCT01870687|PMS|pms
4947605|NCT01870687|prospective|prospective
4947606|NCT01870674|safety|safety
4947607|NCT01870674|tolerability|tolerability
4947608|NCT01870674|pharmacokinetics|pharmacokinetics
4947609|NCT01870674|pharmacodynamics|pharmacodynamics
4947610|NCT01870661|Intravenous placement|intravenous placement
4947611|NCT01870661|Ultrasound|ultrasound
4947612|NCT01870648|Low-middle income country|low-middle income country
4947613|NCT01870648|Dehydration|dehydration
4947614|NCT01870648|Intravenous Rehydration|intravenous rehydration
4947615|NCT01870648|Pakistan|pakistan
4947616|NCT01870635|Low-middle income country|low-middle income country
4947617|NCT01870635|Dehydration|dehydration
4947618|NCT01870635|Intravenous Rehydration|intravenous rehydration
4947619|NCT01870635|Pakistan|pakistan
4947620|NCT01870622|Newborn,|newborn,
4947621|NCT01870622|Infant,|infant,
4947622|NCT01870622|Endotracheal Intubation,|endotracheal intubation,
4947623|NCT01870622|Carbon dioxide detector,|carbon dioxide detector,
4947624|NCT01870622|Flow waves|flow waves
4947625|NCT01870583|Cesarean delivery|cesarean delivery
4947626|NCT01870583|Surgical site infection|surgical site infection
4947627|NCT01870583|Pregnancy|pregnancy
4947628|NCT01870583|Postpartum|postpartum
4947629|NCT01870570|Glycaemia|glycaemia
4947630|NCT01870570|Insulinemia|insulinemia
4947631|NCT01870557|Diabetes Mellitus|diabetes mellitus
4947632|NCT01870557|Bone|bone
4947633|NCT01870557|Bone Status|bone status
4947634|NCT01870557|Glycemic Markers|glycemic markers
4947635|NCT01870557|Osteoporosis|osteoporosis
4947636|NCT01870557|Osteopenia|osteopenia
4947637|NCT01870544|gastric bypass|gastric bypass
4947638|NCT01870544|microbiota|microbiota
4947639|NCT01870544|probiotic|probiotic
4947640|NCT01870531|Transient Ischemic Attack|transient ischemic attack
4947641|NCT01870518|Parkinson's disease|parkinson's disease
4947642|NCT01870518|Dementia|dementia
4947643|NCT01870505|BYL719|byl719
4947644|NCT01870505|Letrozole|letrozole
4947645|NCT01870505|Exemestane|exemestane
4947646|NCT01870505|13-027|13-027
4947647|NCT01870492|IV-tPA|iv-tpa
4947648|NCT01870492|Activase|activase
4947649|NCT01870492|endovascular therapy|endovascular therapy
4947650|NCT01870479|Malignant Lymphoma|malignant lymphoma
4947651|NCT01870479|Chemotherapy|chemotherapy
4947652|NCT01870479|Music therapy|music therapy
4947653|NCT01870453|Alzheimer Disease|alzheimer disease
4947654|NCT01870453|Dementia|dementia
4947655|NCT01870453|Postoperative Care|postoperative care
4947656|NCT01870453|Cognitive Reserve|cognitive reserve
4947657|NCT01870440|Uveitis|uveitis
4947658|NCT01870440|Macular Edema|macular edema
4947659|NCT01870427|Macular Edema|macular edema
4947660|NCT01870427|Central Retinal Vein Occlusion|central retinal vein occlusion
4947661|NCT01870427|CRVO|crvo
4947662|NCT01870427|Aflibercept|aflibercept
4947663|NCT01870427|VEGF Trap-Eye|vegf trap-eye
4947664|NCT01870427|Eylea|eylea
4947665|NCT01870427|Ranibizumab|ranibizumab
4947666|NCT01870427|Bevacizumab|bevacizumab
4947667|NCT01870375|Mucopolysaccharidosis|mucopolysaccharidosis
4947668|NCT01870375|Longitudinal|longitudinal
4947669|NCT01870375|Brain|brain
4947670|NCT01870375|Cognition|cognition
4947671|NCT01870375|Quality-of-Life|quality-of-life
4947672|NCT01870375|Hurler syndrome|hurler syndrome
4947673|NCT01870375|Hunter syndrome|hunter syndrome
4947674|NCT01870375|Hurler-Scheie syndrome|hurler-scheie syndrome
4947675|NCT01870375|Scheie syndrome|scheie syndrome
4947676|NCT01870375|Maroteaux-Lamy syndrome|maroteaux-lamy syndrome
4947677|NCT01870375|MPS I|mps i
4947678|NCT01870375|MPS II|mps ii
4947679|NCT01870375|MPS VI|mps vi
4947680|NCT01870375|Mucopolysaccharidosis type I|mucopolysaccharidosis type i
4947681|NCT01870375|Mucopolysaccharidosis type II|mucopolysaccharidosis type ii
4947682|NCT01870375|Mucopolysaccharidosis type VI|mucopolysaccharidosis type vi
4947683|NCT01870375|MPS IV|mps iv
4947684|NCT01870375|MPS VII|mps vii
4947685|NCT01870375|Mucopolysaccharidosis type IV|mucopolysaccharidosis type iv
4947686|NCT01870375|Mucopolysaccharidosis type VII|mucopolysaccharidosis type vii
4947687|NCT01870375|Morquio syndrome|morquio syndrome
4947688|NCT01870375|Sly syndrome|sly syndrome
4947689|NCT01870349|cytokines|cytokines
4947690|NCT01870349|dental implants|dental implants
4947691|NCT01870349|peri-implantitis|peri-implantitis
4947692|NCT01870310|Heart failure|heart failure
4947693|NCT01870310|Renal denervation|renal denervation
4947694|NCT01870271|PTSD|ptsd
4947695|NCT01870271|childhood sexual abuse|childhood sexual abuse
4947696|NCT01870271|physical abuse|physical abuse
4947697|NCT01870271|developmentally adapted cognitive processing therapy|developmentally adapted cognitive processing therapy
4947698|NCT01870258|Myocardial infarction|myocardial infarction
4947699|NCT01870258|artificial neural networks|artificial neural networks
4947700|NCT01870258|Electrocardiography|electrocardiography
4947701|NCT01870232|Greater palatine nerve Block|greater palatine nerve block
4947702|NCT01870232|Inferior Alveolar nerve block|inferior alveolar nerve block
4947703|NCT01870232|dental anesthesia|dental anesthesia
4947704|NCT01870232|Ultrasonography|ultrasonography
4947705|NCT01870219|sevoflurane|sevoflurane
4947706|NCT01870219|ketamine|ketamine
4947707|NCT01870219|QT interval|qt interval
4947708|NCT01870206|Immunogenicity|immunogenicity
4947709|NCT01870206|Safety|safety
4947710|NCT01870206|Efficacy|efficacy
4947711|NCT01870206|Poliomyelitis|poliomyelitis
4947712|NCT01870206|Newborn|newborn
4947713|NCT01870193|Glutathione deficiency in aging|glutathione deficiency in aging
4947714|NCT01870193|Impaired mitochondrial fatty-acid oxidation in aging|impaired mitochondrial fatty-acid oxidation in aging
4947715|NCT01870180|Meibomian Glad Dysfunction|meibomian glad dysfunction
4947716|NCT01870180|EyeBag|eyebag
4947717|NCT01870180|Hot Compress|hot compress
4947718|NCT01870180|Dry Eyes|dry eyes
4947719|NCT01870167|PEG|peg
4947720|NCT01870167|Percutaneous Endoscopic Gastrostomy|percutaneous endoscopic gastrostomy
4947721|NCT01870167|antibiotic prophylaxis|antibiotic prophylaxis
4947722|NCT01870154|Burnout syndrome|burnout syndrome
4947723|NCT01870154|Job stressors|job stressors
4947724|NCT01870154|Primary Health Care|primary health care
4947725|NCT01870154|Health professional|health professional
4947726|NCT01870141|Glucose Control|glucose control
4947727|NCT01870141|Depression|depression
4947728|NCT01870141|Self-Efficacy|self-efficacy
4947729|NCT01870128|Rheumatoid arthritis|rheumatoid arthritis
4947730|NCT01870128|Steroid|steroid
4947731|NCT01870115|Melatonin|melatonin
4947732|NCT01870115|Strontium Citrate|strontium citrate
4947733|NCT01870115|Osteoporosis|osteoporosis
4947734|NCT01870115|Osteopenia|osteopenia
4947735|NCT01870089|Non invasive ventilation|non invasive ventilation
4947736|NCT01870089|Computer-driven system|computer-driven system
4947737|NCT01870089|Acute respiratory failure|acute respiratory failure
4947738|NCT01870063|5 minute bleeding test|5 minute bleeding test
4947739|NCT01870063|swamb|swamb
4947740|NCT01870063|fibtem|fibtem
4947741|NCT01870063|extem|extem
4947742|NCT01870050|lichen simplex chronicus|lichen simplex chronicus
4947743|NCT01870050|prurigo|prurigo
4947744|NCT01870037|OAB, gene therapy|oab, gene therapy
4947745|NCT01870024|status epilepticus|status epilepticus
4947746|NCT01870024|epilepsy|epilepsy
4947747|NCT01870024|seizures|seizures
4947748|NCT01870024|convulsive seizures|convulsive seizures
4947749|NCT01870024|convulsions|convulsions
4947750|NCT01870024|benzodiazepines|benzodiazepines
4947751|NCT01870024|anticonvulsants|anticonvulsants
4947752|NCT01870011|Propofol, renal protection, kidney transplantation|propofol, renal protection, kidney transplantation
4947753|NCT01869998|Vortex|vortex
4947754|NCT01869998|Thrombus|thrombus
4947755|NCT01869998|Contrast echocardiography|contrast echocardiography
4947756|NCT01869998|Prediction and prevention of apical thrombus formation in acute myocardial infarction patient by using Vortex parameters.|prediction and prevention of apical thrombus formation in acute myocardial infarction patient by using vortex parameters.
4947757|NCT01869985|HCP1104|hcp1104
4947758|NCT01869985|Eperisone Hydrochloride|eperisone hydrochloride
4947759|NCT01869985|Aceclofenac|aceclofenac
4947760|NCT01869972|PKU|pku
4947761|NCT01869972|phenylketonuria|phenylketonuria
4947762|NCT01869972|hyperphenylalaninemia|hyperphenylalaninemia
4947763|NCT01869972|Kuvan|kuvan
4947764|NCT01869972|sapropterin|sapropterin
4947765|NCT01869946|Hip arthroplasty|hip arthroplasty
4947766|NCT01869933|Proliferative, Diabetic, Retinopathy|proliferative, diabetic, retinopathy
4947767|NCT01869920|breastfeeding|breastfeeding
4947768|NCT01869920|education|education
4947769|NCT01869920|intervention|intervention
4947770|NCT01869894|Malignant biliary obstruction|malignant biliary obstruction
4947771|NCT01869894|metal stent|metal stent
4947772|NCT01869894|patency|patency
4947773|NCT01869855|chronic subdural hematoma|chronic subdural hematoma
4947774|NCT01869855|traumatic brain injury|traumatic brain injury
4947775|NCT01869855|burr hole trepanation|burr hole trepanation
4947776|NCT01869855|drainage after evacuation of chronic subdural hematoma|drainage after evacuation of chronic subdural hematoma
4947777|NCT01869855|intracranial bleed|intracranial bleed
4947778|NCT01869842|Resolute zotarolumus-eluting stent|resolute zotarolumus-eluting stent
4947905|NCT01869218|Solid|solid
4947779|NCT01869842|optical coherence tomography|optical coherence tomography
4947780|NCT01869829|Candida|candida
4947781|NCT01869829|Pediatric|pediatric
4947782|NCT01869829|Antifungal|antifungal
4947783|NCT01869738|heart attack|heart attack
4947784|NCT01869725|Neuroendocrine Tumor|neuroendocrine tumor
4947785|NCT01869725|Ga-DOTATOC PET|ga-dotatoc pet
4947786|NCT01869725|Imaging|imaging
4947787|NCT01869712|cupping therapy|cupping therapy
4947788|NCT01869712|acupuncture|acupuncture
4947789|NCT01869712|partially randomized|partially randomized
4947790|NCT01869712|patient preference|patient preference
4947791|NCT01869712|fibromyalgia|fibromyalgia
4947792|NCT01869712|criteria formulated by American College Rheumatology 2002|criteria formulated by american college rheumatology 2002
4947793|NCT01869699|Fever|fever
4947794|NCT01869699|Acetaminophen|acetaminophen
4947795|NCT01869699|Critical Care|critical care
4947796|NCT01869699|ICU|icu
4947797|NCT01869699|Febrile|febrile
4947798|NCT01869673|Difficult mask ventilation|difficult mask ventilation
4947799|NCT01869673|extubation|extubation
4947800|NCT01869673|nasal surgery|nasal surgery
4947801|NCT01869660|First hospitalization|first hospitalization
4947802|NCT01869647|kidney stones|kidney stones
4947803|NCT01869634|HIV|hiv
4947804|NCT01869634|cardiovascular risk|cardiovascular risk
4947805|NCT01869634|systemic immune activation|systemic immune activation
4947806|NCT01869608|postpartum screening|postpartum screening
4947807|NCT01869608|type 2 diabetes|type 2 diabetes
4947808|NCT01869595|2000 MSM and TG sites in Bangkok,Lampang,Ubonratchathani|2000 msm and tg sites in bangkok,lampang,ubonratchathani
4947809|NCT01869582|Fetal hypoxia|fetal hypoxia
4947810|NCT01869582|Birth asphyxia|birth asphyxia
4947811|NCT01869582|Neonatal resuscitation|neonatal resuscitation
4947812|NCT01869569|Radiation|radiation
4947813|NCT01869569|Neuropathic Pain|neuropathic pain
4947814|NCT01869569|Pregabalin|pregabalin
4947815|NCT01869556|pregnancy|pregnancy
4947816|NCT01869556|postpartum hemorrhage|postpartum hemorrhage
4947817|NCT01869556|Cesarean delivery|cesarean delivery
4947818|NCT01869556|failure to progress in labor|failure to progress in labor
4947819|NCT01869504|Ballooned intercostal drain|ballooned intercostal drain
4947820|NCT01869504|Pleural effusion|pleural effusion
4947821|NCT01869491|Gastroesophageal Reflux Disease|gastroesophageal reflux disease
4947822|NCT01869491|GERD|gerd
4947823|NCT01869491|Dyspepsia|dyspepsia
4947824|NCT01869491|Indigestion|indigestion
4947825|NCT01869491|Heartburn|heartburn
4947826|NCT01869491|Acid reflux|acid reflux
4947827|NCT01869491|Compound Sodium Alginate Double Action Chewable Tablets|compound sodium alginate double action chewable tablets
4947828|NCT01869491|Gaviscon Double Action Tablets|gaviscon double action tablets
4947829|NCT01869452|education|education
4947830|NCT01869452|risk factors|risk factors
4947831|NCT01869452|quality of life|quality of life
4947832|NCT01869452|coronary disease|coronary disease
4947833|NCT01869452|telephone follow up|telephone follow up
4947834|NCT01869452|dedicated nurse|dedicated nurse
4947835|NCT01869439|Pressure Ulcers|pressure ulcers
4947836|NCT01869439|Bed Sores|bed sores
4947837|NCT01869439|Measuring|measuring
4947838|NCT01869439|Visual Images|visual images
4947839|NCT01869439|Thermal Images|thermal images
4947840|NCT01869439|External Wounds|external wounds
4947841|NCT01869439|Area|area
4947842|NCT01869439|Length|length
4947843|NCT01869439|Width|width
4947844|NCT01869439|Gradient|gradient
4947845|NCT01869426|colics|colics
4947846|NCT01869413|urothelial cell carcinoma|urothelial cell carcinoma
4947847|NCT01869413|transition cell carcinoma|transition cell carcinoma
4947848|NCT01869413|bladder cancer|bladder cancer
4947849|NCT01869413|radical cystectomy|radical cystectomy
4947850|NCT01869413|cystectomy|cystectomy
4947851|NCT01869413|bladder removal|bladder removal
4947852|NCT01869413|tranexamic acid|tranexamic acid
4947853|NCT01869413|cyklokapron|cyklokapron
4947854|NCT01869374|Depression|depression
4947855|NCT01869374|Brain Stimulation|brain stimulation
4947856|NCT01869374|Seizure therapy|seizure therapy
4947857|NCT01869374|Convulsive Therapy|convulsive therapy
4947858|NCT01869361|preterm labor|preterm labor
4947859|NCT01869361|tocolysis|tocolysis
4947860|NCT01869361|indomethacin|indomethacin
4947861|NCT01869348|Physical activity|physical activity
4947862|NCT01869348|Activity monitor|activity monitor
4947863|NCT01869348|Technology|technology
4947864|NCT01869348|Obesity|obesity
4947865|NCT01869348|Aging muscle|aging muscle
4947866|NCT01869335|breast cancer|breast cancer
4947867|NCT01869335|MRI|mri
4947868|NCT01869335|mammography|mammography
4947869|NCT01869335|microcalcifications|microcalcifications
4947870|NCT01869335|Local staging of breast microcalcifications|local staging of breast microcalcifications
4947871|NCT01869335|Evaluation of ex vivo MRI for breast malignancies detected by MRI only|evaluation of ex vivo mri for breast malignancies detected by mri only
4947872|NCT01869322|Humerus|humerus
4947873|NCT01869322|Fracture|fracture
4947874|NCT01869322|Sling|sling
4947875|NCT01869322|Splint|splint
4947876|NCT01869322|Coaptation|coaptation
4947877|NCT01869309|Coronary artery disease|coronary artery disease
4947878|NCT01869309|anti-platelet medications|anti-platelet medications
4947879|NCT01869309|Platelet-aggregation Inhibitors|platelet-aggregation inhibitors
4947880|NCT01869296|unsedated|unsedated
4947881|NCT01869296|water immersion colonoscopy|water immersion colonoscopy
4947882|NCT01869296|endoscope water pump flow rates|endoscope water pump flow rates
4947883|NCT01869283|Physical Therapy Modalities|physical therapy modalities
4947884|NCT01869283|Myofascial Pain Syndromes|myofascial pain syndromes
4947885|NCT01869283|Skeletal Muscle|skeletal muscle
4947886|NCT01869270|hexosaminidase deficiency|hexosaminidase deficiency
4947887|NCT01869270|Tay-Sachs disease|tay-sachs disease
4947888|NCT01869270|Sandhoff disease|sandhoff disease
4947889|NCT01869270|late-onset Tay-Sachs disease|late-onset tay-sachs disease
4948476|NCT01866488|Cytotec|cytotec
4947890|NCT01869270|adult-onset Tay-Sachs disease|adult-onset tay-sachs disease
4947891|NCT01869270|late onset Tay Sachs disease|late onset tay sachs disease
4947892|NCT01869270|adult onset Tay Sachs disease|adult onset tay sachs disease
4947893|NCT01869270|retrospective|retrospective
4947894|NCT01869270|hexosaminidase A activity|hexosaminidase a activity
4947895|NCT01869270|GM2-ganglioside|gm2-ganglioside
4947896|NCT01869270|gangliosidoses|gangliosidoses
4947897|NCT01869270|natural history|natural history
4947898|NCT01869270|hexosaminidase|hexosaminidase
4947899|NCT01869257|triclosan|triclosan
4947900|NCT01869257|colorectal|colorectal
4947901|NCT01869257|surgery|surgery
4947902|NCT01869257|surgical site infection|surgical site infection
4947903|NCT01869218|Cancer|cancer
4947904|NCT01869218|Advanced|advanced
4947906|NCT01869218|Hematological|hematological
4947907|NCT01869218|Malignancy|malignancy
4947908|NCT01869218|Tissue|tissue
4947909|NCT01869218|Bank|bank
4947910|NCT01869205|COPD|copd
4947911|NCT01869205|Emphysema|emphysema
4947912|NCT01869205|Bronchoscopic lung volume reduction|bronchoscopic lung volume reduction
4947913|NCT01869205|Endobronchial valve|endobronchial valve
4947914|NCT01869192|Malignant|malignant
4947915|NCT01869192|Neoplasm|neoplasm
4947916|NCT01869192|Cancer|cancer
4947917|NCT01869192|Female|female
4947918|NCT01869192|Breast|breast
4947919|NCT01869192|Stage II|stage ii
4947920|NCT01869192|Stage III|stage iii
4947921|NCT01869179|Well being|well being
4947922|NCT01869179|Low income|low income
4947923|NCT01869179|Choir singing|choir singing
4947924|NCT01869179|Spanish speaking|spanish speaking
4947925|NCT01869179|Community based|community based
4947926|NCT01869179|Seniors|seniors
4947927|NCT01869179|60+ aged adults|60+ aged adults
4947928|NCT01869166|chemotherapy and/or EGFR-antibody/kinase inhibitor therapy refractory solid tumors|chemotherapy and/or egfr-antibody/kinase inhibitor therapy refractory solid tumors
4947929|NCT01869153|Growth, weight|growth, weight
4947930|NCT01869127|hookworm|hookworm
4947931|NCT01869127|necator americanus|necator americanus
4947932|NCT01869127|ancyclostoma duodenale|ancyclostoma duodenale
4947933|NCT01869127|shoes|shoes
4947934|NCT01869127|anaemia|anaemia
4947935|NCT01869127|children|children
4947936|NCT01869101|Prediabetes|prediabetes
4947937|NCT01869101|Diabetes prevention|diabetes prevention
4947938|NCT01869088|TACE|tace
4947939|NCT01869088|Carcinoma,Hepatocellular|carcinoma,hepatocellular
4947940|NCT01869088|Liver Neoplasms|liver neoplasms
4947941|NCT01869088|overall survival|overall survival
4947942|NCT01869088|Recombinant Human Adenovirus Type 5 Injection|recombinant human adenovirus type 5 injection
4947943|NCT01869075|Quality Improvement|quality improvement
4947944|NCT01869075|Patient Safety|patient safety
4947945|NCT01869075|Knowledge Translation|knowledge translation
4947946|NCT01869062|CRT|crt
4947947|NCT01869049|Immune Thrombocytopenia|immune thrombocytopenia
4947948|NCT01869049|macrophage|macrophage
4947949|NCT01869049|spleen tissue|spleen tissue
4947950|NCT01869036|Caudal|caudal
4947951|NCT01869036|anesthesia|anesthesia
4947952|NCT01869036|morphine|morphine
4947953|NCT01869036|children|children
4947954|NCT01869023|Advanced Malignant Pleural Mesothelioma|advanced malignant pleural mesothelioma
4947955|NCT01869023|Gemcitabine and cisplatin|gemcitabine and cisplatin
4947956|NCT01869023|Gemcitabine continuous infusion|gemcitabine continuous infusion
4947957|NCT01869010|HIV infection|hiv infection
4947958|NCT01869010|Antiretroviral treatment|antiretroviral treatment
4947959|NCT01869010|Renal disease|renal disease
4947960|NCT01869010|Renal tubular damage|renal tubular damage
4947961|NCT01869010|Free-water clearance|free-water clearance
4947962|NCT01868997|Thyroid Eye Disease, Graves Orbitopathy, Thyroid Associated|thyroid eye disease, graves orbitopathy, thyroid associated
4947963|NCT01868997|Ophthalmopathy|ophthalmopathy
4947964|NCT01868971|EndoRings|endorings
4947965|NCT01868958|Magnetic resonance imaging (MRI)|magnetic resonance imaging (mri)
4947966|NCT01868958|Diffusion tensor imaging|diffusion tensor imaging
4947967|NCT01868958|Spine|spine
4947968|NCT01868945|Vitamin D3|vitamin d3
4947969|NCT01868945|Calcifediol 25|calcifediol 25
4947970|NCT01868945|Frail|frail
4947971|NCT01868945|Dose-response|dose-response
4947972|NCT01868932|wheeze|wheeze
4947973|NCT01868932|early childhood|early childhood
4947974|NCT01868932|asthma|asthma
4947975|NCT01868932|bronchiolitis|bronchiolitis
4947976|NCT01868932|infection triggered|infection triggered
4947977|NCT01868919|"Pilot Projects[Mesh]"|"pilot projects[mesh]"
4947978|NCT01868919|"Parenting[Mesh]"|"parenting[mesh]"
4947979|NCT01868919|"Child Behaviour[Mesh]"|"child behaviour[mesh]"
4947980|NCT01868919|"Mental Health[Mesh]"|"mental health[mesh]"
4947981|NCT01868919|"Family Practice[Mesh]"|"family practice[mesh]"
4947982|NCT01868906|Anaplastic Astrocytoma|anaplastic astrocytoma
4947983|NCT01868906|Brain Tumors|brain tumors
4947984|NCT01868906|Cancer Imaging|cancer imaging
4947985|NCT01868906|Fluoromisonidazole|fluoromisonidazole
4947986|NCT01868906|FMISO PET|fmiso pet
4947987|NCT01868906|Glioblastoma|glioblastoma
4947988|NCT01868906|High Grade Glioma|high grade glioma
4947989|NCT01868906|Hypoxia Modification|hypoxia modification
4947990|NCT01868906|Positron Emission Tomography|positron emission tomography
4947991|NCT01868906|Radiation-Sensitizing Agents|radiation-sensitizing agents
4947992|NCT01868906|Spinal Cord Stimulation|spinal cord stimulation
4947993|NCT01868906|Tumor Hypoxia Measurement|tumor hypoxia measurement
4947994|NCT01868854|Tip catheter|tip catheter
4947995|NCT01868854|Peritoneal Dialysis|peritoneal dialysis
4947996|NCT01868854|Risk Factot|risk factot
4947997|NCT01868854|Mecanical Function|mecanical function
4947998|NCT01868841|123I-mIBG|123i-mibg
4947999|NCT01868841|AdreView|adreview
4948000|NCT01868841|SPECT|spect
4948001|NCT01868841|Heart to Mediastinal Ratio|heart to mediastinal ratio
4948002|NCT01868828|Multiple Myeloma|multiple myeloma
4948003|NCT01868828|Combination Therapy|combination therapy
4948004|NCT01868802|Ketamine|ketamine
4948005|NCT01868802|Depression|depression
4948006|NCT01868802|Depressive Disorder|depressive disorder
4948007|NCT01868789|Adult-acquired flatfoot disorder (AAFD)|adult-acquired flatfoot disorder (aafd)
4948008|NCT01868789|flexible flatfoot|flexible flatfoot
4948009|NCT01868789|computed tomography (CT)|computed tomography (ct)
4948010|NCT01868763|telemedicine|telemedicine
4948011|NCT01868763|coaching|coaching
4948012|NCT01868763|lifestyle change|lifestyle change
4948013|NCT01868763|weight loss|weight loss
4948014|NCT01868737|Human Immunodeficiency Virus|human immunodeficiency virus
4948015|NCT01868737|Necrotizing Enterocolitis|necrotizing enterocolitis
4948016|NCT01868737|Premature infant|premature infant
4948017|NCT01868737|Probiotic|probiotic
4948018|NCT01868737|Very Low Birth Weight|very low birth weight
4948019|NCT01868724|Kidney Renal|kidney renal
4948020|NCT01868711|Major Depressive Disorder|major depressive disorder
4948021|NCT01868711|Cognitive Behavior Therapy|cognitive behavior therapy
4948022|NCT01868711|Psychological Mindedness|psychological mindedness
4948023|NCT01868698|Physical Therapy Modalities|physical therapy modalities
4948024|NCT01868698|Electric Stimulation Therapy|electric stimulation therapy
4948025|NCT01868698|Hyperthermia, Induced|hyperthermia, induced
4948026|NCT01868698|Diabetes Mellitus|diabetes mellitus
4948027|NCT01868685|Muscle, anabolism, cachexia, respiratory failure, diaphragm|muscle, anabolism, cachexia, respiratory failure, diaphragm
4948028|NCT01868672|Secondhand smoke exposure|secondhand smoke exposure
4948029|NCT01868672|Smoke-free homes|smoke-free homes
4948030|NCT01868672|Smoke-free home bans|smoke-free home bans
4948031|NCT01868646|Combined Treatment of Patients With Type II Diabetes Mellitus|combined treatment of patients with type ii diabetes mellitus
4948032|NCT01868633|Cesarean delivery|cesarean delivery
4948033|NCT01868633|Analgesia|analgesia
4948034|NCT01868633|Pain|pain
4948035|NCT01868633|Dexamethasone|dexamethasone
4948036|NCT01868633|intrathecal morphine|intrathecal morphine
4948037|NCT01868633|spinal anesthesia|spinal anesthesia
4948038|NCT01868620|Progressive keratoconus|progressive keratoconus
4948039|NCT01868620|standard CXL|standard cxl
4948040|NCT01868620|iontophoretic CXL|iontophoretic cxl
4948041|NCT01868620|keratometry|keratometry
4948042|NCT01868607|Respiratory resistance|respiratory resistance
4948043|NCT01868607|Respiratory reactance|respiratory reactance
4948044|NCT01868607|Adult lung function|adult lung function
4948045|NCT01868607|Forced oscillation technique|forced oscillation technique
4948046|NCT01868607|subjects|subjects
4948047|NCT01868594|Combined treatment of patients with type I diabetes mellitus|combined treatment of patients with type i diabetes mellitus
4948048|NCT01868490|Cholangiocarcinoma|cholangiocarcinoma
4948049|NCT01868490|Cytokine induced killer cells|cytokine induced killer cells
4948050|NCT01868490|CIK|cik
4948051|NCT01868490|Treg|treg
4948052|NCT01868490|Th17|th17
4948053|NCT01868477|myelodysplastic syndrome|myelodysplastic syndrome
4948054|NCT01868477|MDS|mds
4948055|NCT01868477|myelodysplasia|myelodysplasia
4948056|NCT01868477|blood disorder|blood disorder
4948057|NCT01868477|cytopenias|cytopenias
4948058|NCT01868477|low blood counts|low blood counts
4948059|NCT01868477|progressive bone marrow failure|progressive bone marrow failure
4948060|NCT01868464|challenge|challenge
4948061|NCT01868464|Mycobacterium tuberculosis|mycobacterium tuberculosis
4948062|NCT01868464|parent protocol|parent protocol
4948063|NCT01868464|TB|tb
4948064|NCT01868464|Tice BCG|tice bcg
4948065|NCT01868464|tuberculosis|tuberculosis
4948066|NCT01868451|DACARBAZINE|dacarbazine
4948067|NCT01868451|DOXORUBICIN/ADRIAMYCIN|doxorubicin/adriamycin
4948068|NCT01868451|SGN-35 (BRENTUXIMAB VEDOTIN)|sgn-35 (brentuximab vedotin)
4948069|NCT01868451|VINBLASTINE|vinblastine
4948070|NCT01868451|Involved-site radiation therapy (ISRT)|involved-site radiation therapy (isrt)
4948071|NCT01868451|Early stage|early stage
4948072|NCT01868451|13-034|13-034
4948073|NCT01868438|Pyronaridine artesunate tablet|pyronaridine artesunate tablet
4948074|NCT01868438|Pyronaridine artesunate granules|pyronaridine artesunate granules
4948075|NCT01868438|Pyramax tablet|pyramax tablet
4948076|NCT01868438|Pyramax granules|pyramax granules
4948077|NCT01868438|Bioavailability|bioavailability
4948078|NCT01868412|Wound healing|wound healing
4948079|NCT01868412|Wound infection|wound infection
4948080|NCT01868412|Resin salve|resin salve
4948081|NCT01868412|Medical honey|medical honey
4948082|NCT01868399|dengue virus|dengue virus
4948083|NCT01868386|Radiotherapy, hypofractionated|radiotherapy, hypofractionated
4948084|NCT01868386|Salvage therapy|salvage therapy
4948677|NCT01865565|neoadjuvant|neoadjuvant
4948085|NCT01868386|Radiotherapy, adjuvant|radiotherapy, adjuvant
4948086|NCT01868373|commensal microbiota bacteroides colitis pseudomembranous|commensal microbiota bacteroides colitis pseudomembranous
4948087|NCT01868360|cornea|cornea
4948088|NCT01868360|transplant|transplant
4948089|NCT01868360|graft|graft
4948090|NCT01868360|neovascularization|neovascularization
4948091|NCT01868347|obese patients|obese patients
4948092|NCT01868347|specific elastance|specific elastance
4948093|NCT01868347|Trendelenburg Position|trendelenburg position
4948094|NCT01868347|Pneumoperitoneum|pneumoperitoneum
4948095|NCT01868347|robotic surgery|robotic surgery
4948096|NCT01868347|Prostatectomy|prostatectomy
4948097|NCT01868334|influenza vaccine|influenza vaccine
4948098|NCT01868334|PPSV|ppsv
4948099|NCT01868334|Tdap|tdap
4948100|NCT01868334|vaccination|vaccination
4948101|NCT01868334|adult|adult
4948102|NCT01868321|Mechanical ventilation|mechanical ventilation
4948103|NCT01868321|Acute respiratory failure|acute respiratory failure
4948104|NCT01868321|Acute respiratory distress syndrome|acute respiratory distress syndrome
4948105|NCT01868282|anterior cruciate ligament repair, Obturator nerve block, Hamstrings graft, Ropivacaine,|anterior cruciate ligament repair, obturator nerve block, hamstrings graft, ropivacaine,
4948106|NCT01868282|Postoperative pain|postoperative pain
4948107|NCT01868256|myocardial infarction|myocardial infarction
4948108|NCT01868256|primary percutaneous intervention|primary percutaneous intervention
4948109|NCT01868256|prognosis|prognosis
4948110|NCT01868256|early discharge|early discharge
4948111|NCT01868243|Atrial Fibrillation|atrial fibrillation
4948112|NCT01868243|Bioprosthesis|bioprosthesis
4948113|NCT01868243|Stroke|stroke
4948114|NCT01868243|Dabigatran|dabigatran
4948115|NCT01868243|Warfarin|warfarin
4948116|NCT01868204|Obesity|obesity
4948117|NCT01868204|Binge eating disorder|binge eating disorder
4948118|NCT01868204|Pharmacogenetic|pharmacogenetic
4948119|NCT01868204|Food craving|food craving
4948120|NCT01868204|Brain areas|brain areas
4948121|NCT01868204|Topiramate|topiramate
4948122|NCT01868191|Diabetes|diabetes
4948123|NCT01868191|Neuropathy|neuropathy
4948124|NCT01868178|awareness|awareness
4948125|NCT01868165|Cognitive decline|cognitive decline
4948126|NCT01868165|High blood pressure|high blood pressure
4948127|NCT01868165|Hypertension|hypertension
4948128|NCT01868165|Ageing|ageing
4948129|NCT01868165|Dementia|dementia
4948130|NCT01868165|Antihypertensives|antihypertensives
4948131|NCT01868152|sufentanil|sufentanil
4948132|NCT01868152|individual variation|individual variation
4948133|NCT01868152|pain threshold|pain threshold
4948134|NCT01868152|narcotrend index|narcotrend index
4948135|NCT01868139|Cryotherapy|cryotherapy
4948136|NCT01868139|Esophageal cancer|esophageal cancer
4948137|NCT01868139|Esophageal carcinoma|esophageal carcinoma
4948138|NCT01868139|Liquid nitrogen|liquid nitrogen
4948139|NCT01868139|Esophageal adenocarcinoma|esophageal adenocarcinoma
4948140|NCT01868139|Esophageal squamous cell carcinoma|esophageal squamous cell carcinoma
4948141|NCT01868139|Endoscopy|endoscopy
4948142|NCT01868139|Ablation|ablation
4948143|NCT01868126|Santen|santen
4948144|NCT01868126|Eye|eye
4948145|NCT01868126|Glaucoma|glaucoma
4948146|NCT01868126|Ocular hypertension|ocular hypertension
4948147|NCT01868113|Children U-5|children u-5
4948148|NCT01868113|ALRI|alri
4948149|NCT01868113|Inhaled Corticosteroids|inhaled corticosteroids
4948150|NCT01868100|Cancer|cancer
4948151|NCT01868100|quality of life|quality of life
4948152|NCT01868100|palliative care|palliative care
4948153|NCT01868100|supportive care|supportive care
4948154|NCT01868100|Financial distress|financial distress
4948155|NCT01868087|nutritional supplement|nutritional supplement
4948156|NCT01868087|immune system|immune system
4948157|NCT01868087|RC surgery|rc surgery
4948158|NCT01868074|pregnancy, arch height, collapsed arch|pregnancy, arch height, collapsed arch
4948159|NCT01868048|Spasticity|spasticity
4948160|NCT01868048|Multiple Sclerosis|multiple sclerosis
4948161|NCT01868035|radioimmunotherapy|radioimmunotherapy
4948162|NCT01868035|Iodine 131 Tositumomab|iodine 131 tositumomab
4948163|NCT01868022|FGFR1|fgfr1
4948164|NCT01868022|FP1039|fp1039
4948165|NCT01868022|GSK3052230|gsk3052230
4948166|NCT01868022|docetaxel|docetaxel
4948167|NCT01868022|FGFR|fgfr
4948168|NCT01868022|carboplatin|carboplatin
4948169|NCT01868022|HGS1036|hgs1036
4948170|NCT01868022|squamous non-small cell lung cancer|squamous non-small cell lung cancer
4948171|NCT01868022|paclitaxel|paclitaxel
4948172|NCT01868009|fluticasone furoate|fluticasone furoate
4948173|NCT01868009|COPD|copd
4948174|NCT01868009|ELLIPTA|ellipta
4948175|NCT01868009|fluticasone propionate|fluticasone propionate
4948176|NCT01868009|DISKUS|diskus
4948177|NCT01868009|Novel Dry Powder Inhaler (NDPI)|novel dry powder inhaler (ndpi)
4948178|NCT01868009|device preference|device preference
4948179|NCT01868009|salmeterol|salmeterol
4948180|NCT01868009|vilanterol|vilanterol
4948181|NCT01867996|Retosiban, Efavirenz, Induction|retosiban, efavirenz, induction
4948182|NCT01867983|Tobacco cessation|tobacco cessation
4948183|NCT01867983|Weight gain prevention|weight gain prevention
4948184|NCT01867970|remote sensing technology|remote sensing technology
4948185|NCT01867970|physical activity|physical activity
4948678|NCT01865565|imatinib|imatinib
4948186|NCT01867970|self-management support|self-management support
4948187|NCT01867970|primary care nursing|primary care nursing
4948188|NCT01867957|anthrax|anthrax
4948189|NCT01867957|vaccine|vaccine
4948190|NCT01867957|bioterrorism|bioterrorism
4948191|NCT01867957|efficacy|efficacy
4948192|NCT01867957|safety|safety
4948193|NCT01867944|Chronic constipation|chronic constipation
4948194|NCT01867944|Hemorrhoids|hemorrhoids
4948195|NCT01867944|Acupressure|acupressure
4948196|NCT01867905|Severe sepsis|severe sepsis
4948197|NCT01867905|Septic shock|septic shock
4948198|NCT01867905|Bacteremia|bacteremia
4948199|NCT01867905|Antibiotics|antibiotics
4948200|NCT01867905|Blood culture positivity|blood culture positivity
4948201|NCT01867892|Locally Advanced Pancreatic Cancer|locally advanced pancreatic cancer
4948202|NCT01867879|Advanced solid tumors (excluding breast cancer) for which no standard therapy exists|advanced solid tumors (excluding breast cancer) for which no standard therapy exists
4948203|NCT01867866|Advanced solid tumors (excluding breast cancer) for which no standard therapy exists|advanced solid tumors (excluding breast cancer) for which no standard therapy exists
4948204|NCT01867801|PCI|pci
4948205|NCT01867801|Coronary disease|coronary disease
4948206|NCT01867801|Ischemia|ischemia
4948207|NCT01867775|Alzheimer's disease|alzheimer's disease
4948208|NCT01867775|Sleep disorders|sleep disorders
4948209|NCT01867775|Mirtazapine|mirtazapine
4948210|NCT01867775|Treatment|treatment
4948211|NCT01867775|Intervention|intervention
4948212|NCT01867775|insomnia|insomnia
4948213|NCT01867762|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
4948214|NCT01867762|JNJ 49095397|jnj 49095397
4948215|NCT01867762|RV568|rv568
4948216|NCT01867762|Forced expiratory volume in one second|forced expiratory volume in one second
4948217|NCT01867762|FEV1|fev1
4948218|NCT01867749|Major Depressive Disorder (MDD)|major depressive disorder (mdd)
4948219|NCT01867749|Miscarriage|miscarriage
4948220|NCT01867749|Stillbirth|stillbirth
4948221|NCT01867749|Neonatal death|neonatal death
4948222|NCT01867749|Interpersonal psychotherapy|interpersonal psychotherapy
4948223|NCT01867749|Group Therapy|group therapy
4948224|NCT01867749|Coping with Depression (CWD)|coping with depression (cwd)
4948225|NCT01867736|Stenosis|stenosis
4948226|NCT01867736|Occlusions|occlusions
4948227|NCT01867736|Infrapopliteal arteries|infrapopliteal arteries
4948228|NCT01867736|Below the knee arteries|below the knee arteries
4948229|NCT01867736|PTA|pta
4948230|NCT01867736|POBA|poba
4948231|NCT01867736|DRB|drb
4948232|NCT01867723|Cancer internet support program|cancer internet support program
4948233|NCT01867710|Mineralocorticoid Excess ; Chemotherapy-Naïve; Metastatic Castration-Resistant Prostate Cancer; Abiraterone Acetate; Zytiga; Prednisone; dexamethasone|mineralocorticoid excess ; chemotherapy-naïve; metastatic castration-resistant prostate cancer; abiraterone acetate; zytiga; prednisone; dexamethasone
4948234|NCT01867684|Stroke|stroke
4948235|NCT01867684|Acquired brain injury|acquired brain injury
4948236|NCT01867671|Allergy, Peanut|allergy, peanut
4948237|NCT01867671|Peanut allergy|peanut allergy
4948238|NCT01867671|Hypersensitivity|hypersensitivity
4948239|NCT01867671|Immunotherapy|immunotherapy
4948240|NCT01867671|Desensitization, Immunologic|desensitization, immunologic
4948241|NCT01867658|Pleural Air Leak|pleural air leak
4948242|NCT01867658|Pulmonary resection|pulmonary resection
4948243|NCT01867658|Video Assisted|video assisted
4948244|NCT01867658|Robotic Assisted|robotic assisted
4948245|NCT01867645|Critical illness|critical illness
4948246|NCT01867645|Critical illness polyneuropathy and/or myopathy|critical illness polyneuropathy and/or myopathy
4948247|NCT01867645|Intravenous immunoglobulins|intravenous immunoglobulins
4948248|NCT01867645|Multiple organ failure|multiple organ failure
4948249|NCT01867645|SIRS|sirs
4948250|NCT01867645|Sepsis|sepsis
4948251|NCT01867632|Palatoplasty|palatoplasty
4948252|NCT01867632|Acellular Dermal Matrix|acellular dermal matrix
4948253|NCT01867619|Brain Neoplasms|brain neoplasms
4948254|NCT01867619|Melanoma|melanoma
4948255|NCT01867619|Metastatic Melanoma|metastatic melanoma
4948256|NCT01867619|Brain Metastasis|brain metastasis
4948257|NCT01867619|Temozolomide|temozolomide
4948258|NCT01867619|Temodar|temodar
4948259|NCT01867619|Thalidomide|thalidomide
4948260|NCT01867619|Thalomid|thalomid
4948261|NCT01867619|Lomustine|lomustine
4948262|NCT01867619|CCNU|ccnu
4948263|NCT01867619|CeeNU|ceenu
4948264|NCT01867593|Newly diagnosed|newly diagnosed
4948265|NCT01867567|cesarean|cesarean
4948266|NCT01867567|bandage removal|bandage removal
4948267|NCT01867567|infection|infection
4948268|NCT01867567|disruption|disruption
4948269|NCT01867567|satisfaction|satisfaction
4948270|NCT01867567|patient satisfaction|patient satisfaction
4948271|NCT01867554|Intellectual disability|intellectual disability
4948272|NCT01867554|Autism spectrum disorders|autism spectrum disorders
4948273|NCT01867554|gene|gene
4948274|NCT01867554|Next generation sequencing|next generation sequencing
4948275|NCT01867541|cataract surgery|cataract surgery
4948276|NCT01867541|intraocular lens power calculation|intraocular lens power calculation
4948277|NCT01867541|effective lens position|effective lens position
4948402|NCT01866865|BRCA1|brca1
4948278|NCT01867541|improving the refractive outcome after cataract surgery|improving the refractive outcome after cataract surgery
4949077|NCT01863966|Achalasia|achalasia
4948279|NCT01867541|predicting the IOL position|predicting the iol position
4948280|NCT01867515|Hearing|hearing
4948281|NCT01867515|Hearing Loss, sensorineural|hearing loss, sensorineural
4948282|NCT01867515|Speech Perception|speech perception
4948283|NCT01867463|Antigen|antigen
4948284|NCT01867463|Ookinetes|ookinetes
4948285|NCT01867463|Mosquito|mosquito
4948286|NCT01867463|Membrane|membrane
4948287|NCT01867463|Assay|assay
4948288|NCT01867450|Biomarkers|biomarkers
4948289|NCT01867450|Deisel Exhaust|deisel exhaust
4948290|NCT01867450|Occupational Exposure|occupational exposure
4948291|NCT01867450|Cross-Sectional Study|cross-sectional study
4948292|NCT01867437|24 Hour Energy Expenditure|24 hour energy expenditure
4948293|NCT01867437|Resting Energy Expenditure|resting energy expenditure
4948294|NCT01867437|Obesity|obesity
4948295|NCT01867437|Healthy Volunteers|healthy volunteers
4948296|NCT01867424|Testosterone Membrane Transporter|testosterone membrane transporter
4948297|NCT01867424|OATP1B3|oatp1b3
4948298|NCT01867424|Castration Resistant Prostate Cancer|castration resistant prostate cancer
4948299|NCT01867424|Prostatectomy|prostatectomy
4948300|NCT01867424|Gadolinium-Based Contrast Agent|gadolinium-based contrast agent
4948301|NCT01867411|Smoking Cessation|smoking cessation
4948302|NCT01867411|Biomarkers|biomarkers
4948303|NCT01867411|fMRI|fmri
4948304|NCT01867411|e-Cigarettes|e-cigarettes
4948305|NCT01867398|Conduct Disorder|conduct disorder
4948306|NCT01867398|Antipsychotic|antipsychotic
4948307|NCT01867398|Treatment Study|treatment study
4948308|NCT01867398|Functional Magnetic Resonance Imaging (fMRI)|functional magnetic resonance imaging (fmri)
4948309|NCT01867398|Adolescents|adolescents
4948310|NCT01867385|Fatigue|fatigue
4948311|NCT01867385|Chronic Hepatitis|chronic hepatitis
4948312|NCT01867385|Chronic Hepatitis B|chronic hepatitis b
4948313|NCT01867385|Chronic Hepatitis C|chronic hepatitis c
4948314|NCT01867385|Hepatitis|hepatitis
4948315|NCT01867372|Alzheimer's Disease|alzheimer's disease
4948316|NCT01867359|Alzheimer Disease|alzheimer disease
4948317|NCT01867359|Molecular|molecular
4948318|NCT01867359|Molecular Genetics|molecular genetics
4948319|NCT01867359|DNA|dna
4948320|NCT01867346|Cognition|cognition
4948321|NCT01867346|Aging|aging
4948322|NCT01867346|Cognitive Decline|cognitive decline
4948323|NCT01867346|Dementia|dementia
4948324|NCT01867346|Alzheimer's Disease|alzheimer's disease
4948325|NCT01867333|Immunotherapy|immunotherapy
4948326|NCT01867333|Gene Transfer|gene transfer
4948327|NCT01867333|Androgen Receptor Antagonist|androgen receptor antagonist
4948328|NCT01867333|PSA|psa
4948329|NCT01867333|Immune Response|immune response
4948330|NCT01867320|HTLV-1|htlv-1
4948331|NCT01867320|HTLV-1 Associated Myelopathy|htlv-1 associated myelopathy
4948332|NCT01867281|aspirin|aspirin
4948333|NCT01867281|asthma|asthma
4948334|NCT01867281|Aspirin desensitization|aspirin desensitization
4948335|NCT01867281|Aspirin induced asthma|aspirin induced asthma
4948336|NCT01867281|Immune System Diseases|immune system diseases
4948337|NCT01867281|Respiratory Hypersensitivity|respiratory hypersensitivity
4948338|NCT01867268|Acetazolamide administration|acetazolamide administration
4948339|NCT01867268|prone positioning|prone positioning
4948340|NCT01867268|Cerebrospinal fluid leakage|cerebrospinal fluid leakage
4948341|NCT01867268|Cerebrospinal fluid collection|cerebrospinal fluid collection
4948342|NCT01867268|wound dehiscence|wound dehiscence
4948343|NCT01867255|venlafaxine|venlafaxine
4948344|NCT01867255|Effexor|effexor
4948345|NCT01867255|antidepressive agent|antidepressive agent
4948346|NCT01867242|cigarette|cigarette
4948347|NCT01867242|snus|snus
4948348|NCT01867242|smoking|smoking
4948349|NCT01867242|tobacco|tobacco
4948350|NCT01867229|pre-menauposal|pre-menauposal
4948351|NCT01867229|neo-adjuvant or adjuvant chemotherapy|neo-adjuvant or adjuvant chemotherapy
4948352|NCT01867229|no metastases|no metastases
4948353|NCT01867190|CLI|cli
4948354|NCT01867177|HIV|hiv
4948355|NCT01867177|health care utilization|health care utilization
4948356|NCT01867177|HIV testing|hiv testing
4948357|NCT01867177|access to care|access to care
4948358|NCT01867164|Vaginitis|vaginitis
4948359|NCT01867164|Infectious vaginosis|infectious vaginosis
4948360|NCT01867164|Terconazole|terconazole
4948361|NCT01867164|Clindamycin|clindamycin
4948362|NCT01867164|Fluocinolone|fluocinolone
4948363|NCT01867164|Metronidazole|metronidazole
4948364|NCT01867164|Nystatin|nystatin
4948365|NCT01867151|Burning Mouth Syndrome|burning mouth syndrome
4948366|NCT01867151|Gluten|gluten
4948367|NCT01867151|Gluten Free Diet|gluten free diet
4948368|NCT01867138|Coagulase negative staphylococcus|coagulase negative staphylococcus
4948369|NCT01867138|nosocomial neonatal sepsis|nosocomial neonatal sepsis
4948370|NCT01867138|cefazolin|cefazolin
4948371|NCT01867138|vancomycin|vancomycin
4948372|NCT01867138|newborn|newborn
4948373|NCT01867086|ovarian cancer|ovarian cancer
4948374|NCT01867060|Cardiac monitoring|cardiac monitoring
4948375|NCT01867060|Biomarkers|biomarkers
4948376|NCT01867060|Transthoracic echocardiography|transthoracic echocardiography
4948377|NCT01867034|non ST segment myocardial infarction|non st segment myocardial infarction
4948378|NCT01867021|Trivalent inactivated subunit influenza vaccines|trivalent inactivated subunit influenza vaccines
4948379|NCT01867021|50 years and above|50 years and above
4948380|NCT01867021|healthy subjects|healthy subjects
4948381|NCT01866995|Ginseng|ginseng
4948382|NCT01866995|Prostatostasis|prostatostasis
4948383|NCT01866995|Erectile Dysfunction|erectile dysfunction
4948384|NCT01866982|umbilical cord milking|umbilical cord milking
4948385|NCT01866982|delayed cord clamping|delayed cord clamping
4948386|NCT01866943|Blood Loss|blood loss
4948387|NCT01866943|Tranexamic Acid|tranexamic acid
4948388|NCT01866943|Total Hip Arthroplasty|total hip arthroplasty
4948389|NCT01866943|Post Op|post op
4948390|NCT01866943|Post Operative|post operative
4948391|NCT01866943|Prevent Post Operative Blood Loss|prevent post operative blood loss
4948392|NCT01866917|Transversis Abdominis Plane Block|transversis abdominis plane block
4948393|NCT01866917|obese|obese
4948394|NCT01866917|robotic surgery|robotic surgery
4948395|NCT01866917|laparoscopic surgery|laparoscopic surgery
4948396|NCT01866904|Coronary artery disease, Myocardial infarction|coronary artery disease, myocardial infarction
4948397|NCT01866891|hemodialysis|hemodialysis
4948398|NCT01866891|microcirculation|microcirculation
4948399|NCT01866891|physical perdialytic activity|physical perdialytic activity
4948400|NCT01866891|cycling|cycling
4948401|NCT01866878|transcutaneous electrical nerve stimulation, sensitivity, multiple sclerosis,Reeducation through labor tactile discrimination|transcutaneous electrical nerve stimulation, sensitivity, multiple sclerosis,reeducation through labor tactile discrimination
4948403|NCT01866865|BRCA2|brca2
4948404|NCT01866852|Longitudinal Study|longitudinal study
4948405|NCT01866839|Acute Lymphoblastic Leukemia (ALL)|acute lymphoblastic leukemia (all)
4948406|NCT01866839|Acute Myelogenous Leukemia (AML)|acute myelogenous leukemia (aml)
4948407|NCT01866839|Chronic Lymphocytic Leukemia (CLL)|chronic lymphocytic leukemia (cll)
4948408|NCT01866839|Chronic Myelogenous Leukemia (CML)|chronic myelogenous leukemia (cml)
4948409|NCT01866839|Myelodyplastic Syndrome (MDS)|myelodyplastic syndrome (mds)
4948410|NCT01866826|HIV|hiv
4948411|NCT01866826|Eradication Strategies|eradication strategies
4948412|NCT01866826|Immune Activation|immune activation
4948413|NCT01866813|breast cancer|breast cancer
4948414|NCT01866813|cancer survivors|cancer survivors
4948415|NCT01866800|TAVI|tavi
4948416|NCT01866800|TAVR|tavr
4948417|NCT01866800|CIN|cin
4948418|NCT01866800|AKI|aki
4948419|NCT01866787|Postoperative orthostatic intolerance|postoperative orthostatic intolerance
4948420|NCT01866787|Surgical inflammatory response|surgical inflammatory response
4948421|NCT01866722|nicotine dependence|nicotine dependence
4948422|NCT01866722|smoking cessation|smoking cessation
4948423|NCT01866722|lapse|lapse
4948424|NCT01866722|relapse|relapse
4948425|NCT01866722|tobacco|tobacco
4948426|NCT01866722|quit attempts|quit attempts
4948427|NCT01866722|abstinence|abstinence
4948428|NCT01866722|motivation|motivation
4948429|NCT01866722|reduction|reduction
4948430|NCT01866696|Computer assisted implant surgery,|computer assisted implant surgery,
4948431|NCT01866696|Immediate loading,|immediate loading,
4948432|NCT01866696|CAD/CAM|cad/cam
4948433|NCT01866683|Yoga|yoga
4948434|NCT01866683|Electroencephalography|electroencephalography
4948435|NCT01866683|Heart rate variability|heart rate variability
4948436|NCT01866683|Breathing Exercises|breathing exercises
4948437|NCT01866683|Quality of life|quality of life
4948438|NCT01866670|spiritual distress|spiritual distress
4948439|NCT01866670|nursing|nursing
4948440|NCT01866670|breast neoplasms|breast neoplasms
4948441|NCT01866657|cerebral oximetry|cerebral oximetry
4948442|NCT01866657|randomized controlled pilot study|randomized controlled pilot study
4948443|NCT01866657|thoracic surgery|thoracic surgery
4948444|NCT01866657|single lung ventilation|single lung ventilation
4948445|NCT01866644|Liver transplantation, n-acetylcysteine|liver transplantation, n-acetylcysteine
4948446|NCT01866618|Natural|natural
4948447|NCT01866618|IVF Cycle|ivf cycle
4948448|NCT01866605|anxiety|anxiety
4948449|NCT01866605|midazolam|midazolam
4948450|NCT01866605|forced-air warming|forced-air warming
4948451|NCT01866592|Psoriasis|psoriasis
4948452|NCT01866592|Cardiovascular Disease|cardiovascular disease
4948453|NCT01866592|Vascular Inflammation|vascular inflammation
4948454|NCT01866592|Lipid Biomarkers|lipid biomarkers
4948455|NCT01866592|Metabolic biomarkers|metabolic biomarkers
4948456|NCT01866592|FDG-PET/CT|fdg-pet/ct
4948457|NCT01866579|Retinal Nerve Fiber Layer Thickness, Optical Coherence Tomography, Ethambutol optic neuropathy|retinal nerve fiber layer thickness, optical coherence tomography, ethambutol optic neuropathy
4948458|NCT01866553|CML|cml
4948459|NCT01866553|suboptimal molecular response|suboptimal molecular response
4948460|NCT01866553|nilotinib|nilotinib
4948461|NCT01866553|pegylated interferon α2b|pegylated interferon α2b
4948462|NCT01866540|influenza, LAIV, immune response|influenza, laiv, immune response
4948463|NCT01866527|Developmental dysplasia of the hip,|developmental dysplasia of the hip,
4948464|NCT01866527|DDH,|ddh,
4948465|NCT01866527|avascular necrosis,|avascular necrosis,
4948466|NCT01866527|late detected cases|late detected cases
4948467|NCT01866514|EZ-IO|ez-io
4948468|NCT01866514|IO|io
4948469|NCT01866514|Intraosseous Vascular Access|intraosseous vascular access
4948470|NCT01866501|Intraosseous Vascular Access|intraosseous vascular access
4948471|NCT01866501|IO Access|io access
4948472|NCT01866501|IO Vascular Access|io vascular access
4948473|NCT01866501|EZ-IO|ez-io
4948474|NCT01866488|Labor induction|labor induction
4948477|NCT01866488|Cook Obstetric Double Balloon Catheter|cook obstetric double balloon catheter
4948478|NCT01866475|IO access|io access
4948479|NCT01866475|Intraosseous vascular access|intraosseous vascular access
4948480|NCT01866475|EZ-IO|ez-io
4948481|NCT01866436|Cognitive skills|cognitive skills
4948482|NCT01866436|Multimedia|multimedia
4948483|NCT01866436|Education|education
4948484|NCT01866436|Colorectal surgery|colorectal surgery
4948485|NCT01866397|cidofovir|cidofovir
4948486|NCT01866397|cvvh|cvvh
4948487|NCT01866397|renal replacement therapy|renal replacement therapy
4948488|NCT01866397|HCMV|hcmv
4948489|NCT01866397|Pharmacokinetics of cidofovir during CVVH|pharmacokinetics of cidofovir during cvvh
4948490|NCT01866397|continuous venovenous hemofiltration|continuous venovenous hemofiltration
4948491|NCT01866371|Retina|retina
4948492|NCT01866371|imaging|imaging
4948493|NCT01866371|retinal degeneration|retinal degeneration
4948494|NCT01866345|orthodontics|orthodontics
4948495|NCT01866345|Tooth Movement|tooth movement
4948496|NCT01866345|Bone Remodeling|bone remodeling
4948497|NCT01866345|Mandible|mandible
4948498|NCT01866345|Osteotomy|osteotomy
4948499|NCT01866332|back pain|back pain
4948500|NCT01866332|tape|tape
4948501|NCT01866332|chronic|chronic
4948502|NCT01866319|PD-1|pd-1
4948503|NCT01866319|PD1|pd1
4948504|NCT01866319|PD-L1|pd-l1
4948505|NCT01866319|PDL1|pdl1
4948506|NCT01866293|Cabozantinib (XL184)|cabozantinib (xl184)
4948507|NCT01866293|12-240|12-240
4948508|NCT01866280|Sleep|sleep
4948509|NCT01866280|Sleep duration|sleep duration
4948510|NCT01866280|Meals|meals
4948511|NCT01866280|Food intake|food intake
4948512|NCT01866280|Obesity|obesity
4948513|NCT01866267|Human Immunodeficiency Virus|human immunodeficiency virus
4948514|NCT01866267|AIDS|aids
4948515|NCT01866254|Hydromorphone|hydromorphone
4948516|NCT01866254|Morphine|morphine
4948517|NCT01866254|cesarean delivery|cesarean delivery
4948518|NCT01866254|pain management|pain management
4948519|NCT01866254|respiratory depression|respiratory depression
4948520|NCT01866228|Consultation Recording|consultation recording
4948521|NCT01866228|Brain Tumor|brain tumor
4948522|NCT01866228|Neuroendocrine Cancer|neuroendocrine cancer
4948523|NCT01866228|Quality of Life|quality of life
4948524|NCT01866228|Patient Satisfaction|patient satisfaction
4948525|NCT01866215|gluconeogenesis|gluconeogenesis
4948526|NCT01866215|de novo lipogenesis|de novo lipogenesis
4948527|NCT01866215|intramyocellular lipids|intramyocellular lipids
4948528|NCT01866215|muscle glycogen|muscle glycogen
4948529|NCT01866215|fructose|fructose
4948530|NCT01866189|ischemic stroke|ischemic stroke
4948531|NCT01866189|hypoxic tissues|hypoxic tissues
4948532|NCT01866189|F-MISO uptake|f-miso uptake
4948533|NCT01866189|Magnetic Resonance Imaging|magnetic resonance imaging
4948534|NCT01866189|F-MISO Positon Emission Tomography|f-miso positon emission tomography
4948535|NCT01866137|Copeptin|copeptin
4948536|NCT01866137|psychological stress|psychological stress
4948537|NCT01866137|The Trier Social Stress Test (TSST)|the trier social stress test (tsst)
4948538|NCT01866124|acute malnutrition|acute malnutrition
4948539|NCT01866124|multiannual and seasonal cash transfers|multiannual and seasonal cash transfers
4948540|NCT01866124|safety nets|safety nets
4948541|NCT01866124|Burkina Faso|burkina faso
4948542|NCT01866098|antipsychotic|antipsychotic
4948543|NCT01866098|severe mental illness|severe mental illness
4948544|NCT01866098|weight loss|weight loss
4948545|NCT01866085|stress urinary incontinence|stress urinary incontinence
4948546|NCT01866085|post prostatectomy|post prostatectomy
4948547|NCT01866072|ACLF|aclf
4948548|NCT01866072|AVH|avh
4948549|NCT01866072|Fibroscan|fibroscan
4948550|NCT01866072|Transient elastography|transient elastography
4948551|NCT01866059|root caries|root caries
4948552|NCT01866059|GIC|gic
4948553|NCT01866059|RMGIC|rmgic
4948554|NCT01866059|Biodentine|biodentine
4948555|NCT01866059|Calcium silicate|calcium silicate
4948556|NCT01866046|battered women|battered women
4948557|NCT01866046|HIV risk|hiv risk
4948558|NCT01866046|STI risk|sti risk
4948559|NCT01866033|Healthy volunteer|healthy volunteer
4948560|NCT01866033|PCI-32765|pci-32765
4948561|NCT01866033|PCI 45227|pci 45227
4948562|NCT01866033|13C6 PCI-32765|13c6 pci-32765
4948563|NCT01866033|Pharmacokinetic|pharmacokinetic
4948564|NCT01866033|Bioavailability|bioavailability
4948565|NCT01866020|aspergillosis|aspergillosis
4948566|NCT01866020|fungal infection|fungal infection
4948567|NCT01866020|ICU|icu
4948568|NCT01866007|Healthy|healthy
4948569|NCT01866007|Guselkumab|guselkumab
4948570|NCT01866007|CNTO1959|cnto1959
4948571|NCT01866007|Pharmacokinetics|pharmacokinetics
4948572|NCT01866007|UltraSafe Passive Delivery System (PFS-U)|ultrasafe passive delivery system (pfs-u)
4948573|NCT01866007|Prefilled syringe facilitated injection device (PFS FID)|prefilled syringe facilitated injection device (pfs fid)
4948574|NCT01865994|Cardiac Output|cardiac output
4948575|NCT01865994|esCCO|escco
4948576|NCT01865994|TEE|tee
4948577|NCT01865994|Pediatric cardiac surgery|pediatric cardiac surgery
4948578|NCT01865981|iPS cells|ips cells
4948579|NCT01865981|cardiomyocytes|cardiomyocytes
4948580|NCT01865981|Brugada|brugada
4949277|NCT01863069|inhaled|inhaled
4948581|NCT01865981|Ventricular Fibrillation|ventricular fibrillation
4948582|NCT01865981|electrophysiology|electrophysiology
4948583|NCT01865968|inactivated HAV vaccine; live attenuated HAV vaccine; immunogenicity; safety|inactivated hav vaccine; live attenuated hav vaccine; immunogenicity; safety
4948584|NCT01865955|Ultrasound|ultrasound
4948585|NCT01865955|Spinal anesthesia|spinal anesthesia
4948586|NCT01865955|Cesarean section|cesarean section
4948587|NCT01865942|spinal metastases|spinal metastases
4948588|NCT01865942|spine surgery|spine surgery
4948589|NCT01865942|metastatic spinal cord compression|metastatic spinal cord compression
4948590|NCT01865942|EQ-5D|eq-5d
4948591|NCT01865942|HRQOL|hrqol
4948592|NCT01865903|NSCLC|nsclc
4948593|NCT01865903|sarcopenia|sarcopenia
4948594|NCT01865903|cachexia|cachexia
4948595|NCT01865890|Plavix or clopidogrel resistance|plavix or clopidogrel resistance
4948596|NCT01865877|Parkinson's disease|parkinson's disease
4948597|NCT01865877|Motor|motor
4948598|NCT01865877|Non-motor|non-motor
4948599|NCT01865877|Progression|progression
4948600|NCT01865877|Complications|complications
4948601|NCT01865864|CPAP|cpap
4948602|NCT01865864|diurnal blood pressure|diurnal blood pressure
4948603|NCT01865864|obstructive sleep apnea|obstructive sleep apnea
4948604|NCT01865864|24 hour blood pressure monitor|24 hour blood pressure monitor
4948605|NCT01865851|Inspired oxygen|inspired oxygen
4948606|NCT01865851|end-tidal oxygen|end-tidal oxygen
4948607|NCT01865851|end-tidal carbon dioxide|end-tidal carbon dioxide
4948608|NCT01865851|respiratory rate|respiratory rate
4948609|NCT01865851|preoxygenation|preoxygenation
4948610|NCT01865851|classic face mask|classic face mask
4948611|NCT01865851|NuMask|numask
4948612|NCT01865838|Total thyroidectomy|total thyroidectomy
4948613|NCT01865838|Seprafilm|seprafilm
4948614|NCT01865838|Swallowing difficulty post thyroidectomy|swallowing difficulty post thyroidectomy
4948615|NCT01865825|Erosive Esophagitis|erosive esophagitis
4948616|NCT01865825|Gastroesophageal reflux disease|gastroesophageal reflux disease
4948617|NCT01865799|FTC/TDF|ftc/tdf
4948618|NCT01865799|PrEP|prep
4948619|NCT01865799|Truvada|truvada
4948620|NCT01865799|Drug utilization|drug utilization
4948621|NCT01865786|FTC/TDF|ftc/tdf
4948622|NCT01865786|Truvada|truvada
4948623|NCT01865786|PrEP|prep
4948624|NCT01865786|Antiretroviral Pregnancy Registry|antiretroviral pregnancy registry
4948625|NCT01865760|Glucagon like peptide 1|glucagon like peptide 1
4948626|NCT01865760|Insulin secretion|insulin secretion
4948627|NCT01865760|Hypoglycemia|hypoglycemia
4948628|NCT01865747|renal cell cancer|renal cell cancer
4948629|NCT01865747|kidney|kidney
4948630|NCT01865747|vascular endothelial growth factor receptor 2 (VEGFR2)|vascular endothelial growth factor receptor 2 (vegfr2)
4948631|NCT01865747|tyrosine kinase inhibitor|tyrosine kinase inhibitor
4948632|NCT01865747|hepatocyte growth factor receptor protein (MET)|hepatocyte growth factor receptor protein (met)
4948633|NCT01865747|von Hippel-Lindau gene|von hippel-lindau gene
4948634|NCT01865734|Fasciitis, Plantar|fasciitis, plantar
4948635|NCT01865734|Heel Pain|heel pain
4948636|NCT01865734|Physical Therapy|physical therapy
4948637|NCT01865734|Podiatry|podiatry
4948638|NCT01865734|Musculoskeletal Manipulations|musculoskeletal manipulations
4948639|NCT01865734|Exercise Therapy|exercise therapy
4948640|NCT01865721|Bowel cancer screening|bowel cancer screening
4948641|NCT01865721|Analgesia|analgesia
4948642|NCT01865721|Entonox|entonox
4948643|NCT01865721|Pain|pain
4948644|NCT01865721|Side effects|side effects
4948645|NCT01865721|Colonoscopy|colonoscopy
4948646|NCT01865708|Ethanol Lock|ethanol lock
4948647|NCT01865708|Alcohol lock|alcohol lock
4948648|NCT01865708|Urinary catheter|urinary catheter
4948649|NCT01865708|Safety|safety
4948650|NCT01865695|pancreatic exocrine insufficiency|pancreatic exocrine insufficiency
4948651|NCT01865695|faecal elastase|faecal elastase
4948652|NCT01865695|diarrhoea|diarrhoea
4948653|NCT01865695|coeliac|coeliac
4948654|NCT01865695|creon|creon
4948655|NCT01865695|gastrointestinal|gastrointestinal
4948656|NCT01865682|Ankle|ankle
4948657|NCT01865682|Knee|knee
4948658|NCT01865682|Orthosis|orthosis
4948659|NCT01865682|Kinematics|kinematics
4948660|NCT01865682|Kinetics|kinetics
4948661|NCT01865669|Uterine contraction|uterine contraction
4948662|NCT01865669|Dose response|dose response
4948663|NCT01865669|Oxytocin|oxytocin
4948664|NCT01865656|provider skill and self-efficacy|provider skill and self-efficacy
4948665|NCT01865656|Appropriate and timely referral for obstetric emergencies|appropriate and timely referral for obstetric emergencies
4948666|NCT01865656|Intervention feasibility and acceptability|intervention feasibility and acceptability
4948667|NCT01865643|Laryngoscopy|laryngoscopy
4948668|NCT01865643|Intubation|intubation
4948669|NCT01865643|Glidescope|glidescope
4948670|NCT01865630|Prophylactic treatment with Etanercept in aSAH.|prophylactic treatment with etanercept in asah.
4948671|NCT01865630|Safety of Etanercept in the prevention of DCI in aSAH.|safety of etanercept in the prevention of dci in asah.
4948672|NCT01865591|hypertension|hypertension
4948673|NCT01865591|uncontrolled hypertension|uncontrolled hypertension
4948674|NCT01865591|resistant hypertension|resistant hypertension
4948675|NCT01865565|gastrointestinal stromal tumor|gastrointestinal stromal tumor
4948676|NCT01865565|GIST|gist
4948679|NCT01865552|Pharmacokinetics|pharmacokinetics
4948680|NCT01865539|Chronic lower back pain|chronic lower back pain
4948681|NCT01865539|Custom foot orthotics|custom foot orthotics
4948682|NCT01865539|Veterans|veterans
4948683|NCT01865526|Chronic kidney disease|chronic kidney disease
4948684|NCT01865526|Low protein diet|low protein diet
4948685|NCT01865526|CKD stage 3b-5|ckd stage 3b-5
4948686|NCT01865513|Anaesthesia|anaesthesia
4948687|NCT01865513|Anaesthesiology|anaesthesiology
4948688|NCT01865513|muscle Relaxants|muscle relaxants
4948689|NCT01865513|POPULAR|popular
4948690|NCT01865513|postoperative pulmonary complications|postoperative pulmonary complications
4948691|NCT01865513|Respiratory failure|respiratory failure
4948692|NCT01865513|Suspected pulmonary infection|suspected pulmonary infection
4948693|NCT01865513|Pulmonary infiltrates|pulmonary infiltrates
4948694|NCT01865513|Pleural effusion|pleural effusion
4948695|NCT01865513|Atelectasis|atelectasis
4948696|NCT01865513|Pneumothorax|pneumothorax
4948697|NCT01865513|Bronchospasm|bronchospasm
4948698|NCT01865513|Aspiration pneumonitis|aspiration pneumonitis
4948699|NCT01865513|Cardiopulmonary oedema|cardiopulmonary oedema
4948700|NCT01865513|European Society of Anaesthesiology|european society of anaesthesiology
4948701|NCT01865513|neuromuscular blockade|neuromuscular blockade
4948702|NCT01865513|europe|europe
4948703|NCT01865500|COPD exacerbation|copd exacerbation
4948704|NCT01865500|Nebulized budesonide|nebulized budesonide
4948705|NCT01865500|Parenteral steroid|parenteral steroid
4948706|NCT01865487|BCG Vaccinated|bcg vaccinated
4948707|NCT01865487|HIV Negative|hiv negative
4948708|NCT01865474|DLBS1033, Type 2 DM, fibrinolytic, hypercoagulation|dlbs1033, type 2 dm, fibrinolytic, hypercoagulation
4948709|NCT01865461|Magnetic Resonance Imaging|magnetic resonance imaging
4948710|NCT01865448|Docosahexaenoic Acids|docosahexaenoic acids
4948711|NCT01865448|Fatty Acids, Omega-3|fatty acids, omega-3
4948712|NCT01865448|Obesity|obesity
4948713|NCT01865448|Inflammation|inflammation
4948714|NCT01865409|Newborn|newborn
4948715|NCT01865409|Prematures|prematures
4948716|NCT01865409|Feeding difficulty|feeding difficulty
4948717|NCT01865409|Kangaroo Care|kangaroo care
4948718|NCT01865409|Heart rate variability|heart rate variability
4948719|NCT01865266|ventilator-associated pneumonia|ventilator-associated pneumonia
4948720|NCT01865266|mechanical ventilation|mechanical ventilation
4948721|NCT01865266|ulinastatin for injection|ulinastatin for injection
4948722|NCT01865266|bronchoalveolar lavage fluid|bronchoalveolar lavage fluid
4948723|NCT01865266|inflammatory factors|inflammatory factors
4948724|NCT01865253|renal denervation|renal denervation
4948725|NCT01865253|blood pressure|blood pressure
4948726|NCT01865253|cardiovascular risk|cardiovascular risk
4948727|NCT01865253|target organ damage|target organ damage
4948728|NCT01865253|sympathetic activity|sympathetic activity
4948729|NCT01865253|chronic kidney disease|chronic kidney disease
4948730|NCT01865253|non-compliance|non-compliance
4948731|NCT01865240|renal denervation|renal denervation
4948732|NCT01865240|blood pressure|blood pressure
4948733|NCT01865240|cardiovascular risk|cardiovascular risk
4948734|NCT01865240|target organ damage|target organ damage
4948735|NCT01865240|sympathetic activity|sympathetic activity
4948736|NCT01865227|Obesity|obesity
4948737|NCT01865227|Bariatric surgery|bariatric surgery
4948738|NCT01865227|Binge Eating Disorder|binge eating disorder
4948739|NCT01865227|Psychological Health|psychological health
4948740|NCT01865227|Counselling|counselling
4948741|NCT01865201|Radiotherapy|radiotherapy
4948742|NCT01865201|Radiation-induced brain necrosis|radiation-induced brain necrosis
4948743|NCT01865201|Edaravone|edaravone
4948744|NCT01865201|Effectiveness|effectiveness
4948745|NCT01865201|Safety|safety
4948746|NCT01865188|LCZ696,|lcz696,
4948747|NCT01865188|amlodipine,|amlodipine,
4948748|NCT01865188|hypertension,|hypertension,
4948749|NCT01865188|ABPM|abpm
4948750|NCT01865162|Glioblastoma multiforme, ketogenic diet, neoplasm|glioblastoma multiforme, ketogenic diet, neoplasm
4948751|NCT01865149|Child|child
4948752|NCT01865149|Optic nerve sheath diameter|optic nerve sheath diameter
4948753|NCT01865149|Hydrocephalus|hydrocephalus
4948754|NCT01865149|Intracranial hypertension|intracranial hypertension
4948755|NCT01865123|post-traumatic stress disorder|post-traumatic stress disorder
4948756|NCT01865123|transcendental meditation|transcendental meditation
4948757|NCT01865123|cognitive behavioral therapy|cognitive behavioral therapy
4948758|NCT01865123|prolonged exposure|prolonged exposure
4948759|NCT01865110|Mantle Cell Lymphoma|mantle cell lymphoma
4948760|NCT01865110|RCHOP|rchop
4948761|NCT01865110|RHAD|rhad
4948762|NCT01865110|rituximab|rituximab
4948763|NCT01865110|lenalidomide|lenalidomide
4948764|NCT01865097|Imagery|imagery
4948765|NCT01865097|Pain|pain
4948766|NCT01865097|Depression|depression
4948767|NCT01865097|Non-Motor|non-motor
4948768|NCT01865071|ileostomy|ileostomy
4948769|NCT01865071|rectal resection|rectal resection
4948770|NCT01865071|proctectomy|proctectomy
4948771|NCT01865071|stoma closure|stoma closure
4948772|NCT01865071|rectal cancer|rectal cancer
4948773|NCT01864993|non celiac gluten sensitivity|non celiac gluten sensitivity
4948774|NCT01864993|gluten|gluten
4948775|NCT01864993|irritable bowel syndrome|irritable bowel syndrome
4949668|NCT01861158|Parenting|parenting
4948776|NCT01864993|functional disorders|functional disorders
4948777|NCT01864967|carbon dioxide infusion|carbon dioxide infusion
4948778|NCT01864967|dilatation of peripheral blood vessels|dilatation of peripheral blood vessels
4948779|NCT01864967|capillaries|capillaries
4948780|NCT01864967|macrophags|macrophags
4948781|NCT01864967|fibroblasts|fibroblasts
4948782|NCT01864967|Improvement granulation tissue in chronic wounds|improvement granulation tissue in chronic wounds
4948783|NCT01864954|Smoking|smoking
4948784|NCT01864954|Postpartum|postpartum
4948785|NCT01864954|Pregnancy|pregnancy
4948786|NCT01864954|Quit|quit
4948787|NCT01864954|Tobacco|tobacco
4948788|NCT01864954|Abstinence|abstinence
4948789|NCT01864954|Relapse|relapse
4948790|NCT01864954|Relapse prevention|relapse prevention
4948791|NCT01864941|Multiple Sclerosis|multiple sclerosis
4948792|NCT01864941|MS|ms
4948793|NCT01864941|CCSVI|ccsvi
4948794|NCT01864941|Zamboni|zamboni
4948795|NCT01864941|catheter venography|catheter venography
4948796|NCT01864941|balloon angioplasty|balloon angioplasty
4948797|NCT01864928|Acute Ischemic stroke|acute ischemic stroke
4948798|NCT01864928|ePRISM|eprism
4948799|NCT01864915|colon capsule|colon capsule
4948800|NCT01864915|bowel preparation|bowel preparation
4948801|NCT01864915|booster|booster
4948802|NCT01864915|prucalopride|prucalopride
4948803|NCT01864915|picosalax|picosalax
4948804|NCT01864902|CD33 positive acute myeloid leukemia (AML)|cd33 positive acute myeloid leukemia (aml)
4948805|NCT01864850|HNSCC|hnscc
4948806|NCT01864850|Elderly|elderly
4948807|NCT01864850|Geriatry|geriatry
4948808|NCT01864837|tongue coating thickness|tongue coating thickness
4948809|NCT01864837|tongue diagnosis system|tongue diagnosis system
4948810|NCT01864837|tongue coating percentage|tongue coating percentage
4948811|NCT01864837|availability|availability
4948812|NCT01864837|diagnostic device|diagnostic device
4948813|NCT01864824|air pollution|air pollution
4948814|NCT01864824|particulate matter 2.5 (PM2.5)|particulate matter 2.5 (pm2.5)
4948815|NCT01864824|methyl donor|methyl donor
4948816|NCT01864824|DNA methylation|dna methylation
4948817|NCT01864824|mRNA|mrna
4948818|NCT01864824|epigenetics|epigenetics
4948819|NCT01864824|controlled human exposures|controlled human exposures
4948820|NCT01864824|cardiovascular responses|cardiovascular responses
4948821|NCT01864811|infants|infants
4948822|NCT01864811|unilateral cerebral pares|unilateral cerebral pares
4948823|NCT01864811|hand function|hand function
4948824|NCT01864811|early intervention|early intervention
4948825|NCT01864811|constraint induced movement therapy|constraint induced movement therapy
4948826|NCT01864798|Young|young
4948827|NCT01864798|Breast Neoplasms|breast neoplasms
4948828|NCT01864798|Denosumab|denosumab
4948829|NCT01864798|RANKL|rankl
4948830|NCT01864785|Operative treatment|operative treatment
4948831|NCT01864785|internal fixation|internal fixation
4948832|NCT01864785|posterior spinal fusion|posterior spinal fusion
4948833|NCT01864772|HNSCC|hnscc
4948834|NCT01864772|Metastatic|metastatic
4948835|NCT01864772|Recurrent|recurrent
4948836|NCT01864772|Elderly|elderly
4948837|NCT01864772|Geriatry|geriatry
4948838|NCT01864759|melanoma|melanoma
4948839|NCT01864759|oncolytic|oncolytic
4948840|NCT01864759|adenovirus|adenovirus
4948841|NCT01864759|virotherapy|virotherapy
4948842|NCT01864759|locally advanced|locally advanced
4948843|NCT01864759|metastatic|metastatic
4948844|NCT01864733|Chronic heart failure|chronic heart failure
4948845|NCT01864733|Undernutrition|undernutrition
4948846|NCT01864733|Rehabilitation|rehabilitation
4948847|NCT01864733|Physical exercise|physical exercise
4948848|NCT01864733|Nutrition|nutrition
4948849|NCT01864733|n-3 fatty acids|n-3 fatty acids
4948850|NCT01864733|Androgen|androgen
4948851|NCT01864733|Testosterone|testosterone
4948852|NCT01864720|stepped care model|stepped care model
4948853|NCT01864720|insomnia|insomnia
4948854|NCT01864720|cancer|cancer
4948855|NCT01864720|cognitive-behavioural therapy|cognitive-behavioural therapy
4948856|NCT01864720|self-help treatment|self-help treatment
4948857|NCT01864720|Internet|internet
4948858|NCT01864720|non-inferiority design|non-inferiority design
4948859|NCT01864720|cost-effectiveness|cost-effectiveness
4948860|NCT01864707|multiple sclerosis, fatigue|multiple sclerosis, fatigue
4948861|NCT01864694|behavioral research|behavioral research
4948862|NCT01864694|diet|diet
4948863|NCT01864694|health information systems|health information systems
4948864|NCT01864681|NSCLC|nsclc
4948865|NCT01864681|TKIs|tkis
4948866|NCT01864681|Metformin|metformin
4948867|NCT01864681|PFS|pfs
4948868|NCT01864681|overall survival|overall survival
4948869|NCT01864681|IL-6|il-6
4948870|NCT01864668|Acute respiratory distress syndrome|acute respiratory distress syndrome
4948871|NCT01864668|lung strain|lung strain
4948872|NCT01864668|small tidal volume|small tidal volume
4948873|NCT01864616|Vitamin D|vitamin d
4948874|NCT01864616|Crohn disease|crohn disease
4948875|NCT01864616|Disease activity|disease activity
4948876|NCT01864616|Inflammation|inflammation
4948877|NCT01864616|prevention|prevention
4948878|NCT01864603|HIV treatment and prevention|hiv treatment and prevention
4948879|NCT01864603|Tuberculosis|tuberculosis
4949669|NCT01861158|Adolescence|adolescence
4948880|NCT01864603|Community health campaign|community health campaign
4948881|NCT01864603|PrEP|prep
4948882|NCT01864590|Open Abdomen|open abdomen
4948883|NCT01864590|Negative Pressure Wound Therapy|negative pressure wound therapy
4948884|NCT01864590|Temporary Abdominal Closure|temporary abdominal closure
4948885|NCT01864590|Mesh|mesh
4948886|NCT01864590|Abdominal reconstruction|abdominal reconstruction
4948887|NCT01864564|Gestational diabetes|gestational diabetes
4948888|NCT01864564|Screening|screening
4948889|NCT01864564|Obesity|obesity
4948890|NCT01864564|Anhydroglucitol|anhydroglucitol
4948891|NCT01864538|TH-302|th-302
4948892|NCT01864538|Advanced Melanoma|advanced melanoma
4948893|NCT01864538|Metastatic|metastatic
4948894|NCT01864538|Biomarker|biomarker
4948895|NCT01864538|Mucosal Melanoma|mucosal melanoma
4948896|NCT01864538|Evofosfamide|evofosfamide
4948897|NCT01864525|voice|voice
4948898|NCT01864525|tremor|tremor
4948899|NCT01864525|essential tremor|essential tremor
4948900|NCT01864525|essential voice tremor|essential voice tremor
4948901|NCT01864525|voice treatment|voice treatment
4948902|NCT01864525|octanoic acid|octanoic acid
4948903|NCT01864525|octanol|octanol
4948904|NCT01864525|voice disorder|voice disorder
4948905|NCT01864525|dysphonia|dysphonia
4948906|NCT01864512|Immune Thrombocytopenia|immune thrombocytopenia
4948907|NCT01864512|eltrombopag|eltrombopag
4948908|NCT01864512|immune regulation|immune regulation
4948909|NCT01864473|Fistula , Bhagandar|fistula , bhagandar
4948910|NCT01864460|autonomic|autonomic
4948911|NCT01864460|neuropathy|neuropathy
4948912|NCT01864460|balance|balance
4948913|NCT01864460|exercise|exercise
4948914|NCT01864447|VTE|vte
4948915|NCT01864447|Exercise|exercise
4948916|NCT01864447|Diet|diet
4948917|NCT01864447|Weight loss|weight loss
4948918|NCT01864447|DVT|dvt
4948919|NCT01864447|PE|pe
4948920|NCT01864434|Knee Prosthesis|knee prosthesis
4948921|NCT01864434|Total Knee Arthroplasty|total knee arthroplasty
4948922|NCT01864434|Cruciate Retaining|cruciate retaining
4948923|NCT01864434|Posterior Cruciate Retaining|posterior cruciate retaining
4948924|NCT01864421|Infant, Newborn|infant, newborn
4948925|NCT01864421|Delivery, Obstetric|delivery, obstetric
4948926|NCT01864421|Umbilical Cord|umbilical cord
4948927|NCT01864408|Patient counseling|patient counseling
4948928|NCT01864408|Patient satisfaction|patient satisfaction
4948929|NCT01864408|Pelvic organ prolapse|pelvic organ prolapse
4948930|NCT01864395|cardiovascular surgery|cardiovascular surgery
4948931|NCT01864395|cardiac surgery|cardiac surgery
4948932|NCT01864395|cardiopulmonary bypass|cardiopulmonary bypass
4948933|NCT01864395|IV fluids|iv fluids
4948934|NCT01864395|blood pressure|blood pressure
4948935|NCT01864395|heart-lung machine|heart-lung machine
4948936|NCT01864395|hemofilter|hemofilter
4948937|NCT01864395|online MUF|online muf
4948938|NCT01864395|offline MUF|offline muf
4948939|NCT01864395|modified ultrafiltration|modified ultrafiltration
4948940|NCT01864395|multiple-pass hemofiltration|multiple-pass hemofiltration
4948941|NCT01864395|centrifugation method|centrifugation method
4948942|NCT01864395|blood transfusion|blood transfusion
4948943|NCT01864395|plasma proteins|plasma proteins
4948944|NCT01864395|post-cardiopulmonary bypass|post-cardiopulmonary bypass
4948945|NCT01864395|hemoglobin|hemoglobin
4948946|NCT01864395|clotting factors|clotting factors
4948947|NCT01864395|systemic blood pressure|systemic blood pressure
4948948|NCT01864395|cardiac index|cardiac index
4948949|NCT01864395|cytokines|cytokines
4948950|NCT01864395|post-operative bleeding|post-operative bleeding
4948951|NCT01864395|protamine administration|protamine administration
4948952|NCT01864395|patient size|patient size
4948953|NCT01864395|allogeneic transfusion|allogeneic transfusion
4948954|NCT01864395|total protein|total protein
4948955|NCT01864395|albumin|albumin
4948956|NCT01864395|vasoactive inotrope score|vasoactive inotrope score
4948957|NCT01864395|fluid balance|fluid balance
4948958|NCT01864395|chest tube loss|chest tube loss
4948959|NCT01864395|length of stay|length of stay
4948960|NCT01864395|ventilation time|ventilation time
4948961|NCT01864395|markers of inflammation|markers of inflammation
4948962|NCT01864382|Trunk performance|trunk performance
4948963|NCT01864382|exercise,|exercise,
4948964|NCT01864382|"core stability,"|"core stability,"
4948965|NCT01864382|sitting balance|sitting balance
4948966|NCT01864369|Heart Failure|heart failure
4948967|NCT01864369|e-counseling|e-counseling
4948968|NCT01864369|quality of life|quality of life
4948969|NCT01864369|self-care|self-care
4948970|NCT01864356|IVF failure|ivf failure
4948971|NCT01864356|Repeated IVF failure|repeated ivf failure
4948972|NCT01864356|Implantation failure|implantation failure
4948973|NCT01864356|Repeated implantation failure|repeated implantation failure
4948974|NCT01864356|IVF|ivf
4948975|NCT01864356|NT100|nt100
4948976|NCT01864343|Myocardial Infarction|myocardial infarction
4948977|NCT01864343|Myocardial Reperfusion Injury|myocardial reperfusion injury
4948978|NCT01864343|Reperfusion Injury|reperfusion injury
4948979|NCT01864343|Anterior Wall Myocardial Infarction|anterior wall myocardial infarction
4948980|NCT01864343|Inferior Wall Myocardial Infarction|inferior wall myocardial infarction
4948981|NCT01864343|Myocardial Ischemia|myocardial ischemia
4948982|NCT01864330|topical lubricants|topical lubricants
4948983|NCT01864330|optical coherence tomography|optical coherence tomography
4948984|NCT01864330|tear break up time|tear break up time
4948985|NCT01864330|Schirmer I test|schirmer i test
4948986|NCT01864317|7-Tesla Magnetic Resonance Imaging|7-tesla magnetic resonance imaging
4948987|NCT01864317|Intraocular Pressure|intraocular pressure
4948988|NCT01864317|Retinal Nerve Fiber Thickness|retinal nerve fiber thickness
4948989|NCT01864317|Visual Field Test|visual field test
4948990|NCT01864304|Williams Syndrome|williams syndrome
4948991|NCT01864291|Auditory Brainstem Implant|auditory brainstem implant
4948992|NCT01864291|ABI|abi
4948993|NCT01864291|Nucleus 24|nucleus 24
4948994|NCT01864291|Deafness|deafness
4948995|NCT01864291|Hearing loss|hearing loss
4948996|NCT01864291|Non-tumor|non-tumor
4948997|NCT01864291|Non-NF2|non-nf2
4948998|NCT01864291|Pediatric|pediatric
4948999|NCT01864291|ABI541|abi541
4949000|NCT01864265|Rheumatoid arthritis|rheumatoid arthritis
4949001|NCT01864265|functional MRI|functional mri
4949002|NCT01864265|Prediction of Response|prediction of response
4949003|NCT01864265|Certolizumab Pegol|certolizumab pegol
4949004|NCT01864265|RF and/or ACPA positive|rf and/or acpa positive
4949005|NCT01864239|Adherence|adherence
4949006|NCT01864187|Pharmacokinetics|pharmacokinetics
4949007|NCT01864187|Dexmedetomidine|dexmedetomidine
4949008|NCT01864187|Obesity|obesity
4949009|NCT01864122|nutrient biomarkers|nutrient biomarkers
4949010|NCT01864122|food frequency questionnaire|food frequency questionnaire
4949011|NCT01864122|predictors of CVD|predictors of cvd
4949012|NCT01864122|fatty acids|fatty acids
4949013|NCT01864122|phylloquinone|phylloquinone
4949014|NCT01864122|dihydrophylloquinone|dihydrophylloquinone
4949015|NCT01864109|CYCLOPHOSPHAMIDE (CYTOXAN)|cyclophosphamide (cytoxan)
4949016|NCT01864109|DOXORUBICIN/ADRIAMYCIN|doxorubicin/adriamycin
4949017|NCT01864109|ETOPOSIDE (VP-16)|etoposide (vp-16)
4949018|NCT01864109|IFOSFAMIDE|ifosfamide
4949019|NCT01864109|IRINOTECAN (CPT-11) CAMPTOSAR|irinotecan (cpt-11) camptosar
4949020|NCT01864109|TEMOZOLOMIDE|temozolomide
4949021|NCT01864109|VINCRISTINE|vincristine
4949022|NCT01864109|13-068|13-068
4949023|NCT01864096|localized|localized
4949024|NCT01864096|prostate|prostate
4949025|NCT01864096|cancer|cancer
4949026|NCT01864096|metformin|metformin
4949027|NCT01864096|active surveillance|active surveillance
4949028|NCT01864083|FACBC PET/PEM|facbc pet/pem
4949029|NCT01864083|MR|mr
4949030|NCT01864083|11-177|11-177
4949031|NCT01864070|Liver cancer|liver cancer
4949032|NCT01864070|Neuroendocrine tumors|neuroendocrine tumors
4949033|NCT01864070|NET|net
4949034|NCT01864070|Liver dominant disease|liver dominant disease
4949035|NCT01864070|TheraSphere|therasphere
4949036|NCT01864070|Yttrium-90|yttrium-90
4949037|NCT01864070|Y-90|y-90
4949038|NCT01864070|Everolimus|everolimus
4949039|NCT01864070|Afinitor|afinitor
4949040|NCT01864070|Zortress|zortress
4949041|NCT01864070|RAD001|rad001
4949042|NCT01864070|Microspheres|microspheres
4949043|NCT01864057|thiamine deficiency|thiamine deficiency
4949044|NCT01864031|Alcohol|alcohol
4949045|NCT01864031|Drinking|drinking
4949046|NCT01864031|Abstainers|abstainers
4949047|NCT01864031|Former drinkers|former drinkers
4949048|NCT01864031|Ex-drinkers|ex-drinkers
4949049|NCT01864031|Aetiology|aetiology
4949050|NCT01864031|Initial presentation|initial presentation
4949051|NCT01864031|Chronic Stable Angina|chronic stable angina
4949052|NCT01864031|Unstable Angina|unstable angina
4949053|NCT01864031|Coronary Heart Disease Not Otherwise Specified|coronary heart disease not otherwise specified
4949054|NCT01864031|Acute Myocardial Infarction|acute myocardial infarction
4949055|NCT01864031|Heart Failure|heart failure
4949056|NCT01864031|ST elevation Myocardial Infarction (STEMI)|st elevation myocardial infarction (stemi)
4949057|NCT01864031|non-ST elevation Myocardial Infarction (nSTEMI)|non-st elevation myocardial infarction (nstemi)
4949058|NCT01864031|Myocardial Infarction Not Otherwise Specified (MI NOS)|myocardial infarction not otherwise specified (mi nos)
4949059|NCT01864031|Ventricular Arrhythmias|ventricular arrhythmias
4949060|NCT01864031|Cardiac Arrest|cardiac arrest
4949061|NCT01864031|Abdominal Aortic Aneurysm|abdominal aortic aneurysm
4949062|NCT01864031|Peripheral Arterial Disease|peripheral arterial disease
4949063|NCT01864031|Ischaemic Stroke|ischaemic stroke
4949064|NCT01864031|Subarachnoid Haemorrhagic Stroke|subarachnoid haemorrhagic stroke
4949065|NCT01864031|Intracerebral haemorrhagic Stroke|intracerebral haemorrhagic stroke
4949066|NCT01864031|Stroke Not Otherwise Specified|stroke not otherwise specified
4949067|NCT01864031|Sudden Cardiac Death|sudden cardiac death
4949068|NCT01864031|Unheralded Coronary Death|unheralded coronary death
4949069|NCT01864031|Mortality|mortality
4949070|NCT01864031|Coronary Heart Disease (CHD)|coronary heart disease (chd)
4949071|NCT01864031|Cardiovascular Disease (CVD)|cardiovascular disease (cvd)
4949072|NCT01864031|Fatal Cardiovascular Disease (fatal CVD)|fatal cardiovascular disease (fatal cvd)
4949073|NCT01864005|Non-ST or ST Elevation Acute Coronary Syndromes, Ticagrelor, Clopidogrel, Antiplatelet Effect|non-st or st elevation acute coronary syndromes, ticagrelor, clopidogrel, antiplatelet effect
4949074|NCT01863992|home ventilation|home ventilation
4949075|NCT01863979|Atrial Fibrillation|atrial fibrillation
4949076|NCT01863979|Thromboembolism|thromboembolism
4949078|NCT01863966|Hot water drinking therapy|hot water drinking therapy
4949079|NCT01863966|Pneumatic dilation|pneumatic dilation
4949080|NCT01863914|ESRD|esrd
4949081|NCT01863914|Diabetes mellitus|diabetes mellitus
4949082|NCT01863914|Endothelial progenitor cells|endothelial progenitor cells
4949083|NCT01863914|Hemodialysis|hemodialysis
4949084|NCT01863914|rosuvastatin|rosuvastatin
4949085|NCT01863875|Cochlear Implant|cochlear implant
4949086|NCT01863875|Hearing loss|hearing loss
4949087|NCT01863875|Language Development|language development
4949088|NCT01863875|Quality of life|quality of life
4949089|NCT01863862|Rectal cancer|rectal cancer
4949090|NCT01863862|Chemoradiation|chemoradiation
4949091|NCT01863862|Complete pathological response|complete pathological response
4949092|NCT01863849|uncontrolled,|uncontrolled,
4949093|NCT01863849|open,|open,
4949094|NCT01863849|multi-centre|multi-centre
4949095|NCT01863849|immunogenicity and tolerability|immunogenicity and tolerability
4949096|NCT01863849|two groups according to age (18-59 years and ≥60 years)|two groups according to age (18-59 years and ≥60 years)
4949097|NCT01863836|Radial endobronchial ultrasound|radial endobronchial ultrasound
4949098|NCT01863836|Peripheral lung lesion|peripheral lung lesion
4949099|NCT01863836|Fluoroscopy|fluoroscopy
4949100|NCT01863836|Lung cancer|lung cancer
4949101|NCT01863823|Symptomatic patients|symptomatic patients
4949102|NCT01863823|asymptomatic individuals|asymptomatic individuals
4949103|NCT01863823|clinical trial|clinical trial
4949104|NCT01863810|Diabetic Neuropathy|diabetic neuropathy
4949105|NCT01863810|Neuropathic Pain|neuropathic pain
4949106|NCT01863810|Pregabalin|pregabalin
4949107|NCT01863784|Hepatic Impairment|hepatic impairment
4949108|NCT01863784|Mild and moderate hepatic impairment|mild and moderate hepatic impairment
4949109|NCT01863784|Normal hepatic function|normal hepatic function
4949110|NCT01863784|Pharmacokinetics|pharmacokinetics
4949111|NCT01863784|JNJ-38518168|jnj-38518168
4949112|NCT01863771|Ulcerative Colitis|ulcerative colitis
4949113|NCT01863771|Japanese|japanese
4949114|NCT01863771|Subcutaneous|subcutaneous
4949115|NCT01863771|Golimumab|golimumab
4949116|NCT01863745|ggastrointestinal stromal tumors|ggastrointestinal stromal tumors
4949117|NCT01863745|gastrointestinal,|gastrointestinal,
4949118|NCT01863745|stromal,|stromal,
4949119|NCT01863745|tumors,|tumors,
4949120|NCT01863745|GIST,|gist,
4949121|NCT01863745|AMN107,|amn107,
4949122|NCT01863745|nilotinib|nilotinib
4949123|NCT01863732|AIN457, ankylosing spondylitis, chronic inflammatory disease, inflammatory back pain, PFS, pre-filled syringe, secukinumab, self-injection|ain457, ankylosing spondylitis, chronic inflammatory disease, inflammatory back pain, pfs, pre-filled syringe, secukinumab, self-injection
4949124|NCT01863719|Colistin|colistin
4949125|NCT01863719|Multi Drug Resistant|multi drug resistant
4949126|NCT01863719|Nosocomial Pneumonia|nosocomial pneumonia
4949127|NCT01863719|Pneumococcal Infections|pneumococcal infections
4949128|NCT01863706|Misoprostol|misoprostol
4949129|NCT01863706|Oxytocin|oxytocin
4949130|NCT01863706|Post Partum Hemorrhage (PPH)|post partum hemorrhage (pph)
4949131|NCT01863706|Third stage of labour|third stage of labour
4949132|NCT01863680|Infertility|infertility
4949133|NCT01863680|COL-1620|col-1620
4949134|NCT01863680|progesterone gel|progesterone gel
4949135|NCT01863680|Fertilization in Vitro|fertilization in vitro
4949136|NCT01863680|Embryo Transfer|embryo transfer
4949137|NCT01863654|Bioequivalence|bioequivalence
4949138|NCT01863654|Mexico|mexico
4949139|NCT01863654|Asthma|asthma
4949140|NCT01863654|Montelukast|montelukast
4949141|NCT01863654|Chewable|chewable
4949142|NCT01863641|lupus nephritis|lupus nephritis
4949143|NCT01863641|proteinuria|proteinuria
4949144|NCT01863641|SLE|sle
4949145|NCT01863641|calcitriol|calcitriol
4949146|NCT01863628|Prodromal Symptoms|prodromal symptoms
4949147|NCT01863628|bipolar disorder|bipolar disorder
4949148|NCT01863628|Neuropsychological Tests|neuropsychological tests
4949149|NCT01863628|Magnetic Resonance Imaging|magnetic resonance imaging
4949150|NCT01863628|Treatment Outcome|treatment outcome
4949151|NCT01863628|aerobic exercise|aerobic exercise
4949152|NCT01863628|psychotherapy|psychotherapy
4949153|NCT01863615|pharmacokinetics|pharmacokinetics
4949154|NCT01863615|Isotretinoin|isotretinoin
4949155|NCT01863615|bioequivalence|bioequivalence
4949157|NCT01863576|Chagas disease|chagas disease
4949158|NCT01863576|Chagas Cardiomyopathy|chagas cardiomyopathy
4949159|NCT01863576|Trypanosoma cruzi|trypanosoma cruzi
4949160|NCT01863576|Omega-3|omega-3
4949161|NCT01863576|Cytokines|cytokines
4949162|NCT01863576|Lipid profile|lipid profile
4949163|NCT01863576|Nutritional assessment|nutritional assessment
4949164|NCT01863563|tonsillectomy|tonsillectomy
4949165|NCT01863563|adenoidectomy|adenoidectomy
4949166|NCT01863563|obstructive sleep apnea|obstructive sleep apnea
4949167|NCT01863524|Abdominal Aortic Aneurysm (AAA),|abdominal aortic aneurysm (aaa),
4949168|NCT01863524|Echocardiography (TTE),|echocardiography (tte),
4949169|NCT01863524|Acute Coronary Syndrome (ACS)|acute coronary syndrome (acs)
4949170|NCT01863524|Patients over 65 years old|patients over 65 years old
4949171|NCT01863511|Treatment options for acute decompensated heart failure|treatment options for acute decompensated heart failure
4949172|NCT01863511|Ultrafiltration|ultrafiltration
4949173|NCT01863511|tolvaptan|tolvaptan
4949174|NCT01863498|pectus excavatum|pectus excavatum
4949175|NCT01863498|pain control|pain control
4949176|NCT01863485|advanced cancer|advanced cancer
4949177|NCT01863459|ADHD|adhd
4949178|NCT01863459|ADD|add
4949179|NCT01863459|Anxiety|anxiety
4949180|NCT01863459|Anxiety Disorders|anxiety disorders
4949181|NCT01863459|Depression|depression
4949182|NCT01863459|Attention|attention
4949183|NCT01863459|Attention Deficit|attention deficit
4949184|NCT01863446|Pregnancy|pregnancy
4949185|NCT01863446|Melatonin|melatonin
4949186|NCT01863446|Contractions|contractions
4949187|NCT01863446|Light|light
4949188|NCT01863420|gastric cancer|gastric cancer
4949189|NCT01863420|rectal cancer|rectal cancer
4949190|NCT01863420|bone marrow toxicity|bone marrow toxicity
4949191|NCT01863420|IMRT|imrt
4949192|NCT01863420|hematologic toxicity|hematologic toxicity
4949193|NCT01863407|Ileus|ileus
4949194|NCT01863407|Intestinal Obstruction|intestinal obstruction
4949195|NCT01863407|Intestinal Diseases|intestinal diseases
4949196|NCT01863407|Gastrointestinal Diseases|gastrointestinal diseases
4949197|NCT01863407|Digestive System Diseases|digestive system diseases
4949198|NCT01863394|Screening|screening
4949199|NCT01863394|Malnutrition|malnutrition
4949200|NCT01863394|Community Management of Acute Malnutrition|community management of acute malnutrition
4949201|NCT01863381|Hydrocephalus|hydrocephalus
4949202|NCT01863381|Idiopathic intracranial hypertension|idiopathic intracranial hypertension
4949203|NCT01863381|Pseudotumor cerebri|pseudotumor cerebri
4949204|NCT01863381|ICP|icp
4949205|NCT01863381|Intracranial pressure|intracranial pressure
4949206|NCT01863381|CSF pressure|csf pressure
4949207|NCT01863381|VIIP|viip
4949208|NCT01863368|Dry eye syndrome|dry eye syndrome
4949209|NCT01863368|Systane Ultra|systane ultra
4949210|NCT01863368|Optive|optive
4949211|NCT01863368|Ocular Surface Staining|ocular surface staining
4949212|NCT01863368|OSDI|osdi
4949213|NCT01863368|Eye drops|eye drops
4949214|NCT01863355|IntravenousPCA, fentanyl, postoperative pain, laparoscopic gastrectomy|intravenouspca, fentanyl, postoperative pain, laparoscopic gastrectomy
4949215|NCT01863342|central sensitization; osteoarthritis; epidural analgesia|central sensitization; osteoarthritis; epidural analgesia
4949216|NCT01863329|Optic nerve sheath diameter|optic nerve sheath diameter
4949217|NCT01863329|Hydrocephalus|hydrocephalus
4949218|NCT01863329|Intracranial hypertension|intracranial hypertension
4949219|NCT01863316|LMA Supreme, i-gel, supraglottic airway|lma supreme, i-gel, supraglottic airway
4949220|NCT01863303|colorectal cancer|colorectal cancer
4949221|NCT01863303|epidemiology|epidemiology
4949222|NCT01863303|industry|industry
4949223|NCT01863303|genetic|genetic
4949224|NCT01863290|prison|prison
4949225|NCT01863290|reentry|reentry
4949226|NCT01863290|health care utilization|health care utilization
4949227|NCT01863264|dysphagia|dysphagia
4949228|NCT01863264|swallowing|swallowing
4949229|NCT01863264|infant|infant
4949230|NCT01863264|premature|premature
4949231|NCT01863264|neonate|neonate
4949232|NCT01863264|thermal|thermal
4949233|NCT01863264|cold|cold
4949234|NCT01863264|bolus|bolus
4949235|NCT01863264|temperature|temperature
4949236|NCT01863264|deglutition|deglutition
4949237|NCT01863264|NICU|nicu
4949238|NCT01863264|bottle|bottle
4949239|NCT01863264|nippling|nippling
4949240|NCT01863251|Opiates|opiates
4949241|NCT01863251|ATS|ats
4949242|NCT01863251|HIV Risks|hiv risks
4949243|NCT01863238|Cystic Fibrosis|cystic fibrosis
4949244|NCT01863199|Wet AMD|wet amd
4949245|NCT01863199|AMD|amd
4949246|NCT01863199|Choroidal neovascularization|choroidal neovascularization
4949247|NCT01863199|Neovascular membrane|neovascular membrane
4949248|NCT01863186|lofexidine|lofexidine
4949249|NCT01863186|opioid dependence|opioid dependence
4949250|NCT01863186|acute withdrawal syndrome|acute withdrawal syndrome
4949251|NCT01863186|opioid withdrawal|opioid withdrawal
4949252|NCT01863173|Thalassemia cardiomyopathy|thalassemia cardiomyopathy
4949253|NCT01863173|metoprolol succinate|metoprolol succinate
4949254|NCT01863173|echocardiography|echocardiography
4949255|NCT01863173|six minute walk test|six minute walk test
4949256|NCT01863160|Safety|safety
4949257|NCT01863160|Tolerability|tolerability
4949258|NCT01863160|Pharmacokinetic profile|pharmacokinetic profile
4949259|NCT01863160|ZEP-3 Cream (0.1% and 1.0%)|zep-3 cream (0.1% and 1.0%)
4949260|NCT01863160|administered topically|administered topically
4949261|NCT01863147|Type 2 diabetes|type 2 diabetes
4949262|NCT01863147|left ventricular mass|left ventricular mass
4949263|NCT01863147|inhibitor of dipeptidyl peptidase-4|inhibitor of dipeptidyl peptidase-4
4949264|NCT01863121|cirrhosis|cirrhosis
4949265|NCT01863121|CTPK|ctpk
4949266|NCT01863121|CTP|ctp
4949267|NCT01863121|MELD|meld
4949268|NCT01863121|Severity Score|severity score
4949269|NCT01863108|Melanoma|melanoma
4949270|NCT01863108|Immunotherapy|immunotherapy
4949271|NCT01863108|Dermatology|dermatology
4949272|NCT01863108|cancer vaccine|cancer vaccine
4949273|NCT01863108|Plasmacytoid dendritic cell line|plasmacytoid dendritic cell line
4949274|NCT01863108|Advanced Medicinal Therapy Product|advanced medicinal therapy product
4949275|NCT01863108|allogeneic|allogeneic
4949276|NCT01863082|Resistant Hypertension|resistant hypertension
4949278|NCT01863069|interferon beta-1a|interferon beta-1a
4949279|NCT01863069|healthy subjects|healthy subjects
4949280|NCT01863056|Sedentary time|sedentary time
4949281|NCT01863056|Non Exercise Activity|non exercise activity
4949282|NCT01863056|Sit Stand Workstation|sit stand workstation
4949283|NCT01863043|Premature Infant|premature infant
4949284|NCT01863043|Nutrition|nutrition
4949285|NCT01863043|Enteral|enteral
4949286|NCT01863030|Resorbable mesh|resorbable mesh
4949287|NCT01863030|Phasix mesh|phasix mesh
4949288|NCT01863017|Obesity|obesity
4949289|NCT01863017|Over weight|over weight
4949290|NCT01862991|Induced Abortion|induced abortion
4949291|NCT01862991|Mifepristone|mifepristone
4949292|NCT01862991|Dilation and Evacuation|dilation and evacuation
4949293|NCT01862991|Cervical Preparation|cervical preparation
4949294|NCT01862991|Osmotic Dilators|osmotic dilators
4949295|NCT01862978|Stroke|stroke
4949296|NCT01862978|Heparin|heparin
4949297|NCT01862978|Nadroparin|nadroparin
4949298|NCT01862965|firstline|firstline
4949299|NCT01862965|treatment|treatment
4949300|NCT01862965|prednisone|prednisone
4949301|NCT01862965|everolimus|everolimus
4949302|NCT01862939|type 2 diabetes mellitus|type 2 diabetes mellitus
4949303|NCT01862926|connective tissue disease|connective tissue disease
4949304|NCT01862926|interstitial lung disease|interstitial lung disease
4949305|NCT01862926|pulmonary fibrosis|pulmonary fibrosis
4949306|NCT01862926|rituximab|rituximab
4949307|NCT01862926|scleroderma|scleroderma
4949308|NCT01862926|polymyositis|polymyositis
4949309|NCT01862926|dermatomyositis|dermatomyositis
4949310|NCT01862913|depression|depression
4949311|NCT01862913|adolescents|adolescents
4949312|NCT01862900|Breast Cancer|breast cancer
4949313|NCT01862900|Metastatic|metastatic
4949314|NCT01862900|Lung metastases|lung metastases
4949315|NCT01862900|Liver metastases|liver metastases
4949316|NCT01862900|Stereotactic body radiation|stereotactic body radiation
4949317|NCT01862900|anti-OX40 antibody|anti-ox40 antibody
4949318|NCT01862900|MEDI6469|medi6469
4949319|NCT01862900|Immunotherapy|immunotherapy
4949320|NCT01862861|Bioidentical Hormone Replacement Therapy|bioidentical hormone replacement therapy
4949321|NCT01862848|Topical Compounded Pain Creams and Pain Perception|topical compounded pain creams and pain perception
4949322|NCT01862822|Paediatrics|paediatrics
4949323|NCT01862822|Urinary tract infection|urinary tract infection
4949324|NCT01862822|Urine collection|urine collection
4949325|NCT01862809|Oral Microbiota|oral microbiota
4949326|NCT01862809|Cigarette Smoking|cigarette smoking
4949327|NCT01862809|Tobacco- Related Cancer|tobacco- related cancer
4949328|NCT01862796|Food Intake|food intake
4949329|NCT01862796|Weight Loss|weight loss
4949330|NCT01862796|Compliance|compliance
4949331|NCT01862783|Erythrocytes|erythrocytes
4949332|NCT01862783|Parasites|parasites
4949333|NCT01862783|Plasmodium Falciparum|plasmodium falciparum
4949334|NCT01862783|Placenta|placenta
4949335|NCT01862783|Resistant|resistant
4949336|NCT01862770|Lung Cancer|lung cancer
4949337|NCT01862770|Smokers|smokers
4949338|NCT01862770|Genetic Risk Communication|genetic risk communication
4949339|NCT01862770|Smoking Cessation|smoking cessation
4949340|NCT01862757|Obesity|obesity
4949341|NCT01862757|Insulin|insulin
4949342|NCT01862757|Skeletal Muscle|skeletal muscle
4949343|NCT01862757|Strength Testing|strength testing
4949344|NCT01862744|Parkinson's Disease|parkinson's disease
4949345|NCT01862744|MRI|mri
4949346|NCT01862744|Cognitive|cognitive
4949347|NCT01862731|Muscle Force|muscle force
4949348|NCT01862731|Knee|knee
4949349|NCT01862731|Magnetic Resonance Imaging|magnetic resonance imaging
4949350|NCT01862731|Quadriceps|quadriceps
4949351|NCT01862731|Ultrasound|ultrasound
4949352|NCT01862718|Fusion|fusion
4949353|NCT01862718|Tracking|tracking
4949354|NCT01862718|Ablation|ablation
4949355|NCT01862718|Hepatic Neoplasms|hepatic neoplasms
4949356|NCT01862666|Barrett's Esophagus|barrett's esophagus
4949357|NCT01862666|Dysplasia|dysplasia
4949358|NCT01862666|Intramucosal Adenocarcinoma|intramucosal adenocarcinoma
4949359|NCT01862666|EMR|emr
4949360|NCT01862666|Endoscopy|endoscopy
4949361|NCT01862653|Post Traumatic Stress Disorder|post traumatic stress disorder
4949362|NCT01862653|Sleep Disturbance|sleep disturbance
4949363|NCT01862653|Acupuncture|acupuncture
4949364|NCT01862640|OPC-34712|opc-34712
4949365|NCT01862640|brexpiprazole|brexpiprazole
4949366|NCT01862640|Dementia|dementia
4949367|NCT01862640|Alzheimer's Disease|alzheimer's disease
4949368|NCT01862640|Cognitive Disorders|cognitive disorders
4949369|NCT01862640|Memory|memory
4949370|NCT01862640|Agitation|agitation
4949371|NCT01862627|Macular retinoschisis|macular retinoschisis
4949372|NCT01862627|Macular detachment|macular detachment
4949373|NCT01862627|vitrectomy|vitrectomy
4949374|NCT01862614|Degree of pulpal anesthesia obtained.|degree of pulpal anesthesia obtained.
4949375|NCT01862614|Primary infiltration in the lower first molar.|primary infiltration in the lower first molar.
4949376|NCT01862614|Buffered local anesthetic.|buffered local anesthetic.
4949377|NCT01862588|septic shock|septic shock
4949378|NCT01862588|acute kidney injury|acute kidney injury
4949379|NCT01862588|renal resistive index|renal resistive index
4949380|NCT01862562|Laparoscopic surgery|laparoscopic surgery
4949381|NCT01862562|Colorectal cancer|colorectal cancer
4949382|NCT01862562|Elderly patient|elderly patient
4949383|NCT01862562|Randomized control study|randomized control study
4949384|NCT01862536|Randomized trial|randomized trial
4949385|NCT01862536|COPD|copd
4949386|NCT01862536|tadalafil|tadalafil
4949387|NCT01862536|Phosphodiesterase inhibitor|phosphodiesterase inhibitor
4949388|NCT01862536|Pulmonary hypertension|pulmonary hypertension
4949389|NCT01862510|Celiac Disease|celiac disease
4949390|NCT01862510|Hypothyroidism|hypothyroidism
4949391|NCT01862510|Celiac Sprue|celiac sprue
4949392|NCT01862510|Malabsorption|malabsorption
4949393|NCT01862497|Intradialytic Hypertension|intradialytic hypertension
4949394|NCT01862497|Hemodialysis|hemodialysis
4949395|NCT01862497|Hypertension|hypertension
4949396|NCT01862497|Extracellular Volume|extracellular volume
4949397|NCT01862497|Endothelial Cell Dysfunction|endothelial cell dysfunction
4949398|NCT01862497|Endothelin 1|endothelin 1
4949399|NCT01862497|Carvedilol|carvedilol
4949400|NCT01862484|ADHD|adhd
4949401|NCT01862484|Diet|diet
4949402|NCT01862484|Functional Magnetic Resonance Imaging|functional magnetic resonance imaging
4949403|NCT01862471|Deep Vein Thrombosis|deep vein thrombosis
4949404|NCT01862471|Neuromuscular Electrical Stimulation|neuromuscular electrical stimulation
4949405|NCT01862471|Intermittent Pneumatic Compression|intermittent pneumatic compression
4949406|NCT01862471|Doppler Ultrasound|doppler ultrasound
4949407|NCT01862458|empyema|empyema
4949408|NCT01862458|tPA|tpa
4949409|NCT01862458|dornase|dornase
4949410|NCT01862445|Chronic Lymphoid Leukemia, Chlorambucil, Rituximab|chronic lymphoid leukemia, chlorambucil, rituximab
4949411|NCT01862393|electrical stimulation|electrical stimulation
4949412|NCT01862393|torque|torque
4949413|NCT01862380|Adrenocortical function|adrenocortical function
4949414|NCT01862380|Adrenal hyperplasia, Congenital|adrenal hyperplasia, congenital
4949415|NCT01862380|21-hydroxylase|21-hydroxylase
4949416|NCT01862380|deficiency|deficiency
4949417|NCT01862380|cortisol|cortisol
4949418|NCT01862380|replacement therapy|replacement therapy
4949419|NCT01862380|Woman|woman
4949420|NCT01862380|Healthy people|healthy people
4949421|NCT01862354|Postoperative analgesia|postoperative analgesia
4949422|NCT01862354|Abdominoplasty|abdominoplasty
4949423|NCT01862354|Continuous wound infusion|continuous wound infusion
4949424|NCT01862354|Transverse abdominal plan block|transverse abdominal plan block
4949425|NCT01862354|Local anesthetics : Ropivacaine|local anesthetics : ropivacaine
4949426|NCT01862354|Regional anesthesia|regional anesthesia
4949427|NCT01862341|Constipation|constipation
4949428|NCT01862341|Bowel movement|bowel movement
4949429|NCT01862341|Intestinal health|intestinal health
4949430|NCT01862328|MLN4924|mln4924
4949431|NCT01862328|Solid Tumors|solid tumors
4949432|NCT01862315|Hepatic Arterial Infusion (HAI)|hepatic arterial infusion (hai)
4949433|NCT01862315|Floxuridine (FUDR)|floxuridine (fudr)
4949434|NCT01862315|Dexamethasone (DEX)|dexamethasone (dex)
4949435|NCT01862315|Gemcitabine|gemcitabine
4949436|NCT01862315|Oxaliplatin|oxaliplatin
4949437|NCT01862315|13-066|13-066
4949438|NCT01862302|Prevention delirium|prevention delirium
4949439|NCT01862302|Cardiac surgery|cardiac surgery
4949440|NCT01862289|difficult asthma|difficult asthma
4949441|NCT01862289|hyperventilation syndrome|hyperventilation syndrome
4949442|NCT01862289|prevalence|prevalence
4949443|NCT01862263|Diabetes,|diabetes,
4949444|NCT01862263|Type 2 diabetes,|type 2 diabetes,
4949445|NCT01862263|Diabetes mellitus,|diabetes mellitus,
4949446|NCT01862263|insulin,|insulin,
4949447|NCT01862237|Type II diabetes|type ii diabetes
4949448|NCT01862237|aortic valve stenosis|aortic valve stenosis
4949449|NCT01862237|left ventricular remodeling|left ventricular remodeling
4949450|NCT01862237|aortic valve replacement surgery|aortic valve replacement surgery
4949451|NCT01862224|Active rheumatoid arthritis despite methotrexate therapy|active rheumatoid arthritis despite methotrexate therapy
4949452|NCT01862224|JNJ-38518168|jnj-38518168
4949453|NCT01862224|Synovial|synovial
4949454|NCT01862211|alpha antitrypsin, hepatic disease, genetic, polymorphism|alpha antitrypsin, hepatic disease, genetic, polymorphism
4949455|NCT01862185|semiquantitative|semiquantitative
4949456|NCT01862185|procalcitonin|procalcitonin
4949457|NCT01862185|sepsis|sepsis
4949458|NCT01862185|antibiotics|antibiotics
4949459|NCT01862185|mortality|mortality
4949460|NCT01862172|Cortical focal atrophy|cortical focal atrophy
4949461|NCT01862172|Stroke|stroke
4949462|NCT01862172|Internal capsule|internal capsule
4949463|NCT01862172|Corticospinal tract|corticospinal tract
4949464|NCT01862172|Wallerian degeneration|wallerian degeneration
4949465|NCT01862172|Primary motor area.|primary motor area.
4949466|NCT01862159|bariatric surgery|bariatric surgery
4949467|NCT01862159|postoperative complications|postoperative complications
4949468|NCT01862146|TCA|tca
4949469|NCT01862146|FMD|fmd
4949470|NCT01862146|IMT|imt
4949471|NCT01862146|Smoking|smoking
4949472|NCT01862133|Electronic Health Record|electronic health record
4949473|NCT01862133|Health Information Technology|health information technology
4949474|NCT01862133|Patient Privacy|patient privacy
4949475|NCT01862133|Personal Health Information|personal health information
4949476|NCT01862120|Recently diagnosed|recently diagnosed
4949477|NCT01862120|Regulatory T Cells|regulatory t cells
4949478|NCT01862120|Tolerance Induction|tolerance induction
4949479|NCT01862120|Paediatrics|paediatrics
4949480|NCT01862120|Low dose|low dose
4949481|NCT01862120|IL-2|il-2
4949482|NCT01862107|Biomarkers|biomarkers
4949483|NCT01862107|Immune Responses|immune responses
4949484|NCT01862107|Lumbar Puncture|lumbar puncture
4949485|NCT01862107|Neurological Diseases|neurological diseases
4949486|NCT01862107|Novel Pathogens|novel pathogens
4949487|NCT01862068|Pronostic factors|pronostic factors
4949488|NCT01862068|Neutrophils|neutrophils
4949489|NCT01862068|Granulomatosis with polyangiitis|granulomatosis with polyangiitis
4949490|NCT01862068|Microscopic polyangiitis|microscopic polyangiitis
4949491|NCT01862068|ANCA associated vasculitis|anca associated vasculitis
4949492|NCT01862068|Proteomics|proteomics
4949493|NCT01862055|Stress|stress
4949494|NCT01862055|Anxiety|anxiety
4949495|NCT01862055|Cesarean Section|cesarean section
4949496|NCT01862055|Spinal anesthesia|spinal anesthesia
4949497|NCT01862055|Hypotension|hypotension
4949498|NCT01862042|Spinal Muscular Atrophy (SMA) type 1|spinal muscular atrophy (sma) type 1
4949499|NCT01862042|Supportive care|supportive care
4949500|NCT01862042|Palliative care|palliative care
4949501|NCT01862029|Mitochondria in Diabetes|mitochondria in diabetes
4949502|NCT01862029|Obesity|obesity
4949503|NCT01862029|Roflumilast|roflumilast
4949504|NCT01862029|Phosphodiesterase-4|phosphodiesterase-4
4949505|NCT01862029|Pre-Diabetes|pre-diabetes
4949506|NCT01862016|Acute respiratory distress syndrome|acute respiratory distress syndrome
4949507|NCT01862016|APRV ventilatory mode|aprv ventilatory mode
4949508|NCT01862016|Spontaneous breathing|spontaneous breathing
4949509|NCT01862016|Intensive Care Unit|intensive care unit
4949510|NCT01862003|Colorectal cancer|colorectal cancer
4949511|NCT01862003|Metastatic Colorectal cancer|metastatic colorectal cancer
4949512|NCT01862003|Recurrent Colorectal cancer|recurrent colorectal cancer
4949513|NCT01862003|FOLFIRI|folfiri
4949514|NCT01862003|AZD8931|azd8931
4949515|NCT01862003|Chemotherapy|chemotherapy
4949516|NCT01862003|EGFR|egfr
4949517|NCT01861990|Glioma|glioma
4949518|NCT01861990|Glioblastoma|glioblastoma
4949519|NCT01861990|Pediatric|pediatric
4949520|NCT01861990|Child|child
4949521|NCT01861990|Brain tumor|brain tumor
4949522|NCT01861990|Astrocytoma|astrocytoma
4949523|NCT01861990|Medulloblastoma|medulloblastoma
4949524|NCT01861990|PNET|pnet
4949525|NCT01861977|Cognitive Therapy|cognitive therapy
4949526|NCT01861977|Health Education|health education
4949527|NCT01861977|Secondary Prevention|secondary prevention
4949528|NCT01861977|Cardiovascular Disease|cardiovascular disease
4949529|NCT01861964|XOS|xos
4949530|NCT01861964|Xylooligosarcharide|xylooligosarcharide
4949531|NCT01861964|Prebiotic|prebiotic
4949532|NCT01861951|soft tissue sarcoma|soft tissue sarcoma
4949533|NCT01861951|firstline treatment|firstline treatment
4949534|NCT01861951|eldery patients|eldery patients
4949535|NCT01861938|melanoma|melanoma
4949536|NCT01861938|vaccine|vaccine
4949537|NCT01861938|Resectable AJCC stage IV|resectable ajcc stage iv
4949538|NCT01861938|AJCC stages IIb-c, III|ajcc stages iib-c, iii
4949539|NCT01861938|Patients with low-burden|patients with low-burden
4949540|NCT01861938|failed|failed
4949541|NCT01861938|respond|respond
4949542|NCT01861938|one treatment line|one treatment line
4949543|NCT01861912|Carcinoma, Hepatocellular|carcinoma, hepatocellular
4949544|NCT01861912|Arsenic trioxide|arsenic trioxide
4949545|NCT01861899|Sacro-iliac Joint|sacro-iliac joint
4949546|NCT01861886|Birth control|birth control
4949547|NCT01861886|Permanent Contraception|permanent contraception
4949548|NCT01861873|liver function|liver function
4949549|NCT01861873|galactose|galactose
4949550|NCT01861873|18-F-deoxy-galactose|18-f-deoxy-galactose
4949551|NCT01861860|stenting using IVUS in long lEsion|stenting using ivus in long lesion
4949552|NCT01861834|Total parenteral nutrition|total parenteral nutrition
4949553|NCT01861834|TPN|tpn
4949554|NCT01861834|Intestinal Failure|intestinal failure
4949555|NCT01861834|Short Bowel Syndrome|short bowel syndrome
4949556|NCT01861834|Cholestasis|cholestasis
4949557|NCT01861834|Intestinal failure associated liver disease|intestinal failure associated liver disease
4949558|NCT01861834|Parenteral nutrition associated liver disease|parenteral nutrition associated liver disease
4949559|NCT01861821|Epidural catheter|epidural catheter
4949560|NCT01861821|Epidural analgesia|epidural analgesia
4949561|NCT01861821|Labor epidural analgesia|labor epidural analgesia
4949562|NCT01861821|Analgesic efficacy|analgesic efficacy
4949563|NCT01861821|Multiport epidural catheter|multiport epidural catheter
4949564|NCT01861821|Uniport epidural catheter|uniport epidural catheter
4949565|NCT01861821|Flexible epidural catheter|flexible epidural catheter
4949566|NCT01861808|Spinal Cord Injuries|spinal cord injuries
4949567|NCT01861808|Cerebrospinal Fluid|cerebrospinal fluid
4949568|NCT01861795|Drug therapy|drug therapy
4949569|NCT01861769|Cognitive Processing Therapy|cognitive processing therapy
4949570|NCT01861769|Consultation|consultation
4949571|NCT01861756|Shared Decision Making|shared decision making
4949572|NCT01861756|Decision Aids|decision aids
4949573|NCT01861743|Multi-modal Pain Management|multi-modal pain management
4949574|NCT01861743|Lumbar fusion|lumbar fusion
4949575|NCT01861743|misTLIF|mistlif
4949576|NCT01861730|BCG Vaccinated|bcg vaccinated
4949577|NCT01861730|HIV Negative|hiv negative
4949578|NCT01861717|excess growth hormone|excess growth hormone
4949579|NCT01861717|excess GH|excess gh
4949580|NCT01861717|gigantism|gigantism
4949581|NCT01861717|pituitary tumor|pituitary tumor
4949582|NCT01861717|pituitary adenoma|pituitary adenoma
4949583|NCT01861717|growth hormone tumor|growth hormone tumor
4949584|NCT01861717|GH secreting adenoma|gh secreting adenoma
4949585|NCT01861717|Somatuline|somatuline
4949586|NCT01861717|lanreotide|lanreotide
4949587|NCT01861704|Mild to moderate hearing loss|mild to moderate hearing loss
4949588|NCT01861691|Transverse colon cancer|transverse colon cancer
4949589|NCT01861691|Descending colon cancer|descending colon cancer
4949590|NCT01861691|Laparoscopic surgery|laparoscopic surgery
4949591|NCT01861691|Randomized controlled trial|randomized controlled trial
4949592|NCT01861678|Rectal cancer|rectal cancer
4949593|NCT01861678|Anterior resection|anterior resection
4949594|NCT01861678|High tie of inferior mesenteric artery|high tie of inferior mesenteric artery
4949595|NCT01861678|Low tie of inferior mesenteric artery|low tie of inferior mesenteric artery
4949596|NCT01861678|Randomized controlled trial|randomized controlled trial
4949597|NCT01861652|Restless legs syndrome, Ekbom syndrome, Restless legs|restless legs syndrome, ekbom syndrome, restless legs
4949598|NCT01861600|Stool composition|stool composition
4949599|NCT01861535|VIN|vin
4949600|NCT01861535|Imiquimod|imiquimod
4949601|NCT01861535|Surgery|surgery
4949602|NCT01861535|HPV|hpv
4949603|NCT01861535|Patient satisfaction|patient satisfaction
4949604|NCT01861522|TAU-284|tau-284
4949605|NCT01861522|Bepotastine besilate|bepotastine besilate
4949606|NCT01861522|Histamine H1 receptor antagonists|histamine h1 receptor antagonists
4949607|NCT01861522|children|children
4949608|NCT01861509|BP-C1|bp-c1
4949609|NCT01861509|CDBPA|cdbpa
4949610|NCT01861509|Metronomic chemotherapy|metronomic chemotherapy
4949611|NCT01861509|Platinum analogue|platinum analogue
4949612|NCT01861509|Cis-coordinated complexes of platinum(II) with polymer of benzene polycarboxylic acids derived from lignin|cis-coordinated complexes of platinum(ii) with polymer of benzene polycarboxylic acids derived from lignin
4949613|NCT01861509|Benzene polycarboxylic acids complex with cis-diammineplatinum(II)|benzene polycarboxylic acids complex with cis-diammineplatinum(ii)
4949614|NCT01861509|Breast cancer|breast cancer
4949615|NCT01861509|Cisplatin|cisplatin
4949616|NCT01861509|Metastatic Breast Cancer|metastatic breast cancer
4949617|NCT01861496|Cisplatin|cisplatin
4949618|NCT01861496|Liposomal formulation|liposomal formulation
4949619|NCT01861496|DRP (Drug Response Prediction)|drp (drug response prediction)
4949620|NCT01861457|nasal sanitizer®|nasal sanitizer®
4949621|NCT01861457|S. aureus|s. aureus
4949622|NCT01861457|general bacteria|general bacteria
4949623|NCT01861457|nasal carriage|nasal carriage
4949624|NCT01861457|decolonization|decolonization
4949625|NCT01861431|HIV, prevention, microfinance, sex work, Mongolia|hiv, prevention, microfinance, sex work, mongolia
4949626|NCT01861418|chronic low back pain|chronic low back pain
4949627|NCT01861418|low back pain|low back pain
4949628|NCT01861418|lumbopelvic manipulation|lumbopelvic manipulation
4949629|NCT01861418|Chicago manipulation|chicago manipulation
4949630|NCT01861418|EMG median frequency|emg median frequency
4949631|NCT01861418|electromyography|electromyography
4949632|NCT01861418|reliability|reliability
4949633|NCT01861392|postural balance sensory motor trayning physical therapy modalities diabetes mellitus|postural balance sensory motor trayning physical therapy modalities diabetes mellitus
4949634|NCT01861366|Implementation|implementation
4949635|NCT01861366|Guidelines|guidelines
4949636|NCT01861366|Nutrition|nutrition
4949637|NCT01861366|Nursing home|nursing home
4949638|NCT01861327|Carbon dioxide|carbon dioxide
4949639|NCT01861327|aortic aneurysm|aortic aneurysm
4949640|NCT01861327|angioplasty|angioplasty
4949641|NCT01861327|Critical lower limb ischemia|critical lower limb ischemia
4949642|NCT01861288|Inflammatory Bowel Disease|inflammatory bowel disease
4949643|NCT01861288|Fecal Calprotectin|fecal calprotectin
4949644|NCT01861288|Clinical IBD score (SCCAI, PUCAI, aPCDAI)|clinical ibd score (sccai, pucai, apcdai)
4949645|NCT01861288|Endoscopic deep remission|endoscopic deep remission
4949646|NCT01861288|Histopathologic deep remission|histopathologic deep remission
4949647|NCT01861288|Immunological deep remission|immunological deep remission
4949648|NCT01861288|Treatment algorithm|treatment algorithm
4949649|NCT01861275|osa|osa
4949650|NCT01861275|cerebral palsy|cerebral palsy
4949651|NCT01861275|thrombolysis in cerebral palsy|thrombolysis in cerebral palsy
4949652|NCT01861275|sleep registration|sleep registration
4949653|NCT01861262|emergency|emergency
4949654|NCT01861262|drug poisoning|drug poisoning
4949655|NCT01861262|StO2 measurement|sto2 measurement
4949656|NCT01861262|blood pressure|blood pressure
4949657|NCT01861262|hemodynamic failure|hemodynamic failure
4949658|NCT01861223|acquired resistance|acquired resistance
4949659|NCT01861223|gefitinib|gefitinib
4949660|NCT01861223|erlotinib|erlotinib
4949661|NCT01861210|Homosexuality, Male|homosexuality, male
4949662|NCT01861197|Efficacy|efficacy
4949663|NCT01861197|Dovitinib|dovitinib
4949664|NCT01861197|Squamous NSCLC|squamous nsclc
4949665|NCT01861184|Lower respiratory tract infection|lower respiratory tract infection
4949666|NCT01861184|LRTI|lrti
4949667|NCT01861184|Pneumococcal carriage|pneumococcal carriage
4949670|NCT01861158|Delinquency|delinquency
4949671|NCT01861158|Online intervention|online intervention
4949672|NCT01861158|Juvenile Justice|juvenile justice
4949673|NCT01861145|Intranasal steroids|intranasal steroids
4949674|NCT01861132|Pregnancy, cesarean delivery, blood pressure, cardiac output|pregnancy, cesarean delivery, blood pressure, cardiac output
4949675|NCT01861106|Allogeneic Donors|allogeneic donors
4949676|NCT01861106|Peripheral Blood Stem Cell|peripheral blood stem cell
4949677|NCT01861106|Immunodeficiency|immunodeficiency
4949678|NCT01861106|Myelodysplasia|myelodysplasia
4949679|NCT01861106|Haploidentical|haploidentical
4949680|NCT01861093|Unrelated Hematopoietic Stem Cell Transplantation|unrelated hematopoietic stem cell transplantation
4949681|NCT01861093|Cryopreserved Cord Blood Units|cryopreserved cord blood units
4949682|NCT01861093|National Cord Blood Program|national cord blood program
4949683|NCT01861080|target organ damage|target organ damage
4949684|NCT01861080|incident hypertension|incident hypertension
4949685|NCT01861080|cohort|cohort
4949686|NCT01861054|Cancer Stem Cells|cancer stem cells
4949687|NCT01861054|Novel targeted therapy|novel targeted therapy
4949688|NCT01861054|CXCR1/2 Inhibitors|cxcr1/2 inhibitors
4949689|NCT01861041|low dose|low dose
4949690|NCT01861041|different baricity|different baricity
4949691|NCT01861041|spinal anesthesia|spinal anesthesia
4949692|NCT01861028|total knee replacement|total knee replacement
4949693|NCT01861028|total knee arthroplasty|total knee arthroplasty
4949694|NCT01861028|patient-specific|patient-specific
4949695|NCT01861002|Relapse|relapse
4949696|NCT01861002|Lymphoblastic|lymphoblastic
4949697|NCT01861002|Leukemia|leukemia
4949698|NCT01861002|Azacytidine|azacytidine
4949699|NCT01861002|Refractory|refractory
4949700|NCT01861002|Myelogenous|myelogenous
4949701|NCT01861002|Acute|acute
4949702|NCT01861002|Childhood|childhood
4949703|NCT01861002|Pediatric|pediatric
4949704|NCT01861002|ALL|all
4949705|NCT01861002|AML|aml
4949706|NCT01861002|Methylation|methylation
4949707|NCT01861002|Epigenetic therapy|epigenetic therapy
4949708|NCT01860989|parasitemia|parasitemia
4949709|NCT01860963|ASIL|asil
4949710|NCT01860963|Anal dysplasia|anal dysplasia
4949711|NCT01860963|IBD|ibd
4949712|NCT01860963|HPV DNA|hpv dna
4949713|NCT01860950|Healthy Adults|healthy adults
4949714|NCT01860950|Pain Perception|pain perception
4949715|NCT01860937|T cell Immunotherapy|t cell immunotherapy
4949716|NCT01860937|CD19 Targeted Therapy|cd19 targeted therapy
4949717|NCT01860937|Chimeric Antigen Receptor (CAR) Modified T cells|chimeric antigen receptor (car) modified t cells
4949718|NCT01860937|Conditioning Chemotherapy|conditioning chemotherapy
4949719|NCT01860937|13-052|13-052
4949720|NCT01860924|exercise|exercise
4949721|NCT01860924|depression|depression
4949722|NCT01860924|smoking|smoking
4949723|NCT01860898|lung|lung
4949724|NCT01860898|cancer|cancer
4949725|NCT01860898|thoracic|thoracic
4949726|NCT01860898|chest|chest
4949727|NCT01860898|pulmonary|pulmonary
4949728|NCT01860885|naloxone|naloxone
4949729|NCT01860885|children|children
4949730|NCT01860885|opioid|opioid
4949731|NCT01860885|respiratory depression|respiratory depression
4949732|NCT01860885|safety|safety
4949733|NCT01860872|Cystic Fibrosis|cystic fibrosis
4949734|NCT01860872|Pulmonary perfusion|pulmonary perfusion
4949735|NCT01860872|Inflammatory markers|inflammatory markers
4949736|NCT01860872|MRI|mri
4949737|NCT01860872|CT of chest|ct of chest
4949738|NCT01860872|Lung Clearance Index|lung clearance index
4949739|NCT01860859|cesarean|cesarean
4949740|NCT01860859|ultrasound|ultrasound
4949741|NCT01860859|hysterotomy|hysterotomy
4949742|NCT01860859|uterus|uterus
4949743|NCT01860859|suture|suture
4949744|NCT01860846|Crohn's Disease|crohn's disease
4949745|NCT01860833|Knee Osteoarthritis|knee osteoarthritis
4949746|NCT01860820|IPC/TEDS|ipc/teds
4949747|NCT01860820|Geko device|geko device
4949748|NCT01860807|methamphetamine|methamphetamine
4949749|NCT01860807|ibudilast|ibudilast
4949750|NCT01860807|HIV|hiv
4949751|NCT01860781|Schizophrenia|schizophrenia
4949752|NCT01860781|Injection|injection
4949753|NCT01860781|Switch|switch
4949754|NCT01860781|Paliperidone|paliperidone
4949755|NCT01860781|refractory, chronic akathisia, poor complianc|refractory, chronic akathisia, poor complianc
4949756|NCT01860768|Acute aortic dissection|acute aortic dissection
4949757|NCT01860768|Serum biomarkers|serum biomarkers
4949758|NCT01860768|Early diagnosis|early diagnosis
4949759|NCT01860755|Sport-related concussion|sport-related concussion
4949760|NCT01860755|Dizziness|dizziness
4949761|NCT01860755|Neck pain|neck pain
4949762|NCT01860755|Headaches|headaches
4949763|NCT01860755|Physiotherapy|physiotherapy
4949764|NCT01860755|Treatment|treatment
4949765|NCT01860742|Peptide Receptor Radionuclide Therapy (PRRT)|peptide receptor radionuclide therapy (prrt)
4949766|NCT01860742|Neuroendocrine Tumors|neuroendocrine tumors
4949767|NCT01860742|Interferon alpha|interferon alpha
4949768|NCT01860716|Melatonin, liver transplant, oxidative stress|melatonin, liver transplant, oxidative stress
4949769|NCT01860703|Ferriprox®|ferriprox®
4949770|NCT01860703|LI|li
4949771|NCT01860703|DFP|dfp
4949772|NCT01860703|Deferiprone|deferiprone
4949773|NCT01860703|Healthy Volunteers|healthy volunteers
4949774|NCT01860690|MTX|mtx
4949775|NCT01860690|Ectopic pregnancy|ectopic pregnancy
4949776|NCT01860690|medical treatment|medical treatment
4949777|NCT01860677|cranial stimulation|cranial stimulation
4949778|NCT01860677|BOLD (Blood Oxygenation Level Dependent)|bold (blood oxygenation level dependent)
4949779|NCT01860677|fMRI (Functional Magnetic Resonance Imaging)|fmri (functional magnetic resonance imaging)
4949780|NCT01860677|spectroscopy|spectroscopy
4949781|NCT01860664|allergy|allergy
4949782|NCT01860664|allergic|allergic
4949783|NCT01860664|conjunctivitis|conjunctivitis
4949784|NCT01860664|corticosteroid|corticosteroid
4949785|NCT01860664|hydrocortisone|hydrocortisone
4949786|NCT01860664|ophthalmic|ophthalmic
4949787|NCT01860664|ointment|ointment
4949788|NCT01860651|Inflammatory Bowel Disease|inflammatory bowel disease
4949789|NCT01860651|Ulcerative Colitis|ulcerative colitis
4949790|NCT01860651|Crohn´s Disease|crohn´s disease
4949791|NCT01860651|Children|children
4949792|NCT01860651|Adolescence|adolescence
4949793|NCT01860651|E-health web-monitoring|e-health web-monitoring
4949794|NCT01860651|Adherence|adherence
4949795|NCT01860651|Disease activity|disease activity
4949796|NCT01860651|Fecal Calprotectin|fecal calprotectin
4949797|NCT01860599|prediabetes|prediabetes
4949798|NCT01860599|EPC's|epc's
4949799|NCT01860599|vascular reactivity|vascular reactivity
4949800|NCT01860586|pvr|pvr
4949801|NCT01860586|rd|rd
4949802|NCT01860586|Proliferative Vitreoretinopathy|proliferative vitreoretinopathy
4949803|NCT01860586|retinal detachment|retinal detachment
4949804|NCT01860586|detachment|detachment
4949805|NCT01860573|Amino acids|amino acids
4949806|NCT01860573|Protein|protein
4949807|NCT01860560|OSA|osa
4949808|NCT01860560|Obstructive Sleep Apnea|obstructive sleep apnea
4949809|NCT01860560|High Flow Therapy|high flow therapy
4949810|NCT01860560|CPAP|cpap
4949811|NCT01860560|HFT|hft
4949812|NCT01860560|Continuous Positive Airway Pressure|continuous positive airway pressure
4949813|NCT01860560|Mild OSA|mild osa
4949814|NCT01860560|Moderate OSA|moderate osa
4949815|NCT01860534|pain|pain
4949816|NCT01860534|mydriasis|mydriasis
4949817|NCT01860534|light|light
4949818|NCT01860521|Termination of pregnancy|termination of pregnancy
4949819|NCT01860521|Second trimester|second trimester
4949820|NCT01860521|Programmed intermittent epidural bolus|programmed intermittent epidural bolus
4949821|NCT01860521|Continuous epidural infusion|continuous epidural infusion
4949822|NCT01860521|Epidural analgesia|epidural analgesia
4949823|NCT01860521|Legally Induced Abortion|legally induced abortion
4949824|NCT01860508|Progression free Survival|progression free survival
4949825|NCT01860495|growth factors|growth factors
4949826|NCT01860495|periodontal pockets|periodontal pockets
4949827|NCT01860482|Refractory Reflux Esophagitis|refractory reflux esophagitis
4949828|NCT01860482|GERD|gerd
4949829|NCT01860482|Phase 4|phase 4
4949830|NCT01860456|Chronic myeloid leukemia|chronic myeloid leukemia
4949831|NCT01860456|Imatinib|imatinib
4949832|NCT01860456|Nilotinib|nilotinib
4949833|NCT01860456|Polymorphism, Single Nucleotide|polymorphism, single nucleotide
4949834|NCT01860456|Pharmacokinetics|pharmacokinetics
4949835|NCT01860456|ATP-Binding Cassette Transporters|atp-binding cassette transporters
4949836|NCT01860456|SLC Transporters|slc transporters
4949837|NCT01860456|Treatment outcome|treatment outcome
4949838|NCT01860456|Toxicity|toxicity
4949839|NCT01860443|depression|depression
4949840|NCT01860443|adolescents|adolescents
4949841|NCT01860430|Locally Advanced|locally advanced
4949842|NCT01860430|Head and Neck Cancer|head and neck cancer
4949843|NCT01860430|Ipilimumab (YERVOY®)|ipilimumab (yervoy®)
4949844|NCT01860417|Degenerative Disc Disease,|degenerative disc disease,
4949845|NCT01860417|Intervertebral Disc Disease|intervertebral disc disease
4949846|NCT01860417|Low Back Pain|low back pain
4949847|NCT01860417|Nucleus pulposus|nucleus pulposus
4949848|NCT01860417|Stem cell|stem cell
4949849|NCT01860417|Cellular therapy|cellular therapy
4949850|NCT01860417|Regenerative therapy|regenerative therapy
4949851|NCT01860417|Mesenchymal stem cells|mesenchymal stem cells
4949852|NCT01860417|Bone marrow|bone marrow
4949853|NCT01860417|Musculoskeletal Diseases|musculoskeletal diseases
4949854|NCT01860417|Mesenchymal Stromal Cells (allogenic)|mesenchymal stromal cells (allogenic)
4949855|NCT01860404|Concussion|concussion
4949856|NCT01860404|Branched chain amino acids|branched chain amino acids
4949857|NCT01860404|BCAA|bcaa
4949858|NCT01860404|HIT HEADS|hit heads
4949859|NCT01860391|Silver|silver
4949860|NCT01860391|Fluoride|fluoride
4949861|NCT01860391|Diammine Silver Fluoride|diammine silver fluoride
4949862|NCT01860391|Saliva|saliva
4949863|NCT01860378|Whooping Cough|whooping cough
4949864|NCT01860378|Pertussis|pertussis
4949865|NCT01860378|Tdap vaccination|tdap vaccination
4949866|NCT01860378|Randomized placebo controlled factorial trial|randomized placebo controlled factorial trial
4949867|NCT01860365|Quality of life|quality of life
4949868|NCT01860365|Integrative medicine|integrative medicine
4949869|NCT01860365|Supportive care|supportive care
4949870|NCT01860365|Cancer|cancer
4949871|NCT01860365|Chemotherapy|chemotherapy
4949872|NCT01860352|Fish Oil|fish oil
4949873|NCT01860352|colon health|colon health
4949874|NCT01860352|fatty acid metabolism|fatty acid metabolism
4949875|NCT01860339|Huntington's Disease|huntington's disease
4949876|NCT01860339|HD|hd
4949877|NCT01860339|Huntington Disease|huntington disease
4949878|NCT01860339|Juvenile Huntington's Disease|juvenile huntington's disease
4949879|NCT01860339|JHD|jhd
4949880|NCT01860326|hepatic impairment|hepatic impairment
4949881|NCT01860326|mild and moderate hepatic impairment|mild and moderate hepatic impairment
4949882|NCT01860326|Alisporivir|alisporivir
4949883|NCT01860313|effectiveness|effectiveness
4949884|NCT01860313|distance learning|distance learning
4949885|NCT01860313|mental health|mental health
4949886|NCT01860300|Tic Disorders|tic disorders
4949887|NCT01860300|Tourette Syndrome|tourette syndrome
4949888|NCT01860287|opioid|opioid
4949889|NCT01860287|subjective|subjective
4949890|NCT01860287|stress|stress
4949891|NCT01860287|buprenorphine|buprenorphine
4949892|NCT01860274|Mesh|mesh
4949893|NCT01860274|Graft|graft
4949894|NCT01860274|Patency|patency
4949895|NCT01860261|HIV|hiv
4949896|NCT01860261|AIDS|aids
4949897|NCT01860261|sedentary|sedentary
4949898|NCT01860261|fitness|fitness
4949899|NCT01860261|aging|aging
4949900|NCT01860261|V02max|v02max
4949901|NCT01860261|d-dimer|d-dimer
4949902|NCT01860261|IL-6|il-6
4949903|NCT01860261|CRP|crp
4949904|NCT01860261|ChiWalking|chiwalking
4949905|NCT01860261|ChiRunning|chirunning
4949906|NCT01860261|aerobic exercise|aerobic exercise
4949907|NCT01860261|strength training|strength training
4949908|NCT01860248|vapocoolant effectiveness|vapocoolant effectiveness
4949909|NCT01860248|arterial puncture|arterial puncture
4949910|NCT01860235|Local anesthesia|local anesthesia
4949911|NCT01860235|Pain measurement|pain measurement
4949912|NCT01860235|Pain perception|pain perception
4949913|NCT01860235|Dental anesthesia|dental anesthesia
4949914|NCT01860235|Root planing|root planing
4949915|NCT01860222|Hepatocellular carcinoma|hepatocellular carcinoma
4949916|NCT01860222|CSPH|csph
4949917|NCT01860222|Hepatectomy|hepatectomy
4949918|NCT01860222|percutaneous local ablative|percutaneous local ablative
4949919|NCT01860222|therapy (PLAT)|therapy (plat)
4949920|NCT01860222|randomized controlled trials(RCTs)|randomized controlled trials(rcts)
4949921|NCT01860209|obstructive sleep apnea|obstructive sleep apnea
4949922|NCT01860209|overhydration|overhydration
4949923|NCT01860209|end stage renal disease|end stage renal disease
4949924|NCT01860209|intermittent ambulatory hemodialysis|intermittent ambulatory hemodialysis
4949925|NCT01860209|polysomnography|polysomnography
4949926|NCT01860209|bioimpedance|bioimpedance
4949927|NCT01860209|leg fluid shift|leg fluid shift
4949928|NCT01860209|neck circumference|neck circumference
4949929|NCT01860183|kidney transplantation|kidney transplantation
4949930|NCT01860183|chronic allograft dysfunction|chronic allograft dysfunction
4949931|NCT01860183|mycophenolate mofetil|mycophenolate mofetil
4949932|NCT01860183|Chronic|chronic
4949933|NCT01860170|Blood and Marrow Transplant (BMT)|blood and marrow transplant (bmt)
4949934|NCT01860170|MRD|mrd
4949935|NCT01860170|MUD|mud
4949936|NCT01860170|GVHD|gvhd
4949937|NCT01860157|rTMS|rtms
4949938|NCT01860157|depression|depression
4949939|NCT01860157|magnetic|magnetic
4949940|NCT01860144|bevacizumab|bevacizumab
4949941|NCT01860144|overall survival|overall survival
4949942|NCT01860144|adverse events|adverse events
4949943|NCT01860144|tumor resection rate|tumor resection rate
4949944|NCT01860131|bariatrics, lifestyle and behavioral modification programs|bariatrics, lifestyle and behavioral modification programs
4949945|NCT01860079|Early discharge|early discharge
4949946|NCT01860079|STEMI|stemi
4949947|NCT01860079|PPCI|ppci
4949948|NCT01860066|COPD|copd
4949949|NCT01860014|Pulmonary hemorrhage|pulmonary hemorrhage
4949950|NCT01860014|Mortality|mortality
4949951|NCT01860014|Newborn|newborn
4949952|NCT01860001|cancer|cancer
4949953|NCT01860001|metabolic acidosis|metabolic acidosis
4949954|NCT01859988|Eczema|eczema
4949955|NCT01859962|Liver diseases|liver diseases
4949956|NCT01859962|Virus diseases|virus diseases
4949957|NCT01859962|Ribavirin|ribavirin
4949958|NCT01859962|protease inhibitor|protease inhibitor
4949959|NCT01859962|NS5B polymerase inhibitor|ns5b polymerase inhibitor
4949960|NCT01859962|NS5A inhibitor|ns5a inhibitor
4949961|NCT01859949|Genotropin(somatropin)|genotropin(somatropin)
4949962|NCT01859949|SGA|sga
4949963|NCT01859949|Short Stature|short stature
4949964|NCT01859949|Long-term|long-term
4949965|NCT01859949|Safety|safety
4949966|NCT01859923|Tuberculosis|tuberculosis
4949967|NCT01859923|Tuberculosis, Multidrug-Resistant|tuberculosis, multidrug-resistant
4949968|NCT01859923|Mycobacterium Infections|mycobacterium infections
4949969|NCT01859923|Actinomycetales Infections|actinomycetales infections
4949970|NCT01859923|Gram-Positive Infections|gram-positive infections
4949971|NCT01859923|Bacterial Infections|bacterial infections
4949972|NCT01859923|Pediatric|pediatric
4949973|NCT01859884|Kidney transplantation|kidney transplantation
4949974|NCT01859884|Increased risk donor kidneys|increased risk donor kidneys
4949975|NCT01859884|Kidney donation|kidney donation
4949976|NCT01859884|Organ donation|organ donation
4949977|NCT01859884|Human Immunodeficiency Virus|human immunodeficiency virus
4949978|NCT01859884|Hepatitis B|hepatitis b
4949979|NCT01859884|Hepatitis C|hepatitis c
4949980|NCT01859884|Infectious disease|infectious disease
4949981|NCT01859884|Disease transmission|disease transmission
4949982|NCT01859884|Centers for Disease Control (CDC)|centers for disease control (cdc)
4949983|NCT01859884|Web-based intervention|web-based intervention
4949984|NCT01859871|Living kidney donation|living kidney donation
4949985|NCT01859871|End-stage renal disease|end-stage renal disease
4949986|NCT01859871|Latinos|latinos
4949987|NCT01859871|Undocumented Immigrants|undocumented immigrants
4949988|NCT01859871|Bilingual|bilingual
4949989|NCT01859871|Spanish|spanish
4949990|NCT01859871|Website|website
4949991|NCT01859871|Dialysis|dialysis
4949992|NCT01859871|Hispanics|hispanics
4949993|NCT01859871|Transplantation|transplantation
4949994|NCT01859858|mCRC (metastatic colorectal cancer)|mcrc (metastatic colorectal cancer)
4949995|NCT01859858|CRC (colorectal cancer)|crc (colorectal cancer)
4949996|NCT01859858|Advanced colorectal cancer|advanced colorectal cancer
4949997|NCT01859858|Metastatic colorectal cancer|metastatic colorectal cancer
4949998|NCT01859858|Colon cancer|colon cancer
4949999|NCT01859845|Melanoma|melanoma
4950000|NCT01859845|Opportunistic surveillance|opportunistic surveillance
4950001|NCT01859845|Melanoma simulation model|melanoma simulation model
4950002|NCT01859845|Smartphone devices|smartphone devices
4950003|NCT01859832|renal transplant|renal transplant
4950004|NCT01859832|kidney transplantation|kidney transplantation
4950005|NCT01859832|immune status|immune status
4950006|NCT01859832|immunosuppressive medications|immunosuppressive medications
4950007|NCT01859819|Pediatric|pediatric
4950008|NCT01859819|Lymphoma (NOT primary mediastinal B-cell lymphoma)|lymphoma (not primary mediastinal b-cell lymphoma)
4950009|NCT01859819|B-Cell---Burkitt's like|b-cell---burkitt's like
4950010|NCT01859819|Rituximab|rituximab
4950011|NCT01859819|Liposomal ARA-C|liposomal ara-c
4950012|NCT01859806|periampullary tumour|periampullary tumour
4950013|NCT01859806|isolated Roux loop PJ|isolated roux loop pj
4950014|NCT01859806|PG|pg
4950015|NCT01859793|dipeptidyl peptidase-4 inhibitor|dipeptidyl peptidase-4 inhibitor
4950016|NCT01859793|endothelium, vascular|endothelium, vascular
4950017|NCT01859793|diabetes type 2|diabetes type 2
4950018|NCT01859793|nitric oxide|nitric oxide
4950019|NCT01859793|inflammation|inflammation
4950020|NCT01859780|Poison control|poison control
4950021|NCT01859780|Child resistant packaging|child resistant packaging
4950022|NCT01859780|prescription vials|prescription vials
4950023|NCT01859780|prescription blisters|prescription blisters
4950024|NCT01859780|drug packaging|drug packaging
4950025|NCT01859767|Alzheimer's disease|alzheimer's disease
4950026|NCT01859767|SPECT|spect
4950027|NCT01859754|Primary Immune Deficiency Syndrome|primary immune deficiency syndrome
4950028|NCT01859754|Primary immunodeficiency Disease (PIDD)|primary immunodeficiency disease (pidd)
4950029|NCT01859754|PID|pid
4950030|NCT01859741|Newly diagnosed Stage IV Small Cell Lung Cancer|newly diagnosed stage iv small cell lung cancer
4950031|NCT01859728|biliary cancer|biliary cancer
4950032|NCT01859728|irinotecan|irinotecan
4950033|NCT01859728|cisplatin|cisplatin
4950034|NCT01859728|gemcitabine|gemcitabine
4950035|NCT01859715|Drug Interactions|drug interactions
4950036|NCT01859715|CYP2D6|cyp2d6
4950037|NCT01859715|opioid efficacy|opioid efficacy
4950038|NCT01859715|pain|pain
4950039|NCT01859715|nausea|nausea
4950040|NCT01859702|Aqueous Humor|aqueous humor
4950041|NCT01859702|Moxifloxacin|moxifloxacin
4950042|NCT01859702|Vigadexa|vigadexa
4950043|NCT01859663|Polycystic Ovary Syndrome (PCOS)|polycystic ovary syndrome (pcos)
4950044|NCT01859663|Diet|diet
4950045|NCT01859663|Exercise|exercise
4950046|NCT01859663|Questionnaires|questionnaires
4950047|NCT01859663|Health Beliefs|health beliefs
4950048|NCT01859637|Filgrastim, immunogenicity, severe chronic neutropenia|filgrastim, immunogenicity, severe chronic neutropenia
4950049|NCT01859624|LOPD|lopd
4950050|NCT01859624|Pompe Disease|pompe disease
4950051|NCT01859598|diabetes|diabetes
4950052|NCT01859598|basal insulin|basal insulin
4950053|NCT01859598|effectiveness and safety|effectiveness and safety
4950054|NCT01859598|oral antidiabetic drugs|oral antidiabetic drugs
4950055|NCT01859598|real world clinical practice|real world clinical practice
4950056|NCT01859585|preemptive analgesia|preemptive analgesia
4950057|NCT01859585|lumbar fusion|lumbar fusion
4950058|NCT01859585|Parecoxib|parecoxib
4950059|NCT01859585|Ketorolac|ketorolac
4950060|NCT01859572|Stroke|stroke
4950061|NCT01859572|Cerebral Infarction|cerebral infarction
4950062|NCT01859572|Brain Disorders|brain disorders
4950063|NCT01859572|Central Nervous System Diseases|central nervous system diseases
4950064|NCT01859572|Nervous System Diseases|nervous system diseases
4950065|NCT01859572|Vascular Diseases|vascular diseases
4950066|NCT01859572|Cardiovascular Diseases|cardiovascular diseases
4950067|NCT01859572|Brain Infarction|brain infarction
4950068|NCT01859572|Brain Ischaemia|brain ischaemia
4950069|NCT01859559|ultrasound|ultrasound
4950070|NCT01859559|peripheral intravenous access|peripheral intravenous access
4950071|NCT01859559|operator experience|operator experience
4950072|NCT01859546|SMS|sms
4950073|NCT01859520|Spermatozoa|spermatozoa
4950074|NCT01859520|DNA fragmentation|dna fragmentation
4950075|NCT01859520|Swim-up|swim-up
4950076|NCT01859520|Density gradient|density gradient
4950077|NCT01859507|Vaginismus|vaginismus
4950078|NCT01859507|Botox|botox
4950079|NCT01859507|Sex|sex
4950080|NCT01859507|Clostridium|clostridium
4950081|NCT01859507|Botulinum|botulinum
4950082|NCT01859507|Neurotoxin|neurotoxin
4950083|NCT01859507|Perineal|perineal
4950084|NCT01859507|Muscles|muscles
4950085|NCT01859455|Hypercholesterolemia,|hypercholesterolemia,
4950086|NCT01859455|LDL cholesterol lowering,|ldl cholesterol lowering,
4950087|NCT01859455|proprotein convertase subtilisin/kexin type 9 (PCSK9),|proprotein convertase subtilisin/kexin type 9 (pcsk9),
4950088|NCT01859455|LGT209,|lgt209,
4950089|NCT01859455|drug safety,|drug safety,
4950090|NCT01859455|pharmacokinetics,|pharmacokinetics,
4950091|NCT01859455|pharmacodynamics|pharmacodynamics
4950092|NCT01859429|Cancer patients|cancer patients
4950093|NCT01859429|Psycho-oncological Care Provision|psycho-oncological care provision
4950094|NCT01859429|Structured Screening|structured screening
4950095|NCT01859429|Stepped care|stepped care
4950096|NCT01859403|veteran|veteran
4950097|NCT01859403|obesity|obesity
4950098|NCT01859403|personalized genomics|personalized genomics
4950099|NCT01859390|Antioxidants|antioxidants
4950100|NCT01859390|Vitamins|vitamins
4950101|NCT01859390|Inflammation|inflammation
4950102|NCT01859390|Oxidative stress|oxidative stress
4950103|NCT01859364|Tobacco|tobacco
4950104|NCT01859364|Smoking|smoking
4950105|NCT01859364|Smoking Cessation|smoking cessation
4950106|NCT01859364|Outcome|outcome
4950107|NCT01859364|Nicotine Dependence|nicotine dependence
4950108|NCT01859325|HIV-MAG pDNA Prime|hiv-mag pdna prime
4950109|NCT01859325|HIV Therapy|hiv therapy
4950110|NCT01859325|Therapeutic Vaccine|therapeutic vaccine
4950111|NCT01859312|Glucocorticoids|glucocorticoids
4950112|NCT01859312|Adrenal Insufficiency|adrenal insufficiency
4950113|NCT01859312|Congenital Adrenal Hyperplasia (CAH)|congenital adrenal hyperplasia (cah)
4950114|NCT01859312|Adrenal|adrenal
4950115|NCT01859299|Oral Tolerance|oral tolerance
4950116|NCT01859299|Uveitis|uveitis
4950117|NCT01859299|AMD|amd
4950118|NCT01859273|renal failure|renal failure
4950119|NCT01859273|medication adherence|medication adherence
4950120|NCT01859273|hypertension|hypertension
4950121|NCT01859260|chronic kidney disease, acute kidney injury, obstructive sleep apnea|chronic kidney disease, acute kidney injury, obstructive sleep apnea
4950122|NCT01859247|cervical dystonia|cervical dystonia
4950123|NCT01859247|torticollis|torticollis
4950124|NCT01859247|rTMS|rtms
4950125|NCT01859234|multiple myeloma|multiple myeloma
4950126|NCT01859234|PET scan|pet scan
4950127|NCT01859221|Prostate cancer|prostate cancer
4950128|NCT01859221|Oligometastatic prostate cancer|oligometastatic prostate cancer
4950129|NCT01859221|Proton radiation|proton radiation
4950130|NCT01859195|HIV/STI|hiv/sti
4950131|NCT01859195|Prevention|prevention
4950132|NCT01859195|Microbicides, Topical|microbicides, topical
4950133|NCT01859169|bili duct neoplasms|bili duct neoplasms
4950134|NCT01859169|bile duct cancer|bile duct cancer
4950135|NCT01859169|photodynamic therapy|photodynamic therapy
4950136|NCT01859169|biliary drainage|biliary drainage
4950137|NCT01859156|Carbon Monoxide|carbon monoxide
4950138|NCT01859156|Carboxyhemoglobin|carboxyhemoglobin
4950139|NCT01859156|End-tidal carbon dioxide|end-tidal carbon dioxide
4950140|NCT01859156|Capnography|capnography
4950141|NCT01859143|Trivalent|trivalent
4950142|NCT01859143|Influenza|influenza
4950143|NCT01859143|FluMist Quadrivalent|flumist quadrivalent
4950144|NCT01859143|Vaccine|vaccine
4950145|NCT01859143|Prevention|prevention
4950146|NCT01859143|Healthy|healthy
4950147|NCT01859117|Peripheral arterial disease|peripheral arterial disease
4950148|NCT01859117|diabetic foot|diabetic foot
4950149|NCT01859091|Lipolysis|lipolysis
4950150|NCT01859091|Cryolipolysis|cryolipolysis
4950151|NCT01859091|Fat Reduction|fat reduction
4950152|NCT01859065|Non-urgent ED visits|non-urgent ed visits
4950153|NCT01859065|Neonates|neonates
4950154|NCT01859065|Newborn care|newborn care
4950155|NCT01859052|migraine|migraine
4950156|NCT01859052|obesity|obesity
4950157|NCT01859052|low fat diet|low fat diet
4950158|NCT01859052|low carbohydrate diet|low carbohydrate diet
4950159|NCT01859039|Egg allergy|egg allergy
4950160|NCT01859039|Anaphylaxis|anaphylaxis
4950161|NCT01859039|Children|children
4950162|NCT01859039|Influenza vaccine|influenza vaccine
4950163|NCT01859026|Epidermal growth factor receptor (EGFR)|epidermal growth factor receptor (egfr)
4950164|NCT01859026|EGFR mutation|egfr mutation
4950165|NCT01859026|Kirsten rat sarcoma 2 viral oncogene homolog(KRAS)|kirsten rat sarcoma 2 viral oncogene homolog(kras)
4950166|NCT01859026|KRAS mutation|kras mutation
4950167|NCT01859026|Non-Small Cell Lung Cancer (NSCLC)|non-small cell lung cancer (nsclc)
4950168|NCT01859026|Advanced-stage IV|advanced-stage iv
4950169|NCT01859000|Adolescents|adolescents
4950170|NCT01859000|Hurricane Katrina|hurricane katrina
4950171|NCT01859000|Family-based treatment|family-based treatment
4950172|NCT01859000|Multidimensional Family Therapy|multidimensional family therapy
4950173|NCT01859000|Group CBT|group cbt
4950174|NCT01858974|multiplex PCR|multiplex pcr
4950175|NCT01858974|MALDI-TOF|maldi-tof
4950176|NCT01858974|pneumonia|pneumonia
4950282|NCT01858532|Diabetes|diabetes
4950177|NCT01858974|microbiological investigation|microbiological investigation
4950178|NCT01858974|intensive care|intensive care
4950179|NCT01858948|Bipolar disorder|bipolar disorder
4950180|NCT01858948|Second-generation antipsychotics|second-generation antipsychotics
4950181|NCT01858948|Obesity|obesity
4950182|NCT01858948|Cardiometabolic risk|cardiometabolic risk
4950183|NCT01858922|Hodgkin's Lymphoma|hodgkin's lymphoma
4950184|NCT01858922|ABVE-PC|abve-pc
4950185|NCT01858922|doxorubicin|doxorubicin
4950186|NCT01858922|bleomycin|bleomycin
4950187|NCT01858922|vincristine|vincristine
4950188|NCT01858922|etoposide|etoposide
4950189|NCT01858922|prednisone|prednisone
4950190|NCT01858922|cyclophosphamide|cyclophosphamide
4950191|NCT01858922|DECA|deca
4950192|NCT01858922|decadron|decadron
4950193|NCT01858922|cisplatin|cisplatin
4950194|NCT01858922|cytarabine|cytarabine
4950195|NCT01858922|Radiation|radiation
4950196|NCT01858909|Sepsis|sepsis
4950197|NCT01858896|hypoglycemia|hypoglycemia
4950198|NCT01858896|GLP-1|glp-1
4950199|NCT01858896|Type 2 diabetes|type 2 diabetes
4950200|NCT01858896|endothelial function|endothelial function
4950201|NCT01858870|Lacosamide|lacosamide
4950202|NCT01858870|Partial Crisis|partial crisis
4950203|NCT01858857|geriatric psychiatry|geriatric psychiatry
4950204|NCT01858857|pharmacovigilance|pharmacovigilance
4950205|NCT01858818|CAIS Computer Assisted Infusion System|cais computer assisted infusion system
4950206|NCT01858818|real life drinking behavior|real life drinking behavior
4950207|NCT01858818|family history of alcoholism|family history of alcoholism
4950208|NCT01858818|conditioning|conditioning
4950209|NCT01858818|instrumental learning|instrumental learning
4950210|NCT01858818|habitization|habitization
4950211|NCT01858805|esophagus carcinoma|esophagus carcinoma
4950212|NCT01858805|surgery|surgery
4950213|NCT01858805|circulating tumor cells|circulating tumor cells
4950214|NCT01858779|stroke|stroke
4950215|NCT01858779|atrial fibrillation|atrial fibrillation
4950216|NCT01858779|secondary prevention of stroke|secondary prevention of stroke
4950217|NCT01858779|peripheral pulse measurement|peripheral pulse measurement
4950218|NCT01858766|Hepatitis|hepatitis
4950219|NCT01858766|HCV Genotype 1|hcv genotype 1
4950220|NCT01858766|HCV Genotype 2|hcv genotype 2
4950221|NCT01858766|HCV Genotype 3|hcv genotype 3
4950222|NCT01858766|HCV Genotype 4|hcv genotype 4
4950223|NCT01858766|HCV Genotype 5|hcv genotype 5
4950224|NCT01858766|HCV Genotype 6|hcv genotype 6
4950225|NCT01858766|treatment naive|treatment naive
4950226|NCT01858753|burn scars|burn scars
4950227|NCT01858753|restrictive|restrictive
4950228|NCT01858753|contractures|contractures
4950229|NCT01858753|autologous fibroblasts|autologous fibroblasts
4950230|NCT01858727|forced-air|forced-air
4950231|NCT01858727|hypothermia|hypothermia
4950232|NCT01858727|TUR-P surgery|tur-p surgery
4950233|NCT01858727|core temperatures|core temperatures
4950234|NCT01858727|prewarming|prewarming
4950235|NCT01858727|general anaesthesia|general anaesthesia
4950236|NCT01858714|obesity|obesity
4950237|NCT01858714|overweight|overweight
4950238|NCT01858714|weight loss|weight loss
4950239|NCT01858701|myopia|myopia
4950240|NCT01858701|hyperopia|hyperopia
4950241|NCT01858701|astigmatism|astigmatism
4950242|NCT01858701|contact lenses|contact lenses
4950243|NCT01858688|Prostate Cancer|prostate cancer
4950244|NCT01858688|MRI|mri
4950245|NCT01858688|Active surveillance in prostate cancer|active surveillance in prostate cancer
4950246|NCT01858675|ProADM|proadm
4950247|NCT01858675|ProANP|proanp
4950248|NCT01858675|proendothelin|proendothelin
4950249|NCT01858675|proAVP|proavp
4950250|NCT01858675|Cr 51|cr 51
4950251|NCT01858675|Volemia|volemia
4950252|NCT01858675|fluid management|fluid management
4950253|NCT01858675|ICU patients|icu patients
4950254|NCT01858675|poly trauma patients|poly trauma patients
4950255|NCT01858662|metastatic colorectal cancer|metastatic colorectal cancer
4950256|NCT01858662|Liver|liver
4950257|NCT01858662|cetuximab|cetuximab
4950258|NCT01858662|Pathological response|pathological response
4950259|NCT01858649|metastatic|metastatic
4950260|NCT01858649|colorectal|colorectal
4950261|NCT01858649|cancer|cancer
4950262|NCT01858649|liver|liver
4950263|NCT01858649|Bevacizumab|bevacizumab
4950264|NCT01858649|Pathological response|pathological response
4950265|NCT01858623|Healthy Normotensive Participants|healthy normotensive participants
4950266|NCT01858623|Fixed dose combination|fixed dose combination
4950267|NCT01858623|Pharmacokinetics|pharmacokinetics
4950268|NCT01858623|Losartan|losartan
4950269|NCT01858623|Hydrochlorothiazide|hydrochlorothiazide
4950270|NCT01858610|Fixed dose combination|fixed dose combination
4950271|NCT01858610|Pharmacokinetics|pharmacokinetics
4950272|NCT01858610|Irbesartan|irbesartan
4950273|NCT01858610|Hydrochlorothiazide|hydrochlorothiazide
4950274|NCT01858610|Pharmacodynamics|pharmacodynamics
4950275|NCT01858610|Normotensive Participants|normotensive participants
4950276|NCT01858597|GDM, FGF|gdm, fgf
4950277|NCT01858584|GER|ger
4950278|NCT01858584|Alginate|alginate
4950279|NCT01858584|Regurgitation|regurgitation
4950280|NCT01858584|questionnaire|questionnaire
4950281|NCT01858571|Childhood Cancer|childhood cancer
4950283|NCT01858532|Nephropathy|nephropathy
4950284|NCT01858519|pancreatic enzyme replacement therapy|pancreatic enzyme replacement therapy
4950285|NCT01858519|antibodies|antibodies
4950286|NCT01858519|porcine viruses|porcine viruses
4950287|NCT01858519|epidemiology|epidemiology
4950288|NCT01858519|prospective|prospective
4950289|NCT01858506|Type 2 diabetes mellitus|type 2 diabetes mellitus
4950290|NCT01858506|Lifestyle counselling|lifestyle counselling
4950291|NCT01858506|Lifestyle assessment|lifestyle assessment
4950292|NCT01858506|Randomized controlled trial|randomized controlled trial
4950293|NCT01858506|Diabetes education|diabetes education
4950294|NCT01858493|Urinary incontinence|urinary incontinence
4950295|NCT01858493|Falls|falls
4950296|NCT01858493|Quality of life|quality of life
4950297|NCT01858493|Stigma|stigma
4950298|NCT01858493|Community-dwelling older women|community-dwelling older women
4950299|NCT01858493|Continence promotion|continence promotion
4950300|NCT01858480|CHF|chf
4950301|NCT01858467|Airway, Cesarean|airway, cesarean
4950302|NCT01858402|Pediatric spinal anesthesia, paracetamol, dipyrone|pediatric spinal anesthesia, paracetamol, dipyrone
4950303|NCT01858389|Non-small cell lung cancer|non-small cell lung cancer
4950304|NCT01858389|T790M mutation. dacomitinib|t790m mutation. dacomitinib
4950305|NCT01858376|LDL cholesterol|ldl cholesterol
4950306|NCT01858376|anti-hyperlipidemic|anti-hyperlipidemic
4950307|NCT01858376|hyperlipidemic|hyperlipidemic
4950308|NCT01858376|Capros|capros
4950309|NCT01858376|Natural Supplement|natural supplement
4950310|NCT01858363|Peripheral arterial disease|peripheral arterial disease
4950311|NCT01858363|claudication|claudication
4950312|NCT01858363|drug-coated balloon|drug-coated balloon
4950313|NCT01858363|drug-eluting balloon|drug-eluting balloon
4950314|NCT01858350|CAM|cam
4950315|NCT01858350|Sedation|sedation
4950316|NCT01858350|MRI|mri
4950317|NCT01858350|Music Therapy|music therapy
4950318|NCT01858337|weaning|weaning
4950319|NCT01858337|infants|infants
4950320|NCT01858337|vegetables|vegetables
4950321|NCT01858337|repeated-exposure|repeated-exposure
4950322|NCT01858324|Preeclampsia|preeclampsia
4950323|NCT01858324|Hypertensive disorders of pregnancy|hypertensive disorders of pregnancy
4950324|NCT01858324|Patient education|patient education
4950325|NCT01858324|Educationnal tools|educationnal tools
4950326|NCT01858324|Pamphlet|pamphlet
4950327|NCT01858324|Video|video
4950328|NCT01858324|Knowledge|knowledge
4950329|NCT01858324|Anxiety|anxiety
4950330|NCT01858324|Satisfaction|satisfaction
4950331|NCT01858311|Stroke survivors|stroke survivors
4950332|NCT01858311|TIA survivors|tia survivors
4950333|NCT01858311|Vitamin E|vitamin e
4950334|NCT01858311|Carotech|carotech
4950335|NCT01858311|Tocotrienol|tocotrienol
4950336|NCT01858298|Dental caries|dental caries
4950337|NCT01858298|Quality of Life|quality of life
4950338|NCT01858298|Pulpectomy|pulpectomy
4950339|NCT01858298|Tooth extraction|tooth extraction
4950340|NCT01858285|Epilepsy|epilepsy
4950341|NCT01858285|Ohtahara|ohtahara
4950342|NCT01858285|Dravet|dravet
4950343|NCT01858285|MMPEI|mmpei
4950344|NCT01858285|EMEE|emee
4950345|NCT01858285|EIEE|eiee
4950346|NCT01858246|Hearing Loss, Conductive|hearing loss, conductive
4950347|NCT01858246|Bone Conduction|bone conduction
4950348|NCT01858246|bone conduction thresholds better than 45 dBHL|bone conduction thresholds better than 45 dbhl
4950349|NCT01858233|Gestational diabetes|gestational diabetes
4950350|NCT01858220|Gastroparesis|gastroparesis
4950351|NCT01858220|Small bowel video capsule|small bowel video capsule
4950352|NCT01858220|gastric retention|gastric retention
4950353|NCT01858207|HCC|hcc
4950354|NCT01858207|hepatocellular carcinoma|hepatocellular carcinoma
4950355|NCT01858207|liver cancer|liver cancer
4950356|NCT01858194|Tachycardia, Renal Sympathetic Denervation|tachycardia, renal sympathetic denervation
4950357|NCT01858194|Catheter Ablation|catheter ablation
4950358|NCT01858194|Cardioverter-Defibrillator|cardioverter-defibrillator
4950359|NCT01858142|Pediatric anesthesia|pediatric anesthesia
4950360|NCT01858142|Pre-operative anxiety|pre-operative anxiety
4950361|NCT01858142|parental presence|parental presence
4950362|NCT01858142|children|children
4950363|NCT01858142|elective surgical procedures|elective surgical procedures
4950364|NCT01858142|mask induction|mask induction
4950365|NCT01858129|TTN|ttn
4950366|NCT01858103|Mucopolysaccharidosis IVA Type A|mucopolysaccharidosis iva type a
4950367|NCT01858103|MPS IVA Type A|mps iva type a
4950368|NCT01858103|Mucopolysaccharidosis IVA|mucopolysaccharidosis iva
4950369|NCT01858103|MPS IVA|mps iva
4950370|NCT01858103|Morquio A Syndrome|morquio a syndrome
4950371|NCT01858103|Lysosomal Storage Disorder|lysosomal storage disorder
4950372|NCT01858103|LSD|lsd
4950373|NCT01858103|N-acetylgalactosamine-6-sulfatase|n-acetylgalactosamine-6-sulfatase
4950374|NCT01858103|N-acetylgalactosamine-6-sulfate|n-acetylgalactosamine-6-sulfate
4950375|NCT01858090|spinal anesthesia|spinal anesthesia
4950376|NCT01858090|caesarean section|caesarean section
4950377|NCT01858090|local anesthetics|local anesthetics
4950378|NCT01858090|levobupivacaine|levobupivacaine
4950379|NCT01858090|sufentanil|sufentanil
4950380|NCT01858090|fentanyl|fentanyl
4950381|NCT01858090|above 18 years of age|above 18 years of age
4950382|NCT01858090|pregnant women|pregnant women
4950383|NCT01858090|multiparous|multiparous
4950384|NCT01858090|nulliparous|nulliparous
4950385|NCT01858064|ADHD|adhd
4950386|NCT01858064|OROS-MPH|oros-mph
4950387|NCT01858064|Adults|adults
4950388|NCT01858064|Functional Magnetic Resonance Imaging|functional magnetic resonance imaging
4950389|NCT01858051|Vitamin D|vitamin d
4950390|NCT01858051|Perioperative immune regulation|perioperative immune regulation
4950391|NCT01858051|LL-37|ll-37
4950392|NCT01858051|Hospital-acquired infection|hospital-acquired infection
4950393|NCT01858051|Surgical site infections|surgical site infections
4950394|NCT01858038|Scar|scar
4950395|NCT01858012|insulin resistance|insulin resistance
4950396|NCT01857999|Renin-aldosterone system|renin-aldosterone system
4950397|NCT01857999|Hemodynamic|hemodynamic
4950398|NCT01857999|Low cardiac output|low cardiac output
4950399|NCT01857999|Vasodilation|vasodilation
4950400|NCT01857999|Natriuretic peptide|natriuretic peptide
4950401|NCT01857986|Endotracheal intubation|endotracheal intubation
4950402|NCT01857986|Mechanical ventilation|mechanical ventilation
4950403|NCT01857986|Critical care|critical care
4950404|NCT01857973|HCL|hcl
4950405|NCT01857973|Type 1 Diabetes|type 1 diabetes
4950406|NCT01857973|Sensor|sensor
4950407|NCT01857960|Acne|acne
4950408|NCT01857960|Treatment|treatment
4950409|NCT01857960|Cost|cost
4950410|NCT01857960|Behavior|behavior
4950411|NCT01857947|AECOPD Mr ProADM Biomarkers ER Outcome|aecopd mr proadm biomarkers er outcome
4950412|NCT01857934|Anti-GD2 monoclonal antibody|anti-gd2 monoclonal antibody
4950413|NCT01857934|hu14.18K322A|hu14.18k322a
4950414|NCT01857934|High-risk neuroblastoma|high-risk neuroblastoma
4950415|NCT01857934|Phase II|phase ii
4950416|NCT01857934|Allogeneic NK cells|allogeneic nk cells
4950417|NCT01857908|Adenocarcinoma|adenocarcinoma
4950418|NCT01857908|Abiraterone|abiraterone
4950419|NCT01857908|Abiraterone Acetate|abiraterone acetate
4950420|NCT01857908|Zytiga|zytiga
4950421|NCT01857908|Correlative study|correlative study
4950422|NCT01857908|Castrate Resistant Prostate Cancer|castrate resistant prostate cancer
4950423|NCT01857908|Abiraterone Correlative study|abiraterone correlative study
4950424|NCT01857895|Nausea|nausea
4950425|NCT01857895|subcutaneous infusion|subcutaneous infusion
4950426|NCT01857895|exenatide|exenatide
4950427|NCT01857882|breast cancer|breast cancer
4950428|NCT01857882|breast reconstruction|breast reconstruction
4950429|NCT01857882|shared decision making|shared decision making
4950430|NCT01857882|decision support intervention|decision support intervention
4950431|NCT01857869|Efficacy|efficacy
4950432|NCT01857869|Sporozoite challenge model|sporozoite challenge model
4950433|NCT01857869|Malaria|malaria
4950434|NCT01857869|Immunogenicity|immunogenicity
4950435|NCT01857869|Malaria- naïve adults|malaria- naïve adults
4950436|NCT01857869|Safety|safety
4950437|NCT01857856|Phospholamban|phospholamban
4950438|NCT01857856|cardiomyopathy|cardiomyopathy
4950439|NCT01857856|Eplerenone|eplerenone
4950440|NCT01857856|presymptomatic|presymptomatic
4950441|NCT01857830|Telomerase|telomerase
4950442|NCT01857830|Telomere Length|telomere length
4950443|NCT01857830|Psychological Stress|psychological stress
4950444|NCT01857830|Amyloid beta proteins|amyloid beta proteins
4950445|NCT01857830|Meditation|meditation
4950446|NCT01857804|peri-implantitis|peri-implantitis
4950447|NCT01857804|surgical therapy|surgical therapy
4950448|NCT01857804|systemic antibiotics|systemic antibiotics
4950449|NCT01857804|local antiseptics|local antiseptics
4950450|NCT01857778|Breastfeeding|breastfeeding
4950451|NCT01857778|Breast tissue|breast tissue
4950452|NCT01857778|Breast pump|breast pump
4950453|NCT01857765|rehabilitation|rehabilitation
4950454|NCT01857765|reconstructive surgery|reconstructive surgery
4950455|NCT01857752|Retinoblastoma|retinoblastoma
4950456|NCT01857726|hepatocellular carcinoma|hepatocellular carcinoma
4950457|NCT01857726|portal vein invasion|portal vein invasion
4950458|NCT01857726|transarterial chemoembolization|transarterial chemoembolization
4950459|NCT01857726|transarterial chemoinfusion|transarterial chemoinfusion
4950460|NCT01857674|Laryngeal edema|laryngeal edema
4950461|NCT01857674|Post-extubation|post-extubation
4950462|NCT01857674|Acute respiratory distress|acute respiratory distress
4950463|NCT01857674|Ultrasonography|ultrasonography
4950464|NCT01857674|Intensive care unit|intensive care unit
4950465|NCT01857661|tinnitus|tinnitus
4950466|NCT01857661|hearing loss|hearing loss
4950467|NCT01857661|hearing devices|hearing devices
4950468|NCT01857648|Physical Activity|physical activity
4950469|NCT01857648|Health Promotion|health promotion
4950470|NCT01857648|Primary Health Care|primary health care
4950471|NCT01857648|Intervention Studies|intervention studies
4950472|NCT01857648|Public health Practice|public health practice
4950473|NCT01857635|Acute respiratory failure|acute respiratory failure
4950474|NCT01857635|Hypercapnia|hypercapnia
4950475|NCT01857635|Non invasive ventilation|non invasive ventilation
4950476|NCT01857635|Transcutaneous CO2 measurement|transcutaneous co2 measurement
4950477|NCT01857622|anticoagulant|anticoagulant
4950478|NCT01857622|DU-176b|du-176b
4950479|NCT01857622|edoxaban|edoxaban
4950480|NCT01857622|factor Xa|factor xa
4950481|NCT01857622|oral|oral
4950482|NCT01857622|atrial fibrillation|atrial fibrillation
4950582|NCT01857245|Dose|dose
4950483|NCT01857622|severe renal impairment|severe renal impairment
4950484|NCT01857609|Metformin|metformin
4950485|NCT01857609|Proton pump inhibitor|proton pump inhibitor
4950486|NCT01857609|Drug interaction|drug interaction
4950487|NCT01857596|Female Sexual Dysfunction|female sexual dysfunction
4950488|NCT01857596|Hypoactive Sexual Desire Disorder|hypoactive sexual desire disorder
4950489|NCT01857596|Sexual Interest/Arousal Disorder|sexual interest/arousal disorder
4950490|NCT01857596|Lorexys|lorexys
4950491|NCT01857596|Premenopausal female health|premenopausal female health
4950492|NCT01857583|anticoagulant|anticoagulant
4950493|NCT01857583|DU-176b|du-176b
4950494|NCT01857583|edoxaban|edoxaban
4950495|NCT01857583|factor Xa|factor xa
4950496|NCT01857583|oral|oral
4950497|NCT01857583|orthopedic surgery of lower limbs|orthopedic surgery of lower limbs
4950498|NCT01857583|severe renal impairment|severe renal impairment
4950499|NCT01857570|Radius fracture|radius fracture
4950500|NCT01857570|Scaphoid fracture|scaphoid fracture
4950501|NCT01857570|Tomography, x-ray computed|tomography, x-ray computed
4950502|NCT01857557|Exercise|exercise
4950503|NCT01857557|Fitness program|fitness program
4950504|NCT01857544|Retinal Vein Occlusion|retinal vein occlusion
4950505|NCT01857544|Central Retinal Vein Occlusion|central retinal vein occlusion
4950506|NCT01857544|Macular Edema|macular edema
4950507|NCT01857531|Smoking Cessation|smoking cessation
4950508|NCT01857531|Quit Smoking|quit smoking
4950509|NCT01857531|Ganaxolone|ganaxolone
4950510|NCT01857531|Nicotine Patch|nicotine patch
4950511|NCT01857505|Total Hip replacement|total hip replacement
4950512|NCT01857505|Fracture table|fracture table
4950513|NCT01857505|DePuySynthes|depuysynthes
4950514|NCT01857505|Direct anterior approach hip replacement|direct anterior approach hip replacement
4950515|NCT01857505|Posterior approach hip replacement|posterior approach hip replacement
4950516|NCT01857492|abdominal pain|abdominal pain
4950517|NCT01857492|pancreatitis|pancreatitis
4950518|NCT01857492|chronic abdominal pain|chronic abdominal pain
4950519|NCT01857492|visceral pain|visceral pain
4950520|NCT01857492|meditation|meditation
4950521|NCT01857492|tDCS|tdcs
4950522|NCT01857492|noninvasive brain stimulation|noninvasive brain stimulation
4950523|NCT01857492|EEG|eeg
4950524|NCT01857492|Kirtan Kriya|kirtan kriya
4950525|NCT01857479|ABPA|abpa
4950526|NCT01857453|Adult Patients Medulloblatoma Standard risk group Chemotherapy Radiotherapy Quality of Life|adult patients medulloblatoma standard risk group chemotherapy radiotherapy quality of life
4950527|NCT01857440|Glaucoma|glaucoma
4950528|NCT01857440|Pupil|pupil
4950529|NCT01857440|Melanopsin|melanopsin
4950530|NCT01857388|school-based program, mental health, implementation|school-based program, mental health, implementation
4950531|NCT01857375|Diabetes - insulin administration|diabetes - insulin administration
4950532|NCT01857362|Orfadin|orfadin
4950533|NCT01857362|Nitisinone|nitisinone
4950534|NCT01857362|Bioequivalence|bioequivalence
4950535|NCT01857349|Efficacy|efficacy
4950536|NCT01857349|surgical scrubs|surgical scrubs
4950537|NCT01857349|Total Knee Arthroplasty|total knee arthroplasty
4950538|NCT01857323|asthma|asthma
4950539|NCT01857323|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
4950540|NCT01857323|COPD|copd
4950541|NCT01857323|Albuterol Spiromax®|albuterol spiromax®
4950542|NCT01857310|Folic Acid|folic acid
4950543|NCT01857310|Zinc|zinc
4950544|NCT01857310|Semen|semen
4950545|NCT01857310|In vitro fertilization|in vitro fertilization
4950546|NCT01857310|Assisted reproductive technology|assisted reproductive technology
4950547|NCT01857310|Ovulation induction|ovulation induction
4950548|NCT01857310|Intrauterine insemination|intrauterine insemination
4950549|NCT01857310|Pregnancy|pregnancy
4950550|NCT01857310|Live Birth|live birth
4950551|NCT01857310|Abortion, spontaneous|abortion, spontaneous
4950552|NCT01857284|Tauroursodeoxycholic Acid|tauroursodeoxycholic acid
4950553|NCT01857284|Primary Biliary Cirrhosis|primary biliary cirrhosis
4950554|NCT01857284|Safety|safety
4950555|NCT01857284|Efficacy|efficacy
4950556|NCT01857258|green tea|green tea
4950557|NCT01857258|catechins|catechins
4950558|NCT01857258|vascular endothelial function|vascular endothelial function
4950559|NCT01857258|postprandial hyperglycemia|postprandial hyperglycemia
4950560|NCT01857258|oxidative stress|oxidative stress
4950561|NCT01857245|addiction|addiction
4950562|NCT01857245|Adherence (attribute)|adherence (attribute)
4950563|NCT01857245|Adverse effects|adverse effects
4950564|NCT01857245|Agonist|agonist
4950565|NCT01857245|Antiviral Agents|antiviral agents
4950566|NCT01857245|arm|arm
4950567|NCT01857245|base|base
4950568|NCT01857245|care delivery|care delivery
4950569|NCT01857245|Caring|caring
4950570|NCT01857245|Chronic Hepatitis C|chronic hepatitis c
4950571|NCT01857245|Clinic|clinic
4950572|NCT01857245|Clinical Trials|clinical trials
4950573|NCT01857245|Complex|complex
4950574|NCT01857245|Computer Simulation|computer simulation
4950575|NCT01857245|cost|cost
4950576|NCT01857245|cost effective|cost effective
4950577|NCT01857245|cost effectiveness|cost effectiveness
4950578|NCT01857245|Data|data
4950579|NCT01857245|Development|development
4950580|NCT01857245|Directly Observed Therapy|directly observed therapy
4950581|NCT01857245|Disease|disease
4950583|NCT01857245|Drug resistance|drug resistance
4950584|NCT01857245|drug resistant virus|drug resistant virus
4950585|NCT01857245|Educational aspects|educational aspects
4950586|NCT01857245|Epidemic|epidemic
4950587|NCT01857245|experience|experience
4950588|NCT01857245|Frequencies (time pattern)|frequencies (time pattern)
4950589|NCT01857245|Fright|fright
4950590|NCT01857245|Genotype|genotype
4950591|NCT01857245|Group Therapy|group therapy
4950592|NCT01857245|Health Care Costs|health care costs
4950593|NCT01857245|Health Personnel|health personnel
4950594|NCT01857245|Healthcare Systems|healthcare systems
4950595|NCT01857245|Hepatitis C|hepatitis c
4950596|NCT01857245|Hepatitis C Prevalence|hepatitis c prevalence
4950597|NCT01857245|Hepatitis C Transmission|hepatitis c transmission
4950598|NCT01857245|Hepatitis C virus|hepatitis c virus
4950599|NCT01857245|HIV|hiv
4950600|NCT01857245|Homelessness|homelessness
4950601|NCT01857245|improved|improved
4950602|NCT01857245|Incidence|incidence
4950603|NCT01857245|Infection|infection
4950604|NCT01857245|Injecting drug user|injecting drug user
4950605|NCT01857245|Injection of therapeutic agent|injection of therapeutic agent
4950606|NCT01857245|Intensive Care|intensive care
4950607|NCT01857245|Interferons|interferons
4950608|NCT01857245|Intervention|intervention
4950609|NCT01857245|Knowledge|knowledge
4950610|NCT01857245|Life|life
4950611|NCT01857245|Liver diseases|liver diseases
4950612|NCT01857245|Liver Failure|liver failure
4950613|NCT01857245|liver transplantation|liver transplantation
4950614|NCT01857245|Living Costs|living costs
4950615|NCT01857245|Mental disorders|mental disorders
4950616|NCT01857245|Methadone|methadone
4950617|NCT01857245|methadone clinic/center|methadone clinic/center
4950618|NCT01857245|Modeling|modeling
4950619|NCT01857245|Mortality Vital Statistics|mortality vital statistics
4950620|NCT01857245|Motivation|motivation
4950621|NCT01857245|multidisciplinary|multidisciplinary
4950622|NCT01857245|Opiates|opiates
4950623|NCT01857245|Oral|oral
4950624|NCT01857245|Outcome|outcome
4950625|NCT01857245|Patients|patients
4950626|NCT01857245|Persons|persons
4950627|NCT01857245|Pharmaceutical Preparations|pharmaceutical preparations
4950628|NCT01857245|Physicians|physicians
4950629|NCT01857245|pill (pharmacologic)|pill (pharmacologic)
4950630|NCT01857245|Play|play
4950631|NCT01857245|Poverty|poverty
4950632|NCT01857245|Primary Health Care|primary health care
4950633|NCT01857245|programs|programs
4950634|NCT01857245|Psychiatric therapeutic procedure|psychiatric therapeutic procedure
4950635|NCT01857245|psychosocial|psychosocial
4950636|NCT01857245|Publishing|publishing
4950637|NCT01857245|Quality-Adjusted Life Years|quality-adjusted life years
4950638|NCT01857245|Randomized|randomized
4950639|NCT01857245|Randomized Controlled Trials|randomized controlled trials
4950640|NCT01857245|randomized trial|randomized trial
4950641|NCT01857245|Recruitment Activity|recruitment activity
4950642|NCT01857245|Regimen|regimen
4950643|NCT01857245|Resistance|resistance
4950644|NCT01857245|Resistance development|resistance development
4950645|NCT01857245|response|response
4950646|NCT01857245|Risk|risk
4950647|NCT01857245|risk perception|risk perception
4950648|NCT01857245|Role|role
4950649|NCT01857245|Site|site
4950650|NCT01857245|skills|skills
4950651|NCT01857245|Social support|social support
4950652|NCT01857245|standard care|standard care
4950653|NCT01857245|substance abuse treatment|substance abuse treatment
4950654|NCT01857245|success|success
4950655|NCT01857245|Time|time
4950656|NCT01857245|Treatment outcome|treatment outcome
4950657|NCT01857245|Treatment Protocols|treatment protocols
4950658|NCT01857245|treatment site|treatment site
4950659|NCT01857245|Trust|trust
4950660|NCT01857245|United States|united states
4950661|NCT01857245|Viral|viral
4950662|NCT01857245|Virus|virus
4950663|NCT01857219|fMRI|fmri
4950664|NCT01857206|Influenza|influenza
4950665|NCT01857206|children and adolescents|children and adolescents
4950666|NCT01857206|trivalent vaccine|trivalent vaccine
4950667|NCT01857206|cell culture|cell culture
4950668|NCT01857206|embryonated chicken eggs|embryonated chicken eggs
4950669|NCT01857193|Open label; dose escalation; ER+; LEE011; CDK4/6; everolimus; advanced breast cancer; mTOR; HR positive; HER2 negative|open label; dose escalation; er+; lee011; cdk4/6; everolimus; advanced breast cancer; mtor; hr positive; her2 negative
4950670|NCT01857167|omega-3 fatty acids|omega-3 fatty acids
4950671|NCT01857167|randomized controlled trial|randomized controlled trial
4950672|NCT01857154|Bone mineral density|bone mineral density
4950673|NCT01857154|Bone mineral content|bone mineral content
4950674|NCT01857154|Bone density|bone density
4950675|NCT01857154|Bone health|bone health
4950676|NCT01857154|Dual-energy x-ray absorptiometry|dual-energy x-ray absorptiometry
4950677|NCT01857141|dexmedetomidine|dexmedetomidine
4950678|NCT01857141|heart rate variability|heart rate variability
4950679|NCT01857141|preemptive epidural|preemptive epidural
4950680|NCT01857141|gastrectomy|gastrectomy
4950681|NCT01857115|Multiple myeloma|multiple myeloma
4950682|NCT01857115|Diagnosis|diagnosis
4950683|NCT01857115|Weekly|weekly
4950684|NCT01857115|CCyd|ccyd
4950685|NCT01857089|Pressure Ulcer|pressure ulcer
4950686|NCT01857089|prevention|prevention
4950687|NCT01857076|Type 2 Diabetes mellitus|type 2 diabetes mellitus
4950688|NCT01857076|Grade I obesity|grade i obesity
4950689|NCT01857076|Inadequate glycemic control|inadequate glycemic control
4950690|NCT01857011|Anemia, Iron-Deficiency|anemia, iron-deficiency
4950691|NCT01857011|bariatric surgery|bariatric surgery
4950692|NCT01857011|abdominoplasty|abdominoplasty
4950693|NCT01857011|surgery, plastic|surgery, plastic
4950694|NCT01857011|iron|iron
4950695|NCT01856998|Therapeutic Equivalence|therapeutic equivalence
4950696|NCT01856998|Propofol|propofol
4950697|NCT01856985|Medical abortion|medical abortion
4950698|NCT01856985|Misoprostol|misoprostol
4950699|NCT01856985|Mifepristone|mifepristone
4950700|NCT01856972|Limited Dorsiflexion Range of Motion|limited dorsiflexion range of motion
4950701|NCT01856972|Gastrocnemius tightness|gastrocnemius tightness
4950702|NCT01856972|Soleus tightness|soleus tightness
4950703|NCT01856959|magnesium sulfate|magnesium sulfate
4950704|NCT01856959|nebulized|nebulized
4950705|NCT01856959|lung function|lung function
4950706|NCT01856933|GBM|gbm
4950707|NCT01856933|Glioblastoma Multiforme|glioblastoma multiforme
4950708|NCT01856933|Gliosarcoma|gliosarcoma
4950709|NCT01856920|Calcitonin|calcitonin
4950710|NCT01856920|T-cells|t-cells
4950711|NCT01856920|Immune Response|immune response
4950712|NCT01856920|HLA Patients|hla patients
4950713|NCT01856920|Vaccine|vaccine
4950714|NCT01856907|prediabetes|prediabetes
4950715|NCT01856907|impaired fasting/impaired glucose tolerance|impaired fasting/impaired glucose tolerance
4950716|NCT01856907|post gestational diabetes|post gestational diabetes
4950717|NCT01856907|diabetes prevention|diabetes prevention
4950718|NCT01856894|polycystic ovary syndrome|polycystic ovary syndrome
4950719|NCT01856894|Anti-Mullerian Hormone|anti-mullerian hormone
4950720|NCT01856894|obesity|obesity
4950721|NCT01856881|Type 2 diabetes|type 2 diabetes
4950722|NCT01856868|BMD|bmd
4950723|NCT01856868|Becker muscular dystrophy|becker muscular dystrophy
4950724|NCT01856868|epicatechin|epicatechin
4950725|NCT01856868|clinical trial|clinical trial
4950726|NCT01856868|neuromuscular disease|neuromuscular disease
4950727|NCT01856855|Prostate Cancer|prostate cancer
4950728|NCT01856855|Prostate Adenocarcinoma|prostate adenocarcinoma
4950729|NCT01856855|Radiation|radiation
4950730|NCT01856855|SBRT|sbrt
4950731|NCT01856855|Stereotactic Body Radiation Therapy|stereotactic body radiation therapy
4950732|NCT01856842|Pulmonary Arteriovenous Malformations|pulmonary arteriovenous malformations
4950733|NCT01856842|Hereditary Hemorrhagic Telangiectasia (HHT)|hereditary hemorrhagic telangiectasia (hht)
4950734|NCT01856842|Embolization|embolization
4950735|NCT01856842|reperfusion rates|reperfusion rates
4950736|NCT01856777|Medical Abortion|medical abortion
4950737|NCT01856777|Pregnancy Test|pregnancy test
4950738|NCT01856777|continuing pregnancy|continuing pregnancy
4950739|NCT01856764|Atopic dermatitis|atopic dermatitis
4950740|NCT01856751|Haemophilia|haemophilia
4950741|NCT01856751|TGA|tga
4950742|NCT01856751|TEM|tem
4950743|NCT01856738|Parkinson's disease|parkinson's disease
4950744|NCT01856738|Visual hallucinations|visual hallucinations
4950745|NCT01856738|Rivastigmine|rivastigmine
4950746|NCT01856738|Cholinesterase inhibitor|cholinesterase inhibitor
4950747|NCT01856738|Randomized controlled trial|randomized controlled trial
4950748|NCT01856738|Cost-effectiveness analysis|cost-effectiveness analysis
4950749|NCT01856712|alcohol|alcohol
4950750|NCT01856712|veterans|veterans
4950751|NCT01856699|supratentorial superficial siderosis|supratentorial superficial siderosis
4950752|NCT01856699|intracerebral hemorrhage|intracerebral hemorrhage
4950753|NCT01856699|cerebral amyloid angiopathy|cerebral amyloid angiopathy
4950754|NCT01856686|ADD|add
4950755|NCT01856686|ADHD|adhd
4950756|NCT01856686|Proteins|proteins
4950757|NCT01856686|Dietary|dietary
4950758|NCT01856686|Nutrition|nutrition
4950759|NCT01856686|QEEG|qeeg
4950760|NCT01856686|ERP|erp
4950761|NCT01856686|ICA|ica
4950762|NCT01856673|Mental Health|mental health
4950763|NCT01856673|Displacement|displacement
4950764|NCT01856673|Torture|torture
4950765|NCT01856673|Violence|violence
4950766|NCT01856673|Post-Traumatic Stress Disorder|post-traumatic stress disorder
4950767|NCT01856673|Depression|depression
4950768|NCT01856673|Anxiety|anxiety
4950769|NCT01856673|Community-based intervention|community-based intervention
4950770|NCT01856673|Prevention trial|prevention trial
4950771|NCT01856673|Disabled Persons|disabled persons
4950772|NCT01856660|Obesity|obesity
4950773|NCT01856660|Weight Loss|weight loss
4950774|NCT01856660|Body Weight Change|body weight change
4950775|NCT01856660|Taste|taste
4950776|NCT01856660|Taste Phenotype|taste phenotype
4950777|NCT01856660|Lifestyle Intervention|lifestyle intervention
4950778|NCT01856647|Psoriasis|psoriasis
4950779|NCT01856647|Obesity|obesity
4950780|NCT01856634|Tuberculosis|tuberculosis
4950781|NCT01856634|Tuberculosis, Multidrug-Resistant|tuberculosis, multidrug-resistant
4950782|NCT01856634|Mycobacterium Infections|mycobacterium infections
4950783|NCT01856634|Actinomycetales Infections|actinomycetales infections
4950784|NCT01856634|Gram-Positive Infections|gram-positive infections
4950785|NCT01856634|Bacterial Infections|bacterial infections
4950786|NCT01856634|Pediatric|pediatric
4950787|NCT01856582|Primary Immunodeficiency Disease(s)|primary immunodeficiency disease(s)
4950788|NCT01856582|Mixed Donor Chimerism|mixed donor chimerism
4950789|NCT01856582|bone marrow failure syndromes|bone marrow failure syndromes
4950790|NCT01856582|allogeneic hematopoietic stem cell transplant (HSCT)|allogeneic hematopoietic stem cell transplant (hsct)
4950791|NCT01856582|children|children
4950792|NCT01856556|safety|safety
4950793|NCT01856556|tolerability|tolerability
4950794|NCT01856556|pharmacokinetics|pharmacokinetics
4950795|NCT01856543|Breast cancer|breast cancer
4950796|NCT01856543|Status post mastectomy|status post mastectomy
4950797|NCT01856543|plan to receive PMRT|plan to receive pmrt
4950798|NCT01856543|Topical|topical
4950799|NCT01856543|steroid cream|steroid cream
4950800|NCT01856543|emollient skin care|emollient skin care
4950801|NCT01856543|Eucerin|eucerin
4950802|NCT01856543|Mometasone Furoate 0.1%|mometasone furoate 0.1%
4950803|NCT01856517|pressor response|pressor response
4950804|NCT01856517|chronotropic response|chronotropic response
4950805|NCT01856504|Heart Disease|heart disease
4950806|NCT01856504|Coronary Artery Disease|coronary artery disease
4950807|NCT01856504|Coronary Arteriosclerosis|coronary arteriosclerosis
4950808|NCT01856491|RELIANCE 4-FRONT|reliance 4-front
4950809|NCT01856491|Implantable Cardioverter Defibrillator (ICD)|implantable cardioverter defibrillator (icd)
4950810|NCT01856491|Cardiac Resynchronization Therapy - Defibrillator (CRT-D)|cardiac resynchronization therapy - defibrillator (crt-d)
4950811|NCT01856465|Bariatric surgery|bariatric surgery
4950812|NCT01856465|NAFLD|nafld
4950813|NCT01856465|Steatohepatitis|steatohepatitis
4950814|NCT01856465|Simple Steatosis|simple steatosis
4950815|NCT01856465|Intestinal Microbiota|intestinal microbiota
4950816|NCT01856452|Sentinel lymph node|sentinel lymph node
4950817|NCT01856452|multimodal|multimodal
4950818|NCT01856452|breast cancer|breast cancer
4950819|NCT01856439|ProSavin|prosavin
4950820|NCT01856439|Gene therapy|gene therapy
4950821|NCT01856426|Hepatitis C infected subjects|hepatitis c infected subjects
4950822|NCT01856413|Prevention|prevention
4950823|NCT01856413|Hepatitis B virus re-infection|hepatitis b virus re-infection
4950824|NCT01856413|HBV-DNA negative|hbv-dna negative
4950825|NCT01856413|Liver transplantation|liver transplantation
4950826|NCT01856400|ventricular arrythmias|ventricular arrythmias
4950827|NCT01856400|SERCA2a|serca2a
4950828|NCT01856400|Chronic Kidney Disease|chronic kidney disease
4950829|NCT01856400|microvolt T wave alternans|microvolt t wave alternans
4950830|NCT01856387|preeclampsia|preeclampsia
4950831|NCT01856387|eclampsia|eclampsia
4950832|NCT01856387|prediction|prediction
4950833|NCT01856387|neutrophil-to Lymphocyte ratio|neutrophil-to lymphocyte ratio
4950834|NCT01856361|Male infertility|male infertility
4950835|NCT01856361|Low sperm count|low sperm count
4950836|NCT01856361|Poor sperm motility|poor sperm motility
4950837|NCT01856361|Poor Sperm shape and morphology|poor sperm shape and morphology
4950838|NCT01856335|Seizures|seizures
4950839|NCT01856335|Epilepsy|epilepsy
4950840|NCT01856322|Colorectal Cancer|colorectal cancer
4950841|NCT01856322|Liver Metastasis|liver metastasis
4950842|NCT01856322|Sulindac|sulindac
4950843|NCT01856309|Rheumatoid Arthritis|rheumatoid arthritis
4950844|NCT01856309|Sirukumab|sirukumab
4950845|NCT01856309|CNTO 136|cnto 136
4950846|NCT01856309|CNTO136ARA3002|cnto136ara3002
4950847|NCT01856309|SIRROUND-D|sirround-d
4950848|NCT01856309|CNTO136ARA3003|cnto136ara3003
4950849|NCT01856309|SIRROUND-T|sirround-t
4950850|NCT01856309|SIRROUND-LTE|sirround-lte
4950851|NCT01856270|Traumatic brain injury|traumatic brain injury
4950852|NCT01856270|Post-traumatic headache|post-traumatic headache
4950853|NCT01856270|Drug therapy|drug therapy
4950854|NCT01856257|Kidney Transplantation|kidney transplantation
4950855|NCT01856257|Transplantation|transplantation
4950856|NCT01856257|NULOJIX|nulojix
4950857|NCT01856257|belatacept|belatacept
4950858|NCT01856257|chronic immunosuppression|chronic immunosuppression
4950859|NCT01856244|Parkinson's Disease|parkinson's disease
4950860|NCT01856244|treadmill training|treadmill training
4950861|NCT01856244|gait|gait
4950862|NCT01856244|balance|balance
4950863|NCT01856244|mobility|mobility
4950864|NCT01856231|COPD|copd
4950865|NCT01856231|Physical activity|physical activity
4950866|NCT01856218|Mucopolysaccharidosis type 7, MPS 7, Sly syndrome, enzyme replacement therapy, rare disease, lysosomal storage disease, metabolic disorder|mucopolysaccharidosis type 7, mps 7, sly syndrome, enzyme replacement therapy, rare disease, lysosomal storage disease, metabolic disorder
4950867|NCT01856205|Japanese Encephalitis, Randomized Controlled Trial, intravenous immunoglobulin, safety, efficacy, Nepal|japanese encephalitis, randomized controlled trial, intravenous immunoglobulin, safety, efficacy, nepal
4950868|NCT01856179|Conversion of ALA and SDA|conversion of ala and sda
4950869|NCT01856179|Metabolism of n-3 fatty acids|metabolism of n-3 fatty acids
4950870|NCT01856166|Nulliparous|nulliparous
4950871|NCT01856166|Singleton|singleton
4950872|NCT01856166|delivery|delivery
4950873|NCT01856166|pregnancy|pregnancy
4950874|NCT01856153|Bioavailability|bioavailability
4950875|NCT01856153|Strawberry polyphenols|strawberry polyphenols
4950876|NCT01856153|Time Influence|time influence
4950877|NCT01856140|adipose derived mesenchymal stem cell|adipose derived mesenchymal stem cell
4950878|NCT01856140|allogeneic stem cell|allogeneic stem cell
4950879|NCT01856127|Sexual Dysfunction|sexual dysfunction
4950880|NCT01856127|Antidepressant|antidepressant
4950881|NCT01856127|Major Depressant|major depressant
4950882|NCT01856127|SSRI|ssri
4950883|NCT01856127|SNRI|snri
4950884|NCT01856127|Vilazodone|vilazodone
4950885|NCT01856127|Sertraline|sertraline
4950886|NCT01856114|Advanced Cancers|advanced cancers
4950887|NCT01856114|Cancer with evidence of active disease|cancer with evidence of active disease
4950888|NCT01856114|Exercise induced breakthrough dyspnea|exercise induced breakthrough dyspnea
4950889|NCT01856114|Shortness of breath|shortness of breath
4950890|NCT01856114|Fentanyl Buccal Tablets|fentanyl buccal tablets
4950891|NCT01856114|FBT|fbt
4950892|NCT01856114|Placebo|placebo
4950893|NCT01856114|Walk tests|walk tests
4950894|NCT01856114|Questionnaires|questionnaires
4950895|NCT01856114|Surveys|surveys
4950896|NCT01856101|TCC|tcc
4950897|NCT01856101|Failure of platinum based chemotherapy|failure of platinum based chemotherapy
4950898|NCT01856088|Coronary artery|coronary artery
4950899|NCT01856088|Drug eluting stent|drug eluting stent
4950900|NCT01856088|thrombosis|thrombosis
4950901|NCT01856075|Atrial Fibrillation|atrial fibrillation
4950902|NCT01856075|Dronedarone|dronedarone
4950903|NCT01856075|Cohort|cohort
4950904|NCT01856075|Effectiveness|effectiveness
4950905|NCT01856062|ovulation induction|ovulation induction
4950906|NCT01856062|dexamethasone|dexamethasone
4950907|NCT01856049|HLHS|hlhs
4950908|NCT01856049|Hypoplastic Left Heart Syndrome|hypoplastic left heart syndrome
4950909|NCT01856049|UCB (umbilical cord blood)|ucb (umbilical cord blood)
4950910|NCT01856049|Umbilical cord blood|umbilical cord blood
4950911|NCT01856049|Cord blood|cord blood
4950912|NCT01856049|Cardiac regeneration|cardiac regeneration
4950913|NCT01856036|Ductal Histology|ductal histology
4950914|NCT01856036|Unifocal|unifocal
4950915|NCT01856036|Estrogen Receptor Positive|estrogen receptor positive
4950916|NCT01856036|her2neu negative|her2neu negative
4950917|NCT01856023|melanoma|melanoma
4950918|NCT01856023|metastatic|metastatic
4950919|NCT01856023|skin cancer|skin cancer
4950920|NCT01856023|Stage IV|stage iv
4950921|NCT01856023|interleukin-2|interleukin-2
4950922|NCT01856010|Dementia|dementia
4950923|NCT01856010|Aggression|aggression
4950924|NCT01856010|Agitation|agitation
4950925|NCT01855984|ADHD|adhd
4950926|NCT01855984|Children|children
4950927|NCT01855984|Tocotrienol|tocotrienol
4950928|NCT01855958|Osteoarthritis|osteoarthritis
4950929|NCT01855958|Electro acupuncture|electro acupuncture
4950930|NCT01855958|Deep intramuscular stimulation|deep intramuscular stimulation
4950931|NCT01855958|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
4950932|NCT01855958|Pain pressure threshold|pain pressure threshold
4950933|NCT01855958|Conditioned pain modulation|conditioned pain modulation
4950934|NCT01855958|Clinical trial|clinical trial
4950935|NCT01855945|Influenza|influenza
4950936|NCT01855919|Chronic Low Back Pain|chronic low back pain
4950937|NCT01855919|CLBP|clbp
4950938|NCT01855906|Total knee replacement|total knee replacement
4950939|NCT01855906|Gap balanced|gap balanced
4950940|NCT01855906|Measured resection|measured resection
4950941|NCT01855893|Neck pain|neck pain
4950942|NCT01855880|psoriasis|psoriasis
4950943|NCT01855880|dermatology|dermatology
4950944|NCT01855880|monoclonal antibody|monoclonal antibody
4950945|NCT01855867|HIV|hiv
4950946|NCT01855867|PEP|pep
4950947|NCT01855867|nPEP|npep
4950948|NCT01855867|Prophylaxis|prophylaxis
4950949|NCT01855867|Post Exposure Prophylaxis|post exposure prophylaxis
4950950|NCT01855867|exposure to HIV|exposure to hiv
4950951|NCT01855867|HIV prevention|hiv prevention
4950952|NCT01855841|ERCP|ercp
4950953|NCT01855841|virgin papilla|virgin papilla
4950954|NCT01855841|risk of post-ERCP acute pancreatitis|risk of post-ercp acute pancreatitis
4950955|NCT01855802|Greece|greece
4950956|NCT01855802|Ophthalmology|ophthalmology
4950957|NCT01855802|Glaucoma|glaucoma
4950958|NCT01855802|Generics|generics
4950959|NCT01855802|Perception|perception
4950960|NCT01855776|Physical Activity/Walking|physical activity/walking
4950961|NCT01855776|Full-time employees|full-time employees
4950962|NCT01855776|RCT|rct
4950963|NCT01855776|Incentives|incentives
4950964|NCT01855776|Wireless pedometer|wireless pedometer
4950965|NCT01855763|gestational diabetes|gestational diabetes
4950966|NCT01855763|type 2 diabetes|type 2 diabetes
4950967|NCT01855763|pregnancy|pregnancy
4950968|NCT01855763|metformin|metformin
4950969|NCT01855763|insulin|insulin
4950970|NCT01855750|Lymphoma|lymphoma
4950971|NCT01855750|B-cell lymphoma|b-cell lymphoma
4950972|NCT01855750|Non-germinal center B-cell subtype|non-germinal center b-cell subtype
4950973|NCT01855750|Diffuse large B-cell lymphoma|diffuse large b-cell lymphoma
4950974|NCT01855750|Bruton's tyrosine kinase inhibitor|bruton's tyrosine kinase inhibitor
4950975|NCT01855750|PCI-32765|pci-32765
4950976|NCT01855750|JNJ-54179060|jnj-54179060
4950977|NCT01855750|Ibrutinib|ibrutinib
4950978|NCT01855750|Rituximab|rituximab
4950979|NCT01855750|Cyclophosphamide|cyclophosphamide
4950980|NCT01855750|Doxorubicin|doxorubicin
4950981|NCT01855750|Vincristine|vincristine
4950982|NCT01855750|Prednisone|prednisone
4950983|NCT01855737|gene guided|gene guided
4950984|NCT01855737|warfarin dose|warfarin dose
4950985|NCT01855737|Chinese|chinese
4950986|NCT01855711|Alosetron hydrochloride|alosetron hydrochloride
4950987|NCT01855711|Global Improvement Scale(GIS)|global improvement scale(gis)
4950988|NCT01855711|Diarrhea-predominant IBS|diarrhea-predominant ibs
4950989|NCT01855698|hematologic neoplasm, profhylaxis, arterial and venous thromboembolism|hematologic neoplasm, profhylaxis, arterial and venous thromboembolism
4950990|NCT01855685|XCGD, lentivirus, cellular therapy|xcgd, lentivirus, cellular therapy
4950991|NCT01855672|Migraine, occipital nerve, stimulation|migraine, occipital nerve, stimulation
4950992|NCT01855659|Lung diseases,|lung diseases,
4950993|NCT01855659|Obstructive,|obstructive,
4950994|NCT01855659|Peak Inspiratory Flow|peak inspiratory flow
4950995|NCT01855659|[C08.381.495.389]|[c08.381.495.389]
4950996|NCT01855620|Contraception|contraception
4950997|NCT01855620|Implant|implant
4950998|NCT01855620|Obesity|obesity
4950999|NCT01855607|chemotherapy induced neuropathy|chemotherapy induced neuropathy
4951000|NCT01855542|metabolic acidosis, plasmalyte solution, 0.9% normal saline|metabolic acidosis, plasmalyte solution, 0.9% normal saline
4951001|NCT01855529|ropivacaine, pain, mastectomy|ropivacaine, pain, mastectomy
4951002|NCT01855516|Antithrombotic prophylaxis|antithrombotic prophylaxis
4951003|NCT01855503|Metastatic|metastatic
4951004|NCT01855503|Breast Cancer|breast cancer
4951005|NCT01855503|Metastatic Breast Cancer|metastatic breast cancer
4951006|NCT01855503|Breast|breast
4951007|NCT01855503|Biopsy|biopsy
4951008|NCT01855503|Molecular|molecular
4951009|NCT01855503|Genetic|genetic
4951010|NCT01855464|pneumothorax|pneumothorax
4951011|NCT01855464|primary pneumothorax|primary pneumothorax
4951012|NCT01855464|lung collapse|lung collapse
4951013|NCT01855451|Human Papilloma Virus|human papilloma virus
4951014|NCT01855451|HPV|hpv
4951015|NCT01855451|Oropharyngeal|oropharyngeal
4951016|NCT01855451|Squamous Cell|squamous cell
4951017|NCT01855451|Carcinoma|carcinoma
4951018|NCT01855438|Live donor kidney transplantation|live donor kidney transplantation
4951019|NCT01855438|Living donation|living donation
4951020|NCT01855438|Patient education|patient education
4951021|NCT01855438|Kidney transplant candidates|kidney transplant candidates
4951022|NCT01855412|PAD|pad
4951023|NCT01855412|LIBERTY|liberty
4951024|NCT01855412|Observational|observational
4951025|NCT01855399|Peer Support|peer support
4951026|NCT01855399|Self Management|self management
4951027|NCT01855399|Health Disparities|health disparities
4951028|NCT01855373|Blood Sugar|blood sugar
4951029|NCT01855373|Endothelial Function|endothelial function
4951030|NCT01855373|Blood Vessel Health|blood vessel health
4951031|NCT01855360|amyloid|amyloid
4951032|NCT01855360|amyloidosis|amyloidosis
4951033|NCT01855360|cardiac amyloidosis|cardiac amyloidosis
4951034|NCT01855360|senile amyloidosis|senile amyloidosis
4951035|NCT01855360|familial amyloidosis|familial amyloidosis
4951036|NCT01855360|transthyretin amyloidosis|transthyretin amyloidosis
4951037|NCT01855347|Prematurity|prematurity
4951038|NCT01855347|Hypoxia|hypoxia
4951039|NCT01855347|Necrotizing Enterocolitis|necrotizing enterocolitis
4951040|NCT01855347|Near Infrared Spectroscopy|near infrared spectroscopy
4951041|NCT01855347|Abdominal tissue oxygenation|abdominal tissue oxygenation
4951042|NCT01855347|NICU|nicu
4951043|NCT01855334|Dialysis|dialysis
4951044|NCT01855334|ESRD|esrd
4951045|NCT01855334|Cardiovascular disease|cardiovascular disease
4951046|NCT01855334|spironolactone|spironolactone
4951047|NCT01855334|L-arginine|l-arginine
4951048|NCT01855334|myocardial perfusion|myocardial perfusion
4951049|NCT01855334|coronary flow reserve|coronary flow reserve
4951050|NCT01855334|diastolic function|diastolic function
4951051|NCT01855321|uncontrolled diabetes|uncontrolled diabetes
4951052|NCT01855321|vitamin D deficiency|vitamin d deficiency
4951053|NCT01855295|Dialysis|dialysis
4951054|NCT01855295|End Stage Renal Disease|end stage renal disease
4951055|NCT01855295|Protein supplementation|protein supplementation
4951056|NCT01855295|Inflammation|inflammation
4951057|NCT01855295|Quality of Life|quality of life
4951058|NCT01855282|Diabetes Type II,|diabetes type ii,
4951059|NCT01855282|Overweight,|overweight,
4951060|NCT01855282|Obesity,|obesity,
4951061|NCT01855282|Behavioral Intervention,|behavioral intervention,
4951062|NCT01855282|Latino, farm worker|latino, farm worker
4951063|NCT01855282|randomized controlled intervention|randomized controlled intervention
4951064|NCT01855269|probiotic|probiotic
4951065|NCT01855269|infantile colic|infantile colic
4951066|NCT01855256|hyperhidrosis|hyperhidrosis
4951067|NCT01855256|oxybutynin|oxybutynin
4951068|NCT01855243|Type 2 D M|type 2 d m
4951069|NCT01855243|sliding scale insulin|sliding scale insulin
4951070|NCT01855243|70/30 insulin|70/30 insulin
4951071|NCT01855243|basals insulin|basals insulin
4951072|NCT01855243|supplemental insulin|supplemental insulin
4951073|NCT01855217|morbid|morbid
4951074|NCT01855217|obesity|obesity
4951075|NCT01855217|sugammadex|sugammadex
4951076|NCT01855217|pharmacodynamics|pharmacodynamics
4951077|NCT01855204|Computed Tomography, Spiral|computed tomography, spiral
4951078|NCT01855204|Urography|urography
4951079|NCT01855204|Radiation dosage|radiation dosage
4951080|NCT01855204|Contrast media|contrast media
4951081|NCT01855178|nocturnal|nocturnal
4951082|NCT01855178|epilepsy|epilepsy
4951083|NCT01855165|chronic heart failure|chronic heart failure
4951084|NCT01855165|drug-drug interactions|drug-drug interactions
4951085|NCT01855165|pharmacist's intervention|pharmacist's intervention
4951086|NCT01855152|Dementia|dementia
4951087|NCT01855152|Care Homes|care homes
4951088|NCT01855152|Quality of life|quality of life
4951089|NCT01855152|Antipsychotic medication|antipsychotic medication
4951090|NCT01855152|Behavioural symptoms|behavioural symptoms
4951091|NCT01855152|Cost effectiveness|cost effectiveness
4951092|NCT01855152|Implementation|implementation
4951093|NCT01855152|Person centred care|person centred care
4951094|NCT01855152|Social interaction|social interaction
4951095|NCT01855139|Non-valvular atrial fibrillation|non-valvular atrial fibrillation
4951096|NCT01855139|Stroke|stroke
4951097|NCT01855139|Systemic embolism|systemic embolism
4951098|NCT01855139|Oral anticoagulation|oral anticoagulation
4951099|NCT01855139|Real-life setting|real-life setting
4951100|NCT01855139|Preventive measure|preventive measure
4951101|NCT01855126|light|light
4951102|NCT01855126|circadian rhythms|circadian rhythms
4951103|NCT01855126|dim light melatonin onset|dim light melatonin onset
4951104|NCT01855126|sleep|sleep
4951105|NCT01855113|PAIN|pain
4951106|NCT01855113|ORTHODONTIC TREATMENT|orthodontic treatment
4951107|NCT01855113|INVISALIGN|invisalign
4951108|NCT01855100|Treatment of acute deep vein thrombosis|treatment of acute deep vein thrombosis
4951109|NCT01855100|Prevention of recurrence|prevention of recurrence
4951110|NCT01855100|Oral anticoagulation|oral anticoagulation
4951111|NCT01855100|Real-life setting|real-life setting
4951112|NCT01855074|Schizophrenia|schizophrenia
4951113|NCT01855074|Schizophreniform Disorder|schizophreniform disorder
4951114|NCT01855074|Schizoaffective Disorder|schizoaffective disorder
4951115|NCT01855074|Risperidone|risperidone
4951116|NCT01855074|Risperdal consta|risperdal consta
4951117|NCT01855061|Feasibility studies|feasibility studies
4951118|NCT01855061|Sequence analysis, DNA|sequence analysis, dna
4951119|NCT01855061|Biological markers|biological markers
4951120|NCT01855061|Solid tumors|solid tumors
4951121|NCT01855061|Neoplasm metastasis|neoplasm metastasis
4951122|NCT01855061|Irinotecan|irinotecan
4951123|NCT01855061|Pharmacokinetics SN-38|pharmacokinetics sn-38
4951124|NCT01855061|Carboxylesterase activity within metastasis|carboxylesterase activity within metastasis
4951125|NCT01855048|N-Rephasin® SAL200|n-rephasin® sal200
4951126|NCT01855048|endolysin|endolysin
4951127|NCT01855048|Placebo|placebo
4951128|NCT01855035|ischemic stroke|ischemic stroke
4951129|NCT01855035|ECG monitoring|ecg monitoring
4951130|NCT01855035|atrial fibrillation (/flutter)|atrial fibrillation (/flutter)
4951131|NCT01855022|Motivational interviewing|motivational interviewing
4951132|NCT01855022|Interactive voice response|interactive voice response
4951133|NCT01855022|Hospital readmission|hospital readmission
4951134|NCT01855009|Quality of Life|quality of life
4951135|NCT01855009|Body Weight and Measures|body weight and measures
4951136|NCT01855009|Malnutrition|malnutrition
4951137|NCT01855009|Adolescent Nutrition Sciences|adolescent nutrition sciences
4951138|NCT01855009|Sleep Initiation and Maintenance Disorder|sleep initiation and maintenance disorder
4951139|NCT01855009|Motor Activity|motor activity
4951140|NCT01855009|Drinking|drinking
4951141|NCT01854983|fluorescence colposcopy|fluorescence colposcopy
4951142|NCT01854983|cervical cancer|cervical cancer
4951143|NCT01854957|Multiple sclerosis|multiple sclerosis
4951144|NCT01854957|Mesenchymal stem cells|mesenchymal stem cells
4951145|NCT01854931|Tai Ji Quan|tai ji quan
4951146|NCT01854931|fall prevention|fall prevention
4951147|NCT01854931|community dissemination|community dissemination
4951148|NCT01854918|High cholesterol|high cholesterol
4951149|NCT01854918|Raised cholesterol|raised cholesterol
4951150|NCT01854918|Cholesterol|cholesterol
4951151|NCT01854918|Elevated Cholesterol|elevated cholesterol
4951152|NCT01854892|low back pain|low back pain
4951153|NCT01854892|manipulation|manipulation
4951154|NCT01854892|laser therapy|laser therapy
4951155|NCT01854892|osteopathic|osteopathic
4951156|NCT01854892|chiropractic|chiropractic
4951157|NCT01854892|mobilization|mobilization
4951158|NCT01854892|muscle energy|muscle energy
4951159|NCT01854892|physical therapy|physical therapy
4951160|NCT01854892|muscle|muscle
4951161|NCT01854892|spine|spine
4951162|NCT01854892|adjustment|adjustment
4951163|NCT01854892|rehabilitation|rehabilitation
4951164|NCT01854866|Pleural Effusion|pleural effusion
4951165|NCT01854866|ascites|ascites
4951166|NCT01854866|Malignant|malignant
4951167|NCT01854853|unsafe sex|unsafe sex
4951168|NCT01854853|safer sex|safer sex
4951169|NCT01854853|HIV|hiv
4951170|NCT01854853|STI|sti
4951171|NCT01854853|Pregnancy|pregnancy
4951172|NCT01854840|hyaline membrane disease|hyaline membrane disease
4951173|NCT01854840|placenta|placenta
4951174|NCT01854840|betamethasone|betamethasone
4951175|NCT01854827|Biliary atresia|biliary atresia
4951176|NCT01854827|Hepatic portoenterostomy|hepatic portoenterostomy
4951177|NCT01854827|Intravenous immunoglobulin|intravenous immunoglobulin
4951178|NCT01854801|IEI-EMF|iei-emf
4951179|NCT01854801|WI-FI|wi-fi
4951180|NCT01854801|DECT|dect
4951181|NCT01854801|Electro-sensitivity|electro-sensitivity
4951182|NCT01854801|Radiofrequency|radiofrequency
4951183|NCT01854801|EHS|ehs
4951184|NCT01854801|Idiopathic|idiopathic
4951185|NCT01854801|Environmental|environmental
4951186|NCT01854801|Intolerance fields|intolerance fields
4951187|NCT01854801|Mobile phone|mobile phone
4951188|NCT01854788|Airway clearance techniques|airway clearance techniques
4951189|NCT01854788|Mucus clearance|mucus clearance
4951190|NCT01854788|Chest physiotherapy|chest physiotherapy
4951191|NCT01854788|Autogenic drainage|autogenic drainage
4951192|NCT01854788|Slow expiration with glottis opened in lateral posture(ELTGOL)|slow expiration with glottis opened in lateral posture(eltgol)
4951193|NCT01854788|Temporary-positive expiratory pressure (T-PEP)|temporary-positive expiratory pressure (t-pep)
4951194|NCT01854788|Non cystic fibrosis bronchiectasis|non cystic fibrosis bronchiectasis
4951195|NCT01854775|Adolescents|adolescents
4951196|NCT01854775|HIV-1|hiv-1
4951197|NCT01854775|HIV|hiv
4951198|NCT01854775|Treatment-naive|treatment-naive
4951199|NCT01854762|HIV|hiv
4951200|NCT01854762|Treatment|treatment
4951201|NCT01854762|Pregnancy|pregnancy
4951202|NCT01854749|ESCC|escc
4951203|NCT01854736|Allergy|allergy
4951204|NCT01854736|Phleum pratense|phleum pratense
4951205|NCT01854736|Rhinoconjunctivitis|rhinoconjunctivitis
4951206|NCT01854736|asthma|asthma
4951207|NCT01854736|positive SPT to Phleum pratense|positive spt to phleum pratense
4951208|NCT01854723|Diabetes|diabetes
4951209|NCT01854723|Insulin glargine|insulin glargine
4951210|NCT01854723|NPH insulin|nph insulin
4951211|NCT01854710|ADASUVE|adasuve
4951212|NCT01854710|inhaled loxapine|inhaled loxapine
4951213|NCT01854710|thorough QT/QTc study|thorough qt/qtc study
4951214|NCT01854697|Chronic Hepatitis C|chronic hepatitis c
4951215|NCT01854697|Interferon Free|interferon free
4951216|NCT01854697|Hepatitis C Treatment Naive|hepatitis c treatment naive
4951217|NCT01854697|Hepatitis C Virus|hepatitis c virus
4951218|NCT01854697|Hepatitis C Genotype 1|hepatitis c genotype 1
4951219|NCT01854671|postpartum contraception|postpartum contraception
4951220|NCT01854671|contraceptive counseling|contraceptive counseling
4951221|NCT01854632|influenza vaccine|influenza vaccine
4951222|NCT01854632|trivalent live-attenuated influenza vaccine|trivalent live-attenuated influenza vaccine
4951223|NCT01854632|efficacy|efficacy
4951224|NCT01854632|Africa|africa
4951225|NCT01854632|Senegal|senegal
4951226|NCT01854619|chronic rhinosinusitis|chronic rhinosinusitis
4951227|NCT01854619|sinusitis|sinusitis
4951228|NCT01854619|photodisinfection|photodisinfection
4951229|NCT01854619|photodynamic therapy|photodynamic therapy
4951230|NCT01854619|antimicrobial photodynamic therapy|antimicrobial photodynamic therapy
4951231|NCT01854619|aPDT|apdt
4951232|NCT01854619|PDT|pdt
4951233|NCT01854619|paranasal sinus diseases|paranasal sinus diseases
4951234|NCT01854619|respiratory tract infections|respiratory tract infections
4951235|NCT01854619|respiratory tract diseases|respiratory tract diseases
4951236|NCT01854606|Diffuse Large B-Cell Lymphoma, DBCL, AEB071, Everolimus|diffuse large b-cell lymphoma, dbcl, aeb071, everolimus
4951237|NCT01854580|Comparative effectiveness research|comparative effectiveness research
4951238|NCT01854580|health economic evaluation|health economic evaluation
4951239|NCT01854567|Cord Blood|cord blood
4951240|NCT01854567|Stem Cells|stem cells
4951241|NCT01854567|MPC|mpc
4951242|NCT01854567|Mesoblast|mesoblast
4951243|NCT01854567|Expanded|expanded
4951244|NCT01854567|AML|aml
4951245|NCT01854567|ALL|all
4951246|NCT01854567|NHL|nhl
4951247|NCT01854567|Leukemia|leukemia
4951248|NCT01854567|Lymphoma|lymphoma
4951249|NCT01854554|Brain cancer|brain cancer
4951250|NCT01854554|Glioblastoma|glioblastoma
4951251|NCT01854554|Glioblastoma Multiforme|glioblastoma multiforme
4951252|NCT01854554|GBM|gbm
4951253|NCT01854554|Intensity Modulated Proton Radiotherapy|intensity modulated proton radiotherapy
4951254|NCT01854554|IMPT|impt
4951255|NCT01854554|Intensity Modulated Radiotherapy|intensity modulated radiotherapy
4951256|NCT01854554|IMRT|imrt
4951257|NCT01854554|Radiotherapy|radiotherapy
4951258|NCT01854554|XRT|xrt
4951259|NCT01854554|Cognitive tests|cognitive tests
4951260|NCT01854554|Thinking skills tests|thinking skills tests
4951261|NCT01854554|Questionnaires|questionnaires
4951262|NCT01854554|Surveys|surveys
4951263|NCT01854554|Quality of life|quality of life
4951264|NCT01854554|QOL|qol
4951265|NCT01854541|Cancer|cancer
4951266|NCT01854541|Radiotherapy|radiotherapy
4951267|NCT01854528|Partial responder|partial responder
4951268|NCT01854528|Interferon free|interferon free
4951269|NCT01854528|Treatment-experienced|treatment-experienced
4951270|NCT01854528|Relapser|relapser
4951271|NCT01854528|Hepatitis C Virus|hepatitis c virus
4951272|NCT01854528|Null responder|null responder
4951273|NCT01854528|Hepatitis C Genotype 1|hepatitis c genotype 1
4951274|NCT01854528|paritaprevir|paritaprevir
4951275|NCT01854528|ombitasvir|ombitasvir
4951276|NCT01854528|dasabuvir|dasabuvir
4951277|NCT01854528|ribavirin|ribavirin
4951278|NCT01854528|Viekira PAK|viekira pak
4951279|NCT01854528|Chronic hepatitis C|chronic hepatitis c
4951280|NCT01854502|Young children|young children
4951281|NCT01854502|counseling|counseling
4951282|NCT01854502|fluoride|fluoride
4951283|NCT01854502|xylitol|xylitol
4951284|NCT01854489|Buprenorphine|buprenorphine
4951285|NCT01854489|Rifampicin|rifampicin
4951286|NCT01854489|Interactions|interactions
4951287|NCT01854489|Pharmakokinetics|pharmakokinetics
4951288|NCT01854489|Pharmakodynamics|pharmakodynamics
4951289|NCT01854476|Hemodialysis|hemodialysis
4951290|NCT01854476|Bleeding|bleeding
4951291|NCT01854476|Hemostatic dressing|hemostatic dressing
4951292|NCT01854476|Tranexamic Acid|tranexamic acid
4951293|NCT01854463|DIABETES MELLITUS|diabetes mellitus
4951294|NCT01854463|VITAMIN D|vitamin d
4951295|NCT01854463|ARTERIAL STIFFNESS|arterial stiffness
4951296|NCT01854463|FATTY LIVER|fatty liver
4951297|NCT01854463|BONE TURNOVER|bone turnover
4951298|NCT01854450|Occipitoposterior position|occipitoposterior position
4951299|NCT01854450|Maternal posturing|maternal posturing
4951300|NCT01854450|Labor|labor
4951301|NCT01854437|mg oxide|mg oxide
4951302|NCT01854437|hyperphosphatemia|hyperphosphatemia
4951303|NCT01854437|plasma phosphor level|plasma phosphor level
4951304|NCT01854424|Fibrocyte|fibrocyte
4951305|NCT01854424|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
4951306|NCT01854424|Serum Amyloid P|serum amyloid p
4951307|NCT01854424|Fibrosis|fibrosis
4951308|NCT01854424|Mortality|mortality
4951309|NCT01854411|Analgesics|analgesics
4951310|NCT01854411|Ibuprofene|ibuprofene
4951311|NCT01854411|Ketoprofene|ketoprofene
4951312|NCT01854411|Breastmilk|breastmilk
4951313|NCT01854411|Relative Infant Dose|relative infant dose
4951314|NCT01854411|Theoric Infant Dose|theoric infant dose
4951315|NCT01854398|Obstructive sleep apnea|obstructive sleep apnea
4951316|NCT01854398|Continuous positive airway pressure|continuous positive airway pressure
4951317|NCT01854398|diastolic function|diastolic function
4951318|NCT01854385|Post-traumatic headache|post-traumatic headache
4951319|NCT01854385|Traumatic brain injury|traumatic brain injury
4951320|NCT01854385|Sumatriptan|sumatriptan
4951321|NCT01854359|Multiple Sclerosis|multiple sclerosis
4951322|NCT01854359|Extension Trial|extension trial
4951323|NCT01854346|Autism spectrum disorder|autism spectrum disorder
4951324|NCT01854346|Social skills training|social skills training
4951325|NCT01854346|Group training|group training
4951326|NCT01854346|Comorbidity|comorbidity
4951327|NCT01854346|Intervention|intervention
4951328|NCT01854346|Evidence-based|evidence-based
4951329|NCT01854333|Diagnostics|diagnostics
4951330|NCT01854333|ADOS|ados
4951331|NCT01854333|ADI-R|adi-r
4951332|NCT01854333|Psychometrics|psychometrics
4951333|NCT01854333|Autism spectrum disorders|autism spectrum disorders
4951334|NCT01854333|Autism|autism
4951335|NCT01854307|Difference of|difference of
4951336|NCT01854307|measurements|measurements
4951337|NCT01854307|before and after|before and after
4951338|NCT01854294|ALS|als
4951339|NCT01854294|motorneuron disease|motorneuron disease
4951340|NCT01854294|Central Nervous System (CNS) disease|central nervous system (cns) disease
4951341|NCT01854294|neurodegeneration|neurodegeneration
4951342|NCT01854294|neuroprotective|neuroprotective
4951343|NCT01854294|mechanisms of action|mechanisms of action
4951344|NCT01854294|pathways|pathways
4951345|NCT01854294|biomarkers|biomarkers
4951346|NCT01854294|Cerebral Spinal Fluid (CSF)|cerebral spinal fluid (csf)
4951347|NCT01854294|blood biomarkers|blood biomarkers
4951348|NCT01854294|multi-factorial|multi-factorial
4951349|NCT01854294|multisystem|multisystem
4951350|NCT01854294|single target|single target
4951351|NCT01854294|pathogenic mechanisms|pathogenic mechanisms
4951352|NCT01854294|Protein Bands Selection by Function|protein bands selection by function
4951353|NCT01854294|in silico analysis|in silico analysis
4951354|NCT01854294|active site|active site
4951355|NCT01854294|protein|protein
4951356|NCT01854294|peptide|peptide
4951357|NCT01854294|embryonic stage|embryonic stage
4951358|NCT01854294|endogenous|endogenous
4951359|NCT01854294|master regulators|master regulators
4951360|NCT01854294|fetal development|fetal development
4951361|NCT01854294|embryonic development|embryonic development
4951362|NCT01854294|common pathways|common pathways
4951363|NCT01854294|Blood Brain Barrier (BBB)|blood brain barrier (bbb)
4951364|NCT01854294|anti-inflammatory|anti-inflammatory
4951365|NCT01854294|anti-apoptotic|anti-apoptotic
4951366|NCT01854294|anti-oxidative|anti-oxidative
4951367|NCT01854294|regenerative|regenerative
4951368|NCT01854294|distress signals|distress signals
4951369|NCT01854294|neurotrophin|neurotrophin
4951370|NCT01854294|Motoneuronotrophic factor (MNTF)|motoneuronotrophic factor (mntf)
4951371|NCT01854294|ALS model|als model
4951372|NCT01854294|life span|life span
4951373|NCT01854294|disease onset|disease onset
4951374|NCT01854294|grip strength|grip strength
4951375|NCT01854294|protein expression|protein expression
4951376|NCT01854294|DNA microarray|dna microarray
4951377|NCT01854294|differential expression|differential expression
4951378|NCT01854294|Phase 1 clinical trial|phase 1 clinical trial
4951379|NCT01854294|rare disease|rare disease
4951380|NCT01854294|common underlying pathogenic mechanisms|common underlying pathogenic mechanisms
4951381|NCT01854294|neurological deficits|neurological deficits
4951382|NCT01854294|gene mutation|gene mutation
4951383|NCT01854294|misfolded proteins|misfolded proteins
4951384|NCT01854294|inadvertent errors|inadvertent errors
4951385|NCT01854294|modulation of genes|modulation of genes
4951386|NCT01854294|master regulator peptide drug|master regulator peptide drug
4951387|NCT01854294|ALS related genes|als related genes
4951388|NCT01854294|mitochondria dysfunction|mitochondria dysfunction
4951389|NCT01854294|excitotoxicity|excitotoxicity
4951390|NCT01854294|axonal transport|axonal transport
4951391|NCT01854294|oxidative stress|oxidative stress
4951392|NCT01854294|protein aggregation|protein aggregation
4951393|NCT01854294|pathogenesis|pathogenesis
4951394|NCT01854294|target biomarkers|target biomarkers
4951395|NCT01854294|efficacy biomarkers|efficacy biomarkers
4951396|NCT01854281|Patent foramen ovale|patent foramen ovale
4951397|NCT01854281|Catheter-based closure|catheter-based closure
4951398|NCT01854281|Nitrogen bubbles|nitrogen bubbles
4951399|NCT01854281|Decompression sickness|decompression sickness
4951400|NCT01854268|cough|cough
4951401|NCT01854255|Gastric|gastric
4951402|NCT01854255|Cancer|cancer
4951403|NCT01854255|Chemotherapy|chemotherapy
4951404|NCT01854255|Intraperitoneal|intraperitoneal
4951405|NCT01854229|Morphine|morphine
4951406|NCT01854229|Implantable Infusion Pumps|implantable infusion pumps
4951407|NCT01854229|Intrathecal Pump|intrathecal pump
4951408|NCT01854216|Rotigotine|rotigotine
4951409|NCT01854216|Neupro|neupro
4951410|NCT01854216|Japanese|japanese
4951411|NCT01854216|Caucasian|caucasian
4951412|NCT01854216|Male|male
4951413|NCT01854216|Female|female
4951414|NCT01854216|Single dose|single dose
4951415|NCT01854216|Pharmacokinetics|pharmacokinetics
4951416|NCT01854203|Cisplatin|cisplatin
4951417|NCT01854203|neoadjuvant chemotherapy|neoadjuvant chemotherapy
4951418|NCT01854203|intensity-modulated radiation therapy|intensity-modulated radiation therapy
4951419|NCT01854203|concurrent chemoradiotherapy|concurrent chemoradiotherapy
4951420|NCT01854190|Obstructive sleep apnea|obstructive sleep apnea
4951421|NCT01854190|Resistent hypertension|resistent hypertension
4951422|NCT01854190|Endothelial function|endothelial function
4951423|NCT01854190|Blood pressure|blood pressure
4951424|NCT01854177|breathlessness; substance P; beta-endorphin|breathlessness; substance p; beta-endorphin
4951549|NCT01853514|Low income|low income
4951425|NCT01854164|HGE, impaired fasting glucose, clinical trial|hge, impaired fasting glucose, clinical trial
4951426|NCT01854151|Medication errors|medication errors
4951427|NCT01854151|Medication dosing|medication dosing
4951428|NCT01854138|primary knee arthroplasty|primary knee arthroplasty
4951429|NCT01854138|primary hip arthroplasty|primary hip arthroplasty
4951430|NCT01854138|negative pressure wound therapy|negative pressure wound therapy
4951431|NCT01854125|immun function|immun function
4951432|NCT01854125|liver function|liver function
4951433|NCT01854125|ascites|ascites
4951434|NCT01854125|quality of life|quality of life
4951435|NCT01854125|Child-Pugh score|child-pugh score
4951436|NCT01854112|Helical tomotherapy|helical tomotherapy
4951437|NCT01854112|total skin electron therapy|total skin electron therapy
4951438|NCT01854112|TSEB|tseb
4951439|NCT01854112|irradiation 5.|irradiation 5.
4951440|NCT01854099|Brain Tumor|brain tumor
4951441|NCT01854086|osteoporosis|osteoporosis
4951442|NCT01854086|postmenopausal|postmenopausal
4951443|NCT01854086|patient compliance|patient compliance
4951444|NCT01854086|compliance|compliance
4951445|NCT01854086|diphosphonates|diphosphonates
4951446|NCT01854086|bisphosphonates|bisphosphonates
4951447|NCT01854060|Irritable bowel syndrome|irritable bowel syndrome
4951448|NCT01854060|Epidimiology|epidimiology
4951449|NCT01854060|Deterioration in the severity of irritable bowel syndrome|deterioration in the severity of irritable bowel syndrome
4951450|NCT01854034|Advanced disease|advanced disease
4951451|NCT01854034|EGFR mutation|egfr mutation
4951452|NCT01854021|Anesthesia|anesthesia
4951453|NCT01854021|general|general
4951454|NCT01854021|Immunity|immunity
4951455|NCT01854021|Tongue neoplasms|tongue neoplasms
4951456|NCT01854021|immune|immune
4951457|NCT01854021|general anesthesia|general anesthesia
4951458|NCT01854008|Exercise, Physical activity, Rehabilitation, COPD.|exercise, physical activity, rehabilitation, copd.
4951459|NCT01853995|Fixed Lingual Mandibular Growth Modificator (FLMGM)|fixed lingual mandibular growth modificator (flmgm)
4951460|NCT01853995|Class II division 1 malocclusion|class ii division 1 malocclusion
4951461|NCT01853995|Sagittal Occlusal Correction|sagittal occlusal correction
4951462|NCT01853995|Skeletal changes|skeletal changes
4951463|NCT01853995|Dental changes|dental changes
4951464|NCT01853956|Mexico|mexico
4951465|NCT01853956|Bioequivalence|bioequivalence
4951466|NCT01853956|Alprazolam|alprazolam
4951467|NCT01853956|Pharmacokinetics|pharmacokinetics
4951468|NCT01853943|Transradial approach|transradial approach
4951469|NCT01853943|radial occlusion|radial occlusion
4951470|NCT01853943|hand grip|hand grip
4951471|NCT01853943|coronary angiography|coronary angiography
4951472|NCT01853930|reading rehabilitation|reading rehabilitation
4951473|NCT01853930|macular degeneration|macular degeneration
4951474|NCT01853930|eccentric viewing|eccentric viewing
4951475|NCT01853904|Bronchoscopy|bronchoscopy
4951476|NCT01853904|BAL|bal
4951477|NCT01853904|Suction|suction
4951478|NCT01853878|Non-Small Cell Lung Cancer|non-small cell lung cancer
4951479|NCT01853878|Immunotherapy|immunotherapy
4951480|NCT01853878|Antigen-Specific|antigen-specific
4951481|NCT01853865|Endometrial cancer|endometrial cancer
4951482|NCT01853865|Follow-up examination|follow-up examination
4951483|NCT01853813|colorectal cancer|colorectal cancer
4951484|NCT01853813|advanced disease|advanced disease
4951485|NCT01853813|LDH|ldh
4951486|NCT01853800|Relative bioavailability|relative bioavailability
4951487|NCT01853800|Rivaroxaban|rivaroxaban
4951488|NCT01853787|COPD|copd
4951489|NCT01853787|bronchial inflammation|bronchial inflammation
4951490|NCT01853787|NO concentration|no concentration
4951491|NCT01853787|small airways|small airways
4951492|NCT01853787|LABA|laba
4951493|NCT01853787|Small Airways Stretching|small airways stretching
4951494|NCT01853787|Stretch and strain of small airways in COPD|stretch and strain of small airways in copd
4951495|NCT01853787|Acute LABA effect on NO production|acute laba effect on no production
4951496|NCT01853787|Pulmonary desufflation|pulmonary desufflation
4951497|NCT01853774|Tailored navigation|tailored navigation
4951498|NCT01853774|Tailored messages|tailored messages
4951499|NCT01853761|abdominal fat|abdominal fat
4951500|NCT01853761|metabolic syndrome|metabolic syndrome
4951501|NCT01853761|microcurrent|microcurrent
4951502|NCT01853761|aerobic exercise|aerobic exercise
4951503|NCT01853722|DCN01|dcn01
4951504|NCT01853722|Ocular Surgical Preparation|ocular surgical preparation
4951505|NCT01853722|Prophylaxis against infection|prophylaxis against infection
4951506|NCT01853722|Pre-operative prep|pre-operative prep
4951507|NCT01853683|General Surgery|general surgery
4951508|NCT01853644|Cancer|cancer
4951509|NCT01853644|Recurrent|recurrent
4951510|NCT01853644|Ovary|ovary
4951511|NCT01853644|Fallopian Tube|fallopian tube
4951512|NCT01853644|Primary Peritioneal|primary peritioneal
4951513|NCT01853644|Phase II|phase ii
4951514|NCT01853644|Platinum Resistant|platinum resistant
4951515|NCT01853631|chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
4951516|NCT01853631|refractory|refractory
4951517|NCT01853631|recurrent|recurrent
4951518|NCT01853631|aggressive B-cell Lymphoma|aggressive b-cell lymphoma
4951519|NCT01853631|CD19|cd19
4951520|NCT01853631|Non-Hodgkin Lymphoma|non-hodgkin lymphoma
4951521|NCT01853631|CD28|cd28
4951522|NCT01853631|CD137|cd137
4951523|NCT01853631|4-1BB|4-1bb
4951524|NCT01853631|acute lymphocytic leukemia|acute lymphocytic leukemia
4951525|NCT01853618|Blocking of Immune Suppression|blocking of immune suppression
4951526|NCT01853618|Monoclonal Antibody|monoclonal antibody
4951527|NCT01853618|Immunotherapy|immunotherapy
4951528|NCT01853618|Ablative Therapy|ablative therapy
4951529|NCT01853592|Gadolinium Contrast|gadolinium contrast
4951530|NCT01853592|Cardiac MRI|cardiac mri
4951531|NCT01853592|MRA|mra
4951532|NCT01853592|MRI|mri
4951533|NCT01853592|MRI Safety|mri safety
4951534|NCT01853579|Randomized controlled trial|randomized controlled trial
4951535|NCT01853579|Subclinical hypothyroidism|subclinical hypothyroidism
4951536|NCT01853579|Levothyroxine|levothyroxine
4951537|NCT01853579|Depression|depression
4951538|NCT01853566|Muscle Strength|muscle strength
4951539|NCT01853566|Growth Hormone|growth hormone
4951540|NCT01853566|men|men
4951541|NCT01853540|Ciliary Beat Frequency (CBF)|ciliary beat frequency (cbf)
4951542|NCT01853540|Nasal Nitric Oxide (nNO)|nasal nitric oxide (nno)
4951543|NCT01853540|Mucociliary Dysfunction|mucociliary dysfunction
4951544|NCT01853527|CT coronary angiography|ct coronary angiography
4951545|NCT01853527|Contrast stress echocardiography|contrast stress echocardiography
4951546|NCT01853527|Arterial stiffness|arterial stiffness
4951547|NCT01853527|Quality of life|quality of life
4951548|NCT01853527|Biochemical and genetic markers|biochemical and genetic markers
4951550|NCT01853514|Fruit and vegetables|fruit and vegetables
4951551|NCT01853514|Conventional produce|conventional produce
4951552|NCT01853514|Organic produce|organic produce
4951553|NCT01853514|Pesticide|pesticide
4951554|NCT01853514|Purchasing behavior|purchasing behavior
4951555|NCT01853514|Message framing|message framing
4951556|NCT01853501|POF|pof
4951557|NCT01853488|Osteoporosis|osteoporosis
4951558|NCT01853488|BMD|bmd
4951559|NCT01853488|SCI|sci
4951560|NCT01853488|DXA|dxa
4951561|NCT01853488|pQCT|pqct
4951562|NCT01853475|pharmacokinetics|pharmacokinetics
4951563|NCT01853475|safety|safety
4951564|NCT01853475|tolerability|tolerability
4951565|NCT01853475|bioavailability|bioavailability
4951566|NCT01853449|Fentanyl Citrate|fentanyl citrate
4951567|NCT01853449|Opioids|opioids
4951568|NCT01853449|Exercise|exercise
4951569|NCT01853436|Breast Cancer|breast cancer
4951570|NCT01853436|Reconstructive Tissue Matrix|reconstructive tissue matrix
4951571|NCT01853436|Acellular Dermal Matrices (ADM)|acellular dermal matrices (adm)
4951572|NCT01853423|Rapamune|rapamune
4951573|NCT01853423|Topical|topical
4951574|NCT01853423|Pediatric|pediatric
4951575|NCT01853423|Safety|safety
4951576|NCT01853423|Efficiency|efficiency
4951577|NCT01853423|Angiofibroma|angiofibroma
4951578|NCT01853423|Skin Cream|skin cream
4951579|NCT01853410|coronary artery disease|coronary artery disease
4951580|NCT01853410|coronary flow reserve|coronary flow reserve
4951581|NCT01853410|endothelial function|endothelial function
4951582|NCT01853384|Venous leg ulcer|venous leg ulcer
4951583|NCT01853384|ulcer|ulcer
4951584|NCT01853384|venous stasis|venous stasis
4951585|NCT01853384|compression|compression
4951586|NCT01853384|venous|venous
4951587|NCT01853384|venous stasis ulcer|venous stasis ulcer
4951588|NCT01853384|vlu|vlu
4951589|NCT01853384|wound|wound
4951590|NCT01853384|varicose veins|varicose veins
4951591|NCT01853384|venous insufficiency|venous insufficiency
4951592|NCT01853384|dvt|dvt
4951593|NCT01853384|deep vein thrombosis|deep vein thrombosis
4951594|NCT01853358|hematological malignancy|hematological malignancy
4951595|NCT01853358|stem cell transplantation|stem cell transplantation
4951596|NCT01853345|Refractory|refractory
4951597|NCT01853345|Recurrent|recurrent
4951598|NCT01853345|High Risk|high risk
4951599|NCT01853332|Cardiovascular Disease|cardiovascular disease
4951600|NCT01853332|Diabetes|diabetes
4951601|NCT01853332|Adjustment|adjustment
4951602|NCT01853332|Adversity|adversity
4951603|NCT01853332|Psychology|psychology
4951604|NCT01853332|Midlife|midlife
4951605|NCT01853332|Functioning|functioning
4951606|NCT01853332|Socioeconomic|socioeconomic
4951607|NCT01853332|Psychosocial outcomes|psychosocial outcomes
4951608|NCT01853319|Regorafenib|regorafenib
4951609|NCT01853319|Metastatic colorectal cancer|metastatic colorectal cancer
4951610|NCT01853306|High grade serous ovarian cancer|high grade serous ovarian cancer
4951611|NCT01853306|BRCA mutated breast cancer|brca mutated breast cancer
4951612|NCT01853306|BRCA mutated|brca mutated
4951613|NCT01853306|Oncology|oncology
4951614|NCT01853293|Alcohol Abuse|alcohol abuse
4951615|NCT01853293|Alcohol Dependence|alcohol dependence
4951616|NCT01853293|Heavy drinking days|heavy drinking days
4951617|NCT01853293|Kudzu|kudzu
4951618|NCT01853280|ADHD|adhd
4951619|NCT01853280|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
4951620|NCT01853280|Deplin|deplin
4951621|NCT01853280|L-methylfolate|l-methylfolate
4951622|NCT01853280|Natural Treatments|natural treatments
4951623|NCT01853280|Medical Food|medical food
4951624|NCT01853267|Colorectal|colorectal
4951625|NCT01853267|Surgery|surgery
4951626|NCT01853267|Perianal|perianal
4951627|NCT01853267|Abscess|abscess
4951628|NCT01853241|small intestine|small intestine
4951629|NCT01853241|endoscopy, gastrointestinal|endoscopy, gastrointestinal
4951630|NCT01853228|Acute myeloid leukemia|acute myeloid leukemia
4951631|NCT01853228|Relapsed or refractory acute myeloid leukemia|relapsed or refractory acute myeloid leukemia
4951632|NCT01853228|Children|children
4951633|NCT01853228|Decitabine|decitabine
4951634|NCT01853228|DACOGEN|dacogen
4951635|NCT01853228|Cytarabine|cytarabine
4951636|NCT01853215|sternal intraosseous infusion study|sternal intraosseous infusion study
4951637|NCT01853202|Cancer|cancer
4951638|NCT01853202|Chemotherapy|chemotherapy
4951639|NCT01853202|Thrombosis|thrombosis
4951640|NCT01853202|Prevention|prevention
4951641|NCT01853202|Exercise|exercise
4951642|NCT01853189|pediatrics|pediatrics
4951643|NCT01853189|asthma|asthma
4951644|NCT01853189|osteopathic manipulative treatment|osteopathic manipulative treatment
4951645|NCT01853176|Pain, Postoperative|pain, postoperative
4951646|NCT01853176|Analgesia|analgesia
4951647|NCT01853176|Anesthesia, local|anesthesia, local
4951648|NCT01853176|Abdominoplasty|abdominoplasty
4951649|NCT01853163|Gadolinium|gadolinium
4951650|NCT01853163|Contrast Agent|contrast agent
4951651|NCT01853163|Long-term retention|long-term retention
4951652|NCT01853137|Class II division 1 malocclusion|class ii division 1 malocclusion
4951653|NCT01853137|Dentofacial orthopedics|dentofacial orthopedics
4951654|NCT01853137|Fixed Lingual Mandibular Growth Modificator (FLMGM)|fixed lingual mandibular growth modificator (flmgm)
4951655|NCT01853124|Diarrhea|diarrhea
4951656|NCT01853098|loving-kindness meditation|loving-kindness meditation
4951657|NCT01853098|mindfulness meditation|mindfulness meditation
4951658|NCT01853098|compassion|compassion
4951659|NCT01853072|Diabetes Type I|diabetes type i
4951660|NCT01853072|Diabetes Type II|diabetes type ii
4951661|NCT01853072|non-proliferative diabetic retinopathy|non-proliferative diabetic retinopathy
4951662|NCT01853072|macular edema|macular edema
4951663|NCT01853072|Cataract|cataract
4951664|NCT01853059|Anal cancer|anal cancer
4951665|NCT01853059|Squamous cell cancer|squamous cell cancer
4951666|NCT01853059|Radiotherapy|radiotherapy
4951667|NCT01853059|Chemoradiotherapy|chemoradiotherapy
4951668|NCT01853059|Conformational radiotherapy|conformational radiotherapy
4951669|NCT01853059|Intensity modulated radiation therapy|intensity modulated radiation therapy
4951670|NCT01853059|IMRT|imrt
4951671|NCT01853046|Regorafenib|regorafenib
4951672|NCT01853046|pharmacokinetics|pharmacokinetics
4951673|NCT01853046|safety|safety
4951674|NCT01853046|severe renal impairment|severe renal impairment
4951675|NCT01853046|Solid tumors|solid tumors
4951676|NCT01853033|Tolerability|tolerability
4951677|NCT01853033|Immunogenicity|immunogenicity
4951678|NCT01853033|Safety|safety
4951679|NCT01853033|Rheumatoid Arthritis|rheumatoid arthritis
4951680|NCT01853033|Pharmacokinetics|pharmacokinetics
4951681|NCT01853020|Cannabinoids|cannabinoids
4951682|NCT01853020|Eyeblink Conditioning|eyeblink conditioning
4951683|NCT01853020|EBC|ebc
4951684|NCT01853007|End stage renal disease|end stage renal disease
4951685|NCT01853007|Kidney transplantation|kidney transplantation
4951686|NCT01853007|Transplant options (living and deceased donor)|transplant options (living and deceased donor)
4951687|NCT01853007|Patient education|patient education
4951688|NCT01853007|Communication skills training|communication skills training
4951689|NCT01852981|Physical activity promotion|physical activity promotion
4951690|NCT01852981|Intervention|intervention
4951691|NCT01852981|Public Health|public health
4951692|NCT01852968|hypoglycemia|hypoglycemia
4951693|NCT01852968|hypoglycemia unawareness|hypoglycemia unawareness
4951694|NCT01852968|type 1 diabetes, hippocampus|type 1 diabetes, hippocampus
4951695|NCT01852968|glucose transport|glucose transport
4951696|NCT01852968|cognitive dysfunction|cognitive dysfunction
4951697|NCT01852955|Outpatient|outpatient
4951698|NCT01852955|Surgery|surgery
4951699|NCT01852955|Breast|breast
4951700|NCT01852955|Pain|pain
4951701|NCT01852942|Infection|infection
4951702|NCT01852942|HIV 1|hiv 1
4951703|NCT01852942|HIV|hiv
4951704|NCT01852942|Losartan|losartan
4951705|NCT01852942|Fibrosis|fibrosis
4951706|NCT01852942|Immune Activation|immune activation
4951707|NCT01852942|Immune Reconstitution|immune reconstitution
4951708|NCT01852929|Memory|memory
4951709|NCT01852916|RDS|rds
4951710|NCT01852903|vitamin C|vitamin c
4951711|NCT01852903|calcium ascorbate|calcium ascorbate
4951712|NCT01852903|ascorbic acid|ascorbic acid
4951713|NCT01852903|bioavailability|bioavailability
4951714|NCT01852890|Ascorbate|ascorbate
4951715|NCT01852890|Vitamin C|vitamin c
4951716|NCT01852890|Radiation|radiation
4951717|NCT01852890|Gemcitabine|gemcitabine
4951718|NCT01852890|Ascorbic Acid|ascorbic acid
4951719|NCT01852877|HIV Diagnosis|hiv diagnosis
4951720|NCT01852877|Case Management|case management
4951721|NCT01852877|Telemedicine|telemedicine
4951722|NCT01852877|Patient Compliance|patient compliance
4951723|NCT01852877|Prisoners|prisoners
4951724|NCT01852864|Prostate cancer|prostate cancer
4951725|NCT01852864|testosterone|testosterone
4951726|NCT01852864|castration|castration
4951727|NCT01852864|degarelix|degarelix
4951728|NCT01852864|proliferation|proliferation
4951729|NCT01852838|lung cancer|lung cancer
4951730|NCT01852838|volatile organic compounds|volatile organic compounds
4951731|NCT01852838|Warburg effect|warburg effect
4951732|NCT01852838|early detection|early detection
4951733|NCT01852799|Multiple myeloma|multiple myeloma
4951734|NCT01852799|PAD|pad
4951735|NCT01852799|ASCT|asct
4951736|NCT01852799|Bone metabolites|bone metabolites
4951737|NCT01852799|Bone marker|bone marker
4951738|NCT01852786|Contraception|contraception
4951739|NCT01852786|Hyperandrogenism|hyperandrogenism
4951740|NCT01852786|Female sexual function|female sexual function
4951741|NCT01852773|blunt|blunt
4951742|NCT01852773|injury|injury
4951743|NCT01852773|aorta|aorta
4951744|NCT01852773|endovascular|endovascular
4951745|NCT01852760|endoscopic ultrasound|endoscopic ultrasound
4951746|NCT01852760|ulcerative colitis|ulcerative colitis
4951747|NCT01852760|inflammatory bowel disease|inflammatory bowel disease
4951748|NCT01852747|Spinal Deformity|spinal deformity
4951749|NCT01852747|Multilevel|multilevel
4951750|NCT01852747|Posterior|posterior
4951751|NCT01852747|Lumbar|lumbar
4951752|NCT01852747|Fusion|fusion
4951753|NCT01852747|Levoscoliosis|levoscoliosis
4951754|NCT01852747|Dextroscoliosis|dextroscoliosis
4951755|NCT01852747|Graft|graft
4951756|NCT01852721|Cardiovascular diseases|cardiovascular diseases
4951757|NCT01852721|Nutritional intervention program|nutritional intervention program
4951758|NCT01852721|Self-Determination Theory|self-determination theory
4951759|NCT01852721|Motivational interviewing|motivational interviewing
4951760|NCT01852721|Gender differences|gender differences
4951761|NCT01852721|Women|women
4951762|NCT01852721|Men|men
4951763|NCT01852721|Motivation|motivation
4951764|NCT01852721|Dietary intakes|dietary intakes
4951765|NCT01852721|Mediterranean diet|mediterranean diet
4951766|NCT01852721|Eating behaviors|eating behaviors
4951767|NCT01852721|Lipid profile|lipid profile
4951768|NCT01852708|22q|22q
4951769|NCT01852708|1p36|1p36
4951770|NCT01852708|Angelman|angelman
4951771|NCT01852708|Cri-du-chat|cri-du-chat
4951772|NCT01852708|Prader-Willi|prader-willi
4951773|NCT01852708|DiGeorge|digeorge
4951774|NCT01852708|Turner syndrome|turner syndrome
4951775|NCT01852708|Patau syndrome|patau syndrome
4951776|NCT01852708|Edwards syndrome|edwards syndrome
4951777|NCT01852708|Down syndrome|down syndrome
4951778|NCT01852695|Family integrated Care|family integrated care
4951779|NCT01852695|Family centered care|family centered care
4951780|NCT01852695|NICU family centered care|nicu family centered care
4951781|NCT01852695|NICU parent program|nicu parent program
4951782|NCT01852682|Peritoneal Dialysis|peritoneal dialysis
4951783|NCT01852682|Hyperphosphatemia|hyperphosphatemia
4951784|NCT01852656|Influenza, Human|influenza, human
4951785|NCT01852656|Immunization|immunization
4951786|NCT01852643|Rhinoplasty|rhinoplasty
4951787|NCT01852643|Spreader graft technique|spreader graft technique
4951788|NCT01852643|Lateral crural overlay technique|lateral crural overlay technique
4951789|NCT01852643|Rhinomanometry|rhinomanometry
4951790|NCT01852617|Smoking Cessation|smoking cessation
4951791|NCT01852617|Pregnancy|pregnancy
4951792|NCT01852617|Implementation|implementation
4951793|NCT01852617|Knowledge translation|knowledge translation
4951794|NCT01852604|HCV|hcv
4951795|NCT01852604|Hepatitis C|hepatitis c
4951796|NCT01852604|chronic hepatitis C|chronic hepatitis c
4951797|NCT01852604|antiviral|antiviral
4951798|NCT01852591|autologous transplant|autologous transplant
4951799|NCT01852591|multiple myeloma|multiple myeloma
4951800|NCT01852578|Metastatic NSCLC|metastatic nsclc
4951801|NCT01852578|2nd Line|2nd line
4951802|NCT01852578|Docetaxel-based treatment|docetaxel-based treatment
4951803|NCT01852578|Progressed|progressed
4951804|NCT01852578|Refractory|refractory
4951805|NCT01852565|CYP3A4|cyp3a4
4951806|NCT01852565|Lp-PLA2|lp-pla2
4951807|NCT01852565|Atherosclerosis|atherosclerosis
4951808|NCT01852565|healthy volunteer|healthy volunteer
4951809|NCT01852565|Drug interaction|drug interaction
4951810|NCT01852552|Aortic stenosis|aortic stenosis
4951811|NCT01852552|Transcatheter aortic valve implantation|transcatheter aortic valve implantation
4951812|NCT01852552|Aortic valve replacement|aortic valve replacement
4951813|NCT01852552|Costs|costs
4951814|NCT01852552|Cognitive function|cognitive function
4951815|NCT01852552|Quality of life|quality of life
4951816|NCT01852539|LMA insertion|lma insertion
4951817|NCT01852539|dexmedetomidine|dexmedetomidine
4951818|NCT01852539|propofol|propofol
4951819|NCT01852526|degenerative disc disease|degenerative disc disease
4951820|NCT01852526|spondylolisthesis|spondylolisthesis
4951821|NCT01852526|Lumbar spine|lumbar spine
4951822|NCT01852526|fusion|fusion
4951823|NCT01852526|adjacent instability|adjacent instability
4951824|NCT01852487|Pumpkin seed oil|pumpkin seed oil
4951825|NCT01852487|Hair growth|hair growth
4951827|NCT01852474|motor learning|motor learning
4951828|NCT01852474|cortical plasticity|cortical plasticity
4951829|NCT01852474|direct current stimulation|direct current stimulation
4951830|NCT01852461|natural surfactants; perfusion index|natural surfactants; perfusion index
4951831|NCT01852435|diffuse large B-cell lymphoma|diffuse large b-cell lymphoma
4951832|NCT01852435|follicular lymphoma grade 3B|follicular lymphoma grade 3b
4951833|NCT01852409|refractory malignant ascites|refractory malignant ascites
4951834|NCT01852409|Bevacizumab|bevacizumab
4951835|NCT01852409|intraperitoneal|intraperitoneal
4951836|NCT01852409|phase I|phase i
4951837|NCT01852396|Infraclavicular block|infraclavicular block
4951838|NCT01852396|Brachial Plexus|brachial plexus
4951839|NCT01852396|Retroclavicular Approach|retroclavicular approach
4951840|NCT01852396|Complications of retroclavicular approach|complications of retroclavicular approach
4951841|NCT01852396|Success of retroclavicular approach|success of retroclavicular approach
4951842|NCT01852383|Duloxetine|duloxetine
4951843|NCT01852383|Antidepressant|antidepressant
4951844|NCT01852383|Depression|depression
4951845|NCT01852383|Dysthymic Disorder|dysthymic disorder
4951846|NCT01852383|Side Effects|side effects
4951847|NCT01852383|Elderly|elderly
4951848|NCT01852370|Lung transplantation|lung transplantation
4951849|NCT01852370|Bone Marrow Transplantation|bone marrow transplantation
4951850|NCT01852370|Unrelated Donor|unrelated donor
4951851|NCT01852370|Cadaveric Donor|cadaveric donor
4951852|NCT01852370|Deceased Donor|deceased donor
4951853|NCT01852370|HLA-mismatch|hla-mismatch
4951854|NCT01852370|BOLT|bolt
4951855|NCT01852370|BMT|bmt
4951856|NCT01852370|HSCT|hsct
4951857|NCT01852344|Methylphenidate|methylphenidate
4951858|NCT01852344|Effortful Control|effortful control
4951859|NCT01852344|Attention Control|attention control
4951860|NCT01852344|Cognitive functions|cognitive functions
4951861|NCT01852331|Schizophrenia|schizophrenia
4951862|NCT01852331|Schizophrenic Disorder|schizophrenic disorder
4951863|NCT01852331|Hyperprolactinemia|hyperprolactinemia
4951864|NCT01852331|Hyperprolactinaemia|hyperprolactinaemia
4951865|NCT01852331|Chinese herbal medicine|chinese herbal medicine
4951866|NCT01852331|Traditional Chinese medicine|traditional chinese medicine
4951867|NCT01852331|Peony-Glycyrrhiza Decoction|peony-glycyrrhiza decoction
4951868|NCT01852331|PGD|pgd
4951869|NCT01852331|Glycyrrhiza Radix|glycyrrhiza radix
4951870|NCT01852331|Liquorice Root|liquorice root
4951871|NCT01852331|Gancao|gancao
4951872|NCT01852331|Paeoniae Alba Radix|paeoniae alba radix
4951873|NCT01852331|White Peony Root|white peony root
4951874|NCT01852331|Baishao|baishao
4951875|NCT01852318|uremic pruritus|uremic pruritus
4951876|NCT01852318|pregabalin|pregabalin
4951877|NCT01852318|gabapentin|gabapentin
4951878|NCT01852318|fexofenadine|fexofenadine
4951879|NCT01852305|Obstructive sleep apnea|obstructive sleep apnea
4951880|NCT01852305|Continuous positive airway pressure (CPAP)|continuous positive airway pressure (cpap)
4951881|NCT01852305|Oximetry|oximetry
4951882|NCT01852305|Bariatric Surgery|bariatric surgery
4951883|NCT01852305|Anesthesia|anesthesia
4951884|NCT01852305|Oxygen desaturation index (ODI)|oxygen desaturation index (odi)
4951885|NCT01852292|platinum pre-treated recurrent or metastatic|platinum pre-treated recurrent or metastatic
4951886|NCT01852292|Head and neck squamous cell carcinoma|head and neck squamous cell carcinoma
4951887|NCT01852292|recurrent|recurrent
4951888|NCT01852292|metastatic|metastatic
4951889|NCT01852292|BKM120|bkm120
4951890|NCT01852253|Dental implants|dental implants
4951891|NCT01852253|Periodontal diseases|periodontal diseases
4951892|NCT01852253|Peri-implantitis|peri-implantitis
4951893|NCT01852253|Chlorhexidine|chlorhexidine
4951894|NCT01852253|Microbiology|microbiology
4951895|NCT01852214|Diabetes mellitus|diabetes mellitus
4951896|NCT01852214|Coronary artery disease|coronary artery disease
4951897|NCT01852214|prasugrel|prasugrel
4951898|NCT01852214|ticagrelor|ticagrelor
4951899|NCT01852188|Intrapartum|intrapartum
4951900|NCT01852188|Glove|glove
4951901|NCT01852188|Chorioamnionitis|chorioamnionitis
4951902|NCT01852175|Coronary artery disease|coronary artery disease
4951903|NCT01852175|Dual antiplatelet therapy|dual antiplatelet therapy
4951904|NCT01852175|prasugrel|prasugrel
4951905|NCT01852175|ticagrelor|ticagrelor
4951906|NCT01852162|Coronary artery disease|coronary artery disease
4951907|NCT01852162|antiplatelet therapy|antiplatelet therapy
4951908|NCT01852162|anticoagulant therapy|anticoagulant therapy
4951909|NCT01852149|Mitral Valve Regurgitation|mitral valve regurgitation
4951910|NCT01852149|Coaptation|coaptation
4951911|NCT01852149|Mitral Valve Repair|mitral valve repair
4951912|NCT01852149|Plication|plication
4951913|NCT01852149|Leaflet|leaflet
4951914|NCT01852149|Annulus|annulus
4951915|NCT01852149|Mitral Annuloplasty|mitral annuloplasty
4951916|NCT01852136|pen needle|pen needle
4951917|NCT01852136|insulin|insulin
4951918|NCT01852123|High-sensitivity troponin assay|high-sensitivity troponin assay
4951919|NCT01852123|Myocardial infarction|myocardial infarction
4951920|NCT01852123|Unstable angina|unstable angina
4951921|NCT01852123|Myocardial injury|myocardial injury
4951922|NCT01852123|Cluster randomized trial|cluster randomized trial
4951923|NCT01852097|Inflammatory Bowel Disease (IBD)|inflammatory bowel disease (ibd)
4951924|NCT01852097|Crohn's disease|crohn's disease
4951925|NCT01852097|Ulcerative colitis|ulcerative colitis
4951926|NCT01852097|Cognitive Behavioural Therapy (CBT)|cognitive behavioural therapy (cbt)
4951927|NCT01852097|Medication adherence|medication adherence
4951928|NCT01852071|gene therapy, hematopoietic stem cell, SCID, lentivirus|gene therapy, hematopoietic stem cell, scid, lentivirus
4951929|NCT01852032|Breast Cancer|breast cancer
4951930|NCT01852019|CAD|cad
4951931|NCT01851993|Ondansetron|ondansetron
4951932|NCT01851993|Exercise|exercise
4951933|NCT01851980|Furosemide|furosemide
4951934|NCT01851980|Exercise|exercise
4951935|NCT01851980|Restrictive pulmonary disorder|restrictive pulmonary disorder
4951936|NCT01851967|Major depressive disorder|major depressive disorder
4951937|NCT01851967|Cognitive behavioral therapy|cognitive behavioral therapy
4951938|NCT01851967|Computerized CBT|computerized cbt
4951939|NCT01851967|Online CBT|online cbt
4951940|NCT01851915|Major depression|major depression
4951941|NCT01851915|Interpersonal psychotherapy|interpersonal psychotherapy
4951942|NCT01851915|Cognitive Behavioral Therapy|cognitive behavioral therapy
4951943|NCT01851915|Alliance|alliance
4951944|NCT01851915|Return to Work|return to work
4951945|NCT01851902|Atrial Fibrillation|atrial fibrillation
4951946|NCT01851902|Atrial Flutter|atrial flutter
4951947|NCT01851902|Arrhythmia|arrhythmia
4951948|NCT01851863|functional dyspepsia|functional dyspepsia
4951949|NCT01851863|depression|depression
4951950|NCT01851863|compliance|compliance
4951951|NCT01851850|PD|pd
4951952|NCT01851850|Off periods|off periods
4951953|NCT01851850|quality of life|quality of life
4951954|NCT01851850|dyskinesia|dyskinesia
4951955|NCT01851850|end-off-dose motor fluctuations|end-off-dose motor fluctuations
4951956|NCT01851811|OSA|osa
4951957|NCT01851798|OSA|osa
4951958|NCT01851798|Sleep disordered breathing|sleep disordered breathing
4951959|NCT01851798|anesthesia|anesthesia
4951960|NCT01851798|ambulatory orthopedic surgery|ambulatory orthopedic surgery
4951961|NCT01851785|Knee Arthroplasty|knee arthroplasty
4951962|NCT01851785|Knee Osteoarthritis|knee osteoarthritis
4951963|NCT01851785|Osteoarthritis|osteoarthritis
4951964|NCT01851785|disparity|disparity
4951965|NCT01851785|joint replacement|joint replacement
4951966|NCT01851772|cervical|cervical
4951967|NCT01851772|cancer|cancer
4951968|NCT01851772|brachytherapy|brachytherapy
4951969|NCT01851772|electronic|electronic
4951970|NCT01851772|device|device
4951971|NCT01851772|applicator|applicator
4951972|NCT01851772|toxicity|toxicity
4951973|NCT01851772|gynecologic|gynecologic
4951974|NCT01851772|high-dose-rate (HDR)|high-dose-rate (hdr)
4951975|NCT01851772|x-ray|x-ray
4951976|NCT01851772|safety|safety
4951977|NCT01851772|external beam radiation therapy (EBRT)|external beam radiation therapy (ebrt)
4951978|NCT01851746|recurrent ovarian cancer|recurrent ovarian cancer
4951979|NCT01851746|lobaplatin|lobaplatin
4951980|NCT01851746|docetaxel|docetaxel
4951981|NCT01851746|carboplatin|carboplatin
4951982|NCT01851694|Cystic Fibrosis|cystic fibrosis
4951983|NCT01851694|Diabetes|diabetes
4951984|NCT01851694|Pancreatic insufficiency|pancreatic insufficiency
4951985|NCT01851681|dental implants|dental implants
4951986|NCT01851681|wound healing|wound healing
4951987|NCT01851681|amoxicillin|amoxicillin
4951988|NCT01851681|pain|pain
4951989|NCT01851668|vibration|vibration
4951990|NCT01851668|noise|noise
4951991|NCT01851668|transfer|transfer
4951992|NCT01851668|intraventricular hemorrhage|intraventricular hemorrhage
4951993|NCT01851655|rehabilitation|rehabilitation
4951994|NCT01851655|plyometric|plyometric
4951995|NCT01851642|Macrophage|macrophage
4951996|NCT01851642|Alpha-1 Antitrypsin Deficiency|alpha-1 antitrypsin deficiency
4951997|NCT01851642|Cystic Fibrosis|cystic fibrosis
4951998|NCT01851629|Locomotor training|locomotor training
4951999|NCT01851629|Walking recovery|walking recovery
4952000|NCT01851629|Neuroplasticity|neuroplasticity
4952001|NCT01851616|glucose, blood|glucose, blood
4952002|NCT01851603|Schizophrenia|schizophrenia
4952003|NCT01851590|Dermatophyte onychomycosis|dermatophyte onychomycosis
4952004|NCT01851590|Fungal nail infection|fungal nail infection
4952005|NCT01851590|Resin Lacquer|resin lacquer
4952006|NCT01851590|Amorolfine|amorolfine
4952007|NCT01851590|Terbinafine|terbinafine
4952008|NCT01851577|Coparenting|coparenting
4952009|NCT01851577|Problem solving|problem solving
4952010|NCT01851577|Child development|child development
4952011|NCT01851577|Father involvement|father involvement
4952012|NCT01851564|Gastrointestinal Haemorrhage|gastrointestinal haemorrhage
4952013|NCT01851564|Varices|varices
4952014|NCT01851564|Liver Cirrhosis|liver cirrhosis
4952015|NCT01851564|Stent|stent
4952016|NCT01851551|NHL|nhl
4952017|NCT01851551|non-Hodgkin's lymphoma|non-hodgkin's lymphoma
4952018|NCT01851551|diffuse large b-cell lymphoma|diffuse large b-cell lymphoma
4952019|NCT01851551|mantle cell lymphoma|mantle cell lymphoma
4952020|NCT01851538|Heart failure|heart failure
4952021|NCT01851538|Biomarkers|biomarkers
4952022|NCT01851538|Echocardiography|echocardiography
4952023|NCT01851525|Atrial fibrillation|atrial fibrillation
4952024|NCT01851525|Ablation|ablation
4952025|NCT01851499|Neuropathic pain following spinal cord injury|neuropathic pain following spinal cord injury
4952026|NCT01851473|Cocaine|cocaine
4952027|NCT01851473|Pharmacokinetics|pharmacokinetics
4952028|NCT01851473|Pharmacodynamics|pharmacodynamics
4952029|NCT01851473|Drug Interactions|drug interactions
4952030|NCT01851473|Acetazolamide|acetazolamide
4952031|NCT01851460|Staphylococcus Infection|staphylococcus infection
4952032|NCT01851460|RFA|rfa
4952033|NCT01851460|Hepatic|hepatic
4952034|NCT01851460|CGD|cgd
4952035|NCT01851447|Muscle|muscle
4952036|NCT01851447|Inflammatory Cytokines|inflammatory cytokines
4952037|NCT01851447|Exercise|exercise
4952038|NCT01851447|Biomarkers|biomarkers
4952039|NCT01851447|Predictors of Outcome|predictors of outcome
4952040|NCT01851434|OCT|oct
4952041|NCT01851434|Multiple Sclerosis|multiple sclerosis
4952042|NCT01851434|Optic Neuritis|optic neuritis
4952043|NCT01851434|Magnetic Resonance Imaging (MRI)|magnetic resonance imaging (mri)
4952044|NCT01851421|Body Fat|body fat
4952045|NCT01851421|Adult|adult
4952046|NCT01851421|Obesity|obesity
4952047|NCT01851421|Free Fatty Acids|free fatty acids
4952048|NCT01851421|Melanocortin-3 Receptor|melanocortin-3 receptor
4952049|NCT01851408|Sorafenib|sorafenib
4952050|NCT01851408|Temsirolimus|temsirolimus
4952051|NCT01851408|Stage IV|stage iv
4952052|NCT01851408|recurrent|recurrent
4952053|NCT01851408|unresectable|unresectable
4952054|NCT01851408|non-choroidal origin|non-choroidal origin
4952055|NCT01851408|CCI-779|cci-779
4952056|NCT01851408|BAY43-9006|bay43-9006
4952057|NCT01851408|metastatic melanoma|metastatic melanoma
4952058|NCT01851395|Palliative|palliative
4952059|NCT01851395|Tumor Heterogeneity|tumor heterogeneity
4952060|NCT01851395|Genomic and Proteomic Alterations|genomic and proteomic alterations
4952185|NCT01850953|smoking|smoking
4952061|NCT01851395|Deep Sequencing and Global Analysis|deep sequencing and global analysis
4952062|NCT01851395|Clonal Evolution|clonal evolution
4952063|NCT01851382|ELISA|elisa
4952064|NCT01851382|Spectrometry|spectrometry
4952065|NCT01851382|Protein Biomarkers|protein biomarkers
4952066|NCT01851382|Proteomic Analyses|proteomic analyses
4952067|NCT01851369|Solid Tumors|solid tumors
4952068|NCT01851369|Lymphomas|lymphomas
4952069|NCT01851369|DNA Damage|dna damage
4952070|NCT01851369|Pharmacodynamics|pharmacodynamics
4952071|NCT01851369|Pharmacokinetics|pharmacokinetics
4952072|NCT01851356|PBR28|pbr28
4952073|NCT01851356|Depression|depression
4952074|NCT01851356|PET Imaging|pet imaging
4952075|NCT01851356|Neuroinflammation|neuroinflammation
4952076|NCT01851343|Stem Cell Infusion|stem cell infusion
4952077|NCT01851343|Crohns|crohns
4952078|NCT01851343|Ulcerative Colitis|ulcerative colitis
4952079|NCT01851343|Inflammation|inflammation
4952080|NCT01851343|Diarrhea|diarrhea
4952081|NCT01851330|HCV genotype 1 (GT-1)|hcv genotype 1 (gt-1)
4952082|NCT01851330|HCV|hcv
4952083|NCT01851330|Sustained Virologic Response|sustained virologic response
4952084|NCT01851330|Direct Acting Antiviral|direct acting antiviral
4952085|NCT01851330|Combination Therapy|combination therapy
4952086|NCT01851330|GS-7977|gs-7977
4952087|NCT01851330|GS-5885|gs-5885
4952088|NCT01851330|Ribavirin|ribavirin
4952089|NCT01851330|Open Label|open label
4952090|NCT01851330|Sofosbuvir|sofosbuvir
4952091|NCT01851330|Additional relevant MeSH terms:|additional relevant mesh terms:
4952092|NCT01851330|Hepatitis|hepatitis
4952093|NCT01851330|Hepatitis, Chronic|hepatitis, chronic
4952094|NCT01851330|Hepatitis C|hepatitis c
4952095|NCT01851330|Hepatitis C, Chronic|hepatitis c, chronic
4952096|NCT01851330|Liver Diseases|liver diseases
4952097|NCT01851330|Digestive System Diseases|digestive system diseases
4952098|NCT01851330|Hepatitis, Viral, Human|hepatitis, viral, human
4952099|NCT01851330|Virus Diseases|virus diseases
4952100|NCT01851330|Enterovirus Infections|enterovirus infections
4952101|NCT01851330|Picornaviridae Infections|picornaviridae infections
4952102|NCT01851330|RNA Virus Infections|rna virus infections
4952103|NCT01851330|Flaviviridae Infections|flaviviridae infections
4952104|NCT01851330|Antiviral Agents|antiviral agents
4952105|NCT01851330|Anti-Infective Agents|anti-infective agents
4952106|NCT01851330|Therapeutic Uses|therapeutic uses
4952107|NCT01851330|Pharmacologic Actions|pharmacologic actions
4952108|NCT01851330|Antimetabolites|antimetabolites
4952109|NCT01851330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
4952110|NCT01851304|beta-Glucans|beta-glucans
4952111|NCT01851304|Bitter|bitter
4952112|NCT01851304|Bread|bread
4952113|NCT01851304|Coffee|coffee
4952114|NCT01851304|Gentiana lutea|gentiana lutea
4952115|NCT01851304|Melanoidins|melanoidins
4952116|NCT01851304|Microencapsulation|microencapsulation
4952117|NCT01851278|injection|injection
4952118|NCT01851278|arthritis|arthritis
4952119|NCT01851278|corticosteroid|corticosteroid
4952120|NCT01851265|oncology, cancer, tumour, neoplasm, anticancer drug, food effect, area under the curve, pharmacokinetics, olaparib, solid tumour, metabolites, drug availability|oncology, cancer, tumour, neoplasm, anticancer drug, food effect, area under the curve, pharmacokinetics, olaparib, solid tumour, metabolites, drug availability
4952121|NCT01851252|Cirrhotics|cirrhotics
4952122|NCT01851252|Esophageal varices|esophageal varices
4952123|NCT01851252|Portal Hypertension|portal hypertension
4952124|NCT01851239|Venous Thromboembolism Prophylaxis|venous thromboembolism prophylaxis
4952125|NCT01851239|ICU|icu
4952126|NCT01851213|genomics|genomics
4952127|NCT01851213|cancer|cancer
4952128|NCT01851213|registry|registry
4952129|NCT01851213|neoplasm metastasis|neoplasm metastasis
4952130|NCT01851200|Testicular neoplasms|testicular neoplasms
4952131|NCT01851200|Germ Cell cancers|germ cell cancers
4952132|NCT01851200|Embryonal Carcinoma|embryonal carcinoma
4952133|NCT01851200|Metastatic|metastatic
4952134|NCT01851200|Brentuximab Vedotin|brentuximab vedotin
4952135|NCT01851187|Psychological intervention,|psychological intervention,
4952136|NCT01851187|prenatal period,|prenatal period,
4952137|NCT01851187|cesarean section rate,|cesarean section rate,
4952138|NCT01851187|stage of labor|stage of labor
4952139|NCT01851148|osteopathic manipulative treatment|osteopathic manipulative treatment
4952140|NCT01851148|migraine|migraine
4952141|NCT01851135|Quality of life|quality of life
4952142|NCT01851135|Neuropsychological disorders|neuropsychological disorders
4952143|NCT01851135|Neurofibromatosis type 1|neurofibromatosis type 1
4952144|NCT01851122|l-theanine|l-theanine
4952145|NCT01851122|alertness|alertness
4952146|NCT01851122|well-being|well-being
4952147|NCT01851109|ovarian cancer|ovarian cancer
4952148|NCT01851109|prevention|prevention
4952149|NCT01851109|prophylactic surgery|prophylactic surgery
4952150|NCT01851109|risk|risk
4952151|NCT01851109|biomarkers|biomarkers
4952152|NCT01851109|screening|screening
4952153|NCT01851109|symptoms|symptoms
4952154|NCT01851096|Hsp90|hsp90
4952155|NCT01851096|SNX-5422|snx-5422
4952156|NCT01851096|Erlotinib|erlotinib
4952157|NCT01851096|Lung adenocarcinoma|lung adenocarcinoma
4952158|NCT01851083|Traumatic Brain Injury|traumatic brain injury
4952159|NCT01851083|TBI|tbi
4952160|NCT01851083|pediatric|pediatric
4952161|NCT01851083|acute|acute
4952162|NCT01851083|stem cells|stem cells
4952163|NCT01851057|Epilepsy|epilepsy
4952164|NCT01851044|Platelet Rich Plasma|platelet rich plasma
4952165|NCT01851044|Whole Blood Injection|whole blood injection
4952166|NCT01851044|Lateral Epicondylitis|lateral epicondylitis
4952167|NCT01851044|Tennis Elbow|tennis elbow
4952168|NCT01851031|medial or low condylar fractures|medial or low condylar fractures
4952169|NCT01851031|the minor parotid anterior approach|the minor parotid anterior approach
4952170|NCT01851031|the retromandibular approach|the retromandibular approach
4952171|NCT01851018|Prostate cancer|prostate cancer
4952172|NCT01851018|brachytherapy|brachytherapy
4952173|NCT01851018|hypofractionated radiation therapy|hypofractionated radiation therapy
4952174|NCT01851018|hormonal therapy|hormonal therapy
4952175|NCT01851005|Dexmedetomidine|dexmedetomidine
4952176|NCT01851005|Anesthesia|anesthesia
4952177|NCT01851005|Recovery profile|recovery profile
4952178|NCT01850992|Obstructive sleep apnea.|obstructive sleep apnea.
4952179|NCT01850992|sleep|sleep
4952180|NCT01850992|male hormones|male hormones
4952181|NCT01850979|CYCLOSPORINE/TACROLIMUS [VA Drug Interaction]|cyclosporine/tacrolimus [va drug interaction]
4952182|NCT01850966|Arthritis, Rheumatoid, Iguratimod|arthritis, rheumatoid, iguratimod
4952183|NCT01850953|Varenicline|varenicline
4952184|NCT01850953|Schizophrenia|schizophrenia
4952186|NCT01850953|Lapse|lapse
4952187|NCT01850940|Cirrhotic Patients|cirrhotic patients
4952188|NCT01850940|Hyponatremia|hyponatremia
4952189|NCT01850940|tolvaptan|tolvaptan
4952190|NCT01850914|Normal pressure hydrocephalus|normal pressure hydrocephalus
4952191|NCT01850914|Vascular risk factors|vascular risk factors
4952192|NCT01850901|Hypertension|hypertension
4952193|NCT01850901|Renal denervation|renal denervation
4952194|NCT01850901|Sympathetic denervation|sympathetic denervation
4952195|NCT01850888|neuroblastoma|neuroblastoma
4952196|NCT01850888|pheochromocytoma|pheochromocytoma
4952197|NCT01850875|Eye-Movement-Desensitization and Reprocessing|eye-movement-desensitization and reprocessing
4952198|NCT01850875|EMDR|emdr
4952199|NCT01850875|Chronic back pain|chronic back pain
4952200|NCT01850875|CBP|cbp
4952201|NCT01850875|treatment|treatment
4952202|NCT01850836|Aphasia, Stroke, repetitive transcranial magnetic stimulation.|aphasia, stroke, repetitive transcranial magnetic stimulation.
4952203|NCT01850797|oral anticoagulants|oral anticoagulants
4952204|NCT01850797|ischemic stroke|ischemic stroke
4952205|NCT01850797|blood thinner|blood thinner
4952206|NCT01850797|intracranial hemorrhage|intracranial hemorrhage
4952207|NCT01850784|Congenital heart disease, Growth,Neurodevelopment|congenital heart disease, growth,neurodevelopment
4952208|NCT01850771|Lumbar Radiculopathy|lumbar radiculopathy
4952209|NCT01850771|Disc bulge|disc bulge
4952210|NCT01850771|Disc herniation|disc herniation
4952211|NCT01850771|Disc degeneration|disc degeneration
4952212|NCT01850758|ACL|acl
4952213|NCT01850758|Anterior Cruciate Ligament|anterior cruciate ligament
4952214|NCT01850758|ACL Tear|acl tear
4952215|NCT01850758|Anterior Cruciate Ligament Tear|anterior cruciate ligament tear
4952216|NCT01850758|Partial ACL Tear|partial acl tear
4952217|NCT01850745|Chronic hepatitis C virus infection (CHC)|chronic hepatitis c virus infection (chc)
4952218|NCT01850719|Tibial meniscus|tibial meniscus
4952219|NCT01850719|Arthroscopy|arthroscopy
4952220|NCT01850719|Meniscectomy|meniscectomy
4952221|NCT01850719|Conservative treatment|conservative treatment
4952222|NCT01850719|Physical therapy|physical therapy
4952223|NCT01850719|Osteoarthritis knee joint|osteoarthritis knee joint
4952224|NCT01850706|uNGF|ungf
4952225|NCT01850706|urinary nerve growth factor|urinary nerve growth factor
4952226|NCT01850706|detrusor overactivity|detrusor overactivity
4952227|NCT01850706|InterStim|interstim
4952228|NCT01850706|sacral neuromodulation|sacral neuromodulation
4952229|NCT01850706|sacral nerve stimulation|sacral nerve stimulation
4952230|NCT01850706|quality of life|quality of life
4952231|NCT01850706|questionnaire|questionnaire
4952232|NCT01850706|urodynamic detrusor overactivity|urodynamic detrusor overactivity
4952233|NCT01850706|overactive bladder|overactive bladder
4952234|NCT01850693|coronary artery disease|coronary artery disease
4952235|NCT01850693|stroke|stroke
4952236|NCT01850693|coronary CT angiography|coronary ct angiography
4952237|NCT01850667|Hepatocellular carcinoma|hepatocellular carcinoma
4952238|NCT01850667|Stereotactic body radiotherapy|stereotactic body radiotherapy
4952239|NCT01850667|Stereotactic ablative radiotherapy|stereotactic ablative radiotherapy
4952240|NCT01850654|colorectal cancer|colorectal cancer
4952241|NCT01850654|colon cancer|colon cancer
4952242|NCT01850654|rectal cancer|rectal cancer
4952243|NCT01850654|endometrial cancer|endometrial cancer
4952244|NCT01850654|Lynch syndrome|lynch syndrome
4952245|NCT01850654|Ohio colon cancer study|ohio colon cancer study
4952246|NCT01850654|OSU colon study|osu colon study
4952247|NCT01850641|Hemodialysis|hemodialysis
4952248|NCT01850641|Hyperphosphatemia|hyperphosphatemia
4952249|NCT01850628|National Surgical Adjuvant Breast and Bowel Project (NSABP)|national surgical adjuvant breast and bowel project (nsabp)
4952250|NCT01850628|paclitaxel|paclitaxel
4952251|NCT01850628|trastuzumab|trastuzumab
4952252|NCT01850628|pertuzumab|pertuzumab
4952253|NCT01850628|HER2 positive (human epidermal growth factor receptor 2)|her2 positive (human epidermal growth factor receptor 2)
4952254|NCT01850628|Proteomics|proteomics
4952255|NCT01850628|Neoadjuvant Therapy|neoadjuvant therapy
4952256|NCT01850628|Anthracycline therapy|anthracycline therapy
4952257|NCT01850628|Locally advanced|locally advanced
4952258|NCT01850628|Operable|operable
4952259|NCT01850628|Biomarkers|biomarkers
4952260|NCT01850602|Hemodialysis|hemodialysis
4952261|NCT01850602|Hyperphosphatemia|hyperphosphatemia
4952262|NCT01850576|prevention|prevention
4952263|NCT01850576|testing|testing
4952264|NCT01850576|counseling|counseling
4952265|NCT01850576|linkage|linkage
4952266|NCT01850563|Demonstrate coordination of HBO with SRS treatments is feasible.|demonstrate coordination of hbo with srs treatments is feasible.
4952267|NCT01850563|Demonstrate outcomes for patients treated with combination of HBO and SRS are non-inferior .|demonstrate outcomes for patients treated with combination of hbo and srs are non-inferior .
4952268|NCT01850550|Weight loss|weight loss
4952269|NCT01850537|DDD|ddd
4952270|NCT01850537|PROW|prow
4952271|NCT01850537|FUSION|fusion
4952272|NCT01850537|eSPIN|espin
4952273|NCT01850537|Cage|cage
4952274|NCT01850537|IBF|ibf
4952275|NCT01850537|Discectomy|discectomy
4952276|NCT01850537|Lumbar Fusion|lumbar fusion
4952277|NCT01850537|TLIF|tlif
4952278|NCT01850537|MIS|mis
4952279|NCT01850524|Newly Diagnosed multiple myeloma|newly diagnosed multiple myeloma
4952280|NCT01850524|multiple myeloma|multiple myeloma
4952281|NCT01850524|MLN9708|mln9708
4952282|NCT01850524|IXAZOMIB|ixazomib
4952283|NCT01850524|Proteasome inhibitor|proteasome inhibitor
4952284|NCT01850524|Tourmaline MM2|tourmaline mm2
4952285|NCT01850511|Nasal obstruction|nasal obstruction
4952286|NCT01850511|Vibrissae|vibrissae
4952287|NCT01850511|Nasal hair|nasal hair
4952288|NCT01850498|Epilepsy|epilepsy
4952289|NCT01850498|Seizure|seizure
4952290|NCT01850498|Motor|motor
4952291|NCT01850498|Motion|motion
4952292|NCT01850498|Accelerometer|accelerometer
4952293|NCT01850485|cardiac arrest|cardiac arrest
4952294|NCT01850485|therapeutic hypothermia|therapeutic hypothermia
4952295|NCT01850485|microcirculation|microcirculation
4952296|NCT01850472|Anhedonia|anhedonia
4952297|NCT01850472|Depression|depression
4952298|NCT01850472|Stress|stress
4952299|NCT01850472|Cortisol|cortisol
4952300|NCT01850472|Inflammatory cytokines|inflammatory cytokines
4952301|NCT01850472|Learning|learning
4952302|NCT01850472|Magnetic resonance imaging (MRI)|magnetic resonance imaging (mri)
4952303|NCT01850433|BDD|bdd
4952304|NCT01850433|CBT|cbt
4952305|NCT01850420|fibromyalgia|fibromyalgia
4952306|NCT01850420|Myofascial|myofascial
4952307|NCT01850407|Lack of Preparation for Abused Children during Medical Examination|lack of preparation for abused children during medical examination
4952308|NCT01850381|Parkinson Disease|parkinson disease
4952309|NCT01850381|Efficacy|efficacy
4952310|NCT01850381|Safety|safety
4952311|NCT01850381|Tolerability|tolerability
4952312|NCT01850381|Phase 2A|phase 2a
4952313|NCT01850381|Pilot trial|pilot trial
4952314|NCT01850381|human Motoneuronotrophic Factor|human motoneuronotrophic factor
4952315|NCT01850381|neuroprotective agent|neuroprotective agent
4952316|NCT01850381|neurodegenerative diseases|neurodegenerative diseases
4952317|NCT01850381|rate of clinical progression of PD|rate of clinical progression of pd
4952318|NCT01850381|UPDRS|updrs
4952319|NCT01850381|Proof of principle|proof of principle
4952320|NCT01850368|Hepatocellular carcinoma|hepatocellular carcinoma
4952321|NCT01850368|Stereotactic ablative radiotherapy|stereotactic ablative radiotherapy
4952322|NCT01850368|Stereotactic body radiotherapy|stereotactic body radiotherapy
4952323|NCT01850368|Portal vein tumor thrombus|portal vein tumor thrombus
4952324|NCT01850355|Autism Spectrum Disorders|autism spectrum disorders
4952325|NCT01850355|Anxiety|anxiety
4952326|NCT01850355|Children|children
4952327|NCT01850355|Adolescents|adolescents
4952328|NCT01850355|Buspar|buspar
4952329|NCT01850355|Buspirone|buspirone
4952330|NCT01850355|Pervasive Developmental Disorders|pervasive developmental disorders
4952331|NCT01850342|Male stress urinary incontinence|male stress urinary incontinence
4952332|NCT01850342|Cell-assisted lipotransfer|cell-assisted lipotransfer
4952333|NCT01850342|Adipose-derived regenerative cells|adipose-derived regenerative cells
4952334|NCT01850342|ADRC|adrc
4952335|NCT01850342|Micrograft|micrograft
4952336|NCT01850342|Fat tissue|fat tissue
4952337|NCT01850342|Stem cells|stem cells
4952338|NCT01850303|Elderly|elderly
4952339|NCT01850303|lung cancer|lung cancer
4952340|NCT01850303|switch|switch
4952341|NCT01850303|maintenance|maintenance
4952342|NCT01850303|Elderly patients (between 70 and 89 years)|elderly patients (between 70 and 89 years)
4952343|NCT01850303|NSCLC|nsclc
4952344|NCT01850290|TBI|tbi
4952345|NCT01850277|Atrial fibrillation|atrial fibrillation
4952346|NCT01850277|Cardiac resynchronization therapy|cardiac resynchronization therapy
4952347|NCT01850277|Heart failure|heart failure
4952348|NCT01850277|Rhythm control strategy|rhythm control strategy
4952349|NCT01850264|cardiac resynchronization therapy; heart failure, congestive|cardiac resynchronization therapy; heart failure, congestive
4952350|NCT01850251|Hip fractures|hip fractures
4952351|NCT01850251|Ageing|ageing
4952352|NCT01850251|Sarcopenia|sarcopenia
4952353|NCT01850251|Function|function
4952354|NCT01850238|Alzheimer disease|alzheimer disease
4952355|NCT01850238|tau protein|tau protein
4952356|NCT01850238|neurofibrillary degeneration|neurofibrillary degeneration
4952357|NCT01850238|disease-modifying|disease-modifying
4952358|NCT01850212|Treatment Experienced|treatment experienced
4952359|NCT01850212|Male greater than or equal to 50 years|male greater than or equal to 50 years
4952360|NCT01850212|Female postmenopausal|female postmenopausal
4952361|NCT01850199|Gestational diabetes|gestational diabetes
4952362|NCT01850199|Telemedicine|telemedicine
4952363|NCT01850199|Artificial Intelligence|artificial intelligence
4952364|NCT01850160|Hypertension|hypertension
4952365|NCT01850160|High blood pressure|high blood pressure
4952366|NCT01850160|Drug therapy combination|drug therapy combination
4952367|NCT01850160|Valsartan|valsartan
4952368|NCT01850160|Chlorthalidone|chlorthalidone
4952369|NCT01850160|Safety|safety
4952370|NCT01850160|Efficacy|efficacy
4952371|NCT01850147|sunitinib|sunitinib
4952372|NCT01850147|chemotherapy|chemotherapy
4952373|NCT01850147|non-small cell lung cancer|non-small cell lung cancer
4952374|NCT01850147|NSCLC|nsclc
4952375|NCT01850121|Ankylosing Spondylitis|ankylosing spondylitis
4952376|NCT01850121|infiximab|infiximab
4952377|NCT01850121|single armed trial|single armed trial
4952378|NCT01850095|acne|acne
4952379|NCT01850095|adult|adult
4952380|NCT01850095|women|women
4952381|NCT01850095|TLR|tlr
4952382|NCT01850095|CD1d|cd1d
4952383|NCT01850095|androgens|androgens
4952384|NCT01850082|Coronary artery disease|coronary artery disease
4952385|NCT01850082|CABG|cabg
4952386|NCT01850082|Coronary revascularization|coronary revascularization
4952387|NCT01850082|Endoscopic vein harvest|endoscopic vein harvest
4952388|NCT01850082|Saphenous vein graft|saphenous vein graft
4952389|NCT01850082|Graft failure|graft failure
4952390|NCT01850069|Intracranial hypertension|intracranial hypertension
4952391|NCT01850069|intracranial elastance|intracranial elastance
4952392|NCT01850056|drug eluting balloon catheter|drug eluting balloon catheter
4952393|NCT01850017|Opiate consumption|opiate consumption
4952394|NCT01850017|Visual Analogue Scale|visual analogue scale
4952395|NCT01849991|Crying|crying
4952396|NCT01849991|Fussiness|fussiness
4952397|NCT01849991|Gas|gas
4952398|NCT01849991|Hydrogen Breath|hydrogen breath
4952399|NCT01849991|Fecal Calprotectin|fecal calprotectin
4952400|NCT01849978|breast cancer|breast cancer
4952401|NCT01849978|survivor|survivor
4952402|NCT01849978|exercise|exercise
4952403|NCT01849978|physical activity|physical activity
4952404|NCT01849978|strenuous exercise|strenuous exercise
4952405|NCT01849978|moderate exercise|moderate exercise
4952406|NCT01849978|enjoyable exercise|enjoyable exercise
4952407|NCT01849978|enjoy exercise|enjoy exercise
4952408|NCT01849978|breast cancer survivor|breast cancer survivor
4952409|NCT01849965|diabetic foot ulcers|diabetic foot ulcers
4952410|NCT01849965|Wagner Grade 1 or 2 ulcers|wagner grade 1 or 2 ulcers
4952411|NCT01849952|glioblastoma|glioblastoma
4952412|NCT01849952|miRNA|mirna
4952413|NCT01849952|GBM|gbm
4952414|NCT01849952|astrocytoma|astrocytoma
4952415|NCT01849939|Allogeneic transplantation of hematopoietic stem cells transplantation|allogeneic transplantation of hematopoietic stem cells transplantation
4952416|NCT01849939|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
4952417|NCT01849939|Donor Lymphocyte Injection|donor lymphocyte injection
4952418|NCT01849939|Preemptive immunointervention|preemptive immunointervention
4952419|NCT01849913|neck pain|neck pain
4952420|NCT01849913|hydrocortisone|hydrocortisone
4952421|NCT01849913|stress|stress
4952422|NCT01849913|electromyography|electromyography
4952423|NCT01849913|adolescent|adolescent
4952424|NCT01849913|low-level laser therapy|low-level laser therapy
4952425|NCT01849900|Menstrual cycle|menstrual cycle
4952426|NCT01849900|Ovulation time|ovulation time
4952427|NCT01849900|pregnancy recognition|pregnancy recognition
4952428|NCT01849900|Community-based participatory research|community-based participatory research
4952429|NCT01849900|Unintended pregnancy|unintended pregnancy
4952430|NCT01849861|Cardiopulmonary Capacity|cardiopulmonary capacity
4952431|NCT01849861|Ranges of TSH|ranges of tsh
4952432|NCT01849861|Elderly Population|elderly population
4952433|NCT01849835|rate of positive detection|rate of positive detection
4952434|NCT01849822|neural|neural
4952435|NCT01849822|prosthetic|prosthetic
4952436|NCT01849822|brain machine interface|brain machine interface
4952437|NCT01849822|brain computer interface|brain computer interface
4952438|NCT01849822|brain control|brain control
4952439|NCT01849822|paralysis|paralysis
4952440|NCT01849822|tetraplegia|tetraplegia
4952441|NCT01849822|quadriplegia|quadriplegia
4952442|NCT01849822|spinal cord injury|spinal cord injury
4952443|NCT01849796|tDCS|tdcs
4952444|NCT01849796|Neuropathic|neuropathic
4952445|NCT01849796|Facial|facial
4952446|NCT01849796|Pain|pain
4952447|NCT01849796|Neuralgia|neuralgia
4952448|NCT01849796|deafferentation|deafferentation
4952449|NCT01849796|Trigeminal|trigeminal
4952450|NCT01849770|SALS|sals
4952451|NCT01849770|Mexiletine|mexiletine
4952452|NCT01849770|Safety|safety
4952453|NCT01849757|Cardiopulmonary bypass|cardiopulmonary bypass
4952454|NCT01849757|prime|prime
4952455|NCT01849757|crystalloid|crystalloid
4952456|NCT01849757|albumin|albumin
4952457|NCT01849757|HES 130/0.4|hes 130/0.4
4952458|NCT01849744|Focal Adhesion Kinase inhibitor|focal adhesion kinase inhibitor
4952459|NCT01849744|FAK inhibitor|fak inhibitor
4952460|NCT01849744|Cancer Stem Cells|cancer stem cells
4952461|NCT01849744|CSC|csc
4952462|NCT01849731|Diabetes Mellitus type 2;|diabetes mellitus type 2;
4952463|NCT01849731|Primary Care, healthcare inequalities;|primary care, healthcare inequalities;
4952464|NCT01849731|Diabetes self-management,|diabetes self-management,
4952465|NCT01849731|Quality of diabetes care|quality of diabetes care
4952466|NCT01849705|Obesity|obesity
4952467|NCT01849705|MC4R|mc4r
4952468|NCT01849705|Blood pressure|blood pressure
4952469|NCT01849705|Blood glucose|blood glucose
4952470|NCT01849692|Exudative Age-Related Macular Degeneration|exudative age-related macular degeneration
4952471|NCT01849692|Wet AMD|wet amd
4952472|NCT01849692|Choroidal neovascularization (CNV)|choroidal neovascularization (cnv)
4952473|NCT01849692|Vascular endothelial growth factor (VEGF)|vascular endothelial growth factor (vegf)
4952474|NCT01849679|Dysphagia|dysphagia
4952475|NCT01849679|extubation|extubation
4952476|NCT01849679|aspiration|aspiration
4952477|NCT01849653|vaginal swabs|vaginal swabs
4952478|NCT01849653|diagnosis|diagnosis
4952479|NCT01849640|Malaria|malaria
4952480|NCT01849640|Drug resistance|drug resistance
4952481|NCT01849640|DHA-piperaquine|dha-piperaquine
4952482|NCT01849640|Cambodia|cambodia
4952483|NCT01849640|Transmission Blocking|transmission blocking
4952484|NCT01849627|weight loss maintenance|weight loss maintenance
4952485|NCT01849588|Hepatitis C positive|hepatitis c positive
4952486|NCT01849575|Ultrasonography|ultrasonography
4952487|NCT01849575|Cardiovascular diseases|cardiovascular diseases
4952488|NCT01849575|Prevention|prevention
4952489|NCT01849575|Risk communication|risk communication
4952490|NCT01849575|Risk assessment|risk assessment
4953098|NCT01846988|APAP|apap
4952491|NCT01849575|Behavioral change|behavioral change
4952492|NCT01849562|Hepatitis C, Chronic|hepatitis c, chronic
4952493|NCT01849562|Genotype 1|genotype 1
4952494|NCT01849562|Hepatitis C|hepatitis c
4952495|NCT01849562|Liver Diseases|liver diseases
4952496|NCT01849562|Hepatitis, viral, human|hepatitis, viral, human
4952497|NCT01849562|ribavirin|ribavirin
4952498|NCT01849562|antiviral agents|antiviral agents
4952499|NCT01849562|anti-infective agents|anti-infective agents
4952500|NCT01849562|protease inhibitors|protease inhibitors
4952501|NCT01849562|NS5a inhibitors|ns5a inhibitors
4952502|NCT01849549|neuropsychological Study|neuropsychological study
4952503|NCT01849549|brain Imaging|brain imaging
4952504|NCT01849536|Open angle glaucoma|open angle glaucoma
4952505|NCT01849536|Corneal biomechanics|corneal biomechanics
4952506|NCT01849536|Intra ocular pressure|intra ocular pressure
4952507|NCT01849536|IOP|iop
4952508|NCT01849536|IOP fluctuation|iop fluctuation
4952509|NCT01849536|Continuous IOP monitoring|continuous iop monitoring
4952510|NCT01849536|SENSIMED Triggerfish®|sensimed triggerfish®
4952511|NCT01849523|Neuroendocrine tumor|neuroendocrine tumor
4952512|NCT01849523|Website|website
4952513|NCT01849523|Information|information
4952514|NCT01849523|Psychosocial support|psychosocial support
4952515|NCT01849510|spinal metastases|spinal metastases
4952516|NCT01849510|vertebral body|vertebral body
4952517|NCT01849510|stereotaxis|stereotaxis
4952518|NCT01849510|image-guided radiotherapy|image-guided radiotherapy
4952519|NCT01849510|hypofractionated|hypofractionated
4952520|NCT01849510|dose intensified|dose intensified
4952521|NCT01849510|dose elevation|dose elevation
4952522|NCT01849497|LDL-C, triglycerides, high cholesterol|ldl-c, triglycerides, high cholesterol
4952523|NCT01849484|meningioma|meningioma
4952524|NCT01849484|skull base meningioma|skull base meningioma
4952525|NCT01849484|pituitary adenoma|pituitary adenoma
4952526|NCT01849484|brain metastases|brain metastases
4952527|NCT01849484|small cell lung carcinoma|small cell lung carcinoma
4952528|NCT01849471|socioeconomic aspects|socioeconomic aspects
4952529|NCT01849471|costs of therapy|costs of therapy
4952530|NCT01849471|follow-up costs|follow-up costs
4952531|NCT01849471|primary radiation|primary radiation
4952532|NCT01849471|percutaneous|percutaneous
4952533|NCT01849471|interstitial|interstitial
4952534|NCT01849393|Adolescents|adolescents
4952535|NCT01849393|Medication Compliance|medication compliance
4952536|NCT01849393|Rewards-Based Incentive Programs|rewards-based incentive programs
4952537|NCT01849380|Local Advanced Breast Neoplasms|local advanced breast neoplasms
4952538|NCT01849380|Neoadjuvant Chemotherapy|neoadjuvant chemotherapy
4952539|NCT01849380|S-1|s-1
4952540|NCT01849341|COPD|copd
4952541|NCT01849302|Appetite|appetite
4952542|NCT01849302|Satiety hormones|satiety hormones
4952543|NCT01849302|Dietary Protein|dietary protein
4952544|NCT01849237|Mesenchymal Stromal Cells|mesenchymal stromal cells
4952545|NCT01849237|Septic Shock|septic shock
4952546|NCT01849237|Neutropenia|neutropenia
4952547|NCT01849237|Procalcitonin|procalcitonin
4952548|NCT01849237|Interleukin-6|interleukin-6
4952549|NCT01849237|Interleukin-10|interleukin-10
4952550|NCT01849237|C-reactive protein|c-reactive protein
4952551|NCT01849237|Survival|survival
4952552|NCT01849237|Organ dysfunction|organ dysfunction
4952553|NCT01849224|Lower extremity edema|lower extremity edema
4952554|NCT01849224|Lower leg lymphedema|lower leg lymphedema
4952555|NCT01849224|Lower leg edema|lower leg edema
4952556|NCT01849224|Lymphedema|lymphedema
4952557|NCT01849224|Pelvic lymphadenectomy|pelvic lymphadenectomy
4952558|NCT01849224|Exercise|exercise
4952559|NCT01849211|ventilation|ventilation
4952560|NCT01849211|face mask|face mask
4952561|NCT01849211|NMBA|nmba
4952562|NCT01849198|accelerometry|accelerometry
4952563|NCT01849198|neuromuscular block|neuromuscular block
4952564|NCT01849198|m. trapezius|m. trapezius
4952565|NCT01849185|Hypercholesterolemia|hypercholesterolemia
4952566|NCT01849159|Mesenchymal stem cells|mesenchymal stem cells
4952567|NCT01849159|Hypoxia|hypoxia
4952568|NCT01849159|Emphysema|emphysema
4952569|NCT01849133|Breast cancer|breast cancer
4952570|NCT01849133|conservative surgery|conservative surgery
4952571|NCT01849133|intraoperative radiation therapy|intraoperative radiation therapy
4952572|NCT01849133|mobile linear accelerator|mobile linear accelerator
4952573|NCT01849120|near infrared spectroscopy (NIRS)|near infrared spectroscopy (nirs)
4952574|NCT01849120|EQUANOX Advance 8004CB probes|equanox advance 8004cb probes
4952575|NCT01849120|cerebral vascular circulation|cerebral vascular circulation
4952576|NCT01849120|peripheral perfusion|peripheral perfusion
4952577|NCT01849107|Radiation-induced small bowel toxicity|radiation-induced small bowel toxicity
4952578|NCT01849107|Plasma citrulline|plasma citrulline
4952579|NCT01849081|Non-alcoholic fatty liver disease|non-alcoholic fatty liver disease
4952580|NCT01849081|Obstructive sleep apnea|obstructive sleep apnea
4952581|NCT01849029|Post traumatic Stress Disorders|post traumatic stress disorders
4952582|NCT01849029|PTSD|ptsd
4952583|NCT01849029|HIV risk|hiv risk
4952584|NCT01849029|sexual risk|sexual risk
4952585|NCT01849029|substance use|substance use
4952586|NCT01849029|alcohol misuse|alcohol misuse
4952587|NCT01849029|Substance Abuse|substance abuse
4953099|NCT01846988|CPAP|cpap
4952588|NCT01849029|Substance Addiction|substance addiction
4952589|NCT01849029|Substance Dependence|substance dependence
4952590|NCT01849029|Substance Use Disorders|substance use disorders
4952591|NCT01849029|Alcohol-Related Disorders|alcohol-related disorders
4952592|NCT01849029|Binge Drinking|binge drinking
4952593|NCT01849029|Sexual Partners|sexual partners
4952594|NCT01849029|Sexual Behavior|sexual behavior
4952595|NCT01849029|Unsafe Sex|unsafe sex
4952596|NCT01849016|Sickle Cell Disease|sickle cell disease
4952597|NCT01849016|Sickle Cell Anemia|sickle cell anemia
4952598|NCT01849016|Pain|pain
4952599|NCT01849016|N-Acetylcysteine|n-acetylcysteine
4952600|NCT01849016|Acetylcysteine|acetylcysteine
4952601|NCT01849016|Oxidative stress|oxidative stress
4952602|NCT01849003|Long QT Syndrome|long qt syndrome
4952603|NCT01849003|LQTS|lqts
4952604|NCT01849003|Long QT-3 Syndrome|long qt-3 syndrome
4952605|NCT01849003|LQT-3|lqt-3
4952606|NCT01849003|prolonged QT interval|prolonged qt interval
4952607|NCT01849003|GS-6615|gs-6615
4952608|NCT01849003|late sodium current inhibitor|late sodium current inhibitor
4952609|NCT01848990|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
4952610|NCT01848990|Sub Cutaneous Insulin Infusion|sub cutaneous insulin infusion
4952611|NCT01848990|Rapid Acting Analog Insulin|rapid acting analog insulin
4952612|NCT01848990|Hylenex|hylenex
4952613|NCT01848990|Halozyme|halozyme
4952614|NCT01848990|Phase 4|phase 4
4952615|NCT01848977|Measures|measures
4952616|NCT01848977|near-Infrared spectroscopy|near-infrared spectroscopy
4952617|NCT01848977|ischemia|ischemia
4952618|NCT01848977|reperfusion|reperfusion
4952619|NCT01848964|amputation|amputation
4952620|NCT01848964|prosthesis|prosthesis
4952621|NCT01848964|stump|stump
4952622|NCT01848964|socket|socket
4952623|NCT01848964|pressure|pressure
4952624|NCT01848964|gait|gait
4952625|NCT01848964|posture|posture
4952626|NCT01848938|female|female
4952627|NCT01848938|stress urinary incontinence|stress urinary incontinence
4952628|NCT01848938|treatment|treatment
4952629|NCT01848938|pelvic floor muscle training|pelvic floor muscle training
4952630|NCT01848938|smartphone|smartphone
4952631|NCT01848938|internet|internet
4952632|NCT01848938|life style|life style
4952633|NCT01848938|eHealth|ehealth
4952634|NCT01848925|SANGUINATE|sanguinate
4952635|NCT01848899|Coronary angiography|coronary angiography
4952636|NCT01848899|Percutaneous coronary intervention|percutaneous coronary intervention
4952637|NCT01848899|Contrast media|contrast media
4952638|NCT01848899|Platelet activity|platelet activity
4952639|NCT01848899|Thrombin generation|thrombin generation
4952640|NCT01848899|Fibrinolysis|fibrinolysis
4952641|NCT01848886|ERAH|erah
4952642|NCT01848886|Endoscopic Radial Artery Harvest|endoscopic radial artery harvest
4952643|NCT01848886|Y-graft|y-graft
4952644|NCT01848886|Radial Artery Harvest|radial artery harvest
4952645|NCT01848886|Total Arterial Revascularisation|total arterial revascularisation
4952646|NCT01848886|CABG|cabg
4952647|NCT01848886|Radial Artery Conduit|radial artery conduit
4952648|NCT01848873|Hyperhomocysteinemia|hyperhomocysteinemia
4952649|NCT01848873|Amlodipine-folic acid tablets|amlodipine-folic acid tablets
4952650|NCT01848873|Hypertension|hypertension
4952651|NCT01848873|MTHFR C677T|mthfr c677t
4952652|NCT01848860|Pneumothorax|pneumothorax
4952653|NCT01848860|thoracoscopy|thoracoscopy
4952654|NCT01848860|mesh|mesh
4952655|NCT01848860|pleurodesis|pleurodesis
4952656|NCT01848860|treatment|treatment
4952657|NCT01848847|Hysteroscopy|hysteroscopy
4952658|NCT01848847|Bladder|bladder
4952659|NCT01848847|Pain|pain
4952660|NCT01848847|Feasibility|feasibility
4952661|NCT01848847|Duration|duration
4952662|NCT01848834|PD-1|pd-1
4952663|NCT01848834|PD1|pd1
4952664|NCT01848834|PD-L1|pd-l1
4952665|NCT01848834|PDL1|pdl1
4952666|NCT01848821|OASIS ultra|oasis ultra
4952667|NCT01848821|faster healing time|faster healing time
4952668|NCT01848821|better healing quality|better healing quality
4952669|NCT01848821|standard of care|standard of care
4952670|NCT01848795|Type 2 Diabetes|type 2 diabetes
4952671|NCT01848795|Obesity|obesity
4952672|NCT01848795|gastrointestinal hormones|gastrointestinal hormones
4952673|NCT01848795|intestinal bypass|intestinal bypass
4952674|NCT01848795|endoscopy|endoscopy
4952675|NCT01848782|abstract|abstract
4952676|NCT01848782|meta-analysis|meta-analysis
4952677|NCT01848782|systematic review|systematic review
4952678|NCT01848782|interpretation|interpretation
4952679|NCT01848782|results|results
4952680|NCT01848782|quality|quality
4952681|NCT01848782|bias|bias
4952682|NCT01848782|spin|spin
4952683|NCT01848782|limits|limits
4952684|NCT01848782|limitation|limitation
4952685|NCT01848782|risk of bias|risk of bias
4952686|NCT01848769|Asthma|asthma
4952687|NCT01848769|ICS+LABA|ics+laba
4952688|NCT01848769|Children|children
4952689|NCT01848769|Inhalation|inhalation
4952690|NCT01848769|pMDI|pmdi
4952691|NCT01848756|SNX-5422|snx-5422
4952692|NCT01848756|HER2 positive cancer|her2 positive cancer
4952693|NCT01848743|tenofovir, lamivudine, hepatitis B, acute exacerbation|tenofovir, lamivudine, hepatitis b, acute exacerbation
4952694|NCT01848704|spin|spin
4952695|NCT01848704|interpretation|interpretation
4952696|NCT01848704|bias|bias
4952697|NCT01848652|cerebral lymphoma B cell refractory|cerebral lymphoma b cell refractory
4952698|NCT01848652|Myocet|myocet
4952699|NCT01848652|efficacy|efficacy
4952700|NCT01848652|safety|safety
4952701|NCT01848639|chronic kidney disease|chronic kidney disease
4952702|NCT01848639|end-stage renal disease|end-stage renal disease
4952703|NCT01848639|hemodialysis (ESRD)|hemodialysis (esrd)
4952704|NCT01848639|cardiovascular morbimortality|cardiovascular morbimortality
4952705|NCT01848639|aldosterone antagonist|aldosterone antagonist
4952706|NCT01848639|spironolactone|spironolactone
4952707|NCT01848600|limitation|limitation
4952708|NCT01848600|quality|quality
4952709|NCT01848600|bias|bias
4952710|NCT01848600|meta-analysis|meta-analysis
4952711|NCT01848600|interpretation|interpretation
4952712|NCT01848600|abstract|abstract
4952713|NCT01848587|Pregnancy|pregnancy
4952714|NCT01848587|Acupuncture|acupuncture
4952715|NCT01848587|Pelvic and low back pain|pelvic and low back pain
4952716|NCT01848587|Impairment|impairment
4952717|NCT01848587|Economic evaluation|economic evaluation
4952718|NCT01848574|Understanding|understanding
4952719|NCT01848574|Patients|patients
4952720|NCT01848574|Emergency|emergency
4952721|NCT01848574|Information|information
4952722|NCT01848561|Inflammatory Bowel Diseases|inflammatory bowel diseases
4952723|NCT01848561|Gastroenteritis|gastroenteritis
4952724|NCT01848561|Adalimumab|adalimumab
4952725|NCT01848561|Ulcerative Colitis|ulcerative colitis
4952726|NCT01848561|Registry|registry
4952727|NCT01848561|Gastrointestinal Diseases|gastrointestinal diseases
4952728|NCT01848561|Colitis|colitis
4952729|NCT01848535|intestinal microbiota composition|intestinal microbiota composition
4952730|NCT01848535|intestinal microbiota activity|intestinal microbiota activity
4952731|NCT01848535|gastro-intestinal complains|gastro-intestinal complains
4952732|NCT01848522|qualitative study|qualitative study
4952733|NCT01848522|rehabilitation|rehabilitation
4952734|NCT01848522|physical therapy|physical therapy
4952735|NCT01848522|patient education|patient education
4952736|NCT01848522|health care|health care
4952737|NCT01848522|administration|administration
4952738|NCT01848522|patient satisfaction|patient satisfaction
4952739|NCT01848522|handicap|handicap
4952740|NCT01848509|CPAP|cpap
4952741|NCT01848509|adherence|adherence
4952742|NCT01848509|SAOS|saos
4952743|NCT01848509|telemedicine|telemedicine
4952744|NCT01848483|Early Palliative Care|early palliative care
4952745|NCT01848483|Motivational Interviewing|motivational interviewing
4952746|NCT01848483|Persons Living With Human immunodeficiency virus(HIV)|persons living with human immunodeficiency virus(hiv)
4952747|NCT01848483|Acquired Immunodeficiency Syndrome (AIDS)|acquired immunodeficiency syndrome (aids)
4952748|NCT01848457|Osteosarcoma|osteosarcoma
4952749|NCT01848457|Cancer|cancer
4952750|NCT01848457|Nephrotoxicity|nephrotoxicity
4952751|NCT01848457|Ototoxicity|ototoxicity
4952752|NCT01848457|Cisplatin|cisplatin
4952753|NCT01848457|High-dose methotrexate|high-dose methotrexate
4952754|NCT01848457|Biomarkers|biomarkers
4952755|NCT01848457|Patient reported outcomes|patient reported outcomes
4952756|NCT01848444|Public Health|public health
4952757|NCT01848444|Epidemiology|epidemiology
4952758|NCT01848444|Pharmacy Toxicology|pharmacy toxicology
4952759|NCT01848444|Perinatal period|perinatal period
4952760|NCT01848418|ICF|icf
4952761|NCT01848418|Core sets|core sets
4952762|NCT01848418|Systemic sclerosis|systemic sclerosis
4952763|NCT01848418|Function|function
4952764|NCT01848418|Evaluation|evaluation
4952765|NCT01848392|Cystic fibrosis|cystic fibrosis
4952766|NCT01848392|Adults|adults
4952767|NCT01848392|Physical activity|physical activity
4952768|NCT01848366|Frequency|frequency
4952769|NCT01848366|urgency|urgency
4952770|NCT01848366|incontinence|incontinence
4952771|NCT01848340|mass balance|mass balance
4952772|NCT01848340|GSK1265744|gsk1265744
4952773|NCT01848340|supratherapeutic|supratherapeutic
4952774|NCT01848340|integrase inhibitor|integrase inhibitor
4952775|NCT01848340|healthy volunteer|healthy volunteer
4952776|NCT01848327|Cognition|cognition
4952777|NCT01848327|Neuropsychology|neuropsychology
4952778|NCT01848327|Multiple Sclerosis|multiple sclerosis
4952779|NCT01848301|Optical Coherence Tomography|optical coherence tomography
4952780|NCT01848301|OCT|oct
4952781|NCT01848301|Coronary Allograft Vasculopathy|coronary allograft vasculopathy
4952782|NCT01848301|Donor Specific Antibodies|donor specific antibodies
4952783|NCT01848301|Acetylcholine|acetylcholine
4952784|NCT01848301|Coronary endothelial function|coronary endothelial function
4952785|NCT01848301|Brachial Artery Flow Mediated Dilation|brachial artery flow mediated dilation
4952786|NCT01848301|Heart transplantation|heart transplantation
4952787|NCT01848288|Cataract|cataract
4952788|NCT01848288|Phacoemulsification|phacoemulsification
4952789|NCT01848288|Cumulative Dissipated Energy (CDE)|cumulative dissipated energy (cde)
4952790|NCT01848262|ECALMIST|ecalmist
4952791|NCT01848262|InSurE|insure
4952792|NCT01848262|CPAP|cpap
4952793|NCT01848262|Ventilation|ventilation
4952794|NCT01848262|Vascular Catheter|vascular catheter
4952795|NCT01848249|deceased donors|deceased donors
4952796|NCT01848249|kidney donor|kidney donor
4952797|NCT01848249|transplant recipients|transplant recipients
4952798|NCT01848249|kidney transplant|kidney transplant
4952799|NCT01848249|delayed graft function|delayed graft function
4952800|NCT01848249|biomarkers|biomarkers
4952801|NCT01848249|end stage renal disease|end stage renal disease
4952802|NCT01848249|graft failure|graft failure
4952803|NCT01848223|quality of life|quality of life
4952804|NCT01848223|QoL|qol
4952805|NCT01848223|late menopause|late menopause
4952806|NCT01848210|Drug therapy|drug therapy
4952807|NCT01848184|PARIETEX Composite Ventral Patch|parietex composite ventral patch
4952808|NCT01848184|PCO VP OR PCOVP|pco vp or pcovp
4952809|NCT01848184|Primary ventral hernia repair|primary ventral hernia repair
4952810|NCT01848184|Panacea|panacea
4952811|NCT01848171|Hypothyroidism|hypothyroidism
4952812|NCT01848171|Lipid|lipid
4952813|NCT01848171|Atherosclerosis|atherosclerosis
4952814|NCT01848171|Oxidative Stress|oxidative stress
4952815|NCT01848171|Chronic Inflammation|chronic inflammation
4952816|NCT01848171|Endothelial Function|endothelial function
4952817|NCT01848171|Adipocytokine|adipocytokine
4952818|NCT01848171|L-thyroxine|l-thyroxine
4952819|NCT01848158|acupuncture|acupuncture
4952820|NCT01848158|pediatric|pediatric
4952821|NCT01848158|critical care|critical care
4952822|NCT01848158|mechanical ventilation|mechanical ventilation
4952823|NCT01848158|sedation|sedation
4952824|NCT01848158|comfort|comfort
4952825|NCT01848145|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
4952826|NCT01848145|Ofatumumab|ofatumumab
4952827|NCT01848145|Rapid Infusion|rapid infusion
4952828|NCT01848132|Lymphoma|lymphoma
4952829|NCT01848132|Large B-Cell|large b-cell
4952830|NCT01848119|Gabapentin|gabapentin
4952831|NCT01848119|Cesarean section|cesarean section
4952832|NCT01848106|Percutaneous Coronary Intervention|percutaneous coronary intervention
4952833|NCT01848106|Coronary Artery Disease|coronary artery disease
4952834|NCT01848106|Acute Coronary Syndrome|acute coronary syndrome
4952835|NCT01848106|Regado|regado
4952836|NCT01848106|Reg 1|reg 1
4952837|NCT01848106|bivalirudin|bivalirudin
4952838|NCT01848093|lung|lung
4952839|NCT01848093|airway|airway
4952840|NCT01848093|pulmonary exacerbation|pulmonary exacerbation
4952841|NCT01848093|mucus|mucus
4952842|NCT01848080|Telemedicine|telemedicine
4952843|NCT01848080|Telerehabilitation|telerehabilitation
4952844|NCT01848080|Acute Stroke|acute stroke
4952845|NCT01848080|Tai Chi|tai chi
4952846|NCT01848080|Tai Ji|tai ji
4952847|NCT01848080|Rehabilitation|rehabilitation
4952848|NCT01848080|Home care services|home care services
4952849|NCT01848080|Single blind method|single blind method
4952850|NCT01848080|Randomized controlled trial|randomized controlled trial
4952851|NCT01848054|opioid dependence, buprenorphine/naloxone, sublingual|opioid dependence, buprenorphine/naloxone, sublingual
4952852|NCT01848041|Blepharoptosis|blepharoptosis
4952853|NCT01848041|Ptosis|ptosis
4952854|NCT01848028|Patient registry|patient registry
4952855|NCT01848028|Germany|germany
4952856|NCT01848028|Psoriasis|psoriasis
4952857|NCT01848028|psoriatic-arthritis|psoriatic-arthritis
4952858|NCT01848028|Efalizumab|efalizumab
4952859|NCT01848028|Psonet|psonet
4952860|NCT01848028|Effectiveness|effectiveness
4952861|NCT01848028|Safety|safety
4952862|NCT01848015|CTCs before and after gastrectomy|ctcs before and after gastrectomy
4952863|NCT01847976|breast|breast
4952864|NCT01847976|bone pain|bone pain
4952865|NCT01847963|Urolithiasis|urolithiasis
4952866|NCT01847963|Kalladaippu Kudineer|kalladaippu kudineer
4952867|NCT01847963|Siddha|siddha
4952868|NCT01847963|Sindhuvallathy|sindhuvallathy
4952869|NCT01847963|Kidney stones|kidney stones
4952870|NCT01847911|self instructed resuscitation training|self instructed resuscitation training
4952871|NCT01847898|Osteoporosis|osteoporosis
4952872|NCT01847898|Vertebral Body|vertebral body
4952873|NCT01847898|Compression Fracture|compression fracture
4952874|NCT01847898|Kyphoplasty|kyphoplasty
4952875|NCT01847885|electrical stimulation|electrical stimulation
4952876|NCT01847885|neurostimulation|neurostimulation
4952877|NCT01847885|neuromodulation|neuromodulation
4952878|NCT01847885|post-stroke shoulder pain|post-stroke shoulder pain
4952879|NCT01847885|hemiplegic shoulder pain|hemiplegic shoulder pain
4952880|NCT01847872|Inactivated Poliovirus Vaccine|inactivated poliovirus vaccine
4952881|NCT01847872|Randomised Control Phase IV Study|randomised control phase iv study
4952882|NCT01847872|Gambia|gambia
4952883|NCT01847872|IPV|ipv
4952884|NCT01847872|Safety and Immunogenicity|safety and immunogenicity
4952885|NCT01847872|Non-interference study|non-interference study
4952886|NCT01847872|IM Jet injector|im jet injector
4952887|NCT01847872|ID Jet Injector|id jet injector
4952888|NCT01847859|Cardiothoracic surgery|cardiothoracic surgery
4952889|NCT01847859|Post-operative|post-operative
4952890|NCT01847859|Nurses|nurses
4952891|NCT01847859|Cardiac|cardiac
4952892|NCT01847859|Echocardiography|echocardiography
4952893|NCT01847859|Pocket-size|pocket-size
4952894|NCT01847859|Hand-held|hand-held
4952895|NCT01847820|ROM|rom
4952896|NCT01847820|PROM|prom
4952897|NCT01847820|PPROM (preterm premature rupture of membranes)|pprom (preterm premature rupture of membranes)
4952898|NCT01847807|5-10 gram astragalus per day|5-10 gram astragalus per day
4952899|NCT01847781|Opsonophagocytic antibodies|opsonophagocytic antibodies
4952900|NCT01847781|Cellular immunity|cellular immunity
4952901|NCT01847781|Vaccine immunity|vaccine immunity
4952902|NCT01847781|Antimicrobial peptides|antimicrobial peptides
4952903|NCT01847768|asthma|asthma
4952904|NCT01847768|rhinovirus|rhinovirus
4952905|NCT01847768|remodeling mediators|remodeling mediators
4952906|NCT01847768|human rhinovirus infection|human rhinovirus infection
4952907|NCT01847729|Opiate dependence|opiate dependence
4952908|NCT01847729|Opiate substitution treatment|opiate substitution treatment
4952909|NCT01847729|co-addictions|co-addictions
4952910|NCT01847729|Patients addicted to opiates|patients addicted to opiates
4952911|NCT01847729|methadone|methadone
4952912|NCT01847729|buprenorhine|buprenorhine
4952913|NCT01847729|morphine|morphine
4952914|NCT01847729|OST in place|ost in place
4952915|NCT01847729|pathological gambling|pathological gambling
4952916|NCT01847729|pharmacokinetic|pharmacokinetic
4952917|NCT01847729|pharmacogenetic|pharmacogenetic
4952918|NCT01847729|polymorphism|polymorphism
4952919|NCT01847729|cytochrome P450 2D6|cytochrome p450 2d6
4952920|NCT01847729|Therapeutic Drug Monitoring|therapeutic drug monitoring
4952921|NCT01847716|Muscle weakness|muscle weakness
4952922|NCT01847716|Pulmonary arterial hypertension|pulmonary arterial hypertension
4952923|NCT01847716|Transforming growth factor beta|transforming growth factor beta
4952924|NCT01847716|Growth and differentiation factor 15|growth and differentiation factor 15
4952925|NCT01847690|Addison Disease|addison disease
4952926|NCT01847677|ovarian cancer|ovarian cancer
4952927|NCT01847677|neoadyuvant|neoadyuvant
4952928|NCT01847677|bevacizumab|bevacizumab
4952929|NCT01847651|hepatic encephalopathy|hepatic encephalopathy
4952930|NCT01847651|minimal hepatic encephalopathy|minimal hepatic encephalopathy
4952931|NCT01847651|cirrhosis|cirrhosis
4952932|NCT01847651|lateral vastus|lateral vastus
4952933|NCT01847651|muscle biopsy|muscle biopsy
4952934|NCT01847651|L ornithine L aspartate|l ornithine l aspartate
4952935|NCT01847651|functional magnetic resonance imaging|functional magnetic resonance imaging
4952936|NCT01847651|magnetic resonance spectroscopy|magnetic resonance spectroscopy
4952937|NCT01847651|cognitive testing|cognitive testing
4952938|NCT01847651|Paper and pencil Hepatic Encephalopathy score (PHES)|paper and pencil hepatic encephalopathy score (phes)
4952939|NCT01847651|Cogstate|cogstate
4952940|NCT01847651|urine metabonomics|urine metabonomics
4952941|NCT01847651|plasma metabonomics|plasma metabonomics
4952942|NCT01847651|muscle metabonomics|muscle metabonomics
4952943|NCT01847638|Retinal edema|retinal edema
4952944|NCT01847638|Cataract|cataract
4952945|NCT01847638|inflammation|inflammation
4952946|NCT01847612|per operative cholangiography|per operative cholangiography
4952947|NCT01847612|liver resection|liver resection
4952948|NCT01847612|biliary fistula|biliary fistula
4952949|NCT01847599|educational intervention|educational intervention
4952950|NCT01847599|adherence|adherence
4952951|NCT01847599|capecitabine|capecitabine
4952952|NCT01847599|lapatinib|lapatinib
4952953|NCT01847586|Alzheimer's Disease|alzheimer's disease
4952954|NCT01847586|Brain stimulation|brain stimulation
4952955|NCT01847586|transcranial magnetic stimulation|transcranial magnetic stimulation
4952956|NCT01847573|halofuginone hydrobromide|halofuginone hydrobromide
4952957|NCT01847573|anti-fibrotic|anti-fibrotic
4952958|NCT01847573|anti-inflammatory|anti-inflammatory
4952959|NCT01847573|muscle regeneration|muscle regeneration
4952960|NCT01847573|protein synthesis inhibitor|protein synthesis inhibitor
4952961|NCT01847495|Stage IV Colorectal Carcinoma|stage iv colorectal carcinoma
4952962|NCT01847495|Liver metastasis|liver metastasis
4952963|NCT01847495|Cyberknife|cyberknife
4952964|NCT01847495|Stereotactic Body Radiotherapy|stereotactic body radiotherapy
4952965|NCT01847495|SBRT|sbrt
4952966|NCT01847495|Irinotecan HCl|irinotecan hcl
4952967|NCT01847495|CPT-11|cpt-11
4952968|NCT01847482|Cardiac arrest|cardiac arrest
4952969|NCT01847482|Return of Spontaneous Circulation (ROSC)|return of spontaneous circulation (rosc)
4952970|NCT01847482|IntraVascular Temperature Management (IVTM)|intravascular temperature management (ivtm)
4952971|NCT01847482|Therapeutic Hypothermia|therapeutic hypothermia
4952972|NCT01847482|Japan|japan
4952973|NCT01847469|Alcohol Dependence|alcohol dependence
4952974|NCT01847469|Post-Traumatic Stress Disorder (PTSD)|post-traumatic stress disorder (ptsd)
4952975|NCT01847469|Zonisamide|zonisamide
4952976|NCT01847469|Cognitive Processing Therapy (CPT)|cognitive processing therapy (cpt)
4952977|NCT01847456|whole body insulin sensitivity|whole body insulin sensitivity
4952978|NCT01847456|insulin action in the brain|insulin action in the brain
4952979|NCT01847443|nicotine|nicotine
4952980|NCT01847443|nicotine replacement therapy|nicotine replacement therapy
4952981|NCT01847443|nicotine gum|nicotine gum
4952982|NCT01847430|Healthy|healthy
4952983|NCT01847430|Hepatitis B|hepatitis b
4952984|NCT01847430|Adolescents|adolescents
4952985|NCT01847430|Engerix™-B Kinder|engerix™-b kinder
4952986|NCT01847417|Acetylsalicylic acid|acetylsalicylic acid
4952987|NCT01847417|Pantoprazole|pantoprazole
4952988|NCT01847417|Fixed dose combination|fixed dose combination
4952989|NCT01847404|Fixed dose combination|fixed dose combination
4952990|NCT01847404|Acetylsalicylic acid|acetylsalicylic acid
4952991|NCT01847404|Pantoprazole|pantoprazole
4953100|NCT01846975|Abatacept|abatacept
4952992|NCT01847391|Ischemic Heart Disease|ischemic heart disease
4952993|NCT01847391|Heart Disease|heart disease
4952994|NCT01847378|ventricular tachycardia|ventricular tachycardia
4952995|NCT01847378|catheter ablation|catheter ablation
4952996|NCT01847378|chagas disease|chagas disease
4952997|NCT01847378|epicardial mapping|epicardial mapping
4952998|NCT01847378|magnetic resonance imaging|magnetic resonance imaging
4952999|NCT01847365|Retinitis Pigmentosa|retinitis pigmentosa
4953000|NCT01847365|Transcorneal electrical stimulation|transcorneal electrical stimulation
4953001|NCT01847365|Okustim|okustim
4953002|NCT01847352|Hypoxia|hypoxia
4953003|NCT01847352|Pulmonary hypertension|pulmonary hypertension
4953004|NCT01847352|Iron deficiency|iron deficiency
4953005|NCT01847352|Hypoxic pulmonary vasoconstriction|hypoxic pulmonary vasoconstriction
4953006|NCT01847300|alcohol abuse|alcohol abuse
4953007|NCT01847300|tobacco dependence|tobacco dependence
4953008|NCT01847300|substance abuse|substance abuse
4953009|NCT01847300|SBIRT|sbirt
4953010|NCT01847287|Multiple sclerosis|multiple sclerosis
4953011|NCT01847287|Tysabri|tysabri
4953012|NCT01847287|MRI|mri
4953013|NCT01847287|Natalizumab|natalizumab
4953014|NCT01847274|ovarian cancer|ovarian cancer
4953015|NCT01847274|platinum sensitive|platinum sensitive
4953016|NCT01847274|gBRCAmut|gbrcamut
4953017|NCT01847274|BRCA|brca
4953018|NCT01847274|high-grade serous histology|high-grade serous histology
4953019|NCT01847274|PARP inhibitor|parp inhibitor
4953020|NCT01847261|soy|soy
4953021|NCT01847261|whey|whey
4953022|NCT01847261|muscle|muscle
4953023|NCT01847261|older|older
4953024|NCT01847261|mTOR|mtor
4953025|NCT01847261|sarcopenia|sarcopenia
4953026|NCT01847248|sepsis|sepsis
4953027|NCT01847248|biomarker|biomarker
4953028|NCT01847248|HSPA12B|hspa12b
4953029|NCT01847235|Temozolomide|temozolomide
4953030|NCT01847209|lung nodule|lung nodule
4953031|NCT01847209|lung cancer|lung cancer
4953032|NCT01847209|lung mass|lung mass
4953033|NCT01847196|Pulmonary Embolism|pulmonary embolism
4953034|NCT01847196|PE|pe
4953035|NCT01847196|DVT|dvt
4953036|NCT01847196|Deep Vein Thrombosis|deep vein thrombosis
4953037|NCT01847196|VTE|vte
4953038|NCT01847196|Venous Thromboembolism|venous thromboembolism
4953039|NCT01847196|prophylaxis|prophylaxis
4953040|NCT01847196|thromboprophylaxis|thromboprophylaxis
4953041|NCT01847196|contraindications to thromboprophylaxis|contraindications to thromboprophylaxis
4953042|NCT01847196|prophylactic|prophylactic
4953043|NCT01847196|prevention|prevention
4953044|NCT01847196|Inferior vena cava filter|inferior vena cava filter
4953045|NCT01847196|IVC filter|ivc filter
4953046|NCT01847196|filter|filter
4953047|NCT01847196|prevention of pulmonary embolism|prevention of pulmonary embolism
4953048|NCT01847196|trauma|trauma
4953049|NCT01847196|critically-ill|critically-ill
4953050|NCT01847183|heavy drinking|heavy drinking
4953051|NCT01847183|prevention|prevention
4953052|NCT01847183|high school|high school
4953053|NCT01847183|adolescence|adolescence
4953054|NCT01847157|recovery of function|recovery of function
4953055|NCT01847157|stroke|stroke
4953056|NCT01847157|Upper extremity|upper extremity
4953057|NCT01847157|Motor|motor
4953058|NCT01847157|transcranial direct current stimulation|transcranial direct current stimulation
4953059|NCT01847131|Rhinitis|rhinitis
4953060|NCT01847131|Oxymetazoline|oxymetazoline
4953061|NCT01847092|albuminuria|albuminuria
4953062|NCT01847066|wrinkles|wrinkles
4953063|NCT01847066|acne scars|acne scars
4953064|NCT01847066|pigmentation|pigmentation
4953065|NCT01847053|Cinnamon|cinnamon
4953066|NCT01847053|Bioavailability|bioavailability
4953067|NCT01847053|Glucose|glucose
4953068|NCT01847053|Proanthocyanidins|proanthocyanidins
4953069|NCT01847040|Traumatic Brain Injury|traumatic brain injury
4953070|NCT01847040|Epidemiology|epidemiology
4953071|NCT01847040|Concussion|concussion
4953072|NCT01847040|Outcomes|outcomes
4953073|NCT01847040|PTSD|ptsd
4953074|NCT01847040|Prospective|prospective
4953075|NCT01847040|Longitudinal|longitudinal
4953076|NCT01847040|Military|military
4953077|NCT01847040|Symptoms|symptoms
4953078|NCT01847040|Validation|validation
4953079|NCT01847040|Screening|screening
4953080|NCT01847040|Mild Traumatic Brain Injury|mild traumatic brain injury
4953081|NCT01847027|Healthy|healthy
4953082|NCT01847027|Stem cells|stem cells
4953083|NCT01847027|Aging|aging
4953084|NCT01847027|Increase stem cell replacement|increase stem cell replacement
4953085|NCT01847027|decreased stem cell proliferation|decreased stem cell proliferation
4953086|NCT01847014|Pulmonary Arterial Hypertension (PAH)|pulmonary arterial hypertension (pah)
4953087|NCT01847014|psychometric instrument|psychometric instrument
4953088|NCT01847014|PAH-SYMPACT|pah-sympact
4953089|NCT01847001|Breast Cancer|breast cancer
4953090|NCT01847001|Neoadjuvant|neoadjuvant
4953091|NCT01847001|Experimental|experimental
4953092|NCT01847001|Biomarker|biomarker
4953093|NCT01847001|Breast imaging|breast imaging
4953094|NCT01846988|Obstructive Sleep Apnea|obstructive sleep apnea
4953095|NCT01846988|Pediatric Obstructive Sleep Apnea|pediatric obstructive sleep apnea
4953096|NCT01846988|Auto PAP|auto pap
4953097|NCT01846988|Auto-adjustable Positive Airway Pressure|auto-adjustable positive airway pressure
4953101|NCT01846975|Low disease activity|low disease activity
4953102|NCT01846975|Intravenous|intravenous
4953103|NCT01846975|Subcutaneous|subcutaneous
4953104|NCT01846975|Rheumatoid arthritis|rheumatoid arthritis
4953105|NCT01846962|Eosinophilic esophagitis (EoE)|eosinophilic esophagitis (eoe)
4953106|NCT01846962|budesonide|budesonide
4953107|NCT01846962|fluticasione|fluticasione
4953108|NCT01846962|six-foods elimination diet|six-foods elimination diet
4953109|NCT01846936|one lung ventilation|one lung ventilation
4953110|NCT01846936|efficacy|efficacy
4953111|NCT01846936|bronchial blocker|bronchial blocker
4953112|NCT01846910|Cessation|cessation
4953113|NCT01846845|Amputee|amputee
4953114|NCT01846832|Hepatitis C, Chronic|hepatitis c, chronic
4953115|NCT01846832|Infection|infection
4953116|NCT01846832|Triple therapy|triple therapy
4953117|NCT01846832|TMC435|tmc435
4953118|NCT01846832|simeprevir|simeprevir
4953119|NCT01846832|Pegylated interferon alfa-2a (PegIFNα-2a)|pegylated interferon alfa-2a (pegifnα-2a)
4953120|NCT01846832|ribavirin (RBV)|ribavirin (rbv)
4953121|NCT01846832|PEGASYS|pegasys
4953122|NCT01846832|COPEGUS|copegus
4953123|NCT01846806|Hepatic Encephalopathy|hepatic encephalopathy
4953124|NCT01846793|Benign prostatic hyperplasia|benign prostatic hyperplasia
4953126|NCT01846793|Lower urinary tract symptoms|lower urinary tract symptoms
4953127|NCT01846793|LUTS|luts
4953128|NCT01846793|LUTS secondary to BPH|luts secondary to bph
4953129|NCT01846793|LUTS/BPH|luts/bph
4953130|NCT01846793|Benign prostatic obstruction (BPO)|benign prostatic obstruction (bpo)
4953131|NCT01846793|BPO|bpo
4953132|NCT01846793|Bladder outlet obstruction|bladder outlet obstruction
4953133|NCT01846793|BOO|boo
4953134|NCT01846767|13CO2|13co2
4953135|NCT01846767|Breath test|breath test
4953136|NCT01846767|Glucose oxidation|glucose oxidation
4953137|NCT01846767|Diabetes mellitus|diabetes mellitus
4953138|NCT01846754|Hemodialysis|hemodialysis
4953139|NCT01846754|Fatigue|fatigue
4953140|NCT01846754|Muscle strength|muscle strength
4953141|NCT01846754|Metabolomics|metabolomics
4953142|NCT01846741|Automatic Magnet Mode (AMM)|automatic magnet mode (amm)
4953143|NCT01846741|Vagus Nerve Stimulation (VNS)|vagus nerve stimulation (vns)
4953144|NCT01846715|Kidney disease|kidney disease
4953145|NCT01846715|Renal insufficiency|renal insufficiency
4953146|NCT01846715|CKD|ckd
4953147|NCT01846715|Autologous cell therapy|autologous cell therapy
4953148|NCT01846676|Hearing loss, rehabilitation programs, adherence to hearing aids.|hearing loss, rehabilitation programs, adherence to hearing aids.
4953149|NCT01846663|Hepatic Encephalopathy|hepatic encephalopathy
4953150|NCT01846663|Liver Failure|liver failure
4953151|NCT01846663|Hepatic Insufficiency|hepatic insufficiency
4953152|NCT01846663|Liver Diseases|liver diseases
4953153|NCT01846663|Brain Diseases|brain diseases
4953154|NCT01846663|Rifaximin|rifaximin
4953155|NCT01846663|Cirrhosis|cirrhosis
4953156|NCT01846611|Ovarian neoplasms|ovarian neoplasms
4953157|NCT01846611|Peritoneal neoplasms|peritoneal neoplasms
4953158|NCT01846611|Fallopian tube neoplasms|fallopian tube neoplasms
4953159|NCT01846611|Advanced-relapsed epithelial ovarian cancer|advanced-relapsed epithelial ovarian cancer
4953160|NCT01846611|Advanced-relapsed primary peritoneal cancer|advanced-relapsed primary peritoneal cancer
4953161|NCT01846611|Advanced-relapsed fallopian tube cancer|advanced-relapsed fallopian tube cancer
4953162|NCT01846611|Trabectedin|trabectedin
4953163|NCT01846611|Yondelis|yondelis
4953164|NCT01846611|Doxil|doxil
4953165|NCT01846611|Caelyx|caelyx
4953166|NCT01846611|Platinum sensitive|platinum sensitive
4953167|NCT01846611|Tthird-line|tthird-line
4953168|NCT01846611|BRCA|brca
4953169|NCT01846611|Patient related outcome|patient related outcome
4953170|NCT01846572|Stroke|stroke
4953171|NCT01846572|Clopidogrel|clopidogrel
4953172|NCT01846572|Aggregometry|aggregometry
4953173|NCT01846572|Antiplatelet therapy|antiplatelet therapy
4953174|NCT01846572|Platelet function tests|platelet function tests
4953175|NCT01846559|Immune system processes|immune system processes
4953176|NCT01846546|Traumatic brain injury;|traumatic brain injury;
4953177|NCT01846546|Endostatin/collagen XVIII;|endostatin/collagen xviii;
4953178|NCT01846546|Cerebrospinal fluid;|cerebrospinal fluid;
4953179|NCT01846546|Prognosis|prognosis
4953180|NCT01846507|Heavy Menstrual Bleeding|heavy menstrual bleeding
4953181|NCT01846507|HMB|hmb
4953182|NCT01846507|Lysteda|lysteda
4953183|NCT01846481|Cocaine|cocaine
4953184|NCT01846468|Healthy volunteers and patients,|healthy volunteers and patients,
4953185|NCT01846468|renal insufficiency,|renal insufficiency,
4953186|NCT01846455|Hepatic|hepatic
4953187|NCT01846455|Hepatitis C Virus|hepatitis c virus
4953188|NCT01846455|Suboxone|suboxone
4953189|NCT01846455|Buprenorphine|buprenorphine
4953190|NCT01846455|Naloxone|naloxone
4953191|NCT01846442|Vulvar/vaginal atrophy|vulvar/vaginal atrophy
4953192|NCT01846442|Atrophic Vaginitis|atrophic vaginitis
4953193|NCT01846442|Dehydroepiandrosterone|dehydroepiandrosterone
4953194|NCT01846442|DHEA|dhea
4953195|NCT01846442|Prasterone|prasterone
4953196|NCT01846442|Vaginorm|vaginorm
4953197|NCT01846442|Menopause|menopause
4953198|NCT01846442|Intrarosa|intrarosa
4953199|NCT01846429|cancer|cancer
4953200|NCT01846429|pain fibers|pain fibers
4953201|NCT01846429|acid levels|acid levels
4953202|NCT01846429|tumor related pain|tumor related pain
4953203|NCT01846429|cancer related pain|cancer related pain
4953204|NCT01846429|sodium bicarbonate|sodium bicarbonate
4953205|NCT01846429|pain reliever|pain reliever
4953206|NCT01846429|metastatic|metastatic
4953207|NCT01846429|unresectable|unresectable
4953208|NCT01846429|solid malignancy|solid malignancy
4953209|NCT01846429|hematologic malignancy|hematologic malignancy
4953210|NCT01846429|multiple myeloma|multiple myeloma
4953211|NCT01846429|lymphoma|lymphoma
4953212|NCT01846377|video game|video game
4953213|NCT01846377|diet|diet
4953214|NCT01846377|physical activity|physical activity
4953215|NCT01846377|sedentary behavior|sedentary behavior
4953216|NCT01846377|obesity|obesity
4953217|NCT01846377|diabetes|diabetes
4953218|NCT01846364|Thyroid|thyroid
4953219|NCT01846364|DIM|dim
4953220|NCT01846351|choroidal neovascularization|choroidal neovascularization
4953221|NCT01846351|epiretinal membrane|epiretinal membrane
4953222|NCT01846351|anti-VEGF|anti-vegf
4953223|NCT01846338|acne, EGCG, green tea|acne, egcg, green tea
4953224|NCT01846299|Vision Impairment|vision impairment
4953225|NCT01846286|Neuropathic Pain|neuropathic pain
4953226|NCT01846286|Squamous cell cancer of the head and neck|squamous cell cancer of the head and neck
4953227|NCT01846286|acute pain|acute pain
4953228|NCT01846286|pain management|pain management
4953229|NCT01846286|genome-wide analyses|genome-wide analyses
4953230|NCT01846286|Squamous cell carcinoma of the head and neck|squamous cell carcinoma of the head and neck
4953231|NCT01846286|chronic pain|chronic pain
4953232|NCT01846286|neuropathic|neuropathic
4953233|NCT01846286|locoregional squamous cell carcinoma of the head and neck|locoregional squamous cell carcinoma of the head and neck
4953234|NCT01846247|stroke|stroke
4953235|NCT01846234|Multiple Sclerosis|multiple sclerosis
4953236|NCT01846234|Salt|salt
4953237|NCT01846221|Analgesia|analgesia
4953238|NCT01846221|Epidural|epidural
4953239|NCT01846221|Pregnancy|pregnancy
4953240|NCT01846221|Labor|labor
4953241|NCT01846221|Clonidine|clonidine
4953242|NCT01846221|Fentanyl|fentanyl
4953243|NCT01846221|Bupivacaine|bupivacaine
4953244|NCT01846221|Childbirth|childbirth
4953245|NCT01846208|Egg Allergy|egg allergy
4953246|NCT01846208|Egg Oral Immunotherapy|egg oral immunotherapy
4953247|NCT01846208|Food Allergy|food allergy
4953248|NCT01846195|blood loss|blood loss
4953249|NCT01846182|Gulf War Illness|gulf war illness
4953250|NCT01846182|Pregabalin|pregabalin
4953251|NCT01846182|Duloxetine|duloxetine
4953252|NCT01846182|Gulf War Veterans|gulf war veterans
4953253|NCT01846182|Cymbalta|cymbalta
4953254|NCT01846182|Lyrica|lyrica
4953255|NCT01846169|food insecurity|food insecurity
4953256|NCT01846169|older adults|older adults
4953257|NCT01846169|nutrition|nutrition
4953258|NCT01846169|food deliveries|food deliveries
4953259|NCT01846156|convulsion rate|convulsion rate
4953260|NCT01846130|Bed rest,|bed rest,
4953261|NCT01846117|lignans|lignans
4953262|NCT01846117|oxidative stress|oxidative stress
4953263|NCT01846117|inflammation|inflammation
4953264|NCT01846117|aging|aging
4953265|NCT01846117|muscle weakness|muscle weakness
4953266|NCT01846117|pain|pain
4953267|NCT01846052|achromatopsia, CNGB3|achromatopsia, cngb3
4953268|NCT01846013|Sit-Stand Workstations|sit-stand workstations
4953269|NCT01846013|Increase Workplace Physical Activity|increase workplace physical activity
4953270|NCT01846000|temporomandibular joint|temporomandibular joint
4953271|NCT01846000|temporomandibular disorder|temporomandibular disorder
4953272|NCT01846000|electromyography|electromyography
4953273|NCT01846000|low-level laser therapy|low-level laser therapy
4953274|NCT01845987|Palmoplantaris Pustulosis|palmoplantaris pustulosis
4953275|NCT01845987|CNTO 1959|cnto 1959
4953276|NCT01845987|Psoriasis|psoriasis
4953277|NCT01845987|Anti-IL 23 Monoclonal Antibody|anti-il 23 monoclonal antibody
4953278|NCT01845974|Radiofrequency Catheter Ablation|radiofrequency catheter ablation
4953279|NCT01845974|Atrial Fibrillation|atrial fibrillation
4953280|NCT01845948|parents|parents
4953281|NCT01845948|school transition|school transition
4953282|NCT01845948|parental-child relationship|parental-child relationship
4953283|NCT01845935|Cryoablation|cryoablation
4953284|NCT01845935|Venous vascular malformation|venous vascular malformation
4953285|NCT01845935|MRI|mri
4953286|NCT01845935|safety|safety
4953287|NCT01845935|pain|pain
4953288|NCT01845922|Refeeding Syndrome|refeeding syndrome
4953289|NCT01845922|low sodium|low sodium
4953290|NCT01845922|slowly absorbed carbohydrates|slowly absorbed carbohydrates
4953291|NCT01845922|hypopotassemia|hypopotassemia
4953292|NCT01845922|hypophosphatemia|hypophosphatemia
4953293|NCT01845909|Sudden cardiac death|sudden cardiac death
4953294|NCT01845909|Young adults|young adults
4953295|NCT01845909|Cardiac Disease|cardiac disease
4953296|NCT01845909|Arrhythmia|arrhythmia
4953297|NCT01845909|Sports|sports
4953298|NCT01845896|high intensity interval training|high intensity interval training
4953299|NCT01845896|combined training|combined training
4953300|NCT01845896|insulin resistance|insulin resistance
4953301|NCT01845896|muscle contractile properties|muscle contractile properties
4953302|NCT01845857|Long term health problems|long term health problems
4953303|NCT01845857|chronic disease|chronic disease
4953304|NCT01845831|Diabetes|diabetes
4953305|NCT01845831|DPP4 inhibitors|dpp4 inhibitors
4953306|NCT01845831|Sitagliptin|sitagliptin
4953307|NCT01845831|Glargine|glargine
4953308|NCT01845831|RCT|rct
4953309|NCT01845831|basal insulin|basal insulin
4953310|NCT01845831|hospital hyperglycemia|hospital hyperglycemia
4953311|NCT01845831|inpatient diabetes|inpatient diabetes
4953312|NCT01845818|work productivity|work productivity
4953313|NCT01845818|multicenter study|multicenter study
4953314|NCT01845792|Metastatic Castrate Resistant Prostate Cancer|metastatic castrate resistant prostate cancer
4953315|NCT01845766|sepsis, septic shock, rehabilitation, exercise|sepsis, septic shock, rehabilitation, exercise
4953316|NCT01845740|systemic lupus erythematoses|systemic lupus erythematoses
4953317|NCT01845740|lupus|lupus
4953318|NCT01845740|SLE|sle
4953319|NCT01845727|Cutaneous leishmaniasis|cutaneous leishmaniasis
4953320|NCT01845727|Topical treatment|topical treatment
4953321|NCT01845727|Colombia|colombia
4953322|NCT01845714|Keratoconus|keratoconus
4953323|NCT01845714|Corneal cross Linking|corneal cross linking
4953324|NCT01845714|Topo guided PRK|topo guided prk
4953325|NCT01845714|Quality of Life|quality of life
4953326|NCT01845701|malaria, cure rate, efficacy, safety|malaria, cure rate, efficacy, safety
4953327|NCT01845688|Idiopathic Membranous Nephropathy|idiopathic membranous nephropathy
4953328|NCT01845688|Traditional Chinese Medicine|traditional chinese medicine
4953329|NCT01845688|Randomized Control Trial|randomized control trial
4953330|NCT01845675|temozolomide|temozolomide
4953331|NCT01845675|endostatin|endostatin
4953332|NCT01845675|advanced|advanced
4953333|NCT01845675|well-differentiated|well-differentiated
4953334|NCT01845675|pancreatic neuroendocrine tumor|pancreatic neuroendocrine tumor
4953335|NCT01845662|splenectomy|splenectomy
4953336|NCT01845662|embolization|embolization
4953337|NCT01845662|observation|observation
4953338|NCT01845662|blood transfusion|blood transfusion
4953339|NCT01845649|Vulvovaginal Atrophy|vulvovaginal atrophy
4953340|NCT01845649|Dyspareunia|dyspareunia
4953341|NCT01845649|Postmenopausal|postmenopausal
4953342|NCT01845636|Olfaction|olfaction
4953343|NCT01845636|Donepezil|donepezil
4953344|NCT01845636|Alzheimer's Disease|alzheimer's disease
4953345|NCT01845636|Mild Cognitive Impairment|mild cognitive impairment
4953346|NCT01845636|Memory|memory
4953347|NCT01845623|Asthma|asthma
4953348|NCT01845623|Indacaterol|indacaterol
4953349|NCT01845623|QAB149|qab149
4953350|NCT01845584|IVIG in Neuromyelitis Optica spectrum disorder|ivig in neuromyelitis optica spectrum disorder
4953351|NCT01845584|Patients with Neuromyelitis Optica spectrum disorder|patients with neuromyelitis optica spectrum disorder
4953352|NCT01845558|Muscle soreness|muscle soreness
4953353|NCT01845558|Exercise induced muscle damage|exercise induced muscle damage
4953354|NCT01845558|Inflammation|inflammation
4953355|NCT01845558|Proteolytic enzymes|proteolytic enzymes
4953356|NCT01845558|Muscle strength Dynamometer|muscle strength dynamometer
4953357|NCT01845545|microfinance|microfinance
4953358|NCT01845545|under five mortality|under five mortality
4953359|NCT01845545|underweight|underweight
4953360|NCT01845545|malnutrition|malnutrition
4953361|NCT01845506|wireless pressure sensor|wireless pressure sensor
4953362|NCT01845506|Elderly|elderly
4953363|NCT01845493|asthma|asthma
4953364|NCT01845493|Asthmatics|asthmatics
4953365|NCT01845493|allergic|allergic
4953366|NCT01845493|allergies|allergies
4953367|NCT01845480|health promotion|health promotion
4953368|NCT01845480|obesity prevention|obesity prevention
4953369|NCT01845480|Childhood obesity|childhood obesity
4953370|NCT01845480|home-based|home-based
4953371|NCT01845480|Lifestyle intervention|lifestyle intervention
4953372|NCT01845480|Body composition|body composition
4953373|NCT01845480|quality of life|quality of life
4953374|NCT01845480|physical activity|physical activity
4953375|NCT01845480|nutrition|nutrition
4953376|NCT01845467|Secretin MRCP, diagnosis, Autoimmune pancreatitis|secretin mrcp, diagnosis, autoimmune pancreatitis
4953377|NCT01845454|Barrett's Esophagus|barrett's esophagus
4953378|NCT01845454|Spray cryotherapy|spray cryotherapy
4953379|NCT01845441|Dexmedetomidine|dexmedetomidine
4953380|NCT01845441|Endovascular procedure|endovascular procedure
4953381|NCT01845441|Stroke|stroke
4953382|NCT01845441|Vasospasm, intracranial|vasospasm, intracranial
4953383|NCT01845441|Conscious sedation|conscious sedation
4953384|NCT01845428|nephrotic|nephrotic
4953385|NCT01845428|hyperlipidemia|hyperlipidemia
4953386|NCT01845428|oxLDL|oxldl
4953387|NCT01845428|kidney|kidney
4953388|NCT01845402|Kidney Failure, Chronic|kidney failure, chronic
4953389|NCT01845402|Adolescent|adolescent
4953390|NCT01845402|Heart Defects, Congenital|heart defects, congenital
4953391|NCT01845389|Anesthesia|anesthesia
4953392|NCT01845389|Regional|regional
4953393|NCT01845389|Epidural|epidural
4953394|NCT01845389|Continuous spinal|continuous spinal
4953395|NCT01845389|Wiley Catheter|wiley catheter
4953396|NCT01845389|Geriatric|geriatric
4953397|NCT01845389|TURP|turp
4953398|NCT01845376|Inflammatory Markers after Inguinal Hernia Repair|inflammatory markers after inguinal hernia repair
4953399|NCT01845376|Anesthetic technique for hernia repair|anesthetic technique for hernia repair
4953400|NCT01845363|Obesity|obesity
4953401|NCT01845363|Bariatric surgery|bariatric surgery
4953402|NCT01845363|Cefazolin|cefazolin
4953403|NCT01845363|antimicrobial prophylaxis|antimicrobial prophylaxis
4953404|NCT01845363|administration and dosage|administration and dosage
4953405|NCT01845324|Pregnancy|pregnancy
4953406|NCT01845324|Diabetes Mellitus|diabetes mellitus
4953407|NCT01845285|transcatheter valve replacement|transcatheter valve replacement
4953408|NCT01845285|aortic valve disease|aortic valve disease
4953409|NCT01845285|aortic stenosis|aortic stenosis
4953410|NCT01845285|Aortic regurgitation,catheter|aortic regurgitation,catheter
4953411|NCT01845285|Effective orifice area|effective orifice area
4953412|NCT01845246|Colistin|colistin
4953413|NCT01845246|Polymyxins|polymyxins
4953414|NCT01845246|Therapeutic drug monitoring|therapeutic drug monitoring
4953415|NCT01845246|Multi Drug resistant Gram negative bacterial infections|multi drug resistant gram negative bacterial infections
4953416|NCT01845220|Broccoli sprouts|broccoli sprouts
4953417|NCT01845220|alcohol sensitivity|alcohol sensitivity
4953418|NCT01845220|sulforaphane|sulforaphane
4953419|NCT01845220|alcohol metabolism|alcohol metabolism
4953420|NCT01845220|in the Asian Community|in the asian community
4953421|NCT01845207|Aortic stenosis|aortic stenosis
4953422|NCT01845207|Aortic valve replacement|aortic valve replacement
4953423|NCT01845207|Transcatheter aortic valve implantation|transcatheter aortic valve implantation
4953424|NCT01845207|Outcomes|outcomes
4953425|NCT01845207|Frailty|frailty
4953426|NCT01845207|Elderly|elderly
4953427|NCT01845194|pharmacokinetic|pharmacokinetic
4953428|NCT01845194|heritability|heritability
4953429|NCT01845194|drug membrane transport|drug membrane transport
4953430|NCT01845194|drug biotransformation|drug biotransformation
4953431|NCT01845181|Adenosine A1 receptor antagonist|adenosine a1 receptor antagonist
4953432|NCT01845181|Asthma|asthma
4953433|NCT01845181|adenosine receptor modulator|adenosine receptor modulator
4953434|NCT01845181|COPD|copd
4953435|NCT01845168|Bleeding peptic ulcer|bleeding peptic ulcer
4953436|NCT01845168|NSAID and Aspirin|nsaid and aspirin
4953437|NCT01845168|Computer-alert|computer-alert
4953438|NCT01845168|General practitioner|general practitioner
4953439|NCT01845155|Tinnitus|tinnitus
4953440|NCT01845155|music therapy|music therapy
4953441|NCT01845155|directive counselling|directive counselling
4953442|NCT01845155|acoustic stimulation|acoustic stimulation
4953443|NCT01845155|group comparison|group comparison
4953444|NCT01845155|subjective evaluation|subjective evaluation
4953445|NCT01845155|pitch|pitch
4953446|NCT01845142|vitamin D|vitamin d
4953447|NCT01845142|vitamin D deficiency|vitamin d deficiency
4953448|NCT01845142|immune cells|immune cells
4953449|NCT01845142|pharmacokinetic|pharmacokinetic
4953450|NCT01845142|< 50 nmol/L 25(OH)D serum concentration|< 50 nmol/l 25(oh)d serum concentration
4953451|NCT01845116|PNALD|pnald
4953452|NCT01845116|Cholestasis|cholestasis
4953453|NCT01845116|Omegaven®|omegaven®
4953454|NCT01845116|Short Bowel Syndrome|short bowel syndrome
4953455|NCT01845103|ANGINA|angina
4953456|NCT01845103|Thoracoscopic|thoracoscopic
4953457|NCT01845064|type 2 diabetes|type 2 diabetes
4953458|NCT01845064|diabetes mellitus|diabetes mellitus
4953459|NCT01845064|type 2 diabetes mellitus|type 2 diabetes mellitus
4953460|NCT01845064|HbA1c|hba1c
4953461|NCT01845064|blood glucose|blood glucose
4953462|NCT01845064|glucose control|glucose control
4953463|NCT01845064|DiaMedica|diamedica
4953464|NCT01845064|DM-199|dm-199
4953465|NCT01845064|DM199|dm199
4953466|NCT01845064|recombinant human tissue kallikrein-1|recombinant human tissue kallikrein-1
4953467|NCT01845064|tissue kallikrein-1|tissue kallikrein-1
4953468|NCT01845051|Migraine|migraine
4953469|NCT01845051|allergic rhinitis|allergic rhinitis
4953470|NCT01845051|Specific Immunoglobulin E (IgE)|specific immunoglobulin e (ige)
4953471|NCT01845051|nasal symptoms|nasal symptoms
4953472|NCT01845051|signs of allergy.|signs of allergy.
4953473|NCT01845025|Asthma|asthma
4953474|NCT01845025|formoterol fumarate|formoterol fumarate
4953475|NCT01845025|Foradil|foradil
4953476|NCT01845025|inhaled corticosteroid|inhaled corticosteroid
4953477|NCT01845025|fluticasone propionate|fluticasone propionate
4953478|NCT01845025|safety|safety
4953479|NCT01845012|Short daily hemodialysis|short daily hemodialysis
4953480|NCT01845012|Low dialysate flow|low dialysate flow
4953481|NCT01845012|End stage renal disease|end stage renal disease
4953482|NCT01844999|Prostate cancer|prostate cancer
4953483|NCT01844999|Decision|decision
4953484|NCT01844986|BRCA|brca
4953485|NCT01844986|Ovarian Cancer|ovarian cancer
4953486|NCT01844986|Chemotherapy|chemotherapy
4953487|NCT01844986|PARP inhibitor|parp inhibitor
4953488|NCT01844986|First Line|first line
4953489|NCT01844986|FIGO Stage III|figo stage iii
4953490|NCT01844986|FIGO Stage IV|figo stage iv
4953491|NCT01844960|Single Incision Surgery|single incision surgery
4953492|NCT01844960|SILS|sils
4953493|NCT01844960|Laparoscopic Gastric Band|laparoscopic gastric band
4953494|NCT01844960|Morbid Obesity|morbid obesity
4953495|NCT01844960|Bariatric Surgery|bariatric surgery
4953496|NCT01844934|Knee Arthroplasty|knee arthroplasty
4953497|NCT01844934|Knee Replacement|knee replacement
4953498|NCT01844934|Prehabilitation|prehabilitation
4953499|NCT01844882|The effects|the effects
4953500|NCT01844882|dietary|dietary
4953501|NCT01844882|fiber|fiber
4953502|NCT01844882|kidney function|kidney function
4953503|NCT01844882|CKD patients|ckd patients
4953504|NCT01844869|omacetaxine|omacetaxine
4953505|NCT01844869|omacetaxine mepesuccinate|omacetaxine mepesuccinate
4953506|NCT01844869|pharmacokinetics|pharmacokinetics
4953507|NCT01844869|hematologic malignancies|hematologic malignancies
4953508|NCT01844869|advanced solid tumors|advanced solid tumors
4953509|NCT01844843|Drug eluting stents|drug eluting stents
4953510|NCT01844843|coronary artery disease|coronary artery disease
4953511|NCT01844843|Percutaneous Coronary Intervention|percutaneous coronary intervention
4953512|NCT01844843|Tomography, Optical Coherence|tomography, optical coherence
4953513|NCT01844830|operative|operative
4953514|NCT01844830|dental procedure|dental procedure
4953515|NCT01844817|untreated|untreated
4953516|NCT01844817|metastatic|metastatic
4953517|NCT01844817|OGX-427|ogx-427
4953518|NCT01844804|Bioequivalence|bioequivalence
4953519|NCT01844804|Biosimilarity|biosimilarity
4953520|NCT01844804|Similarity|similarity
4953521|NCT01844804|PK|pk
4953522|NCT01844804|Phase 1|phase 1
4953523|NCT01844804|Infliximab|infliximab
4953524|NCT01844804|Healthy Volunteers|healthy volunteers
4953525|NCT01844804|Single-dose|single-dose
4953526|NCT01844804|Immunology|immunology
4953527|NCT01844791|Non-small cell lung cancer|non-small cell lung cancer
4953528|NCT01844791|OCZ103-OS|ocz103-os
4953529|NCT01844791|Pentamidine bis(2-hydroxyethanesulfonate)|pentamidine bis(2-hydroxyethanesulfonate)
4953530|NCT01844791|platinum-gemcitabine based doublet first line therapy|platinum-gemcitabine based doublet first line therapy
4953531|NCT01844778|Cystic Fibrosis, Pseudomonas aeruginosa, FEV1, tobramycin inhalation powder, TOBI,|cystic fibrosis, pseudomonas aeruginosa, fev1, tobramycin inhalation powder, tobi,
4953532|NCT01844778|colistimethate|colistimethate
4953533|NCT01844778|Cystic Fibrosis, Pseudomonas aeruginosa, FEV1, tobramycin inhalation powder, TOBI, colistimethate|cystic fibrosis, pseudomonas aeruginosa, fev1, tobramycin inhalation powder, tobi, colistimethate
4953534|NCT01844765|Tasigna|tasigna
4953535|NCT01844765|nilotinib treatment|nilotinib treatment
4953536|NCT01844765|chronic phase|chronic phase
4953537|NCT01844765|Ph+ CML|ph+ cml
4953538|NCT01844765|accelerated phase|accelerated phase
4953539|NCT01844765|newly diagnosed Ph+ CML|newly diagnosed ph+ cml
4953540|NCT01844765|pediatric|pediatric
4953541|NCT01844765|24 month treatment|24 month treatment
4953542|NCT01844752|acne|acne
4953543|NCT01844739|Propionibacterium acnes|propionibacterium acnes
4953544|NCT01844739|acne|acne
4953545|NCT01844726|healthy individuals|healthy individuals
4953546|NCT01844726|schizophrenia|schizophrenia
4953547|NCT01844726|schizoaffective disorder|schizoaffective disorder
4953548|NCT01844726|learning|learning
4953549|NCT01844726|memory|memory
4953550|NCT01844726|cognitive enhancement|cognitive enhancement
4953551|NCT01844726|fMRI|fmri
4953552|NCT01844713|Kidney transplant|kidney transplant
4953553|NCT01844713|Renal transplant|renal transplant
4953554|NCT01844713|Sun protection|sun protection
4953555|NCT01844713|Skin cancer|skin cancer
4953556|NCT01844700|MC4R genotype|mc4r genotype
4953557|NCT01844700|antipsychotic induced weight gain|antipsychotic induced weight gain
4953558|NCT01844700|pediatric population|pediatric population
4953559|NCT01844687|reinforcement, good drug effect, high, mood, cannabidiol|reinforcement, good drug effect, high, mood, cannabidiol
4953560|NCT01844661|Mesenchymal stem cells|mesenchymal stem cells
4953561|NCT01844661|Oncolytic adenovirus|oncolytic adenovirus
4953562|NCT01844648|Parkinson's disease|parkinson's disease
4953563|NCT01844648|Sialorrhea|sialorrhea
4953564|NCT01844648|Tropicamide|tropicamide
4953565|NCT01844648|Non-motor symptoms|non-motor symptoms
4953566|NCT01844648|Thin strip delivery|thin strip delivery
4953567|NCT01844622|Digestive System Diseases Disease|digestive system diseases disease
4953568|NCT01844609|Comprehension|comprehension
4953569|NCT01844609|Verbal Learning|verbal learning
4953570|NCT01844609|Writing|writing
4953571|NCT01844609|Testing|testing
4953572|NCT01844596|linkage to care|linkage to care
4953573|NCT01844596|hypertension management|hypertension management
4953574|NCT01844596|behavioral science|behavioral science
4953575|NCT01844596|cardiovascular health|cardiovascular health
4953576|NCT01844596|global health|global health
4953577|NCT01844596|multi-disciplinary implementation research approach|multi-disciplinary implementation research approach
4953578|NCT01844596|linking and retaining|linking and retaining
4953579|NCT01844596|community health workers|community health workers
4953580|NCT01844596|CHWs|chws
4953581|NCT01844596|behavioral communication strategy|behavioral communication strategy
4953582|NCT01844596|smartphone-based tool|smartphone-based tool
4953583|NCT01844596|electronic health record|electronic health record
4953584|NCT01844596|retention to care|retention to care
4953585|NCT01844557|Head And Neck Cancer|head and neck cancer
4953586|NCT01844557|Nasopharyngeal cancer|nasopharyngeal cancer
4953587|NCT01844557|Oropharyngeal cancer|oropharyngeal cancer
4953588|NCT01844557|Hypopharyngeal cancer|hypopharyngeal cancer
4953589|NCT01844557|Laryngeal cancer|laryngeal cancer
4953590|NCT01844557|Primary cancer with cervical metastases|primary cancer with cervical metastases
4953591|NCT01844557|Swallowing exercises|swallowing exercises
4953592|NCT01844557|Videotape|videotape
4953593|NCT01844557|Videocamera|videocamera
4953594|NCT01844557|M.D. Anderson Symptom Inventory|m.d. anderson symptom inventory
4953595|NCT01844557|Questionnaires|questionnaires
4953596|NCT01844557|Surveys|surveys
4953597|NCT01844544|drug related problems|drug related problems
4953598|NCT01844544|clinical pharmacist|clinical pharmacist
4953599|NCT01844544|femoral neck fractures|femoral neck fractures
4953600|NCT01844544|orthopedic patients|orthopedic patients
4953601|NCT01844492|decision making for incapacitated patients|decision making for incapacitated patients
4953602|NCT01844492|intensive care|intensive care
4953603|NCT01844492|surrogate decision making|surrogate decision making
4953604|NCT01844492|patient centered care|patient centered care
4953605|NCT01844492|Palliative Care|palliative care
4953606|NCT01844492|End of Life|end of life
4953607|NCT01844492|Quality of Communication|quality of communication
4953608|NCT01844479|diabetic foot ulcer|diabetic foot ulcer
4953609|NCT01844479|diabetic foot|diabetic foot
4953610|NCT01844466|course of motor and visual rehabilitation|course of motor and visual rehabilitation
4953611|NCT01844466|improvement of deficits|improvement of deficits
4953612|NCT01844466|stroke patients|stroke patients
4953613|NCT01844453|Subfertility|subfertility
4953614|NCT01844453|Recurrent Implantation Failure|recurrent implantation failure
4953615|NCT01844440|GERD|gerd
4953616|NCT01844440|tLESR|tlesr
4953617|NCT01844440|impedance|impedance
4953618|NCT01844440|manometry|manometry
4953619|NCT01844427|ADHD|adhd
4953620|NCT01844427|Executive function deficits|executive function deficits
4953621|NCT01844427|Psychiatry|psychiatry
4953622|NCT01844427|Psychopharmacology|psychopharmacology
4953623|NCT01844427|Namenda|namenda
4953624|NCT01844414|Homeless Men|homeless men
4953625|NCT01844414|Parolees|parolees
4953626|NCT01844414|Hepatitis B|hepatitis b
4953627|NCT01844414|Hepatitis C|hepatitis c
4953628|NCT01844414|HIV|hiv
4953629|NCT01844414|Community Drug Treatment|community drug treatment
4953630|NCT01844414|Recidivism|recidivism
4953631|NCT01844401|persistent asthma|persistent asthma
4953632|NCT01844401|Albuterol Spiromax®|albuterol spiromax®
4953633|NCT01844401|ProAir® HFA|proair® hfa
4953634|NCT01844401|Pediatric Patients|pediatric patients
4953635|NCT01844401|Phase 1|phase 1
4953636|NCT01844375|oral carbohydrate loading|oral carbohydrate loading
4953637|NCT01844375|walking capacity|walking capacity
4953638|NCT01844362|uterus|uterus
4953639|NCT01844362|transplantation|transplantation
4953640|NCT01844362|infertility|infertility
4953641|NCT01844349|North Africa|north africa
4953642|NCT01844349|Urban women|urban women
4953643|NCT01844349|Double burden of malnutrition|double burden of malnutrition
4953644|NCT01844349|Iron depletion|iron depletion
4953645|NCT01844349|Overweight/obesity|overweight/obesity
4953646|NCT01844349|Metabolic syndrome|metabolic syndrome
4953647|NCT01844349|Abdominal obesity|abdominal obesity
4953648|NCT01844349|Excess body fat|excess body fat
4953649|NCT01844284|Absorb™ BVS|absorb™ bvs
4953650|NCT01844284|Angioplasty|angioplasty
4953651|NCT01844284|Bioabsorbable|bioabsorbable
4953652|NCT01844284|Bioreabsorbable|bioreabsorbable
4953653|NCT01844284|BVS|bvs
4953654|NCT01844284|Coronary Artery Disease|coronary artery disease
4953655|NCT01844284|Coronary Artery Endothelial Responsiveness|coronary artery endothelial responsiveness
4953656|NCT01844284|Coronary artery restenosis|coronary artery restenosis
4953657|NCT01844284|Coronary artery stenosis|coronary artery stenosis
4953658|NCT01844284|Coronary scaffold|coronary scaffold
4953659|NCT01844284|Coronary Stent|coronary stent
4953660|NCT01844284|Drug eluting stents|drug eluting stents
4953661|NCT01844284|Everolimus|everolimus
4953662|NCT01844284|Myocardial ischemia|myocardial ischemia
4953663|NCT01844284|Stent thrombosis|stent thrombosis
4953664|NCT01844284|Stents|stents
4953665|NCT01844271|LLLT|lllt
4953666|NCT01844271|muscle fatigue and recovery|muscle fatigue and recovery
4953667|NCT01844271|phototherapy parameter|phototherapy parameter
4953668|NCT01844258|pediatric cataract|pediatric cataract
4953669|NCT01844258|lens regeneration|lens regeneration
4953670|NCT01844258|endogenous lens epithelial stem cells|endogenous lens epithelial stem cells
4953671|NCT01844258|visual axis opacification|visual axis opacification
4953672|NCT01844258|visual function|visual function
4953673|NCT01844245|Cholangiocarcinoma|cholangiocarcinoma
4953674|NCT01844245|Ampullary carcinoma|ampullary carcinoma
4953675|NCT01844245|Endoscopic retrograde cholangiopancreatography|endoscopic retrograde cholangiopancreatography
4953676|NCT01844245|Radiofrequency ablation|radiofrequency ablation
4953677|NCT01844232|Multiple sclerosis|multiple sclerosis
4953678|NCT01844232|spasticity|spasticity
4953679|NCT01844232|arbaclofen|arbaclofen
4953680|NCT01844219|aortic surgery|aortic surgery
4953681|NCT01844219|acute kidney injury|acute kidney injury
4953682|NCT01844219|gray zone approach|gray zone approach
4953683|NCT01844206|Post-cesarean analgesia|post-cesarean analgesia
4953684|NCT01844206|Second dose of epidural morphine after surgery|second dose of epidural morphine after surgery
4953685|NCT01844206|Post-operative analgesia|post-operative analgesia
4953686|NCT01844206|Self-administered epidural morphine|self-administered epidural morphine
4953687|NCT01844206|Pain management after cesarean|pain management after cesarean
4953688|NCT01844180|Irritable Bowel Syndrome|irritable bowel syndrome
4953689|NCT01844180|IBS|ibs
4953690|NCT01844180|ONO-2952|ono-2952
4953691|NCT01844167|noxipoint|noxipoint
4953692|NCT01844167|physical therapy|physical therapy
4953693|NCT01844167|cervical pain|cervical pain
4953694|NCT01844167|trigger point|trigger point
4953695|NCT01844167|neck pain|neck pain
4953696|NCT01844167|TENS|tens
4953697|NCT01844167|transcutaneous electrical nerve stimulation|transcutaneous electrical nerve stimulation
4953698|NCT01844141|phenol|phenol
4953699|NCT01844141|ingrown toenail|ingrown toenail
4953700|NCT01844141|chemical matricectomy|chemical matricectomy
4953701|NCT01844128|MMA, AFC, Ovarian reserve|mma, afc, ovarian reserve
4953702|NCT01844115|Generalized Anxiety Disorder, GAD|generalized anxiety disorder, gad
4953703|NCT01844102|HIV Prevention, PrePex, voluntary medical circumcision, non-surgical,|hiv prevention, prepex, voluntary medical circumcision, non-surgical,
4953704|NCT01844102|medical device, wound healing, Zambia|medical device, wound healing, zambia
4953705|NCT01844089|Postpartum hemorrhage|postpartum hemorrhage
4953706|NCT01844089|Bakri Postpartum Balloon|bakri postpartum balloon
4953707|NCT01844076|advanced stage colorectal adenocarcinoma|advanced stage colorectal adenocarcinoma
4953708|NCT01844050|Chinese herbal medicine|chinese herbal medicine
4953709|NCT01844050|diabetes symptoms|diabetes symptoms
4953710|NCT01844011|fetal movement|fetal movement
4953711|NCT01844011|pregnancy|pregnancy
4953712|NCT01843998|Early stage|early stage
4953713|NCT01843998|Stage 1A|stage 1a
4953714|NCT01843998|Cutaneous T-cell Lymphoma|cutaneous t-cell lymphoma
4953715|NCT01843998|CTCL|ctcl
4953716|NCT01843985|Stage IV cancer|stage iv cancer
4953717|NCT01843985|Survival|survival
4953718|NCT01843959|adenovirus-36|adenovirus-36
4953719|NCT01843959|Emirati population|emirati population
4953721|NCT01843920|pneumatic retinopexy|pneumatic retinopexy
4953722|NCT01843920|topical|topical
4953723|NCT01843894|sever dry eye,keratoconjunctivitis sicca|sever dry eye,keratoconjunctivitis sicca
4953724|NCT01843881|Gastric Bypass|gastric bypass
4953725|NCT01843881|bariatric surgery|bariatric surgery
4953726|NCT01843881|carbohydrate metabolism|carbohydrate metabolism
4953727|NCT01843868|Lymphoma|lymphoma
4953728|NCT01843868|Non-Hodgkin|non-hodgkin
4953729|NCT01843868|Emesis|emesis
4953730|NCT01843868|Chemotherapy|chemotherapy
4953731|NCT01843868|Nausea|nausea
4953732|NCT01843868|Vomiting|vomiting
4953733|NCT01843868|Aprepitant|aprepitant
4953734|NCT01843855|Gastric Bypass|gastric bypass
4953735|NCT01843855|bariatric surgery|bariatric surgery
4953736|NCT01843855|glucose metabolism|glucose metabolism
4953737|NCT01843829|Oesophageal cancer|oesophageal cancer
4953738|NCT01843816|Tragus-to-wall distance|tragus-to-wall distance
4953739|NCT01843816|obesity|obesity
4953740|NCT01843816|body shape|body shape
4953741|NCT01843816|height|height
4953742|NCT01843816|weight|weight
4953743|NCT01843803|patient centered care|patient centered care
4953744|NCT01843803|collaborative decision making|collaborative decision making
4953745|NCT01843803|cost impact|cost impact
4953746|NCT01843777|hearing loss|hearing loss
4953747|NCT01843777|hearing aids|hearing aids
4953748|NCT01843777|motivational interviewing|motivational interviewing
4953749|NCT01843777|counseling|counseling
4953750|NCT01843777|rehabilitation|rehabilitation
4953751|NCT01843764|RDT|rdt
4953752|NCT01843764|malaria|malaria
4953753|NCT01843764|treatment follow up|treatment follow up
4953754|NCT01843764|diagnosis|diagnosis
4953755|NCT01843725|breast cancer|breast cancer
4953756|NCT01843725|digestive cancer|digestive cancer
4953757|NCT01843712|Caloric compensation|caloric compensation
4953758|NCT01843712|Eating in the absence of hunger|eating in the absence of hunger
4953759|NCT01843712|Children|children
4953760|NCT01843712|Parental feeding practices|parental feeding practices
4953761|NCT01843686|Acute 2nd and 3rd Degree Burns|acute 2nd and 3rd degree burns
4953762|NCT01843686|Autologous Platelet Rich Plasma (PRP)|autologous platelet rich plasma (prp)
4953763|NCT01843686|Skin Grafting|skin grafting
4953764|NCT01843686|Magellan® System|magellan® system
4953765|NCT01843686|Wounds|wounds
4953766|NCT01843673|Lip, Oral Cavity and Pharynx|lip, oral cavity and pharynx
4953767|NCT01843673|Larynx|larynx
4953768|NCT01843660|Low back pain|low back pain
4953769|NCT01843660|Shoulder pain|shoulder pain
4953770|NCT01843660|Neck pain|neck pain
4953771|NCT01843660|Tramadol hydrochloride|tramadol hydrochloride
4953772|NCT01843660|Paracetamol|paracetamol
4953773|NCT01843621|Dengue, Vaccine, Thailand|dengue, vaccine, thailand
4953774|NCT01843608|Physical treatment|physical treatment
4953775|NCT01843608|Exercise prescription to breast cancer survival|exercise prescription to breast cancer survival
4953776|NCT01843608|Side cancer effect treatment|side cancer effect treatment
4953777|NCT01843582|Keyword: blind spot|keyword: blind spot
4953778|NCT01843569|In Vitro Maturation|in vitro maturation
4953779|NCT01843569|IVM|ivm
4953780|NCT01843569|Natural cycle IVF|natural cycle ivf
4953781|NCT01843569|PCOS|pcos
4953782|NCT01843543|Functional MRI (fMRI)|functional mri (fmri)
4953783|NCT01843543|Resting state functional connectivity MRI (rs-fcMRI)|resting state functional connectivity mri (rs-fcmri)
4953784|NCT01843543|Diffusion Tensor Imaging (DTI)|diffusion tensor imaging (dti)
4953785|NCT01843517|Pain|pain
4953786|NCT01843517|Facilitation|facilitation
4953787|NCT01843517|Inhibition|inhibition
4953788|NCT01843517|Oxytocin|oxytocin
4953789|NCT01843517|Postpartum|postpartum
4953790|NCT01843504|platelet rich plasma|platelet rich plasma
4953791|NCT01843504|PRP|prp
4953792|NCT01843504|plasma|plasma
4953793|NCT01843504|plasma injection|plasma injection
4953794|NCT01843504|patellar tendinopathy|patellar tendinopathy
4953795|NCT01843504|patella tendon|patella tendon
4953796|NCT01843504|patella|patella
4953797|NCT01843504|ultrasound|ultrasound
4953798|NCT01843504|shear wave ultrasound|shear wave ultrasound
4953799|NCT01843504|tendinosis|tendinosis
4953800|NCT01843504|tendinopathy|tendinopathy
4953801|NCT01843504|tendinitis|tendinitis
4953802|NCT01843504|jumper's knee|jumper's knee
4953803|NCT01843478|women|women
4953804|NCT01843478|human immunodeficiency virus|human immunodeficiency virus
4953805|NCT01843478|cervical cancer screening|cervical cancer screening
4953806|NCT01843478|Pap testing|pap testing
4953807|NCT01843478|human papillomavirus|human papillomavirus
4953808|NCT01843465|atrial fibrillation|atrial fibrillation
4953809|NCT01843465|balloon cryoablation|balloon cryoablation
4953810|NCT01843465|pulmonary veins|pulmonary veins
4953811|NCT01843439|Acute exacerbation|acute exacerbation
4953812|NCT01843439|Quality of life|quality of life
4953813|NCT01843439|Magnesium deficiency|magnesium deficiency
4953814|NCT01843439|Multidisciplinary intervention|multidisciplinary intervention
4953815|NCT01843426|Comorbidity|comorbidity
4953816|NCT01843413|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
4953817|NCT01843400|Regorafenib|regorafenib
4953818|NCT01843400|Colorectal Neoplasms|colorectal neoplasms
4953819|NCT01843387|Diabetic nephropathy|diabetic nephropathy
4953820|NCT01843387|Chronic kidney disease|chronic kidney disease
4953821|NCT01843387|Metabolic disease|metabolic disease
4953822|NCT01843387|Diabetes mellitus, type 2|diabetes mellitus, type 2
4953823|NCT01843374|tremelimumab|tremelimumab
4953824|NCT01843374|pleural, peritoneal|pleural, peritoneal
4953825|NCT01843374|malignant mesothelioma|malignant mesothelioma
4953826|NCT01843374|CTLA-4|ctla-4
4953827|NCT01843361|Stroke|stroke
4953828|NCT01843361|Clopidogrel|clopidogrel
4953829|NCT01843361|Aggregometry|aggregometry
4953830|NCT01843361|Antiplatelet therapy|antiplatelet therapy
4953831|NCT01843361|Platelet function tests|platelet function tests
4953832|NCT01843348|Transplant|transplant
4953833|NCT01843348|Renal transplant|renal transplant
4953834|NCT01843348|Rejection,allograf|rejection,allograf
4953835|NCT01843348|Rejection|rejection
4953836|NCT01843348|Xenograft rejection|xenograft rejection
4953837|NCT01843348|Host vs graft disease|host vs graft disease
4953838|NCT01843348|Kidney Transplant|kidney transplant
4953839|NCT01843335|Cardiovascular Diagnostic Technique|cardiovascular diagnostic technique
4953840|NCT01843335|Ultrasound|ultrasound
4953841|NCT01843322|Image guided therapy|image guided therapy
4953842|NCT01843322|Endovascular procedures|endovascular procedures
4953843|NCT01843322|Angiography|angiography
4953844|NCT01843322|Vascular surgical procedures|vascular surgical procedures
4953845|NCT01843296|Spinal Anesthesia|spinal anesthesia
4953846|NCT01843296|Bupivacaine|bupivacaine
4953847|NCT01843296|Fentanyl|fentanyl
4953848|NCT01843296|Magnesium sulfate|magnesium sulfate
4953849|NCT01843296|Postoperative Pain|postoperative pain
4953850|NCT01843283|Mild Cognitive Impairment|mild cognitive impairment
4953851|NCT01843283|Family Caregivers|family caregivers
4953852|NCT01843283|Intervention studies|intervention studies
4953853|NCT01843270|general anesthesia|general anesthesia
4953854|NCT01843270|body weight|body weight
4953855|NCT01843270|laryngeal mask airway size|laryngeal mask airway size
4953856|NCT01843257|Alcohol intake after bariatric surgery|alcohol intake after bariatric surgery
4953857|NCT01843257|Alcohol and bariatric surgery|alcohol and bariatric surgery
4953858|NCT01843244|plethysmography|plethysmography
4953859|NCT01843231|g-Cath EZ Suture Anchor Delivery Catheter|g-cath ez suture anchor delivery catheter
4953860|NCT01843231|Weight Loss Intervention|weight loss intervention
4953861|NCT01843218|Localized rectal cancer in a male patient|localized rectal cancer in a male patient
4953862|NCT01843179|Newly diagnosed|newly diagnosed
4953863|NCT01843179|Complete Remission|complete remission
4953864|NCT01843166|Pessary|pessary
4953865|NCT01843166|Patient Satisfaction|patient satisfaction
4953866|NCT01843166|Estrogen Cream|estrogen cream
4953867|NCT01843153|pain score|pain score
4953868|NCT01843140|cancer|cancer
4953869|NCT01843140|fertility preservation|fertility preservation
4953870|NCT01843140|infertility|infertility
4953871|NCT01843140|pregnancy|pregnancy
4953872|NCT01843114|Retinal blood flow|retinal blood flow
4953873|NCT01843114|Retinal vessel diameter|retinal vessel diameter
4953874|NCT01843114|Fourier Domain Optical Coherence Tomography|fourier domain optical coherence tomography
4953875|NCT01843114|Retinal blood velocities|retinal blood velocities
4953876|NCT01843101|Optical Coherence Tomography|optical coherence tomography
4953877|NCT01843101|Cornea|cornea
4953878|NCT01843101|Imaging|imaging
4953879|NCT01843088|Pain|pain
4953880|NCT01843088|exercise|exercise
4953881|NCT01843088|muscle|muscle
4953882|NCT01843062|Selumetinib, Differentiated Thyroid Cancer , AZD6244|selumetinib, differentiated thyroid cancer , azd6244
4953883|NCT01843036|Child Abuse|child abuse
4953884|NCT01843036|Child Neglect|child neglect
4954184|NCT01841502|telaprevir|telaprevir
4953885|NCT01843036|Child Emergency Medical Care Presentations|child emergency medical care presentations
4953886|NCT01843036|Child Well-Care Compliance|child well-care compliance
4953887|NCT01843036|Mother Well-Care Compliance|mother well-care compliance
4953888|NCT01843036|Mother Emergency Medical Care Presentations|mother emergency medical care presentations
4953889|NCT01843036|Mother Mental Health|mother mental health
4953890|NCT01843036|Family Connections to Community Resources|family connections to community resources
4953891|NCT01843036|Parent-Child Relationship Quality|parent-child relationship quality
4953892|NCT01843023|opioid dependence|opioid dependence
4953893|NCT01843010|NSAIDs|nsaids
4953894|NCT01843010|Hyperalgesia|hyperalgesia
4953895|NCT01843010|Postlaparoscopic shoulder pain|postlaparoscopic shoulder pain
4953896|NCT01842997|Flu|flu
4953897|NCT01842997|non-adjuvanted H1N1 vaccine|non-adjuvanted h1n1 vaccine
4953898|NCT01842997|Safety|safety
4953899|NCT01842997|pregnant women|pregnant women
4953900|NCT01842984|Loneliness|loneliness
4953901|NCT01842984|Social isolation|social isolation
4953902|NCT01842984|Depression|depression
4953903|NCT01842984|Older adults|older adults
4953904|NCT01842984|Social competence|social competence
4953905|NCT01842984|Social integration|social integration
4953906|NCT01842971|two stage hepatectomy|two stage hepatectomy
4953907|NCT01842971|liver metastasis|liver metastasis
4953908|NCT01842971|colorectal cancer|colorectal cancer
4953909|NCT01842958|Dental Implant|dental implant
4953910|NCT01842945|Procrastination|procrastination
4953911|NCT01842945|internet based cognitive behavior therapy|internet based cognitive behavior therapy
4953912|NCT01842945|randomized controlled trial|randomized controlled trial
4953913|NCT01842932|Colonoscopy|colonoscopy
4953914|NCT01842932|Anticholinergics|anticholinergics
4953915|NCT01842906|positive end expiratory pressure|positive end expiratory pressure
4953916|NCT01842906|acute mountain sickness|acute mountain sickness
4953917|NCT01842906|prevention|prevention
4953918|NCT01842906|high altitude|high altitude
4953919|NCT01842893|fentanyl|fentanyl
4953920|NCT01842893|breakthrough pain|breakthrough pain
4953921|NCT01842893|opioid treated cancer patients|opioid treated cancer patients
4953922|NCT01842880|MicroRNAs|micrornas
4953923|NCT01842880|Chagas disease|chagas disease
4953924|NCT01842880|Biomarkers|biomarkers
4953925|NCT01842867|Syndecan-4|syndecan-4
4953926|NCT01842867|Chagas disease|chagas disease
4953927|NCT01842867|Biomarkers|biomarkers
4953928|NCT01842854|Galectin-3|galectin-3
4953929|NCT01842854|Chagas disease|chagas disease
4953930|NCT01842854|Biomarkers|biomarkers
4953931|NCT01842789|Acessa|acessa
4953932|NCT01842789|Fibroids|fibroids
4953933|NCT01842789|Halt|halt
4953934|NCT01842789|Targeting Animation|targeting animation
4953935|NCT01842789|Image Overlay|image overlay
4953936|NCT01842789|Radiofrequency Ablation|radiofrequency ablation
4953937|NCT01842789|RFA|rfa
4953938|NCT01842763|Chronic daily headache|chronic daily headache
4953939|NCT01842763|treated by occipital nerves stimulation|treated by occipital nerves stimulation
4953940|NCT01842763|peripheral neuromodulation|peripheral neuromodulation
4953941|NCT01842763|occipital nerves|occipital nerves
4953942|NCT01842763|network|network
4953943|NCT01842763|database|database
4953944|NCT01842737|Low Back Pain|low back pain
4953945|NCT01842737|Chiropractic|chiropractic
4953946|NCT01842737|Spinal Manipulation|spinal manipulation
4953947|NCT01842737|Massage|massage
4953948|NCT01842698|Thoracotomy surgery|thoracotomy surgery
4953949|NCT01842698|Anesthesia|anesthesia
4953950|NCT01842698|Ultrasound-guided PVB|ultrasound-guided pvb
4953951|NCT01842698|Post-operative pain|post-operative pain
4953952|NCT01842685|Overactive Bladder|overactive bladder
4953953|NCT01842685|Bladder Distention|bladder distention
4953954|NCT01842672|pediatric non-hodgkins lymphoma|pediatric non-hodgkins lymphoma
4953955|NCT01842672|pediatric acute leukemia|pediatric acute leukemia
4953956|NCT01842672|clofarabine|clofarabine
4953957|NCT01842672|mitoxantrone|mitoxantrone
4953958|NCT01842659|MI|mi
4953959|NCT01842659|amniocentesis|amniocentesis
4953960|NCT01842659|cord blood|cord blood
4953961|NCT01842659|placenta|placenta
4953962|NCT01842659|Silver Russell Syndrome|silver russell syndrome
4953963|NCT01842659|Beckwith Wiedemann Syndrome|beckwith wiedemann syndrome
4953964|NCT01842646|Leukemia|leukemia
4953965|NCT01842646|Myeloid Malignancies|myeloid malignancies
4953966|NCT01842620|Metformin|metformin
4953967|NCT01842620|Bioequivalence|bioequivalence
4953968|NCT01842607|eosinophils|eosinophils
4953969|NCT01842607|mepolizumab|mepolizumab
4953970|NCT01842607|SB-240563|sb-240563
4953971|NCT01842607|safety|safety
4953972|NCT01842607|extension study|extension study
4953973|NCT01842607|Severe refractory asthma|severe refractory asthma
4953974|NCT01842594|Sarcoma, Hydroxychloroquine, Sirolimus, PET|sarcoma, hydroxychloroquine, sirolimus, pet
4953975|NCT01842581|Liver Failure|liver failure
4953976|NCT01842581|Hepatic Insufficiency|hepatic insufficiency
4953977|NCT01842581|Liver Diseases|liver diseases
4953978|NCT01842581|Brain Diseases|brain diseases
4953979|NCT01842581|Rifaximin|rifaximin
4953980|NCT01842581|Cirrhosis|cirrhosis
4953981|NCT01842568|Cardiac surgery|cardiac surgery
4953982|NCT01842568|Troponin|troponin
4953983|NCT01842568|Vascular events|vascular events
4954185|NCT01841502|paroxetine|paroxetine
4953984|NCT01842568|Myocardial injury|myocardial injury
4953985|NCT01842568|Observational cohort study|observational cohort study
4953986|NCT01842568|Public health|public health
4953987|NCT01842555|PDT|pdt
4953988|NCT01842555|Photodynamic therapy|photodynamic therapy
4953989|NCT01842542|Postpartum Depression, NeuroStar TMS Therapy, TMS|postpartum depression, neurostar tms therapy, tms
4953990|NCT01842503|alcohol dependence|alcohol dependence
4953991|NCT01842503|cue reactivity|cue reactivity
4953992|NCT01842503|alcohol self administration|alcohol self administration
4953993|NCT01842490|Biomarker|biomarker
4953994|NCT01842490|Carotid enhanced ultrasound|carotid enhanced ultrasound
4953995|NCT01842490|Intraplaque neovascularization|intraplaque neovascularization
4953996|NCT01842438|Sexual Dysfunctions, Psychological|sexual dysfunctions, psychological
4953997|NCT01842425|Liver volume|liver volume
4953998|NCT01842425|Gastric bypass|gastric bypass
4953999|NCT01842425|Magnetic resonance imaging|magnetic resonance imaging
4954000|NCT01842412|Mitochondria, Muscle|mitochondria, muscle
4954001|NCT01842412|Exercise|exercise
4954002|NCT01842399|Vascular Stiffness|vascular stiffness
4954003|NCT01842399|Aging|aging
4954004|NCT01842399|Resveratrol|resveratrol
4954005|NCT01842399|Aerobic Capacity|aerobic capacity
4954006|NCT01842399|Inflammation|inflammation
4954007|NCT01842386|Anti-CD20|anti-cd20
4954008|NCT01842386|Anticytokine Autoanitbody-Associated Disease|anticytokine autoanitbody-associated disease
4954009|NCT01842386|Rituximab|rituximab
4954010|NCT01842373|topical anesthetics|topical anesthetics
4954011|NCT01842373|laser resurfacing|laser resurfacing
4954012|NCT01842360|Vaccine|vaccine
4954013|NCT01842360|Chronic obstructive pulmonary disease (COPD)|chronic obstructive pulmonary disease (copd)
4954014|NCT01842334|Nicotine Dependence|nicotine dependence
4954015|NCT01842334|Smoking Cessation|smoking cessation
4954016|NCT01842334|D-cycloserine|d-cycloserine
4954017|NCT01842321|locally advanced|locally advanced
4954018|NCT01842321|metastatic|metastatic
4954019|NCT01842321|Breast Cancer|breast cancer
4954020|NCT01842321|Molecular Apocrine|molecular apocrine
4954021|NCT01842321|HER2-negative|her2-negative
4954022|NCT01842321|Abiraterone acetate|abiraterone acetate
4954023|NCT01842295|Obesity|obesity
4954024|NCT01842295|Bariatric surgery|bariatric surgery
4954025|NCT01842295|Sperm quality|sperm quality
4954026|NCT01842295|Fertility|fertility
4954027|NCT01842282|diabetes mellitus type 2|diabetes mellitus type 2
4954028|NCT01842282|non alcoholic fatty liver disease|non alcoholic fatty liver disease
4954029|NCT01842282|obesity|obesity
4954030|NCT01842282|amlexanox|amlexanox
4954031|NCT01842269|Mycophenolate Mofetil|mycophenolate mofetil
4954032|NCT01842269|MMF|mmf
4954033|NCT01842256|Telminouveau|telminouveau
4954034|NCT01842256|Atorvastatin|atorvastatin
4954035|NCT01842256|Pharmacokinetic|pharmacokinetic
4954036|NCT01842256|Healthy volunteers|healthy volunteers
4954037|NCT01842243|Ventricular dysfunction|ventricular dysfunction
4954038|NCT01842243|MRI|mri
4954039|NCT01842243|Echocardiography|echocardiography
4954040|NCT01842243|Pacemakers|pacemakers
4954041|NCT01842230|Telminuvo|telminuvo
4954042|NCT01842230|Telmisartan|telmisartan
4954043|NCT01842230|S-amlodipine|s-amlodipine
4954044|NCT01842230|Atorvastatin|atorvastatin
4954045|NCT01842230|pharmacokinetics|pharmacokinetics
4954046|NCT01842230|Healthy volunteers|healthy volunteers
4954047|NCT01842217|18F-FES PET|18f-fes pet
4954048|NCT01842217|Nuclear Medicine|nuclear medicine
4954049|NCT01842217|Premenopausal|premenopausal
4954050|NCT01842217|Postmenopausal|postmenopausal
4954051|NCT01842217|Estrogen receptor|estrogen receptor
4954052|NCT01842217|Anxiety|anxiety
4954053|NCT01842217|Depression|depression
4954054|NCT01842217|Cognition|cognition
4954055|NCT01842204|inguinal hernia|inguinal hernia
4954056|NCT01842191|R-R MS|r-r ms
4954057|NCT01842165|Peptide Receptor Radionuclide Therapy (PRRT)|peptide receptor radionuclide therapy (prrt)
4954058|NCT01842165|Neuroendocrine Tumors|neuroendocrine tumors
4954059|NCT01842126|Sciatica|sciatica
4954060|NCT01842100|Induced abortion|induced abortion
4954061|NCT01842100|Postaboral pelvic inflammatory disease|postaboral pelvic inflammatory disease
4954062|NCT01842100|Sexually transmitted infections|sexually transmitted infections
4954063|NCT01842100|Universal antibiotic prophylaxis|universal antibiotic prophylaxis
4954064|NCT01842100|Screen-and-treat approach|screen-and-treat approach
4954065|NCT01842087|Chronic Kidney Disease|chronic kidney disease
4954066|NCT01842087|Fiber|fiber
4954067|NCT01842087|BUN|bun
4954068|NCT01842087|Serum Creatinine|serum creatinine
4954069|NCT01842087|Uremic Symptoms|uremic symptoms
4954070|NCT01842087|Quality of Life|quality of life
4954071|NCT01842074|bortezomib|bortezomib
4954072|NCT01842074|desensitization|desensitization
4954073|NCT01842074|living kidney transplantation|living kidney transplantation
4954074|NCT01842061|active living|active living
4954075|NCT01842061|retirement|retirement
4954076|NCT01842048|External-beam radiotherapy|external-beam radiotherapy
4954077|NCT01842048|Hyperthermia|hyperthermia
4954078|NCT01842035|Implantable cardiac defibrillator|implantable cardiac defibrillator
4954079|NCT01842035|regadenoson|regadenoson
4954080|NCT01842035|sudden cardiac death|sudden cardiac death
4954081|NCT01842035|heart rate response|heart rate response
4954082|NCT01842022|Glycemic load|glycemic load
4954083|NCT01842022|memory|memory
4954084|NCT01842022|mood|mood
4954085|NCT01842009|transcranial stimulation|transcranial stimulation
4954086|NCT01842009|direct current|direct current
4954087|NCT01841983|Total worker health|total worker health
4954088|NCT01841983|Sleep|sleep
4954089|NCT01841983|MSDs|msds
4954090|NCT01841983|Diet|diet
4954091|NCT01841983|Physical Activity|physical activity
4954092|NCT01841957|Bilateral Cataract|bilateral cataract
4954093|NCT01841957|Simultaneous Cataract Surgery|simultaneous cataract surgery
4954094|NCT01841957|ISBCS|isbcs
4954095|NCT01841944|Fatty Acids, Omega-3|fatty acids, omega-3
4954096|NCT01841944|Aged|aged
4954097|NCT01841944|Myocardial Infarction|myocardial infarction
4954098|NCT01841931|Opioids|opioids
4954099|NCT01841931|Dependence|dependence
4954100|NCT01841931|Buprenorphine|buprenorphine
4954101|NCT01841931|Pain|pain
4954102|NCT01841905|Alzheimer's Disease|alzheimer's disease
4954103|NCT01841905|Family History|family history
4954104|NCT01841905|Memory Concerns|memory concerns
4954105|NCT01841866|post operative sore throat|post operative sore throat
4954106|NCT01841866|laryngeal mask airway|laryngeal mask airway
4954107|NCT01841866|children|children
4954108|NCT01841853|Elderly|elderly
4954109|NCT01841853|Health promotion|health promotion
4954110|NCT01841853|Randomized controlled study|randomized controlled study
4954111|NCT01841853|Immigrant|immigrant
4954112|NCT01841853|Vulnerable population|vulnerable population
4954113|NCT01841853|ADL|adl
4954114|NCT01841853|KASAM|kasam
4954115|NCT01841853|Implementation|implementation
4954116|NCT01841840|Stroke|stroke
4954117|NCT01841840|Hemiparetic|hemiparetic
4954118|NCT01841840|Passive Vibration|passive vibration
4954119|NCT01841840|Arterial Stiffness|arterial stiffness
4954120|NCT01841840|Pulse Wave Velocity|pulse wave velocity
4954121|NCT01841840|Wave Reflection|wave reflection
4954122|NCT01841840|Body Composition|body composition
4954123|NCT01841840|Autonomic Function|autonomic function
4954124|NCT01841814|Lymphoma|lymphoma
4954125|NCT01841814|Osteoporosis|osteoporosis
4954126|NCT01841814|Chemotherapy|chemotherapy
4954127|NCT01841814|Patient with|patient with
4954128|NCT01841775|Hepatitis C, Chronic|hepatitis c, chronic
4954129|NCT01841775|Genotype 2/3|genotype 2/3
4954130|NCT01841775|Interferon α 2b|interferon α 2b
4954131|NCT01841775|Ribavirin|ribavirin
4954132|NCT01841775|Pharmacovigilance|pharmacovigilance
4954133|NCT01841762|PAH-SYMPACT|pah-sympact
4954134|NCT01841762|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
4954135|NCT01841762|psychometric instrument|psychometric instrument
4954136|NCT01841749|Breast cancer|breast cancer
4954137|NCT01841710|Bitter Taste|bitter taste
4954138|NCT01841710|Pediatric Medications|pediatric medications
4954139|NCT01841697|Diabetes Mellitus|diabetes mellitus
4954140|NCT01841697|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
4954141|NCT01841697|Glucose Metabolism Disorders|glucose metabolism disorders
4954142|NCT01841697|Metabolic Diseases|metabolic diseases
4954143|NCT01841697|Endocrine System Diseases|endocrine system diseases
4954144|NCT01841697|Glimepiride|glimepiride
4954145|NCT01841697|Metformin|metformin
4954146|NCT01841697|Hypoglycemic Agents|hypoglycemic agents
4954147|NCT01841697|Physiological Effects of Drugs|physiological effects of drugs
4954148|NCT01841697|Pharmacologic Actions|pharmacologic actions
4954149|NCT01841684|HoFH|hofh
4954150|NCT01841671|Polio|polio
4954151|NCT01841671|IPV|ipv
4954152|NCT01841671|bOPV|bopv
4954153|NCT01841671|mOPV|mopv
4954154|NCT01841671|vaccination|vaccination
4954155|NCT01841658|Folate Status|folate status
4954156|NCT01841658|Folate Biomarkers|folate biomarkers
4954157|NCT01841645|CLA-enriched butter|cla-enriched butter
4954158|NCT01841645|CLA metabolism|cla metabolism
4954159|NCT01841645|inflammation|inflammation
4954160|NCT01841632|Liver transplantation|liver transplantation
4954161|NCT01841632|Allogeneic liver transplantation|allogeneic liver transplantation
4954162|NCT01841632|Solid organ transplantation|solid organ transplantation
4954163|NCT01841619|skin, lupus, intravenous immunoglobulin, ivig|skin, lupus, intravenous immunoglobulin, ivig
4954164|NCT01841606|Spinal anesthesia|spinal anesthesia
4954165|NCT01841606|Elective cesarean deliveries|elective cesarean deliveries
4954166|NCT01841606|Ondansetron|ondansetron
4954167|NCT01841580|Tear proteins profiles|tear proteins profiles
4954168|NCT01841580|Longitudinal|longitudinal
4954169|NCT01841580|Ocular surface damage|ocular surface damage
4954170|NCT01841580|Trabeculectomy|trabeculectomy
4954171|NCT01841567|hip|hip
4954172|NCT01841567|knee|knee
4954173|NCT01841554|Mitral Valve|mitral valve
4954174|NCT01841554|Annuloplasty|annuloplasty
4954175|NCT01841541|Tuberculosis|tuberculosis
4954176|NCT01841541|Informal providers|informal providers
4954177|NCT01841541|Informal carers|informal carers
4954178|NCT01841541|Barriers to health system|barriers to health system
4954179|NCT01841528|Polycystic Ovary Syndrome|polycystic ovary syndrome
4954180|NCT01841528|Infertility|infertility
4954181|NCT01841528|In-vitro fertilization|in-vitro fertilization
4954182|NCT01841528|fresh embryo transfer|fresh embryo transfer
4954183|NCT01841528|frozen-thawed embryo transfer|frozen-thawed embryo transfer
4954186|NCT01841502|interaction|interaction
4954187|NCT01841502|pharmacokinetics|pharmacokinetics
4954188|NCT01841489|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
4954189|NCT01841489|CLL|cll
4954190|NCT01841476|Peripheral blood|peripheral blood
4954191|NCT01841476|HSC|hsc
4954192|NCT01841476|Mobilization|mobilization
4954193|NCT01841476|CXCR4|cxcr4
4954194|NCT01841476|volunteers|volunteers
4954195|NCT01841463|Malignant Melanoma|malignant melanoma
4954196|NCT01841450|Primary open-angle glaucoma (POAG)|primary open-angle glaucoma (poag)
4954197|NCT01841450|Trabecular meshwork|trabecular meshwork
4954198|NCT01841450|iStent|istent
4954199|NCT01841437|Primary open-angle glaucoma (POAG)|primary open-angle glaucoma (poag)
4954200|NCT01841437|Trabecular meshwork|trabecular meshwork
4954201|NCT01841437|iStent|istent
4954202|NCT01841424|dietary counseling|dietary counseling
4954203|NCT01841424|food diary|food diary
4954204|NCT01841424|obesity|obesity
4954205|NCT01841424|pregnancy|pregnancy
4954206|NCT01841424|weight gain|weight gain
4954207|NCT01841411|bacterial vaginosis, recurrence, N-Acetyl cysteine|bacterial vaginosis, recurrence, n-acetyl cysteine
4954208|NCT01841398|Cardiovascular|cardiovascular
4954209|NCT01841398|Prevention|prevention
4954210|NCT01841398|Ethnicity|ethnicity
4954211|NCT01841398|Culture|culture
4954212|NCT01841398|Internet|internet
4954213|NCT01841398|Text Message|text message
4954214|NCT01841385|Exercise|exercise
4954215|NCT01841385|spirometry|spirometry
4954216|NCT01841385|muscle strength|muscle strength
4954217|NCT01841385|physical therapy modalities|physical therapy modalities
4954218|NCT01841372|Obesity|obesity
4954219|NCT01841372|Overweight|overweight
4954220|NCT01841372|Weight Maintenance|weight maintenance
4954221|NCT01841359|Hypoglycemia|hypoglycemia
4954222|NCT01841359|Gastric bypass surgery|gastric bypass surgery
4954223|NCT01841346|Outcome after PCI|outcome after pci
4954224|NCT01841346|Middle Eastern Patients|middle eastern patients
4954225|NCT01841333|Lymphoblastic leukemia in remission|lymphoblastic leukemia in remission
4954226|NCT01841333|Myeloid leukemia in remission|myeloid leukemia in remission
4954227|NCT01841333|Recurrent lymphoblastic leukemia|recurrent lymphoblastic leukemia
4954228|NCT01841333|Recurrent myeloid leukemia|recurrent myeloid leukemia
4954229|NCT01841281|Asthma|asthma
4954230|NCT01841281|Severe Asthma|severe asthma
4954231|NCT01841268|premature, preterm, premie, skin|premature, preterm, premie, skin
4954232|NCT01841255|Preoxygenation|preoxygenation
4954233|NCT01841255|Device|device
4954234|NCT01841255|Tolerability|tolerability
4954235|NCT01841255|Efficacy|efficacy
4954236|NCT01841242|Infection|infection
4954237|NCT01841242|Cardiac Resynchronization Device|cardiac resynchronization device
4954238|NCT01841242|Heart Failure|heart failure
4954239|NCT01841216|Gluteus Maximus|gluteus maximus
4954240|NCT01841216|Gluteus Medius|gluteus medius
4954241|NCT01841216|TFL|tfl
4954242|NCT01841216|EMG|emg
4954243|NCT01841216|Perceived Exertion|perceived exertion
4954244|NCT01841216|Thera-Band|thera-band
4954245|NCT01841203|Diagnosis|diagnosis
4954246|NCT01841203|Rapid tests|rapid tests
4954247|NCT01841203|non-treponemal serology|non-treponemal serology
4954248|NCT01841203|eradication|eradication
4954249|NCT01841190|Prognosis|prognosis
4954250|NCT01841190|Sepsis|sepsis
4954251|NCT01841190|Septic shock|septic shock
4954252|NCT01841190|Procalcitonin|procalcitonin
4954253|NCT01841190|SOFA|sofa
4954254|NCT01841177|Congenital Heart Disease|congenital heart disease
4954255|NCT01841177|Pediatrics|pediatrics
4954256|NCT01841177|Milrinone|milrinone
4954257|NCT01841177|Cardiopulmonary Bypass|cardiopulmonary bypass
4954258|NCT01841177|Therapeutic Drug Monitoring|therapeutic drug monitoring
4954259|NCT01841164|Leukotriene responsiveness|leukotriene responsiveness
4954260|NCT01841164|LTE4|lte4
4954261|NCT01841164|asthma|asthma
4954262|NCT01841164|airway hyperresponsiveness|airway hyperresponsiveness
4954263|NCT01841164|bronchoprovocation|bronchoprovocation
4954264|NCT01841164|anti-asthmatic agents|anti-asthmatic agents
4954265|NCT01841164|human|human
4954266|NCT01841151|AD/HD in Children and Adolescents|ad/hd in children and adolescents
4954267|NCT01841138|colonoscopy|colonoscopy
4954268|NCT01841138|bowel preparation|bowel preparation
4954269|NCT01841138|electrolytes|electrolytes
4954270|NCT01841138|osmolality|osmolality
4954271|NCT01841138|water|water
4954272|NCT01841125|Alzheimer's Disease|alzheimer's disease
4954273|NCT01841125|depressive disorder|depressive disorder
4954274|NCT01841073|Prediabetes|prediabetes
4954275|NCT01841073|Fermentable carbohydrate|fermentable carbohydrate
4954276|NCT01841073|Appetite|appetite
4954277|NCT01841073|Glucose homeostasis|glucose homeostasis
4954278|NCT01841073|Weight management|weight management
4954279|NCT01841060|Malignant Non-small Cell Neoplasm of Lung|malignant non-small cell neoplasm of lung
4954280|NCT01841047|Retroperitoneal liposarcoma operable|retroperitoneal liposarcoma operable
4954281|NCT01841034|Male|male
4954282|NCT01841021|Peripheral T-Cell Lymphoma (PTCL)|peripheral t-cell lymphoma (ptcl)
4954283|NCT01841021|Relapsed|relapsed
4954284|NCT01841021|Refractory|refractory
4954285|NCT01841021|CD30 Receptor|cd30 receptor
4954286|NCT01841021|Large B-Cell Lymphoma|large b-cell lymphoma
4954287|NCT01841008|[C17.800.621]|[c17.800.621]
4954288|NCT01840995|stellate ganglion block|stellate ganglion block
4954289|NCT01840982|Mixed grains|mixed grains
4954290|NCT01840982|Glycemic index|glycemic index
4954291|NCT01840982|Giant embryonic brown rice|giant embryonic brown rice
4954292|NCT01840982|Giant embryonic rice|giant embryonic rice
4954293|NCT01840982|diabetes|diabetes
4954294|NCT01840969|off-pump coronary artery bypass surgery|off-pump coronary artery bypass surgery
4954295|NCT01840969|common carotid artery|common carotid artery
4954296|NCT01840969|speckle tracking analysis|speckle tracking analysis
4954297|NCT01840969|peak strain|peak strain
4954298|NCT01840956|End-stage Renal Disease|end-stage renal disease
4954299|NCT01840956|Hemodialysis|hemodialysis
4954300|NCT01840956|Chronic Renal Insufficiency|chronic renal insufficiency
4954301|NCT01840956|Renal Dialysis|renal dialysis
4954302|NCT01840956|Hemodiafiltration|hemodiafiltration
4954303|NCT01840956|Blood Vessel Prosthesis|blood vessel prosthesis
4954304|NCT01840956|Tissue-Engineered Vascular Graft|tissue-engineered vascular graft
4954305|NCT01840956|Vascular Prosthesis Implantation|vascular prosthesis implantation
4954306|NCT01840956|Kidney Diseases|kidney diseases
4954307|NCT01840956|Kidney Failure, Chronic|kidney failure, chronic
4954308|NCT01840956|Renal Insufficiency|renal insufficiency
4954309|NCT01840956|Urologic Diseases|urologic diseases
4954310|NCT01840943|Epithelial ovarian cancer|epithelial ovarian cancer
4954311|NCT01840943|Recurrent epithelial ovarian carcinoma|recurrent epithelial ovarian carcinoma
4954312|NCT01840943|Carcinoma|carcinoma
4954313|NCT01840943|Malignancy|malignancy
4954314|NCT01840943|Ovarian carcinoma|ovarian carcinoma
4954315|NCT01840943|CAELYX|caelyx
4954316|NCT01840943|Topotecan hydrochloride|topotecan hydrochloride
4954317|NCT01840943|Topotecan|topotecan
4954318|NCT01840943|Platinum-based regimen chemotherapy|platinum-based regimen chemotherapy
4954319|NCT01840943|Chinese patients|chinese patients
4954320|NCT01840930|Cohort|cohort
4954321|NCT01840930|Cerebral Palsy|cerebral palsy
4954322|NCT01840930|Children|children
4954323|NCT01840930|Pain|pain
4954324|NCT01840930|Orthopedic complications|orthopedic complications
4954325|NCT01840930|Epidemiology|epidemiology
4954326|NCT01840865|young healthy subjects|young healthy subjects
4954327|NCT01840865|brain stimulation|brain stimulation
4954328|NCT01840865|tSOS|tsos
4954329|NCT01840865|tDCS|tdcs
4954330|NCT01840865|sleep|sleep
4954331|NCT01840865|daytime sleep|daytime sleep
4954332|NCT01840865|nap|nap
4954333|NCT01840865|memory|memory
4954334|NCT01840865|memory consolidation|memory consolidation
4954335|NCT01840839|aging|aging
4954336|NCT01840839|cognitive decline|cognitive decline
4954337|NCT01840839|brain stimulation|brain stimulation
4954338|NCT01840839|tSOS|tsos
4954339|NCT01840839|tDCS|tdcs
4954340|NCT01840839|sleep|sleep
4954341|NCT01840839|nap|nap
4954342|NCT01840839|daytime sleep|daytime sleep
4954343|NCT01840839|memory|memory
4954344|NCT01840839|memory consolidation|memory consolidation
4954345|NCT01840826|Rehospitalization|rehospitalization
4954346|NCT01840826|Reutilization|reutilization
4954347|NCT01840826|Depressive Symptoms|depressive symptoms
4954348|NCT01840826|Pharmacotherapy|pharmacotherapy
4954349|NCT01840826|Cognitive Therapy|cognitive therapy
4954350|NCT01840826|Self-help|self-help
4954351|NCT01840826|Complementary Therapies|complementary therapies
4954352|NCT01840813|Intraumbilical misoprostol|intraumbilical misoprostol
4954353|NCT01840813|Retained placenta|retained placenta
4954354|NCT01840813|Active management of third stage of labour|active management of third stage of labour
4954355|NCT01840800|Postoperative pain|postoperative pain
4954356|NCT01840800|anterior cruciate ligament reconstruction|anterior cruciate ligament reconstruction
4954357|NCT01840800|ultrasound guided nerve blocks|ultrasound guided nerve blocks
4954358|NCT01840800|opioid consumption|opioid consumption
4954359|NCT01840761|delayed vasospasm,|delayed vasospasm,
4954360|NCT01840761|medicine,|medicine,
4954361|NCT01840761|standardization|standardization
4954362|NCT01840735|CF|cf
4954363|NCT01840735|Cystic Fibrosis|cystic fibrosis
4954364|NCT01840735|PK|pk
4954365|NCT01840722|HIV|hiv
4954366|NCT01840722|HCV|hcv
4954367|NCT01840722|Substance abuse|substance abuse
4954368|NCT01840722|women|women
4954369|NCT01840709|Systemic lupus erythematosus|systemic lupus erythematosus
4954370|NCT01840709|Psychotherapy|psychotherapy
4954371|NCT01840683|Age-Related Macular Degeneration (AMD)|age-related macular degeneration (amd)
4954372|NCT01840683|Age Related Eye Disease Study (AREDS)|age related eye disease study (areds)
4954373|NCT01840683|Best-Corrected Visual Acuity (BCVA)|best-corrected visual acuity (bcva)
4954374|NCT01840683|Early Treatment Diabetic Retinopathy Study (ETDRS)|early treatment diabetic retinopathy study (etdrs)
4954375|NCT01840683|Heparin-Induced Extracorporeal LDL-Cholesterol Precipitation (HELP)|heparin-induced extracorporeal ldl-cholesterol precipitation (help)
4954376|NCT01840683|Visual Function Questionnaire (VFQ)|visual function questionnaire (vfq)
4954377|NCT01840670|Inferior Vena Cava|inferior vena cava
4954378|NCT01840670|Central Venous Pressure|central venous pressure
4954379|NCT01840670|Abdominal Pressure|abdominal pressure
4954380|NCT01840657|CMDIR (Congenital Muscle Disease International Registry)|cmdir (congenital muscle disease international registry)
4954381|NCT01840657|X-linked myotubular myopathy|x-linked myotubular myopathy
4954382|NCT01840657|centronuclear myopathy|centronuclear myopathy
4954383|NCT01840657|myotubularin|myotubularin
4954384|NCT01840657|MTM1 gene|mtm1 gene
4954385|NCT01840657|mutation|mutation
4954386|NCT01840657|survival|survival
4954387|NCT01840657|adverse event|adverse event
4954388|NCT01840657|disease complication|disease complication
4954389|NCT01840657|hospital admission|hospital admission
4954390|NCT01840657|emergency room visit|emergency room visit
4954391|NCT01840657|motor function|motor function
4954392|NCT01840657|respiratory function|respiratory function
4954393|NCT01840657|natural history study|natural history study
4954394|NCT01840631|Obesity|obesity
4954395|NCT01840631|Nutritional counseling|nutritional counseling
4954396|NCT01840631|Physical activity|physical activity
4954397|NCT01840631|Food diary|food diary
4954398|NCT01840618|insulin function|insulin function
4954399|NCT01840618|sleep apnea|sleep apnea
4954400|NCT01840618|girls|girls
4954401|NCT01840618|PCOS|pcos
4954402|NCT01840618|insulin action|insulin action
4954403|NCT01840592|Liver|liver
4954404|NCT01840592|Sorafenib|sorafenib
4954405|NCT01840592|Doxorubicin|doxorubicin
4954406|NCT01840592|12-259|12-259
4954407|NCT01840566|Relapsed|relapsed
4954408|NCT01840566|Refractory|refractory
4954409|NCT01840566|Autologous Stem Cell Transplantation|autologous stem cell transplantation
4954410|NCT01840566|HIGH DOSE CHEMOTHERAPY|high dose chemotherapy
4954411|NCT01840566|19-28z T cells/kg|19-28z t cells/kg
4954412|NCT01840566|12-117|12-117
4954413|NCT01840540|renal artery stenosis|renal artery stenosis
4954414|NCT01840540|renovascular hypertension|renovascular hypertension
4954415|NCT01840540|ischemic nephropathy|ischemic nephropathy
4954416|NCT01840540|chronic kidney disease|chronic kidney disease
4954417|NCT01840527|Biomarker|biomarker
4954418|NCT01840527|BRAF|braf
4954419|NCT01840527|blood-based|blood-based
4954420|NCT01840514|recipient|recipient
4954421|NCT01840501|Healthy|healthy
4954422|NCT01840501|JNJ-42721458|jnj-42721458
4954423|NCT01840501|Male|male
4954424|NCT01840501|Safety|safety
4954425|NCT01840501|Tolerability|tolerability
4954426|NCT01840501|Pharmacokinetics|pharmacokinetics
4954427|NCT01840501|Pharmacodynamics|pharmacodynamics
4954428|NCT01840501|Immunogenicity|immunogenicity
4954429|NCT01840436|MUCIPLIQ|mucipliq
4954430|NCT01840436|Matrix therapy|matrix therapy
4954431|NCT01840436|RGTA|rgta
4954432|NCT01840436|Oral mucositis|oral mucositis
4954433|NCT01840423|First in man study|first in man study
4954434|NCT01840423|Volunteer study|volunteer study
4954435|NCT01840410|Vision Impairment|vision impairment
4954436|NCT01840410|Abnormal growth of blood vessels|abnormal growth of blood vessels
4954437|NCT01840397|S-100B|s-100b
4954438|NCT01840397|NSE|nse
4954439|NCT01840384|Healthy infants|healthy infants
4954440|NCT01840384|Anemia, iron-deficiency|anemia, iron-deficiency
4954441|NCT01840371|ERCP|ercp
4954442|NCT01840371|Sedation|sedation
4954443|NCT01840371|Fentanyl|fentanyl
4954444|NCT01840371|Propofol|propofol
4954445|NCT01840358|Hypoglycemias|hypoglycemias
4954446|NCT01840358|Insulin pump|insulin pump
4954447|NCT01840358|Children|children
4954448|NCT01840345|uncontrolled|uncontrolled
4954449|NCT01840345|neuropathic pain|neuropathic pain
4954450|NCT01840332|thyroid cancer|thyroid cancer
4954451|NCT01840280|carcinoma|carcinoma
4954452|NCT01840280|colorectal cancer|colorectal cancer
4954453|NCT01840280|ambulant chemotherapy|ambulant chemotherapy
4954454|NCT01840280|treatment cycles|treatment cycles
4954455|NCT01840280|Irinotecan|irinotecan
4954456|NCT01840280|Irinotecan onkovis|irinotecan onkovis
4954457|NCT01840280|Quantity of Irinotecan|quantity of irinotecan
4954458|NCT01840280|Packaging Sizes|packaging sizes
4954459|NCT01840267|pneumoperitoneum|pneumoperitoneum
4954460|NCT01840267|pediatric laparoscopy|pediatric laparoscopy
4954461|NCT01840267|optic nerve sheath diameter|optic nerve sheath diameter
4954462|NCT01840267|intracranial pressure|intracranial pressure
4954463|NCT01840254|PONV|ponv
4954464|NCT01840254|IV PCA|iv pca
4954465|NCT01840254|dexmedetomidine|dexmedetomidine
4954466|NCT01840254|Female|female
4954467|NCT01840254|non-smoking|non-smoking
4954468|NCT01840254|lumbar spine surgery|lumbar spine surgery
4954469|NCT01840241|sodium bicarbonate|sodium bicarbonate
4954470|NCT01840241|acute kidney injury|acute kidney injury
4954471|NCT01840241|OPCAB|opcab
4954472|NCT01840228|Preterm|preterm
4954473|NCT01840228|Progesterone|progesterone
4954474|NCT01840189|Addison disease|addison disease
4954475|NCT01840189|Type 1 diabetes|type 1 diabetes
4954476|NCT01840189|treatment|treatment
4954477|NCT01840176|McCall culdoplasty|mccall culdoplasty
4954478|NCT01840176|Total laparoscopic hysterectomy|total laparoscopic hysterectomy
4954479|NCT01840176|Vaginal vault prolapse|vaginal vault prolapse
4954480|NCT01840176|Sexual function|sexual function
4954481|NCT01840124|Fibroids|fibroids
4954482|NCT01840124|Radiofrequency ablation|radiofrequency ablation
4954483|NCT01840111|smoking environment|smoking environment
4954484|NCT01840111|cue-exposure|cue-exposure
4954485|NCT01840111|cigarettes|cigarettes
4954486|NCT01840111|nicotine|nicotine
4954487|NCT01840111|fMRI|fmri
4954488|NCT01840085|Diabetic foot ulcer|diabetic foot ulcer
4954489|NCT01840085|plantar neuropathic ulcer|plantar neuropathic ulcer
4954490|NCT01840085|plantar neuroischemic ulcer|plantar neuroischemic ulcer
4954491|NCT01840085|Wagner Grade 1 or Grade 2 DFU|wagner grade 1 or grade 2 dfu
4954492|NCT01840072|Ischemic stroke|ischemic stroke
4954493|NCT01840072|Hypertension|hypertension
4954494|NCT01840072|Antihypertensive Agents|antihypertensive agents
4954495|NCT01840072|Randomized Controlled Trial|randomized controlled trial
4954496|NCT01840059|Cardiac Failure|cardiac failure
4954497|NCT01840059|Autonomic Denervation|autonomic denervation
4954498|NCT01840020|bariatric surgery|bariatric surgery
4954499|NCT01840020|alcohol drinking|alcohol drinking
4954500|NCT01840020|alcoholism|alcoholism
4954501|NCT01840020|ethanol|ethanol
4954502|NCT01840020|metabolism|metabolism
4954503|NCT01839994|prostate cancer,|prostate cancer,
4954504|NCT01839994|high-dose-rate brachytherapy boost,|high-dose-rate brachytherapy boost,
4954505|NCT01839994|stereotactic body radiotherapy boost,|stereotactic body radiotherapy boost,
4954506|NCT01839994|conformal radiotherapy,|conformal radiotherapy,
4954507|NCT01839994|randomized trial|randomized trial
4954508|NCT01839942|Hernia, Ventral|hernia, ventral
4954509|NCT01839929|tacrolimus|tacrolimus
4954510|NCT01839929|immunosuppressant|immunosuppressant
4954511|NCT01839929|FK506|fk506
4954512|NCT01839903|Smoking|smoking
4954513|NCT01839903|Tobacco|tobacco
4954514|NCT01839903|Emergency Department|emergency department
4954515|NCT01839890|Paclitaxel|paclitaxel
4954516|NCT01839890|stent|stent
4954517|NCT01839890|Acute infarction|acute infarction
4954518|NCT01839890|Systolic time elevation|systolic time elevation
4954519|NCT01839877|Metastatic colorectal Cancer|metastatic colorectal cancer
4954520|NCT01839864|Promotoras|promotoras
4954521|NCT01839864|Hispanic Adults|hispanic adults
4954522|NCT01839864|metabolic syndrome|metabolic syndrome
4954523|NCT01839864|rural|rural
4954524|NCT01839864|patient attitudes|patient attitudes
4954525|NCT01839864|provider cultural competency|provider cultural competency
4954526|NCT01839864|patient activation measure|patient activation measure
4954527|NCT01839851|Hair cortisol|hair cortisol
4954528|NCT01839851|asthma|asthma
4954529|NCT01839851|allergic rhinitis|allergic rhinitis
4954530|NCT01839851|inhaled corticosteroids|inhaled corticosteroids
4954531|NCT01839851|intranasal glucocorticoids|intranasal glucocorticoids
4954532|NCT01839838|Women|women
4954533|NCT01839838|age 50 and above|age 50 and above
4954534|NCT01839838|with|with
4954535|NCT01839838|that has been|that has been
4954536|NCT01839838|surgically excised|surgically excised
4954537|NCT01839825|elderly|elderly
4954538|NCT01839825|fall|fall
4954539|NCT01839825|acute illness|acute illness
4954540|NCT01839825|care giver|care giver
4954541|NCT01839812|Cardiopulmonary bypass|cardiopulmonary bypass
4954542|NCT01839812|Cortisol|cortisol
4954543|NCT01839812|Dexamethasone|dexamethasone
4954544|NCT01839799|Patients|patients
4954545|NCT01839799|with|with
4954546|NCT01839799|resected|resected
4954547|NCT01839786|Pulmonary Hypertension|pulmonary hypertension
4954548|NCT01839786|Doppler|doppler
4954549|NCT01839786|Valsalva|valsalva
4954550|NCT01839773|Stomach Neoplasms|stomach neoplasms
4954551|NCT01839773|Cancer of Stomach|cancer of stomach
4954552|NCT01839773|Gastric Cancer|gastric cancer
4954553|NCT01839773|Gastric Neoplasms|gastric neoplasms
4954554|NCT01839773|Neoplasms, Gastric|neoplasms, gastric
4954555|NCT01839773|Neoplasms, Stomach|neoplasms, stomach
4954556|NCT01839773|Stomach Cancer|stomach cancer
4954557|NCT01839773|paclitaxel|paclitaxel
4954558|NCT01839773|Taxol|taxol
4954559|NCT01839760|Influenza|influenza
4954560|NCT01839760|Virus|virus
4954561|NCT01839760|Viral shedding|viral shedding
4954562|NCT01839760|Epidemiology|epidemiology
4954563|NCT01839747|Pediatric|pediatric
4954564|NCT01839734|CD4+|cd4+
4954565|NCT01839721|Probiotics|probiotics
4954566|NCT01839721|radiation-induced enteritis|radiation-induced enteritis
4954567|NCT01839721|radiation-induced diarrhea|radiation-induced diarrhea
4954568|NCT01839721|radiation, diarrhea, enteritis|radiation, diarrhea, enteritis
4954569|NCT01839721|diet|diet
4954570|NCT01839721|nutrition|nutrition
4954571|NCT01839708|Intervention|intervention
4954572|NCT01839695|Thoracic Aneurysm|thoracic aneurysm
4954573|NCT01839695|Endovascular Aortic Repair|endovascular aortic repair
4954574|NCT01839695|TEVAR|tevar
4954575|NCT01839682|StabiliT|stabilit
4954576|NCT01839682|Kyphoplasty|kyphoplasty
4954577|NCT01839682|Vertebral|vertebral
4954578|NCT01839682|Compression|compression
4954579|NCT01839682|Fracture|fracture
4954580|NCT01839682|Osteoporosis|osteoporosis
4954581|NCT01839669|conservative therapy|conservative therapy
4954582|NCT01839669|Foot-Function-Index|foot-function-index
4954583|NCT01839669|functional movement changes|functional movement changes
4954584|NCT01839669|non-surgical treatment|non-surgical treatment
4954585|NCT01839669|pes planovalgus|pes planovalgus
4954586|NCT01839669|posterior tibial tendon dysfunction|posterior tibial tendon dysfunction
4954587|NCT01839656|Spinal Muscular Atrophy|spinal muscular atrophy
4954588|NCT01839656|SMA|sma
4954589|NCT01839656|SMN|smn
4954590|NCT01839656|SMNRx|smnrx
4954591|NCT01839656|ISIS-SMNRx|isis-smnrx
4954592|NCT01839656|ISIS 396443|isis 396443
4954593|NCT01839656|IONIS-SMNRx|ionis-smnrx
4954594|NCT01839656|Spinraza|spinraza
4954595|NCT01839656|Nusinersen|nusinersen
4954596|NCT01839643|pharmacokinetic|pharmacokinetic
4954597|NCT01839630|Sorafenib|sorafenib
4954598|NCT01839630|Hepatocellular cancer|hepatocellular cancer
4954599|NCT01839630|TACE combination|tace combination
4954600|NCT01839630|Treatment pattern|treatment pattern
4954601|NCT01839630|Safety|safety
4954602|NCT01839630|Effectiveness|effectiveness
4954603|NCT01839617|parenteral nutrition|parenteral nutrition
4954604|NCT01839617|early nutrition|early nutrition
4954605|NCT01839617|abdominal surgery|abdominal surgery
4954606|NCT01839617|cancer|cancer
4954607|NCT01839604|Child-Pugh A to B7,|child-pugh a to b7,
4954608|NCT01839604|Advanced/Metastatic Hepatocellular Carcinoma,|advanced/metastatic hepatocellular carcinoma,
4954609|NCT01839604|AZD9150,|azd9150,
4954610|NCT01839604|Antisense Oligonucleotide Inhibitor of STAT3|antisense oligonucleotide inhibitor of stat3
4954611|NCT01839578|cytokines|cytokines
4954612|NCT01839578|blood purification|blood purification
4954613|NCT01839578|super high flux hemodialysis|super high flux hemodialysis
4954614|NCT01839565|Adverse events|adverse events
4954615|NCT01839565|Osteosynthesis|osteosynthesis
4954616|NCT01839565|Quality of life|quality of life
4954617|NCT01839552|Fentanyl Citrate Nasal Spray (FCNS)|fentanyl citrate nasal spray (fcns)
4954618|NCT01839552|Lazanda|lazanda
4954619|NCT01839552|Breakthrough pain in cancer patients|breakthrough pain in cancer patients
4954620|NCT01839539|colorectal cancer|colorectal cancer
4954621|NCT01839539|DC-CIK|dc-cik
4954622|NCT01839539|CRC|crc
4954623|NCT01839526|Fabry disease|fabry disease
4954624|NCT01839513|Analgesia/nociception index|analgesia/nociception index
4954625|NCT01839513|Desflurane|desflurane
4954626|NCT01839513|Remifentanil|remifentanil
4954627|NCT01839513|Orthopedic surgery|orthopedic surgery
4954628|NCT01839513|Ear-nose-throat surgery|ear-nose-throat surgery
4954629|NCT01839513|Hemodynamic reactivity|hemodynamic reactivity
4954630|NCT01839487|pancreatic ductal carcinoma(PDA)|pancreatic ductal carcinoma(pda)
4954631|NCT01839487|Pancreatic ductal carcinoma|pancreatic ductal carcinoma
4954632|NCT01839487|PEGPH20|pegph20
4954633|NCT01839487|Gemcitabine|gemcitabine
4954634|NCT01839487|Nab-paclitaxel|nab-paclitaxel
4954635|NCT01839474|Continuous Positive Airway Pressure|continuous positive airway pressure
4954636|NCT01839474|Controlled trial|controlled trial
4954637|NCT01839474|Pneumonia|pneumonia
4954638|NCT01839474|Children|children
4954639|NCT01839461|Pharmacogenetics|pharmacogenetics
4954640|NCT01839461|postoperative|postoperative
4954641|NCT01839461|pediatric|pediatric
4954642|NCT01839461|opioid|opioid
4954643|NCT01839461|perioperative|perioperative
4954644|NCT01839461|respiratory depression|respiratory depression
4954645|NCT01839461|chronic pain|chronic pain
4954646|NCT01839448|post partum diabetes|post partum diabetes
4954647|NCT01839448|impaired fasting glucose|impaired fasting glucose
4954648|NCT01839435|appendectomy|appendectomy
4954649|NCT01839435|acute appendicitis|acute appendicitis
4954650|NCT01839435|outpatient|outpatient
4954651|NCT01839409|Circadian Rhythm|circadian rhythm
4954652|NCT01839409|Exercise|exercise
4954653|NCT01839409|Reflex, Vestibular Ocular|reflex, vestibular ocular
4954654|NCT01839409|Postural Balance|postural balance
4954655|NCT01839396|Intrepid, Vercise, PD, DBS, Boston Scientific|intrepid, vercise, pd, dbs, boston scientific
4954656|NCT01839370|Pramlintide|pramlintide
4954657|NCT01839370|Closed Loop|closed loop
4954658|NCT01839370|Continuous Glucose Monitor (CGM)|continuous glucose monitor (cgm)
4954659|NCT01839370|Diabetes Assistant (DiAs)|diabetes assistant (dias)
4954660|NCT01839357|Rivaroxaban|rivaroxaban
4954661|NCT01839357|Oral anticoagulant|oral anticoagulant
4954662|NCT01839357|Nonvalvular atrial fibrillation|nonvalvular atrial fibrillation
4954663|NCT01839357|Left atrial thrombus|left atrial thrombus
4954664|NCT01839357|Transesophageal echocardiography|transesophageal echocardiography
4954665|NCT01839357|Thrombus resolution|thrombus resolution
4954666|NCT01839357|Stroke|stroke
4954667|NCT01839357|Thromboembolism|thromboembolism
4954668|NCT01839344|hyperglycemia|hyperglycemia
4954669|NCT01839344|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
4954670|NCT01839344|endothelial dysfunction|endothelial dysfunction
4954671|NCT01839344|quercetin|quercetin
4954672|NCT01839344|Acarbose|acarbose
4954673|NCT01839344|glucose tolerance|glucose tolerance
4954674|NCT01839344|maltose|maltose
4954675|NCT01839331|osteoarthritis|osteoarthritis
4954676|NCT01839331|osteoarthrisis of the knee|osteoarthrisis of the knee
4954677|NCT01839318|Soft contact lenses|soft contact lenses
4954678|NCT01839318|Daily disposable contact lenses|daily disposable contact lenses
4954679|NCT01839318|Tear Film Break Up Time|tear film break up time
4954680|NCT01839318|Contact lens wettability|contact lens wettability
4954681|NCT01839305|Kinematics|kinematics
4954682|NCT01839305|Fibromyalgia|fibromyalgia
4954683|NCT01839305|Physical Therapy|physical therapy
4954684|NCT01839305|3D Kinematics|3d kinematics
4954685|NCT01839305|Heart Rate Frequency|heart rate frequency
4954686|NCT01839305|Hydrotherapy|hydrotherapy
4954687|NCT01839292|gastric outlet obstruction|gastric outlet obstruction
4954688|NCT01839292|palliative treatment|palliative treatment
4954689|NCT01839292|stent|stent
4954690|NCT01839266|acute PTE, prognostic factors|acute pte, prognostic factors
4954691|NCT01839253|antihypertensive agents|antihypertensive agents
4954692|NCT01839253|hemodynamic|hemodynamic
4954693|NCT01839253|anesthetics reduction|anesthetics reduction
4954694|NCT01839253|orthognathic surgery|orthognathic surgery
4954695|NCT01839227|Post-operative cognitive dysfunction|post-operative cognitive dysfunction
4954696|NCT01839227|regional cerebral oxygen saturation|regional cerebral oxygen saturation
4954697|NCT01839227|elderly|elderly
4954698|NCT01839201|anesthesia|anesthesia
4954699|NCT01839201|modification of dreaming|modification of dreaming
4954700|NCT01839201|suggestions|suggestions
4954701|NCT01839162|Transradial approach|transradial approach
4954702|NCT01839162|shield drape|shield drape
4954703|NCT01839162|radiation|radiation
4954704|NCT01839162|PTCA|ptca
4954705|NCT01839149|Refractory Chronic Migraine|refractory chronic migraine
4954706|NCT01839149|Medically Intractable Chronic Migraine|medically intractable chronic migraine
4954707|NCT01839149|Oxytocin|oxytocin
4954708|NCT01839149|Intranasal oxytocin|intranasal oxytocin
4954709|NCT01839136|Assisted Reproductive Techniques|assisted reproductive techniques
4954710|NCT01839136|Health Services Accessibility|health services accessibility
4954711|NCT01839136|Ovulation Induction|ovulation induction
4954712|NCT01839136|Embryo Transfer|embryo transfer
4954713|NCT01839123|Amputee|amputee
4954714|NCT01839110|pulmonary hypertension|pulmonary hypertension
4954715|NCT01839110|right ventricular function|right ventricular function
4954716|NCT01839110|ranolazine|ranolazine
4954717|NCT01839097|PTCL|ptcl
4954718|NCT01839097|Maximum Tolerated Dose|maximum tolerated dose
4954719|NCT01839097|Belinostat|belinostat
4954720|NCT01839084|Xenon|xenon
4954721|NCT01839084|Isoflurane|isoflurane
4954722|NCT01839084|Anesthetics, Inhalation|anesthetics, inhalation
4954723|NCT01839084|Nephroprotection|nephroprotection
4954724|NCT01839084|Partial nephrectomy|partial nephrectomy
4954725|NCT01839084|Xenon versus Isoflurane anesthesia|xenon versus isoflurane anesthesia
4954726|NCT01839058|Non Cardiac Chest Pain|non cardiac chest pain
4954727|NCT01839045|Woman|woman
4954728|NCT01839045|Breast Cancer|breast cancer
4954729|NCT01839045|Cancer|cancer
4954730|NCT01839045|Mammogram|mammogram
4954731|NCT01839045|Ultrasound|ultrasound
4954732|NCT01839045|Imaging|imaging
4954733|NCT01839045|Biomarkers|biomarkers
4954734|NCT01839045|ACR BI RAD Category 3|acr bi rad category 3
4954735|NCT01839045|ACR BI RAD Category 4|acr bi rad category 4
4954736|NCT01839019|Healthy volunteers|healthy volunteers
4954737|NCT01839006|hydronephrosis|hydronephrosis
4954738|NCT01839006|ultrasonography|ultrasonography
4954739|NCT01839006|Kidney Function Test|kidney function test
4954740|NCT01839006|Patients with unilateral UPJO and patients with preop HN in USG and supranormal renal function in DTPA renography|patients with unilateral upjo and patients with preop hn in usg and supranormal renal function in dtpa renography
4954741|NCT01838993|anesthetics,|anesthetics,
4954742|NCT01838993|local,|local,
4954743|NCT01838993|lidocaine;|lidocaine;
4954744|NCT01838993|nebulizers and vaporizers;|nebulizers and vaporizers;
4954745|NCT01838993|complications,|complications,
4954746|NCT01838993|intubation,|intubation,
4954747|NCT01838993|intratracheal.|intratracheal.
4954748|NCT01838980|Colonoscopy Cleaning|colonoscopy cleaning
4954749|NCT01838967|cilnidipin and valsartn|cilnidipin and valsartn
4954750|NCT01838967|pharmacokinetic drug drug interaction|pharmacokinetic drug drug interaction
4954751|NCT01838967|oral administration|oral administration
4954752|NCT01838967|healthy male subjects|healthy male subjects
4954753|NCT01838954|hand osteoarthritis|hand osteoarthritis
4954754|NCT01838954|short-wave diathermy|short-wave diathermy
4954755|NCT01838941|Peroxisome Biogenesis Disorder|peroxisome biogenesis disorder
4954756|NCT01838941|PBD|pbd
4954757|NCT01838941|neonatal adrenoleukodystrophy|neonatal adrenoleukodystrophy
4954758|NCT01838941|infantile Refsum disease|infantile refsum disease
4954759|NCT01838941|PEX1 mutation|pex1 mutation
4954760|NCT01838941|Betaine|betaine
4954761|NCT01838928|Axillary brachial plexus block|axillary brachial plexus block
4954762|NCT01838928|Ultrasound|ultrasound
4954763|NCT01838928|Minimum effective concentration|minimum effective concentration
4954764|NCT01838928|Bupivacaine|bupivacaine
4954765|NCT01838928|ultrasound-guided axillary brachial plexus block|ultrasound-guided axillary brachial plexus block
4954766|NCT01838915|HIV|hiv
4954767|NCT01838915|immunoactivation|immunoactivation
4954768|NCT01838915|bacterial translocation|bacterial translocation
4954769|NCT01838915|prebiotics|prebiotics
4954770|NCT01838915|glutamine|glutamine
4954771|NCT01838915|microbiota|microbiota
4954772|NCT01838902|Malaria|malaria
4954773|NCT01838902|Falciparum|falciparum
4954774|NCT01838902|Direct membrane feeding|direct membrane feeding
4954775|NCT01838902|QT-NASBA|qt-nasba
4954776|NCT01838902|Asexual parasite|asexual parasite
4954777|NCT01838902|Asymptomatic carrier|asymptomatic carrier
4954778|NCT01838902|Gametocytocidal, Gametocyte|gametocytocidal, gametocyte
4954779|NCT01838902|Transmission blocking|transmission blocking
4954780|NCT01838902|Sexual stage|sexual stage
4954781|NCT01838902|Primaquine|primaquine
4954782|NCT01838902|Dihydroartemisinin|dihydroartemisinin
4954783|NCT01838902|Piperaquine|piperaquine
4954784|NCT01838902|Gambia|gambia
4954785|NCT01838902|Africa|africa
4954786|NCT01838889|Culturally adapted|culturally adapted
4954787|NCT01838889|Group psychological intervention|group psychological intervention
4954788|NCT01838889|British South Asian women|british south asian women
4954789|NCT01838889|CBT|cbt
4954790|NCT01838876|Major Depressive Disorder|major depressive disorder
4954791|NCT01838876|MDD|mdd
4954792|NCT01838876|Depression|depression
4954793|NCT01838863|coagulopathy|coagulopathy
4954794|NCT01838863|hemorrhagic shock|hemorrhagic shock
4954795|NCT01838863|plasma|plasma
4954796|NCT01838863|blood product transfusion|blood product transfusion
4954797|NCT01838824|Processing Speed|processing speed
4954798|NCT01838824|Intervention|intervention
4954799|NCT01838824|Multiple Sclerosis|multiple sclerosis
4954800|NCT01838824|Cognition|cognition
4954801|NCT01838811|Processing Speed|processing speed
4954802|NCT01838811|Intervention|intervention
4954803|NCT01838811|Traumatic Brain Injury|traumatic brain injury
4954804|NCT01838811|Cognition|cognition
4954805|NCT01838798|cognitive disorders|cognitive disorders
4954806|NCT01838798|quality of life|quality of life
4954807|NCT01838798|Intensive care|intensive care
4954808|NCT01838785|18F-DTBZ AV-133 imaging|18f-dtbz av-133 imaging
4954809|NCT01838772|HCV and HIV co-infection|hcv and hiv co-infection
4954810|NCT01838759|Bioimpedance spectroscopy|bioimpedance spectroscopy
4954811|NCT01838759|Hypervolemia|hypervolemia
4954812|NCT01838759|Hypovolemia|hypovolemia
4954813|NCT01838746|Percutaneous coronary intervention|percutaneous coronary intervention
4954814|NCT01838746|Coronary artery bypass grafting|coronary artery bypass grafting
4954815|NCT01838746|Coronary artery bypass surgery|coronary artery bypass surgery
4954816|NCT01838746|Survival|survival
4954817|NCT01838746|Acute coronary syndrome|acute coronary syndrome
4954818|NCT01838746|ST segment elevation myocardial infarction|st segment elevation myocardial infarction
4954819|NCT01838746|Non-ST segment elevation myocardial infarction|non-st segment elevation myocardial infarction
4954820|NCT01838746|Younge patient|younge patient
4954821|NCT01838720|renal cell carcinoma|renal cell carcinoma
4954822|NCT01838720|ischemia|ischemia
4954823|NCT01838720|radio frequency ablation|radio frequency ablation
4954824|NCT01838707|postoperative|postoperative
4954825|NCT01838707|spine surgery|spine surgery
4954826|NCT01838655|Albinism|albinism
4954827|NCT01838655|Nitisinone|nitisinone
4954828|NCT01838655|Melanin|melanin
4954829|NCT01838655|Vision Loss|vision loss
4954830|NCT01838642|Monoclonal Antibody|monoclonal antibody
4954831|NCT01838642|AP24534|ap24534
4954832|NCT01838642|RET Mutation Positive|ret mutation positive
4954833|NCT01838642|RET Mutation Negative|ret mutation negative
4954834|NCT01838642|RET Inhibitor|ret inhibitor
4954835|NCT01838616|Severe chronic low back pain|severe chronic low back pain
4954836|NCT01838616|Neuropathic pain|neuropathic pain
4954837|NCT01838616|Constipation|constipation
4954838|NCT01838590|Liver Diseases|liver diseases
4954839|NCT01838590|Digestive System Diseases|digestive system diseases
4954840|NCT01838590|Hepatitis, Viral, Human|hepatitis, viral, human
4954841|NCT01838590|Virus Diseases|virus diseases
4954842|NCT01838590|Enterovirus Infections|enterovirus infections
4954843|NCT01838590|Picornaviridae Infections|picornaviridae infections
4954844|NCT01838590|RNA Virus Infections|rna virus infections
4954845|NCT01838590|Flaviviridae Infections|flaviviridae infections
4954846|NCT01838590|Antiviral Agents|antiviral agents
4954847|NCT01838590|Anti-Infective Agents|anti-infective agents
4954848|NCT01838590|Therapeutic Uses|therapeutic uses
4954849|NCT01838590|Pharmacologic Actions|pharmacologic actions
4954850|NCT01838590|Antimetabolites|antimetabolites
4954851|NCT01838590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
4954852|NCT01838590|HCV genotype 4 (GT-4)|hcv genotype 4 (gt-4)
4954853|NCT01838590|HCV|hcv
4954854|NCT01838590|Sustained Virologic Response|sustained virologic response
4954855|NCT01838590|Direct Acting Antiviral|direct acting antiviral
4954856|NCT01838590|Combination Therapy|combination therapy
4954857|NCT01838590|GS-7977|gs-7977
4954858|NCT01838590|Ribavirin|ribavirin
4954859|NCT01838590|Open Label|open label
4954860|NCT01838590|Sofosbuvir|sofosbuvir
4954861|NCT01838590|Additional relevant MeSH terms:|additional relevant mesh terms:
4954862|NCT01838590|Hepatitis|hepatitis
4954863|NCT01838590|Hepatitis, Chronic|hepatitis, chronic
4954864|NCT01838590|Hepatitis C|hepatitis c
4954865|NCT01838590|Hepatitis C, Chronic|hepatitis c, chronic
4954866|NCT01838564|Pediatric Advanced Cancer|pediatric advanced cancer
4954867|NCT01838564|Children|children
4954868|NCT01838564|Quality of Life|quality of life
4954869|NCT01838564|Health Information technology|health information technology
4954870|NCT01838564|Patient reported outcomes|patient reported outcomes
4954871|NCT01838525|sepsis|sepsis
4954872|NCT01838525|alpha-1-acid glycoprotein (AGP)|alpha-1-acid glycoprotein (agp)
4954873|NCT01838525|diagnosis|diagnosis
4954874|NCT01838525|prognosis|prognosis
4954875|NCT01838525|SIRS|sirs
4954876|NCT01838486|Interstitial cystitis|interstitial cystitis
4954877|NCT01838486|painful bladder syndrome|painful bladder syndrome
4954878|NCT01838486|bladder hydrodistention|bladder hydrodistention
4954879|NCT01838486|hyperthermia|hyperthermia
4954880|NCT01838473|smokeless tobacco|smokeless tobacco
4954881|NCT01838473|Nicotine|nicotine
4954882|NCT01838473|Cadmium|cadmium
4954883|NCT01838473|lead|lead
4954884|NCT01838473|Tobacco Specific Nitrosamines|tobacco specific nitrosamines
4954885|NCT01838447|Vitamin D|vitamin d
4954886|NCT01838447|Congenital Heart Disease|congenital heart disease
4954887|NCT01838447|Cardiac Surgery|cardiac surgery
4954888|NCT01838447|Pediatrics|pediatrics
4954889|NCT01838447|Phase II Clinical Trial|phase ii clinical trial
4954890|NCT01838408|screening colonoscopy|screening colonoscopy
4954891|NCT01838408|surveillance colonoscopy|surveillance colonoscopy
4954892|NCT01838408|colonoscopy|colonoscopy
4954893|NCT01838395|AML|aml
4954894|NCT01838395|Acute Myeloid Leukemia|acute myeloid leukemia
4954895|NCT01838395|Relapsed Acute Myeloid Leukemia|relapsed acute myeloid leukemia
4954896|NCT01838395|Refractory Acute Myeloid Leukemia|refractory acute myeloid leukemia
4954897|NCT01838382|pain|pain
4954898|NCT01838382|total laparoscopic hysterectomy|total laparoscopic hysterectomy
4954899|NCT01838356|Depression|depression
4954900|NCT01838356|Vascular depression|vascular depression
4954901|NCT01838356|Intracranial atherosclerosis|intracranial atherosclerosis
4954902|NCT01838356|Coronary artery disease|coronary artery disease
4954903|NCT01838356|Coronary artery bypass graft|coronary artery bypass graft
4954904|NCT01838356|Cognitive impairment|cognitive impairment
4954905|NCT01838330|Kidney Disease|kidney disease
4954906|NCT01838330|Fiber|fiber
4954907|NCT01838330|Dietary Intervention|dietary intervention
4954908|NCT01838304|propofol sedation endoscopy|propofol sedation endoscopy
4954909|NCT01838291|Ferriprox|ferriprox
4954910|NCT01838291|Deferiprone|deferiprone
4954911|NCT01838291|DFP|dfp
4954912|NCT01838291|L1|l1
4954913|NCT01838278|Vojta therapy|vojta therapy
4954914|NCT01838278|Exercise Movement Technique|exercise movement technique
4954915|NCT01838278|Early intervention|early intervention
4954916|NCT01838252|Ectropion|ectropion
4954917|NCT01838252|Hyaluronic Acid|hyaluronic acid
4954918|NCT01838252|Keratoconjunctivitis Sicca|keratoconjunctivitis sicca
4954919|NCT01838252|Lower eyelid retraction|lower eyelid retraction
4954920|NCT01838239|Fish oil|fish oil
4954921|NCT01838239|Omega-3 fatty acids|omega-3 fatty acids
4954922|NCT01838226|Chronic Disease|chronic disease
4954923|NCT01838226|Prevention|prevention
4954924|NCT01838226|cardiovascular disease|cardiovascular disease
4954925|NCT01838213|Urinary tract infection|urinary tract infection
4954926|NCT01838213|ESBL|esbl
4954927|NCT01838213|treatment|treatment
4954928|NCT01838213|carriage|carriage
4954929|NCT01838213|risk factors|risk factors
4954930|NCT01838213|water contamination|water contamination
4954931|NCT01838200|BCG|bcg
4954932|NCT01838200|Bacillus Calmette-Guérin|bacillus calmette-guérin
4954933|NCT01838200|Ipilimumab|ipilimumab
4954934|NCT01838200|YERVOY|yervoy
4954935|NCT01838200|Advanced Metastatic Melanoma|advanced metastatic melanoma
4954936|NCT01838200|Metastatic Melanoma|metastatic melanoma
4954937|NCT01838174|Optic Neuritis|optic neuritis
4954938|NCT01838161|adolescents|adolescents
4954939|NCT01838161|immunizations|immunizations
4954940|NCT01838148|coronary artery disease|coronary artery disease
4954941|NCT01838148|angina, stable|angina, stable
4954942|NCT01838148|exercise test|exercise test
4954943|NCT01838148|biological Markers|biological markers
4954944|NCT01838148|SPECT|spect
4954945|NCT01838135|wheelchair|wheelchair
4954946|NCT01838135|manual wheelchair|manual wheelchair
4954947|NCT01838135|rehabilitation|rehabilitation
4954948|NCT01838135|self-efficacy|self-efficacy
4954949|NCT01838135|older adults|older adults
4954950|NCT01838135|feasibility|feasibility
4954951|NCT01838135|intervention|intervention
4954952|NCT01838135|training|training
4954953|NCT01838122|PCOS|pcos
4954954|NCT01838122|HbA1C|hba1c
4954955|NCT01838122|Insulin resistance|insulin resistance
4954956|NCT01838122|OGTT|ogtt
4954957|NCT01838122|HOMA-IR|homa-ir
4954958|NCT01838122|HOMA-B-cell|homa-b-cell
4954959|NCT01838070|Hepatitis A|hepatitis a
4954960|NCT01838070|Hepatitis A vaccine|hepatitis a vaccine
4954961|NCT01838070|AVAXIM 160U|avaxim 160u
4954962|NCT01838031|antenatal thyroid screening|antenatal thyroid screening
4954963|NCT01838031|subclinical hypothyroidism|subclinical hypothyroidism
4954964|NCT01838031|thyroid function|thyroid function
4954965|NCT01838031|thyroid antibody|thyroid antibody
4954966|NCT01838031|pregnancy outcome|pregnancy outcome
4954967|NCT01838031|childhood cognitive function|childhood cognitive function
4954968|NCT01838018|PKAN|pkan
4954969|NCT01838018|brain iron|brain iron
4954970|NCT01838018|NBIA|nbia
4954971|NCT01838018|neurodegeneration with brain iron accumulation|neurodegeneration with brain iron accumulation
4954972|NCT01838018|Hallervorden Spatz Syndrome|hallervorden spatz syndrome
4954973|NCT01838005|Contingency management|contingency management
4954974|NCT01838005|conditional cash transfer|conditional cash transfer
4954975|NCT01838005|PMTCT|pmtct
4954976|NCT01838005|Retention|retention
4954977|NCT01838005|HIV|hiv
4954978|NCT01837979|prenatal testing for fetal aneuploidy|prenatal testing for fetal aneuploidy
4954979|NCT01837979|dried blood spots|dried blood spots
4954980|NCT01837979|cell-free fetal DNA|cell-free fetal dna
4954981|NCT01837979|detection rate|detection rate
4954982|NCT01837979|cost-effectiveness|cost-effectiveness
4954983|NCT01837966|re-operative anxiety|re-operative anxiety
4954984|NCT01837966|breast surgery|breast surgery
4954985|NCT01837966|lavender oil|lavender oil
4954986|NCT01837966|aromatherapy|aromatherapy
4954987|NCT01837927|Efficacy, NVA237, Tiotropium, Chronic Obstructive Pulmonary Disease, COPD|efficacy, nva237, tiotropium, chronic obstructive pulmonary disease, copd
4954988|NCT01837901|transcorneal electrostimulation|transcorneal electrostimulation
4954989|NCT01837888|wheelchair|wheelchair
4954990|NCT01837888|manual wheelchair|manual wheelchair
4954991|NCT01837888|rehabilitation|rehabilitation
4954992|NCT01837888|self-efficacy|self-efficacy
4954993|NCT01837888|older adults|older adults
4954994|NCT01837888|feasibility|feasibility
4954995|NCT01837888|intervention|intervention
4954996|NCT01837888|training|training
4954997|NCT01837888|Wheelchair mobility|wheelchair mobility
4954998|NCT01837875|Intervention|intervention
4954999|NCT01837875|Quality of life|quality of life
4955000|NCT01837875|African American|african american
4955001|NCT01837875|Stress|stress
4955002|NCT01837862|pilomyxoid astrocytoma|pilomyxoid astrocytoma
4955003|NCT01837862|Pilocytic Astrocytoma|pilocytic astrocytoma
4955004|NCT01837862|Glioma|glioma
4955005|NCT01837862|Optic Nerve Glioma|optic nerve glioma
4955006|NCT01837862|mebendazole|mebendazole
4955007|NCT01837862|Pleomorphic Xanthoastrocytoma|pleomorphic xanthoastrocytoma
4955008|NCT01837862|glioblastoma multiforme|glioblastoma multiforme
4955009|NCT01837862|anaplastic astrocytoma|anaplastic astrocytoma
4955010|NCT01837862|gliosarcoma|gliosarcoma
4955011|NCT01837862|diffuse intrinsic pontine glioma|diffuse intrinsic pontine glioma
4955012|NCT01837862|DIPG|dipg
4955013|NCT01837862|low-grade glioma|low-grade glioma
4955014|NCT01837862|high-grade glioma|high-grade glioma
4955015|NCT01837862|brainstem glioma|brainstem glioma
4955016|NCT01837862|pediatric|pediatric
4955017|NCT01837849|heart failure|heart failure
4955018|NCT01837849|rhBNP|rhbnp
4955019|NCT01837849|Dobutamine|dobutamine
4955020|NCT01837836|Health education|health education
4955021|NCT01837836|water handling practices|water handling practices
4955022|NCT01837836|Bacteriological quality of water|bacteriological quality of water
4955023|NCT01837823|Coronary artery disease|coronary artery disease
4955024|NCT01837823|Lipid|lipid
4955025|NCT01837823|Regression|regression
4955026|NCT01837823|Plaque|plaque
4955027|NCT01837810|Post tonsillectomy hemorrhage|post tonsillectomy hemorrhage
4955028|NCT01837810|post operative hemorrhage|post operative hemorrhage
4955029|NCT01837810|complications|complications
4955030|NCT01837810|tonsillectomy|tonsillectomy
4955031|NCT01837758|Platelet function|platelet function
4955032|NCT01837758|hemofiltration|hemofiltration
4955033|NCT01837758|Multiplate|multiplate
4955034|NCT01837732|Chronic pain|chronic pain
4955035|NCT01837732|elderly|elderly
4955036|NCT01837732|relational touch|relational touch
4955037|NCT01837706|Empathy|empathy
4955038|NCT01837706|Communication|communication
4955039|NCT01837706|Physician litigation|physician litigation
4955040|NCT01837693|cervical cancer screening|cervical cancer screening
4955041|NCT01837693|CIN|cin
4955042|NCT01837693|cervical cancer|cervical cancer
4955043|NCT01837693|biomarkers|biomarkers
4955044|NCT01837693|sensitivity and specificity|sensitivity and specificity
4955045|NCT01837680|Insulin, Long-Acting|insulin, long-acting
4955046|NCT01837654|Detrusor Overactivity|detrusor overactivity
4955047|NCT01837654|Plantarflexion|plantarflexion
4955048|NCT01837654|Urgency|urgency
4955049|NCT01837628|Urodynamic|urodynamic
4955050|NCT01837628|Paraffin oil|paraffin oil
4955051|NCT01837628|Lidocaine gel|lidocaine gel
4955052|NCT01837628|Pain|pain
4955053|NCT01837615|Ulcerative Colitis|ulcerative colitis
4955054|NCT01837615|Ulcerative Proctitis|ulcerative proctitis
4955055|NCT01837615|Low Level Light Therapy|low level light therapy
4955056|NCT01837615|Safety|safety
4955057|NCT01837615|Efficacy|efficacy
4955058|NCT01837602|refractory to at least one standard therapy|refractory to at least one standard therapy
4955059|NCT01837602|newly diagnosed|newly diagnosed
4955060|NCT01837602|with operable triple negative breast cancer|with operable triple negative breast cancer
4955061|NCT01837589|Cystic fibrosis-DXA-QCT-Osteopenia- Osteoporosis|cystic fibrosis-dxa-qct-osteopenia- osteoporosis
4955062|NCT01837576|Psoriasis Vulgaris|psoriasis vulgaris
4955063|NCT01837576|Calcipotriol|calcipotriol
4955064|NCT01837576|Betamethasone Dipropionate|betamethasone dipropionate
4955065|NCT01837550|audiologic rehabilitation|audiologic rehabilitation
4955066|NCT01837550|hearing loss|hearing loss
4955067|NCT01837550|patient education|patient education
4955068|NCT01837550|patient participation|patient participation
4955069|NCT01837550|structured rehabilitation|structured rehabilitation
4955070|NCT01837550|counseling|counseling
4955071|NCT01837550|Internet|internet
4955072|NCT01837524|Dietary advice|dietary advice
4955073|NCT01837524|Nutritional knowledge|nutritional knowledge
4955074|NCT01837524|Self-efficacy|self-efficacy
4955075|NCT01837524|Nutrition|nutrition
4955076|NCT01837511|Tumor antigens|tumor antigens
4955077|NCT01837511|Asiatic patients|asiatic patients
4955078|NCT01837511|Reverse Transciptase-Polymerase chain reaction (RT-PCR)|reverse transciptase-polymerase chain reaction (rt-pcr)
4955079|NCT01837511|Non-small cell lung cancer (NSCLC)|non-small cell lung cancer (nsclc)
4955183|NCT01837134|obesity|obesity
4955080|NCT01837498|residual neuromuscular blockade, sugammadex, neostigmine, thoracic surgery|residual neuromuscular blockade, sugammadex, neostigmine, thoracic surgery
4955081|NCT01837485|Irritable bowel syndrome|irritable bowel syndrome
4955082|NCT01837485|Functional gastrointestinal disorders|functional gastrointestinal disorders
4955083|NCT01837485|Gut flora|gut flora
4955084|NCT01837485|Probiotics|probiotics
4955085|NCT01837472|Irritable bowel syndrome|irritable bowel syndrome
4955086|NCT01837472|Functional gastrointestinal disorders|functional gastrointestinal disorders
4955087|NCT01837472|Gut flora|gut flora
4955088|NCT01837472|Probiotics|probiotics
4955089|NCT01837459|Obstructive Sleep Apnea|obstructive sleep apnea
4955090|NCT01837459|Sleep Disordered Breathing|sleep disordered breathing
4955091|NCT01837459|Vascular function|vascular function
4955092|NCT01837459|Arterial stiffness|arterial stiffness
4955093|NCT01837459|Polysomnography|polysomnography
4955094|NCT01837459|Cytokines|cytokines
4955095|NCT01837446|mucositis|mucositis
4955096|NCT01837446|topical morphine|topical morphine
4955098|NCT01837446|head and neck carcinoma|head and neck carcinoma
4955099|NCT01837433|Efficacy|efficacy
4955100|NCT01837433|safety|safety
4955101|NCT01837433|short|short
4955102|NCT01837433|term|term
4955103|NCT01837433|subacute thyroiditis|subacute thyroiditis
4955104|NCT01837407|Soft tissue loss|soft tissue loss
4955105|NCT01837407|nerve defect|nerve defect
4955106|NCT01837407|dorsal branch of the proper digital nerve|dorsal branch of the proper digital nerve
4955107|NCT01837407|heterodigital arterialized nerve pedicle flap|heterodigital arterialized nerve pedicle flap
4955108|NCT01837407|Composite Flap|composite flap
4955109|NCT01837407|nerve flap|nerve flap
4955110|NCT01837407|nerve transfer|nerve transfer
4955111|NCT01837394|Nerve block|nerve block
4955112|NCT01837394|Ultrasound|ultrasound
4955113|NCT01837394|postoperative pain|postoperative pain
4955114|NCT01837394|Saphenous nerve|saphenous nerve
4955115|NCT01837394|Obturator nerve|obturator nerve
4955116|NCT01837329|Non-Squamous|non-squamous
4955117|NCT01837329|NSCLC|nsclc
4955118|NCT01837329|Adenocarcinoma|adenocarcinoma
4955119|NCT01837329|Lung Cancer|lung cancer
4955120|NCT01837329|Tetrathiomolybdate|tetrathiomolybdate
4955121|NCT01837329|Copper|copper
4955122|NCT01837329|Carboplatin|carboplatin
4955123|NCT01837329|Pemetrexed Platinum|pemetrexed platinum
4955124|NCT01837329|Newly Diagnosed|newly diagnosed
4955125|NCT01837329|Chemo-naive|chemo-naive
4955126|NCT01837316|pharmacodynamics|pharmacodynamics
4955127|NCT01837316|FF/VI|ff/vi
4955128|NCT01837316|asthma|asthma
4955129|NCT01837316|duration of action|duration of action
4955130|NCT01837303|Cervical dysplasia|cervical dysplasia
4955131|NCT01837303|Cervical cancer|cervical cancer
4955132|NCT01837290|Renal failure,|renal failure,
4955133|NCT01837290|hip fracture,|hip fracture,
4955134|NCT01837290|spinal anesthesia,|spinal anesthesia,
4955135|NCT01837290|dexmedetomidine|dexmedetomidine
4955136|NCT01837290|patient|patient
4955137|NCT01837264|Magellan MAR01|magellan mar01
4955138|NCT01837264|Autologous Platelet Rich Plasma|autologous platelet rich plasma
4955139|NCT01837264|Compartment Syndrome|compartment syndrome
4955140|NCT01837264|Battlefield Trauma|battlefield trauma
4955141|NCT01837264|Fasciotomy|fasciotomy
4955142|NCT01837251|Ovarian Carcinoma|ovarian carcinoma
4955143|NCT01837251|Bevacizumab|bevacizumab
4955144|NCT01837251|Gemcitabine|gemcitabine
4955145|NCT01837251|PLD|pld
4955146|NCT01837251|pegylated liposomal doxorubicin|pegylated liposomal doxorubicin
4955147|NCT01837251|Carboplatin|carboplatin
4955148|NCT01837251|best therapeutic index|best therapeutic index
4955149|NCT01837251|progression-free survival|progression-free survival
4955150|NCT01837238|hemodialysis|hemodialysis
4955151|NCT01837238|physical function|physical function
4955152|NCT01837225|Fluorescence Imaging|fluorescence imaging
4955153|NCT01837225|Breast Tumor Margins|breast tumor margins
4955154|NCT01837225|Real-time Assessment|real-time assessment
4955155|NCT01837199|Periodontal disease|periodontal disease
4955156|NCT01837199|Scaling and root planing|scaling and root planing
4955157|NCT01837199|Metronidazole|metronidazole
4955158|NCT01837199|Amoxicillin|amoxicillin
4955159|NCT01837199|Generalized chronic periodontitis|generalized chronic periodontitis
4955160|NCT01837199|Periodontal treatment|periodontal treatment
4955161|NCT01837186|Surgery|surgery
4955162|NCT01837186|NSCLC|nsclc
4955163|NCT01837173|Adenocarcinoma|adenocarcinoma
4955164|NCT01837173|Squamous Cell Carcinoma|squamous cell carcinoma
4955165|NCT01837173|Neoadjuvant treatment|neoadjuvant treatment
4955166|NCT01837173|Esophagectomy|esophagectomy
4955167|NCT01837160|Angiogenesis|angiogenesis
4955168|NCT01837160|Fibrosis|fibrosis
4955169|NCT01837160|Aortic Stenosis|aortic stenosis
4955170|NCT01837160|Imaging|imaging
4955171|NCT01837160|CT-PET|ct-pet
4955172|NCT01837160|PET-CT|pet-ct
4955173|NCT01837160|Cardiac MRI|cardiac mri
4955174|NCT01837147|primary prevention|primary prevention
4955175|NCT01837147|sedentary|sedentary
4955176|NCT01837147|overweight|overweight
4955177|NCT01837147|obesity|obesity
4955178|NCT01837147|breast cancer|breast cancer
4955179|NCT01837147|post-menopausal|post-menopausal
4955180|NCT01837147|women|women
4955181|NCT01837134|telemedicine|telemedicine
4955182|NCT01837134|overweight|overweight
4955184|NCT01837121|not-attended rate|not-attended rate
4955185|NCT01837121|re-visit|re-visit
4955186|NCT01837121|vision|vision
4955187|NCT01837121|knowledge|knowledge
4955188|NCT01837121|satisfaction|satisfaction
4955189|NCT01837108|healthy|healthy
4955190|NCT01837095|Overall survival|overall survival
4955191|NCT01837095|Progression free survival|progression free survival
4955192|NCT01837082|Heart Failure|heart failure
4955193|NCT01837082|Iron Deficiency|iron deficiency
4955194|NCT01837082|Anemia|anemia
4955195|NCT01837082|Ferric Carboxymaltose|ferric carboxymaltose
4955196|NCT01837069|Hypertension|hypertension
4955197|NCT01837069|Diabetes|diabetes
4955198|NCT01837069|Coronary Artery Disease|coronary artery disease
4955199|NCT01837069|Peripheral Vascular Disease|peripheral vascular disease
4955200|NCT01837056|Toxoplasma gondii|toxoplasma gondii
4955201|NCT01837056|Toxocara canis|toxocara canis
4955202|NCT01837043|Delayed Graft Function|delayed graft function
4955203|NCT01837043|Renal Transplantation|renal transplantation
4955204|NCT01837043|Kidney Transplant|kidney transplant
4955205|NCT01837017|Falls,|falls,
4955206|NCT01837017|Balance,|balance,
4955207|NCT01837017|Gait,|gait,
4955208|NCT01837017|Older adults|older adults
4955209|NCT01837004|adherence|adherence
4955210|NCT01837004|cognition|cognition
4955211|NCT01837004|exercise|exercise
4955212|NCT01837004|aging|aging
4955213|NCT01836991|gastric cancer|gastric cancer
4955214|NCT01836991|surgery|surgery
4955215|NCT01836991|surgery safety|surgery safety
4955216|NCT01836991|effect|effect
4955217|NCT01836965|Aspergers|aspergers
4955218|NCT01836965|Social Skills|social skills
4955219|NCT01836965|Adolescents|adolescents
4955220|NCT01836965|High-functioning Autism|high-functioning autism
4955221|NCT01836939|psoriasis, oral therapy|psoriasis, oral therapy
4955222|NCT01836939|ova|ova
4955223|NCT01836939|Trichuris suis ova|trichuris suis ova
4955224|NCT01836939|TSO|tso
4955225|NCT01836939|CNDO 201 Trichuris suis ova|cndo 201 trichuris suis ova
4955226|NCT01836926|sphincter sparing procedures|sphincter sparing procedures
4955227|NCT01836926|intersphincteric resection|intersphincteric resection
4955228|NCT01836926|rectal cancer|rectal cancer
4955229|NCT01836926|low rectal cancer|low rectal cancer
4955230|NCT01836926|sphincter preserving procedures|sphincter preserving procedures
4955231|NCT01836926|Abdominoperineal resection|abdominoperineal resection
4955232|NCT01836926|laparoscopic resection of rectal cancer|laparoscopic resection of rectal cancer
4955233|NCT01836926|laparoscopic versus open colorectal resection|laparoscopic versus open colorectal resection
4955234|NCT01836926|laparoscopic versus open rectal surgery|laparoscopic versus open rectal surgery
4955235|NCT01836926|neoadjuvant chemo-radiotherapy for rectal cancer|neoadjuvant chemo-radiotherapy for rectal cancer
4955236|NCT01836913|PET/CT|pet/ct
4955237|NCT01836913|Esophageal cancer|esophageal cancer
4955238|NCT01836913|Radiotherapy|radiotherapy
4955239|NCT01836900|OTSC|otsc
4955240|NCT01836900|Upper gastrointestinal bleeding|upper gastrointestinal bleeding
4955241|NCT01836887|Polyphenol|polyphenol
4955242|NCT01836887|Fruit|fruit
4955243|NCT01836887|Metabolic|metabolic
4955244|NCT01836887|Healthy|healthy
4955245|NCT01836874|Migraine|migraine
4955246|NCT01836874|Indian|indian
4955247|NCT01836874|Topiramate|topiramate
4955248|NCT01836861|Phase I|phase i
4955249|NCT01836861|healthy male volunteers|healthy male volunteers
4955250|NCT01836861|ADME|adme
4955251|NCT01836861|Bioavailability|bioavailability
4955252|NCT01836861|PI3K inhibitor|pi3k inhibitor
4955253|NCT01836861|Absorption|absorption
4955254|NCT01836861|Distribution|distribution
4955255|NCT01836861|Metabolism|metabolism
4955256|NCT01836861|Excretion|excretion
4955257|NCT01836861|safety|safety
4955258|NCT01836848|subarachnoid hemorrhage|subarachnoid hemorrhage
4955259|NCT01836848|near-infrared-spectroscopy|near-infrared-spectroscopy
4955260|NCT01836848|indocyanine green|indocyanine green
4955261|NCT01836848|secondary ischemia|secondary ischemia
4955262|NCT01836835|Hyperemesis gravidarum|hyperemesis gravidarum
4955263|NCT01836835|Pregnancy|pregnancy
4955264|NCT01836835|Nausea|nausea
4955265|NCT01836835|Nutritional status|nutritional status
4955266|NCT01836835|Questionnaire|questionnaire
4955267|NCT01836835|Case-control|case-control
4955268|NCT01836822|mediastinal lymph node enlargement|mediastinal lymph node enlargement
4955269|NCT01836822|sarcoidosis|sarcoidosis
4955270|NCT01836822|bronchoscopy|bronchoscopy
4955271|NCT01836822|EBUS guided transbronchial needle aspiration (EBUS-TBNA)|ebus guided transbronchial needle aspiration (ebus-tbna)
4955272|NCT01836822|transbronchial needle aspiration (EBUS-TBNA)|transbronchial needle aspiration (ebus-tbna)
4955273|NCT01836822|EBUS guided transbronchial forceps biopsy EBUS-TBFB)|ebus guided transbronchial forceps biopsy ebus-tbfb)
4955274|NCT01836809|Total Artificial Heart|total artificial heart
4955275|NCT01836809|Left Ventricular Assist Device|left ventricular assist device
4955276|NCT01836809|Natriuretic peptides|natriuretic peptides
4955277|NCT01836809|Heart Failure|heart failure
4955278|NCT01836809|Cardiorenal Syndrome|cardiorenal syndrome
4955279|NCT01836783|Allograft|allograft
4955280|NCT01836783|Amnion Allograft|amnion allograft
4955281|NCT01836770|Transforaminal Epidural Steroid Injections|transforaminal epidural steroid injections
4955282|NCT01836757|osteoarthritis|osteoarthritis
4955283|NCT01836757|CAM treatments|cam treatments
4955284|NCT01836757|MSM|msm
4955285|NCT01836731|weight-for age|weight-for age
4955286|NCT01836731|height-for-age|height-for-age
4955287|NCT01836731|water sanitation facilities|water sanitation facilities
4955288|NCT01836731|hygiene behavior|hygiene behavior
4955289|NCT01836718|Hepatitis C Virus|hepatitis c virus
4955290|NCT01836718|Liver Transplantation|liver transplantation
4955291|NCT01836718|Antiviral Therapy|antiviral therapy
4955292|NCT01836718|HCV|hcv
4955293|NCT01836679|Chidamide,lung cancer|chidamide,lung cancer
4955294|NCT01836653|Bevacizumab|bevacizumab
4955295|NCT01836653|Cetuximab|cetuximab
4955296|NCT01836653|KRAS wild type colorectal cancer|kras wild type colorectal cancer
4955297|NCT01836653|RAS wild type colorectal cancer|ras wild type colorectal cancer
4955298|NCT01836653|liver metastasis|liver metastasis
4955299|NCT01836627|Congenital Muscular Dystrophy|congenital muscular dystrophy
4955300|NCT01836627|Collagen VI Deficiency|collagen vi deficiency
4955301|NCT01836627|Hyperinsufflation|hyperinsufflation
4955302|NCT01836627|Cough Assist|cough assist
4955303|NCT01836627|LAMA2- Muscular Dystrophy|lama2- muscular dystrophy
4955304|NCT01836601|safety|safety
4955305|NCT01836601|patient experience|patient experience
4955306|NCT01836601|family-centered rounds|family-centered rounds
4955307|NCT01836575|Advanced NSCLC|advanced nsclc
4955308|NCT01836575|PS2|ps2
4955309|NCT01836575|Pemetrexed|pemetrexed
4955310|NCT01836575|First line|first line
4955311|NCT01836575|non squamous|non squamous
4955312|NCT01836562|Autism stem cell MNCs|autism stem cell mncs
4955313|NCT01836536|High grade glioma|high grade glioma
4955314|NCT01836536|Bevacizumab|bevacizumab
4955315|NCT01836536|Chemotherapy|chemotherapy
4955316|NCT01836536|Myeloid Cells|myeloid cells
4955317|NCT01836536|Treg|treg
4955318|NCT01836510|Heart Failure|heart failure
4955319|NCT01836510|Remote Monitoring|remote monitoring
4955320|NCT01836510|Lung Edema|lung edema
4955321|NCT01836510|Patient Monitoring|patient monitoring
4955322|NCT01836510|Prediction|prediction
4955323|NCT01836484|Surgically staged endometrial carcinoma|surgically staged endometrial carcinoma
4955324|NCT01836484|Surgically staged cervical carcinoma|surgically staged cervical carcinoma
4955325|NCT01836458|Malaria, KAE609|malaria, kae609
4955326|NCT01836432|Pancreatic Cancer|pancreatic cancer
4955327|NCT01836432|Immunotherapy|immunotherapy
4955328|NCT01836432|Vaccine Therapy|vaccine therapy
4955329|NCT01836419|classic laryngeal mask airway|classic laryngeal mask airway
4955330|NCT01836419|elderly patients|elderly patients
4955331|NCT01836406|ketorolac|ketorolac
4955332|NCT01836406|remote ischemic preconditioning|remote ischemic preconditioning
4955333|NCT01836406|partial nephrectomy|partial nephrectomy
4955335|NCT01836393|Efficacy|efficacy
4955336|NCT01836393|OA knee|oa knee
4955337|NCT01836393|The efficacy study of Plai cream for OA knee|the efficacy study of plai cream for oa knee
4955338|NCT01836367|Actinic Keratosis|actinic keratosis
4955339|NCT01836367|Face|face
4955340|NCT01836367|Scalp|scalp
4955341|NCT01836367|Ingenol Mebutate|ingenol mebutate
4955342|NCT01836354|stroke|stroke
4955343|NCT01836354|interactive educational intervention|interactive educational intervention
4955344|NCT01836354|acute ischemic stroke|acute ischemic stroke
4955345|NCT01836354|transient ischemic attack|transient ischemic attack
4955346|NCT01836341|Afatinib|afatinib
4955347|NCT01836341|Cisplatin|cisplatin
4955348|NCT01836341|Carboplatin|carboplatin
4955349|NCT01836341|Pemetrexed|pemetrexed
4955350|NCT01836341|Radiation therapy|radiation therapy
4955351|NCT01836341|EGFR mutation|egfr mutation
4955352|NCT01836341|12-279|12-279
4955353|NCT01836328|Methadone|methadone
4955354|NCT01836328|Pain|pain
4955355|NCT01836328|Neoplasms|neoplasms
4955356|NCT01836328|Ratio|ratio
4955357|NCT01836237|Surgical site infection rate|surgical site infection rate
4955358|NCT01836237|Wound protector use|wound protector use
4955359|NCT01836237|Whipple|whipple
4955360|NCT01836211|Chest pain|chest pain
4955361|NCT01836211|Acute coronary syndrome|acute coronary syndrome
4955362|NCT01836211|Cardiac biomarkers|cardiac biomarkers
4955363|NCT01836211|Computed coronary tomography angiography|computed coronary tomography angiography
4955364|NCT01836211|Emergency department|emergency department
4955365|NCT01836172|The treatment of diabetic complication|the treatment of diabetic complication
4955366|NCT01836159|Stroke Rehabilitation|stroke rehabilitation
4955367|NCT01836159|iPad|ipad
4955368|NCT01836159|Fine Motor Function|fine motor function
4955369|NCT01836159|Ischemic Stroke|ischemic stroke
4955370|NCT01836159|Visual Neglect|visual neglect
4955371|NCT01836120|second-line chemotherapy|second-line chemotherapy
4955372|NCT01836120|Raltitrexed|raltitrexed
4955373|NCT01836107|Clinical notes|clinical notes
4955374|NCT01836107|Communication between physicians|communication between physicians
4955375|NCT01836107|Quality|quality
4955376|NCT01836107|Cross-cultural adaptation|cross-cultural adaptation
4955377|NCT01836094|Methylene Blue|methylene blue
4955378|NCT01836094|Memory|memory
4955379|NCT01836094|Mental Fatigue|mental fatigue
4955380|NCT01836094|Brain metabolism|brain metabolism
4955381|NCT01836094|fMRI|fmri
4955382|NCT01836094|psychomotor vigilance task (PVT)|psychomotor vigilance task (pvt)
4955967|NCT01833299|TACE|tace
4955383|NCT01836094|delayed match-to-sample memory task|delayed match-to-sample memory task
4955384|NCT01836094|PVT|pvt
4955385|NCT01836094|DMS|dms
4955386|NCT01836081|fluid responsiveness|fluid responsiveness
4955387|NCT01836081|carotid artery peak velocity variation|carotid artery peak velocity variation
4955388|NCT01836081|coronary disease|coronary disease
4955389|NCT01836068|HIV positive|hiv positive
4955390|NCT01836068|HIV-1|hiv-1
4955391|NCT01836068|Bone Marrow Transplant|bone marrow transplant
4955392|NCT01836068|Allogeneic BMT|allogeneic bmt
4955393|NCT01836068|BMT|bmt
4955394|NCT01836055|Multiple Sclerosis|multiple sclerosis
4955395|NCT01836055|White Matter Lesions|white matter lesions
4955396|NCT01836055|Contrast Agent|contrast agent
4955397|NCT01836055|Magnetic Resonance Imaging|magnetic resonance imaging
4955398|NCT01836042|Primary open-angle glaucoma (POAG)|primary open-angle glaucoma (poag)
4955399|NCT01836042|Trabecular meshwork|trabecular meshwork
4955400|NCT01836042|iStent|istent
4955401|NCT01836029|SCCHN|scchn
4955402|NCT01836029|HNSCC|hnscc
4955403|NCT01836016|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
4955404|NCT01836016|Comparative effectiveness research|comparative effectiveness research
4955405|NCT01836016|Medicine, Chinese Traditional|medicine, chinese traditional
4955406|NCT01836016|Humans|humans
4955407|NCT01836016|Treatment Outcome|treatment outcome
4955408|NCT01836003|Pregnancy|pregnancy
4955409|NCT01836003|Prevention of Mother to Child Transmission|prevention of mother to child transmission
4955410|NCT01836003|Short Message Service (SMS)|short message service (sms)
4955411|NCT01836003|HIV infection|hiv infection
4955412|NCT01836003|CD4 testing|cd4 testing
4955413|NCT01836003|Antiretroviral therapy|antiretroviral therapy
4955414|NCT01835990|venous thromboembolism|venous thromboembolism
4955415|NCT01835990|trauma|trauma
4955416|NCT01835990|mechanical methods of prophylaxis|mechanical methods of prophylaxis
4955417|NCT01835977|Focal therapy|focal therapy
4955418|NCT01835977|Irreversible electroporation|irreversible electroporation
4955419|NCT01835977|Unilateral prostate cancer|unilateral prostate cancer
4955420|NCT01835964|Glucose Variability (GV)|glucose variability (gv)
4955421|NCT01835964|Continuous Glucose Monitor (CGM)|continuous glucose monitor (cgm)
4955422|NCT01835951|Simulation|simulation
4955423|NCT01835951|Debriefing|debriefing
4955424|NCT01835951|Anaesthesia Crisis Management|anaesthesia crisis management
4955425|NCT01835951|Cardiac Arrest|cardiac arrest
4955426|NCT01835951|Pregnancy|pregnancy
4955427|NCT01835938|Hepatitis C Virus infection|hepatitis c virus infection
4955428|NCT01835938|entry inhibitor|entry inhibitor
4955429|NCT01835938|kinase inhibitor|kinase inhibitor
4955430|NCT01835925|adenocarcinoma of rectum|adenocarcinoma of rectum
4955431|NCT01835925|rectal cancer|rectal cancer
4955432|NCT01835925|stage II|stage ii
4955433|NCT01835925|stage III|stage iii
4955434|NCT01835912|performance|performance
4955435|NCT01835912|speed|speed
4955436|NCT01835912|exertion|exertion
4955437|NCT01835860|BPH|bph
4955438|NCT01835834|zirconia crown|zirconia crown
4955439|NCT01835821|zirconia|zirconia
4955440|NCT01835821|crown|crown
4955441|NCT01835821|IPS e.max CAD|ips e.max cad
4955442|NCT01835808|Fractional flow reserve|fractional flow reserve
4955443|NCT01835795|Myofascial Pain Syndromes|myofascial pain syndromes
4955444|NCT01835795|Myofascial Trigger Point|myofascial trigger point
4955445|NCT01835795|Low Back Pain|low back pain
4955446|NCT01835795|Lumbago|lumbago
4955447|NCT01835795|Shock Waves, High-Energy|shock waves, high-energy
4955448|NCT01835795|High-Energy Shock Waves|high-energy shock waves
4955449|NCT01835795|Interdisciplinary Health Team|interdisciplinary health team
4955450|NCT01835795|Multidisciplinary Pain Centers|multidisciplinary pain centers
4955451|NCT01835782|ALS|als
4955452|NCT01835782|L-Serine|l-serine
4955453|NCT01835782|BMAA|bmaa
4955454|NCT01835717|Preclinical phase of Alzheimer's disease|preclinical phase of alzheimer's disease
4955455|NCT01835717|Asymptomatic phase of Alzheimer's disease|asymptomatic phase of alzheimer's disease
4955456|NCT01835717|Cognitive normal|cognitive normal
4955457|NCT01835717|Exogenous factors|exogenous factors
4955458|NCT01835717|Endogenous factors|endogenous factors
4955459|NCT01835717|Episodic memory test|episodic memory test
4955460|NCT01835717|Executive function test|executive function test
4955461|NCT01835717|Memory binding test validation into Spanish|memory binding test validation into spanish
4955462|NCT01835717|Memory binding test validation into Catalan|memory binding test validation into catalan
4955463|NCT01835691|Chronic Kidney Disease|chronic kidney disease
4955464|NCT01835691|Vitamin D|vitamin d
4955465|NCT01835691|Vitamin D2|vitamin d2
4955466|NCT01835691|Vitamin D3|vitamin d3
4955467|NCT01835652|Exercise|exercise
4955468|NCT01835652|Parkinson's Disease|parkinson's disease
4955469|NCT01835652|Positron Emission Tomography|positron emission tomography
4955470|NCT01835652|fMRI|fmri
4955471|NCT01835639|Glomerular Disease|glomerular disease
4955472|NCT01835639|Vitamin D|vitamin d
4955473|NCT01835639|Steroid-resistant nephrotic syndrome|steroid-resistant nephrotic syndrome
4955474|NCT01835639|Minimal change disease|minimal change disease
4955475|NCT01835639|Focal segmental glomerulosclerosis (FSGS)|focal segmental glomerulosclerosis (fsgs)
4955476|NCT01835639|Membranous Nephropathy|membranous nephropathy
4955968|NCT01833299|Sorafenib|sorafenib
4955477|NCT01835639|Membranoprolfierative Glomerulonephritis|membranoprolfierative glomerulonephritis
4955478|NCT01835639|immunoglobulin A (IgA) Nephropathy|immunoglobulin a (iga) nephropathy
4955479|NCT01835639|FSGS|fsgs
4955480|NCT01835639|IgA Nephropathy|iga nephropathy
4955481|NCT01835626|Locally advanced basal cell carcinoma|locally advanced basal cell carcinoma
4955482|NCT01835626|Skin cancer|skin cancer
4955483|NCT01835626|Radiation therapy|radiation therapy
4955484|NCT01835626|Vismodegib|vismodegib
4955485|NCT01835626|Head and neck cancer|head and neck cancer
4955486|NCT01835626|Cutaneous malignancy|cutaneous malignancy
4955487|NCT01835613|Rheumatoid Arthritis|rheumatoid arthritis
4955488|NCT01835613|Early RA|early ra
4955489|NCT01835613|RA|ra
4955490|NCT01835613|IL-6|il-6
4955491|NCT01835613|IL-6R|il-6r
4955492|NCT01835613|Inhibitor|inhibitor
4955493|NCT01835613|Inhibition|inhibition
4955494|NCT01835613|Tocilizumab|tocilizumab
4955495|NCT01835613|Biomarkers|biomarkers
4955496|NCT01835613|DMARDs|dmards
4955497|NCT01835613|Biological|biological
4955498|NCT01835613|DAS|das
4955499|NCT01835613|SDAI|sdai
4955500|NCT01835613|AR/BIOM|ar/biom
4955501|NCT01835613|OEG|oeg
4955502|NCT01835587|Acute myeloid leukemia,|acute myeloid leukemia,
4955503|NCT01835587|myelodysplastic syndromes,|myelodysplastic syndromes,
4955504|NCT01835587|CC-486, oral Azacitidine,|cc-486, oral azacitidine,
4955505|NCT01835587|transplantation,|transplantation,
4955506|NCT01835587|allogeneic,|allogeneic,
4955507|NCT01835587|HSCT.|hsct.
4955508|NCT01835574|Amphetamine-type substance use|amphetamine-type substance use
4955509|NCT01835561|Hepatic, Liver disease; Pharmacokinetic; Healthy|hepatic, liver disease; pharmacokinetic; healthy
4955510|NCT01835509|Childhood Cancer Survivors|childhood cancer survivors
4955511|NCT01835496|sickle cell disease|sickle cell disease
4955512|NCT01835496|iron overload|iron overload
4955513|NCT01835496|pharmacokinetics|pharmacokinetics
4955514|NCT01835496|Ferriprox|ferriprox
4955515|NCT01835496|deferiprone|deferiprone
4955516|NCT01835457|Endotoxemia|endotoxemia
4955517|NCT01835457|Autonomic Nervous System|autonomic nervous system
4955518|NCT01835457|Inflammation|inflammation
4955519|NCT01835457|Meditation|meditation
4955520|NCT01835457|Concentration|concentration
4955521|NCT01835457|Iceman|iceman
4955522|NCT01835457|LPS|lps
4955523|NCT01835457|Cortisol|cortisol
4955524|NCT01835457|Catecholamines|catecholamines
4955525|NCT01835444|Physician Assistant|physician assistant
4955526|NCT01835444|Substitution|substitution
4955527|NCT01835444|Hospital ward care|hospital ward care
4955528|NCT01835444|Secondary health care|secondary health care
4955529|NCT01835418|managed with bedtime administration of lisinopril versus amlodipine|managed with bedtime administration of lisinopril versus amlodipine
4955530|NCT01835392|Remote ischemic preconditioning|remote ischemic preconditioning
4955531|NCT01835392|Heart defects, congenital|heart defects, congenital
4955532|NCT01835392|cardiac surgery|cardiac surgery
4955533|NCT01835392|Neurodevelopmental outcomes|neurodevelopmental outcomes
4955534|NCT01835379|Diabetes|diabetes
4955535|NCT01835379|Diabetic Foot Ulcer|diabetic foot ulcer
4955536|NCT01835379|Diabetic Foot Wound|diabetic foot wound
4955537|NCT01835379|Non-healing foot wound|non-healing foot wound
4955538|NCT01835379|Oasis|oasis
4955539|NCT01835379|Diabetic neuropathy|diabetic neuropathy
4955540|NCT01835353|prasugrel|prasugrel
4955541|NCT01835353|ST elevation myocardial infarction|st elevation myocardial infarction
4955542|NCT01835327|intraoperative, post-operative recovery|intraoperative, post-operative recovery
4955543|NCT01835327|thoracic surgery|thoracic surgery
4955544|NCT01835327|cerebral oximetry|cerebral oximetry
4955545|NCT01835262|pain|pain
4955546|NCT01835262|Ketamine|ketamine
4955547|NCT01835262|Emergency Medicine|emergency medicine
4955548|NCT01835262|morphine|morphine
4955549|NCT01835249|Hypertension|hypertension
4955550|NCT01835249|Nighttime blood pressure|nighttime blood pressure
4955551|NCT01835236|Breast cancer|breast cancer
4955552|NCT01835236|HER2-positive|her2-positive
4955553|NCT01835236|Metastases|metastases
4955554|NCT01835197|Phase 1|phase 1
4955555|NCT01835197|Randomized|randomized
4955556|NCT01835197|Double Blind|double blind
4955557|NCT01835197|Placebo-Controlled|placebo-controlled
4955558|NCT01835197|Single- & Multiple Dose Escalation|single- & multiple dose escalation
4955559|NCT01835197|Safety|safety
4955560|NCT01835197|Tolerability|tolerability
4955561|NCT01835197|PK|pk
4955562|NCT01835197|PD|pd
4955563|NCT01835197|Pf-04965842|pf-04965842
4955564|NCT01835132|Scleritis|scleritis
4955565|NCT01835132|IL-1|il-1
4955566|NCT01835119|gynecological malignancies|gynecological malignancies
4955567|NCT01835119|postoperative|postoperative
4955568|NCT01835119|bowel activity|bowel activity
4955569|NCT01835119|gum chewing|gum chewing
4955570|NCT01835106|Postoperative Care|postoperative care
4955693|NCT01834456|Quality in Healthcare|quality in healthcare
4955571|NCT01835080|Obstructive Sleep Apnea, OSA, Pulmonary Arterial Hypertension, PAH, sleep study, polysomnogram, Respiratory Disturbance Index, RDI|obstructive sleep apnea, osa, pulmonary arterial hypertension, pah, sleep study, polysomnogram, respiratory disturbance index, rdi
4955572|NCT01835067|Macular degeneration|macular degeneration
4955573|NCT01835067|Submacular haemorrhage|submacular haemorrhage
4955574|NCT01835054|Mitral regurgitation|mitral regurgitation
4955575|NCT01835054|Mitral valve prolapse|mitral valve prolapse
4955576|NCT01835054|Echocardiography, Doppler|echocardiography, doppler
4955577|NCT01835054|Stress echocardiography|stress echocardiography
4955578|NCT01835054|Cardiopulmonary exercice testing|cardiopulmonary exercice testing
4955579|NCT01835054|Magnetic Resonance Imaging|magnetic resonance imaging
4955580|NCT01835054|Cardiac neurohormones|cardiac neurohormones
4955581|NCT01835054|Visceral obesity|visceral obesity
4955582|NCT01835054|Cardiometabolic risk|cardiometabolic risk
4955583|NCT01835054|Risk stratification|risk stratification
4955584|NCT01835028|Aortic Stenosis|aortic stenosis
4955585|NCT01835028|Low Flow|low flow
4955586|NCT01835028|Low Gradient|low gradient
4955587|NCT01835028|Left Ventricle|left ventricle
4955588|NCT01835028|Echocardiography, Doppler|echocardiography, doppler
4955589|NCT01835015|First in human|first in human
4955590|NCT01835015|Safety|safety
4955591|NCT01835015|Tolerability|tolerability
4955592|NCT01835015|Serum PK|serum pk
4955593|NCT01835015|Intravitreal (IVT)|intravitreal (ivt)
4955594|NCT01835015|Age-related macular degeneration|age-related macular degeneration
4955595|NCT01835015|AMD|amd
4955596|NCT01835015|Geographic Atrophy|geographic atrophy
4955597|NCT01835015|Choroidal neovascularization|choroidal neovascularization
4955598|NCT01835002|transcorneal electrostimulation|transcorneal electrostimulation
4955599|NCT01834976|cardiac biomarker|cardiac biomarker
4955600|NCT01834976|congenital heart disease|congenital heart disease
4955601|NCT01834976|surgery|surgery
4955602|NCT01834937|ExAblate|exablate
4955603|NCT01834937|MRgFUS|mrgfus
4955604|NCT01834937|Bone Metastases|bone metastases
4955605|NCT01834937|Pain Palliation|pain palliation
4955606|NCT01834924|Health literacy|health literacy
4955607|NCT01834924|Patient education|patient education
4955608|NCT01834911|Huntington disease|huntington disease
4955609|NCT01834911|HD|hd
4955610|NCT01834911|tetrabenazine|tetrabenazine
4955611|NCT01834911|Stroop|stroop
4955612|NCT01834898|postoperative|postoperative
4955613|NCT01834898|analgesia|analgesia
4955614|NCT01834898|adverse effects|adverse effects
4955615|NCT01834898|opioid|opioid
4955616|NCT01834898|oxycodone|oxycodone
4955617|NCT01834885|COPD|copd
4955618|NCT01834859|weight reduction programs|weight reduction programs
4955619|NCT01834859|diet|diet
4955620|NCT01834859|Caloric restriction|caloric restriction
4955621|NCT01834859|weight loss|weight loss
4955622|NCT01834859|weight gain|weight gain
4955623|NCT01834846|comparative study|comparative study
4955624|NCT01834846|Cardiac Surgical Procedures|cardiac surgical procedures
4955625|NCT01834833|Acute heart failure; rehospitalisation; education; follow-up|acute heart failure; rehospitalisation; education; follow-up
4955626|NCT01834820|Bronchiolitis|bronchiolitis
4955627|NCT01834820|Epinephrine|epinephrine
4955628|NCT01834820|Dexamethasone|dexamethasone
4955629|NCT01834820|Hospitalization|hospitalization
4955630|NCT01834820|Hypertonic Saline|hypertonic saline
4955631|NCT01834794|Tobacco Use|tobacco use
4955632|NCT01834781|multiple chemical sensitivity, re5 therapy, pulsed electromagnetic fields|multiple chemical sensitivity, re5 therapy, pulsed electromagnetic fields
4955633|NCT01834742|Moviprep|moviprep
4955634|NCT01834742|PEG3350|peg3350
4955635|NCT01834742|Laxative|laxative
4955636|NCT01834742|Stool Output|stool output
4955637|NCT01834690|Liver transplantation/epidemiology|liver transplantation/epidemiology
4955638|NCT01834690|Liver transplantation/pharmacology|liver transplantation/pharmacology
4955639|NCT01834690|Health status/drug effects|health status/drug effects
4955640|NCT01834690|Agents, immunosuppressive agents|agents, immunosuppressive agents
4955641|NCT01834677|Depression|depression
4955642|NCT01834677|Neurocognition|neurocognition
4955643|NCT01834677|Electroconvulsive Therapy (ECT)|electroconvulsive therapy (ect)
4955644|NCT01834677|Parkinson's Disease|parkinson's disease
4955645|NCT01834664|Ataxic Infantile Cerebral Palsy stem cell therapy|ataxic infantile cerebral palsy stem cell therapy
4955646|NCT01834651|liver metastasis|liver metastasis
4955647|NCT01834651|lung metastasis|lung metastasis
4955648|NCT01834651|metastatic castrate-resistant|metastatic castrate-resistant
4955649|NCT01834651|prostate cancer|prostate cancer
4955650|NCT01834638|schizophrenia|schizophrenia
4955651|NCT01834612|blood loss, hemorrhage, hemorrhagic shcok|blood loss, hemorrhage, hemorrhagic shcok
4955652|NCT01834599|placental oxygenation|placental oxygenation
4955653|NCT01834599|obstetric anesthesia|obstetric anesthesia
4955654|NCT01834599|NIRS|nirs
4955655|NCT01834599|cerebral oximetry|cerebral oximetry
4955656|NCT01834599|cerebral oximeter|cerebral oximeter
4955657|NCT01834573|inflammatory bowel disease|inflammatory bowel disease
4955658|NCT01834573|IBD|ibd
4955659|NCT01834573|quality of life|quality of life
4955660|NCT01834573|Inflammatory Bowel Disease Questionnaire|inflammatory bowel disease questionnaire
4955661|NCT01834560|deep brain stimulation|deep brain stimulation
4955662|NCT01834560|subgenual cortex (CG25)|subgenual cortex (cg25)
4955663|NCT01834547|chess, cognition|chess, cognition
4955664|NCT01834521|Breast cancer|breast cancer
4955665|NCT01834521|psychosocial|psychosocial
4955666|NCT01834521|website|website
4955667|NCT01834521|empowerment|empowerment
4955668|NCT01834508|Experienced Treatment|experienced treatment
4956799|NCT01829646|DWI|dwi
4955669|NCT01834495|Peripheral artery disease|peripheral artery disease
4955670|NCT01834495|atherosclerosis|atherosclerosis
4955671|NCT01834495|stent|stent
4955672|NCT01834482|seizures|seizures
4955673|NCT01834482|epilepsy|epilepsy
4955674|NCT01834482|adult|adult
4955675|NCT01834482|intractable|intractable
4955676|NCT01834482|medically refractory|medically refractory
4955677|NCT01834482|Atkins|atkins
4955678|NCT01834482|ketogenic|ketogenic
4955679|NCT01834482|diet|diet
4955680|NCT01834469|Ovarian,metastasis|ovarian,metastasis
4955681|NCT01834456|Medically Complex Children|medically complex children
4955682|NCT01834456|Family Experience in Healthcare|family experience in healthcare
4955683|NCT01834456|Patient Centered Care|patient centered care
4955684|NCT01834456|Family Centered Care|family centered care
4955685|NCT01834456|Case Management|case management
4955686|NCT01834456|Care Management|care management
4955687|NCT01834456|Care Coordination|care coordination
4955688|NCT01834456|Care Plan|care plan
4955689|NCT01834456|Extensivist|extensivist
4955690|NCT01834456|Medical Home|medical home
4955691|NCT01834456|Children with Special Health Care Needs|children with special health care needs
4955692|NCT01834456|Coordinated Care|coordinated care
4955694|NCT01834456|Satisfaction in Healthcare|satisfaction in healthcare
4955695|NCT01834456|Cost|cost
4955696|NCT01834456|Utilization|utilization
4955697|NCT01834456|Impact on Family|impact on family
4955698|NCT01834456|Quality of Life|quality of life
4955699|NCT01834456|Palliative Care|palliative care
4955700|NCT01834456|Complex Chronic Conditions|complex chronic conditions
4955701|NCT01834456|Life-limiting illness|life-limiting illness
4955702|NCT01834456|Integrative Care|integrative care
4955703|NCT01834456|Primary Care|primary care
4955704|NCT01834456|Comprehensive Care|comprehensive care
4955705|NCT01834456|Behavioral Care|behavioral care
4955706|NCT01834443|spatial neglect|spatial neglect
4955707|NCT01834443|galvanic vestibular stimulation as therapy|galvanic vestibular stimulation as therapy
4955708|NCT01834417|Pressure ulcer, spinal cord injury, on-board device|pressure ulcer, spinal cord injury, on-board device
4955709|NCT01834404|Obesity|obesity
4955710|NCT01834404|BMI|bmi
4955711|NCT01834404|Incretin|incretin
4955712|NCT01834404|Satiety|satiety
4955713|NCT01834404|Phentermine|phentermine
4955714|NCT01834404|Topiramate|topiramate
4955715|NCT01834378|diabetes|diabetes
4955716|NCT01834378|insulin resistance|insulin resistance
4955717|NCT01834378|exercise|exercise
4955718|NCT01834365|Hypertension|hypertension
4955719|NCT01834352|Walnut hypersensitivity|walnut hypersensitivity
4955720|NCT01834352|Tree nut hypersensitivity|tree nut hypersensitivity
4955721|NCT01834339|vestibuloplasty|vestibuloplasty
4955722|NCT01834326|dental implants|dental implants
4955723|NCT01834326|deficient keratinized oral mucosa|deficient keratinized oral mucosa
4955724|NCT01834313|Willingness-to-pay|willingness-to-pay
4955725|NCT01834313|Patient-centredness|patient-centredness
4955726|NCT01834313|Health insurers|health insurers
4955727|NCT01834313|Fertility care|fertility care
4955728|NCT01834300|Hepatic insulin sensitivity|hepatic insulin sensitivity
4955729|NCT01834300|Muscle insulin sensitivity|muscle insulin sensitivity
4955730|NCT01834300|B cell function|b cell function
4955731|NCT01834300|VLDL1 TG metabolism|vldl1 tg metabolism
4955732|NCT01834300|VLDL2 TG metabolism|vldl2 tg metabolism
4955733|NCT01834287|Physical Activity|physical activity
4955734|NCT01834287|Latinas|latinas
4955735|NCT01834287|Web-based|web-based
4955736|NCT01834287|Spanish-language|spanish-language
4955737|NCT01834274|Drug Therapy|drug therapy
4955738|NCT01834261|oxytocin|oxytocin
4955739|NCT01834261|trust|trust
4955740|NCT01834261|kinship|kinship
4955741|NCT01834261|kin selection|kin selection
4955742|NCT01834235|Pancreatic neoplasms|pancreatic neoplasms
4955743|NCT01834235|Pancreatic cancer|pancreatic cancer
4955744|NCT01834235|Pancreatic cancer, adult|pancreatic cancer, adult
4955745|NCT01834235|Adenoma of the pancreas|adenoma of the pancreas
4955746|NCT01834235|Carcinoma of the pancreas|carcinoma of the pancreas
4955747|NCT01834209|Prostate neoplasms|prostate neoplasms
4955748|NCT01834209|Prostate cancer|prostate cancer
4955749|NCT01834209|Metastatic prostate cancer|metastatic prostate cancer
4955750|NCT01834209|Metatatic castration resistant prostate cancer|metatatic castration resistant prostate cancer
4955751|NCT01834209|Abiraterone acetate|abiraterone acetate
4955752|NCT01834209|Prednisone|prednisone
4955753|NCT01834209|Prednisolone|prednisolone
4955754|NCT01834209|Early access program|early access program
4955755|NCT01834196|retinal vascular disease|retinal vascular disease
4955756|NCT01834196|Swept-Source Ocular Coherence Tomography|swept-source ocular coherence tomography
4955757|NCT01834196|SSOCT|ssoct
4955758|NCT01834183|Metastatic|metastatic
4955759|NCT01834170|Pancreatic cancer|pancreatic cancer
4955760|NCT01834170|Pancreatic adenocarcinoma|pancreatic adenocarcinoma
4955761|NCT01834170|Endoscopic ultrasound|endoscopic ultrasound
4955762|NCT01834144|Type 1 Diabetes|type 1 diabetes
4955763|NCT01834144|Hypoglycaemia|hypoglycaemia
4955764|NCT01834144|Glycaemic variability|glycaemic variability
4955765|NCT01834144|Vigorous Intensity Physical Activity|vigorous intensity physical activity
4955766|NCT01834144|Continuous Glucose Monitoring|continuous glucose monitoring
4955767|NCT01834131|hypertension|hypertension
4955768|NCT01834131|community health worker|community health worker
4955769|NCT01834131|home health education|home health education
4955770|NCT01834131|medication adherence|medication adherence
4955771|NCT01834131|mobile health|mobile health
4955772|NCT01834131|physician education|physician education
4955773|NCT01834131|home blood pressure monitoring|home blood pressure monitoring
4955774|NCT01834131|implementation|implementation
4955775|NCT01834105|Postmenopausal osteoporosis; Kidney Yin deficiency syndrome; Liuwei dihuang pill; CLCF1; JAK - STAT signal pathway|postmenopausal osteoporosis; kidney yin deficiency syndrome; liuwei dihuang pill; clcf1; jak - stat signal pathway
4955776|NCT01834092|Abdominal Aortic Aneurism|abdominal aortic aneurism
4955777|NCT01834092|Endothelia|endothelia
4955778|NCT01834092|Glycocalyx|glycocalyx
4955779|NCT01834092|Reperfusion|reperfusion
4955780|NCT01834092|Plasma|plasma
4955781|NCT01834079|Optic Atrophy,Stem cell therapy|optic atrophy,stem cell therapy
4955782|NCT01834066|muscular Dystrophy stem cell|muscular dystrophy stem cell
4955783|NCT01834053|Huntington Disease,stem cell therapy|huntington disease,stem cell therapy
4955784|NCT01834040|Duchenne Muscular Dystrophy|duchenne muscular dystrophy
4955785|NCT01834040|Muscular Dystrophy|muscular dystrophy
4955786|NCT01834040|Myopathy|myopathy
4955787|NCT01834027|music|music
4955788|NCT01834027|stress|stress
4955789|NCT01834027|anxiety|anxiety
4955790|NCT01834027|post-surgical|post-surgical
4955791|NCT01834027|pain|pain
4955792|NCT01834014|Liver only metastasis from KRAS Exon 2 wild type|liver only metastasis from kras exon 2 wild type
4955793|NCT01834014|Liver only metastasis from RAS wild type|liver only metastasis from ras wild type
4955794|NCT01834001|MRI|mri
4955795|NCT01834001|Prostate Cancer|prostate cancer
4955796|NCT01834001|MRI-Guided Biopsy|mri-guided biopsy
4955797|NCT01834001|Radiation|radiation
4955798|NCT01834001|Biochemical Failure|biochemical failure
4955799|NCT01833988|bionic pancreas|bionic pancreas
4955800|NCT01833988|artificial pancreas|artificial pancreas
4955801|NCT01833988|insulin|insulin
4955802|NCT01833988|glucagon|glucagon
4955803|NCT01833988|continuous glucose monitoring (CGM)|continuous glucose monitoring (cgm)
4955804|NCT01833988|outpatient|outpatient
4955805|NCT01833988|insulin pump|insulin pump
4955806|NCT01833988|pediatrics|pediatrics
4955807|NCT01833988|children|children
4955808|NCT01833988|camp|camp
4955809|NCT01833988|summer camp|summer camp
4955810|NCT01833975|Spinal Cord Injury stem cell|spinal cord injury stem cell
4955811|NCT01833962|Lumbar fusion rates|lumbar fusion rates
4955812|NCT01833962|Actifuse synthetic bone graft|actifuse synthetic bone graft
4955813|NCT01833962|Baxter Healthcare|baxter healthcare
4955814|NCT01833962|Other synthetic bone graft|other synthetic bone graft
4955944|NCT01833390|HXe|hxe
4955815|NCT01833949|polycystic ovary syndrome,laparoscopic ovarian drilling|polycystic ovary syndrome,laparoscopic ovarian drilling
4955816|NCT01833936|Achilles|achilles
4955817|NCT01833923|Advanced cancer|advanced cancer
4955818|NCT01833910|Cardiopulmonary Resuscitation|cardiopulmonary resuscitation
4955819|NCT01833910|Education|education
4955820|NCT01833897|Bipolar Disorder|bipolar disorder
4955821|NCT01833884|Hodgkin Lymphoma, Adult|hodgkin lymphoma, adult
4955822|NCT01833884|Cytokines|cytokines
4955823|NCT01833884|TARC|tarc
4955824|NCT01833884|IL-6|il-6
4955825|NCT01833884|IL1-RA|il1-ra
4955826|NCT01833884|sCD30|scd30
4955827|NCT01833884|TNFR1|tnfr1
4955828|NCT01833845|HCV|hcv
4955829|NCT01833845|Hepatitis C|hepatitis c
4955830|NCT01833845|Hep-C|hep-c
4955831|NCT01833832|Synergy for Cisplatin and Hyperthermia|synergy for cisplatin and hyperthermia
4955832|NCT01833832|Rare Tumor|rare tumor
4955833|NCT01833832|Poor Prognosis|poor prognosis
4955834|NCT01833819|Laparoscopic cholecystectomy,|laparoscopic cholecystectomy,
4955835|NCT01833819|Total intravenous anesthesia,|total intravenous anesthesia,
4955836|NCT01833819|Propofol,|propofol,
4955837|NCT01833819|Dexmedetomidine,|dexmedetomidine,
4955838|NCT01833819|Lidocaine,|lidocaine,
4955839|NCT01833819|Remifentanil,|remifentanil,
4955840|NCT01833819|Postoperative analgesic consumption,|postoperative analgesic consumption,
4955841|NCT01833819|Postoperative nausea and vomiting|postoperative nausea and vomiting
4955842|NCT01833793|Mirena|mirena
4955843|NCT01833793|Contraception|contraception
4955844|NCT01833793|Amenorrhea|amenorrhea
4955845|NCT01833780|carriage status|carriage status
4955846|NCT01833780|Culture|culture
4955847|NCT01833780|PCR|pcr
4955848|NCT01833754|Osteoporosis, Bone, Renal, Insufficiency, Kidney, Hemodialysis, Impairment|osteoporosis, bone, renal, insufficiency, kidney, hemodialysis, impairment
4955849|NCT01833715|Pain, Postoperative|pain, postoperative
4955850|NCT01833715|Analgesics, Opioid|analgesics, opioid
4955851|NCT01833715|Methadone|methadone
4955852|NCT01833715|Morphine|morphine
4955853|NCT01833702|Sickle cell|sickle cell
4955854|NCT01833702|Pain|pain
4955855|NCT01833689|glucose response|glucose response
4955856|NCT01833689|glycaemic index|glycaemic index
4955857|NCT01833676|sevoflurane|sevoflurane
4955858|NCT01833676|desflurane|desflurane
4955859|NCT01833676|protective airway reflexes|protective airway reflexes
4955860|NCT01833676|elderly|elderly
4955861|NCT01833663|Overactive Bladder|overactive bladder
4955862|NCT01833663|Solifenacin Succinate Tablets|solifenacin succinate tablets
4955863|NCT01833663|Estrogen|estrogen
4955864|NCT01833650|thyroid cancer|thyroid cancer
4955865|NCT01833650|radioiodine treatment|radioiodine treatment
4955866|NCT01833650|xerostomia|xerostomia
4955867|NCT01833650|sialadenitis|sialadenitis
4955868|NCT01833637|Advanced Care Planning|advanced care planning
4955869|NCT01833637|Palliative Care|palliative care
4955870|NCT01833637|Women|women
4955871|NCT01833598|Chronic tendinopathy|chronic tendinopathy
4955872|NCT01833598|platelet rich plasma|platelet rich plasma
4955873|NCT01833598|tendonitis|tendonitis
4955874|NCT01833598|percutaneous tendon tenotomy|percutaneous tendon tenotomy
4955875|NCT01833598|pain|pain
4955876|NCT01833598|shoulder|shoulder
4955877|NCT01833598|knee|knee
4955878|NCT01833598|ankle|ankle
4955879|NCT01833598|foot|foot
4955880|NCT01833585|critical limb ischemia|critical limb ischemia
4955881|NCT01833585|atherosclerosis|atherosclerosis
4955882|NCT01833585|ischemic ulcer|ischemic ulcer
4955883|NCT01833585|rest pain|rest pain
4955884|NCT01833585|gangrene|gangrene
4955885|NCT01833572|epidermal growth factor receptor|epidermal growth factor receptor
4955886|NCT01833572|EGFR mutation|egfr mutation
4955887|NCT01833572|Tyrosine kinase inhibitor|tyrosine kinase inhibitor
4955888|NCT01833572|gefitinib|gefitinib
4955889|NCT01833572|neo-adjuvant therapy|neo-adjuvant therapy
4955890|NCT01833546|Solid tumor|solid tumor
4955891|NCT01833546|Pancreatic cancer|pancreatic cancer
4955892|NCT01833546|TH-302|th-302
4955893|NCT01833546|gemcitabine|gemcitabine
4955894|NCT01833546|Evofosfamide|evofosfamide
4955895|NCT01833533|Chronic Hepatitis C|chronic hepatitis c
4955896|NCT01833533|Hepatitis C Virus|hepatitis c virus
4955897|NCT01833533|Hepatitis C Genotype 1a|hepatitis c genotype 1a
4955898|NCT01833533|Hepatitis C|hepatitis c
4955899|NCT01833533|Treatment-Naïve|treatment-naïve
4955900|NCT01833533|Interferon-Free|interferon-free
4955901|NCT01833533|Paritaprevir|paritaprevir
4955902|NCT01833533|Ombitasvir|ombitasvir
4955903|NCT01833533|Dasabuvir|dasabuvir
4955904|NCT01833533|Ribavirin|ribavirin
4955905|NCT01833533|Viekira PAK|viekira pak
4955906|NCT01833520|Sarcoma|sarcoma
4955907|NCT01833520|Osteosarcoma|osteosarcoma
4955908|NCT01833520|recurrent or metastatic|recurrent or metastatic
4955909|NCT01833520|Ra-223 dichloride|ra-223 dichloride
4955910|NCT01833520|Radium-223 chloride|radium-223 chloride
4955911|NCT01833520|Alpharadin|alpharadin
4955912|NCT01833507|increased activity|increased activity
4955913|NCT01833507|weight loss|weight loss
4955914|NCT01833507|obesity|obesity
4955915|NCT01833494|Hemodialysis|hemodialysis
4955916|NCT01833494|Hyperphosphatemia|hyperphosphatemia
4955917|NCT01833481|Surgical approach|surgical approach
4955918|NCT01833481|Direct-anterior|direct-anterior
4955919|NCT01833481|Anterior-lateral|anterior-lateral
4955920|NCT01833481|Posterior-lateral|posterior-lateral
4955921|NCT01833481|Hip implant|hip implant
4955922|NCT01833481|Total Hip Arthroplasty|total hip arthroplasty
4955923|NCT01833481|Total Hip replacement|total hip replacement
4955924|NCT01833481|Hip replacement|hip replacement
4955925|NCT01833481|Hip prosthesis|hip prosthesis
4955926|NCT01833468|ankylosing spondylitis|ankylosing spondylitis
4955927|NCT01833468|Psoriatic arthritis|psoriatic arthritis
4955928|NCT01833468|Foot|foot
4955929|NCT01833468|FAOS|faos
4955930|NCT01833468|SpA-TRI|spa-tri
4955931|NCT01833442|OCD|ocd
4955932|NCT01833442|YBOCS|ybocs
4955933|NCT01833429|Resistant hypertension|resistant hypertension
4955934|NCT01833429|White-coat phenomenon|white-coat phenomenon
4955935|NCT01833429|Heart rate variability|heart rate variability
4955936|NCT01833429|autonomic activity|autonomic activity
4955937|NCT01833416|CMV infection|cmv infection
4955938|NCT01833416|CMV disease|cmv disease
4955939|NCT01833416|Natural history|natural history
4955940|NCT01833416|Kidney transplant|kidney transplant
4955941|NCT01833403|bariatric surgery, l|bariatric surgery, l
4955942|NCT01833403|liver insulin resistance,|liver insulin resistance,
4955943|NCT01833390|Hyperpolarized Xenon|hyperpolarized xenon
4955945|NCT01833390|MagniXene|magnixene
4955946|NCT01833377|obesity|obesity
4955947|NCT01833377|overweight|overweight
4955948|NCT01833377|BMI|bmi
4955949|NCT01833364|Parkinson's Disease|parkinson's disease
4955950|NCT01833364|Deep Brain Stimulation|deep brain stimulation
4955951|NCT01833364|Peripheral Nerve Graft|peripheral nerve graft
4955952|NCT01833351|Phase I|phase i
4955953|NCT01833351|safety and pharmacokinetics,|safety and pharmacokinetics,
4955954|NCT01833351|intravenous ascorbate,|intravenous ascorbate,
4955955|NCT01833351|IV Vitamin C,|iv vitamin c,
4955956|NCT01833351|Oncology|oncology
4955957|NCT01833338|Non ST elevation myocardial infarction|non st elevation myocardial infarction
4955958|NCT01833338|optical coherence tomography|optical coherence tomography
4955959|NCT01833338|intravascular ultrasound|intravascular ultrasound
4955960|NCT01833338|multi-slice computed tomography|multi-slice computed tomography
4955961|NCT01833325|Age-Related Macular Degeneration|age-related macular degeneration
4955962|NCT01833325|Macular Degeneration|macular degeneration
4955963|NCT01833325|Proton radiation|proton radiation
4955964|NCT01833325|Choroidal Neovascular Membranes|choroidal neovascular membranes
4955965|NCT01833312|acute ischemic stroke|acute ischemic stroke
4955966|NCT01833312|hypothermia|hypothermia
4955969|NCT01833299|overall survival|overall survival
4955970|NCT01833299|time to progression|time to progression
4955971|NCT01833286|hepatocellular carcinoma|hepatocellular carcinoma
4955972|NCT01833286|repeat hepatectomy|repeat hepatectomy
4955973|NCT01833286|radiofrequency ablation|radiofrequency ablation
4955974|NCT01833286|transcatheter arterial chemoembolization|transcatheter arterial chemoembolization
4955975|NCT01833247|epilepsy|epilepsy
4955976|NCT01833247|lactic acid|lactic acid
4955977|NCT01833247|saliva|saliva
4955978|NCT01833247|postictal|postictal
4955979|NCT01833234|epilepsy|epilepsy
4955980|NCT01833234|quality of life|quality of life
4955981|NCT01833234|seizure severity|seizure severity
4955982|NCT01833234|antiepileptic drug side effects|antiepileptic drug side effects
4955983|NCT01833234|questionnaire|questionnaire
4955984|NCT01833234|patient reported outcomes|patient reported outcomes
4955985|NCT01833221|facial palsy|facial palsy
4955986|NCT01833221|lengthening temporalis myoplasty|lengthening temporalis myoplasty
4955987|NCT01833221|neurotization of facial muscles|neurotization of facial muscles
4955988|NCT01833195|molecular diagnostics|molecular diagnostics
4955989|NCT01833195|heart transplantation|heart transplantation
4955990|NCT01833195|risk factors|risk factors
4955991|NCT01833195|prognosis|prognosis
4955992|NCT01833182|falls in community dwelling older adults|falls in community dwelling older adults
4955993|NCT01833182|falls and ADL performance|falls and adl performance
4955994|NCT01833182|tailored home intervention|tailored home intervention
4955995|NCT01833169|Solid tumor|solid tumor
4955996|NCT01833169|malignancy|malignancy
4955997|NCT01833169|hematologic malignancy|hematologic malignancy
4955998|NCT01833169|PI3K pathway activation|pi3k pathway activation
4955999|NCT01833169|P13K activated tumors|p13k activated tumors
4956000|NCT01833169|BKM120|bkm120
4956001|NCT01833169|signature|signature
4956002|NCT01833169|AML|aml
4956003|NCT01833169|acute myelogenous leukemia|acute myelogenous leukemia
4956004|NCT01833169|cervical|cervical
4956005|NCT01833169|ovarian|ovarian
4956006|NCT01833169|hepatobiliary|hepatobiliary
4956007|NCT01833169|buparlisib|buparlisib
4956008|NCT01833156|local edema|local edema
4956009|NCT01833156|dielectric constant values|dielectric constant values
4956010|NCT01833156|validation study|validation study
4956011|NCT01833143|KRAS-Mutant|kras-mutant
4956012|NCT01833143|Bortezomib|bortezomib
4956013|NCT01833143|KRAS G12D|kras g12d
4956014|NCT01833143|12-222|12-222
4956015|NCT01833117|Dry eye|dry eye
4956016|NCT01833117|Tear film|tear film
4956017|NCT01833117|Tear break-up time|tear break-up time
4956018|NCT01833117|Ocular surface|ocular surface
4956019|NCT01833117|Eye drops|eye drops
4956020|NCT01833104|Healthy subjects|healthy subjects
4956021|NCT01833039|Mantle Cell Lymphoma|mantle cell lymphoma
4956022|NCT01833039|Ibrutinib|ibrutinib
4956023|NCT01833026|pulmonary disease|pulmonary disease
4956024|NCT01833026|chronic obstructive airflow|chronic obstructive airflow
4956025|NCT01833026|spirometry|spirometry
4956026|NCT01833026|primary healthcare|primary healthcare
4956027|NCT01833026|guideline-based therapy|guideline-based therapy
4956028|NCT01833013|Endometriosis|endometriosis
4956029|NCT01833013|Cohort study|cohort study
4956030|NCT01833013|fertility|fertility
4956031|NCT01833013|pregnancy|pregnancy
4956032|NCT01833013|assisted reproductive technics|assisted reproductive technics
4956033|NCT01833013|laparoscopy|laparoscopy
4956034|NCT01833000|rectal bleeding|rectal bleeding
4956035|NCT01833000|necrotizing enterolitis|necrotizing enterolitis
4956036|NCT01833000|splanchnic oxygenation|splanchnic oxygenation
4956037|NCT01833000|mesenteric doppler|mesenteric doppler
4956038|NCT01832987|co-trimoxazole|co-trimoxazole
4956039|NCT01832987|sulfamethoxazole|sulfamethoxazole
4956040|NCT01832987|tuberculosis|tuberculosis
4956041|NCT01832987|pharmacokinetics|pharmacokinetics
4956042|NCT01832974|Adrenal Gland Cancer|adrenal gland cancer
4956043|NCT01832974|Treatment Refractory Malignancies|treatment refractory malignancies
4956044|NCT01832974|Metastatic Cancer|metastatic cancer
4956045|NCT01832961|COPD|copd
4956046|NCT01832961|physiotherapy care|physiotherapy care
4956047|NCT01832961|lung function testing|lung function testing
4956048|NCT01832961|inflammation|inflammation
4956049|NCT01832935|Glargin|glargin
4956050|NCT01832935|NPH|nph
4956051|NCT01832935|Cost-effectiveness|cost-effectiveness
4956052|NCT01832922|bendamustine|bendamustine
4956053|NCT01832922|rituximab|rituximab
4956054|NCT01832922|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
4956055|NCT01832922|comorbidities|comorbidities
4956056|NCT01832922|renal insufficiency|renal insufficiency
4956057|NCT01832909|metabolizable energy|metabolizable energy
4956058|NCT01832909|walnuts|walnuts
4956059|NCT01832909|Atwater factors|atwater factors
4956060|NCT01832909|energy value|energy value
4956061|NCT01832896|Hereditary Angioedema|hereditary angioedema
4956062|NCT01832896|Children|children
4956063|NCT01832896|Adolescents|adolescents
4956064|NCT01832896|Ecallantide|ecallantide
4956065|NCT01832857|metastatic|metastatic
4956066|NCT01832857|advanced|advanced
4956067|NCT01832857|solid tumor|solid tumor
4956068|NCT01832857|cancer|cancer
4956069|NCT01832857|colon cancer|colon cancer
4956800|NCT01829646|DCE MRI|dce mri
4956070|NCT01832857|hepatocellular carcinoma|hepatocellular carcinoma
4956071|NCT01832857|breast cancer|breast cancer
4956072|NCT01832857|lung cancer|lung cancer
4956073|NCT01832857|gastric cancer|gastric cancer
4956074|NCT01832857|esophageal cancer|esophageal cancer
4956075|NCT01832844|Scan control|scan control
4956076|NCT01832844|Epidural infiltration|epidural infiltration
4956077|NCT01832844|visual analogue scale (VAS)|visual analogue scale (vas)
4956078|NCT01832818|Total Disc Replacement|total disc replacement
4956079|NCT01832805|depression|depression
4956080|NCT01832779|Achalasia|achalasia
4956081|NCT01832766|schizophrenia|schizophrenia
4956082|NCT01832766|dronabinol|dronabinol
4956083|NCT01832766|P50|p50
4956084|NCT01832766|cannabis|cannabis
4956085|NCT01832766|memory|memory
4956086|NCT01832766|symptoms|symptoms
4956087|NCT01832753|Down syndrome|down syndrome
4956088|NCT01832753|subclinical hypothyroidism|subclinical hypothyroidism
4956089|NCT01832753|thyroid|thyroid
4956090|NCT01832753|levothyroxine|levothyroxine
4956091|NCT01832740|young healthy subjects|young healthy subjects
4956092|NCT01832740|brain stimulation|brain stimulation
4956093|NCT01832740|tSOS|tsos
4956094|NCT01832740|tDCS|tdcs
4956095|NCT01832740|sleep|sleep
4956096|NCT01832740|memory|memory
4956097|NCT01832740|memory consolidation|memory consolidation
4956098|NCT01832727|multiple myeloma|multiple myeloma
4956099|NCT01832727|oprozomib|oprozomib
4956100|NCT01832727|OPZ|opz
4956101|NCT01832727|ONX 0912|onx 0912
4956102|NCT01832727|Onyx|onyx
4956103|NCT01832727|proteasome inhibitor|proteasome inhibitor
4956104|NCT01832727|oprozomib tablets|oprozomib tablets
4956105|NCT01832714|Concussion|concussion
4956106|NCT01832714|mTBI|mtbi
4956107|NCT01832714|military|military
4956108|NCT01832714|MACE|mace
4956109|NCT01832714|NKI|nki
4956110|NCT01832714|NOTC|notc
4956111|NCT01832714|VNG|vng
4956112|NCT01832714|VOG|vog
4956113|NCT01832714|Neuro Kinetics|neuro kinetics
4956114|NCT01832714|oculomotor|oculomotor
4956115|NCT01832714|vestibular|vestibular
4956116|NCT01832714|reaction time|reaction time
4956117|NCT01832714|I-Portal|i-portal
4956118|NCT01832714|eye tracking|eye tracking
4956119|NCT01832714|Dizziness Handicap Inventory|dizziness handicap inventory
4956120|NCT01832688|iron and folic acid supplements|iron and folic acid supplements
4956121|NCT01832688|anemia|anemia
4956122|NCT01832688|gestational weight gain|gestational weight gain
4956123|NCT01832675|Endoscopy|endoscopy
4956124|NCT01832675|Anesthetics, Local|anesthetics, local
4956125|NCT01832675|Bupivacaine|bupivacaine
4956126|NCT01832675|Lidocaine|lidocaine
4956127|NCT01832649|Exercise|exercise
4956128|NCT01832649|Cocaine dependence|cocaine dependence
4956129|NCT01832636|L-Alanyl-L-Glutamine|l-alanyl-l-glutamine
4956130|NCT01832636|Environmental enteric dysfunction|environmental enteric dysfunction
4956131|NCT01832636|Tropical enteropathy|tropical enteropathy
4956132|NCT01832623|Vitamin D|vitamin d
4956133|NCT01832623|bone|bone
4956134|NCT01832623|cardiovascular status|cardiovascular status
4956135|NCT01832623|nutritional status|nutritional status
4956136|NCT01832584|Red Grapes|red grapes
4956137|NCT01832584|polyphenols|polyphenols
4956138|NCT01832584|cyclists|cyclists
4956139|NCT01832584|resveratrol|resveratrol
4956140|NCT01832584|aerobic fitness|aerobic fitness
4956141|NCT01832584|trained|trained
4956142|NCT01832571|HIV|hiv
4956143|NCT01832571|PrEP|prep
4956144|NCT01832571|Female Sex Workers|female sex workers
4956145|NCT01832571|Kenya|kenya
4956146|NCT01832545|Aquatic exercise|aquatic exercise
4956147|NCT01832545|Knee Osteoarthritis|knee osteoarthritis
4956148|NCT01832545|Exercise|exercise
4956149|NCT01832545|Pain|pain
4956150|NCT01832545|Obesity.|obesity.
4956151|NCT01832532|Sleep Apnea|sleep apnea
4956152|NCT01832532|Sleep Disordered Breathing|sleep disordered breathing
4956153|NCT01832532|liraglutide|liraglutide
4956154|NCT01832532|glucagon-like peptide-1 agonist|glucagon-like peptide-1 agonist
4956155|NCT01832532|Orexin|orexin
4956156|NCT01832532|leptin,|leptin,
4956157|NCT01832519|Cystic Fibrosis|cystic fibrosis
4956158|NCT01832519|CF|cf
4956159|NCT01832519|MRI|mri
4956160|NCT01832519|vascularization|vascularization
4956161|NCT01832519|perfusion|perfusion
4956162|NCT01832506|Solid Tumors|solid tumors
4956163|NCT01832506|MSC2156119J|msc2156119j
4956164|NCT01832506|c-Met inhibitor|c-met inhibitor
4956165|NCT01832506|Japanese|japanese
4956166|NCT01832506|Phase 1|phase 1
4956167|NCT01832480|Trichomonas vaginalis|trichomonas vaginalis
4956168|NCT01832480|metronidazole|metronidazole
4956169|NCT01832467|cetuximab-based chemotherapy|cetuximab-based chemotherapy
4956170|NCT01832467|previously treated|previously treated
4956171|NCT01832454|cerebral palsy stem cells [MNCS]|cerebral palsy stem cells [mncs]
4956172|NCT01832441|Diabetes Mellitus stem cells [MNCS ]|diabetes mellitus stem cells [mncs ]
4956173|NCT01832415|First line treatment|first line treatment
4956174|NCT01832415|Ovarian cancer|ovarian cancer
4956175|NCT01832415|Avastin|avastin
4956176|NCT01832415|fallopian tube or primary peritoneal|fallopian tube or primary peritoneal
4956177|NCT01832402|Advanced Cancers|advanced cancers
4956178|NCT01832402|Exercise-Induced Breakthrough Dyspnea|exercise-induced breakthrough dyspnea
4956179|NCT01832402|Shortness of breath|shortness of breath
4956180|NCT01832402|Fentanyl pectin nasal spray|fentanyl pectin nasal spray
4956181|NCT01832402|Placebo nasal spray|placebo nasal spray
4956182|NCT01832402|Walk test|walk test
4956183|NCT01832402|Questionnaires|questionnaires
4956184|NCT01832402|Surveys|surveys
4956185|NCT01832402|Mental ability tests|mental ability tests
4956186|NCT01832389|Subarachnoid Haemorrhage (SAH)|subarachnoid haemorrhage (sah)
4956187|NCT01832389|vasospasm|vasospasm
4956188|NCT01832389|delayed cerebral ischaemia (DCI)|delayed cerebral ischaemia (dci)
4956189|NCT01832389|goal directed therapy (GDT)|goal directed therapy (gdt)
4956190|NCT01832389|Pulse Contour Cardiac Output (PiCCO)|pulse contour cardiac output (picco)
4956191|NCT01832376|Calcific tendinitis|calcific tendinitis
4956192|NCT01832376|Shoulder|shoulder
4956193|NCT01832376|Needle lavage|needle lavage
4956194|NCT01832376|Ultrasound-guided|ultrasound-guided
4956195|NCT01832363|Severe asthma|severe asthma
4956196|NCT01832363|Bronchial thermoplasty|bronchial thermoplasty
4956197|NCT01832363|MagniXene|magnixene
4956198|NCT01832363|Hyperpolarized Xenon|hyperpolarized xenon
4956199|NCT01832363|HXe|hxe
4956200|NCT01832363|HyXe|hyxe
4956201|NCT01832324|Food Allergy|food allergy
4956202|NCT01832324|Eosinophilic Esophagitis|eosinophilic esophagitis
4956203|NCT01832324|Food Protein Induced Enterocolitis|food protein induced enterocolitis
4956204|NCT01832324|iNKT Cells|inkt cells
4956205|NCT01832324|T cells|t cells
4956206|NCT01832311|type 2 diabetes mellitus|type 2 diabetes mellitus
4956207|NCT01832311|cataract|cataract
4956208|NCT01832311|cytokines|cytokines
4956209|NCT01832311|chemokines|chemokines
4956210|NCT01832311|aqueous humor|aqueous humor
4956211|NCT01832298|Tolerability|tolerability
4956212|NCT01832298|Pharmacokinetics|pharmacokinetics
4956213|NCT01832285|fluvoxamine|fluvoxamine
4956214|NCT01832285|cognition|cognition
4956215|NCT01832285|schizophrenia|schizophrenia
4956216|NCT01832285|protein expression|protein expression
4956217|NCT01832272|Osteoarthritis|osteoarthritis
4956218|NCT01832272|Knee|knee
4956219|NCT01832272|Total knee arthroplasty|total knee arthroplasty
4956220|NCT01832272|Tourniquet|tourniquet
4956221|NCT01832272|Early release|early release
4956222|NCT01832272|Reinflation|reinflation
4956223|NCT01832246|endoscopy|endoscopy
4956224|NCT01832246|endosonography|endosonography
4956225|NCT01832246|stomach cancer|stomach cancer
4956226|NCT01832246|tumor staging|tumor staging
4956227|NCT01832220|Genomics|genomics
4956228|NCT01832220|Microbiome|microbiome
4956229|NCT01832220|Microflora|microflora
4956230|NCT01832220|Virome|virome
4956231|NCT01832220|Alpha-1|alpha-1
4956232|NCT01832194|Scrotal pain|scrotal pain
4956233|NCT01832194|Botox|botox
4956234|NCT01832181|Diabetes|diabetes
4956235|NCT01832181|MiTy|mity
4956236|NCT01832181|Metformin in Women|metformin in women
4956237|NCT01832181|Type 2 Diabetes Pregnancy|type 2 diabetes pregnancy
4956238|NCT01832155|Yoga|yoga
4956239|NCT01832155|Knee osteoarthritis|knee osteoarthritis
4956240|NCT01832155|Symptom management|symptom management
4956241|NCT01832155|Older women|older women
4956242|NCT01832155|Pain|pain
4956243|NCT01832155|Stiffness|stiffness
4956244|NCT01832155|Physical function)|physical function)
4956245|NCT01832155|Physical function of the lower extremities|physical function of the lower extremities
4956246|NCT01832155|Quality of sleep|quality of sleep
4956247|NCT01832155|Quality of life|quality of life
4956248|NCT01832116|Pancreatic cancer|pancreatic cancer
4956249|NCT01832116|Ovarian cancer|ovarian cancer
4956250|NCT01832090|aging|aging
4956251|NCT01832090|hands|hands
4956252|NCT01832077|sensibility|sensibility
4956253|NCT01832077|specificity|specificity
4956254|NCT01832077|positive predictive value|positive predictive value
4956255|NCT01832077|negative predictive value|negative predictive value
4956256|NCT01832077|Cost-effectiveness|cost-effectiveness
4956257|NCT01832064|chronic disease|chronic disease
4956258|NCT01832064|patient education|patient education
4956259|NCT01832064|self management|self management
4956260|NCT01832051|HER2-PET|her2-pet
4956261|NCT01832051|89Zr-trastuzumab|89zr-trastuzumab
4956262|NCT01832051|metastatic breast cancer|metastatic breast cancer
4956263|NCT01832051|clinical dilemma|clinical dilemma
4956264|NCT01832038|Lacosamide|lacosamide
4956265|NCT01832038|Epilepsy|epilepsy
4956266|NCT01832038|Partial-onset Seizures|partial-onset seizures
4956267|NCT01832025|intraoperative|intraoperative
4956268|NCT01832025|postoperative|postoperative
4956269|NCT01832025|complications|complications
4956270|NCT01832025|discomfort|discomfort
4956271|NCT01832025|external|external
4956272|NCT01832025|internal|internal
4956273|NCT01832025|maxillary|maxillary
4956274|NCT01832025|elevation|elevation
4956275|NCT01832025|implant|implant
4956276|NCT01832025|reconstruction|reconstruction
4956277|NCT01832025|bone|bone
4956278|NCT01832025|sinus|sinus
4956279|NCT01832012|Eliciting which type of refresher provides the greatest improvement in BLS CPR skills.|eliciting which type of refresher provides the greatest improvement in bls cpr skills.
4956280|NCT01831999|Web-based|web-based
4956281|NCT01831999|HIV Assessment|hiv assessment
4956282|NCT01831999|Outreach|outreach
4956283|NCT01831999|Retention|retention
4956284|NCT01831999|Substance Abuse Treatment|substance abuse treatment
4956285|NCT01831986|Schizophrenia|schizophrenia
4956286|NCT01831986|Schizoaffective disorder|schizoaffective disorder
4956287|NCT01831986|Pregnenolone|pregnenolone
4956288|NCT01831986|L-Theanine|l-theanine
4956289|NCT01831986|Augmentation|augmentation
4956290|NCT01831960|Intrepid|intrepid
4956291|NCT01831960|cortexolone|cortexolone
4956292|NCT01831960|cortexolone 17α-propionate|cortexolone 17α-propionate
4956293|NCT01831960|anti-androgen|anti-androgen
4956294|NCT01831947|age-related macular degeneration|age-related macular degeneration
4956295|NCT01831947|Ranibizumab|ranibizumab
4956296|NCT01831934|Mitochondrial disorder|mitochondrial disorder
4956297|NCT01831934|Trivalent inactivated influenza vaccine|trivalent inactivated influenza vaccine
4956298|NCT01831934|Adolescents and adults|adolescents and adults
4956299|NCT01831934|Immune response|immune response
4956300|NCT01831934|Metabolic response|metabolic response
4956301|NCT01831921|pre diabetes|pre diabetes
4956302|NCT01831921|obesity|obesity
4956303|NCT01831921|weight loss|weight loss
4956304|NCT01831921|lifestyle|lifestyle
4956305|NCT01831921|prevention|prevention
4956306|NCT01831908|cardiovascular health, stroke, ischemic heart disease|cardiovascular health, stroke, ischemic heart disease
4956307|NCT01831895|Hypertension|hypertension
4956308|NCT01831895|Carotid Sinus|carotid sinus
4956309|NCT01831869|Subclinical hypothyroidism|subclinical hypothyroidism
4956310|NCT01831869|L-thyroxine|l-thyroxine
4956311|NCT01831869|Lipid|lipid
4956312|NCT01831869|endothelial function|endothelial function
4956313|NCT01831869|inflammatory factor|inflammatory factor
4956314|NCT01831869|adipocytokine|adipocytokine
4956315|NCT01831856|Cardiovascular diseases|cardiovascular diseases
4956316|NCT01831856|Chronic Heart Failure|chronic heart failure
4956317|NCT01831843|core body temperature|core body temperature
4956318|NCT01831843|humidity|humidity
4956319|NCT01831843|circuit temperature|circuit temperature
4956320|NCT01831830|traumatic brain injury|traumatic brain injury
4956321|NCT01831830|occupational therapy|occupational therapy
4956322|NCT01831830|family|family
4956323|NCT01831804|diabetic foot ulcer|diabetic foot ulcer
4956324|NCT01831804|pharmacodynamics|pharmacodynamics
4956325|NCT01831804|pharmacokinetics|pharmacokinetics
4956326|NCT01831804|ischemic|ischemic
4956327|NCT01831791|male pattern hair loss|male pattern hair loss
4956328|NCT01831791|hair growth|hair growth
4956329|NCT01831791|hair restoration|hair restoration
4956330|NCT01831791|Dutasteride|dutasteride
4956331|NCT01831791|Androgenetic alopecia|androgenetic alopecia
4956332|NCT01831791|safety|safety
4956333|NCT01831791|efficacy|efficacy
4956334|NCT01831778|mammography|mammography
4956335|NCT01831778|screening|screening
4956336|NCT01831752|Diabetes|diabetes
4956337|NCT01831752|Type 1|type 1
4956338|NCT01831752|Continuous glucose monitor|continuous glucose monitor
4956339|NCT01831739|Genomics|genomics
4956340|NCT01831739|Microbiome|microbiome
4956341|NCT01831739|Microflora|microflora
4956342|NCT01831739|Virome|virome
4956343|NCT01831726|Solid tumor malignancy|solid tumor malignancy
4956344|NCT01831726|hematologic malignancy|hematologic malignancy
4956345|NCT01831726|mutation|mutation
4956346|NCT01831726|translocations|translocations
4956347|NCT01831726|FGFR|fgfr
4956348|NCT01831726|PDGFR|pdgfr
4956349|NCT01831726|VEGF|vegf
4956350|NCT01831726|cKIT|ckit
4956351|NCT01831726|FLT3|flt3
4956352|NCT01831726|CSR1|csr1
4956354|NCT01831726|RET|ret
4956355|NCT01831726|TKI258|tki258
4956356|NCT01831726|dovitinib|dovitinib
4956357|NCT01831726|signature|signature
4956358|NCT01831726|AML|aml
4956359|NCT01831726|acute myelogenous leukemia|acute myelogenous leukemia
4956360|NCT01831726|GIST|gist
4956361|NCT01831726|gastrointestinal stromal tumor|gastrointestinal stromal tumor
4956362|NCT01831726|Head and Neck cancer|head and neck cancer
4956363|NCT01831726|Melanoma|melanoma
4956364|NCT01831726|NSCLC|nsclc
4956365|NCT01831726|non-small cell lung carcinoma|non-small cell lung carcinoma
4956366|NCT01831726|lung cancer|lung cancer
4956367|NCT01831726|ovarian cancer|ovarian cancer
4956368|NCT01831726|thyroid cancer|thyroid cancer
4956369|NCT01831726|amplification|amplification
4956370|NCT01831648|IGF1|igf1
4956371|NCT01831648|standards|standards
4956372|NCT01831648|Assays|assays
4956373|NCT01831648|Z-score|z-score
4956374|NCT01831648|Healthy volunteers|healthy volunteers
4956375|NCT01831648|Population|population
4956376|NCT01831622|Decision-Making|decision-making
4956377|NCT01831622|functional MRI|functional mri
4956378|NCT01831622|pharmacological MRI|pharmacological mri
4956379|NCT01831622|Reinforcement Learning|reinforcement learning
4956380|NCT01831622|Methylphenidate|methylphenidate
4956381|NCT01831609|Gastrointestinal|gastrointestinal
4956382|NCT01831609|Genitourinary|genitourinary
4956383|NCT01831609|Rare Cancer|rare cancer
4956384|NCT01831583|sleep apnea|sleep apnea
4956385|NCT01831570|Hand osteoarthritis|hand osteoarthritis
4956386|NCT01831570|predictive factors|predictive factors
4956801|NCT01829646|ADC|adc
4956387|NCT01831570|erosive hand OA|erosive hand oa
4956388|NCT01831544|Heart Failure|heart failure
4956389|NCT01831518|Heart Failure|heart failure
4956390|NCT01831518|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
4956391|NCT01831518|ECG Imaging|ecg imaging
4956392|NCT01831518|Body Surface Mapping|body surface mapping
4956393|NCT01831505|personalized medicine|personalized medicine
4956394|NCT01831505|in vivo drug sensitivity|in vivo drug sensitivity
4956395|NCT01831505|chemotherapy|chemotherapy
4956396|NCT01831505|lymphoma|lymphoma
4956397|NCT01831505|microinjection|microinjection
4956398|NCT01831492|performance|performance
4956399|NCT01831492|acidosis|acidosis
4956400|NCT01831492|oxidative stress|oxidative stress
4956401|NCT01831492|inflammation|inflammation
4956402|NCT01831492|oxygen uptake|oxygen uptake
4956403|NCT01831479|Pharmacokinetics, drug-drug interaction|pharmacokinetics, drug-drug interaction
4956404|NCT01831466|plaque psoriasis|plaque psoriasis
4956405|NCT01831466|vulgaris|vulgaris
4956406|NCT01831466|topical treatment|topical treatment
4956407|NCT01831466|skin diseases|skin diseases
4956408|NCT01831466|papulosquamous|papulosquamous
4956409|NCT01831466|Tofacitinib|tofacitinib
4956410|NCT01831466|CP-690550|cp-690550
4956411|NCT01831466|Xeljanz|xeljanz
4956412|NCT01831466|psoriasis|psoriasis
4956413|NCT01831466|moderate|moderate
4956414|NCT01831466|severe|severe
4956415|NCT01831466|itch|itch
4956416|NCT01831466|nail psoriasis|nail psoriasis
4956417|NCT01831453|omega-3|omega-3
4956418|NCT01831453|recurrent aphthous stomatitis|recurrent aphthous stomatitis
4956419|NCT01831453|quality of life|quality of life
4956420|NCT01831440|depression|depression
4956421|NCT01831440|remission|remission
4956422|NCT01831440|Pharmacotherapy|pharmacotherapy
4956423|NCT01831440|psychotherapy|psychotherapy
4956424|NCT01831440|neuroimaging|neuroimaging
4956425|NCT01831440|psychology|psychology
4956426|NCT01831427|ulcerative colitis|ulcerative colitis
4956427|NCT01831427|moderate|moderate
4956428|NCT01831427|severe|severe
4956429|NCT01831414|Lung function|lung function
4956430|NCT01831414|Water immersion|water immersion
4956431|NCT01831414|Balneotherapy|balneotherapy
4956432|NCT01831401|Acetabular component inclination|acetabular component inclination
4956433|NCT01831388|Dyspnea|dyspnea
4956434|NCT01831388|Breath Training Exercise|breath training exercise
4956435|NCT01831388|12-261|12-261
4956436|NCT01831336|International|international
4956437|NCT01831336|Multicenter|multicenter
4956438|NCT01831336|Observational registry|observational registry
4956439|NCT01831336|Orsiro Drug Eluting Stent (DES)|orsiro drug eluting stent (des)
4956440|NCT01831336|Stenting|stenting
4956441|NCT01831336|Treatment of Coronary Artery Disease|treatment of coronary artery disease
4956442|NCT01831336|Coronary revascularization|coronary revascularization
4956443|NCT01831336|Percutaneous Coronary Intervention|percutaneous coronary intervention
4956444|NCT01831336|STEMI|stemi
4956445|NCT01831336|NSTEMI|nstemi
4956446|NCT01831336|Ischemia|ischemia
4956447|NCT01831336|Angina|angina
4956448|NCT01831336|Subgroups|subgroups
4956449|NCT01831336|Acute Myocardial Infarction|acute myocardial infarction
4956450|NCT01831336|Diabetes|diabetes
4956451|NCT01831336|Small Vessels|small vessels
4956452|NCT01831336|Chronic Total Occlusion (CTO)|chronic total occlusion (cto)
4956453|NCT01831310|Colorectal cancer|colorectal cancer
4956454|NCT01831310|nutrition|nutrition
4956455|NCT01831310|neutrophil phagocytosis|neutrophil phagocytosis
4956456|NCT01831310|neutrophil adhesivity|neutrophil adhesivity
4956457|NCT01831310|glutamine|glutamine
4956458|NCT01831310|omega 3 fatty acids|omega 3 fatty acids
4956459|NCT01831271|Exercise, Physical|exercise, physical
4956460|NCT01831271|Physical Activity|physical activity
4956461|NCT01831271|Outcome Measures|outcome measures
4956462|NCT01831219|osteoarthritis|osteoarthritis
4956463|NCT01831219|arthroplasty|arthroplasty
4956464|NCT01831219|hip arthroplasty|hip arthroplasty
4956465|NCT01831206|corneal ulcer|corneal ulcer
4956466|NCT01831206|keratitis|keratitis
4956467|NCT01831180|hair|hair
4956468|NCT01831180|scalp|scalp
4956469|NCT01831180|blood flow|blood flow
4956470|NCT01831180|Caucasian|caucasian
4956471|NCT01831180|Histamine stimulation|histamine stimulation
4956472|NCT01831180|Wake Forest|wake forest
4956473|NCT01831167|dynamic light application|dynamic light application
4956474|NCT01831167|sustained attention|sustained attention
4956475|NCT01831167|divided attention|divided attention
4956476|NCT01831167|nursing|nursing
4956477|NCT01831154|Glycemic control|glycemic control
4956478|NCT01831141|Congenital Solitary Kidney|congenital solitary kidney
4956479|NCT01831141|Glomerular filtration rate|glomerular filtration rate
4956480|NCT01831141|Chronic kidney damage|chronic kidney damage
4956481|NCT01831141|Hypertension|hypertension
4956482|NCT01831141|Proteinuria|proteinuria
4956483|NCT01831128|Congestive Heart Failure|congestive heart failure
4956484|NCT01831128|Central Sleep Apnea|central sleep apnea
4956485|NCT01831128|Sleep-Disordered Breathing|sleep-disordered breathing
4956486|NCT01831115|heart failure|heart failure
4956488|NCT01831115|acute dyspnoea|acute dyspnoea
4956489|NCT01831102|insulin resistance|insulin resistance
4956490|NCT01831102|ethnic disparities|ethnic disparities
4956491|NCT01831102|adiponectin|adiponectin
4956492|NCT01831076|Breast cancer|breast cancer
4956493|NCT01831076|estrogen receptor-positive breast cancer|estrogen receptor-positive breast cancer
4956494|NCT01831076|progesterone receptor-positive breast cancer|progesterone receptor-positive breast cancer
4956495|NCT01831076|Postmenopausal|postmenopausal
4956496|NCT01831076|Exemestane|exemestane
4956497|NCT01831076|Tamoxifen|tamoxifen
4956498|NCT01831063|Seizure|seizure
4956499|NCT01831063|Caregivers|caregivers
4956500|NCT01831063|Family Centered Care|family centered care
4956501|NCT01831063|Learning modality|learning modality
4956502|NCT01831050|Poliovirus|poliovirus
4956503|NCT01831050|Inactivated poliovirus vaccine|inactivated poliovirus vaccine
4956504|NCT01831050|Trivalent oral polio vaccine|trivalent oral polio vaccine
4956505|NCT01831050|Bivalent oral polio vaccine|bivalent oral polio vaccine
4956506|NCT01831050|Stool shedding index|stool shedding index
4956507|NCT01831050|Polio eradication|polio eradication
4956508|NCT01831037|Hepatocellular carcinoma|hepatocellular carcinoma
4956509|NCT01831037|Regressed cirrhosis|regressed cirrhosis
4956510|NCT01831037|Hepatitis C|hepatitis c
4956511|NCT01831037|Hepatitis B|hepatitis b
4956512|NCT01831037|Noninvasive markers of fibrosis|noninvasive markers of fibrosis
4956513|NCT01831037|FibroTest|fibrotest
4956514|NCT01831037|FibroSure|fibrosure
4956515|NCT01831037|FibroScan|fibroscan
4956516|NCT01831037|Transient elastography|transient elastography
4956517|NCT01831024|Cold cap|cold cap
4956518|NCT01831024|Scalp cooling|scalp cooling
4956519|NCT01831024|Chemotherapy induced alopecia|chemotherapy induced alopecia
4956520|NCT01831024|Breast cancer|breast cancer
4956521|NCT01831011|randomized trial|randomized trial
4956522|NCT01831011|acute ischemic stroke|acute ischemic stroke
4956523|NCT01831011|mildronate|mildronate
4956524|NCT01830998|Dementia|dementia
4956525|NCT01830998|Olfactory|olfactory
4956526|NCT01830959|Sarcoidosis, fibrosis, bronchiectasis|sarcoidosis, fibrosis, bronchiectasis
4956527|NCT01830946|Protein|protein
4956528|NCT01830946|Metabolism|metabolism
4956529|NCT01830946|Nighttime eating|nighttime eating
4956530|NCT01830946|Exercise Training|exercise training
4956531|NCT01830933|Breast cancer concern, breast cancer risk perception, breast cancer risk|breast cancer concern, breast cancer risk perception, breast cancer risk
4956532|NCT01830920|Acute Kidney Injury|acute kidney injury
4956533|NCT01830920|AKI|aki
4956534|NCT01830920|Cardiac surgery|cardiac surgery
4956535|NCT01830907|Malnutrition|malnutrition
4956536|NCT01830907|Gastric cancer|gastric cancer
4956537|NCT01830907|preoperative nutrition|preoperative nutrition
4956538|NCT01830881|pain|pain
4956539|NCT01830881|anxiety|anxiety
4956540|NCT01830881|surgical abortion|surgical abortion
4956541|NCT01830881|midazolam|midazolam
4956542|NCT01830881|benzodiazepine|benzodiazepine
4956543|NCT01830868|ZNS|zns
4956544|NCT01830868|AED|aed
4956545|NCT01830868|Partial Onset Seizures|partial onset seizures
4956546|NCT01830868|Retention Rate|retention rate
4956547|NCT01830868|Seizure Control|seizure control
4956548|NCT01830868|Antiepileptic|antiepileptic
4956549|NCT01830868|Secondary generalization|secondary generalization
4956550|NCT01830868|Seizure freedom rates|seizure freedom rates
4956551|NCT01830842|Nicotine|nicotine
4956552|NCT01830842|Smoking|smoking
4956553|NCT01830842|Cigarettes|cigarettes
4956554|NCT01830842|Reinforcement Learning|reinforcement learning
4956555|NCT01830842|fMRI|fmri
4956556|NCT01830829|BPH|bph
4956557|NCT01830829|CPPS|cpps
4956558|NCT01830816|Relapsed|relapsed
4956559|NCT01830816|Refractory|refractory
4956560|NCT01830816|Multiple Myeloma|multiple myeloma
4956561|NCT01830816|Advanced solid tumors|advanced solid tumors
4956562|NCT01830803|howRU|howru
4956563|NCT01830803|howRwe|howrwe
4956564|NCT01830803|reliability|reliability
4956565|NCT01830803|quality of life|quality of life
4956566|NCT01830803|quality of care|quality of care
4956567|NCT01830803|patient satisfaction|patient satisfaction
4956568|NCT01830751|self treatment technique|self treatment technique
4956569|NCT01830751|chronic|chronic
4956570|NCT01830751|non specific|non specific
4956571|NCT01830751|LBP|lbp
4956572|NCT01830751|control trunk flexion|control trunk flexion
4956573|NCT01830751|diurnal|diurnal
4956574|NCT01830738|laparoscopy|laparoscopy
4956575|NCT01830738|hysterectomy|hysterectomy
4956576|NCT01830738|single-port trocar|single-port trocar
4956577|NCT01830738|surgical technique|surgical technique
4956578|NCT01830738|trocar|trocar
4956579|NCT01830725|Xanthine Oxidase|xanthine oxidase
4956580|NCT01830725|Gout|gout
4956581|NCT01830725|Hyperuricemia|hyperuricemia
4956582|NCT01830725|SNP|snp
4956583|NCT01830725|Single Nucleotide Polymorphisms|single nucleotide polymorphisms
4956584|NCT01830699|Rilonacept|rilonacept
4956585|NCT01830699|Subacromial Bursitis treatment|subacromial bursitis treatment
4956586|NCT01830699|Corticosteroid Injection|corticosteroid injection
4956587|NCT01830686|Sugarcane bagasse, glucose tolerance, insulin resistance|sugarcane bagasse, glucose tolerance, insulin resistance
4956588|NCT01830673|T-regulatory cells|t-regulatory cells
4956589|NCT01830673|TH1, TH2 cells|th1, th2 cells
4956590|NCT01830673|specific IgE|specific ige
4956591|NCT01830673|specific IgG|specific igg
4956592|NCT01830673|specific IgG4|specific igg4
4956594|NCT01830673|IL5|il5
4956595|NCT01830673|IL10|il10
4956596|NCT01830673|IL12/23|il12/23
4956597|NCT01830673|Y-IFN|y-ifn
4956598|NCT01830673|TNF-a|tnf-a
4956599|NCT01830634|Community-dwelling elderly|community-dwelling elderly
4956600|NCT01830634|Rehabilitation|rehabilitation
4956601|NCT01830634|Theraband|theraband
4956602|NCT01830634|Strengthening and stretching exercise|strengthening and stretching exercise
4956603|NCT01830582|MRI|mri
4956604|NCT01830582|rectum|rectum
4956605|NCT01830582|13-019|13-019
4956606|NCT01830569|Decision Support Systems, Clinical|decision support systems, clinical
4956607|NCT01830569|Evidence-Based practice|evidence-based practice
4956608|NCT01830569|Family Practice|family practice
4956609|NCT01830543|Atrial Fibrillation|atrial fibrillation
4956610|NCT01830543|Irregular heart beat|irregular heart beat
4956611|NCT01830543|rivaroxaban|rivaroxaban
4956612|NCT01830543|aspirin|aspirin
4956613|NCT01830543|clopidogrel|clopidogrel
4956614|NCT01830543|prasugrel|prasugrel
4956615|NCT01830543|ticagrelor|ticagrelor
4956616|NCT01830543|vitamin K antagonist|vitamin k antagonist
4956617|NCT01830530|arterial hypertension|arterial hypertension
4956618|NCT01830530|high altitude|high altitude
4956619|NCT01830530|hypobaric hypoxia|hypobaric hypoxia
4956620|NCT01830530|combination treatment|combination treatment
4956621|NCT01830530|angiotensin receptor blocker|angiotensin receptor blocker
4956622|NCT01830530|calcium antagonist|calcium antagonist
4956623|NCT01830504|thyroid cancers|thyroid cancers
4956624|NCT01830504|refractory|refractory
4956625|NCT01830504|PI3K inhibitor|pi3k inhibitor
4956626|NCT01830465|Non Hodgkin's Follicular Lymphoma|non hodgkin's follicular lymphoma
4956627|NCT01830465|relapsed|relapsed
4956628|NCT01830465|progressed|progressed
4956629|NCT01830452|Chronic pain|chronic pain
4956630|NCT01830452|Progrip Mesh|progrip mesh
4956631|NCT01830452|Self gripping mesh|self gripping mesh
4956632|NCT01830452|Lichtenstein|lichtenstein
4956633|NCT01830439|tuberculosis|tuberculosis
4956634|NCT01830439|PK|pk
4956635|NCT01830439|PA-824|pa-824
4956636|NCT01830439|food effect|food effect
4956637|NCT01830439|pretomanid|pretomanid
4956638|NCT01830439|CL-009|cl-009
4956639|NCT01830413|stent, systematic Intracranial artery stenosis|stent, systematic intracranial artery stenosis
4956640|NCT01830400|ESL|esl
4956641|NCT01830400|Partial onset seizures|partial onset seizures
4956642|NCT01830400|Retention Rate|retention rate
4956643|NCT01830400|Seizure Control|seizure control
4956644|NCT01830400|Antiepileptic|antiepileptic
4956645|NCT01830400|Secondary Generalisation|secondary generalisation
4956646|NCT01830387|Polymetric Clips (Hem-o-Lok)|polymetric clips (hem-o-lok)
4956647|NCT01830387|Laparoscopic Appendectomy|laparoscopic appendectomy
4956648|NCT01830387|Endoscopic Staplers|endoscopic staplers
4956649|NCT01830374|Bulimia nervosa|bulimia nervosa
4956650|NCT01830374|Eating disorder|eating disorder
4956651|NCT01830374|Weight suppression|weight suppression
4956652|NCT01830374|Dieting|dieting
4956653|NCT01830361|AML|aml
4956654|NCT01830361|Acute Myeloid Leukemia|acute myeloid leukemia
4956655|NCT01830361|c-KIT|c-kit
4956656|NCT01830361|FLT3-ITD|flt3-itd
4956657|NCT01830361|t(8;21)|t(8;21)
4956658|NCT01830361|chemotherapy|chemotherapy
4956659|NCT01830361|midostaurin|midostaurin
4956660|NCT01830348|diabetic foot ulcers|diabetic foot ulcers
4956661|NCT01830348|Wagner Grade 1 or 2 foot ulcers|wagner grade 1 or 2 foot ulcers
4956662|NCT01830322|metastatic|metastatic
4956663|NCT01830322|pancreatic|pancreatic
4956664|NCT01830322|adenocarcinoma|adenocarcinoma
4956665|NCT01830322|cancer|cancer
4956666|NCT01830309|Food-Effect|food-effect
4956667|NCT01830309|Pharmacokinetics|pharmacokinetics
4956668|NCT01830309|Pharmacodynamics|pharmacodynamics
4956669|NCT01830296|Postthoracotomy pain,|postthoracotomy pain,
4956670|NCT01830296|patient controlled analgesia,|patient controlled analgesia,
4956671|NCT01830296|remifentanil and|remifentanil and
4956672|NCT01830296|morphine.|morphine.
4956673|NCT01830270|medical oncology|medical oncology
4956674|NCT01830270|chemotherapy optimization|chemotherapy optimization
4956675|NCT01830270|dose density|dose density
4956676|NCT01830244|chemotherapy|chemotherapy
4956677|NCT01830244|nab paclitaxel|nab paclitaxel
4956678|NCT01830244|neoadjuvant therapy|neoadjuvant therapy
4956679|NCT01830244|breast cancer|breast cancer
4956680|NCT01830244|pathologic complete response|pathologic complete response
4956681|NCT01830231|TCCU|tccu
4956682|NCT01830231|Vinflunine|vinflunine
4956683|NCT01830231|Cabazitaxel|cabazitaxel
4956684|NCT01830231|Metastatic|metastatic
4956685|NCT01830231|Locally advance|locally advance
4956686|NCT01830192|endometrial cancer|endometrial cancer
4956687|NCT01830192|score|score
4956688|NCT01830192|nomogram|nomogram
4956689|NCT01830192|ultrasound|ultrasound
4956690|NCT01830192|HE4|he4
4956691|NCT01830153|Soft tissue sarcomas|soft tissue sarcomas
4956692|NCT01830153|Bone sarcomas|bone sarcomas
4956693|NCT01830153|RAD001|rad001
4956694|NCT01830153|Refractory to conventional chemotherapy|refractory to conventional chemotherapy
4956695|NCT01830114|alcohol abuse|alcohol abuse
4956696|NCT01830114|drug abuse|drug abuse
4956697|NCT01830114|hazardous alcohol use|hazardous alcohol use
4956698|NCT01830114|hazardous drug use|hazardous drug use
4956699|NCT01830101|recurrent glioblastoma|recurrent glioblastoma
4956700|NCT01830101|re-irradiation|re-irradiation
4956701|NCT01830101|continuous low-dose temozolomide|continuous low-dose temozolomide
4956702|NCT01830036|cardiological treatment|cardiological treatment
4956703|NCT01830036|sleep Apnea|sleep apnea
4956704|NCT01830023|cardiac ultrasound|cardiac ultrasound
4956705|NCT01830023|vitality|vitality
4956706|NCT01830023|data|data
4956707|NCT01830023|patients|patients
4956708|NCT01830023|examined|examined
4956709|NCT01829984|Injection Teaching|injection teaching
4956710|NCT01829984|13-057|13-057
4956711|NCT01829971|microRNA|microrna
4956712|NCT01829971|Advanced cancer|advanced cancer
4956713|NCT01829958|Geriatric|geriatric
4956714|NCT01829958|Toxicity|toxicity
4956715|NCT01829958|rituximab|rituximab
4956716|NCT01829958|prednisone|prednisone
4956717|NCT01829958|Comprehensive Geriatric Assessment (CGA)|comprehensive geriatric assessment (cga)
4956718|NCT01829958|13-028|13-028
4956719|NCT01829932|Diet|diet
4956720|NCT01829919|Menopause|menopause
4956721|NCT01829919|Hot flashes|hot flashes
4956722|NCT01829919|Vasomotor symptoms|vasomotor symptoms
4956723|NCT01829919|Climacteric symptoms|climacteric symptoms
4956724|NCT01829919|perimenopause|perimenopause
4956725|NCT01829919|Mesafem|mesafem
4956726|NCT01829919|Brisdelle|brisdelle
4956727|NCT01829919|Low-Dose Mesylate salt of Paroxetine (LDMP)|low-dose mesylate salt of paroxetine (ldmp)
4956728|NCT01829906|weight loss|weight loss
4956729|NCT01829906|bariatric surgery|bariatric surgery
4956730|NCT01829906|gastric bypass|gastric bypass
4956731|NCT01829906|health education|health education
4956732|NCT01829906|nutrition therapy|nutrition therapy
4956733|NCT01829906|diet|diet
4956734|NCT01829906|exercise|exercise
4956735|NCT01829906|cognitive therapy|cognitive therapy
4956736|NCT01829893|Benign Prostatic Hyperplasia (BPH)|benign prostatic hyperplasia (bph)
4956737|NCT01829893|pharmacokinetics|pharmacokinetics
4956738|NCT01829893|bioequivalence|bioequivalence
4956739|NCT01829893|finasteirde|finasteirde
4956740|NCT01829893|tamsulosin|tamsulosin
4956741|NCT01829880|Chronic heart failure|chronic heart failure
4956742|NCT01829880|Bisoprolol|bisoprolol
4956743|NCT01829880|Ramipril|ramipril
4956744|NCT01829880|Pharmacokinetic|pharmacokinetic
4956745|NCT01829880|Cachexia|cachexia
4956746|NCT01829880|Body composition|body composition
4956747|NCT01829880|Renal function|renal function
4956748|NCT01829880|Iohexol|iohexol
4956749|NCT01829841|MRCC|mrcc
4956750|NCT01829841|Metastatic Renal Cell Cancer|metastatic renal cell cancer
4956751|NCT01829841|Famitinib|famitinib
4956752|NCT01829841|Sunitinib|sunitinib
4956753|NCT01829828|Pain|pain
4956754|NCT01829828|Cancer pain|cancer pain
4956755|NCT01829828|Self-reported pain scoring tool|self-reported pain scoring tool
4956756|NCT01829828|Opioid analgesics|opioid analgesics
4956757|NCT01829815|Child|child
4956758|NCT01829815|Parents|parents
4956759|NCT01829815|Parenting|parenting
4956760|NCT01829815|Child Development|child development
4956761|NCT01829815|Parent Child Relations|parent child relations
4956762|NCT01829815|Malaria|malaria
4956763|NCT01829815|Primary Prevention|primary prevention
4956764|NCT01829815|Punishment|punishment
4956765|NCT01829815|Education|education
4956766|NCT01829802|HIV|hiv
4956767|NCT01829802|Raltegravir|raltegravir
4956768|NCT01829802|Boosted atazanavir|boosted atazanavir
4956769|NCT01829789|Adolescents|adolescents
4956770|NCT01829789|Teens|teens
4956771|NCT01829789|Parents|parents
4956772|NCT01829789|Parenting|parenting
4956773|NCT01829789|Substance Abuse|substance abuse
4956774|NCT01829789|Treatment Efficacy|treatment efficacy
4956775|NCT01829776|Accidental falls|accidental falls
4956776|NCT01829776|Multiple Sclerosis|multiple sclerosis
4956777|NCT01829776|Education|education
4956778|NCT01829776|Exercise|exercise
4956779|NCT01829776|Postural balance|postural balance
4956780|NCT01829750|Univentricular heart|univentricular heart
4956781|NCT01829737|Asymptomatic Parasitemia|asymptomatic parasitemia
4956782|NCT01829737|RBC Polymorphism|rbc polymorphism
4956783|NCT01829737|Acquired Immunity|acquired immunity
4956784|NCT01829724|Functional Brain Imaging|functional brain imaging
4956785|NCT01829724|Cerebral Palsy|cerebral palsy
4956786|NCT01829724|Motion Analysis|motion analysis
4956787|NCT01829724|Macro- EMG|macro- emg
4956788|NCT01829711|Moxetumomab Paudotox|moxetumomab paudotox
4956789|NCT01829711|CAT-8015|cat-8015
4956790|NCT01829711|anti-CD22 recombination immunotoxin|anti-cd22 recombination immunotoxin
4956791|NCT01829711|Biologic Therapy|biologic therapy
4956792|NCT01829711|Recombinant Immunotoxin|recombinant immunotoxin
4956793|NCT01829711|Monoclonal Antibody|monoclonal antibody
4956794|NCT01829711|Pseudomonas Exotoxin|pseudomonas exotoxin
4956795|NCT01829711|Targeted Therapy|targeted therapy
4956796|NCT01829698|tudca PBC Cholestasis tauroursodeoxycholic acid taurolite|tudca pbc cholestasis tauroursodeoxycholic acid taurolite
4956797|NCT01829672|Early diagnosis of pulmonary arterial hypertension|early diagnosis of pulmonary arterial hypertension
4956798|NCT01829672|dynamic dual-energy computed tomography|dynamic dual-energy computed tomography
4956802|NCT01829646|FDG PET|fdg pet
4956803|NCT01829646|Hypoxia|hypoxia
4956804|NCT01829646|Prognostic and predictive model|prognostic and predictive model
4956805|NCT01829620|suicide|suicide
4956806|NCT01829620|suicide intervention|suicide intervention
4956807|NCT01829620|suicide prevention|suicide prevention
4956808|NCT01829620|military|military
4956809|NCT01829620|military suicide|military suicide
4956810|NCT01829620|caring letters|caring letters
4956811|NCT01829620|caring contacts|caring contacts
4956812|NCT01829620|text messages|text messages
4956813|NCT01829594|Case Management|case management
4956814|NCT01829594|Frail Elderly|frail elderly
4956815|NCT01829594|Health Services Administration|health services administration
4956816|NCT01829594|Delivery of Health Care|delivery of health care
4956817|NCT01829594|Accidental Falls|accidental falls
4956818|NCT01829594|Health Status|health status
4956819|NCT01829594|Health Care Economics|health care economics
4956820|NCT01829542|flow-mediated dilation|flow-mediated dilation
4956821|NCT01829542|blueberry polyphenols|blueberry polyphenols
4956822|NCT01829542|dose-dependency|dose-dependency
4956823|NCT01829529|Antibiotic prophylaxis|antibiotic prophylaxis
4956824|NCT01829503|Phase II|phase ii
4956825|NCT01829503|decitabine|decitabine
4956826|NCT01829503|cytarabine|cytarabine
4956827|NCT01829503|older patients|older patients
4956828|NCT01829503|newly diagnosed|newly diagnosed
4956829|NCT01829503|AML|aml
4956830|NCT01829503|Newly Diagnosed AML|newly diagnosed aml
4956831|NCT01829490|Vaccine|vaccine
4956832|NCT01829490|Immunogenicity|immunogenicity
4956833|NCT01829477|Drug Therapy|drug therapy
4956834|NCT01829464|Drug Therapy|drug therapy
4956835|NCT01829438|exercise tolerance|exercise tolerance
4956836|NCT01829438|6MWT|6mwt
4956837|NCT01829425|Hypnosis|hypnosis
4956838|NCT01829425|Mind-Body Therapy|mind-body therapy
4956839|NCT01829425|Anticholinergics|anticholinergics
4956840|NCT01829425|fMRI|fmri
4956841|NCT01829425|Functional Neuroimaging|functional neuroimaging
4956842|NCT01829425|Gyrus Cinguli|gyrus cinguli
4956843|NCT01829425|Female Urogenital Diseases|female urogenital diseases
4956844|NCT01829399|Tourniquet pain|tourniquet pain
4956845|NCT01829399|Subcutaneous axillary local anesthetic|subcutaneous axillary local anesthetic
4956846|NCT01829399|ability to tolerate tourniquet discomfort.|ability to tolerate tourniquet discomfort.
4956847|NCT01829373|lung cancer|lung cancer
4956848|NCT01829347|liver failure|liver failure
4956849|NCT01829347|acute alcoholic hepatitis|acute alcoholic hepatitis
4956850|NCT01829347|patients failing steroid therapy|patients failing steroid therapy
4956851|NCT01829347|alcoholic hepatitis|alcoholic hepatitis
4956852|NCT01829347|steroid failure|steroid failure
4956853|NCT01829347|Lille criteria|lille criteria
4956854|NCT01829347|ELAD|elad
4956855|NCT01829334|dental caries|dental caries
4956856|NCT01829308|implementation|implementation
4956857|NCT01829308|SBIRT|sbirt
4956858|NCT01829308|alcohol screening|alcohol screening
4956859|NCT01829308|drug screening|drug screening
4956860|NCT01829308|Brief Intervention|brief intervention
4956861|NCT01829308|Referral to Treatment|referral to treatment
4956862|NCT01829308|adolescents|adolescents
4956863|NCT01829308|Federally Qualified Health Centers|federally qualified health centers
4956864|NCT01829295|antimetabolite, noninfectious|antimetabolite, noninfectious
4956865|NCT01829282|Implementation|implementation
4956866|NCT01829282|HIV|hiv
4956867|NCT01829282|serodiscordant couples|serodiscordant couples
4956868|NCT01829282|African American|african american
4956869|NCT01829282|Cultural congruency|cultural congruency
4956870|NCT01829243|Milnacipran|milnacipran
4956871|NCT01829243|Fibromyalgia|fibromyalgia
4956872|NCT01829243|Neurocognition|neurocognition
4956873|NCT01829178|cisplatin|cisplatin
4956874|NCT01829178|nephrotoxicity|nephrotoxicity
4956875|NCT01829178|antioxidant|antioxidant
4956876|NCT01829178|urine neutrophil gelatinase-associated lipocalin (NGAL)|urine neutrophil gelatinase-associated lipocalin (ngal)
4956877|NCT01829152|heart failure|heart failure
4956878|NCT01829139|Common bile duct stone|common bile duct stone
4956879|NCT01829139|Gallbladder in situ|gallbladder in situ
4956880|NCT01829139|Choleretics|choleretics
4956881|NCT01829113|Recurrent Lung Cancer|recurrent lung cancer
4956882|NCT01829113|Stage IV Lung Cancer|stage iv lung cancer
4956883|NCT01829113|OGX-427|ogx-427
4956884|NCT01829113|Sarah Cannon Research Institute|sarah cannon research institute
4956885|NCT01829113|SCRI|scri
4956886|NCT01829113|OncoGenex|oncogenex
4956887|NCT01829113|NSCLC|nsclc
4956888|NCT01829113|Non Small Cell Lung Cancer|non small cell lung cancer
4956889|NCT01829100|Adolescent|adolescent
4956890|NCT01829100|Transdiagnostic therapy|transdiagnostic therapy
4956891|NCT01829100|Behavioral activation|behavioral activation
4956892|NCT01829100|Exposure therapy|exposure therapy
4956893|NCT01829100|Depressive Disorder|depressive disorder
4956894|NCT01829100|Anxiety Disorders|anxiety disorders
4956895|NCT01829074|Laryngopharyngeal Reflux|laryngopharyngeal reflux
4956896|NCT01829074|Hoarseness|hoarseness
4956897|NCT01829074|Throat Clearing|throat clearing
4956898|NCT01829074|Globus Sensation|globus sensation
4956899|NCT01829061|Type I Diabetes|type i diabetes
4956900|NCT01829061|Type II Diabetes|type ii diabetes
4956901|NCT01829061|HbA1C|hba1c
4956902|NCT01829048|PF-02545920|pf-02545920
4956903|NCT01829048|safety|safety
4956904|NCT01829048|schizophrenia|schizophrenia
4956905|NCT01829035|TACE|tace
4956906|NCT01829035|Sorafenib|sorafenib
4956907|NCT01829022|Myoma|myoma
4956908|NCT01829022|Uterine myomectomy|uterine myomectomy
4956909|NCT01829009|Sarcopenia|sarcopenia
4956910|NCT01829009|Elderly|elderly
4956911|NCT01829009|Women|women
4956912|NCT01829009|Resistance|resistance
4956913|NCT01829009|Exercise|exercise
4956914|NCT01828996|Chronic pelvic pain syndrome|chronic pelvic pain syndrome
4956915|NCT01828996|Chronic prostatitis|chronic prostatitis
4956916|NCT01828996|Shock wave therapy|shock wave therapy
4956917|NCT01828996|Prostate|prostate
4956918|NCT01828996|Pelvic floor|pelvic floor
4956919|NCT01828996|Pain|pain
4956920|NCT01828983|Telephone|telephone
4956921|NCT01828983|Support groups|support groups
4956922|NCT01828983|Social support|social support
4956923|NCT01828983|Depression|depression
4956924|NCT01828970|Diabetes Mellitus|diabetes mellitus
4956925|NCT01828970|Hemodialysis|hemodialysis
4956926|NCT01828970|Continuous glucose monitoring|continuous glucose monitoring
4956927|NCT01828970|Insulin analogues|insulin analogues
4956928|NCT01828957|Human Umbilical Cord Blood Derived Mesenchymal Stem Cells|human umbilical cord blood derived mesenchymal stem cells
4956929|NCT01828957|Bronchopulmonary dysplasia|bronchopulmonary dysplasia
4956930|NCT01828957|Premature infants|premature infants
4956931|NCT01828944|Vitamin D|vitamin d
4956932|NCT01828944|bone loss|bone loss
4956933|NCT01828918|early diagnosis|early diagnosis
4956934|NCT01828918|prediction|prediction
4956935|NCT01828918|prognosis|prognosis
4956936|NCT01828905|tibia fracture|tibia fracture
4956937|NCT01828905|bone graft|bone graft
4956938|NCT01828905|iliac crest|iliac crest
4956939|NCT01828905|bone graft substitute|bone graft substitute
4956940|NCT01828905|Cerament|cerament
4956941|NCT01828905|void filler|void filler
4956942|NCT01828905|quality of life|quality of life
4956943|NCT01828905|pain|pain
4956944|NCT01828905|costs of care|costs of care
4956945|NCT01828892|Autologous platelet rich fibrin glue|autologous platelet rich fibrin glue
4956946|NCT01828892|Enterocutaneous fistulas|enterocutaneous fistulas
4956947|NCT01828892|Single low output GI fistulas|single low output gi fistulas
4956948|NCT01828879|Dermatitis, Atopic|dermatitis, atopic
4956949|NCT01828879|Tacrolimus|tacrolimus
4956950|NCT01828866|EMDR|emdr
4956951|NCT01828866|Alcohol|alcohol
4956952|NCT01828866|Relapse|relapse
4956953|NCT01828866|Craving|craving
4956954|NCT01828853|Membrane sweeping|membrane sweeping
4956955|NCT01828853|Membrane stripping|membrane stripping
4956956|NCT01828853|Maternal outcomes|maternal outcomes
4956957|NCT01828853|Neonatal outcomes|neonatal outcomes
4956958|NCT01828840|morphine|morphine
4956959|NCT01828840|fentanyl|fentanyl
4956960|NCT01828840|methadone|methadone
4956961|NCT01828840|epidural|epidural
4956962|NCT01828840|intravenous|intravenous
4956963|NCT01828840|pain|pain
4956964|NCT01828840|analgesia|analgesia
4956965|NCT01828827|tuberculosis|tuberculosis
4956966|NCT01828827|PK|pk
4956967|NCT01828827|PA-824|pa-824
4956968|NCT01828827|food effect,|food effect,
4956969|NCT01828827|bioavailability|bioavailability
4956970|NCT01828827|pretomanid|pretomanid
4956971|NCT01828827|CL-003|cl-003
4956972|NCT01828814|pediatrics|pediatrics
4956973|NCT01828814|Ready-to-use Supplementary Food|ready-to-use supplementary food
4956974|NCT01828814|corn soy blend|corn soy blend
4956975|NCT01828814|cash transfer|cash transfer
4956976|NCT01828814|prevention of malnutrition|prevention of malnutrition
4956977|NCT01828814|Niger|niger
4956978|NCT01828801|Adverse Local Tissue Reaction|adverse local tissue reaction
4956979|NCT01828801|Metal Ions|metal ions
4956980|NCT01828801|Serum|serum
4956981|NCT01828801|Whole Blood|whole blood
4956982|NCT01828801|Metal-on-Metal|metal-on-metal
4956983|NCT01828801|Total Hip Arthroplasty|total hip arthroplasty
4956984|NCT01828788|Sternotomy|sternotomy
4956985|NCT01828788|Anesthesia|anesthesia
4956986|NCT01828788|Post-operative pain|post-operative pain
4956987|NCT01828762|DC|dc
4956988|NCT01828762|Immunotherapy|immunotherapy
4956989|NCT01828762|TC|tc
4956990|NCT01828749|blunt abdominal trauma|blunt abdominal trauma
4956991|NCT01828749|CT|ct
4956992|NCT01828749|radiation exposure, pediatric|radiation exposure, pediatric
4956993|NCT01828736|Urothelial carcinoma|urothelial carcinoma
4956994|NCT01828736|Trastuzumab|trastuzumab
4956995|NCT01828736|Treatment|treatment
4956996|NCT01828723|Autologous Adult Stem Cell|autologous adult stem cell
4956997|NCT01828723|Adipose Derived Stem Cell|adipose derived stem cell
4956998|NCT01828723|Stromal Vascular Fraction|stromal vascular fraction
4956999|NCT01828723|SVF|svf
4957000|NCT01828723|Antria|antria
4957001|NCT01828723|Shah Rahimian|shah rahimian
4957002|NCT01828723|Leonard Maliver|leonard maliver
4957003|NCT01828723|David Bizousky|david bizousky
4957004|NCT01828723|Rahul Gore|rahul gore
4957005|NCT01828723|Lee Quist|lee quist
4957006|NCT01828723|Dudley McNitt|dudley mcnitt
4957007|NCT01828710|Myo-inositol|myo-inositol
4957008|NCT01828710|oligoasthenoteratospermia|oligoasthenoteratospermia
4957009|NCT01828710|semen parameters|semen parameters
4957010|NCT01828710|IVF|ivf
4957011|NCT01828697|Low-molecular-weight heparin|low-molecular-weight heparin
4957012|NCT01828697|Pregnancy|pregnancy
4957013|NCT01828697|Venous thrombosis|venous thrombosis
4957014|NCT01828684|Migraine with Aura|migraine with aura
4957015|NCT01828684|Migraine without Aura|migraine without aura
4957016|NCT01828684|Photophobia|photophobia
4957017|NCT01828684|Chronic Daily Headache|chronic daily headache
4957018|NCT01828671|Soy|soy
4957019|NCT01828671|Corn|corn
4957020|NCT01828671|Flour|flour
4957021|NCT01828671|Tortilla|tortilla
4957022|NCT01828671|Glycemic|glycemic
4957023|NCT01828671|Glucose,|glucose,
4957024|NCT01828671|glycemic index|glycemic index
4957025|NCT01828658|hemodialysis|hemodialysis
4957026|NCT01828658|fluid management|fluid management
4957027|NCT01828658|bioimpedance|bioimpedance
4957028|NCT01828658|mortality|mortality
4957029|NCT01828658|arterial stiffness|arterial stiffness
4957030|NCT01828645|gastric emptying|gastric emptying
4957031|NCT01828645|whey protein|whey protein
4957032|NCT01828645|carbohydrate|carbohydrate
4957033|NCT01828645|fasting|fasting
4957034|NCT01828632|Obesity, Morbid; Hypoxemia; Postoperative complications; Bariatric surgery; Respiratory physical therapy; Preoperative care.|obesity, morbid; hypoxemia; postoperative complications; bariatric surgery; respiratory physical therapy; preoperative care.
4957035|NCT01828619|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
4957036|NCT01828619|Busulfan|busulfan
4957037|NCT01828619|Fludarabine|fludarabine
4957038|NCT01828606|leg lymphedema|leg lymphedema
4957039|NCT01828606|volume measurement|volume measurement
4957040|NCT01828606|compression therapy|compression therapy
4957041|NCT01828606|interface pressure|interface pressure
4957042|NCT01828606|static stiffness index (SSI)|static stiffness index (ssi)
4957043|NCT01828606|volume change|volume change
4957044|NCT01828580|laparoscopic Cholecystectomy|laparoscopic cholecystectomy
4957045|NCT01828580|Gallbladder removal|gallbladder removal
4957046|NCT01828580|laparoscope holder|laparoscope holder
4957047|NCT01828567|veterans|veterans
4957048|NCT01828567|health risk assessment|health risk assessment
4957049|NCT01828567|primary prevention|primary prevention
4957050|NCT01828567|shared decision making|shared decision making
4957051|NCT01828567|Healthy Living Assessment|healthy living assessment
4957052|NCT01828554|Capecitabine pharmacokinetics PK|capecitabine pharmacokinetics pk
4957053|NCT01828554|Elevated Body Mass Index (BMI)|elevated body mass index (bmi)
4957054|NCT01828554|Advanced Solid Tumors|advanced solid tumors
4957055|NCT01828541|Burn injuries|burn injuries
4957056|NCT01828528|Nonalcoholic fatty liver disease|nonalcoholic fatty liver disease
4957057|NCT01828528|Nonalcoholic steatohepatitis|nonalcoholic steatohepatitis
4957058|NCT01828528|Obesity|obesity
4957059|NCT01828528|Bariatric surgery|bariatric surgery
4957060|NCT01828528|Weight loss|weight loss
4957061|NCT01828502|Cotinine|cotinine
4957062|NCT01828502|Secondhand Smoke Exposure (SHSE)|secondhand smoke exposure (shse)
4957063|NCT01828502|Secondhand Smoke (SHS)|secondhand smoke (shs)
4957064|NCT01828476|prostate cancer|prostate cancer
4957065|NCT01828476|hormone-resistant prostate cancer|hormone-resistant prostate cancer
4957066|NCT01828476|recurrent prostate cancer|recurrent prostate cancer
4957067|NCT01828476|stage IV prostate cancer|stage iv prostate cancer
4957068|NCT01828424|acute pain|acute pain
4957069|NCT01828411|Cardiac surgery|cardiac surgery
4957070|NCT01828411|Echocardiography|echocardiography
4957071|NCT01828411|Cerebral perfusion|cerebral perfusion
4957072|NCT01828411|Intraoperative period|intraoperative period
4957073|NCT01828385|Physiological Effects of Drugs|physiological effects of drugs
4957074|NCT01828385|Rocuronium|rocuronium
4957075|NCT01828385|Sugammadex sodium|sugammadex sodium
4957076|NCT01828385|Magnesium|magnesium
4957077|NCT01828385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
4957078|NCT01828385|Neuromuscular block, antagonism|neuromuscular block, antagonism
4957079|NCT01828385|Pharmacologic Actions|pharmacologic actions
4957080|NCT01828372|concomitant diseases|concomitant diseases
4957081|NCT01828372|multiple drug consumption|multiple drug consumption
4957082|NCT01828372|therapeutic drug monitoring|therapeutic drug monitoring
4957083|NCT01828372|TDM|tdm
4957084|NCT01828372|drug monitoring|drug monitoring
4957085|NCT01828372|drug level|drug level
4957086|NCT01828372|quantification|quantification
4957087|NCT01828372|drug|drug
4957088|NCT01828372|drug concentration|drug concentration
4957089|NCT01828372|concentration|concentration
4957090|NCT01828372|therapeutic range|therapeutic range
4957091|NCT01828372|therapeutic index|therapeutic index
4957092|NCT01828346|TL32711|tl32711
4957093|NCT01828346|Birinapant|birinapant
4957094|NCT01828346|5-Azacitidine|5-azacitidine
4957095|NCT01828346|Myelodysplastic syndrome|myelodysplastic syndrome
4957096|NCT01828346|MDS|mds
4957097|NCT01828346|Relapsed|relapsed
4957098|NCT01828346|Refractory|refractory
4957099|NCT01828346|Failed|failed
4957100|NCT01828346|open-label|open-label
4957101|NCT01828346|non-Randomized|non-randomized
4957102|NCT01828346|dose-escalation|dose-escalation
4957103|NCT01828346|dose-expansion|dose-expansion
4957104|NCT01828333|Malaria|malaria
4957105|NCT01828333|Severe|severe
4957106|NCT01828333|Artesunate|artesunate
4957107|NCT01828333|Quinine|quinine
4957108|NCT01828333|Democratic Republic of Congo|democratic republic of congo
4957109|NCT01828320|Risk: Emotional, Cognitive, Behavioral, Social, Physical|risk: emotional, cognitive, behavioral, social, physical
4957110|NCT01828294|MG|mg
4957111|NCT01828268|HIV|hiv
4957112|NCT01828268|Metabolomics Fingerprinting|metabolomics fingerprinting
4957113|NCT01828242|HbA1C|hba1c
4957114|NCT01828229|Inactivity|inactivity
4957115|NCT01828229|Obesity|obesity
4957116|NCT01828229|Type 2 diabetes|type 2 diabetes
4957117|NCT01828229|glucose metabolism|glucose metabolism
4957118|NCT01828229|Lipid metabolism|lipid metabolism
4957119|NCT01828229|Cognitive function|cognitive function
4957120|NCT01828203|minocycline|minocycline
4957121|NCT01828203|randomized control trial|randomized control trial
4957122|NCT01828203|phase 3|phase 3
4957123|NCT01828203|spinal cord injury|spinal cord injury
4957124|NCT01828190|crohn's disease|crohn's disease
4957125|NCT01828190|perianal fistulas|perianal fistulas
4957126|NCT01828190|TNF alpha blockers|tnf alpha blockers
4957127|NCT01828190|hyperbaric oxygen therapy|hyperbaric oxygen therapy
4957128|NCT01828177|PreCision|precision
4957129|NCT01828177|PDI-320|pdi-320
4957130|NCT01828177|Foam|foam
4957131|NCT01828164|Orthodontics|orthodontics
4957132|NCT01828164|Braces|braces
4957133|NCT01828164|Tooth|tooth
4957134|NCT01828151|Pressure ulcer|pressure ulcer
4957135|NCT01828151|Noninvasive ventilation|noninvasive ventilation
4957136|NCT01828138|Proteinuria|proteinuria
4957137|NCT01828138|Pregnancy|pregnancy
4957138|NCT01828138|Hypertension|hypertension
4957139|NCT01828138|Plasmin|plasmin
4957140|NCT01828138|Plasminogen|plasminogen
4957141|NCT01828138|Aldosterone|aldosterone
4957142|NCT01828138|Angiotensin|angiotensin
4957143|NCT01828138|Renin|renin
4957144|NCT01828138|sodium chloride|sodium chloride
4957145|NCT01828138|epithelial sodium channel|epithelial sodium channel
4957146|NCT01828138|Placenta|placenta
4957147|NCT01828125|Type 1 diabetes|type 1 diabetes
4957148|NCT01828125|Hypoglycemia|hypoglycemia
4957149|NCT01828125|Glucagon|glucagon
4957150|NCT01828125|Hypoglycaemic hyperinsulinemic clamp|hypoglycaemic hyperinsulinemic clamp
4957151|NCT01828112|Non-Small Cell Lung Cancer|non-small cell lung cancer
4957152|NCT01828112|ALK|alk
4957153|NCT01828112|LDK378|ldk378
4957154|NCT01828112|Non-small cell lung carcinoma (NSCLC)|non-small cell lung carcinoma (nsclc)
4957155|NCT01828112|treatment of lung cancer after first metastasis|treatment of lung cancer after first metastasis
4957156|NCT01828112|lung cancer|lung cancer
4957157|NCT01828112|lung adenocarcinoma|lung adenocarcinoma
4957158|NCT01828112|Non small cell lung carcinoma|non small cell lung carcinoma
4957159|NCT01828112|Non small cell lung cancer|non small cell lung cancer
4957160|NCT01828112|NSCLC|nsclc
4957161|NCT01828112|chemotherapy|chemotherapy
4957162|NCT01828112|ALK-positive|alk-positive
4957163|NCT01828112|ALK-rearranged advanced non-small cell lung cancer|alk-rearranged advanced non-small cell lung cancer
4957164|NCT01828112|crizotinib|crizotinib
4957165|NCT01828099|Non-Small Cell Lung Cancer|non-small cell lung cancer
4957166|NCT01828099|NSCLC|nsclc
4957167|NCT01828099|ALK|alk
4957168|NCT01828099|LDK378|ldk378
4957169|NCT01828099|Non-small cell lung carcinoma (NSCLC)|non-small cell lung carcinoma (nsclc)
4957170|NCT01828099|treatment of lung cancer after first metastasis|treatment of lung cancer after first metastasis
4957171|NCT01828099|lung cancer|lung cancer
4957172|NCT01828099|lung adenocarcinoma|lung adenocarcinoma
4957173|NCT01828099|Non small cell lung carcinoma|non small cell lung carcinoma
4957174|NCT01828099|Non small cell lung cancer|non small cell lung cancer
4957175|NCT01828099|non-squamous non-small cell lung cancer|non-squamous non-small cell lung cancer
4957176|NCT01828086|Psoriasis, chronic plaque-type psoriasis, IL17, monoclonal antibody|psoriasis, chronic plaque-type psoriasis, il17, monoclonal antibody
4957177|NCT01828034|Gemcitabine|gemcitabine
4957178|NCT01828034|Cisplatin|cisplatin
4957179|NCT01828034|MEK162|mek162
4957180|NCT01828034|13-004|13-004
4957181|NCT01828021|HER2 2+|her2 2+
4957182|NCT01828021|FISH non-amplified|fish non-amplified
4957183|NCT01828021|Relapsed|relapsed
4957184|NCT01828021|Refractory|refractory
4957185|NCT01828021|Advanced|advanced
4957186|NCT01828021|Margetuximab|margetuximab
4957187|NCT01828021|MGAH22|mgah22
4957188|NCT01828008|Mabthera|mabthera
4957189|NCT01828008|cytokine induced killer cell|cytokine induced killer cell
4957190|NCT01827995|Low sensitivity urinary hCG|low sensitivity urinary hcg
4957191|NCT01827995|follow up|follow up
4957192|NCT01827995|medical abortion|medical abortion
4957193|NCT01827995|rural India|rural india
4957194|NCT01827995|RCT|rct
4957195|NCT01827982|Healthy|healthy
4957196|NCT01827982|Safety|safety
4957197|NCT01827982|Tolerability|tolerability
4957198|NCT01827982|Pharmacokinetic|pharmacokinetic
4957199|NCT01827982|Alzheimer's Disease|alzheimer's disease
4957200|NCT01827982|JNJ-54861911|jnj-54861911
4957201|NCT01827969|Women|women
4957202|NCT01827969|breast tumor|breast tumor
4957203|NCT01827969|planned mastectomy|planned mastectomy
4957204|NCT01827956|Upper aero-digestive tract tumours|upper aero-digestive tract tumours
4957205|NCT01827956|FCGR3A and FCGR2A receptor polymorphism|fcgr3a and fcgr2a receptor polymorphism
4957310|NCT01827527|Validation|validation
4957206|NCT01827956|Cetuximab efficacy|cetuximab efficacy
4957207|NCT01827943|Relapsed bladder cancer|relapsed bladder cancer
4957208|NCT01827930|chronic myeloid leukemia in chronic phase|chronic myeloid leukemia in chronic phase
4957209|NCT01827904|ExAblate Transcranial MRgFUS|exablate transcranial mrgfus
4957210|NCT01827891|acute kidney injury|acute kidney injury
4957211|NCT01827891|percutaneous coronary intervention|percutaneous coronary intervention
4957212|NCT01827891|remote ischemic preconditioning|remote ischemic preconditioning
4957213|NCT01827839|Adults|adults
4957214|NCT01827839|Safety|safety
4957215|NCT01827839|Immunogenicity|immunogenicity
4957216|NCT01827839|Zoster|zoster
4957217|NCT01827826|Intervention|intervention
4957218|NCT01827826|Telephone|telephone
4957219|NCT01827826|Diabetes|diabetes
4957220|NCT01827826|Prevention|prevention
4957221|NCT01827813|prostate-specific antigen|prostate-specific antigen
4957222|NCT01827813|digital rectal examination|digital rectal examination
4957223|NCT01827813|transrectal ultrasonography|transrectal ultrasonography
4957224|NCT01827813|needle biopsy|needle biopsy
4957225|NCT01827813|prostate cancer|prostate cancer
4957226|NCT01827800|weight loss|weight loss
4957227|NCT01827800|primary care|primary care
4957228|NCT01827800|eHealth|ehealth
4957229|NCT01827774|Pelvic organ prolapse|pelvic organ prolapse
4957230|NCT01827774|Graft repair|graft repair
4957231|NCT01827761|chemotherapy teaching|chemotherapy teaching
4957232|NCT01827761|questionnaire|questionnaire
4957233|NCT01827748|Autorefractor|autorefractor
4957234|NCT01827735|Interleukin 2|interleukin 2
4957235|NCT01827735|Type 1 diabetes|type 1 diabetes
4957236|NCT01827735|T regulatory cells|t regulatory cells
4957237|NCT01827735|Adaptive trial|adaptive trial
4957238|NCT01827722|Macular edema|macular edema
4957239|NCT01827722|Central retinal vein occlusion|central retinal vein occlusion
4957240|NCT01827722|CRVO|crvo
4957241|NCT01827722|Retinal vein occlusion|retinal vein occlusion
4957242|NCT01827722|RVO|rvo
4957243|NCT01827722|Ozurdex|ozurdex
4957244|NCT01827722|Dexamethasone intravitreal implant|dexamethasone intravitreal implant
4957245|NCT01827722|Lucentis|lucentis
4957246|NCT01827722|Ranibizumab|ranibizumab
4957247|NCT01827709|DWI|dwi
4957248|NCT01827709|ADC|adc
4957249|NCT01827709|DCE-MRI|dce-mri
4957250|NCT01827709|FDG-PET|fdg-pet
4957251|NCT01827709|SUV|suv
4957252|NCT01827709|Hypoxia|hypoxia
4957253|NCT01827709|Head and neck squamous cell carcinoma|head and neck squamous cell carcinoma
4957254|NCT01827696|Muscle|muscle
4957255|NCT01827696|Soreness|soreness
4957256|NCT01827696|Muscle function|muscle function
4957257|NCT01827696|Damage|damage
4957258|NCT01827696|Ginseng|ginseng
4957259|NCT01827683|hyperbaric oxygen|hyperbaric oxygen
4957260|NCT01827683|fibromyalgia|fibromyalgia
4957261|NCT01827683|chronic pain syndrome|chronic pain syndrome
4957262|NCT01827657|plasma|plasma
4957263|NCT01827657|tolerability|tolerability
4957264|NCT01827657|safety|safety
4957265|NCT01827657|matched control|matched control
4957266|NCT01827657|GSK2336805|gsk2336805
4957267|NCT01827657|hepatic impairment|hepatic impairment
4957268|NCT01827657|pharmacokinetics|pharmacokinetics
4957269|NCT01827644|AKT inhibitor|akt inhibitor
4957270|NCT01827644|formulation|formulation
4957271|NCT01827644|food effect|food effect
4957272|NCT01827644|bioavailability|bioavailability
4957273|NCT01827644|GSK2110183|gsk2110183
4957274|NCT01827631|healthy|healthy
4957275|NCT01827631|GSK1605786|gsk1605786
4957276|NCT01827631|CCR9 receptor antagonist|ccr9 receptor antagonist
4957277|NCT01827631|Chinese subjects|chinese subjects
4957278|NCT01827631|pharmacokinetics|pharmacokinetics
4957279|NCT01827618|bladder|bladder
4957280|NCT01827618|Cancer|cancer
4957281|NCT01827618|Cystectomy|cystectomy
4957282|NCT01827618|Rapamycin|rapamycin
4957283|NCT01827605|Relapsed follicular Lymphoma|relapsed follicular lymphoma
4957284|NCT01827605|RIT|rit
4957285|NCT01827605|Zevalin|zevalin
4957286|NCT01827579|Transplant|transplant
4957287|NCT01827579|CD25/71 allodepleted donor T cells|cd25/71 allodepleted donor t cells
4957288|NCT01827579|Infection|infection
4957289|NCT01827579|Acute Myeloid Leukaemia|acute myeloid leukaemia
4957290|NCT01827579|Acute Lymphoblastic Leukaemia|acute lymphoblastic leukaemia
4957291|NCT01827579|Adult|adult
4957292|NCT01827579|Diffuse Large B-Cell Lymphoma|diffuse large b-cell lymphoma
4957293|NCT01827579|Mantle Cell Lymphoma|mantle cell lymphoma
4957294|NCT01827566|Celiac Disease|celiac disease
4957295|NCT01827566|Gluten Sensitivity|gluten sensitivity
4957296|NCT01827566|Gluten|gluten
4957297|NCT01827566|Double-blind challenge, placebo-controlled challenge|double-blind challenge, placebo-controlled challenge
4957298|NCT01827566|Gluten free flour|gluten free flour
4957299|NCT01827553|pancreatic cancer|pancreatic cancer
4957300|NCT01827553|chemoradiotherapy|chemoradiotherapy
4957301|NCT01827553|chemotherapy|chemotherapy
4957302|NCT01827553|FOLFIRINOX|folfirinox
4957303|NCT01827553|gemcitabine|gemcitabine
4957304|NCT01827540|HIV/AIDS|hiv/aids
4957305|NCT01827540|Cenicriviroc (CVC)|cenicriviroc (cvc)
4957306|NCT01827540|Dolutegravir (DTG)|dolutegravir (dtg)
4957307|NCT01827540|Midazolam|midazolam
4957308|NCT01827540|Healthy Subjects|healthy subjects
4957309|NCT01827527|Adenosine Triphosphate|adenosine triphosphate
4957311|NCT01827527|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
4957312|NCT01827527|Optical Spectroscopy|optical spectroscopy
4957313|NCT01827514|cancer, erythropoetin|cancer, erythropoetin
4957314|NCT01827501|postoperative delirium|postoperative delirium
4957315|NCT01827501|hemodynamic management|hemodynamic management
4957316|NCT01827501|goal directed therapy|goal directed therapy
4957317|NCT01827475|musculoskeletal pain|musculoskeletal pain
4957318|NCT01827475|acetaminophen|acetaminophen
4957319|NCT01827475|ibuprofen|ibuprofen
4957320|NCT01827462|Inactivated, trivalent influenza vaccine|inactivated, trivalent influenza vaccine
4957321|NCT01827462|elderly|elderly
4957322|NCT01827462|immunosenescence|immunosenescence
4957323|NCT01827462|longitudinal study|longitudinal study
4957324|NCT01827462|Inactivated, High-Dose trivalent influenza vaccine|inactivated, high-dose trivalent influenza vaccine
4957325|NCT01827462|Inactivated, quadrivalent influenza vaccine|inactivated, quadrivalent influenza vaccine
4957326|NCT01827462|young adults|young adults
4957327|NCT01827449|rewarming|rewarming
4957328|NCT01827449|core cooling|core cooling
4957329|NCT01827449|afterdrop|afterdrop
4957330|NCT01827449|hospital treatment|hospital treatment
4957331|NCT01827449|hypothermia|hypothermia
4957332|NCT01827436|pediatric stroke|pediatric stroke
4957333|NCT01827436|hemiplegia|hemiplegia
4957334|NCT01827436|physical therapy|physical therapy
4957335|NCT01827436|gait training|gait training
4957336|NCT01827436|transcranial magnetic stimulation|transcranial magnetic stimulation
4957337|NCT01827436|gait asymmetry|gait asymmetry
4957338|NCT01827423|squamous cell carcinoma antigen|squamous cell carcinoma antigen
4957339|NCT01827423|sinonasal inverted papilloma|sinonasal inverted papilloma
4957340|NCT01827423|clinical marker|clinical marker
4957341|NCT01827423|hidden reccurence|hidden reccurence
4957342|NCT01827423|surgery|surgery
4957343|NCT01827397|Safety of this HIV vaccine|safety of this hiv vaccine
4957344|NCT01827371|Smallpox, vaccine, IMVAMUNE, Stratis, parent protocol|smallpox, vaccine, imvamune, stratis, parent protocol
4957345|NCT01827358|antibacterial agent|antibacterial agent
4957346|NCT01827358|children|children
4957347|NCT01827358|colonisation|colonisation
4957348|NCT01827358|critically ill|critically ill
4957349|NCT01827358|infants|infants
4957350|NCT01827358|mupirocin|mupirocin
4957351|NCT01827358|prevention|prevention
4957352|NCT01827358|Staphylococcus aureus|staphylococcus aureus
4957353|NCT01827345|Vitamin D|vitamin d
4957354|NCT01827345|Falls|falls
4957355|NCT01827345|Balance|balance
4957356|NCT01827345|Physical Function|physical function
4957357|NCT01827332|marijuana|marijuana
4957358|NCT01827332|substance abuse|substance abuse
4957359|NCT01827332|drug abuse|drug abuse
4957360|NCT01827332|marijuana dependence|marijuana dependence
4957361|NCT01827332|drug addiction|drug addiction
4957362|NCT01827319|Angina|angina
4957363|NCT01827319|Transmyocardial revascularization|transmyocardial revascularization
4957364|NCT01827280|endothelial function|endothelial function
4957365|NCT01827280|microvascular function|microvascular function
4957366|NCT01827280|incretins|incretins
4957367|NCT01827280|diabetes mellitus|diabetes mellitus
4957368|NCT01827280|postprandial lipemia|postprandial lipemia
4957369|NCT01827267|Lung cancer|lung cancer
4957370|NCT01827267|Puma|puma
4957371|NCT01827267|neratinib|neratinib
4957372|NCT01827267|HKI-272|hki-272
4957373|NCT01827267|PB-272|pb-272
4957374|NCT01827267|Nerlynx|nerlynx
4957375|NCT01827254|sutent rechallenge|sutent rechallenge
4957376|NCT01827241|Gastroenterology|gastroenterology
4957377|NCT01827241|Colonoscopy|colonoscopy
4957378|NCT01827241|Screening|screening
4957379|NCT01827241|Surveillance|surveillance
4957380|NCT01827241|Symptom evaluation|symptom evaluation
4957381|NCT01827241|Chart review|chart review
4957382|NCT01827241|Data review|data review
4957383|NCT01827241|Examination findings|examination findings
4957384|NCT01827241|Resection techniques|resection techniques
4957385|NCT01827241|Pathology reports|pathology reports
4957386|NCT01827228|HIV|hiv
4957387|NCT01827228|transmission prevention|transmission prevention
4957388|NCT01827228|social network and venue|social network and venue
4957389|NCT01827228|community intervention|community intervention
4957390|NCT01827228|treatment as prevention|treatment as prevention
4957391|NCT01827228|recent infection|recent infection
4957392|NCT01827228|phylogenetics|phylogenetics
4957393|NCT01827228|infection chains|infection chains
4957394|NCT01827215|Preconception Care|preconception care
4957395|NCT01827215|Racial Disparities|racial disparities
4957396|NCT01827215|Health Information Technology|health information technology
4957397|NCT01827202|renin-angiotensin-system|renin-angiotensin-system
4957398|NCT01827202|RAS blockade|ras blockade
4957399|NCT01827189|primary care, Medicare costs, hospitalizations|primary care, medicare costs, hospitalizations
4957400|NCT01827176|Characteristic|characteristic
4957401|NCT01827176|Recurrent Acute Rhinosinusitis|recurrent acute rhinosinusitis
4957402|NCT01827176|Children|children
4957403|NCT01827163|Paclitaxel|paclitaxel
4957404|NCT01827163|Trastuzumab|trastuzumab
4957405|NCT01827163|Lapatinib|lapatinib
4957406|NCT01827163|HER2|her2
4957407|NCT01827163|13-002|13-002
4957408|NCT01827137|WT1 Analog Peptide Vaccine|wt1 analog peptide vaccine
4957409|NCT01827137|12-288|12-288
4957410|NCT01827124|CARBETOCIN AND OXYTOCIN AND SECOND TRIMESTER INTERRUPTION|carbetocin and oxytocin and second trimester interruption
4957411|NCT01827111|Melanoma|melanoma
4957412|NCT01827111|Metastatic Melanoma|metastatic melanoma
4957413|NCT01827111|Advanced stage IV melanoma|advanced stage iv melanoma
4957414|NCT01827111|Unresectable stage III mucosal melanoma|unresectable stage iii mucosal melanoma
4957415|NCT01827111|Cutaneous melanoma|cutaneous melanoma
4957416|NCT01827111|Progression-free survival|progression-free survival
4957417|NCT01827111|(PFS)|(pfs)
4957418|NCT01827111|ABI-007|abi-007
4957419|NCT01827111|Nab-paclitaxel|nab-paclitaxel
4957420|NCT01827111|Paclitaxel|paclitaxel
4957421|NCT01827111|Abraxane|abraxane
4957422|NCT01827111|Ipilimumab|ipilimumab
4957423|NCT01827111|Yervoy|yervoy
4957424|NCT01827111|BMS-734016|bms-734016
4957425|NCT01827111|MDX010|mdx010
4957426|NCT01827098|Immature teeth|immature teeth
4957427|NCT01827098|Calcium Hydroxide|calcium hydroxide
4957428|NCT01827098|Blood clot|blood clot
4957429|NCT01827098|Revascularization|revascularization
4957430|NCT01827098|Revitalization|revitalization
4957431|NCT01827072|IVIG in Multifocal Motor Neuropathy|ivig in multifocal motor neuropathy
4957432|NCT01827072|Patients with Multifocal Motor Neuropathy|patients with multifocal motor neuropathy
4957433|NCT01827046|intracerebral hemorrhage|intracerebral hemorrhage
4957434|NCT01827046|ICH|ich
4957435|NCT01827046|brain hemorrhage|brain hemorrhage
4957436|NCT01827046|minimally invasive surgery|minimally invasive surgery
4957437|NCT01827046|rt-PA|rt-pa
4957438|NCT01827007|norepinephrine infusion|norepinephrine infusion
4957439|NCT01827007|under 48 hours in ICU|under 48 hours in icu
4957440|NCT01826968|Lung recruitment, cesarean, lung compliance, atelectasis|lung recruitment, cesarean, lung compliance, atelectasis
4957441|NCT01826955|pneumoperitoneum, cognitive function|pneumoperitoneum, cognitive function
4957442|NCT01826942|Scar prevention|scar prevention
4957443|NCT01826942|CO2 fractional laser|co2 fractional laser
4957444|NCT01826929|Health Services Research|health services research
4957445|NCT01826929|Cardiovascular Diseases|cardiovascular diseases
4957446|NCT01826929|Primary Care|primary care
4957447|NCT01826929|Secondary Prevention.|secondary prevention.
4957448|NCT01826903|Depression|depression
4957449|NCT01826903|Cognitive Behavior Therapy|cognitive behavior therapy
4957450|NCT01826903|Child Development|child development
4957451|NCT01826890|Ventilator Weaning|ventilator weaning
4957452|NCT01826890|Mechanical Ventilation|mechanical ventilation
4957453|NCT01826890|Critical Care|critical care
4957454|NCT01826890|Neurally Adjusted Ventilatory Assist|neurally adjusted ventilatory assist
4957455|NCT01826890|Diaphragm|diaphragm
4957456|NCT01826851|Pain management|pain management
4957457|NCT01826851|Anesthetic, local|anesthetic, local
4957458|NCT01826851|Nerve blockade|nerve blockade
4957459|NCT01826851|Coronary Artery Bypass Surgery|coronary artery bypass surgery
4957460|NCT01826851|Analgesics, opioid|analgesics, opioid
4957461|NCT01826851|Postoperative complications|postoperative complications
4957462|NCT01826851|Bupivacaine|bupivacaine
4957463|NCT01826838|Prostate Cancer|prostate cancer
4957464|NCT01826825|aging|aging
4957465|NCT01826825|cognition|cognition
4957466|NCT01826825|surgery|surgery
4957467|NCT01826799|sleep|sleep
4957468|NCT01826799|noise|noise
4957469|NCT01826799|ICU|icu
4957470|NCT01826799|delirium|delirium
4957471|NCT01826799|RCSQ|rcsq
4957472|NCT01826786|Healthy|healthy
4957473|NCT01826786|Anxiety Disorders|anxiety disorders
4957474|NCT01826786|Anxiety Modulation|anxiety modulation
4957475|NCT01826786|Male|male
4957476|NCT01826773|CardioPET|cardiopet
4957477|NCT01826773|Coronary Artery Disease|coronary artery disease
4957478|NCT01826773|Myocardial Perfusion Imaging|myocardial perfusion imaging
4957479|NCT01826773|Coronary Angiography|coronary angiography
4957480|NCT01826773|Myocardial Fatty Acid Utilization|myocardial fatty acid utilization
4957481|NCT01826747|intrauterine insemination|intrauterine insemination
4957482|NCT01826747|luteal phase|luteal phase
4957483|NCT01826747|gonadotrophins|gonadotrophins
4957484|NCT01826734|dacryolith|dacryolith
4957485|NCT01826734|dacryocystorhinostomy|dacryocystorhinostomy
4957486|NCT01826734|composition|composition
4957487|NCT01826734|chemical analysis|chemical analysis
4957488|NCT01826734|infrared spectrometry|infrared spectrometry
4957489|NCT01826734|scanning electron microscopy|scanning electron microscopy
4957490|NCT01826734|elemental analysis|elemental analysis
4957491|NCT01826721|Solid organ transplantation|solid organ transplantation
4957492|NCT01826721|Immunosuppression|immunosuppression
4957493|NCT01826721|Education|education
4957494|NCT01826721|E-learning|e-learning
4957495|NCT01826721|Medication knowledge|medication knowledge
4957496|NCT01826721|Patient satisfaction|patient satisfaction
4957497|NCT01826721|Medication adherence|medication adherence
4957498|NCT01826708|Chromosomal translocations|chromosomal translocations
4957499|NCT01826708|psychomotor delay|psychomotor delay
4957500|NCT01826695|Fibromyalgia, neurodynamic, dexterity|fibromyalgia, neurodynamic, dexterity
4957501|NCT01826682|COPD, physiotherapy, exacerbation|copd, physiotherapy, exacerbation
4957502|NCT01826656|intramembranous bone healing|intramembranous bone healing
4957503|NCT01826656|post-menopausal osteoporosis|post-menopausal osteoporosis
4957504|NCT01826656|tooth extraction|tooth extraction
4957505|NCT01826630|CLn Body Wash|cln body wash
4957506|NCT01826630|CLn BodyWash|cln bodywash
4957507|NCT01826617|Prostate Disease Nomogram|prostate disease nomogram
4957508|NCT01826617|Asian Men|asian men
4957509|NCT01826604|cesarean section|cesarean section
4957510|NCT01826604|Pregnant|pregnant
4957511|NCT01826565|success|success
4957512|NCT01826552|Orsiro hybrid stent|orsiro hybrid stent
4957513|NCT01826552|Drug-eluting stent|drug-eluting stent
4957514|NCT01826552|Zotarolimus-eluting stent|zotarolimus-eluting stent
4957515|NCT01826552|Coronary heart disease|coronary heart disease
4957516|NCT01826552|Cobalt chromium|cobalt chromium
4957517|NCT01826539|Dorsal digital nerve|dorsal digital nerve
4957518|NCT01826539|dorsal branch of the digital nerve|dorsal branch of the digital nerve
4957519|NCT01826539|dorsal branch of the digital artery|dorsal branch of the digital artery
4957520|NCT01826539|dorsal digital island flap|dorsal digital island flap
4957521|NCT01826539|finger pulp defect.|finger pulp defect.
4957522|NCT01826513|Obstructive sleep apnea|obstructive sleep apnea
4957523|NCT01826513|Efficacy|efficacy
4957524|NCT01826513|Subjective feedback|subjective feedback
4957525|NCT01826513|Preference|preference
4957526|NCT01826500|embryo transfer|embryo transfer
4957527|NCT01826500|IVF cycle|ivf cycle
4957528|NCT01826500|endometriosis|endometriosis
4957529|NCT01826487|Duchenne muscular dystrophy|duchenne muscular dystrophy
4957530|NCT01826487|Dystrophinopathy|dystrophinopathy
4957531|NCT01826487|Nonsense mutation|nonsense mutation
4957532|NCT01826487|Premature stop codon|premature stop codon
4957533|NCT01826487|Becker muscular dystrophy|becker muscular dystrophy
4957534|NCT01826487|DMD/BMD|dmd/bmd
4957535|NCT01826487|PTC124|ptc124
4957536|NCT01826487|Ataluren|ataluren
4957537|NCT01826474|Duchenne muscular dystrophy|duchenne muscular dystrophy
4957539|NCT01826474|Prosensa|prosensa
4957540|NCT01826474|Duchenne|duchenne
4957541|NCT01826461|atopic dermatitis|atopic dermatitis
4957542|NCT01826461|eczema|eczema
4957543|NCT01826461|PDI-192|pdi-192
4957544|NCT01826461|Precision|precision
4957545|NCT01826422|Muscular Dystrophy|muscular dystrophy
4957546|NCT01826422|Duchenne Muscular Dystrophy|duchenne muscular dystrophy
4957547|NCT01826422|Becker Muscular Dystrophy|becker muscular dystrophy
4957548|NCT01826422|Omega 3|omega 3
4957549|NCT01826422|Eicosapentaenoic fatty acid|eicosapentaenoic fatty acid
4957550|NCT01826422|Docosahexaenoic fatty acid|docosahexaenoic fatty acid
4957551|NCT01826383|Infant|infant
4957552|NCT01826383|Immunization|immunization
4957553|NCT01826357|metabolic syndrome|metabolic syndrome
4957554|NCT01826357|cluster analysis|cluster analysis
4957555|NCT01826357|PCOS|pcos
4957556|NCT01826318|Stress|stress
4957557|NCT01826318|coping|coping
4957558|NCT01826318|simulation|simulation
4957559|NCT01826292|Post anesthesia care unit length of stay|post anesthesia care unit length of stay
4957560|NCT01826279|Obesity|obesity
4957561|NCT01826279|Gastric bypass surgery|gastric bypass surgery
4957562|NCT01826279|Resveratrol|resveratrol
4957563|NCT01826279|Insulin sensitivity|insulin sensitivity
4957564|NCT01826279|Lipid turnover|lipid turnover
4957565|NCT01826279|VLDL-triglyceride uptake|vldl-triglyceride uptake
4957566|NCT01826279|Liver|liver
4957567|NCT01826266|PER977|per977
4957568|NCT01826266|Activated partial thromboplastin time|activated partial thromboplastin time
4957569|NCT01826266|Assessment|assessment
4957570|NCT01826266|D-dimer|d-dimer
4957571|NCT01826266|Enrollment|enrollment
4957572|NCT01826266|Investigational drug|investigational drug
4957573|NCT01826266|Investigational treatment|investigational treatment
4957574|NCT01826266|Period|period
4957575|NCT01826266|Premature subject withdrawal|premature subject withdrawal
4957576|NCT01826266|Prothrombin time|prothrombin time
4957577|NCT01826266|Randomization number|randomization number
4957578|NCT01826266|Study discontinuation|study discontinuation
4957579|NCT01826266|Study drug|study drug
4957580|NCT01826266|Subject number|subject number
4957581|NCT01826266|Study treatment|study treatment
4957582|NCT01826266|Thromboelastography-reaction time|thromboelastography-reaction time
4957583|NCT01826253|Hypovolemia|hypovolemia
4957584|NCT01826253|Fluid challenge|fluid challenge
4957585|NCT01826253|Fluid expansion|fluid expansion
4957586|NCT01826253|Oxygene delivery|oxygene delivery
4957587|NCT01826253|Cardiac output|cardiac output
4957588|NCT01826227|PET (Positron Emission Tomography)|pet (positron emission tomography)
4957589|NCT01826227|18F-FDG|18f-fdg
4957590|NCT01826227|Cytoreductive Surgery|cytoreductive surgery
4957591|NCT01826227|13-017|13-017
4957592|NCT01826214|acute myeloid leukemia|acute myeloid leukemia
4957593|NCT01826214|AML|aml
4957594|NCT01826214|acute lymphoblastic leukemia|acute lymphoblastic leukemia
4957595|NCT01826214|ALL|all
4957596|NCT01826214|leukemia|leukemia
4957597|NCT01826214|acute|acute
4957598|NCT01826214|LDE225|lde225
4957599|NCT01826214|adult patients|adult patients
4957600|NCT01826214|relapsed/refractory|relapsed/refractory
4957601|NCT01826201|psoriasis|psoriasis
4957602|NCT01826188|Crohn's disease|crohn's disease
4957603|NCT01826188|IBD Cannabis|ibd cannabis
4957604|NCT01826188|THC|thc
4957605|NCT01826188|CBD|cbd
4957606|NCT01826175|Optical Coherence Tomography|optical coherence tomography
4957607|NCT01826175|ticagrelor|ticagrelor
4957608|NCT01826175|clopidogrel|clopidogrel
4957609|NCT01826123|Coagulopathy|coagulopathy
4957610|NCT01826123|Hemorrhage|hemorrhage
4957611|NCT01826123|Cardiac surgery|cardiac surgery
4957612|NCT01826123|Point-of-Care testing|point-of-care testing
4957613|NCT01826123|POC|poc
4957614|NCT01826123|ROTEM|rotem
4957615|NCT01826123|multiplate|multiplate
4957616|NCT01826123|Multiple electrode aggregometry (MEA)|multiple electrode aggregometry (mea)
4957617|NCT01826097|Cytology|cytology
4957618|NCT01826097|Whole body massage vibration|whole body massage vibration
4957619|NCT01826071|Osgood-Schlatter syndrome (OSS)|osgood-schlatter syndrome (oss)
4957620|NCT01826071|Sinding-Larsen and Johansson syndrome (SLJ)|sinding-larsen and johansson syndrome (slj)
4957621|NCT01826071|Sever's disease|sever's disease
4957622|NCT01826071|apophysitis|apophysitis
4957623|NCT01826058|Stereotactic body radiation therapy|stereotactic body radiation therapy
4957624|NCT01826058|Radiosurgery|radiosurgery
4957625|NCT01826045|Treatment of Cervical Intraepithelial Neoplasia(CIN1)|treatment of cervical intraepithelial neoplasia(cin1)
4957626|NCT01826006|Myocardial Infarction|myocardial infarction
4957627|NCT01826006|No-reflow|no-reflow
4957628|NCT01826006|Primary PCI|primary pci
4957629|NCT01826006|Coronary no-reflow phenomenon|coronary no-reflow phenomenon
4957630|NCT01826006|Primary percoutaneous coronary intervention (primary PCI)|primary percoutaneous coronary intervention (primary pci)
4957631|NCT01825993|Peridural catheter|peridural catheter
4957632|NCT01825993|Morphine PCA|morphine pca
4957633|NCT01825993|Transabdominal Block|transabdominal block
4957634|NCT01825993|laparoscopic sigmoidectomy|laparoscopic sigmoidectomy
4957635|NCT01825954|Fibromyalgia|fibromyalgia
4957636|NCT01825954|Pain|pain
4957637|NCT01825954|Brain|brain
4957638|NCT01825954|Stimulation|stimulation
4957639|NCT01825954|Device|device
4957640|NCT01825941|migraine|migraine
4957641|NCT01825941|headache|headache
4957642|NCT01825941|metoclopramide|metoclopramide
4957643|NCT01825941|diphenhydramine|diphenhydramine
4957644|NCT01825928|Methamphetamine|methamphetamine
4957645|NCT01825928|paliperidone|paliperidone
4957646|NCT01825915|Laparoscopic|laparoscopic
4957647|NCT01825915|Hysterectomy|hysterectomy
4957648|NCT01825915|Total|total
4957649|NCT01825915|Subtotal|subtotal
4957650|NCT01825915|Recovery|recovery
4957651|NCT01825915|Outcomes|outcomes
4957652|NCT01825915|Surgery|surgery
4957653|NCT01825863|Laparoscopy|laparoscopy
4957654|NCT01825863|Adult|adult
4957655|NCT01825863|Nerve block|nerve block
4957656|NCT01825863|Ultrasonography|ultrasonography
4957657|NCT01825837|bipolar I disorder|bipolar i disorder
4957658|NCT01825837|Eslicarbazepine acetate|eslicarbazepine acetate
4957659|NCT01825837|BIA 2-093|bia 2-093
4957660|NCT01825824|Hepatocellular carcinoma|hepatocellular carcinoma
4957661|NCT01825824|Stereotactic ablative radiotherapy|stereotactic ablative radiotherapy
4957662|NCT01825824|Stereotactic body radiotherapy|stereotactic body radiotherapy
4957663|NCT01825811|Cell mediated gene therapy|cell mediated gene therapy
4957664|NCT01825811|Osteoarthritis|osteoarthritis
4957665|NCT01825811|Fibrin-glue|fibrin-glue
4957666|NCT01825811|Degenerative Arthritis|degenerative arthritis
4957667|NCT01825798|Metformin|metformin
4957668|NCT01825798|Overweight|overweight
4957669|NCT01825798|Atypical Antipsychotic|atypical antipsychotic
4957670|NCT01825798|Medication|medication
4957671|NCT01825798|Randomized Clinical Trial|randomized clinical trial
4957672|NCT01825798|Children|children
4957673|NCT01825772|Cross-Sectional Studies|cross-sectional studies
4957674|NCT01825772|Prevalence|prevalence
4957675|NCT01825772|Peri-Implantitis|peri-implantitis
4957676|NCT01825733|palonosetron, ramosetron, PONV, opioid|palonosetron, ramosetron, ponv, opioid
4957677|NCT01825720|GIK, valvular heart surgery, lactate|gik, valvular heart surgery, lactate
4957678|NCT01825694|Substance Abuse|substance abuse
4957679|NCT01825694|Traumatic Stress|traumatic stress
4957680|NCT01825681|positive affect|positive affect
4957681|NCT01825681|caregivers|caregivers
4957682|NCT01825681|caregiving|caregiving
4957683|NCT01825681|stress|stress
4957684|NCT01825681|mood|mood
4957685|NCT01825681|dementia|dementia
4957686|NCT01825681|Alzheimer's|alzheimer's
4957687|NCT01825681|FTD|ftd
4957688|NCT01825681|Lewy|lewy
4957689|NCT01825681|mindfulness|mindfulness
4957690|NCT01825681|help|help
4957691|NCT01825642|Prostate cancer|prostate cancer
4957692|NCT01825642|sexual function|sexual function
4957693|NCT01825642|seminal vesicle sparing|seminal vesicle sparing
4957694|NCT01825642|nerve-sparing|nerve-sparing
4957695|NCT01825642|radical prostatectomy|radical prostatectomy
4957696|NCT01825629|Pain|pain
4957697|NCT01825629|Temporomandibular joint|temporomandibular joint
4957698|NCT01825629|Manual therapy|manual therapy
4957699|NCT01825629|Physical therapy|physical therapy
4957700|NCT01825629|Fibromyalgia Syndrome|fibromyalgia syndrome
4957701|NCT01825616|Strength|strength
4957702|NCT01825616|Anaerobic power|anaerobic power
4957703|NCT01825616|Muscle soreness|muscle soreness
4957704|NCT01825616|Immune function|immune function
4957705|NCT01825590|hemodialysis|hemodialysis
4957706|NCT01825590|dialysate and serum sodium|dialysate and serum sodium
4957707|NCT01825577|Alzheimer Dementia|alzheimer dementia
4957708|NCT01825577|Gait|gait
4957709|NCT01825564|G-tube|g-tube
4957710|NCT01825564|Feeding tube|feeding tube
4957711|NCT01825564|Feeding tube placement verification|feeding tube placement verification
4957712|NCT01825564|Enteral feeding|enteral feeding
4957713|NCT01825551|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
4957714|NCT01825551|Granulocyte Colony Stimulating Factor|granulocyte colony stimulating factor
4957715|NCT01825538|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
4957716|NCT01825538|Pulmonary fibrosis|pulmonary fibrosis
4957717|NCT01825538|Advanced care planning|advanced care planning
4957718|NCT01825512|chronic iron overload|chronic iron overload
4957719|NCT01825512|hereditary haemoglobinopathy|hereditary haemoglobinopathy
4957720|NCT01825512|beta thalassaemia major|beta thalassaemia major
4957721|NCT01825512|chelating agents|chelating agents
4957722|NCT01825512|deferiprone|deferiprone
4957723|NCT01825512|deferasirox|deferasirox
4957724|NCT01825512|children|children
4957725|NCT01825512|paediatrics|paediatrics
4957726|NCT01825499|Birth weight|birth weight
4957727|NCT01825499|Gestational age|gestational age
4957728|NCT01825499|Very low birth weight|very low birth weight
4957729|NCT01825486|Balance|balance
4957730|NCT01825486|Gait characteristics|gait characteristics
4957731|NCT01825473|neonate|neonate
4957732|NCT01825473|apnea|apnea
4957733|NCT01825473|preterm|preterm
4957734|NCT01825473|reflux|reflux
4957735|NCT01825473|gastroesophageal reflux|gastroesophageal reflux
4957736|NCT01825473|impedance|impedance
4957737|NCT01825473|erythromycin|erythromycin
4957738|NCT01825473|desaturation|desaturation
4957739|NCT01825473|bradycardia|bradycardia
4957740|NCT01825473|hypoxia|hypoxia
4957741|NCT01825460|Cervical spine|cervical spine
4957742|NCT01825460|Neck pain|neck pain
4957743|NCT01825460|Manual therapy|manual therapy
4957744|NCT01825460|Controlled clinical trial|controlled clinical trial
4957745|NCT01825447|abuse potential|abuse potential
4957746|NCT01825447|abuse liability|abuse liability
4957747|NCT01825447|drug liking|drug liking
4957748|NCT01825447|oxycodone|oxycodone
4957749|NCT01825447|naltrexone|naltrexone
4957750|NCT01825447|intravenous|intravenous
4957751|NCT01825447|pharmacodynamic|pharmacodynamic
4957752|NCT01825434|chronic constipation|chronic constipation
4957753|NCT01825434|Lactobacillus acidophilus NCFM|lactobacillus acidophilus ncfm
4957754|NCT01825434|Bifidobacterium lactis HN019|bifidobacterium lactis hn019
4957755|NCT01825421|Infant|infant
4957756|NCT01825421|Infection|infection
4957757|NCT01825421|Newborn|newborn
4957758|NCT01825421|Antibiotics|antibiotics
4957759|NCT01825421|Neutrophil CD64|neutrophil cd64
4957760|NCT01825421|Blood Culture|blood culture
4957761|NCT01825369|congenital heart disease|congenital heart disease
4957762|NCT01825369|ventricular septal defect|ventricular septal defect
4957763|NCT01825369|atrioventricular septal defect|atrioventricular septal defect
4957764|NCT01825369|increased pulmonary blood flow|increased pulmonary blood flow
4957765|NCT01825369|nitric oxide|nitric oxide
4957766|NCT01825343|fall|fall
4957767|NCT01825343|burn|burn
4957768|NCT01825343|road traffic crash|road traffic crash
4957769|NCT01825330|Alzheimer's Disease|alzheimer's disease
4957770|NCT01825330|Alzheimer's|alzheimer's
4957771|NCT01825330|TMS|tms
4957772|NCT01825330|Cognitive Training|cognitive training
4957773|NCT01825330|NeuroAD|neuroad
4957774|NCT01825317|Alzheimer's disease|alzheimer's disease
4957775|NCT01825317|TMS|tms
4957776|NCT01825317|NeuroAd|neuroad
4957777|NCT01825317|cognitive training|cognitive training
4957778|NCT01825317|ADAS-Cog|adas-cog
4957779|NCT01825304|mechanical ventilation|mechanical ventilation
4957780|NCT01825304|Intra-abdominal hypertension|intra-abdominal hypertension
4957781|NCT01825304|positive end-expiratory pressure|positive end-expiratory pressure
4957782|NCT01825291|sleep apnea|sleep apnea
4957783|NCT01825291|co-morbidities of sleep apnea|co-morbidities of sleep apnea
4957784|NCT01825291|CPAP treatment|cpap treatment
4957785|NCT01825278|respiratory rate|respiratory rate
4957786|NCT01825278|tidal volume|tidal volume
4957787|NCT01825278|minute ventilation|minute ventilation
4957788|NCT01825278|obese patients|obese patients
4957789|NCT01825278|obstructive sleep apnea|obstructive sleep apnea
4957790|NCT01825265|Neoplasm Metastasis|neoplasm metastasis
4957791|NCT01825265|Breast Cancer|breast cancer
4957792|NCT01825265|Docetaxel|docetaxel
4957793|NCT01825265|RAD001|rad001
4957794|NCT01825265|Taxotere|taxotere
4957795|NCT01825252|HIV|hiv
4957796|NCT01825252|sexually transmitted diseases|sexually transmitted diseases
4957797|NCT01825239|ischemic cardiomyopathy|ischemic cardiomyopathy
4957798|NCT01825239|cardiomyopathy|cardiomyopathy
4957799|NCT01825239|left ventricular lead|left ventricular lead
4957800|NCT01825239|cardiac electrophysiologic studies|cardiac electrophysiologic studies
4957801|NCT01825213|Liver disease|liver disease
4957802|NCT01825213|Multi Spectral CT|multi spectral ct
4957803|NCT01825200|Influenza|influenza
4957804|NCT01825148|Diabetes|diabetes
4957805|NCT01825135|muscle strength|muscle strength
4957806|NCT01825135|muscle function|muscle function
4957807|NCT01825135|functional status|functional status
4957808|NCT01825109|Rotavirus|rotavirus
4957809|NCT01825109|Immunogenicity|immunogenicity
4957810|NCT01825109|vaccine, Bangladesh|vaccine, bangladesh
4957811|NCT01825096|cerebral metabolism|cerebral metabolism
4957812|NCT01825096|functional magnetic resonance imaging|functional magnetic resonance imaging
4957813|NCT01825096|near infrared spectroscopy|near infrared spectroscopy
4957814|NCT01825083|Hypercarbia|hypercarbia
4957815|NCT01825083|TOSCA monitor|tosca monitor
4957816|NCT01825083|Ketamine|ketamine
4957817|NCT01825083|Fentanyl|fentanyl
4957818|NCT01825083|Intraoperative monitoring|intraoperative monitoring
4957819|NCT01825070|Montmorency tart cherries|montmorency tart cherries
4957820|NCT01825070|Inflammation|inflammation
4957821|NCT01825070|Uric acid|uric acid
4957822|NCT01825057|implementation study|implementation study
4957823|NCT01825057|motivational interviewing|motivational interviewing
4957824|NCT01825057|substance use|substance use
4957825|NCT01825044|Traumatic Brain Injury|traumatic brain injury
4957826|NCT01825044|TBI|tbi
4957827|NCT01825044|ciclosporin|ciclosporin
4957828|NCT01825044|pharmacokinetic|pharmacokinetic
4957829|NCT01825044|safety|safety
4957830|NCT01825044|microdialysis|microdialysis
4957831|NCT01825044|mitochondrial protection|mitochondrial protection
4957832|NCT01825031|HIV|hiv
4957833|NCT01825018|HIV|hiv
4957834|NCT01825018|AIDS|aids
4957835|NCT01825018|treatment adherence|treatment adherence
4957836|NCT01825005|cervical cancer|cervical cancer
4957837|NCT01824966|Esophagectomy|esophagectomy
4957838|NCT01824966|Signet Ring Cells|signet ring cells
4957839|NCT01824953|Gastric atrophy|gastric atrophy
4957840|NCT01824953|Helicobacter pylori|helicobacter pylori
4957841|NCT01824953|Pepsinogen|pepsinogen
4957842|NCT01824953|Gastric cancer|gastric cancer
4957843|NCT01824953|Gastric adenoma|gastric adenoma
4957844|NCT01824940|Cluster randomized trial|cluster randomized trial
4957845|NCT01824940|Nutrition|nutrition
4957846|NCT01824940|Water Sanitation Hygiene|water sanitation hygiene
4957847|NCT01824940|Environmental enteropathy|environmental enteropathy
4957848|NCT01824914|videolaryngoscope|videolaryngoscope
4957849|NCT01824914|tracheal intubation|tracheal intubation
4957850|NCT01824914|Cormack-Lehane grade|cormack-lehane grade
4957851|NCT01824914|airway evaluation|airway evaluation
4957852|NCT01824914|sedation|sedation
4957853|NCT01824914|anesthesia|anesthesia
4957854|NCT01824901|AZD4547|azd4547
4958227|NCT01823185|King Fahd Hospital|king fahd hospital
4957855|NCT01824901|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
4957857|NCT01824888|hand rub|hand rub
4957858|NCT01824888|European standard|european standard
4957859|NCT01824862|clinically significant macular edema|clinically significant macular edema
4957860|NCT01824862|foveal thickness|foveal thickness
4957861|NCT01824862|foveal sensitivity|foveal sensitivity
4957862|NCT01824862|perimetry|perimetry
4957863|NCT01824862|diabetic retinopathy|diabetic retinopathy
4957864|NCT01824849|Vocal cords|vocal cords
4957865|NCT01824849|Vocal cord paralysis|vocal cord paralysis
4957866|NCT01824849|Arytenoid cartilage|arytenoid cartilage
4957867|NCT01824823|afatinib|afatinib
4957868|NCT01824823|head and neck squamous cell carcinoma|head and neck squamous cell carcinoma
4957869|NCT01824810|Intramuscular Stimulation|intramuscular stimulation
4957870|NCT01824810|myoActivation|myoactivation
4957871|NCT01824810|Neural Prolotherapy|neural prolotherapy
4957872|NCT01824810|Whiplash-Associated Disorders|whiplash-associated disorders
4957873|NCT01824810|myofascial pain|myofascial pain
4957874|NCT01824797|Bone mineral density|bone mineral density
4957875|NCT01824797|sleeve gastrectomy|sleeve gastrectomy
4957876|NCT01824797|roux-en-y|roux-en-y
4957877|NCT01824797|postmenopausal females|postmenopausal females
4957878|NCT01824797|bone loss|bone loss
4957879|NCT01824784|Normal Eyes|normal eyes
4957880|NCT01824771|Continuous veno-venoous haemofiltration|continuous veno-venoous haemofiltration
4957881|NCT01824771|Plasma lactate|plasma lactate
4957882|NCT01824771|Critical illness|critical illness
4957883|NCT01824771|Acute kidney injurytissue perfusion|acute kidney injurytissue perfusion
4957884|NCT01824771|Multiple organ dysfunction syndrome|multiple organ dysfunction syndrome
4957885|NCT01824758|esmolol, injection pain, lidocaine, rocuronium|esmolol, injection pain, lidocaine, rocuronium
4957886|NCT01824706|cranial prosthesis|cranial prosthesis
4957887|NCT01824680|Obesity|obesity
4957888|NCT01824680|Appetite regulation|appetite regulation
4957889|NCT01824680|Hormones|hormones
4957890|NCT01824680|Adolescents|adolescents
4957891|NCT01824680|Exercise|exercise
4957892|NCT01824654|Aortic Aneurysm, Abdominal|aortic aneurysm, abdominal
4957893|NCT01824654|Imaging, Three-Dimensional|imaging, three-dimensional
4957894|NCT01824654|Tomography Scanners, X-Ray Computed|tomography scanners, x-ray computed
4957895|NCT01824654|Angiography, Digital Subtraction|angiography, digital subtraction
4957896|NCT01824654|Endovascular Procedures|endovascular procedures
4957897|NCT01824654|Radiography, Interventional|radiography, interventional
4957898|NCT01824641|Acute myocardial infarction|acute myocardial infarction
4957899|NCT01824641|Manual thrombus aspiration|manual thrombus aspiration
4957900|NCT01824641|Coronary physiology|coronary physiology
4957901|NCT01824615|Sunitinib|sunitinib
4957902|NCT01824615|recurrent ovarian cancer|recurrent ovarian cancer
4957903|NCT01824615|clear cell carcinoma|clear cell carcinoma
4957904|NCT01824602|BIPOLAR I DISORDER, Eslicarbazepine acetate|bipolar i disorder, eslicarbazepine acetate
4957905|NCT01824589|traumatic brain injury|traumatic brain injury
4957906|NCT01824589|TBI|tbi
4957907|NCT01824589|ITPR|itpr
4957908|NCT01824589|intrathoracic pressure regulator|intrathoracic pressure regulator
4957909|NCT01824589|hepatic encephalopathy|hepatic encephalopathy
4957910|NCT01824589|pseudotumorcerebri|pseudotumorcerebri
4957911|NCT01824589|obstructive hydrocephalus|obstructive hydrocephalus
4957912|NCT01824589|intracranial hemorrhage|intracranial hemorrhage
4957913|NCT01824576|ITPR|itpr
4957914|NCT01824576|CPP|cpp
4957915|NCT01824576|TBI|tbi
4957916|NCT01824576|traumatic brain injury|traumatic brain injury
4957917|NCT01824576|cerebral perfusion pressure|cerebral perfusion pressure
4957918|NCT01824576|intrathoracic pressure regulator|intrathoracic pressure regulator
4957919|NCT01824537|Human papillomavirus (HPV)|human papillomavirus (hpv)
4957920|NCT01824537|Vaccination|vaccination
4957921|NCT01824537|Cervical cancer prevention|cervical cancer prevention
4957922|NCT01824537|Herd immunity|herd immunity
4957923|NCT01824524|Pain|pain
4957924|NCT01824524|Hydromorphone|hydromorphone
4957925|NCT01824524|OROS|oros
4957926|NCT01824511|smoking|smoking
4957927|NCT01824511|nicotine|nicotine
4957928|NCT01824511|tobacco|tobacco
4957929|NCT01824511|anhedonia|anhedonia
4957930|NCT01824511|reward|reward
4957931|NCT01824511|withdrawal|withdrawal
4957932|NCT01824498|omega-3 fatty acids|omega-3 fatty acids
4957933|NCT01824498|sex hormones|sex hormones
4957934|NCT01824498|urinary sex hormone metabolites|urinary sex hormone metabolites
4957935|NCT01824485|Osteoarthritis|osteoarthritis
4957936|NCT01824485|Knee|knee
4957937|NCT01824485|Viscosupplementation|viscosupplementation
4957938|NCT01824485|Clinical Trial|clinical trial
4957939|NCT01824459|Non-intestinal type gastric cancer|non-intestinal type gastric cancer
4957940|NCT01824459|Advance Gastric Cancer|advance gastric cancer
4957941|NCT01824459|Recurrent Gastric Cancer|recurrent gastric cancer
4957942|NCT01824459|Gastroesophageal Junction Adenocarcinoma|gastroesophageal junction adenocarcinoma
4957943|NCT01824459|SOX, S-1+Oxaliplatin|sox, s-1+oxaliplatin
4957944|NCT01824459|OS,|os,
4957945|NCT01824459|ORR,|orr,
4957946|NCT01824459|TTP,|ttp,
4957947|NCT01824459|TTF,|ttf,
4957948|NCT01824459|safety|safety
4957949|NCT01824433|venlafaxine|venlafaxine
4957950|NCT01824433|fluoxetine|fluoxetine
4957951|NCT01824433|postmenopause|postmenopause
4957952|NCT01824433|major depressive disorder|major depressive disorder
4957953|NCT01824420|Refractory overactive bladder syndrome|refractory overactive bladder syndrome
4957954|NCT01824420|Antimuscarinic agent|antimuscarinic agent
4957955|NCT01824407|foot|foot
4957956|NCT01824407|ulcers|ulcers
4957957|NCT01824407|diabetes|diabetes
4957958|NCT01824407|wound|wound
4957959|NCT01824407|healing|healing
4957960|NCT01824394|nMARQ|nmarq
4957961|NCT01824394|Atrial Fibrillation|atrial fibrillation
4957962|NCT01824394|Drug Refractory|drug refractory
4957963|NCT01824394|Radio Frequency|radio frequency
4957964|NCT01824381|extensive wounds|extensive wounds
4957965|NCT01824381|amniotic membrane|amniotic membrane
4957966|NCT01824381|healing|healing
4957967|NCT01824381|patients|patients
4957968|NCT01824381|phase granulation|phase granulation
4957969|NCT01824329|Bladder Cancer|bladder cancer
4957970|NCT01824329|Transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
4957971|NCT01824264|Type 2 Diabetes mellitus, SGLT inhibitors, dose-response|type 2 diabetes mellitus, sglt inhibitors, dose-response
4957972|NCT01824251|IVIG in Chronic Inflammatory Demyelinating Polyneuropathy|ivig in chronic inflammatory demyelinating polyneuropathy
4957973|NCT01824251|Patients with Chronic Inflammatory Demyelinating Polyneuropathy|patients with chronic inflammatory demyelinating polyneuropathy
4957974|NCT01824225|aflibercept|aflibercept
4957975|NCT01824225|intravitreal injection|intravitreal injection
4957976|NCT01824212|Ventricular fibrillation|ventricular fibrillation
4957977|NCT01824212|Cardiac arrest|cardiac arrest
4957978|NCT01824212|Mobile technology|mobile technology
4957979|NCT01824199|Esophagitis|esophagitis
4957980|NCT01824173|muscle|muscle
4957981|NCT01824173|mitochondria|mitochondria
4957982|NCT01824173|amino acids|amino acids
4957983|NCT01824173|exercise|exercise
4957984|NCT01824147|ASS-Nonresponse|ass-nonresponse
4957985|NCT01824147|cardiac|cardiac
4957986|NCT01824147|surgery|surgery
4957987|NCT01824121|Progressive Supranuclear palsy|progressive supranuclear palsy
4957988|NCT01824121|stem cell therapy|stem cell therapy
4957989|NCT01824108|Lumbar disc herniation|lumbar disc herniation
4957990|NCT01824108|Wallis interspinous implants|wallis interspinous implants
4957991|NCT01824108|lumbar discectomy|lumbar discectomy
4957992|NCT01824108|interspinous dynamic stability system|interspinous dynamic stability system
4957993|NCT01824082|phantom pain|phantom pain
4957994|NCT01824082|traumatic limb amputation|traumatic limb amputation
4957995|NCT01824082|amputees|amputees
4957996|NCT01824069|Critical Ischemia|critical ischemia
4957997|NCT01824069|Amputation|amputation
4957998|NCT01824056|18F-FDG|18f-fdg
4957999|NCT01824043|diabetic retinopathy|diabetic retinopathy
4958000|NCT01824043|vitreous hemorrhage|vitreous hemorrhage
4958001|NCT01824043|intravitreal ranibizumab|intravitreal ranibizumab
4958002|NCT01824030|FFR, OCT, Seattle Angina Questionnaire|ffr, oct, seattle angina questionnaire
4958003|NCT01824017|Type 2 diabetes|type 2 diabetes
4958004|NCT01824017|metabolic syndrome|metabolic syndrome
4958005|NCT01824017|oxidative stress|oxidative stress
4958006|NCT01824017|GSH|gsh
4958007|NCT01824004|Gastric cancer|gastric cancer
4958008|NCT01824004|Adjuvant|adjuvant
4958009|NCT01824004|Chemoradiotherapy|chemoradiotherapy
4958010|NCT01824004|S-1|s-1
4958011|NCT01824004|Cisplatin|cisplatin
4958012|NCT01823991|polyphenolics|polyphenolics
4958013|NCT01823991|anthocyanins|anthocyanins
4958014|NCT01823991|n-3 fatty acids|n-3 fatty acids
4958015|NCT01823978|metastatic|metastatic
4958016|NCT01823978|castration resistant prostate cancer|castration resistant prostate cancer
4958017|NCT01823978|Therapeutic Vaccine|therapeutic vaccine
4958018|NCT01823978|Dendritic cell|dendritic cell
4958019|NCT01823978|BPX-201|bpx-201
4958020|NCT01823978|BPX201|bpx201
4958021|NCT01823978|AP1903|ap1903
4958022|NCT01823952|HAMS|hams
4958023|NCT01823952|ORS|ors
4958024|NCT01823952|Cholera|cholera
4958025|NCT01823952|Diarrhea|diarrhea
4958026|NCT01823939|Cholera|cholera
4958027|NCT01823939|V. Cholerae O1|v. cholerae o1
4958028|NCT01823939|iOWH032|iowh032
4958029|NCT01823939|diarrhoea|diarrhoea
4958030|NCT01823939|pharmacokinetic|pharmacokinetic
4958031|NCT01823939|Bangladesh|bangladesh
4958032|NCT01823926|vibrating mesh nebulizers|vibrating mesh nebulizers
4958033|NCT01823926|noninvasive ventilation|noninvasive ventilation
4958034|NCT01823926|residual volume|residual volume
4958035|NCT01823926|pulmonary scintigraphy|pulmonary scintigraphy
4958036|NCT01823926|radioaerosol|radioaerosol
4958037|NCT01823926|nebulization.|nebulization.
4958038|NCT01823913|Pharmacokinetics|pharmacokinetics
4958039|NCT01823900|Pharmacokinetics|pharmacokinetics
4958040|NCT01823887|Heart Failure|heart failure
4958041|NCT01823887|Vagus Nerve|vagus nerve
4958042|NCT01823887|VNS|vns
4958043|NCT01823874|Virtual reality analgesia|virtual reality analgesia
4958044|NCT01823874|pain control|pain control
4958045|NCT01823848|constipation|constipation
4958046|NCT01823848|enema|enema
4958047|NCT01823822|Anorexia nervosa|anorexia nervosa
4958048|NCT01823822|Protein supplements|protein supplements
4958049|NCT01823822|IGF-I|igf-i
4958050|NCT01823809|Coronary Artery Disease|coronary artery disease
4958051|NCT01823809|Computed Tomography|computed tomography
4958052|NCT01823809|Cardiac Magnetic Resonance|cardiac magnetic resonance
4958053|NCT01823809|Fractional Flow Reserve|fractional flow reserve
4958054|NCT01823796|Fibromyalgia|fibromyalgia
4958055|NCT01823796|balance|balance
4958056|NCT01823796|falls|falls
4958057|NCT01823783|Duchenne muscular distrophy|duchenne muscular distrophy
4958058|NCT01823783|Endomysial Fibrosis|endomysial fibrosis
4958059|NCT01823783|Muscular Inflammatory Response|muscular inflammatory response
4958060|NCT01823783|Calcium Homeostasis Dysfunction|calcium homeostasis dysfunction
4958061|NCT01823783|Muscle biopsy|muscle biopsy
4958062|NCT01823770|Restless Legs Syndrome (RLS)|restless legs syndrome (rls)
4958063|NCT01823770|Rotigotine|rotigotine
4958064|NCT01823770|HTA|hta
4958065|NCT01823770|Cardiovascular diseases|cardiovascular diseases
4958066|NCT01823770|Periodic Limb Movements in Sleep (PLMS)|periodic limb movements in sleep (plms)
4958067|NCT01823770|dopaminergic agonist|dopaminergic agonist
4958068|NCT01823770|Sympathetic overactivity|sympathetic overactivity
4958069|NCT01823770|blood pressure|blood pressure
4958070|NCT01823757|elderly|elderly
4958071|NCT01823757|potential inappropriate medications|potential inappropriate medications
4958072|NCT01823757|pharmaceutical care|pharmaceutical care
4958073|NCT01823757|quality of life|quality of life
4958074|NCT01823757|medical expenditure|medical expenditure
4958075|NCT01823744|micronutrient|micronutrient
4958076|NCT01823744|genomic|genomic
4958077|NCT01823744|SAM/SAH ratio|sam/sah ratio
4958078|NCT01823731|PCI,SOTOC, Ovarian cancer|pci,sotoc, ovarian cancer
4958079|NCT01823692|Radius Fracture|radius fracture
4958080|NCT01823692|Sensitivity|sensitivity
4958081|NCT01823692|Reduction|reduction
4958082|NCT01823692|Adequacy|adequacy
4958083|NCT01823666|Dementia|dementia
4958084|NCT01823666|Alzheimer's disease|alzheimer's disease
4958085|NCT01823666|mild cognitive impairment|mild cognitive impairment
4958086|NCT01823640|HRV|hrv
4958087|NCT01823640|Pharmacodynamics / kinetics|pharmacodynamics / kinetics
4958088|NCT01823640|Resistance|resistance
4958089|NCT01823627|COPD|copd
4958090|NCT01823627|Psychiatric inpatient|psychiatric inpatient
4958091|NCT01823627|Smoking|smoking
4958092|NCT01823614|HIV infection|hiv infection
4958093|NCT01823614|tropism determination|tropism determination
4958094|NCT01823614|genotypic methodic|genotypic methodic
4958095|NCT01823614|R5-tropic variant|r5-tropic variant
4958096|NCT01823614|X4-tropic variant|x4-tropic variant
4958097|NCT01823601|Well-Being|well-being
4958098|NCT01823601|Life Management Program|life management program
4958099|NCT01823601|Breathing|breathing
4958100|NCT01823601|Meditation|meditation
4958101|NCT01823601|Cognitive-Behavioral Training|cognitive-behavioral training
4958102|NCT01823575|malignant ureteral obstruction|malignant ureteral obstruction
4958476|NCT01822145|ventricular tachycardia|ventricular tachycardia
4958103|NCT01823575|silicone-covered metallic ureteral stent|silicone-covered metallic ureteral stent
4958104|NCT01823575|double-J stent|double-j stent
4958105|NCT01823562|Lyophilized Black Raspberry|lyophilized black raspberry
4958106|NCT01823562|Prostate Cancer|prostate cancer
4958107|NCT01823562|Surgery|surgery
4958108|NCT01823549|CAM|cam
4958109|NCT01823549|Alternative Medicine|alternative medicine
4958110|NCT01823536|Meningitis|meningitis
4958111|NCT01823510|Antiplatelet|antiplatelet
4958112|NCT01823510|Ticagrelor|ticagrelor
4958113|NCT01823510|Clopidogrel|clopidogrel
4958114|NCT01823510|Thrombosis|thrombosis
4958115|NCT01823510|Diabetes|diabetes
4958116|NCT01823510|Coronary Artery Disease|coronary artery disease
4958117|NCT01823497|Neonatal Intensive Care Unit|neonatal intensive care unit
4958118|NCT01823497|neonate|neonate
4958119|NCT01823497|pain|pain
4958120|NCT01823497|morphine|morphine
4958121|NCT01823497|Parent/Nurse Controlled Analgesia|parent/nurse controlled analgesia
4958122|NCT01823484|hemofilter|hemofilter
4958123|NCT01823484|coagulation|coagulation
4958124|NCT01823484|CRRT|crrt
4958125|NCT01823484|critically ill|critically ill
4958126|NCT01823471|HNPCC|hnpcc
4958127|NCT01823471|Hereditary non-polyposis colon carcinoma|hereditary non-polyposis colon carcinoma
4958128|NCT01823471|Lynch syndrome|lynch syndrome
4958129|NCT01823471|i-scan|i-scan
4958130|NCT01823471|virtual chromo-endoscopy|virtual chromo-endoscopy
4958131|NCT01823471|chromo-endoscopy|chromo-endoscopy
4958132|NCT01823471|high definition endoscopy|high definition endoscopy
4958133|NCT01823471|polyp detection|polyp detection
4958134|NCT01823471|adenoma detection|adenoma detection
4958135|NCT01823471|adenoma miss rate|adenoma miss rate
4958136|NCT01823458|behavioral economics|behavioral economics
4958137|NCT01823458|incentives|incentives
4958138|NCT01823458|health behavior|health behavior
4958139|NCT01823458|exercise|exercise
4958140|NCT01823445|Xylitol|xylitol
4958141|NCT01823445|Dental caries|dental caries
4958142|NCT01823393|balloon aortic valvuloplasty indication|balloon aortic valvuloplasty indication
4958143|NCT01823393|heparin|heparin
4958144|NCT01823393|hemorrhagic|hemorrhagic
4958145|NCT01823393|ischemic|ischemic
4958146|NCT01823380|Amyotrophic lateral sclerosis|amyotrophic lateral sclerosis
4958147|NCT01823380|Vitamin D|vitamin d
4958148|NCT01823380|Blood Levels|blood levels
4958149|NCT01823367|type 2 diabetes mellitus prevention|type 2 diabetes mellitus prevention
4958150|NCT01823367|gestational diabetes mellitus|gestational diabetes mellitus
4958151|NCT01823367|pre-diabetes|pre-diabetes
4958152|NCT01823367|lifestyle interventions|lifestyle interventions
4958153|NCT01823367|pediatric primary prevention of type 2 diabetes|pediatric primary prevention of type 2 diabetes
4958154|NCT01823354|Restless Legs Syndrome|restless legs syndrome
4958155|NCT01823354|Polysomnography|polysomnography
4958156|NCT01823354|Executive cognition|executive cognition
4958157|NCT01823341|Type 1 Diabetes|type 1 diabetes
4958158|NCT01823341|Hypoglycemia|hypoglycemia
4958159|NCT01823341|Continuous Glucose Monitoring|continuous glucose monitoring
4958160|NCT01823341|Pump Suspension|pump suspension
4958161|NCT01823328|Intubation|intubation
4958162|NCT01823328|Airway|airway
4958163|NCT01823328|Emergent intubation|emergent intubation
4958164|NCT01823328|Rapid sequence intubation|rapid sequence intubation
4958165|NCT01823328|Rapid sequence induction|rapid sequence induction
4958166|NCT01823328|RSI|rsi
4958167|NCT01823328|Ketamine|ketamine
4958168|NCT01823328|Etomidate|etomidate
4958169|NCT01823328|Sepsis|sepsis
4958170|NCT01823328|Sedative|sedative
4958171|NCT01823328|Sedation|sedation
4958172|NCT01823302|Children with picky-eating behaviors|children with picky-eating behaviors
4958173|NCT01823302|Children aged 2.5 - 5 years|children aged 2.5 - 5 years
4958174|NCT01823302|reported by caregivers|reported by caregivers
4958175|NCT01823302|with weight-for-height z-scores ≤ 25th percentile at enrollment|with weight-for-height z-scores ≤ 25th percentile at enrollment
4958176|NCT01823289|Invasive Pulmonary Fungal Infection|invasive pulmonary fungal infection
4958177|NCT01823289|Itraconazole|itraconazole
4958178|NCT01823250|Hispanic|hispanic
4958179|NCT01823250|adolescent|adolescent
4958180|NCT01823250|drug abuse treatment|drug abuse treatment
4958181|NCT01823250|evidence-based|evidence-based
4958182|NCT01823250|family therapy|family therapy
4958183|NCT01823250|adaptive family treatment|adaptive family treatment
4958184|NCT01823250|Culturally Informed Family-Based Treatment for Adolescents|culturally informed family-based treatment for adolescents
4958185|NCT01823237|Dystonia|dystonia
4958186|NCT01823237|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
4958187|NCT01823237|Rehabilitation|rehabilitation
4958188|NCT01823237|Plasticity|plasticity
4958189|NCT01823211|ICD (Implantable cardioverter-defibrillator)|icd (implantable cardioverter-defibrillator)
4958190|NCT01823211|Heart rate variability|heart rate variability
4958191|NCT01823211|MTWA (Microvolt T-alternans)|mtwa (microvolt t-alternans)
4958192|NCT01823211|Magnetic resonance imaging (MRI)|magnetic resonance imaging (mri)
4958193|NCT01823198|Leukemia|leukemia
4958194|NCT01823198|Acute myeloid leukemia|acute myeloid leukemia
4958195|NCT01823198|AML|aml
4958196|NCT01823198|Myelodysplastic syndromes|myelodysplastic syndromes
4958197|NCT01823198|MDS|mds
4958198|NCT01823198|Blood And Marrow Transplantation|blood and marrow transplantation
4958199|NCT01823198|Myeloproliferative Diseases|myeloproliferative diseases
4958200|NCT01823198|High Risk Myeloid Malignancies|high risk myeloid malignancies
4958201|NCT01823198|Allogeneic stem cell transplant|allogeneic stem cell transplant
4958202|NCT01823198|Natural Killer Cells|natural killer cells
4958203|NCT01823198|NK|nk
4958204|NCT01823198|Immune cells|immune cells
4958205|NCT01823198|Stem cell transplant|stem cell transplant
4958206|NCT01823198|Busulfan|busulfan
4958207|NCT01823198|Busulfex|busulfex
4958208|NCT01823198|Myleran|myleran
4958209|NCT01823198|Interleukin-2|interleukin-2
4958210|NCT01823198|IL-2|il-2
4958211|NCT01823198|Aldesleukin|aldesleukin
4958212|NCT01823198|Proleukin|proleukin
4958213|NCT01823198|Thymoglobulin|thymoglobulin
4958214|NCT01823198|Antithymocyte globulin|antithymocyte globulin
4958215|NCT01823198|ATG|atg
4958216|NCT01823198|G-CSF|g-csf
4958217|NCT01823198|Filgrastim|filgrastim
4958218|NCT01823198|Neupogen|neupogen
4958219|NCT01823198|Tacrolimus|tacrolimus
4958220|NCT01823198|Prograf|prograf
4958221|NCT01823198|Methotrexate|methotrexate
4958222|NCT01823185|Clopidogrel|clopidogrel
4958223|NCT01823185|Ticagrelor|ticagrelor
4958224|NCT01823185|Prasugrel|prasugrel
4958225|NCT01823185|Platelet aggregation inhibitor|platelet aggregation inhibitor
4958226|NCT01823185|Dammam University|dammam university
4958228|NCT01823185|Purinergic P2 receptor Antagonists|purinergic p2 receptor antagonists
4958229|NCT01823172|breast cancer|breast cancer
4958230|NCT01823172|melanoma|melanoma
4958231|NCT01823172|sentinel lymph node biopsy|sentinel lymph node biopsy
4958232|NCT01823172|lymphadenectomy|lymphadenectomy
4958233|NCT01823159|retigabine|retigabine
4958234|NCT01823159|cortical excitability|cortical excitability
4958235|NCT01823159|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
4958236|NCT01823146|oxytocin|oxytocin
4958237|NCT01823146|socioemotional functioning|socioemotional functioning
4958238|NCT01823146|trust|trust
4958239|NCT01823146|amygdala|amygdala
4958240|NCT01823146|aging|aging
4958241|NCT01823120|Self harm|self harm
4958242|NCT01823120|Emergency Department|emergency department
4958243|NCT01823120|Repetition|repetition
4958244|NCT01823120|Supportive Text messages|supportive text messages
4958245|NCT01823120|Interactive|interactive
4958246|NCT01823107|Meso BioMatrix|meso biomatrix
4958247|NCT01823107|Breast|breast
4958248|NCT01823107|Breast Cancer|breast cancer
4958249|NCT01823107|Mastectomy|mastectomy
4958250|NCT01823107|Biologic Mesh|biologic mesh
4958251|NCT01823107|Breast Reconstruction|breast reconstruction
4958252|NCT01823094|lung cancer|lung cancer
4958253|NCT01823094|computed tomography|computed tomography
4958254|NCT01823094|blood flow|blood flow
4958255|NCT01823068|Lung cancer|lung cancer
4958256|NCT01823068|RET fusion|ret fusion
4958257|NCT01823068|Vandetanib|vandetanib
4958258|NCT01823042|Crohn's Disease|crohn's disease
4958259|NCT01823042|maintain remission|maintain remission
4958260|NCT01823042|postoperative recurrence|postoperative recurrence
4958261|NCT01823042|surgery|surgery
4958262|NCT01823042|living quality|living quality
4958263|NCT01823029|Crohn's Disease|crohn's disease
4958264|NCT01823029|intravenous iron|intravenous iron
4958265|NCT01823029|iron deficiency anaemia|iron deficiency anaemia
4958266|NCT01823029|Oxidative Stress|oxidative stress
4958267|NCT01823029|inflammation|inflammation
4958268|NCT01823016|Uncontrolled, persistent asthma|uncontrolled, persistent asthma
4958269|NCT01823003|Carcinoma, Non-Small-Cell Lung|carcinoma, non-small-cell lung
4958270|NCT01823003|Neoplasm Metastasis|neoplasm metastasis
4958271|NCT01823003|Radiosurgery|radiosurgery
4958272|NCT01822990|Anti-beta2-glycoprotein antibodies|anti-beta2-glycoprotein antibodies
4958273|NCT01822990|Peripheral arterial disease|peripheral arterial disease
4958274|NCT01822990|Inflammation|inflammation
4958275|NCT01822990|Nitric oxide|nitric oxide
4958276|NCT01822990|Endothelial dysfunction|endothelial dysfunction
4958277|NCT01822977|gut microbiota|gut microbiota
4958278|NCT01822977|proton pump inhibitor|proton pump inhibitor
4958279|NCT01822977|Clostridium difficile infection|clostridium difficile infection
4958280|NCT01822977|Fecal microbiome|fecal microbiome
4958281|NCT01822977|single episode of CDI|single episode of cdi
4958282|NCT01822951|DAT Study|dat study
4958283|NCT01822925|Diabetes|diabetes
4958284|NCT01822925|Pain|pain
4958285|NCT01822925|Neuropathy|neuropathy
4958286|NCT01822912|Skilled Nursing Facility|skilled nursing facility
4958287|NCT01822912|Heart Failure|heart failure
4958288|NCT01822912|Transitional Care|transitional care
4958289|NCT01822899|Novel Dry Powder Inhaler (NDPI)|novel dry powder inhaler (ndpi)
4958290|NCT01822899|umeclidinium bromide (UMEC)|umeclidinium bromide (umec)
4958291|NCT01822899|GSK573719|gsk573719
4958292|NCT01822899|lung function|lung function
4958293|NCT01822899|GW642444|gw642444
4958294|NCT01822899|salmeterol (SAL)|salmeterol (sal)
4958295|NCT01822899|fluticasone propionate (FP)|fluticasone propionate (fp)
4958296|NCT01822899|vilanterol (VI)|vilanterol (vi)
4958297|NCT01822899|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
4958298|NCT01822886|T-cell lymphoma|t-cell lymphoma
4958299|NCT01822886|Romidepsin|romidepsin
4958300|NCT01822860|Hypertension|hypertension
4958301|NCT01822860|Endothelial dysfunction|endothelial dysfunction
4958302|NCT01822847|adrenal|adrenal
4958303|NCT01822847|steroids|steroids
4958304|NCT01822847|cortisol|cortisol
4958305|NCT01822847|stress|stress
4958306|NCT01822821|Males or females|males or females
4958307|NCT01822821|18 years of age or older.|18 years of age or older.
4958308|NCT01822821|Non-emergency|non-emergency
4958309|NCT01822821|cardiac surgery|cardiac surgery
4958310|NCT01822821|midline sternotomy.|midline sternotomy.
4958311|NCT01822808|acute heart failure|acute heart failure
4958312|NCT01822808|left ventricular dysfunction|left ventricular dysfunction
4958313|NCT01822808|hydralazine|hydralazine
4958314|NCT01822808|isosorbide dinitrate|isosorbide dinitrate
4958315|NCT01822795|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
4958316|NCT01822795|Endoscopic lung volume reduction|endoscopic lung volume reduction
4958317|NCT01822782|Perineal tear|perineal tear
4958318|NCT01822782|Perineal lesion|perineal lesion
4958319|NCT01822782|Vaginal flora|vaginal flora
4958320|NCT01822782|Birth|birth
4958321|NCT01822769|congenital heart disease|congenital heart disease
4958322|NCT01822769|adult congenital heart disease|adult congenital heart disease
4958323|NCT01822769|cardiac rehabilitation|cardiac rehabilitation
4958324|NCT01822769|cardiopulmonary rehabilitation|cardiopulmonary rehabilitation
4958325|NCT01822769|exercise|exercise
4958326|NCT01822769|cardiopulmonary exercise testing|cardiopulmonary exercise testing
4958327|NCT01822769|peak vO2|peak vo2
4958328|NCT01822769|quality of life|quality of life
4958329|NCT01822743|Osteopathy|osteopathy
4958330|NCT01822743|Sleep Apnea Syndromes|sleep apnea syndromes
4958331|NCT01822743|Obstructive Sleep Apnea|obstructive sleep apnea
4958332|NCT01822743|Pcrit|pcrit
4958333|NCT01822743|Polysomnography|polysomnography
4958334|NCT01822730|Methamphetamine-Associated Psychosis|methamphetamine-associated psychosis
4958335|NCT01822730|Aripiprazole|aripiprazole
4958336|NCT01822730|Risperidone|risperidone
4958337|NCT01822717|Diabetes|diabetes
4958338|NCT01822717|Visual Impairment|visual impairment
4958339|NCT01822717|Blindness|blindness
4958340|NCT01822717|Foot Care|foot care
4958341|NCT01822717|Self-Management|self-management
4958342|NCT01822704|Stroke|stroke
4958343|NCT01822704|Exercise|exercise
4958344|NCT01822704|Rehabilitation|rehabilitation
4958345|NCT01822704|Vibration|vibration
4958346|NCT01822691|myelodysplastic syndromes (MDS)|myelodysplastic syndromes (mds)
4958347|NCT01822691|neoplastic stem cell disorders|neoplastic stem cell disorders
4958348|NCT01822691|refractory cytopenias|refractory cytopenias
4958349|NCT01822691|dysplastic morphological features|dysplastic morphological features
4958350|NCT01822691|acute myeloid leukemia (AML)|acute myeloid leukemia (aml)
4958351|NCT01822652|Neuroblastoma|neuroblastoma
4958352|NCT01822652|Solid tumor|solid tumor
4958353|NCT01822652|Neuroblastoma-specific immunotherapy targeting GD2|neuroblastoma-specific immunotherapy targeting gd2
4958354|NCT01822652|CAR T cells|car t cells
4958355|NCT01822652|Gene Therapy|gene therapy
4958356|NCT01822652|Relapsed|relapsed
4958357|NCT01822652|Refractory|refractory
4958358|NCT01822639|Hypertension|hypertension
4958359|NCT01822639|enalapril maleate|enalapril maleate
4958360|NCT01822639|healthy volunteers|healthy volunteers
4958361|NCT01822639|amlodipine|amlodipine
4958362|NCT01822639|pharmacokinetics|pharmacokinetics
4958363|NCT01822626|overweight|overweight
4958365|NCT01822626|children|children
4958366|NCT01822626|BMI|bmi
4958367|NCT01822626|counseling|counseling
4958368|NCT01822626|pediatrician|pediatrician
4958369|NCT01822613|esophageal cancer|esophageal cancer
4958370|NCT01822600|hypoalbuminemia|hypoalbuminemia
4958371|NCT01822600|peptic ulcer|peptic ulcer
4958372|NCT01822600|rebleeding|rebleeding
4958373|NCT01822600|hospitalization|hospitalization
4958374|NCT01822587|Drug Abuse|drug abuse
4958375|NCT01822587|Cocaine|cocaine
4958376|NCT01822587|Addiction|addiction
4958377|NCT01822561|Central Serous Chorioretinopathy|central serous chorioretinopathy
4958378|NCT01822561|Eplerenone|eplerenone
4958379|NCT01822561|Optical Coherence Tomography|optical coherence tomography
4958380|NCT01822561|Enhanced Depth Imaging|enhanced depth imaging
4958381|NCT01822561|Subretinal Fluid|subretinal fluid
4958382|NCT01822548|EPC|epc
4958383|NCT01822548|diabetes|diabetes
4958384|NCT01822548|DPP IV inhibitors|dpp iv inhibitors
4958385|NCT01822535|Quadriplegia|quadriplegia
4958386|NCT01822535|Spinal Cord Injuries|spinal cord injuries
4958387|NCT01822535|Body Temperature Regulation|body temperature regulation
4958388|NCT01822535|Mild Cognitive Impairment|mild cognitive impairment
4958389|NCT01822483|Renal transplantation|renal transplantation
4958390|NCT01822483|mycophenolic acid|mycophenolic acid
4958391|NCT01822483|mycophenolate mofetil|mycophenolate mofetil
4958392|NCT01822483|mycophenolate sodium|mycophenolate sodium
4958393|NCT01822483|area under the curve|area under the curve
4958394|NCT01822470|functional dyspepsia|functional dyspepsia
4958395|NCT01822470|post prandial distress syndrome|post prandial distress syndrome
4958396|NCT01822470|small bowel bacteria overgrowth|small bowel bacteria overgrowth
4958397|NCT01822470|epigastric pain syndrome|epigastric pain syndrome
4958398|NCT01822470|diarrhea|diarrhea
4958399|NCT01822470|bloating|bloating
4958400|NCT01822470|post prandial fullness|post prandial fullness
4958401|NCT01822470|weight loss|weight loss
4958402|NCT01822444|Colorectal Cancer|colorectal cancer
4958403|NCT01822444|Advanced Colorectal Cancer|advanced colorectal cancer
4958404|NCT01822444|Metastatic Colorectal Cancer|metastatic colorectal cancer
4958405|NCT01822444|Locally Advanced Colorectal Cancer|locally advanced colorectal cancer
4958406|NCT01822444|Colon Cancer|colon cancer
4958407|NCT01822444|Rectal Cancer|rectal cancer
4958408|NCT01822418|Schizophrenia|schizophrenia
4958409|NCT01822418|Depression|depression
4958410|NCT01822418|Cognition|cognition
4958411|NCT01822418|Agomelatine|agomelatine
4958412|NCT01822418|Antidepressant|antidepressant
4958413|NCT01822392|Online treatment|online treatment
4958414|NCT01822392|Treatment of conduct problems|treatment of conduct problems
4958415|NCT01822392|Parent training|parent training
4958416|NCT01822366|Children|children
4958417|NCT01822366|Adolescents|adolescents
4958418|NCT01822366|Trauma-focused Cognitive Behavioral Therapy (TF-CBT)|trauma-focused cognitive behavioral therapy (tf-cbt)
4958419|NCT01822366|Low- and Middle-Income Countries (LAMIC)|low- and middle-income countries (lamic)
4958420|NCT01822366|Randomized Controlled Trial (RCT)|randomized controlled trial (rct)
4958421|NCT01822366|Evidence-Based Practice (EBP)|evidence-based practice (ebp)
4958422|NCT01822366|Childhood Traumatic Grief (CTG)|childhood traumatic grief (ctg)
4958423|NCT01822366|Post-Traumatic Stress Disorder (PTSD)|post-traumatic stress disorder (ptsd)
4958424|NCT01822366|Kenya|kenya
4958425|NCT01822366|Tanzania|tanzania
4958426|NCT01822366|East Africa|east africa
4958427|NCT01822366|Mental Health|mental health
4958428|NCT01822353|food allergy|food allergy
4958429|NCT01822353|milk allergy|milk allergy
4958430|NCT01822353|egg allergy|egg allergy
4958431|NCT01822353|nut allergy|nut allergy
4958432|NCT01822340|AGHD|aghd
4958433|NCT01822314|breast|breast
4958434|NCT01822314|cancer|cancer
4958435|NCT01822314|unilateral|unilateral
4958436|NCT01822314|non metastatic|non metastatic
4958437|NCT01822314|HER2 negative|her2 negative
4958438|NCT01822301|Craniomaxillofacial (CMF) Battle-injured (BI)|craniomaxillofacial (cmf) battle-injured (bi)
4958439|NCT01822301|Facial Trauma|facial trauma
4958440|NCT01822301|Fat Grafts|fat grafts
4958441|NCT01822301|Autogenous Fat Transfers (AFT)|autogenous fat transfers (aft)
4958442|NCT01822301|Wounded warriors|wounded warriors
4958443|NCT01822288|Menopause|menopause
4958444|NCT01822288|Tibolone|tibolone
4958445|NCT01822288|Estradiol|estradiol
4958446|NCT01822288|Hormone therapy|hormone therapy
4958447|NCT01822275|GBM|gbm
4958448|NCT01822262|Cholecystolithotomy with gallbladder reservation|cholecystolithotomy with gallbladder reservation
4958449|NCT01822262|cholecystolithiasis|cholecystolithiasis
4958450|NCT01822249|Rett syndrome|rett syndrome
4958451|NCT01822249|EPI-743|epi-743
4958452|NCT01822249|Edison|edison
4958453|NCT01822236|low back pain|low back pain
4958454|NCT01822236|Manual Therapy|manual therapy
4958455|NCT01822236|Randomized Controlled Trial|randomized controlled trial
4958456|NCT01822236|Quality of life|quality of life
4958457|NCT01822223|Dental Implants|dental implants
4958458|NCT01822223|Implant abutments|implant abutments
4958459|NCT01822210|Botulinum Toxins|botulinum toxins
4958460|NCT01822210|Injections|injections
4958461|NCT01822210|Stomach|stomach
4958462|NCT01822210|Tomography, X-Ray Computed|tomography, x-ray computed
4958463|NCT01822197|Phototherapy|phototherapy
4958464|NCT01822184|Neurodevelopmental Status|neurodevelopmental status
4958465|NCT01822184|Pediatric Hunter syndrome patients|pediatric hunter syndrome patients
4958466|NCT01822184|Central Nervous System (CNS) involvement|central nervous system (cns) involvement
4958467|NCT01822184|Observational study|observational study
4958468|NCT01822184|Cognitive impairment|cognitive impairment
4958469|NCT01822171|Heart Failure|heart failure
4958470|NCT01822171|Medication Therapy Management|medication therapy management
4958471|NCT01822158|Vaginal Delivery|vaginal delivery
4958472|NCT01822158|Debrief|debrief
4958473|NCT01822158|Medical Team Communication|medical team communication
4958474|NCT01822158|Obstetrical Safety|obstetrical safety
4958475|NCT01822145|implantable-cardioverter-defibrillator|implantable-cardioverter-defibrillator
4958477|NCT01822145|ventricular fibrillation|ventricular fibrillation
4958478|NCT01822145|sudden cardiac arrest|sudden cardiac arrest
4958479|NCT01822080|Endometriosis|endometriosis
4958480|NCT01822080|Efficacy|efficacy
4958481|NCT01822080|Safety|safety
4958482|NCT01822080|Dienogest|dienogest
4958483|NCT01822041|healthy volunteers|healthy volunteers
4958484|NCT01822041|mass balance study|mass balance study
4958485|NCT01822041|Pharmacokinetics|pharmacokinetics
4958486|NCT01822028|diarrhea|diarrhea
4958487|NCT01822002|Vertigo|vertigo
4958488|NCT01822002|Nystagmus|nystagmus
4958489|NCT01822002|BPPV = benign paroxysmal positional vertigo|bppv = benign paroxysmal positional vertigo
4958490|NCT01822002|Treatment outcome|treatment outcome
4958491|NCT01821963|Infection|infection
4958492|NCT01821963|Hepatitis C Genotype 1 Infection|hepatitis c genotype 1 infection
4958493|NCT01821963|Hepatitis C virus|hepatitis c virus
4958494|NCT01821963|HCV|hcv
4958495|NCT01821963|Hepatocellular Carcinoma|hepatocellular carcinoma
4958496|NCT01821963|HCC|hcc
4958497|NCT01821963|Liver Transplantation|liver transplantation
4958498|NCT01821963|Pegylated Interferon Alfa 2a|pegylated interferon alfa 2a
4958499|NCT01821963|PegIFN alfa-2a|pegifn alfa-2a
4958500|NCT01821963|Ribavirin|ribavirin
4958501|NCT01821963|RBV|rbv
4958502|NCT01821963|Telaprevir|telaprevir
4958503|NCT01821963|Incivek|incivek
4958504|NCT01821963|Antiviral drugs|antiviral drugs
4958505|NCT01821950|Mental health|mental health
4958506|NCT01821950|Substance use|substance use
4958507|NCT01821950|Substance use initiation|substance use initiation
4958508|NCT01821950|Education|education
4958509|NCT01821950|Mind Body Therapies|mind body therapies
4958510|NCT01821950|Yoga|yoga
4958511|NCT01821950|Meditation|meditation
4958512|NCT01821950|Adolescent|adolescent
4958513|NCT01821950|Adolescence|adolescence
4958514|NCT01821950|Child|child
4958515|NCT01821950|Children|children
4958516|NCT01821950|Middle School|middle school
4958517|NCT01821898|Eosinophil|eosinophil
4958518|NCT01821898|Reflux|reflux
4958519|NCT01821898|Esophagus|esophagus
4958520|NCT01821898|Food allergy|food allergy
4958521|NCT01821898|Trouble Swallowing|trouble swallowing
4958522|NCT01821898|Pediatrics|pediatrics
4958523|NCT01821885|Spirometry|spirometry
4958524|NCT01821885|screening|screening
4958525|NCT01821885|smoking cessation|smoking cessation
4958526|NCT01821885|tobacco|tobacco
4958527|NCT01821885|COPD|copd
4958528|NCT01821872|paracetamol|paracetamol
4958529|NCT01821872|acetaminophen|acetaminophen
4958530|NCT01821872|AM404|am404
4958531|NCT01821872|CSF|csf
4958532|NCT01821872|pharmacokinetics|pharmacokinetics
4958533|NCT01821833|omega-3|omega-3
4958534|NCT01821833|fatty acids|fatty acids
4958535|NCT01821833|paclitaxel|paclitaxel
4958536|NCT01821833|acute pain syndrome|acute pain syndrome
4958537|NCT01821833|peripheral neuropathy|peripheral neuropathy
4958538|NCT01821833|chemotherapy induced neuropathy|chemotherapy induced neuropathy
4958539|NCT01821820|Inflammation|inflammation
4958540|NCT01821820|Oxidative stress|oxidative stress
4958541|NCT01821820|Immune dysfunction|immune dysfunction
4958542|NCT01821820|Metabolites|metabolites
4958543|NCT01821807|spinal anesthesia|spinal anesthesia
4958544|NCT01821807|spinal needle|spinal needle
4958545|NCT01821807|cesarean section|cesarean section
4958546|NCT01821807|headache|headache
4958547|NCT01821807|backache|backache
4958548|NCT01821781|Immune deficiency|immune deficiency
4958549|NCT01821781|Immune disorders|immune disorders
4958550|NCT01821781|Immune dysregulatory|immune dysregulatory
4958551|NCT01821781|Reduced Intensity|reduced intensity
4958552|NCT01821781|Alemtuzumab|alemtuzumab
4958553|NCT01821781|Campath|campath
4958554|NCT01821742|Shock|shock
4958555|NCT01821742|Fluid bolus|fluid bolus
4958556|NCT01821742|Cardiac output|cardiac output
4958557|NCT01821742|Children in intensive care|children in intensive care
4958558|NCT01821729|Locally Advanced|locally advanced
4958559|NCT01821716|standardization|standardization
4958560|NCT01821716|skin prick test|skin prick test
4958561|NCT01821716|inmunotherapy|inmunotherapy
4958562|NCT01821690|Traumatic Brain Injury|traumatic brain injury
4958563|NCT01821690|Buspirone|buspirone
4958564|NCT01821690|Behavior|behavior
4958565|NCT01821690|Irritability|irritability
4958566|NCT01821690|Aggression|aggression
4958567|NCT01821664|Prosthetic vascular graft infection|prosthetic vascular graft infection
4958568|NCT01821664|negative pressure wound therapy|negative pressure wound therapy
4958569|NCT01821664|microbiology|microbiology
4958570|NCT01821664|antimicrobial therapy|antimicrobial therapy
4958571|NCT01821651|TAVI|tavi
4958572|NCT01821651|MitraClip|mitraclip
4958573|NCT01821651|image modality|image modality
4958574|NCT01821651|echocardiography|echocardiography
4958575|NCT01821651|angiography|angiography
4958576|NCT01821638|Heart failure|heart failure
4958577|NCT01821638|Cognition|cognition
4958578|NCT01821638|Brain|brain
4958579|NCT01821638|Older adults|older adults
4958580|NCT01821625|Thrombocytopenia|thrombocytopenia
4958581|NCT01821625|HCV|hcv
4958582|NCT01821625|Hepatitis|hepatitis
4958583|NCT01821625|Platelets|platelets
4958584|NCT01821625|Eltrombopag|eltrombopag
4958585|NCT01821625|Liver Disease|liver disease
4958586|NCT01821625|Antiviral Treatment|antiviral treatment
4958587|NCT01821599|Anterior Cruciate Ligament|anterior cruciate ligament
4958588|NCT01821599|Knee|knee
4958589|NCT01821599|Rehabilitation|rehabilitation
4958590|NCT01821586|Diarrhoea;|diarrhoea;
4958591|NCT01821586|Severe malnutrition;|severe malnutrition;
4958592|NCT01821586|Benefiber;|benefiber;
4958593|NCT01821586|ReSoMal;|resomal;
4958594|NCT01821586|modified ORS|modified ors
4958595|NCT01821573|botulinum toxin injection,3D motion analysis, muscular lengthening,muscle strength|botulinum toxin injection,3d motion analysis, muscular lengthening,muscle strength
4958596|NCT01821560|Nicotine Addiction|nicotine addiction
4958597|NCT01821560|fMRI|fmri
4958598|NCT01821560|Baclofen|baclofen
4958599|NCT01821508|Gastroplasty, Diabetes Mellitus Type II, Obesity|gastroplasty, diabetes mellitus type ii, obesity
4958600|NCT01821495|NPC,DC-CIK|npc,dc-cik
4958601|NCT01821482|Hepatocellular carcinoma, DC-CIK|hepatocellular carcinoma, dc-cik
4958602|NCT01821469|bipolar disorders|bipolar disorders
4958603|NCT01821469|euthymic|euthymic
4958604|NCT01821469|psychotherapy|psychotherapy
4958731|NCT01821001|Adenomyosis|adenomyosis
4958706|NCT01821053|angiotensin|angiotensin
4958605|NCT01821469|Functional magnetic resonance imaging|functional magnetic resonance imaging
4958606|NCT01821456|hematological malignancies|hematological malignancies
4958607|NCT01821456|cancer|cancer
4958608|NCT01821456|chemotherapy|chemotherapy
4958609|NCT01821456|anti-infectives|anti-infectives
4958610|NCT01821456|treatment|treatment
4958611|NCT01821456|outcome|outcome
4958612|NCT01821443|1 to 10 measurable brain metastases|1 to 10 measurable brain metastases
4958613|NCT01821430|Chronic Pain|chronic pain
4958614|NCT01821430|Narcotic Abuse|narcotic abuse
4958615|NCT01821430|Opioid related disorders|opioid related disorders
4958616|NCT01821430|Opiate substitution treatment|opiate substitution treatment
4958617|NCT01821430|Buprenorphrine|buprenorphrine
4958618|NCT01821430|Pregabalin|pregabalin
4958619|NCT01821430|Methadone|methadone
4958620|NCT01821417|dental implants|dental implants
4958621|NCT01821417|screw-vent dental implants|screw-vent dental implants
4958622|NCT01821404|Apoptosis|apoptosis
4958623|NCT01821404|Atorvastatin|atorvastatin
4958624|NCT01821404|Inflammation|inflammation
4958625|NCT01821404|Pre-surgical trial|pre-surgical trial
4958626|NCT01821404|Proliferation|proliferation
4958627|NCT01821404|Prostate cancer|prostate cancer
4958628|NCT01821391|actinic keratoses|actinic keratoses
4958629|NCT01821391|photodynamic therapy|photodynamic therapy
4958630|NCT01821391|natural daylight|natural daylight
4958631|NCT01821378|Schizophrenia|schizophrenia
4958632|NCT01821378|Lurasidone|lurasidone
4958633|NCT01821378|Latuda|latuda
4958634|NCT01821365|COPD,PETCO2,PaCO2|copd,petco2,paco2
4958635|NCT01821326|capsule endoscopy|capsule endoscopy
4958636|NCT01821326|obscure gastrointestinal bleeding|obscure gastrointestinal bleeding
4958637|NCT01821326|rebleeding|rebleeding
4958638|NCT01821326|risk factors|risk factors
4958639|NCT01821313|Childhood obesity|childhood obesity
4958640|NCT01821313|Inflammation|inflammation
4958641|NCT01821313|Endothelial function|endothelial function
4958642|NCT01821313|Exercise|exercise
4958643|NCT01821300|Down syndrome|down syndrome
4958644|NCT01821300|Philadelphia|philadelphia
4958645|NCT01821300|The Children's Hospital of Philadelphia|the children's hospital of philadelphia
4958646|NCT01821300|Body composition|body composition
4958647|NCT01821300|Obesity|obesity
4958648|NCT01821300|Cardiovascular|cardiovascular
4958649|NCT01821222|Maternal health|maternal health
4958650|NCT01821222|Neonatal health|neonatal health
4958651|NCT01821222|mHealth|mhealth
4958652|NCT01821222|Mobile phones|mobile phones
4958653|NCT01821222|Access to health services|access to health services
4958654|NCT01821222|Health behavior|health behavior
4958655|NCT01821209|prostate cancer, robotic surgery, urethral sling,|prostate cancer, robotic surgery, urethral sling,
4958656|NCT01821196|Tumor Markers, Biological|tumor markers, biological
4958657|NCT01821196|PGP9.5 protein, human|pgp9.5 protein, human
4958658|NCT01821196|adenocarcinoma|adenocarcinoma
4958659|NCT01821170|ADHD|adhd
4958660|NCT01821170|children|children
4958661|NCT01821170|cognitive remediation|cognitive remediation
4958662|NCT01821170|virtual reality|virtual reality
4958663|NCT01821157|crown lengthening|crown lengthening
4958664|NCT01821157|gingivoplasty|gingivoplasty
4958665|NCT01821157|surgical procedures|surgical procedures
4958666|NCT01821157|gingivectomy|gingivectomy
4958667|NCT01821157|esthetic surgery|esthetic surgery
4958668|NCT01821144|dietary salt|dietary salt
4958669|NCT01821144|24 hour urinary sodium|24 hour urinary sodium
4958670|NCT01821144|blood pressure|blood pressure
4958671|NCT01821131|flax|flax
4958672|NCT01821131|muffin|muffin
4958673|NCT01821131|cholesterol|cholesterol
4958674|NCT01821131|lignan|lignan
4958675|NCT01821131|ALA|ala
4958676|NCT01821118|Cerebral amyloid angiopathy (CAA)|cerebral amyloid angiopathy (caa)
4958677|NCT01821118|cerebrovascular reactivity|cerebrovascular reactivity
4958678|NCT01821118|functional MRI|functional mri
4958679|NCT01821118|randomized|randomized
4958680|NCT01821118|double blind|double blind
4958681|NCT01821118|safety|safety
4958682|NCT01821118|efficacy|efficacy
4958683|NCT01821105|computed tomography|computed tomography
4958684|NCT01821105|CT scan|ct scan
4958685|NCT01821105|positron emission tomography|positron emission tomography
4958686|NCT01821105|PET|pet
4958687|NCT01821105|Metastatic Colorectal Cancer|metastatic colorectal cancer
4958688|NCT01821092|osseointegrated Implant, bone level|osseointegrated implant, bone level
4958689|NCT01821079|Single dose|single dose
4958690|NCT01821079|Relative Bioavailability|relative bioavailability
4958691|NCT01821079|Food effect|food effect
4958692|NCT01821079|Healthy subjects|healthy subjects
4958693|NCT01821079|Diabetes Mellitus Type 2|diabetes mellitus type 2
4958694|NCT01821066|PD-0332991|pd-0332991
4958695|NCT01821066|palbociclib|palbociclib
4958696|NCT01821066|tamoxifen|tamoxifen
4958697|NCT01821066|drug-drug interaction (DDI) study|drug-drug interaction (ddi) study
4958698|NCT01821053|Preeclampsia|preeclampsia
4958699|NCT01821053|Pregestational Type 1 diabetes|pregestational type 1 diabetes
4958700|NCT01821053|diabetes mellitus|diabetes mellitus
4958701|NCT01821053|proteinuria|proteinuria
4958702|NCT01821053|plasminogen|plasminogen
4958703|NCT01821053|plasmin|plasmin
4958704|NCT01821053|renin|renin
4958705|NCT01821053|aldosterone|aldosterone
4958707|NCT01821053|epithelial sodium channel|epithelial sodium channel
4958708|NCT01821053|ENaC|enac
4958709|NCT01821040|Polymyalgia rheumatica|polymyalgia rheumatica
4958710|NCT01821040|PMR|pmr
4958711|NCT01821040|Modified release prednisone|modified release prednisone
4958712|NCT01821027|Healthy|healthy
4958713|NCT01821027|Canagliflozin (JNJ-28431754)|canagliflozin (jnj-28431754)
4958714|NCT01821027|Pharmacokinetics|pharmacokinetics
4958715|NCT01821027|Pharmacodynamics|pharmacodynamics
4958716|NCT01821027|Simvastatin (ZOCOR)|simvastatin (zocor)
4958717|NCT01821014|Diagnostic concordance|diagnostic concordance
4958718|NCT01821014|Treatment concordance|treatment concordance
4958719|NCT01821014|patient satisfaction|patient satisfaction
4958720|NCT01821014|physician satisfaction|physician satisfaction
4958721|NCT01821014|Medical Outreach Clinics|medical outreach clinics
4958722|NCT01821014|Medical Brigades|medical brigades
4958723|NCT01821014|Medical Missions|medical missions
4958724|NCT01821014|Telemedicine|telemedicine
4958725|NCT01821014|Videoconference|videoconference
4958726|NCT01821014|diagnoses|diagnoses
4958727|NCT01821014|treatments|treatments
4958728|NCT01821014|Satellite Internet|satellite internet
4958729|NCT01821014|VSAT|vsat
4958730|NCT01821014|cross cultural telemedicine|cross cultural telemedicine
4958732|NCT01821001|Dysmenorrhea|dysmenorrhea
4958733|NCT01821001|Abnormal Uterine bleeding|abnormal uterine bleeding
4958734|NCT01821001|Heavy Menstrual Bleeding|heavy menstrual bleeding
4958735|NCT01821001|Menorrhagia|menorrhagia
4958736|NCT01820975|Muscle protein synthesis|muscle protein synthesis
4958737|NCT01820975|Dietary protein|dietary protein
4958738|NCT01820962|hematological patients|hematological patients
4958739|NCT01820962|central venous catheters|central venous catheters
4958740|NCT01820962|catheter related thrombosis|catheter related thrombosis
4958741|NCT01820962|catheter related infections|catheter related infections
4958742|NCT01820962|concentrated citrate|concentrated citrate
4958743|NCT01820949|patient blood management|patient blood management
4958744|NCT01820949|patients safety|patients safety
4958745|NCT01820936|Healthy volunteers|healthy volunteers
4958746|NCT01820936|PCI-32765|pci-32765
4958747|NCT01820936|PCI-45227|pci-45227
4958748|NCT01820936|Pharmacokinetics|pharmacokinetics
4958749|NCT01820871|T2DM|t2dm
4958750|NCT01820871|smartphone application|smartphone application
4958751|NCT01820871|serum fasting glucose|serum fasting glucose
4958752|NCT01820871|HbA1c|hba1c
4958753|NCT01820845|Plethysmographic Variability Index|plethysmographic variability index
4958754|NCT01820845|Esophageal Doppler|esophageal doppler
4958755|NCT01820845|Scoliosis|scoliosis
4958756|NCT01820845|Children|children
4958757|NCT01820845|Age < 18 years|age < 18 years
4958758|NCT01820845|Scheduled for Scoliosis Surgery|scheduled for scoliosis surgery
4958759|NCT01820832|mild proteinuria|mild proteinuria
4958760|NCT01820832|calcitriol|calcitriol
4958761|NCT01820832|renal function|renal function
4958762|NCT01820832|blood pressure|blood pressure
4958763|NCT01820819|Inpatient|inpatient
4958764|NCT01820819|Liver cirrhosis|liver cirrhosis
4958765|NCT01820819|Liver Cirrhosis, Alcoholic|liver cirrhosis, alcoholic
4958766|NCT01820819|Physician's Practice Patterns|physician's practice patterns
4958767|NCT01820819|Liver Transplantation|liver transplantation
4958768|NCT01820819|Delivery of Health Care|delivery of health care
4958769|NCT01820819|Resource Allocation|resource allocation
4958770|NCT01820793|antibiotic resistance|antibiotic resistance
4958771|NCT01820793|E.coli|e.coli
4958772|NCT01820793|cefoxitin|cefoxitin
4958773|NCT01820793|pyelonephritis|pyelonephritis
4958774|NCT01820780|Heart failure|heart failure
4958775|NCT01820780|Disease management program|disease management program
4958776|NCT01820767|Chronic Kidney Disease|chronic kidney disease
4958777|NCT01820767|Vd-stadium.|vd-stadium.
4958778|NCT01820767|Inflammatory patterns|inflammatory patterns
4958779|NCT01820767|Paricalcitol|paricalcitol
4958780|NCT01820767|Atorvastatin|atorvastatin
4958781|NCT01820754|Non Small Cell Lung Cancer|non small cell lung cancer
4958782|NCT01820754|Lung Cancer|lung cancer
4958783|NCT01820754|Non Small Cell|non small cell
4958784|NCT01820702|bone metabolism|bone metabolism
4958785|NCT01820702|acid base balance|acid base balance
4958786|NCT01820702|bed rest|bed rest
4958787|NCT01820663|stroke|stroke
4958788|NCT01820663|ketones|ketones
4958789|NCT01820663|ketogenic diet|ketogenic diet
4958790|NCT01820663|impairment|impairment
4958791|NCT01820663|disability|disability
4958792|NCT01820650|osteoarthritis|osteoarthritis
4958793|NCT01820650|knee replacement|knee replacement
4958794|NCT01820650|patient-specific|patient-specific
4958795|NCT01820637|atherosclerosis|atherosclerosis
4958796|NCT01820637|SFA|sfa
4958797|NCT01820637|PPA|ppa
4958798|NCT01820637|lower extremities|lower extremities
4958799|NCT01820637|stenting|stenting
4958800|NCT01820637|paclitaxel|paclitaxel
4958801|NCT01820585|fibromyalgia|fibromyalgia
4958802|NCT01820585|Eslicarbazepine acetate (BIA 2-093)|eslicarbazepine acetate (bia 2-093)
4958803|NCT01820585|ESL|esl
4958804|NCT01820559|migraine; ESL; eslicarbazepine acetate|migraine; esl; eslicarbazepine acetate
4958805|NCT01820533|Smoking|smoking
4958806|NCT01820533|Cellular phones|cellular phones
4958807|NCT01820533|Low income population|low income population
4958808|NCT01820507|Post-extubation respiratory failure|post-extubation respiratory failure
4958809|NCT01820507|Endotracheal intubation|endotracheal intubation
4958810|NCT01820507|Mechanical ventilation|mechanical ventilation
4958811|NCT01820494|growth|growth
4958812|NCT01820494|infants|infants
4958813|NCT01820481|Asthma|asthma
4958814|NCT01820481|Bronchial Diseases|bronchial diseases
4958815|NCT01820481|Respiratory Tract Diseases|respiratory tract diseases
4958816|NCT01820481|Lung Diseases, Obstructive|lung diseases, obstructive
4958817|NCT01820481|Lung Diseases|lung diseases
4958818|NCT01820455|MRSA decolonization|mrsa decolonization
4958819|NCT01820455|MRSA subtyping|mrsa subtyping
4958820|NCT01820455|MRSA infection rates|mrsa infection rates
4958821|NCT01820442|lofexidine|lofexidine
4958822|NCT01820442|buprenorphine|buprenorphine
4958823|NCT01820442|interaction|interaction
4958824|NCT01820442|pharmacodynamic|pharmacodynamic
4958825|NCT01820442|ECG|ecg
4958826|NCT01820442|QTc|qtc
4958827|NCT01820429|Platelet aggregation|platelet aggregation
4958828|NCT01820429|Aspirin|aspirin
4958829|NCT01820416|Hearing Loss, Bilateral|hearing loss, bilateral
4958830|NCT01820416|Hearing Loss, Sensorineural|hearing loss, sensorineural
4958831|NCT01820390|Deep Brain Stimulation (DBS)|deep brain stimulation (dbs)
4958832|NCT01820390|Parkinson's Disease|parkinson's disease
4958833|NCT01820390|Essential Tremor|essential tremor
4958834|NCT01820377|Peer-mentoring|peer-mentoring
4958835|NCT01820377|Obesity|obesity
4958836|NCT01820377|Type 2 Diabetes|type 2 diabetes
4958837|NCT01820377|Physical Activity|physical activity
4958838|NCT01820377|After-school program|after-school program
4958839|NCT01820364|open-label study|open-label study
4958840|NCT01820364|BRAF inhibitor|braf inhibitor
4958841|NCT01820364|LGX818|lgx818
4958842|NCT01820364|MEK1620|mek1620
4958843|NCT01820364|MAPK1/2 inhibitor|mapk1/2 inhibitor
4958844|NCT01820364|Pi3K inhibitor|pi3k inhibitor
4958845|NCT01820364|FGFR|fgfr
4958846|NCT01820364|c-Met|c-met
4958847|NCT01820364|CDK4/6|cdk4/6
4958848|NCT01820364|metastatic melanoma|metastatic melanoma
4958849|NCT01820364|BRAF|braf
4958850|NCT01820364|V600|v600
4958851|NCT01820338|Children, Obesity, Intervention|children, obesity, intervention
4958852|NCT01820325|Squamous non-small cell lung cancer|squamous non-small cell lung cancer
4958853|NCT01820325|NSCLC|nsclc
4958854|NCT01820325|stage IV|stage iv
4958855|NCT01820325|BKM120|bkm120
4958856|NCT01820286|Bipolar disorder|bipolar disorder
4958857|NCT01820286|Depression|depression
4958858|NCT01820286|Positive psychology|positive psychology
4958859|NCT01820273|Type 2 diabetes|type 2 diabetes
4958860|NCT01820273|Bariatric surgery|bariatric surgery
4958861|NCT01820273|incretines|incretines
4958862|NCT01820273|GLP-1|glp-1
4958863|NCT01820273|GIP|gip
4958864|NCT01820273|gastric bypass|gastric bypass
4958865|NCT01820273|foregut|foregut
4958866|NCT01820273|hindgut|hindgut
4958867|NCT01820247|Crohn's Disease|crohn's disease
4958868|NCT01820247|enteral nutrition|enteral nutrition
4958869|NCT01820247|Tripterygium Glycosides|tripterygium glycosides
4958870|NCT01820247|induction remission|induction remission
4958871|NCT01820234|Skin cancer|skin cancer
4958872|NCT01820234|Teledermatology|teledermatology
4958873|NCT01820234|Screening|screening
4958874|NCT01820234|Store-and-forward|store-and-forward
4958875|NCT01820221|cesarean delivery|cesarean delivery
4958876|NCT01820221|wound complications|wound complications
4958877|NCT01820221|skin closure methods|skin closure methods
4958878|NCT01820195|Contrast Nephropathy|contrast nephropathy
4958879|NCT01820195|N-Acetyl Cystein|n-acetyl cystein
4958880|NCT01820195|Prophylaxy|prophylaxy
4958881|NCT01820117|long-term health outcomes|long-term health outcomes
4958882|NCT01820078|Chronic|chronic
4958883|NCT01820078|Kidney|kidney
4958884|NCT01820078|Disease|disease
4958885|NCT01820078|Proteinuria|proteinuria
4958886|NCT01820078|Albuminuria|albuminuria
4958887|NCT01820078|Paricalcitol|paricalcitol
4958888|NCT01820052|Fibromyalgia|fibromyalgia
4958889|NCT01820039|e-health intervention|e-health intervention
4958890|NCT01820039|infertility|infertility
4958891|NCT01820039|primary care|primary care
4958892|NCT01820039|referral rate|referral rate
4958893|NCT01820026|healthcare infection cirrhosis antibiotic|healthcare infection cirrhosis antibiotic
4958894|NCT01820013|Pelvic Girdle pain|pelvic girdle pain
4958895|NCT01820013|Symphysis Pubis Dysfunction|symphysis pubis dysfunction
4958896|NCT01820013|Sacroiliac Joint|sacroiliac joint
4958897|NCT01820013|Sacroiliitis|sacroiliitis
4958898|NCT01820013|Physiotherapy|physiotherapy
4958899|NCT01820013|Physical Therapy|physical therapy
4958900|NCT01820013|Orthotic Devices|orthotic devices
4958901|NCT01819987|Overweight|overweight
4958902|NCT01819987|mother|mother
4958903|NCT01819987|childhood obesity prevention|childhood obesity prevention
4958904|NCT01819987|Chinese American|chinese american
4958905|NCT01819948|Breast cancer|breast cancer
4958906|NCT01819948|Stage 0-IIIA|stage 0-iiia
4958907|NCT01819948|No evidence of disease|no evidence of disease
4958908|NCT01819935|MRSA. pneumonia|mrsa. pneumonia
4958909|NCT01819935|outcomes|outcomes
4958910|NCT01819922|Cardiopulmonary exercise testing|cardiopulmonary exercise testing
4958911|NCT01819922|metabolic parameters|metabolic parameters
4958912|NCT01819922|Diabetes Mellitus Type 2|diabetes mellitus type 2
4958913|NCT01819909|Rotator cuff repair|rotator cuff repair
4958914|NCT01819909|Shoulder|shoulder
4958915|NCT01819909|Surgery|surgery
4958916|NCT01819909|Rehabilitation|rehabilitation
4958917|NCT01819909|Pulleys|pulleys
4958918|NCT01819909|Jackins|jackins
4958919|NCT01819870|Carvedilol|carvedilol
4958920|NCT01819870|Dilatrend SR capsule|dilatrend sr capsule
4958921|NCT01819870|Dilatrend Tablet|dilatrend tablet
4958922|NCT01819870|Pharmacokinetics|pharmacokinetics
4958923|NCT01819870|Healthy male subjects|healthy male subjects
4958924|NCT01819844|Closed-loop blood glucose control|closed-loop blood glucose control
4958925|NCT01819844|Continuous glucose monitoring|continuous glucose monitoring
4958926|NCT01819844|Bionic pancreas|bionic pancreas
4958927|NCT01819844|Artificial pancreas|artificial pancreas
4958928|NCT01819831|extremity soft tissue sarcoma|extremity soft tissue sarcoma
4958929|NCT01819831|proton radiation|proton radiation
4958930|NCT01819831|preoperative radiation|preoperative radiation
4958931|NCT01819818|Schizophrenia|schizophrenia
4958932|NCT01819818|Paliperidone palmitate|paliperidone palmitate
4958933|NCT01819818|Invega|invega
4958934|NCT01819818|Sustenna|sustenna
4958935|NCT01819818|Korea|korea
4958936|NCT01819805|Chronic pain|chronic pain
4958937|NCT01819805|Chronic non-malignant pain|chronic non-malignant pain
4958938|NCT01819805|Non-malignant|non-malignant
4958939|NCT01819805|Pain|pain
4958940|NCT01819805|Extended release tablet|extended release tablet
4958941|NCT01819805|Tramadol hydrochloride|tramadol hydrochloride
4958942|NCT01819805|Tramadol HCl|tramadol hcl
4958943|NCT01819805|Acetaminophen|acetaminophen
4958944|NCT01819805|Ultracet ER|ultracet er
4958945|NCT01819792|Acute Myeloid Leukemia|acute myeloid leukemia
4958946|NCT01819766|Cancer|cancer
4958947|NCT01819766|Colorectal Cancer|colorectal cancer
4958948|NCT01819766|Neoplasm|neoplasm
4958949|NCT01819766|Colorectal Neoplasm|colorectal neoplasm
4958950|NCT01819766|Intestinal Neoplasms|intestinal neoplasms
4958951|NCT01819766|Gastrointestinal Neoplasms|gastrointestinal neoplasms
4958952|NCT01819766|Digestive System Neoplasms|digestive system neoplasms
4958953|NCT01819766|Neoplasms by Site|neoplasms by site
4958954|NCT01819766|Neoplasms|neoplasms
4958955|NCT01819766|Digestive System Diseases|digestive system diseases
4958956|NCT01819766|Gastrointestinal Diseases|gastrointestinal diseases
4958957|NCT01819766|Colonic Diseases|colonic diseases
4958958|NCT01819766|Intestinal Diseases|intestinal diseases
4958959|NCT01819766|Inflammatory Bowel Disease|inflammatory bowel disease
4958960|NCT01819766|Primary Sclerosing Cholangitis|primary sclerosing cholangitis
4958961|NCT01819753|percutaneous nephrolithotomy|percutaneous nephrolithotomy
4958962|NCT01819753|urinary Stones|urinary stones
4958963|NCT01819753|99m-Technetium-Dimercaptosuccinic Acid|99m-technetium-dimercaptosuccinic acid
4958964|NCT01819727|PKU|pku
4958965|NCT01819727|PEG-PAL|peg-pal
4958966|NCT01819727|BioMarin|biomarin
4958967|NCT01819727|rAv-PAL PEG|rav-pal peg
4958968|NCT01819727|BMN 165|bmn 165
4958969|NCT01819727|open label|open label
4958970|NCT01819727|Prism301|prism301
4958971|NCT01819727|Pegvaliase|pegvaliase
4958972|NCT01819714|Snoezelen|snoezelen
4958973|NCT01819714|Multi-sensorial care session|multi-sensorial care session
4958974|NCT01819714|Alzheimer's-type neurodegenerative disease|alzheimer's-type neurodegenerative disease
4958975|NCT01819714|Dementia|dementia
4958976|NCT01819688|laparoscopic liver resection|laparoscopic liver resection
4958977|NCT01819688|cytokine release|cytokine release
4958978|NCT01819675|Neuronal plasticity|neuronal plasticity
4958979|NCT01819675|Neurotransmitter agents|neurotransmitter agents
4958980|NCT01819675|Receptors, neurotransmitter|receptors, neurotransmitter
4958981|NCT01819675|Transcranial magnetic stimulation|transcranial magnetic stimulation
4958982|NCT01819675|Stroke|stroke
4958983|NCT01819675|gamma-Aminobutyric Acid|gamma-aminobutyric acid
4958984|NCT01819662|Pacemaker, heart failure, hospitalisation|pacemaker, heart failure, hospitalisation
4958985|NCT01819649|selenium|selenium
4958986|NCT01819649|selenium supplementation|selenium supplementation
4958987|NCT01819649|randomised controlled trial|randomised controlled trial
4958988|NCT01819649|prevention|prevention
4958989|NCT01819636|Blood triglyceride|blood triglyceride
4958990|NCT01819636|Bicarbonated mineral wate|bicarbonated mineral wate
4958991|NCT01819636|Post-prandial triglyceridemia|post-prandial triglyceridemia
4958992|NCT01819636|lipid metabolism|lipid metabolism
4958993|NCT01819636|Cardiovascular risk|cardiovascular risk
4958994|NCT01819623|Mild Cognitive Impairment|mild cognitive impairment
4958995|NCT01819623|Cognitive training|cognitive training
4958996|NCT01819610|Postoperative pain management|postoperative pain management
4958997|NCT01819597|Intracranial Arterial Stenosis|intracranial arterial stenosis
4958998|NCT01819597|Atherosclerosis|atherosclerosis
4959000|NCT01819597|EDAS|edas
4959001|NCT01819597|Angiogenesis|angiogenesis
4959002|NCT01819571|pulse pressure variation|pulse pressure variation
4959003|NCT01819571|fluid responsiveness|fluid responsiveness
4959004|NCT01819571|diastolic dysfunction|diastolic dysfunction
4959005|NCT01819558|acute myeloid leukemia|acute myeloid leukemia
4959006|NCT01819558|chronic myeloid leukemia|chronic myeloid leukemia
4959007|NCT01819558|myelodysplastic syndrome|myelodysplastic syndrome
4959008|NCT01819558|allograft|allograft
4959009|NCT01819558|WT1 expression|wt1 expression
4959010|NCT01819545|Alzheimer's disease|alzheimer's disease
4959011|NCT01819545|diagnosis|diagnosis
4959012|NCT01819545|MicRNA|micrna
4959013|NCT01819545|mRNA|mrna
4959014|NCT01819532|neonate|neonate
4959015|NCT01819532|umbilical cord|umbilical cord
4959016|NCT01819532|cord milking|cord milking
4959017|NCT01819532|prematurity|prematurity
4959018|NCT01819519|Intervention studies|intervention studies
4959019|NCT01819519|Pregnancy|pregnancy
4959020|NCT01819519|Cytomegalovirus Infections|cytomegalovirus infections
4959021|NCT01819506|rehabilitation|rehabilitation
4959022|NCT01819506|occupational therapy|occupational therapy
4959023|NCT01819506|upper extremity|upper extremity
4959024|NCT01819493|Diabetes Prevention|diabetes prevention
4959025|NCT01819493|Lifestyle Intervention|lifestyle intervention
4959026|NCT01819493|African American Families|african american families
4959027|NCT01819480|Surgery|surgery
4959028|NCT01819480|Robotic|robotic
4959029|NCT01819480|Carcinoma|carcinoma
4959030|NCT01819480|squamous cell of head and neck|squamous cell of head and neck
4959031|NCT01819454|chronic rhinosinusitis|chronic rhinosinusitis
4959032|NCT01819454|extraesophageal reflux|extraesophageal reflux
4959033|NCT01819454|Restech system|restech system
4959034|NCT01819454|antireflux therapy|antireflux therapy
4959035|NCT01819441|cerebral small Vessel diseases, blood pressure,CCB, ACEI|cerebral small vessel diseases, blood pressure,ccb, acei
4959036|NCT01819428|EGFR mutation|egfr mutation
4959037|NCT01819428|Lung Adenocarcinoma|lung adenocarcinoma
4959038|NCT01819428|Firstline therapy|firstline therapy
4959039|NCT01819428|Second generation of tyrosine kinase|second generation of tyrosine kinase
4959040|NCT01819415|wet AMD|wet amd
4959041|NCT01819415|Omega-3|omega-3
4959042|NCT01819415|VEGF|vegf
4959043|NCT01819415|Lipidomics|lipidomics
4959044|NCT01819415|DHA|dha
4959045|NCT01819415|EPA|epa
4959046|NCT01819402|visceral fat metabolism; FDG-PET/CT; pioglitazone; glimepiride; adiponectin|visceral fat metabolism; fdg-pet/ct; pioglitazone; glimepiride; adiponectin
4959047|NCT01819389|Chronic myeloid leukemia|chronic myeloid leukemia
4959048|NCT01819389|suboptimal response|suboptimal response
4959049|NCT01819389|imatinib|imatinib
4959050|NCT01819389|nilotinib|nilotinib
4959051|NCT01819376|Obesity|obesity
4959052|NCT01819376|Overweight|overweight
4959053|NCT01819376|Adolescents|adolescents
4959054|NCT01819376|Teenagers|teenagers
4959055|NCT01819376|Facebook|facebook
4959056|NCT01819376|Social Networks|social networks
4959057|NCT01819363|Pleural effusion|pleural effusion
4959058|NCT01819363|Pleural elastance|pleural elastance
4959059|NCT01819363|Pleurodesis|pleurodesis
4959060|NCT01819363|Quality of life|quality of life
4959061|NCT01819363|Computed Tomography|computed tomography
4959062|NCT01819350|Dental caries|dental caries
4959063|NCT01819350|Sucrose|sucrose
4959064|NCT01819350|Oral administration|oral administration
4959065|NCT01819350|Ion Concentration of Hydrogen|ion concentration of hydrogen
4959066|NCT01819350|Pediatric medicines|pediatric medicines
4959067|NCT01819324|breast cancer survivors|breast cancer survivors
4959068|NCT01819324|lifestyle intervention|lifestyle intervention
4959069|NCT01819324|health behaviors|health behaviors
4959070|NCT01819285|Malignant Neoplasm of Prostate|malignant neoplasm of prostate
4959071|NCT01819285|Tumor-node-metastasis (TNM) Staging Regional Lymph Nodes (N0-2)|tumor-node-metastasis (tnm) staging regional lymph nodes (n0-2)
4959072|NCT01819285|Not suitable for local treatment with curative intent|not suitable for local treatment with curative intent
4959073|NCT01819259|Nonsmoker|nonsmoker
4959074|NCT01819259|ADHD|adhd
4959075|NCT01819259|Nicotine|nicotine
4959076|NCT01819259|Nicotine Nasal Spray|nicotine nasal spray
4959077|NCT01819259|Nicotine Reinforcement|nicotine reinforcement
4959078|NCT01819181|TAVI|tavi
4959079|NCT01819181|women|women
4959080|NCT01819181|aortic stenosis|aortic stenosis
4959081|NCT01819181|VARC2|varc2
4959082|NCT01819155|influenza|influenza
4959083|NCT01819155|influenza vaccine|influenza vaccine
4959084|NCT01819155|immunogenicity|immunogenicity
4959085|NCT01819155|Africa|africa
4959086|NCT01819155|Senegal|senegal
4959087|NCT01819142|non healing wound|non healing wound
4959088|NCT01819142|pressure ulcer|pressure ulcer
4959089|NCT01819116|Tissue Oxygen Saturation|tissue oxygen saturation
4959090|NCT01819116|Management of the DNC Organ Donor|management of the dnc organ donor
4959091|NCT01819103|Mortality|mortality
4959092|NCT01819103|Acute Myocardial Infarction|acute myocardial infarction
4959093|NCT01819103|Drug Adherence|drug adherence
4959094|NCT01819103|Drug Compliance|drug compliance
4959095|NCT01819103|Health-related quality of life|health-related quality of life
4959096|NCT01819090|Neuromuscular disorder|neuromuscular disorder
4959097|NCT01819090|Mechanical ventilation|mechanical ventilation
4959098|NCT01819090|Speech|speech
4959099|NCT01819090|Respiratory failure|respiratory failure
4959100|NCT01819077|Cervical cancer|cervical cancer
4959101|NCT01819077|TMMR|tmmr
4959102|NCT01819077|therapeutic lymphadenectomy|therapeutic lymphadenectomy
4959103|NCT01819077|register study|register study
4959104|NCT01819064|Atropine|atropine
4959105|NCT01819064|bradycardia|bradycardia
4959106|NCT01819064|tachycardia|tachycardia
4959107|NCT01819025|Depression|depression
4959108|NCT01819025|Behavioral activation|behavioral activation
4959109|NCT01819025|Smartphone application|smartphone application
4959110|NCT01819025|Face-to-face|face-to-face
4959111|NCT01819025|Blended therapy|blended therapy
4959112|NCT01819012|Isoflurane|isoflurane
4959113|NCT01819012|mitral valve annular velocity|mitral valve annular velocity
4959114|NCT01819012|tissue Doppler imaging|tissue doppler imaging
4959115|NCT01819012|Monitoring|monitoring
4959116|NCT01819012|echocardiography|echocardiography
4959117|NCT01818999|METASTATIC BREAST CANCER|metastatic breast cancer
4959118|NCT01818973|Rectal Cancer|rectal cancer
4959119|NCT01818973|Bevacizumab|bevacizumab
4959120|NCT01818973|capecitabine|capecitabine
4959121|NCT01818973|oxaliplatin|oxaliplatin
4959122|NCT01818973|preoporative IMRT|preoporative imrt
4959123|NCT01818960|Stent, Myocardial Infarction, Coronary Intervention|stent, myocardial infarction, coronary intervention
4959124|NCT01818947|Lung cancer|lung cancer
4959125|NCT01818947|epidermal growth factor receptor mutation|epidermal growth factor receptor mutation
4959126|NCT01818947|gefitinib|gefitinib
4959127|NCT01818947|Iressa|iressa
4959128|NCT01818934|hip dysplasia|hip dysplasia
4959129|NCT01818934|screening|screening
4959130|NCT01818921|Beloranib|beloranib
4959131|NCT01818921|ZGN-440|zgn-440
4959132|NCT01818921|ZGN-440 for injectable suspension|zgn-440 for injectable suspension
4959133|NCT01818921|ZGN-433|zgn-433
4959134|NCT01818908|non-Hodgkin's lymphoma|non-hodgkin's lymphoma
4959135|NCT01818908|hemophagocytic lymphohistiocytosis|hemophagocytic lymphohistiocytosis
4959136|NCT01818908|DA-EPOCH|da-epoch
4959137|NCT01818908|rituximab|rituximab
4959138|NCT01818895|Mechanical ventilation|mechanical ventilation
4959139|NCT01818895|End of life|end of life
4959140|NCT01818895|Extubation|extubation
4959141|NCT01818895|Terminal weaning|terminal weaning
4959142|NCT01818895|Complicated grief|complicated grief
4959143|NCT01818882|Vscan|vscan
4959144|NCT01818882|portable ultrasound|portable ultrasound
4959145|NCT01818882|emergency care|emergency care
4959146|NCT01818882|emergency room|emergency room
4959147|NCT01818869|Safety,|safety,
4959148|NCT01818869|tolerability,|tolerability,
4959149|NCT01818869|Phase I,|phase i,
4959150|NCT01818869|pharmacokinetic,|pharmacokinetic,
4959151|NCT01818869|pharmacodynamic,|pharmacodynamic,
4959152|NCT01818869|inhaled|inhaled
4959153|NCT01818856|Chronic hepatitis C|chronic hepatitis c
4959154|NCT01818856|HIV-infection|hiv-infection
4959155|NCT01818856|Drug interaction|drug interaction
4959156|NCT01818843|Carbon monoxide|carbon monoxide
4959157|NCT01818843|safety|safety
4959158|NCT01818843|Adverse Reaction|adverse reaction
4959159|NCT01818843|newborn|newborn
4959160|NCT01818817|Ultrasound-guided paravertebral block|ultrasound-guided paravertebral block
4959161|NCT01818817|regional anesthesia|regional anesthesia
4959162|NCT01818817|breast surgery|breast surgery
4959163|NCT01818765|Cardiac resynchronisation therapy|cardiac resynchronisation therapy
4959164|NCT01818765|Endocardial|endocardial
4959165|NCT01818765|Pacing|pacing
4959166|NCT01818739|Endometrial Cancer|endometrial cancer
4959167|NCT01818739|Robotic-Assisted Staging|robotic-assisted staging
4959168|NCT01818726|Aplastic anemia, deferasirox, renal function|aplastic anemia, deferasirox, renal function
4959169|NCT01818713|2B3-101, liposomal doxorubicin, leptomeningeal metastases|2b3-101, liposomal doxorubicin, leptomeningeal metastases
4959170|NCT01818661|apraxia of speech|apraxia of speech
4959171|NCT01818661|non-fluent aphasia|non-fluent aphasia
4959172|NCT01818661|aphasia|aphasia
4959173|NCT01818622|Bipolar disorder|bipolar disorder
4959174|NCT01818622|Mania|mania
4959175|NCT01818622|Blue-blockers|blue-blockers
4959176|NCT01818622|Virtual darkness therapy|virtual darkness therapy
4959177|NCT01818622|Actigraphy|actigraphy
4959178|NCT01818622|Randomized controlled trial|randomized controlled trial
4959179|NCT01818609|sarcopenia|sarcopenia
4959180|NCT01818609|muscle|muscle
4959181|NCT01818609|reduced activity|reduced activity
4959182|NCT01818609|insulin sensitivity|insulin sensitivity
4959183|NCT01818609|protein|protein
4959184|NCT01818609|step reduction|step reduction
4959185|NCT01818609|muscle protein synthesis|muscle protein synthesis
4959186|NCT01818609|whey protein|whey protein
4959187|NCT01818609|leg strength|leg strength
4959188|NCT01818609|whole body protein|whole body protein
4959189|NCT01818596|HIV|hiv
4959190|NCT01818596|HIV-1 Infected|hiv-1 infected
4959191|NCT01818596|Treatment Experienced|treatment experienced
4959192|NCT01818596|Treatment Naive|treatment naive
4959193|NCT01818583|Atrial fibrillation|atrial fibrillation
4959194|NCT01818583|Atrial flutter|atrial flutter
4959195|NCT01818583|Potassium|potassium
4959196|NCT01818583|Cardioversion|cardioversion
4959197|NCT01818570|Gastroesophageal Reflux|gastroesophageal reflux
4959198|NCT01818557|glucose monitoring|glucose monitoring
4959199|NCT01818557|gestational diabetes|gestational diabetes
4959200|NCT01818544|Elastase Inhibition|elastase inhibition
4959201|NCT01818531|Partial knee replacement|partial knee replacement
4959202|NCT01818518|Preterm delivery|preterm delivery
4959203|NCT01818518|Premature delivery|premature delivery
4959204|NCT01818518|Premature birth|premature birth
4959205|NCT01818505|antiphospholipid syndrome|antiphospholipid syndrome
4959206|NCT01818505|gouty arthritis|gouty arthritis
4959207|NCT01818505|Hyperuricemia|hyperuricemia
4959208|NCT01818505|metabolic syndrome|metabolic syndrome
4959209|NCT01818505|osteoarthritis|osteoarthritis
4959210|NCT01818505|cardiovascular co-morbidities|cardiovascular co-morbidities
4959211|NCT01818492|Emapalumab|emapalumab
4959212|NCT01818453|Mood Disorders|mood disorders
4959213|NCT01818453|Depression|depression
4959214|NCT01818453|Genetics|genetics
4959215|NCT01818453|Treatment response|treatment response
4959216|NCT01818453|Treatment study|treatment study
4959217|NCT01818440|Surgical Navigation|surgical navigation
4959218|NCT01818440|Liver|liver
4959219|NCT01818440|Cancer|cancer
4959220|NCT01818440|Image-guided Therapy|image-guided therapy
4959221|NCT01818427|hemmorhagic shock, plasma, air medical transport, randomized, multicenter|hemmorhagic shock, plasma, air medical transport, randomized, multicenter
4959222|NCT01818414|Misoprostol administration & dosage|misoprostol administration & dosage
4959223|NCT01818414|Abortion techniques|abortion techniques
4959224|NCT01818414|Abortion Induced methods|abortion induced methods
4959225|NCT01818414|Dilatation and Curettage|dilatation and curettage
4959226|NCT01818401|Ancillary tailored|ancillary tailored
4959227|NCT01818401|medico-economic study,|medico-economic study,
4959228|NCT01818401|total knee replacement|total knee replacement
4959229|NCT01818401|primary or secondary osteoarthritis|primary or secondary osteoarthritis
4959230|NCT01818362|Influenza|influenza
4959231|NCT01818362|T cells|t cells
4959232|NCT01818349|stroke|stroke
4959233|NCT01818349|exercise|exercise
4959234|NCT01818349|muscle strength|muscle strength
4959235|NCT01818349|gait|gait
4959236|NCT01818349|rehabilitation|rehabilitation
4959237|NCT01818336|penicillin allergy|penicillin allergy
4959238|NCT01818323|Chimeric antigen receptor|chimeric antigen receptor
4959239|NCT01818323|Immunotherapy|immunotherapy
4959240|NCT01818323|Head and Neck Cancer|head and neck cancer
4959241|NCT01818323|Phase I trial|phase i trial
4959242|NCT01818323|Maximum tolerated dose|maximum tolerated dose
4959243|NCT01818310|ischemia|ischemia
4959244|NCT01818310|diabetes mellitus|diabetes mellitus
4959245|NCT01818310|bone marrow aspirate concentrate (BMAC)|bone marrow aspirate concentrate (bmac)
4959246|NCT01818284|Blood And Marrow Transplantation|blood and marrow transplantation
4959247|NCT01818284|Normal allogeneic donors|normal allogeneic donors
4959248|NCT01818284|Stem cell mobilization|stem cell mobilization
4959249|NCT01818284|peripheral blood progenitor cells|peripheral blood progenitor cells
4959250|NCT01818284|PBPC|pbpc
4959251|NCT01818284|Allogeneic hematopoietic stem cell transplantation|allogeneic hematopoietic stem cell transplantation
4959252|NCT01818284|HSCT|hsct
4959253|NCT01818284|Donating blood stem cells|donating blood stem cells
4959254|NCT01818284|C-CSF|c-csf
4959255|NCT01818284|Neupogen|neupogen
4959256|NCT01818284|Filgrastim|filgrastim
4959257|NCT01818284|Plerixafor|plerixafor
4959258|NCT01818284|Mobozil|mobozil
4959259|NCT01818284|Apheresis|apheresis
4959260|NCT01818271|community-stroke-rehabilitation,|community-stroke-rehabilitation,
4959261|NCT01818271|group-exercise,|group-exercise,
4959262|NCT01818271|balance-mobility-exercise,|balance-mobility-exercise,
4959263|NCT01818271|instrumented treadmill|instrumented treadmill
4959264|NCT01818258|HIV|hiv
4959265|NCT01818258|Children|children
4959266|NCT01818258|HAART|haart
4959267|NCT01818258|Malnourished|malnourished
4959268|NCT01818219|Electrical activity of the diaphragm|electrical activity of the diaphragm
4959269|NCT01818219|Neuro regulation of breathing|neuro regulation of breathing
4959270|NCT01818219|Abnormal respiratory mechanics|abnormal respiratory mechanics
4959271|NCT01818219|Assisted mechanical ventilation|assisted mechanical ventilation
4959272|NCT01818219|Pressure support|pressure support
4959273|NCT01818219|Neurally adjusted ventilatory assist|neurally adjusted ventilatory assist
4959274|NCT01818206|Cystic Fibrosis|cystic fibrosis
4959275|NCT01818206|Bacteriophages|bacteriophages
4959276|NCT01818206|Pseudomonas aeruginosa|pseudomonas aeruginosa
4959277|NCT01818206|Sputum|sputum
4959278|NCT01818193|Pulmonary transplant|pulmonary transplant
4959279|NCT01818167|Hidradenitis Suppurativa|hidradenitis suppurativa
4959280|NCT01818167|HS|hs
4959281|NCT01818167|Acne Inversa|acne inversa
4959282|NCT01818167|Velpeau's disease|velpeau's disease
4959283|NCT01818167|Verneuil's disease|verneuil's disease
4959284|NCT01818154|phototherapy|phototherapy
4959285|NCT01818154|light emitting diode|light emitting diode
4959286|NCT01818154|minimal erythema dose|minimal erythema dose
4959287|NCT01818154|narrowband UVB|narrowband uvb
4959288|NCT01818115|POAG|poag
4959289|NCT01818115|PXG|pxg
4959290|NCT01818115|IOL Surgery|iol surgery
4959291|NCT01818115|CE Surgery|ce surgery
4959292|NCT01818024|healthy volunteer|healthy volunteer
4959293|NCT01818024|TNFR1|tnfr1
4959294|NCT01818024|domain antibody|domain antibody
4959295|NCT01818024|Lung injury|lung injury
4959296|NCT01818011|Japanese, GSK1322322, pharmacokinetics, relative bioavailability, single dose, repeat dose, healthy subjects, dose-escalation, antimicrobial, over granulation,|japanese, gsk1322322, pharmacokinetics, relative bioavailability, single dose, repeat dose, healthy subjects, dose-escalation, antimicrobial, over granulation,
4959297|NCT01817985|Hepatitis C (HCV) Infection|hepatitis c (hcv) infection
4959298|NCT01817985|Moderate Hepatic Impairment|moderate hepatic impairment
4959299|NCT01817985|Severe Hepatic Impairment|severe hepatic impairment
4959300|NCT01817972|Crohn's Disease|crohn's disease
4959301|NCT01817972|Crohn's colitis|crohn's colitis
4959302|NCT01817972|Crohn's ileocolitis|crohn's ileocolitis
4959303|NCT01817959|Pancreatic islet transplantation|pancreatic islet transplantation
4959304|NCT01817959|Diabetes Mellitus Type 1|diabetes mellitus type 1
4959305|NCT01817959|Islet transplantation graft survival & function|islet transplantation graft survival & function
4959306|NCT01817946|Congenital Myopathy|congenital myopathy
4959307|NCT01817946|Centronuclear Myopathy|centronuclear myopathy
4959308|NCT01817946|Myotubular Myopathy|myotubular myopathy
4959309|NCT01817946|Myotubularin|myotubularin
4959310|NCT01817946|MTM1 Gene|mtm1 gene
4959311|NCT01817946|Genetic testing|genetic testing
4959312|NCT01817946|Sequencing|sequencing
4959313|NCT01817946|Deletion/Duplication Mutation|deletion/duplication mutation
4959314|NCT01817946|CGH array|cgh array
4959315|NCT01817907|Apnea- Hypopnea index|apnea- hypopnea index
4959316|NCT01817907|Arousal Threshold|arousal threshold
4959317|NCT01817894|Unwanted facial hair growth|unwanted facial hair growth
4959318|NCT01817868|Hemophilia|hemophilia
4959319|NCT01817868|Turkey|turkey
4959320|NCT01817868|Observational|observational
4959321|NCT01817868|Adult|adult
4959322|NCT01817855|Phase 1,|phase 1,
4959323|NCT01817855|Safety,|safety,
4959324|NCT01817855|Tolerability,|tolerability,
4959325|NCT01817855|Healthy,|healthy,
4959326|NCT01817855|COPD patients|copd patients
4959327|NCT01817842|mHealth|mhealth
4959328|NCT01817842|EMA|ema
4959329|NCT01817842|Ecological Momentary Assessment|ecological momentary assessment
4959330|NCT01817842|Personal Informatics|personal informatics
4959331|NCT01817842|Tobacco Quitline|tobacco quitline
4959332|NCT01817803|Heart failure|heart failure
4959333|NCT01817803|diuretics|diuretics
4959334|NCT01817803|kidney|kidney
4959335|NCT01817803|glomerular filtration rate|glomerular filtration rate
4959336|NCT01817777|Socioeconomic category|socioeconomic category
4959337|NCT01817777|Medication compliance|medication compliance
4959338|NCT01817777|Metformin|metformin
4959339|NCT01817777|small pack|small pack
4959340|NCT01817764|umeclidinium bromide (UMEC)|umeclidinium bromide (umec)
4959341|NCT01817764|vilanterol (VI)|vilanterol (vi)
4959342|NCT01817764|salmeterol (SAL)|salmeterol (sal)
4959343|NCT01817764|fluticasone propionate (FP)|fluticasone propionate (fp)
4959344|NCT01817764|Novel Dry Powder Inhaler (NDPI)|novel dry powder inhaler (ndpi)
4959345|NCT01817764|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
4959346|NCT01817764|GW642444|gw642444
4959347|NCT01817764|GSK573719|gsk573719
4959348|NCT01817764|lung function|lung function
4959349|NCT01817751|central nervous system|central nervous system
4959350|NCT01817751|Brain and Nervous System|brain and nervous system
4959351|NCT01817738|Metastatic|metastatic
4959352|NCT01817738|Castrate-refractory|castrate-refractory
4959353|NCT01817725|Therapeutic vaccine|therapeutic vaccine
4959354|NCT01817725|HBsAg clearance|hbsag clearance
4959355|NCT01817725|Immune clearance|immune clearance
4959356|NCT01817725|HBsAg clearance induced by vaccination|hbsag clearance induced by vaccination
4959357|NCT01817725|s seroconversion in carriers after vaccination|s seroconversion in carriers after vaccination
4959358|NCT01817712|Posttraumatic neuroses|posttraumatic neuroses
4959359|NCT01817712|posttraumatic stress disorder|posttraumatic stress disorder
4959360|NCT01817712|PTSD|ptsd
4959361|NCT01817712|Supported employment|supported employment
4959362|NCT01817712|IPS|ips
4959363|NCT01817712|CWT|cwt
4959364|NCT01817712|TWP|twp
4959365|NCT01817712|Individual placement and support|individual placement and support
4959366|NCT01817712|Compensated work therapy|compensated work therapy
4959367|NCT01817712|Transitional work program|transitional work program
4959368|NCT01817699|Cholecalciferol|cholecalciferol
4959369|NCT01817699|Methoxy polyethylene glycol-epoetin beta|methoxy polyethylene glycol-epoetin beta
4959370|NCT01817699|Hematinics|hematinics
4959371|NCT01817699|Bone Diseases, Metabolic|bone diseases, metabolic
4959372|NCT01817699|Neoplasms|neoplasms
4959373|NCT01817699|Cardiovascular Diseases|cardiovascular diseases
4959374|NCT01817699|Graft Rejection|graft rejection
4959375|NCT01817660|popliteal artery aneurysm|popliteal artery aneurysm
4959376|NCT01817660|endovascular repair|endovascular repair
4959377|NCT01817660|open surgical repair|open surgical repair
4959378|NCT01817660|comparative study|comparative study
4959379|NCT01817647|AL|al
4959380|NCT01817647|Enhanced recovery after surgery (ERAS)|enhanced recovery after surgery (eras)
4959381|NCT01817647|reduce postoperative complications|reduce postoperative complications
4959382|NCT01817647|increased risk of delayed diagnosis and treatment of AL|increased risk of delayed diagnosis and treatment of al
4959383|NCT01817647|diagnose anastomotic leak|diagnose anastomotic leak
4959384|NCT01817634|Malnutrition.|malnutrition.
4959385|NCT01817621|Body Image Disturbance|body image disturbance
4959386|NCT01817621|Medication Adherence|medication adherence
4959387|NCT01817621|Sexual Risk Behavior|sexual risk behavior
4959388|NCT01817621|HIV|hiv
4959389|NCT01817621|MSM|msm
4959390|NCT01817608|sf-36|sf-36
4959391|NCT01817608|Katz|katz
4959392|NCT01817595|Type 2 Diabetes|type 2 diabetes
4959393|NCT01817595|Internet Blood Glucose Monitoring|internet blood glucose monitoring
4959394|NCT01817595|iphone|iphone
4959395|NCT01817595|meter|meter
4959396|NCT01817582|Dry Eye Disease|dry eye disease
4959397|NCT01817569|Diabetes Mellitus (DM)|diabetes mellitus (dm)
4959398|NCT01817569|Byetta|byetta
4959399|NCT01817569|Exenatide|exenatide
4959400|NCT01817543|venous leg ulcers|venous leg ulcers
4959401|NCT01817543|non healing wounds|non healing wounds
4959402|NCT01817530|Uterine Fibroids|uterine fibroids
4959403|NCT01817530|Leiomyomata|leiomyomata
4959404|NCT01817530|Elagolix|elagolix
4959405|NCT01817530|Menorrhagia|menorrhagia
4959406|NCT01817530|Elagolix sodium|elagolix sodium
4959407|NCT01817530|Heavy Uterine Bleeding|heavy uterine bleeding
4959408|NCT01817530|ABT-620|abt-620
4959409|NCT01817504|Renal failure,|renal failure,
4959410|NCT01817504|Transplantectomy|transplantectomy
4959411|NCT01817504|Immunosuppression|immunosuppression
4959412|NCT01817504|Sensitization|sensitization
4959413|NCT01817491|Vegan Diet|vegan diet
4959414|NCT01817491|Hypercholesterolemia|hypercholesterolemia
4959415|NCT01817491|American Heart Association Diet|american heart association diet
4959416|NCT01817491|Cardiovascular Risk|cardiovascular risk
4959417|NCT01817491|Obesity|obesity
4959418|NCT01817478|conjunctival flora|conjunctival flora
4959419|NCT01817439|oral Amiodarone|oral amiodarone
4959420|NCT01817439|IV Amiodarone|iv amiodarone
4959421|NCT01817439|phlebitis|phlebitis
4959422|NCT01817439|thrombophlebitis|thrombophlebitis
4959423|NCT01817439|adverse events|adverse events
4959424|NCT01817413|Calcium hydroxide|calcium hydroxide
4959425|NCT01817413|Pulp regeneration|pulp regeneration
4959426|NCT01817413|Regenerative endodontics|regenerative endodontics
4959427|NCT01817413|Pulp revitalisation|pulp revitalisation
4959428|NCT01817413|Triple antibiotic paste|triple antibiotic paste
4959429|NCT01817413|Root canal therapy|root canal therapy
4959430|NCT01817413|Root end closure|root end closure
4959431|NCT01817413|Tooth root|tooth root
4959432|NCT01817413|Tooth apex|tooth apex
4959433|NCT01817413|Dental trauma|dental trauma
4959434|NCT01817413|Non-vital|non-vital
4959435|NCT01817413|Immature|immature
4959436|NCT01817413|Incisor|incisor
4959437|NCT01817413|Periapical periodontitis|periapical periodontitis
4959438|NCT01817413|Dental pulp|dental pulp
4959439|NCT01817374|Breast Cancer|breast cancer
4959440|NCT01817374|Definity|definity
4959441|NCT01817374|Ultrasound|ultrasound
4959442|NCT01817361|oral health|oral health
4959443|NCT01817348|Adhesive capsulitis|adhesive capsulitis
4959444|NCT01817348|Frozen shoulder|frozen shoulder
4959445|NCT01817348|Shoulder pain|shoulder pain
4959446|NCT01817348|Intra-articular injection|intra-articular injection
4959447|NCT01817348|Lidocaine injection|lidocaine injection
4959448|NCT01817348|Physiotherapy|physiotherapy
4959449|NCT01817348|Manipulation|manipulation
4959450|NCT01817348|Stretch exercise|stretch exercise
4959451|NCT01817322|kidney transplantation|kidney transplantation
4959452|NCT01817309|renal failure|renal failure
4959453|NCT01817309|survival|survival
4959454|NCT01817309|peritoneal failure|peritoneal failure
4959455|NCT01817296|Klinefelter|klinefelter
4959456|NCT01817296|Fertility|fertility
4959457|NCT01817283|HIV-infected immunological non-responders|hiv-infected immunological non-responders
4959458|NCT01817283|Triptolide|triptolide
4959459|NCT01817283|immune activation|immune activation
4959460|NCT01817283|inflammation|inflammation
4959461|NCT01817283|CD4 T cell|cd4 t cell
4959462|NCT01817257|Cancer|cancer
4959463|NCT01817257|Thrombosis|thrombosis
4959464|NCT01817257|Venous thromboembolism|venous thromboembolism
4959465|NCT01817257|Deep vein thrombosis|deep vein thrombosis
4959466|NCT01817257|Pulmonary embolus|pulmonary embolus
4959467|NCT01817244|care management|care management
4959468|NCT01817244|depression|depression
4959469|NCT01817244|elderly|elderly
4959470|NCT01817244|Korea|korea
4959471|NCT01817231|breast cancer|breast cancer
4959472|NCT01817231|vitamin D|vitamin d
4959473|NCT01817231|25 OH vitamin D|25 oh vitamin d
4959474|NCT01817218|PRP|prp
4959475|NCT01817218|chronic vascular ulcer|chronic vascular ulcer
4959476|NCT01817218|primary care|primary care
4959477|NCT01817192|Non-Squamous|non-squamous
4959478|NCT01817192|Adjuvant Chemotherapy|adjuvant chemotherapy
4959479|NCT01817179|hemiplegia, cerebral palsy, neuroprosthesis, children|hemiplegia, cerebral palsy, neuroprosthesis, children
4959480|NCT01817166|cholecalciferol|cholecalciferol
4959481|NCT01817166|vitamin D|vitamin d
4959482|NCT01817166|immune disease|immune disease
4959483|NCT01817166|clinically isolated syndrome|clinically isolated syndrome
4959484|NCT01817140|oral cancer|oral cancer
4959485|NCT01817140|mandibular invasion|mandibular invasion
4959486|NCT01817140|SWIFT MRI|swift mri
4959487|NCT01817114|Remote Ischemic Conditioning|remote ischemic conditioning
4959489|NCT01817114|STEMI|stemi
4959490|NCT01817114|LAD|lad
4959491|NCT01817088|Deep Brain Stimulation (DBS)|deep brain stimulation (dbs)
4959492|NCT01817088|Parkinson disease|parkinson disease
4959493|NCT01817088|Stereotaxis Technique|stereotaxis technique
4959494|NCT01817088|Subthalamic nucleus|subthalamic nucleus
4959495|NCT01817062|Capillary leakage|capillary leakage
4959496|NCT01817062|Acute Abdomen|acute abdomen
4959497|NCT01817062|Low birth weight|low birth weight
4959498|NCT01817049|prevention|prevention
4959499|NCT01817049|sport injury|sport injury
4959500|NCT01817049|soccer|soccer
4959501|NCT01817049|youth|youth
4959502|NCT01817049|neuromuscular training|neuromuscular training
4959503|NCT01817049|intervention|intervention
4959504|NCT01817049|behaviour|behaviour
4959505|NCT01817036|vitamin D|vitamin d
4959506|NCT01817036|deficiency|deficiency
4959507|NCT01817036|dose response|dose response
4959508|NCT01817023|Nasopharyngeal carcinoma|nasopharyngeal carcinoma
4959509|NCT01817023|current chemotherapy|current chemotherapy
4959510|NCT01817023|intensity-modulated radiotherapy|intensity-modulated radiotherapy
4959511|NCT01817023|low-risk|low-risk
4959512|NCT01817010|Total Hip Arthroplasty|total hip arthroplasty
4959513|NCT01817010|Muscle Strength|muscle strength
4959514|NCT01817010|Hip Osteoarthritis|hip osteoarthritis
4959515|NCT01816997|Statins|statins
4959516|NCT01816997|Glucose homeostasis|glucose homeostasis
4959517|NCT01816997|Diabetes|diabetes
4959518|NCT01816997|Impaired fasting glucose|impaired fasting glucose
4959519|NCT01816958|thalamocortical dysrhythmia|thalamocortical dysrhythmia
4959520|NCT01816958|transcranial magnetic stimulation (TMS)|transcranial magnetic stimulation (tms)
4959521|NCT01816958|transcranial Electrical Stimulation (tES)|transcranial electrical stimulation (tes)
4959522|NCT01816958|(N-methyl-D-aspartate) NMDA-R antagonist|(n-methyl-d-aspartate) nmda-r antagonist
4959523|NCT01816958|ketamine infusion|ketamine infusion
4959524|NCT01816958|neuromodulation|neuromodulation
4959525|NCT01816958|synergistic effect|synergistic effect
4959526|NCT01816958|remission|remission
4959527|NCT01816945|Depression|depression
4959528|NCT01816945|Stress|stress
4959529|NCT01816945|Social support|social support
4959530|NCT01816945|Social capital|social capital
4959531|NCT01816945|Maternal|maternal
4959532|NCT01816893|Hypoglycemia|hypoglycemia
4959533|NCT01816893|Autonomic Nervous System|autonomic nervous system
4959534|NCT01816893|baroreflex sensitivity|baroreflex sensitivity
4959535|NCT01816893|muscle sympathetic nerve activity|muscle sympathetic nerve activity
4959536|NCT01816893|lower body negative pressure|lower body negative pressure
4959537|NCT01816867|hernia|hernia
4959538|NCT01816867|Treatment|treatment
4959539|NCT01816867|laparoscopic|laparoscopic
4959540|NCT01816867|open technique|open technique
4959541|NCT01816854|SFA,|sfa,
4959542|NCT01816854|stent,|stent,
4959543|NCT01816854|endovascular|endovascular
4959544|NCT01816854|Patient outcome|patient outcome
4959545|NCT01816841|Direct Visual Fluorescense|direct visual fluorescense
4959546|NCT01816841|Oral Examination|oral examination
4959547|NCT01816841|oral cancer|oral cancer
4959548|NCT01816828|HIV, MSM, unprotected anal intercourse, sexual health|hiv, msm, unprotected anal intercourse, sexual health
4959549|NCT01816815|PK/PD|pk/pd
4959550|NCT01816815|BAY1002670|bay1002670
4959551|NCT01816802|In vitro fertilization|in vitro fertilization
4959552|NCT01816802|Assisted reproductive therapy|assisted reproductive therapy
4959553|NCT01816802|Time-lapse image recording|time-lapse image recording
4959554|NCT01816802|Image analysis software|image analysis software
4959555|NCT01816789|Starting dose|starting dose
4959556|NCT01816789|rFSH|rfsh
4959557|NCT01816789|controlled|controlled
4959558|NCT01816789|ovarian|ovarian
4959559|NCT01816789|stimulation|stimulation
4959560|NCT01816789|IVF/ICSI|ivf/icsi
4959561|NCT01816789|cycles|cycles
4959562|NCT01816763|Health Care Quality, Access, and Evaluation|health care quality, access, and evaluation
4959563|NCT01816763|Primary Health Care|primary health care
4959564|NCT01816763|Medical Informatics|medical informatics
4959565|NCT01816750|CT coronary angiography|ct coronary angiography
4959566|NCT01816750|Coronary disease|coronary disease
4959567|NCT01816750|Gemstone Spectral Imaging|gemstone spectral imaging
4959568|NCT01816750|Diagnostic value|diagnostic value
4959569|NCT01816750|Adaptive statistical iterative reconstruction|adaptive statistical iterative reconstruction
4959570|NCT01816750|iterative reconstruction|iterative reconstruction
4959571|NCT01816750|Feasibility of coronary and myocardial assessment|feasibility of coronary and myocardial assessment
4959572|NCT01816750|novel Cardiac CT GSI protocol|novel cardiac ct gsi protocol
4959573|NCT01816724|NOCTURIA|nocturia
4959574|NCT01816724|SYMPTOMATIC QUESTIONNAIRE|symptomatic questionnaire
4959575|NCT01816724|N-QOL|n-qol
4959576|NCT01816711|Frail elderly|frail elderly
4959577|NCT01816711|Hip fracture|hip fracture
4959578|NCT01816711|Vitamin D|vitamin d
4959579|NCT01816711|Geriatrics|geriatrics
4959580|NCT01816698|Hypertension|hypertension
4959581|NCT01816698|Taurine|taurine
4959582|NCT01816698|Metabolism|metabolism
4959583|NCT01816672|Wagner 1|wagner 1
4959584|NCT01816672|Wagner 2|wagner 2
4959585|NCT01816672|Non healing diabetic foot wound|non healing diabetic foot wound
4959586|NCT01816659|Colorectal Carcinoma|colorectal carcinoma
4959587|NCT01816659|Endoscopically Non- Resectable Adenomas|endoscopically non- resectable adenomas
4959588|NCT01816659|Colonic lesion|colonic lesion
4959589|NCT01816659|Biomarker|biomarker
4959590|NCT01816659|Metformin-ER|metformin-er
4959591|NCT01816659|Metformin|metformin
4959592|NCT01816659|Extended release|extended release
4959593|NCT01816659|Colonoscopy|colonoscopy
4959594|NCT01816659|Colon cancer surgery|colon cancer surgery
4959595|NCT01816646|Blood And Marrow Transplantation|blood and marrow transplantation
4959596|NCT01816646|Hemorrhagic Cystitis|hemorrhagic cystitis
4959597|NCT01816646|Bleeding from bladder|bleeding from bladder
4959598|NCT01816646|Foley catheter|foley catheter
4959599|NCT01816646|Probenecid|probenecid
4959600|NCT01816646|Cidofovir|cidofovir
4959601|NCT01816646|Vistide|vistide
4959602|NCT01816633|non healing wound|non healing wound
4959603|NCT01816620|POEMS Syndrome|poems syndrome
4959604|NCT01816620|lenalidomide|lenalidomide
4959605|NCT01816620|newly diagnosed|newly diagnosed
4959606|NCT01816620|plasma cell disorder|plasma cell disorder
4959607|NCT01816620|Dexamethasone|dexamethasone
4959608|NCT01816607|Magnetic Resonance Imaging|magnetic resonance imaging
4959609|NCT01816607|Magnetic Resonance Imaging, Functional|magnetic resonance imaging, functional
4959610|NCT01816594|HER2, breast cancer, neoadjuvant, PI3K inhibitor, first line chemotherapy, trastuzumab, GBG, SOLTI, BIG|her2, breast cancer, neoadjuvant, pi3k inhibitor, first line chemotherapy, trastuzumab, gbg, solti, big
4959611|NCT01816568|appendicitis, laparoscopy, single incision|appendicitis, laparoscopy, single incision
4959612|NCT01816542|patch-testing|patch-testing
4959613|NCT01816542|personal-care|personal-care
4959614|NCT01816542|cosmetic|cosmetic
4959615|NCT01816542|dermatitis|dermatitis
4959617|NCT01816542|sensitive skin|sensitive skin
4959618|NCT01816516|childhood obesity|childhood obesity
4959619|NCT01816516|low-income|low-income
4959620|NCT01816516|maternal responsiveness|maternal responsiveness
4959621|NCT01816516|infant feeding|infant feeding
4959622|NCT01816516|infant feeding practices|infant feeding practices
4959623|NCT01816516|infant feeding style|infant feeding style
4959624|NCT01816516|primary prevention|primary prevention
4959625|NCT01816503|Pain|pain
4959626|NCT01816503|Cancer pain|cancer pain
4959627|NCT01816503|Fentanyl|fentanyl
4959628|NCT01816503|Fentanyl matrix|fentanyl matrix
4959629|NCT01816503|Opioid analgesic|opioid analgesic
4959630|NCT01816464|Influenza|influenza
4959631|NCT01816464|Vaccination|vaccination
4959632|NCT01816451|aerobic capacity|aerobic capacity
4959633|NCT01816451|cardiorespiratory training|cardiorespiratory training
4959634|NCT01816451|blood lactate concentration|blood lactate concentration
4959635|NCT01816451|heart rate|heart rate
4959636|NCT01816438|abnormal histological colorectal lesions|abnormal histological colorectal lesions
4959637|NCT01816425|Dental Prosthesis|dental prosthesis
4959638|NCT01816425|Dental Prosthesis Design|dental prosthesis design
4959639|NCT01816412|Arms|arms
4959640|NCT01816412|Experimental|experimental
4959641|NCT01816412|Drug Coated Angioplasty Balloon|drug coated angioplasty balloon
4959642|NCT01816412|Active Comparator|active comparator
4959643|NCT01816412|Standard angioplasty balloon|standard angioplasty balloon
4959644|NCT01816386|acupuncture|acupuncture
4959645|NCT01816386|anaesthetic recovery|anaesthetic recovery
4959646|NCT01816386|perioperative care|perioperative care
4959647|NCT01816386|Age 18+|age 18+
4959648|NCT01816386|ASA-score ≤ 2|asa-score ≤ 2
4959649|NCT01816386|Surgery: Uterus|surgery: uterus
4959650|NCT01816386|Surgery: Adnex|surgery: adnex
4959651|NCT01816386|Surgery: Ovaries|surgery: ovaries
4959652|NCT01816373|Chest wall; Chest, funnel; pectus excavatum; congenital abnormality|chest wall; chest, funnel; pectus excavatum; congenital abnormality
4959653|NCT01816360|Womens health|womens health
4959654|NCT01816360|Menopause|menopause
4959655|NCT01816360|Complementary therapies|complementary therapies
4959656|NCT01816360|Aromatherapy|aromatherapy
4959657|NCT01816360|Essential oils|essential oils
4959658|NCT01816360|Yogatherapy|yogatherapy
4959659|NCT01816360|Psychoneuroendocrineimmunology|psychoneuroendocrineimmunology
4959660|NCT01816334|sciatica|sciatica
4959661|NCT01816334|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal
4959662|NCT01816334|Glucocorticoids|glucocorticoids
4959663|NCT01816308|AF|af
4959664|NCT01816308|MCI|mci
4959665|NCT01816282|TKR|tkr
4959666|NCT01816282|Blood loss|blood loss
4959667|NCT01816282|Fibrin Sealant|fibrin sealant
4959668|NCT01816269|Helicobacter pylori|helicobacter pylori
4959669|NCT01816269|Dental scaling|dental scaling
4959670|NCT01816269|Eradication|eradication
4959671|NCT01816269|Reinfection|reinfection
4959672|NCT01816269|Helicobacter status|helicobacter status
4959673|NCT01816243|Chronic Pain|chronic pain
4959674|NCT01816243|Chronic Non-Malignant Pain|chronic non-malignant pain
4959675|NCT01816243|TTS-fentanyl|tts-fentanyl
4959676|NCT01816243|Durogesic|durogesic
4959677|NCT01816217|Difficult intubation|difficult intubation
4959678|NCT01816217|Complications|complications
4959679|NCT01816217|Intensive care units|intensive care units
4959680|NCT01816217|Videolaryngoscope|videolaryngoscope
4959681|NCT01816217|Laryngoscopy|laryngoscopy
4959682|NCT01816204|anxiety treatment|anxiety treatment
4959683|NCT01816204|anxiety online treatment|anxiety online treatment
4959684|NCT01816204|anxiety electronic treatment|anxiety electronic treatment
4959685|NCT01816204|anxiety therapist assisted|anxiety therapist assisted
4959686|NCT01816178|Autism spectrum Disorders|autism spectrum disorders
4959687|NCT01816178|Voice Output Communication|voice output communication
4959688|NCT01816165|diabetes|diabetes
4959689|NCT01816165|insulin|insulin
4959690|NCT01816165|blood vessel|blood vessel
4959691|NCT01816165|type 1|type 1
4959692|NCT01816152|light treatment|light treatment
4959693|NCT01816152|circadian rhythms|circadian rhythms
4959694|NCT01816152|sleep|sleep
4959695|NCT01816152|agitation|agitation
4959696|NCT01816152|depression|depression
4959697|NCT01816139|vaginal dryness|vaginal dryness
4959698|NCT01816139|vaginal atrophy|vaginal atrophy
4959699|NCT01816139|estrogen|estrogen
4959700|NCT01816113|PvDBP|pvdbp
4959701|NCT01816113|Malaria|malaria
4959702|NCT01816113|Plasmodium vivax|plasmodium vivax
4959703|NCT01816100|multiple sclerosis|multiple sclerosis
4959704|NCT01816100|exercise|exercise
4959705|NCT01816100|MEG|meg
4959706|NCT01816100|DTI|dti
4959707|NCT01816100|Brain changes|brain changes
4959708|NCT01816074|Mothers|mothers
4959709|NCT01816074|ADHD|adhd
4959710|NCT01816074|Treatment|treatment
4959711|NCT01816074|Child|child
4959712|NCT01816061|Veterans Health|veterans health
4959713|NCT01816061|Social Adjustment|social adjustment
4959714|NCT01816061|Traumatic Brain Injury (TBI)|traumatic brain injury (tbi)
4959715|NCT01816061|Post-Traumatic Stress Disorder (PTSD)|post-traumatic stress disorder (ptsd)
4959716|NCT01816061|Independent Living|independent living
4959717|NCT01816061|Goals|goals
4959718|NCT01816061|Education|education
4959719|NCT01816048|prostate, prostate cancer|prostate, prostate cancer
4959720|NCT01816022|CMPN|cmpn
4959721|NCT01816022|Fracture|fracture
4959722|NCT01816022|Osteoporosis|osteoporosis
4959723|NCT01816022|Biochemical Bone Markers|biochemical bone markers
4959724|NCT01816009|infection|infection
4959725|NCT01816009|antibiotic|antibiotic
4959726|NCT01816009|prosthesis|prosthesis
4959727|NCT01815996|Pregnancy|pregnancy
4959728|NCT01815996|pulmonary embolism|pulmonary embolism
4959729|NCT01815996|myocardial infarction|myocardial infarction
4959730|NCT01815996|autoimmune disease|autoimmune disease
4959731|NCT01815996|healthy controls|healthy controls
4959732|NCT01815983|Laryngoscopy|laryngoscopy
4959733|NCT01815983|Tracheal Intubation|tracheal intubation
4959734|NCT01815983|Video Laryngoscopy|video laryngoscopy
4959735|NCT01815970|dyspnea|dyspnea
4959736|NCT01815970|exercise|exercise
4959737|NCT01815970|neuromechanical uncoupling|neuromechanical uncoupling
4959738|NCT01815970|COPD|copd
4959739|NCT01815970|pulmonary rehabilitation|pulmonary rehabilitation
4959740|NCT01815957|coronary microcirculation|coronary microcirculation
4959741|NCT01815957|coronary artery disease|coronary artery disease
4959742|NCT01815957|myocardial disease|myocardial disease
4959743|NCT01815957|ischemia|ischemia
4959744|NCT01815944|onset time|onset time
4959745|NCT01815944|ultrasound-guided supraclavicular block|ultrasound-guided supraclavicular block
4959746|NCT01815944|ropivacaine|ropivacaine
4959747|NCT01815944|normal saline|normal saline
4959748|NCT01815944|dextrose 5%|dextrose 5%
4959749|NCT01815918|Orthopedic Procedures|orthopedic procedures
4959750|NCT01815918|Prostheses and Implants|prostheses and implants
4959751|NCT01815918|Joint Prosthesis|joint prosthesis
4959752|NCT01815918|Knee Prosthesis|knee prosthesis
4959753|NCT01815918|Arthroplasty, Knee|arthroplasty, knee
4959754|NCT01815918|Thromboembolism|thromboembolism
4959755|NCT01815918|Inflammation|inflammation
4959756|NCT01815918|B-Cell Differentiation Factor-2|b-cell differentiation factor-2
4959757|NCT01815918|Differentiation Factor-2, B-Cell|differentiation factor-2, b-cell
4959758|NCT01815918|B-Cell Stimulatory Factor-2|b-cell stimulatory factor-2
4959759|NCT01815918|BSF-2|bsf-2
4959760|NCT01815918|IFN-beta 2|ifn-beta 2
4959761|NCT01815918|MGI-2|mgi-2
4959762|NCT01815918|Interleukin-6 (IL-6)|interleukin-6 (il-6)
4959763|NCT01815918|Steroids|steroids
4959764|NCT01815918|Pregnenediones|pregnenediones
4959765|NCT01815918|Hydrocortisone|hydrocortisone
4959766|NCT01815918|Physiological Effects of Drugs|physiological effects of drugs
4959767|NCT01815918|Therapeutic Uses|therapeutic uses
4959768|NCT01815892|Hemodialysis|hemodialysis
4959769|NCT01815892|Response to Furosemide|response to furosemide
4959770|NCT01815879|metastatic colorectal cancer|metastatic colorectal cancer
4959771|NCT01815879|liver metastases|liver metastases
4959772|NCT01815879|90Y resin microsphere radioembolization|90y resin microsphere radioembolization
4959773|NCT01815879|retrospective data analysis|retrospective data analysis
4959774|NCT01815866|Positive Nontuberculous Mycobacteria|positive nontuberculous mycobacteria
4959775|NCT01815853|Neoadjuvant|neoadjuvant
4959776|NCT01815853|Chemoradiotherapy|chemoradiotherapy
4959777|NCT01815853|Chemotherapy|chemotherapy
4959778|NCT01815853|Locally advanced gastric cancer|locally advanced gastric cancer
4959779|NCT01815853|Pathological complete response|pathological complete response
4959780|NCT01815853|D2 gastrectomy|d2 gastrectomy
4959781|NCT01815814|spasticity|spasticity
4959782|NCT01815814|cerebral palsy|cerebral palsy
4959783|NCT01815814|hemiplegia|hemiplegia
4959784|NCT01815814|hemiparesis|hemiparesis
4959785|NCT01815814|diplegia|diplegia
4959786|NCT01815814|paraplegia|paraplegia
4959787|NCT01815814|quadriplegia|quadriplegia
4959788|NCT01815814|quadriparesis|quadriparesis
4959789|NCT01815775|Normal pressure hydrocephalus|normal pressure hydrocephalus
4959790|NCT01815775|flow MRI|flow mri
4959791|NCT01815775|dementia|dementia
4959792|NCT01815775|cerebrospinal fluid|cerebrospinal fluid
4959793|NCT01815775|shunt|shunt
4959794|NCT01815762|bioimpedance|bioimpedance
4959795|NCT01815762|overhydration|overhydration
4959796|NCT01815762|hemodialysis|hemodialysis
4959797|NCT01815762|arterial stiffness|arterial stiffness
4959798|NCT01815762|mortality|mortality
4959799|NCT01815736|HIV|hiv
4959800|NCT01815736|HIV 1 Infected|hiv 1 infected
4959801|NCT01815736|Virologically-Suppressed|virologically-suppressed
4959802|NCT01815723|Psoriasis|psoriasis
4959803|NCT01815723|Dimethyl fumarate|dimethyl fumarate
4959804|NCT01815723|Fumaderm®|fumaderm®
4959805|NCT01815710|Clinical Pathways|clinical pathways
4959806|NCT01815710|Knowledge translation|knowledge translation
4959807|NCT01815710|Evaluation|evaluation
4959808|NCT01815697|Lower Urinary Tract Symptoms|lower urinary tract symptoms
4959809|NCT01815697|Benign Prostatic Hyperplasia|benign prostatic hyperplasia
4959810|NCT01815697|Urinary Retention|urinary retention
4959811|NCT01815697|Vascular Endothelium|vascular endothelium
4959812|NCT01815697|Counterpulsation, External|counterpulsation, external
4959813|NCT01815684|Phase I|phase i
4959814|NCT01815684|ASP3652|asp3652
4959815|NCT01815684|Dose escalation|dose escalation
4959816|NCT01815684|Maximum Tolerated Dose (MTD)|maximum tolerated dose (mtd)
4959817|NCT01815671|colonoscopy|colonoscopy
4959818|NCT01815671|technique|technique
4959819|NCT01815671|tilt|tilt
4959820|NCT01815671|insertion|insertion
4959821|NCT01815671|safety|safety
4959822|NCT01815671|efficacy|efficacy
4959823|NCT01815645|Cocaine related disorders|cocaine related disorders
4959824|NCT01815645|Contingency Management|contingency management
4959825|NCT01815645|psychosocial treatment|psychosocial treatment
4959826|NCT01815632|multiple sclerosis|multiple sclerosis
4959827|NCT01815632|progressive MS|progressive ms
4959828|NCT01815632|stem cell|stem cell
4959829|NCT01815632|cell therapy|cell therapy
4959830|NCT01815632|neurodegeneration|neurodegeneration
4959831|NCT01815632|CNS repair|cns repair
4959832|NCT01815606|Pancreas|pancreas
4959833|NCT01815606|cancer|cancer
4959834|NCT01815606|EUS-FNA|eus-fna
4959835|NCT01815606|19Gauge|19gauge
4959836|NCT01815606|25Gauge|25gauge
4959837|NCT01815606|35mm mass|35mm mass
4959838|NCT01815593|Erectile Dysfunction|erectile dysfunction
4959839|NCT01815593|Vascular Endothelium|vascular endothelium
4959840|NCT01815593|Counterpulsation, External|counterpulsation, external
4959841|NCT01815580|HIV|hiv
4959842|NCT01815580|Treatment as Prevention|treatment as prevention
4959843|NCT01815580|Seek, Test, Treat, Retain Strategies|seek, test, treat, retain strategies
4959844|NCT01815567|Hypertension|hypertension
4959845|NCT01815567|Retinal Disorder|retinal disorder
4959846|NCT01815567|Cognitive impairment|cognitive impairment
4959847|NCT01815554|Tetraplegia|tetraplegia
4959848|NCT01815554|Spinal Cord Injury|spinal cord injury
4959849|NCT01815554|Ventilator|ventilator
4959850|NCT01815554|Diaphragmatic Pacing System|diaphragmatic pacing system
4959851|NCT01815541|subcutaneous teicoplanin|subcutaneous teicoplanin
4959852|NCT01815541|osteoarticular|osteoarticular
4959853|NCT01815541|infections|infections
4959854|NCT01815541|tolerance|tolerance
4959855|NCT01815541|teicoplanin|teicoplanin
4959856|NCT01815528|recurrent epithelial ovarian cancer|recurrent epithelial ovarian cancer
4959857|NCT01815515|Metastatic Prostate Cancer|metastatic prostate cancer
4959858|NCT01815502|Single ventricle|single ventricle
4959859|NCT01815502|Fontan|fontan
4959860|NCT01815502|Sildenafil|sildenafil
4959861|NCT01815502|Pressure-Volume Loops|pressure-volume loops
4959862|NCT01815489|Necrotizing Pancreatitis|necrotizing pancreatitis
4959863|NCT01815489|Pancreatitis|pancreatitis
4959864|NCT01815489|Infection|infection
4959865|NCT01815489|Bacteria|bacteria
4959866|NCT01815489|Microbiology|microbiology
4959867|NCT01815476|DCIS|dcis
4959868|NCT01815476|Early Stage Invasive breast cancer|early stage invasive breast cancer
4959869|NCT01815476|Prone breast radiotherapy|prone breast radiotherapy
4959870|NCT01815463|stool|stool
4959871|NCT01815463|monoclonal antibody|monoclonal antibody
4959872|NCT01815463|Adnab-9|adnab-9
4959873|NCT01815463|FOBT|fobt
4959875|NCT01815463|iFOBT|ifobt
4959876|NCT01815463|colonoscopy|colonoscopy
4959877|NCT01815463|barium enema|barium enema
4959878|NCT01815463|flexible sigmoidoscopy|flexible sigmoidoscopy
4959879|NCT01815424|Tofacitinib|tofacitinib
4959880|NCT01815424|CP-690|cp-690
4959881|NCT01815424|550|550
4959882|NCT01815424|Xeljanz|xeljanz
4959883|NCT01815424|Jak-Inhibitor|jak-inhibitor
4959884|NCT01815424|Oral Treatment|oral treatment
4959885|NCT01815424|Psoriasis vulgaris|psoriasis vulgaris
4959886|NCT01815424|Pruritus|pruritus
4959887|NCT01815424|Itch|itch
4959888|NCT01815424|DLQI|dlqi
4959889|NCT01815424|moderate|moderate
4959890|NCT01815424|severe|severe
4959891|NCT01815424|chronic|chronic
4959892|NCT01815424|plaque psoriasis|plaque psoriasis
4959893|NCT01815411|Rheumatoid arthritis|rheumatoid arthritis
4959894|NCT01815411|symptom score|symptom score
4959895|NCT01815411|fatigue|fatigue
4959896|NCT01815411|life quality|life quality
4959897|NCT01815411|cytokines|cytokines
4959898|NCT01815411|mRNA expression|mrna expression
4959899|NCT01815411|Quality of Life|quality of life
4959900|NCT01815411|Signs and Symptoms|signs and symptoms
4959901|NCT01815411|Indication for Modification of Patient Physical Status|indication for modification of patient physical status
4959998|NCT01815112|Dementia|dementia
4959902|NCT01815385|Term gestation|term gestation
4959903|NCT01815385|Environmental exposure|environmental exposure
4959904|NCT01815385|Benzo(a)pyrene|benzo(a)pyrene
4959905|NCT01815385|Polycyclic aromatic hydrocarbons|polycyclic aromatic hydrocarbons
4959906|NCT01815385|Adiposity|adiposity
4959907|NCT01815385|Cytosine methylation|cytosine methylation
4959908|NCT01815372|nerve blocks|nerve blocks
4959909|NCT01815372|ultrasound-guided|ultrasound-guided
4959910|NCT01815372|leg surgery|leg surgery
4959911|NCT01815359|ICARuS|icarus
4959912|NCT01815359|Intraperitoneal Chemotherapy|intraperitoneal chemotherapy
4959913|NCT01815359|hyperthermic intraperitoneal chemotherapy|hyperthermic intraperitoneal chemotherapy
4959914|NCT01815359|Optimal Surgical Debulking|optimal surgical debulking
4959915|NCT01815359|Leucovorin|leucovorin
4959916|NCT01815359|Floxuridine (FUDR)|floxuridine (fudr)
4959917|NCT01815359|Mitomycin|mitomycin
4959918|NCT01815359|12-289|12-289
4959919|NCT01815346|Breast Cancer|breast cancer
4959920|NCT01815346|Breast cancer survivors|breast cancer survivors
4959921|NCT01815346|Chronic, taxane-based chemotherapy-induced peripheral neuropathy|chronic, taxane-based chemotherapy-induced peripheral neuropathy
4959922|NCT01815346|CIPN|cipn
4959923|NCT01815346|Acupuncture treatments|acupuncture treatments
4959924|NCT01815346|Quality of life|quality of life
4959925|NCT01815346|Hand function|hand function
4959926|NCT01815346|Balance|balance
4959927|NCT01815346|Questionnaires|questionnaires
4959928|NCT01815346|Surveys|surveys
4959929|NCT01815333|Cancer of Lymph Node|cancer of lymph node
4959930|NCT01815333|Magnetic resonance imaging|magnetic resonance imaging
4959931|NCT01815333|MRI|mri
4959932|NCT01815333|Ultrasuperparamagnetic nanoparticle iron oxide|ultrasuperparamagnetic nanoparticle iron oxide
4959933|NCT01815333|USPIO|uspio
4959934|NCT01815333|Feraheme|feraheme
4959935|NCT01815333|Ferumoxytole|ferumoxytole
4959936|NCT01815320|Renal Transplant|renal transplant
4959937|NCT01815320|Contrast-enhanced ultrasound|contrast-enhanced ultrasound
4959938|NCT01815320|Acute allograft rejection|acute allograft rejection
4959939|NCT01815294|Ovarian cancer|ovarian cancer
4959940|NCT01815294|Breast cancer|breast cancer
4959941|NCT01815294|Solid malignancy|solid malignancy
4959942|NCT01815294|Advanced or refractory solid malignancy|advanced or refractory solid malignancy
4959943|NCT01815294|Metastatic cancer|metastatic cancer
4959944|NCT01815294|DOXIL/CAELYX|doxil/caelyx
4959945|NCT01815294|Doxorubicin HCL|doxorubicin hcl
4959946|NCT01815294|Bioequivalence|bioequivalence
4959947|NCT01815268|Randomized Controlled Trial|randomized controlled trial
4959948|NCT01815268|Influenza|influenza
4959949|NCT01815268|Influenza vaccine|influenza vaccine
4959950|NCT01815268|Flu Vaccine|flu vaccine
4959951|NCT01815268|Fluzone|fluzone
4959952|NCT01815268|HD Fluzone|hd fluzone
4959953|NCT01815268|Nursing Home|nursing home
4959954|NCT01815268|Hospitalization|hospitalization
4959955|NCT01815268|Mortality|mortality
4959956|NCT01815268|Health Care worker vaccination|health care worker vaccination
4959957|NCT01815268|ADL decline|adl decline
4959958|NCT01815268|Effectiveness|effectiveness
4959959|NCT01815268|Elderly|elderly
4959960|NCT01815268|Morbidity|morbidity
4959961|NCT01815268|Nursing Home resident|nursing home resident
4959962|NCT01815268|Frail|frail
4959963|NCT01815268|Institutionalized|institutionalized
4959964|NCT01815268|Epidemiology|epidemiology
4959965|NCT01815268|CDC|cdc
4959966|NCT01815268|US|us
4959967|NCT01815268|city|city
4959968|NCT01815255|TDF-based regimen|tdf-based regimen
4959969|NCT01815255|HIV-infected children|hiv-infected children
4959970|NCT01815255|Thai|thai
4959971|NCT01815255|generic|generic
4959972|NCT01815255|safety and efficacy|safety and efficacy
4959973|NCT01815255|renal status|renal status
4959974|NCT01815255|To assess effect of TDF on renal problem in HIV-infected children receiving TDF-based once daily regimen|to assess effect of tdf on renal problem in hiv-infected children receiving tdf-based once daily regimen
4959975|NCT01815255|To compare the effectiveness and clinical usefulness of different tools of adherence|to compare the effectiveness and clinical usefulness of different tools of adherence
4959976|NCT01815229|endotracheal|endotracheal
4959977|NCT01815229|intubation|intubation
4959978|NCT01815216|Bariatric surgery|bariatric surgery
4959979|NCT01815216|Cognition|cognition
4959980|NCT01815216|Satiety hormones|satiety hormones
4959981|NCT01815216|Brain networks|brain networks
4959982|NCT01815216|Inhibitory control|inhibitory control
4959983|NCT01815216|Food intake|food intake
4959984|NCT01815203|Caffeine effects|caffeine effects
4959985|NCT01815203|Inhibitory control|inhibitory control
4959986|NCT01815190|immune complex vasculitis|immune complex vasculitis
4959987|NCT01815190|cutaneous vasculitis|cutaneous vasculitis
4959988|NCT01815190|IgA vasculitis|iga vasculitis
4959989|NCT01815190|IgA nephropathy|iga nephropathy
4959990|NCT01815138|OHSS, GnRH agonist trigger, low dose hCG, PCOS, IVF|ohss, gnrh agonist trigger, low dose hcg, pcos, ivf
4959991|NCT01815125|Mild traumatic brain injury|mild traumatic brain injury
4959992|NCT01815125|Brain concussion|brain concussion
4959993|NCT01815125|Post-concussion syndrome|post-concussion syndrome
4959994|NCT01815125|Emergency department|emergency department
4959995|NCT01815125|Ondansetron|ondansetron
4959996|NCT01815112|Neurodegenerative disease|neurodegenerative disease
4959997|NCT01815112|Elderly|elderly
4959999|NCT01815112|FDG-PET|fdg-pet
4960000|NCT01815112|MRI|mri
4960001|NCT01815112|Neuroimaging|neuroimaging
4960002|NCT01815086|Radioimmunoimaging|radioimmunoimaging
4960003|NCT01815086|AL Amyloidosis|al amyloidosis
4960004|NCT01815086|PET/CT|pet/ct
4960005|NCT01815047|Vitamin D|vitamin d
4960006|NCT01815047|Pregnancy|pregnancy
4960007|NCT01815047|Inflammation|inflammation
4960008|NCT01815047|Infection|infection
4960009|NCT01815047|Placenta|placenta
4960010|NCT01815047|Cytokine|cytokine
4960011|NCT01815047|Microbiome|microbiome
4960012|NCT01815008|Platelet aggregation|platelet aggregation
4960013|NCT01815008|Clopidogrel|clopidogrel
4960014|NCT01815008|Platelet transcriptome|platelet transcriptome
4960015|NCT01814995|behavioural|behavioural
4960016|NCT01814995|diabetes prevention|diabetes prevention
4960017|NCT01814995|overweight|overweight
4960018|NCT01814995|physical activity|physical activity
4960019|NCT01814995|gestational diabetes|gestational diabetes
4960020|NCT01814982|Traumatic brain injury|traumatic brain injury
4960021|NCT01814982|JNJ-17299425|jnj-17299425
4960022|NCT01814982|Intracranial pressure|intracranial pressure
4960023|NCT01814982|Intravascular bolus injection|intravascular bolus injection
4960024|NCT01814969|Rectal neoplasm|rectal neoplasm
4960025|NCT01814969|Preoperative hyperfractionated radiotherapy|preoperative hyperfractionated radiotherapy
4960026|NCT01814969|Preoperative hyperfractionated radiochemotherapy|preoperative hyperfractionated radiochemotherapy
4960027|NCT01814943|Uncomplicated peptic ulcer|uncomplicated peptic ulcer
4960028|NCT01814943|Acid-suppressing drugs|acid-suppressing drugs
4960029|NCT01814943|Epidemiology|epidemiology
4960030|NCT01814891|vitamin A|vitamin a
4960031|NCT01814891|maize|maize
4960032|NCT01814891|total body reserves|total body reserves
4960033|NCT01814891|Condition is vitamin A status.|condition is vitamin a status.
4960034|NCT01814891|Focus: change in vitamin A status with maize feeding.|focus: change in vitamin a status with maize feeding.
4960035|NCT01814891|Focus: feeding orange maize to children for 90 days.|focus: feeding orange maize to children for 90 days.
4960036|NCT01814891|Focus: total body reserves of vitamin A.|focus: total body reserves of vitamin a.
4960037|NCT01814878|Pain, Postoperative|pain, postoperative
4960038|NCT01814878|Tramadol Hydrochloride|tramadol hydrochloride
4960039|NCT01814878|Acetaminophen|acetaminophen
4960040|NCT01814878|Ultracet|ultracet
4960041|NCT01814865|Post-menopausal|post-menopausal
4960042|NCT01814865|ER+|er+
4960043|NCT01814865|Stage I-IIIA|stage i-iiia
4960044|NCT01814865|Operable|operable
4960045|NCT01814865|Breast Cancer|breast cancer
4960046|NCT01814852|Low Intensity Shockwave|low intensity shockwave
4960047|NCT01814852|Extracorporeal shockwave therapy|extracorporeal shockwave therapy
4960048|NCT01814852|Erectile dysfunction|erectile dysfunction
4960049|NCT01814839|RNAi therapeutic|rnai therapeutic
4960050|NCT01814826|MLN4924|mln4924
4960051|NCT01814826|Acute|acute
4960052|NCT01814826|Myelogenous|myelogenous
4960053|NCT01814826|Leukemia|leukemia
4960054|NCT01814800|PIDD, PID, humoral immunity, antibody deficiency|pidd, pid, humoral immunity, antibody deficiency
4960055|NCT01814787|Type 2 Diabetes|type 2 diabetes
4960056|NCT01814787|Pediatrics|pediatrics
4960057|NCT01814787|Computerized Decision Support System|computerized decision support system
4960058|NCT01814748|Diabetes Mellitus|diabetes mellitus
4960059|NCT01814748|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
4960060|NCT01814748|Glucose Metabolism Disorders|glucose metabolism disorders
4960061|NCT01814748|Metabolic Diseases|metabolic diseases
4960062|NCT01814748|Endocrine System Diseases|endocrine system diseases
4960063|NCT01814748|Metformin|metformin
4960064|NCT01814748|Hypoglycemic Agents|hypoglycemic agents
4960065|NCT01814748|Pharmacologic Actions|pharmacologic actions
4960066|NCT01814748|Therapeutic Uses|therapeutic uses
4960067|NCT01814722|HIV Infections|hiv infections
4960068|NCT01814722|Anti-HIV Agents|anti-hiv agents
4960069|NCT01814722|Anti-Retroviral Agents|anti-retroviral agents
4960070|NCT01814722|Nucleoside Reverse Transcriptase Inhibitors|nucleoside reverse transcriptase inhibitors
4960071|NCT01814722|Non-nucleoside Reverse Transcriptase Inhibitor|non-nucleoside reverse transcriptase inhibitor
4960072|NCT01814722|Protease inhibitors|protease inhibitors
4960073|NCT01814696|Heart Failure|heart failure
4960074|NCT01814696|Congestive Heart Failure|congestive heart failure
4960075|NCT01814696|Medication Adherence|medication adherence
4960076|NCT01814696|Medication Compliance|medication compliance
4960077|NCT01814696|Telemedicine|telemedicine
4960078|NCT01814696|Telehealth|telehealth
4960079|NCT01814683|Vivax malaria|vivax malaria
4960080|NCT01814683|Primaquine|primaquine
4960081|NCT01814683|Placebo|placebo
4960082|NCT01814683|Recurrence|recurrence
4960083|NCT01814657|Infertility|infertility
4960084|NCT01814605|Sciatic Nerve Block|sciatic nerve block
4960085|NCT01814605|Subgluteal space|subgluteal space
4960086|NCT01814605|Infragluteal space|infragluteal space
4960087|NCT01814592|coronally positioned flap|coronally positioned flap
4960088|NCT01814592|connective tissue|connective tissue
4960089|NCT01814592|gingival margin|gingival margin
4960090|NCT01814592|gingival recession/ treatment|gingival recession/ treatment
4960091|NCT01814592|gingival recession/ surgery|gingival recession/ surgery
4960092|NCT01814592|subepithelial connective tissue graft|subepithelial connective tissue graft
4960093|NCT01814592|randomized controlled clinical trial|randomized controlled clinical trial
4960094|NCT01814592|surgical flaps|surgical flaps
4960095|NCT01814592|Treatment outcome|treatment outcome
4960096|NCT01814579|vaginal|vaginal
4960097|NCT01814579|cuff|cuff
4960098|NCT01814579|robotic|robotic
4960099|NCT01814579|hysterectomy|hysterectomy
4960100|NCT01814579|vloc|vloc
4960101|NCT01814579|v-loc|v-loc
4960102|NCT01814579|vicryl|vicryl
4960103|NCT01814579|unidirectional|unidirectional
4960104|NCT01814579|barbed|barbed
4960105|NCT01814579|suture|suture
4960106|NCT01814527|Fish oil|fish oil
4960107|NCT01814527|Omega 3 Fatty acids|omega 3 fatty acids
4960108|NCT01814527|Docosahexaenoic acid|docosahexaenoic acid
4960109|NCT01814527|Mild Concussion|mild concussion
4960110|NCT01814527|Brain Concussion|brain concussion
4960111|NCT01814527|Cerebral Concussion|cerebral concussion
4960112|NCT01814514|hypertensive|hypertensive
4960113|NCT01814514|phase|phase
4960114|NCT01814514|success rate|success rate
4960116|NCT01814501|Metastatic colon cancer|metastatic colon cancer
4960117|NCT01814488|Active acute leukemia|active acute leukemia
4960118|NCT01814488|PIF|pif
4960119|NCT01814488|Allogeneic transplant|allogeneic transplant
4960120|NCT01814488|Acute Myeloid Leukemia|acute myeloid leukemia
4960121|NCT01814488|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
4960122|NCT01814488|Marrow Unrelated Donor|marrow unrelated donor
4960123|NCT01814488|Cord Blood|cord blood
4960124|NCT01814488|Family Haploidentical donor|family haploidentical donor
4960125|NCT01814475|myelofibrosis|myelofibrosis
4960126|NCT01814475|unfavourable prognostic factors|unfavourable prognostic factors
4960127|NCT01814475|Allogeneic stem cell transplantation|allogeneic stem cell transplantation
4960128|NCT01814475|Progression Free Survival|progression free survival
4960129|NCT01814475|thrombocythemia vera|thrombocythemia vera
4960130|NCT01814475|polycythemia vera|polycythemia vera
4960131|NCT01814475|Reduced-intensity conditioning|reduced-intensity conditioning
4960132|NCT01814462|Obstructive Sleep Apnea|obstructive sleep apnea
4960133|NCT01814462|Pulse wave analysis|pulse wave analysis
4960134|NCT01814449|Breast cancer|breast cancer
4960135|NCT01814449|Hypoxia|hypoxia
4960136|NCT01814449|Hypoxia related gene|hypoxia related gene
4960137|NCT01814449|Endocrine therapy|endocrine therapy
4960138|NCT01814449|Treatment resistance|treatment resistance
4960139|NCT01814423|Plasmodium falciparum|plasmodium falciparum
4960140|NCT01814423|malaria|malaria
4960141|NCT01814423|chloroquine|chloroquine
4960142|NCT01814423|pharmacokinetic|pharmacokinetic
4960143|NCT01814423|children|children
4960144|NCT01814410|Intravenous Ethanol|intravenous ethanol
4960145|NCT01814410|Intravenous Nicotine|intravenous nicotine
4960146|NCT01814410|Interactive effects|interactive effects
4960147|NCT01814410|cognition|cognition
4960148|NCT01814410|subjective effects|subjective effects
4960149|NCT01814410|healthy subjects|healthy subjects
4960150|NCT01814397|Aromatase inhibitor|aromatase inhibitor
4960151|NCT01814397|Pain threshold|pain threshold
4960152|NCT01814384|Ancillary tailored|ancillary tailored
4960153|NCT01814384|medico-economic study,|medico-economic study,
4960154|NCT01814384|total knee replacement|total knee replacement
4960155|NCT01814384|primary or secondary osteoarthritis|primary or secondary osteoarthritis
4960156|NCT01814371|Abscesses|abscesses
4960157|NCT01814371|Furunculosis|furunculosis
4960158|NCT01814371|Staphylococcus aureus colonization|staphylococcus aureus colonization
4960159|NCT01814371|Staphylococcal Skin Infection|staphylococcal skin infection
4960160|NCT01814371|MRSA|mrsa
4960161|NCT01814345|Her2 testing (Human Epidermal Growth Factor Receptor 2)|her2 testing (human epidermal growth factor receptor 2)
4960162|NCT01814332|Stress disorders, Post-traumatic|stress disorders, post-traumatic
4960163|NCT01814332|Sleep|sleep
4960164|NCT01814319|heart failure|heart failure
4960165|NCT01814319|ejection fraction equal or less than 40%|ejection fraction equal or less than 40%
4960166|NCT01814306|LMA Supreme,LMA Proseal,airway management,prone position|lma supreme,lma proseal,airway management,prone position
4960167|NCT01814293|Pediatric|pediatric
4960168|NCT01814293|Upper Respiratory infection|upper respiratory infection
4960169|NCT01814293|Over the Counter Drugs|over the counter drugs
4960170|NCT01814293|Drugs, Non-Prescription|drugs, non-prescription
4960171|NCT01814293|Vaporizer|vaporizer
4960172|NCT01814280|Medication errors|medication errors
4960173|NCT01814280|Medication review|medication review
4960174|NCT01814280|Risk stratification|risk stratification
4960175|NCT01814280|Patient safety|patient safety
4960176|NCT01814267|innovative care|innovative care
4960177|NCT01814267|telemedicine|telemedicine
4960178|NCT01814267|cost effectiveness|cost effectiveness
4960179|NCT01814267|diabetes|diabetes
4960180|NCT01814241|Peanut allergy|peanut allergy
4960181|NCT01814215|Obesity|obesity
4960182|NCT01814215|Prevention and Control|prevention and control
4960183|NCT01814215|Diet|diet
4960184|NCT01814215|Motor Activity|motor activity
4960185|NCT01814215|Intervention Studies|intervention studies
4960186|NCT01814215|Child, Preschool|child, preschool
4960187|NCT01814215|Child Care|child care
4960188|NCT01814215|Food Habits|food habits
4960189|NCT01814215|Feeding Behavior|feeding behavior
4960190|NCT01814215|Child Behavior|child behavior
4961879|NCT01806064|TRC105|trc105
4960191|NCT01814163|First line treatment|first line treatment
4960192|NCT01814163|Non small cell lung cancer, non squamous|non small cell lung cancer, non squamous
4960193|NCT01814150|Docetaxel|docetaxel
4960194|NCT01814150|Alpha 1 Acid Glycoprotein|alpha 1 acid glycoprotein
4960195|NCT01814150|Outcome|outcome
4960196|NCT01814111|Hypertension|hypertension
4960197|NCT01814111|Atrial Fibrillation|atrial fibrillation
4960198|NCT01814111|Arrhythmias, Cardiac|arrhythmias, cardiac
4960199|NCT01814111|Heart Diseases|heart diseases
4960200|NCT01814111|Cardiovascular Diseases|cardiovascular diseases
4960201|NCT01814098|Depressive Disorder, Major|depressive disorder, major
4960202|NCT01814098|Escitalopram|escitalopram
4960203|NCT01814098|Lexapro|lexapro
4960204|NCT01814085|Major Depressive Disorder|major depressive disorder
4960205|NCT01814085|Escitalopram|escitalopram
4960206|NCT01814085|Lexapro|lexapro
4960207|NCT01814059|Sirolimus|sirolimus
4960208|NCT01814059|Eosinophilic Esophagitis|eosinophilic esophagitis
4960209|NCT01814059|Eosinophilic Gastroenteritis|eosinophilic gastroenteritis
4960210|NCT01814059|T -Cells|t -cells
4960211|NCT01814059|Food Allergy|food allergy
4960212|NCT01814046|Metastatic|metastatic
4960213|NCT01814046|Ocular Melanoma|ocular melanoma
4960214|NCT01814046|Autologous Tumor-Infiltrating Lymphocytes|autologous tumor-infiltrating lymphocytes
4960215|NCT01814046|Uveal Melanoma|uveal melanoma
4960216|NCT01814046|Adoptive Cell Therapy|adoptive cell therapy
4960217|NCT01814033|LRU|lru
4960218|NCT01814033|Total Knee Arthroplasty|total knee arthroplasty
4960219|NCT01814033|Total Knee Replacement|total knee replacement
4960220|NCT01814033|Acute Rehabilitation Total Knee|acute rehabilitation total knee
4960221|NCT01814033|Total Knee Range of Motion|total knee range of motion
4960222|NCT01814033|Total Knee Acute care Outcomes|total knee acute care outcomes
4960223|NCT01814020|DSO|dso
4960224|NCT01814007|Lipolysis|lipolysis
4960225|NCT01814007|Cryolipolysis|cryolipolysis
4960226|NCT01814007|Fat Reduction|fat reduction
4960227|NCT01813994|Statin; Gastric inflammation; Gastric cancer|statin; gastric inflammation; gastric cancer
4960228|NCT01813968|Ischemic postconditioning|ischemic postconditioning
4960229|NCT01813968|Adult cardiac surgery|adult cardiac surgery
4960230|NCT01813968|Aortic valve surgery|aortic valve surgery
4960231|NCT01813968|Swan-Ganz|swan-ganz
4960232|NCT01813968|Cardiac index|cardiac index
4960233|NCT01813955|phosphodiesterase inhibitor|phosphodiesterase inhibitor
4960234|NCT01813955|Psychophysiology|psychophysiology
4960235|NCT01813955|Cognition|cognition
4960236|NCT01813955|Schizophrenia|schizophrenia
4960237|NCT01813955|Papaverine|papaverine
4960238|NCT01813942|clinical narrative report|clinical narrative report
4960239|NCT01813942|time series data|time series data
4960240|NCT01813942|missing value|missing value
4960241|NCT01813929|Diabetes|diabetes
4960242|NCT01813929|Insulin|insulin
4960243|NCT01813929|Metformin|metformin
4960244|NCT01813929|Vascular|vascular
4960245|NCT01813929|Vessels|vessels
4960246|NCT01813929|Type 1|type 1
4960247|NCT01813916|Osteoarthritis|osteoarthritis
4960248|NCT01813916|synovial fluid|synovial fluid
4960249|NCT01813916|hyaluronic acid|hyaluronic acid
4960250|NCT01813890|Bunionectomy|bunionectomy
4960251|NCT01813890|Acute pain|acute pain
4960252|NCT01813890|Post-operative pain|post-operative pain
4960253|NCT01813890|Tapentadol IR|tapentadol ir
4960254|NCT01813890|Analgesia|analgesia
4960255|NCT01813890|Hallux valgus|hallux valgus
4960256|NCT01813864|treatment planning|treatment planning
4960257|NCT01813864|resource guide|resource guide
4960258|NCT01813864|service matching|service matching
4960259|NCT01813864|Service matching for substance abuse clients|service matching for substance abuse clients
4960260|NCT01813864|CASPAR resource guide|caspar resource guide
4960261|NCT01813864|Improved treatment planning|improved treatment planning
4960262|NCT01813851|Dialysis, Exercise, Protein Energy Wasting, Nutrition and Physical Fitness|dialysis, exercise, protein energy wasting, nutrition and physical fitness
4960263|NCT01813825|Mammosite|mammosite
4960264|NCT01813799|Diabetic Neuropathies|diabetic neuropathies
4960265|NCT01813734|RET gene mutation|ret gene mutation
4960266|NCT01813721|NHL|nhl
4960267|NCT01813721|Breast Cancer|breast cancer
4960268|NCT01813721|Lung Cancer|lung cancer
4960269|NCT01813708|Type 2 Diabetes|type 2 diabetes
4960270|NCT01813708|Intensive Life-Style|intensive life-style
4960271|NCT01813708|Collaborative Education|collaborative education
4960272|NCT01813708|Clinical Trial|clinical trial
4960273|NCT01813708|Metabolic Control|metabolic control
4960274|NCT01813695|Preemptive genetic testing|preemptive genetic testing
4960275|NCT01813695|Pain|pain
4960276|NCT01813695|Pediatrics|pediatrics
4960277|NCT01813695|Orthopedics|orthopedics
4960278|NCT01813695|Pectus excavatum|pectus excavatum
4960279|NCT01813695|Scoliosis|scoliosis
4960280|NCT01813682|preterm infant|preterm infant
4960281|NCT01813682|anemia|anemia
4960282|NCT01813682|iron fortified TPN|iron fortified tpn
4960283|NCT01813669|Childhood anxiety|childhood anxiety
4960284|NCT01813669|Pediatric Pain|pediatric pain
4960285|NCT01813669|Yoga|yoga
4960286|NCT01813669|Cognitive behavioral therapy|cognitive behavioral therapy
4960287|NCT01813656|Methamphetamine-Associated Psychosis|methamphetamine-associated psychosis
4960288|NCT01813656|Aripiprazole|aripiprazole
4960289|NCT01813643|Methamphetamine-Associated Psychosis|methamphetamine-associated psychosis
4960290|NCT01813643|Aripiprazole|aripiprazole
4960291|NCT01813643|Risperidone|risperidone
4960292|NCT01813630|Turner's Syndrome|turner's syndrome
4960293|NCT01813630|Short Stature|short stature
4960294|NCT01813630|Dwarfism|dwarfism
4960295|NCT01813617|Polymyositis|polymyositis
4960296|NCT01813617|Dermatomyositis|dermatomyositis
4960297|NCT01813617|Muscle endurance|muscle endurance
4960298|NCT01813617|Muscle stength|muscle stength
4960299|NCT01813617|Outcome|outcome
4960300|NCT01813604|Polio|polio
4960301|NCT01813604|Inactivated polio vaccine|inactivated polio vaccine
4960302|NCT01813604|oral polio vaccine|oral polio vaccine
4960303|NCT01813604|vaccine trial|vaccine trial
4960304|NCT01813591|Chronic Migraine|chronic migraine
4960305|NCT01813591|Headache|headache
4960306|NCT01813591|Refractory Chronic Migraine|refractory chronic migraine
4960307|NCT01813578|Systemic sclerosis|systemic sclerosis
4960308|NCT01813578|Exercise|exercise
4960309|NCT01813578|Physical capacity|physical capacity
4960310|NCT01813578|Aerobic capacity|aerobic capacity
4960311|NCT01813578|Muscle function|muscle function
4960312|NCT01813578|Fatigue|fatigue
4960313|NCT01813552|HCV|hcv
4960314|NCT01813552|Hepatitis C|hepatitis c
4960315|NCT01813552|antiviral drugs|antiviral drugs
4960316|NCT01813552|liver|liver
4960317|NCT01813539|malignancy|malignancy
4960318|NCT01813513|HCV|hcv
4960319|NCT01813513|Hepatitis C Virus|hepatitis c virus
4960320|NCT01813513|Hepatitis C|hepatitis c
4960321|NCT01813513|antiviral drugs|antiviral drugs
4960322|NCT01813513|liver|liver
4960323|NCT01813474|Cancer|cancer
4960324|NCT01813474|Tumour|tumour
4960325|NCT01813474|Solid Malignancies|solid malignancies
4960326|NCT01813461|BAL8557|bal8557
4960327|NCT01813461|14C-labeled isavuconazole|14c-labeled isavuconazole
4960328|NCT01813461|14C-labeled prodrug isavuconazonium sulfate (BAL8557)/([cyano-14C]ASP9766 sulfate)|14c-labeled prodrug isavuconazonium sulfate (bal8557)/([cyano-14c]asp9766 sulfate)
4960329|NCT01813448|Fidaxomicin|fidaxomicin
4960330|NCT01813448|OPT-80|opt-80
4960331|NCT01813448|Healthy Subjects|healthy subjects
4960332|NCT01813435|CAD|cad
4960333|NCT01813435|ACS|acs
4960334|NCT01813435|All comers|all comers
4960335|NCT01813435|DAPT|dapt
4960336|NCT01813435|PCI|pci
4960337|NCT01813422|Cholesterol|cholesterol
4960338|NCT01813422|High Cholesterol|high cholesterol
4960339|NCT01813422|Elevated Cholesterol|elevated cholesterol
4960340|NCT01813422|Raised Cholesterol|raised cholesterol
4960341|NCT01813396|shoulder|shoulder
4960342|NCT01813396|muscle stiffness|muscle stiffness
4960343|NCT01813396|shoulder physical activity|shoulder physical activity
4960344|NCT01813396|range of motion|range of motion
4960345|NCT01813396|joint mobility|joint mobility
4960346|NCT01813383|Celiac disease|celiac disease
4960347|NCT01813383|HLA-DQ2.2|hla-dq2.2
4960348|NCT01813383|HLA-DQ2.5|hla-dq2.5
4960349|NCT01813383|HLA-DR7-DQ2|hla-dr7-dq2
4960350|NCT01813383|HLA-DR3-DQ2|hla-dr3-dq2
4960351|NCT01813370|TAX 3503|tax 3503
4960352|NCT01813370|MSKCC IRB#07-101|mskcc irb#07-101
4960353|NCT01813370|12-225|12-225
4960354|NCT01813357|HIV|hiv
4960355|NCT01813357|Cardiovascular disease|cardiovascular disease
4960356|NCT01813357|Inflammation|inflammation
4960357|NCT01813357|Statin|statin
4960358|NCT01813344|Adult lymphoblastic lymphoma|adult lymphoblastic lymphoma
4960359|NCT01813344|Hyper-CVAD|hyper-cvad
4960360|NCT01813344|first-line treatment|first-line treatment
4960361|NCT01813305|Diabetic Foot Ulcer|diabetic foot ulcer
4960362|NCT01813305|Diabetes Mellitus|diabetes mellitus
4960363|NCT01813305|Debridement|debridement
4960364|NCT01813305|Standard of Care|standard of care
4960365|NCT01813305|wounds|wounds
4960366|NCT01813292|male patients|male patients
4960367|NCT01813292|treated by TRUVADA® or VIREAD® for more than 60 months|treated by truvada® or viread® for more than 60 months
4960368|NCT01813253|epidermal growth factor receptor|epidermal growth factor receptor
4960369|NCT01813253|second line|second line
4960370|NCT01813214|melanoma|melanoma
4960371|NCT01813214|vemurafenib|vemurafenib
4960372|NCT01813214|cobitmetinib|cobitmetinib
4960373|NCT01813201|Testosterone|testosterone
4960374|NCT01813201|Anabolic deterioration|anabolic deterioration
4960375|NCT01813188|Fractures|fractures
4960376|NCT01813188|Bone|bone
4960377|NCT01813188|Stem Cells|stem cells
4960378|NCT01813149|Complex Regional Pain Syndrome (CRPS)|complex regional pain syndrome (crps)
4960379|NCT01813136|radioiodine refractory Differentiated Thyroid Carcinoma|radioiodine refractory differentiated thyroid carcinoma
4960380|NCT01813136|pazopanib|pazopanib
4960381|NCT01813136|intermittent administration|intermittent administration
4960382|NCT01813136|time to treatment failure|time to treatment failure
4960383|NCT01813136|TUTHYREF|tuthyref
4960384|NCT01813123|gender-specific|gender-specific
4960385|NCT01813123|web-based|web-based
4960386|NCT01813123|drug abuse|drug abuse
4960387|NCT01813123|prevention|prevention
4960388|NCT01813110|inflammation|inflammation
4960389|NCT01813110|omega-3|omega-3
4960390|NCT01813110|fish oil|fish oil
4960482|NCT01812759|Fentanyl nasal spray|fentanyl nasal spray
4960483|NCT01812759|Lazanda|lazanda
4960391|NCT01813097|To detective the effect of the treatment of combination iodine 125 seed implants and LHRH agonists for the patients with locally advanced prostate cancer.|to detective the effect of the treatment of combination iodine 125 seed implants and lhrh agonists for the patients with locally advanced prostate cancer.
4960392|NCT01813071|Enterobacteriaceae Infections|enterobacteriaceae infections
4960393|NCT01813071|Gram-Negative Bacterial Infections|gram-negative bacterial infections
4960394|NCT01813071|Bacterial Infections|bacterial infections
4960395|NCT01813071|Gastroenteritis|gastroenteritis
4960396|NCT01813071|Gastrointestinal Diseases|gastrointestinal diseases
4960397|NCT01813071|Digestive System Diseases|digestive system diseases
4960398|NCT01813071|Intestinal Diseases|intestinal diseases
4960399|NCT01813071|Shigellosis|shigellosis
4960400|NCT01813058|Tranexamic acid, Blood loss|tranexamic acid, blood loss
4960401|NCT01813045|Angiogenesis|angiogenesis
4960402|NCT01813045|Fibrosis|fibrosis
4960403|NCT01813045|Myocardial Infarction|myocardial infarction
4960404|NCT01813045|Imaging|imaging
4960405|NCT01813045|CT-PET|ct-pet
4960406|NCT01813045|PET-CT|pet-ct
4960407|NCT01813045|Cardiac MRI|cardiac mri
4960408|NCT01813032|firefighters|firefighters
4960409|NCT01813032|police officers|police officers
4960410|NCT01813032|emergency service professionals|emergency service professionals
4960411|NCT01813032|myocardial infarction|myocardial infarction
4960412|NCT01813032|endothelial function|endothelial function
4960413|NCT01813032|thrombosis|thrombosis
4960414|NCT01813019|Obsessive compulsive disorder (OCD), obsessive fears, obsessions,|obsessive compulsive disorder (ocd), obsessive fears, obsessions,
4960415|NCT01813019|compulsions, OCD SSRI resistant|compulsions, ocd ssri resistant
4960416|NCT01812993|Ischemic stroke, sleep apnea, non-invasive ventilatory treatment|ischemic stroke, sleep apnea, non-invasive ventilatory treatment
4960417|NCT01812980|Influenza|influenza
4960418|NCT01812980|Human Immunodeficiency Virus|human immunodeficiency virus
4960419|NCT01812954|moderate-to-severe psoriasis|moderate-to-severe psoriasis
4960420|NCT01812954|cost utility analysis|cost utility analysis
4960421|NCT01812954|cost effectiveness analysis|cost effectiveness analysis
4960422|NCT01812954|systemic treatment|systemic treatment
4960423|NCT01812941|burns|burns
4960424|NCT01812941|trauma|trauma
4960425|NCT01812928|Flexible Cystoscopy|flexible cystoscopy
4960426|NCT01812928|Pain control|pain control
4960427|NCT01812928|Diclofenac|diclofenac
4960428|NCT01812928|Non steroidal anti inflammatory drug|non steroidal anti inflammatory drug
4960429|NCT01812915|Cuff pressure|cuff pressure
4960430|NCT01812915|Cylindrical cuff|cylindrical cuff
4960431|NCT01812915|Endotracheal tube|endotracheal tube
4960432|NCT01812915|Nitrous oxide|nitrous oxide
4960433|NCT01812915|Tapered cuff|tapered cuff
4960434|NCT01812902|Prostate cancer|prostate cancer
4960435|NCT01812902|Prostate specific antigen|prostate specific antigen
4960436|NCT01812902|lymphadenectomy|lymphadenectomy
4960437|NCT01812902|Limited lymphadenectomy|limited lymphadenectomy
4960438|NCT01812902|Extended lymphadenectomy|extended lymphadenectomy
4960439|NCT01812902|Immunohistochemistry|immunohistochemistry
4960440|NCT01812889|bacterial vaginosis, vulvovaginal candidiasis, TOL-463, intravaginal therapy, vaginitis, women, cross-over|bacterial vaginosis, vulvovaginal candidiasis, tol-463, intravaginal therapy, vaginitis, women, cross-over
4960441|NCT01812863|Pain Management|pain management
4960442|NCT01812863|Child|child
4960443|NCT01812863|Surgery|surgery
4960444|NCT01812850|Temporomandibular joint|temporomandibular joint
4960445|NCT01812850|Orofacial muscular complex|orofacial muscular complex
4960446|NCT01812850|Bruxism|bruxism
4960447|NCT01812850|Clenching|clenching
4960448|NCT01812850|Orthodontic treatment|orthodontic treatment
4960449|NCT01812850|Invisalign®|invisalign®
4960450|NCT01812837|actinic keratosis|actinic keratosis
4960451|NCT01812837|microneedles|microneedles
4960452|NCT01812837|photodynamic therapy|photodynamic therapy
4960453|NCT01812837|levulan|levulan
4960454|NCT01812837|Aminolevulinic acid|aminolevulinic acid
4960455|NCT01812824|Preconception Health|preconception health
4960456|NCT01812824|Health Information Technology|health information technology
4960457|NCT01812824|Reproductive Life Plan|reproductive life plan
4960458|NCT01812824|Healthcare Disparities|healthcare disparities
4960459|NCT01812824|Low birth-weight|low birth-weight
4960460|NCT01812824|Preterm Delivery|preterm delivery
4960461|NCT01812811|pulse wave analysis|pulse wave analysis
4960462|NCT01812811|pulse wave velocity|pulse wave velocity
4960463|NCT01812811|Arteriograph24|arteriograph24
4960464|NCT01812811|Ambulatory|ambulatory
4960465|NCT01812811|diabetes|diabetes
4960466|NCT01812811|reproducibility|reproducibility
4960467|NCT01812811|diurnal variation|diurnal variation
4960468|NCT01812798|Peanut allergy|peanut allergy
4960469|NCT01812798|Threshold|threshold
4960470|NCT01812798|Modelling|modelling
4960471|NCT01812798|Risk assessment|risk assessment
4960472|NCT01812785|Fever|fever
4960473|NCT01812785|Children|children
4960474|NCT01812785|Non-malaria fevers|non-malaria fevers
4960475|NCT01812785|Diagnosis|diagnosis
4960476|NCT01812772|urinary stents|urinary stents
4960477|NCT01812772|ureteroscopy|ureteroscopy
4960478|NCT01812759|Pain|pain
4960479|NCT01812759|Breakthrough cancer pain|breakthrough cancer pain
4960480|NCT01812759|Emergency Department|emergency department
4960481|NCT01812759|ED|ed
4961088|NCT01809899|Abuse|abuse
4960484|NCT01812759|Placebo nasal spray|placebo nasal spray
4960485|NCT01812759|Hydromorphone PCA|hydromorphone pca
4960486|NCT01812759|Dilaudid|dilaudid
4960487|NCT01812694|Pregnancy|pregnancy
4960488|NCT01812694|Weight Control|weight control
4960489|NCT01812694|Weight Gain|weight gain
4960490|NCT01812681|vitamin D, Respiratory distress syndrome, sepsis, preterm|vitamin d, respiratory distress syndrome, sepsis, preterm
4960491|NCT01812655|pain|pain
4960492|NCT01812655|anxiety|anxiety
4960493|NCT01812655|children|children
4960494|NCT01812655|adolescents|adolescents
4960495|NCT01812655|burn|burn
4960496|NCT01812655|virtual reality|virtual reality
4960497|NCT01812655|distraction|distraction
4960498|NCT01812642|Schizophrenia|schizophrenia
4960499|NCT01812642|JNJ-37822681|jnj-37822681
4960500|NCT01812642|Placebo|placebo
4960501|NCT01812616|Cancer|cancer
4960502|NCT01812616|Safety|safety
4960503|NCT01812603|Cancer|cancer
4960504|NCT01812603|Safety|safety
4960505|NCT01812564|Platelet rich plasma|platelet rich plasma
4960506|NCT01812564|Interventional|interventional
4960507|NCT01812564|Randomized|randomized
4960508|NCT01812564|Double-blind|double-blind
4960509|NCT01812551|cystic fibrosis|cystic fibrosis
4960510|NCT01812551|children|children
4960511|NCT01812551|adolescents|adolescents
4960512|NCT01812551|low bone mass|low bone mass
4960513|NCT01812551|osteoporosis|osteoporosis
4960514|NCT01812551|alendronate|alendronate
4960515|NCT01812551|fractures|fractures
4960516|NCT01812525|Bronchiolitis|bronchiolitis
4960517|NCT01812525|Moderate to Severe|moderate to severe
4960518|NCT01812525|Hypertonic saline|hypertonic saline
4960519|NCT01812525|NaCl 3% inhalations|nacl 3% inhalations
4960520|NCT01812525|Standard therapy|standard therapy
4960521|NCT01812525|Wang score|wang score
4960522|NCT01812525|in-patients|in-patients
4960523|NCT01812512|Heart Failure|heart failure
4960524|NCT01812512|Communication|communication
4960525|NCT01812512|Telemedicine|telemedicine
4960526|NCT01812512|Veterans|veterans
4960527|NCT01812512|Nurse-patient relations|nurse-patient relations
4960528|NCT01812499|blood transfusion|blood transfusion
4960529|NCT01812499|adverse event|adverse event
4960530|NCT01812499|incident reporting|incident reporting
4960531|NCT01812473|protein binding|protein binding
4960532|NCT01812473|voriconazole|voriconazole
4960533|NCT01812473|pediatrics|pediatrics
4960534|NCT01812473|hematology|hematology
4960535|NCT01812473|intensive care|intensive care
4960536|NCT01812473|albumin|albumin
4960537|NCT01812473|alpha-1-acid-glycoprotein|alpha-1-acid-glycoprotein
4960538|NCT01812460|COPD|copd
4960539|NCT01812460|muscle strength|muscle strength
4960540|NCT01812460|resistance training|resistance training
4960541|NCT01812460|Physiotherapi|physiotherapi
4960542|NCT01812460|m. quadriceps|m. quadriceps
4960543|NCT01812460|Acute exacerbation|acute exacerbation
4960544|NCT01812447|Endobronchial Valves|endobronchial valves
4960545|NCT01812447|Intrabronchial Valves|intrabronchial valves
4960546|NCT01812447|Bronchial Valve|bronchial valve
4960547|NCT01812447|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
4960548|NCT01812447|COPD|copd
4960549|NCT01812447|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
4960550|NCT01812447|Bronchoscopic Lung Volume Reduction|bronchoscopic lung volume reduction
4960551|NCT01812447|BLVR|blvr
4960552|NCT01812447|TLVR|tlvr
4960553|NCT01812447|Emphysema|emphysema
4960554|NCT01812447|Pulmonary Emphysema|pulmonary emphysema
4960555|NCT01812447|Pathologic Process|pathologic process
4960556|NCT01812447|Lung Diseases|lung diseases
4960557|NCT01812447|Respiratory Tract Disease|respiratory tract disease
4960558|NCT01812395|thyroidectomy|thyroidectomy
4960559|NCT01812395|ultrasonic dissector|ultrasonic dissector
4960560|NCT01812395|harmonic focus device|harmonic focus device
4960561|NCT01812395|superior laryngeal nerve|superior laryngeal nerve
4960562|NCT01812382|Penetration|penetration
4960563|NCT01812382|Antibiotic|antibiotic
4960564|NCT01812382|Microdialysis|microdialysis
4960565|NCT01812382|Formulation Pharmacokinetics|formulation pharmacokinetics
4960566|NCT01812382|Feasibility|feasibility
4960567|NCT01812356|Atrial fibrillation|atrial fibrillation
4960568|NCT01812356|maze operation|maze operation
4960569|NCT01812356|cryoablation|cryoablation
4960570|NCT01812343|Ankle Brachial Index|ankle brachial index
4960571|NCT01812343|Maximal Exercise Test|maximal exercise test
4960572|NCT01812330|ACS|acs
4960573|NCT01812330|CR|cr
4960574|NCT01812330|PCI|pci
4960575|NCT01812330|Platelet funtion|platelet funtion
4960576|NCT01812330|Ticagrelor|ticagrelor
4960577|NCT01812317|firefighters|firefighters
4960578|NCT01812317|fire-simulation training|fire-simulation training
4960579|NCT01812317|myocardial infarction|myocardial infarction
4960580|NCT01812317|endothelial function|endothelial function
4960581|NCT01812317|thrombosis|thrombosis
4960582|NCT01812291|Major Depression|major depression
4960583|NCT01812291|Minor Depression|minor depression
4960584|NCT01812291|Sub-Threshold Depression|sub-threshold depression
4960585|NCT01812291|Affective Condition|affective condition
4960586|NCT01812291|Mood Disorder|mood disorder
4960587|NCT01812291|Light Affective Disorder|light affective disorder
4960588|NCT01812291|Subclinical Depressive Symptoms|subclinical depressive symptoms
4960589|NCT01812291|Diabetes Mellitus|diabetes mellitus
4960590|NCT01812291|Diabetes-Related Distress|diabetes-related distress
4960591|NCT01812291|Self-Care Behaviour|self-care behaviour
4960592|NCT01812291|Glycaemic Control|glycaemic control
4960593|NCT01812291|Inflammatory Markers|inflammatory markers
4960594|NCT01812252|myelodysplastic syndrome|myelodysplastic syndrome
4960595|NCT01812252|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
4960596|NCT01812252|bone marrow transplant|bone marrow transplant
4960597|NCT01812252|hypomethylating agent|hypomethylating agent
4960598|NCT01812252|induction chemotherapy|induction chemotherapy
4960599|NCT01812239|premature birth|premature birth
4960600|NCT01812239|twins|twins
4960601|NCT01812239|short cervix|short cervix
4960602|NCT01812213|Mild Cognitive Impairment|mild cognitive impairment
4960603|NCT01812187|Alcohol|alcohol
4960604|NCT01812187|Alcohol Abuse|alcohol abuse
4960605|NCT01812187|Alcohol Dependence|alcohol dependence
4960606|NCT01812187|Veterans|veterans
4960607|NCT01812174|heart valve|heart valve
4960608|NCT01812161|Electro-acupuncture|electro-acupuncture
4960609|NCT01812161|HCG stimulation test|hcg stimulation test
4960610|NCT01812161|Menstrual frequency|menstrual frequency
4960611|NCT01812161|polycystic ovary syndrome|polycystic ovary syndrome
4960612|NCT01812161|Randomized|randomized
4960613|NCT01812161|controlled|controlled
4960614|NCT01812161|trial|trial
4960615|NCT01812148|Peritoneal Mesotheliomas|peritoneal mesotheliomas
4960616|NCT01812148|hyperthermic intra-peritoneal chemotherapy (HIPEC)|hyperthermic intra-peritoneal chemotherapy (hipec)
4960617|NCT01812148|Oxaliplatin|oxaliplatin
4960618|NCT01812148|Cytoreductive surgery|cytoreductive surgery
4960619|NCT01812148|Oxaliplatin HIPEC|oxaliplatin hipec
4960620|NCT01812109|Acute Scrotum|acute scrotum
4960621|NCT01812109|Testicular Torsion|testicular torsion
4960622|NCT01812096|multiple myeloma|multiple myeloma
4960623|NCT01812096|bortezomib|bortezomib
4960624|NCT01812096|Subcutaneous|subcutaneous
4960625|NCT01812083|Periodontitis; adverse pregnancy outcomes; IL-1 polymorphism|periodontitis; adverse pregnancy outcomes; il-1 polymorphism
4960626|NCT01812070|smoking cessation|smoking cessation
4960627|NCT01812070|quit smoking|quit smoking
4960628|NCT01812057|Anesthesia|anesthesia
4960629|NCT01812057|Cesarean Section|cesarean section
4960630|NCT01812057|Pain, Postoperative|pain, postoperative
4960631|NCT01812057|Postoperative Nausea and Vomiting|postoperative nausea and vomiting
4960632|NCT01812057|Dexamethasone|dexamethasone
4960633|NCT01812057|Injections, Spinal|injections, spinal
4960634|NCT01812057|morphine|morphine
4960635|NCT01812031|PET/CT|pet/ct
4960636|NCT01812031|18F-fluoro-2-deoxyglucose|18f-fluoro-2-deoxyglucose
4960637|NCT01812031|lung neoplasms|lung neoplasms
4960638|NCT01812031|respiratory motion|respiratory motion
4960639|NCT01812018|Soft Tissue Sarcoma|soft tissue sarcoma
4960640|NCT01812018|Pulmonary metastases|pulmonary metastases
4960641|NCT01812005|MLN8237|mln8237
4960642|NCT01812005|B-cell Non Hodgkin Lymphoma|b-cell non hodgkin lymphoma
4960643|NCT01812005|Rituximab|rituximab
4960644|NCT01811979|eye examination, oral sucrose, premature infant pain scale|eye examination, oral sucrose, premature infant pain scale
4960645|NCT01811966|preoperative volume substitution|preoperative volume substitution
4960646|NCT01811966|hypovolemia|hypovolemia
4960647|NCT01811966|preoperative fasting|preoperative fasting
4960648|NCT01811940|cocaine dependence|cocaine dependence
4960649|NCT01811940|adderall|adderall
4960650|NCT01811940|topiramate|topiramate
4960651|NCT01811914|focused TTE|focused tte
4960652|NCT01811914|intraoperative TTE|intraoperative tte
4960653|NCT01811914|transthoracic echocardiography|transthoracic echocardiography
4960654|NCT01811914|high risk non-cardiac surgery|high risk non-cardiac surgery
4960655|NCT01811914|hemodynamic instabilities|hemodynamic instabilities
4960656|NCT01811901|inhospital delays, door-to-needle time, thrombolysis, acute ischemic stroke, SITS, SITS-WATCH, stroke registry|inhospital delays, door-to-needle time, thrombolysis, acute ischemic stroke, sits, sits-watch, stroke registry
4960657|NCT01811875|Haemophilia A|haemophilia a
4960658|NCT01811862|Acupuncture|acupuncture
4960659|NCT01811862|Hematopoietic stem cell transplantation (HSCT)|hematopoietic stem cell transplantation (hsct)
4960660|NCT01811862|13-038|13-038
4960661|NCT01811849|diabetes|diabetes
4960662|NCT01811823|Tuberculosis|tuberculosis
4960663|NCT01811823|HIV infection|hiv infection
4960664|NCT01811823|Immune responses to Influenza vaccination|immune responses to influenza vaccination
4960665|NCT01811810|Men under the age of 75 with histologically confirmed high risk|men under the age of 75 with histologically confirmed high risk
4960666|NCT01811797|Erectile Dysfunction|erectile dysfunction
4960667|NCT01811797|Extracorporeal shockwave|extracorporeal shockwave
4960668|NCT01811797|Low intensity shockwaves|low intensity shockwaves
4960669|NCT01811784|Nipah virus infection|nipah virus infection
4960670|NCT01811784|date palm sap|date palm sap
4960671|NCT01811784|community intervention|community intervention
4960672|NCT01811784|capacity building|capacity building
4960673|NCT01811784|disease prevention|disease prevention
4960674|NCT01811784|Bangladesh|bangladesh
4960675|NCT01811784|Healthy Community people|healthy community people
4960676|NCT01811784|Sap harvesters|sap harvesters
4960677|NCT01811784|Date palm three owners|date palm three owners
4961290|NCT01808885|olesoxime|olesoxime
4960678|NCT01811784|Date palm sap consumers|date palm sap consumers
4960679|NCT01811758|Culturally Specific Cognitive Behavioral Therapy|culturally specific cognitive behavioral therapy
4960680|NCT01811758|Standard Cognitive Behavioral Therapy|standard cognitive behavioral therapy
4960681|NCT01811745|Aged|aged
4960682|NCT01811745|Cognition|cognition
4960683|NCT01811745|Exercise|exercise
4960684|NCT01811745|Falls|falls
4960685|NCT01811745|Gait|gait
4960686|NCT01811745|Physical function|physical function
4960687|NCT01811745|Dual-task|dual-task
4960688|NCT01811745|Music|music
4960689|NCT01811745|Postural Balance|postural balance
4960690|NCT01811745|Randomized controlled trial|randomized controlled trial
4960691|NCT01811732|Bacterial skin infection|bacterial skin infection
4960692|NCT01811732|skin infection|skin infection
4960693|NCT01811732|infection|infection
4960694|NCT01811732|skin|skin
4960695|NCT01811732|delafloxacin|delafloxacin
4960696|NCT01811732|vancomycin|vancomycin
4960697|NCT01811732|aztreonam|aztreonam
4960698|NCT01811732|MRSA bacteria|mrsa bacteria
4960699|NCT01811732|bacterial infection|bacterial infection
4960700|NCT01811732|Anti-Infective Agents|anti-infective agents
4960701|NCT01811732|Anti-Bacterial Agents|anti-bacterial agents
4960702|NCT01811719|Intimate Partner Physical Violence|intimate partner physical violence
4960703|NCT01811719|Intimate Partner Emotional Abuse|intimate partner emotional abuse
4960704|NCT01811719|Intimate Partner Controlling Behaivor|intimate partner controlling behaivor
4960705|NCT01811719|Pregnancy Outcomes|pregnancy outcomes
4960706|NCT01811719|Quality of Parental Care Giving|quality of parental care giving
4960707|NCT01811719|Maternal Life Course|maternal life course
4960708|NCT01811693|Stroke|stroke
4960709|NCT01811693|Intracerebral Hemorrhage|intracerebral hemorrhage
4960710|NCT01811693|Prehospital|prehospital
4960711|NCT01811693|Antihypertensive|antihypertensive
4960712|NCT01811680|Stroke|stroke
4960713|NCT01811680|Hemiplegia|hemiplegia
4960714|NCT01811680|Variable automated treadmill treadmill|variable automated treadmill treadmill
4960715|NCT01811667|Vascular Abnormalities|vascular abnormalities
4960716|NCT01811654|Patellofemoral|patellofemoral
4960717|NCT01811654|Hyaluronan|hyaluronan
4960718|NCT01811654|Intra-articular|intra-articular
4960719|NCT01811654|Hyaluronic acid|hyaluronic acid
4960720|NCT01811641|season of conception|season of conception
4960721|NCT01811641|maternal nutritional status|maternal nutritional status
4960722|NCT01811641|infant DNA methylation|infant dna methylation
4960723|NCT01811628|Cancer Prevention|cancer prevention
4960724|NCT01811628|Tobacco Use Cessation|tobacco use cessation
4960725|NCT01811628|Smokers|smokers
4960726|NCT01811628|Recent quitters|recent quitters
4960727|NCT01811628|Latino|latino
4960728|NCT01811628|Hispanic|hispanic
4960729|NCT01811628|Information|information
4960730|NCT01811628|Interview|interview
4960731|NCT01811628|Questionnaire|questionnaire
4960732|NCT01811628|Survey|survey
4960733|NCT01811628|Audio-recorded|audio-recorded
4960734|NCT01811602|Training|training
4960735|NCT01811602|Physiotherapy|physiotherapy
4960736|NCT01811602|Pelvic floor muscles|pelvic floor muscles
4960737|NCT01811589|ventricular catheter, hydrocephalus, shunt, brain disease|ventricular catheter, hydrocephalus, shunt, brain disease
4960738|NCT01811576|Growth hormone deficiency|growth hormone deficiency
4960739|NCT01811576|Insulin-like growth factor I (IGF-I)|insulin-like growth factor i (igf-i)
4960740|NCT01811576|TV-1106|tv-1106
4960741|NCT01811563|Total Knee Replacement|total knee replacement
4960742|NCT01811563|Lower Quarter Y-Balance Test|lower quarter y-balance test
4960743|NCT01811563|Functional Outcomes|functional outcomes
4960744|NCT01811563|Patient Reported Outcomes|patient reported outcomes
4960745|NCT01811537|Artificial Chordae|artificial chordae
4960746|NCT01811537|Mitral Valve Repair|mitral valve repair
4960747|NCT01811524|Brain tumor|brain tumor
4960748|NCT01811524|Glioma|glioma
4960749|NCT01811524|Meningioma|meningioma
4960750|NCT01811524|Diagnosis|diagnosis
4960751|NCT01811524|Prognosis|prognosis
4960752|NCT01811524|Heredity|heredity
4960753|NCT01811472|Multi-center,|multi-center,
4960754|NCT01811472|randomized,|randomized,
4960755|NCT01811472|double-blind,|double-blind,
4960756|NCT01811472|NAFLD,|nafld,
4960757|NCT01811472|elevated triglycerides|elevated triglycerides
4960758|NCT01811459|Delirium|delirium
4960760|NCT01811459|Burn patients|burn patients
4960761|NCT01811459|Antipsychotics|antipsychotics
4960762|NCT01811459|Haloperidol|haloperidol
4960763|NCT01811459|Quetiapine|quetiapine
4960764|NCT01811433|Postoperative Period|postoperative period
4960765|NCT01811433|Anesthesia Recovery Period|anesthesia recovery period
4960766|NCT01811433|Postoperative Complications|postoperative complications
4960767|NCT01811433|Pulse Oximetry|pulse oximetry
4960768|NCT01811420|dental caries|dental caries
4960769|NCT01811420|caries removal|caries removal
4960770|NCT01811420|chemomechanical caries removal|chemomechanical caries removal
4960771|NCT01811394|sacral chordoma|sacral chordoma
4960772|NCT01811394|chordoma|chordoma
4960773|NCT01811394|carbon ion therapy|carbon ion therapy
4960774|NCT01811394|proton therapy|proton therapy
4960775|NCT01811394|hypofractionation|hypofractionation
4960776|NCT01811381|Alzheimer|alzheimer
4960777|NCT01811381|Prevention|prevention
4960778|NCT01811381|mild cognitive impairment|mild cognitive impairment
4960779|NCT01811381|physical exercise|physical exercise
4960780|NCT01811381|synergism|synergism
4960781|NCT01811381|curcumin|curcumin
4960782|NCT01811381|dietary supplement|dietary supplement
4960783|NCT01811381|anti-inflammatory|anti-inflammatory
4960784|NCT01811381|anti-tau|anti-tau
4960785|NCT01811381|subjective memory complaints without MCI|subjective memory complaints without mci
4960786|NCT01811381|plasma-exosomes|plasma-exosomes
4960787|NCT01811381|plasm- extracellular-derived-vesicles|plasm- extracellular-derived-vesicles
4960788|NCT01811355|Muscle cramps|muscle cramps
4960789|NCT01811355|Cramp|cramp
4960790|NCT01811355|ALS|als
4960791|NCT01811355|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
4960792|NCT01811355|Lou Gehrig's disease|lou gehrig's disease
4960793|NCT01811355|Motor Neuron Disease|motor neuron disease
4960794|NCT01811355|MND|mnd
4960795|NCT01811342|Hemoglobin|hemoglobin
4960796|NCT01811342|Patient Monitoring|patient monitoring
4960797|NCT01811277|palliative chemotherapy|palliative chemotherapy
4960798|NCT01811277|ORR|orr
4960799|NCT01811277|PFS|pfs
4960800|NCT01811277|OS|os
4960801|NCT01811277|safety|safety
4960802|NCT01811277|advanced Biliary Tract Carcinoma|advanced biliary tract carcinoma
4960803|NCT01811264|Metastatic|metastatic
4960804|NCT01811264|Quality of life|quality of life
4960805|NCT01811264|Decision making|decision making
4960806|NCT01811251|Co-analgesia|co-analgesia
4960807|NCT01811251|Dexamethasone|dexamethasone
4960808|NCT01811251|Pregabalin|pregabalin
4960809|NCT01811251|Lumbar slipped disc surgery|lumbar slipped disc surgery
4960810|NCT01811251|Post-operative pain|post-operative pain
4960811|NCT01811238|spinal disorders|spinal disorders
4960812|NCT01811225|Women|women
4960813|NCT01811225|Pregnancy|pregnancy
4960814|NCT01811225|Smoking|smoking
4960815|NCT01811199|Thyroid cancer|thyroid cancer
4960816|NCT01811199|Breast cancer|breast cancer
4960817|NCT01811199|Dexamethasone|dexamethasone
4960818|NCT01811199|Emesis|emesis
4960819|NCT01811186|moderate to severe non-malignant chronic pain|moderate to severe non-malignant chronic pain
4960820|NCT01811173|multimorbidity|multimorbidity
4960821|NCT01811173|primary care|primary care
4960822|NCT01811173|physician - nurse team|physician - nurse team
4960823|NCT01811173|proactive monitoring|proactive monitoring
4960824|NCT01811173|support for self-care|support for self-care
4960825|NCT01811173|primary caregiver|primary caregiver
4960826|NCT01811160|Melatonin|melatonin
4960827|NCT01811160|Second generation antipsychotic|second generation antipsychotic
4960828|NCT01811160|bipolar disorder|bipolar disorder
4960829|NCT01811160|schizophrenia|schizophrenia
4960830|NCT01811160|Metabolic|metabolic
4960831|NCT01811147|Bipolar|bipolar
4960832|NCT01811147|Depression|depression
4960833|NCT01811147|Mania|mania
4960834|NCT01811147|Hypomania|hypomania
4960835|NCT01811147|fMRI|fmri
4960836|NCT01811147|antidepressant|antidepressant
4960837|NCT01811134|endovascular procedure; flow diverter stent|endovascular procedure; flow diverter stent
4960838|NCT01811121|Glioblastoma|glioblastoma
4960839|NCT01811121|5ALA|5ala
4960840|NCT01811121|fluorescence|fluorescence
4960841|NCT01811121|resection|resection
4960842|NCT01811108|mCRC|mcrc
4960843|NCT01811108|KRAS mutation|kras mutation
4960844|NCT01811108|Chemotherapy|chemotherapy
4960845|NCT01811108|Anti-angiogenic agent|anti-angiogenic agent
4960846|NCT01811108|Bevacizumab|bevacizumab
4960847|NCT01811108|1st Line|1st line
4960848|NCT01811095|Robotics|robotics
4960849|NCT01811095|Computer-assisted surgery|computer-assisted surgery
4960850|NCT01811095|Computer simulation|computer simulation
4960851|NCT01811095|Gynecology|gynecology
4960852|NCT01811095|General surgery|general surgery
4960853|NCT01811069|Obese patients|obese patients
4960854|NCT01811069|Upper airway patency|upper airway patency
4960855|NCT01811056|medical abortion|medical abortion
4960856|NCT01811056|mifepristone|mifepristone
4960857|NCT01811043|breast biopsy|breast biopsy
4960858|NCT01811043|anxiety|anxiety
4960859|NCT01810978|congenital heart disease, probiotic, prebiotic|congenital heart disease, probiotic, prebiotic
4960860|NCT01810965|Hemochromatosis type 1|hemochromatosis type 1
4960861|NCT01810952|glucocorticoids|glucocorticoids
4960862|NCT01810952|hyperglycemia|hyperglycemia
4960863|NCT01810952|diabetes mellitus|diabetes mellitus
4960864|NCT01810939|Chronic Kidney Disease|chronic kidney disease
4960865|NCT01810939|Treatment of Hyperkalemia|treatment of hyperkalemia
4960866|NCT01810939|Hyperkalemia|hyperkalemia
4960867|NCT01810926|indication for HSCT|indication for hsct
4960868|NCT01810926|matched related donor|matched related donor
4960869|NCT01810926|MRD|mrd
4960870|NCT01810926|Matched Unrelated Donor|matched unrelated donor
4960871|NCT01810926|MUD|mud
4960872|NCT01810900|anti-adhesive effect and safety, laparoscopic myomectomy|anti-adhesive effect and safety, laparoscopic myomectomy
4960873|NCT01810887|Healthy|healthy
4960874|NCT01810887|Darunavir|darunavir
4960875|NCT01810887|JNS011|jns011
4960876|NCT01810887|Ritonavir|ritonavir
4960877|NCT01810874|extraperitoneal|extraperitoneal
4960878|NCT01810874|transperitoneal|transperitoneal
4960879|NCT01810874|laparoscopic aortic lymphadenectomy|laparoscopic aortic lymphadenectomy
4960880|NCT01810874|endometrial ovarian cancer|endometrial ovarian cancer
4960881|NCT01810874|ovarian cancer|ovarian cancer
4960882|NCT01810874|surgical staging|surgical staging
4960883|NCT01810861|serotype distribution|serotype distribution
4960884|NCT01810861|streptococcus pneumoniae|streptococcus pneumoniae
4960885|NCT01810861|pneumonia|pneumonia
4960886|NCT01810848|Knee Osteoarthritis|knee osteoarthritis
4960887|NCT01810848|Osteoarthritis|osteoarthritis
4960888|NCT01810848|Synvisc|synvisc
4960889|NCT01810848|Hylan G-F 20|hylan g-f 20
4960890|NCT01810848|Exercise|exercise
4960891|NCT01810848|Cardiovascular risk|cardiovascular risk
4960892|NCT01810848|Knee pain|knee pain
4960893|NCT01810848|Pain|pain
4960894|NCT01810835|HBV mother-to-child transmission|hbv mother-to-child transmission
4960895|NCT01810835|women with HBV DNA > 105 I.U./mL|women with hbv dna > 105 i.u./ml
4960896|NCT01810835|France|france
4960897|NCT01810822|oxidative stress|oxidative stress
4960898|NCT01810822|genetic susceptibility|genetic susceptibility
4960899|NCT01810822|GPX4|gpx4
4960900|NCT01810822|NOX2|nox2
4960901|NCT01810809|Osteoarthritis|osteoarthritis
4960902|NCT01810809|Hip|hip
4960903|NCT01810809|Viscosupplementation|viscosupplementation
4960904|NCT01810809|Clinical Trial|clinical trial
4960905|NCT01810770|Radium-223 Dichloride|radium-223 dichloride
4960906|NCT01810770|Prostatic Neoplasms|prostatic neoplasms
4960907|NCT01810770|Bone Metastasis|bone metastasis
4960908|NCT01810731|influenza vaccine immunogenicity|influenza vaccine immunogenicity
4960909|NCT01810731|HIV|hiv
4960910|NCT01810731|pregnancy|pregnancy
4960911|NCT01810731|influenza vaccine safety|influenza vaccine safety
4960912|NCT01810718|cGVHD|cgvhd
4960913|NCT01810718|steroid therapy|steroid therapy
4960914|NCT01810718|Nilotinib|nilotinib
4960915|NCT01810718|cGVHD steroid refractory|cgvhd steroid refractory
4960916|NCT01810718|intolerant to steroid therapy|intolerant to steroid therapy
4960917|NCT01810718|Tasigna|tasigna
4960918|NCT01810718|MTD|mtd
4960919|NCT01810705|myeloid|myeloid
4960920|NCT01810705|leukemia|leukemia
4960921|NCT01810679|aortic valve replacement|aortic valve replacement
4960922|NCT01810679|aortic stenosis|aortic stenosis
4960923|NCT01810679|aortic steno-insufficiency|aortic steno-insufficiency
4960924|NCT01810679|Perceval|perceval
4960925|NCT01810679|Sutureless aortic heart valve|sutureless aortic heart valve
4960926|NCT01810653|Macrogol|macrogol
4960927|NCT01810640|Liver biopsy|liver biopsy
4960928|NCT01810640|organ donation|organ donation
4960929|NCT01810640|donor management|donor management
4960930|NCT01810627|Prostate|prostate
4960931|NCT01810627|Cancer|cancer
4960932|NCT01810614|ADPKD|adpkd
4960933|NCT01810614|PKD|pkd
4960934|NCT01810614|Kidney Disease|kidney disease
4960935|NCT01810614|ADPKD diet|adpkd diet
4960936|NCT01810601|Embryo transfer, transabdominal ultrasound, IVF, ICSI|embryo transfer, transabdominal ultrasound, ivf, icsi
4960937|NCT01810588|Allogeneic transplant|allogeneic transplant
4960938|NCT01810588|Hematologic Malignancies|hematologic malignancies
4960939|NCT01810588|Acute Leukemia|acute leukemia
4960940|NCT01810588|Myeloproliferative disorders|myeloproliferative disorders
4960941|NCT01810588|Lymphoma|lymphoma
4960942|NCT01810588|Myeloma|myeloma
4960943|NCT01810562|Stroke|stroke
4960944|NCT01810562|Tactile|tactile
4960945|NCT01810562|Sensibility|sensibility
4960946|NCT01810562|Stimulation|stimulation
4960947|NCT01810562|Extremities|extremities
4960948|NCT01810562|Arm|arm
4960949|NCT01810562|Leg|leg
4960950|NCT01810549|Fatigue|fatigue
4960951|NCT01810536|Cystic fibrosis|cystic fibrosis
4960952|NCT01810536|oxygen|oxygen
4960953|NCT01810536|respiratory failure|respiratory failure
4960954|NCT01810523|Acute|acute
4960955|NCT01810523|lower|lower
4960956|NCT01810523|extremity|extremity
4960957|NCT01810523|not requiring|not requiring
4960958|NCT01810523|diagnostic|diagnostic
4960959|NCT01810523|imaging|imaging
4960960|NCT01810510|respiration, artificial|respiration, artificial
4960961|NCT01810497|External ear|external ear
4960962|NCT01810497|Ear abnormalities|ear abnormalities
4960963|NCT01810497|External ear cartilages|external ear cartilages
4960964|NCT01810484|Ulthera® System|ulthera® system
4960965|NCT01810484|Ultherapy® Treatment|ultherapy® treatment
4960966|NCT01810484|Ulthera, Inc.|ulthera, inc.
4960967|NCT01810484|Ultrasound treatment for skin|ultrasound treatment for skin
4960968|NCT01810458|Liver|liver
4960969|NCT01810458|Fibrosis|fibrosis
4960970|NCT01810458|Alpha-1|alpha-1
4960971|NCT01810458|AAT|aat
4960972|NCT01810458|AATD|aatd
4960973|NCT01810445|Bladder Cancer|bladder cancer
4960974|NCT01810445|Laser|laser
4960975|NCT01810445|Optical|optical
4960976|NCT01810419|splenomegaly|splenomegaly
4960977|NCT01810419|ultrasound|ultrasound
4960978|NCT01810419|Vscan|vscan
4960979|NCT01810367|PFS|pfs
4960980|NCT01810354|Cefazolin|cefazolin
4960981|NCT01810354|Tissue concentration|tissue concentration
4960982|NCT01810354|infection|infection
4960983|NCT01810354|cesarean section|cesarean section
4960985|NCT01810341|Autism|autism
4960986|NCT01810341|Autism Spectrum Disorders|autism spectrum disorders
4960987|NCT01810341|RNA|rna
4961483|NCT01808131|Gout|gout
4960988|NCT01810341|Gene expression|gene expression
4960989|NCT01810341|Developmental Delay|developmental delay
4960990|NCT01810341|Metabolites|metabolites
4960991|NCT01810341|DNA|dna
4960992|NCT01810302|Vasospasm|vasospasm
4960993|NCT01810302|Subarachnoid hemorrhage|subarachnoid hemorrhage
4960994|NCT01810302|Aneurysmal subarachnoid hemorrhage|aneurysmal subarachnoid hemorrhage
4960995|NCT01810302|Nicardipine|nicardipine
4960996|NCT01810302|Intrathecal|intrathecal
4960997|NCT01810302|SAH|sah
4960998|NCT01810302|aSAH|asah
4960999|NCT01810289|HIV, ART, CD4|hiv, art, cd4
4961000|NCT01810276|traumatic head injury|traumatic head injury
4961001|NCT01810276|intracranial hemorrhage|intracranial hemorrhage
4961002|NCT01810276|platelets|platelets
4961003|NCT01810276|anti-platelet therapy|anti-platelet therapy
4961004|NCT01810276|plavix|plavix
4961005|NCT01810276|asprin|asprin
4961006|NCT01810263|stroke|stroke
4961007|NCT01810263|malnutrition|malnutrition
4961008|NCT01810263|high protein|high protein
4961009|NCT01810211|Shoulder|shoulder
4961010|NCT01810211|Surgery|surgery
4961011|NCT01810211|Posterior Shoulder Tightness|posterior shoulder tightness
4961012|NCT01810211|Flexibility|flexibility
4961013|NCT01810211|Range of Motion|range of motion
4961014|NCT01810198|Coronary Artery Disease|coronary artery disease
4961015|NCT01810198|Cardiac CT|cardiac ct
4961016|NCT01810198|Catheterization|catheterization
4961017|NCT01810185|Inflammatory Bowel Disease|inflammatory bowel disease
4961018|NCT01810185|Crohn's disease|crohn's disease
4961019|NCT01810185|Ulcerative colitis|ulcerative colitis
4961020|NCT01810185|Naltrexone|naltrexone
4961021|NCT01810185|Low Dose Naltrexone|low dose naltrexone
4961022|NCT01810185|Inflammatory Bowel Disease Questionnaire|inflammatory bowel disease questionnaire
4961023|NCT01810172|lobectomy|lobectomy
4961024|NCT01810172|segmentectomy|segmentectomy
4961025|NCT01810172|pneumothorax|pneumothorax
4961026|NCT01810172|pleural|pleural
4961027|NCT01810172|digital|digital
4961028|NCT01810172|air leak|air leak
4961029|NCT01810159|substance use disorders|substance use disorders
4961030|NCT01810159|implementation science|implementation science
4961031|NCT01810159|collaborative care|collaborative care
4961032|NCT01810159|opiate disorders|opiate disorders
4961033|NCT01810159|alcohol disorders|alcohol disorders
4961034|NCT01810146|Patients eligible for bariatric surgery (BMI>40kg/m2)|patients eligible for bariatric surgery (bmi>40kg/m2)
4961035|NCT01810133|Comorbidity|comorbidity
4961036|NCT01810120|Hematologic|hematologic
4961037|NCT01810120|Malignant|malignant
4961038|NCT01810120|Non-Malignant|non-malignant
4961039|NCT01810120|Allogeneic|allogeneic
4961040|NCT01810120|Transplant|transplant
4961041|NCT01810120|Non-Hodgkin Lymphoma|non-hodgkin lymphoma
4961042|NCT01810120|Pediatric|pediatric
4961043|NCT01810120|Acute lymphoblastic leukemia|acute lymphoblastic leukemia
4961044|NCT01810120|Acute Myeloid leukemia|acute myeloid leukemia
4961045|NCT01810120|Myelodysplastic Syndromes|myelodysplastic syndromes
4961046|NCT01810120|T cells receptor alfa beta|t cells receptor alfa beta
4961047|NCT01810094|thoracolumbar fracture|thoracolumbar fracture
4961048|NCT01810094|fixation|fixation
4961049|NCT01810094|fixateur interne|fixateur interne
4961050|NCT01810094|minimal invasive|minimal invasive
4961051|NCT01810094|percutaneous|percutaneous
4961052|NCT01810081|Cholelithiasis|cholelithiasis
4961053|NCT01810081|Gastric H.Pylori infection|gastric h.pylori infection
4961054|NCT01810081|H.Pylori infection|h.pylori infection
4961055|NCT01810081|Gastric mucosa|gastric mucosa
4961056|NCT01810068|BPH- Erectile function- Transurethral- Laser|bph- erectile function- transurethral- laser
4961057|NCT01810042|age-related macular degeneration|age-related macular degeneration
4961058|NCT01810042|choroidal neovascularization|choroidal neovascularization
4961059|NCT01810042|ranibizumab|ranibizumab
4961060|NCT01810042|indocyanine angiography|indocyanine angiography
4961061|NCT01810029|transcendental meditation|transcendental meditation
4961062|NCT01810029|cardiac rehabilitation|cardiac rehabilitation
4961063|NCT01810016|NY-ESO-1|ny-eso-1
4961064|NCT01810016|Metastatic Melanoma|metastatic melanoma
4961065|NCT01810016|Ipilimumab|ipilimumab
4961066|NCT01810016|Phase I|phase i
4961067|NCT01810016|Adjuvant|adjuvant
4961068|NCT01810016|Immunologic|immunologic
4961069|NCT01810016|Vaccination|vaccination
4961070|NCT01810016|Immunotherapy|immunotherapy
4961071|NCT01810016|Neoplasm|neoplasm
4961072|NCT01810003|Cardiovascular disease|cardiovascular disease
4961073|NCT01810003|Inflammation|inflammation
4961074|NCT01810003|EPA/DHA supplementation|epa/dha supplementation
4961075|NCT01809990|cognitive behavior therapy|cognitive behavior therapy
4961076|NCT01809990|pediatric obsessive-compulsive disorder|pediatric obsessive-compulsive disorder
4961077|NCT01809990|internet-delivered cognitive behavior therapy|internet-delivered cognitive behavior therapy
4961078|NCT01809977|Keratoconus|keratoconus
4961079|NCT01809977|remove|remove
4961080|NCT01809977|cornea|cornea
4961081|NCT01809977|visual acuity|visual acuity
4961082|NCT01809938|Gastrointestinal tract emptying|gastrointestinal tract emptying
4961083|NCT01809938|Pre-operative fasting|pre-operative fasting
4961084|NCT01809938|Ultrasound|ultrasound
4961085|NCT01809938|Paracetamol Absorption|paracetamol absorption
4961086|NCT01809912|solid tumor|solid tumor
4961087|NCT01809899|Trauma|trauma
4961089|NCT01809899|Domestic Violence|domestic violence
4961090|NCT01809899|Rape|rape
4961091|NCT01809899|Assault|assault
4961092|NCT01809899|MRI|mri
4961093|NCT01809886|Neuromuscular relaxants|neuromuscular relaxants
4961094|NCT01809886|short-term pediatric surgery|short-term pediatric surgery
4961095|NCT01809886|reverses neuromuscular blockade|reverses neuromuscular blockade
4961096|NCT01809873|Malaria|malaria
4961097|NCT01809873|Diagnostics|diagnostics
4961098|NCT01809873|Health Services|health services
4961099|NCT01809860|isavuconazole|isavuconazole
4961100|NCT01809860|sirolimus|sirolimus
4961101|NCT01809860|BAL8557|bal8557
4961102|NCT01809860|Healthy Volunteers|healthy volunteers
4961103|NCT01809847|CLL|cll
4961104|NCT01809847|Chronic Lymphatic Leukemia|chronic lymphatic leukemia
4961105|NCT01809847|Leukemia|leukemia
4961106|NCT01809847|HLA|hla
4961107|NCT01809847|Histocompatibility|histocompatibility
4961108|NCT01809847|HCT|hct
4961109|NCT01809847|hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
4961110|NCT01809847|Ofatumumab|ofatumumab
4961111|NCT01809847|CD20|cd20
4961112|NCT01809821|Hypertension|hypertension
4961113|NCT01809821|Sleep Disorders|sleep disorders
4961114|NCT01809821|Insomnia|insomnia
4961115|NCT01809821|Cardiovascular Diseases|cardiovascular diseases
4961116|NCT01809821|Internet treatment|internet treatment
4961117|NCT01809808|Acromegaly|acromegaly
4961118|NCT01809808|Pituitary tumor|pituitary tumor
4961119|NCT01809795|Obesity|obesity
4961120|NCT01809795|Exercise|exercise
4961121|NCT01809795|Blueberry Plant|blueberry plant
4961122|NCT01809743|Coronary artery disease|coronary artery disease
4961123|NCT01809743|Regadenoson|regadenoson
4961124|NCT01809743|Adenosine|adenosine
4961125|NCT01809743|Maximal hyperemia|maximal hyperemia
4961126|NCT01809743|Fractional flow reserve|fractional flow reserve
4961127|NCT01809743|FFR|ffr
4961128|NCT01809691|Prostate cancer|prostate cancer
4961129|NCT01809691|TAK-700|tak-700
4961130|NCT01809691|Bicalutamide|bicalutamide
4961131|NCT01809691|S1216|s1216
4961132|NCT01809691|androgen therapy|androgen therapy
4961133|NCT01809691|Phase III|phase iii
4961134|NCT01809678|Smoking|smoking
4961135|NCT01809678|Tobacco|tobacco
4961136|NCT01809678|Yoga|yoga
4961137|NCT01809665|ICD therapy|icd therapy
4961138|NCT01809665|CRT-P therapy|crt-p therapy
4961139|NCT01809665|MRI|mri
4961140|NCT01809652|Pacemaker|pacemaker
4961141|NCT01809652|Defibrillator|defibrillator
4961142|NCT01809652|Remote Consultation|remote consultation
4961143|NCT01809639|Concussion|concussion
4961144|NCT01809613|Parkinson disease|parkinson disease
4961145|NCT01809613|Deep Brain Stimulation|deep brain stimulation
4961146|NCT01809613|Functional Magnetic Resonance Imaging|functional magnetic resonance imaging
4961147|NCT01809574|Interstitial lung disease|interstitial lung disease
4961148|NCT01809574|Idiopathic pulmonary fibrosis|idiopathic pulmonary fibrosis
4961149|NCT01809574|Connective tissue disease|connective tissue disease
4961150|NCT01809561|endometriosis|endometriosis
4961151|NCT01809561|telomere|telomere
4961152|NCT01809561|telomerase|telomerase
4961153|NCT01809548|complementary feeding|complementary feeding
4961154|NCT01809548|premature infant|premature infant
4961155|NCT01809548|body composition|body composition
4961156|NCT01809548|atopy|atopy
4961157|NCT01809548|neurodevelopmental outcome|neurodevelopmental outcome
4961158|NCT01809548|obesity|obesity
4961159|NCT01809535|endoscopic variceal ligation|endoscopic variceal ligation
4961160|NCT01809535|post-EVL ulcer|post-evl ulcer
4961161|NCT01809535|variceal bleeding|variceal bleeding
4961162|NCT01809522|Robotic-assisted radical prostatectomy|robotic-assisted radical prostatectomy
4961163|NCT01809522|Urinary continence|urinary continence
4961164|NCT01809522|Posterior reconstruction of the rhabdosphincter|posterior reconstruction of the rhabdosphincter
4961165|NCT01809522|Posterior musculofascial plate reconstruction|posterior musculofascial plate reconstruction
4961166|NCT01809509|CYTOKINES , IL11 IL6 IMLANTATION RATE IVF.|cytokines , il11 il6 imlantation rate ivf.
4961167|NCT01809496|hearing loss|hearing loss
4961168|NCT01809496|hearing aids|hearing aids
4961169|NCT01809496|spouses|spouses
4961170|NCT01809496|rehabilitation|rehabilitation
4961171|NCT01809483|mechanical corneal erosion|mechanical corneal erosion
4961172|NCT01809483|bandage contact lens|bandage contact lens
4961173|NCT01809483|pressure patching|pressure patching
4961174|NCT01809483|erosion area|erosion area
4961175|NCT01809483|pain scale|pain scale
4961176|NCT01809470|Blood pressure|blood pressure
4961177|NCT01809470|Appetite|appetite
4961178|NCT01809470|Heart rate|heart rate
4961179|NCT01809470|Salivary cortisol|salivary cortisol
4961180|NCT01809457|educational poster, knowledge, dental trauma,|educational poster, knowledge, dental trauma,
4961181|NCT01809431|gestational diabetes|gestational diabetes
4961182|NCT01809431|women|women
4961183|NCT01809431|infants|infants
4961184|NCT01809431|blood glucose|blood glucose
4961185|NCT01809431|weight|weight
4961186|NCT01809431|adiposity|adiposity
4961187|NCT01809431|health behaviors|health behaviors
4961188|NCT01809431|self-efficacy|self-efficacy
4961189|NCT01809392|Decitabine|decitabine
4961190|NCT01809392|hematopoietic stem cell transplant|hematopoietic stem cell transplant
4961191|NCT01809392|Wilms' tumor 1|wilms' tumor 1
4961192|NCT01809392|cytolytic T lymphocyte|cytolytic t lymphocyte
4961193|NCT01809392|Regulatory T cell|regulatory t cell
4961194|NCT01809379|ovarian cancer, recurrent, chemotherapy, intraperitoneal|ovarian cancer, recurrent, chemotherapy, intraperitoneal
4961195|NCT01809366|seminal plasma/uterine receptivity|seminal plasma/uterine receptivity
4961196|NCT01809353|Healthy|healthy
4961197|NCT01809353|Japanese|japanese
4961198|NCT01809353|Caucasian|caucasian
4961199|NCT01809353|Male|male
4961200|NCT01809353|Pharmacokinetic|pharmacokinetic
4961201|NCT01809353|JNJ-54452840|jnj-54452840
4961202|NCT01809340|Depressive Disorder|depressive disorder
4961203|NCT01809340|Major Depressive Disorder|major depressive disorder
4961204|NCT01809340|Depression|depression
4961205|NCT01809340|Bipolar Disorder Type II|bipolar disorder type ii
4961206|NCT01809340|Anti-depressant|anti-depressant
4961207|NCT01809340|Ketamine|ketamine
4961208|NCT01809340|Minocycline|minocycline
4961209|NCT01809327|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
4961210|NCT01809327|Diabetes Mellitus|diabetes mellitus
4961211|NCT01809327|Canagliflozin (JNJ-28431754)|canagliflozin (jnj-28431754)
4961212|NCT01809327|Metformin|metformin
4961213|NCT01809301|Bioavailability|bioavailability
4961214|NCT01809288|Women|women
4961215|NCT01809288|Diet|diet
4961216|NCT01809288|Obesity|obesity
4961217|NCT01809288|African|african
4961218|NCT01809288|African Americans|african americans
4961219|NCT01809275|Crohn's Disease|crohn's disease
4961220|NCT01809275|Inflammatory Bowel Disease|inflammatory bowel disease
4961221|NCT01809275|CDAI|cdai
4961222|NCT01809249|Living donor liver transplantation|living donor liver transplantation
4961223|NCT01809249|Donar safety|donar safety
4961224|NCT01809210|MEK1/2 inhibitor,|mek1/2 inhibitor,
4961225|NCT01809210|Non Small Cell Lung Cancer,|non small cell lung cancer,
4961226|NCT01809210|metastatic,|metastatic,
4961227|NCT01809210|first line treatment for Non Small Cell Lung Cancer|first line treatment for non small cell lung cancer
4961228|NCT01809197|Refractive error|refractive error
4961229|NCT01809197|Myopia|myopia
4961230|NCT01809197|Hyperopia|hyperopia
4961231|NCT01809197|Astigmatism|astigmatism
4961232|NCT01809197|Presbyopia|presbyopia
4961233|NCT01809197|Contact lenses|contact lenses
4961234|NCT01809197|Contact lens solution|contact lens solution
4961235|NCT01809197|Comfort|comfort
4961236|NCT01809145|sarcoidosis|sarcoidosis
4961237|NCT01809145|occupational exposure|occupational exposure
4961238|NCT01809145|MELISA|melisa
4961239|NCT01809132|Hepatitis, alcoholic|hepatitis, alcoholic
4961240|NCT01809132|pentoxifylline|pentoxifylline
4961241|NCT01809132|zinc|zinc
4961242|NCT01809132|anakinra|anakinra
4961243|NCT01809132|glucocorticoids|glucocorticoids
4961244|NCT01809132|MELD score|meld score
4961245|NCT01809132|Intestinal mucosa|intestinal mucosa
4961246|NCT01809119|Kidney Neoplasms, Minimally invasive surgery, Renal cell carcinoma|kidney neoplasms, minimally invasive surgery, renal cell carcinoma
4961247|NCT01809106|cancer pain|cancer pain
4961248|NCT01809106|major opioid|major opioid
4961249|NCT01809106|analgesics|analgesics
4961250|NCT01809093|PEDF|pedf
4961251|NCT01809093|TSP1|tsp1
4961252|NCT01809093|Thrombospondin|thrombospondin
4961253|NCT01809093|pigment epithelium derived factor|pigment epithelium derived factor
4961254|NCT01809093|Wills Eye Institute|wills eye institute
4961255|NCT01809093|Pars plana vitrectomy|pars plana vitrectomy
4961256|NCT01809093|Vitreous levels|vitreous levels
4961257|NCT01809093|Mid Atlantic Retina|mid atlantic retina
4961258|NCT01809093|Blood draw|blood draw
4961259|NCT01809093|Blood test|blood test
4961260|NCT01809067|stress|stress
4961261|NCT01809067|anxiety|anxiety
4961262|NCT01809067|MRI|mri
4961263|NCT01809067|aromatherapy|aromatherapy
4961264|NCT01809054|Hip, Knee, Arthroplasty, venous thromboembolic events, blood loss|hip, knee, arthroplasty, venous thromboembolic events, blood loss
4961265|NCT01809028|cell block, number of passes|cell block, number of passes
4961266|NCT01809015|Oral Anticoagulation|oral anticoagulation
4961267|NCT01809015|Regular Medical Care|regular medical care
4961268|NCT01809015|Coagulation Service|coagulation service
4961269|NCT01809015|Vitamin-K Antagonists|vitamin-k antagonists
4961270|NCT01809015|Quality of therapy|quality of therapy
4961271|NCT01809015|Atrial fibrillation|atrial fibrillation
4961272|NCT01809015|Venous thromboembolism|venous thromboembolism
4961273|NCT01809015|Bypass surgery|bypass surgery
4961274|NCT01809015|Prosthetic heart valve|prosthetic heart valve
4961275|NCT01808989|peripheral artery disease|peripheral artery disease
4961276|NCT01808989|tcpo2|tcpo2
4961277|NCT01808989|treadmill walking test|treadmill walking test
4961278|NCT01808989|intermittent claudication|intermittent claudication
4961279|NCT01808963|Enthalpy|enthalpy
4961280|NCT01808963|Physiologic Monitors|physiologic monitors
4961281|NCT01808963|Critical Care Medicine|critical care medicine
4961282|NCT01808911|Acquired haemophilia|acquired haemophilia
4961283|NCT01808911|Comparative and randomized study|comparative and randomized study
4961284|NCT01808911|Cyclophosphamide|cyclophosphamide
4961285|NCT01808911|Rituximab|rituximab
4961286|NCT01808898|Ablation|ablation
4961287|NCT01808898|Outpatient|outpatient
4961288|NCT01808885|safety|safety
4961289|NCT01808885|multiple sclerosis|multiple sclerosis
4961291|NCT01808885|double-blind|double-blind
4961292|NCT01808885|randomized|randomized
4961293|NCT01808859|Total Knee Arthroplasty|total knee arthroplasty
4961294|NCT01808859|Thigh Tourniquet|thigh tourniquet
4961295|NCT01808846|Obesity|obesity
4961296|NCT01808846|Insulin Resistance|insulin resistance
4961297|NCT01808846|functional magnetic resonance imaging|functional magnetic resonance imaging
4961298|NCT01808846|glucose|glucose
4961299|NCT01808846|fructose|fructose
4961300|NCT01808846|hypothalamus|hypothalamus
4961301|NCT01808846|neuronal circuits|neuronal circuits
4961302|NCT01808846|feeding behavior|feeding behavior
4961303|NCT01808833|Frailty|frailty
4961304|NCT01808833|Geriatric oncology|geriatric oncology
4961305|NCT01808820|Malignant Glioma|malignant glioma
4961306|NCT01808820|Glioblastoma Multiforme|glioblastoma multiforme
4961307|NCT01808820|Anaplastic Astrocytoma|anaplastic astrocytoma
4961308|NCT01808820|High Grade Glioma|high grade glioma
4961309|NCT01808820|HGG|hgg
4961310|NCT01808820|Dendritic Cell Vaccine|dendritic cell vaccine
4961311|NCT01808820|DC Vaccine|dc vaccine
4961312|NCT01808820|Leukapheresis|leukapheresis
4961313|NCT01808807|cesarean section rate|cesarean section rate
4961314|NCT01808807|the cesarean section rate audit|the cesarean section rate audit
4961315|NCT01808794|membranes|membranes
4961316|NCT01808794|Mucograft|mucograft
4961317|NCT01808794|Dynamatrixw|dynamatrixw
4961318|NCT01808794|ridge|ridge
4961319|NCT01808794|preservation|preservation
4961320|NCT01808794|bone|bone
4961321|NCT01808794|allograft|allograft
4961322|NCT01808794|extraction|extraction
4961323|NCT01808794|site|site
4961324|NCT01808794|healing|healing
4961325|NCT01808781|Power|power
4961326|NCT01808781|muscle strength|muscle strength
4961327|NCT01808781|total knee replacement|total knee replacement
4961328|NCT01808781|physical activity behavior|physical activity behavior
4961329|NCT01808755|recurrent urinary tract infections|recurrent urinary tract infections
4961330|NCT01808755|D Mannose|d mannose
4961331|NCT01808755|cystitis|cystitis
4961332|NCT01808755|antibiotic treatment|antibiotic treatment
4961333|NCT01808729|fibromuscular dysplasia|fibromuscular dysplasia
4961334|NCT01808729|coronary artery disease|coronary artery disease
4961335|NCT01808716|low-level laser therapy|low-level laser therapy
4961336|NCT01808716|muscle damage|muscle damage
4961337|NCT01808703|Periodontitis|periodontitis
4961338|NCT01808703|Periodontal pocket|periodontal pocket
4961339|NCT01808703|Periodontal diseases|periodontal diseases
4961340|NCT01808690|Adolescent|adolescent
4961341|NCT01808690|Youth|youth
4961342|NCT01808690|Diabetes|diabetes
4961343|NCT01808690|Insulin Resistance|insulin resistance
4961344|NCT01808690|Cardiovascular|cardiovascular
4961345|NCT01808690|Metformin|metformin
4961346|NCT01808677|Non-Small Cell Lung Cancer|non-small cell lung cancer
4961347|NCT01808677|NSCLC|nsclc
4961348|NCT01808677|Thoracic reirradiation|thoracic reirradiation
4961349|NCT01808677|Proton beam therapy|proton beam therapy
4961350|NCT01808677|PBT|pbt
4961351|NCT01808677|Intensity modulated radiation therapy|intensity modulated radiation therapy
4961352|NCT01808677|IMRT|imrt
4961353|NCT01808677|Registry|registry
4961354|NCT01808677|Data|data
4961355|NCT01808638|Adenocarcinoma|adenocarcinoma
4961356|NCT01808638|Pancreas|pancreas
4961357|NCT01808638|Gemcitabine|gemcitabine
4961358|NCT01808638|Atu027|atu027
4961359|NCT01808625|BRAIN MALIGNANCIES , RADIATION THERAPY|brain malignancies , radiation therapy
4961360|NCT01808586|Neck|neck
4961361|NCT01808586|chronic pain|chronic pain
4961362|NCT01808586|facet injection|facet injection
4961363|NCT01808573|Neratinib|neratinib
4961364|NCT01808573|Nerlynx|nerlynx
4961365|NCT01808521|Purpura, Thrombotic Thrombocytopenic|purpura, thrombotic thrombocytopenic
4961366|NCT01808521|TTP|ttp
4961367|NCT01808508|Down syndrome|down syndrome
4961368|NCT01808508|Obstructive sleep apnea syndrome|obstructive sleep apnea syndrome
4961369|NCT01808508|Continuous positive airway pressure|continuous positive airway pressure
4961370|NCT01808508|sham or placebo CPAP|sham or placebo cpap
4961371|NCT01808495|Human corneal fibroblasts|human corneal fibroblasts
4961372|NCT01808495|Fibulin-1|fibulin-1
4961373|NCT01808495|Nuclear accumulation|nuclear accumulation
4961374|NCT01808482|monoclonal antibody|monoclonal antibody
4961375|NCT01808482|Multiple Sclerosis|multiple sclerosis
4961376|NCT01808482|Interleukin-7 Receptor|interleukin-7 receptor
4961377|NCT01808456|kidney transplant|kidney transplant
4961378|NCT01808456|heart transplant|heart transplant
4961379|NCT01808456|lung transplant|lung transplant
4961380|NCT01808456|influenza vaccine|influenza vaccine
4961381|NCT01808443|cryotherapy|cryotherapy
4961382|NCT01808443|laser|laser
4961383|NCT01808443|cutaneous warts|cutaneous warts
4961384|NCT01808430|NSCLC|nsclc
4961385|NCT01808404|Acceptance and Commitment Therapy|acceptance and commitment therapy
4961386|NCT01808404|Mindfulness|mindfulness
4961387|NCT01808404|Guided Self-Help|guided self-help
4961388|NCT01808404|College|college
4961389|NCT01808391|Coronary artery disease|coronary artery disease
4961390|NCT01808391|Heart disease|heart disease
4961391|NCT01808391|Myocardial ischemia|myocardial ischemia
4961392|NCT01808391|Cardiovascular disease|cardiovascular disease
4961484|NCT01808118|Spondylitis|spondylitis
4961393|NCT01808391|Arteriosclerosis|arteriosclerosis
4961394|NCT01808391|Vascular disease|vascular disease
4961395|NCT01808378|Bilateral limbic associated keratopathy|bilateral limbic associated keratopathy
4961396|NCT01808378|Expanded Adipose Derived Stem Cells|expanded adipose derived stem cells
4961397|NCT01808365|Neisseria meningitidis|neisseria meningitidis
4961398|NCT01808365|Philippines|philippines
4961399|NCT01808365|carriage|carriage
4961400|NCT01808365|meningococcus|meningococcus
4961401|NCT01808352|AE adverse event|ae adverse event
4961402|NCT01808352|AIDS acquired immunodeficiency syndrome|aids acquired immunodeficiency syndrome
4961403|NCT01808352|ALT (SGPT) alanine aminotransferase|alt (sgpt) alanine aminotransferase
4961404|NCT01808352|ART antiretroviral therapy|art antiretroviral therapy
4961405|NCT01808352|AST (SGOT) aspartate aminotransferase|ast (sgot) aspartate aminotransferase
4961406|NCT01808352|DCF data collection forms|dcf data collection forms
4961407|NCT01808352|DMC Data Monitoring Committee|dmc data monitoring committee
4961408|NCT01808352|FDA (U.S.) Food and Drug Administration|fda (u.s.) food and drug administration
4961409|NCT01808352|GCP Good Clinical Practice guidelines|gcp good clinical practice guidelines
4961410|NCT01808352|HB sAg Hepatitis B surface antigen|hb sag hepatitis b surface antigen
4961411|NCT01808352|ICH International Conference of Harmonisation|ich international conference of harmonisation
4961412|NCT01808352|IND Investigational New Drug Application|ind investigational new drug application
4961413|NCT01808352|IRB Institutional Review Board|irb institutional review board
4961414|NCT01808352|IU International units|iu international units
4961415|NCT01808352|mg milligram(s)|mg milligram(s)
4961416|NCT01808352|mm3 cubic millimeter(s)|mm3 cubic millimeter(s)
4961417|NCT01808352|PCR polymerase chain reaction|pcr polymerase chain reaction
4961418|NCT01808352|SAE serious adverse event|sae serious adverse event
4961419|NCT01808352|µg microgram|µg microgram
4961420|NCT01808352|ULN upper limit of the normal range|uln upper limit of the normal range
4961421|NCT01808352|WB Western Blot|wb western blot
4961422|NCT01808339|Fluticasone Furoate, FF Inhalation Powder, morning dosing, evening dosing, efficacy, FEV1|fluticasone furoate, ff inhalation powder, morning dosing, evening dosing, efficacy, fev1
4961423|NCT01808287|Transcatheter Aortic Valve Replacement|transcatheter aortic valve replacement
4961424|NCT01808287|Aortic Stenosis|aortic stenosis
4961425|NCT01808274|Transcatheter Aortic Valve Replacement|transcatheter aortic valve replacement
4961426|NCT01808274|Aortic Stenosis|aortic stenosis
4961427|NCT01808261|Ischemic Stroke|ischemic stroke
4961428|NCT01808248|HCV genotype 2 (GT-2)|hcv genotype 2 (gt-2)
4961429|NCT01808248|HCV genotype 3 (GT-3)|hcv genotype 3 (gt-3)
4961430|NCT01808248|HCV|hcv
4961431|NCT01808248|Sustained Virologic Response|sustained virologic response
4961432|NCT01808248|Direct Acting Antiviral|direct acting antiviral
4961433|NCT01808248|Combination Therapy|combination therapy
4961434|NCT01808248|Treatment-Naïve|treatment-naïve
4961435|NCT01808248|GS-7977|gs-7977
4961436|NCT01808248|Ribavirin|ribavirin
4961437|NCT01808248|RBV|rbv
4961438|NCT01808248|Peginterferon Alfa 2a|peginterferon alfa 2a
4961439|NCT01808248|PEG|peg
4961440|NCT01808248|Additional relevant MeSH terms:|additional relevant mesh terms:
4961441|NCT01808248|Hepatitis|hepatitis
4961442|NCT01808248|Hepatitis A|hepatitis a
4961443|NCT01808248|Hepatitis, Chronic|hepatitis, chronic
4961444|NCT01808248|Hepatitis C|hepatitis c
4961445|NCT01808248|Hepatitis C, Chronic|hepatitis c, chronic
4961446|NCT01808248|Liver Diseases|liver diseases
4961447|NCT01808248|Digestive System Diseases|digestive system diseases
4961448|NCT01808248|Hepatitis, Viral, Human|hepatitis, viral, human
4961449|NCT01808248|Virus Diseases|virus diseases
4961450|NCT01808248|Enterovirus Infections|enterovirus infections
4961451|NCT01808248|Picornaviridae Infections|picornaviridae infections
4961452|NCT01808248|RNA Virus Infections|rna virus infections
4961453|NCT01808248|Flaviviridae Infections|flaviviridae infections
4961454|NCT01808248|Peginterferon alfa-2a|peginterferon alfa-2a
4961455|NCT01808248|Interferon-alpha|interferon-alpha
4961456|NCT01808248|Antiviral Agents|antiviral agents
4961457|NCT01808248|Anti-Infective Agents|anti-infective agents
4961458|NCT01808248|Therapeutic Uses|therapeutic uses
4961459|NCT01808248|Pharmacologic Actions|pharmacologic actions
4961460|NCT01808248|Antimetabolites|antimetabolites
4961461|NCT01808248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
4961462|NCT01808248|Immunologic Factors|immunologic factors
4961463|NCT01808248|Physiological Effects of Drugs|physiological effects of drugs
4961464|NCT01808196|Eosinophilic Esophagitis|eosinophilic esophagitis
4961465|NCT01808196|Connective Tissue Disorders|connective tissue disorders
4961466|NCT01808196|Drug trial|drug trial
4961467|NCT01808183|supracondylar|supracondylar
4961468|NCT01808183|pediatric|pediatric
4961469|NCT01808183|humerus|humerus
4961470|NCT01808183|NIRS|nirs
4961471|NCT01808183|near Infrared spectroscopy|near infrared spectroscopy
4961472|NCT01808183|compartment perfusion|compartment perfusion
4961473|NCT01808170|Laparoscopy|laparoscopy
4961474|NCT01808170|AMH|amh
4961475|NCT01808170|AFC|afc
4961476|NCT01808170|Endometrioma|endometrioma
4961477|NCT01808170|ovarian reserve|ovarian reserve
4961478|NCT01808170|Ovarian cystectomy|ovarian cystectomy
4961479|NCT01808170|ovarian cyst deroofing|ovarian cyst deroofing
4961480|NCT01808157|atopic dermatitis|atopic dermatitis
4961481|NCT01808157|pruritus|pruritus
4961482|NCT01808144|Gout|gout
4961485|NCT01808118|Spondylarthropathy|spondylarthropathy
4961486|NCT01808118|Ankylosing Spondyloarthritis|ankylosing spondyloarthritis
4961487|NCT01808118|Spondyloarthritis|spondyloarthritis
4961488|NCT01808118|Spinal Diseases|spinal diseases
4961489|NCT01808118|Musculoskeletal Diseases|musculoskeletal diseases
4961490|NCT01808118|Arthritis|arthritis
4961491|NCT01808118|Joint Diseases|joint diseases
4961492|NCT01808118|Adalimumab|adalimumab
4961493|NCT01808118|Antirheumatic Agents|antirheumatic agents
4961494|NCT01808118|Anti-Inflammatory Agents|anti-inflammatory agents
4961495|NCT01808092|Ceftazidime,|ceftazidime,
4961496|NCT01808092|Meropenem,|meropenem,
4961497|NCT01808092|Anti-Bacterial Agents,|anti-bacterial agents,
4961498|NCT01808092|Anti-Infective Agents,|anti-infective agents,
4961499|NCT01808092|Therapeutic Uses,|therapeutic uses,
4961500|NCT01808092|Pharmacologic Actions,|pharmacologic actions,
4961501|NCT01808092|Physiological Effects of Drugs|physiological effects of drugs
4961502|NCT01808040|breast cancer|breast cancer
4961503|NCT01808040|ER positive|er positive
4961504|NCT01808040|PR positive|pr positive
4961505|NCT01808040|post menopausal|post menopausal
4961506|NCT01808027|quality of life drug adherence drug compliance mortality|quality of life drug adherence drug compliance mortality
4961507|NCT01808014|nefopam, spinal surgery, postoperative pain control|nefopam, spinal surgery, postoperative pain control
4961508|NCT01807988|Relapse, Recurrence, Depression, Internet, Sick-leave|relapse, recurrence, depression, internet, sick-leave
4961509|NCT01807962|Injections, Subcutaneous|injections, subcutaneous
4961510|NCT01807962|Cortisone|cortisone
4961511|NCT01807962|Anesthetics, Local|anesthetics, local
4961512|NCT01807936|Esophageal Neoplasms|esophageal neoplasms
4961513|NCT01807936|lymphadenectomy|lymphadenectomy
4961514|NCT01807910|Obesity|obesity
4961515|NCT01807910|NAFLD|nafld
4961516|NCT01807910|NASH|nash
4961517|NCT01807910|Steatosis|steatosis
4961518|NCT01807897|Heart Failure|heart failure
4961519|NCT01807897|Sleep Apnea|sleep apnea
4961520|NCT01807897|Ventricular Ejection Fraction|ventricular ejection fraction
4961521|NCT01807897|Exercise Test|exercise test
4961522|NCT01807884|Microaspiration|microaspiration
4961523|NCT01807884|Ventilator acquired Pneumonia|ventilator acquired pneumonia
4961524|NCT01807884|Amylase|amylase
4961525|NCT01807884|Mechanical ventilation|mechanical ventilation
4961526|NCT01807884|Suction|suction
4961527|NCT01807871|nicotine dependence|nicotine dependence
4961528|NCT01807871|smoking cessation|smoking cessation
4961529|NCT01807871|lapse|lapse
4961530|NCT01807871|relapse|relapse
4961531|NCT01807871|tobacco|tobacco
4961532|NCT01807871|nicotine patch|nicotine patch
4961533|NCT01807871|nicotine replacement therapy|nicotine replacement therapy
4961534|NCT01807871|NRT|nrt
4961535|NCT01807858|Necrotizing enterocolitis|necrotizing enterocolitis
4961536|NCT01807858|Sepsis|sepsis
4961537|NCT01807858|Length of hospital stay|length of hospital stay
4961538|NCT01807858|Mortality|mortality
4961539|NCT01807845|Casein micelles|casein micelles
4961540|NCT01807845|vitamin D3 (cholecalciferol)|vitamin d3 (cholecalciferol)
4961541|NCT01807845|Bioavailability|bioavailability
4961542|NCT01807845|Nanoencapsulation|nanoencapsulation
4961543|NCT01807845|Nutrition|nutrition
4961544|NCT01807832|chronic cough|chronic cough
4961545|NCT01807832|cough reflex hypersensitivity|cough reflex hypersensitivity
4961546|NCT01807832|capsaicin|capsaicin
4961547|NCT01807819|Heart Failure|heart failure
4961548|NCT01807819|Myocardial Strain|myocardial strain
4961549|NCT01807819|Functional Capacity|functional capacity
4961550|NCT01807806|veterans, military, families|veterans, military, families
4961551|NCT01807793|Stroke|stroke
4961552|NCT01807793|TIA|tia
4961553|NCT01807793|African American|african american
4961554|NCT01807754|automated ultrasound imaging (AUS)|automated ultrasound imaging (aus)
4961555|NCT01807754|digital breast tomosynthesis (DBT)|digital breast tomosynthesis (dbt)
4961556|NCT01807754|photoacoustic imaging (PAT)|photoacoustic imaging (pat)
4961557|NCT01807741|Bipolar Disorder|bipolar disorder
4961558|NCT01807741|Depression|depression
4961559|NCT01807728|Quality of life|quality of life
4961560|NCT01807728|Participation|participation
4961561|NCT01807728|Training|training
4961562|NCT01807715|first trimester|first trimester
4961563|NCT01807715|surgical abortion|surgical abortion
4961564|NCT01807715|contraception|contraception
4961565|NCT01807702|dichloroacetate|dichloroacetate
4961566|NCT01807702|pyruvate|pyruvate
4961567|NCT01807702|lactate|lactate
4961568|NCT01807702|pyruvate dehydrogenase|pyruvate dehydrogenase
4961569|NCT01807689|Dry mouth|dry mouth
4961570|NCT01807689|Dry eyes|dry eyes
4961571|NCT01807689|Saliva|saliva
4961572|NCT01807689|Salivary gland biopsy|salivary gland biopsy
4961573|NCT01807663|neuromuscular disease|neuromuscular disease
4961574|NCT01807650|Split-Thickness Skin Graft (STSG) donor site|split-thickness skin graft (stsg) donor site
4961575|NCT01807650|Split-thickness skin graft|split-thickness skin graft
4961576|NCT01807650|STSG|stsg
4961577|NCT01807650|Wound healing|wound healing
4961578|NCT01807650|Skin grafting|skin grafting
4961579|NCT01807650|Superficial wound|superficial wound
4961580|NCT01807650|Partial-thickness wound|partial-thickness wound
4961581|NCT01807650|Time to wound closure|time to wound closure
4961582|NCT01807624|Pharmacokinetic|pharmacokinetic
4961583|NCT01807611|Haploidentical donor transplantation|haploidentical donor transplantation
4961584|NCT01807611|NK cell|nk cell
4961585|NCT01807585|GSV|gsv
4961586|NCT01807559|Single Sided Deafness|single sided deafness
4961587|NCT01807559|Conductive Hearing Loss|conductive hearing loss
4961588|NCT01807559|Unilateral Hearing Loss|unilateral hearing loss
4961589|NCT01807559|SSD|ssd
4961590|NCT01807546|Head and neck cancer|head and neck cancer
4961591|NCT01807546|Platinum-resistant|platinum-resistant
4961592|NCT01807546|Squamous cell carcinoma|squamous cell carcinoma
4961593|NCT01807533|Environment|environment
4961594|NCT01807533|Gene|gene
4961595|NCT01807533|Intervention|intervention
4961596|NCT01807533|Neurodevelopment|neurodevelopment
4961597|NCT01807533|Pathways|pathways
4961598|NCT01807533|Preterm infants|preterm infants
4961599|NCT01807520|Moderate nail psoriasis|moderate nail psoriasis
4961600|NCT01807520|Severe nail psoriasis|severe nail psoriasis
4961601|NCT01807520|psoriasis|psoriasis
4961602|NCT01807520|Secukinumab|secukinumab
4961603|NCT01807507|Veins|veins
4961604|NCT01807507|Vascular Access|vascular access
4961605|NCT01807481|Mircera|mircera
4961606|NCT01807481|PD|pd
4961607|NCT01807481|Maitenance|maitenance
4961608|NCT01807468|haploidentical stem cell transplantation|haploidentical stem cell transplantation
4961609|NCT01807468|natural killer cell therapy|natural killer cell therapy
4961610|NCT01807468|pediatric solid tumor|pediatric solid tumor
4961611|NCT01807442|Acute Coronary Syndrome|acute coronary syndrome
4961612|NCT01807442|Positive Psychology|positive psychology
4961613|NCT01807442|Adherence to Health Behaviors|adherence to health behaviors
4961614|NCT01807429|Ketamine,|ketamine,
4961615|NCT01807429|Midazolam,|midazolam,
4961616|NCT01807429|Morphine,|morphine,
4961617|NCT01807429|visual analogue score|visual analogue score
4961618|NCT01807416|Osseointegrated Implant, Bone level|osseointegrated implant, bone level
4961619|NCT01807403|Obsessive-Compulsive Disorder|obsessive-compulsive disorder
4961620|NCT01807403|Deep brain stimulation|deep brain stimulation
4961621|NCT01807403|Subthalamic nucleus|subthalamic nucleus
4961622|NCT01807403|Caudate nucleus|caudate nucleus
4961623|NCT01807403|Nucleus accumbens|nucleus accumbens
4961624|NCT01807390|Minimally invasive surgery|minimally invasive surgery
4961625|NCT01807390|Patient perspectives|patient perspectives
4961626|NCT01807390|Lung cancer|lung cancer
4961627|NCT01807390|Esophageal cancer|esophageal cancer
4961628|NCT01807390|Pain|pain
4961629|NCT01807364|Congenital adrenal hyperplasia (CAH)|congenital adrenal hyperplasia (cah)
4961630|NCT01807364|Cardiovascular risk|cardiovascular risk
4961631|NCT01807364|Microvascular dysfunction|microvascular dysfunction
4961632|NCT01807351|Diabetes Mellitus|diabetes mellitus
4961633|NCT01807351|Hypertension|hypertension
4961634|NCT01807351|Impaired Fasting Glucose|impaired fasting glucose
4961635|NCT01807351|Primary Health Care|primary health care
4961636|NCT01807351|Chinese|chinese
4961637|NCT01807312|colonoscopy|colonoscopy
4961638|NCT01807299|Physical Training|physical training
4961639|NCT01807299|ADHD-Attention deficit hyperactivity disorder|adhd-attention deficit hyperactivity disorder
4961640|NCT01807299|Omega 3|omega 3
4961641|NCT01807286|Myeloma|myeloma
4961642|NCT01807286|Untreated Systemic AL Amyloidosis|untreated systemic al amyloidosis
4961643|NCT01807286|Amyloid light-chain (AL) amyloidosis|amyloid light-chain (al) amyloidosis
4961644|NCT01807286|Pomalidomide|pomalidomide
4961645|NCT01807286|Melphalan|melphalan
4961646|NCT01807286|Alkeran|alkeran
4961647|NCT01807286|Dexamethasone|dexamethasone
4961648|NCT01807286|Decadron|decadron
4961649|NCT01807286|Questionnaires|questionnaires
4961650|NCT01807286|Surveys|surveys
4961651|NCT01807273|hemiplegic|hemiplegic
4961652|NCT01807273|time up and go test|time up and go test
4961653|NCT01807273|motion analysis|motion analysis
4961654|NCT01807273|center of mass|center of mass
4961655|NCT01807247|Strengthening muscle|strengthening muscle
4961656|NCT01807247|Central nervous system diseases|central nervous system diseases
4961657|NCT01807247|Gait|gait
4961658|NCT01807221|Heart Decompensation|heart decompensation
4961659|NCT01807208|Acute myocardial infarction|acute myocardial infarction
4961660|NCT01807208|patient education|patient education
4961661|NCT01807208|prevention|prevention
4961662|NCT01807195|contrast|contrast
4961663|NCT01807195|Intensive care unit|intensive care unit
4961664|NCT01807195|Acute kidney injury|acute kidney injury
4961665|NCT01807169|colon|colon
4961666|NCT01807169|endoscopy|endoscopy
4961667|NCT01807169|resection|resection
4961668|NCT01807169|clopidogrel|clopidogrel
4961669|NCT01807156|Tivozanib|tivozanib
4961670|NCT01807156|Advanced hepatocellular cancer|advanced hepatocellular cancer
4961671|NCT01807156|Angiogenesis|angiogenesis
4961672|NCT01807130|Heart Failure|heart failure
4961673|NCT01807130|Medical Therapy|medical therapy
4961674|NCT01807130|ICD|icd
4961675|NCT01807130|CRT|crt
4961676|NCT01807104|Anterior Approach|anterior approach
4961677|NCT01807104|Posterior Approach|posterior approach
4961678|NCT01807078|Coronary artery disease|coronary artery disease
4961679|NCT01807039|hip fracture|hip fracture
4961680|NCT01807039|proximal femur|proximal femur
4961681|NCT01807039|pertrochanteric fracture|pertrochanteric fracture
4961682|NCT01807039|subtrochanteric fracture|subtrochanteric fracture
4961683|NCT01807039|subcapital fracture|subcapital fracture
4961684|NCT01807039|safety issue|safety issue
4961685|NCT01807039|anesthesia|anesthesia
4961686|NCT01807013|cirrhosis|cirrhosis
4961687|NCT01807013|liver|liver
4961688|NCT01807013|elastometry|elastometry
4961689|NCT01807013|ultrasound|ultrasound
4961690|NCT01807013|laparoscopy|laparoscopy
4961691|NCT01807013|diagnosis|diagnosis
4961692|NCT01806987|school readiness|school readiness
4961693|NCT01806987|literacy|literacy
4961694|NCT01806987|social emotional skills|social emotional skills
4961695|NCT01806987|self regulation|self regulation
4961696|NCT01806987|caregiver involvement|caregiver involvement
4961697|NCT01806987|socioeconomic disadvantage|socioeconomic disadvantage
4961698|NCT01806974|Periodontitis|periodontitis
4961699|NCT01806974|rheumatoid arthritis|rheumatoid arthritis
4961700|NCT01806974|anti-interleukin 6|anti-interleukin 6
4961701|NCT01806974|immunotherapy|immunotherapy
4961702|NCT01806974|inflammation|inflammation
4961703|NCT01806974|bacteria|bacteria
4961704|NCT01806974|periodontal sulci|periodontal sulci
4961705|NCT01806974|periodontal pockets|periodontal pockets
4961706|NCT01806935|associated|associated
4961707|NCT01806935|aged population|aged population
4961708|NCT01806922|Yoga|yoga
4961709|NCT01806922|Stroke|stroke
4961710|NCT01806922|Standing balance|standing balance
4961711|NCT01806922|Depression|depression
4961712|NCT01806909|Flu Vaccine|flu vaccine
4961713|NCT01806909|Healthy Volunteer|healthy volunteer
4961714|NCT01806883|Hemiparesis,|hemiparesis,
4961715|NCT01806883|Rehabilitation,|rehabilitation,
4961716|NCT01806883|WII,|wii,
4961717|NCT01806883|Upper limb,|upper limb,
4961718|NCT01806883|Movement strategies.|movement strategies.
4961719|NCT01806870|HIV|hiv
4961720|NCT01806870|ART|art
4961721|NCT01806857|Amyotrophic lateral sclerosis|amyotrophic lateral sclerosis
4961722|NCT01806857|ALS|als
4961723|NCT01806857|Nuedexta|nuedexta
4961724|NCT01806857|Bulbar function|bulbar function
4961725|NCT01806857|motor neurons|motor neurons
4961726|NCT01806844|Cardiac arrest|cardiac arrest
4961727|NCT01806844|Cerebral oxygenation|cerebral oxygenation
4961728|NCT01806844|Pre-hospital|pre-hospital
4961729|NCT01806805|Movement disorder|movement disorder
4961730|NCT01806805|Myoclonus dystonia|myoclonus dystonia
4961731|NCT01806805|DYT 11|dyt 11
4961732|NCT01806805|Antiepileptic drugs|antiepileptic drugs
4961733|NCT01806805|Zonisamide|zonisamide
4961734|NCT01806805|Clinical Trial|clinical trial
4961735|NCT01806805|Double-mind method|double-mind method
4961736|NCT01806792|Osteoporosis|osteoporosis
4961737|NCT01806779|Nicotine addiction|nicotine addiction
4961738|NCT01806779|Cigarette smoking|cigarette smoking
4961739|NCT01806779|Smoking cessation|smoking cessation
4961740|NCT01806779|Zyban|zyban
4961741|NCT01806779|Chantix|chantix
4961742|NCT01806779|Nicotine patches|nicotine patches
4961743|NCT01806779|varenicline|varenicline
4961744|NCT01806779|bupropion|bupropion
4961745|NCT01806766|cementless total hip arthroplasty|cementless total hip arthroplasty
4961746|NCT01806766|ceramic on ceramic bearing|ceramic on ceramic bearing
4961747|NCT01806766|ceramic on highly cross linked polyethylene|ceramic on highly cross linked polyethylene
4961748|NCT01806766|young patient|young patient
4961749|NCT01806753|Endoscopic submucosal dissection|endoscopic submucosal dissection
4961750|NCT01806753|Sedation|sedation
4961751|NCT01806753|Propofol|propofol
4961752|NCT01806753|Midazolam|midazolam
4961753|NCT01806740|DCE-MRI|dce-mri
4961754|NCT01806740|Sorafenib response|sorafenib response
4961755|NCT01806727|Diabetes|diabetes
4961756|NCT01806727|Diabetes Self Management|diabetes self management
4961757|NCT01806727|LIFT Diabetes|lift diabetes
4961758|NCT01806727|Weight Loss|weight loss
4961759|NCT01806727|Diet|diet
4961760|NCT01806727|Physical Activity|physical activity
4961761|NCT01806727|Overweight|overweight
4961762|NCT01806727|Obese|obese
4961763|NCT01806714|HPV vaccination|hpv vaccination
4961764|NCT01806714|Adolescent well care|adolescent well care
4961765|NCT01806714|Adolescent HPV immunization|adolescent hpv immunization
4961766|NCT01806714|HPV|hpv
4961767|NCT01806701|fMRI|fmri
4961768|NCT01806701|neuroimaging|neuroimaging
4961769|NCT01806701|PTSD|ptsd
4961770|NCT01806701|adolescent|adolescent
4961771|NCT01806701|trauma|trauma
4961772|NCT01806701|brain|brain
4961773|NCT01806688|satiety|satiety
4961774|NCT01806688|appetite|appetite
4961775|NCT01806688|snack|snack
4961776|NCT01806662|Atopic Dermatitis|atopic dermatitis
4961777|NCT01806662|Eczema|eczema
4961778|NCT01806649|esophageal cancer|esophageal cancer
4961779|NCT01806649|second line therapy|second line therapy
4961780|NCT01806649|BKM120|bkm120
4961781|NCT01806636|Coil|coil
4961782|NCT01806636|RePneu|repneu
4961783|NCT01806636|PneumRx|pneumrx
4961784|NCT01806636|LVRC|lvrc
4961785|NCT01806610|Randomized|randomized
4961786|NCT01806610|Placebo-controlled trial|placebo-controlled trial
4961787|NCT01806610|BPS804|bps804
4961788|NCT01806610|Safety, tolerability, and PK|safety, tolerability, and pk
4961789|NCT01806610|Patients with late-stage chronic kidney disease.|patients with late-stage chronic kidney disease.
4961790|NCT01806597|Skin condition, itching, psoriasis vulgaris, relapsing remitting psoriasis, immune-med systemic disease, skin lesions, scaly patches, papules, plaques|skin condition, itching, psoriasis vulgaris, relapsing remitting psoriasis, immune-med systemic disease, skin lesions, scaly patches, papules, plaques
4961791|NCT01806584|Vascular Injury|vascular injury
4961792|NCT01806584|Arteriovenous Graft Surgery|arteriovenous graft surgery
4961793|NCT01806584|Hemodialysis Access|hemodialysis access
4961794|NCT01806558|Breast cancer|breast cancer
4961795|NCT01806558|molecular breast imaging|molecular breast imaging
4961796|NCT01806558|breast|breast
4961797|NCT01806558|breast lesion|breast lesion
4961798|NCT01806545|Arteriovenous Fistula Surgery|arteriovenous fistula surgery
4961799|NCT01806545|Vascular Injury|vascular injury
4961800|NCT01806545|Hemodialysis Access|hemodialysis access
4961801|NCT01806532|computed tomography and positron emission tomography|computed tomography and positron emission tomography
4961802|NCT01806532|respiration, artificial|respiration, artificial
4961803|NCT01806532|respiratory distress syndrome, adult|respiratory distress syndrome, adult
4961804|NCT01806519|neck pain|neck pain
4961805|NCT01806519|motor control|motor control
4961806|NCT01806519|intervention|intervention
4961807|NCT01806519|forward head posture|forward head posture
4961808|NCT01806506|Bariatric surgery|bariatric surgery
4961809|NCT01806506|Gastric bypass|gastric bypass
4961810|NCT01806506|Sleeve gastrectomy|sleeve gastrectomy
4961811|NCT01806506|Weight loss|weight loss
4961812|NCT01806506|Lipoproteins|lipoproteins
4961813|NCT01806506|Insulin resistance|insulin resistance
4961814|NCT01806506|Incretins|incretins
4961815|NCT01806506|Quality of life|quality of life
4961816|NCT01806493|body composition|body composition
4961817|NCT01806493|obesity|obesity
4961818|NCT01806480|Breastfeeding, Preterm Infant, Neonatal Care, Support, Mothers.|breastfeeding, preterm infant, neonatal care, support, mothers.
4961819|NCT01806415|Fenobam,|fenobam,
4961820|NCT01806415|Pharmacokinetics|pharmacokinetics
4961821|NCT01806415|side effects|side effects
4961822|NCT01806389|Breast milk|breast milk
4961823|NCT01806389|Breastfeeding|breastfeeding
4961824|NCT01806389|Lactation|lactation
4961825|NCT01806389|Buprenorphine|buprenorphine
4961826|NCT01806389|Opioid|opioid
4961827|NCT01806363|Pharmacokinetics|pharmacokinetics
4961828|NCT01806363|Safety|safety
4961829|NCT01806363|Male|male
4961830|NCT01806350|Pelvic floor muscle training; incontinence; quality of life|pelvic floor muscle training; incontinence; quality of life
4961831|NCT01806337|peripheral T cell lymphoma|peripheral t cell lymphoma
4961832|NCT01806337|alemtuzumab|alemtuzumab
4961833|NCT01806337|consolidation|consolidation
4961834|NCT01806311|Pharmacokinetics|pharmacokinetics
4961835|NCT01806311|Safety|safety
4961836|NCT01806311|Male|male
4961837|NCT01806298|Adult Growth hormone deficiency|adult growth hormone deficiency
4961838|NCT01806298|Saizen®|saizen®
4961839|NCT01806298|Recombinant human growth hormone (r-hGH)|recombinant human growth hormone (r-hgh)
4961840|NCT01806298|Somatropin|somatropin
4961841|NCT01806285|Respiratory Virus|respiratory virus
4961842|NCT01806272|rhGM-CSF|rhgm-csf
4961843|NCT01806272|Oral Mucositis|oral mucositis
4961844|NCT01806272|Primary Nasopharyngeal Cancers|primary nasopharyngeal cancers
4961845|NCT01806272|Chemoradiotherapy|chemoradiotherapy
4961846|NCT01806246|rehabilitation|rehabilitation
4961847|NCT01806246|adolescent|adolescent
4961848|NCT01806246|heart rate variability biofeedback|heart rate variability biofeedback
4961849|NCT01806246|psychoeducation|psychoeducation
4961850|NCT01806220|Gastroesophageal Reflux Disease (GERD)|gastroesophageal reflux disease (gerd)
4961851|NCT01806220|Chronic Laryngitis|chronic laryngitis
4961852|NCT01806220|Epidermal Growth factor receptor|epidermal growth factor receptor
4961853|NCT01806168|Post-traumatic stress disorder|post-traumatic stress disorder
4961854|NCT01806168|Repetitive transcranial magnetic stimulation|repetitive transcranial magnetic stimulation
4961855|NCT01806168|Civilians|civilians
4961856|NCT01806168|Neurostimulation|neurostimulation
4961857|NCT01806168|Dorsolateral prefrontal cortex|dorsolateral prefrontal cortex
4961858|NCT01806155|craniotomy|craniotomy
4961859|NCT01806155|headache|headache
4961860|NCT01806155|postoperative|postoperative
4961861|NCT01806116|myelodysplastic syndrome|myelodysplastic syndrome
4961862|NCT01806116|higher-risk|higher-risk
4961863|NCT01806116|acute myeloid leukemia|acute myeloid leukemia
4961864|NCT01806116|relapsed /refractory|relapsed /refractory
4961865|NCT01806116|decitabine|decitabine
4961866|NCT01806116|hematopoietic cell transplantation|hematopoietic cell transplantation
4961867|NCT01806116|bridge therapy|bridge therapy
4961868|NCT01806103|antimicrobial stewardship program|antimicrobial stewardship program
4961869|NCT01806103|inappropriate prescribing of antibiotics|inappropriate prescribing of antibiotics
4961870|NCT01806103|physician prescribing|physician prescribing
4961871|NCT01806103|antibiotic prescribing for respiratory tract infections|antibiotic prescribing for respiratory tract infections
4961872|NCT01806103|respiratory tract infections|respiratory tract infections
4961873|NCT01806077|Cardiovascular Diseases|cardiovascular diseases
4961874|NCT01806077|Vascular Diseases|vascular diseases
4961875|NCT01806077|Coronary Artery Disease|coronary artery disease
4961876|NCT01806077|Coronary Disease|coronary disease
4961877|NCT01806077|Arteriosclerosis|arteriosclerosis
4961878|NCT01806077|Platelet Aggregation Inhibitors|platelet aggregation inhibitors
4961880|NCT01806064|CD105|cd105
4961881|NCT01806064|RCC|rcc
4961882|NCT01806064|Renal Cell Carcinoma|renal cell carcinoma
4961883|NCT01806064|Axitinib|axitinib
4961884|NCT01806064|INLYTA|inlyta
4961885|NCT01806064|Advanced Renal Cell Carcinoma|advanced renal cell carcinoma
4961886|NCT01806038|Adverse events|adverse events
4961887|NCT01806038|Drug interactions|drug interactions
4961888|NCT01806038|Healthcare utilization|healthcare utilization
4961889|NCT01806038|Discharge medication counseling|discharge medication counseling
4961890|NCT01806025|Cystic Fibrosis|cystic fibrosis
4961891|NCT01806025|Haptoglobin|haptoglobin
4961892|NCT01806012|Supracervical Hysterectomy|supracervical hysterectomy
4961893|NCT01806012|Leiomyomas|leiomyomas
4961894|NCT01806012|Adenomyosis|adenomyosis
4961895|NCT01805999|Ispaghula|ispaghula
4961896|NCT01805999|Gastrointestinal physiology|gastrointestinal physiology
4961897|NCT01805999|Gastrointestinal response to sugars|gastrointestinal response to sugars
4961898|NCT01805999|MRI|mri
4961899|NCT01805999|gastrointestinal|gastrointestinal
4961900|NCT01805999|stomach|stomach
4961901|NCT01805999|small bowel|small bowel
4961902|NCT01805999|colon|colon
4961903|NCT01805986|Multiple Sclerosis, other neurological conditions|multiple sclerosis, other neurological conditions
4961904|NCT01805934|Helicobacter pylori, rescue, quadruple therapy，dual therapy|helicobacter pylori, rescue, quadruple therapy，dual therapy
4961905|NCT01805921|Respiratory Syncytial Virus|respiratory syncytial virus
4961906|NCT01805921|RSV|rsv
4961907|NCT01805921|Vaccine|vaccine
4961908|NCT01805908|metastatic|metastatic
4961909|NCT01805908|breast cancer|breast cancer
4961910|NCT01805908|herceptin|herceptin
4961911|NCT01805908|imaging|imaging
4961912|NCT01805908|tumour response|tumour response
4961913|NCT01805908|adenocarcinoma|adenocarcinoma
4961914|NCT01805908|SPECT-CT|spect-ct
4961915|NCT01805908|pertuzumab|pertuzumab
4961916|NCT01805908|trastuzumab|trastuzumab
4961917|NCT01805908|locally advanced|locally advanced
4961918|NCT01805895|Stroke|stroke
4961919|NCT01805895|Acute Intracerebral Hemorrhage|acute intracerebral hemorrhage
4961920|NCT01805895|Intracerebral Hemorrhage|intracerebral hemorrhage
4961921|NCT01805895|Hemorrhagic stroke|hemorrhagic stroke
4961922|NCT01805895|Hemorrhage|hemorrhage
4961923|NCT01805895|Minocycline|minocycline
4961924|NCT01805882|Interferon Sparing|interferon sparing
4961925|NCT01805882|Directly Acting Antiviral|directly acting antiviral
4961926|NCT01805882|Ribavarin Sparing|ribavarin sparing
4961927|NCT01805869|Third Molar|third molar
4961928|NCT01805869|Specimen Acquisition|specimen acquisition
4961929|NCT01805856|antimicrobial prophylaxis|antimicrobial prophylaxis
4961930|NCT01805856|AMP|amp
4961931|NCT01805856|surgical site infection|surgical site infection
4961932|NCT01805856|SSI|ssi
4961933|NCT01805856|thyroid|thyroid
4961934|NCT01805856|thyroidectomy|thyroidectomy
4961935|NCT01805856|parathyroid|parathyroid
4961936|NCT01805856|surgery|surgery
4961937|NCT01805843|Pulmonary hypertension|pulmonary hypertension
4961938|NCT01805843|chronic myeloid leukemia|chronic myeloid leukemia
4961939|NCT01805843|dasatinib|dasatinib
4961940|NCT01805843|nilotinib|nilotinib
4961941|NCT01805830|Type2DM / DPP-IV inhibitors|type2dm / dpp-iv inhibitors
4961942|NCT01805817|lipid profile|lipid profile
4961943|NCT01805817|bleeding scores|bleeding scores
4961944|NCT01805817|menstrual pattern|menstrual pattern
4961945|NCT01805817|beneficial|beneficial
4961946|NCT01805817|side effects|side effects
4961947|NCT01805817|changes in a year period|changes in a year period
4961948|NCT01805804|dual chamber pacing, left ventricle remodeling, valsartan|dual chamber pacing, left ventricle remodeling, valsartan
4961949|NCT01805791|Ulcerative Colitis,|ulcerative colitis,
4961950|NCT01805791|UC|uc
4961951|NCT01805791|Patients|patients
4961952|NCT01805791|active|active
4961953|NCT01805791|mild|mild
4961954|NCT01805791|moderate|moderate
4961955|NCT01805765|menopausal syndrome|menopausal syndrome
4961956|NCT01805765|climacteric syndrome|climacteric syndrome
4961957|NCT01805765|Hot flashes|hot flashes
4961958|NCT01805765|Sweat|sweat
4961959|NCT01805752|Prevention of mother to child HIV transmission|prevention of mother to child hiv transmission
4961960|NCT01805752|HIV/AIDS|hiv/aids
4961961|NCT01805739|transcatheter aortic valve implantation|transcatheter aortic valve implantation
4961962|NCT01805739|CT|ct
4961963|NCT01805739|MRI|mri
4961964|NCT01805739|angiography|angiography
4961965|NCT01805739|echocardiography|echocardiography
4961966|NCT01805739|rotational C-arm CT|rotational c-arm ct
4961967|NCT01805726|bronchoscopy|bronchoscopy
4961968|NCT01805726|sedation|sedation
4961969|NCT01805726|pulmonary function|pulmonary function
4961970|NCT01805726|tolerance|tolerance
4961971|NCT01805726|xylocain|xylocain
4961972|NCT01805726|dexmedetomidine|dexmedetomidine
4961973|NCT01805726|alfentanil|alfentanil
4961974|NCT01805713|Biomarkers|biomarkers
4961975|NCT01805700|type 1|type 1
4961976|NCT01805700|diabetes|diabetes
4961977|NCT01805700|caffeine-enhanced energy drink|caffeine-enhanced energy drink
4961978|NCT01805700|cardiac output|cardiac output
4961979|NCT01805700|glucose|glucose
4961980|NCT01805700|cognitive performance|cognitive performance
4961981|NCT01805674|menopause|menopause
4961982|NCT01805674|quality of life|quality of life
4961983|NCT01805674|soy isoflavones|soy isoflavones
4961984|NCT01805674|magnolia extract|magnolia extract
4961985|NCT01805661|early ambulation|early ambulation
4961986|NCT01805661|knee arthroplasty|knee arthroplasty
4961987|NCT01805648|ITP|itp
4961988|NCT01805648|rhTPO|rhtpo
4961989|NCT01805635|Children|children
4961990|NCT01805635|Asthma|asthma
4961991|NCT01805635|Allergic rhinitis|allergic rhinitis
4961992|NCT01805635|Atopic dermatitis|atopic dermatitis
4961993|NCT01805635|Urticaria|urticaria
4961994|NCT01805635|Healthy|healthy
4961995|NCT01805622|community-based participatory research|community-based participatory research
4961996|NCT01805622|colorectal cancer screening|colorectal cancer screening
4961997|NCT01805609|practice nurse|practice nurse
4961998|NCT01805609|clinical Nurse|clinical nurse
4961999|NCT01805609|inpatient staff|inpatient staff
4962000|NCT01805609|inpatient social worker|inpatient social worker
4962001|NCT01805609|didactic training sessions|didactic training sessions
4962002|NCT01805609|13-030|13-030
4962003|NCT01805596|coronary artery disease|coronary artery disease
4962004|NCT01805596|endothelial function|endothelial function
4962005|NCT01805596|antiplatelet agent|antiplatelet agent
4962006|NCT01805570|platelet inhibitor|platelet inhibitor
4962007|NCT01805570|ST-segment Elevation|st-segment elevation
4962008|NCT01805570|Myocardial Infarction|myocardial infarction
4962009|NCT01805570|stent|stent
4962010|NCT01805570|prasugrel|prasugrel
4962011|NCT01805570|ticagrelor|ticagrelor
4962012|NCT01805557|Diffuse Large B-cell Lymphoma (DLBCL)|diffuse large b-cell lymphoma (dlbcl)
4962013|NCT01805557|Bortezomib|bortezomib
4962014|NCT01805544|SF36 questionnaire|sf36 questionnaire
4962015|NCT01805544|Anti Clot Treatment Scale|anti clot treatment scale
4962016|NCT01805544|Satisfaction|satisfaction
4962017|NCT01805544|Quality of Life|quality of life
4962018|NCT01805544|Rivaroxaban|rivaroxaban
4962019|NCT01805544|Prevention & control|prevention & control
4962020|NCT01805544|Pulmonary embolism|pulmonary embolism
4962021|NCT01805531|SF36 questionnaire|sf36 questionnaire
4962022|NCT01805531|Anti Clot Treatment Scale|anti clot treatment scale
4962023|NCT01805531|Satisfaction|satisfaction
4962024|NCT01805531|Quality of Life|quality of life
4962025|NCT01805531|Rivaroxaban|rivaroxaban
4962026|NCT01805531|Stroke prevention|stroke prevention
4962027|NCT01805518|CNSVS|cnsvs
4962028|NCT01805518|Tower of London|tower of london
4962029|NCT01805518|Letter-Number Test|letter-number test
4962030|NCT01805518|Trail Making Test|trail making test
4962031|NCT01805518|Vital signs|vital signs
4962032|NCT01805518|Mood|mood
4962033|NCT01805518|Suicidal ideation|suicidal ideation
4962034|NCT01805518|ECG|ecg
4962035|NCT01805518|Physical exam|physical exam
4962036|NCT01805518|Blood|blood
4962037|NCT01805518|Urine (Including pregnancy and drug screen)|urine (including pregnancy and drug screen)
4962038|NCT01805518|Cytokines|cytokines
4962039|NCT01805518|Side effects|side effects
4962040|NCT01805518|Brief Psychiatric Rating Scale|brief psychiatric rating scale
4962041|NCT01805518|Positive and Negative Symptom Scale|positive and negative symptom scale
4962042|NCT01805505|Female infertility|female infertility
4962043|NCT01805505|Oocyte donation|oocyte donation
4962044|NCT01805505|Embryo transfer|embryo transfer
4962045|NCT01805505|Transvaginal ultrasonography|transvaginal ultrasonography
4962046|NCT01805505|Transabdominal ultrasonography|transabdominal ultrasonography
4962047|NCT01805492|Heart diseases|heart diseases
4962048|NCT01805492|Cardiovascular diseases|cardiovascular diseases
4962049|NCT01805492|Lifestyle modification|lifestyle modification
4962050|NCT01805492|Diet|diet
4962051|NCT01805492|Exercise|exercise
4962052|NCT01805479|exercise|exercise
4962053|NCT01805479|depression|depression
4962054|NCT01805479|traumatic brain injury|traumatic brain injury
4962055|NCT01805466|Extracorporeal Vacuum Assisted Device Optimised (EVADO)|extracorporeal vacuum assisted device optimised (evado)
4962056|NCT01805453|Glioblastoma|glioblastoma
4962057|NCT01805453|Angiotensin-II inhibitors|angiotensin-ii inhibitors
4962058|NCT01805453|Losartan|losartan
4962059|NCT01805453|steroids|steroids
4962060|NCT01805453|Radiotherapy|radiotherapy
4962061|NCT01805453|Edema|edema
4962062|NCT01805453|Randomized trial|randomized trial
4962063|NCT01805440|Adolescent|adolescent
4962064|NCT01805440|Bipolar Disorder|bipolar disorder
4962065|NCT01805440|Bipolar Depression|bipolar depression
4962066|NCT01805440|Manic Depression|manic depression
4962067|NCT01805440|Neuroimaging|neuroimaging
4962068|NCT01805440|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
4962069|NCT01805440|Uridine|uridine
4962070|NCT01805440|Pyrimidines|pyrimidines
4962071|NCT01805427|trough concentration|trough concentration
4962072|NCT01805427|weight|weight
4962073|NCT01805427|HIV|hiv
4962074|NCT01805427|virological failure|virological failure
4962075|NCT01805414|inpatient diabetes|inpatient diabetes
4962076|NCT01805414|inpatient diabetes nutrition|inpatient diabetes nutrition
4962077|NCT01805401|Decision-making|decision-making
4962078|NCT01805401|Impulse control|impulse control
4962079|NCT01805401|Transcranial direct current stimulation|transcranial direct current stimulation
4962080|NCT01805401|Brain stimulation|brain stimulation
4962081|NCT01805401|Neuromodulation|neuromodulation
4962082|NCT01805401|tDCS|tdcs
4962083|NCT01805401|Iowa Gambling Task|iowa gambling task
4962084|NCT01805401|Stroop Word-Color Task|stroop word-color task
4962085|NCT01805388|Dental Pulp Regeneration|dental pulp regeneration
4962086|NCT01805375|Phase I, Cancer, CD19 positive, B-Cell lymphoma, chronic lymphocytic leukaemia|phase i, cancer, cd19 positive, b-cell lymphoma, chronic lymphocytic leukaemia
4962087|NCT01805375|Waldenström Macroglobulinaemia|waldenström macroglobulinaemia
4962088|NCT01805336|Relapsing-Remitting MS|relapsing-remitting ms
4962089|NCT01805336|cognitive impairment|cognitive impairment
4962090|NCT01805336|virtual reality|virtual reality
4962091|NCT01805310|Pelvic organ prolapse|pelvic organ prolapse
4962092|NCT01805310|Prolapse|prolapse
4962093|NCT01805310|Cathartics|cathartics
4962094|NCT01805310|Mechanical bowel preparation|mechanical bowel preparation
4962095|NCT01805297|Proliferative Diabetic Retinopathy|proliferative diabetic retinopathy
4962096|NCT01805284|pneumonia|pneumonia
4962097|NCT01805271|ER-positive HER2-negative|er-positive her2-negative
4962098|NCT01805258|India|india
4962099|NCT01805258|Nevirapine|nevirapine
4962100|NCT01805258|Rifampicin|rifampicin
4962101|NCT01805258|Efavirenz|efavirenz
4962102|NCT01805258|HIV|hiv
4962103|NCT01805258|TB|tb
4962104|NCT01805232|severe|severe
4962105|NCT01805232|Falciaparum|falciaparum
4962106|NCT01805232|Malaria|malaria
4962107|NCT01805206|Prematurity|prematurity
4962108|NCT01805206|Necrotizing Enterocolitis|necrotizing enterocolitis
4962109|NCT01805206|Biomarkers|biomarkers
4962110|NCT01805206|Intestinal Fatty Acid Binding Protein|intestinal fatty acid binding protein
4962111|NCT01805206|Feeding|feeding
4962112|NCT01805193|Coronary heart disease|coronary heart disease
4962113|NCT01805193|computed tomography myocardial perfusion|computed tomography myocardial perfusion
4962114|NCT01805193|positron emission tomography|positron emission tomography
4962115|NCT01805193|oxygen 15 labelled water|oxygen 15 labelled water
4962116|NCT01805193|myocardial perfusion|myocardial perfusion
4962117|NCT01805193|myocardial blood flow|myocardial blood flow
4962118|NCT01805167|Subject with cochlear implant|subject with cochlear implant
4962119|NCT01805141|Cervix Uteri|cervix uteri
4962120|NCT01805128|Schizophrenia|schizophrenia
4962121|NCT01805128|Autistic Disorder|autistic disorder
4962122|NCT01805128|social cognition|social cognition
4962123|NCT01805115|hysteroscopy|hysteroscopy
4962124|NCT01805115|misoprostol|misoprostol
4962125|NCT01805102|In vitro fertilization|in vitro fertilization
4962126|NCT01805102|implantation|implantation
4962127|NCT01805102|miscarriage|miscarriage
4962128|NCT01805102|live birth|live birth
4962129|NCT01805063|firefighters|firefighters
4962130|NCT01805063|myocardial infarction|myocardial infarction
4962131|NCT01805063|endothelial function|endothelial function
4962132|NCT01805063|thrombosis|thrombosis
4962133|NCT01805063|fire suppression|fire suppression
4962134|NCT01805063|non-fire emergency duty|non-fire emergency duty
4962135|NCT01805063|sedentary shift|sedentary shift
4962136|NCT01805050|HAGL|hagl
4962137|NCT01805050|Shoulder instability|shoulder instability
4962138|NCT01804998|laparoscopic sentinel lymph node biopsy|laparoscopic sentinel lymph node biopsy
4962139|NCT01804998|phase 3|phase 3
4962140|NCT01804998|early gastric cancer|early gastric cancer
4962141|NCT01804972|Patient information|patient information
4962142|NCT01804972|Vascular disease|vascular disease
4962143|NCT01804972|Abdominal aortic aneurysm|abdominal aortic aneurysm
4962144|NCT01804972|Varicose veins|varicose veins
4962145|NCT01804972|Web based information|web based information
4962146|NCT01804933|profound muscle relaxation|profound muscle relaxation
4962147|NCT01804933|muscle trauma|muscle trauma
4962148|NCT01804933|postoperative analgesic demand|postoperative analgesic demand
4962149|NCT01804933|postoperative pulmonary function|postoperative pulmonary function
4962150|NCT01804907|HAART adherence|haart adherence
4962151|NCT01804907|HIV|hiv
4962152|NCT01804907|Fatigue|fatigue
4962153|NCT01804907|treatment|treatment
4962154|NCT01804868|case vignette|case vignette
4962155|NCT01804868|nurse|nurse
4962156|NCT01804868|critical assessment|critical assessment
4962157|NCT01804868|randomized controlled trial|randomized controlled trial
4962158|NCT01804855|Obesity; mobile health; telemedicine; family-based treatment|obesity; mobile health; telemedicine; family-based treatment
4962159|NCT01804829|HCV Liver Transplant Immunoglobulin PCR SVR|hcv liver transplant immunoglobulin pcr svr
4962160|NCT01804816|Chronic Heart Failure|chronic heart failure
4962161|NCT01804816|Heart Failure|heart failure
4962162|NCT01804803|glycated hemoglobin|glycated hemoglobin
4962163|NCT01804803|hyperglycemia|hyperglycemia
4962164|NCT01804803|hypoglycemia|hypoglycemia
4962165|NCT01804803|insulin|insulin
4962166|NCT01804803|self-monitoring of blood glucose|self-monitoring of blood glucose
4962167|NCT01804803|telemedicine|telemedicine
4962168|NCT01804790|rectum|rectum
4962169|NCT01804790|cancer|cancer
4962170|NCT01804790|locally advanced|locally advanced
4962171|NCT01804777|ENaC|enac
4962172|NCT01804777|Amiloride|amiloride
4962173|NCT01804777|Hydrochlorothiazide(HCTZ)|hydrochlorothiazide(hctz)
4962174|NCT01804777|Hypertension|hypertension
4962175|NCT01804777|Type II Diabetes|type ii diabetes
4962176|NCT01804777|Natriuresis|natriuresis
4962177|NCT01804777|Proteinuria|proteinuria
4962178|NCT01804764|Severe Sepsis|severe sepsis
4962179|NCT01804764|Septic Shock|septic shock
4962180|NCT01804764|Sepsis Six bundle|sepsis six bundle
4962181|NCT01804738|Ethnic differences|ethnic differences
4962182|NCT01804738|Inter-individual variability|inter-individual variability
4962183|NCT01804738|Glycemic response|glycemic response
4962184|NCT01804738|Insulin response|insulin response
4962185|NCT01804738|Mastication|mastication
4962186|NCT01804738|Salivary alpha-amylase|salivary alpha-amylase
4962187|NCT01804738|Gastric emptying|gastric emptying
4962188|NCT01804738|Metagenome|metagenome
4962189|NCT01804725|bike seats|bike seats
4962190|NCT01804725|Erectile dysfunction|erectile dysfunction
4962191|NCT01804725|Perineum|perineum
4962192|NCT01804725|Impotence|impotence
4962193|NCT01804712|Prostate|prostate
4962194|NCT01804712|Cancer|cancer
4962195|NCT01804712|Castration-resistant|castration-resistant
4962196|NCT01804712|Rituximab|rituximab
4962197|NCT01804712|neoadjuvant|neoadjuvant
4962198|NCT01804712|Rituxan|rituxan
4962199|NCT01804699|ARVC, Cardiomyopathy|arvc, cardiomyopathy
4962200|NCT01804686|Chronic lymphocytic leukemia|chronic lymphocytic leukemia
4962201|NCT01804686|Small lymphocytic lymphoma|small lymphocytic lymphoma
4962202|NCT01804686|Mantle cell lymphoma|mantle cell lymphoma
4962203|NCT01804686|Follicular lymphoma|follicular lymphoma
4962204|NCT01804686|Diffuse large B-cell lymphoma|diffuse large b-cell lymphoma
4962205|NCT01804686|PCI-32765|pci-32765
4962206|NCT01804686|Ibrutinib|ibrutinib
4962207|NCT01804686|Bruton's tyrosine kinase inhibitor|bruton's tyrosine kinase inhibitor
4962208|NCT01804686|IMBRUVICA|imbruvica
4962209|NCT01804686|JNJ-54179060|jnj-54179060
4962210|NCT01804673|Postoperative Pain|postoperative pain
4962211|NCT01804673|Fentanyl Hydrochloride|fentanyl hydrochloride
4962212|NCT01804673|IONSYS|ionsys
4962213|NCT01804660|Multiple Sclerosis (MS)|multiple sclerosis (ms)
4962214|NCT01804660|Multiple Sclerosis associated RetroVirus (MSRV)|multiple sclerosis associated retrovirus (msrv)
4962215|NCT01804660|MSRV envelop protein (MSRV-Env)|msrv envelop protein (msrv-env)
4962216|NCT01804647|Multiple sclerosis (MS)|multiple sclerosis (ms)
4962217|NCT01804647|Relapsing-Remitting MS|relapsing-remitting ms
4962218|NCT01804647|Primary progressive MS|primary progressive ms
4962219|NCT01804647|Secondary progressive MS|secondary progressive ms
4962220|NCT01804647|Clinically Isolated Syndrome (CIS)|clinically isolated syndrome (cis)
4962221|NCT01804647|Multiple Sclerosis associated RetroVirus (MSRV)|multiple sclerosis associated retrovirus (msrv)
4962222|NCT01804647|MSRV envelop protein (MSRV-Env)|msrv envelop protein (msrv-env)
4962223|NCT01804634|Solid Tumors|solid tumors
4962224|NCT01804634|Neuroblastoma|neuroblastoma
4962225|NCT01804634|Osteosarcoma|osteosarcoma
4962226|NCT01804634|Ewing Sarcoma|ewing sarcoma
4962227|NCT01804634|Rhabdomyosarcoma|rhabdomyosarcoma
4962228|NCT01804634|Hepatoblastoma|hepatoblastoma
4962229|NCT01804634|Melanoma|melanoma
4962355|NCT01804257|Computers, handheld|computers, handheld
4962230|NCT01804634|Desmoplastic Round Cell Tumor|desmoplastic round cell tumor
4962231|NCT01804634|brain tumors|brain tumors
4962232|NCT01804621|Exercise|exercise
4962233|NCT01804621|Nutrition|nutrition
4962234|NCT01804621|Mammography|mammography
4962235|NCT01804621|Colorectal screening|colorectal screening
4962236|NCT01804595|Worksite intervention|worksite intervention
4962237|NCT01804595|Sun protection intervention|sun protection intervention
4962238|NCT01804595|Operating Engineers|operating engineers
4962239|NCT01804582|Family navigator|family navigator
4962240|NCT01804582|Patient Centered Outcomes|patient centered outcomes
4962241|NCT01804582|Pediatric Antipsychotic treatment|pediatric antipsychotic treatment
4962242|NCT01804556|muscle cramps, trigger points, sleep disturbance|muscle cramps, trigger points, sleep disturbance
4962243|NCT01804530|solid tumors|solid tumors
4962244|NCT01804530|activating NTRK point or fusion mutations|activating ntrk point or fusion mutations
4962245|NCT01804530|Tenosynovial giant cell tumor|tenosynovial giant cell tumor
4962246|NCT01804530|TGCT|tgct
4962247|NCT01804517|migraine|migraine
4962248|NCT01804504|Metabolic syndrome|metabolic syndrome
4962249|NCT01804504|Eating out of home|eating out of home
4962250|NCT01804504|Nutrition education|nutrition education
4962251|NCT01804465|castration resistant|castration resistant
4962252|NCT01804465|prostate|prostate
4962253|NCT01804465|cancer|cancer
4962254|NCT01804465|ipilimumab|ipilimumab
4962255|NCT01804465|provenge|provenge
4962256|NCT01804465|SipT|sipt
4962257|NCT01804452|Progressive Supranuclear Palsy|progressive supranuclear palsy
4962258|NCT01804452|Corticobasal Degeneration|corticobasal degeneration
4962259|NCT01804452|Biomarker|biomarker
4962260|NCT01804452|Neuroimaging|neuroimaging
4962261|NCT01804452|MRI|mri
4962262|NCT01804452|Tau|tau
4962263|NCT01804452|Oculomotor|oculomotor
4962264|NCT01804439|Heart diseases|heart diseases
4962265|NCT01804439|Cardiovascular diseases|cardiovascular diseases
4962266|NCT01804439|Coronary heart disease not otherwise specified|coronary heart disease not otherwise specified
4962267|NCT01804439|Cerebrovascular disorders|cerebrovascular disorders
4962268|NCT01804439|Brain diseases|brain diseases
4962269|NCT01804439|Central nervous system diseases|central nervous system diseases
4962270|NCT01804439|Nervous system diseases|nervous system diseases
4962271|NCT01804439|Atherosclerosis|atherosclerosis
4962272|NCT01804439|Arteriosclerosis|arteriosclerosis
4962273|NCT01804439|Pathologic processes|pathologic processes
4962274|NCT01804439|Acute myocardial infarction|acute myocardial infarction
4962275|NCT01804439|Myocardial infarction|myocardial infarction
4962276|NCT01804439|Myocardial ischemia|myocardial ischemia
4962277|NCT01804439|Infarction|infarction
4962278|NCT01804439|Necrosis|necrosis
4962279|NCT01804439|Unstable angina|unstable angina
4962280|NCT01804439|Chronic stable angina|chronic stable angina
4962281|NCT01804439|Stable angina|stable angina
4962282|NCT01804439|Angina pectoris|angina pectoris
4962283|NCT01804439|Chest pain|chest pain
4962284|NCT01804439|Pain|pain
4962285|NCT01804439|Signs and symptoms|signs and symptoms
4962286|NCT01804439|Ischemia|ischemia
4962287|NCT01804439|Ischemic stroke|ischemic stroke
4962288|NCT01804439|Hemorrhagic stroke|hemorrhagic stroke
4962289|NCT01804439|Stroke|stroke
4962290|NCT01804439|Subarachnoid hemorrhage|subarachnoid hemorrhage
4962291|NCT01804439|Transient ischemic attack|transient ischemic attack
4962292|NCT01804439|Abdominal aortic aneurysm|abdominal aortic aneurysm
4962293|NCT01804439|Aneurysm|aneurysm
4962294|NCT01804439|Aortic aneurysm|aortic aneurysm
4962295|NCT01804439|Aortic aneurysm, abdominal|aortic aneurysm, abdominal
4962296|NCT01804439|Aortic diseases|aortic diseases
4962297|NCT01804439|Peripheral arterial diseases|peripheral arterial diseases
4962298|NCT01804439|Peripheral vascular diseases|peripheral vascular diseases
4962299|NCT01804439|Vascular diseases|vascular diseases
4962300|NCT01804439|Peripheral occlusive diseases|peripheral occlusive diseases
4962301|NCT01804439|Sudden coronary death|sudden coronary death
4962302|NCT01804439|Ventricular arrhythmia|ventricular arrhythmia
4962303|NCT01804439|Sudden cardiac death|sudden cardiac death
4962304|NCT01804439|Cardiac arrest|cardiac arrest
4962305|NCT01804439|Heart failure|heart failure
4962306|NCT01804426|PTSD|ptsd
4962307|NCT01804426|Post Traumatic Stress Disorder|post traumatic stress disorder
4962308|NCT01804426|Cortisol|cortisol
4962309|NCT01804426|Alpha-Amylase|alpha-amylase
4962310|NCT01804426|bio-Markers|bio-markers
4962311|NCT01804413|Pegvisomant|pegvisomant
4962312|NCT01804413|Growth hormone|growth hormone
4962313|NCT01804413|Cortisol|cortisol
4962314|NCT01804413|Glucagon|glucagon
4962315|NCT01804413|Insulin|insulin
4962316|NCT01804387|Chronic Hepatitis B|chronic hepatitis b
4962317|NCT01804387|Telbivudine|telbivudine
4962318|NCT01804387|Adefovir|adefovir
4962319|NCT01804387|Lamivudine resistance|lamivudine resistance
4962320|NCT01804374|osteosarcoma|osteosarcoma
4962321|NCT01804374|sorafenib|sorafenib
4962322|NCT01804374|everolimus|everolimus
4962323|NCT01804374|sarcoma|sarcoma
4962324|NCT01804361|Dry Eye Syndromes|dry eye syndromes
4962325|NCT01804348|PROM|prom
4962326|NCT01804335|Lymphoma|lymphoma
4962327|NCT01804335|Early Stage Cutaneous T-Cell Lymphoma|early stage cutaneous t-cell lymphoma
4962328|NCT01804335|CTCL|ctcl
4962329|NCT01804335|CD5789 0.01% cream|cd5789 0.01% cream
4962330|NCT01804322|epilepsy|epilepsy
4962331|NCT01804322|chronic comorbidities|chronic comorbidities
4962332|NCT01804322|educational strategies|educational strategies
4962333|NCT01804322|drug interactions|drug interactions
4962334|NCT01804322|drug adverse effects|drug adverse effects
4962335|NCT01804309|axyllary lymph node|axyllary lymph node
4962336|NCT01804309|sentinel lymph node|sentinel lymph node
4962337|NCT01804309|lymphatic drainage|lymphatic drainage
4962338|NCT01804309|early breast cancer|early breast cancer
4962339|NCT01804309|axillary lymph node dissection|axillary lymph node dissection
4962340|NCT01804296|Teen|teen
4962341|NCT01804296|Adolescent|adolescent
4962342|NCT01804296|Depression|depression
4962343|NCT01804296|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
4962344|NCT01804296|TMS|tms
4962345|NCT01804270|Teen|teen
4962346|NCT01804270|Adolescent|adolescent
4962347|NCT01804270|Depression|depression
4962348|NCT01804270|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
4962349|NCT01804270|TMS|tms
4962350|NCT01804257|Adherence|adherence
4962351|NCT01804257|Bipolar disorder|bipolar disorder
4962352|NCT01804257|Cellular phone|cellular phone
4962353|NCT01804257|Cloud computing|cloud computing
4962354|NCT01804257|Computers|computers
4962356|NCT01804257|Digital health|digital health
4962357|NCT01804257|Digital health feedback system|digital health feedback system
4962358|NCT01804257|Ingestion Sensor|ingestion sensor
4962359|NCT01804257|Medication adherence|medication adherence
4962360|NCT01804257|Medication non-adherence|medication non-adherence
4962361|NCT01804257|Medication nonadherence|medication nonadherence
4962362|NCT01804257|Mobile phone|mobile phone
4962363|NCT01804257|Mobile health|mobile health
4962364|NCT01804257|Patient adherence|patient adherence
4962365|NCT01804257|Patient non-adherence|patient non-adherence
4962366|NCT01804257|Patient nonadherence|patient nonadherence
4962367|NCT01804257|Schizophrenia|schizophrenia
4962368|NCT01804257|Telehealth|telehealth
4962369|NCT01804257|Telemedicine|telemedicine
4962370|NCT01804257|Telenursing|telenursing
4962371|NCT01804257|Wearable sensor|wearable sensor
4962372|NCT01804244|Healthy|healthy
4962373|NCT01804244|Pharmacokinetics|pharmacokinetics
4962374|NCT01804244|Japanese|japanese
4962375|NCT01804231|Prostate Cancer|prostate cancer
4962376|NCT01804231|PET|pet
4962377|NCT01804231|MRI|mri
4962378|NCT01804231|Hybrid|hybrid
4962379|NCT01804231|Recurrence|recurrence
4962380|NCT01804231|Fluorocholine|fluorocholine
4962381|NCT01804205|magnesium sulfate|magnesium sulfate
4962382|NCT01804205|rocuronium|rocuronium
4962383|NCT01804205|neuromuscular block|neuromuscular block
4962384|NCT01804205|onset time|onset time
4962385|NCT01804205|elderly|elderly
4962386|NCT01804192|Acu-TENS|acu-tens
4962387|NCT01804192|MAP|map
4962388|NCT01804192|HR|hr
4962389|NCT01804192|HRV|hrv
4962390|NCT01804179|colon|colon
4962391|NCT01804179|rectum|rectum
4962392|NCT01804179|cancer|cancer
4962393|NCT01804179|screening|screening
4962394|NCT01804179|questionnaire|questionnaire
4962395|NCT01804179|testing|testing
4962396|NCT01804179|educational materials|educational materials
4962397|NCT01804166|Lymphoma, T-Cell, Peripheral, Infliximab, Golimumab, Remicade, Simponi, Ulcerative Colitis, Crohn's Disease, Inflammatory Bowel Disease|lymphoma, t-cell, peripheral, infliximab, golimumab, remicade, simponi, ulcerative colitis, crohn's disease, inflammatory bowel disease
4962398|NCT01804153|Feminine stress urinary incontinence|feminine stress urinary incontinence
4962399|NCT01804153|Autologous expanded stem cells|autologous expanded stem cells
4962400|NCT01804127|DLBCL|dlbcl
4962401|NCT01804127|R-CHOP|r-chop
4962402|NCT01804127|PET/CT|pet/ct
4962403|NCT01804088|Peripheral artery disease|peripheral artery disease
4962404|NCT01804088|Iliac arteries|iliac arteries
4962405|NCT01804088|Balloon-expandable stent|balloon-expandable stent
4962406|NCT01804075|NAS|nas
4962407|NCT01804075|NICU|nicu
4962408|NCT01804075|EMMC|emmc
4962409|NCT01804049|metformin|metformin
4962410|NCT01804049|muscle|muscle
4962411|NCT01804049|insulin resistance|insulin resistance
4962412|NCT01804049|sarcopenia|sarcopenia
4962413|NCT01804049|older adults|older adults
4962414|NCT01804049|impaired fasting glucose|impaired fasting glucose
4962415|NCT01803997|Child|child
4962416|NCT01803997|Nutrition|nutrition
4962417|NCT01803997|resonance Raman spectroscopy|resonance raman spectroscopy
4962418|NCT01803997|Fruit & Vegetable|fruit & vegetable
4962419|NCT01803997|Children Cooking|children cooking
4962420|NCT01803984|Migraine|migraine
4962421|NCT01803984|Brain structure|brain structure
4962422|NCT01803984|MRI|mri
4962423|NCT01803971|cardiac arrest|cardiac arrest
4962424|NCT01803971|peripheral venous access|peripheral venous access
4962425|NCT01803971|intraosseous access|intraosseous access
4962426|NCT01803945|Parkinson's disease|parkinson's disease
4962427|NCT01803945|cognitive impairment|cognitive impairment
4962428|NCT01803945|movement disorder|movement disorder
4962429|NCT01803932|intimate partner violence|intimate partner violence
4962430|NCT01803932|gender|gender
4962431|NCT01803932|primary prevention intervention|primary prevention intervention
4962432|NCT01803932|conflict|conflict
4962433|NCT01803932|Cote d'Ivoire|cote d'ivoire
4962434|NCT01803932|Ivory Coast|ivory coast
4962435|NCT01803919|Spinal cord injuries|spinal cord injuries
4962436|NCT01803919|Urinary tract infection|urinary tract infection
4962437|NCT01803919|Urinary catheters|urinary catheters
4962438|NCT01803919|Protocol|protocol
4962439|NCT01803919|Randomized clinical trial|randomized clinical trial
4962440|NCT01803906|mitochondrial disorder|mitochondrial disorder
4962441|NCT01803906|mitochondria|mitochondria
4962442|NCT01803906|oxidative phosphorylation|oxidative phosphorylation
4962443|NCT01803906|oxidative phosphorylation disorders|oxidative phosphorylation disorders
4962444|NCT01803906|respiratory chain disorders|respiratory chain disorders
4962445|NCT01803906|mitochondrial disease|mitochondrial disease
4962446|NCT01803906|melas|melas
4962447|NCT01803906|kearns sayer|kearns sayer
4962448|NCT01803906|NARP|narp
4962449|NCT01803906|MNGIE|mngie
4962450|NCT01803906|LHON|lhon
4962451|NCT01803906|Mitochondrial depletion syndrome|mitochondrial depletion syndrome
4962452|NCT01803906|Leigh's disease|leigh's disease
4962453|NCT01803893|In vitro fertilization|in vitro fertilization
4962454|NCT01803893|implantation|implantation
4962455|NCT01803893|miscarriage|miscarriage
4962456|NCT01803893|live birth|live birth
4962457|NCT01803880|Articular cartilage|articular cartilage
4962458|NCT01803880|Cartilage lesion|cartilage lesion
4962459|NCT01803880|Cartilage defect|cartilage defect
4962460|NCT01803880|Radiofrequency|radiofrequency
4962461|NCT01803880|Debridement|debridement
4962462|NCT01803880|Cartilage|cartilage
4962463|NCT01803880|Coblation|coblation
4962464|NCT01803880|Knee|knee
4962465|NCT01803880|Meniscus|meniscus
4962466|NCT01803880|Meniscectomy|meniscectomy
4962467|NCT01803880|MR imaging|mr imaging
4962468|NCT01803880|Mechanical debridement|mechanical debridement
4962469|NCT01803880|Mechanical shaver|mechanical shaver
4962470|NCT01803880|Torn meniscus|torn meniscus
4962471|NCT01803880|Arthroscopic knee surgery|arthroscopic knee surgery
4962472|NCT01803880|Damaged cartilage|damaged cartilage
4962473|NCT01803867|MS|ms
4962474|NCT01803867|Multiple Sclerosis|multiple sclerosis
4962475|NCT01803841|Coronary artery disease|coronary artery disease
4962476|NCT01803828|Diabetic Cardiomyopathy|diabetic cardiomyopathy
4962477|NCT01803828|Genders|genders
4962478|NCT01803828|Phosphodiesterase 5A inhibitors|phosphodiesterase 5a inhibitors
4962479|NCT01803828|miRNAs|mirnas
4962480|NCT01803828|Chemokines|chemokines
4962481|NCT01803815|obstructive sleep apnea|obstructive sleep apnea
4962482|NCT01803815|hypertension|hypertension
4962483|NCT01803815|antihypertensive drugs|antihypertensive drugs
4962484|NCT01803802|childhood sexual abuse|childhood sexual abuse
4962485|NCT01803802|depression|depression
4962486|NCT01803802|PTSD|ptsd
4962487|NCT01803802|sexual function|sexual function
4962488|NCT01803802|women|women
4962489|NCT01803789|Metacarpal V Fractures|metacarpal v fractures
4962490|NCT01803789|Single Kirschner Wires|single kirschner wires
4962491|NCT01803789|Double Kirschner Wires|double kirschner wires
4962492|NCT01803776|child|child
4962493|NCT01803776|physical activity|physical activity
4962494|NCT01803776|sedentary activity|sedentary activity
4962495|NCT01803776|nutrition|nutrition
4962496|NCT01803776|diet|diet
4962497|NCT01803776|body composition|body composition
4962498|NCT01803776|overweight|overweight
4962499|NCT01803776|obesity|obesity
4962500|NCT01803776|glucose metabolism disorders|glucose metabolism disorders
4962501|NCT01803776|lipid metabolism disorders|lipid metabolism disorders
4962502|NCT01803776|physical fitness|physical fitness
4962503|NCT01803776|cardiovascular system|cardiovascular system
4962504|NCT01803776|musculoskeletal system|musculoskeletal system
4962505|NCT01803776|bone mineral density|bone mineral density
4962506|NCT01803776|oral health|oral health
4962507|NCT01803776|quality of life|quality of life
4962508|NCT01803776|wellbeing|wellbeing
4962509|NCT01803776|gene-lifestyle interaction|gene-lifestyle interaction
4962510|NCT01803776|health economics|health economics
4962511|NCT01803763|Omalizumab|omalizumab
4962512|NCT01803763|Xolair|xolair
4962513|NCT01803763|Urticaria|urticaria
4962514|NCT01803763|basophils|basophils
4962515|NCT01803763|chronic Urticaria|chronic urticaria
4962516|NCT01803763|Fc Receptor|fc receptor
4962517|NCT01803750|Primary Care Providers|primary care providers
4962518|NCT01803750|Latino Populations|latino populations
4962519|NCT01803750|Disseminate Cancer Prevention|disseminate cancer prevention
4962520|NCT01803750|semi-structured interviews|semi-structured interviews
4962521|NCT01803750|13-031|13-031
4962522|NCT01803737|Weight Loss|weight loss
4962523|NCT01803737|Physical Activity|physical activity
4962524|NCT01803737|Dietary Intake|dietary intake
4962525|NCT01803737|Weight Loss Self-Efficacy|weight loss self-efficacy
4962526|NCT01803737|Motivation|motivation
4962527|NCT01803724|Irritable Bowel Syndrome|irritable bowel syndrome
4962528|NCT01803724|Small Intestinal Bacterial Overgrowth|small intestinal bacterial overgrowth
4962529|NCT01803724|Lactulose breath test|lactulose breath test
4962530|NCT01803724|Glucose breath test|glucose breath test
4962531|NCT01803724|Rifaximin|rifaximin
4962532|NCT01803711|Omega 3 fatty acid|omega 3 fatty acid
4962533|NCT01803711|Fish oil|fish oil
4962534|NCT01803711|Depression|depression
4962535|NCT01803711|cancer|cancer
4962536|NCT01803711|diabetes|diabetes
4962537|NCT01803711|high blood pressure|high blood pressure
4962538|NCT01803711|cardiovascular|cardiovascular
4962539|NCT01803698|Pregnancy|pregnancy
4962540|NCT01803698|Gestational weight gain|gestational weight gain
4962541|NCT01803698|Primary care|primary care
4962542|NCT01803698|Guidelines|guidelines
4962543|NCT01803685|Intracranial Arteriovenous Malformations|intracranial arteriovenous malformations
4962544|NCT01803685|Surgical removal|surgical removal
4962545|NCT01803685|Endovascular embolism|endovascular embolism
4962546|NCT01803685|Stereotaxic radiosurgery|stereotaxic radiosurgery
4962547|NCT01803685|Outcomes|outcomes
4962548|NCT01803672|Adventure-Based training|adventure-based training
4962549|NCT01803672|Health education|health education
4962550|NCT01803672|childhood cancer|childhood cancer
4962551|NCT01803672|physical activity|physical activity
4962552|NCT01803659|b-carotene|b-carotene
4962553|NCT01803659|breastmilk|breastmilk
4962554|NCT01803659|vitamin A|vitamin a
4962555|NCT01803568|Myokine|myokine
4962556|NCT01803568|Insulin sensitivity|insulin sensitivity
4962557|NCT01803568|Exercise|exercise
4962558|NCT01803568|Skeletal muscle|skeletal muscle
4962559|NCT01803555|Budesonide/Formoterol SPIROMAX®|budesonide/formoterol spiromax®
4962560|NCT01803555|SYMBICORT® TURBOHALER®|symbicort® turbohaler®
4962561|NCT01803555|Asthma|asthma
4962562|NCT01803542|Non-small Cell Lung Cancer|non-small cell lung cancer
4962563|NCT01803542|Stereotactic radiation for Lung Cancer|stereotactic radiation for lung cancer
4962564|NCT01803542|Cone beam CT for Lung Cancer|cone beam ct for lung cancer
4962565|NCT01803542|PET/CT for Lung Cancer|pet/ct for lung cancer
4962566|NCT01803529|thorax|thorax
4962567|NCT01803529|Intercostal Muscles|intercostal muscles
4962568|NCT01803529|massage|massage
4962569|NCT01803529|heat-pack|heat-pack
4962570|NCT01803529|hot temperature|hot temperature
4962571|NCT01803516|Quality of Life|quality of life
4962572|NCT01803516|Assessments|assessments
4962573|NCT01803516|Radiation|radiation
4962574|NCT01803516|Telangiectasias|telangiectasias
4962575|NCT01803516|13-013|13-013
4962576|NCT01803464|Botox|botox
4962577|NCT01803464|Muscle strength|muscle strength
4962578|NCT01803451|gastric bypass|gastric bypass
4962579|NCT01803451|glucose metabolism|glucose metabolism
4962678|NCT01803113|Pregnancy|pregnancy
4962580|NCT01803451|hypoglycemia|hypoglycemia
4962581|NCT01803438|paroxysmal Atrial Fibrillation|paroxysmal atrial fibrillation
4962582|NCT01803438|Cryoablation|cryoablation
4962583|NCT01803438|Pulmonary Vein Isolation|pulmonary vein isolation
4962584|NCT01803425|Post-marketing surveillance|post-marketing surveillance
4962585|NCT01803425|Prescribing Information (PI)|prescribing information (pi)
4962586|NCT01803425|Healthy infants and children|healthy infants and children
4962587|NCT01803425|Streptococcus pneumoniae|streptococcus pneumoniae
4962588|NCT01803425|Synflorix™|synflorix™
4962589|NCT01803425|Sri Lanka|sri lanka
4962590|NCT01803412|GSK2402968|gsk2402968
4962591|NCT01803412|open-label extension|open-label extension
4962592|NCT01803412|safety|safety
4962593|NCT01803412|drisapersen|drisapersen
4962594|NCT01803412|Duchenne Muscular Dystrophy|duchenne muscular dystrophy
4962595|NCT01803412|tolerability|tolerability
4962596|NCT01803412|Quality of Life|quality of life
4962597|NCT01803399|cardiac repolarization|cardiac repolarization
4962598|NCT01803399|oral|oral
4962599|NCT01803399|QTc|qtc
4962600|NCT01803399|GSK1322322|gsk1322322
4962601|NCT01803399|antibiotic|antibiotic
4962602|NCT01803399|12-lead ECG|12-lead ecg
4962603|NCT01803399|placebo|placebo
4962604|NCT01803399|IV|iv
4962605|NCT01803399|moxifloxacin|moxifloxacin
4962606|NCT01803386|ALS|als
4962607|NCT01803386|EIM|eim
4962608|NCT01803373|Healthy|healthy
4962609|NCT01803373|Biological Availability|biological availability
4962610|NCT01803373|Bioavailability|bioavailability
4962611|NCT01803373|TMC207|tmc207
4962612|NCT01803373|Bedaquiline|bedaquiline
4962613|NCT01803373|R207910|r207910
4962614|NCT01803347|phase III|phase iii
4962615|NCT01803347|Adipose derived stem cells|adipose derived stem cells
4962616|NCT01803347|Anal fistula|anal fistula
4962617|NCT01803347|Cell therapy|cell therapy
4962618|NCT01803347|Stem cell therapy|stem cell therapy
4962619|NCT01803334|surgical incision|surgical incision
4962620|NCT01803334|laparoscopy|laparoscopy
4962621|NCT01803334|pain|pain
4962622|NCT01803321|SJIA|sjia
4962623|NCT01803308|Hepatitis C Infection|hepatitis c infection
4962624|NCT01803308|Treatment Naïve, Chronic|treatment naïve, chronic
4962625|NCT01803308|First In Human|first in human
4962626|NCT01803308|Single Ascending Dose|single ascending dose
4962627|NCT01803308|Multiple Ascending Dose|multiple ascending dose
4962628|NCT01803295|Non Muscle Invasive Bladder Cancer|non muscle invasive bladder cancer
4962629|NCT01803295|Intravesical instillation|intravesical instillation
4962630|NCT01803295|Mitomycin C|mitomycin c
4962631|NCT01803295|Hydrogel Reverse thermal gelation|hydrogel reverse thermal gelation
4962632|NCT01803295|Drug retention|drug retention
4962633|NCT01803295|Urinary Bladder Neoplasms|urinary bladder neoplasms
4962634|NCT01803295|Urologic Neoplasms|urologic neoplasms
4962635|NCT01803295|Urinary Bladder Diseases|urinary bladder diseases
4962636|NCT01803295|Urologic Diseases|urologic diseases
4962637|NCT01803295|Mitomycin|mitomycin
4962638|NCT01803282|Solid Tumor|solid tumor
4962639|NCT01803282|NSCLC|nsclc
4962640|NCT01803282|Pancreatic|pancreatic
4962641|NCT01803282|Esophagogastric|esophagogastric
4962642|NCT01803282|Colorectal|colorectal
4962643|NCT01803282|Breast|breast
4962644|NCT01803230|children|children
4962645|NCT01803204|Anxiety|anxiety
4962646|NCT01803204|Orthognathic surgery|orthognathic surgery
4962647|NCT01803204|Patient educational as topic|patient educational as topic
4962648|NCT01803204|Patient educational handout|patient educational handout
4962649|NCT01803204|Pamphlets|pamphlets
4962650|NCT01803191|Transrectal ultrasound-guided prostate biopsy|transrectal ultrasound-guided prostate biopsy
4962651|NCT01803191|Bacteriuria|bacteriuria
4962652|NCT01803191|Antibiotic prophylaxis|antibiotic prophylaxis
4962653|NCT01803191|Prostate-Specific antigen|prostate-specific antigen
4962654|NCT01803178|vascular function|vascular function
4962655|NCT01803178|plant sterols|plant sterols
4962656|NCT01803178|blood lipids|blood lipids
4962657|NCT01803165|emesis,post operative.|emesis,post operative.
4962658|NCT01803165|cognitive dysfunction, post operative.|cognitive dysfunction, post operative.
4962659|NCT01803165|wound infection, post operative.|wound infection, post operative.
4962660|NCT01803165|pain, post operative.|pain, post operative.
4962661|NCT01803165|Anesthesia, Conduction/methods|anesthesia, conduction/methods
4962662|NCT01803165|Anesthesiology/methods|anesthesiology/methods
4962663|NCT01803165|Arteriovenous Shunt, Surgical/adverse effects|arteriovenous shunt, surgical/adverse effects
4962664|NCT01803165|Regional Blood Flow/drug effects|regional blood flow/drug effects
4962665|NCT01803165|Risk Factors|risk factors
4962666|NCT01803165|Thrombosis|thrombosis
4962667|NCT01803165|Treatment Outcome|treatment outcome
4962668|NCT01803165|Vascular Surgical Procedures/methods|vascular surgical procedures/methods
4962669|NCT01803165|Vasodilation/drug effects|vasodilation/drug effects
4962670|NCT01803152|Metastatic Sarcoma|metastatic sarcoma
4962671|NCT01803152|Relapsed Sarcoma|relapsed sarcoma
4962672|NCT01803152|Dendritic Cell|dendritic cell
4962673|NCT01803152|Myeloid Derived Suppressor Cells|myeloid derived suppressor cells
4962674|NCT01803152|MDSC|mdsc
4962675|NCT01803152|MDSC Inhibition|mdsc inhibition
4962676|NCT01803139|Breast cancer radiotherapy IMRT|breast cancer radiotherapy imrt
4962677|NCT01803126|atherosclerosis|atherosclerosis
4962679|NCT01803113|hCG|hcg
4962680|NCT01803100|Bacterial Colonization|bacterial colonization
4962681|NCT01803087|adolescents|adolescents
4962682|NCT01803087|adults|adults
4962683|NCT01803061|Head and neck cancer|head and neck cancer
4962684|NCT01803061|Quality of life|quality of life
4962685|NCT01803061|Symptom-burden|symptom-burden
4962686|NCT01803061|Late effects|late effects
4962687|NCT01803048|Traumatic Brain Injury|traumatic brain injury
4962688|NCT01803048|Diffusion Weighted Imaging|diffusion weighted imaging
4962689|NCT01803048|Resting State Functional Connectivity|resting state functional connectivity
4962690|NCT01803048|Cognition|cognition
4962691|NCT01803035|Impetigo|impetigo
4962692|NCT01803035|LTX-109|ltx-109
4962693|NCT01803035|Topical|topical
4962694|NCT01803035|Antibiotic|antibiotic
4962695|NCT01803035|Placebo|placebo
4962696|NCT01803035|Lytic|lytic
4962697|NCT01803035|Peptide|peptide
4962698|NCT01803035|Gram Positive|gram positive
4962699|NCT01803022|Venous Thromboembolism|venous thromboembolism
4962700|NCT01803022|Cancer|cancer
4962701|NCT01803022|Low Molecular Weight Heparin|low molecular weight heparin
4962702|NCT01802983|Aged|aged
4962703|NCT01802983|Multiple organ failure|multiple organ failure
4962704|NCT01802983|Extubation|extubation
4962705|NCT01802983|Prognosis|prognosis
4962706|NCT01802983|MODS|mods
4962707|NCT01802983|invasive mechanical ventilation|invasive mechanical ventilation
4962708|NCT01802970|Anakinra|anakinra
4962709|NCT01802970|Nab Paclitaxel|nab paclitaxel
4962710|NCT01802970|Capecitabine|capecitabine
4962711|NCT01802970|Eribulin|eribulin
4962712|NCT01802970|Vinorelbin|vinorelbin
4962713|NCT01802931|GSK239512|gsk239512
4962714|NCT01802931|H3 receptor antagonist|h3 receptor antagonist
4962715|NCT01802931|drug-drug interaction|drug-drug interaction
4962716|NCT01802931|pharmacokinetics|pharmacokinetics
4962717|NCT01802931|ketoconazole|ketoconazole
4962718|NCT01802918|single dose|single dose
4962719|NCT01802918|HIV|hiv
4962720|NCT01802918|maturation inhibitor|maturation inhibitor
4962721|NCT01802918|GSK2838232|gsk2838232
4962722|NCT01802918|FTIH|ftih
4962723|NCT01802918|healthy subjects|healthy subjects
4962724|NCT01802905|neoplasm|neoplasm
4962725|NCT01802905|metastatic cancer|metastatic cancer
4962726|NCT01802905|cancer genome|cancer genome
4962727|NCT01802905|genomic analysis|genomic analysis
4962728|NCT01802905|adults|adults
4962729|NCT01802892|ronacaleret|ronacaleret
4962730|NCT01802892|parathyroid hormone (PTH)|parathyroid hormone (pth)
4962731|NCT01802892|CD34+cells|cd34+cells
4962732|NCT01802892|calcium sensing receptor antagonist|calcium sensing receptor antagonist
4962733|NCT01802892|hematopoietic stem cells|hematopoietic stem cells
4962734|NCT01802892|stem cell mobilization|stem cell mobilization
4962735|NCT01802892|plerixafor|plerixafor
4962736|NCT01802892|healthy human volunteer, phase Ib|healthy human volunteer, phase ib
4962737|NCT01802879|Hematologic Neoplasms, LBH589,|hematologic neoplasms, lbh589,
4962738|NCT01802879|Panobinostat,|panobinostat,
4962739|NCT01802866|Geographic atrophy|geographic atrophy
4962740|NCT01802866|GA|ga
4962741|NCT01802866|Dry AMD|dry amd
4962742|NCT01802827|airway colonization|airway colonization
4962743|NCT01802827|tracheobronchitis|tracheobronchitis
4962744|NCT01802827|pneumonia|pneumonia
4962745|NCT01802814|ALL|all
4962746|NCT01802788|Aortic Stenosis|aortic stenosis
4962747|NCT01802788|Heart Valve Prosthesis|heart valve prosthesis
4962748|NCT01802788|Trans Catheter Aortic Valve Replacement|trans catheter aortic valve replacement
4962749|NCT01802788|TAVR|tavr
4962750|NCT01802788|Trans Catheter Aortic Valve Implant|trans catheter aortic valve implant
4962751|NCT01802788|TAVI|tavi
4962752|NCT01802749|second line|second line
4962753|NCT01802749|platinum sensitive|platinum sensitive
4962754|NCT01802749|first line bevacizumab|first line bevacizumab
4962755|NCT01802749|biologic factors|biologic factors
4962756|NCT01802749|clinical factors|clinical factors
4962757|NCT01802736|Alcohol HIV intervention counselling|alcohol hiv intervention counselling
4962758|NCT01802736|Alcohol Use in HIV infected Persons|alcohol use in hiv infected persons
4962759|NCT01802697|volunteers|volunteers
4962760|NCT01802684|unresectable|unresectable
4962761|NCT01802684|metastatic|metastatic
4962762|NCT01802684|colorectal|colorectal
4962763|NCT01802684|cancer|cancer
4962764|NCT01802684|OPTIMOX|optimox
4962765|NCT01802684|aflibercept|aflibercept
4962766|NCT01802671|Low back pain|low back pain
4962767|NCT01802671|Cognitive behavioural treatment|cognitive behavioural treatment
4962768|NCT01802671|internet|internet
4962769|NCT01802671|disability|disability
4962770|NCT01802658|Bone marrow demineralization lesions,: efficacy and tolerability, zoledronic acid|bone marrow demineralization lesions,: efficacy and tolerability, zoledronic acid
4962771|NCT01802645|neoadjuvant|neoadjuvant
4962772|NCT01802645|cetuximab|cetuximab
4962773|NCT01802645|irinotecan|irinotecan
4962774|NCT01802645|bevacizumab|bevacizumab
4962775|NCT01802645|oxaliplatin|oxaliplatin
4962776|NCT01802645|5-FU|5-fu
4962777|NCT01802645|Resection|resection
4962778|NCT01802645|colorectal liver metastases|colorectal liver metastases
4962779|NCT01802645|liver resection|liver resection
4962780|NCT01802645|Chemotherapy|chemotherapy
4962781|NCT01802645|k-ras|k-ras
4962782|NCT01802645|non-resectable|non-resectable
4962783|NCT01802632|Oncology,|oncology,
4962784|NCT01802632|Non Small Cell Lung Cancer,|non small cell lung cancer,
4962785|NCT01802632|Metastatic,|metastatic,
4962786|NCT01802632|EGFR sensitivity mutation,|egfr sensitivity mutation,
4962787|NCT01802632|T790M resistance mutation|t790m resistance mutation
4962788|NCT01802606|surgery|surgery
4962789|NCT01802606|administration|administration
4962790|NCT01802606|infection|infection
4962791|NCT01802593|Pediatric|pediatric
4962792|NCT01802593|Crohn's disease|crohn's disease
4962793|NCT01802593|Infliximab|infliximab
4962794|NCT01802593|Thiopurine|thiopurine
4962795|NCT01802554|Behavioral Activation|behavioral activation
4962796|NCT01802554|Caregiver|caregiver
4962797|NCT01802554|Dementia|dementia
4962798|NCT01802554|Cardiovascular Disease|cardiovascular disease
4962799|NCT01802554|Alzheimer's Disease|alzheimer's disease
4962800|NCT01802554|Coagulation|coagulation
4962801|NCT01802541|diacylglycerol oil|diacylglycerol oil
4962802|NCT01802541|insulin sensitivity|insulin sensitivity
4962803|NCT01802541|type 2 diabetes|type 2 diabetes
4962804|NCT01802541|cardiovascular disease|cardiovascular disease
4962805|NCT01802541|risk factors|risk factors
4962806|NCT01802528|obturator externus|obturator externus
4962807|NCT01802515|addiction|addiction
4962808|NCT01802515|cocaine|cocaine
4962809|NCT01802515|methadone|methadone
4962810|NCT01802515|opiates|opiates
4962811|NCT01802515|atomoxetine|atomoxetine
4962812|NCT01802502|tuberculous meningitis|tuberculous meningitis
4962813|NCT01802502|rifampicin|rifampicin
4962814|NCT01802502|bioequivalence|bioequivalence
4962815|NCT01802502|oral administration|oral administration
4962816|NCT01802502|intravenous administration|intravenous administration
4962817|NCT01802489|Optic neuritis|optic neuritis
4962818|NCT01802489|Multiple sclerosis|multiple sclerosis
4962819|NCT01802489|Retinal nerve fibre layer|retinal nerve fibre layer
4962820|NCT01802489|Axonal loss|axonal loss
4962821|NCT01802489|Neuroprotection|neuroprotection
4962822|NCT01802489|MRI|mri
4962823|NCT01802489|Optical coherence tomography|optical coherence tomography
4962824|NCT01802489|Amiloride|amiloride
4962825|NCT01802489|Acid Sensing Ion Channels|acid sensing ion channels
4962826|NCT01802476|PD-0332991|pd-0332991
4962827|NCT01802476|Absolute Bioavailability Study|absolute bioavailability study
4962828|NCT01802424|Open trial|open trial
4962829|NCT01802424|Indicative prevention|indicative prevention
4962830|NCT01802424|Youth anxiety|youth anxiety
4962831|NCT01802424|Cognitive behavioral therapy|cognitive behavioral therapy
4962832|NCT01802411|liposome bupivacaine|liposome bupivacaine
4962833|NCT01802411|posterolateral thoracotomy|posterolateral thoracotomy
4962834|NCT01802411|intercostal nerve block|intercostal nerve block
4962835|NCT01802411|postoperative pain|postoperative pain
4962836|NCT01802398|Risk Stratification|risk stratification
4962837|NCT01802398|Syncope|syncope
4962838|NCT01802398|Geriatric|geriatric
4962839|NCT01802385|cryptococcal meningitis|cryptococcal meningitis
4962840|NCT01802385|cryptococcus|cryptococcus
4962841|NCT01802385|meningitis|meningitis
4962842|NCT01802385|yeast|yeast
4962843|NCT01802385|fungus|fungus
4962844|NCT01802372|Hypertension|hypertension
4962845|NCT01802372|High Blood Pressure|high blood pressure
4962846|NCT01802372|Cardiovascular Diseases|cardiovascular diseases
4962847|NCT01802372|Health Insurance Coverage|health insurance coverage
4962848|NCT01802372|Low income countries|low income countries
4962849|NCT01802372|Ghana|ghana
4962850|NCT01802372|Low resource settings|low resource settings
4962851|NCT01802372|Comparative Effectiveness|comparative effectiveness
4962852|NCT01802372|Global Health|global health
4962853|NCT01802359|Erectile dysfunction|erectile dysfunction
4962854|NCT01802359|Mirodenafil|mirodenafil
4962855|NCT01802359|Bravonto|bravonto
4962856|NCT01802307|Focal therapy|focal therapy
4962857|NCT01802307|Brachytherapy|brachytherapy
4962858|NCT01802307|Active surveillance|active surveillance
4962859|NCT01802307|low risk cancer|low risk cancer
4962860|NCT01802294|Randomized Controlled Trials as Topic|randomized controlled trials as topic
4962861|NCT01802294|Child|child
4962862|NCT01802294|Parents|parents
4962863|NCT01802268|sirolimus|sirolimus
4962864|NCT01802268|tacrolimus|tacrolimus
4962865|NCT01802268|early conversion|early conversion
4962866|NCT01802255|Inhalatory sedation|inhalatory sedation
4962867|NCT01802255|Sevoflurane|sevoflurane
4962868|NCT01802255|AnaConDa|anaconda
4962869|NCT01802255|Nephrotoxicity|nephrotoxicity
4962870|NCT01802255|Hepatotoxicity|hepatotoxicity
4962871|NCT01802255|Midazolam|midazolam
4962872|NCT01802255|Propofol|propofol
4962873|NCT01802242|Prostate Cancer|prostate cancer
4962874|NCT01802242|Prostate tumour|prostate tumour
4962875|NCT01802242|Prostate radiotherapy|prostate radiotherapy
4962876|NCT01802242|prostate cancer treatment|prostate cancer treatment
4962877|NCT01802216|chronic kidney disease progression|chronic kidney disease progression
4962878|NCT01802216|periodontal disease|periodontal disease
4962879|NCT01802216|intensive periodontal disease treatment|intensive periodontal disease treatment
4962880|NCT01802203|Barrett esophagus|barrett esophagus
4962881|NCT01802203|Esophageal dysplasia|esophageal dysplasia
4962882|NCT01802203|Upper gastrointestinal squamous dysplasia|upper gastrointestinal squamous dysplasia
4962883|NCT01802203|Esophageal cancer|esophageal cancer
4962884|NCT01802203|Endobronchial cancer|endobronchial cancer
4962885|NCT01802203|Central airway cancer|central airway cancer
4962886|NCT01802203|Central airway precancerous disease|central airway precancerous disease
4962887|NCT01802203|Central airway granulation tissue|central airway granulation tissue
4962888|NCT01802203|Central airway papillomatosis|central airway papillomatosis
4962889|NCT01802203|Central airway sarcoidosis|central airway sarcoidosis
4962890|NCT01802203|Central airway tuberculosis|central airway tuberculosis
4962891|NCT01802203|Tracheal stenosis|tracheal stenosis
4962892|NCT01802203|Bronchial stenosis|bronchial stenosis
4962893|NCT01802190|Genetic deafness|genetic deafness
4962894|NCT01802190|SLC17A8 et POU4F3 genes|slc17a8 et pou4f3 genes
4962895|NCT01802177|Alopecia areata|alopecia areata
4962896|NCT01802177|Excimer|excimer
4962898|NCT01802151|probiotics|probiotics
4962899|NCT01802151|microbiota|microbiota
4962900|NCT01802151|survival|survival
4962901|NCT01802151|gastrointestinal|gastrointestinal
4962902|NCT01802151|wellness|wellness
4962903|NCT01802138|refractory/relapsed neuroblastoma patients|refractory/relapsed neuroblastoma patients
4962904|NCT01802112|Colonic transit|colonic transit
4962905|NCT01802112|Dietary Fiber|dietary fiber
4962906|NCT01802112|Radiopaque marker|radiopaque marker
4962907|NCT01802099|mechanical ventilation|mechanical ventilation
4962908|NCT01802099|early enteral nutrition|early enteral nutrition
4962909|NCT01802099|intensive care unit|intensive care unit
4962910|NCT01802099|early parenteral nutrition|early parenteral nutrition
4962911|NCT01802099|critical care medicine|critical care medicine
4962912|NCT01802099|nosocomial infection|nosocomial infection
4962913|NCT01802099|mortality|mortality
4962914|NCT01802099|shock|shock
4962915|NCT01802099|vasoactive drug|vasoactive drug
4962916|NCT01802086|Children|children
4962917|NCT01802086|Pain|pain
4962918|NCT01802086|Vaccination|vaccination
4962919|NCT01802086|Emla|emla
4962920|NCT01802086|Pneumococcal|pneumococcal
4962921|NCT01802086|Painscale|painscale
4962922|NCT01802073|Inflammation of the bile ducts|inflammation of the bile ducts
4962923|NCT01802073|biliary scarring|biliary scarring
4962924|NCT01802073|obstruction|obstruction
4962925|NCT01802060|Persona|persona
4962926|NCT01802060|E3G|e3g
4962927|NCT01802060|LH|lh
4962928|NCT01802060|ovulation|ovulation
4962929|NCT01802047|Mothers of Preterms|mothers of preterms
4962930|NCT01802047|Breastfeeding Mothers of Preterm infants|breastfeeding mothers of preterm infants
4962931|NCT01802047|mother milk feeding|mother milk feeding
4962932|NCT01802021|chinese medicine|chinese medicine
4962933|NCT01802021|non-small cell lung cancer|non-small cell lung cancer
4962934|NCT01802021|immunosuppression|immunosuppression
4962935|NCT01802008|Polyp/adenoma detection rate|polyp/adenoma detection rate
4962936|NCT01802008|Polyp/adenoma miss rate|polyp/adenoma miss rate
4962937|NCT01802008|Colonoscopy withdrawal time|colonoscopy withdrawal time
4962938|NCT01801982|PPHN; development progress after PPHN; developmental progress after sildenafil.|pphn; development progress after pphn; developmental progress after sildenafil.
4962939|NCT01801969|Brain injuries|brain injuries
4962940|NCT01801969|Rehabilitation services|rehabilitation services
4962941|NCT01801969|Return to Work|return to work
4962942|NCT01801969|Quality of life|quality of life
4962943|NCT01801956|Maximum oxygen uptake|maximum oxygen uptake
4962944|NCT01801956|Physical activity|physical activity
4962945|NCT01801956|Physical inactivity|physical inactivity
4962946|NCT01801956|Motivational interview|motivational interview
4962947|NCT01801956|Cardiorespiratory fitness|cardiorespiratory fitness
4962948|NCT01801956|Primary care|primary care
4962949|NCT01801956|Community care|community care
4962950|NCT01801930|OCV-C02|ocv-c02
4962951|NCT01801930|Colorectal Cancer|colorectal cancer
4962952|NCT01801930|Antigen specific cancer immunotherapeutic|antigen specific cancer immunotherapeutic
4962953|NCT01801917|Polymyositis|polymyositis
4962954|NCT01801917|Myositis|myositis
4962955|NCT01801917|PM|pm
4962956|NCT01801917|chronic muscle inflammation|chronic muscle inflammation
4962957|NCT01801917|inflammatory myopathy|inflammatory myopathy
4962958|NCT01801917|inclusion body myositis|inclusion body myositis
4962959|NCT01801904|cetuximab-refractory|cetuximab-refractory
4962960|NCT01801891|Venous ulceration|venous ulceration
4962961|NCT01801891|Leg ulcers|leg ulcers
4962962|NCT01801891|Venous haemodynamics|venous haemodynamics
4962963|NCT01801891|Surface neuromuscular electrical stimulation|surface neuromuscular electrical stimulation
4962964|NCT01801891|SNMES|snmes
4962965|NCT01801878|breast cancer|breast cancer
4962966|NCT01801878|loss of elasticity in irradiated breast skin|loss of elasticity in irradiated breast skin
4962967|NCT01801878|Other Reconstructive Surgery|other reconstructive surgery
4962968|NCT01801865|NICU|nicu
4962969|NCT01801865|MRI|mri
4962970|NCT01801865|Neonatal|neonatal
4962971|NCT01801865|Cincinnati|cincinnati
4962972|NCT01801813|Neuro-surgery|neuro-surgery
4962973|NCT01801813|Post-operative complications|post-operative complications
4962974|NCT01801813|Neuro-ICU resources|neuro-icu resources
4962975|NCT01801800|Aneurysmal subarachnoid haemorrhage|aneurysmal subarachnoid haemorrhage
4962976|NCT01801774|post-operative inflammation|post-operative inflammation
4962977|NCT01801774|steroid|steroid
4962978|NCT01801774|intraocular pressure|intraocular pressure
4962979|NCT01801748|wheat allergy|wheat allergy
4962980|NCT01801748|wheat outgrowing|wheat outgrowing
4962981|NCT01801748|wheat hypersensitivity|wheat hypersensitivity
4962982|NCT01801748|omega-5-gliadin|omega-5-gliadin
4962983|NCT01801748|natural history of wheat hypersensitivity|natural history of wheat hypersensitivity
4962984|NCT01801709|Brain Gene Therapy|brain gene therapy
4962985|NCT01801709|Adeno Associated vector|adeno associated vector
4962986|NCT01801709|Lysosomal sotage diseases|lysosomal sotage diseases
4962987|NCT01801709|Leukodystrophies|leukodystrophies
4962988|NCT01801696|Massage|massage
4962989|NCT01801696|effectiveness|effectiveness
4962990|NCT01801696|autism|autism
4962991|NCT01801696|parent stress|parent stress
4962992|NCT01801683|EBM|ebm
4962993|NCT01801683|general practice|general practice
4962994|NCT01801670|itch|itch
4962995|NCT01801670|pruritus|pruritus
4962996|NCT01801670|skin|skin
4962997|NCT01801670|vorinostat|vorinostat
4962998|NCT01801670|cutaneous T-cell lymphoma|cutaneous t-cell lymphoma
4962999|NCT01801670|mycosis fungoides|mycosis fungoides
4963000|NCT01801657|bronchiectasis|bronchiectasis
4963001|NCT01801657|exacerbation|exacerbation
4963002|NCT01801657|virus|virus
4963003|NCT01801644|bladder cancer|bladder cancer
4963004|NCT01801644|neoadjuvant chemotherapy|neoadjuvant chemotherapy
4963005|NCT01801644|gem/cis|gem/cis
4963006|NCT01801631|Type 2 diabetes|type 2 diabetes
4963007|NCT01801631|Acute Coronary Event (ACE)|acute coronary event (ace)
4963008|NCT01801631|Distress|distress
4963009|NCT01801631|Self-efficacy|self-efficacy
4963010|NCT01801631|Quality of Life|quality of life
4963011|NCT01801631|Depression|depression
4963012|NCT01801631|Primary care|primary care
4963013|NCT01801631|Illness representations|illness representations
4963014|NCT01801618|HIV|hiv
4963015|NCT01801618|PI based 2nd line ARV treatment|pi based 2nd line arv treatment
4963016|NCT01801618|Virological failure|virological failure
4963017|NCT01801618|Drug resistance|drug resistance
4963018|NCT01801618|Cambodia|cambodia
4963019|NCT01801618|Adherence|adherence
4963020|NCT01801605|IBS - rectal hypersensitivity - rectal barostat - rTMS.|ibs - rectal hypersensitivity - rectal barostat - rtms.
4963021|NCT01801592|OBSTRUCTIVE SLEEP APNOEA|obstructive sleep apnoea
4963022|NCT01801592|INTERMITTENT CLAUDICATION|intermittent claudication
4963023|NCT01801592|Respiratory disease|respiratory disease
4963024|NCT01801592|Peripheral artery disease|peripheral artery disease
4963025|NCT01801579|Ankle Brachial Index|ankle brachial index
4963026|NCT01801579|Maximal exercise|maximal exercise
4963027|NCT01801566|Mandibular Prosthesis Implantation|mandibular prosthesis implantation
4963028|NCT01801566|Prostheses and Implants|prostheses and implants
4963029|NCT01801566|Denture, Complete, Lower|denture, complete, lower
4963030|NCT01801553|spinal manipulation|spinal manipulation
4963031|NCT01801553|low back pain|low back pain
4963032|NCT01801553|manual therapy|manual therapy
4963033|NCT01801553|clinical predictive rule|clinical predictive rule
4963034|NCT01801527|Telehealth|telehealth
4963035|NCT01801527|Fatigue|fatigue
4963036|NCT01801527|Breast cancer|breast cancer
4963037|NCT01801527|Exercise|exercise
4963038|NCT01801527|Quality of life|quality of life
4963039|NCT01801527|Telerehabilitation|telerehabilitation
4963040|NCT01801475|Pharmacokinetics of ondansetron in women|pharmacokinetics of ondansetron in women
4963041|NCT01801475|Pharmacokinetics of ondansetron in neonates|pharmacokinetics of ondansetron in neonates
4963042|NCT01801475|Term pregnancy|term pregnancy
4963043|NCT01801475|Cesarean section|cesarean section
4963044|NCT01801462|Medical education|medical education
4963045|NCT01801462|Simulation|simulation
4963046|NCT01801462|Ultrasound training|ultrasound training
4963047|NCT01801462|Patient safety|patient safety
4963048|NCT01801449|DIRA|dira
4963049|NCT01801449|Clinical Trial|clinical trial
4963050|NCT01801449|IL-1|il-1
4963051|NCT01801449|Autoinflammatory Syndrome|autoinflammatory syndrome
4963052|NCT01801449|Rilonacept|rilonacept
4963053|NCT01801436|Multiple Myeloma|multiple myeloma
4963054|NCT01801436|Bortezomib|bortezomib
4963055|NCT01801436|Velcade|velcade
4963056|NCT01801423|transcranial Doppler|transcranial doppler
4963057|NCT01801423|stroke|stroke
4963058|NCT01801423|sickle cell anemia|sickle cell anemia
4963059|NCT01801423|Nigeria|nigeria
4963060|NCT01801423|hydroxyurea|hydroxyurea
4963061|NCT01801423|low income country|low income country
4963062|NCT01801410|pre-eclampsia|pre-eclampsia
4963063|NCT01801410|labor induction|labor induction
4963064|NCT01801410|misoprostol|misoprostol
4963065|NCT01801410|Foley catheter|foley catheter
4963066|NCT01801384|pregnancy|pregnancy
4963067|NCT01801384|cigarette smoking|cigarette smoking
4963068|NCT01801384|incentives|incentives
4963069|NCT01801384|smoking cessation|smoking cessation
4963070|NCT01801384|birth outcomes|birth outcomes
4963071|NCT01801371|Glioma|glioma
4963072|NCT01801371|Diagnostic imaging|diagnostic imaging
4963073|NCT01801371|Integrin receptor|integrin receptor
4963074|NCT01801371|68Ga-BNOTA-PRGD2|68ga-bnota-prgd2
4963075|NCT01801371|PET/CT|pet/ct
4963076|NCT01801358|Melanoma,|melanoma,
4963077|NCT01801358|melanoma of the eye,|melanoma of the eye,
4963078|NCT01801358|uveal,|uveal,
4963079|NCT01801358|MEK162,|mek162,
4963080|NCT01801358|AEB071|aeb071
4963081|NCT01801345|Human Performance|human performance
4963082|NCT01801345|Clinical Performance|clinical performance
4963083|NCT01801319|major depressive disorder (MDD)|major depressive disorder (mdd)
4963084|NCT01801319|deep brain stimulation (DBS)|deep brain stimulation (dbs)
4963085|NCT01801319|subcallosal cingulate gyrus|subcallosal cingulate gyrus
4963086|NCT01801319|Therapy-Resistant Depression|therapy-resistant depression
4963087|NCT01801319|Electrical Stimulation of the Brain|electrical stimulation of the brain
4963088|NCT01801319|Brain Stimulation, Deep|brain stimulation, deep
4963089|NCT01801293|RSV infection|rsv infection
4963090|NCT01801280|immunosuppressive medication|immunosuppressive medication
4963091|NCT01801280|mycophenolic acid|mycophenolic acid
4963092|NCT01801280|interaction|interaction
4963093|NCT01801280|proton pump inhibitor|proton pump inhibitor
4963094|NCT01801280|pantoprazole|pantoprazole
4963095|NCT01801280|renal transplant patients|renal transplant patients
4963096|NCT01801280|pharmacokinetics|pharmacokinetics
4963097|NCT01801280|pharmacodynamics|pharmacodynamics
4963098|NCT01801280|bioavailability|bioavailability
4963099|NCT01801267|Hydrocephalus|hydrocephalus
4963100|NCT01801267|Pediatric|pediatric
4963101|NCT01801267|Ventricular shunt|ventricular shunt
4963102|NCT01801267|Ventriculoperitoneal shunt|ventriculoperitoneal shunt
4963103|NCT01801267|Third ventriculostomy|third ventriculostomy
4963104|NCT01801267|Randomized controlled trial|randomized controlled trial
4963105|NCT01801254|Obesity|obesity
4963106|NCT01801254|Type II diabetes|type ii diabetes
4963107|NCT01801254|Cardiovascular disease|cardiovascular disease
4963108|NCT01801254|Health behavior promotion|health behavior promotion
4963109|NCT01801254|Neuroeconomics|neuroeconomics
4963110|NCT01801254|EEG biofeedback|eeg biofeedback
4963111|NCT01801254|Low-resolution electromagnetic tomography (LORETA)|low-resolution electromagnetic tomography (loreta)
4963112|NCT01801254|EEG|eeg
4963113|NCT01801176|proved by biopsy|proved by biopsy
4963114|NCT01801150|Diabetes|diabetes
4963115|NCT01801150|Apnea- hypopnea Syndrome|apnea- hypopnea syndrome
4963116|NCT01801150|Glycemic control|glycemic control
4963117|NCT01801150|Prevalence|prevalence
4963118|NCT01801150|SAHS|sahs
4963119|NCT01801150|life quality|life quality
4963120|NCT01801124|analgesia|analgesia
4963121|NCT01801124|hernia repair|hernia repair
4963122|NCT01801098|TAVI|tavi
4963123|NCT01801098|complete AV-block|complete av-block
4963124|NCT01801098|HV-interval|hv-interval
4963125|NCT01801098|permanent pacemaker|permanent pacemaker
4963126|NCT01801085|Time-and-Motion|time-and-motion
4963127|NCT01801085|Neoplasm|neoplasm
4963128|NCT01801085|Colorectal Cancer|colorectal cancer
4963129|NCT01801059|colon cancer|colon cancer
4963130|NCT01801059|Colorectal Cancer Screening|colorectal cancer screening
4963131|NCT01801033|Trioodothyronine (T3)|trioodothyronine (t3)
4963132|NCT01801033|Thyroid Hormone Action|thyroid hormone action
4963133|NCT01801033|Deiodinases|deiodinases
4963134|NCT01801033|Hypothyroid|hypothyroid
4963135|NCT01801033|Propylthiouracil (PTU)|propylthiouracil (ptu)
4963136|NCT01801020|temperature|temperature
4963137|NCT01800994|convenience|convenience
4963138|NCT01800981|Functionality|functionality
4963139|NCT01800981|extremities|extremities
4963140|NCT01800981|ROM|rom
4963141|NCT01800981|Upper and lower Extremity for burned patients|upper and lower extremity for burned patients
4963142|NCT01800955|physical therapy|physical therapy
4963143|NCT01800955|diathermy|diathermy
4963144|NCT01800955|knee|knee
4963145|NCT01800955|osteoarthritis|osteoarthritis
4963146|NCT01800955|pain|pain
4963147|NCT01800955|physical function|physical function
4963148|NCT01800942|prevention|prevention
4963149|NCT01800942|bacterial infection|bacterial infection
4963150|NCT01800942|neonates|neonates
4963151|NCT01800942|women in labour|women in labour
4963152|NCT01800942|Azithromycin|azithromycin
4963153|NCT01800916|ileostomy|ileostomy
4963154|NCT01800916|Subjects|subjects
4963155|NCT01800890|stoma ileostomy|stoma ileostomy
4963156|NCT01800877|hypotension|hypotension
4963157|NCT01800877|vasopressors|vasopressors
4963158|NCT01800877|titration|titration
4963159|NCT01800877|tissue perfusion|tissue perfusion
4963160|NCT01800877|organ failure|organ failure
4963161|NCT01800851|Kidney transplantation|kidney transplantation
4963162|NCT01800851|Energy expenditure|energy expenditure
4963163|NCT01800851|Weight gain|weight gain
4963164|NCT01800851|Insulin resistance|insulin resistance
4963165|NCT01800825|Pregnancy|pregnancy
4963166|NCT01800825|Prematurity|prematurity
4963167|NCT01800825|Preterm birth|preterm birth
4963168|NCT01800825|bacterial vaginosis|bacterial vaginosis
4963169|NCT01800799|Urinary tract infection|urinary tract infection
4963170|NCT01800799|Urothelium|urothelium
4963171|NCT01800799|Inflammation|inflammation
4963172|NCT01800799|Apoptosis|apoptosis
4963173|NCT01800773|PTSD|ptsd
4963174|NCT01800773|exposure treatment|exposure treatment
4963175|NCT01800773|clinical trial|clinical trial
4963176|NCT01800773|trauma|trauma
4963177|NCT01800760|healthy|healthy
4963178|NCT01800760|obese|obese
4963179|NCT01800760|women|women
4963180|NCT01800747|Delayed antibiotic treatment|delayed antibiotic treatment
4963181|NCT01800747|Acute respiratory infections|acute respiratory infections
4963182|NCT01800747|Pediatrics|pediatrics
4963183|NCT01800747|Satisfaction|satisfaction
4963184|NCT01800734|Mixed meal test|mixed meal test
4963185|NCT01800734|Insulin pump|insulin pump
4963186|NCT01800734|Continuous glucose monitoring|continuous glucose monitoring
4963187|NCT01800734|Metabolic control analysis|metabolic control analysis
4963188|NCT01800734|Closed loop control|closed loop control
4963189|NCT01800734|Artificial pancreas|artificial pancreas
4963190|NCT01800721|HIV|hiv
4963191|NCT01800721|testing|testing
4963192|NCT01800721|Social Network|social network
4963193|NCT01800721|African American|african american
4963194|NCT01800721|MSM|msm
4963195|NCT01800721|Men who have sex with men|men who have sex with men
4963196|NCT01800695|GBM|gbm
4963197|NCT01800682|Healthy|healthy
4963198|NCT01800682|Tramodol|tramodol
4963199|NCT01800682|Ultram|ultram
4963200|NCT01800669|Computer based clinical decision support|computer based clinical decision support
4963201|NCT01800669|medical legal partnership|medical legal partnership
4963202|NCT01800669|child|child
4963203|NCT01800669|pediatrics|pediatrics
4963204|NCT01800643|Busulfan|busulfan
4963205|NCT01800643|plasmatic dosage|plasmatic dosage
4963206|NCT01800643|Stem Cell Transplantation|stem cell transplantation
4963207|NCT01800578|Cerebral State Index Monitor|cerebral state index monitor
4963208|NCT01800565|precocious puberty|precocious puberty
4963209|NCT01800565|urinary LH|urinary lh
4963210|NCT01800565|GnRH stimulation test|gnrh stimulation test
4963211|NCT01800565|gonadotropins|gonadotropins
4963212|NCT01800552|Infiltration|infiltration
4963213|NCT01800552|Extravasation|extravasation
4963214|NCT01800552|Leaking|leaking
4963215|NCT01800552|PIV Infiltration|piv infiltration
4963216|NCT01800552|IV Infiltration|iv infiltration
4963217|NCT01800552|Ultrasound Detection of Infiltration|ultrasound detection of infiltration
4963218|NCT01800552|Ultrasound Imaging|ultrasound imaging
4963219|NCT01800539|Autism|autism
4963220|NCT01800539|Early Intervention|early intervention
4963221|NCT01800539|Minority|minority
4963222|NCT01800526|Sickle Cell Disease|sickle cell disease
4963223|NCT01800526|Sickle Cell Anemia|sickle cell anemia
4963224|NCT01800513|Implantation Failure|implantation failure
4963225|NCT01800513|In-vitro Fertilization|in-vitro fertilization
4963226|NCT01800513|Infertility|infertility
4963227|NCT01800513|Endometrial Biopsy|endometrial biopsy
4963228|NCT01800487|Drug-induced liver injury|drug-induced liver injury
4963229|NCT01800487|Tuberculosis|tuberculosis
4963230|NCT01800487|Silymarin|silymarin
4963231|NCT01800461|Participation|participation
4963232|NCT01800461|Occupational Therapy|occupational therapy
4963233|NCT01800461|Valued Activities|valued activities
4963234|NCT01800448|Respiratory monitoring|respiratory monitoring
4963235|NCT01800448|cardiac monitoring|cardiac monitoring
4963236|NCT01800448|skin conductance monitoring|skin conductance monitoring
4963237|NCT01800448|variability|variability
4963238|NCT01800409|Tetraplegia|tetraplegia
4963239|NCT01800396|Bacterial infection|bacterial infection
4963240|NCT01800396|Dairy|dairy
4963241|NCT01800396|Diarrhea|diarrhea
4963242|NCT01800396|Diet|diet
4963243|NCT01800396|E.Coli|e.coli
4963244|NCT01800396|Gastroenteritis|gastroenteritis
4963245|NCT01800396|Milk|milk
4963246|NCT01800396|Stool consistency|stool consistency
4963247|NCT01800383|posttraumatic stress disorder|posttraumatic stress disorder
4963248|NCT01800383|fear conditioning|fear conditioning
4963249|NCT01800383|proton magnetic resonance spectroscopy|proton magnetic resonance spectroscopy
4963250|NCT01800383|GABA|gaba
4963251|NCT01800370|Healthy|healthy
4963252|NCT01800370|Male|male
4963253|NCT01800357|randomized trial|randomized trial
4963254|NCT01800357|acute ischemic stroke|acute ischemic stroke
4963255|NCT01800357|mildronate|mildronate
4963256|NCT01800344|Airway Cuff|airway cuff
4963258|NCT01800344|Ultra|ultra
4963259|NCT01800344|Cuff Pressure|cuff pressure
4963260|NCT01800344|Ventilation|ventilation
4963261|NCT01800344|Anesthesia|anesthesia
4963262|NCT01800344|Intubation|intubation
4963263|NCT01800318|NESAP|nesap
4963264|NCT01800318|sucrose|sucrose
4963265|NCT01800318|pain|pain
4963266|NCT01800318|infants|infants
4963267|NCT01800305|PK & PD study|pk & pd study
4963268|NCT01800305|rhEPO|rhepo
4963269|NCT01800305|Pegylated rhEPO|pegylated rhepo
4963270|NCT01800305|male healthy subject|male healthy subject
4963271|NCT01800292|Pulmonary Artery Hypertension|pulmonary artery hypertension
4963272|NCT01800292|pulmonary capillary wedge pressure|pulmonary capillary wedge pressure
4963273|NCT01800292|sildenafil|sildenafil
4963274|NCT01800292|echocardiography|echocardiography
4963275|NCT01800292|left ventricular longitudinal wall strain|left ventricular longitudinal wall strain
4963276|NCT01800292|strain rate pre and post medical therapy|strain rate pre and post medical therapy
4963277|NCT01800292|speckle tracking|speckle tracking
4963278|NCT01800279|Fibromyalgia Syndrome, Temporomandibular Joint, Pain.|fibromyalgia syndrome, temporomandibular joint, pain.
4963279|NCT01800266|Supervision|supervision
4963280|NCT01800266|Implementation|implementation
4963281|NCT01800266|Community Based Mental Health Services|community based mental health services
4963282|NCT01800266|Trauma Focused Cognitive Behavioral Therapy|trauma focused cognitive behavioral therapy
4963283|NCT01800266|Skill Building and Behavioral Rehearsal|skill building and behavioral rehearsal
4963284|NCT01800266|Symptom and Fidelity Monitoring|symptom and fidelity monitoring
4963285|NCT01800266|Children|children
4963286|NCT01800266|Adolescents|adolescents
4963287|NCT01800214|neurodengeneration|neurodengeneration
4963288|NCT01800214|neuroimaging|neuroimaging
4963289|NCT01800201|Initial occurrence Acute Myocardial Infarction (AMI)|initial occurrence acute myocardial infarction (ami)
4963290|NCT01800188|Dialysis|dialysis
4963291|NCT01800188|Incretin hormones|incretin hormones
4963292|NCT01800149|Tooth extraction|tooth extraction
4963293|NCT01800149|Ridge Preservation|ridge preservation
4963294|NCT01800149|Ridge Augmentation|ridge augmentation
4963295|NCT01800149|Guided Bone Regeneration|guided bone regeneration
4963296|NCT01800136|pain|pain
4963297|NCT01800136|neuropathic|neuropathic
4963298|NCT01800136|cortical stimulation|cortical stimulation
4963299|NCT01800136|motor cortex|motor cortex
4963300|NCT01800136|plasticity|plasticity
4963301|NCT01800136|rTMS|rtms
4963302|NCT01800136|tDCS|tdcs
4963303|NCT01800123|Intoxication, overdose, poisoning, EtCO2, emergency medicine|intoxication, overdose, poisoning, etco2, emergency medicine
4963304|NCT01800097|stroke|stroke
4963305|NCT01800097|fatigue|fatigue
4963306|NCT01800097|modafinil|modafinil
4963307|NCT01800084|ASIR|asir
4963308|NCT01800084|image acquisition|image acquisition
4963309|NCT01800084|FBP|fbp
4963310|NCT01800071|Nasopharyngeal cancer|nasopharyngeal cancer
4963311|NCT01800071|Epstein Barr Virus Infections|epstein barr virus infections
4963312|NCT01800071|Vaccination|vaccination
4963313|NCT01800045|Narcolepsy|narcolepsy
4963314|NCT01800045|Cataplexy|cataplexy
4963315|NCT01800045|Sleep disorder|sleep disorder
4963316|NCT01800045|Excessive daytime sleepiness|excessive daytime sleepiness
4963317|NCT01800006|Atrial Fibrillation|atrial fibrillation
4963318|NCT01800006|Observation|observation
4963319|NCT01800006|Stroke|stroke
4963320|NCT01800006|Embolism|embolism
4963321|NCT01799993|Gram-negative pneumonia|gram-negative pneumonia
4963322|NCT01799993|Intubation|intubation
4963323|NCT01799993|Mechanical ventilation|mechanical ventilation
4963324|NCT01799993|Amikacin|amikacin
4963325|NCT01799980|Lung cancer|lung cancer
4963326|NCT01799980|Cervical mediastinoscopy|cervical mediastinoscopy
4963327|NCT01799980|Endobronchial ultrasound|endobronchial ultrasound
4963328|NCT01799980|Staging|staging
4963329|NCT01799967|gastro-esophageal junction|gastro-esophageal junction
4963330|NCT01799967|minimally invasive|minimally invasive
4963331|NCT01799967|Achalasia|achalasia
4963332|NCT01799967|Paraesophageal hernia|paraesophageal hernia
4963333|NCT01799967|GERD|gerd
4963334|NCT01799967|Epiphrenic diverticula|epiphrenic diverticula
4963335|NCT01799967|Zenker's diverticulum|zenker's diverticulum
4963336|NCT01799967|All minimally invasive surgeries of the gastro-esophageal junction|all minimally invasive surgeries of the gastro-esophageal junction
4963337|NCT01799902|Observational|observational
4963338|NCT01799902|Non-Interventional Prospective|non-interventional prospective
4963339|NCT01799902|Phase IV Treatment|phase iv treatment
4963340|NCT01799902|Overactive Bladder Syndrome|overactive bladder syndrome
4963341|NCT01799902|Solifenacin|solifenacin
4963342|NCT01799889|GS-US-339-0102|gs-us-339-0102
4963343|NCT01799889|SYK inhibitor|syk inhibitor
4963344|NCT01799889|GS-9973|gs-9973
4963345|NCT01799889|entospletinib|entospletinib
4963346|NCT01799889|CLL|cll
4963347|NCT01799889|leukemia|leukemia
4963348|NCT01799889|lymphoma|lymphoma
4963349|NCT01799889|MCL|mcl
4963350|NCT01799889|DLBCL|dlbcl
4963351|NCT01799889|iNHL|inhl
4963352|NCT01799889|FL|fl
4963353|NCT01799889|MZL|mzl
4963354|NCT01799889|LPL|lpl
4963355|NCT01799889|SLL|sll
4963356|NCT01799889|WM|wm
4963357|NCT01799889|Waldenström's macroglobulinemia|waldenström's macroglobulinemia
4963358|NCT01799876|knee|knee
4963359|NCT01799876|cartilage|cartilage
4963360|NCT01799876|microfracture|microfracture
4963361|NCT01799876|cell therapy|cell therapy
4963362|NCT01799863|Conjunctivitis, Viral|conjunctivitis, viral
4963363|NCT01799863|Ketorolac|ketorolac
4963364|NCT01799863|Artificial tears|artificial tears
4963365|NCT01799850|muscle|muscle
4963366|NCT01799850|glucose transporters|glucose transporters
4963367|NCT01799850|GLUT4|glut4
4963368|NCT01799850|GLUT5|glut5
4963369|NCT01799850|Actos|actos
4963370|NCT01799837|PTSD|ptsd
4963371|NCT01799811|allograft|allograft
4963372|NCT01799811|limb salvage|limb salvage
4963373|NCT01799811|patency|patency
4963374|NCT01799811|Cryopreserved|cryopreserved
4963375|NCT01799811|open bypass|open bypass
4963376|NCT01799798|Osteogenesis imperfecta|osteogenesis imperfecta
4963377|NCT01799798|COL1A1/A2|col1a1/a2
4963378|NCT01799798|Denosumab|denosumab
4963379|NCT01799798|Bisphosphonates|bisphosphonates
4963380|NCT01799798|Children|children
4963381|NCT01799798|Areal bone mineral density|areal bone mineral density
4963382|NCT01799759|Body Mass Percentile|body mass percentile
4963383|NCT01799759|Authoritative parenting|authoritative parenting
4963384|NCT01799759|Online interventions|online interventions
4963385|NCT01799759|Prevention|prevention
4963386|NCT01799733|Premenstrual Dysphoric Disorder|premenstrual dysphoric disorder
4963387|NCT01799733|Women|women
4963388|NCT01799733|Depression|depression
4963389|NCT01799733|Light therapy|light therapy
4963390|NCT01799733|Wake therapy|wake therapy
4963391|NCT01799733|Phase|phase
4963392|NCT01799733|Chronobiology|chronobiology
4963393|NCT01799720|blood cholesterol|blood cholesterol
4963394|NCT01799720|blood lipid profile|blood lipid profile
4963395|NCT01799720|triglycerides|triglycerides
4963396|NCT01799720|commercial pills|commercial pills
4963397|NCT01799720|fish oil|fish oil
4963398|NCT01799720|lipid peroxidation|lipid peroxidation
4963399|NCT01799720|Circulating lipidic profile|circulating lipidic profile
4963400|NCT01799707|vision|vision
4963401|NCT01799707|restoration|restoration
4963402|NCT01799707|visual field|visual field
4963403|NCT01799694|Urinary incontinence|urinary incontinence
4963404|NCT01799694|Autologous expanded stem cells|autologous expanded stem cells
4963405|NCT01799694|Radical prostate cancer surgery|radical prostate cancer surgery
4963406|NCT01799681|randomised controlled trial, postural balance, rehabilitation, exercise therapy, accidental falls|randomised controlled trial, postural balance, rehabilitation, exercise therapy, accidental falls
4963407|NCT01799668|Psychotherapy|psychotherapy
4963408|NCT01799668|Preferences|preferences
4963409|NCT01799642|dyspnea|dyspnea
4963410|NCT01799642|exercise|exercise
4963411|NCT01799642|cystic fibrosis|cystic fibrosis
4963412|NCT01799642|neuromechanical dissociation|neuromechanical dissociation
4963413|NCT01799629|Glycerin suppositories|glycerin suppositories
4963414|NCT01799629|Feeding intolerance|feeding intolerance
4963415|NCT01799629|preterm infants|preterm infants
4963416|NCT01799629|prophylactic use|prophylactic use
4963417|NCT01799629|elimination of meconium|elimination of meconium
4963418|NCT01799616|MODIC changes|modic changes
4963419|NCT01799616|Chronic low back pain|chronic low back pain
4963420|NCT01799616|Pamidronate|pamidronate
4963421|NCT01799616|Magnetic resonance imaging|magnetic resonance imaging
4963422|NCT01799616|Vertebrae|vertebrae
4963423|NCT01799616|Intervertebral disc|intervertebral disc
4963424|NCT01799603|Healthy|healthy
4963425|NCT01799603|TMC435|tmc435
4963426|NCT01799603|G008|g008
4963427|NCT01799590|Migraine|migraine
4963428|NCT01799590|Topiramate|topiramate
4963429|NCT01799577|laparoscopy, accuracy, duration|laparoscopy, accuracy, duration
4963430|NCT01799564|Geographic atrophy|geographic atrophy
4963431|NCT01799564|Age-related macular degeneration|age-related macular degeneration
4963432|NCT01799564|Fundus autofluorescence|fundus autofluorescence
4963433|NCT01799551|Depression|depression
4963434|NCT01799551|Culture|culture
4963435|NCT01799551|CBT|cbt
4963436|NCT01799551|Adaptation|adaptation
4963437|NCT01799538|Albuterol|albuterol
4963438|NCT01799538|Bronchodilator|bronchodilator
4963439|NCT01799538|Nebulizer|nebulizer
4963440|NCT01799538|Metered Dose Inhaler|metered dose inhaler
4963441|NCT01799525|Aneurysm|aneurysm
4963442|NCT01799525|subarachnoid hemorrhage|subarachnoid hemorrhage
4963443|NCT01799525|vasospasm|vasospasm
4963444|NCT01799525|cerebral ischemia|cerebral ischemia
4963445|NCT01799525|stroke|stroke
4963446|NCT01799512|medical ICU patients|medical icu patients
4963447|NCT01799512|APACHE-II score ≥20|apache-ii score ≥20
4963448|NCT01799499|Non Muscle Invasive Bladder Cancer|non muscle invasive bladder cancer
4963449|NCT01799499|Intravesical instillation|intravesical instillation
4963450|NCT01799499|Mitomycin C|mitomycin c
4963451|NCT01799499|Hydrogel|hydrogel
4963452|NCT01799499|Reverse thermal gelation|reverse thermal gelation
4963453|NCT01799499|Drug retention|drug retention
4963454|NCT01799499|Urinary Bladder Neoplasms|urinary bladder neoplasms
4963455|NCT01799499|Carcinoma|carcinoma
4963456|NCT01799499|Urologic Neoplasms|urologic neoplasms
4963457|NCT01799499|Urogenital Neoplasms|urogenital neoplasms
4963458|NCT01799499|Neoplasms by Site|neoplasms by site
4963459|NCT01799499|Neoplasms|neoplasms
4963460|NCT01799499|Urinary Bladder Diseases|urinary bladder diseases
4963461|NCT01799499|Urologic Diseases|urologic diseases
4963462|NCT01799499|Neoplasms, Glandular and Epithelial|neoplasms, glandular and epithelial
4963463|NCT01799499|Neoplasms by Histologic Type Mitomycins|neoplasms by histologic type mitomycins
4963464|NCT01799499|Mitomycin|mitomycin
4963465|NCT01799499|Antibiotics, Antineoplastic|antibiotics, antineoplastic
4963466|NCT01799499|Antineoplastic Agents|antineoplastic agents
4963467|NCT01799499|Therapeutic Uses|therapeutic uses
4963468|NCT01799499|Pharmacologic Actions|pharmacologic actions
4963469|NCT01799499|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors
4963470|NCT01799499|Enzyme Inhibitors|enzyme inhibitors
4963471|NCT01799499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
4963472|NCT01799499|Alkylating Agents|alkylating agents
4963473|NCT01799486|Telbivudine|telbivudine
4963474|NCT01799486|renoprotective efficacy|renoprotective efficacy
4963475|NCT01799486|liver cirrhosis|liver cirrhosis
4963476|NCT01799473|Tyvaso|tyvaso
4963477|NCT01799473|PAH|pah
4963478|NCT01799460|single-nucleotide-polymorphism|single-nucleotide-polymorphism
4963479|NCT01799460|Traditional Chinese Medicine|traditional chinese medicine
4963480|NCT01799460|the Comprehensive Treatment Regimen|the comprehensive treatment regimen
4963481|NCT01799447|Early intervention|early intervention
4963482|NCT01799447|Intervention study|intervention study
4963483|NCT01799447|Infant mother relations|infant mother relations
4963484|NCT01799447|First time mothers|first time mothers
4963485|NCT01799447|Parental program|parental program
4963486|NCT01799447|Marte Meo method|marte meo method
4963487|NCT01799447|Video guidances|video guidances
4963488|NCT01799369|Surgical Apgar Score|surgical apgar score
4963489|NCT01799356|Treatment, moksifloksasin|treatment, moksifloksasin
4963490|NCT01799343|Prenatal care|prenatal care
4963491|NCT01799343|Blood flow velocity|blood flow velocity
4963492|NCT01799343|Hydrotherapy|hydrotherapy
4963493|NCT01799343|Fetalplacental circulation|fetalplacental circulation
4963494|NCT01799343|Uteroplacental circulation|uteroplacental circulation
4963495|NCT01799330|COPD|copd
4963496|NCT01799330|Rehabilitation|rehabilitation
4963497|NCT01799330|Exercise|exercise
4963498|NCT01799330|TCEMS|tcems
4963499|NCT01799304|Locomotion|locomotion
4963500|NCT01799304|cerebral palsy|cerebral palsy
4963501|NCT01799304|Postural; Defect|postural; defect
4963502|NCT01799291|Decision Making|decision making
4963503|NCT01799291|Pediatric Bipolar Disorder|pediatric bipolar disorder
4963504|NCT01799291|Assessment|assessment
4963505|NCT01799291|Intervention|intervention
4963506|NCT01799278|Metastatic prostate carcinoma|metastatic prostate carcinoma
4963507|NCT01799265|obstructive sleep apnea|obstructive sleep apnea
4963508|NCT01799265|OSA|osa
4963509|NCT01799265|AutoPAP|autopap
4963510|NCT01799265|PAP|pap
4963511|NCT01799265|sleep disordered breathing|sleep disordered breathing
4963512|NCT01799265|CPAP|cpap
4963513|NCT01799265|Apnea hypopnea index|apnea hypopnea index
4963514|NCT01799265|AHI|ahi
4963515|NCT01799252|medical abortion|medical abortion
4963516|NCT01799252|doxycycline|doxycycline
4963517|NCT01799252|antibiotics|antibiotics
4963518|NCT01799252|adherence|adherence
4963519|NCT01799252|nausea|nausea
4963520|NCT01799239|stoma ileostomy|stoma ileostomy
4963521|NCT01799213|Knee Osteoarthritis|knee osteoarthritis
4963522|NCT01799213|NSAID|nsaid
4963523|NCT01799213|Cognitive Behavioral Therapy|cognitive behavioral therapy
4963524|NCT01799200|Collegiate Athletes|collegiate athletes
4963525|NCT01799200|Hip Pathomorphology|hip pathomorphology
4963526|NCT01799200|Age-Matched Controls|age-matched controls
4963527|NCT01799200|Femoroacetabular Impingement|femoroacetabular impingement
4963528|NCT01799200|Dysplasia|dysplasia
4963529|NCT01799187|Immature Permanent Teeth|immature permanent teeth
4963530|NCT01799161|NSCLC|nsclc
4963531|NCT01799161|Lung Cancer|lung cancer
4963532|NCT01799161|gp96|gp96
4963533|NCT01799161|gp96 Vaccine|gp96 vaccine
4963534|NCT01799161|AD100-gp96Ig-HLA A1|ad100-gp96ig-hla a1
4963535|NCT01799148|Acute coronary syndrome|acute coronary syndrome
4963536|NCT01799148|Air pollution.|air pollution.
4963537|NCT01799148|Inflammation.|inflammation.
4963538|NCT01799148|Oxidative Stress.|oxidative stress.
4963539|NCT01799148|Prognosis|prognosis
4963540|NCT01799109|magnesium sulfate|magnesium sulfate
4963541|NCT01799109|nebulization|nebulization
4963542|NCT01799109|lung function|lung function
4963543|NCT01799083|Advanced solid tumors|advanced solid tumors
4963544|NCT01799083|B cell lymphoma|b cell lymphoma
4963545|NCT01799070|Prediction|prediction
4963546|NCT01799070|Transcranial Doppler|transcranial doppler
4963547|NCT01799057|Peripheral Arterial Disease|peripheral arterial disease
4963548|NCT01799057|Intermittent Claudication|intermittent claudication
4963549|NCT01799057|Peripheral Vascular Diseases|peripheral vascular diseases
4963550|NCT01799057|Vascular Diseases|vascular diseases
4963551|NCT01799057|Cardiovascular Diseases|cardiovascular diseases
4963552|NCT01799057|Arterial Occlusive Diseases|arterial occlusive diseases
4963553|NCT01799057|Atherosclerosis|atherosclerosis
4963554|NCT01799057|Insulin Resistance|insulin resistance
4963555|NCT01799057|Glucose Metabolism|glucose metabolism
4963556|NCT01799057|Blood Glucose|blood glucose
4963557|NCT01799057|Metformin|metformin
4963558|NCT01799057|Biguanides|biguanides
4963559|NCT01799057|Hypoglycemic Agents|hypoglycemic agents
4963560|NCT01799057|Endothelium, Vascular|endothelium, vascular
4963561|NCT01799057|Hemorheology|hemorheology
4963562|NCT01799057|Blood Circulation|blood circulation
4963563|NCT01799057|Regional Blood Flow|regional blood flow
4963564|NCT01799057|Microcirculation|microcirculation
4963565|NCT01799057|Exercise|exercise
4963566|NCT01799057|Physical Fitness|physical fitness
4963567|NCT01799057|Exercise Test|exercise test
4963568|NCT01799057|Sedentary Lifestyle|sedentary lifestyle
4963569|NCT01799057|Quality of Life|quality of life
4963570|NCT01799057|Plethysmography|plethysmography
4963571|NCT01799044|Irreversible electroporation|irreversible electroporation
4963572|NCT01799044|IRE|ire
4963573|NCT01799044|Electroporation|electroporation
4963574|NCT01799044|Colorectal liver metastases|colorectal liver metastases
4963575|NCT01799044|CRLM|crlm
4963576|NCT01799044|Safety|safety
4963577|NCT01799044|Feasibility|feasibility
4963578|NCT01799044|Efficacy|efficacy
4963579|NCT01799044|Single-center|single-center
4963580|NCT01799044|Low Energy Direct Current|low energy direct current
4963581|NCT01799044|Ablate-and-resect|ablate-and-resect
4963582|NCT01799044|Nonthermal ablation|nonthermal ablation
4963583|NCT01799044|Ablation|ablation
4963584|NCT01799018|Xanthine Oxidase|xanthine oxidase
4963585|NCT01799018|Cerebrospinal fluid|cerebrospinal fluid
4963586|NCT01799005|flavanols|flavanols
4963587|NCT01799005|diet|diet
4963588|NCT01799005|endothelial function|endothelial function
4963589|NCT01799005|blood pressure|blood pressure
4963590|NCT01799005|FLAVIOLA|flaviola
4963591|NCT01798992|ejection fraction|ejection fraction
4963592|NCT01798992|beta-blocker|beta-blocker
4963593|NCT01798992|carvedilol|carvedilol
4963594|NCT01798992|metoprolol|metoprolol
4963595|NCT01798992|myocardial gene expression|myocardial gene expression
4963596|NCT01798992|human heart|human heart
4963597|NCT01798992|ventricular remodeling|ventricular remodeling
4963598|NCT01798992|wall stress|wall stress
4963599|NCT01798992|adrenergic signaling|adrenergic signaling
4963600|NCT01798992|myosin heavy chain|myosin heavy chain
4963601|NCT01798953|Ulcerative Colitis|ulcerative colitis
4963602|NCT01798953|Primary Sclerosing Cholangitis|primary sclerosing cholangitis
4963603|NCT01798953|Ileal pouch-anal anastomosis|ileal pouch-anal anastomosis
4963604|NCT01798953|Ileorectal anastomosis|ileorectal anastomosis
4963605|NCT01798953|Surgical outcome|surgical outcome
4963606|NCT01798953|Functional outcome|functional outcome
4963607|NCT01798953|Failure|failure
4963608|NCT01798927|Parkinson's disease|parkinson's disease
4963609|NCT01798927|ankle foot orthosis (AFO)|ankle foot orthosis (afo)
4963610|NCT01798927|gait|gait
4963611|NCT01798901|Acute Myeloid Leukemia|acute myeloid leukemia
4963612|NCT01798901|AML|aml
4963613|NCT01798901|AR-42|ar-42
4963614|NCT01798901|Decitabine|decitabine
4963615|NCT01798888|Deep Brain Stimulation|deep brain stimulation
4963616|NCT01798888|Alcohol Dependence|alcohol dependence
4963617|NCT01798875|pcos|pcos
4963618|NCT01798875|metformin|metformin
4963619|NCT01798875|oral contraception|oral contraception
4963620|NCT01798875|cyproterone acetate|cyproterone acetate
4963621|NCT01798862|Failed IVF cycles|failed ivf cycles
4963622|NCT01798862|IVF outcome parameters|ivf outcome parameters
4963623|NCT01798862|endometrial injury|endometrial injury
4963624|NCT01798862|hysteroscopy|hysteroscopy
4963625|NCT01798862|pipelle sampling|pipelle sampling
4963626|NCT01798862|Repeated implantation failures|repeated implantation failures
4963627|NCT01798836|IVF/ICSI cycles, poor responders, ultrashort flare protocol, antagonist protocol|ivf/icsi cycles, poor responders, ultrashort flare protocol, antagonist protocol
4963628|NCT01798823|children|children
4963629|NCT01798823|asthma|asthma
4963630|NCT01798810|Surgical Site Infection Risk Prediction|surgical site infection risk prediction
4963631|NCT01798810|Bacterial species type and antibacterial sensitivities|bacterial species type and antibacterial sensitivities
4963632|NCT01798810|Resource Utilization and Cost|resource utilization and cost
4963633|NCT01798797|Heart Failure|heart failure
4963634|NCT01798797|HFRS|hfrs
4963635|NCT01798797|OptiVol|optivol
4963636|NCT01798797|ICD|icd
4963637|NCT01798797|CRT-D|crt-d
4963638|NCT01798771|primary brain tumor|primary brain tumor
4963639|NCT01798771|malignant glioma|malignant glioma
4963640|NCT01798771|intraoperative MRI|intraoperative mri
4963641|NCT01798771|5-ALA|5-ala
4963642|NCT01798745|Heart failure|heart failure
4963643|NCT01798745|JNJ-54452840|jnj-54452840
4963644|NCT01798745|Anti-beta-1 adrenergic receptor auto antibodies|anti-beta-1 adrenergic receptor auto antibodies
4963645|NCT01798745|Beta-1 adrenergic receptor|beta-1 adrenergic receptor
4963646|NCT01798745|Antibodies|antibodies
4963647|NCT01798745|Auto antibodies|auto antibodies
4963648|NCT01798745|Systolic function|systolic function
4963649|NCT01798719|NAFLD|nafld
4963650|NCT01798719|Clinical Trial|clinical trial
4963651|NCT01798719|Mediterranean Diet|mediterranean diet
4963652|NCT01798719|Low Glycemic Index|low glycemic index
4963653|NCT01798693|Shoulder|shoulder
4963654|NCT01798693|Supplement|supplement
4963655|NCT01798693|Amino Acids|amino acids
4963656|NCT01798693|Collagen|collagen
4963657|NCT01798693|Standard of Care|standard of care
4963658|NCT01798641|Hydrocephalus|hydrocephalus
4963659|NCT01798641|Cross-over|cross-over
4963660|NCT01798628|Healthy volunteers|healthy volunteers
4963661|NCT01798628|Abiraterone acetate|abiraterone acetate
4963662|NCT01798628|Pharmacokinetics|pharmacokinetics
4963663|NCT01798602|H1N1|h1n1
4963664|NCT01798602|Rosuvastatin|rosuvastatin
4963665|NCT01798589|ethylenediamine dihydrochloride|ethylenediamine dihydrochloride
4963666|NCT01798563|Parkinson|parkinson
4963667|NCT01798563|Parkinson Disease|parkinson disease
4963668|NCT01798550|Enoxaparin dosing|enoxaparin dosing
4963669|NCT01798550|Obesity|obesity
4963670|NCT01798524|Transplant|transplant
4963671|NCT01798524|Kidney|kidney
4963672|NCT01798524|England|england
4963673|NCT01798511|enteral nutrition|enteral nutrition
4963674|NCT01798511|acute pancreatitis|acute pancreatitis
4963675|NCT01798511|oral food intolerance|oral food intolerance
4963676|NCT01798472|displaced femoral neck fractures|displaced femoral neck fractures
4963677|NCT01798472|treatment|treatment
4963678|NCT01798472|uncemented arthroplasty|uncemented arthroplasty
4963679|NCT01798472|cemented arthroplasty|cemented arthroplasty
4963680|NCT01798459|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
4963681|NCT01798459|Methylphenidate|methylphenidate
4963682|NCT01798459|Placebo|placebo
4963683|NCT01798459|State anxiety|state anxiety
4963684|NCT01798446|Renal cell carcinoma|renal cell carcinoma
4963685|NCT01798446|Nonclear cell|nonclear cell
4963686|NCT01798446|Temsirolimus resistance|temsirolimus resistance
4963687|NCT01798433|Angioplasty|angioplasty
4963688|NCT01798433|Transluminal|transluminal
4963689|NCT01798433|Percutaneous Coronary|percutaneous coronary
4963690|NCT01798420|COPD|copd
4963691|NCT01798420|Diabetes|diabetes
4963692|NCT01798420|steroids|steroids
4963693|NCT01798420|Hemoglobin A1C DIFFERENCE|hemoglobin a1c difference
4963694|NCT01798407|Deep Brain Stimulation|deep brain stimulation
4963695|NCT01798407|Major Depressive Disorder|major depressive disorder
4963696|NCT01798407|Depression|depression
4963697|NCT01798407|Lateral Habenula|lateral habenula
4963698|NCT01798407|Intractable Depression|intractable depression
4963699|NCT01798407|Treatment Resistant Depression (TRD)|treatment resistant depression (trd)
4963700|NCT01798394|pregnant|pregnant
4963701|NCT01798394|smoker|smoker
4963702|NCT01798394|cigarette|cigarette
4963703|NCT01798394|tobacco|tobacco
4963704|NCT01798355|Dental Fear|dental fear
4963705|NCT01798355|Dental Phobia|dental phobia
4963706|NCT01798355|Cognitive Behavior Therapy|cognitive behavior therapy
4963707|NCT01798355|Specific Phobia|specific phobia
4963708|NCT01798355|Children and Adolescents anxiety|children and adolescents anxiety
4963709|NCT01798355|Self Efficacy|self efficacy
4963710|NCT01798342|preoperative care|preoperative care
4963711|NCT01798342|maltodextrine|maltodextrine
4963712|NCT01798342|glutamine|glutamine
4963713|NCT01798342|gastric residual volume|gastric residual volume
4963714|NCT01798342|MRI|mri
4963715|NCT01798329|Minimal Hepatic Encephalopathy|minimal hepatic encephalopathy
4963716|NCT01798329|Pre-hepatic Portal Hypertension|pre-hepatic portal hypertension
4963717|NCT01798329|portal vein thrombosis|portal vein thrombosis
4963718|NCT01798316|IV Acetaminophen|iv acetaminophen
4963719|NCT01798316|Laparoscopic cholecystectomy|laparoscopic cholecystectomy
4963720|NCT01798316|Postoperative nausea|postoperative nausea
4963721|NCT01798316|Postoperative vomiting|postoperative vomiting
4963722|NCT01798277|Keywords provided by Newmarket Electrophysiology Research Group Inc:|keywords provided by newmarket electrophysiology research group inc:
4963723|NCT01798277|Ventricular tachycardia|ventricular tachycardia
4963724|NCT01798277|Ventricular tachyarrhythmia|ventricular tachyarrhythmia
4963725|NCT01798277|Ablation|ablation
4963726|NCT01798277|Coronary artery disease|coronary artery disease
4963727|NCT01798277|Ischemic heart disease|ischemic heart disease
4963728|NCT01798277|Amiodarone|amiodarone
4963729|NCT01798277|Sotalol|sotalol
4963730|NCT01798277|Anti-Arrhythmia Agents|anti-arrhythmia agents
4963731|NCT01798277|Therapeutic Uses|therapeutic uses
4963732|NCT01798277|Pharmacologic Actions|pharmacologic actions
4963733|NCT01798277|Additional relevant MeSH terms:|additional relevant mesh terms:
4963734|NCT01798277|Atrial Fibrillation|atrial fibrillation
4963735|NCT01798277|Arrhythmias, Cardiac|arrhythmias, cardiac
4963736|NCT01798277|Heart Diseases|heart diseases
4963737|NCT01798277|Cardiovascular Diseases|cardiovascular diseases
4963738|NCT01798277|Pathologic Processes|pathologic processes
4963739|NCT01798277|Catheter Ablation, Radiofrequency|catheter ablation, radiofrequency
4963740|NCT01798251|Elderly Gastric Cancer|elderly gastric cancer
4963741|NCT01798251|Capecitabine Maintenance|capecitabine maintenance
4963742|NCT01798238|Type 2 Diabetes Mellitus / Dipeptidyl peptidase-IV inhibitors|type 2 diabetes mellitus / dipeptidyl peptidase-iv inhibitors
4963743|NCT01798225|Periodontal Disease|periodontal disease
4963744|NCT01798225|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
4963745|NCT01798225|Gullah African Americans|gullah african americans
4963746|NCT01798212|GERD|gerd
4963747|NCT01798199|Alzheimer|alzheimer
4963748|NCT01798199|virtual reality system|virtual reality system
4963749|NCT01798199|Alzheimer's disease related conditions|alzheimer's disease related conditions
4963750|NCT01798173|Hepatocellular carcinoma|hepatocellular carcinoma
4963751|NCT01798173|Cirrhosis|cirrhosis
4963752|NCT01798173|Environmental risk factors|environmental risk factors
4963753|NCT01798173|Nutrition|nutrition
4963754|NCT01798173|Metabolic syndrome|metabolic syndrome
4963755|NCT01798147|Cholangiocellular Carcinoma|cholangiocellular carcinoma
4963756|NCT01798147|TACE|tace
4963757|NCT01798147|SIRT|sirt
4963758|NCT01798134|To show safety|to show safety
4963759|NCT01798134|and efficacy|and efficacy
4963760|NCT01798134|investigational product|investigational product
4963761|NCT01798121|PPD|ppd
4963762|NCT01798121|Tuberculosis|tuberculosis
4963763|NCT01798108|Advanced skeletal metastases|advanced skeletal metastases
4963764|NCT01798108|Radium-223|radium-223
4963765|NCT01798108|Radium-223 dichloride|radium-223 dichloride
4963766|NCT01798108|Alpharadin|alpharadin
4963767|NCT01798095|TB, Aplisol|tb, aplisol
4963768|NCT01798056|≥18 years of age|≥18 years of age
4963769|NCT01798056|Chemotherapy|chemotherapy
4963770|NCT01798056|Solid tumours|solid tumours
4963771|NCT01798056|Immunogenicity|immunogenicity
4963772|NCT01798056|Herpes Zoster|herpes zoster
4963773|NCT01798056|Safety|safety
4963774|NCT01798056|Shingles|shingles
4963775|NCT01798030|Vitamin D|vitamin d
4963776|NCT01798030|Diabetes|diabetes
4963777|NCT01798030|Osteoporosis|osteoporosis
4963778|NCT01798030|Cardiovascular Risk|cardiovascular risk
4963878|NCT01797523|Femara|femara
4963779|NCT01798017|menstrual regulation|menstrual regulation
4963780|NCT01798017|mifepristone|mifepristone
4963781|NCT01798017|misoprostol|misoprostol
4963782|NCT01797991|Hypersensitivity, drug|hypersensitivity, drug
4963783|NCT01797978|Sepsis|sepsis
4963784|NCT01797978|Septic shock|septic shock
4963785|NCT01797978|Methylene blue|methylene blue
4963786|NCT01797952|lactobacillus CD 2|lactobacillus cd 2
4963787|NCT01797952|oral mucositis|oral mucositis
4963788|NCT01797952|hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
4963789|NCT01797939|Erosive reflux disease (ERD)|erosive reflux disease (erd)
4963790|NCT01797939|Non-erosive reflux disease (NERD)|non-erosive reflux disease (nerd)
4963791|NCT01797939|Functional heartburn (FH)|functional heartburn (fh)
4963792|NCT01797926|pharmacokinetics|pharmacokinetics
4963793|NCT01797926|Hypertension|hypertension
4963794|NCT01797926|losartan|losartan
4963795|NCT01797926|healthy volunteers|healthy volunteers
4963796|NCT01797926|amlodipine|amlodipine
4963797|NCT01797900|adjuvants|adjuvants
4963798|NCT01797900|inductive|inductive
4963799|NCT01797900|concurrent|concurrent
4963800|NCT01797900|chemoradiotherapy|chemoradiotherapy
4963801|NCT01797900|high-risk|high-risk
4963802|NCT01797900|locally advanced|locally advanced
4963803|NCT01797900|NPC|npc
4963804|NCT01797887|Burnout-Syndrome|burnout-syndrome
4963805|NCT01797887|Ayurveda|ayurveda
4963806|NCT01797887|Ayurvedic|ayurvedic
4963807|NCT01797887|Traditional Indian Medicine|traditional indian medicine
4963808|NCT01797887|CAM|cam
4963809|NCT01797887|Whole Medical System|whole medical system
4963810|NCT01797887|Diet and Lifestyle Counseling|diet and lifestyle counseling
4963811|NCT01797874|pazopanib maintenance|pazopanib maintenance
4963812|NCT01797874|efficacy|efficacy
4963813|NCT01797874|SCLC|sclc
4963814|NCT01797861|chronic central serous chorioretinopathy|chronic central serous chorioretinopathy
4963815|NCT01797861|photodynamic therapy|photodynamic therapy
4963816|NCT01797861|micropulse laser|micropulse laser
4963817|NCT01797835|adolescents|adolescents
4963818|NCT01797835|intervention|intervention
4963819|NCT01797835|motivational interviewing|motivational interviewing
4963820|NCT01797835|alcohol and drug use|alcohol and drug use
4963821|NCT01797783|Myopia|myopia
4963822|NCT01797783|Presbyopia|presbyopia
4963823|NCT01797783|Refractive error|refractive error
4963824|NCT01797783|Contact lenses|contact lenses
4963825|NCT01797783|Multifocal|multifocal
4963826|NCT01797770|mechanical bowel preparation|mechanical bowel preparation
4963827|NCT01797770|Colon Cancer|colon cancer
4963828|NCT01797757|EPA|epa
4963829|NCT01797757|LC-PUFA|lc-pufa
4963830|NCT01797757|Orlistat|orlistat
4963831|NCT01797757|Obesity|obesity
4963832|NCT01797744|Stroke|stroke
4963833|NCT01797744|Dizziness|dizziness
4963834|NCT01797744|Vestibular rehabiliation|vestibular rehabiliation
4963835|NCT01797744|Balance|balance
4963836|NCT01797731|Orthalign|orthalign
4963837|NCT01797731|KneeAlign|kneealign
4963838|NCT01797731|Total Knee Replacement|total knee replacement
4963839|NCT01797731|Total Knee Arthroplasty|total knee arthroplasty
4963840|NCT01797731|Degenerative joint disease|degenerative joint disease
4963841|NCT01797731|Osteoarthritis|osteoarthritis
4963842|NCT01797731|Unilateral|unilateral
4963843|NCT01797718|Puberty|puberty
4963844|NCT01797718|Constitutional|constitutional
4963845|NCT01797718|Delay|delay
4963846|NCT01797718|Letrozole|letrozole
4963847|NCT01797718|Testosterone|testosterone
4963848|NCT01797692|prostate cancer cured|prostate cancer cured
4963849|NCT01797692|aged patients|aged patients
4963850|NCT01797679|Osteoarthritis,Articular Cartilage, Relaxometry, Morphometry, MRI, T2 mapping, T1 rho|osteoarthritis,articular cartilage, relaxometry, morphometry, mri, t2 mapping, t1 rho
4963851|NCT01797640|Tibia Fractures|tibia fractures
4963852|NCT01797640|Medial Fractures|medial fractures
4963853|NCT01797640|Posterior Malleolar Fractures|posterior malleolar fractures
4963854|NCT01797627|Pediatric Hydrocephalus|pediatric hydrocephalus
4963855|NCT01797627|Ventricular Size|ventricular size
4963856|NCT01797627|Neuropsychological Outcomes|neuropsychological outcomes
4963857|NCT01797627|Quality of Life|quality of life
4963858|NCT01797614|intra-abdominal pressure|intra-abdominal pressure
4963859|NCT01797614|spontaneous breathing trail|spontaneous breathing trail
4963860|NCT01797614|weaning|weaning
4963861|NCT01797588|Total Knee Arthroplasty|total knee arthroplasty
4963862|NCT01797588|Pain|pain
4963863|NCT01797588|Periarticular infiltration|periarticular infiltration
4963864|NCT01797588|Adductor canal block|adductor canal block
4963865|NCT01797588|Postoperative|postoperative
4963866|NCT01797575|Bipolar Disorder|bipolar disorder
4963867|NCT01797575|Mood Disorder|mood disorder
4963868|NCT01797575|Bipolar Depression|bipolar depression
4963869|NCT01797575|Mood Swings|mood swings
4963870|NCT01797562|Contact dermatitis|contact dermatitis
4963871|NCT01797562|Eczema|eczema
4963872|NCT01797549|Traumatic brain injury|traumatic brain injury
4963873|NCT01797549|functional near infrared spectroscopy|functional near infrared spectroscopy
4963874|NCT01797523|Endometrial cancer|endometrial cancer
4963875|NCT01797523|Advanced or Recurrent Endometrial Carcinoma|advanced or recurrent endometrial carcinoma
4963876|NCT01797523|Metformin|metformin
4963877|NCT01797523|Letrozole|letrozole
4963879|NCT01797523|Everolimus|everolimus
4963880|NCT01797523|Afinitor|afinitor
4963881|NCT01797523|Zortress|zortress
4963882|NCT01797523|RAD001|rad001
4963883|NCT01797497|Parents|parents
4963884|NCT01797497|Primary Care Providers|primary care providers
4963885|NCT01797497|Specialists|specialists
4963886|NCT01797497|Children with Special Healthcare Needs|children with special healthcare needs
4963887|NCT01797497|Referral|referral
4963888|NCT01797497|Health Outcomes|health outcomes
4963889|NCT01797497|Self-Efficacy|self-efficacy
4963890|NCT01797497|Communication|communication
4963891|NCT01797484|ischemia|ischemia
4963892|NCT01797484|myocardium|myocardium
4963893|NCT01797484|Ranolazine|ranolazine
4963894|NCT01797484|dyskinesia|dyskinesia
4963895|NCT01797484|speckle tracking echocardiography|speckle tracking echocardiography
4963896|NCT01797471|Non-Small Cell Lung Cancer|non-small cell lung cancer
4963897|NCT01797471|NSCLC|nsclc
4963898|NCT01797471|Lung Cancer|lung cancer
4963899|NCT01797458|Class II carious primary molar|class ii carious primary molar
4963900|NCT01797458|Non-Restorative Caries Treatment|non-restorative caries treatment
4963901|NCT01797458|Hall Technique|hall technique
4963902|NCT01797458|Conventional restorations|conventional restorations
4963903|NCT01797458|Children|children
4963904|NCT01797445|HIV|hiv
4963905|NCT01797445|Treatment Naive|treatment naive
4963906|NCT01797445|HIV 1 Infected|hiv 1 infected
4963907|NCT01797445|Women|women
4963908|NCT01797445|Female|female
4963909|NCT01797419|Respiratory|respiratory
4963910|NCT01797419|Syncytial|syncytial
4963911|NCT01797419|Virus|virus
4963912|NCT01797419|RSV|rsv
4963913|NCT01797380|Depression|depression
4963914|NCT01797380|HIV|hiv
4963915|NCT01797367|HIV|hiv
4963916|NCT01797367|COPD|copd
4963917|NCT01797367|FEV1|fev1
4963918|NCT01797367|respiratory function|respiratory function
4963919|NCT01797354|patients at the end of treatment|patients at the end of treatment
4963920|NCT01797341|Renal Transplantation|renal transplantation
4963921|NCT01797341|Kidney transplantation|kidney transplantation
4963922|NCT01797341|Pancreas Transplantation|pancreas transplantation
4963923|NCT01797341|Tacrolimus|tacrolimus
4963924|NCT01797341|Advagraf|advagraf
4963925|NCT01797341|Prograf|prograf
4963926|NCT01797341|Drug Adherence|drug adherence
4963927|NCT01797328|brown adipose tissue, human|brown adipose tissue, human
4963928|NCT01797302|Obesity|obesity
4963929|NCT01797302|Vitamin D Deficiency|vitamin d deficiency
4963930|NCT01797302|Vascular Function|vascular function
4963931|NCT01797302|Insulin resistance|insulin resistance
4963932|NCT01797302|metabolic syndrome|metabolic syndrome
4963933|NCT01797289|syncope|syncope
4963934|NCT01797289|pulmonary embolism|pulmonary embolism
4963935|NCT01797276|Dichloroacetate (DCA)|dichloroacetate (dca)
4963936|NCT01797276|Congenital Lactic Acidosis (CLA)|congenital lactic acidosis (cla)
4963937|NCT01797276|acidosis|acidosis
4963938|NCT01797276|orphan disease|orphan disease
4963939|NCT01797263|fibromyalgia|fibromyalgia
4963940|NCT01797263|yoga|yoga
4963941|NCT01797263|exercise|exercise
4963942|NCT01797263|pain|pain
4963943|NCT01797237|surgery|surgery
4963944|NCT01797237|fixation|fixation
4963945|NCT01797237|intramedullary nail|intramedullary nail
4963946|NCT01797224|Autoimmune disease|autoimmune disease
4963947|NCT01797224|certolizumab pegol|certolizumab pegol
4963948|NCT01797224|Cimzia|cimzia
4963949|NCT01797224|pregnancy|pregnancy
4963950|NCT01797224|birth defect|birth defect
4963951|NCT01797224|birth outcome|birth outcome
4963952|NCT01797224|TNF|tnf
4963953|NCT01797224|Tumor necrosis factor|tumor necrosis factor
4963954|NCT01797211|Mediterranean diet; FMD; obesity; cardiovascular risk.|mediterranean diet; fmd; obesity; cardiovascular risk.
4963955|NCT01797198|Phase I|phase i
4963956|NCT01797198|ASP3652|asp3652
4963957|NCT01797198|Gemfibrozil|gemfibrozil
4963958|NCT01797198|Repaglinide|repaglinide
4963959|NCT01797198|Pharmacokinetics|pharmacokinetics
4963960|NCT01797185|baclofen, spasticity|baclofen, spasticity
4963961|NCT01797172|nucleoplasty|nucleoplasty
4963962|NCT01797172|pulsed radio frequency|pulsed radio frequency
4963963|NCT01797172|herniated disc|herniated disc
4963964|NCT01797172|cervical|cervical
4963965|NCT01797172|percutaneous disc decompression|percutaneous disc decompression
4963966|NCT01797172|cervical radiculopathy|cervical radiculopathy
4963967|NCT01797159|Prophylactic Cranial Irradiation|prophylactic cranial irradiation
4963968|NCT01797159|PCI|pci
4963969|NCT01797159|Hippocampal-sparing irradiation|hippocampal-sparing irradiation
4963970|NCT01797120|Post-Menopausal Patients|post-menopausal patients
4963971|NCT01797120|Hormone-Receptor Positive|hormone-receptor positive
4963972|NCT01797120|Resistant to Aromatase Inhibitor Therapy|resistant to aromatase inhibitor therapy
4963973|NCT01797120|Fulvestrant|fulvestrant
4963974|NCT01797120|Faslodex|faslodex
4963975|NCT01797120|mTOR Inhibitor|mtor inhibitor
4963976|NCT01797120|Everolimus|everolimus
4963977|NCT01797120|RAD001|rad001
4963978|NCT01797120|Afinitor|afinitor
4963979|NCT01797107|Meibomian gland dysfunction|meibomian gland dysfunction
4963980|NCT01797068|HEALTHCARE UTILIZATION|healthcare utilization
4963981|NCT01797068|ED UTILIZATION|ed utilization
4963982|NCT01797068|PRIMARY CARE UTILIZATION|primary care utilization
4963983|NCT01797068|PATIENT NAVIGATION|patient navigation
4963984|NCT01797068|UNDERSERVED POPULATIONS|underserved populations
4963985|NCT01797068|HEALTH DISPARITIES|health disparities
4963986|NCT01797055|transferrin|transferrin
4963987|NCT01797055|anemia|anemia
4963988|NCT01797055|iron overload|iron overload
4963989|NCT01797042|Fructose|fructose
4963990|NCT01797042|High fructose corn syrup|high fructose corn syrup
4963991|NCT01797042|Energy regulation|energy regulation
4963992|NCT01797042|Ectopic fat|ectopic fat
4963993|NCT01797042|Understanding|understanding
4963994|NCT01797042|potential|potential
4963995|NCT01797016|Myocardial Infarction|myocardial infarction
4963996|NCT01797016|flow cytometry|flow cytometry
4963997|NCT01797016|Blood Cell Count|blood cell count
4963998|NCT01797016|Platelet Activation|platelet activation
4963999|NCT01797003|osteoarthritis|osteoarthritis
4964000|NCT01797003|osteotomy|osteotomy
4964001|NCT01797003|closing|closing
4964002|NCT01797003|opening|opening
4964003|NCT01797003|wedge|wedge
4964004|NCT01797003|kne|kne
4964005|NCT01797003|tibia|tibia
4964006|NCT01796990|physical activity|physical activity
4964007|NCT01796990|psychological well-being|psychological well-being
4964008|NCT01796990|acceptance and commitment therapy|acceptance and commitment therapy
4964009|NCT01796990|adults|adults
4964010|NCT01796977|Nipple-sparing Mastectomy|nipple-sparing mastectomy
4964011|NCT01796977|NSM|nsm
4964012|NCT01796977|Nipple Sparing Mastectomy|nipple sparing mastectomy
4964013|NCT01796964|Age-Related Macular Degeneration|age-related macular degeneration
4964014|NCT01796964|Wet|wet
4964015|NCT01796964|Exudative|exudative
4964016|NCT01796964|AMD|amd
4964017|NCT01796964|Intravitreal injection|intravitreal injection
4964018|NCT01796964|Retina|retina
4964019|NCT01796938|Lacosamide|lacosamide
4964020|NCT01796938|Vimpat|vimpat
4964021|NCT01796938|Single Dose|single dose
4964022|NCT01796938|Pharmacokinetics|pharmacokinetics
4964023|NCT01796938|Renal Impairment|renal impairment
4964024|NCT01796925|Apnea|apnea
4964025|NCT01796925|Respiration Disorders|respiration disorders
4964026|NCT01796925|Signs and Symptoms|signs and symptoms
4964027|NCT01796925|Signs and Symptoms, Respiratory|signs and symptoms, respiratory
4964028|NCT01796925|Sleep Apnea Syndromes|sleep apnea syndromes
4964029|NCT01796925|Sleep Apnea, Obstructive|sleep apnea, obstructive
4964030|NCT01796925|Respiratory Tract Diseases|respiratory tract diseases
4964031|NCT01796925|Sleep Disorders, Intrinsic|sleep disorders, intrinsic
4964032|NCT01796925|Sleep Disorders|sleep disorders
4964033|NCT01796925|Nervous System Diseases|nervous system diseases
4964034|NCT01796899|Healthy Volunteers|healthy volunteers
4964035|NCT01796899|Brivaracetam|brivaracetam
4964036|NCT01796873|Female|female
4964037|NCT01796873|Hispanic|hispanic
4964038|NCT01796873|Percutaneous Coronary Intervention|percutaneous coronary intervention
4964039|NCT01796860|Gait|gait
4964040|NCT01796860|AFO|afo
4964041|NCT01796860|MS|ms
4964042|NCT01796847|ICU|icu
4964043|NCT01796847|Hyperglycemia|hyperglycemia
4964044|NCT01796847|Length of stay|length of stay
4964045|NCT01796834|Mindfulness-Based Stress Reduction|mindfulness-based stress reduction
4964046|NCT01796834|Diabetes Management|diabetes management
4964047|NCT01796834|Stress Reduction|stress reduction
4964048|NCT01796834|Diabetes Testing|diabetes testing
4964049|NCT01796821|Condyloma acuminata|condyloma acuminata
4964050|NCT01796821|Genital warts|genital warts
4964051|NCT01796821|Condylomata acuminata|condylomata acuminata
4964052|NCT01796821|Venereal warts|venereal warts
4964053|NCT01796808|pedal|pedal
4964054|NCT01796808|atrophy|atrophy
4964055|NCT01796808|fat grafting|fat grafting
4964056|NCT01796808|adipose tissue|adipose tissue
4964057|NCT01796795|common wart|common wart
4964058|NCT01796795|verruca vulgaris|verruca vulgaris
4964059|NCT01796769|Obstructive Sleep Apnea Syndrome|obstructive sleep apnea syndrome
4964060|NCT01796769|Telemedicine|telemedicine
4964061|NCT01796769|Patient Compliance|patient compliance
4964062|NCT01796756|Handover|handover
4964063|NCT01796756|Handoff|handoff
4964064|NCT01796756|Signout|signout
4964065|NCT01796756|Quality Improvement|quality improvement
4964066|NCT01796756|General Internal Medicine|general internal medicine
4964067|NCT01796743|MRI|mri
4964068|NCT01796743|Double Inversion radial fast Spin Echo T2 mapping|double inversion radial fast spin echo t2 mapping
4964069|NCT01796743|Heart failure risk stratification|heart failure risk stratification
4964070|NCT01796743|30 day post hospitalization outcome|30 day post hospitalization outcome
4964071|NCT01796730|efficacy|efficacy
4964072|NCT01796730|safety|safety
4964073|NCT01796730|Bambuterol tablets|bambuterol tablets
4964074|NCT01796730|COPD|copd
4964075|NCT01796717|Piperacillin/tazobactam|piperacillin/tazobactam
4964076|NCT01796717|MIC|mic
4964077|NCT01796704|functional capacity|functional capacity
4964078|NCT01796704|NYHA class|nyha class
4964079|NCT01796691|Clopidogrel|clopidogrel
4964080|NCT01796691|aspirin|aspirin
4964081|NCT01796691|low response|low response
4964082|NCT01796691|platelet aggregation|platelet aggregation
4964083|NCT01796691|Acute Coronary Syndrome|acute coronary syndrome
4964084|NCT01796691|Coronary Stent Implantation|coronary stent implantation
4964085|NCT01796678|sickle cell disease|sickle cell disease
4964086|NCT01796678|vaso-occlusive pain episodes|vaso-occlusive pain episodes
4964087|NCT01796678|arginine|arginine
4964088|NCT01796678|nitric oxide|nitric oxide
4964089|NCT01796652|Acute interstitial pancreatitis|acute interstitial pancreatitis
4964090|NCT01796652|Home therapy|home therapy
4964091|NCT01796600|distal limbs fracture, acute trauma, imaging, cone beam computed tomography,|distal limbs fracture, acute trauma, imaging, cone beam computed tomography,
4964092|NCT01796574|status epilepticus|status epilepticus
4964093|NCT01796574|seizure|seizure
4964094|NCT01796574|epilepsy|epilepsy
4964095|NCT01796574|ketogenic diet|ketogenic diet
4964096|NCT01796574|modified Atkins diet|modified atkins diet
4964097|NCT01796548|Detrusor function, overactive|detrusor function, overactive
4964098|NCT01796548|Urinary incontinence|urinary incontinence
4964099|NCT01796548|Oxybutynin|oxybutynin
4964100|NCT01796548|Lyrinel|lyrinel
4964101|NCT01796509|Quality of life,|quality of life,
4964102|NCT01796509|Sequela disorders,|sequela disorders,
4964103|NCT01796509|Socio-professional impact,|socio-professional impact,
4964104|NCT01796509|Anxiety, depression,|anxiety, depression,
4964105|NCT01796509|Post traumatic stress disorder,|post traumatic stress disorder,
4964106|NCT01796509|ICU acquired paresis.|icu acquired paresis.
4964107|NCT01796496|Low back pain.|low back pain.
4964108|NCT01796496|Manipulative therapy techniques.|manipulative therapy techniques.
4964109|NCT01796496|Randomized controlled trial.|randomized controlled trial.
4964110|NCT01796496|Chronic pain.|chronic pain.
4964111|NCT01796483|Parkinson disease|parkinson disease
4964112|NCT01796483|STN-DBS|stn-dbs
4964113|NCT01796483|Impulsivity|impulsivity
4964114|NCT01796483|Akinesia|akinesia
4964115|NCT01796483|Noradrenergic|noradrenergic
4964116|NCT01796483|system|system
4964117|NCT01796470|GS-US-339-0103|gs-us-339-0103
4964118|NCT01796470|SYK inhibitor|syk inhibitor
4964119|NCT01796470|PI3K inhibitor|pi3k inhibitor
4964120|NCT01796470|GS-9973|gs-9973
4964121|NCT01796470|GS 9973|gs 9973
4964122|NCT01796470|GS-1101|gs-1101
4964123|NCT01796470|GS 1101|gs 1101
4964124|NCT01796470|Cal-101|cal-101
4964125|NCT01796470|Cal 101|cal 101
4964126|NCT01796470|idelalisib|idelalisib
4964127|NCT01796470|leukemia|leukemia
4964128|NCT01796470|lymphoma|lymphoma
4964129|NCT01796470|CLL|cll
4964130|NCT01796470|MCL|mcl
4964131|NCT01796470|DLBCL|dlbcl
4964132|NCT01796470|iNHL|inhl
4964133|NCT01796470|FL|fl
4964134|NCT01796470|MZL|mzl
4964135|NCT01796470|LPL|lpl
4964136|NCT01796470|SLL|sll
4964137|NCT01796470|WM|wm
4964138|NCT01796470|Waldenström's macroglobulinemia|waldenström's macroglobulinemia
4964139|NCT01796457|Hepatitis B|hepatitis b
4964140|NCT01796457|Immunology|immunology
4964141|NCT01796457|HBV|hbv
4964142|NCT01796457|Immune tolerant|immune tolerant
4964143|NCT01796457|Immune active|immune active
4964144|NCT01796444|Breast Cancer|breast cancer
4964145|NCT01796444|Sentinel Lymph Node Biopsy|sentinel lymph node biopsy
4964146|NCT01796444|Axillary Lymph Node Dissection|axillary lymph node dissection
4964147|NCT01796392|emphysema|emphysema
4964148|NCT01796392|endobronchial valve|endobronchial valve
4964149|NCT01796392|treatments|treatments
4964150|NCT01796392|pulmonary rehabilitation|pulmonary rehabilitation
4964151|NCT01796392|lung volume reduction|lung volume reduction
4964152|NCT01796353|heart disease|heart disease
4964153|NCT01796353|sexual dysfunction|sexual dysfunction
4964154|NCT01796353|exercise test|exercise test
4964155|NCT01796353|comprehensive rehabilitation|comprehensive rehabilitation
4964156|NCT01796353|complex intervention|complex intervention
4964157|NCT01796340|cue exposure|cue exposure
4964158|NCT01796340|childhood|childhood
4964159|NCT01796340|overeating|overeating
4964160|NCT01796340|overweight|overweight
4964161|NCT01796340|obese|obese
4964162|NCT01796340|treatment|treatment
4964163|NCT01796327|dacomitinib|dacomitinib
4964164|NCT01796327|PF-00299804|pf-00299804
4964165|NCT01796327|pharmacokinetics|pharmacokinetics
4964166|NCT01796327|bioavailability|bioavailability
4964167|NCT01796314|Therapeutic educational programme for Alzheimer's disease patients and their caregiver|therapeutic educational programme for alzheimer's disease patients and their caregiver
4964168|NCT01796314|Alzheimer's disease, mild to moderately severe stages|alzheimer's disease, mild to moderately severe stages
4964169|NCT01796314|Community dwelling patients with family caregiver|community dwelling patients with family caregiver
4964170|NCT01796314|quality of life|quality of life
4964171|NCT01796301|Postmenopausal Osteoporosis|postmenopausal osteoporosis
4964172|NCT01796288|NSCLC|nsclc
4964173|NCT01796288|oligometastatic|oligometastatic
4964174|NCT01796288|second-line|second-line
4964175|NCT01796288|Radiotherapy|radiotherapy
4964176|NCT01796288|Erlotinib|erlotinib
4964177|NCT01796262|ADHD|adhd
4964178|NCT01796262|DHA|dha
4964179|NCT01796262|neuropsychological task|neuropsychological task
4964180|NCT01796262|fNIRS|fnirs
4964181|NCT01796262|Docosahexaenoic Acid|docosahexaenoic acid
4964182|NCT01796262|n-3 polyunsaturated fatty acid|n-3 polyunsaturated fatty acid
4964183|NCT01796262|cognition|cognition
4964184|NCT01796262|behavior|behavior
4964185|NCT01796249|Analgesia Nociception Index|analgesia nociception index
4964186|NCT01796249|ANI|ani
4964187|NCT01796236|Bone anchored hearing aid|bone anchored hearing aid
4964188|NCT01796236|Bone anchored implant|bone anchored implant
4964189|NCT01796236|Abbreviated Profile of Hearing Aid Benefit (APHAB)|abbreviated profile of hearing aid benefit (aphab)
4964190|NCT01796236|Health Utility Index (HUI)|health utility index (hui)
4964191|NCT01796236|Holgers Index|holgers index
4964192|NCT01796236|Implant stability|implant stability
4964193|NCT01796223|Community mental health services|community mental health services
4964194|NCT01796223|Psychotherapy|psychotherapy
4964195|NCT01796223|Physician-Patient Relations|physician-patient relations
4964196|NCT01796223|Norway|norway
4964197|NCT01796210|Analgesia/nociception index|analgesia/nociception index
4964198|NCT01796210|Bispectral index|bispectral index
4964199|NCT01796210|Propofol|propofol
4964200|NCT01796210|Remifentanil|remifentanil
4964201|NCT01796210|Suspension laryngoscopy|suspension laryngoscopy
4964202|NCT01796210|Endoscopy|endoscopy
4964203|NCT01796210|Ear-nose-throat|ear-nose-throat
4964204|NCT01796184|Inflammation|inflammation
4964205|NCT01796184|Glycation|glycation
4964206|NCT01796184|Continuous glucose monitoring|continuous glucose monitoring
4964207|NCT01796184|Adult population|adult population
4964208|NCT01796171|Radioimmunotherapy|radioimmunotherapy
4964209|NCT01796171|Lu-177|lu-177
4964210|NCT01796171|Phase I study|phase i study
4964211|NCT01796171|Phase II study|phase ii study
4964212|NCT01796171|Betalutin|betalutin
4964213|NCT01796158|adolescents|adolescents
4964214|NCT01796158|alcohol abuse|alcohol abuse
4964215|NCT01796158|drug abuse|drug abuse
4964216|NCT01796158|substance use|substance use
4964217|NCT01796132|Depression|depression
4964218|NCT01796132|Lactation|lactation
4964219|NCT01796132|Breastfeeding|breastfeeding
4964220|NCT01796132|Pharmacokinetics|pharmacokinetics
4964221|NCT01796132|Antidepressant|antidepressant
4964222|NCT01796119|Dental implants, Ridge splitting, Ridge expansion|dental implants, ridge splitting, ridge expansion
4964223|NCT01796106|caries infiltration|caries infiltration
4964224|NCT01796106|caries progression|caries progression
4964225|NCT01796106|Icon|icon
4964226|NCT01796093|Digoxin|digoxin
4964227|NCT01796093|Ivabradine|ivabradine
4964228|NCT01796093|Cardiac failure|cardiac failure
4964229|NCT01796093|Economics|economics
4964230|NCT01796067|Motivational intervention|motivational intervention
4964231|NCT01796067|Positive Parenting Intervention|positive parenting intervention
4964232|NCT01796067|Obesity|obesity
4964233|NCT01796067|Physical Activity|physical activity
4964234|NCT01796067|Diet|diet
4964235|NCT01796067|African American|african american
4964236|NCT01796067|Adolescent|adolescent
4964237|NCT01796054|Perceived stress|perceived stress
4964238|NCT01796054|Burnout|burnout
4964239|NCT01796054|Mindfulness|mindfulness
4964240|NCT01796054|Intent to leave nursing|intent to leave nursing
4964241|NCT01796028|Prostate Cancer|prostate cancer
4964242|NCT01796015|paediatrics|paediatrics
4964243|NCT01796015|optic nerve sheath diameter|optic nerve sheath diameter
4964244|NCT01796015|ultrasound|ultrasound
4964245|NCT01796002|PTCL|ptcl
4964246|NCT01795989|Coil|coil
4964247|NCT01795989|MRI|mri
4964248|NCT01795989|safety|safety
4964249|NCT01795989|efficacy|efficacy
4964250|NCT01795989|musculoskeletal imaging|musculoskeletal imaging
4964251|NCT01795989|Cincinnati|cincinnati
4964252|NCT01795989|Safety and efficacy of a new elbow coil on pediatric patients and healthy participants|safety and efficacy of a new elbow coil on pediatric patients and healthy participants
4964253|NCT01795976|Oesophageal cancer|oesophageal cancer
4964254|NCT01795963|intimate partner violence|intimate partner violence
4964255|NCT01795950|cell therapy|cell therapy
4964256|NCT01795950|Pulmonary arterial hypertension|pulmonary arterial hypertension
4964257|NCT01795898|Osteoarthritis|osteoarthritis
4964258|NCT01795898|Low back pain|low back pain
4964259|NCT01795898|Fentanyl transdermal patch|fentanyl transdermal patch
4964260|NCT01795898|Durogesic-D-Trans|durogesic-d-trans
4964261|NCT01795885|Pregnancy in Adolescence|pregnancy in adolescence
4964262|NCT01795885|Contraception|contraception
4964263|NCT01795859|Huntington disease|huntington disease
4964264|NCT01795859|Chorea|chorea
4964265|NCT01795859|Tetrabenazine|tetrabenazine
4964266|NCT01795846|allergen specific immunotherapy, house dust mite (Der p), monosensitization, polysensitization, allergic rhinitis, asthma,|allergen specific immunotherapy, house dust mite (der p), monosensitization, polysensitization, allergic rhinitis, asthma,
4964267|NCT01795833|Prediabetes|prediabetes
4964268|NCT01795833|Prediabetic State|prediabetic state
4964269|NCT01795820|ticagrelor|ticagrelor
4964270|NCT01795820|clopidogrel|clopidogrel
4964271|NCT01795820|platelet aggregation|platelet aggregation
4964272|NCT01795781|Anticoagulant measurement|anticoagulant measurement
4964273|NCT01795781|Anticoagulant reversal|anticoagulant reversal
4964274|NCT01795781|Dabigatran|dabigatran
4964275|NCT01795781|Rivaroxaban|rivaroxaban
4964276|NCT01795768|Non randomised|non randomised
4964277|NCT01795768|Open label|open label
4964278|NCT01795768|Multicentre|multicentre
4964279|NCT01795768|Phase II biomarker study|phase ii biomarker study
4964280|NCT01795755|Horse Assisted Therapy (HAT)|horse assisted therapy (hat)
4964281|NCT01795755|Equine Assisted Psychotherapy (EAP)|equine assisted psychotherapy (eap)
4964282|NCT01795755|clinical trial|clinical trial
4964283|NCT01795755|Randomised Controlled Trial (RCT)|randomised controlled trial (rct)
4964284|NCT01795755|psychotherapy|psychotherapy
4964285|NCT01795742|Asthma|asthma
4964286|NCT01795742|Nebulizers|nebulizers
4964287|NCT01795742|Salbutamol|salbutamol
4964288|NCT01795742|Developing Countries|developing countries
4964289|NCT01795729|Heart transplant|heart transplant
4964290|NCT01795729|Coronary artery disease|coronary artery disease
4964291|NCT01795729|Allograft vascular disease|allograft vascular disease
4964292|NCT01795729|Coronary stent|coronary stent
4964293|NCT01795729|Optimal medical therapy|optimal medical therapy
4964294|NCT01795729|Prognosis|prognosis
4964295|NCT01795703|Prostate Cancer|prostate cancer
4964296|NCT01795703|Abiraterone Acetate|abiraterone acetate
4964297|NCT01795703|JNJ-212082|jnj-212082
4964298|NCT01795690|Anemia|anemia
4964299|NCT01795690|Cancer|cancer
4964300|NCT01795690|Hemoglobin|hemoglobin
4964301|NCT01795690|Quality of Life|quality of life
4964302|NCT01795690|FACT-An|fact-an
4964303|NCT01795690|FACT-GP|fact-gp
4964304|NCT01795690|Erythropoiesis-Stimulating Agents (ESA)|erythropoiesis-stimulating agents (esa)
4964305|NCT01795690|Epoetin|epoetin
4964306|NCT01795690|Ferric Carboxymaltose|ferric carboxymaltose
4964307|NCT01795690|Blood Transfusions|blood transfusions
4964308|NCT01795677|JAK2 inhibitor RUXOLITINIB|jak2 inhibitor ruxolitinib
4964309|NCT01795677|Primary or secondary myelofibrosis|primary or secondary myelofibrosis
4964310|NCT01795664|Asthma|asthma
4964311|NCT01795664|Salmeterol xinafoate and Fluticasone propionate|salmeterol xinafoate and fluticasone propionate
4964312|NCT01795664|Seretide Evohaler|seretide evohaler
4964313|NCT01795664|Functional Respiratory Imaging|functional respiratory imaging
4964314|NCT01795664|Computational Fluid Dynamic|computational fluid dynamic
4964315|NCT01795651|teaching|teaching
4964316|NCT01795651|knowledge translation|knowledge translation
4964317|NCT01795651|ICU|icu
4964318|NCT01795651|postgraduate|postgraduate
4964319|NCT01795651|lecture|lecture
4964320|NCT01795638|anthropometrics|anthropometrics
4964321|NCT01795638|weight|weight
4964322|NCT01795638|nutrition|nutrition
4964323|NCT01795586|breast - female|breast - female
4964324|NCT01795586|advanced breast cancer|advanced breast cancer
4964325|NCT01795586|histologically confirmed|histologically confirmed
4964326|NCT01795586|cytologically confirmed|cytologically confirmed
4964327|NCT01795586|metastatic|metastatic
4964328|NCT01795586|locally advanced|locally advanced
4964329|NCT01795586|unresectable|unresectable
4964330|NCT01795573|GVHD|gvhd
4964331|NCT01795573|AML|aml
4964332|NCT01795573|ALL|all
4964333|NCT01795573|MDS|mds
4964334|NCT01795573|CLL|cll
4964335|NCT01795573|NHL|nhl
4964336|NCT01795573|HL|hl
4964337|NCT01795573|MM|mm
4964338|NCT01795560|Periappendicular abscess|periappendicular abscess
4964339|NCT01795560|Ultrasound|ultrasound
4964340|NCT01795521|NSCLC, SBRT, PET, Medically Inoperable|nsclc, sbrt, pet, medically inoperable
4964341|NCT01795508|Parent training|parent training
4964342|NCT01795508|Child behavior|child behavior
4964343|NCT01795508|Randomized Controlled Trials|randomized controlled trials
4964344|NCT01795495|Spinal Fusion|spinal fusion
4964345|NCT01795495|Scoliosis|scoliosis
4964346|NCT01795495|Methadone|methadone
4964347|NCT01795495|Magnesium|magnesium
4964348|NCT01795495|Adolescents|adolescents
4964349|NCT01795495|Back Surgery|back surgery
4964350|NCT01795482|perioperative hypothermia|perioperative hypothermia
4964351|NCT01795482|prewarming|prewarming
4964352|NCT01795482|preoperative warming|preoperative warming
4964353|NCT01795482|general anaesthesia|general anaesthesia
4964354|NCT01795482|epidural anaesthesia|epidural anaesthesia
4964355|NCT01795482|temperature measurement|temperature measurement
4964356|NCT01795469|POTS|pots
4964357|NCT01795469|Orthostatic|orthostatic
4964358|NCT01795469|Adolescent|adolescent
4964359|NCT01795456|Takayasu's arteritis|takayasu's arteritis
4964360|NCT01795456|Giant Cell arteritis|giant cell arteritis
4964361|NCT01795456|Arteritis|arteritis
4964362|NCT01795456|Vasculitis|vasculitis
4964363|NCT01795456|Aortitis|aortitis
4964364|NCT01795456|Disease Activity|disease activity
4964365|NCT01795456|Carotidynia|carotidynia
4964366|NCT01795456|Neovascularization|neovascularization
4964367|NCT01795456|Carotid Intima Media Thickness|carotid intima media thickness
4964368|NCT01795443|vibration|vibration
4964369|NCT01795443|proprioception|proprioception
4964370|NCT01795417|wrinkles|wrinkles
4964371|NCT01795417|rhytids|rhytids
4964372|NCT01795417|periorbital|periorbital
4964373|NCT01795404|IBSR|ibsr
4964374|NCT01795404|Cancer Survivors|cancer survivors
4964375|NCT01795404|Katie Byron|katie byron
4964376|NCT01795404|Quality of Life|quality of life
4964377|NCT01795404|Stress|stress
4964378|NCT01795404|Stress reduction|stress reduction
4964379|NCT01795391|Prevention|prevention
4964380|NCT01795391|Dressings|dressings
4964381|NCT01795391|Catheters|catheters
4964382|NCT01795378|acute myelogenous leukemia|acute myelogenous leukemia
4964383|NCT01795378|acute lymphoblastic leukemia|acute lymphoblastic leukemia
4964384|NCT01795378|donor natural killer cells|donor natural killer cells
4964385|NCT01795378|HLA-haploidentical hematopoietic cell transplantation|hla-haploidentical hematopoietic cell transplantation
4964386|NCT01795352|EGFR,|egfr,
4964387|NCT01795352|lung cancer,|lung cancer,
4964388|NCT01795352|mutated|mutated
4964389|NCT01795339|AZD3293|azd3293
4964390|NCT01795339|Healthy volunteers|healthy volunteers
4964391|NCT01795339|Elderly volunteers|elderly volunteers
4964392|NCT01795339|Alzheimer's Disease patients|alzheimer's disease patients
4964393|NCT01795339|AD patients|ad patients
4964394|NCT01795339|Phase 1|phase 1
4964395|NCT01795339|Multiple Ascending Dose Study|multiple ascending dose study
4964396|NCT01795326|Effectiveness of risk minimization|effectiveness of risk minimization
4964397|NCT01795326|Metabolic monitoring|metabolic monitoring
4964398|NCT01795326|Seroquel®|seroquel®
4964399|NCT01795326|Seroquel® XR/quetiapine fumarate|seroquel® xr/quetiapine fumarate
4964400|NCT01795287|tibial fracture|tibial fracture
4964401|NCT01795287|intramedullary nailing|intramedullary nailing
4964402|NCT01795287|spinal anesthesia|spinal anesthesia
4964403|NCT01795287|patient safety|patient safety
4964404|NCT01795261|HIV|hiv
4964405|NCT01795248|gestational diabetes mellitus|gestational diabetes mellitus
4964406|NCT01795248|incretin|incretin
4964407|NCT01795248|glucose homeostasis|glucose homeostasis
4964408|NCT01795248|GLP-1|glp-1
4964409|NCT01795248|type 2 diabetes mellitus|type 2 diabetes mellitus
4964410|NCT01795248|liraglutide|liraglutide
4964411|NCT01795248|Victoza|victoza
4964412|NCT01795235|men|men
4964413|NCT01795222|conscious sedation|conscious sedation
4964414|NCT01795222|stress psychological|stress psychological
4964415|NCT01795222|dental care for children|dental care for children
4964416|NCT01795222|child behavior|child behavior
4964417|NCT01795222|saliva|saliva
4964418|NCT01795209|Branch retinal vein occlusion|branch retinal vein occlusion
4964419|NCT01795209|Macular edema|macular edema
4964420|NCT01795209|Ranibizumab|ranibizumab
4964421|NCT01795196|pediatric extubation failure|pediatric extubation failure
4964422|NCT01795196|weaning|weaning
4964423|NCT01795196|integrated pulmonary index|integrated pulmonary index
4964424|NCT01795196|mechanical ventilation|mechanical ventilation
4964425|NCT01795196|extubation readiness|extubation readiness
4964426|NCT01795196|respiratory monitoring tool|respiratory monitoring tool
4964427|NCT01795196|Endotracheal Extubation|endotracheal extubation
4964428|NCT01795196|Pediatric Intensive Care Unit|pediatric intensive care unit
4964429|NCT01795196|Rapid Shallow Breathing Index|rapid shallow breathing index
4964430|NCT01795196|Physiologic Deadspace|physiologic deadspace
4964431|NCT01795170|Pyridoxine Dependant Epilepsy|pyridoxine dependant epilepsy
4964432|NCT01795170|Antiquitin Deficiency|antiquitin deficiency
4964433|NCT01795170|Lysine Restricted Diet|lysine restricted diet
4964434|NCT01795157|decision support systems, clinical|decision support systems, clinical
4964435|NCT01795157|decision making, computer assisted|decision making, computer assisted
4964436|NCT01795157|evidence based practice|evidence based practice
4964437|NCT01795157|practice guidelines as topic|practice guidelines as topic
4964438|NCT01795131|Nutritional anemia|nutritional anemia
4964439|NCT01795131|Vitamin B12|vitamin b12
4964440|NCT01795131|flu vaccine|flu vaccine
4964441|NCT01795131|immunity|immunity
4964442|NCT01795092|Cellulitis|cellulitis
4964443|NCT01795092|Outpatient Medicine|outpatient medicine
4964444|NCT01795079|transcranial stimulation|transcranial stimulation
4964445|NCT01795079|direct current|direct current
4964446|NCT01795053|ADHD preschoolers|adhd preschoolers
4964447|NCT01795053|playtraining|playtraining
4964448|NCT01795053|child-focused intervention|child-focused intervention
4964449|NCT01795040|omega-3/omega-6 fatty acids|omega-3/omega-6 fatty acids
4964450|NCT01795040|Pre-school children with ADHD symptoms|pre-school children with adhd symptoms
4964451|NCT01795040|randomized controlled trial|randomized controlled trial
4964452|NCT01795027|gastric cancer|gastric cancer
4964453|NCT01795027|chemotherapy|chemotherapy
4964454|NCT01795027|D2 resection|d2 resection
4964455|NCT01795027|S-1|s-1
4964456|NCT01795001|pathophysiology|pathophysiology
4964457|NCT01794988|Acute Pain|acute pain
4964458|NCT01794988|Low Back Pain|low back pain
4964459|NCT01794988|Back Pain|back pain
4964460|NCT01794988|Functional Magnetic Resonance Imaging (fMRI)|functional magnetic resonance imaging (fmri)
4964461|NCT01794988|Cognitive Behavioral Therapy|cognitive behavioral therapy
4964462|NCT01794988|Pain Education|pain education
4964463|NCT01794975|PET|pet
4964464|NCT01794975|striatum|striatum
4964465|NCT01794975|receptor occupancy|receptor occupancy
4964466|NCT01794975|noradrenaline|noradrenaline
4964467|NCT01794975|alpha2c|alpha2c
4964468|NCT01794962|Classification|classification
4964469|NCT01794962|LBP|lbp
4964470|NCT01794962|Cognitive functional therapy|cognitive functional therapy
4964471|NCT01794962|Manual Therapy|manual therapy
4964472|NCT01794949|Angioplasty|angioplasty
4964473|NCT01794949|Atherosclerosis|atherosclerosis
4964474|NCT01794949|Wound Healing|wound healing
4964475|NCT01794936|Prostate cancer|prostate cancer
4964476|NCT01794936|Nerve Sparing Prostatectomy|nerve sparing prostatectomy
4964477|NCT01794936|VTI Probe|vti probe
4964478|NCT01794923|Delayed onset muscle soreness|delayed onset muscle soreness
4964479|NCT01794923|ibuprofen|ibuprofen
4964480|NCT01794923|topical|topical
4964481|NCT01794910|Pregnancy|pregnancy
4964482|NCT01794910|Pelvic Floor|pelvic floor
4964483|NCT01794910|Muscle strength|muscle strength
4964484|NCT01794910|Exercise therapy|exercise therapy
4965267|NCT01791296|sedation|sedation
4964485|NCT01794910|natural childbirth|natural childbirth
4964486|NCT01794910|cesarean section|cesarean section
4964487|NCT01794910|physiotherapy|physiotherapy
4964488|NCT01794884|Glutamine|glutamine
4964489|NCT01794884|Cardiosurgery|cardiosurgery
4964490|NCT01794884|Cardiopulmonary bypass|cardiopulmonary bypass
4964491|NCT01794884|Cardiac function|cardiac function
4964492|NCT01794884|Recovery|recovery
4964493|NCT01794845|SCCHN|scchn
4964494|NCT01794845|Head and Neck Cancer|head and neck cancer
4964495|NCT01794845|Squamous Cell Carcinoma|squamous cell carcinoma
4964496|NCT01794845|Recurrent|recurrent
4964497|NCT01794832|HRQoL|hrqol
4964498|NCT01794832|Aortic stenosis|aortic stenosis
4964499|NCT01794832|Aortic valve surgery|aortic valve surgery
4964500|NCT01794819|antibiotics|antibiotics
4964501|NCT01794819|primary care|primary care
4964502|NCT01794819|radiology/radiography|radiology/radiography
4964503|NCT01794819|respiratory tract infections|respiratory tract infections
4964504|NCT01794793|SOM230,|som230,
4964505|NCT01794793|roll-over study|roll-over study
4964506|NCT01794793|pasireotide LAR|pasireotide lar
4964507|NCT01794793|Cushing's disease|cushing's disease
4964508|NCT01794793|Acromegaly|acromegaly
4964509|NCT01794793|neuroendocrine tumorsNETs|neuroendocrine tumorsnets
4964510|NCT01794793|pituitary tumors|pituitary tumors
4964511|NCT01794793|Ectopic ACTH secreting|ectopic acth secreting
4964512|NCT01794793|EAS|eas
4964513|NCT01794793|Dumping Syndrome|dumping syndrome
4964514|NCT01794793|metastatic prostate cancer, metastatic melanoma|metastatic prostate cancer, metastatic melanoma
4964515|NCT01794793|bRAF|braf
4964516|NCT01794793|nRAS|nras
4964517|NCT01794767|peripheral venous catheter, children.|peripheral venous catheter, children.
4964518|NCT01794754|Hand osteoarthritis|hand osteoarthritis
4964519|NCT01794754|CMC1-joint|cmc1-joint
4964520|NCT01794754|surgery|surgery
4964521|NCT01794754|occupational therapy|occupational therapy
4964522|NCT01794754|hand exercises|hand exercises
4964523|NCT01794754|assistive devices|assistive devices
4964524|NCT01794754|orthoses|orthoses
4964525|NCT01794728|Pain Management|pain management
4964526|NCT01794715|Heart failure|heart failure
4964527|NCT01794715|Nurse led|nurse led
4964528|NCT01794715|Outpatient clinic|outpatient clinic
4964529|NCT01794715|Echocardiography|echocardiography
4964530|NCT01794715|Pocket-size|pocket-size
4964531|NCT01794715|Ultrasound|ultrasound
4964532|NCT01794702|Leukemia|leukemia
4964533|NCT01794702|Acute Leukemia|acute leukemia
4964534|NCT01794702|Acute myelogenous leukemia|acute myelogenous leukemia
4964535|NCT01794702|AML|aml
4964536|NCT01794702|Acute lymphoblastic leukemia|acute lymphoblastic leukemia
4964537|NCT01794702|ALL|all
4964538|NCT01794702|Maximum Tolerated Dose|maximum tolerated dose
4964539|NCT01794702|MTD|mtd
4964540|NCT01794702|Response Rate|response rate
4964541|NCT01794702|Decitabine|decitabine
4964542|NCT01794702|Dacogen|dacogen
4964543|NCT01794702|Idarubicin|idarubicin
4964544|NCT01794702|Idamycin|idamycin
4964545|NCT01794702|Cytarabine|cytarabine
4964546|NCT01794702|Ara-C|ara-c
4964547|NCT01794702|Cytosar|cytosar
4964548|NCT01794702|DepoCyt|depocyt
4964549|NCT01794702|Cytosine Arabinosine Hydrochloride|cytosine arabinosine hydrochloride
4964550|NCT01794676|Pancreatic cancer|pancreatic cancer
4964551|NCT01794676|Thymic cancer|thymic cancer
4964552|NCT01794676|Parathyroid disease|parathyroid disease
4964553|NCT01794676|MEN1 syndrome|men1 syndrome
4964554|NCT01794676|Genomic DNA|genomic dna
4964555|NCT01794676|MEN1 gene sequence|men1 gene sequence
4964556|NCT01794663|Early kidney graft dysfunction|early kidney graft dysfunction
4964557|NCT01794663|renal transplantation|renal transplantation
4964558|NCT01794650|T1DM, Exercise, Hypoglycaemia|t1dm, exercise, hypoglycaemia
4964559|NCT01794637|End stage liver disease|end stage liver disease
4964560|NCT01794637|Peripheral microcirculatory dysfunction|peripheral microcirculatory dysfunction
4964561|NCT01794637|Liver transplantation|liver transplantation
4964562|NCT01794637|Near infrared spectroscopy|near infrared spectroscopy
4964563|NCT01794624|TMD|tmd
4964564|NCT01794624|TMJD|tmjd
4964565|NCT01794624|Temporomandibular Joint Disorders|temporomandibular joint disorders
4964566|NCT01794624|Sleep Continuity Disturbance|sleep continuity disturbance
4964567|NCT01794624|Pain Catastrophizing|pain catastrophizing
4964568|NCT01794624|Cognitive Therapy|cognitive therapy
4964569|NCT01794624|Behavioral Therapy|behavioral therapy
4964570|NCT01794598|Heart failure|heart failure
4964571|NCT01794598|depression|depression
4964572|NCT01794598|depression care education|depression care education
4964573|NCT01794585|traumatic brain injury|traumatic brain injury
4964574|NCT01794585|balance deficits|balance deficits
4964575|NCT01794585|virtual reality|virtual reality
4964576|NCT01794585|home-based therapy|home-based therapy
4964577|NCT01794572|Multiple Myeloma|multiple myeloma
4964578|NCT01794572|Relapse|relapse
4964579|NCT01794572|Complete Remission|complete remission
4964580|NCT01794572|Very Good Partial Remission|very good partial remission
4964581|NCT01794559|Depression, EEG, QEEG, mTBI, PTSD, efficiency, safety, suicidality|depression, eeg, qeeg, mtbi, ptsd, efficiency, safety, suicidality
4964582|NCT01794546|pediatric obesity|pediatric obesity
4964583|NCT01794546|telehealth|telehealth
4964584|NCT01794533|Irreversible Pulpitis|irreversible pulpitis
4964585|NCT01794533|Infiltration injection|infiltration injection
4964586|NCT01794533|Fentanyl|fentanyl
4964587|NCT01794533|Lidocaine|lidocaine
4964588|NCT01794520|relapsed multiple myeloma|relapsed multiple myeloma
4964589|NCT01794520|refractory multiple myeloma|refractory multiple myeloma
4964590|NCT01794520|multiple myeloma|multiple myeloma
4964591|NCT01794520|relapsed/refractory multiple myeloma|relapsed/refractory multiple myeloma
4964592|NCT01794507|relapsed/refractory multiple myeloma|relapsed/refractory multiple myeloma
4964593|NCT01794507|relapsed multiple myeloma|relapsed multiple myeloma
4964594|NCT01794507|refractory multiple myeloma|refractory multiple myeloma
4964595|NCT01794507|multiple myeloma|multiple myeloma
4964596|NCT01794494|Peripheal arterial disease|peripheal arterial disease
4964597|NCT01794494|Critical limb ischemia|critical limb ischemia
4964598|NCT01794494|Bypass surgery|bypass surgery
4964599|NCT01794494|Subintimal angioplasty|subintimal angioplasty
4964600|NCT01794494|Health related cost|health related cost
4964601|NCT01794468|Dermal blood flow|dermal blood flow
4964602|NCT01794468|critically ill|critically ill
4964603|NCT01794455|Depression|depression
4964604|NCT01794455|Depressive Disorder|depressive disorder
4964605|NCT01794455|Geriatrics|geriatrics
4964606|NCT01794455|Hypertension|hypertension
4964607|NCT01794429|Obesity|obesity
4964608|NCT01794429|The Metabolic Syndrome/disturbances|the metabolic syndrome/disturbances
4964609|NCT01794429|Drug-induced adipositas|drug-induced adipositas
4964610|NCT01794429|Schizophrenia|schizophrenia
4964611|NCT01794429|GLP-1 analogue|glp-1 analogue
4964612|NCT01794429|cerebral effects|cerebral effects
4964613|NCT01794403|Prostate Cancer|prostate cancer
4964614|NCT01794403|Prostate|prostate
4964615|NCT01794403|Radiation Therapy|radiation therapy
4964616|NCT01794403|Hypofractionation Radiotherapy|hypofractionation radiotherapy
4964617|NCT01794403|Extended Hypofractionation Radiotherapy|extended hypofractionation radiotherapy
4964618|NCT01794403|Accelerated Hypofractionation Radiotherapy|accelerated hypofractionation radiotherapy
4964619|NCT01794403|AHRT|ahrt
4964620|NCT01794403|EHRT|ehrt
4964621|NCT01794390|COPD (Chronic Obstructive Pulmonary Disease)|copd (chronic obstructive pulmonary disease)
4964622|NCT01794390|Asthma|asthma
4964623|NCT01794390|Pulmojet|pulmojet
4964624|NCT01794390|Inhalers|inhalers
4964625|NCT01794390|Respiratory|respiratory
4964626|NCT01794390|Inhaler Technique|inhaler technique
4964627|NCT01794390|Critical Errors|critical errors
4964628|NCT01794377|Obesity|obesity
4964629|NCT01794364|T2DM|t2dm
4964630|NCT01794364|Diabetes Mellitus Type 2|diabetes mellitus type 2
4964631|NCT01794325|Occupational radiation exposure|occupational radiation exposure
4964632|NCT01794325|Transradial approach|transradial approach
4964633|NCT01794325|Transfemoral approach|transfemoral approach
4964634|NCT01794299|Haploidentical stem cell transplantation|haploidentical stem cell transplantation
4964635|NCT01794299|Graft-versus-host disease|graft-versus-host disease
4964636|NCT01794299|Immune reconstitution|immune reconstitution
4964637|NCT01794299|Alloreactive T-cells|alloreactive t-cells
4964638|NCT01794299|Photodepletion|photodepletion
4964639|NCT01794299|Photodynamic treatment|photodynamic treatment
4964640|NCT01794299|TH9402|th9402
4964641|NCT01794299|Transplant-related mortality|transplant-related mortality
4964642|NCT01794299|Hematologic malignancy|hematologic malignancy
4964643|NCT01794273|Ephedrine|ephedrine
4964644|NCT01794273|Phenylephrine|phenylephrine
4964645|NCT01794273|Vasopressor|vasopressor
4964646|NCT01794273|Carotid surgery|carotid surgery
4964647|NCT01794273|Hypotension|hypotension
4964648|NCT01794273|Haemodynamics|haemodynamics
4964649|NCT01794273|Brain ischemia|brain ischemia
4964650|NCT01794273|Tissue perfusion|tissue perfusion
4964651|NCT01794273|Stroke|stroke
4964652|NCT01794273|anaesthesia;|anaesthesia;
4964653|NCT01794260|Osteoarthritis|osteoarthritis
4964654|NCT01794260|Moderate ot severe pain|moderate ot severe pain
4964655|NCT01794260|ZINGIBER CASSUMUNAR ROXB|zingiber cassumunar roxb
4964656|NCT01794221|circumcision|circumcision
4964657|NCT01794221|2 octyl cyanoacrylate|2 octyl cyanoacrylate
4964658|NCT01794221|phimosis|phimosis
4964659|NCT01794208|in-vitro fertilization|in-vitro fertilization
4964660|NCT01794208|reproductive disorder|reproductive disorder
4964661|NCT01794195|Parkinson's disease|parkinson's disease
4964662|NCT01794195|Apathy|apathy
4964663|NCT01794195|diffusion tensor imaging|diffusion tensor imaging
4964664|NCT01794195|tractography|tractography
4964665|NCT01794156|Inference-based therapy|inference-based therapy
4964666|NCT01794156|Cognitive behavior therapy|cognitive behavior therapy
4964667|NCT01794156|Obsessive compulsive disorder|obsessive compulsive disorder
4964668|NCT01794156|Randomized clinical trial|randomized clinical trial
4964669|NCT01794143|Treatment of Type 2 diabetes|treatment of type 2 diabetes
4964670|NCT01794143|Comparative effectiveness research|comparative effectiveness research
4964671|NCT01794143|Clinical trial|clinical trial
4964672|NCT01794143|Patient-centered outcomes|patient-centered outcomes
4964673|NCT01794117|Anakinra|anakinra
4964674|NCT01794117|Pustular Psoriasis|pustular psoriasis
4964675|NCT01794117|Palmoplantar Pustulosis|palmoplantar pustulosis
4964676|NCT01794117|DITRA|ditra
4964677|NCT01794117|Subcorneal Pustular Dermatosis|subcorneal pustular dermatosis
4964678|NCT01794104|Topoisomerase Inhibitor|topoisomerase inhibitor
4964679|NCT01794104|Advanced Malignancies|advanced malignancies
4964680|NCT01794104|Pharmacodynamics|pharmacodynamics
4964681|NCT01794104|DNA Damage|dna damage
4964682|NCT01794104|Pharmacokinetics|pharmacokinetics
4964683|NCT01794091|Cardiac Magnetic Resonance Imaging|cardiac magnetic resonance imaging
4964684|NCT01794091|Diabetes|diabetes
4964685|NCT01794078|Acute Mountain Sickness|acute mountain sickness
4964686|NCT01794078|High altitude induced fatigue|high altitude induced fatigue
4964687|NCT01794026|diffusion weighted|diffusion weighted
4964688|NCT01794026|magnetic resonance imaging|magnetic resonance imaging
4964689|NCT01794026|surgery|surgery
4964690|NCT01794026|histopathology|histopathology
4964691|NCT01794013|Parent training|parent training
4964692|NCT01794013|DIR/ Floortime Approach|dir/ floortime approach
4964693|NCT01794013|Children with developmental disabilities|children with developmental disabilities
4964694|NCT01793987|blood loss between two groups|blood loss between two groups
4964695|NCT01793974|LADA|lada
4964696|NCT01793974|Latent Autoimmune Diabetes in Adults|latent autoimmune diabetes in adults
4964697|NCT01793974|Latent Autoimmune Diabetes|latent autoimmune diabetes
4964698|NCT01793974|Latent Diabetes in Adults|latent diabetes in adults
4964699|NCT01793935|Schizophrenia|schizophrenia
4964700|NCT01793935|Sensoril|sensoril
4964701|NCT01793935|Withania Somnifera extract|withania somnifera extract
4964702|NCT01793935|Total/ Positive / Negative Symptoms|total/ positive / negative symptoms
4964703|NCT01793935|Stress|stress
4964704|NCT01793935|Inflammation|inflammation
4964705|NCT01793935|Immunomodulation|immunomodulation
4964706|NCT01793909|Type 2 Diabetes|type 2 diabetes
4964707|NCT01793909|Exercise Impairment|exercise impairment
4964708|NCT01793909|Blood Flow|blood flow
4964709|NCT01793909|Muscle Oxygen Uptake|muscle oxygen uptake
4964710|NCT01793909|Exercise Training|exercise training
4964711|NCT01793896|Metabolic syndrome|metabolic syndrome
4964712|NCT01793896|Ageing|ageing
4964713|NCT01793896|Mitochondrial density|mitochondrial density
4964714|NCT01793896|Oxidative damage|oxidative damage
4964715|NCT01793896|Inflammatory mediators|inflammatory mediators
4964716|NCT01793896|AMPK|ampk
4964717|NCT01793896|Adipogenesis|adipogenesis
4964718|NCT01793883|Influenza Laninamivir Octanoate|influenza laninamivir octanoate
4964719|NCT01793870|pharmacokinetic|pharmacokinetic
4964720|NCT01793870|carvedilol|carvedilol
4964721|NCT01793870|Stable isotope technique|stable isotope technique
4964722|NCT01793857|Primary caregiver|primary caregiver
4964723|NCT01793857|Survey|survey
4964724|NCT01793857|Acute Otitis Media|acute otitis media
4964725|NCT01793857|Ear infection|ear infection
4964726|NCT01793857|Panama|panama
4964727|NCT01793857|Healthcare seeking behaviour|healthcare seeking behaviour
4964728|NCT01793844|diffuse large B cell lymphoma|diffuse large b cell lymphoma
4964729|NCT01793844|DFS|dfs
4964730|NCT01793844|OS|os
4964731|NCT01793831|Crohn's diseases|crohn's diseases
4964732|NCT01793831|Inflammatory bowel disease|inflammatory bowel disease
4964733|NCT01793831|Fecal transplantation|fecal transplantation
4964734|NCT01793831|Fecal bacteriotherapy|fecal bacteriotherapy
4964735|NCT01793831|Fecal microbiota transplantation|fecal microbiota transplantation
4964736|NCT01793818|Vaccine|vaccine
4964737|NCT01793818|HIV-1|hiv-1
4964738|NCT01793818|Tat|tat
4964739|NCT01793792|intracranial, saccular, aneurysms, stenting, coiling|intracranial, saccular, aneurysms, stenting, coiling
4964740|NCT01793740|sickle cell disease|sickle cell disease
4964741|NCT01793740|pediatric|pediatric
4964742|NCT01793740|learning disability|learning disability
4964743|NCT01793740|cognitive impairment|cognitive impairment
4964744|NCT01793740|memory|memory
4964745|NCT01793740|attention|attention
4964746|NCT01793740|Children with sickle cell disease|children with sickle cell disease
4964747|NCT01793727|infants|infants
4964748|NCT01793727|general anesthesia|general anesthesia
4964749|NCT01793727|tracheal intubation|tracheal intubation
4964750|NCT01793714|Magnetic Resonance Imaging|magnetic resonance imaging
4964751|NCT01793701|Cervical Cancer, Intensity-modulated radiotherapy|cervical cancer, intensity-modulated radiotherapy
4964752|NCT01793688|UNASYN-S|unasyn-s
4964753|NCT01793688|High Dose|high dose
4964754|NCT01793662|Aortobifemoral bypass|aortobifemoral bypass
4964755|NCT01793662|Laparoscopic aortic surgery|laparoscopic aortic surgery
4964756|NCT01793662|Aortoiliac occlusive disease|aortoiliac occlusive disease
4964757|NCT01793662|TASC Type D Lesions|tasc type d lesions
4964758|NCT01793662|Open aortic surgery|open aortic surgery
4964759|NCT01793649|Respiratory health|respiratory health
4964760|NCT01793649|Cystic Fibrosis|cystic fibrosis
4964761|NCT01793649|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
4964762|NCT01793623|atrial fibrillation|atrial fibrillation
4964763|NCT01793623|genetics|genetics
4964764|NCT01793623|cardiac arrhythmias|cardiac arrhythmias
4964765|NCT01793623|heart disease|heart disease
4964766|NCT01793610|MDMA|mdma
4964767|NCT01793610|Posttraumatic stress disorder|posttraumatic stress disorder
4964768|NCT01793610|sleep|sleep
4964769|NCT01793610|Depression|depression
4964770|NCT01793610|Safety|safety
4964771|NCT01793597|ticagrelor|ticagrelor
4964772|NCT01793597|Coronary artery bypass surgery|coronary artery bypass surgery
4964773|NCT01793597|platelet function|platelet function
4964774|NCT01793597|receptor binding|receptor binding
4964775|NCT01793597|platelet reactivity|platelet reactivity
4964776|NCT01793597|reversible binding|reversible binding
4964777|NCT01793584|Comparative effectiveness|comparative effectiveness
4964778|NCT01793584|Surgical success|surgical success
4964779|NCT01793571|Abdominal Muscles/Ultrasonography|abdominal muscles/ultrasonography
4964780|NCT01793571|Adult|adult
4964781|NCT01793571|Ambulatory Surgical Procedures|ambulatory surgical procedures
4964782|NCT01793571|Anesthetics, Local/Administration & Dosage|anesthetics, local/administration & dosage
4964783|NCT01793571|Levobupivacaine/Administration & Dosage|levobupivacaine/administration & dosage
4964784|NCT01793571|Levobupivacaine/Analogs & Derivatives|levobupivacaine/analogs & derivatives
4964785|NCT01793571|Hernia, Inguinal/Surgery|hernia, inguinal/surgery
4964786|NCT01793571|Humans|humans
4964787|NCT01793571|Nerve Block/Methods|nerve block/methods
4964788|NCT01793571|Pain Measurement/Methods|pain measurement/methods
4964789|NCT01793571|Pain, Postoperative/Prevention & Control|pain, postoperative/prevention & control
4964790|NCT01793571|Ultrasonography, Interventional|ultrasonography, interventional
4964791|NCT01793558|Thermoregulation Impairment|thermoregulation impairment
4964792|NCT01793558|hypothermia|hypothermia
4964793|NCT01793558|Postoperative shivering|postoperative shivering
4964794|NCT01793558|cesarean section|cesarean section
4964795|NCT01793558|newborn|newborn
4964796|NCT01793545|Endometrial Cancer|endometrial cancer
4964797|NCT01793545|Gynecological Cancers|gynecological cancers
4964798|NCT01793545|Screening|screening
4964799|NCT01793532|PET Imaging|pet imaging
4964800|NCT01793532|Epilepsy|epilepsy
4964801|NCT01793532|Inflammation|inflammation
4964802|NCT01793532|Brain Imaging|brain imaging
4964803|NCT01793519|Rheumatoid Arthritis|rheumatoid arthritis
4964804|NCT01793519|Autoimmune Diseases|autoimmune diseases
4964805|NCT01793519|Anti-TNF|anti-tnf
4964806|NCT01793506|immunodeficiency|immunodeficiency
4964807|NCT01793493|Mild Cognitive Impairment|mild cognitive impairment
4964808|NCT01793493|Cognitive Stimulation|cognitive stimulation
4964809|NCT01793493|Aging|aging
4964810|NCT01793493|Elderly|elderly
4964811|NCT01793493|Randomized Controlled Trial|randomized controlled trial
4964812|NCT01793480|Methadone in cancer pain|methadone in cancer pain
4964813|NCT01793428|adults admitted in vital emergency unit|adults admitted in vital emergency unit
4964814|NCT01793389|gingival recession|gingival recession
4964815|NCT01793389|fibrin|fibrin
4964816|NCT01793389|connective tissue|connective tissue
4964817|NCT01793389|root coverage|root coverage
4964818|NCT01793389|microsurgery|microsurgery
4964819|NCT01793389|case-control studies|case-control studies
4964820|NCT01793363|Tracheotomy|tracheotomy
4964821|NCT01793363|Weaning from mechanical ventilation|weaning from mechanical ventilation
4964822|NCT01793363|Lung ultrasound score|lung ultrasound score
4964823|NCT01793350|Diabetes|diabetes
4964824|NCT01793350|Mellitus|mellitus
4964825|NCT01793350|Painful|painful
4964826|NCT01793350|Neuropathy|neuropathy
4964827|NCT01793350|Peripheral|peripheral
4964828|NCT01793324|Effectiveness of risk minimization|effectiveness of risk minimization
4964829|NCT01793324|Metabolic monitoring|metabolic monitoring
4964830|NCT01793324|Seroquel® or Seroquel® XR/quetiapine fumarate|seroquel® or seroquel® xr/quetiapine fumarate
4964831|NCT01793311|intraocular pressure|intraocular pressure
4964832|NCT01793311|caffeine|caffeine
4964833|NCT01793311|dosage|dosage
4964834|NCT01793246|lung cancer|lung cancer
4964835|NCT01793246|lung neoplasms|lung neoplasms
4964836|NCT01793246|lung transplant|lung transplant
4964837|NCT01793194|venous insufficiency|venous insufficiency
4964838|NCT01793194|varicose veins|varicose veins
4964839|NCT01793194|pregnancy|pregnancy
4964840|NCT01793194|DVT|dvt
4964841|NCT01793194|superficial thrombophlebitis|superficial thrombophlebitis
4964842|NCT01793181|Vitamin d deficiency|vitamin d deficiency
4964843|NCT01793181|Central retinal vein occlusion|central retinal vein occlusion
4964844|NCT01793168|Rare Diseases|rare diseases
4964845|NCT01793168|Neglected Diseases|neglected diseases
4964846|NCT01793168|Orphan Diseases|orphan diseases
4964847|NCT01793168|Rare Disease Research|rare disease research
4964848|NCT01793168|Registries|registries
4964849|NCT01793168|WAGR Syndrome|wagr syndrome
4964850|NCT01793168|Ataxia|ataxia
4964851|NCT01793168|Cornelia de Lange Syndrome|cornelia de lange syndrome
4964852|NCT01793168|Stickler Syndrome|stickler syndrome
4964853|NCT01793168|Ataxia Telangiectasia|ataxia telangiectasia
4964854|NCT01793168|Kawasaki Disease|kawasaki disease
4964855|NCT01793168|Batten Disease|batten disease
4964856|NCT01793168|Mucolipidosis IV|mucolipidosis iv
4964857|NCT01793168|Klippel-Feil Syndrome|klippel-feil syndrome
4964858|NCT01793168|Multiple Endocrine Neoplasia|multiple endocrine neoplasia
4964859|NCT01793168|Atypical Hemolytic Uremic Syndrome|atypical hemolytic uremic syndrome
4964860|NCT01793168|Undiagnosed|undiagnosed
4964861|NCT01793168|Uncommon Disease|uncommon disease
4964862|NCT01793168|Kabuki Syndrome|kabuki syndrome
4964863|NCT01793168|Hypersomnia|hypersomnia
4964864|NCT01793168|Hyperacusis|hyperacusis
4964865|NCT01793168|Kleine-Levin Syndrome|kleine-levin syndrome
4964992|NCT01792752|HIV/AIDS|hiv/aids
4964866|NCT01793168|Marinesco-Sjogren Syndrome|marinesco-sjogren syndrome
4964867|NCT01793168|Leiomyosarcoma|leiomyosarcoma
4964868|NCT01793168|4p-/Wolf-Hirschhorn Syndrome|4p-/wolf-hirschhorn syndrome
4964869|NCT01793168|Hypophosphatasia|hypophosphatasia
4964870|NCT01793168|Narcolepsy|narcolepsy
4964871|NCT01793168|Wiedermann-Steiner Syndrome|wiedermann-steiner syndrome
4964872|NCT01793168|Breast Implant-Associated Anaplastic Large Cell Lymphoma|breast implant-associated anaplastic large cell lymphoma
4964873|NCT01793168|Autoimmune/inflammatory Syndrome Induced by Adjuvants (ASIA)|autoimmune/inflammatory syndrome induced by adjuvants (asia)
4964874|NCT01793168|Hemophagocytic Lymphohistiocytosis (HLH)|hemophagocytic lymphohistiocytosis (hlh)
4964875|NCT01793168|Behcet's Disease|behcet's disease
4964876|NCT01793155|Lung cancer surgery|lung cancer surgery
4964877|NCT01793155|Inspiratory muscle training|inspiratory muscle training
4964878|NCT01793155|Postoperative pulmonary complications|postoperative pulmonary complications
4964879|NCT01793155|Functional outcomes|functional outcomes
4964880|NCT01793155|Health related quality of life|health related quality of life
4964881|NCT01793142|Osteoporosis|osteoporosis
4964882|NCT01793142|postmenopausal|postmenopausal
4964883|NCT01793142|SERM|serm
4964884|NCT01793129|NICHD Neonatal Research Network|nichd neonatal research network
4964885|NCT01793129|Hypoxic-ischemic encephalopathy (HIE)|hypoxic-ischemic encephalopathy (hie)
4964886|NCT01793129|Hypothermia|hypothermia
4964887|NCT01793129|Neonatal depression|neonatal depression
4964888|NCT01793129|Perinatal asphyxia|perinatal asphyxia
4964889|NCT01793116|NICHD Neonatal Research Network|nichd neonatal research network
4964890|NCT01793116|Moderately Preterm|moderately preterm
4964891|NCT01793090|Cobalamin C defect|cobalamin c defect
4964892|NCT01793090|methylmalonic aciduria with homocystinuria|methylmalonic aciduria with homocystinuria
4964893|NCT01793090|Visual function|visual function
4964894|NCT01793090|VEP|vep
4964895|NCT01793090|ERG|erg
4964896|NCT01793090|antioxidant drugs|antioxidant drugs
4964897|NCT01793077|Prostate Cancer|prostate cancer
4964898|NCT01793077|Phase 4|phase 4
4964899|NCT01793077|Data collection|data collection
4964900|NCT01793077|Observational|observational
4964901|NCT01793077|Depo-Eligard|depo-eligard
4964902|NCT01793077|Prospective|prospective
4964903|NCT01793077|Non-interventional|non-interventional
4964904|NCT01793077|Treatment|treatment
4964905|NCT01793064|Pedometer,|pedometer,
4964906|NCT01793064|adaptive,|adaptive,
4964907|NCT01793064|exercise,|exercise,
4964908|NCT01793064|reinforcement,|reinforcement,
4964909|NCT01793064|goal setting,|goal setting,
4964910|NCT01793064|technology,|technology,
4964911|NCT01793064|email,|email,
4964912|NCT01793064|weight loss|weight loss
4964913|NCT01793064|mHealth|mhealth
4964914|NCT01793064|eHealth|ehealth
4964915|NCT01793051|Myeloma|myeloma
4964916|NCT01793051|Multiple Myeloma|multiple myeloma
4964917|NCT01793051|MM|mm
4964918|NCT01793051|Symptom Burden|symptom burden
4964919|NCT01793051|Symptom reduction|symptom reduction
4964920|NCT01793051|Maintenance therapy with lenalidomide|maintenance therapy with lenalidomide
4964921|NCT01793051|Minocycline|minocycline
4964922|NCT01793051|Dynacin|dynacin
4964923|NCT01793051|Minocin|minocin
4964924|NCT01793051|Minocin PAC|minocin pac
4964925|NCT01793051|Myrac|myrac
4964926|NCT01793051|Solodyn|solodyn
4964927|NCT01793051|Placebo|placebo
4964928|NCT01793051|Sugar pill|sugar pill
4964929|NCT01793051|MD Anderson Symptom Inventory|md anderson symptom inventory
4964930|NCT01793051|MDASI|mdasi
4964931|NCT01793051|Questionnaires|questionnaires
4964932|NCT01793051|Surveys|surveys
4964933|NCT01793038|PCOS|pcos
4964934|NCT01793038|clomiphene citrate resistant PCOS|clomiphene citrate resistant pcos
4964935|NCT01793038|Aromatase inhibitors|aromatase inhibitors
4964936|NCT01793025|leukemia|leukemia
4964937|NCT01793025|myeloid|myeloid
4964938|NCT01793025|acute|acute
4964939|NCT01793025|acute myeloid leukemia|acute myeloid leukemia
4964940|NCT01793025|allogeneic|allogeneic
4964941|NCT01793025|transient chimerism|transient chimerism
4964942|NCT01793025|cell therapy|cell therapy
4964943|NCT01793025|immunotherapy|immunotherapy
4964944|NCT01793012|therapeutic drug monitoring|therapeutic drug monitoring
4964945|NCT01793012|antibiotics|antibiotics
4964946|NCT01793012|inflammation parameters|inflammation parameters
4964947|NCT01793012|critically ill patients|critically ill patients
4964948|NCT01793012|septicaemia|septicaemia
4964949|NCT01793012|intensive care unit|intensive care unit
4964950|NCT01792999|Breast CT|breast ct
4964951|NCT01792986|Diabetes|diabetes
4964952|NCT01792986|Fasting|fasting
4964953|NCT01792986|Pre-diabetes|pre-diabetes
4964954|NCT01792986|Hemoglobin A1C|hemoglobin a1c
4964955|NCT01792973|HIV|hiv
4964956|NCT01792973|HPV|hpv
4964957|NCT01792973|Women|women
4964958|NCT01792973|Thailand|thailand
4964959|NCT01792973|Antiretrovirals|antiretrovirals
4964960|NCT01792973|Cervical cancer|cervical cancer
4964961|NCT01792934|Debulking, cytoreduction, RFA, SABR, palliative chemotherapy|debulking, cytoreduction, rfa, sabr, palliative chemotherapy
4964962|NCT01792921|Age 7-10 years old|age 7-10 years old
4964963|NCT01792921|regular education system|regular education system
4964964|NCT01792921|no moderate or severe neurological and/or psychiatric disorders|no moderate or severe neurological and/or psychiatric disorders
4964965|NCT01792908|ankle lateral ligament|ankle lateral ligament
4964966|NCT01792908|athletic tape|athletic tape
4964967|NCT01792908|position sense|position sense
4964968|NCT01792908|Proprioception|proprioception
4964969|NCT01792895|Posterior Neck Pain|posterior neck pain
4964970|NCT01792895|Cervical spine pain|cervical spine pain
4964971|NCT01792895|Manual therapy|manual therapy
4964972|NCT01792856|coaching|coaching
4964973|NCT01792856|early psychosis|early psychosis
4964974|NCT01792856|schizophrenia|schizophrenia
4964975|NCT01792830|Coronary Artery Bypass Graft surgery|coronary artery bypass graft surgery
4964976|NCT01792817|Cluster Headache|cluster headache
4964977|NCT01792817|GammaCore|gammacore
4964978|NCT01792817|vagal nerve stimulation|vagal nerve stimulation
4964979|NCT01792817|nVNS|nvns
4964980|NCT01792817|VNS|vns
4964981|NCT01792817|non invasive|non invasive
4964982|NCT01792817|vagus nerve stimulation|vagus nerve stimulation
4964983|NCT01792804|Staphylococcus aureus|staphylococcus aureus
4964984|NCT01792804|Bloodstream infection|bloodstream infection
4964985|NCT01792804|Oral switch|oral switch
4964986|NCT01792778|IV Catheters|iv catheters
4964987|NCT01792778|Blood control|blood control
4964988|NCT01792765|urolithiasis|urolithiasis
4964989|NCT01792765|radiation free|radiation free
4964990|NCT01792765|ultrasound guidance|ultrasound guidance
4964991|NCT01792765|ureteroscopy|ureteroscopy
4964993|NCT01792752|Drug Users|drug users
4964994|NCT01792752|Puerto Rico|puerto rico
4964995|NCT01792739|Probiotics|probiotics
4964996|NCT01792739|Diarrhea|diarrhea
4964997|NCT01792739|Intentive care units|intentive care units
4964998|NCT01792726|breast cancer|breast cancer
4964999|NCT01792726|radiotherapy|radiotherapy
4965000|NCT01792726|TARGIT|targit
4965001|NCT01792726|Intrabeam|intrabeam
4965002|NCT01792713|Skin alterations|skin alterations
4965003|NCT01792713|Atopic Dermatitis|atopic dermatitis
4965004|NCT01792687|Metastatic castrate resistant prostate cancer (CRPC)|metastatic castrate resistant prostate cancer (crpc)
4965005|NCT01792674|Education|education
4965006|NCT01792674|Patient simulation|patient simulation
4965007|NCT01792674|In situ simulation|in situ simulation
4965008|NCT01792674|Stress|stress
4965009|NCT01792661|Chronic Kidney Disease|chronic kidney disease
4965010|NCT01792661|Electronic Health Record|electronic health record
4965011|NCT01792661|Personal Health Record|personal health record
4965012|NCT01792661|Chronic Kidney Disease registry|chronic kidney disease registry
4965013|NCT01792661|Glomerular Filtration Rate|glomerular filtration rate
4965014|NCT01792661|Patient Navigator|patient navigator
4965015|NCT01792648|Almond|almond
4965016|NCT01792648|Carbohydrate|carbohydrate
4965017|NCT01792648|Diet|diet
4965018|NCT01792648|Cholesterol|cholesterol
4965019|NCT01792635|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
4965020|NCT01792635|Pharmacodynamics|pharmacodynamics
4965021|NCT01792635|Safety & Tolerability|safety & tolerability
4965022|NCT01792622|Instrument Development|instrument development
4965023|NCT01792622|Patient Reported Outcomes|patient reported outcomes
4965024|NCT01792622|Pulmonary Arterial Hypertension.|pulmonary arterial hypertension.
4965025|NCT01792609|Scoliosis|scoliosis
4965026|NCT01792609|Cobb Angle|cobb angle
4965027|NCT01792609|Screw Density|screw density
4965028|NCT01792609|Outcomes Measures|outcomes measures
4965029|NCT01792583|pregnancy|pregnancy
4965030|NCT01792570|HIV-1|hiv-1
4965031|NCT01792570|darunavir|darunavir
4965032|NCT01792570|rilpivirine|rilpivirine
4965033|NCT01792570|strategic study|strategic study
4965034|NCT01792557|Pilonidal sinus|pilonidal sinus
4965035|NCT01792557|Crystallized phenol|crystallized phenol
4965036|NCT01792557|Limberg Flap|limberg flap
4965037|NCT01792557|Modified Limberg Flap|modified limberg flap
4965038|NCT01792557|Karydakis|karydakis
4965039|NCT01792557|Recurrence|recurrence
4965040|NCT01792557|Complications|complications
4965041|NCT01792557|Recovery duration|recovery duration
4965042|NCT01792557|Time to return to work|time to return to work
4965043|NCT01792531|children|children
4965044|NCT01792531|obesity|obesity
4965045|NCT01792531|treatment|treatment
4965046|NCT01792531|family|family
4965047|NCT01792492|Thyroid Neoplasms|thyroid neoplasms
4965048|NCT01792492|Optical Devices|optical devices
4965049|NCT01792492|Spectrum Analysis|spectrum analysis
4965050|NCT01792492|Thyroid diseases|thyroid diseases
4965051|NCT01792479|NSCLC|nsclc
4965052|NCT01792479|lung cancer|lung cancer
4965053|NCT01792466|difficult biliary cannulation|difficult biliary cannulation
4965054|NCT01792453|Gastrointestinal physiology|gastrointestinal physiology
4965055|NCT01792453|MRI|mri
4965056|NCT01792453|Small bowel water volumes|small bowel water volumes
4965057|NCT01792453|Gastric volumes|gastric volumes
4965058|NCT01792401|Critical illness|critical illness
4965059|NCT01792401|Dietary supplements|dietary supplements
4965060|NCT01792401|Gastrointestinal tract/physio-pathology|gastrointestinal tract/physio-pathology
4965061|NCT01792388|Crohn's Disease|crohn's disease
4965062|NCT01792388|Vitamin D|vitamin d
4965063|NCT01792388|Intestinal Permeability|intestinal permeability
4965064|NCT01792388|Tara Raftery|tara raftery
4965065|NCT01792375|Cervical ripening|cervical ripening
4965066|NCT01792375|Dinoprostone|dinoprostone
4965067|NCT01792375|Labor induction|labor induction
4965068|NCT01792375|Membrane sweeping|membrane sweeping
4965069|NCT01792375|Nulliparous women|nulliparous women
4965070|NCT01792375|Trial|trial
4965268|NCT01791296|sleep|sleep
4965071|NCT01792362|Anti-mullerian hormone (AMH) level, poly cystic ovarian syndrome obese infertility weight loss diet|anti-mullerian hormone (amh) level, poly cystic ovarian syndrome obese infertility weight loss diet
4965072|NCT01792336|Repetitive TMS (rTMS)|repetitive tms (rtms)
4965073|NCT01792336|Transcranial Magnetic Stimulation (TMS)|transcranial magnetic stimulation (tms)
4965074|NCT01792336|Motor Cortex|motor cortex
4965075|NCT01792336|Focal Hand Dystonia|focal hand dystonia
4965076|NCT01792336|Facilitation|facilitation
4965077|NCT01792323|insulin pump therapy|insulin pump therapy
4965078|NCT01792323|insulin bolus|insulin bolus
4965079|NCT01792323|rapid acting insulin|rapid acting insulin
4965080|NCT01792323|insulin lispro|insulin lispro
4965081|NCT01792323|pharmacodynamics|pharmacodynamics
4965082|NCT01792323|pharmacokinetics|pharmacokinetics
4965083|NCT01792323|glucose clamp|glucose clamp
4965084|NCT01792310|Glioma|glioma
4965085|NCT01792310|Solid Tumours|solid tumours
4965086|NCT01792310|Minerval|minerval
4965087|NCT01792297|Sarcopenia|sarcopenia
4965088|NCT01792297|Osteoporosis|osteoporosis
4965089|NCT01792297|Cognition|cognition
4965090|NCT01792297|Inflammation|inflammation
4965091|NCT01792271|COPD|copd
4965092|NCT01792271|Chronic Bronchitis|chronic bronchitis
4965093|NCT01792271|Hypertonic Saline|hypertonic saline
4965094|NCT01792258|Percutaneous tracheostomy|percutaneous tracheostomy
4965095|NCT01792258|Intensive Care Unit|intensive care unit
4965096|NCT01792258|Ineffective Airway Clearance|ineffective airway clearance
4965097|NCT01792258|Weaning failure|weaning failure
4965098|NCT01792245|narrow band UVB; PUVA; psoriasis; eczema; hand|narrow band uvb; puva; psoriasis; eczema; hand
4965099|NCT01792232|Diesel exhaust|diesel exhaust
4965100|NCT01792232|Air pollution|air pollution
4965101|NCT01792232|Airway responsiveness|airway responsiveness
4965102|NCT01792232|Allergies|allergies
4965103|NCT01792219|interprofessional learning|interprofessional learning
4965104|NCT01792219|interprofessional collaboration|interprofessional collaboration
4965105|NCT01792219|residents|residents
4965106|NCT01792219|nursing homes|nursing homes
4965107|NCT01792206|Stage 3 chronic kidney disease (CKD)|stage 3 chronic kidney disease (ckd)
4965108|NCT01792206|Stage 4 chronic kidney disease (CKD)|stage 4 chronic kidney disease (ckd)
4965109|NCT01792206|CKD|ckd
4965110|NCT01792180|Gait speed|gait speed
4965111|NCT01792180|Mobility|mobility
4965112|NCT01792180|Falls|falls
4965113|NCT01792180|Fall risk|fall risk
4965114|NCT01792180|Self-management|self-management
4965115|NCT01792180|Mental wellbeing|mental wellbeing
4965116|NCT01792180|Elderly|elderly
4965117|NCT01792115|Fatty Liver|fatty liver
4965118|NCT01792115|Alpha-Tocopherol|alpha-tocopherol
4965119|NCT01792115|Vitamin E|vitamin e
4965120|NCT01792115|Non-Alcoholic Steatohepatitis|non-alcoholic steatohepatitis
4965121|NCT01792102|Multiple Myeloma|multiple myeloma
4965122|NCT01792102|Carfilzomib|carfilzomib
4965123|NCT01792102|Krypolis|krypolis
4965124|NCT01792102|60 minute infusion|60 minute infusion
4965125|NCT01792089|de novo lipogenesis|de novo lipogenesis
4965126|NCT01792089|fructose|fructose
4965127|NCT01792089|roux-en-Y gastric bypass|roux-en-y gastric bypass
4965128|NCT01792089|post-prandial triglycerides|post-prandial triglycerides
4965129|NCT01792050|IDO|ido
4965130|NCT01792050|IDO Inhibitor|ido inhibitor
4965131|NCT01792050|Metastatic Breast Cancer|metastatic breast cancer
4965132|NCT01792011|Elective living donor liver transplantation|elective living donor liver transplantation
4965133|NCT01791985|Breast Cancer|breast cancer
4965134|NCT01791985|AZD4547|azd4547
4965135|NCT01791985|Safety Run-In|safety run-in
4965136|NCT01791985|FGFR1|fgfr1
4965137|NCT01791985|ER positive breast cancer|er positive breast cancer
4965138|NCT01791985|Single arm phase IIa study|single arm phase iia study
4965139|NCT01791972|Exercise-Induced Bronchoconstriction (EIB)|exercise-induced bronchoconstriction (eib)
4965140|NCT01791972|Spiromax®|spiromax®
4965141|NCT01791972|Albuterol sulfate|albuterol sulfate
4965142|NCT01791946|lazy eye|lazy eye
4965143|NCT01791946|cross eye|cross eye
4965144|NCT01791946|cross eyed|cross eyed
4965145|NCT01791933|LBP|lbp
4965146|NCT01791933|Neck pain|neck pain
4965147|NCT01791933|Integrative package|integrative package
4965148|NCT01791933|CAM|cam
4965149|NCT01791868|Generalized convulsive status epilepticus|generalized convulsive status epilepticus
4965150|NCT01791868|Sodium valproate|sodium valproate
4965151|NCT01791868|Refractory status epilepticus|refractory status epilepticus
4965152|NCT01791868|Mortality|mortality
4965153|NCT01791868|Epilepsy|epilepsy
4965154|NCT01791868|Intensive Care Unit|intensive care unit
4965155|NCT01791868|Neurological sequela|neurological sequela
4965156|NCT01791868|Quality of life|quality of life
4965157|NCT01791868|Adult|adult
4965158|NCT01791855|Subjects with Renal Impairment|subjects with renal impairment
4965159|NCT01791855|healthy|healthy
4965160|NCT01791842|fibrous dysplasia of bone|fibrous dysplasia of bone
4965161|NCT01791842|tocilizumab|tocilizumab
4965162|NCT01791842|McCune-Albright syndrome|mccune-albright syndrome
4965163|NCT01791829|Luminal A|luminal a
4965164|NCT01791829|Ipsilateral Breast Tumour Recurrence|ipsilateral breast tumour recurrence
4965165|NCT01791816|Vasovagal Syncope|vasovagal syncope
4965166|NCT01791816|Postural Tachycardia Syndrome|postural tachycardia syndrome
4965167|NCT01791816|Orthostatic Intolerance|orthostatic intolerance
4965168|NCT01791816|Nitric Oxide (NO)|nitric oxide (no)
4965169|NCT01791816|Orthostatic Stress|orthostatic stress
4965170|NCT01791816|L-Ng-monomethyl Arginine (L-NMMA)|l-ng-monomethyl arginine (l-nmma)
4965171|NCT01791816|Phenylephrine|phenylephrine
4965172|NCT01791816|Sodium Nitroprusside|sodium nitroprusside
4965173|NCT01791803|Smoking cessation|smoking cessation
4965174|NCT01791803|Tobacco abstinence|tobacco abstinence
4965175|NCT01791803|hypnotherapy|hypnotherapy
4965176|NCT01791803|Nicotine replacement therapy|nicotine replacement therapy
4965177|NCT01791790|old Subjects|old subjects
4965178|NCT01791790|Controls|controls
4965179|NCT01791790|brain stimulation|brain stimulation
4965180|NCT01791790|tSOS|tsos
4965181|NCT01791790|tDCS|tdcs
4965182|NCT01791790|sleep|sleep
4965183|NCT01791790|memory|memory
4965184|NCT01791790|memory consolidation|memory consolidation
4965185|NCT01791777|fidelity|fidelity
4965186|NCT01791777|implementation science|implementation science
4965187|NCT01791777|competence|competence
4965188|NCT01791777|training|training
4965189|NCT01791777|coaching|coaching
4965190|NCT01791738|Total Hip Arthroplasty (THA)|total hip arthroplasty (tha)
4965191|NCT01791738|Patient-Specific Instruments|patient-specific instruments
4965192|NCT01791738|Acetabular Cup Placement|acetabular cup placement
4965193|NCT01791738|Accuracy|accuracy
4965194|NCT01791699|atrial fibrillation|atrial fibrillation
4965195|NCT01791699|paroxysmal|paroxysmal
4965196|NCT01791699|persistent|persistent
4965197|NCT01791699|ablation|ablation
4965198|NCT01791699|pulmonary vein isolation|pulmonary vein isolation
4965199|NCT01791699|recurrence|recurrence
4965200|NCT01791686|Dense Deposit Disease|dense deposit disease
4965201|NCT01791686|DDD|ddd
4965202|NCT01791673|Glaucoma|glaucoma
4965203|NCT01791673|Cyclocoagulation|cyclocoagulation
4965204|NCT01791673|HIFU - High Intensity Focused Ultrasound|hifu - high intensity focused ultrasound
4965205|NCT01791673|Ciliary Body|ciliary body
4965206|NCT01791647|Polycystic ovary syndrome|polycystic ovary syndrome
4965207|NCT01791647|myoinositol|myoinositol
4965208|NCT01791647|metformin|metformin
4965209|NCT01791647|glucose-insulinemic metabolism|glucose-insulinemic metabolism
4965210|NCT01791647|menstrual pattern|menstrual pattern
4965211|NCT01791647|insulin-lowering therapies|insulin-lowering therapies
4965212|NCT01791621|Irritable Bowel Syndrome|irritable bowel syndrome
4965213|NCT01791621|Elimination diet|elimination diet
4965214|NCT01791621|Food allergies|food allergies
4965215|NCT01791608|Child, Preschool|child, preschool
4965216|NCT01791608|Dietary Zinc|dietary zinc
4965217|NCT01791608|Zinc sulfate|zinc sulfate
4965218|NCT01791608|zinc-glycine chelate|zinc-glycine chelate
4965219|NCT01791595|Phase I|phase i
4965220|NCT01791595|Cancer|cancer
4965221|NCT01791595|Solid Tumours|solid tumours
4965222|NCT01791595|Diffuse Large B Cell Lymphoma|diffuse large b cell lymphoma
4965223|NCT01791595|Monocarboxylate Transporter 1 Inhibitor|monocarboxylate transporter 1 inhibitor
4965224|NCT01791595|lactate|lactate
4965225|NCT01791595|Burkitt Lymphoma|burkitt lymphoma
4965226|NCT01791556|HIV|hiv
4965227|NCT01791556|AIDS|aids
4965228|NCT01791556|Kenya|kenya
4965229|NCT01791556|viral load|viral load
4965230|NCT01791556|Antiretroviral therapy|antiretroviral therapy
4965231|NCT01791556|randomized clinical trial|randomized clinical trial
4965232|NCT01791556|ART monitoring|art monitoring
4965233|NCT01791556|treatment failure|treatment failure
4965234|NCT01791556|HIV resistance|hiv resistance
4965235|NCT01791543|ventricular tachycardia|ventricular tachycardia
4965236|NCT01791543|ablation|ablation
4965237|NCT01791543|ventricular arrhythmia|ventricular arrhythmia
4965238|NCT01791530|VAT|vat
4965239|NCT01791530|VAP|vap
4965240|NCT01791530|Transition from VAT to VAP|transition from vat to vap
4965241|NCT01791504|Abdominoplasty|abdominoplasty
4965367|NCT01790711|Bacteriotherapy|bacteriotherapy
4965242|NCT01791478|-Metastatic breast cancer, PI3K inhibitor, Endocrine therapy|-metastatic breast cancer, pi3k inhibitor, endocrine therapy
4965243|NCT01791465|HIV|hiv
4965244|NCT01791465|Diabetes|diabetes
4965245|NCT01791400|Metoclopramide|metoclopramide
4965246|NCT01791400|Sumatriptan|sumatriptan
4965247|NCT01791400|migraine|migraine
4965248|NCT01791400|headache|headache
4965249|NCT01791387|Renal cell|renal cell
4965250|NCT01791387|Kidney|kidney
4965251|NCT01791387|Cancer|cancer
4965252|NCT01791387|Metastatic carcinoma|metastatic carcinoma
4965253|NCT01791374|Advanced Solid Tumors|advanced solid tumors
4965254|NCT01791374|Advanced or Metastatic Gastric Cancer|advanced or metastatic gastric cancer
4965255|NCT01791374|Advanced or Metastatic GEJ|advanced or metastatic gej
4965256|NCT01791374|Gastric Cancer|gastric cancer
4965257|NCT01791361|Metastatic colorectal cancer|metastatic colorectal cancer
4965258|NCT01791335|Glottis|glottis
4965259|NCT01791335|Respiratory Muscles|respiratory muscles
4965260|NCT01791335|Upper airway|upper airway
4965261|NCT01791335|Noninvasive ventilation|noninvasive ventilation
4965262|NCT01791309|Vemurafenib|vemurafenib
4965263|NCT01791309|Panitumumab|panitumumab
4965264|NCT01791309|V600E BRAF mutation|v600e braf mutation
4965265|NCT01791309|colon|colon
4965266|NCT01791309|12-221|12-221
4965269|NCT01791296|delirium|delirium
4965270|NCT01791296|critical illness|critical illness
4965271|NCT01791296|sub-syndromal delirium|sub-syndromal delirium
4965272|NCT01791296|intensive care|intensive care
4965273|NCT01791283|Left ventricular stroke volume|left ventricular stroke volume
4965274|NCT01791283|Arterial waveform analysis|arterial waveform analysis
4965275|NCT01791283|Esofageal doppler|esofageal doppler
4965276|NCT01791283|Ultrasound|ultrasound
4965277|NCT01791283|Cardiac magnetic Imaging|cardiac magnetic imaging
4965278|NCT01791283|Limits of agreement|limits of agreement
4965279|NCT01791270|Obstructive Sleep Apnea|obstructive sleep apnea
4965280|NCT01791270|Hypertension|hypertension
4965281|NCT01791270|β1 Subunit of Maxi-k+Channel|β1 subunit of maxi-k+channel
4965282|NCT01791270|Cardiovascular Risk|cardiovascular risk
4965283|NCT01791257|delayed|delayed
4965284|NCT01791257|cerebral|cerebral
4965285|NCT01791257|ischemia|ischemia
4965286|NCT01791257|microrna|microrna
4965287|NCT01791257|cerebrospinal fluid|cerebrospinal fluid
4965288|NCT01791257|subarachnoid|subarachnoid
4965289|NCT01791257|hemorrhage|hemorrhage
4965290|NCT01791244|Multiple Sclerosis|multiple sclerosis
4965291|NCT01791244|Relapsing-Remitting|relapsing-remitting
4965292|NCT01791244|Rebif|rebif
4965293|NCT01791244|RebiSmart|rebismart
4965294|NCT01791244|Patient support program|patient support program
4965295|NCT01791231|Healthy|healthy
4965296|NCT01791231|Male|male
4965297|NCT01791231|Canagliflozin (JNJ-28431754)|canagliflozin (jnj-28431754)
4965298|NCT01791231|Radiolabeled 14C-canagliflozin|radiolabeled 14c-canagliflozin
4965299|NCT01791231|Absorption|absorption
4965300|NCT01791231|Metabolism|metabolism
4965301|NCT01791231|Excretion|excretion
4965302|NCT01791231|Radioactivity|radioactivity
4965303|NCT01791218|Pulmonary vein isolation|pulmonary vein isolation
4965304|NCT01791218|Paroxysmal atrial fibrillation|paroxysmal atrial fibrillation
4965305|NCT01791218|Quality of life|quality of life
4965306|NCT01791192|Uveitis, Fingolimod, Phase II, Visual Acuity, Vitreous Haze, OCT|uveitis, fingolimod, phase ii, visual acuity, vitreous haze, oct
4965307|NCT01791114|Insulin sensitivity|insulin sensitivity
4965308|NCT01791114|Diabetes Prevention|diabetes prevention
4965309|NCT01791114|Obesity|obesity
4965310|NCT01791114|Brown adipose tissue|brown adipose tissue
4965311|NCT01791101|Thrombocytopenia|thrombocytopenia
4965312|NCT01791101|Eltrombopag|eltrombopag
4965313|NCT01791075|DSAEK|dsaek
4965314|NCT01791075|Tan Endoglide|tan endoglide
4965315|NCT01791075|Endosaver/Endoserter|endosaver/endoserter
4965316|NCT01791062|cartilage tissue engineering|cartilage tissue engineering
4965317|NCT01791062|hyaluronan|hyaluronan
4965318|NCT01791062|hyaluronic acid|hyaluronic acid
4965319|NCT01791049|Gram-positive|gram-positive
4965320|NCT01791049|Infections|infections
4965321|NCT01791049|Bacterial infections|bacterial infections
4965322|NCT01791036|Adductor canal block|adductor canal block
4965323|NCT01791036|Femoral Nerve Block|femoral nerve block
4965324|NCT01791023|Depression|depression
4965325|NCT01791023|Physical exercise|physical exercise
4965326|NCT01791023|Stress|stress
4965327|NCT01791010|Breathing exercises|breathing exercises
4965328|NCT01791010|Aged|aged
4965329|NCT01790997|DLBS1033|dlbs1033
4965330|NCT01790997|Lumbrokinase|lumbrokinase
4965331|NCT01790997|Acute ischemic stroke|acute ischemic stroke
4965332|NCT01790997|Bleeding profile|bleeding profile
4965333|NCT01790997|Clinical outcome|clinical outcome
4965334|NCT01790997|Aspirin|aspirin
4965335|NCT01790997|Clopidogrel|clopidogrel
4965336|NCT01790984|Dietary extrinsic sugars, atherogenic lipoprotein phenotype, lipoprotein kinetics, fatty liver|dietary extrinsic sugars, atherogenic lipoprotein phenotype, lipoprotein kinetics, fatty liver
4965337|NCT01790971|Obstructive sleep apnea|obstructive sleep apnea
4965338|NCT01790971|Spinal morphine|spinal morphine
4965339|NCT01790932|Metastatic|metastatic
4965340|NCT01790932|Triple Negative|triple negative
4965341|NCT01790919|Depression, Adults|depression, adults
4965342|NCT01790906|Chronic Heart Failure|chronic heart failure
4965343|NCT01790906|Renal Sympathetic Denervation|renal sympathetic denervation
4965344|NCT01790893|Histoplasmosis|histoplasmosis
4965345|NCT01790880|Aphasia|aphasia
4965346|NCT01790880|Stroke|stroke
4965347|NCT01790880|Speech Rehabilitation|speech rehabilitation
4965348|NCT01790854|prasugrel|prasugrel
4965349|NCT01790854|antiplatelet|antiplatelet
4965350|NCT01790854|Acute Coronary Syndrome|acute coronary syndrome
4965351|NCT01790815|Acute Malnutrition|acute malnutrition
4965352|NCT01790815|Mid Upper Arm Circumference|mid upper arm circumference
4965353|NCT01790815|Screening|screening
4965354|NCT01790802|laser treatment, high risk, early AMD|laser treatment, high risk, early amd
4965355|NCT01790776|urethrography|urethrography
4965356|NCT01790763|Burn|burn
4965357|NCT01790763|Second-degree|second-degree
4965358|NCT01790750|PDA|pda
4965359|NCT01790750|Echo|echo
4965360|NCT01790750|PES|pes
4965361|NCT01790750|Handheld echo system|handheld echo system
4965362|NCT01790737|myeloma, stem cell mobilization, autologous stem cell transplantation|myeloma, stem cell mobilization, autologous stem cell transplantation
4965363|NCT01790737|induction treatment, maintenance treatment|induction treatment, maintenance treatment
4965364|NCT01790711|Gut bacteria|gut bacteria
4965365|NCT01790711|Bacteria|bacteria
4965468|NCT01790191|Nutrient|nutrient
4965366|NCT01790711|Fecal transplant|fecal transplant
4965368|NCT01790698|Necrotizing fasciitis|necrotizing fasciitis
4965369|NCT01790698|Streptococcus pyogenes|streptococcus pyogenes
4965370|NCT01790698|Staphylococcus aureus|staphylococcus aureus
4965371|NCT01790698|Immunopathogenesis|immunopathogenesis
4965372|NCT01790672|Antioxidants|antioxidants
4965373|NCT01790672|Central Nervous System Agents|central nervous system agents
4965374|NCT01790672|Wine|wine
4965375|NCT01790659|leishmaniasis|leishmaniasis
4965376|NCT01790659|cutaneous leishmaniasis|cutaneous leishmaniasis
4965377|NCT01790659|Leishmania panamensis|leishmania panamensis
4965378|NCT01790659|L panamensis|l panamensis
4965379|NCT01790659|Paromomycin|paromomycin
4965380|NCT01790659|Paromomycin/Gentamicin|paromomycin/gentamicin
4965381|NCT01790633|rapid test|rapid test
4965382|NCT01790633|screening|screening
4965383|NCT01790633|ELISA|elisa
4965384|NCT01790633|hepatitis B virus|hepatitis b virus
4965385|NCT01790633|hepatitis C virus|hepatitis c virus
4965386|NCT01790633|human immunodeficiency virus|human immunodeficiency virus
4965387|NCT01790633|access to care|access to care
4965388|NCT01790620|Severe sepsis|severe sepsis
4965389|NCT01790620|Septic shock|septic shock
4965390|NCT01790620|Acute renal failure|acute renal failure
4965391|NCT01790620|Acute kidney injury|acute kidney injury
4965392|NCT01790620|Continuous renal replacement therapies CRRT|continuous renal replacement therapies crrt
4965393|NCT01790607|Adult healthy subjects will be matched with individual subjects by age (± 5 years, gender, and BMI (± 15%)|adult healthy subjects will be matched with individual subjects by age (± 5 years, gender, and bmi (± 15%)
4965394|NCT01790594|transplantation|transplantation
4965395|NCT01790594|kidney|kidney
4965396|NCT01790594|pancreas|pancreas
4965397|NCT01790594|immunosuppression|immunosuppression
4965398|NCT01790594|calcineurin inhibitor (CNI)|calcineurin inhibitor (cni)
4965399|NCT01790581|Chronic Ankle Instability|chronic ankle instability
4965400|NCT01790555|Postsurgical|postsurgical
4965401|NCT01790555|Pain|pain
4965402|NCT01790555|THC|thc
4965403|NCT01790555|Sensitization|sensitization
4965404|NCT01790542|Iron|iron
4965405|NCT01790542|Intestinal inflammation|intestinal inflammation
4965406|NCT01790542|ROS|ros
4965407|NCT01790516|Head and neck cancer|head and neck cancer
4965408|NCT01790516|genetic testing|genetic testing
4965409|NCT01790516|cisplatin|cisplatin
4965410|NCT01790516|erbitux|erbitux
4965411|NCT01790516|radiation therapy|radiation therapy
4965412|NCT01790503|glioblastoma|glioblastoma
4965413|NCT01790503|GBM|gbm
4965414|NCT01790477|Tonsillectomy|tonsillectomy
4965415|NCT01790477|Acupuncture|acupuncture
4965416|NCT01790464|Glossopharyngeal nerve block|glossopharyngeal nerve block
4965417|NCT01790464|Airway anesthesia|airway anesthesia
4965418|NCT01790464|Awake intubation|awake intubation
4965419|NCT01790451|focal therapy|focal therapy
4965420|NCT01790451|irreversible electroporation|irreversible electroporation
4965421|NCT01790451|prostate cancer|prostate cancer
4965422|NCT01790412|pregnancy, exercise, gestational diabetes|pregnancy, exercise, gestational diabetes
4965423|NCT01790399|SENTINEL NODE|sentinel node
4965424|NCT01790386|hemostasis|hemostasis
4965425|NCT01790386|thromboelastography|thromboelastography
4965426|NCT01790386|coagulation|coagulation
4965427|NCT01790386|TEG|teg
4965428|NCT01790373|Suubi|suubi
4965429|NCT01790373|Adolescents|adolescents
4965430|NCT01790373|Poverty|poverty
4965431|NCT01790373|Economic empowerment interventions|economic empowerment interventions
4965432|NCT01790373|Adherence to HIV antiretroviral therapy|adherence to hiv antiretroviral therapy
4965433|NCT01790373|Wisepill|wisepill
4965434|NCT01790373|HIV/AIDS infected Children|hiv/aids infected children
4965435|NCT01790373|Medical event monitoring system|medical event monitoring system
4965436|NCT01790373|Uganda|uganda
4965437|NCT01790360|MSM|msm
4965438|NCT01790360|HIV|hiv
4965439|NCT01790360|Substance Abuse|substance abuse
4965440|NCT01790360|Sexual Behavior|sexual behavior
4965441|NCT01790347|Exercise|exercise
4965442|NCT01790347|Aerobic|aerobic
4965443|NCT01790347|Resistance training|resistance training
4965444|NCT01790347|Pregnancy|pregnancy
4965445|NCT01790347|Maternal weight gain|maternal weight gain
4965446|NCT01790347|IOM recommendations|iom recommendations
4965447|NCT01790295|Myelofibrosis|myelofibrosis
4965448|NCT01790295|Stem cell transplant|stem cell transplant
4965449|NCT01790295|Ruxolitinib|ruxolitinib
4965450|NCT01790282|luteal support|luteal support
4965451|NCT01790282|high responder|high responder
4965452|NCT01790282|ICSI|icsi
4965453|NCT01790282|ivf|ivf
4965454|NCT01790282|cycle outcome|cycle outcome
4965455|NCT01790269|Relapsing-Remitting Multiple Sclerosis|relapsing-remitting multiple sclerosis
4965456|NCT01790269|NK cells|nk cells
4965457|NCT01790269|Fingolimod|fingolimod
4965458|NCT01790204|mutant p53|mutant p53
4965459|NCT01790204|watercress|watercress
4965460|NCT01790204|Phenethyl isothyocyanate|phenethyl isothyocyanate
4965461|NCT01790204|oral cells of smokers|oral cells of smokers
4965462|NCT01790191|Children|children
4965463|NCT01790191|Eating behaviour|eating behaviour
4965464|NCT01790191|Intake|intake
4965465|NCT01790191|Liking|liking
4965466|NCT01790191|Conditioned liking|conditioned liking
4965467|NCT01790191|Flavour|flavour
4965469|NCT01790191|Vegetable|vegetable
4965470|NCT01790165|Onychomycosis|onychomycosis
4965471|NCT01790165|Open Label|open label
4965472|NCT01790165|PK|pk
4965473|NCT01790126|Men with Biochemically Relapsed Hormone Sensitive Prostate Cancer|men with biochemically relapsed hormone sensitive prostate cancer
4965474|NCT01790074|cervicogenic headache|cervicogenic headache
4965475|NCT01790074|trigger point|trigger point
4965476|NCT01790074|sternocleidomastoid|sternocleidomastoid
4965477|NCT01790074|manual therapy|manual therapy
4965478|NCT01790061|Gut bacteria|gut bacteria
4965479|NCT01790061|Gut flora|gut flora
4965480|NCT01790061|Bacteriotherapy|bacteriotherapy
4965481|NCT01790061|Fecal Microbiota Transplantation|fecal microbiota transplantation
4965482|NCT01790061|Inflammatory bowel disease|inflammatory bowel disease
4965483|NCT01790061|Ulcerative colitis|ulcerative colitis
4965484|NCT01790048|MAM|mam
4965485|NCT01790009|ADME|adme
4965486|NCT01790009|Flavanols|flavanols
4965487|NCT01790009|Age|age
4965488|NCT01790009|Pharmacokinetics|pharmacokinetics
4965489|NCT01789996|6 minute walk test|6 minute walk test
4965490|NCT01789996|idiopathic pulmonary fibrosis|idiopathic pulmonary fibrosis
4965491|NCT01789996|pulmonary arterial hypertension|pulmonary arterial hypertension
4965492|NCT01789983|Physical Activity|physical activity
4965493|NCT01789983|Chemotherapy|chemotherapy
4965494|NCT01789983|Elderly|elderly
4965495|NCT01789983|Geriatric|geriatric
4965496|NCT01789983|Walking|walking
4965497|NCT01789983|Geriatric Assessment|geriatric assessment
4965498|NCT01789983|Geriatric Oncology|geriatric oncology
4965499|NCT01789970|chronic low back pain|chronic low back pain
4965500|NCT01789970|hydrocodone bitartrate|hydrocodone bitartrate
4965501|NCT01789970|opioids|opioids
4965502|NCT01789944|Childhood Obesity|childhood obesity
4965503|NCT01789918|Hypertension|hypertension
4965504|NCT01789918|Blood pressure|blood pressure
4965505|NCT01789918|Renal denervation|renal denervation
4965506|NCT01789905|Tygacil|tygacil
4965507|NCT01789905|Tigecycline|tigecycline
4965508|NCT01789905|Post marketing surveillance|post marketing surveillance
4965509|NCT01789905|Japanese|japanese
4965510|NCT01789905|Infection|infection
4965511|NCT01789879|Levonorgestrel|levonorgestrel
4965512|NCT01789879|Efavirenz|efavirenz
4965513|NCT01789879|Nevirapine|nevirapine
4965514|NCT01789879|Pharmacokinetics|pharmacokinetics
4965515|NCT01789866|DHA|dha
4965516|NCT01789866|lutein|lutein
4965517|NCT01789866|cognitive development|cognitive development
4965518|NCT01789866|fMRI|fmri
4965519|NCT01789853|stroke, rehabilitation, gait training|stroke, rehabilitation, gait training
4965520|NCT01789840|BPH|bph
4965521|NCT01789840|Prostate|prostate
4965522|NCT01789840|Prostatic Hyperplasia|prostatic hyperplasia
4965523|NCT01789840|enlarged prostate|enlarged prostate
4965524|NCT01789840|LUTS|luts
4965525|NCT01789840|urinary retention|urinary retention
4965526|NCT01789814|Percutaneous Coronary Intervention|percutaneous coronary intervention
4965527|NCT01789814|Platelet Aggregation Inhibitors|platelet aggregation inhibitors
4965528|NCT01789814|bivalirudin|bivalirudin
4965529|NCT01789762|Platelet transfusions|platelet transfusions
4965530|NCT01789762|Pathogen reduction|pathogen reduction
4965531|NCT01789762|Haemorrhagic episodes|haemorrhagic episodes
4965532|NCT01789749|snare tip soft coagulation|snare tip soft coagulation
4965533|NCT01789749|endoscopic mucosal resection|endoscopic mucosal resection
4965534|NCT01789749|adenoma recurrence|adenoma recurrence
4965535|NCT01789749|adenoma|adenoma
4965536|NCT01789749|colonoscopy|colonoscopy
4965537|NCT01789736|Glaucoma|glaucoma
4965538|NCT01789736|Ocular hypertension|ocular hypertension
4965539|NCT01789736|AR-12286|ar-12286
4965540|NCT01789736|Travoprost|travoprost
4965541|NCT01789710|smoking|smoking
4965542|NCT01789710|homelessness|homelessness
4965543|NCT01789710|contingency management|contingency management
4965544|NCT01789684|cluster|cluster
4965545|NCT01789684|genetic counseling|genetic counseling
4965546|NCT01789684|breast cancer|breast cancer
4965547|NCT01789684|HBOC|hboc
4965548|NCT01789684|provider intervention|provider intervention
4965549|NCT01789671|Childhood Obesity|childhood obesity
4965550|NCT01789658|Oral Mucositis|oral mucositis
4965551|NCT01789658|Children|children
4965552|NCT01789658|Cryotherapy|cryotherapy
4965553|NCT01789658|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
4965554|NCT01789645|Carpal tunnel|carpal tunnel
4965555|NCT01789645|Physical therapy|physical therapy
4965556|NCT01789645|Surgery|surgery
4965557|NCT01789645|Efficacy|efficacy
4965558|NCT01789606|Self-selection and actual use/compliance trial.|self-selection and actual use/compliance trial.
4965559|NCT01789580|Experimental study, moderators, online gambling,|experimental study, moderators, online gambling,
4965560|NCT01789580|problem gambling prevention|problem gambling prevention
4965561|NCT01789554|Out of hospital cardiac arrest|out of hospital cardiac arrest
4965562|NCT01789554|Cardiopulmonary resuscitation|cardiopulmonary resuscitation
4965563|NCT01789554|Bystander CPR|bystander cpr
4965564|NCT01789554|Mobile phone positioning system|mobile phone positioning system
4965565|NCT01789528|Phase I,|phase i,
4965566|NCT01789528|open label,|open label,
4965567|NCT01789528|CAZ-AVI,|caz-avi,
4965568|NCT01789528|CXL,|cxl,
4965569|NCT01789528|healthy volunteers,|healthy volunteers,
4965570|NCT01789528|intestinal flora.|intestinal flora.
4965571|NCT01789502|self-expandable metal stent; plastic stent|self-expandable metal stent; plastic stent
4965572|NCT01789476|pain|pain
4965573|NCT01789476|acute pain|acute pain
4965574|NCT01789476|kappa agonis|kappa agonis
4965575|NCT01789476|opioid analgesia|opioid analgesia
4965576|NCT01789476|bunionectomy|bunionectomy
4965577|NCT01789476|peripheral nervous system agents|peripheral nervous system agents
4965578|NCT01789476|physiological effects of drugs|physiological effects of drugs
4965579|NCT01789476|surgery|surgery
4965580|NCT01789476|post-operative|post-operative
4965581|NCT01789476|post-operative complications|post-operative complications
4965582|NCT01789450|sensitivity|sensitivity
4965583|NCT01789450|section of periareolar dermis|section of periareolar dermis
4965584|NCT01789450|breast reduction|breast reduction
4965585|NCT01789437|retinal vein occlusion|retinal vein occlusion
4965586|NCT01789437|systemic hypertension|systemic hypertension
4965587|NCT01789437|arteriolar diameter|arteriolar diameter
4965588|NCT01789385|Deep brain stimulation|deep brain stimulation
4965589|NCT01789385|Parkinson|parkinson
4965590|NCT01789372|paroxysmal atrial fibrillation|paroxysmal atrial fibrillation
4965591|NCT01789372|yoga|yoga
4965592|NCT01789372|quality of life|quality of life
4965593|NCT01789372|blood pressure|blood pressure
4965594|NCT01789372|heart rate|heart rate
4965595|NCT01789372|heart rate variability|heart rate variability
4965596|NCT01789359|anthocyanin|anthocyanin
4965597|NCT01789359|bioavailability|bioavailability
4965598|NCT01789359|urine|urine
4965599|NCT01789359|long-term|long-term
4965600|NCT01789346|Scar|scar
4965601|NCT01789346|Scars|scars
4965602|NCT01789346|Surgical Scar|surgical scar
4965603|NCT01789346|Surgical Scars|surgical scars
4965604|NCT01789346|Cicatrix|cicatrix
4965605|NCT01789346|Hypertrophic Cicatrix|hypertrophic cicatrix
4965606|NCT01789346|Keloid|keloid
4965607|NCT01789346|Hypertrophic Scar|hypertrophic scar
4965608|NCT01789346|Surgical Incision|surgical incision
4965609|NCT01789346|Scarring|scarring
4965610|NCT01789346|Abdominoplasty|abdominoplasty
4965611|NCT01789346|Tummy Tuck|tummy tuck
4965612|NCT01789346|Augmentation Mammoplasty|augmentation mammoplasty
4965613|NCT01789346|Breast Augmentation|breast augmentation
4965614|NCT01789346|Thyroidectomy|thyroidectomy
4965615|NCT01789333|Keratoconus|keratoconus
4965616|NCT01789333|Ectasia|ectasia
4965617|NCT01789333|UVA light|uva light
4965618|NCT01789333|riboflavin|riboflavin
4965619|NCT01789333|post-LASIK|post-lasik
4965620|NCT01789333|irregular astigmatism|irregular astigmatism
4965621|NCT01789320|uveitis|uveitis
4965622|NCT01789320|intermediate uveitis|intermediate uveitis
4965623|NCT01789320|posterior uveitis|posterior uveitis
4965624|NCT01789320|panuveitis|panuveitis
4965625|NCT01789320|noninfectious uveitis|noninfectious uveitis
4965626|NCT01789320|microneedle|microneedle
4965627|NCT01789320|suprachoroidal space|suprachoroidal space
4965628|NCT01789320|SCS|scs
4965629|NCT01789320|inflammation|inflammation
4965630|NCT01789320|ocular inflammatory conditions|ocular inflammatory conditions
4965631|NCT01789320|triamcinolone acetonide|triamcinolone acetonide
4965632|NCT01789320|TA|ta
4965633|NCT01789320|Triesence|triesence
4965634|NCT01789320|injection|injection
4965635|NCT01789320|IVT|ivt
4965636|NCT01789320|intravitreal|intravitreal
4965637|NCT01789320|corticosteroid|corticosteroid
4965638|NCT01789320|sympathetic ophthalmia|sympathetic ophthalmia
4965639|NCT01789320|temporal arteritis|temporal arteritis
4965640|NCT01789320|vitreous haze|vitreous haze
4965641|NCT01789294|lymphoid nodular hyperplasia|lymphoid nodular hyperplasia
4965642|NCT01789294|food allergy|food allergy
4965643|NCT01789281|Neoplasms, Carcinoid tumor, Neuroendocrine tumor|neoplasms, carcinoid tumor, neuroendocrine tumor
4965644|NCT01789268|acute|acute
4965645|NCT01789268|adaptive cellular immune phenotypes|adaptive cellular immune phenotypes
4965646|NCT01789268|infants|infants
4965647|NCT01789268|Lymphocyte|lymphocyte
4965648|NCT01789268|premature|premature
4965649|NCT01789268|respiratory viral infections|respiratory viral infections
4965650|NCT01789229|biobank|biobank
4965651|NCT01789229|fresh-frozen tissue|fresh-frozen tissue
4965652|NCT01789216|Pilon fractures|pilon fractures
4965653|NCT01789216|Calcaneus fractures|calcaneus fractures
4965654|NCT01789216|Acute pain|acute pain
4965655|NCT01789216|Chronic pain|chronic pain
4965656|NCT01789216|Isolated|isolated
4965657|NCT01789216|unilateral|unilateral
4965658|NCT01789216|Grade I|grade i
4965659|NCT01789216|Grade II|grade ii
4965660|NCT01789216|open|open
4965661|NCT01789216|closed|closed
4965662|NCT01789203|BK infection|bk infection
4965663|NCT01789203|BK viremia|bk viremia
4965664|NCT01789203|BK nephropathy|bk nephropathy
4965665|NCT01789203|polyomavirus|polyomavirus
4965666|NCT01789203|fluoroquinolone|fluoroquinolone
4965667|NCT01789203|ciprofloxacin|ciprofloxacin
4965668|NCT01789190|Honeymoon|honeymoon
4965669|NCT01789190|Type 1 diabetes|type 1 diabetes
4965670|NCT01789177|Spirometry|spirometry
4965671|NCT01789177|Postoperative Care|postoperative care
4965672|NCT01789164|TBI|tbi
4965673|NCT01789164|fNIRS|fnirs
4965674|NCT01789164|hypercapnea|hypercapnea
4965675|NCT01789164|Cerebrovascular reactivity|cerebrovascular reactivity
4965676|NCT01789151|arthritis|arthritis
4965677|NCT01789151|nuclear imaging|nuclear imaging
4965678|NCT01789151|rheumatoid|rheumatoid
4965679|NCT01789151|ankylosing spondylitis|ankylosing spondylitis
4965680|NCT01789151|glucosamine|glucosamine
4965681|NCT01789138|Antiretroviral Therapy|antiretroviral therapy
4965682|NCT01789138|Adherence|adherence
4965683|NCT01789138|Intervention|intervention
4965684|NCT01789125|anxiety|anxiety
4965685|NCT01789125|stress|stress
4965686|NCT01789125|smoking|smoking
4965687|NCT01789125|cessation|cessation
4965688|NCT01789099|Lung cancer|lung cancer
4965689|NCT01789099|Peptide vaccine|peptide vaccine
4965690|NCT01789073|Postoperative|postoperative
4965691|NCT01789073|Complications|complications
4965692|NCT01789073|Elective|elective
4965693|NCT01789073|Surgery|surgery
4965694|NCT01789073|GI surgery|gi surgery
4965695|NCT01789073|Immunonutrition|immunonutrition
4965696|NCT01789073|Immune-enhancing|immune-enhancing
4965697|NCT01789073|Immune-modulating|immune-modulating
4965698|NCT01789073|Nutrition|nutrition
4965699|NCT01789073|Pancreatic cancer|pancreatic cancer
4965700|NCT01789073|Postoperative complications and length of hospital stay after major gastrointestinal (GI) elective surgery.|postoperative complications and length of hospital stay after major gastrointestinal (gi) elective surgery.
4965701|NCT01789047|Parkinson's disease|parkinson's disease
4965702|NCT01789047|dyskinesia|dyskinesia
4965703|NCT01789047|Indonesia|indonesia
4965704|NCT01789047|amantadine|amantadine
4965705|NCT01789021|blood glucose monitoring systems|blood glucose monitoring systems
4965706|NCT01789021|ISO 15197|iso 15197
4965707|NCT01789021|system accuracy|system accuracy
4965708|NCT01789008|Transient elastography|transient elastography
4965709|NCT01789008|Alcoholic liver disease|alcoholic liver disease
4965710|NCT01789008|liver fibrosis|liver fibrosis
4965711|NCT01788982|Thyroid Cancer|thyroid cancer
4965712|NCT01788982|Medullary thyroid cancer (MTC)|medullary thyroid cancer (mtc)
4965713|NCT01788982|Differentiated thyroid cancer (DTC)|differentiated thyroid cancer (dtc)
4965714|NCT01788969|Gait training|gait training
4965715|NCT01788969|Lexapro|lexapro
4965716|NCT01788969|Tizanidine|tizanidine
4965717|NCT01788956|venous oximeter|venous oximeter
4965718|NCT01788956|CO-Oximeter|co-oximeter
4965719|NCT01788956|ICU Patients|icu patients
4965720|NCT01788956|Sepsis|sepsis
4965721|NCT01788956|non-invasive device|non-invasive device
4965722|NCT01788943|positron emission tomography|positron emission tomography
4965723|NCT01788943|nicotine receptor|nicotine receptor
4965724|NCT01788917|n-3 LC-PUFA, vegetarians, fatty acids, blood lipids|n-3 lc-pufa, vegetarians, fatty acids, blood lipids
4965725|NCT01788904|Acute mesenteric ischemia|acute mesenteric ischemia
4965726|NCT01788904|Percutaneous endovascular revascularization|percutaneous endovascular revascularization
4965727|NCT01788904|Intestinal plasma fatty acid binding protein (i-FABP)|intestinal plasma fatty acid binding protein (i-fabp)
4965728|NCT01788904|Bowel necrosis|bowel necrosis
4965729|NCT01788891|longitudinal observational cohort study|longitudinal observational cohort study
4965730|NCT01788891|multicenter|multicenter
4965731|NCT01788891|pediatrics|pediatrics
4965732|NCT01788891|Asian|asian
4965733|NCT01788891|treatment failure|treatment failure
4965734|NCT01788891|renal status|renal status
4965735|NCT01788891|toxicities|toxicities
4965736|NCT01788891|therapeutic drug monitoring (TDM)|therapeutic drug monitoring (tdm)
4965737|NCT01788891|drug levels in blood and hair|drug levels in blood and hair
4965738|NCT01788878|socio-professional future|socio-professional future
4965739|NCT01788865|covered Metal stent|covered metal stent
4965740|NCT01788865|ureteral obstruction|ureteral obstruction
4965741|NCT01788852|HPV|hpv
4965742|NCT01788852|HIV|hiv
4965743|NCT01788852|cervical/anal dysplasia|cervical/anal dysplasia
4965744|NCT01788852|intraepithelial neoplasia|intraepithelial neoplasia
4965745|NCT01788852|E6/E7 biomarker|e6/e7 biomarker
4965746|NCT01788852|perinatally HIV-infected adolescents|perinatally hiv-infected adolescents
4965747|NCT01788852|behaviorally HIV-infected adolescents|behaviorally hiv-infected adolescents
4965748|NCT01788852|anal and pap smear|anal and pap smear
4965749|NCT01788839|Sexual and Reproductive Health|sexual and reproductive health
4965750|NCT01788839|premenopausal|premenopausal
4965751|NCT01788839|postmenopausal|postmenopausal
4965752|NCT01788839|12-249|12-249
4965753|NCT01788839|Fertility|fertility
4965754|NCT01788826|Ventral hernia|ventral hernia
4965755|NCT01788826|surgical meshes|surgical meshes
4965756|NCT01788826|polypropylenes|polypropylenes
4965757|NCT01788813|Repeat Dose Safety|repeat dose safety
4965758|NCT01788813|Allergic Asthma|allergic asthma
4965759|NCT01788813|Effect on Allergen Reactivity|effect on allergen reactivity
4965760|NCT01788813|Allergic Rhinitis|allergic rhinitis
4965761|NCT01788813|TLR7 Agonist|tlr7 agonist
4965762|NCT01788813|Pharmacodynamics|pharmacodynamics
4965763|NCT01788800|Panic disorder|panic disorder
4965764|NCT01788800|Physical activity|physical activity
4965765|NCT01788787|Cancer Prevention|cancer prevention
4965766|NCT01788787|Tobacco Use Cessation|tobacco use cessation
4965767|NCT01788787|Ask Advise Connect|ask advise connect
4965768|NCT01788787|AAC|aac
4965769|NCT01788787|Smoking Cessation Treatment|smoking cessation treatment
4965770|NCT01788787|Texas Quitline|texas quitline
4965771|NCT01788787|Saliva sample|saliva sample
4965772|NCT01788787|Telephone Counseling|telephone counseling
4965773|NCT01788787|Nicotine replacement|nicotine replacement
4965774|NCT01788787|Interviews|interviews
4965775|NCT01788774|Pharmacokinetics|pharmacokinetics
4965776|NCT01788774|Safety|safety
4965777|NCT01788774|Risperidone ISM®|risperidone ism®
4965778|NCT01788774|Intramuscular|intramuscular
4965779|NCT01788774|Schizophrenia|schizophrenia
4965780|NCT01788761|Probiotics|probiotics
4965781|NCT01788761|Feeding Tolerance|feeding tolerance
4965782|NCT01788761|Extremely Low Birthweight Infants|extremely low birthweight infants
4965783|NCT01788748|fractional|fractional
4965784|NCT01788748|bipolar|bipolar
4965785|NCT01788748|radiofrequency|radiofrequency
4965786|NCT01788748|striae|striae
4965787|NCT01788748|infrared|infrared
4965788|NCT01788748|combined|combined
4965789|NCT01788735|unexplained infertility|unexplained infertility
4965790|NCT01788735|asthma|asthma
4965791|NCT01788735|allergy|allergy
4965792|NCT01788709|colonoscopy|colonoscopy
4965793|NCT01788709|preparation|preparation
4965794|NCT01788696|Parkinsonism|parkinsonism
4965795|NCT01788696|Idiopathic Parkinson Disease|idiopathic parkinson disease
4965796|NCT01788683|Rotator Cuff|rotator cuff
4965797|NCT01788683|Rotator Cuff Tear|rotator cuff tear
4965798|NCT01788683|Supraspinatus Tear|supraspinatus tear
4965799|NCT01788670|Antioxidants, Central Nervous System Agents|antioxidants, central nervous system agents
4965800|NCT01788657|Depression|depression
4965801|NCT01788657|Internet|internet
4965802|NCT01788657|Cognitive Behavior Therapy|cognitive behavior therapy
4965803|NCT01788644|Child adiposity|child adiposity
4965804|NCT01788644|Infancy|infancy
4965805|NCT01788644|Motor activity|motor activity
4965806|NCT01788644|Feeding behavior|feeding behavior
4965807|NCT01788644|Sleep|sleep
4965808|NCT01788644|Stress, Physiological|stress, physiological
4965809|NCT01788618|Cognitive functions|cognitive functions
4965810|NCT01788618|Quality of life|quality of life
4965811|NCT01788618|Cancer|cancer
4965812|NCT01788605|hematologic malignancies|hematologic malignancies
4965813|NCT01788605|hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
4965814|NCT01788605|ramosetron|ramosetron
4965815|NCT01788605|emesis|emesis
4965816|NCT01788592|coronary artery disease|coronary artery disease
4965817|NCT01788592|drug eluting stent|drug eluting stent
4965818|NCT01788579|Intimate Partner Violence (IPV)|intimate partner violence (ipv)
4965819|NCT01788579|Drug Abuse|drug abuse
4965820|NCT01788579|Criminal Justice|criminal justice
4965821|NCT01788553|remission|remission
4965822|NCT01788553|generalized anxiety disorder|generalized anxiety disorder
4965823|NCT01788540|Recurrent miscarriage|recurrent miscarriage
4965824|NCT01788540|Implantation failure|implantation failure
4965825|NCT01788540|Intralipid|intralipid
4965826|NCT01788540|ICSI / IVF failure|icsi / ivf failure
4965827|NCT01788527|Diabetes|diabetes
4965828|NCT01788527|Type 1|type 1
4965829|NCT01788527|CGM|cgm
4965830|NCT01788527|Continuous Glucose Monitor|continuous glucose monitor
4965831|NCT01788527|HGM|hgm
4965832|NCT01788527|HbA1c|hba1c
4965833|NCT01788488|procalcitonin|procalcitonin
4965834|NCT01788488|antimicrobial stewardship|antimicrobial stewardship
4965835|NCT01788488|pneumonia|pneumonia
4965836|NCT01788475|Diabetic Macular Edema|diabetic macular edema
4965837|NCT01788475|DME|dme
4965838|NCT01788475|Pars Plana Vitrectomy|pars plana vitrectomy
4965839|NCT01788462|Tesamorelin|tesamorelin
4965840|NCT01788462|Egrifta|egrifta
4965841|NCT01788462|HIV|hiv
4965842|NCT01788462|Lipodystrophy|lipodystrophy
4965843|NCT01788462|Sleep Apnea|sleep apnea
4965844|NCT01788449|Antibiotic Bacterial Resistance|antibiotic bacterial resistance
4965845|NCT01788436|Schizophrenia|schizophrenia
4965846|NCT01788436|Young healthy volunteers|young healthy volunteers
4965847|NCT01788436|Elderly healthy volunteers|elderly healthy volunteers
4965848|NCT01788436|Learning performance|learning performance
4965849|NCT01788423|presbycusis|presbycusis
4965850|NCT01788423|hearing aids|hearing aids
4965851|NCT01788410|Cryoablation|cryoablation
4965852|NCT01788410|Nerves|nerves
4965853|NCT01788410|Facet joint|facet joint
4965854|NCT01788410|Pain|pain
4965855|NCT01788410|Neuralgia|neuralgia
4965856|NCT01788410|Neuropathy|neuropathy
4965857|NCT01788410|Image-guided|image-guided
4965858|NCT01788397|physical disabilities|physical disabilities
4965859|NCT01788397|rehabilitation|rehabilitation
4965860|NCT01788384|acne|acne
4965861|NCT01788384|Clindamycin Phosphate/Benzoyl Peroxide|clindamycin phosphate/benzoyl peroxide
4965862|NCT01788384|Acanya|acanya
4965863|NCT01788384|Mild to severe acne vulgaris|mild to severe acne vulgaris
4965864|NCT01788358|Drug combination|drug combination
4965865|NCT01788358|Nifedipine GITS|nifedipine gits
4965866|NCT01788358|Candesartan Cilexetil|candesartan cilexetil
4965867|NCT01788358|Hypertension|hypertension
4965868|NCT01788358|Combination therapy|combination therapy
4965869|NCT01788345|non-invasion ventilation|non-invasion ventilation
4965870|NCT01788345|Boussignac|boussignac
4965871|NCT01788332|NSCLC|nsclc
4965872|NCT01788332|non-small cell|non-small cell
4965873|NCT01788332|lung cancer|lung cancer
4965874|NCT01788319|laser trabeculoplasty|laser trabeculoplasty
4965875|NCT01788319|glaucoma|glaucoma
4965876|NCT01788306|Elevated risk|elevated risk
4965877|NCT01788306|opioid overdose|opioid overdose
4965878|NCT01788293|Fluid management|fluid management
4965879|NCT01788293|Pleth Variability Index (PVI)|pleth variability index (pvi)
4965880|NCT01788293|monitoring|monitoring
4965881|NCT01788293|high-risk surgery|high-risk surgery
4965882|NCT01788267|Cystic Fibrosis|cystic fibrosis
4965883|NCT01788267|High-Resolution peripheral Quantitative Computed Tomography|high-resolution peripheral quantitative computed tomography
4965884|NCT01788267|Bone Mass Density|bone mass density
4965885|NCT01788254|pharmacokinetic/genetic|pharmacokinetic/genetic
4965886|NCT01788254|Cyp450 polymorphisms|cyp450 polymorphisms
4965887|NCT01788254|Noninvasive functional characterization of liver heart and kidneys using MRI|noninvasive functional characterization of liver heart and kidneys using mri
4965888|NCT01788241|coronary artery disease|coronary artery disease
4965889|NCT01788241|Atherosclerosis|atherosclerosis
4965890|NCT01788241|Coronary Stenosis|coronary stenosis
4965891|NCT01788241|Cardiovascular Diseases|cardiovascular diseases
4965892|NCT01788241|Non-significant coronary artery disease|non-significant coronary artery disease
4965893|NCT01788241|Mild Stenosis|mild stenosis
4965894|NCT01788241|Vascular Irregularities|vascular irregularities
4965895|NCT01788241|Psychosocial factors|psychosocial factors
4965896|NCT01788241|Personality|personality
4965897|NCT01788241|Type D personality|type d personality
4965898|NCT01788241|Hostility|hostility
4965899|NCT01788241|Depression|depression
4965900|NCT01788241|Anxiety|anxiety
4965901|NCT01788241|Fatigue|fatigue
4965902|NCT01788241|Social Support|social support
4965903|NCT01788241|Socioeconomic Status|socioeconomic status
4965904|NCT01788241|Patient Reported Outcomes|patient reported outcomes
4965905|NCT01788241|Patient Perceived Symptoms|patient perceived symptoms
4965906|NCT01788241|Health Status|health status
4965907|NCT01788241|Quality of Life|quality of life
4965908|NCT01788241|Chest pain|chest pain
4965909|NCT01788241|Cardiac risk factors|cardiac risk factors
4965910|NCT01788241|Metabolic Syndrome|metabolic syndrome
4965911|NCT01788241|BMI|bmi
4965912|NCT01788241|Obesity|obesity
4965913|NCT01788241|Waist Circumference|waist circumference
4965914|NCT01788241|Lifestyle|lifestyle
4965915|NCT01788241|Smoking|smoking
4965916|NCT01788241|Alcohol use|alcohol use
4965917|NCT01788241|Activity|activity
4965918|NCT01788241|Hypertension|hypertension
4965919|NCT01788241|Diabetes|diabetes
4965920|NCT01788241|Familial Cardiovascular Disease|familial cardiovascular disease
4965921|NCT01788241|Coronary angiography|coronary angiography
4965922|NCT01788241|Computed Tomography|computed tomography
4965923|NCT01788228|Vaccine|vaccine
4965924|NCT01788228|Occupational exposure|occupational exposure
4965925|NCT01788228|Influenza|influenza
4965926|NCT01788228|H5N1|h5n1
4965927|NCT01788215|Polycystic Ovarian Syndrome|polycystic ovarian syndrome
4965928|NCT01788215|Irregular Menstrual Cycles|irregular menstrual cycles
4965929|NCT01788215|Androgen Excess in Women|androgen excess in women
4965930|NCT01788202|cocaine and general anesthesia|cocaine and general anesthesia
4965931|NCT01788189|Lymphoma|lymphoma
4965932|NCT01788189|CD20|cd20
4965933|NCT01788189|Relapse|relapse
4965934|NCT01788189|Lenalidomide|lenalidomide
4965935|NCT01788176|Complex Regional Pain Syndromes|complex regional pain syndromes
4965936|NCT01788176|drug therapy|drug therapy
4965937|NCT01788176|zoledronic acid|zoledronic acid
4965938|NCT01788163|EGFR|egfr
4965939|NCT01788163|aNSCLC|ansclc
4965940|NCT01788163|mutation status|mutation status
4965941|NCT01788163|diagnostic study|diagnostic study
4965942|NCT01788163|Russia|russia
4965943|NCT01788163|China|china
4965944|NCT01788163|Asia|asia
4965945|NCT01788137|T-cell lymphoma,DFS,OS|t-cell lymphoma,dfs,os
4965946|NCT01788124|Speculum|speculum
4965947|NCT01788124|Metal|metal
4965948|NCT01788124|Plastic|plastic
4965949|NCT01788124|Visual Analoge Scale|visual analoge scale
4965950|NCT01788124|Discomfort|discomfort
4965951|NCT01788085|GERD|gerd
4965952|NCT01788072|Autism Spectrum Disorders|autism spectrum disorders
4965953|NCT01788072|Oxytocin|oxytocin
4965954|NCT01788072|Adults|adults
4965955|NCT01788059|nonunion|nonunion
4965956|NCT01788059|mesenchymal stem cell|mesenchymal stem cell
4965957|NCT01788059|long bone|long bone
4965958|NCT01788046|Secondary Hyperparathyroidism (SHPT), chronic kidney disease (CKD), hemodialysis, parathyroid hormone (PTH), hypocalcemia, bone and mineral metabolism|secondary hyperparathyroidism (shpt), chronic kidney disease (ckd), hemodialysis, parathyroid hormone (pth), hypocalcemia, bone and mineral metabolism
4965959|NCT01788007|Actinic Keratosis|actinic keratosis
4965960|NCT01788007|Imiquimod Topical Cream 3.75%|imiquimod topical cream 3.75%
4965961|NCT01788007|Zyclara® (imiquimod) Topical Cream 3.75%|zyclara® (imiquimod) topical cream 3.75%
4965962|NCT01787968|Congenital transmission|congenital transmission
4965963|NCT01787968|Trypanosoma cruzi|trypanosoma cruzi
4965964|NCT01787968|Chagas disease|chagas disease
4965965|NCT01787955|Pylorus preserving pancreaticoduodenectomy(PPPD), Delayed gastric emptying syndrome(DGE), Braun anastomosis|pylorus preserving pancreaticoduodenectomy(pppd), delayed gastric emptying syndrome(dge), braun anastomosis
4965966|NCT01787942|Lipid thickness|lipid thickness
4965967|NCT01787942|Blepharoplasty|blepharoplasty
4965968|NCT01787942|Tear break up time|tear break up time
4965969|NCT01787942|Corneal staining|corneal staining
4965970|NCT01787916|type 1 diabetes|type 1 diabetes
4965971|NCT01787916|overweight|overweight
4965972|NCT01787916|insulin|insulin
4965973|NCT01787916|liraglutide|liraglutide
4965974|NCT01787903|Type 1 diabetes mellitus|type 1 diabetes mellitus
4965975|NCT01787903|Hypoglycemia unawareness|hypoglycemia unawareness
4965976|NCT01787903|Real-time continuous glucose monitoring|real-time continuous glucose monitoring
4965977|NCT01787903|Glucose control|glucose control
4965978|NCT01787877|Cerebrovascular Accident, Inflammatory biomarkers|cerebrovascular accident, inflammatory biomarkers
4965979|NCT01787864|Barrett's Esophagus|barrett's esophagus
4965980|NCT01787864|Intestinal metaplasia|intestinal metaplasia
4965981|NCT01787864|Intramucosal Adenocarcinoma|intramucosal adenocarcinoma
4965982|NCT01787864|Gastric Cardia|gastric cardia
4965983|NCT01787864|High Cardia Dysplasia|high cardia dysplasia
4965984|NCT01787864|Radiofrequency ablation (RFA)|radiofrequency ablation (rfa)
4965985|NCT01787851|Heart failure|heart failure
4965986|NCT01787851|Anaplerosis|anaplerosis
4965987|NCT01787851|Medium-chain fatty acid|medium-chain fatty acid
4965988|NCT01787838|Pneumococcal vaccination rates, ambulatory settings|pneumococcal vaccination rates, ambulatory settings
4965989|NCT01787825|intestinal disease|intestinal disease
4965990|NCT01787825|inflammatory bowel disease|inflammatory bowel disease
4965991|NCT01787825|crohn disease|crohn disease
4965992|NCT01787825|ulcer|ulcer
4965993|NCT01787825|celiac disease|celiac disease
4965994|NCT01787825|angioectasia|angioectasia
4965995|NCT01787825|polyp|polyp
4965996|NCT01787799|Drug-eluting stents|drug-eluting stents
4965997|NCT01787786|Crohn's Disease|crohn's disease
4965998|NCT01787786|Ulcerative Colitis|ulcerative colitis
4965999|NCT01787786|Optimal Use of infliximab|optimal use of infliximab
4966000|NCT01787773|Inferior Vena Cava Filter|inferior vena cava filter
4966001|NCT01787773|Vena Cava Filters|vena cava filters
4966002|NCT01787747|Pharmacokinetics|pharmacokinetics
4966003|NCT01787747|Healthy Volunteers|healthy volunteers
4966004|NCT01787747|dextromethorphan with quinidine|dextromethorphan with quinidine
4966005|NCT01787747|deuterated dextromethorphan|deuterated dextromethorphan
4966006|NCT01787721|Gait|gait
4966007|NCT01787721|Ankle joint|ankle joint
4966008|NCT01787721|Manipulation, Chiropractic|manipulation, chiropractic
4966009|NCT01787708|Vitiligo|vitiligo
4966010|NCT01787708|red|red
4966011|NCT01787708|laser|laser
4966012|NCT01787708|light|light
4966013|NCT01787695|Vitiligo|vitiligo
4966014|NCT01787695|UVA1|uva1
4966015|NCT01787695|Phototherapy|phototherapy
4966016|NCT01787682|CHF|chf
4966017|NCT01787682|Protein digestion|protein digestion
4966018|NCT01787682|Fat digestion|fat digestion
4966019|NCT01787682|Gut function|gut function
4966020|NCT01787682|Glucose absorption|glucose absorption
4966021|NCT01787682|Muscle function|muscle function
4966022|NCT01787669|diabetic macular oedema|diabetic macular oedema
4966023|NCT01787669|diabetic macular edema|diabetic macular edema
4966024|NCT01787669|diabetic retinopathy|diabetic retinopathy
4966025|NCT01787669|dexamethasone|dexamethasone
4966026|NCT01787669|Ozurdex|ozurdex
4966027|NCT01787669|Avastin|avastin
4966028|NCT01787669|bevacizumab|bevacizumab
4966029|NCT01787669|DME|dme
4966030|NCT01787669|DMO|dmo
4966031|NCT01787643|height-adjustable desk|height-adjustable desk
4966032|NCT01787643|office workers|office workers
4966033|NCT01787643|sitting occupations|sitting occupations
4966034|NCT01787643|energy expenditure|energy expenditure
4966035|NCT01787643|BMI|bmi
4966036|NCT01787643|Weight|weight
4966037|NCT01787643|Lower fat diet|lower fat diet
4966038|NCT01787630|Prostatic cancer|prostatic cancer
4966039|NCT01787630|Radiotherapy|radiotherapy
4966040|NCT01787630|Hyaluronic acid|hyaluronic acid
4966041|NCT01787617|Exercise Training|exercise training
4966042|NCT01787617|Strength Training|strength training
4966043|NCT01787617|African American Men|african american men
4966044|NCT01787617|Insulin Resistance|insulin resistance
4966045|NCT01787604|Valve-sparing|valve-sparing
4966046|NCT01787604|Valve repair|valve repair
4966047|NCT01787591|Vitamin E|vitamin e
4966048|NCT01787591|Metabolic syndrome|metabolic syndrome
4966049|NCT01787591|Liver disease|liver disease
4966050|NCT01787591|Non-alcoholic liver steatohepatitis|non-alcoholic liver steatohepatitis
4966051|NCT01787591|Fatty liver|fatty liver
4966052|NCT01787591|Dairy consumption|dairy consumption
4966053|NCT01787578|X-linked adrenoleukodystrophy|x-linked adrenoleukodystrophy
4966054|NCT01787578|adrenomyeloneuropathy|adrenomyeloneuropathy
4966055|NCT01787578|sobetirome|sobetirome
4966056|NCT01787578|thyroid|thyroid
4966057|NCT01787578|thyromimetic|thyromimetic
4966058|NCT01787565|non-interventional|non-interventional
4966059|NCT01787565|clinical|clinical
4966060|NCT01787565|investigation|investigation
4966061|NCT01787565|low|low
4966062|NCT01787565|back|back
4966063|NCT01787565|pain|pain
4966064|NCT01787565|painPREMIER|painpremier
4966065|NCT01787552|Dose escalation|dose escalation
4966066|NCT01787552|Maximum Tolerated Dose|maximum tolerated dose
4966067|NCT01787552|MTD|mtd
4966068|NCT01787552|Safety Expansion|safety expansion
4966069|NCT01787552|Safety|safety
4966070|NCT01787552|Efficacy|efficacy
4966071|NCT01787552|Myelofibrosis|myelofibrosis
4966072|NCT01787552|Post-polycythemia vera myelofbrosis (Post PV-PMF)|post-polycythemia vera myelofbrosis (post pv-pmf)
4966073|NCT01787552|Post essential thrombocythemia myelofibrosis (Post ET-MF)|post essential thrombocythemia myelofibrosis (post et-mf)
4966074|NCT01787552|Primary myelofibrosis (PMF)|primary myelofibrosis (pmf)
4966075|NCT01787552|Intermediate risk myelofibrosis|intermediate risk myelofibrosis
4966076|NCT01787552|High risk myelofibrosis|high risk myelofibrosis
4966077|NCT01787552|Combination Treatment|combination treatment
4966078|NCT01787552|Hedgehog Signaling Pathway|hedgehog signaling pathway
4966079|NCT01787552|Smoothened inhibitor|smoothened inhibitor
4966080|NCT01787552|JAK inhibitor|jak inhibitor
4966081|NCT01787539|gastric cancer|gastric cancer
4966082|NCT01787539|perioperative chemotherapy|perioperative chemotherapy
4966083|NCT01787539|combined modality therapy|combined modality therapy
4966084|NCT01787539|gastrectomy|gastrectomy
4966085|NCT01787526|iron depletion|iron depletion
4966086|NCT01787526|donor safety|donor safety
4966087|NCT01787526|blood donation|blood donation
4966088|NCT01787526|transfusion medicine|transfusion medicine
4966089|NCT01787526|iron deficiency|iron deficiency
4966090|NCT01787526|intravenous iron|intravenous iron
4966091|NCT01787526|fatigue|fatigue
4966092|NCT01787526|restless legs syndrome|restless legs syndrome
4966093|NCT01787526|anemia|anemia
4966094|NCT01787500|Advanced Cancers|advanced cancers
4966095|NCT01787500|Advanced Solid Cancers|advanced solid cancers
4966096|NCT01787500|BRAF V600 Mutant Advanced Solid Malignancies|braf v600 mutant advanced solid malignancies
4966097|NCT01787500|Metastatic|metastatic
4966098|NCT01787500|Unresectable|unresectable
4966099|NCT01787500|BRAF mutant, KRAS wild type colorectal cancer|braf mutant, kras wild type colorectal cancer
4966100|NCT01787500|BRAF mutant, KRAS wild type solid tumor cancers|braf mutant, kras wild type solid tumor cancers
4966101|NCT01787500|Vemurafenib|vemurafenib
4966102|NCT01787500|PLX4032|plx4032
4966103|NCT01787500|RO5185426|ro5185426
4966104|NCT01787500|Cetuximab|cetuximab
4966105|NCT01787500|C225|c225
4966106|NCT01787500|Erbitux|erbitux
4966107|NCT01787500|IMC-C225|imc-c225
4966108|NCT01787500|Irinotecan|irinotecan
4966109|NCT01787500|CPT-11|cpt-11
4966110|NCT01787500|Camptosar|camptosar
4966111|NCT01787487|Leukemia|leukemia
4966112|NCT01787487|Myelofibrosis|myelofibrosis
4966113|NCT01787487|Myelodysplastic syndrome|myelodysplastic syndrome
4966114|NCT01787487|Myeloproliferative neoplasm|myeloproliferative neoplasm
4966115|NCT01787487|Ruxolitinib|ruxolitinib
4966116|NCT01787487|RUX|rux
4966117|NCT01787487|Jakafi|jakafi
4966118|NCT01787487|INCB018424|incb018424
4966119|NCT01787487|INC424|inc424
4966120|NCT01787487|Azacitidine|azacitidine
4966121|NCT01787487|AZA|aza
4966122|NCT01787487|5-Azacitidine|5-azacitidine
4966123|NCT01787487|5-aza|5-aza
4966124|NCT01787487|Vidaza|vidaza
4966125|NCT01787487|5-AZC|5-azc
4966126|NCT01787487|AZA-CR|aza-cr
4966127|NCT01787487|Ladakamycin|ladakamycin
4966128|NCT01787487|NSC-102816|nsc-102816
4966129|NCT01787474|Leukemia|leukemia
4966130|NCT01787474|Acute Myeloid Leukemia|acute myeloid leukemia
4966131|NCT01787474|Blood And Marrow Transplantation|blood and marrow transplantation
4966132|NCT01787474|Natural killer cells|natural killer cells
4966133|NCT01787474|NK|nk
4966134|NCT01787474|mbIL21-expanded haploidentical NK cells|mbil21-expanded haploidentical nk cells
4966135|NCT01787474|G-CSF|g-csf
4966136|NCT01787474|Filgrastim|filgrastim
4966137|NCT01787474|Neupogen|neupogen
4966138|NCT01787474|Fludarabine monophosphate|fludarabine monophosphate
4966139|NCT01787474|Fludarabine Phosphate|fludarabine phosphate
4966140|NCT01787474|Fludara|fludara
4966141|NCT01787474|Cytarabine|cytarabine
4966142|NCT01787474|Ara-C|ara-c
4966143|NCT01787474|Cytosar|cytosar
4966144|NCT01787474|DepoCyt|depocyt
4966145|NCT01787474|Cytosine arabinosine hydrochloride|cytosine arabinosine hydrochloride
4966146|NCT01787461|Trial assessing effects of an oral dietary supplement on overall facial appearance among healthy women with photodamaged skin.|trial assessing effects of an oral dietary supplement on overall facial appearance among healthy women with photodamaged skin.
4966147|NCT01787448|repeat insult patch test|repeat insult patch test
4966148|NCT01787435|Asthma,|asthma,
4966149|NCT01787435|acid-suppressing drugs,|acid-suppressing drugs,
4966150|NCT01787435|pregnancy,|pregnancy,
4966151|NCT01787435|epidemiology|epidemiology
4966152|NCT01787422|Telemedicine|telemedicine
4966153|NCT01787383|Actinic Keratosis|actinic keratosis
4966154|NCT01787383|Ingenol mebutate gel|ingenol mebutate gel
4966155|NCT01787370|coronary artery disease, endothelial dysfunction|coronary artery disease, endothelial dysfunction
4966156|NCT01787357|Healthy|healthy
4966157|NCT01787357|Canagliflozin (JNJ-28431754)|canagliflozin (jnj-28431754)
4966158|NCT01787357|Pharmacokinetics|pharmacokinetics
4966159|NCT01787357|Moxifloxacin|moxifloxacin
4966160|NCT01787357|Electrocardiogram Parameters|electrocardiogram parameters
4966161|NCT01787357|QT/QTc Interval|qt/qtc interval
4966162|NCT01787357|Therapeutic dose|therapeutic dose
4966163|NCT01787357|Supra-Therapeutic dose|supra-therapeutic dose
4966164|NCT01787344|Other Infantile Cerebral Palsy|other infantile cerebral palsy
4966165|NCT01787305|microbiome|microbiome
4966166|NCT01787305|commensals|commensals
4966167|NCT01787305|autoantibodies|autoantibodies
4966168|NCT01787305|autoreactive T cells|autoreactive t cells
4966169|NCT01787292|Exercise|exercise
4966170|NCT01787292|Magnetic Resonance Imaging|magnetic resonance imaging
4966171|NCT01787292|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
4966172|NCT01787292|Aging|aging
4966173|NCT01787214|glucose variability|glucose variability
4966174|NCT01787214|glycemia|glycemia
4966175|NCT01787214|type-2 diabetes|type-2 diabetes
4966176|NCT01787175|Medication Therapy Management|medication therapy management
4966177|NCT01787175|Clinical Decision Support Systems|clinical decision support systems
4966178|NCT01787175|Medical Informatics|medical informatics
4966179|NCT01787175|Patient Care Management|patient care management
4966180|NCT01787175|United States Department of Veterans Affairs|united states department of veterans affairs
4966181|NCT01787162|Myeloproliferative disorders|myeloproliferative disorders
4966182|NCT01787162|pulmonary hypertension|pulmonary hypertension
4966183|NCT01787162|pulmonary vascular diseases|pulmonary vascular diseases
4966184|NCT01787149|ENIA11|enia11
4966185|NCT01787149|DMARDs|dmards
4966186|NCT01787149|RA|ra
4966187|NCT01787149|TNF|tnf
4966188|NCT01787110|Acute coronary syndrome|acute coronary syndrome
4966189|NCT01787110|Acute myocardial infarction|acute myocardial infarction
4966190|NCT01787110|Non ST-segment Myocardial Infarction|non st-segment myocardial infarction
4966191|NCT01787110|ST-segment Myocardial Infarction|st-segment myocardial infarction
4966192|NCT01787110|STEMI|stemi
4966193|NCT01787110|NSTEMI|nstemi
4966194|NCT01787110|Oxygen|oxygen
4966195|NCT01787110|Unstable angina|unstable angina
4966196|NCT01787110|Randomised trial|randomised trial
4966197|NCT01787110|CMR|cmr
4966198|NCT01787110|Mortality|mortality
4966199|NCT01787110|RCRT|rcrt
4966200|NCT01787110|RRCT|rrct
4966201|NCT01787084|Aortic Stenosis|aortic stenosis
4966202|NCT01787084|TAVR|tavr
4966203|NCT01787071|fluids|fluids
4966204|NCT01787071|crtically ill patients|crtically ill patients
4966205|NCT01787071|functional hemodynamics|functional hemodynamics
4966206|NCT01787071|cvp|cvp
4966207|NCT01787058|WASH|wash
4966208|NCT01787058|schoolchildren|schoolchildren
4966209|NCT01787058|absenteeism|absenteeism
4966210|NCT01787045|SEPSIS|sepsis
4966211|NCT01787006|non resectable|non resectable
4966212|NCT01787006|locally advanced|locally advanced
4966213|NCT01787006|Cetuximab|cetuximab
4966214|NCT01787006|radiation|radiation
4966215|NCT01786967|overactive bladder|overactive bladder
4966216|NCT01786967|urge urinary incontinence|urge urinary incontinence
4966217|NCT01786967|pharmacogenetics|pharmacogenetics
4966218|NCT01786954|vitreoretinal surgery|vitreoretinal surgery
4966219|NCT01786954|intraocular pressure|intraocular pressure
4966220|NCT01786954|applanation|applanation
4966221|NCT01786954|rebound|rebound
4966222|NCT01786954|tonometry|tonometry
4966223|NCT01786941|Branched-chain Amino Acids|branched-chain amino acids
4966224|NCT01786941|Insulin Sensitivity|insulin sensitivity
4966225|NCT01786941|Exercise|exercise
4966226|NCT01786941|Leucine|leucine
4966227|NCT01786928|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
4966228|NCT01786928|exacerbation|exacerbation
4966229|NCT01786928|resistance training|resistance training
4966230|NCT01786928|muscle force|muscle force
4966231|NCT01786902|growth hormone|growth hormone
4966232|NCT01786876|AME|ame
4966233|NCT01786876|Radiolabelled|radiolabelled
4966234|NCT01786850|Locally advanced Pancreatic Cancer|locally advanced pancreatic cancer
4966235|NCT01786850|Noninvasive treatment|noninvasive treatment
4966236|NCT01786850|High Intensity focused ultrasound|high intensity focused ultrasound
4966237|NCT01786850|Magnetic Resonance|magnetic resonance
4966238|NCT01786837|constipation|constipation
4966239|NCT01786837|gastric emptying|gastric emptying
4966240|NCT01786824|contrast induced nephropathy|contrast induced nephropathy
4966241|NCT01786824|hydration strategy|hydration strategy
4966242|NCT01786824|L-carnitine|l-carnitine
4966243|NCT01786798|Transvaginal sonography|transvaginal sonography
4966244|NCT01786798|Endometrial thickness|endometrial thickness
4966245|NCT01786798|Endometrial pattern|endometrial pattern
4966246|NCT01786798|Abnormal uterine bleeding|abnormal uterine bleeding
4966247|NCT01786798|Endometrial hyperplasia|endometrial hyperplasia
4966248|NCT01786798|Endometrial cancer|endometrial cancer
4966249|NCT01786772|arthroscopic partial meniscectomy|arthroscopic partial meniscectomy
4966250|NCT01786772|meniscus|meniscus
4966251|NCT01786772|quadriceps strength|quadriceps strength
4966252|NCT01786772|quadriceps voluntary activation|quadriceps voluntary activation
4966253|NCT01786772|cryotherapy|cryotherapy
4966254|NCT01786772|compression|compression
4966255|NCT01786772|vasopneumatic compression|vasopneumatic compression
4966256|NCT01786772|intermittent pneumatic compression|intermittent pneumatic compression
4966257|NCT01786759|lipids|lipids
4966258|NCT01786759|preterm infants|preterm infants
4966259|NCT01786759|parenteral nutrition|parenteral nutrition
4966260|NCT01786759|liver function|liver function
4966261|NCT01786746|depression|depression
4966262|NCT01786746|cognitive behavioral therapy|cognitive behavioral therapy
4966263|NCT01786746|culture|culture
4966264|NCT01786746|Chinese Americans|chinese americans
4966265|NCT01786746|psychotherapy|psychotherapy
4966266|NCT01786733|Acute Inpatient Psychiatry|acute inpatient psychiatry
4966267|NCT01786733|Continuity of Care|continuity of care
4966268|NCT01786733|Behavioral Activation|behavioral activation
4966269|NCT01786733|Depression|depression
4966270|NCT01786720|COPD|copd
4966271|NCT01786720|Triple Therapy|triple therapy
4966272|NCT01786720|ICS|ics
4966273|NCT01786720|LABA|laba
4966274|NCT01786720|LAMA|lama
4966275|NCT01786707|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
4966276|NCT01786707|Hyperbaric oxygen therapy (HOT)|hyperbaric oxygen therapy (hot)
4966277|NCT01786707|Autologous Bone Marrow-Derived Buffy Coat|autologous bone marrow-derived buffy coat
4966278|NCT01786707|Stem cells (SC)|stem cells (sc)
4966279|NCT01786694|rectum|rectum
4966280|NCT01786694|microdialysis|microdialysis
4966281|NCT01786694|quality of life|quality of life
4966282|NCT01786681|Morbid obesity|morbid obesity
4966283|NCT01786681|Bariatric Surgery|bariatric surgery
4966284|NCT01786681|Pulmonary Atelectasis|pulmonary atelectasis
4966285|NCT01786681|Spirometry|spirometry
4966286|NCT01786681|Continuous Positive Airway Pressure|continuous positive airway pressure
4966287|NCT01786681|Physical Therapy Specialty|physical therapy specialty
4966288|NCT01786668|Ankylosing Spondylitis|ankylosing spondylitis
4966289|NCT01786668|Spondylitis|spondylitis
4966290|NCT01786668|Ankylosing|ankylosing
4966291|NCT01786668|Spondyloarthritis|spondyloarthritis
4966292|NCT01786668|Spondyloarthropathy|spondyloarthropathy
4966293|NCT01786668|Oral preparation|oral preparation
4966294|NCT01786655|local anesthetic|local anesthetic
4966295|NCT01786655|neosaxitoxin|neosaxitoxin
4966296|NCT01786655|neoSTX|neostx
4966297|NCT01786655|bupivacaine|bupivacaine
4966298|NCT01786655|safety|safety
4966299|NCT01786655|phase 1|phase 1
4966300|NCT01786655|pharmacokinetic|pharmacokinetic
4966301|NCT01786577|Neuroimaging Biomarkers|neuroimaging biomarkers
4966302|NCT01786577|Cognitive Decline in Elderly|cognitive decline in elderly
4966303|NCT01786577|Memory, Thinking problems for Older Adults|memory, thinking problems for older adults
4966304|NCT01786577|Executive Decline|executive decline
4966305|NCT01786577|Post-operative cognitive change|post-operative cognitive change
4966306|NCT01786564|diabetes|diabetes
4966307|NCT01786564|sleep|sleep
4966308|NCT01786525|Live Donor Kidney Transplantation|live donor kidney transplantation
4966309|NCT01786525|LDKT|ldkt
4966310|NCT01786525|African American|african american
4966311|NCT01786525|Disparity|disparity
4966312|NCT01786525|Education|education
4966313|NCT01786525|Patient Support|patient support
4966314|NCT01786512|Pharmacokinetics|pharmacokinetics
4966315|NCT01786512|Omecamtiv mecarbil|omecamtiv mecarbil
4966316|NCT01786512|AMG 423|amg 423
4966317|NCT01786512|Double-blind|double-blind
4966318|NCT01786512|Randomized|randomized
4966319|NCT01786512|Placebo-controlled|placebo-controlled
4966320|NCT01786512|Oral forumlation|oral forumlation
4966321|NCT01786512|CK-1827452|ck-1827452
4966322|NCT01786512|Cardiac myosin activator|cardiac myosin activator
4966323|NCT01786499|Burnout|burnout
4966324|NCT01786499|Stress|stress
4966325|NCT01786499|Provider|provider
4966326|NCT01786499|Relaxation Response|relaxation response
4966327|NCT01786434|colonoscopy|colonoscopy
4966328|NCT01786434|pain|pain
4966329|NCT01786421|Ethanol|ethanol
4966330|NCT01786421|Lipemia|lipemia
4966331|NCT01786421|Postprandial|postprandial
4966332|NCT01786421|Triglyceride|triglyceride
4966333|NCT01786395|UF-021|uf-021
4966334|NCT01786395|unoprostone|unoprostone
4966335|NCT01786395|rp|rp
4966336|NCT01786369|Schizophrenia|schizophrenia
4966337|NCT01786369|Psychotic Disorders|psychotic disorders
4966338|NCT01786369|Bipolar Disorder|bipolar disorder
4966339|NCT01786369|Antipsychotic Agents|antipsychotic agents
4966340|NCT01786369|Drug Monitoring|drug monitoring
4966341|NCT01786356|posterior capsule opacification|posterior capsule opacification
4966342|NCT01786356|PCO|pco
4966343|NCT01786356|after cataract|after cataract
4966344|NCT01786356|intraocular lens|intraocular lens
4966345|NCT01786343|Leukemia|leukemia
4966346|NCT01786343|Acute myeloid leukemia|acute myeloid leukemia
4966347|NCT01786343|AML|aml
4966348|NCT01786343|Response rates|response rates
4966349|NCT01786343|Decitabine|decitabine
4966350|NCT01786343|Dacogen|dacogen
4966351|NCT01786317|Fecal incontinence, ano-rectal manometry|fecal incontinence, ano-rectal manometry
4966352|NCT01786304|Fecal incontinence, sacral nerve stimulation|fecal incontinence, sacral nerve stimulation
4966353|NCT01786291|obstructive sleep apnea|obstructive sleep apnea
4966354|NCT01786291|continuous positive airway pressure|continuous positive airway pressure
4966355|NCT01786291|cardiopulmonary exercise test|cardiopulmonary exercise test
4966356|NCT01786291|VE/VCO2|ve/vco2
4966357|NCT01786278|adenocarcinoma|adenocarcinoma
4966358|NCT01786278|esophago-gastric junction|esophago-gastric junction
4966359|NCT01786278|dysphagia|dysphagia
4966360|NCT01786278|brachytherapy|brachytherapy
4966361|NCT01786278|endoscopic stenting|endoscopic stenting
4966362|NCT01786265|Prostate Cancer|prostate cancer
4966363|NCT01786265|PSA Progression After Prostatectomy and/or Radiotherapy|psa progression after prostatectomy and/or radiotherapy
4966364|NCT01786265|Prostate specific antigen|prostate specific antigen
4966365|NCT01786265|PSA|psa
4966466|NCT01785940|Home regional|home regional
4966366|NCT01786265|Luteinizing-hormone-releasing hormone|luteinizing-hormone-releasing hormone
4966367|NCT01786265|LHRH|lhrh
4966368|NCT01786265|Finite maximal androgen ablation|finite maximal androgen ablation
4966369|NCT01786265|Lupron|lupron
4966370|NCT01786265|Leuprolide Acetate|leuprolide acetate
4966371|NCT01786265|Lupron Depot|lupron depot
4966372|NCT01786265|Zoladex|zoladex
4966373|NCT01786265|Goserelin|goserelin
4966374|NCT01786265|Degarelix|degarelix
4966375|NCT01786265|Abiraterone Acetate|abiraterone acetate
4966376|NCT01786265|Zytiga|zytiga
4966377|NCT01786265|Prednisone|prednisone
4966378|NCT01786252|embryo|embryo
4966379|NCT01786252|implantation|implantation
4966380|NCT01786252|blastocyst|blastocyst
4966381|NCT01786252|in vitro fertilization|in vitro fertilization
4966382|NCT01786252|human chorionic gonadotropin|human chorionic gonadotropin
4966383|NCT01786239|Adolescence|adolescence
4966384|NCT01786239|Adult|adult
4966385|NCT01786239|Antipsychotic Agents|antipsychotic agents
4966386|NCT01786239|Female|female
4966387|NCT01786239|Human|human
4966388|NCT01786239|Male|male
4966389|NCT01786239|Risperidone|risperidone
4966390|NCT01786239|Omega-3|omega-3
4966391|NCT01786239|Schizophrenia|schizophrenia
4966392|NCT01786239|Schizophreniform|schizophreniform
4966393|NCT01786239|Schizoaffective|schizoaffective
4966394|NCT01786239|Schizophrenia -- *drug therapy|schizophrenia -- *drug therapy
4966395|NCT01786226|leiomyoma, fibroid, mifepristone, antiprogestins|leiomyoma, fibroid, mifepristone, antiprogestins
4966396|NCT01786213|adenoma detection rate, colonoscopy, trainee, learning curve|adenoma detection rate, colonoscopy, trainee, learning curve
4966397|NCT01786200|colon|colon
4966398|NCT01786200|cancer|cancer
4966399|NCT01786200|NSAID|nsaid
4966400|NCT01786200|inflammation|inflammation
4966401|NCT01786187|Lung Cancer|lung cancer
4966402|NCT01786187|Symptoms|symptoms
4966403|NCT01786174|ALS|als
4966404|NCT01786174|Gilenya|gilenya
4966405|NCT01786174|Fingolimod|fingolimod
4966406|NCT01786148|HIV/AIDS|hiv/aids
4966407|NCT01786148|Adherence|adherence
4966408|NCT01786148|Self-management|self-management
4966409|NCT01786148|Antiretroviral therapy|antiretroviral therapy
4966410|NCT01786135|Antibodies, Monoclonal|antibodies, monoclonal
4966411|NCT01786135|Antibody-Drug Conjugate|antibody-drug conjugate
4966412|NCT01786135|Antigens, CD19|antigens, cd19
4966413|NCT01786135|B-Lineage Lymphoblastic Lymphoma|b-lineage lymphoblastic lymphoma
4966414|NCT01786135|Burkitt Lymphoma|burkitt lymphoma
4966415|NCT01786135|Diffuse Large B-Cell Lymphoma|diffuse large b-cell lymphoma
4966416|NCT01786135|Mantle Cell Lymphoma|mantle cell lymphoma
4966417|NCT01786135|B-Cell Lymphoma|b-cell lymphoma
4966418|NCT01786135|Drug Therapy|drug therapy
4966419|NCT01786135|Monomethylauristatin F|monomethylauristatin f
4966420|NCT01786135|Follicular Lymphoma Grade 3|follicular lymphoma grade 3
4966421|NCT01786122|physical exercise|physical exercise
4966422|NCT01786122|Health Related Quality of Life|health related quality of life
4966423|NCT01786122|Non-Small-Cell Lung Carcinoma|non-small-cell lung carcinoma
4966424|NCT01786122|digestive system neoplasms|digestive system neoplasms
4966425|NCT01786122|breast neoplasms|breast neoplasms
4966426|NCT01786109|anandamide|anandamide
4966427|NCT01786109|cannabinoid|cannabinoid
4966428|NCT01786109|fatty acid amide hydrolase|fatty acid amide hydrolase
4966429|NCT01786109|gastric|gastric
4966430|NCT01786109|motility|motility
4966431|NCT01786109|small bowel|small bowel
4966432|NCT01786109|sensory|sensory
4966433|NCT01786109|motor|motor
4966434|NCT01786096|Burkitt Lymphoma|burkitt lymphoma
4966435|NCT01786096|Antibodies, Monoclonal|antibodies, monoclonal
4966436|NCT01786096|Antibody-Drug Conjugate|antibody-drug conjugate
4966437|NCT01786096|B-Lineage Acute Lymphoblastic Leukemia|b-lineage acute lymphoblastic leukemia
4966438|NCT01786096|B-Lineage Lymphoblastic Lymphoma|b-lineage lymphoblastic lymphoma
4966439|NCT01786096|Burkitt Leukemia|burkitt leukemia
4966440|NCT01786096|Monomethylauristatin F|monomethylauristatin f
4966441|NCT01786096|Antigens, CD19|antigens, cd19
4966442|NCT01786096|Drug Therapy|drug therapy
4966443|NCT01786083|family caregivers|family caregivers
4966444|NCT01786083|dependency|dependency
4966445|NCT01786083|Problem Solving Technique|problem solving technique
4966446|NCT01786083|home based nursing|home based nursing
4966447|NCT01786044|patient education|patient education
4966448|NCT01786044|primary health care|primary health care
4966449|NCT01786018|Non Hodgkin lymphomas|non hodgkin lymphomas
4966450|NCT01786018|Allogeneic Transplantation|allogeneic transplantation
4966451|NCT01786018|Thiotepa|thiotepa
4966452|NCT01786018|Busulfan|busulfan
4966453|NCT01786018|Fludarabin|fludarabin
4966454|NCT01785992|Oestrogen receptor|oestrogen receptor
4966455|NCT01785992|Locally advanced|locally advanced
4966456|NCT01785992|Metastatic|metastatic
4966457|NCT01785992|Breast cancer|breast cancer
4966458|NCT01785992|Sulfatase inhibitor|sulfatase inhibitor
4966459|NCT01785966|Critical care|critical care
4966460|NCT01785966|quality improvement|quality improvement
4966461|NCT01785966|checklist|checklist
4966462|NCT01785940|Interscalene Block|interscalene block
4966463|NCT01785940|Perineural catheter|perineural catheter
4966464|NCT01785940|Ropivacaine|ropivacaine
4966465|NCT01785940|Postoperative pain|postoperative pain
4966467|NCT01785927|Antituberculosis|antituberculosis
4966468|NCT01785927|Dry powder aerosols|dry powder aerosols
4966469|NCT01785927|Inhalation|inhalation
4966470|NCT01785901|asthma|asthma
4966471|NCT01785901|control rate|control rate
4966472|NCT01785901|budesonide/formoterol|budesonide/formoterol
4966473|NCT01785901|Non-Interventional study|non-interventional study
4966474|NCT01785888|EGFR,|egfr,
4966475|NCT01785888|aNSCLC,|ansclc,
4966476|NCT01785888|mutation status,|mutation status,
4966477|NCT01785888|diagnostic study,|diagnostic study,
4966478|NCT01785888|Europe,|europe,
4966479|NCT01785888|Japan|japan
4966480|NCT01785875|Secondary Hyperparathyroidism (SHPT), chronic kidney disease (CKD), hemodialysis, parathyroid hormone (PTH), hypocalcemia, bone and mineral metabolism|secondary hyperparathyroidism (shpt), chronic kidney disease (ckd), hemodialysis, parathyroid hormone (pth), hypocalcemia, bone and mineral metabolism
4966481|NCT01785862|sore throat pain|sore throat pain
4966482|NCT01785862|tonsillopharyngitis|tonsillopharyngitis
4966483|NCT01785862|upper respiratory tract infection|upper respiratory tract infection
4966484|NCT01785849|Secondary Hyperparathyroidism (SHPT), chronic kidney disease (CKD), hemodialysis, parathyroid hormone (PTH), hypocalcemia, bone and mineral metabolism|secondary hyperparathyroidism (shpt), chronic kidney disease (ckd), hemodialysis, parathyroid hormone (pth), hypocalcemia, bone and mineral metabolism
4966485|NCT01785823|analgesia|analgesia
4966486|NCT01785823|fentanyl|fentanyl
4966487|NCT01785823|total intravenous anesthesia|total intravenous anesthesia
4966488|NCT01785758|complications, renal;|complications, renal;
4966489|NCT01785758|kidney, failure;|kidney, failure;
4966490|NCT01785758|neuromuscular block, antagonism;|neuromuscular block, antagonism;
4966491|NCT01785758|neuromuscular block, rocuronium;|neuromuscular block, rocuronium;
4966492|NCT01785758|safety, drug|safety, drug
4966493|NCT01785758|sugammadex|sugammadex
4966494|NCT01785745|conservative treatment|conservative treatment
4966495|NCT01785745|shoulder|shoulder
4966496|NCT01785745|neurocognitive therapeutic exercise|neurocognitive therapeutic exercise
4966497|NCT01785745|traditional therapeutic exercise|traditional therapeutic exercise
4966498|NCT01785745|pain|pain
4966499|NCT01785719|Weight Loss|weight loss
4966500|NCT01785719|Polycystic Ovary Syndrome (PCOS)|polycystic ovary syndrome (pcos)
4966501|NCT01785719|Ovarian Follicle Development|ovarian follicle development
4966502|NCT01785719|Metabolism|metabolism
4966503|NCT01785693|Nerve block|nerve block
4966504|NCT01785693|Femoropopliteal bypass|femoropopliteal bypass
4966505|NCT01785693|Postoperative analgesia|postoperative analgesia
4966506|NCT01785693|Peripheral circulation|peripheral circulation
4966507|NCT01785693|Levobupivacaine|levobupivacaine
4966508|NCT01785693|Clonidine|clonidine
4966509|NCT01785693|Pain|pain
4966510|NCT01785680|MAM|mam
4966511|NCT01785680|SAM|sam
4966512|NCT01785654|Reventilation collapse|reventilation collapse
4966513|NCT01785654|Rate of reventilation collapse|rate of reventilation collapse
4966514|NCT01785654|Risk factor of reventilation collapse|risk factor of reventilation collapse
4966515|NCT01785654|Hemodynamic profile of reventilation collapse|hemodynamic profile of reventilation collapse
4966516|NCT01785654|Biologic approach of reventilation collapse|biologic approach of reventilation collapse
4966517|NCT01785641|peritoneal dialysis|peritoneal dialysis
4966518|NCT01785641|peritonitis|peritonitis
4966519|NCT01785628|Parkinson's disease|parkinson's disease
4966520|NCT01785628|dementia|dementia
4966521|NCT01785628|NMDA|nmda
4966522|NCT01785628|event related potential|event related potential
4966523|NCT01785628|Bereitschaftspotential|bereitschaftspotential
4966524|NCT01785615|metabolic syndrome|metabolic syndrome
4966525|NCT01785615|atorvastatin|atorvastatin
4966526|NCT01785615|women|women
4966527|NCT01785602|Atopic eczema|atopic eczema
4966528|NCT01785602|Skin Diseases|skin diseases
4966529|NCT01785589|coronary artery disease|coronary artery disease
4966530|NCT01785589|cardiac nuclear medicine|cardiac nuclear medicine
4966531|NCT01785589|myocardial perfusion imaging|myocardial perfusion imaging
4966532|NCT01785589|invasive coronary angiography|invasive coronary angiography
4966533|NCT01785576|couples|couples
4966534|NCT01785576|head and neck cancer|head and neck cancer
4966535|NCT01785576|oncology|oncology
4966536|NCT01785576|spousal support|spousal support
4966537|NCT01785563|NAVA|nava
4966538|NCT01785563|NIV-NAVA|niv-nava
4966539|NCT01785563|VLBW|vlbw
4966540|NCT01785563|electrical activity of the diaphragm|electrical activity of the diaphragm
4966541|NCT01785563|neural trigger, mechanical ventilation|neural trigger, mechanical ventilation
4966542|NCT01785563|respiratory distress syndrome|respiratory distress syndrome
4966543|NCT01785537|e-cigarette smoking|e-cigarette smoking
4966544|NCT01785537|cigarette smoking|cigarette smoking
4966545|NCT01785537|cardiovascular disease|cardiovascular disease
4966546|NCT01785537|hospitalization|hospitalization
4966547|NCT01785537|chronic obstructive pulmonary diseases|chronic obstructive pulmonary diseases
4966548|NCT01785537|observational study|observational study
4966549|NCT01785537|efficacy|efficacy
4966550|NCT01785537|safety|safety
4966551|NCT01785524|Cardiovascular Diseases|cardiovascular diseases
4966552|NCT01785524|Vascular Diseases|vascular diseases
4966553|NCT01785524|Arterial Occlusive Diseases|arterial occlusive diseases
4966554|NCT01785524|Diabetes|diabetes
4966555|NCT01785524|Exercise|exercise
4966556|NCT01785524|Functional Capacity|functional capacity
4966557|NCT01785511|hypertension|hypertension
4966558|NCT01785511|UV radiation|uv radiation
4966559|NCT01785511|coronary flow reserve|coronary flow reserve
4966560|NCT01785511|nitric oxide|nitric oxide
4966561|NCT01785498|children|children
4966562|NCT01785498|quality of life|quality of life
4966563|NCT01785498|physical activity|physical activity
4966564|NCT01785498|healthy lifestyle|healthy lifestyle
4966565|NCT01785485|Integrative medicine|integrative medicine
4966566|NCT01785485|primary care|primary care
4966567|NCT01785485|cost-effectiveness|cost-effectiveness
4966568|NCT01785472|Essential hypertension|essential hypertension
4966569|NCT01785472|LCZ696|lcz696
4966570|NCT01785459|headache|headache
4966571|NCT01785459|migraine|migraine
4966572|NCT01785459|bupivacaine|bupivacaine
4966573|NCT01785446|Dexmedetomidine|dexmedetomidine
4966574|NCT01785446|Cisatracurion infusion|cisatracurion infusion
4966575|NCT01785446|Sufentanil|sufentanil
4966576|NCT01785446|Recovery Index|recovery index
4966577|NCT01785446|Closed loop computer control system|closed loop computer control system
4966578|NCT01785433|COPD, pharmacokinetics, tiotropium|copd, pharmacokinetics, tiotropium
4966579|NCT01785420|Pre-operative Trastuzumab Protocol|pre-operative trastuzumab protocol
4966580|NCT01785407|Iron bio availability|iron bio availability
4966581|NCT01785407|Hepcidin|hepcidin
4966582|NCT01785407|Iron absorption|iron absorption
4966583|NCT01785394|pollinosis|pollinosis
4966584|NCT01785394|sublingual immunotherapy|sublingual immunotherapy
4966585|NCT01785394|exhaled breath temperature|exhaled breath temperature
4966586|NCT01785381|Osteoporosis, hip fracture, fractures, Bone density|osteoporosis, hip fracture, fractures, bone density
4966587|NCT01785368|guidelines|guidelines
4966588|NCT01785368|referral guidelines|referral guidelines
4966589|NCT01785368|exam delays|exam delays
4966590|NCT01785368|exam relevance|exam relevance
4966591|NCT01785355|periodontal disease|periodontal disease
4966592|NCT01785355|CKD|ckd
4966593|NCT01785355|nutrition|nutrition
4966594|NCT01785355|inflammation|inflammation
4966595|NCT01785355|anemia response to ESA|anemia response to esa
4966596|NCT01785355|quality of life|quality of life
4966597|NCT01785355|hemodialysis|hemodialysis
4966598|NCT01785316|Perfusion Cancer Chemotherapy, Regional|perfusion cancer chemotherapy, regional
4966599|NCT01785303|CBT|cbt
4966600|NCT01785303|CPAP|cpap
4966601|NCT01785303|Multidisciplinary Treatment|multidisciplinary treatment
4966602|NCT01785303|Combination treatment|combination treatment
4966603|NCT01785290|Delirium|delirium
4966604|NCT01785290|Survival|survival
4966605|NCT01785290|Side-effects|side-effects
4966606|NCT01785290|QoL|qol
4966607|NCT01785277|Spinal Cord Independence Measure|spinal cord independence measure
4966608|NCT01785277|SCIM|scim
4966609|NCT01785277|Spinal cord injury|spinal cord injury
4966610|NCT01785277|Traumatic spine injury|traumatic spine injury
4966611|NCT01785264|Achilles|achilles
4966612|NCT01785264|Tendon|tendon
4966613|NCT01785264|Rupture|rupture
4966614|NCT01785264|Acute|acute
4966615|NCT01785264|Treatment|treatment
4966616|NCT01785264|Outcome measure|outcome measure
4966617|NCT01785251|Neuromuscular electrical stimulation|neuromuscular electrical stimulation
4966618|NCT01785251|NMES|nmes
4966619|NCT01785251|Deep vein thrombosis|deep vein thrombosis
4966620|NCT01785251|DVT|dvt
4966621|NCT01785251|total hip arthroplasty|total hip arthroplasty
4966622|NCT01785251|lower limb hemodynamics|lower limb hemodynamics
4966623|NCT01785238|preterm infants|preterm infants
4966624|NCT01785238|acute renal failure|acute renal failure
4966625|NCT01785238|nephronic reduction|nephronic reduction
4966626|NCT01785199|apnea-hypopnea index|apnea-hypopnea index
4966627|NCT01785199|obstructive sleep apnea|obstructive sleep apnea
4966628|NCT01785199|body posture|body posture
4966629|NCT01785199|ultra-wideband|ultra-wideband
4966631|NCT01785186|Tuberculosis|tuberculosis
4966632|NCT01785186|MAMS - Multiple-arm, multiple-stage|mams - multiple-arm, multiple-stage
4966633|NCT01785186|Pulmonary|pulmonary
4966634|NCT01785186|SQ109|sq109
4966635|NCT01785186|High dose rifampicin|high dose rifampicin
4966636|NCT01785186|moxifloxacin|moxifloxacin
4966637|NCT01785173|Endoscopes|endoscopes
4966638|NCT01785173|Esophago-gastro-duodenoscopy|esophago-gastro-duodenoscopy
4966639|NCT01785173|Transnasal endoscopy|transnasal endoscopy
4966640|NCT01785173|Nasal anesthesia|nasal anesthesia
4966641|NCT01785147|Tobacco addition|tobacco addition
4966642|NCT01785134|Obesity|obesity
4966643|NCT01785134|Bariatric Surgery|bariatric surgery
4966644|NCT01785134|Insulin Sensitivity|insulin sensitivity
4966645|NCT01785108|Diamyd|diamyd
4966646|NCT01785108|Diabetes|diabetes
4966647|NCT01785108|Juvenile Diabetes|juvenile diabetes
4966648|NCT01785108|Diabetes type 1|diabetes type 1
4966649|NCT01785108|Autoimmune Diabetes|autoimmune diabetes
4966650|NCT01785108|Insulin dependent Diabetes|insulin dependent diabetes
4966651|NCT01785108|Type 1 diabetes|type 1 diabetes
4966652|NCT01785108|Type 1 diabetes mellitus|type 1 diabetes mellitus
4966653|NCT01785108|rhGAD65|rhgad65
4966654|NCT01785108|GAD|gad
4966655|NCT01785108|GAD65|gad65
4966656|NCT01785108|GAD-alum|gad-alum
4966657|NCT01785108|Diabetes Mellitus|diabetes mellitus
4966658|NCT01785108|Diabetes Mellitus, Type 1|diabetes mellitus, type 1
4966659|NCT01785108|Glucose Metabolism Disorders|glucose metabolism disorders
4966660|NCT01785108|Metabolic Diseases|metabolic diseases
4966661|NCT01785108|Vitamin D|vitamin d
4966662|NCT01785108|Ibuprofen|ibuprofen
4966663|NCT01785082|13-C-Methacetin|13-c-methacetin
4966664|NCT01785082|partial liver resection|partial liver resection
4966665|NCT01785082|liver function tests|liver function tests
4966666|NCT01785056|Systemic Sclerosis|systemic sclerosis
4966667|NCT01785056|Diffuse Scleroderma|diffuse scleroderma
4966668|NCT01785056|SSc|ssc
4966669|NCT01785043|DIABETES Mellitus Type 2|diabetes mellitus type 2
4966670|NCT01785043|Difficult control|difficult control
4966671|NCT01785017|critical|critical
4966672|NCT01785017|asthma|asthma
4966673|NCT01785017|children|children
4966674|NCT01785004|Adiposity|adiposity
4966675|NCT01785004|Body composition|body composition
4966676|NCT01785004|Vitamin D|vitamin d
4966677|NCT01785004|Adipokines|adipokines
4966678|NCT01785004|Omega-3 fatty acid|omega-3 fatty acid
4966679|NCT01784991|Pain|pain
4966680|NCT01784991|Opioids|opioids
4966681|NCT01784991|Hydromorphone|hydromorphone
4966682|NCT01784991|regimen|regimen
4966683|NCT01784978|cancer|cancer
4966684|NCT01784978|renal|renal
4966685|NCT01784978|metastatic|metastatic
4966686|NCT01784978|clear|clear
4966687|NCT01784978|cell|cell
4966688|NCT01784978|Sunitinib|sunitinib
4966689|NCT01784978|Everolimus|everolimus
4966690|NCT01784978|Alternating|alternating
4966691|NCT01784939|hereditary hemochromatosis C282Y homozygous|hereditary hemochromatosis c282y homozygous
4966692|NCT01784939|Iron Reabsorption Index (IRI)|iron reabsorption index (iri)
4966693|NCT01784939|Hepcidin / ferritin (H / F) ratio|hepcidin / ferritin (h / f) ratio
4966694|NCT01784926|cataract surgery|cataract surgery
4966695|NCT01784926|scleral suturing|scleral suturing
4966696|NCT01784926|Verisyse|verisyse
4966697|NCT01784926|Late in-the-bag IOL dislocation|late in-the-bag iol dislocation
4966698|NCT01784913|Prostate|prostate
4966699|NCT01784913|cancer|cancer
4966700|NCT01784913|vaccine|vaccine
4966701|NCT01784874|Rabies|rabies
4966702|NCT01784874|Human Diploid Cell Vaccine|human diploid cell vaccine
4966703|NCT01784874|Imovax® Rabies|imovax® rabies
4966704|NCT01784848|high blood pressure|high blood pressure
4966705|NCT01784848|hypertension|hypertension
4966706|NCT01784848|bariatric surgery|bariatric surgery
4966707|NCT01784848|Laparoscopic Roux-en-Y gastric bypass (LRYGB)|laparoscopic roux-en-y gastric bypass (lrygb)
4966708|NCT01784848|obesity|obesity
4966709|NCT01784835|Osteopathic manipulative treatment|osteopathic manipulative treatment
4966710|NCT01784835|neonatology|neonatology
4966711|NCT01784835|neonatal care|neonatal care
4966712|NCT01784835|prematurity|prematurity
4966713|NCT01784835|complementary and alternative medicine|complementary and alternative medicine
4966714|NCT01784835|length of stay|length of stay
4966715|NCT01784822|Ventral hernia|ventral hernia
4966716|NCT01784822|Graft repair|graft repair
4966717|NCT01784809|HIV|hiv
4966718|NCT01784809|STIs|stis
4966719|NCT01784809|Condom Use|condom use
4966720|NCT01784809|Criminal Justice|criminal justice
4966721|NCT01784809|Drug Use|drug use
4966722|NCT01784796|cardiovascular disease|cardiovascular disease
4966723|NCT01784796|women's health|women's health
4966724|NCT01784796|psychological stress|psychological stress
4966725|NCT01784796|Veterans|veterans
4966726|NCT01784796|stroke|stroke
4966727|NCT01784783|HIV transmission|hiv transmission
4966728|NCT01784783|PMTCT|pmtct
4966729|NCT01784783|Discordancy|discordancy
4966730|NCT01784783|Home-based testing|home-based testing
4966731|NCT01784783|Couple counseling|couple counseling
4966732|NCT01784783|Couple testing|couple testing
4966733|NCT01784783|Facility delivery|facility delivery
4966734|NCT01784783|Exclusive breastfeeding|exclusive breastfeeding
4966735|NCT01784783|Family planning|family planning
4966736|NCT01784783|Postpartum contraceptives|postpartum contraceptives
4966737|NCT01784783|Linkage to care|linkage to care
4966738|NCT01784783|ART initiation|art initiation
4966739|NCT01784770|Legionnaires' disease|legionnaires' disease
4966740|NCT01784770|Legionella pneumophila|legionella pneumophila
4966741|NCT01784770|Zithromax|zithromax
4966742|NCT01784770|Zithromac|zithromac
4966743|NCT01784770|Japanese|japanese
4966744|NCT01784770|Regulatory Post Marketing Commitment Plan|regulatory post marketing commitment plan
4966745|NCT01784744|Autism|autism
4966746|NCT01784744|ASD|asd
4966747|NCT01784744|Aspergers|aspergers
4966748|NCT01784744|Autism Spectrum Disorder|autism spectrum disorder
4966749|NCT01784692|Immulina|immulina
4966750|NCT01784692|Elderly|elderly
4966751|NCT01784692|Immune|immune
4966752|NCT01784679|Hereditary Inclusion Body Myopathy|hereditary inclusion body myopathy
4966753|NCT01784679|GNE Myopathy|gne myopathy
4966754|NCT01784679|Nonaka Disease|nonaka disease
4966755|NCT01784679|Quadriceps Sparing Myopathy|quadriceps sparing myopathy
4966756|NCT01784679|distal myopathy with rimmed vacuoles|distal myopathy with rimmed vacuoles
4966757|NCT01784679|ultragenyx|ultragenyx
4966758|NCT01784679|rare disease|rare disease
4966759|NCT01784666|Bipolar Disorder|bipolar disorder
4966760|NCT01784666|Depression|depression
4966761|NCT01784666|Lithium|lithium
4966762|NCT01784666|Valproate|valproate
4966763|NCT01784666|Isradipine|isradipine
4966764|NCT01784653|Substance abuse|substance abuse
4966765|NCT01784653|Drug abuse|drug abuse
4966766|NCT01784653|Alcohol abuse|alcohol abuse
4966767|NCT01784653|Tobacco|tobacco
4966768|NCT01784653|Adolescent|adolescent
4966769|NCT01784627|substance use|substance use
4966770|NCT01784627|alcohol abuse|alcohol abuse
4966771|NCT01784627|cannabis abuse|cannabis abuse
4966772|NCT01784627|nicotine dependence|nicotine dependence
4966773|NCT01784627|adolescents|adolescents
4966774|NCT01784601|Interscalene block|interscalene block
4966775|NCT01784601|Hemidiaphragm palsy|hemidiaphragm palsy
4966776|NCT01784575|Quality of care|quality of care
4966777|NCT01784575|Pediatric|pediatric
4966778|NCT01784575|Pregnancy|pregnancy
4966779|NCT01784575|Low-income|low-income
4966780|NCT01784575|Low literacy|low literacy
4966781|NCT01784562|Chronic thromboembolic pulmonary hypertension|chronic thromboembolic pulmonary hypertension
4966782|NCT01784549|NSCL|nscl
4966783|NCT01784549|biomarkers|biomarkers
4966784|NCT01784549|Customized Neoadjuvant Therapy|customized neoadjuvant therapy
4966785|NCT01784523|antiphospholipid autoantibodies|antiphospholipid autoantibodies
4966786|NCT01784523|antiphospholipid positive|antiphospholipid positive
4966787|NCT01784497|Health Related Quality of Life (HRQL)|health related quality of life (hrql)
4966788|NCT01784497|Living Donor Liver Transplantation(LDLT)|living donor liver transplantation(ldlt)
4966789|NCT01784471|Foot Symptoms|foot symptoms
4966790|NCT01784471|Diabetes|diabetes
4966791|NCT01784471|Peripheral Vascular Disease|peripheral vascular disease
4966792|NCT01784471|Magic Foot shoe|magic foot shoe
4966793|NCT01784458|severe sepsis|severe sepsis
4966794|NCT01784458|intra-abdominal hypertension|intra-abdominal hypertension
4966795|NCT01784458|intra-abdominal pressure|intra-abdominal pressure
4966796|NCT01784445|Endoscopic Retrograde Cholangiopancreatography,|endoscopic retrograde cholangiopancreatography,
4966797|NCT01784432|low-level laser therapy|low-level laser therapy
4966798|NCT01784432|muscle performance|muscle performance
4966799|NCT01784432|strength training|strength training
4966800|NCT01784432|gene expression|gene expression
4966801|NCT01784432|microarrays|microarrays
4966802|NCT01784419|Cystic fibrosis|cystic fibrosis
4966803|NCT01784419|Ivacaftor|ivacaftor
4966804|NCT01784419|Genotype|genotype
4966805|NCT01784419|Phenotype|phenotype
4966806|NCT01784419|Sweat chloride|sweat chloride
4966807|NCT01784419|Pancreatic sufficient|pancreatic sufficient
4966808|NCT01784406|Self-management intervention|self-management intervention
4966809|NCT01784406|Psychosocial care|psychosocial care
4966810|NCT01784406|Autonomy-supportive|autonomy-supportive
4966811|NCT01784406|Gynaecological cancer survivors|gynaecological cancer survivors
4966812|NCT01784406|Guided self-Determination|guided self-determination
4966813|NCT01784367|Hypercapnia|hypercapnia
4966814|NCT01784367|noninvasive ventilation|noninvasive ventilation
4966815|NCT01784367|acute respiratory failure|acute respiratory failure
4966816|NCT01784367|endotracheal intubation|endotracheal intubation
4966817|NCT01784367|invasive mechanical ventilation|invasive mechanical ventilation
4966818|NCT01784341|Bipolar, Circadian, Melatonin|bipolar, circadian, melatonin
4966819|NCT01784328|Peristeen Bowel Irrigation System|peristeen bowel irrigation system
4966820|NCT01784328|Cauda Equina Syndrome|cauda equina syndrome
4966821|NCT01784328|Lower Motor Neuron Neurogenic Bowel|lower motor neuron neurogenic bowel
4966822|NCT01784315|The presence of parasites in the blood|the presence of parasites in the blood
4966823|NCT01784289|Interleukin 7|interleukin 7
4966824|NCT01784289|adipose tissue|adipose tissue
4966825|NCT01784276|Children|children
4966826|NCT01784276|Autism Spectrum Disorders|autism spectrum disorders
4966827|NCT01784276|Electronic Screen Media|electronic screen media
4966828|NCT01784276|Dental fear|dental fear
4966829|NCT01784263|Intervention|intervention
4966830|NCT01784263|Autism|autism
4966831|NCT01784263|Treatment sensitivity|treatment sensitivity
4966832|NCT01784263|School aged|school aged
4966833|NCT01784263|Cognitive behavioral therapy|cognitive behavioral therapy
4966834|NCT01784250|Clonidine|clonidine
4966835|NCT01784250|Propranolol|propranolol
4966836|NCT01784250|Third molar|third molar
4966837|NCT01784250|Anxiety|anxiety
4966838|NCT01784237|Endoscopes|endoscopes
4966839|NCT01784237|Esophago-gastro-duodenoscopy|esophago-gastro-duodenoscopy
4966840|NCT01784237|Transnasal endoscopy|transnasal endoscopy
4966841|NCT01784237|Anterior meatoscopy|anterior meatoscopy
4966842|NCT01784198|pregnancy|pregnancy
4966843|NCT01784198|protein requirements|protein requirements
4966844|NCT01784198|Indicator Amino acid oxidation|indicator amino acid oxidation
4966845|NCT01784198|Stable isotopes|stable isotopes
4966846|NCT01784185|EBUS guided transbronchial needle aspiration (EBUS-TBNA)|ebus guided transbronchial needle aspiration (ebus-tbna)
4966847|NCT01784185|virtual bronchoscopy (VB)|virtual bronchoscopy (vb)
4966848|NCT01784185|VB guided transbronchial needle aspiration VB-TBNA)|vb guided transbronchial needle aspiration vb-tbna)
4966849|NCT01784185|mediastinal sampling|mediastinal sampling
4966850|NCT01784185|transbronchial needle aspiration (TBNA)|transbronchial needle aspiration (tbna)
4966851|NCT01784172|efficacy|efficacy
4966852|NCT01784172|safety|safety
4966853|NCT01784172|electroacupuncture|electroacupuncture
4966854|NCT01784172|simple female stress urinary incontinence|simple female stress urinary incontinence
4966855|NCT01784133|rosacea|rosacea
4966856|NCT01784120|breast cancer|breast cancer
4966857|NCT01784120|doxorubicin|doxorubicin
4966858|NCT01784120|genexol-PM|genexol-pm
4966859|NCT01784120|paclitaxel|paclitaxel
4966860|NCT01784107|SCLC|sclc
4966861|NCT01784107|belotecan|belotecan
4966862|NCT01784107|Ifosfamide|ifosfamide
4966863|NCT01784081|palliative care|palliative care
4966864|NCT01784081|decision aid|decision aid
4966865|NCT01784068|Ph+ CML-CP|ph+ cml-cp
4966866|NCT01784068|chronic phase|chronic phase
4966867|NCT01784068|nilotinib treatment|nilotinib treatment
4966868|NCT01784068|2 years treatment|2 years treatment
4966869|NCT01784068|MR 4.5|mr 4.5
4966870|NCT01784068|Loss of MR 4|loss of mr 4
4966871|NCT01784068|Loss of MMR|loss of mmr
4966872|NCT01784055|NeoChord|neochord
4966873|NCT01784055|DS1000|ds1000
4966874|NCT01784055|Mitral Valve|mitral valve
4966875|NCT01784055|Mitral Valve Regurgitation|mitral valve regurgitation
4966877|NCT01784055|Mitral Valve Repair|mitral valve repair
4966878|NCT01784055|Mitral Valve Prolapse|mitral valve prolapse
4966879|NCT01784055|Artificial Chordae|artificial chordae
4966880|NCT01784042|breast cancer|breast cancer
4966881|NCT01784042|omega-3 fatty acids|omega-3 fatty acids
4966882|NCT01784029|adolescents|adolescents
4966883|NCT01784029|minority|minority
4966884|NCT01783964|Elacytarabine|elacytarabine
4966885|NCT01783964|pharmacokinetic|pharmacokinetic
4966886|NCT01783964|Microdose|microdose
4966887|NCT01783964|Mass Balance Recovery|mass balance recovery
4966888|NCT01783951|Gastric cancer|gastric cancer
4966889|NCT01783951|S-1|s-1
4966890|NCT01783951|DC-CIK|dc-cik
4966891|NCT01783951|T cell|t cell
4966892|NCT01783912|Smoking|smoking
4966893|NCT01783912|Nicotine Dependence|nicotine dependence
4966894|NCT01783912|Mental Disorders|mental disorders
4966895|NCT01783886|Diabetic Macular Edema|diabetic macular edema
4966896|NCT01783886|DME|dme
4966897|NCT01783886|VEGF Trap-Eye|vegf trap-eye
4966898|NCT01783886|best-corrected visual acuity (BCVA)|best-corrected visual acuity (bcva)
4966899|NCT01783860|Azithromycin|azithromycin
4966900|NCT01783860|Doxycycline|doxycycline
4966901|NCT01783860|Posterior Blepharitis|posterior blepharitis
4966902|NCT01783847|Erythropoietin|erythropoietin
4966903|NCT01783847|Traumatic Optic Neuropathy|traumatic optic neuropathy
4966904|NCT01783847|Visual function|visual function
4966905|NCT01783834|Pemetrexed|pemetrexed
4966906|NCT01783834|Gefitinib|gefitinib
4966907|NCT01783834|iressa|iressa
4966908|NCT01783834|alimta|alimta
4966909|NCT01783821|Acute respiratory distress syndrome (ARDS)|acute respiratory distress syndrome (ards)
4966910|NCT01783808|COPD|copd
4966911|NCT01783808|Physical capacity|physical capacity
4966912|NCT01783808|Physical activity|physical activity
4966913|NCT01783808|Inflammatory markers|inflammatory markers
4966914|NCT01783808|Health related quality of life|health related quality of life
4966915|NCT01783795|Dent|dent
4966916|NCT01783795|Dents|dents
4966917|NCT01783795|Dent Disease|dent disease
4966918|NCT01783795|Dent genetic testing|dent genetic testing
4966919|NCT01783795|CLCN5|clcn5
4966920|NCT01783795|OCRL1|ocrl1
4966921|NCT01783795|Genetic testing for Dent Disease|genetic testing for dent disease
4966922|NCT01783795|Hereditary study for Dent Disease|hereditary study for dent disease
4966923|NCT01783782|Capsule Endoscopy|capsule endoscopy
4966924|NCT01783782|colon cleansing|colon cleansing
4966925|NCT01783782|children|children
4966926|NCT01783782|age 2 -18 years|age 2 -18 years
4966927|NCT01783769|neurosurgery|neurosurgery
4966928|NCT01783769|operating room personnel|operating room personnel
4966929|NCT01783769|sterile procedures|sterile procedures
4966930|NCT01783769|infection|infection
4966931|NCT01783769|Conditions requiring surgery|conditions requiring surgery
4966932|NCT01783743|Trichiasis|trichiasis
4966933|NCT01783743|Trachoma|trachoma
4966934|NCT01783743|Mass treatment|mass treatment
4966935|NCT01783730|Rheumatoid arthritis|rheumatoid arthritis
4966936|NCT01783704|hip fracture|hip fracture
4966937|NCT01783704|randomized controlled trial|randomized controlled trial
4966938|NCT01783704|exercise|exercise
4966939|NCT01783691|Sickle cell disease|sickle cell disease
4966940|NCT01783652|Adolescent depression|adolescent depression
4966941|NCT01783652|internet intervention|internet intervention
4966942|NCT01783639|Carotid|carotid
4966943|NCT01783639|Carotid artery stenting|carotid artery stenting
4966944|NCT01783639|Stent|stent
4966945|NCT01783639|Embolic protection|embolic protection
4966946|NCT01783639|Atherosclerotic Disease|atherosclerotic disease
4966947|NCT01783600|Peripheral Arterial Disease|peripheral arterial disease
4966948|NCT01783600|Infrapopliteal lesions|infrapopliteal lesions
4966949|NCT01783600|balloon catheter|balloon catheter
4966950|NCT01783574|Depression|depression
4966951|NCT01783574|Major Depressive Disorder (MDD)|major depressive disorder (mdd)
4966952|NCT01783561|caffeine|caffeine
4966953|NCT01783561|intubation|intubation
4966954|NCT01783561|hemodynamic|hemodynamic
4966955|NCT01783548|allergic rhinitis|allergic rhinitis
4966956|NCT01783548|pediatric subjects|pediatric subjects
4966957|NCT01783548|BDP nasal aerosol|bdp nasal aerosol
4966958|NCT01783535|intraocular retinoblastoma|intraocular retinoblastoma
4967058|NCT01783080|Unemployment|unemployment
4967455|NCT01781169|Vitamin D,|vitamin d,
4966959|NCT01783509|GENETICALLY CONFIRMED limb girdle muscular dystrophy|genetically confirmed limb girdle muscular dystrophy
4966960|NCT01783483|CABG|cabg
4966961|NCT01783483|Valve replacement|valve replacement
4966962|NCT01783483|sternal closure|sternal closure
4966963|NCT01783483|midline sternotomy|midline sternotomy
4966964|NCT01783483|sternal plates|sternal plates
4966965|NCT01783470|adipose tissue, brown|adipose tissue, brown
4966966|NCT01783470|obesity|obesity
4966967|NCT01783470|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists
4966968|NCT01783470|thermogenesis|thermogenesis
4966969|NCT01783470|metabolism|metabolism
4966970|NCT01783457|First psychotic episode|first psychotic episode
4966971|NCT01783457|Individual psychoeducation|individual psychoeducation
4966972|NCT01783457|Telemedicine|telemedicine
4966973|NCT01783457|BDNF|bdnf
4966974|NCT01783457|Oxidative stress|oxidative stress
4966975|NCT01783444|Estrogen receptor positive, locally advanced, metastatic breast cancer|estrogen receptor positive, locally advanced, metastatic breast cancer
4966976|NCT01783418|mindfulness-based meditation|mindfulness-based meditation
4966977|NCT01783418|pediatric cancer|pediatric cancer
4966978|NCT01783418|adolescence|adolescence
4966979|NCT01783418|quality of life|quality of life
4966980|NCT01783418|sleep|sleep
4966981|NCT01783418|affect|affect
4966982|NCT01783418|health psychology|health psychology
4966983|NCT01783405|LDLR mutation|ldlr mutation
4966984|NCT01783405|Statin|statin
4966985|NCT01783405|Cardiovascular disease|cardiovascular disease
4966986|NCT01783392|overactive bladder|overactive bladder
4966987|NCT01783392|transcutaneous posterior tibial nerve stimulation|transcutaneous posterior tibial nerve stimulation
4966988|NCT01783392|placebo PTNS|placebo ptns
4966989|NCT01783379|invasive fungal infection|invasive fungal infection
4966990|NCT01783379|micafungin|micafungin
4966991|NCT01783379|intensive care|intensive care
4966992|NCT01783379|pharmacokinetics|pharmacokinetics
4966993|NCT01783366|nasogastric tube, tube exchange catheter|nasogastric tube, tube exchange catheter
4966994|NCT01783353|Recalcitrant cutaneous warts|recalcitrant cutaneous warts
4966995|NCT01783353|verruca|verruca
4966996|NCT01783340|Malaria|malaria
4966997|NCT01783340|P falciparum|p falciparum
4966998|NCT01783340|Chloroquine|chloroquine
4966999|NCT01783340|Azithromycin|azithromycin
4967000|NCT01783340|Immunization|immunization
4967001|NCT01783327|Diabetes Mellitus, Type 1|diabetes mellitus, type 1
4967002|NCT01783327|Self care|self care
4967003|NCT01783327|Coping skills|coping skills
4967004|NCT01783327|Adolescent|adolescent
4967005|NCT01783327|Internet|internet
4967006|NCT01783327|Intervention Studies|intervention studies
4967007|NCT01783327|Chronic Disease|chronic disease
4967008|NCT01783314|hepatic fibrosis|hepatic fibrosis
4967010|NCT01783314|gadoxetate disodium|gadoxetate disodium
4967011|NCT01783314|biomarker|biomarker
4967012|NCT01783314|liver biopsy|liver biopsy
4967013|NCT01783314|liver function|liver function
4967014|NCT01783314|MRI|mri
4967015|NCT01783314|Hepatitis C|hepatitis c
4967016|NCT01783301|follicle stimulating hormone|follicle stimulating hormone
4967017|NCT01783301|ovarian stimulation|ovarian stimulation
4967018|NCT01783301|antimullerian hormone|antimullerian hormone
4967019|NCT01783301|antral follicle count|antral follicle count
4967020|NCT01783301|assisted reproductive technologies|assisted reproductive technologies
4967021|NCT01783288|Postural tachycardia syndrome|postural tachycardia syndrome
4967022|NCT01783288|orthostatic intolerance|orthostatic intolerance
4967023|NCT01783288|orthostatic tachycardia|orthostatic tachycardia
4967024|NCT01783288|POTS|pots
4967025|NCT01783275|Obesity|obesity
4967026|NCT01783275|Type 2 diabetes|type 2 diabetes
4967027|NCT01783275|Liver|liver
4967028|NCT01783236|VATS|vats
4967029|NCT01783236|thoracic surgery|thoracic surgery
4967030|NCT01783236|acetaminophen|acetaminophen
4967031|NCT01783236|ofirmev|ofirmev
4967032|NCT01783236|lung surgery|lung surgery
4967033|NCT01783236|thoracoscopic|thoracoscopic
4967034|NCT01783236|intravenous acetaminophen|intravenous acetaminophen
4967035|NCT01783158|head and neck carcinoma|head and neck carcinoma
4967036|NCT01783158|chromoendoscopy|chromoendoscopy
4967037|NCT01783158|Lugol's solution|lugol's solution
4967038|NCT01783158|esophageal carcinoma|esophageal carcinoma
4967039|NCT01783158|synchronous tumors|synchronous tumors
4967040|NCT01783158|deglutition|deglutition
4967041|NCT01783158|deglutition disorders|deglutition disorders
4967042|NCT01783158|Newly diagnosed HNSCC|newly diagnosed hnscc
4967043|NCT01783145|survivorship care|survivorship care
4967044|NCT01783145|testicular cancer|testicular cancer
4967045|NCT01783145|shared care model|shared care model
4967046|NCT01783119|Ulcerative Colitis|ulcerative colitis
4967047|NCT01783119|Aloe Vera|aloe vera
4967048|NCT01783106|Crohn's|crohn's
4967049|NCT01783106|antibiotics|antibiotics
4967050|NCT01783106|hydroxychloroquine|hydroxychloroquine
4967051|NCT01783106|ciprofloxacin|ciprofloxacin
4967052|NCT01783106|doxycycline|doxycycline
4967053|NCT01783080|Chronic depression|chronic depression
4967054|NCT01783080|Dysthymic disorder|dysthymic disorder
4967055|NCT01783080|Double Depression|double depression
4967056|NCT01783080|Behavioral Activation therapy|behavioral activation therapy
4967057|NCT01783080|Work impairment|work impairment
4967059|NCT01783067|Biofortification|biofortification
4967060|NCT01783067|Pearl millet|pearl millet
4967061|NCT01783067|Iron absorption|iron absorption
4967062|NCT01783067|Zinc absorption|zinc absorption
4967063|NCT01783054|NEOADJUVANT GEMCITABINE AND ABRAXANE CHEMOTHERAPY|neoadjuvant gemcitabine and abraxane chemotherapy
4967064|NCT01783054|SURGERY|surgery
4967065|NCT01783054|RESECTABLE ADENOCARCINOMA OF THE PANCREAS|resectable adenocarcinoma of the pancreas
4967066|NCT01783041|Prematurity|prematurity
4967067|NCT01783041|Carnitine supplementation|carnitine supplementation
4967068|NCT01783041|Neonatal Intensive Care|neonatal intensive care
4967069|NCT01783041|MRI|mri
4967070|NCT01783041|Amplitude-integrated EEG|amplitude-integrated eeg
4967071|NCT01783041|NICU Network Neurobehavioral Scale|nicu network neurobehavioral scale
4967072|NCT01783041|Bayley Scale of Infant Development III|bayley scale of infant development iii
4967073|NCT01783028|asthma|asthma
4967074|NCT01783015|Rheumatoid arthritis|rheumatoid arthritis
4967075|NCT01783015|etanercept|etanercept
4967076|NCT01783015|methotrexate|methotrexate
4967077|NCT01783015|infliximab|infliximab
4967078|NCT01783015|adalimumab|adalimumab
4967079|NCT01783015|anti-drug antibody|anti-drug antibody
4967080|NCT01782989|geographic atrophy|geographic atrophy
4967081|NCT01782989|non-exudative age-related macular degeneration|non-exudative age-related macular degeneration
4967082|NCT01782989|macular degeneration|macular degeneration
4967083|NCT01782989|dry macular degeneration|dry macular degeneration
4967084|NCT01782989|dry AMD|dry amd
4967085|NCT01782976|Glioblastoma|glioblastoma
4967086|NCT01782976|GBM|gbm
4967087|NCT01782976|Intracranial glioblastoma|intracranial glioblastoma
4967088|NCT01782976|Recurrent|recurrent
4967089|NCT01782976|MD Anderson Symptom Inventory for Brain Tumors|md anderson symptom inventory for brain tumors
4967090|NCT01782976|MDASI-BT|mdasi-bt
4967091|NCT01782976|Questionnaire|questionnaire
4967092|NCT01782976|Survey|survey
4967093|NCT01782963|Newly diagnosed|newly diagnosed
4967094|NCT01782950|HIV|hiv
4967095|NCT01782950|Tuberculosis|tuberculosis
4967096|NCT01782950|Antituberculosis drugs|antituberculosis drugs
4967097|NCT01782911|Androgen|androgen
4967098|NCT01782911|IVF|ivf
4967099|NCT01782911|Resveratrol|resveratrol
4967100|NCT01782911|PCOS.|pcos.
4967101|NCT01782898|Anesthesia|anesthesia
4967102|NCT01782898|MEDOC neuro sensory analyzer|medoc neuro sensory analyzer
4967103|NCT01782898|Pain|pain
4967104|NCT01782898|Quality of recovery|quality of recovery
4967105|NCT01782885|Osteoarthritis|osteoarthritis
4967106|NCT01782885|Platelet-Rich Plasma|platelet-rich plasma
4967107|NCT01782885|Intra-articular|intra-articular
4967108|NCT01782885|Injection|injection
4967109|NCT01782807|Ovarian function|ovarian function
4967110|NCT01782807|Hysterectomy|hysterectomy
4967111|NCT01782807|Salpingectomy|salpingectomy
4967112|NCT01782807|Anti mullerian hormone|anti mullerian hormone
4967113|NCT01782794|Vaccination|vaccination
4967114|NCT01782794|Acceptability|acceptability
4967115|NCT01782794|General population|general population
4967116|NCT01782794|Hepatitis B|hepatitis b
4967117|NCT01782794|Vaccine coverage|vaccine coverage
4967118|NCT01782781|Analgesia|analgesia
4967119|NCT01782781|Local infiltration analgesia|local infiltration analgesia
4967120|NCT01782781|Pain, relief|pain, relief
4967121|NCT01782781|Pain, Postoperative|pain, postoperative
4967122|NCT01782781|Ropivacaine|ropivacaine
4967123|NCT01782781|Ketorolac|ketorolac
4967124|NCT01782781|Epinephrine|epinephrine
4967125|NCT01782781|Adrenergic Agonists|adrenergic agonists
4967126|NCT01782781|Sympathomimetics|sympathomimetics
4967127|NCT01782781|Therapeutic Uses|therapeutic uses
4967128|NCT01782781|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal
4967129|NCT01782781|Analgesics, Non-Narcotic|analgesics, non-narcotic
4967130|NCT01782781|Analgesics|analgesics
4967131|NCT01782781|Opioids|opioids
4967132|NCT01782781|Morphine|morphine
4967133|NCT01782781|Pain|pain
4967134|NCT01782781|Postoperative Complications|postoperative complications
4967135|NCT01782781|Physiological Effects of Drugs|physiological effects of drugs
4967136|NCT01782781|Anesthetics, Local|anesthetics, local
4967137|NCT01782781|Anesthetics|anesthetics
4967138|NCT01782768|Neural respiratory drive in different level of NPPV|neural respiratory drive in different level of nppv
4967139|NCT01782755|Probiotics|probiotics
4967140|NCT01782755|Ventilator Associated Pneumonia (VAP)|ventilator associated pneumonia (vap)
4967141|NCT01782755|Infection|infection
4967142|NCT01782755|Antibiotic-Associated Diarrhea|antibiotic-associated diarrhea
4967143|NCT01782755|C-Difficile|c-difficile
4967144|NCT01782742|Mild to Moderate Alzheimer's Disease|mild to moderate alzheimer's disease
4967145|NCT01782729|Dermatitis, Atopic|dermatitis, atopic
4967146|NCT01782729|Tacrolimus|tacrolimus
4967147|NCT01782716|Mortality|mortality
4967148|NCT01782716|Length|length
4967149|NCT01782716|hospitalization|hospitalization
4967150|NCT01782716|cardiac surgery|cardiac surgery
4967151|NCT01782716|patients|patients
4967152|NCT01782703|Atopic Dermatitis|atopic dermatitis
4967153|NCT01782703|Filaggrin|filaggrin
4967154|NCT01782703|Biomarkers|biomarkers
4967155|NCT01782703|Eczema|eczema
4967156|NCT01782664|PASI|pasi
4967157|NCT01782664|DLQI|dlqi
4967158|NCT01782664|GSK2586184|gsk2586184
4967159|NCT01782664|plaque-type psoriasis|plaque-type psoriasis
4967160|NCT01782664|PGA|pga
4967161|NCT01782664|inflammatory gene transcription|inflammatory gene transcription
4967162|NCT01782664|JAK-1 inhibitor|jak-1 inhibitor
4967163|NCT01782664|serum neopterin|serum neopterin
4967164|NCT01782664|skin biopsy|skin biopsy
4967165|NCT01782664|ACR response criteria|acr response criteria
4967166|NCT01782664|VAS itch score|vas itch score
4967167|NCT01782651|HER2 positive|her2 positive
4967168|NCT01782651|Breast Cancer|breast cancer
4967169|NCT01782651|treatment patterns|treatment patterns
4967170|NCT01782638|Parkinson's disease|parkinson's disease
4967171|NCT01782638|Deep brain stimulation|deep brain stimulation
4967172|NCT01782638|Gait|gait
4967173|NCT01782638|Freezing|freezing
4967174|NCT01782638|Electrode placements|electrode placements
4967175|NCT01782625|diving|diving
4967176|NCT01782625|cognitive impairment|cognitive impairment
4967177|NCT01782625|nitrogen narcosis|nitrogen narcosis
4967178|NCT01782625|narcosis|narcosis
4967179|NCT01782625|end tidal carbon dioxide|end tidal carbon dioxide
4967180|NCT01782625|arterial carbon dioxide|arterial carbon dioxide
4967181|NCT01782625|immersion|immersion
4967182|NCT01782612|Balanced Anesthesia|balanced anesthesia
4967183|NCT01782612|Nerve Block|nerve block
4967184|NCT01782612|Postoperative Recovery|postoperative recovery
4967185|NCT01782612|Delirium|delirium
4967186|NCT01782612|Postoperative Complications|postoperative complications
4967187|NCT01782612|Stress|stress
4967188|NCT01782612|Inflammation|inflammation
4967189|NCT01782586|kidney transplant|kidney transplant
4967190|NCT01782586|gene expression markers|gene expression markers
4967191|NCT01782586|renal allograft function|renal allograft function
4967192|NCT01782573|pre - disinfection scrubbing solution|pre - disinfection scrubbing solution
4967193|NCT01782573|surgical site culture|surgical site culture
4967194|NCT01782573|surgical site infection|surgical site infection
4967195|NCT01782573|liver tumors|liver tumors
4967196|NCT01782573|hepatectomy|hepatectomy
4967197|NCT01782573|chlorhexidine gluconate|chlorhexidine gluconate
4967198|NCT01782560|Laryngomalacia|laryngomalacia
4967199|NCT01782560|Acid-reflux|acid-reflux
4967200|NCT01782547|diabetes mellitus|diabetes mellitus
4967201|NCT01782547|adolescents|adolescents
4967202|NCT01782521|Bracket failure rate|bracket failure rate
4967203|NCT01782521|Orthodontic bonding|orthodontic bonding
4967204|NCT01782521|Primer|primer
4967205|NCT01782508|melanoma,adjuvant therapy,kit mutated melanoma|melanoma,adjuvant therapy,kit mutated melanoma
4967206|NCT01782495|Hepatitis C Genotype 4|hepatitis c genotype 4
4967207|NCT01782495|Chronic Hepatitis|chronic hepatitis
4967208|NCT01782495|Interferon-Free|interferon-free
4967209|NCT01782495|Hepatitis C Virus (HCV)|hepatitis c virus (hcv)
4967210|NCT01782495|Renal Transplant|renal transplant
4967211|NCT01782495|Liver Transplant|liver transplant
4967212|NCT01782495|Hepatitis C Genotype 1|hepatitis c genotype 1
4967213|NCT01782482|Color contact lenses|color contact lenses
4967214|NCT01782482|Refractive error|refractive error
4967215|NCT01782482|Myopia|myopia
4967216|NCT01782469|Synovitis|synovitis
4967217|NCT01782469|Rheumatoid Arthritis|rheumatoid arthritis
4967218|NCT01782443|Progressive|progressive
4967219|NCT01782443|Metastatic|metastatic
4967220|NCT01782430|Preoxygenation|preoxygenation
4967221|NCT01782430|Intubation|intubation
4967222|NCT01782417|osteoarthritis|osteoarthritis
4967223|NCT01782417|Hispanic|hispanic
4967224|NCT01782417|behavior|behavior
4967225|NCT01782417|intervention|intervention
4967226|NCT01782417|Spanish|spanish
4967227|NCT01782391|mild cognitive impairment|mild cognitive impairment
4967228|NCT01782391|dementia|dementia
4967229|NCT01782391|MCI|mci
4967230|NCT01782391|brain stimulation|brain stimulation
4967231|NCT01782391|tSOS|tsos
4967232|NCT01782391|tDCS|tdcs
4967233|NCT01782391|sleep|sleep
4967234|NCT01782391|memory|memory
4967235|NCT01782391|memory consolidation|memory consolidation
4967236|NCT01782378|Persian Gulf Syndrome|persian gulf syndrome
4967237|NCT01782378|Veterans Health|veterans health
4967238|NCT01782378|Executive Function|executive function
4967239|NCT01782378|Memory|memory
4967240|NCT01782378|Attention|attention
4967241|NCT01782378|Cognition|cognition
4967242|NCT01782378|Laser Therapy, Low-Level|laser therapy, low-level
4967243|NCT01782378|Phototherapy|phototherapy
4967244|NCT01782378|Light Therapy|light therapy
4967245|NCT01782378|Depression|depression
4967246|NCT01782365|mild cognitive impairment|mild cognitive impairment
4967247|NCT01782365|dementia|dementia
4967248|NCT01782365|MCI|mci
4967249|NCT01782365|brain stimulation|brain stimulation
4967250|NCT01782365|tSOS|tsos
4967251|NCT01782365|tDCS|tdcs
4967252|NCT01782365|sleep|sleep
4967253|NCT01782365|nap|nap
4967254|NCT01782365|daytime sleep|daytime sleep
4967255|NCT01782365|memory|memory
4967256|NCT01782365|memory consolidation|memory consolidation
4967257|NCT01782352|age-related macular degeneration|age-related macular degeneration
4967258|NCT01782352|incidence|incidence
4967259|NCT01782352|progression|progression
4967356|NCT01781728|residual|residual
4967357|NCT01781728|stereotactic body radiation therapy (SBRT)|stereotactic body radiation therapy (sbrt)
4967260|NCT01782326|COPD, QVA149, FLAME( EFfect of Indacaterol Glycopyronium Vs Fluticasone salmeterol on COPD Exacerbations)|copd, qva149, flame( effect of indacaterol glycopyronium vs fluticasone salmeterol on copd exacerbations)
4967261|NCT01782287|Neoplasm Metastasis|neoplasm metastasis
4967262|NCT01782287|Brain metastasis|brain metastasis
4967263|NCT01782287|Lung cancer|lung cancer
4967264|NCT01782274|Neoplasm Metastasis|neoplasm metastasis
4967265|NCT01782274|Brain metastasis|brain metastasis
4967266|NCT01782274|Breast cancer|breast cancer
4967267|NCT01782261|autoimmune disease|autoimmune disease
4967268|NCT01782261|diabetes type 1|diabetes type 1
4967269|NCT01782261|incretin effect|incretin effect
4967270|NCT01782222|Parkinson's Disease|parkinson's disease
4967271|NCT01782222|Rotigotine|rotigotine
4967272|NCT01782222|Apathy|apathy
4967273|NCT01782222|Nonmotor|nonmotor
4967274|NCT01782222|Motor|motor
4967275|NCT01782222|Neupro|neupro
4967276|NCT01782209|BK virus viremia|bk virus viremia
4967277|NCT01782209|renal transplant|renal transplant
4967278|NCT01782209|other viral pathogens|other viral pathogens
4967279|NCT01782183|sore throat|sore throat
4967280|NCT01782183|thermal camera photo|thermal camera photo
4967281|NCT01782183|normal tonsils and pharynx|normal tonsils and pharynx
4967282|NCT01782183|redness of tonsils and/or pharynx|redness of tonsils and/or pharynx
4967283|NCT01782183|exudates on tonsils|exudates on tonsils
4967284|NCT01782183|petechiae of the palate|petechiae of the palate
4967285|NCT01782170|Gingivitis|gingivitis
4967286|NCT01782170|Biomarkers|biomarkers
4967287|NCT01782170|Biological Markers of Inflammation|biological markers of inflammation
4967288|NCT01782157|dementia|dementia
4967289|NCT01782144|Obesity|obesity
4967290|NCT01782144|Foot pain|foot pain
4967291|NCT01782105|weight gain|weight gain
4967292|NCT01782105|healthy lifestyle|healthy lifestyle
4967293|NCT01782105|gestational diabetes|gestational diabetes
4967294|NCT01782105|adipokins|adipokins
4967295|NCT01782105|glycemic regulation|glycemic regulation
4967296|NCT01782092|diabetes|diabetes
4967297|NCT01782079|Lactobacillus brevis|lactobacillus brevis
4967298|NCT01782079|Oral health|oral health
4967299|NCT01782079|Bacterial adhesion|bacterial adhesion
4967300|NCT01782040|Premenstrual syndrome|premenstrual syndrome
4967301|NCT01782040|Physical distress|physical distress
4967302|NCT01782040|Behavioral changes|behavioral changes
4967303|NCT01782027|healthy controls|healthy controls
4967304|NCT01782027|Tangier Disease|tangier disease
4967305|NCT01782027|Adenosine triphosphate-binding cassette transporter 1 (ABCA1)|adenosine triphosphate-binding cassette transporter 1 (abca1)
4967306|NCT01782027|apoA-I|apoa-i
4967307|NCT01782027|LCAT deficiency|lcat deficiency
4967308|NCT01782027|Scavenger receptor BI (SRBI) deficiency|scavenger receptor bi (srbi) deficiency
4967309|NCT01782027|CETP deficiency|cetp deficiency
4967310|NCT01782014|Screening colonoscopy|screening colonoscopy
4967311|NCT01782014|Water method|water method
4967312|NCT01782014|Carbon dioxide method|carbon dioxide method
4967313|NCT01782014|Air method|air method
4967314|NCT01782014|Water versus carbon dioxide versus air insufflation colonoscopy|water versus carbon dioxide versus air insufflation colonoscopy
4967315|NCT01782014|Adenoma Detection Rate|adenoma detection rate
4967316|NCT01782014|Pain Scores in colonoscopy|pain scores in colonoscopy
4967317|NCT01782001|Vitamin A|vitamin a
4967318|NCT01782001|Zinc|zinc
4967319|NCT01782001|Malaria|malaria
4967320|NCT01782001|Morbidity|morbidity
4967321|NCT01782001|MRDR|mrdr
4967322|NCT01781988|lung cancer|lung cancer
4967323|NCT01781988|gemcitabine|gemcitabine
4967324|NCT01781988|carboplatin|carboplatin
4967325|NCT01781988|pemetrexed|pemetrexed
4967326|NCT01781949|HIV infection|hiv infection
4967327|NCT01781949|Targeted screening|targeted screening
4967328|NCT01781949|Nontargeted screening|nontargeted screening
4967329|NCT01781949|Emergency department|emergency department
4967330|NCT01781949|Urgent care|urgent care
4967331|NCT01781949|Effectiveness|effectiveness
4967332|NCT01781923|Cognitive remediation|cognitive remediation
4967333|NCT01781923|Social Cognition|social cognition
4967334|NCT01781910|branched chain amino acids, exercise, delayed onset muscle soreness|branched chain amino acids, exercise, delayed onset muscle soreness
4967335|NCT01781897|acupuncture|acupuncture
4967336|NCT01781897|electro-acupuncture|electro-acupuncture
4967337|NCT01781871|Pneumococcal vaccination|pneumococcal vaccination
4967338|NCT01781871|immunogenicity|immunogenicity
4967339|NCT01781871|solid organ transplant|solid organ transplant
4967340|NCT01781858|Pulmonary embolism|pulmonary embolism
4967341|NCT01781858|Chronic thromboembolic pulmonary hypertension|chronic thromboembolic pulmonary hypertension
4967342|NCT01781858|Venous thromboembolism|venous thromboembolism
4967343|NCT01781793|dyspnea, exercise endurance, lung disease|dyspnea, exercise endurance, lung disease
4967344|NCT01781780|Obesity|obesity
4967345|NCT01781780|Weight Loss|weight loss
4967346|NCT01781780|Breakfast|breakfast
4967347|NCT01781767|UCP2|ucp2
4967348|NCT01781767|Thyroid function|thyroid function
4967349|NCT01781767|Thyroid carcinoma|thyroid carcinoma
4967350|NCT01781754|Glycemic control|glycemic control
4967351|NCT01781754|Metabolic control|metabolic control
4967352|NCT01781754|Oxidative stress|oxidative stress
4967353|NCT01781754|Diabetes|diabetes
4967354|NCT01781728|recurrent|recurrent
4967355|NCT01781728|unresectable|unresectable
4967358|NCT01781728|palliative management|palliative management
4967359|NCT01781715|STEMI, Multivessel Coronary Artery Disease, Primary PCI, multivessel stenting, zotarolimus-eluting stent|stemi, multivessel coronary artery disease, primary pci, multivessel stenting, zotarolimus-eluting stent
4967360|NCT01781689|cortical activation|cortical activation
4967361|NCT01781689|motor function|motor function
4967362|NCT01781689|activity of daily living|activity of daily living
4967363|NCT01781650|Warm Water Infusion colonoscopy|warm water infusion colonoscopy
4967364|NCT01781650|Water Immersion colonoscopy|water immersion colonoscopy
4967365|NCT01781650|Water Exchange colonoscopy|water exchange colonoscopy
4967366|NCT01781650|Painless unsedated colonoscopy|painless unsedated colonoscopy
4967367|NCT01781650|Adenoma detection rate|adenoma detection rate
4967368|NCT01781650|Adenoma resection rate|adenoma resection rate
4967369|NCT01781637|Xolair|xolair
4967370|NCT01781637|omalizumab|omalizumab
4967371|NCT01781637|peanut|peanut
4967372|NCT01781637|oral desensitization|oral desensitization
4967373|NCT01781611|lupus|lupus
4967374|NCT01781611|dipyridamole|dipyridamole
4967375|NCT01781598|Total knee arthroplasty|total knee arthroplasty
4967376|NCT01781598|Patient specific instruments|patient specific instruments
4967377|NCT01781598|Patient matched cutting blocks|patient matched cutting blocks
4967378|NCT01781598|Alignment|alignment
4967379|NCT01781598|Learning curve|learning curve
4967380|NCT01781598|VISIONAIRE|visionaire
4967381|NCT01781585|Sustained low-efficiency dialysis;|sustained low-efficiency dialysis;
4967382|NCT01781585|Continuous venovenous hemofiltration;|continuous venovenous hemofiltration;
4967383|NCT01781585|hemodynamic stability,|hemodynamic stability,
4967384|NCT01781585|Intracranial pressure|intracranial pressure
4967385|NCT01781546|drug eluting balloon|drug eluting balloon
4967386|NCT01781546|bare metal stent|bare metal stent
4967387|NCT01781546|coronary artery disease|coronary artery disease
4967388|NCT01781546|acute coronary syndrome|acute coronary syndrome
4967389|NCT01781546|percutaneous coronary intervention|percutaneous coronary intervention
4967390|NCT01781546|DEB|deb
4967391|NCT01781546|BMS|bms
4967392|NCT01781520|Pancreatic Cancer|pancreatic cancer
4967393|NCT01781520|S1|s1
4967394|NCT01781520|DC-CIK|dc-cik
4967395|NCT01781507|Asthma|asthma
4967396|NCT01781507|Allergic rhinitis|allergic rhinitis
4967397|NCT01781507|Cetirizine|cetirizine
4967398|NCT01781507|Impulse oscillometry|impulse oscillometry
4967399|NCT01781481|Psychosocial Stress and Adjustment|psychosocial stress and adjustment
4967400|NCT01781481|Pediatric Chronic Illness|pediatric chronic illness
4967401|NCT01781481|Decision-support tool|decision-support tool
4967402|NCT01781481|Integrated Health Care|integrated health care
4967403|NCT01781481|Case Complexity|case complexity
4967404|NCT01781442|Metastatic Renal Cell Carcinoma|metastatic renal cell carcinoma
4967405|NCT01781416|cardiovascular risk|cardiovascular risk
4967406|NCT01781416|SCORE|score
4967407|NCT01781416|cardiovascular primary prevention|cardiovascular primary prevention
4967408|NCT01781416|risk factors|risk factors
4967409|NCT01781403|Temozolomide|temozolomide
4967410|NCT01781403|capecitabine|capecitabine
4967411|NCT01781403|rectal cancer|rectal cancer
4967412|NCT01781390|Acute Myocardial Infarction|acute myocardial infarction
4967413|NCT01781390|STEMI|stemi
4967414|NCT01781390|Heart Attack|heart attack
4967415|NCT01781390|AMI|ami
4967416|NCT01781390|Stem Cells|stem cells
4967417|NCT01781377|NAUSEA|nausea
4967418|NCT01781377|VOMITING|vomiting
4967419|NCT01781377|CESAREAN SECTION|cesarean section
4967420|NCT01781377|PREVENTION|prevention
4967421|NCT01781377|PROPOFOL|propofol
4967422|NCT01781364|Brain Oscillations|brain oscillations
4967423|NCT01781364|Cognitive Performance|cognitive performance
4967424|NCT01781325|musculoskeletal, physical therapy|musculoskeletal, physical therapy
4967425|NCT01781299|Breast Cancer|breast cancer
4967426|NCT01781299|Mastectomy|mastectomy
4967427|NCT01781299|Immediate reconstruction|immediate reconstruction
4967428|NCT01781286|Obesity|obesity
4967429|NCT01781286|Snacking|snacking
4967430|NCT01781286|Appetite|appetite
4967431|NCT01781286|Protein|protein
4967432|NCT01781286|Soy|soy
4967433|NCT01781286|Reward driven eating|reward driven eating
4967434|NCT01781286|Satiety|satiety
4967435|NCT01781273|impaired driving|impaired driving
4967436|NCT01781260|Prone position|prone position
4967437|NCT01781260|Cardiac output|cardiac output
4967438|NCT01781260|Liver Circulation|liver circulation
4967439|NCT01781247|Stress Disorders, Post-Traumatic|stress disorders, post-traumatic
4967440|NCT01781247|Myocardial Infarction|myocardial infarction
4967441|NCT01781247|Psychotherapy|psychotherapy
4967442|NCT01781247|Preventive Therapy|preventive therapy
4967443|NCT01781247|Randomized Controlled Trial|randomized controlled trial
4967444|NCT01781247|Cardiovascular Diseases|cardiovascular diseases
4967445|NCT01781247|Psychological Stress|psychological stress
4967446|NCT01781247|Biomarkers|biomarkers
4967447|NCT01781195|Advagraf|advagraf
4967448|NCT01781195|MELD-score|meld-score
4967449|NCT01781195|Na-MELD-score|na-meld-score
4967450|NCT01781195|liver function|liver function
4967451|NCT01781195|LiMAx-test|limax-test
4967452|NCT01781195|infection rate|infection rate
4967453|NCT01781195|HLA-DR status|hla-dr status
4967454|NCT01781195|immunostatus|immunostatus
4967456|NCT01781169|Oral supplementation,|oral supplementation,
4967457|NCT01781169|Obese males|obese males
4967458|NCT01781156|phosphorus|phosphorus
4967459|NCT01781156|hemodialysis|hemodialysis
4967460|NCT01781156|cardiac biomarkers|cardiac biomarkers
4967461|NCT01781117|Benign prostatic obstruction (BPO)|benign prostatic obstruction (bpo)
4967462|NCT01781117|Detrusor overactivity (DO)|detrusor overactivity (do)
4967463|NCT01781117|Urinary nerve growth factor (NGF)|urinary nerve growth factor (ngf)
4967464|NCT01781104|constipation gastric emptying gastrointestinal motility ghrelin|constipation gastric emptying gastrointestinal motility ghrelin
4967465|NCT01781078|Single chamber pacing|single chamber pacing
4967466|NCT01781078|Dual chamber pacing|dual chamber pacing
4967467|NCT01781078|MRI|mri
4967468|NCT01781078|MR scans|mr scans
4967469|NCT01781052|Iloprost Compliance|iloprost compliance
4967470|NCT01781039|"hair cell"|"hair cell"
4967471|NCT01781039|"hearing aid"|"hearing aid"
4967472|NCT01781039|"hearing loss"|"hearing loss"
4967473|NCT01781039|"auditory nerve"|"auditory nerve"
4967474|NCT01781039|synaptopathy|synaptopathy
4967475|NCT01781026|B-raf V600E|b-raf v600e
4967476|NCT01781026|V600K mutation|v600k mutation
4967477|NCT01781026|metastatic melanoma|metastatic melanoma
4967478|NCT01781013|Depression screening|depression screening
4967479|NCT01781013|Depression monitoring|depression monitoring
4967480|NCT01781013|Chronic illness|chronic illness
4967481|NCT01781013|Behavioral health|behavioral health
4967482|NCT01781013|Care management|care management
4967483|NCT01781013|Automatic telephone assessment|automatic telephone assessment
4967484|NCT01781013|Clinical decision support|clinical decision support
4967485|NCT01781013|Suicide alert|suicide alert
4967486|NCT01781000|Cognitive Training|cognitive training
4967487|NCT01781000|Neuroplasticity|neuroplasticity
4967488|NCT01781000|MEG|meg
4967489|NCT01781000|MATRICS|matrics
4967490|NCT01780987|DVT|dvt
4967491|NCT01780987|PE|pe
4967492|NCT01780987|VTE|vte
4967493|NCT01780974|Hypertension|hypertension
4967494|NCT01780974|Vascular Risk|vascular risk
4967495|NCT01780974|Alzheimer's Risk|alzheimer's risk
4967496|NCT01780974|fish oil|fish oil
4967497|NCT01780974|Lipoic acid|lipoic acid
4967498|NCT01780961|Esophageal Cancer|esophageal cancer
4967499|NCT01780961|ESBX|esbx
4967500|NCT01780948|Drug Interaction|drug interaction
4967501|NCT01780948|Pharmacokinetics|pharmacokinetics
4967502|NCT01780948|Everolimus|everolimus
4967503|NCT01780948|Atorvastatin|atorvastatin
4967504|NCT01780922|Inflammation|inflammation
4967505|NCT01780922|Oxidative Stress|oxidative stress
4967506|NCT01780922|Vaccinium macrocarpon|vaccinium macrocarpon
4967507|NCT01780896|Topographical Memory|topographical memory
4967508|NCT01780896|Non-Topographical Memory|non-topographical memory
4967509|NCT01780896|Vestibular Function|vestibular function
4967510|NCT01780896|Alzheimer's Disease|alzheimer's disease
4967511|NCT01780883|melatonin|melatonin
4967512|NCT01780883|childhood autism|childhood autism
4967513|NCT01780883|6-Sulphatoxymelatonin|6-sulphatoxymelatonin
4967514|NCT01780883|autistic disorder|autistic disorder
4967515|NCT01780883|dose-effect relation|dose-effect relation
4967516|NCT01780870|Overweight|overweight
4967517|NCT01780870|Obesity|obesity
4967518|NCT01780870|Obese|obese
4967519|NCT01780870|Weight loss|weight loss
4967520|NCT01780857|palmoplantar pustulosis|palmoplantar pustulosis
4967521|NCT01780857|psoriasis|psoriasis
4967522|NCT01780844|Kidney Transplantation|kidney transplantation
4967523|NCT01780844|de novo Kidney Transplantation|de novo kidney transplantation
4967524|NCT01780844|ASKP1240|askp1240
4967525|NCT01780818|Warm Water Infusion colonoscopy|warm water infusion colonoscopy
4967526|NCT01780818|Water Immersion colonoscopy|water immersion colonoscopy
4967527|NCT01780818|Water Exchange colonoscopy|water exchange colonoscopy
4967528|NCT01780818|Painless unsedated colonoscopy|painless unsedated colonoscopy
4967529|NCT01780818|Adenoma detection rate|adenoma detection rate
4967530|NCT01780818|Adenoma resection rate|adenoma resection rate
4967531|NCT01780792|multiple sclerosis|multiple sclerosis
4967532|NCT01780792|mobility|mobility
4967533|NCT01780792|cognition|cognition
4967534|NCT01780792|neuroplasticity|neuroplasticity
4967535|NCT01780792|videogame play|videogame play
4967536|NCT01780779|Diffusion weighted MRI|diffusion weighted mri
4967537|NCT01780779|Patient outcome assessment|patient outcome assessment
4967538|NCT01780779|Treatment response|treatment response
4967539|NCT01780779|Histopathology|histopathology
4967540|NCT01780766|Whole body MRI|whole body mri
4967541|NCT01780766|Multiple myeloma|multiple myeloma
4967542|NCT01780766|Diffusion Weighted MRI|diffusion weighted mri
4967543|NCT01780766|Whole body scan|whole body scan
4967544|NCT01780753|Primaquine|primaquine
4967545|NCT01780753|Vivax malaria|vivax malaria
4967546|NCT01780753|G6PD|g6pd
4967547|NCT01780740|Bypass Surgery, Coronary Artery|bypass surgery, coronary artery
4967548|NCT01780740|Atrial fibrillation|atrial fibrillation
4967549|NCT01780740|Ischaemia-reperfusion injury|ischaemia-reperfusion injury
4967550|NCT01780740|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors
4967551|NCT01780740|Statins, HMG-CoA|statins, hmg-coa
4967552|NCT01780727|echocardiography|echocardiography
4967553|NCT01780727|hemodynamic management|hemodynamic management
4967554|NCT01780714|smoking|smoking
4967555|NCT01780714|cigarette|cigarette
4967556|NCT01780714|exposure|exposure
4967557|NCT01780714|biomarker|biomarker
4967558|NCT01780714|human smoking topography (HST)|human smoking topography (hst)
4967559|NCT01780714|modified risk tobacco product (MRTP)|modified risk tobacco product (mrtp)
4967560|NCT01780714|THS 2.1|ths 2.1
4967561|NCT01780701|prostate cancer aggressiveness|prostate cancer aggressiveness
4967562|NCT01780701|magnetic resonance imaging|magnetic resonance imaging
4967563|NCT01780701|fatty acid synthase|fatty acid synthase
4967564|NCT01780688|Modified risk tobacco product (MRTP)|modified risk tobacco product (mrtp)
4967565|NCT01780688|Smoking|smoking
4967566|NCT01780688|Nicotine profile|nicotine profile
4967567|NCT01780675|Prophylactic Cranial Irradiation|prophylactic cranial irradiation
4967568|NCT01780675|Hippocampal Avoidance Prophylactic Cranial Irradiation|hippocampal avoidance prophylactic cranial irradiation
4967569|NCT01780649|IMSI|imsi
4967570|NCT01780649|ICSI|icsi
4967571|NCT01780649|ART Assisted reproductive technology|art assisted reproductive technology
4967572|NCT01780649|Spermatozoa|spermatozoa
4967573|NCT01780649|male infertility|male infertility
4967574|NCT01780649|vacuoles|vacuoles
4967575|NCT01780636|Non relaxing puborectalis syndrome|non relaxing puborectalis syndrome
4967576|NCT01780636|Botulinum toxin A|botulinum toxin a
4967577|NCT01780636|Botox|botox
4967578|NCT01780636|Constipation|constipation
4967579|NCT01780623|fatigue|fatigue
4967580|NCT01780623|sleep|sleep
4967581|NCT01780623|quality of life|quality of life
4967582|NCT01780623|light|light
4967583|NCT01780623|cancer|cancer
4967584|NCT01780610|endometrium preparation protocols|endometrium preparation protocols
4967585|NCT01780610|frozen-thawed embryo transfer|frozen-thawed embryo transfer
4967586|NCT01780610|irregular cycle|irregular cycle
4967587|NCT01780610|randomized controlled trial|randomized controlled trial
4967588|NCT01780597|Heart transplantation|heart transplantation
4967589|NCT01780597|Ev Vivo Perfusion|ev vivo perfusion
4967590|NCT01780597|Cardiac function|cardiac function
4967591|NCT01780584|congenital heart surgery, thyroid hormones|congenital heart surgery, thyroid hormones
4967592|NCT01780571|Obesity|obesity
4967593|NCT01780571|general anaesthesia|general anaesthesia
4967594|NCT01780571|preoxygenation|preoxygenation
4967595|NCT01780571|atelectasis|atelectasis
4967596|NCT01780558|endometrium preparation protocols|endometrium preparation protocols
4967597|NCT01780558|frozen-thawed embryo transfer|frozen-thawed embryo transfer
4967598|NCT01780558|natural cycles|natural cycles
4967599|NCT01780558|hormone replacement therapy cycles|hormone replacement therapy cycles
4967600|NCT01780558|randomized controlled trial|randomized controlled trial
4967601|NCT01780545|OGX-427|ogx-427
4967602|NCT01780545|Docetaxel|docetaxel
4967603|NCT01780519|Alzheimer's disease (AD)|alzheimer's disease (ad)
4967604|NCT01780506|HIV|hiv
4967605|NCT01780506|Treatment Naive|treatment naive
4967606|NCT01780506|HIV 1 Infected|hiv 1 infected
4967607|NCT01780506|Female|female
4967608|NCT01780506|Women|women
4967609|NCT01780493|Nipple|nipple
4967610|NCT01780493|Technique|technique
4967611|NCT01780493|Ureter|ureter
4967612|NCT01780493|Vesicoureteral Reflux|vesicoureteral reflux
4967613|NCT01780480|Ischemic Stroke|ischemic stroke
4967614|NCT01780480|Convalescence|convalescence
4967615|NCT01780480|Randomized Controlled Trial|randomized controlled trial
4967616|NCT01780480|Pilot Study|pilot study
4967617|NCT01780480|Traditional Chinese Medicine|traditional chinese medicine
4967618|NCT01780467|Loss aversion|loss aversion
4967619|NCT01780467|Dopamine|dopamine
4967620|NCT01780467|Parkinson's disease|parkinson's disease
4967621|NCT01780454|End Stage Renal Disease|end stage renal disease
4967622|NCT01780454|Renal Transplant|renal transplant
4967623|NCT01780454|Bone Marrow Transplant|bone marrow transplant
4967624|NCT01780454|Tolerance|tolerance
4967625|NCT01780454|Chimerism|chimerism
4967626|NCT01780454|ESRD|esrd
4967627|NCT01780441|Tuberous Sclerosis Complex|tuberous sclerosis complex
4967628|NCT01780441|TSC|tsc
4967629|NCT01780441|Autism|autism
4967630|NCT01780441|ASD|asd
4967631|NCT01780441|Biomarkers|biomarkers
4967632|NCT01780441|Infants|infants
4967633|NCT01780428|Pain|pain
4967634|NCT01780428|Nausea|nausea
4967635|NCT01780428|Vomiting|vomiting
4967636|NCT01780415|Blastocoele fluid|blastocoele fluid
4967637|NCT01780415|Human DNA|human dna
4967638|NCT01780415|molecular diagnosis|molecular diagnosis
4967639|NCT01780402|feeding difficulty|feeding difficulty
4967640|NCT01780402|eating difficulty|eating difficulty
4967641|NCT01780402|dementia|dementia
4967642|NCT01780402|nursing home|nursing home
4967643|NCT01780402|careful hand feeding|careful hand feeding
4967644|NCT01780389|Knee|knee
4967645|NCT01780389|Pain|pain
4967646|NCT01780389|Osteoarthritis|osteoarthritis
4967647|NCT01780376|whole-body vibration|whole-body vibration
4967648|NCT01780376|latency|latency
4967649|NCT01780376|reflex response|reflex response
4967650|NCT01780376|muscle|muscle
4967651|NCT01780337|Oxytocin|oxytocin
4967652|NCT01780337|Arrhythmia|arrhythmia
4967653|NCT01780298|COPD|copd
4967654|NCT01780298|Biomarkers|biomarkers
4967655|NCT01780298|Cigarette Smoke|cigarette smoke
4968050|NCT01778595|Feces|feces
4967656|NCT01780298|Lung Inflammation|lung inflammation
4967657|NCT01780298|FEV|fev
4967658|NCT01780298|Sputum|sputum
4967659|NCT01780285|Hiatal hernia|hiatal hernia
4967660|NCT01780285|Gastro-oesophageal reflux disease|gastro-oesophageal reflux disease
4967661|NCT01780285|Laparoscopic hiatal repair|laparoscopic hiatal repair
4967662|NCT01780285|Laparoscopic anti-reflux surgery|laparoscopic anti-reflux surgery
4967663|NCT01780285|Partially absorbable lightweight mesh|partially absorbable lightweight mesh
4967664|NCT01780285|Polytetrafluoroethylene|polytetrafluoroethylene
4967665|NCT01780285|PTFE|ptfe
4967666|NCT01780285|Nitinol|nitinol
4967667|NCT01780285|Nitinol-framed lightweight PTFE mesh|nitinol-framed lightweight ptfe mesh
4967668|NCT01780259|Healthy|healthy
4967669|NCT01780259|Esketamine|esketamine
4967670|NCT01780259|Pharmacokinetics|pharmacokinetics
4967671|NCT01780259|Intranasal|intranasal
4967672|NCT01780246|Spinal Muscular Atrophy|spinal muscular atrophy
4967673|NCT01780246|SMA|sma
4967674|NCT01780246|SMN|smn
4967675|NCT01780246|SMNRx|smnrx
4967676|NCT01780246|ISIS-SMNRx|isis-smnrx
4967677|NCT01780246|ISIS 396443|isis 396443
4967678|NCT01780220|abiraterone|abiraterone
4967679|NCT01780220|biochemically-relapsing|biochemically-relapsing
4967680|NCT01780220|prostate adenocarcinoma|prostate adenocarcinoma
4967681|NCT01780181|lung cancer|lung cancer
4967682|NCT01780181|traditional Chinese medicine|traditional chinese medicine
4967683|NCT01780168|Mitochondrial Disorders|mitochondrial disorders
4967684|NCT01780168|Urea Cycle Disorders|urea cycle disorders
4967685|NCT01780168|Organic Acidemias|organic acidemias
4967686|NCT01780168|Fatty Acid Oxidation Defects|fatty acid oxidation defects
4967687|NCT01780155|Oxidative Stress|oxidative stress
4967688|NCT01780155|Hyperoxia|hyperoxia
4967689|NCT01780155|Brochopulmonary Dysplasia|brochopulmonary dysplasia
4967690|NCT01780155|Retinopathy of Prematurity|retinopathy of prematurity
4967691|NCT01780155|Very Low Birth Rate|very low birth rate
4967692|NCT01780142|Airflow Obstruction|airflow obstruction
4967693|NCT01780142|Airflow Inflammation|airflow inflammation
4967694|NCT01780142|Corticosteroid Resistance|corticosteroid resistance
4967695|NCT01780142|Exacerbations|exacerbations
4967696|NCT01780142|Quality of Life|quality of life
4967697|NCT01780116|schizophrenia|schizophrenia
4967698|NCT01780116|adherence therapy|adherence therapy
4967699|NCT01780116|medication|medication
4967700|NCT01780116|randomized controlled trial|randomized controlled trial
4967701|NCT01780116|cost-effectiveness|cost-effectiveness
4967702|NCT01780090|autism|autism
4967703|NCT01780090|prosody|prosody
4967704|NCT01780090|speech|speech
4967705|NCT01780090|autism spectrum disorder|autism spectrum disorder
4967706|NCT01780077|Scar|scar
4967707|NCT01780077|Scar prevention|scar prevention
4967708|NCT01780077|Fibrosis|fibrosis
4967709|NCT01780051|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
4967710|NCT01780051|Pharmacokinetics|pharmacokinetics
4967711|NCT01780038|Cigarette Smoking|cigarette smoking
4967712|NCT01780038|Nicotine Dependence|nicotine dependence
4967713|NCT01780038|Smoking Abstinence|smoking abstinence
4967714|NCT01780038|Health Literacy|health literacy
4967715|NCT01780038|Genetic Predisposition Testing|genetic predisposition testing
4967716|NCT01780038|Heredity|heredity
4967717|NCT01780025|Hearing|hearing
4967718|NCT01780025|Thresholds|thresholds
4967719|NCT01780025|Coupling to the inner ear|coupling to the inner ear
4967720|NCT01780012|osteoporosis|osteoporosis
4967721|NCT01780012|fragility fracture|fragility fracture
4967722|NCT01780012|secondary prevention|secondary prevention
4967723|NCT01779999|central venous catheters|central venous catheters
4967724|NCT01779999|thrombosis|thrombosis
4967725|NCT01779999|secondary prevention|secondary prevention
4967726|NCT01779973|Skype|skype
4967727|NCT01779973|compliance|compliance
4967728|NCT01779973|remote dosing|remote dosing
4967729|NCT01779973|suboxone|suboxone
4967730|NCT01779973|opiate|opiate
4967731|NCT01779973|opiates|opiates
4967732|NCT01779973|heroin|heroin
4967733|NCT01779973|oxycontin|oxycontin
4967734|NCT01779973|Philadelphia|philadelphia
4967735|NCT01779960|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
4967736|NCT01779960|Motor activity|motor activity
4967737|NCT01779960|Climatologic station|climatologic station
4967738|NCT01779908|Vitamin D supplementation|vitamin d supplementation
4967739|NCT01779908|Insulin resistance|insulin resistance
4967740|NCT01779895|Dust mite|dust mite
4967741|NCT01779895|Perennial allergic rhinitis|perennial allergic rhinitis
4967742|NCT01779869|PET MR myocardial perfusion imaging|pet mr myocardial perfusion imaging
4967743|NCT01779856|End Stage Renal Disease, Hemodialysis, Arrhythmia, Reveal ICM|end stage renal disease, hemodialysis, arrhythmia, reveal icm
4967744|NCT01779843|Newly diagnosed|newly diagnosed
4967745|NCT01779804|foot , ankle, injury|foot , ankle, injury
4967746|NCT01779791|Lymphoma|lymphoma
4967747|NCT01779791|Refractory follicular lymphoma|refractory follicular lymphoma
4967748|NCT01779791|Chemoimmunotherapy-resistant follicular lymphoma|chemoimmunotherapy-resistant follicular lymphoma
4967749|NCT01779791|PCI-32765|pci-32765
4967750|NCT01779791|Ibrutinib|ibrutinib
4967751|NCT01779791|IMBRUVICA|imbruvica
4967753|NCT01779765|Diarrhea|diarrhea
4967754|NCT01779765|Constipation|constipation
4967755|NCT01779765|Fibers|fibers
4967756|NCT01779739|vaginal prolapse|vaginal prolapse
4967757|NCT01779739|sexual function|sexual function
4967758|NCT01779739|sexual dysfunction|sexual dysfunction
4967759|NCT01779739|prolapse surgery|prolapse surgery
4967760|NCT01779726|Organization|organization
4967761|NCT01779726|of fast track|of fast track
4967762|NCT01779713|Aneurysmal subarachnoid hemorrhage|aneurysmal subarachnoid hemorrhage
4967763|NCT01779713|Vasospasm|vasospasm
4967764|NCT01779713|Transcriptomic|transcriptomic
4967765|NCT01779713|Case-Control Study|case-control study
4967766|NCT01779700|psychosis|psychosis
4967767|NCT01779700|schizophrenia|schizophrenia
4967768|NCT01779700|cognition|cognition
4967769|NCT01779700|fingolimod|fingolimod
4967770|NCT01779687|pharmacokinetic|pharmacokinetic
4967771|NCT01779687|interaction|interaction
4967772|NCT01779687|cholesterol|cholesterol
4967773|NCT01779687|raltegravir|raltegravir
4967774|NCT01779687|atorvastatin|atorvastatin
4967775|NCT01779661|Neurodevelopment, Infant-Aquatics, Prematurity|neurodevelopment, infant-aquatics, prematurity
4967776|NCT01779648|deep vein thrombosis|deep vein thrombosis
4967777|NCT01779648|intermittent pneumatic compression|intermittent pneumatic compression
4967778|NCT01779648|venous hemodynamics|venous hemodynamics
4967779|NCT01779635|Heparin-grafted membrane|heparin-grafted membrane
4967780|NCT01779635|Circuit lifespan|circuit lifespan
4967781|NCT01779635|Continuous renal replacement therapy|continuous renal replacement therapy
4967782|NCT01779635|Anticoagulation free|anticoagulation free
4967783|NCT01779635|Bleeding risk|bleeding risk
4967784|NCT01779635|Acute kidney injury|acute kidney injury
4967785|NCT01779635|Critical illness|critical illness
4967786|NCT01779622|mixed meal¨|mixed meal¨
4967787|NCT01779622|insulin|insulin
4967788|NCT01779622|glucagon|glucagon
4967789|NCT01779622|GIP|gip
4967790|NCT01779622|GLP-1|glp-1
4967791|NCT01779596|diabetes|diabetes
4967792|NCT01779596|endothelial function|endothelial function
4967793|NCT01779596|exercise|exercise
4967794|NCT01779596|blood flow|blood flow
4967795|NCT01779596|bosentan|bosentan
4967796|NCT01779583|Advanced gastric cancer|advanced gastric cancer
4967797|NCT01779570|Influenza|influenza
4967798|NCT01779570|Macrolide|macrolide
4967799|NCT01779570|Anti-inflammatory|anti-inflammatory
4967800|NCT01779557|CAPD|capd
4967801|NCT01779557|efficacy|efficacy
4967802|NCT01779557|safety|safety
4967803|NCT01779557|survival rate|survival rate
4967804|NCT01779544|rehabilitation,surgery,brief intervention, exercises|rehabilitation,surgery,brief intervention, exercises
4967805|NCT01779531|HER2-negative Luminal B breast cancer|her2-negative luminal b breast cancer
4967806|NCT01779518|HCV|hcv
4967807|NCT01779518|Sustained Virologic Response|sustained virologic response
4967808|NCT01779518|Direct Acting Antiviral|direct acting antiviral
4967809|NCT01779518|GS-7977|gs-7977
4967810|NCT01779518|Pegylated interferon|pegylated interferon
4967811|NCT01779518|Ribavirin|ribavirin
4967812|NCT01779518|Open Label|open label
4967813|NCT01779518|Sofosbuvir|sofosbuvir
4967814|NCT01779518|Liver transplant|liver transplant
4967815|NCT01779518|Hepatitis|hepatitis
4967816|NCT01779518|Hepatitis, Chronic|hepatitis, chronic
4967817|NCT01779518|Hepatitis C|hepatitis c
4967818|NCT01779518|Hepatitis C, Chronic|hepatitis c, chronic
4967819|NCT01779518|Liver Diseases|liver diseases
4967820|NCT01779518|Digestive System Diseases|digestive system diseases
4967821|NCT01779518|Hepatitis, Viral, Human|hepatitis, viral, human
4967822|NCT01779518|Virus Diseases|virus diseases
4967823|NCT01779518|Enterovirus Infections|enterovirus infections
4967824|NCT01779518|Picornaviridae Infections|picornaviridae infections
4967825|NCT01779518|RNA Virus Infections|rna virus infections
4967826|NCT01779518|Flaviviridae Infections|flaviviridae infections
4967827|NCT01779518|Antiviral Agents|antiviral agents
4967828|NCT01779518|Anti-Infective Agents|anti-infective agents
4967829|NCT01779518|Therapeutic Uses|therapeutic uses
4967830|NCT01779518|Pharmacologic Actions|pharmacologic actions
4967831|NCT01779518|Antimetabolites|antimetabolites
4967832|NCT01779518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
4967833|NCT01779492|Oxycodone, controlled release formulation|oxycodone, controlled release formulation
4967834|NCT01779479|German Breast Group|german breast group
4967835|NCT01779479|GBG Forschungs GmbH|gbg forschungs gmbh
4967836|NCT01779479|GBG|gbg
4967837|NCT01779479|GBG 74|gbg 74
4967838|NCT01779479|Genevieve|genevieve
4967839|NCT01779479|Breast Cancer|breast cancer
4967840|NCT01779479|Primary Breast Cancer|primary breast cancer
4967841|NCT01779479|Cabazitaxel|cabazitaxel
4967842|NCT01779479|Paclitaxel|paclitaxel
4967843|NCT01779479|neo-adjuvant|neo-adjuvant
4967844|NCT01779479|triple negative|triple negative
4967845|NCT01779479|luminal B|luminal b
4967846|NCT01779453|Atorvastatin|atorvastatin
4967847|NCT01779453|Drug-drug interaction|drug-drug interaction
4967848|NCT01779453|Combination therapy|combination therapy
4967849|NCT01779440|Mental Illness|mental illness
4967850|NCT01779440|Tobacco Smoking|tobacco smoking
4967851|NCT01779440|Young Adults|young adults
4967852|NCT01779440|Treatment Engagement|treatment engagement
4967853|NCT01779440|Motivational Intervention|motivational intervention
4967854|NCT01779427|traumatic brain injury (TBI)|traumatic brain injury (tbi)
4967855|NCT01779427|intracranial edema|intracranial edema
4967856|NCT01779427|brain edema|brain edema
4967857|NCT01779427|craniocerebral trauma|craniocerebral trauma
4967858|NCT01779427|head injury|head injury
4967859|NCT01779427|brain hemorrhage, traumatic|brain hemorrhage, traumatic
4967860|NCT01779427|subdural hematoma|subdural hematoma
4967861|NCT01779427|brain concussion|brain concussion
4967862|NCT01779427|head injuries, closed|head injuries, closed
4967863|NCT01779427|epidural hematoma|epidural hematoma
4967864|NCT01779427|extra-axial hemorrhage|extra-axial hemorrhage
4967865|NCT01779427|cortical contusion|cortical contusion
4967866|NCT01779427|wounds and injuries|wounds and injuries
4967867|NCT01779427|disorders of environmental origin|disorders of environmental origin
4967868|NCT01779427|trauma, nervous system|trauma, nervous system
4967869|NCT01779427|brain injuries|brain injuries
4967870|NCT01779427|attention deficit hyperactivity disorder (ADHD)|attention deficit hyperactivity disorder (adhd)
4967871|NCT01779427|attention|attention
4967872|NCT01779414|Suicide Ideation|suicide ideation
4967873|NCT01779401|PCI|pci
4967874|NCT01779401|platelet function monitoring|platelet function monitoring
4967875|NCT01779401|Thrombelastography|thrombelastography
4967876|NCT01779401|clopidogrel|clopidogrel
4967877|NCT01779401|cilostazol|cilostazol
4967878|NCT01779401|in-stent thrombosis|in-stent thrombosis
4967879|NCT01779388|Lung nodule|lung nodule
4967880|NCT01779388|PET scanner|pet scanner
4967881|NCT01779388|Bronchoscopy|bronchoscopy
4967882|NCT01779388|Electromagnetic navigation|electromagnetic navigation
4967883|NCT01779375|Children|children
4967884|NCT01779375|Pediatric|pediatric
4967885|NCT01779349|benign prostatic hyperplasia (BPH)|benign prostatic hyperplasia (bph)
4967886|NCT01779349|acoustic vibration|acoustic vibration
4967887|NCT01779336|Advanced Refractory Solid Tumors|advanced refractory solid tumors
4967888|NCT01779323|SUI|sui
4967889|NCT01779323|stress urinary incontinence|stress urinary incontinence
4967890|NCT01779323|male|male
4967891|NCT01779323|transobturator sling|transobturator sling
4967892|NCT01779297|new integrative weaning indexes|new integrative weaning indexes
4967893|NCT01779297|mechanical ventilation|mechanical ventilation
4967894|NCT01779297|ICU|icu
4967895|NCT01779284|glaucoma|glaucoma
4967896|NCT01779284|fixed combinations|fixed combinations
4967897|NCT01779284|24-hour monitoring|24-hour monitoring
4967898|NCT01779271|Pelubi|pelubi
4967899|NCT01779271|Pelubiprofen|pelubiprofen
4967900|NCT01779271|Loxoprofen|loxoprofen
4967901|NCT01779271|Anti-pyretic|anti-pyretic
4967902|NCT01779271|Fever|fever
4967903|NCT01779258|xerosis|xerosis
4967904|NCT01779258|dry skin|dry skin
4967905|NCT01779258|dermatitis|dermatitis
4967906|NCT01779258|eczema|eczema
4967907|NCT01779258|emollient|emollient
4967908|NCT01779258|corticosteroid|corticosteroid
4967909|NCT01779258|flare|flare
4967910|NCT01779232|endometriosis|endometriosis
4967911|NCT01779232|ivf|ivf
4967912|NCT01779232|ovarian reserve|ovarian reserve
4967913|NCT01779232|danazol|danazol
4967914|NCT01779219|intraoperative magnetic resonance|intraoperative magnetic resonance
4967915|NCT01779219|stereotactic biopsy|stereotactic biopsy
4967916|NCT01779219|brain tumor|brain tumor
4967917|NCT01779219|frameless stereotaxy|frameless stereotaxy
4967918|NCT01779219|image-guided neurosurgery|image-guided neurosurgery
4967919|NCT01779193|group B streptococcus|group b streptococcus
4967920|NCT01779193|pregnancy|pregnancy
4967921|NCT01779193|probiotics|probiotics
4967922|NCT01779180|Vitamin A supplementation|vitamin a supplementation
4967923|NCT01779180|BCG vaccination|bcg vaccination
4967924|NCT01779180|diphtheria-tetanus-pertussis vaccination|diphtheria-tetanus-pertussis vaccination
4967925|NCT01779180|measles vaccination|measles vaccination
4967926|NCT01779180|atopy|atopy
4967927|NCT01779167|WM|wm
4967928|NCT01779154|eosinophilic esophagitis|eosinophilic esophagitis
4967929|NCT01779154|eosinophilic gastritis|eosinophilic gastritis
4967930|NCT01779154|eosinophilic enteritis|eosinophilic enteritis
4967931|NCT01779154|eosinophilic colitis|eosinophilic colitis
4967932|NCT01779141|Type 1 Diabetes Mellitus - T1DM|type 1 diabetes mellitus - t1dm
4967933|NCT01779141|Pregnancy|pregnancy
4967934|NCT01779141|Insulin Pump|insulin pump
4967935|NCT01779141|Glucose Sensor|glucose sensor
4967936|NCT01779141|Continuous Subcutaneous Insulin Infusion - CSII|continuous subcutaneous insulin infusion - csii
4967937|NCT01779141|Sensor Augmented Pump - SAP|sensor augmented pump - sap
4967938|NCT01779141|Continuous Glucose Monitoring - CGM|continuous glucose monitoring - cgm
4967939|NCT01779115|Registry,Diabetes,Health Maintenance Organization|registry,diabetes,health maintenance organization
4967940|NCT01779089|diabetic nephropathy|diabetic nephropathy
4967941|NCT01779089|diabetic kidney disease|diabetic kidney disease
4967942|NCT01779089|minocycline|minocycline
4967943|NCT01779089|proteinuria|proteinuria
4967944|NCT01779089|albuminuria|albuminuria
4967945|NCT01779063|lymphedema|lymphedema
4967946|NCT01779063|self-care|self-care
4967947|NCT01779063|breast cancer|breast cancer
4967948|NCT01779024|Addiction|addiction
4967949|NCT01779024|Alcohol|alcohol
4967950|NCT01779024|Alcohol Clamp|alcohol clamp
4967951|NCT01778998|incision|incision
4967952|NCT01778998|pre-cut|pre-cut
4967953|NCT01778998|wound architecture|wound architecture
4967954|NCT01778998|OCT|oct
4967955|NCT01778985|Pelvic organ prolapse|pelvic organ prolapse
4967956|NCT01778985|Menopause|menopause
4967957|NCT01778985|Estrogen|estrogen
4967958|NCT01778985|Premarin|premarin
4967959|NCT01778972|Fall prevention|fall prevention
4967960|NCT01778972|Home exercise|home exercise
4967961|NCT01778972|Strength training|strength training
4967962|NCT01778972|Balance training|balance training
4967963|NCT01778946|Nicotine|nicotine
4967964|NCT01778946|Down Syndrome|down syndrome
4967965|NCT01778946|Mild Cognitive Impairment|mild cognitive impairment
4967966|NCT01778946|Event Related Potential|event related potential
4967967|NCT01778946|Memory|memory
4967968|NCT01778946|Attention|attention
4967969|NCT01778946|Trisomy 21|trisomy 21
4967970|NCT01778946|Neuroprotection|neuroprotection
4967971|NCT01778946|Cognitive Enhancement|cognitive enhancement
4967972|NCT01778946|Alzheimer's Disease|alzheimer's disease
4967973|NCT01778946|Dementia|dementia
4967974|NCT01778946|APOE|apoe
4967975|NCT01778933|Renal cell carcinoma|renal cell carcinoma
4967976|NCT01778933|Renal nodules|renal nodules
4967977|NCT01778907|Pharmacogenetics|pharmacogenetics
4967978|NCT01778907|Depression|depression
4967979|NCT01778907|Depressive Disorder|depressive disorder
4967980|NCT01778907|Cytochrome P-450 CYP2D6|cytochrome p-450 cyp2d6
4967981|NCT01778907|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic
4967982|NCT01778907|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation
4967983|NCT01778907|Poor Metabolizer Due to Cytochrome P450 CYP2D6 Variant|poor metabolizer due to cytochrome p450 cyp2d6 variant
4967984|NCT01778907|Intermediate Metabolizer Due to Cytochrome P450 CYP2D6 Variant|intermediate metabolizer due to cytochrome p450 cyp2d6 variant
4967985|NCT01778907|Ultrarapid Metabolizer Due to Cytochrome P450 CYP2D6 Variant|ultrarapid metabolizer due to cytochrome p450 cyp2d6 variant
4967986|NCT01778907|Multicenter studies|multicenter studies
4967987|NCT01778894|Diastolic Dysfunction, Diastolic Heart Failure, Diastolic|diastolic dysfunction, diastolic heart failure, diastolic
4967988|NCT01778894|Echocardiography|echocardiography
4967989|NCT01778881|Bruxism|bruxism
4967990|NCT01778881|Physical therapy modalities|physical therapy modalities
4967991|NCT01778881|Massage|massage
4967992|NCT01778881|Muscle stretching exercises|muscle stretching exercises
4967993|NCT01778881|Relaxation therapy|relaxation therapy
4967994|NCT01778881|Imagination|imagination
4967995|NCT01778855|stroke|stroke
4967996|NCT01778855|hypothermia|hypothermia
4967997|NCT01778855|thrombolysis|thrombolysis
4967998|NCT01778855|imaging|imaging
4967999|NCT01778855|collateral circulation|collateral circulation
4968000|NCT01778855|recanalization|recanalization
4968001|NCT01778855|reperfusion|reperfusion
4968002|NCT01778842|antiplatelet effect|antiplatelet effect
4968003|NCT01778842|prasugrel|prasugrel
4968004|NCT01778842|clopidogrel|clopidogrel
4968005|NCT01778842|acute coronary syndrome|acute coronary syndrome
4968006|NCT01778816|Achilles tendon, muscle volume, Achilles tendon length, force, ATRS, Hannover, AOFAS|achilles tendon, muscle volume, achilles tendon length, force, atrs, hannover, aofas
4968007|NCT01778777|rotator cuff tear arthropathy|rotator cuff tear arthropathy
4968008|NCT01778777|inverse prosthesis|inverse prosthesis
4968009|NCT01778777|safety|safety
4968010|NCT01778777|universe reverse|universe reverse
4968011|NCT01778751|Self-Management Support|self-management support
4968012|NCT01778751|Depression|depression
4968013|NCT01778751|Home Telehealth|home telehealth
4968014|NCT01778725|Chorioamnionitis, S100B, Brain, Neuro-development|chorioamnionitis, s100b, brain, neuro-development
4968015|NCT01778712|Multi-level intervention|multi-level intervention
4968016|NCT01778712|Menopause|menopause
4968017|NCT01778712|Body composition|body composition
4968018|NCT01778712|Abdominal adipose tissue|abdominal adipose tissue
4968019|NCT01778712|Visceral adipose tissue|visceral adipose tissue
4968020|NCT01778712|Perceived stress|perceived stress
4968021|NCT01778712|Computed tomography|computed tomography
4968022|NCT01778712|Dual energy X-ray absorptiometry|dual energy x-ray absorptiometry
4968023|NCT01778699|Lactobacillus brevis CD2|lactobacillus brevis cd2
4968024|NCT01778699|caries incidence|caries incidence
4968025|NCT01778699|plaque-pH|plaque-ph
4968026|NCT01778686|Positron Emission Tomography|positron emission tomography
4968027|NCT01778686|Serotonin|serotonin
4968028|NCT01778686|5-HT2A|5-ht2a
4968029|NCT01778686|Radioligand|radioligand
4968030|NCT01778660|Fecal Incontinence|fecal incontinence
4968031|NCT01778660|Treatment options|treatment options
4968032|NCT01778660|Patient Satisfaction|patient satisfaction
4968033|NCT01778647|ADHD|adhd
4968034|NCT01778647|Omega- 3 Fatty acids|omega- 3 fatty acids
4968035|NCT01778647|CGI|cgi
4968036|NCT01778647|Conners rating scale|conners rating scale
4968037|NCT01778647|Stimulants|stimulants
4968038|NCT01778634|Ureaplasma parvum|ureaplasma parvum
4968039|NCT01778634|Ureaplasma urealyticum|ureaplasma urealyticum
4968040|NCT01778634|prematurity|prematurity
4968041|NCT01778634|bronchopulmonary dysplasia|bronchopulmonary dysplasia
4968042|NCT01778634|azithromycin|azithromycin
4968043|NCT01778621|Acupuncture|acupuncture
4968044|NCT01778621|AMH|amh
4968045|NCT01778621|Infertility|infertility
4968046|NCT01778621|PCOS|pcos
4968047|NCT01778621|Pregnancy rate|pregnancy rate
4968048|NCT01778608|Sedation|sedation
4968049|NCT01778595|Microbiome|microbiome
4968051|NCT01778595|Cancer Screening|cancer screening
4968052|NCT01778582|Emotion|emotion
4968053|NCT01778582|Informed Consent|informed consent
4968054|NCT01778569|Imaging|imaging
4968055|NCT01778569|Cardiovascular Risk Factors|cardiovascular risk factors
4968056|NCT01778569|Inflammation|inflammation
4968057|NCT01778569|Lipoproteins|lipoproteins
4968058|NCT01778569|Metabolic Dysfunction|metabolic dysfunction
4968059|NCT01778556|Lipodystrophy|lipodystrophy
4968060|NCT01778556|Leptin|leptin
4968061|NCT01778556|Energy Expenditure|energy expenditure
4968062|NCT01778556|Diabetes|diabetes
4968063|NCT01778556|Hypertriglyceridemia|hypertriglyceridemia
4968064|NCT01778543|Coloboma|coloboma
4968065|NCT01778530|Glioblastoma|glioblastoma
4968066|NCT01778530|Anti-Angiogenesis|anti-angiogenesis
4968067|NCT01778530|Radiotherapy|radiotherapy
4968068|NCT01778530|Malignant Glioma|malignant glioma
4968069|NCT01778530|Progression|progression
4968070|NCT01778517|Psychogenic Movement Disorders|psychogenic movement disorders
4968071|NCT01778504|Children and Adolescents|children and adolescents
4968072|NCT01778504|Natural History Study|natural history study
4968073|NCT01778504|Neurodevelopmental Disorders|neurodevelopmental disorders
4968074|NCT01778504|Autism|autism
4968075|NCT01778504|Obsessive Compulsive Disorder|obsessive compulsive disorder
4968076|NCT01778491|Phenotype-Genotype correlation|phenotype-genotype correlation
4968077|NCT01778491|Phenotype|phenotype
4968078|NCT01778491|Phenotypes|phenotypes
4968079|NCT01778491|Age Related Macular Degeneration|age related macular degeneration
4968080|NCT01778478|Anxiety|anxiety
4968081|NCT01778478|Depression|depression
4968082|NCT01778478|Adolescents and Adults|adolescents and adults
4968083|NCT01778478|Cancer Diagnosis|cancer diagnosis
4968084|NCT01778465|Chronic Rhinosinusitis|chronic rhinosinusitis
4968085|NCT01778465|Aspirin exacerbated respiratory disease|aspirin exacerbated respiratory disease
4968086|NCT01778465|Asthma|asthma
4968087|NCT01778465|Aspirin sensitivity|aspirin sensitivity
4968088|NCT01778465|Salicylate|salicylate
4968089|NCT01778452|Endometrial priming, genomic expression. Natural cycle. Antagonist GnRH.|endometrial priming, genomic expression. natural cycle. antagonist gnrh.
4968090|NCT01778439|Phase 1|phase 1
4968091|NCT01778439|Dose escalation|dose escalation
4968092|NCT01778439|relapsed or refractory|relapsed or refractory
4968093|NCT01778439|solid tumor|solid tumor
4968094|NCT01778426|Chronic neuropathic pain syndrome|chronic neuropathic pain syndrome
4968095|NCT01778426|Spinal Cord Stimulation|spinal cord stimulation
4968096|NCT01778426|Painstim devices|painstim devices
4968097|NCT01778426|Efficacy|efficacy
4968098|NCT01778426|Safety|safety
4968099|NCT01778400|Ultrasound|ultrasound
4968100|NCT01778400|Radiofrequency|radiofrequency
4968101|NCT01778400|Ethanol|ethanol
4968102|NCT01778400|Predominantly cystic thyroid nodule|predominantly cystic thyroid nodule
4968103|NCT01778400|Thyroid nodule|thyroid nodule
4968104|NCT01778400|Thyroid|thyroid
4968105|NCT01778374|Emergency Medicine|emergency medicine
4968106|NCT01778374|Screening|screening
4968107|NCT01778374|Point of care testing|point of care testing
4968108|NCT01778374|Video assisted counseling|video assisted counseling
4968109|NCT01778361|Human immunodeficiency virus|human immunodeficiency virus
4968110|NCT01778361|low bone mineral density|low bone mineral density
4968111|NCT01778361|osteopenia|osteopenia
4968112|NCT01778361|osteoporosis|osteoporosis
4968113|NCT01778361|fracture|fracture
4968114|NCT01778348|Type 1 diabetes|type 1 diabetes
4968115|NCT01778348|Closed-loop glucose control|closed-loop glucose control
4968116|NCT01778348|Artificial Pancreas|artificial pancreas
4968117|NCT01778348|Continuous subcutaneous insulin infusion|continuous subcutaneous insulin infusion
4968118|NCT01778348|Continuous glucose monitoring|continuous glucose monitoring
4968119|NCT01778335|recanalization|recanalization
4968120|NCT01778335|endovascular|endovascular
4968121|NCT01778335|thrombectomy|thrombectomy
4968122|NCT01778309|aseptic inflammation|aseptic inflammation
4968123|NCT01778309|skeletal muscle function|skeletal muscle function
4968124|NCT01778309|exercise|exercise
4968125|NCT01778296|Dorsal branch of the digital nerve;|dorsal branch of the digital nerve;
4968126|NCT01778296|dorsal digital artery;|dorsal digital artery;
4968127|NCT01778296|dorsal digital island flap;|dorsal digital island flap;
4968128|NCT01778296|neurocutaneous island flap.|neurocutaneous island flap.
4968129|NCT01778270|pleural effusion|pleural effusion
4968130|NCT01778270|pleural drainage|pleural drainage
4968131|NCT01778270|thorax impedance|thorax impedance
4968132|NCT01778270|respiration parameters|respiration parameters
4968133|NCT01778270|heart sounds analysis|heart sounds analysis
4968134|NCT01778257|Mate extracts|mate extracts
4968135|NCT01778257|Obesity|obesity
4968136|NCT01778257|abdominal fat|abdominal fat
4968137|NCT01778244|schizophrenia; dyslipidemia|schizophrenia; dyslipidemia
4968138|NCT01778231|Focus|focus
4968139|NCT01778231|uptake|uptake
4968140|NCT01778231|Lutein|lutein
4968141|NCT01778231|Zeaxanthin|zeaxanthin
4968142|NCT01778231|individuals|individuals
4968143|NCT01778218|Coronary Artery Disease|coronary artery disease
4968144|NCT01778218|CAD|cad
4968145|NCT01778192|Bowel preparation|bowel preparation
4968146|NCT01778192|Polyethylene glycol|polyethylene glycol
4968147|NCT01778192|Sodium picosulphate|sodium picosulphate
4968148|NCT01778179|Lentigines|lentigines
4968149|NCT01778179|Cryotherapy|cryotherapy
4968150|NCT01778179|hyperpigmentation|hyperpigmentation
4968151|NCT01778166|Early enteral nutrition|early enteral nutrition
4968152|NCT01778166|Laparoscopic gastrointestinal surgery|laparoscopic gastrointestinal surgery
4968153|NCT01778166|Immuno-enhanced nutrition|immuno-enhanced nutrition
4968154|NCT01778153|Fitness training|fitness training
4968155|NCT01778153|Personal training|personal training
4968156|NCT01778140|Clinical Decision Support Systems|clinical decision support systems
4968157|NCT01778140|Contrast-induced nephropathy|contrast-induced nephropathy
4968158|NCT01778127|Cancer Survivor|cancer survivor
4968159|NCT01778127|Physical Activity|physical activity
4968160|NCT01778127|Health Outcomes|health outcomes
4968161|NCT01778127|Rewards-Based Intervention|rewards-based intervention
4968162|NCT01778127|Cardiovascular Health|cardiovascular health
4968163|NCT01778127|Musculoskeletal Health|musculoskeletal health
4968164|NCT01778127|Exercise|exercise
4968165|NCT01778114|Vitamin D2|vitamin d2
4968166|NCT01778114|Vitamin D3|vitamin d3
4968167|NCT01778114|Vitamin D|vitamin d
4968168|NCT01778114|Orange Juice|orange juice
4968169|NCT01778101|preterm infants|preterm infants
4968170|NCT01778101|reflux|reflux
4968171|NCT01778101|impedance|impedance
4968172|NCT01778101|pH|ph
4968173|NCT01778101|monitoring|monitoring
4968174|NCT01778101|lansoprazole|lansoprazole
4968175|NCT01778075|Healthy|healthy
4968176|NCT01778075|Ultracet extended release (ER)|ultracet extended release (er)
4968177|NCT01778075|Tramadol hydrochloride|tramadol hydrochloride
4968178|NCT01778075|Acetaminophen|acetaminophen
4968179|NCT01778075|Bioequivalence|bioequivalence
4968180|NCT01778036|Neck movement|neck movement
4968181|NCT01778036|motor control|motor control
4968182|NCT01778036|disability|disability
4968183|NCT01778036|psychological variables|psychological variables
4968184|NCT01778036|Head Movements|head movements
4968185|NCT01778036|Physical therapy|physical therapy
4968186|NCT01778036|Fear avoidance|fear avoidance
4968187|NCT01778036|Self Efficacy|self efficacy
4968188|NCT01778036|Catastrophizing|catastrophizing
4968189|NCT01778036|Fly test|fly test
4968190|NCT01778036|Postural sway|postural sway
4968191|NCT01778010|cocaine|cocaine
4968192|NCT01778010|modafinil|modafinil
4968193|NCT01778010|self-administration|self-administration
4968194|NCT01778010|DRD4|drd4
4968195|NCT01777906|nasal polyps|nasal polyps
4968196|NCT01777906|nasal steriod sprays|nasal steriod sprays
4968197|NCT01777893|Type-2 diabetes mellitus|type-2 diabetes mellitus
4968198|NCT01777893|Obesity|obesity
4968199|NCT01777893|High protein diet|high protein diet
4968200|NCT01777893|Low GI|low gi
4968201|NCT01777893|Physical activity|physical activity
4968202|NCT01777815|NeoChord|neochord
4968203|NCT01777815|DS1000|ds1000
4968204|NCT01777815|Mitral Valve|mitral valve
4968205|NCT01777815|Mitral Valve Regurgitation|mitral valve regurgitation
4968206|NCT01777815|MR|mr
4968207|NCT01777815|Mitral Valve Repair|mitral valve repair
4968208|NCT01777815|Mitral Valve Prolapse|mitral valve prolapse
4968209|NCT01777815|Artificial Chordae|artificial chordae
4968210|NCT01777789|fMRI|fmri
4968211|NCT01777789|Dementia|dementia
4968212|NCT01777789|Alzheimer's disease|alzheimer's disease
4968213|NCT01777789|functional neuroimaging|functional neuroimaging
4968214|NCT01777789|Memory|memory
4968215|NCT01777776|Open-label dose escalation|open-label dose escalation
4968216|NCT01777776|BRAF inhibitor|braf inhibitor
4968217|NCT01777776|LEE011|lee011
4968218|NCT01777776|CDK4/6|cdk4/6
4968219|NCT01777776|LGX818|lgx818
4968220|NCT01777776|RAF kinase inhibitor|raf kinase inhibitor
4968221|NCT01777776|Metastatic melanoma|metastatic melanoma
4968222|NCT01777776|BRAF|braf
4968223|NCT01777776|V600|v600
4968224|NCT01777750|Myocardial Infarction|myocardial infarction
4968225|NCT01777750|Myocardial Reperfusion Injury|myocardial reperfusion injury
4968226|NCT01777750|Reperfusion Injury|reperfusion injury
4968227|NCT01777750|Anterior Wall Myocardial Infarction|anterior wall myocardial infarction
4968228|NCT01777750|Inferior Wall Myocardial Infarction|inferior wall myocardial infarction
4968229|NCT01777750|Pathologic Processes|pathologic processes
4968230|NCT01777750|Myocardial Ischemia|myocardial ischemia
4968231|NCT01777737|Idiopathic Pulmonary Fibrosis|idiopathic pulmonary fibrosis
4968232|NCT01777737|Trimethoprim-sulfamethoxazole|trimethoprim-sulfamethoxazole
4968233|NCT01777737|Pneumocystis jiroveci|pneumocystis jiroveci
4968234|NCT01777711|mental contrasting|mental contrasting
4968235|NCT01777711|weight loss|weight loss
4968236|NCT01777711|obese couples|obese couples
4968237|NCT01777711|obesity|obesity
4968238|NCT01777711|overweight|overweight
4968239|NCT01777711|planning|planning
4968240|NCT01777711|health|health
4968241|NCT01777711|diet|diet
4968242|NCT01777711|exercise|exercise
4968243|NCT01777711|physical activity|physical activity
4968244|NCT01777711|goal|goal
4968245|NCT01777711|goal-setting|goal-setting
4968246|NCT01777698|body composition|body composition
4968247|NCT01777698|hepatocellular carcinoma|hepatocellular carcinoma
4968248|NCT01777698|chemoembolization|chemoembolization
4968249|NCT01777685|Sulpiride|sulpiride
4968757|NCT01775449|Dysesthesia|dysesthesia
4968250|NCT01777685|Therapeutic drug monitoring|therapeutic drug monitoring
4968251|NCT01777685|Pharmacokinetics|pharmacokinetics
4968252|NCT01777659|exercise|exercise
4968253|NCT01777659|neuromodulation|neuromodulation
4968254|NCT01777659|blood flow|blood flow
4968255|NCT01777659|exercise capacity|exercise capacity
4968256|NCT01777646|Mesenchymal Strmal Cells (MSC)|mesenchymal strmal cells (msc)
4968257|NCT01777646|Amyotrophic Lateral Sclerosis (ALS)|amyotrophic lateral sclerosis (als)
4968258|NCT01777646|Neuroprotection|neuroprotection
4968259|NCT01777646|Neurodegeneration|neurodegeneration
4968260|NCT01777646|Stem cells|stem cells
4968261|NCT01777594|hepatocellular carcinoma|hepatocellular carcinoma
4968262|NCT01777594|HCC|hcc
4968263|NCT01777594|liver|liver
4968264|NCT01777594|liver cancer|liver cancer
4968265|NCT01777594|sorafenib|sorafenib
4968266|NCT01777581|sciatica radiculopathy lumbar disc lumbosacral disc|sciatica radiculopathy lumbar disc lumbosacral disc
4968267|NCT01777555|Parkinson's Disease|parkinson's disease
4968268|NCT01777555|Motor fluctuations|motor fluctuations
4968269|NCT01777555|levodopa|levodopa
4968270|NCT01777555|inhaled drugs|inhaled drugs
4968271|NCT01777555|Off episodes|off episodes
4968272|NCT01777542|Rett syndrome|rett syndrome
4968273|NCT01777542|RTT|rtt
4968274|NCT01777542|IGF-1|igf-1
4968275|NCT01777542|autism spectrum disorder|autism spectrum disorder
4968276|NCT01777529|Measles|measles
4968277|NCT01777529|Mumps|mumps
4968278|NCT01777529|Rubella|rubella
4968279|NCT01777516|Platelet Aggregation|platelet aggregation
4968280|NCT01777516|Cardiovascular Diseases|cardiovascular diseases
4968281|NCT01777516|Salicylic Acid|salicylic acid
4968282|NCT01777503|acute coronary syndrome|acute coronary syndrome
4968283|NCT01777503|elderly|elderly
4968284|NCT01777503|percutaneous revascularization|percutaneous revascularization
4968285|NCT01777503|antiaggregant drugs|antiaggregant drugs
4968286|NCT01777490|Caregivers - Not professionals|caregivers - not professionals
4968287|NCT01777490|Frail Elderly|frail elderly
4968288|NCT01777490|Long-term Care|long-term care
4968289|NCT01777490|Quality of Life|quality of life
4968290|NCT01777451|Whole Body Imaging|whole body imaging
4968291|NCT01777451|Magnetic Resonance Imaging|magnetic resonance imaging
4968292|NCT01777451|Neurofibromatosis 1|neurofibromatosis 1
4968293|NCT01777451|Diffusion Magnetic Resonance Imaging|diffusion magnetic resonance imaging
4968294|NCT01777451|Peripheral Nerve Sheath Tumors, Malignant|peripheral nerve sheath tumors, malignant
4968295|NCT01777412|NMO|nmo
4968296|NCT01777412|NMOSD|nmosd
4968297|NCT01777412|NMO-IgG|nmo-igg
4968298|NCT01777412|Aquaporin-4|aquaporin-4
4968299|NCT01777412|AQP4|aqp4
4968300|NCT01777412|anti-AQP4|anti-aqp4
4968301|NCT01777386|scar|scar
4968302|NCT01777386|contracture|contracture
4968303|NCT01777386|perforator flap|perforator flap
4968304|NCT01777386|preexpanded perforator flap|preexpanded perforator flap
4968305|NCT01777386|perforator vessel|perforator vessel
4968306|NCT01777386|artery diameter|artery diameter
4968307|NCT01777373|conducting airway, bronchiolization|conducting airway, bronchiolization
4968308|NCT01777360|severe|severe
4968309|NCT01777360|uncontrolled|uncontrolled
4968310|NCT01777347|Keywords provided by ASSISTANCE PUBLIQUE HOPITAUX DE PARIS:|keywords provided by assistance publique hopitaux de paris:
4968311|NCT01777347|Acute Viral bronchiolitis|acute viral bronchiolitis
4968312|NCT01777347|Hypertonic saline|hypertonic saline
4968313|NCT01777347|Hospitalization|hospitalization
4968314|NCT01777347|Infants|infants
4968315|NCT01777347|Hospital admissions|hospital admissions
4968316|NCT01777347|Additional relevant MeSH terms:|additional relevant mesh terms:
4968317|NCT01777347|Bronchiolitis|bronchiolitis
4968318|NCT01777347|Bronchiolitis, Viral|bronchiolitis, viral
4968319|NCT01777347|Bronchial Diseases|bronchial diseases
4968320|NCT01777347|Respiratory Tract Diseases|respiratory tract diseases
4968321|NCT01777347|Lung Diseases, Obstructive|lung diseases, obstructive
4968322|NCT01777347|Respiratory Tract Infections|respiratory tract infections
4968323|NCT01777347|Virus Diseases|virus diseases
4968324|NCT01777321|Herpes Zoster|herpes zoster
4968325|NCT01777321|Intramuscular|intramuscular
4968326|NCT01777321|Subcutaneous|subcutaneous
4968327|NCT01777321|Safety|safety
4968328|NCT01777321|≥50 years of age|≥50 years of age
4968329|NCT01777321|Adults|adults
4968330|NCT01777321|Immunogenicity|immunogenicity
4968331|NCT01777321|Elderly|elderly
4968332|NCT01777308|Immunogenicity|immunogenicity
4968333|NCT01777308|Booster|booster
4968334|NCT01777308|Healthy|healthy
4968335|NCT01777308|Vaccine response|vaccine response
4968336|NCT01777308|Safety|safety
4968337|NCT01777308|Neisseria meningiditis|neisseria meningiditis
4968338|NCT01777308|Antibody persistence|antibody persistence
4968339|NCT01777308|Meningococcal conjugate vaccine|meningococcal conjugate vaccine
4968340|NCT01777295|Adults|adults
4968341|NCT01777295|Reactogenicity|reactogenicity
4968342|NCT01777295|Naive|naive
4968343|NCT01777295|Immune responses|immune responses
4968344|NCT01777295|Read-outs|read-outs
4968345|NCT01777295|Hepatitis B|hepatitis b
4968346|NCT01777295|Healthy|healthy
4968347|NCT01777282|albiglutide|albiglutide
4968348|NCT01777282|Japanese|japanese
4968349|NCT01777282|glucagon-like peptide-1|glucagon-like peptide-1
4968350|NCT01777282|GSK716155|gsk716155
4968351|NCT01777256|systemic lupus erythematosus|systemic lupus erythematosus
4968352|NCT01777256|adaptive design|adaptive design
4968353|NCT01777256|clinical safety and efficacy|clinical safety and efficacy
4968354|NCT01777256|pharmacodynamics|pharmacodynamics
4968355|NCT01777243|pharmacokinetic|pharmacokinetic
4968356|NCT01777243|systemic amyloidosis|systemic amyloidosis
4968357|NCT01777243|safety|safety
4968358|NCT01777243|dose escalation|dose escalation
4968359|NCT01777243|Carboxy Pyrrolidine Hexanoyl Pyrrolidine Carboxylate (CPHPC)|carboxy pyrrolidine hexanoyl pyrrolidine carboxylate (cphpc)
4968360|NCT01777243|biomarker|biomarker
4968361|NCT01777243|GSK2315698|gsk2315698
4968362|NCT01777243|GSK2398852|gsk2398852
4968363|NCT01777243|SAP|sap
4968364|NCT01777243|pharmacodynamic|pharmacodynamic
4968365|NCT01777243|co-administration|co-administration
4968366|NCT01777243|intravenous|intravenous
4968367|NCT01777217|Urination Disorder|urination disorder
4968368|NCT01777217|Overactive Bladder|overactive bladder
4968369|NCT01777217|Prostate Cancer Radiation|prostate cancer radiation
4968370|NCT01777217|Vesicare|vesicare
4968371|NCT01777204|Renal transplant, Gastrointestinal motility, Biomagnetism|renal transplant, gastrointestinal motility, biomagnetism
4968372|NCT01777178|bicarbonate|bicarbonate
4968373|NCT01777178|dialysis|dialysis
4968374|NCT01777165|GFR|gfr
4968375|NCT01777165|Acute Kidney Injury|acute kidney injury
4968376|NCT01777165|High Risk cardiac surgery|high risk cardiac surgery
4968377|NCT01777152|Antibodies, Monoclonal|antibodies, monoclonal
4968378|NCT01777152|Antibody-Drug Conjugate|antibody-drug conjugate
4968379|NCT01777152|Antigens, CD30|antigens, cd30
4968380|NCT01777152|Drug Therapy|drug therapy
4968381|NCT01777152|Hematologic Diseases|hematologic diseases
4968382|NCT01777152|Lymphoma|lymphoma
4968383|NCT01777152|Monomethyl auristatin E|monomethyl auristatin e
4968384|NCT01777152|Lymphoma, T-Cell|lymphoma, t-cell
4968385|NCT01777152|Lymphoma, Non-Hodgkin|lymphoma, non-hodgkin
4968386|NCT01777152|Lymphoma, Large-Cell, Anaplastic|lymphoma, large-cell, anaplastic
4968387|NCT01777139|Retigabine|retigabine
4968388|NCT01777139|Drug-Resistant|drug-resistant
4968389|NCT01777139|Epilepsy|epilepsy
4968390|NCT01777139|Partial-Onset Seizures|partial-onset seizures
4968391|NCT01777139|Safety and Tolerability|safety and tolerability
4968392|NCT01777139|Immediate Release|immediate release
4968393|NCT01777139|Long-Term|long-term
4968394|NCT01777139|Adjunctive Therapy|adjunctive therapy
4968395|NCT01777139|Asian Subjects|asian subjects
4968396|NCT01777139|Efficacy|efficacy
4968397|NCT01777139|GW582892|gw582892
4968398|NCT01777126|cystectomy|cystectomy
4968399|NCT01777126|parenteral nutrition|parenteral nutrition
4968400|NCT01777126|discharge|discharge
4968401|NCT01777126|outcome|outcome
4968402|NCT01777113|Chronic Stroke|chronic stroke
4968403|NCT01777113|Gait|gait
4968404|NCT01777113|Exercise|exercise
4968405|NCT01777113|High intensity aerobic training|high intensity aerobic training
4968406|NCT01777113|Strength training|strength training
4968407|NCT01777113|Randomized controlled trial|randomized controlled trial
4968408|NCT01777100|Postoperative pain|postoperative pain
4968409|NCT01777100|Patient controlled analgesia|patient controlled analgesia
4968410|NCT01777100|Hyperalgesia|hyperalgesia
4968411|NCT01777100|Remifentanil|remifentanil
4968412|NCT01777100|Sufentanil|sufentanil
4968413|NCT01777100|Morphine|morphine
4968414|NCT01777100|Abdominal surgery|abdominal surgery
4968415|NCT01777100|Safety|safety
4968416|NCT01777087|Pain|pain
4968417|NCT01777087|Functional Magnetic Resonance Imaging|functional magnetic resonance imaging
4968418|NCT01777074|Vaccination|vaccination
4968419|NCT01777074|Acceptability|acceptability
4968420|NCT01777074|Hepatitis B|hepatitis b
4968421|NCT01777061|Prostate Cancer|prostate cancer
4968422|NCT01777061|Recurrent Prostate Cancer|recurrent prostate cancer
4968423|NCT01777061|PET Scan|pet scan
4968424|NCT01777061|FDG-PET|fdg-pet
4968425|NCT01777061|[11C]Acetate|[11c]acetate
4968426|NCT01777061|C11-Acetate|c11-acetate
4968427|NCT01777035|mechanical ventilation|mechanical ventilation
4968428|NCT01777035|physical therapy|physical therapy
4968429|NCT01777035|occupational therapy|occupational therapy
4968430|NCT01777035|ICU acquired weakness|icu acquired weakness
4968431|NCT01777035|critical illness myopathy|critical illness myopathy
4968432|NCT01777022|Education, Stillbirth, Prevention, Management|education, stillbirth, prevention, management
4968433|NCT01777009|Total Knee Replacement|total knee replacement
4968434|NCT01777009|Patellar Eversion|patellar eversion
4968435|NCT01777009|Surgical Exposure|surgical exposure
4968436|NCT01777009|Outcomes|outcomes
4968437|NCT01777009|Quadriceps Strength|quadriceps strength
4968438|NCT01777009|Straight Leg Raise|straight leg raise
4968439|NCT01777009|SF-36|sf-36
4968440|NCT01776996|Expanded access, HIV, maraviroc|expanded access, hiv, maraviroc
4968441|NCT01776970|Motor Neuron Disease|motor neuron disease
4968442|NCT01776970|Amyotrophic lateral sclerosis|amyotrophic lateral sclerosis
4968443|NCT01776970|Cannabinoids|cannabinoids
4968444|NCT01776970|Sativex|sativex
4968445|NCT01776970|Spasticity|spasticity
4968446|NCT01776957|Abortion rate|abortion rate
4968447|NCT01776957|Intrauterine device|intrauterine device
4968448|NCT01776944|Resting energy expenditure|resting energy expenditure
4968449|NCT01776944|Handheld calorimeter|handheld calorimeter
4968450|NCT01776944|Obese and overweight|obese and overweight
4968451|NCT01776944|Pediatrics|pediatrics
4968452|NCT01776931|Indicator Amino acid technique|indicator amino acid technique
4968453|NCT01776931|Lysine requirements|lysine requirements
4968454|NCT01776931|Pregnancy|pregnancy
4968455|NCT01776931|Dietary protein|dietary protein
4968456|NCT01776918|POLG1 Mutation|polg1 mutation
4968457|NCT01776918|Phenylketonuria|phenylketonuria
4968458|NCT01776905|Melanoma|melanoma
4968459|NCT01776905|Cancer|cancer
4968460|NCT01776892|Collagenase|collagenase
4968461|NCT01776892|Needle aponeurotomy|needle aponeurotomy
4968462|NCT01776866|Coronary Angiography|coronary angiography
4968463|NCT01776866|Rotational Coronary Angiography|rotational coronary angiography
4968464|NCT01776866|Contrast Media|contrast media
4968465|NCT01776866|Radiation|radiation
4968466|NCT01776866|Quantitative Coronary Angiography|quantitative coronary angiography
4968467|NCT01776853|Irritable Bowel Syndrome|irritable bowel syndrome
4968468|NCT01776853|Fructose|fructose
4968469|NCT01776853|Fructans|fructans
4968470|NCT01776853|MRI|mri
4968471|NCT01776853|Fermentation|fermentation
4968472|NCT01776853|Breath Tests|breath tests
4968473|NCT01776853|Flatulence|flatulence
4968474|NCT01776853|Abdominal Pain|abdominal pain
4968475|NCT01776853|Diarrhoea|diarrhoea
4968476|NCT01776840|Mantle cell lymphoma|mantle cell lymphoma
4968477|NCT01776840|Ibrutinib|ibrutinib
4968478|NCT01776840|Bruton's tyrosine kinase inhibitor|bruton's tyrosine kinase inhibitor
4968479|NCT01776840|Bendamustine hydrochloride|bendamustine hydrochloride
4968480|NCT01776840|Rituximab|rituximab
4968481|NCT01776827|GERD|gerd
4968482|NCT01776827|Hiatal Hernia|hiatal hernia
4968483|NCT01776827|Paraesophageal Hernia|paraesophageal hernia
4968484|NCT01776827|Biologic Mesh|biologic mesh
4968485|NCT01776814|Entecair|entecair
4968486|NCT01776814|Tenofovir|tenofovir
4968487|NCT01776801|intracranial baroreflex|intracranial baroreflex
4968488|NCT01776762|Nutrition|nutrition
4968489|NCT01776762|Rehabilitation|rehabilitation
4968490|NCT01776762|Weightloss|weightloss
4968491|NCT01776749|low back pain|low back pain
4968492|NCT01776749|failed back surgery syndrome|failed back surgery syndrome
4968493|NCT01776749|spinal cord stimulation|spinal cord stimulation
4968494|NCT01776749|subcutaneous stimulation|subcutaneous stimulation
4968495|NCT01776749|peripheral nerve field stimulation|peripheral nerve field stimulation
4968496|NCT01776736|Scoliosis|scoliosis
4968497|NCT01776736|Posture correction|posture correction
4968498|NCT01776723|Chronic Myelomonocytic Leukemia|chronic myelomonocytic leukemia
4968499|NCT01776723|CMML|cmml
4968500|NCT01776723|Leukemia|leukemia
4969012|NCT01774383|Parkinson's disease|parkinson's disease
4968501|NCT01776710|Intermittent claudication|intermittent claudication
4968502|NCT01776710|Behavior therapy|behavior therapy
4968503|NCT01776710|Walking|walking
4968504|NCT01776710|Exercise|exercise
4968505|NCT01776710|Patient education|patient education
4968506|NCT01776710|Randomized controlled trial|randomized controlled trial
4968507|NCT01776658|Ocular pain|ocular pain
4968508|NCT01776658|Dry Eye Syndrome|dry eye syndrome
4968509|NCT01776658|siRNA|sirna
4968510|NCT01776658|RNAi|rnai
4968511|NCT01776658|TRPV1|trpv1
4968512|NCT01776619|Safety|safety
4968513|NCT01776619|tolerability|tolerability
4968514|NCT01776619|PK|pk
4968515|NCT01776593|bladder capacity; bladder diary; bladder oversensitivity; lower urinary tract symptoms|bladder capacity; bladder diary; bladder oversensitivity; lower urinary tract symptoms
4968516|NCT01776580|Pelvic organ prolapse|pelvic organ prolapse
4968517|NCT01776580|lower urinary tract symptoms|lower urinary tract symptoms
4968518|NCT01776580|sexual dysfunction|sexual dysfunction
4968519|NCT01776567|coronary artery disease|coronary artery disease
4968520|NCT01776567|stents|stents
4968521|NCT01776567|optical imaging|optical imaging
4968522|NCT01776554|Influenza, Pandemic, H5N1, Children|influenza, pandemic, h5n1, children
4968523|NCT01776541|Influenza, Pandemic, H5N1, Adults|influenza, pandemic, h5n1, adults
4968524|NCT01776515|Low back pain|low back pain
4968525|NCT01776515|Wontran|wontran
4968526|NCT01776515|Wontran SR Tab.|wontran sr tab.
4968527|NCT01776515|Tramadol Hydrochloride/Acetaminophen|tramadol hydrochloride/acetaminophen
4968528|NCT01776489|Food allergy|food allergy
4968529|NCT01776489|Sphingosine-1-phosphate|sphingosine-1-phosphate
4968530|NCT01776489|Biomarker|biomarker
4968531|NCT01776489|Double-blind placebo-controlled food challenge|double-blind placebo-controlled food challenge
4968532|NCT01776489|Anaphylaxis|anaphylaxis
4968533|NCT01776476|glutamine dipeptide|glutamine dipeptide
4968534|NCT01776476|randomized controlled trial|randomized controlled trial
4968535|NCT01776476|insulin resistance|insulin resistance
4968536|NCT01776476|critical illness|critical illness
4968537|NCT01776476|trauma|trauma
4968538|NCT01776463|Z-360|z-360
4968539|NCT01776463|Japanese|japanese
4968540|NCT01776463|pK|pk
4968541|NCT01776450|Abdominal Aortic Aneurysm|abdominal aortic aneurysm
4968542|NCT01776424|Cardiovascular events|cardiovascular events
4968543|NCT01776424|Rivaroxaban|rivaroxaban
4968544|NCT01776424|Xarelto|xarelto
4968545|NCT01776424|anticoagulant|anticoagulant
4968546|NCT01776424|blood thinner|blood thinner
4968547|NCT01776424|aspirin|aspirin
4968548|NCT01776424|ASA|asa
4968549|NCT01776424|CAD|cad
4968550|NCT01776424|coronary disease|coronary disease
4968551|NCT01776424|artery disease|artery disease
4968552|NCT01776424|coronary artery bypass graft|coronary artery bypass graft
4968553|NCT01776424|stroke|stroke
4968554|NCT01776424|heart attack|heart attack
4968555|NCT01776424|angina|angina
4968556|NCT01776424|arterial vascular disease|arterial vascular disease
4968557|NCT01776424|transient ischemic attack|transient ischemic attack
4968558|NCT01776424|TIA|tia
4968559|NCT01776424|heart disease|heart disease
4968560|NCT01776398|COPD|copd
4968561|NCT01776398|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
4968562|NCT01776398|Lung disease|lung disease
4968563|NCT01776398|Emphysema|emphysema
4968564|NCT01776398|Smoking|smoking
4968565|NCT01776398|Healthy Smoker|healthy smoker
4968566|NCT01776398|Smoker|smoker
4968567|NCT01776398|Non-smoker|non-smoker
4968568|NCT01776385|[C08.785.640]|[c08.785.640]
4968569|NCT01776385|(C08.528.778)|(c08.528.778)
4968570|NCT01776385|[C19.642.713]|[c19.642.713]
4968571|NCT01776385|mesothelium|mesothelium
4968572|NCT01776372|Drainage|drainage
4968573|NCT01776372|Chest tubes|chest tubes
4968574|NCT01776372|Randomized Controlled Trial|randomized controlled trial
4968575|NCT01776359|Muscle|muscle
4968576|NCT01776359|Protein|protein
4968577|NCT01776359|Diet|diet
4968578|NCT01776359|Exercise|exercise
4968579|NCT01776333|ICU|icu
4968580|NCT01776320|Erectile Dysfunction|erectile dysfunction
4968581|NCT01776320|Topical Alprostadil|topical alprostadil
4968582|NCT01776307|BBI608|bbi608
4968583|NCT01776294|Prehypertension|prehypertension
4968584|NCT01776294|Prevalence|prevalence
4968585|NCT01776294|Cardiovascular Risk Factors|cardiovascular risk factors
4968586|NCT01776281|effects|effects
4968587|NCT01776281|KMC|kmc
4968588|NCT01776281|LBW|lbw
4968589|NCT01776281|preterm|preterm
4968590|NCT01776281|temperature|temperature
4968591|NCT01776281|breastfeeding|breastfeeding
4968592|NCT01776281|secondary hospitals|secondary hospitals
4968593|NCT01776268|antimicrobial proteins|antimicrobial proteins
4968594|NCT01776255|Obesity|obesity
4968595|NCT01776255|Overweight|overweight
4968596|NCT01776255|Lifestyle|lifestyle
4968597|NCT01776255|American Indian|american indian
4968598|NCT01776242|low back pain|low back pain
4968599|NCT01776242|elderly|elderly
4968600|NCT01776242|back pain|back pain
4968601|NCT01776242|lumbar pain|lumbar pain
4968602|NCT01776242|over 65|over 65
4968603|NCT01776229|nightmare|nightmare
4968604|NCT01776229|PTSD|ptsd
4968605|NCT01776229|trauma|trauma
4968606|NCT01776229|children|children
4968607|NCT01776229|cognitive behavior therapy|cognitive behavior therapy
4968608|NCT01776229|stress|stress
4968609|NCT01776229|sleep|sleep
4968610|NCT01776216|Endothelial function|endothelial function
4968611|NCT01776216|Dairy|dairy
4968612|NCT01776177|Allergic asthma|allergic asthma
4968613|NCT01776177|Omalizumab therapy|omalizumab therapy
4968614|NCT01776177|IgE profile|ige profile
4968615|NCT01776164|Friedreich|friedreich
4968616|NCT01776164|ataxia|ataxia
4968617|NCT01776164|FRDA|frda
4968618|NCT01776164|FA|fa
4968619|NCT01776164|recessive|recessive
4968620|NCT01776164|neurodegenerative|neurodegenerative
4968621|NCT01776164|cerebellum|cerebellum
4968622|NCT01776151|HIV|hiv
4968623|NCT01776151|cardiovascular diseases|cardiovascular diseases
4968624|NCT01776151|vascular stiffness|vascular stiffness
4968625|NCT01776138|Elderly|elderly
4968626|NCT01776138|Chemotherapy|chemotherapy
4968627|NCT01776138|Cystectomy|cystectomy
4968628|NCT01776138|Radical Cystectomy|radical cystectomy
4968629|NCT01776138|University of North Carolina|university of north carolina
4968630|NCT01776138|Cancer|cancer
4968631|NCT01776138|Bladder Cancer|bladder cancer
4968632|NCT01776138|Bladder|bladder
4968633|NCT01776125|Neurofibromatosis Type One|neurofibromatosis type one
4968634|NCT01776125|Scoliosis|scoliosis
4968635|NCT01776112|schizophrenia|schizophrenia
4968636|NCT01776112|negative symptoms|negative symptoms
4968637|NCT01776112|cognitive deficits|cognitive deficits
4968638|NCT01776112|synaptic plasticity|synaptic plasticity
4968639|NCT01776099|type 2 diabetes|type 2 diabetes
4968640|NCT01776099|nutrition|nutrition
4968641|NCT01776099|fibers|fibers
4968642|NCT01776073|Transplantation|transplantation
4968643|NCT01776073|Healthcare Disparities|healthcare disparities
4968644|NCT01776073|Quality Assurance|quality assurance
4968645|NCT01776060|Primary Progressive Multiple Sclerosis|primary progressive multiple sclerosis
4968646|NCT01776060|Multiple Sclerosis|multiple sclerosis
4968647|NCT01776060|biomarker|biomarker
4968648|NCT01776060|'omic|'omic
4968649|NCT01776060|progression|progression
4968650|NCT01776034|Self Care|self care
4968651|NCT01776034|Exercise|exercise
4968652|NCT01776034|Weight management|weight management
4968653|NCT01776021|Urinary tract infection|urinary tract infection
4968654|NCT01776021|Recurrent urinary tract infection|recurrent urinary tract infection
4968655|NCT01776021|Cranberry|cranberry
4968656|NCT01776021|Prevention|prevention
4968657|NCT01776021|E-coli|e-coli
4968658|NCT01775995|Chronic Pain|chronic pain
4968659|NCT01775995|Low Back Pain|low back pain
4968660|NCT01775982|French language validation|french language validation
4968661|NCT01775982|The Confusion Assessment Method (CAM)|the confusion assessment method (cam)
4968662|NCT01775943|Epidermal growth factor receptor|epidermal growth factor receptor
4968663|NCT01775943|Mutation|mutation
4968664|NCT01775943|Lung cancer|lung cancer
4968665|NCT01775943|Drug sensitivity|drug sensitivity
4968666|NCT01775930|Kidney Cancer|kidney cancer
4968667|NCT01775930|Refractory Renal Cell Carcinoma|refractory renal cell carcinoma
4968669|NCT01775930|Clear cell kidney cancer with metastatic disease|clear cell kidney cancer with metastatic disease
4968670|NCT01775930|Carfilzomib|carfilzomib
4968671|NCT01775891|pilsicainide|pilsicainide
4968672|NCT01775891|class IC antiarrhythmic drug|class ic antiarrhythmic drug
4968673|NCT01775891|paroxysmal atrial fibrillation|paroxysmal atrial fibrillation
4968674|NCT01775891|catheter ablation|catheter ablation
4968675|NCT01775878|Diabetes|diabetes
4968676|NCT01775878|HbA1c|hba1c
4968677|NCT01775878|Fructosamine|fructosamine
4968678|NCT01775878|Blood Pressure|blood pressure
4968679|NCT01775878|Telemonitoring|telemonitoring
4968680|NCT01775865|aortic stiffness|aortic stiffness
4968681|NCT01775865|endothelium-dependent dilation|endothelium-dependent dilation
4968682|NCT01775865|vascular aging|vascular aging
4968683|NCT01775865|oxidative stress|oxidative stress
4968684|NCT01775865|inflammation|inflammation
4968685|NCT01775865|nitric oxide|nitric oxide
4968686|NCT01775865|nuclear factor kappa B|nuclear factor kappa b
4968687|NCT01775852|Acceptance and Commitment Therapy (ACT)|acceptance and commitment therapy (act)
4968688|NCT01775852|Depression|depression
4968689|NCT01775852|Illness Management|illness management
4968690|NCT01775852|Behavioral treatment|behavioral treatment
4968691|NCT01775852|Impairment|impairment
4968692|NCT01775826|physical activity|physical activity
4968693|NCT01775826|sedentary behavior|sedentary behavior
4968694|NCT01775826|accelerometer|accelerometer
4968695|NCT01775826|GPS|gps
4968696|NCT01775826|GIS|gis
4968697|NCT01775826|machine learning|machine learning
4968698|NCT01775813|Insulin resistance|insulin resistance
4968699|NCT01775813|Puberty|puberty
4968700|NCT01775813|Obesity|obesity
4968701|NCT01775813|Hypogonadism|hypogonadism
4968702|NCT01775813|Gonadal dysfunction|gonadal dysfunction
4968703|NCT01775813|Metformin|metformin
4968704|NCT01775787|smoking|smoking
4968705|NCT01775774|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
4968706|NCT01775774|Acute Lung Injury|acute lung injury
4968707|NCT01775774|Allogeneic Bone Marrow-Derived Human Mesenchymal Stem Cells|allogeneic bone marrow-derived human mesenchymal stem cells
4968708|NCT01775761|Thorough QTc evaluation of tafamidis compared to the effects of moxifloxacin and placebo in healthy volunteers.|thorough qtc evaluation of tafamidis compared to the effects of moxifloxacin and placebo in healthy volunteers.
4968709|NCT01775748|Grape juice|grape juice
4968710|NCT01775735|headache|headache
4968711|NCT01775735|pain|pain
4968712|NCT01775735|chronic|chronic
4968713|NCT01775709|middler ear infection|middler ear infection
4968714|NCT01775696|Alzheimer's disease|alzheimer's disease
4968715|NCT01775696|Pittsburgh binding Compound (PiB)|pittsburgh binding compound (pib)
4968716|NCT01775696|Positron Emission Tomography (PET)|positron emission tomography (pet)
4968717|NCT01775696|Inflammation|inflammation
4968718|NCT01775696|Anti Abeta immune responses|anti abeta immune responses
4968719|NCT01775696|Blood markers|blood markers
4968720|NCT01775696|MRI|mri
4968721|NCT01775683|homelessness|homelessness
4968722|NCT01775670|Arthrosis|arthrosis
4968723|NCT01775657|pulmonary air leak|pulmonary air leak
4968724|NCT01775657|Thopaz|thopaz
4968725|NCT01775657|digital|digital
4968726|NCT01775657|analog|analog
4968727|NCT01775657|randomized|randomized
4968728|NCT01775618|Hemophilia A|hemophilia a
4968729|NCT01775618|Factor VIII|factor viii
4968730|NCT01775618|Prophylaxis|prophylaxis
4968731|NCT01775618|Pediatric|pediatric
4968732|NCT01775605|Subject|subject
4968733|NCT01775592|P.f resistance|p.f resistance
4968734|NCT01775553|Relapsed Multiple Myeloma|relapsed multiple myeloma
4968735|NCT01775553|Refractory Multiple Myeloma|refractory multiple myeloma
4968736|NCT01775553|High-Dose Carfilzomib|high-dose carfilzomib
4968737|NCT01775553|Standard Dose Carfilzomib|standard dose carfilzomib
4968738|NCT01775553|Carfilzomib|carfilzomib
4968739|NCT01775540|Dry eye|dry eye
4968740|NCT01775540|Artificial tears|artificial tears
4968741|NCT01775540|Ocular surface inflammation|ocular surface inflammation
4968742|NCT01775501|sorafenib|sorafenib
4968743|NCT01775501|FOLFOX|folfox
4968744|NCT01775488|Benign Prostatic Hyperplasia|benign prostatic hyperplasia
4968745|NCT01775488|BPH|bph
4968746|NCT01775488|LUTS|luts
4968747|NCT01775488|Vortx Rx|vortx rx
4968748|NCT01775488|Histotripsy|histotripsy
4968749|NCT01775462|Hypohidrotic Ectodermal Dysplasia|hypohidrotic ectodermal dysplasia
4968750|NCT01775462|XLHED|xlhed
4968751|NCT01775449|Anticancer drug;|anticancer drug;
4968752|NCT01775449|Oxaliplatin;|oxaliplatin;
4968753|NCT01775449|Digestive cancer system|digestive cancer system
4968754|NCT01775449|Acute oxaliplatin-induced hypersensitivity|acute oxaliplatin-induced hypersensitivity
4968755|NCT01775449|Hyperalgesia;|hyperalgesia;
4968756|NCT01775449|Allodynia;|allodynia;
4968758|NCT01775449|Polyamines depleted diet|polyamines depleted diet
4968759|NCT01775436|palliative care|palliative care
4968760|NCT01775436|HIV/AIDS|hiv/aids
4968761|NCT01775436|quality of life|quality of life
4968762|NCT01775436|adherence|adherence
4968763|NCT01775436|spiritual|spiritual
4968764|NCT01775436|threat appraisal|threat appraisal
4968765|NCT01775436|treatment congruence|treatment congruence
4968766|NCT01775436|treatment preferences|treatment preferences
4968767|NCT01775436|dialysis|dialysis
4968768|NCT01775436|hospitalization|hospitalization
4968769|NCT01775436|communication|communication
4968770|NCT01775436|family intervention|family intervention
4968771|NCT01775436|Family Centered Advance Care Planning|family centered advance care planning
4968772|NCT01775436|decision making|decision making
4968773|NCT01775436|advance care planning|advance care planning
4968774|NCT01775436|end of life|end of life
4968775|NCT01775397|Clostridium|clostridium
4968776|NCT01775397|Difficile|difficile
4968777|NCT01775397|Infections|infections
4968778|NCT01775397|Immunosuppression|immunosuppression
4968779|NCT01775397|Fidaxomicin|fidaxomicin
4968780|NCT01775397|Vancomycin|vancomycin
4968781|NCT01775397|Efficacy|efficacy
4968782|NCT01775397|Stem Cells|stem cells
4968783|NCT01775397|Transplantation|transplantation
4968784|NCT01775397|Adult|adult
4968785|NCT01775397|Dificid|dificid
4968786|NCT01775384|Inflammation|inflammation
4968787|NCT01775384|Oxidative stress|oxidative stress
4968788|NCT01775384|Immune dysfunction|immune dysfunction
4968789|NCT01775384|Metabolomics.|metabolomics.
4968790|NCT01775371|Pain|pain
4968791|NCT01775371|Emergency|emergency
4968792|NCT01775371|Analgesia|analgesia
4968793|NCT01775371|ED patients|ed patients
4968794|NCT01775371|acute pain|acute pain
4968795|NCT01775371|IV opioid|iv opioid
4968796|NCT01775345|Partial meniscectomy|partial meniscectomy
4968797|NCT01775345|Physiotherapy|physiotherapy
4968798|NCT01775345|Isokinetics|isokinetics
4968799|NCT01775345|Cost-effectiveness|cost-effectiveness
4968800|NCT01775319|Zinc|zinc
4968801|NCT01775293|Non-absorbable polypropylene mesh|non-absorbable polypropylene mesh
4968802|NCT01775293|WSRS|wsrs
4968803|NCT01775293|Rhytidectomy|rhytidectomy
4968804|NCT01775254|Colon Cancer|colon cancer
4968805|NCT01775254|FOLFOX|folfox
4968806|NCT01775254|Laparoscopic Colectomy|laparoscopic colectomy
4968807|NCT01775254|Open Colectomy|open colectomy
4968808|NCT01775254|Robotic Colectomy|robotic colectomy
4968809|NCT01775254|Quality of Life|quality of life
4968810|NCT01775254|Sexual Function|sexual function
4968811|NCT01775254|Peripheral Neuropathy|peripheral neuropathy
4968812|NCT01775254|Demands of Illness|demands of illness
4968813|NCT01775254|Cancer Survivor|cancer survivor
4968814|NCT01775228|Depression, peer support, recovery, health services|depression, peer support, recovery, health services
4968815|NCT01775215|Left Ventricular Function|left ventricular function
4968816|NCT01775215|Aortic Valve Replacement|aortic valve replacement
4968817|NCT01775215|Late Gadolinium Enhancement|late gadolinium enhancement
4968818|NCT01775215|Cardiac I123 MIBG|cardiac i123 mibg
4968819|NCT01775215|Longitudinal Strain|longitudinal strain
4968820|NCT01775215|Brain Natriuretic Peptide|brain natriuretic peptide
4968821|NCT01775215|High Sensitivity Troponin I|high sensitivity troponin i
4968822|NCT01775189|Relative abuse potential study|relative abuse potential study
4968823|NCT01775189|Chronic pain|chronic pain
4968824|NCT01775189|oxycodone|oxycodone
4968825|NCT01775189|naltrexone|naltrexone
4968826|NCT01775189|opioid-related disorders|opioid-related disorders
4968827|NCT01775189|drug abusers|drug abusers
4968828|NCT01775176|PCOS, Weight, Insulin Sensitivity, Reproductive Function|pcos, weight, insulin sensitivity, reproductive function
4968829|NCT01775163|Energy|energy
4968830|NCT01775163|Metabolism|metabolism
4968831|NCT01775163|Weight Loss|weight loss
4968832|NCT01775163|Exercise|exercise
4968833|NCT01775150|mobile phone text messaging|mobile phone text messaging
4968834|NCT01775150|maternality|maternality
4968835|NCT01775150|infant|infant
4968836|NCT01775150|death rate|death rate
4968837|NCT01775137|CF, Open-label, TIP, phase IV, extension study|cf, open-label, tip, phase iv, extension study
4968838|NCT01775124|Macular degeneration,|macular degeneration,
4968839|NCT01775124|age-related macular degeneration (ARMD),|age-related macular degeneration (armd),
4968840|NCT01775124|vision loss,|vision loss,
4968841|NCT01775124|macula damage,|macula damage,
4968842|NCT01775124|retina damage,|retina damage,
4968843|NCT01775124|dry macular degeneration,|dry macular degeneration,
4968844|NCT01775124|wet macular degeneration,|wet macular degeneration,
4968845|NCT01775124|AMD|amd
4968846|NCT01775111|strength training|strength training
4968847|NCT01775111|protein supplementation|protein supplementation
4968848|NCT01775111|sarcopenia|sarcopenia
4968849|NCT01775098|Gout|gout
4968850|NCT01775098|uric acid|uric acid
4968851|NCT01775098|allopurinol|allopurinol
4968852|NCT01775085|Interventions|interventions
4968853|NCT01775085|Meaning-Centered Group (MCG)|meaning-centered group (mcg)
4968854|NCT01775085|Discussion Group (DG)|discussion group (dg)
4968855|NCT01775085|Modules|modules
4968856|NCT01775085|Sessions|sessions
4968857|NCT01775085|12-291|12-291
4968858|NCT01775072|tissue|tissue
4968859|NCT01775072|blood|blood
4968860|NCT01775072|salvia|salvia
4968861|NCT01775072|buccal swab|buccal swab
4968862|NCT01775072|Genomic Profiling|genomic profiling
4968863|NCT01775072|Solid Tumors|solid tumors
4968864|NCT01775072|hematologic cancer|hematologic cancer
4968865|NCT01775072|Clinical Assay|clinical assay
4968866|NCT01775072|Research Assay|research assay
4968867|NCT01775072|12-245|12-245
4968868|NCT01775046|Valiant|valiant
4968869|NCT01775046|Captivia|captivia
4968870|NCT01775046|Stent Graft|stent graft
4968871|NCT01775046|Thoracic|thoracic
4968872|NCT01775046|Aortic|aortic
4968873|NCT01775033|Pediatrics|pediatrics
4968874|NCT01775033|Emergency medical services|emergency medical services
4968875|NCT01775033|Emergency Treatment|emergency treatment
4968876|NCT01775033|Telemedicine|telemedicine
4968877|NCT01775007|Lens|lens
4968878|NCT01775007|Cornea|cornea
4968879|NCT01775007|Stiffness|stiffness
4968880|NCT01775007|Brillouin Shift|brillouin shift
4968881|NCT01775007|Young Modulus|young modulus
4968882|NCT01774994|volunteers|volunteers
4968883|NCT01774942|Diabetes Mellitus|diabetes mellitus
4968884|NCT01774942|C-Reactive Protein|c-reactive protein
4968885|NCT01774942|Dental Implants, Single-Tooth|dental implants, single-tooth
4968886|NCT01774942|Dental Prosthesis, Implant-Supported|dental prosthesis, implant-supported
4968887|NCT01774929|Osteoarthritis|osteoarthritis
4968888|NCT01774929|Transdermal Therapeutic System (TTS)-fentanyl|transdermal therapeutic system (tts)-fentanyl
4968889|NCT01774929|Durogesic|durogesic
4968890|NCT01774903|Low Back Pain|low back pain
4968891|NCT01774903|TTS-fentanyl|tts-fentanyl
4968892|NCT01774903|Durogesic|durogesic
4968893|NCT01774877|xinfeng capsule;|xinfeng capsule;
4968894|NCT01774877|rheumatoid arthritis (RA);|rheumatoid arthritis (ra);
4968895|NCT01774877|randomized;|randomized;
4968896|NCT01774877|double-blind;|double-blind;
4968897|NCT01774851|HER-2 Gene Amplification|her-2 gene amplification
4968898|NCT01774851|Esophagus Cancer|esophagus cancer
4968899|NCT01774851|Gastroesophageal Junction Cancer|gastroesophageal junction cancer
4968900|NCT01774851|Stomach Cancer|stomach cancer
4968901|NCT01774851|Her2 Positive|her2 positive
4968902|NCT01774851|Her2+|her2+
4968903|NCT01774851|Esophageal Cancer|esophageal cancer
4968904|NCT01774851|Metastatic|metastatic
4968905|NCT01774825|Irritable bowel syndrome|irritable bowel syndrome
4968906|NCT01774825|IBS|ibs
4968907|NCT01774812|vitamin D|vitamin d
4968908|NCT01774812|hemodialysis|hemodialysis
4968909|NCT01774812|sudden cardiac death|sudden cardiac death
4968910|NCT01774812|heart rate variability|heart rate variability
4968911|NCT01774812|cardiac autonomic tone|cardiac autonomic tone
4968912|NCT01774799|advanced dementia|advanced dementia
4968913|NCT01774799|advance care planning|advance care planning
4968914|NCT01774799|nursing home|nursing home
4968915|NCT01774760|18F-EF5|18f-ef5
4968916|NCT01774760|PET/CT|pet/ct
4968917|NCT01774760|Reproducibility|reproducibility
4968918|NCT01774747|Pharmacokinetics|pharmacokinetics
4968919|NCT01774734|Chronic neck pain|chronic neck pain
4968920|NCT01774734|Neck strength exerciser|neck strength exerciser
4968921|NCT01774734|Biofeedback|biofeedback
4968922|NCT01774734|Physiotherapy|physiotherapy
4968923|NCT01774734|Strengthening exercise|strengthening exercise
4968924|NCT01774734|Randomized trials|randomized trials
4968925|NCT01774721|first-line|first-line
4968926|NCT01774721|locally advanced or metastatic|locally advanced or metastatic
4968927|NCT01774721|non-small cell lung cancer|non-small cell lung cancer
4968928|NCT01774721|epidermal growth factor receptor|epidermal growth factor receptor
4968929|NCT01774721|EGFR|egfr
4968930|NCT01774721|Archer|archer
4968931|NCT01774721|mutation|mutation
4968932|NCT01774721|dacomitinib|dacomitinib
4968933|NCT01774721|SFJ|sfj
4968934|NCT01774721|PF-00299804|pf-00299804
4968935|NCT01774695|IBS|ibs
4968936|NCT01774695|physical activity|physical activity
4968937|NCT01774695|exercise|exercise
4968938|NCT01774682|obesity|obesity
4968939|NCT01774682|surgery|surgery
4968940|NCT01774669|ischemic stroke|ischemic stroke
4968941|NCT01774669|hemorrhagic stroke|hemorrhagic stroke
4968942|NCT01774669|upper limb|upper limb
4968943|NCT01774669|virtual reality|virtual reality
4968944|NCT01774669|physiotherapy|physiotherapy
4968945|NCT01774669|occupational therapy|occupational therapy
4968946|NCT01774656|heart-assist device|heart-assist device
4968947|NCT01774643|Pancreatic cancer|pancreatic cancer
4968948|NCT01774643|Liver metastases|liver metastases
4968949|NCT01774643|Tumor tissue biopsy|tumor tissue biopsy
4968950|NCT01774643|Blood samples|blood samples
4968951|NCT01774643|Xenografts|xenografts
4968952|NCT01774643|Murine|murine
4968953|NCT01774643|Genomic profiling|genomic profiling
4968954|NCT01774643|Circulating biomarkers|circulating biomarkers
4968955|NCT01774630|Treatment, relapse, complete molecular response|treatment, relapse, complete molecular response
4968956|NCT01774617|portal hypertension|portal hypertension
4968957|NCT01774617|elastography|elastography
4968958|NCT01774617|Hepatic venous pressure gradient measurement|hepatic venous pressure gradient measurement
4968959|NCT01774604|Post ERCP acute pancreatitis|post ercp acute pancreatitis
4969063|NCT01774136|breastfeeding|breastfeeding
4968960|NCT01774604|Post Fine Needle Aspiration (FNA) acute pancreatitis|post fine needle aspiration (fna) acute pancreatitis
4968961|NCT01774604|Indomethacin|indomethacin
4968962|NCT01774604|Rectal Non Steroidal Anti-Inflammatory Drugs (NSAIDs)|rectal non steroidal anti-inflammatory drugs (nsaids)
4968963|NCT01774591|Post Menopause|post menopause
4968964|NCT01774591|Female|female
4968965|NCT01774591|Obese|obese
4968966|NCT01774578|Non-small Cell Lung Cancer|non-small cell lung cancer
4968967|NCT01774578|Vaccine Therapy|vaccine therapy
4968968|NCT01774578|Immunotherapy|immunotherapy
4968969|NCT01774578|Second line therapy|second line therapy
4968970|NCT01774578|Progressive|progressive
4968971|NCT01774578|Relapsed|relapsed
4968972|NCT01774565|Diabetes|diabetes
4968973|NCT01774565|Insulin|insulin
4968974|NCT01774565|Closed-Loop|closed-loop
4968975|NCT01774565|Real-time CGM|real-time cgm
4968976|NCT01774565|Subcutaneous insulin pump|subcutaneous insulin pump
4968977|NCT01774565|Hospital|hospital
4968978|NCT01774539|Fracture|fracture
4968979|NCT01774539|Physeal injury|physeal injury
4968980|NCT01774539|Diffusion MRI|diffusion mri
4968981|NCT01774500|biomarkers|biomarkers
4968982|NCT01774500|Emergency Department|emergency department
4968983|NCT01774500|Seizures|seizures
4968984|NCT01774500|epilepsy|epilepsy
4968985|NCT01774500|S100b|s100b
4968986|NCT01774500|copeptin|copeptin
4968987|NCT01774487|Biliary Atresia|biliary atresia
4968988|NCT01774487|Pentoxifylline|pentoxifylline
4968989|NCT01774487|Trental|trental
4968990|NCT01774487|Serum bilirubin|serum bilirubin
4968991|NCT01774487|Conjugated bilirubin|conjugated bilirubin
4968992|NCT01774487|Liver transplantation|liver transplantation
4968993|NCT01774487|Fibrosis|fibrosis
4968994|NCT01774474|Prevention|prevention
4968995|NCT01774448|Dementia|dementia
4968996|NCT01774448|Spouse Caregiver|spouse caregiver
4968997|NCT01774448|Depression|depression
4968998|NCT01774448|Mind Body Therapy|mind body therapy
4968999|NCT01774448|Cognitive Therapy|cognitive therapy
4969000|NCT01774448|Quality of Life|quality of life
4969001|NCT01774448|Attention|attention
4969002|NCT01774448|Memory|memory
4969003|NCT01774435|Schizophrenia|schizophrenia
4969004|NCT01774435|Schizophrenic|schizophrenic
4969005|NCT01774435|Stable Schizophrenic|stable schizophrenic
4969006|NCT01774422|Hypercapnia|hypercapnia
4969007|NCT01774422|Respiratory Distress Syndrome|respiratory distress syndrome
4969008|NCT01774422|Extracorporeal CO2 remover|extracorporeal co2 remover
4969009|NCT01774422|Noninvasive ventilation|noninvasive ventilation
4969010|NCT01774409|all advanced malignant tumor|all advanced malignant tumor
4969011|NCT01774396|Hands Rejuvenation, fillers|hands rejuvenation, fillers
4969013|NCT01774383|sub-thalamic nucleus|sub-thalamic nucleus
4969014|NCT01774383|oscillation|oscillation
4969015|NCT01774383|local field potential|local field potential
4969016|NCT01774344|Regorafenib|regorafenib
4969017|NCT01774344|BAY73-4506|bay73-4506
4969018|NCT01774318|sleep-wake-cycles|sleep-wake-cycles
4969019|NCT01774318|preterm infants|preterm infants
4969021|NCT01774318|conventional EEG|conventional eeg
4969022|NCT01774318|polysomnography|polysomnography
4969023|NCT01774292|Impact of alkalized lidocaine on coughing at extubation|impact of alkalized lidocaine on coughing at extubation
4969024|NCT01774266|Gastric Cancer|gastric cancer
4969025|NCT01774266|DNA methylation|dna methylation
4969026|NCT01774266|Reprimo|reprimo
4969027|NCT01774266|cell-free DNA|cell-free dna
4969028|NCT01774266|non-invasive|non-invasive
4969029|NCT01774253|DIPG|dipg
4969030|NCT01774240|Delirium|delirium
4969031|NCT01774240|Cardiac surgery|cardiac surgery
4969032|NCT01774240|DOS scale|dos scale
4969033|NCT01774227|Refractory glaucoma|refractory glaucoma
4969034|NCT01774227|Transcleral cyclophotocoagulation (TSCPC)|transcleral cyclophotocoagulation (tscpc)
4969035|NCT01774227|Dark iris|dark iris
4969036|NCT01774227|Pops-titration|pops-titration
4969037|NCT01774227|Slow-coagulation|slow-coagulation
4969038|NCT01774227|Neovascular glaucoma|neovascular glaucoma
4969039|NCT01774214|Resuscitation|resuscitation
4969040|NCT01774214|Shock|shock
4969041|NCT01774214|Fluid Therapy|fluid therapy
4969042|NCT01774214|Pediatrics|pediatrics
4969043|NCT01774201|Multiple sclerosis|multiple sclerosis
4969044|NCT01774201|Self-assessment|self-assessment
4969045|NCT01774201|Physical endurance|physical endurance
4969046|NCT01774201|Respiratory function|respiratory function
4969047|NCT01774201|Fatigue|fatigue
4969048|NCT01774188|Enhanced Extracorporeal Counterpulsation|enhanced extracorporeal counterpulsation
4969049|NCT01774188|intraocular pressure|intraocular pressure
4969050|NCT01774188|Pen type tonometer|pen type tonometer
4969051|NCT01774175|Bowel preparation|bowel preparation
4969052|NCT01774175|PEG with ascorbic acid|peg with ascorbic acid
4969053|NCT01774175|Picosulfate|picosulfate
4969054|NCT01774162|Endoscopic Ultrasound|endoscopic ultrasound
4969055|NCT01774162|Fine needle aspiration|fine needle aspiration
4969056|NCT01774162|Fine needle biopsy|fine needle biopsy
4969057|NCT01774162|ProCore|procore
4969058|NCT01774136|community health workers|community health workers
4969059|NCT01774136|HIV|hiv
4969060|NCT01774136|PMTCT|pmtct
4969061|NCT01774136|antenatal|antenatal
4969062|NCT01774136|postnatal|postnatal
4969354|NCT01772914|Copeptin|copeptin
4969064|NCT01774136|South Africa|south africa
4969065|NCT01774110|stroke|stroke
4969066|NCT01774110|gait|gait
4969067|NCT01774110|acute|acute
4969068|NCT01774097|Peripheral Artery Disease|peripheral artery disease
4969069|NCT01774097|Intermittent Claudication|intermittent claudication
4969070|NCT01774097|Autologous Stem Cells|autologous stem cells
4969071|NCT01774097|ALDH cells|aldh cells
4969072|NCT01774097|Claudicants|claudicants
4969073|NCT01774097|PAD|pad
4969074|NCT01774097|Peak Walking Time|peak walking time
4969075|NCT01774097|MRI|mri
4969076|NCT01774097|Vascular Flow|vascular flow
4969077|NCT01774097|Anatomy|anatomy
4969078|NCT01774097|Perfusion|perfusion
4969079|NCT01774084|Insulin sensitivity|insulin sensitivity
4969080|NCT01774084|Beta cell function|beta cell function
4969081|NCT01774084|Carbohydrate preload|carbohydrate preload
4969082|NCT01774084|Elective hip replacement|elective hip replacement
4969083|NCT01774084|Double-blind randomized control study|double-blind randomized control study
4969084|NCT01774071|89Zr-DFO-MSTP2109A|89zr-dfo-mstp2109a
4969085|NCT01774071|tracer|tracer
4969086|NCT01774071|pet scan|pet scan
4969087|NCT01774071|12-178|12-178
4969088|NCT01774058|blood flow volume|blood flow volume
4969089|NCT01774058|ilomedin|ilomedin
4969090|NCT01774058|measurement|measurement
4969091|NCT01774058|intraarterial|intraarterial
4969092|NCT01774058|neuropathy|neuropathy
4969093|NCT01774045|Major depressive disorder|major depressive disorder
4969094|NCT01774045|Depression|depression
4969095|NCT01774019|Pancreatic|pancreatic
4969096|NCT01774019|Periampullary Cancer|periampullary cancer
4969097|NCT01774019|Preoperative Biliary Drainage|preoperative biliary drainage
4969098|NCT01774019|Resectable|resectable
4969099|NCT01774006|In vitro fertilization|in vitro fertilization
4969100|NCT01774006|Embryo transfer|embryo transfer
4969101|NCT01774006|Embryo culture|embryo culture
4969102|NCT01774006|individual culture|individual culture
4969103|NCT01774006|Group culture|group culture
4969104|NCT01774006|embryo quality|embryo quality
4969105|NCT01774006|Pregnancy rate|pregnancy rate
4969106|NCT01774006|Implantation|implantation
4969107|NCT01773993|Lyrica|lyrica
4969108|NCT01773993|pregabalin|pregabalin
4969109|NCT01773993|Good post marketing practice|good post marketing practice
4969110|NCT01773993|Post Marketing Surveillance|post marketing surveillance
4969111|NCT01773993|Regulatory Post Marketing Commitment Plan|regulatory post marketing commitment plan
4969112|NCT01773993|Fibromyalgia|fibromyalgia
4969113|NCT01773967|Lactobacillus rhamnosus GG|lactobacillus rhamnosus gg
4969114|NCT01773967|LGG|lgg
4969115|NCT01773967|Probiotic|probiotic
4969116|NCT01773967|Gastroenteritis|gastroenteritis
4969117|NCT01773967|acute gastroenteritis|acute gastroenteritis
4969118|NCT01773967|child|child
4969119|NCT01773967|pediatric|pediatric
4969120|NCT01773967|RCT|rct
4969121|NCT01773954|amd|amd
4969122|NCT01773954|age related macular degeneration|age related macular degeneration
4969123|NCT01773954|macular degeneration|macular degeneration
4969124|NCT01773954|neovascular|neovascular
4969125|NCT01773928|Active immunization against influenza disease|active immunization against influenza disease
4969126|NCT01773889|Epithelial Ovarian Cancer|epithelial ovarian cancer
4969127|NCT01773889|FIGO (Int Federation of Gyn and Ob )Stage III or Stage IV|figo (int federation of gyn and ob )stage iii or stage iv
4969128|NCT01773889|Extraovarian Peritoneal Cancer|extraovarian peritoneal cancer
4969129|NCT01773889|Fallopian Tube Carcinoma Failing|fallopian tube carcinoma failing
4969130|NCT01773876|survival without proven invasive candidiasis|survival without proven invasive candidiasis
4969131|NCT01773876|effectiveness|effectiveness
4969132|NCT01773876|micafungin versus placebo|micafungin versus placebo
4969133|NCT01773876|pharmacokinetic|pharmacokinetic
4969134|NCT01773876|pharmacodynamic|pharmacodynamic
4969135|NCT01773876|tolerance|tolerance
4969136|NCT01773863|Community-acquired pneumonia|community-acquired pneumonia
4969137|NCT01773863|Acute myocardial infarction|acute myocardial infarction
4969138|NCT01773863|Platelet activation|platelet activation
4969139|NCT01773863|Coagulation abnormalities,|coagulation abnormalities,
4969140|NCT01773863|Thrombosis|thrombosis
4969141|NCT01773863|Isoprosantes|isoprosantes
4969142|NCT01773863|NADPH oxidase|nadph oxidase
4969143|NCT01773863|Major adverse cardiac and cerebrovascular events|major adverse cardiac and cerebrovascular events
4969144|NCT01773850|breast cancer|breast cancer
4969145|NCT01773837|asthenia|asthenia
4969146|NCT01773837|advanced cancer|advanced cancer
4969147|NCT01773837|randomized controlled trial|randomized controlled trial
4969148|NCT01773824|antibiotic|antibiotic
4969149|NCT01773824|prescription rate|prescription rate
4969150|NCT01773811|Posttraumatic Stress Disorder (PTSD)|posttraumatic stress disorder (ptsd)
4969151|NCT01773811|Narrative Writing|narrative writing
4969152|NCT01773759|Immunizations|immunizations
4969153|NCT01773759|Child care|child care
4969154|NCT01773759|School health promotion|school health promotion
4969155|NCT01773746|neonatal|neonatal
4969156|NCT01773746|resuscitation|resuscitation
4969157|NCT01773746|room air|room air
4969158|NCT01773720|cardiac index|cardiac index
4969159|NCT01773720|coronary artery bypass|coronary artery bypass
4969160|NCT01773720|uncalibrated pulse contour analysis|uncalibrated pulse contour analysis
4969161|NCT01773720|hemodynamic monitoring|hemodynamic monitoring
4969162|NCT01773707|prevention of type 1 diabetes|prevention of type 1 diabetes
4969163|NCT01773707|prevention of abnormal glucose tolerance|prevention of abnormal glucose tolerance
4969164|NCT01773694|Post-operative management|post-operative management
4969165|NCT01773694|Post-operative complications|post-operative complications
4969166|NCT01773694|Post-operative treatment|post-operative treatment
4969167|NCT01773694|water|water
4969168|NCT01773694|skin|skin
4969169|NCT01773694|Dermatologic Surgical Procedures|dermatologic surgical procedures
4969170|NCT01773655|somatic|somatic
4969171|NCT01773655|germline|germline
4969172|NCT01773655|mutations|mutations
4969173|NCT01773655|BAP1 (BRCA associated protein-1)|bap1 (brca associated protein-1)
4969174|NCT01773655|12-235|12-235
4969175|NCT01773642|pediatric HIV diagnosis disclosure|pediatric hiv diagnosis disclosure
4969176|NCT01773642|cognitive behavioral intervention|cognitive behavioral intervention
4969177|NCT01773642|Uganda|uganda
4969178|NCT01773629|Depression|depression
4969179|NCT01773629|Pregnancy|pregnancy
4969180|NCT01773629|Postpartum|postpartum
4969181|NCT01773629|Perinatal|perinatal
4969182|NCT01773616|Systemic lupus erythematosus|systemic lupus erythematosus
4969183|NCT01773616|Lupus|lupus
4969184|NCT01773616|Nephritis|nephritis
4969185|NCT01773603|Time-lapse|time-lapse
4969186|NCT01773603|morphokinetics|morphokinetics
4969187|NCT01773603|blastocyst transfer|blastocyst transfer
4969188|NCT01773603|eSET|eset
4969189|NCT01773577|EHR|ehr
4969190|NCT01773577|VHR|vhr
4969191|NCT01773577|Electronic Health Record|electronic health record
4969192|NCT01773564|Dressings, Prevention,|dressings, prevention,
4969193|NCT01773538|quality of life|quality of life
4969194|NCT01773512|Intravascular ultrasound|intravascular ultrasound
4969195|NCT01773512|Virtual histology|virtual histology
4969196|NCT01773512|Optical coherence tomography|optical coherence tomography
4969197|NCT01773512|Coronary atherosclerosis|coronary atherosclerosis
4969198|NCT01773512|Statins|statins
4969199|NCT01773512|Retinal imaging|retinal imaging
4969200|NCT01773499|cellulitis|cellulitis
4969201|NCT01773499|ultrasound|ultrasound
4969202|NCT01773486|Obesity|obesity
4969203|NCT01773486|Insulin Resistance|insulin resistance
4969204|NCT01773486|Endothelial dysfunction|endothelial dysfunction
4969205|NCT01773486|Blood pressure|blood pressure
4969206|NCT01773460|everolimus progress exemestane|everolimus progress exemestane
4969207|NCT01773460|treated with exemestane and everolimus|treated with exemestane and everolimus
4969208|NCT01773460|progress under this treatment|progress under this treatment
4969209|NCT01773395|Advanced|advanced
4969210|NCT01773369|cerebral palsy|cerebral palsy
4969211|NCT01773369|physical therapy|physical therapy
4969212|NCT01773369|rehabilitation|rehabilitation
4969213|NCT01773356|Obesity|obesity
4969214|NCT01773356|Body Weight|body weight
4969215|NCT01773356|Body Composition|body composition
4969216|NCT01773356|Metabolism|metabolism
4969217|NCT01773356|Resting Energy Expenditure|resting energy expenditure
4969218|NCT01773343|skin texture, efficacy, adverse effects|skin texture, efficacy, adverse effects
4969219|NCT01773330|high resolution manometry|high resolution manometry
4969220|NCT01773330|provocative swallow|provocative swallow
4969221|NCT01773330|impedence|impedence
4969222|NCT01773304|Obesity|obesity
4969223|NCT01773304|Adults|adults
4969224|NCT01773304|Bone metabolism|bone metabolism
4969225|NCT01773304|Metabolic profile|metabolic profile
4969226|NCT01773304|Dairy protein|dairy protein
4969227|NCT01773304|Meat protein|meat protein
4969228|NCT01773291|Acupuncture; laser acupuncture; traumatic brain injury|acupuncture; laser acupuncture; traumatic brain injury
4969229|NCT01773278|Antioxidant treatment|antioxidant treatment
4969230|NCT01773278|Oxysterols|oxysterols
4969231|NCT01773278|Cholesterol deficiency|cholesterol deficiency
4969232|NCT01773278|Accumulation of 7-dehydrocholesterol|accumulation of 7-dehydrocholesterol
4969233|NCT01773278|electroretinogram (ERG)|electroretinogram (erg)
4969234|NCT01773278|Auditory Brainstem Response (ABR)|auditory brainstem response (abr)
4969235|NCT01773252|RLS|rls
4969236|NCT01773252|RTLS|rtls
4969237|NCT01773252|PFO|pfo
4969238|NCT01773252|ASD|asd
4969239|NCT01773252|shunt|shunt
4969240|NCT01773252|cardiac|cardiac
4969241|NCT01773252|paradoxical thromboembolism|paradoxical thromboembolism
4969242|NCT01773252|interventional cardiology|interventional cardiology
4969243|NCT01773252|stroke|stroke
4969244|NCT01773252|migraine|migraine
4969245|NCT01773252|aura|aura
4969246|NCT01773252|obstructive sleep apnea|obstructive sleep apnea
4969247|NCT01773252|decompression illness|decompression illness
4969248|NCT01773252|neurology|neurology
4969249|NCT01773252|transesophageal echocardiography|transesophageal echocardiography
4969250|NCT01773252|TEE|tee
4969251|NCT01773252|transthoracic echocardiography|transthoracic echocardiography
4969252|NCT01773252|TTE|tte
4969253|NCT01773252|transcranial Doppler|transcranial doppler
4969254|NCT01773252|ultrasound|ultrasound
4969255|NCT01773252|TCD|tcd
4969256|NCT01773252|power m Mode|power m mode
4969257|NCT01773252|indocyanine green dye|indocyanine green dye
4969258|NCT01773252|ICG|icg
4969259|NCT01773252|Valsalva|valsalva
4969260|NCT01773239|social cognition|social cognition
4969261|NCT01773239|cognitive deficits|cognitive deficits
4969262|NCT01773239|prodromal schizophrenia|prodromal schizophrenia
4969263|NCT01773239|recent-onset schizophrenia|recent-onset schizophrenia
4969264|NCT01773239|remediation|remediation
4969265|NCT01773239|computer training|computer training
4969266|NCT01773239|cognitive training exercises|cognitive training exercises
4969267|NCT01773226|Autologous Protein Solution|autologous protein solution
4969268|NCT01773226|APS|aps
4969269|NCT01773226|Osteoarthritis|osteoarthritis
4969270|NCT01773226|Injection|injection
4969271|NCT01773213|Lower urinary tract|lower urinary tract
4969272|NCT01773213|Bladder|bladder
4969273|NCT01773213|Neuropathic bladder|neuropathic bladder
4969274|NCT01773213|Overactive bladder|overactive bladder
4969275|NCT01773200|endothelial progenitor cells|endothelial progenitor cells
4969276|NCT01773200|aneurysmal subarachnoid hemorrhage|aneurysmal subarachnoid hemorrhage
4969277|NCT01773200|vasospasm|vasospasm
4969278|NCT01773200|BNP|bnp
4969279|NCT01773187|Myelofibrosis|myelofibrosis
4969280|NCT01773187|Post-Polycythemia Vera Myelofibrosis|post-polycythemia vera myelofibrosis
4969281|NCT01773187|Post-Essential Thrombocythemia Myelofibrosis|post-essential thrombocythemia myelofibrosis
4969282|NCT01773187|Primary Myelofibrosis|primary myelofibrosis
4969283|NCT01773187|Polycythemia|polycythemia
4969284|NCT01773187|Polycythemia Vera|polycythemia vera
4969285|NCT01773187|Thrombocythemia, Essential|thrombocythemia, essential
4969286|NCT01773187|Thrombocythemia|thrombocythemia
4969287|NCT01773187|Myeloproliferative Disorders|myeloproliferative disorders
4969288|NCT01773187|Bone Marrow Disease|bone marrow disease
4969289|NCT01773187|Hematologic Diseases|hematologic diseases
4969290|NCT01773187|Blood Platelet Disorders|blood platelet disorders
4969291|NCT01773187|Hemorrhagic Disorders|hemorrhagic disorders
4969292|NCT01773187|Splenomegaly|splenomegaly
4969293|NCT01773187|Pacritinib|pacritinib
4969294|NCT01773187|MPN-SAF|mpn-saf
4969295|NCT01773187|MPN-SAF TSS|mpn-saf tss
4969296|NCT01773187|Anemia|anemia
4969297|NCT01773187|Myeloproliferative|myeloproliferative
4969298|NCT01773187|Myeloproliferative Neoplasm|myeloproliferative neoplasm
4969299|NCT01773187|Spleen|spleen
4969300|NCT01773187|Spleen volume|spleen volume
4969301|NCT01773187|Thrombocytopenia|thrombocytopenia
4969302|NCT01773187|SB1518|sb1518
4969303|NCT01773161|Cerebral Palsy|cerebral palsy
4969304|NCT01773161|Hip surgery|hip surgery
4969305|NCT01773161|Quality of Life|quality of life
4969306|NCT01773135|threatened preterm labor|threatened preterm labor
4969307|NCT01773135|ACTH|acth
4969308|NCT01773135|PTL|ptl
4969309|NCT01773109|Male and female subjects 18 years of age and older|male and female subjects 18 years of age and older
4969310|NCT01773109|metastatic or recurrent NSCLC|metastatic or recurrent nsclc
4969311|NCT01773109|who have failed 2nd line therapy (with up to two prior cytotoxic regimens and one prior exposure to an oral TKI).|who have failed 2nd line therapy (with up to two prior cytotoxic regimens and one prior exposure to an oral tki).
4969312|NCT01773096|opioid-induced|opioid-induced
4969313|NCT01773083|Inhalation trauma|inhalation trauma
4969314|NCT01773083|pulmonary coagulopathy|pulmonary coagulopathy
4969315|NCT01773083|heparin nebulization|heparin nebulization
4969316|NCT01773083|mechanical ventilation|mechanical ventilation
4969317|NCT01773070|Chronic Hepatitis C|chronic hepatitis c
4969318|NCT01773070|Hepatitis C virus|hepatitis c virus
4969319|NCT01773070|Direct Acting Antiviral|direct acting antiviral
4969320|NCT01773070|Sustained Virologic Response|sustained virologic response
4969321|NCT01773070|Hepatitis C|hepatitis c
4969322|NCT01773070|Persistence of treatment-emergent substitutions|persistence of treatment-emergent substitutions
4969323|NCT01773057|Computerized Decision Support System|computerized decision support system
4969324|NCT01773057|Heart failure|heart failure
4969325|NCT01773057|Effects on quality of care|effects on quality of care
4969326|NCT01773057|Process of care|process of care
4969327|NCT01773057|Patient outcomes|patient outcomes
4969328|NCT01773031|Autoimmune pancreatitis|autoimmune pancreatitis
4969329|NCT01773031|MR pancreatography|mr pancreatography
4969330|NCT01773005|Anesthetics, Intravenous|anesthetics, intravenous
4969331|NCT01772992|HIV couples adherence linkage to care viral suppression|hiv couples adherence linkage to care viral suppression
4969332|NCT01772979|Trabectedin|trabectedin
4969333|NCT01772979|BRCA1 and BRCA2|brca1 and brca2
4969334|NCT01772979|BRCAness|brcaness
4969335|NCT01772979|Ovarian cancer|ovarian cancer
4969336|NCT01772966|neck|neck
4969337|NCT01772966|pain|pain
4969338|NCT01772966|chronic|chronic
4969339|NCT01772966|manipulation|manipulation
4969340|NCT01772966|control|control
4969341|NCT01772966|randomized trial|randomized trial
4969342|NCT01772953|AML|aml
4969343|NCT01772953|MDS|mds
4969344|NCT01772953|Treosulfan|treosulfan
4969345|NCT01772940|First-line therapy|first-line therapy
4969346|NCT01772940|Protease inhibitor|protease inhibitor
4969347|NCT01772940|Non-Nucleoside Reverse transcriptase Inhibitor|non-nucleoside reverse transcriptase inhibitor
4969348|NCT01772940|Resource-limited setting|resource-limited setting
4969349|NCT01772927|parenteral nutrition|parenteral nutrition
4969350|NCT01772927|Very low birth weight infants|very low birth weight infants
4969351|NCT01772927|preterm infants|preterm infants
4969352|NCT01772927|biochemical tolerance|biochemical tolerance
4969353|NCT01772927|nutritional intake|nutritional intake
4969355|NCT01772914|eating|eating
4969356|NCT01772914|glucose tolerance test|glucose tolerance test
4969357|NCT01772914|mixed meal test|mixed meal test
4969358|NCT01772914|physiological|physiological
4969359|NCT01772901|influenza|influenza
4969360|NCT01772901|influenza vaccines|influenza vaccines
4969361|NCT01772901|infectious disease|infectious disease
4969362|NCT01772901|pregnancy|pregnancy
4969363|NCT01772875|urinary catheter|urinary catheter
4969364|NCT01772875|UTI|uti
4969365|NCT01772875|bladder lavage|bladder lavage
4969366|NCT01772862|childhood|childhood
4969367|NCT01772862|cancer|cancer
4969368|NCT01772862|physical activity|physical activity
4969369|NCT01772862|quality of life|quality of life
4969370|NCT01772849|childhood|childhood
4969371|NCT01772849|cancer|cancer
4969372|NCT01772849|education|education
4969373|NCT01772849|physical activity|physical activity
4969374|NCT01772849|quality of life|quality of life
4969375|NCT01772823|HIV, PrEP, FTC/TDF, Truvada®|hiv, prep, ftc/tdf, truvada®
4969376|NCT01772810|Paralysis, spinal cord injury, chronic spinal cord injury, cspine injury, neck injury|paralysis, spinal cord injury, chronic spinal cord injury, cspine injury, neck injury
4969377|NCT01772797|anaplastic lymphoma kinase, ALK-rearranged lung cancer, non-small cell lung cancer|anaplastic lymphoma kinase, alk-rearranged lung cancer, non-small cell lung cancer
4969378|NCT01772784|subjects|subjects
4969379|NCT01772771|Cancer|cancer
4969380|NCT01772771|Molecular testing|molecular testing
4969381|NCT01772771|Personalized Cancer Therapy Program|personalized cancer therapy program
4969382|NCT01772771|Bladder|bladder
4969383|NCT01772771|Bone|bone
4969384|NCT01772771|Breast|breast
4969385|NCT01772771|Cytology|cytology
4969386|NCT01772771|Endocrine|endocrine
4969387|NCT01772771|Gynecology|gynecology
4969388|NCT01772771|Endocrine - Neoplasia|endocrine - neoplasia
4969389|NCT01772771|genitourinary|genitourinary
4969390|NCT01772771|Research Biorepository|research biorepository
4969391|NCT01772771|Head and Neck|head and neck
4969392|NCT01772771|Aerodigestive Tract|aerodigestive tract
4969393|NCT01772771|Hematopathology|hematopathology
4969394|NCT01772771|Human Cancer Genetics|human cancer genetics
4969395|NCT01772771|Kidney|kidney
4969396|NCT01772771|Leukemia|leukemia
4969397|NCT01772771|Lower Gastrointestinal|lower gastrointestinal
4969398|NCT01772771|Lymphoma|lymphoma
4969399|NCT01772771|Melanoma|melanoma
4969400|NCT01772771|Neurology|neurology
4969401|NCT01772771|Brain|brain
4969402|NCT01772771|Non-Melanoma Skin|non-melanoma skin
4969403|NCT01772771|Pancreas|pancreas
4969404|NCT01772771|Pediatrics|pediatrics
4969405|NCT01772771|Prostate|prostate
4969406|NCT01772771|Breast Cancer Patients, Serum|breast cancer patients, serum
4969407|NCT01772771|Plasma|plasma
4969408|NCT01772771|Soft Tissue Sarcoma|soft tissue sarcoma
4969409|NCT01772771|Thoracic|thoracic
4969410|NCT01772771|Lung|lung
4969411|NCT01772771|S.P.O.R.E.|s.p.o.r.e.
4969412|NCT01772771|Upper Gastrointestinal|upper gastrointestinal
4969413|NCT01772758|CF, cystic fibrosis, exercise|cf, cystic fibrosis, exercise
4969414|NCT01772745|single incision|single incision
4969415|NCT01772745|cholecystectomy|cholecystectomy
4969416|NCT01772745|laparoscopy|laparoscopy
4969417|NCT01772732|Simotinib|simotinib
4969418|NCT01772732|Non-small Cell Lung Cancer|non-small cell lung cancer
4969419|NCT01772719|refractory multiple myeloma|refractory multiple myeloma
4969420|NCT01772706|Head and neck cancer|head and neck cancer
4969421|NCT01772706|Low level laser therapy|low level laser therapy
4969422|NCT01772706|Mucositis induced by radiochemotherpy|mucositis induced by radiochemotherpy
4969423|NCT01772693|ExAblate Transcranial MRgFUS|exablate transcranial mrgfus
4969424|NCT01772680|Thalassemia|thalassemia
4969425|NCT01772680|Diabetes|diabetes
4969426|NCT01772680|Zinc|zinc
4969427|NCT01772680|Iron-Overload|iron-overload
4969428|NCT01772667|pulmonary fibrosis|pulmonary fibrosis
4969429|NCT01772667|interstitial lung disease|interstitial lung disease
4969430|NCT01772667|pulmonary rehabilitation|pulmonary rehabilitation
4969431|NCT01772667|exercise capacity|exercise capacity
4969432|NCT01772667|physical activity|physical activity
4969433|NCT01772667|quality of life|quality of life
4969434|NCT01772654|Epilepsy|epilepsy
4969435|NCT01772654|Arterial Spin Labeled MRI|arterial spin labeled mri
4969436|NCT01772654|Brain lesions|brain lesions
4969437|NCT01772654|Cerebral blood flow|cerebral blood flow
4969438|NCT01772641|cigarette|cigarette
4969439|NCT01772641|smoking|smoking
4969440|NCT01772641|cessation|cessation
4969441|NCT01772641|varenicline|varenicline
4969442|NCT01772641|scheduled reduction|scheduled reduction
4969443|NCT01772641|craving|craving
4969444|NCT01772628|Communication|communication
4969445|NCT01772628|Healthy sexual behaviour|healthy sexual behaviour
4969446|NCT01772628|Sexual and reproductive health|sexual and reproductive health
4969447|NCT01772628|Adolescents|adolescents
4969448|NCT01772615|EcN, Nissle, Mutaflor, Ulcerative Colitis, antibiotics, Inflammatory Bowel Diseases|ecn, nissle, mutaflor, ulcerative colitis, antibiotics, inflammatory bowel diseases
4969449|NCT01772602|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
4969450|NCT01772602|Lou Gehrig's Disease|lou gehrig's disease
4969451|NCT01772602|Motor Neuron Disease|motor neuron disease
4969452|NCT01772576|Reliance|reliance
4969554|NCT01772160|Incidence|incidence
4969453|NCT01772576|Implantable Cardioverter Defibrillator (ICD)|implantable cardioverter defibrillator (icd)
4969454|NCT01772576|Cardiac Resynchronization Therapy - Defibrillator (CRT-D)|cardiac resynchronization therapy - defibrillator (crt-d)
4969455|NCT01772550|CECT, catheter, contrast|cect, catheter, contrast
4969456|NCT01772537|thoracoabdominal|thoracoabdominal
4969457|NCT01772537|aneurysm|aneurysm
4969458|NCT01772537|open|open
4969459|NCT01772537|stent|stent
4969460|NCT01772537|cardiopulmonary|cardiopulmonary
4969461|NCT01772537|abdominal|abdominal
4969462|NCT01772537|bypass|bypass
4969463|NCT01772524|Migraine Disorders|migraine disorders
4969464|NCT01772524|Phase 1|phase 1
4969465|NCT01772524|ALD403|ald403
4969466|NCT01772511|questionnaire|questionnaire
4969467|NCT01772511|prior therapy|prior therapy
4969468|NCT01772511|prior study volunteer|prior study volunteer
4969469|NCT01772511|prior study patient|prior study patient
4969470|NCT01772511|cancer|cancer
4969471|NCT01772511|oncology|oncology
4969472|NCT01772498|depression|depression
4969473|NCT01772498|anxiety|anxiety
4969474|NCT01772498|sleep|sleep
4969475|NCT01772498|pain|pain
4969476|NCT01772498|biofeedback|biofeedback
4969477|NCT01772498|breathing|breathing
4969478|NCT01772498|resonant|resonant
4969479|NCT01772459|Scoliosis|scoliosis
4969480|NCT01772459|Adolescents|adolescents
4969481|NCT01772459|Questionnaire|questionnaire
4969482|NCT01772459|Reliability|reliability
4969483|NCT01772446|diabetes|diabetes
4969484|NCT01772446|management|management
4969485|NCT01772446|glycated hemoglobin|glycated hemoglobin
4969486|NCT01772446|preventive activities|preventive activities
4969487|NCT01772433|Low Back Pain|low back pain
4969488|NCT01772433|Topical Olive Oil|topical olive oil
4969489|NCT01772433|Phonophoresis|phonophoresis
4969490|NCT01772407|Colon Cancer Surgery|colon cancer surgery
4969491|NCT01772407|Laparoscopy|laparoscopy
4969492|NCT01772407|Open surgery|open surgery
4969493|NCT01772407|Costs|costs
4969494|NCT01772407|Mortality|mortality
4969495|NCT01772407|Morbidity|morbidity
4969496|NCT01772407|Quality of life|quality of life
4969497|NCT01772394|Anorexia Nervosa|anorexia nervosa
4969498|NCT01772394|Cognitive remediation therapy|cognitive remediation therapy
4969499|NCT01772394|Randomized clinical trial|randomized clinical trial
4969500|NCT01772381|Dexamethasone, term, elective cesarean section|dexamethasone, term, elective cesarean section
4969501|NCT01772368|Asthma|asthma
4969502|NCT01772368|dry powder inhaler|dry powder inhaler
4969503|NCT01772368|long-acting beta2-agonist|long-acting beta2-agonist
4969504|NCT01772368|bronchodilation|bronchodilation
4969505|NCT01772368|bronchodilator|bronchodilator
4969506|NCT01772368|metered dose inhaler|metered dose inhaler
4969507|NCT01772368|inhaled corticosteroid|inhaled corticosteroid
4969508|NCT01772355|orbit; tumor; core biopsy|orbit; tumor; core biopsy
4969509|NCT01772342|Sleep Fragmentation|sleep fragmentation
4969510|NCT01772342|Quality of Life|quality of life
4969511|NCT01772342|Air Filters|air filters
4969512|NCT01772303|Pressure Ulcers, diabetic Ulcers, post operational wounds|pressure ulcers, diabetic ulcers, post operational wounds
4969513|NCT01772277|Endoscopic dacryocystorhinostomy|endoscopic dacryocystorhinostomy
4969514|NCT01772277|Mitomycin C|mitomycin c
4969515|NCT01772251|Diabetes Mellitus|diabetes mellitus
4969516|NCT01772251|Oral Insulin|oral insulin
4969517|NCT01772238|Mexico|mexico
4969518|NCT01772238|Respiratory infections|respiratory infections
4969519|NCT01772238|Amoxicillin-Clavulanic Acid|amoxicillin-clavulanic acid
4969520|NCT01772238|Bioequivalence|bioequivalence
4969521|NCT01772225|Observational Retrospective|observational retrospective
4969522|NCT01772225|Health-related quality of life (HRQoL)|health-related quality of life (hrqol)
4969523|NCT01772225|Patients|patients
4969524|NCT01772225|Stage IB-IIIA|stage ib-iiia
4969525|NCT01772225|Burden of Illness|burden of illness
4969526|NCT01772225|Non-small Cell Lung Cancer (NSCLC)|non-small cell lung cancer (nsclc)
4969527|NCT01772212|Mexico|mexico
4969528|NCT01772212|terbinafine|terbinafine
4969529|NCT01772212|mycoses|mycoses
4969530|NCT01772212|pharmacokinetics|pharmacokinetics
4969531|NCT01772199|GSK239512|gsk239512
4969532|NCT01772199|remyelination|remyelination
4969533|NCT01772199|magnetic resonance imaging|magnetic resonance imaging
4969534|NCT01772199|Relapsing Remitting Multiple Sclerosis|relapsing remitting multiple sclerosis
4969535|NCT01772199|Histamine 3 Receptor Antagonist|histamine 3 receptor antagonist
4969536|NCT01772199|magnetization transfer ratio|magnetization transfer ratio
4969537|NCT01772186|Freezing of gait|freezing of gait
4969538|NCT01772186|Parkinson's disease|parkinson's disease
4969539|NCT01772186|Somatosensory stimulation|somatosensory stimulation
4969540|NCT01772186|Fall prevention|fall prevention
4969541|NCT01772173|diabetes|diabetes
4969542|NCT01772173|computer|computer
4969543|NCT01772173|retina|retina
4969544|NCT01772173|vessel|vessel
4969545|NCT01772173|analysis|analysis
4969546|NCT01772160|Adults|adults
4969547|NCT01772160|Italy|italy
4969548|NCT01772160|Herpes Zoster|herpes zoster
4969549|NCT01772160|Complications|complications
4969550|NCT01772160|Quality of life|quality of life
4969551|NCT01772160|Surveillance|surveillance
4969552|NCT01772160|Burden|burden
4969553|NCT01772160|Cost|cost
4969555|NCT01772121|HBV, HCV, chronic, India, observational study, prevalence,|hbv, hcv, chronic, india, observational study, prevalence,
4969556|NCT01772121|genotypes, SNPs, viral hepatitis|genotypes, snps, viral hepatitis
4969557|NCT01772108|Heart Valve Diseases|heart valve diseases
4969558|NCT01772095|Donepezil (Dementis)|donepezil (dementis)
4969559|NCT01772095|Elderly|elderly
4969560|NCT01772069|systemic lupus erythematosus, disease activity, sleep, quality of life|systemic lupus erythematosus, disease activity, sleep, quality of life
4969561|NCT01772056|Dermatitis, Atopic|dermatitis, atopic
4969562|NCT01772056|Randomized Controlled Trial|randomized controlled trial
4969563|NCT01772056|Child|child
4969564|NCT01772056|Fluticasone|fluticasone
4969565|NCT01772056|Preventive therapy|preventive therapy
4969566|NCT01772043|muscular dystrophy|muscular dystrophy
4969567|NCT01772043|tissue bank|tissue bank
4969568|NCT01772030|Atrial Fibrillation|atrial fibrillation
4969569|NCT01772030|Cryoballoon Ablation|cryoballoon ablation
4969570|NCT01772017|Obstructive Sleep Apnea|obstructive sleep apnea
4969572|NCT01772017|Snoring|snoring
4969573|NCT01772017|Tongue Advancement Retainer Device|tongue advancement retainer device
4969574|NCT01772004|Solid Tumors|solid tumors
4969575|NCT01772004|MSB0010718C|msb0010718c
4969576|NCT01772004|Phase 1|phase 1
4969577|NCT01772004|Pharmacokinetic|pharmacokinetic
4969578|NCT01772004|anti PD-L1|anti pd-l1
4969579|NCT01772004|Non-small cell lung cancer (NSCLC)|non-small cell lung cancer (nsclc)
4969580|NCT01772004|Metastatic breast cancer (MBC)|metastatic breast cancer (mbc)
4969581|NCT01772004|Gastric and gastroesophageal junction (GEJ) cancer|gastric and gastroesophageal junction (gej) cancer
4969582|NCT01772004|Ovarian cancer|ovarian cancer
4969583|NCT01772004|Colorectal cancer (CRC)|colorectal cancer (crc)
4969584|NCT01772004|Castrate-resistant prostate cancer (CRPC)|castrate-resistant prostate cancer (crpc)
4969585|NCT01772004|Melanoma|melanoma
4969586|NCT01772004|Urothelial carcinoma|urothelial carcinoma
4969587|NCT01772004|Bladder cancer|bladder cancer
4969588|NCT01772004|Head and neck squamous cell carcinoma (HNSCC)|head and neck squamous cell carcinoma (hnscc)
4969589|NCT01772004|Renal cell carcinoma (RCC)|renal cell carcinoma (rcc)
4969590|NCT01772004|Adrenocortical carcinoma (ACC)|adrenocortical carcinoma (acc)
4969591|NCT01771991|fibrosis|fibrosis
4969592|NCT01771991|radiation|radiation
4969593|NCT01771991|neck|neck
4969594|NCT01771991|cancer|cancer
4969595|NCT01771991|Sodermix|sodermix
4969596|NCT01771978|ischaemia-reperfusion injury|ischaemia-reperfusion injury
4969597|NCT01771978|cardiac surgery|cardiac surgery
4969598|NCT01771978|oxidative stress markers|oxidative stress markers
4969599|NCT01771978|troponin|troponin
4969600|NCT01771978|diltiazem|diltiazem
4969601|NCT01771978|acetylcystein|acetylcystein
4969602|NCT01771952|Patellofemoral Chondromalacia|patellofemoral chondromalacia
4969603|NCT01771952|Anterior Knee Pain|anterior knee pain
4969604|NCT01771952|Patellofemoral Pain Syndrome|patellofemoral pain syndrome
4969605|NCT01771952|Synvisc-One|synvisc-one
4969606|NCT01771952|Hyaluronic Acid|hyaluronic acid
4969607|NCT01771939|Idiopathic epiretinal membranes|idiopathic epiretinal membranes
4969608|NCT01771939|25-G surgery in idiopathic epiretinal membranes|25-g surgery in idiopathic epiretinal membranes
4969609|NCT01771926|resistant starch|resistant starch
4969610|NCT01771926|lifestyle intervention|lifestyle intervention
4969611|NCT01771913|adipocytes|adipocytes
4969612|NCT01771913|cell transplantations|cell transplantations
4969613|NCT01771913|mesenchymal stem cell|mesenchymal stem cell
4969614|NCT01771913|immunophenotyping|immunophenotyping
4969615|NCT01771913|adipose tissue|adipose tissue
4969616|NCT01771913|breast reconstruction|breast reconstruction
4969617|NCT01771913|mammaplasty|mammaplasty
4969618|NCT01771913|magnetic resonance imaging|magnetic resonance imaging
4969619|NCT01771913|fat necrosis|fat necrosis
4969620|NCT01771900|heart failure|heart failure
4969621|NCT01771900|exercise|exercise
4969622|NCT01771900|adherence to exercise|adherence to exercise
4969623|NCT01771887|Diabetic Type2|diabetic type2
4969624|NCT01771887|education|education
4969625|NCT01771887|self-management behaviors|self-management behaviors
4969626|NCT01771887|self-efficacy|self-efficacy
4969627|NCT01771887|HbA1c|hba1c
4969628|NCT01771874|MDMA|mdma
4969629|NCT01771874|pharmacokinetics|pharmacokinetics
4969630|NCT01771874|pharmacodynamics|pharmacodynamics
4969631|NCT01771874|emotions|emotions
4969632|NCT01771874|Mechanism of action of MDMA|mechanism of action of mdma
4969633|NCT01771874|Interaction study|interaction study
4969634|NCT01771874|Effect of MDMA and bupropion on emotions|effect of mdma and bupropion on emotions
4969635|NCT01771848|Malaria|malaria
4969636|NCT01771848|Plasmodium falciparum|plasmodium falciparum
4969637|NCT01771835|diabetes mellitus|diabetes mellitus
4969638|NCT01771835|retinal venous pressure|retinal venous pressure
4969639|NCT01771835|endothelin-1|endothelin-1
4969640|NCT01771822|cumulative irritancy patch test (CIPT)|cumulative irritancy patch test (cipt)
4969641|NCT01771809|Anti-TNF Refractory|anti-tnf refractory
4969642|NCT01771809|Active Ulcerative Colitis|active ulcerative colitis
4969643|NCT01771809|Immunosuppressant Refractory|immunosuppressant refractory
4969644|NCT01771796|Exercise; lung cancer; aerobic training, resistance training; respiratory muscle training|exercise; lung cancer; aerobic training, resistance training; respiratory muscle training
4969645|NCT01771783|RAS-Peptide Profile|ras-peptide profile
4969646|NCT01771783|Renin-Angiotensin-System|renin-angiotensin-system
4969647|NCT01771783|Angiotensin-Converting-Enzyme-Inhibitor|angiotensin-converting-enzyme-inhibitor
4969648|NCT01771783|Angiotensin-Receptor-Antagonist|angiotensin-receptor-antagonist
4969649|NCT01771783|Renin-inhibitor|renin-inhibitor
4969650|NCT01771770|retinal venous pressure (RVP)|retinal venous pressure (rvp)
4969651|NCT01771770|chronically reduced ambient pressure|chronically reduced ambient pressure
4969652|NCT01771770|oxygen partial pressure|oxygen partial pressure
4969653|NCT01771770|mountain sickness|mountain sickness
4969654|NCT01771757|retinal venous pressure|retinal venous pressure
4969655|NCT01771757|reduced ambient pressure|reduced ambient pressure
4969656|NCT01771757|oxygen partial pressure|oxygen partial pressure
4969657|NCT01771757|short-term hypoxic changes|short-term hypoxic changes
4969658|NCT01771705|Transplantation|transplantation
4969659|NCT01771705|Kidney|kidney
4969660|NCT01771705|calcineurin inhibitor|calcineurin inhibitor
4969661|NCT01771705|NFAT|nfat
4969662|NCT01771705|tacrolimus|tacrolimus
4969663|NCT01771692|Orthodontics|orthodontics
4969664|NCT01771679|Mesenchymal Stem Cells|mesenchymal stem cells
4969665|NCT01771679|Bone Marrow Cells|bone marrow cells
4969666|NCT01771679|Allogeneic Transplantation|allogeneic transplantation
4969667|NCT01771679|Skin Wrinkling|skin wrinkling
4969668|NCT01771679|Solar Aging of Skin|solar aging of skin
4969669|NCT01771679|Intravenous Administration|intravenous administration
4969670|NCT01771653|Hepatitis C infection|hepatitis c infection
4969671|NCT01771653|Hepatitis C Virus|hepatitis c virus
4969672|NCT01771653|HCV|hcv
4969673|NCT01771640|ALS intrathecal injection bone marrow mesenchymal stem cell|als intrathecal injection bone marrow mesenchymal stem cell
4969674|NCT01771614|Glucotoxicity|glucotoxicity
4969675|NCT01771614|Exercise|exercise
4969676|NCT01771614|Beta-cell function|beta-cell function
4969677|NCT01771601|Near-infrared spectroscopy, cerebral oxygenation, term newborn, reproducibility,|near-infrared spectroscopy, cerebral oxygenation, term newborn, reproducibility,
4969678|NCT01771562|HIV-1|hiv-1
4969679|NCT01771562|Child|child
4969680|NCT01771562|Adolescent|adolescent
4969681|NCT01771562|Growth|growth
4969682|NCT01771562|Lipodystrophy|lipodystrophy
4969683|NCT01771562|ARV treatment|arv treatment
4969684|NCT01771562|Senegal|senegal
4969685|NCT01771549|Adriamycin|adriamycin
4969686|NCT01771549|Trastuzumab|trastuzumab
4969687|NCT01771549|Brain Natriuretic Peptide (BNP)|brain natriuretic peptide (bnp)
4969688|NCT01771549|Troponin|troponin
4969689|NCT01771523|thyroidectomy|thyroidectomy
4969690|NCT01771523|drain use|drain use
4969691|NCT01771497|Breast CT|breast ct
4969692|NCT01771484|tachycardia|tachycardia
4969693|NCT01771484|pots|pots
4969694|NCT01771484|orthostatic intolerance|orthostatic intolerance
4969695|NCT01771471|back pain|back pain
4969696|NCT01771471|intervertebral disc|intervertebral disc
4969697|NCT01771471|lumbar spine|lumbar spine
4969698|NCT01771458|Metastatic/Reccurent|metastatic/reccurent
4969699|NCT01771458|Solid Tumor|solid tumor
4969700|NCT01771458|Refractory|refractory
4969701|NCT01771458|Molecular profile|molecular profile
4969702|NCT01771458|Targeted treatment|targeted treatment
4969703|NCT01771445|IL-1|il-1
4969704|NCT01771445|IL-6|il-6
4969705|NCT01771445|Inflammation|inflammation
4969706|NCT01771419|loop-tip|loop-tip
4969707|NCT01771419|ERCP|ercp
4969708|NCT01771419|cannulation of CBD|cannulation of cbd
4969709|NCT01771393|arthroscanner|arthroscanner
4969710|NCT01771393|cone-beam computed tomodensitometry|cone-beam computed tomodensitometry
4969711|NCT01771354|Volunteers|volunteers
4969712|NCT01771354|Identify|identify
4969713|NCT01771354|Biomarkers|biomarkers
4969714|NCT01771354|Vaccine Safety|vaccine safety
4969715|NCT01771341|NAVA|nava
4969716|NCT01771341|post operative|post operative
4969717|NCT01771328|Adrenal Hyperplasia, Congenital|adrenal hyperplasia, congenital
4969718|NCT01771315|total knee arthroplasty|total knee arthroplasty
4969719|NCT01771315|telephone follow-up|telephone follow-up
4969720|NCT01771315|physical function|physical function
4969721|NCT01771315|health related quality of life|health related quality of life
4969722|NCT01771315|self-efficacy|self-efficacy
4969723|NCT01771302|PRGF-Endoret|prgf-endoret
4969724|NCT01771302|Bone graft|bone graft
4969725|NCT01771302|Maxillary sinus|maxillary sinus
4969726|NCT01771302|Vertical bone augmentation|vertical bone augmentation
4969727|NCT01771289|Lung Cancer|lung cancer
4969728|NCT01771276|POSE|pose
4969729|NCT01771263|Anesthesia|anesthesia
4969730|NCT01771263|Propofol|propofol
4969731|NCT01771263|Remifentanil|remifentanil
4969732|NCT01771263|NeuroSENSE|neurosense
4969733|NCT01771237|HIV infection|hiv infection
4969734|NCT01771224|Palmitoleic acid ulcerative colitis|palmitoleic acid ulcerative colitis
4969735|NCT01771211|MCI|mci
4969736|NCT01771211|Word-retrieval|word-retrieval
4969737|NCT01771211|tDCS|tdcs
4969738|NCT01771211|fMRI|fmri
4969739|NCT01771198|Chronic rhinosinusitis|chronic rhinosinusitis
4969740|NCT01771198|Refractory to treatment|refractory to treatment
4969741|NCT01771198|SIMVASTATIN|simvastatin
4969742|NCT01771185|Diabetes|diabetes
4969743|NCT01771185|metabolic surgery|metabolic surgery
4969744|NCT01771185|insulin resistance|insulin resistance
4969745|NCT01771159|Spinal cord injury|spinal cord injury
4969746|NCT01771159|Urinary dysfunction|urinary dysfunction
4969747|NCT01771159|Bladder drainage|bladder drainage
4969748|NCT01771146|Non-metastatic Pancreas Cancer|non-metastatic pancreas cancer
4969749|NCT01771146|Pancreatic Cancer|pancreatic cancer
4969750|NCT01771146|Cancer of Pancreas|cancer of pancreas
4969751|NCT01771146|Adenocarcinoma of Pancreas|adenocarcinoma of pancreas
4969752|NCT01771146|Neoadjuvant|neoadjuvant
4969753|NCT01771133|Obesity|obesity
4969754|NCT01771133|Maternal Welfare|maternal welfare
4969755|NCT01771133|Child Welfare|child welfare
4969756|NCT01771133|Nutritional Sciences|nutritional sciences
4969757|NCT01771133|Clinical Trial|clinical trial
4969758|NCT01771133|Pregnancy|pregnancy
4969759|NCT01771133|Physical activity|physical activity
4969760|NCT01771133|Fetal Development|fetal development
4969761|NCT01771133|Metabolic Diseases|metabolic diseases
4969762|NCT01771133|Life style|life style
4969763|NCT01771133|Behavior and Behavior Mechanisms|behavior and behavior mechanisms
4969764|NCT01771133|LIFE-Moms|life-moms
4969765|NCT01771120|Asthma|asthma
4969766|NCT01771120|Rhinitis|rhinitis
4969767|NCT01771120|Control|control
4969768|NCT01771120|Burden|burden
4969769|NCT01771081|Longitudinal Studies,|longitudinal studies,
4969770|NCT01771081|Observation|observation
4969771|NCT01771081|Epidemiology|epidemiology
4969772|NCT01771055|Trauma|trauma
4969773|NCT01771055|Hypovolemia|hypovolemia
4969774|NCT01771042|weight loss|weight loss
4969775|NCT01771042|metabolic syndrome|metabolic syndrome
4969776|NCT01771042|sympathetic nervous system|sympathetic nervous system
4969777|NCT01771042|insulin resistance|insulin resistance
4969778|NCT01771042|glucose tolerance|glucose tolerance
4969779|NCT01771029|Procalcitonin|procalcitonin
4969780|NCT01771029|Infection|infection
4969781|NCT01771029|Point-of-Care|point-of-care
4969782|NCT01771016|Emergency contraception|emergency contraception
4969783|NCT01771016|Emergency hormonal contraception|emergency hormonal contraception
4969784|NCT01771016|Community pharmacies|community pharmacies
4969785|NCT01771016|Pharmaceutical care|pharmaceutical care
4969786|NCT01771016|Time to access|time to access
4969787|NCT01771016|Written assessments|written assessments
4969788|NCT01771016|Switzerland|switzerland
4969789|NCT01771003|Partial nephrectomy|partial nephrectomy
4969790|NCT01771003|renal cell carcinoma|renal cell carcinoma
4969791|NCT01771003|Renal Function|renal function
4969792|NCT01771003|Remote ischemia preconditioning|remote ischemia preconditioning
4969793|NCT01770990|depression|depression
4969794|NCT01770990|telephone-based psychotherapy|telephone-based psychotherapy
4969795|NCT01770990|cognitive-behavioral psychotherapy|cognitive-behavioral psychotherapy
4969796|NCT01770990|manualized psychotherapy|manualized psychotherapy
4969797|NCT01770990|telephone counseling|telephone counseling
4969798|NCT01770990|telephone psychological treatment|telephone psychological treatment
4969799|NCT01770990|telephone-administered therapy|telephone-administered therapy
4969800|NCT01770990|low-intensity treatment|low-intensity treatment
4969801|NCT01770990|motivational mail|motivational mail
4969802|NCT01770990|reminder|reminder
4969803|NCT01770990|letter|letter
4969804|NCT01770977|Light-emitting diode therapy|light-emitting diode therapy
4969805|NCT01770977|Muscle performance|muscle performance
4969806|NCT01770977|Aerobic performance|aerobic performance
4969807|NCT01770977|Lactate|lactate
4969808|NCT01770977|Creatine kinase|creatine kinase
4969809|NCT01770938|Light-emitting diode therapy|light-emitting diode therapy
4969810|NCT01770938|Muscle performance|muscle performance
4969811|NCT01770938|Gene expression|gene expression
4969812|NCT01770938|Functional performance|functional performance
4969813|NCT01770912|facial pain|facial pain
4969814|NCT01770912|temporomandibular joint|temporomandibular joint
4969815|NCT01770912|arthrocentesis|arthrocentesis
4969816|NCT01770912|steroid|steroid
4969817|NCT01770899|Montelukast|montelukast
4969818|NCT01770899|Singulair|singulair
4969819|NCT01770899|status asthmaticus|status asthmaticus
4969820|NCT01770886|Drug Safety|drug safety
4969821|NCT01770873|Youth|youth
4969822|NCT01770873|Violence|violence
4969823|NCT01770873|Assault-injured|assault-injured
4969824|NCT01770873|Mentoring|mentoring
4969825|NCT01770873|Emergency Room|emergency room
4969826|NCT01770873|Urban|urban
4969827|NCT01770860|Adhesive Bandages|adhesive bandages
4969828|NCT01770860|Dermabrasion Wounds|dermabrasion wounds
4969829|NCT01770821|sip drink|sip drink
4969830|NCT01770821|protein|protein
4969831|NCT01770821|muscle strength|muscle strength
4969832|NCT01770821|6 minutes walking test|6 minutes walking test
4969833|NCT01770808|Bloating|bloating
4969834|NCT01770808|Flatulence|flatulence
4969835|NCT01770808|Stomach discomfort|stomach discomfort
4969836|NCT01770795|non-small cell lung cancer|non-small cell lung cancer
4969837|NCT01770795|gemcitabine|gemcitabine
4969838|NCT01770795|genexol-PM|genexol-pm
4969839|NCT01770795|paclitaxel|paclitaxel
4969840|NCT01770782|Palatal Expansion Technique|palatal expansion technique
4969841|NCT01770782|Orthognathic Surgery|orthognathic surgery
4969842|NCT01770782|Three Dimensional images|three dimensional images
4969843|NCT01770769|Femoral Neck Fracture|femoral neck fracture
4969844|NCT01770769|undisplaced|undisplaced
4969845|NCT01770769|minimally displaced|minimally displaced
4972019|NCT01760967|sepsis|sepsis
4969846|NCT01770769|internal fixation|internal fixation
4969847|NCT01770769|hemiarthroplasty|hemiarthroplasty
4969848|NCT01770769|harris hip score|harris hip score
4969849|NCT01770769|hospital cost|hospital cost
4969850|NCT01770769|society cost|society cost
4969851|NCT01770769|quality of life|quality of life
4969852|NCT01770769|Timed Up and go test|timed up and go test
4969853|NCT01770756|Hypertension|hypertension
4969854|NCT01770756|High blood pressure|high blood pressure
4969855|NCT01770756|Willpower|willpower
4969856|NCT01770756|Self care|self care
4969857|NCT01770743|post-exposure prophylaxis|post-exposure prophylaxis
4969858|NCT01770743|toxin neutralization assay|toxin neutralization assay
4969859|NCT01770730|urine LAM strip test|urine lam strip test
4969860|NCT01770730|diagnostics|diagnostics
4969861|NCT01770730|tuberculosis|tuberculosis
4969862|NCT01770704|Bipolar disorder|bipolar disorder
4969863|NCT01770704|Clinical management|clinical management
4969864|NCT01770704|Clinical outcomes|clinical outcomes
4969865|NCT01770678|Children|children
4969866|NCT01770678|Cerebral Palsy|cerebral palsy
4969867|NCT01770678|Randomised|randomised
4969868|NCT01770678|Constraint Induced Movement Therapy|constraint induced movement therapy
4969869|NCT01770652|Renal Impairment|renal impairment
4969870|NCT01770652|Kidney Impairment|kidney impairment
4969871|NCT01770652|Kidney Disease|kidney disease
4969872|NCT01770652|Ferriprox|ferriprox
4969873|NCT01770652|Deferiprone|deferiprone
4969874|NCT01770652|DFP (deferiprone)|dfp (deferiprone)
4969875|NCT01770652|L1|l1
4969876|NCT01770639|charcot foot|charcot foot
4969877|NCT01770639|charcot neuroarthropathy|charcot neuroarthropathy
4969878|NCT01770639|midfoot arthrodesis|midfoot arthrodesis
4969879|NCT01770639|midfoot fusion|midfoot fusion
4969880|NCT01770613|Adult|adult
4969881|NCT01770613|Allogeneic|allogeneic
4969882|NCT01770613|Stem|stem
4969883|NCT01770613|Cells|cells
4969884|NCT01770613|Myocardial|myocardial
4969885|NCT01770613|Infarction|infarction
4969886|NCT01770600|Age 19 to 64|age 19 to 64
4969887|NCT01770600|Medically stable|medically stable
4969888|NCT01770600|No current or history of psychosis|no current or history of psychosis
4969889|NCT01770600|No alcohol or benzodiazepine withdrawal|no alcohol or benzodiazepine withdrawal
4969890|NCT01770587|Insomnia|insomnia
4969891|NCT01770587|Sleep|sleep
4969892|NCT01770587|Behavioral Medicine|behavioral medicine
4969893|NCT01770587|Suicide|suicide
4969894|NCT01770587|Suicidal Ideation|suicidal ideation
4969895|NCT01770574|calcaneal lengthening|calcaneal lengthening
4969896|NCT01770574|calcium ceramics|calcium ceramics
4969897|NCT01770574|noninferiority|noninferiority
4969898|NCT01770574|radiostereometric analysis|radiostereometric analysis
4969899|NCT01770535|Ovarian cancer, paclitaxel|ovarian cancer, paclitaxel
4969900|NCT01770522|Bodyweight|bodyweight
4969901|NCT01770522|Physical Acivitiy|physical acivitiy
4969902|NCT01770522|Diet|diet
4969903|NCT01770522|Bodymass index|bodymass index
4969904|NCT01770522|Pregnancy|pregnancy
4969905|NCT01770522|Postnatal|postnatal
4969906|NCT01770509|Chronic venous leg ulcers|chronic venous leg ulcers
4969907|NCT01770509|Venous ulcer|venous ulcer
4969908|NCT01770509|Stasis ulcer|stasis ulcer
4969909|NCT01770509|Varicose ulcer|varicose ulcer
4969910|NCT01770496|immunization|immunization
4969911|NCT01770496|vaccination|vaccination
4969912|NCT01770496|immunization information system|immunization information system
4969913|NCT01770496|immunization registry|immunization registry
4969914|NCT01770496|reminder / recall|reminder / recall
4969915|NCT01770483|Nitazoxanide,|nitazoxanide,
4969916|NCT01770483|Sustained viral response|sustained viral response
4969917|NCT01770483|Type 2 DIABETICS|type 2 diabetics
4969918|NCT01770470|serum phosphate|serum phosphate
4969919|NCT01770470|chitosan|chitosan
4969920|NCT01770470|kidney disease|kidney disease
4969921|NCT01770470|salivary phosphate|salivary phosphate
4969922|NCT01770457|ICU population|icu population
4969923|NCT01770444|Acute coronary syndrome|acute coronary syndrome
4969924|NCT01770444|Cardiac computed tomographic angiography|cardiac computed tomographic angiography
4969925|NCT01770444|Radiation dose reduction|radiation dose reduction
4969926|NCT01770444|Medical radiation exposure|medical radiation exposure
4969927|NCT01770431|Huaier Granule;|huaier granule;
4969928|NCT01770431|After radical hepatectomy;|after radical hepatectomy;
4969929|NCT01770431|Prevention of Recurrence and Metastasis;|prevention of recurrence and metastasis;
4969930|NCT01770431|Safety.|safety.
4969931|NCT01770418|Non Small Cell Lung Cancer|non small cell lung cancer
4969932|NCT01770418|Cancer|cancer
4969933|NCT01770418|Lung|lung
4969934|NCT01770418|Proton|proton
4969935|NCT01770418|Radiation|radiation
4969936|NCT01770405|endomicroscopy|endomicroscopy
4969937|NCT01770405|needle-based|needle-based
4969938|NCT01770405|pancreatic|pancreatic
4969939|NCT01770405|cyst|cyst
4969940|NCT01770405|mass|mass
4969941|NCT01770405|EUSFNA|eusfna
4969942|NCT01770379|Rheumatoid Arthritis, RA, IL-17 blocker, subcutaneous, self-injection, AIN457, AIN457F, secukinumab, anti-TNFα, pre-filled syringe|rheumatoid arthritis, ra, il-17 blocker, subcutaneous, self-injection, ain457, ain457f, secukinumab, anti-tnfα, pre-filled syringe
4969943|NCT01770366|obesity|obesity
4969944|NCT01770366|weight loss surgery|weight loss surgery
4969945|NCT01770366|virtual support|virtual support
4969946|NCT01770366|wireless devices|wireless devices
4969947|NCT01770366|Internet|internet
4969948|NCT01770353|solid tumors|solid tumors
4969949|NCT01770353|Triple Negative Breast Cancer|triple negative breast cancer
4969950|NCT01770353|Colorectal Cancer|colorectal cancer
4969951|NCT01770353|MM-398|mm-398
4969952|NCT01770353|nanoliposomal irinotecan|nanoliposomal irinotecan
4969953|NCT01770353|Ferumoxytol|ferumoxytol
4969954|NCT01770353|ER/PR positive Breast Cancer|er/pr positive breast cancer
4969955|NCT01770353|Pancreatic Cancer|pancreatic cancer
4969956|NCT01770353|Ovarian Cancer|ovarian cancer
4969957|NCT01770353|Gastric Cancer|gastric cancer
4969958|NCT01770353|Gastro-Esophageal Junction Adenocarcinoma|gastro-esophageal junction adenocarcinoma
4969959|NCT01770353|Head and Neck Cancer|head and neck cancer
4969960|NCT01770353|TNBC|tnbc
4969961|NCT01770340|radical prostatectomy|radical prostatectomy
4969962|NCT01770340|erectile function|erectile function
4969963|NCT01770340|nerve grafting|nerve grafting
4969964|NCT01770340|allogenic|allogenic
4969965|NCT01770340|prostate cancer|prostate cancer
4969966|NCT01770340|Allogenic nerve graft|allogenic nerve graft
4969967|NCT01770340|Time required for nerve grafting|time required for nerve grafting
4969968|NCT01770314|Opioid Pain Medication|opioid pain medication
4969969|NCT01770314|Medication Safety|medication safety
4969970|NCT01770314|Correct storage|correct storage
4969971|NCT01770314|Correct disposal|correct disposal
4969972|NCT01770314|Correct Use|correct use
4969973|NCT01770288|Anerobic exercise|anerobic exercise
4969974|NCT01770288|Pain|pain
4969975|NCT01770288|Analgesia|analgesia
4969976|NCT01770288|Diffuse Noxious Inhibitory Control (DNIC)|diffuse noxious inhibitory control (dnic)
4969977|NCT01770288|psychological stress|psychological stress
4969978|NCT01770275|esophagus|esophagus
4969979|NCT01770249|dysphagia|dysphagia
4969980|NCT01770210|hypercholesterolemia|hypercholesterolemia
4969981|NCT01770210|atorvastatin|atorvastatin
4969982|NCT01770210|cardiovascular events|cardiovascular events
4969983|NCT01770197|China|china
4969984|NCT01770197|Stroke|stroke
4969985|NCT01770197|Thrombolytic therapy|thrombolytic therapy
4969986|NCT01770184|Self-management|self-management
4969987|NCT01770184|Rehabilitation|rehabilitation
4969988|NCT01770184|Occupational Therapy|occupational therapy
4969989|NCT01770171|endometrial cancer|endometrial cancer
4969990|NCT01770171|recurrent endometrial cancer|recurrent endometrial cancer
4969991|NCT01770171|bevacizumab|bevacizumab
4969992|NCT01770158|Acute myeloid leukemia (AML)|acute myeloid leukemia (aml)
4969993|NCT01770158|Histamine Dihydrochloride|histamine dihydrochloride
4969994|NCT01770158|Interleukin-2|interleukin-2
4969995|NCT01770145|Motor symptoms|motor symptoms
4969996|NCT01770145|Parkinson's Disease|parkinson's disease
4969997|NCT01770145|Delayed Onset|delayed onset
4969998|NCT01770145|Akinesia|akinesia
4969999|NCT01770145|Hypomobility|hypomobility
4970000|NCT01770145|Unified Parkinson Disease Rating Scale (UPDRS) motor scores|unified parkinson disease rating scale (updrs) motor scores
4970001|NCT01770145|Dopamine agonist|dopamine agonist
4970002|NCT01770145|Apomorphine|apomorphine
4970003|NCT01770145|Apokyn|apokyn
4970004|NCT01770145|Levodopa|levodopa
4970005|NCT01770119|Measles|measles
4970006|NCT01770119|Mumps|mumps
4970007|NCT01770119|Rubella|rubella
4970008|NCT01770119|Pediatric|pediatric
4970009|NCT01770119|Solid-organ transplant|solid-organ transplant
4970010|NCT01770119|serology|serology
4970011|NCT01770119|vaccine|vaccine
4970012|NCT01770106|Rheumatoid arthritis|rheumatoid arthritis
4970013|NCT01770106|Bone density|bone density
4970014|NCT01770106|Bone microarchitecture|bone microarchitecture
4970015|NCT01770106|HR-pQCT|hr-pqct
4970016|NCT01770067|Cardiac Resynchronization Therapy Devices|cardiac resynchronization therapy devices
4970017|NCT01770054|metabolic syndrome|metabolic syndrome
4970018|NCT01770054|diabetes mellitus|diabetes mellitus
4970019|NCT01770028|Obesity|obesity
4970020|NCT01770028|Pregnancy|pregnancy
4970021|NCT01770028|Spouse|spouse
4970022|NCT01770028|Weight loss|weight loss
4970023|NCT01770028|Behavioral|behavioral
4970024|NCT01770015|patient ventilated for at least five days|patient ventilated for at least five days
4970025|NCT01769963|Advanced glycation end-products|advanced glycation end-products
4970026|NCT01769963|chronic kidney disease|chronic kidney disease
4970027|NCT01769963|nutrition|nutrition
4970028|NCT01769963|inflammation|inflammation
4970029|NCT01769963|insulin resistance|insulin resistance
4970030|NCT01769963|endothelial function|endothelial function
4970031|NCT01769950|Choline PET|choline pet
4970032|NCT01769950|Choline PET-CT|choline pet-ct
4970033|NCT01769950|Positron emission tomography|positron emission tomography
4970034|NCT01769950|Prostate cancer|prostate cancer
4970035|NCT01769937|Lupus|lupus
4970036|NCT01769937|SLE|sle
4970037|NCT01769937|ACTH|acth
4970038|NCT01769937|Acthar|acthar
4970039|NCT01769924|Kidney donors|kidney donors
4970040|NCT01769924|Arterial stiffness|arterial stiffness
4970041|NCT01769924|Blood pressure|blood pressure
4970042|NCT01769924|Nephrectomy|nephrectomy
4970043|NCT01769898|Bronchiectasis|bronchiectasis
4970044|NCT01769898|Theophylline|theophylline
4972020|NCT01760967|mortality|mortality
4970045|NCT01769898|Therapeutic Uses|therapeutic uses
4970046|NCT01769898|HDAC|hdac
4970047|NCT01769898|HAT|hat
4970048|NCT01769898|Random placebo study|random placebo study
4970049|NCT01769898|ICS(inhaled corticosteroid)|ics(inhaled corticosteroid)
4970050|NCT01769898|corticosteroid|corticosteroid
4970051|NCT01769898|Inhaled corticosteroid|inhaled corticosteroid
4970052|NCT01769859|Bipolar Disorder|bipolar disorder
4970053|NCT01769859|Major Depressive Disorder|major depressive disorder
4970054|NCT01769859|Genetics|genetics
4970055|NCT01769833|HBsAg|hbsag
4970056|NCT01769833|Chronic hepatitis B|chronic hepatitis b
4970057|NCT01769833|PEGinterferon Alfa-2A|peginterferon alfa-2a
4970058|NCT01769820|Heavy menstrual bleeding (HMB)|heavy menstrual bleeding (hmb)
4970059|NCT01769820|Dexamethasone|dexamethasone
4970060|NCT01769820|glucocorticoid|glucocorticoid
4970061|NCT01769807|Sleep apnea|sleep apnea
4970062|NCT01769807|CPAP treatment|cpap treatment
4970063|NCT01769807|Plasma nitrate|plasma nitrate
4970064|NCT01769807|Urinary norepinephrine|urinary norepinephrine
4970065|NCT01769807|Blood pressure|blood pressure
4970066|NCT01769794|Hand, Foot and Mouth Disease|hand, foot and mouth disease
4970067|NCT01769794|Medicine, Chinese Traditional|medicine, chinese traditional
4970068|NCT01769794|Enterovirus|enterovirus
4970069|NCT01769794|Fever|fever
4970070|NCT01769781|endometriosis recurrence|endometriosis recurrence
4970071|NCT01769781|pelvic pain|pelvic pain
4970072|NCT01769781|aromatase inhibitor|aromatase inhibitor
4970073|NCT01769768|Adults, Hh (Hedgehog) pathway inhibitor, LDE225, Warfarin, Bupropion, advanced solid tumor, drug-drug interaction, pharmacokinetic|adults, hh (hedgehog) pathway inhibitor, lde225, warfarin, bupropion, advanced solid tumor, drug-drug interaction, pharmacokinetic
4970074|NCT01769755|Crohn's disease|crohn's disease
4970075|NCT01769755|Fistula|fistula
4970076|NCT01769755|Diarrhea|diarrhea
4970077|NCT01769755|Colon|colon
4970078|NCT01769755|Stem cells|stem cells
4970079|NCT01769742|Pneumonia|pneumonia
4970080|NCT01769742|promotion of activity|promotion of activity
4970081|NCT01769729|integrated primary care|integrated primary care
4970082|NCT01769729|depression|depression
4970083|NCT01769729|chronic low back pain|chronic low back pain
4970084|NCT01769716|Global developmental delay|global developmental delay
4970085|NCT01769716|Umbilical cord blood|umbilical cord blood
4970086|NCT01769716|Rehabilitation|rehabilitation
4970087|NCT01769690|PD|pd
4970088|NCT01769690|Parkinson's Disease|parkinson's disease
4970089|NCT01769690|DBS|dbs
4970090|NCT01769690|deep brain stimulation|deep brain stimulation
4970091|NCT01769677|Bioequivalence|bioequivalence
4970092|NCT01769677|Hydrocodone bitartrate extended-release tablets|hydrocodone bitartrate extended-release tablets
4970093|NCT01769664|Acne vulgaris|acne vulgaris
4970094|NCT01769664|Clindamycin 1%/Benzoyl Peroxide 5% Topical Gel|clindamycin 1%/benzoyl peroxide 5% topical gel
4970095|NCT01769664|Duac® Topical Gel|duac® topical gel
4970096|NCT01769651|drug user patients|drug user patients
4970097|NCT01769651|addiction nurses|addiction nurses
4970098|NCT01769651|overdose risk|overdose risk
4970099|NCT01769638|Orally disintegrating Film|orally disintegrating film
4970100|NCT01769638|Film Coated Tablet|film coated tablet
4970101|NCT01769638|Sildenafil|sildenafil
4970102|NCT01769638|Pharmacokinetics|pharmacokinetics
4970103|NCT01769625|breast|breast
4970104|NCT01769625|high risk women|high risk women
4970105|NCT01769625|biomarkers|biomarkers
4970106|NCT01769625|vitamin D|vitamin d
4970107|NCT01769612|Leishmaniasis, Leishmania|leishmaniasis, leishmania
4970108|NCT01769586|Sedation|sedation
4970109|NCT01769586|Endoscopy|endoscopy
4970110|NCT01769586|Diphenhydramine|diphenhydramine
4970111|NCT01769586|Midazolam|midazolam
4970112|NCT01769573|normal|normal
4970113|NCT01769560|tailored intervention|tailored intervention
4970114|NCT01769560|college aged students|college aged students
4970115|NCT01769560|HPV|hpv
4970116|NCT01769521|Glaucoma|glaucoma
4970117|NCT01769521|IOP|iop
4970118|NCT01769521|Blood pressure|blood pressure
4970119|NCT01769521|ECG|ecg
4970120|NCT01769508|Esophagogastric Adenocarcinoma|esophagogastric adenocarcinoma
4970121|NCT01769508|5-Fluorouracil|5-fluorouracil
4970122|NCT01769508|Oxaliplatin|oxaliplatin
4970123|NCT01769508|Lapatinib|lapatinib
4970124|NCT01769508|Radiation Therapy|radiation therapy
4970125|NCT01769508|Surgery|surgery
4970126|NCT01769495|Emergency department, Geriatrics, mortality, readmission rates.|emergency department, geriatrics, mortality, readmission rates.
4970127|NCT01769495|Patients 75 years of age and older.|patients 75 years of age and older.
4970128|NCT01769482|microvascular angina|microvascular angina
4970129|NCT01769482|PDE-5 inhibitors|pde-5 inhibitors
4970130|NCT01769482|Heart disease|heart disease
4970131|NCT01769482|Ischemia|ischemia
4970132|NCT01769482|Cardiac MRI|cardiac mri
4970133|NCT01769469|Tenofovir|tenofovir
4970134|NCT01769469|Emtricitabine|emtricitabine
4970135|NCT01769469|Truvada|truvada
4970136|NCT01769469|Renal, endocrine, bone changes|renal, endocrine, bone changes
4970137|NCT01769469|HIV prevention|hiv prevention
4970138|NCT01769469|PrEP|prep
4970139|NCT01769456|HIV, PrEP, FTC/TDF, Truvada®|hiv, prep, ftc/tdf, truvada®
4970140|NCT01769443|desensitization therapy|desensitization therapy
4970141|NCT01769443|bortezomib (VELCADE®)|bortezomib (velcade®)
4970142|NCT01769443|plasmapheresis|plasmapheresis
4970143|NCT01769430|influenza virus|influenza virus
4970144|NCT01769430|aerosol transmission|aerosol transmission
4970145|NCT01769430|contact transmission|contact transmission
4970146|NCT01769430|large droplet transmission|large droplet transmission
4970147|NCT01769430|airborne infection|airborne infection
4970148|NCT01769391|NSCLC|nsclc
4970149|NCT01769365|Helicobacter pylori infection|helicobacter pylori infection
4970150|NCT01769352|cystoid macular edema|cystoid macular edema
4970151|NCT01769339|Vulvar Candidiasis|vulvar candidiasis
4970152|NCT01769339|Miconazole|miconazole
4970153|NCT01769339|Hydrocortisone|hydrocortisone
4970154|NCT01769339|Daktacort Feminine Care Cream|daktacort feminine care cream
4970155|NCT01769326|Stroke|stroke
4970156|NCT01769313|Cataract|cataract
4970157|NCT01769313|Laser-assisted|laser-assisted
4970158|NCT01769313|Femtosecond|femtosecond
4970159|NCT01769300|Clinical decision support|clinical decision support
4970160|NCT01769300|Electronic health records|electronic health records
4970161|NCT01769300|Electronic medical records|electronic medical records
4970162|NCT01769300|Attention deficit-hyperactivity disorder|attention deficit-hyperactivity disorder
4970163|NCT01769300|Primary care Pediatric research network|primary care pediatric research network
4970164|NCT01769287|Atrial fibrillation|atrial fibrillation
4970165|NCT01769287|Electrophysiological Assessment|electrophysiological assessment
4970166|NCT01769287|12 months post-operatively|12 months post-operatively
4970167|NCT01769287|High Intensity Ultrasound|high intensity ultrasound
4970168|NCT01769261|quality of health care|quality of health care
4970169|NCT01769261|continuity of patient care|continuity of patient care
4970170|NCT01769261|adverse effects|adverse effects
4970171|NCT01769261|outcome and process assessment (health care)|outcome and process assessment (health care)
4970172|NCT01769248|EUS|eus
4970173|NCT01769248|FNA|fna
4970174|NCT01769248|FNB|fnb
4970175|NCT01769235|Acne Vulgaris|acne vulgaris
4970176|NCT01769235|Clindamycin Phosphate and Benzoyl Peroxide Gel|clindamycin phosphate and benzoyl peroxide gel
4970177|NCT01769235|Acanya® Gel|acanya® gel
4970178|NCT01769196|Idiopathic|idiopathic
4970179|NCT01769196|Pulmonary|pulmonary
4970180|NCT01769196|Fibrosis|fibrosis
4970181|NCT01769196|IPF|ipf
4970182|NCT01769183|Proliferative Diabetic Retinopathy|proliferative diabetic retinopathy
4970183|NCT01769170|CMV|cmv
4970184|NCT01769170|Hematopoietic Stem Cell Transplant Recipients|hematopoietic stem cell transplant recipients
4970185|NCT01769170|CMV seropositive|cmv seropositive
4970186|NCT01769144|wound healing|wound healing
4970187|NCT01769144|wound infection|wound infection
4970188|NCT01769144|pain|pain
4970189|NCT01769144|pruritus|pruritus
4970190|NCT01769144|cicatrix|cicatrix
4970191|NCT01769144|dressings|dressings
4970192|NCT01769144|acticoat absorbent|acticoat absorbent
4970193|NCT01769144|BCT|bct
4970194|NCT01769144|KoCarbonAg|kocarbonag
4970195|NCT01769131|cervix|cervix
4970196|NCT01769131|Allis|allis
4970197|NCT01769131|Tenaculum|tenaculum
4970198|NCT01769131|gynecology|gynecology
4970199|NCT01769118|Autonomic nervous system|autonomic nervous system
4970200|NCT01769105|Meibomian Gland Dysfunction|meibomian gland dysfunction
4970201|NCT01769105|Lipiflow|lipiflow
4970202|NCT01769092|Epilepsy|epilepsy
4970203|NCT01769092|Seizure|seizure
4970204|NCT01769092|Fish Oil|fish oil
4970205|NCT01769053|Acute Lung Injury|acute lung injury
4970206|NCT01769053|Adult Respiratory Distress Syndrome|adult respiratory distress syndrome
4970207|NCT01769053|Interactive Ventilatory Support|interactive ventilatory support
4970208|NCT01769053|Positive-Pressure Respiration|positive-pressure respiration
4970209|NCT01769053|Ventilator-Induced Lung Injury|ventilator-induced lung injury
4970210|NCT01769040|Decompensated liver cirrhosis|decompensated liver cirrhosis
4970211|NCT01769040|Ascites|ascites
4970212|NCT01769040|Haemodynamics|haemodynamics
4970213|NCT01769040|Small intestinal bacterial overgrowth|small intestinal bacterial overgrowth
4970214|NCT01769040|Pathophysiology|pathophysiology
4970215|NCT01769014|adherence|adherence
4970216|NCT01769001|Fabry disease|fabry disease
4970217|NCT01769001|Alpha galactosidase deficiency|alpha galactosidase deficiency
4970218|NCT01769001|Metabolic storage disease|metabolic storage disease
4970219|NCT01768975|Knee|knee
4970220|NCT01768975|Osteoarthritis|osteoarthritis
4970221|NCT01768975|OA|oa
4970222|NCT01768975|Knee pain|knee pain
4970223|NCT01768975|Moderate pain|moderate pain
4970224|NCT01768975|Severe pain|severe pain
4970225|NCT01768975|Inflammation|inflammation
4970226|NCT01768975|Safety|safety
4970227|NCT01768975|Efficacy|efficacy
4970228|NCT01768975|Randomized|randomized
4970229|NCT01768975|Topical|topical
4970230|NCT01768975|Gel|gel
4970231|NCT01768975|Olatec|olatec
4970232|NCT01768975|OLT1177|olt1177
4970233|NCT01768975|Joint Diseases|joint diseases
4970234|NCT01768975|Musculoskeletal Diseases|musculoskeletal diseases
4970235|NCT01768975|Rheumatic Diseases|rheumatic diseases
4970236|NCT01768975|Arthritis|arthritis
4970237|NCT01768975|Therapeutic|therapeutic
4970238|NCT01768975|Analgesic|analgesic
4970239|NCT01768962|Microbicides|microbicides
4970240|NCT01768962|Tenofovir|tenofovir
4970241|NCT01768962|Reduced-glycerin|reduced-glycerin
4970242|NCT01768962|Vaginal use|vaginal use
4970243|NCT01768962|Rectal use|rectal use
4970244|NCT01768962|Pharmacokinetics|pharmacokinetics
4970245|NCT01768949|Acute respiratory distress syndrome|acute respiratory distress syndrome
4970246|NCT01768949|Echocardiography|echocardiography
4970247|NCT01768949|Recruitment maneuver|recruitment maneuver
4970248|NCT01768936|on-demand relaparotomy|on-demand relaparotomy
4970249|NCT01768936|PCT|pct
4970250|NCT01768936|procalcitonin|procalcitonin
4970251|NCT01768936|peritonitis|peritonitis
4970252|NCT01768936|sepsis|sepsis
4970253|NCT01768936|focus index|focus index
4970254|NCT01768923|Early Rheumatoid Arthritis|early rheumatoid arthritis
4970255|NCT01768923|Arterial stiffness|arterial stiffness
4970256|NCT01768923|SDAI remission group|sdai remission group
4970257|NCT01768923|Minimal disease activity remission group|minimal disease activity remission group
4970258|NCT01768910|lower urinary tract|lower urinary tract
4970259|NCT01768910|bladder|bladder
4970260|NCT01768910|supraspinal control|supraspinal control
4970261|NCT01768910|neuroimaging|neuroimaging
4970262|NCT01768910|functional magnetic resonance imaging|functional magnetic resonance imaging
4970263|NCT01768910|diffusion tensor imaging|diffusion tensor imaging
4970264|NCT01768910|functional connectivity|functional connectivity
4970265|NCT01768910|neurogenic lower urinary tract dysfunction|neurogenic lower urinary tract dysfunction
4970266|NCT01768910|overactive bladder|overactive bladder
4970267|NCT01768910|multiple sclerosis|multiple sclerosis
4970268|NCT01768910|spinal cord injury|spinal cord injury
4970269|NCT01768884|Infants|infants
4970270|NCT01768884|Bronchiolitis|bronchiolitis
4970271|NCT01768884|NO|no
4970272|NCT01768884|inhalation|inhalation
4970273|NCT01768858|Arthritis|arthritis
4970274|NCT01768858|Morbus Crohn|morbus crohn
4970275|NCT01768858|Adherence|adherence
4970276|NCT01768858|Spondylitis|spondylitis
4970277|NCT01768858|Ulcerative colitis|ulcerative colitis
4970278|NCT01768858|Monoclonals|monoclonals
4970279|NCT01768858|Rheumatoid|rheumatoid
4970280|NCT01768858|Antibodies|antibodies
4970281|NCT01768858|Ankylosing|ankylosing
4970282|NCT01768858|Plaque psoriasis|plaque psoriasis
4970283|NCT01768858|Psoriatic|psoriatic
4970284|NCT01768858|Crohn´s disease|crohn´s disease
4970285|NCT01768858|Antirheumatic Agents|antirheumatic agents
4970286|NCT01768845|Chronic myelogenous leukemia (CML)|chronic myelogenous leukemia (cml)
4970287|NCT01768845|Acute myelogenous leukemia (AML)|acute myelogenous leukemia (aml)
4970288|NCT01768845|Myelodysplastic syndrome|myelodysplastic syndrome
4970289|NCT01768845|Multiple myeloma|multiple myeloma
4970290|NCT01768845|Hodgkin lymphoma|hodgkin lymphoma
4970291|NCT01768845|Non Hodgkin lymphoma|non hodgkin lymphoma
4970292|NCT01768845|Chronic lymphocytic leukemia (CLL)|chronic lymphocytic leukemia (cll)
4970293|NCT01768845|Acute lymphocytic leukemia (ALL)|acute lymphocytic leukemia (all)
4970294|NCT01768845|Severe Aplastic Anemia|severe aplastic anemia
4970295|NCT01768845|Cord Blood|cord blood
4970296|NCT01768845|Umbilical cord blood transplantation|umbilical cord blood transplantation
4970297|NCT01768845|UBC transplantation|ubc transplantation
4970298|NCT01768832|Parkinson disease|parkinson disease
4970299|NCT01768832|walking|walking
4970300|NCT01768832|fMRI|fmri
4970301|NCT01768832|exercise|exercise
4970302|NCT01768832|dance|dance
4970303|NCT01768832|treadmill|treadmill
4970304|NCT01768819|aging|aging
4970305|NCT01768819|exercise|exercise
4970306|NCT01768819|muscle strength|muscle strength
4970307|NCT01768819|physical activity|physical activity
4970308|NCT01768806|Autism|autism
4970309|NCT01768806|Autism Spectrum Disorder|autism spectrum disorder
4970310|NCT01768806|PLAY and Language for Autistic Youngsters|play and language for autistic youngsters
4970311|NCT01768806|Intensive Early Intervention|intensive early intervention
4970312|NCT01768806|Parent Training|parent training
4970313|NCT01768793|Obesity|obesity
4970314|NCT01768793|Pregnancy|pregnancy
4970315|NCT01768793|Body Weight Changes|body weight changes
4970316|NCT01768793|Diet Therapy|diet therapy
4970317|NCT01768780|spinal anesthesia|spinal anesthesia
4970318|NCT01768780|peripheral nerve stimulator|peripheral nerve stimulator
4970319|NCT01768780|sensory block level|sensory block level
4970320|NCT01768754|Exercise testing|exercise testing
4970321|NCT01768754|Functional status|functional status
4970322|NCT01768754|Pulmonary rehabilitation|pulmonary rehabilitation
4970323|NCT01768741|hepatocellular carcinoma|hepatocellular carcinoma
4970324|NCT01768715|Alcoholic hepatitis|alcoholic hepatitis
4970325|NCT01768715|Liver transplantation|liver transplantation
4970326|NCT01768715|Survival|survival
4970327|NCT01768715|Alcoholism|alcoholism
4970328|NCT01768702|Chronic Heart Failure of Ischemic Origin|chronic heart failure of ischemic origin
4970329|NCT01768689|adherence|adherence
4970330|NCT01768689|chronic myeloid leukemia|chronic myeloid leukemia
4970331|NCT01768689|tyrosine kinase inhibitors|tyrosine kinase inhibitors
4970332|NCT01768676|healthy male|healthy male
4970333|NCT01768650|traumatic brain injury|traumatic brain injury
4970334|NCT01768650|chronic pain|chronic pain
4970335|NCT01768650|headache|headache
4970336|NCT01768650|Veteran|veteran
4970337|NCT01768637|Chronic kidney disease|chronic kidney disease
4970338|NCT01768637|Platelet function|platelet function
4970339|NCT01768637|aspirin|aspirin
4970340|NCT01768637|antiplatelet agent|antiplatelet agent
4970341|NCT01768624|chronic kidney disease|chronic kidney disease
4970342|NCT01768624|dialysis|dialysis
4970343|NCT01768624|pre dialysis education|pre dialysis education
4970344|NCT01768624|transplantation|transplantation
4970345|NCT01768624|conservative care|conservative care
4970346|NCT01768598|Wrist Fracture|wrist fracture
4970347|NCT01768598|Adolescents|adolescents
4970348|NCT01768598|Risk Taking Behaviour|risk taking behaviour
4970349|NCT01768598|Bone Microstructure|bone microstructure
4970350|NCT01768546|Diabetes Prevention Program|diabetes prevention program
4970351|NCT01768546|obesity|obesity
4970352|NCT01768546|activity|activity
4970353|NCT01768546|diabetes|diabetes
4970354|NCT01768533|pediatric|pediatric
4970355|NCT01768533|obesity|obesity
4970356|NCT01768533|prevention|prevention
4970357|NCT01768533|health behaviors|health behaviors
4970358|NCT01768533|guidelines|guidelines
4970359|NCT01768481|Obesity|obesity
4970360|NCT01768481|Dyslipidemia|dyslipidemia
4970361|NCT01768481|Cholesterol|cholesterol
4970362|NCT01768481|Intima media thickness|intima media thickness
4970363|NCT01768468|LAYLA|layla
4970364|NCT01768468|Non-inferiority|non-inferiority
4970365|NCT01768468|100mm pain VAS|100mm pain vas
4970366|NCT01768442|Head and neck cancer|head and neck cancer
4970367|NCT01768403|Hypercholesterolemia|hypercholesterolemia
4970368|NCT01768403|Cardiovascular disease|cardiovascular disease
4970369|NCT01768403|Hypertension|hypertension
4970370|NCT01768403|Coronary Heart disease|coronary heart disease
4970371|NCT01768403|Peripheral Arterial disease|peripheral arterial disease
4970372|NCT01768390|caries|caries
4970373|NCT01768390|prevention|prevention
4970374|NCT01768390|orthodontics|orthodontics
4970375|NCT01768390|fixed appliances|fixed appliances
4970376|NCT01768390|adolescents|adolescents
4970377|NCT01768377|Awake intubation|awake intubation
4970378|NCT01768377|Nerve block|nerve block
4970379|NCT01768377|Sedation|sedation
4970380|NCT01768377|Physician satisfaction|physician satisfaction
4970381|NCT01768351|anemia|anemia
4970382|NCT01768351|chronic kidney disease|chronic kidney disease
4970383|NCT01768351|vitamin D|vitamin d
4970384|NCT01768351|paricalcitol|paricalcitol
4970385|NCT01768351|hyperparathyroidism|hyperparathyroidism
4970386|NCT01768325|ProCore Needle|procore needle
4970387|NCT01768299|abortion|abortion
4970388|NCT01768299|medical abortion|medical abortion
4970389|NCT01768299|mifepristone|mifepristone
4970390|NCT01768299|misoprostol|misoprostol
4970391|NCT01768286|HCV genotype 1 (GT-1)|hcv genotype 1 (gt-1)
4970392|NCT01768286|HCV|hcv
4970393|NCT01768286|Sustained Virologic Response|sustained virologic response
4970394|NCT01768286|Direct Acting Antiviral|direct acting antiviral
4970395|NCT01768286|Combination Therapy|combination therapy
4970396|NCT01768286|GS-7977|gs-7977
4970397|NCT01768286|GS-5885|gs-5885
4970398|NCT01768286|Ribavirin|ribavirin
4970399|NCT01768286|Open Label|open label
4970400|NCT01768286|Sofosbuvir|sofosbuvir
4970401|NCT01768286|Additional relevant MeSH terms:|additional relevant mesh terms:
4970402|NCT01768286|Hepatitis|hepatitis
4970403|NCT01768286|Hepatitis, Chronic|hepatitis, chronic
4970404|NCT01768286|Hepatitis C|hepatitis c
4970405|NCT01768286|Hepatitis C, Chronic|hepatitis c, chronic
4970406|NCT01768286|Liver Diseases|liver diseases
4970407|NCT01768286|Digestive System Diseases|digestive system diseases
4970408|NCT01768286|Hepatitis, Viral, Human|hepatitis, viral, human
4970409|NCT01768286|Virus Diseases|virus diseases
4970410|NCT01768286|Enterovirus Infections|enterovirus infections
4970411|NCT01768286|Picornaviridae Infections|picornaviridae infections
4970412|NCT01768286|RNA Virus Infections|rna virus infections
4970413|NCT01768286|Flaviviridae Infections|flaviviridae infections
4970414|NCT01768286|Antiviral Agents|antiviral agents
4970415|NCT01768286|Anti-Infective Agents|anti-infective agents
4970416|NCT01768286|Therapeutic Uses|therapeutic uses
4970417|NCT01768286|Pharmacologic Actions|pharmacologic actions
4970418|NCT01768286|Antimetabolites|antimetabolites
4970419|NCT01768286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
4970420|NCT01768273|PA-824,|pa-824,
4970421|NCT01768273|midazolam|midazolam
4970422|NCT01768273|drug-drug interaction|drug-drug interaction
4970423|NCT01768273|pharmacokinetics|pharmacokinetics
4970424|NCT01768273|pretomanid|pretomanid
4970425|NCT01768273|CL-006|cl-006
4970426|NCT01768260|visual acuity|visual acuity
4970427|NCT01768260|artery flow velocity|artery flow velocity
4970428|NCT01768260|Enhanced External Counterpulsation|enhanced external counterpulsation
4970429|NCT01768260|Ischemic|ischemic
4970430|NCT01768260|Optic Neuropathy|optic neuropathy
4970431|NCT01768247|endometrium|endometrium
4970432|NCT01768247|thickness|thickness
4970433|NCT01768247|pregnancy|pregnancy
4970434|NCT01768247|HCG|hcg
4970435|NCT01768247|frozen cycles|frozen cycles
4970436|NCT01768234|cognition|cognition
4970437|NCT01768234|hydration|hydration
4970438|NCT01768234|schoolchildren|schoolchildren
4970439|NCT01768221|Palliative Care|palliative care
4970440|NCT01768221|Caregiver Outlook|caregiver outlook
4970441|NCT01768195|Lymphoma|lymphoma
4970442|NCT01768195|Hepatitis B Virus|hepatitis b virus
4970443|NCT01768195|Therapeutic Uses|therapeutic uses
4970444|NCT01768195|Antiviral Agents|antiviral agents
4970445|NCT01768195|rituximab|rituximab
4970446|NCT01768182|folic acid; folates; Vascular Reactivity; HIV|folic acid; folates; vascular reactivity; hiv
4970447|NCT01768169|metabolic syndrome,|metabolic syndrome,
4970448|NCT01768169|waist, blood pressure,|waist, blood pressure,
4970449|NCT01768169|fasting plasma glucose,|fasting plasma glucose,
4970450|NCT01768169|HDL cholesterol,|hdl cholesterol,
4970451|NCT01768169|triglycerides|triglycerides
4970452|NCT01768156|ovarian cancer|ovarian cancer
4970453|NCT01768156|biomarker|biomarker
4970454|NCT01768156|metastatic|metastatic
4970455|NCT01768143|Propofol|propofol
4970456|NCT01768143|Sedation|sedation
4970457|NCT01768143|Endoscopy|endoscopy
4970458|NCT01768143|nonanesthesiologist|nonanesthesiologist
4970459|NCT01768104|upper gastrointestinal submucosal tumors|upper gastrointestinal submucosal tumors
4970460|NCT01768104|SMTs|smts
4970461|NCT01768104|Gastrointestinal stromal tumors|gastrointestinal stromal tumors
4970462|NCT01768104|GISTs|gists
4970463|NCT01768104|Leiomyoma|leiomyoma
4970464|NCT01768104|Endoscopic submucosal tunnel dissection|endoscopic submucosal tunnel dissection
4970465|NCT01768104|ESTD|estd
4970466|NCT01768104|Submucosal tunneling endoscopic resection|submucosal tunneling endoscopic resection
4970467|NCT01768104|STER|ster
4970468|NCT01768104|Submucosal endoscopic tumor resection|submucosal endoscopic tumor resection
4970469|NCT01768104|SET|set
4970470|NCT01768091|Esophageal achalasia|esophageal achalasia
4970471|NCT01768091|Peroral endoscopic myotomy|peroral endoscopic myotomy
4970472|NCT01768091|POEM|poem
4970473|NCT01768091|Pneumatic dilation|pneumatic dilation
4970474|NCT01768065|NEPAP|nepap
4970475|NCT01768065|CPAP|cpap
4970476|NCT01768065|alternative|alternative
4970477|NCT01768065|OSAS|osas
4970478|NCT01768052|MDD, major depression, treatment-resistant|mdd, major depression, treatment-resistant
4970479|NCT01768039|Multiple sclerosis|multiple sclerosis
4970480|NCT01768039|Vitamin D|vitamin d
4970481|NCT01768039|EDSS|edss
4970482|NCT01768039|ARR|arr
4970483|NCT01768026|Dystrophic Epidermolysis Bullosa|dystrophic epidermolysis bullosa
4970484|NCT01768026|Type VII Collagen|type vii collagen
4970485|NCT01768026|QOL Evaluation in Epidermolysis Bullosa|qol evaluation in epidermolysis bullosa
4970486|NCT01768026|Instrument for Scoring Clinical Outcomes for Research of Epidermolysis Bullosa|instrument for scoring clinical outcomes for research of epidermolysis bullosa
4970487|NCT01768026|Birmingham Epidermolysis Bullosa Severity Score|birmingham epidermolysis bullosa severity score
4970488|NCT01768000|Psychosis|psychosis
4970489|NCT01768000|Psychosis NOS|psychosis nos
4970490|NCT01768000|Schizophrenia|schizophrenia
4970491|NCT01768000|Schizoaffective Disorder|schizoaffective disorder
4970492|NCT01768000|Bipolar Disorder|bipolar disorder
4970493|NCT01767987|Acute Coronary Syndrome|acute coronary syndrome
4970494|NCT01767987|ACS|acs
4970495|NCT01767987|Percutaneous Coronary Intervention|percutaneous coronary intervention
4970496|NCT01767987|PCI|pci
4970497|NCT01767987|Ranolazine|ranolazine
4970498|NCT01767987|Coronary Angiogram|coronary angiogram
4970499|NCT01767987|Cardioprotectant|cardioprotectant
4970500|NCT01767974|Non-Small Cell lung cancer|non-small cell lung cancer
4970501|NCT01767948|Hepatic Impairment|hepatic impairment
4970502|NCT01767948|PCI 32765|pci 32765
4970503|NCT01767948|Metabolite PCI-45227|metabolite pci-45227
4970504|NCT01767948|Pharmacokinetics|pharmacokinetics
4970505|NCT01767922|Super-Oxyd-Dismutase|super-oxyd-dismutase
4970506|NCT01767922|SOD|sod
4970507|NCT01767922|melon juce|melon juce
4970508|NCT01767922|perceived stress|perceived stress
4970509|NCT01767909|Intranasal insulin|intranasal insulin
4970510|NCT01767909|Alzheimer's disease|alzheimer's disease
4970511|NCT01767909|Amnestic mild cognitive impairment|amnestic mild cognitive impairment
4970512|NCT01767909|Dementia|dementia
4970513|NCT01767909|Brain diseases|brain diseases
4970514|NCT01767909|Memory problems|memory problems
4970515|NCT01767909|Mental disorders|mental disorders
4970516|NCT01767909|Cognitive disorders|cognitive disorders
4970517|NCT01767896|Influenza vaccine|influenza vaccine
4970518|NCT01767883|Chronic Kidney Disease|chronic kidney disease
4970519|NCT01767883|CKD|ckd
4970520|NCT01767883|TRANSLATE|translate
4970521|NCT01767883|Practice Facilitation|practice facilitation
4970522|NCT01767883|Practice-based research|practice-based research
4970523|NCT01767883|CKD Guidelines|ckd guidelines
4970524|NCT01767870|advanced colorectal adenoma|advanced colorectal adenoma
4970525|NCT01767870|colonoscopy|colonoscopy
4970526|NCT01767870|sigmoidoscopy|sigmoidoscopy
4970527|NCT01767870|fecal immunochemical test|fecal immunochemical test
4970528|NCT01767857|Pivotal|pivotal
4970529|NCT01767857|Colorectal|colorectal
4970530|NCT01767857|Survival|survival
4970531|NCT01767857|Phase 3|phase 3
4970532|NCT01767844|Rheumatoid Arthritis|rheumatoid arthritis
4970533|NCT01767844|Arthritis|arthritis
4970534|NCT01767844|Rheumatology|rheumatology
4970535|NCT01767844|Creatine|creatine
4970536|NCT01767831|Type 1 Diabetes Mellitus (T1DM)|type 1 diabetes mellitus (t1dm)
4970537|NCT01767831|Continuous Glucose Monitor (CGM)|continuous glucose monitor (cgm)
4970538|NCT01767831|Simulation-based Education|simulation-based education
4970539|NCT01767818|Parkinson's Disease|parkinson's disease
4970540|NCT01767792|Neurofibromatosis Type 2|neurofibromatosis type 2
4970541|NCT01767792|Progressive Vestibular Schwannomas|progressive vestibular schwannomas
4970542|NCT01767779|Epilepsy|epilepsy
4970543|NCT01767779|TSC|tsc
4970544|NCT01767779|Tuberous Sclerosis Complex|tuberous sclerosis complex
4970545|NCT01767779|Infants|infants
4970546|NCT01767779|Seizures|seizures
4970547|NCT01767779|Biomarkers|biomarkers
4970548|NCT01767779|EEG|eeg
4970549|NCT01767753|Glaucoma|glaucoma
4970550|NCT01767753|SLT|slt
4970551|NCT01767740|Rotator Cuff Tear|rotator cuff tear
4970552|NCT01767740|Supraspinatus Tear|supraspinatus tear
4970553|NCT01767727|surgical flap;|surgical flap;
4970554|NCT01767727|dorsal branch of the digital artery|dorsal branch of the digital artery
4970555|NCT01767714|hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
4970556|NCT01767701|raltegravir|raltegravir
4970557|NCT01767701|MS|ms
4970558|NCT01767701|RRMS|rrms
4970559|NCT01767701|Charcot Project|charcot project
4970560|NCT01767688|Diabetes Mellitus|diabetes mellitus
4970561|NCT01767688|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
4970562|NCT01767688|Glucose Metabolism Disorders|glucose metabolism disorders
4970563|NCT01767688|Metabolic Diseases|metabolic diseases
4970564|NCT01767688|Endocrine System Diseases|endocrine system diseases
4970565|NCT01767675|Secondary Cytoreductive Surgery|secondary cytoreductive surgery
4970566|NCT01767675|Carboplatin|carboplatin
4970567|NCT01767675|Hyperthermic Intraperitoneal Chemotherapy (HIPEC)|hyperthermic intraperitoneal chemotherapy (hipec)
4970568|NCT01767675|12-275|12-275
4970569|NCT01767662|TCV|tcv
4970570|NCT01767649|Pregnancy|pregnancy
4970571|NCT01767649|Remodelling|remodelling
4970572|NCT01767649|Extracellular matrix|extracellular matrix
4970573|NCT01767649|Biomarkers|biomarkers
4970574|NCT01767597|rapid test|rapid test
4970575|NCT01767597|screening|screening
4970576|NCT01767597|ELISA|elisa
4970577|NCT01767597|hepatitis B virus|hepatitis b virus
4970578|NCT01767597|access to care|access to care
4970579|NCT01767584|Pharmacokinetics|pharmacokinetics
4970580|NCT01767584|Bioequivalence|bioequivalence
4970581|NCT01767584|Mexico|mexico
4970582|NCT01767584|Cephalexin|cephalexin
4970583|NCT01767571|Mexico|mexico
4970584|NCT01767571|Respiratory infections|respiratory infections
4970585|NCT01767571|Bioequivalence|bioequivalence
4970586|NCT01767571|Cepphalexin|cepphalexin
4970587|NCT01767532|Cephalexin|cephalexin
4970588|NCT01767532|Respiratory infections|respiratory infections
4970589|NCT01767532|Mexico|mexico
4970590|NCT01767532|Bioequivalence|bioequivalence
4970591|NCT01767506|Trachoma|trachoma
4970592|NCT01767506|Azithromycin|azithromycin
4970593|NCT01767506|Mass treatment|mass treatment
4970594|NCT01767493|Multiple sclerosis|multiple sclerosis
4970595|NCT01767480|Intensive Robot Assisted Therapy|intensive robot assisted therapy
4970596|NCT01767480|Subacute Stroke|subacute stroke
4970597|NCT01767480|Brain Reorganization|brain reorganization
4970598|NCT01767480|Sensory Motor|sensory motor
4970599|NCT01767480|Physiological Marker|physiological marker
4970600|NCT01767467|Immunogenicity|immunogenicity
4970601|NCT01767467|Safety|safety
4970602|NCT01767467|Herpes zoster|herpes zoster
4970603|NCT01767467|Vaccination|vaccination
4970604|NCT01767467|Haematologic malignancies|haematologic malignancies
4970605|NCT01767454|BRAF V600E|braf v600e
4970606|NCT01767454|Melanoma|melanoma
4970607|NCT01767454|V600K|v600k
4970608|NCT01767454|Trametinib|trametinib
4970609|NCT01767454|Dabrafenib|dabrafenib
4970610|NCT01767454|Ipilimumab|ipilimumab
4970611|NCT01767441|bariatric surgery|bariatric surgery
4970612|NCT01767441|gastric bypass|gastric bypass
4970613|NCT01767441|gastric banding|gastric banding
4970614|NCT01767441|sleeve gastrectomy|sleeve gastrectomy
4970615|NCT01767441|weight loss|weight loss
4970616|NCT01767441|Type 2 Diabetes mellitus|type 2 diabetes mellitus
4970617|NCT01767441|GLP1|glp1
4970618|NCT01767441|obesity|obesity
4970619|NCT01767441|mixed meal test|mixed meal test
4970620|NCT01767415|brain tumor|brain tumor
4970621|NCT01767415|resection|resection
4970622|NCT01767415|indigo carmine dye|indigo carmine dye
4970623|NCT01767402|Safety|safety
4970624|NCT01767402|Pneumococcal Infections|pneumococcal infections
4970625|NCT01767402|Immunogenicity|immunogenicity
4970626|NCT01767402|PhtD vaccine|phtd vaccine
4970627|NCT01767402|Healthy adults|healthy adults
4970628|NCT01767402|Reactogenicity|reactogenicity
4970629|NCT01767389|utilization|utilization
4970630|NCT01767389|acute pancreatitis|acute pancreatitis
4970631|NCT01767389|Exenatide|exenatide
4970632|NCT01767389|DPP-4 inhibitors|dpp-4 inhibitors
4970633|NCT01767389|liraglutide|liraglutide
4970634|NCT01767389|GLP-1 receptor agonist|glp-1 receptor agonist
4970635|NCT01767389|adherence|adherence
4970636|NCT01767376|Young adults|young adults
4970637|NCT01767376|Adolescents|adolescents
4970638|NCT01767376|Reactogenicity|reactogenicity
4970639|NCT01767376|Diphtheria|diphtheria
4970640|NCT01767376|pertussis|pertussis
4970641|NCT01767376|Immunogenicity|immunogenicity
4970642|NCT01767376|Tetanus|tetanus
4970643|NCT01767376|Meningococcal vaccines|meningococcal vaccines
4970644|NCT01767376|Safety|safety
4970645|NCT01767376|Neisseria meningitidis|neisseria meningitidis
4970646|NCT01767376|Healthy|healthy
4970647|NCT01767363|5-alpha reductase inhibitor|5-alpha reductase inhibitor
4970648|NCT01767363|benign prostatic hyperplasia treatment|benign prostatic hyperplasia treatment
4970649|NCT01767363|Prostate cancer mortality|prostate cancer mortality
4970650|NCT01767350|Pediatric transplantation|pediatric transplantation
4970651|NCT01767350|Pharmacogenetics|pharmacogenetics
4970652|NCT01767350|Pharmacokinetics|pharmacokinetics
4970653|NCT01767350|Calcineurin inhibitors|calcineurin inhibitors
4970654|NCT01767350|CYP3A|cyp3a
4970655|NCT01767350|Pgp|pgp
4970656|NCT01767337|microneedle-based delivery|microneedle-based delivery
4970657|NCT01767337|hollow microneedle|hollow microneedle
4970658|NCT01767337|intracutaneous|intracutaneous
4970659|NCT01767337|drug delivery|drug delivery
4970660|NCT01767324|microneedle-based array|microneedle-based array
4970661|NCT01767324|hollow microneedle|hollow microneedle
4970662|NCT01767324|intracutaneous|intracutaneous
4970663|NCT01767324|drug delivery|drug delivery
4970664|NCT01767324|vaccine delivery|vaccine delivery
4970665|NCT01767311|Alzheimer's Disease|alzheimer's disease
4970666|NCT01767311|BAN2401|ban2401
4970667|NCT01767298|Fixed dose combination|fixed dose combination
4970668|NCT01767298|Pharmacokinetics|pharmacokinetics
4970669|NCT01767298|Valsartan|valsartan
4970670|NCT01767298|Hydrochlorothiazide|hydrochlorothiazide
4970671|NCT01767285|Etonogestrel Implant|etonogestrel implant
4970672|NCT01767285|Implanon|implanon
4970673|NCT01767285|Nexplanon|nexplanon
4970674|NCT01767285|Long Acting Reversible Contraception|long acting reversible contraception
4970675|NCT01767272|Fexofenadine|fexofenadine
4970676|NCT01767272|Pharmacokinetics|pharmacokinetics
4970677|NCT01767272|Bioavailability|bioavailability
4970678|NCT01767272|Linearity|linearity
4970679|NCT01767272|HPLC|hplc
4970680|NCT01767272|Dose proportionality of fexofenadine in Egyptian volunteers|dose proportionality of fexofenadine in egyptian volunteers
4970681|NCT01767259|Fixed dose combination|fixed dose combination
4970682|NCT01767259|Pharmacokinetics|pharmacokinetics
4970683|NCT01767259|Valsartan|valsartan
4970684|NCT01767259|Hydrochlorothiazide|hydrochlorothiazide
4970685|NCT01767233|Acute necrotizing pancreatitis|acute necrotizing pancreatitis
4970686|NCT01767233|ERCP|ercp
4970687|NCT01767233|Pancreatic stenting|pancreatic stenting
4970688|NCT01767220|ventricular tachycardia|ventricular tachycardia
4970689|NCT01767220|endocardial ablation|endocardial ablation
4970690|NCT01767220|epicardial ablation|epicardial ablation
4970691|NCT01767181|Light therapy|light therapy
4970692|NCT01767181|physical exercise|physical exercise
4970693|NCT01767181|night shift workers|night shift workers
4970694|NCT01767181|genetic markers|genetic markers
4970695|NCT01767181|PBMCs|pbmcs
4970696|NCT01767142|Lipolysis|lipolysis
4970697|NCT01767142|Cryolipolysis|cryolipolysis
4970698|NCT01767142|Fat Reduction|fat reduction
4970699|NCT01767129|levodopa|levodopa
4970700|NCT01767129|dyskinesia|dyskinesia
4970701|NCT01767129|parkinson's disease|parkinson's disease
4970702|NCT01767129|AVP-923|avp-923
4970703|NCT01767129|dextromethorphan|dextromethorphan
4970704|NCT01767129|quinidine|quinidine
4970705|NCT01767116|Interferon-Free|interferon-free
4970706|NCT01767116|Hepatitis C Genotype 1b|hepatitis c genotype 1b
4970707|NCT01767116|Chronic Hepatitis C|chronic hepatitis c
4970708|NCT01767116|Hepatitis C Virus|hepatitis c virus
4970709|NCT01767116|Hepatitis C|hepatitis c
4970710|NCT01767116|Treatment-Naive|treatment-naive
4970711|NCT01767116|Paritaprevir|paritaprevir
4970712|NCT01767116|Ombitasvir|ombitasvir
4970713|NCT01767116|Dasabuvir|dasabuvir
4970714|NCT01767116|Viekira PAK|viekira pak
4970715|NCT01767116|Ribavirin|ribavirin
4970716|NCT01767103|Hepatic Impairment|hepatic impairment
4970717|NCT01767103|Liver Impairment|liver impairment
4970718|NCT01767103|Liver Disease|liver disease
4970719|NCT01767103|Ferriprox®|ferriprox®
4970720|NCT01767103|LI|li
4970721|NCT01767103|DFP|dfp
4970722|NCT01767103|Deferiprone|deferiprone
4970723|NCT01767090|Endometriosis|endometriosis
4970724|NCT01767090|ASP1707|asp1707
4970725|NCT01767090|Pelvic pain|pelvic pain
4970726|NCT01767090|Double-blind|double-blind
4970727|NCT01767090|Placebo-controlled|placebo-controlled
4970728|NCT01767090|Phase 2|phase 2
4970729|NCT01767077|Saturated fat|saturated fat
4970730|NCT01767077|Dairy products|dairy products
4970731|NCT01767077|Milk fat globule membrane|milk fat globule membrane
4970732|NCT01767077|Cholesterol|cholesterol
4970733|NCT01767077|Butter|butter
4970734|NCT01767077|Cream|cream
4970735|NCT01767064|ARIs, antibiotics, public commitment, quality improvement|aris, antibiotics, public commitment, quality improvement
4970736|NCT01767051|PCOS|pcos
4970737|NCT01767051|Children|children
4970738|NCT01767051|Cardiovascular|cardiovascular
4970739|NCT01767051|Follow-up|follow-up
4970740|NCT01767025|Influence|influence
4970741|NCT01767025|oxytocin|oxytocin
4970742|NCT01767025|automatic imitation|automatic imitation
4970743|NCT01767025|behaviour|behaviour
4970744|NCT01767025|volunteers|volunteers
4970745|NCT01766999|pulse oximetry|pulse oximetry
4970746|NCT01766999|tumescent anesthesia|tumescent anesthesia
4970747|NCT01766960|Bile acids|bile acids
4970748|NCT01766960|Pharmacokinetics|pharmacokinetics
4970749|NCT01766947|Glaucoma|glaucoma
4970750|NCT01766947|Deep sclerectomy|deep sclerectomy
4970751|NCT01766934|Peripheral blood progenitor cell mobilization|peripheral blood progenitor cell mobilization
4970752|NCT01766934|allogenic hematopoetic stem cell transplantation|allogenic hematopoetic stem cell transplantation
4970753|NCT01766934|recombinant human granulocyte colony stimulating factor|recombinant human granulocyte colony stimulating factor
4970754|NCT01766934|filgrastim|filgrastim
4970755|NCT01766921|Influenza, Pandemic, H5N1, Elderly adults|influenza, pandemic, h5n1, elderly adults
4970756|NCT01766908|Timing of Umbilical Cord clamping|timing of umbilical cord clamping
4970757|NCT01766908|Cord Clamp 20 seconds|cord clamp 20 seconds
4970758|NCT01766908|Cord Clamp 40 seconds|cord clamp 40 seconds
4970759|NCT01766908|Cord Clamp 60 seconds|cord clamp 60 seconds
4970760|NCT01766895|uremia|uremia
4970761|NCT01766895|HBV|hbv
4970762|NCT01766895|HCV|hcv
4970763|NCT01766895|seroclearance|seroclearance
4970764|NCT01766882|Hemodialysis|hemodialysis
4970765|NCT01766882|Blood Pressure|blood pressure
4970766|NCT01766882|Hydration Status|hydration status
4970767|NCT01766882|Low-sodium diet|low-sodium diet
4970768|NCT01766869|Prostate Cancer|prostate cancer
4970769|NCT01766869|MRI/MRS|mri/mrs
4970770|NCT01766856|perforation|perforation
4970771|NCT01766856|tympanoplasty|tympanoplasty
4970772|NCT01766856|myringoplasty|myringoplasty
4970773|NCT01766856|Eustachian tube function|eustachian tube function
4970774|NCT01766856|tympanostomy tube|tympanostomy tube
4970775|NCT01766817|IPF|ipf
4970776|NCT01766804|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
4970777|NCT01766804|Bovine Colostrum|bovine colostrum
4970778|NCT01766804|Inflammation|inflammation
4970779|NCT01766804|Infection|infection
4970780|NCT01766804|Toxicity|toxicity
4970781|NCT01766791|resistance exercise|resistance exercise
4970782|NCT01766791|muscle mass|muscle mass
4970783|NCT01766791|abdominal fat|abdominal fat
4970784|NCT01766791|strength|strength
4970785|NCT01766791|Coronary Heart Disease (CHD)-risk|coronary heart disease (chd)-risk
4970786|NCT01766791|myocardial mass|myocardial mass
4970787|NCT01766778|type-2 diabetes mellitus, inadequately controlled Metformin|type-2 diabetes mellitus, inadequately controlled metformin
4970788|NCT01766739|GL-ONC1|gl-onc1
4970789|NCT01766739|pleural effusion|pleural effusion
4970790|NCT01766739|12-169|12-169
4970791|NCT01766726|HIV|hiv
4970792|NCT01766726|Atherosclerosis|atherosclerosis
4970793|NCT01766700|Obesity, weight loss, weight maintenance|obesity, weight loss, weight maintenance
4970794|NCT01766687|Chronic Kidney Disease|chronic kidney disease
4970795|NCT01766687|estimated glomerular filtration rate|estimated glomerular filtration rate
4970796|NCT01766687|water intake|water intake
4970797|NCT01766687|fluid intake|fluid intake
4970798|NCT01766687|renal decline|renal decline
4970799|NCT01766674|Kyphosis|kyphosis
4970800|NCT01766648|Distal|distal
4970801|NCT01766648|Femur|femur
4970802|NCT01766648|Locking|locking
4970803|NCT01766648|Screw|screw
4970804|NCT01766648|Fracture|fracture
4970805|NCT01766648|Healing|healing
4970806|NCT01766622|Apoptosis|apoptosis
4970807|NCT01766622|Pro-Apoptotic Effects|pro-apoptotic effects
4970808|NCT01766622|PET Imaging|pet imaging
4970809|NCT01766622|TL32711|tl32711
4970810|NCT01766622|Relapsed Platinum Resistant or Refractory Epithelial Ovarian Cancer|relapsed platinum resistant or refractory epithelial ovarian cancer
4970811|NCT01766609|Vitiligo; Intralesional; Triamcinolone acetonide|vitiligo; intralesional; triamcinolone acetonide
4970812|NCT01766596|Ophthalmology|ophthalmology
4970813|NCT01766596|Age-related ocular pathologies|age-related ocular pathologies
4970814|NCT01766583|Open label, 3 + 3 dose escalation study followed by an expansion phase.|open label, 3 + 3 dose escalation study followed by an expansion phase.
4970815|NCT01766570|insulin sensitivity,|insulin sensitivity,
4970816|NCT01766570|glucose tolerance,|glucose tolerance,
4970817|NCT01766570|inflammatory markers,|inflammatory markers,
4970818|NCT01766570|lipid profile,|lipid profile,
4970819|NCT01766570|oxidative stress,|oxidative stress,
4970820|NCT01766570|pancreatic β-cell function|pancreatic β-cell function
4970821|NCT01766557|Polycystic ovarian syndrome, sex hormones, ovarian function, women, fish protein, insulin sensitivity, glucose tolerance, β-cell function, inflammation|polycystic ovarian syndrome, sex hormones, ovarian function, women, fish protein, insulin sensitivity, glucose tolerance, β-cell function, inflammation
4970822|NCT01766544|asthma|asthma
4970823|NCT01766544|COPD|copd
4970824|NCT01766544|guidelines|guidelines
4970825|NCT01766544|knowledge transfer|knowledge transfer
4970826|NCT01766544|medical education|medical education
4970827|NCT01766544|care gaps|care gaps
4970828|NCT01766531|Bioelectrical impedance|bioelectrical impedance
4970829|NCT01766531|Nutrition|nutrition
4970830|NCT01766531|Phase angle|phase angle
4970831|NCT01766531|ICU patients|icu patients
4970832|NCT01766518|liver transplantation|liver transplantation
4970833|NCT01766518|LT|lt
4970834|NCT01766518|Mycophenolate mofetil|mycophenolate mofetil
4970835|NCT01766518|MMF|mmf
4970836|NCT01766505|hypertension, heart failure, candesartan, losartan|hypertension, heart failure, candesartan, losartan
4970837|NCT01766492|prostate cancer|prostate cancer
4970838|NCT01766492|CyberKnife|cyberknife
4970839|NCT01766479|Colorectal cancer|colorectal cancer
4970840|NCT01766479|colorectal neoplasia|colorectal neoplasia
4970841|NCT01766479|CT colonography|ct colonography
4972122|NCT01760499|metastatic|metastatic
4970842|NCT01766479|advanced neoplasia|advanced neoplasia
4970843|NCT01766479|colonoscopy|colonoscopy
4970844|NCT01766479|family history|family history
4970845|NCT01766453|South Asian|south asian
4970846|NCT01766453|Cardiovascular|cardiovascular
4970847|NCT01766453|Exercise|exercise
4970848|NCT01766453|Obesity|obesity
4970849|NCT01766453|Visceral Adipose Tissue|visceral adipose tissue
4970850|NCT01766401|Generalized Anxiety Disorder|generalized anxiety disorder
4970851|NCT01766401|GAD|gad
4970852|NCT01766375|idarubicin|idarubicin
4970853|NCT01766375|busulfan|busulfan
4970854|NCT01766375|cyclophosphamide|cyclophosphamide
4970855|NCT01766375|pretreatment|pretreatment
4970856|NCT01766375|high-risk acute myeloid leukemia patient|high-risk acute myeloid leukemia patient
4970857|NCT01766349|Esophageal cancer|esophageal cancer
4970858|NCT01766349|Respiratory muscle strength|respiratory muscle strength
4970859|NCT01766349|Pulmonary function testing|pulmonary function testing
4970860|NCT01766349|Functional exercise capacity|functional exercise capacity
4970861|NCT01766336|Agitation|agitation
4970862|NCT01766336|Aggression|aggression
4970863|NCT01766336|AD patients|ad patients
4970864|NCT01766323|Morphine|morphine
4970865|NCT01766323|Palliation|palliation
4970866|NCT01766323|Cancer|cancer
4970867|NCT01766323|Hospice|hospice
4970868|NCT01766323|Sleepiness|sleepiness
4970869|NCT01766323|Modafinil|modafinil
4970870|NCT01766310|Folic acid|folic acid
4970871|NCT01766310|Folate|folate
4970872|NCT01766310|Homocysteine|homocysteine
4970873|NCT01766310|Obese|obese
4970874|NCT01766310|Children|children
4970875|NCT01766297|Breast Cancer|breast cancer
4970876|NCT01766297|Proton|proton
4970877|NCT01766297|Radiation|radiation
4970878|NCT01766284|Human Papillomavirus|human papillomavirus
4970879|NCT01766284|Optical Coherence Tomography|optical coherence tomography
4970880|NCT01766284|Imaging Systems|imaging systems
4970881|NCT01766284|Cervical intraepithelial neoplasia|cervical intraepithelial neoplasia
4970882|NCT01766284|Cervical Cancer|cervical cancer
4970883|NCT01766284|Cervical Dysplasia|cervical dysplasia
4970884|NCT01766271|Coronary heart disease|coronary heart disease
4970885|NCT01766271|cardiovascular disease|cardiovascular disease
4970886|NCT01766271|risk|risk
4970887|NCT01766258|Parkinson's Disease|parkinson's disease
4970888|NCT01766258|Motor-fluctuation|motor-fluctuation
4970889|NCT01766258|Wearing-off|wearing-off
4970890|NCT01766245|mm|mm
4970891|NCT01766206|conjugate vaccine|conjugate vaccine
4970892|NCT01766206|phase IV clinical trial|phase iv clinical trial
4970893|NCT01766206|Neisseria meningitidis|neisseria meningitidis
4970894|NCT01766193|Delivery, obstetric|delivery, obstetric
4970895|NCT01766193|Obstetric Surgical Procedures|obstetric surgical procedures
4970896|NCT01766193|Vacuum Extraction, Obstetrical|vacuum extraction, obstetrical
4970897|NCT01766193|Cesarean Section|cesarean section
4970898|NCT01766193|Obstetrical Forceps|obstetrical forceps
4970899|NCT01766193|Epidemiology|epidemiology
4970900|NCT01766193|Norway|norway
4970901|NCT01766180|Memory|memory
4970902|NCT01766180|Fruitflow|fruitflow
4970903|NCT01766180|Resveratrol (resVida)|resveratrol (resvida)
4970904|NCT01766180|Cerebral blood flow|cerebral blood flow
4970905|NCT01766180|Cardiopulmonary exercise test|cardiopulmonary exercise test
4970906|NCT01766180|Maximal VO2|maximal vo2
4970907|NCT01766167|Genotype 2|genotype 2
4970908|NCT01766154|tirofiban|tirofiban
4970909|NCT01766154|pharmacokinetic|pharmacokinetic
4970910|NCT01766154|renal insufficiency|renal insufficiency
4970911|NCT01766154|Phase 1|phase 1
4970912|NCT01766154|pharmacodynamic|pharmacodynamic
4970913|NCT01766141|Spinal manipulation|spinal manipulation
4970914|NCT01766141|Tumor necrosis factor|tumor necrosis factor
4970915|NCT01766141|Interleukin 1|interleukin 1
4970916|NCT01766141|Interleukin 10|interleukin 10
4970917|NCT01766141|Inflammatory cytokines|inflammatory cytokines
4970918|NCT01766128|Parkinson disease|parkinson disease
4970919|NCT01766128|Early stage|early stage
4970920|NCT01766128|Zonisamide|zonisamide
4970921|NCT01766128|UPDRS|updrs
4970922|NCT01766115|HCV|hcv
4970923|NCT01766115|needlestick|needlestick
4970924|NCT01766115|occupational|occupational
4970925|NCT01766115|transmission|transmission
4970926|NCT01766115|health care worker|health care worker
4970927|NCT01766115|telaprevir|telaprevir
4970928|NCT01766102|Mammography|mammography
4970929|NCT01766089|Caesarean delivery|caesarean delivery
4970930|NCT01766089|severe pre-eclampsia|severe pre-eclampsia
4970931|NCT01766089|remifentanil|remifentanil
4970932|NCT01766089|dexmedetomidine|dexmedetomidine
4970933|NCT01766089|cardiovascular response|cardiovascular response
4970934|NCT01766076|immune activation|immune activation
4970935|NCT01766076|antiretroviral therapy|antiretroviral therapy
4970936|NCT01766076|atorvastatin|atorvastatin
4970937|NCT01766076|immune exhaustion|immune exhaustion
4970938|NCT01766076|adults|adults
4970939|NCT01766076|Africa|africa
4970940|NCT01766063|Multiple Sclerosis|multiple sclerosis
4970941|NCT01766063|Sleep|sleep
4970942|NCT01766063|Quality of life|quality of life
4970943|NCT01766063|Observational study|observational study
4970944|NCT01766037|obesity|obesity
4970945|NCT01766037|obese|obese
4970946|NCT01766037|weight loss|weight loss
4970947|NCT01766024|interferon beta-1a|interferon beta-1a
4970948|NCT01766024|pharmacokinetics|pharmacokinetics
4970949|NCT01766024|pharmacodynamics|pharmacodynamics
4970950|NCT01766024|volunteers|volunteers
4970951|NCT01765998|Crohn's disease, endothelial progenitor cells, probiotic|crohn's disease, endothelial progenitor cells, probiotic
4970952|NCT01765985|palmoplantar|palmoplantar
4970953|NCT01765959|Insomnia|insomnia
4970954|NCT01765959|Auricular acupuncture|auricular acupuncture
4970955|NCT01765959|CBT|cbt
4970956|NCT01765946|Insulin resistance|insulin resistance
4970957|NCT01765946|Prediabetes|prediabetes
4970958|NCT01765946|Longevity genes|longevity genes
4970959|NCT01765946|Inflammation|inflammation
4970960|NCT01765946|Metformin|metformin
4970961|NCT01765933|1,3-dimethylamylamine|1,3-dimethylamylamine
4970962|NCT01765894|glucose homeostasis|glucose homeostasis
4970963|NCT01765894|endogenous glucose production|endogenous glucose production
4970964|NCT01765894|moderate exercise|moderate exercise
4970965|NCT01765894|type 2 diabetes|type 2 diabetes
4970966|NCT01765894|metformin|metformin
4970967|NCT01765881|Induction of labor|induction of labor
4970968|NCT01765881|cervical ripening|cervical ripening
4970969|NCT01765881|misoprostol,|misoprostol,
4970970|NCT01765881|prostaglandin|prostaglandin
4970971|NCT01765881|cost-effectiveness|cost-effectiveness
4970972|NCT01765868|Betrixaban|betrixaban
4970973|NCT01765868|Healthy|healthy
4970974|NCT01765868|Bioavailability|bioavailability
4970975|NCT01765855|Betrixaban|betrixaban
4970976|NCT01765855|Healthy|healthy
4970977|NCT01765855|Mass Balance|mass balance
4970978|NCT01765842|Lupus Nephritis|lupus nephritis
4970979|NCT01765842|remission|remission
4970980|NCT01765842|immunosuppressive treatment|immunosuppressive treatment
4970981|NCT01765829|Non Affective Psychosis|non affective psychosis
4970982|NCT01765829|First episode|first episode
4970983|NCT01765829|Discontinuation scheme|discontinuation scheme
4970984|NCT01765816|Exercise|exercise
4970985|NCT01765816|Elderly|elderly
4970986|NCT01765816|Blood volume|blood volume
4970987|NCT01765816|Hemoglobin|hemoglobin
4970988|NCT01765803|Mellaril|mellaril
4970989|NCT01765803|Thioridazine|thioridazine
4970990|NCT01765803|CD34+|cd34+
4970991|NCT01765803|Stem cells|stem cells
4970992|NCT01765803|Progenitor cells|progenitor cells
4970993|NCT01765803|Peripheral blood|peripheral blood
4970994|NCT01765803|mobilization|mobilization
4970995|NCT01765803|circulation|circulation
4970996|NCT01765777|Low back pain|low back pain
4970997|NCT01765777|Lower back pain|lower back pain
4970998|NCT01765777|Chronic back pain|chronic back pain
4970999|NCT01765751|Cervical pain|cervical pain
4971000|NCT01765751|Neck pain|neck pain
4971001|NCT01765751|Arm pain|arm pain
4971002|NCT01765738|PICC|picc
4971003|NCT01765725|Chronic Fatigue Syndrome|chronic fatigue syndrome
4971004|NCT01765725|Coping|coping
4971005|NCT01765725|Patient education|patient education
4971006|NCT01765712|PRP|prp
4971007|NCT01765712|BPTB|bptb
4971008|NCT01765712|VAS|vas
4971009|NCT01765712|Anterior Knee Pain|anterior knee pain
4971010|NCT01765673|Swallowing|swallowing
4971011|NCT01765673|Stroke|stroke
4971012|NCT01765673|Sensory stimulation|sensory stimulation
4971013|NCT01765673|Home based therapy|home based therapy
4971014|NCT01765673|Head and Neck Cancer|head and neck cancer
4971015|NCT01765660|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
4971016|NCT01765660|Mesenchymal Stem Cells|mesenchymal stem cells
4971017|NCT01765660|Chronic Graft-versus-host disease|chronic graft-versus-host disease
4971018|NCT01765647|Celiac disease|celiac disease
4971019|NCT01765647|AGY|agy
4971020|NCT01765634|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
4971021|NCT01765634|Mesenchymal Stem Cells|mesenchymal stem cells
4971022|NCT01765634|Acute Graft-versus-host disease|acute graft-versus-host disease
4971023|NCT01765621|health care expenditure|health care expenditure
4971024|NCT01765621|drug drug interactions|drug drug interactions
4971025|NCT01765621|electronic decision support systems|electronic decision support systems
4971026|NCT01765621|pharmacogenetics|pharmacogenetics
4971027|NCT01765621|Potential Reduction|potential reduction
4971028|NCT01765608|Zonisamide|zonisamide
4971029|NCT01765608|Zonegran|zonegran
4971030|NCT01765608|Obstructive Sleep apnea|obstructive sleep apnea
4971031|NCT01765608|Apnea|apnea
4971032|NCT01765608|Respiration Disorders|respiration disorders
4971033|NCT01765608|Sleep Disorders|sleep disorders
4971034|NCT01765608|Obesity|obesity
4971035|NCT01765608|Anti-Obesity Agents|anti-obesity agents
4971036|NCT01765608|Carbonic Anhydrase|carbonic anhydrase
4971037|NCT01765608|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors
4971038|NCT01765608|Enzyme Inhibitors|enzyme inhibitors
4971039|NCT01765608|Sulfonamides|sulfonamides
4971040|NCT01765608|Therapeutic Uses|therapeutic uses
4971041|NCT01765608|Pharmacologic Actions|pharmacologic actions
4971042|NCT01765595|health care expenditure|health care expenditure
4971043|NCT01765595|drug drug interactions|drug drug interactions
4971044|NCT01765595|electronic decision support systems|electronic decision support systems
4971045|NCT01765595|Potential reduction|potential reduction
4971046|NCT01765530|Medical Devices|medical devices
4971142|NCT01764984|total knee arthroplasty|total knee arthroplasty
4971047|NCT01765530|Ventilator-Associated Pneumonia (VAP)|ventilator-associated pneumonia (vap)
4971048|NCT01765530|Ventilator-Associated Events (VAE)|ventilator-associated events (vae)
4971049|NCT01765530|Endotracheal Tube|endotracheal tube
4971050|NCT01765530|Microbial Diversity|microbial diversity
4971051|NCT01765530|Anti-Resistance|anti-resistance
4971052|NCT01765530|Computed Tomography (CT)|computed tomography (ct)
4971053|NCT01765517|Diabetes Mellitus|diabetes mellitus
4971054|NCT01765504|Cardiac surgery; near infrared spectroscopy|cardiac surgery; near infrared spectroscopy
4971055|NCT01765491|colonoscopy|colonoscopy
4971056|NCT01765491|bowel preparation|bowel preparation
4971057|NCT01765491|polyethylene glycol|polyethylene glycol
4971058|NCT01765478|Rheumatoid Arthritis|rheumatoid arthritis
4971059|NCT01765465|postcholecystectomy syndrome|postcholecystectomy syndrome
4971060|NCT01765465|laparoscopic cholecystectomy|laparoscopic cholecystectomy
4971061|NCT01765465|Rowachol|rowachol
4971062|NCT01765439|bile acids|bile acids
4971063|NCT01765439|metabolism|metabolism
4971064|NCT01765439|probiotics|probiotics
4971065|NCT01765426|Prophylactic vaccination|prophylactic vaccination
4971066|NCT01765413|To identify|to identify
4971067|NCT01765413|biomarkers|biomarkers
4971068|NCT01765413|of vaccine safety|of vaccine safety
4971069|NCT01765413|Volunteers|volunteers
4971070|NCT01765400|Heart failure|heart failure
4971071|NCT01765400|Antiplatelet therapy|antiplatelet therapy
4971072|NCT01765400|Platelet aggregation|platelet aggregation
4971073|NCT01765400|Clopidogrel|clopidogrel
4971074|NCT01765400|Prasugrel|prasugrel
4971075|NCT01765387|Spatherpy|spatherpy
4971076|NCT01765387|Aerobic exercise|aerobic exercise
4971077|NCT01765374|rituximab|rituximab
4971078|NCT01765374|sonography|sonography
4971079|NCT01765374|clinical response|clinical response
4971080|NCT01765348|language impairment|language impairment
4971081|NCT01765348|language disorders|language disorders
4971082|NCT01765348|syntax treatment|syntax treatment
4971083|NCT01765348|narrative-based treatment|narrative-based treatment
4971084|NCT01765335|heart failure, BNP, NICaS system, readmition|heart failure, bnp, nicas system, readmition
4971085|NCT01765309|Tissue expanders|tissue expanders
4971086|NCT01765309|Botulinum toxin|botulinum toxin
4971087|NCT01765309|Botox|botox
4971088|NCT01765283|CN,|cn,
4971089|NCT01765283|UCD|ucd
4971090|NCT01765270|Diabetes|diabetes
4971091|NCT01765270|Diabetes Mellitus|diabetes mellitus
4971092|NCT01765270|Type 2 Diabetes|type 2 diabetes
4971093|NCT01765270|Cardiovascular Disease|cardiovascular disease
4971094|NCT01765270|Coronary Artery Bypass Surgery|coronary artery bypass surgery
4971095|NCT01765257|Drug-naïve patients with Parkinson's disease|drug-naïve patients with parkinson's disease
4971096|NCT01765257|Apathy|apathy
4971097|NCT01765257|Rasagiline|rasagiline
4971098|NCT01765244|Corneal trophic ulcers, limbal deficiency, cornea blindness|corneal trophic ulcers, limbal deficiency, cornea blindness
4971099|NCT01765231|Lymphoma|lymphoma
4971100|NCT01765231|Hepatitis B virus|hepatitis b virus
4971101|NCT01765231|Therapeutic Uses|therapeutic uses
4971102|NCT01765231|Antiviral Agents|antiviral agents
4971103|NCT01765218|Hypoxic ischemic encephalopathy|hypoxic ischemic encephalopathy
4971104|NCT01765218|HIE|hie
4971105|NCT01765218|Perinatal depression|perinatal depression
4971106|NCT01765218|Whole body cooling|whole body cooling
4971107|NCT01765218|Therapeutic hypothermia|therapeutic hypothermia
4971108|NCT01765205|congenital cardiovascular malformation|congenital cardiovascular malformation
4971109|NCT01765205|newborn|newborn
4971110|NCT01765192|Drug therapy|drug therapy
4971111|NCT01765179|testosterone|testosterone
4971112|NCT01765179|male hypogonadism|male hypogonadism
4971113|NCT01765179|low testosterone|low testosterone
4971114|NCT01765166|Social Skill Training|social skill training
4971115|NCT01765166|Social Interaction|social interaction
4971116|NCT01765166|Peer relations|peer relations
4971117|NCT01765153|physical therapy|physical therapy
4971118|NCT01765153|rehabilitation|rehabilitation
4971119|NCT01765153|neuroplasticity|neuroplasticity
4971120|NCT01765140|3,4 diaminopyridine (DAP)|3,4 diaminopyridine (dap)
4971121|NCT01765101|knee osteoarthritis|knee osteoarthritis
4971122|NCT01765101|therapeutic effect|therapeutic effect
4971123|NCT01765101|insole|insole
4971124|NCT01765088|High-grade glioma|high-grade glioma
4971125|NCT01765088|chemotherapy|chemotherapy
4971126|NCT01765088|Temozolomide|temozolomide
4971127|NCT01765088|Interferon-alpha|interferon-alpha
4971128|NCT01765075|Electrophysiological mapping|electrophysiological mapping
4971129|NCT01765075|Multi-electrode catheter|multi-electrode catheter
4971130|NCT01765062|Rapid maxillary expansion|rapid maxillary expansion
4971131|NCT01765062|Cross bite|cross bite
4971132|NCT01765062|Haas appliance|haas appliance
4971133|NCT01765062|Lateral cephalograms|lateral cephalograms
4971134|NCT01765049|breast density change|breast density change
4971135|NCT01765049|endocrine therapy response|endocrine therapy response
4971136|NCT01765049|aromatase inhibitor|aromatase inhibitor
4971137|NCT01765036|contrast-enhanced endoscopic ultrasound|contrast-enhanced endoscopic ultrasound
4971138|NCT01765036|pancreatic adenocarcinoma|pancreatic adenocarcinoma
4971139|NCT01765010|Vitamin D|vitamin d
4971140|NCT01765010|Serum sclerostin|serum sclerostin
4971141|NCT01765010|Serum dickkopf1|serum dickkopf1
4971143|NCT01764984|trabecular metal|trabecular metal
4971144|NCT01764984|bone mineral density|bone mineral density
4971145|NCT01764971|Chronic ITP, Cerebral dysfunction|chronic itp, cerebral dysfunction
4971146|NCT01764958|mother-infant interaction|mother-infant interaction
4971147|NCT01764958|general movements|general movements
4971148|NCT01764958|preterm infants|preterm infants
4971149|NCT01764893|Overactive Bladder|overactive bladder
4971150|NCT01764880|Heparanase inhibitor|heparanase inhibitor
4971151|NCT01764880|Multiple myeloma|multiple myeloma
4971152|NCT01764867|major depressive disorder|major depressive disorder
4971153|NCT01764867|algorithm guided treatment|algorithm guided treatment
4971154|NCT01764867|treatment as usual|treatment as usual
4971155|NCT01764867|escitalopram|escitalopram
4971156|NCT01764867|mirtazapine|mirtazapine
4971157|NCT01764867|transcranial magnetic stimulation (rTMS)|transcranial magnetic stimulation (rtms)
4971158|NCT01764867|modified electroconvulsive therapy (mECT)|modified electroconvulsive therapy (mect)
4971159|NCT01764867|remission|remission
4971160|NCT01764867|relapse|relapse
4971161|NCT01764867|quality of life|quality of life
4971162|NCT01764854|Hemodialysis|hemodialysis
4971163|NCT01764841|Ciprofloxacin|ciprofloxacin
4971164|NCT01764841|Dry Powder for Inhalation|dry powder for inhalation
4971165|NCT01764841|Exacerbation|exacerbation
4971166|NCT01764841|Bronchiectasis|bronchiectasis
4971167|NCT01764828|Phase I|phase i
4971168|NCT01764828|Pharmacokinetics|pharmacokinetics
4971169|NCT01764828|Safety measurements|safety measurements
4971170|NCT01764802|Psychosexual Intervention|psychosexual intervention
4971171|NCT01764802|Cancer|cancer
4971172|NCT01764802|Gynecologic Cancer|gynecologic cancer
4971173|NCT01764802|Breast Cancer|breast cancer
4971174|NCT01764789|psychological intervention|psychological intervention
4971175|NCT01764789|breast cancer|breast cancer
4971176|NCT01764789|gynecologic cancer|gynecologic cancer
4971177|NCT01764776|LDE225|lde225
4971178|NCT01764776|Pharmacokinetics|pharmacokinetics
4971179|NCT01764776|PK|pk
4971180|NCT01764776|Postmenopausal women|postmenopausal women
4971181|NCT01764776|normal hepatic function|normal hepatic function
4971182|NCT01764776|mild hepatic impairment|mild hepatic impairment
4971183|NCT01764776|moderate hepatic impairment|moderate hepatic impairment
4971184|NCT01764776|severe hepatic impairment|severe hepatic impairment
4971185|NCT01764750|Intrasite|intrasite
4971186|NCT01764750|Antibiotic|antibiotic
4971187|NCT01764750|Vancomycin|vancomycin
4971188|NCT01764750|Infection|infection
4971189|NCT01764750|Pharmacokinetics|pharmacokinetics
4971190|NCT01764737|VX15/2503|vx15/2503
4971191|NCT01764737|Semaphorin 4D|semaphorin 4d
4971192|NCT01764737|SEMA4D|sema4d
4971193|NCT01764737|CD100|cd100
4971194|NCT01764737|safety|safety
4971195|NCT01764737|tolerability|tolerability
4971196|NCT01764737|pharmacokinetics|pharmacokinetics
4971197|NCT01764737|immunogenicity|immunogenicity
4971198|NCT01764737|multiple sclerosis|multiple sclerosis
4971199|NCT01764737|monoclonal antibody|monoclonal antibody
4971200|NCT01764724|Attitudes and understanding of sodium claims|attitudes and understanding of sodium claims
4971201|NCT01764724|General canadian population|general canadian population
4971202|NCT01764711|POTS|pots
4971203|NCT01764698|anxiety disorders|anxiety disorders
4971204|NCT01764698|substance use disorders|substance use disorders
4971205|NCT01764698|treatment effectiveness|treatment effectiveness
4971206|NCT01764698|cognitive behavioral therapy|cognitive behavioral therapy
4971207|NCT01764672|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
4971208|NCT01764672|Healthy Adults|healthy adults
4971209|NCT01764672|Methylphenidate|methylphenidate
4971210|NCT01764672|Functional connectivity|functional connectivity
4971211|NCT01764672|Functional Magnetic Resonance Imaging|functional magnetic resonance imaging
4971212|NCT01764659|4D-CT|4d-ct
4971213|NCT01764659|Contrast Enhanced CT|contrast enhanced ct
4971214|NCT01764659|Radiotherapy Simulation|radiotherapy simulation
4971215|NCT01764646|Prostate cancer|prostate cancer
4971216|NCT01764646|Radiation therapy|radiation therapy
4971217|NCT01764633|High cholesterol|high cholesterol
4971218|NCT01764633|Treatment for high cholesterol|treatment for high cholesterol
4971219|NCT01764633|Lowering cholesterol|lowering cholesterol
4971220|NCT01764633|Lowering high cholesterol|lowering high cholesterol
4971221|NCT01764633|Hypercholesterolemia|hypercholesterolemia
4971222|NCT01764620|shoulder|shoulder
4971223|NCT01764620|muscle fatigue|muscle fatigue
4971224|NCT01764620|kinematics|kinematics
4971225|NCT01764620|athletes|athletes
4971226|NCT01764607|Squamous|squamous
4971227|NCT01764607|Renal|renal
4971228|NCT01764607|Transplant|transplant
4971229|NCT01764594|Lupus|lupus
4971230|NCT01764594|SLE|sle
4971231|NCT01764581|immune monitoring|immune monitoring
4971232|NCT01764581|immune cell function ImmuKnow|immune cell function immuknow
4971233|NCT01764581|randomized controlled trial|randomized controlled trial
4971234|NCT01764581|immunosuppression management|immunosuppression management
4971235|NCT01764581|infection|infection
4971236|NCT01764581|rejection|rejection
4971237|NCT01764581|liver transplantation|liver transplantation
4971238|NCT01764581|Cylex|cylex
4971239|NCT01764568|Metacognitive training|metacognitive training
4971426|NCT01763723|home-use|home-use
4971240|NCT01764568|Cognitive behavioral therapy|cognitive behavioral therapy
4971241|NCT01764568|Clinical trial|clinical trial
4971242|NCT01764568|Group intervention|group intervention
4971243|NCT01764568|Group therapy|group therapy
4971244|NCT01764568|Schizophrenia|schizophrenia
4971245|NCT01764568|Psychosis|psychosis
4971246|NCT01764568|Cognitive remediation|cognitive remediation
4971247|NCT01764542|Ulcerative colitis|ulcerative colitis
4971248|NCT01764542|dysplasia|dysplasia
4971249|NCT01764542|risk factor|risk factor
4971250|NCT01764542|surgery|surgery
4971251|NCT01764516|zinc|zinc
4971252|NCT01764516|selenium|selenium
4971253|NCT01764516|serum|serum
4971254|NCT01764516|epilepsy|epilepsy
4971255|NCT01764516|antioxidants|antioxidants
4971256|NCT01764503|ampullary tumors|ampullary tumors
4971257|NCT01764503|endoscopic treatment|endoscopic treatment
4971380|NCT01763892|TBI|tbi
4971381|NCT01763892|Apolipoprotein E|apolipoprotein e
4971382|NCT01763892|apo-E|apo-e
4971258|NCT01764490|Bloodstream infections caused by multidrug-resistant Enterobacteriaceae, extended-spectrum β-lactamase-producers, carbapenemase-producing organisms|bloodstream infections caused by multidrug-resistant enterobacteriaceae, extended-spectrum β-lactamase-producers, carbapenemase-producing organisms
4971259|NCT01764464|post laminectomy pain syndrome, failed back surgery syndrome|post laminectomy pain syndrome, failed back surgery syndrome
4971260|NCT01764451|Hispanic|hispanic
4971261|NCT01764425|P7435|p7435
4971262|NCT01764425|Healthy,overweight and or obese subjects|healthy,overweight and or obese subjects
4971263|NCT01764425|Single ascending dose|single ascending dose
4971264|NCT01764425|Multiple ascending dose|multiple ascending dose
4971265|NCT01764425|Pharmacokinetics|pharmacokinetics
4971266|NCT01764412|Healthy women|healthy women
4971267|NCT01764412|Menstrual cycle|menstrual cycle
4971268|NCT01764412|Hepcidin|hepcidin
4971269|NCT01764412|Seric iron|seric iron
4971270|NCT01764399|cardiovascular risk factors|cardiovascular risk factors
4971271|NCT01764386|obesity, overweight|obesity, overweight
4971272|NCT01764373|Pain|pain
4971273|NCT01764373|Fitness|fitness
4971274|NCT01764373|Diabetes|diabetes
4971275|NCT01764373|Aerobic Exercise|aerobic exercise
4971276|NCT01764334|NonST elevation myocardial infarction (NSTEMI)|nonst elevation myocardial infarction (nstemi)
4971277|NCT01764334|Fractional flow reserve (FFR)|fractional flow reserve (ffr)
4971278|NCT01764334|Coronary angiogram|coronary angiogram
4971279|NCT01764334|Diagnosis|diagnosis
4971280|NCT01764334|Coronary revascularization|coronary revascularization
4971281|NCT01764334|Prognosis|prognosis
4971282|NCT01764334|Health economics|health economics
4971283|NCT01764321|Certolizumab Pegol|certolizumab pegol
4971284|NCT01764321|Cimzia®|cimzia®
4971285|NCT01764321|TNF inhibitor|tnf inhibitor
4971286|NCT01764321|DMARD|dmard
4971287|NCT01764321|Rheumatoid Arthritis|rheumatoid arthritis
4971288|NCT01764308|acne; omega-3; isotretinoin; placebo|acne; omega-3; isotretinoin; placebo
4971289|NCT01764282|HIV|hiv
4971290|NCT01764282|serodiscordant couples HIV sero-conversion|serodiscordant couples hiv sero-conversion
4971291|NCT01764282|anti-retroviral therapy|anti-retroviral therapy
4971292|NCT01764282|intervention|intervention
4971293|NCT01764256|rotavirus|rotavirus
4971294|NCT01764256|vaccine|vaccine
4971295|NCT01764243|Alzheimer's Disease|alzheimer's disease
4971296|NCT01764243|Nicotinic Acetylcholine Receptor Agonist|nicotinic acetylcholine receptor agonist
4971297|NCT01764243|Cognitive function|cognitive function
4971298|NCT01764243|Dementia|dementia
4971299|NCT01764243|Central Nervous System Agents|central nervous system agents
4971300|NCT01764230|Hodgkin lymphoma|hodgkin lymphoma
4971301|NCT01764230|Hodgkin disease|hodgkin disease
4971302|NCT01764217|Cervix Cancer|cervix cancer
4971303|NCT01764217|SUV|suv
4971304|NCT01764217|Radiotherapy|radiotherapy
4971305|NCT01764217|Outcome Prediction|outcome prediction
4971306|NCT01764217|Imaging|imaging
4971307|NCT01764217|PET|pet
4971308|NCT01764178|Pitavastatin|pitavastatin
4971309|NCT01764178|Valsartan|valsartan
4971310|NCT01764165|COPD|copd
4971311|NCT01764165|Sleep|sleep
4971312|NCT01764165|Supplemental oxygen|supplemental oxygen
4971313|NCT01764165|Breathing mechanics|breathing mechanics
4971314|NCT01764165|nasal insufflation|nasal insufflation
4971315|NCT01764152|Prevention,|prevention,
4971316|NCT01764152|influenza,|influenza,
4971317|NCT01764152|adults hospitalized,|adults hospitalized,
4971318|NCT01764152|vaccines,|vaccines,
4971319|NCT01764152|Effectiveness|effectiveness
4971320|NCT01764139|Minimal knee changes|minimal knee changes
4971321|NCT01764126|Safety|safety
4971322|NCT01764126|immunogenicity|immunogenicity
4971323|NCT01764126|pneumococcal|pneumococcal
4971324|NCT01764126|protein|protein
4971325|NCT01764126|vaccine|vaccine
4971326|NCT01764113|Obesity|obesity
4971327|NCT01764113|Adolescence|adolescence
4971328|NCT01764113|Mindful Eating|mindful eating
4971329|NCT01764087|Stomach Neoplasms|stomach neoplasms
4971330|NCT01764087|Breast Neoplasms|breast neoplasms
4971331|NCT01764087|Carcinoma|carcinoma
4971332|NCT01764087|Neoplasms|neoplasms
4971333|NCT01764087|Paclitaxel|paclitaxel
4971334|NCT01764087|Tubulin Modulators|tubulin modulators
4971335|NCT01764087|Antimitotic Agents|antimitotic agents
4971427|NCT01763723|subjects|subjects
4971336|NCT01764087|Protein Kinase Inhibitors|protein kinase inhibitors
4971337|NCT01764087|Enzyme Inhibitors|enzyme inhibitors
4971338|NCT01764087|Pharmacologic Actions|pharmacologic actions
4971339|NCT01764074|Bipolar Disorder|bipolar disorder
4971340|NCT01764074|Sleep Intervention|sleep intervention
4971341|NCT01764074|Suicide|suicide
4971342|NCT01764074|Cognitive Behavioral Therapy|cognitive behavioral therapy
4971343|NCT01764074|Sleep Quality|sleep quality
4971344|NCT01764061|Red Cells|red cells
4971345|NCT01764061|Blood donors|blood donors
4971346|NCT01764048|pain management|pain management
4971347|NCT01764048|cesarean section|cesarean section
4971348|NCT01764035|Psychotherapy|psychotherapy
4971349|NCT01764035|Bipolar Disorder|bipolar disorder
4971350|NCT01764035|Sleep Problems|sleep problems
4971351|NCT01764035|Insomnia|insomnia
4971352|NCT01764035|Hypersomnia|hypersomnia
4971353|NCT01764035|Mindfulness|mindfulness
4971354|NCT01764035|Meditation|meditation
4971355|NCT01764035|Sleep Disturbance|sleep disturbance
4971356|NCT01764022|breast cancer|breast cancer
4971357|NCT01764022|trastuzumab|trastuzumab
4971358|NCT01764009|Advanced Melanoma|advanced melanoma
4971359|NCT01764009|Metastatic Melanoma|metastatic melanoma
4971360|NCT01764009|Melanoma Stage III and IV|melanoma stage iii and iv
4971361|NCT01763996|Drug therapy|drug therapy
4971362|NCT01763983|Multiple Sclerosis|multiple sclerosis
4971363|NCT01763983|Stress, Psychological|stress, psychological
4971364|NCT01763983|Psychological Stress|psychological stress
4971365|NCT01763983|Emotional Stress|emotional stress
4971366|NCT01763983|Cognitive Deficits|cognitive deficits
4971367|NCT01763983|Cognitive Dysfunction|cognitive dysfunction
4971368|NCT01763970|Stereotactic|stereotactic
4971369|NCT01763970|Radiotherapy|radiotherapy
4971370|NCT01763970|Hypofractionated|hypofractionated
4971371|NCT01763944|diet|diet
4971372|NCT01763944|prostate cancer|prostate cancer
4971373|NCT01763944|carbohydrate|carbohydrate
4971374|NCT01763944|lifestyle|lifestyle
4971375|NCT01763931|Digoxin|digoxin
4971376|NCT01763918|High cholesterol, Treatment for high cholesterol, Lowering cholesterol, Lowering high cholesterol, Hypercholesterolemia|high cholesterol, treatment for high cholesterol, lowering cholesterol, lowering high cholesterol, hypercholesterolemia
4971377|NCT01763905|High Cholesterol, Treatment for high cholesterol, Lowering cholesterol, Lowering high cholesterol, Hypercholesterolemia|high cholesterol, treatment for high cholesterol, lowering cholesterol, lowering high cholesterol, hypercholesterolemia
4971378|NCT01763892|Pediatric|pediatric
4971379|NCT01763892|Traumatic Brain Injury|traumatic brain injury
4971383|NCT01763892|Vasospasm|vasospasm
4971384|NCT01763892|Genetics|genetics
4971385|NCT01763892|Physiologic Mechanisms|physiologic mechanisms
4971386|NCT01763892|Neurocognitive Outcomes|neurocognitive outcomes
4971387|NCT01763892|Endothelin 1|endothelin 1
4971388|NCT01763879|Thoracic surgery|thoracic surgery
4971389|NCT01763879|one lung ventilation|one lung ventilation
4971390|NCT01763879|pressure-controlled ventilation|pressure-controlled ventilation
4971391|NCT01763879|volume-controlled ventilation|volume-controlled ventilation
4971392|NCT01763879|right ventricular function|right ventricular function
4971393|NCT01763866|High cholesterol, Treatment for high cholesterol, Lowering cholesterol, Lowering high cholesterol, Hypercholesterolemia|high cholesterol, treatment for high cholesterol, lowering cholesterol, lowering high cholesterol, hypercholesterolemia
4971394|NCT01763853|Acute respiratory distress syndrome (ARDS)|acute respiratory distress syndrome (ards)
4971395|NCT01763853|Pulmonary edema|pulmonary edema
4971396|NCT01763853|Alveolar fluid clearance|alveolar fluid clearance
4971397|NCT01763853|Alveolar epithelial dysfunction|alveolar epithelial dysfunction
4971398|NCT01763853|Receptor for advanced glycation end-products (RAGE)|receptor for advanced glycation end-products (rage)
4971399|NCT01763853|Fluid resuscitation therapy|fluid resuscitation therapy
4971400|NCT01763853|Hypovolemia|hypovolemia
4971401|NCT01763853|Crystalloid|crystalloid
4971402|NCT01763853|Hydroxyethyl Starch|hydroxyethyl starch
4971403|NCT01763853|Intensive care unit|intensive care unit
4971404|NCT01763840|Pediatric Abdominal Trauma Ultrasound Contrast|pediatric abdominal trauma ultrasound contrast
4971405|NCT01763827|High cholesterol, Treatment for high cholesterol, Lowering cholesterol, Lowering high cholesterol, Hypercholesterolemia|high cholesterol, treatment for high cholesterol, lowering cholesterol, lowering high cholesterol, hypercholesterolemia
4971406|NCT01763801|chemo port|chemo port
4971407|NCT01763801|intravenous electrocardiographic guidance|intravenous electrocardiographic guidance
4971408|NCT01763801|P maximal wave|p maximal wave
4971409|NCT01763801|P submaximal wave|p submaximal wave
4971410|NCT01763801|catheter tip|catheter tip
4971411|NCT01763775|weight|weight
4971412|NCT01763775|total body water|total body water
4971413|NCT01763775|body fat|body fat
4971414|NCT01763775|muscle mass|muscle mass
4971415|NCT01763775|bone mass|bone mass
4971416|NCT01763762|Electrical pudendal nerve stimulation|electrical pudendal nerve stimulation
4971417|NCT01763762|Pelvic floor muscle training|pelvic floor muscle training
4971418|NCT01763762|Transvaginal electrical stimulation|transvaginal electrical stimulation
4971419|NCT01763762|Stress urinary incontinence|stress urinary incontinence
4971420|NCT01763762|Comparative study|comparative study
4971421|NCT01763723|Intense pulsed light,|intense pulsed light,
4971422|NCT01763723|UV-exposure,|uv-exposure,
4971423|NCT01763723|skin type,|skin type,
4971424|NCT01763723|safety,|safety,
4971425|NCT01763723|pigment,|pigment,
4971428|NCT01763710|Breast cancer|breast cancer
4971429|NCT01763710|Neurotoxicity|neurotoxicity
4971430|NCT01763697|Taste acuity|taste acuity
4971431|NCT01763697|Feeding behavior|feeding behavior
4971432|NCT01763697|opioid|opioid
4971433|NCT01763697|Quantitative assessment|quantitative assessment
4971434|NCT01763684|Osteoarthritis|osteoarthritis
4971435|NCT01763684|Osteoarthritis, Knee|osteoarthritis, knee
4971436|NCT01763684|Osteonecrosis|osteonecrosis
4971437|NCT01763684|Arthritis|arthritis
4971438|NCT01763684|Knee Arthritis|knee arthritis
4971439|NCT01763684|Knee Replacement|knee replacement
4971440|NCT01763671|Lung cancer|lung cancer
4971441|NCT01763671|Paclitaxel bevacizumab|paclitaxel bevacizumab
4971442|NCT01763658|ITP, antioxidant therapy, oxidant status|itp, antioxidant therapy, oxidant status
4971443|NCT01763645|NSCLC|nsclc
4971444|NCT01763645|bevacizumab|bevacizumab
4971445|NCT01763645|pharmacokinetics|pharmacokinetics
4971446|NCT01763632|Hyperbilirubinemia|hyperbilirubinemia
4971447|NCT01763632|Neonatal|neonatal
4971448|NCT01763632|Transcutaneous Bilirubin|transcutaneous bilirubin
4971449|NCT01763619|Cervical DDD|cervical ddd
4971450|NCT01763619|DDD|ddd
4971451|NCT01763619|degenerative disc disease|degenerative disc disease
4971452|NCT01763619|C3-C7|c3-c7
4971453|NCT01763606|Enoxaparin|enoxaparin
4971454|NCT01763606|Aspirin|aspirin
4971455|NCT01763606|stroke|stroke
4971456|NCT01763606|12-264|12-264
4971457|NCT01763593|Patients having cataract|patients having cataract
4971458|NCT01763580|Glomerulonephritis|glomerulonephritis
4971459|NCT01763580|Tacrolimus|tacrolimus
4971460|NCT01763580|Nephrotic syndrome|nephrotic syndrome
4971461|NCT01763567|Medtronic|medtronic
4971462|NCT01763567|Diabetes|diabetes
4971463|NCT01763567|Hospital|hospital
4971464|NCT01763567|Continuous Glucose Monitor|continuous glucose monitor
4971465|NCT01763567|Intensive Care Unit|intensive care unit
4971466|NCT01763554|Lu-177|lu-177
4971467|NCT01763554|Lutetium-177|lutetium-177
4971468|NCT01763554|DOTA-TATE|dota-tate
4971469|NCT01763554|Neuroendocrine tumors|neuroendocrine tumors
4971470|NCT01763554|radiopharmaceutical|radiopharmaceutical
4971471|NCT01763541|Natriuretic Peptides|natriuretic peptides
4971472|NCT01763528|body weight|body weight
4971473|NCT01763528|Low-density-lipoprotein-type|low-density-lipoprotein-type
4971474|NCT01763515|Joint Diseases|joint diseases
4971475|NCT01763515|Arthritis|arthritis
4971476|NCT01763515|Osteoarthritis|osteoarthritis
4971477|NCT01763502|Cognitive development|cognitive development
4971478|NCT01763502|Anemia|anemia
4971479|NCT01763502|Preschool|preschool
4971480|NCT01763502|Food transfers|food transfers
4971481|NCT01763502|Cash transfers|cash transfers
4971482|NCT01763502|Early childhood|early childhood
4971483|NCT01763502|Nutrition|nutrition
4971484|NCT01763489|randomized controlled trial|randomized controlled trial
4971485|NCT01763489|applicability|applicability
4971486|NCT01763489|ASSIST tool|assist tool
4971487|NCT01763489|surgery|surgery
4971488|NCT01763489|digestive cancer|digestive cancer
4971489|NCT01763476|long infrapopliteal artery lesions|long infrapopliteal artery lesions
4971490|NCT01763476|drug-coated balloon angioplasty|drug-coated balloon angioplasty
4971491|NCT01763476|atherectomy|atherectomy
4971492|NCT01763463|pneumonia requiring hospitalization|pneumonia requiring hospitalization
4971493|NCT01763463|COPD|copd
4971494|NCT01763463|long-acting bronchodilators (LABD)|long-acting bronchodilators (labd)
4971495|NCT01763463|Inhaled Corticosteroids (ICS)|inhaled corticosteroids (ics)
4971496|NCT01763450|Bevacizumab|bevacizumab
4971497|NCT01763450|conversion therapy|conversion therapy
4971498|NCT01763450|liver metastases|liver metastases
4971499|NCT01763450|colorectal cancer|colorectal cancer
4971500|NCT01763450|objective response rate|objective response rate
4971501|NCT01763437|Chalazia|chalazia
4971502|NCT01763437|Chalazion|chalazion
4971503|NCT01763437|Meibomian gland dysfunction|meibomian gland dysfunction
4971504|NCT01763437|Rosacea|rosacea
4971505|NCT01763437|Ocular rosacea|ocular rosacea
4971506|NCT01763411|Cataract|cataract
4971507|NCT01763411|Vision|vision
4971508|NCT01763411|Intraocular lens|intraocular lens
4971509|NCT01763411|Multifocal|multifocal
4971510|NCT01763411|Monofocal|monofocal
4971511|NCT01763385|Erlotinib|erlotinib
4971512|NCT01763385|brain radiotherapy|brain radiotherapy
4971513|NCT01763385|NSCLC|nsclc
4971514|NCT01763385|brain metastases|brain metastases
4971515|NCT01763372|Arthroscopic|arthroscopic
4971516|NCT01763372|Iliopsoas|iliopsoas
4971517|NCT01763372|MRI|mri
4971518|NCT01763359|acetabular fracture|acetabular fracture
4971519|NCT01763359|pelvic fracture|pelvic fracture
4971520|NCT01763359|hip adductor strength|hip adductor strength
4971521|NCT01763359|obturator nerve palsy|obturator nerve palsy
4971522|NCT01763359|modified Stoppa approach|modified stoppa approach
4971523|NCT01763346|type 2 diabetes|type 2 diabetes
4971524|NCT01763346|prediabetes|prediabetes
4971525|NCT01763346|obesity|obesity
4971526|NCT01763346|gastric banding|gastric banding
4971527|NCT01763346|metformin|metformin
4971528|NCT01763320|ischemic stroke|ischemic stroke
4971529|NCT01763320|intracranial stenting|intracranial stenting
4971530|NCT01763320|vascular risk factor management|vascular risk factor management
4971531|NCT01763307|EGFRI|egfri
4971532|NCT01763307|COLON CANCER|colon cancer
4971533|NCT01763307|SKIN TOXICITY|skin toxicity
4971534|NCT01763307|RECONVAL K1 cream|reconval k1 cream
4971535|NCT01763294|multifocal refractory epilepsy|multifocal refractory epilepsy
4971536|NCT01763294|tDCS|tdcs
4971537|NCT01763294|neurostimulation|neurostimulation
4971538|NCT01763294|seizures|seizures
4971539|NCT01763268|Immunogenicity|immunogenicity
4971540|NCT01763268|Reactogenicity|reactogenicity
4971541|NCT01763268|Trivivac|trivivac
4971542|NCT01763268|Measles|measles
4971543|NCT01763268|Mump|mump
4971544|NCT01763268|Rubella|rubella
4971545|NCT01763255|cerebral palsy CD133 cells intrathecal injection|cerebral palsy cd133 cells intrathecal injection
4971546|NCT01763242|CKD, Anaemia, Synchronization, Monthly dosing, Home Delivery|ckd, anaemia, synchronization, monthly dosing, home delivery
4971547|NCT01763216|depressive symptoms|depressive symptoms
4971548|NCT01763216|clinical depression|clinical depression
4971549|NCT01763216|visual processing speed|visual processing speed
4971550|NCT01763216|anxiety|anxiety
4971551|NCT01763216|pain|pain
4971552|NCT01763216|health-related quality of life|health-related quality of life
4971553|NCT01763203|Self-management|self-management
4971554|NCT01763203|Chronic Care Model|chronic care model
4971555|NCT01763203|Community health worker|community health worker
4971556|NCT01763177|nebulizer|nebulizer
4971557|NCT01763177|oxygen|oxygen
4971558|NCT01763177|post-operative sore throat|post-operative sore throat
4971559|NCT01763164|Melanoma|melanoma
4971560|NCT01763164|Cutaneous melanoma|cutaneous melanoma
4971561|NCT01763164|Skin disease|skin disease
4971562|NCT01763164|Skin cancer|skin cancer
4971563|NCT01763164|Skin Neoplasms|skin neoplasms
4971564|NCT01763164|Neoplasm Metastasis|neoplasm metastasis
4971565|NCT01763151|cataract surgery, astigmatism, opposite clear corneal incision, toric IOL, IOL rotational stability|cataract surgery, astigmatism, opposite clear corneal incision, toric iol, iol rotational stability
4971566|NCT01763125|circulating tumor cells|circulating tumor cells
4971567|NCT01763125|CTC|ctc
4971568|NCT01763125|tumor marker|tumor marker
4971569|NCT01763112|Influence of training with whole body vibration device|influence of training with whole body vibration device
4971570|NCT01763099|Autologous Hematopoietic Stem Cell Transplantation|autologous hematopoietic stem cell transplantation
4971571|NCT01763099|Mesenchymal Stem Cells|mesenchymal stem cells
4971572|NCT01763099|Cord Blood|cord blood
4971573|NCT01763099|Graft failure|graft failure
4971574|NCT01763086|Poor Graft Function|poor graft function
4971575|NCT01763086|Mesenchymal Stem Cells|mesenchymal stem cells
4971576|NCT01763086|Allogeneic hematopoietic stem cell transplantation|allogeneic hematopoietic stem cell transplantation
4971577|NCT01763086|Third-party Donors|third-party donors
4971578|NCT01763060|ards|ards
4971579|NCT01763060|ecmo|ecmo
4971580|NCT01763060|h1n1|h1n1
4971581|NCT01763060|pandemics|pandemics
4971582|NCT01763021|Healthy participants|healthy participants
4971583|NCT01763021|PCI-32765|pci-32765
4971584|NCT01763021|Rifampin|rifampin
4971585|NCT01763021|PCI-45227|pci-45227
4971586|NCT01763021|CYP3A4|cyp3a4
4971587|NCT01763008|Pneumonia, Bacterial|pneumonia, bacterial
4971588|NCT01763008|Nosocomial Infection|nosocomial infection
4971589|NCT01763008|Intraabdominal Infections|intraabdominal infections
4971590|NCT01763008|Urinary Tract Infection|urinary tract infection
4971591|NCT01763008|Ventilator-associated pneumonia|ventilator-associated pneumonia
4971592|NCT01763008|Doripenem|doripenem
4971593|NCT01763008|Doribax|doribax
4971594|NCT01763008|Filipino|filipino
4971595|NCT01762995|Dolutegravir, pharmacokinetics, calcium, iron, drug interaction, healthy volunteers|dolutegravir, pharmacokinetics, calcium, iron, drug interaction, healthy volunteers
4971596|NCT01762956|Pelvic floor|pelvic floor
4971597|NCT01762956|Physical Therapy|physical therapy
4971598|NCT01762956|Prostate cancer|prostate cancer
4971599|NCT01762956|Radiotherapy|radiotherapy
4971600|NCT01762956|Nuclear magnetic resonance|nuclear magnetic resonance
4971601|NCT01762904|Antiseptics|antiseptics
4971602|NCT01762904|Administration cutaneously|administration cutaneously
4971603|NCT01762904|Anti-infecting agents, local|anti-infecting agents, local
4971604|NCT01762891|Coumadin|coumadin
4971605|NCT01762891|celecoxib|celecoxib
4971606|NCT01762891|rofecoxib|rofecoxib
4971607|NCT01762891|acetaminophen|acetaminophen
4971608|NCT01762891|antiphospholipid syndrome and INR|antiphospholipid syndrome and inr
4971609|NCT01762878|pharmacodynamics|pharmacodynamics
4971610|NCT01762878|pharmacokinetics|pharmacokinetics
4971611|NCT01762878|healthy volunteers|healthy volunteers
4971612|NCT01762878|Pi3K-delta|pi3k-delta
4971613|NCT01762878|GSK2269557|gsk2269557
4971614|NCT01762878|safety|safety
4971615|NCT01762878|dry powder inhaler|dry powder inhaler
4971616|NCT01762865|acute bronchitis, bacteria, virus, clinical symoptoms|acute bronchitis, bacteria, virus, clinical symoptoms
4971617|NCT01762852|Benlysta|benlysta
4971618|NCT01762852|efficacy|efficacy
4971619|NCT01762852|proteinuria|proteinuria
4971620|NCT01762852|Idiopathic membranous nephropathy|idiopathic membranous nephropathy
4971621|NCT01762852|GSK1550188|gsk1550188
4971622|NCT01762852|anti-phospholipase A2 receptor antibodies|anti-phospholipase a2 receptor antibodies
4971623|NCT01762852|safety|safety
4971624|NCT01762852|placebo|placebo
4971625|NCT01762852|BLyS|blys
4971626|NCT01762852|belimumab|belimumab
4971627|NCT01762852|Lymphostat-B|lymphostat-b
4971628|NCT01762852|membrane attack complex|membrane attack complex
4971629|NCT01762826|Inositol|inositol
4971631|NCT01762813|Colon cancer|colon cancer
4971632|NCT01762813|rectal cancer|rectal cancer
4971633|NCT01762813|liver metastasis|liver metastasis
4971634|NCT01762813|survival|survival
4971635|NCT01762813|biomarker|biomarker
4971636|NCT01762813|molecular profile|molecular profile
4971637|NCT01762774|COPD|copd
4971638|NCT01762774|forearm blood flow|forearm blood flow
4971639|NCT01762774|soluble Epoxide Hydrolase inhibitor|soluble epoxide hydrolase inhibitor
4971640|NCT01762761|eltrombopag|eltrombopag
4971641|NCT01762761|TPO-R agonist|tpo-r agonist
4971642|NCT01762761|Chronic ITP|chronic itp
4971643|NCT01762748|Probiotic|probiotic
4971644|NCT01762748|liver|liver
4971645|NCT01762748|transplant|transplant
4971646|NCT01762748|permeability|permeability
4971647|NCT01762722|Spectroscopy, near infrared|spectroscopy, near infrared
4971648|NCT01762722|Oximetry|oximetry
4971649|NCT01762722|Hypoxemia|hypoxemia
4971650|NCT01762722|Tissue oxygenation|tissue oxygenation
4971651|NCT01762709|Video-assisted thoracoscopic surgery|video-assisted thoracoscopic surgery
4971652|NCT01762709|one lung ventilation|one lung ventilation
4971653|NCT01762709|low tidal volume|low tidal volume
4971654|NCT01762709|acute lung injury|acute lung injury
4971655|NCT01762709|lung water content|lung water content
4971656|NCT01762696|marijuana|marijuana
4971657|NCT01762696|intervention|intervention
4971658|NCT01762696|adolescent, young adult|adolescent, young adult
4971659|NCT01762696|primary care|primary care
4971660|NCT01762696|mobile|mobile
4971661|NCT01762683|pregnancy|pregnancy
4971662|NCT01762683|obesity|obesity
4971663|NCT01762683|differentiation|differentiation
4971664|NCT01762670|Bacterial Vaginosis|bacterial vaginosis
4971665|NCT01762670|BV|bv
4971666|NCT01762657|Type 1 Diabetes|type 1 diabetes
4971667|NCT01762657|Insulin Independence|insulin independence
4971668|NCT01762657|Beta Regeneration|beta regeneration
4971669|NCT01762657|Immune Tolerance Agent|immune tolerance agent
4971670|NCT01762657|Lanzoprazole|lanzoprazole
4971671|NCT01762657|Cyclosporine|cyclosporine
4971672|NCT01762644|Type 1 Diabetes|type 1 diabetes
4971673|NCT01762644|Insulin Independence|insulin independence
4971674|NCT01762644|Beta Regeneration|beta regeneration
4971675|NCT01762644|Immune Tolerance Agent|immune tolerance agent
4971676|NCT01762644|Omeprazole|omeprazole
4971677|NCT01762644|Cyclosporine|cyclosporine
4971678|NCT01762618|Group Cognitive Behavior Therapy, Alzheimer's disease, Caregivers¡|group cognitive behavior therapy, alzheimer's disease, caregivers¡
4971679|NCT01762579|Not-celiac wheat sensitivity|not-celiac wheat sensitivity
4971680|NCT01762579|Gluten|gluten
4971681|NCT01762579|esophagogastroduodenoscopy|esophagogastroduodenoscopy
4971682|NCT01762579|Rectoscopy|rectoscopy
4971683|NCT01762566|Not-celiac gluten (wheat) sensitivity|not-celiac gluten (wheat) sensitivity
4971684|NCT01762566|Bioelectrical impedance analysis|bioelectrical impedance analysis
4971685|NCT01762566|Bloating|bloating
4971686|NCT01762566|Swelling|swelling
4971687|NCT01762540|Protein breakdown|protein breakdown
4971688|NCT01762540|Insulin resistance|insulin resistance
4971689|NCT01762540|Glucose intolerance|glucose intolerance
4971690|NCT01762540|Lipolysis|lipolysis
4971691|NCT01762527|Adaptive radiotherapy|adaptive radiotherapy
4971692|NCT01762527|Bladder cancer|bladder cancer
4971693|NCT01762514|Nasopharyngeal carcinoma|nasopharyngeal carcinoma
4971694|NCT01762514|Amifostine|amifostine
4971695|NCT01762514|Myelosuppression|myelosuppression
4971696|NCT01762514|Xerostomia|xerostomia
4971697|NCT01762514|Mucositis|mucositis
4971698|NCT01762501|Hypertension|hypertension
4971699|NCT01762488|Treatment Resistant Hypertension|treatment resistant hypertension
4971700|NCT01762488|Renal Denervation|renal denervation
4971701|NCT01762475|Magnetic resonance imaging|magnetic resonance imaging
4971702|NCT01762475|Blood oxygen level dependent signal|blood oxygen level dependent signal
4971703|NCT01762475|Hypercapnia|hypercapnia
4971704|NCT01762475|Endothelial progenitor cells|endothelial progenitor cells
4971705|NCT01762449|Scleroderma|scleroderma
4971706|NCT01762449|interstitial lung disease|interstitial lung disease
4971707|NCT01762410|Advanced refractory solid tumors|advanced refractory solid tumors
4971708|NCT01762371|ACL|acl
4971709|NCT01762371|Knee|knee
4971710|NCT01762371|Ligament|ligament
4971711|NCT01762371|Cruciate|cruciate
4971712|NCT01762371|Anterior|anterior
4971713|NCT01762358|ACL|acl
4971714|NCT01762358|Ligament|ligament
4971715|NCT01762358|Knee|knee
4971716|NCT01762345|Stress urinary incontinence|stress urinary incontinence
4971717|NCT01762345|SUI|sui
4971718|NCT01762332|nociception|nociception
4971719|NCT01762332|analgesia|analgesia
4971720|NCT01762332|intraoperative monitoring|intraoperative monitoring
4971721|NCT01762293|CRC|crc
4971722|NCT01762293|Famitinib|famitinib
4971723|NCT01762293|Phase II|phase ii
4971724|NCT01762293|Colorectal Cancer|colorectal cancer
4971725|NCT01762280|Famitinib|famitinib
4971726|NCT01762280|Advanced Solid tumor|advanced solid tumor
4971727|NCT01762280|Phase I|phase i
4971728|NCT01762254|pain score|pain score
4971729|NCT01762254|complication|complication
4971730|NCT01762241|Prostate cancer|prostate cancer
4971731|NCT01762241|Androgen deprivation therapy|androgen deprivation therapy
4971732|NCT01762241|Exercise|exercise
4971733|NCT01762241|Xbox|xbox
4971734|NCT01762228|Oropharyngeal dysphagia|oropharyngeal dysphagia
4971735|NCT01762228|Elderly|elderly
4971736|NCT01762228|Transcutaneous electrical stimulation|transcutaneous electrical stimulation
4971737|NCT01762228|TRPV1 agonist|trpv1 agonist
4971738|NCT01762215|Epilepsy|epilepsy
4971739|NCT01762215|Seizure|seizure
4971740|NCT01762215|Veteran|veteran
4971741|NCT01762202|CLL|cll
4971742|NCT01762202|Fludarabine|fludarabine
4971743|NCT01762202|Cyclophosphamide|cyclophosphamide
4971744|NCT01762202|Ofatumumab|ofatumumab
4971745|NCT01762189|Hyperbilirubinemia|hyperbilirubinemia
4971746|NCT01762189|Neonatal|neonatal
4971747|NCT01762189|Incidence|incidence
4971748|NCT01762189|Risk factors|risk factors
4971749|NCT01762176|Early Rheumatoid Arthritis|early rheumatoid arthritis
4971750|NCT01762176|Usual care|usual care
4971751|NCT01762176|Intensive Care|intensive care
4971752|NCT01762176|Boolean criteria|boolean criteria
4971753|NCT01762163|Ischemic Stroke,adaptive design, randomized, double-blind|ischemic stroke,adaptive design, randomized, double-blind
4971754|NCT01762150|collected duct carcinoma|collected duct carcinoma
4971755|NCT01762150|sorafenib|sorafenib
4971756|NCT01762137|Aneurysm|aneurysm
4971757|NCT01762137|Coiling|coiling
4971758|NCT01762137|Flow Diversion|flow diversion
4971759|NCT01762124|Pulmonary valve|pulmonary valve
4971760|NCT01762124|Congenital heart disease|congenital heart disease
4971761|NCT01762124|Transcatheter pulmonary valve|transcatheter pulmonary valve
4971762|NCT01762124|Percutaneous pulmonary valve|percutaneous pulmonary valve
4971763|NCT01762111|Anti-Mullerian Hormone|anti-mullerian hormone
4971764|NCT01762111|In-Vitro fertilization|in-vitro fertilization
4971765|NCT01762098|In vitro fertilization|in vitro fertilization
4971766|NCT01762098|Hysteroscopy|hysteroscopy
4971767|NCT01762098|Endometrial biopsy|endometrial biopsy
4971768|NCT01762085|neuropathic diabetic foot ulcer|neuropathic diabetic foot ulcer
4971769|NCT01762085|nerve decompression surgery|nerve decompression surgery
4971770|NCT01762072|homocysteine-vitamin B12-fish oil-ferritin|homocysteine-vitamin b12-fish oil-ferritin
4971771|NCT01762059|bionic pancreas|bionic pancreas
4971772|NCT01762059|artificial pancreas|artificial pancreas
4971773|NCT01762059|insulin|insulin
4971774|NCT01762059|glucagon|glucagon
4971775|NCT01762059|continuous glucose monitoring|continuous glucose monitoring
4971776|NCT01762059|CGM|cgm
4971777|NCT01762059|outpatient|outpatient
4971778|NCT01762059|insulin pump|insulin pump
4971779|NCT01762046|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
4971780|NCT01762046|Pharmacogenetics|pharmacogenetics
4971781|NCT01762046|Genetics|genetics
4971782|NCT01762046|Obesity|obesity
4971783|NCT01762033|Renal cell carcinoma|renal cell carcinoma
4971784|NCT01762033|Renal cell cancer|renal cell cancer
4971785|NCT01762033|ASONEP|asonep
4971786|NCT01762033|Sonepcizumab|sonepcizumab
4971787|NCT01762020|Women with Breast Cancer|women with breast cancer
4971788|NCT01762020|Receiving Adjuvant Radiation Therapy|receiving adjuvant radiation therapy
4971789|NCT01762007|hypospadias, bladder outlet obstruction, ultrasonography|hypospadias, bladder outlet obstruction, ultrasonography
4971790|NCT01761994|nafamostat mesilate|nafamostat mesilate
4971791|NCT01761994|heparin|heparin
4971792|NCT01761994|continuous renal replacement therapy|continuous renal replacement therapy
4971793|NCT01761981|Haemorrhagic Hereditary Telangiectasia|haemorrhagic hereditary telangiectasia
4971794|NCT01761981|Rendu Osler Weber Syndrome|rendu osler weber syndrome
4971795|NCT01761981|Osler Weber Rendu Syndrome|osler weber rendu syndrome
4971796|NCT01761981|HHT|hht
4971797|NCT01761968|chronic myeloproliferative neoplasms|chronic myeloproliferative neoplasms
4971798|NCT01761968|Polycythemia Vera|polycythemia vera
4971799|NCT01761968|Essential Thrombocythemia|essential thrombocythemia
4971800|NCT01761968|Primary Myelofibrosis|primary myelofibrosis
4971801|NCT01761968|Post-Polycythemia Vera Myelofibrosis|post-polycythemia vera myelofibrosis
4971802|NCT01761968|Post-Essential Thrombocythemia Myelofibrosis|post-essential thrombocythemia myelofibrosis
4971803|NCT01761968|Givinostat|givinostat
4971804|NCT01761955|body weight|body weight
4971805|NCT01761955|lipids|lipids
4971806|NCT01761955|glucose|glucose
4971807|NCT01761955|insulin|insulin
4971808|NCT01761942|omega-3 fatty acids|omega-3 fatty acids
4971809|NCT01761942|anorexia nervosa|anorexia nervosa
4971810|NCT01761942|efficacy|efficacy
4971811|NCT01761942|safety|safety
4971812|NCT01761929|oligometastatic|oligometastatic
4971813|NCT01761929|oligometastases|oligometastases
4971814|NCT01761929|stereotactic body radiotherapy|stereotactic body radiotherapy
4971815|NCT01761929|radiation therapy|radiation therapy
4971816|NCT01761929|Oligometastasis|oligometastasis
4971817|NCT01761929|Stereotactic ablative body|stereotactic ablative body
4971818|NCT01761929|radiotherapy|radiotherapy
4971819|NCT01761916|captopril, clonidine, pregnancy-induced hypertension,|captopril, clonidine, pregnancy-induced hypertension,
4971820|NCT01761890|Chronic Myeloid Leukemia|chronic myeloid leukemia
4971821|NCT01761890|Early phase|early phase
4971822|NCT01761890|CML|cml
4971823|NCT01761890|Dasatinib|dasatinib
4971924|NCT01761448|ECG- vest|ecg- vest
4971925|NCT01761435|Influenza|influenza
4971824|NCT01761877|breast cancer, nonsteroidal antiinflammatory drug , breast density, chemoprevention, aromatase inhibitors|breast cancer, nonsteroidal antiinflammatory drug , breast density, chemoprevention, aromatase inhibitors
4971825|NCT01761851|Resting metabolic rate|resting metabolic rate
4971826|NCT01761851|nutrition status|nutrition status
4971827|NCT01761851|dietary intake|dietary intake
4971828|NCT01761838|spinal manipulative therapy|spinal manipulative therapy
4971829|NCT01761838|low back pain|low back pain
4971830|NCT01761838|experimental pain|experimental pain
4971831|NCT01761838|spinal stiffness|spinal stiffness
4971832|NCT01761838|lumbar multifidus|lumbar multifidus
4971833|NCT01761838|degeneration|degeneration
4971834|NCT01761812|Prostate cancer|prostate cancer
4971835|NCT01761812|MRI|mri
4971836|NCT01761812|Elastography|elastography
4971837|NCT01761812|Gadofosveset|gadofosveset
4971838|NCT01761799|Influenza|influenza
4971839|NCT01761799|Pertussis|pertussis
4971840|NCT01761799|Vaccination|vaccination
4971841|NCT01761786|Myocardial Infarction|myocardial infarction
4971842|NCT01761786|Thrombosis|thrombosis
4971843|NCT01761786|Acute Coronary Syndrome|acute coronary syndrome
4971844|NCT01761786|Myocardial Ischemia|myocardial ischemia
4971845|NCT01761786|Heart Diseases|heart diseases
4971846|NCT01761786|Cardiovascular Diseases|cardiovascular diseases
4971847|NCT01761786|Vascular Diseases|vascular diseases
4971848|NCT01761786|Embolism and Thrombosis|embolism and thrombosis
4971849|NCT01761786|Genetic Testing|genetic testing
4971850|NCT01761786|Clopidogrel|clopidogrel
4971851|NCT01761786|Prasugrel|prasugrel
4971852|NCT01761786|Ticagrelor|ticagrelor
4971853|NCT01761786|Platelet Aggregation Inhibitors|platelet aggregation inhibitors
4971854|NCT01761786|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists
4971855|NCT01761747|Squamous Cell Carcinoma|squamous cell carcinoma
4971856|NCT01761734|Influenza vaccination|influenza vaccination
4971857|NCT01761721|Endometrial cancer (MeSH)|endometrial cancer (mesh)
4971858|NCT01761721|Robotics (MeSH)|robotics (mesh)
4971859|NCT01761708|primary ventral hernia repair with mesh|primary ventral hernia repair with mesh
4971860|NCT01761708|umbilical hernia repair|umbilical hernia repair
4971861|NCT01761708|epigastric hernia repair|epigastric hernia repair
4971862|NCT01761708|C-Qur V-patch|c-qur v-patch
4971863|NCT01761708|Size tailored repair|size tailored repair
4971864|NCT01761708|preperitoneal repair|preperitoneal repair
4971865|NCT01761708|abdominal hernia|abdominal hernia
4971866|NCT01761708|dual sided mesh|dual sided mesh
4971867|NCT01761708|trocar-site hernia|trocar-site hernia
4971868|NCT01761656|stable angina|stable angina
4971869|NCT01761656|unstable angina|unstable angina
4971870|NCT01761656|acute non-ST-segment elevation myocardial infarction|acute non-st-segment elevation myocardial infarction
4971871|NCT01761656|PCI|pci
4971872|NCT01761656|perioperative myocardial infarction|perioperative myocardial infarction
4971873|NCT01761656|major adverse cardiac events|major adverse cardiac events
4971874|NCT01761643|PrEP|prep
4971875|NCT01761643|Pre exposure Prophylaxis|pre exposure prophylaxis
4971876|NCT01761643|Text Messaging|text messaging
4971877|NCT01761643|Truvada|truvada
4971878|NCT01761643|iTab|itab
4971879|NCT01761643|CCTG|cctg
4971880|NCT01761643|595|595
4971881|NCT01761630|Asthma|asthma
4971882|NCT01761630|Severe Asthma|severe asthma
4971883|NCT01761630|SARP|sarp
4971884|NCT01761617|Yoga|yoga
4971885|NCT01761617|Chronic Low Back Pain|chronic low back pain
4971886|NCT01761617|CAM|cam
4971887|NCT01761617|Complementary and Alternative Medicine|complementary and alternative medicine
4971888|NCT01761617|Minorities|minorities
4971889|NCT01761591|CAD|cad
4971890|NCT01761591|PCI|pci
4971891|NCT01761591|BMS|bms
4971892|NCT01761591|Svelte|svelte
4971893|NCT01761591|Acrobat|acrobat
4971894|NCT01761591|direct stenting|direct stenting
4971895|NCT01761591|RCT|rct
4971896|NCT01761578|Bioresorbable|bioresorbable
4971897|NCT01761578|Coronary|coronary
4971898|NCT01761578|Stent|stent
4971899|NCT01761578|Vascular Remodeling|vascular remodeling
4971900|NCT01761578|Angioplasty|angioplasty
4971901|NCT01761578|Coronary Artery Disease|coronary artery disease
4971902|NCT01761552|in ASA 4 AND ASA 4E patients|in asa 4 and asa 4e patients
4971903|NCT01761539|pancreatitis|pancreatitis
4971904|NCT01761539|pancreatitis, alcoholic|pancreatitis, alcoholic
4971905|NCT01761526|Rotigotine|rotigotine
4971906|NCT01761526|Neupro|neupro
4971907|NCT01761526|Japanese|japanese
4971908|NCT01761526|Caucasian|caucasian
4971909|NCT01761526|Male|male
4971910|NCT01761526|Female|female
4971911|NCT01761526|Single dose|single dose
4971912|NCT01761526|Pharmacokinetics|pharmacokinetics
4971913|NCT01761500|Non-Hodgkin's lymphoma;|non-hodgkin's lymphoma;
4971914|NCT01761500|Childhood and adolescence;|childhood and adolescence;
4971915|NCT01761500|Survival Rate|survival rate
4971916|NCT01761474|Carbon dioxide insufflation|carbon dioxide insufflation
4971917|NCT01761474|Air insufflatioin|air insufflatioin
4971918|NCT01761474|ERCP|ercp
4971919|NCT01761474|Sedation|sedation
4971920|NCT01761448|Coronary Artery Disease|coronary artery disease
4971921|NCT01761448|Cardiac rehabilitation program|cardiac rehabilitation program
4971922|NCT01761448|telemedical homely rehabilitation|telemedical homely rehabilitation
4971923|NCT01761448|guided exercise|guided exercise
4971926|NCT01761435|Solid Organ Transplant Recipients|solid organ transplant recipients
4971927|NCT01761396|Anxiety|anxiety
4971928|NCT01761396|Fear|fear
4971929|NCT01761396|Worry|worry
4971930|NCT01761396|Therapy|therapy
4971931|NCT01761396|Cognitive behavioral therapy|cognitive behavioral therapy
4971932|NCT01761383|Chronic Schizophrenia|chronic schizophrenia
4971933|NCT01761383|Nintendo Wii|nintendo wii
4971934|NCT01761383|Quality of Life|quality of life
4971935|NCT01761370|Non alcoholic Steatohepatitis|non alcoholic steatohepatitis
4971936|NCT01761370|Intra-gastric balloon|intra-gastric balloon
4971937|NCT01761357|Aortic valve stenosis|aortic valve stenosis
4971938|NCT01761357|Quality of life|quality of life
4971939|NCT01761357|Burden co morbidities|burden co morbidities
4971940|NCT01761357|Transcatheter aortic valve implantation|transcatheter aortic valve implantation
4971941|NCT01761357|Geriatric assessment|geriatric assessment
4971942|NCT01761331|infant, colic, crying, acupuncture, stooling, sleep|infant, colic, crying, acupuncture, stooling, sleep
4971943|NCT01761318|Diabetes mellitus type 2|diabetes mellitus type 2
4971944|NCT01761318|Glucagon-Like Peptide 1|glucagon-like peptide 1
4971945|NCT01761318|Magnetic Resonance Imaging|magnetic resonance imaging
4971946|NCT01761318|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
4971947|NCT01761318|Steatosis|steatosis
4971948|NCT01761305|Idiopathic scoliosis|idiopathic scoliosis
4971949|NCT01761305|Brace|brace
4971950|NCT01761305|Scoliosis specific exercise|scoliosis specific exercise
4971951|NCT01761305|Physical activity|physical activity
4971952|NCT01761279|Colonic polyps|colonic polyps
4971953|NCT01761266|Hepatocellular Carcinoma|hepatocellular carcinoma
4971954|NCT01761266|Neoplasms|neoplasms
4971955|NCT01761266|Cancer|cancer
4971956|NCT01761253|comorbidity, multiple chronic conditions, Medicaid, prediction of cost|comorbidity, multiple chronic conditions, medicaid, prediction of cost
4971957|NCT01761253|Predictive models, cost containment, managed care|predictive models, cost containment, managed care
4971958|NCT01761227|Vascular dementia|vascular dementia
4971959|NCT01761227|Fufangdanshen Tablets|fufangdanshen tablets
4971960|NCT01761227|Randomized Controlled trial|randomized controlled trial
4971961|NCT01761227|Chinese Medicine|chinese medicine
4971962|NCT01761214|bacteriology, inflammation, bronchiectasis, exacerbation|bacteriology, inflammation, bronchiectasis, exacerbation
4971963|NCT01761201|Prophylaxis|prophylaxis
4971964|NCT01761201|Tuberculosis|tuberculosis
4971965|NCT01761201|Transplant recipients|transplant recipients
4971966|NCT01761201|Transplant waiting list|transplant waiting list
4971967|NCT01761188|Persistent Atrial fibrillation;LA substrate;ablation;voltage mapping|persistent atrial fibrillation;la substrate;ablation;voltage mapping
4971968|NCT01761149|remifentanil,|remifentanil,
4971969|NCT01761149|opioid,|opioid,
4971970|NCT01761149|hyperalgesia,|hyperalgesia,
4971971|NCT01761149|visual analogue score|visual analogue score
4971972|NCT01761149|thyroidectomy,|thyroidectomy,
4971973|NCT01761123|Prevention of Influenza|prevention of influenza
4971974|NCT01761110|Opioid dependence|opioid dependence
4971975|NCT01761110|Injection drug use|injection drug use
4971976|NCT01761110|Buprenorphine|buprenorphine
4971977|NCT01761110|Opioid agonist treatment|opioid agonist treatment
4971978|NCT01761110|Access to care|access to care
4971979|NCT01761110|HIV risk behaviors|hiv risk behaviors
4971980|NCT01761110|Opioids|opioids
4971981|NCT01761097|Adenoma, polyp, colonoscopy.|adenoma, polyp, colonoscopy.
4971982|NCT01761084|Osteoporosis|osteoporosis
4971983|NCT01761084|Spine fracture|spine fracture
4971984|NCT01761084|Vertebral fracture|vertebral fracture
4971985|NCT01761084|Exercise Interventions|exercise interventions
4971986|NCT01761084|Exercise|exercise
4971987|NCT01761058|Asthma|asthma
4971988|NCT01761058|Bronchial Diseases|bronchial diseases
4971989|NCT01761058|Respiratory Tract Diseases|respiratory tract diseases
4971990|NCT01761058|Lung Diseases, Obstructive|lung diseases, obstructive
4971991|NCT01761058|Lung Diseases|lung diseases
4971992|NCT01761058|Respiratory Hypersensitivity|respiratory hypersensitivity
4971993|NCT01761058|Hypersensitivity, Immediate|hypersensitivity, immediate
4971994|NCT01761058|Hypersensitivity|hypersensitivity
4971995|NCT01761058|Immune System Disease|immune system disease
4971996|NCT01761045|Monosodium L-Glutamate (MSG)|monosodium l-glutamate (msg)
4971997|NCT01761045|Nucleic Acid (IMP)|nucleic acid (imp)
4971999|NCT01761045|Gastrointestinal Sensation|gastrointestinal sensation
4972000|NCT01761045|Consommé Soups|consommé soups
4972001|NCT01761045|Snack Intake|snack intake
4972002|NCT01761032|Tanning|tanning
4972003|NCT01761032|neuroimaging|neuroimaging
4972004|NCT01761032|dopamine|dopamine
4972005|NCT01761032|MRI|mri
4972006|NCT01761032|SPECT|spect
4972007|NCT01761019|psoriasis|psoriasis
4972008|NCT01761019|Taclonex|taclonex
4972009|NCT01761019|Acitretin|acitretin
4972010|NCT01761019|Methotrexate|methotrexate
4972011|NCT01761006|COPD|copd
4972012|NCT01761006|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
4972013|NCT01761006|Exhaled Nitric Oxide|exhaled nitric oxide
4972014|NCT01761006|NIOX MINO|niox mino
4972015|NCT01761006|Acute COPD exacerbation|acute copd exacerbation
4972016|NCT01760993|Not Required|not required
4972017|NCT01760980|Rate and extend of absorption of Exemestane|rate and extend of absorption of exemestane
4972018|NCT01760967|Dexmedetomidine|dexmedetomidine
4972021|NCT01760967|duration of mechanical ventilation|duration of mechanical ventilation
4972022|NCT01760967|organ failure|organ failure
4972023|NCT01760954|Gonadotropin-Releasing Hormone Antagonist|gonadotropin-releasing hormone antagonist
4972024|NCT01760954|Non-Menstrual Pelvic Pain (NMPP)|non-menstrual pelvic pain (nmpp)
4972025|NCT01760954|Dysmenorrhea (DYS)|dysmenorrhea (dys)
4972026|NCT01760954|Endometriosis associated pain|endometriosis associated pain
4972027|NCT01760954|Elagolix|elagolix
4972028|NCT01760941|Urology|urology
4972029|NCT01760941|Prostate|prostate
4972030|NCT01760941|Breast|breast
4972031|NCT01760941|Lung|lung
4972032|NCT01760941|Chest|chest
4972033|NCT01760915|asthma|asthma
4972034|NCT01760915|severe|severe
4972035|NCT01760902|Inflammation|inflammation
4972036|NCT01760876|Optical Coherence Tomography|optical coherence tomography
4972037|NCT01760876|Biofreedom Stent|biofreedom stent
4972038|NCT01760863|Revision|revision
4972039|NCT01760863|Knee|knee
4972040|NCT01760863|Hip|hip
4972041|NCT01760863|Arthroplasty|arthroplasty
4972042|NCT01760863|Oral|oral
4972043|NCT01760863|Antibiotics|antibiotics
4972044|NCT01760863|Infection|infection
4972045|NCT01760837|cow's milk allergy|cow's milk allergy
4972046|NCT01760837|baked milk|baked milk
4972047|NCT01760837|tolerance|tolerance
4972048|NCT01760837|infants and children|infants and children
4972049|NCT01760824|Sequential|sequential
4972050|NCT01760824|Quadruple|quadruple
4972051|NCT01760824|First|first
4972052|NCT01760824|Line|line
4972053|NCT01760824|Helicobacter|helicobacter
4972054|NCT01760824|pylori|pylori
4972055|NCT01760824|infection|infection
4972056|NCT01760811|tongue|tongue
4972057|NCT01760811|Squamous cell carcinoma|squamous cell carcinoma
4972058|NCT01760811|locally advanced|locally advanced
4972059|NCT01760811|cetuximab|cetuximab
4972060|NCT01760798|osteoporosis|osteoporosis
4972061|NCT01760798|Teriparatide|teriparatide
4972062|NCT01760785|Veterans|veterans
4972063|NCT01760785|Traumatic Brain Injury(TBI)|traumatic brain injury(tbi)
4972064|NCT01760785|Alcoholism|alcoholism
4972065|NCT01760772|heart disease|heart disease
4972066|NCT01760772|GLP-1|glp-1
4972067|NCT01760772|Exendin-9|exendin-9
4972068|NCT01760772|postprandial lipids|postprandial lipids
4972069|NCT01760759|HIV|hiv
4972070|NCT01760759|Antiretroviral therapy adherence|antiretroviral therapy adherence
4972071|NCT01760746|Proliferative Diabetic Retinopathy|proliferative diabetic retinopathy
4972072|NCT01760746|Vitrectomy|vitrectomy
4972073|NCT01760746|Inflammatory Cytokines|inflammatory cytokines
4972074|NCT01760707|Diabetes mellitus|diabetes mellitus
4972075|NCT01760707|Peripheral neuropathy|peripheral neuropathy
4972076|NCT01760707|Exercise|exercise
4972077|NCT01760707|Balance performance|balance performance
4972078|NCT01760694|Pancreatic|pancreatic
4972079|NCT01760694|Pancreas|pancreas
4972080|NCT01760694|Intraoperative Radiation Therapy|intraoperative radiation therapy
4972081|NCT01760694|Chemotherapy|chemotherapy
4972082|NCT01760668|Sex chromosome|sex chromosome
4972083|NCT01760668|Turner Syndrome|turner syndrome
4972084|NCT01760668|Marfan syndrome|marfan syndrome
4972085|NCT01760668|Bicuspid aortic valve|bicuspid aortic valve
4972086|NCT01760668|Aortic Aneurysm|aortic aneurysm
4972087|NCT01760668|Epigenetics|epigenetics
4972088|NCT01760668|Transcriptome|transcriptome
4972089|NCT01760668|non-coding RNA|non-coding rna
4972090|NCT01760668|Electron microscopy|electron microscopy
4972091|NCT01760668|Proteomics|proteomics
4972092|NCT01760642|metabolite profiles|metabolite profiles
4972093|NCT01760642|pharmacokinetics|pharmacokinetics
4972094|NCT01760642|CYP3A|cyp3a
4972095|NCT01760642|metabolomics|metabolomics
4972096|NCT01760629|Encephalopathy, Newborn, Low and Middle-income countries, Hypothermia|encephalopathy, newborn, low and middle-income countries, hypothermia
4972097|NCT01760616|Huaier Granule;|huaier granule;
4972098|NCT01760616|After non-radical hepatectomy;|after non-radical hepatectomy;
4972099|NCT01760616|Prevention of Disease Progression of Hepatocarcinoma;|prevention of disease progression of hepatocarcinoma;
4972100|NCT01760616|Safety.|safety.
4972101|NCT01760603|pelvic organ prolapse|pelvic organ prolapse
4972102|NCT01760590|neck pain|neck pain
4972103|NCT01760590|cervical pain|cervical pain
4972104|NCT01760590|pain pressure thresholds|pain pressure thresholds
4972105|NCT01760590|pain catastrophizing|pain catastrophizing
4972106|NCT01760577|osteoarthritis, botulinum toxin, hyaluronate|osteoarthritis, botulinum toxin, hyaluronate
4972107|NCT01760564|Niemann-Pick disease type C|niemann-pick disease type c
4972108|NCT01760564|miglustat|miglustat
4972109|NCT01760551|Fracture|fracture
4972110|NCT01760551|Trauma|trauma
4972111|NCT01760551|impairment|impairment
4972112|NCT01760538|Cardiac transplant recipients|cardiac transplant recipients
4972113|NCT01760538|Heart rate variability|heart rate variability
4972114|NCT01760538|Exercise training|exercise training
4972115|NCT01760525|p53, solid tumor|p53, solid tumor
4972116|NCT01760512|Gastric bypass|gastric bypass
4972117|NCT01760512|Robot-assisted surgery|robot-assisted surgery
4972118|NCT01760512|Conventional laparoscopy|conventional laparoscopy
4972119|NCT01760512|Pain assessment|pain assessment
4972120|NCT01760512|Health economics outcomes|health economics outcomes
4972121|NCT01760499|skin|skin
4972123|NCT01760473|opioid dependence|opioid dependence
4972124|NCT01760434|scoliosis|scoliosis
4972125|NCT01760434|long-term outcomes|long-term outcomes
4972126|NCT01760434|sagittal plane|sagittal plane
4972127|NCT01760434|quality of life|quality of life
4972128|NCT01760434|curve progression|curve progression
4972129|NCT01760434|pulmonary function|pulmonary function
4972130|NCT01760382|Acute myocardial infarction|acute myocardial infarction
4972131|NCT01760382|ST elevation myocardial infarction|st elevation myocardial infarction
4972132|NCT01760382|primary PCI|primary pci
4972133|NCT01760382|reperfusion therapy|reperfusion therapy
4972134|NCT01760382|angioplasty|angioplasty
4972135|NCT01760382|stent|stent
4972136|NCT01760356|Liver transplantation|liver transplantation
4972137|NCT01760356|Calcineurin inhibitors|calcineurin inhibitors
4972138|NCT01760356|Pharmacodynamic biomarkers|pharmacodynamic biomarkers
4972139|NCT01760356|Calcineurin pathway|calcineurin pathway
4972140|NCT01760356|Tacrolimus|tacrolimus
4972141|NCT01760356|interindividual variability|interindividual variability
4972142|NCT01760304|COPD|copd
4972143|NCT01760278|Time-lapse monitoring of embryos.|time-lapse monitoring of embryos.
4972144|NCT01760278|Embryoscope|embryoscope
4972145|NCT01760278|IVF-ET/ICSI|ivf-et/icsi
4972146|NCT01760278|Cetrorelix|cetrorelix
4972147|NCT01760278|Gonal-F|gonal-f
4972148|NCT01760265|dysbetalipoproteinemia|dysbetalipoproteinemia
4972149|NCT01760265|artery calcium score|artery calcium score
4972150|NCT01760265|carotid intima media|carotid intima media
4972151|NCT01760265|ankle brachial index|ankle brachial index
4972152|NCT01760265|dysbetalipoproteinemic patients|dysbetalipoproteinemic patients
4972153|NCT01760252|Pancreatic Cancer|pancreatic cancer
4972154|NCT01760239|Adolescent Hypertension|adolescent hypertension
4972155|NCT01760239|Adolescent Pre Hypertension|adolescent pre hypertension
4972156|NCT01760239|Adolescent Pre Hypertension and Obesity|adolescent pre hypertension and obesity
4972157|NCT01760226|DLBCL|dlbcl
4972158|NCT01760226|Diffuse large B cell lymphoma|diffuse large b cell lymphoma
4972159|NCT01760226|dose adjusted|dose adjusted
4972160|NCT01760226|EPOCH|epoch
4972161|NCT01760226|Etoposide|etoposide
4972162|NCT01760226|Doxorubicin|doxorubicin
4972163|NCT01760226|Vincristine|vincristine
4972164|NCT01760226|Cyclophosphamide|cyclophosphamide
4972165|NCT01760226|Prednisone|prednisone
4972166|NCT01760226|Rituximab|rituximab
4972167|NCT01760200|Coronary angioplasty|coronary angioplasty
4972168|NCT01760200|Coronary stent|coronary stent
4972169|NCT01760200|paclitaxel drug-eluting stent|paclitaxel drug-eluting stent
4972170|NCT01760200|drug eluting balloon|drug eluting balloon
4972171|NCT01760174|Transversus abdominis plane catheter|transversus abdominis plane catheter
4972172|NCT01760161|postoperative pain|postoperative pain
4972173|NCT01760161|opioid consumption|opioid consumption
4972174|NCT01760161|termanalgesia|termanalgesia
4972175|NCT01760161|plasmaropivacain level|plasmaropivacain level
4972176|NCT01760148|Hepatitis C Virus|hepatitis c virus
4972177|NCT01760148|HCV|hcv
4972178|NCT01760148|Interferon|interferon
4972179|NCT01760148|Prediction|prediction
4972180|NCT01760148|SVR|svr
4972181|NCT01760148|Sustained Virus Response|sustained virus response
4972182|NCT01760135|trauma|trauma
4972183|NCT01760135|nutrition|nutrition
4972184|NCT01760135|hyperglycemia|hyperglycemia
4972185|NCT01760122|peginterferon|peginterferon
4972186|NCT01760122|HBeAg Positive|hbeag positive
4972187|NCT01760122|Chronic hepatitis B|chronic hepatitis b
4972188|NCT01760109|Respiratory and urinary tract infections|respiratory and urinary tract infections
4972189|NCT01760109|Piperacillin Sodium and Sulbactam Sodium for Injection (2:1)|piperacillin sodium and sulbactam sodium for injection (2:1)
4972190|NCT01760109|Phase IV|phase iv
4972191|NCT01760096|Paroxysmal Nocturnal Hemoglobinuria|paroxysmal nocturnal hemoglobinuria
4972192|NCT01760096|Anemia|anemia
4972193|NCT01760096|Hematologic Diseases|hematologic diseases
4972194|NCT01760096|bone marrow failure|bone marrow failure
4972195|NCT01760096|Immunologic Factors|immunologic factors
4972196|NCT01760096|Physiological Effects of Drugs|physiological effects of drugs
4972197|NCT01760096|Levamisole|levamisole
4972198|NCT01760096|cyclosporine A|cyclosporine a
4972199|NCT01760070|cancer|cancer
4972200|NCT01760070|endoscopy|endoscopy
4972201|NCT01760070|endoscopic submucosal dissection|endoscopic submucosal dissection
4972202|NCT01760044|tissue oxygenation|tissue oxygenation
4972203|NCT01760044|perfusion status|perfusion status
4972204|NCT01760031|preconditioning|preconditioning
4972205|NCT01760031|contrast-induced acute kidney injury|contrast-induced acute kidney injury
4972206|NCT01760031|renal faliure|renal faliure
4972207|NCT01760018|desflurane, total intravenous anesthesia, QoR-40|desflurane, total intravenous anesthesia, qor-40
4972208|NCT01760005|Alzheimer's|alzheimer's
4972209|NCT01760005|Alzheimer's Disease|alzheimer's disease
4972210|NCT01760005|Dementia|dementia
4972211|NCT01760005|Mutation|mutation
4972212|NCT01760005|Genetic Mutation|genetic mutation
4972213|NCT01760005|Dominantly Inherited Alzheimer's Disease|dominantly inherited alzheimer's disease
4972214|NCT01760005|Dominantly Inherited Alzheimer's Network|dominantly inherited alzheimer's network
4972215|NCT01760005|Autosomal Dominant Alzheimer's Disease|autosomal dominant alzheimer's disease
4972216|NCT01760005|Early Onset Alzheimer's Disease|early onset alzheimer's disease
4972217|NCT01760005|DIAN|dian
4972218|NCT01760005|DIAN-TU|dian-tu
4972219|NCT01760005|DIAN TU|dian tu
4972220|NCT01759992|Frail elderly|frail elderly
4972221|NCT01759992|Muscle weakness|muscle weakness
4972222|NCT01759992|Institutionalization|institutionalization
4972223|NCT01759992|Respiratory muscle training|respiratory muscle training
4972224|NCT01759979|Cholelithiasis, Common Bile Duct|cholelithiasis, common bile duct
4972225|NCT01759979|Choledocholithiasis|choledocholithiasis
4972226|NCT01759966|Heart transplantation|heart transplantation
4972227|NCT01759966|Autonomic cardiovascular control|autonomic cardiovascular control
4972228|NCT01759966|Acute rejection|acute rejection
4972229|NCT01759966|Cardiac allograft vasculopathy|cardiac allograft vasculopathy
4972230|NCT01759953|Diabetes Mellitus|diabetes mellitus
4972231|NCT01759953|Insulin|insulin
4972232|NCT01759953|Video Games|video games
4972233|NCT01759953|Medical Education|medical education
4972234|NCT01759953|Educational Technology|educational technology
4972235|NCT01759953|Continuing Medical Education|continuing medical education
4972236|NCT01759940|carotid|carotid
4972237|NCT01759940|endarterectomy|endarterectomy
4972238|NCT01759940|cervical block|cervical block
4972239|NCT01759927|Physical activity counselor|physical activity counselor
4972240|NCT01759927|Workplace intervention|workplace intervention
4972241|NCT01759927|Active and healthy lifestyle|active and healthy lifestyle
4972242|NCT01759901|hepatectomy|hepatectomy
4972243|NCT01759901|vascular inflow occlusion|vascular inflow occlusion
4972244|NCT01759862|kidney transplant|kidney transplant
4972245|NCT01759862|Aminophylline|aminophylline
4972246|NCT01759862|pediatric|pediatric
4972247|NCT01759849|Asthma|asthma
4972248|NCT01759849|β-chain signaling|β-chain signaling
4972249|NCT01759849|allergen inhalation challenges|allergen inhalation challenges
4972250|NCT01759849|sputum|sputum
4972251|NCT01759849|bone marrow aspirate|bone marrow aspirate
4972252|NCT01759849|blood collection|blood collection
4972253|NCT01759849|-methacholine challenge|-methacholine challenge
4972254|NCT01759836|Prostatectomy|prostatectomy
4972255|NCT01759836|Statins|statins
4972256|NCT01759810|Glioblastoma, recurrent glioblastoma|glioblastoma, recurrent glioblastoma
4972257|NCT01759797|ALS bone marrow mesenchymal stem cell intravenous injection|als bone marrow mesenchymal stem cell intravenous injection
4972258|NCT01759784|mesenchymal stem cell intraventricular injection ALS|mesenchymal stem cell intraventricular injection als
4972259|NCT01759771|Prostate Cancer|prostate cancer
4972260|NCT01759771|Vitamin D3|vitamin d3
4972261|NCT01759771|Active surveillance|active surveillance
4972262|NCT01759758|boxer's fracture|boxer's fracture
4972263|NCT01759758|metacarpal neck fracture|metacarpal neck fracture
4972264|NCT01759758|metacarpal fracture|metacarpal fracture
4972265|NCT01759732|Aplastic anemia|aplastic anemia
4972266|NCT01759732|T cell dose|t cell dose
4972267|NCT01759732|CD3 depletion|cd3 depletion
4972268|NCT01759732|Haploidentical hematopoietic stem cell transplantation|haploidentical hematopoietic stem cell transplantation
4972269|NCT01759719|platinum-chromium stents|platinum-chromium stents
4972270|NCT01759719|concertina effect|concertina effect
4972271|NCT01759719|stent deformation|stent deformation
4972272|NCT01759719|everolimus eluting stents|everolimus eluting stents
4972273|NCT01759719|stent lenght|stent lenght
4972274|NCT01759693|Platelet activation|platelet activation
4972275|NCT01759680|Risk of falls|risk of falls
4972276|NCT01759680|Whole Body Vibration|whole body vibration
4972277|NCT01759680|Nursing Home|nursing home
4972278|NCT01759667|Diet-induced Thermogenesis;|diet-induced thermogenesis;
4972279|NCT01759667|Respiratory Quotient;|respiratory quotient;
4972280|NCT01759667|Roux-en-Y Gastric Bypass;|roux-en-y gastric bypass;
4972281|NCT01759667|Energy Expenditure.|energy expenditure.
4972282|NCT01759641|Dialysis|dialysis
4972283|NCT01759641|Monitoring|monitoring
4972284|NCT01759641|Cardiovascular stability|cardiovascular stability
4972285|NCT01759641|biosignals|biosignals
4972286|NCT01759628|Steatohepatitis,|steatohepatitis,
4972287|NCT01759628|Helicobacter pylori,|helicobacter pylori,
4972288|NCT01759628|Insulin resistance,|insulin resistance,
4972289|NCT01759628|Alanine aminotransferase,|alanine aminotransferase,
4972290|NCT01759628|Aspartate aminotransferase,|aspartate aminotransferase,
4972291|NCT01759615|Preterm|preterm
4972293|NCT01759615|AREDF|aredf
4972294|NCT01759615|Early feeding|early feeding
4972295|NCT01759615|Late feeding|late feeding
4972296|NCT01759615|Feed intolerence|feed intolerence
4972297|NCT01759615|Necrotizing enterocolitis|necrotizing enterocolitis
4972298|NCT01759602|Neuromyelitis optica|neuromyelitis optica
4972299|NCT01759602|Devic's disease|devic's disease
4972300|NCT01759602|NMO|nmo
4972301|NCT01759602|Devic|devic
4972302|NCT01759589|electroconvulsive therapy,sevoflurane,propofol,remifentanil|electroconvulsive therapy,sevoflurane,propofol,remifentanil
4972303|NCT01759576|Renal Insufficiency|renal insufficiency
4972304|NCT01759576|Healthy|healthy
4972305|NCT01759576|Canagliflozin (JNJ-28431754)|canagliflozin (jnj-28431754)
4972306|NCT01759576|Pharmacokinetics|pharmacokinetics
4972307|NCT01759576|Pharmacodynamics|pharmacodynamics
4972308|NCT01759576|Dialysis|dialysis
4972309|NCT01759550|Gastric Procedures|gastric procedures
4972310|NCT01759550|Force Triad|force triad
4972311|NCT01759550|LigaSure Advance Pistol Grip|ligasure advance pistol grip
4972312|NCT01759550|LigaSure Blunt Tip|ligasure blunt tip
4972313|NCT01759524|local anaesthesia|local anaesthesia
4972314|NCT01759524|analgesia|analgesia
4972315|NCT01759524|bupivacaine|bupivacaine
4972316|NCT01759524|lidocaine|lidocaine
4972317|NCT01759524|clonidine|clonidine
4972318|NCT01759524|sciatic nerve|sciatic nerve
4972319|NCT01759524|saphenous nerve|saphenous nerve
4972320|NCT01759511|Idiopathic|idiopathic
4972321|NCT01759511|Pulmonary|pulmonary
4972322|NCT01759511|Fibrosis|fibrosis
4972323|NCT01759511|IPF|ipf
4972324|NCT01759498|Inflammation|inflammation
4972325|NCT01759498|Pain intensity|pain intensity
4972326|NCT01759498|Flexibility|flexibility
4972327|NCT01759498|RICE protocol|rice protocol
4972328|NCT01759498|Swelling|swelling
4972329|NCT01759485|Clozapine|clozapine
4972330|NCT01759485|Schizophrenia|schizophrenia
4972331|NCT01759485|Vitamin-D|vitamin-d
4972332|NCT01759485|Treatment-resistant|treatment-resistant
4972333|NCT01759472|leukotriene|leukotriene
4972334|NCT01759472|leukotriene receptor antagonist|leukotriene receptor antagonist
4972335|NCT01759420|Ondansetron|ondansetron
4972336|NCT01759420|QT interval|qt interval
4972337|NCT01759420|QTc|qtc
4972338|NCT01759420|QT prolongation|qt prolongation
4972339|NCT01759420|Drug induced QT prolongation|drug induced qt prolongation
4972340|NCT01759381|Spinal Deformity|spinal deformity
4972341|NCT01759381|Complex Spinal Surgery|complex spinal surgery
4972342|NCT01759381|Negative Pressure Wound Therapy|negative pressure wound therapy
4972343|NCT01759381|Post-Operative Infection|post-operative infection
4972344|NCT01759368|self-care, heart failure, telemonitoring, health care utilization|self-care, heart failure, telemonitoring, health care utilization
4972345|NCT01759342|Cystic fibrosis; pulmonary exacerbation, exercise|cystic fibrosis; pulmonary exacerbation, exercise
4972346|NCT01759329|overweight|overweight
4972347|NCT01759329|body weight|body weight
4972348|NCT01759329|coffee|coffee
4972349|NCT01759290|Angioplasty|angioplasty
4972350|NCT01759290|Bioabsorbable|bioabsorbable
4972351|NCT01759290|Bioresorbable|bioresorbable
4972352|NCT01759290|BVS|bvs
4972353|NCT01759290|Coronary Artery Endothelial Responsiveness|coronary artery endothelial responsiveness
4972354|NCT01759290|Coronary Scaffold|coronary scaffold
4972355|NCT01759290|Coronary Stent|coronary stent
4972356|NCT01759264|Fecal Calprotectin|fecal calprotectin
4972357|NCT01759264|Crohn's Disease|crohn's disease
4972358|NCT01759264|Adalimumab|adalimumab
4972359|NCT01759251|Meniere Disease|meniere disease
4972360|NCT01759251|Betahistine Dihydrochloride|betahistine dihydrochloride
4972361|NCT01759251|Vertigo|vertigo
4972362|NCT01759238|colorectal cancer|colorectal cancer
4972363|NCT01759238|metastases|metastases
4972364|NCT01759238|non resectable|non resectable
4972365|NCT01759238|chemoradiation|chemoradiation
4972366|NCT01759225|Registry, Cardiovascular, CVD, Health Maintenance Organization|registry, cardiovascular, cvd, health maintenance organization
4972367|NCT01759212|stem cell implantation|stem cell implantation
4972368|NCT01759212|coronary artery disease|coronary artery disease
4972369|NCT01759212|left ventricular assist device|left ventricular assist device
4972370|NCT01759199|COPD|copd
4972371|NCT01759199|ST6: The six minute Stepper Test|st6: the six minute stepper test
4972372|NCT01759199|Conventional respiratory rehabilitation|conventional respiratory rehabilitation
4972373|NCT01759199|Pulmonary rehabilitation|pulmonary rehabilitation
4972374|NCT01759186|Asthma|asthma
4972375|NCT01759186|Biomakers|biomakers
4972376|NCT01759186|Phenotype|phenotype
4972377|NCT01759173|Minor traumatic brain injury (TBI)|minor traumatic brain injury (tbi)
4972378|NCT01759173|Concussion|concussion
4972379|NCT01759160|Target control infusion|target control infusion
4972380|NCT01759160|propofol|propofol
4972381|NCT01759160|cardiac depression|cardiac depression
4972382|NCT01759160|induction of anesthesia|induction of anesthesia
4972383|NCT01759160|hemodynamics|hemodynamics
4972384|NCT01759134|Premature neonate|premature neonate
4972385|NCT01759134|Post-discharge|post-discharge
4972386|NCT01759134|Formula|formula
4972387|NCT01759121|severe non-proliferative diabetic retinopathy|severe non-proliferative diabetic retinopathy
4972388|NCT01759121|subthreshold|subthreshold
4972389|NCT01759121|panretinal photocoagulation|panretinal photocoagulation
4972390|NCT01759121|PASCAL|pascal
4972391|NCT01759121|endpoint management|endpoint management
4972392|NCT01759108|xerostomia|xerostomia
4972393|NCT01759108|rebamipide|rebamipide
4972394|NCT01759108|efficacy|efficacy
4972395|NCT01759108|safety|safety
4972396|NCT01759095|adherence|adherence
4972397|NCT01759095|electronic monitoring|electronic monitoring
4972398|NCT01759095|primary care|primary care
4972399|NCT01759095|community pharmacy|community pharmacy
4972400|NCT01759095|multidrug blister pack|multidrug blister pack
4972401|NCT01759095|pill box|pill box
4972402|NCT01759056|Ulcerative colitis|ulcerative colitis
4972403|NCT01759043|coronary artery disease|coronary artery disease
4972404|NCT01759043|Myocardial Infarction|myocardial infarction
4972405|NCT01759043|Radial Artery|radial artery
4972406|NCT01759043|Catheters|catheters
4972407|NCT01759030|rheumatoid arthritis, DMARDs|rheumatoid arthritis, dmards
4972408|NCT01759030|rituximab|rituximab
4972409|NCT01759030|biosimilar|biosimilar
4972410|NCT01759030|interchangeability|interchangeability
4972411|NCT01759017|Crohn's disease|crohn's disease
4972412|NCT01759017|Inflammatory bowel disease|inflammatory bowel disease
4972413|NCT01759017|IBD|ibd
4972414|NCT01759017|Infliximab|infliximab
4972415|NCT01759017|PET|pet
4972416|NCT01759017|PET/CT|pet/ct
4972417|NCT01759004|lipoedema|lipoedema
4972418|NCT01759004|obesity|obesity
4972419|NCT01758978|bioequivalence, hydrocodone bitartrate extended-release tablets|bioequivalence, hydrocodone bitartrate extended-release tablets
4972420|NCT01758952|Peri-operative stroke|peri-operative stroke
4972421|NCT01758952|incidence|incidence
4972422|NCT01758952|risk factors|risk factors
4972423|NCT01758952|prospective|prospective
4972424|NCT01758939|Peg Interferon,|peg interferon,
4972425|NCT01758939|Ribavirin,|ribavirin,
4972426|NCT01758939|HCV,|hcv,
4972427|NCT01758939|Genotype IV.|genotype iv.
4972428|NCT01758926|Inflammatory Bowel Disease|inflammatory bowel disease
4972429|NCT01758926|Confocal Laser Endomicroscopy|confocal laser endomicroscopy
4972430|NCT01758913|Bronchopulmonary dysplasia|bronchopulmonary dysplasia
4972431|NCT01758913|patent ductus arteriosus|patent ductus arteriosus
4972432|NCT01758913|prostaglandin|prostaglandin
4972433|NCT01758913|Respiratory distress syndrome|respiratory distress syndrome
4972434|NCT01758900|Single-Balloon Enteroscopy|single-balloon enteroscopy
4972435|NCT01758874|Critical limb ischemia|critical limb ischemia
4972436|NCT01758874|Phlebotomy|phlebotomy
4972437|NCT01758874|Amputation|amputation
4972438|NCT01758874|Rutherford classification Grade 3, Category 5 or 6|rutherford classification grade 3, category 5 or 6
4972439|NCT01758874|Fontaine stage IV|fontaine stage iv
4972440|NCT01758861|Erythropoietin|erythropoietin
4972441|NCT01758861|acute kidney injury|acute kidney injury
4972442|NCT01758861|valvular heart surgery|valvular heart surgery
4972443|NCT01758848|overactive bladder|overactive bladder
4972444|NCT01758848|pelvic floor muscles|pelvic floor muscles
4972445|NCT01758848|deep abdominal muscles|deep abdominal muscles
4972446|NCT01758835|ER-stress-test negative|er-stress-test negative
4972447|NCT01758835|unimalleolar|unimalleolar
4972448|NCT01758835|fibula|fibula
4972449|NCT01758835|Weber-B fractures|weber-b fractures
4972450|NCT01758822|meconium stained amniotic fluid|meconium stained amniotic fluid
4972451|NCT01758822|endotracheal suction|endotracheal suction
4972452|NCT01758822|non vigorous neonates|non vigorous neonates
4972453|NCT01758809|Video Assisted Thoracic Surgery|video assisted thoracic surgery
4972454|NCT01758809|Postoperative Pain|postoperative pain
4972455|NCT01758809|Intravenous Patient Controlled Analgesia|intravenous patient controlled analgesia
4972456|NCT01758809|Bupivacaine|bupivacaine
4972457|NCT01758809|Major Pulmonary Resection|major pulmonary resection
4972458|NCT01758809|Post Pulmonary Resection|post pulmonary resection
4972459|NCT01758796|ER-stress positive|er-stress positive
4972460|NCT01758796|Unimalleolar fibula fracture|unimalleolar fibula fracture
4972461|NCT01758796|Operative vs non-operative treatment|operative vs non-operative treatment
4972462|NCT01758770|osteoporosis|osteoporosis
4972463|NCT01758770|osteoarthritis|osteoarthritis
4972464|NCT01758770|bone mineral density|bone mineral density
4972465|NCT01758770|computed xray tomography|computed xray tomography
4972466|NCT01758770|liver steatosis|liver steatosis
4972467|NCT01758770|obesity|obesity
4972468|NCT01758757|Proliferative diabetic retinopathy|proliferative diabetic retinopathy
4972469|NCT01758757|Vitrectomy|vitrectomy
4972470|NCT01758744|COPD PH|copd ph
4972471|NCT01758744|COPD associated Pulmonary Hypertension|copd associated pulmonary hypertension
4972472|NCT01758744|COPD and Pulmonary Hypertension|copd and pulmonary hypertension
4972473|NCT01758744|Disease|disease
4972474|NCT01758731|Stage IVA-B Squamous Cell Carcinomas|stage iva-b squamous cell carcinomas
4972475|NCT01758731|Head and Neck Cancer|head and neck cancer
4972476|NCT01758731|Heavy drinking|heavy drinking
4972477|NCT01758731|Smoking|smoking
4972478|NCT01758718|Down's syndrome|down's syndrome
4972479|NCT01758718|entropion|entropion
4972480|NCT01758718|lid plasty|lid plasty
4972481|NCT01758705|Psoriasis|psoriasis
4972482|NCT01758705|Related to Health Quality of Life|related to health quality of life
4972483|NCT01758705|Patient Reported Outcomes|patient reported outcomes
4972484|NCT01758705|Venezuelan Patients|venezuelan patients
4972485|NCT01758692|spinal cord injury|spinal cord injury
4972486|NCT01758692|autonomic integrity|autonomic integrity
4972487|NCT01758692|autonomic dysreflexia|autonomic dysreflexia
4972488|NCT01758692|baroreceptor integrity|baroreceptor integrity
4972489|NCT01758692|sympathetic integrity|sympathetic integrity
4972490|NCT01758692|vagal integrity|vagal integrity
4972491|NCT01758679|Iodine[131I] Metuximab Injection|iodine[131i] metuximab injection
4972492|NCT01758653|CO poisoning|co poisoning
4972493|NCT01758640|mechanical heart valve|mechanical heart valve
4972494|NCT01758640|pregnancy|pregnancy
4972495|NCT01758640|warfarin|warfarin
4972496|NCT01758640|phenindione|phenindione
4972497|NCT01758627|Peritoneal dialysis,|peritoneal dialysis,
4972498|NCT01758627|chronic kidney disease,|chronic kidney disease,
4972499|NCT01758627|refractory heart failure|refractory heart failure
4972500|NCT01758614|carotid artery occlusion|carotid artery occlusion
4972501|NCT01758614|middle cerebral artery occlusion|middle cerebral artery occlusion
4972502|NCT01758614|EC-IC bypass surgery|ec-ic bypass surgery
4972503|NCT01758614|stroke|stroke
4972504|NCT01758601|white fish|white fish
4972505|NCT01758601|Metabolic syndrome|metabolic syndrome
4972506|NCT01758601|Cardiovascular risk|cardiovascular risk
4972507|NCT01758588|Primary myelofibrosis|primary myelofibrosis
4972508|NCT01758588|PMF|pmf
4972509|NCT01758575|Patients|patients
4972510|NCT01758549|pancreatitis|pancreatitis
4972511|NCT01758549|cholangiopancreatography, endoscopic retrograde|cholangiopancreatography, endoscopic retrograde
4972512|NCT01758549|hyperamylasemia|hyperamylasemia
4972513|NCT01758536|ischemic stroke|ischemic stroke
4972514|NCT01758536|neural function|neural function
4972515|NCT01758536|life quality|life quality
4972516|NCT01758523|neuroactive steroids|neuroactive steroids
4972517|NCT01758510|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
4972518|NCT01758510|ALS|als
4972519|NCT01758510|Neurodegenerative disease|neurodegenerative disease
4972520|NCT01758510|Motor Neuron Disease|motor neuron disease
4972521|NCT01758510|Central Nervous System Disease|central nervous system disease
4972522|NCT01758510|Neuromuscular Disease|neuromuscular disease
4972523|NCT01758510|Bone marrow derived stem cell|bone marrow derived stem cell
4972524|NCT01758510|stem cell therapy|stem cell therapy
4972525|NCT01758510|intrathecal injection|intrathecal injection
4972526|NCT01758497|Fascia Iliaca compartment block, Pain, Sensorial blockade|fascia iliaca compartment block, pain, sensorial blockade
4972527|NCT01758484|Hematopoietic cell transplantation|hematopoietic cell transplantation
4972528|NCT01758484|Supportive/palliative care|supportive/palliative care
4972529|NCT01758471|Type 2 Diabetes|type 2 diabetes
4972530|NCT01758471|gut microbiome|gut microbiome
4972531|NCT01758471|incretin|incretin
4972532|NCT01758471|Sulfonylurea|sulfonylurea
4972533|NCT01758471|α-glucosidase inhibitor|α-glucosidase inhibitor
4972534|NCT01758445|Breast|breast
4972535|NCT01758445|Cancer|cancer
4972536|NCT01758445|Radiation|radiation
4972537|NCT01758445|Proton|proton
4972538|NCT01758432|Healthy volunteers|healthy volunteers
4972539|NCT01758419|post-RT|post-rt
4972540|NCT01758419|myocardial perfusion images|myocardial perfusion images
4972541|NCT01758406|Cardiac stem ce heart failure cardiac function intracoronary transplantation|cardiac stem ce heart failure cardiac function intracoronary transplantation
4972542|NCT01758393|IgG4-related disease|igg4-related disease
4972543|NCT01758393|IgG4-RD|igg4-rd
4972544|NCT01758380|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
4972545|NCT01758380|Ramadan|ramadan
4972546|NCT01758380|Vildagliptin|vildagliptin
4972547|NCT01758380|Hypoglycemia|hypoglycemia
4972548|NCT01758367|demethylating agent|demethylating agent
4972549|NCT01758367|immunogenicity|immunogenicity
4972550|NCT01758367|decitabine(DAC)|decitabine(dac)
4972551|NCT01758367|donor lymphocyte infusion(DLI)|donor lymphocyte infusion(dli)
4972552|NCT01758367|AML|aml
4972553|NCT01758354|Pompe disease|pompe disease
4972554|NCT01758354|alpha glucosidase deficiency|alpha glucosidase deficiency
4972555|NCT01758341|Malignant biliary obstruction|malignant biliary obstruction
4972556|NCT01758341|Endoscopic radiofrequency ablation|endoscopic radiofrequency ablation
4972557|NCT01758341|Therapeutic endoscopy|therapeutic endoscopy
4972558|NCT01758328|BUSULFAN|busulfan
4972559|NCT01758328|FLUDARABINE|fludarabine
4972560|NCT01758328|G-CSF|g-csf
4972561|NCT01758328|MELPHALAN|melphalan
4972562|NCT01758328|RABBIT ATG WT1|rabbit atg wt1
4972563|NCT01758328|PEPTIDE SPECIFIC T CELLS|peptide specific t cells
4972564|NCT01758328|12-175|12-175
4972565|NCT01758315|Ambulatory|ambulatory
4972566|NCT01758315|Outpatient|outpatient
4972567|NCT01758315|Malpractice|malpractice
4972568|NCT01758315|Quality Improvement|quality improvement
4972569|NCT01758315|Patient Safety|patient safety
4972570|NCT01758302|taste test|taste test
4972571|NCT01758302|food consumption|food consumption
4972572|NCT01758302|hunger|hunger
4972573|NCT01758289|Venezuelan Patients|venezuelan patients
4972574|NCT01758289|Depressive Symptoms|depressive symptoms
4972575|NCT01758289|Health Related Quality of Life|health related quality of life
4972576|NCT01758276|smoking, pregnancy|smoking, pregnancy
4972577|NCT01758263|Hypertension|hypertension
4972578|NCT01758263|Health Care Cost|health care cost
4972579|NCT01758263|Monthly health care cost|monthly health care cost
4972580|NCT01758250|Autoimmune diseases with cutaneous involvement|autoimmune diseases with cutaneous involvement
4972581|NCT01758250|Systemic sclerosis|systemic sclerosis
4972582|NCT01758250|Scleroderma|scleroderma
4972583|NCT01758250|Morphea|morphea
4972584|NCT01758250|Dermatomyositis|dermatomyositis
4972585|NCT01758250|Cutaneous lupus|cutaneous lupus
4972586|NCT01758250|Vasculitis|vasculitis
4972587|NCT01758250|Sickle Cell Disease|sickle cell disease
4972588|NCT01758250|Graft versus Host Disease|graft versus host disease
4972589|NCT01758237|Laser Peripheral Iridotomy|laser peripheral iridotomy
4972590|NCT01758237|Visual Dysphotopsia|visual dysphotopsia
4972591|NCT01758237|Visual Disturbances|visual disturbances
4972592|NCT01758237|Angle Closure Glaucoma|angle closure glaucoma
4972593|NCT01758224|Multiple Sclerosis|multiple sclerosis
4972594|NCT01758224|Functional Magnetic Stimulation|functional magnetic stimulation
4972595|NCT01758224|Pulmonary Function|pulmonary function
4972596|NCT01758211|Intracranial Arteriovenous Malformations|intracranial arteriovenous malformations
4972597|NCT01758211|Functional Magnetic Resonance Imaging|functional magnetic resonance imaging
4972598|NCT01758211|Neuronavigation|neuronavigation
4972599|NCT01758185|Inactivated split influenza vaccine|inactivated split influenza vaccine
4972600|NCT01758185|Immunogenicity|immunogenicity
4972601|NCT01758185|Safety|safety
4972602|NCT01758185|Consistence|consistence
4972603|NCT01758172|pancreaticoduodenectomy|pancreaticoduodenectomy
4972604|NCT01758172|postoperative patient|postoperative patient
4972605|NCT01758172|colloid|colloid
4972606|NCT01758172|albumin|albumin
4972607|NCT01758172|hetastarch|hetastarch
4972608|NCT01758146|Breast cancer|breast cancer
4972609|NCT01758146|obesity|obesity
4972610|NCT01758146|aromatase inhibitors|aromatase inhibitors
4972611|NCT01758146|postmenopausal|postmenopausal
4972612|NCT01758120|IgA nephropathy|iga nephropathy
4972613|NCT01758120|Cyclophosphamide|cyclophosphamide
4972614|NCT01758120|prednisone|prednisone
4972615|NCT01758094|hypogonadism|hypogonadism
4972616|NCT01758094|Retinol binding globulin 4|retinol binding globulin 4
4972617|NCT01758094|Testosterone treatment|testosterone treatment
4972618|NCT01758068|Preterms|preterms
4972619|NCT01758068|Coconut Oil application|coconut oil application
4972620|NCT01758068|Trans epidermal water loss|trans epidermal water loss
4972621|NCT01758068|Weight gain|weight gain
4972622|NCT01758055|Mesenchymal stem cell, emphysema, lung function|mesenchymal stem cell, emphysema, lung function
4972623|NCT01758042|Kidney|kidney
4972624|NCT01758042|Chronic Kidney Disease|chronic kidney disease
4972625|NCT01758042|CKD|ckd
4972626|NCT01758042|Bone Marrow|bone marrow
4972627|NCT01758042|Bone Marrow Transplant|bone marrow transplant
4972628|NCT01758042|BMT|bmt
4972629|NCT01758042|Leukemia|leukemia
4972630|NCT01758042|AML|aml
4972631|NCT01758042|ALL|all
4972632|NCT01758042|CML|cml
4972633|NCT01758042|CLL|cll
4972634|NCT01758042|MM|mm
4972635|NCT01758042|NHL|nhl
4972636|NCT01758042|MDS|mds
4972637|NCT01758029|quality of life|quality of life
4972638|NCT01758029|Testosterone Undecanoate|testosterone undecanoate
4972639|NCT01758029|partner|partner
4972640|NCT01758029|questionnaire|questionnaire
4972641|NCT01758003|Physical Activity|physical activity
4972642|NCT01758003|Sedentary Behaviour|sedentary behaviour
4972643|NCT01758003|Healthy Volunteer|healthy volunteer
4972644|NCT01758003|Quality of Life|quality of life
4972645|NCT01758003|Exercise Capacity|exercise capacity
4972646|NCT01758003|Transtheoretical Model|transtheoretical model
4972647|NCT01757990|dental caries|dental caries
4972648|NCT01757990|Stevioside|stevioside
4972649|NCT01757990|Rebaudioside|rebaudioside
4972650|NCT01757990|plaque pH|plaque ph
4972651|NCT01757990|Streptococcus mutans|streptococcus mutans
4972652|NCT01757977|Vivasight DL|vivasight dl
4972653|NCT01757977|double lumen endotracheal tube|double lumen endotracheal tube
4972654|NCT01757977|fiberoptic confirmation of tube position|fiberoptic confirmation of tube position
4972655|NCT01757964|Crohns Disease|crohns disease
4972656|NCT01757964|Ulcerative Colitis|ulcerative colitis
4972657|NCT01757964|Inflammatory Bowel Disease|inflammatory bowel disease
4972658|NCT01757964|IBD|ibd
4972659|NCT01757951|Ankle|ankle
4972660|NCT01757951|Fracture|fracture
4972661|NCT01757951|medial malleolus|medial malleolus
4972662|NCT01757951|Osteosynthesis|osteosynthesis
4972663|NCT01757938|HIV|hiv
4972664|NCT01757938|Prevention|prevention
4972665|NCT01757938|Adult Male Circumcision|adult male circumcision
4972666|NCT01757938|Uganda|uganda
4972667|NCT01757938|Shang Ring|shang ring
4972668|NCT01757925|activity|activity
4972669|NCT01757925|gaming|gaming
4972670|NCT01757925|obesity|obesity
4972671|NCT01757925|Active Gaming|active gaming
4972672|NCT01757925|Control|control
4972673|NCT01757912|mechanical ventilation|mechanical ventilation
4972674|NCT01757899|ALI|ali
4972675|NCT01757899|Acute Lung Injury|acute lung injury
4972676|NCT01757899|ARDS|ards
4972677|NCT01757899|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
4972678|NCT01757899|Pediatric Critical Care Medicine|pediatric critical care medicine
4972679|NCT01757899|Inflammatory Response|inflammatory response
4972680|NCT01757886|Myocardial infarction, Inflammation, Thrombus, Coronary angioplasty.|myocardial infarction, inflammation, thrombus, coronary angioplasty.
4972681|NCT01757847|Binge-Eating Disorder|binge-eating disorder
4972682|NCT01757847|Obesity|obesity
4972683|NCT01757847|emotional eating|emotional eating
4972684|NCT01757834|Thyroid Nodule|thyroid nodule
4972685|NCT01757834|Thyroid Neoplasm|thyroid neoplasm
4972686|NCT01757834|Differential Diagnosis|differential diagnosis
4972687|NCT01757834|Elastography|elastography
4972688|NCT01757834|Elasticity Imaging Technique|elasticity imaging technique
4972689|NCT01757834|Sonoelastography|sonoelastography
4972690|NCT01757821|Stroke|stroke
4972691|NCT01757821|rTMS|rtms
4972692|NCT01757821|TMS|tms
4972693|NCT01757808|PAH|pah
4972694|NCT01757808|Ranolazine|ranolazine
4972695|NCT01757808|right ventricle|right ventricle
4972696|NCT01757808|Safety|safety
4972697|NCT01757808|cardiopulmonary exercise testing|cardiopulmonary exercise testing
4972698|NCT01757795|acute ischemic stroke|acute ischemic stroke
4972699|NCT01757795|ischemic stroke|ischemic stroke
4972700|NCT01757795|stroke|stroke
4972701|NCT01757769|Lower urinary tract symptoms|lower urinary tract symptoms
4972702|NCT01757769|benign prostatic hyperplasia|benign prostatic hyperplasia
4972703|NCT01757743|Heart Septal Defects, Atrial|heart septal defects, atrial
4972704|NCT01757743|Oedema formation|oedema formation
4972705|NCT01757717|radiation therapy|radiation therapy
4972706|NCT01757717|HDR brachytherapy|hdr brachytherapy
4972707|NCT01757717|Ir-192 high dose rate|ir-192 high dose rate
4972708|NCT01757717|12-260|12-260
4972709|NCT01757704|Cardiac de-airing|cardiac de-airing
4972710|NCT01757704|Air emboli|air emboli
4972711|NCT01757704|Trans-cranial Echo-Doppler|trans-cranial echo-doppler
4972712|NCT01757704|Intraoperative Trans-esophageal Echocardiography|intraoperative trans-esophageal echocardiography
4972713|NCT01757691|Acute demyelinating optic neuritis|acute demyelinating optic neuritis
4972714|NCT01757691|Optic neuritis|optic neuritis
4972715|NCT01757678|Coronary Artery Disease Computed Fractional Flow Reserve|coronary artery disease computed fractional flow reserve
4972716|NCT01757665|Aortic valve replacement|aortic valve replacement
4972717|NCT01757665|Mitral valve replacement|mitral valve replacement
4972718|NCT01757626|Bone Marrow|bone marrow
4972719|NCT01757626|Hu3F8|hu3f8
4972720|NCT01757626|GM-CSF|gm-csf
4972721|NCT01757626|12-230|12-230
4972722|NCT01757587|Type 2 Diabetes|type 2 diabetes
4972723|NCT01757587|Galvus|galvus
4972724|NCT01757587|basal insulin|basal insulin
4972725|NCT01757587|HbA1c|hba1c
4972726|NCT01757574|CIDP- chronic inflammatory demyelinating neuropathy|cidp- chronic inflammatory demyelinating neuropathy
4972727|NCT01757574|demyelinating neuropathy|demyelinating neuropathy
4972728|NCT01757574|alemtuzumab|alemtuzumab
4972729|NCT01757561|jugular bulb oxygen saturation|jugular bulb oxygen saturation
4972730|NCT01757561|postoperative cognitive dysfunction|postoperative cognitive dysfunction
4972731|NCT01757561|propofol|propofol
4972732|NCT01757561|sevoflurane|sevoflurane
4972733|NCT01757548|varicocele; male infertile;varicocelectomy|varicocele; male infertile;varicocelectomy
4972734|NCT01757535|Maintenance therapy|maintenance therapy
4972735|NCT01757535|AML|aml
4972736|NCT01757535|Acute Myeloid Leukemia|acute myeloid leukemia
4972737|NCT01757535|oral Azacitidine|oral azacitidine
4972738|NCT01757535|best supportive care|best supportive care
4972739|NCT01757535|complete remission|complete remission
4972740|NCT01757509|Parkinson's disease|parkinson's disease
4972741|NCT01757509|Set dancing|set dancing
4972742|NCT01757496|Bronchiolitis|bronchiolitis
4972743|NCT01757496|Respiratory Syncytial Virus|respiratory syncytial virus
4972744|NCT01757496|Cough Assist|cough assist
4972745|NCT01757496|Physiotherapy|physiotherapy
4972746|NCT01757470|effectiveness of risk mitigation,|effectiveness of risk mitigation,
4972747|NCT01757470|knowledge and understanding survey,|knowledge and understanding survey,
4972748|NCT01757470|drug utilisation study,|drug utilisation study,
4972749|NCT01757470|post marketing commitments|post marketing commitments
4972750|NCT01757457|inflammation|inflammation
4972751|NCT01757457|thrombosis|thrombosis
4972752|NCT01757457|platelets|platelets
4972753|NCT01757457|adhesion molecules|adhesion molecules
4972754|NCT01757457|endothelium|endothelium
4972755|NCT01757418|Sickle Cell Disease|sickle cell disease
4972756|NCT01757418|Pain|pain
4972757|NCT01757418|Immune Globulin|immune globulin
4972758|NCT01757405|with Factor VIII (FVIII) or Factor IX (FIX) inhibitors|with factor viii (fviii) or factor ix (fix) inhibitors
4972759|NCT01757392|Treatment|treatment
4972760|NCT01757392|common wart lesions|common wart lesions
4972761|NCT01757392|(verruca vulgaris)|(verruca vulgaris)
4972762|NCT01757379|Short chain fatty acids|short chain fatty acids
4972763|NCT01757379|Acetate|acetate
4972764|NCT01757379|Propionate|propionate
4972765|NCT01757379|Butyrate|butyrate
4972766|NCT01757379|Bioavailability|bioavailability
4972767|NCT01757314|arterial lines|arterial lines
4972768|NCT01757301|Pain|pain
4972769|NCT01757301|Depression|depression
4972770|NCT01757301|Anxiety|anxiety
4972771|NCT01757301|Musculoskeletal|musculoskeletal
4972772|NCT01757301|Fibromyalgia|fibromyalgia
4972773|NCT01757288|STAGE IIIA/B NSCLC / INOPERABLE LUNG CANCER|stage iiia/b nsclc / inoperable lung cancer
4972774|NCT01757275|peptic ulcer bleeding|peptic ulcer bleeding
4972775|NCT01757275|prevention of rebleeding|prevention of rebleeding
4972776|NCT01757275|successful endoscopic haemostatic therapy|successful endoscopic haemostatic therapy
4972777|NCT01757262|Coronary Heart Disease|coronary heart disease
4972778|NCT01757236|Antibiotic|antibiotic
4972779|NCT01757236|linezolid|linezolid
4972780|NCT01757236|linezolid/rifampin|linezolid/rifampin
4972781|NCT01757223|Diffuse Coronary Artery Disease (CAD)|diffuse coronary artery disease (cad)
4972782|NCT01757210|Aprepitant|aprepitant
4972783|NCT01757210|Pediatrics|pediatrics
4972784|NCT01757210|Chemotherapy-induced nausea/vomiting|chemotherapy-induced nausea/vomiting
4972785|NCT01757210|Survey|survey
4972786|NCT01757184|Enzyme Replacement Therapy (ERT)|enzyme replacement therapy (ert)
4972787|NCT01757184|Lysosomal Storage Disease|lysosomal storage disease
4972788|NCT01757184|Late Onset Lysosomal Acid Lipase (LAL) Deficiency|late onset lysosomal acid lipase (lal) deficiency
4972789|NCT01757184|Acid cholesteryl ester hydrolase deficiency, type 2|acid cholesteryl ester hydrolase deficiency, type 2
4972790|NCT01757184|Acid lipase disease|acid lipase disease
4972791|NCT01757184|Cholesterol ester hydrolase deficiency|cholesterol ester hydrolase deficiency
4972792|NCT01757184|LAL Deficiency|lal deficiency
4972793|NCT01757184|LIPA Deficiency|lipa deficiency
4972794|NCT01757184|Wolman disease|wolman disease
4972795|NCT01757171|Gastric Cancer|gastric cancer
4972796|NCT01757158|lung cancer|lung cancer
4972797|NCT01757158|lobectomy|lobectomy
4972798|NCT01757158|local recurrence|local recurrence
4972799|NCT01757145|Cord blood transplantation|cord blood transplantation
4972800|NCT01757145|Eltrombopag|eltrombopag
4972801|NCT01757145|Platelet engraftment|platelet engraftment
4972802|NCT01757106|xenon anesthesia|xenon anesthesia
4972803|NCT01757106|sevoflurane anesthesia|sevoflurane anesthesia
4972804|NCT01757106|off-pump coronary artery bypass graft surgery|off-pump coronary artery bypass graft surgery
4972805|NCT01757093|INDIRECT CALORIMETRY|indirect calorimetry
4972806|NCT01757093|MECHANICAL VENTILATION|mechanical ventilation
4972807|NCT01757093|WEANING VENTILATOR|weaning ventilator
4972808|NCT01757093|AUTOMATIC TUBE COMPENSATION|automatic tube compensation
4972809|NCT01757067|ablations|ablations
4972810|NCT01757067|CHF|chf
4972811|NCT01757067|PVC|pvc
4972812|NCT01757054|probiotic|probiotic
4972813|NCT01757054|LGG|lgg
4972814|NCT01757054|BB-12|bb-12
4972815|NCT01757054|fecal recovery|fecal recovery
4972816|NCT01757054|healthy subjects|healthy subjects
4972817|NCT01757041|Streptococcus agalactiae|streptococcus agalactiae
4972818|NCT01757041|Maternal|maternal
4972819|NCT01757041|Newborn|newborn
4972820|NCT01757041|Africa|africa
4972821|NCT01757028|Maternal and newborn health|maternal and newborn health
4972822|NCT01757028|Africa|africa
4972823|NCT01757015|COPD|copd
4972824|NCT01757015|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
4972825|NCT01757015|Moderate to severe airflow limitation|moderate to severe airflow limitation
4972826|NCT01757015|GOLD spirometric classification 2 and 3|gold spirometric classification 2 and 3
4972827|NCT01757015|GOLD group B and D|gold group b and d
4972828|NCT01757015|NVA237|nva237
4972829|NCT01757015|Salmeterol fluticasone propionate|salmeterol fluticasone propionate
4972830|NCT01757002|Urban adolescents|urban adolescents
4972831|NCT01757002|Acute asthma|acute asthma
4972832|NCT01757002|Asthma|asthma
4972833|NCT01757002|Computer tailoring|computer tailoring
4972834|NCT01757002|Web-based intervention|web-based intervention
4972835|NCT01757002|Puff City|puff city
4972836|NCT01756950|Influenza|influenza
4972837|NCT01756950|Virus|virus
4972838|NCT01756950|Monoclonal|monoclonal
4972839|NCT01756950|Antibody|antibody
4972840|NCT01756950|Immunization|immunization
4972841|NCT01756950|Treatment|treatment
4972842|NCT01756937|osteoarthritis of the knee|osteoarthritis of the knee
4972843|NCT01756924|prosthetic joint infection|prosthetic joint infection
4972844|NCT01756924|hip arthroplasty|hip arthroplasty
4972845|NCT01756924|MRSA|mrsa
4972846|NCT01756924|knee arthroplasty|knee arthroplasty
4972847|NCT01756911|MFM|mfm
4972848|NCT01756911|Multilayer Flow Modulator|multilayer flow modulator
4972849|NCT01756911|Multilayer stent|multilayer stent
4972850|NCT01756911|Thoracoabdominal Aortic Aneurysm|thoracoabdominal aortic aneurysm
4972851|NCT01756898|Atopic Dermatitis|atopic dermatitis
4972852|NCT01756898|eczema|eczema
4972853|NCT01756885|Smoking cessation|smoking cessation
4972854|NCT01756885|Nicotine dependence|nicotine dependence
4972855|NCT01756885|Varenicline|varenicline
4972856|NCT01756885|Chantix|chantix
4972857|NCT01756885|Cancer|cancer
4972858|NCT01756872|infertility|infertility
4972859|NCT01756872|Assisted reproductive technology|assisted reproductive technology
4972860|NCT01756872|ovarian reserve|ovarian reserve
4972861|NCT01756859|Portal hypertension|portal hypertension
4972862|NCT01756859|HVPG|hvpg
4972863|NCT01756859|MRI|mri
4972864|NCT01756846|HEART score|heart score
4972865|NCT01756846|risk score|risk score
4972866|NCT01756846|impact|impact
4972867|NCT01756846|chest pain|chest pain
4972868|NCT01756833|abdominal|abdominal
4972869|NCT01756833|aortic|aortic
4972870|NCT01756833|aneurysm|aneurysm
4972871|NCT01756820|Carpal Tunnel Syndrome|carpal tunnel syndrome
4972872|NCT01756820|transverse ligament|transverse ligament
4972873|NCT01756820|carpal tunnel release|carpal tunnel release
4972874|NCT01756820|endoscopic|endoscopic
4972875|NCT01756820|minimal invasive|minimal invasive
4972876|NCT01756820|mini-open|mini-open
4972877|NCT01756820|median nerve|median nerve
4972878|NCT01756807|Optical Coherence Tomography|optical coherence tomography
4972879|NCT01756807|Geneous Stent|geneous stent
4972880|NCT01756807|Combo Stent|combo stent
4972881|NCT01756794|Alcoholic hepatitis|alcoholic hepatitis
4972882|NCT01756794|Liver transplantation|liver transplantation
4972883|NCT01756794|Alcohol relapse|alcohol relapse
4972884|NCT01756794|Alcoholic cirrhosis|alcoholic cirrhosis
4972885|NCT01756781|PD-0332991|pd-0332991
4972886|NCT01756781|Midazolam|midazolam
4972887|NCT01756781|Drug-Drug Interaction Study|drug-drug interaction study
4972888|NCT01756781|Healthy Adult Volunteer|healthy adult volunteer
4972889|NCT01756768|Phase 1|phase 1
4972890|NCT01756768|Mass Balance study|mass balance study
4972891|NCT01756768|Radio-labeled dose|radio-labeled dose
4972892|NCT01756768|PD-0332991|pd-0332991
4972893|NCT01756755|Sepsis|sepsis
4972894|NCT01756742|Pleural Effusion|pleural effusion
4972895|NCT01756742|Respiratory physiotherapy|respiratory physiotherapy
4972896|NCT01756742|Length of stay|length of stay
4972897|NCT01756729|Brain tumor|brain tumor
4972898|NCT01756729|Treatment|treatment
4972899|NCT01756729|Minimal toxicity|minimal toxicity
4972900|NCT01756729|GBM|gbm
4972901|NCT01756729|Glioblastoma|glioblastoma
4972902|NCT01756729|Recurrent|recurrent
4972903|NCT01756729|TTFields|ttfields
4972904|NCT01756716|Diabetic Nephropathy|diabetic nephropathy
4972905|NCT01756703|Diabetic Nephropathy|diabetic nephropathy
4972906|NCT01756690|respiratory distress syndrome, adult|respiratory distress syndrome, adult
4972907|NCT01756690|blood component transfusion|blood component transfusion
4972908|NCT01756690|gastrointestinal hemorrhage|gastrointestinal hemorrhage
4972909|NCT01756690|blood coagulation|blood coagulation
4972910|NCT01756651|Intranasal fentanyl|intranasal fentanyl
4972911|NCT01756651|Cystoscopy|cystoscopy
4972912|NCT01756638|Prostate cancer|prostate cancer
4972913|NCT01756638|Abiraterone acetate|abiraterone acetate
4972914|NCT01756638|JNJ-212082|jnj-212082
4972915|NCT01756625|cetuximab|cetuximab
4972916|NCT01756625|nicotine|nicotine
4972917|NCT01756625|magnesium|magnesium
4972918|NCT01756586|popliteal block|popliteal block
4972919|NCT01756586|analgesia duration|analgesia duration
4972920|NCT01756573|block duration|block duration
4972921|NCT01756573|analgesia|analgesia
4972922|NCT01756560|anterior cruciate ligament|anterior cruciate ligament
4972923|NCT01756560|block duration|block duration
4972924|NCT01756547|Nephrocalcinosis|nephrocalcinosis
4972925|NCT01756547|Extreme premature|extreme premature
4972926|NCT01756521|QT,|qt,
4972927|NCT01756521|QTc,|qtc,
4972928|NCT01756521|electrocardiogram,|electrocardiogram,
4972929|NCT01756521|moxifloxacin|moxifloxacin
4972930|NCT01756508|eculizumab|eculizumab
4972931|NCT01756508|kidney transplantation|kidney transplantation
4972932|NCT01756508|reperfusion|reperfusion
4972933|NCT01756508|rejection|rejection
4972934|NCT01756508|infection|infection
4972935|NCT01756495|QTc,|qtc,
4972936|NCT01756495|GW856553 .|gw856553 .
4972937|NCT01756495|P38,|p38,
4972938|NCT01756482|Respiratory|respiratory
4972939|NCT01756482|Syncytial|syncytial
4972940|NCT01756482|Virus|virus
4972941|NCT01756482|Infections|infections
4972942|NCT01756482|RSV|rsv
4972943|NCT01756456|Keratitis|keratitis
4972944|NCT01756456|Corneal Ulcer|corneal ulcer
4972945|NCT01756443|sciatic nerve block|sciatic nerve block
4972946|NCT01756443|ORIF lateral malleolus|orif lateral malleolus
4972947|NCT01756443|sequential injection|sequential injection
4972948|NCT01756443|premixed injection|premixed injection
4972949|NCT01756443|local anaesthetics|local anaesthetics
4972950|NCT01756430|Carvedilol SR|carvedilol sr
4972951|NCT01756430|Carvedilol IR|carvedilol ir
4972952|NCT01756430|Hypertension|hypertension
4972953|NCT01756430|Essential Hypertension|essential hypertension
4972954|NCT01756417|Healthy|healthy
4972955|NCT01756417|Canagliflozin (JNJ-28431754)|canagliflozin (jnj-28431754)
4972956|NCT01756417|Metformin|metformin
4972957|NCT01756417|Pharmacokinetics|pharmacokinetics
4972958|NCT01756417|Pharmacodynamics|pharmacodynamics
4972959|NCT01756404|Healthy|healthy
4972960|NCT01756404|Canagliflozin (JNJ-28431754)|canagliflozin (jnj-28431754)
4972961|NCT01756404|Pharmacokinetics|pharmacokinetics
4972962|NCT01756404|Pharmacodynamics|pharmacodynamics
4972963|NCT01756404|Obesity|obesity
4972964|NCT01756391|pediatric|pediatric
4972965|NCT01756391|childhood|childhood
4972966|NCT01756391|allergy|allergy
4972967|NCT01756378|Mobilization with movement,knee osteoarthritis,|mobilization with movement,knee osteoarthritis,
4972968|NCT01756352|FET|fet
4972969|NCT01756352|Fluoroethyl tyrosine|fluoroethyl tyrosine
4972970|NCT01756352|GBM|gbm
4972971|NCT01756352|Response to treatment|response to treatment
4972972|NCT01756352|Avastin|avastin
4972973|NCT01756352|Brain Tumor|brain tumor
4972974|NCT01756339|Pneumonia|pneumonia
4972975|NCT01756339|CABP|cabp
4972976|NCT01756339|CAP|cap
4972977|NCT01756339|Macrolide|macrolide
4972978|NCT01756326|Non-Union Fractures|non-union fractures
4972979|NCT01756326|Impaired Healing|impaired healing
4972980|NCT01756326|Fractures|fractures
4972981|NCT01756326|Orthopedics|orthopedics
4972982|NCT01756326|Bone|bone
4972983|NCT01756326|Musculoskeletal Disorders|musculoskeletal disorders
4972984|NCT01756300|Essential Hypertension|essential hypertension
4972985|NCT01756300|Renal Denervation|renal denervation
4972986|NCT01756300|Vascular Disease|vascular disease
4972987|NCT01756300|Renal Catheter Ablation|renal catheter ablation
4972988|NCT01756300|Primary Hypertension|primary hypertension
4972989|NCT01756261|EYLEA|eylea
4972990|NCT01756261|Age-Related Macular Degeneration|age-related macular degeneration
4972991|NCT01756261|QOL|qol
4972992|NCT01756248|EYLEA|eylea
4972993|NCT01756248|Age-Related Macular Degeneration|age-related macular degeneration
4972994|NCT01756235|Post-marketing observational study (PMOS) Protocol|post-marketing observational study (pmos) protocol
4972995|NCT01756235|Rheumatoid Arthritis|rheumatoid arthritis
4972996|NCT01756235|Physical Activity|physical activity
4972997|NCT01756235|Adalimumab|adalimumab
4972998|NCT01756235|Humira®|humira®
4972999|NCT01756222|Bicuspid Aortic Valve Disease|bicuspid aortic valve disease
4973000|NCT01756222|Bicuspid Aortic Valve|bicuspid aortic valve
4973001|NCT01756222|BAV|bav
4973102|NCT01755702|tension headache|tension headache
4973103|NCT01755689|pertussis|pertussis
4973002|NCT01756196|Spinal injection; Steroid; Systemic reaction; Complication; Side effect; Diabetes mellitus; Hypertension; Risk factor|spinal injection; steroid; systemic reaction; complication; side effect; diabetes mellitus; hypertension; risk factor
4973003|NCT01756170|cervical cancer|cervical cancer
4973004|NCT01756170|radiotherapy|radiotherapy
4973005|NCT01756170|postoperative therapy|postoperative therapy
4973006|NCT01756170|chemotherapy|chemotherapy
4973007|NCT01756157|Crossover|crossover
4973008|NCT01756157|Prevention|prevention
4973009|NCT01756157|Hereditary Angioedema|hereditary angioedema
4973010|NCT01756157|C1 esterase inhibitor|c1 esterase inhibitor
4973011|NCT01756157|C1 inhibitor|c1 inhibitor
4973012|NCT01756157|Subcutaneous|subcutaneous
4973013|NCT01756157|Recombinant human hyaluronidase|recombinant human hyaluronidase
4973014|NCT01756092|Breast Cancer|breast cancer
4973015|NCT01756092|Lumpectomy|lumpectomy
4973016|NCT01756092|Mastectomy, Segmental|mastectomy, segmental
4973017|NCT01756066|Obesity|obesity
4973018|NCT01756066|Weight loss program|weight loss program
4973019|NCT01756066|incentives|incentives
4973020|NCT01756053|Smoking|smoking
4973021|NCT01756053|Tobacco|tobacco
4973022|NCT01756040|intestinal permeability|intestinal permeability
4973023|NCT01756040|preterm infants|preterm infants
4973024|NCT01756040|dual sugar test|dual sugar test
4973025|NCT01756027|Rosacea|rosacea
4973026|NCT01756027|Ulthera System|ulthera system
4973027|NCT01756027|Ultherapy™ Treatment|ultherapy™ treatment
4973028|NCT01756027|Ulthera, Inc.|ulthera, inc.
4973029|NCT01756027|Ultrasound treatment for the skin|ultrasound treatment for the skin
4973030|NCT01755988|Telemedicine|telemedicine
4973031|NCT01755988|Heart Failure|heart failure
4973032|NCT01755988|Self care|self care
4973033|NCT01755988|Quality of life|quality of life
4973034|NCT01755988|Mortality|mortality
4973035|NCT01755988|Hospitalization|hospitalization
4973036|NCT01755975|LENALIDOMIDE (CC-5013)|lenalidomide (cc-5013)
4973037|NCT01755975|Romidepsin (Istodax)|romidepsin (istodax)
4973038|NCT01755975|12-170|12-170
4973039|NCT01755962|diet|diet
4973040|NCT01755962|obese|obese
4973041|NCT01755962|overweight|overweight
4973042|NCT01755962|exercise|exercise
4973043|NCT01755962|resistance training|resistance training
4973044|NCT01755962|nutrition|nutrition
4973045|NCT01755962|glycemic load|glycemic load
4973046|NCT01755962|body composition|body composition
4973047|NCT01755962|weight training|weight training
4973048|NCT01755962|lifestyle|lifestyle
4973049|NCT01755949|atrial fibrillation|atrial fibrillation
4973050|NCT01755949|catheter ablation|catheter ablation
4973051|NCT01755949|colchicine|colchicine
4973052|NCT01755949|c reactive protein|c reactive protein
4973053|NCT01755949|CRP|crp
4973054|NCT01755936|Aortic Stenosis|aortic stenosis
4973055|NCT01755936|Cardiac magnetic resonance imaging|cardiac magnetic resonance imaging
4973056|NCT01755936|Late Gadolinium enhancement|late gadolinium enhancement
4973057|NCT01755936|T1 mapping techniques|t1 mapping techniques
4973058|NCT01755936|Replacement fibrosis|replacement fibrosis
4973059|NCT01755936|Diffuse interstitial fibrosis|diffuse interstitial fibrosis
4973060|NCT01755923|non-small cell lung cancer|non-small cell lung cancer
4973061|NCT01755923|wild-type EGFR|wild-type egfr
4973062|NCT01755923|gefitinib|gefitinib
4973063|NCT01755923|docetaxel|docetaxel
4973064|NCT01755923|second-line therapy|second-line therapy
4973065|NCT01755910|Breast Surgery|breast surgery
4973066|NCT01755910|Thoracic Paravertebral Block|thoracic paravertebral block
4973067|NCT01755910|HRV|hrv
4973068|NCT01755910|Autonomic Nervous System|autonomic nervous system
4973069|NCT01755884|Wheat allergy|wheat allergy
4973070|NCT01755884|Immunotherapy|immunotherapy
4973071|NCT01755884|Desensitization|desensitization
4973072|NCT01755884|Food allergy|food allergy
4973073|NCT01755884|T cells|t cells
4973074|NCT01755858|elamipretide|elamipretide
4973075|NCT01755845|cervical cancer|cervical cancer
4973076|NCT01755845|radiotherapy|radiotherapy
4973077|NCT01755845|postoperative therapy|postoperative therapy
4973078|NCT01755845|chemotherapy|chemotherapy
4973079|NCT01755832|inflammatory rheumatic joint disease|inflammatory rheumatic joint disease
4973080|NCT01755832|text message|text message
4973081|NCT01755832|> 18 years|> 18 years
4973082|NCT01755832|Norwegian speaking|norwegian speaking
4973083|NCT01755806|Aortic annulus|aortic annulus
4973084|NCT01755806|Aortic calcification|aortic calcification
4973085|NCT01755806|Multislice computed tomography|multislice computed tomography
4973086|NCT01755806|Cardiac cycle|cardiac cycle
4973087|NCT01755767|MET diagnostic-high|met diagnostic-high
4973088|NCT01755767|Unresectable|unresectable
4973089|NCT01755767|Hepatocellular|hepatocellular
4973090|NCT01755767|Carcinoma|carcinoma
4973091|NCT01755767|c-Met inhibitor|c-met inhibitor
4973092|NCT01755728|Paracetamol|paracetamol
4973093|NCT01755728|Acetaminophen|acetaminophen
4973094|NCT01755728|PDA|pda
4973095|NCT01755728|Preterm infants|preterm infants
4973096|NCT01755715|Abortion|abortion
4973097|NCT01755715|Contraception|contraception
4973098|NCT01755715|Intrauterine Devices|intrauterine devices
4973099|NCT01755715|Intrauterine Device Expulsion|intrauterine device expulsion
4973100|NCT01755702|caffeine|caffeine
4973101|NCT01755702|paracetamol|paracetamol
4973403|NCT01754376|Metastatic|metastatic
4973104|NCT01755689|Meningococcal meningitis|meningococcal meningitis
4973105|NCT01755689|Meningococcal infections|meningococcal infections
4973106|NCT01755689|HPV|hpv
4973107|NCT01755689|Neisseria meningitidis|neisseria meningitidis
4973108|NCT01755689|Vaccines, conjugate|vaccines, conjugate
4973109|NCT01755689|tetanus|tetanus
4973110|NCT01755689|diphtheria|diphtheria
4973111|NCT01755689|Meningococcal vaccines|meningococcal vaccines
4973112|NCT01755689|Immunogenicity|immunogenicity
4973113|NCT01755663|CT coronary|ct coronary
4973114|NCT01755663|Coronary arterial disease|coronary arterial disease
4973115|NCT01755663|ivabradine|ivabradine
4973116|NCT01755663|metoprolol|metoprolol
4973117|NCT01755650|18F FPM|18f fpm
4973118|NCT01755650|PET/CT|pet/ct
4973119|NCT01755650|microdosing|microdosing
4973120|NCT01755624|Non-Small Cell Lung Cancer|non-small cell lung cancer
4973121|NCT01755624|NSCLC|nsclc
4973122|NCT01755624|Brain metastases|brain metastases
4973123|NCT01755624|Treatment|treatment
4973124|NCT01755624|Minimal toxicity|minimal toxicity
4973125|NCT01755624|TTFields|ttfields
4973127|NCT01755624|Tumor Treating Fields|tumor treating fields
4973128|NCT01755624|NovoCure|novocure
4973129|NCT01755611|Minocycline|minocycline
4973130|NCT01755611|Mexico|mexico
4973131|NCT01755611|Acne|acne
4973132|NCT01755611|bioequivalence|bioequivalence
4973133|NCT01755598|Positive Interferon-γ release assay|positive interferon-γ release assay
4973134|NCT01755598|Efficacy|efficacy
4973135|NCT01755598|Adults|adults
4973136|NCT01755598|Tuberculosis vaccine|tuberculosis vaccine
4973137|NCT01755598|Endemic region|endemic region
4973138|NCT01755585|Radiation therapy|radiation therapy
4973139|NCT01755585|5-fluorouracil|5-fluorouracil
4973140|NCT01755585|Cisplatin|cisplatin
4973141|NCT01755585|Pharmacokinetics|pharmacokinetics
4973142|NCT01755585|Matrix Metalloproteinase|matrix metalloproteinase
4973143|NCT01755572|Type 2 Diabetes|type 2 diabetes
4973144|NCT01755572|Hypertension|hypertension
4973145|NCT01755572|Liraglutide|liraglutide
4973146|NCT01755572|GLP-1|glp-1
4973147|NCT01755559|malaria|malaria
4973148|NCT01755559|artemisinin|artemisinin
4973149|NCT01755559|artemisinin-based combination therapies|artemisinin-based combination therapies
4973150|NCT01755559|Plasmodium falciparum|plasmodium falciparum
4973151|NCT01755559|efficacy|efficacy
4973152|NCT01755546|Chronic Pain|chronic pain
4973153|NCT01755546|CLBP|clbp
4973154|NCT01755546|Chronic Low Back Pain|chronic low back pain
4973155|NCT01755546|Back Pain|back pain
4973156|NCT01755546|Osteoarthritis|osteoarthritis
4973157|NCT01755546|OA|oa
4973158|NCT01755546|Neuropathic Pain|neuropathic pain
4973159|NCT01755546|Nerve pain|nerve pain
4973160|NCT01755546|Painful neuropathy|painful neuropathy
4973161|NCT01755533|adolescent substance use|adolescent substance use
4973162|NCT01755533|rural substance use|rural substance use
4973163|NCT01755533|middle school prevention|middle school prevention
4973164|NCT01755533|implementation processes|implementation processes
4973165|NCT01755533|implementation quality|implementation quality
4973166|NCT01755533|adaptation of prevention curricula|adaptation of prevention curricula
4973167|NCT01755533|dissemination|dissemination
4973168|NCT01755520|CABG|cabg
4973169|NCT01755520|CAD|cad
4973170|NCT01755520|antiplatelet drug|antiplatelet drug
4973171|NCT01755520|Ticagrelor|ticagrelor
4973172|NCT01755520|Aspirin|aspirin
4973173|NCT01755507|PSC|psc
4973174|NCT01755494|Type 2 diabetes, Saxagliptin, Metformin,Fixed dose combination tablet, Bioequivalence, pharmacokinetic, safety, tolerability|type 2 diabetes, saxagliptin, metformin,fixed dose combination tablet, bioequivalence, pharmacokinetic, safety, tolerability
4973175|NCT01755468|beta-cell function, type 2 diabetes, intermittent insulin|beta-cell function, type 2 diabetes, intermittent insulin
4973176|NCT01755455|Cystic fibrosis|cystic fibrosis
4973177|NCT01755455|Iron|iron
4973178|NCT01755455|Hepcidin|hepcidin
4973179|NCT01755455|Anemia|anemia
4973180|NCT01755455|Erythropoiesis|erythropoiesis
4973181|NCT01755442|Ambulatory blood pressure|ambulatory blood pressure
4973182|NCT01755442|Type 2 diabetes|type 2 diabetes
4973183|NCT01755416|Type 1 diabetes|type 1 diabetes
4973184|NCT01755416|closed loop|closed loop
4973185|NCT01755416|artificial pancreas|artificial pancreas
4973186|NCT01755416|insulin|insulin
4973187|NCT01755416|victoza|victoza
4973188|NCT01755416|liraglutide|liraglutide
4973189|NCT01755338|cerebrospinal fluid|cerebrospinal fluid
4973190|NCT01755338|inflammatory markers|inflammatory markers
4973191|NCT01755338|heart surgery|heart surgery
4973192|NCT01755338|neuronal damage|neuronal damage
4973193|NCT01755338|blood brain barrier|blood brain barrier
4973194|NCT01755299|Energy drinks|energy drinks
4973195|NCT01755299|Wakefulness|wakefulness
4973196|NCT01755299|Caffeine|caffeine
4973197|NCT01755273|Pancreaticoduodenectomy|pancreaticoduodenectomy
4973198|NCT01755273|Diabetes|diabetes
4973199|NCT01755260|POPF|popf
4973200|NCT01755260|pancreaticoduodenectomy|pancreaticoduodenectomy
4973201|NCT01755260|enteral nutrition|enteral nutrition
4973202|NCT01755260|parenteral nutrition|parenteral nutrition
4973203|NCT01755247|acne|acne
4973204|NCT01755234|Outpatient|outpatient
4973205|NCT01755234|Surgery|surgery
4973206|NCT01755234|Anesthesia|anesthesia
4973509|NCT01753882|Lexapro|lexapro
4973207|NCT01755221|Laryngopharyngeal reflux (LPR)|laryngopharyngeal reflux (lpr)
4973208|NCT01755221|Extraesophageal reflux|extraesophageal reflux
4973209|NCT01755221|Reflux laryngitis|reflux laryngitis
4973210|NCT01755221|Posterior laryngitis|posterior laryngitis
4973211|NCT01755221|Proton pump inhibitor (PPI) medication|proton pump inhibitor (ppi) medication
4973212|NCT01755221|Restech pH probe|restech ph probe
4973213|NCT01755195|Dual Inhibitor of MET and VEGFR|dual inhibitor of met and vegfr
4973214|NCT01755195|XL184|xl184
4973215|NCT01755195|Metastatic Refractory|metastatic refractory
4973216|NCT01755195|Soft Tissue Sarcoma|soft tissue sarcoma
4973217|NCT01755195|Rare Heterogeneous Tumor|rare heterogeneous tumor
4973218|NCT01755182|locoregional treatment|locoregional treatment
4973219|NCT01755182|liver metastases|liver metastases
4973220|NCT01755182|transarterial embolization|transarterial embolization
4973221|NCT01755182|upfront treatment|upfront treatment
4973222|NCT01755182|inoperable|inoperable
4973223|NCT01755182|octreotide|octreotide
4973224|NCT01755182|gastroenteropancreatic (GEP)primary|gastroenteropancreatic (gep)primary
4973225|NCT01755182|pulmonary primary|pulmonary primary
4973226|NCT01755182|primary unknown origin|primary unknown origin
4973227|NCT01755182|systemic therapy|systemic therapy
4973228|NCT01755169|Chronic pain|chronic pain
4973229|NCT01755169|Child|child
4973230|NCT01755169|Pediatric|pediatric
4973231|NCT01755169|Ketamine|ketamine
4973232|NCT01755130|Breast Cancer|breast cancer
4973233|NCT01755130|LOUIS-3D|louis-3d
4973234|NCT01755130|Breast Study|breast study
4973235|NCT01755130|x-ray|x-ray
4973236|NCT01755130|Multimode Laser Optoacoustic Ultrasonic Tomography System|multimode laser optoacoustic ultrasonic tomography system
4973237|NCT01755130|Mass palpable or nonpalpable|mass palpable or nonpalpable
4973238|NCT01755130|Breast lesions|breast lesions
4973239|NCT01755130|Ductal carcinomas|ductal carcinomas
4973240|NCT01755130|Lobular carcinomas|lobular carcinomas
4973241|NCT01755130|Fibroadenomas|fibroadenomas
4973242|NCT01755078|Phosphate binder|phosphate binder
4973243|NCT01755065|laparoscopic surgery|laparoscopic surgery
4973244|NCT01755065|teenager|teenager
4973245|NCT01755052|Acute Myocardial Infarction|acute myocardial infarction
4973246|NCT01755052|Geriatrics|geriatrics
4973247|NCT01755052|Cardiology|cardiology
4973248|NCT01755052|Aging|aging
4973249|NCT01755052|Heart Attack|heart attack
4973250|NCT01755052|Risk Factors|risk factors
4973251|NCT01755052|Quality of Care|quality of care
4973252|NCT01755052|Risk Models|risk models
4973253|NCT01755026|Cesarean Delivery|cesarean delivery
4973254|NCT01755026|Wound infection|wound infection
4973255|NCT01755026|Obesity|obesity
4973256|NCT01755026|Prophylactic antibiotics|prophylactic antibiotics
4973257|NCT01755013|Cholangiocarcinoma|cholangiocarcinoma
4973258|NCT01755013|Biliary Stricture|biliary stricture
4973259|NCT01755013|Biliary obstruction|biliary obstruction
4973260|NCT01755013|Bile Duct Cancer|bile duct cancer
4973261|NCT01755013|PDT|pdt
4973262|NCT01755013|Photodynamic Therapy|photodynamic therapy
4973263|NCT01755013|Plastic optic Diffuser|plastic optic diffuser
4973264|NCT01755013|Laser|laser
4973265|NCT01754987|Vitamins|vitamins
4973266|NCT01754987|Malignant Tumor, Tumour|malignant tumor, tumour
4973267|NCT01754987|Integrative Medicine|integrative medicine
4973268|NCT01754987|Complementary Medicine|complementary medicine
4973269|NCT01754987|Alternative Medicine Antioxidants|alternative medicine antioxidants
4973270|NCT01754987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
4973271|NCT01754987|Pharmacologic Actions|pharmacologic actions
4973272|NCT01754987|Protective Agents|protective agents
4973273|NCT01754987|Physiological Effects of Drugs|physiological effects of drugs
4973274|NCT01754987|Micronutrients|micronutrients
4973275|NCT01754987|Growth Substances|growth substances
4973276|NCT01754987|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic
4973277|NCT01754987|Antineoplastic Agents|antineoplastic agents
4973278|NCT01754987|Therapeutic Uses|therapeutic uses
4973279|NCT01754987|Radiation-Sensitizing Agents|radiation-sensitizing agents
4973280|NCT01754987|Liver Cancer|liver cancer
4973281|NCT01754948|asthma|asthma
4973282|NCT01754948|reactive airway disease|reactive airway disease
4973283|NCT01754948|cough|cough
4973284|NCT01754948|air pollution|air pollution
4973285|NCT01754948|nano particles|nano particles
4973286|NCT01754922|exercise tolerance|exercise tolerance
4973287|NCT01754922|Veterans|veterans
4973288|NCT01754922|operation enduring freedom|operation enduring freedom
4973289|NCT01754922|operation Iraqi freedom|operation iraqi freedom
4973290|NCT01754909|lung cancer|lung cancer
4973291|NCT01754909|radiation pneumonitis|radiation pneumonitis
4973292|NCT01754909|mitigation|mitigation
4973293|NCT01754909|enalapril|enalapril
4973294|NCT01754909|placebo|placebo
4973295|NCT01754896|colorectal cancer|colorectal cancer
4973296|NCT01754896|fecal immunochemical test|fecal immunochemical test
4973297|NCT01754896|fecal occult blood test|fecal occult blood test
4973298|NCT01754896|screening|screening
4973299|NCT01754883|Posttraumatic Stess Disorder|posttraumatic stess disorder
4973300|NCT01754883|Lithium|lithium
4973301|NCT01754870|CLL|cll
4973302|NCT01754870|SLL|sll
4973303|NCT01754857|Lymphoid Leukemia|lymphoid leukemia
4973304|NCT01754857|Bendamustine|bendamustine
4973305|NCT01754857|Rituximab|rituximab
4973306|NCT01754857|Small Lymphocytic Lymphoma|small lymphocytic lymphoma
4973307|NCT01754844|Phase 1|phase 1
4973308|NCT01754844|Healthy Volunteers|healthy volunteers
4973309|NCT01754844|Single Ascending Dose (SAD)|single ascending dose (sad)
4973310|NCT01754844|First Time in Man|first time in man
4973311|NCT01754844|Pharmacokinetics|pharmacokinetics
4973312|NCT01754844|Pharmacodynamics|pharmacodynamics
4973313|NCT01754831|children|children
4973314|NCT01754831|fluoride varnish|fluoride varnish
4973315|NCT01754818|Pharmacokinetics|pharmacokinetics
4973316|NCT01754818|volunteers|volunteers
4973317|NCT01754805|ASP015K|asp015k
4973318|NCT01754805|Rheumatoid Arthritis|rheumatoid arthritis
4973319|NCT01754779|calcium phosphate|calcium phosphate
4973320|NCT01754779|urolithiasis|urolithiasis
4973321|NCT01754779|kidney stones|kidney stones
4973322|NCT01754779|hypercalciuria|hypercalciuria
4973323|NCT01754753|Mental well-being|mental well-being
4973324|NCT01754753|Befriending|befriending
4973325|NCT01754740|Xerostomia, Salivary flow, Burning Mouth Syndrome.|xerostomia, salivary flow, burning mouth syndrome.
4973326|NCT01754727|Ankylosing Spondylitis|ankylosing spondylitis
4973327|NCT01754727|Effectiveness|effectiveness
4973328|NCT01754727|Post-marketing observational study (PMOS)|post-marketing observational study (pmos)
4973329|NCT01754727|Adalimumab|adalimumab
4973330|NCT01754727|Humira®|humira®
4973331|NCT01754714|Steatohepatitis|steatohepatitis
4973332|NCT01754662|Type 2 diabetes|type 2 diabetes
4973333|NCT01754662|Cardiovascular risk|cardiovascular risk
4973334|NCT01754662|Endothelial function|endothelial function
4973335|NCT01754662|Insulin resistance|insulin resistance
4973336|NCT01754662|Soy|soy
4973337|NCT01754662|Isoflavones|isoflavones
4973338|NCT01754662|Cocoa|cocoa
4973339|NCT01754662|Diet|diet
4973340|NCT01754649|intrauterine device|intrauterine device
4973341|NCT01754649|insertion failure|insertion failure
4973342|NCT01754636|Colorectal neoplasms|colorectal neoplasms
4973343|NCT01754636|Elderly|elderly
4973344|NCT01754636|Randomized clinical trials|randomized clinical trials
4973345|NCT01754636|Inclusion.|inclusion.
4973346|NCT01754623|Pancreas|pancreas
4973347|NCT01754623|Pancreatic|pancreatic
4973348|NCT01754623|Neoplasms|neoplasms
4973349|NCT01754623|Stereotactic|stereotactic
4973350|NCT01754623|Radiosurgery|radiosurgery
4973351|NCT01754623|Borderline|borderline
4973352|NCT01754623|Resectable|resectable
4973353|NCT01754623|Gastrointestinal|gastrointestinal
4973354|NCT01754623|Gemcitabine|gemcitabine
4973355|NCT01754623|Capecitabine|capecitabine
4973356|NCT01754623|Fluorouracil|fluorouracil
4973357|NCT01754623|Docetaxel|docetaxel
4973358|NCT01754623|SBRT|sbrt
4973359|NCT01754623|GTX Chemotherapy|gtx chemotherapy
4973360|NCT01754610|family trauma|family trauma
4973361|NCT01754610|multi-family therapy|multi-family therapy
4973362|NCT01754610|Posttraumatic Stress Disorder|posttraumatic stress disorder
4973363|NCT01754610|poverty|poverty
4973364|NCT01754597|Patients with breast cancer requiring surgical management with general anesthesia|patients with breast cancer requiring surgical management with general anesthesia
4973365|NCT01754584|hyaluronan including concentrations|hyaluronan including concentrations
4973366|NCT01754584|molecular weight|molecular weight
4973367|NCT01754584|mucociliary differentiation|mucociliary differentiation
4973368|NCT01754584|human respiratory epithelial cells|human respiratory epithelial cells
4973498|NCT01754012|Inflammation|inflammation
4973369|NCT01754571|medication overuse headache|medication overuse headache
4973370|NCT01754545|Infusions, Intravenous|infusions, intravenous
4973371|NCT01754545|Plasma|plasma
4973372|NCT01754545|ADAMTS-13 protein, human|adamts-13 protein, human
4973373|NCT01754532|Schizophrenia|schizophrenia
4973374|NCT01754532|Schizo-Affective Disorder|schizo-affective disorder
4973375|NCT01754532|Stress|stress
4973376|NCT01754532|Cortisol|cortisol
4973377|NCT01754532|PANSS|panss
4973378|NCT01754506|leg ulcers|leg ulcers
4973379|NCT01754506|wounds|wounds
4973380|NCT01754506|fish oil|fish oil
4973381|NCT01754506|lipid mediators|lipid mediators
4973382|NCT01754506|chronic venous stasis ulcers|chronic venous stasis ulcers
4973383|NCT01754493|Major Depression|major depression
4973384|NCT01754493|Irritable Bowel Syndrome|irritable bowel syndrome
4973385|NCT01754493|Somatization|somatization
4973386|NCT01754493|Cymbalta|cymbalta
4973387|NCT01754493|Duloxetine|duloxetine
4973388|NCT01754480|Fibrin Sealant|fibrin sealant
4973389|NCT01754480|Parenchymous tissue open surgery|parenchymous tissue open surgery
4973390|NCT01754480|Hepatic Resection|hepatic resection
4973391|NCT01754480|Oxidized cellulose pads|oxidized cellulose pads
4973392|NCT01754441|Spinal Muscular Atrophy|spinal muscular atrophy
4973393|NCT01754441|SMA|sma
4973394|NCT01754441|Motor Neuron Abnormalities|motor neuron abnormalities
4973395|NCT01754428|Respiratory|respiratory
4973396|NCT01754428|Syncytial|syncytial
4973397|NCT01754428|Virus|virus
4973398|NCT01754428|RSV|rsv
4973399|NCT01754415|Aging|aging
4973400|NCT01754415|Chronic illness|chronic illness
4973401|NCT01754415|Resistance circuit training|resistance circuit training
4973402|NCT01754402|Multiple Myeloma|multiple myeloma
4973404|NCT01754376|Unresectable|unresectable
4973405|NCT01754376|V600E mutation|v600e mutation
4973406|NCT01754363|Osteoarthritis|osteoarthritis
4973407|NCT01754350|ketogenic diet|ketogenic diet
4973408|NCT01754350|glioma|glioma
4973409|NCT01754350|fasting|fasting
4973410|NCT01754350|reirradiation|reirradiation
4973411|NCT01754350|nutrition|nutrition
4973412|NCT01754337|Type 1 diabetes|type 1 diabetes
4973413|NCT01754337|Hypoglycemia|hypoglycemia
4973414|NCT01754337|Insulin|insulin
4973415|NCT01754337|Glucagon|glucagon
4973416|NCT01754337|Closed-loop system|closed-loop system
4973417|NCT01754337|Artificial pancreas|artificial pancreas
4973418|NCT01754324|Neonatal Abstinence Syndrome|neonatal abstinence syndrome
4973419|NCT01754324|Pharmacokinetics|pharmacokinetics
4973420|NCT01754324|Methadone|methadone
4973421|NCT01754324|Neonate|neonate
4973422|NCT01754324|Newborn|newborn
4973423|NCT01754311|HTLV-I|htlv-i
4973424|NCT01754298|osteochondritis dissecans (OCD)|osteochondritis dissecans (ocd)
4973425|NCT01754298|juvenile osteochondritis dissecans (JOCD)|juvenile osteochondritis dissecans (jocd)
4973426|NCT01754298|knee osteochondritis dissecans|knee osteochondritis dissecans
4973427|NCT01754298|retro-articular drilling|retro-articular drilling
4973428|NCT01754298|trans-articular drilling|trans-articular drilling
4973429|NCT01754298|stable osteochondritis dissecans lesion|stable osteochondritis dissecans lesion
4973430|NCT01754272|metastatic colorectal cancer|metastatic colorectal cancer
4973431|NCT01754272|mCRC|mcrc
4973432|NCT01754272|Aflibercept|aflibercept
4973433|NCT01754272|FOLFIRI|folfiri
4973434|NCT01754272|translational research|translational research
4973435|NCT01754272|retrospective|retrospective
4973436|NCT01754272|noninterventional|noninterventional
4973437|NCT01754272|biomarkers|biomarkers
4973438|NCT01754272|angiogenesis|angiogenesis
4973439|NCT01754259|type 1 diabetes|type 1 diabetes
4973440|NCT01754259|type 2 diabetes|type 2 diabetes
4973441|NCT01754259|exertion angina|exertion angina
4973442|NCT01754259|suspected CAD|suspected cad
4973443|NCT01754259|known CAD|known cad
4973444|NCT01754194|Gastric Sleeve|gastric sleeve
4973445|NCT01754194|Gastric Bypass|gastric bypass
4973446|NCT01754194|Roux en Y|roux en y
4973447|NCT01754194|Morbid Obesity|morbid obesity
4973448|NCT01754194|Laparoscopy|laparoscopy
4973449|NCT01754181|Glycemic control algorithm|glycemic control algorithm
4973450|NCT01754181|closed loop|closed loop
4973451|NCT01754181|artificial pancreas|artificial pancreas
4973452|NCT01754168|Parkinson disease|parkinson disease
4973453|NCT01754168|Cognition|cognition
4973454|NCT01754155|Vitamin E|vitamin e
4973455|NCT01754155|Zimmer|zimmer
4973456|NCT01754155|RSA|rsa
4973457|NCT01754155|Radiostereometric Analysis|radiostereometric analysis
4973458|NCT01754129|Caregiver|caregiver
4973459|NCT01754129|Quality of Life|quality of life
4973460|NCT01754129|Parkinson's Disease|parkinson's disease
4973461|NCT01754116|healthy subjects|healthy subjects
4973462|NCT01754116|GSK1265744 LAP|gsk1265744 lap
4973463|NCT01754116|integrase inhibitor|integrase inhibitor
4973464|NCT01754116|HIV-1 infection|hiv-1 infection
4973465|NCT01754116|long acting retroviral|long acting retroviral
4973466|NCT01754116|relative bioavailability|relative bioavailability
4973467|NCT01754103|blind|blind
4973468|NCT01754103|tactile stimulation|tactile stimulation
4973469|NCT01754103|cross-modality|cross-modality
4973470|NCT01754103|visual qualia|visual qualia
4973471|NCT01754103|resting state MRI|resting state mri
4973472|NCT01754103|functional connectivity|functional connectivity
4973473|NCT01754103|neuroplasticity|neuroplasticity
4973474|NCT01754090|alcohol|alcohol
4973475|NCT01754090|online intervention|online intervention
4973476|NCT01754090|hazardous drinking|hazardous drinking
4973477|NCT01754090|harmful drinking|harmful drinking
4973478|NCT01754090|early intervention|early intervention
4973479|NCT01754090|behavior change intervention|behavior change intervention
4973480|NCT01754077|Language|language
4973481|NCT01754077|Behavior change|behavior change
4973482|NCT01754077|Intervention|intervention
4973483|NCT01754077|Home visiting|home visiting
4973484|NCT01754077|Child language development|child language development
4973485|NCT01754064|Bradycardia|bradycardia
4973486|NCT01754064|Tachycardia|tachycardia
4973487|NCT01754064|Arrhythimas|arrhythimas
4973488|NCT01754064|ICD|icd
4973489|NCT01754064|pacemaker|pacemaker
4973490|NCT01754064|pacing lead|pacing lead
4973491|NCT01754038|Patient Reported Outcomes|patient reported outcomes
4973492|NCT01754038|PRO|pro
4973493|NCT01754038|Registry|registry
4973494|NCT01754025|Gene Mutation|gene mutation
4973495|NCT01754012|Nutrition|nutrition
4973496|NCT01754012|Dietary intervention|dietary intervention
4973497|NCT01754012|Aging|aging
4973499|NCT01754012|Elderly|elderly
4973500|NCT01754012|Europe|europe
4973501|NCT01753999|World Trade Center (WTC)|world trade center (wtc)
4973502|NCT01753999|nasal symptoms|nasal symptoms
4973503|NCT01753999|nasal inflammation|nasal inflammation
4973504|NCT01753999|CPAP|cpap
4973505|NCT01753973|Metabolic syndrome|metabolic syndrome
4973506|NCT01753973|Renal transplantation|renal transplantation
4973507|NCT01753895|Healthy Volunteers|healthy volunteers
4973508|NCT01753882|Gait training|gait training
4973510|NCT01753882|Tizanidine|tizanidine
4973511|NCT01753843|Preterm Birth|preterm birth
4973512|NCT01753830|Double-blind|double-blind
4973513|NCT01753830|Randomized|randomized
4973514|NCT01753830|Intraarticular injection|intraarticular injection
4973515|NCT01753830|Hyaluronic acid|hyaluronic acid
4973516|NCT01753830|Placebo|placebo
4973517|NCT01753830|Knee osteoarthritis|knee osteoarthritis
4973518|NCT01753817|Coronary catheterization|coronary catheterization
4973519|NCT01753817|Transradial patency|transradial patency
4973520|NCT01753804|DMD|dmd
4973521|NCT01753804|Myopathy|myopathy
4973522|NCT01753804|Natural History|natural history
4973523|NCT01753804|Muscular dystrophy|muscular dystrophy
4973524|NCT01753804|Biomarkers|biomarkers
4973525|NCT01753804|Muscle testing|muscle testing
4973526|NCT01753778|Nerve Entrapment, Morton's neuroma, entrapment neuropathy|nerve entrapment, morton's neuroma, entrapment neuropathy
4973527|NCT01753765|occipital neuralgia|occipital neuralgia
4973528|NCT01753726|stretching, diaphragm, spinal movement, thoracic movement|stretching, diaphragm, spinal movement, thoracic movement
4973529|NCT01753700|crossover|crossover
4973530|NCT01753700|UHT milk|uht milk
4973531|NCT01753700|Pasteurised milk|pasteurised milk
4973532|NCT01753700|supplement|supplement
4973533|NCT01753687|break up time|break up time
4973534|NCT01753687|tear film thickness|tear film thickness
4973535|NCT01753687|tear film osmolarity|tear film osmolarity
4973536|NCT01753687|objective scattering index|objective scattering index
4973537|NCT01753687|impression cytology|impression cytology
4973538|NCT01753687|tear cytokines/chemokines|tear cytokines/chemokines
4973539|NCT01753687|visual acuity|visual acuity
4973540|NCT01753687|fluorescein staining|fluorescein staining
4973541|NCT01753674|metabolic syndrome, insulin resistance, HDL cholesterol,|metabolic syndrome, insulin resistance, hdl cholesterol,
4973542|NCT01753661|Hearing loss|hearing loss
4973543|NCT01753661|Language|language
4973544|NCT01753661|Behavior change|behavior change
4973545|NCT01753661|Early Intervention|early intervention
4973546|NCT01753661|Home visiting|home visiting
4973547|NCT01753648|retinal blood flow|retinal blood flow
4973548|NCT01753648|retinal blood velocity|retinal blood velocity
4973549|NCT01753648|retinal oxygen saturation|retinal oxygen saturation
4973550|NCT01753648|retinal vessel diameter|retinal vessel diameter
4973551|NCT01753648|ocular perfusion pressure|ocular perfusion pressure
4973552|NCT01753635|Baska mask|baska mask
4973553|NCT01753635|LMA|lma
4973554|NCT01753635|single use LMA device|single use lma device
4973555|NCT01753635|laryngeal mask airway|laryngeal mask airway
4973556|NCT01753635|supraglottic airway device|supraglottic airway device
4973557|NCT01753622|Overweight, obese, pregnant, depression, outcomes|overweight, obese, pregnant, depression, outcomes
4973558|NCT01753609|Over weight|over weight
4973559|NCT01753609|Obesity|obesity
4973560|NCT01753596|topical lubricants|topical lubricants
4973561|NCT01753596|tear film thickness|tear film thickness
4973562|NCT01753596|break up time|break up time
4973563|NCT01753596|ocular surface disease index|ocular surface disease index
4973564|NCT01753596|Schirmer I test|schirmer i test
4973565|NCT01753583|optical coherence tomography|optical coherence tomography
4973566|NCT01753583|corneal abrasion|corneal abrasion
4973567|NCT01753583|corneal infiltrate|corneal infiltrate
4973568|NCT01753570|Feron|feron
4973569|NCT01753557|Pegasys|pegasys
4973570|NCT01753531|Ultra Influenza A and B|ultra influenza a and b
4973571|NCT01753531|Influenza Type A|influenza type a
4973572|NCT01753531|Influenza Type B|influenza type b
4973573|NCT01753531|Flu|flu
4973574|NCT01753531|Sekisui Diagnostics|sekisui diagnostics
4973575|NCT01753518|Subcuticular suture|subcuticular suture
4973576|NCT01753518|Subcuticular staple|subcuticular staple
4973577|NCT01753518|Skin closure|skin closure
4973578|NCT01753518|Incision closure|incision closure
4973579|NCT01753518|Wound|wound
4973580|NCT01753505|multidetector coronary CT angiography, renal transplantation|multidetector coronary ct angiography, renal transplantation
4973581|NCT01753492|Intraocular pressure|intraocular pressure
4973582|NCT01753492|glaucoma|glaucoma
4973583|NCT01753492|trabeculectomy|trabeculectomy
4973584|NCT01753492|Ologen|ologen
4973585|NCT01753479|Pancreatic adenocarcinoma|pancreatic adenocarcinoma
4973586|NCT01753453|Hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
4973587|NCT01753453|Tumour cell mobilization|tumour cell mobilization
4973588|NCT01753440|coronary artery disease|coronary artery disease
4973589|NCT01753440|heart failure|heart failure
4973590|NCT01753440|stem cells implantation|stem cells implantation
4973591|NCT01753427|COPD,|copd,
4973592|NCT01753427|symptoms,|symptoms,
4973593|NCT01753427|Non-Interventional study,|non-interventional study,
4973594|NCT01753414|Lung Cancer|lung cancer
4973595|NCT01753401|SLE|sle
4973596|NCT01753401|Lupus|lupus
4973597|NCT01753375|Multiple Sclerosis|multiple sclerosis
4973598|NCT01753375|Relapsing rate|relapsing rate
4973599|NCT01753375|Expanded disability status scale|expanded disability status scale
4973600|NCT01753375|Vitamin D3|vitamin d3
4973601|NCT01753323|acute malaria, KAF156|acute malaria, kaf156
4973602|NCT01753245|Anti-TNF drugs efficacy|anti-tnf drugs efficacy
4973603|NCT01753245|Moderate-to-severe psoriasis vulgaris|moderate-to-severe psoriasis vulgaris
4973604|NCT01753245|Gene polymorphism|gene polymorphism
4973605|NCT01753232|DALI adsorber|dali adsorber
4973606|NCT01753232|MONET lipoprotein filter|monet lipoprotein filter
4973607|NCT01753193|Systemic Lupus Erythematosus|systemic lupus erythematosus
4973608|NCT01753180|CTO|cto
4973609|NCT01753180|PCI|pci
4973610|NCT01753180|Angioplasty|angioplasty
4973611|NCT01753154|Peritoneal Dialysis|peritoneal dialysis
4973612|NCT01753154|Biocompatible dialysis solution|biocompatible dialysis solution
4973613|NCT01753154|Hydration status|hydration status
4973614|NCT01753154|Residual renal function|residual renal function
4973615|NCT01753154|Body composition monitor|body composition monitor
4973616|NCT01753154|Bioimpedance spectroscopy|bioimpedance spectroscopy
4973617|NCT01753154|Cancer antigen 125|cancer antigen 125
4973618|NCT01753141|Cognitive Behavioral Therapy|cognitive behavioral therapy
4973619|NCT01753141|Smoking Cessation|smoking cessation
4973620|NCT01753115|post-exposure prophylaxis|post-exposure prophylaxis
4973621|NCT01753115|toxin neutralization assay|toxin neutralization assay
4973622|NCT01753102|Estradiol|estradiol
4973623|NCT01753102|Vulvar atrophy|vulvar atrophy
4973624|NCT01753102|vaginal atrophy|vaginal atrophy
4973625|NCT01753089|Metastatic|metastatic
4973626|NCT01753076|Amyotrophic lateral sclerosis|amyotrophic lateral sclerosis
4973627|NCT01753076|efficacy|efficacy
4973628|NCT01753076|ozanezumab|ozanezumab
4973629|NCT01753076|safety|safety
4973630|NCT01753063|Obesity|obesity
4973631|NCT01753063|Children|children
4973632|NCT01753063|Adolescents|adolescents
4973633|NCT01753063|Attrition|attrition
4973634|NCT01753037|Hyperandrogenism|hyperandrogenism
4973635|NCT01753037|Inflammation|inflammation
4973636|NCT01753037|Insulin sensitivity|insulin sensitivity
4973637|NCT01753037|Body composition|body composition
4973638|NCT01753024|exocrine pancreatic insufficiency|exocrine pancreatic insufficiency
4973639|NCT01753024|fecal elastase-1|fecal elastase-1
4973640|NCT01753024|amylase|amylase
4973641|NCT01753024|lipase|lipase
4973642|NCT01753024|critical illness|critical illness
4973643|NCT01753024|enteral nutrition|enteral nutrition
4973644|NCT01753024|malnutrition|malnutrition
4973645|NCT01753024|sepsis|sepsis
4973646|NCT01753024|diabetes|diabetes
4973647|NCT01753024|hyperlactacidemia|hyperlactacidemia
4973648|NCT01753024|hemodialysis|hemodialysis
4973649|NCT01753024|mechanical ventilation|mechanical ventilation
4973650|NCT01753011|Stress urinary Incontinence|stress urinary incontinence
4973651|NCT01753011|Transobturator sling|transobturator sling
4973653|NCT01752998|pain|pain
4973654|NCT01752998|depression|depression
4973655|NCT01752998|substance use|substance use
4973656|NCT01752972|Arsenic|arsenic
4973657|NCT01752972|Keratosis|keratosis
4973658|NCT01752972|Linoleic acid|linoleic acid
4973659|NCT01752972|Palm|palm
4973660|NCT01752972|Spirulina|spirulina
4973661|NCT01752972|Vitamin E|vitamin e
4973662|NCT01752972|Zinc|zinc
4973663|NCT01752920|FGFR|fgfr
4973664|NCT01752920|ARQ 087|arq 087
4973665|NCT01752920|Targeted therapy|targeted therapy
4973666|NCT01752920|Molecular therapy|molecular therapy
4973667|NCT01752920|Tyrosine kinase inhibitor|tyrosine kinase inhibitor
4973668|NCT01752920|TKI|tki
4973669|NCT01752920|Receptor tyrosine kinase|receptor tyrosine kinase
4973670|NCT01752920|RTK|rtk
4973671|NCT01752920|Biomarker|biomarker
4973672|NCT01752920|Phase 1|phase 1
4973673|NCT01752920|Phase I|phase i
4973674|NCT01752920|Solid tumor|solid tumor
4973675|NCT01752920|Liver Cancer|liver cancer
4973676|NCT01752920|Hepatobiliary carcinoma|hepatobiliary carcinoma
4973677|NCT01752920|Biliary tract cancer|biliary tract cancer
4973678|NCT01752920|Cholangiocarcinoma|cholangiocarcinoma
4973679|NCT01752920|Intrahepatic cholangiocarcinoma|intrahepatic cholangiocarcinoma
4973680|NCT01752920|FGFR inhibitor|fgfr inhibitor
4973681|NCT01752920|Targeted FGFR kinase inhibitor|targeted fgfr kinase inhibitor
4973682|NCT01752920|Pan-FGFR inhibitor|pan-fgfr inhibitor
4973683|NCT01752920|Selective FGFR inhibitor|selective fgfr inhibitor
4973684|NCT01752920|FGFR pathway|fgfr pathway
4973685|NCT01752920|FGFR signaling|fgfr signaling
4973686|NCT01752920|Fibroblast growth factor|fibroblast growth factor
4973687|NCT01752920|FGFR1|fgfr1
4973688|NCT01752920|FGFR2|fgfr2
4973689|NCT01752920|FGFR3|fgfr3
4973690|NCT01752920|FGFR4|fgfr4
4973691|NCT01752920|FGF|fgf
4973692|NCT01752920|FGF19|fgf19
4973693|NCT01752920|FGF21|fgf21
4973694|NCT01752920|FGF23|fgf23
4973695|NCT01752920|FGFR mutation|fgfr mutation
4973696|NCT01752920|FGFR gene fusion|fgfr gene fusion
4973697|NCT01752920|FGFR gene translocation|fgfr gene translocation
4973698|NCT01752920|FGFR genetic aberration|fgfr genetic aberration
4973699|NCT01752920|FGFR2 fusion|fgfr2 fusion
4973700|NCT01752920|FGFR2 translocation|fgfr2 translocation
4973701|NCT01752920|Phase 1 Clinical Trial|phase 1 clinical trial
4973702|NCT01752920|Phase I Clinical Trial|phase i clinical trial
4973703|NCT01752920|Clinical oncology|clinical oncology
4973704|NCT01752920|Tumor|tumor
4973705|NCT01752920|Tumour|tumour
4973706|NCT01752907|Breast cancer|breast cancer
4973707|NCT01752907|Chemotherapy|chemotherapy
4973708|NCT01752907|Pegfilgrastim|pegfilgrastim
4973709|NCT01752907|Neulasta|neulasta
4973710|NCT01752907|Bone Pain|bone pain
4973711|NCT01752907|Education|education
4973712|NCT01752881|Influenza|influenza
4973713|NCT01752881|Vaccine|vaccine
4973714|NCT01752881|Immunogenicity|immunogenicity
4973715|NCT01752855|Rheumatoid Arthritis|rheumatoid arthritis
4973716|NCT01752842|Diabetes|diabetes
4973717|NCT01752842|Diabetic Cardiomyopathy|diabetic cardiomyopathy
4973718|NCT01752842|Triglycerides|triglycerides
4973719|NCT01752829|Obesity|obesity
4973720|NCT01752829|gastric|gastric
4973721|NCT01752829|banding|banding
4973722|NCT01752829|Weight|weight
4973723|NCT01752829|co-morbidities|co-morbidities
4973724|NCT01752829|dilatation|dilatation
4973725|NCT01752829|Excess weight loss|excess weight loss
4973726|NCT01752829|adjustable gastric banding|adjustable gastric banding
4973727|NCT01752816|endurance training,|endurance training,
4973728|NCT01752816|strength training,|strength training,
4973729|NCT01752816|aerobic capacity,|aerobic capacity,
4973730|NCT01752816|muscle strenght|muscle strenght
4973731|NCT01752816|physical capacity|physical capacity
4973732|NCT01752790|Pediatric Crohn's disease|pediatric crohn's disease
4973733|NCT01752790|Biologics|biologics
4973734|NCT01752790|Immunomodulators|immunomodulators
4973735|NCT01752790|Top-down|top-down
4973736|NCT01752790|step-up|step-up
4973737|NCT01752777|HIV/AIDS, HIV infectiousness, Medication adherence, Sexual risks reduction|hiv/aids, hiv infectiousness, medication adherence, sexual risks reduction
4973738|NCT01752751|Neck cancer|neck cancer
4973739|NCT01752751|Head cancer|head cancer
4973740|NCT01752751|Lung cancer|lung cancer
4973741|NCT01752725|supracervical hysterectomy|supracervical hysterectomy
4973742|NCT01752725|vessel sealing|vessel sealing
4973743|NCT01752725|bipolar electrocoagulation|bipolar electrocoagulation
4973744|NCT01752712|Oxytocin|oxytocin
4973745|NCT01752712|Social function|social function
4973746|NCT01752712|CBSST|cbsst
4973747|NCT01752699|neuropathic pain,|neuropathic pain,
4973748|NCT01752699|post-herpetic neuralgia,|post-herpetic neuralgia,
4973749|NCT01752699|methadone,|methadone,
4973750|NCT01752686|Triple negative breast cancer|triple negative breast cancer
4973751|NCT01752686|adjuvant chemotherapy|adjuvant chemotherapy
4973752|NCT01752673|randomized controlled study|randomized controlled study
4973753|NCT01752660|Exercise therapy|exercise therapy
4973754|NCT01752660|Aerobic training|aerobic training
4973755|NCT01752660|Endurance training|endurance training
4973756|NCT01752647|lung cancer|lung cancer
4973757|NCT01752647|screening|screening
4973758|NCT01752647|low dose|low dose
4973759|NCT01752647|computed tomography|computed tomography
4973760|NCT01752634|Psoriatic arthritis, PsA, ACR, CASPAR, PASDAS|psoriatic arthritis, psa, acr, caspar, pasdas
4973761|NCT01752621|Acromegaly|acromegaly
4973762|NCT01752621|mortality|mortality
4973763|NCT01752621|morbidity|morbidity
4973764|NCT01752621|incidence|incidence
4973765|NCT01752621|prevalence|prevalence
4973766|NCT01752608|Depression|depression
4973767|NCT01752608|Real-time|real-time
4973768|NCT01752608|iPhone|iphone
4973769|NCT01752608|CBT|cbt
4973770|NCT01752608|Cognitive behavioral therapy|cognitive behavioral therapy
4973771|NCT01752582|BuMA|buma
4973772|NCT01752582|EXCEL|excel
4973773|NCT01752582|OCT|oct
4973774|NCT01752582|stent|stent
4973775|NCT01752582|neointima formation|neointima formation
4973776|NCT01752569|HIV|hiv
4973777|NCT01752569|Kaposi's sarcoma|kaposi's sarcoma
4973778|NCT01752569|Anti-retroviral therapy|anti-retroviral therapy
4973779|NCT01752569|HAART|haart
4973780|NCT01752569|AIDS|aids
4973781|NCT01752556|Sleep apnea, Portable monitor,autoCPAP|sleep apnea, portable monitor,autocpap
4973782|NCT01752543|Vasopressin|vasopressin
4973783|NCT01752543|Exercise capacity|exercise capacity
4973784|NCT01752543|Conivaptan|conivaptan
4973785|NCT01752530|ADHD|adhd
4973786|NCT01752517|small cell lung cancer|small cell lung cancer
4973787|NCT01752517|chemotherapy|chemotherapy
4973788|NCT01752517|vinorelbine|vinorelbine
4973789|NCT01752517|ifosfamide|ifosfamide
4973790|NCT01752517|third-line treatment|third-line treatment
4973791|NCT01752504|HIV prevention|hiv prevention
4973792|NCT01752504|HIV positive communities|hiv positive communities
4973793|NCT01752491|Ascorbate|ascorbate
4973794|NCT01752491|Ascorbic acid|ascorbic acid
4973795|NCT01752491|Vitamin C|vitamin c
4973796|NCT01752491|Radiation|radiation
4973797|NCT01752491|Temozolomide|temozolomide
4973798|NCT01752478|ptosis|ptosis
4973799|NCT01752478|retina surgery|retina surgery
4973800|NCT01752478|droopy eye lid|droopy eye lid
4973801|NCT01752465|Health behaviour|health behaviour
4973802|NCT01752465|Antipsychotic agents|antipsychotic agents
4973803|NCT01752465|Adverse effects|adverse effects
4973804|NCT01752465|Goals|goals
4973805|NCT01752465|Life style|life style
4973806|NCT01752439|Chronic Migraine|chronic migraine
4973807|NCT01752439|Medication Overuse Headache|medication overuse headache
4973808|NCT01752439|Refractory|refractory
4973809|NCT01752439|transcranial direct current stimulation|transcranial direct current stimulation
4973810|NCT01752426|Leukemia|leukemia
4973811|NCT01752426|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
4973812|NCT01752426|CLL|cll
4973813|NCT01752426|Small Lymphocytic Lymphoma|small lymphocytic lymphoma
4973814|NCT01752426|SLL|sll
4973815|NCT01752426|PCI-32765|pci-32765
4973816|NCT01752426|Ibrutinib|ibrutinib
4973817|NCT01752426|Btk inhibitor|btk inhibitor
4973818|NCT01752426|Heavy water|heavy water
4973819|NCT01752426|2H2O|2h2o
4973820|NCT01752413|Iron depletion|iron depletion
4973821|NCT01752413|blood donors|blood donors
4973822|NCT01752413|iron replacement|iron replacement
4973823|NCT01752400|Advanced|advanced
4973824|NCT01752361|Gastrointestinal Motility|gastrointestinal motility
4973825|NCT01752361|Inflammatory Bowel Disease|inflammatory bowel disease
4973826|NCT01752361|Transit time|transit time
4973827|NCT01752348|sepsis|sepsis
4973828|NCT01752348|cytokine release|cytokine release
4973829|NCT01752348|fever|fever
4973830|NCT01752335|Rheumatoid Arthritis, tocilizumab, cardiovascular risk factors|rheumatoid arthritis, tocilizumab, cardiovascular risk factors
4973831|NCT01752309|Early Rheumatoid arthritis|early rheumatoid arthritis
4973832|NCT01752309|Rheumatoid arthritis|rheumatoid arthritis
4973833|NCT01752309|Ultrasound|ultrasound
4973834|NCT01752309|Predictive|predictive
4973835|NCT01752309|Prognosis|prognosis
4973836|NCT01752296|Morquio|morquio
4973837|NCT01752296|Mucopolysaccharidosis IV|mucopolysaccharidosis iv
4973838|NCT01752296|Psychological health|psychological health
4973839|NCT01752283|Videoassited|videoassited
4973840|NCT01752283|Thyroidectomy|thyroidectomy
4973841|NCT01752283|Minimal invasive surgery|minimal invasive surgery
4973842|NCT01752283|General anesthesia|general anesthesia
4973843|NCT01752283|Hypnosis|hypnosis
4973844|NCT01752257|Melanoma|melanoma
4973845|NCT01752244|Obesity, vitamin D analogue, VDR, PPARg, PGC1a|obesity, vitamin d analogue, vdr, pparg, pgc1a
4973846|NCT01752218|Femto-second Laser|femto-second laser
4973847|NCT01752218|arcuate incision|arcuate incision
4973848|NCT01752218|corneal astigmatism|corneal astigmatism
4973849|NCT01752218|astigmatic keratotomy|astigmatic keratotomy
4973850|NCT01752218|Cataract|cataract
4973851|NCT01752205|Esophageal Squamous Carcinoma|esophageal squamous carcinoma
4973852|NCT01752205|Erlotinib|erlotinib
4973853|NCT01752205|Chemoradiotherapy|chemoradiotherapy
4973854|NCT01752192|Rehabilitation|rehabilitation
4973855|NCT01752192|Telemedicine|telemedicine
4973856|NCT01752192|Heart patients|heart patients
4973857|NCT01752192|Social media|social media
4973858|NCT01752192|Organisational aspects|organisational aspects
4973859|NCT01752179|Kinesio taping|kinesio taping
4973860|NCT01752179|Piriformis syndrome|piriformis syndrome
4973861|NCT01752179|Trigger point|trigger point
4973862|NCT01752166|Candida|candida
4973863|NCT01752166|Candidemia|candidemia
4973864|NCT01752166|Blood culture|blood culture
4973865|NCT01752166|Diagnostics|diagnostics
4973866|NCT01752153|Focus|focus
4973867|NCT01752153|immunomodulatory effect|immunomodulatory effect
4973868|NCT01752153|of silymarin|of silymarin
4973869|NCT01752153|on cell mediated immunity|on cell mediated immunity
4973870|NCT01752153|Beta-Thalassemia|beta-thalassemia
4973871|NCT01752153|major patients.|major patients.
4973872|NCT01752140|Prostate cancer|prostate cancer
4973873|NCT01752140|Prostate biopsy|prostate biopsy
4973874|NCT01752140|Vienna nomogram|vienna nomogram
4973875|NCT01752127|Drug-eluting stent|drug-eluting stent
4973876|NCT01752127|diabetes|diabetes
4973877|NCT01752127|small vessel disease|small vessel disease
4973878|NCT01752114|Precancerous conditions|precancerous conditions
4973879|NCT01752114|Carcinoma|carcinoma
4973880|NCT01752101|Precancerous Conditions|precancerous conditions
4973881|NCT01752101|Carcinoma|carcinoma
4973882|NCT01752088|apularis, MRI clinical, results|apularis, mri clinical, results
4973883|NCT01752075|Multiple myeloma|multiple myeloma
4973884|NCT01752062|Chronic Myeloid Leukemia|chronic myeloid leukemia
4973885|NCT01752062|CML|cml
4973886|NCT01752062|Pregnancy|pregnancy
4973887|NCT01752049|Hereditary Hemorrhagic Telangiectasia|hereditary hemorrhagic telangiectasia
4973888|NCT01752049|Anti-angiogenic Therapy|anti-angiogenic therapy
4973889|NCT01752049|vascular malformations|vascular malformations
4973890|NCT01752049|HHT|hht
4973891|NCT01752036|stereotactic radiotherapy|stereotactic radiotherapy
4973892|NCT01752036|SRS|srs
4973893|NCT01751984|lipid-lowering drugs|lipid-lowering drugs
4973894|NCT01751984|statin intolerance|statin intolerance
4973895|NCT01751945|EmONC|emonc
4973896|NCT01751945|Neonatal mortality|neonatal mortality
4973897|NCT01751945|Perinatal mortality|perinatal mortality
4973898|NCT01751919|CML|cml
4973899|NCT01751919|GIST|gist
4973900|NCT01751906|Absorb™ BVS|absorb™ bvs
4973901|NCT01751906|Angioplasty|angioplasty
4973902|NCT01751906|Bioabsorbable|bioabsorbable
4973903|NCT01751906|BVS|bvs
4973904|NCT01751906|Bioresorbable|bioresorbable
4973905|NCT01751906|Coronary Artery Disease|coronary artery disease
4973906|NCT01751906|Coronary Artery Endothelial Responsiveness|coronary artery endothelial responsiveness
4973907|NCT01751906|Coronary artery restenosis|coronary artery restenosis
4973908|NCT01751906|Coronary artery stenosis|coronary artery stenosis
4973909|NCT01751906|Coronary scaffold|coronary scaffold
4973910|NCT01751906|Coronary Stent|coronary stent
4973911|NCT01751906|Drug eluting stents|drug eluting stents
4973912|NCT01751906|Everolimus|everolimus
4973913|NCT01751906|Myocardial ischemia|myocardial ischemia
4973914|NCT01751906|Stent thrombosis|stent thrombosis
4973915|NCT01751906|Stents|stents
4973916|NCT01751893|Hand-foot syndrome|hand-foot syndrome
4973917|NCT01751893|palmar-plantar erythrodysesthesia|palmar-plantar erythrodysesthesia
4973918|NCT01751893|capecitabine|capecitabine
4973919|NCT01751893|pegylated liposomal doxorubicin|pegylated liposomal doxorubicin
4973920|NCT01751893|henna|henna
4973921|NCT01751880|Gastric cancer, minimally invasive gastrectomy, Physical activity intervention|gastric cancer, minimally invasive gastrectomy, physical activity intervention
4973922|NCT01751867|Myelodysplastic Syndrome|myelodysplastic syndrome
4973923|NCT01751867|Dacogen|dacogen
4973924|NCT01751867|Oncology|oncology
4973925|NCT01751867|Decitabine|decitabine
4973926|NCT01751867|Bone marrow disorders|bone marrow disorders
4973927|NCT01751854|pharmacology|pharmacology
4973928|NCT01751854|rehabilitation|rehabilitation
4973929|NCT01751854|locomotion|locomotion
4973930|NCT01751828|Depression|depression
4973931|NCT01751828|Major Depressive Disorder|major depressive disorder
4973932|NCT01751802|Lesch Nyhan Disease|lesch nyhan disease
4973933|NCT01751802|Self-Injury|self-injury
4973934|NCT01751789|illicit opioid drug use|illicit opioid drug use
4973935|NCT01751789|health service utilization|health service utilization
4973936|NCT01751737|prostate|prostate
4973937|NCT01751737|cancer|cancer
4973938|NCT01751737|biopsy|biopsy
4973939|NCT01751737|18F-choline|18f-choline
4973940|NCT01751737|PET|pet
4973941|NCT01751737|MRI|mri
4973942|NCT01751724|Premature infants|premature infants
4973943|NCT01751724|Caffeine|caffeine
4973944|NCT01751724|Methylxanthines|methylxanthines
4973945|NCT01751724|Mechanical ventilation|mechanical ventilation
4973946|NCT01751724|Oxygen|oxygen
4973947|NCT01751724|Weaning|weaning
4973948|NCT01751724|Bronchopulmonary dysplasia|bronchopulmonary dysplasia
4973949|NCT01751698|Autism|autism
4973950|NCT01751698|Minimally Verbal|minimally verbal
4973951|NCT01751698|School Age|school age
4973952|NCT01751685|kyphosis|kyphosis
4973953|NCT01751672|SBIRT|sbirt
4973954|NCT01751672|Substance Use|substance use
4973955|NCT01751672|Screening|screening
4973956|NCT01751672|Brief Intervention|brief intervention
4973957|NCT01751672|Primary Care|primary care
4973958|NCT01751633|Burst fractures|burst fractures
4973959|NCT01751633|Thoracic or Lumbar Vertebrae/injuries [MeSH]|thoracic or lumbar vertebrae/injuries [mesh]
4973960|NCT01751633|Thoracic or Lumbar Vertebrae/surgery [MeSH]|thoracic or lumbar vertebrae/surgery [mesh]
4973961|NCT01751633|Spinal Fusion/methods [MeSH]|spinal fusion/methods [mesh]
4973962|NCT01751633|Thoracolumbar fracture management|thoracolumbar fracture management
4973963|NCT01751633|Quality of life|quality of life
4973964|NCT01751633|Functional outcome|functional outcome
4973965|NCT01751607|AF, catheter ablation, non-PV triggers, SNP|af, catheter ablation, non-pv triggers, snp
4973966|NCT01751581|Obesity|obesity
4973967|NCT01751581|Resting Metabolic Rate|resting metabolic rate
4973968|NCT01751581|Sleep|sleep
4973969|NCT01751581|Eating|eating
4973970|NCT01751555|HBV co-infection ART TDF|hbv co-infection art tdf
4973971|NCT01751529|renal malignancy|renal malignancy
4973972|NCT01751529|Pilot Study|pilot study
4973973|NCT01751529|LCCC 1219|lccc 1219
4973974|NCT01751529|UNC Lineberger|unc lineberger
4973975|NCT01751529|kidney cancer|kidney cancer
4973976|NCT01751529|contrast-enhanced ultrasound|contrast-enhanced ultrasound
4973977|NCT01751529|ultrasound|ultrasound
4973978|NCT01751503|Foot drop deformity|foot drop deformity
4973979|NCT01751503|gold standard treatment|gold standard treatment
4973980|NCT01751503|Tibialis posterior tendon transfer|tibialis posterior tendon transfer
4973981|NCT01751503|Interosseous route|interosseous route
4973982|NCT01751503|Extramembranous or circumtibial route|extramembranous or circumtibial route
4973983|NCT01751490|shoulder|shoulder
4973984|NCT01751490|instability|instability
4973985|NCT01751490|atraumatic|atraumatic
4973986|NCT01751477|Very Low Birth Weight Infants|very low birth weight infants
4973987|NCT01751477|Probiotics|probiotics
4973988|NCT01751477|Necrotizing Enterocolitis|necrotizing enterocolitis
4973989|NCT01751464|youth|youth
4973990|NCT01751464|violence|violence
4973991|NCT01751464|injury|injury
4973992|NCT01751464|emergency department|emergency department
4973993|NCT01751464|intervention|intervention
4973994|NCT01751451|ABIRATERONE ACETATE (CB 7630)|abiraterone acetate (cb 7630)
4973995|NCT01751451|DEGARELIX|degarelix
4973996|NCT01751451|PREDNISONE|prednisone
4973997|NCT01751451|12-187|12-187
4973998|NCT01751438|Prostate cancer|prostate cancer
4973999|NCT01751438|Prostate carcinoma|prostate carcinoma
4974000|NCT01751438|Metastatic|metastatic
4974001|NCT01751438|M1|m1
4974002|NCT01751438|Best Systemic Therapy|best systemic therapy
4974003|NCT01751438|BST|bst
4974130|NCT01750801|clinical trial|clinical trial
4974004|NCT01751438|Androgen deprivation therapy|androgen deprivation therapy
4974005|NCT01751438|Bilateral orchiectomy|bilateral orchiectomy
4974006|NCT01751438|Radiation|radiation
4974007|NCT01751438|Radiation Therapy|radiation therapy
4974008|NCT01751438|External beam radiation therapy|external beam radiation therapy
4974009|NCT01751438|External-beam radiotherapy|external-beam radiotherapy
4974010|NCT01751438|Xray therapy|xray therapy
4974011|NCT01751438|XRT|xrt
4974012|NCT01751438|Surgery|surgery
4974013|NCT01751425|Leukemia|leukemia
4974014|NCT01751425|Chronic Myeloid Leukemia|chronic myeloid leukemia
4974015|NCT01751425|CML|cml
4974016|NCT01751425|Minimal Residual Disease|minimal residual disease
4974017|NCT01751425|Philadelphia chromosome|philadelphia chromosome
4974018|NCT01751425|(Ph)-positive|(ph)-positive
4974019|NCT01751425|BCR/ABL-positive|bcr/abl-positive
4974020|NCT01751425|Ruxolitinib|ruxolitinib
4974021|NCT01751425|Jakafi|jakafi
4974022|NCT01751425|INCB018424|incb018424
4974023|NCT01751425|INC424|inc424
4974024|NCT01751425|TKI|tki
4974025|NCT01751425|Tyrosine kinase inhibitor|tyrosine kinase inhibitor
4974026|NCT01751412|Hodgkin|hodgkin
4974027|NCT01751412|Non-Hodgkin Lymphoma|non-hodgkin lymphoma
4974028|NCT01751412|Mediastinal|mediastinal
4974029|NCT01751412|Adult Lymphoma|adult lymphoma
4974030|NCT01751412|Pediatric Lymphoma|pediatric lymphoma
4974031|NCT01751386|Addiction|addiction
4974032|NCT01751386|Cue-Induced Craving|cue-induced craving
4974033|NCT01751386|Craving|craving
4974034|NCT01751386|Anxiety|anxiety
4974035|NCT01751386|Alcohol Consumption|alcohol consumption
4974036|NCT01751373|Botulinum Toxin|botulinum toxin
4974037|NCT01751373|Rehabilitation|rehabilitation
4974038|NCT01751373|Electromyography|electromyography
4974039|NCT01751373|Electroencephalography|electroencephalography
4974040|NCT01751373|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
4974041|NCT01751347|Local anesthetics|local anesthetics
4974042|NCT01751347|Elective hand surgeries|elective hand surgeries
4974043|NCT01751334|Arthroplasty|arthroplasty
4974044|NCT01751334|Replacement|replacement
4974045|NCT01751334|Knee|knee
4974046|NCT01751334|Rotational Alignment|rotational alignment
4974047|NCT01751282|Stem Cells|stem cells
4974048|NCT01751282|chronic wounds|chronic wounds
4974049|NCT01751282|fibrin|fibrin
4974050|NCT01751282|Bone marrow-derived mesenchymal stem cells|bone marrow-derived mesenchymal stem cells
4974051|NCT01751256|Postcesarean Section|postcesarean section
4974052|NCT01751256|Postoperative Pain|postoperative pain
4974053|NCT01751256|Care, Postoperative|care, postoperative
4974054|NCT01751256|Anesthesia, Local|anesthesia, local
4974055|NCT01751256|Breast Feeding|breast feeding
4974056|NCT01751256|Morphine|morphine
4974057|NCT01751256|Pain Measurement|pain measurement
4974058|NCT01751256|levobupivacaine|levobupivacaine
4974059|NCT01751230|pregnancy|pregnancy
4974060|NCT01751230|weight loss|weight loss
4974061|NCT01751217|Substance Abuse|substance abuse
4974062|NCT01751217|Adolescents|adolescents
4974063|NCT01751217|Families|families
4974064|NCT01751217|Functional Family Therapy|functional family therapy
4974065|NCT01751217|Video|video
4974066|NCT01751217|Teleconferencing|teleconferencing
4974067|NCT01751217|Telemedicine|telemedicine
4974068|NCT01751165|≥ 50 years of age|≥ 50 years of age
4974069|NCT01751165|Herpes zoster|herpes zoster
4974070|NCT01751165|Safety|safety
4974071|NCT01751165|Immunogenicity|immunogenicity
4974072|NCT01751165|Adults|adults
4974073|NCT01751139|Endemic regions|endemic regions
4974074|NCT01751139|Brazil|brazil
4974075|NCT01751139|Incidence|incidence
4974076|NCT01751139|Surveillance|surveillance
4974077|NCT01751139|Dengue|dengue
4974078|NCT01751126|vernal keratoconjunctivitis|vernal keratoconjunctivitis
4974079|NCT01751126|ciclosporin|ciclosporin
4974080|NCT01751126|cyclosporine|cyclosporine
4974081|NCT01751087|abortion, induced|abortion, induced
4974082|NCT01751074|Drug interaction, rosuvastatin, healthy volunteer, Lp-PLA2, atherosclerosis, darapladib, pharmacokinetics.|drug interaction, rosuvastatin, healthy volunteer, lp-pla2, atherosclerosis, darapladib, pharmacokinetics.
4974083|NCT01751061|prolonged mechanical ventilation|prolonged mechanical ventilation
4974084|NCT01751061|chronic critical illness|chronic critical illness
4974085|NCT01751061|decision making|decision making
4974086|NCT01751061|decision aid|decision aid
4974087|NCT01751061|decisional support|decisional support
4974088|NCT01751061|critical illness|critical illness
4974089|NCT01751061|intensive care unit|intensive care unit
4974090|NCT01751048|GLA-SE,LEISH-F3,leishmaniasis,MPL-SE,parent protocol,vaccine|gla-se,leish-f3,leishmaniasis,mpl-se,parent protocol,vaccine
4974091|NCT01751022|heart failure|heart failure
4974092|NCT01751022|cardiac pacing|cardiac pacing
4974093|NCT01751022|cardiac resynchronization therapy|cardiac resynchronization therapy
4974094|NCT01751022|left ventricular lead|left ventricular lead
4974095|NCT01751009|vitamin A, complementary foods, malnutrition, children|vitamin a, complementary foods, malnutrition, children
4974096|NCT01750983|Advanced Cancers|advanced cancers
4974097|NCT01750983|Advanced Malignancies|advanced malignancies
4974098|NCT01750983|Metastatic cancers|metastatic cancers
4974099|NCT01750983|Ipilimumab|ipilimumab
4974100|NCT01750983|Yervoy|yervoy
4974101|NCT01750983|BMS-734016|bms-734016
4974102|NCT01750983|MDX010|mdx010
4974103|NCT01750983|Lenalidomide|lenalidomide
4974104|NCT01750983|CC-5013|cc-5013
4974105|NCT01750983|Revlimid|revlimid
4974106|NCT01750944|Blood pressure site|blood pressure site
4974107|NCT01750944|Good health|good health
4974108|NCT01750944|Brachial blood pressure|brachial blood pressure
4974109|NCT01750944|Ankle|ankle
4974110|NCT01750944|Toe|toe
4974111|NCT01750944|Walking test|walking test
4974112|NCT01750944|Exercise|exercise
4974113|NCT01750931|BE study of Meloxicam GSK 15mg|be study of meloxicam gsk 15mg
4974114|NCT01750918|MEK inhibitor|mek inhibitor
4974115|NCT01750918|anti-EGFR antibody|anti-egfr antibody
4974116|NCT01750918|colorectal cancer|colorectal cancer
4974117|NCT01750918|BRAF inhibitor|braf inhibitor
4974118|NCT01750879|peanut|peanut
4974119|NCT01750879|allergy|allergy
4974120|NCT01750879|food|food
4974121|NCT01750879|immunotherapy|immunotherapy
4974122|NCT01750879|tolerance|tolerance
4974123|NCT01750879|desensitization|desensitization
4974124|NCT01750866|Prostrate Cancer|prostrate cancer
4974125|NCT01750866|Castrate-resistant metastatic prostate cancer|castrate-resistant metastatic prostate cancer
4974126|NCT01750866|Cabazitaxel|cabazitaxel
4974127|NCT01750827|platelet function|platelet function
4974128|NCT01750827|atherosclerosis,|atherosclerosis,
4974129|NCT01750827|SB-659032|sb-659032
4974131|NCT01750801|mouthwash|mouthwash
4974132|NCT01750801|propolis|propolis
4974133|NCT01750801|plaque|plaque
4974134|NCT01750801|gingivitis|gingivitis
4974135|NCT01750801|compliance|compliance
4974136|NCT01750788|Stroke|stroke
4974137|NCT01750788|Embolism|embolism
4974138|NCT01750788|Atrial Fibrillation|atrial fibrillation
4974139|NCT01750775|sinus bradycardia|sinus bradycardia
4974140|NCT01750775|ventricular premature contraction|ventricular premature contraction
4974141|NCT01750749|Venous ulcer|venous ulcer
4974142|NCT01750749|Cell therapy|cell therapy
4974143|NCT01750736|Augmented Exercise|augmented exercise
4974144|NCT01750736|Cervicalgia|cervicalgia
4974145|NCT01750736|Manual Therapy|manual therapy
4974146|NCT01750736|Manipulation|manipulation
4974147|NCT01750736|Quantitative Sensory|quantitative sensory
4974148|NCT01750723|Acetazolamide|acetazolamide
4974149|NCT01750723|Headache|headache
4974150|NCT01750723|Migraine|migraine
4974151|NCT01750710|Charcot-Marie-Tooth disease type 1A neuropathy|charcot-marie-tooth disease type 1a neuropathy
4974152|NCT01750710|Isokinetic|isokinetic
4974153|NCT01750710|Electromyography|electromyography
4974154|NCT01750710|Walking|walking
4974155|NCT01750684|Acute|acute
4974156|NCT01750684|Traumatic|traumatic
4974157|NCT01750684|SCI|sci
4974158|NCT01750684|Spinal Cord Injury|spinal cord injury
4974159|NCT01750671|ICU|icu
4974160|NCT01750671|Body composition|body composition
4974161|NCT01750671|Nutrition|nutrition
4974162|NCT01750671|Survival|survival
4974163|NCT01750671|Morbidity|morbidity
4974164|NCT01750658|Biomarkers|biomarkers
4974165|NCT01750658|Exacerbations|exacerbations
4974166|NCT01750658|COPD|copd
4974167|NCT01750593|radiofrequency|radiofrequency
4974168|NCT01750593|thyroid|thyroid
4974169|NCT01750593|nodule|nodule
4974170|NCT01750567|Relapsed Chronic Lymphocytic Leukemia|relapsed chronic lymphocytic leukemia
4974171|NCT01750567|untreated CLL patients|untreated cll patients
4974172|NCT01750567|genomic deletion 11q|genomic deletion 11q
4974173|NCT01750554|SpHb; hemoglobin monitoring;bupivacaine digital nerve block|sphb; hemoglobin monitoring;bupivacaine digital nerve block
4974174|NCT01750515|Acupuncture|acupuncture
4974175|NCT01750515|Hepatitis C (HCV)|hepatitis c (hcv)
4974176|NCT01750489|COPD|copd
4974177|NCT01750476|oral contraception|oral contraception
4974178|NCT01750476|Depo-Provera|depo-provera
4974179|NCT01750476|Mirena|mirena
4974180|NCT01750463|Pediatric critically ill|pediatric critically ill
4974181|NCT01750463|Masimo|masimo
4974182|NCT01750463|hemoglobin|hemoglobin
4974183|NCT01750463|monitoring|monitoring
4974184|NCT01750463|UNC|unc
4974185|NCT01750463|PICU|picu
4974186|NCT01750450|Pressure Volume Area|pressure volume area
4974187|NCT01750450|Pressure Flow Area|pressure flow area
4974188|NCT01750450|Myocardial Work|myocardial work
4974189|NCT01750437|NERD|nerd
4974190|NCT01750424|Scar|scar
4974191|NCT01750424|Fat Grafting|fat grafting
4974192|NCT01750424|Adipose Grafting|adipose grafting
4974193|NCT01750424|3-D imaging|3-d imaging
4974194|NCT01750424|Manchester Scar Scale|manchester scar scale
4974195|NCT01750411|Severe Asthma|severe asthma
4974196|NCT01750411|SARP|sarp
4974197|NCT01750398|Testosterone, Leuprolide, Goserelin|testosterone, leuprolide, goserelin
4974198|NCT01750385|Esophageal Achalasia|esophageal achalasia
4974199|NCT01750385|antibiotic prophylaxis|antibiotic prophylaxis
4974200|NCT01750385|blood culture|blood culture
4974201|NCT01750385|procalcitonin levels|procalcitonin levels
4974202|NCT01750372|Artificial limbs|artificial limbs
4974203|NCT01750372|Questionnaires|questionnaires
4974204|NCT01750372|Mobility limitation|mobility limitation
4974205|NCT01750359|antioxidants|antioxidants
4974206|NCT01750359|curcumin|curcumin
4974207|NCT01750359|depression|depression
4974208|NCT01750346|Blepharospasm|blepharospasm
4974209|NCT01750346|Treatment|treatment
4974210|NCT01750346|Dystonia|dystonia
4974211|NCT01750346|Acetyl-Hexapeptide|acetyl-hexapeptide
4974212|NCT01750320|Breast CT|breast ct
4974213|NCT01750320|Biopsy|biopsy
4974214|NCT01750307|Attention Deficit Hyperactivity Disorder (ADHD)|attention deficit hyperactivity disorder (adhd)
4974215|NCT01750307|Essential fatty acids (EFAs)|essential fatty acids (efas)
4974216|NCT01750307|Electroencephalography (EEG)|electroencephalography (eeg)
4974217|NCT01750307|Event-related potential (ERP)|event-related potential (erp)
4974218|NCT01750307|Omega 3|omega 3
4974219|NCT01750307|Randomised Control Trial|randomised control trial
4974220|NCT01750307|Fish oil|fish oil
4974221|NCT01750307|Supplementation|supplementation
4974222|NCT01750307|Reading|reading
4974223|NCT01750307|Spelling|spelling
4974224|NCT01750307|Behaviour|behaviour
4974225|NCT01750307|Emotional lability|emotional lability
4974226|NCT01750294|hypertension|hypertension
4974227|NCT01750294|kidney disease|kidney disease
4974228|NCT01750281|Mitogen-Activated Protein Kinase Kinase inhibitor|mitogen-activated protein kinase kinase inhibitor
4974229|NCT01750281|Non Small Cell Lung Cancer|non small cell lung cancer
4974230|NCT01750281|Metastatic|metastatic
4974231|NCT01750281|Second line treatment for Non Small Cell Lung Cancer|second line treatment for non small cell lung cancer
4974232|NCT01750268|TBI|tbi
4974233|NCT01750268|hazardous and harmful alcohol use|hazardous and harmful alcohol use
4974234|NCT01750268|veterans|veterans
4974235|NCT01750268|co-occurring disorders|co-occurring disorders
4974236|NCT01750268|pharmacotherapy|pharmacotherapy
4974237|NCT01750255|Pharmaceutical care|pharmaceutical care
4974238|NCT01750255|Pharmacotherapy follow-up|pharmacotherapy follow-up
4974239|NCT01750255|Bipolar disorder|bipolar disorder
4974240|NCT01750255|Pharmacy services|pharmacy services
4974241|NCT01750203|Diabetic foot ulcers, venous leg ulcers, pressure sores, acute wounds|diabetic foot ulcers, venous leg ulcers, pressure sores, acute wounds
4974242|NCT01750190|anemia|anemia
4974243|NCT01750190|chronic kidney disease (CKD)|chronic kidney disease (ckd)
4974244|NCT01750190|non-dialysis|non-dialysis
4974245|NCT01750190|Hemoglobin (Hb)|hemoglobin (hb)
4974246|NCT01750190|End-Stage Renal Disease|end-stage renal disease
4974247|NCT01750190|erythropoeitin|erythropoeitin
4974248|NCT01750190|ASP1517|asp1517
4974249|NCT01750190|erythropoeisis stimulating-agent|erythropoeisis stimulating-agent
4974250|NCT01750190|AZD9941|azd9941
4974251|NCT01750164|Breast Cancer|breast cancer
4974252|NCT01750125|Doppler|doppler
4974253|NCT01750112|Pectus excavatum|pectus excavatum
4974254|NCT01750112|funnel chest|funnel chest
4974255|NCT01750112|sunken chest|sunken chest
4974256|NCT01750099|Labor|labor
4974257|NCT01750099|analgesia|analgesia
4974258|NCT01750099|epidural|epidural
4974259|NCT01750099|spinal|spinal
4974260|NCT01750086|osteoporosis|osteoporosis
4974261|NCT01750086|postmenopausal|postmenopausal
4974262|NCT01750086|denosumab|denosumab
4974263|NCT01750086|teriparatide|teriparatide
4974264|NCT01750086|alendronate|alendronate
4974265|NCT01750086|Forteo®|forteo®
4974266|NCT01750086|Prolia®|prolia®
4974267|NCT01750047|pain perception|pain perception
4974268|NCT01750047|postoperative pain|postoperative pain
4974269|NCT01750047|demography|demography
4974270|NCT01750047|smoking|smoking
4974271|NCT01750047|alcohol|alcohol
4974272|NCT01750034|Burns|burns
4974273|NCT01750034|Wounds and injuries|wounds and injuries
4974274|NCT01750034|Bandages|bandages
4974275|NCT01750008|Symptomatic Uterine Fibroids|symptomatic uterine fibroids
4974276|NCT01750008|Menorrhagia|menorrhagia
4974277|NCT01750008|Heavy Bleeding|heavy bleeding
4974278|NCT01750008|Myomas|myomas
4974279|NCT01750008|Radiofrequency Ablation|radiofrequency ablation
4974280|NCT01750008|RFA|rfa
4974281|NCT01750008|Leiomyoma|leiomyoma
4974282|NCT01750008|Fibroids|fibroids
4974283|NCT01749995|Elderly cancer patients|elderly cancer patients
4974284|NCT01749995|Screening tool|screening tool
4974285|NCT01749995|Cognitive impairment|cognitive impairment
4974286|NCT01749995|Freund Clock Drawing Test|freund clock drawing test
4974287|NCT01749982|arsenic|arsenic
4974288|NCT01749982|Bangladesh|bangladesh
4974289|NCT01749982|choline|choline
4974290|NCT01749982|betaine|betaine
4974291|NCT01749982|methylation|methylation
4974292|NCT01749956|Rectal Cancer|rectal cancer
4974293|NCT01749956|Chemoradiation|chemoradiation
4974294|NCT01749956|Aflibercept|aflibercept
4974295|NCT01749956|Surgery|surgery
4974296|NCT01749930|Intraocular pressure|intraocular pressure
4974297|NCT01749917|Parkinson.|parkinson.
4974298|NCT01749917|Dexterity.|dexterity.
4974299|NCT01749917|Balance.|balance.
4974300|NCT01749917|Exercises.|exercises.
4974301|NCT01749904|Intraocular pressure|intraocular pressure
4974302|NCT01749891|Age Related Wet Macular Degeneration|age related wet macular degeneration
4974303|NCT01749813|Carbohydrate Specific Diet|carbohydrate specific diet
4974304|NCT01749813|Crohn's Disease|crohn's disease
4974305|NCT01749813|Immunomodulators|immunomodulators
4974306|NCT01749800|TBI|tbi
4974307|NCT01749800|Attention deficits|attention deficits
4974308|NCT01749800|Upper extremity weakness|upper extremity weakness
4974309|NCT01749787|arthritis|arthritis
4974310|NCT01749787|rheumatoid|rheumatoid
4974311|NCT01749787|methotrexate|methotrexate
4974312|NCT01749787|leflunomide|leflunomide
4974313|NCT01749774|Physical activity|physical activity
4974314|NCT01749774|Testicular cancer|testicular cancer
4974315|NCT01749774|Chemotherapy|chemotherapy
4974316|NCT01749774|Feasibility|feasibility
4974317|NCT01749761|IDH, intradialytic hypotension,|idh, intradialytic hypotension,
4974318|NCT01749761|hypotension on hemodialysis,|hypotension on hemodialysis,
4974319|NCT01749761|hemodialysis,|hemodialysis,
4974320|NCT01749761|Blood pressure guided biofeedback|blood pressure guided biofeedback
4974321|NCT01749748|Breast diseases|breast diseases
4974322|NCT01749748|magnetic resonance spectroscopy|magnetic resonance spectroscopy
4974323|NCT01749722|Colorectal Cancer|colorectal cancer
4974324|NCT01749722|Polyp|polyp
4974325|NCT01749722|Adenoma|adenoma
4974326|NCT01749722|Detection Rate|detection rate
4974327|NCT01749722|Colonoscopy|colonoscopy
4974328|NCT01749722|NaviAid™ G-Eye procedure|naviaid™ g-eye procedure
4974329|NCT01749722|NaviAid™ G-Eye system|naviaid™ g-eye system
4974330|NCT01749722|G-Eye procedure|g-eye procedure
4974331|NCT01749722|G-Eye system|g-eye system
4974332|NCT01749709|Stroke|stroke
4974333|NCT01749709|Recovery|recovery
4974334|NCT01749709|Music|music
4974335|NCT01749696|Pelvic organ prolapse|pelvic organ prolapse
4974336|NCT01749696|Connective tissue|connective tissue
4974337|NCT01749696|Elastin|elastin
4974338|NCT01749696|Collagen|collagen
4974339|NCT01749670|Autism Spectrum Disorder|autism spectrum disorder
4974340|NCT01749670|Exosomal miRNA expression|exosomal mirna expression
4974341|NCT01749657|biomechanics|biomechanics
4974342|NCT01749657|outcomes|outcomes
4974343|NCT01749657|foot|foot
4974344|NCT01749657|orthotic device|orthotic device
4974345|NCT01749644|Cystic Fibrosis, Chronic Pseudomonas Infection, Inhaled Tobramycin|cystic fibrosis, chronic pseudomonas infection, inhaled tobramycin
4974346|NCT01749631|Patients suspected to have difficult intubation|patients suspected to have difficult intubation
4974347|NCT01749631|Intratracheal intubation|intratracheal intubation
4974348|NCT01749631|Difficult to intubate|difficult to intubate
4974349|NCT01749618|Seronegative Inflammatory Arthritis|seronegative inflammatory arthritis
4974350|NCT01749618|SpA|spa
4974351|NCT01749618|PsA|psa
4974352|NCT01749618|Randomized|randomized
4974353|NCT01749618|Behavioural Change|behavioural change
4974354|NCT01749592|hearing loss|hearing loss
4974355|NCT01749592|cochlear implant|cochlear implant
4974356|NCT01749592|PET|pet
4974357|NCT01749592|EEG|eeg
4974358|NCT01749592|MEG|meg
4974359|NCT01749579|propofol|propofol
4974360|NCT01749579|midazolam|midazolam
4974361|NCT01749579|duration of recovery|duration of recovery
4974362|NCT01749579|emergency procedure|emergency procedure
4974363|NCT01749566|HIV/AIDS, preexposure prophylaxis, women's health|hiv/aids, preexposure prophylaxis, women's health
4974364|NCT01749527|24-hour pad test|24-hour pad test
4974365|NCT01749527|Activity|activity
4974366|NCT01749527|Stress urinary incontinence|stress urinary incontinence
4974367|NCT01749514|Myelodysplastic Syndrome|myelodysplastic syndrome
4974368|NCT01749488|Dietitian|dietitian
4974369|NCT01749488|Nutritional recommendations|nutritional recommendations
4974370|NCT01749488|ICU nutrition|icu nutrition
4974371|NCT01749462|chronic obstructive pulmonary disease,|chronic obstructive pulmonary disease,
4974372|NCT01749462|COPD,|copd,
4974373|NCT01749462|Oxis,|oxis,
4974374|NCT01749449|high protein|high protein
4974375|NCT01749449|high carbohydrate|high carbohydrate
4974376|NCT01749449|meal frequency|meal frequency
4974377|NCT01749449|abdominal body fat|abdominal body fat
4974378|NCT01749449|postprandial thermogenesis|postprandial thermogenesis
4974379|NCT01749436|Atelectasis|atelectasis
4974380|NCT01749436|Pneumoperitoneum|pneumoperitoneum
4974381|NCT01749436|Hypoxemia|hypoxemia
4974382|NCT01749371|Alpha-Tocopherol|alpha-tocopherol
4974383|NCT01749371|Inflammation|inflammation
4974384|NCT01749371|Oxidative Stress|oxidative stress
4974385|NCT01749371|Malondialdehyde|malondialdehyde
4974386|NCT01749371|Isoprostanes|isoprostanes
4974387|NCT01749371|Lung Dysfunction|lung dysfunction
4974388|NCT01749371|Wound Healing|wound healing
4974389|NCT01749358|stroke|stroke
4974390|NCT01749358|hemiparesis|hemiparesis
4974391|NCT01749358|physical therapy|physical therapy
4974392|NCT01749358|occupational therapy|occupational therapy
4974393|NCT01749358|neurorehabilitation|neurorehabilitation
4974394|NCT01749358|patient focused|patient focused
4974395|NCT01749358|motor learning|motor learning
4974396|NCT01749358|motor control|motor control
4974397|NCT01749358|skill acquisition|skill acquisition
4974398|NCT01749358|skill training|skill training
4974399|NCT01749358|motor recovery|motor recovery
4974400|NCT01749358|task oriented training|task oriented training
4974401|NCT01749358|task specific training|task specific training
4974402|NCT01749358|arm function|arm function
4974403|NCT01749358|hand function|hand function
4974404|NCT01749358|upper extremity|upper extremity
4974405|NCT01749358|arm therapy|arm therapy
4974406|NCT01749358|physical rehabilitation|physical rehabilitation
4974407|NCT01749358|arm rehabilitation|arm rehabilitation
4974408|NCT01749358|motor function|motor function
4974409|NCT01749332|blood draw|blood draw
4974410|NCT01749332|Perihepatic Phlebotomy|perihepatic phlebotomy
4974411|NCT01749332|12-236|12-236
4974412|NCT01749319|baclofen, withdrawal, interuption, spasticity, pharmacokinetics, tolerability, intravenous, oral|baclofen, withdrawal, interuption, spasticity, pharmacokinetics, tolerability, intravenous, oral
4974413|NCT01749306|epidermolysis bullosa, chronic wound, wound healing, dermal repair, fibroblasts, Dermagraft|epidermolysis bullosa, chronic wound, wound healing, dermal repair, fibroblasts, dermagraft
4974414|NCT01749280|Abdominal Aortic Aneurysm|abdominal aortic aneurysm
4974416|NCT01749280|USPIO|uspio
4974417|NCT01749267|dentin remineralization|dentin remineralization
4974418|NCT01749267|caries regression|caries regression
4974419|NCT01749254|Culprit plaques|culprit plaques
4974420|NCT01749254|Vulnerable Plaques|vulnerable plaques
4974421|NCT01749254|PET|pet
4974422|NCT01749254|calcification|calcification
4974423|NCT01749254|inflammation|inflammation
4974424|NCT01749228|Fed|fed
4974425|NCT01749215|pharmacotherapy|pharmacotherapy
4974426|NCT01749215|alcohol dependence|alcohol dependence
4974427|NCT01749215|Veterans|veterans
4974428|NCT01749202|Omega 3 fatty acids|omega 3 fatty acids
4974429|NCT01749202|Omega 3 Index|omega 3 index
4974430|NCT01749202|Stearidonic acid (SDA)|stearidonic acid (sda)
4974431|NCT01749202|Red Blood Cells|red blood cells
4974432|NCT01749202|Lipids|lipids
4974433|NCT01749189|soy|soy
4974434|NCT01749189|whey|whey
4974435|NCT01749189|casein|casein
4974436|NCT01749189|muscle|muscle
4974437|NCT01749189|strength|strength
4974438|NCT01749189|protein|protein
4974439|NCT01749176|High risk Latino patients with diabetes|high risk latino patients with diabetes
4974440|NCT01749137|Overweight|overweight
4974441|NCT01749124|mental illness|mental illness
4974442|NCT01749124|depression|depression
4974443|NCT01749124|schizophrenia|schizophrenia
4974444|NCT01749124|bipolar disorder|bipolar disorder
4974445|NCT01749124|IVR|ivr
4974446|NCT01749124|automated|automated
4974447|NCT01749124|telephone|telephone
4974448|NCT01749111|bone marrow transplantation|bone marrow transplantation
4974449|NCT01749111|graft versus host disease|graft versus host disease
4974450|NCT01749111|Acute myelogenous leukemia|acute myelogenous leukemia
4974451|NCT01749111|Acute lymphoid leukemia|acute lymphoid leukemia
4974452|NCT01749111|Myeloproliferative disease|myeloproliferative disease
4974453|NCT01749111|Myelodysplastic syndrome|myelodysplastic syndrome
4974454|NCT01749111|Chronic myeloid leukemia|chronic myeloid leukemia
4974455|NCT01749111|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
4974456|NCT01749098|PF-04958242|pf-04958242
4974457|NCT01749098|ketamine|ketamine
4974458|NCT01749098|cognition|cognition
4974459|NCT01749098|healthy volunteers|healthy volunteers
4974460|NCT01749085|PF-04449913|pf-04449913
4974461|NCT01749085|Food Effect|food effect
4974462|NCT01749085|Drug-drug interaction|drug-drug interaction
4974463|NCT01749085|CYP3A4 inhibitor|cyp3a4 inhibitor
4974464|NCT01749085|Pharmacokinetics|pharmacokinetics
4974465|NCT01749072|non small cell lung cancer|non small cell lung cancer
4974466|NCT01749072|chemotherapy|chemotherapy
4974467|NCT01749072|gefitinib|gefitinib
4974468|NCT01749072|vinorelbine|vinorelbine
4974469|NCT01749072|ifosfamide|ifosfamide
4974470|NCT01749046|Epileptic seizures, Partial seizures|epileptic seizures, partial seizures
4974471|NCT01749033|Intubation|intubation
4974472|NCT01749033|Airway|airway
4974473|NCT01749033|Laryngeal Mask Airway|laryngeal mask airway
4974474|NCT01749020|Diabetes type II, Insulin sensitivity|diabetes type ii, insulin sensitivity
4974475|NCT01749007|Veterans|veterans
4974476|NCT01749007|HIV|hiv
4974477|NCT01749007|AIDS|aids
4974478|NCT01749007|Cognitive Functioning|cognitive functioning
4974479|NCT01749007|Suicide|suicide
4974480|NCT01748994|Obesity|obesity
4974481|NCT01748994|Fat distribution|fat distribution
4974482|NCT01748994|Adipogenesis|adipogenesis
4974483|NCT01748994|Adipocyte|adipocyte
4974484|NCT01748994|Preadipocyte|preadipocyte
4974485|NCT01748994|Ectopic fat|ectopic fat
4974486|NCT01748981|Pulmonary function|pulmonary function
4974487|NCT01748981|Maximal oxygen uptake|maximal oxygen uptake
4974488|NCT01748981|Cardiorespiratory fitness|cardiorespiratory fitness
4974489|NCT01748981|High-intensity training|high-intensity training
4974490|NCT01748981|Surgery|surgery
4974491|NCT01748968|Veterans|veterans
4974492|NCT01748968|Human Immunodeficiency Virus Infection(HIV)/Acquired Immunodeficiency Syndrome (AIDS)|human immunodeficiency virus infection(hiv)/acquired immunodeficiency syndrome (aids)
4974493|NCT01748968|Self-Directed Violence|self-directed violence
4974494|NCT01748955|Major Depressive Disorder|major depressive disorder
4974495|NCT01748955|MDD|mdd
4974496|NCT01748955|Reward|reward
4974497|NCT01748955|BOLD signal|bold signal
4974498|NCT01748955|Suicide|suicide
4974499|NCT01748929|Global Health|global health
4974500|NCT01748929|Deworming|deworming
4974501|NCT01748929|Postpartum|postpartum
4974502|NCT01748929|Soil-Transmitted Helminths|soil-transmitted helminths
4974503|NCT01748929|Pregnant Women|pregnant women
4974504|NCT01748916|Papaya|papaya
4974505|NCT01748916|Carrot|carrot
4974506|NCT01748916|Tomato|tomato
4974507|NCT01748916|Carotenoids|carotenoids
4974508|NCT01748916|Lycopene|lycopene
4974509|NCT01748916|Beta-carotene|beta-carotene
4974510|NCT01748916|Beta-cryptoxanthin|beta-cryptoxanthin
4974511|NCT01748903|intracranial aneurysm|intracranial aneurysm
4974512|NCT01748903|cerebral aneurysm|cerebral aneurysm
4974513|NCT01748903|packing density|packing density
4974514|NCT01748903|Target Coils|target coils
4974515|NCT01748903|aneurysm embolization|aneurysm embolization
4974516|NCT01748877|shingles,|shingles,
4974517|NCT01748877|neuropathic pain|neuropathic pain
4974518|NCT01748877|post herpetic neuralgia|post herpetic neuralgia
4974519|NCT01748877|sleep|sleep
4974520|NCT01748864|Volunteers|volunteers
4974521|NCT01748825|MK-1775|mk-1775
4974522|NCT01748825|Refractory|refractory
4974523|NCT01748825|Solid Tumors|solid tumors
4974524|NCT01748825|Wee1 Inhibitor|wee1 inhibitor
4974525|NCT01748825|Tyrosine Kinase|tyrosine kinase
4974526|NCT01748812|Tumor Induced Osteomalacia|tumor induced osteomalacia
4974527|NCT01748812|Hypophosphatemic Rickets|hypophosphatemic rickets
4974528|NCT01748799|Cannabis dependence|cannabis dependence
4974529|NCT01748799|Sativex|sativex
4974530|NCT01748786|Fibromyalgia|fibromyalgia
4974531|NCT01748786|Mindfulness|mindfulness
4974532|NCT01748786|On-line intervention|on-line intervention
4974533|NCT01748786|Chronic pain|chronic pain
4974534|NCT01748760|Suicide Attempts|suicide attempts
4974535|NCT01748760|Suicidal Ideation|suicidal ideation
4974536|NCT01748734|Depression|depression
4974537|NCT01748708|Magnetic seizure therapy|magnetic seizure therapy
4974538|NCT01748708|Electroconvulsive therapy|electroconvulsive therapy
4974539|NCT01748708|Treatment resistant depression|treatment resistant depression
4974540|NCT01748708|Treatment resistance|treatment resistance
4974541|NCT01748708|Randomized controlled trial|randomized controlled trial
4974542|NCT01748695|Neuropathic pain|neuropathic pain
4974543|NCT01748695|Spinal cord injury|spinal cord injury
4974544|NCT01748682|Very low calorie diet|very low calorie diet
4974545|NCT01748682|liquid diet|liquid diet
4974546|NCT01748682|visceral fat|visceral fat
4974547|NCT01748682|liver fat.|liver fat.
4974548|NCT01748669|Arsenic|arsenic
4974549|NCT01748669|Arsenicosis|arsenicosis
4974550|NCT01748669|Garlic oil|garlic oil
4974551|NCT01748669|Keratosis|keratosis
4974552|NCT01748656|Noninvasive ventilation|noninvasive ventilation
4974553|NCT01748656|Obesity Hypoventilation Syndrome|obesity hypoventilation syndrome
4974554|NCT01748630|scoliosis, sedation, children, fentanyl consumption, pain|scoliosis, sedation, children, fentanyl consumption, pain
4974555|NCT01748604|Lymphedema|lymphedema
4974556|NCT01748604|Physical Therapies|physical therapies
4974557|NCT01748604|Randomized controlled study|randomized controlled study
4974558|NCT01748604|Decongestive lymphatic therapy|decongestive lymphatic therapy
4974559|NCT01748604|Manual lymph drainage|manual lymph drainage
4974560|NCT01748604|Intermittent pneumatic compression|intermittent pneumatic compression
4974561|NCT01748604|Multilayer bandages|multilayer bandages
4974562|NCT01748578|Healthy|healthy
4974563|NCT01748578|Interleukin 1 Receptor Inhibitor|interleukin 1 receptor inhibitor
4974564|NCT01748578|Dry Eye|dry eye
4974565|NCT01748565|biomarkers|biomarkers
4974566|NCT01748565|oxidative stress|oxidative stress
4974567|NCT01748565|BPD|bpd
4974568|NCT01748565|prematurity|prematurity
4974569|NCT01748526|Healthy|healthy
4974570|NCT01748526|Canagliflozin (JNJ-28431754)|canagliflozin (jnj-28431754)
4974571|NCT01748526|Pharmacokinetics|pharmacokinetics
4974572|NCT01748526|Pharmacodynamics|pharmacodynamics
4974573|NCT01748526|Indian|indian
4974574|NCT01748513|morbidly obese patients,|morbidly obese patients,
4974575|NCT01748513|preoperative volume-challenge,|preoperative volume-challenge,
4974576|NCT01748513|transthoracic echocardiography,|transthoracic echocardiography,
4974577|NCT01748513|TTE,|tte,
4974578|NCT01748513|rapid weight loss,|rapid weight loss,
4974579|NCT01748513|venous return,|venous return,
4974580|NCT01748513|bariatric surgery,|bariatric surgery,
4974581|NCT01748513|left ventricular outflow tract,|left ventricular outflow tract,
4974582|NCT01748513|stroke volume,|stroke volume,
4974583|NCT01748513|diastolic function,|diastolic function,
4974584|NCT01748513|hypervolemia,|hypervolemia,
4974585|NCT01748513|hypovolemia|hypovolemia
4974586|NCT01748500|metastatic|metastatic
4974587|NCT01748461|intervention study in elderly (65+)|intervention study in elderly (65+)
4974588|NCT01748461|cycle ergometer|cycle ergometer
4974589|NCT01748461|physical activity|physical activity
4974590|NCT01748461|physical fitness|physical fitness
4974591|NCT01748461|assisted living facility|assisted living facility
4974592|NCT01748448|Cutaneous malignant melanoma|cutaneous malignant melanoma
4974593|NCT01748448|Vitamin D|vitamin d
4974594|NCT01748448|Cholecalciferol|cholecalciferol
4974595|NCT01748435|Neuropathic pain|neuropathic pain
4974596|NCT01748435|Lower limb amputation|lower limb amputation
4974597|NCT01748435|Pre-emptive analgesia|pre-emptive analgesia
4974598|NCT01748422|Neuropathic pain|neuropathic pain
4974599|NCT01748422|Arteriovenous fistulae|arteriovenous fistulae
4974600|NCT01748422|End stage renal disease|end stage renal disease
4974601|NCT01748409|Autonomic failure, Parkinson's disease, electrophysiological assessment, neuropathological assessment|autonomic failure, parkinson's disease, electrophysiological assessment, neuropathological assessment
4974602|NCT01748396|FGF-23|fgf-23
4974603|NCT01748396|Calcitriol|calcitriol
4974604|NCT01748396|Calcium carbonate|calcium carbonate
4974605|NCT01748396|CKD Stage 3|ckd stage 3
4974606|NCT01748383|Bone marrow cells|bone marrow cells
4974607|NCT01748383|Acute myocardial infarction|acute myocardial infarction
4974608|NCT01748383|Transplantation of autologous mononuclear|transplantation of autologous mononuclear
4974609|NCT01748383|Transplantation of autologous CD133 + cells|transplantation of autologous cd133 + cells
4974610|NCT01748370|vitamin D|vitamin d
4974611|NCT01748370|hypogonadism|hypogonadism
4974612|NCT01748370|testosterone|testosterone
4974613|NCT01748370|intervention|intervention
4974614|NCT01748357|Tuberculosis|tuberculosis
4974615|NCT01748357|Volatile organic compounds|volatile organic compounds
4974616|NCT01748357|exhaled breath|exhaled breath
4974617|NCT01748357|Siemens|siemens
4974618|NCT01748331|Heart Failure|heart failure
4974619|NCT01748331|Hyponatremia|hyponatremia
4974620|NCT01748331|Fluid restriction|fluid restriction
4974621|NCT01748318|Community acquired MRSA|community acquired mrsa
4974622|NCT01748318|New Mexico Honey|new mexico honey
4974623|NCT01748305|GDM|gdm
4974624|NCT01748305|A1GDM|a1gdm
4974625|NCT01748305|A2GDM|a2gdm
4974626|NCT01748292|Age related|age related
4974627|NCT01748292|Macular|macular
4974628|NCT01748292|sub retinal fluid|sub retinal fluid
4974629|NCT01748292|Age related Macular degeneration|age related macular degeneration
4974630|NCT01748279|COPD|copd
4974631|NCT01748279|Atorvastatin|atorvastatin
4974632|NCT01748279|statins|statins
4974633|NCT01748279|COPD treatment|copd treatment
4974634|NCT01748279|microarrays|microarrays
4974635|NCT01748266|StO2|sto2
4974636|NCT01748266|microcirculation|microcirculation
4974637|NCT01748266|NIRS|nirs
4974638|NCT01748227|self-management|self-management
4974639|NCT01748227|peer support|peer support
4974640|NCT01748227|social support|social support
4974641|NCT01748214|continuous positive airway pressure|continuous positive airway pressure
4974642|NCT01748214|high flow nasal cannula|high flow nasal cannula
4974643|NCT01748214|hearing outcomes|hearing outcomes
4974644|NCT01748214|noise exposure|noise exposure
4974645|NCT01748214|preterm infants|preterm infants
4974646|NCT01748201|Osteoarthritis|osteoarthritis
4974647|NCT01748201|Hemarthrosis|hemarthrosis
4974648|NCT01748201|Hemophilia A|hemophilia a
4974649|NCT01748201|Hemophilia B|hemophilia b
4974650|NCT01748201|Viscosupplementation|viscosupplementation
4974651|NCT01748188|Subacromial syndrome|subacromial syndrome
4974652|NCT01748188|Dexketoprofen|dexketoprofen
4974653|NCT01748188|Phonophoresis|phonophoresis
4974654|NCT01748188|Iontophoresis|iontophoresis
4974655|NCT01748188|Ultrasounds|ultrasounds
4974656|NCT01748188|VAS|vas
4974657|NCT01748188|DASH score|dash score
4974658|NCT01748188|Constant score|constant score
4974659|NCT01748175|Severe asthma|severe asthma
4974660|NCT01748175|longitudinal study|longitudinal study
4974661|NCT01748175|phenotypes|phenotypes
4974662|NCT01748162|croup|croup
4974663|NCT01748162|recurrent croup|recurrent croup
4974664|NCT01748162|barky cough|barky cough
4974665|NCT01748149|recurrent/refractory BRAFV600E-mutant gliomas|recurrent/refractory brafv600e-mutant gliomas
4974666|NCT01748149|pediatrics|pediatrics
4974667|NCT01748149|children|children
4974668|NCT01748149|neo-adjuvant vemurafenib|neo-adjuvant vemurafenib
4974669|NCT01748123|Pragmatic|pragmatic
4974670|NCT01748123|Comparative Effectiveness|comparative effectiveness
4974671|NCT01748110|quality of life|quality of life
4974672|NCT01748110|erectile function|erectile function
4974673|NCT01748097|infiltration|infiltration
4974674|NCT01748097|extravasation|extravasation
4974675|NCT01748097|sodium bicarbonate|sodium bicarbonate
4974676|NCT01748097|capnography|capnography
4974677|NCT01748097|end tidal carbon dioxide|end tidal carbon dioxide
4974678|NCT01748097|chemotherapy|chemotherapy
4974679|NCT01748084|Systemic sclerosis|systemic sclerosis
4974680|NCT01748084|Arthritis|arthritis
4974681|NCT01748084|B-cell therapy, Anti-CD20 therapy|b-cell therapy, anti-cd20 therapy
4974682|NCT01748084|Quality of life|quality of life
4974683|NCT01748084|Scleroderma|scleroderma
4974684|NCT01748084|Lung fibrosis|lung fibrosis
4974685|NCT01748084|Randomised controled trial|randomised controled trial
4974686|NCT01748071|fentanyl|fentanyl
4974687|NCT01748071|sufentanil|sufentanil
4974688|NCT01748071|individual variation|individual variation
4974689|NCT01748071|pain threshold|pain threshold
4974690|NCT01748071|nacro-trend index|nacro-trend index
4974691|NCT01748045|Inhaled Nitric Oxide|inhaled nitric oxide
4974692|NCT01748045|Bronchopulmonary Dysplasia|bronchopulmonary dysplasia
4974693|NCT01748045|Late Prematurity|late prematurity
4974694|NCT01748045|Chronic Respiratory Morbidity|chronic respiratory morbidity
4974695|NCT01748032|depression|depression
4974696|NCT01748032|intervention studies|intervention studies
4974697|NCT01748019|ST1968|st1968
4974698|NCT01748019|Camptothecin|camptothecin
4974699|NCT01748019|Solid tumors|solid tumors
4974700|NCT01748019|Topoisomerase I|topoisomerase i
4974701|NCT01747993|Urinary retention; urinary catheterization; alpha blocking agents; women; elder|urinary retention; urinary catheterization; alpha blocking agents; women; elder
4974702|NCT01747980|Gaucher disease|gaucher disease
4974703|NCT01747980|human glucocerebrosidase|human glucocerebrosidase
4974704|NCT01747980|plant recombinant human glucocerebrosidase|plant recombinant human glucocerebrosidase
4974705|NCT01747967|Antibodies|antibodies
4974706|NCT01747967|Beta cells|beta cells
4974707|NCT01747967|C-peptide|c-peptide
4974708|NCT01747967|GAD|gad
4974709|NCT01747967|Glucose|glucose
4974710|NCT01747967|Glycemia|glycemia
4974711|NCT01747967|Insulin|insulin
4974712|NCT01747967|Meal test|meal test
4974713|NCT01747967|Pancreas|pancreas
4974714|NCT01747967|Proinsulin,|proinsulin,
4974715|NCT01747967|T lymphocytes|t lymphocytes
4974716|NCT01747954|Respiratory Insufficiency|respiratory insufficiency
4974717|NCT01747954|Physiotherapy Techniques|physiotherapy techniques
4974718|NCT01747954|Respiratory Mechanics|respiratory mechanics
4974719|NCT01747928|usability study|usability study
4974720|NCT01747915|Primary Generalized Tonic Clonic Seizures|primary generalized tonic clonic seizures
4974721|NCT01747915|Epilepsy|epilepsy
4974722|NCT01747915|Safety|safety
4974723|NCT01747915|Efficacy|efficacy
4974724|NCT01747915|Tolerability|tolerability
4974725|NCT01747915|Pregabalin|pregabalin
4974726|NCT01747915|Lyrica|lyrica
4974727|NCT01747915|Adjunctive treatment|adjunctive treatment
4974728|NCT01747915|Placebo Controlled|placebo controlled
4974729|NCT01747915|Blinded|blinded
4974730|NCT01747889|chest tube|chest tube
4974731|NCT01747889|lung resection|lung resection
4974732|NCT01747889|patient satisfaction|patient satisfaction
4974733|NCT01747889|mobility|mobility
4974734|NCT01747876|Phase 1|phase 1
4974735|NCT01747876|pediatric|pediatric
4974736|NCT01747876|CDK4/6 inhibitor|cdk4/6 inhibitor
4974737|NCT01747876|dose escalation|dose escalation
4974738|NCT01747876|malignant rhabdoid tumors|malignant rhabdoid tumors
4974739|NCT01747876|MRT|mrt
4974740|NCT01747876|neuroblastoma|neuroblastoma
4974741|NCT01747863|Hypoxic Ischemic encephalopathy|hypoxic ischemic encephalopathy
4974742|NCT01747837|Renal sympathetic denervation|renal sympathetic denervation
4974743|NCT01747837|Renal catheter ablation|renal catheter ablation
4974744|NCT01747837|Ventricular tachycardia|ventricular tachycardia
4974745|NCT01747824|agitation|agitation
4974746|NCT01747824|excited delirium|excited delirium
4974747|NCT01747824|pain|pain
4974748|NCT01747824|unexplained-in-custody-death|unexplained-in-custody-death
4974749|NCT01747824|UICD|uicd
4974750|NCT01747824|visual analog scale|visual analog scale
4974751|NCT01747824|VAS|vas
4974752|NCT01747824|altered mental status|altered mental status
4974753|NCT01747824|AMS|ams
4974754|NCT01747811|Mild traumatic brain injury|mild traumatic brain injury
4974755|NCT01747811|Concussion|concussion
4974756|NCT01747811|Sleep problems|sleep problems
4974757|NCT01747811|brain imaging|brain imaging
4974758|NCT01747811|functional magnetic resonance imaging (FMRI)|functional magnetic resonance imaging (fmri)
4974759|NCT01747785|Heart failure|heart failure
4974760|NCT01747785|HFpEF|hfpef
4974761|NCT01747785|Dyspnea|dyspnea
4974762|NCT01747785|Fatigue|fatigue
4974763|NCT01747785|Shortness of Breath|shortness of breath
4974764|NCT01747785|exercise|exercise
4974765|NCT01747785|strain|strain
4974766|NCT01747785|myocardial deformation|myocardial deformation
4974767|NCT01747785|cardiac rehabilitation|cardiac rehabilitation
4974768|NCT01747785|cardiac hemodynamics|cardiac hemodynamics
4974769|NCT01747772|Non-focal Liver Disease|non-focal liver disease
4974770|NCT01747772|Fibrosis|fibrosis
4974771|NCT01747772|Shear Wave Sonoelastography|shear wave sonoelastography
4974772|NCT01747772|Metavir Liver Fibrosis Grading|metavir liver fibrosis grading
4974773|NCT01747759|• Knee osteoarthritis|• knee osteoarthritis
4974774|NCT01747759|Total knee arthroplasty|total knee arthroplasty
4974775|NCT01747759|Selfcare|selfcare
4974776|NCT01747759|Booklet|booklet
4974777|NCT01747759|Rehabilitation|rehabilitation
4974778|NCT01747746|Rivaroxaban|rivaroxaban
4974779|NCT01747746|Warfarin|warfarin
4974780|NCT01747746|Anticoagulation|anticoagulation
4974781|NCT01747746|Stroke|stroke
4974782|NCT01747746|Thrombo-embolism|thrombo-embolism
4974783|NCT01747746|Bleeding|bleeding
4974784|NCT01747746|Atrial Fibrillation|atrial fibrillation
4974785|NCT01747746|Cardioversion|cardioversion
4974786|NCT01747733|Endoscopy|endoscopy
4974787|NCT01747733|ERCP|ercp
4974788|NCT01747733|PCS|pcs
4974789|NCT01747733|Sedation|sedation
4974790|NCT01747733|Bispectral index|bispectral index
4974791|NCT01747720|breast cancer|breast cancer
4974792|NCT01747720|mammographic breast density|mammographic breast density
4974793|NCT01747720|vitamin D|vitamin d
4974794|NCT01747720|prevention|prevention
4974795|NCT01747720|randomized controlled trial|randomized controlled trial
4974796|NCT01747707|gastric cancer|gastric cancer
4974797|NCT01747707|gastroesophageal junction cancer|gastroesophageal junction cancer
4974798|NCT01747707|chemotherapy|chemotherapy
4974799|NCT01747707|docetaxel|docetaxel
4974800|NCT01747707|cisplatin|cisplatin
4974801|NCT01747707|S-1|s-1
4974802|NCT01747694|COPD,Respiratory muscle training,Exercise tolerance|copd,respiratory muscle training,exercise tolerance
4974803|NCT01747681|chondral defect|chondral defect
4974804|NCT01747681|microfracture|microfracture
4974805|NCT01747681|arthroscopy|arthroscopy
4974806|NCT01747681|cartilage repair|cartilage repair
4974807|NCT01747681|outcome study|outcome study
4974808|NCT01747681|Lysholm score|lysholm score
4974809|NCT01747668|Mother and Infant Pairs|mother and infant pairs
4974810|NCT01747655|Early Observational Advanced|early observational advanced
4974811|NCT01747655|Parkinson's Disease|parkinson's disease
4974812|NCT01747642|Hepatocellular carcinoma|hepatocellular carcinoma
4974813|NCT01747642|Oncoxin|oncoxin
4974814|NCT01747642|Surafenib|surafenib
4974815|NCT01747629|Asthma|asthma
4974816|NCT01747629|dry powder inhaler|dry powder inhaler
4974817|NCT01747629|short-acting beta2-agonist|short-acting beta2-agonist
4974818|NCT01747629|SABA|saba
4974819|NCT01747629|bronchoconstriction|bronchoconstriction
4974820|NCT01747629|bronchodilation|bronchodilation
4974821|NCT01747629|bronchodilator|bronchodilator
4974822|NCT01747629|metered dose inhaler|metered dose inhaler
4974823|NCT01747629|Albuterol Spiromax®|albuterol spiromax®
4974824|NCT01747616|Chitosan-N-Acetylcysteine|chitosan-n-acetylcysteine
4974825|NCT01747616|contact lenses|contact lenses
4974826|NCT01747616|safety and tolerability|safety and tolerability
4974827|NCT01747603|Late preterm infant|late preterm infant
4974828|NCT01747603|Complications|complications
4974829|NCT01747603|Hospital readmissions|hospital readmissions
4974830|NCT01747603|Follow-up|follow-up
4974831|NCT01747603|Pilot study|pilot study
4974832|NCT01747577|Muscarine antagonist|muscarine antagonist
4974833|NCT01747577|Prostatectomy|prostatectomy
4974834|NCT01747577|Uroflowmetry|uroflowmetry
4974835|NCT01747564|Pharmacokinetics|pharmacokinetics
4974836|NCT01747564|Mirabegron|mirabegron
4974837|NCT01747564|Phase 1|phase 1
4974838|NCT01747564|YM178|ym178
4974839|NCT01747551|Advanced|advanced
4974840|NCT01747538|Uveitis|uveitis
4974841|NCT01747538|Non-infectious Uveitis|non-infectious uveitis
4974842|NCT01747538|Intermediate Uveitis|intermediate uveitis
4974843|NCT01747538|Posterior Uveitis|posterior uveitis
4974844|NCT01747538|Panuveitis|panuveitis
4974845|NCT01747512|99mTc Pertechnetate|99mtc pertechnetate
4974846|NCT01747512|thyroidectomy|thyroidectomy
4974847|NCT01747512|thyroid neoplasms|thyroid neoplasms
4974848|NCT01747473|Subjects|subjects
4974849|NCT01747460|Subjects|subjects
4974850|NCT01747408|subarachnoid hemorrhage|subarachnoid hemorrhage
4974851|NCT01747395|Heart Failure|heart failure
4974852|NCT01747395|Exercise and Physical Fitness|exercise and physical fitness
4974853|NCT01747382|Treatment-resistant Hypertension|treatment-resistant hypertension
4974854|NCT01747382|Chronic Kidney Disease|chronic kidney disease
4974855|NCT01747382|Symplicity catheters|symplicity catheters
4974856|NCT01747382|Renal denervation|renal denervation
4974857|NCT01747369|surveillance study|surveillance study
4974858|NCT01747369|prospective|prospective
4974859|NCT01747369|observational|observational
4974860|NCT01747369|health center-based|health center-based
4974861|NCT01747369|pneumonia, bacterial|pneumonia, bacterial
4974862|NCT01747369|pneumonia, viral|pneumonia, viral
4974863|NCT01747369|meningitis, bacterial|meningitis, bacterial
4974864|NCT01747369|Africa south of the Sahara|africa south of the sahara
4974865|NCT01747343|Incontinence|incontinence
4974866|NCT01747343|Enuresis|enuresis
4974867|NCT01747330|cystic fibrosis|cystic fibrosis
4974868|NCT01747317|FFR|ffr
4974869|NCT01747317|fractional flow reserve|fractional flow reserve
4974870|NCT01747317|CT|ct
4974871|NCT01747317|Computed Tomography|computed tomography
4974872|NCT01747304|Atypical Femur Fracture|atypical femur fracture
4974873|NCT01747304|DXA|dxa
4974874|NCT01747278|Pneumocystis carinii pneumonia|pneumocystis carinii pneumonia
4974875|NCT01747278|prophylaxis|prophylaxis
4974876|NCT01747278|trimethoprim/sulfamethoxazole|trimethoprim/sulfamethoxazole
4974877|NCT01747239|Ovarian cancer|ovarian cancer
4974878|NCT01747239|Platinum refractory|platinum refractory
4974879|NCT01747226|Oral malodor|oral malodor
4974880|NCT01747226|Halitosis|halitosis
4974881|NCT01747226|Bad Breath|bad breath
4974882|NCT01747226|Mouth rinses|mouth rinses
4974883|NCT01747226|Mouthwashes|mouthwashes
4974884|NCT01747226|Amine fluoride/Stannous fluoride|amine fluoride/stannous fluoride
4974885|NCT01747226|Zinc ions|zinc ions
4974886|NCT01747226|Chlorhexidine|chlorhexidine
4974887|NCT01747213|Neurodegenerative|neurodegenerative
4974888|NCT01747213|Cholinergic|cholinergic
4974889|NCT01747213|Single Dose|single dose
4974890|NCT01747213|Inhibitor|inhibitor
4974891|NCT01747213|Tolerability|tolerability
4974892|NCT01747200|Repetitive TMS (rTMS)|repetitive tms (rtms)
4974893|NCT01747187|Septic shock|septic shock
4974894|NCT01747187|Critical care|critical care
4974895|NCT01747187|cardiac failure|cardiac failure
4974896|NCT01747174|STEMI|stemi
4974897|NCT01747174|Microvascular Obstruction|microvascular obstruction
4974898|NCT01747174|No-reflow|no-reflow
4974899|NCT01747174|Adenosine|adenosine
4974900|NCT01747174|Sodium Nitroprusside|sodium nitroprusside
4974901|NCT01747148|Antisense|antisense
4974902|NCT01747148|Influenza|influenza
4974903|NCT01747148|IV Injection|iv injection
4974904|NCT01747148|RNA Based Therapeutic|rna based therapeutic
4974905|NCT01747148|RNA Interference|rna interference
4974906|NCT01747135|2-Hydroxypropyl-B-Cyclodextrin|2-hydroxypropyl-b-cyclodextrin
4974907|NCT01747135|Niemann-Pick Disease, Type C1|niemann-pick disease, type c1
4974908|NCT01747135|Neurodegeneration|neurodegeneration
4974909|NCT01747122|epidurals|epidurals
4974910|NCT01747122|wound catheters|wound catheters
4974911|NCT01747122|liver resection|liver resection
4974912|NCT01747122|liver surgery|liver surgery
4974913|NCT01747109|Acute hypoxemic respiratory failure|acute hypoxemic respiratory failure
4974914|NCT01747109|Preoxygenation|preoxygenation
4974915|NCT01747109|Crash induction|crash induction
4974916|NCT01747096|Gastroenteropancreatic Neuroendocrine Tumors|gastroenteropancreatic neuroendocrine tumors
4974917|NCT01747096|immuno PET (iPET)|immuno pet (ipet)
4974918|NCT01747096|Gallium (68-Ga)|gallium (68-ga)
4974919|NCT01747096|DOTANOC|dotanoc
4974920|NCT01747070|Electro Acupuncture|electro acupuncture
4974921|NCT01747070|Knee Osteoarthritis|knee osteoarthritis
4974922|NCT01747070|Chronic pain|chronic pain
4975427|NCT01744691|CLL|cll
4974923|NCT01747070|Cortical Excitability|cortical excitability
4974924|NCT01747044|Fibromyalgia|fibromyalgia
4974925|NCT01747044|Diffuse Noxious Inhibitory Controls|diffuse noxious inhibitory controls
4974926|NCT01747044|Milnacipran|milnacipran
4974927|NCT01747031|iFR|ifr
4974928|NCT01747031|FFR|ffr
4974929|NCT01747031|instantaneous wave-free ratio|instantaneous wave-free ratio
4974930|NCT01747031|fractional flow reserve|fractional flow reserve
4974931|NCT01747018|Platelet-Rich Plasma|platelet-rich plasma
4974932|NCT01747018|Knee pain|knee pain
4974933|NCT01747018|osteoarthritis|osteoarthritis
4974934|NCT01747018|degenerative chondropathy|degenerative chondropathy
4974935|NCT01747018|Intraarticular injection|intraarticular injection
4974936|NCT01747005|abdominal hysterectomy|abdominal hysterectomy
4974937|NCT01747005|enhanced recovery after surgery|enhanced recovery after surgery
4974938|NCT01747005|inflammatory response|inflammatory response
4974939|NCT01747005|ERAS|eras
4974940|NCT01747005|combined spinal-epidural anesthesia|combined spinal-epidural anesthesia
4974941|NCT01746979|TH-302|th-302
4974942|NCT01746979|Evofosfamide|evofosfamide
4974943|NCT01746979|Pancreatic Cancer|pancreatic cancer
4974944|NCT01746979|EMR200592-001|emr200592-001
4974945|NCT01746966|gleno-humeral joint synovitis|gleno-humeral joint synovitis
4974946|NCT01746966|anterior shoulder US|anterior shoulder us
4974947|NCT01746966|rotator interval|rotator interval
4974948|NCT01746940|Surgery|surgery
4974949|NCT01746940|Surgeries|surgeries
4974950|NCT01746940|Nasal|nasal
4974951|NCT01746940|Cavities|cavities
4974952|NCT01746940|Diagnosis|diagnosis
4974953|NCT01746940|Diagnostic|diagnostic
4974954|NCT01746940|Nose|nose
4974955|NCT01746940|Rhinoplasty|rhinoplasty
4974956|NCT01746940|Endoscopy|endoscopy
4974957|NCT01746940|Bronchoscopy|bronchoscopy
4974958|NCT01746927|cricoid pressure, glidescope|cricoid pressure, glidescope
4974959|NCT01746901|Relative abuse potential study; oxycodone; nalteone; Opioid-related disorders; drug abusers|relative abuse potential study; oxycodone; nalteone; opioid-related disorders; drug abusers
4974960|NCT01746901|Chronic pain|chronic pain
4974961|NCT01746875|Angiogenesis inhibitors|angiogenesis inhibitors
4974962|NCT01746875|Photochemotherapy|photochemotherapy
4974963|NCT01746875|Vascular Endothelium Growth Factors|vascular endothelium growth factors
4974964|NCT01746875|Aflibercept|aflibercept
4974965|NCT01746862|Saizen®|saizen®
4974966|NCT01746862|Recombinant human growth hormone (r-hGH)|recombinant human growth hormone (r-hgh)
4974967|NCT01746862|Idiopathic short stature|idiopathic short stature
4974968|NCT01746862|Height velocity|height velocity
4974969|NCT01746862|Bone age|bone age
4974970|NCT01746849|LUPRON DEPOT|lupron depot
4974971|NCT01746849|PALIFERMIN|palifermin
4974972|NCT01746849|12-077|12-077
4974973|NCT01746836|Leukemia|leukemia
4974974|NCT01746836|Chronic Myeloid Leukemia|chronic myeloid leukemia
4974975|NCT01746836|CML|cml
4974976|NCT01746836|Imatinib-resistant or intolerant|imatinib-resistant or intolerant
4974977|NCT01746836|Imatinib failure|imatinib failure
4974978|NCT01746836|Ph-positive (by cytogenetics or FISH)|ph-positive (by cytogenetics or fish)
4974979|NCT01746836|BCR-ABL-positive (by PCR) CML in chronic phase|bcr-abl-positive (by pcr) cml in chronic phase
4974980|NCT01746836|Ponatinib|ponatinib
4974981|NCT01746836|AP24534|ap24534
4974982|NCT01746823|Keratoconus|keratoconus
4974983|NCT01746823|Proteomics|proteomics
4974984|NCT01746810|Metastatic|metastatic
4974985|NCT01746810|Lung Cancer|lung cancer
4974986|NCT01746810|NSCLC|nsclc
4974987|NCT01746797|infertility|infertility
4974988|NCT01746797|depression|depression
4974989|NCT01746797|IVF|ivf
4974990|NCT01746797|IUI|iui
4974991|NCT01746797|fertility treatment|fertility treatment
4974992|NCT01746784|Cystic Fibrosis|cystic fibrosis
4974993|NCT01746784|F508del-CFTR|f508del-cftr
4974994|NCT01746784|N6022|n6022
4974995|NCT01746784|S-Nitrosoglutathione|s-nitrosoglutathione
4974996|NCT01746771|HM781-36B, Paclitaxel, Trastuzumab|hm781-36b, paclitaxel, trastuzumab
4974997|NCT01746758|Reproductive health, mHealth, Cluster randomised trial|reproductive health, mhealth, cluster randomised trial
4974998|NCT01746693|retinal vessel diameter|retinal vessel diameter
4974999|NCT01746693|retinal oxygen saturation|retinal oxygen saturation
4975000|NCT01746693|high resolution functional and anatomical imaging|high resolution functional and anatomical imaging
4975001|NCT01746693|inner retinal function|inner retinal function
4975002|NCT01746693|flicker response|flicker response
4975003|NCT01746680|rheumatoid arthritis|rheumatoid arthritis
4975004|NCT01746680|RA|ra
4975005|NCT01746680|tacrolimus|tacrolimus
4975006|NCT01746680|Disease Activity Score 28|disease activity score 28
4975007|NCT01746680|EULAR|eular
4975008|NCT01746667|Social Anxiety Disorder|social anxiety disorder
4975009|NCT01746667|Social Phobia|social phobia
4975010|NCT01746667|Virtual Reality|virtual reality
4975011|NCT01746667|Exposure|exposure
4975012|NCT01746654|S.aureus|s.aureus
4975013|NCT01746654|Methicillin Resistant S.aureus (MRSA)|methicillin resistant s.aureus (mrsa)
4975014|NCT01746654|Nasal carrier status|nasal carrier status
4975015|NCT01746654|Prophylaxis|prophylaxis
4975016|NCT01746641|Remifentanil|remifentanil
4975017|NCT01746641|Propofol|propofol
4975018|NCT01746641|Sedation|sedation
4975019|NCT01746641|Endoscopy|endoscopy
4975428|NCT01744691|SLL|sll
4975020|NCT01746641|Gastroenterology|gastroenterology
4975021|NCT01746641|Target controlled infusion effect site|target controlled infusion effect site
4975022|NCT01746628|type 0 myomata|type 0 myomata
4975023|NCT01746628|type 1 myomata|type 1 myomata
4975024|NCT01746628|type 2 myomata|type 2 myomata
4975025|NCT01746628|bleeding|bleeding
4975026|NCT01746628|hemorrhage|hemorrhage
4975027|NCT01746628|hysteroscopy|hysteroscopy
4975028|NCT01746628|FloSeal|floseal
4975029|NCT01746615|branch retinal vein occlusion|branch retinal vein occlusion
4975030|NCT01746615|dynamic vessel analyzer|dynamic vessel analyzer
4975031|NCT01746615|fourier-domain OCT|fourier-domain oct
4975032|NCT01746615|retinal oxygen saturation|retinal oxygen saturation
4975033|NCT01746602|topical lubricants|topical lubricants
4975034|NCT01746602|tear film thickness|tear film thickness
4975035|NCT01746602|anti-glaucoma drugs|anti-glaucoma drugs
4975036|NCT01746602|break up time|break up time
4975037|NCT01746602|anti-glaucoma treatment|anti-glaucoma treatment
4975038|NCT01746589|LASIK|lasik
4975039|NCT01746576|volunteers|volunteers
4975040|NCT01746563|Proliferative Diabetic Retinopathy|proliferative diabetic retinopathy
4975041|NCT01746563|Ranibizumab|ranibizumab
4975042|NCT01746563|Panretinal Photocoagulation|panretinal photocoagulation
4975043|NCT01746524|Arthroplasty|arthroplasty
4975044|NCT01746524|Replacement|replacement
4975045|NCT01746524|Knee|knee
4975046|NCT01746511|glycerin suppositories|glycerin suppositories
4975047|NCT01746511|glycerin shaves|glycerin shaves
4975048|NCT01746511|neonatal hyperbilirubinemia|neonatal hyperbilirubinemia
4975049|NCT01746511|idiopathic hyperbilirubinemia|idiopathic hyperbilirubinemia
4975050|NCT01746511|jaundice|jaundice
4975051|NCT01746511|neonatal jaundice|neonatal jaundice
4975052|NCT01746511|prematurity|prematurity
4975053|NCT01746498|Alzheimer disease|alzheimer disease
4975054|NCT01746498|Direct current stimulation|direct current stimulation
4975055|NCT01746498|cognitive function|cognitive function
4975056|NCT01746498|memory|memory
4975057|NCT01746485|Volunteers|volunteers
4975058|NCT01746459|Sustainability of Innovations|sustainability of innovations
4975059|NCT01746459|Knowledge Translation|knowledge translation
4975060|NCT01746459|Gerontology|gerontology
4975061|NCT01746459|Mobility|mobility
4975062|NCT01746420|elbow|elbow
4975063|NCT01746407|Emergency Department|emergency department
4975064|NCT01746407|Infection|infection
4975065|NCT01746407|Sepsis|sepsis
4975066|NCT01746394|obesity|obesity
4975067|NCT01746394|pregnant women|pregnant women
4975068|NCT01746394|nutrition assessment|nutrition assessment
4975069|NCT01746394|health behavior|health behavior
4975070|NCT01746381|amyotrophic lateral sclerosis|amyotrophic lateral sclerosis
4975071|NCT01746381|non-invasive ventilation|non-invasive ventilation
4975072|NCT01746381|home ventilation|home ventilation
4975073|NCT01746381|IVAPS|ivaps
4975074|NCT01746381|neuromuscular diseases|neuromuscular diseases
4975075|NCT01746368|advance directives|advance directives
4975076|NCT01746355|atypical facial pain|atypical facial pain
4975077|NCT01746355|atypical odontalgia|atypical odontalgia
4975078|NCT01746355|repetitive transcranial magnetic stimulation|repetitive transcranial magnetic stimulation
4975079|NCT01746355|neuropathic pain|neuropathic pain
4975080|NCT01746355|chronic pain|chronic pain
4975081|NCT01746355|assessment|assessment
4975082|NCT01746329|Obesity, insulin resistance, muscle perfusion|obesity, insulin resistance, muscle perfusion
4975083|NCT01746303|Working memory|working memory
4975084|NCT01746303|Long-term memory|long-term memory
4975085|NCT01746303|Neurocognition|neurocognition
4975086|NCT01746303|Dietary supplementation|dietary supplementation
4975087|NCT01746303|dementia|dementia
4975088|NCT01746290|Cardiac Arrest, cardiopulmonary resuscitation, automated external defibrillators, smartphones|cardiac arrest, cardiopulmonary resuscitation, automated external defibrillators, smartphones
4975089|NCT01746277|non small cell lung cancer|non small cell lung cancer
4975090|NCT01746277|chemotherapy|chemotherapy
4975091|NCT01746277|epidermal growth factor receptor tyrosine kinase inhibitor|epidermal growth factor receptor tyrosine kinase inhibitor
4975092|NCT01746277|retreatment|retreatment
4975093|NCT01746264|Obesity|obesity
4975094|NCT01746264|Endothelial dysfunction|endothelial dysfunction
4975095|NCT01746264|Vitamin D deficiency|vitamin d deficiency
4975096|NCT01746251|EGFR mutation|egfr mutation
4975097|NCT01746251|Resected|resected
4975098|NCT01746238|soft tissue|soft tissue
4975099|NCT01746238|high grade|high grade
4975100|NCT01746225|Metastatic|metastatic
4975101|NCT01746225|Breast|breast
4975102|NCT01746225|Cancer|cancer
4975103|NCT01746225|HER2-negative Stage IV|her2-negative stage iv
4975104|NCT01746225|No previous chemotherapy|no previous chemotherapy
4975105|NCT01746212|Degenerative Disc Disease|degenerative disc disease
4975106|NCT01746212|InQu Bone Graft Extender and Substitute|inqu bone graft extender and substitute
4975107|NCT01746212|Anterior Lumbar Interbody Fusion|anterior lumbar interbody fusion
4975108|NCT01746212|Oswestry Disability Index|oswestry disability index
4975109|NCT01746212|Visual Analog Scale|visual analog scale
4975110|NCT01746212|Stand-alone ALIF|stand-alone alif
4975111|NCT01746212|Bone Marrow Aspirate Concentrate|bone marrow aspirate concentrate
4975112|NCT01746212|Fusion rate|fusion rate
4975113|NCT01746212|Disc Height|disc height
4975114|NCT01746212|Mean Optical Density|mean optical density
4975115|NCT01746212|Integrated Optical Density|integrated optical density
4975116|NCT01746173|T Cell lymphoma|t cell lymphoma
4975117|NCT01746160|dental implant|dental implant
4975118|NCT01746160|healing|healing
4975119|NCT01746160|implant stability|implant stability
4975120|NCT01746147|MDS|mds
4975121|NCT01746147|AML|aml
4975122|NCT01746147|allogeneic SCT|allogeneic sct
4975123|NCT01746108|Pneumococcal infection|pneumococcal infection
4975124|NCT01746108|Synflorix|synflorix
4975125|NCT01746108|Children|children
4975126|NCT01746108|Immunogenicity|immunogenicity
4975127|NCT01746108|Safety|safety
4975128|NCT01746095|Cystic Fibrosis|cystic fibrosis
4975129|NCT01746095|MRSA|mrsa
4975130|NCT01746095|Methicillin-resistant Staphylococcus aureus|methicillin-resistant staphylococcus aureus
4975131|NCT01746095|Lung infection|lung infection
4975132|NCT01746095|AeroVanc|aerovanc
4975133|NCT01746095|Vancomycin|vancomycin
4975134|NCT01746082|influenza, H3N2, H3N2v, vaccine, unadjuvanted, Parent Protocol|influenza, h3n2, h3n2v, vaccine, unadjuvanted, parent protocol
4975135|NCT01746069|smoking|smoking
4975136|NCT01746069|smoke cessation|smoke cessation
4975137|NCT01746069|sms|sms
4975138|NCT01746069|quit smoke|quit smoke
4975139|NCT01746056|Warts|warts
4975140|NCT01746056|Verruca|verruca
4975141|NCT01746056|Heat patch|heat patch
4975142|NCT01746043|Esophageal cancer|esophageal cancer
4975143|NCT01746043|Chemotherapy|chemotherapy
4975144|NCT01746043|Radiation therapy|radiation therapy
4975145|NCT01746043|XRT|xrt
4975146|NCT01746043|Chemoradiation|chemoradiation
4975147|NCT01746043|CXRT|cxrt
4975148|NCT01746043|Symptom Burden|symptom burden
4975149|NCT01746043|Armodafinil|armodafinil
4975150|NCT01746043|Nuvigil|nuvigil
4975151|NCT01746043|Minocycline|minocycline
4975152|NCT01746043|Dynacin|dynacin
4975153|NCT01746043|Minocin|minocin
4975154|NCT01746043|Minocin PAC|minocin pac
4975155|NCT01746043|Myrac|myrac
4975156|NCT01746043|Solodyn|solodyn
4975157|NCT01746043|Placebo|placebo
4975158|NCT01746043|Sugar pill|sugar pill
4975159|NCT01746043|Questionnaires|questionnaires
4975160|NCT01746043|Surveys|surveys
4975161|NCT01745952|Epilepsies, Partial|epilepsies, partial
4975162|NCT01745952|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
4975163|NCT01745939|Back pain|back pain
4975164|NCT01745913|Leukemia|leukemia
4975165|NCT01745913|Lymphoma|lymphoma
4975166|NCT01745900|Diabetes|diabetes
4975167|NCT01745900|Gestational Diabetes|gestational diabetes
4975168|NCT01745900|Female|female
4975169|NCT01745887|Dry Eye Syndrome|dry eye syndrome
4975170|NCT01745887|Interleukin 1 Receptor Inhibitor|interleukin 1 receptor inhibitor
4975171|NCT01745874|Rectal cancer|rectal cancer
4975172|NCT01745874|Whole-body MRI|whole-body mri
4975173|NCT01745874|FDG-PET-CT|fdg-pet-ct
4975174|NCT01745874|preoperative staging|preoperative staging
4975175|NCT01745848|Roflumilast|roflumilast
4975176|NCT01745848|COPD|copd
4975177|NCT01745822|Hepatitis B|hepatitis b
4975178|NCT01745822|Hepatitis B sAg|hepatitis b sag
4975179|NCT01745822|Hepatitis B eAg|hepatitis b eag
4975180|NCT01745822|pregnancy|pregnancy
4975181|NCT01745796|Pseudomonas Aeruginosa|pseudomonas aeruginosa
4975182|NCT01745796|Ventilated Acquired Pneumonia|ventilated acquired pneumonia
4975183|NCT01745796|Transmission modes|transmission modes
4975184|NCT01745718|prostate cancer|prostate cancer
4975185|NCT01745718|targeted biopsies|targeted biopsies
4975186|NCT01745718|cytological imprints|cytological imprints
4975187|NCT01745718|histology|histology
4975188|NCT01745705|Manipulation|manipulation
4975189|NCT01745705|Balance|balance
4975190|NCT01745705|Proprioception|proprioception
4975191|NCT01745679|Ceftriaxone|ceftriaxone
4975192|NCT01745679|Adverse drug effects|adverse drug effects
4975193|NCT01745679|Therapeutic monitoring|therapeutic monitoring
4975194|NCT01745679|Meningitis|meningitis
4975195|NCT01745666|Long QT syndrome, stress tests|long qt syndrome, stress tests
4975196|NCT01745640|Multiple myeloma|multiple myeloma
4975197|NCT01745640|dexamethasone|dexamethasone
4975198|NCT01745640|pomalidomide|pomalidomide
4975199|NCT01745640|response|response
4975200|NCT01745640|safety|safety
4975201|NCT01745640|del 17p|del 17p
4975202|NCT01745640|t 4-14|t 4-14
4975203|NCT01745614|Bioequivalence|bioequivalence
4975204|NCT01745614|Nimesulide|nimesulide
4975205|NCT01745614|Pharmacokinetics|pharmacokinetics
4975206|NCT01745614|Mexico|mexico
4975207|NCT01745588|CC-4047(Pomalidomide)Pomalyst|cc-4047(pomalidomide)pomalyst
4975208|NCT01745588|Clarithromycin|clarithromycin
4975209|NCT01745588|Biaxin|biaxin
4975210|NCT01745588|DEXAMETHASONE|dexamethasone
4975211|NCT01745588|(ClaPD)|(clapd)
4975212|NCT01745588|Stem cell|stem cell
4975213|NCT01745588|12-138|12-138
4975214|NCT01745575|Bioequivalence|bioequivalence
4975215|NCT01745575|Alprazolam|alprazolam
4975216|NCT01745575|Anxiety disorders|anxiety disorders
4975217|NCT01745575|Mexico|mexico
4975218|NCT01745562|Alprazolam|alprazolam
4975219|NCT01745562|Anxiety disorders|anxiety disorders
4975220|NCT01745562|Bioequivalence|bioequivalence
4975221|NCT01745562|Mexico|mexico
4975222|NCT01745549|diabetes|diabetes
4975223|NCT01745549|insulin therapy|insulin therapy
4975224|NCT01745549|needle|needle
4975225|NCT01745536|Oocyte vitrification|oocyte vitrification
4975226|NCT01745536|survival rate|survival rate
4975227|NCT01745536|egg banking|egg banking
4975228|NCT01745536|ovum donation|ovum donation
4975229|NCT01745523|Oocyte vitrification|oocyte vitrification
4975230|NCT01745523|survival rate|survival rate
4975231|NCT01745523|egg banking|egg banking
4975232|NCT01745523|ovum donation|ovum donation
4975233|NCT01745510|docosahexaenoic acid|docosahexaenoic acid
4975234|NCT01745510|n-3 fatty acids|n-3 fatty acids
4975235|NCT01745510|necrotizing enterocolitis|necrotizing enterocolitis
4975236|NCT01745510|preterm infants|preterm infants
4975237|NCT01745497|Autism Spectrum Disorder|autism spectrum disorder
4975238|NCT01745497|Insomnia|insomnia
4975239|NCT01745484|SPECT|spect
4975240|NCT01745484|Toxicity|toxicity
4975241|NCT01745484|Non-small-cell lung cancer|non-small-cell lung cancer
4975242|NCT01745484|Definitive Radiotherapy|definitive radiotherapy
4975243|NCT01745484|Radiation pneumonitis|radiation pneumonitis
4975244|NCT01745484|Randomized study|randomized study
4975245|NCT01745471|Abdominal Adipose|abdominal adipose
4975246|NCT01745471|Gluteal Adipose|gluteal adipose
4975247|NCT01745471|Polycystic Ovary Syndrome|polycystic ovary syndrome
4975248|NCT01745471|Obesity|obesity
4975249|NCT01745471|Women|women
4975250|NCT01745445|limited-stage small cell lung cancer|limited-stage small cell lung cancer
4975251|NCT01745445|concurrent chemo-radiotherapy|concurrent chemo-radiotherapy
4975252|NCT01745432|ADBLOCK|adblock
4975253|NCT01745432|Adhesion Barrier System|adhesion barrier system
4975254|NCT01745432|laparoscopic surgery|laparoscopic surgery
4975255|NCT01745432|myomectomy|myomectomy
4975256|NCT01745419|COPD|copd
4975257|NCT01745419|Exacerbation|exacerbation
4975258|NCT01745419|Haptoglobin|haptoglobin
4975259|NCT01745393|Smoking Cessation|smoking cessation
4975260|NCT01745393|Secondhand Smoke|secondhand smoke
4975261|NCT01745393|Passive Smoking|passive smoking
4975262|NCT01745393|Cotinine|cotinine
4975263|NCT01745393|Nicotine Replacement Products|nicotine replacement products
4975264|NCT01745380|operative|operative
4975265|NCT01745380|dental procedure|dental procedure
4975266|NCT01745367|Tivozanib hydrochloride|tivozanib hydrochloride
4975267|NCT01745367|triple negative breast cancer|triple negative breast cancer
4975268|NCT01745367|paclitaxel|paclitaxel
4975269|NCT01745367|pharmacokinetics|pharmacokinetics
4975270|NCT01745367|biomarkers|biomarkers
4975271|NCT01745367|metastatic breast cancer|metastatic breast cancer
4975272|NCT01745367|mBC|mbc
4975273|NCT01745367|TNBC|tnbc
4975274|NCT01745328|recurrent urinary tract infection|recurrent urinary tract infection
4975275|NCT01745328|antibiotics|antibiotics
4975276|NCT01745328|traditional chinese medicine|traditional chinese medicine
4975277|NCT01745315|total laparoscopic hysterectomy|total laparoscopic hysterectomy
4975278|NCT01745315|LigaSure|ligasure
4975279|NCT01745315|EnSeal|enseal
4975280|NCT01745315|Halo PKS Cutting forceps|halo pks cutting forceps
4975281|NCT01745315|electrothermal bipolar vessel sealer|electrothermal bipolar vessel sealer
4975282|NCT01745315|advanced bipolar device|advanced bipolar device
4975283|NCT01745302|lung cancer|lung cancer
4975284|NCT01745302|traditional Chinese medicine|traditional chinese medicine
4975285|NCT01745302|EGFR-TKI|egfr-tki
4975286|NCT01745289|Breast Cancer|breast cancer
4975287|NCT01745289|Survival|survival
4975288|NCT01745289|Recurrence|recurrence
4975289|NCT01745276|Pin fixation|pin fixation
4975290|NCT01745276|Osteotomy|osteotomy
4975291|NCT01745276|hemicallotasis|hemicallotasis
4975292|NCT01745250|lip|lip
4975293|NCT01745250|fillers|fillers
4975294|NCT01745250|Hyaluronic acid|hyaluronic acid
4975295|NCT01745237|Sarcoidosis|sarcoidosis
4975296|NCT01745237|Cardiac Magnetic Resonance|cardiac magnetic resonance
4975297|NCT01745198|homocysteinemia|homocysteinemia
4975298|NCT01745198|dementia|dementia
4975299|NCT01745198|depression|depression
4975300|NCT01745198|vitamin B12|vitamin b12
4975301|NCT01745198|folate|folate
4975302|NCT01745198|mild cognitive impairment|mild cognitive impairment
4975303|NCT01745198|alzheimer's|alzheimer's
4975304|NCT01745198|homocysteine|homocysteine
4975305|NCT01745185|Fabry Disease|fabry disease
4975306|NCT01745185|immunity|immunity
4975307|NCT01745185|antibody|antibody
4975308|NCT01745159|tacrolimus|tacrolimus
4975309|NCT01745159|Protopic|protopic
4975310|NCT01745159|pediatric|pediatric
4975311|NCT01745159|atopic dermatitis|atopic dermatitis
4975312|NCT01745159|China|china
4975313|NCT01745146|traumatic brain injury|traumatic brain injury
4975314|NCT01745146|TBI|tbi
4975315|NCT01745146|head injury|head injury
4975316|NCT01745146|brain injury|brain injury
4975317|NCT01745146|Psych-educational treatment|psych-educational treatment
4975318|NCT01745146|Anger|anger
4975319|NCT01745146|irritability|irritability
4975320|NCT01745146|anger management|anger management
4975321|NCT01745133|Olux E foam|olux e foam
4975322|NCT01745133|Sorilux foam|sorilux foam
4975323|NCT01745120|gene therapy|gene therapy
4975324|NCT01745120|beta thalassemia|beta thalassemia
4975325|NCT01745120|hemoglobin|hemoglobin
4975326|NCT01745120|anemia|anemia
4975327|NCT01745120|CD34|cd34
4975826|NCT01742988|PI3K|pi3k
4975328|NCT01745107|T2-3N0M0 disease of esophageal neoplasm|t2-3n0m0 disease of esophageal neoplasm
4975329|NCT01745107|postoperative radiotherapy|postoperative radiotherapy
4975330|NCT01745107|intensity modulated radiation therapy|intensity modulated radiation therapy
4975331|NCT01745107|survival|survival
4975332|NCT01745094|mirabegron|mirabegron
4975333|NCT01745094|solifenacin|solifenacin
4975334|NCT01745068|fragility fracture|fragility fracture
4975335|NCT01745068|osteoporosis|osteoporosis
4975336|NCT01745068|fall prevention|fall prevention
4975337|NCT01745068|integrated program|integrated program
4975338|NCT01745068|interorganizational collaboration|interorganizational collaboration
4975339|NCT01745068|Canada|canada
4975340|NCT01745068|controlled clinical trial|controlled clinical trial
4975341|NCT01745068|evaluation|evaluation
4975342|NCT01745055|Pharmacokinetics|pharmacokinetics
4975343|NCT01745055|oral JAK inhibitor|oral jak inhibitor
4975344|NCT01745055|methotrexate (MTX)|methotrexate (mtx)
4975345|NCT01745055|rheumatoid arthritis (RA)|rheumatoid arthritis (ra)
4975346|NCT01745042|Postmenopausal Women|postmenopausal women
4975347|NCT01745042|Body Composition|body composition
4975348|NCT01745042|Metabolic Syndrome|metabolic syndrome
4975349|NCT01745042|Menopause Symptoms|menopause symptoms
4975350|NCT01745029|Gastrointestinal Motility|gastrointestinal motility
4975351|NCT01745029|Inflammatory Bowel Disease|inflammatory bowel disease
4975352|NCT01745029|Transit time|transit time
4975353|NCT01745016|dietary supplement|dietary supplement
4975354|NCT01745016|carnosine|carnosine
4975355|NCT01745003|Fibromyalgia|fibromyalgia
4975356|NCT01744990|Nuts|nuts
4975357|NCT01744990|allergy|allergy
4975358|NCT01744990|Oral food challenge|oral food challenge
4975359|NCT01744990|skin testing|skin testing
4975360|NCT01744990|basophil activation tests|basophil activation tests
4975361|NCT01744990|specific IgE's|specific ige's
4975362|NCT01744964|apomorphine|apomorphine
4975363|NCT01744964|dopamine transporter gene|dopamine transporter gene
4975364|NCT01744964|SLC6A3|slc6a3
4975365|NCT01744964|cold pressor test|cold pressor test
4975366|NCT01744964|tolerance|tolerance
4975367|NCT01744964|experimental pain|experimental pain
4975368|NCT01744964|dopamine agonist|dopamine agonist
4975369|NCT01744951|Adoption|adoption
4975370|NCT01744951|Foster care|foster care
4975371|NCT01744951|Substance abuse|substance abuse
4975372|NCT01744951|Older children|older children
4975373|NCT01744951|Mental health|mental health
4975374|NCT01744938|Postoperative Complications,|postoperative complications,
4975375|NCT01744938|mortality,|mortality,
4975376|NCT01744938|length of Stay,|length of stay,
4975377|NCT01744938|economics|economics
4975378|NCT01744912|Lymphoma|lymphoma
4975379|NCT01744912|monoclonal antibody|monoclonal antibody
4975380|NCT01744912|immunomodulatory agent|immunomodulatory agent
4975381|NCT01744912|ublituximab|ublituximab
4975382|NCT01744912|lenalidomide|lenalidomide
4975383|NCT01744899|Lumbosacral spine|lumbosacral spine
4975384|NCT01744899|Nerve roots|nerve roots
4975385|NCT01744899|Sitting|sitting
4975386|NCT01744899|H-reflex|h-reflex
4975387|NCT01744886|One-Lung Ventilation|one-lung ventilation
4975388|NCT01744886|Thoracic Surgical Procedures|thoracic surgical procedures
4975389|NCT01744886|Cardiac Surgical Procedures|cardiac surgical procedures
4975390|NCT01744834|Reward-based learning|reward-based learning
4975391|NCT01744834|Pavlovian-to-instrumental transfer|pavlovian-to-instrumental transfer
4975392|NCT01744834|Functional imaging|functional imaging
4975393|NCT01744834|alcohol use disorder risk|alcohol use disorder risk
4975394|NCT01744821|High Risk|high risk
4975395|NCT01744808|Healthy|healthy
4975396|NCT01744808|Normal|normal
4975397|NCT01744795|cardiac output|cardiac output
4975398|NCT01744795|thermodilution|thermodilution
4975399|NCT01744795|esophageal doppler|esophageal doppler
4975400|NCT01744795|trending ability|trending ability
4975401|NCT01744782|Nephropathic Cystinosis|nephropathic cystinosis
4975402|NCT01744782|Cysteamine|cysteamine
4975403|NCT01744782|Delayed-release Cysteamine|delayed-release cysteamine
4975404|NCT01744782|CTNS Protein, Human|ctns protein, human
4975405|NCT01744782|Orphan Disease|orphan disease
4975406|NCT01744769|thyroid cancer|thyroid cancer
4975407|NCT01744769|hypothyroidism|hypothyroidism
4975408|NCT01744769|metabolic parameters|metabolic parameters
4975409|NCT01744769|Hypothyroidism after levothyroxine withdrawal|hypothyroidism after levothyroxine withdrawal
4975410|NCT01744756|Subconjunctival Bevacizumab|subconjunctival bevacizumab
4975411|NCT01744756|Recurrent pterygium|recurrent pterygium
4975412|NCT01744743|preconception|preconception
4975413|NCT01744743|hypothyroidism|hypothyroidism
4975414|NCT01744743|neurocognitive development|neurocognitive development
4975415|NCT01744730|Bacterial infections|bacterial infections
4975416|NCT01744730|Obesity|obesity
4975417|NCT01744730|pharmacokinetics|pharmacokinetics
4975418|NCT01744730|clindamycin|clindamycin
4975419|NCT01744717|Pain|pain
4975420|NCT01744717|mechanical ventilation|mechanical ventilation
4975421|NCT01744717|uncommunicative|uncommunicative
4975422|NCT01744717|Adult ICU patients pain|adult icu patients pain
4975423|NCT01744704|Nerve Growth Factor|nerve growth factor
4975424|NCT01744704|Ophthalmic Solutions|ophthalmic solutions
4975425|NCT01744704|Eye Drops|eye drops
4975426|NCT01744704|rh-NGF|rh-ngf
4975429|NCT01744665|CML, chronic myeloid leukemia, stop, niotinib, discontinue, imatinib, switch, MR4.5, undetectable, bcr-abl|cml, chronic myeloid leukemia, stop, niotinib, discontinue, imatinib, switch, mr4.5, undetectable, bcr-abl
4975430|NCT01744652|Advanced Cancers|advanced cancers
4975431|NCT01744652|Advanced Malignancies|advanced malignancies
4975432|NCT01744652|Unresectable|unresectable
4975433|NCT01744652|Metastatic|metastatic
4975434|NCT01744652|Crizotinib|crizotinib
4975435|NCT01744652|PF-02341066|pf-02341066
4975436|NCT01744652|Xalkori|xalkori
4975437|NCT01744652|Dasatinib|dasatinib
4975438|NCT01744652|BMS-354825|bms-354825
4975439|NCT01744652|Sprycel|sprycel
4975440|NCT01744639|Hepatocellular carcinoma|hepatocellular carcinoma
4975441|NCT01744639|Radioablation|radioablation
4975442|NCT01744626|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
4975443|NCT01744626|Small Lymphocytic Lymphoma|small lymphocytic lymphoma
4975444|NCT01744613|Clopidogrel|clopidogrel
4975445|NCT01744613|platelet inhibition|platelet inhibition
4975446|NCT01744613|antiplatelet therapy|antiplatelet therapy
4975447|NCT01744613|peripheral arterial disease|peripheral arterial disease
4975448|NCT01744613|endovascular treatment|endovascular treatment
4975449|NCT01744613|angioplasty|angioplasty
4975450|NCT01744613|stenting|stenting
4975451|NCT01744600|Dementia|dementia
4975452|NCT01744600|Music Therapy|music therapy
4975453|NCT01744587|EBV|ebv
4975454|NCT01744587|EGCG|egcg
4975455|NCT01744561|Exercise|exercise
4975456|NCT01744561|Motivation|motivation
4975457|NCT01744561|Feedback|feedback
4975458|NCT01744561|web-based diary|web-based diary
4975459|NCT01744561|pedometer|pedometer
4975460|NCT01744535|smartphone|smartphone
4975461|NCT01744535|smartphone app|smartphone app
4975462|NCT01744535|smartphone application|smartphone application
4975463|NCT01744535|obesity|obesity
4975464|NCT01744535|overweight|overweight
4975465|NCT01744535|self monitoring|self monitoring
4975466|NCT01744496|Parkinson's Disease|parkinson's disease
4975467|NCT01744496|Rotigotine|rotigotine
4975468|NCT01744496|Chronic Pain|chronic pain
4975469|NCT01744496|Nonmotor symptoms|nonmotor symptoms
4975470|NCT01744483|pneumonia|pneumonia
4975471|NCT01744483|endotracheal intubation|endotracheal intubation
4975472|NCT01744470|Renal|renal
4975473|NCT01744470|Transplantation|transplantation
4975474|NCT01744470|Tacrolimus|tacrolimus
4975475|NCT01744457|tear film osmolarity|tear film osmolarity
4975476|NCT01744457|objective scattering index|objective scattering index
4975477|NCT01744457|tear break up time|tear break up time
4975478|NCT01744457|Schirmer I test|schirmer i test
4975479|NCT01744418|ESRD|esrd
4975480|NCT01744418|HEMODIALYSIS|hemodialysis
4975481|NCT01744418|CHRONIC RENAL INSUFFICIENCY|chronic renal insufficiency
4975482|NCT01744418|Renal Dialysis|renal dialysis
4975483|NCT01744418|Hemodiafiltration|hemodiafiltration
4975484|NCT01744418|Blood Vessel Prosthesis|blood vessel prosthesis
4975485|NCT01744418|Tissue-Engineered Vascular Graft|tissue-engineered vascular graft
4975486|NCT01744418|Vascular Prosthesis Implantation|vascular prosthesis implantation
4975487|NCT01744405|Chagas disease|chagas disease
4975488|NCT01744405|lactation|lactation
4975489|NCT01744405|breastmilk|breastmilk
4975490|NCT01744405|postpartum period|postpartum period
4975491|NCT01744405|infants|infants
4975492|NCT01744405|pediatric clinical pharmacology|pediatric clinical pharmacology
4975493|NCT01744405|developmental clinical pharmacology|developmental clinical pharmacology
4975494|NCT01744405|parasitology|parasitology
4975495|NCT01744405|trypanosoma cruzi|trypanosoma cruzi
4975496|NCT01744405|nifurtimox|nifurtimox
4975497|NCT01744353|newly diagnosed|newly diagnosed
4975498|NCT01744353|advanced pancreatic cancer|advanced pancreatic cancer
4975499|NCT01744353|pancreatic cancer|pancreatic cancer
4975500|NCT01744353|metastatic pancreatic cancer|metastatic pancreatic cancer
4975501|NCT01744353|pancreas|pancreas
4975502|NCT01744340|Head and Neck|head and neck
4975503|NCT01744340|Colon|colon
4975504|NCT01744314|Elbow trauma,Heterotopic Ossification,Indomethacin, Prophylaxis|elbow trauma,heterotopic ossification,indomethacin, prophylaxis
4975505|NCT01744301|Seizure|seizure
4975506|NCT01744301|Acid-suppressing drugs|acid-suppressing drugs
4975507|NCT01744301|Epidemiology|epidemiology
4975508|NCT01744288|Phase 1 Safety ,|phase 1 safety ,
4975509|NCT01744288|pharmacodynamic,|pharmacodynamic,
4975510|NCT01744288|Ticagrelor,|ticagrelor,
4975511|NCT01744288|Clopidogrel,|clopidogrel,
4975512|NCT01744288|Platelets|platelets
4975513|NCT01744275|Epilepsy|epilepsy
4975514|NCT01744275|Omega 3 fatty acids|omega 3 fatty acids
4975515|NCT01744262|intraocular pressure, total intravenous anesthesia, laparoscopic prostatectomy|intraocular pressure, total intravenous anesthesia, laparoscopic prostatectomy
4975516|NCT01744249|Advanced neuroendocrine tumours of non-pancreatic origin|advanced neuroendocrine tumours of non-pancreatic origin
4975517|NCT01744249|axitinib|axitinib
4975518|NCT01744236|GLP-1 Receptor Agonists, DPP-4 inhibitors|glp-1 receptor agonists, dpp-4 inhibitors
4975519|NCT01744223|iCaspase9|icaspase9
4975520|NCT01744223|iCasp9|icasp9
4975521|NCT01744223|Inducible Caspase|inducible caspase
4975522|NCT01744223|AP1903|ap1903
4975523|NCT01744223|Dimerizer drug|dimerizer drug
4975524|NCT01744223|T depleted|t depleted
4975525|NCT01744223|Suicide gene|suicide gene
4975526|NCT01744223|CD-34 selection|cd-34 selection
4975527|NCT01744223|haplotransplantation|haplotransplantation
4975528|NCT01744223|Graft versus host disease|graft versus host disease
4975529|NCT01744223|Allogenic transplantation|allogenic transplantation
4975530|NCT01744197|Pain control|pain control
4975531|NCT01744197|Needle stick pain|needle stick pain
4975532|NCT01744197|Venipuncture pain|venipuncture pain
4975533|NCT01744184|gastroscopy|gastroscopy
4975534|NCT01744184|diagnostic|diagnostic
4975535|NCT01744184|entonox|entonox
4975536|NCT01744158|cerebral palsy|cerebral palsy
4975537|NCT01744158|spasticity|spasticity
4975538|NCT01744158|dystonia|dystonia
4975539|NCT01744158|hypertonia|hypertonia
4975540|NCT01744158|register|register
4975541|NCT01744158|motor function|motor function
4975542|NCT01744132|eye care utilization|eye care utilization
4975543|NCT01744132|ophthalmology|ophthalmology
4975544|NCT01744132|educational intervention|educational intervention
4975545|NCT01744132|public health screening|public health screening
4975547|NCT01744093|COPD|copd
4975548|NCT01744093|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
4975549|NCT01744093|Emphysema|emphysema
4975550|NCT01744080|Rotator cuff|rotator cuff
4975551|NCT01744067|Renal transplantation|renal transplantation
4975552|NCT01744067|Interventional study|interventional study
4975553|NCT01744067|Glomerular filtration rate|glomerular filtration rate
4975554|NCT01744067|Renal function|renal function
4975555|NCT01744067|Proteinuria|proteinuria
4975556|NCT01744067|Cardiovascular risk markers|cardiovascular risk markers
4975557|NCT01744067|Blood pressure|blood pressure
4975558|NCT01744067|Flow mediated vasodilation|flow mediated vasodilation
4975559|NCT01744067|Heart rate variability|heart rate variability
4975560|NCT01744067|Pulse wave velocity|pulse wave velocity
4975561|NCT01744067|Lipids|lipids
4975562|NCT01744067|Blood glucose|blood glucose
4975563|NCT01744067|Bone mineral density|bone mineral density
4975564|NCT01744067|Body composition|body composition
4975565|NCT01744067|Fat distribution|fat distribution
4975566|NCT01744067|Body mass index|body mass index
4975567|NCT01744067|Fatty acid composition|fatty acid composition
4975568|NCT01744067|Tacrolimus pharmacokinetics|tacrolimus pharmacokinetics
4975569|NCT01744067|Omega-3 fatty acids|omega-3 fatty acids
4975570|NCT01744067|Marine n-3 fatty acids|marine n-3 fatty acids
4975571|NCT01744067|Fatty acids|fatty acids
4975572|NCT01744067|Gas chromatography|gas chromatography
4975573|NCT01744067|Interstitial fibrosis|interstitial fibrosis
4975574|NCT01744067|Inflammation|inflammation
4975575|NCT01744041|depression|depression
4975576|NCT01744041|pregnancy|pregnancy
4975577|NCT01744041|postpartum|postpartum
4975578|NCT01744041|psychotherapy|psychotherapy
4975579|NCT01744028|COPD, remote patient monitoring, Hub, exacerbations, EXACT|copd, remote patient monitoring, hub, exacerbations, exact
4975580|NCT01744015|Low back pain|low back pain
4975581|NCT01744002|Shoulder, Impingement syndrome, Neck|shoulder, impingement syndrome, neck
4975582|NCT01743976|neuropathic pain|neuropathic pain
4975583|NCT01743976|diabetic neuropathy|diabetic neuropathy
4975584|NCT01743976|neuropathic pain after back surgery|neuropathic pain after back surgery
4975585|NCT01743963|efficacy|efficacy
4975586|NCT01743963|glucocorticoid|glucocorticoid
4975587|NCT01743950|Glioblastoma|glioblastoma
4975588|NCT01743950|anaplastic glioma|anaplastic glioma
4975589|NCT01743937|Ischemic preconditioning|ischemic preconditioning
4975590|NCT01743937|Ticagrelor|ticagrelor
4975591|NCT01743937|Antiplatelet therapy|antiplatelet therapy
4975592|NCT01743937|Acute coronary syndrome|acute coronary syndrome
4975593|NCT01743924|Broccoli; Isothiocyanates; Pharmacokinetics; Sulforaphane; Myrosinase|broccoli; isothiocyanates; pharmacokinetics; sulforaphane; myrosinase
4975594|NCT01743911|Tadalafil|tadalafil
4975595|NCT01743911|Resistant Hypertension|resistant hypertension
4975596|NCT01743911|Left Ventricle Diastolic Dysfunction|left ventricle diastolic dysfunction
4975597|NCT01743911|Brain natriuretic peptide|brain natriuretic peptide
4975598|NCT01743885|Hemangioma|hemangioma
4975599|NCT01743885|Beta-blocker|beta-blocker
4975600|NCT01743885|Acebutolol|acebutolol
4975601|NCT01743885|Propranolol|propranolol
4975602|NCT01743885|Randomized controlled trial|randomized controlled trial
4975603|NCT01743885|Infants|infants
4975604|NCT01743872|Optical Coherence Tomography|optical coherence tomography
4975605|NCT01743872|Contrast|contrast
4975606|NCT01743872|Dextran|dextran
4975607|NCT01743872|Carbon Dioxide|carbon dioxide
4975608|NCT01743872|Imaging|imaging
4975609|NCT01743872|Catheter|catheter
4975610|NCT01743872|Lower Extremity Artery|lower extremity artery
4975611|NCT01743859|Myeloid|myeloid
4975612|NCT01743859|Leukemia|leukemia
4975613|NCT01743807|Relapsed|relapsed
4975614|NCT01743807|Minimal Residual Disease|minimal residual disease
4975615|NCT01743807|MRD|mrd
4975616|NCT01743807|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
4975617|NCT01743807|Acute Myelogenous Leukemia|acute myelogenous leukemia
4975618|NCT01743807|ALL|all
4975619|NCT01743807|AML|aml
4975620|NCT01743807|GNKG168|gnkg168
4975621|NCT01743807|Pediatric|pediatric
4975622|NCT01743807|Childhood|childhood
4975623|NCT01743781|comprehensive eye examination|comprehensive eye examination
4975624|NCT01743781|acceptance|acceptance
4975625|NCT01743781|glaucoma|glaucoma
4975626|NCT01743781|diabetic retinopathy|diabetic retinopathy
4975627|NCT01743768|Antisense oligonucleotide|antisense oligonucleotide
4975628|NCT01743768|Asthma|asthma
4975629|NCT01743768|Healthy subjects|healthy subjects
4975630|NCT01743768|Phase 1|phase 1
4975631|NCT01743768|Transcription factor GATA-3|transcription factor gata-3
4975632|NCT01743768|Oral inhalation|oral inhalation
4975633|NCT01743755|Community-acquired pneumonia|community-acquired pneumonia
4975634|NCT01743755|Dexamethasone|dexamethasone
4975635|NCT01743755|Corticosteroid|corticosteroid
4975636|NCT01743742|Oral vitamin E and vitamin C|oral vitamin e and vitamin c
4975637|NCT01743729|SAR 1118|sar 1118
4975638|NCT01743716|Major Depressive Disorder|major depressive disorder
4975639|NCT01743716|MDD|mdd
4975640|NCT01743716|depression|depression
4975641|NCT01743716|adolescent|adolescent
4975642|NCT01743703|traumatic injuries|traumatic injuries
4975643|NCT01743703|Whole-body MRI|whole-body mri
4975644|NCT01743703|Skeletal survey|skeletal survey
4975645|NCT01743703|Children|children
4975646|NCT01743703|Diagnostic|diagnostic
4975647|NCT01743690|Probiotic|probiotic
4975648|NCT01743690|Candida|candida
4975649|NCT01743690|Oral Lichen Planus|oral lichen planus
4975650|NCT01743677|TQT study|tqt study
4975651|NCT01743677|CP-690,550|cp-690,550
4975652|NCT01743664|Posttraumatic Stress Disorders|posttraumatic stress disorders
4975653|NCT01743664|Multiple Sclerosis|multiple sclerosis
4975654|NCT01743664|Eye Movement Desensitization Reprocessing|eye movement desensitization reprocessing
4975655|NCT01743664|Psychotherapy|psychotherapy
4975656|NCT01743664|Anxiety|anxiety
4975657|NCT01743664|Depression|depression
4975658|NCT01743664|Quality of Life|quality of life
4975659|NCT01743651|spasticity|spasticity
4975660|NCT01743651|multiple sclerosis|multiple sclerosis
4975661|NCT01743651|arbaclofen|arbaclofen
4975662|NCT01743612|healthy subject|healthy subject
4975663|NCT01743612|hand blood flow|hand blood flow
4975664|NCT01743612|laser speckle contrast imaging|laser speckle contrast imaging
4975665|NCT01743586|Lung cancer|lung cancer
4975666|NCT01743586|Chest physiotherapy|chest physiotherapy
4975667|NCT01743586|Respiratory muscle strength|respiratory muscle strength
4975668|NCT01743586|Dyspnea, Functional capacity|dyspnea, functional capacity
4975669|NCT01743586|Quality of life|quality of life
4975670|NCT01743560|Breast Neoplasms|breast neoplasms
4975671|NCT01743560|Neoplasms|neoplasms
4975672|NCT01743560|Breast diseases|breast diseases
4975673|NCT01743560|Skin diseases|skin diseases
4975674|NCT01743560|Exemestane|exemestane
4975675|NCT01743560|Antibiotics, Antineoplastic|antibiotics, antineoplastic
4975676|NCT01743560|Everolimus|everolimus
4975677|NCT01743560|Antineoplastic Agents|antineoplastic agents
4975678|NCT01743560|Therapeutic Uses|therapeutic uses
4975679|NCT01743560|Pharmacologic Actions|pharmacologic actions
4975680|NCT01743560|Immunosuppressive Agents|immunosuppressive agents
4975681|NCT01743560|Physiological Effects of Drugs|physiological effects of drugs
4975682|NCT01743560|Aromatase Inhibitors|aromatase inhibitors
4975683|NCT01743560|Enzyme Inhibitors|enzyme inhibitors
4975684|NCT01743560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
4975685|NCT01743547|Women|women
4975686|NCT01743547|Yoga|yoga
4975687|NCT01743547|Ovarian Cancer|ovarian cancer
4975688|NCT01743547|Lifestyle|lifestyle
4975689|NCT01743521|Hepatitis C|hepatitis c
4975690|NCT01743521|Individualised therapy|individualised therapy
4975691|NCT01743521|Response-guided therapy|response-guided therapy
4975692|NCT01743521|Telaprevir|telaprevir
4975693|NCT01743521|PEG-IFN|peg-ifn
4975694|NCT01743521|Ribavirin|ribavirin
4975695|NCT01743521|Hepatitis|hepatitis
4975696|NCT01743508|incomplete abortion|incomplete abortion
4975697|NCT01743508|misoprostol treatment|misoprostol treatment
4975698|NCT01743508|midwife|midwife
4975699|NCT01743508|uganda|uganda
4975700|NCT01743495|Medical Costs|medical costs
4975701|NCT01743495|improved IADLs|improved iadls
4975702|NCT01743495|and/or ADL's|and/or adl's
4975703|NCT01743495|decreased nursing home admissions|decreased nursing home admissions
4975704|NCT01743482|Testicular Cancer|testicular cancer
4975705|NCT01743482|Germ Cell Tumors|germ cell tumors
4975706|NCT01743482|Salvage Therapy|salvage therapy
4975707|NCT01743482|Pazopanib|pazopanib
4975708|NCT01743469|Advanced|advanced
4975709|NCT01743469|Metastatic|metastatic
4975710|NCT01743469|Hepatocellular cancer|hepatocellular cancer
4975711|NCT01743469|Ovarian cancer|ovarian cancer
4975712|NCT01743469|Renal cell cancer|renal cell cancer
4975713|NCT01743469|Gastric carcinoma|gastric carcinoma
4975714|NCT01743456|Postoperative cognitive dysfunction|postoperative cognitive dysfunction
4975715|NCT01743456|Coronary artery bypass graft surgery|coronary artery bypass graft surgery
4975716|NCT01743456|Postoperative cognitive improvement|postoperative cognitive improvement
4975717|NCT01743456|Postoperative delirium|postoperative delirium
4975718|NCT01743443|Corneal sensitivity|corneal sensitivity
4975719|NCT01743443|Cross-linking|cross-linking
4975720|NCT01743443|Keratoconus|keratoconus
4975721|NCT01743430|telerehabilitation|telerehabilitation
4975722|NCT01743430|stroke|stroke
4975723|NCT01743430|Berg balance scale|berg balance scale
4975724|NCT01743430|stroke impact scale|stroke impact scale
4975725|NCT01743430|mobility|mobility
4975726|NCT01743417|Cognitive rehabilitation|cognitive rehabilitation
4975727|NCT01743417|malaria|malaria
4975728|NCT01743417|neuropsychology|neuropsychology
4975729|NCT01743417|attention|attention
4975730|NCT01743417|working memory|working memory
4975731|NCT01743404|atherosclerosis|atherosclerosis
4975732|NCT01743404|inflammation|inflammation
4975733|NCT01743404|intima-media thickness|intima-media thickness
4975734|NCT01743391|IVF treatment|ivf treatment
4975735|NCT01743391|Office-hysteroscopy|office-hysteroscopy
4975736|NCT01743391|Endometrial biopsy|endometrial biopsy
4975737|NCT01743352|Large arteries|large arteries
4975738|NCT01743352|stiffness|stiffness
4975739|NCT01743352|intima media thickness|intima media thickness
4975740|NCT01743352|ultrasound imaging|ultrasound imaging
4975741|NCT01743339|Randomized Controlled Trial|randomized controlled trial
4975742|NCT01743339|Cognitive Therapy|cognitive therapy
4975743|NCT01743339|Stress Disorders, Post-Traumatic|stress disorders, post-traumatic
4975744|NCT01743339|Depression|depression
4975745|NCT01743339|Sleep|sleep
4975746|NCT01743326|Zygapophyseal Joint|zygapophyseal joint
4975747|NCT01743313|glucose metabolism disorders|glucose metabolism disorders
4975748|NCT01743313|metabolic syndrome|metabolic syndrome
4975749|NCT01743313|joint replacement|joint replacement
4975750|NCT01743313|osteoarthritis|osteoarthritis
4975751|NCT01743300|sunitinib|sunitinib
4975752|NCT01743300|pharmacokinetics|pharmacokinetics
4975753|NCT01743300|phenotyping|phenotyping
4975754|NCT01743300|interaction|interaction
4975755|NCT01743287|osteoarthritis of the knee|osteoarthritis of the knee
4975756|NCT01743274|acute coronary syndromes|acute coronary syndromes
4975757|NCT01743274|non-ST elevation myocardial infarction|non-st elevation myocardial infarction
4975758|NCT01743274|angioplasty|angioplasty
4975759|NCT01743274|fractional flow reserve|fractional flow reserve
4975760|NCT01743274|optical coherence tomography|optical coherence tomography
4975761|NCT01743261|severe brain injury|severe brain injury
4975762|NCT01743261|graded intensive rehabilitation|graded intensive rehabilitation
4975763|NCT01743248|vestibular schwannoma|vestibular schwannoma
4975764|NCT01743248|balance|balance
4975765|NCT01743248|psychological factors|psychological factors
4975766|NCT01743235|HSDD|hsdd
4975767|NCT01743209|androgen antagonists|androgen antagonists
4975768|NCT01743196|Folic acid|folic acid
4975769|NCT01743196|Folate|folate
4975770|NCT01743196|Pharmacokinetics|pharmacokinetics
4975771|NCT01743196|Women of Child Bearing Age|women of child bearing age
4975772|NCT01743183|hypertension|hypertension
4975773|NCT01743170|Blood pressure control|blood pressure control
4975774|NCT01743170|Hypertension|hypertension
4975775|NCT01743170|Office blood pressure|office blood pressure
4975776|NCT01743170|Self-measured blood pressure|self-measured blood pressure
4975777|NCT01743170|Telemonitoring|telemonitoring
4975778|NCT01743144|emergence agitation in children|emergence agitation in children
4975779|NCT01743144|sevoflurane|sevoflurane
4975780|NCT01743144|general anesthesia|general anesthesia
4975781|NCT01743144|magnesium sulphate|magnesium sulphate
4975782|NCT01743105|diaphragm movement|diaphragm movement
4975783|NCT01743105|ultrasound|ultrasound
4975784|NCT01743105|emergency room|emergency room
4975785|NCT01743092|Pathological gambling|pathological gambling
4975786|NCT01743092|treatment|treatment
4975787|NCT01743092|online counselling|online counselling
4975788|NCT01743092|webinar|webinar
4975789|NCT01743092|workbook|workbook
4975790|NCT01743079|Telbivudine|telbivudine
4975791|NCT01743079|Lamivudine|lamivudine
4975792|NCT01743079|safety|safety
4975793|NCT01743079|efficacy|efficacy
4975794|NCT01743079|pregnancy|pregnancy
4975795|NCT01743066|Arsenic|arsenic
4975796|NCT01743066|Arsenicosis|arsenicosis
4975797|NCT01743066|Buccal cells|buccal cells
4975798|NCT01743066|Serum|serum
4975799|NCT01743066|Vitamin E|vitamin e
4975800|NCT01743066|Cholesterol|cholesterol
4975801|NCT01743040|Coronary Artery Disease|coronary artery disease
4975802|NCT01743040|Nuclear Stress Test|nuclear stress test
4975803|NCT01743040|CT Angiography|ct angiography
4975804|NCT01743040|Angiography|angiography
4975805|NCT01743027|Allergic conjunctivitis|allergic conjunctivitis
4975806|NCT01743027|Olopatadine HCl solution|olopatadine hcl solution
4975807|NCT01743027|Conjunctival Allergen Challenge|conjunctival allergen challenge
4975808|NCT01743027|Itching eyes|itching eyes
4975809|NCT01743027|Ocular allergies|ocular allergies
4975810|NCT01743027|PATADAY|pataday
4975811|NCT01743027|PATANOL|patanol
4975812|NCT01743014|diabetes|diabetes
4975813|NCT01743014|diabetic nephropathy|diabetic nephropathy
4975814|NCT01743014|vascular inflammation|vascular inflammation
4975815|NCT01743014|oxidative stress|oxidative stress
4975816|NCT01743014|endothelial dysfunction|endothelial dysfunction
4975817|NCT01743014|Asymmetric dimethylarginine|asymmetric dimethylarginine
4975818|NCT01743014|High sensitivity CRP|high sensitivity crp
4975819|NCT01743014|albumine to creatinine ratio|albumine to creatinine ratio
4975820|NCT01743014|isoprostane|isoprostane
4975821|NCT01743014|clopidogrel|clopidogrel
4975822|NCT01743014|ramipril|ramipril
4975823|NCT01743014|carotid intima media thickness|carotid intima media thickness
4975824|NCT01743001|exercise capacity|exercise capacity
4975825|NCT01743001|Eisenmenger Syndrome|eisenmenger syndrome
4975827|NCT01742988|HDAC|hdac
4975828|NCT01742988|Open-Label|open-label
4975829|NCT01742988|Dose-Escalation|dose-escalation
4975830|NCT01742962|Prostatectomy|prostatectomy
4975831|NCT01742962|Prostate cancer|prostate cancer
4975832|NCT01742962|Orgasm|orgasm
4975833|NCT01742962|Urinary incontinence|urinary incontinence
4975834|NCT01742962|Climacturia(orgasm related urinary incontinence)|climacturia(orgasm related urinary incontinence)
4975835|NCT01742962|Penis|penis
4975836|NCT01742962|Dysorgasmia (pain in relation to orgasm)|dysorgasmia (pain in relation to orgasm)
4975837|NCT01742962|Pain|pain
4975838|NCT01742962|Anorgasmia|anorgasmia
4975839|NCT01742962|Penile shortening|penile shortening
4975840|NCT01742962|Erectile dysfunction|erectile dysfunction
4975841|NCT01742923|hypertension|hypertension
4975842|NCT01742923|medication adherence|medication adherence
4975843|NCT01742923|motivational interviewing|motivational interviewing
4975844|NCT01742897|Osteoarthritis, Knee|osteoarthritis, knee
4975845|NCT01742897|Transdermal therapeutic system (TTS) fentanyl|transdermal therapeutic system (tts) fentanyl
4975846|NCT01742897|Durogesic|durogesic
4975847|NCT01742884|Dry Eye Syndrome|dry eye syndrome
4975848|NCT01742871|Antivitamin K|antivitamin k
4975849|NCT01742871|Bleeding|bleeding
4975850|NCT01742871|Haemorrhage|haemorrhage
4975851|NCT01742871|Nutritional status|nutritional status
4975852|NCT01742871|impedancemetry|impedancemetry
4975853|NCT01742845|Ultrasound-guided|ultrasound-guided
4975854|NCT01742845|regional anaesthesia|regional anaesthesia
4975855|NCT01742845|Cervical block|cervical block
4975856|NCT01742832|Vilazodone|vilazodone
4975857|NCT01742832|Citalopram|citalopram
4975858|NCT01742832|Major Depressive Disorder|major depressive disorder
4975859|NCT01742819|Glaucoma, Optical Coherence Tomography, Progression|glaucoma, optical coherence tomography, progression
4975860|NCT01742806|Gastric cancer|gastric cancer
4975861|NCT01742806|Minimally invasive surgery|minimally invasive surgery
4975862|NCT01742806|Distal gastrectomy|distal gastrectomy
4975863|NCT01742806|Bio-absorbable Felt|bio-absorbable felt
4975864|NCT01742793|relapsed /refractory Hodgkin lymphoma|relapsed /refractory hodgkin lymphoma
4975865|NCT01742793|mature T-cell lymphoma|mature t-cell lymphoma
4975866|NCT01742793|multiple myeloma|multiple myeloma
4975867|NCT01742780|Intraosseous Vascular Access|intraosseous vascular access
4975868|NCT01742780|IO Access|io access
4975869|NCT01742780|IO Vascular Access|io vascular access
4975870|NCT01742780|EZ-IO|ez-io
4975871|NCT01742767|NSCLC; split dose Cisplatinum; Pemetrexed|nsclc; split dose cisplatinum; pemetrexed
4975872|NCT01742741|Diabetes Mellitus, Type 1 (T1DM)|diabetes mellitus, type 1 (t1dm)
4975873|NCT01742741|Continuous Glucose Monitor (CGM)|continuous glucose monitor (cgm)
4975874|NCT01742741|Artificial Pancreas (AP)|artificial pancreas (ap)
4975875|NCT01742741|Insulin Pump|insulin pump
4975876|NCT01742741|Closed Loop Control (CLC)|closed loop control (clc)
4975877|NCT01742741|Open Loop treatment|open loop treatment
4975878|NCT01742741|Diabetes Assistant|diabetes assistant
4975879|NCT01742741|DiAs|dias
4975880|NCT01742728|oxidative stress, antioxidant, periodontitis, serum immunoglobulin G|oxidative stress, antioxidant, periodontitis, serum immunoglobulin g
4975881|NCT01742728|antibody titer|antibody titer
4975882|NCT01742715|ARDS|ards
4975883|NCT01742715|Lung compliance|lung compliance
4975884|NCT01742702|Blood pressure|blood pressure
4975885|NCT01742702|Hypertension|hypertension
4975886|NCT01742702|Arterial stiffness|arterial stiffness
4975887|NCT01742702|Cardiac output|cardiac output
4975888|NCT01742702|Vascular resistance|vascular resistance
4975889|NCT01742702|Pulse wave reflection|pulse wave reflection
4975890|NCT01742702|Head-up tilt|head-up tilt
4975891|NCT01742689|Renal colic|renal colic
4975892|NCT01742689|Pain|pain
4975893|NCT01742689|Desmopressin|desmopressin
4975894|NCT01742689|Urinary obstruction|urinary obstruction
4975895|NCT01742689|Indomethacin|indomethacin
4975896|NCT01742676|tacrolimus|tacrolimus
4975898|NCT01742663|Diclofenac Sodium Gel 3%|diclofenac sodium gel 3%
4975899|NCT01742663|Solaraze® (diclofenac sodium) Gel 3%|solaraze® (diclofenac sodium) gel 3%
4975900|NCT01742663|Actinic Keratosis|actinic keratosis
4975901|NCT01742650|ankle; fracture; syndesmosis;|ankle; fracture; syndesmosis;
4975902|NCT01742637|Acne Vulgaris|acne vulgaris
4975903|NCT01742637|Adapalene and Benzoyl Peroxide Gel 0.1%/2.5%|adapalene and benzoyl peroxide gel 0.1%/2.5%
4975904|NCT01742637|Epiduo®|epiduo®
4975905|NCT01742624|immunosuppressant|immunosuppressant
4975906|NCT01742624|new-onset diabetes after kidney transplantation|new-onset diabetes after kidney transplantation
4975907|NCT01742624|NODAT|nodat
4975908|NCT01742611|CKD|ckd
4975909|NCT01742611|Not on dialysis|not on dialysis
4975910|NCT01742611|ASP1585|asp1585
4975911|NCT01742611|Bixalomer|bixalomer
4975912|NCT01742598|TAVI|tavi
4975913|NCT01742598|TAVR|tavr
4975914|NCT01742598|aortic stenosis|aortic stenosis
4975915|NCT01742598|Transcatheter|transcatheter
4975916|NCT01742598|valvular heart disease|valvular heart disease
4975917|NCT01742598|aortic valve stenosis|aortic valve stenosis
4975918|NCT01742598|aortic valve replacement|aortic valve replacement
4975919|NCT01742598|transcatheter aortic valve implantation|transcatheter aortic valve implantation
4975920|NCT01742585|CKD|ckd
4975921|NCT01742585|Not on dialysis|not on dialysis
4975922|NCT01742585|ASP1585|asp1585
4975923|NCT01742585|Bixalomer|bixalomer
4975924|NCT01742572|weight loss|weight loss
4975925|NCT01742572|obesity|obesity
4975926|NCT01742572|overweight|overweight
4975927|NCT01742572|diet|diet
4975928|NCT01742559|Treatment|treatment
4975929|NCT01742546|myofascial pain syndrome|myofascial pain syndrome
4975930|NCT01742546|therapeutic ultrasound|therapeutic ultrasound
4975931|NCT01742546|combine therapy|combine therapy
4975932|NCT01742533|Hormone Replacement Therapy，|hormone replacement therapy，
4975933|NCT01742533|Premature Ovarian Failure，|premature ovarian failure，
4975934|NCT01742533|Stem Cell Therapy|stem cell therapy
4975935|NCT01742520|Preterm infant|preterm infant
4975936|NCT01742520|pain|pain
4975937|NCT01742520|neurodevelopment|neurodevelopment
4975938|NCT01742507|Stent, OCT|stent, oct
4975939|NCT01742494|Esophageal Achalasia,|esophageal achalasia,
4975940|NCT01742494|Peroral endoscopic myotomy,|peroral endoscopic myotomy,
4975941|NCT01742494|Water-jet assisted|water-jet assisted
4975942|NCT01742481|childhood cancer survivors|childhood cancer survivors
4975943|NCT01742481|long-term follow-up care|long-term follow-up care
4975944|NCT01742481|health communication|health communication
4975945|NCT01742481|ethnic/racial minorities|ethnic/racial minorities
4975946|NCT01742481|longterm survivors|longterm survivors
4975947|NCT01742468|n-3 LC-PUFA, DHA, rheumatoid arthritis|n-3 lc-pufa, dha, rheumatoid arthritis
4975948|NCT01742455|Peripheral artery disease|peripheral artery disease
4975949|NCT01742455|Arterial Occlusive Diseases|arterial occlusive diseases
4975950|NCT01742455|Vascular Diseases|vascular diseases
4975951|NCT01742455|Cardiovascular Diseases|cardiovascular diseases
4975952|NCT01742455|Coronary Artery Disease|coronary artery disease
4975953|NCT01742455|Myocardial Ischemia|myocardial ischemia
4975954|NCT01742455|Arteriosclerosis|arteriosclerosis
4975955|NCT01742455|Pathologic Processes|pathologic processes
4975956|NCT01742442|Cancer|cancer
4975957|NCT01742442|elderly OR older|elderly or older
4975958|NCT01742442|chemotherapy|chemotherapy
4975959|NCT01742442|geriatric assessment|geriatric assessment
4975960|NCT01742429|Helicobacter pylori|helicobacter pylori
4975961|NCT01742429|second line treatment|second line treatment
4975962|NCT01742416|Arterial Cannulation|arterial cannulation
4975963|NCT01742416|Ultrasound|ultrasound
4975964|NCT01742416|Palpation Method|palpation method
4975965|NCT01742416|Pediatrics|pediatrics
4975966|NCT01742416|Cardiac Surgery|cardiac surgery
4975967|NCT01742416|Craniotomies|craniotomies
4975968|NCT01742416|Cranial Vault Surgery|cranial vault surgery
4975969|NCT01742416|Abdominal Procedures|abdominal procedures
4975970|NCT01742403|Prostate|prostate
4975971|NCT01742403|IGRT|igrt
4975972|NCT01742403|VMAT|vmat
4975973|NCT01742390|schizophrenia|schizophrenia
4975974|NCT01742390|risperidone|risperidone
4975975|NCT01742390|paliperidone|paliperidone
4975976|NCT01742390|aripiprazole|aripiprazole
4975977|NCT01742377|GERD|gerd
4975978|NCT01742377|Dyspepsia|dyspepsia
4975979|NCT01742377|Ambulatory 24-hour Esophageal pH Monitoring|ambulatory 24-hour esophageal ph monitoring
4975980|NCT01742377|Minimal change erosions|minimal change erosions
4975981|NCT01742364|disposable syringe jet injector (DSJI)|disposable syringe jet injector (dsji)
4975982|NCT01742364|DSJI|dsji
4975983|NCT01742364|BCG|bcg
4975984|NCT01742364|tuberculosis|tuberculosis
4975985|NCT01742364|intradermal delivery|intradermal delivery
4975986|NCT01742364|South Africa|south africa
4975987|NCT01742338|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
4975988|NCT01742338|COPD|copd
4975989|NCT01742338|Chronic bronchitis|chronic bronchitis
4975990|NCT01742338|emphysema|emphysema
4975991|NCT01742338|Corticosteroids|corticosteroids
4975992|NCT01742325|fatigue|fatigue
4975993|NCT01742325|walking|walking
4975994|NCT01742325|childhood cancer|childhood cancer
4975995|NCT01742325|sleep disturbance|sleep disturbance
4975996|NCT01742312|neoadjuvant chemotherapy|neoadjuvant chemotherapy
4975997|NCT01742312|oesophageal cancer|oesophageal cancer
4975998|NCT01742312|cardiorespiratory performance|cardiorespiratory performance
4975999|NCT01742299|Glivec/Gleevec|glivec/gleevec
4976000|NCT01742299|CML|cml
4976001|NCT01742299|GIST|gist
4976002|NCT01742299|Imatinib mesylate|imatinib mesylate
4976003|NCT01742286|pediatric|pediatric
4976004|NCT01742286|anaplastic lymphoma kinase|anaplastic lymphoma kinase
4976005|NCT01742286|ALK|alk
4976006|NCT01742286|ALK-activated tumors|alk-activated tumors
4976007|NCT01742286|neuroblastoma|neuroblastoma
4976008|NCT01742286|rhabdomyosarcoma|rhabdomyosarcoma
4976009|NCT01742286|anaplastic large-cell lymphoma|anaplastic large-cell lymphoma
4976010|NCT01742286|inflammatory myofibroblastic tumor|inflammatory myofibroblastic tumor
4976011|NCT01742260|Cranioplasty|cranioplasty
4976012|NCT01742260|Mesenchymal stromal cells|mesenchymal stromal cells
4976013|NCT01742260|Bioceramic polymer|bioceramic polymer
4976014|NCT01742247|Moisturizer, laser|moisturizer, laser
4976015|NCT01742221|Safety and Tolerability, Cytokines, Acute Radiation Syndrome, Hematopoietic Syndrome, Radiation Countermeasure|safety and tolerability, cytokines, acute radiation syndrome, hematopoietic syndrome, radiation countermeasure
4976016|NCT01742195|Endobronchial ultrasound|endobronchial ultrasound
4976017|NCT01742195|Bronchoscopy|bronchoscopy
4976018|NCT01742195|Patient satisfaction|patient satisfaction
4976019|NCT01742182|Parkinson's Disease|parkinson's disease
4976020|NCT01742182|Excessive Daytime Sleepiness|excessive daytime sleepiness
4976021|NCT01742182|Circadian Rhythms|circadian rhythms
4976022|NCT01742182|Light Therapy|light therapy
4976023|NCT01742169|Colorectal Cancer Screening|colorectal cancer screening
4976024|NCT01742169|Fecal Occult Blood Testing|fecal occult blood testing
4976026|NCT01742156|microangiopathy|microangiopathy
4976027|NCT01742156|patients|patients
4976028|NCT01742156|more likely|more likely
4976029|NCT01742156|to have tortuosity|to have tortuosity
4976030|NCT01742156|of conjunctival vessels|of conjunctival vessels
4976031|NCT01742143|Quality of life|quality of life
4976032|NCT01742143|cancer|cancer
4976033|NCT01742143|12-223|12-223
4976034|NCT01742130|Contrast-induced nephropathy|contrast-induced nephropathy
4976035|NCT01742130|Contrast media|contrast media
4976036|NCT01742130|Angiography|angiography
4976037|NCT01742130|Coronary percutaneous intervention|coronary percutaneous intervention
4976038|NCT01742117|percutaneous coronary intervention|percutaneous coronary intervention
4976039|NCT01742117|angioplasty|angioplasty
4976040|NCT01742104|glaucoma|glaucoma
4976041|NCT01742104|primary open-angle glaucoma|primary open-angle glaucoma
4976042|NCT01742104|observational study|observational study
4976043|NCT01742104|quality of life|quality of life
4976044|NCT01742091|Postmenopausal females|postmenopausal females
4976045|NCT01742091|Volunteers|volunteers
4976046|NCT01742078|Postmenopausal females|postmenopausal females
4976047|NCT01742078|Volunteers|volunteers
4976048|NCT01742065|Colorectal Cancer Screening|colorectal cancer screening
4976049|NCT01742065|Cancer Screening|cancer screening
4976050|NCT01742065|Pragmatic Trial|pragmatic trial
4976051|NCT01742052|relapsing-remitting multiple sclerosis|relapsing-remitting multiple sclerosis
4976052|NCT01742052|RRMS|rrms
4976053|NCT01742026|High risk aspergillosis infection patients|high risk aspergillosis infection patients
4976054|NCT01742013|Chronic Fatigue|chronic fatigue
4976055|NCT01742013|CFS|cfs
4976056|NCT01742013|ICF|icf
4976057|NCT01742013|human placenta|human placenta
4976058|NCT01742000|postmenopause|postmenopause
4976059|NCT01742000|phytoestrogen|phytoestrogen
4976060|NCT01742000|atherosclerosis|atherosclerosis
4976061|NCT01742000|intima-media thickness|intima-media thickness
4976062|NCT01741974|perimenopause|perimenopause
4976063|NCT01741974|phytoestrogen|phytoestrogen
4976064|NCT01741974|atherosclerosis|atherosclerosis
4976065|NCT01741974|intima-media thickness|intima-media thickness
4976066|NCT01741961|uncontrolled glaucoma|uncontrolled glaucoma
4976067|NCT01741961|glaucoma drainage device|glaucoma drainage device
4976068|NCT01741948|Provoked vestibulodynia|provoked vestibulodynia
4976069|NCT01741948|Hormonal contraceptives|hormonal contraceptives
4976070|NCT01741922|Low dose|low dose
4976071|NCT01741922|aspirin|aspirin
4976072|NCT01741922|ASA|asa
4976073|NCT01741922|Hypertension|hypertension
4976074|NCT01741922|blood pressure|blood pressure
4976075|NCT01741909|azythromycin|azythromycin
4976076|NCT01741909|community acquired pneumonia|community acquired pneumonia
4976077|NCT01741909|intravenous|intravenous
4976078|NCT01741909|oral|oral
4976079|NCT01741883|Randomized Controlled Trial|randomized controlled trial
4976080|NCT01741883|Patients´ Expectations|patients´ expectations
4976081|NCT01741883|Breast Cancer|breast cancer
4976082|NCT01741883|Adjuvant Endocrine Treatment|adjuvant endocrine treatment
4976083|NCT01741883|Nocebo|nocebo
4976084|NCT01741870|Nutritional supplement|nutritional supplement
4976085|NCT01741870|Nutritional status|nutritional status
4976086|NCT01741870|Physical functional activity|physical functional activity
4976087|NCT01741870|Nursing home elderly|nursing home elderly
4976088|NCT01741844|Acquired Immune Deficiency Syndrome|acquired immune deficiency syndrome
4976089|NCT01741844|TMC125|tmc125
4976090|NCT01741844|Etravirine|etravirine
4976091|NCT01741844|Intelence|intelence
4976092|NCT01741844|AIDS|aids
4976093|NCT01741831|Acquired Immune Deficiency Syndrome|acquired immune deficiency syndrome
4976094|NCT01741831|AIDS|aids
4976095|NCT01741831|TMC114|tmc114
4976096|NCT01741831|Darunavir|darunavir
4976097|NCT01741831|Prezista|prezista
4976098|NCT01741818|IVC|ivc
4976099|NCT01741818|ultrasonography|ultrasonography
4976100|NCT01741818|IVC collapsibility index|ivc collapsibility index
4976101|NCT01741818|IVC diameter|ivc diameter
4976102|NCT01741792|Relapsed DLBCL|relapsed dlbcl
4976103|NCT01741792|Refractory DLBCL|refractory dlbcl
4976104|NCT01741792|adult DLBCL|adult dlbcl
4976105|NCT01741792|Lymphoma|lymphoma
4976106|NCT01741792|Non-Hodgkin Lymphoma|non-hodgkin lymphoma
4976107|NCT01741792|Lymphatic diseases|lymphatic diseases
4976108|NCT01741792|Lymphoproliferative disorders|lymphoproliferative disorders
4976109|NCT01741792|bispecific antibody|bispecific antibody
4976110|NCT01741792|anti-CD19|anti-cd19
4976111|NCT01741792|Immunotherapeutic treatment|immunotherapeutic treatment
4976112|NCT01741792|Immunoproliferative disorders|immunoproliferative disorders
4976113|NCT01741779|whole body vibration training|whole body vibration training
4976114|NCT01741779|hypocaloric diet|hypocaloric diet
4976115|NCT01741779|prehypertension|prehypertension
4976116|NCT01741779|hypertension|hypertension
4976117|NCT01741779|obesity|obesity
4976118|NCT01741779|arterial function|arterial function
4976119|NCT01741779|arterial stiffness|arterial stiffness
4976120|NCT01741779|pulse wave velocity|pulse wave velocity
4976121|NCT01741779|autonomic function|autonomic function
4976122|NCT01741779|endothelial function|endothelial function
4976123|NCT01741779|adipocytokines|adipocytokines
4976124|NCT01741766|prehypertension|prehypertension
4976125|NCT01741766|hypertension|hypertension
4976126|NCT01741766|obesity|obesity
4976127|NCT01741766|stretching|stretching
4976128|NCT01741766|arterial function|arterial function
4976129|NCT01741766|arterial stiffness|arterial stiffness
4976130|NCT01741766|pulse wave velocity|pulse wave velocity
4976131|NCT01741766|autonomic function|autonomic function
4976132|NCT01741766|endothelial function|endothelial function
4976133|NCT01741753|Docetaxel Pretreated|docetaxel pretreated
4976134|NCT01741753|Castrate Resistant|castrate resistant
4976135|NCT01741753|Metastatic|metastatic
4976136|NCT01741740|pain, hernia, chronic, discomfort, retrospective|pain, hernia, chronic, discomfort, retrospective
4976137|NCT01741675|Questionnaires|questionnaires
4976138|NCT01741675|Quality of Life|quality of life
4976139|NCT01741675|Response rate|response rate
4976140|NCT01741649|Surgical wound infection|surgical wound infection
4976141|NCT01741649|Clorhexidine|clorhexidine
4976142|NCT01741649|Povidone|povidone
4976143|NCT01741610|Anaesthesia Spinal|anaesthesia spinal
4976144|NCT01741610|Ephedrine|ephedrine
4976145|NCT01741610|Fluid Therapy|fluid therapy
4976146|NCT01741610|Hypotension|hypotension
4976147|NCT01741558|Myocardial Ischemia|myocardial ischemia
4976148|NCT01741558|Myocardial Infarction|myocardial infarction
4976149|NCT01741558|Methotrexate|methotrexate
4976150|NCT01741558|Inflammation|inflammation
4976151|NCT01741558|Anti-Inflammatory Agents|anti-inflammatory agents
4976152|NCT01741558|Inflammation Mediators|inflammation mediators
4976153|NCT01741532|Pantothenate Kinase-associated Neurodegeneration|pantothenate kinase-associated neurodegeneration
4976154|NCT01741532|PKAN|pkan
4976155|NCT01741532|NBIA|nbia
4976156|NCT01741532|Deferiprone|deferiprone
4976157|NCT01741532|Ferriprox|ferriprox
4976158|NCT01741519|PK|pk
4976159|NCT01741519|PD|pd
4976160|NCT01741519|landiolol|landiolol
4976161|NCT01741519|esmolol|esmolol
4976162|NCT01741519|healthy volunteers phase I study|healthy volunteers phase i study
4976163|NCT01741506|Lung cancer|lung cancer
4976164|NCT01741506|Surgery|surgery
4976165|NCT01741506|Thromboembolism|thromboembolism
4976166|NCT01741506|Bleeding|bleeding
4976167|NCT01741493|Rheumatoid Arthritis|rheumatoid arthritis
4976168|NCT01741493|Methotrexate|methotrexate
4976169|NCT01741493|Tolerability|tolerability
4976170|NCT01741493|Pharmacokinetics|pharmacokinetics
4976171|NCT01741493|Safety|safety
4976172|NCT01741493|Tofacitinib|tofacitinib
4976173|NCT01741480|Outcomes|outcomes
4976174|NCT01741480|Early warning systems|early warning systems
4976175|NCT01741480|ICU transfer|icu transfer
4976176|NCT01741454|Tolterodine|tolterodine
4976177|NCT01741454|Tamsulosin|tamsulosin
4976178|NCT01741454|Ureteral Obstruction|ureteral obstruction
4976179|NCT01741441|Duodenogastroesophageal reflux|duodenogastroesophageal reflux
4976180|NCT01741441|Weakly acidic reflux|weakly acidic reflux
4976181|NCT01741441|Gastric emptying|gastric emptying
4976182|NCT01741441|Laparoscopic fundoplication|laparoscopic fundoplication
4976183|NCT01741428|CVD Risk score|cvd risk score
4976184|NCT01741428|Physical activity|physical activity
4976185|NCT01741428|Overweight|overweight
4976186|NCT01741428|Cholesterol|cholesterol
4976187|NCT01741428|LDL-Cholesterol|ldl-cholesterol
4976188|NCT01741428|HDL-Cholesterol|hdl-cholesterol
4976189|NCT01741428|Triglycerides|triglycerides
4976190|NCT01741428|HbA1C|hba1c
4976191|NCT01741428|Quality of life|quality of life
4976192|NCT01741402|Control posture|control posture
4976193|NCT01741402|Gait|gait
4976194|NCT01741402|Virtual Reality|virtual reality
4976195|NCT01741402|Elderly|elderly
4976196|NCT01741389|Circadian variation, hemostasis, melatonin, tetraplegia|circadian variation, hemostasis, melatonin, tetraplegia
4976197|NCT01741363|iFOBT|ifobt
4976198|NCT01741363|one-day sample|one-day sample
4976199|NCT01741363|two-day sample|two-day sample
4976200|NCT01741363|Helicobacter pylori stool antigen|helicobacter pylori stool antigen
4976201|NCT01741350|Methadone-maintenance|methadone-maintenance
4976202|NCT01741350|HIV|hiv
4976203|NCT01741350|Risk behavior|risk behavior
4976204|NCT01741350|Injection drug use|injection drug use
4976205|NCT01741350|Condom use|condom use
4976206|NCT01741350|Health care participation|health care participation
4976207|NCT01741350|Opioid replacement therapy|opioid replacement therapy
4976208|NCT01741337|central sleep apneas syndrome|central sleep apneas syndrome
4976209|NCT01741337|heart failure|heart failure
4976210|NCT01741337|all coronary reperfusions|all coronary reperfusions
4976211|NCT01741337|adaptive servo-ventilation treatment|adaptive servo-ventilation treatment
4976212|NCT01741311|viral load|viral load
4976213|NCT01741311|HIV|hiv
4976214|NCT01741311|CD4|cd4
4976215|NCT01741311|methadone maintenance|methadone maintenance
4976216|NCT01741311|substance use|substance use
4976217|NCT01741311|Antiretroviral therapy (ART)|antiretroviral therapy (art)
4976218|NCT01741298|Metabolic syndrome|metabolic syndrome
4976219|NCT01741285|Asthma|asthma
4976220|NCT01741285|Adenosine|adenosine
4976221|NCT01741285|Small airways|small airways
4976222|NCT01741285|Smokers|smokers
4976223|NCT01741285|Ex-smokers|ex-smokers
4976224|NCT01741272|rotator cuff tear|rotator cuff tear
4976225|NCT01741272|arthroscopically assisted|arthroscopically assisted
4976226|NCT01741272|health related quality of life(HRQL)|health related quality of life(hrql)
4976227|NCT01741272|functional outcome|functional outcome
4976228|NCT01741259|analgesia|analgesia
4976229|NCT01741259|meperidine|meperidine
4976230|NCT01741259|epidural|epidural
4976231|NCT01741246|Episodic migraine|episodic migraine
4976232|NCT01741246|Chronic migraine|chronic migraine
4976233|NCT01741246|Magnetic resonance imaging|magnetic resonance imaging
4976234|NCT01741246|Positron emission tomography|positron emission tomography
4976235|NCT01741233|SNPs|snps
4976236|NCT01741233|vitamin D|vitamin d
4976237|NCT01741233|Vitamin D status|vitamin d status
4976238|NCT01741233|UVB irradiation|uvb irradiation
4976239|NCT01741233|genetics|genetics
4976240|NCT01741181|25(OH)Vitamin D|25(oh)vitamin d
4976241|NCT01741181|Diabetes mellitus|diabetes mellitus
4976242|NCT01741181|Endothelial Function|endothelial function
4976243|NCT01741142|Major Depressive Disorder|major depressive disorder
4976244|NCT01741129|Nasal CPAP|nasal cpap
4976245|NCT01741129|Nasal IMV|nasal imv
4976246|NCT01741129|Surfactant|surfactant
4976247|NCT01741129|Preterm infants|preterm infants
4976248|NCT01741116|castration-resistant prostate cancer|castration-resistant prostate cancer
4976249|NCT01741116|TKI258|tki258
4976250|NCT01741116|FGF23|fgf23
4976251|NCT01741090|Autologous Mesenchymal stem cell|autologous mesenchymal stem cell
4976252|NCT01741090|alcoholic liver cirrhosis|alcoholic liver cirrhosis
4976253|NCT01741077|pregnancy|pregnancy
4976254|NCT01741077|folic acid supplementation|folic acid supplementation
4976255|NCT01741077|reproduction|reproduction
4976256|NCT01741077|folate|folate
4976257|NCT01741064|Secondary Hyperparathyroidism|secondary hyperparathyroidism
4976258|NCT01741064|Renal Transplantation|renal transplantation
4976259|NCT01741064|Myocardial Infarction|myocardial infarction
4976260|NCT01741064|Fracture|fracture
4976261|NCT01741064|Graft Failure|graft failure
4976262|NCT01741051|Air pollution|air pollution
4976263|NCT01741051|Particulate matter|particulate matter
4976264|NCT01741051|Mongolia|mongolia
4976265|NCT01741051|Pregnancy|pregnancy
4976266|NCT01741051|Intrauterine growth restriction (IUGR)|intrauterine growth restriction (iugr)
4976267|NCT01741051|Fetal growth|fetal growth
4976268|NCT01741051|Birth weight|birth weight
4976269|NCT01741051|Gestational age|gestational age
4976270|NCT01741038|Cancer Vaccine|cancer vaccine
4976271|NCT01741038|AlloStim®|allostim®
4976272|NCT01741038|Immunovative|immunovative
4976273|NCT01741038|Immunotherapy|immunotherapy
4976274|NCT01741038|Allogeneic Cell Therapy|allogeneic cell therapy
4976275|NCT01741038|Cryoablation|cryoablation
4976277|NCT01740986|Asthma|asthma
4976278|NCT01740973|SILC|silc
4976279|NCT01740973|lap. cholecystectomy|lap. cholecystectomy
4976280|NCT01740973|trocar-site hernia|trocar-site hernia
4976281|NCT01740960|delta-9-tetrahydrocannabinol|delta-9-tetrahydrocannabinol
4976282|NCT01740960|THC|thc
4976283|NCT01740960|Cannabis|cannabis
4976284|NCT01740947|Selective decontamination of the digestive tract|selective decontamination of the digestive tract
4976285|NCT01740947|anastomotic leakage|anastomotic leakage
4976286|NCT01740947|colorectal cancer|colorectal cancer
4976287|NCT01740934|rosacea|rosacea
4976288|NCT01740934|anatabine|anatabine
4976289|NCT01740934|Anatabloc|anatabloc
4976290|NCT01740934|dermatology|dermatology
4976291|NCT01740921|GLP-1 analogues|glp-1 analogues
4976292|NCT01740921|microvascular|microvascular
4976293|NCT01740921|inflammation|inflammation
4976294|NCT01740921|fat tissue|fat tissue
4976295|NCT01740921|clot structure|clot structure
4976296|NCT01740908|hyperbaric oxygen|hyperbaric oxygen
4976297|NCT01740908|stem cell|stem cell
4976298|NCT01740882|incisional hernia|incisional hernia
4976299|NCT01740882|mesh fixation|mesh fixation
4976300|NCT01740882|absorbable tacks|absorbable tacks
4976301|NCT01740869|autism|autism
4976302|NCT01740869|autism spectrum|autism spectrum
4976303|NCT01740869|stem cells|stem cells
4976304|NCT01740869|children|children
4976305|NCT01740856|cardiac catheterization|cardiac catheterization
4976306|NCT01740856|safety|safety
4976307|NCT01740856|nursing care|nursing care
4976308|NCT01740856|rest|rest
4976309|NCT01740856|Patients|patients
4976310|NCT01740817|diabetes|diabetes
4976311|NCT01740817|obesity|obesity
4976312|NCT01740817|inflammation|inflammation
4976313|NCT01740804|Circulating tumor cell|circulating tumor cell
4976314|NCT01740804|Non-small cell lung cancer|non-small cell lung cancer
4976315|NCT01740804|chemotherapy|chemotherapy
4976316|NCT01740791|Hepatitis C|hepatitis c
4976317|NCT01740791|HCV|hcv
4976318|NCT01740791|Genotype 1|genotype 1
4976319|NCT01740791|Genotype 2|genotype 2
4976320|NCT01740791|Genotype 3|genotype 3
4976321|NCT01740791|Genotype 4|genotype 4
4976322|NCT01740791|Genotype 5|genotype 5
4976323|NCT01740791|Genotype 6|genotype 6
4976324|NCT01740791|Liver Disease|liver disease
4976325|NCT01740778|Diabetes|diabetes
4976326|NCT01740778|Medical Device|medical device
4976327|NCT01740778|Lancing|lancing
4976328|NCT01740752|anorexia nervosa|anorexia nervosa
4976329|NCT01740752|eating disorder|eating disorder
4976330|NCT01740752|couples|couples
4976331|NCT01740752|relationships|relationships
4976332|NCT01740752|couple therapy|couple therapy
4976333|NCT01740739|Health Risk Appraisal|health risk appraisal
4976334|NCT01740739|HCardiac Risk Factors|hcardiac risk factors
4976335|NCT01740726|Depression|depression
4976336|NCT01740726|Behavioral Activation|behavioral activation
4976337|NCT01740726|Fluoxetine|fluoxetine
4976338|NCT01740726|Prozac|prozac
4976339|NCT01740726|Treatment|treatment
4976340|NCT01740726|Therapy|therapy
4976341|NCT01740726|Psychotherapy|psychotherapy
4976342|NCT01740726|Antidepressant|antidepressant
4976343|NCT01740726|Intervention|intervention
4976344|NCT01740713|chronic iron overload|chronic iron overload
4976345|NCT01740713|hereditary haemoglobinopathy|hereditary haemoglobinopathy
4976346|NCT01740713|beta thalassaemia major|beta thalassaemia major
4976347|NCT01740700|Abdominal aortic aneurysm|abdominal aortic aneurysm
4976348|NCT01740700|Endovascular|endovascular
4976349|NCT01740700|Fenestration|fenestration
4976350|NCT01740700|Juxtarenal|juxtarenal
4976351|NCT01740700|Off-the-shelf|off-the-shelf
4976352|NCT01740700|Pararenal|pararenal
4976353|NCT01740687|Endometrial Ablation|endometrial ablation
4976354|NCT01740687|Permanent Sterilization|permanent sterilization
4976355|NCT01740687|Essure|essure
4976356|NCT01740687|NovaSure|novasure
4976357|NCT01740687|Prevention of Pregnancy|prevention of pregnancy
4976358|NCT01740674|internet data collection|internet data collection
4976359|NCT01740674|longitudinal research|longitudinal research
4976360|NCT01740674|cohort retention|cohort retention
4976361|NCT01740648|MEK Inhibitor|mek inhibitor
4976362|NCT01740648|Trametinib|trametinib
4976363|NCT01740648|Rectal Cancers|rectal cancers
4976364|NCT01740648|KRAS|kras
4976365|NCT01740648|BRAF|braf
4976366|NCT01740648|NRAS Mutant|nras mutant
4976367|NCT01740648|Fluorouracil|fluorouracil
4976368|NCT01740635|rehabilitation|rehabilitation
4976369|NCT01740635|wheelchair|wheelchair
4976370|NCT01740635|manual wheelchair|manual wheelchair
4976371|NCT01740635|wheelchair users|wheelchair users
4976372|NCT01740635|older adults|older adults
4976373|NCT01740635|cognitive computer games|cognitive computer games
4976374|NCT01740635|home-based training|home-based training
4976375|NCT01740635|community mobility|community mobility
4976376|NCT01740622|Injury|injury
4976377|NCT01740622|Injury Prevention|injury prevention
4976378|NCT01740622|Cincinnati Home Injury Prevention|cincinnati home injury prevention
4976379|NCT01740622|Injury Hazards|injury hazards
4976380|NCT01740622|Modifiable Injury Hazards|modifiable injury hazards
4976381|NCT01740609|Phase 1|phase 1
4976382|NCT01740609|RN168|rn168
4976383|NCT01740609|Healthy Volunteers|healthy volunteers
4976384|NCT01740596|NYHA III|nyha iii
4976385|NCT01740596|NYHA IV|nyha iv
4976386|NCT01740596|ACC Stage C|acc stage c
4976387|NCT01740596|Heart Failure|heart failure
4976388|NCT01740596|Congestive Heart Failure|congestive heart failure
4976389|NCT01740596|C-Pulse|c-pulse
4976390|NCT01740596|Counterpulsation|counterpulsation
4976391|NCT01740596|Heart Assist|heart assist
4976392|NCT01740596|Sunshine Heart|sunshine heart
4976393|NCT01740596|Left Heart Failure|left heart failure
4976394|NCT01740583|mitral valve, regurgitation, annuloplasty|mitral valve, regurgitation, annuloplasty
4976395|NCT01740570|Brain cancer|brain cancer
4976396|NCT01740570|Malignant glioma|malignant glioma
4976397|NCT01740570|Glioblastoma multiforme|glioblastoma multiforme
4976398|NCT01740570|Gliosarcoma|gliosarcoma
4976399|NCT01740570|Anaplastic astrocytoma|anaplastic astrocytoma
4976400|NCT01740570|Anaplastic oligodendroglioma|anaplastic oligodendroglioma
4976401|NCT01740570|Anaplastic oligoastrocytoma|anaplastic oligoastrocytoma
4976402|NCT01740570|Cabazitaxel|cabazitaxel
4976403|NCT01740570|Jevtana|jevtana
4976404|NCT01740557|Melanoma|melanoma
4976405|NCT01740557|Metastatic Melanoma|metastatic melanoma
4976406|NCT01740557|Stage III in-transit, subcutaneous, or regional nodal disease|stage iii in-transit, subcutaneous, or regional nodal disease
4976407|NCT01740557|Cytoxan|cytoxan
4976408|NCT01740557|Cyclophosphamide|cyclophosphamide
4976409|NCT01740557|Neosar|neosar
4976410|NCT01740557|Mesna|mesna
4976411|NCT01740557|Mesnex|mesnex
4976412|NCT01740557|Fludarabine|fludarabine
4976413|NCT01740557|Fludarabine Phosphate|fludarabine phosphate
4976414|NCT01740557|Fludara|fludara
4976415|NCT01740557|IL-2|il-2
4976416|NCT01740557|Interleukin-2|interleukin-2
4976417|NCT01740557|Aldesleukin|aldesleukin
4976418|NCT01740557|Proleukin|proleukin
4976419|NCT01740557|T-cells|t-cells
4976420|NCT01740557|Autologous tumor infiltrating lymphocytes|autologous tumor infiltrating lymphocytes
4976421|NCT01740557|TIL|til
4976422|NCT01740557|CXCR2|cxcr2
4976423|NCT01740531|S303 treated RBCs|s303 treated rbcs
4976424|NCT01740505|energy cost of walking|energy cost of walking
4976425|NCT01740505|energy metabolism|energy metabolism
4976426|NCT01740505|aged|aged
4976427|NCT01740505|older adult|older adult
4976428|NCT01740505|exercise|exercise
4976429|NCT01740505|gait|gait
4976430|NCT01740505|walking|walking
4976431|NCT01740505|aerobic|aerobic
4976432|NCT01740505|motor skill|motor skill
4976433|NCT01740492|Ketamine|ketamine
4976434|NCT01740492|Acute pain|acute pain
4976435|NCT01740492|Pain control|pain control
4976436|NCT01740492|Pain|pain
4976437|NCT01740479|STEMI|stemi
4976438|NCT01740479|ticagrelor|ticagrelor
4976439|NCT01740479|multi-vessel disease|multi-vessel disease
4976440|NCT01740479|culprit lesion|culprit lesion
4976441|NCT01740466|Prevalence|prevalence
4976442|NCT01740466|Vision disorders|vision disorders
4976443|NCT01740466|Eye diseases|eye diseases
4976444|NCT01740466|Visual acuity|visual acuity
4976445|NCT01740466|Primary health care|primary health care
4976446|NCT01740440|Healthy females|healthy females
4976447|NCT01740427|breast cancer|breast cancer
4976448|NCT01740427|postmenopausal women|postmenopausal women
4976449|NCT01740427|estrogen-receptor positive|estrogen-receptor positive
4976450|NCT01740427|HER2 negative|her2 negative
4976451|NCT01740427|locoregionally recurrent|locoregionally recurrent
4976452|NCT01740427|metastatic|metastatic
4976453|NCT01740427|Palbociclib (PD-0332991)|palbociclib (pd-0332991)
4976454|NCT01740427|PALOMA-2|paloma-2
4976455|NCT01740414|prescription opioid abuse|prescription opioid abuse
4976456|NCT01740414|pain|pain
4976457|NCT01740414|opioid withdrawal|opioid withdrawal
4976458|NCT01740414|oxycodone|oxycodone
4976459|NCT01740414|ibudilast|ibudilast
4976460|NCT01740401|Melanoma|melanoma
4976461|NCT01740401|Advanced Malignant Melanoma|advanced malignant melanoma
4976462|NCT01740401|Anti CTLA4 Blockade|anti ctla4 blockade
4976463|NCT01740401|Progression Free Survival|progression free survival
4976464|NCT01740401|Interventional Therapy|interventional therapy
4976465|NCT01740401|Phase II Clinical Trial|phase ii clinical trial
4976466|NCT01740401|Immunotherapy|immunotherapy
4976467|NCT01740401|T Cell Activation|t cell activation
4976468|NCT01740362|CP-690|cp-690
4976469|NCT01740362|550|550
4976470|NCT01740362|pharmacokinetics|pharmacokinetics
4976471|NCT01740362|renal impairment|renal impairment
4976472|NCT01740323|Breast Cancer|breast cancer
4976473|NCT01740323|Chemotherapy|chemotherapy
4976474|NCT01740323|Radiotherapy|radiotherapy
4976475|NCT01740323|NF-kB|nf-kb
4976476|NCT01740323|DNA Binding|dna binding
4976477|NCT01740323|Curcumin|curcumin
4976478|NCT01740323|IL-6|il-6
4976479|NCT01740323|TNF|tnf
4976480|NCT01740323|sTNFR2|stnfr2
4976481|NCT01740323|IL-1-ra|il-1-ra
4976482|NCT01740323|Fatigue|fatigue
4976483|NCT01740323|Cytokine|cytokine
4976484|NCT01740310|pregnancy,|pregnancy,
4976485|NCT01740310|vaccine acceptance,|vaccine acceptance,
4976486|NCT01740310|vaccination,|vaccination,
4976487|NCT01740310|influenza,|influenza,
4976488|NCT01740310|pertussis,|pertussis,
4976489|NCT01740310|Tdap,|tdap,
4976490|NCT01740310|minority,|minority,
4976491|NCT01740310|African-American|african-american
4976492|NCT01740297|melanoma, talimogene laherparepvec, ipilimumab, metastatic melanoma, melanoma, immunotherapy, unresectable melanoma, oncolytic immunotherapy,|melanoma, talimogene laherparepvec, ipilimumab, metastatic melanoma, melanoma, immunotherapy, unresectable melanoma, oncolytic immunotherapy,
4976493|NCT01740271|breast cancer|breast cancer
4976494|NCT01740271|non-metastatic carcinoma of the breast chemotherapy|non-metastatic carcinoma of the breast chemotherapy
4976495|NCT01740271|adjuvant therapy|adjuvant therapy
4976496|NCT01740271|neoadjuvant|neoadjuvant
4976497|NCT01740258|malignant glioma|malignant glioma
4976498|NCT01740258|Grade 4 malignant glioma|grade 4 malignant glioma
4976499|NCT01740258|glioblastoma|glioblastoma
4976500|NCT01740258|gliosarcoma|gliosarcoma
4976501|NCT01740258|adult brain tumor|adult brain tumor
4976502|NCT01740245|Laser therapy|laser therapy
4976503|NCT01740245|Cervical lesions|cervical lesions
4976504|NCT01740245|Polyhexamethylene biguanide|polyhexamethylene biguanide
4976505|NCT01740245|Chlorhexidine|chlorhexidine
4976506|NCT01740219|Health promotion|health promotion
4976507|NCT01740219|Religion and medicine|religion and medicine
4976508|NCT01740219|Hispanic Americans|hispanic americans
4976509|NCT01740219|Randomized controlled trial|randomized controlled trial
4976510|NCT01740219|Program evaluation|program evaluation
4976511|NCT01740219|Neoplasms/prevention & control|neoplasms/prevention & control
4976512|NCT01740219|Mass screening|mass screening
4976513|NCT01740219|Female|female
4976514|NCT01740219|Male|male
4976515|NCT01740219|Preventive Health Services/methods|preventive health services/methods
4976516|NCT01740219|Adult|adult
4976517|NCT01740219|Organizations|organizations
4976518|NCT01740193|Pain|pain
4976519|NCT01740193|Regional Anesthesia|regional anesthesia
4976520|NCT01740193|ultrasound|ultrasound
4976521|NCT01740193|transversus abdominis plane|transversus abdominis plane
4976522|NCT01740193|herniorrhaphy|herniorrhaphy
4976523|NCT01740193|pediatrics|pediatrics
4976524|NCT01740167|prodrome|prodrome
4976525|NCT01740167|mental illness|mental illness
4976526|NCT01740167|health promotion|health promotion
4976527|NCT01740167|lifestyle behavior|lifestyle behavior
4976528|NCT01740141|Pain|pain
4976529|NCT01740128|spinal cord injuries|spinal cord injuries
4976530|NCT01740128|paraplegia|paraplegia
4976531|NCT01740128|postural balance|postural balance
4976532|NCT01740128|locomotor activity|locomotor activity
4976533|NCT01740128|exercise therapy|exercise therapy
4976534|NCT01740128|electromyography|electromyography
4976535|NCT01740128|transcranial magnetic stimulation, single pulse|transcranial magnetic stimulation, single pulse
4976537|NCT01740115|Alcohol Use|alcohol use
4976538|NCT01740115|Bone Disease|bone disease
4976539|NCT01740115|Bone Mineral Density|bone mineral density
4976540|NCT01740115|Bone Microarchitecture|bone microarchitecture
4976541|NCT01740115|Substance Dependence|substance dependence
4976542|NCT01740102|Ischemic preconditioning|ischemic preconditioning
4976543|NCT01740102|Coronary artery bypass|coronary artery bypass
4976544|NCT01740102|Preoperative care|preoperative care
4976545|NCT01740102|Postoperative period|postoperative period
4976546|NCT01740089|Hepatitis C|hepatitis c
4976547|NCT01740089|Cepeginterferon alfa|cepeginterferon alfa
4976548|NCT01740089|Peginterferon|peginterferon
4976549|NCT01740089|Treatment|treatment
4976550|NCT01740076|isoflavones, hypertension, soy, diet, nutrition, women, inflammation, hot flashes|isoflavones, hypertension, soy, diet, nutrition, women, inflammation, hot flashes
4976551|NCT01740037|Chronic care program|chronic care program
4976552|NCT01740037|Nurse specialist|nurse specialist
4976553|NCT01740037|Atrial Fibrillation guideline|atrial fibrillation guideline
4976554|NCT01740024|Immunotherapy|immunotherapy
4976555|NCT01740024|Subcutaneous immunotherapy|subcutaneous immunotherapy
4976556|NCT01740024|Skin Prick Test|skin prick test
4976557|NCT01740024|Dose Response Prick Test|dose response prick test
4976558|NCT01739985|Postoperative|postoperative
4976559|NCT01739985|Vomiting|vomiting
4976560|NCT01739985|Children|children
4976561|NCT01739985|Prophylaxis|prophylaxis
4976562|NCT01739985|Droperidol|droperidol
4976563|NCT01739985|Ondansetron|ondansetron
4976564|NCT01739985|Dexamethasone|dexamethasone
4976565|NCT01739972|Desiccated thyroid extract and levothyroxine|desiccated thyroid extract and levothyroxine
4976566|NCT01739959|Necrotizing fasciitis|necrotizing fasciitis
4976567|NCT01739959|Fournier's gangrene|fournier's gangrene
4976568|NCT01739959|Cellulitis|cellulitis
4976569|NCT01739959|Serum Lactate|serum lactate
4976570|NCT01739933|Delirium|delirium
4976571|NCT01739933|Delirium/coma-free days|delirium/coma-free days
4976572|NCT01739933|Long term cognitive impairment|long term cognitive impairment
4976573|NCT01739933|Sedation|sedation
4976574|NCT01739933|Intensive care|intensive care
4976575|NCT01739933|Mechanical Ventilation|mechanical ventilation
4976576|NCT01739933|Dexmedetomidine|dexmedetomidine
4976577|NCT01739933|Propofol|propofol
4976578|NCT01739933|Coma-free days|coma-free days
4976579|NCT01739933|Sepsis|sepsis
4976580|NCT01739933|Organ dysfunction|organ dysfunction
4976581|NCT01739933|Acute Respiratory Distress|acute respiratory distress
4976582|NCT01739933|Markers of inflammation|markers of inflammation
4976583|NCT01739920|Povidone-Iodine|povidone-iodine
4976584|NCT01739920|Ophthalmic Solutions|ophthalmic solutions
4976585|NCT01739920|Endophthalmitis|endophthalmitis
4976586|NCT01739920|Preoperative procedures|preoperative procedures
4976587|NCT01739907|Iron deficiency|iron deficiency
4976588|NCT01739907|Menstruating women|menstruating women
4976589|NCT01739907|Vitamin D|vitamin d
4976590|NCT01739907|Functional food|functional food
4976591|NCT01739894|Advanced gastric cancer|advanced gastric cancer
4976592|NCT01739894|unresectable gastric cancer|unresectable gastric cancer
4976593|NCT01739894|recurrent gastric cancer|recurrent gastric cancer
4976594|NCT01739894|with peritoneal metastasis|with peritoneal metastasis
4976595|NCT01739894|cancer cells on peritoneal cytology|cancer cells on peritoneal cytology
4976596|NCT01739881|Exhaled breath condensate (EBC) method|exhaled breath condensate (ebc) method
4976597|NCT01739881|Volatile Organic Compounds (VOCs)|volatile organic compounds (vocs)
4976598|NCT01739881|Endobronchial Ultrasound (EBUS)|endobronchial ultrasound (ebus)
4976599|NCT01739881|Confocal Endoscopy|confocal endoscopy
4976600|NCT01739881|Exhaled alveolar gas|exhaled alveolar gas
4976601|NCT01739868|Pre-diabetes|pre-diabetes
4976602|NCT01739868|Type 2 diabetes|type 2 diabetes
4976603|NCT01739868|Biomarkers|biomarkers
4976604|NCT01739868|Diabetes risk score|diabetes risk score
4976605|NCT01739842|Alcohol consumption|alcohol consumption
4976606|NCT01739842|Kudzu extract|kudzu extract
4976607|NCT01739842|Cerebral blood flow|cerebral blood flow
4976608|NCT01739829|xenotransplantation|xenotransplantation
4976609|NCT01739829|type 1 diabetes|type 1 diabetes
4976610|NCT01739829|porcine islets|porcine islets
4976611|NCT01739816|Compliance|compliance
4976612|NCT01739816|Adherence|adherence
4976613|NCT01739816|Polypharmacy|polypharmacy
4976614|NCT01739816|Medicines use|medicines use
4976615|NCT01739816|Medication review|medication review
4976616|NCT01739816|Pharmaceutical care|pharmaceutical care
4976617|NCT01739816|Primary care|primary care
4976618|NCT01739816|Drug related problem|drug related problem
4976619|NCT01739816|Patient safety|patient safety
4976620|NCT01739803|Immunosuppressant therapy adherence|immunosuppressant therapy adherence
4976621|NCT01739803|Quality of life|quality of life
4976622|NCT01739803|Economic outcomes|economic outcomes
4976623|NCT01739790|COPD|copd
4976624|NCT01739790|Chronic Bronchitis|chronic bronchitis
4976625|NCT01739790|N-acetylcysteine|n-acetylcysteine
4976626|NCT01739777|Heart Failure|heart failure
4976627|NCT01739777|Coronary Heart Disease|coronary heart disease
4976628|NCT01739777|Adult Stem Cells|adult stem cells
4976629|NCT01739777|Umbilical Progenitor Cells|umbilical progenitor cells
4976630|NCT01739777|Umbilical Cord Stem Cells Allogenic|umbilical cord stem cells allogenic
4976631|NCT01739777|Left Ventricular Function|left ventricular function
4976632|NCT01739777|Intravenous Injection|intravenous injection
4976633|NCT01739751|COPD|copd
4976634|NCT01739751|Physical activity|physical activity
4976635|NCT01739751|Pedometers|pedometers
4976636|NCT01739751|steps|steps
4976637|NCT01739751|non pharmacological treatment|non pharmacological treatment
4976638|NCT01739751|rehabilitation|rehabilitation
4976639|NCT01739751|exercise|exercise
4976640|NCT01739738|peristalsis, kidney stones, hydronephrosis, ureteral stent|peristalsis, kidney stones, hydronephrosis, ureteral stent
4976641|NCT01739725|kidney stones, ureteral stent, pain,|kidney stones, ureteral stent, pain,
4976642|NCT01739712|Diabetes|diabetes
4976643|NCT01739712|Sleep problems|sleep problems
4976644|NCT01739712|School|school
4976645|NCT01739712|Neurobehavioral|neurobehavioral
4976646|NCT01739699|craniotomy|craniotomy
4976647|NCT01739699|brain surgery|brain surgery
4976648|NCT01739699|acetaminophen|acetaminophen
4976649|NCT01739699|Tylenol|tylenol
4976650|NCT01739686|Quality of Life|quality of life
4976651|NCT01739686|Symptoms|symptoms
4976652|NCT01739686|Palliative care|palliative care
4976653|NCT01739686|Symptom management|symptom management
4976654|NCT01739686|Disease management|disease management
4976655|NCT01739686|Health delivery|health delivery
4976656|NCT01739673|Infectious Keratitis|infectious keratitis
4976657|NCT01739660|Chronic Kidney Disease Stage 5|chronic kidney disease stage 5
4976658|NCT01739660|Hemodialysis|hemodialysis
4976659|NCT01739660|pegloticase|pegloticase
4976660|NCT01739647|AZD3293|azd3293
4976661|NCT01739647|Healthy volunteers|healthy volunteers
4976662|NCT01739647|Elderly volunteers|elderly volunteers
4976663|NCT01739647|Phase 1|phase 1
4976664|NCT01739647|Single Ascending Dose Study|single ascending dose study
4976665|NCT01739634|Diarrhea|diarrhea
4976666|NCT01739634|Medullary thyroid cancer|medullary thyroid cancer
4976667|NCT01739608|CRC|crc
4976668|NCT01739569|Diet treatment|diet treatment
4976669|NCT01739569|Mental Health|mental health
4976670|NCT01739569|Reaction time|reaction time
4976671|NCT01739569|State of moods|state of moods
4976672|NCT01739569|Working hours|working hours
4976673|NCT01739569|Medical Hospital Staff|medical hospital staff
4976674|NCT01739556|antiplatelet therapy|antiplatelet therapy
4976675|NCT01739556|primary PCI|primary pci
4976676|NCT01739556|modification|modification
4976677|NCT01739517|Short bowel syndrome|short bowel syndrome
4976678|NCT01739517|Cholestasis|cholestasis
4976679|NCT01739517|Omegaven|omegaven
4976680|NCT01739517|Parenteral nutrition-associated Liver Disease|parenteral nutrition-associated liver disease
4976681|NCT01739504|Arthritis|arthritis
4976682|NCT01739504|Joint pain|joint pain
4976683|NCT01739504|Articular cartilage|articular cartilage
4976684|NCT01739504|Mesenchymal stem cells|mesenchymal stem cells
4976685|NCT01739504|Autologous|autologous
4976686|NCT01739504|Adipose tissue|adipose tissue
4976687|NCT01739491|Chronic lymphocytic leukemia|chronic lymphocytic leukemia
4976688|NCT01739491|Bendamustine hydrochloride|bendamustine hydrochloride
4976689|NCT01739491|Leukemia|leukemia
4976690|NCT01739491|Filipino|filipino
4976691|NCT01739465|Cholangiocarcinoma|cholangiocarcinoma
4976692|NCT01739465|Pathologic|pathologic
4976693|NCT01739465|Digestive System|digestive system
4976694|NCT01739465|Neoplasms|neoplasms
4976695|NCT01739465|Neoplasms by Site|neoplasms by site
4976696|NCT01739465|Digestive System Diseases|digestive system diseases
4976697|NCT01739465|Bile Duct Diseases|bile duct diseases
4976698|NCT01739465|Biliary Tract Diseases|biliary tract diseases
4976699|NCT01739465|Pathological Conditions|pathological conditions
4976700|NCT01739465|Constriction|constriction
4976701|NCT01739465|Adenocarcinoma|adenocarcinoma
4976702|NCT01739465|Carcinoma|carcinoma
4976703|NCT01739452|Low-risk MDS|low-risk mds
4976704|NCT01739452|myelodysplastic syndrome|myelodysplastic syndrome
4976705|NCT01739452|retrospective|retrospective
4976706|NCT01739426|LigaSure V (TM)|ligasure v (tm)
4976707|NCT01739400|Eisenmenger Syndrome|eisenmenger syndrome
4976708|NCT01739400|exercise capacity|exercise capacity
4976709|NCT01739387|Flutiform®|flutiform®
4976710|NCT01739387|Asthma|asthma
4976711|NCT01739387|COPD|copd
4976712|NCT01739374|pelvic floor reconstruction|pelvic floor reconstruction
4976713|NCT01739374|mesh implants|mesh implants
4976714|NCT01739335|Stress Disorders, Post-Traumatic|stress disorders, post-traumatic
4976715|NCT01739335|Mifepristone|mifepristone
4976716|NCT01739335|Veterans|veterans
4976717|NCT01739335|Clinical Trial|clinical trial
4976718|NCT01739322|skin prick test|skin prick test
4976719|NCT01739322|inmunotherapy|inmunotherapy
4976720|NCT01739322|standarization|standarization
4976721|NCT01739309|Non- Hodgkins Lymphoma|non- hodgkins lymphoma
4976722|NCT01739296|osteoarthritis|osteoarthritis
4976723|NCT01739296|osteoarthritis, knee|osteoarthritis, knee
4976724|NCT01739296|foot orthoses|foot orthoses
4976725|NCT01739296|orthotic insoles|orthotic insoles
4976726|NCT01739270|analgesia|analgesia
4976727|NCT01739270|regional anesthesia|regional anesthesia
4976728|NCT01739270|surgery|surgery
4976729|NCT01739270|duration of analgesia|duration of analgesia
4976730|NCT01739270|dexamethasone added to levobupivacaine compared to levobupivacaine alone|dexamethasone added to levobupivacaine compared to levobupivacaine alone
4976731|NCT01739244|Glaucoma|glaucoma
4976732|NCT01739244|Open Angle Glaucoma|open angle glaucoma
4976733|NCT01739244|Ocular Hypertension|ocular hypertension
4976734|NCT01739244|IOP|iop
4976735|NCT01739244|RNAi|rnai
4976736|NCT01739244|siRNA|sirna
4976737|NCT01739244|beta inhibitor|beta inhibitor
4976738|NCT01739205|Type 2 diabetes and depression|type 2 diabetes and depression
4976739|NCT01739179|Ventricular peritoneal Shunt|ventricular peritoneal shunt
4976740|NCT01739179|Shunt Complications|shunt complications
4976741|NCT01739179|Shunt Failure|shunt failure
4976742|NCT01739179|Hydrocephalus|hydrocephalus
4976743|NCT01739166|Health Services Research|health services research
4976744|NCT01739166|Quality Assurance|quality assurance
4976745|NCT01739153|Dairy|dairy
4976746|NCT01739153|Cheese|cheese
4976747|NCT01739153|Blood lipid concentrations|blood lipid concentrations
4976748|NCT01739153|Blood lipid sizes|blood lipid sizes
4976749|NCT01739153|Fecal fat|fecal fat
4976750|NCT01739153|Fat digestibility|fat digestibility
4976751|NCT01739153|bile acids|bile acids
4976752|NCT01739127|Antipsychotic agents|antipsychotic agents
4976753|NCT01739127|Adverse effects|adverse effects
4976754|NCT01739127|Magnetic Resonance Imaging|magnetic resonance imaging
4976755|NCT01739114|Lung aeration|lung aeration
4976756|NCT01739114|Bronchopulmonary dysplasia|bronchopulmonary dysplasia
4976757|NCT01739114|Positive Pressure Respiration|positive pressure respiration
4976758|NCT01739114|Sustained Inflation|sustained inflation
4976759|NCT01739114|Continuous Positive Airway Pressure|continuous positive airway pressure
4976760|NCT01739088|Congenital heart disease|congenital heart disease
4976761|NCT01739088|pediatrics|pediatrics
4976762|NCT01739088|ischemia-reperfusion injury|ischemia-reperfusion injury
4976763|NCT01739088|long term outcomes|long term outcomes
4976764|NCT01739062|PSA test|psa test
4976765|NCT01739062|Prostate cancer|prostate cancer
4976766|NCT01739062|Genetic screening|genetic screening
4976767|NCT01739036|Malaria|malaria
4976768|NCT01739036|Vaccine|vaccine
4976769|NCT01739036|Plasmodium|plasmodium
4976770|NCT01739036|Falciparum|falciparum
4976771|NCT01739023|paraplegia|paraplegia
4976772|NCT01739023|cell therapy|cell therapy
4976773|NCT01739023|Schwann cells|schwann cells
4976774|NCT01739023|spinal cord injury|spinal cord injury
4976775|NCT01738997|Benign|benign
4976776|NCT01738997|Esophageal strictures|esophageal strictures
4976777|NCT01738997|Esophagus|esophagus
4976778|NCT01738997|Balloon Dilation|balloon dilation
4976779|NCT01738984|exercise|exercise
4976780|NCT01738984|video|video
4976781|NCT01738984|DVD|dvd
4976782|NCT01738984|mother|mother
4976783|NCT01738984|infant|infant
4976784|NCT01738971|emergency contraception|emergency contraception
4976785|NCT01738971|community pharmacy|community pharmacy
4976786|NCT01738958|Probiotic bacteria|probiotic bacteria
4976787|NCT01738958|Caries dentalis|caries dentalis
4976788|NCT01738958|QLF|qlf
4976789|NCT01738932|endometriosis|endometriosis
4976790|NCT01738932|mannan-binding lectin|mannan-binding lectin
4976791|NCT01738932|immunology|immunology
4976792|NCT01738893|Gabapentin|gabapentin
4976793|NCT01738893|Bioequivalence|bioequivalence
4976794|NCT01738893|Pharmacokinetics|pharmacokinetics
4976795|NCT01738893|Mexico|mexico
4976796|NCT01738867|Pharmacogenetics|pharmacogenetics
4976797|NCT01738867|OPRM1|oprm1
4976798|NCT01738867|Pharmacodynamics|pharmacodynamics
4976799|NCT01738867|Addiction|addiction
4976800|NCT01738867|mu opioid receptors|mu opioid receptors
4976801|NCT01738854|laryngeal mask airway supreme|laryngeal mask airway supreme
4976802|NCT01738854|airway sealing|airway sealing
4976803|NCT01738854|intracuff pressure|intracuff pressure
4976804|NCT01738841|Combined measles-mumps-rubella-varicella vaccine|combined measles-mumps-rubella-varicella vaccine
4976805|NCT01738841|Priorix-Tetra™|priorix-tetra™
4976806|NCT01738841|MMRV|mmrv
4976807|NCT01738841|children|children
4976808|NCT01738841|Post-marketing surveillance|post-marketing surveillance
4976809|NCT01738841|Philippines|philippines
4976810|NCT01738815|bladder cancer|bladder cancer
4976811|NCT01738815|hematuria|hematuria
4976812|NCT01738815|sodium valproate|sodium valproate
4976813|NCT01738815|valproic acid|valproic acid
4976814|NCT01738802|Type 2 Diabetes|type 2 diabetes
4976815|NCT01738802|carotid intima medial thickness|carotid intima medial thickness
4976816|NCT01738802|micronutrient|micronutrient
4976817|NCT01738802|anti-oxidant|anti-oxidant
4976818|NCT01738789|Adnexal masses|adnexal masses
4976819|NCT01738789|Magnetic resonance imaging|magnetic resonance imaging
4976820|NCT01738789|Ovarian tumor|ovarian tumor
4976821|NCT01738776|hip fracture|hip fracture
4976822|NCT01738776|risk factors|risk factors
4976823|NCT01738776|vitamin K1|vitamin k1
4976824|NCT01738776|vitamin D|vitamin d
4976825|NCT01738776|bone turnover markers|bone turnover markers
4976826|NCT01738776|osteocalcin|osteocalcin
4976827|NCT01738776|undercarboxylated osteocalcin|undercarboxylated osteocalcin
4976828|NCT01738776|bone specific alkaline phosphatase (BALP)|bone specific alkaline phosphatase (balp)
4976829|NCT01738776|insulin like growth factor 1 (IGF1)|insulin like growth factor 1 (igf1)
4976830|NCT01738776|parathyroid hormone (PTH)|parathyroid hormone (pth)
4976831|NCT01738763|Glucose|glucose
4976832|NCT01738763|Insulin|insulin
4976833|NCT01738763|3-O-methyl-D-chiro-inositol|3-o-methyl-d-chiro-inositol
4976834|NCT01738750|surgical choice|surgical choice
4976835|NCT01738750|cost of care|cost of care
4976836|NCT01738750|decision making|decision making
4976837|NCT01738750|health care|health care
4976838|NCT01738750|health care cost|health care cost
4976839|NCT01738750|pediatric|pediatric
4976840|NCT01738750|children|children
4976841|NCT01738750|appendicitis|appendicitis
4976842|NCT01738750|patient satisfaction|patient satisfaction
4976843|NCT01738711|Idiopathic pulmonary fibrosis|idiopathic pulmonary fibrosis
4976844|NCT01738711|Cognitive behavioural therapy|cognitive behavioural therapy
4976845|NCT01738711|Anxiety|anxiety
4976846|NCT01738711|Quality of life|quality of life
4976847|NCT01738685|Breast Cancer.|breast cancer.
4976848|NCT01738685|Adjuvant Endocrine therapy.|adjuvant endocrine therapy.
4976849|NCT01738672|Nitrous oxide|nitrous oxide
4976850|NCT01738672|labor and delivery|labor and delivery
4976851|NCT01738672|analgesia|analgesia
4976852|NCT01738659|sodium ,diuretics, PCWP|sodium ,diuretics, pcwp
4976853|NCT01738646|vorinostat|vorinostat
4976854|NCT01738646|SAHA|saha
4976855|NCT01738646|bevacizumab|bevacizumab
4976856|NCT01738646|AVASTIN|avastin
4976857|NCT01738646|malignant glioma|malignant glioma
4976858|NCT01738646|GBM|gbm
4976859|NCT01738646|glioblastoma multiforme|glioblastoma multiforme
4976860|NCT01738646|brain tumor|brain tumor
4976861|NCT01738633|Esophageal Cancer|esophageal cancer
4976862|NCT01738633|Quality of Life|quality of life
4976863|NCT01738620|esophageal cancer|esophageal cancer
4976864|NCT01738620|sleep disturbance|sleep disturbance
4976865|NCT01738620|quality of life|quality of life
4976866|NCT01738607|fecal incontinence, dietary fiber|fecal incontinence, dietary fiber
4976867|NCT01738581|focal hand dystonia (FHD)|focal hand dystonia (fhd)
4976868|NCT01738581|repetitive transcranial magnetic stimulation (rTMS)|repetitive transcranial magnetic stimulation (rtms)
4976869|NCT01738581|sensorimotor retraining|sensorimotor retraining
4976870|NCT01738568|High intensity aerobic training|high intensity aerobic training
4976871|NCT01738555|amdoxovir|amdoxovir
4976872|NCT01738555|zidovudine|zidovudine
4976873|NCT01738555|HIV|hiv
4976874|NCT01738555|HAART|haart
4976875|NCT01738555|antiretroviral|antiretroviral
4976876|NCT01738542|Bosentan|bosentan
4976877|NCT01738542|Peripheral Arterial Disease|peripheral arterial disease
4976878|NCT01738529|confocal laser endomicroscopy|confocal laser endomicroscopy
4976879|NCT01738529|Crohn´disease|crohn´disease
4976880|NCT01738503|Opioid Dependence, Buprenorphine, Depot, SUBUTEX, RBP-6000|opioid dependence, buprenorphine, depot, subutex, rbp-6000
4976881|NCT01738490|Bone anchored hearing aid|bone anchored hearing aid
4976882|NCT01738490|Bone anchored implant|bone anchored implant
4976883|NCT01738490|Implant stability|implant stability
4976884|NCT01738490|Wide diameter implant|wide diameter implant
4976885|NCT01738490|Linear incision|linear incision
4976886|NCT01738490|Ponto|ponto
4976887|NCT01738477|Booster|booster
4976888|NCT01738477|Tdap|tdap
4976889|NCT01738477|Immunogenicity|immunogenicity
4976890|NCT01738477|Repeat dose|repeat dose
4976891|NCT01738477|Safety|safety
4976892|NCT01738477|BoostrixTM|boostrixtm
4976893|NCT01738477|Persistence|persistence
4976894|NCT01738464|Pelvic Pain|pelvic pain
4976895|NCT01738464|Interstitial Cystitis|interstitial cystitis
4976896|NCT01738464|Microbiome|microbiome
4976897|NCT01738464|Prostatitis|prostatitis
4976898|NCT01738464|Chronic|chronic
4976899|NCT01738464|Depression|depression
4976900|NCT01738451|ECG intervals and morphology|ecg intervals and morphology
4976901|NCT01738451|BRAF-mutation positive tumor|braf-mutation positive tumor
4976902|NCT01738451|Holter monitor|holter monitor
4976903|NCT01738451|BRAF inhibitor|braf inhibitor
4976904|NCT01738451|GSK2118436|gsk2118436
4976905|NCT01738451|safety|safety
4976906|NCT01738451|cancer|cancer
4976907|NCT01738451|QTc|qtc
4976908|NCT01738451|pharmacokinetics|pharmacokinetics
4976909|NCT01738438|Metastatic|metastatic
4976910|NCT01738438|Triple Negative|triple negative
4976911|NCT01738438|Stage IV|stage iv
4976912|NCT01738425|GIC-1001|gic-1001
4976913|NCT01738425|opioid agonist|opioid agonist
4976914|NCT01738425|sulfide|sulfide
4976915|NCT01738425|colonoscopy|colonoscopy
4976916|NCT01738425|gicare|gicare
4976917|NCT01738425|Phase I|phase i
4976918|NCT01738425|safety|safety
4976919|NCT01738425|tolerability|tolerability
4976920|NCT01738425|pharmacokinetics|pharmacokinetics
4976921|NCT01738425|healthy subjects|healthy subjects
4976922|NCT01738425|single ascending dose|single ascending dose
4976923|NCT01738425|multiple ascending dose|multiple ascending dose
4976924|NCT01738425|SAD|sad
4976925|NCT01738425|MAD|mad
4976926|NCT01738425|food effect|food effect
4976927|NCT01738412|Stroke|stroke
4976928|NCT01738399|Insulin resistance|insulin resistance
4976929|NCT01738399|Coffee|coffee
4976930|NCT01738399|Glucose metabolism|glucose metabolism
4976931|NCT01738386|Adaptation|adaptation
4976932|NCT01738386|Coping|coping
4976933|NCT01738386|Presenile Dementia|presenile dementia
4976934|NCT01738386|Caregiver Burden|caregiver burden
4976935|NCT01738373|autologous stem cell transplantation|autologous stem cell transplantation
4976936|NCT01738373|lymphoma|lymphoma
4976937|NCT01738373|multiple myeloma|multiple myeloma
4976938|NCT01738360|Arsenic trioxide|arsenic trioxide
4976939|NCT01738360|Systemic Lupus|systemic lupus
4976940|NCT01738360|clinically|clinically
4976941|NCT01738360|biologically active|biologically active
4976942|NCT01738334|Meditation|meditation
4976943|NCT01738334|Cognition|cognition
4976944|NCT01738334|Attention Deficit Disorder with Hyperactivity|attention deficit disorder with hyperactivity
4976945|NCT01738308|Healing Touch|healing touch
4976946|NCT01738308|Pediatrics|pediatrics
4976947|NCT01738308|surgery|surgery
4976948|NCT01738308|stress|stress
4976949|NCT01738308|pain|pain
4976950|NCT01738308|Pediatric Stress|pediatric stress
4976951|NCT01738308|maladaptive behaviors|maladaptive behaviors
4976952|NCT01738308|energy medicine|energy medicine
4976953|NCT01738308|emergence delirium|emergence delirium
4976954|NCT01738308|emergence agitation|emergence agitation
4976955|NCT01738308|length of stay|length of stay
4976956|NCT01738308|ease of wake up|ease of wake up
4976957|NCT01738308|distress parents|distress parents
4976958|NCT01738308|distress pediatric patients|distress pediatric patients
4976959|NCT01738308|Pediatric Post-Traumatic Stress Disorder|pediatric post-traumatic stress disorder
4976960|NCT01738295|acetylcholine|acetylcholine
4976961|NCT01738295|cholinergic system|cholinergic system
4976962|NCT01738295|visual perception|visual perception
4976963|NCT01738295|visual attention|visual attention
4976964|NCT01738295|multiple objects tracking|multiple objects tracking
4976965|NCT01738295|perceptual learning|perceptual learning
4976966|NCT01738295|vision training|vision training
4976967|NCT01738282|baclofene|baclofene
4976968|NCT01738282|Alcohol dependence|alcohol dependence
4976969|NCT01738282|Maintenance of abstinence|maintenance of abstinence
4976970|NCT01738269|Ovarian cancer, HE4, normal range|ovarian cancer, he4, normal range
4976971|NCT01738256|Cognitive Behavior Therapy|cognitive behavior therapy
4976972|NCT01738256|Acceptance Commitment Therapy|acceptance commitment therapy
4976973|NCT01738256|Psychological Stress|psychological stress
4976974|NCT01738256|Metabolic Syndrome|metabolic syndrome
4976975|NCT01738256|Overweight|overweight
4976976|NCT01738256|Life Style|life style
4976977|NCT01738243|Thyroid|thyroid
4976978|NCT01738243|Thyroid Eye Disease|thyroid eye disease
4976979|NCT01738243|Thyroid Orbitopathy|thyroid orbitopathy
4976980|NCT01738243|Eyelid Retraction|eyelid retraction
4976981|NCT01738243|Upper Eyelid Retraction|upper eyelid retraction
4976982|NCT01738217|Intra-operative imaging|intra-operative imaging
4976983|NCT01738217|NIR Fluorescence|nir fluorescence
4976984|NCT01738217|Liver surgery|liver surgery
4976985|NCT01738217|Tumoral margins|tumoral margins
4976986|NCT01738204|endometriosis|endometriosis
4976987|NCT01738204|dysmenorrhea|dysmenorrhea
4976988|NCT01738204|pelvic pain|pelvic pain
4976989|NCT01738204|women's health|women's health
4976990|NCT01738204|adolescence|adolescence
4976991|NCT01738204|biorepository|biorepository
4976992|NCT01738204|observational|observational
4976993|NCT01738204|women|women
4976994|NCT01738204|female|female
4976995|NCT01738204|gynecology|gynecology
4976996|NCT01738204|fertility|fertility
4976997|NCT01738204|infertility|infertility
4976998|NCT01738191|Parkinson's disease|parkinson's disease
4976999|NCT01738165|Prospective|prospective
4977000|NCT01738165|Multi-Center|multi-center
4977001|NCT01738165|Pilot Study|pilot study
4977002|NCT01738165|Single Arm|single arm
4977003|NCT01738165|Safety|safety
4977004|NCT01738165|Efficacy|efficacy
4977005|NCT01738152|HYALOGYN VAGINAL GEL|hyalogyn vaginal gel
4977006|NCT01738152|vaginal dryness|vaginal dryness
4977007|NCT01738152|12-232|12-232
4977008|NCT01738139|Advanced Cancers|advanced cancers
4977009|NCT01738139|Advanced Malignancies|advanced malignancies
4977010|NCT01738139|Metastatic|metastatic
4977011|NCT01738139|Unresectable|unresectable
4977012|NCT01738139|Ipilimumab|ipilimumab
4977013|NCT01738139|Yervoy|yervoy
4977014|NCT01738139|BMS-734016|bms-734016
4977015|NCT01738139|MDX010|mdx010
4977016|NCT01738139|Imatinib Mesylate|imatinib mesylate
4977017|NCT01738139|Imatinib|imatinib
4977018|NCT01738139|Gleevec|gleevec
4977019|NCT01738139|STI 571|sti 571
4977020|NCT01738139|NSC-716051|nsc-716051
4977021|NCT01738126|cerebellum|cerebellum
4977022|NCT01738126|fMRI|fmri
4977023|NCT01738126|DTI|dti
4977024|NCT01738126|pain|pain
4977025|NCT01738126|heat|heat
4977026|NCT01738126|noxious|noxious
4977027|NCT01738126|aversion|aversion
4977028|NCT01738126|unpleasantness|unpleasantness
4977029|NCT01738126|anger|anger
4977030|NCT01738126|aversive stimulus|aversive stimulus
4977031|NCT01738126|motor|motor
4977032|NCT01738126|human|human
4977033|NCT01738126|image analysis|image analysis
4977034|NCT01738126|perception|perception
4977035|NCT01738126|central nervous system|central nervous system
4977036|NCT01738126|sensory|sensory
4977037|NCT01738126|somatosensory cortex|somatosensory cortex
4977038|NCT01738126|trigeminal system|trigeminal system
4977039|NCT01738126|white matter|white matter
4977040|NCT01738113|Ilizarov|ilizarov
4977041|NCT01738113|distraction osteogenesis|distraction osteogenesis
4977042|NCT01738113|Muscle architecture|muscle architecture
4977043|NCT01738113|muscle mechanics|muscle mechanics
4977044|NCT01738113|Rehabilitation|rehabilitation
4977045|NCT01738087|patients|patients
4977046|NCT01738087|Adult|adult
4977047|NCT01738074|rotavirus|rotavirus
4977048|NCT01738074|trivalent genetic reassortment vaccine|trivalent genetic reassortment vaccine
4977049|NCT01738074|Phase three clinical trials|phase three clinical trials
4977050|NCT01738061|Older workers|older workers
4977051|NCT01738061|Multidimensional intervention|multidimensional intervention
4977052|NCT01738061|Worksite health promotion|worksite health promotion
4977053|NCT01738061|Taiwan|taiwan
4977054|NCT01738048|Pain|pain
4977055|NCT01738048|Neuropathic pain|neuropathic pain
4977056|NCT01738048|Chronic pain|chronic pain
4977057|NCT01738035|IgA nephropathy|iga nephropathy
4977058|NCT01738022|Sleep apnea|sleep apnea
4977059|NCT01738022|Pathophysiology|pathophysiology
4977060|NCT01738009|Sleep Apnea|sleep apnea
4977061|NCT01738009|Pathophysiology|pathophysiology
4977062|NCT01737983|cystic fibrosis|cystic fibrosis
4977063|NCT01737983|probiotics|probiotics
4977064|NCT01737983|Lactobacillus reuteri|lactobacillus reuteri
4977065|NCT01737957|Proliferative Diabetic retinopathy|proliferative diabetic retinopathy
4977066|NCT01737957|Pan-retinal photocoagulation|pan-retinal photocoagulation
4977067|NCT01737944|methotrexate injection, subcutaneous, autoinjector|methotrexate injection, subcutaneous, autoinjector
4977068|NCT01737931|SPM 962|spm 962
4977069|NCT01737931|rotigotine|rotigotine
4977070|NCT01737931|application site reaction|application site reaction
4977071|NCT01737918|urge urinary incontinence, cesa, vasa, TOT, solifenacin|urge urinary incontinence, cesa, vasa, tot, solifenacin
4977072|NCT01737905|Asthma|asthma
4977073|NCT01737905|Safety|safety
4977074|NCT01737905|Efficacy|efficacy
4977075|NCT01737905|Epinephrine|epinephrine
4977076|NCT01737905|Bronchodilator|bronchodilator
4977077|NCT01737905|Metered dose inhaler|metered dose inhaler
4977078|NCT01737892|Asthma|asthma
4977079|NCT01737892|Pharmacokinetics|pharmacokinetics
4977080|NCT01737892|Epinephrine|epinephrine
4977081|NCT01737892|Bronchodilator|bronchodilator
4977082|NCT01737892|Metered dose inhaler|metered dose inhaler
4977083|NCT01737879|Anemia, Chronic Kidney Disease, End Stage Renal Disease, erythropoiesis-stimulating agents, Hemodialysis, Hemoglobin|anemia, chronic kidney disease, end stage renal disease, erythropoiesis-stimulating agents, hemodialysis, hemoglobin
4977084|NCT01737866|Heart, Failure, Renal, Insufficiency, Cardiac, Kidney, Hemodialysis, Impairment, omecamtiv mecarbil, cardiac myosin activator, CK-1827452|heart, failure, renal, insufficiency, cardiac, kidney, hemodialysis, impairment, omecamtiv mecarbil, cardiac myosin activator, ck-1827452
4977085|NCT01737853|Primary Open-Angle Glaucoma|primary open-angle glaucoma
4977086|NCT01737853|Ocular Hypertension|ocular hypertension
4977087|NCT01737853|Ganfort|ganfort
4977088|NCT01737840|dyspepsia|dyspepsia
4977089|NCT01737840|pantoprazole|pantoprazole
4977090|NCT01737840|ranitidine|ranitidine
4977091|NCT01737840|emergency department|emergency department
4977092|NCT01737827|INC280, advanced hepatocellular carcinoma, c-MET pathway dysregulation|inc280, advanced hepatocellular carcinoma, c-met pathway dysregulation
4977093|NCT01737814|sickle cell disease|sickle cell disease
4977094|NCT01737814|vaso-occlusive crisis|vaso-occlusive crisis
4977095|NCT01737801|Lung function|lung function
4977096|NCT01737801|Physiotherapy|physiotherapy
4977097|NCT01737788|Cervical cerclage|cervical cerclage
4977098|NCT01737788|Uterine Cervical Incompetence|uterine cervical incompetence
4977099|NCT01737775|diaphragmatic dysfunction|diaphragmatic dysfunction
4977100|NCT01737775|ultrasonography|ultrasonography
4977101|NCT01737775|respiratory distress|respiratory distress
4977102|NCT01737775|abdominal surgery|abdominal surgery
4977103|NCT01737775|Age|age
4977104|NCT01737775|gender|gender
4977105|NCT01737775|biometric|biometric
4977106|NCT01737775|body mass index|body mass index
4977107|NCT01737775|ASA score|asa score
4977108|NCT01737775|smoking status|smoking status
4977109|NCT01737775|history of respiratory disease|history of respiratory disease
4977110|NCT01737762|Venous leg ulcer|venous leg ulcer
4977111|NCT01737762|ulcer|ulcer
4977112|NCT01737762|Venous stasis|venous stasis
4977113|NCT01737762|compression|compression
4977114|NCT01737762|venous|venous
4977115|NCT01737762|venous stasis ulcer|venous stasis ulcer
4977116|NCT01737762|vlu|vlu
4977117|NCT01737762|wound|wound
4977118|NCT01737762|varicose veins|varicose veins
4977119|NCT01737762|venous insufficiency|venous insufficiency
4977120|NCT01737762|dvt|dvt
4977121|NCT01737762|deep vein thrombosis|deep vein thrombosis
4977122|NCT01737749|Stroke|stroke
4977123|NCT01737736|Stroke|stroke
4977124|NCT01737723|Stroke|stroke
4977125|NCT01737710|Influenza Vaccines|influenza vaccines
4977126|NCT01737710|Dermatitis|dermatitis
4977127|NCT01737710|Injections, Intradermal|injections, intradermal
4977128|NCT01737710|Injections, Intramuscular|injections, intramuscular
4977129|NCT01737710|Skin Diseases|skin diseases
4977130|NCT01737710|Skin Diseases, Eczematous|skin diseases, eczematous
4977131|NCT01737710|Hypersensitivity, Immediate|hypersensitivity, immediate
4977132|NCT01737710|Hypersensitivity|hypersensitivity
4977133|NCT01737710|Immune System Diseases|immune system diseases
4977134|NCT01737710|Genetic Diseases, Inborn|genetic diseases, inborn
4977135|NCT01737710|Skin Diseases, Genetic|skin diseases, genetic
4977136|NCT01737671|Brain tumor|brain tumor
4977137|NCT01737671|Malignant Fourth Ventricular Brain Tumors|malignant fourth ventricular brain tumors
4977138|NCT01737671|Ependymoma involving brain|ependymoma involving brain
4977139|NCT01737671|Ependymoma involving spine|ependymoma involving spine
4977140|NCT01737671|Recurrent ependymoma involving brain and/or spine|recurrent ependymoma involving brain and/or spine
4977141|NCT01737671|Recurrent atypical teratoid/rhabdoid tumor involving brain|recurrent atypical teratoid/rhabdoid tumor involving brain
4977142|NCT01737671|Recurrent atypical teratoid/rhabdoid tumor involving spine|recurrent atypical teratoid/rhabdoid tumor involving spine
4977143|NCT01737671|AT/RT|at/rt
4977144|NCT01737671|Ommaya reservoir catheter|ommaya reservoir catheter
4977145|NCT01737671|Methotrexate|methotrexate
4977146|NCT01737671|Medulloblastoma|medulloblastoma
4977147|NCT01737671|ATRT|atrt
4977148|NCT01737671|Atypical teratoid rhabdoid tumor|atypical teratoid rhabdoid tumor
4977149|NCT01737671|Ependymoma|ependymoma
4977150|NCT01737671|Pediatric brain tumor|pediatric brain tumor
4977151|NCT01737671|Intraventricular chemotherapy|intraventricular chemotherapy
4977152|NCT01737632|Adolescents|adolescents
4977153|NCT01737632|Residential Treatment|residential treatment
4977154|NCT01737632|Outpatient Treatment|outpatient treatment
4977155|NCT01737632|Substance Abuse|substance abuse
4977156|NCT01737632|Delinquency|delinquency
4977157|NCT01737632|Family Therapy|family therapy
4977158|NCT01737632|Multidimensional Family therapy|multidimensional family therapy
4977159|NCT01737619|Gynecologic cancer|gynecologic cancer
4977160|NCT01737619|Endometrial Cancer|endometrial cancer
4977161|NCT01737619|Lymph Nodes Metastasis|lymph nodes metastasis
4977162|NCT01737619|Surgical Staging|surgical staging
4977163|NCT01737619|False negative rate|false negative rate
4977164|NCT01737619|Detection of positive lymph nodes|detection of positive lymph nodes
4977165|NCT01737619|Histologically confirmed high grade endometrial cancer|histologically confirmed high grade endometrial cancer
4977166|NCT01737619|Sentinel lymph node mapping|sentinel lymph node mapping
4977167|NCT01737606|Cerebral pulsatility|cerebral pulsatility
4977168|NCT01737606|Fast Cerebral Pulsatility Imaging or FCPI|fast cerebral pulsatility imaging or fcpi
4977169|NCT01737606|MRI|mri
4977170|NCT01737606|Arteriel Spin Labelling|arteriel spin labelling
4977171|NCT01737606|Cognitive tasks|cognitive tasks
4977172|NCT01737606|Aging|aging
4977173|NCT01737593|acetaminophen|acetaminophen
4977174|NCT01737593|emergence agitation|emergence agitation
4977175|NCT01737593|children|children
4977176|NCT01737593|sevoflurane|sevoflurane
4977177|NCT01737580|influenza, human|influenza, human
4977178|NCT01737580|influenza vaccines|influenza vaccines
4977179|NCT01737580|older adults|older adults
4977180|NCT01737580|immune response|immune response
4977181|NCT01737554|Central venous access device|central venous access device
4977182|NCT01737554|Catheter resistance monitoring|catheter resistance monitoring
4977183|NCT01737541|Cerebrovascular Disorders|cerebrovascular disorders
4977184|NCT01737541|Cardiovascular Diseases|cardiovascular diseases
4977185|NCT01737541|Intracerebral Hemorrhage|intracerebral hemorrhage
4977186|NCT01737541|Serotonin Uptake Inhibitors|serotonin uptake inhibitors
4977187|NCT01737541|Therapeutic Uses|therapeutic uses
4977188|NCT01737528|severe symptomatic native aortic valve stenosis|severe symptomatic native aortic valve stenosis
4977189|NCT01737528|inoperable or high risk for open aortic valve replacement|inoperable or high risk for open aortic valve replacement
4977190|NCT01737476|age 18-65|age 18-65
4977191|NCT01737463|Ampulla of Vater adenoma|ampulla of vater adenoma
4977192|NCT01737450|Metastatic head and neck cancer|metastatic head and neck cancer
4977193|NCT01737450|PI3K inhibitor|pi3k inhibitor
4977194|NCT01737450|Recurrent head and meck cancer|recurrent head and meck cancer
4977195|NCT01737450|Progressive head and neck cancer|progressive head and neck cancer
4977196|NCT01737450|BKM120|bkm120
4977197|NCT01737411|surgery, solifenacin, urge urinary incontinence|surgery, solifenacin, urge urinary incontinence
4977198|NCT01737398|FAP|fap
4977199|NCT01737398|Familial Amyloid Polyneuropathy|familial amyloid polyneuropathy
4977200|NCT01737398|TTR|ttr
4977201|NCT01737398|Transthyretin|transthyretin
4977202|NCT01737398|Amyloidosis|amyloidosis
4977203|NCT01737385|microcirculation|microcirculation
4977204|NCT01737385|proximal humeral fractures|proximal humeral fractures
4977205|NCT01737385|O2C|o2c
4977206|NCT01737372|Multiple Sclerosis|multiple sclerosis
4977207|NCT01737372|Secondary Progressive Multiple Sclerosis|secondary progressive multiple sclerosis
4977208|NCT01737372|Clinically Isolated Syndrome|clinically isolated syndrome
4977209|NCT01737359|amdoxovir|amdoxovir
4977210|NCT01737359|zidovudine|zidovudine
4977211|NCT01737359|tenofovir DF|tenofovir df
4977212|NCT01737359|HIV|hiv
4977213|NCT01737359|HAART|haart
4977214|NCT01737359|antiretroviral|antiretroviral
4977215|NCT01737346|glioblastoma, recurrent, refractory, CCNU, procarbazine|glioblastoma, recurrent, refractory, ccnu, procarbazine
4977216|NCT01737320|gram negative bacteremia|gram negative bacteremia
4977217|NCT01737320|Duration of antibiotic treatment|duration of antibiotic treatment
4977218|NCT01737320|safety|safety
4977219|NCT01737320|efficacy|efficacy
4977220|NCT01737320|short-course|short-course
4977221|NCT01737307|Fluoride Varnish|fluoride varnish
4977222|NCT01737307|CPP-ACP paste|cpp-acp paste
4977223|NCT01737307|Dry mouth|dry mouth
4977224|NCT01737307|Burning sensation|burning sensation
4977225|NCT01737307|Chemotherapy|chemotherapy
4977226|NCT01737294|Phase IV|phase iv
4977227|NCT01737294|Peripheral Neuropathic Pain|peripheral neuropathic pain
4977228|NCT01737294|QUTENZA|qutenza
4977229|NCT01737281|Smoking|smoking
4977230|NCT01737281|Tobacco control|tobacco control
4977231|NCT01737281|Counseling|counseling
4977232|NCT01737281|mental health|mental health
4977233|NCT01737268|patients|patients
4977234|NCT01737268|Major depressive episode|major depressive episode
4977235|NCT01737268|FK949E|fk949e
4977236|NCT01737255|Li-Fraumeni Syndrome|li-fraumeni syndrome
4977237|NCT01737255|Whole Body Magnetic Resonance Imaging|whole body magnetic resonance imaging
4977238|NCT01737255|TP53|tp53
4977239|NCT01737255|Psychological Impact|psychological impact
4977240|NCT01737242|Prostate cancer|prostate cancer
4977241|NCT01737242|PSA|psa
4977242|NCT01737216|Aged|aged
4977243|NCT01737216|patients|patients
4977244|NCT01737203|Viagra|viagra
4977245|NCT01737203|ODT|odt
4977246|NCT01737203|bioquivalence|bioquivalence
4977247|NCT01737190|esophageal pressure|esophageal pressure
4977248|NCT01737190|ARDSnet protocol|ardsnet protocol
4977249|NCT01737177|MCL|mcl
4977250|NCT01737177|Mantle Cell Lymphoma|mantle cell lymphoma
4977251|NCT01737177|RELAPSED-REFRACTORY|relapsed-refractory
4977252|NCT01737164|Glucose|glucose
4977253|NCT01737164|Lipid|lipid
4977254|NCT01737164|Metabolism|metabolism
4977255|NCT01737164|Non Diabetic|non diabetic
4977256|NCT01737164|Healthy|healthy
4977257|NCT01737138|Resistant hypertension|resistant hypertension
4977258|NCT01737138|All-cause mortality|all-cause mortality
4977259|NCT01737138|Renal function|renal function
4977260|NCT01737112|Lung Cancer|lung cancer
4977261|NCT01737112|integrin αvβ3 receptor|integrin αvβ3 receptor
4977262|NCT01737112|99mTc-3PRGD2|99mtc-3prgd2
4977263|NCT01737112|SPECT/CT|spect/ct
4977264|NCT01737112|efficacy and safety|efficacy and safety
4977265|NCT01737099|omega-3|omega-3
4977266|NCT01737099|DHA|dha
4977267|NCT01737099|triglycerides|triglycerides
4977268|NCT01737099|lipids|lipids
4977269|NCT01737099|cardiovascular|cardiovascular
4977270|NCT01737099|hypertriglyceridemia|hypertriglyceridemia
4977271|NCT01737073|chronic pain|chronic pain
4977272|NCT01737073|opioid|opioid
4977273|NCT01737073|cognitive behavior therapy|cognitive behavior therapy
4977274|NCT01737060|Reversed prosthesis, Philos, Severe displaced|reversed prosthesis, philos, severe displaced
4977275|NCT01737047|HIV|hiv
4977276|NCT01737047|Ageing|ageing
4977277|NCT01737034|partitioning of weight gain|partitioning of weight gain
4977278|NCT01737034|refeeding|refeeding
4977279|NCT01737034|catch-up fat phenomenon|catch-up fat phenomenon
4977280|NCT01737034|glycemic index|glycemic index
4977281|NCT01737021|PICU|picu
4977282|NCT01737021|Critical illness|critical illness
4977283|NCT01737021|Outcomes|outcomes
4977284|NCT01737021|Mental health|mental health
4977285|NCT01737021|Education|education
4977286|NCT01737021|Randomized Controlled Trial (RCT)|randomized controlled trial (rct)
4977287|NCT01737021|Pilot|pilot
4977288|NCT01737021|Feasibility|feasibility
4977289|NCT01737008|Head and neck|head and neck
4977290|NCT01737008|Squamous cell carcinoma|squamous cell carcinoma
4977291|NCT01737008|Phase 1|phase 1
4977292|NCT01737008|Dacomitinib|dacomitinib
4977293|NCT01737008|Radiation|radiation
4977294|NCT01737008|Radiotherapy|radiotherapy
4977295|NCT01737008|Chemotherapy|chemotherapy
4977296|NCT01737008|Chemoradiation|chemoradiation
4977297|NCT01737008|Chemoradiotherapy|chemoradiotherapy
4977298|NCT01737008|Cisplatin|cisplatin
4977299|NCT01737008|Pharmacokinetics|pharmacokinetics
4977300|NCT01737008|Maximum tolerated dose|maximum tolerated dose
4977301|NCT01737008|Safety|safety
4977302|NCT01737008|Human epidermal growth factor receptor|human epidermal growth factor receptor
4977303|NCT01737008|Previously Untreated|previously untreated
4977304|NCT01737008|Local or Locally Advanced|local or locally advanced
4977305|NCT01736995|Substance Abuse|substance abuse
4977306|NCT01736995|Adolescents|adolescents
4977307|NCT01736995|Families|families
4977308|NCT01736995|Functional Family Therapy|functional family therapy
4977309|NCT01736995|Cognitive Behavioral Therapy|cognitive behavioral therapy
4977310|NCT01736995|Motivational Therapy|motivational therapy
4977311|NCT01736995|Contingency Management|contingency management
4977312|NCT01736982|Cigarette Smoking|cigarette smoking
4977313|NCT01736982|Homeless|homeless
4977314|NCT01736982|Contingency Management|contingency management
4977315|NCT01736982|Smoking Cessation|smoking cessation
4977316|NCT01736956|aortic stenosis|aortic stenosis
4977317|NCT01736956|hypoplastic left heart syndrome|hypoplastic left heart syndrome
4977318|NCT01736956|fetal aortic valvuloplasty|fetal aortic valvuloplasty
4977319|NCT01736943|Bortezomib|bortezomib
4977320|NCT01736943|Doxil|doxil
4977321|NCT01736930|Type 1 Diabetes|type 1 diabetes
4977322|NCT01736930|Hypoglycemia|hypoglycemia
4977323|NCT01736930|Continuous Glucose Monitoring|continuous glucose monitoring
4977324|NCT01736930|Pump Suspension|pump suspension
4977325|NCT01736917|Fosaprepitant|fosaprepitant
4977326|NCT01736917|5HT3 Receptor Antagonists|5ht3 receptor antagonists
4977327|NCT01736917|Dexamethasone|dexamethasone
4977328|NCT01736917|Germ Cell Tumors|germ cell tumors
4977329|NCT01736917|Testis Cancer|testis cancer
4977330|NCT01736917|Rescue Medications|rescue medications
4977331|NCT01736904|advanced colorectal cancer|advanced colorectal cancer
4977332|NCT01736904|FOLFIRI|folfiri
4977333|NCT01736904|XELIRI|xeliri
4977334|NCT01736891|Motor fluctuations|motor fluctuations
4977335|NCT01736891|Parkinson´s Disease|parkinson´s disease
4977336|NCT01736891|Rasagiline|rasagiline
4977337|NCT01736878|Medullary Thyroid Carcinoma|medullary thyroid carcinoma
4977338|NCT01736878|Sorafenib|sorafenib
4977339|NCT01736878|Efficacy|efficacy
4977340|NCT01736852|Premature Rupture of Membrane (Pregnancy)|premature rupture of membrane (pregnancy)
4977341|NCT01736852|PROM|prom
4977342|NCT01736852|Cervical Ripening|cervical ripening
4977343|NCT01736852|Induced Labor|induced labor
4977344|NCT01736826|plasma nucleosome concentration|plasma nucleosome concentration
4977345|NCT01736826|plasma free DNA concentration|plasma free dna concentration
4977346|NCT01736813|colorectal cancer|colorectal cancer
4977347|NCT01736813|liver metastases|liver metastases
4977348|NCT01736813|chemotherapy|chemotherapy
4977349|NCT01736813|chemokine|chemokine
4977350|NCT01736813|CCR5 inhibition|ccr5 inhibition
4977351|NCT01736800|Temozolomide|temozolomide
4977352|NCT01736800|Topotecan|topotecan
4977353|NCT01736800|Central Nervous System Metastases|central nervous system metastases
4977354|NCT01736800|Chemotherapy|chemotherapy
4977355|NCT01736800|Brain Metastases|brain metastases
4977356|NCT01736800|Solid Tumors|solid tumors
4977357|NCT01736787|Cauliflower Mushroom extract|cauliflower mushroom extract
4977358|NCT01736787|immunity|immunity
4977359|NCT01736774|Manual therapy|manual therapy
4977360|NCT01736774|Exercise|exercise
4977361|NCT01736748|obesity|obesity
4977362|NCT01736748|physical activity|physical activity
4977363|NCT01736748|metabolism|metabolism
4977364|NCT01736748|environment|environment
4977365|NCT01736748|obese children, as defined by a body mass index > 95th percentile|obese children, as defined by a body mass index > 95th percentile
4977366|NCT01736748|for age and sex|for age and sex
4977367|NCT01736722|Laser Induced Thermal Therapy|laser induced thermal therapy
4977368|NCT01736722|Metastatic cancer|metastatic cancer
4977369|NCT01736722|Brain Tumor|brain tumor
4977370|NCT01736722|Visualase|visualase
4977371|NCT01736722|Treatment resistant|treatment resistant
4977372|NCT01736722|Magnetic Resonance Thermal Imaging|magnetic resonance thermal imaging
4977373|NCT01736722|Magnetic Imaging|magnetic imaging
4977374|NCT01736709|2012-2013 trivalent seasonal influenza vaccine|2012-2013 trivalent seasonal influenza vaccine
4977375|NCT01736709|immunogenicity,|immunogenicity,
4977376|NCT01736709|safety|safety
4977377|NCT01736696|Psoriasis|psoriasis
4977378|NCT01736696|PASI|pasi
4977379|NCT01736696|plaques|plaques
4977380|NCT01736696|skin biopsy|skin biopsy
4977381|NCT01736696|immunomodulation|immunomodulation
4977382|NCT01736683|ACE-011|ace-011
4977383|NCT01736683|anemia|anemia
4977384|NCT01736683|dose-ranging|dose-ranging
4977385|NCT01736683|intermediate-1 risk myelodysplastic syndromes|intermediate-1 risk myelodysplastic syndromes
4977386|NCT01736683|low risk myelodysplastic syndromes (MDS)|low risk myelodysplastic syndromes (mds)
4977387|NCT01736683|multicenter|multicenter
4977388|NCT01736683|open-label|open-label
4977389|NCT01736683|parallel|parallel
4977390|NCT01736683|phase 2|phase 2
4977391|NCT01736683|randomized|randomized
4977392|NCT01736683|Sotatercept|sotatercept
4977393|NCT01736683|Non-proliferative chronic myelomonocytic leukemia (CMML)|non-proliferative chronic myelomonocytic leukemia (cmml)
4977394|NCT01736683|hemoglobin|hemoglobin
4977395|NCT01736683|transfusions|transfusions
4977396|NCT01736644|blood loss|blood loss
4977397|NCT01736644|bipolar sealer|bipolar sealer
4977398|NCT01736644|aquamantys|aquamantys
4977399|NCT01736644|total knee replacement|total knee replacement
4977400|NCT01736644|primary total knee arthroplasty|primary total knee arthroplasty
4977401|NCT01736631|social phobia|social phobia
4977402|NCT01736631|bipolar disorder|bipolar disorder
4977403|NCT01736631|cognitive behavioural therapy|cognitive behavioural therapy
4977404|NCT01736618|subcutaneous implantable defibrillator, post approval study, sudden cardiac arrest, Cameron Health defibrillator|subcutaneous implantable defibrillator, post approval study, sudden cardiac arrest, cameron health defibrillator
4977405|NCT01736605|Massage|massage
4977406|NCT01736605|Meditation|meditation
4977407|NCT01736605|Breast Cancer|breast cancer
4977408|NCT01736605|Breast Surgery|breast surgery
4977409|NCT01736605|Breast Reconstruction|breast reconstruction
4977410|NCT01736566|Primary Care|primary care
4977411|NCT01736566|Cardiology|cardiology
4977412|NCT01736566|Hypertrophic Cardiomyopathy|hypertrophic cardiomyopathy
4977413|NCT01736566|Dilated Cardiomyopathy|dilated cardiomyopathy
4977414|NCT01736566|Whole Genome Sequencing|whole genome sequencing
4977415|NCT01736553|Spinal Muscular Atrophy (SMA) Biomarkers|spinal muscular atrophy (sma) biomarkers
4977416|NCT01736553|Healthy controls|healthy controls
4977417|NCT01736553|Infants|infants
4977516|NCT01736085|telephone counseling|telephone counseling
4977517|NCT01736085|self-help|self-help
4978223|NCT01732848|Volunteers|volunteers
4977418|NCT01736540|iron overload, liver iron concentration (LIC), cardiac siderosis, transfusional siderosis, magnetic resonance imaging (MRI)|iron overload, liver iron concentration (lic), cardiac siderosis, transfusional siderosis, magnetic resonance imaging (mri)
4977419|NCT01736514|xanthine oxidase inhibitor|xanthine oxidase inhibitor
4977420|NCT01736514|Uric acid lowering drug|uric acid lowering drug
4977421|NCT01736488|Hypertension|hypertension
4977422|NCT01736488|Antihypertensive efficacy|antihypertensive efficacy
4977423|NCT01736488|Neurohormonal markers|neurohormonal markers
4977424|NCT01736488|Blood Pressure Response|blood pressure response
4977425|NCT01736488|Exercise|exercise
4977426|NCT01736462|Cornea|cornea
4977427|NCT01736462|Endothelial cell density|endothelial cell density
4977428|NCT01736449|pterygium|pterygium
4977429|NCT01736449|bevacizumab|bevacizumab
4977430|NCT01736449|recurrence of pterygium|recurrence of pterygium
4977431|NCT01736436|MDS|mds
4977432|NCT01736436|Myelodysplastic syndrome|myelodysplastic syndrome
4977433|NCT01736436|Low and intermediate risk|low and intermediate risk
4977434|NCT01736436|Transfusion-dependent patients|transfusion-dependent patients
4977435|NCT01736436|Transfusion|transfusion
4977436|NCT01736436|Anemia|anemia
4977437|NCT01736423|YM060|ym060
4977438|NCT01736423|Ramosetron|ramosetron
4977439|NCT01736423|long term study|long term study
4977440|NCT01736423|Diarrhea-predominant Irritable Bowel Syndrome|diarrhea-predominant irritable bowel syndrome
4977441|NCT01736423|Female|female
4977442|NCT01736397|CKD|ckd
4977443|NCT01736397|Chronic Kidney Disease|chronic kidney disease
4977444|NCT01736397|Phosphorus|phosphorus
4977445|NCT01736397|Iron Deficiency|iron deficiency
4977446|NCT01736397|Iron Deficiency Anemia|iron deficiency anemia
4977447|NCT01736397|Elevated Phosphorus|elevated phosphorus
4977448|NCT01736371|Sevoflurane|sevoflurane
4977449|NCT01736371|Cisatracurium infusion consumption|cisatracurium infusion consumption
4977450|NCT01736371|Closed loop computer control system|closed loop computer control system
4977451|NCT01736371|Recovery Index|recovery index
4977452|NCT01736358|Sprix|sprix
4977453|NCT01736358|Intranasal ketoralac|intranasal ketoralac
4977454|NCT01736358|Ketoralac|ketoralac
4977455|NCT01736358|Urolithiasis|urolithiasis
4977456|NCT01736358|Kidney stone|kidney stone
4977457|NCT01736358|Uretal stone|uretal stone
4977458|NCT01736358|Ureteroscopic removal of stones|ureteroscopic removal of stones
4977459|NCT01736358|URS|urs
4977460|NCT01736358|Pain management|pain management
4977461|NCT01736358|Pain|pain
4977462|NCT01736332|Methamphetamine|methamphetamine
4977463|NCT01736332|Amphetamines|amphetamines
4977464|NCT01736332|Opiates|opiates
4977465|NCT01736332|Oral Opiates (poppy seeds)|oral opiates (poppy seeds)
4977466|NCT01736332|Intranasal amphetamines|intranasal amphetamines
4977467|NCT01736319|Artemisinin-based Combination Therapies|artemisinin-based combination therapies
4977468|NCT01736319|Recrudescence|recrudescence
4977469|NCT01736319|DHA-PPQ|dha-ppq
4977470|NCT01736319|Parasite Clearance Rate|parasite clearance rate
4977471|NCT01736306|Breast Cancer|breast cancer
4977472|NCT01736306|Breast Milk|breast milk
4977473|NCT01736306|Epigenetics|epigenetics
4977474|NCT01736293|Retinal Degeneration|retinal degeneration
4977475|NCT01736280|Symptoms|symptoms
4977476|NCT01736280|Immunogenetics|immunogenetics
4977477|NCT01736280|Digestive Disorders|digestive disorders
4977478|NCT01736280|Gastrointestinal|gastrointestinal
4977479|NCT01736267|Auditory Brainstem Implant|auditory brainstem implant
4977480|NCT01736267|ABI|abi
4977481|NCT01736267|Nucleus 24|nucleus 24
4977482|NCT01736267|Deafness|deafness
4977483|NCT01736267|Hearing loss|hearing loss
4977484|NCT01736267|Non-tumor|non-tumor
4977485|NCT01736267|Non-NF2|non-nf2
4977486|NCT01736267|ABI541|abi541
4977487|NCT01736228|xenotransplantation|xenotransplantation
4977488|NCT01736228|type 1 diabetes|type 1 diabetes
4977489|NCT01736228|porcine islets|porcine islets
4977490|NCT01736215|Anemia - cancer related|anemia - cancer related
4977491|NCT01736215|Eprex (Erythropoietin alfa)|eprex (erythropoietin alfa)
4977492|NCT01736202|oral fat|oral fat
4977493|NCT01736202|insulin sensitivity|insulin sensitivity
4977494|NCT01736189|Rheumatoid arthritis|rheumatoid arthritis
4977495|NCT01736176|Safety and efficacy|safety and efficacy
4977496|NCT01736176|Advanced Parkinson's disease|advanced parkinson's disease
4977497|NCT01736176|levodopa-carbidopa intestinal gel,|levodopa-carbidopa intestinal gel,
4977498|NCT01736176|carbidopa|carbidopa
4977499|NCT01736176|levodopa|levodopa
4977500|NCT01736176|Non-Motor Symptom Scale|non-motor symptom scale
4977501|NCT01736150|Hemodialysis|hemodialysis
4977502|NCT01736137|Heart failure|heart failure
4977503|NCT01736137|Autonomic Nervous System|autonomic nervous system
4977504|NCT01736137|Heart rate|heart rate
4977505|NCT01736137|Quality of life|quality of life
4977506|NCT01736124|computerize cognitive training|computerize cognitive training
4977507|NCT01736124|dementia|dementia
4977508|NCT01736124|cognitive decline|cognitive decline
4977509|NCT01736124|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
4977510|NCT01736111|obesity|obesity
4977511|NCT01736111|weight loss|weight loss
4977512|NCT01736111|text message|text message
4977513|NCT01736085|tobacco cessation|tobacco cessation
4977514|NCT01736085|smoking cessation|smoking cessation
4977515|NCT01736085|nicotine|nicotine
4977518|NCT01736085|smoking abstinence|smoking abstinence
4977519|NCT01736085|tobacco use disorder|tobacco use disorder
4977520|NCT01736085|nicotine replacement therapy|nicotine replacement therapy
4977521|NCT01736085|voucher|voucher
4977522|NCT01736072|Rectal Cancer|rectal cancer
4977523|NCT01736072|Colorectal Cancer|colorectal cancer
4977524|NCT01736072|Laparoscopic Surgery|laparoscopic surgery
4977525|NCT01736072|Robotic Surgery|robotic surgery
4977526|NCT01736072|Robotic Assisted Laparoscopic Surgery|robotic assisted laparoscopic surgery
4977527|NCT01736059|Stem cells|stem cells
4977528|NCT01736059|intravitreal|intravitreal
4977529|NCT01736059|bone marrow CD34+ cells|bone marrow cd34+ cells
4977530|NCT01736059|retinal disease|retinal disease
4977531|NCT01736059|clinical trial|clinical trial
4977532|NCT01736059|autologous|autologous
4977533|NCT01736046|CT Enterography|ct enterography
4977534|NCT01736046|Crohn's Disease|crohn's disease
4977535|NCT01736046|Inflammatory Bowel Disease|inflammatory bowel disease
4977536|NCT01736033|Lower Urinary Tracts Symptoms|lower urinary tracts symptoms
4977537|NCT01736033|5 alpha reductase inhibitor|5 alpha reductase inhibitor
4977538|NCT01736033|Proscar|proscar
4977539|NCT01736033|Finasteride|finasteride
4977540|NCT01736033|alpha blocker|alpha blocker
4977541|NCT01736033|Tamsulosin|tamsulosin
4977542|NCT01736033|Harnal D|harnal d
4977543|NCT01736007|alopecia areata child|alopecia areata child
4977544|NCT01736007|scalp|scalp
4977545|NCT01735994|Eating disorders|eating disorders
4977546|NCT01735994|body image|body image
4977547|NCT01735994|female athletes|female athletes
4977548|NCT01735994|female athlete triad|female athlete triad
4977549|NCT01735994|eating disorder prevention|eating disorder prevention
4977550|NCT01735994|cluster randomization|cluster randomization
4977551|NCT01735994|risk factors|risk factors
4977552|NCT01735994|prevention|prevention
4977553|NCT01735981|Huntington's Disease|huntington's disease
4977554|NCT01735981|gait|gait
4977555|NCT01735981|exercise|exercise
4977556|NCT01735981|balance|balance
4977557|NCT01735981|video game|video game
4977558|NCT01735968|Imatinib mesylate|imatinib mesylate
4977559|NCT01735968|BYL719|byl719
4977560|NCT01735968|GIST|gist
4977561|NCT01735955|Tasigna|tasigna
4977562|NCT01735955|CML|cml
4977563|NCT01735955|GIST|gist
4977564|NCT01735955|nilotinib|nilotinib
4977565|NCT01735890|Safety|safety
4977566|NCT01735890|Pharmacokinetics|pharmacokinetics
4977567|NCT01735877|Hemispatial neglect, Stroke|hemispatial neglect, stroke
4977568|NCT01735864|Indigo naturalis extract in oil|indigo naturalis extract in oil
4977569|NCT01735851|Thoracic epidural analgesia|thoracic epidural analgesia
4977570|NCT01735851|Paravertebral block|paravertebral block
4977571|NCT01735851|pain|pain
4977572|NCT01735851|postoperative|postoperative
4977573|NCT01735825|coronary artery disease|coronary artery disease
4977574|NCT01735825|stent|stent
4977575|NCT01735825|restenosis|restenosis
4977576|NCT01735812|cryoablation|cryoablation
4977577|NCT01735812|uterine fibroid|uterine fibroid
4977578|NCT01735812|uterine myoma|uterine myoma
4977579|NCT01735812|who completed her family planning|who completed her family planning
4977580|NCT01735812|but wishes to preserve her uterus|but wishes to preserve her uterus
4977581|NCT01735786|Endoscopic Hemostasis|endoscopic hemostasis
4977582|NCT01735786|EndoClot Absorbable Polysaccharide Hemostat|endoclot absorbable polysaccharide hemostat
4977583|NCT01735786|Colonic Polyps|colonic polyps
4977584|NCT01735773|hemodialysis|hemodialysis
4977585|NCT01735773|inflammation|inflammation
4977586|NCT01735773|iron|iron
4977587|NCT01735773|peritoneal dialysis|peritoneal dialysis
4977588|NCT01735773|prohepcidin|prohepcidin
4977589|NCT01735773|uremia|uremia
4977590|NCT01735760|airway management|airway management
4977591|NCT01735760|cricothyroid membrane|cricothyroid membrane
4977592|NCT01735747|Lymphoma|lymphoma
4977593|NCT01735734|Skin disease|skin disease
4977594|NCT01735734|Capillary Malformation|capillary malformation
4977595|NCT01735734|Laser therapy|laser therapy
4977596|NCT01735721|Sinus Floor Augmentation|sinus floor augmentation
4977597|NCT01735721|Bone Transplantation|bone transplantation
4977598|NCT01735721|Bone Substitute|bone substitute
4977599|NCT01735708|pain|pain
4977600|NCT01735708|depression|depression
4977601|NCT01735708|HIV|hiv
4977602|NCT01735708|adherence|adherence
4977603|NCT01735695|Meconium|meconium
4977604|NCT01735695|concentration|concentration
4977605|NCT01735695|level|level
4977606|NCT01735682|older adults|older adults
4977607|NCT01735682|exercise|exercise
4977608|NCT01735682|balance|balance
4977609|NCT01735682|gait|gait
4977610|NCT01735682|fall|fall
4977611|NCT01735682|rehabilitation|rehabilitation
4977612|NCT01735682|vibration|vibration
4977613|NCT01735682|muscle|muscle
4977614|NCT01735669|Remifentanil|remifentanil
4977615|NCT01735669|Breech presentation|breech presentation
4977616|NCT01735669|Nitrous oxide|nitrous oxide
4977617|NCT01735669|Pregnancy complications|pregnancy complications
4977618|NCT01735669|Caesarean section|caesarean section
4977619|NCT01735669|Fetal version|fetal version
4977620|NCT01735656|Coronary heart disease;|coronary heart disease;
4977621|NCT01735656|Percutaneous coronary intervention;|percutaneous coronary intervention;
4977622|NCT01735656|Bifurcation lesion;|bifurcation lesion;
4977623|NCT01735656|Double kissing culotte technique;|double kissing culotte technique;
4977624|NCT01735656|clinical trial|clinical trial
4977625|NCT01735643|type 2 diabetes mellitus|type 2 diabetes mellitus
4977626|NCT01735643|physical activity|physical activity
4977627|NCT01735643|lifestyle change|lifestyle change
4977628|NCT01735643|motivation|motivation
4977629|NCT01735643|patient empowerment|patient empowerment
4977630|NCT01735630|Agitation|agitation
4977631|NCT01735630|Aggression|aggression
4977632|NCT01735630|patients|patients
4977633|NCT01735617|congenital adrenal hyperplasia|congenital adrenal hyperplasia
4977634|NCT01735617|glucocorticoids|glucocorticoids
4977635|NCT01735617|cortisol|cortisol
4977636|NCT01735617|adrenal|adrenal
4977637|NCT01735591|Liver cirrhosis|liver cirrhosis
4977638|NCT01735591|Liver transplantation|liver transplantation
4977639|NCT01735591|Probiotics|probiotics
4977640|NCT01735591|Mortality|mortality
4977641|NCT01735591|Liver function|liver function
4977642|NCT01735591|Infections|infections
4977643|NCT01735578|splanchnic oxygen saturations|splanchnic oxygen saturations
4977644|NCT01735565|NET formation|net formation
4977645|NCT01735565|neutraphil extracellular traps|neutraphil extracellular traps
4977646|NCT01735565|post-engraftment immune system|post-engraftment immune system
4977647|NCT01735552|gut reperfusion injury|gut reperfusion injury
4977648|NCT01735552|blood transfusions|blood transfusions
4977649|NCT01735552|premature infants|premature infants
4977650|NCT01735552|anemia|anemia
4977651|NCT01735552|regional oxygen saturations|regional oxygen saturations
4977652|NCT01735552|necrotizing enterocolitis|necrotizing enterocolitis
4977653|NCT01735552|mesenteric oxygenation|mesenteric oxygenation
4977654|NCT01735539|old age|old age
4977655|NCT01735539|sarcopenia|sarcopenia
4977656|NCT01735539|essential amino acid|essential amino acid
4977657|NCT01735539|arginine|arginine
4977658|NCT01735539|contrast enhanced ultrasound|contrast enhanced ultrasound
4977659|NCT01735539|muscle microcirculation|muscle microcirculation
4977660|NCT01735539|muscle protein synthesis|muscle protein synthesis
4977661|NCT01735526|Allogeneic and autologous|allogeneic and autologous
4977662|NCT01735526|hematopoietic stem-cell transplantation|hematopoietic stem-cell transplantation
4977663|NCT01735526|Lung diffusing capacity|lung diffusing capacity
4977664|NCT01735526|for nitric oxide|for nitric oxide
4977665|NCT01735526|carbon monoxide|carbon monoxide
4977666|NCT01735526|Lung tissue density|lung tissue density
4977667|NCT01735526|microvascular damage|microvascular damage
4977668|NCT01735513|transaortic TAVI or TAVR|transaortic tavi or tavr
4977669|NCT01735513|embolic protection device|embolic protection device
4977670|NCT01735513|EmbolX|embolx
4977671|NCT01735513|efficacy|efficacy
4977672|NCT01735513|during transaortic TAVI|during transaortic tavi
4977673|NCT01735513|reduce the incidence of new foci of restricted diffusion on diffusion-weighted MRI|reduce the incidence of new foci of restricted diffusion on diffusion-weighted mri
4977674|NCT01735500|Prei-procedural|prei-procedural
4977675|NCT01735500|Elevation|elevation
4977676|NCT01735500|cardia Troponin T|cardia troponin t
4977677|NCT01735500|in stable|in stable
4977678|NCT01735500|unknown|unknown
4977679|NCT01735474|manual therapy|manual therapy
4977680|NCT01735474|respiratory disease|respiratory disease
4977681|NCT01735474|thoracic movement|thoracic movement
4977682|NCT01735448|smoking cessation|smoking cessation
4977683|NCT01735448|tobacco|tobacco
4977684|NCT01735448|addiction|addiction
4977685|NCT01735448|Aboriginal|aboriginal
4977686|NCT01735448|youth|youth
4977687|NCT01735448|Indigenous|indigenous
4977688|NCT01735448|pharmacological|pharmacological
4977689|NCT01735448|focus group|focus group
4977690|NCT01735448|interview|interview
4977691|NCT01735435|geriatric patients|geriatric patients
4977692|NCT01735435|nutritional support|nutritional support
4977693|NCT01735422|Infertility|infertility
4977694|NCT01735422|Ovulation induction|ovulation induction
4977695|NCT01735422|Recombinant human Luteinizing Hormone (r-hLH)|recombinant human luteinizing hormone (r-hlh)
4977696|NCT01735422|Urinary human Chorionic Gonadotrophin (u-hCG)|urinary human chorionic gonadotrophin (u-hcg)
4977697|NCT01735422|Recombinant human Follicle Stimulating Hormone (Gonal-f®)|recombinant human follicle stimulating hormone (gonal-f®)
4977698|NCT01735409|Advanced Nasopharyngeal Carcinoma|advanced nasopharyngeal carcinoma
4977699|NCT01735409|Abraxane|abraxane
4977700|NCT01735409|Cisplatin|cisplatin
4977701|NCT01735409|Dose|dose
4977702|NCT01735396|African American men|african american men
4977703|NCT01735396|metastatic prostate cancer|metastatic prostate cancer
4977704|NCT01735396|castration resistant|castration resistant
4977705|NCT01735357|Eicosapentaenoic acid|eicosapentaenoic acid
4977706|NCT01735357|Docosahexaenoic acid|docosahexaenoic acid
4977707|NCT01735357|Cardiovascular risk|cardiovascular risk
4977708|NCT01735357|Platelet function|platelet function
4977709|NCT01735357|Endothelial function|endothelial function
4977710|NCT01735357|Vascular function|vascular function
4977711|NCT01735357|young males|young males
4977712|NCT01735331|Vascular endothelial growth factor, Recurrent Pregnancy Loss|vascular endothelial growth factor, recurrent pregnancy loss
4977713|NCT01735305|Coronary Artery Disease|coronary artery disease
4977714|NCT01735305|antiplatelet therapy|antiplatelet therapy
4977715|NCT01735292|Ventilation, timer|ventilation, timer
4977716|NCT01735279|tobacco dependence|tobacco dependence
4977717|NCT01735279|tobacco treatment|tobacco treatment
4977718|NCT01735279|omega 3 series|omega 3 series
4977719|NCT01735279|polyunsaturated fatty acids|polyunsaturated fatty acids
4977720|NCT01735266|Colonoscopy|colonoscopy
4977721|NCT01735253|metabolic surgery|metabolic surgery
4977722|NCT01735253|gastric bypass|gastric bypass
4977723|NCT01735253|duodenojejunal bypass|duodenojejunal bypass
4977724|NCT01735253|type 2 DM|type 2 dm
4977725|NCT01735240|Phase I,|phase i,
4977726|NCT01735240|healthy volunteers,|healthy volunteers,
4977727|NCT01735240|fixed-sequence,|fixed-sequence,
4977728|NCT01735240|open-label,|open-label,
4977729|NCT01735240|ketoconazole,|ketoconazole,
4977730|NCT01735240|combination,|combination,
4977731|NCT01735240|safety|safety
4977732|NCT01735227|pantoprazole|pantoprazole
4977733|NCT01735227|omeprazole|omeprazole
4977734|NCT01735227|anti - platelet effect|anti - platelet effect
4977735|NCT01735188|Natural history study|natural history study
4977736|NCT01735175|biosimilars|biosimilars
4977737|NCT01735175|Pegfilgrastim,|pegfilgrastim,
4977738|NCT01735175|G-CSF,|g-csf,
4977739|NCT01735175|neutropenia,|neutropenia,
4977740|NCT01735175|breast cancer,|breast cancer,
4977741|NCT01735175|myelosuppressive chemotherapy,|myelosuppressive chemotherapy,
4977742|NCT01735175|supportive care|supportive care
4977743|NCT01735175|granulocyte-colony-stimulating factor|granulocyte-colony-stimulating factor
4977744|NCT01735162|Renal angina|renal angina
4977745|NCT01735162|AKI|aki
4977746|NCT01735162|Pediatric Intensive Care|pediatric intensive care
4977747|NCT01735123|infant formula|infant formula
4977748|NCT01735123|diet|diet
4977749|NCT01735123|diabetes mellitus, type 1|diabetes mellitus, type 1
4977750|NCT01735123|autoimmunity|autoimmunity
4977751|NCT01735097|Arsenic|arsenic
4977752|NCT01735097|Keratosis|keratosis
4977753|NCT01735097|Nigella sativa|nigella sativa
4977754|NCT01735097|Palm|palm
4977755|NCT01735097|Vitamin E|vitamin e
4977756|NCT01735084|randomized controlled trial|randomized controlled trial
4977757|NCT01735084|pneumococcal conjugate vaccines|pneumococcal conjugate vaccines
4977758|NCT01735084|booster dose|booster dose
4977759|NCT01735084|immunogenicity|immunogenicity
4977760|NCT01735084|nasopharyngeal carriage|nasopharyngeal carriage
4977761|NCT01735084|Australian Indigenous|australian indigenous
4977762|NCT01735084|pediatric|pediatric
4977763|NCT01735071|ovarian cancer|ovarian cancer
4977764|NCT01735071|bevacizumab|bevacizumab
4977765|NCT01735071|trabectedin|trabectedin
4977766|NCT01735071|carboplatin|carboplatin
4977767|NCT01735071|randomized trial|randomized trial
4977768|NCT01735071|phase II|phase ii
4977769|NCT01735032|focal epilepsy|focal epilepsy
4977770|NCT01735032|pre-surgical evaluation|pre-surgical evaluation
4977771|NCT01735032|multimodal imaging|multimodal imaging
4977772|NCT01735032|SEEG|seeg
4977773|NCT01735019|EC95, effective concentration in 95% of subjects|ec95, effective concentration in 95% of subjects
4977774|NCT01735006|Human Papillomavirus 16|human papillomavirus 16
4977775|NCT01735006|Human Papillomavirus 18|human papillomavirus 18
4977776|NCT01735006|vaccine|vaccine
4977777|NCT01735006|Cervical Intraepithelial Neoplasia|cervical intraepithelial neoplasia
4977778|NCT01735006|cervical Cancer|cervical cancer
4977779|NCT01735006|Vaginal intraepithelial neoplasia|vaginal intraepithelial neoplasia
4977780|NCT01735006|Vulvar intraepithelial neoplasia|vulvar intraepithelial neoplasia
4977781|NCT01734980|Endobronchial Ultrasound|endobronchial ultrasound
4977782|NCT01734980|transbronchial needle aspiration|transbronchial needle aspiration
4977783|NCT01734967|confocal laser endomicroscopy|confocal laser endomicroscopy
4977784|NCT01734967|Pancreatic Neoplasms|pancreatic neoplasms
4977785|NCT01734967|CHRONIC PANCREATITIS|chronic pancreatitis
4977786|NCT01734967|Endoscopic ultrasound|endoscopic ultrasound
4977787|NCT01734954|Nerve block|nerve block
4977788|NCT01734954|Sciatic nerve|sciatic nerve
4977789|NCT01734954|Ultrasonography|ultrasonography
4977790|NCT01734954|Orthopedics|orthopedics
4977791|NCT01734954|Hallux Valgus|hallux valgus
4977792|NCT01734954|Amputation|amputation
4977793|NCT01734954|Arthrodesis|arthrodesis
4977794|NCT01734954|Arthroscopy|arthroscopy
4977795|NCT01734954|Fracture fixation|fracture fixation
4977796|NCT01734954|Osteotomy|osteotomy
4977797|NCT01734954|Tendon transfer|tendon transfer
4977798|NCT01734954|Tenodesis|tenodesis
4977799|NCT01734954|Tenotomy|tenotomy
4977800|NCT01734954|Orthopedic procedure|orthopedic procedure
4977801|NCT01734941|Autism|autism
4977802|NCT01734941|Trichuris Suis Ova|trichuris suis ova
4977803|NCT01734941|Behavior|behavior
4977804|NCT01734941|Irritability|irritability
4977805|NCT01734928|Multiple Myeloma|multiple myeloma
4977806|NCT01734928|Pomalidomide|pomalidomide
4977807|NCT01734915|Advanced|advanced
4977808|NCT01734915|EGFR mutation|egfr mutation
4977809|NCT01734889|nitisinone|nitisinone
4977810|NCT01734889|Orfadin|orfadin
4977811|NCT01734889|suspension|suspension
4977812|NCT01734889|taste|taste
4977813|NCT01734889|acceptability|acceptability
4977814|NCT01734876|Parkinson´s disease|parkinson´s disease
4977815|NCT01734876|Pain|pain
4977816|NCT01734876|Sleep|sleep
4977817|NCT01734876|HPA axis function|hpa axis function
4977818|NCT01734876|Health Related Quality of Life|health related quality of life
4977819|NCT01734850|HIV-1|hiv-1
4977820|NCT01734837|Laparoscopic appendectomy|laparoscopic appendectomy
4977821|NCT01734837|appendical stump closure|appendical stump closure
4977822|NCT01734824|bone marrow edema, denosumab, PTH 1-84|bone marrow edema, denosumab, pth 1-84
4977823|NCT01734811|Vaccine|vaccine
4977824|NCT01734811|Bronchospasm|bronchospasm
4977825|NCT01734798|locally advanced bladder cancer|locally advanced bladder cancer
4977826|NCT01734798|Postoperative radiotherapy|postoperative radiotherapy
4977827|NCT01734798|Adjuvant chemotherapy|adjuvant chemotherapy
4977828|NCT01734798|Radical Cystectomy|radical cystectomy
4977829|NCT01734759|medication palatability|medication palatability
4977830|NCT01734759|medication taste|medication taste
4977831|NCT01734746|ovarian cancer|ovarian cancer
4977832|NCT01734746|sentinel node|sentinel node
4977833|NCT01734733|Parkinson's Disease|parkinson's disease
4977834|NCT01734733|Xenotransplantation|xenotransplantation
4977835|NCT01734733|choroid plexus|choroid plexus
4977836|NCT01734707|atherosclerosis|atherosclerosis
4977837|NCT01734707|regression|regression
4977838|NCT01734707|Allicor|allicor
4977839|NCT01734707|garlic|garlic
4977840|NCT01734707|intima-media thickness|intima-media thickness
4977841|NCT01734642|Medication errors, patients hospitalized, ADRs, adverse events|medication errors, patients hospitalized, adrs, adverse events
4977842|NCT01734629|Coronary Disease|coronary disease
4977843|NCT01734629|COPD|copd
4977844|NCT01734629|Spirometry|spirometry
4977845|NCT01734629|Coronary tomography|coronary tomography
4977846|NCT01734616|Microvascular|microvascular
4977847|NCT01734616|Muscle|muscle
4977848|NCT01734616|Nutrition|nutrition
4977849|NCT01734616|Exercise|exercise
4977850|NCT01734616|Ageing|ageing
4977851|NCT01734603|Assessment|assessment
4977852|NCT01734603|Rehabilitation|rehabilitation
4977853|NCT01734603|Walking Constant Test|walking constant test
4977854|NCT01734603|Walking Graded test|walking graded test
4977855|NCT01734603|Six minute Walking test|six minute walking test
4977856|NCT01734603|Walking Distance|walking distance
4977857|NCT01734590|Flour,|flour,
4977858|NCT01734590|carbohydrate,|carbohydrate,
4977859|NCT01734590|digestibility|digestibility
4977860|NCT01734590|subjects|subjects
4977861|NCT01734577|Back pain|back pain
4977862|NCT01734551|Prenatal opiate exposure|prenatal opiate exposure
4977863|NCT01734551|neonatal withdrawal|neonatal withdrawal
4977864|NCT01734551|Pharmacologic treatment|pharmacologic treatment
4977865|NCT01734525|candidemia|candidemia
4977866|NCT01734525|intensive care unit|intensive care unit
4977867|NCT01734525|1,3 beta-D-glucan|1,3 beta-d-glucan
4977868|NCT01734512|pediatric recurrent progressive low-grade gliomas|pediatric recurrent progressive low-grade gliomas
4977869|NCT01734512|pediatric progressive low-grade gliomas|pediatric progressive low-grade gliomas
4977870|NCT01734512|everolimus|everolimus
4977871|NCT01734512|mTOR inhibition|mtor inhibition
4977872|NCT01734499|Breast cancer|breast cancer
4977873|NCT01734499|Survivorship|survivorship
4977874|NCT01734499|Coping|coping
4977875|NCT01734499|Quality of Life|quality of life
4977876|NCT01734473|COPD|copd
4977877|NCT01734473|Protein synthesis|protein synthesis
4977878|NCT01734473|Protein breakdown|protein breakdown
4977879|NCT01734473|Muscle wasting|muscle wasting
4977880|NCT01734473|Leucine|leucine
4977881|NCT01734473|Hydrolyzed|hydrolyzed
4977882|NCT01734473|Casein protein|casein protein
4977883|NCT01734473|Carbohydrates|carbohydrates
4977884|NCT01734460|pregnancy, snoring, fetal growth|pregnancy, snoring, fetal growth
4977885|NCT01734434|Health care access, Pregnant women|health care access, pregnant women
4977886|NCT01734421|Smoking cessation|smoking cessation
4977887|NCT01734421|Primary health care|primary health care
4977888|NCT01734421|Young people|young people
4977889|NCT01734421|Cellular phone|cellular phone
4977890|NCT01734408|immunogenicity|immunogenicity
4977891|NCT01734408|safety|safety
4977892|NCT01734408|inactivated EV71 vaccine|inactivated ev71 vaccine
4977893|NCT01734395|Alzheimer's disease|alzheimer's disease
4977894|NCT01734395|Caregiver's Burden in Alzheimer's disease|caregiver's burden in alzheimer's disease
4977895|NCT01734395|Galantamine|galantamine
4977896|NCT01734395|Razadyne|razadyne
4977897|NCT01734395|Reminyl|reminyl
4977898|NCT01734369|Dermatomyositis|dermatomyositis
4977899|NCT01734369|Inclusion Body Myositis|inclusion body myositis
4977900|NCT01734369|Myositis|myositis
4977901|NCT01734369|Polymyositis|polymyositis
4977902|NCT01734369|Military|military
4977903|NCT01734356|iPS|ips
4977904|NCT01734356|fibroblast|fibroblast
4977905|NCT01734356|arrhythmias|arrhythmias
4977906|NCT01734356|valvulopathies|valvulopathies
4977907|NCT01734356|electrophysiology|electrophysiology
4977908|NCT01734356|genetics|genetics
4977909|NCT01734343|posterior capsule opacification|posterior capsule opacification
4977910|NCT01734343|PCO|pco
4977911|NCT01734343|after cataract|after cataract
4977912|NCT01734343|intraocular lens|intraocular lens
4977913|NCT01734330|behavior cognitive therapy|behavior cognitive therapy
4977914|NCT01734330|Smokers|smokers
4977915|NCT01734330|randomized clinical trial|randomized clinical trial
4977916|NCT01734304|vaccination|vaccination
4977917|NCT01734304|postremission therapy|postremission therapy
4977918|NCT01734304|acute myeloid leukemia|acute myeloid leukemia
4977919|NCT01734304|dendritic cells|dendritic cells
4977920|NCT01734291|Family psychoeducation|family psychoeducation
4977921|NCT01734291|Major depressive disorder|major depressive disorder
4977922|NCT01734291|Family burden|family burden
4977923|NCT01734174|transesophageal and transthoracic echocardiogram|transesophageal and transthoracic echocardiogram
4977924|NCT01734174|thermodilution|thermodilution
4977925|NCT01734174|left ventricular volume|left ventricular volume
4977926|NCT01734174|ejection volume|ejection volume
4977927|NCT01734161|cesarean section|cesarean section
4977928|NCT01734161|nausea|nausea
4977929|NCT01734161|vomiting|vomiting
4977930|NCT01734161|dexamethasone|dexamethasone
4977931|NCT01734161|postoperative nausea and vomiting|postoperative nausea and vomiting
4977932|NCT01734161|antiemetics|antiemetics
4977933|NCT01734148|pediatric|pediatric
4977934|NCT01734148|sleep difficulties in children|sleep difficulties in children
4977935|NCT01734148|Sleep Education|sleep education
4977936|NCT01734135|B type natriuretic peptide|b type natriuretic peptide
4977937|NCT01734135|heart failure|heart failure
4977938|NCT01734135|cardiac imaging|cardiac imaging
4977939|NCT01734135|quality of care|quality of care
4977940|NCT01734122|Stereotactic Radiosurgery|stereotactic radiosurgery
4977941|NCT01734122|Essential Tremor|essential tremor
4977942|NCT01734122|Parkinsonian Tremor|parkinsonian tremor
4977943|NCT01734122|Quality of Life|quality of life
4977944|NCT01734122|Severity of Tremor|severity of tremor
4977945|NCT01734109|Negative Pressure Wound Therapy|negative pressure wound therapy
4977946|NCT01734109|Irrigation Therapy|irrigation therapy
4977947|NCT01734109|Pressure Ulcers|pressure ulcers
4977948|NCT01734109|Sacral Ulcers|sacral ulcers
4977949|NCT01734096|hypertension|hypertension
4977950|NCT01734096|obesity|obesity
4977951|NCT01734096|white coat hypertension|white coat hypertension
4977952|NCT01734096|resistant hypertension|resistant hypertension
4977953|NCT01734083|rehabilitation|rehabilitation
4977954|NCT01734083|exercise|exercise
4977955|NCT01734083|fall|fall
4977956|NCT01734083|muscle|muscle
4977957|NCT01734083|vibration|vibration
4977958|NCT01734083|mobility|mobility
4977959|NCT01734083|cognition|cognition
4977960|NCT01734070|anthocyanins|anthocyanins
4977961|NCT01734070|catechins|catechins
4977962|NCT01734070|chlorogenic acid|chlorogenic acid
4977963|NCT01734070|flavanol glycosides|flavanol glycosides
4977964|NCT01734057|Recombinant Human Thrombopoietin|recombinant human thrombopoietin
4977965|NCT01734057|rhTPO|rhtpo
4977966|NCT01734057|Rituximab|rituximab
4977967|NCT01734057|Dexamethasone|dexamethasone
4977968|NCT01734044|Recombinant Human Thrombopoietin|recombinant human thrombopoietin
4977969|NCT01734044|rhTPO|rhtpo
4977970|NCT01734044|Dexamethasone|dexamethasone
4977971|NCT01733953|Cardiovascular Disease|cardiovascular disease
4977972|NCT01733953|Childhood ALL|childhood all
4977973|NCT01733953|Childhood NHL|childhood nhl
4977974|NCT01733927|HIV screening|hiv screening
4977975|NCT01733927|Rapid test for HIV|rapid test for hiv
4977976|NCT01733914|shoulder pain|shoulder pain
4977977|NCT01733914|acupuncture|acupuncture
4977978|NCT01733901|Coronary heart disease|coronary heart disease
4977979|NCT01733901|PCI|pci
4977980|NCT01733901|Renal sympathetic denervation|renal sympathetic denervation
4977981|NCT01733901|Hypertension|hypertension
4977982|NCT01733901|Diabetes|diabetes
4977983|NCT01733888|caries|caries
4977984|NCT01733888|caries infiltration|caries infiltration
4977985|NCT01733888|fluorosis treatment|fluorosis treatment
4977986|NCT01733875|Safety|safety
4977987|NCT01733875|Pharmacokinetics|pharmacokinetics
4977988|NCT01733875|Food effect|food effect
4977989|NCT01733875|Healthy subjects|healthy subjects
4977990|NCT01733862|Impact|impact
4977991|NCT01733862|Vaccination|vaccination
4977992|NCT01733862|Hospitalizations|hospitalizations
4977993|NCT01733862|Rotavirus gastroenteritis|rotavirus gastroenteritis
4977994|NCT01733862|Japan|japan
4977995|NCT01733849|Bulgaria|bulgaria
4977996|NCT01733849|Primary care settings|primary care settings
4977997|NCT01733849|Children|children
4977998|NCT01733849|Latvia|latvia
4977999|NCT01733849|Acute gastroenteritis|acute gastroenteritis
4978000|NCT01733810|Esophagitis|esophagitis
4978001|NCT01733810|Reflux esophagitis|reflux esophagitis
4978002|NCT01733810|Gastroesophageal reflux disease|gastroesophageal reflux disease
4978003|NCT01733810|Acid|acid
4978004|NCT01733810|Inflammation|inflammation
4978005|NCT01733810|Esophagus|esophagus
4978006|NCT01733810|Cytokines|cytokines
4978007|NCT01733810|Esophageal squamous cell|esophageal squamous cell
4978008|NCT01733810|Reflux|reflux
4978009|NCT01733810|Squamous epithelium|squamous epithelium
4978010|NCT01733797|Trismus|trismus
4978011|NCT01733797|Therabite|therabite
4978012|NCT01733797|Wooden spatula|wooden spatula
4978013|NCT01733797|Head and Neck cancer|head and neck cancer
4978014|NCT01733784|Sleep Apnea|sleep apnea
4978015|NCT01733784|Pathophysiology|pathophysiology
4978016|NCT01733771|complementary medicine|complementary medicine
4978017|NCT01733771|hospitalized|hospitalized
4978018|NCT01733758|albiglutide|albiglutide
4978019|NCT01733758|Japanese|japanese
4978020|NCT01733758|GSK716155|gsk716155
4978021|NCT01733758|Type 2 diabetes mellitus|type 2 diabetes mellitus
4978022|NCT01733758|glucagon-like peptide 1|glucagon-like peptide 1
4978023|NCT01733745|dry eye|dry eye
4978024|NCT01733745|lipid deficiency|lipid deficiency
4978025|NCT01733745|meibomian gland|meibomian gland
4978026|NCT01733732|Dry eye|dry eye
4978027|NCT01733732|Lipid deficiency|lipid deficiency
4978028|NCT01733732|Inflammatory markers|inflammatory markers
4978029|NCT01733706|No Nicotine Electronic Cigarette|no nicotine electronic cigarette
4978030|NCT01733706|Antismoke intervention|antismoke intervention
4978031|NCT01733693|Buprenorphine|buprenorphine
4978032|NCT01733693|Methadone|methadone
4978033|NCT01733693|Cognition|cognition
4978034|NCT01733680|ADHD|adhd
4978035|NCT01733680|executive function|executive function
4978036|NCT01733680|emotional self-regulation|emotional self-regulation
4978037|NCT01733667|synechia|synechia
4978038|NCT01733667|Fess|fess
4978039|NCT01733667|sinus surgery|sinus surgery
4978040|NCT01733654|depression|depression
4978041|NCT01733654|major depressive disorder|major depressive disorder
4978042|NCT01733628|Hypertension|hypertension
4978043|NCT01733628|Bevacizumab Response Predictors|bevacizumab response predictors
4978044|NCT01733628|Metastatic Breast Cancer|metastatic breast cancer
4978045|NCT01733628|Metastatic Colon Cancer|metastatic colon cancer
4978046|NCT01733615|Mucopolysaccharidosis Type IVA|mucopolysaccharidosis type iva
4978047|NCT01733615|Mucopolysaccharidosis Type IV|mucopolysaccharidosis type iv
4978048|NCT01733615|MPS Type IVA|mps type iva
4978049|NCT01733615|MPS Type IV|mps type iv
4978050|NCT01733615|Morquio Syndrome|morquio syndrome
4978051|NCT01733615|Morquio Syndrome Type A|morquio syndrome type a
4978052|NCT01733615|Urine biomarkers|urine biomarkers
4978053|NCT01733589|Recombinant human endostatin|recombinant human endostatin
4978054|NCT01733589|Non-small-Cell Lung Cancer|non-small-cell lung cancer
4978055|NCT01733589|chemoradiotherapy|chemoradiotherapy
4978056|NCT01733563|sugar sweetened beverages|sugar sweetened beverages
4978057|NCT01733563|fructose|fructose
4978058|NCT01733563|lipogenesis|lipogenesis
4978059|NCT01733563|beta-oxidation|beta-oxidation
4978060|NCT01733550|Intraocular Pressure|intraocular pressure
4978061|NCT01733550|Tonometry, Ocular|tonometry, ocular
4978062|NCT01733550|iCare|icare
4978063|NCT01733537|traffic accidents, motorcycle, injury, conspicuity|traffic accidents, motorcycle, injury, conspicuity
4978064|NCT01733524|adolescence|adolescence
4978065|NCT01733524|self care|self care
4978066|NCT01733485|Asthma|asthma
4978067|NCT01733485|Electrophilic Fatty Acids|electrophilic fatty acids
4978068|NCT01733485|Inflammation|inflammation
4978069|NCT01733472|anaesthetic techniques|anaesthetic techniques
4978070|NCT01733472|subarachnoid|subarachnoid
4978071|NCT01733472|analgesia|analgesia
4978072|NCT01733459|PCOS, DLBS3233, metformin,oral anti-hyperglycemic agent|pcos, dlbs3233, metformin,oral anti-hyperglycemic agent
4978073|NCT01733446|High frequency jet ventilation|high frequency jet ventilation
4978074|NCT01733407|inherited neuropathies|inherited neuropathies
4978075|NCT01733394|Epilepsy|epilepsy
4978076|NCT01733394|Generic|generic
4978077|NCT01733381|Barefoot running, minimally shod running, non-invasive measures of autonomic nervous system (ANS) functioning and mood state.|barefoot running, minimally shod running, non-invasive measures of autonomic nervous system (ans) functioning and mood state.
4978078|NCT01733368|CRT|crt
4978079|NCT01733368|Optimization|optimization
4978080|NCT01733368|Responders|responders
4978081|NCT01733329|Buccal Misoprostol|buccal misoprostol
4978082|NCT01733329|Uterine Atony|uterine atony
4978083|NCT01733329|Postpartum Hemorrhage|postpartum hemorrhage
4978084|NCT01733316|Nephropathic Cystinosis|nephropathic cystinosis
4978085|NCT01733316|Cysteamine|cysteamine
4978086|NCT01733316|Delayed-Release Cysteamine|delayed-release cysteamine
4978087|NCT01733316|Orphan Disease|orphan disease
4978088|NCT01733316|CTNS Protein, Human|ctns protein, human
4978089|NCT01733290|Botulinum Toxin A (BoNT-A)|botulinum toxin a (bont-a)
4978090|NCT01733290|Dysfunctional voiding|dysfunctional voiding
4978091|NCT01733277|Neuropathic pain|neuropathic pain
4978092|NCT01733277|Knee osteoarthritis|knee osteoarthritis
4978093|NCT01733277|MRI|mri
4978094|NCT01733238|PNT2258|pnt2258
4978095|NCT01733238|Lymphoma|lymphoma
4978096|NCT01733238|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
4978097|NCT01733238|NHL|nhl
4978098|NCT01733212|Nausea|nausea
4978099|NCT01733212|Vomiting|vomiting
4978100|NCT01733212|Cesaraen|cesaraen
4978101|NCT01733212|Ginger|ginger
4978102|NCT01733212|cesarean section|cesarean section
4978103|NCT01733199|Parkinson's disease|parkinson's disease
4978104|NCT01733199|Behavioural addictions|behavioural addictions
4978105|NCT01733199|Pathological gambling|pathological gambling
4978106|NCT01733199|Dopamine agonist|dopamine agonist
4978107|NCT01733199|Dopamine dysregulation syndrome|dopamine dysregulation syndrome
4978108|NCT01733199|Pharmacokinetic|pharmacokinetic
4978109|NCT01733199|Pramipexole|pramipexole
4978110|NCT01733186|human umbilical cord blood-derived mesenchymal stem cells|human umbilical cord blood-derived mesenchymal stem cells
4978111|NCT01733186|MSC|msc
4978112|NCT01733186|cartilage lesion|cartilage lesion
4978113|NCT01733186|cartilage defect|cartilage defect
4978114|NCT01733186|degenerative arthritis|degenerative arthritis
4978115|NCT01733186|stem cell implantation|stem cell implantation
4978116|NCT01733173|mass in posterior fossa|mass in posterior fossa
4978117|NCT01733173|benign|benign
4978118|NCT01733173|malignant|malignant
4978119|NCT01733173|surgical resection|surgical resection
4978120|NCT01733173|MRI|mri
4978121|NCT01733173|fMRI|fmri
4978122|NCT01733173|DTI|dti
4978123|NCT01733173|12-121|12-121
4978124|NCT01733160|Atrial Fibrillation|atrial fibrillation
4978125|NCT01733160|Stroke|stroke
4978126|NCT01733160|Anticoagulants|anticoagulants
4978127|NCT01733147|Barrett's esophagus|barrett's esophagus
4978128|NCT01733147|Obesity|obesity
4978129|NCT01733147|Omega-3 fatty acid|omega-3 fatty acid
4978130|NCT01733134|acute heart failure|acute heart failure
4978131|NCT01733134|emergency department|emergency department
4978132|NCT01733134|copeptin|copeptin
4978133|NCT01733134|adh antagonists|adh antagonists
4978134|NCT01733108|Healthy|healthy
4978135|NCT01733108|Canagliflozin (JNJ-28431754)|canagliflozin (jnj-28431754)
4978136|NCT01733108|Pharmacokinetics|pharmacokinetics
4978137|NCT01733108|Pharmacodynamics|pharmacodynamics
4978138|NCT01733108|Glyburide (MICRONASE)|glyburide (micronase)
4978139|NCT01733056|Dermatology|dermatology
4978140|NCT01733056|Influenza Vaccine|influenza vaccine
4978141|NCT01733030|PTSD|ptsd
4978142|NCT01733017|heart failure|heart failure
4978143|NCT01733017|nutrition therapy|nutrition therapy
4978144|NCT01733017|symptoms|symptoms
4978145|NCT01733017|quality of life|quality of life
4978146|NCT01733017|lycopene|lycopene
4978147|NCT01733017|omega-3 fatty acids|omega-3 fatty acids
4978148|NCT01733004|Cancer|cancer
4978149|NCT01733004|Hepatocellular Carcinoma|hepatocellular carcinoma
4978150|NCT01733004|Oncology|oncology
4978151|NCT01733004|Phase I|phase i
4978152|NCT01733004|ErbB3|erbb3
4978153|NCT01733004|IGF-1R|igf-1r
4978154|NCT01733004|Everolimus|everolimus
4978155|NCT01733004|Gemcitabine|gemcitabine
4978156|NCT01733004|Abraxane|abraxane
4978157|NCT01732991|Prostatic Hypertrophy, Benign|prostatic hypertrophy, benign
4978158|NCT01732991|Greenlight laser|greenlight laser
4978159|NCT01732991|Prostatic photovaporization|prostatic photovaporization
4978160|NCT01732991|Prostatic MRI|prostatic mri
4978161|NCT01732991|Prostatic contrast-enhanced ultrasound|prostatic contrast-enhanced ultrasound
4978162|NCT01732991|Urinary irritative signs|urinary irritative signs
4978163|NCT01732991|Postoperative necrotic area|postoperative necrotic area
4978164|NCT01732978|Crying record|crying record
4978165|NCT01732978|Newborn|newborn
4978166|NCT01732965|Vitiligo|vitiligo
4978167|NCT01732965|Phototherapy|phototherapy
4978168|NCT01732965|Photochemotherapy|photochemotherapy
4978169|NCT01732952|the prevalence,lipid abnormalities,CV risks|the prevalence,lipid abnormalities,cv risks
4978170|NCT01732926|iNHL|inhl
4978171|NCT01732926|indolent NHL|indolent nhl
4978172|NCT01732926|follicular lymphoma|follicular lymphoma
4978173|NCT01732926|CAL-101|cal-101
4978174|NCT01732926|rituximab|rituximab
4978175|NCT01732926|bendamustine|bendamustine
4978176|NCT01732926|small lymphocytic lymphoma|small lymphocytic lymphoma
4978177|NCT01732926|lymphoplasmacytoid lymphoma|lymphoplasmacytoid lymphoma
4978178|NCT01732926|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
4978179|NCT01732926|LPL|lpl
4978180|NCT01732926|WM|wm
4978181|NCT01732926|Marginal zone lymphoma|marginal zone lymphoma
4978182|NCT01732926|MZL|mzl
4978183|NCT01732926|SLL|sll
4978184|NCT01732926|FL|fl
4978185|NCT01732926|GS-1101|gs-1101
4978186|NCT01732926|PI3K inhibitor|pi3k inhibitor
4978187|NCT01732926|idelalisib|idelalisib
4978188|NCT01732913|iNHL|inhl
4978189|NCT01732913|indolent NHL|indolent nhl
4978190|NCT01732913|follicular lymphoma|follicular lymphoma
4978191|NCT01732913|CAL-101|cal-101
4978192|NCT01732913|Rituximab|rituximab
4978193|NCT01732913|Small lymphocytic lymphoma|small lymphocytic lymphoma
4978194|NCT01732913|lymphoplasmacytoid lymphoma|lymphoplasmacytoid lymphoma
4978195|NCT01732913|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
4978196|NCT01732913|LPL|lpl
4978197|NCT01732913|WM|wm
4978198|NCT01732913|Marginal zone lymphoma|marginal zone lymphoma
4978199|NCT01732913|MZL|mzl
4978200|NCT01732913|SLL|sll
4978201|NCT01732913|FL|fl
4978202|NCT01732913|GS-1101|gs-1101
4978203|NCT01732913|idelalisib|idelalisib
4978204|NCT01732900|In vitro fertilization|in vitro fertilization
4978205|NCT01732900|Assisted reproduction|assisted reproduction
4978206|NCT01732900|pregnancy outcome|pregnancy outcome
4978207|NCT01732900|cumulus cells|cumulus cells
4978208|NCT01732887|cochlear implants|cochlear implants
4978209|NCT01732887|speech comprehension|speech comprehension
4978210|NCT01732887|cognitive training|cognitive training
4978211|NCT01732887|cognitive fitness|cognitive fitness
4978212|NCT01732887|intervention|intervention
4978213|NCT01732887|memory|memory
4978214|NCT01732887|attention|attention
4978215|NCT01732887|rehabilitation|rehabilitation
4978216|NCT01732874|DHA|dha
4978217|NCT01732874|Preterm infant|preterm infant
4978218|NCT01732874|Inflammation|inflammation
4978219|NCT01732874|Growth|growth
4978220|NCT01732874|Developement|developement
4978221|NCT01732861|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
4978222|NCT01732861|Small Lymphocytic Leukemia|small lymphocytic leukemia
4978224|NCT01732835|Aortic Insufficiency (AI) Aortic Regurgitation (AR)|aortic insufficiency (ai) aortic regurgitation (ar)
4978225|NCT01732822|Peripheral artery disease Atherothrombotic events Atherosclerosis|peripheral artery disease atherothrombotic events atherosclerosis
4978226|NCT01732809|wrinkles|wrinkles
4978227|NCT01732809|botulinum toxin|botulinum toxin
4978228|NCT01732783|Wild-type RAS|wild-type ras
4978229|NCT01732783|Metastatic Colorectal Cancer|metastatic colorectal cancer
4978230|NCT01732783|Vectibix|vectibix
4978231|NCT01732744|biofilm, castor bean, sodium hypochlorite, alkaline peroxide|biofilm, castor bean, sodium hypochlorite, alkaline peroxide
4978232|NCT01732731|Cerebral palsy|cerebral palsy
4978233|NCT01732731|treadmill training|treadmill training
4978234|NCT01732718|sickle cell disease|sickle cell disease
4978235|NCT01732718|endothelial function|endothelial function
4978236|NCT01732718|albuminuria|albuminuria
4978237|NCT01732718|atorvastatin|atorvastatin
4978238|NCT01732718|soluble fms-like tyrosine kinase-1|soluble fms-like tyrosine kinase-1
4978239|NCT01732705|Type 2 diabetes|type 2 diabetes
4978240|NCT01732705|Insulin sensitivity|insulin sensitivity
4978241|NCT01732705|High intensity interval training|high intensity interval training
4978242|NCT01732692|Bowel preparation, MOVIPREP®|bowel preparation, moviprep®
4978243|NCT01732679|stroke, rehabilitation, multidisciplinary, description|stroke, rehabilitation, multidisciplinary, description
4978244|NCT01732666|Opioid-induced hyperalgesia (OIH)|opioid-induced hyperalgesia (oih)
4978245|NCT01732653|virtual reality,|virtual reality,
4978246|NCT01732653|falls,|falls,
4978247|NCT01732653|elderly,|elderly,
4978248|NCT01732653|Parkinson's disease,|parkinson's disease,
4978249|NCT01732653|MCI|mci
4978250|NCT01732640|Squamous cell carcinoma of the head and neck|squamous cell carcinoma of the head and neck
4978251|NCT01732627|Meningitis|meningitis
4978252|NCT01732627|Meningococcal Meningitis|meningococcal meningitis
4978253|NCT01732627|Menactra®|menactra®
4978254|NCT01732627|Menomune® A/C/Y/W-135|menomune® a/c/y/w-135
4978255|NCT01732614|Diabetic Macular Edema|diabetic macular edema
4978256|NCT01732614|DME|dme
4978257|NCT01732614|Laser|laser
4978258|NCT01732614|Topcon|topcon
4978259|NCT01732614|EndPoint Management|endpoint management
4978260|NCT01732601|Suicide Attempt|suicide attempt
4978261|NCT01732601|Suicidal Ideation|suicidal ideation
4978262|NCT01732601|NSSI|nssi
4978263|NCT01732601|Substance Use|substance use
4978264|NCT01732588|Bioavailability|bioavailability
4978265|NCT01732575|everyday activities|everyday activities
4978266|NCT01732575|rehabilitation|rehabilitation
4978267|NCT01732575|mental illness|mental illness
4978268|NCT01732575|occupational therapy|occupational therapy
4978269|NCT01732562|Primary Total Knee Arthroplasty|primary total knee arthroplasty
4978270|NCT01732562|Patient Expectations|patient expectations
4978271|NCT01732562|Patient Satisfaction|patient satisfaction
4978272|NCT01732562|Patient Education|patient education
4978273|NCT01732562|e-Learning|e-learning
4978274|NCT01732536|corticosteroid-eluting sinus implant|corticosteroid-eluting sinus implant
4978275|NCT01732536|chronic rhinosinusitis|chronic rhinosinusitis
4978276|NCT01732536|mometasone furoate|mometasone furoate
4978277|NCT01732536|polyposis|polyposis
4978278|NCT01732523|Carotid stenosis|carotid stenosis
4978279|NCT01732523|Vasa Vasorum|vasa vasorum
4978280|NCT01732523|Ultrasonography|ultrasonography
4978281|NCT01732497|Underarm Hair|underarm hair
4978282|NCT01732497|Underarm Hair Reduction|underarm hair reduction
4978283|NCT01732497|Axillary Hair|axillary hair
4978284|NCT01732497|Axillary Hair Reduction|axillary hair reduction
4978285|NCT01732497|Underarm Odor|underarm odor
4978286|NCT01732497|Axillary Odor|axillary odor
4978287|NCT01732471|EMR 700733_510, Genetic disorder, Phenylketonuria, phenylalanine, Kuvan, sapropterin dihydrochloride|emr 700733_510, genetic disorder, phenylketonuria, phenylalanine, kuvan, sapropterin dihydrochloride
4978288|NCT01732419|Rehabilitation, exercise therapy, coronary artery disease|rehabilitation, exercise therapy, coronary artery disease
4978289|NCT01732393|Quercetin|quercetin
4978290|NCT01732393|Chemotherapy|chemotherapy
4978291|NCT01732393|Mucositis|mucositis
4978292|NCT01732393|Hematologic Malignancies|hematologic malignancies
4978293|NCT01732367|Tenofovir|tenofovir
4978294|NCT01732367|Lamivudine|lamivudine
4978295|NCT01732367|Adefovir|adefovir
4978296|NCT01732367|Chronic Hepatitis B|chronic hepatitis b
4978297|NCT01732354|Hepatitis B virus, Tenofovir|hepatitis b virus, tenofovir
4978298|NCT01732341|STEMI|stemi
4978300|NCT01732341|Self-expanding stent|self-expanding stent
4978301|NCT01732315|Adolescent vaccination|adolescent vaccination
4978302|NCT01732315|Immunization rates|immunization rates
4978303|NCT01732315|Barriers to vaccination|barriers to vaccination
4978304|NCT01732315|Attitudes|attitudes
4978305|NCT01732315|Intentions|intentions
4978306|NCT01732302|Drug Utilization Review|drug utilization review
4978307|NCT01732302|Aged|aged
4978308|NCT01732302|Aged, 80 and over|aged, 80 and over
4978309|NCT01732302|Primary Health Care|primary health care
4978310|NCT01732289|Age-related hearing loss|age-related hearing loss
4978311|NCT01732289|Gene|gene
4978312|NCT01732289|Single nucleotide polymorphism|single nucleotide polymorphism
4978313|NCT01732289|environmental factors|environmental factors
4978314|NCT01732276|Triple-negative breast cancer|triple-negative breast cancer
4978315|NCT01732276|Epidermal growth factor receptor|epidermal growth factor receptor
4978316|NCT01732276|Gefitinib|gefitinib
4978317|NCT01732250|Gram-Negative Bacterial Infections|gram-negative bacterial infections
4978318|NCT01732250|Resistant Bacteria|resistant bacteria
4978319|NCT01732250|Drug Resistance, Bacterial|drug resistance, bacterial
4978320|NCT01732250|Colistin|colistin
4978321|NCT01732237|Healthy|healthy
4978322|NCT01732237|JNJ-42396302|jnj-42396302
4978323|NCT01732237|JNJ-42692507|jnj-42692507
4978324|NCT01732237|JNJ-53773187|jnj-53773187
4978325|NCT01732237|Pharmacokinetics|pharmacokinetics
4978326|NCT01732211|Phase 2|phase 2
4978327|NCT01732211|Randomized|randomized
4978328|NCT01732211|Double Blind|double blind
4978329|NCT01732211|Placebo Controlled|placebo controlled
4978330|NCT01732211|Parallel|parallel
4978331|NCT01732211|20 Week Safety|20 week safety
4978332|NCT01732211|Tolerability|tolerability
4978333|NCT01732211|and Efficacy Study|and efficacy study
4978334|NCT01732185|Congenital lung malformation|congenital lung malformation
4978335|NCT01732185|Congenital Cystic Adenomatoid Malformation|congenital cystic adenomatoid malformation
4978336|NCT01732185|Cystic lung disease|cystic lung disease
4978337|NCT01732172|Urethritis|urethritis
4978338|NCT01732172|Prevalence of a chronic inflammatory male genital tract|prevalence of a chronic inflammatory male genital tract
4978339|NCT01732159|Ambulatory surgery|ambulatory surgery
4978340|NCT01732159|Checklist|checklist
4978341|NCT01732159|Cancellation|cancellation
4978342|NCT01732146|Hypoxic Ischemic Encephalopathy|hypoxic ischemic encephalopathy
4978343|NCT01732146|Term neonate|term neonate
4978344|NCT01732146|Neuroprotection|neuroprotection
4978345|NCT01732146|erythropoietin|erythropoietin
4978346|NCT01732133|Hypotension|hypotension
4978347|NCT01732133|Cesarean delivery|cesarean delivery
4978348|NCT01732120|off-clamp|off-clamp
4978349|NCT01732120|partial nephrectomy|partial nephrectomy
4978350|NCT01732120|renal cancer treatment|renal cancer treatment
4978351|NCT01732120|renal ischemia|renal ischemia
4978352|NCT01732107|Dovitinib|dovitinib
4978353|NCT01732107|FGFR3 Mutations|fgfr3 mutations
4978354|NCT01732107|BCG-Refractory Urothelial Carcinoma|bcg-refractory urothelial carcinoma
4978355|NCT01732094|Poor ovarian response|poor ovarian response
4978356|NCT01732094|Poor ovarian responders|poor ovarian responders
4978357|NCT01732094|Bologna criteria for poor ovarian response|bologna criteria for poor ovarian response
4978358|NCT01732081|Hepatitis B|hepatitis b
4978359|NCT01732068|Poor ovarian response|poor ovarian response
4978360|NCT01732068|Poor ovarian responders|poor ovarian responders
4978361|NCT01732068|Bologna criteria for poor ovarian response|bologna criteria for poor ovarian response
4978362|NCT01732055|Pregnancy|pregnancy
4978363|NCT01732055|Antenatal|antenatal
4978364|NCT01732055|Major Depressive Disorder|major depressive disorder
4978365|NCT01732055|Psychotherapy|psychotherapy
4978366|NCT01732055|Antidepressant Medication|antidepressant medication
4978367|NCT01732055|Partners|partners
4978368|NCT01732055|Spouses|spouses
4978369|NCT01732055|Interpersonal Psychotherapy|interpersonal psychotherapy
4978370|NCT01732042|retinal venous pressure|retinal venous pressure
4978371|NCT01732029|pulse oximeter|pulse oximeter
4978372|NCT01732029|oxygen saturation|oxygen saturation
4978373|NCT01732029|heart rate|heart rate
4978374|NCT01732029|calibration|calibration
4978375|NCT01732029|accuracy|accuracy
4978376|NCT01732016|pulse oximeter|pulse oximeter
4978377|NCT01732016|oxygen saturation|oxygen saturation
4978378|NCT01732016|heart rate|heart rate
4978379|NCT01732016|calibration|calibration
4978380|NCT01732016|accuracy|accuracy
4978381|NCT01732003|Omega-3|omega-3
4978382|NCT01732003|Skeletal Muscle|skeletal muscle
4978383|NCT01732003|Eicosapentaenoic acid|eicosapentaenoic acid
4978384|NCT01732003|Docosahexaenoic acid|docosahexaenoic acid
4978385|NCT01732003|Exercise|exercise
4978386|NCT01732003|Membrane Composition|membrane composition
4978387|NCT01732003|Lipid Metabolism|lipid metabolism
4978388|NCT01731990|Peripheral artery disease|peripheral artery disease
4978389|NCT01731990|Intermittent claudication|intermittent claudication
4978390|NCT01731990|magnetic resonance imaging|magnetic resonance imaging
4978391|NCT01731977|Psychotherapy, Psychotic disorders, Caregiver|psychotherapy, psychotic disorders, caregiver
4978392|NCT01731964|Macular Degeneration|macular degeneration
4978393|NCT01731964|Visual Impairment|visual impairment
4978394|NCT01731964|Implantable Telescope|implantable telescope
4978395|NCT01731951|Myelofibrosis|myelofibrosis
4978396|NCT01731951|Myelodysplastic Syndromes|myelodysplastic syndromes
4978397|NCT01731951|Myeloproliferative Neoplasm|myeloproliferative neoplasm
4978398|NCT01731951|Imetelstat|imetelstat
4978399|NCT01731951|GRN163L|grn163l
4978400|NCT01731938|Fibrin Sealant|fibrin sealant
4978401|NCT01731938|Soft tissue open surgery|soft tissue open surgery
4978402|NCT01731938|Oxidized cellulose pads|oxidized cellulose pads
4978403|NCT01731925|midgut carcinoid tumors|midgut carcinoid tumors
4978404|NCT01731925|progressive|progressive
4978405|NCT01731925|advanced|advanced
4978406|NCT01731925|metastatic|metastatic
4978407|NCT01731899|major depression|major depression
4978408|NCT01731899|fibromyalgia|fibromyalgia
4978409|NCT01731899|agomelatine|agomelatine
4978410|NCT01731899|Becks' Depression Inventory (BDI)|becks' depression inventory (bdi)
4978411|NCT01731899|Pittsburgh's Sleep Quality Index (PSQI)|pittsburgh's sleep quality index (psqi)
4978412|NCT01731886|Stem cell transplant|stem cell transplant
4978413|NCT01731886|plasma cell myeloma|plasma cell myeloma
4978414|NCT01731886|multiple myeloma|multiple myeloma
4978415|NCT01731873|postoperative pain|postoperative pain
4978416|NCT01731873|children|children
4978417|NCT01731873|pharmacogenetic|pharmacogenetic
4978418|NCT01731873|opioid adverse effects|opioid adverse effects
4978419|NCT01731873|respiratory depression|respiratory depression
4978420|NCT01731873|analgesia|analgesia
4978421|NCT01731873|genetic polymorphisms|genetic polymorphisms
4978422|NCT01731860|PET/CT|pet/ct
4978423|NCT01731860|Philips|philips
4978424|NCT01731847|dysphagia,endoscopy, electrical stimulation,stroke|dysphagia,endoscopy, electrical stimulation,stroke
4978425|NCT01731834|Pain|pain
4978426|NCT01731834|Stress|stress
4978427|NCT01731834|Physiotherapy|physiotherapy
4978428|NCT01731834|Children|children
4978429|NCT01731821|Pancreaticoduodenectomy|pancreaticoduodenectomy
4978430|NCT01731821|Pancreaticojejunostomy|pancreaticojejunostomy
4978431|NCT01731808|Nursing counseling|nursing counseling
4978432|NCT01731808|diabetic foot|diabetic foot
4978433|NCT01731795|acute respiratory distress syndrome, mechanical ventilation|acute respiratory distress syndrome, mechanical ventilation
4978434|NCT01731782|colorectal surgery|colorectal surgery
4978435|NCT01731769|Seroma Formation|seroma formation
4978436|NCT01731769|Axillary Lymph Node Dissection|axillary lymph node dissection
4978437|NCT01731769|Breast cancer|breast cancer
4978438|NCT01731769|Early Vacuum Assisted Closure|early vacuum assisted closure
4978439|NCT01731756|Palm|palm
4978440|NCT01731756|Arsenic|arsenic
4978441|NCT01731756|Keratosis|keratosis
4978442|NCT01731756|Salicylic acid|salicylic acid
4978443|NCT01731756|Azadirachta indica|azadirachta indica
4978444|NCT01731756|Neem|neem
4978445|NCT01731730|Postsurgical pain|postsurgical pain
4978446|NCT01731730|Total knee arthroplasty|total knee arthroplasty
4978447|NCT01731730|Total knee replacement|total knee replacement
4978448|NCT01731717|depression|depression
4978449|NCT01731717|stepped care|stepped care
4978450|NCT01731717|evidence-based medicine|evidence-based medicine
4978451|NCT01731717|health services research|health services research
4978452|NCT01731717|psychotherapy|psychotherapy
4978453|NCT01731717|complex intervention|complex intervention
4978454|NCT01731717|guideline|guideline
4978455|NCT01731704|5 or more brain metastases|5 or more brain metastases
4978456|NCT01731704|proven diagnosis of a non-hematopoietic malignancy|proven diagnosis of a non-hematopoietic malignancy
4978457|NCT01731704|non-small cell lung cancer or germ cell malignancy|non-small cell lung cancer or germ cell malignancy
4978458|NCT01731665|Crohn's disease|crohn's disease
4978459|NCT01731665|ulcerative colitis|ulcerative colitis
4978460|NCT01731665|epidemiology|epidemiology
4978461|NCT01731665|Korea|korea
4978462|NCT01731652|bladder cancer|bladder cancer
4978463|NCT01731652|carcinoma in situ|carcinoma in situ
4978464|NCT01731652|non muscle invasive bladder cancer|non muscle invasive bladder cancer
4978465|NCT01731587|Non-small cell lung cancer (NSCLC)|non-small cell lung cancer (nsclc)
4978466|NCT01731587|exploratory study|exploratory study
4978467|NCT01731587|L-BLP25|l-blp25
4978468|NCT01731561|Granulomatosis with Polyangiitis|granulomatosis with polyangiitis
4978469|NCT01731561|Microscopic polyangiitis|microscopic polyangiitis
4978470|NCT01731561|Renal limited forms|renal limited forms
4978471|NCT01731561|ANCA-associated vasculitis|anca-associated vasculitis
4978472|NCT01731561|Rituximab|rituximab
4978473|NCT01731535|osteoporosis, low trauma fracture, non-union fracture, delayed healing fracture, bisphosphonate|osteoporosis, low trauma fracture, non-union fracture, delayed healing fracture, bisphosphonate
4978474|NCT01731509|congenital diaphragmatic hernia|congenital diaphragmatic hernia
4978475|NCT01731509|fetoscopy|fetoscopy
4978476|NCT01731509|fetal endoscopic tracheal occlusion|fetal endoscopic tracheal occlusion
4978477|NCT01731509|pulmonary hypoplasia|pulmonary hypoplasia
4978478|NCT01731509|fetal surgery|fetal surgery
4978479|NCT01731509|fetal lung|fetal lung
4978480|NCT01731496|Human Papillomavirus|human papillomavirus
4978481|NCT01731483|virulence factors|virulence factors
4978482|NCT01731457|ischemia, reperfusion, kidney, transplantation|ischemia, reperfusion, kidney, transplantation
4978483|NCT01731444|blood loss|blood loss
4978484|NCT01731444|burn|burn
4978485|NCT01731444|hemostasis|hemostasis
4978486|NCT01731431|Gestational Diabetes,|gestational diabetes,
4978487|NCT01731431|Insulin,|insulin,
4978488|NCT01731431|Glyburide,|glyburide,
4978489|NCT01731431|Glycemia|glycemia
4978490|NCT01731418|Post Traumatic Stress Disorder|post traumatic stress disorder
4978491|NCT01731418|Depression|depression
4978492|NCT01731418|Intimate Partner violence|intimate partner violence
4978493|NCT01731418|Narrative Exposure Therapy|narrative exposure therapy
4978494|NCT01731405|Medication Guides|medication guides
4978496|NCT01731405|Prototype|prototype
4978497|NCT01731405|Format|format
4978498|NCT01731392|Diarrhea|diarrhea
4978499|NCT01731392|Children|children
4978500|NCT01731392|Lactobacilli|lactobacilli
4978501|NCT01731379|spectroscopy|spectroscopy
4978502|NCT01731379|nerve|nerve
4978503|NCT01731379|muscle|muscle
4978504|NCT01731379|fat|fat
4978505|NCT01731353|invasive fungal infection|invasive fungal infection
4978506|NCT01731353|Web-based registry|web-based registry
4978507|NCT01731340|Calcium Supplements|calcium supplements
4978508|NCT01731340|Dairy Foods|dairy foods
4978509|NCT01731340|Cardiovascular Diseases|cardiovascular diseases
4978510|NCT01731340|Osteoporosis|osteoporosis
4978511|NCT01731340|Postmenopause|postmenopause
4978512|NCT01731340|Vitamin D|vitamin d
4978513|NCT01731340|Micronutrients|micronutrients
4978514|NCT01731340|Primary Prevention|primary prevention
4978515|NCT01731340|Bone Health|bone health
4978516|NCT01731327|Phase 1|phase 1
4978517|NCT01731327|relative bioavailability|relative bioavailability
4978518|NCT01731327|modified release|modified release
4978519|NCT01731327|tofacitinib|tofacitinib
4978520|NCT01731327|CP-690|cp-690
4978521|NCT01731327|550|550
4978522|NCT01731327|pharmacokinetic|pharmacokinetic
4978523|NCT01731301|Chronic hepatitis C|chronic hepatitis c
4978524|NCT01731301|HCV|hcv
4978525|NCT01731301|End stage renal disease|end stage renal disease
4978526|NCT01731301|ESRD|esrd
4978527|NCT01731301|Boceprevir|boceprevir
4978528|NCT01731301|Ribavirin|ribavirin
4978529|NCT01731301|Peg-interferon|peg-interferon
4978530|NCT01731301|Triple therapy|triple therapy
4978531|NCT01731288|pregnancy|pregnancy
4978532|NCT01731288|childbirth|childbirth
4978533|NCT01731288|pain|pain
4978534|NCT01731288|vulvodynia|vulvodynia
4978535|NCT01731288|provoked vestibulodynia|provoked vestibulodynia
4978536|NCT01731275|Healthy volunteers|healthy volunteers
4978537|NCT01731275|immunogenicity|immunogenicity
4978538|NCT01731275|anti-E6011 antibody|anti-e6011 antibody
4978539|NCT01731262|Arthritis, Rheumatoid|arthritis, rheumatoid
4978540|NCT01731262|Sonic hedgehog protein, human|sonic hedgehog protein, human
4978541|NCT01731262|Neovascularization, Pathologic|neovascularization, pathologic
4978542|NCT01731262|Synovitis|synovitis
4978543|NCT01731249|Sublingual immunotherapy|sublingual immunotherapy
4978544|NCT01731249|Birch pollen extract solution|birch pollen extract solution
4978545|NCT01731249|Allergic rhinoconjunctivitis|allergic rhinoconjunctivitis
4978546|NCT01731236|Carnitine metabolism|carnitine metabolism
4978547|NCT01731236|gut flora|gut flora
4978548|NCT01731223|Insomnia|insomnia
4978549|NCT01731223|Primary health care|primary health care
4978550|NCT01731197|obesity, isolated soy protein, satiety, food intake|obesity, isolated soy protein, satiety, food intake
4978551|NCT01731184|acute traumatic pain, pre-hospital setting, Midazolam|acute traumatic pain, pre-hospital setting, midazolam
4978552|NCT01731171|mania|mania
4978553|NCT01731171|manic episode|manic episode
4978554|NCT01731171|mixed episode|mixed episode
4978555|NCT01731171|bipolar disorder|bipolar disorder
4978556|NCT01731171|schizoaffective disorder|schizoaffective disorder
4978557|NCT01731171|probiotics|probiotics
4978558|NCT01731171|probiotic supplement|probiotic supplement
4978559|NCT01731171|relapse prevention|relapse prevention
4978560|NCT01731171|new mood episode|new mood episode
4978561|NCT01731171|re-hospitalization|re-hospitalization
4978562|NCT01731145|Tremor|tremor
4978563|NCT01731145|SNUMAP|snumap
4978564|NCT01731145|accelerometry|accelerometry
4978565|NCT01731145|gyroscope|gyroscope
4978566|NCT01731145|clinical rating scale|clinical rating scale
4978567|NCT01731132|HRQoL|hrqol
4978569|NCT01731132|Contraception|contraception
4978570|NCT01731132|SEC-QoL|sec-qol
4978571|NCT01731119|Latuda,lurasidone,antipsychotics,autism, mood, psychosis|latuda,lurasidone,antipsychotics,autism, mood, psychosis
4978572|NCT01731093|aged|aged
4978573|NCT01731093|health|health
4978574|NCT01731093|brain|brain
4978575|NCT01731054|lupus nephritis|lupus nephritis
4978576|NCT01731054|normal healthy volunteer|normal healthy volunteer
4978577|NCT01731054|MRI|mri
4978578|NCT01731041|coronary disease, platelet function, platelet inhibitors|coronary disease, platelet function, platelet inhibitors
4978579|NCT01731002|Glaucoma|glaucoma
4978580|NCT01730989|menopause|menopause
4978581|NCT01730989|Kupperman|kupperman
4978582|NCT01730989|hot flushes|hot flushes
4978583|NCT01730989|isoflavones|isoflavones
4978584|NCT01730989|magnolia|magnolia
4978585|NCT01730989|chaste tree|chaste tree
4978586|NCT01730976|asthma, elderly, vitamin D|asthma, elderly, vitamin d
4978587|NCT01730924|Atrial fibrillation|atrial fibrillation
4978588|NCT01730924|Contact force|contact force
4978589|NCT01730924|Ablation|ablation
4978590|NCT01730911|Bleeding|bleeding
4978591|NCT01730911|Cramping|cramping
4978592|NCT01730911|Pregnancy with intrauterine device in place|pregnancy with intrauterine device in place
4978593|NCT01730911|Intrauterine device expulsion|intrauterine device expulsion
4978594|NCT01730911|Intrauterine device removal|intrauterine device removal
4978595|NCT01730859|Balance exercise|balance exercise
4978596|NCT01730859|Ankle|ankle
4978597|NCT01730859|Postural stability|postural stability
4978598|NCT01730859|Taping|taping
4978599|NCT01730859|Biodex|biodex
4978600|NCT01730846|smoking lapse behavior|smoking lapse behavior
4978601|NCT01730846|smoking cessation|smoking cessation
4978602|NCT01730846|doxazosin|doxazosin
4978603|NCT01730846|medication effect on smoking lapse behavior|medication effect on smoking lapse behavior
4978604|NCT01730846|medication effect on smoking cessation|medication effect on smoking cessation
4978605|NCT01730846|stress|stress
4978606|NCT01730807|Atrial Flutter|atrial flutter
4978607|NCT01730807|Ablation|ablation
4978608|NCT01730807|Type I Atrial Flutter|type i atrial flutter
4978609|NCT01730807|Atrial Arrhythmia|atrial arrhythmia
4978610|NCT01730794|Acute Respiratory Failure|acute respiratory failure
4978611|NCT01730794|Mechanical Ventilation|mechanical ventilation
4978612|NCT01730794|NAVA|nava
4978613|NCT01730794|Lung protective ventilation|lung protective ventilation
4978614|NCT01730794|invasive ventilation|invasive ventilation
4978615|NCT01730794|noninvasive ventilation|noninvasive ventilation
4978616|NCT01730781|Cannabis dependence|cannabis dependence
4978617|NCT01730781|Brain Imaging|brain imaging
4978618|NCT01730781|Schizophrenia|schizophrenia
4978619|NCT01730768|schizophrenia, chronic stable schizophrenia, cognition, memory, visual learning, CogState|schizophrenia, chronic stable schizophrenia, cognition, memory, visual learning, cogstate
4978620|NCT01730755|Polycythemia|polycythemia
4978621|NCT01730716|Human spinal cord derived neural stem cell transplantation|human spinal cord derived neural stem cell transplantation
4978622|NCT01730716|ALS|als
4978623|NCT01730703|walking|walking
4978624|NCT01730703|incentives|incentives
4978625|NCT01730703|elderly|elderly
4978626|NCT01730690|Bacterial meningitis in adults|bacterial meningitis in adults
4978627|NCT01730690|determinants of in-hospital mortality|determinants of in-hospital mortality
4978628|NCT01730677|Lapatinib|lapatinib
4978629|NCT01730677|Vinorelbine|vinorelbine
4978630|NCT01730664|ertapenem|ertapenem
4978631|NCT01730664|tuberculosis|tuberculosis
4978632|NCT01730664|pharmacokinetics|pharmacokinetics
4978633|NCT01730651|cervical cancer with metastatic lymphadenopathies|cervical cancer with metastatic lymphadenopathies
4978634|NCT01730638|thyroid,|thyroid,
4978635|NCT01730638|endocrine tumour|endocrine tumour
4978636|NCT01730638|Nuclear medicine,|nuclear medicine,
4978637|NCT01730638|molecular imaging|molecular imaging
4978638|NCT01730638|ImmunoTEP|immunotep
4978639|NCT01730625|Attention bias modification treatment (ABMT)|attention bias modification treatment (abmt)
4978640|NCT01730625|Attention biases|attention biases
4978641|NCT01730625|Anxious children|anxious children
4978642|NCT01730625|Cognitive Behavioral Therapy (CBT)|cognitive behavioral therapy (cbt)
4978643|NCT01730612|ImmunoTEP|immunotep
4978644|NCT01730612|HER2 negative|her2 negative
4978645|NCT01730612|Breast Cancer|breast cancer
4978646|NCT01730586|Colorectal Cancer|colorectal cancer
4978647|NCT01730586|Cancer of Gastrointestinal Tract|cancer of gastrointestinal tract
4978648|NCT01730586|CIMP-high Colorectal Adenocarcinoma|cimp-high colorectal adenocarcinoma
4978649|NCT01730586|Small Bowel Adenocarcinomas|small bowel adenocarcinomas
4978650|NCT01730586|Colorectal|colorectal
4978651|NCT01730586|Small bowel cancer|small bowel cancer
4978652|NCT01730586|Abraxane|abraxane
4978653|NCT01730586|Nab-Paclitaxel|nab-paclitaxel
4978654|NCT01730586|Paclitaxel (Protein-Bound)|paclitaxel (protein-bound)
4978655|NCT01730586|ABI-007|abi-007
4978656|NCT01730573|interscalene|interscalene
4978657|NCT01730573|suprascapular|suprascapular
4978658|NCT01730573|axillary|axillary
4978659|NCT01730547|Mesenchymal stem cells|mesenchymal stem cells
4978660|NCT01730547|Multiple Sclerosis|multiple sclerosis
4978661|NCT01730547|Autoimmune diseases|autoimmune diseases
4978662|NCT01730534|Phase IIIb|phase iiib
4978663|NCT01730534|T2DM|t2dm
4978664|NCT01730534|cardiovascular events|cardiovascular events
4978665|NCT01730495|Chronic fatigue syndrome|chronic fatigue syndrome
4978666|NCT01730495|CFS|cfs
4978667|NCT01730495|Myalgic Encephalomyelitis (ME)|myalgic encephalomyelitis (me)
4978668|NCT01730495|CFS/ME|cfs/me
4978669|NCT01730495|Tumor necrosis factor-alpha|tumor necrosis factor-alpha
4978670|NCT01730495|TNF-alpha|tnf-alpha
4978671|NCT01730495|Etanercept|etanercept
4978672|NCT01730482|excretion|excretion
4978673|NCT01730482|healthy volunteer|healthy volunteer
4978674|NCT01730482|migalastat hydrochloride|migalastat hydrochloride
4978675|NCT01730482|AT1001|at1001
4978676|NCT01730482|pharmacokinetics|pharmacokinetics
4978677|NCT01730482|Fabry disease|fabry disease
4978678|NCT01730469|Pharmacokinetics|pharmacokinetics
4978679|NCT01730469|GR181413|gr181413
4978680|NCT01730469|Safety|safety
4978681|NCT01730469|AT1001|at1001
4978682|NCT01730469|Migalastat hydrochloride|migalastat hydrochloride
4978683|NCT01730443|traumatic brain injury|traumatic brain injury
4978684|NCT01730430|non-AD dementias|non-ad dementias
4978685|NCT01730430|healthy elderly controls|healthy elderly controls
4978686|NCT01730417|Phase 1|phase 1
4978687|NCT01730417|no carrier added metaiodobenzylguanidine|no carrier added metaiodobenzylguanidine
4978688|NCT01730417|radiation dosimetry|radiation dosimetry
4978689|NCT01730378|Influenza vaccine|influenza vaccine
4978690|NCT01730365|spectroscopy|spectroscopy
4978691|NCT01730365|tumour|tumour
4978692|NCT01730365|biopsy|biopsy
4978693|NCT01730365|malignancy|malignancy
4978694|NCT01730352|immune thrombocytopenic purpura|immune thrombocytopenic purpura
4978695|NCT01730352|chronic immune thrombocytopenic purpura|chronic immune thrombocytopenic purpura
4978696|NCT01730352|secondary immune thrombocytopenic purpura|secondary immune thrombocytopenic purpura
4978697|NCT01730352|Helicobacter pylori infection|helicobacter pylori infection
4978698|NCT01730352|Helicobacter pylori gastritis|helicobacter pylori gastritis
4978699|NCT01730352|children|children
4978700|NCT01730352|adolescents|adolescents
4978701|NCT01730339|Skin scarring|skin scarring
4978702|NCT01730339|cicatrix|cicatrix
4978703|NCT01730339|breast scar|breast scar
4978704|NCT01730339|hypertrophic scar|hypertrophic scar
4978705|NCT01730326|Headache|headache
4978706|NCT01730326|paracetamol|paracetamol
4978707|NCT01730326|dexketoprofen|dexketoprofen
4978708|NCT01730326|emergency department|emergency department
4978709|NCT01730313|Nodding syndrome|nodding syndrome
4978710|NCT01730287|Stepwise Excavation|stepwise excavation
4978711|NCT01730287|Pulpal vitality|pulpal vitality
4978712|NCT01730287|Deep caries lesions|deep caries lesions
4978713|NCT01730287|Clinical symptoms|clinical symptoms
4978714|NCT01730287|Radiographic evaluation|radiographic evaluation
4978715|NCT01730261|Traumatic Brain Injury|traumatic brain injury
4978716|NCT01730261|TBI|tbi
4978717|NCT01730261|Executive Dysfunction|executive dysfunction
4978718|NCT01730261|Emotional Regulation|emotional regulation
4978719|NCT01730261|Problem Solving|problem solving
4978720|NCT01730261|Self-regulation|self-regulation
4978721|NCT01730261|Cognitive Rehabilitation|cognitive rehabilitation
4978722|NCT01730261|Metacognitive Strategies|metacognitive strategies
4978723|NCT01730261|Cognitive-behavioral therapy|cognitive-behavioral therapy
4978724|NCT01730261|Online Therapy|online therapy
4978725|NCT01730261|Group therapy|group therapy
4978726|NCT01730261|Group videoconference|group videoconference
4978727|NCT01730261|Telehealth|telehealth
4978728|NCT01730261|Telerehabilitation|telerehabilitation
4978729|NCT01730248|Myelofibrosis,|myelofibrosis,
4978730|NCT01730248|PMF,|pmf,
4978731|NCT01730248|PPV-MF,|ppv-mf,
4978732|NCT01730248|PET-MF,|pet-mf,
4978733|NCT01730248|Primary Myelofibrosis,|primary myelofibrosis,
4978734|NCT01730248|Post-polycythemia vera myelofibrosis,|post-polycythemia vera myelofibrosis,
4978735|NCT01730248|Post-essential thrombocythemia myelofibrosis|post-essential thrombocythemia myelofibrosis
4978736|NCT01730222|pancreatic adenocarcinoma|pancreatic adenocarcinoma
4978737|NCT01730222|stage III disease|stage iii disease
4978738|NCT01730222|stage IV disease|stage iv disease
4978739|NCT01730222|chemotherapy|chemotherapy
4978740|NCT01730209|Tuberous Sclerosis Complex|tuberous sclerosis complex
4978741|NCT01730209|TSC|tsc
4978742|NCT01730209|Autism|autism
4978743|NCT01730209|Learning problems|learning problems
4978744|NCT01730209|Everolimus|everolimus
4978745|NCT01730209|RAD001|rad001
4978746|NCT01730209|Treatment|treatment
4978747|NCT01730209|Cognition|cognition
4978748|NCT01730209|Intellectual disability|intellectual disability
4978749|NCT01730170|Epilepsy|epilepsy
4978750|NCT01730170|Pregnancy|pregnancy
4978751|NCT01730144|Nasal Spray Vaccine|nasal spray vaccine
4978752|NCT01730144|Nasal Cells|nasal cells
4978753|NCT01730131|Immune Reconstitution Syndrome|immune reconstitution syndrome
4978754|NCT01730131|Human Immunodeficiency Virus|human immunodeficiency virus
4978755|NCT01730131|Multiple Sclerosis|multiple sclerosis
4978756|NCT01730118|Metastatic Solid Tumors|metastatic solid tumors
4978757|NCT01730118|Human Epidermal Growth Factor Receptor 2 Expression (HER2/neu)|human epidermal growth factor receptor 2 expression (her2/neu)
4978758|NCT01730118|Trastuzumab Exposure|trastuzumab exposure
4978759|NCT01730118|Dendritic Cell Vaccine|dendritic cell vaccine
4978760|NCT01730118|Breast Cancer|breast cancer
4978761|NCT01730105|Adaptive Thermogenesis|adaptive thermogenesis
4978762|NCT01730105|Adipose Tissue|adipose tissue
4978763|NCT01730105|Body Composition|body composition
4978764|NCT01730105|Body Weight Regulation|body weight regulation
4978765|NCT01730105|Brown Adipose Tissue|brown adipose tissue
4978766|NCT01730092|Vascular Inflammation|vascular inflammation
4978767|NCT01730092|Microarray|microarray
4978768|NCT01730092|Right Ventricular Function|right ventricular function
4978769|NCT01730092|Endothelial Dysfunction|endothelial dysfunction
4978770|NCT01730092|Magnetic Resonance Imaging|magnetic resonance imaging
4978771|NCT01730079|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
4978772|NCT01730079|Autism|autism
4978773|NCT01730079|Near Infrared Spectroscopy|near infrared spectroscopy
4978774|NCT01730079|Brain Activity|brain activity
4978775|NCT01730066|Probiotics|probiotics
4978776|NCT01730066|Pathogenic enteric bacteria|pathogenic enteric bacteria
4978777|NCT01730066|Oropharyngeal flora|oropharyngeal flora
4978778|NCT01730066|CRP|crp
4978779|NCT01730066|WBC|wbc
4978780|NCT01729949|Nutrition|nutrition
4978781|NCT01729949|Polyphenols|polyphenols
4978782|NCT01729949|Berries|berries
4978783|NCT01729949|Overweight|overweight
4978784|NCT01729949|Lipid Panels|lipid panels
4978785|NCT01729936|Sitting time|sitting time
4978786|NCT01729936|Overweight|overweight
4978787|NCT01729936|Obese|obese
4978788|NCT01729936|Primary Health Care|primary health care
4978789|NCT01729910|overweight|overweight
4978790|NCT01729910|obesity|obesity
4978791|NCT01729910|rural|rural
4978792|NCT01729910|primary care|primary care
4978793|NCT01729897|gastroscopy|gastroscopy
4978794|NCT01729897|sedation|sedation
4978795|NCT01729897|etomidate|etomidate
4978796|NCT01729871|Atrial Fibrillation|atrial fibrillation
4978797|NCT01729871|Irregular heart beat|irregular heart beat
4978798|NCT01729871|Catheter Ablation|catheter ablation
4978799|NCT01729871|Rivaroxaban|rivaroxaban
4978800|NCT01729793|TNFalpha|tnfalpha
4978801|NCT01729793|IL6|il6
4978802|NCT01729793|postprandial|postprandial
4978803|NCT01729793|digestive|digestive
4979312|NCT01727843|fracture|fracture
4978804|NCT01729793|inflammation|inflammation
4978805|NCT01729793|IL1beta|il1beta
4978806|NCT01729793|CRP|crp
4978807|NCT01729793|CBC|cbc
4978808|NCT01729793|ESR|esr
4978809|NCT01729780|EEG-NF|eeg-nf
4978810|NCT01729780|Neurofeedback|neurofeedback
4978811|NCT01729780|Prevention|prevention
4978812|NCT01729780|ACS|acs
4978813|NCT01729741|Drain or no drain|drain or no drain
4978814|NCT01729741|Thyroid surgery|thyroid surgery
4978815|NCT01729741|Randomized Trial|randomized trial
4978816|NCT01729728|Tonsillectomy|tonsillectomy
4978817|NCT01729728|Dental surgery|dental surgery
4978818|NCT01729728|Ear surgery|ear surgery
4978819|NCT01729728|Nose surgery|nose surgery
4978820|NCT01729728|Throat surgery|throat surgery
4978821|NCT01729715|Pediatric|pediatric
4978822|NCT01729715|Insomnia|insomnia
4978823|NCT01729702|1- Hypertrophic cardiomyopathy|1- hypertrophic cardiomyopathy
4978824|NCT01729702|2- BNP|2- bnp
4978825|NCT01729702|3- NT-proBNP|3- nt-probnp
4978826|NCT01729702|4- Neurohormons|4- neurohormons
4978827|NCT01729663|melanoma|melanoma
4978828|NCT01729663|irradiated-allogeneic cells|irradiated-allogeneic cells
4978829|NCT01729663|therapeutic vaccine|therapeutic vaccine
4978830|NCT01729663|Interferon alpha 2-b|interferon alpha 2-b
4978831|NCT01729650|Psychotic Disorders,|psychotic disorders,
4978832|NCT01729650|Heart Diseases|heart diseases
4978833|NCT01729637|Lung Transplantation|lung transplantation
4978834|NCT01729637|Respiratory Mechanics|respiratory mechanics
4978835|NCT01729637|Isolated lung perfusion|isolated lung perfusion
4978836|NCT01729637|Ex-vivo lung perfusion|ex-vivo lung perfusion
4978837|NCT01729637|Lung mechanics|lung mechanics
4978838|NCT01729624|Wegener Granulomatosis|wegener granulomatosis
4978839|NCT01729624|Microscopic Polyangiitis|microscopic polyangiitis
4978840|NCT01729624|Churg-Strauss Syndrome|churg-strauss syndrome
4978841|NCT01729624|Antibodies, Antineutrophil Cytoplasmic|antibodies, antineutrophil cytoplasmic
4978842|NCT01729611|Scleroderma|scleroderma
4978843|NCT01729611|Cirrhosis|cirrhosis
4978844|NCT01729598|cognitively normal elderly population|cognitively normal elderly population
4978845|NCT01729598|safety and tolerability|safety and tolerability
4978846|NCT01729585|cystic fibrosis|cystic fibrosis
4978847|NCT01729585|quality of life|quality of life
4978848|NCT01729572|schizophrenia|schizophrenia
4978849|NCT01729572|Schizoaffective Disorder|schizoaffective disorder
4978850|NCT01729572|disease management|disease management
4978851|NCT01729572|treatment|treatment
4978852|NCT01729572|rehabilitation|rehabilitation
4978853|NCT01729572|pharmacotherapy|pharmacotherapy
4978854|NCT01729559|venous thromboembolic disease|venous thromboembolic disease
4978855|NCT01729559|deep vein thrombosis|deep vein thrombosis
4978856|NCT01729559|pulmonary embolism|pulmonary embolism
4978857|NCT01729559|trauma|trauma
4978858|NCT01729559|antithrombotic prophylaxis|antithrombotic prophylaxis
4978859|NCT01729546|SMBG (self-monitoring of blood glucose)|smbg (self-monitoring of blood glucose)
4978860|NCT01729546|POCT|poct
4978861|NCT01729546|System Accuracy|system accuracy
4978862|NCT01729533|ICSI|icsi
4978863|NCT01729533|IMSI|imsi
4978864|NCT01729533|Pregnancy|pregnancy
4978865|NCT01729533|Sperm morphology|sperm morphology
4978866|NCT01729533|Unexplained infertility|unexplained infertility
4978867|NCT01729520|Total knee arthroplasty|total knee arthroplasty
4978868|NCT01729520|Total knee replacement|total knee replacement
4978869|NCT01729520|Strength training|strength training
4978870|NCT01729520|Resistance training|resistance training
4978871|NCT01729520|Physical therapy modalities|physical therapy modalities
4978872|NCT01729520|Fatigue|fatigue
4978873|NCT01729507|Smoking cessation|smoking cessation
4978874|NCT01729507|Add on and smoking cessation|add on and smoking cessation
4978875|NCT01729507|Therapy for tobacco dependence|therapy for tobacco dependence
4978876|NCT01729507|Transcranial direct current stimulation|transcranial direct current stimulation
4978877|NCT01729494|belatacept|belatacept
4978878|NCT01729494|rabbit antithymocyte globulin|rabbit antithymocyte globulin
4978879|NCT01729494|alemtuzumab|alemtuzumab
4978880|NCT01729494|corticosteroid withdrawal|corticosteroid withdrawal
4978881|NCT01729468|Low Dose Acetylsalicylic Acid|low dose acetylsalicylic acid
4978882|NCT01729468|Prevention|prevention
4978883|NCT01729468|Pre-eclampsia|pre-eclampsia
4978884|NCT01729468|Intra-uterine Growth Restriction|intra-uterine growth restriction
4978885|NCT01729468|Primiparous Women|primiparous women
4978886|NCT01729468|Bilateral Uterine Artery Notches|bilateral uterine artery notches
4978887|NCT01729468|First Quarter|first quarter
4978888|NCT01729455|Belimumab|belimumab
4978889|NCT01729455|Connective Tissue Diseases|connective tissue diseases
4978890|NCT01729455|Lupus|lupus
4978891|NCT01729455|Additional relevant MeSH terms:|additional relevant mesh terms:
4978892|NCT01729455|Lupus Erythematosus, Systemic|lupus erythematosus, systemic
4978893|NCT01729455|Autoimmune Diseases|autoimmune diseases
4978894|NCT01729455|SLE|sle
4978895|NCT01729455|Systemic Lupus Erythematosus|systemic lupus erythematosus
4978896|NCT01729455|Autoimmune Disease|autoimmune disease
4978897|NCT01729455|Antibodies|antibodies
4978898|NCT01729455|Immune System Diseases|immune system diseases
4978899|NCT01729429|Papillomavirus Vaccines|papillomavirus vaccines
4978900|NCT01729429|Intervention Studies|intervention studies
4979313|NCT01727843|hip|hip
4978901|NCT01729429|Health Services Research|health services research
4978902|NCT01729429|Cancer of Cervix|cancer of cervix
4978903|NCT01729416|colon|colon
4978904|NCT01729416|cancer|cancer
4978905|NCT01729416|screening|screening
4978906|NCT01729416|water exchange|water exchange
4978908|NCT01729416|method|method
4978909|NCT01729416|polyp|polyp
4978910|NCT01729416|adenoma|adenoma
4978911|NCT01729416|detection|detection
4978912|NCT01729416|rate|rate
4978913|NCT01729416|sedation|sedation
4978914|NCT01729416|time|time
4978915|NCT01729416|procedure|procedure
4978916|NCT01729390|Feeding behavior|feeding behavior
4978917|NCT01729364|elective CABG|elective cabg
4978918|NCT01729364|renal impairment|renal impairment
4978919|NCT01729364|GFR|gfr
4978920|NCT01729364|renal blood flow|renal blood flow
4978921|NCT01729364|colloid|colloid
4978922|NCT01729364|crystalloid|crystalloid
4978923|NCT01729364|thermodilution technique|thermodilution technique
4978924|NCT01729364|oxygen supply demand|oxygen supply demand
4978925|NCT01729351|Primary Care|primary care
4978926|NCT01729351|Particle size|particle size
4978927|NCT01729351|beclomethasone dipropionate|beclomethasone dipropionate
4978928|NCT01729351|Asthma Management|asthma management
4978929|NCT01729351|Maintenance Therapy|maintenance therapy
4978930|NCT01729351|Metered-Dose Inhaler|metered-dose inhaler
4978931|NCT01729351|Smoking|smoking
4978932|NCT01729325|Post-traumatic Stress disorder (PTSD)|post-traumatic stress disorder (ptsd)
4978933|NCT01729325|Aggressive Behavior|aggressive behavior
4978934|NCT01729325|Appetitive Aggression|appetitive aggression
4978935|NCT01729325|Resilience|resilience
4978936|NCT01729325|Preventive Narrative Exposure Therapy|preventive narrative exposure therapy
4978937|NCT01729299|ghrelin|ghrelin
4978938|NCT01729299|glucose control|glucose control
4978939|NCT01729299|GLP-1|glp-1
4978940|NCT01729299|Exendin (9-39)|exendin (9-39)
4978941|NCT01729299|insulin|insulin
4978942|NCT01729260|Glioblastoma|glioblastoma
4978943|NCT01729260|mebendazole|mebendazole
4978944|NCT01729260|temozolomide|temozolomide
4978945|NCT01729247|Asthma|asthma
4978946|NCT01729234|age related Endothelial Dysfunction|age related endothelial dysfunction
4978947|NCT01729221|Hepatocellular carcinoma|hepatocellular carcinoma
4978948|NCT01729221|Hepatitis C virus|hepatitis c virus
4978949|NCT01729208|myopia progression|myopia progression
4978950|NCT01729208|myopia control|myopia control
4978951|NCT01729195|bioabsorbable implant|bioabsorbable implant
4978952|NCT01729195|bone screw|bone screw
4978953|NCT01729195|local antibiotic prophylaxis|local antibiotic prophylaxis
4978954|NCT01729195|syndesmosis injury|syndesmosis injury
4978955|NCT01729195|ankle fracture|ankle fracture
4978956|NCT01729195|ciprofloxacin|ciprofloxacin
4978957|NCT01729182|Low dose Aspirin(LDA)|low dose aspirin(lda)
4978958|NCT01729182|Gastric ulcer or duodenal ulcer|gastric ulcer or duodenal ulcer
4978959|NCT01729182|Nexium|nexium
4978960|NCT01729169|Sarcoidosis|sarcoidosis
4978961|NCT01729169|Cardiac sarcoidosis|cardiac sarcoidosis
4978962|NCT01729169|18-FDG PET|18-fdg pet
4978963|NCT01729169|68Ga-DOTANOC PET|68ga-dotanoc pet
4978964|NCT01729156|Type 2 diabetes|type 2 diabetes
4978965|NCT01729156|Hepatic fatty acid oxidation|hepatic fatty acid oxidation
4978966|NCT01729156|Dyslipidemia|dyslipidemia
4978967|NCT01729156|Metformin|metformin
4978968|NCT01729143|black pepper|black pepper
4978969|NCT01729143|metabolic chamber|metabolic chamber
4978970|NCT01729143|respiratory chamber|respiratory chamber
4978971|NCT01729117|Type 2 diabetes|type 2 diabetes
4978972|NCT01729117|Obesity|obesity
4978973|NCT01729117|Insulin|insulin
4978974|NCT01729117|Hispanic|hispanic
4978975|NCT01729117|Low-income|low-income
4978976|NCT01729117|Meal replacement|meal replacement
4978977|NCT01729104|Lymphoma|lymphoma
4978978|NCT01729104|Mantle cell lymphoma|mantle cell lymphoma
4978979|NCT01729104|MCL|mcl
4978980|NCT01729104|Relapsed|relapsed
4978981|NCT01729104|Refractory|refractory
4978982|NCT01729104|Carfilzomib|carfilzomib
4978983|NCT01729104|Rituximab|rituximab
4978984|NCT01729104|Rituxan|rituxan
4978985|NCT01729104|Lenalidomide|lenalidomide
4978986|NCT01729104|CC-5013|cc-5013
4978987|NCT01729104|Revlimid|revlimid
4978988|NCT01729091|Myeloma|myeloma
4978989|NCT01729091|Multiple myeloma|multiple myeloma
4978990|NCT01729091|MM|mm
4978991|NCT01729091|Umbilical cord blood|umbilical cord blood
4978992|NCT01729091|UCB|ucb
4978993|NCT01729091|Natural killer cells|natural killer cells
4978994|NCT01729091|NK|nk
4978995|NCT01729091|Autologous stem cell transplant|autologous stem cell transplant
4978996|NCT01729091|Stem cell infusion|stem cell infusion
4978997|NCT01729091|High dose chemotherapy|high dose chemotherapy
4978998|NCT01729091|Lenalidomide|lenalidomide
4978999|NCT01729091|CC-5013|cc-5013
4979000|NCT01729091|Revlimid|revlimid
4979001|NCT01729091|Melphalan|melphalan
4979002|NCT01729091|Alkeran|alkeran
4979003|NCT01729091|G-CSF|g-csf
4979004|NCT01729091|Filgrastim|filgrastim
4979005|NCT01729091|Neupogen|neupogen
4979006|NCT01729091|Elotuzumab|elotuzumab
4979007|NCT01729091|Dexamethasone|dexamethasone
4979008|NCT01729091|Decadron|decadron
4979519|NCT01726751|Diarrhea|diarrhea
4979009|NCT01729065|Spinal Accessory Nerve Palsy, Cranial Nerve XI, shoulder weakness, neck stiffness, head and neck cancer, neck dissection|spinal accessory nerve palsy, cranial nerve xi, shoulder weakness, neck stiffness, head and neck cancer, neck dissection
4979010|NCT01729052|Acupuncture|acupuncture
4979011|NCT01729052|Children|children
4979012|NCT01729052|Postoperative nausea and vomiting|postoperative nausea and vomiting
4979013|NCT01729052|Postoperative pain|postoperative pain
4979014|NCT01729052|Parental attitudes|parental attitudes
4979015|NCT01729052|Parental expectations|parental expectations
4979016|NCT01729039|rehabilitation|rehabilitation
4979017|NCT01729039|aged|aged
4979018|NCT01729039|aged, 80 and over|aged, 80 and over
4979019|NCT01729039|vestibular diseases|vestibular diseases
4979020|NCT01729026|Veterans|veterans
4979021|NCT01729026|Posttraumatic Stress Disorder|posttraumatic stress disorder
4979022|NCT01729026|dog adoption|dog adoption
4979023|NCT01729026|companion animal|companion animal
4979024|NCT01729013|vitamin D|vitamin d
4979025|NCT01729013|fat|fat
4979026|NCT01729013|biopsy|biopsy
4979027|NCT01729000|prematurity|prematurity
4979028|NCT01729000|infection control|infection control
4979029|NCT01729000|necrotizing entercolitis|necrotizing entercolitis
4979030|NCT01728974|Obstructive Sleep Apnea|obstructive sleep apnea
4979031|NCT01728974|Pathophysiology|pathophysiology
4979032|NCT01728961|HIV 1|hiv 1
4979033|NCT01728961|NVP|nvp
4979034|NCT01728961|malaria|malaria
4979035|NCT01728961|Children|children
4979036|NCT01728961|Youth|youth
4979037|NCT01728961|nevirapine|nevirapine
4979038|NCT01728961|Coartem Dispersible|coartem dispersible
4979039|NCT01728961|Artemether|artemether
4979040|NCT01728961|Lumefantrine|lumefantrine
4979041|NCT01728961|Pharmacokinetics|pharmacokinetics
4979042|NCT01728948|Sorafenib|sorafenib
4979043|NCT01728948|renal cell carcinoma(RCC)|renal cell carcinoma(rcc)
4979044|NCT01728948|elderly|elderly
4979045|NCT01728948|effectiveness|effectiveness
4979046|NCT01728948|safety|safety
4979047|NCT01728935|HBV|hbv
4979048|NCT01728935|Tenofovir|tenofovir
4979049|NCT01728935|HBV DNA|hbv dna
4979050|NCT01728935|HBsAg|hbsag
4979051|NCT01728935|Resistance|resistance
4979052|NCT01728922|Clinically isolated syndrome|clinically isolated syndrome
4979053|NCT01728922|Multiple sclerosis|multiple sclerosis
4979054|NCT01728922|Vitamin D|vitamin d
4979055|NCT01728922|Immune response|immune response
4979056|NCT01728922|CD4 T cell subsets|cd4 t cell subsets
4979057|NCT01728922|Cytokine|cytokine
4979058|NCT01728909|Oxytocin|oxytocin
4979059|NCT01728909|Syntocinon|syntocinon
4979060|NCT01728909|Social Cognition|social cognition
4979061|NCT01728909|Social Approach Behaviors|social approach behaviors
4979062|NCT01728896|Acute pancreatitis, nutrition|acute pancreatitis, nutrition
4979063|NCT01728883|Diabetic Retinopathy|diabetic retinopathy
4979064|NCT01728883|Diabetic Macular Edema|diabetic macular edema
4979065|NCT01728883|Macular Edema|macular edema
4979066|NCT01728883|Maculopathy|maculopathy
4979067|NCT01728883|home monitoring|home monitoring
4979068|NCT01728883|shape discrimination hyperacuity|shape discrimination hyperacuity
4979069|NCT01728883|Psychophysical Testing|psychophysical testing
4979070|NCT01728870|Pediatric|pediatric
4979071|NCT01728870|Crohn's disease|crohn's disease
4979072|NCT01728870|Mild to moderate Crohn's Disease|mild to moderate crohn's disease
4979073|NCT01728870|Diet|diet
4979074|NCT01728870|Enteral Nutrition|enteral nutrition
4979075|NCT01728857|Lipolysis|lipolysis
4979076|NCT01728857|Cryolipolysis|cryolipolysis
4979077|NCT01728857|Fat Reduction|fat reduction
4979078|NCT01728831|Red Cell Transfusion|red cell transfusion
4979079|NCT01728831|Cerebral tissue oxygenation|cerebral tissue oxygenation
4979080|NCT01728831|Traumatic brain injury|traumatic brain injury
4979081|NCT01728805|Cutaneous T-Cell Lymphoma (CTCL)|cutaneous t-cell lymphoma (ctcl)
4979082|NCT01728805|myocis fungoides (MF)|myocis fungoides (mf)
4979083|NCT01728805|Sezary Syndrome (SS)|sezary syndrome (ss)
4979084|NCT01728792|Prophylactic vaccination|prophylactic vaccination
4979085|NCT01728766|Breast milk zinc transfer|breast milk zinc transfer
4979086|NCT01728766|Bangladeshi infants|bangladeshi infants
4979087|NCT01728766|appropriate-for-gestational-age|appropriate-for-gestational-age
4979088|NCT01728766|small-for-gestational-age|small-for-gestational-age
4979089|NCT01728766|plasma zinc|plasma zinc
4979090|NCT01728740|Bioequivalence|bioequivalence
4979091|NCT01728740|Acarbose|acarbose
4979092|NCT01728740|Metformin|metformin
4979093|NCT01728740|FDC|fdc
4979094|NCT01728727|liver cirrhosis|liver cirrhosis
4979095|NCT01728727|end stage liver disease|end stage liver disease
4979096|NCT01728727|umbilical cord|umbilical cord
4979097|NCT01728727|mesenchymal stem cells|mesenchymal stem cells
4979098|NCT01728727|HBV|hbv
4979099|NCT01728714|Diabetes; compliance|diabetes; compliance
4979100|NCT01728701|Malaria|malaria
4979101|NCT01728701|Plasmodium falciparum|plasmodium falciparum
4979102|NCT01728701|PfSPZ Challenge|pfspz challenge
4979103|NCT01728701|Chemoprophylaxis|chemoprophylaxis
4979104|NCT01728701|PfSPZ-CVac|pfspz-cvac
4979105|NCT01728688|liver cirrhosis|liver cirrhosis
4979106|NCT01728688|stem cell|stem cell
4979107|NCT01728688|peripheral blood|peripheral blood
4979108|NCT01728688|autologous|autologous
4979109|NCT01728688|HBV|hbv
4979110|NCT01728688|end stage liver disease|end stage liver disease
4979111|NCT01728675|Aging|aging
4979112|NCT01728675|Skeletal muscle|skeletal muscle
4979113|NCT01728675|Biomarkers|biomarkers
4979114|NCT01728675|Adaptation|adaptation
4979115|NCT01728662|emphysema|emphysema
4979116|NCT01728662|lung volume reduction therapy|lung volume reduction therapy
4979117|NCT01728649|Acute Ischemic Stroke|acute ischemic stroke
4979118|NCT01728649|Mild Hypothermia|mild hypothermia
4979119|NCT01728649|Stroke|stroke
4979120|NCT01728649|Hypothermia|hypothermia
4979121|NCT01728623|Thyroid cancer|thyroid cancer
4979122|NCT01728610|irritable bowel syndrome|irritable bowel syndrome
4979123|NCT01728610|probiotic|probiotic
4979124|NCT01728610|pain|pain
4979125|NCT01728610|bloating|bloating
4979126|NCT01728610|diarrhoea|diarrhoea
4979127|NCT01728610|constipation|constipation
4979128|NCT01728597|no history of cardiovascular diseases|no history of cardiovascular diseases
4979129|NCT01728571|COPD|copd
4979130|NCT01728571|asthma|asthma
4979131|NCT01728571|pulmonary function|pulmonary function
4979132|NCT01728571|pneumonia|pneumonia
4979133|NCT01728558|Sedation|sedation
4979134|NCT01728558|Delirium|delirium
4979135|NCT01728558|Goal Directed|goal directed
4979136|NCT01728558|Dexmedetomidine|dexmedetomidine
4979137|NCT01728558|Mortality|mortality
4979138|NCT01728558|Mechanical ventilation|mechanical ventilation
4979139|NCT01728558|Intensive care|intensive care
4979140|NCT01728558|Critically Ill|critically ill
4979141|NCT01728545|Cord blood registry|cord blood registry
4979142|NCT01728545|Umbilical Cord Blood|umbilical cord blood
4979143|NCT01728545|fetal blood|fetal blood
4979144|NCT01728545|placenta|placenta
4979145|NCT01728545|Placental Blood Stem Cell Transplantation|placental blood stem cell transplantation
4979146|NCT01728545|hematopoietic progenitor cells|hematopoietic progenitor cells
4979147|NCT01728545|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
4979148|NCT01728545|cord blood unit total nucleated cell|cord blood unit total nucleated cell
4979149|NCT01728545|TNC|tnc
4979150|NCT01728545|CD34-positive(+) cell|cd34-positive(+) cell
4979151|NCT01728545|human leukocyte antigen|human leukocyte antigen
4979152|NCT01728545|HLA|hla
4979153|NCT01728545|allogeneic transplantation|allogeneic transplantation
4979154|NCT01728519|Allergy|allergy
4979155|NCT01728519|Birch Pollen|birch pollen
4979156|NCT01728519|Immunotherapy|immunotherapy
4979157|NCT01728506|breast cancer survivor|breast cancer survivor
4979158|NCT01728506|Weight loss|weight loss
4979159|NCT01728506|Exercise|exercise
4979160|NCT01728493|Prevalence|prevalence
4979161|NCT01728493|Primary aldosteronism|primary aldosteronism
4979162|NCT01728493|Organ damage|organ damage
4979163|NCT01728493|Mineralocorticoid receptor antagonists|mineralocorticoid receptor antagonists
4979164|NCT01728441|PAD|pad
4979165|NCT01728441|stenting|stenting
4979166|NCT01728441|angioplasty|angioplasty
4979167|NCT01728428|hemifacial spasm|hemifacial spasm
4979168|NCT01728428|observational study|observational study
4979169|NCT01728428|clinical manifestation|clinical manifestation
4979170|NCT01728428|treatment|treatment
4979171|NCT01728428|Chinese|chinese
4979172|NCT01728415|Exercise|exercise
4979173|NCT01728415|Hemodialysis|hemodialysis
4979174|NCT01728415|Physical therapy|physical therapy
4979175|NCT01728415|high-intensity|high-intensity
4979176|NCT01728389|allogenic stem cell transplantation|allogenic stem cell transplantation
4979177|NCT01728389|peripheral blood stem cells|peripheral blood stem cells
4979178|NCT01728389|intrabone|intrabone
4979179|NCT01728389|intra-bone|intra-bone
4979180|NCT01728389|leukemia|leukemia
4979181|NCT01728389|lymphoma|lymphoma
4979182|NCT01728363|Staphylococcal|staphylococcal
4979183|NCT01728350|traumatic brain injury|traumatic brain injury
4979184|NCT01728350|volunteering|volunteering
4979185|NCT01728350|well being|well being
4979186|NCT01728350|cortisol|cortisol
4979187|NCT01728337|botulinum toxin,|botulinum toxin,
4979188|NCT01728337|wrinkles|wrinkles
4979189|NCT01728298|House Dust Mite|house dust mite
4979190|NCT01728298|allergy|allergy
4979191|NCT01728298|rhinitis|rhinitis
4979192|NCT01728298|asthma|asthma
4979193|NCT01728285|specific allergen immunotherapy|specific allergen immunotherapy
4979194|NCT01728285|sublingual immunotherapy|sublingual immunotherapy
4979195|NCT01728285|allergen tablets|allergen tablets
4979196|NCT01728285|compliance|compliance
4979197|NCT01728285|electronic compliance device|electronic compliance device
4979198|NCT01728272|metoprolol, atrial fibrillation|metoprolol, atrial fibrillation
4979199|NCT01728246|Osteoarthritis|osteoarthritis
4979200|NCT01728246|Celecoxib|celecoxib
4979201|NCT01728246|Tramadol|tramadol
4979202|NCT01728246|Paracetamol|paracetamol
4979203|NCT01728233|Molecular Targeted Therapy|molecular targeted therapy
4979204|NCT01728233|Neoadjuvant therapy|neoadjuvant therapy
4979205|NCT01728233|Dacomitinib|dacomitinib
4979206|NCT01728220|Inhaled nitric oxide (iNO)|inhaled nitric oxide (ino)
4979207|NCT01728220|Pulmonary hypertension (PH)|pulmonary hypertension (ph)
4979208|NCT01728220|Chronic obstructive pulmonary disease (COPD)|chronic obstructive pulmonary disease (copd)
4979209|NCT01728220|Long term oxygen therapy (LTOT)|long term oxygen therapy (ltot)
4979210|NCT01728207|NHL|nhl
4979211|NCT01728207|CLL|cll
4979212|NCT01728207|follicular lymphoma|follicular lymphoma
4979213|NCT01728207|mantle cell lymphoma|mantle cell lymphoma
4979214|NCT01728207|marginal zone lymphoma|marginal zone lymphoma
4979215|NCT01728207|chronic lymphocytic leukemia|chronic lymphocytic leukemia
4979216|NCT01728207|small lymphocytic lymphoma|small lymphocytic lymphoma
4979217|NCT01728194|Depression|depression
4979218|NCT01728194|Depressive Disorder|depressive disorder
4979219|NCT01728194|Behavioral Symptoms|behavioral symptoms
4979220|NCT01728194|Mood Disorders|mood disorders
4979221|NCT01728194|Mental Disorders|mental disorders
4979222|NCT01728194|Escitalopram|escitalopram
4979223|NCT01728194|Central Nervous System Agents|central nervous system agents
4979224|NCT01728194|Therapeutic Uses|therapeutic uses
4979225|NCT01728194|Pharmacologic Actions|pharmacologic actions
4979226|NCT01728194|Physiological Effects of Drugs|physiological effects of drugs
4979227|NCT01728194|Muscarinic Antagonists|muscarinic antagonists
4979228|NCT01728194|Antidepressive Agents|antidepressive agents
4979229|NCT01728194|Psychotropic Drugs|psychotropic drugs
4979230|NCT01728194|Serotonin Uptake Inhibitors|serotonin uptake inhibitors
4979231|NCT01728194|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors
4979232|NCT01728194|Serotonin Agents|serotonin agents
4979233|NCT01728194|Magnetic Resonance Imaging, Functional|magnetic resonance imaging, functional
4979234|NCT01728194|fMRI|fmri
4979235|NCT01728194|Magnetic Resonance Imaging|magnetic resonance imaging
4979236|NCT01728168|lupin|lupin
4979237|NCT01728168|peanut|peanut
4979238|NCT01728168|soy|soy
4979239|NCT01728168|pea|pea
4979240|NCT01728168|legumes|legumes
4979241|NCT01728168|cross-reactivity|cross-reactivity
4979242|NCT01728168|sensitization|sensitization
4979243|NCT01728168|atopy|atopy
4979244|NCT01728155|NEUROBLASTOMA, LOW RISK, INTERMEDIATE RISK|neuroblastoma, low risk, intermediate risk
4979245|NCT01728142|DANA|dana
4979246|NCT01728142|ANAM|anam
4979247|NCT01728142|Concussion|concussion
4979248|NCT01728142|mild traumatic brain injury|mild traumatic brain injury
4979249|NCT01728129|Concussion|concussion
4979250|NCT01728129|Mild traumatic brain injury|mild traumatic brain injury
4979251|NCT01728129|DANA|dana
4979252|NCT01728129|MACE|mace
4979253|NCT01728116|glycemic control, type 2 diabetes, device, obese|glycemic control, type 2 diabetes, device, obese
4979254|NCT01728090|handwashing|handwashing
4979255|NCT01728090|hand sanitizer|hand sanitizer
4979256|NCT01728090|absenteeism|absenteeism
4979257|NCT01728090|school age children|school age children
4979258|NCT01728090|preschool children|preschool children
4979259|NCT01728077|Brivaracetam|brivaracetam
4979260|NCT01728077|Long-term Follow-up|long-term follow-up
4979261|NCT01728077|Epilepsy|epilepsy
4979262|NCT01728077|Partial Onset Seizures|partial onset seizures
4979263|NCT01728077|Adjunctive treatment|adjunctive treatment
4979264|NCT01728064|Friedreich's|friedreich's
4979265|NCT01728064|Ataxia|ataxia
4979266|NCT01728064|FRDA|frda
4979267|NCT01728064|FA|fa
4979268|NCT01728064|EPI-743|epi-743
4979269|NCT01728064|Edison|edison
4979270|NCT01728038|Bronchiolitis|bronchiolitis
4979271|NCT01728038|Cough|cough
4979272|NCT01728038|Ear Infection|ear infection
4979273|NCT01728038|Respiratory Infection|respiratory infection
4979274|NCT01728038|Wheezing|wheezing
4979275|NCT01728025|Long QT syndrome|long qt syndrome
4979276|NCT01728025|Ranolazine|ranolazine
4979277|NCT01728012|Successful transplantation|successful transplantation
4979278|NCT01728012|Long-term observation|long-term observation
4979279|NCT01727999|TPO response|tpo response
4979280|NCT01727999|ITP|itp
4979281|NCT01727999|immune thrombocytopenia|immune thrombocytopenia
4979282|NCT01727973|Graves' orbitopathy|graves' orbitopathy
4979283|NCT01727973|Graves´ ophthalmopathy|graves´ ophthalmopathy
4979284|NCT01727973|Thyroid eye disease|thyroid eye disease
4979285|NCT01727973|Thyroid-associated ophthalmopathy|thyroid-associated ophthalmopathy
4979286|NCT01727973|Doxycycline|doxycycline
4979287|NCT01727973|EUGOGO|eugogo
4979288|NCT01727973|CAS|cas
4979289|NCT01727960|Education|education
4979290|NCT01727960|Neck pain|neck pain
4979291|NCT01727960|Shoulder pain|shoulder pain
4979292|NCT01727960|Prevalence|prevalence
4979293|NCT01727960|Associated factors|associated factors
4979294|NCT01727960|Students|students
4979295|NCT01727934|Antisense|antisense
4979296|NCT01727934|miR-122 antagonist|mir-122 antagonist
4979297|NCT01727934|host factor|host factor
4979298|NCT01727934|Chronic hepatitis C|chronic hepatitis c
4979299|NCT01727934|Hepatitis C|hepatitis c
4979300|NCT01727921|ProCore FNA biopsy|procore fna biopsy
4979301|NCT01727908|Familial Gastric Cancer Screening|familial gastric cancer screening
4979302|NCT01727895|Betaglucan, immune modulation, immunoparalysis, immune suppression|betaglucan, immune modulation, immunoparalysis, immune suppression
4979303|NCT01727882|Paroled offenders|paroled offenders
4979304|NCT01727882|Interactive Voice Response|interactive voice response
4979305|NCT01727882|Stress|stress
4979306|NCT01727882|Mental symptoms|mental symptoms
4979307|NCT01727882|Alcohol consumption|alcohol consumption
4979308|NCT01727882|Substance use|substance use
4979309|NCT01727856|rehabilitation|rehabilitation
4979310|NCT01727856|physical therapy|physical therapy
4979311|NCT01727856|telemedicine|telemedicine
4979314|NCT01727843|tranexamic acid|tranexamic acid
4979315|NCT01727843|topical|topical
4979316|NCT01727817|Diabetes Mellitus, Type 1|diabetes mellitus, type 1
4979317|NCT01727817|Continuous Glucose Monitor|continuous glucose monitor
4979318|NCT01727817|Artificial Pancreas|artificial pancreas
4979319|NCT01727817|Insulin Pump|insulin pump
4979320|NCT01727817|Closed Loop|closed loop
4979321|NCT01727817|Open Loop|open loop
4979322|NCT01727817|Diabetes Assistant|diabetes assistant
4979323|NCT01727817|DiAs|dias
4979324|NCT01727817|Cell Phone|cell phone
4979325|NCT01727791|pharmacokinetic|pharmacokinetic
4979326|NCT01727791|pregabalin|pregabalin
4979327|NCT01727791|lactation|lactation
4979328|NCT01727765|Asthma, inspiratory muscle training|asthma, inspiratory muscle training
4979329|NCT01727739|Tibial tunnel widening|tibial tunnel widening
4979330|NCT01727739|Interference screws|interference screws
4979331|NCT01727726|OPC-34712|opc-34712
4979332|NCT01727726|brexpiprazole|brexpiprazole
4979333|NCT01727726|Major Depressive Disorder|major depressive disorder
4979334|NCT01727726|Adjunctive Treatment|adjunctive treatment
4979335|NCT01727713|Tourette Syndrome|tourette syndrome
4979336|NCT01727713|Basal Ganglia Diseases|basal ganglia diseases
4979337|NCT01727713|Brain Diseases|brain diseases
4979338|NCT01727713|Central Nervous System Diseases|central nervous system diseases
4979339|NCT01727713|Tic Disorders|tic disorders
4979340|NCT01727713|Tics|tics
4979341|NCT01727713|Movement Disorders|movement disorders
4979342|NCT01727713|Mental Disorders|mental disorders
4979343|NCT01727713|Aripiprazole|aripiprazole
4979344|NCT01727700|Tourette Syndrome|tourette syndrome
4979345|NCT01727700|Basal Ganglia Diseases|basal ganglia diseases
4979346|NCT01727700|Brain Diseases|brain diseases
4979347|NCT01727700|Central Nervous System Diseases|central nervous system diseases
4979348|NCT01727700|Tic Disorders|tic disorders
4979349|NCT01727700|Tics|tics
4979350|NCT01727700|Movement Disorders|movement disorders
4979351|NCT01727700|Mental Disorders|mental disorders
4979352|NCT01727700|Aripiprazole|aripiprazole
4979353|NCT01727687|To asses the training effects on traffic safety between normal and patients with Parkinson's disease|to asses the training effects on traffic safety between normal and patients with parkinson's disease
4979354|NCT01727674|Depression|depression
4979355|NCT01727674|experiences of communication|experiences of communication
4979356|NCT01727661|diabetes mellitus|diabetes mellitus
4979357|NCT01727661|cardiopulmonary fitness|cardiopulmonary fitness
4979358|NCT01727661|lung function|lung function
4979359|NCT01727661|muscular oxygenation|muscular oxygenation
4979360|NCT01727648|Stroke rehabilitation|stroke rehabilitation
4979361|NCT01727648|Comparative efficacy research|comparative efficacy research
4979362|NCT01727648|Combined therapy|combined therapy
4979363|NCT01727648|Robot-Assisted Therapy|robot-assisted therapy
4979364|NCT01727648|Constraint-Induced Therapy|constraint-induced therapy
4979365|NCT01727648|Kinematic analysis|kinematic analysis
4979366|NCT01727635|Breast cancer, survivors, partners, group therapy|breast cancer, survivors, partners, group therapy
4979367|NCT01727609|Preterm|preterm
4979368|NCT01727609|Very low birth weight|very low birth weight
4979369|NCT01727609|Feeding|feeding
4979370|NCT01727609|Enteral|enteral
4979371|NCT01727609|Milk|milk
4979372|NCT01727609|Sepsis|sepsis
4979373|NCT01727609|Necrotizing enterocolitis (NEC)|necrotizing enterocolitis (nec)
4979374|NCT01727583|Healthy|healthy
4979375|NCT01727570|Cancer|cancer
4979376|NCT01727570|Colon|colon
4979377|NCT01727570|Rectum|rectum
4979378|NCT01727570|Surgery|surgery
4979379|NCT01727557|Hemodialysis and AV fistula|hemodialysis and av fistula
4979380|NCT01727544|superior semicircular canal|superior semicircular canal
4979381|NCT01727544|non-vestibular dizziness|non-vestibular dizziness
4979382|NCT01727544|vestibular dizziness|vestibular dizziness
4979383|NCT01727531|chloroquine|chloroquine
4979384|NCT01727531|WBRT|wbrt
4979385|NCT01727531|survival|survival
4979386|NCT01727531|brain metastasis|brain metastasis
4979387|NCT01727531|radiotherapy|radiotherapy
4979388|NCT01727531|SNPs|snps
4979389|NCT01727531|gene coding|gene coding
4979390|NCT01727531|immunoregulatory enzyme IDO2|immunoregulatory enzyme ido2
4979391|NCT01727518|natural history|natural history
4979392|NCT01727518|lung function|lung function
4979393|NCT01727518|general population|general population
4979394|NCT01727518|COPD|copd
4979395|NCT01727505|hypoxemia|hypoxemia
4979396|NCT01727505|desaturation|desaturation
4979397|NCT01727505|mechanical ventilation|mechanical ventilation
4979398|NCT01727505|preterm infants|preterm infants
4979399|NCT01727505|volume guarantee ventilation|volume guarantee ventilation
4979400|NCT01727492|prevention|prevention
4979401|NCT01727492|noise-induced tinnitus|noise-induced tinnitus
4979402|NCT01727492|noise-induced hearing loss|noise-induced hearing loss
4979403|NCT01727492|young population|young population
4979404|NCT01727479|Peak VO2 consumption|peak vo2 consumption
4979405|NCT01727479|3km time trial|3km time trial
4979406|NCT01727479|fatigue perception|fatigue perception
4979407|NCT01727479|lactate|lactate
4979408|NCT01727479|time to complete|time to complete
4979409|NCT01727440|severe acne|severe acne
4979410|NCT01727440|severe acne vulgaris|severe acne vulgaris
4979411|NCT01727440|acne|acne
4979412|NCT01727440|acne vulgaris|acne vulgaris
4979413|NCT01727440|isotretinoin|isotretinoin
4979414|NCT01727440|Accutane|accutane
4979415|NCT01727440|Sortret|sortret
4979416|NCT01727440|Amnesteem|amnesteem
4979417|NCT01727440|Claravis|claravis
4979418|NCT01727440|Clarus|clarus
4979419|NCT01727440|Decutan|decutan
4979420|NCT01727440|Isotane|isotane
4979421|NCT01727440|Izotek|izotek
4979422|NCT01727440|Oratane|oratane
4979423|NCT01727440|Isotret|isotret
4979424|NCT01727440|Roaccutane|roaccutane
4979425|NCT01727427|Unsuspected|unsuspected
4979426|NCT01727427|pulmonary embolism|pulmonary embolism
4979427|NCT01727427|cancer|cancer
4979428|NCT01727414|ADHD|adhd
4979429|NCT01727414|Inattention|inattention
4979430|NCT01727414|Methylphenidate|methylphenidate
4979431|NCT01727414|Pharmacogenetics|pharmacogenetics
4979432|NCT01727401|Fondaparinux|fondaparinux
4979433|NCT01727401|medical patient|medical patient
4979434|NCT01727401|vein thromboembolism|vein thromboembolism
4979435|NCT01727401|prophylaxis|prophylaxis
4979436|NCT01727401|thrombocytopenia|thrombocytopenia
4979437|NCT01727388|rectal examination|rectal examination
4979438|NCT01727388|colorectal cancer|colorectal cancer
4979439|NCT01727375|delirium, light, ICU, sleep|delirium, light, icu, sleep
4979440|NCT01727362|Breast Cancer|breast cancer
4979441|NCT01727362|Acupuncture|acupuncture
4979442|NCT01727362|Quality of Life|quality of life
4979443|NCT01727258|Tooth Sensitivity|tooth sensitivity
4979444|NCT01727232|ITP|itp
4979445|NCT01727232|Rituximab|rituximab
4979446|NCT01727232|Efficacy|efficacy
4979447|NCT01727232|Anti-CD20|anti-cd20
4979448|NCT01727232|Regimen|regimen
4979449|NCT01727206|Erdheim-Chester disease|erdheim-chester disease
4979450|NCT01727206|Tocilizumab|tocilizumab
4979451|NCT01727206|Treatment|treatment
4979452|NCT01727206|Phase II|phase ii
4979453|NCT01727193|myasthenia gravis|myasthenia gravis
4979454|NCT01727193|leflunomide|leflunomide
4979455|NCT01727167|cardiac disease|cardiac disease
4979456|NCT01727167|mitochondrial biogenesis|mitochondrial biogenesis
4979457|NCT01727167|carbon monoxide|carbon monoxide
4979458|NCT01727141|COPD, QVA149|copd, qva149
4979459|NCT01727128|Hepatic impairment|hepatic impairment
4979460|NCT01727128|Clinical pharmacology study|clinical pharmacology study
4979461|NCT01727128|Volunteer study|volunteer study
4979462|NCT01727063|Chronic ischemic heart disease|chronic ischemic heart disease
4979463|NCT01727063|Coronary artery disease|coronary artery disease
4979464|NCT01727063|Angina pectoris|angina pectoris
4979465|NCT01727063|Myocardial ischemia|myocardial ischemia
4979466|NCT01727063|Cardiac surgery|cardiac surgery
4979467|NCT01727037|Emphysema|emphysema
4979468|NCT01727037|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
4979469|NCT01727037|COPD|copd
4979470|NCT01727037|Bulla|bulla
4979471|NCT01727037|Interventional bronchoscopy|interventional bronchoscopy
4979472|NCT01727037|Lung volume reduction|lung volume reduction
4979473|NCT01727024|Breezhaler|breezhaler
4979474|NCT01727024|Respimat|respimat
4979475|NCT01727024|Indacaterol|indacaterol
4979476|NCT01727024|Tiotropium|tiotropium
4979477|NCT01727011|Single fraction|single fraction
4979478|NCT01727011|Elderly|elderly
4979479|NCT01727011|Breast Irradiation|breast irradiation
4979480|NCT01726959|methotrexate|methotrexate
4979481|NCT01726946|Chronic Hepatitis C|chronic hepatitis c
4979482|NCT01726946|HCV|hcv
4979483|NCT01726946|CHC|chc
4979484|NCT01726933|psoriasis, systemic treatment|psoriasis, systemic treatment
4979485|NCT01726920|Migraine|migraine
4979486|NCT01726920|Naratriptan|naratriptan
4979487|NCT01726920|Naproxen|naproxen
4979488|NCT01726907|submandibular gland|submandibular gland
4979489|NCT01726907|robotic|robotic
4979490|NCT01726907|endoscopic|endoscopic
4979491|NCT01726907|face lift|face lift
4979492|NCT01726907|hairline|hairline
4979493|NCT01726894|Focal Therapy|focal therapy
4979494|NCT01726881|chronic|chronic
4979495|NCT01726881|Spinal Cord Injury patients|spinal cord injury patients
4979496|NCT01726855|tendon repair|tendon repair
4979497|NCT01726829|Type 1 Diabetes|type 1 diabetes
4979498|NCT01726829|Artificial Pancreas|artificial pancreas
4979499|NCT01726829|Closed Loop|closed loop
4979500|NCT01726816|Diabetic nephropathy|diabetic nephropathy
4979501|NCT01726816|Albumin creatinine ratio|albumin creatinine ratio
4979502|NCT01726816|Probucol|probucol
4979503|NCT01726803|Low Back Pain|low back pain
4979504|NCT01726803|Primary Care|primary care
4979505|NCT01726803|Physical Therapy|physical therapy
4979506|NCT01726790|corneal endothelium|corneal endothelium
4979507|NCT01726790|Bevacizumab|bevacizumab
4979508|NCT01726790|Intravitreal injection|intravitreal injection
4979509|NCT01726790|Confoscan|confoscan
4979510|NCT01726777|Randomized controlled clinical trial|randomized controlled clinical trial
4979511|NCT01726777|Diabetes|diabetes
4979512|NCT01726777|Vitamin D|vitamin d
4979513|NCT01726777|Oral glucose tolerance|oral glucose tolerance
4979514|NCT01726777|Blood glucose|blood glucose
4979515|NCT01726777|Insulin resistance|insulin resistance
4979516|NCT01726751|Spinal cord stimulation|spinal cord stimulation
4979517|NCT01726751|Irritable bowel syndrome|irritable bowel syndrome
4979518|NCT01726751|Abdominal pain|abdominal pain
4979520|NCT01726738|Melanoma|melanoma
4979521|NCT01726738|Stage III|stage iii
4979522|NCT01726738|Stage IV|stage iv
4979523|NCT01726738|Unresectable|unresectable
4979524|NCT01726738|BRAF Mutant|braf mutant
4979525|NCT01726738|Dabrafenib|dabrafenib
4979526|NCT01726738|Trametinib|trametinib
4979527|NCT01726738|Kinome|kinome
4979528|NCT01726738|Resistance|resistance
4979529|NCT01726738|Sequencing|sequencing
4979530|NCT01726738|Mutations|mutations
4979531|NCT01726738|Kinases|kinases
4979532|NCT01726738|Mechanism|mechanism
4979533|NCT01726725|hemifacial spasm|hemifacial spasm
4979534|NCT01726725|microvascular decompression surgery|microvascular decompression surgery
4979535|NCT01726725|desflurane|desflurane
4979536|NCT01726712|Patient Care Management|patient care management
4979537|NCT01726712|Primary Health Care|primary health care
4979538|NCT01726712|HIV|hiv
4979539|NCT01726712|Patient Acceptance of Health Care|patient acceptance of health care
4979540|NCT01726686|Total Knee Arthroplasty|total knee arthroplasty
4979541|NCT01726673|Stroke|stroke
4979542|NCT01726673|Cerebrovascular Accident|cerebrovascular accident
4979543|NCT01726673|Cerebral Stroke|cerebral stroke
4979544|NCT01726673|CVA|cva
4979545|NCT01726673|Robotic therapy|robotic therapy
4979546|NCT01726673|Upper extremity recovery|upper extremity recovery
4979547|NCT01726673|tDCS|tdcs
4979548|NCT01726673|Non-invasive brain stimulation|non-invasive brain stimulation
4979549|NCT01726660|Stroke|stroke
4979550|NCT01726660|Cerebrovascular Accident|cerebrovascular accident
4979551|NCT01726660|Cerebral stroke|cerebral stroke
4979552|NCT01726660|CVA|cva
4979553|NCT01726660|robotic therapy|robotic therapy
4979554|NCT01726660|upper extremity recovery|upper extremity recovery
4979555|NCT01726660|kinematic training|kinematic training
4979556|NCT01726647|obese women|obese women
4979557|NCT01726647|fat mass distribution|fat mass distribution
4979558|NCT01726647|Metabolomic profiles|metabolomic profiles
4979559|NCT01726634|upper limb|upper limb
4979560|NCT01726634|functional test|functional test
4979561|NCT01726634|elastic tape|elastic tape
4979562|NCT01726595|critical care|critical care
4979563|NCT01726595|severe sepsis|severe sepsis
4979564|NCT01726595|microvascular function|microvascular function
4979565|NCT01726595|ultrasound|ultrasound
4979566|NCT01726582|pancreas|pancreas
4979567|NCT01726582|adenocarcinoma|adenocarcinoma
4979568|NCT01726582|molecular profile|molecular profile
4979569|NCT01726582|molecular profiling|molecular profiling
4979570|NCT01726582|pancreatic cancer|pancreatic cancer
4979571|NCT01726582|pancreas cancer|pancreas cancer
4979572|NCT01726582|cancer|cancer
4979573|NCT01726582|molecular target|molecular target
4979574|NCT01726582|pancreas head|pancreas head
4979575|NCT01726582|pancreas neck|pancreas neck
4979576|NCT01726582|pancreas uncinate|pancreas uncinate
4979577|NCT01726582|pancreas body|pancreas body
4979578|NCT01726582|pancreas tail|pancreas tail
4979579|NCT01726569|glaucoma|glaucoma
4979580|NCT01726569|educational intervention|educational intervention
4979581|NCT01726569|post-operative satisfaction|post-operative satisfaction
4979582|NCT01726569|knowledges|knowledges
4979583|NCT01726556|Pleural effusion|pleural effusion
4979584|NCT01726556|Semirigid thoracoscopy|semirigid thoracoscopy
4979585|NCT01726556|Rigid thoracoscopy|rigid thoracoscopy
4979586|NCT01726543|canaloplasty|canaloplasty
4979587|NCT01726543|non-penetrating deep sclerectomy|non-penetrating deep sclerectomy
4979588|NCT01726543|glaucoma|glaucoma
4979589|NCT01726543|cataract|cataract
4979590|NCT01726543|ophthalmology|ophthalmology
4979591|NCT01726543|glaucoma surgery|glaucoma surgery
4979592|NCT01726530|transdermal fentanyl patch, postoperative pain,|transdermal fentanyl patch, postoperative pain,
4979593|NCT01726517|HCV genotype 1 (GT-1)|hcv genotype 1 (gt-1)
4979594|NCT01726517|HCV|hcv
4979595|NCT01726517|Sustained Virologic Response|sustained virologic response
4979596|NCT01726517|Direct Acting Antiviral|direct acting antiviral
4979597|NCT01726517|Combination Therapy|combination therapy
4979598|NCT01726517|GS-7977|gs-7977
4979599|NCT01726517|GS-5885|gs-5885
4979600|NCT01726517|Ribavirin|ribavirin
4979601|NCT01726517|Open Label|open label
4979602|NCT01726517|Sofosbuvir|sofosbuvir
4979603|NCT01726517|Treatment-Naïve|treatment-naïve
4979604|NCT01726517|Protease Inhibitors|protease inhibitors
4979605|NCT01726517|PI|pi
4979606|NCT01726504|chronic functional constipation|chronic functional constipation
4979607|NCT01726504|electro-acupuncture|electro-acupuncture
4979608|NCT01726504|multi-center randomized controlled trial|multi-center randomized controlled trial
4979609|NCT01726504|efficacy|efficacy
4979610|NCT01726504|safety|safety
4979611|NCT01726491|Insulin resistance|insulin resistance
4979612|NCT01726491|Exercise|exercise
4979613|NCT01726491|Type 2 diabetes mellitus|type 2 diabetes mellitus
4979614|NCT01726491|Obesity|obesity
4979615|NCT01726491|Epigenetic studies|epigenetic studies
4979616|NCT01726478|Oxytocin|oxytocin
4979617|NCT01726478|Uterine tone|uterine tone
4979618|NCT01726478|Mulago Hospital|mulago hospital
4979619|NCT01726478|Dose|dose
4979620|NCT01726478|Side effects|side effects
4979621|NCT01726465|N-Acetylcysteine|n-acetylcysteine
4979622|NCT01726465|Methylprednisolone|methylprednisolone
4979623|NCT01726465|Liver ischemia reperfusion injury|liver ischemia reperfusion injury
4979624|NCT01726465|Pringle manoeuvre|pringle manoeuvre
4979625|NCT01726465|Hepatic resection|hepatic resection
4979626|NCT01726426|Chronic arsenic poisoning|chronic arsenic poisoning
4979627|NCT01726426|Palmer arsenical keratosis|palmer arsenical keratosis
4979628|NCT01726413|Diabetic neuropathy|diabetic neuropathy
4979629|NCT01726400|Hepatitis C|hepatitis c
4979630|NCT01726400|Interferon|interferon
4979631|NCT01726400|Ribavirin|ribavirin
4979632|NCT01726400|Hepcidin|hepcidin
4979633|NCT01726400|Iron metabolism|iron metabolism
4979634|NCT01726361|Multidimension Treatment Foster Care|multidimension treatment foster care
4979635|NCT01726361|Adolescents|adolescents
4979636|NCT01726361|Disadvantaged families|disadvantaged families
4979637|NCT01726361|Out-of-home placement|out-of-home placement
4979638|NCT01726361|Conduct Disorder|conduct disorder
4979639|NCT01726361|Family program|family program
4979640|NCT01726361|Denmark|denmark
4979641|NCT01726361|Youth|youth
4979642|NCT01726348|Human Immunodeficiency Virus-Type 1|human immunodeficiency virus-type 1
4979643|NCT01726348|HIV-1|hiv-1
4979644|NCT01726348|TMC114|tmc114
4979645|NCT01726348|Darunavir|darunavir
4979646|NCT01726348|Ritonavir|ritonavir
4979647|NCT01726348|Filipino|filipino
4979648|NCT01726335|Schizophrenia|schizophrenia
4979649|NCT01726335|Risperidone|risperidone
4979650|NCT01726335|Risperdal consta|risperdal consta
4979651|NCT01726283|fruste keratoconus|fruste keratoconus
4979652|NCT01726283|ectasia|ectasia
4979653|NCT01726257|Infrarenal|infrarenal
4979654|NCT01726257|Abdominal|abdominal
4979655|NCT01726257|Aortic|aortic
4979656|NCT01726257|Aneurysm|aneurysm
4979657|NCT01726257|AAA|aaa
4979658|NCT01726257|Endologix|endologix
4979659|NCT01726257|EVAS|evas
4979660|NCT01726257|EndoVascular|endovascular
4979661|NCT01726257|Sealing|sealing
4979662|NCT01726257|System|system
4979663|NCT01726231|Laparoscopic access|laparoscopic access
4979664|NCT01726231|Abdominal wall lifting|abdominal wall lifting
4979665|NCT01726231|Direct trocar insertion|direct trocar insertion
4979666|NCT01726231|Safety endoscopy|safety endoscopy
4979667|NCT01726218|Stroke|stroke
4979668|NCT01726218|Physical Medicine & Rehabilitation|physical medicine & rehabilitation
4979669|NCT01726218|Neurology|neurology
4979670|NCT01726218|Neurophysiology|neurophysiology
4979671|NCT01726218|Neuroscience|neuroscience
4979672|NCT01726218|Transcranial Magnetic Stimulation (TMS)|transcranial magnetic stimulation (tms)
4979673|NCT01726179|caries infiltration|caries infiltration
4979674|NCT01726179|caries arrest|caries arrest
4979675|NCT01726179|dental anxiety|dental anxiety
4979676|NCT01726179|dental stress|dental stress
4979677|NCT01726166|Infant|infant
4979678|NCT01726166|contamination rates|contamination rates
4979679|NCT01726166|urinary catheterization|urinary catheterization
4979680|NCT01726166|suprapubic aspiration|suprapubic aspiration
4979681|NCT01726153|Condom Use|condom use
4979682|NCT01726153|HIV+ gay males|hiv+ gay males
4979683|NCT01726153|Intervention|intervention
4979684|NCT01726153|Tailored|tailored
4979685|NCT01726153|On-line|on-line
4979686|NCT01726153|Internet|internet
4979687|NCT01726153|Web-based|web-based
4979688|NCT01726140|intubation|intubation
4979689|NCT01726140|respiratory failure|respiratory failure
4979690|NCT01726140|cardiac surgery|cardiac surgery
4979691|NCT01726114|Diabetes|diabetes
4979692|NCT01726114|Diabetes Mellitus|diabetes mellitus
4979693|NCT01726114|continuous Glucose Monitor|continuous glucose monitor
4979694|NCT01726088|Modafinil|modafinil
4979695|NCT01726088|p50|p50
4979696|NCT01726088|Attentional Bias|attentional bias
4979697|NCT01726075|diabetic retinopathy|diabetic retinopathy
4979698|NCT01726062|Motivational Incentives|motivational incentives
4979699|NCT01726062|Motivational Interviewing|motivational interviewing
4979700|NCT01726062|Secondhand Smoke|secondhand smoke
4979701|NCT01726062|Neonatal Intensive Care Unit|neonatal intensive care unit
4979702|NCT01726062|NICU|nicu
4979703|NCT01726062|High respiratory risk infants|high respiratory risk infants
4979704|NCT01726062|Low birth weight infants|low birth weight infants
4979705|NCT01726062|Environmental Tobacco Smoke|environmental tobacco smoke
4979706|NCT01726062|Smoking|smoking
4979707|NCT01726062|Contingency management|contingency management
4979708|NCT01726062|Infants|infants
4979709|NCT01726062|Children|children
4979710|NCT01726049|HFpEF|hfpef
4979711|NCT01726049|PH|ph
4979712|NCT01726036|neonatal circumcision|neonatal circumcision
4979713|NCT01726036|neonatal surgical pain|neonatal surgical pain
4979714|NCT01726036|Mogen|mogen
4979715|NCT01726036|Gomco|gomco
4979716|NCT01726023|Ceftazidime-avibactam,|ceftazidime-avibactam,
4979717|NCT01726023|Metronidazole,|metronidazole,
4979718|NCT01726023|Meropenem,|meropenem,
4979719|NCT01726023|Anti-Bacterial Agents,|anti-bacterial agents,
4979720|NCT01726023|Anti-Infective Agents,|anti-infective agents,
4979721|NCT01726023|Therapeutic Uses,|therapeutic uses,
4979722|NCT01726023|Pharmacologic Actions,|pharmacologic actions,
4979723|NCT01726023|Physiological Effects of Drugs|physiological effects of drugs
4979724|NCT01725997|acromioclavicular joint dislocation|acromioclavicular joint dislocation
4979725|NCT01725997|ac joint dislocation|ac joint dislocation
4979726|NCT01725997|acromioclavicular joint separation|acromioclavicular joint separation
4979727|NCT01725997|hook plate|hook plate
4979728|NCT01725997|Rockwood|rockwood
4979729|NCT01725984|Male Incontinence|male incontinence
4979730|NCT01725984|AdVance Male Sling|advance male sling
4979731|NCT01725984|AdVance XP Male Sling|advance xp male sling
4979732|NCT01725984|Male Sling|male sling
4979733|NCT01725971|Silicosis|silicosis
4979734|NCT01725971|forced oscillations|forced oscillations
4979735|NCT01725971|respiratory mechanics|respiratory mechanics
4979736|NCT01725945|DASH|dash
4979737|NCT01725945|diet|diet
4979738|NCT01725945|asthma|asthma
4979739|NCT01725945|adults|adults
4979740|NCT01725945|asthma control|asthma control
4979741|NCT01725932|culture, depression, cognitive therapy, behaviour therapy,|culture, depression, cognitive therapy, behaviour therapy,
4979742|NCT01725919|motor|motor
4979743|NCT01725919|stroke|stroke
4979744|NCT01725919|hemiparesis|hemiparesis
4979745|NCT01725919|rehabilitation|rehabilitation
4979746|NCT01725919|constraint induced movement therapy|constraint induced movement therapy
4979747|NCT01725919|CI therapy|ci therapy
4979748|NCT01725906|genotypic resistance guided therapy|genotypic resistance guided therapy
4979749|NCT01725893|Claw Toe|claw toe
4979750|NCT01725880|Spinal Cord Injury|spinal cord injury
4979751|NCT01725880|HuCNS-SC cells|hucns-sc cells
4979752|NCT01725880|Human Neural Stem Cells|human neural stem cells
4979753|NCT01725880|Neural Stem Cells|neural stem cells
4979754|NCT01725880|Stem Cells|stem cells
4979755|NCT01725867|temporomandibular joint disorder|temporomandibular joint disorder
4979756|NCT01725867|myofascial pain|myofascial pain
4979757|NCT01725867|manual myofascial release|manual myofascial release
4979758|NCT01725867|physical therapy|physical therapy
4979759|NCT01725867|oral appliance|oral appliance
4979760|NCT01725841|To determine the prevalence of ESBL-producing among Enterobacteriaceae isolates in Taiwan|to determine the prevalence of esbl-producing among enterobacteriaceae isolates in taiwan
4979761|NCT01725841|To determine the susceptibility of ertapenem and other antimicrobial agents against Enterobacteriaceae isolates with and without expression of ESBLs|to determine the susceptibility of ertapenem and other antimicrobial agents against enterobacteriaceae isolates with and without expression of esbls
4979762|NCT01725841|To determine the molecular typing of the Enterobacteriaceae isolates with expression of ESBLs|to determine the molecular typing of the enterobacteriaceae isolates with expression of esbls
4979763|NCT01725841|To analyze the association between geographic area, hospital types against the antimicrobial susceptibility|to analyze the association between geographic area, hospital types against the antimicrobial susceptibility
4979764|NCT01725828|Cricothyroid membrane|cricothyroid membrane
4979765|NCT01725828|Ultrasound|ultrasound
4979766|NCT01725828|Neck landmarks|neck landmarks
4979767|NCT01725828|External palpation|external palpation
4979768|NCT01725789|Acute isovolemic anemia after gastrectomy for gastric cancer|acute isovolemic anemia after gastrectomy for gastric cancer
4979769|NCT01725776|Pulmonary hypertension|pulmonary hypertension
4979770|NCT01725776|Cardiac surgery|cardiac surgery
4979771|NCT01725776|Cardiopulmonary Bypass (CPB)|cardiopulmonary bypass (cpb)
4979772|NCT01725750|Traumatic Brain Injury|traumatic brain injury
4979773|NCT01725750|TBI|tbi
4979774|NCT01725750|Fatigue|fatigue
4979775|NCT01725750|Post-TBI Fatigue|post-tbi fatigue
4979776|NCT01725750|PTBIF|ptbif
4979777|NCT01725750|Depressed Mood|depressed mood
4979778|NCT01725750|Excessive Daytime Sleepiness|excessive daytime sleepiness
4979779|NCT01725750|Circadian Rhythm|circadian rhythm
4979780|NCT01725750|Anxiety|anxiety
4979781|NCT01725750|Cognitive Dysfunction|cognitive dysfunction
4979782|NCT01725750|Intervention|intervention
4979783|NCT01725750|Treatment|treatment
4979784|NCT01725737|ADHD|adhd
4979785|NCT01725737|GlyTI-M|glyti-m
4979786|NCT01725724|Autologous blood transfusion|autologous blood transfusion
4979787|NCT01725724|Allogeneic blood transfusion|allogeneic blood transfusion
4979788|NCT01725724|Infection rate|infection rate
4979789|NCT01725685|healthy volunteers|healthy volunteers
4979790|NCT01725685|Umeclidinium|umeclidinium
4979791|NCT01725685|tolerability|tolerability
4979792|NCT01725685|Safety|safety
4979793|NCT01725685|Fluticasone Furoate|fluticasone furoate
4979794|NCT01725685|Pharmacokinetics|pharmacokinetics
4979795|NCT01725672|healthy volunteers|healthy volunteers
4979796|NCT01725672|Diabetes mellitus|diabetes mellitus
4979797|NCT01725672|glimepiride|glimepiride
4979798|NCT01725672|pharmacokinetics|pharmacokinetics
4979799|NCT01725672|metformin|metformin
4979800|NCT01725659|Stroke|stroke
4979801|NCT01725659|electric stimulation|electric stimulation
4979802|NCT01725659|robotics|robotics
4979803|NCT01725659|motor learning|motor learning
4979804|NCT01725646|Hypertriglyceridemia, omega-3-acid ethyl ester|hypertriglyceridemia, omega-3-acid ethyl ester
4979805|NCT01725633|Stretching|stretching
4979806|NCT01725633|Nonlinear Aerobic Training|nonlinear aerobic training
4979807|NCT01725633|14-170|14-170
4979808|NCT01725607|dexmedetomidine, thoracic epidural anesthesia|dexmedetomidine, thoracic epidural anesthesia
4979809|NCT01725581|OSAT|osat
4979810|NCT01725581|Pelvic Examination|pelvic examination
4979811|NCT01725581|Validation|validation
4979812|NCT01725581|Reliability|reliability
4979813|NCT01725542|HCV-HIV Co-Infection|hcv-hiv co-infection
4979814|NCT01725542|Quadruple therapy|quadruple therapy
4979911|NCT01725165|SRS|srs
4979815|NCT01725542|null responder to a standard Pegylated interferon/Ribavirin regimen|null responder to a standard pegylated interferon/ribavirin regimen
4979816|NCT01725529|Hepatitis C, Chronic|hepatitis c, chronic
4979817|NCT01725529|TMC435|tmc435
4979818|NCT01725529|Ribavirin|ribavirin
4979819|NCT01725529|peginterferon-alpha (PegIFNα-2a)|peginterferon-alpha (pegifnα-2a)
4979820|NCT01725503|creatine synthesis|creatine synthesis
4979821|NCT01725490|chemoprevention, metformin, familial adenomatous polyposis|chemoprevention, metformin, familial adenomatous polyposis
4979822|NCT01725464|thoracotomy|thoracotomy
4979823|NCT01725464|oxygen saturation|oxygen saturation
4979824|NCT01725464|postoperative|postoperative
4979825|NCT01725438|Circulating Trophoblastic Cells|circulating trophoblastic cells
4979826|NCT01725438|Non-Invasive Prenatal Diagnosis|non-invasive prenatal diagnosis
4979827|NCT01725438|Genetic analysis|genetic analysis
4979828|NCT01725438|Trisomy 21|trisomy 21
4979829|NCT01725438|Down's Syndrome|down's syndrome
4979830|NCT01725425|snack food (chips)|snack food (chips)
4979831|NCT01725425|fruit (red grapes) consumed in each condition|fruit (red grapes) consumed in each condition
4979832|NCT01725425|mood|mood
4979833|NCT01725399|post-operative vomiting|post-operative vomiting
4979834|NCT01725373|left main, stent,angioplasty|left main, stent,angioplasty
4979835|NCT01725360|asthma|asthma
4979836|NCT01725360|airway hyperresponsiveness|airway hyperresponsiveness
4979837|NCT01725347|nutrition assessment|nutrition assessment
4979838|NCT01725347|children|children
4979839|NCT01725347|preschool|preschool
4979840|NCT01725347|eating behavior|eating behavior
4979841|NCT01725347|Head Start|head start
4979842|NCT01725347|digital technology|digital technology
4979843|NCT01725334|Schizophrenia|schizophrenia
4979844|NCT01725334|Negative Symptoms|negative symptoms
4979845|NCT01725334|Treatment Resistance|treatment resistance
4979846|NCT01725334|Deep Brain Stimulation|deep brain stimulation
4979847|NCT01725334|Electrical Stimulation|electrical stimulation
4979848|NCT01725334|Mental Disorders|mental disorders
4979849|NCT01725334|Brain Diseases|brain diseases
4979850|NCT01725334|Neurologic Manifestations|neurologic manifestations
4979851|NCT01725334|Signs and Symptoms|signs and symptoms
4979852|NCT01725321|Colonoscopy|colonoscopy
4979853|NCT01725321|colonic adenoma|colonic adenoma
4979854|NCT01725321|serrated polyps|serrated polyps
4979855|NCT01725308|FK949E|fk949e
4979856|NCT01725308|Major depressive episode|major depressive episode
4979857|NCT01725308|patients|patients
4979858|NCT01725295|fibromyalgia treatment|fibromyalgia treatment
4979859|NCT01725295|physical therapy|physical therapy
4979860|NCT01725295|hydrotherapy|hydrotherapy
4979861|NCT01725282|patients|patients
4979862|NCT01725282|FK949E|fk949e
4979863|NCT01725269|AIR001|air001
4979864|NCT01725269|sodium nitrite|sodium nitrite
4979865|NCT01725269|PAH|pah
4979866|NCT01725269|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
4979867|NCT01725269|inhaled sodium nitrite|inhaled sodium nitrite
4979868|NCT01725256|AIR001|air001
4979869|NCT01725256|sodium nitrite|sodium nitrite
4979870|NCT01725256|PAH|pah
4979871|NCT01725256|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
4979872|NCT01725256|inhaled sodium nitrite|inhaled sodium nitrite
4979873|NCT01725243|pregnancy|pregnancy
4979874|NCT01725243|postpartum hemorrhage|postpartum hemorrhage
4979875|NCT01725243|Cesarean delivery|cesarean delivery
4979876|NCT01725243|carbetocin|carbetocin
4979877|NCT01725243|failure to progress in labor|failure to progress in labor
4979878|NCT01725230|Fostamatinib,|fostamatinib,
4979879|NCT01725230|simvastatin,|simvastatin,
4979880|NCT01725230|rosuvastatin,|rosuvastatin,
4979881|NCT01725230|Phase I,|phase i,
4979882|NCT01725230|Healthy Subjects,|healthy subjects,
4979883|NCT01725230|Pharmacokinetics|pharmacokinetics
4979884|NCT01725217|Meningitis|meningitis
4979885|NCT01725217|children|children
4979886|NCT01725217|adolescents|adolescents
4979887|NCT01725217|adults|adults
4979888|NCT01725217|MenACWY|menacwy
4979889|NCT01725204|dasatinib|dasatinib
4979890|NCT01725204|Protein Kinase Inhibitors|protein kinase inhibitors
4979891|NCT01725204|pegylated IFN-alpha 2B|pegylated ifn-alpha 2b
4979892|NCT01725204|Interferon-alpha|interferon-alpha
4979893|NCT01725178|Mild Cognitive Impairment|mild cognitive impairment
4979894|NCT01725178|Dementia|dementia
4979895|NCT01725178|Memory disorders|memory disorders
4979896|NCT01725178|Physical fitness|physical fitness
4979897|NCT01725165|Lung cancer|lung cancer
4979898|NCT01725165|Non-Small Cell Lung Cancer|non-small cell lung cancer
4979899|NCT01725165|NSCLC|nsclc
4979900|NCT01725165|Oligometastatic Disease|oligometastatic disease
4979901|NCT01725165|Chemotherapy|chemotherapy
4979902|NCT01725165|Surgical control|surgical control
4979903|NCT01725165|primary and metastatic sites of disease|primary and metastatic sites of disease
4979904|NCT01725165|Radiation therapy|radiation therapy
4979905|NCT01725165|external beam radiation|external beam radiation
4979906|NCT01725165|2D/conventional techniques|2d/conventional techniques
4979907|NCT01725165|three-dimensional conformal therapy|three-dimensional conformal therapy
4979908|NCT01725165|intensity modulated radiation therapy|intensity modulated radiation therapy
4979909|NCT01725165|IMRT|imrt
4980040|NCT01724632|Obesity|obesity
4979910|NCT01725165|stereotactic radiosurgery|stereotactic radiosurgery
4979912|NCT01725165|proton beam therapy|proton beam therapy
4979913|NCT01725165|PBT|pbt
4979914|NCT01725152|fragile x syndrome|fragile x syndrome
4979915|NCT01725152|ganaxolone|ganaxolone
4979916|NCT01725152|anxiety|anxiety
4979917|NCT01725152|attention|attention
4979918|NCT01725152|pediatric|pediatric
4979919|NCT01725126|metformin|metformin
4979920|NCT01725126|diabetes|diabetes
4979921|NCT01725126|obesity|obesity
4979922|NCT01725126|liraglutide|liraglutide
4979923|NCT01725100|GSK1120212|gsk1120212
4979924|NCT01725100|DMSO content|dmso content
4979925|NCT01725100|pharmacokinetics|pharmacokinetics
4979926|NCT01725100|solid tumors|solid tumors
4979927|NCT01725100|MEK inhibitor|mek inhibitor
4979928|NCT01725100|dissolution|dissolution
4979929|NCT01725100|trametinib|trametinib
4979930|NCT01725100|relative bioavailability|relative bioavailability
4979931|NCT01725074|Coronary Heart Disease, multimorbidity, primary care, case management, loneliness, depression, social support|coronary heart disease, multimorbidity, primary care, case management, loneliness, depression, social support
4979932|NCT01725048|Major depressive disorder|major depressive disorder
4979933|NCT01725048|Neoplasms|neoplasms
4979934|NCT01725035|De Novo Lipogenesis|de novo lipogenesis
4979935|NCT01725035|Fatty Liver|fatty liver
4979936|NCT01725035|Hepatic Steatosis|hepatic steatosis
4979937|NCT01725035|Gene variants|gene variants
4979938|NCT01725022|stem cell transplant|stem cell transplant
4979939|NCT01725022|bowel microbiota|bowel microbiota
4979940|NCT01725022|home care|home care
4979941|NCT01725009|Healthy volunteers|healthy volunteers
4979942|NCT01725009|Japanese|japanese
4979943|NCT01725009|Caucasian|caucasian
4979944|NCT01724983|pain|pain
4979945|NCT01724983|mood|mood
4979946|NCT01724983|depression|depression
4979947|NCT01724983|respiration|respiration
4979948|NCT01724970|anesthesia|anesthesia
4979949|NCT01724970|postanesthetic recovery|postanesthetic recovery
4979950|NCT01724970|ventilation|ventilation
4979951|NCT01724970|bariatric surgery|bariatric surgery
4979952|NCT01724957|Fractional flow reserve,|fractional flow reserve,
4979953|NCT01724957|coronary bifurcation stenosis,|coronary bifurcation stenosis,
4979954|NCT01724957|intracoronary ECG,|intracoronary ecg,
4979955|NCT01724957|coronary stent|coronary stent
4979956|NCT01724957|Coronary bifurcation lesions|coronary bifurcation lesions
4979957|NCT01724957|icECG|icecg
4979958|NCT01724944|Interval debulking surgery|interval debulking surgery
4979959|NCT01724944|IDS|ids
4979960|NCT01724944|NACT|nact
4979961|NCT01724944|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
4979962|NCT01724944|Lymphadenectomy|lymphadenectomy
4979963|NCT01724944|Ovarian cancer|ovarian cancer
4979964|NCT01724931|antifolate|antifolate
4979965|NCT01724931|antiinflammatory|antiinflammatory
4979966|NCT01724931|autoimmune disease|autoimmune disease
4979967|NCT01724931|hematological treatment|hematological treatment
4979968|NCT01724931|rheumatic disease|rheumatic disease
4979969|NCT01724931|folic acid antagonist|folic acid antagonist
4979970|NCT01724931|enzyme inhibitor|enzyme inhibitor
4979971|NCT01724918|IV lacosamide|iv lacosamide
4979972|NCT01724918|focal epilepsy|focal epilepsy
4979973|NCT01724918|EEG|eeg
4979974|NCT01724918|EKG|ekg
4979975|NCT01724905|Diet|diet
4979976|NCT01724905|Obesity|obesity
4979977|NCT01724905|Chronic disease|chronic disease
4979978|NCT01724879|philadelphia chromosome|philadelphia chromosome
4979979|NCT01724879|BCR-ABL|bcr-abl
4979980|NCT01724879|ALL|all
4979981|NCT01724879|acute lymphoblastic leukemia|acute lymphoblastic leukemia
4979982|NCT01724879|dasatinib|dasatinib
4979983|NCT01724879|Sprycel|sprycel
4979984|NCT01724853|Carpometacarpal|carpometacarpal
4979985|NCT01724853|osteoarthritis|osteoarthritis
4979986|NCT01724853|outcome measures|outcome measures
4979987|NCT01724827|Dental caries|dental caries
4979988|NCT01724827|inlays|inlays
4979989|NCT01724827|composite resins|composite resins
4979990|NCT01724827|IPS-Empress ceramic|ips-empress ceramic
4979991|NCT01724827|bicuspid|bicuspid
4979992|NCT01724827|FDI dental restorations evaluation criteria|fdi dental restorations evaluation criteria
4979993|NCT01724801|EGFR mutant|egfr mutant
4979994|NCT01724775|complete mesocolic excision|complete mesocolic excision
4979995|NCT01724775|colon cancer|colon cancer
4979996|NCT01724775|efficacy|efficacy
4979997|NCT01724775|safety|safety
4979998|NCT01724762|Baths|baths
4979999|NCT01724762|Anxiety|anxiety
4980000|NCT01724762|Acute Coronary Syndrome|acute coronary syndrome
4980001|NCT01724762|Education, Nursing|education, nursing
4980002|NCT01724749|Atherosclerosis|atherosclerosis
4980003|NCT01724749|Sodium-Fluoride|sodium-fluoride
4980004|NCT01724749|18F-Sodium Fluoride|18f-sodium fluoride
4980005|NCT01724749|18F-NaF|18f-naf
4980006|NCT01724749|fluorodeoxyglucose|fluorodeoxyglucose
4980007|NCT01724749|18F-FDG|18f-fdg
4980008|NCT01724749|FDG|fdg
4980009|NCT01724749|Positron emission tomography|positron emission tomography
4980010|NCT01724749|PET|pet
4980011|NCT01724736|microbiome|microbiome
4980012|NCT01724736|prebiotic|prebiotic
4980013|NCT01724736|cobiotic|cobiotic
4980014|NCT01724736|NM504|nm504
4980015|NCT01724736|GI microbiome|gi microbiome
4980016|NCT01724723|hepatitis during anti-tuberculous treatment|hepatitis during anti-tuberculous treatment
4980017|NCT01724723|tuberculosis|tuberculosis
4980018|NCT01724723|hepatitis B virus|hepatitis b virus
4980019|NCT01724723|viral load|viral load
4980020|NCT01724723|entecavir|entecavir
4980021|NCT01724697|liver cirrhosis|liver cirrhosis
4980022|NCT01724697|end stage liver disease|end stage liver disease
4980023|NCT01724697|HBV|hbv
4980024|NCT01724697|autologous|autologous
4980025|NCT01724697|stem cell|stem cell
4980026|NCT01724697|bone morrow|bone morrow
4980027|NCT01724671|MRSA|mrsa
4980028|NCT01724671|Bacteremia|bacteremia
4980029|NCT01724671|ABSSSI|absssi
4980030|NCT01724671|Pneumonia|pneumonia
4980031|NCT01724671|Vancomycin|vancomycin
4980032|NCT01724671|Ceftaroline|ceftaroline
4980033|NCT01724658|female sexual function|female sexual function
4980034|NCT01724658|postmenopause|postmenopause
4980035|NCT01724658|testosterone|testosterone
4980036|NCT01724645|Korean Traditional diets|korean traditional diets
4980037|NCT01724645|hypertension|hypertension
4980038|NCT01724645|diabetes|diabetes
4980039|NCT01724632|Overweight|overweight
4980041|NCT01724632|Weight Loss|weight loss
4980042|NCT01724606|Whole Brain Radiotherapy (WBRT)|whole brain radiotherapy (wbrt)
4980043|NCT01724606|Sorafenib (BAY 43-9006)|sorafenib (bay 43-9006)
4980044|NCT01724606|12-046|12-046
4980045|NCT01724593|functional recovery, critical illness, pediatrics|functional recovery, critical illness, pediatrics
4980046|NCT01724567|Interval Training|interval training
4980047|NCT01724567|Weight Loss|weight loss
4980048|NCT01724567|Secondary Prevention|secondary prevention
4980049|NCT01724567|Rehabilitation|rehabilitation
4980050|NCT01724567|Cardiovascular Risk Factors|cardiovascular risk factors
4980051|NCT01724528|Febuxostat, Tumor lysis syndrome, leukemia, lymphoma|febuxostat, tumor lysis syndrome, leukemia, lymphoma
4980052|NCT01724515|insulin resistance|insulin resistance
4980053|NCT01724502|insulin resistance|insulin resistance
4980054|NCT01724463|Systemic Inflammatory Response Syndrome (SIRS)|systemic inflammatory response syndrome (sirs)
4980055|NCT01724463|Sepsis|sepsis
4980056|NCT01724463|Severe Sepsis|severe sepsis
4980057|NCT01724463|Septic Shock|septic shock
4980058|NCT01724463|Electronic Health Record|electronic health record
4980059|NCT01724463|Health Screening|health screening
4980060|NCT01724463|Goal Directed Therapy|goal directed therapy
4980061|NCT01724463|Infant|infant
4980062|NCT01724463|Child|child
4980063|NCT01724463|Pediatric|pediatric
4980064|NCT01724463|Adolescent|adolescent
4980065|NCT01724463|Critical Illness|critical illness
4980066|NCT01724463|Outcomes Research|outcomes research
4980067|NCT01724463|Resource Utilization|resource utilization
4980068|NCT01724450|Breast Cancer|breast cancer
4980069|NCT01724450|Heart Failure|heart failure
4980070|NCT01724450|Cardiotoxicity|cardiotoxicity
4980071|NCT01724450|Biomarkers|biomarkers
4980072|NCT01724411|Overweight and Obesity|overweight and obesity
4980073|NCT01724411|Appetite|appetite
4980074|NCT01724411|Gut hormones and obesity|gut hormones and obesity
4980075|NCT01724411|Resistant Starch|resistant starch
4980076|NCT01724411|Gut microbiota and obesity|gut microbiota and obesity
4980077|NCT01724411|SmartPill|smartpill
4980078|NCT01724398|mesenchymal stem cells|mesenchymal stem cells
4980079|NCT01724398|plasma exchange|plasma exchange
4980080|NCT01724398|liver failure|liver failure
4980081|NCT01724398|hepatitis B virus|hepatitis b virus
4980082|NCT01724385|bevacizumab,|bevacizumab,
4980083|NCT01724385|proliferative diabetic retinopathy,|proliferative diabetic retinopathy,
4980084|NCT01724385|vitreous hemorrhage,|vitreous hemorrhage,
4980085|NCT01724359|Schizophrenia|schizophrenia
4980086|NCT01724359|Paliperidone extended-release (ER)|paliperidone extended-release (er)
4980087|NCT01724359|Antipsychotic agents|antipsychotic agents
4980088|NCT01724346|CLL, SLL|cll, sll
4980089|NCT01724333|EORTC QLQ-C30|eortc qlq-c30
4980090|NCT01724333|Oral health|oral health
4980091|NCT01724333|Quality of life|quality of life
4980092|NCT01724333|Questionnaires|questionnaires
4980093|NCT01724333|Patient reported|patient reported
4980094|NCT01724333|outcomes|outcomes
4980095|NCT01724320|solid tumors|solid tumors
4980096|NCT01724320|first-in-man|first-in-man
4980097|NCT01724320|phase I|phase i
4980098|NCT01724320|cancer|cancer
4980099|NCT01724320|galectin|galectin
4980100|NCT01724281|lateral ventricles|lateral ventricles
4980101|NCT01724281|Asymetry|asymetry
4980102|NCT01724255|Caesarian section|caesarian section
4980103|NCT01724255|Surgical Wound|surgical wound
4980104|NCT01724242|Vaginal dryness|vaginal dryness
4980105|NCT01724242|Breast Cancer|breast cancer
4980106|NCT01724242|Urinary Incontinence|urinary incontinence
4980107|NCT01724242|Quality of Life|quality of life
4980108|NCT01724242|Sexual Satisfaction|sexual satisfaction
4980109|NCT01724229|Incontinence-associated dermatitis|incontinence-associated dermatitis
4980110|NCT01724229|Skin care regimen for moisture-associated conditions|skin care regimen for moisture-associated conditions
4980111|NCT01724229|Perineal skin care|perineal skin care
4980112|NCT01724229|Fungal infection in perineal area|fungal infection in perineal area
4980113|NCT01724203|Probiotics for infants|probiotics for infants
4980114|NCT01724203|Bacterial and viral infections in infants|bacterial and viral infections in infants
4980115|NCT01724190|Type 1 Diabetes|type 1 diabetes
4980116|NCT01724190|Vitamin D|vitamin d
4980117|NCT01724190|Clinical Remission|clinical remission
4980118|NCT01724177|Lenalidomide|lenalidomide
4980119|NCT01724177|ATL|atl
4980120|NCT01724177|ATLL|atll
4980121|NCT01724138|deferasirox|deferasirox
4980122|NCT01724125|serious mental illness|serious mental illness
4980123|NCT01724099|Obesity|obesity
4980124|NCT01724099|Herbal product|herbal product
4980125|NCT01724099|Korean Medicine|korean medicine
4980126|NCT01724086|Chronic hepatitis C|chronic hepatitis c
4980127|NCT01724086|Chronic hepatitis C-infected patients|chronic hepatitis c-infected patients
4980128|NCT01724086|TMC647055|tmc647055
4980129|NCT01724086|TMC435|tmc435
4980130|NCT01724086|Ritonavir|ritonavir
4980131|NCT01724086|Ribavirin|ribavirin
4980132|NCT01724086|Genotype 1a|genotype 1a
4980133|NCT01724086|Genotype 1b|genotype 1b
4980134|NCT01724086|GSK2336805|gsk2336805
4980135|NCT01724073|food to food fortification strategy|food to food fortification strategy
4980136|NCT01724073|leafy vegetable|leafy vegetable
4980137|NCT01724073|iron|iron
4980138|NCT01724073|zinc|zinc
4980139|NCT01724073|vitamin A|vitamin a
4980140|NCT01724073|growth|growth
4980141|NCT01724047|Autism|autism
4980142|NCT01724047|School Based Intervention|school based intervention
4980143|NCT01724034|Weaning|weaning
4980144|NCT01724034|Mechanical Ventilation|mechanical ventilation
4980145|NCT01724034|Lung Ultrasound|lung ultrasound
4980146|NCT01723995|nipple/injure|nipple/injure
4980147|NCT01723995|breastfeeding|breastfeeding
4980148|NCT01723995|pain|pain
4980149|NCT01723995|laser|laser
4980150|NCT01723956|Cervical Dysplasia|cervical dysplasia
4980151|NCT01723956|Cin 2|cin 2
4980152|NCT01723956|Cin 3|cin 3
4980153|NCT01723956|HIV positive women|hiv positive women
4980154|NCT01723956|South Africa|south africa
4980155|NCT01723904|Rotigotine|rotigotine
4980156|NCT01723904|Neupro|neupro
4980157|NCT01723865|Heart failure|heart failure
4980158|NCT01723865|Remote Monitoring|remote monitoring
4980159|NCT01723865|ICD|icd
4980160|NCT01723865|Follow-up|follow-up
4980161|NCT01723852|Vitamin D|vitamin d
4980162|NCT01723852|Infectious diseases|infectious diseases
4980163|NCT01723852|cognitive development|cognitive development
4980164|NCT01723852|Bone mineral density|bone mineral density
4980165|NCT01723852|Immunoregulation|immunoregulation
4980166|NCT01723852|Allergy|allergy
4980167|NCT01723852|Growth|growth
4980168|NCT01723839|CLL|cll
4980169|NCT01723839|FCR|fcr
4980170|NCT01723839|Rituximab|rituximab
4980171|NCT01723839|Lenalidomide|lenalidomide
4980172|NCT01723839|Cyclophosphamide|cyclophosphamide
4980173|NCT01723813|Immunotherapy|immunotherapy
4980174|NCT01723813|Tumor-specific peptides|tumor-specific peptides
4980175|NCT01723813|GM-CT-01|gm-ct-01
4980176|NCT01723761|air pollution|air pollution
4980177|NCT01723761|pacemaker|pacemaker
4980178|NCT01723761|ICD|icd
4980179|NCT01723761|remote monitoring|remote monitoring
4980180|NCT01723761|supraventricular arrhythmias|supraventricular arrhythmias
4980181|NCT01723761|ventricular arrhythmias|ventricular arrhythmias
4980182|NCT01723748|Acromegaly|acromegaly
4980183|NCT01723748|Somatostatin treatment|somatostatin treatment
4980184|NCT01723748|metabolic effect|metabolic effect
4980185|NCT01723722|Neonatal Abstinence Syndrome|neonatal abstinence syndrome
4980186|NCT01723722|Methadone|methadone
4980187|NCT01723722|Diluted Deodorized Tincture of Opium|diluted deodorized tincture of opium
4980188|NCT01723722|dDTO|ddto
4980189|NCT01723722|Phenobarbital|phenobarbital
4980190|NCT01723709|multiple sclerosis|multiple sclerosis
4980191|NCT01723709|immune response|immune response
4980192|NCT01723709|genetic|genetic
4980193|NCT01723709|progression|progression
4980194|NCT01723709|relapse|relapse
4980195|NCT01723709|biomarkers|biomarkers
4980196|NCT01723709|disease|disease
4980197|NCT01723709|proteomics|proteomics
4980198|NCT01723709|genome|genome
4980199|NCT01723709|gene|gene
4980200|NCT01723696|In-utero smoke;|in-utero smoke;
4980201|NCT01723696|Pulmonary function testing;|pulmonary function testing;
4980202|NCT01723696|Wheeze;|wheeze;
4980203|NCT01723696|Vitamin C;|vitamin c;
4980204|NCT01723696|Forced expiratory flows|forced expiratory flows
4980205|NCT01723683|Preterm infants|preterm infants
4980206|NCT01723683|RDS|rds
4980207|NCT01723683|Surfactant|surfactant
4980208|NCT01723683|MISTCPAP|mistcpap
4980209|NCT01723683|CPAP|cpap
4980210|NCT01723657|Leukemia|leukemia
4980211|NCT01723657|Myeloid|myeloid
4980212|NCT01723657|Acute|acute
4980213|NCT01723657|Young|young
4980214|NCT01723657|CETLAM|cetlam
4980215|NCT01723644|antibiotherapy, community acquired pneumonia, procalcitonin guided guidelines, clinical reassessment|antibiotherapy, community acquired pneumonia, procalcitonin guided guidelines, clinical reassessment
4980216|NCT01723631|Multiple sclerosis|multiple sclerosis
4980217|NCT01723631|TRAP|trap
4980218|NCT01723631|TRAP-Myéline|trap-myéline
4980219|NCT01723605|insitu repair|insitu repair
4980220|NCT01723605|intestinal motility|intestinal motility
4980221|NCT01723592|chemotherapy|chemotherapy
4980222|NCT01723592|vaginal flora|vaginal flora
4980223|NCT01723553|aphasia|aphasia
4980224|NCT01723553|logopenic|logopenic
4980225|NCT01723553|PCA|pca
4980226|NCT01723553|LPA|lpa
4980227|NCT01723540|Cholecystectomy,minilaparotomy,laparascopy,ultrasonic dissection|cholecystectomy,minilaparotomy,laparascopy,ultrasonic dissection
4980228|NCT01723527|Cocaine|cocaine
4980229|NCT01723527|Heroin|heroin
4980230|NCT01723527|HIV|hiv
4980231|NCT01723527|Contingency Management|contingency management
4980232|NCT01723527|Incentives|incentives
4980233|NCT01723527|Criminal Justice|criminal justice
4980234|NCT01723527|Methadone|methadone
4980235|NCT01723527|Buprenorphine|buprenorphine
4980236|NCT01723527|Employment|employment
4980237|NCT01723527|Job Training|job training
4980238|NCT01723527|Wage Subsidies|wage subsidies
4980239|NCT01723514|Migraine|migraine
4980240|NCT01723501|chlorhexidine|chlorhexidine
4980241|NCT01723501|sepsis|sepsis
4980242|NCT01723501|neonatal|neonatal
4980243|NCT01723501|whole-body skin cleansing|whole-body skin cleansing
4980244|NCT01723488|AD|ad
4980245|NCT01723475|Phase I|phase i
4980246|NCT01723475|Dose Escalation|dose escalation
4980247|NCT01723475|Prostate cancer|prostate cancer
4980248|NCT01723475|Antibodies|antibodies
4980249|NCT01723475|Bispecific T-cell Engager (BiTE)|bispecific t-cell engager (bite)
4980250|NCT01723436|Decision fatigue|decision fatigue
4980251|NCT01723423|breast cancer|breast cancer
4980252|NCT01723423|evidence based medicine|evidence based medicine
4980253|NCT01723423|reconstruction|reconstruction
4980254|NCT01723423|mastectomy|mastectomy
4980255|NCT01723423|outcomes|outcomes
4980256|NCT01723423|quality of life|quality of life
4980257|NCT01723384|methamphetamine|methamphetamine
4980258|NCT01723384|alcohol|alcohol
4980259|NCT01723384|HIV|hiv
4980260|NCT01723384|sexual behavior|sexual behavior
4980261|NCT01723371|Pulmonary Arterial Hypertension (PAH|pulmonary arterial hypertension (pah
4980262|NCT01723371|Pediatrics|pediatrics
4980263|NCT01723371|Right Heart Failure (RHF)|right heart failure (rhf)
4980264|NCT01723371|Carvedilol|carvedilol
4980265|NCT01723371|Beta-blockers|beta-blockers
4980266|NCT01723358|pediatrics|pediatrics
4980267|NCT01723358|dysphagia|dysphagia
4980268|NCT01723345|elective percutaneous coronary intervention|elective percutaneous coronary intervention
4980269|NCT01723345|omega 3 polyunsaturated fatty acids (PUFAs)|omega 3 polyunsaturated fatty acids (pufas)
4980270|NCT01723345|short-term MACE|short-term mace
4980271|NCT01723345|long-term MACE|long-term mace
4980272|NCT01723332|Transition from pediatric to adult clinical care|transition from pediatric to adult clinical care
4980273|NCT01723319|ADHD|adhd
4980274|NCT01723319|TMS|tms
4980275|NCT01723319|brain stimulation|brain stimulation
4980276|NCT01723319|clinical improvement|clinical improvement
4980277|NCT01723306|T cells|t cells
4980278|NCT01723306|gene transfer|gene transfer
4980279|NCT01723306|immunotherapy|immunotherapy
4980280|NCT01723306|metastatic cancers|metastatic cancers
4980281|NCT01723306|lung cancer|lung cancer
4980282|NCT01723306|gastric cancer|gastric cancer
4980283|NCT01723306|colorectal cancer|colorectal cancer
4980284|NCT01723306|solid tumors|solid tumors
4980285|NCT01723293|Fetal heart rate, pregnancy, fetus, cardiovascular system|fetal heart rate, pregnancy, fetus, cardiovascular system
4980286|NCT01723267|IVF|ivf
4980287|NCT01723267|3D ultrasound|3d ultrasound
4980288|NCT01723267|SonoAVC|sonoavc
4980289|NCT01723267|patients in IVF treatment|patients in ivf treatment
4980290|NCT01723254|Vaccines|vaccines
4980291|NCT01723254|Phase 1|phase 1
4980292|NCT01723254|Allergic Rhinitis|allergic rhinitis
4980293|NCT01723241|volunteers|volunteers
4980294|NCT01723228|Parkinson's Disease|parkinson's disease
4980295|NCT01723228|Cognition|cognition
4980296|NCT01723228|Rasagiline|rasagiline
4980297|NCT01723215|Attention bias modification|attention bias modification
4980298|NCT01723215|resilience|resilience
4980300|NCT01723215|PTSD|ptsd
4980301|NCT01723215|Depression|depression
4980302|NCT01723215|Anxiety|anxiety
4980303|NCT01723202|BRAF|braf
4980304|NCT01723202|BRAFi|brafi
4980305|NCT01723202|thyroid cancer|thyroid cancer
4980306|NCT01723202|thyroid carcinoma|thyroid carcinoma
4980307|NCT01723189|central apnoeas|central apnoeas
4980308|NCT01723189|stroke|stroke
4980309|NCT01723176|goal-directed echocardiography|goal-directed echocardiography
4980310|NCT01723176|cardiopulmonary failure|cardiopulmonary failure
4980311|NCT01723176|critical care ultrasound|critical care ultrasound
4980312|NCT01723163|veteran|veteran
4980313|NCT01723163|smoking cessation|smoking cessation
4980314|NCT01723150|Klebsiella pneumoniae|klebsiella pneumoniae
4980315|NCT01723137|Pain|pain
4980316|NCT01723137|Pain measurement|pain measurement
4980317|NCT01723137|Visual analog scale|visual analog scale
4980318|NCT01723137|Anxiety|anxiety
4980319|NCT01723137|Stress|stress
4980320|NCT01723137|Opioid|opioid
4980321|NCT01723137|Emergency department|emergency department
4980322|NCT01723137|Demographics|demographics
4980323|NCT01723124|Dense breast tissue|dense breast tissue
4980324|NCT01723124|breast cancer screening|breast cancer screening
4980325|NCT01723124|molecular breast imaging|molecular breast imaging
4980326|NCT01723124|breast cancer|breast cancer
4980327|NCT01723124|breast|breast
4980328|NCT01723111|hepcidin|hepcidin
4980329|NCT01723111|ESA|esa
4980330|NCT01723111|hemodialysis|hemodialysis
4980331|NCT01723111|peritoneal dialysis|peritoneal dialysis
4980332|NCT01723111|iron metabolism|iron metabolism
4980333|NCT01723111|dialysis modality|dialysis modality
4980334|NCT01723098|Pregnancy, cardiovascular system, physical exercise|pregnancy, cardiovascular system, physical exercise
4980335|NCT01723085|Anti-Mullerian hormone|anti-mullerian hormone
4980336|NCT01723085|Myomectomy|myomectomy
4980337|NCT01723085|Laparotomy|laparotomy
4980338|NCT01723072|Chronic spontanous urticaria, refractory CSU, Angioedema|chronic spontanous urticaria, refractory csu, angioedema
4980339|NCT01723046|Upper extremity|upper extremity
4980340|NCT01723046|Rehabilitation|rehabilitation
4980341|NCT01723046|Robot assisted therapy|robot assisted therapy
4980342|NCT01723046|Robotics|robotics
4980343|NCT01723046|Devices|devices
4980344|NCT01723046|Orthosis|orthosis
4980345|NCT01723046|clinical outcome|clinical outcome
4980346|NCT01723033|PTSD|ptsd
4980347|NCT01723033|OCD|ocd
4980348|NCT01723020|Solid Tumors|solid tumors
4980349|NCT01723020|Multiple Myeloma|multiple myeloma
4980350|NCT01723007|Weight loss|weight loss
4980351|NCT01723007|cholesterol|cholesterol
4980352|NCT01722968|Metastatic breast cancer|metastatic breast cancer
4980353|NCT01722955|Prewarmed fluid|prewarmed fluid
4980354|NCT01722955|monitored anesthesia care|monitored anesthesia care
4980355|NCT01722955|core body temperature|core body temperature
4980356|NCT01722955|anesthetic satisfaction|anesthetic satisfaction
4980357|NCT01722942|Chagas cardiomyopathy|chagas cardiomyopathy
4980358|NCT01722942|sudden cardiac death|sudden cardiac death
4980359|NCT01722942|primary prevention of death|primary prevention of death
4980360|NCT01722942|amiodarone|amiodarone
4980361|NCT01722942|implantable cardioverter defibrillator|implantable cardioverter defibrillator
4980362|NCT01722903|colorectal cancer|colorectal cancer
4980363|NCT01722903|liver metastases|liver metastases
4980364|NCT01722903|lung metastases|lung metastases
4980365|NCT01722890|HER2-positive breast cancer|her2-positive breast cancer
4980366|NCT01722890|durable complete response|durable complete response
4980367|NCT01722890|cytogenetic characteristics|cytogenetic characteristics
4980368|NCT01722890|molecular characteristics|molecular characteristics
4980369|NCT01722890|trastuzumab|trastuzumab
4980370|NCT01722877|Restenosis|restenosis
4980371|NCT01722877|aspiration|aspiration
4980372|NCT01722877|in-stent restenosis|in-stent restenosis
4980373|NCT01722877|atherectomy|atherectomy
4980374|NCT01722877|superficial femoral artery|superficial femoral artery
4980375|NCT01722877|popliteal artery|popliteal artery
4980376|NCT01722851|Breast Cancer|breast cancer
4980377|NCT01722851|miRNAs|mirnas
4980378|NCT01722851|Newly diagnosed|newly diagnosed
4980379|NCT01722851|Recurrent|recurrent
4980380|NCT01722838|Black MSM|black msm
4980381|NCT01722838|HIV Prevention|hiv prevention
4980382|NCT01722799|angioplasty|angioplasty
4980383|NCT01722799|Percutaneous Transluminal Coronary Angioplasty|percutaneous transluminal coronary angioplasty
4980384|NCT01722799|Drug elluting Balloon|drug elluting balloon
4980385|NCT01722799|Coronary Balloon|coronary balloon
4980386|NCT01722799|Dilatation|dilatation
4980387|NCT01722786|severe bleeding|severe bleeding
4980388|NCT01722786|dabigatran|dabigatran
4980389|NCT01722786|rivaroxaban|rivaroxaban
4980390|NCT01722786|apixaban|apixaban
4980391|NCT01722786|edoxaban|edoxaban
4980392|NCT01722786|PCC|pcc
4980393|NCT01722786|aPCC|apcc
4980394|NCT01722786|rVIIa|rviia
4980395|NCT01722786|hemodialysis|hemodialysis
4980396|NCT01722786|antidots|antidots
4980397|NCT01722786|idarucizumab|idarucizumab
4980398|NCT01722773|COPD|copd
4980399|NCT01722760|Neonatal|neonatal
4980400|NCT01722760|Preterm|preterm
4980401|NCT01722760|Bronchopulmonary Dysplasia|bronchopulmonary dysplasia
4980402|NCT01722760|Nasal Continuous Positive airway Pressure (CPAP)|nasal continuous positive airway pressure (cpap)
4980403|NCT01722760|Oxygen|oxygen
4980404|NCT01722760|Vitamin A|vitamin a
4980405|NCT01722760|Vitamin D|vitamin d
4980406|NCT01722760|Nitrogen oxide (NO)|nitrogen oxide (no)
4980407|NCT01722760|Reference material|reference material
4980408|NCT01722734|Malaria|malaria
4980409|NCT01722734|ACTs|acts
4980410|NCT01722708|Abnormal vaginal flora|abnormal vaginal flora
4980411|NCT01722708|clindamycin Vs metronidazole|clindamycin vs metronidazole
4980412|NCT01722708|High risk pregnancies for preterm labor|high risk pregnancies for preterm labor
4980413|NCT01722708|Preterm labor|preterm labor
4980414|NCT01722708|Late abortion|late abortion
4980415|NCT01722708|bacterial vaginosis|bacterial vaginosis
4980416|NCT01722682|Diabetes|diabetes
4980417|NCT01722669|quercetin|quercetin
4980418|NCT01722669|isoquercetin|isoquercetin
4980419|NCT01722669|pharmacokinetic|pharmacokinetic
4980420|NCT01722669|pharmacodynamic|pharmacodynamic
4980421|NCT01722656|PED|ped
4980422|NCT01722656|AMD|amd
4980423|NCT01722656|CNV|cnv
4980424|NCT01722630|dopamine|dopamine
4980425|NCT01722630|laparoscopy|laparoscopy
4980426|NCT01722630|fluid management|fluid management
4980427|NCT01722578|Cirrhosis|cirrhosis
4980428|NCT01722578|Encephalopathy|encephalopathy
4980429|NCT01722578|L-ornithine L-aspartate|l-ornithine l-aspartate
4980430|NCT01722565|Parastomal hernias|parastomal hernias
4980431|NCT01722565|Tolerance of lightweight meshes|tolerance of lightweight meshes
4980432|NCT01722565|laparoscopic abdominoperineal resection|laparoscopic abdominoperineal resection
4980434|NCT01722552|AIDS|aids
4980435|NCT01722552|antiretroviral therapy|antiretroviral therapy
4980436|NCT01722552|adherence|adherence
4980437|NCT01722552|China|china
4980438|NCT01722539|intermittent|intermittent
4980439|NCT01722539|preventive|preventive
4980440|NCT01722539|treatment|treatment
4980441|NCT01722539|malaria|malaria
4980442|NCT01722539|soil transmitted helminths|soil transmitted helminths
4980443|NCT01722539|schistosomiasis|schistosomiasis
4980444|NCT01722539|schoolchildren|schoolchildren
4980445|NCT01722526|Human acid sphingomyelinase deficiency|human acid sphingomyelinase deficiency
4980446|NCT01722513|Contrast Induced Nephropathy|contrast induced nephropathy
4980447|NCT01722500|International|international
4980448|NCT01722500|Childhood|childhood
4980449|NCT01722500|Obesity|obesity
4980450|NCT01722500|ISCOLE|iscole
4980451|NCT01722500|Pennington Biomedical Research Center|pennington biomedical research center
4980452|NCT01722500|PBRC|pbrc
4980453|NCT01722500|longitudinal|longitudinal
4980454|NCT01722500|multinational|multinational
4980455|NCT01722487|CLL, SLL|cll, sll
4980456|NCT01722474|Pulse Wave Analysis|pulse wave analysis
4980457|NCT01722474|Arterial Stiffness|arterial stiffness
4980458|NCT01722461|Excessive underarm sweating|excessive underarm sweating
4980459|NCT01722448|muscle|muscle
4980460|NCT01722448|muscle dysfunction|muscle dysfunction
4980461|NCT01722448|choline|choline
4980462|NCT01722448|exercise|exercise
4980463|NCT01722448|exertional rhabdomyolysis|exertional rhabdomyolysis
4980464|NCT01722448|rhabdomyolysis|rhabdomyolysis
4980465|NCT01722435|opioid dependence|opioid dependence
4980466|NCT01722435|opiate substitution treatment|opiate substitution treatment
4980467|NCT01722435|methadone|methadone
4980468|NCT01722435|completion|completion
4980469|NCT01722435|termination|termination
4980470|NCT01722422|sepsis|sepsis
4980471|NCT01722422|shock|shock
4980472|NCT01722422|hyperoxia|hyperoxia
4980473|NCT01722422|hypertonic saline|hypertonic saline
4980474|NCT01722409|dexmedetomidine, endovascular coil embolization|dexmedetomidine, endovascular coil embolization
4980475|NCT01722357|bariatric surgery|bariatric surgery
4980476|NCT01722357|physical activity|physical activity
4980477|NCT01722357|morbid obesity|morbid obesity
4980478|NCT01722344|Severe mental illness|severe mental illness
4980479|NCT01722344|Vocational rehabilitation|vocational rehabilitation
4980480|NCT01722344|Supported employment|supported employment
4980481|NCT01722344|Individual placement and support|individual placement and support
4980482|NCT01722344|Cognitive remediation|cognitive remediation
4980483|NCT01722344|Social skill training|social skill training
4980484|NCT01722279|bariatric surgery|bariatric surgery
4980485|NCT01722279|long-term outcomes|long-term outcomes
4980486|NCT01722279|obesity|obesity
4980487|NCT01722266|Liraglutide|liraglutide
4980488|NCT01722266|Glucagon|glucagon
4980489|NCT01722266|Systolic blood pressure|systolic blood pressure
4980490|NCT01722266|Weight|weight
4980491|NCT01722266|Carbohydrate intake|carbohydrate intake
4980492|NCT01722266|Insulin dose|insulin dose
4980493|NCT01722266|HbA1c|hba1c
4980494|NCT01722266|Post-prandial glucagon|post-prandial glucagon
4980495|NCT01722253|electroacupuncture|electroacupuncture
4980496|NCT01722253|acupuncture|acupuncture
4980497|NCT01722253|pain management|pain management
4980498|NCT01722214|Psoriasis|psoriasis
4980499|NCT01722214|Vascular Inflammation|vascular inflammation
4980500|NCT01722214|Coronary Atherosclerosis|coronary atherosclerosis
4980501|NCT01722214|Ascending aorta|ascending aorta
4980502|NCT01722214|Pet scan|pet scan
4980503|NCT01722214|MRI|mri
4980504|NCT01722188|Optim|optim
4980505|NCT01722188|Insulation|insulation
4980506|NCT01722149|malignant pleural mesothelioma|malignant pleural mesothelioma
4980507|NCT01722149|re-directed T cells|re-directed t cells
4980508|NCT01722149|FAP|fap
4980509|NCT01722149|fibroblast activation protein|fibroblast activation protein
4980510|NCT01722149|CD8 positive T cells|cd8 positive t cells
4980511|NCT01722149|pleural effusion|pleural effusion
4980512|NCT01722123|Decision fatigue|decision fatigue
4980513|NCT01722071|Oxytocin|oxytocin
4980514|NCT01722071|Functional Magnetic Resonance Imaging|functional magnetic resonance imaging
4980515|NCT01722071|Social|social
4980516|NCT01722071|Motivation|motivation
4980517|NCT01722058|peptide|peptide
4980518|NCT01722058|colon|colon
4980519|NCT01722058|flat lesions|flat lesions
4980520|NCT01722045|AMD|amd
4980521|NCT01722032|childhood obesity, early childhood, nutrition|childhood obesity, early childhood, nutrition
4980522|NCT01722019|venous insufficiency|venous insufficiency
4980523|NCT01722006|methamphetamine|methamphetamine
4980524|NCT01722006|subjective|subjective
4980525|NCT01722006|conditioning|conditioning
4980526|NCT01722006|preference|preference
4980527|NCT01721993|oral zoledronic acid|oral zoledronic acid
4980528|NCT01721967|chest pain|chest pain
4980529|NCT01721967|dyspnea|dyspnea
4980530|NCT01721954|colon|colon
4980531|NCT01721954|rectum|rectum
4980532|NCT01721954|metastatic colorectal cancer|metastatic colorectal cancer
4980533|NCT01721954|liver metastases|liver metastases
4980534|NCT01721941|hepatocellular carcinoma|hepatocellular carcinoma
4980535|NCT01721941|HCC|hcc
4980536|NCT01721941|liver cancer|liver cancer
4980537|NCT01721941|hepatoma|hepatoma
4980538|NCT01721941|TACE|tace
4980539|NCT01721941|transarterial chemoembolization|transarterial chemoembolization
4980540|NCT01721941|TH302|th302
4980541|NCT01721928|Acute kidney injury|acute kidney injury
4980542|NCT01721928|Deep venous thrombosis|deep venous thrombosis
4980543|NCT01721928|Dialysis|dialysis
4980544|NCT01721928|Prophylaxis|prophylaxis
4980545|NCT01721915|Polycystic Ovary Syndrome (PCOS)|polycystic ovary syndrome (pcos)
4980546|NCT01721915|glucose metabolism|glucose metabolism
4980547|NCT01721915|Vitamin D deficiency|vitamin d deficiency
4980548|NCT01721915|vitamin D supplementation|vitamin d supplementation
4980549|NCT01721915|pharmakogenetics|pharmakogenetics
4980550|NCT01721915|women|women
4980551|NCT01721863|Atrial Fibrillation|atrial fibrillation
4980552|NCT01721863|Exercise Training|exercise training
4980553|NCT01721863|Endothelial Function|endothelial function
4980554|NCT01721863|Autonomic Nerve Modulation|autonomic nerve modulation
4980555|NCT01721863|Exercise Capacity|exercise capacity
4980556|NCT01721863|Quality of Life|quality of life
4980557|NCT01721850|infant nutrition, infantile colic|infant nutrition, infantile colic
4980558|NCT01721824|Supported employment|supported employment
4980559|NCT01721824|Individual Placement and Support|individual placement and support
4980560|NCT01721824|Workability|workability
4980561|NCT01721824|Return to work|return to work
4980562|NCT01721798|AE adverse event|ae adverse event
4980563|NCT01721798|AIDS acquired immunodeficiency syndrome|aids acquired immunodeficiency syndrome
4980564|NCT01721798|ALT (SGPT) alanine aminotransferase|alt (sgpt) alanine aminotransferase
4980565|NCT01721798|ART antiretroviral therapy|art antiretroviral therapy
4980566|NCT01721798|AST (SGOT) aspartate aminotransferase|ast (sgot) aspartate aminotransferase
4980567|NCT01721798|DCF data collection forms|dcf data collection forms
4980568|NCT01721798|DMC Data Monitoring Committee|dmc data monitoring committee
4980569|NCT01721798|FDA (U.S.) Food and Drug Administration|fda (u.s.) food and drug administration
4980570|NCT01721798|GCP Good Clinical Practice guidelines|gcp good clinical practice guidelines
4980571|NCT01721798|HB sAg Hepatitis B surface antigen|hb sag hepatitis b surface antigen
4980572|NCT01721798|ICH International Council for Harmonization|ich international council for harmonization
4980573|NCT01721798|IND Investigational New Drug Application|ind investigational new drug application
4980574|NCT01721798|IRB Institutional Review Board|irb institutional review board
4980575|NCT01721798|IU International units|iu international units
4980576|NCT01721798|mg milligram(s)|mg milligram(s)
4980577|NCT01721798|mm3 cubic millimeter(s)|mm3 cubic millimeter(s)
4980578|NCT01721798|PCR polymerase chain reaction|pcr polymerase chain reaction
4980579|NCT01721798|SAE serious adverse event|sae serious adverse event
4980580|NCT01721798|µg microgram|µg microgram
4980581|NCT01721798|ULN upper limit of the normal range|uln upper limit of the normal range
4980582|NCT01721798|WB Western Blot|wb western blot
4980583|NCT01721785|Nodal imaging|nodal imaging
4980584|NCT01721785|Restaging|restaging
4980586|NCT01721733|Leigh syndrome|leigh syndrome
4980587|NCT01721733|respiratory chain disease|respiratory chain disease
4980588|NCT01721733|mitochondrial disorders|mitochondrial disorders
4980589|NCT01721720|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
4980590|NCT01721720|Behavioral Phenotype|behavioral phenotype
4980591|NCT01721720|Brain Development|brain development
4980592|NCT01721720|Complex Disease|complex disease
4980593|NCT01721720|Social Networks|social networks
4980594|NCT01721707|glaucoma|glaucoma
4980595|NCT01721707|ocular hypertension|ocular hypertension
4980596|NCT01721707|latanoprost|latanoprost
4980597|NCT01721707|brinzolamide|brinzolamide
4980598|NCT01721694|bacterial ocular inflammation|bacterial ocular inflammation
4980599|NCT01721694|blepharitis|blepharitis
4980600|NCT01721694|keratitis|keratitis
4980601|NCT01721694|conjunctivitis|conjunctivitis
4980602|NCT01721655|Spironolactone|spironolactone
4980603|NCT01721655|Preterm Infants|preterm infants
4980604|NCT01721655|Chronic Lung Disease|chronic lung disease
4980605|NCT01721655|Bronchopulmonary Dysplasia|bronchopulmonary dysplasia
4980606|NCT01721655|Electrolyte Supplementation|electrolyte supplementation
4980607|NCT01721642|access|access
4980608|NCT01721642|closure|closure
4980609|NCT01721642|trans-apical|trans-apical
4980610|NCT01721642|trans-catheter aortic valve implantation|trans-catheter aortic valve implantation
4980611|NCT01721642|TAVI|tavi
4980612|NCT01721642|trans-catheter aortic valve repair|trans-catheter aortic valve repair
4980613|NCT01721642|TAVR|tavr
4980614|NCT01721629|Nasal cpap weaning|nasal cpap weaning
4980615|NCT01721629|Premature infants|premature infants
4980616|NCT01721629|Respiratory distress syndrome|respiratory distress syndrome
4980617|NCT01721629|Randomized controlled trial|randomized controlled trial
4980618|NCT01721603|BRAFV600E melanoma patients|brafv600e melanoma patients
4980619|NCT01721603|melanoma|melanoma
4980620|NCT01721603|stereotactic radiosurgery|stereotactic radiosurgery
4980621|NCT01721603|BRAFV600E melanoma brain metastases|brafv600e melanoma brain metastases
4980622|NCT01721603|dabrafenib|dabrafenib
4980623|NCT01721603|SRS|srs
4980624|NCT01721590|high on-treatment platelet reactivity|high on-treatment platelet reactivity
4980625|NCT01721590|Coronary Heart Disease|coronary heart disease
4980626|NCT01721590|Tongxinluo|tongxinluo
4980627|NCT01721577|glioblastoma|glioblastoma
4980628|NCT01721577|gliosarcoma|gliosarcoma
4980629|NCT01721577|anaplastic astrocytoma|anaplastic astrocytoma
4980630|NCT01721577|anaplastic oligodendroglioma|anaplastic oligodendroglioma
4980631|NCT01721577|anaplastic oligoastrocytoma|anaplastic oligoastrocytoma
4980632|NCT01721577|AXL1717|axl1717
4980633|NCT01721577|IGF-1 receptor inhibitor|igf-1 receptor inhibitor
4980634|NCT01721577|picropodophyllin|picropodophyllin
4980635|NCT01721551|Dialysis fatigue,|dialysis fatigue,
4980636|NCT01721551|exercise intolerance,|exercise intolerance,
4980637|NCT01721551|muscle atrophy,|muscle atrophy,
4980638|NCT01721551|cachexia,|cachexia,
4980639|NCT01721551|disability,|disability,
4980640|NCT01721551|Sleep disorders|sleep disorders
4980641|NCT01721551|Depression|depression
4980642|NCT01721551|Mental Fatigue,|mental fatigue,
4980643|NCT01721551|Cognitive function|cognitive function
4980644|NCT01721551|Physical Fatigue|physical fatigue
4980645|NCT01721538|stroke|stroke
4980646|NCT01721538|prevention|prevention
4980647|NCT01721538|obesity|obesity
4980648|NCT01721538|weight reduction|weight reduction
4980649|NCT01721525|BIBW2992 (AFATINIB)|bibw2992 (afatinib)
4980650|NCT01721525|CARBOPLATIN|carboplatin
4980651|NCT01721525|RIBAVIRIN-ICN (VIRAZOLE)|ribavirin-icn (virazole)
4980652|NCT01721525|TAXOL (PACLITAXEL)|taxol (paclitaxel)
4980653|NCT01721525|OROPHARYNX|oropharynx
4980654|NCT01721525|HPV associated|hpv associated
4980655|NCT01721525|12-150|12-150
4980656|NCT01721512|Prospective observational study|prospective observational study
4980657|NCT01721512|Breast feeding|breast feeding
4980658|NCT01721512|Infant formula|infant formula
4980659|NCT01721512|Infant|infant
4980660|NCT01721512|Indonesia|indonesia
4980661|NCT01721499|Stress|stress
4980662|NCT01721499|obesity|obesity
4980663|NCT01721499|overeating|overeating
4980664|NCT01721486|tonsillitis|tonsillitis
4980665|NCT01721486|recurrent tonsillitis|recurrent tonsillitis
4980666|NCT01721486|obstructed air passages|obstructed air passages
4980667|NCT01721486|swallowing difficulties|swallowing difficulties
4980668|NCT01721473|Tobacco|tobacco
4980669|NCT01721473|Positron Emission Tomography|positron emission tomography
4980670|NCT01721473|Marijuana|marijuana
4980671|NCT01721473|Caffeine|caffeine
4980672|NCT01721473|Menthol|menthol
4980673|NCT01721460|SubThalamic Nucleus|subthalamic nucleus
4980674|NCT01721460|Microelectrode recording|microelectrode recording
4980675|NCT01721460|Deep Brain Stimulation Electrode implantation|deep brain stimulation electrode implantation
4980676|NCT01721447|Atrial fibrillation|atrial fibrillation
4980677|NCT01721447|stroke|stroke
4980678|NCT01721447|TEE|tee
4980679|NCT01721447|Left atrial thrombus|left atrial thrombus
4980680|NCT01721434|levosimendan|levosimendan
4980681|NCT01721434|diaphragm function|diaphragm function
4980682|NCT01721434|mechanically ventilated patients|mechanically ventilated patients
4980683|NCT01721434|neuro-mechanical efficiency|neuro-mechanical efficiency
4980684|NCT01721421|haemodialysis|haemodialysis
4980685|NCT01721421|Crossover|crossover
4980686|NCT01721421|Treatment time|treatment time
4980687|NCT01721421|nutritional status|nutritional status
4980688|NCT01721395|Cough|cough
4980689|NCT01721395|Nocturnal Cough|nocturnal cough
4980690|NCT01721395|Agave|agave
4980691|NCT01721395|Sleep Quality|sleep quality
4980692|NCT01721395|Childhood cough|childhood cough
4980693|NCT01721382|cystic fibrosis|cystic fibrosis
4980694|NCT01721382|CF|cf
4980695|NCT01721382|CFRD|cfrd
4980696|NCT01721382|sitagliptin|sitagliptin
4980697|NCT01721382|incretins|incretins
4980698|NCT01721382|GLP1|glp1
4980699|NCT01721382|GIP|gip
4980700|NCT01721382|beta cell function|beta cell function
4980701|NCT01721382|adolescents|adolescents
4980702|NCT01721330|ADHD|adhd
4980703|NCT01721330|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
4980704|NCT01721330|Psychopharmacology|psychopharmacology
4980705|NCT01721330|Psychiatry|psychiatry
4980706|NCT01721330|Non-stimulant treatment|non-stimulant treatment
4980707|NCT01721317|Ezogabine/Retigabine|ezogabine/retigabine
4980708|NCT01721317|Adjunctive Treatment|adjunctive treatment
4980709|NCT01721317|Safety|safety
4980710|NCT01721317|Efficacy|efficacy
4980711|NCT01721317|Epilepsy|epilepsy
4980712|NCT01721317|Tolerability|tolerability
4980713|NCT01721317|Immediate Release|immediate release
4980714|NCT01721317|GW582892|gw582892
4980715|NCT01721317|Dose-Optimization|dose-optimization
4980716|NCT01721317|Partial-Onset Seizures|partial-onset seizures
4980717|NCT01721304|decision making|decision making
4980718|NCT01721304|abnormal uterine bleeding|abnormal uterine bleeding
4980719|NCT01721304|adaptive conjoint analysis|adaptive conjoint analysis
4980720|NCT01721304|satisfaction|satisfaction
4980721|NCT01721304|regret|regret
4980722|NCT01721291|CHRONIC OBSTRUCTIVE PULMONARY DISEASE|chronic obstructive pulmonary disease
4980723|NCT01721291|ASTHMA|asthma
4980724|NCT01721291|SALBUTAMOL|salbutamol
4980725|NCT01721291|ALBUTEROL|albuterol
4980726|NCT01721291|VENTOLIN|ventolin
4980727|NCT01721291|LUNG PHYSIOLOGY|lung physiology
4980728|NCT01721291|LUNG DEPOSITION|lung deposition
4980729|NCT01721291|INHALERS|inhalers
4980730|NCT01721291|DRUG THERAPY|drug therapy
4980731|NCT01721265|HCV|hcv
4980732|NCT01721265|Hepatitis C|hepatitis c
4980733|NCT01721265|IDX184|idx184
4980734|NCT01721265|IDX719|idx719
4980735|NCT01721252|non-small cell lung cancer|non-small cell lung cancer
4980736|NCT01721252|Erlotinib|erlotinib
4980737|NCT01721252|TarcevaTM|tarcevatm
4980738|NCT01721252|proteomic signature|proteomic signature
4980739|NCT01721239|ICU|icu
4980740|NCT01721239|Follow-up consultations|follow-up consultations
4980741|NCT01721239|Quality of life|quality of life
4980742|NCT01721239|Sense Of Coherence|sense of coherence
4980743|NCT01721239|RCT multicenter study|rct multicenter study
4980744|NCT01721226|Linkage to HIV care following release from prison|linkage to hiv care following release from prison
4980745|NCT01721226|Anti-retroviral therapy adherence after release from prison|anti-retroviral therapy adherence after release from prison
4980746|NCT01721226|HIV loads after release from prison|hiv loads after release from prison
4980747|NCT01721226|information technology and ART adherence|information technology and art adherence
4980748|NCT01721226|information technology and linkage to HIV care|information technology and linkage to hiv care
4980749|NCT01721213|Epilepsy|epilepsy
4980750|NCT01721213|survey|survey
4980751|NCT01721213|retigabine|retigabine
4980752|NCT01721213|patient information leaflet|patient information leaflet
4980753|NCT01721213|physician's guide|physician's guide
4980754|NCT01721213|Trobalt™|trobalt™
4980755|NCT01721200|Rheumatoid Arthritis|rheumatoid arthritis
4980756|NCT01721200|web based interactive learning tool|web based interactive learning tool
4980757|NCT01721187|fMRI|fmri
4980758|NCT01721187|Satiety|satiety
4980759|NCT01721187|Willingness to Pay|willingness to pay
4980760|NCT01721187|Incentive Delay|incentive delay
4980761|NCT01721187|Dietary Disinhibition|dietary disinhibition
4980762|NCT01721174|Pancreatic cancer|pancreatic cancer
4980763|NCT01721174|Cholangiocarcinoma|cholangiocarcinoma
4980764|NCT01721174|Endoscopic radiofrequency ablation|endoscopic radiofrequency ablation
4980765|NCT01721161|Optic Neuritis|optic neuritis
4980766|NCT01721135|moxifloxacin|moxifloxacin
4980767|NCT01721135|GSK2190915|gsk2190915
4980768|NCT01721135|pharmacokinetics|pharmacokinetics
4980769|NCT01721135|QTc|qtc
4980770|NCT01721109|Adolescents|adolescents
4980771|NCT01721109|HIV-1|hiv-1
4980772|NCT01721109|HIV|hiv
4980773|NCT01721109|Treatment Naive|treatment naive
4980774|NCT01721096|Angioplasty|angioplasty
4980775|NCT01721096|Drug eluting stents|drug eluting stents
4980776|NCT01721096|Stents|stents
4980777|NCT01721096|Real world|real world
4980778|NCT01721083|intramuscular injection|intramuscular injection
4980779|NCT01721083|bunch|bunch
4980780|NCT01721083|z-track|z-track
4980781|NCT01721070|Area under curve, time to maximum concentration|area under curve, time to maximum concentration
4980782|NCT01721031|Catheter Related Bladder Discomfort|catheter related bladder discomfort
4980783|NCT01721031|Dorsal Penile Nerve Block|dorsal penile nerve block
4980784|NCT01721018|Oncolytic virus|oncolytic virus
4980785|NCT01721018|HSV1716|hsv1716
4980786|NCT01721018|Mesothelioma|mesothelioma
4980787|NCT01721018|MPM|mpm
4980788|NCT01721018|Woll|woll
4980789|NCT01721018|Sheffield|sheffield
4980790|NCT01721018|Weston Park|weston park
4980791|NCT01721018|Virttu|virttu
4980792|NCT01721018|Crusade|crusade
4980793|NCT01721005|atrial fibrillation|atrial fibrillation
4980794|NCT01721005|thromboembolism|thromboembolism
4980795|NCT01721005|patient education|patient education
4980796|NCT01720979|TBI|tbi
4980797|NCT01720979|Traumatic Brain Injury|traumatic brain injury
4980798|NCT01720979|Children|children
4980799|NCT01720979|Prognosis|prognosis
4980800|NCT01720979|Neurocognition|neurocognition
4980801|NCT01720966|Adhesions|adhesions
4980802|NCT01720966|laparoscopy|laparoscopy
4980803|NCT01720966|laparotomy|laparotomy
4980804|NCT01720966|liver resection|liver resection
4980805|NCT01720966|colorectal malignancy|colorectal malignancy
4980806|NCT01720953|Borderline Personality Disorder|borderline personality disorder
4980807|NCT01720953|Mentalization Based Therapy|mentalization based therapy
4980808|NCT01720953|DNA methylation|dna methylation
4980809|NCT01720953|BDNF|bdnf
4980810|NCT01720953|Cortisol|cortisol
4980811|NCT01720953|Neuropsychology|neuropsychology
4980812|NCT01720927|Acute Pharyngitis, GABHS|acute pharyngitis, gabhs
4980813|NCT01720888|Autologous|autologous
4980814|NCT01720888|Bone Marrow|bone marrow
4980815|NCT01720888|Mesenchymal Stem Cells|mesenchymal stem cells
4980816|NCT01720888|Ischemic Dilated Cardiomyopathy|ischemic dilated cardiomyopathy
4980817|NCT01720862|migraine|migraine
4980818|NCT01720862|episodic migraine|episodic migraine
4980819|NCT01720862|chronic migraine|chronic migraine
4980820|NCT01720862|obesity|obesity
4980821|NCT01720862|non-obese|non-obese
4980822|NCT01720823|Obstructive Sleep Apnea syndrome|obstructive sleep apnea syndrome
4980823|NCT01720823|polysomnography|polysomnography
4980824|NCT01720823|Home monitoring|home monitoring
4980825|NCT01720797|Malocclusion|malocclusion
4980826|NCT01720797|Accelerated tooth movement|accelerated tooth movement
4980827|NCT01720797|Braces|braces
4980828|NCT01720797|Orthodontic treatment|orthodontic treatment
4980829|NCT01720797|Propel|propel
4980830|NCT01720771|bacteriotherapy|bacteriotherapy
4980831|NCT01720771|caries|caries
4980832|NCT01720771|preschool children|preschool children
4980833|NCT01720771|probiotics|probiotics
4980834|NCT01720745|EUS|eus
4980835|NCT01720745|FNA|fna
4980836|NCT01720745|Wet suction|wet suction
4980837|NCT01720745|Dry suction|dry suction
4980838|NCT01720745|Solid lesions|solid lesions
4980839|NCT01720719|Non-alcoholic Fatty Liver Disease|non-alcoholic fatty liver disease
4980840|NCT01720719|Dyslipidemias|dyslipidemias
4980841|NCT01720719|Diabetes Mellitus|diabetes mellitus
4980842|NCT01720719|atorvastatin|atorvastatin
4980843|NCT01720719|Vitamin E|vitamin e
4980844|NCT01720706|Liver tumour|liver tumour
4980845|NCT01720706|Kidney tumour|kidney tumour
4980846|NCT01720706|Hepatectomy|hepatectomy
4980847|NCT01720706|Nephrectomy|nephrectomy
4980848|NCT01720706|Metastatic Colon Cancer|metastatic colon cancer
4980849|NCT01720706|Renal Cell Carcinoma|renal cell carcinoma
4980850|NCT01720693|partial nephrectomy|partial nephrectomy
4980851|NCT01720693|hypoperfusion|hypoperfusion
4980852|NCT01720693|renal function|renal function
4980853|NCT01720680|COPD|copd
4980854|NCT01720680|Functional Imaging|functional imaging
4980855|NCT01720680|Patient Reported Outcome (PRO)|patient reported outcome (pro)
4980856|NCT01720680|Lung Function|lung function
4980857|NCT01720680|AlphaCore|alphacore
4980858|NCT01720680|Computational Fluid Dynamics|computational fluid dynamics
4980859|NCT01720667|Seizures|seizures
4980860|NCT01720667|Neonates|neonates
4980861|NCT01720667|Anticonvulsants|anticonvulsants
4980862|NCT01720667|Treatment|treatment
4980863|NCT01720667|Levetiracetam|levetiracetam
4980864|NCT01720667|Phenobarbital|phenobarbital
4980865|NCT01720654|Expedited Partner Therapy|expedited partner therapy
4980866|NCT01720654|MSM|msm
4980867|NCT01720654|Peru|peru
4980868|NCT01720654|Gonorrhea|gonorrhea
4980869|NCT01720654|Chlamydia|chlamydia
4980870|NCT01720641|MSM|msm
4980871|NCT01720641|Transgender Women|transgender women
4980872|NCT01720641|Partner Notification|partner notification
4980873|NCT01720641|Syphilis|syphilis
4980874|NCT01720641|Peru|peru
4980875|NCT01720628|Angiogenin, Behçet's disease, bFGF, VEGF|angiogenin, behçet's disease, bfgf, vegf
4980876|NCT01720615|EEG|eeg
4980877|NCT01720615|AEP|aep
4980878|NCT01720615|Propofol|propofol
4980879|NCT01720615|Sevoflurane|sevoflurane
4980880|NCT01720615|Remifentanil|remifentanil
4980881|NCT01720615|General anesthesia|general anesthesia
4980882|NCT01720589|Obesity|obesity
4980883|NCT01720589|Dietary fat|dietary fat
4980884|NCT01720589|Energy expenditure|energy expenditure
4980885|NCT01720589|Food intake|food intake
4980886|NCT01720563|Cancer-related fatigue|cancer-related fatigue
4980887|NCT01720563|astragalus polysaccharides|astragalus polysaccharides
4980888|NCT01720563|concurrent chemoradiotherapy|concurrent chemoradiotherapy
4980889|NCT01720563|squamous cell carcinoma of head and neck|squamous cell carcinoma of head and neck
4980890|NCT01720550|Cancer-related fatigue|cancer-related fatigue
4980891|NCT01720550|Palliative Treatment|palliative treatment
4980892|NCT01720550|Astragalus polysaccharides|astragalus polysaccharides
4980893|NCT01720537|High Cholesterol|high cholesterol
4980894|NCT01720537|Dyslipidemia|dyslipidemia
4980895|NCT01720524|persistent pulmonary hypertension|persistent pulmonary hypertension
4980896|NCT01720524|newborn|newborn
4980897|NCT01720524|neonates|neonates
4980898|NCT01720524|iv sildenafil|iv sildenafil
4980899|NCT01720524|hypoxic respiratory failure and at risk of persistent pulmonary hypertension of the newborn|hypoxic respiratory failure and at risk of persistent pulmonary hypertension of the newborn
4980900|NCT01720472|Aging|aging
4980901|NCT01720472|Healthy Aging|healthy aging
4980902|NCT01720472|Physical Performance|physical performance
4980903|NCT01720472|Physical Functioning|physical functioning
4980904|NCT01720472|Cognitive Functioning|cognitive functioning
4980905|NCT01720472|Fitness|fitness
4980906|NCT01720472|Physical Activity|physical activity
4980907|NCT01720433|laparoscopic pain prospective blinded trial|laparoscopic pain prospective blinded trial
4980908|NCT01720420|edentulous|edentulous
4980909|NCT01720420|maxilla|maxilla
4980910|NCT01720420|mandible|mandible
4980911|NCT01720420|dental implant|dental implant
4980912|NCT01720420|bar|bar
4980913|NCT01720420|overdenture|overdenture
4980914|NCT01720420|Oral Health Impact Profile (OHIP)|oral health impact profile (ohip)
4980915|NCT01720420|survival rate|survival rate
4980916|NCT01720420|technical complications|technical complications
4980917|NCT01720420|marginal bone level|marginal bone level
4980918|NCT01720420|soft tissue|soft tissue
4980919|NCT01720407|Dermatology/ Skin cancers/Lentigo maligna melanoma|dermatology/ skin cancers/lentigo maligna melanoma
4980920|NCT01720381|monitoring|monitoring
4980921|NCT01720381|blood glucose|blood glucose
4980922|NCT01720381|intensive care unit|intensive care unit
4980923|NCT01720368|IBD|ibd
4980924|NCT01720368|Crohn's|crohn's
4980925|NCT01720342|Medtronic Enable® aortic bioprosthesis|medtronic enable® aortic bioprosthesis
4980926|NCT01720342|Aortic valve stenosis|aortic valve stenosis
4980927|NCT01720342|Aortic valve insufficiency|aortic valve insufficiency
4980928|NCT01720342|"Real world patients"|"real world patients"
4980929|NCT01720316|Glycine|glycine
4980930|NCT01720316|Glycine decarboxylase|glycine decarboxylase
4980931|NCT01720316|Psychosis|psychosis
4980932|NCT01720316|Mutation|mutation
4980933|NCT01720277|Randomized Controlled Trial|randomized controlled trial
4980934|NCT01720277|Influenza|influenza
4980935|NCT01720277|Influenza vaccine|influenza vaccine
4980936|NCT01720277|Flu Vaccine|flu vaccine
4980937|NCT01720277|Fluzone|fluzone
4980938|NCT01720277|HD Fluzone|hd fluzone
4980939|NCT01720277|Nursing Homes|nursing homes
4980940|NCT01720277|Hospitalization|hospitalization
4980941|NCT01720277|Mortality|mortality
4980942|NCT01720277|Health Care worker vaccination|health care worker vaccination
4980943|NCT01720277|ADL decline|adl decline
4980944|NCT01720277|Pilot|pilot
4980945|NCT01720277|Effectiveness|effectiveness
4980946|NCT01720251|allergic rhinitis|allergic rhinitis
4980947|NCT01720251|birch pollen|birch pollen
4980948|NCT01720251|immunotherapy|immunotherapy
4980949|NCT01720238|Compensated Liver Cirrhosis|compensated liver cirrhosis
4980950|NCT01720238|Early Antiviral Therapy|early antiviral therapy
4980951|NCT01720238|Cost Effectiveness|cost effectiveness
4980952|NCT01720225|Leukemia|leukemia
4980953|NCT01720225|Myelodysplastic syndromes|myelodysplastic syndromes
4980954|NCT01720225|MDS|mds
4980955|NCT01720225|Low and Intermediate-1 Risk Disease|low and intermediate-1 risk disease
4980956|NCT01720225|Decitabine|decitabine
4980957|NCT01720225|DAC|dac
4980958|NCT01720225|Dacogen|dacogen
4980959|NCT01720225|Azacitidine|azacitidine
4980960|NCT01720225|AZA|aza
4980961|NCT01720225|5-azacytidine|5-azacytidine
4980962|NCT01720225|5-aza|5-aza
4980963|NCT01720225|Vidaza|vidaza
4980964|NCT01720225|5-AZC|5-azc
4980965|NCT01720225|AZA-CR|aza-cr
4980966|NCT01720225|Ladakamycin|ladakamycin
4980967|NCT01720225|NSC-102816|nsc-102816
4980968|NCT01720212|YM178|ym178
4980969|NCT01720212|Mirabegron|mirabegron
4980970|NCT01720212|OCAS|ocas
4980971|NCT01720212|Chinese Healthy Volunteers|chinese healthy volunteers
4980972|NCT01720212|PK|pk
4980973|NCT01720212|Safety|safety
4980974|NCT01720199|universal prevention|universal prevention
4980975|NCT01720199|primary prevention|primary prevention
4980976|NCT01720199|health promotion|health promotion
4980977|NCT01720199|wellbeing|wellbeing
4980978|NCT01720199|smoking|smoking
4980979|NCT01720199|alcohol|alcohol
4980980|NCT01720199|diet|diet
4980981|NCT01720199|physical activity|physical activity
4980982|NCT01720199|emotional and social skills|emotional and social skills
4980983|NCT01720186|Lung Cancer|lung cancer
4980984|NCT01720186|PET/CT|pet/ct
4980985|NCT01720186|FDG|fdg
4980986|NCT01720186|Respiratory synchronization|respiratory synchronization
4980987|NCT01720147|Fanconi Anemia|fanconi anemia
4980988|NCT01720147|FA|fa
4980989|NCT01720147|Quercetin|quercetin
4980990|NCT01720043|multiple myeloma|multiple myeloma
4980991|NCT01720030|Renal|renal
4980992|NCT01720030|Acute Kidney Injury|acute kidney injury
4980993|NCT01720030|AKI|aki
4980994|NCT01720030|Levosimendan|levosimendan
4980995|NCT01720030|Simdax|simdax
4980996|NCT01720030|Renal perfusion|renal perfusion
4980997|NCT01720030|Mortality|mortality
4980998|NCT01720030|Renal flow|renal flow
4980999|NCT01720017|Airtraq|airtraq
4981000|NCT01720017|laryngoscope|laryngoscope
4981001|NCT01720017|airway|airway
4981002|NCT01720017|difficult|difficult
4981003|NCT01720017|training|training
4981004|NCT01720017|manikin|manikin
4981005|NCT01720004|human labour|human labour
4981006|NCT01720004|hands-and-knees positioning|hands-and-knees positioning
4981007|NCT01720004|pilot trial|pilot trial
4981008|NCT01719991|Primary care|primary care
4981009|NCT01719991|Self-management|self-management
4981010|NCT01719991|Self-support|self-support
4981011|NCT01719991|Nurse case management|nurse case management
4981012|NCT01719978|Local Anaesthetics|local anaesthetics
4981013|NCT01719978|Mepivacaine|mepivacaine
4981014|NCT01719978|hyaluronoglucosaminidase|hyaluronoglucosaminidase
4981015|NCT01719978|Hemodynamic|hemodynamic
4981016|NCT01719978|Electrocardiography and Dentistry.|electrocardiography and dentistry.
4981017|NCT01719965|Community Advisory Board|community advisory board
4981018|NCT01719965|Focus Group Discussion|focus group discussion
4981019|NCT01719965|Interview|interview
4981020|NCT01719965|Community Engagement|community engagement
4981021|NCT01719965|Thailand|thailand
4981022|NCT01719952|pregnancy|pregnancy
4981023|NCT01719952|anaesthesia|anaesthesia
4981024|NCT01719952|caesarean section|caesarean section
4981025|NCT01719926|Colorectal|colorectal
4981026|NCT01719926|Esophageal|esophageal
4981027|NCT01719926|Indomethacin|indomethacin
4981028|NCT01719926|PIFA|pifa
4981029|NCT01719900|Dietary intervention|dietary intervention
4981030|NCT01719900|Dietary fibre|dietary fibre
4981031|NCT01719900|Obesity|obesity
4981032|NCT01719900|Metabolic syndrome|metabolic syndrome
4981033|NCT01719900|Weight loss|weight loss
4981034|NCT01719900|Glucose regulation|glucose regulation
4981035|NCT01719900|Pulse fibre|pulse fibre
4981036|NCT01719887|humerus|humerus
4981037|NCT01719887|humeral|humeral
4981038|NCT01719887|shaft|shaft
4981039|NCT01719887|diaphysis|diaphysis
4981040|NCT01719887|fracture|fracture
4981041|NCT01719887|RCT|rct
4981042|NCT01719874|Influenza|influenza
4981043|NCT01719874|monoclonal antibody|monoclonal antibody
4981044|NCT01719848|Physical examinations, Percentage of glottic opening(POGO)|physical examinations, percentage of glottic opening(pogo)
4981045|NCT01719835|T-Cell Lymphoma|t-cell lymphoma
4981046|NCT01719835|Untreated|untreated
4981047|NCT01719822|Treatment Outcome [E01.789.800]|treatment outcome [e01.789.800]
4981048|NCT01719822|Rehabilitation [N02.421.784]|rehabilitation [n02.421.784]
4981049|NCT01719822|Physical Fitness [I03.621]|physical fitness [i03.621]
4981050|NCT01719822|Lung Diseases, Obstructive [C08.381.495]|lung diseases, obstructive [c08.381.495]
4981051|NCT01719822|Pulmonary Disease, Chronic Obstructive [C08.381.495.389]|pulmonary disease, chronic obstructive [c08.381.495.389]
4981052|NCT01719822|Bronchitis, Chronic [C08.381.495.389.500]|bronchitis, chronic [c08.381.495.389.500]
4981053|NCT01719809|Glaucoma|glaucoma
4981054|NCT01719809|Eye Drop|eye drop
4981055|NCT01719809|Eye Drop Technique|eye drop technique
4981056|NCT01719809|Training|training
4981057|NCT01719809|Instilling Eye Drops|instilling eye drops
4981058|NCT01719783|influenza|influenza
4981059|NCT01719783|vaccine|vaccine
4981060|NCT01719783|pandemic|pandemic
4981061|NCT01719770|cardiac arrest|cardiac arrest
4981062|NCT01719770|therapeutic hypothermia|therapeutic hypothermia
4981063|NCT01719770|skeletal muscle paralysis|skeletal muscle paralysis
4981064|NCT01719770|shivering|shivering
4981065|NCT01719770|serum drug levels|serum drug levels
4981066|NCT01719770|basal metabolism|basal metabolism
4981067|NCT01719757|Targin, Cancer Pain|targin, cancer pain
4981068|NCT01719744|ENMD-2076|enmd-2076
4981069|NCT01719744|advanced|advanced
4981070|NCT01719744|metastatic|metastatic
4981071|NCT01719744|soft tissue sarcoma|soft tissue sarcoma
4981072|NCT01719731|BPD|bpd
4981073|NCT01719718|ventral hernia|ventral hernia
4981074|NCT01719705|caesarean delivery|caesarean delivery
4981075|NCT01719705|spinal anesthesia|spinal anesthesia
4981076|NCT01719705|pregabalin|pregabalin
4981077|NCT01719705|postoperative pain|postoperative pain
4981078|NCT01719705|morphine|morphine
4981079|NCT01719679|school located vaccine program|school located vaccine program
4981080|NCT01719666|MPFL|mpfl
4981081|NCT01719666|patella|patella
4981082|NCT01719666|dislocation|dislocation
4981083|NCT01719666|release|release
4981084|NCT01719653|Colonoscopy|colonoscopy
4981085|NCT01719653|Bowel Preparation|bowel preparation
4981086|NCT01719653|MiraLAX|miralax
4981087|NCT01719653|Gatorade|gatorade
4981088|NCT01719653|PEG-3350|peg-3350
4981089|NCT01719653|MoviPrep|moviprep
4981090|NCT01719653|SUPREP|suprep
4981091|NCT01719653|Chicago Bowel Preparation Scale|chicago bowel preparation scale
4981092|NCT01719653|Boston Bowel Preparation Scale|boston bowel preparation scale
4981093|NCT01719640|mesenchymal stem cells|mesenchymal stem cells
4981094|NCT01719640|bone marrow mononeclear cells|bone marrow mononeclear cells
4981095|NCT01719640|type 2 diabetes mellitus|type 2 diabetes mellitus
4981096|NCT01719627|HIV, Maraviroc, PrEP, Ex vivo infection, rectal mucosa.|hiv, maraviroc, prep, ex vivo infection, rectal mucosa.
4981097|NCT01719614|Healthy participants|healthy participants
4981098|NCT01719614|Rilpivirine|rilpivirine
4981099|NCT01719614|Metformin|metformin
4981100|NCT01719614|Pharmacokinetics|pharmacokinetics
4981101|NCT01719601|Moderate to severe acute non-cancer pain|moderate to severe acute non-cancer pain
4981102|NCT01719601|Immediate release tapentadol hydrochloride|immediate release tapentadol hydrochloride
4981103|NCT01719601|Tapentadol IR|tapentadol ir
4981104|NCT01719601|Nucynta IR|nucynta ir
4981105|NCT01719588|Moderate to severe chronic non-cancer pain|moderate to severe chronic non-cancer pain
4981106|NCT01719588|Prolonged release tapentadol hydrochloride|prolonged release tapentadol hydrochloride
4981107|NCT01719588|Tapentadol PR|tapentadol pr
4981108|NCT01719588|Extended release tapentadol hydrochloride|extended release tapentadol hydrochloride
4981109|NCT01719588|Nucynta PR|nucynta pr
4981110|NCT01719549|Gastric Cancer|gastric cancer
4981111|NCT01719549|Dovitinib|dovitinib
4981112|NCT01719523|Tourette syndrome|tourette syndrome
4981113|NCT01719523|Tics|tics
4981114|NCT01719523|Tic Disorders|tic disorders
4981115|NCT01719510|Group B Streptococcus,|group b streptococcus,
4981116|NCT01719510|Vaginal screening|vaginal screening
4981117|NCT01719510|Per partum antibiotic prophylaxis|per partum antibiotic prophylaxis
4981118|NCT01719510|Meningitis|meningitis
4981119|NCT01719510|Neonatal infection|neonatal infection
4981120|NCT01719510|PCR|pcr
4981121|NCT01719510|Streptococcus agalactiae.|streptococcus agalactiae.
4981122|NCT01719445|Energy Intake|energy intake
4981123|NCT01719432|Filgrastim|filgrastim
4981124|NCT01719432|Obese|obese
4981125|NCT01719432|Non-obese|non-obese
4981126|NCT01719432|Pharmacokinetics|pharmacokinetics
4981127|NCT01719406|Gestational diabetes|gestational diabetes
4981128|NCT01719406|Exercise|exercise
4981129|NCT01719406|Diet|diet
4981130|NCT01719406|Fruits|fruits
4981131|NCT01719406|Vegetables|vegetables
4981132|NCT01719406|Whole grains|whole grains
4981133|NCT01719406|pregnancy weight|pregnancy weight
4981134|NCT01719393|Asthma|asthma
4981135|NCT01719393|Pulse spectrum analysis|pulse spectrum analysis
4981136|NCT01719393|lung function|lung function
4981137|NCT01719393|exhaled nitric oxide|exhaled nitric oxide
4981138|NCT01719393|metabolites|metabolites
4981139|NCT01719393|exhaled breath condensate|exhaled breath condensate
4981237|NCT01718847|Pan-Her inhibitor|pan-her inhibitor
4981238|NCT01718834|prophylactic vaccine|prophylactic vaccine
4981239|NCT01718834|chronic HCV patients|chronic hcv patients
4981140|NCT01719380|Open-label dose escalation; BRAF inhibitor; LGX818; PI3K inhibitor; BYL719; EGFR; cetuximab; metastatic colorectal cancer; KRAS; BRAF; V600|open-label dose escalation; braf inhibitor; lgx818; pi3k inhibitor; byl719; egfr; cetuximab; metastatic colorectal cancer; kras; braf; v600
4981141|NCT01719367|Baseline (pre-atenolol)|baseline (pre-atenolol)
4981142|NCT01719367|Post-atenolol|post-atenolol
4981143|NCT01719354|Community Mental Health Centers|community mental health centers
4981144|NCT01719354|Norway|norway
4981145|NCT01719354|Aftercare|aftercare
4981146|NCT01719328|yoga,|yoga,
4981147|NCT01719328|exercise|exercise
4981148|NCT01719328|affect|affect
4981149|NCT01719328|mind/body therapies|mind/body therapies
4981150|NCT01719328|stress, psychological|stress, psychological
4981151|NCT01719302|Soft tissue sarcoma|soft tissue sarcoma
4981152|NCT01719302|gemcitabine|gemcitabine
4981153|NCT01719302|docetaxel|docetaxel
4981154|NCT01719302|pazopanib|pazopanib
4981155|NCT01719289|depression|depression
4981156|NCT01719289|problem solving|problem solving
4981157|NCT01719263|emphysema|emphysema
4981158|NCT01719263|InterVapor|intervapor
4981159|NCT01719263|treatments|treatments
4981160|NCT01719263|pulmonary rehabilitation|pulmonary rehabilitation
4981161|NCT01719263|lung volume reduction|lung volume reduction
4981162|NCT01719263|endoscopic lung volume reduction|endoscopic lung volume reduction
4981163|NCT01719237|Onset|onset
4981164|NCT01719237|Duration|duration
4981165|NCT01719237|Upper Limb Block|upper limb block
4981166|NCT01719237|Ultrasound guided supraclavicular block|ultrasound guided supraclavicular block
4981167|NCT01719237|Ropivacaine|ropivacaine
4981168|NCT01719237|Chloroprocaine|chloroprocaine
4981169|NCT01719211|MVP, mitral valve|mvp, mitral valve
4981170|NCT01719198|adenoma|adenoma
4981171|NCT01719198|calprotectin|calprotectin
4981172|NCT01719159|Progressive multiple sclerosis|progressive multiple sclerosis
4981173|NCT01719159|Monoclonal antibodies|monoclonal antibodies
4981174|NCT01719159|Mabthera|mabthera
4981175|NCT01719159|Intrathecal treatment|intrathecal treatment
4981176|NCT01719146|Anemia|anemia
4981177|NCT01719146|Chronic Kidney Disease|chronic kidney disease
4981178|NCT01719146|Erythropoiesis Stimulating Agents|erythropoiesis stimulating agents
4981179|NCT01719146|Erythropoietin|erythropoietin
4981180|NCT01719146|Iron|iron
4981181|NCT01719146|Iron Deficiency|iron deficiency
4981182|NCT01719133|allergy|allergy
4981183|NCT01719133|birch|birch
4981184|NCT01719120|Insomnia|insomnia
4981185|NCT01719120|Cognitive-Behavioral Therapy|cognitive-behavioral therapy
4981186|NCT01719120|Internet-Based|internet-based
4981187|NCT01719120|Self-Help|self-help
4981188|NCT01719120|Randomized Controlled Trial|randomized controlled trial
4981189|NCT01719107|Functional abdominal pain|functional abdominal pain
4981190|NCT01719107|Probiotics|probiotics
4981191|NCT01719107|Lactobacilus reuteri|lactobacilus reuteri
4981192|NCT01719081|Sacroiliac Joint|sacroiliac joint
4981193|NCT01719081|Ultrasound|ultrasound
4981194|NCT01719081|Fluoroscopy|fluoroscopy
4981195|NCT01719081|Chronic Pain|chronic pain
4981196|NCT01719068|Mesothelioma|mesothelioma
4981197|NCT01719068|Lung Cancer|lung cancer
4981198|NCT01719068|Early Detection|early detection
4981199|NCT01719055|stimulation|stimulation
4981200|NCT01719055|implantable|implantable
4981201|NCT01719055|pulse generator|pulse generator
4981202|NCT01719055|back pain|back pain
4981203|NCT01719055|chronic pain|chronic pain
4981204|NCT01719055|leg pain|leg pain
4981205|NCT01719029|continuous glucose monitoring|continuous glucose monitoring
4981206|NCT01719029|gestational diabetes|gestational diabetes
4981207|NCT01719029|diet therapy|diet therapy
4981208|NCT01719016|Reversible ischemia|reversible ischemia
4981209|NCT01719016|microvascular dysfunction|microvascular dysfunction
4981210|NCT01718977|Intervention|intervention
4981211|NCT01718977|Body Weight Supported Treadmill Training|body weight supported treadmill training
4981212|NCT01718977|Arm Cycle Ergometry Training|arm cycle ergometry training
4981213|NCT01718977|carotid-to-femoral pulse wave velocity|carotid-to-femoral pulse wave velocity
4981214|NCT01718951|spondyloarthropathy|spondyloarthropathy
4981215|NCT01718951|ankylosing spondylitis|ankylosing spondylitis
4981216|NCT01718938|Gastroparesis|gastroparesis
4981217|NCT01718938|Diabetic|diabetic
4981218|NCT01718938|Idiopathic|idiopathic
4981219|NCT01718938|Delayed gastric emptying|delayed gastric emptying
4981220|NCT01718912|periodontal disease|periodontal disease
4981221|NCT01718912|bleeding on probing|bleeding on probing
4981222|NCT01718912|periodontal pockets|periodontal pockets
4981223|NCT01718912|disabled|disabled
4981224|NCT01718886|Obesity|obesity
4981225|NCT01718886|Weight loss|weight loss
4981226|NCT01718886|Weight control|weight control
4981227|NCT01718886|Intragastric balloon|intragastric balloon
4981228|NCT01718886|gastric balloon|gastric balloon
4981229|NCT01718873|metastatic|metastatic
4981230|NCT01718873|stage IV|stage iv
4981231|NCT01718860|Cost Analysis|cost analysis
4981232|NCT01718860|Postoperative Complications|postoperative complications
4981233|NCT01718860|Length of Stay|length of stay
4981234|NCT01718860|Intensive Care Units|intensive care units
4981235|NCT01718847|EGFR Tyrosine Kinase Inhibitor|egfr tyrosine kinase inhibitor
4981236|NCT01718847|Aquired resistance to EGFR TKI|aquired resistance to egfr tki
4981539|NCT01717755|mechanical|mechanical
4981240|NCT01718834|healthy risk volunteers|healthy risk volunteers
4981241|NCT01718808|Metastatic Colorectal Cancer|metastatic colorectal cancer
4981242|NCT01718808|KRAS|kras
4981243|NCT01718808|BRAF|braf
4981244|NCT01718808|Wild-type Metastatic|wild-type metastatic
4981245|NCT01718808|Cetuximab|cetuximab
4981246|NCT01718808|Capecitabine|capecitabine
4981247|NCT01718808|Phase II Trial|phase ii trial
4981248|NCT01718808|Elderly Patients|elderly patients
4981249|NCT01718795|Airway|airway
4981250|NCT01718795|Cardiac Arrest|cardiac arrest
4981251|NCT01718795|CPR|cpr
4981252|NCT01718795|Ventilation|ventilation
4981253|NCT01718782|laryngeal mask, leakage pressure, ventilation|laryngeal mask, leakage pressure, ventilation
4981254|NCT01718769|Nutritional assessment|nutritional assessment
4981255|NCT01718769|children|children
4981256|NCT01718769|malnutrition|malnutrition
4981257|NCT01718756|Orthopaedic|orthopaedic
4981258|NCT01718756|General anaesthesia|general anaesthesia
4981259|NCT01718756|lornoxicam|lornoxicam
4981260|NCT01718756|patient controlled analgesia|patient controlled analgesia
4981261|NCT01718756|morphine consumption|morphine consumption
4981262|NCT01718743|Myeloma|myeloma
4981263|NCT01718743|Multiple Myeloma|multiple myeloma
4981264|NCT01718743|MM|mm
4981265|NCT01718743|Post Autologous Stem Cell Transplant|post autologous stem cell transplant
4981266|NCT01718743|Lenalidomide|lenalidomide
4981267|NCT01718743|CC-5013|cc-5013
4981268|NCT01718743|Revlimid|revlimid
4981269|NCT01718743|MLN9708|mln9708
4981270|NCT01718743|Questionnaire|questionnaire
4981271|NCT01718743|Survey|survey
4981272|NCT01718730|TMS|tms
4981273|NCT01718730|Adolescent|adolescent
4981274|NCT01718730|Child|child
4981275|NCT01718730|MDD|mdd
4981276|NCT01718730|Major depressive disorder|major depressive disorder
4981277|NCT01718730|Mild MDD|mild mdd
4981278|NCT01718730|Mild depression|mild depression
4981279|NCT01718730|SSRI|ssri
4981280|NCT01718730|Motor cortex|motor cortex
4981281|NCT01718730|Cortical excitability|cortical excitability
4981282|NCT01718730|Cortical inhibition|cortical inhibition
4981283|NCT01718730|Cortical silent period|cortical silent period
4981284|NCT01718730|Motor threshold|motor threshold
4981285|NCT01718730|Intracortical facilitation|intracortical facilitation
4981286|NCT01718730|Intracortical inhibition|intracortical inhibition
4981287|NCT01718730|gamma-aminobutyric acid (GABA)|gamma-aminobutyric acid (gaba)
4981288|NCT01718730|Glutamate|glutamate
4981289|NCT01718730|N-methyl-D-aspartate (NMDA)|n-methyl-d-aspartate (nmda)
4981290|NCT01718730|Magnetic resonance spectroscopy|magnetic resonance spectroscopy
4981291|NCT01718730|MRS|mrs
4981292|NCT01718717|Thoracotomy|thoracotomy
4981293|NCT01718717|Thoracic epidural analgesia|thoracic epidural analgesia
4981294|NCT01718717|Arrythmiogenesis|arrythmiogenesis
4981295|NCT01718717|Atrial fibrillation|atrial fibrillation
4981296|NCT01718717|Sympathetic outflow|sympathetic outflow
4981297|NCT01718704|rehabilitation|rehabilitation
4981298|NCT01718704|erectile dysfunction|erectile dysfunction
4981299|NCT01718704|incontinence|incontinence
4981300|NCT01718678|Multiple sclerosis|multiple sclerosis
4981301|NCT01718678|Melatonin|melatonin
4981302|NCT01718678|Fatigue|fatigue
4981303|NCT01718678|Quality of life|quality of life
4981304|NCT01718652|Healthy|healthy
4981305|NCT01718652|Canagliflozin (JNJ-28431754)|canagliflozin (jnj-28431754)
4981306|NCT01718652|Pharmacokinetics|pharmacokinetics
4981307|NCT01718652|Cyclosporine|cyclosporine
4981308|NCT01718600|carotid artery stenting|carotid artery stenting
4981309|NCT01718600|neuropsychological testing|neuropsychological testing
4981310|NCT01718600|microembolization|microembolization
4981311|NCT01718600|MRI|mri
4981312|NCT01718587|umbilical cord mesenchyma stem cell|umbilical cord mesenchyma stem cell
4981313|NCT01718587|liver cirrhosis|liver cirrhosis
4981314|NCT01718587|antiviral therapy|antiviral therapy
4981315|NCT01718574|self-help book|self-help book
4981316|NCT01718574|support service|support service
4981317|NCT01718561|Airway assessment|airway assessment
4981318|NCT01718561|Intubation|intubation
4981319|NCT01718561|Mask ventilation|mask ventilation
4981320|NCT01718535|Cyp2C19|cyp2c19
4981321|NCT01718535|Genotyping|genotyping
4981322|NCT01718535|Spartan|spartan
4981323|NCT01718535|Comparison|comparison
4981324|NCT01718535|Sequencing|sequencing
4981325|NCT01718496|dyspnea|dyspnea
4981326|NCT01718496|COPD|copd
4981327|NCT01718496|exercise tolerance|exercise tolerance
4981328|NCT01718496|opioids|opioids
4981329|NCT01718496|morphine|morphine
4981330|NCT01718496|single dose oral Morphine|single dose oral morphine
4981331|NCT01718470|Systolic blood pressure|systolic blood pressure
4981332|NCT01718470|Heart rate|heart rate
4981333|NCT01718470|Laryngeal mask|laryngeal mask
4981334|NCT01718470|Endotracheal tube|endotracheal tube
4981335|NCT01718470|craniotomy|craniotomy
4981336|NCT01718457|Endobarrier|endobarrier
4981337|NCT01718457|Diabetes|diabetes
4981338|NCT01718457|Obesity|obesity
4981339|NCT01718457|Weight|weight
4981340|NCT01718457|BMI|bmi
4981341|NCT01718457|Lipid profile|lipid profile
4981342|NCT01718457|fatty liver|fatty liver
4981343|NCT01718457|gut peptides|gut peptides
4981344|NCT01718457|HbA1c|hba1c
4981345|NCT01718444|PCOS|pcos
4981346|NCT01718444|Polycystic ovary syndrome|polycystic ovary syndrome
4981347|NCT01718444|Infertility|infertility
4981348|NCT01718444|Anovulation|anovulation
4981349|NCT01718444|Clomiphene citrate|clomiphene citrate
4981350|NCT01718444|Clomid|clomid
4981351|NCT01718444|Progestin|progestin
4981352|NCT01718444|Provera|provera
4981353|NCT01718444|Progesterone|progesterone
4981354|NCT01718444|Endometrial shedding|endometrial shedding
4981355|NCT01718392|combined training|combined training
4981356|NCT01718392|insulin resistance|insulin resistance
4981357|NCT01718379|Myelodysplasia|myelodysplasia
4981358|NCT01718340|PCOS|pcos
4981359|NCT01718340|Hyper insulinaemia|hyper insulinaemia
4981360|NCT01718340|metformin|metformin
4981361|NCT01718340|recurrent abortion|recurrent abortion
4981362|NCT01718327|Cholangiocarcinoma|cholangiocarcinoma
4981363|NCT01718314|Hysteroscopy|hysteroscopy
4981364|NCT01718314|Misoprostol|misoprostol
4981365|NCT01718314|Lidocaine|lidocaine
4981366|NCT01718314|Visual analogue score|visual analogue score
4981367|NCT01718301|HCV|hcv
4981368|NCT01718301|HIV|hiv
4981369|NCT01718301|Coinfection|coinfection
4981370|NCT01718288|PAD; iloprost; walking distance; cardiovascular events|pad; iloprost; walking distance; cardiovascular events
4981371|NCT01718275|Appendicitis|appendicitis
4981372|NCT01718275|Pediatrics|pediatrics
4981373|NCT01718275|Children|children
4981374|NCT01718275|Non-operative|non-operative
4981375|NCT01718262|Ropivacaine Level|ropivacaine level
4981376|NCT01718262|continuous peripheral nerve blocks.|continuous peripheral nerve blocks.
4981377|NCT01718249|Deep Brain Stimulation (DBS)|deep brain stimulation (dbs)
4981378|NCT01718249|Post-coma|post-coma
4981379|NCT01718249|Consciousness|consciousness
4981380|NCT01718249|Vegetative state|vegetative state
4981381|NCT01718249|Minimally conscious state|minimally conscious state
4981382|NCT01718236|caesarean section|caesarean section
4981383|NCT01718236|rocuronium|rocuronium
4981384|NCT01718236|sugammadex|sugammadex
4981385|NCT01718210|GM-CSF|gm-csf
4981386|NCT01718210|recurrent implantation failure|recurrent implantation failure
4981387|NCT01718210|pregnancy rate|pregnancy rate
4981388|NCT01718210|IVF|ivf
4981389|NCT01718197|Severe Asthma|severe asthma
4981390|NCT01718197|Bronchoscopy|bronchoscopy
4981391|NCT01718184|sulcoflex|sulcoflex
4981392|NCT01718184|toric|toric
4981393|NCT01718184|corneal implantation|corneal implantation
4981394|NCT01718171|Appendicitis|appendicitis
4981395|NCT01718171|SIRS|sirs
4981396|NCT01718171|C-reactive protein|c-reactive protein
4981397|NCT01718132|Quality of the anaesthetic care in a PACU|quality of the anaesthetic care in a pacu
4981398|NCT01718132|reduction of postoperative pain|reduction of postoperative pain
4981399|NCT01718132|reduction of postoperative nausea and vomiting|reduction of postoperative nausea and vomiting
4981400|NCT01718132|quality markers|quality markers
4981401|NCT01718106|coronary artery disease|coronary artery disease
4981402|NCT01718106|drug eluting stent|drug eluting stent
4981403|NCT01718106|bioabsorbable polymer|bioabsorbable polymer
4981404|NCT01718106|percutaneous coronary intervention|percutaneous coronary intervention
4981405|NCT01718106|restenosis|restenosis
4981406|NCT01718106|late thrombosis|late thrombosis
4981407|NCT01718093|Adolescents|adolescents
4981408|NCT01718080|Obese, Lean, Pubertal, Prepubertal, Glucose, Adolescents, Type 2 Diabetes|obese, lean, pubertal, prepubertal, glucose, adolescents, type 2 diabetes
4981409|NCT01718067|Chest physiotherapy|chest physiotherapy
4981410|NCT01718067|Rehabilitation|rehabilitation
4981411|NCT01718067|Chronic respiratory diseases|chronic respiratory diseases
4981412|NCT01718054|Vascular function|vascular function
4981413|NCT01718054|Ready to use supplementary foods|ready to use supplementary foods
4981414|NCT01718054|Chloroquine|chloroquine
4981415|NCT01718054|Children|children
4981416|NCT01718054|Growth|growth
4981417|NCT01718054|Nitric Oxide|nitric oxide
4981418|NCT01718041|Growth hormone|growth hormone
4981419|NCT01718041|Growth hormone deficiency|growth hormone deficiency
4981420|NCT01718041|Growth|growth
4981421|NCT01718041|Pediatric growth hormone deficiency|pediatric growth hormone deficiency
4981422|NCT01718041|Long acting growth hormone|long acting growth hormone
4981423|NCT01718041|GHD|ghd
4981424|NCT01718041|PGHD|pghd
4981425|NCT01718041|VRS 317|vrs 317
4981426|NCT01718041|Exten|exten
4981427|NCT01718041|Versartis|versartis
4981428|NCT01718028|Systane BALANCE|systane balance
4981429|NCT01718028|Dry eye|dry eye
4981430|NCT01718028|lipid deficiency|lipid deficiency
4981431|NCT01718028|NITFBUT|nitfbut
4981432|NCT01718015|Vascular Endothelial Growth Factor|vascular endothelial growth factor
4981433|NCT01718015|Brain-Derived Neurothropic Factor|brain-derived neurothropic factor
4981434|NCT01718015|Diabetes Mellitus|diabetes mellitus
4981435|NCT01718015|CD-163|cd-163
4981436|NCT01718015|Cerebrospinal fluid|cerebrospinal fluid
4981437|NCT01718015|Peripheral Nervous System Diseases|peripheral nervous system diseases
4981438|NCT01718015|Mass spectrometry|mass spectrometry
4981439|NCT01718002|Nursing|nursing
4981440|NCT01718002|Simulation|simulation
4981441|NCT01718002|Education|education
4981442|NCT01717989|Dialysis|dialysis
4981443|NCT01717989|Prospective Payment System|prospective payment system
4981444|NCT01717989|Center for Medicare and Medicaide Services|center for medicare and medicaide services
4981445|NCT01717989|End Stage Renal Disease|end stage renal disease
4981446|NCT01717989|Concomitant Medications Dosage /Treatment patterns|concomitant medications dosage /treatment patterns
4981447|NCT01717976|emergency department use|emergency department use
4981448|NCT01717976|Veterans|veterans
4981449|NCT01717950|Human Hookworm|human hookworm
4981450|NCT01717950|Necator americanus|necator americanus
4981451|NCT01717950|Hookworm|hookworm
4981452|NCT01717950|Hookworm Disease|hookworm disease
4981453|NCT01717950|Iron-deficiency anemia|iron-deficiency anemia
4981454|NCT01717950|Soil-transmitted helminth infection|soil-transmitted helminth infection
4981455|NCT01717950|Neglected Tropical Disease|neglected tropical disease
4981456|NCT01717950|Na-APR-1|na-apr-1
4981457|NCT01717937|retinovascular disease|retinovascular disease
4981458|NCT01717937|imaging|imaging
4981459|NCT01717937|fluorescein angiography|fluorescein angiography
4981460|NCT01717937|FA|fa
4981461|NCT01717937|angiography|angiography
4981462|NCT01717937|optical coherence tomography|optical coherence tomography
4981463|NCT01717937|OCT|oct
4981464|NCT01717937|phase variance|phase variance
4981465|NCT01717937|comparison|comparison
4981466|NCT01717937|age-related macular degeneration|age-related macular degeneration
4981467|NCT01717937|diabetic retinopathy|diabetic retinopathy
4981468|NCT01717937|hypertensive retinopathy|hypertensive retinopathy
4981469|NCT01717937|retinal vein occlusion|retinal vein occlusion
4981470|NCT01717937|retinal artery occlusion|retinal artery occlusion
4981471|NCT01717924|Signet ring cell|signet ring cell
4981472|NCT01717924|gastric adenocarcinoma|gastric adenocarcinoma
4981473|NCT01717924|peri-operative chemotherapy|peri-operative chemotherapy
4981474|NCT01717924|surgery|surgery
4981475|NCT01717911|Newly diagnosed type 2 diabetes|newly diagnosed type 2 diabetes
4981476|NCT01717911|Insulin, metformin, sitagliptin|insulin, metformin, sitagliptin
4981477|NCT01717911|beta-cell function, glycemic control|beta-cell function, glycemic control
4981478|NCT01717898|Castrate-resistant prostate cancer|castrate-resistant prostate cancer
4981479|NCT01717885|Pharmacokinetics|pharmacokinetics
4981480|NCT01717885|Antimalarial|antimalarial
4981481|NCT01717885|HIV|hiv
4981482|NCT01717885|Antiretrovirals|antiretrovirals
4981483|NCT01717885|Childhood development|childhood development
4981484|NCT01717885|Pregnancy|pregnancy
4981485|NCT01717872|glottis, laryngoscopy, laryngoscope blade|glottis, laryngoscopy, laryngoscope blade
4981486|NCT01717859|Rheumatoid Arthritis|rheumatoid arthritis
4981487|NCT01717846|Apoptosos|apoptosos
4981488|NCT01717846|Rheumatoid Arthritis|rheumatoid arthritis
4981489|NCT01717846|T cells, B cells|t cells, b cells
4981490|NCT01717846|DAS28|das28
4981491|NCT01717846|Clinical Disease activity Index|clinical disease activity index
4981492|NCT01717846|CDAI|cdai
4981493|NCT01717833|ICU acquired weakness|icu acquired weakness
4981494|NCT01717833|Critical illness polyneuromyopathy|critical illness polyneuromyopathy
4981495|NCT01717833|post ICU rehabilitation|post icu rehabilitation
4981496|NCT01717833|neuromuscular electrical rehabilitation|neuromuscular electrical rehabilitation
4981497|NCT01717833|handgrip|handgrip
4981498|NCT01717820|Obesity|obesity
4981499|NCT01717820|Postmenopausal women|postmenopausal women
4981500|NCT01717820|Body composition|body composition
4981501|NCT01717820|Resveratrol|resveratrol
4981502|NCT01717820|Inflammatory biomarkers|inflammatory biomarkers
4981503|NCT01717820|Bone formation|bone formation
4981504|NCT01717820|Adipose metabolism|adipose metabolism
4981505|NCT01717807|epithelial growth factor receptors|epithelial growth factor receptors
4981506|NCT01717807|lung cancer|lung cancer
4981507|NCT01717807|advanced tumor of pancrease|advanced tumor of pancrease
4981508|NCT01717807|erlotinib|erlotinib
4981509|NCT01717807|C11-Erlotinib PET/CT|c11-erlotinib pet/ct
4981510|NCT01717794|operative time|operative time
4981511|NCT01717794|laparoscopy|laparoscopy
4981512|NCT01717794|total hysterectomy|total hysterectomy
4981513|NCT01717794|pelvic lymphadenectomy|pelvic lymphadenectomy
4981514|NCT01717794|endometrial cancer|endometrial cancer
4981515|NCT01717794|Thunderbeat|thunderbeat
4981516|NCT01717781|operative time|operative time
4981517|NCT01717781|laparoscopy|laparoscopy
4981518|NCT01717781|radical hysterectomy|radical hysterectomy
4981519|NCT01717781|pelvic lymphadenectomy|pelvic lymphadenectomy
4981520|NCT01717781|cervical cancer|cervical cancer
4981521|NCT01717781|thunderbeat|thunderbeat
4981522|NCT01717768|hypogonadism|hypogonadism
4981523|NCT01717768|Gonadal Disorders|gonadal disorders
4981524|NCT01717768|Endocrine System Diseases|endocrine system diseases
4981525|NCT01717768|Testosterone|testosterone
4981526|NCT01717768|Testosterone enanthate|testosterone enanthate
4981527|NCT01717768|Testosterone undecanoate|testosterone undecanoate
4981528|NCT01717768|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate
4981529|NCT01717768|Methyltestosterone|methyltestosterone
4981530|NCT01717768|Androgens|androgens
4981531|NCT01717768|Hormones|hormones
4981532|NCT01717768|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists
4981533|NCT01717768|Physiological Effects of Drugs|physiological effects of drugs
4981534|NCT01717768|Pharmacologic Actions|pharmacologic actions
4981535|NCT01717768|Therapeutic Uses|therapeutic uses
4981536|NCT01717768|Anabolic Agents|anabolic agents
4981537|NCT01717755|basilar|basilar
4981538|NCT01717755|stroke|stroke
4981540|NCT01717755|thrombolysis|thrombolysis
4981541|NCT01717755|intra-arterial|intra-arterial
4981542|NCT01717755|trombectomy|trombectomy
4981543|NCT01717742|Randomized controlled trial|randomized controlled trial
4981544|NCT01717742|Pleural Empyema|pleural empyema
4981545|NCT01717742|tPA|tpa
4981546|NCT01717742|DNase|dnase
4981547|NCT01717729|HCC, RFA, Iodine-125, Recurrence|hcc, rfa, iodine-125, recurrence
4981548|NCT01717716|boys|boys
4981549|NCT01717716|obesity|obesity
4981550|NCT01717716|glucose|glucose
4981551|NCT01717716|sucrose|sucrose
4981552|NCT01717716|high-fructose corn syrup-55|high-fructose corn syrup-55
4981553|NCT01717703|prevention|prevention
4981554|NCT01717690|MRSA|mrsa
4981555|NCT01717690|chlorhexidine|chlorhexidine
4981556|NCT01717664|Relapsing Remitting Multiple Sclerosis|relapsing remitting multiple sclerosis
4981557|NCT01717664|MAP|map
4981558|NCT01717664|antibiotic|antibiotic
4981559|NCT01717664|Interferon beta 1-a|interferon beta 1-a
4981560|NCT01717664|MS|ms
4981561|NCT01717664|MRI|mri
4981562|NCT01717664|EDSS|edss
4981563|NCT01717664|relapse rate|relapse rate
4981564|NCT01717651|Atrophy|atrophy
4981565|NCT01717651|Muscle wasting|muscle wasting
4981566|NCT01717651|Sepsis|sepsis
4981567|NCT01717638|Meningococcal disease, vaccines, children, persistence|meningococcal disease, vaccines, children, persistence
4981568|NCT01717625|montelukast|montelukast
4981569|NCT01717625|BPD|bpd
4981570|NCT01717625|singulair|singulair
4981571|NCT01717625|prematurity|prematurity
4981572|NCT01717612|gastric varices, thrombin, histoacryl|gastric varices, thrombin, histoacryl
4981573|NCT01717599|Post ERCP pancreatitis|post ercp pancreatitis
4981574|NCT01717599|Diclofenac|diclofenac
4981575|NCT01717599|NSAID|nsaid
4981576|NCT01717586|preeclampsia|preeclampsia
4981577|NCT01717586|pravastatin|pravastatin
4981578|NCT01717586|Pravachol®|pravachol®
4981579|NCT01717586|statin|statin
4981580|NCT01717586|high-risk pregnancy|high-risk pregnancy
4981581|NCT01717586|safety|safety
4981582|NCT01717586|fetal morbidity and mortality|fetal morbidity and mortality
4981583|NCT01717586|maternal morbidity and mortality|maternal morbidity and mortality
4981584|NCT01717586|neonatal mortality|neonatal mortality
4981585|NCT01717586|premature delivery|premature delivery
4981586|NCT01717586|preemie|preemie
4981587|NCT01717573|STEMI|stemi
4981588|NCT01717573|No-reflow|no-reflow
4981589|NCT01717573|Primary percutaneous intervention|primary percutaneous intervention
4981590|NCT01717573|Deferred stenting|deferred stenting
4981591|NCT01717560|chronic hepatitis C|chronic hepatitis c
4981592|NCT01717560|illicit drug use|illicit drug use
4981593|NCT01717560|Substance-Related Disorders|substance-related disorders
4981594|NCT01717560|multidisciplinary care|multidisciplinary care
4981595|NCT01717560|integrated care|integrated care
4981596|NCT01717560|mental health care|mental health care
4981597|NCT01717560|intensive case management|intensive case management
4981598|NCT01717547|Veterans|veterans
4981599|NCT01717547|Yoga|yoga
4981600|NCT01717547|Stress|stress
4981601|NCT01717534|Diarrhea|diarrhea
4981602|NCT01717534|Children|children
4981603|NCT01717534|Heat-treated lactobacilli|heat-treated lactobacilli
4981604|NCT01717521|hysterectomy|hysterectomy
4981605|NCT01717521|gynecological abdominal surgery|gynecological abdominal surgery
4981606|NCT01717508|MDD|mdd
4981607|NCT01717508|depression|depression
4981608|NCT01717508|major depressive disorder|major depressive disorder
4981609|NCT01717508|adolescent|adolescent
4981610|NCT01717495|Pacemaker|pacemaker
4981611|NCT01717495|Implantable-cardioverter defibrillator|implantable-cardioverter defibrillator
4981612|NCT01717495|Cardiac Pacing, Artificial/adverse effects|cardiac pacing, artificial/adverse effects
4981613|NCT01717495|Venous thrombosis|venous thrombosis
4981614|NCT01717495|Pulmonary embolism|pulmonary embolism
4981615|NCT01717495|Phlebography|phlebography
4981616|NCT01717495|Biological markers|biological markers
4981617|NCT01717495|Computed tomography angiography|computed tomography angiography
4981618|NCT01717482|Bronchoscopy|bronchoscopy
4981619|NCT01717482|Metformin|metformin
4981620|NCT01717469|Pacemaker|pacemaker
4981621|NCT01717469|Pacemaker implantation|pacemaker implantation
4981622|NCT01717469|Coronary sinus|coronary sinus
4981623|NCT01717469|Ventricular dysfunction|ventricular dysfunction
4981624|NCT01717469|Right ventricular pacing|right ventricular pacing
4981625|NCT01717469|Left ventricular pacing|left ventricular pacing
4981626|NCT01717456|Fecal incontinence|fecal incontinence
4981627|NCT01717456|Frail elders|frail elders
4981628|NCT01717456|Home health care|home health care
4981629|NCT01717456|Nurse|nurse
4981630|NCT01717456|Patient education|patient education
4981631|NCT01717443|Human Papillomavirus|human papillomavirus
4981632|NCT01717443|Renal transplantation|renal transplantation
4981633|NCT01717430|Injections, epidural|injections, epidural
4981634|NCT01717430|Injections, intra-articular|injections, intra-articular
4981635|NCT01717430|Chronic pain|chronic pain
4981636|NCT01717430|Neck pain|neck pain
4981637|NCT01717430|Back pain|back pain
4981638|NCT01717430|Low back pain|low back pain
4981639|NCT01717430|Sciatica|sciatica
4981640|NCT01717430|Sacroiliac joint|sacroiliac joint
4981641|NCT01717430|Corticosteroids|corticosteroids
4981642|NCT01717430|Dexamethasone|dexamethasone
4981643|NCT01717430|Adrenocorticotropic hormone|adrenocorticotropic hormone
4981644|NCT01717430|Adrenal insufficiency|adrenal insufficiency
4981645|NCT01717430|Hemoglobin A, glycosylated|hemoglobin a, glycosylated
4981646|NCT01717417|impacted canine|impacted canine
4981647|NCT01717417|miniscrew|miniscrew
4981648|NCT01717417|cone beam|cone beam
4981649|NCT01717404|IBS|ibs
4981650|NCT01717391|radiotherapy|radiotherapy
4981651|NCT01717391|Positron-Emission Tomography and Computed Tomography|positron-emission tomography and computed tomography
4981652|NCT01717391|chemotherapy|chemotherapy
4981653|NCT01717391|bone marrow|bone marrow
4981654|NCT01717378|Patient Recruitment|patient recruitment
4981655|NCT01717378|Research Subject Recruitment|research subject recruitment
4981656|NCT01717378|Research Subject Selection|research subject selection
4981657|NCT01717378|Selection of Subjects|selection of subjects
4981658|NCT01717378|Health Surveys|health surveys
4981659|NCT01717378|Health Questionnaires|health questionnaires
4981660|NCT01717378|Health Interviews|health interviews
4981661|NCT01717365|SCOPE|scope
4981662|NCT01717352|Weight loss|weight loss
4981663|NCT01717274|Functional Endoscopic Sinus Surgery|functional endoscopic sinus surgery
4981664|NCT01717274|Hot water irrigation|hot water irrigation
4981665|NCT01717261|breast cancer|breast cancer
4981666|NCT01717261|early breast cancer|early breast cancer
4981667|NCT01717261|partial breast irradiation|partial breast irradiation
4981668|NCT01717261|preoperative radiation|preoperative radiation
4981669|NCT01717222|Lignocaine|lignocaine
4981670|NCT01717222|Laparoscopic cholecystectomy|laparoscopic cholecystectomy
4981671|NCT01717222|Pain relief|pain relief
4981672|NCT01717209|heart failure|heart failure
4981673|NCT01717209|hypertension, pulmonary|hypertension, pulmonary
4981674|NCT01717209|heart failure, right-sided|heart failure, right-sided
4981675|NCT01717209|heart-assist devices|heart-assist devices
4981676|NCT01717209|Heart Transplantation|heart transplantation
4981677|NCT01717196|sample adequacy|sample adequacy
4981678|NCT01717196|diagnostic accuracy|diagnostic accuracy
4981679|NCT01717196|complications|complications
4981680|NCT01717183|Patient|patient
4981681|NCT01717170|Non-infectious Uveitis, Tocilizumab|non-infectious uveitis, tocilizumab
4981682|NCT01717157|Healthy|healthy
4981683|NCT01717157|Fentanyl|fentanyl
4981684|NCT01717157|Transdermal patch|transdermal patch
4981685|NCT01717157|DUROGESIC|durogesic
4981686|NCT01717144|therapeutic education|therapeutic education
4981687|NCT01717144|Parkinson's disease|parkinson's disease
4981688|NCT01717144|quality of life|quality of life
4981689|NCT01717131|Invasive breast cancer|invasive breast cancer
4981690|NCT01717118|Evaluation|evaluation
4981691|NCT01717118|Immunogenicity|immunogenicity
4981692|NCT01717118|Levels|levels
4981693|NCT01717118|Women|women
4981694|NCT01717118|HPV|hpv
4981695|NCT01717118|Vaccine|vaccine
4981696|NCT01717118|Mexico|mexico
4981697|NCT01717105|Non-small cell lung cancer (NSCLC)|non-small cell lung cancer (nsclc)
4981698|NCT01717105|Epidermal growth factor receptor (EGFR) positive mutation|epidermal growth factor receptor (egfr) positive mutation
4981699|NCT01717066|Hepatocellular Carcinoma|hepatocellular carcinoma
4981700|NCT01717066|ginsenoside Rg3|ginsenoside rg3
4981701|NCT01717040|Bipolar Disorder|bipolar disorder
4981702|NCT01717040|Insulin Resistance|insulin resistance
4981703|NCT01717027|pharmacokinetics|pharmacokinetics
4981704|NCT01717027|bioavailability|bioavailability
4981705|NCT01717027|oxycodone|oxycodone
4981706|NCT01717027|management of moderate to severe pain|management of moderate to severe pain
4981707|NCT01717014|rectal cancer|rectal cancer
4981708|NCT01717014|stapler|stapler
4981709|NCT01717001|kinematics|kinematics
4981710|NCT01717001|knee joint|knee joint
4981711|NCT01716988|Micafungin|micafungin
4981712|NCT01716988|pharmacokinetics|pharmacokinetics
4981713|NCT01716988|invasive candidiasis|invasive candidiasis
4981714|NCT01716988|intensive care|intensive care
4981715|NCT01716975|Schizophrenia|schizophrenia
4981716|NCT01716975|Cognition|cognition
4981717|NCT01716975|Cognition Impairment|cognition impairment
4981718|NCT01716975|Alpha-7 nAChR|alpha-7 nachr
4981719|NCT01716962|Acute respiratory distress syndrome, Fluid responsiveness, Pulse pressure variation|acute respiratory distress syndrome, fluid responsiveness, pulse pressure variation
4981720|NCT01716962|Pleth variability index, Passive leg raising test|pleth variability index, passive leg raising test
4981721|NCT01716949|rectal cancer|rectal cancer
4981722|NCT01716949|recurrent rectal cancer|recurrent rectal cancer
4981723|NCT01716949|hyperthermia|hyperthermia
4981724|NCT01716949|radiation|radiation
4981725|NCT01716949|chemoradiation|chemoradiation
4981726|NCT01716949|5-FU|5-fu
4981727|NCT01716949|capecitabine|capecitabine
4981728|NCT01716949|oxaliplatin|oxaliplatin
4981729|NCT01716936|Thoracic Insufficiency Syndrome|thoracic insufficiency syndrome
4981730|NCT01716936|Early Onset Spinal Deformity|early onset spinal deformity
4981731|NCT01716884|STEMI|stemi
4981732|NCT01716884|reperfution|reperfution
4981733|NCT01716884|primary PCI|primary pci
4981734|NCT01716858|Schizophrenia|schizophrenia
4981735|NCT01716858|Sulforaphane|sulforaphane
4981736|NCT01716858|Psychosis|psychosis
4981737|NCT01716858|Cognition|cognition
4981738|NCT01716858|Oxidative stress|oxidative stress
4981739|NCT01716858|Antioxidant|antioxidant
4981740|NCT01716858|Anti-inflammatory|anti-inflammatory
4981741|NCT01716845|autism|autism
4981742|NCT01716845|autism spectrum disorders|autism spectrum disorders
4981743|NCT01716845|RNA|rna
4981744|NCT01716845|gene expression|gene expression
4981745|NCT01716845|developmental delay|developmental delay
4981746|NCT01716819|Heart failure, abdominal obesity, RAAS|heart failure, abdominal obesity, raas
4981747|NCT01716806|Antibody-Drug Conjugate|antibody-drug conjugate
4981748|NCT01716806|Antibodies, Monoclonal|antibodies, monoclonal
4981749|NCT01716806|Hematologic Diseases|hematologic diseases
4981750|NCT01716806|Hodgkin Disease|hodgkin disease
4981751|NCT01716806|Antigens, CD30|antigens, cd30
4981752|NCT01716806|Lymphoma|lymphoma
4981753|NCT01716806|monomethylauristatin E|monomethylauristatin e
4981754|NCT01716806|Drug Therapy|drug therapy
4981755|NCT01716793|Primary AML|primary aml
4981756|NCT01716793|Risk-adapted treatment|risk-adapted treatment
4981757|NCT01716793|Hematopoietic transplantation|hematopoietic transplantation
4981758|NCT01716793|CD34+ cell selection|cd34+ cell selection
4981759|NCT01716767|Carpal tunnel syndrome|carpal tunnel syndrome
4981760|NCT01716767|hand pain|hand pain
4981761|NCT01716767|wrist pain|wrist pain
4981762|NCT01716767|arm pain|arm pain
4981763|NCT01716767|topical menthol|topical menthol
4981764|NCT01716754|asthma|asthma
4981765|NCT01716754|asthma control|asthma control
4981766|NCT01716754|allergy|allergy
4981767|NCT01716754|atopic|atopic
4981768|NCT01716754|IgE|ige
4981769|NCT01716754|double-blind|double-blind
4981770|NCT01716754|placebo|placebo
4981771|NCT01716754|omalizumab|omalizumab
4981772|NCT01716741|Gaucher disease|gaucher disease
4981773|NCT01716741|lysosomal storage disorder|lysosomal storage disorder
4981774|NCT01716741|metabolic disease|metabolic disease
4981775|NCT01716741|medical records review|medical records review
4981776|NCT01716728|Lysosomal Acid Lipase Deficiency|lysosomal acid lipase deficiency
4981777|NCT01716728|Cholesterol Ester Storage Disease|cholesterol ester storage disease
4981778|NCT01716728|Wolman Disease|wolman disease
4981779|NCT01716728|Lysosomal Storage Disorder|lysosomal storage disorder
4981780|NCT01716728|Metabolic Disease|metabolic disease
4981781|NCT01716728|Recessive Inheritance|recessive inheritance
4981782|NCT01716702|Prostate Cancer|prostate cancer
4981783|NCT01716702|Psychosocial Intervention|psychosocial intervention
4981784|NCT01716702|Sexual Rehabilitation|sexual rehabilitation
4981785|NCT01716702|Online Intervention|online intervention
4981786|NCT01716663|Symptomatic paroxysmal|symptomatic paroxysmal
4981787|NCT01716663|Atrial fibrillation|atrial fibrillation
4981788|NCT01716663|Observational|observational
4981789|NCT01716663|Acute procedural outcomes|acute procedural outcomes
4981790|NCT01716663|Ablation|ablation
4981791|NCT01716650|ankle|ankle
4981792|NCT01716650|saphenous nerve block|saphenous nerve block
4981793|NCT01716637|Alzheimer's Disease|alzheimer's disease
4981794|NCT01716637|Dementia|dementia
4981795|NCT01716637|Cognitive decline|cognitive decline
4981796|NCT01716637|Cognitive disorder|cognitive disorder
4981797|NCT01716637|Degenerative brain disease|degenerative brain disease
4981798|NCT01716637|Cognitive impairment|cognitive impairment
4981799|NCT01716637|Memory loss|memory loss
4981800|NCT01716637|TNF-alpha|tnf-alpha
4981801|NCT01716624|Pediatric|pediatric
4981802|NCT01716611|liver cirrhosis|liver cirrhosis
4981803|NCT01716611|hyponatemia|hyponatemia
4981804|NCT01716611|ascites|ascites
4981805|NCT01716611|vaptans|vaptans
4981806|NCT01716611|antidiuretic hormon|antidiuretic hormon
4981807|NCT01716611|arginine vasopressin|arginine vasopressin
4981808|NCT01716598|COPD|copd
4981809|NCT01716598|TLD Therapy|tld therapy
4981810|NCT01716598|Targeted Lung Denervation Therapy|targeted lung denervation therapy
4981811|NCT01716598|IPS|ips
4981812|NCT01716598|Innovative Pulmonary Solutions, Inc.|innovative pulmonary solutions, inc.
4981813|NCT01716598|Holaira, Inc.|holaira, inc.
4981814|NCT01716585|Hepatitis C Virus|hepatitis c virus
4981815|NCT01716585|Hepatitis C Genotype 1|hepatitis c genotype 1
4981816|NCT01716585|Hepatitis C|hepatitis c
4981817|NCT01716585|Treatment-Naïve|treatment-naïve
4981818|NCT01716585|Interferon-Free|interferon-free
4981819|NCT01716585|Chronic Hepatitis C|chronic hepatitis c
4981820|NCT01716585|Viekira Pak|viekira pak
4981821|NCT01716585|ombitasvir|ombitasvir
4981822|NCT01716585|paritaprevir|paritaprevir
4981823|NCT01716585|dasabuvir|dasabuvir
4981824|NCT01716572|Upper gastrointestinal bleeding|upper gastrointestinal bleeding
4981825|NCT01716572|Endoscopy|endoscopy
4981826|NCT01716572|Erythromycin|erythromycin
4981827|NCT01716572|Gastric lavage|gastric lavage
4981828|NCT01716546|Advanced cancer of the stomach|advanced cancer of the stomach
4981829|NCT01716546|Chemotherapy - naive patients|chemotherapy - naive patients
4981830|NCT01716546|DCF|dcf
4981831|NCT01716533|Serological|serological
4981832|NCT01716533|Adults|adults
4981833|NCT01716533|Clostridium difficile|clostridium difficile
4981834|NCT01716533|Adult CDI patients|adult cdi patients
4981835|NCT01716520|long-acting muscarinic antagonist|long-acting muscarinic antagonist
4981836|NCT01716520|long-acting beta-agonist|long-acting beta-agonist
4981837|NCT01716520|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
4981838|NCT01716520|vilanterol|vilanterol
4981839|NCT01716520|umeclidinium|umeclidinium
4981840|NCT01716507|RRD|rrd
4981841|NCT01716507|Rhegmatogenous|rhegmatogenous
4981842|NCT01716507|Retinal|retinal
4981843|NCT01716507|Detachment|detachment
4981844|NCT01716507|PPV|ppv
4981845|NCT01716507|Pars Plana Vitrectomy|pars plana vitrectomy
4981846|NCT01716507|Gauge|gauge
4981847|NCT01716494|asthma|asthma
4981848|NCT01716481|Stroke|stroke
4981849|NCT01716481|Mesenchymal stem cells|mesenchymal stem cells
4981850|NCT01716481|Stem cells|stem cells
4981851|NCT01716481|Neurogenesis|neurogenesis
4981852|NCT01716468|Ketogenic Diet, Advanced Cancer, Neoplasm|ketogenic diet, advanced cancer, neoplasm
4981853|NCT01716468|Low carbohydrate|low carbohydrate
4981854|NCT01716442|rituximab|rituximab
4981855|NCT01716442|nephrotic|nephrotic
4981856|NCT01716442|refractory|refractory
4981857|NCT01716429|vegetarian|vegetarian
4981858|NCT01716429|vegan|vegan
4981859|NCT01716429|low calorie|low calorie
4981860|NCT01716429|weight Loss|weight loss
4981861|NCT01716429|infertility|infertility
4981862|NCT01716429|PCOS|pcos
4981863|NCT01716403|C hepatitis, telaprevir concentration, ribavirin oncentration, anemia|c hepatitis, telaprevir concentration, ribavirin oncentration, anemia
4981864|NCT01716377|Neck Pain|neck pain
4981865|NCT01716377|Musculoskeletal pain|musculoskeletal pain
4981866|NCT01716377|Venlafaxine|venlafaxine
4981867|NCT01716351|Randomized Clinical Control Trial|randomized clinical control trial
4981868|NCT01716351|Complementary and Alternative Medicine|complementary and alternative medicine
4981869|NCT01716351|Yoga|yoga
4981870|NCT01716351|Electrophysiology|electrophysiology
4981871|NCT01716351|Implantable Cardioverter Defibrillator|implantable cardioverter defibrillator
4981872|NCT01716351|Psychosocial|psychosocial
4981873|NCT01716351|Anxiety|anxiety
4981874|NCT01716351|Self-Compassion|self-compassion
4981875|NCT01716351|Anti-Tachycardia Pacing Events|anti-tachycardia pacing events
4981876|NCT01716338|glyburide|glyburide
4981877|NCT01716338|glybenclamide|glybenclamide
4981878|NCT01716338|hypoglycemia|hypoglycemia
4981879|NCT01716312|Safety Of Omalizumab In Patients With SLE|safety of omalizumab in patients with sle
4981880|NCT01716312|Systemic Lupus Erythematosus|systemic lupus erythematosus
4981881|NCT01716299|HIV|hiv
4981882|NCT01716299|Diagnostics|diagnostics
4981883|NCT01716247|Mammography (CESM)|mammography (cesm)
4981884|NCT01716247|MRI|mri
4981885|NCT01716247|Breast screening|breast screening
4981886|NCT01716247|12-214|12-214
4981887|NCT01716208|Fresh Frozen Plasma|fresh frozen plasma
4981888|NCT01716208|Complement|complement
4981889|NCT01716208|Monoclonal Antibody|monoclonal antibody
4981890|NCT01716195|Human Papillomavirus|human papillomavirus
4981891|NCT01716195|HPV|hpv
4981892|NCT01716143|atrial fibrillation|atrial fibrillation
4981893|NCT01716143|catheter ablation|catheter ablation
4981894|NCT01716143|Mapping|mapping
4981895|NCT01716130|Fluzone Intradermal vaccine|fluzone intradermal vaccine
4981896|NCT01716117|Large aneurysm|large aneurysm
4981897|NCT01716117|Giant aneurysm|giant aneurysm
4981898|NCT01716117|Wide neck aneurysm|wide neck aneurysm
4981899|NCT01716091|focus of study is postoperative enfectious morbidity and postoperative GİS functionally recovery|focus of study is postoperative enfectious morbidity and postoperative gis functionally recovery
4981900|NCT01716078|Brachial Plexus|brachial plexus
4981901|NCT01716078|Nerve Block|nerve block
4981902|NCT01716078|Nerve Conduction|nerve conduction
4981903|NCT01716065|Anesthesia, Circulating tumor cells|anesthesia, circulating tumor cells
4981904|NCT01716052|Mammogram|mammogram
4981905|NCT01716052|Ibuprofen|ibuprofen
4981906|NCT01716052|Pain management|pain management
4981907|NCT01716039|Moderately to severely active Ulcerative Colitis|moderately to severely active ulcerative colitis
4981908|NCT01716026|high myopia|high myopia
4981909|NCT01716026|choroidal neovascularization|choroidal neovascularization
4981910|NCT01716000|vaginal gel|vaginal gel
4981911|NCT01716000|vaginal coating|vaginal coating
4981912|NCT01716000|sensory perceptions|sensory perceptions
4981913|NCT01715987|Hepatitis B|hepatitis b
4981914|NCT01715987|Antiviral|antiviral
4981915|NCT01715987|Tubular dysfunction|tubular dysfunction
4981916|NCT01715987|Entecavir|entecavir
4981917|NCT01715987|Tenofovir|tenofovir
4981918|NCT01715974|G-CSF, IVF failure,pregnancy|g-csf, ivf failure,pregnancy
4981919|NCT01715961|70 years old|70 years old
4981920|NCT01715961|DLBCL|dlbcl
4981921|NCT01715961|Rituximab-CHOP|rituximab-chop
4981922|NCT01715961|Sarcopenia|sarcopenia
4981923|NCT01715948|CROS hearing aid|cros hearing aid
4981924|NCT01715948|Bone-anchored hearing device|bone-anchored hearing device
4981925|NCT01715935|Clear cells renal carcinoma|clear cells renal carcinoma
4981926|NCT01715935|everolimus|everolimus
4981927|NCT01715935|neo-adjuvant treatment|neo-adjuvant treatment
4981928|NCT01715922|Cryptococcal meningitis|cryptococcal meningitis
4981929|NCT01715922|HIV Infections|hiv infections
4981930|NCT01715922|Oral treatment|oral treatment
4981931|NCT01715922|High dose of fluconazole|high dose of fluconazole
4981932|NCT01715922|Flucytosine|flucytosine
4981933|NCT01715922|Burundi|burundi
4981934|NCT01715922|Ivory Coast|ivory coast
4981935|NCT01715896|Rheumatoid Arthritis|rheumatoid arthritis
4981936|NCT01715896|Golimumab|golimumab
4981937|NCT01715896|Mavrilimumab|mavrilimumab
4981938|NCT01715883|Lung transplant|lung transplant
4981939|NCT01715883|Pulmonary Graft Dysfunction|pulmonary graft dysfunction
4981940|NCT01715883|Sodium Nitrite|sodium nitrite
4981941|NCT01715870|Age related macular degeneration|age related macular degeneration
4981942|NCT01715870|Food habits|food habits
4981943|NCT01715870|Life style|life style
4981944|NCT01715870|Risk factors|risk factors
4981945|NCT01715870|questionnaire|questionnaire
4981946|NCT01715857|Economics, Pharmaceutical|economics, pharmaceutical
4981947|NCT01715857|Physician's Practice Patterns|physician's practice patterns
4981948|NCT01715857|Chinese|chinese
4981949|NCT01715857|Sevoflurane|sevoflurane
4981950|NCT01715844|L-citrulline|l-citrulline
4981951|NCT01715844|ADMA|adma
4981952|NCT01715844|Asthma|asthma
4981953|NCT01715844|Obesity|obesity
4981954|NCT01715805|MDD|mdd
4981955|NCT01715805|Major Depressive Disorder|major depressive disorder
4981956|NCT01715792|Solid organ transplant rejection|solid organ transplant rejection
4981957|NCT01715792|United Kingdom|united kingdom
4981958|NCT01715792|Influenza|influenza
4981959|NCT01715792|H1N1|h1n1
4981960|NCT01715792|Pandemrix™|pandemrix™
4981961|NCT01715779|Liver transplantation|liver transplantation
4981962|NCT01715779|ENABLE|enable
4981963|NCT01715779|observational|observational
4981964|NCT01715779|mortality|mortality
4981965|NCT01715779|Thromboembolic Events|thromboembolic events
4981966|NCT01715779|Hepatic decompensation|hepatic decompensation
4981967|NCT01715779|Long-Term follow-up|long-term follow-up
4981968|NCT01715779|TEE|tee
4981969|NCT01715766|Proteomics study|proteomics study
4981970|NCT01715766|biomarker study of pain|biomarker study of pain
4981971|NCT01715753|Function|function
4981972|NCT01715753|Muscle mass|muscle mass
4981973|NCT01715740|Chinese herbal medicine|chinese herbal medicine
4981974|NCT01715740|Urticaria|urticaria
4981975|NCT01715740|Antipruritics|antipruritics
4981976|NCT01715740|Phase III clinical trial|phase iii clinical trial
4981977|NCT01715727|diffusion kurtosis imaging|diffusion kurtosis imaging
4981978|NCT01715727|parkinson disease|parkinson disease
4981979|NCT01715727|parkinsonism|parkinsonism
4981980|NCT01715727|diagnosis|diagnosis
4981981|NCT01715727|differential diagnosis|differential diagnosis
4981982|NCT01715714|Coronary Artery Disease|coronary artery disease
4981983|NCT01715714|Statins|statins
4981984|NCT01715714|Coronary Artery Bypass Grafting|coronary artery bypass grafting
4981985|NCT01715714|Cardiac Surgery|cardiac surgery
4981986|NCT01715675|asthma|asthma
4981987|NCT01715675|allergy|allergy
4981988|NCT01715675|sitostanol|sitostanol
4981989|NCT01715675|cytokines|cytokines
4981990|NCT01715675|Th1|th1
4981991|NCT01715675|Treg|treg
4981992|NCT01715675|antibodies|antibodies
4981993|NCT01715675|IgE|ige
4981994|NCT01715675|vaccination|vaccination
4981995|NCT01715662|rehabilitation|rehabilitation
4981996|NCT01715662|lower limb amputation|lower limb amputation
4981997|NCT01715662|unilateral transtibial amputation|unilateral transtibial amputation
4981998|NCT01715662|unilateral transfemoral amputation|unilateral transfemoral amputation
4981999|NCT01715662|older adults|older adults
4982000|NCT01715662|cognitive computer games|cognitive computer games
4982001|NCT01715662|home-based training|home-based training
4982002|NCT01715662|Nintendo Wii|nintendo wii
4982003|NCT01715662|virtual reality|virtual reality
4982004|NCT01715649|Type 2 diabetes|type 2 diabetes
4982005|NCT01715649|self-management|self-management
4982006|NCT01715649|remote patient monitoring|remote patient monitoring
4982007|NCT01715623|polymorphism|polymorphism
4982008|NCT01715623|serum Ig|serum ig
4982009|NCT01715597|uterine leiomyoma|uterine leiomyoma
4982010|NCT01715597|laparoscopic myomectomy|laparoscopic myomectomy
4982011|NCT01715597|intraoperative blood loss|intraoperative blood loss
4982012|NCT01715597|ascorbic acid|ascorbic acid
4982013|NCT01715584|Hypertension|hypertension
4982014|NCT01715584|Sevoflurane|sevoflurane
4982015|NCT01715584|Inhaled Anesthetic|inhaled anesthetic
4982016|NCT01715584|Angiotensin Converting Enzyme Inhibitor|angiotensin converting enzyme inhibitor
4982017|NCT01715584|Angiotensin II Receptor Blocking Agent|angiotensin ii receptor blocking agent
4982018|NCT01715571|erectile dysfunction|erectile dysfunction
4982019|NCT01715571|vibratory stimulation|vibratory stimulation
4982020|NCT01715571|viberect|viberect
4982021|NCT01715545|day-3 poor quality embryo|day-3 poor quality embryo
4982022|NCT01715545|vitrification|vitrification
4982023|NCT01715545|clinical outcome|clinical outcome
4982024|NCT01715532|Huachansu|huachansu
4982025|NCT01715532|Na+/K+-ATPase α3|na+/k+-atpase α3
4982026|NCT01715532|transcatheter arterial chemoembolization|transcatheter arterial chemoembolization
4982027|NCT01715532|randomized controlled trial|randomized controlled trial
4982028|NCT01715519|Vilazodone|vilazodone
4982029|NCT01715519|PTSD|ptsd
4982030|NCT01715519|Depression|depression
4982031|NCT01715506|Dementia|dementia
4982032|NCT01715506|Resident|resident
4982033|NCT01715506|Nursinghome|nursinghome
4982034|NCT01715506|Use of restraint|use of restraint
4982035|NCT01715506|Agitation|agitation
4982036|NCT01715493|COPD|copd
4982037|NCT01715493|Asthma|asthma
4982038|NCT01715493|Lysozyme Hydrochloride|lysozyme hydrochloride
4982039|NCT01715480|broccoli sprout|broccoli sprout
4982040|NCT01715480|sickle cell|sickle cell
4982041|NCT01715480|NRF2|nrf2
4982042|NCT01715467|Dupuytren|dupuytren
4982043|NCT01715467|Contracture|contracture
4982044|NCT01715467|Auxilium|auxilium
4982045|NCT01715467|XIAFLEX|xiaflex
4982046|NCT01715441|Metastatic colorectal cancer patients|metastatic colorectal cancer patients
4982047|NCT01715441|KRAS mutation|kras mutation
4982048|NCT01715441|Sorafenib|sorafenib
4982049|NCT01715428|diabetes, cardiovascular risk|diabetes, cardiovascular risk
4982050|NCT01715415|Hepatitis C|hepatitis c
4982051|NCT01715415|Treatment-Experienced|treatment-experienced
4982052|NCT01715415|Null responder|null responder
4982053|NCT01715415|Partial Responder|partial responder
4982054|NCT01715415|Chronic Hepatitis|chronic hepatitis
4982055|NCT01715415|Hepatitis C Genotype 1|hepatitis c genotype 1
4982056|NCT01715415|Interferon-Free|interferon-free
4982057|NCT01715415|Hepatitis C Virus|hepatitis c virus
4982058|NCT01715415|Relapser|relapser
4982059|NCT01715415|Non responder|non responder
4982060|NCT01715415|Viekira Pak|viekira pak
4982061|NCT01715415|ombitasvir|ombitasvir
4982062|NCT01715415|ribavirin|ribavirin
4982063|NCT01715415|ritonavir|ritonavir
4982064|NCT01715415|paritaprevir|paritaprevir
4982065|NCT01715415|dasabuvir|dasabuvir
4982066|NCT01715402|liver tumor|liver tumor
4982067|NCT01715402|carcinoma|carcinoma
4982068|NCT01715402|cholangiocarcinoma|cholangiocarcinoma
4982069|NCT01715402|metastasis|metastasis
4982071|NCT01715389|Goals|goals
4982072|NCT01715389|Shared Decision Making|shared decision making
4982073|NCT01715389|Patient Portal|patient portal
4982074|NCT01715389|Electronic Medical Record|electronic medical record
4982075|NCT01715376|traditional chinese medicine|traditional chinese medicine
4982076|NCT01715376|complementary therapies|complementary therapies
4982077|NCT01715376|traditional chinese medicine syndrome scale|traditional chinese medicine syndrome scale
4982078|NCT01715350|Alzheimer's Disease|alzheimer's disease
4982079|NCT01715337|muscle fibre|muscle fibre
4982080|NCT01715337|capillary|capillary
4982081|NCT01715337|rehabilitation|rehabilitation
4982082|NCT01715337|exercise training|exercise training
4982083|NCT01715324|In vitro fertilization|in vitro fertilization
4982084|NCT01715324|Antagonist protocol|antagonist protocol
4982085|NCT01715324|Growth Hormone|growth hormone
4982086|NCT01715311|COPD|copd
4982087|NCT01715311|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
4982088|NCT01715311|indacaterol|indacaterol
4982089|NCT01715311|tiotropium|tiotropium
4982090|NCT01715298|Anticholinergic|anticholinergic
4982091|NCT01715298|Antimuscarinic|antimuscarinic
4982092|NCT01715298|Chronic Obstructive Airway Disease|chronic obstructive airway disease
4982093|NCT01715298|Chronic Obstructive Lung Disease|chronic obstructive lung disease
4982094|NCT01715298|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
4982095|NCT01715298|COPD|copd
4982096|NCT01715298|LAMA|lama
4982097|NCT01715298|Lung Disease|lung disease
4982098|NCT01715298|Lung Diseases, Obstructive|lung diseases, obstructive
4982099|NCT01715298|Lung Function|lung function
4982100|NCT01715298|Muscarinic receptor antagonist|muscarinic receptor antagonist
4982101|NCT01715298|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
4982102|NCT01715298|Respiratory Tract Diseases|respiratory tract diseases
4982103|NCT01715285|Prostate neoplasms|prostate neoplasms
4982104|NCT01715285|Prostate cancer|prostate cancer
4982105|NCT01715285|Metastatic prostate cancer|metastatic prostate cancer
4982106|NCT01715285|Abiraterone acetate|abiraterone acetate
4982107|NCT01715285|ZYTIGA|zytiga
4982108|NCT01715285|Prednisone|prednisone
4982109|NCT01715285|Androgen deprivation therapy|androgen deprivation therapy
4982110|NCT01715259|Renal insufficiency|renal insufficiency
4982111|NCT01715259|Renal impairment|renal impairment
4982112|NCT01715259|End-stage renal disease|end-stage renal disease
4982113|NCT01715259|Abiraterone acetate|abiraterone acetate
4982114|NCT01715259|Pharmacokinetics|pharmacokinetics
4982115|NCT01715246|healthy babbies|healthy babbies
4982116|NCT01715246|infant formula|infant formula
4982117|NCT01715246|growth|growth
4982118|NCT01715246|HMO|hmo
4982119|NCT01715220|Nitroglycerin|nitroglycerin
4982120|NCT01715220|Biliary Colic|biliary colic
4982121|NCT01715220|Cholelithiasis|cholelithiasis
4982122|NCT01715220|Abdominal Pain.|abdominal pain.
4982123|NCT01715194|OSAS|osas
4982124|NCT01715194|CPAP|cpap
4982125|NCT01715194|Adherence|adherence
4982126|NCT01715194|Telemedicine|telemedicine
4982127|NCT01715168|Doxil generic|doxil generic
4982128|NCT01715168|Caelyx generic|caelyx generic
4982129|NCT01715168|generic treatment|generic treatment
4982130|NCT01715168|ovarian cancer|ovarian cancer
4982131|NCT01715168|ovary|ovary
4982132|NCT01715168|progressed|progressed
4982133|NCT01715168|recurred cancer|recurred cancer
4982134|NCT01715168|platinum based therapy|platinum based therapy
4982135|NCT01715155|Metastatic Breast Cancer,|metastatic breast cancer,
4982136|NCT01715155|retrospective study,|retrospective study,
4982137|NCT01715155|disease progression,|disease progression,
4982138|NCT01715155|clinical management|clinical management
4982139|NCT01715142|Pancreatic cancer|pancreatic cancer
4982140|NCT01715142|Nab-paclitaxel|nab-paclitaxel
4982141|NCT01715142|Gemcitabine|gemcitabine
4982238|NCT01714700|protein|protein
4982142|NCT01715142|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
4982143|NCT01715116|Cardiac arrhythmias|cardiac arrhythmias
4982144|NCT01715116|Implantable Cardioverter-Defibrillator|implantable cardioverter-defibrillator
4982145|NCT01715116|Patient Safety|patient safety
4982146|NCT01715116|Quality of life|quality of life
4982147|NCT01715103|HIV infection|hiv infection
4982148|NCT01715103|mucosa|mucosa
4982149|NCT01715103|immunological parameters|immunological parameters
4982150|NCT01715103|genital sampling|genital sampling
4982151|NCT01715103|healthy women volunteers|healthy women volunteers
4982152|NCT01715077|melanoma|melanoma
4982153|NCT01715077|stage IV|stage iv
4982154|NCT01715077|stage III|stage iii
4982155|NCT01715077|unresectable|unresectable
4982156|NCT01715064|Prostate Cancer|prostate cancer
4982157|NCT01715064|Exercise|exercise
4982158|NCT01715064|Cortical Inhibition|cortical inhibition
4982159|NCT01715064|Cortical Silent Period|cortical silent period
4982160|NCT01715064|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
4982161|NCT01715051|cocaine|cocaine
4982162|NCT01715051|D-serine|d-serine
4982163|NCT01715051|Drug dependence|drug dependence
4982164|NCT01715038|malnutrition|malnutrition
4982165|NCT01715038|stunting|stunting
4982166|NCT01715038|LNS|lns
4982167|NCT01715038|micronutrient powder|micronutrient powder
4982168|NCT01715038|hemoglobin|hemoglobin
4982169|NCT01715025|measured|measured
4982170|NCT01715025|heavy menstrual bleeding|heavy menstrual bleeding
4982171|NCT01715025|combined oral contraceptive|combined oral contraceptive
4982172|NCT01715025|alkaline haematin method|alkaline haematin method
4982173|NCT01715012|Burn|burn
4982174|NCT01715012|Diabetes|diabetes
4982175|NCT01715012|Skin graft|skin graft
4982176|NCT01715012|Donor site|donor site
4982177|NCT01714999|olecranon|olecranon
4982178|NCT01714999|prepatellar|prepatellar
4982179|NCT01714999|bursa|bursa
4982180|NCT01714999|trauma|trauma
4982181|NCT01714999|laceration|laceration
4982182|NCT01714999|bursectomy|bursectomy
4982183|NCT01714999|bursa reconstruction|bursa reconstruction
4982184|NCT01714986|Diabetes mellitus|diabetes mellitus
4982185|NCT01714986|Depression|depression
4982186|NCT01714986|Anxiety|anxiety
4982187|NCT01714986|Alexithymia|alexithymia
4982188|NCT01714986|Self Image|self image
4982189|NCT01714986|HbA1c|hba1c
4982190|NCT01714986|Psychoeducation|psychoeducation
4982191|NCT01714934|IDIOPATHIC PULMONARY FIBROSIS|idiopathic pulmonary fibrosis
4982192|NCT01714934|MICROASPIRATION|microaspiration
4982193|NCT01714908|NSCLC|nsclc
4982194|NCT01714908|EGFR mutation|egfr mutation
4982195|NCT01714908|unresectable|unresectable
4982196|NCT01714908|erlotinib|erlotinib
4982197|NCT01714908|concurrent radiotherapy|concurrent radiotherapy
4982198|NCT01714895|Interstitial glucose dynamics|interstitial glucose dynamics
4982199|NCT01714895|Accuracy of continuous glucose monitoring under hypoglycemia|accuracy of continuous glucose monitoring under hypoglycemia
4982200|NCT01714895|Glucose clamp|glucose clamp
4982201|NCT01714882|Infertility|infertility
4982202|NCT01714882|In Vitro Fertilization (IVF)|in vitro fertilization (ivf)
4982203|NCT01714882|Stress Management|stress management
4982204|NCT01714882|Stress Reduction|stress reduction
4982205|NCT01714869|Swedish massage|swedish massage
4982206|NCT01714869|massage|massage
4982207|NCT01714869|osteoarthritis|osteoarthritis
4982208|NCT01714869|knee|knee
4982209|NCT01714843|ASP0456|asp0456
4982210|NCT01714843|constipation|constipation
4982211|NCT01714843|irritable bowel syndrome (IBS)|irritable bowel syndrome (ibs)
4982212|NCT01714843|linaclotide|linaclotide
4982213|NCT01714804|Bone Morphogenetic Protein (BMP)|bone morphogenetic protein (bmp)
4982214|NCT01714804|Demineralized bone matrix (DBM)|demineralized bone matrix (dbm)
4982215|NCT01714804|Fusion rates|fusion rates
4982216|NCT01714804|Interbody fusion|interbody fusion
4982217|NCT01714804|Lumbar spine|lumbar spine
4982218|NCT01714804|Transverse lumbar interbody fusion (TLIF)|transverse lumbar interbody fusion (tlif)
4982219|NCT01714804|Patient reported outcomes|patient reported outcomes
4982220|NCT01714804|Posterolateral lumbar fusion (PLF)|posterolateral lumbar fusion (plf)
4982221|NCT01714791|Coronary Artery Bypass Graft|coronary artery bypass graft
4982222|NCT01714791|Osteopathic Medicine|osteopathic medicine
4982223|NCT01714791|Vital Capacity|vital capacity
4982224|NCT01714791|Quality of Life|quality of life
4982225|NCT01714791|Cardiac rehabilitation|cardiac rehabilitation
4982226|NCT01714765|Metastatic Clear Cell Renal Cancer Dovitinib Everolimus Cohort Maximum administered dose maximum tolerated dose|metastatic clear cell renal cancer dovitinib everolimus cohort maximum administered dose maximum tolerated dose
4982227|NCT01714752|Diagnosis|diagnosis
4982228|NCT01714752|Left ventricular end diastolic pressure (LVEDP)|left ventricular end diastolic pressure (lvedp)
4982229|NCT01714752|Exercise echocardiography|exercise echocardiography
4982230|NCT01714752|Left atrial remodeling|left atrial remodeling
4982231|NCT01714726|MEDI2070|medi2070
4982232|NCT01714726|inflammatory bowel disease|inflammatory bowel disease
4982233|NCT01714726|moderate to severe Crohn's disease|moderate to severe crohn's disease
4982234|NCT01714713|Schizophrenia|schizophrenia
4982235|NCT01714713|Cognition|cognition
4982236|NCT01714713|Cognition Impairment|cognition impairment
4982237|NCT01714713|Alpha-7 nAChR|alpha-7 nachr
4982239|NCT01714700|resistance exercise ghrelin|resistance exercise ghrelin
4982240|NCT01714700|overweight|overweight
4982241|NCT01714674|cardiac troponin T|cardiac troponin t
4982242|NCT01714674|cTnT|ctnt
4982243|NCT01714674|exercise|exercise
4982244|NCT01714674|dietary nitrate|dietary nitrate
4982245|NCT01714661|Schizophrenia|schizophrenia
4982246|NCT01714661|Cognition|cognition
4982247|NCT01714661|Cognition Impairment|cognition impairment
4982248|NCT01714661|Alpha-7 nAChR|alpha-7 nachr
4982249|NCT01714648|OVULATION INDUCTION|ovulation induction
4982250|NCT01714635|cataract|cataract
4982252|NCT01714635|intraocular lens|intraocular lens
4982253|NCT01714622|metabolic syndrome|metabolic syndrome
4982254|NCT01714622|insulin resistance|insulin resistance
4982255|NCT01714622|gastric cancer|gastric cancer
4982256|NCT01714609|portal hypertension|portal hypertension
4982257|NCT01714609|sorafenib|sorafenib
4982258|NCT01714596|Oral Antibiotic|oral antibiotic
4982259|NCT01714596|Intravenous Antibiotic|intravenous antibiotic
4982260|NCT01714596|Wound infection|wound infection
4982261|NCT01714596|Randomized Controlled Trial|randomized controlled trial
4982262|NCT01714583|Mechanical ventilation|mechanical ventilation
4982263|NCT01714583|ARDS|ards
4982264|NCT01714583|acute lung injury|acute lung injury
4982265|NCT01714583|cardiac function|cardiac function
4982266|NCT01714583|cardiac index|cardiac index
4982267|NCT01714583|heart-lung interaction|heart-lung interaction
4982268|NCT01714531|Mild TBI|mild tbi
4982269|NCT01714518|Interstitial Lung Disease|interstitial lung disease
4982270|NCT01714518|Diagnosis|diagnosis
4982271|NCT01714518|Cryobiopsy|cryobiopsy
4982272|NCT01714518|Video-assisted thoracic surgery|video-assisted thoracic surgery
4982273|NCT01714518|Lung biopsy|lung biopsy
4982274|NCT01714505|Diabetes Mellitus, Type 1|diabetes mellitus, type 1
4982275|NCT01714505|Continuous Glucose Monitor|continuous glucose monitor
4982276|NCT01714505|Artificial Pancreas|artificial pancreas
4982277|NCT01714505|Insulin Pump|insulin pump
4982278|NCT01714505|Closed Loop control|closed loop control
4982279|NCT01714505|Open Loop treatment|open loop treatment
4982280|NCT01714492|Total Knee Arthroplasty (TKA)|total knee arthroplasty (tka)
4982281|NCT01714492|in vivo mechanics|in vivo mechanics
4982282|NCT01714492|kinematics|kinematics
4982283|NCT01714492|fluoroscopy|fluoroscopy
4982284|NCT01714440|genomics of kidney transplantation|genomics of kidney transplantation
4982285|NCT01714440|genetic variation|genetic variation
4982286|NCT01714440|recipient genotypes|recipient genotypes
4982287|NCT01714440|donor genotypes|donor genotypes
4982288|NCT01714414|HIV|hiv
4982289|NCT01714414|Fozivudine|fozivudine
4982290|NCT01714414|Zidovudine|zidovudine
4982291|NCT01714414|FATI|fati
4982292|NCT01714388|remifentanil|remifentanil
4982293|NCT01714388|heart rate|heart rate
4982294|NCT01714388|autonomic nervous system|autonomic nervous system
4982295|NCT01714388|heart rate variability|heart rate variability
4982296|NCT01714388|autonomic nervous activity|autonomic nervous activity
4982297|NCT01714388|vagotonic effect|vagotonic effect
4982298|NCT01714388|single dose|single dose
4982299|NCT01714362|oculocardiac effect|oculocardiac effect
4982300|NCT01714362|bradycardia|bradycardia
4982301|NCT01714362|HRV|hrv
4982302|NCT01714349|Spinal cord injury|spinal cord injury
4982303|NCT01714349|nerve transfer|nerve transfer
4982304|NCT01714349|tetraplegia|tetraplegia
4982305|NCT01714349|quadriplegia|quadriplegia
4982306|NCT01714336|Arbeitsgemeinschaft für Osteosynthesefragen (AO) fracture|arbeitsgemeinschaft für osteosynthesefragen (ao) fracture
4982307|NCT01714336|Orthopaedic Trauma Association (OTA) fracture|orthopaedic trauma association (ota) fracture
4982308|NCT01714323|Cigarette smoking|cigarette smoking
4982309|NCT01714323|Tobacco smoking|tobacco smoking
4982310|NCT01714323|Tobacco use disorder|tobacco use disorder
4982311|NCT01714310|severe mood dysregulation|severe mood dysregulation
4982312|NCT01714310|irritability|irritability
4982313|NCT01714310|lisdexamfetamine|lisdexamfetamine
4982314|NCT01714310|fluoxetine|fluoxetine
4982315|NCT01714310|newly recognized syndrome|newly recognized syndrome
4982316|NCT01714297|cemented total hip arthroplasty|cemented total hip arthroplasty
4982317|NCT01714297|blood loss|blood loss
4982318|NCT01714297|wound discharge|wound discharge
4982319|NCT01714297|thromboprophylaxis|thromboprophylaxis
4982320|NCT01714297|biomarkers|biomarkers
4982321|NCT01714284|psoriasis|psoriasis
4982322|NCT01714258|cardiac output|cardiac output
4982323|NCT01714258|fick method|fick method
4982324|NCT01714258|thermodilution|thermodilution
4982325|NCT01714245|Eczema|eczema
4982326|NCT01714245|Atopic Dermatitis|atopic dermatitis
4982327|NCT01714245|Compromised Skin|compromised skin
4982328|NCT01714245|Inflamed Skin|inflamed skin
4982329|NCT01714219|prostatic neoplasms|prostatic neoplasms
4982330|NCT01714219|prostatectomy|prostatectomy
4982331|NCT01714219|robotics|robotics
4982332|NCT01714219|urinary incontinence|urinary incontinence
4982333|NCT01714206|Healthy|healthy
4982334|NCT01714206|Canagliflozin (JNJ-28431754)|canagliflozin (jnj-28431754)
4982335|NCT01714206|Pharmacokinetics|pharmacokinetics
4982336|NCT01714206|Digoxin (LANOXIN)|digoxin (lanoxin)
4982337|NCT01714193|Healthy|healthy
4982338|NCT01714193|Canagliflozin (JNJ-28431754)|canagliflozin (jnj-28431754)
4982339|NCT01714193|Pharmacokinetics|pharmacokinetics
4982340|NCT01714193|Contraceptives, Oral|contraceptives, oral
4982341|NCT01714193|Ethinyl Estradiol|ethinyl estradiol
4982342|NCT01714193|Levonorgestrel|levonorgestrel
4982343|NCT01714193|LEVORA|levora
4982344|NCT01714180|Acyclovir|acyclovir
4982345|NCT01714180|Pharmacokinetics|pharmacokinetics
4982346|NCT01714180|Obese|obese
4982347|NCT01714180|Non-obese|non-obese
4982348|NCT01714180|Weight|weight
4982349|NCT01714180|Distribution|distribution
4982350|NCT01714180|Clearance|clearance
4982351|NCT01714167|Chronic|chronic
4982352|NCT01714167|Ischemic Stroke|ischemic stroke
4982353|NCT01714167|Intracerebral Hemorrhage|intracerebral hemorrhage
4982354|NCT01714167|Bone Marrow Mesenchymal Stem Cell|bone marrow mesenchymal stem cell
4982355|NCT01714141|Technology based intervention|technology based intervention
4982356|NCT01714141|Emerging adults|emerging adults
4982357|NCT01714141|African Americans|african americans
4982358|NCT01714141|Asthma|asthma
4982359|NCT01714141|Controller medications|controller medications
4982360|NCT01714141|Motivational intervention|motivational intervention
4982361|NCT01714128|NCI protocol #8762|nci protocol #8762
4982362|NCT01714128|Estrogen receptor positive breast cancer|estrogen receptor positive breast cancer
4982363|NCT01714128|recurrent breast cancer|recurrent breast cancer
4982364|NCT01714128|stage IV breast cancer|stage iv breast cancer
4982365|NCT01714102|Obesity|obesity
4982366|NCT01714102|Insulin resistance|insulin resistance
4982367|NCT01714102|Metabolic syndrome|metabolic syndrome
4982368|NCT01714102|Pre-diabetes|pre-diabetes
4982369|NCT01714089|Relapsing remitting multiple sclerosis|relapsing remitting multiple sclerosis
4982370|NCT01714089|RR-MS|rr-ms
4982371|NCT01714063|pediatric|pediatric
4982372|NCT01714063|asthma|asthma
4982373|NCT01714063|metered dose inhaler|metered dose inhaler
4982374|NCT01714063|valved holding chamber|valved holding chamber
4982375|NCT01714063|pMDI|pmdi
4982376|NCT01714063|VHC|vhc
4982377|NCT01714050|seasonal affective disorder|seasonal affective disorder
4982378|NCT01714050|winter depression|winter depression
4982379|NCT01714050|cognitive-behavioral therapy|cognitive-behavioral therapy
4982380|NCT01714050|light therapy|light therapy
4982381|NCT01714037|Safety|safety
4982382|NCT01714037|Efficacy|efficacy
4982383|NCT01714037|HSP90|hsp90
4982384|NCT01714037|Debio 0932|debio 0932
4982385|NCT01714037|Standard of care treatment, NSCLC|standard of care treatment, nsclc
4982386|NCT01714024|Dental|dental
4982387|NCT01714024|Implant|implant
4982388|NCT01714024|UNC Dental School|unc dental school
4982389|NCT01714024|Trabecular Metal|trabecular metal
4982390|NCT01714024|Titanium|titanium
4982391|NCT01714024|Healthy Volunteers|healthy volunteers
4982392|NCT01714024|Diabetic|diabetic
4982393|NCT01714024|Osteopenic|osteopenic
4982394|NCT01714024|Bone Inductive Properties|bone inductive properties
4982395|NCT01714024|Osseous Healing|osseous healing
4982396|NCT01714024|GO Health|go health
4982397|NCT01714024|Offenbacher|offenbacher
4982398|NCT01714024|Zimmer Dental, Inc.|zimmer dental, inc.
4982399|NCT01714011|Randomized|randomized
4982400|NCT01714011|Controlled|controlled
4982401|NCT01714011|Trial|trial
4982402|NCT01714011|Safety|safety
4982403|NCT01714011|Efficacy|efficacy
4982404|NCT01714011|Aripiprazole|aripiprazole
4982405|NCT01714011|Ziprasidone|ziprasidone
4982406|NCT01714011|Metabolic Syndrome|metabolic syndrome
4982407|NCT01713998|Ulthera® System|ulthera® system
4982408|NCT01713998|Ultherapy™ Treatment|ultherapy™ treatment
4982409|NCT01713998|Ulthera, Inc.|ulthera, inc.
4982410|NCT01713998|Ultrasound treatment for skin tightening|ultrasound treatment for skin tightening
4982411|NCT01713985|Ulthera® System|ulthera® system
4982412|NCT01713985|Ultherapy™ Treatment|ultherapy™ treatment
4982413|NCT01713985|Ulthera, Inc.|ulthera, inc.
4982414|NCT01713985|Ultrasound treatment for skin tightening|ultrasound treatment for skin tightening
4982415|NCT01713972|BRAFi|brafi
4982416|NCT01713972|BRAF-mutated|braf-mutated
4982417|NCT01713959|Underarm sweating|underarm sweating
4982418|NCT01713946|TSC seizures,|tsc seizures,
4982419|NCT01713946|TSC epilepsy,|tsc epilepsy,
4982420|NCT01713946|mTOR inhibitor,|mtor inhibitor,
4982421|NCT01713946|RAD001,|rad001,
4982422|NCT01713946|Everolimus|everolimus
4982423|NCT01713933|Ulthera® System|ulthera® system
4982424|NCT01713933|Ultherapy™ treatment|ultherapy™ treatment
4982425|NCT01713933|Ulthera, Inc.|ulthera, inc.
4982426|NCT01713907|Ultherapy™ treatment|ultherapy™ treatment
4982427|NCT01713907|Ulthera® System|ulthera® system
4982428|NCT01713907|Ulthera, Inc.|ulthera, inc.
4982429|NCT01713907|Ultrasound treatment for skin tightening|ultrasound treatment for skin tightening
4982430|NCT01713894|Counseling|counseling
4982431|NCT01713894|Limits of viability|limits of viability
4982432|NCT01713881|Polyp|polyp
4982433|NCT01713881|colonoscopy|colonoscopy
4982434|NCT01713881|surveillance|surveillance
4982435|NCT01713868|Breastfeeding|breastfeeding
4982436|NCT01713868|Safe Sleep|safe sleep
4982437|NCT01713868|Messaging|messaging
4982438|NCT01713868|Social Media|social media
4982439|NCT01713855|ITP|itp
4982440|NCT01713855|Rituximab|rituximab
4982441|NCT01713855|Vaccine|vaccine
4982442|NCT01713855|Immune Reconstitution|immune reconstitution
4982443|NCT01713842|Tocilizumab|tocilizumab
4982444|NCT01713842|Polymyalgia Rheumatica|polymyalgia rheumatica
4982445|NCT01713842|Glucocorticotherapy|glucocorticotherapy
4982446|NCT01713842|PMR-AS|pmr-as
4982447|NCT01713829|cranberry|cranberry
4982448|NCT01713829|gamma delta T cell|gamma delta t cell
4982449|NCT01713829|improvement in immune cell function in healthy humans|improvement in immune cell function in healthy humans
4982450|NCT01713829|proliferation|proliferation
4982451|NCT01713816|Glutathione|glutathione
4982452|NCT01713816|Ascorbate|ascorbate
4982453|NCT01713816|Alzheimer's disease|alzheimer's disease
4982454|NCT01713816|Aging|aging
4982455|NCT01713816|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
4982456|NCT01713790|physical functional performance|physical functional performance
4982457|NCT01713790|postural balance|postural balance
4982458|NCT01713790|reaction time|reaction time
4982459|NCT01713790|mobility|mobility
4982460|NCT01713790|muscle strength|muscle strength
4982461|NCT01713790|cognition|cognition
4982462|NCT01713777|Seizures|seizures
4982463|NCT01713764|diabetes|diabetes
4982464|NCT01713764|obesity|obesity
4982465|NCT01713764|mindful eating|mindful eating
4982466|NCT01713764|positive affect|positive affect
4982467|NCT01713764|low carbohydrate|low carbohydrate
4982468|NCT01713764|diet|diet
4982469|NCT01713751|Surgical site infection|surgical site infection
4982470|NCT01713751|Cesarean section|cesarean section
4982471|NCT01713738|ITP|itp
4982472|NCT01713738|rituximab|rituximab
4982473|NCT01713738|bleeding score|bleeding score
4982474|NCT01713738|platelet count|platelet count
4982475|NCT01713738|health-related quality of life|health-related quality of life
4982476|NCT01713738|HRQL|hrql
4982477|NCT01713725|Chronic urticaria|chronic urticaria
4982478|NCT01713725|Chronic spontaneous urticaria|chronic spontaneous urticaria
4982479|NCT01713725|Autoimmune and non autoimmune urticaria|autoimmune and non autoimmune urticaria
4982480|NCT01713725|UAS7|uas7
4982481|NCT01713712|Pregnancy|pregnancy
4982482|NCT01713712|Obesity|obesity
4982483|NCT01713712|Nutrition therapy|nutrition therapy
4982484|NCT01713699|CTC, cytology, meningeal carcinomatosis, leptomeningeal metastases|ctc, cytology, meningeal carcinomatosis, leptomeningeal metastases
4982485|NCT01713686|Ulthera® System|ulthera® system
4982486|NCT01713686|Ultherapy™ Treatment|ultherapy™ treatment
4982487|NCT01713686|Ulthera, Inc.|ulthera, inc.
4982488|NCT01713686|Micro-focused Ultrasound with Visualization (MFU-V)|micro-focused ultrasound with visualization (mfu-v)
4982489|NCT01713673|Hyperhidrosis|hyperhidrosis
4982490|NCT01713673|Axillary sweating|axillary sweating
4982491|NCT01713673|Ulthera® System|ulthera® system
4982492|NCT01713673|Ultherapy™ Treatment|ultherapy™ treatment
4982493|NCT01713673|Ulthera, Inc.|ulthera, inc.
4982494|NCT01713660|Cataract surgery|cataract surgery
4982495|NCT01713660|Femtosecond laser|femtosecond laser
4982496|NCT01713660|Corneal incisions|corneal incisions
4982497|NCT01713647|Bio-equivalence, crossover|bio-equivalence, crossover
4982498|NCT01713634|Bone resorption|bone resorption
4982499|NCT01713634|Diet|diet
4982500|NCT01713621|P. falciparum|p. falciparum
4982501|NCT01713621|malaria|malaria
4982502|NCT01713608|malaria|malaria
4982503|NCT01713608|dose escalation|dose escalation
4982504|NCT01713608|safety|safety
4982505|NCT01713608|tolerability|tolerability
4982506|NCT01713608|maximum tolerated dose|maximum tolerated dose
4982507|NCT01713595|Acute Lung Injury|acute lung injury
4982508|NCT01713595|Mechanical Ventilation|mechanical ventilation
4982509|NCT01713569|Ulthera® System|ulthera® system
4982510|NCT01713569|Ultherapy™ Treatment|ultherapy™ treatment
4982511|NCT01713569|Ulthera, Inc.|ulthera, inc.
4982512|NCT01713569|Ultrasound treatment for skin tightening|ultrasound treatment for skin tightening
4982513|NCT01713556|PTSD, Propranolol|ptsd, propranolol
4982514|NCT01713543|falls|falls
4982515|NCT01713517|Mosquito Control|mosquito control
4982516|NCT01713517|Insecticide Resistance|insecticide resistance
4982517|NCT01713491|brain ischemia|brain ischemia
4982518|NCT01713491|thrombolytic therapy|thrombolytic therapy
4982519|NCT01713491|Impaired cognition|impaired cognition
4982520|NCT01713491|dementia|dementia
4982521|NCT01713478|hepatic cirrhosis|hepatic cirrhosis
4982522|NCT01713478|subclinical myocardial dysfunction|subclinical myocardial dysfunction
4982523|NCT01713478|echocardiography|echocardiography
4982524|NCT01713478|specific biomarkers|specific biomarkers
4982525|NCT01713478|vascular assessment|vascular assessment
4982526|NCT01713465|Diabetes|diabetes
4982527|NCT01713465|Hypertension|hypertension
4982528|NCT01713465|Hypercholesterolemia|hypercholesterolemia
4982529|NCT01713465|Obesity|obesity
4982530|NCT01713452|Surgical Stomas|surgical stomas
4982531|NCT01713452|ileostomy|ileostomy
4982532|NCT01713452|surgical site infection|surgical site infection
4982533|NCT01713439|Relapsed/Refractory Neuroblastoma|relapsed/refractory neuroblastoma
4982534|NCT01713439|Retroviral vector injections|retroviral vector injections
4982535|NCT01713439|Allogeneic neuroblastoma cells|allogeneic neuroblastoma cells
4982536|NCT01713439|Lymphotactin|lymphotactin
4982537|NCT01713439|Interleukin-2 (IL-2)|interleukin-2 (il-2)
4982538|NCT01713426|Post herpetic neuralgia|post herpetic neuralgia
4982539|NCT01713426|Qutenza|qutenza
4982540|NCT01713426|NGX-4010|ngx-4010
4982541|NCT01713426|Peripheral Neuropathic Pain|peripheral neuropathic pain
4982542|NCT01713426|Pregabalin|pregabalin
4982543|NCT01713413|Oxymizer|oxymizer
4982544|NCT01713413|endurance time|endurance time
4982545|NCT01713413|exercise test|exercise test
4982546|NCT01713413|nasal cannula|nasal cannula
4982547|NCT01713413|COPD|copd
4982548|NCT01713413|ILD|ild
4982549|NCT01713413|oxygenation|oxygenation
4982550|NCT01713400|Acute Graft vs. Host Disease (aGVHD)|acute graft vs. host disease (agvhd)
4982551|NCT01713400|Graft vs. Host Disease (GVHD)|graft vs. host disease (gvhd)
4982552|NCT01713387|adjuvant chemotherapy|adjuvant chemotherapy
4982553|NCT01713374|endothelial function|endothelial function
4982554|NCT01713374|sympathetic nervous system|sympathetic nervous system
4982555|NCT01713361|total knee arthroplasty|total knee arthroplasty
4982556|NCT01713361|Prophylaxis|prophylaxis
4982557|NCT01713348|CGM|cgm
4982558|NCT01713348|MDI|mdi
4982559|NCT01713322|parent education|parent education
4982560|NCT01713322|pain management|pain management
4982561|NCT01713322|immunization|immunization
4982562|NCT01713322|infant|infant
4982563|NCT01713309|Filgrastim|filgrastim
4982564|NCT01713309|G-CSF|g-csf
4982565|NCT01713309|Heparin-binding protein|heparin-binding protein
4982566|NCT01713309|critically ill|critically ill
4982567|NCT01713309|acute respiratory failure|acute respiratory failure
4982568|NCT01713296|SCLC|sclc
4982569|NCT01713296|2nd Line|2nd line
4982570|NCT01713296|Relapsed or Refractory|relapsed or refractory
4982571|NCT01713270|Hypertension|hypertension
4982572|NCT01713270|Atrial Fibrillation|atrial fibrillation
4982573|NCT01713270|Arrhythmias, Cardiac|arrhythmias, cardiac
4982574|NCT01713270|Heart Diseases|heart diseases
4982575|NCT01713257|Critically ill patients|critically ill patients
4982576|NCT01713244|Hepatocellular Carcinoma|hepatocellular carcinoma
4982577|NCT01713244|Radiofrequency Ablation|radiofrequency ablation
4982578|NCT01713244|Hepatectomy|hepatectomy
4982579|NCT01713244|Recurrence|recurrence
4982580|NCT01713231|osteogenesis imperfecta|osteogenesis imperfecta
4982581|NCT01713231|high-dose vitamin D|high-dose vitamin d
4982582|NCT01713231|bone density|bone density
4982583|NCT01713231|muscle function|muscle function
4982584|NCT01713218|Pancreas|pancreas
4982585|NCT01713218|Cancer|cancer
4982586|NCT01713218|Hedgehog inhibitor|hedgehog inhibitor
4982587|NCT01713218|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
4982588|NCT01713218|Dynamic imaging|dynamic imaging
4982589|NCT01713205|trauma ; sepsis; Multiple Organ Dysfunction Syndrome; Prediction; risk|trauma ; sepsis; multiple organ dysfunction syndrome; prediction; risk
4982590|NCT01713153|postpartum hemorrhage|postpartum hemorrhage
4982591|NCT01713153|prevention|prevention
4982592|NCT01713153|misoprostol|misoprostol
4982593|NCT01713153|Uniject|uniject
4982594|NCT01713153|oxytocin|oxytocin
4982595|NCT01713140|strength training|strength training
4982596|NCT01713140|resistance training|resistance training
4982597|NCT01713140|fatigue|fatigue
4982598|NCT01713140|knee extension|knee extension
4982599|NCT01713140|total knee arthroplasty|total knee arthroplasty
4982600|NCT01713140|total knee replacement|total knee replacement
4982601|NCT01713140|electromyography|electromyography
4982602|NCT01713140|physical therapy modalities|physical therapy modalities
4982603|NCT01713101|Gastrointestinal Hemorrhage|gastrointestinal hemorrhage
4982604|NCT01713101|Peptic Ulcer Hemorrhage|peptic ulcer hemorrhage
4982605|NCT01713101|Hematemesis|hematemesis
4982606|NCT01713101|Melena|melena
4982607|NCT01713101|Tranexamic acid|tranexamic acid
4982608|NCT01713088|multisystemic therapy, RCT, young offenders, U.K.|multisystemic therapy, rct, young offenders, u.k.
4982609|NCT01713075|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
4982610|NCT01713075|Symbicort|symbicort
4982611|NCT01713075|long-term use|long-term use
4982612|NCT01713049|FLT PET|flt pet
4982613|NCT01713049|breast neoplasms|breast neoplasms
4982614|NCT01713049|mammography|mammography
4982615|NCT01713049|breast ultrasound|breast ultrasound
4982616|NCT01713036|Mass balance, bioavailability, cancer, 14C|mass balance, bioavailability, cancer, 14c
4982617|NCT01713023|type 1 diabetes|type 1 diabetes
4982618|NCT01713023|fructose|fructose
4982619|NCT01713023|glucose|glucose
4982620|NCT01713023|TAS1R2|tas1r2
4982621|NCT01713023|oxidative stress|oxidative stress
4982622|NCT01713010|Keywords provided by Atlantic Health System:|keywords provided by atlantic health system:
4982623|NCT01713010|Rapid Shallow Breathing Index|rapid shallow breathing index
4982624|NCT01713010|Mechanical Ventilation|mechanical ventilation
4982625|NCT01713010|Additional relevant MeSH terms:|additional relevant mesh terms:
4982626|NCT01713010|Respiration Disorders|respiration disorders
4982627|NCT01713010|Traumatic Brain Injury|traumatic brain injury
4982628|NCT01713010|Weaning Failure|weaning failure
4982629|NCT01713010|Mechanical ventilation complication|mechanical ventilation complication
4982630|NCT01712997|Treatment of|treatment of
4982631|NCT01712984|Influenza|influenza
4982632|NCT01712984|Fluzone® Intradermal vaccine|fluzone® intradermal vaccine
4982633|NCT01712984|Influenza Virus Vaccine USP Quadrivalent|influenza virus vaccine usp quadrivalent
4982634|NCT01712984|Influenza Virus Vaccine USP Trivalent Types A and B|influenza virus vaccine usp trivalent types a and b
4982635|NCT01712971|surgery|surgery
4982636|NCT01712971|pancreas|pancreas
4982637|NCT01712971|tumour|tumour
4982638|NCT01712971|blood loss|blood loss
4982639|NCT01712958|CRC miRNA|crc mirna
4982640|NCT01712945|Alemtuzumab|alemtuzumab
4982641|NCT01712945|Palifermin|palifermin
4982642|NCT01712945|Reconstitution|reconstitution
4982643|NCT01712945|Thymus|thymus
4982644|NCT01712919|Locoregionally advanced nasopharyngeal carcinoma|locoregionally advanced nasopharyngeal carcinoma
4982645|NCT01712919|cetuximab|cetuximab
4982646|NCT01712919|chemoradiation|chemoradiation
4982647|NCT01712893|breast cancer|breast cancer
4982648|NCT01712893|adjuvant therapy|adjuvant therapy
4982649|NCT01712893|Ovarian suppression|ovarian suppression
4982650|NCT01712854|COPD|copd
4982651|NCT01712854|Chronic Obstructive Lung Disease|chronic obstructive lung disease
4982652|NCT01712854|Long acting beta agonist|long acting beta agonist
4982653|NCT01712841|Dry AMD|dry amd
4982654|NCT01712841|Age-related macular degeneration|age-related macular degeneration
4982655|NCT01712841|Optical coherenece tomography|optical coherenece tomography
4982656|NCT01712841|Imaging|imaging
4982657|NCT01712841|Blood flow|blood flow
4982658|NCT01712828|Lenalidomide,|lenalidomide,
4982659|NCT01712828|Revlimid,|revlimid,
4982660|NCT01712828|pharmacokinetics,|pharmacokinetics,
4982661|NCT01712828|healthy male subjects|healthy male subjects
4982662|NCT01712789|Multiple Myeloma|multiple myeloma
4982663|NCT01712789|Relapsed Multiple Myeloma|relapsed multiple myeloma
4982664|NCT01712789|Relapsed and refractory Multiple Myeloma|relapsed and refractory multiple myeloma
4982665|NCT01712789|Pomalidomide|pomalidomide
4982666|NCT01712789|Dexamethasone|dexamethasone
4982667|NCT01712776|Vapocoolant|vapocoolant
4982668|NCT01712763|Endometriosis|endometriosis
4982669|NCT01712763|long acting GnRH antagonist|long acting gnrh antagonist
4982670|NCT01712763|Degarelix|degarelix
4982671|NCT01712763|Recurrence|recurrence
4982672|NCT01712763|Pelvic Pain|pelvic pain
4982673|NCT01712750|Regional tissue oximetry|regional tissue oximetry
4982674|NCT01712750|Cardiopulmonary bypass|cardiopulmonary bypass
4982675|NCT01712750|Cardiac surgical procedures|cardiac surgical procedures
4982676|NCT01712737|raisins, grapes, snacks, appetite, food intake|raisins, grapes, snacks, appetite, food intake
4982677|NCT01712724|exercise therapy|exercise therapy
4982678|NCT01712724|rehabilitation|rehabilitation
4982679|NCT01712711|Steatohepatitis,|steatohepatitis,
4982680|NCT01712711|Helicobacter pylori,|helicobacter pylori,
4982681|NCT01712711|Insulin resistance,|insulin resistance,
4982682|NCT01712711|Alanine aminotransferase,|alanine aminotransferase,
4982683|NCT01712711|Aspartate aminotransferase,|aspartate aminotransferase,
4982684|NCT01712698|trauma|trauma
4982685|NCT01712698|spinal cord injury|spinal cord injury
4982686|NCT01712698|cervical spine|cervical spine
4982687|NCT01712685|Kidney Neoplasm|kidney neoplasm
4982688|NCT01712685|RCC|rcc
4982689|NCT01712685|Biodistribution of 18F-VM4-037|biodistribution of 18f-vm4-037
4982690|NCT01712685|CAIX Staining|caix staining
4982691|NCT01712685|Tumor Angiogenesis|tumor angiogenesis
4982692|NCT01712672|Dental Plaque|dental plaque
4982693|NCT01712672|Biofilm|biofilm
4982694|NCT01712672|Bacterial Interactions|bacterial interactions
4982695|NCT01712672|Receptor Polysaccharide|receptor polysaccharide
4982696|NCT01712672|Oral Streptococci|oral streptococci
4982697|NCT01712659|JAK 1/2|jak 1/2
4982698|NCT01712659|Human T-Cell Lymphotropic Virus 1|human t-cell lymphotropic virus 1
4982699|NCT01712659|HTLV-1|htlv-1
4982700|NCT01712659|Janus Kinase Inhibitor|janus kinase inhibitor
4982701|NCT01712646|Oxytocin|oxytocin
4982702|NCT01712646|Childhood Onset Schizophrenia|childhood onset schizophrenia
4982703|NCT01712646|Double Blind|double blind
4982704|NCT01712633|fMRI|fmri
4982705|NCT01712633|Brain Perfusion|brain perfusion
4982706|NCT01712620|Microarray|microarray
4982707|NCT01712620|Magnetic Resonance Imaging|magnetic resonance imaging
4982708|NCT01712620|Mineralocorticoid Receptor Antagonist|mineralocorticoid receptor antagonist
4982709|NCT01712620|Neurohormonal Axis|neurohormonal axis
4982710|NCT01712620|Vascular Inflammation|vascular inflammation
4982711|NCT01712620|Pulmonary Hypertension|pulmonary hypertension
4982712|NCT01712620|Cardiovascular Disease|cardiovascular disease
4982713|NCT01712620|Vascular Disease|vascular disease
4982714|NCT01712607|laparoscopy|laparoscopy
4982715|NCT01712607|surgery|surgery
4982716|NCT01712607|warm-up|warm-up
4982717|NCT01712607|preoperative|preoperative
4982718|NCT01712607|surgical skills|surgical skills
4982719|NCT01712594|United Kingdom Overnight closed loop|united kingdom overnight closed loop
4982720|NCT01712581|normal myocardial T1, T2 and T2* values|normal myocardial t1, t2 and t2* values
4982721|NCT01712555|Anophthalmic orbits|anophthalmic orbits
4982722|NCT01712555|autologous fat|autologous fat
4982723|NCT01712555|platelet rich plasma|platelet rich plasma
4982724|NCT01712555|orbital atrophy|orbital atrophy
4982725|NCT01712555|anophthalmos|anophthalmos
4982726|NCT01712555|cannula|cannula
4982727|NCT01712529|Systemic lupus erythematosus|systemic lupus erythematosus
4982728|NCT01712529|endothelium|endothelium
4982729|NCT01712529|exercise|exercise
4982730|NCT01712516|COPD, QVA149|copd, qva149
4982731|NCT01712503|Cataract|cataract
4982732|NCT01712503|Astigmatism|astigmatism
4982733|NCT01712503|Toric|toric
4982734|NCT01712503|Phacoemulsification|phacoemulsification
4982735|NCT01712503|Intraocular lens|intraocular lens
4982736|NCT01712490|Hodgkin Lymphoma|hodgkin lymphoma
4982737|NCT01712490|Hodgkins Lymphoma|hodgkins lymphoma
4982738|NCT01712490|Antibody, Monoclonal|antibody, monoclonal
4982739|NCT01712490|Antibody-Drug Conjugate|antibody-drug conjugate
4982740|NCT01712490|Antigens, CD-30|antigens, cd-30
4982741|NCT01712490|Immunotherapy|immunotherapy
4982742|NCT01712490|Lymphoma|lymphoma
4982743|NCT01712490|Lymphoma, Classical|lymphoma, classical
4982744|NCT01712490|ECHELON-1|echelon-1
4982745|NCT01712451|adiposity|adiposity
4982746|NCT01712438|Previously untreated patients|previously untreated patients
4982747|NCT01712425|vaccine|vaccine
4982748|NCT01712425|recently HIV-1 infected individuals|recently hiv-1 infected individuals
4982749|NCT01712373|Multiple sclerosis|multiple sclerosis
4982750|NCT01712373|Ginseng|ginseng
4982751|NCT01712373|Fatigue|fatigue
4982752|NCT01712373|Quality of life|quality of life
4982753|NCT01712360|Tinea Pedis|tinea pedis
4982754|NCT01712360|Tinea Cruris|tinea cruris
4982755|NCT01712360|Athlete foot|athlete foot
4982756|NCT01712360|Jock itch|jock itch
4982757|NCT01712321|Social Anxiety Disorder|social anxiety disorder
4982758|NCT01712321|Social Anxiety|social anxiety
4982759|NCT01712321|Social Phobia|social phobia
4982760|NCT01712321|SAD|sad
4982761|NCT01712308|Leukemia|leukemia
4982762|NCT01712308|Myeloproliferative Neoplasm|myeloproliferative neoplasm
4982763|NCT01712308|MPN|mpn
4982764|NCT01712308|Associated Myelofibrosis|associated myelofibrosis
4982765|NCT01712308|Anemia|anemia
4982766|NCT01712308|Sotatercept|sotatercept
4982767|NCT01712308|ACE-011|ace-011
4982768|NCT01712295|Warts|warts
4982769|NCT01712295|salicylic acid|salicylic acid
4982770|NCT01712295|ethyl pyruvate|ethyl pyruvate
4982771|NCT01712282|Physical Activity|physical activity
4982772|NCT01712282|Accelerometer|accelerometer
4982773|NCT01712256|CD4|cd4
4982774|NCT01712256|Clinical trial|clinical trial
4982775|NCT01712256|Human immunodeficiency virus-1 (HIV-1)|human immunodeficiency virus-1 (hiv-1)
4982776|NCT01712256|HIV|hiv
4982777|NCT01712256|Immunomodulary|immunomodulary
4982778|NCT01712256|Infection|infection
4982779|NCT01712256|Phase II|phase ii
4982780|NCT01712256|Re-boost|re-boost
4982781|NCT01712256|Vaccine|vaccine
4982782|NCT01712256|Vacc-4x|vacc-4x
4982783|NCT01712230|hormone therapy|hormone therapy
4982784|NCT01712230|obesity|obesity
4982785|NCT01712230|menopause|menopause
4982786|NCT01712230|disease /disorder proneness /risk|disease /disorder proneness /risk
4982787|NCT01712230|insulin sensitivity /resistance|insulin sensitivity /resistance
4982788|NCT01712230|metabolic syndrome|metabolic syndrome
4982789|NCT01712230|women's health|women's health
4982790|NCT01712217|Non-small cell lung cancer|non-small cell lung cancer
4982791|NCT01712204|Prophylaxis of Acute Gout Flares|prophylaxis of acute gout flares
4982792|NCT01712204|Urate-Lowering Therapy|urate-lowering therapy
4982793|NCT01712204|Hyperuricemia|hyperuricemia
4982794|NCT01712204|Gouty arthritis|gouty arthritis
4982795|NCT01712191|NUsurface|nusurface
4982796|NCT01712191|Meniscus|meniscus
4982797|NCT01712191|Knee|knee
4982798|NCT01712191|KOOS|koos
4982799|NCT01712178|Pharmacodynamic,Pharmacokinetic|pharmacodynamic,pharmacokinetic
4982800|NCT01712165|Folic acid supplement|folic acid supplement
4982801|NCT01712165|Neural tube defect-affected pregnancy|neural tube defect-affected pregnancy
4982802|NCT01712165|Homocysteine concentration|homocysteine concentration
4982803|NCT01712165|Plasma Folate concentration|plasma folate concentration
4982804|NCT01712165|Plasma vitamin B12 concentration|plasma vitamin b12 concentration
4982805|NCT01712152|Duchenne muscular dystrophy|duchenne muscular dystrophy
4982806|NCT01712152|carrier|carrier
4982807|NCT01712152|cardiac MRI|cardiac mri
4982808|NCT01712152|myocardial fibrosis|myocardial fibrosis
4982809|NCT01712152|female|female
4982810|NCT01712087|spasticity|spasticity
4982811|NCT01712087|muscle spasticity|muscle spasticity
4982812|NCT01712087|muscle rigidity|muscle rigidity
4982813|NCT01712087|motor neuron disease|motor neuron disease
4982814|NCT01712087|hyperreflexia|hyperreflexia
4982815|NCT01712074|Randomized|randomized
4982816|NCT01712074|Double Blind|double blind
4982817|NCT01712074|Safety and Efficacy|safety and efficacy
4982818|NCT01712061|Diabetic nephropathy|diabetic nephropathy
4982819|NCT01712061|type 2 diabetes|type 2 diabetes
4982820|NCT01712061|albuminuria|albuminuria
4982821|NCT01712061|chemokine antagonist|chemokine antagonist
4982822|NCT01712035|Wet AMD|wet amd
4982823|NCT01712035|Age-related macular degeneration|age-related macular degeneration
4982824|NCT01712035|Optical coherenece tomography|optical coherenece tomography
4982825|NCT01712035|Imaging|imaging
4982826|NCT01712035|Blood flow|blood flow
4982827|NCT01712009|Breast cancer|breast cancer
4982828|NCT01712009|Chemotherapy|chemotherapy
4982829|NCT01712009|Neulasta|neulasta
4982830|NCT01712009|Pegfilgrastim|pegfilgrastim
4982831|NCT01712009|Naproxen|naproxen
4982832|NCT01712009|Loratadine|loratadine
4982833|NCT01712009|Non-steroidal antiinflammatory drug (NSAID)|non-steroidal antiinflammatory drug (nsaid)
4982834|NCT01712009|Anti-histamine|anti-histamine
4982835|NCT01712009|Bone Pain|bone pain
4982836|NCT01711996|hydronephrosis|hydronephrosis
4982837|NCT01711996|biopsy|biopsy
4982838|NCT01711996|biomarker|biomarker
4982839|NCT01711957|Complications|complications
4982840|NCT01711957|Mortality|mortality
4982841|NCT01711957|Liver transplantation|liver transplantation
4982842|NCT01711957|Platelet count|platelet count
4982843|NCT01711957|Survival|survival
4982844|NCT01711944|childhood cancer|childhood cancer
4982845|NCT01711944|Internet communication|internet communication
4982846|NCT01711944|parents|parents
4982847|NCT01711944|caregivers|caregivers
4982848|NCT01711944|problem solving|problem solving
4982849|NCT01711931|percutaneous coronary intervention|percutaneous coronary intervention
4982850|NCT01711931|bioresorbable vascular scaffold stents|bioresorbable vascular scaffold stents
4982851|NCT01711931|everolimus|everolimus
4982852|NCT01711931|biolimus|biolimus
4982853|NCT01711918|gastroparesis|gastroparesis
4982854|NCT01711918|domperidone|domperidone
4982855|NCT01711918|nausea|nausea
4982856|NCT01711918|vomiting|vomiting
4982857|NCT01711892|Prostatic Neoplasms|prostatic neoplasms
4982858|NCT01711892|Prostate Cancer|prostate cancer
4982859|NCT01711892|Exercise|exercise
4982860|NCT01711892|Soccer|soccer
4982861|NCT01711892|Androgen Deprivation Therapy|androgen deprivation therapy
4982862|NCT01711892|Body Composition|body composition
4982863|NCT01711892|Cardiovascular fitness|cardiovascular fitness
4982864|NCT01711892|Bone Health|bone health
4982865|NCT01711892|Health Related Quality of Life|health related quality of life
4982866|NCT01711866|Rotigotine|rotigotine
4982867|NCT01711866|Neupro|neupro
4982868|NCT01711866|Switch|switch
4982869|NCT01711866|Dopamine agonists|dopamine agonists
4982870|NCT01711840|Bronchial asthma|bronchial asthma
4982871|NCT01711840|Symbicort Turbuhaler|symbicort turbuhaler
4982872|NCT01711827|isavuconazole|isavuconazole
4982873|NCT01711827|prednisone|prednisone
4982874|NCT01711827|prednisolone|prednisolone
4982875|NCT01711827|BAL8557|bal8557
4982876|NCT01711827|healthy volunteers|healthy volunteers
4982877|NCT01711814|Rheumatoid Arthritis|rheumatoid arthritis
4982878|NCT01711814|ASP015K|asp015k
4982879|NCT01711788|Hematopoietic stem cells|hematopoietic stem cells
4982880|NCT01711788|Umbilical cord blood transplantation|umbilical cord blood transplantation
4982881|NCT01711788|Intrabone infusion|intrabone infusion
4982882|NCT01711788|Platelet recovery|platelet recovery
4982883|NCT01711788|Neutrophil recovery|neutrophil recovery
4982884|NCT01711788|Pediatric patients|pediatric patients
4982885|NCT01711736|Immunogenicity|immunogenicity
4982886|NCT01711736|Children|children
4982887|NCT01711736|Safety|safety
4982888|NCT01711736|Seasonal influenza|seasonal influenza
4982889|NCT01711736|Fluarix|fluarix
4982890|NCT01711723|darapladib|darapladib
4982891|NCT01711723|Lp-PLA2- inhibitor|lp-pla2- inhibitor
4982892|NCT01711723|healthy volunteer|healthy volunteer
4982893|NCT01711723|renal impairment|renal impairment
4982894|NCT01711723|pharmacokinetics|pharmacokinetics
4982895|NCT01711710|Breast cancer|breast cancer
4982896|NCT01711710|reconstruction|reconstruction
4982897|NCT01711710|augmentation|augmentation
4982898|NCT01711710|cohesive silicone gel|cohesive silicone gel
4982899|NCT01711710|breast implant|breast implant
4982900|NCT01711710|rupture|rupture
4982901|NCT01711710|capsular contracture|capsular contracture
4982902|NCT01711684|Neoplasm Metastasis|neoplasm metastasis
4982903|NCT01711684|Melanoma|melanoma
4982904|NCT01711645|Acellular|acellular
4982905|NCT01711645|Adacel®|adacel®
4982906|NCT01711645|Diptheria toxoids|diptheria toxoids
4982907|NCT01711645|Pertussis|pertussis
4982908|NCT01711645|postpartum|postpartum
4982909|NCT01711645|Tdap|tdap
4982910|NCT01711645|Tetanus|tetanus
4982911|NCT01711645|women|women
4982912|NCT01711632|VEMURAFENIB|vemurafenib
4982913|NCT01711632|BRAF Inhibitor|braf inhibitor
4982914|NCT01711632|12-200|12-200
4982915|NCT01711632|Zelboraf™|zelboraf™
4982916|NCT01711606|Fragile-X Syndrome|fragile-x syndrome
4982917|NCT01711606|registry|registry
4982918|NCT01711606|non-interventional trial|non-interventional trial
4982919|NCT01711606|patient-related outcome study|patient-related outcome study
4982920|NCT01711606|drug utilization|drug utilization
4982921|NCT01711606|effectiveness|effectiveness
4982922|NCT01711606|treatment patterns|treatment patterns
4982923|NCT01711606|patient characteristics under real life conditions|patient characteristics under real life conditions
4982924|NCT01711606|quality of life|quality of life
4982925|NCT01711606|economics|economics
4982926|NCT01711593|Asthma|asthma
4982927|NCT01711593|Allergic|allergic
4982928|NCT01711593|Inflammation|inflammation
4982929|NCT01711593|Airway|airway
4982930|NCT01711593|Challenge|challenge
4982931|NCT01711593|Chemokines|chemokines
4982932|NCT01711593|Tolerization|tolerization
4982933|NCT01711580|Recurrent glioma|recurrent glioma
4982934|NCT01711580|Quality of life|quality of life
4982935|NCT01711580|Glioblastoma multiforme|glioblastoma multiforme
4982936|NCT01711580|Anaplastic glioma|anaplastic glioma
4982937|NCT01711580|Cognition|cognition
4982938|NCT01711580|Re-irradiation|re-irradiation
4982939|NCT01711567|Chronic Hepatitis B|chronic hepatitis b
4982940|NCT01711567|TENOFOVIR|tenofovir
4982941|NCT01711567|ENTECAVIR|entecavir
4982942|NCT01711567|PARTIAL RESPONDER|partial responder
4983452|NCT01709175|Fitness|fitness
4982943|NCT01711502|metastatic breast cancer,|metastatic breast cancer,
4982944|NCT01711502|epidemiology,|epidemiology,
4982945|NCT01711502|retrospective cohort|retrospective cohort
4982946|NCT01711489|isavuconazole|isavuconazole
4982947|NCT01711489|mycophenolate mofetil (MMF)|mycophenolate mofetil (mmf)
4982948|NCT01711489|BAL8557|bal8557
4982949|NCT01711489|BAL4815|bal4815
4982950|NCT01711489|healthy volunteers|healthy volunteers
4982951|NCT01711489|Mycophenolic acid (MPA)|mycophenolic acid (mpa)
4982952|NCT01711489|Phenolic glucuronide of MPA (MPAG)|phenolic glucuronide of mpa (mpag)
4982953|NCT01711489|CellCept|cellcept
4982954|NCT01711476|PCOS|pcos
4982955|NCT01711476|Bdiet|bdiet
4982956|NCT01711476|Ddiet|ddiet
4982957|NCT01711476|OGTT|ogtt
4982958|NCT01711463|Pharmacodynamics|pharmacodynamics
4982959|NCT01711463|Fluticasone furoate (FF)|fluticasone furoate (ff)
4982960|NCT01711463|novel dry powder device|novel dry powder device
4982961|NCT01711463|Safety and tolerability|safety and tolerability
4982962|NCT01711463|vilanterol(VI)|vilanterol(vi)
4982963|NCT01711463|Healthy Chinese subjects|healthy chinese subjects
4982964|NCT01711463|Pharmacokinetics|pharmacokinetics
4982965|NCT01711437|colonoscopy|colonoscopy
4982966|NCT01711437|colon cleansing|colon cleansing
4982967|NCT01711437|children|children
4982968|NCT01711437|age 2 -18 years|age 2 -18 years
4982969|NCT01711411|HIV prevention|hiv prevention
4982970|NCT01711411|PrePex|prepex
4982971|NCT01711411|voluntary medical male circumcision|voluntary medical male circumcision
4982972|NCT01711411|non-surgical|non-surgical
4982973|NCT01711411|medical device|medical device
4982974|NCT01711411|wound healing|wound healing
4982975|NCT01711411|Kenya|kenya
4982976|NCT01711398|solid tumor|solid tumor
4982977|NCT01711398|peptide|peptide
4982978|NCT01711385|Oral Health|oral health
4982979|NCT01711385|Prediabetes|prediabetes
4982980|NCT01711385|Diabetes|diabetes
4982981|NCT01711385|Periodontitis|periodontitis
4982982|NCT01711385|Early Identification|early identification
4982983|NCT01711385|Prevention|prevention
4982984|NCT01711372|ADHD|adhd
4982985|NCT01711320|Omeprazole|omeprazole
4982986|NCT01711320|Metformin|metformin
4982987|NCT01711307|Achilles|achilles
4982988|NCT01711307|Rupture|rupture
4982989|NCT01711294|Pancreatic Cystic Lesions|pancreatic cystic lesions
4982990|NCT01711294|PCL|pcl
4982991|NCT01711294|EUS-FNA|eus-fna
4982992|NCT01711281|Heart Failure|heart failure
4982993|NCT01711281|Implantable Cardioverter-Defibrillator|implantable cardioverter-defibrillator
4982994|NCT01711281|Intracardiac Impedance Measurement|intracardiac impedance measurement
4982995|NCT01711281|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
4982996|NCT01711281|Home Monitoring|home monitoring
4982997|NCT01711281|Reverse Remodeling|reverse remodeling
4982998|NCT01711268|Sunitinib|sunitinib
4982999|NCT01711268|Renal Cell Carcinoma|renal cell carcinoma
4983000|NCT01711268|Therapeutic Drug Monitoring|therapeutic drug monitoring
4983001|NCT01711268|Pharmacokinetic|pharmacokinetic
4983002|NCT01711268|Treatment toxicity|treatment toxicity
4983003|NCT01711255|Multiple sclerosis|multiple sclerosis
4983004|NCT01711255|Coagulation|coagulation
4983005|NCT01711255|Alternative Medicine|alternative medicine
4983006|NCT01711255|Clotting|clotting
4983007|NCT01711255|Complementary Medicine|complementary medicine
4983008|NCT01711255|Inflammation|inflammation
4983009|NCT01711242|gastric cancer|gastric cancer
4983010|NCT01711242|radiotherapy|radiotherapy
4983011|NCT01711242|postoperative therapy|postoperative therapy
4983012|NCT01711242|chemotherapy|chemotherapy
4983013|NCT01711229|oral acetaminophen|oral acetaminophen
4983014|NCT01711229|IV acetaminophen|iv acetaminophen
4983015|NCT01711229|Ofirmev|ofirmev
4983016|NCT01711229|equianalgesic|equianalgesic
4983017|NCT01711229|arthroscopic rotator cuff repair|arthroscopic rotator cuff repair
4983018|NCT01711216|Dydrogesterone|dydrogesterone
4983019|NCT01711216|Irregular Menstrual Cycle|irregular menstrual cycle
4983020|NCT01711216|Progestins|progestins
4983021|NCT01711203|Spondylolysis|spondylolysis
4983022|NCT01711203|Spondylolisthesis|spondylolisthesis
4983023|NCT01711203|Rehabilitation|rehabilitation
4983024|NCT01711203|Physical Therapy|physical therapy
4983025|NCT01711203|Children|children
4983026|NCT01711190|glaucoma|glaucoma
4983027|NCT01711190|trabeculectomy|trabeculectomy
4983028|NCT01711190|astigmatism|astigmatism
4983029|NCT01711190|intraocular pressure|intraocular pressure
4983030|NCT01711177|primary open angle glaucoma|primary open angle glaucoma
4983031|NCT01711177|retinal oximetry|retinal oximetry
4983032|NCT01711164|HCV|hcv
4983033|NCT01711164|T regulatory cells (Tregs)|t regulatory cells (tregs)
4983034|NCT01711164|FGL2|fgl2
4983035|NCT01711151|ILD|ild
4983036|NCT01711138|Physical Activity|physical activity
4983037|NCT01711138|Physical Fitness|physical fitness
4983038|NCT01711138|Transportation|transportation
4983039|NCT01711138|Environment Design|environment design
4983040|NCT01711138|Child|child
4983041|NCT01711138|Adolescent|adolescent
4983042|NCT01711086|asthma|asthma
4983043|NCT01711086|dry powder inhaler|dry powder inhaler
4983044|NCT01711047|catheter ablation|catheter ablation
4983045|NCT01711047|atrial fibrillation|atrial fibrillation
4983046|NCT01711047|pulmonary vein isolation|pulmonary vein isolation
4983047|NCT01711047|linear ablation|linear ablation
4983048|NCT01711047|CFAE ablation|cfae ablation
4983049|NCT01711034|Solid tumors|solid tumors
4983050|NCT01711021|ADHD|adhd
4983051|NCT01711008|Breakfast size|breakfast size
4983052|NCT01711008|Exercise|exercise
4983053|NCT01711008|Cognitive performance|cognitive performance
4983054|NCT01711008|Mood|mood
4983055|NCT01711008|Appetite|appetite
4983056|NCT01711008|Active women|active women
4983057|NCT01710956|concurrent chemoradiation in patients with limited disease small cell lung cancer|concurrent chemoradiation in patients with limited disease small cell lung cancer
4983058|NCT01710943|Web-based CBT|web-based cbt
4983059|NCT01710943|PTSD|ptsd
4983060|NCT01710943|Alcohol Misuse|alcohol misuse
4983061|NCT01710943|Substance Misuse|substance misuse
4983062|NCT01710943|Integrated Primary Care|integrated primary care
4983063|NCT01710943|OEF/OIF Veterans|oef/oif veterans
4983064|NCT01710930|Allergic Broncho-Pulmonary Aspergillosis|allergic broncho-pulmonary aspergillosis
4983065|NCT01710917|Chronic pain|chronic pain
4983066|NCT01710917|Severe pain|severe pain
4983067|NCT01710917|Oxycodon|oxycodon
4983068|NCT01710917|Naloxon|naloxon
4983069|NCT01710917|Opioid-induced constipation|opioid-induced constipation
4983070|NCT01710917|Opioid|opioid
4983071|NCT01710917|Quality of life|quality of life
4983072|NCT01710917|Laxative|laxative
4983073|NCT01710917|Analgesic rescue medication|analgesic rescue medication
4983074|NCT01710904|Chronic pain|chronic pain
4983075|NCT01710904|Severe pain|severe pain
4983076|NCT01710904|Oxycodone|oxycodone
4983077|NCT01710904|Naloxone|naloxone
4983078|NCT01710904|Opioid-induced constipation|opioid-induced constipation
4983079|NCT01710904|Opioid|opioid
4983080|NCT01710904|Quality of life|quality of life
4983081|NCT01710904|Laxative|laxative
4983082|NCT01710904|Analgesic rescue medication|analgesic rescue medication
4983083|NCT01710891|endotracheal intubation|endotracheal intubation
4983084|NCT01710891|direct laryngoscopy|direct laryngoscopy
4983085|NCT01710891|video laryngoscopy|video laryngoscopy
4983086|NCT01710865|Caries prevention|caries prevention
4983087|NCT01710865|pit and fissure sealants|pit and fissure sealants
4983088|NCT01710852|Atrial Fibrillation|atrial fibrillation
4983089|NCT01710852|Paroxysmal Atrial Fibrillation|paroxysmal atrial fibrillation
4983090|NCT01710852|AF|af
4983091|NCT01710839|CRVO|crvo
4983092|NCT01710839|BRVO|brvo
4983093|NCT01710839|HRVO|hrvo
4983094|NCT01710839|Macular edema|macular edema
4983095|NCT01710839|vein occlusion|vein occlusion
4983096|NCT01710813|pompe disease|pompe disease
4983097|NCT01710813|alglucosidase alfa|alglucosidase alfa
4983098|NCT01710813|anaphylaxis|anaphylaxis
4983099|NCT01710813|severe cutaneous|severe cutaneous
4983100|NCT01710813|systemic immune complex-mediated reactions|systemic immune complex-mediated reactions
4983101|NCT01710800|impedance|impedance
4983102|NCT01710800|reflux|reflux
4983103|NCT01710800|GERD|gerd
4983104|NCT01710787|operative|operative
4983105|NCT01710787|dental procedure|dental procedure
4983106|NCT01710774|Diabetic Foot|diabetic foot
4983107|NCT01710774|Diabetes Mellitus|diabetes mellitus
4983108|NCT01710774|Foot Ulcer|foot ulcer
4983109|NCT01710774|Wound Healing|wound healing
4983110|NCT01710774|Delivery of Health Care|delivery of health care
4983111|NCT01710774|Depression|depression
4983112|NCT01710774|sequela|sequela
4983113|NCT01710774|Sick Leave|sick leave
4983114|NCT01710774|Quality of Life|quality of life
4983115|NCT01710774|Amputation|amputation
4983116|NCT01710761|nitric oxide|nitric oxide
4983117|NCT01710761|cycling performance|cycling performance
4983118|NCT01710761|lactate|lactate
4983119|NCT01710761|VO2|vo2
4983120|NCT01710748|Percutaneous coronary intervention|percutaneous coronary intervention
4983121|NCT01710748|Drug eluting stent|drug eluting stent
4983122|NCT01710748|Neointimal hyperplasia|neointimal hyperplasia
4983123|NCT01710748|Diabetes Mellitus|diabetes mellitus
4983124|NCT01710735|TP|tp
4983125|NCT01710735|Myofascial pain|myofascial pain
4983126|NCT01710709|Aripiprazole, Intramuscular (IM) Depot, Bipolar|aripiprazole, intramuscular (im) depot, bipolar
4983127|NCT01710683|Discectomy|discectomy
4983128|NCT01710683|1st postoperative day|1st postoperative day
4983129|NCT01710683|Intensive exercise training|intensive exercise training
4983130|NCT01710683|Randomized controlled trial|randomized controlled trial
4983131|NCT01710670|Brivaracetam|brivaracetam
4983132|NCT01710670|Ethanol|ethanol
4983133|NCT01710670|Pharmacodynamics|pharmacodynamics
4983134|NCT01710670|Pharmacokinetic|pharmacokinetic
4983135|NCT01710670|Interaction|interaction
4983136|NCT01710657|Lacosamide|lacosamide
4983137|NCT01710657|Epilepsy|epilepsy
4983138|NCT01710657|Partial Onset Seizures|partial onset seizures
4983139|NCT01710631|Sleep|sleep
4983140|NCT01710618|Protein Expression of Sciatic Nerve|protein expression of sciatic nerve
4983141|NCT01710618|traumatized sciatic nerve|traumatized sciatic nerve
4983142|NCT01710605|Circulating tumor cells|circulating tumor cells
4983143|NCT01710605|Breast Cancer|breast cancer
4983144|NCT01710605|Hormone-receptors positive|hormone-receptors positive
4983145|NCT01710579|Primary esophageal achalasia|primary esophageal achalasia
4983146|NCT01710579|endoscopic myotomy|endoscopic myotomy
4983147|NCT01710579|high resolution manometry|high resolution manometry
4983148|NCT01710566|Postpartum hemorrhage|postpartum hemorrhage
4983149|NCT01710566|prevention|prevention
4983150|NCT01710566|oxytocin|oxytocin
4983151|NCT01710566|misoprostol|misoprostol
4983152|NCT01710566|Uniject|uniject
4983153|NCT01710566|community|community
4983154|NCT01710527|Healthy Volunteers|healthy volunteers
4983155|NCT01710488|COPD exacerbation|copd exacerbation
4983156|NCT01710488|fluoroquinolones,|fluoroquinolones,
4983157|NCT01710449|Lung Transplant|lung transplant
4983158|NCT01710423|Obesity|obesity
4983159|NCT01710423|Nutrition|nutrition
4983160|NCT01710423|Home Food Preparation|home food preparation
4983161|NCT01710423|Peer Mentoring|peer mentoring
4983162|NCT01710423|Early Head Start|early head start
4983163|NCT01710423|Cooking|cooking
4983164|NCT01710423|Diet|diet
4983165|NCT01710410|transcranial direct current stimulation|transcranial direct current stimulation
4983166|NCT01710410|nicotine dependence|nicotine dependence
4983167|NCT01710410|dorsolateral prefrontal cortex|dorsolateral prefrontal cortex
4983168|NCT01710410|nicotine replacement therapy|nicotine replacement therapy
4983169|NCT01710410|nicotine patch|nicotine patch
4983170|NCT01710410|addiction|addiction
4983171|NCT01710410|smoking cessation|smoking cessation
4983172|NCT01710410|neuroplasticity|neuroplasticity
4983173|NCT01710397|Antiretroviral therapy|antiretroviral therapy
4983174|NCT01710397|South Africa|south africa
4983175|NCT01710384|late preterm, betamethasone,|late preterm, betamethasone,
4983176|NCT01710332|Persistent|persistent
4983177|NCT01710332|Central|central
4983178|NCT01710332|Serous|serous
4983179|NCT01710332|Chorioretinopathy|chorioretinopathy
4983180|NCT01710332|Regeneron|regeneron
4983181|NCT01710332|CSR|csr
4983182|NCT01710332|CSCR|cscr
4983183|NCT01710319|Immunoregulation|immunoregulation
4983184|NCT01710319|Natural Killer Cells|natural killer cells
4983185|NCT01710306|Women|women
4983186|NCT01710306|Veterans|veterans
4983187|NCT01710306|PTSD|ptsd
4983188|NCT01710293|Electronic Health Records|electronic health records
4983189|NCT01710293|Diagnostic Delay|diagnostic delay
4983190|NCT01710293|Triggers|triggers
4983191|NCT01710280|Lipemia|lipemia
4983192|NCT01710280|Vascular function|vascular function
4983193|NCT01710280|Blood pressure|blood pressure
4983194|NCT01710254|MRI|mri
4983195|NCT01710254|Atrial Fibrillation|atrial fibrillation
4983196|NCT01710228|MS|ms
4983197|NCT01710228|Natalizumab|natalizumab
4983198|NCT01710228|copaxone|copaxone
4983199|NCT01710215|Colorectal Neoplasms|colorectal neoplasms
4983200|NCT01710215|Colorectal Cancer|colorectal cancer
4983201|NCT01710215|Colon Cancer|colon cancer
4983202|NCT01710215|Mass Screening|mass screening
4983203|NCT01710215|Health Services Research|health services research
4983204|NCT01710215|Comparative Effectiveness Research|comparative effectiveness research
4983205|NCT01710202|Hydrocortisone|hydrocortisone
4983206|NCT01710202|Cortisol|cortisol
4983207|NCT01710202|Testosterone|testosterone
4983208|NCT01710202|Stress|stress
4983209|NCT01710202|Serotonin|serotonin
4983210|NCT01710202|5-HTTLPR|5-httlpr
4983211|NCT01710202|Amygdala|amygdala
4983212|NCT01710202|Depression|depression
4983213|NCT01710189|Tick-Borne Encephalitis Virus|tick-borne encephalitis virus
4983214|NCT01710163|Lithium Carbonate|lithium carbonate
4983215|NCT01710163|Lithium|lithium
4983216|NCT01710163|Central Nervous System Agents|central nervous system agents
4983217|NCT01710163|Therapeutic Uses|therapeutic uses
4983218|NCT01710163|Pharmacologic Actions|pharmacologic actions
4983219|NCT01710163|Enzyme Inhibitors|enzyme inhibitors
4983220|NCT01710163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
4983221|NCT01710163|Neurotransmitter Agents|neurotransmitter agents
4983222|NCT01710163|Physiological Effects of Drugs|physiological effects of drugs
4983223|NCT01710163|Antimanic Agents|antimanic agents
4983224|NCT01710163|Tranquilizing Agents|tranquilizing agents
4983225|NCT01710163|Central Nervous System Depressants|central nervous system depressants
4983226|NCT01710163|Psychotropic Drugs|psychotropic drugs
4983227|NCT01710163|Sensory System Agents|sensory system agents
4983228|NCT01710163|Antipsychotic Agents|antipsychotic agents
4983229|NCT01710163|Antidepressive Agents|antidepressive agents
4983230|NCT01710150|typical aflutter (AFLT)|typical aflutter (aflt)
4983231|NCT01710150|CTI ablation|cti ablation
4983232|NCT01710150|Atrial Fibrillation (AF)|atrial fibrillation (af)
4983233|NCT01710150|PVI|pvi
4983234|NCT01710137|Smoking cessation|smoking cessation
4983235|NCT01710137|Nicotine dependence|nicotine dependence
4983236|NCT01710137|Varenicline|varenicline
4983237|NCT01710137|Chantix|chantix
4983238|NCT01710137|HIV|hiv
4983239|NCT01710137|AIDS|aids
4983240|NCT01710124|grocery purchases|grocery purchases
4983241|NCT01710124|financial incentives|financial incentives
4983242|NCT01710124|obesogenic home food environment|obesogenic home food environment
4983243|NCT01710111|Human challenge model|human challenge model
4983244|NCT01710111|Quarantine study|quarantine study
4983245|NCT01710111|Influenza virus|influenza virus
4983246|NCT01710111|Modes of transmission|modes of transmission
4983247|NCT01710111|Droplet spray|droplet spray
4983248|NCT01710111|Droplet nuclei|droplet nuclei
4983249|NCT01710111|Secondary attack rate|secondary attack rate
4983250|NCT01710111|Face shield|face shield
4983251|NCT01710111|Hand hygiene|hand hygiene
4983252|NCT01710111|Fomites|fomites
4983253|NCT01710111|Environmental deposition|environmental deposition
4983254|NCT01710111|Environmental dispersion|environmental dispersion
4983255|NCT01710098|testosterone|testosterone
4983256|NCT01710098|S3-Adherence|s3-adherence
4983257|NCT01710098|Quality of Life|quality of life
4983258|NCT01710085|Diffusion weighted MRI|diffusion weighted mri
4983259|NCT01710085|Curative surgery|curative surgery
4983260|NCT01710085|Recurrence|recurrence
4983261|NCT01710072|aneurysm, inflammation, MRI|aneurysm, inflammation, mri
4983262|NCT01710059|Health Status Disparities|health status disparities
4983263|NCT01710059|Minority Health|minority health
4983264|NCT01710059|Pediatrics|pediatrics
4983265|NCT01710059|Behavioral Intervention|behavioral intervention
4983266|NCT01710059|Cellular Phone|cellular phone
4983267|NCT01710059|Peer Group|peer group
4983268|NCT01710046|plaque psoriasis|plaque psoriasis
4983269|NCT01710046|tofacitinib|tofacitinib
4983270|NCT01710046|biopsy|biopsy
4983271|NCT01710046|Janus Kinase|janus kinase
4983272|NCT01710046|randomized placebo controlled clinical trial|randomized placebo controlled clinical trial
4983273|NCT01710046|psoriasis vulgaris|psoriasis vulgaris
4983274|NCT01710033|CP-690,550|cp-690,550
4983275|NCT01710033|kidney transplant|kidney transplant
4983276|NCT01710020|CP-690|cp-690
4983277|NCT01710020|550|550
4983278|NCT01710020|pharmacokinetics|pharmacokinetics
4983279|NCT01710020|end-stage renal disease|end-stage renal disease
4983280|NCT01710007|HMG-CoA reductase inhibitors|hmg-coa reductase inhibitors
4983281|NCT01709994|cardiovascular events|cardiovascular events
4983282|NCT01709994|chronic kidney disease|chronic kidney disease
4983283|NCT01709994|bleedings|bleedings
4983284|NCT01709994|progression|progression
4983285|NCT01709994|antiinflammatory effects|antiinflammatory effects
4983286|NCT01709968|Nocturnal Leg Cramps|nocturnal leg cramps
4983287|NCT01709968|Quality of life|quality of life
4983288|NCT01709968|Quality of sleep|quality of sleep
4983289|NCT01709955|Obesity|obesity
4983290|NCT01709955|Overweight|overweight
4983291|NCT01709955|Glucomannan|glucomannan
4983292|NCT01709942|GnRH antagonist|gnrh antagonist
4983293|NCT01709942|PCOS|pcos
4983294|NCT01709942|OHSS|ohss
4983295|NCT01709942|COH|coh
4983296|NCT01709942|IVF|ivf
4983297|NCT01709916|Glaucoma|glaucoma
4983298|NCT01709916|intra ocular pressure|intra ocular pressure
4983299|NCT01709916|diurnal fluctuations|diurnal fluctuations
4983300|NCT01709903|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
4983301|NCT01709877|Multiport laparoscopy|multiport laparoscopy
4983302|NCT01709877|Single Port Laparoscopy|single port laparoscopy
4983303|NCT01709877|Symptomatic Gallstones|symptomatic gallstones
4983304|NCT01709864|Anticholinergic|anticholinergic
4983305|NCT01709864|Antimuscarinic|antimuscarinic
4983306|NCT01709864|Chronic Obstructive Airway Disease|chronic obstructive airway disease
4983307|NCT01709864|Chronic Obstructive Lung Disease|chronic obstructive lung disease
4983308|NCT01709864|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
4983309|NCT01709864|COPD|copd
4983310|NCT01709864|LAMA|lama
4983311|NCT01709864|Lung Disease|lung disease
4983312|NCT01709864|Lung Diseases, Obstructive|lung diseases, obstructive
4983313|NCT01709864|Lung Function|lung function
4983314|NCT01709864|Muscarinic receptor antagonist|muscarinic receptor antagonist
4983315|NCT01709864|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
4983316|NCT01709864|Respiratory Tract Diseases|respiratory tract diseases
4983317|NCT01709851|Type 1 diabetes|type 1 diabetes
4983318|NCT01709851|Intravascular continuous glucose monitoring|intravascular continuous glucose monitoring
4983319|NCT01709851|Subcutaneous continuous glucose monitoring|subcutaneous continuous glucose monitoring
4983320|NCT01709838|Non-transfusion dependent thalassemia, NTDT|non-transfusion dependent thalassemia, ntdt
4983321|NCT01709825|probiotics|probiotics
4983322|NCT01709825|cold|cold
4983323|NCT01709825|flu|flu
4983324|NCT01709825|immune function|immune function
4983325|NCT01709825|microbiota|microbiota
4983326|NCT01709799|Cognitive Training|cognitive training
4983327|NCT01709799|Aging|aging
4983328|NCT01709799|Seniors|seniors
4983329|NCT01709786|Hemorrhage|hemorrhage
4983330|NCT01709786|Hemoglobin|hemoglobin
4983331|NCT01709786|Non-invasive monitoring|non-invasive monitoring
4983332|NCT01709786|Medical device accuracy|medical device accuracy
4983333|NCT01709760|ENIA11|enia11
4983334|NCT01709760|MTX|mtx
4983335|NCT01709760|RA|ra
4983336|NCT01709760|TNF|tnf
4983337|NCT01709747|Hydromorphone Hydrochloride|hydromorphone hydrochloride
4983338|NCT01709747|Hydromorphone|hydromorphone
4983339|NCT01709747|Pain|pain
4983340|NCT01709747|Chronic Pain|chronic pain
4983341|NCT01709747|Implantable Pump|implantable pump
4983342|NCT01709747|Pump|pump
4983343|NCT01709747|Intrathecal|intrathecal
4983344|NCT01709734|prostate cancer CRPC|prostate cancer crpc
4983345|NCT01709721|Hydromorphone|hydromorphone
4983346|NCT01709721|Hydromorphone Hydrochloride|hydromorphone hydrochloride
4983347|NCT01709721|Pain Management|pain management
4983348|NCT01709721|Non-narcotic analgesics|non-narcotic analgesics
4983349|NCT01709708|Migraine|migraine
4983350|NCT01709708|Headache|headache
4983351|NCT01709708|Chronic Migraine|chronic migraine
4983352|NCT01709708|Marcaine|marcaine
4983353|NCT01709708|Tx360|tx360
4983354|NCT01709695|Intuniv|intuniv
4983355|NCT01709695|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
4983356|NCT01709695|fMRI|fmri
4983357|NCT01709682|atrial fibrillation|atrial fibrillation
4983358|NCT01709682|arrhythmias|arrhythmias
4983359|NCT01709682|anti-arrhythmic agents|anti-arrhythmic agents
4983360|NCT01709669|acute coronary syndrome|acute coronary syndrome
4983361|NCT01709669|gratitude|gratitude
4983362|NCT01709669|health behavior|health behavior
4983363|NCT01709669|myocardial infarction|myocardial infarction
4983364|NCT01709669|unstable angina|unstable angina
4983365|NCT01709617|carbohydrate, glycogen, glucose|carbohydrate, glycogen, glucose
4983366|NCT01709604|acute paraquat poisoning|acute paraquat poisoning
4983367|NCT01709604|hemoperfusion|hemoperfusion
4983368|NCT01709604|continuous blood purification|continuous blood purification
4983369|NCT01709591|intrapartum pain management, epidural|intrapartum pain management, epidural
4983370|NCT01709565|Sepsis|sepsis
4983371|NCT01709565|Lactic acid|lactic acid
4983372|NCT01709565|Shock|shock
4983373|NCT01709565|Resuscitation|resuscitation
4983374|NCT01709539|Cancer diagnosis center|cancer diagnosis center
4983375|NCT01709539|Time to diagnosis|time to diagnosis
4983376|NCT01709539|Survival|survival
4983377|NCT01709539|Health economics|health economics
4983378|NCT01709539|Biomarkers|biomarkers
4983379|NCT01709526|Psychosocial functioning|psychosocial functioning
4983380|NCT01709526|Cognitive performance of inpatients|cognitive performance of inpatients
4983381|NCT01709526|Psychiatric diseases|psychiatric diseases
4983382|NCT01709487|HIPEC|hipec
4983383|NCT01709487|ovarian carcinoma|ovarian carcinoma
4983384|NCT01709487|Bordet|bordet
4983385|NCT01709474|SLE|sle
4983386|NCT01709474|Vitamin D3|vitamin d3
4983387|NCT01709474|Vitamin D deficiency|vitamin d deficiency
4983388|NCT01709474|IFN alpha expression|ifn alpha expression
4983389|NCT01709448|Neoplasms, Squamous Cell|neoplasms, squamous cell
4983390|NCT01709448|Papillomavirus Infections|papillomavirus infections
4983391|NCT01709448|HIV|hiv
4983392|NCT01709422|Propofol|propofol
4983393|NCT01709422|Midazolam|midazolam
4983394|NCT01709422|Meperidine|meperidine
4983395|NCT01709409|Prematurity|prematurity
4983396|NCT01709383|Aphasia|aphasia
4983397|NCT01709383|Stroke|stroke
4983398|NCT01709383|Transcranial Direct Current Stimulation|transcranial direct current stimulation
4983399|NCT01709383|Neuroplasticity|neuroplasticity
4983400|NCT01709357|manual therapy|manual therapy
4983401|NCT01709357|trigger point|trigger point
4983402|NCT01709357|range of motion|range of motion
4983403|NCT01709357|pain threshold|pain threshold
4983404|NCT01709357|pain perception|pain perception
4983405|NCT01709292|Thyroid Cancer|thyroid cancer
4983406|NCT01709292|ERK|erk
4983407|NCT01709292|Extracellular-signal-regulated kinase|extracellular-signal-regulated kinase
4983408|NCT01709292|Biomarkers|biomarkers
4983409|NCT01709292|Papillary thyroid cancer|papillary thyroid cancer
4983410|NCT01709292|PTC|ptc
4983411|NCT01709292|BRAF mutated|braf mutated
4983412|NCT01709292|Vemurafenib|vemurafenib
4983413|NCT01709292|PLX4032|plx4032
4983414|NCT01709292|RO5185426|ro5185426
4983415|NCT01709292|Zelboraf™|zelboraf™
4983416|NCT01709279|Ischemic heart failure|ischemic heart failure
4983417|NCT01709279|Myocardial regeneration|myocardial regeneration
4983418|NCT01709279|ADRC|adrc
4983419|NCT01709253|hpofractionation study using proton beam therapy|hpofractionation study using proton beam therapy
4983420|NCT01709240|Chitosan|chitosan
4983421|NCT01709240|Plasma|plasma
4983422|NCT01709240|Incision Closure|incision closure
4983423|NCT01709227|Acute kidney injury|acute kidney injury
4983424|NCT01709227|AKI|aki
4983425|NCT01709227|cardiopulmonary bypass|cardiopulmonary bypass
4983426|NCT01709214|Osteoarthritis|osteoarthritis
4983427|NCT01709214|Knee|knee
4983428|NCT01709214|Pain|pain
4983429|NCT01709214|Chronic|chronic
4983430|NCT01709214|OA|oa
4983431|NCT01709214|Arthritis|arthritis
4983432|NCT01709201|Alcohol abuse|alcohol abuse
4983433|NCT01709201|Drug abuse|drug abuse
4983434|NCT01709201|Diabetes Mellitus|diabetes mellitus
4983435|NCT01709201|Persistent Asthma|persistent asthma
4983436|NCT01709201|Juvenile Arthritis|juvenile arthritis
4983437|NCT01709201|Ulcerative Colitis|ulcerative colitis
4983438|NCT01709188|Musical Dual Task Training|musical dual task training
4983439|NCT01709188|dementia|dementia
4983440|NCT01709188|attention control|attention control
4983441|NCT01709188|dual task cost|dual task cost
4983442|NCT01709188|gait stability|gait stability
4983443|NCT01709175|Cancer|cancer
4983444|NCT01709175|Breast Cancer|breast cancer
4983445|NCT01709175|Gynecologic Cancer|gynecologic cancer
4983446|NCT01709175|Strength Training|strength training
4983447|NCT01709175|Exercise|exercise
4983448|NCT01709175|Physical Activity|physical activity
4983449|NCT01709175|Fatigue|fatigue
4983450|NCT01709175|Quality of Life|quality of life
4983451|NCT01709175|Strength|strength
4983453|NCT01709175|Cancer Survivor|cancer survivor
4983454|NCT01709175|Survivor|survivor
4983455|NCT01709123|Diabetes Mellitus, Juvenile Onset|diabetes mellitus, juvenile onset
4983456|NCT01709123|Cardiovascular Diseases|cardiovascular diseases
4983457|NCT01709123|Hyperglycemia|hyperglycemia
4983458|NCT01709123|Hyperketonemia|hyperketonemia
4983459|NCT01709110|Bone Loss|bone loss
4983460|NCT01709110|Vertebral fractures|vertebral fractures
4983461|NCT01709097|Adherence|adherence
4983462|NCT01709097|Compliance|compliance
4983463|NCT01709097|Kidney Transplant Recipient|kidney transplant recipient
4983464|NCT01709097|An electronic drug dispenser|an electronic drug dispenser
4983465|NCT01709097|The Portal|the portal
4983466|NCT01709084|Human immunodeficiency virus-type 1 infection|human immunodeficiency virus-type 1 infection
4983467|NCT01709084|HIV-1|hiv-1
4983468|NCT01709084|Infectious diseases|infectious diseases
4983469|NCT01709084|Ribonucleic acid|ribonucleic acid
4983470|NCT01709084|RNA|rna
4983471|NCT01709084|Tenofovir disoproxil fumarate|tenofovir disoproxil fumarate
4983472|NCT01709084|Emtricitabine|emtricitabine
4983473|NCT01709084|Rilpivirine|rilpivirine
4983474|NCT01709084|Efavirenz|efavirenz
4983475|NCT01709084|Edurant|edurant
4983476|NCT01709084|TMC278|tmc278
4983477|NCT01709084|R278474|r278474
4983478|NCT01709084|Fixed dose combination|fixed dose combination
4983479|NCT01709071|Vaccination|vaccination
4983480|NCT01709071|Inactivated poliomyelitis vaccine|inactivated poliomyelitis vaccine
4983481|NCT01709071|poliomyelitis|poliomyelitis
4983482|NCT01709071|Sabin strains|sabin strains
4983483|NCT01709058|Back Pain|back pain
4983484|NCT01709058|Therapeutics|therapeutics
4983485|NCT01709058|Aged|aged
4983486|NCT01709058|Injections, Intramuscular|injections, intramuscular
4983487|NCT01709058|Oxygen|oxygen
4983488|NCT01709058|Ozone|ozone
4983489|NCT01709058|Geriatric Assessment|geriatric assessment
4983490|NCT01709058|Trace Elements|trace elements
4983491|NCT01709058|Oxidative stress|oxidative stress
4983492|NCT01709045|Endarterectomy, Carotid|endarterectomy, carotid
4983493|NCT01709045|Carotid Arteries|carotid arteries
4983494|NCT01709032|Thalassemia|thalassemia
4983495|NCT01709032|Chelation|chelation
4983496|NCT01709032|Transfusion|transfusion
4983497|NCT01709032|Safety|safety
4983498|NCT01709006|Head and neck cancer|head and neck cancer
4983499|NCT01708980|Arthroplasty, Replacement, Knee|arthroplasty, replacement, knee
4983500|NCT01708980|Electromyography|electromyography
4983501|NCT01708980|Resistance training|resistance training
4983502|NCT01708980|Physical Therapy Modalities|physical therapy modalities
4983503|NCT01708967|transnasal endoscopy|transnasal endoscopy
4983504|NCT01708967|pretreatment method|pretreatment method
4983505|NCT01708928|Ulthera® System|ulthera® system
4983506|NCT01708928|Ultherapy™ Treatment|ultherapy™ treatment
4983507|NCT01708928|Ulthera, Inc.|ulthera, inc.
4983508|NCT01708928|Ultrasound treatment for skin tightening|ultrasound treatment for skin tightening
4983509|NCT01708876|uncomplicated|uncomplicated
4983510|NCT01708876|plasmodium|plasmodium
4983511|NCT01708876|knowlesi|knowlesi
4983512|NCT01708876|malaria|malaria
4983513|NCT01708876|infection|infection
4983514|NCT01708863|Hypoplastic Left Heart Syndrome|hypoplastic left heart syndrome
4983515|NCT01708863|Stage II palliative surgery|stage ii palliative surgery
4983516|NCT01708863|Glenn procedure|glenn procedure
4983517|NCT01708863|Congenital heart defect|congenital heart defect
4983518|NCT01708863|Congenital heart disease|congenital heart disease
4983519|NCT01708863|Underdeveloped left ventricle|underdeveloped left ventricle
4983520|NCT01708837|Postoperative Cognitive Dysfunction|postoperative cognitive dysfunction
4983521|NCT01708837|Bispectral index|bispectral index
4983522|NCT01708824|colorectal cancer|colorectal cancer
4983523|NCT01708824|cancer survivor|cancer survivor
4983524|NCT01708824|western pattern diet|western pattern diet
4983525|NCT01708824|physical activity|physical activity
4983526|NCT01708824|behavioral intervention|behavioral intervention
4983527|NCT01708824|acceptability|acceptability
4983528|NCT01708824|feasibility|feasibility
4983529|NCT01708824|randomized controlled trial|randomized controlled trial
4983530|NCT01708824|compliance|compliance
4983531|NCT01708811|Contractility|contractility
4983532|NCT01708811|human|human
4983533|NCT01708811|myometrium|myometrium
4983534|NCT01708811|hyponatraemia|hyponatraemia
4983535|NCT01708798|Diastolic heart failure|diastolic heart failure
4983536|NCT01708785|obesity|obesity
4983537|NCT01708785|overweight|overweight
4983538|NCT01708785|overweight children|overweight children
4983539|NCT01708785|overweight parents|overweight parents
4983540|NCT01708785|overeating|overeating
4983541|NCT01708785|eating in the absence of hunger|eating in the absence of hunger
4983542|NCT01708785|families with overweight child|families with overweight child
4983543|NCT01708785|body mass index|body mass index
4983544|NCT01708785|BMI|bmi
4983545|NCT01708785|weight|weight
4983546|NCT01708785|childhood obesity|childhood obesity
4983547|NCT01708785|treatment|treatment
4983548|NCT01708785|cue exposure treatment|cue exposure treatment
4983549|NCT01708785|cravings|cravings
4983550|NCT01708785|habituation to food cues|habituation to food cues
4983551|NCT01708785|psychophysiological response to food cues|psychophysiological response to food cues
4983552|NCT01708785|intervention|intervention
4983553|NCT01708785|experiments|experiments
4983554|NCT01708785|family based treatment|family based treatment
4983555|NCT01708785|behavioral treatment|behavioral treatment
4983556|NCT01708772|TNF alpha|tnf alpha
4983557|NCT01708772|SOFA score|sofa score
4983558|NCT01708759|Serum Il-8|serum il-8
4983559|NCT01708759|IL8 polymorphism|il8 polymorphism
4983560|NCT01708759|critically ill patients|critically ill patients
4983561|NCT01708733|HCV carrier|hcv carrier
4983562|NCT01708733|Chinese herbal medicine|chinese herbal medicine
4983563|NCT01708733|Liver function|liver function
4983564|NCT01708733|HCV RNA titer|hcv rna titer
4983565|NCT01708720|Vaccination|vaccination
4983566|NCT01708720|Inactivated Poliomyelitis Vaccine|inactivated poliomyelitis vaccine
4983567|NCT01708720|Polio|polio
4983568|NCT01708720|Sabin|sabin
4983569|NCT01708681|Seafood|seafood
4983570|NCT01708681|Meat|meat
4983571|NCT01708681|Egg|egg
4983572|NCT01708681|Milk|milk
4983573|NCT01708681|Postprandial lipid metabolism|postprandial lipid metabolism
4983574|NCT01708681|Postprandial glucose metabolism|postprandial glucose metabolism
4983575|NCT01708681|Triglycerides|triglycerides
4983576|NCT01708681|Cholesterol|cholesterol
4983577|NCT01708681|Postprandial incretins|postprandial incretins
4983578|NCT01708681|Postprandial hormones|postprandial hormones
4983579|NCT01708668|Fever|fever
4983580|NCT01708668|Patient controlled epidural analgesia|patient controlled epidural analgesia
4983581|NCT01708668|Labor analgesia|labor analgesia
4983582|NCT01708668|Epidural analgesia|epidural analgesia
4983583|NCT01708668|Combined spinal-epidural analgesia|combined spinal-epidural analgesia
4983584|NCT01708655|Cystic Fibrosis|cystic fibrosis
4983585|NCT01708655|Sweat Evaporimeter|sweat evaporimeter
4983586|NCT01708629|psoriasis, brodalumab, AMG 827|psoriasis, brodalumab, amg 827
4983587|NCT01708603|psoriasis, brodalumab, AMG 827|psoriasis, brodalumab, amg 827
4983588|NCT01708590|psoriasis, brodalumab (AMG 827)|psoriasis, brodalumab (amg 827)
4983589|NCT01708577|heart rate|heart rate
4983590|NCT01708577|sweating|sweating
4983591|NCT01708577|respiration|respiration
4983592|NCT01708577|acceleration of body movement|acceleration of body movement
4983593|NCT01708577|heart activity.|heart activity.
4983594|NCT01708551|Hyperhidrosis|hyperhidrosis
4983595|NCT01708551|Axillary sweating|axillary sweating
4983596|NCT01708551|Ulthera® System|ulthera® system
4983597|NCT01708551|Ultherapy™ Treatment|ultherapy™ treatment
4983598|NCT01708551|Ulthera, Inc.|ulthera, inc.
4983599|NCT01708538|keratoconus, corneal collagen crosslinking, riboflavin, corneal ectasia|keratoconus, corneal collagen crosslinking, riboflavin, corneal ectasia
4983600|NCT01708525|Ulthera® System|ulthera® system
4983601|NCT01708525|Ultherapy® Treatment|ultherapy® treatment
4983602|NCT01708525|Ulthera, Inc.|ulthera, inc.
4983603|NCT01708525|Ultrasound treatment for skin tightening|ultrasound treatment for skin tightening
4983604|NCT01708512|Ulthera® System|ulthera® system
4983605|NCT01708512|Ultherapy™ Treatment|ultherapy™ treatment
4983606|NCT01708512|Ulthera, Inc.|ulthera, inc.
4983607|NCT01708512|Ultrasound treatment for skin tightening|ultrasound treatment for skin tightening
4983608|NCT01708499|Ulthera® System|ulthera® system
4983609|NCT01708499|Ultherapy™ Treatment|ultherapy™ treatment
4983610|NCT01708499|Ulthera, Inc.|ulthera, inc.
4983611|NCT01708499|Ultrasound treatment for skin tightening|ultrasound treatment for skin tightening
4983612|NCT01708486|asthma|asthma
4983613|NCT01708486|Dry Powder Inhalers|dry powder inhalers
4983614|NCT01708486|FSI-10 questionnaire|fsi-10 questionnaire
4983615|NCT01708460|Ulthera® System|ulthera® system
4983616|NCT01708460|Ultherapy™ Treatment|ultherapy™ treatment
4983617|NCT01708460|Ulthera, Inc.|ulthera, inc.
4983618|NCT01708460|Ultrasound treatment for skin tightening|ultrasound treatment for skin tightening
4983619|NCT01708434|Skin laxity|skin laxity
4983620|NCT01708434|Knees|knees
4983621|NCT01708408|biorepository|biorepository
4983622|NCT01708408|biobank|biobank
4983623|NCT01708408|registry|registry
4983624|NCT01708408|community|community
4983625|NCT01708408|biospecimens|biospecimens
4983626|NCT01708408|volunteers|volunteers
4983627|NCT01708408|chronic disease|chronic disease
4983628|NCT01708408|longitudinal|longitudinal
4983629|NCT01708408|blood|blood
4983630|NCT01708408|electronic health records|electronic health records
4983631|NCT01708408|follow-up|follow-up
4983632|NCT01708395|Ulcerative colitis|ulcerative colitis
4983633|NCT01708382|Ulthera® System|ulthera® system
4983634|NCT01708382|Ultherapy™ Treatment|ultherapy™ treatment
4983635|NCT01708382|Ulthera, Inc.|ulthera, inc.
4983636|NCT01708382|Ultrasound treatment for skin tightening|ultrasound treatment for skin tightening
4983637|NCT01708369|human carboxylesterase-1|human carboxylesterase-1
4983638|NCT01708369|human carboxylesterase-2|human carboxylesterase-2
4983639|NCT01708369|alcohol|alcohol
4983640|NCT01708369|pharmacokinetics|pharmacokinetics
4983641|NCT01708356|Air Pollution|air pollution
4983642|NCT01708356|Particulate Matter|particulate matter
4983643|NCT01708356|Exercise|exercise
4983644|NCT01708356|Respiratory Rate|respiratory rate
4983645|NCT01708356|Inflammation|inflammation
4983646|NCT01708356|Oxidative Stress|oxidative stress
4983647|NCT01708356|Plethysmography|plethysmography
4983850|NCT01707563|Variability|variability
4983648|NCT01708343|Myofascial Pain Syndrome,|myofascial pain syndrome,
4983649|NCT01708343|intramuscular stimulation,|intramuscular stimulation,
4983650|NCT01708343|acupuncture,|acupuncture,
4983651|NCT01708343|sleep quality,|sleep quality,
4983652|NCT01708343|pain threshold.|pain threshold.
4983653|NCT01708330|manual vacuum aspiration|manual vacuum aspiration
4983654|NCT01708330|missed abortion|missed abortion
4983655|NCT01708330|incomplete abortion|incomplete abortion
4983656|NCT01708330|nonviable pregnancy|nonviable pregnancy
4983657|NCT01708330|topical lidocaine|topical lidocaine
4983658|NCT01708317|ACASI|acasi
4983659|NCT01708317|Gonorrhea|gonorrhea
4983660|NCT01708317|Chlamydia|chlamydia
4983661|NCT01708317|Emergency Department|emergency department
4983662|NCT01708317|Youth|youth
4983663|NCT01708317|Adolescents|adolescents
4983664|NCT01708317|Computer|computer
4983665|NCT01708317|Questionnaire|questionnaire
4983666|NCT01708304|Dementia|dementia
4983667|NCT01708304|Alzheimer's Disease|alzheimer's disease
4983668|NCT01708304|Exercise|exercise
4983669|NCT01708304|Caregiver|caregiver
4983670|NCT01708304|Behavior modification|behavior modification
4983671|NCT01708291|youth|youth
4983672|NCT01708291|Stress|stress
4983673|NCT01708291|mindfulness|mindfulness
4983674|NCT01708291|foster care|foster care
4983675|NCT01708291|stress reduction|stress reduction
4983676|NCT01708291|high risk teens|high risk teens
4983677|NCT01708278|COPD|copd
4983678|NCT01708278|Emphysema|emphysema
4983679|NCT01708278|chronic bronchitis|chronic bronchitis
4983680|NCT01708278|Quercetin|quercetin
4983681|NCT01708278|flavonoids|flavonoids
4983682|NCT01708265|Mitral Valve Insufficiency|mitral valve insufficiency
4983683|NCT01708265|Mitral Valve Regurgitation|mitral valve regurgitation
4983684|NCT01708265|Asymptomatic Mitral Valve Regurgitation|asymptomatic mitral valve regurgitation
4983685|NCT01708265|Asymptomatic Mitral Valve Insufficiency|asymptomatic mitral valve insufficiency
4983686|NCT01708265|Mitral Valve Repair|mitral valve repair
4983687|NCT01708265|Watchful Waiting|watchful waiting
4983688|NCT01708252|Ulthera® System|ulthera® system
4983689|NCT01708252|Ultherapy™ Treatment|ultherapy™ treatment
4983690|NCT01708252|Ulthera, Inc.|ulthera, inc.
4983691|NCT01708252|Ultrasound treatment for skin tightening|ultrasound treatment for skin tightening
4983692|NCT01708239|Pregnancy|pregnancy
4983693|NCT01708239|Deep vein thrombosis|deep vein thrombosis
4983694|NCT01708239|Clinical probability|clinical probability
4983695|NCT01708239|D-Dimer|d-dimer
4983696|NCT01708239|Compression ultrasonography|compression ultrasonography
4983697|NCT01708226|OCD|ocd
4983698|NCT01708226|obsessive compulsive disorder|obsessive compulsive disorder
4983699|NCT01708226|children|children
4983700|NCT01708213|soft tissue|soft tissue
4983701|NCT01708213|augmentation|augmentation
4983702|NCT01708213|correction|correction
4983703|NCT01708213|wrinkles|wrinkles
4983704|NCT01708200|Memory|memory
4983705|NCT01708200|Intervention|intervention
4983706|NCT01708200|Computerized|computerized
4983707|NCT01708200|Psychoeducational|psychoeducational
4983708|NCT01708200|Mental Illness|mental illness
4983709|NCT01708187|Peroneal tendon|peroneal tendon
4983710|NCT01708174|medulloblastoma,|medulloblastoma,
4983711|NCT01708174|relapsed,|relapsed,
4983712|NCT01708174|pediatric,|pediatric,
4983713|NCT01708174|children,|children,
4983714|NCT01708174|adults,|adults,
4983715|NCT01708174|Hh pathway inhibitor,|hh pathway inhibitor,
4983716|NCT01708174|LDE225|lde225
4983717|NCT01708161|PIK3CA mutation|pik3ca mutation
4983718|NCT01708161|advanced solid tumor|advanced solid tumor
4983719|NCT01708161|breast cancer|breast cancer
4983720|NCT01708161|ovarian cancer|ovarian cancer
4983721|NCT01708161|cancers with a mass|cancers with a mass
4983722|NCT01708161|bulky tumor|bulky tumor
4983723|NCT01708161|nodule|nodule
4983724|NCT01708161|lump|lump
4983725|NCT01708161|advanced cancer|advanced cancer
4983726|NCT01708161|advanced solid malignancies|advanced solid malignancies
4983727|NCT01708122|Intranasal fentanyl|intranasal fentanyl
4983728|NCT01708122|Cystoscopy|cystoscopy
4983729|NCT01708070|asthma|asthma
4983730|NCT01708070|depression|depression
4983731|NCT01708070|anxiety|anxiety
4983732|NCT01708057|COPD|copd
4983733|NCT01708057|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
4983734|NCT01708044|Pramlintide,|pramlintide,
4983735|NCT01708044|insulin,|insulin,
4983736|NCT01708044|type 1 diabetes,|type 1 diabetes,
4983737|NCT01708044|reduction in postprandial glucose,|reduction in postprandial glucose,
4983738|NCT01708044|pramlintide:insulin dose-ratio|pramlintide:insulin dose-ratio
4983739|NCT01708018|Pregnancy|pregnancy
4983740|NCT01708018|Stress, Psychological|stress, psychological
4983741|NCT01708018|Low Back Pain|low back pain
4983742|NCT01708018|Breech Presentation|breech presentation
4983743|NCT01708018|Relaxation|relaxation
4983744|NCT01708018|Hydrotherapy|hydrotherapy
4983745|NCT01708018|Acupressure|acupressure
4983746|NCT01708018|WATSU|watsu
4983747|NCT01708005|Mild Cognitive Impairment|mild cognitive impairment
4983748|NCT01708005|Vitamin D|vitamin d
4983749|NCT01708005|Cholecalciferol|cholecalciferol
4983750|NCT01708005|Lecitone®Se-Vitamin D3|lecitone®se-vitamin d3
4983851|NCT01707563|Fibrillin 1|fibrillin 1
4983751|NCT01707979|Near infrared light|near infrared light
4983752|NCT01707979|Diabetic neuropathy|diabetic neuropathy
4983753|NCT01707979|Sensory neuropathy|sensory neuropathy
4983754|NCT01707979|Autonomic neuropathy|autonomic neuropathy
4983755|NCT01707979|Vagus|vagus
4983756|NCT01707979|Sudomotor function|sudomotor function
4983757|NCT01707979|Monofilament|monofilament
4983758|NCT01707979|Impedance|impedance
4983759|NCT01707966|adenocarcinoma of the prostate|adenocarcinoma of the prostate
4983760|NCT01707966|metastatic castration-resistant prostate cancer|metastatic castration-resistant prostate cancer
4983761|NCT01707966|maintenance therapy|maintenance therapy
4983762|NCT01707966|orteronel|orteronel
4983763|NCT01707966|TAK-700|tak-700
4983764|NCT01707927|EOA|eoa
4983765|NCT01707914|oxidative stress|oxidative stress
4983766|NCT01707914|dyslipidemia|dyslipidemia
4983767|NCT01707914|inflammation|inflammation
4983768|NCT01707901|GERD|gerd
4983769|NCT01707862|Intravenous leiomyomatosis|intravenous leiomyomatosis
4983770|NCT01707862|Surgery|surgery
4983771|NCT01707862|Smooth muscle tumor|smooth muscle tumor
4983772|NCT01707849|Hepatitis C|hepatitis c
4983773|NCT01707849|Liver Fibrosis|liver fibrosis
4983774|NCT01707849|m-TOR inhibitors|m-tor inhibitors
4983775|NCT01707810|Liver transplatation|liver transplatation
4983776|NCT01707797|dental caries|dental caries
4983777|NCT01707797|high risk|high risk
4983778|NCT01707797|dental cavities|dental cavities
4983779|NCT01707797|children dental care|children dental care
4983780|NCT01707784|Pregnancy|pregnancy
4983781|NCT01707784|Stress|stress
4983782|NCT01707784|Anxiety|anxiety
4983783|NCT01707784|Cortisol|cortisol
4983784|NCT01707784|Copeptin|copeptin
4983785|NCT01707784|Gestational diabetes|gestational diabetes
4983786|NCT01707758|pancreatic cancer|pancreatic cancer
4983787|NCT01707758|nanoparticle|nanoparticle
4983788|NCT01707758|proteases|proteases
4983789|NCT01707758|cell survival|cell survival
4983790|NCT01707758|tumor progression|tumor progression
4983791|NCT01707758|angiogenesis|angiogenesis
4983792|NCT01707758|tissue remodeling/invasion|tissue remodeling/invasion
4983793|NCT01707732|Obesity|obesity
4983794|NCT01707732|thromboprophylaxis|thromboprophylaxis
4983795|NCT01707732|Enoxaparin|enoxaparin
4983796|NCT01707719|Alzheimer's disease|alzheimer's disease
4983797|NCT01707719|Oxidative stress|oxidative stress
4983798|NCT01707719|HPA axis|hpa axis
4983799|NCT01707706|Insomnia|insomnia
4983800|NCT01707706|Depression|depression
4983801|NCT01707706|Electroacupuncture|electroacupuncture
4983802|NCT01707706|Acupuncture|acupuncture
4983803|NCT01707706|Randomized Clinical Trial|randomized clinical trial
4983804|NCT01707706|Traditional Chinese Medicine|traditional chinese medicine
4983805|NCT01707693|physical activity|physical activity
4983806|NCT01707693|prevention|prevention
4983807|NCT01707693|coronary heart disease|coronary heart disease
4983808|NCT01707693|women|women
4983809|NCT01707680|weaning|weaning
4983810|NCT01707680|mechanical ventilation|mechanical ventilation
4983811|NCT01707680|dexmedetomidine|dexmedetomidine
4983812|NCT01707680|propofol|propofol
4983813|NCT01707680|midazolam|midazolam
4983814|NCT01707654|defect;|defect;
4983815|NCT01707654|dorsal branch of the proper digital nerve;|dorsal branch of the proper digital nerve;
4983816|NCT01707654|proper digital nerve;|proper digital nerve;
4983817|NCT01707654|finger sensory reconstruction.|finger sensory reconstruction.
4983818|NCT01707628|NHL|nhl
4983819|NCT01707628|influenza vaccination|influenza vaccination
4983820|NCT01707628|rituximab|rituximab
4983821|NCT01707615|proanthocyanidin,atherosclerosis, carotid plaque|proanthocyanidin,atherosclerosis, carotid plaque
4983822|NCT01707602|Intradermal|intradermal
4983823|NCT01707602|transcutaneous|transcutaneous
4983824|NCT01707602|influenza|influenza
4983825|NCT01707602|routes of vaccination|routes of vaccination
4983826|NCT01707602|T cell responses|t cell responses
4983827|NCT01707602|humoral responses|humoral responses
4983828|NCT01707602|skin|skin
4983829|NCT01707602|clinical trial|clinical trial
4983830|NCT01707602|Novel application of influenza vaccine|novel application of influenza vaccine
4983831|NCT01707602|Transcutaneous vaccination(hair follicular targeting)|transcutaneous vaccination(hair follicular targeting)
4983959|NCT01707108|bone loss|bone loss
4983832|NCT01707602|Intradermal vaccination(micro-needle)|intradermal vaccination(micro-needle)
4983833|NCT01707589|monitoring|monitoring
4983834|NCT01707589|heart rate|heart rate
4983835|NCT01707589|respiration rate|respiration rate
4983836|NCT01707589|temperature|temperature
4983837|NCT01707589|motion|motion
4983838|NCT01707589|noninvasive|noninvasive
4983839|NCT01707589|physiologic parameters|physiologic parameters
4983840|NCT01707589|NICU|nicu
4983841|NCT01707576|Follow-Up Studies|follow-up studies
4983842|NCT01707576|Adolescent|adolescent
4983843|NCT01707576|Depressive Disorder, Major/diagnosis|depressive disorder, major/diagnosis
4983844|NCT01707576|Attempted/prevention & control|attempted/prevention & control
4983845|NCT01707576|Self-report questionnaire|self-report questionnaire
4983846|NCT01707576|emmergency department|emmergency department
4983847|NCT01707576|parental perception|parental perception
4983848|NCT01707576|Emergency|emergency
4983849|NCT01707563|Marfan syndrome|marfan syndrome
4983852|NCT01707563|clinical expression|clinical expression
4983853|NCT01707537|OCV|ocv
4983854|NCT01707537|cholera|cholera
4983855|NCT01707511|Arterial carbondioxide pressure|arterial carbondioxide pressure
4983856|NCT01707511|Colon surgery|colon surgery
4983857|NCT01707511|End-tidal carbondioxide|end-tidal carbondioxide
4983858|NCT01707511|Laparoscopic Trendelenburg|laparoscopic trendelenburg
4983859|NCT01707498|BCI|bci
4983860|NCT01707498|TETRAPLEGIA|tetraplegia
4983861|NCT01707498|COMMUNICATION|communication
4983862|NCT01707498|P300|p300
4983863|NCT01707498|ASSISTIVE TECHNOLOGIE|assistive technologie
4983864|NCT01707485|Antibiotics|antibiotics
4983865|NCT01707472|Liver Fibrosis|liver fibrosis
4983866|NCT01707472|Fibrosis|fibrosis
4983867|NCT01707472|HIV|hiv
4983868|NCT01707472|HCV|hcv
4983869|NCT01707472|GS-6624|gs-6624
4983870|NCT01707472|Hepatitis|hepatitis
4983871|NCT01707472|Hepatitis C|hepatitis c
4983872|NCT01707459|platelet function|platelet function
4983873|NCT01707459|perioperative complications|perioperative complications
4983874|NCT01707459|major adverse cardiac events (MACE)|major adverse cardiac events (mace)
4983875|NCT01707459|thromboelastography|thromboelastography
4983876|NCT01707459|polymorphism analysis|polymorphism analysis
4983877|NCT01707459|coronary stents|coronary stents
4983878|NCT01707459|non-cardiac surgery|non-cardiac surgery
4983879|NCT01707446|Cardiac surgery|cardiac surgery
4983880|NCT01707446|Delirium|delirium
4983881|NCT01707446|Cerebral Oximetry|cerebral oximetry
4983882|NCT01707433|spondyloepiphyseal dysplasia|spondyloepiphyseal dysplasia
4983883|NCT01707433|multiple epiphyseal dysplasia|multiple epiphyseal dysplasia
4983884|NCT01707433|bilateral Legg Calve Perthes|bilateral legg calve perthes
4983885|NCT01707433|bilateral proximal femoral epiphyseal dysplasia|bilateral proximal femoral epiphyseal dysplasia
4983886|NCT01707433|GALNS|galns
4983887|NCT01707420|pediatric pain|pediatric pain
4983888|NCT01707420|post operative pain|post operative pain
4983889|NCT01707420|opioids|opioids
4983890|NCT01707420|emergence agitation|emergence agitation
4983891|NCT01707420|preoperative anxiety|preoperative anxiety
4983892|NCT01707420|pharmacogenomics|pharmacogenomics
4983893|NCT01707407|CC-4047|cc-4047
4983894|NCT01707407|Pomalidomide|pomalidomide
4983895|NCT01707407|Ketoconazole|ketoconazole
4983896|NCT01707407|Fluvoxamine|fluvoxamine
4983897|NCT01707407|Carbamazepine|carbamazepine
4983898|NCT01707407|DDI|ddi
4983899|NCT01707407|safety|safety
4983900|NCT01707407|tolerability|tolerability
4983901|NCT01707407|pharmacokinetic|pharmacokinetic
4983902|NCT01707368|Psoriasis|psoriasis
4983903|NCT01707368|Psoriasis vulgaris|psoriasis vulgaris
4983904|NCT01707368|Plaque Psoriasis|plaque psoriasis
4983905|NCT01707368|Daivobet® Gel|daivobet® gel
4983906|NCT01707368|Germany|germany
4983907|NCT01707355|education, knowledge, poster, dental trauma|education, knowledge, poster, dental trauma
4983908|NCT01707342|Healthy male participants|healthy male participants
4983909|NCT01707342|Absolute bioavailability|absolute bioavailability
4983910|NCT01707342|Bioavailability|bioavailability
4983911|NCT01707342|Pharmacokinetics|pharmacokinetics
4983912|NCT01707342|Simeprevir|simeprevir
4983913|NCT01707342|TMC435|tmc435
4983914|NCT01707342|[3H]-TMC435|[3h]-tmc435
4983915|NCT01707342|Hepatitis C virus|hepatitis c virus
4983916|NCT01707342|HCV|hcv
4983917|NCT01707316|Healthy|healthy
4983918|NCT01707316|JNJ-28431754|jnj-28431754
4983919|NCT01707316|Canagliflozin|canagliflozin
4983920|NCT01707316|Pharmacokinetics|pharmacokinetics
4983921|NCT01707316|Pharmacodynamics|pharmacodynamics
4983922|NCT01707303|ICU|icu
4983923|NCT01707303|Critical Care|critical care
4983924|NCT01707303|Intensive Care|intensive care
4983925|NCT01707303|Critical Illness|critical illness
4983926|NCT01707303|Acute Respiratory Failure|acute respiratory failure
4983927|NCT01707303|Mechanical Ventilation|mechanical ventilation
4983928|NCT01707303|Physical Therapy|physical therapy
4983929|NCT01707303|Strength|strength
4983930|NCT01707303|Functional Status|functional status
4983931|NCT01707303|Short Physical Performance Battery|short physical performance battery
4983932|NCT01707277|Heart failure with preserved ejection fraction|heart failure with preserved ejection fraction
4983933|NCT01707277|Inspiratory muscle training|inspiratory muscle training
4983934|NCT01707277|Exercise capacity|exercise capacity
4983935|NCT01707264|AL amyloidosis|al amyloidosis
4983936|NCT01707264|Primary amyloidosis|primary amyloidosis
4983937|NCT01707251|Obesity, Morbid|obesity, morbid
4983938|NCT01707251|Bariatric Surgery|bariatric surgery
4983939|NCT01707251|Laparoscopy|laparoscopy
4983940|NCT01707251|Intravenous Ibuprofen|intravenous ibuprofen
4983941|NCT01707251|Analgesia|analgesia
4983942|NCT01707251|Morphine|morphine
4983943|NCT01707225|GI Bleeding|gi bleeding
4983944|NCT01707225|Gastrointestinal bleeding|gastrointestinal bleeding
4983945|NCT01707225|LVAD|lvad
4983946|NCT01707212|parent education|parent education
4983947|NCT01707212|pain management|pain management
4983948|NCT01707212|immunization|immunization
4983949|NCT01707212|infant|infant
4983950|NCT01707199|P. falciparum|p. falciparum
4983951|NCT01707199|Sulphadoxine-pyrimethamine|sulphadoxine-pyrimethamine
4983952|NCT01707199|Artesunate|artesunate
4983953|NCT01707199|Artemisinin Combination Therapy (ACT)|artemisinin combination therapy (act)
4983954|NCT01707173|SIDS|sids
4983955|NCT01707121|morbidity|morbidity
4983956|NCT01707121|sick-leave|sick-leave
4983957|NCT01707121|hospital stay|hospital stay
4983958|NCT01707108|dental implants|dental implants
4983960|NCT01707095|Electrosurgery|electrosurgery
4983961|NCT01707095|Radiofrequency energy|radiofrequency energy
4983962|NCT01707095|Monopolar instruments|monopolar instruments
4983963|NCT01707095|Capacitive coupling|capacitive coupling
4983964|NCT01707095|Thermal injury|thermal injury
4983965|NCT01707095|Surgical complications|surgical complications
4983966|NCT01707056|levothyroxine|levothyroxine
4983967|NCT01707056|synthroid|synthroid
4983968|NCT01707056|coffee|coffee
4983969|NCT01707056|absorption|absorption
4983970|NCT01707056|tea|tea
4983971|NCT01707056|thyroid carcinoma|thyroid carcinoma
4983972|NCT01707043|plaque psoriasis|plaque psoriasis
4983973|NCT01707043|taclonex|taclonex
4983974|NCT01707043|crossover|crossover
4983975|NCT01707030|clinical trial|clinical trial
4983976|NCT01707030|veteran|veteran
4983977|NCT01707030|substance use disorder|substance use disorder
4983978|NCT01706978|rotator cuff tear|rotator cuff tear
4983979|NCT01706952|Endoscopic sinus surgery|endoscopic sinus surgery
4983980|NCT01706952|Bleeding|bleeding
4983981|NCT01706952|Topical Vasocontriction|topical vasocontriction
4983982|NCT01706952|Cocaine|cocaine
4983983|NCT01706952|Adrenaline|adrenaline
4983984|NCT01706939|Reduced radiotherapy|reduced radiotherapy
4983985|NCT01706939|Randomization, Phase III|randomization, phase iii
4983986|NCT01706939|Reduced radiation therapy|reduced radiation therapy
4983987|NCT01706939|head and neck|head and neck
4983988|NCT01706939|oropharynx|oropharynx
4983989|NCT01706939|unknown primary (cervical lymph nodes)|unknown primary (cervical lymph nodes)
4983990|NCT01706939|nasopharynx primary|nasopharynx primary
4983991|NCT01706939|HPV|hpv
4983992|NCT01706939|p16|p16
4983993|NCT01706926|Rheumatoid Arthritis|rheumatoid arthritis
4983994|NCT01706926|Mavrilimumab|mavrilimumab
4983995|NCT01706926|CAM-3001|cam-3001
4983996|NCT01706887|Nedd4-2|nedd4-2
4983997|NCT01706887|blood pressure|blood pressure
4983998|NCT01706887|polymorphism|polymorphism
4983999|NCT01706887|salt intake|salt intake
4984000|NCT01706887|between 18 and 35 years old|between 18 and 35 years old
4984001|NCT01706887|BMI between 18 and 28 Kg per m2|bmi between 18 and 28 kg per m2
4984002|NCT01706887|no active disease|no active disease
4984003|NCT01706887|no alcool or drug abuse or smoke|no alcool or drug abuse or smoke
4984004|NCT01706874|Rheumatoid arthritis|rheumatoid arthritis
4984005|NCT01706874|P.gingivalis|p.gingivalis
4984006|NCT01706874|Periodontal disease|periodontal disease
4984007|NCT01706874|Plaque control|plaque control
4984008|NCT01706874|Prophylaxis|prophylaxis
4984009|NCT01706874|Oral hygiene instruction|oral hygiene instruction
4984010|NCT01706835|solid tumor|solid tumor
4984011|NCT01706835|aldoxorubicin|aldoxorubicin
4984012|NCT01706835|phase 1|phase 1
4984013|NCT01706835|pharmacokinetic|pharmacokinetic
4984014|NCT01706835|INNO-206|inno-206
4984015|NCT01706796|Pain|pain
4984016|NCT01706744|Hospital Readmissions|hospital readmissions
4984017|NCT01706744|Community Health Services|community health services
4984018|NCT01706744|Preventive Health Services|preventive health services
4984019|NCT01706744|Norway|norway
4984020|NCT01706731|Buddhist monks|buddhist monks
4984021|NCT01706731|CBT|cbt
4984022|NCT01706731|elderly|elderly
4984023|NCT01706731|depression|depression
4984024|NCT01706718|Beetroot|beetroot
4984025|NCT01706718|Blood pressure|blood pressure
4984026|NCT01706718|Vascular function|vascular function
4984027|NCT01706705|Cervical Cancer|cervical cancer
4984028|NCT01706705|Radiation therapy|radiation therapy
4984029|NCT01706705|XRT|xrt
4984030|NCT01706705|External beam therapy|external beam therapy
4984031|NCT01706705|Brachytherapy|brachytherapy
4984032|NCT01706705|Intracavitary brachytherapy|intracavitary brachytherapy
4984033|NCT01706705|ICBT|icbt
4984034|NCT01706705|MRI compatible intracavitary applicators|mri compatible intracavitary applicators
4984035|NCT01706705|Computed tomography|computed tomography
4984036|NCT01706705|CT|ct
4984037|NCT01706705|Magnetic resonance imaging|magnetic resonance imaging
4984038|NCT01706705|MRI|mri
4984039|NCT01706705|MRI compatible applicators|mri compatible applicators
4984040|NCT01706705|3D image guided treatment planning|3d image guided treatment planning
4984041|NCT01706705|2D treatment planning|2d treatment planning
4984042|NCT01706692|Methotrexate|methotrexate
4984043|NCT01706692|Acitretin|acitretin
4984044|NCT01706692|Cyclosporine A|cyclosporine a
4984045|NCT01706692|Systemic PUVA|systemic puva
4984046|NCT01706692|Infliximab|infliximab
4984047|NCT01706692|Adalimumab|adalimumab
4984048|NCT01706692|Etanercept|etanercept
4984049|NCT01706692|Ustekinumab|ustekinumab
4984050|NCT01706692|Fumaric acids|fumaric acids
4984051|NCT01706692|Psoriasis|psoriasis
4984052|NCT01706692|Psoriatic arthritis|psoriatic arthritis
4984053|NCT01706692|Skin disease|skin disease
4984054|NCT01706679|Healthy volunteers|healthy volunteers
4984055|NCT01706666|Maintenance|maintenance
4984056|NCT01706666|Consolidation|consolidation
4984057|NCT01706653|Polyphenol|polyphenol
4984058|NCT01706653|Fruit|fruit
4984059|NCT01706653|Metabolic|metabolic
4984060|NCT01706653|Healthy|healthy
4984061|NCT01706627|cancer|cancer
4984062|NCT01706627|melatonin|melatonin
4984063|NCT01706627|adjuvant therapy|adjuvant therapy
4984064|NCT01706627|quality of life|quality of life
4984065|NCT01706627|survival|survival
4984066|NCT01706627|adverse events|adverse events
4984067|NCT01706627|oxidative stress|oxidative stress
4984068|NCT01706588|diclofenac, postsurgical pain, oral surgery|diclofenac, postsurgical pain, oral surgery
4984069|NCT01706562|Neutropenia|neutropenia
4984070|NCT01706562|Hematologic malignancy|hematologic malignancy
4984071|NCT01706562|Itraconazole|itraconazole
4984072|NCT01706562|Fungal infection|fungal infection
4984073|NCT01706562|Antifungal agent|antifungal agent
4984074|NCT01706562|Neutropenic fever|neutropenic fever
4984075|NCT01706549|Chronic pain|chronic pain
4984076|NCT01706549|Hysterectomy|hysterectomy
4984077|NCT01706549|Quality of life|quality of life
4984078|NCT01706523|Autism Spectrum Disorders|autism spectrum disorders
4984079|NCT01706523|Autism|autism
4984080|NCT01706523|Asperger|asperger
4984081|NCT01706523|Pervasive Developmental Disorder - Not otherwise specified|pervasive developmental disorder - not otherwise specified
4984082|NCT01706510|Clopidogrel|clopidogrel
4984083|NCT01706510|Ticagrelor|ticagrelor
4984084|NCT01706510|Coronary Artery Disease|coronary artery disease
4984085|NCT01706510|Myocardial Ischemia|myocardial ischemia
4984086|NCT01706510|Coronary Disease|coronary disease
4984087|NCT01706510|Heart Diseases|heart diseases
4984088|NCT01706510|Cardiovascular Diseases|cardiovascular diseases
4984089|NCT01706510|Arteriosclerosis|arteriosclerosis
4984090|NCT01706510|Arterial Occlusive Diseases|arterial occlusive diseases
4984091|NCT01706510|Vascular Diseases|vascular diseases
4984092|NCT01706510|Platelet Aggregation Inhibitors|platelet aggregation inhibitors
4984093|NCT01706510|Hematologic Agents|hematologic agents
4984094|NCT01706510|Therapeutic Uses|therapeutic uses
4984095|NCT01706510|Pharmacologic Actions|pharmacologic actions
4984096|NCT01706510|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists
4984097|NCT01706510|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists
4984098|NCT01706510|Purinergic Antagonists|purinergic antagonists
4984099|NCT01706510|Purinergic Agents|purinergic agents
4984100|NCT01706510|Physiological Effects of Drugs|physiological effects of drugs
4984101|NCT01706497|cerebral tissue oxygen saturation|cerebral tissue oxygen saturation
4984102|NCT01706497|congenital cardiac surgery|congenital cardiac surgery
4984103|NCT01706497|pediatric intensive care unit|pediatric intensive care unit
4984104|NCT01706497|Near Infra-Red Spectroscopy|near infra-red spectroscopy
4984105|NCT01706497|early warning monitor|early warning monitor
4984106|NCT01706497|outcome prediction|outcome prediction
4984107|NCT01706484|randomized clinical trial|randomized clinical trial
4984108|NCT01706484|chronic rhinosinusitis|chronic rhinosinusitis
4984109|NCT01706484|herbal extract BNO 1016|herbal extract bno 1016
4984110|NCT01706484|exacerbation|exacerbation
4984111|NCT01706484|pharmacoeconomic|pharmacoeconomic
4984112|NCT01706484|quality of life|quality of life
4984113|NCT01706471|verLowCNI|verlowcni
4984114|NCT01706458|Vaccine|vaccine
4984115|NCT01706458|pTVG-HP|ptvg-hp
4984116|NCT01706458|Prostate Cancer|prostate cancer
4984117|NCT01706458|Castrate Resistant|castrate resistant
4984118|NCT01706445|cystic fibrosis|cystic fibrosis
4984119|NCT01706445|exercise|exercise
4984120|NCT01706445|children|children
4984121|NCT01706445|cardiorespiratory fitness|cardiorespiratory fitness
4984122|NCT01706445|muscle strength|muscle strength
4984123|NCT01706445|pulmonary function|pulmonary function
4984124|NCT01706445|quality of life|quality of life
4984125|NCT01706419|vitamin A|vitamin a
4984126|NCT01706419|iron|iron
4984127|NCT01706419|zinc|zinc
4984128|NCT01706419|school children|school children
4984129|NCT01706419|fortified rice|fortified rice
4984130|NCT01706419|morbidity|morbidity
4984131|NCT01706419|growth|growth
4984132|NCT01706406|female sexual arousal|female sexual arousal
4984133|NCT01706406|female sexual desire|female sexual desire
4984134|NCT01706406|psychoeducational intervention|psychoeducational intervention
4984135|NCT01706393|probiotics|probiotics
4984136|NCT01706393|intestinal microbiome|intestinal microbiome
4984137|NCT01706393|radiotherapy|radiotherapy
4984138|NCT01706380|Substance use disorders|substance use disorders
4984139|NCT01706380|Adolescents|adolescents
4984140|NCT01706380|Retention|retention
4984141|NCT01706380|Mobile telephone|mobile telephone
4984142|NCT01706380|Follow-up|follow-up
4984143|NCT01706380|Interactive voice response|interactive voice response
4984144|NCT01706367|Clostridium difficile|clostridium difficile
4984145|NCT01706367|vaccine|vaccine
4984146|NCT01706354|end stage renal disease|end stage renal disease
4984147|NCT01706354|vascular access|vascular access
4984148|NCT01706354|regional anaesthesia|regional anaesthesia
4984149|NCT01706341|cesarean section|cesarean section
4984150|NCT01706341|intravenous fluid|intravenous fluid
4984151|NCT01706341|a glucose-containing solution|a glucose-containing solution
4984152|NCT01706341|fetal hypoglycemia|fetal hypoglycemia
4984153|NCT01706341|neonatal hypoglycemia|neonatal hypoglycemia
4984154|NCT01706328|Vilanterol (VI)|vilanterol (vi)
4984155|NCT01706328|Novel Dry Powder Inhaler (NDPI)|novel dry powder inhaler (ndpi)
4984156|NCT01706328|FEV1|fev1
4984157|NCT01706328|Fluticasone Furoate (FF)|fluticasone furoate (ff)
4984158|NCT01706328|COPD|copd
4984159|NCT01706302|General Practice Research Database|general practice research database
4984160|NCT01706302|Burden of Disease|burden of disease
4984161|NCT01706302|Clinical Practice Research Datalink|clinical practice research datalink
4984162|NCT01706302|Hospital Episode Statistics|hospital episode statistics
4984163|NCT01706302|Office of National Statistics|office of national statistics
4984164|NCT01706302|RSV|rsv
4984165|NCT01706289|diabetes|diabetes
4984166|NCT01706289|cardiovascular autonomic neuropathy|cardiovascular autonomic neuropathy
4984167|NCT01706289|VAP 1|vap 1
4984168|NCT01706237|Myopia|myopia
4984169|NCT01706237|LASIK|lasik
4984170|NCT01706224|Pertussis antibodies|pertussis antibodies
4984171|NCT01706224|Bordetella pertussis|bordetella pertussis
4984172|NCT01706224|sero-prevalence|sero-prevalence
4984173|NCT01706224|Healthcare professionals (HCP)|healthcare professionals (hcp)
4984174|NCT01706224|Spain|spain
4984175|NCT01706211|non insulin dependent diabetes mellitus, rosiglitazone|non insulin dependent diabetes mellitus, rosiglitazone
4984176|NCT01706198|respiratory|respiratory
4984177|NCT01706198|adult|adult
4984178|NCT01706198|asthma|asthma
4984179|NCT01706185|Patients|patients
4984180|NCT01706185|Tumor antigens|tumor antigens
4984181|NCT01706185|Bladder cancer|bladder cancer
4984182|NCT01706172|TMD|tmd
4984183|NCT01706172|temporomandibular|temporomandibular
4984184|NCT01706172|dextrose|dextrose
4984185|NCT01706172|prolotherapy|prolotherapy
4984186|NCT01706146|atrial fibrillation|atrial fibrillation
4984187|NCT01706146|reveal xt|reveal xt
4984188|NCT01706146|oral anticoagulation|oral anticoagulation
4984189|NCT01706146|dabigatran|dabigatran
4984190|NCT01706146|rivaroxaban|rivaroxaban
4984191|NCT01706146|apixaban|apixaban
4984192|NCT01706133|Frailty, emergency services, elderly|frailty, emergency services, elderly
4984193|NCT01706120|prognostic factors|prognostic factors
4984194|NCT01706120|biologic factors|biologic factors
4984195|NCT01706120|clinical factors|clinical factors
4984196|NCT01706120|routine clinical practice|routine clinical practice
4984197|NCT01706107|Quality of life|quality of life
4984198|NCT01706094|stroke|stroke
4984199|NCT01706094|head position|head position
4984200|NCT01706081|acupuncture|acupuncture
4984201|NCT01706068|acute ECG changes|acute ecg changes
4984202|NCT01706068|acute illness of gallbladder|acute illness of gallbladder
4984203|NCT01706068|acute illness of biliary tract|acute illness of biliary tract
4984204|NCT01706055|Multiple Sclerosis (MS)|multiple sclerosis (ms)
4984205|NCT01706055|Interferon|interferon
4984206|NCT01706003|Migraine|migraine
4984207|NCT01706003|Headaches|headaches
4984208|NCT01706003|Telemedicine|telemedicine
4984209|NCT01705990|HIV|hiv
4984210|NCT01705990|AIDS|aids
4984211|NCT01705990|HIV vaccine|hiv vaccine
4984212|NCT01705990|HIV prevention|hiv prevention
4984213|NCT01705977|Antibodies|antibodies
4984214|NCT01705977|Lupus|lupus
4984215|NCT01705977|SLE|sle
4984216|NCT01705977|Systemic Lupus Erythematosus|systemic lupus erythematosus
4984217|NCT01705977|Autoimmune Disease|autoimmune disease
4984218|NCT01705977|Belimumab|belimumab
4984219|NCT01705964|Status asthmaticus|status asthmaticus
4984220|NCT01705964|Asthma exacerbation|asthma exacerbation
4984221|NCT01705964|Epinephrine|epinephrine
4984222|NCT01705964|Adjunctive therapy|adjunctive therapy
4984223|NCT01705951|Smoking|smoking
4984224|NCT01705951|Insulin resistance|insulin resistance
4984225|NCT01705951|Metabolic Syndrome|metabolic syndrome
4984226|NCT01705951|Endothelial Function|endothelial function
4984227|NCT01705951|Smoking Cessation|smoking cessation
4984228|NCT01705951|Resistance Training|resistance training
4984229|NCT01705951|Nicotine Replacement|nicotine replacement
4984230|NCT01705951|Exercise|exercise
4984231|NCT01705951|Cardiovascular Disease|cardiovascular disease
4984232|NCT01705951|Arterial Stiffness|arterial stiffness
4984233|NCT01705951|Body Composition|body composition
4984234|NCT01705912|fall|fall
4984235|NCT01705912|prevention|prevention
4984236|NCT01705899|Type 1 Diabetes|type 1 diabetes
4984237|NCT01705899|Islet transplant|islet transplant
4984238|NCT01705899|Kidney transplant|kidney transplant
4984239|NCT01705886|Osteoarthritis|osteoarthritis
4984240|NCT01705886|Joint Disease|joint disease
4984241|NCT01705886|Arthritis|arthritis
4984242|NCT01705886|Musculoskeletal Disease|musculoskeletal disease
4984243|NCT01705886|Knee osteoarthritis|knee osteoarthritis
4984244|NCT01705873|HIV|hiv
4984245|NCT01705873|cardiovascular|cardiovascular
4984246|NCT01705873|risk|risk
4984247|NCT01705873|mortality|mortality
4984248|NCT01705860|Collagen, collagenase, scar|collagen, collagenase, scar
4984249|NCT01705847|chronic lymphocytic leukemia (CLL)|chronic lymphocytic leukemia (cll)
4984250|NCT01705847|non-Hodgkin lymphoma (NHL)|non-hodgkin lymphoma (nhl)
4984251|NCT01705847|Hodgkin lymphoma (HL)|hodgkin lymphoma (hl)
4984252|NCT01705847|indolent non-Hodgkin lymphoma (iNHL)|indolent non-hodgkin lymphoma (inhl)
4984253|NCT01705847|diffuse large B-cell lymphoma-activated B-cell (DLBCL-ABC)|diffuse large b-cell lymphoma-activated b-cell (dlbcl-abc)
4984254|NCT01705847|DLBCL-germinal center B-cell (GCB)|dlbcl-germinal center b-cell (gcb)
4984255|NCT01705847|mantle cell lymphoma (MCL)|mantle cell lymphoma (mcl)
4984256|NCT01705847|GS-9820|gs-9820
4984257|NCT01705847|phosphatidylinositol 3-kinase (PI3K)|phosphatidylinositol 3-kinase (pi3k)
4984258|NCT01705834|Arthritis|arthritis
4984259|NCT01705834|Stiffness|stiffness
4984260|NCT01705834|Range of movement|range of movement
4984261|NCT01705834|Goniometry|goniometry
4984262|NCT01705834|Digital|digital
4984263|NCT01705834|Dataglove|dataglove
4984264|NCT01705834|Outcome|outcome
4984265|NCT01705821|Skull base|skull base
4984266|NCT01705821|Pituitary|pituitary
4984267|NCT01705821|Robotics|robotics
4984268|NCT01705821|Endonasal surgery|endonasal surgery
4984269|NCT01705821|Sinus surgery|sinus surgery
4984270|NCT01705769|treatment|treatment
4984271|NCT01705769|severe acute malnutrition|severe acute malnutrition
4984272|NCT01705756|Colchicine|colchicine
4984273|NCT01705756|Anakinra|anakinra
4984274|NCT01705756|Colchicine resistance|colchicine resistance
4984275|NCT01705756|Familial Mediterranean fever|familial mediterranean fever
4984276|NCT01705743|anaesthesia|anaesthesia
4984277|NCT01705743|middle aged|middle aged
4984278|NCT01705743|minimal alveolar concentration|minimal alveolar concentration
4984279|NCT01705743|sevoflurane|sevoflurane
4984280|NCT01705743|nitrous oxide|nitrous oxide
4984281|NCT01705743|isoelectric EEG|isoelectric eeg
4984282|NCT01705678|Males|males
4984283|NCT01705678|Metabolic syndrome|metabolic syndrome
4984284|NCT01705678|Otherwise healthy|otherwise healthy
4984285|NCT01705652|nexrutine|nexrutine
4984286|NCT01705652|prostate cancer|prostate cancer
4984287|NCT01705639|diabetes|diabetes
4984288|NCT01705639|melatonin|melatonin
4984289|NCT01705639|glucose tolerance|glucose tolerance
4984290|NCT01705639|sleep|sleep
4984291|NCT01705626|Peripheral Nervous System Diseases|peripheral nervous system diseases
4984292|NCT01705626|Neuromuscular Diseases|neuromuscular diseases
4984293|NCT01705626|Nervous System Diseases|nervous system diseases
4984294|NCT01705626|Metabolism, Inborn Errors|metabolism, inborn errors
4984295|NCT01705626|Genetic Diseases, Inborn|genetic diseases, inborn
4984296|NCT01705613|Attention Deficit/Hyperactivity Disorder|attention deficit/hyperactivity disorder
4984297|NCT01705613|ADHD|adhd
4984298|NCT01705613|Methylphenidate Immediate-release|methylphenidate immediate-release
4984299|NCT01705613|Cost-effectiveness|cost-effectiveness
4984300|NCT01705613|Cost-utility|cost-utility
4984301|NCT01705613|QALYs|qalys
4984302|NCT01705600|Central Sensitization|central sensitization
4984303|NCT01705600|Low Back Pain|low back pain
4984304|NCT01705600|Pain|pain
4984305|NCT01705600|Pain Catastrophizing|pain catastrophizing
4984306|NCT01705600|Brence|brence
4984307|NCT01705587|osteoporosis|osteoporosis
4984308|NCT01705587|atypical femoral fractures|atypical femoral fractures
4984309|NCT01705587|prior bisphosphonate treatment|prior bisphosphonate treatment
4984310|NCT01705587|postmenopausal women|postmenopausal women
4984311|NCT01705587|bone loss|bone loss
4984312|NCT01705574|HIV-1|hiv-1
4984313|NCT01705574|HIV|hiv
4984314|NCT01705574|Treatment-Naive|treatment-naive
4984315|NCT01705574|Women|women
4984316|NCT01705574|WAVES|waves
4984317|NCT01705561|fertility|fertility
4984318|NCT01705561|chemotherapy|chemotherapy
4984319|NCT01705561|breast cancer|breast cancer
4984320|NCT01705561|latin american women|latin american women
4984321|NCT01705561|pre menopausal|pre menopausal
4984322|NCT01705548|Brain metastasis|brain metastasis
4984323|NCT01705535|Fecal incontinence|fecal incontinence
4984324|NCT01705535|Pelvic floor muscle exercises|pelvic floor muscle exercises
4984325|NCT01705535|Physiotherapy|physiotherapy
4984326|NCT01705522|IBD|ibd
4984327|NCT01705522|ulcerative colitis|ulcerative colitis
4984328|NCT01705522|Crohn's disease|crohn's disease
4984329|NCT01705522|NAFLD|nafld
4984330|NCT01705522|biomarkers|biomarkers
4984331|NCT01705522|vitamin D|vitamin d
4984332|NCT01705509|The Effects of Ranolazine on CPET Parameters in Ischemic|the effects of ranolazine on cpet parameters in ischemic
4984333|NCT01705509|Cardiomyopathy Patients|cardiomyopathy patients
4984334|NCT01705496|Phase II|phase ii
4984335|NCT01705496|FIAU|fiau
4984336|NCT01705496|Fialuridine|fialuridine
4984337|NCT01705496|Prosthetic|prosthetic
4984338|NCT01705496|Joint|joint
4984339|NCT01705496|Infection|infection
4984340|NCT01705496|PET-CT|pet-ct
4984341|NCT01705483|ASP9853|asp9853
4984342|NCT01705483|Docetaxel|docetaxel
4984343|NCT01705483|Paclitaxel|paclitaxel
4984344|NCT01705470|Furosemide|furosemide
4984345|NCT01705470|Anemia|anemia
4984346|NCT01705470|LV dysfunction|lv dysfunction
4984347|NCT01705470|blood transfusion|blood transfusion
4984348|NCT01705457|multiple sclerosis|multiple sclerosis
4984349|NCT01705457|Vitamin A|vitamin a
4984350|NCT01705457|retinoic acid receptor|retinoic acid receptor
4984351|NCT01705457|retinoic x receptor|retinoic x receptor
4984352|NCT01705444|Urinary retention|urinary retention
4984353|NCT01705444|Foley catheter|foley catheter
4984354|NCT01705444|The Spanner|the spanner
4984355|NCT01705444|Quality of life|quality of life
4984356|NCT01705431|Emotional Disturbance|emotional disturbance
4984357|NCT01705431|Behavioral Disturbance|behavioral disturbance
4984358|NCT01705431|EBD|ebd
4984359|NCT01705431|Middle School|middle school
4984360|NCT01705431|Special Education|special education
4984361|NCT01705431|School Psychology|school psychology
4984362|NCT01705418|Parkinson disease|parkinson disease
4984363|NCT01705418|Deep brain stimulation|deep brain stimulation
4984364|NCT01705418|behavior and psychiatric symptoms improvement|behavior and psychiatric symptoms improvement
4984365|NCT01705405|cancer|cancer
4984366|NCT01705405|prostate|prostate
4984367|NCT01705379|Neisseria meningitidis, conjugate vaccine, phase IV clinical trial|neisseria meningitidis, conjugate vaccine, phase iv clinical trial
4984368|NCT01705366|Osteoarthritis|osteoarthritis
4984369|NCT01705366|Joint Disease|joint disease
4984370|NCT01705366|Arthritis|arthritis
4984371|NCT01705366|Musculoskeletal Disease|musculoskeletal disease
4984372|NCT01705353|Stroke|stroke
4984373|NCT01705353|Cerebrovascular Accident|cerebrovascular accident
4984374|NCT01705353|HMGB-1|hmgb-1
4984375|NCT01705353|cytokines|cytokines
4984376|NCT01705353|functional recovery|functional recovery
4984377|NCT01705353|inflammation|inflammation
4984378|NCT01705353|immune response|immune response
4984379|NCT01705327|Parkinson's|parkinson's
4984380|NCT01705327|Biomarkers|biomarkers
4984381|NCT01705327|Neurodegenerative disorder|neurodegenerative disorder
4984382|NCT01705314|human influenza children|human influenza children
4984383|NCT01705288|laparotomy|laparotomy
4984384|NCT01705288|hysterectomy|hysterectomy
4984385|NCT01705262|compliance|compliance
4984386|NCT01705262|Bowel preparations|bowel preparations
4984387|NCT01705262|Moviprep|moviprep
4984388|NCT01705262|Phosphoral|phosphoral
4984389|NCT01705223|prophylactic|prophylactic
4984390|NCT01705223|vaccine|vaccine
4984391|NCT01705184|Stop and go|stop and go
4984392|NCT01705184|Non-small cell lung cancer|non-small cell lung cancer
4984393|NCT01705184|Non-squamous|non-squamous
4984394|NCT01705184|Bevacizumab|bevacizumab
4984395|NCT01705171|IBS|ibs
4984396|NCT01705171|fructose intolerance|fructose intolerance
4984397|NCT01705171|GLUT 5|glut 5
4984398|NCT01705171|GLUT 2|glut 2
4984399|NCT01705158|ovarian cancer in relapse|ovarian cancer in relapse
4984400|NCT01705158|sensitive in platin|sensitive in platin
4984401|NCT01705145|Cystic Fibrosis|cystic fibrosis
4984402|NCT01705119|Mechanically Ventilated|mechanically ventilated
4984403|NCT01705119|Critical Care|critical care
4984404|NCT01705093|strawberry, cardiovascular, obesity, adolescent|strawberry, cardiovascular, obesity, adolescent
4984405|NCT01705080|Renal Denervation|renal denervation
4984406|NCT01705080|Renal artery|renal artery
4984407|NCT01705067|Osteoarthritis, Degenerative Knee Disease, TKA|osteoarthritis, degenerative knee disease, tka
4984408|NCT01705054|Angina|angina
4984409|NCT01705054|Stable ischemic heart disease|stable ischemic heart disease
4984410|NCT01705054|Quality of Life|quality of life
4984411|NCT01705054|Seattle Angina Questionnaire (SAQ)|seattle angina questionnaire (saq)
4984412|NCT01705015|exercise|exercise
4984413|NCT01705002|phase 1|phase 1
4984414|NCT01705002|dose escalating|dose escalating
4984415|NCT01705002|prodrug|prodrug
4984416|NCT01705002|mitomycin C|mitomycin c
4984417|NCT01705002|Capecitabine|capecitabine
4984418|NCT01704989|Glaucoma, SLT|glaucoma, slt
4984419|NCT01704963|Recurrent mature B-cell neoplasms|recurrent mature b-cell neoplasms
4984420|NCT01704963|B-cell malignancies|b-cell malignancies
4984421|NCT01704963|Bruton's Tyrosine Kinase (Btk) Inhibitor|bruton's tyrosine kinase (btk) inhibitor
4984422|NCT01704963|PCI-32765|pci-32765
4984423|NCT01704963|Tumor|tumor
4984424|NCT01704963|Pharmacokinetics|pharmacokinetics
4984425|NCT01704963|Japanese|japanese
4984426|NCT01704937|Fecal Microbiota Transplant|fecal microbiota transplant
4984427|NCT01704937|Clostridium difficile|clostridium difficile
4984428|NCT01704937|Diarrhea|diarrhea
4984429|NCT01704924|Prevena|prevena
4984430|NCT01704924|negative pressure wound therapy|negative pressure wound therapy
4984431|NCT01704924|Incisional wound vac|incisional wound vac
4984432|NCT01704911|Transradial|transradial
4984433|NCT01704911|Transfemoral|transfemoral
4984434|NCT01704911|Coronary Intervention|coronary intervention
4984435|NCT01704898|efavirenz|efavirenz
4984436|NCT01704898|bioequivalence|bioequivalence
4984437|NCT01704898|fasting|fasting
4984438|NCT01704898|healthy volunteers|healthy volunteers
4984439|NCT01704885|Childhood Cancer|childhood cancer
4984440|NCT01704885|Sibling Play intervention|sibling play intervention
4984441|NCT01704885|Sibling Behavioral Intervention|sibling behavioral intervention
4984442|NCT01704885|Siblings of Cancer Patients|siblings of cancer patients
4984443|NCT01704872|Neuroblastoma|neuroblastoma
4984444|NCT01704872|Refractory neuroblastoma|refractory neuroblastoma
4984445|NCT01704872|ch14.18/CHO|ch14.18/cho
4984446|NCT01704859|fracture|fracture
4984447|NCT01704833|Psychosis|psychosis
4984448|NCT01704833|Paranoia|paranoia
4984449|NCT01704833|Cognitive Behavioral Therapy|cognitive behavioral therapy
4984450|NCT01704833|Delusions|delusions
4984451|NCT01704833|Group Therapy|group therapy
4984452|NCT01704820|Colon Polyps|colon polyps
4984453|NCT01704820|Colon Cancer screening|colon cancer screening
4984454|NCT01704820|Colonoscopy|colonoscopy
4984455|NCT01704807|Low Back Pain|low back pain
4984456|NCT01704807|Chronic|chronic
4984457|NCT01704807|Orthotic Device|orthotic device
4984458|NCT01704807|Applied Kinesiology|applied kinesiology
4984459|NCT01704807|Manual Muscle Testing|manual muscle testing
4984460|NCT01704807|Chiropractic|chiropractic
4984461|NCT01704794|Sickle Cell Anemia|sickle cell anemia
4984462|NCT01704794|Quality of Life|quality of life
4984463|NCT01704794|Antioxidant|antioxidant
4984464|NCT01704794|Anti inflammatory|anti inflammatory
4984465|NCT01704794|Sorghum bicolor|sorghum bicolor
4984467|NCT01704781|Clinical trial|clinical trial
4984468|NCT01704781|Dose escalation assessment lenalidomide|dose escalation assessment lenalidomide
4984469|NCT01704781|Human immunodeficiency virus-1 (HIV-1)|human immunodeficiency virus-1 (hiv-1)
4984470|NCT01704781|HIV|hiv
4984471|NCT01704781|Immunomodulatory|immunomodulatory
4984472|NCT01704781|Infection|infection
4984473|NCT01704781|Lenalidomide|lenalidomide
4984474|NCT01704781|Phase I/II|phase i/ii
4984475|NCT01704781|Vaccine|vaccine
4984476|NCT01704781|Vacc-4x|vacc-4x
4984477|NCT01704768|Randomized Controlled Trial|randomized controlled trial
4984478|NCT01704768|School-Based Intervention|school-based intervention
4984479|NCT01704755|Cirrhosis|cirrhosis
4984480|NCT01704755|Hepatitis C|hepatitis c
4984481|NCT01704755|Child Pugh A|child pugh a
4984482|NCT01704755|Compensated Cirrhosis|compensated cirrhosis
4984483|NCT01704755|Hepatitis C Genotype 1|hepatitis c genotype 1
4984484|NCT01704755|Cirrhotic|cirrhotic
4984485|NCT01704755|Chronic Hepatitis C|chronic hepatitis c
4984486|NCT01704755|Hepatitis C Virus|hepatitis c virus
4984487|NCT01704755|ombitasvir|ombitasvir
4984488|NCT01704755|paritaprevir|paritaprevir
4984489|NCT01704755|dasabuvir|dasabuvir
4984490|NCT01704755|Interferon-Free|interferon-free
4984491|NCT01704755|Viekira Pak|viekira pak
4984492|NCT01704742|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
4984493|NCT01704742|Hodgkin's Lymphoma|hodgkin's lymphoma
4984494|NCT01704742|Kenya|kenya
4984495|NCT01704742|Epstein Barr Virus (EBV)|epstein barr virus (ebv)
4984496|NCT01704742|Human Immunodeficiency Virus (HIV)|human immunodeficiency virus (hiv)
4984497|NCT01704742|Kaposi's Sarcoma Herpes Virus (KSHV)|kaposi's sarcoma herpes virus (kshv)
4984498|NCT01704729|Myopia|myopia
4984499|NCT01704729|Focus groups|focus groups
4984500|NCT01704729|refraction|refraction
4984501|NCT01704729|Glasses|glasses
4984502|NCT01704729|spectacles|spectacles
4984503|NCT01704716|neuroblastoma|neuroblastoma
4984504|NCT01704716|immunotherapy|immunotherapy
4984505|NCT01704716|MAT|mat
4984506|NCT01704716|antibody treatment|antibody treatment
4984507|NCT01704703|colorectal cancer|colorectal cancer
4984508|NCT01704703|FOLFIRI|folfiri
4984509|NCT01704703|Panitumumab|panitumumab
4984510|NCT01704703|KRAS, PIK3Ca,BRAF and NRAS genes|kras, pik3ca,braf and nras genes
4984511|NCT01704703|highly sensitive techniques|highly sensitive techniques
4984512|NCT01704690|Esophageal cancer|esophageal cancer
4984513|NCT01704690|Chemotherapy|chemotherapy
4984514|NCT01704690|Efficacy|efficacy
4984515|NCT01704690|Toxicity|toxicity
4984516|NCT01704677|Chronic low back pain|chronic low back pain
4984517|NCT01704677|Degenerated disc|degenerated disc
4984518|NCT01704677|Total disc replacement|total disc replacement
4984519|NCT01704677|Multidisciplinary rehabilitation|multidisciplinary rehabilitation
4984520|NCT01704677|Long term results|long term results
4984521|NCT01704664|malnutrition,|malnutrition,
4984522|NCT01704664|perioperative artificial nutrition,|perioperative artificial nutrition,
4984523|NCT01704664|immunonutrition,|immunonutrition,
4984524|NCT01704664|gastrectomy,|gastrectomy,
4984525|NCT01704664|lymphocytes,|lymphocytes,
4984526|NCT01704664|interleukin,|interleukin,
4984527|NCT01704664|blood platelets,|blood platelets,
4984528|NCT01704664|phagocytic and bactericidal activity of blood platelets|phagocytic and bactericidal activity of blood platelets
4984529|NCT01704651|Ovary|ovary
4984530|NCT01704651|Ovarian|ovarian
4984531|NCT01704651|Fallopian|fallopian
4984532|NCT01704651|Peritoneal|peritoneal
4984533|NCT01704651|Cancer|cancer
4984534|NCT01704651|Gynecological|gynecological
4984535|NCT01704651|Female|female
4984536|NCT01704625|pain|pain
4984537|NCT01704625|headache|headache
4984538|NCT01704612|local anesthetic|local anesthetic
4984539|NCT01704612|sciatic|sciatic
4984540|NCT01704612|diabetes|diabetes
4984541|NCT01704612|block|block
4984542|NCT01704612|duration|duration
4984543|NCT01704599|Psoriasis|psoriasis
4984544|NCT01704599|Adalimumab|adalimumab
4984545|NCT01704599|B vitamins|b vitamins
4984546|NCT01704599|Homocysteine|homocysteine
4984547|NCT01704599|Folic acid|folic acid
4984548|NCT01704599|Cyanocobalamin|cyanocobalamin
4984549|NCT01704599|Pyridoxine|pyridoxine
4984550|NCT01704599|Vitamin B6|vitamin b6
4984551|NCT01704599|Vitamin B9|vitamin b9
4984552|NCT01704599|Vitamin B12|vitamin b12
4984553|NCT01704586|Differentiated thyroid carcinoma|differentiated thyroid carcinoma
4984554|NCT01704586|PET/CT|pet/ct
4984555|NCT01704586|Radioiodine Remnant Ablation|radioiodine remnant ablation
4984556|NCT01704586|I-124|i-124
4984557|NCT01704586|Quality of life|quality of life
4984558|NCT01704573|PET Scan|pet scan
4984559|NCT01704547|Breast cancer|breast cancer
4984560|NCT01704547|Lumpectomy|lumpectomy
4984561|NCT01704547|Breast Irradiation|breast irradiation
4984562|NCT01704534|Hidradenitis suppurativa|hidradenitis suppurativa
4984563|NCT01704534|Acne ectopica|acne ectopica
4984564|NCT01704534|Inverse acne|inverse acne
4984565|NCT01704534|Ustekinumab|ustekinumab
4984566|NCT01704534|Stelara|stelara
4984567|NCT01704521|Hepatitis C|hepatitis c
4984568|NCT01704521|HCV|hcv
4984569|NCT01704521|Hemophilia|hemophilia
4984570|NCT01704508|Falciparum malaria|falciparum malaria
4984571|NCT01704508|children|children
4984572|NCT01704508|treatment|treatment
4984573|NCT01704495|Uncontrolled Asthma,|uncontrolled asthma,
4984574|NCT01704495|Exacerbation,|exacerbation,
4984575|NCT01704495|Safety|safety
4984576|NCT01704469|Opioid induced hyperalgesia|opioid induced hyperalgesia
4984577|NCT01704456|provoked vestibulodynia|provoked vestibulodynia
4984578|NCT01704456|dyspareunia|dyspareunia
4984579|NCT01704456|vulvodynia|vulvodynia
4984580|NCT01704456|mindfulness|mindfulness
4984581|NCT01704456|cognitive behavioural therapy|cognitive behavioural therapy
4984582|NCT01704443|provoked vestibulodynia|provoked vestibulodynia
4984583|NCT01704443|dyspareunia|dyspareunia
4984584|NCT01704443|vulvodynia|vulvodynia
4984585|NCT01704443|mindfulness|mindfulness
4984586|NCT01704443|cognitive behavioural therapy|cognitive behavioural therapy
4984587|NCT01704430|Cardiac surgery|cardiac surgery
4984588|NCT01704430|Cardiac bypass|cardiac bypass
4984589|NCT01704430|Intensive Care|intensive care
4984590|NCT01704430|Nosocomial infection|nosocomial infection
4984591|NCT01704430|Glutamine|glutamine
4984592|NCT01704430|Randomized trial|randomized trial
4984593|NCT01704404|Long acting muscarinic antagonist|long acting muscarinic antagonist
4984594|NCT01704404|Chronic Bronchitis|chronic bronchitis
4984595|NCT01704404|Emphysema|emphysema
4984596|NCT01704404|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
4984597|NCT01704404|COPD|copd
4984598|NCT01704352|Cognitive Behavioral Therapy|cognitive behavioral therapy
4984599|NCT01704352|CBT-I|cbt-i
4984600|NCT01704339|End stage renal failure|end stage renal failure
4984601|NCT01704339|Neuropathic pain|neuropathic pain
4984602|NCT01704339|Critical digital ischaemia|critical digital ischaemia
4984603|NCT01704326|Deuce|deuce
4984604|NCT01704326|Journey Deuce|journey deuce
4984605|NCT01704326|Knee pain|knee pain
4984606|NCT01704326|Osteoarthritis|osteoarthritis
4984607|NCT01704326|Bicompartmental|bicompartmental
4984608|NCT01704326|Femoral|femoral
4984609|NCT01704326|Medial|medial
4984610|NCT01704313|Vascular access|vascular access
4984611|NCT01704313|Haemodialysis|haemodialysis
4984612|NCT01704313|Suturing technique|suturing technique
4984613|NCT01704300|Abdominal aortic aneurysm|abdominal aortic aneurysm
4984614|NCT01704300|Acute Myocardial Infarction|acute myocardial infarction
4984615|NCT01704300|Coronary heart disease not otherwise specified|coronary heart disease not otherwise specified
4984616|NCT01704300|Haemorrhagic stroke|haemorrhagic stroke
4984617|NCT01704300|Heart failure|heart failure
4984618|NCT01704300|Ischaemic stroke|ischaemic stroke
4984619|NCT01704300|Peripheral arterial disease|peripheral arterial disease
4984620|NCT01704300|Stable angina|stable angina
4984621|NCT01704300|Unheralded coronary death|unheralded coronary death
4984622|NCT01704300|Unstable angina|unstable angina
4984623|NCT01704300|Ventricular arrhythmias, cardiac arrest and sudden cardiac death|ventricular arrhythmias, cardiac arrest and sudden cardiac death
4984624|NCT01704300|Transient Ischemic Attack|transient ischemic attack
4984625|NCT01704287|PD-1|pd-1
4984626|NCT01704287|PD1|pd1
4984627|NCT01704287|PD-L1|pd-l1
4984628|NCT01704287|PDL1|pdl1
4984629|NCT01704274|biochemical|biochemical
4984630|NCT01704274|recurrence|recurrence
4984631|NCT01704274|prostate|prostate
4984632|NCT01704274|cancer|cancer
4984633|NCT01704274|active|active
4984634|NCT01704274|surveillence|surveillence
4984635|NCT01704248|eye drops self-instillation|eye drops self-instillation
4984636|NCT01704235|screening|screening
4984637|NCT01704222|Children|children
4984638|NCT01704222|nursery|nursery
4984639|NCT01704222|CMV|cmv
4984640|NCT01704222|Infection|infection
4984641|NCT01704183|relapse-remitting multiple sclerosis|relapse-remitting multiple sclerosis
4984642|NCT01704183|heart rate variability|heart rate variability
4984643|NCT01704183|fingolimod|fingolimod
4984644|NCT01704183|cardiac autonomic regulation|cardiac autonomic regulation
4984645|NCT01704157|Osteoarthritis|osteoarthritis
4984646|NCT01704157|knee|knee
4984647|NCT01704157|chronic pain|chronic pain
4984648|NCT01704144|Efavirenz|efavirenz
4984649|NCT01704144|rifampin|rifampin
4984650|NCT01704144|Pharmacokinetics|pharmacokinetics
4984651|NCT01704144|Drug-drug interactions|drug-drug interactions
4984652|NCT01704144|Drug-gene interactions|drug-gene interactions
4984653|NCT01704144|Children|children
4984654|NCT01704131|Levosimendan|levosimendan
4984655|NCT01704131|Children|children
4984656|NCT01704131|Pharmacokinetics|pharmacokinetics
4984657|NCT01704118|I-gel|i-gel
4984658|NCT01704118|ProSeal laryngeal mask|proseal laryngeal mask
4984659|NCT01704118|small infants|small infants
4984660|NCT01704118|neonates|neonates
4984661|NCT01704105|Chlorine water treatment|chlorine water treatment
4984662|NCT01704105|Point-of-use water treatment|point-of-use water treatment
4984663|NCT01704105|Household water treatment with safe storage|household water treatment with safe storage
4984664|NCT01704105|Handwashing with soap|handwashing with soap
4984665|NCT01704105|Hand hygiene|hand hygiene
4984666|NCT01704105|Latrines|latrines
4984667|NCT01704105|Water|water
4984668|NCT01704105|Sanitation|sanitation
4984669|NCT01704105|Handwashing|handwashing
4984670|NCT01704105|Breast Feeding|breast feeding
4984671|NCT01704105|Complementary Feeding|complementary feeding
4984672|NCT01704105|Micronutrients|micronutrients
4984673|NCT01704105|Malnutrition|malnutrition
4984674|NCT01704105|Nutrition Disorders|nutrition disorders
4984675|NCT01704105|Diarrhea|diarrhea
4984676|NCT01704105|Child Development|child development
4984677|NCT01704105|Child potties|child potties
4984678|NCT01704105|Point-of-use fortification|point-of-use fortification
4984679|NCT01704105|Lipid-based nutrient supplement|lipid-based nutrient supplement
4984680|NCT01704105|Exclusive breastfeeding|exclusive breastfeeding
4984681|NCT01704105|Environmental enteropathy|environmental enteropathy
4984682|NCT01704105|Tropical enteropathy|tropical enteropathy
4984683|NCT01704105|Gut function|gut function
4984684|NCT01704105|Intestinal parasitic infection|intestinal parasitic infection
4984685|NCT01704105|Soil transmitted helminths|soil transmitted helminths
4984686|NCT01704105|Intestinal protozoans|intestinal protozoans
4984687|NCT01704105|Antibody response|antibody response
4984688|NCT01704079|Parathyroid Diseases|parathyroid diseases
4984689|NCT01704079|Renal Insufficiency|renal insufficiency
4984690|NCT01704079|Kidney Failure, Chronic|kidney failure, chronic
4984691|NCT01704079|Hyperparathyroidism, Secondary|hyperparathyroidism, secondary
4984692|NCT01704079|Vitamin D|vitamin d
4984693|NCT01704079|Hyperparathyroidism|hyperparathyroidism
4984694|NCT01704079|Kidney Diseases|kidney diseases
4984695|NCT01704079|Kidney Failure|kidney failure
4984696|NCT01704079|Renal Insufficiency, Chronic|renal insufficiency, chronic
4984697|NCT01704066|ARDS|ards
4984698|NCT01704066|Chest radiograph|chest radiograph
4984699|NCT01704066|Berlin Definition|berlin definition
4984700|NCT01704066|Inter-observer agreement|inter-observer agreement
4984701|NCT01704053|New Oral Anticoagulants|new oral anticoagulants
4984702|NCT01704053|Dabigatran|dabigatran
4984703|NCT01704053|Rivaroxaban|rivaroxaban
4984704|NCT01704053|Thrombelastometry/-graphy (ROTEM, TEG)|thrombelastometry/-graphy (rotem, teg)
4984705|NCT01704053|Multiple Platelet Function Analyzer (Multiplate)|multiple platelet function analyzer (multiplate)
4984706|NCT01704040|Healthy volunteers and asthma|healthy volunteers and asthma
4984707|NCT01704040|CNTO 3157|cnto 3157
4984708|NCT01704040|Rhinovirus|rhinovirus
4984709|NCT01704027|Localized|localized
4984710|NCT01704027|High risk|high risk
4984711|NCT01704014|occurrence of|occurrence of
4984712|NCT01704001|ART-123|art-123
4984713|NCT01704001|Disseminated Intravascular Coagulation|disseminated intravascular coagulation
4984714|NCT01704001|Pharmacokinetics|pharmacokinetics
4984715|NCT01703988|Spinal Muscular Atrophy|spinal muscular atrophy
4984716|NCT01703988|SMA|sma
4984717|NCT01703988|SMN|smn
4984718|NCT01703988|SMNRx|smnrx
4984719|NCT01703988|ISIS-SMNRx|isis-smnrx
4984720|NCT01703988|ISIS 396443|isis 396443
4984721|NCT01703975|Simulation efficiency|simulation efficiency
4984722|NCT01703975|Collaborative learning|collaborative learning
4984723|NCT01703962|Glioma|glioma
4984724|NCT01703962|IDH1|idh1
4984725|NCT01703962|Spectroscopy|spectroscopy
4984726|NCT01703962|Plasma|plasma
4984727|NCT01703936|economic intervention|economic intervention
4984728|NCT01703936|ex-combatant|ex-combatant
4984729|NCT01703936|agriculture|agriculture
4984730|NCT01703936|life skills|life skills
4984731|NCT01703910|Genomic expression profile in tumor samples|genomic expression profile in tumor samples
4984732|NCT01703910|Adult patients|adult patients
4984733|NCT01703910|metastatic disease status and progression after two lines of systemic therapy|metastatic disease status and progression after two lines of systemic therapy
4984734|NCT01703897|gastric by-pass surgery|gastric by-pass surgery
4984735|NCT01703884|Malria diagnosis|malria diagnosis
4984736|NCT01703884|Malaria prevention in pregnancy|malaria prevention in pregnancy
4984737|NCT01703884|ANC services improvement|anc services improvement
4984738|NCT01703832|acute stress reaction|acute stress reaction
4984739|NCT01703832|stress|stress
4984740|NCT01703832|stress perception|stress perception
4984741|NCT01703832|physiological stress response|physiological stress response
4984742|NCT01703832|Neurexan|neurexan
4984743|NCT01703819|acute stress reaction|acute stress reaction
4984744|NCT01703819|stress|stress
4984745|NCT01703819|stress perception|stress perception
4984746|NCT01703819|physiological stress response|physiological stress response
4984747|NCT01703819|Neurexan|neurexan
4984748|NCT01703806|Mitral regurgitation|mitral regurgitation
4984749|NCT01703806|Mitral valve repair|mitral valve repair
4984750|NCT01703806|Watchful waiting|watchful waiting
4984751|NCT01703767|patient satisfaction|patient satisfaction
4984752|NCT01703767|Gulf War 1 Veteran|gulf war 1 veteran
4984753|NCT01703767|Desert Storm Veteran|desert storm veteran
4984754|NCT01703754|Genetically Modified Organism|genetically modified organism
4984755|NCT01703754|Metastatic Breast Cancer|metastatic breast cancer
4984756|NCT01703754|Recurrent Breast Cancer|recurrent breast cancer
4984757|NCT01703754|Breast Cancer|breast cancer
4984758|NCT01703754|Palifosfamide|palifosfamide
4984759|NCT01703754|INXN1001|inxn1001
4984760|NCT01703754|INXN2001|inxn2001
4984761|NCT01703754|Adenoviral vector|adenoviral vector
4984762|NCT01703715|Hydration|hydration
4984763|NCT01703715|Elderly patients|elderly patients
4984764|NCT01703715|Age 65 years and over|age 65 years and over
4984765|NCT01703715|Admitted acutely to medical admissions ward|admitted acutely to medical admissions ward
4984766|NCT01703689|Quality indicators|quality indicators
4984767|NCT01703689|quality of care|quality of care
4984768|NCT01703689|nursing home|nursing home
4984769|NCT01703689|long-term care unit|long-term care unit
4984770|NCT01703689|nursing home organisation|nursing home organisation
4984771|NCT01703689|nursing home structure|nursing home structure
4984772|NCT01703689|disability|disability
4984773|NCT01703689|dependence|dependence
4984774|NCT01703689|functional decline|functional decline
4984775|NCT01703689|functional impairment|functional impairment
4984776|NCT01703689|older adults|older adults
4984777|NCT01703689|elderly|elderly
4984778|NCT01703689|audit and feedback|audit and feedback
4984779|NCT01703689|cooperative work|cooperative work
4984780|NCT01703689|geriatrician|geriatrician
4984781|NCT01703689|medication|medication
4984782|NCT01703689|hospitalisation|hospitalisation
4984783|NCT01703689|comorbidity|comorbidity
4984784|NCT01703676|Hypogonadism, Klinefelter Syndrome, Cardiovascular Risk, Epigenetics, Methylation of Genes|hypogonadism, klinefelter syndrome, cardiovascular risk, epigenetics, methylation of genes
4984785|NCT01703676|Cardiovascular risk factors|cardiovascular risk factors
4984786|NCT01703676|Gonadal status|gonadal status
4984787|NCT01703676|Gene expression|gene expression
4984788|NCT01703676|Methylation|methylation
4984789|NCT01703663|Stroke|stroke
4984790|NCT01703663|Sleep Apnea|sleep apnea
4984791|NCT01703650|CT|ct
4984792|NCT01703650|pancreas adenocarcinoma|pancreas adenocarcinoma
4984793|NCT01703650|RECIST|recist
4984794|NCT01703650|perfusion|perfusion
4984795|NCT01703637|Sitagliptin|sitagliptin
4984796|NCT01703637|Vildagliptin|vildagliptin
4984797|NCT01703637|Saxagliptin|saxagliptin
4984798|NCT01703637|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
4984799|NCT01703624|glycopyrronium bromide|glycopyrronium bromide
4984800|NCT01703624|glycopyrrolate|glycopyrrolate
4984801|NCT01703624|oral inhalation|oral inhalation
4984802|NCT01703624|COPD|copd
4984803|NCT01703624|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
4984804|NCT01703624|lung function|lung function
4984805|NCT01703624|pharmacokinetics|pharmacokinetics
4984806|NCT01703624|tolerability|tolerability
4984807|NCT01703624|safety|safety
4984808|NCT01703624|cross-over|cross-over
4984809|NCT01703624|single-dose|single-dose
4984810|NCT01703624|dose-ranging|dose-ranging
4984811|NCT01703611|Nutrition|nutrition
4984812|NCT01703611|Medical Nutrition Therapy|medical nutrition therapy
4984813|NCT01703611|Diabetes Mellitus|diabetes mellitus
4984814|NCT01703611|Nutrition outcomes|nutrition outcomes
4984815|NCT01703611|Evidence Based Guidelines|evidence based guidelines
4984816|NCT01703598|Parkinson's disease|parkinson's disease
4984817|NCT01703598|Deep Brain Stimulation|deep brain stimulation
4984818|NCT01703585|genomic analysis|genomic analysis
4984819|NCT01703585|genome|genome
4984820|NCT01703585|tumor|tumor
4984821|NCT01703585|tissue|tissue
4984822|NCT01703585|archival|archival
4984823|NCT01703585|biopsy|biopsy
4984824|NCT01703585|core needle|core needle
4984825|NCT01703585|fine needle|fine needle
4984826|NCT01703585|DNA|dna
4984827|NCT01703585|gene|gene
4984828|NCT01703585|expression|expression
4984829|NCT01703585|sequencing|sequencing
4984830|NCT01703572|Phase 1|phase 1
4984831|NCT01703572|Dose escalation|dose escalation
4984832|NCT01703572|relapsed or refractory|relapsed or refractory
4984833|NCT01703572|lymphoid malignancies|lymphoid malignancies
4984834|NCT01703559|Glare|glare
4984835|NCT01703559|Starburst|starburst
4984836|NCT01703559|Halos|halos
4984837|NCT01703559|Reduced contrast sensitivity|reduced contrast sensitivity
4984838|NCT01703546|Morbid Obesity|morbid obesity
4984839|NCT01703546|Weight Loss Surgery|weight loss surgery
4984840|NCT01703546|Laparoscopic Adjustable Gastric Band|laparoscopic adjustable gastric band
4984841|NCT01703546|Laparoscopic Gastric Plication|laparoscopic gastric plication
4984842|NCT01703546|Imbrication|imbrication
4984843|NCT01703533|Autism|autism
4984844|NCT01703533|Rett's Syndrome|rett's syndrome
4984845|NCT01703533|Rett Disorder|rett disorder
4984846|NCT01703533|Rett's Disorder|rett's disorder
4984847|NCT01703533|Ataxia|ataxia
4984848|NCT01703520|Males breast cancer|males breast cancer
4984849|NCT01703520|Finasteride|finasteride
4984850|NCT01703520|PROSCAR®|proscar®
4984851|NCT01703520|PROPECIA®|propecia®
4984852|NCT01703494|C. difficile|c. difficile
4984853|NCT01703494|fecal transplant|fecal transplant
4984854|NCT01703494|stool transplant|stool transplant
4984855|NCT01703494|fecal flora reconstitution|fecal flora reconstitution
4984856|NCT01703494|fecal microbiota transplant|fecal microbiota transplant
4984857|NCT01703494|FMT|fmt
4984858|NCT01703481|Tumor|tumor
4984859|NCT01703481|Fibroblast Growth Factor Receptor (FGFR)|fibroblast growth factor receptor (fgfr)
4984860|NCT01703481|Non-Small Cell Lung Cancer (NSCLC)|non-small cell lung cancer (nsclc)
4984861|NCT01703481|Small Cell Lung Cancer (SCLC)|small cell lung cancer (sclc)
4984862|NCT01703481|JNJ-42756493|jnj-42756493
4985265|NCT01701713|NAMING|naming
4984863|NCT01703455|Salivary gland cancer metastatic disease recurrent disease clinical trial|salivary gland cancer metastatic disease recurrent disease clinical trial
4984864|NCT01703429|Multiple Sclerosis|multiple sclerosis
4984865|NCT01703429|MS|ms
4984866|NCT01703429|Complementary and Alternative|complementary and alternative
4984867|NCT01703429|CAM|cam
4984868|NCT01703416|COPD|copd
4984869|NCT01703416|GOLD group C and D|gold group c and d
4984870|NCT01703416|CDLM questionnaire|cdlm questionnaire
4984871|NCT01703416|visual scale - physician evaluation|visual scale - physician evaluation
4984872|NCT01703403|physical therapy|physical therapy
4984873|NCT01703403|treated at NTUH and received rehabilitation at the PTC in recent ten years.|treated at ntuh and received rehabilitation at the ptc in recent ten years.
4984874|NCT01703390|metastatic colorectal cancer|metastatic colorectal cancer
4984875|NCT01703390|mCRC|mcrc
4984876|NCT01703390|ERCC-1|ercc-1
4984877|NCT01703390|ERCC1|ercc1
4984878|NCT01703390|AGMT|agmt
4984879|NCT01703364|CLL|cll
4984880|NCT01703364|Lenalidomide|lenalidomide
4984881|NCT01703364|Revlimid|revlimid
4984882|NCT01703364|AGMT|agmt
4984883|NCT01703364|T cell|t cell
4984884|NCT01703351|pain control, VATS|pain control, vats
4984885|NCT01703338|assessment model|assessment model
4984886|NCT01703338|biomechanical changes|biomechanical changes
4984887|NCT01703338|functional activities|functional activities
4984888|NCT01703338|magnetic resonance imaging (MRI)|magnetic resonance imaging (mri)
4984889|NCT01703338|causal relationship|causal relationship
4984890|NCT01703338|core muscles activation pattern|core muscles activation pattern
4984891|NCT01703338|pathological changes|pathological changes
4984892|NCT01703338|early rehabilitation|early rehabilitation
4984893|NCT01703338|core stability exercise|core stability exercise
4984894|NCT01703338|minimally invasive lumbar spinal fusion surgery|minimally invasive lumbar spinal fusion surgery
4984895|NCT01703325|Psoriatic nails|psoriatic nails
4984896|NCT01703325|Triamcinolone injection|triamcinolone injection
4984897|NCT01703325|clobetasol propionate|clobetasol propionate
4984898|NCT01703312|Allergies, asthma, IgE|allergies, asthma, ige
4984899|NCT01703299|imipenem|imipenem
4984900|NCT01703299|ertapenem|ertapenem
4984901|NCT01703299|resistance|resistance
4984902|NCT01703299|commensal flora|commensal flora
4984903|NCT01703273|Extreme Obesity Keywords: obesity, adiposity, psychosocial, healthcare, co-morbidities, low key intervention, quality of life|extreme obesity keywords: obesity, adiposity, psychosocial, healthcare, co-morbidities, low key intervention, quality of life
4984904|NCT01703260|Drug therapy|drug therapy
4984905|NCT01703247|Arrhythmias|arrhythmias
4984906|NCT01703247|Ablation|ablation
4984907|NCT01703234|FGF-23 , ramipril, endothelial dysfunction|fgf-23 , ramipril, endothelial dysfunction
4984908|NCT01703195|Vaginal Cancer|vaginal cancer
4984909|NCT01703195|Malignancies involving the vagina|malignancies involving the vagina
4984910|NCT01703195|Middle third and the distal third of the vagina|middle third and the distal third of the vagina
4984911|NCT01703195|Pre and post radiation therapy|pre and post radiation therapy
4984912|NCT01703195|Diffusion weighted magnetic resonance imaging|diffusion weighted magnetic resonance imaging
4984913|NCT01703195|DWMR|dwmr
4984914|NCT01703195|Magnetic resonance imaging|magnetic resonance imaging
4984915|NCT01703195|MRI|mri
4984916|NCT01703195|Tumor involvement|tumor involvement
4984917|NCT01703195|Response to radiation therapy|response to radiation therapy
4984918|NCT01703195|XRT|xrt
4984919|NCT01703182|transcutaneous oximetry|transcutaneous oximetry
4984920|NCT01703182|transcutaneous carbon dioxide|transcutaneous carbon dioxide
4984921|NCT01703182|leg amputation|leg amputation
4984922|NCT01703182|wound healing failure|wound healing failure
4984923|NCT01703182|amputation revision|amputation revision
4984924|NCT01703169|severe aplastic anemia|severe aplastic anemia
4984925|NCT01703169|very severe aplastic anemia|very severe aplastic anemia
4984926|NCT01703169|moderate aplastic anemia|moderate aplastic anemia
4984927|NCT01703169|bleeding|bleeding
4984928|NCT01703156|Low Risk ACS, Acute Coronary Syndrome, Stress Testing, Non-Stress Testing|low risk acs, acute coronary syndrome, stress testing, non-stress testing
4984929|NCT01703130|ISPB|ispb
4984930|NCT01703130|Brachial Plexus Block|brachial plexus block
4984931|NCT01703130|Anesthesia|anesthesia
4984932|NCT01703130|Pain Management|pain management
4984933|NCT01703130|Surgery|surgery
4984934|NCT01703117|Alzheimer's Disease|alzheimer's disease
4984935|NCT01703117|Dementia|dementia
4984936|NCT01703104|Sorghum bicolor|sorghum bicolor
4984937|NCT01703104|sickle cell anaemia|sickle cell anaemia
4984938|NCT01703104|haematological parameters|haematological parameters
4984939|NCT01703065|Prostate cancer|prostate cancer
4984940|NCT01703065|Bone metastases|bone metastases
4984941|NCT01703039|Major Depression|major depression
4984942|NCT01703039|Major Depressive Disorder|major depressive disorder
4984943|NCT01703039|Depression|depression
4984944|NCT01703039|Riluzole|riluzole
4984945|NCT01703039|Glutamate|glutamate
4984946|NCT01703039|Sertraline|sertraline
4984947|NCT01703013|Demonstrate that DEFA4 is a reliable biomarker for the prediction of adrenal insufficiency|demonstrate that defa4 is a reliable biomarker for the prediction of adrenal insufficiency
4984948|NCT01703000|drug eluting coronary stent|drug eluting coronary stent
4984949|NCT01702987|ubiquinol (coenzyme Q10)|ubiquinol (coenzyme q10)
4984950|NCT01702974|HIV|hiv
4984951|NCT01702974|cholecalciferol|cholecalciferol
4984952|NCT01702974|sodium phenylbutyrate|sodium phenylbutyrate
4984953|NCT01702974|antimicrobial peptides|antimicrobial peptides
4984954|NCT01702974|immune response|immune response
4984955|NCT01702974|inflammation|inflammation
4984956|NCT01702961|Lymphoma|lymphoma
4984957|NCT01702961|Hodgkin's Disease|hodgkin's disease
4984958|NCT01702948|Functional Magnetic Resonance Imaging (fMRI)|functional magnetic resonance imaging (fmri)
4984959|NCT01702948|Nicotine|nicotine
4984960|NCT01702948|Repetitive TMS (rTMS)|repetitive tms (rtms)
4984961|NCT01702948|fMRI|fmri
4984962|NCT01702935|Ovarian Failure|ovarian failure
4985348|NCT01701401|RNA Virus Infections|rna virus infections
4984963|NCT01702935|Premature Ovarian Failure|premature ovarian failure
4984964|NCT01702935|Infertility|infertility
4984965|NCT01702935|Primary Ovarian Insufficiency|primary ovarian insufficiency
4984966|NCT01702935|Stem Cells|stem cells
4984968|NCT01702922|Marriage|marriage
4984969|NCT01702922|Dyadic Coping|dyadic coping
4984970|NCT01702922|Mother|mother
4984971|NCT01702922|Father|father
4984972|NCT01702909|Metastatic Renal Cell|metastatic renal cell
4984973|NCT01702909|Metastatic Kidney Cancer|metastatic kidney cancer
4984974|NCT01702896|Metastatic Melanoma|metastatic melanoma
4984975|NCT01702883|prescriptions|prescriptions
4984976|NCT01702883|hypertension|hypertension
4984977|NCT01702883|high cholesterol|high cholesterol
4984978|NCT01702883|diabetes|diabetes
4984979|NCT01702883|depression|depression
4984980|NCT01702883|adherence|adherence
4984981|NCT01702870|Magnetic resonance imaging|magnetic resonance imaging
4984982|NCT01702857|Dengue|dengue
4984983|NCT01702857|Dengue fever|dengue fever
4984984|NCT01702857|Dengue Hemorrhagic Fever|dengue hemorrhagic fever
4984985|NCT01702857|Flavivirus|flavivirus
4984986|NCT01702844|Nab paclitaxel|nab paclitaxel
4984987|NCT01702844|Abraxane|abraxane
4984988|NCT01702844|First Line|first line
4984989|NCT01702844|Non small cell lung cancer|non small cell lung cancer
4984990|NCT01702844|NSCLC|nsclc
4984991|NCT01702844|Phase II|phase ii
4984992|NCT01702844|Non-Randomized|non-randomized
4984993|NCT01702844|Elderly|elderly
4984994|NCT01702844|Lineberger|lineberger
4984995|NCT01702844|UNC|unc
4984996|NCT01702844|LCCC 1210|lccc 1210
4984997|NCT01702831|Newly Diagnosed multiple myeloma|newly diagnosed multiple myeloma
4984998|NCT01702818|Hypoactive Sexual Desire Disorder|hypoactive sexual desire disorder
4984999|NCT01702818|HSDD|hsdd
4985000|NCT01702818|Cortisol|cortisol
4985001|NCT01702818|DHEA|dhea
4985002|NCT01702818|Stress Hormones|stress hormones
4985003|NCT01702818|Sexual Desire|sexual desire
4985004|NCT01702818|Mood|mood
4985005|NCT01702818|Sexual Function|sexual function
4985006|NCT01702818|Childhood Maltreatment|childhood maltreatment
4985007|NCT01702818|Childhood Abuse|childhood abuse
4985008|NCT01702805|NICHD Neonatal Research Network|nichd neonatal research network
4985009|NCT01702805|Very Low Birth Weight (VLBW)|very low birth weight (vlbw)
4985010|NCT01702805|Extremely Low Birth Weight (ELBW)|extremely low birth weight (elbw)
4985011|NCT01702805|Transfusions|transfusions
4985012|NCT01702792|Immunotherapy, cancer vaccine, glioblastoma, hybridoma|immunotherapy, cancer vaccine, glioblastoma, hybridoma
4985013|NCT01702779|Weaning from mechanical ventilation|weaning from mechanical ventilation
4985014|NCT01702779|Lung ultrasound|lung ultrasound
4985015|NCT01702779|Oxygen inhalation therapy|oxygen inhalation therapy
4985016|NCT01702740|Cutaneous lupus erythematosus|cutaneous lupus erythematosus
4985017|NCT01702740|Systemic lupus erythematosus|systemic lupus erythematosus
4985018|NCT01702740|Lupus erythematosus|lupus erythematosus
4985019|NCT01702740|Human anti-IL 6 monoclonal antibody|human anti-il 6 monoclonal antibody
4985020|NCT01702740|Sirukumab|sirukumab
4985021|NCT01702727|Amblyopia|amblyopia
4985022|NCT01702727|I-BiT TM|i-bit tm
4985023|NCT01702727|Interactive games|interactive games
4985024|NCT01702727|Binocular|binocular
4985025|NCT01702675|Safety|safety
4985026|NCT01702675|Pharmacokinetics|pharmacokinetics
4985027|NCT01702675|Tolerability|tolerability
4985028|NCT01702675|Healthy men|healthy men
4985029|NCT01702636|Intracerebral Hemorrhage|intracerebral hemorrhage
4985030|NCT01702636|ICH|ich
4985031|NCT01702636|Stroke|stroke
4985032|NCT01702636|Cerebrovascular Disorders|cerebrovascular disorders
4985033|NCT01702636|Brain Diseases|brain diseases
4985034|NCT01702636|Central Nervous System Diseases|central nervous system diseases
4985035|NCT01702636|Nervous System Diseases|nervous system diseases
4985036|NCT01702636|Vascular Diseases|vascular diseases
4985037|NCT01702636|Cardiovascular Diseases|cardiovascular diseases
4985038|NCT01702636|Tranexamic Acid|tranexamic acid
4985039|NCT01702636|Antifibrinolytic Agents|antifibrinolytic agents
4985040|NCT01702636|Fibrin Modulating Agents|fibrin modulating agents
4985041|NCT01702636|Pharmacologic Actions|pharmacologic actions
4985042|NCT01702636|Cardiovascular Agents|cardiovascular agents
4985043|NCT01702636|Therapeutic Uses|therapeutic uses
4985044|NCT01702636|Hematologic Agents|hematologic agents
4985045|NCT01702636|Hemostatics|hemostatics
4985046|NCT01702636|Contrast Media|contrast media
4985047|NCT01702636|Angiography|angiography
4985048|NCT01702636|Cerebral Angiography|cerebral angiography
4985049|NCT01702636|Tomography, X-Ray Computed|tomography, x-ray computed
4985050|NCT01702584|stent|stent
4985051|NCT01702584|intracranial aneurysm|intracranial aneurysm
4985052|NCT01702584|embolization|embolization
4985053|NCT01702584|adverse event|adverse event
4985054|NCT01702532|provoked craving|provoked craving
4985055|NCT01702506|Dacomitinib|dacomitinib
4985056|NCT01702506|PF-00299804|pf-00299804
4985057|NCT01702506|fed|fed
4985058|NCT01702506|fasted|fasted
4985059|NCT01702506|antacid|antacid
4985060|NCT01702506|relative Bioavailability|relative bioavailability
4985061|NCT01702493|SRT2104|srt2104
4985062|NCT01702493|Modified Release|modified release
4985063|NCT01702493|Bioavailability|bioavailability
4985064|NCT01702493|Crossover|crossover
4985065|NCT01702480|Consumer Healthcare|consumer healthcare
4985066|NCT01702480|Ketones|ketones
4985067|NCT01702480|Medium Chain Triglycerides|medium chain triglycerides
4985068|NCT01702480|Age related cognitive decline|age related cognitive decline
4985069|NCT01702480|GSK Nutrition|gsk nutrition
4985070|NCT01702467|Lp-PLA2|lp-pla2
4985071|NCT01702467|Alzheimer's disease|alzheimer's disease
4985072|NCT01702454|GSK Biologicals quadrivalent influenza vaccine|gsk biologicals quadrivalent influenza vaccine
4985073|NCT01702454|Influenza|influenza
4985074|NCT01702454|Children|children
4985075|NCT01702454|Safety|safety
4985076|NCT01702454|Immunogenicity|immunogenicity
4985077|NCT01702428|Safety|safety
4985078|NCT01702428|Consistency study|consistency study
4985079|NCT01702428|Measles, mumps and rubella diseases|measles, mumps and rubella diseases
4985080|NCT01702428|Healthy children|healthy children
4985081|NCT01702428|Immunogenicity|immunogenicity
4985082|NCT01702415|Cystic fibrosis|cystic fibrosis
4985083|NCT01702415|Bone density|bone density
4985084|NCT01702402|intervention|intervention
4985085|NCT01702389|opioid induced hyperalgesia|opioid induced hyperalgesia
4985086|NCT01702389|Pain|pain
4985087|NCT01702389|Postoperative pain|postoperative pain
4985088|NCT01702389|Hyperalgesia|hyperalgesia
4985089|NCT01702363|Chronic Obstructive Pulmonary Disease (COPD), GSK573719, Pharmacogenetics|chronic obstructive pulmonary disease (copd), gsk573719, pharmacogenetics
4985090|NCT01702350|Healthy Subjects|healthy subjects
4985091|NCT01702350|Relative Bioavailability|relative bioavailability
4985092|NCT01702350|Pharmacokinetics|pharmacokinetics
4985093|NCT01702350|Elderly Subjects|elderly subjects
4985094|NCT01702337|Gardasil|gardasil
4985095|NCT01702337|Prevalence-model|prevalence-model
4985096|NCT01702337|Cervarix|cervarix
4985097|NCT01702337|economic|economic
4985098|NCT01702337|health|health
4985099|NCT01702324|Psoriasis Vulgaris|psoriasis vulgaris
4985100|NCT01702324|Plaque|plaque
4985101|NCT01702324|Topical|topical
4985102|NCT01702324|Treatment|treatment
4985103|NCT01702311|Diabetes|diabetes
4985104|NCT01702311|Point of care testing|point of care testing
4985105|NCT01702311|Hypoglycemia|hypoglycemia
4985106|NCT01702311|Basal bolus insulin|basal bolus insulin
4985107|NCT01702285|Advanced Solid Tumors|advanced solid tumors
4985108|NCT01702285|EGFR|egfr
4985109|NCT01702285|HDAC|hdac
4985110|NCT01702285|Her2|her2
4985111|NCT01702285|Open-Label|open-label
4985112|NCT01702285|Dose-Escalation|dose-escalation
4985113|NCT01702246|sickle cell disease|sickle cell disease
4985114|NCT01702246|statins|statins
4985115|NCT01702246|vaso-occlusive pain|vaso-occlusive pain
4985116|NCT01702246|inflammation|inflammation
4985117|NCT01702246|biomarkers|biomarkers
4985118|NCT01702220|Generalized Anxiety Disorder|generalized anxiety disorder
4985119|NCT01702220|Geriatric|geriatric
4985120|NCT01702207|Prograf®|prograf®
4985121|NCT01702207|Advagraf®|advagraf®
4985122|NCT01702207|tacrolimus|tacrolimus
4985123|NCT01702207|kidney transplant|kidney transplant
4985124|NCT01702207|renal transplant|renal transplant
4985125|NCT01702207|cardiovascular risk|cardiovascular risk
4985126|NCT01702207|Framingham Risk|framingham risk
4985127|NCT01702207|Reynolds Risk|reynolds risk
4985128|NCT01702207|immunosuppression|immunosuppression
4985130|NCT01702194|Opioid Induced Constipation|opioid induced constipation
4985131|NCT01702194|Constipation|constipation
4985132|NCT01702181|Atopic Dermatitis, Eczema|atopic dermatitis, eczema
4985133|NCT01702168|PTSD|ptsd
4985134|NCT01702168|EBT|ebt
4985135|NCT01702168|EST|est
4985136|NCT01702168|Community|community
4985137|NCT01702168|Latino|latino
4985138|NCT01702142|Addiction Treatment|addiction treatment
4985139|NCT01702129|EGFR|egfr
4985140|NCT01702129|liposomes|liposomes
4985141|NCT01702129|immunoliposomes|immunoliposomes
4985142|NCT01702116|rectal adenocarcinoma|rectal adenocarcinoma
4985143|NCT01702116|Standard APR|standard apr
4985144|NCT01702116|Extralevator APR|extralevator apr
4985145|NCT01702090|HIV-1|hiv-1
4985146|NCT01702090|TMC114|tmc114
4985147|NCT01702090|Darunavir|darunavir
4985148|NCT01702090|PREZISTA|prezista
4985149|NCT01702090|Ritonavir|ritonavir
4985150|NCT01702090|Antiretrovirals|antiretrovirals
4985151|NCT01702090|Early access|early access
4985152|NCT01702090|Early treatment|early treatment
4985153|NCT01702090|Treatment naive|treatment naive
4985154|NCT01702077|neurofeedback|neurofeedback
4985155|NCT01702077|biofeedback|biofeedback
4985156|NCT01702077|real-time fMRI|real-time fmri
4985157|NCT01702077|rt-fMRI|rt-fmri
4985158|NCT01702077|functional connectivity|functional connectivity
4985159|NCT01702077|fMRI|fmri
4985160|NCT01702064|CML|cml
4985161|NCT01702064|CP-CML|cp-cml
4985162|NCT01702064|Chronic Phase-CML (CP-CML)|chronic phase-cml (cp-cml)
4985163|NCT01702064|chronic myeloid leukemia|chronic myeloid leukemia
4985164|NCT01702051|Pancreatogenic diabetes|pancreatogenic diabetes
4985165|NCT01702051|Autologou Islet Transplantation|autologou islet transplantation
4985166|NCT01702051|Pancreas|pancreas
4985167|NCT01702051|Pancreatectomy|pancreatectomy
4985168|NCT01702025|Hypoxia|hypoxia
4985169|NCT01702025|Altitude|altitude
4985170|NCT01702025|Exercise|exercise
4985171|NCT01702012|Diabetes-Obesity|diabetes-obesity
4985172|NCT01701999|Botulism Vaccine|botulism vaccine
4985173|NCT01701986|Lymphoma|lymphoma
4985174|NCT01701986|Aggressive lymphomas|aggressive lymphomas
4985175|NCT01701986|Allogeneic stem-cell transplant|allogeneic stem-cell transplant
4985176|NCT01701986|alloSCT|allosct
4985177|NCT01701986|Refractory B-cell|refractory b-cell
4985178|NCT01701986|T-cell|t-cell
4985179|NCT01701986|Non-Hodgkin's lymphoma|non-hodgkin's lymphoma
4985180|NCT01701986|Hodgkin's lymphoma|hodgkin's lymphoma
4985181|NCT01701986|Gemcitabine|gemcitabine
4985182|NCT01701986|Gemcitabine Hydrochloride|gemcitabine hydrochloride
4985183|NCT01701986|Gemzar|gemzar
4985184|NCT01701986|Clofarabine|clofarabine
4985185|NCT01701986|Clofarex|clofarex
4985186|NCT01701986|Clolar|clolar
4985187|NCT01701986|Busulfan|busulfan
4985188|NCT01701986|Busulfex|busulfex
4985189|NCT01701986|Myleran|myleran
4985190|NCT01701986|Anti-Thymocyte Globulin|anti-thymocyte globulin
4985191|NCT01701986|ATG|atg
4985192|NCT01701986|Thymoglobulin|thymoglobulin
4985193|NCT01701986|Rituximab|rituximab
4985194|NCT01701986|Rituxan|rituxan
4985195|NCT01701986|Filgrastim|filgrastim
4985196|NCT01701986|G-CSF|g-csf
4985197|NCT01701986|Neupogen|neupogen
4985198|NCT01701986|Tacrolimus|tacrolimus
4985199|NCT01701986|Prograf|prograf
4985200|NCT01701986|Mycophenolate Mofetil|mycophenolate mofetil
4985201|NCT01701986|MMF|mmf
4985202|NCT01701986|CellCept|cellcept
4985203|NCT01701973|obesity|obesity
4985204|NCT01701973|growth hormone|growth hormone
4985205|NCT01701947|Factor XI deficiency|factor xi deficiency
4985206|NCT01701947|EAP|eap
4985207|NCT01701947|postpartum hemorrhage|postpartum hemorrhage
4985208|NCT01701947|surgery|surgery
4985209|NCT01701947|delivery|delivery
4985210|NCT01701947|Child birth|child birth
4985211|NCT01701934|COPD|copd
4985212|NCT01701934|Intrabdominal adiposity|intrabdominal adiposity
4985213|NCT01701934|Body composition|body composition
4985214|NCT01701934|Triglycerides|triglycerides
4985215|NCT01701934|Cholesterol|cholesterol
4985216|NCT01701921|cardiac surgery|cardiac surgery
4985217|NCT01701921|pregabalin|pregabalin
4985218|NCT01701921|postoperative pain|postoperative pain
4985219|NCT01701908|PPCs|ppcs
4985220|NCT01701908|abdominal surgery|abdominal surgery
4985221|NCT01701908|postoperative infections|postoperative infections
4985222|NCT01701908|postoperative residual curarization|postoperative residual curarization
4985223|NCT01701908|tracheal re-intubation|tracheal re-intubation
4985224|NCT01701908|mortality|mortality
4985225|NCT01701908|ICU stay|icu stay
4985226|NCT01701895|Complera|complera
4985227|NCT01701895|short-term|short-term
4985228|NCT01701895|long-term|long-term
4985229|NCT01701895|compliance|compliance
4985230|NCT01701895|caloric|caloric
4985231|NCT01701895|intake|intake
4985232|NCT01701895|HIV|hiv
4985233|NCT01701895|positive|positive
4985234|NCT01701895|women|women
4985235|NCT01701856|relapsing-remitting multiple sclerosis|relapsing-remitting multiple sclerosis
4985236|NCT01701856|natalizumab|natalizumab
4985237|NCT01701856|de-escalation|de-escalation
4985238|NCT01701856|interferon beta-1b|interferon beta-1b
4985239|NCT01701830|omentin-1|omentin-1
4985240|NCT01701830|carotid atherosclerosis|carotid atherosclerosis
4985241|NCT01701830|kidney disease|kidney disease
4985242|NCT01701817|Atrial Fibrillation|atrial fibrillation
4985243|NCT01701817|Irregular heart beat|irregular heart beat
4985244|NCT01701804|Failed Back Surgery Syndrome|failed back surgery syndrome
4985245|NCT01701791|Depression|depression
4985246|NCT01701791|Primary care|primary care
4985247|NCT01701791|Computerized decision support system|computerized decision support system
4985248|NCT01701791|General practitioner|general practitioner
4985249|NCT01701778|Dexmedetomidine|dexmedetomidine
4985250|NCT01701778|Postoperative pain reaction|postoperative pain reaction
4985251|NCT01701778|anesthesia|anesthesia
4985252|NCT01701778|children|children
4985253|NCT01701765|Severe mental disorders|severe mental disorders
4985254|NCT01701765|Discharge|discharge
4985255|NCT01701765|Outcome evaluation|outcome evaluation
4985256|NCT01701752|Influenza A|influenza a
4985257|NCT01701726|Essential Hypertension|essential hypertension
4985258|NCT01701726|Acupuncture|acupuncture
4985259|NCT01701726|Specificity|specificity
4985260|NCT01701726|Acupoints effect|acupoints effect
4985261|NCT01701726|randomized controlled trials|randomized controlled trials
4985262|NCT01701713|TDCS|tdcs
4985263|NCT01701713|STROKE|stroke
4985264|NCT01701713|APHASIA|aphasia
4985266|NCT01701700|portable electronic magnifiers|portable electronic magnifiers
4985267|NCT01701687|Cirrhosis|cirrhosis
4985268|NCT01701687|Alcoholic liver disease|alcoholic liver disease
4985269|NCT01701687|Decompensated liver cirrhosis|decompensated liver cirrhosis
4985270|NCT01701687|Hazardous alcohol|hazardous alcohol
4985271|NCT01701674|skin cancer|skin cancer
4985272|NCT01701661|venous surgery|venous surgery
4985273|NCT01701661|compression therapy|compression therapy
4985274|NCT01701648|Vitiligo, amniotic membrane, malanocytes, C02 laser.|vitiligo, amniotic membrane, malanocytes, c02 laser.
4985275|NCT01701635|Disclosure|disclosure
4985276|NCT01701635|HIV-infected children|hiv-infected children
4985277|NCT01701635|Resource-limited settings|resource-limited settings
4985278|NCT01701622|Blood Pressure|blood pressure
4985279|NCT01701622|Gout|gout
4985280|NCT01701622|allopurinol|allopurinol
4985281|NCT01701622|febuxostat|febuxostat
4985282|NCT01701622|uric acid|uric acid
4985283|NCT01701609|early-onset schizophrenia|early-onset schizophrenia
4985284|NCT01701609|adolescents|adolescents
4985285|NCT01701609|cognition|cognition
4985286|NCT01701609|cognitive remediation therapy|cognitive remediation therapy
4985287|NCT01701596|Rotational atherectomy|rotational atherectomy
4985288|NCT01701596|Coronary dissection|coronary dissection
4985289|NCT01701596|Percutaneous coronary intervention|percutaneous coronary intervention
4985290|NCT01701596|Calcification|calcification
4985291|NCT01701583|Chronic Idiopathic Urticaria|chronic idiopathic urticaria
4985292|NCT01701583|CIU|ciu
4985293|NCT01701583|Urticaria|urticaria
4985294|NCT01701583|Chronic Hives|chronic hives
4985295|NCT01701583|Xolair|xolair
4985296|NCT01701570|Type 2 Diabetes|type 2 diabetes
4985297|NCT01701570|Exercise|exercise
4985298|NCT01701570|Rate of Perceived Exertion|rate of perceived exertion
4985299|NCT01701557|Ketoacidosis Fluids|ketoacidosis fluids
4985300|NCT01701518|Ozurdex|ozurdex
4985301|NCT01701518|Dexamethasone|dexamethasone
4985302|NCT01701518|Epiretinal membrane|epiretinal membrane
4985303|NCT01701518|Macular edema|macular edema
4985304|NCT01701505|operative|operative
4985305|NCT01701505|dental procedure|dental procedure
4985306|NCT01701492|pediatric|pediatric
4985307|NCT01701492|hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
4985308|NCT01701492|allogeneic bone marrow transplantation|allogeneic bone marrow transplantation
4985309|NCT01701479|Neuroblastoma|neuroblastoma
4985310|NCT01701479|Refractory neuroblastoma|refractory neuroblastoma
4985311|NCT01701479|Relapsed neuroblastoma|relapsed neuroblastoma
4985312|NCT01701479|ch14.18/CHO|ch14.18/cho
4985313|NCT01701479|Aldesleukin (IL-2)|aldesleukin (il-2)
4985314|NCT01701466|Patients|patients
4985315|NCT01701466|with|with
4985316|NCT01701453|duration of DAPT|duration of dapt
4985317|NCT01701427|Hyperalgesia|hyperalgesia
4985318|NCT01701427|Persistent pain|persistent pain
4985319|NCT01701427|deep pain|deep pain
4985320|NCT01701427|electrical stimulation|electrical stimulation
4985321|NCT01701427|groin hernia|groin hernia
4985322|NCT01701414|Femur|femur
4985323|NCT01701414|Hip|hip
4985324|NCT01701414|Fracture|fracture
4985325|NCT01701414|Femoral neck|femoral neck
4985326|NCT01701414|Femoral head|femoral head
4985327|NCT01701401|HCV genotype 1 (GT-1)|hcv genotype 1 (gt-1)
4985328|NCT01701401|HCV|hcv
4985329|NCT01701401|Sustained Virologic Response|sustained virologic response
4985330|NCT01701401|Direct Acting Antiviral|direct acting antiviral
4985331|NCT01701401|Combination Therapy|combination therapy
4985332|NCT01701401|GS-7977|gs-7977
4985333|NCT01701401|GS-5885|gs-5885
4985334|NCT01701401|Ribavirin|ribavirin
4985335|NCT01701401|Open Label|open label
4985336|NCT01701401|Sofosbuvir|sofosbuvir
4985337|NCT01701401|Additional relevant MeSH terms:|additional relevant mesh terms:
4985338|NCT01701401|Hepatitis|hepatitis
4985339|NCT01701401|Hepatitis, Chronic|hepatitis, chronic
4985340|NCT01701401|Hepatitis C|hepatitis c
4985341|NCT01701401|Hepatitis C, Chronic|hepatitis c, chronic
4985342|NCT01701401|Liver Diseases|liver diseases
4985343|NCT01701401|Digestive System Diseases|digestive system diseases
4985344|NCT01701401|Hepatitis, Viral, Human|hepatitis, viral, human
4985345|NCT01701401|Virus Diseases|virus diseases
4985346|NCT01701401|Enterovirus Infections|enterovirus infections
4985347|NCT01701401|Picornaviridae Infections|picornaviridae infections
4985349|NCT01701401|Flaviviridae Infections|flaviviridae infections
4985350|NCT01701401|Antiviral Agents|antiviral agents
4985351|NCT01701401|Anti-Infective Agents|anti-infective agents
4985352|NCT01701401|Therapeutic Uses|therapeutic uses
4985353|NCT01701401|Pharmacologic Actions|pharmacologic actions
4985354|NCT01701401|Antimetabolites|antimetabolites
4985355|NCT01701401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
4985356|NCT01701388|Ekso|ekso
4985357|NCT01701388|Exoskeleton|exoskeleton
4985358|NCT01701388|Spinal Cord Injury|spinal cord injury
4985359|NCT01701388|Motor Complete Incomplete|motor complete incomplete
4985360|NCT01701362|post-traumatic peripheral neuropathic pain|post-traumatic peripheral neuropathic pain
4985361|NCT01701349|ATC|atc
4985362|NCT01701349|Anaplastic Thyroid Cancer|anaplastic thyroid cancer
4985363|NCT01701349|Stage IVC Anaplastic Thyroid Cancer|stage ivc anaplastic thyroid cancer
4985364|NCT01701349|Thyroid Cancer|thyroid cancer
4985365|NCT01701349|Head and Neck Tumors|head and neck tumors
4985366|NCT01701336|Hepatitis|hepatitis
4985367|NCT01701336|Hepatitis C|hepatitis c
4985368|NCT01701336|HCV|hcv
4985369|NCT01701336|vaccine|vaccine
4985370|NCT01701336|adenovirus|adenovirus
4985371|NCT01701336|MVA|mva
4985372|NCT01701336|T cells|t cells
4985373|NCT01701336|ELISpot|elispot
4985374|NCT01701310|Adenocarcinoma|adenocarcinoma
4985375|NCT01701310|Anemia|anemia
4985376|NCT01701310|Blood Transfusion|blood transfusion
4985377|NCT01701310|Colorectal surgery|colorectal surgery
4985378|NCT01701310|Preoperative care|preoperative care
4985379|NCT01701310|Perioperative care|perioperative care
4985380|NCT01701310|Postoperative care|postoperative care
4985381|NCT01701310|Iron|iron
4985382|NCT01701310|Hematinics|hematinics
4985383|NCT01701310|Hepcidin|hepcidin
4985384|NCT01701310|Quality of life|quality of life
4985385|NCT01701310|Postoperative complications|postoperative complications
4985386|NCT01701297|Cirrhosis, ascites, infection|cirrhosis, ascites, infection
4985387|NCT01701284|repetitive Transcranial Magnetic Stimulation|repetitive transcranial magnetic stimulation
4985388|NCT01701284|Cancer Survivors|cancer survivors
4985389|NCT01701284|Depression|depression
4985390|NCT01701284|Anxiety|anxiety
4985391|NCT01701271|Baldness|baldness
4985392|NCT01701271|Androgenetic Alopecia|androgenetic alopecia
4985393|NCT01701271|Alopecia|alopecia
4985394|NCT01701258|Depression|depression
4985395|NCT01701258|Childhood Sexual Abuse|childhood sexual abuse
4985396|NCT01701258|Dopamine|dopamine
4985397|NCT01701258|MRI|mri
4985398|NCT01701258|PET|pet
4985399|NCT01701258|ERP|erp
4985400|NCT01701258|Stress|stress
4985401|NCT01701258|Reward|reward
4985402|NCT01701258|Childhood trauma|childhood trauma
4985403|NCT01701258|Amisulpride|amisulpride
4985404|NCT01701245|vagus nerve stimulation|vagus nerve stimulation
4985405|NCT01701245|vagal nerve stimulation|vagal nerve stimulation
4985406|NCT01701245|nVNS|nvns
4985407|NCT01701245|VNS|vns
4985408|NCT01701245|cluster headache|cluster headache
4985409|NCT01701245|chronic|chronic
4985410|NCT01701245|non invasive|non invasive
4985411|NCT01701245|gammacore|gammacore
4985412|NCT01701232|lymphoma, non-Hodgkin's|lymphoma, non-hodgkin's
4985413|NCT01701219|Staphylococcus aureus bacteremia|staphylococcus aureus bacteremia
4985414|NCT01701219|Methicillin-resistant Staphylococcus aureus bacteremia|methicillin-resistant staphylococcus aureus bacteremia
4985415|NCT01701219|MRSA bacteremia|mrsa bacteremia
4985416|NCT01701219|Blood|blood
4985417|NCT01701219|Adult|adult
4985418|NCT01701219|Infections|infections
4985419|NCT01701219|Blood Culture|blood culture
4985420|NCT01701206|HIV|hiv
4985421|NCT01701206|social networking|social networking
4985422|NCT01701206|at-risk populations|at-risk populations
4985423|NCT01701206|sexual risk behaviors|sexual risk behaviors
4985424|NCT01701180|Male Volunteers|male volunteers
4985425|NCT01701154|Pompe respiratory|pompe respiratory
4985426|NCT01701141|Positron Emission Tomography (PET)|positron emission tomography (pet)
4985427|NCT01701141|Magnetic resonance imaging (MRI)|magnetic resonance imaging (mri)
4985428|NCT01701141|reward|reward
4985429|NCT01701141|stress|stress
4985430|NCT01701141|learning|learning
4985431|NCT01701141|Major Depressive Disorder|major depressive disorder
4985432|NCT01701141|Anhedonia|anhedonia
4985433|NCT01701128|Physical activity, treadmill training, rehabilitation|physical activity, treadmill training, rehabilitation
4985434|NCT01701115|Interscalene Block|interscalene block
4985435|NCT01701076|Relapsed / refractory multiple myeloma|relapsed / refractory multiple myeloma
4985436|NCT01701076|2nd line treatment|2nd line treatment
4985437|NCT01701050|circulating tumor cells|circulating tumor cells
4985438|NCT01701050|CTC|ctc
4985439|NCT01701050|metastatic breast cancer|metastatic breast cancer
4985440|NCT01701050|endocrine therapy|endocrine therapy
4985441|NCT01701050|hormone therapy|hormone therapy
4985442|NCT01701037|Melanoma, B-RAF, biomarkers, targeted therapy, resistance|melanoma, b-raf, biomarkers, targeted therapy, resistance
4985443|NCT01701024|Acne|acne
4985444|NCT01701011|coping|coping
4985445|NCT01701011|intervention|intervention
4985446|NCT01701011|waiting-period|waiting-period
4985447|NCT01700985|psoriasis|psoriasis
4985448|NCT01700985|plaque psoriasis|plaque psoriasis
4985449|NCT01700985|122-0551|122-0551
4985450|NCT01700985|steroid|steroid
4985451|NCT01700959|Melatonin|melatonin
4985452|NCT01700959|Neurocognitive impairment|neurocognitive impairment
4985453|NCT01700959|Sleep disturbance|sleep disturbance
4985454|NCT01700959|Childhood cancer survivors|childhood cancer survivors
4985455|NCT01700946|leukemia|leukemia
4985456|NCT01700946|lymphoma|lymphoma
4985457|NCT01700946|Non-Hodgkins|non-hodgkins
4985458|NCT01700933|Exercise therapy|exercise therapy
4985459|NCT01700920|Osteonecrosis of the femoral head|osteonecrosis of the femoral head
4985460|NCT01700920|Stem Cell|stem cell
4985461|NCT01700920|Mesenchymal Stem Cells|mesenchymal stem cells
4985462|NCT01700920|Femoral Head|femoral head
4985463|NCT01700907|Postoperative cognitive dysfunction|postoperative cognitive dysfunction
4985464|NCT01700907|elderly patients|elderly patients
4985465|NCT01700907|long surgery|long surgery
4985466|NCT01700894|Physical Activity|physical activity
4985467|NCT01700894|African American|african american
4985468|NCT01700894|Adherence|adherence
4985469|NCT01700881|Rheumatoid Arthritis, Diet, Fat-Restricted, Diet, Vegetarian|rheumatoid arthritis, diet, fat-restricted, diet, vegetarian
4985470|NCT01700868|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
4985471|NCT01700868|Diet, Vegetarian|diet, vegetarian
4985472|NCT01700868|Diet, Fat-Restricted|diet, fat-restricted
4985473|NCT01700868|Glycemic Index|glycemic index
4985474|NCT01700855|Electroacupuncture|electroacupuncture
4985475|NCT01700855|Analgesia|analgesia
4985476|NCT01700855|Anesthesia|anesthesia
4985477|NCT01700855|Nasal septoplasty|nasal septoplasty
4985478|NCT01700855|Mammaplasty|mammaplasty
4985479|NCT01700842|ceftaroline, infection, CAPB, CAP, ABSSSI, cSSTI|ceftaroline, infection, capb, cap, absssi, cssti
4985480|NCT01700829|Ketamine|ketamine
4985481|NCT01700829|Midazolam|midazolam
4985482|NCT01700829|Major Depressive Disorder|major depressive disorder
4985483|NCT01700829|Suicidal ideation|suicidal ideation
4985484|NCT01700829|Suicide|suicide
4985485|NCT01700829|Depression|depression
4985486|NCT01700829|Treatment|treatment
4985487|NCT01700829|Ketamine Treatment|ketamine treatment
4985488|NCT01700816|Delirium|delirium
4985489|NCT01700816|Hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
4985490|NCT01700816|Bone marrow transplantation|bone marrow transplantation
4985491|NCT01700816|Bright Light Therapy|bright light therapy
4985492|NCT01700803|Betadine|betadine
4985493|NCT01700803|Povidine Iodine|povidine iodine
4985494|NCT01700803|Hand scrubbing|hand scrubbing
4985495|NCT01700803|Cesarean section wound infections|cesarean section wound infections
4985496|NCT01700803|post cesarean section|post cesarean section
4985497|NCT01700790|HIV|hiv
4985498|NCT01700790|AIDS|aids
4985499|NCT01700790|Tuberculosis|tuberculosis
4985500|NCT01700790|Rifampin|rifampin
4985501|NCT01700790|Lopinavir|lopinavir
4985502|NCT01700790|Pharmacokinetic|pharmacokinetic
4985503|NCT01700777|bimanual training|bimanual training
4985504|NCT01700777|lower limb|lower limb
4985505|NCT01700777|intensive rehabilitation|intensive rehabilitation
4985506|NCT01700777|regular rehabilitation|regular rehabilitation
4985507|NCT01700777|hemiplegia|hemiplegia
4985508|NCT01700725|Gulf War Illness|gulf war illness
4985509|NCT01700725|xylitol|xylitol
4985510|NCT01700725|nasal irrigation|nasal irrigation
4985511|NCT01700725|Desert Storm|desert storm
4985512|NCT01700725|Persian Gulf Conflicts|persian gulf conflicts
4985513|NCT01700725|neti pot|neti pot
4985514|NCT01700725|cytokines|cytokines
4985515|NCT01700725|nasal mucus|nasal mucus
4985516|NCT01700725|inflammatory mediator|inflammatory mediator
4985517|NCT01700725|lactoferrin|lactoferrin
4985518|NCT01700725|lysozyme|lysozyme
4985519|NCT01700712|Caries, probiotic bacteria|caries, probiotic bacteria
4985520|NCT01700699|thyroid cancer|thyroid cancer
4985521|NCT01700699|tyrosine kinase inhibitors|tyrosine kinase inhibitors
4985522|NCT01700699|BRAF|braf
4985523|NCT01700699|Sorafenib|sorafenib
4985524|NCT01700699|Pazopanib|pazopanib
4985525|NCT01700699|Sunitinib|sunitinib
4985526|NCT01700699|Cabozantinib|cabozantinib
4985527|NCT01700673|maintenance treatment|maintenance treatment
4985528|NCT01700673|stem cell transplant|stem cell transplant
4985529|NCT01700673|cytarabine-based chemotherapy|cytarabine-based chemotherapy
4985530|NCT01700647|Larynx cancer|larynx cancer
4985531|NCT01700647|Volatile organic compounds|volatile organic compounds
4985532|NCT01700647|Diagnosis|diagnosis
4985533|NCT01700647|Bronchoscopy|bronchoscopy
4985534|NCT01700647|Cancer staging|cancer staging
4985535|NCT01700634|fMRI, BOLD, pressure stimuli|fmri, bold, pressure stimuli
4985536|NCT01700621|rotavirus|rotavirus
4985537|NCT01700582|lung cancer|lung cancer
4985538|NCT01700582|biomarkers|biomarkers
4985539|NCT01700582|EGFR|egfr
4985540|NCT01700582|KRAS|kras
4985541|NCT01700582|ALK|alk
4985542|NCT01700582|HER2|her2
4985543|NCT01700582|PI3K|pi3k
4985544|NCT01700582|BRAF|braf
4985545|NCT01700569|high-grade|high-grade
4985546|NCT01700569|glioma|glioma
4985547|NCT01700569|epigenetic|epigenetic
4985548|NCT01700556|Alzheimer Disease|alzheimer disease
4985549|NCT01700556|Family Caregiver|family caregiver
4985550|NCT01700556|Caregiver Burden|caregiver burden
4985551|NCT01700556|Home Care Services|home care services
4985552|NCT01700556|Assistive Technologies|assistive technologies
4985553|NCT01700543|Stemless shoulder implant|stemless shoulder implant
4985554|NCT01700543|Osteoarthritis|osteoarthritis
4985555|NCT01700543|Rheumatoid Arthritis|rheumatoid arthritis
4985556|NCT01700543|Hemi Shoulder Arthroplasty|hemi shoulder arthroplasty
4985557|NCT01700543|Total Shoulder Arthroplasty|total shoulder arthroplasty
4985558|NCT01700543|Prospective|prospective
4985559|NCT01700543|Multi-center|multi-center
4985560|NCT01700543|Europe|europe
4985561|NCT01700543|Non-Controlled|non-controlled
4985562|NCT01700543|Good Bone Stock|good bone stock
4985563|NCT01700530|mitochondria|mitochondria
4985564|NCT01700530|fitness|fitness
4985565|NCT01700530|statins|statins
4985566|NCT01700530|cholesterol|cholesterol
4985567|NCT01700530|metabolic syndrome|metabolic syndrome
4985568|NCT01700517|total knee arthroplasty, analgesia, ultrasonography|total knee arthroplasty, analgesia, ultrasonography
4985569|NCT01700504|Axillary drainage volume|axillary drainage volume
4985570|NCT01700504|Lavage with gentamicin solution|lavage with gentamicin solution
4985571|NCT01700491|Paravertebral Catheter|paravertebral catheter
4985572|NCT01700491|Epidural Catheter|epidural catheter
4985573|NCT01700491|Analgesia|analgesia
4985574|NCT01700491|Hypotension|hypotension
4985575|NCT01700491|Analgesia,Epidural|analgesia,epidural
4985576|NCT01700491|Analgesia,Paravertebral|analgesia,paravertebral
4985577|NCT01700478|Myomectomy|myomectomy
4985578|NCT01700465|Hemodialysis|hemodialysis
4985579|NCT01700465|Hemodynamics|hemodynamics
4985580|NCT01700452|Lung cancer|lung cancer
4985581|NCT01700452|Pulmonary nodules|pulmonary nodules
4985582|NCT01700452|FISH Test|fish test
4985583|NCT01700439|Aortic valve|aortic valve
4985584|NCT01700439|Heart valve|heart valve
4985585|NCT01700439|Tissue valve|tissue valve
4985586|NCT01700439|Bioprosthesis|bioprosthesis
4985587|NCT01700439|Valve disorder|valve disorder
4985588|NCT01700439|Valve disease|valve disease
4985589|NCT01700439|Cardiac surgery|cardiac surgery
4985590|NCT01700439|Less invasive cardiac surgery|less invasive cardiac surgery
4985591|NCT01700439|Aortic valve stenosis|aortic valve stenosis
4985592|NCT01700439|Aortic valve regurgitation|aortic valve regurgitation
4985593|NCT01700439|Bovine pericardium|bovine pericardium
4985594|NCT01700426|Iron Deficiency|iron deficiency
4985595|NCT01700426|Iron Deficiency Anemia|iron deficiency anemia
4985596|NCT01700413|acute|acute
4985597|NCT01700413|myeloid|myeloid
4985598|NCT01700413|leukemia|leukemia
4985599|NCT01700413|CETLAM|cetlam
4985600|NCT01700413|Idarubicin|idarubicin
4985601|NCT01700400|Lung Cancer|lung cancer
4985602|NCT01700400|Non Small Cell Lung Cancer|non small cell lung cancer
4985603|NCT01700400|Advanced Lung Cancer|advanced lung cancer
4985604|NCT01700387|Migraine|migraine
4985605|NCT01700387|Chronic Migraine|chronic migraine
4985606|NCT01700387|Cognitive Efficiency|cognitive efficiency
4985607|NCT01700387|Pilot Study|pilot study
4985608|NCT01700387|Long Term Effect|long term effect
4985609|NCT01700374|pregnancy|pregnancy
4985610|NCT01700374|stress, psychological|stress, psychological
4985611|NCT01700374|stress, physiological|stress, physiological
4985612|NCT01700374|maternal-fetal relations|maternal-fetal relations
4985613|NCT01700361|sexual arousal|sexual arousal
4985614|NCT01700361|pelvic floor sEMG|pelvic floor semg
4985615|NCT01700348|moderate gingivitis|moderate gingivitis
4985616|NCT01700322|Coronary artery disease|coronary artery disease
4985617|NCT01700322|coronary stenting|coronary stenting
4985618|NCT01700322|platelet aggregation|platelet aggregation
4985619|NCT01700309|Obesity prevention; Adolescent; Physical activity; Health counselling|obesity prevention; adolescent; physical activity; health counselling
4985620|NCT01700283|Colorectal Cancer、Fatigue、Muscle strength、Metabolomics|colorectal cancer、fatigue、muscle strength、metabolomics
4985621|NCT01700257|Lung cancer screening|lung cancer screening
4985622|NCT01700257|Smokers or former smokers|smokers or former smokers
4985623|NCT01700257|Family history of lung cancer|family history of lung cancer
4985624|NCT01700231|hepatorenal syndrome, liver regeneration, liver dysfunction|hepatorenal syndrome, liver regeneration, liver dysfunction
4985625|NCT01700218|telemonitoring|telemonitoring
4985626|NCT01700205|Formula Feeding|formula feeding
4985627|NCT01700205|Mother|mother
4985628|NCT01700205|Moms|moms
4985629|NCT01700205|Infants|infants
4985630|NCT01700205|Babies|babies
4985631|NCT01700205|Baby|baby
4985632|NCT01700205|growth|growth
4985633|NCT01700205|energy balance|energy balance
4985634|NCT01700166|Autologous|autologous
4985635|NCT01700166|Cord Blood|cord blood
4985636|NCT01700166|Stem Cells|stem cells
4985637|NCT01700166|Pediatric stroke|pediatric stroke
4985638|NCT01700166|Children with ischemic stroke|children with ischemic stroke
4985639|NCT01700166|Cerebral Palsy|cerebral palsy
4985640|NCT01700166|Perinatal AIS|perinatal ais
4985641|NCT01700153|Robotic-assisted therapy|robotic-assisted therapy
4985642|NCT01700153|cerebral palsy|cerebral palsy
4985644|NCT01700127|immune response|immune response
4985645|NCT01700127|infants|infants
4985646|NCT01700127|rotavirus vaccine|rotavirus vaccine
4985647|NCT01700114|Pigmented Skin Lesions|pigmented skin lesions
4985648|NCT01700114|Dermatology|dermatology
4985649|NCT01700114|Skin Cancer|skin cancer
4985650|NCT01700114|Melanoma|melanoma
4985651|NCT01700114|MelaFind|melafind
4985652|NCT01700088|hypoxemia|hypoxemia
4985653|NCT01700088|Post Pulmonary Resection|post pulmonary resection
4985654|NCT01700075|atherosclerosis, development of concept, weight loss therapy|atherosclerosis, development of concept, weight loss therapy
4985655|NCT01700062|medium-calorie|medium-calorie
4985656|NCT01700062|standard calorie|standard calorie
4985657|NCT01700062|parenteral nutrition|parenteral nutrition
4985658|NCT01700049|advanced BCC|advanced bcc
4985659|NCT01700049|high risk|high risk
4985660|NCT01700049|locally advanced|locally advanced
4985661|NCT01700023|acute heart failure|acute heart failure
4985662|NCT01700010|Urothelial|urothelial
4985663|NCT01700010|Bladder|bladder
4985664|NCT01700010|Cancer|cancer
4985665|NCT01699997|Schizophrenia|schizophrenia
4985666|NCT01699997|Oxytocin|oxytocin
4985667|NCT01699997|RCT|rct
4985668|NCT01699984|Cognitive impairment.|cognitive impairment.
4985669|NCT01699984|Geriatrics.|geriatrics.
4985670|NCT01699984|Hospital admission.|hospital admission.
4985671|NCT01699984|Hospital discharge.|hospital discharge.
4985672|NCT01699958|Problem solving therapy|problem solving therapy
4985673|NCT01699958|Behavior change|behavior change
4985674|NCT01699945|Verbal autopsies|verbal autopsies
4985675|NCT01699945|Maternal deaths|maternal deaths
4985676|NCT01699945|Still births|still births
4985677|NCT01699919|perioperative lignocaine infusion|perioperative lignocaine infusion
4985678|NCT01699919|elective open abdominal surgeries|elective open abdominal surgeries
4985679|NCT01699919|postoperative pain|postoperative pain
4985680|NCT01699906|Obesity|obesity
4985681|NCT01699880|tracheal intubation|tracheal intubation
4985682|NCT01699880|preoxygenation|preoxygenation
4985683|NCT01699880|desaturation|desaturation
4985684|NCT01699880|hypoxemia|hypoxemia
4985685|NCT01699880|oxygen therapy|oxygen therapy
4985686|NCT01699880|high flow nasal cannula oxygen therapy|high flow nasal cannula oxygen therapy
4985687|NCT01699867|lumpectomy|lumpectomy
4985688|NCT01699867|breast cancer|breast cancer
4985689|NCT01699867|optical coherence tomography|optical coherence tomography
4985690|NCT01699867|tumor margin|tumor margin
4985691|NCT01699867|imaging|imaging
4985692|NCT01699828|buspirone|buspirone
4985693|NCT01699828|smoking cessation|smoking cessation
4985694|NCT01699828|dopamine|dopamine
4985695|NCT01699828|PET imaging|pet imaging
4985696|NCT01699828|[11C]-(+)-PHNO|[11c]-(+)-phno
4985697|NCT01699815|acetaminophen|acetaminophen
4985698|NCT01699815|timing|timing
4985699|NCT01699815|arthroplasty|arthroplasty
4985700|NCT01699789|Community Partnered Participatory Research|community partnered participatory research
4985701|NCT01699789|Community Engagement|community engagement
4985702|NCT01699789|Implementation|implementation
4985703|NCT01699789|Community Based Participatory Research|community based participatory research
4985704|NCT01699789|Quality Improvement|quality improvement
4985705|NCT01699789|Evidence Based Practice|evidence based practice
4985706|NCT01699789|Patient Centered Outcomes Research|patient centered outcomes research
4985707|NCT01699776|Digoxin|digoxin
4985708|NCT01699776|Ivabradine|ivabradine
4985709|NCT01699776|with atrial fibrillation.|with atrial fibrillation.
4985710|NCT01699750|contact lenses|contact lenses
4985711|NCT01699750|contact lens solution|contact lens solution
4985712|NCT01699750|myopia|myopia
4985713|NCT01699750|astigmatism|astigmatism
4985714|NCT01699737|Diabetes|diabetes
4985715|NCT01699724|JZoloft|jzoloft
4985716|NCT01699724|Sertraline hydrochloride|sertraline hydrochloride
4985717|NCT01699724|ODT|odt
4985718|NCT01699724|bioequivalence|bioequivalence
4985719|NCT01699711|APP function (amyloid precursor protein, cognitive stimulation, alzheimer disease. program|app function (amyloid precursor protein, cognitive stimulation, alzheimer disease. program
4985720|NCT01699698|Pancreatic adenocarcinoma|pancreatic adenocarcinoma
4985721|NCT01699685|Moderate to severe COPD patients are included|moderate to severe copd patients are included
4985722|NCT01699685|NVA|nva
4985723|NCT01699685|QAB|qab
4985724|NCT01699672|Patient education|patient education
4985725|NCT01699672|information|information
4985726|NCT01699672|communication|communication
4985727|NCT01699659|Allergic Rhinitis|allergic rhinitis
4985728|NCT01699659|Allergen Immunotherapy|allergen immunotherapy
4985729|NCT01699646|Intrapartum fetal surveillance|intrapartum fetal surveillance
4985730|NCT01699646|CTG|ctg
4985731|NCT01699646|cardiotocography|cardiotocography
4985732|NCT01699646|STAN|stan
4985733|NCT01699646|ST-Analysis|st-analysis
4985734|NCT01699646|metabolic acidosis in umbilical artery|metabolic acidosis in umbilical artery
4985735|NCT01699646|operative delivery|operative delivery
4985736|NCT01699633|Drug-drug interactions|drug-drug interactions
4985737|NCT01699633|Drug-gene interactions|drug-gene interactions
4985738|NCT01699633|Nevirapine|nevirapine
4985739|NCT01699633|Rifampicin|rifampicin
4985740|NCT01699633|children|children
4985741|NCT01699620|Bone anchored hearing aid|bone anchored hearing aid
4985742|NCT01699620|Soft tissue healing|soft tissue healing
4985743|NCT01699620|Implant stability|implant stability
4985744|NCT01699620|Linear incision|linear incision
4985745|NCT01699620|Dermatome technique|dermatome technique
4985746|NCT01699620|Hearing Aids|hearing aids
4985747|NCT01699620|Implants, Artificial|implants, artificial
4985748|NCT01699620|Surgical Procedures, Operative|surgical procedures, operative
4985749|NCT01699607|Cigarette Smokers|cigarette smokers
4985750|NCT01699607|Healthy Non Smokers|healthy non smokers
4985751|NCT01699607|Amphetamine|amphetamine
4985752|NCT01699607|PET|pet
4985753|NCT01699607|Controls|controls
4985754|NCT01699594|asthma|asthma
4985755|NCT01699594|allergies|allergies
4985756|NCT01699594|mannitol|mannitol
4985757|NCT01699594|methacholine|methacholine
4985758|NCT01699581|Hodgkin's Lymphoma|hodgkin's lymphoma
4985759|NCT01699581|Multiple Myeloma|multiple myeloma
4985760|NCT01699581|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
4985761|NCT01699568|dental implant stability|dental implant stability
4985762|NCT01699568|dental implant surface treatment|dental implant surface treatment
4985763|NCT01699568|resonance frequence analysis|resonance frequence analysis
4985764|NCT01699555|Multiple sclerosis|multiple sclerosis
4985765|NCT01699555|GNbAC1|gnbac1
4985766|NCT01699555|Monoclonal antibody|monoclonal antibody
4985767|NCT01699555|Multiple Sclerosis Associated Retrovirus (MSRV)|multiple sclerosis associated retrovirus (msrv)
4985768|NCT01699542|Refractory Anastomotic esophageal strictures|refractory anastomotic esophageal strictures
4985769|NCT01699516|allogeneic transplantation; intestinal graft-vs.-host disease; contrast enhanced ultrasound sonography|allogeneic transplantation; intestinal graft-vs.-host disease; contrast enhanced ultrasound sonography
4985770|NCT01699503|Dementia|dementia
4985771|NCT01699503|Alzheimer's Disease|alzheimer's disease
4985772|NCT01699503|Mild Cognitive Impairment|mild cognitive impairment
4985773|NCT01699503|Screening|screening
4985774|NCT01699490|Major Depressive Disorder|major depressive disorder
4985775|NCT01699490|Antidepressants|antidepressants
4985776|NCT01699490|Insulin|insulin
4985777|NCT01699490|Fluoxetine|fluoxetine
4985778|NCT01699477|FUS|fus
4985779|NCT01699477|focused ultrasound|focused ultrasound
4985780|NCT01699477|functional brain disorders|functional brain disorders
4985781|NCT01699477|neuropathic pain|neuropathic pain
4985782|NCT01699477|movement disorders|movement disorders
4985783|NCT01699464|Glaucoma|glaucoma
4985784|NCT01699438|Irritable Bowel Syndrome|irritable bowel syndrome
4985785|NCT01699438|Inflammation|inflammation
4985786|NCT01699438|Mesalazine|mesalazine
4985787|NCT01699425|Stress urinary incontinence.|stress urinary incontinence.
4985788|NCT01699425|Suburethral sling.|suburethral sling.
4985789|NCT01699425|Single-incision suburethral sling.|single-incision suburethral sling.
4985790|NCT01699425|Ajust.|ajust.
4985791|NCT01699425|Transobturator tape.|transobturator tape.
4985792|NCT01699412|Bone Marrow Transplantation|bone marrow transplantation
4985793|NCT01699412|Graft vs Host Disease|graft vs host disease
4985794|NCT01699412|Oral Manifestations|oral manifestations
4985795|NCT01699399|colonoscopy|colonoscopy
4985796|NCT01699399|pain|pain
4985797|NCT01699399|sedation|sedation
4985798|NCT01699399|water|water
4985799|NCT01699360|Kidney Transplantation|kidney transplantation
4985800|NCT01699360|Immunosuppressive Agents|immunosuppressive agents
4985801|NCT01699360|Hydrocortisone|hydrocortisone
4985802|NCT01699360|Cortisone|cortisone
4985803|NCT01699347|OK432, CYSTIC MALFORMATION|ok432, cystic malformation
4985804|NCT01699334|Whiplash injuries|whiplash injuries
4985805|NCT01699334|patient education|patient education
4985806|NCT01699334|illness perceptions|illness perceptions
4985807|NCT01699334|RCT|rct
4985808|NCT01699334|motor vehicle accidents|motor vehicle accidents
4985809|NCT01699321|physical activity|physical activity
4985810|NCT01699321|barbershop|barbershop
4985811|NCT01699321|cancer prevention|cancer prevention
4985812|NCT01699321|exercise|exercise
4985813|NCT01699321|men's health|men's health
4985814|NCT01699321|African American men|african american men
4985815|NCT01699308|Traumatic Brain Injury|traumatic brain injury
4985816|NCT01699308|Growth Hormone|growth hormone
4985817|NCT01699308|Neuroimaging|neuroimaging
4985818|NCT01699295|academic achievement|academic achievement
4985819|NCT01699295|elementary school|elementary school
4985820|NCT01699295|physical activity|physical activity
4985821|NCT01699295|exercise|exercise
4985822|NCT01699282|oral anticoagulant|oral anticoagulant
4985823|NCT01699282|in the long term (> 12 months)|in the long term (> 12 months)
4985824|NCT01699269|High grade brain tumor|high grade brain tumor
4985825|NCT01699269|Glioma|glioma
4985826|NCT01699269|Glioblastoma Multiform|glioblastoma multiform
4985827|NCT01699269|Brain Cancer|brain cancer
4985828|NCT01699269|Diffusion-Weighted Magnetic Resonance Imaging|diffusion-weighted magnetic resonance imaging
4985829|NCT01699269|High order diffusion tensor|high order diffusion tensor
4985830|NCT01699269|Imaging guided biopsy|imaging guided biopsy
4985831|NCT01699269|Histopathologic evaluation|histopathologic evaluation
4985832|NCT01699269|Infiltration percentage|infiltration percentage
4985833|NCT01699256|General Practice|general practice
4985834|NCT01699256|Low Back Pain|low back pain
4985835|NCT01699256|Guideline|guideline
4985836|NCT01699256|Health Plan Implementation|health plan implementation
4985837|NCT01699256|Referral and Consultation|referral and consultation
4985838|NCT01699243|pregnancy|pregnancy
4985839|NCT01699243|labor|labor
4985840|NCT01699243|epidural|epidural
4985841|NCT01699243|fetal intervention|fetal intervention
4985842|NCT01699230|Elective cardiac surgery|elective cardiac surgery
4985843|NCT01699230|with sternotomy and|with sternotomy and
4985844|NCT01699230|cardiopulmonary bypass|cardiopulmonary bypass
4985845|NCT01699230|for coronary artery|for coronary artery
4985846|NCT01699230|bypass graft.|bypass graft.
4985847|NCT01699217|Chronic Myeloid Leukaemia|chronic myeloid leukaemia
4985848|NCT01699217|Philadelphia positive|philadelphia positive
4985849|NCT01699217|BCR-ABL positive|bcr-abl positive
4985850|NCT01699204|Air pollution|air pollution
4985851|NCT01699204|Diesel exhaust|diesel exhaust
4985852|NCT01699204|Airway responsiveness|airway responsiveness
4985853|NCT01699204|Asthma|asthma
4985854|NCT01699204|Anti-oxidant|anti-oxidant
4985855|NCT01699191|Irritable Bowel Syndrome|irritable bowel syndrome
4985856|NCT01699191|Celiac Desease|celiac desease
4985857|NCT01699191|Probiotic|probiotic
4985858|NCT01699191|Lactobacillus plantarum|lactobacillus plantarum
4985859|NCT01699191|Bifidobacterium breve|bifidobacterium breve
4985860|NCT01699191|Lactobacillus casei|lactobacillus casei
4985961|NCT01698762|RA|ra
4985861|NCT01699191|Bifidobacterium animalis|bifidobacterium animalis
4985862|NCT01699165|rhinitis|rhinitis
4985863|NCT01699165|allergic|allergic
4985864|NCT01699165|seasonal|seasonal
4985865|NCT01699165|double blind|double blind
4985866|NCT01699165|doubleblind|doubleblind
4985867|NCT01699165|randomized|randomized
4985868|NCT01699165|randomised|randomised
4985869|NCT01699165|placebo|placebo
4985870|NCT01699165|crossover|crossover
4985871|NCT01699165|clinical|clinical
4985872|NCT01699165|nasal|nasal
4985873|NCT01699165|filter|filter
4985874|NCT01699165|controlled|controlled
4985875|NCT01699165|trial|trial
4985876|NCT01699165|hayfever|hayfever
4985877|NCT01699165|hay|hay
4985878|NCT01699165|fever|fever
4985879|NCT01699165|efficacy|efficacy
4985880|NCT01699165|safety|safety
4985881|NCT01699165|prevention|prevention
4985882|NCT01699165|adult|adult
4985883|NCT01699165|grass|grass
4985884|NCT01699165|pollen|pollen
4985885|NCT01699165|symptom|symptom
4985886|NCT01699165|Total nasal symptom score|total nasal symptom score
4985887|NCT01699165|acoustic rhinometry|acoustic rhinometry
4985888|NCT01699152|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
4985889|NCT01699152|Small Lymphocytic Lymphoma|small lymphocytic lymphoma
4985890|NCT01699139|supine position|supine position
4985891|NCT01699126|Obstructive Sleep Apnea|obstructive sleep apnea
4985892|NCT01699126|CPAP|cpap
4985893|NCT01699126|Endothelium dysfunction|endothelium dysfunction
4985894|NCT01699126|Hypertension|hypertension
4985895|NCT01699113|YF476|yf476
4985896|NCT01699113|gastrin receptor antagonist|gastrin receptor antagonist
4985897|NCT01699113|gastric pH|gastric ph
4985898|NCT01699113|gastrin|gastrin
4985899|NCT01699113|rabeprazole|rabeprazole
4985900|NCT01699113|proton-pump inhibitor|proton-pump inhibitor
4985901|NCT01699113|gastric function|gastric function
4985902|NCT01699113|healthy subjects|healthy subjects
4985903|NCT01699100|offloading|offloading
4985904|NCT01699100|plantar pressure|plantar pressure
4985905|NCT01699100|insole|insole
4985906|NCT01699100|foot ulcer|foot ulcer
4985907|NCT01699087|PRK|prk
4985908|NCT01699087|myopia|myopia
4985909|NCT01699087|astigmatism|astigmatism
4985910|NCT01699074|Korean White Ginseng|korean white ginseng
4985911|NCT01699074|Type 2 diabetes|type 2 diabetes
4985912|NCT01699074|Metabolic syndrome|metabolic syndrome
4985913|NCT01699048|multivessel PCI,MIDCAB,CABG|multivessel pci,midcab,cabg
4985914|NCT01699048|Hybrid coronary revascularization|hybrid coronary revascularization
4985915|NCT01699035|stroke|stroke
4985916|NCT01699035|work|work
4985917|NCT01699035|vocational rehabilitation|vocational rehabilitation
4985918|NCT01699022|Contraceptive|contraceptive
4985919|NCT01699022|Injectable|injectable
4985920|NCT01699009|Migraines, diet, vegan, vegetarian, plant-based|migraines, diet, vegan, vegetarian, plant-based
4985921|NCT01698996|abscess|abscess
4985922|NCT01698996|packing|packing
4985923|NCT01698996|emergency medicine|emergency medicine
4985924|NCT01698996|wound care|wound care
4985925|NCT01698996|incision and drainage|incision and drainage
4985926|NCT01698970|Probiotic|probiotic
4985927|NCT01698970|capsules|capsules
4985928|NCT01698970|Crohn's disease|crohn's disease
4985929|NCT01698970|recurrent endoscopic ileo-colonic lesions|recurrent endoscopic ileo-colonic lesions
4985930|NCT01698957|Pregnant women|pregnant women
4985931|NCT01698957|Uterine Artery Doppler Velocimetry|uterine artery doppler velocimetry
4985932|NCT01698918|metastatic breast cancer, locally advanced breast cancer, HER2-, ER+, everolimus, Afinitor|metastatic breast cancer, locally advanced breast cancer, her2-, er+, everolimus, afinitor
4985933|NCT01698905|Phase II, single arm, open label, nilotinib, treatment-free remission, MR4.5, confirmed loss of MR4, loss of MMR, Ph+ CML-CP|phase ii, single arm, open label, nilotinib, treatment-free remission, mr4.5, confirmed loss of mr4, loss of mmr, ph+ cml-cp
4985934|NCT01698892|I.V. sedation, midazolam, bronchoscopy|i.v. sedation, midazolam, bronchoscopy
4985935|NCT01698866|Low grade lymphoma|low grade lymphoma
4985936|NCT01698866|follicular lymphoma|follicular lymphoma
4985937|NCT01698866|indolent lymphoproliferative disorders|indolent lymphoproliferative disorders
4985938|NCT01698866|Vaccin GenHevac B Pasteur|vaccin genhevac b pasteur
4985939|NCT01698840|Vitamin D|vitamin d
4985940|NCT01698840|Transitional Formula|transitional formula
4985941|NCT01698827|gastrostomy|gastrostomy
4985942|NCT01698827|tube|tube
4985943|NCT01698827|endoscopic|endoscopic
4985944|NCT01698827|replacement|replacement
4985945|NCT01698827|tube rupture|tube rupture
4985946|NCT01698827|durability|durability
4985947|NCT01698827|tube loss|tube loss
4985948|NCT01698827|balloon rupture|balloon rupture
4985949|NCT01698814|ocular safety|ocular safety
4985950|NCT01698814|allergic conjunctivitis|allergic conjunctivitis
4985951|NCT01698801|Lenalidomide|lenalidomide
4985952|NCT01698801|dexamethasone|dexamethasone
4985953|NCT01698801|newly diagnosed multiple myeloma|newly diagnosed multiple myeloma
4985954|NCT01698788|diabetic macular edema|diabetic macular edema
4985955|NCT01698788|taut posterior hyaloid membrane|taut posterior hyaloid membrane
4985956|NCT01698788|ozurdex|ozurdex
4985957|NCT01698762|Musculoskeletal Diseases|musculoskeletal diseases
4985958|NCT01698762|Osteoarthritis|osteoarthritis
4985959|NCT01698762|OA|oa
4985960|NCT01698762|Rheumatoid Arthritis|rheumatoid arthritis
4985962|NCT01698762|Osteoporosis|osteoporosis
4985963|NCT01698762|OP|op
4985964|NCT01698762|Multimedia Patient Decision Aids|multimedia patient decision aids
4985965|NCT01698762|MM-PtDAs|mm-ptdas
4985966|NCT01698762|DVD|dvd
4985967|NCT01698762|Comparative Effectiveness Research Summary Guide|comparative effectiveness research summary guide
4985968|NCT01698762|CERSG|cersg
4985969|NCT01698762|Booklet|booklet
4985970|NCT01698762|Questionnaires|questionnaires
4985971|NCT01698762|Surveys|surveys
4985972|NCT01698749|Ozurdex|ozurdex
4985973|NCT01698749|Diabetic macular edema|diabetic macular edema
4985974|NCT01698749|Central macular thickness|central macular thickness
4985975|NCT01698736|ABO isoagglutinins|abo isoagglutinins
4985976|NCT01698736|ABO incompatible transplantation|abo incompatible transplantation
4985977|NCT01698736|immunoadsorption|immunoadsorption
4985978|NCT01698736|membrane filtration|membrane filtration
4985979|NCT01698736|plasmapheresis|plasmapheresis
4985980|NCT01698723|ACLF|aclf
4985981|NCT01698723|HEV|hev
4985982|NCT01698723|Ribavirin|ribavirin
4985983|NCT01698710|Premalignant|premalignant
4985984|NCT01698710|Malignant|malignant
4985985|NCT01698684|ED|ed
4985986|NCT01698645|quality of life|quality of life
4985987|NCT01698645|PecFent|pecfent
4985988|NCT01698645|Lazanda|lazanda
4985989|NCT01698645|fentanyl|fentanyl
4985990|NCT01698645|intranasal|intranasal
4985991|NCT01698645|breakthrough cancer pain|breakthrough cancer pain
4985992|NCT01698632|Adnexal masses|adnexal masses
4985993|NCT01698632|Ovarian cysts|ovarian cysts
4985994|NCT01698632|Ovarian tumors|ovarian tumors
4985995|NCT01698606|childhood obesity|childhood obesity
4985996|NCT01698606|multidisciplinary|multidisciplinary
4985997|NCT01698606|preschool children|preschool children
4985998|NCT01698606|community-based|community-based
4985999|NCT01698606|lifestyle intervention|lifestyle intervention
4986000|NCT01698606|family-centered|family-centered
4986001|NCT01698593|Bupivacaine|bupivacaine
4986002|NCT01698593|digital nerve block|digital nerve block
4986003|NCT01698593|epinephrine|epinephrine
4986004|NCT01698593|duration of action|duration of action
4986005|NCT01698593|pain|pain
4986006|NCT01698593|touch|touch
4986007|NCT01698593|pressure|pressure
4986008|NCT01698593|temperature|temperature
4986009|NCT01698580|accidental falls|accidental falls
4986010|NCT01698580|aged|aged
4986011|NCT01698580|aged, 80 and over|aged, 80 and over
4986012|NCT01698580|prevention and control|prevention and control
4986013|NCT01698567|Infants|infants
4986014|NCT01698567|Cardiopulmonary bypass|cardiopulmonary bypass
4986015|NCT01698567|anticoaglution|anticoaglution
4986016|NCT01698541|Renal|renal
4986017|NCT01698541|Transplantation|transplantation
4986018|NCT01698541|Elderly|elderly
4986019|NCT01698528|Diabetes|diabetes
4986020|NCT01698528|diabetes technologies|diabetes technologies
4986021|NCT01698528|telemedicine|telemedicine
4986022|NCT01698502|Incretin|incretin
4986023|NCT01698502|Training|training
4986024|NCT01698502|Glucagon like peptide|glucagon like peptide
4986025|NCT01698502|glucose dependent insulinotropic peptide|glucose dependent insulinotropic peptide
4986026|NCT01698502|Gut|gut
4986027|NCT01698502|Exercise|exercise
4986028|NCT01698502|Insulin|insulin
4986029|NCT01698502|Focus:|focus:
4986030|NCT01698502|Gut hormone|gut hormone
4986031|NCT01698502|adaptations|adaptations
4986032|NCT01698476|pulmonary TB|pulmonary tb
4986033|NCT01698476|cholecalciferol|cholecalciferol
4986034|NCT01698476|sodium phenylbutyrate|sodium phenylbutyrate
4986035|NCT01698476|antimicrobial peptides|antimicrobial peptides
4986036|NCT01698476|immune response|immune response
4986037|NCT01698463|Falls, Fractures, Osteoporosis, Frailty, Older Adults.|falls, fractures, osteoporosis, frailty, older adults.
4986038|NCT01698450|FUS|fus
4986039|NCT01698450|focused ultrasound|focused ultrasound
4986040|NCT01698450|functional brain disorder|functional brain disorder
4986041|NCT01698450|neuropathic pain|neuropathic pain
4986042|NCT01698450|movement disorders|movement disorders
4986043|NCT01698450|malignant brain tumors|malignant brain tumors
4986044|NCT01698437|FUS|fus
4986045|NCT01698437|focused ultrasound|focused ultrasound
4986046|NCT01698437|functional brain disorders|functional brain disorders
4986047|NCT01698437|neuropathic pain|neuropathic pain
4986048|NCT01698437|movement disorders|movement disorders
4986049|NCT01698437|malignant of brain tumors|malignant of brain tumors
4986050|NCT01698411|hypertension|hypertension
4986051|NCT01698411|sleep|sleep
4986052|NCT01698411|insomnia|insomnia
4986053|NCT01698372|Cardiac surgery.|cardiac surgery.
4986054|NCT01698372|Wound healing.|wound healing.
4986055|NCT01698372|Leg wound infection.|leg wound infection.
4986056|NCT01698372|Wound care.|wound care.
4986057|NCT01698346|Pertussis|pertussis
4986058|NCT01698346|Infants|infants
4986059|NCT01698346|Vaccination|vaccination
4986060|NCT01698346|Pregnancy|pregnancy
4986061|NCT01698333|122-0551|122-0551
4986062|NCT01698333|steroid|steroid
4986063|NCT01698333|HPA|hpa
4986064|NCT01698307|Crohn's Disease|crohn's disease
4986065|NCT01698307|Deep Remission|deep remission
4986066|NCT01698307|Complications|complications
4986067|NCT01698294|gut microbiome|gut microbiome
4986068|NCT01698294|hormones|hormones
4986069|NCT01698294|women|women
4986070|NCT01698294|race|race
4986071|NCT01698294|phytoestrogens|phytoestrogens
4986072|NCT01698255|Depression|depression
4986073|NCT01698255|Geriatrics|geriatrics
4986074|NCT01698242|Heart failure|heart failure
4986075|NCT01698242|Self-Management|self-management
4986076|NCT01698242|Behavioral Clinical Trial|behavioral clinical trial
4986077|NCT01698229|Cerebrospinal fluid|cerebrospinal fluid
4986078|NCT01698229|Lumbar puncture|lumbar puncture
4986079|NCT01698229|Spinal tap|spinal tap
4986080|NCT01698229|Late infantile neuronal ceroid lipofuscinosis|late infantile neuronal ceroid lipofuscinosis
4986081|NCT01698229|Batten disease|batten disease
4986082|NCT01698216|Paliperidone|paliperidone
4986083|NCT01698216|Palmitate|palmitate
4986084|NCT01698216|switching|switching
4986085|NCT01698216|schizophrenia|schizophrenia
4986086|NCT01698216|subjective well-being|subjective well-being
4986087|NCT01698177|Influenza|influenza
4986088|NCT01698177|Cancer|cancer
4986089|NCT01698177|Vaccination|vaccination
4986090|NCT01698177|Immune response to influenza vaccination|immune response to influenza vaccination
4986091|NCT01698164|lipid profiles|lipid profiles
4986092|NCT01698164|coronary heart disease|coronary heart disease
4986093|NCT01698164|menopausal syndrome|menopausal syndrome
4986094|NCT01698164|MMSE|mmse
4986095|NCT01698164|MENQOL|menqol
4986096|NCT01698164|HAD|had
4986097|NCT01698151|Chronic obstructive Pulmonary Disease|chronic obstructive pulmonary disease
4986098|NCT01698151|COPD|copd
4986099|NCT01698138|Spinal cord injury|spinal cord injury
4986100|NCT01698138|Neurogenic overactive bladder|neurogenic overactive bladder
4986101|NCT01698138|Onabotulinum toxin A|onabotulinum toxin a
4986102|NCT01698138|Prevention|prevention
4986103|NCT01698138|Botulinum Toxins, Type A|botulinum toxins, type a
4986104|NCT01698125|Delirium|delirium
4986105|NCT01698125|Autonomic cardiovascular control|autonomic cardiovascular control
4986106|NCT01698125|Abdominal surgery|abdominal surgery
4986107|NCT01698125|Tilt-test|tilt-test
4986108|NCT01698086|Multiple Sclerosis|multiple sclerosis
4986109|NCT01698086|Balance|balance
4986110|NCT01698086|Fatigue|fatigue
4986111|NCT01698086|Eye movement|eye movement
4986112|NCT01698073|Teen pregnancy prevention|teen pregnancy prevention
4986113|NCT01698073|American Indian|american indian
4986114|NCT01698073|Group-randomized trial|group-randomized trial
4986115|NCT01698060|Prevention of Avian Influenza|prevention of avian influenza
4986116|NCT01698047|Depressive symptoms|depressive symptoms
4986117|NCT01698047|sub-threshold depression|sub-threshold depression
4986118|NCT01698047|resiliency|resiliency
4986119|NCT01698047|Health Promotion|health promotion
4986120|NCT01698047|minority health|minority health
4986121|NCT01698034|volunteering|volunteering
4986122|NCT01698034|cardiovascular health|cardiovascular health
4986123|NCT01698021|Creatine Kinase, MB form|creatine kinase, mb form
4986124|NCT01698021|Troponin|troponin
4986125|NCT01698021|Acute coronary syndrome|acute coronary syndrome
4986126|NCT01698021|myocardial infarction|myocardial infarction
4986127|NCT01698021|Unstable angina|unstable angina
4986128|NCT01697995|right ventricle|right ventricle
4986129|NCT01697995|radiotracer uptake|radiotracer uptake
4986130|NCT01697995|Myocardial Perfusion Imaging|myocardial perfusion imaging
4986131|NCT01697995|balanced ischemia|balanced ischemia
4986132|NCT01697982|pilot study|pilot study
4986133|NCT01697982|psychosocial intervention|psychosocial intervention
4986134|NCT01697982|advanced cancer|advanced cancer
4986135|NCT01697969|allergic conjunctivitis|allergic conjunctivitis
4986136|NCT01697969|Pataday|pataday
4986137|NCT01697969|Olopatadine|olopatadine
4986138|NCT01697956|Pediatric Subjects|pediatric subjects
4986139|NCT01697943|Gastric Malignant Tumor|gastric malignant tumor
4986140|NCT01697943|Total Gastrectomy|total gastrectomy
4986141|NCT01697943|Reconstruction|reconstruction
4986142|NCT01697930|PET Imaging|pet imaging
4986143|NCT01697930|18F] 4-L-Fluoroglutam (2S,4R)|18f] 4-l-fluoroglutam (2s,4r)
4986144|NCT01697930|12-168|12-168
4986145|NCT01697917|Adenocarcinoma of Esophagogastric Junction|adenocarcinoma of esophagogastric junction
4986146|NCT01697917|Total Gastrectomy|total gastrectomy
4986147|NCT01697917|Proximal Gastrectomy|proximal gastrectomy
4986148|NCT01697891|Radiation Treatment|radiation treatment
4986149|NCT01697891|Head and Neck Cancer|head and neck cancer
4986150|NCT01697891|Dysphagia|dysphagia
4986151|NCT01697878|obstructive sleep apnea|obstructive sleep apnea
4986152|NCT01697878|obesity|obesity
4986153|NCT01697878|respiratory function|respiratory function
4986154|NCT01697878|weight loss surgery|weight loss surgery
4986155|NCT01697865|Reverse total shoulder|reverse total shoulder
4986156|NCT01697852|vector control|vector control
4986157|NCT01697852|LLIN|llin
4986158|NCT01697852|IRS|irs
4986159|NCT01697826|Clindamycin|clindamycin
4986160|NCT01697826|Clotrimazole|clotrimazole
4986161|NCT01697826|Vaginal formulation|vaginal formulation
4986162|NCT01697826|Bacterial vaginosis|bacterial vaginosis
4986163|NCT01697826|Candidiasis|candidiasis
4986164|NCT01697826|Trichomoniasis|trichomoniasis
4986165|NCT01697826|Mixed vaginitis|mixed vaginitis
4986166|NCT01697826|Infective vaginitis|infective vaginitis
4986167|NCT01697787|Treatment, diagnosis|treatment, diagnosis
4986168|NCT01697761|Crohn's disease,acupuncture,moxibustion,inflammation factors|crohn's disease,acupuncture,moxibustion,inflammation factors
4986169|NCT01697748|cesarean section incisions|cesarean section incisions
4986170|NCT01697748|silver|silver
4986171|NCT01697748|c-section|c-section
4986172|NCT01697748|wound infection|wound infection
4986173|NCT01697748|scar appearance|scar appearance
4986174|NCT01697722|Primary care|primary care
4986175|NCT01697722|Asthma management|asthma management
4986176|NCT01697722|Inhaled corticosteroids|inhaled corticosteroids
4986177|NCT01697722|Extra-fine hydrofluoroalkane|extra-fine hydrofluoroalkane
4986178|NCT01697722|Long-acting beta-agonist|long-acting beta-agonist
4986179|NCT01697722|Fixed-dose combination therapy|fixed-dose combination therapy
4986180|NCT01697709|cannabis|cannabis
4986181|NCT01697709|marijuana|marijuana
4986182|NCT01697709|pharmacotherapy|pharmacotherapy
4986183|NCT01697696|COPD, NVA237, QAB149, glycopyrronium bromide|copd, nva237, qab149, glycopyrronium bromide
4986184|NCT01697605|Phase I, open-label, dose escalation, BGJ398, Japanese, Asian, FGF-R|phase i, open-label, dose escalation, bgj398, japanese, asian, fgf-r
4986185|NCT01697566|Gynecology|gynecology
4986186|NCT01697566|Endometrial Cancer Chemoprevention|endometrial cancer chemoprevention
4986187|NCT01697566|Obese|obese
4986188|NCT01697566|Body Mass Index (BMI) >/= 35 kg.m2|body mass index (bmi) >/= 35 kg.m2
4986189|NCT01697566|Post-menopausal|post-menopausal
4986190|NCT01697566|Hyperinsulinemia|hyperinsulinemia
4986191|NCT01697566|Metformin|metformin
4986192|NCT01697566|Placebo|placebo
4986193|NCT01697566|Sugar pill|sugar pill
4986194|NCT01697566|Lifestyle intervention|lifestyle intervention
4986195|NCT01697566|Diet|diet
4986196|NCT01697566|Exercise|exercise
4986197|NCT01697514|recurrent medulloblastoma|recurrent medulloblastoma
4986198|NCT01697397|Irritable bowel syndrome|irritable bowel syndrome
4986199|NCT01697397|IBS|ibs
4986200|NCT01697397|Gastrointestinal pain|gastrointestinal pain
4986201|NCT01697397|Gastrointestinal functional disorder|gastrointestinal functional disorder
4986202|NCT01697384|prostate cancer, PSA|prostate cancer, psa
4986203|NCT01697358|FBSS|fbss
4986204|NCT01697358|post laminectomy syndrome|post laminectomy syndrome
4986205|NCT01697358|SCS|scs
4986206|NCT01697358|RCT|rct
4986207|NCT01697358|back pain|back pain
4986208|NCT01697345|Vaginal Testosterone|vaginal testosterone
4986209|NCT01697345|Vaginal atrophy|vaginal atrophy
4986210|NCT01697345|Female Sexual Dysfunction|female sexual dysfunction
4986211|NCT01697345|Aromatase Inhibitors|aromatase inhibitors
4986212|NCT01697332|COPD|copd
4986213|NCT01697319|Mucopolysaccharidosis IVA Type A|mucopolysaccharidosis iva type a
4986214|NCT01697319|MPS IVA Type A|mps iva type a
4986215|NCT01697319|Mucopolysaccharidosis IVA|mucopolysaccharidosis iva
4986216|NCT01697319|MPS IVA|mps iva
4986217|NCT01697319|Morquio A Syndrome|morquio a syndrome
4986218|NCT01697319|Lysosomal Storage Disorder|lysosomal storage disorder
4986219|NCT01697319|LSD|lsd
4986220|NCT01697319|N-acetylgalactosamine-6-sulfatase|n-acetylgalactosamine-6-sulfatase
4986221|NCT01697319|N-acetylgalactosamine-6-sulfate|n-acetylgalactosamine-6-sulfate
4986222|NCT01697319|sulfatase|sulfatase
4986223|NCT01697319|galactose-6-sulfatase|galactose-6-sulfatase
4986224|NCT01697319|GALNS|galns
4986225|NCT01697319|enzyme replacement therapy|enzyme replacement therapy
4986226|NCT01697319|ERT|ert
4986227|NCT01697319|MOR-006|mor-006
4986228|NCT01697319|CPET|cpet
4986229|NCT01697319|Limited ambulation|limited ambulation
4986230|NCT01697319|Grip/ Pinch|grip/ pinch
4986231|NCT01697306|non muscle invasive bladder cancer|non muscle invasive bladder cancer
4986232|NCT01697280|Polio supplementary immunization activities|polio supplementary immunization activities
4986233|NCT01697280|Routine EPI vaccine|routine epi vaccine
4986234|NCT01697280|Integration of polio NID and routine EPI|integration of polio nid and routine epi
4986235|NCT01697267|vasculitis|vasculitis
4986236|NCT01697267|ANCA vasculitis|anca vasculitis
4986237|NCT01697267|microscopic polyangiitis|microscopic polyangiitis
4986238|NCT01697267|granulomatosis|granulomatosis
4986239|NCT01697267|Wegener's|wegener's
4986240|NCT01697267|AAV|aav
4986241|NCT01697267|vasculitides|vasculitides
4986242|NCT01697241|Exercise Therapy|exercise therapy
4986243|NCT01697241|Education|education
4986244|NCT01697241|Osteoarthritis|osteoarthritis
4986245|NCT01697241|Hip|hip
4986246|NCT01697241|Hip replacement|hip replacement
4986247|NCT01697228|Diabetes|diabetes
4986248|NCT01697228|Vitamin D|vitamin d
4986249|NCT01697228|Proinflammatory markers|proinflammatory markers
4986250|NCT01697189|professional drivers|professional drivers
4986251|NCT01697189|sleepiness|sleepiness
4986252|NCT01697189|stress|stress
4986253|NCT01697189|safe driving|safe driving
4986254|NCT01697189|training|training
4986255|NCT01697163|De Novo Resistance|de novo resistance
4986256|NCT01697163|Iressa|iressa
4986257|NCT01697163|EGFR mutation|egfr mutation
4986258|NCT01697163|lung cancer|lung cancer
4986259|NCT01697150|Type 1 diabetes mellitus|type 1 diabetes mellitus
4986260|NCT01697150|closed loop artificial pancreas|closed loop artificial pancreas
4986261|NCT01697124|Physical activity|physical activity
4986262|NCT01697124|children|children
4986263|NCT01697124|Head Start|head start
4986264|NCT01697124|SPARK-EC|spark-ec
4986265|NCT01697111|YAZ|yaz
4986266|NCT01697111|Flexible regimen|flexible regimen
4986267|NCT01697111|Drospirenone|drospirenone
4986268|NCT01697111|Ethinylestradiol Betadex|ethinylestradiol betadex
4986269|NCT01697111|Endometriosis|endometriosis
4986270|NCT01697111|Dienogest|dienogest
4986271|NCT01697111|Japanese Patients|japanese patients
4986272|NCT01697098|Dexamethasone|dexamethasone
4986273|NCT01697098|preterm labour|preterm labour
4986274|NCT01697098|respiratory distress|respiratory distress
4986275|NCT01697085|sea buckthorn|sea buckthorn
4986276|NCT01697085|mucous membrane|mucous membrane
4986277|NCT01697085|dryness|dryness
4986278|NCT01697085|metabolic syndrome|metabolic syndrome
4986279|NCT01697085|vaginal atrophy|vaginal atrophy
4986280|NCT01697072|Gastric Cancer|gastric cancer
4986281|NCT01697072|First Line Treatment Gastroesophageal Junction (GEJ)|first line treatment gastroesophageal junction (gej)
4986282|NCT01697072|Gastroesophageal Junction Cancer (GEJ)|gastroesophageal junction cancer (gej)
4986283|NCT01697072|GEJ Cancer|gej cancer
4986284|NCT01697059|appendicitis|appendicitis
4986285|NCT01697046|peri-exposure|peri-exposure
4986286|NCT01697046|chemoprophylaxis|chemoprophylaxis
4986287|NCT01696942|Crohn's disease|crohn's disease
4986288|NCT01696942|certolizumab|certolizumab
4986289|NCT01696942|mesalamine|mesalamine
4986290|NCT01696942|recurrence|recurrence
4986291|NCT01696929|tocilizumab|tocilizumab
4986292|NCT01696929|safety|safety
4986293|NCT01696929|tolerability|tolerability
4986294|NCT01696929|efficacy|efficacy
4986295|NCT01696929|schizophrenia|schizophrenia
4986296|NCT01696929|improvement|improvement
4986297|NCT01696929|cognition|cognition
4986298|NCT01696929|psychotic symptoms|psychotic symptoms
4986299|NCT01696929|baseline IL-6 levels|baseline il-6 levels
4986300|NCT01696916|COPD|copd
4986301|NCT01696916|carbon dioxide|carbon dioxide
4986302|NCT01696916|6-minute walking test|6-minute walking test
4986303|NCT01696903|Postoperative pancreatic fistula|postoperative pancreatic fistula
4986304|NCT01696903|Pancreatic texture|pancreatic texture
4986305|NCT01696903|Pancreatic duct diameter|pancreatic duct diameter
4986306|NCT01696903|Pancreatic consistency|pancreatic consistency
4986307|NCT01696903|Pancreaticoduodenectomy|pancreaticoduodenectomy
4986308|NCT01696890|chronic heart failure|chronic heart failure
4986309|NCT01696890|telemonitoring|telemonitoring
4986310|NCT01696890|first line practitioners|first line practitioners
4986311|NCT01696890|integrated approach|integrated approach
4986312|NCT01696890|efficacy|efficacy
4986313|NCT01696838|Crohn's disease|crohn's disease
4986314|NCT01696838|acupuncture|acupuncture
4986315|NCT01696838|moxibustion|moxibustion
4986316|NCT01696838|fMRI|fmri
4986317|NCT01696838|Gut|gut
4986318|NCT01696812|electrodeposition|electrodeposition
4986319|NCT01696812|Subthalamic Nucleus|subthalamic nucleus
4986320|NCT01696812|Deep Brain Stimulation|deep brain stimulation
4986321|NCT01696812|Parkinson Disease|parkinson disease
4986322|NCT01696773|tomato|tomato
4986323|NCT01696773|tangerine tomato|tangerine tomato
4986324|NCT01696773|carotenoids|carotenoids
4986325|NCT01696773|lycopene|lycopene
4986326|NCT01696773|flavonoids|flavonoids
4986327|NCT01696747|gastroparesis|gastroparesis
4986328|NCT01696747|idiopathic gastroparesis|idiopathic gastroparesis
4986329|NCT01696747|diabetic gastroparesis|diabetic gastroparesis
4986330|NCT01696747|post-Nissen gastroparesis|post-nissen gastroparesis
4986331|NCT01696734|Gastrointestinal diseases|gastrointestinal diseases
4986332|NCT01696734|GI|gi
4986333|NCT01696734|Compassionate use|compassionate use
4986334|NCT01696734|GI motility disorders|gi motility disorders
4986335|NCT01696734|GI disorders|gi disorders
4986336|NCT01696734|Gastroparesis|gastroparesis
4986337|NCT01696734|Gastroesophageal reflux disease|gastroesophageal reflux disease
4986338|NCT01696734|GERD|gerd
4986339|NCT01696734|Chronic nausea and vomiting|chronic nausea and vomiting
4986340|NCT01696734|Questionnaires|questionnaires
4986341|NCT01696734|Surveys|surveys
4986342|NCT01696734|Phone calls|phone calls
4986343|NCT01696734|Domperidone|domperidone
4986344|NCT01696721|Proton Therapy|proton therapy
4986345|NCT01696721|Pediatrics|pediatrics
4986346|NCT01696721|Radiation Oncology|radiation oncology
4986347|NCT01696682|minimally invasive esophagectomy|minimally invasive esophagectomy
4986348|NCT01696682|anastomotic leakage|anastomotic leakage
4986349|NCT01696682|gastric conduit|gastric conduit
4986350|NCT01696669|Ewing's Sarcoma|ewing's sarcoma
4986351|NCT01696669|P6 protocol MSKCC|p6 protocol mskcc
4986352|NCT01696669|Gemcitabine|gemcitabine
4986353|NCT01696669|Docetaxel|docetaxel
4986354|NCT01696656|Gastrointestinal drugs|gastrointestinal drugs
4986355|NCT01696656|Antibiotics|antibiotics
4986356|NCT01696656|Vitamins|vitamins
4986357|NCT01696656|Minerals|minerals
4986358|NCT01696656|Intestinal insufficiency|intestinal insufficiency
4986359|NCT01696656|Short Bowel syndrome|short bowel syndrome
4986360|NCT01696656|Adjuvant therapy|adjuvant therapy
4986361|NCT01696656|Antacids|antacids
4986362|NCT01696656|Gastrointestinal motility modifiers|gastrointestinal motility modifiers
4986363|NCT01696656|Micronutrients|micronutrients
4986364|NCT01696643|Opioid|opioid
4986365|NCT01696643|Constipation|constipation
4986366|NCT01696643|Chronic|chronic
4986367|NCT01696643|Pain|pain
4986368|NCT01696630|anesthesia, epidural anagesia, colorectal surgery, xenon, hemodynamic change|anesthesia, epidural anagesia, colorectal surgery, xenon, hemodynamic change
4986369|NCT01696604|safety|safety
4986370|NCT01696604|pharmacokinetics|pharmacokinetics
4986371|NCT01696604|FTIH|ftih
4986372|NCT01696604|SARM|sarm
4986373|NCT01696591|Alzheimer, Mesenchymal Stem Cells, Umbilical Cord Blood|alzheimer, mesenchymal stem cells, umbilical cord blood
4986374|NCT01696578|PTSD|ptsd
4986375|NCT01696578|Depression|depression
4986376|NCT01696578|Anxiety|anxiety
4986377|NCT01696578|Chronic pain|chronic pain
4986378|NCT01696578|Anger|anger
4986379|NCT01696578|Heart rate variability|heart rate variability
4986380|NCT01696578|Disability|disability
4986381|NCT01696565|myelosuppression|myelosuppression
4986382|NCT01696565|chemotherapy|chemotherapy
4986383|NCT01696565|Astragalus membranaceus|astragalus membranaceus
4986384|NCT01696565|hematopoietic response|hematopoietic response
4986385|NCT01696552|Gonarthritis|gonarthritis
4986386|NCT01696552|TKR|tkr
4986387|NCT01696552|Conventional|conventional
4986388|NCT01696552|Positioning Guides|positioning guides
4986389|NCT01696552|PSPG|pspg
4986390|NCT01696552|CT Perth|ct perth
4986391|NCT01696539|Prostate Cancer|prostate cancer
4986392|NCT01696526|vitamin D|vitamin d
4986393|NCT01696526|bioeffiency|bioeffiency
4986394|NCT01696526|vitamin d fortified fish|vitamin d fortified fish
4986395|NCT01696500|IVIG in Stevens-Johnson syndrome|ivig in stevens-johnson syndrome
4986396|NCT01696500|Toxic Epidermal Necrolysis|toxic epidermal necrolysis
4986397|NCT01696500|Patients with Stevens-Johnson syndrome|patients with stevens-johnson syndrome
4986398|NCT01696500|Toxic Epidermal Necrolysis unresponsive to corticosteroids|toxic epidermal necrolysis unresponsive to corticosteroids
4986399|NCT01696487|non-alcoholic fatty liver disease|non-alcoholic fatty liver disease
4986400|NCT01696487|non-alcoholic steatohepatitis|non-alcoholic steatohepatitis
4986401|NCT01696487|NAFLD|nafld
4986402|NCT01696487|NASH|nash
4986403|NCT01696474|Refractory cold agglutinin disease|refractory cold agglutinin disease
4986404|NCT01696474|Bortezomib|bortezomib
4986405|NCT01696474|blood-transfusion|blood-transfusion
4986406|NCT01696448|Appetite Suppression|appetite suppression
4986407|NCT01696448|CAR-191|car-191
4986408|NCT01696435|Depression|depression
4986409|NCT01696435|Depressive Symptoms|depressive symptoms
4986410|NCT01696435|Mood|mood
4986411|NCT01696435|Geriatric|geriatric
4986412|NCT01696435|Prevention|prevention
4986413|NCT01696422|Dengue|dengue
4986414|NCT01696422|tetravalent attenuated Vaccine|tetravalent attenuated vaccine
4986415|NCT01696422|Healthy adults|healthy adults
4986416|NCT01696396|IBD, Crohn's Disease|ibd, crohn's disease
4986417|NCT01696383|Intraocular Pressure (IOP)|intraocular pressure (iop)
4986418|NCT01696383|Glaucoma|glaucoma
4986419|NCT01696383|Ocular hypertension|ocular hypertension
4986420|NCT01696383|DuoTrav|duotrav
4986421|NCT01696383|Prostaglandin analogue|prostaglandin analogue
4986422|NCT01696383|Beta-blocker|beta-blocker
4986423|NCT01696370|Trimetazidine|trimetazidine
4986424|NCT01696357|Asthma|asthma
4986425|NCT01696357|Adolescents|adolescents
4986426|NCT01696357|Self-monitoring|self-monitoring
4986427|NCT01696357|Quality of life|quality of life
4986428|NCT01696357|Biomedical device|biomedical device
4986429|NCT01696357|Symptom monitoring|symptom monitoring
4986430|NCT01696357|Self-management|self-management
4986431|NCT01696344|LSPAF|lspaf
4986432|NCT01696344|AF termination|af termination
4986433|NCT01696344|PVAI|pvai
4986434|NCT01696344|nonPV triggers|nonpv triggers
4986435|NCT01696344|Long-standing persistent|long-standing persistent
4986436|NCT01696305|Thyroid disease|thyroid disease
4986437|NCT01696305|Hyalobarrier|hyalobarrier
4986438|NCT01696305|Thyroidectomy|thyroidectomy
4986439|NCT01696305|anti-adhesive effect|anti-adhesive effect
4986440|NCT01696240|Pulmonary Hypertension|pulmonary hypertension
4986441|NCT01696240|Exercise Capacity|exercise capacity
4986442|NCT01696240|Cardiopulmonary Exercise Test|cardiopulmonary exercise test
4986443|NCT01696240|Udenafil (Zydena)|udenafil (zydena)
4986444|NCT01696240|Phosphodiesterase Type 5 Inhibitors|phosphodiesterase type 5 inhibitors
4986445|NCT01696227|Nissle 1917|nissle 1917
4986446|NCT01696227|Probiotic|probiotic
4986447|NCT01696227|Uropathogen|uropathogen
4986448|NCT01696214|asthma,smokers|asthma,smokers
4986449|NCT01696201|Pregnancy, outcomes, depression, mood, physical exercise|pregnancy, outcomes, depression, mood, physical exercise
4986450|NCT01696188|Interscalene|interscalene
4986451|NCT01696188|nerve block|nerve block
4986452|NCT01696188|nerve catheter|nerve catheter
4986453|NCT01696188|in-plane|in-plane
4986454|NCT01696188|out-of-plane|out-of-plane
4986455|NCT01696188|anterolateral approach|anterolateral approach
4986456|NCT01696188|posterior approach|posterior approach
4986457|NCT01696188|shoulder surgery|shoulder surgery
4986458|NCT01696175|ScvO2|scvo2
4986459|NCT01696175|venous|venous
4986460|NCT01696175|oxymetry|oxymetry
4986461|NCT01696175|lactate|lactate
4986462|NCT01696175|children|children
4986463|NCT01696175|PICU|picu
4986464|NCT01696175|Admission parameters of shock|admission parameters of shock
4986465|NCT01696162|Knee pain|knee pain
4986466|NCT01696162|Anterior knee pain|anterior knee pain
4986467|NCT01696162|Patellofemoral|patellofemoral
4986468|NCT01696162|Patellofemoral syndrome|patellofemoral syndrome
4986469|NCT01696162|Runners knee|runners knee
4986470|NCT01696149|TENS, sympathetic skin response, skin temperature|tens, sympathetic skin response, skin temperature
4986471|NCT01696136|Ablation|ablation
4986472|NCT01696136|Multi-electrode catheter|multi-electrode catheter
4986473|NCT01696136|Single-tip catheter|single-tip catheter
4986474|NCT01696136|Holter|holter
4986475|NCT01696123|Alzheimer disease|alzheimer disease
4986476|NCT01696123|Cholinesterase inhibitors|cholinesterase inhibitors
4986477|NCT01696123|MLC601|mlc601
4986478|NCT01696123|NeuroAiD|neuroaid
4986479|NCT01696123|neuroprotection|neuroprotection
4986480|NCT01696123|neuroregeneration|neuroregeneration
4986481|NCT01696110|Bivalirudin|bivalirudin
4986482|NCT01696110|Acute myocardial infarction|acute myocardial infarction
4986483|NCT01696110|percutaneous transluminal coronary angioplasty|percutaneous transluminal coronary angioplasty
4986485|NCT01696084|Acute Myeloid Leukemia|acute myeloid leukemia
4986486|NCT01696084|high risk AML|high risk aml
4986487|NCT01696084|secondary AML|secondary aml
4986488|NCT01696084|AML in elderly|aml in elderly
4986489|NCT01696032|Ovarian Cancer|ovarian cancer
4986490|NCT01696019|magnetic resonance imaging|magnetic resonance imaging
4986491|NCT01696019|cognition|cognition
4986492|NCT01696019|Tai Chi|tai chi
4986493|NCT01696019|physical exercise|physical exercise
4986494|NCT01696019|mental exercise|mental exercise
4986495|NCT01696019|intervention trial|intervention trial
4986496|NCT01696019|prevention|prevention
4986497|NCT01696019|dementia|dementia
4986498|NCT01696019|Alzheimer disease|alzheimer disease
4986499|NCT01696019|mild cognitive impairment|mild cognitive impairment
4986500|NCT01696006|perfusion computed tomography|perfusion computed tomography
4986501|NCT01696006|coronary artery disease|coronary artery disease
4986502|NCT01695993|Nausea|nausea
4986503|NCT01695993|Quality of life|quality of life
4986504|NCT01695993|Chemotherapy|chemotherapy
4986505|NCT01695993|Expectancy|expectancy
4986506|NCT01695980|adenotonsillectomy|adenotonsillectomy
4986507|NCT01695967|nasal obstruction|nasal obstruction
4986508|NCT01695954|HIV|hiv
4986509|NCT01695954|Hyperlipidemia|hyperlipidemia
4986510|NCT01695954|Pharmacokinetics|pharmacokinetics
4986511|NCT01695954|Statins|statins
4986512|NCT01695954|Darunavir|darunavir
4986513|NCT01695954|Efavirenz|efavirenz
4986514|NCT01695954|Pitavastatin|pitavastatin
4986515|NCT01695928|Velocity|velocity
4986516|NCT01695928|Location|location
4986517|NCT01695928|Periodontal status|periodontal status
4986518|NCT01695915|constipation|constipation
4986519|NCT01695915|children|children
4986520|NCT01695915|healthy|healthy
4986521|NCT01695915|rectal diameter|rectal diameter
4986522|NCT01695863|Miralax with gatorade and dulcolax|miralax with gatorade and dulcolax
4986523|NCT01695863|Movi pre|movi pre
4986524|NCT01695863|Patient satisfaction and efficacy|patient satisfaction and efficacy
4986525|NCT01695850|Randomized controlled trial|randomized controlled trial
4986526|NCT01695850|Drugs,Chinese Herbal|drugs,chinese herbal
4986527|NCT01695850|Constipation/drug therapy|constipation/drug therapy
4986528|NCT01695837|Diet counseling|diet counseling
4986529|NCT01695837|primary care|primary care
4986530|NCT01695824|catheter ablation|catheter ablation
4986531|NCT01695811|Keratoconus, PKP, femtosecond laser assisted keratoplasty|keratoconus, pkp, femtosecond laser assisted keratoplasty
4986532|NCT01695798|poliomyelitis|poliomyelitis
4986533|NCT01695798|oral polio vaccine|oral polio vaccine
4986534|NCT01695798|OPV|opv
4986535|NCT01695798|seroconversion|seroconversion
4986536|NCT01695798|mucosal immunity|mucosal immunity
4986537|NCT01695798|malnutrition|malnutrition
4986538|NCT01695798|IPV|ipv
4986539|NCT01695798|Inactivated polio vaccine|inactivated polio vaccine
4986540|NCT01695798|Pakistan|pakistan
4986541|NCT01695759|Anemia Secondary|anemia secondary
4986542|NCT01695759|Chronic Kidney Disease|chronic kidney disease
4986543|NCT01695720|Knee Injuries|knee injuries
4986544|NCT01695720|Meniscus Injuries|meniscus injuries
4986545|NCT01695720|Articular Cartilage Injuries|articular cartilage injuries
4986546|NCT01695720|Orthopaedic Diagnostic|orthopaedic diagnostic
4986547|NCT01695720|Magnetic Resonance Imaging|magnetic resonance imaging
4986548|NCT01695707|atopic dermatitis|atopic dermatitis
4986549|NCT01695707|eczema|eczema
4986550|NCT01695681|Quality of life|quality of life
4986551|NCT01695681|Celiac Disease/diet therapy|celiac disease/diet therapy
4986552|NCT01695681|Celiac Disease/diagnosis|celiac disease/diagnosis
4986553|NCT01695681|Prospective Studies|prospective studies
4986554|NCT01695668|Graft versus Host Disease (GVHD)|graft versus host disease (gvhd)
4986555|NCT01695668|dry eyes|dry eyes
4986556|NCT01695668|Bone marrow transplant (BMT)|bone marrow transplant (bmt)
4986557|NCT01695668|Restasis|restasis
4986558|NCT01695668|Lotemax|lotemax
4986559|NCT01695642|lasik, intralase, microkeratome|lasik, intralase, microkeratome
4986560|NCT01695603|Brain injury|brain injury
4986561|NCT01695603|Controlled ventilation|controlled ventilation
4986562|NCT01695603|Intellivent|intellivent
4986563|NCT01695603|Capnia control|capnia control
4986564|NCT01695590|Myeloma|myeloma
4986565|NCT01695590|PRLX93936|prlx93936
4986566|NCT01695577|Traumatic brain injury|traumatic brain injury
4986567|NCT01695577|Dizziness|dizziness
4986568|NCT01695577|Vestibular rehabilitation|vestibular rehabilitation
4986569|NCT01695577|Balance rehabilitation|balance rehabilitation
4986570|NCT01695564|atrial enlargement|atrial enlargement
4986571|NCT01695564|left atrial appendage|left atrial appendage
4986572|NCT01695551|Radiofrequency ablation|radiofrequency ablation
4986573|NCT01695551|fast heart rhythm|fast heart rhythm
4986574|NCT01695551|ventricle|ventricle
4986575|NCT01695551|catheter ablation|catheter ablation
4986576|NCT01695551|ablation|ablation
4986577|NCT01695538|Yoga|yoga
4986578|NCT01695538|atrial tachycardia|atrial tachycardia
4986579|NCT01695525|Neurocardiogenic Syncope|neurocardiogenic syncope
4986580|NCT01695525|Yoga|yoga
4986581|NCT01695486|BIS|bis
4986582|NCT01695486|Comfort|comfort
4986583|NCT01695486|open muscle biopsy|open muscle biopsy
4986584|NCT01695473|Prostate cancer|prostate cancer
4986585|NCT01695473|High-risk prostate cancer|high-risk prostate cancer
4986586|NCT01695473|Radical prostatectomy|radical prostatectomy
4986587|NCT01695473|BKM120|bkm120
4986588|NCT01695460|Migraine|migraine
4986589|NCT01695460|Vitamin D|vitamin d
4986590|NCT01695434|multiple sclerosis|multiple sclerosis
4986591|NCT01695434|MRI|mri
4986592|NCT01695434|Copaxone|copaxone
4986593|NCT01695434|healthy controls|healthy controls
4986594|NCT01695434|glatiramer acetate|glatiramer acetate
4986595|NCT01695421|Transcutaneous Electric Nerve Stimulation|transcutaneous electric nerve stimulation
4986596|NCT01695421|Oxygen Consumption|oxygen consumption
4986597|NCT01695421|Heart Failure|heart failure
4986598|NCT01695408|Drug Treatment|drug treatment
4986599|NCT01695408|Treatment pathways|treatment pathways
4986600|NCT01695408|Clinical routine|clinical routine
4986601|NCT01695408|Registry|registry
4986602|NCT01695408|Outcomes|outcomes
4986603|NCT01695408|Survival|survival
4986604|NCT01695408|Patient-related outcomes|patient-related outcomes
4986605|NCT01695408|Quality of life|quality of life
4986606|NCT01695408|Steroids|steroids
4986607|NCT01695408|Azathioprine|azathioprine
4986608|NCT01695408|N-Acetylcysteine|n-acetylcysteine
4986609|NCT01695408|Pirfenidone|pirfenidone
4986610|NCT01695408|Tyrosine kinase inhibitors|tyrosine kinase inhibitors
4986611|NCT01695408|Nintedanib|nintedanib
4986612|NCT01695408|multicenter|multicenter
4986613|NCT01695408|Germany|germany
4986614|NCT01695408|Safety|safety
4986615|NCT01695408|Adverse event|adverse event
4986616|NCT01695395|intellectual disability|intellectual disability
4986617|NCT01695395|mental disorder|mental disorder
4986618|NCT01695395|dual diagnosis|dual diagnosis
4986619|NCT01695395|provision|provision
4986620|NCT01695395|needs assessment|needs assessment
4986621|NCT01695395|quality of life|quality of life
4986622|NCT01695382|Cancer|cancer
4986623|NCT01695382|Palliative Care|palliative care
4986624|NCT01695382|Patient Navigation|patient navigation
4986625|NCT01695356|Melasma|melasma
4986626|NCT01695356|sunscreens|sunscreens
4986627|NCT01695356|visible light|visible light
4986628|NCT01695356|ultraviolet light|ultraviolet light
4986629|NCT01695343|Cystic Fibrosis|cystic fibrosis
4986630|NCT01695343|Pseudomonas aeruginosa (Pa)|pseudomonas aeruginosa (pa)
4986631|NCT01695343|CF|cf
4986632|NCT01695330|Multiple Myeloma|multiple myeloma
4986633|NCT01695330|Relapsed|relapsed
4986634|NCT01695330|Refractory|refractory
4986635|NCT01695330|Bortezomib|bortezomib
4986636|NCT01695330|Subcutaneous|subcutaneous
4986637|NCT01695330|Oncotherapeutics|oncotherapeutics
4986638|NCT01695317|Migraine|migraine
4986639|NCT01695317|Preventive medication|preventive medication
4986640|NCT01695304|Cryptosporidiosis|cryptosporidiosis
4986641|NCT01695304|Waterborne disease|waterborne disease
4986642|NCT01695304|Diarrheal disease|diarrheal disease
4986643|NCT01695304|Ceramic water filters|ceramic water filters
4986644|NCT01695304|infants|infants
4986645|NCT01695304|young children|young children
4986646|NCT01695304|drinking water|drinking water
4986647|NCT01695304|Kenya|kenya
4986648|NCT01695291|Obsessive compulsive disorder|obsessive compulsive disorder
4986649|NCT01695278|motivational interviewing|motivational interviewing
4986650|NCT01695278|telephone counseling|telephone counseling
4986651|NCT01695278|medical education|medical education
4986652|NCT01695278|diabetes self management|diabetes self management
4986653|NCT01695265|Airflow Obstruction|airflow obstruction
4986654|NCT01695226|Celecoxib|celecoxib
4986655|NCT01695226|Clinical trial, Phase II|clinical trial, phase ii
4986656|NCT01695226|Oligonucleotide Array Sequence Analysis|oligonucleotide array sequence analysis
4986657|NCT01695213|uncemented hip|uncemented hip
4986658|NCT01695213|bone remodeling|bone remodeling
4986659|NCT01695213|DEXA|dexa
4986660|NCT01695213|clinical evaluation|clinical evaluation
4986661|NCT01695187|Herpes, Herpes Labialis, nanoemulsion, NanoBio, NB-001|herpes, herpes labialis, nanoemulsion, nanobio, nb-001
4986662|NCT01695174|Primary Sclerosing Cholangitis|primary sclerosing cholangitis
4986663|NCT01695174|Xifaxan|xifaxan
4986664|NCT01695161|Mucopolysaccharidosis|mucopolysaccharidosis
4986665|NCT01695161|Fabry disease|fabry disease
4986666|NCT01695148|beta-carotene biofortified maize|beta-carotene biofortified maize
4986667|NCT01695148|micronutrients|micronutrients
4986668|NCT01695148|vitamin A|vitamin a
4986669|NCT01695148|serum retinol|serum retinol
4986670|NCT01695148|dark adaptation|dark adaptation
4986671|NCT01695135|Prostate neoplasms|prostate neoplasms
4986672|NCT01695135|Prostate cancer|prostate cancer
4986673|NCT01695135|Metastatic castration resistant prostate cancer|metastatic castration resistant prostate cancer
4986674|NCT01695135|Abiraterone acetate|abiraterone acetate
4986675|NCT01695135|JNJ-212082|jnj-212082
4986676|NCT01695122|Head and Neck Cancer|head and neck cancer
4986677|NCT01695122|Oropharyngeal cancer|oropharyngeal cancer
4986678|NCT01695122|Oral cavity cancer|oral cavity cancer
4986679|NCT01695122|Chemoradiation|chemoradiation
4986680|NCT01695122|valproic acid|valproic acid
4986681|NCT01695122|histone deacetylase|histone deacetylase
4986682|NCT01695109|GLP1|glp1
4986683|NCT01695109|obesity|obesity
4986684|NCT01695109|fMRI|fmri
4986685|NCT01695109|ghrelin|ghrelin
4986686|NCT01695083|Non alcoholic steatohepatitis|non alcoholic steatohepatitis
4986687|NCT01695083|Liver fibrosis,Steatosis|liver fibrosis,steatosis
4986688|NCT01695083|Liver inflammation|liver inflammation
4986689|NCT01695083|Morbid obesity|morbid obesity
4986690|NCT01695083|Non invasive tests|non invasive tests
4986691|NCT01695031|Urban adolescents|urban adolescents
4986692|NCT01695031|Acute asthma|acute asthma
4986693|NCT01695031|Emergency department|emergency department
4986694|NCT01695031|Computer tailoring|computer tailoring
4986695|NCT01695031|Web-based intervention|web-based intervention
4986696|NCT01695018|oral epithelial dysplasia|oral epithelial dysplasia
4986697|NCT01695018|p16 methylation|p16 methylation
4986698|NCT01695018|diagnostic reagents|diagnostic reagents
4986699|NCT01695018|early diagnosis|early diagnosis
4986700|NCT01694992|Stroke|stroke
4986701|NCT01694992|Early Ambulation|early ambulation
4986702|NCT01694992|Rehabilitation|rehabilitation
4986703|NCT01694992|Physical Therapy|physical therapy
4986704|NCT01694992|Randomized controlled trial|randomized controlled trial
4986705|NCT01694979|Pelvic floor|pelvic floor
4986706|NCT01694979|Rehabilitation|rehabilitation
4986707|NCT01694979|Respiration|respiration
4986708|NCT01694979|Urinary incontinence|urinary incontinence
4986709|NCT01694953|MNGIE|mngie
4986710|NCT01694953|Mitochondrial|mitochondrial
4986711|NCT01694953|Mitochondrial Neurogastrointestinal encephalopathy|mitochondrial neurogastrointestinal encephalopathy
4986712|NCT01694940|mitochondrial disorders|mitochondrial disorders
4986713|NCT01694940|Mito Disease|mito disease
4986714|NCT01694940|Mitochondria|mitochondria
4986715|NCT01694940|Mitochondrial disease|mitochondrial disease
4986716|NCT01694940|Mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke (MELAS) Syndrome|mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke (melas) syndrome
4986717|NCT01694940|Myoclonic Epilepsy with Ragged Red Fibers (MERRF)|myoclonic epilepsy with ragged red fibers (merrf)
4986718|NCT01694940|Leber Hereditary Optic Neuropathy (LHON)|leber hereditary optic neuropathy (lhon)
4986719|NCT01694940|Leigh Syndrome|leigh syndrome
4986720|NCT01694940|Neuropathy, ataxia, and retinitis pigmentosa (NARP)|neuropathy, ataxia, and retinitis pigmentosa (narp)
4986721|NCT01694940|Kearns Sayre syndrome|kearns sayre syndrome
4986722|NCT01694940|Alpers Huttenlocher|alpers huttenlocher
4986723|NCT01694940|Pearson|pearson
4986724|NCT01694940|Mitochondrial Neurogastrointestinal Encephalopathy (MNGIE)|mitochondrial neurogastrointestinal encephalopathy (mngie)
4986725|NCT01694940|Barth Syndrome|barth syndrome
4986726|NCT01694940|Coenzyme Q (CoQ) Deficiency|coenzyme q (coq) deficiency
4986850|NCT01694381|Cardiovascular Diseases|cardiovascular diseases
4986727|NCT01694940|Chronic progressive external ophthalmoplegia (CPEO)|chronic progressive external ophthalmoplegia (cpeo)
4986728|NCT01694940|DAD|dad
4986729|NCT01694940|Diabetes and Deafness|diabetes and deafness
4986730|NCT01694940|Encephalopathy|encephalopathy
4986731|NCT01694940|Encephalomyopathy|encephalomyopathy
4986732|NCT01694940|Familial Bilateral Striatal Necrosis (FBSN)|familial bilateral striatal necrosis (fbsn)
4986733|NCT01694940|Hepatocerebral Disease|hepatocerebral disease
4986734|NCT01694940|Leukoencephalopathy|leukoencephalopathy
4986735|NCT01694940|Maternally Inherited Leigh Syndrome (MILS)|maternally inherited leigh syndrome (mils)
4986736|NCT01694940|Complex I Deficiency|complex i deficiency
4986737|NCT01694940|Complex II Deficiency|complex ii deficiency
4986738|NCT01694940|Complex III Deficiency|complex iii deficiency
4986739|NCT01694940|Complex IV Deficiency|complex iv deficiency
4986740|NCT01694940|Complex V Deficiency|complex v deficiency
4986741|NCT01694940|mitochondrial DNA depletion syndrome|mitochondrial dna depletion syndrome
4986742|NCT01694940|mtDNA depletion syndrome|mtdna depletion syndrome
4986743|NCT01694927|Mesenchymal stem cell|mesenchymal stem cell
4986744|NCT01694927|Spinal cord injury|spinal cord injury
4986745|NCT01694914|Corneal Transplantation|corneal transplantation
4986746|NCT01694914|corneal organ culture medium|corneal organ culture medium
4986747|NCT01694914|free animal compound medium|free animal compound medium
4986748|NCT01694888|Students practice, Lecture; Nursing records; Nursing education; Midwifery|students practice, lecture; nursing records; nursing education; midwifery
4986749|NCT01694875|cervix cancer|cervix cancer
4986750|NCT01694875|HPV|hpv
4986751|NCT01694875|APTIMA|aptima
4986752|NCT01694862|quasi experimental|quasi experimental
4986753|NCT01694862|evaluation|evaluation
4986754|NCT01694862|intervention|intervention
4986755|NCT01694862|service integration|service integration
4986756|NCT01694862|cost analysis|cost analysis
4986757|NCT01694862|HIV|hiv
4986758|NCT01694862|FP|fp
4986759|NCT01694862|PNC|pnc
4986760|NCT01694862|Sub-Saharan Africa|sub-saharan africa
4986761|NCT01694849|PPARs|ppars
4986762|NCT01694849|NASH|nash
4986763|NCT01694849|Non-Alcoholic Steatohepatitis|non-alcoholic steatohepatitis
4986764|NCT01694849|Liver Diseases|liver diseases
4986765|NCT01694849|Fibrosis|fibrosis
4986766|NCT01694836|Allergic rhinitis|allergic rhinitis
4986767|NCT01694836|Allergic rhinoconjunctivitis|allergic rhinoconjunctivitis
4986768|NCT01694836|Allergy induced asthma|allergy induced asthma
4986769|NCT01694836|Birch (Betula alba)|birch (betula alba)
4986770|NCT01694836|Hayfever|hayfever
4986771|NCT01694836|Immunotherapy|immunotherapy
4986772|NCT01694823|Cartilage repair|cartilage repair
4986773|NCT01694823|Cartilage defects|cartilage defects
4986774|NCT01694823|cell sheet|cell sheet
4986775|NCT01694823|Autologous chondrocyte implantation|autologous chondrocyte implantation
4986776|NCT01694810|acne vulgaris|acne vulgaris
4986777|NCT01694758|Benchmarking could improve quality of patient care|benchmarking could improve quality of patient care
4986778|NCT01694758|ESC and ATP III Guidelines|esc and atp iii guidelines
4986779|NCT01694745|Newborns|newborns
4986780|NCT01694745|Premature|premature
4986781|NCT01694745|Pain|pain
4986782|NCT01694745|Pain assessment|pain assessment
4986783|NCT01694745|Endotracheal Intubation|endotracheal intubation
4986784|NCT01694745|Analgesia|analgesia
4986785|NCT01694745|Sedation|sedation
4986786|NCT01694745|Longterm effects of pain|longterm effects of pain
4986787|NCT01694745|Epidemiology|epidemiology
4986788|NCT01694732|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
4986789|NCT01694732|Varenicline|varenicline
4986790|NCT01694732|Smoking cessation|smoking cessation
4986791|NCT01694719|Depression|depression
4986792|NCT01694719|Major Depressive Disorder|major depressive disorder
4986793|NCT01694719|Behavioral Activation|behavioral activation
4986794|NCT01694719|Cognitive Training|cognitive training
4986795|NCT01694680|AMD|amd
4986796|NCT01694680|Lutein|lutein
4986797|NCT01694680|Visual function|visual function
4986798|NCT01694680|Early signs of AMD|early signs of amd
4986799|NCT01694680|AREDS-category 2|areds-category 2
4986800|NCT01694641|time lapse monitoring|time lapse monitoring
4986801|NCT01694641|blastocyst|blastocyst
4986802|NCT01694641|single embryo transfer|single embryo transfer
4986803|NCT01694641|clinical pregnancy|clinical pregnancy
4986804|NCT01694641|implantation rate|implantation rate
4986805|NCT01694615|Lung Transplantation|lung transplantation
4986806|NCT01694615|Acute Rejection|acute rejection
4986807|NCT01694602|Cachexia|cachexia
4986808|NCT01694602|Sarcopenia|sarcopenia
4986809|NCT01694602|De Novo|de novo
4986810|NCT01694602|Deuterated|deuterated
4986811|NCT01694589|pancreatic cancer|pancreatic cancer
4986812|NCT01694589|resectable pancreatic cancer|resectable pancreatic cancer
4986813|NCT01694576|Nasopharyngeal carcinoma staged N2-3M0|nasopharyngeal carcinoma staged n2-3m0
4986814|NCT01694576|Adjuvant chemotherapy|adjuvant chemotherapy
4986815|NCT01694563|Atrial Fibrillation|atrial fibrillation
4986816|NCT01694550|pacemaker|pacemaker
4986817|NCT01694550|ICD / CRTD|icd / crtd
4986818|NCT01694550|corrected QT-interval|corrected qt-interval
4986819|NCT01694537|lumbrokinase|lumbrokinase
4986820|NCT01694537|fibrinolytic|fibrinolytic
4986821|NCT01694537|plasmin-antiplasmin complex|plasmin-antiplasmin complex
4986822|NCT01694537|euglobulin clot lysis time|euglobulin clot lysis time
4986823|NCT01694537|platelet aggregation|platelet aggregation
4986824|NCT01694511|Endoscopy, Gastrointestinal|endoscopy, gastrointestinal
4986825|NCT01694485|Ulcerative Colitis, IBD|ulcerative colitis, ibd
4986826|NCT01694459|angioplasty|angioplasty
4986827|NCT01694459|heparin|heparin
4986828|NCT01694459|trial|trial
4986829|NCT01694446|Intestinal lipoprotein|intestinal lipoprotein
4986830|NCT01694446|Apo B48 and apoB100|apo b48 and apob100
4986831|NCT01694446|Pancreatic clamp|pancreatic clamp
4986832|NCT01694407|Prevention|prevention
4986833|NCT01694394|atrial fibrillation|atrial fibrillation
4986834|NCT01694394|implantable cardiac monitor|implantable cardiac monitor
4986835|NCT01694394|left atrial enlargement|left atrial enlargement
4986836|NCT01694394|CHA2DS2 VASc Score|cha2ds2 vasc score
4986837|NCT01694394|cardiovascular risk|cardiovascular risk
4986838|NCT01694381|Acute Ischemic Stroke|acute ischemic stroke
4986839|NCT01694381|TS01|ts01
4986840|NCT01694381|Mutant pro-urokinase|mutant pro-urokinase
4986841|NCT01694381|M5|m5
4986842|NCT01694381|C1 inhibitor|c1 inhibitor
4986843|NCT01694381|Safety|safety
4986844|NCT01694381|Stroke|stroke
4986845|NCT01694381|Tolerability|tolerability
4986846|NCT01694381|Ischemia|ischemia
4986847|NCT01694381|Cerebral Infarction|cerebral infarction
4986848|NCT01694381|Cerebrovascular Disorders|cerebrovascular disorders
4986849|NCT01694381|Vascular Diseases|vascular diseases
4986851|NCT01694381|Brain Infarction|brain infarction
4986852|NCT01694381|Brain Ischemia|brain ischemia
4986853|NCT01694381|Fibrinolytic Agents|fibrinolytic agents
4986854|NCT01694381|Thrombolytic Agents|thrombolytic agents
4986855|NCT01694381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
4986856|NCT01694381|Pharmacologic Actions|pharmacologic actions
4986857|NCT01694381|Cardiovascular Agents|cardiovascular agents
4986858|NCT01694381|Therapeutic Uses|therapeutic uses
4986859|NCT01694381|Hematologic Agents|hematologic agents
4986860|NCT01694368|Near infrared spectroscopy; lipid core; vulnerable plaque|near infrared spectroscopy; lipid core; vulnerable plaque
4986861|NCT01694329|Streptococcus pneumoniae|streptococcus pneumoniae
4986862|NCT01694329|Pneumococcal Conjugate Vaccines|pneumococcal conjugate vaccines
4986863|NCT01694329|Immunization|immunization
4986864|NCT01694329|Otitis media|otitis media
4986865|NCT01694316|Computerized neurobehavioral intervention|computerized neurobehavioral intervention
4986866|NCT01694277|Gastrointestinal Stromal Tumour|gastrointestinal stromal tumour
4986867|NCT01694277|GIST|gist
4986868|NCT01694277|non-resectable|non-resectable
4986869|NCT01694277|metastatic|metastatic
4986870|NCT01694277|second line treatment|second line treatment
4986871|NCT01694277|resistance to imatinib|resistance to imatinib
4986872|NCT01694264|HBV surface antigen|hbv surface antigen
4986873|NCT01694264|Anti-HBc positive|anti-hbc positive
4986874|NCT01694264|Anti-TNFα Treatment|anti-tnfα treatment
4986875|NCT01694264|Reactivation|reactivation
4986876|NCT01694251|mitral valve area|mitral valve area
4986877|NCT01694251|pressure half time|pressure half time
4986878|NCT01694251|3 dimensional transesophageal echocardiography|3 dimensional transesophageal echocardiography
4986879|NCT01694251|computed tomography|computed tomography
4986880|NCT01694238|Colostomy|colostomy
4986881|NCT01694238|Surgical technique|surgical technique
4986882|NCT01694225|Breast cancer|breast cancer
4986883|NCT01694225|Anti-estrogen therapy|anti-estrogen therapy
4986884|NCT01694212|Macular edema|macular edema
4986885|NCT01694212|Cataract|cataract
4986886|NCT01694212|Diabetic retinopathy|diabetic retinopathy
4986887|NCT01694212|Anti-inflammatory agents,Non-steroidal|anti-inflammatory agents,non-steroidal
4986888|NCT01694199|Pulsed Radiofrequency Energy (PRFE)|pulsed radiofrequency energy (prfe)
4986889|NCT01694199|Pain|pain
4986890|NCT01694199|Postsurgical|postsurgical
4986891|NCT01694199|Opioids|opioids
4986892|NCT01694199|Pain relief|pain relief
4986893|NCT01694199|Medical device|medical device
4986894|NCT01694199|Endorphins|endorphins
4986895|NCT01694173|Type 2 diabetes mellitus, F18-FDG labelled stem cells|type 2 diabetes mellitus, f18-fdg labelled stem cells
4986896|NCT01694160|kidney transplant patients|kidney transplant patients
4986897|NCT01694160|Albuminuria|albuminuria
4986898|NCT01694147|relationship|relationship
4986899|NCT01694147|endothelial injury|endothelial injury
4986900|NCT01694147|vascular permeability|vascular permeability
4986901|NCT01694147|severe sepsis related ALI/ARDS|severe sepsis related ali/ards
4986902|NCT01694134|Discopathy|discopathy
4986903|NCT01694134|Modic I|modic i
4986904|NCT01694134|Corticoids|corticoids
4986905|NCT01694134|Local Anaesthetic|local anaesthetic
4986906|NCT01694134|Intradiscal injection|intradiscal injection
4986907|NCT01694121|HIV prevention|hiv prevention
4986908|NCT01694121|African American men|african american men
4986909|NCT01694121|evaluation study|evaluation study
4986910|NCT01694095|Geographic atrophy, prognosis, risk factors, natural history|geographic atrophy, prognosis, risk factors, natural history
4986911|NCT01694082|brief intervention|brief intervention
4986912|NCT01694082|web-based interventions|web-based interventions
4986913|NCT01694082|computer-based interventions|computer-based interventions
4986914|NCT01694082|harm reduction|harm reduction
4986915|NCT01694082|young adult|young adult
4986916|NCT01694082|college student|college student
4986917|NCT01694069|piperacillin|piperacillin
4986918|NCT01694069|tazobactam|tazobactam
4986919|NCT01694069|pseudomonas aeruginosa|pseudomonas aeruginosa
4986920|NCT01694069|cystic fibrosis|cystic fibrosis
4986921|NCT01694069|pulmonary exacerbation|pulmonary exacerbation
4986922|NCT01694069|continuous infusion|continuous infusion
4986923|NCT01694069|beta lactam|beta lactam
4986924|NCT01694030|Attachment security priming|attachment security priming
4986925|NCT01694030|depressed mood|depressed mood
4986926|NCT01694017|HIV,treatment,cost effectiveness,drug toxicity,QOL,costs|hiv,treatment,cost effectiveness,drug toxicity,qol,costs
4986927|NCT01694004|Nutrient absorption|nutrient absorption
4986928|NCT01694004|Duodenal feeding tube|duodenal feeding tube
4986929|NCT01694004|Gut-brain-gut axis|gut-brain-gut axis
4986930|NCT01693978|PTSD|ptsd
4986931|NCT01693978|Prolonged Exposure|prolonged exposure
4986932|NCT01693978|Comorbidity|comorbidity
4986933|NCT01693978|Treatment|treatment
4986934|NCT01693978|Methadone Maintenance|methadone maintenance
4986935|NCT01693978|Substance Use Disorder|substance use disorder
4986936|NCT01693939|Lasik|lasik
4986937|NCT01693939|Myopia|myopia
4986938|NCT01693939|Femtosecond Laser|femtosecond laser
4986939|NCT01693926|Obesity|obesity
4986940|NCT01693926|Children|children
4986941|NCT01693926|Physical activity|physical activity
4986942|NCT01693926|Stress|stress
4986943|NCT01693926|Snacking|snacking
4986944|NCT01693900|joint replacement|joint replacement
4986945|NCT01693900|total hip replacement|total hip replacement
4986946|NCT01693900|regional pain block|regional pain block
4986947|NCT01693900|ultrasound guidance|ultrasound guidance
4986948|NCT01693900|fascia iliaca compartment block|fascia iliaca compartment block
4986949|NCT01693887|IFI|ifi
4986950|NCT01693887|empirical therapy|empirical therapy
4986951|NCT01693887|preemptive therapy|preemptive therapy
4986952|NCT01693887|Itraconazole|itraconazole
4986953|NCT01693874|anxiety|anxiety
4986954|NCT01693874|depression|depression
4986955|NCT01693874|cognition|cognition
4986956|NCT01693874|MBSR|mbsr
4986957|NCT01693874|mindfulness|mindfulness
4986958|NCT01693874|stress|stress
4986959|NCT01693874|elderly|elderly
4986960|NCT01693861|Colorectal|colorectal
4986961|NCT01693861|Cancer|cancer
4986962|NCT01693861|Metastatic|metastatic
4986963|NCT01693861|Chronotherapy|chronotherapy
4986964|NCT01693861|Urine|urine
4986965|NCT01693861|Nucleosides|nucleosides
4986966|NCT01693861|Chemotherapy|chemotherapy
4986967|NCT01693861|Treated with chemotherapy|treated with chemotherapy
4986968|NCT01693848|Colorectal|colorectal
4986969|NCT01693848|Cancer|cancer
4986970|NCT01693848|Metastatic|metastatic
4986971|NCT01693848|Control|control
4986972|NCT01693848|Urine|urine
4986973|NCT01693848|Nucleosides|nucleosides
4986974|NCT01693848|Surgery|surgery
4986975|NCT01693848|General anesthesia|general anesthesia
4986976|NCT01693848|Scheduled for surgery|scheduled for surgery
4986977|NCT01693835|Colorectal|colorectal
4986978|NCT01693835|Cancer|cancer
4986979|NCT01693835|Metastatic|metastatic
4986980|NCT01693835|Healthy|healthy
4986981|NCT01693835|Control|control
4986982|NCT01693835|Circadian|circadian
4986983|NCT01693835|Urine|urine
4986984|NCT01693835|Nucleosides|nucleosides
4986985|NCT01693822|metastatic renal cell carcinoma|metastatic renal cell carcinoma
4986986|NCT01693822|predominant clear cell histology|predominant clear cell histology
4986987|NCT01693822|Unsuitable for nephrectomy|unsuitable for nephrectomy
4986988|NCT01693822|unsuitable for 'watch and wait' policy|unsuitable for 'watch and wait' policy
4986989|NCT01693809|Caffeine|caffeine
4986990|NCT01693809|Vestibular Evoked Myogenic Potentials|vestibular evoked myogenic potentials
4986991|NCT01693809|dizziness|dizziness
4986992|NCT01693809|vertigo|vertigo
4986993|NCT01693809|tinnitus|tinnitus
4986994|NCT01693770|Bone Metastasis|bone metastasis
4986995|NCT01693770|Pain Palliation|pain palliation
4986996|NCT01693770|High Intensity Focused Ultrasound|high intensity focused ultrasound
4986997|NCT01693757|Anterior Cruciate Ligament|anterior cruciate ligament
4986998|NCT01693757|Hamstrings versus patellar tendon|hamstrings versus patellar tendon
4986999|NCT01693757|Hop test|hop test
4987000|NCT01693757|Return to sports|return to sports
4987001|NCT01693744|Pseudoexfoliation, chronic kidney disease|pseudoexfoliation, chronic kidney disease
4987002|NCT01693731|Breast cancer|breast cancer
4987003|NCT01693731|Periodontal Diseases|periodontal diseases
4987004|NCT01693731|Aromatase Inhibitors|aromatase inhibitors
4987005|NCT01693731|Oral Health Related Quality of Life|oral health related quality of life
4987006|NCT01693718|cancer|cancer
4987007|NCT01693718|advanced|advanced
4987008|NCT01693718|oral cavity|oral cavity
4987009|NCT01693718|larynx|larynx
4987010|NCT01693705|Tracheostomy|tracheostomy
4987011|NCT01693692|Fibromyalgia|fibromyalgia
4987012|NCT01693679|Tebivudine eGFR non-Tebivudine|tebivudine egfr non-tebivudine
4987013|NCT01693666|Pregnancy|pregnancy
4987014|NCT01693666|Obesity|obesity
4987015|NCT01693666|Weight gain|weight gain
4987016|NCT01693666|Obstetric complications|obstetric complications
4987017|NCT01693666|Lifestyle intervention|lifestyle intervention
4987018|NCT01693653|Behcet's syndrome|behcet's syndrome
4987019|NCT01693653|oral ulcers|oral ulcers
4987020|NCT01693640|Behcet's|behcet's
4987021|NCT01693614|Diffuse large B-cell lymphoma, Mantle cell lymphoma, Follicular lymphoma, PI3K inhibitor, Non-Hodgkin lymphoma, NHL|diffuse large b-cell lymphoma, mantle cell lymphoma, follicular lymphoma, pi3k inhibitor, non-hodgkin lymphoma, nhl
4987022|NCT01693601|Myelofibrosis|myelofibrosis
4987023|NCT01693601|Panobinostat|panobinostat
4987024|NCT01693601|Ruxolitinib|ruxolitinib
4987025|NCT01693588|Pain|pain
4987026|NCT01693588|Postoperative Pain|postoperative pain
4987027|NCT01693588|Surgical Pain|surgical pain
4987028|NCT01693588|Neurosurgical Pain|neurosurgical pain
4987029|NCT01693575|Small pupil cataract surgery|small pupil cataract surgery
4987030|NCT01693575|Intraoperative floppy iris syndrome (IFIS)|intraoperative floppy iris syndrome (ifis)
4987031|NCT01693562|Advanced solid tumors|advanced solid tumors
4987032|NCT01693549|HER-2 negative|her-2 negative
4987033|NCT01693549|Metastatic breast adenocarcinoma|metastatic breast adenocarcinoma
4987034|NCT01693536|Elderly|elderly
4987035|NCT01693536|Sodium reduction|sodium reduction
4987036|NCT01693536|Fitness increase|fitness increase
4987037|NCT01693536|Primary Care|primary care
4987038|NCT01693523|Pancreatic Cancer|pancreatic cancer
4987039|NCT01693523|Pancreatic adenocarcinoma|pancreatic adenocarcinoma
4987040|NCT01693523|Locally advanced|locally advanced
4987041|NCT01693523|Metastatic disease|metastatic disease
4987042|NCT01693523|Symptom reduction|symptom reduction
4987043|NCT01693523|Minocycline|minocycline
4987044|NCT01693523|Dynacin|dynacin
4987045|NCT01693523|Minocin|minocin
4987046|NCT01693523|Minocin PAC|minocin pac
4987047|NCT01693523|Myrac|myrac
4987048|NCT01693523|Solodyn|solodyn
4987049|NCT01693523|Placebo|placebo
4987050|NCT01693523|Sugar Pill|sugar pill
4987051|NCT01693523|Questionnaires|questionnaires
4987052|NCT01693523|Surveys|surveys
4987053|NCT01693510|Excess gestational weight gain (GWG)|excess gestational weight gain (gwg)
4987054|NCT01693510|Obesity|obesity
4987055|NCT01693510|Type 2 diabetes|type 2 diabetes
4987056|NCT01693510|Elevated fats in the blood|elevated fats in the blood
4987057|NCT01693510|High blood pressure|high blood pressure
4987058|NCT01693497|Posttraumatic Stress Disorder|posttraumatic stress disorder
4987059|NCT01693497|PTSD|ptsd
4987060|NCT01693497|psychotherapy|psychotherapy
4987061|NCT01693497|randomized trial|randomized trial
4987062|NCT01693497|gestalt|gestalt
4987063|NCT01693484|Calcaneus|calcaneus
4987064|NCT01693484|Fracture|fracture
4987065|NCT01693484|Indocyanine Green|indocyanine green
4987066|NCT01693484|Angiography|angiography
4987067|NCT01693484|Open Reduction and Internal Fixation|open reduction and internal fixation
4987068|NCT01693471|asthma|asthma
4987069|NCT01693471|SF-36|sf-36
4987070|NCT01693471|HRQOL|hrqol
4987071|NCT01693458|HIV|hiv
4987072|NCT01693458|prevention|prevention
4987073|NCT01693458|HIV-positive|hiv-positive
4987074|NCT01693458|education|education
4987075|NCT01693445|Gastrointestinal neoplasms|gastrointestinal neoplasms
4987076|NCT01693445|Oxaliplatin|oxaliplatin
4987077|NCT01693445|Irinotecan|irinotecan
4987078|NCT01693445|S-1|s-1
4987079|NCT01693432|Esophageal neoplasms|esophageal neoplasms
4987080|NCT01693432|Docetaxel|docetaxel
4987081|NCT01693432|S-1|s-1
4987082|NCT01693419|pancreas neoplasm|pancreas neoplasm
4987083|NCT01693419|gemcitabine|gemcitabine
4987084|NCT01693419|erlotinib|erlotinib
4987085|NCT01693419|S-1|s-1
4987086|NCT01693406|human milk|human milk
4987087|NCT01693406|infant growth|infant growth
4987088|NCT01693406|obesity|obesity
4987089|NCT01693406|diabetes|diabetes
4987090|NCT01693406|breastfeeding|breastfeeding
4987091|NCT01693393|primary Sjogren´s Syndrome|primary sjogren´s syndrome
4987092|NCT01693393|Cyclosporine|cyclosporine
4987093|NCT01693380|Influenza|influenza
4987094|NCT01693380|Vaccination|vaccination
4987095|NCT01693380|Vaccines|vaccines
4987096|NCT01693380|Schoolchildren|schoolchildren
4987097|NCT01693380|Effectiveness|effectiveness
4987098|NCT01693380|Intervention studies|intervention studies
4987099|NCT01693380|Adolescents|adolescents
4987100|NCT01693380|Laboratory Confirmed Influenza|laboratory confirmed influenza
4987101|NCT01693367|Femoral fracture|femoral fracture
4987102|NCT01693367|Periprosthetic fracture|periprosthetic fracture
4987103|NCT01693367|Fracture fixation, internal|fracture fixation, internal
4987104|NCT01693367|Distal femur fractures|distal femur fractures
4987105|NCT01693367|Dynamic Locking Screw|dynamic locking screw
4987106|NCT01693367|WOMAC|womac
4987107|NCT01693354|dialysis|dialysis
4987108|NCT01693354|mortality|mortality
4987109|NCT01693354|cardiovascular stability|cardiovascular stability
4987110|NCT01693354|inflammation|inflammation
4987111|NCT01693354|quality of life|quality of life
4987112|NCT01693341|Chronic stroke patients|chronic stroke patients
4987113|NCT01693341|Stroke rehabilitation|stroke rehabilitation
4987114|NCT01693341|Caregiver|caregiver
4987115|NCT01693341|Caregiver-mediated intervention|caregiver-mediated intervention
4987116|NCT01693328|quality of life|quality of life
4987117|NCT01693328|PecFent|pecfent
4987118|NCT01693328|Lazanda|lazanda
4987119|NCT01693328|fentanyl|fentanyl
4987120|NCT01693328|intranasal|intranasal
4987121|NCT01693328|breakthrough cancer pain|breakthrough cancer pain
4987122|NCT01693302|Blood Glucose|blood glucose
4987123|NCT01693302|Meal insulin|meal insulin
4987124|NCT01693289|Metformin|metformin
4987125|NCT01693289|letrozole|letrozole
4987126|NCT01693289|ovarian drilling|ovarian drilling
4987127|NCT01693289|clomiphene resistance|clomiphene resistance
4987128|NCT01693289|polycystic ovary.|polycystic ovary.
4987129|NCT01693276|pancreatic cancer|pancreatic cancer
4987130|NCT01693263|end stage renal disease (ESRD)|end stage renal disease (esrd)
4987131|NCT01693263|brachiocephalic fistula (BCF)|brachiocephalic fistula (bcf)
4987132|NCT01693263|cephalic arch stenosis (CAS)|cephalic arch stenosis (cas)
4987133|NCT01693263|dialysis|dialysis
4987134|NCT01693250|technology|technology
4987135|NCT01693250|healthy weight management|healthy weight management
4987136|NCT01693250|primary care setting|primary care setting
4987137|NCT01693224|Tests, Diagnostic|tests, diagnostic
4987138|NCT01693224|Mycobacterium tuberculosis|mycobacterium tuberculosis
4987139|NCT01693224|Mycobacterium tuberculosis antigens|mycobacterium tuberculosis antigens
4987140|NCT01693224|TB|tb
4987141|NCT01693224|Tuberculosis|tuberculosis
4987142|NCT01693224|Tuberculosis, Pulmonary|tuberculosis, pulmonary
4987143|NCT01693224|Tuberculosis, Miliary|tuberculosis, miliary
4987144|NCT01693224|Lipoarabinomannan|lipoarabinomannan
4987145|NCT01693211|femtosecond laser|femtosecond laser
4987146|NCT01693211|cataract|cataract
4987147|NCT01693211|control study|control study
4987148|NCT01693211|prospective|prospective
4987149|NCT01693198|allergy|allergy
4987150|NCT01693198|cyanobacteria|cyanobacteria
4987151|NCT01693198|sweet water swimming|sweet water swimming
4987152|NCT01693185|colonoscopy|colonoscopy
4987153|NCT01693185|remifentanil|remifentanil
4987154|NCT01693185|midazolam|midazolam
4987155|NCT01693185|meperidine|meperidine
4987156|NCT01693172|exercise|exercise
4987157|NCT01693172|neoplasm|neoplasm
4987158|NCT01693159|Painful cetuximab-induced rhagades|painful cetuximab-induced rhagades
4987159|NCT01693159|Radioimmunotherapy|radioimmunotherapy
4987160|NCT01693159|Head and neck cancer|head and neck cancer
4987161|NCT01693146|Oxygen|oxygen
4987162|NCT01693146|High Flow|high flow
4987163|NCT01693146|COPD|copd
4987164|NCT01693146|Hypercapnia|hypercapnia
4987165|NCT01693120|ablation|ablation
4987166|NCT01693120|atrial fibrillation|atrial fibrillation
4987167|NCT01693120|Radio frequency|radio frequency
4987168|NCT01693107|Atrial Fibrillation|atrial fibrillation
4987169|NCT01693107|Catheter Ablation|catheter ablation
4987170|NCT01693107|Electrophysiology|electrophysiology
4987171|NCT01693107|Cardiac Arrhythmias|cardiac arrhythmias
4987172|NCT01693081|Parkinson's disease|parkinson's disease
4987173|NCT01693081|inhaled apomorphine|inhaled apomorphine
4987174|NCT01693081|"convert off to on"|"convert off to on"
4987175|NCT01693068|Cutaneous Melanoma|cutaneous melanoma
4987176|NCT01693068|Dacarbazine|dacarbazine
4987177|NCT01693068|Pimasertib|pimasertib
4987178|NCT01693068|N-Ras|n-ras
4987179|NCT01693055|orbital Computed Tomography|orbital computed tomography
4987180|NCT01693055|baggy eyelids|baggy eyelids
4987181|NCT01693055|orbital fat prolapse|orbital fat prolapse
4987182|NCT01693055|UltheraTM|ultheratm
4987183|NCT01693055|high intensity focused ultrasound|high intensity focused ultrasound
4987184|NCT01693042|heart failure|heart failure
4987185|NCT01693042|old myocardial infarction|old myocardial infarction
4987186|NCT01693042|bone marrow-derived mononuclear cells|bone marrow-derived mononuclear cells
4987187|NCT01693042|chronic|chronic
4987188|NCT01693042|ischemic|ischemic
4987189|NCT01693029|erythropoietin alfa|erythropoietin alfa
4987190|NCT01693029|CKD 5d|ckd 5d
4987191|NCT01693016|non-invasive Hb measurement in children|non-invasive hb measurement in children
4987192|NCT01693003|COPD|copd
4987193|NCT01692990|Appetite|appetite
4987194|NCT01692990|Fish oil|fish oil
4987195|NCT01692990|Long-chain n-3 fatty acids|long-chain n-3 fatty acids
4987196|NCT01692912|Psoriatic Arthritis|psoriatic arthritis
4987197|NCT01692912|Randomized|randomized
4987198|NCT01692912|Single blind|single blind
4987199|NCT01692912|Treat to target|treat to target
4987200|NCT01692899|Retention Rates|retention rates
4987201|NCT01692899|of Adalimumab|of adalimumab
4987202|NCT01692899|Etanercept and Infliximab|etanercept and infliximab
4987203|NCT01692899|as First and Second-Line Biotherapy|as first and second-line biotherapy
4987204|NCT01692899|in Patients with Rheumatoid Arthritis|in patients with rheumatoid arthritis
4987205|NCT01692899|in Daily Practice.|in daily practice.
4987206|NCT01692899|TNF inhibitors|tnf inhibitors
4987207|NCT01692899|biotherapy|biotherapy
4987208|NCT01692899|retrospective study|retrospective study
4987209|NCT01692886|13vPnC|13vpnc
4987210|NCT01692886|7vPnC|7vpnc
4987211|NCT01692886|Healthy subjects|healthy subjects
4987212|NCT01692886|China|china
4987213|NCT01692873|pancreatic tumor|pancreatic tumor
4987214|NCT01692860|the impact of a higher dairy-based protein diet in|the impact of a higher dairy-based protein diet in
4987215|NCT01692860|combination with energy restriction on muscle health,|combination with energy restriction on muscle health,
4987216|NCT01692860|metabolic health (including blood pressure) in overweight|metabolic health (including blood pressure) in overweight
4987217|NCT01692860|and obese, middle aged adults|and obese, middle aged adults
4987218|NCT01692847|patient deterioration|patient deterioration
4987219|NCT01692847|rapid response teams|rapid response teams
4987220|NCT01692847|acute care teams|acute care teams
4987221|NCT01692847|early warning scoring|early warning scoring
4987222|NCT01692834|bioequivalence|bioequivalence
4987223|NCT01692834|pharmacokinetics|pharmacokinetics
4987224|NCT01692834|tolerability|tolerability
4987225|NCT01692834|safety|safety
4987226|NCT01692834|ciclosporin|ciclosporin
4987227|NCT01692834|cyclosporine|cyclosporine
4987228|NCT01692834|cyclosporine A|cyclosporine a
4987229|NCT01692834|Sandimmune|sandimmune
4987230|NCT01692834|Sandimmun|sandimmun
4987231|NCT01692834|CicloMulsion|ciclomulsion
4987232|NCT01692834|NeuroSTAT|neurostat
4987233|NCT01692821|retinal oxygen saturation|retinal oxygen saturation
4987234|NCT01692821|retinal blood flow|retinal blood flow
4987235|NCT01692821|hyperoxia|hyperoxia
4987236|NCT01692821|hypoxia|hypoxia
4987237|NCT01692808|Crohn|crohn
4987238|NCT01692808|vitamin D|vitamin d
4987239|NCT01692808|remission|remission
4987240|NCT01692808|inflammation|inflammation
4987241|NCT01692808|tolerance|tolerance
4987242|NCT01692795|Myocardial infarction|myocardial infarction
4987243|NCT01692795|Antiplatelets|antiplatelets
4987244|NCT01692795|Lipid lowering agents|lipid lowering agents
4987245|NCT01692795|ACE inhibitors|ace inhibitors
4987246|NCT01692795|Angiotensin Receptor Blockers|angiotensin receptor blockers
4987247|NCT01692795|Beta blockers|beta blockers
4987248|NCT01692795|Blood pressure lowering drugs|blood pressure lowering drugs
4987249|NCT01692782|ADHD|adhd
4987250|NCT01692782|Attention deficit hyperactivity disorder|attention deficit hyperactivity disorder
4987251|NCT01692769|Trauma|trauma
4987252|NCT01692769|Pediatric|pediatric
4987253|NCT01692769|Intravenous Fluid|intravenous fluid
4987254|NCT01692769|Normal Saline|normal saline
4987255|NCT01692769|Ringer's Lactate|ringer's lactate
4987256|NCT01692743|Telemedicine|telemedicine
4987257|NCT01692743|Inflammatory bowel disease|inflammatory bowel disease
4987258|NCT01692743|Crohn's disease|crohn's disease
4987259|NCT01692743|Ulcerative colitis|ulcerative colitis
4987260|NCT01692743|Quality of life|quality of life
4987261|NCT01692743|Health care utilization|health care utilization
4987262|NCT01692730|Smoking Cessation|smoking cessation
4987263|NCT01692730|Web Assisted Tobacco Intervention|web assisted tobacco intervention
4987264|NCT01692691|Melanoma Metastatic|melanoma metastatic
4987265|NCT01692678|Advanced or Metastatic liposarcoma or leiomyosarcoma|advanced or metastatic liposarcoma or leiomyosarcoma
4987266|NCT01692678|Sarcoma|sarcoma
4987267|NCT01692678|L-sarcoma|l-sarcoma
4987268|NCT01692678|Liposarcoma|liposarcoma
4987269|NCT01692678|Leiomyosarcoma|leiomyosarcoma
4987270|NCT01692678|Trabectedin|trabectedin
4987271|NCT01692678|Dacarbazine|dacarbazine
4987272|NCT01692678|Yondelis|yondelis
4987273|NCT01692678|Chinese patients|chinese patients
4987274|NCT01692678|Overall survival|overall survival
4987275|NCT01692678|Pharmacokinetics|pharmacokinetics
4987276|NCT01692665|meibomian gland dysfunction|meibomian gland dysfunction
4987277|NCT01692665|keratometric value|keratometric value
4987278|NCT01692665|ocular aberration|ocular aberration
4987279|NCT01692626|Cetuximab rash|cetuximab rash
4987280|NCT01692626|Erbitux rash|erbitux rash
4987281|NCT01692626|Rash|rash
4987282|NCT01692626|Pimecrolimus|pimecrolimus
4987283|NCT01692626|1% Topical pimecrolimus cream|1% topical pimecrolimus cream
4987284|NCT01692600|Late oral radiation toxicity|late oral radiation toxicity
4987285|NCT01692600|head and neck cancer patients|head and neck cancer patients
4987286|NCT01692600|optical coherence tomography|optical coherence tomography
4987287|NCT01692600|subsurface imaging|subsurface imaging
4987288|NCT01692600|mirometer-resolution imaging|mirometer-resolution imaging
4987289|NCT01692600|vascular imaging|vascular imaging
4987290|NCT01692600|Doppler optical coherence tomography|doppler optical coherence tomography
4987291|NCT01692600|speckle variance optical coherence tomography|speckle variance optical coherence tomography
4987292|NCT01692587|PSA|psa
4987293|NCT01692587|protein|protein
4987294|NCT01692587|prostate|prostate
4987295|NCT01692574|depression and obesity treatment|depression and obesity treatment
4987296|NCT01692561|Dysautonomia|dysautonomia
4987297|NCT01692561|Postural orthostatic tachycardic hypotension|postural orthostatic tachycardic hypotension
4987298|NCT01692561|Neurocardiogenic vasovagal syncope|neurocardiogenic vasovagal syncope
4987299|NCT01692509|Non invasive ventilation|non invasive ventilation
4987300|NCT01692509|Respiratory failure|respiratory failure
4987301|NCT01692509|Respiratory comfort|respiratory comfort
4987302|NCT01692496|Advanced|advanced
4987303|NCT01692496|Metastatic|metastatic
4987304|NCT01692496|Liposarcoma|liposarcoma
4987305|NCT01692496|Pazopanib|pazopanib
4987306|NCT01692483|Prostate neoplasms|prostate neoplasms
4987307|NCT01692483|Prostate cancer|prostate cancer
4987308|NCT01692483|Castration resistant prostate cancer|castration resistant prostate cancer
4987309|NCT01692483|Hormone refractory prostate cancer|hormone refractory prostate cancer
4987310|NCT01692483|Abiraterone acetate|abiraterone acetate
4987311|NCT01692483|Taxane|taxane
4987312|NCT01692470|Human immunodeficiency virus type 1 (HIV-1) infection|human immunodeficiency virus type 1 (hiv-1) infection
4987313|NCT01692470|HIV-1|hiv-1
4987314|NCT01692470|Anti-retroviral naive|anti-retroviral naive
4987315|NCT01692470|ARV|arv
4987316|NCT01692470|Filipino patients|filipino patients
4987317|NCT01692470|Rilpivirine hydrochloride|rilpivirine hydrochloride
4987318|NCT01692470|Edurant|edurant
4987319|NCT01692457|Rheumatoid Arthritis|rheumatoid arthritis
4987320|NCT01692457|Psoriatic Arthritis|psoriatic arthritis
4987321|NCT01692457|Ankylosing Spondylitis|ankylosing spondylitis
4987322|NCT01692457|Arthritis|arthritis
4987323|NCT01692457|Spondylitis|spondylitis
4987324|NCT01692457|Joint pain|joint pain
4987325|NCT01692457|CNTO148|cnto148
4987326|NCT01692457|Golimumab|golimumab
4987327|NCT01692457|Simponi|simponi
4987328|NCT01692457|Filipino|filipino
4987329|NCT01692457|Post-Marketing|post-marketing
4987330|NCT01692457|Surveillance|surveillance
4987331|NCT01692444|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
4987332|NCT01692444|Fibrosis|fibrosis
4987333|NCT01692444|Fibroblast|fibroblast
4987334|NCT01692444|Lung attenuation|lung attenuation
4987335|NCT01692444|Pletysmography|pletysmography
4987336|NCT01692418|Anaemia|anaemia
4987337|NCT01692418|Blood transfusion|blood transfusion
4987338|NCT01692418|Surgery|surgery
4987339|NCT01692418|Iron|iron
4987340|NCT01692418|Ferric carboxymaltose|ferric carboxymaltose
4987341|NCT01692392|Pectus carinatum|pectus carinatum
4987342|NCT01692392|Quality of life|quality of life
4987343|NCT01692392|Pain, postoperative|pain, postoperative
4987344|NCT01692392|Somatosensory disorders|somatosensory disorders
4987345|NCT01692379|Acute ischemic stroke|acute ischemic stroke
4987346|NCT01692379|endovascular treatment|endovascular treatment
4987347|NCT01692379|clinical trial|clinical trial
4987348|NCT01692353|Flow mediated dilation|flow mediated dilation
4987349|NCT01692353|Carotid intima-media thickness|carotid intima-media thickness
4987350|NCT01692353|Ankle-brachial index|ankle-brachial index
4987351|NCT01692353|Smokeless tobacco|smokeless tobacco
4987352|NCT01692353|Biological markers|biological markers
4987353|NCT01692353|Nicotine|nicotine
4987354|NCT01692353|Tobacco-specific nitrosamines|tobacco-specific nitrosamines
4987355|NCT01692353|Polycyclic aromatic hydrocarbons|polycyclic aromatic hydrocarbons
4987356|NCT01692353|Aromatic amines|aromatic amines
4987357|NCT01692353|Mercapturic acid metabolites|mercapturic acid metabolites
4987358|NCT01692353|Cholesterol|cholesterol
4987359|NCT01692353|Blood lipids|blood lipids
4987360|NCT01692353|Oxidative stress|oxidative stress
4987361|NCT01692353|Inflammation|inflammation
4987362|NCT01692353|Cytokines|cytokines
4987363|NCT01692340|tomato|tomato
4987364|NCT01692340|prostate cancer|prostate cancer
4987365|NCT01692340|metabolism|metabolism
4987366|NCT01692327|glucose intolerance (20)|glucose intolerance (20)
4987367|NCT01692327|Control (20)|control (20)
4987368|NCT01692314|Endothelial function|endothelial function
4987369|NCT01692314|Microvascular reactivity|microvascular reactivity
4987370|NCT01692314|Obesity|obesity
4987371|NCT01692314|Adolescents|adolescents
4987372|NCT01692301|hypertension, elderly, central aortic pulse pressure, central pulse pressure, pulse wave velocity|hypertension, elderly, central aortic pulse pressure, central pulse pressure, pulse wave velocity
4987373|NCT01692262|Metastatic Castrate-Resistant Prostate Cancer (mCRPC),|metastatic castrate-resistant prostate cancer (mcrpc),
4987374|NCT01692262|adenocarcinoma of the prostate,|adenocarcinoma of the prostate,
4987375|NCT01692262|prostate cancer,|prostate cancer,
4987376|NCT01692262|progressive disease,|progressive disease,
4987377|NCT01692262|advanced disease.|advanced disease.
4987378|NCT01692249|chronic shoulder pain|chronic shoulder pain
4987379|NCT01692249|rotator cuff tendinopathy|rotator cuff tendinopathy
4987380|NCT01692249|sap therapy|sap therapy
4987381|NCT01692249|balneotherapy|balneotherapy
4987382|NCT01692236|MRI|mri
4987383|NCT01692236|HIV|hiv
4987384|NCT01692236|Neurocognitive Disorders|neurocognitive disorders
4987385|NCT01692236|Major Depression|major depression
4987386|NCT01692236|Vasculopathy|vasculopathy
4987387|NCT01692223|Personal genomics|personal genomics
4987388|NCT01692223|Genome Sequencing Results|genome sequencing results
4987389|NCT01692223|12-167|12-167
4987390|NCT01692210|Breast Cancer|breast cancer
4987391|NCT01692210|Dexmedetomidine|dexmedetomidine
4987392|NCT01692210|Unilateral mastectomy|unilateral mastectomy
4987393|NCT01692210|Blood sample collections|blood sample collections
4987394|NCT01692210|Immune system|immune system
4987395|NCT01692210|White blood cell levels|white blood cell levels
4987396|NCT01692197|Leukemia|leukemia
4987397|NCT01692197|Acute Myeloid Leukemia|acute myeloid leukemia
4987398|NCT01692197|Acute Myelogenous Leukemia|acute myelogenous leukemia
4987399|NCT01692197|AML|aml
4987400|NCT01692197|Relapsed or Refractory|relapsed or refractory
4987401|NCT01692197|High-Risk Myelodysplastic Syndromes|high-risk myelodysplastic syndromes
4987402|NCT01692197|HRMDS|hrmds
4987403|NCT01692197|E7070|e7070
4987404|NCT01692197|Idarubicin|idarubicin
4987405|NCT01692197|Idamycin|idamycin
4987406|NCT01692197|Cytarabine|cytarabine
4987407|NCT01692197|Cytarabine (ARA-C)|cytarabine (ara-c)
4987408|NCT01692197|Cytosar|cytosar
4987409|NCT01692197|DepoCyt|depocyt
4987410|NCT01692197|Cytosine Arabinosine Hydrochloride|cytosine arabinosine hydrochloride
4987411|NCT01692197|Dexamethasone|dexamethasone
4987412|NCT01692197|Decadron|decadron
4987413|NCT01692184|AVL-292|avl-292
4987414|NCT01692184|Safety|safety
4987415|NCT01692184|Pharmacokinetics|pharmacokinetics
4987416|NCT01692184|Pharmacodynamics|pharmacodynamics
4987417|NCT01692184|Pharmacology, Clinical|pharmacology, clinical
4987418|NCT01692171|Subjects|subjects
4987419|NCT01692158|subjects|subjects
4987420|NCT01692145|Dry eye syndromes|dry eye syndromes
4987421|NCT01692145|Corneal diseases|corneal diseases
4987422|NCT01692145|Conjunctival diseases|conjunctival diseases
4987423|NCT01692132|Chronic Constipation|chronic constipation
4987424|NCT01692132|Prucalopride|prucalopride
4987425|NCT01692132|Post Marketing Surveillance|post marketing surveillance
4987426|NCT01692119|chronic heart failure|chronic heart failure
4987427|NCT01692119|medication adherence|medication adherence
4987428|NCT01692119|pharmacy|pharmacy
4987429|NCT01692119|interdisciplinary care|interdisciplinary care
4987430|NCT01692119|randomized controlled trial|randomized controlled trial
4987431|NCT01692119|mortality|mortality
4987432|NCT01692119|hospitalization|hospitalization
4987433|NCT01692106|Heller myotomy|heller myotomy
4987434|NCT01692093|SCORAD|scorad
4987435|NCT01692093|Atopic dermatits|atopic dermatits
4987436|NCT01692093|Skin health|skin health
4987437|NCT01692067|Rape|rape
4987438|NCT01692067|Women|women
4987439|NCT01692067|Military|military
4987440|NCT01692067|Veterans|veterans
4987441|NCT01692067|Post-traumatic Stress Disorder|post-traumatic stress disorder
4987442|NCT01692067|Traumatic Brain Injury|traumatic brain injury
4987443|NCT01692041|asthma|asthma
4987444|NCT01692041|children|children
4987445|NCT01692028|vitamin D|vitamin d
4987446|NCT01692028|Associational study|associational study
4987447|NCT01691976|Mild cognitive impairment|mild cognitive impairment
4987448|NCT01691976|Androgen deprivation therapy|androgen deprivation therapy
4987449|NCT01691963|Epiglottis|epiglottis
4987450|NCT01691963|Intubation|intubation
4987451|NCT01691963|Laryngoscopy|laryngoscopy
4987452|NCT01691950|Trauma|trauma
4987453|NCT01691950|Limb reconstruction|limb reconstruction
4987454|NCT01691950|Amputation|amputation
4987455|NCT01691950|Functional outcome|functional outcome
4987456|NCT01691950|Sensing|sensing
4987457|NCT01691937|Thoracic paravertebral block|thoracic paravertebral block
4987458|NCT01691937|Postoperative pain|postoperative pain
4987459|NCT01691937|Right lobe hepatectomy|right lobe hepatectomy
4987460|NCT01691937|Patient controlled analgesia|patient controlled analgesia
4987461|NCT01691924|Adenosine A2a receptor antagonist|adenosine a2a receptor antagonist
4987462|NCT01691924|adenosine receptor modulator|adenosine receptor modulator
4987463|NCT01691924|Cancer|cancer
4987464|NCT01691911|Vascular disease|vascular disease
4987465|NCT01691911|Open aortic aneurysm repair|open aortic aneurysm repair
4987466|NCT01691911|Endovascular aneurysm repair|endovascular aneurysm repair
4987467|NCT01691911|Carotid endartrectomy|carotid endartrectomy
4987468|NCT01691911|Lower limb surgical revascularisation|lower limb surgical revascularisation
4987469|NCT01691911|Major lower limb amputation|major lower limb amputation
4987470|NCT01691859|extension study|extension study
4987471|NCT01691859|Severe refractory asthma|severe refractory asthma
4987472|NCT01691859|safety|safety
4987473|NCT01691859|SB-240563|sb-240563
4987474|NCT01691859|mepolizumab|mepolizumab
4987475|NCT01691859|eosinophils|eosinophils
4987476|NCT01691833|Vitamin D|vitamin d
4987477|NCT01691833|nonunion|nonunion
4987478|NCT01691833|long bone fracture|long bone fracture
4987479|NCT01691833|hypovitaminosis D|hypovitaminosis d
4987480|NCT01691820|Adolescent females|adolescent females
4987481|NCT01691820|Cytomegalovirus (CMV)|cytomegalovirus (cmv)
4987482|NCT01691807|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
4987483|NCT01691807|drug-drug interaction|drug-drug interaction
4987484|NCT01691807|ofatumumab|ofatumumab
4987485|NCT01691807|bendamustine|bendamustine
4987486|NCT01691781|Hyperparathyroidism|hyperparathyroidism
4987487|NCT01691781|Renin-angiotensin-aldosterone system|renin-angiotensin-aldosterone system
4987488|NCT01691781|ACE inhibitors|ace inhibitors
4987489|NCT01691768|microbicides|microbicides
4987490|NCT01691768|women|women
4987491|NCT01691768|HIV prevention|hiv prevention
4987492|NCT01691768|PrEP|prep
4987493|NCT01691768|Tenofovir gel|tenofovir gel
4987494|NCT01691742|Postoperative constipation|postoperative constipation
4987495|NCT01691742|Urogynecologic Surgery|urogynecologic surgery
4987496|NCT01691742|MiraLax|miralax
4987497|NCT01691742|Docusate Sodium|docusate sodium
4987498|NCT01691716|Achilles tendinopathy|achilles tendinopathy
4987499|NCT01691716|Tendoactive|tendoactive
4987500|NCT01691716|Eccentric training|eccentric training
4987501|NCT01691703|Fiber Optic Technology/methods|fiber optic technology/methods
4987502|NCT01691703|Intubation, Intratracheal/methods|intubation, intratracheal/methods
4987503|NCT01691703|Laryngoscopy/methods|laryngoscopy/methods
4987504|NCT01691664|Esophageal Cancer|esophageal cancer
4987505|NCT01691664|DC-CIK|dc-cik
4987506|NCT01691664|immunotherapy|immunotherapy
4987507|NCT01691664|cellular therapy|cellular therapy
4987508|NCT01691664|radiation therapy|radiation therapy
4987509|NCT01691651|Keratoconus|keratoconus
4987510|NCT01691651|Tetanus toxin|tetanus toxin
4987511|NCT01691625|Locally advanced esophageal carcinoma|locally advanced esophageal carcinoma
4987512|NCT01691625|DC-CIK|dc-cik
4987513|NCT01691625|Immunotherapy|immunotherapy
4987514|NCT01691612|Role of Pin-1 enzyme in Asthma|role of pin-1 enzyme in asthma
4987515|NCT01691599|Infection|infection
4987516|NCT01691599|Open tibia fractures|open tibia fractures
4987517|NCT01691599|Closed tibia fractures|closed tibia fractures
4987518|NCT01691599|Wound infection|wound infection
4987519|NCT01691586|implantable defibrillators|implantable defibrillators
4987520|NCT01691586|remote patient monitoring|remote patient monitoring
4987521|NCT01691586|patient-reported outcomes|patient-reported outcomes
4987522|NCT01691586|cost-effectiveness|cost-effectiveness
4987523|NCT01691573|ablation|ablation
4987524|NCT01691573|procedure|procedure
4987525|NCT01691573|pediatric|pediatric
4987526|NCT01691573|european|european
4987527|NCT01691573|cardiac|cardiac
4987528|NCT01691573|arrhythmias|arrhythmias
4987529|NCT01691573|registry|registry
4987530|NCT01691573|observational|observational
4987531|NCT01691573|prospective|prospective
4987532|NCT01691573|catheter|catheter
4987533|NCT01691573|cryoablation|cryoablation
4987534|NCT01691573|atrioventricular|atrioventricular
4987535|NCT01691547|GW642444 (Vilanterol)|gw642444 (vilanterol)
4987536|NCT01691547|pharmacokinetics|pharmacokinetics
4987537|NCT01691547|pharmacodynamics|pharmacodynamics
4987538|NCT01691547|GSK573719 (Umeclidinium)|gsk573719 (umeclidinium)
4987539|NCT01691547|healthy subjects|healthy subjects
4987540|NCT01691547|GW685698 (Fluticasone Furoate)|gw685698 (fluticasone furoate)
4987541|NCT01691534|Tuberculosis|tuberculosis
4987542|NCT01691534|EBA|eba
4987543|NCT01691534|PA824|pa824
4987544|NCT01691534|pretomanid|pretomanid
4987545|NCT01691534|TMC207|tmc207
4987546|NCT01691521|safety|safety
4987547|NCT01691521|SB-240563|sb-240563
4987548|NCT01691521|efficacy|efficacy
4987549|NCT01691521|placebo|placebo
4987550|NCT01691521|eosinophils|eosinophils
4987551|NCT01691521|mepolizumab|mepolizumab
4987552|NCT01691521|Severe refractory asthma|severe refractory asthma
4987553|NCT01691508|Safety|safety
4987554|NCT01691508|Steroid Reduction|steroid reduction
4987555|NCT01691508|Efficacy|efficacy
4987556|NCT01691508|SB-240563|sb-240563
4987557|NCT01691508|Eosinophils|eosinophils
4987558|NCT01691508|Quality of Life|quality of life
4987559|NCT01691508|Mepolizumab|mepolizumab
4987560|NCT01691508|Severe Refractory Asthma|severe refractory asthma
4987561|NCT01691495|Physician Adherence|physician adherence
4987562|NCT01691495|superficial vein thrombosis|superficial vein thrombosis
4987563|NCT01691495|Fondaparinux|fondaparinux
4987564|NCT01691469|Bioequivalence|bioequivalence
4987565|NCT01691469|Montelukast Sodium|montelukast sodium
4987566|NCT01691469|crossover|crossover
4987567|NCT01691456|Bioequivalence|bioequivalence
4987568|NCT01691456|Montelukast Sodium|montelukast sodium
4987569|NCT01691456|crossover|crossover
4987570|NCT01691404|Flavonoids|flavonoids
4987571|NCT01691404|Quercetin|quercetin
4987572|NCT01691404|Epicatechin|epicatechin
4987573|NCT01691404|Vascular function|vascular function
4987574|NCT01691404|Blood pressure|blood pressure
4987575|NCT01691404|Endothelial function|endothelial function
4987576|NCT01691391|Advanced CRC|advanced crc
4987577|NCT01691378|Veterans|veterans
4987578|NCT01691378|Window to Hope|window to hope
4987579|NCT01691378|Cognitive Behavioral Therapy|cognitive behavioral therapy
4987580|NCT01691378|Traumatic Brain Injury|traumatic brain injury
4987581|NCT01691378|Hopelessness|hopelessness
4987582|NCT01691378|Suicide|suicide
4987583|NCT01691365|Antioxidant|antioxidant
4987584|NCT01691365|vitamins|vitamins
4987585|NCT01691365|Diet|diet
4987586|NCT01691352|Wound infection|wound infection
4987587|NCT01691352|Ostomy reversal|ostomy reversal
4987588|NCT01691339|Influenza|influenza
4987589|NCT01691339|Influenza virus vaccine|influenza virus vaccine
4987590|NCT01691339|Fluzone® (Influenza Virus Vaccine) 2012-2013 Formulation|fluzone® (influenza virus vaccine) 2012-2013 formulation
4987591|NCT01691339|Fluzone® High-Dose (Influenza Virus Vaccine) 2012-2013 Formulation|fluzone® high-dose (influenza virus vaccine) 2012-2013 formulation
4987592|NCT01691339|Trivalent Inactivated Influenza Vaccine|trivalent inactivated influenza vaccine
4987593|NCT01691339|Fluzone® Intradermal (Influenza Virus Vaccine) 2012-2013 Formulation|fluzone® intradermal (influenza virus vaccine) 2012-2013 formulation
4987594|NCT01691326|Influenza|influenza
4987595|NCT01691326|Fluzone® (Influenza Virus Vaccine) 2012-2013 Formulation|fluzone® (influenza virus vaccine) 2012-2013 formulation
4987596|NCT01691326|Influenza virus vaccine|influenza virus vaccine
4987597|NCT01691326|Trivalent Inactivated Influenza Vaccine|trivalent inactivated influenza vaccine
4987598|NCT01691313|vanoxerine|vanoxerine
4987599|NCT01691313|atrial fibrillation|atrial fibrillation
4987600|NCT01691313|atrial flutter|atrial flutter
4987601|NCT01691313|a-fib|a-fib
4987602|NCT01691300|C11-acetate PET/CT|c11-acetate pet/ct
4987603|NCT01691300|Multiple myeloma|multiple myeloma
4987604|NCT01691300|Pretreatment staging|pretreatment staging
4987605|NCT01691300|Response assessment|response assessment
4987606|NCT01691287|Type 1 Diabetes|type 1 diabetes
4987607|NCT01691287|Metabolic Control|metabolic control
4987608|NCT01691287|Quality of Life|quality of life
4987609|NCT01691274|Epilepsy|epilepsy
4987610|NCT01691274|Phase 1|phase 1
4987611|NCT01691274|Multiple Dose|multiple dose
4987612|NCT01691274|Safety|safety
4987613|NCT01691274|Pharmacokinetics|pharmacokinetics
4987614|NCT01691274|Toleration|toleration
4987615|NCT01691248|Clostridium difficile|clostridium difficile
4987616|NCT01691248|Clostridium difficile-Associated Diarrhea|clostridium difficile-associated diarrhea
4987617|NCT01691248|Prophylaxis|prophylaxis
4987618|NCT01691248|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
4987619|NCT01691235|SIMpill|simpill
4987620|NCT01691235|HCV|hcv
4987621|NCT01691235|Chronic Hepatitis C Virus|chronic hepatitis c virus
4987622|NCT01691222|Bedside percutaneous tracheostomy|bedside percutaneous tracheostomy
4987623|NCT01691222|Intensive Care Unit|intensive care unit
4987624|NCT01691222|Dedicated Double-lumen tube|dedicated double-lumen tube
4987625|NCT01691222|Ineffective Airway Clearance|ineffective airway clearance
4987626|NCT01691222|weaning failure|weaning failure
4987627|NCT01691209|Phoenix|phoenix
4987628|NCT01691209|Hydrocortison|hydrocortison
4987629|NCT01691209|mild atopic dermatitis|mild atopic dermatitis
4987630|NCT01691209|efficacy|efficacy
4987631|NCT01691209|safety|safety
4987632|NCT01691196|Obesity|obesity
4987633|NCT01691196|Peritoneal dialysis|peritoneal dialysis
4987634|NCT01691196|Inflammation|inflammation
4987635|NCT01691196|Macrophages|macrophages
4987636|NCT01691196|Innate immunity|innate immunity
4987637|NCT01691183|Hertel|hertel
4987638|NCT01691183|exophthalmometer|exophthalmometer
4987639|NCT01691183|proptosis|proptosis
4987640|NCT01691183|eye disease|eye disease
4987641|NCT01691170|Pattelofemoral pain syndrome|pattelofemoral pain syndrome
4987642|NCT01691170|Stretching|stretching
4987643|NCT01691170|Strengthening|strengthening
4987644|NCT01691157|Subacromial impingement syndrome|subacromial impingement syndrome
4987645|NCT01691157|Rotator cuff|rotator cuff
4987646|NCT01691157|Exercise|exercise
4987647|NCT01691157|Physiotherapy|physiotherapy
4987648|NCT01691144|cancer|cancer
4987649|NCT01691144|gynecological|gynecological
4987650|NCT01691144|expectations|expectations
4987651|NCT01691144|satisfaction|satisfaction
4987652|NCT01691144|cooperation|cooperation
4987653|NCT01691131|Physical activity in daily life|physical activity in daily life
4987654|NCT01691131|Balance|balance
4987655|NCT01691131|COPD|copd
4987656|NCT01691131|Exercise training|exercise training
4987657|NCT01691118|Hypertension|hypertension
4987658|NCT01691118|Angiotensin Receptor Blocker|angiotensin receptor blocker
4987659|NCT01691118|Diastolic Dysfunction|diastolic dysfunction
4987660|NCT01691105|Tobacco Use Cessation|tobacco use cessation
4987661|NCT01691105|Smoking Cessation|smoking cessation
4987662|NCT01691105|Nicotine Replacement Therapy|nicotine replacement therapy
4987663|NCT01691105|Hospitalized Smokers|hospitalized smokers
4987664|NCT01691092|Depression|depression
4987665|NCT01691092|Ketamine|ketamine
4987666|NCT01691092|PET|pet
4987667|NCT01691092|PTSD|ptsd
4987668|NCT01691053|End stage renal disease|end stage renal disease
4987669|NCT01691053|Hemodialysis|hemodialysis
4987670|NCT01691053|Spironolactone|spironolactone
4987671|NCT01691053|Left ventricular hypertrophy|left ventricular hypertrophy
4987672|NCT01691040|Hepcidin|hepcidin
4987673|NCT01691040|Iron|iron
4987674|NCT01691040|Anemia of Chronic Disease|anemia of chronic disease
4987675|NCT01691040|Anemia|anemia
4987676|NCT01691040|Cancer|cancer
4987677|NCT01691040|Interleukin-6|interleukin-6
4987678|NCT01691040|Iron restriction|iron restriction
4987679|NCT01691040|Lymphoma|lymphoma
4987680|NCT01691040|CLL|cll
4987681|NCT01691040|Multiple Myeloma|multiple myeloma
4987682|NCT01691040|Hodgkin|hodgkin
4987683|NCT01691040|anti-hepcidin|anti-hepcidin
4987684|NCT01691027|scotoma, central|scotoma, central
4987685|NCT01691027|visual motor coordination|visual motor coordination
4987686|NCT01690988|Delirium|delirium
4987687|NCT01690988|ketamine|ketamine
4987688|NCT01690988|surgery|surgery
4987689|NCT01690988|neurological complications|neurological complications
4987690|NCT01690962|diabetic neuropathy, diet, vegan, vegetarian|diabetic neuropathy, diet, vegan, vegetarian
4987691|NCT01690949|inflammation|inflammation
4987692|NCT01690949|COPD|copd
4987693|NCT01690949|respiratory disease|respiratory disease
4987694|NCT01690949|healthy volunteers|healthy volunteers
4987695|NCT01690936|Almonds|almonds
4987696|NCT01690936|Body weight|body weight
4987697|NCT01690936|Snacking|snacking
4987698|NCT01690910|Ventilator|ventilator
4987699|NCT01690910|Mobility Limitations|mobility limitations
4987700|NCT01690910|Critical Care|critical care
4987701|NCT01690910|Rifton Gait Trainer|rifton gait trainer
4987702|NCT01690897|Female sexual desire|female sexual desire
4987703|NCT01690897|Psychoeducational intervention|psychoeducational intervention
4987704|NCT01690897|Mindfulness|mindfulness
4987705|NCT01690884|Adenosine|adenosine
4987706|NCT01690884|Ticagrelor|ticagrelor
4987707|NCT01690884|Microdialysis|microdialysis
4987708|NCT01690871|Malignant PEComa|malignant pecoma
4987709|NCT01690871|Angiomyolipoma|angiomyolipoma
4987710|NCT01690871|Tuberous Sclerosis Complex|tuberous sclerosis complex
4987711|NCT01690871|Pi3kinase /m-tor inhibitors|pi3kinase /m-tor inhibitors
4987712|NCT01690858|Foetal loss|foetal loss
4987713|NCT01690858|complement|complement
4987714|NCT01690858|antiangiogenic factors|antiangiogenic factors
4987715|NCT01690858|Repeated fetal losses|repeated fetal losses
4987716|NCT01690832|Contrast induced acute kidney injury|contrast induced acute kidney injury
4987717|NCT01690819|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
4987718|NCT01690819|Acute Brain Injury|acute brain injury
4987719|NCT01690793|ASTHMA|asthma
4987720|NCT01690793|ACUTE EXACERBATION OF ASTHMA|acute exacerbation of asthma
4987721|NCT01690780|fracture|fracture
4987722|NCT01690780|pediatric|pediatric
4987723|NCT01690780|oral morphine|oral morphine
4987724|NCT01690780|ibuprofen|ibuprofen
4987725|NCT01690767|Urethral catheterization|urethral catheterization
4987726|NCT01690767|Lidocaine|lidocaine
4987727|NCT01690754|SMS|sms
4987728|NCT01690754|tuberculosis|tuberculosis
4987729|NCT01690754|impact evaluation|impact evaluation
4987730|NCT01690741|Cancer|cancer
4987731|NCT01690741|Malignancy|malignancy
4987732|NCT01690741|Solid tumors|solid tumors
4987733|NCT01690728|Obesity|obesity
4987734|NCT01690728|Gastric bypass|gastric bypass
4987735|NCT01690715|Hepatocellular Carcinoma|hepatocellular carcinoma
4987736|NCT01690715|Thrombosis|thrombosis
4987737|NCT01690715|Portal Vein Invasion|portal vein invasion
4987738|NCT01690702|breast cancer|breast cancer
4987739|NCT01690702|tailored|tailored
4987740|NCT01690702|high-risk|high-risk
4987741|NCT01690676|FMD|fmd
4987742|NCT01690676|epicatechin|epicatechin
4987743|NCT01690676|apple polyphenol|apple polyphenol
4987744|NCT01690676|borderline hypertension|borderline hypertension
4987745|NCT01690650|Preterm|preterm
4987746|NCT01690650|Newborn|newborn
4987747|NCT01690650|Neonate|neonate
4987748|NCT01690650|Cerebral oxygenation|cerebral oxygenation
4987749|NCT01690650|Oxygen|oxygen
4987750|NCT01690637|Oseltamivir|oseltamivir
4987751|NCT01690637|Tamiflu|tamiflu
4987752|NCT01690611|Balance Training|balance training
4987753|NCT01690611|Walking|walking
4987754|NCT01690611|Falls|falls
4988973|NCT01685060|ALK|alk
4987755|NCT01690598|Epithelial ovarian cancer|epithelial ovarian cancer
4987756|NCT01690598|BRCA mutation|brca mutation
4987757|NCT01690598|Platinum resistant|platinum resistant
4987758|NCT01690598|Platinum sensitive|platinum sensitive
4987759|NCT01690598|Relapsed ovarian cancer|relapsed ovarian cancer
4987760|NCT01690572|drug eluting balloon|drug eluting balloon
4987761|NCT01690572|constrictive remodeling|constrictive remodeling
4987762|NCT01690559|Ciprofloxacin|ciprofloxacin
4987763|NCT01690559|sepsis|sepsis
4987764|NCT01690559|infection|infection
4987765|NCT01690559|pneumonia|pneumonia
4987766|NCT01690559|peritonitis|peritonitis
4987767|NCT01690559|cholecystitis|cholecystitis
4987768|NCT01690559|cholangitis|cholangitis
4987769|NCT01690559|anthrax|anthrax
4987770|NCT01690546|Opioid Addiction|opioid addiction
4987771|NCT01690546|Addiction|addiction
4987772|NCT01690546|Drug Dependence|drug dependence
4987773|NCT01690533|Avelox|avelox
4987774|NCT01690533|Laryngopharyngitis|laryngopharyngitis
4987775|NCT01690533|Tonsillitis|tonsillitis
4987776|NCT01690533|Bronchitis acute|bronchitis acute
4987777|NCT01690533|Pneumonia|pneumonia
4987778|NCT01690533|Secondary infection in chronic respiratory diseases Sinusitis|secondary infection in chronic respiratory diseases sinusitis
4987779|NCT01690507|demethylating agent|demethylating agent
4987780|NCT01690507|immunogenicity|immunogenicity
4987781|NCT01690494|STI|sti
4987782|NCT01690494|sexually transmitted infection|sexually transmitted infection
4987783|NCT01690494|HIV|hiv
4987784|NCT01690494|criminal justice|criminal justice
4987785|NCT01690494|probation|probation
4987786|NCT01690494|couples|couples
4987787|NCT01690494|drug use|drug use
4987788|NCT01690442|HIV|hiv
4987789|NCT01690442|AIDS|aids
4987790|NCT01690442|Prevention|prevention
4987791|NCT01690429|Arousal detection|arousal detection
4987792|NCT01690429|Pulse Wave Amplitude|pulse wave amplitude
4987793|NCT01690429|Obstructive Sleep Apnea|obstructive sleep apnea
4987794|NCT01690429|Daytime sleepiness|daytime sleepiness
4987795|NCT01690429|Cardiorespiratory risk|cardiorespiratory risk
4987796|NCT01690377|Dendritic Cells|dendritic cells
4987797|NCT01690364|Motor evoked potential monitoring|motor evoked potential monitoring
4987798|NCT01690364|General Anesthesia|general anesthesia
4987799|NCT01690364|Neurosurgery|neurosurgery
4987800|NCT01690364|Cisatracurium|cisatracurium
4987801|NCT01690364|Vecuronium|vecuronium
4987802|NCT01690338|TOFr (train of four ratio)|tofr (train of four ratio)
4987803|NCT01690338|airway extubation|airway extubation
4987804|NCT01690338|PACU (postanesthesia care unit)|pacu (postanesthesia care unit)
4987805|NCT01690338|PORC (postoperative residual curarization)|porc (postoperative residual curarization)
4987806|NCT01690325|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
4987807|NCT01690325|Neoadjuvant cytotoxic-antiangiogenic therapy|neoadjuvant cytotoxic-antiangiogenic therapy
4987808|NCT01690325|Bevacizumab|bevacizumab
4987809|NCT01690325|PET|pet
4987810|NCT01690312|Humans|humans
4987811|NCT01690312|Cardiovascular Disease|cardiovascular disease
4987812|NCT01690312|Statins|statins
4987813|NCT01690312|Fish Oil|fish oil
4987814|NCT01690312|DHA|dha
4987815|NCT01690312|EPA|epa
4987816|NCT01690312|High-DHA|high-dha
4987817|NCT01690312|Triglycerides|triglycerides
4987818|NCT01690312|Total cholesterol [TC]|total cholesterol [tc]
4987819|NCT01690312|Lipoproteins|lipoproteins
4987820|NCT01690312|High-density lipoprotein [HDL2, HDL3]|high-density lipoprotein [hdl2, hdl3]
4987821|NCT01690312|Low-density lipoprotein [LDL1+2+3+4]|low-density lipoprotein [ldl1+2+3+4]
4987822|NCT01690312|Lipoprotein A [Lp(a)]|lipoprotein a [lp(a)]
4987823|NCT01690312|Intermediate-density lipoprotein (IDL)|intermediate-density lipoprotein (idl)
4987824|NCT01690312|Very low-density lipoprotein (VLDL1+2, VLDL3)|very low-density lipoprotein (vldl1+2, vldl3)
4987825|NCT01690312|Remnant Lipoproteins|remnant lipoproteins
4987826|NCT01690312|High-sensitivity C-Reactive Protein [hs-CRP]|high-sensitivity c-reactive protein [hs-crp]
4987827|NCT01690312|Homocysteine|homocysteine
4987828|NCT01690312|Essential Fatty Acid Profile|essential fatty acid profile
4987829|NCT01690312|Apolipoprotein B|apolipoprotein b
4987830|NCT01690312|Apolipoprotein A-1|apolipoprotein a-1
4987831|NCT01690312|Glucose|glucose
4987832|NCT01690312|Insulin|insulin
4987833|NCT01690312|Fasted|fasted
4987834|NCT01690312|Post-Prandial|post-prandial
4987835|NCT01690299|Psoriasis|psoriasis
4987836|NCT01690299|arthritis|arthritis
4987837|NCT01690299|psoriatic|psoriatic
4987838|NCT01690299|palmoplantar|palmoplantar
4987839|NCT01690299|scalp|scalp
4987840|NCT01690299|psoriasis pill|psoriasis pill
4987841|NCT01690299|psoriasis tablet|psoriasis tablet
4987842|NCT01690299|plaque psoriasis|plaque psoriasis
4987843|NCT01690299|plaque type psoriasis|plaque type psoriasis
4987844|NCT01690299|moderate to severe plaque type psoriasis|moderate to severe plaque type psoriasis
4987845|NCT01690299|psoriatic arthritis|psoriatic arthritis
4987846|NCT01690286|Healthy|healthy
4987847|NCT01690286|Ketoconazole|ketoconazole
4987848|NCT01690286|JNJ-38518168|jnj-38518168
4987849|NCT01690286|Pharmacokinetics|pharmacokinetics
4987850|NCT01690273|exercise|exercise
4987851|NCT01690273|mobility|mobility
4987852|NCT01690273|strengthening|strengthening
4987853|NCT01690273|physiotherapy|physiotherapy
4987854|NCT01690260|Bone|bone
4987855|NCT01690260|Morphogenetic|morphogenetic
4987856|NCT01690260|Protein|protein
4987857|NCT01690260|Ilizarow|ilizarow
4987858|NCT01690260|Autologous|autologous
4987859|NCT01690260|Osteoarthritis|osteoarthritis
4987860|NCT01690247|mesenchymal stem cells|mesenchymal stem cells
4987861|NCT01690247|liver transplantation|liver transplantation
4987862|NCT01690247|clinical trial|clinical trial
4987863|NCT01690247|rejection|rejection
4987864|NCT01690234|Low back pain|low back pain
4987865|NCT01690234|Return to work|return to work
4987866|NCT01690234|Sickness absence|sickness absence
4987867|NCT01690234|Rehabilitation|rehabilitation
4987868|NCT01690234|Multidisciplinary intervention|multidisciplinary intervention
4987869|NCT01690221|Anal|anal
4987870|NCT01690221|Fissure|fissure
4987871|NCT01690221|Pain|pain
4987872|NCT01690208|Diabetes|diabetes
4987873|NCT01690208|Structure Care|structure care
4987874|NCT01690182|Gastrointestinal physiology|gastrointestinal physiology
4987875|NCT01690182|MRI|mri
4987876|NCT01690182|gastric volumes|gastric volumes
4987877|NCT01690182|satiety|satiety
4987878|NCT01690156|In-plane|in-plane
4987879|NCT01690156|Ultrasound-guided regional anesthesia performance|ultrasound-guided regional anesthesia performance
4987880|NCT01690156|Probe position|probe position
4987881|NCT01690156|Needle visualization|needle visualization
4987882|NCT01690130|nicotine|nicotine
4987883|NCT01690130|craving|craving
4987884|NCT01690130|smoking|smoking
4987885|NCT01690130|TMS|tms
4987886|NCT01690130|prefrontal cortex|prefrontal cortex
4987887|NCT01690117|family caregiver|family caregiver
4987888|NCT01690117|dementia|dementia
4987889|NCT01690117|intervention|intervention
4987890|NCT01690117|implementation|implementation
4987891|NCT01690104|rifampicin|rifampicin
4987892|NCT01690104|pregnane X receptor|pregnane x receptor
4987893|NCT01690104|blood pressure|blood pressure
4987894|NCT01690091|chronic heart failure|chronic heart failure
4987895|NCT01690091|type 2 diabetes|type 2 diabetes
4987896|NCT01690091|metformin|metformin
4987897|NCT01690091|insulin resistance|insulin resistance
4987898|NCT01690078|Airway modeling|airway modeling
4987899|NCT01690078|Pierre Robin Sequence or PRS|pierre robin sequence or prs
4987900|NCT01690078|Micrognathia|micrognathia
4987901|NCT01690078|Subglottic Stenosis or SGS|subglottic stenosis or sgs
4987902|NCT01690065|chronic myeloid leukemia|chronic myeloid leukemia
4987903|NCT01690065|myeloid blastic phase|myeloid blastic phase
4987904|NCT01690065|bcr-abl(+) acute myeloid leukemia|bcr-abl(+) acute myeloid leukemia
4987905|NCT01690065|nilotinib|nilotinib
4987906|NCT01690052|dry mouth|dry mouth
4987907|NCT01690039|renal tubular acidosis|renal tubular acidosis
4987908|NCT01690039|V-ATPase|v-atpase
4987909|NCT01690039|kidney stones|kidney stones
4987910|NCT01689974|Metastatic Melanoma|metastatic melanoma
4987911|NCT01689974|Radiation Therapy|radiation therapy
4987912|NCT01689974|Immunology|immunology
4987913|NCT01689974|Abscopal|abscopal
4987914|NCT01689961|Nutrition|nutrition
4987915|NCT01689961|Physical activity|physical activity
4987916|NCT01689961|Gestational weight gain|gestational weight gain
4987917|NCT01689961|Pregnancy outcomes|pregnancy outcomes
4987918|NCT01689961|Birth|birth
4987919|NCT01689948|Home care, rehabilitation therapy, Alzheimer's disease|home care, rehabilitation therapy, alzheimer's disease
4987920|NCT01689935|Acne vulgaris|acne vulgaris
4987921|NCT01689935|Photodynamic Therapy|photodynamic therapy
4987922|NCT01689935|Side-effects|side-effects
4987923|NCT01689935|Pain|pain
4987924|NCT01689909|Insomnia|insomnia
4987925|NCT01689909|Depression|depression
4987926|NCT01689909|Suicidal ideation|suicidal ideation
4987927|NCT01689909|Zolpidem CR|zolpidem cr
4987928|NCT01689909|Placebo|placebo
4987929|NCT01689896|Hypogonadism|hypogonadism
4987930|NCT01689896|Low testosterone|low testosterone
4987931|NCT01689896|Pain|pain
4987932|NCT01689883|stroke|stroke
4987933|NCT01689883|electrical stimulation|electrical stimulation
4987934|NCT01689870|OX40|ox40
4987935|NCT01689870|Anti-OX40|anti-ox40
4987936|NCT01689870|Ipilimumab|ipilimumab
4987937|NCT01689870|Melanoma|melanoma
4987938|NCT01689857|hypertropic scar, Vancouver scar scale, silicon gel sheet|hypertropic scar, vancouver scar scale, silicon gel sheet
4987939|NCT01689844|controlled high blood pressure|controlled high blood pressure
4987940|NCT01689818|insomnia, elderly, exercise training|insomnia, elderly, exercise training
4987941|NCT01689805|Atopic dermatitis|atopic dermatitis
4987942|NCT01689805|Filaggrin|filaggrin
4987943|NCT01689779|vitamin D|vitamin d
4987944|NCT01689779|surgery|surgery
4987945|NCT01689779|acute stress|acute stress
4987946|NCT01689766|Renal Cell|renal cell
4987947|NCT01689753|Renal dialyse|renal dialyse
4987948|NCT01689753|Catheter, indwelling|catheter, indwelling
4987949|NCT01689753|Catheter-related infection|catheter-related infection
4987950|NCT01689740|MDMA|mdma
4987951|NCT01689740|Posttraumatic stress disorder|posttraumatic stress disorder
4987952|NCT01689740|PTSD|ptsd
4987953|NCT01689740|Israel|israel
4987954|NCT01689740|psychotherapy|psychotherapy
4987955|NCT01689727|Pituitary Tumors|pituitary tumors
4987956|NCT01689714|Ovarian Carcinoma|ovarian carcinoma
4988058|NCT01689324|Tdap vaccine|tdap vaccine
4987957|NCT01689714|Recurrent Endometrial Carcinoma|recurrent endometrial carcinoma
4987958|NCT01689701|Erosive Gastritis|erosive gastritis
4987959|NCT01689701|Hizikia Fusiformis|hizikia fusiformis
4987960|NCT01689675|musculoskeletal|musculoskeletal
4987961|NCT01689675|pain|pain
4987962|NCT01689675|pain management|pain management
4987963|NCT01689675|computer based intervention|computer based intervention
4987964|NCT01689662|Metastatic Renal Cell Carcinoma|metastatic renal cell carcinoma
4987965|NCT01689649|Epilepsy|epilepsy
4987966|NCT01689649|Seizures|seizures
4987967|NCT01689649|Topiramate|topiramate
4987968|NCT01689649|Anti-epileptic drug|anti-epileptic drug
4987969|NCT01689649|Nervous disorder|nervous disorder
4987970|NCT01689636|Ovarian Cancer|ovarian cancer
4987971|NCT01689623|Healthy participants|healthy participants
4987972|NCT01689623|TMC435|tmc435
4987973|NCT01689623|HMG-CoA reductase inhibitors|hmg-coa reductase inhibitors
4987974|NCT01689623|Atorvastatin|atorvastatin
4987975|NCT01689623|Simvastatin|simvastatin
4987976|NCT01689623|Pharmacokinetic interaction|pharmacokinetic interaction
4987977|NCT01689610|Nab-Paclitaxel|nab-paclitaxel
4987978|NCT01689610|Abraxane|abraxane
4987979|NCT01689610|Nabucco|nabucco
4987980|NCT01689610|safety|safety
4987981|NCT01689610|breast cancer|breast cancer
4987982|NCT01689610|daily routine|daily routine
4987983|NCT01689610|peripheral neuropathy|peripheral neuropathy
4987984|NCT01689610|iOMEDICO|iomedico
4987985|NCT01689584|BRCA1|brca1
4987986|NCT01689584|BRCA2|brca2
4987987|NCT01689584|VUS|vus
4987988|NCT01689584|co-segregation|co-segregation
4987989|NCT01689584|genetic counseling|genetic counseling
4987990|NCT01689584|PALB2|palb2
4987991|NCT01689571|PDE4 inhibitor|pde4 inhibitor
4987992|NCT01689571|Allergen Challenge|allergen challenge
4987993|NCT01689571|Asthma|asthma
4987994|NCT01689558|nasopharynx cancer,Image department of nose pharynx ministry|nasopharynx cancer,image department of nose pharynx ministry
4987995|NCT01689545|HIV|hiv
4987996|NCT01689545|drug abuse|drug abuse
4987997|NCT01689545|social stigma|social stigma
4987998|NCT01689545|Vietnam|vietnam
4987999|NCT01689532|Active Rheumatoid Arthritis Unresponsive to Methotrexate or Sulfasalazine|active rheumatoid arthritis unresponsive to methotrexate or sulfasalazine
4988000|NCT01689532|Sirukumab|sirukumab
4988001|NCT01689532|Human Anti-IL-6 Monoclonal Antibody|human anti-il-6 monoclonal antibody
4988002|NCT01689519|Zelboraf|zelboraf
4988003|NCT01689519|vemurafenib|vemurafenib
4988004|NCT01689519|RG7204|rg7204
4988005|NCT01689519|PLX4032|plx4032
4988006|NCT01689519|Genentech MEK inhibitor|genentech mek inhibitor
4988007|NCT01689519|Genentech BRAF inhibitor|genentech braf inhibitor
4988008|NCT01689519|Roche MEK inhibitor|roche mek inhibitor
4988009|NCT01689519|Roche BRAF inhibitor|roche braf inhibitor
4988010|NCT01689519|RO5185426|ro5185426
4988011|NCT01689519|metastatic melanoma|metastatic melanoma
4988012|NCT01689519|BRAF positive melanoma|braf positive melanoma
4988013|NCT01689519|BRAF mutant melanoma|braf mutant melanoma
4988014|NCT01689519|advanced melanoma|advanced melanoma
4988015|NCT01689519|Genentech RAF inhibitor|genentech raf inhibitor
4988016|NCT01689519|Roche RAF inhibitor|roche raf inhibitor
4988017|NCT01689519|BRAF V600E kinase inhibitor|braf v600e kinase inhibitor
4988018|NCT01689519|Oncogenic BRAF inhibitor|oncogenic braf inhibitor
4988019|NCT01689519|BRAF kinase inhibitor|braf kinase inhibitor
4988020|NCT01689519|GDC-0973|gdc-0973
4988021|NCT01689519|XL518|xl518
4988022|NCT01689519|melanoma|melanoma
4988023|NCT01689480|Muscular Dystrophy|muscular dystrophy
4988024|NCT01689480|Facioscapulohumeral|facioscapulohumeral
4988025|NCT01689480|Physical training|physical training
4988026|NCT01689480|Exercise|exercise
4988027|NCT01689454|IVF|ivf
4988028|NCT01689454|embryo culture|embryo culture
4988029|NCT01689454|Ongoing pregnancy rate|ongoing pregnancy rate
4988030|NCT01689454|Ongoing implantation rate|ongoing implantation rate
4988031|NCT01689454|Miscarriage|miscarriage
4988032|NCT01689428|IVF|ivf
4988033|NCT01689428|Embryo culture|embryo culture
4988034|NCT01689428|Ongoing Pregnancy rate|ongoing pregnancy rate
4988035|NCT01689428|Ongoing Implantation rate|ongoing implantation rate
4988036|NCT01689428|Miscarriage|miscarriage
4988037|NCT01689415|Renal nerve denervation|renal nerve denervation
4988038|NCT01689389|Schizophrenia|schizophrenia
4988039|NCT01689389|Bipolar episodes|bipolar episodes
4988040|NCT01689389|France|france
4988041|NCT01689389|Xeroquel|xeroquel
4988042|NCT01689389|Real-life|real-life
4988043|NCT01689363|hyaluronidase|hyaluronidase
4988044|NCT01689363|enzymes with tissue spreading activity|enzymes with tissue spreading activity
4988045|NCT01689363|allergic reaction|allergic reaction
4988046|NCT01689363|intradermal skin testing|intradermal skin testing
4988047|NCT01689350|Cyclophosphamide|cyclophosphamide
4988048|NCT01689350|genotype-based therapy|genotype-based therapy
4988049|NCT01689350|prospective study|prospective study
4988050|NCT01689337|Microfracture surgery|microfracture surgery
4988051|NCT01689337|Cartilage repair|cartilage repair
4988052|NCT01689337|Knee surgery|knee surgery
4988053|NCT01689324|Pertussis|pertussis
4988054|NCT01689324|Tetanus|tetanus
4988055|NCT01689324|Diphtheria|diphtheria
4988056|NCT01689324|Acellular pertussis|acellular pertussis
4988057|NCT01689324|ADACEL®|adacel®
4988059|NCT01689311|Uterine contraction|uterine contraction
4988060|NCT01689311|Dose response|dose response
4988061|NCT01689311|Non-laboring|non-laboring
4988062|NCT01689311|Laboring|laboring
4988063|NCT01689311|Laboring with oxytocin augmentation|laboring with oxytocin augmentation
4988064|NCT01689311|Oxytocin|oxytocin
4988065|NCT01689311|Ergonovine|ergonovine
4988066|NCT01689311|Prostaglandin F2alpha|prostaglandin f2alpha
4988067|NCT01689311|Misoprostol|misoprostol
4988068|NCT01689298|Uterine contraction|uterine contraction
4988069|NCT01689298|Dose response|dose response
4988070|NCT01689298|Oxytocin pretreatment|oxytocin pretreatment
4988071|NCT01689298|Oxytocin|oxytocin
4988072|NCT01689298|Carbetocin|carbetocin
4988073|NCT01689285|bioequivalence|bioequivalence
4988074|NCT01689285|pharmacokinetics|pharmacokinetics
4988075|NCT01689285|valacyclovir|valacyclovir
4988076|NCT01689285|paediatric formulation|paediatric formulation
4988077|NCT01689272|Kidney transplantation,functional status,survival.|kidney transplantation,functional status,survival.
4988078|NCT01689246|Alzheimer's Disease|alzheimer's disease
4988079|NCT01689246|Alzheimer Disease|alzheimer disease
4988080|NCT01689246|TRx0237|trx0237
4988081|NCT01689246|AD|ad
4988082|NCT01689246|Neurodegenerative Diseases|neurodegenerative diseases
4988083|NCT01689246|Dementia|dementia
4988084|NCT01689246|Brain Diseases|brain diseases
4988085|NCT01689233|Alzheimer's Disease|alzheimer's disease
4988086|NCT01689233|Alzheimer Disease|alzheimer disease
4988087|NCT01689233|TRx0237|trx0237
4988088|NCT01689233|AD|ad
4988089|NCT01689233|Neurodegenerative Diseases|neurodegenerative diseases
4988090|NCT01689233|Dementia|dementia
4988091|NCT01689233|Brain Diseases|brain diseases
4988092|NCT01689207|Phase I, Safety, tolerability, healthy.|phase i, safety, tolerability, healthy.
4988093|NCT01689155|Meningitis|meningitis
4988094|NCT01689155|Meningococcal Infection|meningococcal infection
4988095|NCT01689155|Menactra®|menactra®
4988096|NCT01689103|Alcohol use disorders|alcohol use disorders
4988097|NCT01689103|Treatment|treatment
4988098|NCT01689103|Outpatient|outpatient
4988099|NCT01689103|Therapeutic alliance|therapeutic alliance
4988100|NCT01689051|Type 2 diabetes|type 2 diabetes
4988101|NCT01689051|Blod pressure|blod pressure
4988102|NCT01689051|Glucagon-like peptide-1|glucagon-like peptide-1
4988103|NCT01689051|Human physiology|human physiology
4988104|NCT01689051|Blood flow|blood flow
4988105|NCT01688999|Kidney Cancer|kidney cancer
4988106|NCT01688999|Tyrosine Kinase Inhibitor|tyrosine kinase inhibitor
4988107|NCT01688999|Bladder Cancer|bladder cancer
4988108|NCT01688986|Complex Disease|complex disease
4988109|NCT01688986|DNA Biorepository|dna biorepository
4988110|NCT01688986|Genotype-Phenotype Correlation|genotype-phenotype correlation
4988111|NCT01688986|Genetics|genetics
4988112|NCT01688986|Environmental Factors|environmental factors
4988113|NCT01688947|Pain|pain
4988114|NCT01688947|Neuralgia, Postherpetic|neuralgia, postherpetic
4988115|NCT01688934|Pain|pain
4988116|NCT01688934|Osteoarthritis|osteoarthritis
4988117|NCT01688934|Knee|knee
4988118|NCT01688921|Injections, Jet|injections, jet
4988119|NCT01688921|Influenza Vaccines|influenza vaccines
4988120|NCT01688908|Esophageal Squamous Cell Carcinoma|esophageal squamous cell carcinoma
4988121|NCT01688908|Endoscopic Screening|endoscopic screening
4988122|NCT01688908|Efficacy|efficacy
4988123|NCT01688908|Cost-utility|cost-utility
4988124|NCT01688908|High risk region|high risk region
4988125|NCT01688908|China|china
4988126|NCT01688895|erythropoietic|erythropoietic
4988127|NCT01688895|protoporphyria|protoporphyria
4988128|NCT01688895|cutaneous|cutaneous
4988129|NCT01688895|porphyria|porphyria
4988130|NCT01688882|bullous pemphigoid|bullous pemphigoid
4988131|NCT01688882|QGE031|qge031
4988132|NCT01688869|brain concussion|brain concussion
4988133|NCT01688856|hand|hand
4988134|NCT01688856|arm|arm
4988135|NCT01688856|stroke|stroke
4988136|NCT01688856|hemiplegia|hemiplegia
4988137|NCT01688856|electrical stimulation|electrical stimulation
4988138|NCT01688856|recovery|recovery
4988139|NCT01688856|rehabilitation|rehabilitation
4988140|NCT01688843|bradycardia|bradycardia
4988141|NCT01688843|sinus node dysfunction|sinus node dysfunction
4988142|NCT01688817|Colorectal Neoplasms|colorectal neoplasms
4988143|NCT01688817|Colonoscopy|colonoscopy
4988144|NCT01688817|Early Detection of Cancer|early detection of cancer
4988145|NCT01688817|Patient Selection|patient selection
4988146|NCT01688817|Patient Participation|patient participation
4988147|NCT01688817|Physicians, Primary Care|physicians, primary care
4988148|NCT01688817|Conscious Sedation|conscious sedation
4988149|NCT01688804|Sedentary behavior|sedentary behavior
4988150|NCT01688804|Physical activity|physical activity
4988151|NCT01688804|Obesity|obesity
4988152|NCT01688804|Mobile health|mobile health
4988153|NCT01688804|Smartphone|smartphone
4988154|NCT01688778|Type 2 diabetes|type 2 diabetes
4988155|NCT01688778|Quality of life|quality of life
4988156|NCT01688778|Lifestyle intervention|lifestyle intervention
4988157|NCT01688778|Telemedicine|telemedicine
4988158|NCT01688778|Videoconference|videoconference
4988159|NCT01688765|Schizophrenia|schizophrenia
4988160|NCT01688765|Schizoaffective disorder|schizoaffective disorder
4988766|NCT01686009|intranasal|intranasal
4988161|NCT01688765|Bipolar disorder|bipolar disorder
4988162|NCT01688739|Migraine|migraine
4988163|NCT01688726|Dry eye|dry eye
4988164|NCT01688726|Ocular surface|ocular surface
4988165|NCT01688726|Vision complaint|vision complaint
4988166|NCT01688726|Tear film stability|tear film stability
4988167|NCT01688726|Time controlled functional visual acuity|time controlled functional visual acuity
4988168|NCT01688726|Tear film kinetics|tear film kinetics
4988169|NCT01688700|Esophageal Squamous Cell Carcinoma|esophageal squamous cell carcinoma
4988170|NCT01688700|neoadjuvant therapy|neoadjuvant therapy
4988171|NCT01688700|Nimotuzumab|nimotuzumab
4988172|NCT01688648|Coronary artery bypass graft|coronary artery bypass graft
4988173|NCT01688648|dexmedetomidine|dexmedetomidine
4988174|NCT01688648|lidocaine|lidocaine
4988175|NCT01688648|myocardial injury|myocardial injury
4988176|NCT01688648|arrhythmia|arrhythmia
4988177|NCT01688648|blood electrolyte balance|blood electrolyte balance
4988178|NCT01688635|Volunteers|volunteers
4988179|NCT01688596|Local|local
4988180|NCT01688596|Anesthesia|anesthesia
4988181|NCT01688596|Pain|pain
4988182|NCT01688596|Laparoscopic hysterectomy|laparoscopic hysterectomy
4988183|NCT01688596|Trocar site|trocar site
4988184|NCT01688596|Port site|port site
4988185|NCT01688583|Chronic pain|chronic pain
4988186|NCT01688583|Chronic non-cancer pain|chronic non-cancer pain
4988187|NCT01688583|Fentanyl matrix|fentanyl matrix
4988188|NCT01688583|Transdermal system|transdermal system
4988189|NCT01688570|neuromuscular fatigue|neuromuscular fatigue
4988190|NCT01688570|motor impairment|motor impairment
4988191|NCT01688557|narrow band imaging|narrow band imaging
4988192|NCT01688557|dual focus|dual focus
4988193|NCT01688557|responsive insertion technique|responsive insertion technique
4988194|NCT01688557|scope guide|scope guide
4988195|NCT01688557|colonoscopy|colonoscopy
4988196|NCT01688557|colorectal cancer screening|colorectal cancer screening
4988197|NCT01688544|Ilaprazole|ilaprazole
4988198|NCT01688544|Intragastric pH|intragastric ph
4988199|NCT01688544|Serum Gastrin|serum gastrin
4988200|NCT01688544|Pharmacokinetics|pharmacokinetics
4988201|NCT01688518|Evaluation|evaluation
4988202|NCT01688518|Depth and Duration|depth and duration
4988203|NCT01688518|Anesthesia|anesthesia
4988204|NCT01688505|cerebral small vessel diseases|cerebral small vessel diseases
4988205|NCT01688505|cognitive impairment|cognitive impairment
4988206|NCT01688505|Blood pressure variability|blood pressure variability
4988207|NCT01688492|MDX-010 (Ipilimumab)|mdx-010 (ipilimumab)
4988208|NCT01688492|ABIRATERONE ACETATE (CB 7630)|abiraterone acetate (cb 7630)
4988209|NCT01688492|PREDNISONE|prednisone
4988210|NCT01688492|Immunotherapy-naïve|immunotherapy-naïve
4988211|NCT01688492|castration resistant prostate cancer (CRPC)|castration resistant prostate cancer (crpc)
4988212|NCT01688492|12-120|12-120
4988213|NCT01688479|Postoperative radiotherapy|postoperative radiotherapy
4988214|NCT01688479|breast cancer|breast cancer
4988215|NCT01688466|Immune Modulatory|immune modulatory
4988216|NCT01688466|Systemic Absorption|systemic absorption
4988217|NCT01688466|Oral Agent|oral agent
4988218|NCT01688453|overweight/obesity|overweight/obesity
4988219|NCT01688453|adolescence|adolescence
4988220|NCT01688453|care management|care management
4988221|NCT01688440|Endotracheal Cares|endotracheal cares
4988222|NCT01688440|Neonate|neonate
4988223|NCT01688440|TAC's|tac's
4988224|NCT01688440|Endotracheal Suctioning|endotracheal suctioning
4988225|NCT01688440|Tracheal Aspirate Culture|tracheal aspirate culture
4988226|NCT01688440|Oral Cares|oral cares
4988227|NCT01688440|Neonate oxygen Therapy|neonate oxygen therapy
4988228|NCT01688401|diffuse intrinsic pontine glioma (DIPG)|diffuse intrinsic pontine glioma (dipg)
4988229|NCT01688401|intra-arterial chemotherapy|intra-arterial chemotherapy
4988230|NCT01688401|angiography|angiography
4988231|NCT01688388|Breast Cancer|breast cancer
4988232|NCT01688388|Carcinoma|carcinoma
4988233|NCT01688388|Radiotherapy|radiotherapy
4988234|NCT01688388|Intraoperative Radiotherapy|intraoperative radiotherapy
4988235|NCT01688388|IORT|iort
4988236|NCT01688375|obstructive jaundice|obstructive jaundice
4988237|NCT01688375|ursodeoxycholic acid|ursodeoxycholic acid
4988238|NCT01688362|Prospective Randomized Controlled Double Blinded Trial|prospective randomized controlled double blinded trial
4988239|NCT01688362|Rotator Cuff Tear|rotator cuff tear
4988240|NCT01688362|Platelet Rich Plasma|platelet rich plasma
4988241|NCT01688362|Corticosteroid|corticosteroid
4988242|NCT01688362|Ultrasound|ultrasound
4988243|NCT01688349|Glucocorticoids|glucocorticoids
4988244|NCT01688349|adipose tissue|adipose tissue
4988245|NCT01688349|Cushing|cushing
4988246|NCT01688349|lipodystrophy|lipodystrophy
4988247|NCT01688349|11 beta-HSD1|11 beta-hsd1
4988248|NCT01688336|Pancreatic|pancreatic
4988249|NCT01688336|Phase II|phase ii
4988250|NCT01688336|FOLFIRINOX|folfirinox
4988251|NCT01688336|Unresectable|unresectable
4988252|NCT01688336|Regimen|regimen
4988253|NCT01688336|First-line|first-line
4988254|NCT01688336|Resectable|resectable
4988255|NCT01688336|Borderline|borderline
4988256|NCT01688336|Oxaliplatin|oxaliplatin
4988257|NCT01688336|Leucovorin|leucovorin
4988258|NCT01688336|Irinotecan|irinotecan
4988259|NCT01688336|5FU|5fu
4988260|NCT01688336|Lineberger|lineberger
4988767|NCT01686009|emergency|emergency
4988261|NCT01688336|University of North Carolina|university of north carolina
4988262|NCT01688323|Geriatrics|geriatrics
4988263|NCT01688323|Oncology|oncology
4988264|NCT01688323|Biological Markers|biological markers
4988265|NCT01688323|Survey Instruments|survey instruments
4988266|NCT01688323|p16|p16
4988267|NCT01688323|Geriatric Oncology|geriatric oncology
4988268|NCT01688323|Biological Markers of Aging|biological markers of aging
4988269|NCT01688323|Symptom Assessment|symptom assessment
4988270|NCT01688323|Cancer|cancer
4988271|NCT01688323|Older Persons|older persons
4988272|NCT01688323|Head and Neck Cancer|head and neck cancer
4988273|NCT01688310|Gomco clamp instrument|gomco clamp instrument
4988274|NCT01688310|Tissue adhesive|tissue adhesive
4988275|NCT01688310|Open surgical circumcision|open surgical circumcision
4988276|NCT01688310|Minimally-invasive circumcision|minimally-invasive circumcision
4988277|NCT01688297|Influenza|influenza
4988278|NCT01688297|H1N1|h1n1
4988279|NCT01688297|flu|flu
4988280|NCT01688297|seasonal|seasonal
4988281|NCT01688284|uterine natural killer cells|uterine natural killer cells
4988282|NCT01688284|recurrent miscarriages|recurrent miscarriages
4988283|NCT01688284|alloimmunity|alloimmunity
4988284|NCT01688271|simulation|simulation
4988285|NCT01688271|ultrasound|ultrasound
4988286|NCT01688271|perineural infusion|perineural infusion
4988287|NCT01688271|continuous peripheral nerve block|continuous peripheral nerve block
4988288|NCT01688245|young adults|young adults
4988289|NCT01688245|alcohol consumption|alcohol consumption
4988290|NCT01688245|mobile health|mobile health
4988291|NCT01688245|text message|text message
4988292|NCT01688232|colorectal cancer|colorectal cancer
4988293|NCT01688232|tumor resection|tumor resection
4988294|NCT01688232|immunoscore|immunoscore
4988295|NCT01688232|lymphocytic density|lymphocytic density
4988296|NCT01688232|CD3|cd3
4988297|NCT01688232|CD8|cd8
4988298|NCT01688232|CD45RO|cd45ro
4988299|NCT01688232|biopsy|biopsy
4988300|NCT01688232|genetic feature of the tumor|genetic feature of the tumor
4988301|NCT01688232|relapse|relapse
4988302|NCT01688232|immunohistochemistry|immunohistochemistry
4988303|NCT01688232|image analysis software|image analysis software
4988304|NCT01688219|SAPHO syndrome|sapho syndrome
4988305|NCT01688219|Innate immunity|innate immunity
4988306|NCT01688219|TNF alpha|tnf alpha
4988307|NCT01688219|Polymorphonuclear neutrophils|polymorphonuclear neutrophils
4988308|NCT01688219|Propionibacterium acnes|propionibacterium acnes
4988309|NCT01688219|Interleukin-8|interleukin-8
4988310|NCT01688180|bronchiectasis|bronchiectasis
4988311|NCT01688180|depression|depression
4988312|NCT01688180|anxiety|anxiety
4988313|NCT01688167|HIV|hiv
4988314|NCT01688167|Male circumcision|male circumcision
4988315|NCT01688167|Sexual risk reduction|sexual risk reduction
4988316|NCT01688167|Stages of change|stages of change
4988317|NCT01688141|CKD|ckd
4988318|NCT01688128|Mild cognitive impairment|mild cognitive impairment
4988319|NCT01688128|Cognitive rehabilitation|cognitive rehabilitation
4988320|NCT01688128|Cognitive therapy|cognitive therapy
4988321|NCT01688128|Spaced retrieval Training|spaced retrieval training
4988322|NCT01688128|Alzheimer's disease|alzheimer's disease
4988323|NCT01688128|Memory enhancement|memory enhancement
4988324|NCT01688128|U-healthcare|u-healthcare
4988325|NCT01688089|volunteer|volunteer
4988326|NCT01688089|study|study
4988327|NCT01688063|Skin Elasticity|skin elasticity
4988328|NCT01688063|Scar Elasticity|scar elasticity
4988329|NCT01688063|Cutometer|cutometer
4988330|NCT01688063|Dermal Torque Meter|dermal torque meter
4988331|NCT01688050|Blunt thoracic aortic injury|blunt thoracic aortic injury
4988332|NCT01688050|Transection|transection
4988333|NCT01688050|Endovascular graft|endovascular graft
4988334|NCT01688024|mitomycin C|mitomycin c
4988335|NCT01688011|Myelodysplastic Syndromes|myelodysplastic syndromes
4988336|NCT01688011|MDS|mds
4988337|NCT01688011|Acute Myeloid Leukemia|acute myeloid leukemia
4988338|NCT01688011|AML|aml
4988339|NCT01688011|Registry|registry
4988340|NCT01688011|Connect®|connect®
4988341|NCT01687972|cesarean section|cesarean section
4988342|NCT01687972|insorb staples|insorb staples
4988343|NCT01687972|absorbable staples|absorbable staples
4988344|NCT01687972|transverse skin incision|transverse skin incision
4988345|NCT01687959|cholelithiasis|cholelithiasis
4988346|NCT01687959|laparoscopic cholecystectomy|laparoscopic cholecystectomy
4988347|NCT01687959|endoscopic sphincterotomy|endoscopic sphincterotomy
4988348|NCT01687959|choledocholithiasis|choledocholithiasis
4988349|NCT01687946|Biology of Fibrosis|biology of fibrosis
4988350|NCT01687933|Labor pain|labor pain
4988351|NCT01687933|Virtual reality|virtual reality
4988352|NCT01687933|the first stage of labor|the first stage of labor
4988353|NCT01687933|Pain relief|pain relief
4988354|NCT01687933|Simulator|simulator
4988355|NCT01687920|Cardiac disorders|cardiac disorders
4988356|NCT01687907|fear of childbirth|fear of childbirth
4988357|NCT01687907|outcome of delivery|outcome of delivery
4988358|NCT01687907|music|music
4988359|NCT01687907|mother-baby relationship|mother-baby relationship
4988360|NCT01687894|cerebral oxygen saturation|cerebral oxygen saturation
4988361|NCT01687894|beach chair position|beach chair position
4988362|NCT01687894|hemodynamic|hemodynamic
4988363|NCT01687894|jugular venous oximetry|jugular venous oximetry
4988364|NCT01687881|Chiropractic|chiropractic
4988365|NCT01687881|Manipulative therapy|manipulative therapy
4988366|NCT01687881|Cervicogenic headache|cervicogenic headache
4988367|NCT01687855|Obstructive Sleep|obstructive sleep
4988368|NCT01687855|Apnoea|apnoea
4988369|NCT01687855|tongue|tongue
4988370|NCT01687855|alteration|alteration
4988371|NCT01687829|Macular Holes|macular holes
4988372|NCT01687829|Internal limiting membrane|internal limiting membrane
4988373|NCT01687829|peeling|peeling
4988374|NCT01687829|Surgery|surgery
4988375|NCT01687816|Influenza-Like-Illness|influenza-like-illness
4988376|NCT01687816|nasal swabs|nasal swabs
4988377|NCT01687816|Detection of influenza|detection of influenza
4988378|NCT01687816|sensitivity of detection assays|sensitivity of detection assays
4988379|NCT01687803|Obesity|obesity
4988380|NCT01687803|Sedentary lifestyle|sedentary lifestyle
4988381|NCT01687803|Body weight|body weight
4988382|NCT01687803|Physical fitness|physical fitness
4988383|NCT01687790|molecular breast imaging|molecular breast imaging
4988384|NCT01687790|breast disease|breast disease
4988385|NCT01687790|breast biopsy|breast biopsy
4988386|NCT01687777|Supraspinatus tendon|supraspinatus tendon
4988387|NCT01687777|Mesenchymal stem cells|mesenchymal stem cells
4988388|NCT01687777|OrthADAPT|orthadapt
4988389|NCT01687777|Rotator cuff|rotator cuff
4988390|NCT01687764|Generalized Anxiety Disorder (GAD)|generalized anxiety disorder (gad)
4988391|NCT01687764|Separation Anxiety Disorder (SeAD)|separation anxiety disorder (sead)
4988392|NCT01687764|Social Anxiety Disorder (SoAD)|social anxiety disorder (soad)
4988393|NCT01687751|feasibility studies|feasibility studies
4988394|NCT01687751|conscious sedation/|conscious sedation/
4988395|NCT01687751|dexmedetomidine/|dexmedetomidine/
4988396|NCT01687751|midazolam/|midazolam/
4988397|NCT01687751|infusions, subcutaneous/|infusions, subcutaneous/
4988398|NCT01687751|palliative care/|palliative care/
4988399|NCT01687751|terminal care/|terminal care/
4988400|NCT01687751|terminally ill/|terminally ill/
4988401|NCT01687751|neoplasms/|neoplasms/
4988402|NCT01687751|treatment outcome|treatment outcome
4988403|NCT01687751|Precedex|precedex
4988404|NCT01687751|"end of life"|"end of life"
4988405|NCT01687751|Dying|dying
4988406|NCT01687751|Advanced cancer|advanced cancer
4988407|NCT01687751|mood/delirium/delirious|mood/delirium/delirious
4988408|NCT01687738|non small cell lung cancer|non small cell lung cancer
4988409|NCT01687738|health disparities|health disparities
4988410|NCT01687712|IVF|ivf
4988411|NCT01687712|In vitro fertilization|in vitro fertilization
4988412|NCT01687712|Controlled ovarian stimulation|controlled ovarian stimulation
4988413|NCT01687712|Follitropin|follitropin
4988414|NCT01687712|AFOLIA|afolia
4988415|NCT01687712|Finox|finox
4988416|NCT01687699|cardiovascular event|cardiovascular event
4988417|NCT01687699|hemodialysis|hemodialysis
4988418|NCT01687699|spironolactone|spironolactone
4988419|NCT01687673|Advanced HCC|advanced hcc
4988420|NCT01687673|Temsirolimus|temsirolimus
4988421|NCT01687673|TORISEL|torisel
4988422|NCT01687673|Sorafenib|sorafenib
4988423|NCT01687660|acupuncture|acupuncture
4988424|NCT01687660|migraine prophylaxis|migraine prophylaxis
4988425|NCT01687647|Lung cancer screening|lung cancer screening
4988426|NCT01687647|Asbestos exposed workers|asbestos exposed workers
4988427|NCT01687647|Sputum analysis|sputum analysis
4988428|NCT01687647|Automated cytometry|automated cytometry
4988429|NCT01687647|Predictive biomarkers|predictive biomarkers
4988430|NCT01687634|pregnancy|pregnancy
4988431|NCT01687634|home healthcare visits|home healthcare visits
4988432|NCT01687634|breast feeding|breast feeding
4988433|NCT01687634|nutrition|nutrition
4988434|NCT01687634|community health workers|community health workers
4988435|NCT01687621|Omphalitis|omphalitis
4988436|NCT01687621|Neonate|neonate
4988437|NCT01687621|Zambia|zambia
4988438|NCT01687621|Neonatal mortality|neonatal mortality
4988439|NCT01687621|Umbilical cord infection|umbilical cord infection
4988440|NCT01687608|Hemophilia B|hemophilia b
4988441|NCT01687608|factor IX deficiency|factor ix deficiency
4988442|NCT01687608|gene therapy|gene therapy
4988443|NCT01687595|herpes simplex virus type 2,|herpes simplex virus type 2,
4988444|NCT01687595|genital herpes|genital herpes
4988445|NCT01687582|type 2 diabetes|type 2 diabetes
4988446|NCT01687582|psoriasis|psoriasis
4988447|NCT01687582|exenatide|exenatide
4988448|NCT01687582|liraglutide|liraglutide
4988449|NCT01687569|Glycaemic Response|glycaemic response
4988450|NCT01687556|EGCG|egcg
4988451|NCT01687556|green tea|green tea
4988452|NCT01687543|Clostridium difficile|clostridium difficile
4988453|NCT01687543|WBC|wbc
4988454|NCT01687543|CRP|crp
4988455|NCT01687543|Lactate|lactate
4988456|NCT01687543|Urea|urea
4988457|NCT01687543|Creatinine|creatinine
4988458|NCT01687517|sarcoidosis|sarcoidosis
4988459|NCT01687517|healthy volunteers|healthy volunteers
4988460|NCT01687504|pharmacokinetics|pharmacokinetics
4988461|NCT01687504|children|children
4988462|NCT01687504|HIV|hiv
4988463|NCT01687504|Tuberculosis|tuberculosis
4988464|NCT01687504|Pharmacogenetics|pharmacogenetics
4988465|NCT01687491|Enoxaparin|enoxaparin
4988768|NCT01685996|tobacco|tobacco
4988466|NCT01687491|Acute Coronary Syndrome|acute coronary syndrome
4988467|NCT01687491|Factor X|factor x
4988468|NCT01687465|glaucoma|glaucoma
4988469|NCT01687465|laser|laser
4988470|NCT01687465|SLT|slt
4988471|NCT01687465|ALT|alt
4988472|NCT01687374|proximal humeral fracture|proximal humeral fracture
4988473|NCT01687335|chemotherapy|chemotherapy
4988474|NCT01687322|quality of life|quality of life
4988475|NCT01687322|functioning|functioning
4988476|NCT01687296|PEF|pef
4988477|NCT01687296|inhaled|inhaled
4988478|NCT01687296|Fluticasone Propionate|fluticasone propionate
4988479|NCT01687296|safety|safety
4988480|NCT01687296|prednisone|prednisone
4988481|NCT01687296|acute exacerbation|acute exacerbation
4988482|NCT01687296|asthma|asthma
4988483|NCT01687296|efficacy|efficacy
4988484|NCT01687283|fluticasone propionate inhalation solution|fluticasone propionate inhalation solution
4988485|NCT01687283|budesonide suspension for inhalation|budesonide suspension for inhalation
4988486|NCT01687283|efficacy|efficacy
4988487|NCT01687283|severe persistent asthma|severe persistent asthma
4988488|NCT01687283|pharmacokinetics|pharmacokinetics
4988489|NCT01687283|safety|safety
4988490|NCT01687244|BCG Refractory or Relapsed Superficial Bladder Cancer|bcg refractory or relapsed superficial bladder cancer
4988491|NCT01687244|rAd-IFN|rad-ifn
4988492|NCT01687244|Syn3|syn3
4988493|NCT01687244|Intravesical|intravesical
4988494|NCT01687244|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
4988495|NCT01687244|superficial non-muscle invasive tumor|superficial non-muscle invasive tumor
4988496|NCT01687244|Interferon alpha2b|interferon alpha2b
4988497|NCT01687244|INSTILADRIN|instiladrin
4988498|NCT01687231|Neutropenic Diet, Non-Neutropenic Diet, Allogeneic SCT|neutropenic diet, non-neutropenic diet, allogeneic sct
4988499|NCT01687192|Seroconversion|seroconversion
4988500|NCT01687192|Immunosuppressed treatment|immunosuppressed treatment
4988501|NCT01687192|HPV vaccination|hpv vaccination
4988502|NCT01687192|Immunogenicity|immunogenicity
4988504|NCT01687179|TSC|tsc
4988505|NCT01687179|lymphangioleiomyomatosis|lymphangioleiomyomatosis
4988506|NCT01687166|Paroxysmal Atrial Fibrillation|paroxysmal atrial fibrillation
4988507|NCT01687166|Cardiac Arrhythmias|cardiac arrhythmias
4988508|NCT01687166|Heart Disease|heart disease
4988509|NCT01687166|Cardiovascular Disease|cardiovascular disease
4988510|NCT01687166|Radiofrequency Ablation|radiofrequency ablation
4988511|NCT01687153|traumatic brain injury (TBI)|traumatic brain injury (tbi)
4988512|NCT01687153|post traumatic stress disorder (PTSD)|post traumatic stress disorder (ptsd)
4988513|NCT01687153|Alzheimer's disease (AD)|alzheimer's disease (ad)
4988514|NCT01687153|mild cognitive impairment (MCI)|mild cognitive impairment (mci)
4988515|NCT01687153|dementia|dementia
4988516|NCT01687153|biomarkers|biomarkers
4988517|NCT01687153|amyloid|amyloid
4988518|NCT01687153|neuroimaging|neuroimaging
4988519|NCT01687153|cognition disorder|cognition disorder
4988520|NCT01687153|tau|tau
4988521|NCT01687127|folic acid|folic acid
4988522|NCT01687127|folate|folate
4988523|NCT01687127|5-methyltetrahydrofolate|5-methyltetrahydrofolate
4988524|NCT01687127|supplements|supplements
4988525|NCT01687127|women|women
4988526|NCT01687127|one-carbon metabolism|one-carbon metabolism
4988527|NCT01687127|methionine|methionine
4988528|NCT01687127|DNA methylation|dna methylation
4988529|NCT01687127|in vivo kinetics|in vivo kinetics
4988530|NCT01687114|compliance, proanthocyanidin, phenoic acids, cranberry|compliance, proanthocyanidin, phenoic acids, cranberry
4988531|NCT01687101|acute migraine|acute migraine
4988532|NCT01687101|acute migraine treatment|acute migraine treatment
4988533|NCT01687101|topical treatment|topical treatment
4988534|NCT01687075|coronary angioplasty|coronary angioplasty
4988535|NCT01687075|de novo lesion|de novo lesion
4988536|NCT01687062|NaFeEDTA|nafeedta
4988537|NCT01687062|phytate|phytate
4988538|NCT01687062|injera|injera
4988539|NCT01687062|iron absorption|iron absorption
4988540|NCT01687049|nonmetastatic|nonmetastatic
4988541|NCT01687049|localized|localized
4988542|NCT01687049|prostate|prostate
4988543|NCT01687049|active surveillance|active surveillance
4988544|NCT01687036|Atrial fibrillation|atrial fibrillation
4988545|NCT01687036|Cryoablation|cryoablation
4988546|NCT01687023|Tai Chi|tai chi
4988547|NCT01687023|Wearable sensors|wearable sensors
4988548|NCT01687023|Movement|movement
4988549|NCT01687010|CRP, PCT, IL-6, Diagnosis, Prediction|crp, pct, il-6, diagnosis, prediction
4988550|NCT01686997|Bariatric surgery|bariatric surgery
4988551|NCT01686997|Roux-en-Y Gastric Bypass|roux-en-y gastric bypass
4988552|NCT01686958|Prostate Cancer|prostate cancer
4988553|NCT01686958|High intensity transurethral ultrasound ablation|high intensity transurethral ultrasound ablation
4988554|NCT01686958|MRI-guided|mri-guided
4988555|NCT01686958|Minimally invasive|minimally invasive
4988556|NCT01686958|Real-time temperature feedback control|real-time temperature feedback control
4988557|NCT01686932|vildagliptin|vildagliptin
4988558|NCT01686932|sitagliptin|sitagliptin
4988559|NCT01686932|continuous glucose monitoring (CGM)|continuous glucose monitoring (cgm)
4988560|NCT01686932|glycemic fluctuations|glycemic fluctuations
4988561|NCT01686932|MAGE|mage
4988562|NCT01686932|impact of hypoglycemia on heart function (cardiac dysfuction measured via ECG)|impact of hypoglycemia on heart function (cardiac dysfuction measured via ecg)
4988563|NCT01686932|difference in glycemic profile of vildagliptin compared to sitagliptin|difference in glycemic profile of vildagliptin compared to sitagliptin
4988564|NCT01686919|Gastric bypass|gastric bypass
4988565|NCT01686919|Questionnaires|questionnaires
4988566|NCT01686919|Diet|diet
4988567|NCT01686919|Milk|milk
4988568|NCT01686906|Keratoconus|keratoconus
4988569|NCT01686906|Bowman layer|bowman layer
4988570|NCT01686893|Oxygen, Insufflation, COPD, High Flow Treatment|oxygen, insufflation, copd, high flow treatment
4988571|NCT01686880|Hepatocellular Carcinoma|hepatocellular carcinoma
4988572|NCT01686880|Liver Cirrhosis|liver cirrhosis
4988573|NCT01686880|radioembolization|radioembolization
4988574|NCT01686880|SIRT|sirt
4988575|NCT01686880|TARE|tare
4988576|NCT01686880|Sirspheres|sirspheres
4988577|NCT01686880|neoadjuvant|neoadjuvant
4988578|NCT01686880|liver cancer|liver cancer
4988579|NCT01686867|improved cookstove|improved cookstove
4988580|NCT01686867|ventilated cookstove|ventilated cookstove
4988581|NCT01686867|behavior change|behavior change
4988582|NCT01686867|adoption|adoption
4988583|NCT01686867|indoor air pollution|indoor air pollution
4988584|NCT01686867|DLCO|dlco
4988585|NCT01686867|spirometry|spirometry
4988586|NCT01686867|biomass fuel|biomass fuel
4988587|NCT01686854|cognitive-behavioral approach|cognitive-behavioral approach
4988588|NCT01686854|obesity treatment|obesity treatment
4988589|NCT01686841|Lipolysis|lipolysis
4988590|NCT01686841|Cryolipolysis|cryolipolysis
4988591|NCT01686841|Fat Reduction|fat reduction
4988592|NCT01686828|insulin|insulin
4988593|NCT01686828|androgens|androgens
4988594|NCT01686828|insulin resistance|insulin resistance
4988595|NCT01686828|testosterone|testosterone
4988596|NCT01686828|estradiol|estradiol
4988597|NCT01686828|obesity|obesity
4988598|NCT01686815|metabolic side effects|metabolic side effects
4988599|NCT01686815|atypical antipsychotics|atypical antipsychotics
4988600|NCT01686815|FSIVGTT|fsivgtt
4988601|NCT01686802|oral morphine|oral morphine
4988602|NCT01686802|ibuprofen|ibuprofen
4988603|NCT01686802|post-operative pain|post-operative pain
4988604|NCT01686776|Plasma albumine|plasma albumine
4988605|NCT01686776|Plasma volume|plasma volume
4988606|NCT01686776|Transcapillary escape rate|transcapillary escape rate
4988607|NCT01686776|Inflammation|inflammation
4988608|NCT01686776|Circulation|circulation
4988609|NCT01686750|HIV|hiv
4988610|NCT01686750|injection drug use|injection drug use
4988611|NCT01686750|men who have sex with men|men who have sex with men
4988612|NCT01686750|voluntary counselling and testing|voluntary counselling and testing
4988613|NCT01686750|risk reduction|risk reduction
4988614|NCT01686750|sexually transmitted infections|sexually transmitted infections
4988615|NCT01686750|community viral load|community viral load
4988616|NCT01686750|antiretroviral therapy|antiretroviral therapy
4988617|NCT01686724|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
4988618|NCT01686724|Psychosocial Intervention|psychosocial intervention
4988619|NCT01686724|Behavioral Intervention|behavioral intervention
4988620|NCT01686724|School-home collaborative intervention|school-home collaborative intervention
4988621|NCT01686698|cirrhosis, VSL#3, cognitive function, falls, quality of life|cirrhosis, vsl#3, cognitive function, falls, quality of life
4988622|NCT01686685|ASD|asd
4988623|NCT01686685|autism|autism
4988624|NCT01686685|prematurity|prematurity
4988625|NCT01686685|oxygen-dependant gene activation|oxygen-dependant gene activation
4988626|NCT01686685|CXCR4|cxcr4
4988627|NCT01686685|Language delay|language delay
4988628|NCT01686685|Cognitive delay|cognitive delay
4988629|NCT01686672|Cystic Fibrosis|cystic fibrosis
4988630|NCT01686672|Behavioral Intervention|behavioral intervention
4988631|NCT01686672|Children|children
4988632|NCT01686659|Transfusion|transfusion
4988633|NCT01686659|Continuous Hemoglobin Monitoring|continuous hemoglobin monitoring
4988634|NCT01686659|SpHb|sphb
4988635|NCT01686646|alertness|alertness
4988636|NCT01686633|asthma|asthma
4988637|NCT01686633|pharmacogenetics|pharmacogenetics
4988638|NCT01686633|adult|adult
4988639|NCT01686633|vilanterol|vilanterol
4988640|NCT01686633|adolescents|adolescents
4988641|NCT01686633|fluticasone furoate|fluticasone furoate
4988642|NCT01686620|Mealtime insulin|mealtime insulin
4988643|NCT01686620|Ultra-rapid acting insulin|ultra-rapid acting insulin
4988644|NCT01686620|Prandial insulin|prandial insulin
4988645|NCT01686607|Hepatic toxicity|hepatic toxicity
4988646|NCT01686607|Renal toxicity|renal toxicity
4988647|NCT01686607|Micafungin|micafungin
4988648|NCT01686607|Hepatocellular carcinoma|hepatocellular carcinoma
4988649|NCT01686607|Antifungals (parenteral)|antifungals (parenteral)
4988650|NCT01686594|Mycosis fungoides|mycosis fungoides
4988651|NCT01686594|Psoralen and UVA (PUVA)|psoralen and uva (puva)
4988652|NCT01686594|Photochemotherapy|photochemotherapy
4988653|NCT01686594|Maintenance treatment|maintenance treatment
4988654|NCT01686594|Immune function|immune function
4988655|NCT01686542|atrial fibrillation|atrial fibrillation
4988656|NCT01686529|Pterygium|pterygium
4988657|NCT01686529|bevacizumab|bevacizumab
4988658|NCT01686529|autoconjunctival graft|autoconjunctival graft
4988659|NCT01686516|age|age
4988660|NCT01686516|microstructure|microstructure
4988661|NCT01686516|diffusion MRI|diffusion mri
4988662|NCT01686490|AICD|aicd
4988663|NCT01686490|focus groups|focus groups
4988664|NCT01686490|cognitive-behavioral video/workbook training|cognitive-behavioral video/workbook training
4988665|NCT01686490|pre-implant concern/distress about upcoming AICD|pre-implant concern/distress about upcoming aicd
4988666|NCT01686464|magnetic|magnetic
4988667|NCT01686464|oxygen|oxygen
4988668|NCT01686464|Bell's Palsy|bell's palsy
4988669|NCT01686464|acupuncture|acupuncture
4988670|NCT01686438|cost effectiveness|cost effectiveness
4988671|NCT01686438|patient satisfaction|patient satisfaction
4988672|NCT01686425|Cholestasis|cholestasis
4988673|NCT01686425|Malignancy|malignancy
4988674|NCT01686425|ERCP|ercp
4988675|NCT01686425|PTC|ptc
4988676|NCT01686425|EUS-BD|eus-bd
4988677|NCT01686412|Breast Cancer|breast cancer
4988678|NCT01686412|Hepatocellular carcinoma|hepatocellular carcinoma
4988679|NCT01686399|Sustainable diet|sustainable diet
4988680|NCT01686399|Health promotion|health promotion
4988681|NCT01686399|Obesity|obesity
4988682|NCT01686386|Relapsed|relapsed
4988683|NCT01686386|Multiple Myeloma|multiple myeloma
4988684|NCT01686386|Lenalidomide|lenalidomide
4988685|NCT01686386|Bendamustine|bendamustine
4988686|NCT01686373|Aphasia|aphasia
4988687|NCT01686373|Brain|brain
4988688|NCT01686373|Stimulation|stimulation
4988689|NCT01686373|Communication|communication
4988690|NCT01686373|Stoke|stoke
4988691|NCT01686373|Post|post
4988692|NCT01686373|Phase II Clinical Trial|phase ii clinical trial
4988693|NCT01686373|Treatment|treatment
4988694|NCT01686373|tDCS|tdcs
4988695|NCT01686373|Fridriksson|fridriksson
4988696|NCT01686347|epidural analgesia|epidural analgesia
4988697|NCT01686347|fetal cardiac rythm|fetal cardiac rythm
4988698|NCT01686347|ropivacaine|ropivacaine
4988699|NCT01686347|sufentanil|sufentanil
4988700|NCT01686334|in complete remission|in complete remission
4988701|NCT01686334|Adult (>18 years) at very high risk of relapse|adult (>18 years) at very high risk of relapse
4988702|NCT01686321|elderly patients|elderly patients
4988703|NCT01686321|bendamustine|bendamustine
4988704|NCT01686308|cataract|cataract
4988705|NCT01686308|circadian rhythm|circadian rhythm
4988706|NCT01686308|pupillometry|pupillometry
4988707|NCT01686308|blue light transmission|blue light transmission
4988708|NCT01686308|questionnaire|questionnaire
4988709|NCT01686308|sleep|sleep
4988710|NCT01686295|androgenetic alopecia|androgenetic alopecia
4988711|NCT01686295|Baldness|baldness
4988712|NCT01686282|Blood pressure|blood pressure
4988713|NCT01686282|Arterial Stiffness|arterial stiffness
4988714|NCT01686282|Blueberry Supplementation|blueberry supplementation
4988715|NCT01686282|Aortic Blood Pressure|aortic blood pressure
4988716|NCT01686282|Hypertension|hypertension
4988717|NCT01686282|Postmenopausal|postmenopausal
4988718|NCT01686282|Pulse Wave Velocity|pulse wave velocity
4988719|NCT01686269|Endothelial progenitor cell|endothelial progenitor cell
4988720|NCT01686269|coronary artery bypass|coronary artery bypass
4988721|NCT01686256|Ovarian Cancer|ovarian cancer
4988722|NCT01686256|Endometrial Cancer|endometrial cancer
4988723|NCT01686243|epidural|epidural
4988724|NCT01686230|acupuncture|acupuncture
4988725|NCT01686230|Angina|angina
4988726|NCT01686230|Stable Angina Pectoris|stable angina pectoris
4988727|NCT01686217|ASP015K Extended Release|asp015k extended release
4988728|NCT01686217|ASP015K Immediate Release|asp015k immediate release
4988729|NCT01686217|Food Effect|food effect
4988730|NCT01686217|Healthy Volunteers|healthy volunteers
4988731|NCT01686204|Yogurt|yogurt
4988732|NCT01686204|Intestine|intestine
4988733|NCT01686204|Inflammation|inflammation
4988734|NCT01686204|Obese|obese
4988735|NCT01686191|heart transplantation|heart transplantation
4988736|NCT01686191|chronic renal insufficiency|chronic renal insufficiency
4988737|NCT01686191|pharmacogenomics|pharmacogenomics
4988738|NCT01686191|cyclosporine|cyclosporine
4988739|NCT01686191|tacrolimus|tacrolimus
4988740|NCT01686178|Smoking|smoking
4988741|NCT01686178|Smoking Cessation|smoking cessation
4988742|NCT01686178|Tobacco Use Cessation|tobacco use cessation
4988743|NCT01686178|Social Networks|social networks
4988744|NCT01686178|Social Control, Informal|social control, informal
4988745|NCT01686139|Diabetic mellitus|diabetic mellitus
4988746|NCT01686139|Diabetic foot ulcers|diabetic foot ulcers
4988747|NCT01686139|Ischemic Limb|ischemic limb
4988748|NCT01686126|endometrial hyperplasia|endometrial hyperplasia
4988749|NCT01686126|endometrial adenocarcinoma|endometrial adenocarcinoma
4988750|NCT01686126|Gynecological Cancer|gynecological cancer
4988751|NCT01686113|Taste|taste
4988752|NCT01686113|Fat Taste|fat taste
4988753|NCT01686113|Threshold Testing|threshold testing
4988754|NCT01686100|Coronary artery bypass grafting|coronary artery bypass grafting
4988755|NCT01686100|Saphenous vein grafts|saphenous vein grafts
4988756|NCT01686074|Motor control|motor control
4988757|NCT01686074|walking|walking
4988758|NCT01686074|physical activity|physical activity
4988759|NCT01686074|Muscle activity|muscle activity
4988760|NCT01686022|Grass|grass
4988761|NCT01686022|Major allergen|major allergen
4988762|NCT01686022|cross-reactivity|cross-reactivity
4988763|NCT01686009|pain|pain
4988764|NCT01686009|analgesia|analgesia
4988765|NCT01686009|ketamine|ketamine
4988769|NCT01685996|smoking cessation|smoking cessation
4988770|NCT01685996|nicotine|nicotine
4988771|NCT01685996|cigarettes|cigarettes
4988772|NCT01685996|nicotine withdrawal|nicotine withdrawal
4988773|NCT01685983|Prostate Cancer|prostate cancer
4988774|NCT01685983|Metastatic-castration resistant prostate cancer|metastatic-castration resistant prostate cancer
4988775|NCT01685983|Prostate specific antigen|prostate specific antigen
4988776|NCT01685983|Abiraterone acetate|abiraterone acetate
4988777|NCT01685983|JNJ-212082|jnj-212082
4988778|NCT01685983|Abiraterone|abiraterone
4988779|NCT01685983|Prednisolone|prednisolone
4988780|NCT01685983|Androgen Deprivation|androgen deprivation
4988781|NCT01685983|Docetaxel-based chemotherapy|docetaxel-based chemotherapy
4988782|NCT01685970|Bowel preparation|bowel preparation
4988783|NCT01685970|colonoscopy|colonoscopy
4988784|NCT01685970|polyethylene glycol|polyethylene glycol
4988785|NCT01685970|picosulfate|picosulfate
4988786|NCT01685957|Weight loss|weight loss
4988787|NCT01685957|Dietary intervention|dietary intervention
4988788|NCT01685957|Self-help book|self-help book
4988789|NCT01685957|Cooking|cooking
4988790|NCT01685957|Dietitian|dietitian
4988791|NCT01685957|Dietary therapy|dietary therapy
4988792|NCT01685931|Schizophrenia|schizophrenia
4988793|NCT01685931|Paliperidone Palmitate|paliperidone palmitate
4988794|NCT01685931|Oral Antipsychotics|oral antipsychotics
4988795|NCT01685931|Invega Sustenna|invega sustenna
4988796|NCT01685918|Rheumatoid arthritis|rheumatoid arthritis
4988797|NCT01685918|aged|aged
4988798|NCT01685905|rheumatic disease, latent tuberculosis|rheumatic disease, latent tuberculosis
4988799|NCT01685879|postprandial glycemic response|postprandial glycemic response
4988800|NCT01685879|postprandial insulin response|postprandial insulin response
4988801|NCT01685879|rice|rice
4988802|NCT01685879|appetite|appetite
4988803|NCT01685879|hunger|hunger
4988804|NCT01685866|anesthesia|anesthesia
4988805|NCT01685866|venous access|venous access
4988806|NCT01685840|Heart Failure|heart failure
4988807|NCT01685814|multiple myeloma|multiple myeloma
4988808|NCT01685814|autologous stem cell transplant|autologous stem cell transplant
4988809|NCT01685814|allogeneic stem cell transplant|allogeneic stem cell transplant
4988810|NCT01685814|lenalidomide|lenalidomide
4988811|NCT01685814|bortezomib|bortezomib
4988812|NCT01685775|Gallbladder|gallbladder
4988813|NCT01685775|cholecystectomy|cholecystectomy
4988814|NCT01685775|NOTES|notes
4988815|NCT01685775|natural orifice transluminal endoscopic surgery|natural orifice transluminal endoscopic surgery
4988816|NCT01685775|gallstone|gallstone
4988817|NCT01685762|Endometrial hyperplasia|endometrial hyperplasia
4988818|NCT01685762|Uterus|uterus
4988819|NCT01685762|Pilot|pilot
4988820|NCT01685762|Metformin|metformin
4988821|NCT01685723|Cancer patients|cancer patients
4988822|NCT01685723|Smoking cessation|smoking cessation
4988823|NCT01685723|Risk communication|risk communication
4988824|NCT01685710|Arteriovenous fistula|arteriovenous fistula
4988825|NCT01685710|Patency|patency
4988826|NCT01685710|GTN patch|gtn patch
4988827|NCT01685684|Low back pain|low back pain
4988828|NCT01685684|Chronic back pain|chronic back pain
4988829|NCT01685684|Back pain|back pain
4988830|NCT01685684|Opioid|opioid
4988831|NCT01685684|Oxycodone|oxycodone
4988832|NCT01685684|DETERx|deterx
4988833|NCT01685684|Chronic pain|chronic pain
4988834|NCT01685684|Chronic low back pain|chronic low back pain
4988835|NCT01685684|CLBP|clbp
4988836|NCT01685684|Xtampza|xtampza
4988837|NCT01685671|CKD-11101|ckd-11101
4988838|NCT01685671|NESP|nesp
4988839|NCT01685671|Darbepoetin alfa|darbepoetin alfa
4988840|NCT01685671|Anemia|anemia
4988841|NCT01685671|subcutaneous|subcutaneous
4988842|NCT01685671|Pharmacokinetics|pharmacokinetics
4988843|NCT01685671|Phase 1|phase 1
4988844|NCT01685632|intra peritonal chemo hyperthermia|intra peritonal chemo hyperthermia
4988845|NCT01685632|peritoneal carcinomatosis|peritoneal carcinomatosis
4988846|NCT01685632|colorectal cancer|colorectal cancer
4988847|NCT01685632|ovarian cancer|ovarian cancer
4988848|NCT01685619|AML|aml
4988849|NCT01685619|Acute Myeloid Leukemia|acute myeloid leukemia
4988850|NCT01685619|MDS|mds
4988851|NCT01685619|Myelodysplastic Syndrome|myelodysplastic syndrome
4988852|NCT01685619|Prognostic|prognostic
4988853|NCT01685619|Economic|economic
4988854|NCT01685606|Leukemia|leukemia
4988855|NCT01685606|Lymphoma|lymphoma
4988856|NCT01685606|Mantle cell|mantle cell
4988857|NCT01685606|DLBCL|dlbcl
4988858|NCT01685606|DLBC|dlbc
4988859|NCT01685606|Diffuse large B cell|diffuse large b cell
4988860|NCT01685606|T cell|t cell
4988861|NCT01685606|AML|aml
4988862|NCT01685606|ALL|all
4988863|NCT01685593|abdominal binder|abdominal binder
4988864|NCT01685580|primary lung cancer|primary lung cancer
4988865|NCT01685580|lobectomy|lobectomy
4988866|NCT01685580|pneumonectomy|pneumonectomy
4988867|NCT01685580|non-invasive ventilation|non-invasive ventilation
4988868|NCT01685567|carotid artery disease|carotid artery disease
4988869|NCT01685567|reverse flow|reverse flow
4988870|NCT01685554|perfusion|perfusion
4988871|NCT01685554|cardiopulmonary bypass|cardiopulmonary bypass
4988872|NCT01685554|hypothermia|hypothermia
4988972|NCT01685060|NSCLC|nsclc
4988873|NCT01685554|cerebral oxygenation|cerebral oxygenation
4988874|NCT01685528|Anxiety|anxiety
4988875|NCT01685528|Depression|depression
4988876|NCT01685528|Geriatric|geriatric
4988877|NCT01685528|Veteran|veteran
4988878|NCT01685502|Glucobay OD|glucobay od
4988879|NCT01685502|Diabetes Mellitus|diabetes mellitus
4988880|NCT01685489|Prostate|prostate
4988881|NCT01685489|Neoplasm|neoplasm
4988882|NCT01685489|Adenocarcinoma|adenocarcinoma
4988883|NCT01685489|Cancer|cancer
4988884|NCT01685489|Metastatic|metastatic
4988885|NCT01685489|Castrate resistant|castrate resistant
4988886|NCT01685489|Docetaxel|docetaxel
4988887|NCT01685489|PSK|psk
4988888|NCT01685489|Krestin|krestin
4988889|NCT01685489|Trametes versicolor|trametes versicolor
4988890|NCT01685489|Safety|safety
4988891|NCT01685489|Maximum tolerated dose|maximum tolerated dose
4988892|NCT01685489|Mushroom|mushroom
4988893|NCT01685489|Natural|natural
4988894|NCT01685489|Immunotherapy|immunotherapy
4988895|NCT01685476|Cochlear microphonic potential|cochlear microphonic potential
4988896|NCT01685476|non invasive method|non invasive method
4988897|NCT01685476|indirect monitoring|indirect monitoring
4988898|NCT01685476|intracranial pressure|intracranial pressure
4988899|NCT01685463|methamphetamine, craving, TMS, cortical excitability, prefrontal cortex|methamphetamine, craving, tms, cortical excitability, prefrontal cortex
4988900|NCT01685450|Cochlear microphonic potential|cochlear microphonic potential
4988901|NCT01685450|non invasive method|non invasive method
4988902|NCT01685450|indirect measurement|indirect measurement
4988903|NCT01685450|intracranial pressure|intracranial pressure
4988904|NCT01685450|adults|adults
4988905|NCT01685437|Peyronie's disease, penile plaque, penile curvature|peyronie's disease, penile plaque, penile curvature
4988906|NCT01685424|Etoricoxib|etoricoxib
4988907|NCT01685424|ARCOXIA|arcoxia
4988908|NCT01685424|Osteoarthritis|osteoarthritis
4988909|NCT01685424|Rheumatoid Arthritis|rheumatoid arthritis
4988910|NCT01685424|Ankylosing Spondylitis|ankylosing spondylitis
4988911|NCT01685424|Gout|gout
4988912|NCT01685424|Arthritis|arthritis
4988913|NCT01685385|Dyspnoea|dyspnoea
4988914|NCT01685385|BNP|bnp
4988915|NCT01685385|Chronic heart failure|chronic heart failure
4988916|NCT01685385|congestive heart failure|congestive heart failure
4988917|NCT01685346|advanced (stage IV) non-small cell lung cancer (NSCLC)|advanced (stage iv) non-small cell lung cancer (nsclc)
4988918|NCT01685346|biofeedback-mediated stress management (BFSM)|biofeedback-mediated stress management (bfsm)
4988919|NCT01685333|subject|subject
4988920|NCT01685320|Force|force
4988921|NCT01685320|Pressure|pressure
4988922|NCT01685320|Intubation|intubation
4988923|NCT01685320|laryngoscopy|laryngoscopy
4988924|NCT01685307|ileal digestibility|ileal digestibility
4988925|NCT01685307|metabolism|metabolism
4988926|NCT01685307|stable isotopes|stable isotopes
4988927|NCT01685294|Major Depressive Disorder (MDD)|major depressive disorder (mdd)
4988928|NCT01685294|Suicidality|suicidality
4988929|NCT01685294|Incarcerated Populations|incarcerated populations
4988930|NCT01685294|Prisons|prisons
4988931|NCT01685294|Interpersonal Psychotherapy (IPT)|interpersonal psychotherapy (ipt)
4988932|NCT01685281|ADHD , Inattention|adhd , inattention
4988933|NCT01685268|Prostate Cancer|prostate cancer
4988934|NCT01685255|FIGO Stage III or IV EOC|figo stage iii or iv eoc
4988935|NCT01685255|PPC FTC|ppc ftc
4988936|NCT01685255|increasing CA 125|increasing ca 125
4988937|NCT01685216|VPRIV|vpriv
4988938|NCT01685216|velaglucerase alfa|velaglucerase alfa
4988939|NCT01685203|Hepatitis C Virus|hepatitis c virus
4988940|NCT01685203|Ribavirin-Free|ribavirin-free
4988941|NCT01685203|Hepatitis C Genotype 1|hepatitis c genotype 1
4988942|NCT01685203|Hepatitis C|hepatitis c
4988943|NCT01685203|Interferon-Free|interferon-free
4988944|NCT01685203|Chronic Hepatitis C|chronic hepatitis c
4988945|NCT01685203|Compensated cirrhosis|compensated cirrhosis
4988946|NCT01685203|Hepatitis C Genotype 4|hepatitis c genotype 4
4988947|NCT01685203|Paritaprevir|paritaprevir
4988948|NCT01685203|Ombitasvir|ombitasvir
4988949|NCT01685203|Ritonavir|ritonavir
4988950|NCT01685203|Ribavirin|ribavirin
4988951|NCT01685177|Morbid obesity|morbid obesity
4988952|NCT01685177|Sleeve gastrectomy|sleeve gastrectomy
4988953|NCT01685177|Duodenal Switch|duodenal switch
4988954|NCT01685177|SADI-S|sadi-s
4988955|NCT01685164|nulliparous|nulliparous
4988956|NCT01685164|IUD|iud
4988957|NCT01685164|IUS|ius
4988958|NCT01685164|insertion|insertion
4988959|NCT01685164|expulsion|expulsion
4988960|NCT01685151|Drug therapy|drug therapy
4988961|NCT01685138|Non-Small Cell Lung Cancer, ALK, LDK378|non-small cell lung cancer, alk, ldk378
4988962|NCT01685112|adults|adults
4988963|NCT01685112|ECMO|ecmo
4988964|NCT01685099|diagnosis, inflammation-associated markers, pleural effusion, tuberculosis, tuberculous pleurisy|diagnosis, inflammation-associated markers, pleural effusion, tuberculosis, tuberculous pleurisy
4988965|NCT01685086|latent tuberculosis infection, tuberculosis, chronic kidney disease, peritoneal dialysis, hemodialysis|latent tuberculosis infection, tuberculosis, chronic kidney disease, peritoneal dialysis, hemodialysis
4988966|NCT01685073|marijuana|marijuana
4988967|NCT01685073|cannabis|cannabis
4988968|NCT01685073|treatment|treatment
4988969|NCT01685073|insomnia|insomnia
4988970|NCT01685073|relapse|relapse
4988971|NCT01685060|Non-Small Cell Lung Cancer|non-small cell lung cancer
4988974|NCT01685060|LDK378|ldk378
4988975|NCT01685060|Ceritinib|ceritinib
4988976|NCT01685047|Coronary Artery Disease|coronary artery disease
4988977|NCT01685047|Ventricular Arrhythmias|ventricular arrhythmias
4988978|NCT01685047|ST Segment Changes|st segment changes
4988979|NCT01685034|Eosinophilic esophagitis|eosinophilic esophagitis
4988980|NCT01685034|Environmental allergens|environmental allergens
4988981|NCT01685034|Allergy immunotherapy|allergy immunotherapy
4988982|NCT01685034|Tolerance|tolerance
4988983|NCT01685034|Allergic rhinitis|allergic rhinitis
4988984|NCT01685034|Asthma|asthma
4988985|NCT01685034|Seasonal variation|seasonal variation
4988986|NCT01685021|B-ALL|b-all
4988987|NCT01685021|CD19|cd19
4988988|NCT01685021|MOR208|mor208
4988989|NCT01685021|MOR00208|mor00208
4988990|NCT01685021|Xmab5574|xmab5574
4988991|NCT01685021|B-cell acute lymphoblastic leukemia|b-cell acute lymphoblastic leukemia
4988992|NCT01685021|Fc-optimized Anti-CD19 Antibody|fc-optimized anti-cd19 antibody
4988993|NCT01685008|NHL|nhl
4988994|NCT01685008|CD19|cd19
4988995|NCT01685008|MOR208|mor208
4988996|NCT01685008|MOR00208|mor00208
4988997|NCT01685008|Xmab5574|xmab5574
4988998|NCT01685008|B-Cell Non-Hodgkin´s Lymphoma|b-cell non-hodgkin´s lymphoma
4988999|NCT01685008|Fc-optimized Anti-CD19 Antibody|fc-optimized anti-cd19 antibody
4989000|NCT01684982|Primary PCI|primary pci
4989001|NCT01684982|Drug Eluting Stent|drug eluting stent
4989002|NCT01684969|Nausea|nausea
4989003|NCT01684969|vomiting|vomiting
4989004|NCT01684969|gastrointestinal symptoms|gastrointestinal symptoms
4989005|NCT01684969|palliative care|palliative care
4989006|NCT01684956|intradermal|intradermal
4989007|NCT01684956|pharmacokinetics|pharmacokinetics
4989008|NCT01684956|microneedle|microneedle
4989009|NCT01684956|insulin|insulin
4989010|NCT01684956|glucagon|glucagon
4989011|NCT01684943|Pharmacokinetics|pharmacokinetics
4989012|NCT01684930|Cardiovascular Diseases|cardiovascular diseases
4989013|NCT01684930|Vascular Diseases|vascular diseases
4989014|NCT01684930|Arterial Occlusive Diseases|arterial occlusive diseases
4989015|NCT01684930|Exercise|exercise
4989016|NCT01684930|Functional Capacity|functional capacity
4989017|NCT01684852|dry eye, sicca, HA, Hyaluronic Acid, ectoin, ectoine, bitop|dry eye, sicca, ha, hyaluronic acid, ectoin, ectoine, bitop
4989018|NCT01684839|Painful digital neuroma|painful digital neuroma
4989019|NCT01684839|nerve defect|nerve defect
4989020|NCT01684839|dorsal branch of the digital nerve|dorsal branch of the digital nerve
4989021|NCT01684839|digital nerve|digital nerve
4989022|NCT01684839|pedicled nerve flap|pedicled nerve flap
4989023|NCT01684839|Pain Disorder Associated with Psychological and Physical Factors|pain disorder associated with psychological and physical factors
4989024|NCT01684826|X-rays|x-rays
4989025|NCT01684826|Image processing|image processing
4989026|NCT01684826|Cardiovascular procedure|cardiovascular procedure
4989027|NCT01684813|Diabetes mellitus.|diabetes mellitus.
4989028|NCT01684813|Acute coronary syndrome.|acute coronary syndrome.
4989029|NCT01684813|Percutaneous coronary intervention.|percutaneous coronary intervention.
4989030|NCT01684787|chronic hepatitis C|chronic hepatitis c
4989031|NCT01684787|normal ALT|normal alt
4989032|NCT01684787|HIV/HCV patients|hiv/hcv patients
4989033|NCT01684761|Multicenter Study|multicenter study
4989034|NCT01684761|Randomized Controlled Trial|randomized controlled trial
4989035|NCT01684761|Individualized Medicine|individualized medicine
4989036|NCT01684761|Immunotherapy|immunotherapy
4989037|NCT01684761|Myelin Proteins|myelin proteins
4989038|NCT01684761|Biological Agents|biological agents
4989039|NCT01684748|angiotensin II|angiotensin ii
4989040|NCT01684748|obesity|obesity
4989041|NCT01684748|diabetes|diabetes
4989042|NCT01684735|diffusion-weighted magnetic resonance imaging|diffusion-weighted magnetic resonance imaging
4989043|NCT01684722|vitamin D3|vitamin d3
4989044|NCT01684722|omega-3 fatty acids|omega-3 fatty acids
4989045|NCT01684722|fish oil|fish oil
4989046|NCT01684722|diabetes|diabetes
4989047|NCT01684722|kidney disease|kidney disease
4989048|NCT01684722|albuminuria|albuminuria
4989049|NCT01684722|urine albumin excretion|urine albumin excretion
4989050|NCT01684722|glomerular filtration rate|glomerular filtration rate
4989051|NCT01684722|diabetic kidney disease|diabetic kidney disease
4989052|NCT01684709|Type 2 Diabetes|type 2 diabetes
4989053|NCT01684709|Informal Caregivers|informal caregivers
4989054|NCT01684709|Self Care|self care
4989055|NCT01684709|Quality of Life|quality of life
4989056|NCT01684709|Health Information Technology|health information technology
4989057|NCT01684696|Lung cancer|lung cancer
4989058|NCT01684696|stigma|stigma
4989059|NCT01684696|virtual intervention|virtual intervention
4989060|NCT01684696|mHealth|mhealth
4989061|NCT01684683|Bronchiectasis|bronchiectasis
4989062|NCT01684683|Theophylline|theophylline
4989063|NCT01684683|Therapeutic Uses|therapeutic uses
4989064|NCT01684683|HDAC|hdac
4989065|NCT01684683|HAT|hat
4989066|NCT01684683|Random placebo study|random placebo study
4989067|NCT01684657|Stuttering|stuttering
4989068|NCT01684644|ADHD|adhd
4989069|NCT01684644|Parent Training|parent training
4989070|NCT01684644|RCT|rct
4989071|NCT01684644|Preschool|preschool
4989072|NCT01684618|Preterm|preterm
4989073|NCT01684618|Neonate|neonate
4989074|NCT01684618|Newborn|newborn
4989075|NCT01684618|Cerebral oxygenation|cerebral oxygenation
4989076|NCT01684618|CPAP|cpap
4989077|NCT01684605|CKD-11101|ckd-11101
4989078|NCT01684605|NESP|nesp
4989079|NCT01684605|Darbepoetin alfa|darbepoetin alfa
4989080|NCT01684605|Anemia|anemia
4989081|NCT01684605|intravenous|intravenous
4989082|NCT01684605|Pharmacokinetics|pharmacokinetics
4989083|NCT01684605|Phase 1|phase 1
4989084|NCT01684592|smoking cessation|smoking cessation
4989085|NCT01684592|relapse prevention|relapse prevention
4989086|NCT01684592|pregnancy|pregnancy
4989087|NCT01684592|postpartum|postpartum
4989088|NCT01684579|Breast Cancer|breast cancer
4989089|NCT01684579|African-American Women|african-american women
4989090|NCT01684579|Aerobic Exercise|aerobic exercise
4989091|NCT01684553|Eating speed|eating speed
4989092|NCT01684553|energy intake|energy intake
4989093|NCT01684540|sinusitis, rhinosinusitis, ectoin, ectoine, bitop, SNS, SNS01|sinusitis, rhinosinusitis, ectoin, ectoine, bitop, sns, sns01
4989094|NCT01684514|confocal laser endomicroscopy|confocal laser endomicroscopy
4989095|NCT01684514|inflammatory bowel disease|inflammatory bowel disease
4989096|NCT01684514|colitis, ulcerative|colitis, ulcerative
4989097|NCT01684501|prosthesis|prosthesis
4989098|NCT01684501|amputees|amputees
4989099|NCT01684501|gait|gait
4989100|NCT01684488|Depression/therapy;|depression/therapy;
4989101|NCT01684488|Developing Countries;|developing countries;
4989102|NCT01684488|Interpersonal Relations;|interpersonal relations;
4989103|NCT01684488|Life Change Events;|life change events;
4989104|NCT01684488|Psychotherapy, Group;|psychotherapy, group;
4989105|NCT01684488|Resilience, Psychological;|resilience, psychological;
4989106|NCT01684488|Sierra Leone;|sierra leone;
4989107|NCT01684488|Survivors/psychology;|survivors/psychology;
4989108|NCT01684488|Social Adjustment;|social adjustment;
4989109|NCT01684488|Social Behavior;|social behavior;
4989110|NCT01684488|War|war
4989111|NCT01684475|Novel Treatment Parkinson's disease|novel treatment parkinson's disease
4989112|NCT01684462|Acute Ischemic Stroke|acute ischemic stroke
4989113|NCT01684462|Albumin|albumin
4989114|NCT01684449|Soft tissue sarcoma|soft tissue sarcoma
4989115|NCT01684449|Gemcitabine|gemcitabine
4989116|NCT01684449|Rapamycin|rapamycin
4989117|NCT01684449|Sirolimus|sirolimus
4989118|NCT01684449|mTOR inhibitor|mtor inhibitor
4989119|NCT01684449|Molecular biomarkers|molecular biomarkers
4989120|NCT01684410|Cystic Fibrosis|cystic fibrosis
4989121|NCT01684410|Alpha1-proteinase inhibitor|alpha1-proteinase inhibitor
4989122|NCT01684410|Alpha1-antitrypsin|alpha1-antitrypsin
4989123|NCT01684384|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
4989124|NCT01684384|COPD|copd
4989125|NCT01684384|Exacerbation|exacerbation
4989126|NCT01684384|Functional Respiratory Imaging|functional respiratory imaging
4989127|NCT01684384|High Resolution Computed Tomography|high resolution computed tomography
4989128|NCT01684384|HRCT scan|hrct scan
4989129|NCT01684384|Patient Reported Outcome|patient reported outcome
4989130|NCT01684384|PRO|pro
4989131|NCT01684384|Computational Fluid Dynamic|computational fluid dynamic
4989132|NCT01684384|CFD|cfd
4989133|NCT01684384|Lung function parameters|lung function parameters
4989134|NCT01684371|Osteoarthritis|osteoarthritis
4989135|NCT01684371|Osteoarthritic pain|osteoarthritic pain
4989136|NCT01684371|Arthritic pain|arthritic pain
4989137|NCT01684371|Arthritis|arthritis
4989138|NCT01684371|joint inflammation|joint inflammation
4989139|NCT01684371|Arthralgia|arthralgia
4989140|NCT01684358|Prostate-specific antigen|prostate-specific antigen
4989141|NCT01684358|Contraceptive implant|contraceptive implant
4989142|NCT01684358|Biological marker|biological marker
4989143|NCT01684358|Condoms|condoms
4989144|NCT01684358|Women|women
4989145|NCT01684345|Uveitis|uveitis
4989146|NCT01684345|Non-infectious Uveitis|non-infectious uveitis
4989147|NCT01684345|Intermediate Uveitis|intermediate uveitis
4989148|NCT01684345|Posterior Uveitis|posterior uveitis
4989149|NCT01684345|Panuveitis|panuveitis
4989150|NCT01684332|Antioxidant|antioxidant
4989151|NCT01684332|glucose metabolism|glucose metabolism
4989152|NCT01684332|jam|jam
4989153|NCT01684332|polyphenols|polyphenols
4989154|NCT01684332|postprandial|postprandial
4989155|NCT01684332|strawberry|strawberry
4989156|NCT01684319|Constipation|constipation
4989157|NCT01684319|Gastroeosphageal reflux|gastroeosphageal reflux
4989158|NCT01684319|Colics|colics
4989159|NCT01684306|RsfMRI, brain plasticity, cognitive enhancer|rsfmri, brain plasticity, cognitive enhancer
4989160|NCT01684293|Cocaine|cocaine
4989161|NCT01684293|Cognitive Impairment|cognitive impairment
4989162|NCT01684293|Cognitive Rehabilitation|cognitive rehabilitation
4989163|NCT01684280|abdominal adipose tissue; microRNA|abdominal adipose tissue; microrna
4989164|NCT01684267|Stroke|stroke
4989165|NCT01684267|Gait|gait
4989166|NCT01684267|Rehabilitation|rehabilitation
4989167|NCT01684254|Cerebral Palsy|cerebral palsy
4989168|NCT01684254|Home monitoring|home monitoring
4989169|NCT01684254|Gait|gait
4989170|NCT01684254|Sensorized Shoe|sensorized shoe
4989171|NCT01684241|Biontech|biontech
4989172|NCT01684241|Biontech RNA Pharmaceuticals GmbH|biontech rna pharmaceuticals gmbh
4989173|NCT01684241|Biontech RNA|biontech rna
4989174|NCT01684241|MERIT|merit
4989175|NCT01684241|RNA|rna
4989176|NCT01684241|Immuno Therapy|immuno therapy
4989177|NCT01684241|RB_0001-01|rb_0001-01
4989178|NCT01684241|Ribological|ribological
4989179|NCT01684241|Melanoma|melanoma
4989180|NCT01684241|RBL001|rbl001
4989181|NCT01684241|RBL002|rbl002
4989182|NCT01684241|cancer vaccine|cancer vaccine
4989183|NCT01684228|End stage renal disease|end stage renal disease
4989184|NCT01684228|hemodialysis|hemodialysis
4989185|NCT01684228|breath test|breath test
4989186|NCT01684228|volatile organic compound|volatile organic compound
4989187|NCT01684228|dialysis adequacy|dialysis adequacy
4989188|NCT01684215|Phase 1/2|phase 1/2
4989189|NCT01684215|PD-0332991|pd-0332991
4989190|NCT01684215|palbociclib|palbociclib
4989191|NCT01684215|Cyclin Dependent Kinase 4/6 inhibitor|cyclin dependent kinase 4/6 inhibitor
4989192|NCT01684215|Japanese|japanese
4989193|NCT01684215|solid tumors|solid tumors
4989194|NCT01684215|breast cancer|breast cancer
4989195|NCT01684215|A5481010|a5481010
4989196|NCT01684176|Stroke|stroke
4989197|NCT01684176|Ischemic Attack, Transient|ischemic attack, transient
4989198|NCT01684176|Medication adherence|medication adherence
4989199|NCT01684176|Motivational interviewing|motivational interviewing
4989200|NCT01684176|Stroke prevention|stroke prevention
4989201|NCT01684163|depression|depression
4989202|NCT01684163|MDD|mdd
4989203|NCT01684163|GLYX-13|glyx-13
4989204|NCT01684163|HDRS-17|hdrs-17
4989205|NCT01684163|HAMD-17|hamd-17
4989206|NCT01684150|Leukemia|leukemia
4989207|NCT01684150|Advanced hematologic malignancies|advanced hematologic malignancies
4989208|NCT01684150|Epizyme|epizyme
4989209|NCT01684150|Phase 1|phase 1
4989210|NCT01684150|Mixed Lineage Leukemia (MLL)|mixed lineage leukemia (mll)
4989211|NCT01684137|Food supplements|food supplements
4989212|NCT01684137|Asthma bronchiale|asthma bronchiale
4989213|NCT01684124|oxygen|oxygen
4989214|NCT01684124|critical illness|critical illness
4989215|NCT01684124|mechanical ventilation|mechanical ventilation
4989216|NCT01684111|Non Small Cell Lung Cancer - Stage IV|non small cell lung cancer - stage iv
4989217|NCT01684111|NSCLC Stage IV|nsclc stage iv
4989218|NCT01684098|recurrent or metastatic cancer|recurrent or metastatic cancer
4989219|NCT01684098|head and neck cancer|head and neck cancer
4989220|NCT01684098|pancreas cancer|pancreas cancer
4989221|NCT01684098|bladder cancer|bladder cancer
4989222|NCT01684098|testicular cancer|testicular cancer
4989223|NCT01684085|sleep deprivation, PTSD,prevention|sleep deprivation, ptsd,prevention
4989224|NCT01684072|varicella vaccine|varicella vaccine
4989225|NCT01684072|gelatin|gelatin
4989226|NCT01684046|multi-purpose solution|multi-purpose solution
4989227|NCT01684046|silicone hydrogel|silicone hydrogel
4989228|NCT01684046|contact lenses|contact lenses
4989229|NCT01684046|comfort|comfort
4989230|NCT01684046|Opti-Free|opti-free
4989231|NCT01684046|RevitaLens|revitalens
4989232|NCT01684033|multi-purpose solution|multi-purpose solution
4989233|NCT01684033|silicone hydrogel|silicone hydrogel
4989234|NCT01684033|contact lenses|contact lenses
4989235|NCT01684033|comfort|comfort
4989236|NCT01684033|Opti-Free|opti-free
4989237|NCT01684033|Biotrue|biotrue
4989238|NCT01684020|rhinoplasty|rhinoplasty
4989239|NCT01684020|external rhinoplasty|external rhinoplasty
4989240|NCT01684020|open rhinoplasty|open rhinoplasty
4989241|NCT01684020|nose job|nose job
4989242|NCT01684007|Intraocular lens|intraocular lens
4989243|NCT01684007|Multifocal intraocular lens (MIOL)|multifocal intraocular lens (miol)
4989244|NCT01683994|Angiogenesis Inhibitors|angiogenesis inhibitors
4989245|NCT01683994|Small Molecules|small molecules
4989246|NCT01683994|Tyrosine Kinase Inhibitor|tyrosine kinase inhibitor
4989247|NCT01683981|Idiopathic Pulmonary Arterial Hypertension|idiopathic pulmonary arterial hypertension
4989248|NCT01683981|Eisenmenger Syndrome|eisenmenger syndrome
4989249|NCT01683981|Exercise Capacity|exercise capacity
4989250|NCT01683981|Quality of Life|quality of life
4989251|NCT01683955|Tranexamic Acid|tranexamic acid
4989252|NCT01683955|Blood transfusion|blood transfusion
4989253|NCT01683955|Total hip arthroplasty|total hip arthroplasty
4989254|NCT01683942|cup disc ratio measurement|cup disc ratio measurement
4989255|NCT01683942|digital stereo optic disc images|digital stereo optic disc images
4989256|NCT01683929|Obesity|obesity
4989257|NCT01683929|Overweight|overweight
4989258|NCT01683929|Sugar consumption|sugar consumption
4989259|NCT01683929|Metabolic syndrome|metabolic syndrome
4989260|NCT01683929|Artificially sweetened foods and beverages|artificially sweetened foods and beverages
4989261|NCT01683916|spinal cord injury|spinal cord injury
4989262|NCT01683916|stress hormone|stress hormone
4989263|NCT01683916|surgery|surgery
4989264|NCT01683916|bispectral index value|bispectral index value
4989265|NCT01683916|volatile anesthetic|volatile anesthetic
4989266|NCT01683903|heart failure|heart failure
4989267|NCT01683903|cardiac rehabilitation|cardiac rehabilitation
4989268|NCT01683903|myocardial infarction|myocardial infarction
4989269|NCT01683890|Bladder symptoms|bladder symptoms
4989270|NCT01683890|Sexual function|sexual function
4989271|NCT01683890|Quality of life|quality of life
4989272|NCT01683890|Simple hysterectomy|simple hysterectomy
4989273|NCT01683851|pediatric|pediatric
4989274|NCT01683851|conscious sedation|conscious sedation
4989275|NCT01683851|mouthpiece|mouthpiece
4989276|NCT01683851|airway|airway
4989277|NCT01683851|isolite system|isolite system
4989278|NCT01683838|spinal cord injury|spinal cord injury
4989279|NCT01683838|muscle spasticity|muscle spasticity
4989280|NCT01683825|Amyloidosis|amyloidosis
4989281|NCT01683825|Cardiac|cardiac
4989282|NCT01683825|Heart|heart
4989283|NCT01683825|Imaging|imaging
4989284|NCT01683825|Diagnosis|diagnosis
4989285|NCT01683799|Osteoarthritis|osteoarthritis
4989286|NCT01683799|Insomnia|insomnia
4989287|NCT01683799|Chronic pain|chronic pain
4989288|NCT01683799|Cognitive Behavioral Therapy for Insomnia|cognitive behavioral therapy for insomnia
4989289|NCT01683799|Inflammation|inflammation
4989290|NCT01683799|Inflammatory cytokines|inflammatory cytokines
4989291|NCT01683773|Tuberculosis|tuberculosis
4989292|NCT01683773|Phase I|phase i
4989293|NCT01683773|MVA85A|mva85a
4989294|NCT01683773|AERAS-402|aeras-402
4989295|NCT01683760|Fluconazole|fluconazole
4989296|NCT01683747|sepsis|sepsis
4989297|NCT01683747|shock|shock
4989298|NCT01683747|placebo controlled|placebo controlled
4989299|NCT01683747|double blinded|double blinded
4989300|NCT01683747|interventional|interventional
4989301|NCT01683708|sepsis|sepsis
4989302|NCT01683708|jaundice|jaundice
4989303|NCT01683708|symbiotic|symbiotic
4989304|NCT01683708|translocation|translocation
4989305|NCT01683708|abdominal collection|abdominal collection
4989306|NCT01683708|morbidity|morbidity
4989307|NCT01683695|Lupus Arthritis, Systemic Lupus Erythematosus, AMG 557, Lupus|lupus arthritis, systemic lupus erythematosus, amg 557, lupus
4989308|NCT01683682|Non-Small Lung Cancer|non-small lung cancer
4989309|NCT01683682|NSCLC Stage IV|nsclc stage iv
4989310|NCT01683669|ALI|ali
4989311|NCT01683669|ARDS|ards
4989312|NCT01683669|Noisy pressure support ventilation|noisy pressure support ventilation
4989313|NCT01683656|HIV|hiv
4989314|NCT01683656|Atherosclerosis|atherosclerosis
4989315|NCT01683656|Niacin/laropiprant|niacin/laropiprant
4989316|NCT01683656|HDL|hdl
4989317|NCT01683630|Influenza|influenza
4989318|NCT01683630|Influenza type A|influenza type a
4989319|NCT01683630|Influenza type B|influenza type b
4989320|NCT01683630|hospitalization|hospitalization
4989321|NCT01683630|Manitoba|manitoba
4989322|NCT01683630|Canada|canada
4989323|NCT01683617|Psychological stress|psychological stress
4989324|NCT01683591|Acute stroke|acute stroke
4989325|NCT01683591|Dysphagia|dysphagia
4989326|NCT01683591|High-resolution manometry|high-resolution manometry
4989327|NCT01683578|mechanical ventilation|mechanical ventilation
4989328|NCT01683578|lung function|lung function
4989329|NCT01683578|abdominal surgery, open|abdominal surgery, open
4989330|NCT01683578|systemic inflammation|systemic inflammation
4989331|NCT01683552|ITCH|itch
4989332|NCT01683539|Schizophrenia|schizophrenia
4989333|NCT01683539|Chronic Mental Disorder|chronic mental disorder
4989334|NCT01683539|Employment|employment
4989335|NCT01683539|Cognitive remediation|cognitive remediation
4989336|NCT01683539|Vocational rehabilitation|vocational rehabilitation
4989337|NCT01683539|Brain-derived Neurotrophic Factor (BDNF)|brain-derived neurotrophic factor (bdnf)
4989338|NCT01683526|Urgent endotrachel intubation|urgent endotrachel intubation
4989339|NCT01683526|Direct laryngoscopy|direct laryngoscopy
4989340|NCT01683526|Video laryngoscopy|video laryngoscopy
4989341|NCT01683526|Glidescope|glidescope
4989342|NCT01683526|Critical Care|critical care
4989343|NCT01683513|OHSS|ohss
4989344|NCT01683513|mataphase II oocytes (MII)|mataphase ii oocytes (mii)
4989345|NCT01683513|good quality embryo's|good quality embryo's
4989346|NCT01683513|pregnancy|pregnancy
4989347|NCT01683474|aortic valve stenosis|aortic valve stenosis
4989348|NCT01683474|Calcification|calcification
4989349|NCT01683474|TAVI|tavi
4989350|NCT01683474|aortic valve Prosthesis|aortic valve prosthesis
4989351|NCT01683461|HIV|hiv
4989352|NCT01683461|AIDS|aids
4989353|NCT01683448|Perioperative medications|perioperative medications
4989354|NCT01683448|cardiac surgery|cardiac surgery
4989355|NCT01683448|outcomes|outcomes
4989356|NCT01683396|Erosive Osteoarthritis|erosive osteoarthritis
4989357|NCT01683396|Osteoarthritis|osteoarthritis
4989358|NCT01683396|Osteoarthritis of the Hand|osteoarthritis of the hand
4989359|NCT01683383|Hypoxic ischemic encephalopathy|hypoxic ischemic encephalopathy
4989360|NCT01683383|Therapeutic hypothermia|therapeutic hypothermia
4989361|NCT01683383|Whole body cooling|whole body cooling
4989362|NCT01683383|Transport cooling|transport cooling
4989363|NCT01683357|Liver Metastases|liver metastases
4989364|NCT01683357|Surgery|surgery
4989365|NCT01683357|Intraoperative Ultrasound|intraoperative ultrasound
4989366|NCT01683331|Kidney transplant|kidney transplant
4989367|NCT01683331|New onset diabetes|new onset diabetes
4989368|NCT01683331|Prevention|prevention
4989369|NCT01683331|Insulin|insulin
4989370|NCT01683305|biomarker,|biomarker,
4989371|NCT01683305|NAF|naf
4989372|NCT01683305|Subjects|subjects
4989373|NCT01683292|apomorphine|apomorphine
4989374|NCT01683292|inhaled|inhaled
4989375|NCT01683292|motor fluctuations|motor fluctuations
4989376|NCT01683279|pediatric|pediatric
4989377|NCT01683279|acute lymphoblastic leukemia|acute lymphoblastic leukemia
4989378|NCT01683279|CD19|cd19
4989379|NCT01683279|Chimeric Antigen Receptor|chimeric antigen receptor
4989380|NCT01683240|cholangiography|cholangiography
4989381|NCT01683240|cholangioscopy|cholangioscopy
4989382|NCT01683240|mother-baby|mother-baby
4989383|NCT01683240|cholangioscope|cholangioscope
4989384|NCT01683240|Frimberger cholangioscope|frimberger cholangioscope
4989385|NCT01683240|short access cholangioscopy|short access cholangioscopy
4989386|NCT01683240|ERCP|ercp
4989387|NCT01683240|gallstone therapy|gallstone therapy
4989388|NCT01683227|drug use; emergency department; brief intervention|drug use; emergency department; brief intervention
4989389|NCT01683201|Total hip replacement|total hip replacement
4989390|NCT01683201|Functional exercise class|functional exercise class
4989391|NCT01683201|Randomised controlled trial|randomised controlled trial
4989392|NCT01683188|melanoma|melanoma
4989393|NCT01683188|skin cancer|skin cancer
4989394|NCT01683188|Stage IV|stage iv
4989395|NCT01683175|Erlotinib|erlotinib
4989396|NCT01683175|adjuvant therapy|adjuvant therapy
4989397|NCT01683175|radical operation|radical operation
4989398|NCT01683175|IIIA NSCLC|iiia nsclc
4989399|NCT01683175|EGFR mutation|egfr mutation
4989400|NCT01683162|parenteral nutrition|parenteral nutrition
4989401|NCT01683162|lipid emulsion|lipid emulsion
4989402|NCT01683162|olive oil|olive oil
4989403|NCT01683162|liver function|liver function
4989404|NCT01683162|fatty acid|fatty acid
4989405|NCT01683162|clinical outcomes|clinical outcomes
4989406|NCT01683149|Refractory|refractory
4989407|NCT01683149|Relapsed|relapsed
4989408|NCT01683149|Recurrent|recurrent
4989409|NCT01683149|Pediatric|pediatric
4989410|NCT01683149|Malignancy|malignancy
4989411|NCT01683123|Allogeneic HSCT|allogeneic hsct
4989412|NCT01683123|Busulfan|busulfan
4989413|NCT01683123|Fludarabina|fludarabina
4989414|NCT01683084|Abdominal Aortic Aneurysm|abdominal aortic aneurysm
4989415|NCT01683084|AAA|aaa
4989416|NCT01683084|telmisartan|telmisartan
4989417|NCT01683071|Total knee arthroplasty|total knee arthroplasty
4989418|NCT01683071|Analgesia|analgesia
4989419|NCT01683071|Pain management|pain management
4989420|NCT01683058|Schizophrenia|schizophrenia
4989421|NCT01683045|non-paroxysmal atrial fibrillation|non-paroxysmal atrial fibrillation
4989422|NCT01683045|persistent atrial fibrillation|persistent atrial fibrillation
4989423|NCT01683045|atrial fibrillation|atrial fibrillation
4989424|NCT01683045|heart palpitations|heart palpitations
4989425|NCT01683045|irregular heart beat|irregular heart beat
4989426|NCT01683045|temperature-controlled radiofrequency ablation|temperature-controlled radiofrequency ablation
4989427|NCT01683045|radiofrequency energy|radiofrequency energy
4989428|NCT01683045|TCRF energy|tcrf energy
4989429|NCT01683045|RF energy|rf energy
4989430|NCT01683045|epicardial and endocardial lesions|epicardial and endocardial lesions
4989431|NCT01683045|concomitant heart surgery|concomitant heart surgery
4989432|NCT01683045|surgical ablation|surgical ablation
4989433|NCT01683019|Depression|depression
4989434|NCT01683019|magnetic field|magnetic field
4989435|NCT01683019|alpha frequency|alpha frequency
4989436|NCT01683019|EEG|eeg
4989437|NCT01683019|NeoSync EEG Synchronization Therapy|neosync eeg synchronization therapy
4989438|NCT01682993|corneal cross linking|corneal cross linking
4989439|NCT01682993|topography guided excimer laser|topography guided excimer laser
4989440|NCT01682993|Keratoconus|keratoconus
4989441|NCT01682993|Pellucid marginal degeneration|pellucid marginal degeneration
4989442|NCT01682993|Post Excimer ectasia|post excimer ectasia
4989443|NCT01682980|Osteoarthritis|osteoarthritis
4989444|NCT01682980|Pain|pain
4989445|NCT01682980|Exercise|exercise
4989446|NCT01682980|Function|function
4989447|NCT01682980|Cartilage quality|cartilage quality
4989448|NCT01682967|Parturients|parturients
4989449|NCT01682967|Analgesia, epidural|analgesia, epidural
4989450|NCT01682967|Headache, post-dural puncture|headache, post-dural puncture
4989451|NCT01682954|lifestyle risk reduction|lifestyle risk reduction
4989452|NCT01682941|soy, isoflavones, functional food, prostate cancer|soy, isoflavones, functional food, prostate cancer
4989453|NCT01682928|Oligohydramnios|oligohydramnios
4989454|NCT01682928|Hydrotherapy|hydrotherapy
4989455|NCT01682928|Pregnancy|pregnancy
4989456|NCT01682915|ADHD|adhd
4989457|NCT01682915|endophenotype|endophenotype
4989458|NCT01682915|executive function|executive function
4989459|NCT01682915|diffusion spectrum imaging|diffusion spectrum imaging
4989460|NCT01682915|resting-state fMRI|resting-state fmri
4989461|NCT01682915|frontostriatal and frontoparietal circuitries|frontostriatal and frontoparietal circuitries
4989462|NCT01682915|DAT1|dat1
4989463|NCT01682876|Prevention of meningococcal disease, children, vaccine|prevention of meningococcal disease, children, vaccine
4989464|NCT01682863|COPD, QAB149, QVA149, indacaterol maleate, gylcopyrronium bromide|copd, qab149, qva149, indacaterol maleate, gylcopyrronium bromide
4989465|NCT01682850|COPD|copd
4989466|NCT01682850|Chronic Obstructive Lung Disease|chronic obstructive lung disease
4989467|NCT01682850|lung cancer|lung cancer
4989468|NCT01682850|emphysema|emphysema
4989469|NCT01682850|Pulmonary Rehabilitation|pulmonary rehabilitation
4989470|NCT01682824|Central Nervous System|central nervous system
4989471|NCT01682824|CNS|cns
4989472|NCT01682824|CNS tumor|cns tumor
4989473|NCT01682824|Adolescent or Young Adult|adolescent or young adult
4989474|NCT01682824|AYA|aya
4989475|NCT01682824|Survivors|survivors
4989967|NCT01680900|vilazodone|vilazodone
4989476|NCT01682824|Eating Questionnaire-Ecological Momentary Assessment|eating questionnaire-ecological momentary assessment
4989477|NCT01682824|EQ-EMA|eq-ema
4989478|NCT01682824|Cognitive restraint|cognitive restraint
4989479|NCT01682824|CR|cr
4989480|NCT01682824|Uncontrollable eating|uncontrollable eating
4989481|NCT01682824|UE|ue
4989482|NCT01682824|Three Factor Eating Questionnaire-R18v2|three factor eating questionnaire-r18v2
4989483|NCT01682824|TFEQ-R18v2|tfeq-r18v2
4989484|NCT01682824|Web-based questionnaire|web-based questionnaire
4989485|NCT01682824|Multifactor Screener|multifactor screener
4989486|NCT01682785|Major depressive disorder|major depressive disorder
4989487|NCT01682785|Metabolic syndrome|metabolic syndrome
4989488|NCT01682785|Thyroid dysfunction|thyroid dysfunction
4989489|NCT01682785|incidence|incidence
4989490|NCT01682772|Olaparib|olaparib
4989491|NCT01682772|Adenocarcinoma|adenocarcinoma
4989492|NCT01682772|Prostate|prostate
4989493|NCT01682759|diabetes|diabetes
4989494|NCT01682746|Brain Tumor|brain tumor
4989495|NCT01682746|Photodynamic Therapy|photodynamic therapy
4989496|NCT01682746|Photochemotherapy|photochemotherapy
4989497|NCT01682746|Astrocytoma|astrocytoma
4989498|NCT01682746|Pilocytic Astrocytoma|pilocytic astrocytoma
4989499|NCT01682746|Low grade Astrocytoma|low grade astrocytoma
4989500|NCT01682746|Anaplastic Astrocytoma|anaplastic astrocytoma
4989501|NCT01682746|Glioblastoma|glioblastoma
4989502|NCT01682746|GBM|gbm
4989503|NCT01682746|Chordoma|chordoma
4989504|NCT01682746|Germinoma|germinoma
4989505|NCT01682746|Germ Cell Tumor|germ cell tumor
4989506|NCT01682746|Non-germinaoma|non-germinaoma
4989507|NCT01682746|CNS Lymphoma|cns lymphoma
4989508|NCT01682746|Craniopharyngioma|craniopharyngioma
4989509|NCT01682746|Brain Stem Glioma|brain stem glioma
4989510|NCT01682746|Ependymoma|ependymoma
4989511|NCT01682746|Mixed Glioma|mixed glioma
4989512|NCT01682746|Optic Nerve Glioma|optic nerve glioma
4989513|NCT01682746|Subependymoma|subependymoma
4989514|NCT01682746|Medulloblastoma|medulloblastoma
4989515|NCT01682746|Meningioma|meningioma
4989516|NCT01682746|Metastatic Brain Tumors|metastatic brain tumors
4989517|NCT01682746|Oligodendroglioma|oligodendroglioma
4989518|NCT01682746|Pituitary Tumors|pituitary tumors
4989519|NCT01682746|Primitive Neuroectodermal|primitive neuroectodermal
4989520|NCT01682746|PNET|pnet
4989521|NCT01682746|Desmoplastic Neuroepithelial Tumor|desmoplastic neuroepithelial tumor
4989522|NCT01682746|DNET|dnet
4989523|NCT01682733|Obesity|obesity
4989524|NCT01682733|Weight loss|weight loss
4989525|NCT01682733|Gastric reduction (volume)|gastric reduction (volume)
4989526|NCT01682733|BMI 30-40|bmi 30-40
4989527|NCT01682720|HCV|hcv
4989528|NCT01682720|Genotype 2|genotype 2
4989529|NCT01682720|Genotype 3|genotype 3
4989530|NCT01682707|intubation|intubation
4989531|NCT01682707|coronary disease|coronary disease
4989532|NCT01682707|hemodynamic response|hemodynamic response
4989533|NCT01682707|anesthesia with tracheal intubation|anesthesia with tracheal intubation
4989534|NCT01682707|assessment of hemodynamic response|assessment of hemodynamic response
4989535|NCT01682681|Epilepsy|epilepsy
4989536|NCT01682681|Topiramate|topiramate
4989537|NCT01682681|Topmax|topmax
4989538|NCT01682668|parkinson's disease|parkinson's disease
4989539|NCT01682668|subthalamic nucleus|subthalamic nucleus
4989540|NCT01682668|akinesia|akinesia
4989541|NCT01682668|gait initiation|gait initiation
4989542|NCT01682668|neuronal activity|neuronal activity
4989543|NCT01682668|before STN stimulation|before stn stimulation
4989544|NCT01682668|with STN stimulation|with stn stimulation
4989545|NCT01682668|functional MRI|functional mri
4989546|NCT01682642|endometriosis|endometriosis
4989547|NCT01682642|pregnancy|pregnancy
4989548|NCT01682642|In Vitro Fertilization (IVF)/Intra Cytoplastic Sperm Injection (ICSI)|in vitro fertilization (ivf)/intra cytoplastic sperm injection (icsi)
4989549|NCT01682642|peritoneal implants|peritoneal implants
4989550|NCT01682642|embryo quality|embryo quality
4989551|NCT01682629|Pediatric|pediatric
4989552|NCT01682629|Cardiac|cardiac
4989553|NCT01682629|Arrest|arrest
4989554|NCT01682629|Simulation|simulation
4989555|NCT01682629|Debriefing|debriefing
4989556|NCT01682629|Realism|realism
4989557|NCT01682616|Safety|safety
4989558|NCT01682616|Small Lymphocytic Lymphoma|small lymphocytic lymphoma
4989559|NCT01682616|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
4989560|NCT01682616|Rituximab|rituximab
4989561|NCT01682616|Tolerability|tolerability
4989562|NCT01682616|Pharmacokinetics|pharmacokinetics
4989563|NCT01682616|ABT-199|abt-199
4989564|NCT01682616|Cancer|cancer
4989565|NCT01682616|Preliminary|preliminary
4989566|NCT01682616|Efficacy|efficacy
4989567|NCT01682616|Maximum Tolerated Dose|maximum tolerated dose
4989568|NCT01682616|Venetoclax|venetoclax
4989569|NCT01682603|Nerve growth factor|nerve growth factor
4989570|NCT01682603|P2X3 receptor|p2x3 receptor
4989571|NCT01682603|Transient Receptor Potential Vanilloid 1 (TRPV-1) receptor|transient receptor potential vanilloid 1 (trpv-1) receptor
4989572|NCT01682603|Bladder function|bladder function
4989573|NCT01682603|Glomerular filtration rate|glomerular filtration rate
4989574|NCT01682603|Detrusor overactivity|detrusor overactivity
4989575|NCT01682603|Spinal cord injury|spinal cord injury
4989672|NCT01682161|Schizophrenia|schizophrenia
4989576|NCT01682590|septic shock; acute renal failure; renal remplacement therapy; mortality; intensive care; critical care; acute kidney injury|septic shock; acute renal failure; renal remplacement therapy; mortality; intensive care; critical care; acute kidney injury
4989577|NCT01682577|Perindopril|perindopril
4989578|NCT01682577|Perindoprilat|perindoprilat
4989579|NCT01682577|Bioequivalence|bioequivalence
4989580|NCT01682577|Pharmacokinetic|pharmacokinetic
4989581|NCT01682577|Angiotensin-converting enzyme inhibitor|angiotensin-converting enzyme inhibitor
4989582|NCT01682564|Candemore|candemore
4989583|NCT01682564|Atacand|atacand
4989584|NCT01682564|Candesartan cilexetil|candesartan cilexetil
4989585|NCT01682564|Primary Hypertension|primary hypertension
4989586|NCT01682564|Congestive Hypertension|congestive hypertension
4989587|NCT01682551|High altitude illness|high altitude illness
4989588|NCT01682551|Chinese medicine body constitution|chinese medicine body constitution
4989589|NCT01682551|Chinese Medicine|chinese medicine
4989590|NCT01682551|High altitude medicine|high altitude medicine
4989591|NCT01682551|Mountain trekking|mountain trekking
4989592|NCT01682538|Orfadin|orfadin
4989593|NCT01682538|Nitisinone|nitisinone
4989594|NCT01682538|Bioequivalence|bioequivalence
4989595|NCT01682538|Bioavailability|bioavailability
4989596|NCT01682525|Fertility preservation|fertility preservation
4989597|NCT01682525|Ovarian Tissue|ovarian tissue
4989598|NCT01682525|Cryopreservation|cryopreservation
4989599|NCT01682525|Assisted Reproductive Technology|assisted reproductive technology
4989600|NCT01682499|neuropathy|neuropathy
4989601|NCT01682499|taxane|taxane
4989602|NCT01682499|paclitaxel|paclitaxel
4989603|NCT01682499|calcium|calcium
4989604|NCT01682499|magnesium|magnesium
4989605|NCT01682499|prevention|prevention
4989606|NCT01682486|Medical device|medical device
4989607|NCT01682486|Endotracheal Tube(s), ETT|endotracheal tube(s), ett
4989608|NCT01682486|Bactiguard Coated ETT|bactiguard coated ett
4989609|NCT01682486|Tolerability|tolerability
4989610|NCT01682486|Safety|safety
4989611|NCT01682486|Performance|performance
4989612|NCT01682486|Bacterial colonization on ETT surface|bacterial colonization on ett surface
4989613|NCT01682486|Hospital Acquired Infections, HAI|hospital acquired infections, hai
4989614|NCT01682486|Ventilator Associated Pneumonia, VAP|ventilator associated pneumonia, vap
4989615|NCT01682473|PI3K inhibitor|pi3k inhibitor
4989616|NCT01682473|clinical trial|clinical trial
4989617|NCT01682447|COPD|copd
4989618|NCT01682447|Cognitive Dysfunction|cognitive dysfunction
4989619|NCT01682447|Pulmonary Rehabilitation|pulmonary rehabilitation
4989620|NCT01682447|Quality of life|quality of life
4989621|NCT01682447|Cognitive rehabilitation|cognitive rehabilitation
4989622|NCT01682408|R406,|r406,
4989623|NCT01682408|Fostamatinib,|fostamatinib,
4989624|NCT01682408|Phase I,|phase i,
4989625|NCT01682408|Healthy Subjects,|healthy subjects,
4989626|NCT01682408|Pharmacokinetics,|pharmacokinetics,
4989627|NCT01682408|Fed/Fasted|fed/fasted
4989628|NCT01682395|Intestinal volvulus|intestinal volvulus
4989629|NCT01682395|Colon, sigmoid|colon, sigmoid
4989630|NCT01682395|Anastomosis, surgical|anastomosis, surgical
4989631|NCT01682395|Anastomotic leak|anastomotic leak
4989632|NCT01682395|Malawi|malawi
4989633|NCT01682395|Developing Country|developing country
4989634|NCT01682382|age-related macular degeneration|age-related macular degeneration
4989635|NCT01682382|choroidal neovascular age-related macular degeneration|choroidal neovascular age-related macular degeneration
4989636|NCT01682382|genetics|genetics
4989637|NCT01682382|macular pigment optical density (MPOD)|macular pigment optical density (mpod)
4989638|NCT01682356|heart failure|heart failure
4989639|NCT01682356|hypertension, pulmonary|hypertension, pulmonary
4989640|NCT01682356|oxygen consumption|oxygen consumption
4989641|NCT01682356|exercise tolerance|exercise tolerance
4989642|NCT01682317|eating frequency|eating frequency
4989643|NCT01682304|preeclampsia|preeclampsia
4989644|NCT01682304|hypertension|hypertension
4989645|NCT01682304|blood pressure|blood pressure
4989646|NCT01682304|pregnancy induced hypertension|pregnancy induced hypertension
4989647|NCT01682304|chronic hypertension|chronic hypertension
4989648|NCT01682291|Prehypertension|prehypertension
4989649|NCT01682291|Life-style modifications|life-style modifications
4989650|NCT01682291|Dietary supplementation|dietary supplementation
4989651|NCT01682278|Health complaints|health complaints
4989652|NCT01682278|Amalgam|amalgam
4989653|NCT01682278|Mercury|mercury
4989654|NCT01682278|Plasma|plasma
4989655|NCT01682278|Cytokine|cytokine
4989656|NCT01682226|CYCLOPHOSPHAMIDE (CYTOXAN)|cyclophosphamide (cytoxan)
4989657|NCT01682226|CYCLOSPORINE|cyclosporine
4989658|NCT01682226|FLUDARABINE|fludarabine
4989659|NCT01682226|G-CSF|g-csf
4989660|NCT01682226|MYCOPHENOLATE MOFETIL (MMF)|mycophenolate mofetil (mmf)
4989661|NCT01682226|Cord Blood Transplantation|cord blood transplantation
4989662|NCT01682226|CliniMACS|clinimacs
4989663|NCT01682226|12-153|12-153
4989664|NCT01682213|Dabrafenib|dabrafenib
4989665|NCT01682213|(GSK2118436)|(gsk2118436)
4989666|NCT01682213|BRAFV600E/K|brafv600e/k
4989667|NCT01682213|Resected AJCC Stage IIIC|resected ajcc stage iiic
4989668|NCT01682213|12-124|12-124
4989669|NCT01682200|moderate|moderate
4989670|NCT01682200|facial acne|facial acne
4989671|NCT01682200|acne vulgaris|acne vulgaris
4989965|NCT01680900|menopause|menopause
4989673|NCT01682161|Paliperidone Palmitate|paliperidone palmitate
4989674|NCT01682161|Invega Sustenna|invega sustenna
4989675|NCT01682161|Antipsychotics|antipsychotics
4989676|NCT01682161|Atypical antipsychotics|atypical antipsychotics
4989677|NCT01682161|Medication Satisfaction and Adherence|medication satisfaction and adherence
4989678|NCT01682122|Blood Pressure|blood pressure
4989679|NCT01682122|Pediatrics|pediatrics
4989680|NCT01682122|Infant, Newborn|infant, newborn
4989681|NCT01682122|Cardiology|cardiology
4989682|NCT01682109|prophylaxis|prophylaxis
4989683|NCT01682109|herpes zoster|herpes zoster
4989684|NCT01682109|herpes simplex|herpes simplex
4989685|NCT01682109|valacyclovir|valacyclovir
4989686|NCT01682109|palatability|palatability
4989687|NCT01682109|paediatric|paediatric
4989688|NCT01682096|Chest pain|chest pain
4989689|NCT01682096|Emergency room|emergency room
4989690|NCT01682096|Acute coronary syndrome|acute coronary syndrome
4989691|NCT01682096|Computed tomography coronary angiography|computed tomography coronary angiography
4989692|NCT01682096|Stress echocardiography|stress echocardiography
4989693|NCT01682083|MEK inhibitor|mek inhibitor
4989694|NCT01682083|trametinib|trametinib
4989695|NCT01682083|Oncology|oncology
4989696|NCT01682083|adjuvant melanoma|adjuvant melanoma
4989697|NCT01682083|dabrafenib|dabrafenib
4989698|NCT01682083|dabrafenib and trametinib combination therapy|dabrafenib and trametinib combination therapy
4989699|NCT01682083|BRAF mutation-positive melanoma|braf mutation-positive melanoma
4989700|NCT01682083|BRAF inhibitor|braf inhibitor
4989701|NCT01682070|Sublingual immunotherapy|sublingual immunotherapy
4989702|NCT01682070|Dose range finding|dose range finding
4989703|NCT01682070|Dose tolerability|dose tolerability
4989704|NCT01682070|grass pollen|grass pollen
4989705|NCT01682070|Allergic rhinitis/rhinoconjunctivitis|allergic rhinitis/rhinoconjunctivitis
4989706|NCT01682070|Safety|safety
4989707|NCT01682070|Immunogenicity|immunogenicity
4989708|NCT01682057|High Blood Pressure|high blood pressure
4989709|NCT01682057|Hypertension|hypertension
4989710|NCT01682057|Resistant Hypertension|resistant hypertension
4989711|NCT01682018|emphysema|emphysema
4989712|NCT01682018|lung transplantation|lung transplantation
4989713|NCT01682005|Cost|cost
4989714|NCT01682005|Children|children
4989715|NCT01682005|Rotavirus|rotavirus
4989716|NCT01682005|Rotavirus vaccination|rotavirus vaccination
4989717|NCT01682005|Clinical|clinical
4989718|NCT01681992|Safety|safety
4989719|NCT01681992|Measles, mumps and rubella diseases|measles, mumps and rubella diseases
4989720|NCT01681992|Immunogenicity|immunogenicity
4989721|NCT01681979|fluticasone propionate|fluticasone propionate
4989722|NCT01681979|asthma|asthma
4989723|NCT01681979|pregnancy|pregnancy
4989724|NCT01681979|major congenital malformations|major congenital malformations
4989725|NCT01681927|idiopathic edema nocturia|idiopathic edema nocturia
4989726|NCT01681914|adult HIV positive patients|adult hiv positive patients
4989727|NCT01681875|Biomarkers of exposure|biomarkers of exposure
4989728|NCT01681875|Compensatory smoking|compensatory smoking
4989729|NCT01681875|Nicotine dependence|nicotine dependence
4989730|NCT01681875|Reduced nicotine cigarettes|reduced nicotine cigarettes
4989731|NCT01681875|Tobacco withdrawal|tobacco withdrawal
4989732|NCT01681862|Hypertension|hypertension
4989733|NCT01681862|African American|african american
4989734|NCT01681862|Personal Health Record|personal health record
4989735|NCT01681862|Faith-based Organizations|faith-based organizations
4989736|NCT01681849|PTSD|ptsd
4989737|NCT01681849|childhood abuse|childhood abuse
4989738|NCT01681823|Prostate Cancer|prostate cancer
4989739|NCT01681823|Prostatic Neoplasms|prostatic neoplasms
4989740|NCT01681823|Prostate Specific Antigen|prostate specific antigen
4989741|NCT01681823|Modified Citrus Pectin|modified citrus pectin
4989742|NCT01681823|PectaSol-C|pectasol-c
4989743|NCT01681823|Biochemical Relapse|biochemical relapse
4989744|NCT01681797|fluorescent angiography|fluorescent angiography
4989745|NCT01681797|reconstructive surgery|reconstructive surgery
4989746|NCT01681797|perforator flap|perforator flap
4989747|NCT01681784|lower urinary tract symptoms|lower urinary tract symptoms
4989748|NCT01681784|biomarkers|biomarkers
4989749|NCT01681784|urodynamic studies|urodynamic studies
4989750|NCT01681758|cardiac surgery|cardiac surgery
4989751|NCT01681758|Pulse pressure variation|pulse pressure variation
4989752|NCT01681758|intravenous fluids|intravenous fluids
4989753|NCT01681732|Asthma|asthma
4989754|NCT01681732|child|child
4989755|NCT01681732|pediatric|pediatric
4989756|NCT01681719|VO2|vo2
4989757|NCT01681719|VCO2|vco2
4989758|NCT01681719|VE/VO2|ve/vo2
4989759|NCT01681719|heart rate|heart rate
4989760|NCT01681706|HIV|hiv
4989761|NCT01681706|Indicator disease|indicator disease
4989762|NCT01681654|Head/Neck Cancer|head/neck cancer
4989763|NCT01681654|Exercise|exercise
4989764|NCT01681654|Progressive Strength Training|progressive strength training
4989765|NCT01681654|Quality of Life|quality of life
4989766|NCT01681654|Cancer|cancer
4989767|NCT01681654|Randomized Controlled Trial|randomized controlled trial
4989768|NCT01681654|Nutrition|nutrition
4989769|NCT01681654|Lifestyle Intervention|lifestyle intervention
4989770|NCT01681641|Patients|patients
4989771|NCT01681641|Nursing|nursing
4989772|NCT01681641|Parkinsons disease|parkinsons disease
4989773|NCT01681641|Deep Brain Stimulation|deep brain stimulation
4989774|NCT01681641|Spouses|spouses
4989775|NCT01681628|Thought Field Therapy.|thought field therapy.
4989776|NCT01681628|Post-traumatic stress disorder.|post-traumatic stress disorder.
4989777|NCT01681628|Post-traumatic stress disorder check list for Civilians.|post-traumatic stress disorder check list for civilians.
4989778|NCT01681628|Uganda|uganda
4989779|NCT01681628|Ugandan therapists.|ugandan therapists.
4989780|NCT01681628|Community treatment.|community treatment.
4989781|NCT01681615|Challenge test for Aspirin Hypersensitivity|challenge test for aspirin hypersensitivity
4989782|NCT01681615|Challenge test for Acetylsalicylic Hypersensitivity|challenge test for acetylsalicylic hypersensitivity
4989783|NCT01681602|Alzheimer Disease|alzheimer disease
4989784|NCT01681602|Exercise|exercise
4989785|NCT01681602|Cognition|cognition
4989786|NCT01681602|Quality of life|quality of life
4989787|NCT01681602|Cardiovascular fitness|cardiovascular fitness
4989788|NCT01681602|Behavioural or psychological symptoms|behavioural or psychological symptoms
4989789|NCT01681602|Physical fitness|physical fitness
4989790|NCT01681589|TBI|tbi
4989791|NCT01681589|Traumatic Brain Injury|traumatic brain injury
4989792|NCT01681589|Rehabilitation|rehabilitation
4989793|NCT01681589|Therapy|therapy
4989794|NCT01681576|hypertension, salt sensitivity, valsartan, LCZ696|hypertension, salt sensitivity, valsartan, lcz696
4989795|NCT01681537|Relapsed|relapsed
4989796|NCT01681537|Refractory|refractory
4989797|NCT01681524|Flurpiridaz F18 Injection|flurpiridaz f18 injection
4989798|NCT01681524|Positron Emission Tomography Myocardial Perfusion Imaging|positron emission tomography myocardial perfusion imaging
4989799|NCT01681524|Single Positron Emission Computed Tomography|single positron emission computed tomography
4989800|NCT01681524|Coronary Artery Disease|coronary artery disease
4989801|NCT01681524|Myocardia Ischemia|myocardia ischemia
4989802|NCT01681524|Coronary Disease|coronary disease
4989803|NCT01681524|Heart Diseases|heart diseases
4989804|NCT01681524|Cardiovascular Diseases|cardiovascular diseases
4989805|NCT01681524|Arteriosclerosis|arteriosclerosis
4989806|NCT01681524|Arterial Occlusive Diseases|arterial occlusive diseases
4989807|NCT01681524|Vascular Diseases|vascular diseases
4989808|NCT01681511|Catheter Associated Urinary Tract Infections|catheter associated urinary tract infections
4989809|NCT01681511|CAUTI|cauti
4989810|NCT01681498|pregnant|pregnant
4989811|NCT01681498|fetal ecg|fetal ecg
4989812|NCT01681498|ecg|ecg
4989813|NCT01681485|Traditional Chinese medicine|traditional chinese medicine
4989814|NCT01681485|Non small cell lung cancer|non small cell lung cancer
4989815|NCT01681485|Surgery|surgery
4989816|NCT01681485|Chemotherapy|chemotherapy
4989817|NCT01681485|Radiation therapy|radiation therapy
4989818|NCT01681472|Colon cancer|colon cancer
4989819|NCT01681472|5,10-methylenetetrahydrofolate|5,10-methylenetetrahydrofolate
4989820|NCT01681472|Rectal Neoplasms|rectal neoplasms
4989821|NCT01681472|Colorectal Neoplasms|colorectal neoplasms
4989822|NCT01681472|Intestinal Neoplasms|intestinal neoplasms
4989823|NCT01681472|Gastrointestinal Neoplasms|gastrointestinal neoplasms
4989824|NCT01681472|Digestive System Neoplasms|digestive system neoplasms
4989825|NCT01681472|Gastrointestinal Diseases|gastrointestinal diseases
4989826|NCT01681472|Therapeutic Uses|therapeutic uses
4989827|NCT01681472|Pharmacokinetics|pharmacokinetics
4989828|NCT01681472|Pharmacodynamics|pharmacodynamics
4989829|NCT01681459|Free fatty acid|free fatty acid
4989830|NCT01681459|Triglyceride|triglyceride
4989831|NCT01681459|Gastric emptying|gastric emptying
4989832|NCT01681459|Satiety hormones|satiety hormones
4989833|NCT01681459|Appetite|appetite
4989834|NCT01681459|Severe obesity|severe obesity
4989835|NCT01681446|hepatocellular carcinoma|hepatocellular carcinoma
4989836|NCT01681446|interferon-alpha|interferon-alpha
4989837|NCT01681446|miR-26|mir-26
4989838|NCT01681433|OGX-427|ogx-427
4989839|NCT01681433|Abiraterone Acetate|abiraterone acetate
4989840|NCT01681420|HIV counseling|hiv counseling
4989841|NCT01681420|Blood donor HIV testing|blood donor hiv testing
4989842|NCT01681420|Brazil|brazil
4989843|NCT01681420|Blood banks|blood banks
4989844|NCT01681420|Blood donors|blood donors
4989845|NCT01681407|Depression|depression
4989846|NCT01681407|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors
4989847|NCT01681407|MicroRNAs|micrornas
4989848|NCT01681407|Proteome|proteome
4989849|NCT01681368|NF-Kappa B Pathway|nf-kappa b pathway
4989850|NCT01681368|Response Biomarkers|response biomarkers
4989851|NCT01681368|Progression-Free Survival|progression-free survival
4989852|NCT01681368|Pharmacokinetics|pharmacokinetics
4989853|NCT01681368|Pharmacodynamics|pharmacodynamics
4989854|NCT01681355|Healthy, term, Asian infants|healthy, term, asian infants
4989855|NCT01681355|Infant formula|infant formula
4989856|NCT01681342|stade Ib to IV cervix cancer|stade ib to iv cervix cancer
4989857|NCT01681342|ambulatory high dose rate brachytherapy|ambulatory high dose rate brachytherapy
4989858|NCT01681329|Cognitive-behavioral therapy|cognitive-behavioral therapy
4989859|NCT01681329|Interpretation modification training|interpretation modification training
4989860|NCT01681329|Randomized clinical trial|randomized clinical trial
4989861|NCT01681329|Adults|adults
4989862|NCT01681316|Chronic Stable Angina|chronic stable angina
4989863|NCT01681316|Randomized Controlled Trial|randomized controlled trial
4989966|NCT01680900|hot flashes|hot flashes
4989864|NCT01681316|Traditional Chinese Medicine|traditional chinese medicine
4989865|NCT01681264|Pain|pain
4989866|NCT01681264|Pain Management|pain management
4989867|NCT01681264|Back pain|back pain
4989868|NCT01681264|Neck pain|neck pain
4989869|NCT01681238|perioperative fluid optimization|perioperative fluid optimization
4989870|NCT01681238|goal-directed therapy|goal-directed therapy
4989871|NCT01681238|elderly|elderly
4989872|NCT01681238|high-risk surgery|high-risk surgery
4989873|NCT01681225|ARDS|ards
4989874|NCT01681225|mechanical ventilation|mechanical ventilation
4989875|NCT01681225|ALI|ali
4989876|NCT01681225|esophageal pressure|esophageal pressure
4989877|NCT01681199|statin|statin
4989878|NCT01681199|atherosclerosis|atherosclerosis
4989879|NCT01681199|Coronary heart disease|coronary heart disease
4989880|NCT01681199|OPN|opn
4989881|NCT01681199|OPG|opg
4989882|NCT01681173|Nutritional support|nutritional support
4989883|NCT01681173|Diet therapy|diet therapy
4989884|NCT01681173|Diabetes prevention|diabetes prevention
4989885|NCT01681173|Insoluble fiber|insoluble fiber
4989886|NCT01681173|Healthy life style|healthy life style
4989887|NCT01681173|Weight loss|weight loss
4989888|NCT01681160|MAGGOT THERAPY|maggot therapy
4989889|NCT01681160|DIABETIC FOOT|diabetic foot
4989890|NCT01681160|NURSING CARE|nursing care
4989891|NCT01681160|DRESSING|dressing
4989892|NCT01681147|Gestational Diabetes|gestational diabetes
4989893|NCT01681147|postpartum|postpartum
4989894|NCT01681147|nutrition|nutrition
4989895|NCT01681147|exercise|exercise
4989896|NCT01681134|tacrolimus|tacrolimus
4989897|NCT01681134|Advagraf®|advagraf®
4989898|NCT01681134|Prograf®|prograf®
4989899|NCT01681134|Glomerular Filtration Rate|glomerular filtration rate
4989900|NCT01681134|Effective Renal Plasma Flow|effective renal plasma flow
4989901|NCT01681134|Pharmacokinetics|pharmacokinetics
4989902|NCT01681134|Pharmacodynamics|pharmacodynamics
4989903|NCT01681095|Physiological Effects of Drugs|physiological effects of drugs
4989904|NCT01681095|Cardiovascular Agents|cardiovascular agents
4989905|NCT01681095|Therapeutic Uses|therapeutic uses
4989906|NCT01681095|Pharmacologic Actions|pharmacologic actions
4989907|NCT01681095|Mannitol|mannitol
4989908|NCT01681095|Cardiac Surgery|cardiac surgery
4989909|NCT01681095|Cardioplegic Solutions|cardioplegic solutions
4989910|NCT01681095|HTK solution|htk solution
4989911|NCT01681095|Myocardial protection|myocardial protection
4989912|NCT01681095|Coronary Artery Disease|coronary artery disease
4989913|NCT01681095|Myocardial Ischemia|myocardial ischemia
4989914|NCT01681095|Coronary Disease|coronary disease
4989915|NCT01681095|Heart Diseases|heart diseases
4989916|NCT01681056|autosuggestion|autosuggestion
4989917|NCT01681056|quality of life|quality of life
4989918|NCT01681056|geriatric|geriatric
4989919|NCT01681056|serum cortisol|serum cortisol
4989920|NCT01681056|Interferon gamma|interferon gamma
4989921|NCT01681056|interleukin-2|interleukin-2
4989922|NCT01681056|interleukin-6|interleukin-6
4989923|NCT01681056|neuroplasticity|neuroplasticity
4989924|NCT01681043|Sleep|sleep
4989925|NCT01681017|Perinatal Mortality|perinatal mortality
4989926|NCT01681017|Asphyxia|asphyxia
4989927|NCT01681017|Stillbirth|stillbirth
4989928|NCT01681017|Neonatal Death|neonatal death
4989929|NCT01681017|Resuscitation|resuscitation
4989930|NCT01681017|Helping Babies Breathe|helping babies breathe
4989931|NCT01681017|among births greater than one thousand five hundred grams|among births greater than one thousand five hundred grams
4989932|NCT01681004|si joint|si joint
4989933|NCT01681004|si joint pain|si joint pain
4989934|NCT01681004|si joint injury|si joint injury
4989935|NCT01681004|si joint treatment|si joint treatment
4989936|NCT01681004|si joint injections|si joint injections
4989937|NCT01681004|si joint inflammation|si joint inflammation
4989938|NCT01681004|si joint problems|si joint problems
4989939|NCT01681004|si joint symptoms|si joint symptoms
4989940|NCT01681004|hypermobile si joint|hypermobile si joint
4989941|NCT01681004|si joint arthritis|si joint arthritis
4989942|NCT01681004|si joint pain treatment|si joint pain treatment
4989943|NCT01681004|inflamed si joint|inflamed si joint
4989944|NCT01681004|si joint sclerosis|si joint sclerosis
4989945|NCT01681004|locked si joint|locked si joint
4989946|NCT01681004|si joint injuries|si joint injuries
4989947|NCT01681004|si joint disease|si joint disease
4989948|NCT01681004|si joint infection|si joint infection
4989949|NCT01681004|sacroiliac joint pelvic pain|sacroiliac joint pelvic pain
4989950|NCT01681004|sacroiliac joint arthritis treatment|sacroiliac joint arthritis treatment
4989951|NCT01680965|Graft vs. Host Disease|graft vs. host disease
4989952|NCT01680965|GVHD|gvhd
4989953|NCT01680965|chronic graft versus host disease (cGVHD)|chronic graft versus host disease (cgvhd)
4989954|NCT01680965|Allogeneic Transplant|allogeneic transplant
4989955|NCT01680965|Ofatumumab|ofatumumab
4989956|NCT01680952|RECORD study|record study
4989957|NCT01680939|Pediatrics|pediatrics
4989958|NCT01680939|Obstructive Sleep Apnea|obstructive sleep apnea
4989959|NCT01680939|Adenotonsillectomy|adenotonsillectomy
4989960|NCT01680939|Analgesia|analgesia
4989961|NCT01680926|type 2 diabetes mellitus|type 2 diabetes mellitus
4989962|NCT01680926|insulin|insulin
4989963|NCT01680926|hbA1c|hba1c
4989964|NCT01680926|body weight|body weight
4989968|NCT01680887|Cocaine dependence|cocaine dependence
4989969|NCT01680874|Clostridium difficile|clostridium difficile
4989970|NCT01680874|Diarrhea|diarrhea
4989971|NCT01680874|Infection|infection
4989972|NCT01680874|Lactobacilli|lactobacilli
4989973|NCT01680874|Bifidobacteria|bifidobacteria
4989974|NCT01680874|Lactobacillus acidophilus|lactobacillus acidophilus
4989975|NCT01680874|Lactobacillus paracasei|lactobacillus paracasei
4989976|NCT01680874|Bifidobacterium lactis|bifidobacterium lactis
4989977|NCT01680874|Yogurt|yogurt
4989978|NCT01680874|Probiotics|probiotics
4989979|NCT01680861|Kidney transplant patients|kidney transplant patients
4989980|NCT01680848|Dental caries,|dental caries,
4989981|NCT01680848|Caries diagnosis,|caries diagnosis,
4989982|NCT01680848|Caries treatment,|caries treatment,
4989983|NCT01680848|Caries risk,|caries risk,
4989984|NCT01680848|Practice pattern,|practice pattern,
4989985|NCT01680848|Clinical epidemiology,|clinical epidemiology,
4989986|NCT01680848|Dental Practice-Based Research Network|dental practice-based research network
4989987|NCT01680822|Nontuberculous, Atypical, Mycobacterial|nontuberculous, atypical, mycobacterial
4989988|NCT01680809|Venous insufficiency|venous insufficiency
4989989|NCT01680809|Venous stasis ulcerations|venous stasis ulcerations
4989990|NCT01680809|Compression stockings|compression stockings
4989991|NCT01680809|Compression stocking compliance|compression stocking compliance
4989992|NCT01680796|Multiple Myeloma|multiple myeloma
4989993|NCT01680796|Relapsed Multiple Myeloma|relapsed multiple myeloma
4989994|NCT01680796|Refractory Multiple Myeloma|refractory multiple myeloma
4989995|NCT01680783|noninvasive ventilation|noninvasive ventilation
4989996|NCT01680783|acute hypoxemic respiratory failure|acute hypoxemic respiratory failure
4989997|NCT01680783|Acute respiratory distress syndrome|acute respiratory distress syndrome
4989998|NCT01680783|shock|shock
4989999|NCT01680770|shock|shock
4990000|NCT01680770|transthoracic echocardiography|transthoracic echocardiography
4990001|NCT01680770|critical care|critical care
4990002|NCT01680757|Left Atrial Appendage|left atrial appendage
4990003|NCT01680757|LARIAT|lariat
4990004|NCT01680757|atrial fibrillation|atrial fibrillation
4990005|NCT01680757|contraindication to oral anticoagulation therapy|contraindication to oral anticoagulation therapy
4990006|NCT01680744|Transplantation|transplantation
4990007|NCT01680744|Terminal creatinine|terminal creatinine
4990008|NCT01680744|Renal function|renal function
4990009|NCT01680744|GFR|gfr
4990010|NCT01680731|Pelvic floor injury|pelvic floor injury
4990011|NCT01680731|Levator ani muscle|levator ani muscle
4990012|NCT01680718|oxytocin|oxytocin
4990013|NCT01680718|vasopressin|vasopressin
4990014|NCT01680718|intranasal administration|intranasal administration
4990015|NCT01680718|healthy sample|healthy sample
4990016|NCT01680705|Chronic Rhinosinusitis|chronic rhinosinusitis
4990017|NCT01680705|Endoscopic Sinus Surgery|endoscopic sinus surgery
4990018|NCT01680705|Sinonasal saline irrigation|sinonasal saline irrigation
4990019|NCT01680705|Frequency|frequency
4990020|NCT01680705|Postoperative|postoperative
4990021|NCT01680705|High Volume|high volume
4990022|NCT01680705|Randomized Control Trial|randomized control trial
4990023|NCT01680705|Single Blinded|single blinded
4990024|NCT01680705|Prospective Study|prospective study
4990025|NCT01680705|Quality of Life|quality of life
4990026|NCT01680705|Endoscopic Sinus Score|endoscopic sinus score
4990027|NCT01680692|Analgesia TKA|analgesia tka
4990028|NCT01680692|Total knee arthroplasty|total knee arthroplasty
4990029|NCT01680692|Continuous femoral catheter|continuous femoral catheter
4990030|NCT01680692|Continuous tibial catheter|continuous tibial catheter
4990031|NCT01680692|Single shot sciatic|single shot sciatic
4990032|NCT01680679|Influenza|influenza
4990033|NCT01680679|India|india
4990034|NCT01680679|Children|children
4990035|NCT01680679|Trivalent Influenza Vaccine (TIV)|trivalent influenza vaccine (tiv)
4990036|NCT01680679|Inactivated poliovirus vaccine (IPV)|inactivated poliovirus vaccine (ipv)
4990037|NCT01680679|Direct influenza vaccine effectiveness|direct influenza vaccine effectiveness
4990038|NCT01680679|Total influenza vaccine effectiveness|total influenza vaccine effectiveness
4990039|NCT01680679|Indirect influenza vaccine effectiveness|indirect influenza vaccine effectiveness
4990040|NCT01680640|non alcoholic fatty liver disease|non alcoholic fatty liver disease
4990041|NCT01680640|NAFLD|nafld
4990042|NCT01680640|synbiotic|synbiotic
4990043|NCT01680640|gut microbiota|gut microbiota
4990044|NCT01680640|intervention|intervention
4990045|NCT01680640|RCT|rct
4990046|NCT01680640|biomarkers|biomarkers
4990047|NCT01680588|Alzheimer|alzheimer
4990048|NCT01680575|Neutropenia|neutropenia
4990049|NCT01680575|Paclitaxel|paclitaxel
4990050|NCT01680575|Carboplatin|carboplatin
4990051|NCT01680575|Epithelial ovarian cancer|epithelial ovarian cancer
4990052|NCT01680562|in-vivo skin imaging|in-vivo skin imaging
4990053|NCT01680562|non-invasive non-melanoma skin cancer diagnostics|non-invasive non-melanoma skin cancer diagnostics
4990054|NCT01680523|cervical cancer|cervical cancer
4990055|NCT01680523|bulky early-stage|bulky early-stage
4990056|NCT01680523|locally advanced|locally advanced
4990057|NCT01680523|radical hysterectomy|radical hysterectomy
4990058|NCT01680523|concurrent chemoradiation therapy|concurrent chemoradiation therapy
4990059|NCT01680484|non-stress test|non-stress test
4990060|NCT01680471|emergence agitation|emergence agitation
4990061|NCT01680471|midazolam|midazolam
4990062|NCT01680471|sevoflurane|sevoflurane
4990063|NCT01680471|strabismus|strabismus
4990064|NCT01680458|antifungal treatment|antifungal treatment
4990065|NCT01680458|prophylaxis|prophylaxis
4990066|NCT01680458|administration|administration
4990067|NCT01680458|Japanese|japanese
4990068|NCT01680458|infants|infants
4990069|NCT01680458|fluconazole|fluconazole
4990070|NCT01680458|Diflucan|diflucan
4990071|NCT01680458|Regulatory Post Marketing Commitment Plan.|regulatory post marketing commitment plan.
4990072|NCT01680445|osteoarthritis, arthritis|osteoarthritis, arthritis
4990073|NCT01680432|constipation|constipation
4990074|NCT01680432|probiotics|probiotics
4990075|NCT01680432|bifidobacterium|bifidobacterium
4990076|NCT01680432|cheese|cheese
4990077|NCT01680419|Veterans|veterans
4990078|NCT01680419|Reintegration|reintegration
4990079|NCT01680419|Resilience|resilience
4990080|NCT01680419|Marital|marital
4990081|NCT01680419|Spouse|spouse
4990082|NCT01680419|Behavioral intervention|behavioral intervention
4990083|NCT01680419|PTSD|ptsd
4990084|NCT01680419|Integrative therapies|integrative therapies
4990085|NCT01680419|Complementary therapies|complementary therapies
4990086|NCT01680419|Massage|massage
4990087|NCT01680419|Meditation|meditation
4990088|NCT01680419|Mindfulness|mindfulness
4990089|NCT01680419|Compassion|compassion
4990090|NCT01680419|Mental health|mental health
4990091|NCT01680406|Plasmodium vivax|plasmodium vivax
4990092|NCT01680406|malaria|malaria
4990093|NCT01680406|Ethiopia|ethiopia
4990094|NCT01680406|Sub-Saharan Africa|sub-saharan africa
4990095|NCT01680406|primaquine|primaquine
4990096|NCT01680406|artemether lumefantrine|artemether lumefantrine
4990097|NCT01680406|chloroquine|chloroquine
4990098|NCT01680380|sleep apnea|sleep apnea
4990099|NCT01680380|snoring|snoring
4990100|NCT01680315|Satiety,|satiety,
4990101|NCT01680315|satiation,|satiation,
4990102|NCT01680315|anticipation,|anticipation,
4990103|NCT01680315|food intake|food intake
4990104|NCT01680302|Atrial fibrillation|atrial fibrillation
4990105|NCT01680302|Prevention|prevention
4990106|NCT01680302|Exercise|exercise
4990107|NCT01680289|Dentin bonding agents|dentin bonding agents
4990108|NCT01680289|Composite restorations|composite restorations
4990109|NCT01680289|Dental restoration failure|dental restoration failure
4990110|NCT01680276|intellectual disability|intellectual disability
4990111|NCT01680276|developmental disability|developmental disability
4990112|NCT01680276|challenging behaviour|challenging behaviour
4990113|NCT01680276|behavioural intervention|behavioural intervention
4990114|NCT01680276|training|training
4990115|NCT01680263|Kinesiotaping|kinesiotaping
4990116|NCT01680263|pes anserinus tendino-bursitis|pes anserinus tendino-bursitis
4990117|NCT01680263|nonsteroidal anti-inflammatory drugs|nonsteroidal anti-inflammatory drugs
4990118|NCT01680263|physical therapy|physical therapy
4990119|NCT01680250|Total liver volume|total liver volume
4990120|NCT01680250|Liver cyst|liver cyst
4990121|NCT01680237|cognitive behavior therapy|cognitive behavior therapy
4990122|NCT01680237|exposure in-vivo|exposure in-vivo
4990123|NCT01680237|panic disorder with agoraphobia|panic disorder with agoraphobia
4990124|NCT01680224|Obesity|obesity
4990125|NCT01680224|Weight Gain|weight gain
4990126|NCT01680224|Dissonance|dissonance
4990127|NCT01680224|College,University Students|college,university students
4990128|NCT01680224|Eating Disorders|eating disorders
4990129|NCT01680224|Obesity Prevention|obesity prevention
4990130|NCT01680224|Selective Prevention|selective prevention
4990131|NCT01680224|Effectiveness|effectiveness
4990132|NCT01680211|Blood Sugar,|blood sugar,
4990133|NCT01680211|Lipoproteins,|lipoproteins,
4990134|NCT01680211|Salacia,|salacia,
4990135|NCT01680211|Sesame,|sesame,
4990136|NCT01680211|Prediabetes,|prediabetes,
4990137|NCT01680211|Hyperlipidemia,|hyperlipidemia,
4990138|NCT01680211|Herbal supplement|herbal supplement
4990139|NCT01680198|Vitamin D|vitamin d
4990140|NCT01680198|Paracalcitol|paracalcitol
4990141|NCT01680198|Chronic kidney disease|chronic kidney disease
4990142|NCT01680198|Endothelial dysfunction|endothelial dysfunction
4990143|NCT01680198|Flow mediated vasodilation|flow mediated vasodilation
4990144|NCT01680185|Hyperglycemia|hyperglycemia
4990145|NCT01680185|NODAT|nodat
4990146|NCT01680185|Insulin pump|insulin pump
4990147|NCT01680185|Semiclosed loop|semiclosed loop
4990148|NCT01680172|cancer|cancer
4990149|NCT01680172|depression|depression
4990150|NCT01680172|anxiety|anxiety
4990151|NCT01680172|palliative care|palliative care
4990152|NCT01680159|Infliximab|infliximab
4990153|NCT01680159|REMICADE|remicade
4990154|NCT01680159|TA-650|ta-650
4990155|NCT01680159|psoriasis|psoriasis
4990156|NCT01680107|d-cycloserine, cognitive-behaviour therapy, panic disorder|d-cycloserine, cognitive-behaviour therapy, panic disorder
4990157|NCT01680094|HIV Infection|hiv infection
4990158|NCT01680094|Panobinostat|panobinostat
4990159|NCT01680094|Lentivirus Infections|lentivirus infections
4990160|NCT01680094|Retroviridae Infections|retroviridae infections
4990161|NCT01680094|RNA Virus Infections|rna virus infections
4990162|NCT01680094|Virus Diseases|virus diseases
4990163|NCT01680094|Sexually Transmitted Diseases, Viral|sexually transmitted diseases, viral
4990164|NCT01680094|Sexually Transmitted Diseases|sexually transmitted diseases
4990165|NCT01680094|Immunologic Deficiency Syndromes|immunologic deficiency syndromes
4990166|NCT01680094|Immune System Diseases|immune system diseases
4990167|NCT01680094|Histone Deacetylase Inhibitors|histone deacetylase inhibitors
4990168|NCT01680094|Therapeutic Uses|therapeutic uses
4990169|NCT01680068|Macular hole|macular hole
4990170|NCT01680068|Vitreoretinal surgery|vitreoretinal surgery
4990171|NCT01680068|Macular surgery|macular surgery
4990172|NCT01680068|Air tamponade|air tamponade
4990173|NCT01680042|inflammatory halo|inflammatory halo
4990174|NCT01680042|VAS|vas
4990175|NCT01680016|Rabies virus, postexposure, vaccine schedule, children, older adults|rabies virus, postexposure, vaccine schedule, children, older adults
4990176|NCT01679964|HIV infection|hiv infection
4990177|NCT01679964|Raltegravir|raltegravir
4990178|NCT01679964|Adverse event|adverse event
4990179|NCT01679964|Life quality|life quality
4990180|NCT01679951|Rheumatoid arthritis|rheumatoid arthritis
4990181|NCT01679951|Swollen and tender joints|swollen and tender joints
4990182|NCT01679951|Methotrexate|methotrexate
4990183|NCT01679951|Immunology|immunology
4990184|NCT01679951|Dose range finding study|dose range finding study
4990185|NCT01679938|obesity prevention|obesity prevention
4990186|NCT01679938|cluster-randomized controlled trial|cluster-randomized controlled trial
4990187|NCT01679938|preschool-aged children|preschool-aged children
4990188|NCT01679925|Early puberty|early puberty
4990189|NCT01679925|Psychosocial impact|psychosocial impact
4990190|NCT01679925|Qualitative assessment|qualitative assessment
4990191|NCT01679912|Hereditary angioedema|hereditary angioedema
4990192|NCT01679912|Emergency Medical Service|emergency medical service
4990193|NCT01679912|Health care coast|health care coast
4990194|NCT01679912|Telephone|telephone
4990195|NCT01679899|diabetes|diabetes
4990196|NCT01679899|type 2 diabetes mellitus|type 2 diabetes mellitus
4990197|NCT01679899|osteopenia|osteopenia
4990198|NCT01679899|osteoporosis|osteoporosis
4990199|NCT01679899|glycemic variability|glycemic variability
4990200|NCT01679899|bone markers|bone markers
4990201|NCT01679899|osteocalcin|osteocalcin
4990202|NCT01679899|NTX|ntx
4990203|NCT01679899|CTX|ctx
4990204|NCT01679899|BALP|balp
4990205|NCT01679886|Position emission tomography;|position emission tomography;
4990206|NCT01679886|Rubidium;|rubidium;
4990207|NCT01679886|Women;|women;
4990208|NCT01679886|Overweighted patients|overweighted patients
4990209|NCT01679873|confidence|confidence
4990210|NCT01679873|funding sources|funding sources
4990211|NCT01679873|conflicts of interests|conflicts of interests
4990212|NCT01679873|general practitioner|general practitioner
4990213|NCT01679847|Elemene|elemene
4990214|NCT01679847|pharmacokinetics|pharmacokinetics
4990215|NCT01679847|Blood-brain barrier|blood-brain barrier
4990216|NCT01679821|Temporomandibular disorders.|temporomandibular disorders.
4990217|NCT01679821|Dental prosthesis.|dental prosthesis.
4990218|NCT01679821|Dental students|dental students
4990219|NCT01679808|copd|copd
4990220|NCT01679808|airway obstruction|airway obstruction
4990221|NCT01679808|Tracheobronchomalacia|tracheobronchomalacia
4990222|NCT01679795|hormone replacement therapy; Dopplervelocimetry; Flow-mediated dilation; menopause; tibolone|hormone replacement therapy; dopplervelocimetry; flow-mediated dilation; menopause; tibolone
4990223|NCT01679782|COPD, nervous system, peripheral muscle dysfunction|copd, nervous system, peripheral muscle dysfunction
4990224|NCT01679756|Colorectal cancer|colorectal cancer
4990225|NCT01679756|Laparoscopic right hemicolectomy|laparoscopic right hemicolectomy
4990226|NCT01679756|Intracorporeal anastomosis|intracorporeal anastomosis
4990227|NCT01679743|Metastatic Breast Cancer|metastatic breast cancer
4990228|NCT01679743|Metastatic Lung Cancer|metastatic lung cancer
4990229|NCT01679743|Monoclonal Antibody|monoclonal antibody
4990230|NCT01679743|18FLT|18flt
4990231|NCT01679743|Surgery|surgery
4990232|NCT01679717|Osteoarthritis|osteoarthritis
4990233|NCT01679717|CMC1-joint|cmc1-joint
4990234|NCT01679717|Postoperative therapy|postoperative therapy
4990235|NCT01679717|Interposition arthroplasty of the thumb|interposition arthroplasty of the thumb
4990236|NCT01679717|Occupational therapy|occupational therapy
4990237|NCT01679652|Essential hypertension|essential hypertension
4990238|NCT01679652|Nitric oxide|nitric oxide
4990239|NCT01679652|Nebivolol|nebivolol
4990240|NCT01679652|Fractional excretion of sodium|fractional excretion of sodium
4990241|NCT01679626|cricoid pressure (CP)|cricoid pressure (cp)
4990242|NCT01679626|backward upward rightward pressure (BURP)|backward upward rightward pressure (burp)
4990243|NCT01679626|AP-rima distances|ap-rima distances
4990244|NCT01679626|Glottic area|glottic area
4990371|NCT01679067|GALT|galt
4990245|NCT01679626|Extralaryngeal manoeuvres|extralaryngeal manoeuvres
4990246|NCT01679600|Rehabilitation|rehabilitation
4990247|NCT01679600|Robotics-assisted Treadmill Exercise|robotics-assisted treadmill exercise
4990248|NCT01679600|Aerobic Capacity|aerobic capacity
4990249|NCT01679600|Exercise Testing|exercise testing
4990250|NCT01679574|PCO|pco
4990251|NCT01679561|implantation failure|implantation failure
4990252|NCT01679561|recurrent abortion|recurrent abortion
4990253|NCT01679561|intralipid|intralipid
4990254|NCT01679535|Infant nutrition disorder|infant nutrition disorder
4990255|NCT01679535|Child nutrition disorders|child nutrition disorders
4990256|NCT01679535|Malnutrition|malnutrition
4990257|NCT01679535|Protein-energy malnutrition|protein-energy malnutrition
4990258|NCT01679522|endometrial cancer|endometrial cancer
4990259|NCT01679522|laparoscopic surgical staging|laparoscopic surgical staging
4990260|NCT01679522|single-port|single-port
4990261|NCT01679522|four-port|four-port
4990262|NCT01679496|LDL-cholesterol|ldl-cholesterol
4990263|NCT01679470|cancer|cancer
4990264|NCT01679470|lung|lung
4990265|NCT01679470|laser|laser
4990266|NCT01679470|ablation|ablation
4990267|NCT01679470|airway obstruction|airway obstruction
4990268|NCT01679444|MRS|mrs
4990269|NCT01679444|Heavy dose drinkers|heavy dose drinkers
4990270|NCT01679444|Alcohol|alcohol
4990271|NCT01679444|NIAAA|niaaa
4990272|NCT01679431|Aortic Stenosis|aortic stenosis
4990273|NCT01679431|Obesity, Abdominal|obesity, abdominal
4990274|NCT01679431|Metabolic Syndrome X|metabolic syndrome x
4990275|NCT01679431|Insulin Resistance|insulin resistance
4990276|NCT01679431|Echocardiography, Doppler|echocardiography, doppler
4990277|NCT01679431|Multidetector Computed Tomography|multidetector computed tomography
4990278|NCT01679431|Magnetic Resonance Imaging|magnetic resonance imaging
4990279|NCT01679418|PONV|ponv
4990280|NCT01679418|thyroid|thyroid
4990281|NCT01679418|surgery|surgery
4990282|NCT01679418|nausea and vomiting|nausea and vomiting
4990283|NCT01679418|postoperative|postoperative
4990284|NCT01679405|metastatic biliary tract cancer|metastatic biliary tract cancer
4990285|NCT01679392|Transversus abdominis plane block|transversus abdominis plane block
4990286|NCT01679392|Ultrasound guided nerve block|ultrasound guided nerve block
4990287|NCT01679379|Cesarean Section|cesarean section
4990288|NCT01679379|Obese Women|obese women
4990289|NCT01679379|Surgical Site Infection|surgical site infection
4990290|NCT01679353|inguinal hernia, caudal analgesia, magnesium|inguinal hernia, caudal analgesia, magnesium
4990291|NCT01679340|Gastric cancer|gastric cancer
4990292|NCT01679340|D2 surgery|d2 surgery
4990293|NCT01679340|S-1|s-1
4990294|NCT01679340|Oxaliplatin|oxaliplatin
4990295|NCT01679340|cisplatin|cisplatin
4990296|NCT01679314|COPD|copd
4990297|NCT01679314|vagus nerve stimulation|vagus nerve stimulation
4990298|NCT01679314|vagal nerve stimulation|vagal nerve stimulation
4990299|NCT01679314|nVNS|nvns
4990300|NCT01679314|VNS|vns
4990301|NCT01679314|non invasive|non invasive
4990302|NCT01679314|gammacore|gammacore
4990303|NCT01679301|oxygen|oxygen
4990304|NCT01679288|Hand-Held ultrasonography|hand-held ultrasonography
4990305|NCT01679288|Abdominal Aortic Aneurysm|abdominal aortic aneurysm
4990306|NCT01679288|Abdominal Aortic Atherosclerosis|abdominal aortic atherosclerosis
4990307|NCT01679288|Cardiovascular risk|cardiovascular risk
4990308|NCT01679288|Primary Health Care|primary health care
4990309|NCT01679275|Heart Defects, congenital|heart defects, congenital
4990310|NCT01679275|Patient Monitoring|patient monitoring
4990311|NCT01679275|Infant, Newborn|infant, newborn
4990312|NCT01679275|Physiology|physiology
4990313|NCT01679249|extracellular fluid volume|extracellular fluid volume
4990314|NCT01679249|hypotension|hypotension
4990315|NCT01679249|hemodialysis|hemodialysis
4990316|NCT01679236|Smoking|smoking
4990317|NCT01679236|Smoking cessation|smoking cessation
4990318|NCT01679236|Nicotine|nicotine
4990319|NCT01679236|Tobacco|tobacco
4990320|NCT01679236|Mindfulness|mindfulness
4990321|NCT01679236|Meditation|meditation
4990322|NCT01679236|MBSR|mbsr
4990323|NCT01679236|Mindfulness Training|mindfulness training
4990324|NCT01679236|Behavioral Intervention|behavioral intervention
4990325|NCT01679236|Alcohol|alcohol
4990326|NCT01679236|Young Adults|young adults
4990327|NCT01679223|Breast reconstruction|breast reconstruction
4990328|NCT01679223|Hydroxyproline concentration|hydroxyproline concentration
4990329|NCT01679223|neoangiogenesis|neoangiogenesis
4990330|NCT01679223|collagen deposition|collagen deposition
4990331|NCT01679197|Nonalcoholic fatty liver disease|nonalcoholic fatty liver disease
4990332|NCT01679197|NAFLD|nafld
4990333|NCT01679197|Nonalcoholic steatohepatitis|nonalcoholic steatohepatitis
4990334|NCT01679197|NASH|nash
4990335|NCT01679197|Lipodystrophy|lipodystrophy
4990336|NCT01679197|Leptin|leptin
4990337|NCT01679197|Metreleptin|metreleptin
4990338|NCT01679197|Hypertriglyceridemia|hypertriglyceridemia
4990339|NCT01679197|Diabetes mellitus|diabetes mellitus
4990340|NCT01679171|Elderly|elderly
4990341|NCT01679171|Intensive care unit|intensive care unit
4990342|NCT01679171|Outcome|outcome
4990343|NCT01679171|Comprehensive geriatric assessment|comprehensive geriatric assessment
4990344|NCT01679158|Using POSE as a treatment for Obesity|using pose as a treatment for obesity
4990345|NCT01679145|Reward- based learning|reward- based learning
4990346|NCT01679145|Pavlovian-to-instrumental transfer|pavlovian-to-instrumental transfer
4990347|NCT01679145|Functional imaging|functional imaging
4990348|NCT01679145|Relapse risk|relapse risk
4990349|NCT01679132|Hypertension|hypertension
4990350|NCT01679132|High Blood Pressure|high blood pressure
4990351|NCT01679132|Blood Pressure|blood pressure
4990352|NCT01679132|Cardiovascular Disease|cardiovascular disease
4990353|NCT01679132|Resistant Hypertension|resistant hypertension
4990354|NCT01679119|Diffuse large b cell lymphoma|diffuse large b cell lymphoma
4990355|NCT01679119|Inotuzumab Ozogamicin|inotuzumab ozogamicin
4990356|NCT01679119|Gemcitabine|gemcitabine
4990357|NCT01679119|Rituximab|rituximab
4990358|NCT01679119|Cyclophosphamide|cyclophosphamide
4990359|NCT01679119|Vincristine|vincristine
4990360|NCT01679119|Prednisolone|prednisolone
4990361|NCT01679106|renal transplant|renal transplant
4990362|NCT01679106|flank incision|flank incision
4990363|NCT01679093|postoperative analgesia|postoperative analgesia
4990364|NCT01679093|paracetamol|paracetamol
4990365|NCT01679093|5-HT3 antagonist|5-ht3 antagonist
4990366|NCT01679093|ondansetron|ondansetron
4990367|NCT01679093|PainMatcher|painmatcher
4990368|NCT01679080|Drug therapy|drug therapy
4990369|NCT01679080|Adult|adult
4990370|NCT01679067|HIV|hiv
4990372|NCT01679054|Neoplasm|neoplasm
4990373|NCT01679054|Gastric Cancer|gastric cancer
4990375|NCT01679028|T89 Safety in Healthy Japanese population|t89 safety in healthy japanese population
4990376|NCT01679015|Burning|burning
4990377|NCT01679015|Dryness|dryness
4990378|NCT01679015|Itching|itching
4990379|NCT01679015|Blurry Vision|blurry vision
4990380|NCT01679002|Epilepsy|epilepsy
4990381|NCT01679002|Oxcarbazepine|oxcarbazepine
4990382|NCT01679002|Eslicarbazepine Acetate|eslicarbazepine acetate
4990383|NCT01679002|BIA 2-093|bia 2-093
4990384|NCT01678989|Bipolar disorder|bipolar disorder
4990385|NCT01678989|Children|children
4990386|NCT01678989|Cranial MRI|cranial mri
4990387|NCT01678976|Eslicarbazepine acetate|eslicarbazepine acetate
4990388|NCT01678976|Epilepsy|epilepsy
4990389|NCT01678976|Oxcarbazepine|oxcarbazepine
4990390|NCT01678963|Neovascular AMD|neovascular amd
4990391|NCT01678963|Wet AMD|wet amd
4990392|NCT01678963|AMD|amd
4990393|NCT01678963|Age related macular degeneration|age related macular degeneration
4990394|NCT01678950|Cardiac output monitoring|cardiac output monitoring
4990395|NCT01678950|Echocardiography|echocardiography
4990396|NCT01678950|Pulse contour system|pulse contour system
4990397|NCT01678937|Immunosuppression|immunosuppression
4990398|NCT01678911|Pelvic Pain|pelvic pain
4990399|NCT01678911|Chronic Pelvic Pain|chronic pelvic pain
4990400|NCT01678911|Irritable Bowel Syndrome|irritable bowel syndrome
4990401|NCT01678911|IBS|ibs
4990402|NCT01678911|Ulcerative Colitis|ulcerative colitis
4990403|NCT01678911|UC|uc
4990404|NCT01678911|Interstitial Cystitis|interstitial cystitis
4990405|NCT01678911|IC|ic
4990406|NCT01678911|Prostatitis|prostatitis
4990407|NCT01678911|Pain|pain
4990408|NCT01678898|Fabry disease|fabry disease
4990409|NCT01678898|Alpha galactosidase deficiency|alpha galactosidase deficiency
4990410|NCT01678898|Metabolic storage disease|metabolic storage disease
4990411|NCT01678859|infertility|infertility
4990412|NCT01678859|cervical|cervical
4990413|NCT01678859|mucus|mucus
4990414|NCT01678859|sperm|sperm
4990415|NCT01678859|interaction|interaction
4990416|NCT01678846|corporal punishment|corporal punishment
4990417|NCT01678846|violence|violence
4990418|NCT01678846|education|education
4990419|NCT01678846|depression|depression
4990420|NCT01678846|anxiety|anxiety
4990421|NCT01678846|conduct disorder|conduct disorder
4990422|NCT01678833|Drug Abuse/Dependence|drug abuse/dependence
4990423|NCT01678794|Chronic heart failure (CHF)|chronic heart failure (chf)
4990424|NCT01678794|cardiac and renal dysfunction|cardiac and renal dysfunction
4990425|NCT01678781|Abdominal pain|abdominal pain
4990426|NCT01678781|Diarrhea|diarrhea
4990427|NCT01678781|Mebeverine hydrochloride|mebeverine hydrochloride
4990428|NCT01678781|Constipation|constipation
4990429|NCT01678781|Pinaverium bromide|pinaverium bromide
4990430|NCT01678781|Irritable bowel syndrome|irritable bowel syndrome
4990431|NCT01678781|Bloating|bloating
4990432|NCT01678781|Quality of life|quality of life
4990433|NCT01678755|schizophrenia|schizophrenia
4990434|NCT01678742|Diet|diet
4990435|NCT01678742|Incretins|incretins
4990436|NCT01678742|Gastrointestinal Hormones|gastrointestinal hormones
4990437|NCT01678742|Fish Proteins|fish proteins
4990438|NCT01678729|refractive surgery|refractive surgery
4990439|NCT01678729|pupil|pupil
4990440|NCT01678729|Pupil size|pupil size
4990441|NCT01678716|Anemia|anemia
4990442|NCT01678716|Breastfeeding|breastfeeding
4990443|NCT01678716|Complementary feeding|complementary feeding
4990444|NCT01678716|Stunting|stunting
4990445|NCT01678716|Wasting|wasting
4990446|NCT01678716|Underweight|underweight
4990447|NCT01678716|Micronutrient powder|micronutrient powder
4990448|NCT01678716|Behavior change counseling|behavior change counseling
4990449|NCT01678716|Frontline health worker|frontline health worker
4990450|NCT01678703|late abortion|late abortion
4990451|NCT01678703|laminaria|laminaria
4990452|NCT01678703|Misoprostol|misoprostol
4990453|NCT01678703|Cervical preparation|cervical preparation
4990454|NCT01678677|non-typeable Haemophilus influenzae|non-typeable haemophilus influenzae
4990455|NCT01678677|immunogenicity|immunogenicity
4990456|NCT01678677|reactogenicity|reactogenicity
4990457|NCT01678677|safety|safety
4990458|NCT01678664|cancer|cancer
4990459|NCT01678664|neuroendocrine tumors|neuroendocrine tumors
4990460|NCT01678664|gastrointestinal tract|gastrointestinal tract
4990461|NCT01678664|metastases|metastases
4990462|NCT01678664|liver|liver
4990463|NCT01678664|hepatic|hepatic
4990464|NCT01678651|time-lapse, FSH, kinetics|time-lapse, fsh, kinetics
4990465|NCT01678638|inguinal hernia|inguinal hernia
4990466|NCT01678638|premature infants|premature infants
4990467|NCT01678638|anesthesia safety|anesthesia safety
4990468|NCT01678638|neurodevelopmental outcome|neurodevelopmental outcome
4990469|NCT01678638|preterm infants|preterm infants
4990470|NCT01678638|neonatal prematurity|neonatal prematurity
4990471|NCT01678625|Residual neuromuscular blockade|residual neuromuscular blockade
4990472|NCT01678625|Train-of-four|train-of-four
4990473|NCT01678625|Acceleromyography|acceleromyography
4990474|NCT01678625|Electromyography|electromyography
4990475|NCT01678612|Copper|copper
4990476|NCT01678612|Health-Acquired Infections|health-acquired infections
4990477|NCT01678612|Bacterial Load|bacterial load
4990478|NCT01678612|Intensive Care Units, Pediatric|intensive care units, pediatric
4990479|NCT01678599|Chagas Disease|chagas disease
4990480|NCT01678599|PCR|pcr
4990481|NCT01678599|diagnosis|diagnosis
4990482|NCT01678586|Pain|pain
4990483|NCT01678586|Pain management|pain management
4990484|NCT01678573|Healthy|healthy
4990485|NCT01678573|Pharmacokinetics|pharmacokinetics
4990486|NCT01678573|Abiraterone acetate|abiraterone acetate
4990487|NCT01678573|Abiraterone|abiraterone
4990488|NCT01678573|JNJ-212082|jnj-212082
4990489|NCT01678573|Zytiga|zytiga
4990490|NCT01678573|Chinese|chinese
4990491|NCT01678573|Fasted|fasted
4990492|NCT01678560|Obstructive sleep apnea PAP adherence efficacy economics|obstructive sleep apnea pap adherence efficacy economics
4990493|NCT01678547|Stroke|stroke
4990494|NCT01678547|Robot|robot
4990495|NCT01678547|Treatment|treatment
4990496|NCT01678547|Rehabilitation|rehabilitation
4990497|NCT01678534|Cerebral infarction|cerebral infarction
4990498|NCT01678534|Cellular therapy|cellular therapy
4990499|NCT01678521|Hypercholesterolemia|hypercholesterolemia
4990500|NCT01678521|LDL-apheresis|ldl-apheresis
4990501|NCT01678521|Coronary artery disease|coronary artery disease
4990502|NCT01678521|PTX3|ptx3
4990503|NCT01678521|CRP|crp
4990504|NCT01678521|IL6|il6
4990505|NCT01678521|IL10|il10
4990506|NCT01678482|Acne, LED, blue light|acne, led, blue light
4990507|NCT01678456|Atrial Fibrillation|atrial fibrillation
4990508|NCT01678456|Critical Event Committee|critical event committee
4990509|NCT01678456|Serious adverse events|serious adverse events
4990510|NCT01678456|Thromboembolic complications|thromboembolic complications
4990511|NCT01678456|Cardiac and noncardiac complications|cardiac and noncardiac complications
4990512|NCT01678456|Bleeding complications|bleeding complications
4990513|NCT01678456|Acute heart failure|acute heart failure
4990514|NCT01678456|Syncope|syncope
4990515|NCT01678456|Resuscitation|resuscitation
4990516|NCT01678430|Chronic Lymphocytic Leukaemia|chronic lymphocytic leukaemia
4990517|NCT01678430|Less fit|less fit
4990518|NCT01678430|CD20 antibody|cd20 antibody
4990519|NCT01678430|Ofatumumab|ofatumumab
4990520|NCT01678430|Chlorambucil|chlorambucil
4990521|NCT01678430|Bendamustine|bendamustine
4990522|NCT01678378|Adolescent|adolescent
4990523|NCT01678378|Intervention|intervention
4990524|NCT01678378|Female|female
4990525|NCT01678378|Male|male
4990526|NCT01678378|Interpersonal Relations|interpersonal relations
4990527|NCT01678378|School Health Services|school health services
4990528|NCT01678378|Community-Based Participatory Research|community-based participatory research
4990529|NCT01678378|Randomized Controlled Trial|randomized controlled trial
4990530|NCT01678378|Health Care Provider|health care provider
4990531|NCT01678378|Training Program|training program
4990532|NCT01678378|Harm Reduction|harm reduction
4990533|NCT01678378|Prevention|prevention
4990534|NCT01678378|Reproductive Coercion|reproductive coercion
4990535|NCT01678378|Tech-Based Abuse|tech-based abuse
4990536|NCT01678378|Social Environment|social environment
4990537|NCT01678378|Sexual Partners|sexual partners
4990538|NCT01678365|complicated appendicitis|complicated appendicitis
4990539|NCT01678365|Children|children
4990540|NCT01678365|conservative therapy|conservative therapy
4990541|NCT01678365|Study population: Children 1 month - 14 years with Complicated appendicitis|study population: children 1 month - 14 years with complicated appendicitis
4990542|NCT01678365|Type of the study: prospective, open randomized|type of the study: prospective, open randomized
4990543|NCT01678352|Glioma|glioma
4990544|NCT01678352|Vaccine|vaccine
4990545|NCT01678352|Immunotherapy|immunotherapy
4990546|NCT01678352|WHO Grade II|who grade ii
4990547|NCT01678339|ACS|acs
4990548|NCT01678339|AMI|ami
4990549|NCT01678326|Diseases Classified Elsewhere|diseases classified elsewhere
4990550|NCT01678313|Benign prostatic hyperplasia (BPH)|benign prostatic hyperplasia (bph)
4990551|NCT01678313|Lower urinary tract symptoms (LUTS)|lower urinary tract symptoms (luts)
4990552|NCT01678313|Prostatic specific antigen (PSA)|prostatic specific antigen (psa)
4990553|NCT01678313|Cyclooxygenase-2 (COX-2)|cyclooxygenase-2 (cox-2)
4990554|NCT01678300|Ulcerative Colitis|ulcerative colitis
4990555|NCT01678287|ASP1941|asp1941
4990556|NCT01678274|Turner Syndrome|turner syndrome
4990557|NCT01678274|Aortic Aneurysm|aortic aneurysm
4990558|NCT01678274|Ischemic heart disease|ischemic heart disease
4990559|NCT01678274|Hypertension|hypertension
4990560|NCT01678274|Congenital Heart Defect|congenital heart defect
4990561|NCT01678274|Pulse Wave Velocity|pulse wave velocity
4990562|NCT01678274|Augmentation Index|augmentation index
4990563|NCT01678274|Central Blood Pressure|central blood pressure
4990564|NCT01678274|Agatston Score|agatston score
4990565|NCT01678274|Segment involvement score|segment involvement score
4990566|NCT01678261|Sex chromosome|sex chromosome
4990567|NCT01678261|Turner Syndrome|turner syndrome
4990568|NCT01678261|Klinefelter Syndrome|klinefelter syndrome
4990569|NCT01678261|Triple X Syndrome|triple x syndrome
4990570|NCT01678261|47 XYY syndrome|47 xyy syndrome
4990571|NCT01678261|Aortic Aneurysm|aortic aneurysm
4990572|NCT01678261|Epigenetics|epigenetics
4990573|NCT01678261|Transcriptome|transcriptome
4990574|NCT01678261|non-coding RNA|non-coding rna
4990575|NCT01678235|diabetes|diabetes
4990576|NCT01678235|insulin pump|insulin pump
4990577|NCT01678235|glulisine|glulisine
4990578|NCT01678235|aspart|aspart
4990579|NCT01678235|glycemic index|glycemic index
4990580|NCT01678222|Lymphocyte|lymphocyte
4990581|NCT01678222|Cyclooxygenase 2|cyclooxygenase 2
4990582|NCT01678222|Eicosanoid|eicosanoid
4990583|NCT01678222|Prostaglandin|prostaglandin
4990584|NCT01678209|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
4990585|NCT01678209|Stimulant|stimulant
4990586|NCT01678209|Non-stimulant|non-stimulant
4990587|NCT01678209|Drug|drug
4990588|NCT01678209|Methylphenidate|methylphenidate
4990589|NCT01678209|Atomoxetine|atomoxetine
4990590|NCT01678209|Strattera|strattera
4990591|NCT01678209|Concerta|concerta
4990592|NCT01678209|MACRO|macro
4990593|NCT01678209|Medication|medication
4990594|NCT01678209|Treatment|treatment
4990595|NCT01678209|Youth|youth
4990596|NCT01678209|Adolescent|adolescent
4990597|NCT01678209|Functional Magnetic Resonance Imaging|functional magnetic resonance imaging
4990598|NCT01678209|Brain scan|brain scan
4990599|NCT01678209|Imaging|imaging
4990600|NCT01678209|Response inhibition|response inhibition
4990601|NCT01678209|Inattentive|inattentive
4990602|NCT01678209|Hyperactive|hyperactive
4990603|NCT01678209|Combined|combined
4990604|NCT01678209|Medication Treatment|medication treatment
4990605|NCT01678209|Brain Imaging|brain imaging
4990606|NCT01678196|Family Members|family members
4990607|NCT01678196|Community Outreach|community outreach
4990608|NCT01678196|Internet|internet
4990609|NCT01678170|blood-oxygen functional imaging technology|blood-oxygen functional imaging technology
4990610|NCT01678170|diagnosis|diagnosis
4990611|NCT01678157|Esophageal Hernia|esophageal hernia
4990612|NCT01678157|Hernia, Esophageal|hernia, esophageal
4990613|NCT01678157|Hernia, Paraesophageal|hernia, paraesophageal
4990614|NCT01678157|Hiatal Hernia|hiatal hernia
4990615|NCT01678157|Paraesophageal Hiatal Hernia|paraesophageal hiatal hernia
4990616|NCT01678157|Sliding Esophageal Hernia|sliding esophageal hernia
4990617|NCT01678157|Sliding Hiatal Hernia|sliding hiatal hernia
4990618|NCT01678144|mitral valve|mitral valve
4990619|NCT01678144|mitral surgery|mitral surgery
4990620|NCT01678144|mitral repair|mitral repair
4990621|NCT01678144|mitral annuloplasty|mitral annuloplasty
4990622|NCT01678118|Patient Navigation|patient navigation
4990623|NCT01678118|Tobacco dependent|tobacco dependent
4990624|NCT01678118|smoking|smoking
4990625|NCT01678118|Cessation|cessation
4990626|NCT01678118|11-028|11-028
4990627|NCT01678105|Recurrent Adenoid Cystic Carcinoma of the Salivary Glands|recurrent adenoid cystic carcinoma of the salivary glands
4990628|NCT01678105|Metastatic Adenoid Cystic Carcinoma of the Salivary Glands|metastatic adenoid cystic carcinoma of the salivary glands
4990629|NCT01678105|Salivary Gland Cancers|salivary gland cancers
4990631|NCT01678105|Dovitinib|dovitinib
4990632|NCT01678105|TKI258|tki258
4990633|NCT01678105|RTK Inhibitor|rtk inhibitor
4990634|NCT01678079|Pregnancy|pregnancy
4990635|NCT01678079|Micronutrient Powder|micronutrient powder
4990636|NCT01678079|Calcium|calcium
4990637|NCT01678079|Iron|iron
4990638|NCT01678079|Bangladesh|bangladesh
4990639|NCT01678066|Noninvasive cardiac output.|noninvasive cardiac output.
4990640|NCT01678066|Pediatrics.|pediatrics.
4990641|NCT01678053|Botulinum Toxins, Type A|botulinum toxins, type a
4990642|NCT01678040|Ventricular Volume|ventricular volume
4990643|NCT01678040|Cardiac Magnetic Resonance|cardiac magnetic resonance
4990644|NCT01678040|Echocardiogram|echocardiogram
4990645|NCT01678027|Stomach neoplasm|stomach neoplasm
4990646|NCT01678027|Helicobacter pylori|helicobacter pylori
4990647|NCT01678014|Anorexia|anorexia
4990648|NCT01678014|DBS|dbs
4990649|NCT01678014|Capsulotomy|capsulotomy
4990650|NCT01678014|Signs and Symptoms|signs and symptoms
4990651|NCT01678001|plantar fascia|plantar fascia
4990652|NCT01678001|plantar fascitis|plantar fascitis
4990653|NCT01678001|botulinum toxin|botulinum toxin
4990654|NCT01678001|Xeomin|xeomin
4990655|NCT01677988|NEOADJUVANT FOLFIRINOX CHEMOTHERAPY|neoadjuvant folfirinox chemotherapy
4990656|NCT01677988|LOCALIZED PANCREATIC HEAD ADENOCARCINOMA|localized pancreatic head adenocarcinoma
4990657|NCT01677988|RADIATION THERAPY|radiation therapy
4990658|NCT01677962|locally advanced, unresectable pancreatic adenocarcinoma|locally advanced, unresectable pancreatic adenocarcinoma
4990659|NCT01677962|Poly ICLC|poly iclc
4990660|NCT01677962|dendritic cells|dendritic cells
4990661|NCT01677936|diabetes|diabetes
4990662|NCT01677936|blood pressure|blood pressure
4990663|NCT01677936|lipid|lipid
4990664|NCT01677936|waist circumference|waist circumference
4990665|NCT01677936|BMI|bmi
4990666|NCT01677923|weight|weight
4990667|NCT01677923|body mass index|body mass index
4990668|NCT01677923|lipid profile|lipid profile
4990669|NCT01677923|glucose profile|glucose profile
4990670|NCT01677845|Localized Prostate Cancer|localized prostate cancer
4990671|NCT01677845|Radiation|radiation
4990672|NCT01677806|Percutaneous vertebroplasty|percutaneous vertebroplasty
4990673|NCT01677741|Children and Adolescents|children and adolescents
4990674|NCT01677741|BRAF|braf
4990675|NCT01677741|dabrafenib|dabrafenib
4990676|NCT01677741|dose escalation|dose escalation
4990677|NCT01677741|BRF116013|brf116013
4990678|NCT01677741|V600-mutation positive|v600-mutation positive
4990679|NCT01677741|BRF|brf
4990680|NCT01677728|colorectal liver metastases|colorectal liver metastases
4990681|NCT01677728|chemotherapy|chemotherapy
4990682|NCT01677728|cetuximab|cetuximab
4990683|NCT01677728|bevacizumab|bevacizumab
4990684|NCT01677689|oral temperature|oral temperature
4990685|NCT01677689|respiratory symptom|respiratory symptom
4990686|NCT01677689|cough|cough
4990687|NCT01677689|nasal obstruction|nasal obstruction
4990688|NCT01677689|sore throat|sore throat
4990689|NCT01677689|fever|fever
4990690|NCT01677676|Influenza A|influenza a
4990691|NCT01677663|autism|autism
4990692|NCT01677663|clinical phenotypes|clinical phenotypes
4990693|NCT01677663|neuropsychology|neuropsychology
4990694|NCT01677663|imaging endophenotypes|imaging endophenotypes
4990695|NCT01677663|family-based cohort|family-based cohort
4990696|NCT01677663|knoutout mice|knoutout mice
4990697|NCT01677650|Spinal Fusion|spinal fusion
4990698|NCT01677650|Opioid Analgesia|opioid analgesia
4990699|NCT01677637|osteopenia, postmenopausal|osteopenia, postmenopausal
4990700|NCT01677624|Hypervascular tumor|hypervascular tumor
4990701|NCT01677624|arteriovenous malformation|arteriovenous malformation
4990702|NCT01677624|arterial embolization|arterial embolization
4990703|NCT01677611|Resveratrol|resveratrol
4990704|NCT01677611|SIRT1|sirt1
4990705|NCT01677611|AMPK|ampk
4990706|NCT01677598|Plaque Psoriasis|plaque psoriasis
4990707|NCT01677598|Ustekinumab|ustekinumab
4990708|NCT01677598|CNTO 1275|cnto 1275
4990709|NCT01677598|Asia-Pacific|asia-pacific
4990710|NCT01677546|diabetes|diabetes
4990711|NCT01677546|insulin pump|insulin pump
4990712|NCT01677546|bolus calculator|bolus calculator
4990713|NCT01677546|Contour Link|contour link
4990714|NCT01677533|Panel management|panel management
4990715|NCT01677533|Clinical microsystems|clinical microsystems
4990716|NCT01677533|Hypertension management|hypertension management
4990717|NCT01677533|Smoking cessation|smoking cessation
4990718|NCT01677533|Continuing medical education|continuing medical education
4990719|NCT01677533|Quality improvement,|quality improvement,
4990720|NCT01677533|Population health|population health
4990721|NCT01677520|adipose-derived stem cells|adipose-derived stem cells
4990722|NCT01677520|viable ADSCs|viable adscs
4990723|NCT01677520|apoptosis|apoptosis
4990724|NCT01677520|necrosis|necrosis
4990725|NCT01677520|cryopreservation|cryopreservation
4990726|NCT01677507|glaucoma|glaucoma
4990727|NCT01677507|aqueous humor dynamics|aqueous humor dynamics
4990728|NCT01677507|intraocular pressure|intraocular pressure
4990729|NCT01677468|Hepatocellular carcinoma|hepatocellular carcinoma
4990730|NCT01677468|Transarterial chemoembolization|transarterial chemoembolization
4990731|NCT01677455|Hsp90 inhibitor|hsp90 inhibitor
4990732|NCT01677455|ganetespib|ganetespib
4990733|NCT01677455|STA 9090|sta 9090
4990734|NCT01677442|nonintubated|nonintubated
4990735|NCT01677442|anaesthesia|anaesthesia
4990736|NCT01677442|VATS|vats
4990737|NCT01677429|panic disorder|panic disorder
4990738|NCT01677429|balance impairment|balance impairment
4990739|NCT01677429|virtual reality|virtual reality
4990740|NCT01677416|Rheumatoid arthritis|rheumatoid arthritis
4990741|NCT01677416|Ultrasonography|ultrasonography
4990742|NCT01677416|Synovitis|synovitis
4990743|NCT01677416|Foot joints|foot joints
4990744|NCT01677403|Bronchiectasis|bronchiectasis
4990745|NCT01677403|Tobramycin|tobramycin
4990746|NCT01677403|nebulised|nebulised
4990747|NCT01677390|Antibody-Drug Conjugate|antibody-drug conjugate
4990748|NCT01677390|monomethylauristatin F|monomethylauristatin f
4990749|NCT01677390|Carcinoma, Renal Cell|carcinoma, renal cell
4990750|NCT01677390|Antigens, CD70|antigens, cd70
4990751|NCT01677390|Drug Therapy|drug therapy
4990752|NCT01677377|Schizophrenia|schizophrenia
4990753|NCT01677377|Schizophrenic|schizophrenic
4990754|NCT01677377|Schizophrenias|schizophrenias
4990755|NCT01677364|induction of labour|induction of labour
4990756|NCT01677364|heart disease patients|heart disease patients
4990757|NCT01677351|clonidine|clonidine
4990758|NCT01677351|cataract surgery|cataract surgery
4990759|NCT01677351|arrythmia|arrythmia
4990760|NCT01677351|anesthesic medication|anesthesic medication
4990761|NCT01677286|AL Amyloidosis|al amyloidosis
4990762|NCT01677286|Primary Amyloidosis|primary amyloidosis
4990763|NCT01677286|Hereditary Amyloidosis|hereditary amyloidosis
4990764|NCT01677286|Familial Amyloidosis|familial amyloidosis
4990765|NCT01677286|SSA Amyloidosis|ssa amyloidosis
4990766|NCT01677286|Senile Systemic Amyloidosis|senile systemic amyloidosis
4990767|NCT01677286|AA Amyloidosis|aa amyloidosis
4990768|NCT01677286|Secondary Amyloidosis|secondary amyloidosis
4990769|NCT01677286|Localized Amyloidosis|localized amyloidosis
4990770|NCT01677286|Systemic Amyloidosis|systemic amyloidosis
4990771|NCT01677273|Respiratory chambers|respiratory chambers
4990772|NCT01677273|Energy expenditure|energy expenditure
4990773|NCT01677273|Appetite|appetite
4990774|NCT01677273|Dairy proteins|dairy proteins
4990775|NCT01677273|Diet induced thermogenesis|diet induced thermogenesis
4990776|NCT01677273|Obesity|obesity
4990777|NCT01677260|Biguanide|biguanide
4990778|NCT01677260|anti-hyperglycaemic|anti-hyperglycaemic
4990779|NCT01677260|bioavailability|bioavailability
4990780|NCT01677260|bioequivalence|bioequivalence
4990781|NCT01677260|metformin|metformin
4990782|NCT01677260|pharmacokinetics|pharmacokinetics
4990783|NCT01677247|sulphonylurea|sulphonylurea
4990784|NCT01677247|anti-hyperglycaemic|anti-hyperglycaemic
4990785|NCT01677247|bioavailability|bioavailability
4990786|NCT01677247|bioequivalence|bioequivalence
4990787|NCT01677247|glimepiride|glimepiride
4990788|NCT01677247|pharmacokinetics|pharmacokinetics
4990789|NCT01677234|Blood pressure|blood pressure
4990790|NCT01677221|acne|acne
4990791|NCT01677221|inflammatory acne|inflammatory acne
4990792|NCT01677221|intense pulsed light|intense pulsed light
4990793|NCT01677208|Acute Ischemic Stroke|acute ischemic stroke
4990794|NCT01677208|Randomized Controlled Trial|randomized controlled trial
4990795|NCT01677208|Traditional Chinese Medicine|traditional chinese medicine
4990796|NCT01677195|Mycotoxins|mycotoxins
4990797|NCT01677195|Aflatoxin|aflatoxin
4990798|NCT01677195|Fumonisin|fumonisin
4990799|NCT01677195|Aflatoxicosis|aflatoxicosis
4990800|NCT01677195|Dietary|dietary
4990801|NCT01677195|Cancer|cancer
4990802|NCT01677182|Drug therapy|drug therapy
4990803|NCT01677156|ASGES|asges
4990804|NCT01677156|Corus CAD|corus cad
4990805|NCT01677156|Age/Sex/Gene Expression Score|age/sex/gene expression score
4990806|NCT01677156|Gene Expression|gene expression
4990807|NCT01677156|GES|ges
4990808|NCT01677156|CAD|cad
4990809|NCT01677156|CVD|cvd
4990810|NCT01677156|CHD|chd
4990811|NCT01677156|Precision Medicine|precision medicine
4990812|NCT01677156|Clinical Utility|clinical utility
4990813|NCT01677156|Registry|registry
4990814|NCT01677156|Coronary Artery Disease|coronary artery disease
4990815|NCT01677156|Angina Pectoris|angina pectoris
4990816|NCT01677156|Chest Pain|chest pain
4990817|NCT01677156|Cardiovascular Disease|cardiovascular disease
4990818|NCT01677156|Coronary Heart Disease|coronary heart disease
4990819|NCT01677156|PRESET|preset
4990820|NCT01677143|Local anesthetic|local anesthetic
4990821|NCT01677143|Preemptive analgesia|preemptive analgesia
4990822|NCT01677143|Postoperative pain|postoperative pain
4990823|NCT01677143|Laparoscopy|laparoscopy
4990824|NCT01677143|Gynecological surgery|gynecological surgery
4990825|NCT01677143|Day-case surgery|day-case surgery
4990826|NCT01677130|Clinical efficacy|clinical efficacy
4990827|NCT01677130|safety|safety
4990828|NCT01677130|of HFOV treatment|of hfov treatment
4990829|NCT01677130|of patients|of patients
4990830|NCT01677104|GLP-1|glp-1
4990831|NCT01677104|DPP-IV inhibitor|dpp-iv inhibitor
4990832|NCT01677104|microcirculation|microcirculation
4990833|NCT01677104|Exenatide|exenatide
4990834|NCT01677104|Liraglutide|liraglutide
4990835|NCT01677104|Linagliptin|linagliptin
4990836|NCT01677091|Balance,Hemiplegia,Cervical vibration,Prism adaptation,Rehabilitation|balance,hemiplegia,cervical vibration,prism adaptation,rehabilitation
4990837|NCT01677078|Major depressive disorder|major depressive disorder
4990838|NCT01677078|rTMS|rtms
4990839|NCT01677078|Neuronavigation|neuronavigation
4990840|NCT01677065|Bioavailability|bioavailability
4990841|NCT01677065|Oxycodone|oxycodone
4990842|NCT01677065|Healthy Volunteers|healthy volunteers
4990843|NCT01677039|Bioavailability|bioavailability
4990844|NCT01677039|oxycodone|oxycodone
4990845|NCT01677039|ethanol interaction|ethanol interaction
4990846|NCT01677039|healthy volunteers|healthy volunteers
4990847|NCT01677013|Type 2; diabetes mellitus; stem cell; safety; efficacy|type 2; diabetes mellitus; stem cell; safety; efficacy
4990848|NCT01677000|bone infection|bone infection
4990849|NCT01677000|staphylococcus aureus|staphylococcus aureus
4990850|NCT01677000|registry|registry
4990851|NCT01676987|Asthma|asthma
4990852|NCT01676987|Budesonide|budesonide
4990853|NCT01676987|Adrenergic beta-2 receptor agonists.|adrenergic beta-2 receptor agonists.
4990854|NCT01676974|Drug Resistance, Microbial|drug resistance, microbial
4990855|NCT01676974|Enterobacteriaceae|enterobacteriaceae
4990856|NCT01676974|ESBL|esbl
4990857|NCT01676974|Carbapenemase|carbapenemase
4990858|NCT01676974|Travel|travel
4990859|NCT01676948|SJIA|sjia
4990860|NCT01676948|Systemic Juvenile Idiopathic Arthritis|systemic juvenile idiopathic arthritis
4990861|NCT01676948|children|children
4990862|NCT01676948|systemic autoinflammatory disease, ACZ885, canakinumab|systemic autoinflammatory disease, acz885, canakinumab
4990863|NCT01676948|human monoclonal anti-interleukin-1β (IL-1 β) antibody|human monoclonal anti-interleukin-1β (il-1 β) antibody
4990864|NCT01676948|hildhood immunizations vaccinations|hildhood immunizations vaccinations
4990865|NCT01676909|self-management|self-management
4990866|NCT01676896|children|children
4990867|NCT01676896|asthma|asthma
4990868|NCT01676896|quality of life|quality of life
4990869|NCT01676896|self-management|self-management
4990870|NCT01676883|Body constitution|body constitution
4990871|NCT01676883|Anthropometry|anthropometry
4990872|NCT01676883|Electric impedance|electric impedance
4990873|NCT01676870|exercise training|exercise training
4990874|NCT01676870|exercise therapy|exercise therapy
4990875|NCT01676870|physical fitness|physical fitness
4990876|NCT01676870|risk factors|risk factors
4990877|NCT01676857|chronic pain, prostatitis, pelvic pain|chronic pain, prostatitis, pelvic pain
4990878|NCT01676844|Phosphorus|phosphorus
4990879|NCT01676844|Phosphate|phosphate
4990880|NCT01676844|Hypophosphataemia|hypophosphataemia
4990881|NCT01676844|Osteopenia|osteopenia
4990882|NCT01676844|Prematurity|prematurity
4990883|NCT01676805|Developing Novel Treatment Approaches|developing novel treatment approaches
4990884|NCT01676805|Developing Therapeutic Agents|developing therapeutic agents
4990885|NCT01676805|Analysis of Genetic and Genomic Biology|analysis of genetic and genomic biology
4990886|NCT01676805|New Prognostic and Diagnostic Models|new prognostic and diagnostic models
4990887|NCT01676805|Analysis of Cellular and Molecular Biology|analysis of cellular and molecular biology
4990888|NCT01676792|condyloma acuminate|condyloma acuminate
4990889|NCT01676792|ano-genital warts|ano-genital warts
4990890|NCT01676792|genital warts|genital warts
4990891|NCT01676792|cutaneous condyloma|cutaneous condyloma
4990892|NCT01676792|Vulva pre-cancerous lesions|vulva pre-cancerous lesions
4990893|NCT01676792|Vulvar Intraepitheral Neoplasia|vulvar intraepitheral neoplasia
4990894|NCT01676792|VIN|vin
4990895|NCT01676792|EGW|egw
4990896|NCT01676779|melanoma|melanoma
4990897|NCT01676779|no evidence of disease|no evidence of disease
4990898|NCT01676779|resection|resection
4990899|NCT01676779|macro-metastases|macro-metastases
4990900|NCT01676766|Stargardt Disease|stargardt disease
4990901|NCT01676766|Macular degeneration|macular degeneration
4990902|NCT01676766|Retinal dystrophy|retinal dystrophy
4990903|NCT01676740|hematinic therapy|hematinic therapy
4990904|NCT01676740|blood transfusion|blood transfusion
4990905|NCT01676740|joint replacement|joint replacement
4990906|NCT01676727|Transcatheter Aortic valve Implantation|transcatheter aortic valve implantation
4990907|NCT01676727|Heart Valve Diseases|heart valve diseases
4990908|NCT01676727|Cardiovascular Diseases|cardiovascular diseases
4990909|NCT01676714|Dovitinib|dovitinib
4990910|NCT01676714|Fibroblast Growth Factor Receptor Biomarkers|fibroblast growth factor receptor biomarkers
4990911|NCT01676714|Anti-Vascular Endothelial Growth Factor Therapy|anti-vascular endothelial growth factor therapy
4990912|NCT01676688|alpha-1 antitrypsin|alpha-1 antitrypsin
4990913|NCT01676688|deficiency|deficiency
4990914|NCT01676688|Alfalastin|alfalastin
4990915|NCT01676688|safety|safety
4990916|NCT01676675|whole virus|whole virus
4990917|NCT01676675|inactivated|inactivated
4990918|NCT01676675|influenza|influenza
4990919|NCT01676675|H5N1 vaccine|h5n1 vaccine
4990920|NCT01676675|safety|safety
4990921|NCT01676675|immunogenicity|immunogenicity
4990922|NCT01676662|Urinary Incontinence|urinary incontinence
4990923|NCT01676662|Urinary Incontinence, Stress|urinary incontinence, stress
4990924|NCT01676662|Urination Disorders|urination disorders
4990925|NCT01676662|Urologic Diseases|urologic diseases
4990926|NCT01676662|Urological Manifestations|urological manifestations
4990927|NCT01676662|Signs and Symptoms|signs and symptoms
4990928|NCT01676636|Pregnancy|pregnancy
4990929|NCT01676636|Calcium|calcium
4990930|NCT01676636|Supplements|supplements
4990931|NCT01676623|Child nutrition|child nutrition
4990932|NCT01676623|Stunting|stunting
4990933|NCT01676623|Exclusive breastfeeding|exclusive breastfeeding
4990934|NCT01676623|Complementary feeding|complementary feeding
4990935|NCT01676623|Social franchise|social franchise
4990936|NCT01676623|Mass media|mass media
4990937|NCT01676623|Counseling|counseling
4990938|NCT01676623|Facility-based|facility-based
4990939|NCT01676610|Pulse Oximetry|pulse oximetry
4990940|NCT01676610|Pediatrics|pediatrics
4990941|NCT01676610|Pakistan|pakistan
4990942|NCT01676610|Hypoxemia|hypoxemia
4990943|NCT01676610|Neonatal Sepsis|neonatal sepsis
4990944|NCT01676610|Pneumonia|pneumonia
4990945|NCT01676558|diffuse large B cell lymphoma|diffuse large b cell lymphoma
4990946|NCT01676558|radioimmunotherapy|radioimmunotherapy
4990947|NCT01676558|131I-rituximab|131i-rituximab
4990948|NCT01676532|School Board Health Center|school board health center
4990949|NCT01676532|Pediatrics|pediatrics
4990950|NCT01676506|Wet AMD|wet amd
4990951|NCT01676506|genetic polymorphisms|genetic polymorphisms
4990952|NCT01676506|Ranibizumab|ranibizumab
4990953|NCT01676480|Prostate cancer|prostate cancer
4990954|NCT01676480|ADT|adt
4990955|NCT01676480|Endurance training|endurance training
4990956|NCT01676454|Vasopressin|vasopressin
4990957|NCT01676454|Trauma|trauma
4990958|NCT01676454|Injury|injury
4990959|NCT01676441|spinal cord injury|spinal cord injury
4990960|NCT01676441|mesenchymal stem cell|mesenchymal stem cell
4990961|NCT01676428|Kidney|kidney
4990962|NCT01676428|Renal|renal
4990963|NCT01676428|Radiotherapy|radiotherapy
4990964|NCT01676428|Stereotactic|stereotactic
4990965|NCT01676428|Cancer|cancer
4990966|NCT01676415|Sinus disease|sinus disease
4990967|NCT01676415|Sinonasal complaints|sinonasal complaints
4990968|NCT01676415|Chronic sinusitis|chronic sinusitis
4990969|NCT01676415|Nasal polyps|nasal polyps
4990970|NCT01676415|Chronic rhinosinusitis without nasal polyps|chronic rhinosinusitis without nasal polyps
4990971|NCT01676415|Glucocorticoids|glucocorticoids
4990972|NCT01676415|Prednisone|prednisone
4990973|NCT01676415|Topical mometasone|topical mometasone
4990974|NCT01676415|Anti-inflammatory agents|anti-inflammatory agents
4990975|NCT01676402|Influenza A (H1)|influenza a (h1)
4990976|NCT01676402|Influenza A (H3)|influenza a (h3)
4990977|NCT01676402|Influenza B|influenza b
4990978|NCT01676402|DNA Vaccine|dna vaccine
4990979|NCT01676402|Trivalent Inactivated Vaccine (TIV)|trivalent inactivated vaccine (tiv)
4990980|NCT01676402|Healthy Adults|healthy adults
4990981|NCT01676402|Intradermal (ID)|intradermal (id)
4990982|NCT01676389|Autism Spectrum Disorders|autism spectrum disorders
4990983|NCT01676376|CABG|cabg
4990984|NCT01676376|SVG|svg
4990985|NCT01676376|nitinol mesh|nitinol mesh
4990986|NCT01676376|external saphenous vein graft support|external saphenous vein graft support
4990987|NCT01676363|diflunisal|diflunisal
4990988|NCT01676363|anti-inflammatory agents, non-steroidal|anti-inflammatory agents, non-steroidal
4990989|NCT01676363|antiviral agents|antiviral agents
4990990|NCT01676350|Intraosseous (IO) vascular access|intraosseous (io) vascular access
4990991|NCT01676337|Text messaging|text messaging
4990992|NCT01676337|Clinic appointment attendance|clinic appointment attendance
4990993|NCT01676337|Emergency department|emergency department
4990994|NCT01676337|Primary care|primary care
4990995|NCT01676324|Fecal Calprotectin|fecal calprotectin
4990996|NCT01676311|cognition|cognition
4990997|NCT01676311|seizures|seizures
4990998|NCT01676311|electroencephalography|electroencephalography
4990999|NCT01676311|transcranial magnetic stimulation|transcranial magnetic stimulation
4991000|NCT01676311|huperzine|huperzine
4991001|NCT01676311|chinese club moss|chinese club moss
4991002|NCT01676298|Cyp2C19|cyp2c19
4991003|NCT01676298|Genotyping|genotyping
4991004|NCT01676298|Spartan|spartan
4991005|NCT01676298|Reproducibility|reproducibility
4991006|NCT01676285|Cirrhosis|cirrhosis
4991007|NCT01676285|cirrhotic cardiomyopathy|cirrhotic cardiomyopathy
4991008|NCT01676285|cardiac remodeling|cardiac remodeling
4991009|NCT01676285|cardiomyopathy|cardiomyopathy
4991010|NCT01676285|metoprolol succinate|metoprolol succinate
4991011|NCT01676285|betablockers|betablockers
4991012|NCT01676259|siRNA|sirna
4991013|NCT01676259|RNA interference (RNAi)|rna interference (rnai)
4991014|NCT01676259|Cancer|cancer
4991015|NCT01676259|Pancreatic ductal adenocarcinoma|pancreatic ductal adenocarcinoma
4991016|NCT01676259|Locally Advanced Pancreatic cancer|locally advanced pancreatic cancer
4991017|NCT01676259|Solid tumor|solid tumor
4991018|NCT01676259|Non operable pancreatic ductal adenocarcinoma|non operable pancreatic ductal adenocarcinoma
4991019|NCT01676207|coronary collateral circulation|coronary collateral circulation
4991020|NCT01676207|extracardiac coronary collaterals|extracardiac coronary collaterals
4991021|NCT01676207|coronary artery disease|coronary artery disease
4991022|NCT01676207|coronary circulation|coronary circulation
4991023|NCT01676207|internal mammary artery|internal mammary artery
4991024|NCT01676194|Transarterial Chemoembolization|transarterial chemoembolization
4991025|NCT01676194|Liver transplantation|liver transplantation
4991026|NCT01676194|Hepatocellular carcinoma|hepatocellular carcinoma
4991027|NCT01676181|Obstructive sleep apnea syndrome|obstructive sleep apnea syndrome
4991028|NCT01676181|Children|children
4991029|NCT01676181|Polysomnography|polysomnography
4991030|NCT01676181|Surgery|surgery
4991031|NCT01676181|Coblation|coblation
4991032|NCT01676181|Tonsils|tonsils
4991033|NCT01676181|Tonsillectomy|tonsillectomy
4991034|NCT01676155|Tuberculosis, latent tuberculosis infection, apoptosis, predictor|tuberculosis, latent tuberculosis infection, apoptosis, predictor
4991035|NCT01676129|temporomandibular joint disorders|temporomandibular joint disorders
4991036|NCT01676129|nocipoint|nocipoint
4991037|NCT01676129|physical therapy|physical therapy
4991038|NCT01676103|Parkinson's Disease (PD)|parkinson's disease (pd)
4991039|NCT01676103|Orthostatic hypotension (OH)|orthostatic hypotension (oh)
4991040|NCT01676077|LGMD2B|lgmd2b
4991041|NCT01676077|Miyoshi Myopathy|miyoshi myopathy
4991042|NCT01676077|Dysferlin|dysferlin
4991043|NCT01676077|Dysferlinopathy|dysferlinopathy
4991044|NCT01676077|Limb Girdle muscular dystrophy type 2b|limb girdle muscular dystrophy type 2b
4991045|NCT01676077|Muscular Dystrophy|muscular dystrophy
4991046|NCT01676064|intraocular pressure|intraocular pressure
4991047|NCT01676064|perioperative fluid|perioperative fluid
4991048|NCT01676064|trendelenburg position|trendelenburg position
4991049|NCT01676064|laparoscopic gynecologic surgery|laparoscopic gynecologic surgery
4991050|NCT01676038|Total Knee Replacement, Computer-Assisted Surgery|total knee replacement, computer-assisted surgery
4991051|NCT01676025|pheochromocytoma|pheochromocytoma
4991052|NCT01676025|aldosteronism|aldosteronism
4991053|NCT01676025|cushing's syndrome|cushing's syndrome
4991054|NCT01676025|adrenal incidentaloma|adrenal incidentaloma
4991055|NCT01676025|Conn's syndrome|conn's syndrome
4991056|NCT01675999|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
4991057|NCT01675999|Locally advanced malignant neoplasm|locally advanced malignant neoplasm
4991058|NCT01675999|colon cancer|colon cancer
4991059|NCT01675973|Ranolazine|ranolazine
4991060|NCT01675973|renal impairment|renal impairment
4991061|NCT01675960|chronic irritability|chronic irritability
4991062|NCT01675960|chronic pain|chronic pain
4991063|NCT01675960|Neurologically impaired|neurologically impaired
4991064|NCT01675960|gabapentin|gabapentin
4991065|NCT01675921|Asthma|asthma
4991066|NCT01675921|Facebook|facebook
4991067|NCT01675921|teenagers|teenagers
4991068|NCT01675921|ACT|act
4991069|NCT01675895|Hyperbaric Levobupivacaine|hyperbaric levobupivacaine
4991070|NCT01675895|İntrathecal|intrathecal
4991071|NCT01675895|Lidocaine|lidocaine
4991072|NCT01675895|TUR-P|tur-p
4991073|NCT01675882|Food allergy|food allergy
4991074|NCT01675882|Immediate hypersensitivity|immediate hypersensitivity
4991075|NCT01675882|Whole peanut extract|whole peanut extract
4991076|NCT01675882|Allergenic product|allergenic product
4991077|NCT01675882|Specific Immunotherapy|specific immunotherapy
4991078|NCT01675882|Epicutaneous Immunotherapy (EPIT)|epicutaneous immunotherapy (epit)
4991079|NCT01675869|Attention-Deficit/Hyperactivity Disorder|attention-deficit/hyperactivity disorder
4991080|NCT01675869|Executive function|executive function
4991081|NCT01675869|Preschooler|preschooler
4991082|NCT01675869|Metacognition|metacognition
4991083|NCT01675856|Glasgow-Blatchford score|glasgow-blatchford score
4991084|NCT01675856|Gastrointestinal bleeding|gastrointestinal bleeding
4991085|NCT01675843|Infertility|infertility
4991086|NCT01675843|PCOS|pcos
4991087|NCT01675843|IUI|iui
4991088|NCT01675817|heparin rebound|heparin rebound
4991089|NCT01675817|protamine|protamine
4991090|NCT01675817|cardiopulmonary bypass|cardiopulmonary bypass
4991091|NCT01675817|cardiac surgery|cardiac surgery
4991092|NCT01675817|anti-Xa|anti-xa
4991093|NCT01675817|anti-IIa|anti-iia
4991094|NCT01675804|ADHD|adhd
4991095|NCT01675778|hydromorphone|hydromorphone
4991096|NCT01675778|acute pain|acute pain
4991097|NCT01675778|emergency department|emergency department
4991098|NCT01675765|Cancer|cancer
4991099|NCT01675765|Cancer vaccine|cancer vaccine
4991100|NCT01675765|Listeria monocytogenes|listeria monocytogenes
4991101|NCT01675765|Listeria-based vaccines|listeria-based vaccines
4991102|NCT01675765|Pemetrexed|pemetrexed
4991103|NCT01675765|Cisplatin|cisplatin
4991104|NCT01675765|T regulatory cells|t regulatory cells
4991105|NCT01675765|Mesothelin|mesothelin
4991106|NCT01675765|Malignant Pleural Mesothelioma|malignant pleural mesothelioma
4991107|NCT01675765|Chemotherapy|chemotherapy
4991108|NCT01675765|Standard of care|standard of care
4991109|NCT01675765|Naive|naive
4991110|NCT01675765|Front-line|front-line
4991111|NCT01675765|Immunotherapy|immunotherapy
4991112|NCT01675765|MPM|mpm
4991113|NCT01675752|colonoscopy, narrow-band imaging|colonoscopy, narrow-band imaging
4991114|NCT01675739|colonoscopy|colonoscopy
4991115|NCT01675739|bowel preparation|bowel preparation
4991116|NCT01675739|short message service|short message service
4991117|NCT01675713|Lifestyle|lifestyle
4991118|NCT01675713|Physical activity|physical activity
4991119|NCT01675700|Myofascial pain|myofascial pain
4991120|NCT01675700|Trigger point|trigger point
4991121|NCT01675700|Nitroglycerin|nitroglycerin
4991122|NCT01675687|dietary habits and obesity|dietary habits and obesity
4991123|NCT01675687|exercise habits and obesity|exercise habits and obesity
4991124|NCT01675687|cognition and obesity|cognition and obesity
4991125|NCT01675674|Mucopolysaccharidoses|mucopolysaccharidoses
4991126|NCT01675674|Prevalence|prevalence
4991127|NCT01675674|Pediatric|pediatric
4991128|NCT01675674|Rheumatology|rheumatology
4991129|NCT01675674|Mucopolysaccharidosis I|mucopolysaccharidosis i
4991130|NCT01675674|Mucopolysaccharidosis II|mucopolysaccharidosis ii
4991131|NCT01675674|Mucopolysaccharidosis IV|mucopolysaccharidosis iv
4991132|NCT01675674|Mucopolysaccharidosis VI|mucopolysaccharidosis vi
4991133|NCT01675648|Opiate dependent|opiate dependent
4991134|NCT01675648|inpatient detoxification|inpatient detoxification
4991135|NCT01675622|Cancer Pain|cancer pain
4991136|NCT01675596|Aortic Stenosis|aortic stenosis
4991137|NCT01675596|Transfemoral|transfemoral
4991138|NCT01675596|Transcatheter Heart Valve|transcatheter heart valve
4991139|NCT01675583|Diabetic Wounds|diabetic wounds
4991140|NCT01675583|Hyperbaric Oxygen|hyperbaric oxygen
4991141|NCT01675583|Laser Speckle Imaging|laser speckle imaging
4991142|NCT01675583|Hyperbaric Oxygenation|hyperbaric oxygenation
4991143|NCT01675570|RX-10045|rx-10045
4991144|NCT01675570|Dry Eye Disease|dry eye disease
4991145|NCT01675557|chronic kidney disease|chronic kidney disease
4991146|NCT01675544|Heart failure|heart failure
4991147|NCT01675531|Targin|targin
4991148|NCT01675531|Chemotherapy Induced Peripheral Neuropathy (CIPN)|chemotherapy induced peripheral neuropathy (cipn)
4991149|NCT01675518|Plasma concentration|plasma concentration
4991150|NCT01675518|ASP7991|asp7991
4991151|NCT01675518|food effect|food effect
4991152|NCT01675518|PTH (parathyroid hormone)|pth (parathyroid hormone)
4991153|NCT01675492|Astigmatism|astigmatism
4991154|NCT01675492|refractive|refractive
4991155|NCT01675492|error|error
4991156|NCT01675492|LASIK|lasik
4991157|NCT01675479|refractive|refractive
4991158|NCT01675479|errors|errors
4991159|NCT01675466|non-specific abdominal pain|non-specific abdominal pain
4991664|NCT01673282|AED|aed
4991160|NCT01675466|undifferentiated abdominal pain|undifferentiated abdominal pain
4991161|NCT01675466|appendicitis|appendicitis
4991162|NCT01675466|appendicectomy|appendicectomy
4991163|NCT01675466|appendectomy|appendectomy
4991164|NCT01675466|surgery|surgery
4991165|NCT01675466|laparoscopy|laparoscopy
4991166|NCT01675466|antibiotics|antibiotics
4991167|NCT01675466|randomised controlled trial|randomised controlled trial
4991168|NCT01675466|randomized controlled trial|randomized controlled trial
4991169|NCT01675466|controlled clinical trial|controlled clinical trial
4991170|NCT01675466|randomised|randomised
4991171|NCT01675466|placebo|placebo
4991172|NCT01675453|Organ dysfunction|organ dysfunction
4991173|NCT01675453|Hypertonic solution|hypertonic solution
4991174|NCT01675453|Extravascular water|extravascular water
4991175|NCT01675453|Cardiopulmonary Bypass|cardiopulmonary bypass
4991176|NCT01675414|ASD|asd
4991177|NCT01675414|autism|autism
4991178|NCT01675414|gastrointestinal|gastrointestinal
4991179|NCT01675414|gastrointestinal conditions in children with ASD|gastrointestinal conditions in children with asd
4991180|NCT01675401|Body Weight|body weight
4991181|NCT01675401|Obesity|obesity
4991182|NCT01675401|Weight Loss|weight loss
4991183|NCT01675401|Vascular Function Markers|vascular function markers
4991184|NCT01675388|Neonatal hypoxemic respiratory failure|neonatal hypoxemic respiratory failure
4991185|NCT01675388|Extra Corporeal Membrane Oxygenation|extra corporeal membrane oxygenation
4991186|NCT01675388|Neurodevelopmental outcomes|neurodevelopmental outcomes
4991187|NCT01675388|Neuroimaging|neuroimaging
4991188|NCT01675362|Extracorporeal shockwave lithotripsy (ESWL)|extracorporeal shockwave lithotripsy (eswl)
4991189|NCT01675362|Kidney calculi|kidney calculi
4991190|NCT01675362|Renal protection|renal protection
4991191|NCT01675362|Antioxidants|antioxidants
4991192|NCT01675362|Calcium channel blockers|calcium channel blockers
4991193|NCT01675362|Angiotensin receptor blockers|angiotensin receptor blockers
4991194|NCT01675349|Standardization|standardization
4991195|NCT01675349|Immunotherapy|immunotherapy
4991196|NCT01675349|Skin prick test|skin prick test
4991197|NCT01675323|Restless Legs Syndrome|restless legs syndrome
4991198|NCT01675323|RLS|rls
4991199|NCT01675310|obesity, polycystic ovary syndrome, gestational diabetes|obesity, polycystic ovary syndrome, gestational diabetes
4991200|NCT01675297|Risedronate, cholecalciferol, BMD|risedronate, cholecalciferol, bmd
4991201|NCT01675284|Avian Influenza|avian influenza
4991202|NCT01675284|Influenza A Virus Subtype H5N1|influenza a virus subtype h5n1
4991203|NCT01675284|Inactivated H5N1 Influenza Virion Vaccine|inactivated h5n1 influenza virion vaccine
4991204|NCT01675284|Phase I|phase i
4991205|NCT01675284|Preventive H5N1 vaccination|preventive h5n1 vaccination
4991206|NCT01675271|gestational diabetes|gestational diabetes
4991207|NCT01675271|inflammation|inflammation
4991208|NCT01675271|autonomic nervous system|autonomic nervous system
4991209|NCT01675245|Multiple Myeloma|multiple myeloma
4991210|NCT01675245|Cancer|cancer
4991211|NCT01675245|Velcade|velcade
4991212|NCT01675245|Bortezomib|bortezomib
4991213|NCT01675245|Chinese patients|chinese patients
4991214|NCT01675232|Atopic dermatitis|atopic dermatitis
4991215|NCT01675232|Topical corticosteroid|topical corticosteroid
4991216|NCT01675232|Pediatric|pediatric
4991217|NCT01675232|Eczema|eczema
4991218|NCT01675219|bladder cancer|bladder cancer
4991219|NCT01675219|recurrence|recurrence
4991220|NCT01675219|photodynamic diagnosis|photodynamic diagnosis
4991221|NCT01675219|PDD|pdd
4991222|NCT01675219|cost analysis|cost analysis
4991223|NCT01675206|Vascular calcification|vascular calcification
4991224|NCT01675206|Hemodialysis|hemodialysis
4991225|NCT01675206|Matrix Gla Protein|matrix gla protein
4991226|NCT01675206|Vitamin K2|vitamin k2
4991227|NCT01675193|Amblyopia|amblyopia
4991228|NCT01675193|Vision-Screening|vision-screening
4991229|NCT01675180|pregnancy, oral health, attitude, awareness, streptococcus mutans, lactobacilli, oxidative stress|pregnancy, oral health, attitude, awareness, streptococcus mutans, lactobacilli, oxidative stress
4991230|NCT01675167|CLBP|clbp
4991231|NCT01675167|Chronic Low Back Pain|chronic low back pain
4991232|NCT01675167|Chronic Pain|chronic pain
4991233|NCT01675167|Back Pain|back pain
4991234|NCT01675154|hypertriglyceridemia|hypertriglyceridemia
4991235|NCT01675141|NK Cell Function|nk cell function
4991236|NCT01675141|Immunomodulatory Drugs|immunomodulatory drugs
4991237|NCT01675141|T Cell Activity|t cell activity
4991238|NCT01675141|Immune Stimulatory Effects|immune stimulatory effects
4991239|NCT01675141|Extended Dosing|extended dosing
4991240|NCT01675128|Human Eukaryotic Translation Initiation Factor 4E (eIF4E) protein|human eukaryotic translation initiation factor 4e (eif4e) protein
4991241|NCT01675128|Refractory|refractory
4991242|NCT01675128|Oncogene|oncogene
4991243|NCT01675128|Maximum Tolerated Dose|maximum tolerated dose
4991244|NCT01675128|Safety|safety
4991245|NCT01675115|Ischemic stroke|ischemic stroke
4991246|NCT01675115|Traditional Chinese Medication|traditional chinese medication
4991247|NCT01675115|Aspirin|aspirin
4991248|NCT01675102|del 17p|del 17p
4991249|NCT01675102|chronic lymphocytic leukemia|chronic lymphocytic leukemia
4991250|NCT01675102|cll|cll
4991251|NCT01675102|mutation|mutation
4991252|NCT01675102|p53|p53
4991253|NCT01675089|bone disease|bone disease
4991254|NCT01675089|kidney transplantation|kidney transplantation
4991255|NCT01675089|bisphosphonates|bisphosphonates
4991256|NCT01675076|Hematoma|hematoma
4991257|NCT01675076|novel oral anti-coagulant (NOAC)|novel oral anti-coagulant (noac)
4991258|NCT01675076|Device surgery|device surgery
4991259|NCT01675037|hypothalamic|hypothalamic
4991260|NCT01675037|pituitary,|pituitary,
4991261|NCT01675037|endoscopic third ventriculostomy|endoscopic third ventriculostomy
4991262|NCT01675037|hydrocephalus|hydrocephalus
4991263|NCT01675024|Neupro, Pharmacokinetics, healthy Chinese subjects|neupro, pharmacokinetics, healthy chinese subjects
4991264|NCT01674998|REM Sleep Behavior Disorder|rem sleep behavior disorder
4991265|NCT01674998|RBD|rbd
4991266|NCT01674998|Dream|dream
4991267|NCT01674998|Dreams|dreams
4991268|NCT01674985|Decitabine|decitabine
4991269|NCT01674985|microtransplantation|microtransplantation
4991270|NCT01674985|myelodysplastic syndromes|myelodysplastic syndromes
4991271|NCT01674985|chemotherapy|chemotherapy
4991272|NCT01674972|NAFLD|nafld
4991273|NCT01674972|NASH|nash
4991274|NCT01674972|GLP-1|glp-1
4991275|NCT01674959|gastric cancer|gastric cancer
4991276|NCT01674959|radiation|radiation
4991277|NCT01674959|chemotherapy|chemotherapy
4991278|NCT01674946|GI-physiology|gi-physiology
4991279|NCT01674946|CDCA|cdca
4991280|NCT01674946|bile acids|bile acids
4991281|NCT01674946|TGR5|tgr5
4991282|NCT01674946|satiation peptides|satiation peptides
4991283|NCT01674933|dental|dental
4991284|NCT01674933|prevention|prevention
4991285|NCT01674933|caries|caries
4991286|NCT01674933|oral|oral
4991287|NCT01674933|children|children
4991288|NCT01674920|Pediatric obesity|pediatric obesity
4991289|NCT01674920|resiliency|resiliency
4991290|NCT01674920|physical activity|physical activity
4991291|NCT01674920|dietary patterns|dietary patterns
4991292|NCT01674920|children|children
4991293|NCT01674881|Mindfulness|mindfulness
4991294|NCT01674881|breast cancer|breast cancer
4991295|NCT01674881|chronic pain|chronic pain
4991296|NCT01674881|mediators|mediators
4991297|NCT01674881|distress|distress
4991298|NCT01674881|Breast cancer survivors|breast cancer survivors
4991299|NCT01674881|Effectiveness of MBCT on chronic pain|effectiveness of mbct on chronic pain
4991300|NCT01674881|Potential mediators and moderators|potential mediators and moderators
4991301|NCT01674881|Effectiveness of MBCT on psychological symptoms|effectiveness of mbct on psychological symptoms
4991302|NCT01674868|stroke|stroke
4991303|NCT01674868|recovery|recovery
4991304|NCT01674868|fluoxetine|fluoxetine
4991305|NCT01674868|aphasia|aphasia
4991306|NCT01674868|neglect|neglect
4991307|NCT01674868|motor|motor
4991308|NCT01674855|PEG-G-CSF|peg-g-csf
4991309|NCT01674842|Triple negative|triple negative
4991310|NCT01674842|Stage II|stage ii
4991311|NCT01674842|Stage III|stage iii
4991312|NCT01674803|drug-eluting stent|drug-eluting stent
4991313|NCT01674803|zotarolimus|zotarolimus
4991314|NCT01674803|everolimus|everolimus
4991315|NCT01674803|sirolimus|sirolimus
4991316|NCT01674803|all comers population|all comers population
4991317|NCT01674803|target vessel failure|target vessel failure
4991318|NCT01674803|coronary artery disease|coronary artery disease
4991319|NCT01674803|durable polymer|durable polymer
4991320|NCT01674803|biodegradable polymer|biodegradable polymer
4991321|NCT01674777|ASP1941|asp1941
4991322|NCT01674777|Food effect|food effect
4991323|NCT01674777|Pharmacokinetics|pharmacokinetics
4991324|NCT01674751|pre-ordering|pre-ordering
4991325|NCT01674751|healthy eating|healthy eating
4991326|NCT01674751|mindfulness|mindfulness
4991327|NCT01674751|incentives|incentives
4991328|NCT01674751|employees|employees
4991329|NCT01674738|Non Small Cell Lung Cancer|non small cell lung cancer
4991330|NCT01674738|NSCLC Stage IV|nsclc stage iv
4991331|NCT01674738|Non-Squamous Advanced Non-Small-Cell Lung-Cancer (Stage IV)|non-squamous advanced non-small-cell lung-cancer (stage iv)
4991332|NCT01674725|Hepatitis C virus|hepatitis c virus
4991333|NCT01674725|Hepatitis C Genotype 1|hepatitis c genotype 1
4991334|NCT01674725|Hepatitis C|hepatitis c
4991335|NCT01674725|Interferon-Free|interferon-free
4991336|NCT01674725|Chronic Hepatitis C|chronic hepatitis c
4991337|NCT01674725|Ombitasvir|ombitasvir
4991338|NCT01674725|Ribavirin|ribavirin
4991339|NCT01674725|Viekira PAK|viekira pak
4991340|NCT01674725|Dasabuvir|dasabuvir
4991341|NCT01674725|Paritaprevir|paritaprevir
4991342|NCT01674712|Fibrates|fibrates
4991343|NCT01674712|Dyslipidemia|dyslipidemia
4991344|NCT01674686|Vasospasm|vasospasm
4991345|NCT01674686|Sarpogrelate|sarpogrelate
4991346|NCT01674686|Statin|statin
4991347|NCT01674673|panic disorder|panic disorder
4991348|NCT01674673|SSRIs pharmacotherapy|ssris pharmacotherapy
4991349|NCT01674673|Cognitive Behavioral therapy|cognitive behavioral therapy
4991350|NCT01674660|hemodialysis|hemodialysis
4991351|NCT01674660|blood pressure variability|blood pressure variability
4991352|NCT01674660|volume status|volume status
4991353|NCT01674647|rivaroxaban|rivaroxaban
4991354|NCT01674647|oral anticoagulant|oral anticoagulant
4991355|NCT01674647|nonvalvular atrial fibrillation|nonvalvular atrial fibrillation
4991356|NCT01674647|cardioversion|cardioversion
4991357|NCT01674647|stroke|stroke
4991358|NCT01674647|transient ischemic attack|transient ischemic attack
4991359|NCT01674647|thromboembolism|thromboembolism
4991360|NCT01674647|cardiovascular event|cardiovascular event
4991361|NCT01674634|XIAFLEX|xiaflex
4991362|NCT01674634|XIAPEX|xiapex
4991363|NCT01674634|Dupuytren's disease|dupuytren's disease
4991364|NCT01674634|contracture|contracture
4991365|NCT01674621|BA058|ba058
4991366|NCT01674621|Abaloparatide-SC|abaloparatide-sc
4991367|NCT01674621|abaloparatide|abaloparatide
4991368|NCT01674621|Abaloparatide-TD|abaloparatide-td
4991369|NCT01674621|Osteo|osteo
4991370|NCT01674621|Osteoporosis|osteoporosis
4991371|NCT01674621|Transdermal|transdermal
4991372|NCT01674621|Patch|patch
4991373|NCT01674608|intensive care|intensive care
4991374|NCT01674608|mobilization|mobilization
4991375|NCT01674608|rehabilitation|rehabilitation
4991376|NCT01674608|critical care|critical care
4991377|NCT01674595|Olea sensitization|olea sensitization
4991378|NCT01674582|Glioma|glioma
4991379|NCT01674582|Brain tumors|brain tumors
4991380|NCT01674582|Brain metastases|brain metastases
4991381|NCT01674582|MRI|mri
4991382|NCT01674582|Cognitive measurement|cognitive measurement
4991383|NCT01674582|Neuropsychological evaluation|neuropsychological evaluation
4991384|NCT01674582|DW-MRI|dw-mri
4991385|NCT01674582|P-MRI|p-mri
4991386|NCT01674582|MRS|mrs
4991387|NCT01674569|VEGF|vegf
4991388|NCT01674569|PDGF|pdgf
4991389|NCT01674569|AMD|amd
4991390|NCT01674556|pancreatic|pancreatic
4991391|NCT01674556|cancer|cancer
4991392|NCT01674556|adenocarcinoma|adenocarcinoma
4991393|NCT01674556|Ultrasound|ultrasound
4991394|NCT01674556|CEUS|ceus
4991395|NCT01674543|Physical exercise|physical exercise
4991396|NCT01674543|Schizophrenia|schizophrenia
4991397|NCT01674543|symptoms|symptoms
4991398|NCT01674543|IGF-1|igf-1
4991399|NCT01674517|Bioequivalence|bioequivalence
4991400|NCT01674517|Montelukast Sodium|montelukast sodium
4991401|NCT01674517|crossover|crossover
4991402|NCT01674504|Bioequivalence|bioequivalence
4991403|NCT01674504|Montelukast Sodium|montelukast sodium
4991404|NCT01674504|crossover|crossover
4991405|NCT01674478|NEC, SBS, enterostomy, fish oil, Microlipid, Intralipid,|nec, sbs, enterostomy, fish oil, microlipid, intralipid,
4991406|NCT01674478|enteral fat|enteral fat
4991407|NCT01674465|Kidney fibrosis|kidney fibrosis
4991408|NCT01674465|Kidney hypoxia|kidney hypoxia
4991409|NCT01674465|Calcineurin inhibitors|calcineurin inhibitors
4991410|NCT01674452|Stroke|stroke
4991411|NCT01674452|Exercise and Physical Fitness|exercise and physical fitness
4991412|NCT01674439|Adipose-derived regenerative cells|adipose-derived regenerative cells
4991413|NCT01674439|Cell therapy|cell therapy
4991414|NCT01674439|Autologous fat transfer|autologous fat transfer
4991415|NCT01674439|Tissue engineering|tissue engineering
4991416|NCT01674439|Craniofacial microsomia|craniofacial microsomia
4991417|NCT01674426|functional hypothalamic amenorrhea|functional hypothalamic amenorrhea
4991418|NCT01674426|stress induced anovulation|stress induced anovulation
4991419|NCT01674413|Crohn's Disease|crohn's disease
4991420|NCT01674413|Crohn's|crohn's
4991421|NCT01674413|Crohns|crohns
4991422|NCT01674413|Inflammatory Bowel Disease|inflammatory bowel disease
4991423|NCT01674413|IBD|ibd
4991424|NCT01674413|Humira|humira
4991425|NCT01674413|Adalimumab|adalimumab
4991426|NCT01674413|Adalimumab injection|adalimumab injection
4991427|NCT01674413|Higgins|higgins
4991428|NCT01674413|Calprotectin|calprotectin
4991429|NCT01674413|biomarkers|biomarkers
4991430|NCT01674413|Gastroenterology|gastroenterology
4991431|NCT01674413|University of Michigan|university of michigan
4991432|NCT01674413|U of M|u of m
4991433|NCT01674387|electroacupuncture therapy|electroacupuncture therapy
4991434|NCT01674387|neck pain|neck pain
4991435|NCT01674387|McGill Pain Questionnaire|mcgill pain questionnaire
4991436|NCT01674387|Acupuncture Therapy|acupuncture therapy
4991437|NCT01674387|Electroacupuncture|electroacupuncture
4991438|NCT01674387|Meridians|meridians
4991439|NCT01674348|Diabetes Mellitus|diabetes mellitus
4991440|NCT01674335|Fibromyalgia|fibromyalgia
4991441|NCT01674335|Chronic pain|chronic pain
4991442|NCT01674335|Chronic fatigue|chronic fatigue
4991443|NCT01674335|Activity pacing|activity pacing
4991444|NCT01674335|Operant learning|operant learning
4991445|NCT01674335|Energy conservation|energy conservation
4991446|NCT01674335|Treatment|treatment
4991447|NCT01674335|Intervention|intervention
4991448|NCT01674335|Biopsychosocial factors|biopsychosocial factors
4991449|NCT01674335|Coping|coping
4991450|NCT01674335|Mood|mood
4991451|NCT01674335|Quality of life|quality of life
4991452|NCT01674322|Healthy participants|healthy participants
4991453|NCT01674322|Ibrutinib|ibrutinib
4991454|NCT01674322|PCI-32765|pci-32765
4991455|NCT01674322|B-cell malignancies|b-cell malignancies
4991456|NCT01674322|CYP3A4|cyp3a4
4991457|NCT01674296|Body Weight/physiology*|body weight/physiology*
4991458|NCT01674296|Diet*/statistics & numerical data|diet*/statistics & numerical data
4991459|NCT01674296|Diet*/trends|diet*/trends
4991460|NCT01674296|Exercise/physiology*|exercise/physiology*
4991461|NCT01674296|Female|female
4991462|NCT01674296|Humans|humans
4991463|NCT01674296|Longitudinal Studies|longitudinal studies
4991464|NCT01674296|Middle Aged|middle aged
4991465|NCT01674296|Obesity/epidemiology*|obesity/epidemiology*
4991466|NCT01674296|Seasons*|seasons*
4991467|NCT01674296|Time Factors|time factors
4991468|NCT01674257|Atherosclerosis|atherosclerosis
4991469|NCT01674257|Stroke|stroke
4991470|NCT01674257|Positron-emission tomography|positron-emission tomography
4991471|NCT01674257|Ferumoxytol|ferumoxytol
4991472|NCT01674257|Magnetic resonance imaging|magnetic resonance imaging
4991473|NCT01674257|Genetics|genetics
4991474|NCT01674257|Calcification|calcification
4991475|NCT01674257|Inflammation|inflammation
4991476|NCT01674257|Flurodeoxyglucose F18|flurodeoxyglucose f18
4991477|NCT01674257|Radiopharmaceuticals|radiopharmaceuticals
4991478|NCT01674218|tuberculosis, safety, PA-824, QTc interval, moxifloxacin, healthy volunteers, crossover|tuberculosis, safety, pa-824, qtc interval, moxifloxacin, healthy volunteers, crossover
4991479|NCT01674179|Fibromyalgia|fibromyalgia
4991480|NCT01674179|qEEG|qeeg
4991481|NCT01674179|Sleep|sleep
4991482|NCT01674179|Pain|pain
4991483|NCT01674153|Intra-dialytic exercise|intra-dialytic exercise
4991484|NCT01674153|Toxin removal|toxin removal
4991485|NCT01674153|Hemodiafiltration|hemodiafiltration
4991486|NCT01674153|Inter-compartmental resistance|inter-compartmental resistance
4991487|NCT01674153|Cardiac output|cardiac output
4991488|NCT01674140|estrogen receptor-positive breast cancer|estrogen receptor-positive breast cancer
4991489|NCT01674140|HER2-negative breast cancer|her2-negative breast cancer
4991490|NCT01674140|stage IA breast cancer|stage ia breast cancer
4991491|NCT01674140|stage IB breast cancer|stage ib breast cancer
4991492|NCT01674140|stage II breast cancer|stage ii breast cancer
4991493|NCT01674140|stage IIIA breast cancer|stage iiia breast cancer
4991494|NCT01674140|stage IIIB breast cancer|stage iiib breast cancer
4991495|NCT01674140|stage IIIC breast cancer|stage iiic breast cancer
4991496|NCT01674140|progesterone receptor-positive breast cancer|progesterone receptor-positive breast cancer
4991497|NCT01674140|male breast cancer|male breast cancer
4991498|NCT01674114|Cesarean Section|cesarean section
4991499|NCT01674114|Anesthetics, Local|anesthetics, local
4991500|NCT01674101|Lower extremity malignancy|lower extremity malignancy
4991501|NCT01674088|Irritable Bowel Syndrome|irritable bowel syndrome
4991502|NCT01674088|breath testing|breath testing
4991503|NCT01674088|carbon-13|carbon-13
4991504|NCT01674075|safety|safety
4991505|NCT01674075|J-Tip Delivery System|j-tip delivery system
4991506|NCT01674075|pharmacokinetic profile|pharmacokinetic profile
4991507|NCT01674049|nutrition|nutrition
4991508|NCT01674049|nutrient|nutrient
4991509|NCT01674049|timing|timing
4991510|NCT01674049|diabetes|diabetes
4991511|NCT01674049|family history|family history
4991512|NCT01674049|dairy|dairy
4991513|NCT01673971|hemangioma|hemangioma
4991514|NCT01673958|Eccentric exercise|eccentric exercise
4991515|NCT01673958|Aging|aging
4991516|NCT01673958|Heart failure|heart failure
4991517|NCT01673958|Muscle strength loss|muscle strength loss
4991518|NCT01673958|Sarcopenia|sarcopenia
4991519|NCT01673945|EUS-FNA, Forward viewing EUS scope, accuracy, Curvilinear EUS scope|eus-fna, forward viewing eus scope, accuracy, curvilinear eus scope
4991520|NCT01673932|stroke|stroke
4991521|NCT01673932|chronic stroke|chronic stroke
4991522|NCT01673932|ischemic stroke|ischemic stroke
4991523|NCT01673932|umbilical cord blood|umbilical cord blood
4991524|NCT01673932|mononuclear cell|mononuclear cell
4991525|NCT01673932|transplant|transplant
4991526|NCT01673906|positron-emission tomography|positron-emission tomography
4991527|NCT01673906|neuroendocrine tumors|neuroendocrine tumors
4991528|NCT01673906|endosonography|endosonography
4991529|NCT01673906|tomography, X-ray computed|tomography, x-ray computed
4991530|NCT01673906|biopsy, fine needle|biopsy, fine needle
4991531|NCT01673906|sensitivity and sensibility|sensitivity and sensibility
4991532|NCT01673893|ClearWay|clearway
4991533|NCT01673893|Glycoprotein|glycoprotein
4991534|NCT01673893|Primary Coronary Intervention|primary coronary intervention
4991535|NCT01673893|Abciximab|abciximab
4991536|NCT01673893|ST Elevation Myocardial Infarction|st elevation myocardial infarction
4991537|NCT01673893|Non-ST Elevation Myocardial Infarction|non-st elevation myocardial infarction
4991538|NCT01673893|STEMI|stemi
4991539|NCT01673893|NSTEMI|nstemi
4991540|NCT01673893|Medicare|medicare
4991541|NCT01673893|Medicaid|medicaid
4991542|NCT01673893|Registry|registry
4991543|NCT01673893|catheterization|catheterization
4991544|NCT01673893|readmission|readmission
4991545|NCT01673893|Acute Coronary Syndrome|acute coronary syndrome
4991546|NCT01673893|ClearwayRx Catheter|clearwayrx catheter
4991547|NCT01673841|bypass grafting|bypass grafting
4991548|NCT01673828|Brain Injuries|brain injuries
4991549|NCT01673828|Pregnanolone|pregnanolone
4991550|NCT01673828|Epilepsy|epilepsy
4991551|NCT01673815|optic disk|optic disk
4991552|NCT01673815|fundoscopy|fundoscopy
4991553|NCT01673815|pediatric|pediatric
4991554|NCT01673815|clinical examination|clinical examination
4991555|NCT01673802|Cholangiocarcinoma|cholangiocarcinoma
4991556|NCT01673789|Stem Cell Educator|stem cell educator
4991557|NCT01673789|Cord blood stem cells|cord blood stem cells
4991558|NCT01673789|Immune modulation|immune modulation
4991559|NCT01673789|Alopecia Areata|alopecia areata
4991560|NCT01673776|Proximal femoral fracture|proximal femoral fracture
4991561|NCT01673776|multimodal intervention|multimodal intervention
4991562|NCT01673776|goal directed therapy (GDT)|goal directed therapy (gdt)
4991563|NCT01673776|hemodynamic intervention|hemodynamic intervention
4991564|NCT01673776|outcome|outcome
4991565|NCT01673763|ERCP|ercp
4991566|NCT01673763|endoscopy|endoscopy
4991567|NCT01673763|pancreatitis|pancreatitis
4991568|NCT01673750|Adolescents|adolescents
4991569|NCT01673750|Body Image|body image
4991570|NCT01673698|obesity|obesity
4991571|NCT01673698|weight loss|weight loss
4991572|NCT01673685|COPD|copd
4991573|NCT01673685|Oxygen cylinder|oxygen cylinder
4991574|NCT01673685|Portable oxygen cylinder|portable oxygen cylinder
4991575|NCT01673685|Battery powered delivery device|battery powered delivery device
4991576|NCT01673685|mobility|mobility
4991577|NCT01673685|dyspnoea|dyspnoea
4991578|NCT01673685|Quality of Life|quality of life
4991579|NCT01673685|Cost effectiveness|cost effectiveness
4991580|NCT01673646|SOM230, Pasireotide, acromegaly, Phase II|som230, pasireotide, acromegaly, phase ii
4991581|NCT01673594|ADHD|adhd
4991582|NCT01673594|Naltrexone|naltrexone
4991583|NCT01673594|SODAS MPH|sodas mph
4991584|NCT01673594|Stimulant-Induced Euphoria|stimulant-induced euphoria
4991585|NCT01673594|Substance Abuse|substance abuse
4991586|NCT01673594|Adults|adults
4991587|NCT01673581|Low Risk|low risk
4991588|NCT01673555|GSK1278863|gsk1278863
4991589|NCT01673555|Pulmonary artery pressure|pulmonary artery pressure
4991590|NCT01673529|Pruritus|pruritus
4991591|NCT01673529|TRPV1|trpv1
4991592|NCT01673529|Cowhage|cowhage
4991593|NCT01673529|Atopic Dermatitis|atopic dermatitis
4991594|NCT01673529|Capsaicin|capsaicin
4991595|NCT01673529|Itch|itch
4991596|NCT01673529|Histamine|histamine
4991597|NCT01673529|healthy volunteers|healthy volunteers
4991598|NCT01673529|SB705498|sb705498
4991599|NCT01673529|Clinical|clinical
4991600|NCT01673516|Renal sympathetic denervation|renal sympathetic denervation
4991601|NCT01673516|Impedance cardiography|impedance cardiography
4991602|NCT01673503|Myopia|myopia
4991603|NCT01673503|refractive surgery|refractive surgery
4991604|NCT01673503|all femtosecond laser|all femtosecond laser
4991605|NCT01673503|ReLEx flex|relex flex
4991606|NCT01673503|ReLEx smile|relex smile
4991607|NCT01673490|Benign Prostatic Hyperplasia|benign prostatic hyperplasia
4991608|NCT01673490|dutasteride and tamsulosin|dutasteride and tamsulosin
4991609|NCT01673464|mild Traumatic Brain Injury|mild traumatic brain injury
4991610|NCT01673464|mTBI|mtbi
4991611|NCT01673464|Concussion|concussion
4991612|NCT01673451|insomnia|insomnia
4991613|NCT01673438|solid tumor|solid tumor
4991614|NCT01673438|aldoxorubicin|aldoxorubicin
4991615|NCT01673438|phase 1|phase 1
4991616|NCT01673438|INNO-206|inno-206
4991617|NCT01673438|doxorubicin|doxorubicin
4991618|NCT01673425|Influenza|influenza
4991619|NCT01673425|Influenza Vaccines|influenza vaccines
4991620|NCT01673425|Vaccines, Attenuated|vaccines, attenuated
4991621|NCT01673425|Immunity, Mucosal|immunity, mucosal
4991622|NCT01673412|venous leg ulcer healing prognostic factors|venous leg ulcer healing prognostic factors
4991623|NCT01673399|repeated implantation failure (RIF)|repeated implantation failure (rif)
4991624|NCT01673399|atosiban|atosiban
4991625|NCT01673399|pregnancy|pregnancy
4991626|NCT01673386|Tivozanib hydrochloride|tivozanib hydrochloride
4991627|NCT01673386|renal cell carcinoma|renal cell carcinoma
4991628|NCT01673386|subject preference|subject preference
4991629|NCT01673386|quality of life|quality of life
4991630|NCT01673373|Renal Artery Stenosis|renal artery stenosis
4991631|NCT01673373|Renal Artery Obstruction|renal artery obstruction
4991632|NCT01673373|Renovascular Hypertension|renovascular hypertension
4991633|NCT01673373|Resistant Hypertension|resistant hypertension
4991634|NCT01673373|Renal Revascularization|renal revascularization
4991635|NCT01673373|Atherosclerotic Renal Artery Stenosis|atherosclerotic renal artery stenosis
4991636|NCT01673373|ARAS (Atherosclerotic Renal Artery Stenosis)|aras (atherosclerotic renal artery stenosis)
4991637|NCT01673373|RAS (Renal Artery Stenosis)|ras (renal artery stenosis)
4991638|NCT01673373|Uncontrolled hypertension|uncontrolled hypertension
4991639|NCT01673373|Hypertension|hypertension
4991640|NCT01673373|systolic blood pressure|systolic blood pressure
4991641|NCT01673373|blood pressure|blood pressure
4991642|NCT01673360|vaginal repair|vaginal repair
4991643|NCT01673360|urinary slings|urinary slings
4991644|NCT01673360|POP|pop
4991645|NCT01673360|SUI|sui
4991646|NCT01673360|prolapse|prolapse
4991647|NCT01673360|incontinence|incontinence
4991648|NCT01673347|allograft|allograft
4991649|NCT01673347|great toe|great toe
4991650|NCT01673334|Pancreas Tumor EUS FNA Core Biopsy Procore FNB|pancreas tumor eus fna core biopsy procore fnb
4991651|NCT01673321|Yogurt|yogurt
4991652|NCT01673321|Milk|milk
4991653|NCT01673321|Protein|protein
4991654|NCT01673321|Food intake|food intake
4991655|NCT01673321|Appetite|appetite
4991656|NCT01673321|Glucose|glucose
4991657|NCT01673321|Insulin|insulin
4991658|NCT01673295|Lupus Nephritis|lupus nephritis
4991659|NCT01673295|Rituximab|rituximab
4991660|NCT01673282|Lacosamide|lacosamide
4991661|NCT01673282|Vimpat|vimpat
4991662|NCT01673282|Focal Epilepsy|focal epilepsy
4991663|NCT01673282|Drug Load|drug load
4991665|NCT01673282|SP1065|sp1065
4991666|NCT01673269|ERCP|ercp
4991667|NCT01673269|Direct cholangioscopic examination of the common bile duct|direct cholangioscopic examination of the common bile duct
4991668|NCT01673269|Choledocholithiasis|choledocholithiasis
4991669|NCT01673269|Cholangiocarcinoma|cholangiocarcinoma
4991670|NCT01673269|Benign stricture of common bile duct|benign stricture of common bile duct
4991671|NCT01673243|Smoking cessation|smoking cessation
4991672|NCT01673243|Household smoking bans|household smoking bans
4991673|NCT01673243|Cancer|cancer
4991674|NCT01673243|Sickle cell disease|sickle cell disease
4991675|NCT01673204|surrogate marker,|surrogate marker,
4991676|NCT01673204|circulating soluble TNF receptor,|circulating soluble tnf receptor,
4991677|NCT01673204|diabetic nephropathy|diabetic nephropathy
4991678|NCT01673178|Type 2 diabetes|type 2 diabetes
4991679|NCT01673178|safety|safety
4991680|NCT01673178|multiple dose|multiple dose
4991681|NCT01673178|intravenous|intravenous
4991682|NCT01673152|Obesity|obesity
4991683|NCT01673152|Overweight|overweight
4991684|NCT01673152|Satiety|satiety
4991685|NCT01673152|Oligofructose|oligofructose
4991686|NCT01673152|Prebiotic|prebiotic
4991687|NCT01673139|Atrial fibrillation|atrial fibrillation
4991688|NCT01673139|Exercise|exercise
4991689|NCT01673126|vegetative state|vegetative state
4991690|NCT01673126|minimally conscious state|minimally conscious state
4991691|NCT01673126|disorders of consciousness|disorders of consciousness
4991692|NCT01673126|transcranial direct current stimulation|transcranial direct current stimulation
4991693|NCT01673113|cryolipolysis, sensory nerve function, Zeltiq|cryolipolysis, sensory nerve function, zeltiq
4991694|NCT01673100|physical activity|physical activity
4991695|NCT01673100|percutaneous coronary intervention|percutaneous coronary intervention
4991696|NCT01673100|heart disease|heart disease
4991697|NCT01673087|stress biology|stress biology
4991698|NCT01673087|cortisol|cortisol
4991699|NCT01673087|adrenocorticotropin|adrenocorticotropin
4991700|NCT01673087|salivary biomarkers|salivary biomarkers
4991701|NCT01673061|Abscess|abscess
4991702|NCT01673061|Boils|boils
4991703|NCT01673061|Anesthetics, Local|anesthetics, local
4991704|NCT01673061|Lidocaine|lidocaine
4991705|NCT01673061|Vapocoolant|vapocoolant
4991706|NCT01673061|1,1,1,3,3-Pentafluoropropane|1,1,1,3,3-pentafluoropropane
4991707|NCT01673061|1,1,1,2-Tetrafluoroethane|1,1,1,2-tetrafluoroethane
4991708|NCT01673048|Elastic stable intramedullary nailing|elastic stable intramedullary nailing
4991709|NCT01673048|biomechanical testing|biomechanical testing
4991710|NCT01673048|fracture|fracture
4991711|NCT01673048|femur|femur
4991712|NCT01673048|treatment|treatment
4991713|NCT01673048|children|children
4991714|NCT01673048|adolescents|adolescents
4991715|NCT01673009|Gleevec|gleevec
4991716|NCT01672996|Use in Abdominal|use in abdominal
4991717|NCT01672996|Contrast Enhanced|contrast enhanced
4991718|NCT01672996|Computed Tomography|computed tomography
4991719|NCT01672996|Optimize concentration|optimize concentration
4991720|NCT01672996|dosage of Ioforminol Injection|dosage of ioforminol injection
4991721|NCT01672983|Japanese|japanese
4991722|NCT01672983|Hepatitis C|hepatitis c
4991723|NCT01672983|Genotype 2|genotype 2
4991724|NCT01672983|Genotype 1b|genotype 1b
4991725|NCT01672983|paritaprevir|paritaprevir
4991726|NCT01672983|ombitasvir|ombitasvir
4991727|NCT01672983|ritonavir|ritonavir
4991728|NCT01672983|VIEKIRAX Combination Tablets|viekirax combination tablets
4991729|NCT01672944|Biological specimen banks|biological specimen banks
4991730|NCT01672944|Health education|health education
4991731|NCT01672944|Tissue banks|tissue banks
4991732|NCT01672944|Health care survey|health care survey
4991733|NCT01672944|Tissue|tissue
4991734|NCT01672918|PET/CT|pet/ct
4991735|NCT01672918|Lymphoma|lymphoma
4991736|NCT01672918|Lymphadenopathy|lymphadenopathy
4991737|NCT01672918|ALPS|alps
4991738|NCT01672905|recurrent prostate cancer|recurrent prostate cancer
4991739|NCT01672905|stage I prostate cancer|stage i prostate cancer
4991740|NCT01672905|stage IIA prostate cancer|stage iia prostate cancer
4991741|NCT01672905|stage IIB prostate cancer|stage iib prostate cancer
4991742|NCT01672905|stage III prostate cancer|stage iii prostate cancer
4991743|NCT01672892|gastrointestinal complications|gastrointestinal complications
4991744|NCT01672892|perioperative/postoperative complications|perioperative/postoperative complications
4991745|NCT01672892|radiation toxicity|radiation toxicity
4991746|NCT01672892|urinary complications|urinary complications
4991747|NCT01672892|urinary tract toxicity|urinary tract toxicity
4991748|NCT01672892|endometrial clear cell carcinoma|endometrial clear cell carcinoma
4991749|NCT01672892|endometrial papillary serous carcinoma|endometrial papillary serous carcinoma
4991750|NCT01672892|stage IA endometrial carcinoma|stage ia endometrial carcinoma
4991751|NCT01672892|stage IB endometrial carcinoma|stage ib endometrial carcinoma
4991752|NCT01672892|stage II endometrial carcinoma|stage ii endometrial carcinoma
4991753|NCT01672892|stage IIIA endometrial carcinoma|stage iiia endometrial carcinoma
4991754|NCT01672892|stage IIIB endometrial carcinoma|stage iiib endometrial carcinoma
4991755|NCT01672892|stage IIIC endometrial carcinoma|stage iiic endometrial carcinoma
4991756|NCT01672892|endometrial adenocarcinoma|endometrial adenocarcinoma
4991757|NCT01672892|cervical adenocarcinoma|cervical adenocarcinoma
4991758|NCT01672892|stage IB cervical cancer|stage ib cervical cancer
4991759|NCT01672892|stage IIA cervical cancer|stage iia cervical cancer
4991760|NCT01672892|stage IIB cervical cancer|stage iib cervical cancer
4991761|NCT01672879|NASH|nash
4991762|NCT01672879|cirrhosis|cirrhosis
4991763|NCT01672879|Compensated Liver disease|compensated liver disease
4991764|NCT01672879|Monoclonal antibody|monoclonal antibody
4991765|NCT01672879|LOXL2|loxl2
4991766|NCT01672879|Simtuzumab|simtuzumab
4991767|NCT01672879|Nonalcoholic Steatohepatitis|nonalcoholic steatohepatitis
4991768|NCT01672879|Hepatic venous pressure gradient|hepatic venous pressure gradient
4991769|NCT01672879|HVPG|hvpg
4991770|NCT01672879|NAFLD|nafld
4991771|NCT01672879|MRE|mre
4991772|NCT01672879|Liver biopsy|liver biopsy
4991773|NCT01672866|NASH|nash
4991774|NCT01672866|non cirrhotic|non cirrhotic
4991775|NCT01672866|Monoclonal antibody|monoclonal antibody
4991776|NCT01672866|LOXL2|loxl2
4991777|NCT01672866|Simtuzumab|simtuzumab
4991778|NCT01672866|Nonalcoholic Steatohepatitis|nonalcoholic steatohepatitis
4991779|NCT01672866|NAFLD|nafld
4991780|NCT01672866|Liver biopsy|liver biopsy
4991781|NCT01672866|MRE|mre
4991782|NCT01672853|PSC|psc
4991783|NCT01672853|Sclerosis|sclerosis
4991784|NCT01672853|Monoclonal antibody|monoclonal antibody
4991785|NCT01672853|LOXL2|loxl2
4991786|NCT01672853|Simtuzumab|simtuzumab
4991787|NCT01672853|Primary sclerosing cholangitis|primary sclerosing cholangitis
4991788|NCT01672853|Liver fibrosis|liver fibrosis
4991789|NCT01672853|Liver disease|liver disease
4991790|NCT01672853|MRCP|mrcp
4991791|NCT01672853|MRE|mre
4991792|NCT01672853|Liver biopsy|liver biopsy
4991793|NCT01672840|Stage 1 Hypertension|stage 1 hypertension
4991794|NCT01672840|cocoa consumption|cocoa consumption
4991795|NCT01672840|Blood pressure|blood pressure
4991796|NCT01672840|Endothelial function|endothelial function
4991797|NCT01672840|arterial stiffness|arterial stiffness
4991798|NCT01672827|Alzheimer's Disease|alzheimer's disease
4991799|NCT01672827|Mild Cognitive Impairment|mild cognitive impairment
4991800|NCT01672827|Positron Emission Tomography (PET)|positron emission tomography (pet)
4991801|NCT01672827|PET Images|pet images
4991802|NCT01672814|Keratoconus|keratoconus
4991803|NCT01672814|Collagen Crosslinking|collagen crosslinking
4991804|NCT01672814|Riboflavin|riboflavin
4991805|NCT01672814|Microwave|microwave
4991806|NCT01672814|Keraflex|keraflex
4991807|NCT01672775|Renal Cell Carcinoma|renal cell carcinoma
4991808|NCT01672775|AGS-16C3F|ags-16c3f
4991809|NCT01672775|Pharmacokinetics of AGS-16C3F|pharmacokinetics of ags-16c3f
4991810|NCT01672762|diabetes mellitus|diabetes mellitus
4991811|NCT01672762|serum Insulin|serum insulin
4991812|NCT01672762|blood glucose|blood glucose
4991813|NCT01672762|glucose excretion|glucose excretion
4991814|NCT01672762|hypoglycemic agents|hypoglycemic agents
4991815|NCT01672762|ipragliflozin|ipragliflozin
4991816|NCT01672749|Scoliosis [MESH]|scoliosis [mesh]
4991817|NCT01672749|Pediatrics [MESH]|pediatrics [mesh]
4991818|NCT01672749|Early onset|early onset
4991819|NCT01672749|Growth guidance|growth guidance
4991820|NCT01672749|Growing rod|growing rod
4991821|NCT01672749|Trolley|trolley
4991822|NCT01672749|Dual growing rod technique|dual growing rod technique
4991823|NCT01672736|Relapsed or relapse/refractory Multiple Myeloma|relapsed or relapse/refractory multiple myeloma
4991824|NCT01672723|opioids|opioids
4991825|NCT01672723|social connection|social connection
4991826|NCT01672710|Hubbard detoxification|hubbard detoxification
4991827|NCT01672710|Exercise|exercise
4991828|NCT01672710|Sauna therapy|sauna therapy
4991829|NCT01672710|Niacin|niacin
4991830|NCT01672710|Gulf War illness|gulf war illness
4991831|NCT01672697|anal incontinence|anal incontinence
4991832|NCT01672697|genital trauma|genital trauma
4991833|NCT01672697|physical therapy|physical therapy
4991834|NCT01672697|anal manometry|anal manometry
4991835|NCT01672684|quality of life|quality of life
4991836|NCT01672658|TBI,|tbi,
4991837|NCT01672658|vestibular|vestibular
4991838|NCT01672645|Smoking cessation|smoking cessation
4991839|NCT01672645|vaccine|vaccine
4991840|NCT01672645|Phase 1|phase 1
4991841|NCT01672619|craniosynostoses|craniosynostoses
4991842|NCT01672619|Osteogenesis Distraction|osteogenesis distraction
4991843|NCT01672619|craniotomy|craniotomy
4991844|NCT01672593|Autologous platelet rich fibrin glue;|autologous platelet rich fibrin glue;
4991845|NCT01672593|Enterocutaneous fistulas;|enterocutaneous fistulas;
4991846|NCT01672593|Single low output GI fistulas;|single low output gi fistulas;
4991847|NCT01672580|social networks|social networks
4991848|NCT01672580|nutrition|nutrition
4991849|NCT01672580|vitamins|vitamins
4991850|NCT01672580|chlorine|chlorine
4991851|NCT01672567|Coronary Artery Disease|coronary artery disease
4991852|NCT01672567|Egg Consumption|egg consumption
4991853|NCT01672567|Endothelial Function|endothelial function
4991854|NCT01672554|Schizophrenia|schizophrenia
4991855|NCT01672554|Anxiety disorder|anxiety disorder
4991856|NCT01672541|dating violence|dating violence
4991857|NCT01672541|healthy relationship behaviors|healthy relationship behaviors
4991858|NCT01672528|Patient Reported Outcome Measures|patient reported outcome measures
4991859|NCT01672528|PROMs|proms
4991860|NCT01672528|Cardiac arrhythmia|cardiac arrhythmia
4991861|NCT01672528|Cardiac ablation|cardiac ablation
4991862|NCT01672502|sleep|sleep
4991863|NCT01672502|firefighter|firefighter
4991864|NCT01672502|fire|fire
4991865|NCT01672502|apnea|apnea
4991866|NCT01672502|insomnia|insomnia
4991867|NCT01672502|shift|shift
4991868|NCT01672502|narcolepsy|narcolepsy
4991869|NCT01672502|restless leg|restless leg
4991870|NCT01672502|rls|rls
4991871|NCT01672502|fatigue|fatigue
4991872|NCT01672502|Optalert|optalert
4991873|NCT01672502|actigraph|actigraph
4991874|NCT01672502|actigraphy|actigraphy
4991875|NCT01672502|actiwatch|actiwatch
4991876|NCT01672502|safety|safety
4991877|NCT01672502|sleepiness|sleepiness
4991878|NCT01672502|sleepy|sleepy
4991879|NCT01672502|work|work
4991880|NCT01672502|hours|hours
4991881|NCT01672502|FEMA|fema
4991882|NCT01672502|drowsy|drowsy
4991883|NCT01672489|Drowsy|drowsy
4991884|NCT01672489|Drive|drive
4991885|NCT01672489|Driving|driving
4991886|NCT01672489|Shift Work Disorder|shift work disorder
4991887|NCT01672489|SWD|swd
4991888|NCT01672489|EEG|eeg
4991889|NCT01672489|ECG|ecg
4991890|NCT01672489|Actiwatch|actiwatch
4991891|NCT01672489|Diary|diary
4991892|NCT01672489|Bioharness|bioharness
4991893|NCT01672489|Q-Sensor|q-sensor
4991894|NCT01672489|Q Sensor|q sensor
4991895|NCT01672489|Liberty Mutual|liberty mutual
4991896|NCT01672489|sleep|sleep
4991897|NCT01672489|impaired|impaired
4991898|NCT01672489|Optalert|optalert
4991899|NCT01672489|tracker|tracker
4991900|NCT01672489|vehicle|vehicle
4991901|NCT01672489|questionnaire|questionnaire
4991902|NCT01672489|survey|survey
4991903|NCT01672476|Fimasartan|fimasartan
4991904|NCT01672450|Histologically or cytologically proven melanoma; Stages III-IV; accessible cutaneous, subcutaneous, and/or nodal lesions; ECOG performance status 0 to 2|histologically or cytologically proven melanoma; stages iii-iv; accessible cutaneous, subcutaneous, and/or nodal lesions; ecog performance status 0 to 2
4991905|NCT01672437|Birth and parent preparation|birth and parent preparation
4991906|NCT01672437|Parenting stress|parenting stress
4991907|NCT01672437|Depression|depression
4991908|NCT01672437|self-efficacy|self-efficacy
4991909|NCT01672437|social network and support|social network and support
4991910|NCT01672424|NPO|npo
4991911|NCT01672424|Gastric Emptying|gastric emptying
4991912|NCT01672424|Ice Chips|ice chips
4991913|NCT01672424|Protein Drink|protein drink
4991914|NCT01672424|Ultrasound|ultrasound
4991915|NCT01672411|prostate cancer, PSA, markers, diagnosis, prognosis, pro-PSA|prostate cancer, psa, markers, diagnosis, prognosis, pro-psa
4991916|NCT01672398|CarePartner|carepartner
4991917|NCT01672398|informal caregiver|informal caregiver
4991918|NCT01672398|interactive voice response|interactive voice response
4991919|NCT01672398|transition|transition
4991920|NCT01672398|post-discharge|post-discharge
4991921|NCT01672398|chronic illness|chronic illness
4991922|NCT01672398|readmission|readmission
4991923|NCT01672398|self-care|self-care
4991924|NCT01672385|CarePartner|carepartner
4991925|NCT01672385|informal caregiver|informal caregiver
4991926|NCT01672385|interactive voice response|interactive voice response
4991927|NCT01672385|transition|transition
4991928|NCT01672385|post-discharge|post-discharge
4991929|NCT01672385|chronic illness|chronic illness
4991930|NCT01672385|readmission|readmission
4991931|NCT01672385|self-care|self-care
4991932|NCT01672359|cognitive functioning|cognitive functioning
4991933|NCT01672359|immune function|immune function
4991934|NCT01672359|cytokines|cytokines
4991935|NCT01672359|growth factors|growth factors
4991936|NCT01672359|quality of life|quality of life
4991937|NCT01672359|dietary supplementation|dietary supplementation
4991938|NCT01672359|Ginkgo biloba|ginkgo biloba
4991939|NCT01672359|Improvement of cognitive function|improvement of cognitive function
4991940|NCT01672346|PAF|paf
4991941|NCT01672320|Robotic|robotic
4991942|NCT01672320|Arthroplasty|arthroplasty
4991943|NCT01672320|Total Hip Arthroplasty|total hip arthroplasty
4991944|NCT01672320|Cup Positioning|cup positioning
4991945|NCT01672320|Outcomes|outcomes
4991946|NCT01672307|hypotrichosis of eyebrows|hypotrichosis of eyebrows
4991947|NCT01672307|thinning eyebrows|thinning eyebrows
4991948|NCT01672307|minoxidil|minoxidil
4991949|NCT01672307|placebo|placebo
4991950|NCT01672307|randomized|randomized
4991951|NCT01672294|caregiver|caregiver
4991952|NCT01672294|end of life|end of life
4991953|NCT01672294|self-disclosure|self-disclosure
4991954|NCT01672268|cardiac computed tomography|cardiac computed tomography
4991955|NCT01672268|Transcatheter Aortic Valve Implantation|transcatheter aortic valve implantation
4991956|NCT01672268|safety and efficacy|safety and efficacy
4991957|NCT01672255|exercise|exercise
4991958|NCT01672255|diabetes|diabetes
4991959|NCT01672255|SSRIs|ssris
4991960|NCT01672216|Exercise Therapy|exercise therapy
4991961|NCT01672216|Biofeedback (Psychology)|biofeedback (psychology)
4991962|NCT01672216|Adult|adult
4991963|NCT01672216|Chronic Obstipation/*therapy|chronic obstipation/*therapy
4991964|NCT01672216|EMG - Biofeedback|emg - biofeedback
4991965|NCT01672216|EMG - Triggered Stimulation|emg - triggered stimulation
4991966|NCT01672216|Augmented biofeedback|augmented biofeedback
4991967|NCT01672177|Geriatrics|geriatrics
4991968|NCT01672177|Aged|aged
4991969|NCT01672177|Aging|aging
4991970|NCT01672177|Chronic disease|chronic disease
4991971|NCT01672177|Self management|self management
4991972|NCT01672164|proteogenomic biomarker panels|proteogenomic biomarker panels
4991973|NCT01672151|Refractory Immune Thrombocytopenic Purpura|refractory immune thrombocytopenic purpura
4991974|NCT01672151|rapamycin|rapamycin
4991975|NCT01672151|regulatory T cells|regulatory t cells
4991976|NCT01672138|PVAI|pvai
4991977|NCT01672138|CFAE|cfae
4991978|NCT01672138|NPAF|npaf
4991979|NCT01672112|analgesic efficacy|analgesic efficacy
4991980|NCT01672112|oral codeine|oral codeine
4991981|NCT01672112|oral oxycodone|oral oxycodone
4991982|NCT01672112|postcraniotomy|postcraniotomy
4991983|NCT01672099|vitamin K2|vitamin k2
4991984|NCT01672099|menaquinone-7|menaquinone-7
4991985|NCT01672099|vascular health|vascular health
4991986|NCT01672073|pressure|pressure
4991987|NCT01672073|waveform|waveform
4991988|NCT01672073|arterial|arterial
4991989|NCT01672047|The 25(OH) vitamin D level|the 25(oh) vitamin d level
4991990|NCT01672047|The 1.25(OH) vitamin D level|the 1.25(oh) vitamin d level
4991991|NCT01672047|The intact PTH level|the intact pth level
4991992|NCT01672047|The calcification score of coronary artery|the calcification score of coronary artery
4991993|NCT01672047|The microalbuminuria level|the microalbuminuria level
4991994|NCT01672021|Breast Cancer|breast cancer
4991995|NCT01672021|MRI PET-CT|mri pet-ct
4991996|NCT01672008|NOX-100|nox-100
4991997|NCT01671995|Heart failure|heart failure
4991998|NCT01671995|Quality of life|quality of life
4991999|NCT01671969|determine effects of diet on renal and other parameters|determine effects of diet on renal and other parameters
4992000|NCT01671956|IBD|ibd
4992001|NCT01671956|UC|uc
4992002|NCT01671956|Colitis|colitis
4992003|NCT01671956|Ulcerative Colitis|ulcerative colitis
4992004|NCT01671943|small malignant invasive breast tumors|small malignant invasive breast tumors
4992005|NCT01671917|Total knee arthroplasty|total knee arthroplasty
4992006|NCT01671917|Total knee replacement|total knee replacement
4992007|NCT01671917|Knee osteoarthritis|knee osteoarthritis
4992008|NCT01671917|Education|education
4992009|NCT01671917|Exercise|exercise
4992010|NCT01671917|Handicap|handicap
4992011|NCT01671917|Function|function
4992012|NCT01671917|Cost-effectiveness|cost-effectiveness
4992013|NCT01671917|Cost-utility|cost-utility
4992014|NCT01671917|Quality of life|quality of life
4992015|NCT01671891|rectal cancer|rectal cancer
4992016|NCT01671891|circulating tumor cells|circulating tumor cells
4992017|NCT01671891|predict responses|predict responses
4992018|NCT01671865|FSHD|fshd
4992019|NCT01671865|magnetic resonance imaging|magnetic resonance imaging
4992020|NCT01671865|magnetic resonance spectroscopy|magnetic resonance spectroscopy
4992021|NCT01671826|Multiple Myeloma|multiple myeloma
4992022|NCT01671826|Autologous Stem Cell Transplantation|autologous stem cell transplantation
4992023|NCT01671826|Elderly Patients|elderly patients
4992024|NCT01671813|positive|positive
4992025|NCT01671813|diffuse|diffuse
4992026|NCT01671813|B-Cell|b-cell
4992027|NCT01671813|elderly|elderly
4992028|NCT01671813|EBV|ebv
4992029|NCT01671813|DLBCL|dlbcl
4992030|NCT01671813|malignant|malignant
4992031|NCT01671813|pilot|pilot
4992032|NCT01671800|Hyperhidrosis|hyperhidrosis
4992033|NCT01671800|Botulinum Toxin|botulinum toxin
4992034|NCT01671800|Amputation|amputation
4992035|NCT01671800|Phantom limb pain|phantom limb pain
4992036|NCT01671787|Hepatitis B|hepatitis b
4992037|NCT01671787|HBV|hbv
4992038|NCT01671787|GS-7340|gs-7340
4992039|NCT01671787|TDF|tdf
4992040|NCT01671787|Tenofovir disoproxil fumarate|tenofovir disoproxil fumarate
4992041|NCT01671787|Gilead|gilead
4992042|NCT01671787|Viread|viread
4992043|NCT01671761|Healthy|healthy
4992044|NCT01671761|Control|control
4992045|NCT01671748|Venous Leg Ulcer|venous leg ulcer
4992046|NCT01671748|Varicose Ulcer|varicose ulcer
4992047|NCT01671748|Chronic ulcer|chronic ulcer
4992048|NCT01671748|Chronic wound|chronic wound
4992049|NCT01671748|Ultrasound therapy|ultrasound therapy
4992050|NCT01671748|MIST device|mist device
4992051|NCT01671748|Wound healing|wound healing
4992052|NCT01671748|Low frequency non contact ultrasound|low frequency non contact ultrasound
4992053|NCT01671735|prevention|prevention
4992054|NCT01671735|diabetes|diabetes
4992055|NCT01671722|Bioequivalence|bioequivalence
4992056|NCT01671722|Montelukast Sodium|montelukast sodium
4992057|NCT01671722|crossover|crossover
4992058|NCT01671709|Bioequivalence|bioequivalence
4992059|NCT01671709|Montelukast Sodium|montelukast sodium
4992060|NCT01671709|crossover|crossover
4992061|NCT01671683|rectal cancer|rectal cancer
4992062|NCT01671683|neoadjuvant chemoradiotherapy|neoadjuvant chemoradiotherapy
4992063|NCT01671683|Capecitabine|capecitabine
4992064|NCT01671670|Functional dyspepsia|functional dyspepsia
4992065|NCT01671670|postprandial distress syndrome|postprandial distress syndrome
4992066|NCT01671657|In vitro fertilization|in vitro fertilization
4992067|NCT01671657|Assisted reproductive therapy|assisted reproductive therapy
4992068|NCT01671657|Time-lapse image recording|time-lapse image recording
4992069|NCT01671657|Image analysis software|image analysis software
4992070|NCT01671644|In vitro fertilization|in vitro fertilization
4992071|NCT01671644|Assisted reproductive therapy|assisted reproductive therapy
4992072|NCT01671644|Time-lapse image recording|time-lapse image recording
4992073|NCT01671644|Image analysis software|image analysis software
4992074|NCT01671618|Aortic dissection|aortic dissection
4992075|NCT01671618|Aortic dilation|aortic dilation
4992076|NCT01671618|Aortic Aneurysm|aortic aneurysm
4992077|NCT01671618|ultrasound|ultrasound
4992078|NCT01671618|point-of-care|point-of-care
4992079|NCT01671618|echocardiography|echocardiography
4992080|NCT01671592|Cancer|cancer
4992081|NCT01671592|colorectal|colorectal
4992082|NCT01671592|tumor|tumor
4992083|NCT01671592|neoplasms|neoplasms
4992084|NCT01671592|carcinoma|carcinoma
4992085|NCT01671592|vaccine|vaccine
4992086|NCT01671566|Congenital Heart defect|congenital heart defect
4992087|NCT01671566|Exercise and Physical fitness|exercise and physical fitness
4992088|NCT01671566|Rehabilitation|rehabilitation
4992089|NCT01671566|Quality of life|quality of life
4992090|NCT01671566|Behaviour|behaviour
4992091|NCT01671540|COPD|copd
4992092|NCT01671540|IPV|ipv
4992093|NCT01671527|Deep Brain Stimulation|deep brain stimulation
4992094|NCT01671527|DBS|dbs
4992095|NCT01671527|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
4992096|NCT01671527|TMS|tms
4992097|NCT01671527|Cervical Dystonia|cervical dystonia
4992098|NCT01671527|Dystonia|dystonia
4992099|NCT01671527|Control|control
4992100|NCT01671527|Healthy|healthy
4992101|NCT01671514|mitochondrial biogenesis|mitochondrial biogenesis
4992102|NCT01671514|skeletal muscle|skeletal muscle
4992103|NCT01671514|epicatechin|epicatechin
4992104|NCT01671501|HIV|hiv
4992105|NCT01671501|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
4992106|NCT01671501|Alcoholism|alcoholism
4992107|NCT01671501|Alcoholic Intoxication|alcoholic intoxication
4992108|NCT01671501|Substance-Related Disorders|substance-related disorders
4992109|NCT01671501|Intervention Studies|intervention studies
4992110|NCT01671501|Primary Health Care|primary health care
4992111|NCT01671501|therapy|therapy
4992112|NCT01671501|prevention & control|prevention & control
4992113|NCT01671488|Anal Cancer|anal cancer
4992114|NCT01671488|Mitomycin|mitomycin
4992115|NCT01671488|5-Fluorouracil|5-fluorouracil
4992116|NCT01671488|5-FU|5-fu
4992117|NCT01671488|IMRT|imrt
4992118|NCT01671488|ADXS11-001|adxs11-001
4992119|NCT01671475|Altered Mental Status|altered mental status
4992120|NCT01671475|Non-convulsive seizure|non-convulsive seizure
4992121|NCT01671475|Electroencephalography|electroencephalography
4992122|NCT01671462|HPV|hpv
4992123|NCT01671462|Cervical Cancer|cervical cancer
4992124|NCT01671462|Cervical Neoplasms|cervical neoplasms
4992125|NCT01671449|Gastric cancer|gastric cancer
4992126|NCT01671449|S-1|s-1
4992127|NCT01671449|Cisplatin|cisplatin
4992128|NCT01671449|Oxaliplatin|oxaliplatin
4992129|NCT01671436|Depression|depression
4992130|NCT01671436|Guided Imagery|guided imagery
4992131|NCT01671436|Psychotherapy|psychotherapy
4992132|NCT01671436|Meditation|meditation
4992133|NCT01671423|Cellulitis|cellulitis
4992134|NCT01671423|Skin infection|skin infection
4992135|NCT01671423|Prednisone|prednisone
4992136|NCT01671423|Steroid|steroid
4992137|NCT01671423|Anti-inflammatory|anti-inflammatory
4992138|NCT01671410|Neonatal Abstinence Syndrome|neonatal abstinence syndrome
4992139|NCT01671410|buprenorphine|buprenorphine
4992140|NCT01671410|morphine|morphine
4992141|NCT01671410|benzodiazepine|benzodiazepine
4992142|NCT01671397|Obesity|obesity
4992143|NCT01671397|weight loss|weight loss
4992144|NCT01671397|sleep hygiene|sleep hygiene
4992145|NCT01671397|diet|diet
4992146|NCT01671397|exercise|exercise
4992147|NCT01671384|Valproate|valproate
4992148|NCT01671384|levocarnitine|levocarnitine
4992149|NCT01671384|SMA|sma
4992150|NCT01671384|physiotherapy|physiotherapy
4992151|NCT01671384|placebo|placebo
4992152|NCT01671371|syncope|syncope
4992153|NCT01671371|point of care|point of care
4992154|NCT01671371|ultrasound|ultrasound
4992155|NCT01671371|echocardiography|echocardiography
4992156|NCT01671358|MRSA|mrsa
4992157|NCT01671358|Contamination|contamination
4992158|NCT01671358|Isolation|isolation
4992159|NCT01671332|Carcinoma, non small cell lung|carcinoma, non small cell lung
4992160|NCT01671332|Second line|second line
4992161|NCT01671332|Third line|third line
4992162|NCT01671319|breast cancer|breast cancer
4992163|NCT01671319|female|female
4992164|NCT01671319|women|women
4992165|NCT01671319|adjuvant|adjuvant
4992166|NCT01671306|Coronary collaterals|coronary collaterals
4992167|NCT01671306|diabetes mellitus|diabetes mellitus
4992168|NCT01671306|monocyte subsets|monocyte subsets
4992169|NCT01671280|pneumonia|pneumonia
4992170|NCT01671280|pelvic inflammatory disease|pelvic inflammatory disease
4992171|NCT01671280|Zithromax|zithromax
4992172|NCT01671280|Zithromac|zithromac
4992173|NCT01671280|Japanese|japanese
4992174|NCT01671280|Regulatory Post Marketing Commitment Plan|regulatory post marketing commitment plan
4992175|NCT01671228|dialysis|dialysis
4992176|NCT01671228|chronic kidney failure|chronic kidney failure
4992177|NCT01671228|informed choice|informed choice
4992178|NCT01671228|patient decision making|patient decision making
4992179|NCT01671228|decision aid|decision aid
4992180|NCT01671215|endometrium|endometrium
4992181|NCT01671215|myometrium|myometrium
4992182|NCT01671215|fibroids|fibroids
4992183|NCT01671215|uterine malformations|uterine malformations
4992184|NCT01671176|Wide diameter implant|wide diameter implant
4992185|NCT01671176|ISQ|isq
4992186|NCT01671176|Ponto|ponto
4992187|NCT01671176|Bone anchored implant|bone anchored implant
4992188|NCT01671163|Cancer|cancer
4992189|NCT01671163|Radiation therapy|radiation therapy
4992190|NCT01671163|Fiducial markers|fiducial markers
4992191|NCT01671150|inflammation|inflammation
4992192|NCT01671150|depression|depression
4992193|NCT01671150|social cognition|social cognition
4992194|NCT01671150|neural activity|neural activity
4992195|NCT01671137|Lactobacillus GG|lactobacillus gg
4992196|NCT01671137|Functional Abdominal Pain|functional abdominal pain
4992197|NCT01671137|Children|children
4992198|NCT01671137|Acute|acute
4992199|NCT01671137|Gastroenteritis|gastroenteritis
4992200|NCT01671124|TG|tg
4992201|NCT01671124|TC|tc
4992202|NCT01671124|HDL|hdl
4992203|NCT01671124|LDL|ldl
4992204|NCT01671124|Albumin|albumin
4992205|NCT01671124|Hemoglobin|hemoglobin
4992206|NCT01671124|Hematocrit|hematocrit
4992207|NCT01671124|Uric acid|uric acid
4992208|NCT01671124|Sodium|sodium
4992209|NCT01671124|Potassium|potassium
4992210|NCT01671124|Calcium|calcium
4992211|NCT01671098|nitric oxide|nitric oxide
4992212|NCT01671098|sinuplasty|sinuplasty
4992213|NCT01671072|Chondrocyte cells|chondrocyte cells
4992214|NCT01671072|Osteoarthritis|osteoarthritis
4992215|NCT01671072|Gene therapy|gene therapy
4992216|NCT01671033|Panic disorder|panic disorder
4992217|NCT01671033|cognitive behavior therapy|cognitive behavior therapy
4992218|NCT01671033|Internet|internet
4992219|NCT01671020|fimasartan|fimasartan
4992220|NCT01671020|absolute bioavailability|absolute bioavailability
4992221|NCT01670994|cancer|cancer
4992222|NCT01670994|immunotherapy|immunotherapy
4992223|NCT01670994|immunochemotherapy|immunochemotherapy
4992224|NCT01670994|targeted|targeted
4992225|NCT01670994|metastatic|metastatic
4992226|NCT01670994|interleukin-2|interleukin-2
4992227|NCT01670994|antitumor|antitumor
4992228|NCT01670994|TCR|tcr
4992229|NCT01670994|T-cell receptor|t-cell receptor
4992230|NCT01670994|p53|p53
4992231|NCT01670994|p53 gene|p53 gene
4992232|NCT01670994|p53 tumor supressor protein|p53 tumor supressor protein
4992233|NCT01670994|HLA-A2 positive|hla-a2 positive
4992234|NCT01670994|HLA-A*0201/p53 aa264-272|hla-a*0201/p53 aa264-272
4992235|NCT01670994|HLA complex|hla complex
4992236|NCT01670994|multiple myeloma|multiple myeloma
4992237|NCT01670994|IFN-γ and TNF-α|ifn-γ and tnf-α
4992238|NCT01670994|refractory|refractory
4992239|NCT01670994|relapsed|relapsed
4992240|NCT01670981|Ischemic dilated cardiomyopathy|ischemic dilated cardiomyopathy
4992241|NCT01670981|Heart failure|heart failure
4992242|NCT01670981|ixCELL|ixcell
4992243|NCT01670981|ixCELL DCM|ixcell dcm
4992244|NCT01670981|IDCM|idcm
4992245|NCT01670981|DCM|dcm
4992246|NCT01670981|stem cells|stem cells
4992247|NCT01670981|MSC|msc
4992248|NCT01670981|cell therapy|cell therapy
4992249|NCT01670955|Anemia|anemia
4992250|NCT01670955|preoperative|preoperative
4992251|NCT01670955|gynecological patients|gynecological patients
4992252|NCT01670955|Sorghum bicolor|sorghum bicolor
4992253|NCT01670955|Packed Cells Volume|packed cells volume
4992254|NCT01670942|pneumothorax|pneumothorax
4992255|NCT01670942|trauma|trauma
4992256|NCT01670942|commercial air travel|commercial air travel
4992257|NCT01670929|recurrent miscarriages|recurrent miscarriages
4992258|NCT01670929|progesterone|progesterone
4992259|NCT01670916|Necrotizing enterocolitis|necrotizing enterocolitis
4992260|NCT01670916|Probiotics|probiotics
4992261|NCT01670916|Preterm|preterm
4992262|NCT01670916|Infant|infant
4992263|NCT01670890|temozolomide(TMZ)|temozolomide(tmz)
4992264|NCT01670890|cisplatin(CDDP)|cisplatin(cddp)
4992265|NCT01670890|recurrent malignant gliomas|recurrent malignant gliomas
4992266|NCT01670851|eLAPE,|elape,
4992267|NCT01670851|perineum,|perineum,
4992268|NCT01670851|pelvic floor reconstruction|pelvic floor reconstruction
4992269|NCT01670838|subarachnoid haemorrhage|subarachnoid haemorrhage
4992270|NCT01670838|cardiopulmonary complications|cardiopulmonary complications
4992271|NCT01670825|Occipital neuralgia|occipital neuralgia
4992272|NCT01670825|corticosteroid injection|corticosteroid injection
4992273|NCT01670825|pulsed radiofrequency|pulsed radiofrequency
4992274|NCT01670812|chronic lymphocytic leukemia|chronic lymphocytic leukemia
4992275|NCT01670812|ultra-high risk|ultra-high risk
4992276|NCT01670812|fresh frozen plasma|fresh frozen plasma
4992277|NCT01670812|methylprednisolone|methylprednisolone
4992278|NCT01670812|rituximab|rituximab
4992279|NCT01670799|Ketorolac|ketorolac
4992280|NCT01670799|Bioavailability|bioavailability
4992281|NCT01670799|Pain|pain
4992282|NCT01670760|Deep Tissue Temperature|deep tissue temperature
4992283|NCT01670760|Zero Heat Flux Thermometry|zero heat flux thermometry
4992284|NCT01670760|Thermometry|thermometry
4992285|NCT01670760|Core Temperature|core temperature
4992286|NCT01670708|Substance Use|substance use
4992287|NCT01670708|Illicit Drug Use|illicit drug use
4992288|NCT01670708|Criminal Behavior|criminal behavior
4992289|NCT01670695|IgG4-related disease|igg4-related disease
4992290|NCT01670695|IgG4-RD|igg4-rd
4992291|NCT01670682|Stage III|stage iii
4992292|NCT01670643|AMD|amd
4992293|NCT01670643|vision rehabilitation|vision rehabilitation
4992294|NCT01670643|video camera magnifier|video camera magnifier
4992295|NCT01670643|IVI|ivi
4992296|NCT01670643|DASS|dass
4992297|NCT01670630|speculum|speculum
4992298|NCT01670630|vagina|vagina
4992299|NCT01670630|cervix|cervix
4992300|NCT01670630|examination|examination
4992301|NCT01670578|P.R.P.|p.r.p.
4992302|NCT01670578|viscosupplementation|viscosupplementation
4992303|NCT01670578|double-blind randomized|double-blind randomized
4992304|NCT01670578|intra-articular injections|intra-articular injections
4992305|NCT01670578|knee degenerative pathology|knee degenerative pathology
4992306|NCT01670578|early osteoarthritis|early osteoarthritis
4992307|NCT01670565|Diffuse cutaneous systemic sclerosis|diffuse cutaneous systemic sclerosis
4992308|NCT01670565|Early Diffuse cutaneous systemic sclerosis|early diffuse cutaneous systemic sclerosis
4992309|NCT01670539|Lung Cancer|lung cancer
4992310|NCT01670539|Telemonitoring|telemonitoring
4992311|NCT01670539|Rural|rural
4992312|NCT01670539|Nursing|nursing
4992313|NCT01670526|Traumatic Brain Injury|traumatic brain injury
4992314|NCT01670526|Cognitive Impairment|cognitive impairment
4992315|NCT01670526|Rivastigmine|rivastigmine
4992316|NCT01670526|Pharmacologic Actions|pharmacologic actions
4992317|NCT01670526|TBI|tbi
4992318|NCT01670526|Memory|memory
4992319|NCT01670526|Cholinesterase Inhibitors|cholinesterase inhibitors
4992320|NCT01670526|Cognition|cognition
4992321|NCT01670526|Head Trauma|head trauma
4992322|NCT01670513|Psoriasis|psoriasis
4992323|NCT01670500|germline mutation|germline mutation
4992324|NCT01670500|BRCA1 mutation|brca1 mutation
4992325|NCT01670500|BRCA2 mutation|brca2 mutation
4992326|NCT01670487|Vapocoolant|vapocoolant
4992327|NCT01670474|Temporary hemodialysis catheters|temporary hemodialysis catheters
4992328|NCT01670474|Non-cuffed hemodialysis catheters|non-cuffed hemodialysis catheters
4992329|NCT01670474|Thrombolysis|thrombolysis
4992330|NCT01670474|rt-PA|rt-pa
4992331|NCT01670474|Thrombosis|thrombosis
4992332|NCT01670474|Lifespan|lifespan
4992333|NCT01670474|Blood flow rate|blood flow rate
4992334|NCT01670474|Catheter related bacteriemia|catheter related bacteriemia
4992335|NCT01670461|advance care planning, palliative care, pediatric|advance care planning, palliative care, pediatric
4992336|NCT01670448|Postoperative pain|postoperative pain
4992337|NCT01670448|Chronic pain prevention|chronic pain prevention
4992338|NCT01670448|Regional anesthesia|regional anesthesia
4992339|NCT01670448|Mastectomy|mastectomy
4992340|NCT01670435|Ciprofloxacin|ciprofloxacin
4992341|NCT01670435|sepsis|sepsis
4992342|NCT01670435|infection|infection
4992343|NCT01670435|pneumonia|pneumonia
4992344|NCT01670435|peritonitis|peritonitis
4992345|NCT01670435|cholecystitis|cholecystitis
4992346|NCT01670435|cholangitis|cholangitis
4992347|NCT01670435|anthrax|anthrax
4992348|NCT01670422|CSOJ|csoj
4992349|NCT01670422|recurrence|recurrence
4992350|NCT01670422|life-threatening complications|life-threatening complications
4992351|NCT01670422|risk factors|risk factors
4992352|NCT01670409|Esophageal squamous cell carcinoma|esophageal squamous cell carcinoma
4992353|NCT01670409|SMART|smart
4992354|NCT01670409|IMRT|imrt
4992355|NCT01670409|Chemotherapy|chemotherapy
4992356|NCT01670396|coronary stent implant|coronary stent implant
4992357|NCT01670396|polymorphism|polymorphism
4992358|NCT01670396|G protein|g protein
4992359|NCT01670396|drug-eluting stent|drug-eluting stent
4992360|NCT01670396|restenosis|restenosis
4992361|NCT01670383|Cardiac Arrest|cardiac arrest
4992362|NCT01670383|Sepsis|sepsis
4992363|NCT01670383|Biological Markers|biological markers
4992364|NCT01670383|Anti-Inflammation Agents|anti-inflammation agents
4992365|NCT01670383|Antioxidants|antioxidants
4992366|NCT01670370|Rituximab|rituximab
4992367|NCT01670370|Gemcitabine|gemcitabine
4992368|NCT01670370|Oxaliplatin|oxaliplatin
4992369|NCT01670370|Diffuse large B-cell lymphoma|diffuse large b-cell lymphoma
4992370|NCT01670357|Dry Eye Syndrome|dry eye syndrome
4992371|NCT01670318|Chronic total occlusion|chronic total occlusion
4992372|NCT01670318|Bifurcation lesion|bifurcation lesion
4992373|NCT01670318|Left main trunk lesion|left main trunk lesion
4992374|NCT01670318|Small vessel disease|small vessel disease
4992375|NCT01670318|Multi vessel disease|multi vessel disease
4992376|NCT01670292|Low Back Pain|low back pain
4992377|NCT01670279|Major Depressive Disorder (MDD)|major depressive disorder (mdd)
4992378|NCT01670266|ONO-9054|ono-9054
4992379|NCT01670266|ocular hypertension|ocular hypertension
4992380|NCT01670266|OHT|oht
4992381|NCT01670266|Open angle-glaucoma|open angle-glaucoma
4992382|NCT01670266|OAG|oag
4992383|NCT01670266|Glaucoma|glaucoma
4992384|NCT01670266|Eye diseases|eye diseases
4992385|NCT01670240|IPAA|ipaa
4992386|NCT01670240|Pouchitis|pouchitis
4992387|NCT01670240|Ulcerative colitis|ulcerative colitis
4992388|NCT01670240|Pouch|pouch
4992389|NCT01670240|Adalimumab|adalimumab
4992390|NCT01670240|Humira|humira
4992391|NCT01670227|EARLY CHILDHOOD|early childhood
4992392|NCT01670227|UNIVERSAL PREVENTION|universal prevention
4992393|NCT01670214|RM|rm
4992394|NCT01670214|R-CM|r-cm
4992395|NCT01670214|based on ICHD-2 criteria|based on ichd-2 criteria
4992396|NCT01670188|Pneumatic sequential compression device (SCD)|pneumatic sequential compression device (scd)
4992397|NCT01670188|Peripherally Inserted Central Catheters (PICC)|peripherally inserted central catheters (picc)
4992398|NCT01670175|Histologic verification of solid tumor, including lymphomas|histologic verification of solid tumor, including lymphomas
4992399|NCT01670175|Original diagnosis or relapse|original diagnosis or relapse
4992400|NCT01670162|Pigment Epithelium of Eye|pigment epithelium of eye
4992401|NCT01670162|Wet macular degeneration|wet macular degeneration
4992402|NCT01670162|Macular degeneration|macular degeneration
4992403|NCT01670149|Clostridium difficile|clostridium difficile
4992404|NCT01670149|Diarrhoea|diarrhoea
4992405|NCT01670149|Rifaximin|rifaximin
4992406|NCT01670136|sildenafil|sildenafil
4992407|NCT01670136|preterm infants|preterm infants
4992408|NCT01670136|persistent pulmonary hypertension of the newborn|persistent pulmonary hypertension of the newborn
4992409|NCT01670123|Mobile phone|mobile phone
4992410|NCT01670123|electronic intervention|electronic intervention
4992411|NCT01670123|behavioral intervention|behavioral intervention
4992412|NCT01670123|telehealth|telehealth
4992413|NCT01670123|bipolar disorder|bipolar disorder
4992414|NCT01670110|Polycystic Liver Disease|polycystic liver disease
4992415|NCT01670110|Autosomal dominant polycystic kidney disease|autosomal dominant polycystic kidney disease
4992416|NCT01670110|Autosomal dominant polycystic liver disease|autosomal dominant polycystic liver disease
4992417|NCT01670110|Somatostatin analogs|somatostatin analogs
4992418|NCT01670110|Pasireotide LAR|pasireotide lar
4992419|NCT01670110|SOM230|som230
4992420|NCT01670097|Advanced Cancers|advanced cancers
4992421|NCT01670097|Hematologic Disorder|hematologic disorder
4992422|NCT01670097|Solid Tumors|solid tumors
4992423|NCT01670097|Dyspnea|dyspnea
4992424|NCT01670097|Difficulty breathing|difficulty breathing
4992425|NCT01670097|Shortness of breath|shortness of breath
4992426|NCT01670097|Dexamethasone|dexamethasone
4992427|NCT01670097|Decadron|decadron
4992428|NCT01670097|Placebo|placebo
4992429|NCT01670097|Sugar pill|sugar pill
4992430|NCT01670097|Questionnaires|questionnaires
4992431|NCT01670097|Surveys|surveys
4992432|NCT01670097|Spirometer|spirometer
4992433|NCT01670097|Phone calls|phone calls
4992434|NCT01670071|Schizophrenia|schizophrenia
4992435|NCT01670071|Paliperidone|paliperidone
4992436|NCT01670071|Risperidone|risperidone
4992437|NCT01670071|Paliperidone extended-release (ER)|paliperidone extended-release (er)
4992438|NCT01670071|Risperidone immediate-release (IR)|risperidone immediate-release (ir)
4992439|NCT01670019|Depression|depression
4992440|NCT01670019|Antidepressant|antidepressant
4992441|NCT01670019|Antipsychotic|antipsychotic
4992442|NCT01669993|Outcomes|outcomes
4992443|NCT01669993|Quality improvement|quality improvement
4992444|NCT01669993|Patient Safety|patient safety
4992445|NCT01669993|PACU|pacu
4992446|NCT01669993|Complications|complications
4992447|NCT01669993|Adverse events|adverse events
4992448|NCT01669993|Respiratory arrest|respiratory arrest
4992449|NCT01669993|Pain|pain
4992450|NCT01669993|PONV|ponv
4992451|NCT01669993|Age|age
4992452|NCT01669993|Neonate|neonate
4992453|NCT01669993|Infant|infant
4992454|NCT01669993|Child|child
4992455|NCT01669993|Ambulatory|ambulatory
4992456|NCT01669993|Inpatient|inpatient
4992457|NCT01669993|General Anesthesia|general anesthesia
4992458|NCT01669993|Otolaryngology|otolaryngology
4992459|NCT01669993|Tonsillectomy|tonsillectomy
4992460|NCT01669993|Obstructive sleep apnea|obstructive sleep apnea
4992461|NCT01669980|Infections|infections
4992462|NCT01669980|Pediatrics|pediatrics
4992463|NCT01669980|Teflaro|teflaro
4992464|NCT01669980|Ceftriaxone|ceftriaxone
4992465|NCT01669980|cephalosporin|cephalosporin
4992466|NCT01669980|Vancomycin|vancomycin
4992467|NCT01669980|Clindamycin|clindamycin
4992468|NCT01669980|Amoxicillin Clavulanate|amoxicillin clavulanate
4992469|NCT01669980|Linezolid|linezolid
4992470|NCT01669980|MRSA|mrsa
4992471|NCT01669980|pneumonia|pneumonia
4992472|NCT01669954|HIV|hiv
4992473|NCT01669954|Bone mineral density|bone mineral density
4992474|NCT01669954|Osteoporosis|osteoporosis
4992475|NCT01669954|Vitamin D|vitamin d
4992476|NCT01669954|Fractures|fractures
4992477|NCT01669941|Pregnancy|pregnancy
4992478|NCT01669941|Plasmodium|plasmodium
4992479|NCT01669941|Malaria|malaria
4992480|NCT01669941|Prevention|prevention
4992481|NCT01669941|Kenya|kenya
4992482|NCT01669941|Piperaquine|piperaquine
4992483|NCT01669941|Dihydroartemisinin-Piperaquine|dihydroartemisinin-piperaquine
4992484|NCT01669941|Sulfadoxine Pyrimethamine|sulfadoxine pyrimethamine
4992485|NCT01669876|Randomized|randomized
4992486|NCT01669876|Double-Blind|double-blind
4992487|NCT01669876|Dietary Supplements|dietary supplements
4992488|NCT01669863|ARDS|ards
4992489|NCT01669850|Chronic kidney disease|chronic kidney disease
4992490|NCT01669850|Arteriovenous fistula|arteriovenous fistula
4992491|NCT01669850|Surgical anastomosis|surgical anastomosis
4992492|NCT01669850|Complications|complications
4992493|NCT01669850|Patency|patency
4992494|NCT01669850|Dialysis access|dialysis access
4992495|NCT01669837|Inguinal hernia|inguinal hernia
4992496|NCT01669837|Laparoscopy|laparoscopy
4992497|NCT01669837|Surgical tissue glue|surgical tissue glue
4992498|NCT01669811|Refractory Reflux Esophagitis,|refractory reflux esophagitis,
4992499|NCT01669811|Japanese,|japanese,
4992500|NCT01669811|Nexium,|nexium,
4992501|NCT01669811|twice daily,|twice daily,
4992502|NCT01669811|oral administration|oral administration
4992503|NCT01669798|Recurrent epithelial ovarian carcinoma|recurrent epithelial ovarian carcinoma
4992504|NCT01669798|Persistent epithelial ovarian carcinoma|persistent epithelial ovarian carcinoma
4992505|NCT01669798|Bevacizumab resistant epithelial ovarian carcinoma|bevacizumab resistant epithelial ovarian carcinoma
4992506|NCT01669746|Androgenetic Alopecia|androgenetic alopecia
4992507|NCT01669746|Male Pattern Baldness|male pattern baldness
4992508|NCT01669746|Female Pattern Baldness|female pattern baldness
4992509|NCT01669746|Hair Loss|hair loss
4992510|NCT01669746|Baldness|baldness
4992511|NCT01669733|Breast Surgery|breast surgery
4992512|NCT01669733|Breast Biopsy|breast biopsy
4992513|NCT01669733|Music Therapy|music therapy
4992514|NCT01669720|Metastatic|metastatic
4992515|NCT01669720|Colorectal|colorectal
4992516|NCT01669720|Colorectal Cancer|colorectal cancer
4992517|NCT01669720|Resected or Ablated Metastatic Colorectal Cancer|resected or ablated metastatic colorectal cancer
4992518|NCT01669707|Endostar|endostar
4992519|NCT01669707|advanced Non-small cell lung cancer|advanced non-small cell lung cancer
4992520|NCT01669707|Continued Pumping into vein|continued pumping into vein
4992521|NCT01669707|Gemcitabine|gemcitabine
4992522|NCT01669707|Carboplatin|carboplatin
4992523|NCT01669694|Pelvic Pain|pelvic pain
4992524|NCT01669694|Pelvic Floor Physical Therapy|pelvic floor physical therapy
4992525|NCT01669694|Biomarkers|biomarkers
4992526|NCT01669681|Severe asthma|severe asthma
4992527|NCT01669681|Medical economic|medical economic
4992528|NCT01669681|care|care
4992529|NCT01669681|Cost efficiency|cost efficiency
4992530|NCT01669681|CPAM|cpam
4992531|NCT01669681|EQ5D|eq5d
4992532|NCT01669642|ketamine sedation|ketamine sedation
4992533|NCT01669642|pediatric|pediatric
4992534|NCT01669642|abscess drainage|abscess drainage
4992535|NCT01669642|fracture reduction|fracture reduction
4992536|NCT01669616|Type 2 Diabetes|type 2 diabetes
4992537|NCT01669616|Adults 18 years and older|adults 18 years and older
4992538|NCT01669603|Common cold|common cold
4992539|NCT01669577|predictors|predictors
4992540|NCT01669577|trauma|trauma
4992541|NCT01669577|mortality|mortality
4992542|NCT01669564|Quality of Life|quality of life
4992543|NCT01669564|Tobacco Use Cessation|tobacco use cessation
4992544|NCT01669564|Physical Activity|physical activity
4992545|NCT01669538|Galantamine|galantamine
4992546|NCT01669538|Nicotine Bitartrate|nicotine bitartrate
4992547|NCT01669538|Nicotine Tartrate|nicotine tartrate
4992548|NCT01669538|Nicotine dependence|nicotine dependence
4992549|NCT01669538|Tobacco Dependence|tobacco dependence
4992550|NCT01669512|Malaria vaccine|malaria vaccine
4992551|NCT01669512|Matrix M|matrix m
4992552|NCT01669499|Bone metastases, radiotherapy, dexamethasone, pain flare|bone metastases, radiotherapy, dexamethasone, pain flare
4992553|NCT01669486|Pain|pain
4992554|NCT01669486|ICU|icu
4992555|NCT01669486|Mechanical ventilation|mechanical ventilation
4992556|NCT01669486|CPOT|cpot
4992557|NCT01669486|BPS|bps
4992558|NCT01669473|Diabetes|diabetes
4992559|NCT01669447|dmri, mnvc, lucentis|dmri, mnvc, lucentis
4992560|NCT01669434|Perioperative Period|perioperative period
4992561|NCT01669421|Alpha 1|alpha 1
4992562|NCT01669408|ischemic stroke|ischemic stroke
4992563|NCT01669408|hemorrhagic stroke|hemorrhagic stroke
4992564|NCT01669408|prehospital cooling|prehospital cooling
4992565|NCT01669408|induction of cooling|induction of cooling
4992566|NCT01669408|ambulance|ambulance
4992567|NCT01669408|emergency room|emergency room
4992568|NCT01669408|cold infusions|cold infusions
4992569|NCT01669408|hypothermia|hypothermia
4992570|NCT01669408|normothermia|normothermia
4992571|NCT01669395|Severe heart failure|severe heart failure
4992572|NCT01669395|Homebased rehabilitation|homebased rehabilitation
4992573|NCT01669395|Physical exercise|physical exercise
4992574|NCT01669395|Activities of daily living|activities of daily living
4992575|NCT01669395|Intersectoral Cooperation|intersectoral cooperation
4992576|NCT01669382|AngioSeal, ExoSeal, PCI, puncture site|angioseal, exoseal, pci, puncture site
4992577|NCT01669369|Lithium Carbonate|lithium carbonate
4992578|NCT01669369|Chemotherapy|chemotherapy
4992579|NCT01669369|prognosis|prognosis
4992580|NCT01669356|malnutrition|malnutrition
4992581|NCT01669356|parenteral supplement|parenteral supplement
4992582|NCT01669356|rest metabolic rate|rest metabolic rate
4992583|NCT01669356|postoperative complications|postoperative complications
4992584|NCT01669343|Aromatase Inhibitors|aromatase inhibitors
4992585|NCT01669330|Gastroesophageal Reflux|gastroesophageal reflux
4992586|NCT01669330|Fundoplication|fundoplication
4992587|NCT01669330|Surgical Procedures|surgical procedures
4992588|NCT01669317|Cherry Juice Pilot|cherry juice pilot
4992589|NCT01669304|migraine variant|migraine variant
4992590|NCT01669304|chronic dizziness|chronic dizziness
4992591|NCT01669304|pharmacologic dissection|pharmacologic dissection
4992592|NCT01669278|sheath|sheath
4992593|NCT01669278|flexible|flexible
4992594|NCT01669278|endoscopy|endoscopy
4992595|NCT01669278|otolaryngology|otolaryngology
4992596|NCT01669278|office|office
4992597|NCT01669265|Breast cancer|breast cancer
4992598|NCT01669265|OSNA|osna
4992599|NCT01669265|sentinel lymph node|sentinel lymph node
4992600|NCT01669252|Breast cancer|breast cancer
4992601|NCT01669252|Eribulin|eribulin
4992602|NCT01669252|Neoadjuvant|neoadjuvant
4992603|NCT01669252|PAM50|pam50
4992604|NCT01669252|Triple-negative|triple-negative
4992605|NCT01669252|Luminal A|luminal a
4992606|NCT01669252|Luminal B|luminal b
4992607|NCT01669239|Breast Cancer|breast cancer
4992608|NCT01669239|HER2 positive|her2 positive
4992609|NCT01669239|Neoadjuvant|neoadjuvant
4992610|NCT01669239|Liposomal doxorubicin|liposomal doxorubicin
4992611|NCT01669239|Paclitaxel|paclitaxel
4992612|NCT01669239|Trastuzumab|trastuzumab
4992613|NCT01669239|Pertuzumab|pertuzumab
4992614|NCT01669239|Safety|safety
4992615|NCT01669226|Ovarian Cancer|ovarian cancer
4992616|NCT01669226|intraperitoneal chemotherapy|intraperitoneal chemotherapy
4992617|NCT01669213|5-HT3 receptor antagonist|5-ht3 receptor antagonist
4992618|NCT01669213|hypotension|hypotension
4992619|NCT01669213|spinal anesthesia|spinal anesthesia
4992620|NCT01669174|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
4992621|NCT01669174|COPD; cachexia; muscle wasting|copd; cachexia; muscle wasting
4992622|NCT01669161|Upper|upper
4992623|NCT01669161|Limb|limb
4992624|NCT01669161|Deficits|deficits
4992625|NCT01669161|Rehabilitation|rehabilitation
4992626|NCT01669161|VNS|vns
4992627|NCT01669148|breast cancer|breast cancer
4992628|NCT01669148|imaging|imaging
4992629|NCT01669135|cerebral oximetry|cerebral oximetry
4992630|NCT01669135|cesarean delivery|cesarean delivery
4992631|NCT01669109|Yoga|yoga
4992632|NCT01669109|Colorectal Neoplasms|colorectal neoplasms
4992633|NCT01669109|Quality of Life|quality of life
4992634|NCT01669109|Randomized Controlled Trial|randomized controlled trial
4992635|NCT01669096|adults|adults
4992636|NCT01669096|healthy|healthy
4992637|NCT01669096|Tuberculosis vaccine|tuberculosis vaccine
4992638|NCT01669096|mRNA expression|mrna expression
4992639|NCT01669096|HIV negative|hiv negative
4992640|NCT01669083|Oxytocin Antagonist|oxytocin antagonist
4992641|NCT01669083|Embryo/Blastocyst Implantation|embryo/blastocyst implantation
4992642|NCT01669070|bioavailability|bioavailability
4992643|NCT01669070|Fluticasone Furoate|fluticasone furoate
4992644|NCT01669070|pharmacokinetics|pharmacokinetics
4992645|NCT01669070|dose proportionality|dose proportionality
4992646|NCT01669057|Congenital heart disease|congenital heart disease
4992647|NCT01669057|DNA variation|dna variation
4992648|NCT01669057|methylation|methylation
4992649|NCT01669057|risk factors|risk factors
4992650|NCT01669057|supplements|supplements
4992651|NCT01669031|automated perimetry|automated perimetry
4992652|NCT01669031|visual fields|visual fields
4992653|NCT01669031|reliability|reliability
4992654|NCT01669031|vision tests/standards|vision tests/standards
4992655|NCT01669031|randomized controlled trial|randomized controlled trial
4992656|NCT01669031|false positive reactions|false positive reactions
4992657|NCT01669031|false negative reactions|false negative reactions
4992658|NCT01669031|fixation, ocular|fixation, ocular
4992659|NCT01669031|mean deviation|mean deviation
4992660|NCT01669031|variability|variability
4992661|NCT01669031|program|program
4992662|NCT01669031|software|software
4992663|NCT01669031|glaucoma/diagnosis|glaucoma/diagnosis
4992664|NCT01669031|visual field tests/methods|visual field tests/methods
4992665|NCT01669031|aged|aged
4992666|NCT01669031|humans|humans
4992667|NCT01669031|female|female
4992668|NCT01669031|male|male
4992669|NCT01669031|prospective studies|prospective studies
4992670|NCT01669031|reproducibility of results|reproducibility of results
4992671|NCT01669005|neutropenia|neutropenia
4992672|NCT01669005|multiplex PCR|multiplex pcr
4992673|NCT01669005|infection|infection
4992674|NCT01668992|Parenting|parenting
4992675|NCT01668992|Discipline|discipline
4992676|NCT01668992|Family interventions|family interventions
4992677|NCT01668992|Thailand|thailand
4992678|NCT01668992|Migration|migration
4992679|NCT01668953|Lateral Epicondylitis|lateral epicondylitis
4992680|NCT01668953|Tennis Elbow|tennis elbow
4992681|NCT01668953|Platelet Rich Plasma|platelet rich plasma
4992682|NCT01668953|Whole Blood|whole blood
4992683|NCT01668953|Tendon Fenestration|tendon fenestration
4992684|NCT01668940|Morning Sickness|morning sickness
4992685|NCT01668940|Lillipops Iced Soothies|lillipops iced soothies
4992686|NCT01668940|Pregnancy|pregnancy
4992687|NCT01668940|Obstetrics|obstetrics
4992688|NCT01668914|Breast Cancer|breast cancer
4992689|NCT01668914|Clinically Axillary Node -Positive|clinically axillary node -positive
4992690|NCT01668914|Sentinel Lymph Node Biopsy|sentinel lymph node biopsy
4992691|NCT01668914|Internal Mammary|internal mammary
4992692|NCT01668901|warfarin|warfarin
4992693|NCT01668901|aspirin|aspirin
4992694|NCT01668875|head down postural drainage|head down postural drainage
4992791|NCT01668407|PSP|psp
4992695|NCT01668849|Plant exosomes|plant exosomes
4992696|NCT01668849|Grape exosomes|grape exosomes
4992697|NCT01668849|Grape extract|grape extract
4992698|NCT01668849|Oral mucositis|oral mucositis
4992699|NCT01668849|Head and Neck Cancer|head and neck cancer
4992700|NCT01668849|Immune response|immune response
4992701|NCT01668836|sirtuin|sirtuin
4992702|NCT01668836|atherosclerosis|atherosclerosis
4992703|NCT01668836|longevity|longevity
4992704|NCT01668836|calorie restriction|calorie restriction
4992705|NCT01668836|resveratrol|resveratrol
4992706|NCT01668836|vascular reactivity|vascular reactivity
4992707|NCT01668810|prescription|prescription
4992708|NCT01668810|schizophrenia|schizophrenia
4992709|NCT01668810|depression|depression
4992710|NCT01668810|bipolar disorder|bipolar disorder
4992711|NCT01668771|Self-Affirmation|self-affirmation
4992712|NCT01668771|Affect|affect
4992713|NCT01668771|Alcohol|alcohol
4992714|NCT01668758|Near Infrared Spectroscopy|near infrared spectroscopy
4992715|NCT01668758|Traumatic Brain Injury|traumatic brain injury
4992716|NCT01668745|Child mortality|child mortality
4992717|NCT01668745|Measles vaccine|measles vaccine
4992718|NCT01668745|Non-specific effects|non-specific effects
4992719|NCT01668693|Endometrial receptivity|endometrial receptivity
4992720|NCT01668693|recurrent implantation failure|recurrent implantation failure
4992721|NCT01668693|predictor tool|predictor tool
4992722|NCT01668693|ERA|era
4992723|NCT01668693|customized microarray|customized microarray
4992724|NCT01668693|personalized embryo transfer|personalized embryo transfer
4992725|NCT01668680|Metronomic Chemotherapy|metronomic chemotherapy
4992726|NCT01668680|Anti-Angiogenic|anti-angiogenic
4992727|NCT01668680|Maintenance Treatment|maintenance treatment
4992728|NCT01668680|Colorectal Cancer Metastatic|colorectal cancer metastatic
4992729|NCT01668667|gabapentin enacarbil|gabapentin enacarbil
4992730|NCT01668667|Horizant|horizant
4992731|NCT01668654|Epilepsy|epilepsy
4992732|NCT01668654|Partial Onset epilepsy|partial onset epilepsy
4992733|NCT01668654|Lennox-Gastaut Syndrome|lennox-gastaut syndrome
4992734|NCT01668654|Open-label extension study|open-label extension study
4992735|NCT01668641|Methotrexate insufficient responders|methotrexate insufficient responders
4992736|NCT01668628|quality of life|quality of life
4992737|NCT01668628|depression|depression
4992738|NCT01668628|BCM (body composition minitor)|bcm (body composition minitor)
4992739|NCT01668628|hydrational status|hydrational status
4992740|NCT01668615|idiopathicthrombocytopenic purpura|idiopathicthrombocytopenic purpura
4992741|NCT01668615|all-trans retinoic acid|all-trans retinoic acid
4992742|NCT01668615|regulory T cells|regulory t cells
4992743|NCT01668576|mesenchymal stem cells|mesenchymal stem cells
4992744|NCT01668576|Lung transplantation|lung transplantation
4992745|NCT01668563|Aneurysm|aneurysm
4992746|NCT01668563|Intracranial Aneurysm|intracranial aneurysm
4992747|NCT01668563|Vascular Diseases|vascular diseases
4992748|NCT01668563|Cardiovascular Diseases|cardiovascular diseases
4992749|NCT01668563|Intracranial Arterial Diseases|intracranial arterial diseases
4992750|NCT01668563|Cerebrovascular Disorders|cerebrovascular disorders
4992751|NCT01668563|Brain Diseases|brain diseases
4992752|NCT01668563|Central Nervous System Diseases|central nervous system diseases
4992753|NCT01668563|Nervous System Diseases|nervous system diseases
4992754|NCT01668550|Phase I|phase i
4992755|NCT01668550|Src/Abl inhibitor|src/abl inhibitor
4992756|NCT01668550|Solid Tumours|solid tumours
4992757|NCT01668550|Cancer|cancer
4992758|NCT01668511|Immunogenicity|immunogenicity
4992759|NCT01668511|Safety|safety
4992760|NCT01668511|Tolerability|tolerability
4992761|NCT01668511|Osteoarthritis|osteoarthritis
4992762|NCT01668511|Pharmacokinetics|pharmacokinetics
4992763|NCT01668498|Can preemptive treatment of panitumumab mediated skin|can preemptive treatment of panitumumab mediated skin
4992764|NCT01668498|toxicity with oral doxycycline be replaced by local treatment with erythromycin?|toxicity with oral doxycycline be replaced by local treatment with erythromycin?
4992765|NCT01668498|Panitumumab|panitumumab
4992766|NCT01668485|Type 1 diabetes mellitus|type 1 diabetes mellitus
4992767|NCT01668485|hypoglycemia counterregulation,|hypoglycemia counterregulation,
4992768|NCT01668485|pancreatic islet transplantation|pancreatic islet transplantation
4992769|NCT01668472|Pregnant|pregnant
4992770|NCT01668472|leaking fluid|leaking fluid
4992771|NCT01668459|Transitional cell carcinoma|transitional cell carcinoma
4992772|NCT01668459|Bladder cancer|bladder cancer
4992773|NCT01668459|Cancer|cancer
4992774|NCT01668459|Oncology|oncology
4992775|NCT01668459|Cabazitaxel|cabazitaxel
4992776|NCT01668446|Sildenafil|sildenafil
4992777|NCT01668446|Endometrial thickness|endometrial thickness
4992778|NCT01668446|Frozen embryo transfer|frozen embryo transfer
4992779|NCT01668446|ultrasonographic endometrial thickness|ultrasonographic endometrial thickness
4992780|NCT01668446|endometrial pattern|endometrial pattern
4992781|NCT01668446|Implantation rate|implantation rate
4992782|NCT01668446|chemical pregnancy rate|chemical pregnancy rate
4992783|NCT01668433|G6PD|g6pd
4992784|NCT01668433|Primaquine|primaquine
4992785|NCT01668433|Methylene blue|methylene blue
4992786|NCT01668420|thermal stimulation|thermal stimulation
4992787|NCT01668420|lower extremity|lower extremity
4992788|NCT01668420|temperature|temperature
4992789|NCT01668420|efficacy|efficacy
4992790|NCT01668407|Parkinson's disease|parkinson's disease
4992792|NCT01668407|Robot|robot
4992793|NCT01668407|Gait rehabilitation|gait rehabilitation
4992794|NCT01668381|hepatocellular carcinoma|hepatocellular carcinoma
4992795|NCT01668381|Catheter Ablation|catheter ablation
4992796|NCT01668381|T-Lymphocytes, Regulatory|t-lymphocytes, regulatory
4992797|NCT01668381|IL-10|il-10
4992798|NCT01668381|TGF-β|tgf-β
4992799|NCT01668381|IFN-γ|ifn-γ
4992800|NCT01668368|ARDS|ards
4992801|NCT01668368|Esophageal pressure|esophageal pressure
4992802|NCT01668368|pleural pressure|pleural pressure
4992803|NCT01668368|pulmonary compliance|pulmonary compliance
4992804|NCT01668355|Delivery of Healthcare|delivery of healthcare
4992805|NCT01668355|Health Services Research|health services research
4992806|NCT01668355|Integrated Healthcare Systems|integrated healthcare systems
4992807|NCT01668355|Healthcare Quality, Access, and Evaluation|healthcare quality, access, and evaluation
4992808|NCT01668355|Primary Care|primary care
4992809|NCT01668355|Quality Improvement|quality improvement
4992810|NCT01668355|Psychotic Disorders|psychotic disorders
4992811|NCT01668355|Medical Home|medical home
4992812|NCT01668355|Psychiatry|psychiatry
4992813|NCT01668355|Patient Care Management|patient care management
4992814|NCT01668355|Nursing Care Management|nursing care management
4992815|NCT01668355|Treatment Costs|treatment costs
4992816|NCT01668329|Septic shock|septic shock
4992817|NCT01668329|Inflammatory process|inflammatory process
4992818|NCT01668329|Cytokines|cytokines
4992819|NCT01668329|Hormonal response|hormonal response
4992820|NCT01668329|Oxydative stress|oxydative stress
4992821|NCT01668316|Overweight|overweight
4992822|NCT01668316|Obese|obese
4992823|NCT01668316|Postpartum|postpartum
4992824|NCT01668316|Weight loss|weight loss
4992825|NCT01668316|Inflammation|inflammation
4992826|NCT01668316|Obesity|obesity
4992827|NCT01668316|Cardiovascular|cardiovascular
4992828|NCT01668303|juvenile drug court|juvenile drug court
4992829|NCT01668303|adolescents|adolescents
4992830|NCT01668303|substance abuse|substance abuse
4992831|NCT01668303|delinquency|delinquency
4992832|NCT01668303|family therapy|family therapy
4992833|NCT01668303|multidimensional family therapy|multidimensional family therapy
4992834|NCT01668290|Coronary Artery Disease|coronary artery disease
4992835|NCT01668290|Stress Echocardiography|stress echocardiography
4992836|NCT01668290|Single Photon Emission Computed Tomography|single photon emission computed tomography
4992837|NCT01668290|Cardiac Computed Tomographic Angiography|cardiac computed tomographic angiography
4992838|NCT01668290|outcomes|outcomes
4992839|NCT01668277|Pulmonary Hypertensive Crisis|pulmonary hypertensive crisis
4992840|NCT01668277|Pediatrics|pediatrics
4992841|NCT01668277|Hypertonic Saline|hypertonic saline
4992842|NCT01668264|Pediatrics|pediatrics
4992843|NCT01668264|Congenital Heart Disease|congenital heart disease
4992844|NCT01668264|Diastolic Function|diastolic function
4992845|NCT01668264|Echocardiograph|echocardiograph
4992846|NCT01668264|MRI|mri
4992847|NCT01668251|Turner syndrome|turner syndrome
4992848|NCT01668251|Diagnosis, prenatal|diagnosis, prenatal
4992849|NCT01668238|Thyroid tumor|thyroid tumor
4992850|NCT01668238|Breast tumor|breast tumor
4992851|NCT01668238|Fourier Transform Infrared Spectrometry|fourier transform infrared spectrometry
4992852|NCT01668238|Tumor Diagnosis|tumor diagnosis
4992853|NCT01668186|Peroxisome biogenesis disorders|peroxisome biogenesis disorders
4992854|NCT01668186|PBD|pbd
4992855|NCT01668186|Zellweger spectrum|zellweger spectrum
4992856|NCT01668186|Rhizomelic chondrodysplasia punctata|rhizomelic chondrodysplasia punctata
4992857|NCT01668186|RCDP|rcdp
4992858|NCT01668173|HSP90 Inhibitor|hsp90 inhibitor
4992859|NCT01668173|AUY922|auy922
4992860|NCT01668173|12-076|12-076
4992861|NCT01668160|clinical outcomes|clinical outcomes
4992862|NCT01668160|radiographic outcomes|radiographic outcomes
4992863|NCT01668160|total hip arthroplasty|total hip arthroplasty
4992864|NCT01668160|survivorship|survivorship
4992865|NCT01668147|PET Imaging|pet imaging
4992866|NCT01668147|Efavirenz|efavirenz
4992867|NCT01668147|Ritonavir|ritonavir
4992868|NCT01668147|[11C] desmethyl-loperamide|[11c] desmethyl-loperamide
4992869|NCT01668147|Healthy volunteers|healthy volunteers
4992870|NCT01668108|carcinoma|carcinoma
4992871|NCT01668108|breast cancer|breast cancer
4992872|NCT01668108|non-small cell lung cancer|non-small cell lung cancer
4992873|NCT01668108|ovarial cancer|ovarial cancer
4992874|NCT01668108|ambulant chemotherapy|ambulant chemotherapy
4992875|NCT01668108|treatment cycles|treatment cycles
4992876|NCT01668108|Paclitaxel|paclitaxel
4992877|NCT01668108|Paclitaxel onkovis|paclitaxel onkovis
4992878|NCT01668108|Quantity of Paclitaxel|quantity of paclitaxel
4992879|NCT01668108|Packaging Sizes|packaging sizes
4992880|NCT01668082|Patients with newly identified brain mass|patients with newly identified brain mass
4992881|NCT01668069|nausea|nausea
4992882|NCT01668069|vomiting|vomiting
4992883|NCT01668069|pregnancy|pregnancy
4992884|NCT01668069|ondansetron|ondansetron
4992885|NCT01668069|doxylamine|doxylamine
4992886|NCT01668069|vitamin B6|vitamin b6
4992887|NCT01668069|pyridoxine|pyridoxine
4992888|NCT01668056|in vitro fertilization|in vitro fertilization
4992889|NCT01668056|ovarian stimulation|ovarian stimulation
4992890|NCT01668056|follicular waves|follicular waves
4992891|NCT01668056|luteal phase|luteal phase
4992892|NCT01668043|HIV-1|hiv-1
4992893|NCT01668043|CD4|cd4
4992894|NCT01668043|antibody|antibody
4992895|NCT01668043|immunotherapy|immunotherapy
4992896|NCT01668030|Facial|facial
4992897|NCT01668030|Partial thickness|partial thickness
4992898|NCT01668017|Advanced solid tumors|advanced solid tumors
4992899|NCT01668017|Hepatocellular carcinoma|hepatocellular carcinoma
4992900|NCT01668017|cancer, liver|cancer, liver
4992901|NCT01667991|Colonization|colonization
4992902|NCT01667991|infection|infection
4992903|NCT01667991|multidrug-resistant bacteria|multidrug-resistant bacteria
4992904|NCT01667991|guideline|guideline
4992905|NCT01667978|contraception|contraception
4992906|NCT01667978|mini pill|mini pill
4992907|NCT01667978|norethindrone|norethindrone
4992908|NCT01667978|atazanavir|atazanavir
4992909|NCT01667978|ritonavir|ritonavir
4992910|NCT01667978|norvir|norvir
4992911|NCT01667978|reyataz|reyataz
4992912|NCT01667978|pregnancy prevent|pregnancy prevent
4992913|NCT01667978|birth control|birth control
4992914|NCT01667978|HIV|hiv
4992915|NCT01667978|AIDS|aids
4992916|NCT01667978|antiviral|antiviral
4992917|NCT01667978|antiretroviral|antiretroviral
4992918|NCT01667965|palliative radiation|palliative radiation
4992919|NCT01667965|12-172|12-172
4992920|NCT01667952|Family History Questionnaire (FHQ)|family history questionnaire (fhq)
4992921|NCT01667952|Blood sample|blood sample
4992922|NCT01667952|Salvia sample|salvia sample
4992923|NCT01667952|12-145|12-145
4992924|NCT01667939|adequacy|adequacy
4992925|NCT01667939|diet|diet
4992926|NCT01667939|pregnancy|pregnancy
4992927|NCT01667913|Hip Fracture|hip fracture
4992928|NCT01667913|6-minutes walking test|6-minutes walking test
4992929|NCT01667913|Reliability|reliability
4992930|NCT01667887|Far Cortical Locking|far cortical locking
4992931|NCT01667887|Distal Femur Fracture|distal femur fracture
4992932|NCT01667887|Locking Plate|locking plate
4992933|NCT01667887|MotionLoc|motionloc
4992934|NCT01667887|Fracture Fixation|fracture fixation
4992935|NCT01667874|Randomized controlled trial|randomized controlled trial
4992936|NCT01667874|early joint infection|early joint infection
4992937|NCT01667874|gentamicin impregnated sponges|gentamicin impregnated sponges
4992938|NCT01667861|Glaucoma|glaucoma
4992939|NCT01667861|Wind instruments|wind instruments
4992940|NCT01667848|pain|pain
4992941|NCT01667835|yoga|yoga
4992942|NCT01667835|postmenopausal, sedentary South Asian women|postmenopausal, sedentary south asian women
4992943|NCT01667796|Multiple sclerosis|multiple sclerosis
4992944|NCT01667796|Healthy controls|healthy controls
4992945|NCT01667796|Pharmacokinetics|pharmacokinetics
4992946|NCT01667796|Vitamin D|vitamin d
4992947|NCT01667783|Obesity|obesity
4992948|NCT01667783|Diabetes|diabetes
4992949|NCT01667757|coronary atherosclerosis|coronary atherosclerosis
4992950|NCT01667757|drug eluting stent|drug eluting stent
4992951|NCT01667757|intravascular ultrasound|intravascular ultrasound
4992952|NCT01667757|fractional flow reserve|fractional flow reserve
4992953|NCT01667744|Angina|angina
4992954|NCT01667744|Acute Coronary Syndrome|acute coronary syndrome
4992955|NCT01667744|Emotional Distress|emotional distress
4992956|NCT01667744|Citalopram|citalopram
4992957|NCT01667744|Health Care Utilization|health care utilization
4992958|NCT01667731|Hepatitis C|hepatitis c
4992959|NCT01667731|Chronic|chronic
4992960|NCT01667731|HCV|hcv
4992961|NCT01667731|HIV|hiv
4992962|NCT01667731|Human Immunodeficiency Virus|human immunodeficiency virus
4992963|NCT01667731|Co-Infected|co-infected
4992964|NCT01667718|eradication|eradication
4992965|NCT01667718|helicobacter pylori|helicobacter pylori
4992966|NCT01667718|bismuth|bismuth
4992967|NCT01667705|Stress|stress
4992968|NCT01667705|Anxiety|anxiety
4992969|NCT01667705|Skyceiling|skyceiling
4992970|NCT01667705|Nature|nature
4992971|NCT01667692|H-pylori|h-pylori
4992972|NCT01667692|eradication|eradication
4992973|NCT01667692|azithromycin|azithromycin
4992974|NCT01667692|clarithromycin|clarithromycin
4992975|NCT01667679|Migraine|migraine
4992976|NCT01667679|Headaches|headaches
4992977|NCT01667679|Sumatriptan|sumatriptan
4992978|NCT01667666|trauma|trauma
4992979|NCT01667666|acute lung injury|acute lung injury
4992980|NCT01667666|adult respiratory distress syndrome|adult respiratory distress syndrome
4992981|NCT01667640|Brain metastases|brain metastases
4992982|NCT01667640|radiation|radiation
4992983|NCT01667640|sector|sector
4992984|NCT01667640|singular|singular
4992985|NCT01667640|solitary|solitary
4992986|NCT01667640|neurocognition|neurocognition
4992987|NCT01667627|IBS|ibs
4992988|NCT01667627|Probiotic|probiotic
4992989|NCT01667627|hs-CRP|hs-crp
4992990|NCT01667627|Cholinergic status|cholinergic status
4992991|NCT01667627|Micro-inflammation|micro-inflammation
4992992|NCT01667601|mindfulness-based program|mindfulness-based program
4992993|NCT01667601|Psychoeducation|psychoeducation
4992994|NCT01667601|schizophrenia|schizophrenia
4992995|NCT01667601|Chinese|chinese
4992996|NCT01667601|outpatients|outpatients
4992997|NCT01667588|Chronic Kidney Disease (CKD)|chronic kidney disease (ckd)
4992998|NCT01667588|Pediatrics|pediatrics
4992999|NCT01667588|Sleep Disorders|sleep disorders
4993000|NCT01667549|Breastfeeding|breastfeeding
4993001|NCT01667549|Flavor learning|flavor learning
4993002|NCT01667549|Mother|mother
4993003|NCT01667549|Moms|moms
4993004|NCT01667549|Infants|infants
4993005|NCT01667549|Babies|babies
4993006|NCT01667549|Baby|baby
4993007|NCT01667549|Food Habits|food habits
4993008|NCT01667549|Fruits|fruits
4993009|NCT01667549|Vegetables|vegetables
4993010|NCT01667536|PROSTATE CANCER|prostate cancer
4993011|NCT01667536|HIGH-RISK|high-risk
4993012|NCT01667536|PROSTATECTOMY SURGERY|prostatectomy surgery
4993013|NCT01667536|NEWLY DIAGNOSED|newly diagnosed
4993014|NCT01667523|capsaicin|capsaicin
4993015|NCT01667523|cinnamaldehyde|cinnamaldehyde
4993016|NCT01667510|Prehypertension|prehypertension
4993017|NCT01667510|anti oxidation|anti oxidation
4993018|NCT01667510|lycopene|lycopene
4993019|NCT01667497|Cognitive fatigue|cognitive fatigue
4993020|NCT01667497|multiple sclerosis|multiple sclerosis
4993021|NCT01667484|Cognitive Impairment|cognitive impairment
4993022|NCT01667484|Multiple Sclerosis|multiple sclerosis
4993023|NCT01667484|Processing Speed|processing speed
4993024|NCT01667484|Treatment|treatment
4993025|NCT01667445|total knee arthroplasty|total knee arthroplasty
4993026|NCT01667445|epimorph|epimorph
4993027|NCT01667445|analgesia|analgesia
4993028|NCT01667406|kisspeptin|kisspeptin
4993029|NCT01667406|infertility|infertility
4993030|NCT01667406|in vitro fertilisation|in vitro fertilisation
4993031|NCT01667354|Parental Childhood Vaccine Hesitancy|parental childhood vaccine hesitancy
4993032|NCT01667341|HSV|hsv
4993033|NCT01667341|Herpes|herpes
4993034|NCT01667341|genital infection|genital infection
4993035|NCT01667341|vaccine|vaccine
4993036|NCT01667328|Anxiety|anxiety
4993037|NCT01667328|Presurgical anxiety|presurgical anxiety
4993038|NCT01667328|Breast Cancer|breast cancer
4993039|NCT01667302|NK/T-cell lymphoma|nk/t-cell lymphoma
4993040|NCT01667302|Radiotherapy|radiotherapy
4993041|NCT01667302|Adjuvant chemotherapy|adjuvant chemotherapy
4993042|NCT01667289|NK/T-cell lymphoma|nk/t-cell lymphoma
4993043|NCT01667289|Methotrexate|methotrexate
4993044|NCT01667289|Radiotherapy|radiotherapy
4993045|NCT01667289|Concurrent chemoradiation|concurrent chemoradiation
4993046|NCT01667276|AE adverse event|ae adverse event
4993047|NCT01667276|AIDS acquired immunodeficiency syndrome|aids acquired immunodeficiency syndrome
4993048|NCT01667276|ALT (SGPT) alanine aminotransferase|alt (sgpt) alanine aminotransferase
4993049|NCT01667276|ART antiretroviral therapy|art antiretroviral therapy
4993050|NCT01667276|AST (SGOT) aspartate aminotransferase|ast (sgot) aspartate aminotransferase
4993051|NCT01667276|DCF data collection forms|dcf data collection forms
4993052|NCT01667276|DMC Data Monitoring Committee|dmc data monitoring committee
4993053|NCT01667276|FDA (U.S.) Food and Drug Administration|fda (u.s.) food and drug administration
4993054|NCT01667276|GCP Good Clinical Practice guidelines|gcp good clinical practice guidelines
4993055|NCT01667276|HB sAg Hepatitis B surface antigen|hb sag hepatitis b surface antigen
4993056|NCT01667276|ICH International Conference of Harmonisation|ich international conference of harmonisation
4993057|NCT01667276|IND Investigational New Drug Application|ind investigational new drug application
4993058|NCT01667276|IRB Institutional Review Board|irb institutional review board
4993059|NCT01667276|IU international units|iu international units
4993060|NCT01667276|mg milligram(s)|mg milligram(s)
4993061|NCT01667276|mm3 cubic millimeter(s)|mm3 cubic millimeter(s)
4993062|NCT01667276|PCR polymerase chain reaction|pcr polymerase chain reaction
4993063|NCT01667276|SAE serious adverse event|sae serious adverse event
4993064|NCT01667276|µg microgram|µg microgram
4993065|NCT01667276|ULN upper limit of the normal range|uln upper limit of the normal range
4993066|NCT01667276|WB Western Blot|wb western blot
4993067|NCT01667263|All-trans retinoic acid|all-trans retinoic acid
4993068|NCT01667263|primary immune thrombocytopenia|primary immune thrombocytopenia
4993069|NCT01667263|corticosteroid-resistant|corticosteroid-resistant
4993070|NCT01667263|refractory|refractory
4993071|NCT01667263|danazol|danazol
4993072|NCT01667250|vagus nerve stimulation|vagus nerve stimulation
4993073|NCT01667250|vagal nerve stimulation|vagal nerve stimulation
4993074|NCT01667250|nVNS|nvns
4993075|NCT01667250|VNS|vns
4993076|NCT01667250|chronic migraine|chronic migraine
4993077|NCT01667250|migraine|migraine
4993078|NCT01667250|non invasive|non invasive
4993079|NCT01667250|gammacore|gammacore
4993080|NCT01667237|Pulmonary rehabilitation program|pulmonary rehabilitation program
4993081|NCT01667237|Lung cancer|lung cancer
4993082|NCT01667237|Lung resection surgery|lung resection surgery
4993083|NCT01667237|Home-based|home-based
4993084|NCT01667224|Actiponin|actiponin
4993085|NCT01667224|Obesity|obesity
4993086|NCT01667224|Abdominal fat|abdominal fat
4993087|NCT01667211|Advanced uterine cervical cancer|advanced uterine cervical cancer
4993088|NCT01667185|pediatric|pediatric
4993089|NCT01667185|diabetes mellitus|diabetes mellitus
4993090|NCT01667159|Depression|depression
4993091|NCT01667159|Alcohol Use|alcohol use
4993092|NCT01667159|Outpatient Therapy|outpatient therapy
4993093|NCT01667133|Leukemia|leukemia
4993094|NCT01667133|Leukemia, Myeloid|leukemia, myeloid
4993095|NCT01667133|Leukemia, Myelogenous, Chronic, BCR-ABL Positive|leukemia, myelogenous, chronic, bcr-abl positive
4993096|NCT01667133|Neoplasms by Histologic Type|neoplasms by histologic type
4993097|NCT01667133|Neoplasms|neoplasms
4993098|NCT01667133|Lymphoproliferative Disorders|lymphoproliferative disorders
4993099|NCT01667133|Lymphatic Diseases|lymphatic diseases
4993100|NCT01667133|Immunoproliferative Disorders|immunoproliferative disorders
4993101|NCT01667133|Immune System Diseases|immune system diseases
4993102|NCT01667133|Myeloproliferative Disorders|myeloproliferative disorders
4993103|NCT01667133|Bone Marrow Diseases|bone marrow diseases
4993104|NCT01667133|Hematologic Diseases|hematologic diseases
4993105|NCT01667120|Ketorolac|ketorolac
4993106|NCT01667120|postoperative pain|postoperative pain
4993107|NCT01667120|bleeding events|bleeding events
4993108|NCT01667094|Pulmonary exacerbation|pulmonary exacerbation
4993109|NCT01667094|Continuous infusion|continuous infusion
4993110|NCT01667094|Antipseudomonal beta-lactams|antipseudomonal beta-lactams
4993111|NCT01667068|Cardiac Diseases|cardiac diseases
4993112|NCT01667068|HIV-Infection|hiv-infection
4993113|NCT01667068|AIDS|aids
4993114|NCT01667068|Antiretroviral Therapy|antiretroviral therapy
4993115|NCT01667068|Cardiovascular Medication|cardiovascular medication
4993116|NCT01667068|Risk Factors|risk factors
4993117|NCT01667068|coronary heart disease|coronary heart disease
4993118|NCT01667068|heart failure|heart failure
4993119|NCT01667068|metabolic syndrome|metabolic syndrome
4993120|NCT01667055|drug allergy|drug allergy
4993121|NCT01667055|drug hypersensitivity|drug hypersensitivity
4993122|NCT01667055|beta-lactam allergy|beta-lactam allergy
4993123|NCT01667055|penicillin allergy|penicillin allergy
4993124|NCT01667055|adverse drug reaction|adverse drug reaction
4993125|NCT01667042|Scleroderma Lung|scleroderma lung
4993126|NCT01667042|Gastroesophageal Reflux|gastroesophageal reflux
4993127|NCT01667042|Microaspiration|microaspiration
4993128|NCT01667042|Cough|cough
4993129|NCT01667016|International|international
4993130|NCT01667016|Multicenter|multicenter
4993131|NCT01667016|Observational registry|observational registry
4993132|NCT01667016|Orsiro Drug Eluting Stent (DES)|orsiro drug eluting stent (des)
4993133|NCT01667016|Stenting|stenting
4993134|NCT01667016|Treatment of Coronary Artery Disease|treatment of coronary artery disease
4993135|NCT01667016|Coronary revascularization|coronary revascularization
4993136|NCT01667016|Percutaneous Coronary Intervention|percutaneous coronary intervention
4993137|NCT01667016|STEMI|stemi
4993138|NCT01667016|NSTEMI|nstemi
4993139|NCT01667016|Ischemia|ischemia
4993140|NCT01667016|Angina|angina
4993141|NCT01667016|Subgroups|subgroups
4993142|NCT01667016|Acute Myocardial Infarction|acute myocardial infarction
4993143|NCT01667016|Diabetes|diabetes
4993144|NCT01667016|Small Vessels|small vessels
4993145|NCT01667016|Chronic Total Occlusion (CTO)|chronic total occlusion (cto)
4993146|NCT01667003|International|international
4993147|NCT01667003|Multicenter|multicenter
4993148|NCT01667003|Observational registry|observational registry
4993149|NCT01667003|Orsiro Drug Eluting Stent (DES)|orsiro drug eluting stent (des)
4993150|NCT01667003|Stenting|stenting
4993151|NCT01667003|Treatment of Coronary Artery Disease|treatment of coronary artery disease
4993152|NCT01667003|Coronary revascularization|coronary revascularization
4993153|NCT01667003|Percutaneous Coronary Intervention|percutaneous coronary intervention
4993154|NCT01667003|STEMI|stemi
4993155|NCT01667003|NSTEMI|nstemi
4993156|NCT01667003|Ischemia|ischemia
4993157|NCT01667003|Angina|angina
4993158|NCT01667003|Subgroups|subgroups
4993159|NCT01667003|Acute Myocardial Infarction|acute myocardial infarction
4993160|NCT01667003|Diabetes|diabetes
4993161|NCT01667003|Small Vessels|small vessels
4993162|NCT01666990|Tripterygium wilfordii Hook F (TwHF)|tripterygium wilfordii hook f (twhf)
4993163|NCT01666990|HIV|hiv
4993164|NCT01666990|CD4|cd4
4993165|NCT01666990|immune over-activation|immune over-activation
4993166|NCT01666964|Traumatic brain injury|traumatic brain injury
4993167|NCT01666964|hypopituitarism|hypopituitarism
4993168|NCT01666938|Diabetes Mellitus|diabetes mellitus
4993169|NCT01666938|Telephone|telephone
4993170|NCT01666938|Physical activity|physical activity
4993171|NCT01666912|adolescence|adolescence
4993172|NCT01666912|contraception|contraception
4993173|NCT01666912|postpartum|postpartum
4993174|NCT01666912|rapid repeat pregnancy|rapid repeat pregnancy
4993175|NCT01666873|osteoarthritis|osteoarthritis
4993176|NCT01666860|anterior lumbar interbody fusion|anterior lumbar interbody fusion
4993177|NCT01666847|Umbilical Cord Milking|umbilical cord milking
4993178|NCT01666847|Extremely Low Birth Weight Infant (ELBW)|extremely low birth weight infant (elbw)
4993179|NCT01666834|mechanical ventilation, ARDS, Ventilator strategy, outcome|mechanical ventilation, ards, ventilator strategy, outcome
4993180|NCT01666821|macular degeneration; choroidal neovascularization|macular degeneration; choroidal neovascularization
4993181|NCT01666782|Influenza vaccine|influenza vaccine
4993182|NCT01666782|Oncology|oncology
4993183|NCT01666782|Chemotherapy|chemotherapy
4993184|NCT01666769|Extracorporeal membrane oxygenation|extracorporeal membrane oxygenation
4993185|NCT01666769|ECMO|ecmo
4993186|NCT01666769|Extracorporeal life support|extracorporeal life support
4993187|NCT01666769|Micafungin|micafungin
4993188|NCT01666769|Mycamine|mycamine
4993189|NCT01666769|Pharmacokinetics|pharmacokinetics
4993190|NCT01666743|Community-Acquired Pneumonia|community-acquired pneumonia
4993191|NCT01666743|Lung|lung
4993192|NCT01666743|Adult|adult
4993193|NCT01666743|Infections|infections
4993194|NCT01666691|Obese|obese
4993195|NCT01666691|Obesity|obesity
4993196|NCT01666691|Overweight|overweight
4993197|NCT01666691|Weight loss|weight loss
4993198|NCT01666691|Weight reduction|weight reduction
4993199|NCT01666691|Beloranib|beloranib
4993200|NCT01666678|Bioequivalence|bioequivalence
4993201|NCT01666665|Burn|burn
4993202|NCT01666652|Dengue|dengue
4993203|NCT01666652|Dengue fever|dengue fever
4993204|NCT01666652|Dengue Hemorrhagic Fever|dengue hemorrhagic fever
4993205|NCT01666652|Flavivirus|flavivirus
4993206|NCT01666626|crohn's disease|crohn's disease
4993207|NCT01666626|ultrasound|ultrasound
4993208|NCT01666626|intestinal fibrosis|intestinal fibrosis
4993209|NCT01666626|shear wave imaging|shear wave imaging
4993210|NCT01666626|acoustic radiation force impulse|acoustic radiation force impulse
4993211|NCT01666613|Phase I, Healthy volunteers, pharmacokinetics|phase i, healthy volunteers, pharmacokinetics
4993212|NCT01666613|Bioavailability|bioavailability
4993213|NCT01666613|AUC|auc
4993214|NCT01666548|haemolytic uraemic syndrome|haemolytic uraemic syndrome
4993215|NCT01666548|complications of HUS|complications of hus
4993216|NCT01666548|renal replacement treatment|renal replacement treatment
4993217|NCT01666548|renal function outcome|renal function outcome
4993218|NCT01666548|neuropsychological sequelae|neuropsychological sequelae
4993219|NCT01666548|psychological adjustment|psychological adjustment
4993220|NCT01666548|quality of life|quality of life
4993221|NCT01666535|Influenza vaccine|influenza vaccine
4993222|NCT01666535|Immune response|immune response
4993223|NCT01666535|Remicade (infliximab)|remicade (infliximab)
4993224|NCT01666535|Inflammatory bowel disease|inflammatory bowel disease
4993225|NCT01666522|sarcopenia|sarcopenia
4993226|NCT01666522|osteopenia/osteoporosis|osteopenia/osteoporosis
4993227|NCT01666522|older adults|older adults
4993228|NCT01666522|vitamin D supplementation|vitamin d supplementation
4993229|NCT01666522|physical activity|physical activity
4993230|NCT01666496|Adolescent|adolescent
4993231|NCT01666496|risk|risk
4993232|NCT01666496|HIV|hiv
4993233|NCT01666496|video games|video games
4993234|NCT01666483|hysterectomy|hysterectomy
4993235|NCT01666483|single-port|single-port
4993236|NCT01666483|micro-laparoscopy|micro-laparoscopy
4993237|NCT01666470|Quality of life|quality of life
4993238|NCT01666457|Supporting Oral Feeding in Fragile Infants (SOFFI)|supporting oral feeding in fragile infants (soffi)
4993239|NCT01666457|Infant Oral Feeding|infant oral feeding
4993240|NCT01666457|Infant Growth|infant growth
4993241|NCT01666457|Preterm infant oral feeding|preterm infant oral feeding
4993242|NCT01666457|Preterm infant growth|preterm infant growth
4993243|NCT01666457|Neonatal Intensive Care Unit (NICU)|neonatal intensive care unit (nicu)
4993244|NCT01666444|recurrent epithelial ovarian cancer|recurrent epithelial ovarian cancer
4993245|NCT01666444|recurrent fallopian tube cancer|recurrent fallopian tube cancer
4993246|NCT01666444|recurrent primary peritoneal cavity cancer|recurrent primary peritoneal cavity cancer
4993247|NCT01666444|ovarian serous cystadenocarcinoma|ovarian serous cystadenocarcinoma
4993248|NCT01666444|ovarian endometrioid adenocarcinoma|ovarian endometrioid adenocarcinoma
4993249|NCT01666444|ovarian mucinous cystadenocarcinoma|ovarian mucinous cystadenocarcinoma
4993250|NCT01666444|ovarian undifferentiated adenocarcinoma|ovarian undifferentiated adenocarcinoma
4993251|NCT01666444|ovarian clear cell cystadenocarcinoma|ovarian clear cell cystadenocarcinoma
4993252|NCT01666444|ovarian mixed epithelial carcinoma|ovarian mixed epithelial carcinoma
4993253|NCT01666444|Brenner tumor|brenner tumor
4993254|NCT01666405|Fecal Incontinence|fecal incontinence
4993255|NCT01666405|Bowel Incontinence|bowel incontinence
4993256|NCT01666392|Omega-3 fatty acid|omega-3 fatty acid
4993257|NCT01666392|Fish oil|fish oil
4993258|NCT01666392|Muscle mass|muscle mass
4993259|NCT01666392|Muscle strength|muscle strength
4993260|NCT01666392|Older adults|older adults
4993261|NCT01666392|Circulating inflammatory cytokines|circulating inflammatory cytokines
4993262|NCT01666392|Skeletal muscle mass|skeletal muscle mass
4993263|NCT01666392|Upper body strength|upper body strength
4993264|NCT01666392|Lower body strength|lower body strength
4993265|NCT01666379|Hallux valgus|hallux valgus
4993266|NCT01666379|Forefoot|forefoot
4993267|NCT01666379|transdermal fentanyl|transdermal fentanyl
4993268|NCT01666340|Exercise|exercise
4993269|NCT01666340|Elderly|elderly
4993270|NCT01666340|Mortality|mortality
4993271|NCT01666340|Morbidity|morbidity
4993272|NCT01666340|Prognosis|prognosis
4993273|NCT01666340|Longevity|longevity
4993274|NCT01666327|Crohn's Disease|crohn's disease
4993275|NCT01666327|Ulcerative Colitis|ulcerative colitis
4993276|NCT01666314|castrate resistant prostate cancer,|castrate resistant prostate cancer,
4993277|NCT01666314|CRPC,|crpc,
4993278|NCT01666314|orteronel,|orteronel,
4993279|NCT01666314|TAK-700|tak-700
4993280|NCT01666301|Erythropoietin stimulating agents|erythropoietin stimulating agents
4993281|NCT01666301|Hemoglobin|hemoglobin
4993282|NCT01666301|Reticulocytes|reticulocytes
4993283|NCT01666301|Variability|variability
4993284|NCT01666262|FLU|flu
4993285|NCT01666262|H1N1|h1n1
4993286|NCT01666262|GPO|gpo
4993287|NCT01666262|PLAIV|plaiv
4993288|NCT01666249|FMH; anti-Rh; efficacy|fmh; anti-rh; efficacy
4993490|NCT01665326|Myozyme|myozyme
4993289|NCT01666236|Age-Related Macular Degeneration|age-related macular degeneration
4993290|NCT01666236|Pigment Epithelial Detachment|pigment epithelial detachment
4993291|NCT01666236|Polypoidal Choroidal Vasculopathy|polypoidal choroidal vasculopathy
4993292|NCT01666223|Type 2 diabetes|type 2 diabetes
4993293|NCT01666223|GLP-1|glp-1
4993294|NCT01666223|Bile acid|bile acid
4993295|NCT01666223|TGR-5|tgr-5
4993296|NCT01666197|Acute Joint Pain|acute joint pain
4993297|NCT01666184|Biomarkers study|biomarkers study
4993298|NCT01666171|estrogen receptor-negative breast cancer|estrogen receptor-negative breast cancer
4993299|NCT01666171|progesterone receptor-negative breast cancer|progesterone receptor-negative breast cancer
4993300|NCT01666171|stage IB breast cancer|stage ib breast cancer
4993301|NCT01666171|stage II breast cancer|stage ii breast cancer
4993302|NCT01666171|stage IIIA breast cancer|stage iiia breast cancer
4993303|NCT01666171|stage IIIC breast cancer|stage iiic breast cancer
4993304|NCT01666145|Hepatocellular Cancer|hepatocellular cancer
4993305|NCT01666145|Hepatocellular Carcinoma|hepatocellular carcinoma
4993306|NCT01666145|Hepatoma|hepatoma
4993307|NCT01666145|Liver Cancer, Adult|liver cancer, adult
4993308|NCT01666145|Liver Cell Carcinoma, Adult|liver cell carcinoma, adult
4993309|NCT01666132|LVEF < 40%|lvef < 40%
4993310|NCT01666119|Opioid dependence|opioid dependence
4993311|NCT01666119|Suboxone|suboxone
4993312|NCT01666119|addiction|addiction
4993313|NCT01666119|BEMA Buprenorphine NX|bema buprenorphine nx
4993314|NCT01666119|oral transmucosal|oral transmucosal
4993315|NCT01666093|peripheral artery disease|peripheral artery disease
4993316|NCT01666093|endovascular procedure|endovascular procedure
4993317|NCT01666093|non-healing ulcer|non-healing ulcer
4993318|NCT01666080|second stem cell transplant|second stem cell transplant
4993319|NCT01666080|donor hematopoietic engraftment|donor hematopoietic engraftment
4993320|NCT01666080|hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
4993321|NCT01666080|inherited metabolic disorder|inherited metabolic disorder
4993322|NCT01666067|insulin resistance|insulin resistance
4993323|NCT01666054|Weaning|weaning
4993324|NCT01666054|mechanical ventilation|mechanical ventilation
4993325|NCT01666054|Proportional Assist Ventilation|proportional assist ventilation
4993326|NCT01666041|insulin resistance|insulin resistance
4993327|NCT01666028|Type 1 Diabetes|type 1 diabetes
4993328|NCT01666028|Closed Loop glucose control|closed loop glucose control
4993329|NCT01666028|Artificial Pancreas|artificial pancreas
4993330|NCT01666028|CSII|csii
4993331|NCT01666028|CGM|cgm
4993332|NCT01666015|pediatric|pediatric
4993333|NCT01666015|exercise|exercise
4993334|NCT01666015|hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
4993335|NCT01666015|cancer|cancer
4993336|NCT01666015|quality of life|quality of life
4993337|NCT01666015|immune system|immune system
4993338|NCT01666015|physical activity levels|physical activity levels
4993339|NCT01665937|liver cancer|liver cancer
4993340|NCT01665937|advanced liver cancer|advanced liver cancer
4993341|NCT01665937|advanced hepatocellular cancer|advanced hepatocellular cancer
4993342|NCT01665911|Caries|caries
4993343|NCT01665898|cold biopsy forceps|cold biopsy forceps
4993344|NCT01665898|cold snare biopsy|cold snare biopsy
4993345|NCT01665885|hypothermia|hypothermia
4993346|NCT01665885|induction of hypothermia|induction of hypothermia
4993347|NCT01665885|non invasive cooling|non invasive cooling
4993348|NCT01665885|external cooling|external cooling
4993349|NCT01665885|surface cooling|surface cooling
4993350|NCT01665885|endovascular cooling|endovascular cooling
4993351|NCT01665885|cooling catheter|cooling catheter
4993352|NCT01665885|stroke|stroke
4993353|NCT01665885|shivering|shivering
4993354|NCT01665885|neuro monitoring|neuro monitoring
4993355|NCT01665885|coagulation|coagulation
4993356|NCT01665872|Mothers|mothers
4993357|NCT01665872|Depression|depression
4993358|NCT01665872|Stress|stress
4993359|NCT01665872|Trauma|trauma
4993360|NCT01665872|Public Housing|public housing
4993361|NCT01665859|readmission|readmission
4993362|NCT01665859|recurrence|recurrence
4993363|NCT01665859|umbilical|umbilical
4993364|NCT01665859|epigastric|epigastric
4993365|NCT01665859|hernia|hernia
4993366|NCT01665859|outcome|outcome
4993367|NCT01665859|morbidity|morbidity
4993368|NCT01665846|HIV associated neurocognitive disorders|hiv associated neurocognitive disorders
4993369|NCT01665846|MRI|mri
4993370|NCT01665846|Ferumoxytol|ferumoxytol
4993371|NCT01665833|Angina|angina
4993372|NCT01665833|SYNTAX|syntax
4993373|NCT01665833|Coronary|coronary
4993374|NCT01665833|PCI|pci
4993375|NCT01665833|CABG|cabg
4993376|NCT01665820|chest|chest
4993377|NCT01665820|pathology|pathology
4993378|NCT01665807|influenza|influenza
4993379|NCT01665807|vaccine|vaccine
4993380|NCT01665807|administration|administration
4993381|NCT01665781|Hemoglobin|hemoglobin
4993382|NCT01665781|Erythropoietin|erythropoietin
4993383|NCT01665781|Acute Mountain sickness|acute mountain sickness
4993384|NCT01665742|Obesity|obesity
4993385|NCT01665742|Chronic inflammation|chronic inflammation
4993386|NCT01665742|Anti-inflammatory dietary intervention|anti-inflammatory dietary intervention
4993387|NCT01665742|Genetic susceptibility|genetic susceptibility
4993388|NCT01665729|etiology|etiology
4993389|NCT01665729|pathogenesis|pathogenesis
4993390|NCT01665729|minor ischaemic stroke|minor ischaemic stroke
4993391|NCT01665729|types|types
4993392|NCT01665729|intervention|intervention
4993393|NCT01665703|[18F]|[18f]
4993394|NCT01665703|Fluorodeoxyglucose Positron Emission Tomography-Magnetic Resonance Imaging|fluorodeoxyglucose positron emission tomography-magnetic resonance imaging
4993395|NCT01665703|FDG-PET-MRI|fdg-pet-mri
4993396|NCT01665703|Renal Cell Carcinoma|renal cell carcinoma
4993397|NCT01665703|Pilot Study|pilot study
4993398|NCT01665703|LCCC 1213|lccc 1213
4993399|NCT01665703|UNC Lineberger|unc lineberger
4993400|NCT01665690|patient delivered partner therapy|patient delivered partner therapy
4993401|NCT01665690|expedited partner therapy|expedited partner therapy
4993402|NCT01665690|partner notification|partner notification
4993403|NCT01665690|gonorrhea|gonorrhea
4993404|NCT01665690|chlamydia|chlamydia
4993405|NCT01665677|Graft vs Host Disease|graft vs host disease
4993406|NCT01665677|GVHD|gvhd
4993407|NCT01665677|Allogeneic hematopoietic stem cell transplantation|allogeneic hematopoietic stem cell transplantation
4993408|NCT01665677|HSCT|hsct
4993409|NCT01665677|Atorvastatin|atorvastatin
4993410|NCT01665664|Indirect calorimetry|indirect calorimetry
4993411|NCT01665664|hypocaloric feeding|hypocaloric feeding
4993412|NCT01665638|Healthy|healthy
4993413|NCT01665638|Clearance|clearance
4993414|NCT01665638|Canagliflozin|canagliflozin
4993415|NCT01665638|JNJ-28431754|jnj-28431754
4993416|NCT01665638|Placebo|placebo
4993417|NCT01665638|Somatostatin|somatostatin
4993418|NCT01665638|C-peptide|c-peptide
4993419|NCT01665625|Pancreatic cancer|pancreatic cancer
4993420|NCT01665625|Intra-arterial infusion|intra-arterial infusion
4993421|NCT01665625|Gemcitabine|gemcitabine
4993422|NCT01665612|Contact lens|contact lens
4993423|NCT01665612|Care solution|care solution
4993424|NCT01665612|MPDS|mpds
4993425|NCT01665612|comfort|comfort
4993426|NCT01665586|dexmedetomidine|dexmedetomidine
4993427|NCT01665586|sedation in elderly patient|sedation in elderly patient
4993428|NCT01665586|spinal anesthesia|spinal anesthesia
4993429|NCT01665573|Fear Conditioning|fear conditioning
4993430|NCT01665573|Cannabinoids|cannabinoids
4993431|NCT01665573|Fear Response|fear response
4993432|NCT01665560|smoking|smoking
4993433|NCT01665560|fMRI|fmri
4993434|NCT01665560|odors|odors
4993435|NCT01665560|taste|taste
4993436|NCT01665547|clomiphene resistant|clomiphene resistant
4993437|NCT01665547|pcos|pcos
4993438|NCT01665547|induction of ovulation|induction of ovulation
4993439|NCT01665547|l-carnitine|l-carnitine
4993440|NCT01665534|hypertension|hypertension
4993441|NCT01665534|inflammation|inflammation
4993442|NCT01665534|salt intake|salt intake
4993443|NCT01665521|Acute Coronary Syndrome|acute coronary syndrome
4993444|NCT01665521|Chest pain|chest pain
4993445|NCT01665521|Risk Stratification|risk stratification
4993446|NCT01665521|HEART Pathway|heart pathway
4993447|NCT01665521|Emergency Department|emergency department
4993448|NCT01665508|angina|angina
4993449|NCT01665508|cardiopulmonary testing|cardiopulmonary testing
4993450|NCT01665508|metabolomics|metabolomics
4993451|NCT01665508|nebivolol|nebivolol
4993452|NCT01665495|pericardial effusion|pericardial effusion
4993453|NCT01665495|cardiac tamponade|cardiac tamponade
4993454|NCT01665495|pericardiocentesis|pericardiocentesis
4993455|NCT01665495|pericardial drainage|pericardial drainage
4993456|NCT01665495|prevention|prevention
4993457|NCT01665482|Inflammation|inflammation
4993458|NCT01665482|Insulin sensitivity|insulin sensitivity
4993459|NCT01665482|Interleukin-6 (IL-6)|interleukin-6 (il-6)
4993460|NCT01665482|C-peptide|c-peptide
4993461|NCT01665482|Saturated fatty acid (SFA)|saturated fatty acid (sfa)
4993462|NCT01665482|Monounsaturated fatty acid (MUFA)|monounsaturated fatty acid (mufa)
4993463|NCT01665482|Carbohydrate (CARB)|carbohydrate (carb)
4993464|NCT01665469|anti oxidation|anti oxidation
4993465|NCT01665469|lycopene|lycopene
4993466|NCT01665469|Ox-LDL|ox-ldl
4993467|NCT01665456|complications|complications
4993468|NCT01665417|Icotinib|icotinib
4993469|NCT01665417|EGFR positive mutation|egfr positive mutation
4993470|NCT01665417|First-line treatment|first-line treatment
4993471|NCT01665417|Maintenance treatment|maintenance treatment
4993472|NCT01665378|prepregnancy|prepregnancy
4993473|NCT01665378|micronutrient|micronutrient
4993474|NCT01665378|supplementation|supplementation
4993475|NCT01665378|maternal|maternal
4993476|NCT01665378|child|child
4993477|NCT01665378|health|health
4993478|NCT01665365|Myocardial infarction|myocardial infarction
4993479|NCT01665365|Remote ischemic conditioning|remote ischemic conditioning
4993480|NCT01665365|Clinical outcome|clinical outcome
4993481|NCT01665339|preload|preload
4993482|NCT01665339|anthropometric measures|anthropometric measures
4993483|NCT01665339|cardiovascular risk factors|cardiovascular risk factors
4993484|NCT01665326|Pompe disease|pompe disease
4993485|NCT01665326|Glycogen Storage Disease Type II|glycogen storage disease type ii
4993486|NCT01665326|Acid Maltase Deficiency|acid maltase deficiency
4993487|NCT01665326|CRIM Status|crim status
4993488|NCT01665326|Acid Alpha-Glucosidase Deficiency|acid alpha-glucosidase deficiency
4993489|NCT01665326|Alglucosidase alfa|alglucosidase alfa
4993491|NCT01665326|Enzyme replacement therapy|enzyme replacement therapy
4993492|NCT01665326|Immune Tolerance Induction|immune tolerance induction
4993493|NCT01665313|attention|attention
4993494|NCT01665300|myocardial deformation imaging|myocardial deformation imaging
4993495|NCT01665300|Trastuzumab|trastuzumab
4993496|NCT01665287|Cerebral Oximetry|cerebral oximetry
4993497|NCT01665287|Near infrared spectroscopy|near infrared spectroscopy
4993498|NCT01665287|Fullterm|fullterm
4993499|NCT01665287|Infant|infant
4993500|NCT01665274|xelox|xelox
4993501|NCT01665274|advanced gastric cancer|advanced gastric cancer
4993502|NCT01665261|Congenital heart disease|congenital heart disease
4993503|NCT01665261|Newborn|newborn
4993504|NCT01665261|Pulse oximetry|pulse oximetry
4993505|NCT01665261|Screening|screening
4993506|NCT01665248|18-F Sodium Fluoride|18-f sodium fluoride
4993507|NCT01665248|Acute coronary syndrome|acute coronary syndrome
4993508|NCT01665248|Stable Angina|stable angina
4993509|NCT01665196|IgG4-related disease|igg4-related disease
4993510|NCT01665196|IgG4-RD|igg4-rd
4993511|NCT01665196|18F-FDG|18f-fdg
4993512|NCT01665196|PET/CT|pet/ct
4993513|NCT01665183|argininosuccinate synthetase|argininosuccinate synthetase
4993514|NCT01665183|arginine|arginine
4993515|NCT01665183|arginine deiminase|arginine deiminase
4993516|NCT01665170|Pascoflair|pascoflair
4993517|NCT01665170|tsst|tsst
4993518|NCT01665170|passiflora incarnata|passiflora incarnata
4993519|NCT01665170|non smoking male|non smoking male
4993520|NCT01665170|and female volunteers|and female volunteers
4993521|NCT01665157|Diet Control before Colonoscopy|diet control before colonoscopy
4993522|NCT01665144|Secondary Progressive Multiple Sclerosis|secondary progressive multiple sclerosis
4993523|NCT01665118|Radio frequency|radio frequency
4993524|NCT01665118|thigh|thigh
4993525|NCT01665118|circumference|circumference
4993526|NCT01665118|reduction|reduction
4993527|NCT01665105|Pulse Rate Variability|pulse rate variability
4993528|NCT01665105|Skin Blood Flow|skin blood flow
4993529|NCT01665105|Skin Temperature|skin temperature
4993530|NCT01665105|Electroacupuncture|electroacupuncture
4993531|NCT01665105|Zusanli|zusanli
4993532|NCT01665105|Yanglingquan|yanglingquan
4993533|NCT01665079|anaesthetics iv|anaesthetics iv
4993534|NCT01665079|propofol|propofol
4993535|NCT01665079|pharmacokinetics|pharmacokinetics
4993536|NCT01665079|pharmacodynamic|pharmacodynamic
4993537|NCT01665053|Drug-Eluting Stents|drug-eluting stents
4993538|NCT01665040|neurostimulation|neurostimulation
4993539|NCT01665040|spinal cord stimulation|spinal cord stimulation
4993540|NCT01665040|peripheral nerve stimulation|peripheral nerve stimulation
4993541|NCT01665027|caesarean section,|caesarean section,
4993542|NCT01665027|vacuum,|vacuum,
4993543|NCT01665027|fetal head extraction,|fetal head extraction,
4993544|NCT01665027|maternal complication,|maternal complication,
4993545|NCT01665027|fetal complication|fetal complication
4993546|NCT01665014|autologous hematopoietic stem cell transplantation|autologous hematopoietic stem cell transplantation
4993547|NCT01665014|total marrow irradiation|total marrow irradiation
4993548|NCT01665014|melphalan|melphalan
4993549|NCT01665014|multiple myeloma|multiple myeloma
4993550|NCT01665001|Acute lymphoblastic leukemia|acute lymphoblastic leukemia
4993551|NCT01665001|Induction|induction
4993552|NCT01665001|Consolidation|consolidation
4993553|NCT01665001|Minimal residual disease|minimal residual disease
4993554|NCT01665001|Hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
4993555|NCT01664975|Peripheral T-cell lymphoma;chemotherapy;|peripheral t-cell lymphoma;chemotherapy;
4993556|NCT01664975|RR;PFS;OS|rr;pfs;os
4993557|NCT01664936|18F-FDG PET/CT scan|18f-fdg pet/ct scan
4993558|NCT01664936|131I therapy|131i therapy
4993559|NCT01664936|Cerenkov Luminescence Imaging|cerenkov luminescence imaging
4993560|NCT01664936|12-050|12-050
4993561|NCT01664936|Lymphoma|lymphoma
4993562|NCT01664936|Leukemia|leukemia
4993563|NCT01664936|Metastatic Lymph Nodes|metastatic lymph nodes
4993564|NCT01664923|prostate cancer|prostate cancer
4993565|NCT01664923|enzalutamide|enzalutamide
4993566|NCT01664923|MDV3100|mdv3100
4993567|NCT01664910|Lymphoma|lymphoma
4993568|NCT01664910|CD22 Positive-Lymphoid Malignancies|cd22 positive-lymphoid malignancies
4993569|NCT01664910|Leukemia|leukemia
4993570|NCT01664910|Allogeneic stem cell transplant|allogeneic stem cell transplant
4993571|NCT01664910|CMC-544|cmc-544
4993572|NCT01664910|Inotuzumab Ozogamicin|inotuzumab ozogamicin
4993573|NCT01664910|Fludarabine|fludarabine
4993574|NCT01664910|Fludarabine Phosphate|fludarabine phosphate
4993575|NCT01664910|Fludara|fludara
4993576|NCT01664910|Bendamustine|bendamustine
4993577|NCT01664910|Bendamustine Hydrochloride|bendamustine hydrochloride
4993578|NCT01664910|Bendamustine HCL|bendamustine hcl
4993579|NCT01664910|CEP-18083|cep-18083
4993580|NCT01664910|SDX105|sdx105
4993581|NCT01664910|Treanda|treanda
4993582|NCT01664910|G-CSF|g-csf
4993583|NCT01664910|Filgrastim|filgrastim
4993584|NCT01664910|Neupogen|neupogen
4993585|NCT01664910|Methotrexate|methotrexate
4993586|NCT01664910|Rituximab|rituximab
4993587|NCT01664910|Rituxan|rituxan
4993588|NCT01664910|Thymoglobulin|thymoglobulin
4993590|NCT01664910|Antithymocyte Globulin|antithymocyte globulin
4993591|NCT01664910|Tacrolimus|tacrolimus
4993592|NCT01664910|Prograf|prograf
4993593|NCT01664897|Leukemia|leukemia
4993594|NCT01664897|Acute myeloid leukemia|acute myeloid leukemia
4993595|NCT01664897|AML|aml
4993596|NCT01664897|refractory|refractory
4993597|NCT01664897|relapsed|relapsed
4993598|NCT01664897|Erlotinib|erlotinib
4993599|NCT01664897|Erlotinib Hydrochloride|erlotinib hydrochloride
4993600|NCT01664897|OSI-774|osi-774
4993601|NCT01664897|CP358774|cp358774
4993602|NCT01664897|Tarceva|tarceva
4993603|NCT01664884|INTERNALIZED STIGMA|internalized stigma
4993604|NCT01664884|INSIGHT|insight
4993605|NCT01664884|SOCIAL ADEQUACY|social adequacy
4993606|NCT01664884|BIPOLAR DISORDER|bipolar disorder
4993607|NCT01664884|SCHIZOPHRENIA|schizophrenia
4993608|NCT01664858|Coronary Heart Disease|coronary heart disease
4993609|NCT01664858|Ischaemic Heart Disease|ischaemic heart disease
4993610|NCT01664858|Angina|angina
4993611|NCT01664858|Cardiac Magnetic Resonance Imaging|cardiac magnetic resonance imaging
4993612|NCT01664845|hepatitis c|hepatitis c
4993613|NCT01664845|metformin|metformin
4993614|NCT01664845|pegylated interferon|pegylated interferon
4993615|NCT01664832|Premature Infants|premature infants
4993616|NCT01664832|snychronized ventilation|snychronized ventilation
4993617|NCT01664832|non-invasive ventilation|non-invasive ventilation
4993618|NCT01664832|RDS|rds
4993619|NCT01664806|Electrosurgery|electrosurgery
4993620|NCT01664806|Radiofrequency energy|radiofrequency energy
4993621|NCT01664806|Monopolar instruments|monopolar instruments
4993622|NCT01664806|Capacitive coupling|capacitive coupling
4993623|NCT01664806|Thermal injury|thermal injury
4993624|NCT01664806|Surgical complications|surgical complications
4993625|NCT01664793|influenza|influenza
4993626|NCT01664793|vaccination|vaccination
4993627|NCT01664793|strategies|strategies
4993628|NCT01664793|children/adolescents|children/adolescents
4993629|NCT01664780|standard|standard
4993630|NCT01664780|values|values
4993631|NCT01664780|share|share
4993632|NCT01664780|wave velocity|wave velocity
4993633|NCT01664780|in ARFI imaging|in arfi imaging
4993634|NCT01664767|COPD|copd
4993635|NCT01664767|Thermal water|thermal water
4993636|NCT01664767|Oxidative stress|oxidative stress
4993637|NCT01664767|Inflammation|inflammation
4993638|NCT01664741|Nicotine dependence|nicotine dependence
4993639|NCT01664741|cigarette|cigarette
4993640|NCT01664741|smoking|smoking
4993641|NCT01664741|nicotine replacement therapy|nicotine replacement therapy
4993642|NCT01664741|positron emission tomography|positron emission tomography
4993643|NCT01664728|Prostate neoplasms|prostate neoplasms
4993644|NCT01664728|Hormone refractory prostate cancer|hormone refractory prostate cancer
4993645|NCT01664728|Castration resistant prostate cancer|castration resistant prostate cancer
4993646|NCT01664728|Castration refractory prostate cancer|castration refractory prostate cancer
4993647|NCT01664728|Abiraterone acetate|abiraterone acetate
4993648|NCT01664728|CB7630|cb7630
4993649|NCT01664715|Overweight|overweight
4993650|NCT01664715|Obesity|obesity
4993651|NCT01664715|Exercise|exercise
4993652|NCT01664715|Weight Loss|weight loss
4993653|NCT01664702|Dairy|dairy
4993654|NCT01664702|obesity|obesity
4993655|NCT01664676|liraglutide|liraglutide
4993656|NCT01664676|victoza|victoza
4993657|NCT01664676|GLP-1|glp-1
4993658|NCT01664676|kidney|kidney
4993659|NCT01664676|diabetes|diabetes
4993660|NCT01664676|renal|renal
4993661|NCT01664676|diabetic nephropathy|diabetic nephropathy
4993662|NCT01664663|Radiotherapy|radiotherapy
4993663|NCT01664663|Dose escalation|dose escalation
4993664|NCT01664663|Normal tissue constraints|normal tissue constraints
4993665|NCT01664663|Locally advanced disease|locally advanced disease
4993666|NCT01664663|Good performance status|good performance status
4993667|NCT01664650|menopause|menopause
4993668|NCT01664650|pre-diabetes|pre-diabetes
4993669|NCT01664637|diabetic gastroparesis|diabetic gastroparesis
4993670|NCT01664637|delayed gastric emptying|delayed gastric emptying
4993671|NCT01664637|gastroparesis|gastroparesis
4993672|NCT01664637|diabetes mellitus, Type 1|diabetes mellitus, type 1
4993673|NCT01664637|diabetes mellitus, Type 2|diabetes mellitus, type 2
4993674|NCT01664624|Drug Therapy|drug therapy
4993675|NCT01664611|Remote Ischaemic Conditioning|remote ischaemic conditioning
4993676|NCT01664611|Remodeling|remodeling
4993677|NCT01664611|Heart Failure|heart failure
4993678|NCT01664611|Myocardial Infarction|myocardial infarction
4993679|NCT01664611|Ischaemia/Reperfusion Injury|ischaemia/reperfusion injury
4993680|NCT01664611|successful primary percutaneous coronary intervention following a first STEMI|successful primary percutaneous coronary intervention following a first stemi
4993681|NCT01664585|headache|headache
4993682|NCT01664585|women|women
4993683|NCT01664585|exercise|exercise
4993684|NCT01664585|fear avoidance|fear avoidance
4993685|NCT01664585|physical activity|physical activity
4993686|NCT01664572|laser Doppler flowmetry, skin blood flow|laser doppler flowmetry, skin blood flow
4993687|NCT01664559|intrauterine device|intrauterine device
4993688|NCT01664559|ketorolac|ketorolac
4993689|NCT01664559|toradol|toradol
4993690|NCT01664559|mirena|mirena
4993691|NCT01664559|paragard|paragard
4993692|NCT01664559|pain control|pain control
4993693|NCT01664520|Subarachnoid hemorrhage|subarachnoid hemorrhage
4993694|NCT01664520|Dexmedetomidine|dexmedetomidine
4993695|NCT01664520|Autoregulation|autoregulation
4993696|NCT01664520|Intracranial pressure|intracranial pressure
4993697|NCT01664520|Cerebral oxygenation|cerebral oxygenation
4993698|NCT01664507|croup, dose, epinephrine|croup, dose, epinephrine
4993699|NCT01664273|electroporation|electroporation
4993700|NCT01664273|gen electrotransfer|gen electrotransfer
4993701|NCT01664273|muscle|muscle
4993702|NCT01664273|plasmid AMEP|plasmid amep
4993703|NCT01664260|Posttraumatic Stress Disorder|posttraumatic stress disorder
4993704|NCT01664260|N-acetylcysteine|n-acetylcysteine
4993705|NCT01664260|Magnetic Resonance Imaging|magnetic resonance imaging
4993706|NCT01664234|infants with cleft palate|infants with cleft palate
4993707|NCT01664234|Pierre Robin|pierre robin
4993708|NCT01664234|Treacher Collins|treacher collins
4993709|NCT01664234|trisomy 21|trisomy 21
4993710|NCT01664221|subject|subject
4993711|NCT01664195|subjects|subjects
4993712|NCT01664169|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
4993713|NCT01664169|recurrent pancreatic cancer|recurrent pancreatic cancer
4993714|NCT01664169|stage III pancreatic cancer|stage iii pancreatic cancer
4993715|NCT01664169|stage IV pancreatic cancer|stage iv pancreatic cancer
4993716|NCT01664169|stage IIB pancreatic cancer|stage iib pancreatic cancer
4993717|NCT01664156|Cold hypersensitivity|cold hypersensitivity
4993718|NCT01664156|Korean red ginseng|korean red ginseng
4993719|NCT01664156|Infrared thermography|infrared thermography
4993720|NCT01664156|Cold stress test|cold stress test
4993721|NCT01664156|Distal-dorsal difference|distal-dorsal difference
4993722|NCT01664091|tissue expander|tissue expander
4993723|NCT01664091|acellular dermal matrix|acellular dermal matrix
4993724|NCT01664078|Abdominal Aortic Aneurysm|abdominal aortic aneurysm
4993725|NCT01664065|Patient Safety|patient safety
4993726|NCT01664065|Tolerability|tolerability
4993727|NCT01664065|Pharmacokinetics|pharmacokinetics
4993728|NCT01664039|Glaucoma|glaucoma
4993729|NCT01664039|Ocular hypertension|ocular hypertension
4993730|NCT01664000|Tumors|tumors
4993731|NCT01664000|carcinoma|carcinoma
4993732|NCT01664000|apoptosis|apoptosis
4993733|NCT01664000|p53|p53
4993734|NCT01664000|p21|p21
4993735|NCT01664000|Caspase3|caspase3
4993736|NCT01664000|PARP|parp
4993737|NCT01664000|MDM2|mdm2
4993738|NCT01664000|PUMA|puma
4993739|NCT01663974|Bipolar Disorders|bipolar disorders
4993740|NCT01663974|Sub-syndromal symptoms|sub-syndromal symptoms
4993741|NCT01663974|Acute depressive episode|acute depressive episode
4993742|NCT01663974|Symptomatic remission|symptomatic remission
4993743|NCT01663974|Functioning remission|functioning remission
4993744|NCT01663961|Phase I|phase i
4993745|NCT01663961|Pharmacokinetics|pharmacokinetics
4993746|NCT01663961|YM178 Oral Controlled Absorption System (OCAS)|ym178 oral controlled absorption system (ocas)
4993747|NCT01663961|Digoxin (Lanoxin)|digoxin (lanoxin)
4993748|NCT01663961|DDI (Drug-drug interaction)|ddi (drug-drug interaction)
4993749|NCT01663961|Open-label|open-label
4993750|NCT01663961|Steady-state|steady-state
4993751|NCT01663961|subjects|subjects
4993752|NCT01663948|Plastic bronchitis|plastic bronchitis
4993753|NCT01663948|PB|pb
4993754|NCT01663935|levodopa|levodopa
4993755|NCT01663935|Albinism|albinism
4993756|NCT01663935|dopamine|dopamine
4993757|NCT01663935|oculocutaneous albinism|oculocutaneous albinism
4993758|NCT01663935|vision|vision
4993759|NCT01663935|retina function|retina function
4993760|NCT01663909|Pain|pain
4993761|NCT01663909|Scoliosis|scoliosis
4993762|NCT01663909|Rehabilitation|rehabilitation
4993763|NCT01663909|Cognitive-behavioral interventions|cognitive-behavioral interventions
4993764|NCT01663909|Adolescents|adolescents
4993765|NCT01663883|Blood flow autoregulation|blood flow autoregulation
4993766|NCT01663883|optic nerve head blood flow|optic nerve head blood flow
4993767|NCT01663883|isometric exercise|isometric exercise
4993768|NCT01663883|Autoregulation|autoregulation
4993769|NCT01663883|ocular physiology|ocular physiology
4993770|NCT01663870|Cancer Prevention|cancer prevention
4993771|NCT01663870|Breast cancer survivors|breast cancer survivors
4993772|NCT01663870|Cancer survivorship clinic|cancer survivorship clinic
4993773|NCT01663870|eHealth technology|ehealth technology
4993774|NCT01663870|Internet|internet
4993775|NCT01663870|HealthATM website|healthatm website
4993776|NCT01663870|Questionnaire|questionnaire
4993777|NCT01663870|Clinic stakeholders|clinic stakeholders
4993778|NCT01663870|Clinic nurses|clinic nurses
4993779|NCT01663870|Physicians|physicians
4993780|NCT01663870|Case managers|case managers
4993781|NCT01663870|Oncology patient navigators|oncology patient navigators
4993782|NCT01663870|Audio recorded interviews|audio recorded interviews
4993783|NCT01663844|Cognitive behavior therapy|cognitive behavior therapy
4993784|NCT01663844|Internet treatment|internet treatment
4993785|NCT01663844|Self-help treatment|self-help treatment
4993786|NCT01663844|Insomnia|insomnia
4993787|NCT01663844|Depression|depression
4993788|NCT01663844|ICBT|icbt
4993789|NCT01663844|CBT-i|cbt-i
4993790|NCT01663844|CBT-d|cbt-d
4993791|NCT01663831|Outdoor Malaria Transmission|outdoor malaria transmission
4993792|NCT01663831|Anopheles|anopheles
4993793|NCT01663831|Topical repellent|topical repellent
4993794|NCT01663831|Early biting vector|early biting vector
4993795|NCT01663831|Long Lasting Insecticidal Net (LLIN)|long lasting insecticidal net (llin)
4993796|NCT01663831|Cambodia|cambodia
4993797|NCT01663805|Extended Criteria Donor|extended criteria donor
4993798|NCT01663805|Delayed Graft Function|delayed graft function
4993800|NCT01663805|Deceased donors aged ≥ 60 years|deceased donors aged ≥ 60 years
4993801|NCT01663805|aged between 50 and 59 years|aged between 50 and 59 years
4993802|NCT01663805|history of systemic hypertension|history of systemic hypertension
4993803|NCT01663805|terminal creatinine levels > 1.5 mg/dL|terminal creatinine levels > 1.5 mg/dl
4993804|NCT01663805|death by a cerebrovascular accident|death by a cerebrovascular accident
4993805|NCT01663792|urokinase receptor|urokinase receptor
4993806|NCT01663792|protein expression|protein expression
4993807|NCT01663792|seaweed (Undaria pinnatifida)|seaweed (undaria pinnatifida)
4993808|NCT01663766|GVHD (acute or chronic)|gvhd (acute or chronic)
4993809|NCT01663766|acute myeloid or lymphoblastic leukemia (AML or ALL)|acute myeloid or lymphoblastic leukemia (aml or all)
4993810|NCT01663766|myelodysplastic syndrome|myelodysplastic syndrome
4993811|NCT01663766|Chronic myelogenous leukemia (CML)|chronic myelogenous leukemia (cml)
4993812|NCT01663766|Multiple Myeloma (MM)|multiple myeloma (mm)
4993813|NCT01663766|Non-Hodgekin lymphoma (NHL-both follicular & diffuse large cell)|non-hodgekin lymphoma (nhl-both follicular & diffuse large cell)
4993814|NCT01663766|Chronic lymphocytic leukemia or small lymphocytic leukemia (CLL or SLL)|chronic lymphocytic leukemia or small lymphocytic leukemia (cll or sll)
4993815|NCT01663753|2-fluoro-2-deoxy-d-glucose-positron emission tomography|2-fluoro-2-deoxy-d-glucose-positron emission tomography
4993816|NCT01663753|Positron emission tomography|positron emission tomography
4993817|NCT01663753|Magnetic resonance imaging|magnetic resonance imaging
4993818|NCT01663753|Diffusion weighted MRI|diffusion weighted mri
4993819|NCT01663753|Squamous-cell cervical carcinoma|squamous-cell cervical carcinoma
4993820|NCT01663753|Sensitivity|sensitivity
4993821|NCT01663714|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
4993822|NCT01663714|tositumomab and iodine I 131 tositumomab|tositumomab and iodine i 131 tositumomab
4993823|NCT01663714|Bexxar|bexxar
4993824|NCT01663714|cycolophosphamide, vacristine, and pednisone|cycolophosphamide, vacristine, and pednisone
4993825|NCT01663701|Sepsis|sepsis
4993826|NCT01663701|Severe sepsis|severe sepsis
4993827|NCT01663701|Tuberculosis|tuberculosis
4993828|NCT01663701|Bundle|bundle
4993829|NCT01663701|Zambia|zambia
4993830|NCT01663675|Down syndrome|down syndrome
4993831|NCT01663649|Depression|depression
4993832|NCT01663649|Online-Therapy|online-therapy
4993833|NCT01663649|Deprexis|deprexis
4993834|NCT01663649|Self-help|self-help
4993835|NCT01663636|vaccines|vaccines
4993836|NCT01663636|SMS|sms
4993837|NCT01663636|mobile phones|mobile phones
4993838|NCT01663623|Wegener's Granulomatosis|wegener's granulomatosis
4993839|NCT01663623|anti-MPO|anti-mpo
4993840|NCT01663623|WG|wg
4993841|NCT01663623|Belimumab|belimumab
4993842|NCT01663623|GPA|gpa
4993843|NCT01663623|anti-proteinase 3|anti-proteinase 3
4993844|NCT01663623|anti-neutrophil cytoplasmic antibody|anti-neutrophil cytoplasmic antibody
4993845|NCT01663623|anti-myeloperoxidase|anti-myeloperoxidase
4993846|NCT01663623|Granulomatosis with polyangiitis|granulomatosis with polyangiitis
4993847|NCT01663623|Vasculitis|vasculitis
4993848|NCT01663623|Autoimmune Diseases|autoimmune diseases
4993849|NCT01663623|Microscopic Polyangiitis|microscopic polyangiitis
4993850|NCT01663623|anti-PR3|anti-pr3
4993851|NCT01663623|ANCA|anca
4993852|NCT01663623|MPA|mpa
4993853|NCT01663623|Systemic Vasculitis|systemic vasculitis
4993854|NCT01663584|Spinal Muscular Atrophy (SMA)|spinal muscular atrophy (sma)
4993855|NCT01663584|Carrier Screening|carrier screening
4993856|NCT01663584|Genetic Testing|genetic testing
4993857|NCT01663558|anal dysplasia|anal dysplasia
4993858|NCT01663558|HPV|hpv
4993859|NCT01663558|HIV|hiv
4993860|NCT01663558|MSM|msm
4993861|NCT01663545|Epilepsy|epilepsy
4993862|NCT01663545|Epileptic Focus|epileptic focus
4993863|NCT01663545|Inflammation|inflammation
4993864|NCT01663545|P-Glycoprotein|p-glycoprotein
4993865|NCT01663545|PET Imaging|pet imaging
4993866|NCT01663532|Schizophrenia|schizophrenia
4993867|NCT01663519|Diabetic foot|diabetic foot
4993868|NCT01663519|Offloading|offloading
4993869|NCT01663519|Prevention|prevention
4993870|NCT01663519|Orthotics|orthotics
4993871|NCT01663467|tinnitus|tinnitus
4993872|NCT01663467|smartphone|smartphone
4993873|NCT01663467|Web|web
4993874|NCT01663441|Chemotherapy|chemotherapy
4993875|NCT01663441|Thrombocytopenia|thrombocytopenia
4993876|NCT01663441|Interleukin-11|interleukin-11
4993877|NCT01663441|Platelet|platelet
4993878|NCT01663428|birth related brachial plexus injury|birth related brachial plexus injury
4993879|NCT01663428|brachial plexus|brachial plexus
4993880|NCT01663428|splint|splint
4993881|NCT01663415|MDV3100|mdv3100
4993882|NCT01663415|prostate|prostate
4993883|NCT01663415|cancer|cancer
4993884|NCT01663415|enzalutamide|enzalutamide
4993885|NCT01663389|mass balance|mass balance
4993886|NCT01663389|radiolabel|radiolabel
4993887|NCT01663389|oral|oral
4993888|NCT01663389|IV|iv
4993889|NCT01663389|GSK1322322|gsk1322322
4993890|NCT01663389|healthy volunteer|healthy volunteer
4993891|NCT01663389|antibiotic|antibiotic
4993892|NCT01663363|refractive|refractive
4993893|NCT01663363|LASIK|lasik
4993894|NCT01663337|Posttraumatic Stress Disorder|posttraumatic stress disorder
4993895|NCT01663337|PTSD|ptsd
4993896|NCT01663337|Alcohol Abuse|alcohol abuse
4993897|NCT01663337|Alcohol Dependance|alcohol dependance
4993898|NCT01663337|Alcoholism|alcoholism
4993899|NCT01663337|Comorbid|comorbid
4993900|NCT01663337|Relapse Prevention (RP)|relapse prevention (rp)
4993901|NCT01663337|Cognitive Processing Therapy (CPT)|cognitive processing therapy (cpt)
4993902|NCT01663324|Tinnitus|tinnitus
4993903|NCT01663324|chronic subjective Tinnitus|chronic subjective tinnitus
4993904|NCT01663324|transcranial magnetic stimulation|transcranial magnetic stimulation
4993905|NCT01663324|rTMS|rtms
4993906|NCT01663324|hearing disorders|hearing disorders
4993907|NCT01663311|rTMS|rtms
4993908|NCT01663311|repetitive transcranial magnetic stimulation|repetitive transcranial magnetic stimulation
4993909|NCT01663311|chronic tinnitus|chronic tinnitus
4993910|NCT01663311|subjective tinnitus|subjective tinnitus
4993911|NCT01663311|double cone coil|double cone coil
4993912|NCT01663298|DNA methylation|dna methylation
4993913|NCT01663298|FGF2|fgf2
4993914|NCT01663298|Wound healing|wound healing
4993915|NCT01663298|Smoking|smoking
4993916|NCT01663298|Diabetes|diabetes
4993917|NCT01663298|Implant|implant
4993918|NCT01663285|Urothelial|urothelial
4993919|NCT01663285|Bladder|bladder
4993920|NCT01663285|Cancer|cancer
4993921|NCT01663272|oncology|oncology
4993922|NCT01663272|pancrease|pancrease
4993923|NCT01663233|Essential hypertension|essential hypertension
4993924|NCT01663233|High blood pressure|high blood pressure
4993925|NCT01663220|type 2 diabetes|type 2 diabetes
4993926|NCT01663220|beta cell function|beta cell function
4993927|NCT01663220|meal tolerance test|meal tolerance test
4993928|NCT01663220|maximum stimulation test|maximum stimulation test
4993929|NCT01663220|method standardization|method standardization
4993930|NCT01663220|insulin secretion|insulin secretion
4993931|NCT01663220|prediabetes|prediabetes
4993932|NCT01663220|insulin sensitivity|insulin sensitivity
4993933|NCT01663207|type 2 diabetes|type 2 diabetes
4993934|NCT01663207|beta cell function|beta cell function
4993935|NCT01663207|meal tolerance test|meal tolerance test
4993936|NCT01663207|maximum stimulation test|maximum stimulation test
4993937|NCT01663207|method standardization|method standardization
4993938|NCT01663207|insulin secretion|insulin secretion
4993939|NCT01663207|prediabetes|prediabetes
4993940|NCT01663207|insulin sensitivity|insulin sensitivity
4993941|NCT01663194|N/L ratio, STEMI, primary PCI, Long-term mortality|n/l ratio, stemi, primary pci, long-term mortality
4993942|NCT01663168|HIV|hiv
4993943|NCT01663168|Tuberculosis|tuberculosis
4993944|NCT01663168|Rifabutin|rifabutin
4993945|NCT01663168|HIV Protease Inhibitors|hiv protease inhibitors
4993946|NCT01663168|EARNEST trial|earnest trial
4993947|NCT01663168|Randomized Controlled Trial|randomized controlled trial
4993948|NCT01663168|Pilot Projects|pilot projects
4993949|NCT01663168|Second-line ART|second-line art
4993950|NCT01663168|Drug Toxicity|drug toxicity
4993951|NCT01663168|Pharmacokinetics|pharmacokinetics
4993952|NCT01663168|Drug Interactions|drug interactions
4993953|NCT01663155|lung cancer|lung cancer
4993954|NCT01663155|chest x-ray|chest x-ray
4993955|NCT01663155|CT scan|ct scan
4993956|NCT01663155|computer aided detection (CAD)|computer aided detection (cad)
4993957|NCT01663155|screening|screening
4993958|NCT01663155|smokers|smokers
4993959|NCT01663142|Crohn's disease|crohn's disease
4993960|NCT01663142|gastrointestinal tract|gastrointestinal tract
4993961|NCT01663129|Children|children
4993962|NCT01663129|Osteoporosis|osteoporosis
4993963|NCT01663129|Vertebral Compression Fractures|vertebral compression fractures
4993964|NCT01663129|Chronic Illness|chronic illness
4993965|NCT01663129|Glucocorticoids|glucocorticoids
4993966|NCT01663129|Bone Fragility|bone fragility
4993967|NCT01663116|Rheumatoid arthritis|rheumatoid arthritis
4993968|NCT01663116|Expanded adipose derived allogeneic adult stem cells (eASCs)|expanded adipose derived allogeneic adult stem cells (eascs)
4993969|NCT01663103|Interleukin-1|interleukin-1
4993970|NCT01663103|Endothelium, Vascular|endothelium, vascular
4993971|NCT01663103|Vascular Stiffness|vascular stiffness
4993972|NCT01663103|Oxidative Stress|oxidative stress
4993973|NCT01663103|Inflammation|inflammation
4993974|NCT01663103|Endothelial cells|endothelial cells
4993975|NCT01663090|Newly diagnosed|newly diagnosed
4993976|NCT01663077|Clozapine|clozapine
4993977|NCT01663077|Schizophrenia|schizophrenia
4993978|NCT01663077|Remissia|remissia
4993979|NCT01663077|polymorphism|polymorphism
4993980|NCT01663064|Abdominal aortic aneurysm|abdominal aortic aneurysm
4993981|NCT01663064|Endovascular|endovascular
4993982|NCT01663064|Fenestration|fenestration
4993983|NCT01663064|Juxtarenal|juxtarenal
4993984|NCT01663064|Off-the-shelf|off-the-shelf
4993985|NCT01663064|Pararenal|pararenal
4993986|NCT01663038|Clopidogrel|clopidogrel
4993987|NCT01663038|Aspirin|aspirin
4993988|NCT01663038|Combination|combination
4993989|NCT01663038|Pharmacokinetics|pharmacokinetics
4993990|NCT01663038|Phase 1|phase 1
4993991|NCT01663025|Randomised controlled trial|randomised controlled trial
4993992|NCT01663025|Pain|pain
4993993|NCT01663025|Anxiety|anxiety
4993994|NCT01663025|Ambulatory surgery|ambulatory surgery
4993995|NCT01663025|Hand massage|hand massage
4993996|NCT01663025|Local anaesthetic|local anaesthetic
4993997|NCT01662973|Primary Biliary Cirrhosis|primary biliary cirrhosis
4993998|NCT01662973|Mesenchymal Stem Cells|mesenchymal stem cells
4993999|NCT01662973|Serum alkaline phosphatase|serum alkaline phosphatase
4994000|NCT01662973|Serum Bilirubin|serum bilirubin
4994001|NCT01662960|stroke|stroke
4994002|NCT01662960|hemiparesis|hemiparesis
4994003|NCT01662960|arm movement|arm movement
4994004|NCT01662960|sensory functioning|sensory functioning
4994005|NCT01662947|blood pressure|blood pressure
4994006|NCT01662934|dysmenorrhea|dysmenorrhea
4994007|NCT01662934|transcutaneous electrical nerve stimulation|transcutaneous electrical nerve stimulation
4994008|NCT01662934|heat therapy|heat therapy
4994009|NCT01662921|bolus treatment|bolus treatment
4994010|NCT01662895|Brain hemorrhage|brain hemorrhage
4994011|NCT01662895|Cerebral Hemorrhage|cerebral hemorrhage
4994012|NCT01662895|Deferoxamine|deferoxamine
4994013|NCT01662895|Hi-DEF Trial|hi-def trial
4994014|NCT01662856|Vascular Surgery|vascular surgery
4994015|NCT01662856|Fibrin Sealant|fibrin sealant
4994016|NCT01662856|Polytetrafluoroethylene (PTFE) grafts|polytetrafluoroethylene (ptfe) grafts
4994017|NCT01662843|Dyspnea|dyspnea
4994018|NCT01662843|Ultrasonography|ultrasonography
4994019|NCT01662843|Emergencies|emergencies
4994020|NCT01662843|Critical Care|critical care
4994021|NCT01662830|Obesity|obesity
4994022|NCT01662830|Meal replacements|meal replacements
4994023|NCT01662804|INTERLEUKIN 2|interleukin 2
4994024|NCT01662804|MAB 3F8|mab 3f8
4994025|NCT01662804|GD2-positive tumor|gd2-positive tumor
4994026|NCT01662804|12-116|12-116
4994027|NCT01662791|Parkinson's Disease|parkinson's disease
4994028|NCT01662791|Small Bowel Bacterial Overgrowth|small bowel bacterial overgrowth
4994029|NCT01662791|Weight Loss|weight loss
4994030|NCT01662791|Gastrointestinal|gastrointestinal
4994031|NCT01662791|Rifaximin|rifaximin
4994032|NCT01662778|Monodisperse aerosols|monodisperse aerosols
4994033|NCT01662778|Asthmatics|asthmatics
4994034|NCT01662778|Pharmacokinetics|pharmacokinetics
4994035|NCT01662778|AMP Challenge|amp challenge
4994036|NCT01662778|Multiple Breath Nitrogen Washout|multiple breath nitrogen washout
4994037|NCT01662765|Umbilical pilonidal sinus|umbilical pilonidal sinus
4994038|NCT01662765|Treatment|treatment
4994039|NCT01662765|Surgery|surgery
4994040|NCT01662765|Conservative|conservative
4994041|NCT01662765|Investigational treatment|investigational treatment
4994042|NCT01662765|After care|after care
4994043|NCT01662752|Early colonic cancer|early colonic cancer
4994044|NCT01662752|Sentinel lymph node mapping|sentinel lymph node mapping
4994045|NCT01662752|Sentinel lymph node biopsy|sentinel lymph node biopsy
4994046|NCT01662752|Near infrared imaging|near infrared imaging
4994047|NCT01662752|Indocyanine green|indocyanine green
4994048|NCT01662752|Laparoscopic|laparoscopic
4994049|NCT01662739|Population-Based Cancer Registry|population-based cancer registry
4994050|NCT01662739|Stomach|stomach
4994051|NCT01662739|Epidemiology|epidemiology
4994052|NCT01662739|Risk Factor|risk factor
4994053|NCT01662739|Biomolecular Features|biomolecular features
4994054|NCT01662713|skin cancer|skin cancer
4994055|NCT01662713|optical imaging|optical imaging
4994056|NCT01662713|optical coherence tomography|optical coherence tomography
4994057|NCT01662713|optical frequency domain imaging|optical frequency domain imaging
4994058|NCT01662700|P. vivax infection|p. vivax infection
4994059|NCT01662700|Artesunate|artesunate
4994060|NCT01662700|Chloroquine|chloroquine
4994061|NCT01662700|Primaquine|primaquine
4994062|NCT01662661|Healthy participants|healthy participants
4994063|NCT01662661|Hepatitis C|hepatitis c
4994064|NCT01662661|Relative bioavailability|relative bioavailability
4994065|NCT01662661|Bioavailability|bioavailability
4994066|NCT01662661|Pharmacokinetics|pharmacokinetics
4994067|NCT01662661|JNJ-47910382|jnj-47910382
4994068|NCT01662648|Schizophrenia|schizophrenia
4994069|NCT01662648|Paliperidone|paliperidone
4994070|NCT01662648|Paliperidone extended-release (ER)|paliperidone extended-release (er)
4994071|NCT01662635|Non-small cell lung cancer.|non-small cell lung cancer.
4994072|NCT01662635|Diagnosis,|diagnosis,
4994073|NCT01662635|Adenocarcinoma,|adenocarcinoma,
4994074|NCT01662635|ALK,|alk,
4994075|NCT01662635|FISH,|fish,
4994076|NCT01662635|IHC|ihc
4994077|NCT01662635|RT-qPCR|rt-qpcr
4994078|NCT01662622|anaesthesia|anaesthesia
4994079|NCT01662622|middle aged|middle aged
4994080|NCT01662622|minimal alveolar concentration|minimal alveolar concentration
4994081|NCT01662622|sevoflurane|sevoflurane
4994082|NCT01662622|isoelectric EEG|isoelectric eeg
4994083|NCT01662609|pancreas|pancreas
4994084|NCT01662609|high-risk|high-risk
4994085|NCT01662596|Risk factors,|risk factors,
4994086|NCT01662596|prenatal diagnosis,|prenatal diagnosis,
4994087|NCT01662596|fetal malformations|fetal malformations
4994088|NCT01662583|Influenza|influenza
4994089|NCT01662583|text message|text message
4994090|NCT01662583|vaccination|vaccination
4994091|NCT01662570|Pediatric Obesity|pediatric obesity
4994092|NCT01662570|Child Overweight|child overweight
4994093|NCT01662557|Pediatric Obesity|pediatric obesity
4994094|NCT01662544|Infants|infants
4994095|NCT01662544|Bronchiolitis|bronchiolitis
4994096|NCT01662544|Hypoxia|hypoxia
4994097|NCT01662544|Emergency Department|emergency department
4994098|NCT01662544|Length of Stay|length of stay
4994099|NCT01662544|Pediatrics|pediatrics
4994100|NCT01662466|testosterone|testosterone
4994101|NCT01662466|DHEA|dhea
4994102|NCT01662466|IVF|ivf
4994103|NCT01662466|egg quality|egg quality
4994104|NCT01662466|pregnancy rates|pregnancy rates
4994105|NCT01662453|epilepsy|epilepsy
4994106|NCT01662453|seizures|seizures
4994107|NCT01662453|mortality|mortality
4994108|NCT01662453|sudep|sudep
4994109|NCT01662453|risk factors|risk factors
4994110|NCT01662440|Rabies|rabies
4994111|NCT01662440|JE|je
4994112|NCT01662440|accelerated schedule|accelerated schedule
4994113|NCT01662427|Quality of life|quality of life
4994114|NCT01662427|Noctural Parkinson's Disease Symptoms|noctural parkinson's disease symptoms
4994115|NCT01662401|children|children
4994116|NCT01662401|laparoscopic appendectomy|laparoscopic appendectomy
4994117|NCT01662401|iliohypogastric nerve block|iliohypogastric nerve block
4994118|NCT01662401|rectus sheath nerve block|rectus sheath nerve block
4994119|NCT01662401|ilioinguinal nerve block|ilioinguinal nerve block
4994120|NCT01662388|proximal caries, composite restoration, proximal contact|proximal caries, composite restoration, proximal contact
4994121|NCT01662362|Chagas Disease|chagas disease
4994122|NCT01662362|Trypanosoma cruzi|trypanosoma cruzi
4994123|NCT01662362|American trypanosomiasis|american trypanosomiasis
4994124|NCT01662362|South American trypanosomiasis|south american trypanosomiasis
4994125|NCT01662362|kissing bugs|kissing bugs
4994126|NCT01662362|reduviid bugs|reduviid bugs
4994127|NCT01662336|Human Immunodeficiency Virus infection|human immunodeficiency virus infection
4994128|NCT01662323|Heart failure, general practitioner, medical therapy, quality of live|heart failure, general practitioner, medical therapy, quality of live
4994129|NCT01662310|Schizophrenia|schizophrenia
4994130|NCT01662310|Paliperidone|paliperidone
4994131|NCT01662310|Paliperidone Extended-Release|paliperidone extended-release
4994132|NCT01662297|Quetiapine|quetiapine
4994133|NCT01662297|Trazodone|trazodone
4994134|NCT01662297|Insomnia|insomnia
4994135|NCT01662297|Dual Diagnosis|dual diagnosis
4994136|NCT01662271|obesity|obesity
4994137|NCT01662271|adiposity|adiposity
4994138|NCT01662271|psychosocial|psychosocial
4994139|NCT01662271|healthcare|healthcare
4994140|NCT01662271|co-morbidities|co-morbidities
4994141|NCT01662271|youth with extreme obesity|youth with extreme obesity
4994142|NCT01662271|weight loss|weight loss
4994143|NCT01662258|Community-acquired pneumonia|community-acquired pneumonia
4994144|NCT01662258|Targeted strategy|targeted strategy
4994145|NCT01662258|Empiric therapy|empiric therapy
4994146|NCT01662232|Green tea|green tea
4994147|NCT01662232|EGCG|egcg
4994148|NCT01662232|Cardiovascular diseases|cardiovascular diseases
4994149|NCT01662232|Endothelial function|endothelial function
4994150|NCT01662232|Flow-mediated dilation|flow-mediated dilation
4994151|NCT01662219|superficial cervical plexus block|superficial cervical plexus block
4994152|NCT01662219|quality of recovery|quality of recovery
4994153|NCT01662206|adults|adults
4994154|NCT01662206|probiotics|probiotics
4994155|NCT01662206|immune function|immune function
4994156|NCT01662206|microbiota|microbiota
4994157|NCT01662206|digestive health|digestive health
4994158|NCT01662193|Cholecalciferol|cholecalciferol
4994159|NCT01662193|Calciol|calciol
4994160|NCT01662193|vitamin D3|vitamin d3
4994161|NCT01662193|Diabetes Mellitus|diabetes mellitus
4994162|NCT01662193|Diabetes Mellitus Type 2|diabetes mellitus type 2
4994163|NCT01662193|glucose metabolism disorders|glucose metabolism disorders
4994164|NCT01662193|ergocalciferol|ergocalciferol
4994165|NCT01662193|calcium|calcium
4994166|NCT01662193|adipicytokines|adipicytokines
4994167|NCT01662193|inflammatory biomarkers|inflammatory biomarkers
4994168|NCT01662180|subfertility, IUI, rec FSH, FSH, E2, AMH|subfertility, iui, rec fsh, fsh, e2, amh
4994169|NCT01662141|Cardiac output|cardiac output
4994170|NCT01662141|Perivascular Probe|perivascular probe
4994171|NCT01662128|Breast Cancer|breast cancer
4994172|NCT01662115|ILEUS|ileus
4994173|NCT01662089|Female pattern hair loss|female pattern hair loss
4994174|NCT01662076|Cancer|cancer
4994175|NCT01662076|Fatigue|fatigue
4994176|NCT01662076|Chemotherapy|chemotherapy
4994177|NCT01662076|Pediatrics|pediatrics
4994178|NCT01662076|Homeopathy|homeopathy
4994179|NCT01662050|MCL|mcl
4994180|NCT01662050|Mantle Cell Lymphoma|mantle cell lymphoma
4994181|NCT01662050|Older|older
4994182|NCT01662037|Pulmonary vascular resistance|pulmonary vascular resistance
4994183|NCT01662037|Heart defects, Congenital|heart defects, congenital
4994184|NCT01662037|Receptors, endothelin|receptors, endothelin
4994185|NCT01662037|Bosentan|bosentan
4994186|NCT01662024|Obesity|obesity
4994187|NCT01662024|BMI|bmi
4994188|NCT01662024|Weight loss|weight loss
4994189|NCT01662024|Gastric restriction|gastric restriction
4994190|NCT01662024|Bariatrics|bariatrics
4994191|NCT01662011|patient-ventilator interaction|patient-ventilator interaction
4994192|NCT01662011|neurally adjusted ventilatory assist|neurally adjusted ventilatory assist
4994193|NCT01662011|diaphragm electrical activity|diaphragm electrical activity
4994194|NCT01662011|pressure support ventilation|pressure support ventilation
4994195|NCT01661998|Adolescent Idiopathic Scoliosis|adolescent idiopathic scoliosis
4994196|NCT01661998|Spinal Deformity|spinal deformity
4994197|NCT01661998|Treatment Outcomes|treatment outcomes
4994198|NCT01661985|Mycoplasma genitalium|mycoplasma genitalium
4994199|NCT01661985|Chlamydia trachomatis|chlamydia trachomatis
4994200|NCT01661985|Treatment|treatment
4994201|NCT01661985|Antibiotic resistance|antibiotic resistance
4994202|NCT01661972|colorectal cancer|colorectal cancer
4994203|NCT01661972|all solid tumors|all solid tumors
4994204|NCT01661972|metastatic|metastatic
4994205|NCT01661972|refractory|refractory
4994206|NCT01661972|advanced solid tumors|advanced solid tumors
4994207|NCT01661959|Scoliosis|scoliosis
4994208|NCT01661959|Multi-center Database Registry|multi-center database registry
4994209|NCT01661959|Spinal Deformity|spinal deformity
4994210|NCT01661959|Adolescent Idiopathic Scoliosis|adolescent idiopathic scoliosis
4994211|NCT01661946|vascular endothelial growth factor|vascular endothelial growth factor
4994212|NCT01661946|macular edema|macular edema
4994213|NCT01661946|diabetic retinopathy|diabetic retinopathy
4994214|NCT01661933|celiac disease|celiac disease
4994215|NCT01661933|hookworm|hookworm
4994216|NCT01661933|probiotic|probiotic
4994217|NCT01661920|Community Acquired Pneumonia.|community acquired pneumonia.
4994218|NCT01661920|Treatment duration|treatment duration
4994219|NCT01661907|Elderly|elderly
4994220|NCT01661907|Anesthesia and postoperative analgesia|anesthesia and postoperative analgesia
4994221|NCT01661907|Postoperative period|postoperative period
4994222|NCT01661907|Delirium|delirium
4994223|NCT01661907|Postoperative complications|postoperative complications
4994224|NCT01661881|Newly diagnosed|newly diagnosed
4994225|NCT01661868|BRCA1 mutation|brca1 mutation
4994226|NCT01661868|BRCA2 mutation|brca2 mutation
4994227|NCT01661855|Autism Spectrum Disorders|autism spectrum disorders
4994228|NCT01661842|Autoimmune Hepatitis|autoimmune hepatitis
4994229|NCT01661842|Mesenchymal stem cells|mesenchymal stem cells
4994230|NCT01661842|serum albumin|serum albumin
4994231|NCT01661842|serum Tbil|serum tbil
4994232|NCT01661842|serum immunoglobulin G(IgG)|serum immunoglobulin g(igg)
4994233|NCT01661816|breast cancer|breast cancer
4994234|NCT01661816|everyday issues|everyday issues
4994235|NCT01661816|couple|couple
4994236|NCT01661803|bupivacaine|bupivacaine
4994237|NCT01661803|clonidine|clonidine
4994238|NCT01661803|pediatric spinal|pediatric spinal
4994239|NCT01661803|efficacy|efficacy
4994240|NCT01661803|duration|duration
4994241|NCT01661803|quality|quality
4994242|NCT01661803|side effects|side effects
4994243|NCT01661803|intrathecal bupivacaine alone|intrathecal bupivacaine alone
4994244|NCT01661803|bupivacaine plus clonidine|bupivacaine plus clonidine
4994245|NCT01661790|Bevacizumab;|bevacizumab;
4994246|NCT01661790|non-small cell lung cancer;|non-small cell lung cancer;
4994247|NCT01661790|malignant pleural effusion;|malignant pleural effusion;
4994248|NCT01661790|intrapleural administration|intrapleural administration
4994249|NCT01661777|Eustachian tube dysfunction|eustachian tube dysfunction
4994250|NCT01661777|Endolymphatic hydrops|endolymphatic hydrops
4994251|NCT01661777|Diuretic|diuretic
4994252|NCT01661777|Low salt diet|low salt diet
4994253|NCT01661777|Myringotomy|myringotomy
4994254|NCT01661777|Pressure equalization tube|pressure equalization tube
4994255|NCT01661777|Ear tube|ear tube
4994256|NCT01661777|Ear fullness|ear fullness
4994257|NCT01661777|Ear pressure|ear pressure
4994258|NCT01661777|Allergy|allergy
4994259|NCT01661777|Nasal steroid|nasal steroid
4994260|NCT01661777|Antihistamine|antihistamine
4994261|NCT01661764|Colorectal Neoplasm|colorectal neoplasm
4994262|NCT01661751|Group ACYW135 Meninigococcal Polysaccharide Vaccine|group acyw135 meninigococcal polysaccharide vaccine
4994263|NCT01661738|Group ACYW135 Meninigococcal Polysaccharide Vaccine|group acyw135 meninigococcal polysaccharide vaccine
4994264|NCT01661725|Group ACYW135 Meningococcal Polysaccharide Vaccine|group acyw135 meningococcal polysaccharide vaccine
4994265|NCT01661712|obstructive sleep apnoea,|obstructive sleep apnoea,
4994266|NCT01661712|continuous transcutaneous electrical stimulation|continuous transcutaneous electrical stimulation
4994267|NCT01661699|Obstructive Sleep Apnea|obstructive sleep apnea
4994268|NCT01661686|esophageal cancer|esophageal cancer
4994269|NCT01661686|esophageal stenosis|esophageal stenosis
4994270|NCT01661686|stent|stent
4994271|NCT01661686|endoscopy|endoscopy
4994272|NCT01661634|Acute decompensated heart failure|acute decompensated heart failure
4994273|NCT01661621|Lower urinary tract symptoms (LUTS)|lower urinary tract symptoms (luts)
4994274|NCT01661621|International Prostate Symptom Score (IPSS)|international prostate symptom score (ipss)
4994275|NCT01661621|Antimuscarinics|antimuscarinics
4994276|NCT01661621|α-blockers|α-blockers
4994277|NCT01661608|Gastric Restriction|gastric restriction
4994278|NCT01661595|Fatigue|fatigue
4994279|NCT01661595|Fatigability|fatigability
4994280|NCT01661595|Surface Electromyography (sEMG)|surface electromyography (semg)
4994281|NCT01661595|cyclic guanosine monophosphate (cGMP)|cyclic guanosine monophosphate (cgmp)
4994282|NCT01661595|Nitric Oxide (NO)|nitric oxide (no)
4994283|NCT01661595|NO-cGMP|no-cgmp
4994284|NCT01661595|Phosphodiesterase (PDE)|phosphodiesterase (pde)
4994285|NCT01661595|Sildenafil|sildenafil
4994286|NCT01661595|Tadalafil|tadalafil
4994287|NCT01661595|Isotope|isotope
4994288|NCT01661595|Infusion|infusion
4994289|NCT01661595|Anabolism|anabolism
4994290|NCT01661595|Upregulation|upregulation
4994291|NCT01661595|Accelerometer|accelerometer
4994292|NCT01661595|Placebo|placebo
4994293|NCT01661595|Nitrosylation|nitrosylation
4994294|NCT01661582|Air Pollution|air pollution
4994295|NCT01661582|Myocardial Ischaemia|myocardial ischaemia
4994296|NCT01661582|Coronary Blood Flow|coronary blood flow
4994297|NCT01661582|Diesel Exhaust|diesel exhaust
4994298|NCT01661582|Troponin|troponin
4994299|NCT01661582|Electrocardiography|electrocardiography
4994300|NCT01661569|Mindfulness|mindfulness
4994301|NCT01661569|meditation|meditation
4994302|NCT01661569|stress|stress
4994303|NCT01661569|well-being|well-being
4994304|NCT01661569|work stress|work stress
4994305|NCT01661569|blood pressure|blood pressure
4994306|NCT01661569|cortisol|cortisol
4994307|NCT01661556|Melasma, miconazole, hydroquinone|melasma, miconazole, hydroquinone
4994308|NCT01661530|asthma|asthma
4994309|NCT01661530|pregnancy|pregnancy
4994310|NCT01661530|diet|diet
4994311|NCT01661530|vitamin E|vitamin e
4994312|NCT01661517|substance use treatment|substance use treatment
4994313|NCT01661439|Recurrent miscarriages|recurrent miscarriages
4994314|NCT01661439|recurrent pregnancy loss|recurrent pregnancy loss
4994315|NCT01661439|aps|aps
4994316|NCT01661439|anti coagulants in pregnancy|anti coagulants in pregnancy
4994317|NCT01661426|Adults|adults
4994318|NCT01661426|Weight loss|weight loss
4994319|NCT01661426|Diet|diet
4994320|NCT01661426|Insulin Resistance|insulin resistance
4994321|NCT01661426|Fatty acid composition|fatty acid composition
4994322|NCT01661413|Acute Leukemia|acute leukemia
4994323|NCT01661413|Pediatrics|pediatrics
4994324|NCT01661413|Intrathecal methotrexate|intrathecal methotrexate
4994325|NCT01661413|Chemotherapy|chemotherapy
4994326|NCT01661413|Nausea|nausea
4994327|NCT01661413|Vomiting|vomiting
4994328|NCT01661400|Glioma includes ependymoma and medulloblastoma|glioma includes ependymoma and medulloblastoma
4994329|NCT01661387|Adrenal insufficiency|adrenal insufficiency
4994330|NCT01661387|DuoCort|duocort
4994331|NCT01661387|Congenital adrenal hyperplasia (CAH)|congenital adrenal hyperplasia (cah)
4994332|NCT01661387|Modified release|modified release
4994333|NCT01661387|Hydrocortisone|hydrocortisone
4994334|NCT01661361|vancomycin|vancomycin
4994335|NCT01661361|levels|levels
4994336|NCT01661361|central venous port device|central venous port device
4994337|NCT01661361|peripherally obtained levels|peripherally obtained levels
4994338|NCT01661361|dose adjustments|dose adjustments
4994339|NCT01661361|TDM|tdm
4994340|NCT01661348|Cesarian section|cesarian section
4994341|NCT01661348|Pregnancy|pregnancy
4994342|NCT01661348|Incision management|incision management
4994343|NCT01661335|Nausea|nausea
4994344|NCT01661335|Vomiting|vomiting
4994345|NCT01661335|Children|children
4994346|NCT01661335|Aprepitant|aprepitant
4994347|NCT01661335|Emend®|emend®
4994348|NCT01661322|Acute ischaemic stroke|acute ischaemic stroke
4994349|NCT01661322|TIA|tia
4994350|NCT01661309|Hyperhomocysteinemia|hyperhomocysteinemia
4994351|NCT01661309|Methylcobalamin|methylcobalamin
4994352|NCT01661309|Cardiovascular disease|cardiovascular disease
4994353|NCT01661309|Plasma total homocysteine|plasma total homocysteine
4994354|NCT01661309|Vegetarians|vegetarians
4994355|NCT01661296|cutaneous leishmaniasis, heat therapy, antimony|cutaneous leishmaniasis, heat therapy, antimony
4994356|NCT01661283|MPNST|mpnst
4994357|NCT01661283|malignant peripheral nerve sheath tumors|malignant peripheral nerve sheath tumors
4994358|NCT01661283|RAD001|rad001
4994359|NCT01661283|Everolimus|everolimus
4994360|NCT01661283|Bevacizumab|bevacizumab
4994361|NCT01661283|Sarcoma|sarcoma
4994362|NCT01661283|Avastin|avastin
4994363|NCT01661283|mTOR inhibitor|mtor inhibitor
4994364|NCT01661257|Crohn's disease|crohn's disease
4994365|NCT01661257|Infliximab|infliximab
4994366|NCT01661257|T-cell immunoglobulin- and mucin-domain-containing molecule 3 (TIM-3)|t-cell immunoglobulin- and mucin-domain-containing molecule 3 (tim-3)
4994367|NCT01661231|Vascular intervention|vascular intervention
4994368|NCT01661231|Endovascular|endovascular
4994369|NCT01661231|Peripheral stent|peripheral stent
4994370|NCT01661218|catheters|catheters
4994371|NCT01661218|Central Venous|central venous
4994372|NCT01661218|complications|complications
4994373|NCT01661218|cancer|cancer
4994374|NCT01661205|Persistent AF|persistent af
4994375|NCT01661205|Longstanding Persistent AF|longstanding persistent af
4994376|NCT01661205|Ablation|ablation
4994377|NCT01661205|catheter ablation|catheter ablation
4994378|NCT01661192|Type 1 Diabetes|type 1 diabetes
4994379|NCT01661192|newly diagnosed|newly diagnosed
4994380|NCT01661192|Beta cell preservation|beta cell preservation
4994381|NCT01661179|Medullary Thyroid Carcinoma|medullary thyroid carcinoma
4994382|NCT01661179|Medullary Thyroid Cancer|medullary thyroid cancer
4994383|NCT01661179|Vandetanib|vandetanib
4994384|NCT01661166|Male adult subjects|male adult subjects
4994385|NCT01661166|aged 30-90 years|aged 30-90 years
4994386|NCT01661166|RARP|rarp
4994387|NCT01661166|AUA symptom score greater than 7 will be included|aua symptom score greater than 7 will be included
4994388|NCT01661114|Gemcitabine, Infusional 5-Fluorouracil,Cisplatin|gemcitabine, infusional 5-fluorouracil,cisplatin
4994389|NCT01661114|Advanced Pancreatic and Biliary Cancers|advanced pancreatic and biliary cancers
4994390|NCT01661114|untreated & previously treated pancreatic & biliary cancer.|untreated & previously treated pancreatic & biliary cancer.
4994391|NCT01661101|Perioperative myocardial infarction|perioperative myocardial infarction
4994392|NCT01661101|Myocardial injury|myocardial injury
4994393|NCT01661101|noncardiac surgery|noncardiac surgery
4994394|NCT01661088|Neoadjuvant FOLFIRINOX|neoadjuvant folfirinox
4994395|NCT01661088|FDR-Gemcitabine|fdr-gemcitabine
4994396|NCT01661088|Concurrent|concurrent
4994397|NCT01661088|IMRT|imrt
4994398|NCT01661088|Borderline Resectable Pancreatic Cancer|borderline resectable pancreatic cancer
4994399|NCT01661075|mTBI|mtbi
4994400|NCT01661075|concussion|concussion
4994401|NCT01661075|mild traumatic brain injury|mild traumatic brain injury
4994402|NCT01661075|athlete|athlete
4994403|NCT01661075|college|college
4994404|NCT01661075|football|football
4994405|NCT01661075|soccer|soccer
4994406|NCT01661036|Cognitive Testing|cognitive testing
4994407|NCT01661036|Survey|survey
4994408|NCT01661036|Interview|interview
4994409|NCT01661023|Breast Cancer|breast cancer
4994410|NCT01661023|Epidemiology|epidemiology
4994411|NCT01661010|Infertility|infertility
4994412|NCT01661010|Male Factor Infertility|male factor infertility
4994413|NCT01661010|Female Factor Infertility|female factor infertility
4994414|NCT01661010|Unexplained Infertility|unexplained infertility
4994415|NCT01661010|Sex Chromosome|sex chromosome
4994416|NCT01661010|Klinefelter Syndrome|klinefelter syndrome
4994417|NCT01661010|Turner's Syndrome|turner's syndrome
4994418|NCT01661010|XXY|xxy
4994419|NCT01661010|Y Chromosome Deletion|y chromosome deletion
4994420|NCT01661010|Aneuploidy|aneuploidy
4994421|NCT01660997|Proteasome Inhibitor|proteasome inhibitor
4994422|NCT01660997|Induction Combination Therapy|induction combination therapy
4994423|NCT01660997|Maintenance Strategy|maintenance strategy
4994424|NCT01660997|Potent Anti-Myeloma Effect|potent anti-myeloma effect
4994425|NCT01660997|Precursor Disease|precursor disease
4994426|NCT01660984|Thyroid Tumor|thyroid tumor
4994427|NCT01660984|Multiple Endocrine Neoplasia 2|multiple endocrine neoplasia 2
4994428|NCT01660984|Pheochromocytoma|pheochromocytoma
4994429|NCT01660984|RET Mutations|ret mutations
4994430|NCT01660958|Micronutrient Deficiencies|micronutrient deficiencies
4994431|NCT01660958|Early Child Development|early child development
4994432|NCT01660958|Infant Growth|infant growth
4994433|NCT01660958|Iron Deficiency|iron deficiency
4994434|NCT01660945|statins, insulin resistance|statins, insulin resistance
4994435|NCT01660932|insulin resistance|insulin resistance
4994436|NCT01660919|insulin resistance|insulin resistance
4994437|NCT01660893|operative|operative
4994438|NCT01660893|dental procedure|dental procedure
4994439|NCT01660867|hospital admission within 7 days of 3% NaCl nebulizer vs dexamethasone|hospital admission within 7 days of 3% nacl nebulizer vs dexamethasone
4994440|NCT01660854|Plasmodium|plasmodium
4994441|NCT01660854|falciparum|falciparum
4994442|NCT01660854|malaria|malaria
4994443|NCT01660854|heterologous|heterologous
4994444|NCT01660854|immunity|immunity
4994445|NCT01660841|Magnetic resonance imaging|magnetic resonance imaging
4994446|NCT01660841|central nervous system|central nervous system
4994447|NCT01660841|contrast media|contrast media
4994448|NCT01660841|gadobutrol|gadobutrol
4994449|NCT01660828|Exercise induced (high sensitive) troponin release|exercise induced (high sensitive) troponin release
4994450|NCT01660828|Ischemia reperfusion injury|ischemia reperfusion injury
4994451|NCT01660828|Remote ischemic preconditioning|remote ischemic preconditioning
4994452|NCT01660789|Obesity|obesity
4994453|NCT01660789|Diabetes|diabetes
4994454|NCT01660789|Physical activity|physical activity
4994455|NCT01660776|diffuse large B-cell lymphoma (DLBCL)|diffuse large b-cell lymphoma (dlbcl)
4994456|NCT01660776|Hodgkin lymphoma|hodgkin lymphoma
4994457|NCT01660776|metastatic breast cancer.|metastatic breast cancer.
4994458|NCT01660776|non-small cell lung cancer|non-small cell lung cancer
4994459|NCT01660750|newly diagnosed multiple myeloma|newly diagnosed multiple myeloma
4994460|NCT01660750|transplant eligible multiple myeloma|transplant eligible multiple myeloma
4994461|NCT01660737|Hay fever|hay fever
4994462|NCT01660737|Pascallerg|pascallerg
4994463|NCT01660711|neoadjuvant|neoadjuvant
4994464|NCT01660711|chemotherapy|chemotherapy
4994465|NCT01660711|resectable|resectable
4994466|NCT01660711|adjuvant|adjuvant
4994467|NCT01660711|pancreas|pancreas
4994468|NCT01660711|cancer|cancer
4994469|NCT01660711|adenocarcinoma|adenocarcinoma
4994470|NCT01660711|surgery|surgery
4994471|NCT01660685|Weight loss|weight loss
4994472|NCT01660685|Web-based|web-based
4994473|NCT01660685|Journaling|journaling
4994474|NCT01660685|Body Mass Index between 27 and 45|body mass index between 27 and 45
4994475|NCT01660659|Indoor air pollution|indoor air pollution
4994476|NCT01660659|pneumococcal carriage|pneumococcal carriage
4994477|NCT01660646|Tuberculosis case finding|tuberculosis case finding
4994478|NCT01660633|Multiple Myeloma|multiple myeloma
4994479|NCT01660633|High-Dose Melphalan|high-dose melphalan
4994480|NCT01660633|Propylene Glycol-Free|propylene glycol-free
4994481|NCT01660633|Autologous Stem Cell Transplantation|autologous stem cell transplantation
4994482|NCT01660633|Captisol|captisol
4994575|NCT01660178|early stimulation|early stimulation
4994483|NCT01660620|betaxolol/ retinopathy of prematurity|betaxolol/ retinopathy of prematurity
4994484|NCT01660594|coronary disease|coronary disease
4994485|NCT01660594|tomography, x-ray computed|tomography, x-ray computed
4994486|NCT01660594|calcium|calcium
4994487|NCT01660594|exercise test|exercise test
4994488|NCT01660581|CD133+|cd133+
4994489|NCT01660581|stem cells|stem cells
4994490|NCT01660581|Coronary Artery Disease|coronary artery disease
4994491|NCT01660581|Stable Angina Pectoris|stable angina pectoris
4994492|NCT01660555|Microbiota|microbiota
4994493|NCT01660555|HITChip|hitchip
4994494|NCT01660555|biopsies|biopsies
4994495|NCT01660555|colon|colon
4994496|NCT01660555|protected biopsies|protected biopsies
4994497|NCT01660529|Subjects with metastatic breast cancer who have failed at least one standard|subjects with metastatic breast cancer who have failed at least one standard
4994498|NCT01660529|of care regimen|of care regimen
4994499|NCT01660516|Camellia sinensis|camellia sinensis
4994500|NCT01660516|flavonoids|flavonoids
4994501|NCT01660516|cardiovascular risk|cardiovascular risk
4994502|NCT01660516|flow mediated dilation|flow mediated dilation
4994503|NCT01660503|Calcium absorption|calcium absorption
4994504|NCT01660503|Osteoporosis|osteoporosis
4994505|NCT01660503|Bone Health|bone health
4994506|NCT01660503|Adolescent|adolescent
4994507|NCT01660490|Radiographic Image Enhancement,|radiographic image enhancement,
4994508|NCT01660490|Intraoperative Care|intraoperative care
4994509|NCT01660490|Femoral Fractures|femoral fractures
4994510|NCT01660490|Femoral Neck Fractures|femoral neck fractures
4994511|NCT01660490|Hip Fractures, Internal Fixators|hip fractures, internal fixators
4994512|NCT01660490|Fracture Fixation Internal|fracture fixation internal
4994513|NCT01660490|Fracture Fixation Intramedullary|fracture fixation intramedullary
4994514|NCT01660490|Fractures Bone|fractures bone
4994515|NCT01660477|Isavuconazole|isavuconazole
4994516|NCT01660477|Lopinavir/ritonavir|lopinavir/ritonavir
4994517|NCT01660477|Healthy Volunteers|healthy volunteers
4994518|NCT01660477|BAL8557|bal8557
4994519|NCT01660477|Kaletra ®|kaletra ®
4994520|NCT01660464|Program evaluation|program evaluation
4994521|NCT01660464|ADHD|adhd
4994522|NCT01660451|Clinical trial, phase II|clinical trial, phase ii
4994523|NCT01660451|Phosphatidylinositol 3-Kinase|phosphatidylinositol 3-kinase
4994524|NCT01660451|Class I, Non-Hodgkin's lymphoma|class i, non-hodgkin's lymphoma
4994525|NCT01660438|Stress urinary incontinence|stress urinary incontinence
4994526|NCT01660438|Suburethral sling|suburethral sling
4994527|NCT01660425|Attention deficit-/hyperactivity disorder|attention deficit-/hyperactivity disorder
4994528|NCT01660425|parenting enhancement training|parenting enhancement training
4994529|NCT01660425|guided self-help|guided self-help
4994530|NCT01660425|methylphenidate|methylphenidate
4994531|NCT01660412|Pain|pain
4994532|NCT01660412|Alkalinization|alkalinization
4994533|NCT01660412|Technetium 99m Sulfur Colloid|technetium 99m sulfur colloid
4994656|NCT01659723|Hyperbaric Oxygen|hyperbaric oxygen
4994534|NCT01660412|sentinel lymphoscintigraphy?|sentinel lymphoscintigraphy?
4994535|NCT01660399|salvage chemotherapy|salvage chemotherapy
4994536|NCT01660399|advanced squamous cell lung cancer|advanced squamous cell lung cancer
4994537|NCT01660399|Boanmycin|boanmycin
4994538|NCT01660386|Type 2 Diabetes|type 2 diabetes
4994539|NCT01660386|Dpp-4 inhibitor|dpp-4 inhibitor
4994540|NCT01660386|Sulfonylurea|sulfonylurea
4994541|NCT01660386|beta cell function|beta cell function
4994542|NCT01660373|ticagrelor|ticagrelor
4994543|NCT01660373|tirofiban|tirofiban
4994544|NCT01660373|glycoprotein IIa/IIIa inhibitors|glycoprotein iia/iiia inhibitors
4994545|NCT01660373|P2Y12 blockers|p2y12 blockers
4994546|NCT01660373|acute coronary syndrome|acute coronary syndrome
4994547|NCT01660360|Tanibirumab Phase I trial|tanibirumab phase i trial
4994548|NCT01660334|Systemic Mycosis|systemic mycosis
4994549|NCT01660334|Scedosporium infection|scedosporium infection
4994550|NCT01660334|Scedosporisis|scedosporisis
4994551|NCT01660334|Japanese|japanese
4994552|NCT01660334|voriconazole|voriconazole
4994553|NCT01660334|VFEND|vfend
4994554|NCT01660334|Regulatory Post Marketing Commitment Plan.|regulatory post marketing commitment plan.
4994555|NCT01660321|Pediculosis capitis|pediculosis capitis
4994556|NCT01660321|Head Lice|head lice
4994557|NCT01660295|Severe renal insufficiency certoparin|severe renal insufficiency certoparin
4994558|NCT01660295|Severe renal insufficiency|severe renal insufficiency
4994559|NCT01660243|Pruritus|pruritus
4994560|NCT01660243|Renal dialysis|renal dialysis
4994561|NCT01660243|Receptors, Opioid, kappa|receptors, opioid, kappa
4994562|NCT01660243|Sleep Disorders|sleep disorders
4994563|NCT01660243|Quality of Life|quality of life
4994564|NCT01660230|APC, 3K3A, 3K3A-APC, volunteer, healthy|apc, 3k3a, 3k3a-apc, volunteer, healthy
4994565|NCT01660217|atopic dermatitis|atopic dermatitis
4994566|NCT01660217|eczema action plan|eczema action plan
4994567|NCT01660217|patient education|patient education
4994568|NCT01660217|written handout|written handout
4994569|NCT01660217|investigator's global assessment|investigator's global assessment
4994570|NCT01660217|randomized controlled trial|randomized controlled trial
4994571|NCT01660204|pneumonia, anti-bacterial agents, (cost)efficacy|pneumonia, anti-bacterial agents, (cost)efficacy
4994572|NCT01660191|LDL, HDL|ldl, hdl
4994573|NCT01660178|newborns|newborns
4994574|NCT01660178|intensive care unit|intensive care unit
4994576|NCT01660165|Nutritional status|nutritional status
4994577|NCT01660165|Mental Health|mental health
4994578|NCT01660165|Omega-3|omega-3
4994579|NCT01660165|Pregnancy|pregnancy
4994580|NCT01660165|Postpartum depression|postpartum depression
4994581|NCT01660152|male erectile disorder|male erectile disorder
4994582|NCT01660152|prostate cancer|prostate cancer
4994583|NCT01660152|Laparoscopic prostatectomy|laparoscopic prostatectomy
4994584|NCT01660126|Aged|aged
4994585|NCT01660126|Cardiovascular disease|cardiovascular disease
4994586|NCT01660126|Levothyroxine|levothyroxine
4994587|NCT01660126|Randomised controlled trial|randomised controlled trial
4994588|NCT01660126|Quality of life|quality of life
4994589|NCT01660126|Subclinical hypothyroidism|subclinical hypothyroidism
4994590|NCT01660100|Atrial fibrillation ablation|atrial fibrillation ablation
4994591|NCT01660087|Exhaled breath condensate (EBC) method|exhaled breath condensate (ebc) method
4994592|NCT01660087|Volatile Organic Compounds (VOCs)|volatile organic compounds (vocs)
4994593|NCT01660087|Endobronchial Ultrasound (EBUS)|endobronchial ultrasound (ebus)
4994594|NCT01660087|Confocal Endoscopy|confocal endoscopy
4994595|NCT01660087|Exhaled alveolar gas|exhaled alveolar gas
4994596|NCT01660074|glycemic index, resistant starch, glycemic response|glycemic index, resistant starch, glycemic response
4994597|NCT01660061|Antiphospholipid syndrome|antiphospholipid syndrome
4994598|NCT01660061|Antiphospholipid antibodies|antiphospholipid antibodies
4994599|NCT01660061|Vitamin-K antagonists|vitamin-k antagonists
4994600|NCT01660061|International normalized ratio|international normalized ratio
4994601|NCT01660061|Chromogenic factor X|chromogenic factor x
4994602|NCT01660048|Laparoscopic total extraperitoneal Inguinal hernia repair|laparoscopic total extraperitoneal inguinal hernia repair
4994603|NCT01660022|Healthy|healthy
4994604|NCT01660022|Volunteers|volunteers
4994605|NCT01660009|Endothelial Function|endothelial function
4994606|NCT01660009|Hypoglycemia|hypoglycemia
4994607|NCT01660009|Mitochondria|mitochondria
4994608|NCT01659996|Meningitis|meningitis
4994609|NCT01659996|Meningococcal Infection|meningococcal infection
4994610|NCT01659996|Diphtheria|diphtheria
4994611|NCT01659996|Pertussis|pertussis
4994612|NCT01659996|Menactra®|menactra®
4994613|NCT01659996|Pentacel®|pentacel®
4994614|NCT01659983|complicated appendicitis|complicated appendicitis
4994615|NCT01659983|wound closure|wound closure
4994616|NCT01659983|infection|infection
4994617|NCT01659957|Alcoholism|alcoholism
4994618|NCT01659957|Couples|couples
4994619|NCT01659944|Drug-drug interaction|drug-drug interaction
4994620|NCT01659879|Parents|parents
4994621|NCT01659879|Caregivers|caregivers
4994622|NCT01659879|Anxiety|anxiety
4994623|NCT01659879|Consumer satisfaction|consumer satisfaction
4994624|NCT01659866|Infection|infection
4994625|NCT01659866|Antibiotic resistance|antibiotic resistance
4994626|NCT01659866|Prostate biopsy|prostate biopsy
4994627|NCT01659840|laser,|laser,
4994628|NCT01659840|quality of life,|quality of life,
4994629|NCT01659840|orofacial pain|orofacial pain
4994630|NCT01659814|Major Depressive Disorder|major depressive disorder
4994631|NCT01659814|Anhedonia|anhedonia
4994632|NCT01659814|Dopamine|dopamine
4994633|NCT01659814|Electroencephalography (EEG)|electroencephalography (eeg)
4994634|NCT01659814|Positron Emission Tomography (PET)|positron emission tomography (pet)
4994635|NCT01659814|Reward|reward
4994636|NCT01659801|cataract|cataract
4994637|NCT01659801|cataract surgery|cataract surgery
4994638|NCT01659801|intaocular lens|intaocular lens
4994639|NCT01659801|toric lens|toric lens
4994640|NCT01659788|Advanced Reproductive Age|advanced reproductive age
4994641|NCT01659788|poor ovarian response|poor ovarian response
4994642|NCT01659788|Mitochondrial dysfunction|mitochondrial dysfunction
4994643|NCT01659788|Mitochondrial nutrients|mitochondrial nutrients
4994644|NCT01659788|Coenzyme Q10|coenzyme q10
4994645|NCT01659788|Electron transfer chain|electron transfer chain
4994646|NCT01659762|inflammatory bowel disease|inflammatory bowel disease
4994647|NCT01659762|Crohn's disease|crohn's disease
4994648|NCT01659749|Genetics|genetics
4994649|NCT01659749|Metabolic|metabolic
4994650|NCT01659749|Nutrition|nutrition
4994651|NCT01659749|Maternal PKU|maternal pku
4994652|NCT01659749|Phenylketonuria (PKU)|phenylketonuria (pku)
4994653|NCT01659723|Radio therapy|radio therapy
4994654|NCT01659723|STRI|stri
4994655|NCT01659723|Urinary bladder|urinary bladder
4994657|NCT01659697|lifestyle|lifestyle
4994658|NCT01659697|diabetes prevention|diabetes prevention
4994660|NCT01659697|physical activity|physical activity
4994661|NCT01659684|congenital CMV infection|congenital cmv infection
4994662|NCT01659684|standard immunoglobulins|standard immunoglobulins
4994663|NCT01659684|immunoglobulin therapy|immunoglobulin therapy
4994664|NCT01659684|IgG CMV avidity index|igg cmv avidity index
4994665|NCT01659684|Cytomegalovirus|cytomegalovirus
4994666|NCT01659658|MLN9708|mln9708
4994667|NCT01659658|Amyloidosis|amyloidosis
4994668|NCT01659658|Light Chain|light chain
4994669|NCT01659658|IXAZOMIB|ixazomib
4994670|NCT01659658|Tourmaline AL1|tourmaline al1
4994671|NCT01659658|Drug Therapy|drug therapy
4994672|NCT01659606|dyskeratosis congenita|dyskeratosis congenita
4994673|NCT01659606|bone marrow failure|bone marrow failure
4994674|NCT01659606|aplastic anemia|aplastic anemia
4994874|NCT01658488|rice|rice
4994675|NCT01659606|bone marrow transplantation|bone marrow transplantation
4994676|NCT01659606|reduced intensity conditioning|reduced intensity conditioning
4994677|NCT01659606|campath|campath
4994678|NCT01659606|fludarabine|fludarabine
4994679|NCT01659606|telomere|telomere
4994680|NCT01659593|cognitive disorders|cognitive disorders
4994681|NCT01659593|multiple sclerosis|multiple sclerosis
4994682|NCT01659593|neuropsychology|neuropsychology
4994683|NCT01659580|Angina Pectoris Treatment Prevention|angina pectoris treatment prevention
4994684|NCT01659554|Primary peritoneal|primary peritoneal
4994685|NCT01659541|spinal cord injury|spinal cord injury
4994686|NCT01659541|paralysis|paralysis
4994687|NCT01659541|cough|cough
4994688|NCT01659541|cervical spinal cord injury|cervical spinal cord injury
4994689|NCT01659541|thoracic spinal cord injury|thoracic spinal cord injury
4994690|NCT01659528|Penis|penis
4994691|NCT01659528|Micropenis|micropenis
4994692|NCT01659528|Nomograms|nomograms
4994693|NCT01659528|Ultrasound|ultrasound
4994694|NCT01659528|Fetus|fetus
4994695|NCT01659502|Patients|patients
4994696|NCT01659489|adnexal torsion|adnexal torsion
4994697|NCT01659489|laparoscopy|laparoscopy
4994698|NCT01659476|methacholine|methacholine
4994699|NCT01659476|deep inspiration|deep inspiration
4994700|NCT01659476|bronchoprotective effect|bronchoprotective effect
4994701|NCT01659476|bronchodilating effect|bronchodilating effect
4994702|NCT01659463|CARIES INFILTRATION|caries infiltration
4994703|NCT01659463|CARIES LESION|caries lesion
4994704|NCT01659463|INFILTRANT|infiltrant
4994705|NCT01659450|overweight|overweight
4994706|NCT01659450|obesity|obesity
4994707|NCT01659450|low energy dense|low energy dense
4994708|NCT01659437|M. ulcerans|m. ulcerans
4994709|NCT01659437|Buruli ulcer|buruli ulcer
4994710|NCT01659437|drug trial|drug trial
4994711|NCT01659437|clarithromycin|clarithromycin
4994712|NCT01659424|Rectal cancer|rectal cancer
4994713|NCT01659411|Congenital Heart Disease|congenital heart disease
4994714|NCT01659411|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
4994715|NCT01659398|Alzheimer's Disease|alzheimer's disease
4994716|NCT01659398|cerebral blood flow|cerebral blood flow
4994717|NCT01659398|ophthalmic blood flow|ophthalmic blood flow
4994718|NCT01659398|blood viscosity|blood viscosity
4994719|NCT01659372|temporomandibular disorder|temporomandibular disorder
4994720|NCT01659372|myofascial pain syndrome|myofascial pain syndrome
4994721|NCT01659333|Peritoneal, Dialysis|peritoneal, dialysis
4994722|NCT01659307|Acute Lung Injury|acute lung injury
4994723|NCT01659307|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
4994724|NCT01659307|Aspirin|aspirin
4994725|NCT01659294|Type 2 diabetes|type 2 diabetes
4994726|NCT01659294|outcomes|outcomes
4994727|NCT01659294|case management|case management
4994728|NCT01659281|Artesunate|artesunate
4994729|NCT01659281|Mefloquine|mefloquine
4994730|NCT01659281|Plasmodium Falciparum|plasmodium falciparum
4994731|NCT01659281|Thailand|thailand
4994732|NCT01659281|Uncomplicated Plasmodium Falciparum malaria|uncomplicated plasmodium falciparum malaria
4994733|NCT01659268|teaching|teaching
4994734|NCT01659268|patient simulation|patient simulation
4994735|NCT01659268|laryngeal masks|laryngeal masks
4994736|NCT01659268|baccalaureate nursing education|baccalaureate nursing education
4994737|NCT01659268|teaching strategies|teaching strategies
4994738|NCT01659268|simulation|simulation
4994739|NCT01659242|Rheumatoid arthritis|rheumatoid arthritis
4994740|NCT01659242|Ultrasound|ultrasound
4994741|NCT01659242|Magnetic Resonance Imaging|magnetic resonance imaging
4994742|NCT01659229|knee osteoarthritis|knee osteoarthritis
4994743|NCT01659216|Electrical Pudendal Nerve Stimulation|electrical pudendal nerve stimulation
4994744|NCT01659216|Urgency-Frequency Syndrome|urgency-frequency syndrome
4994745|NCT01659216|long-term efficacy|long-term efficacy
4994746|NCT01659203|extraskeletal chondrosarcoma|extraskeletal chondrosarcoma
4994747|NCT01659164|Cognitive Behavioral Therapy|cognitive behavioral therapy
4994748|NCT01659164|Dialectical Behavioral Therapy|dialectical behavioral therapy
4994749|NCT01659164|Group Treatment|group treatment
4994750|NCT01659164|ADHD|adhd
4994751|NCT01659151|metastatic|metastatic
4994752|NCT01659151|melanoma|melanoma
4994753|NCT01659151|cell transfer|cell transfer
4994754|NCT01659151|ACT|act
4994755|NCT01659151|T-cell|t-cell
4994756|NCT01659151|immunotherapy|immunotherapy
4994757|NCT01659151|antibodies|antibodies
4994758|NCT01659151|lymphocytes|lymphocytes
4994759|NCT01659112|core stabilization, upper extremity, kinetic chain, movement|core stabilization, upper extremity, kinetic chain, movement
4994760|NCT01659099|DLBCL|dlbcl
4994761|NCT01659099|aa-IPI > or equal to 1|aa-ipi > or equal to 1
4994762|NCT01659099|Diagnosis|diagnosis
4994763|NCT01659099|18 to 60 years|18 to 60 years
4994764|NCT01659099|Lymphoma|lymphoma
4994765|NCT01659086|Influenza|influenza
4994766|NCT01659086|Immunogenicity|immunogenicity
4994767|NCT01659086|H9N2|h9n2
4994768|NCT01659086|Safety|safety
4994769|NCT01659073|Caloric Vestibular Stimulation|caloric vestibular stimulation
4994770|NCT01659073|Functional Imaging|functional imaging
4994771|NCT01659060|Cacao|cacao
4994772|NCT01659060|Chocolate|chocolate
4994773|NCT01659060|Theobromine|theobromine
4994774|NCT01659060|Flavonoids|flavonoids
4994875|NCT01658475|IgG titer|igg titer
4994775|NCT01659060|Pregnant women|pregnant women
4994776|NCT01659060|Hypertension pregnancy-induced|hypertension pregnancy-induced
4994777|NCT01659060|Pre-eclampsia|pre-eclampsia
4994778|NCT01659060|Epicatechin|epicatechin
4994779|NCT01659047|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
4994780|NCT01659047|CLL|cll
4994781|NCT01659047|CAL-101|cal-101
4994782|NCT01659047|Ofatumumab|ofatumumab
4994783|NCT01659034|Anti-platelet therapy|anti-platelet therapy
4994784|NCT01659021|CLL|cll
4994785|NCT01659021|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
4994786|NCT01659021|GS-1101|gs-1101
4994787|NCT01659021|CAL-101|cal-101
4994788|NCT01659021|Ofatumumab|ofatumumab
4994789|NCT01659008|acute cyclical heavy menstrual bleeding|acute cyclical heavy menstrual bleeding
4994790|NCT01658995|Implanon|implanon
4994791|NCT01658995|Etonogestrel subdermal implant|etonogestrel subdermal implant
4994792|NCT01658995|Nexplanon|nexplanon
4994793|NCT01658995|Contraception|contraception
4994794|NCT01658995|Irregular Bleeding|irregular bleeding
4994795|NCT01658995|Menometrorrhagia|menometrorrhagia
4994796|NCT01658956|GCSF|gcsf
4994797|NCT01658956|Chemotherapy|chemotherapy
4994798|NCT01658956|Breast cancer|breast cancer
4994799|NCT01658956|Prophylaxis|prophylaxis
4994800|NCT01658917|Tissue Acquisition|tissue acquisition
4994801|NCT01658904|Autologous Transplant|autologous transplant
4994802|NCT01658904|Proteasome Inhibitor|proteasome inhibitor
4994803|NCT01658904|Melphalan|melphalan
4994804|NCT01658904|Filgrastim|filgrastim
4994805|NCT01658839|pediatric glaucoma|pediatric glaucoma
4994806|NCT01658839|pediatric ocular hypertension|pediatric ocular hypertension
4994807|NCT01658839|travoprost|travoprost
4994808|NCT01658826|AIC316|aic316
4994809|NCT01658826|Viral shedding|viral shedding
4994810|NCT01658813|Metastatic Gastrointestinal|metastatic gastrointestinal
4994811|NCT01658813|Metastatic Kidney|metastatic kidney
4994812|NCT01658813|Metastatic Lung|metastatic lung
4994813|NCT01658800|H5N1 Influenza|h5n1 influenza
4994814|NCT01658800|H5N1 Influenza vaccine|h5n1 influenza vaccine
4994815|NCT01658787|Aorta|aorta
4994816|NCT01658761|Myopic traction maculopathy|myopic traction maculopathy
4994817|NCT01658761|vitrectomy|vitrectomy
4994818|NCT01658761|internal limiting membrane|internal limiting membrane
4994819|NCT01658761|Retrospective, case control study|retrospective, case control study
4994820|NCT01658748|Pilot Study|pilot study
4994821|NCT01658748|Longitudinal Study|longitudinal study
4994822|NCT01658748|Amygdaloid Body|amygdaloid body
4994823|NCT01658748|Insula of Reil|insula of reil
4994824|NCT01658748|Cortex, prefrontal|cortex, prefrontal
4994825|NCT01658748|Stimulation, Deep Brain|stimulation, deep brain
4994826|NCT01658748|Chronic Post Traumatic Stress Disorder|chronic post traumatic stress disorder
4994827|NCT01658748|Combat Stress Disorder|combat stress disorder
4994828|NCT01658748|Social Adjustments|social adjustments
4994829|NCT01658748|Positron-Emission Tomography, Computed Tomography|positron-emission tomography, computed tomography
4994830|NCT01658735|Chronic low back pain|chronic low back pain
4994831|NCT01658735|Electrotherapy|electrotherapy
4994832|NCT01658735|H-Wave|h-wave
4994833|NCT01658735|H wave|h wave
4994834|NCT01658735|TENS|tens
4994835|NCT01658735|Trial|trial
4994836|NCT01658683|Coronary Artery Disease|coronary artery disease
4994837|NCT01658683|Cardiac Rehabilitation|cardiac rehabilitation
4994838|NCT01658683|Exercise Maintenance|exercise maintenance
4994839|NCT01658683|Facilitator|facilitator
4994840|NCT01658683|Managed Home Exercise|managed home exercise
4994841|NCT01658683|Community Based Exercise|community based exercise
4994842|NCT01658670|Heart failure|heart failure
4994843|NCT01658670|exercise|exercise
4994844|NCT01658670|adherence|adherence
4994845|NCT01658670|quality of life|quality of life
4994846|NCT01658644|Patient satisfaction|patient satisfaction
4994847|NCT01658644|Memory recall|memory recall
4994848|NCT01658644|Patient-clinician communication|patient-clinician communication
4994849|NCT01658644|health communication|health communication
4994850|NCT01658644|clinical care team recall|clinical care team recall
4994851|NCT01658644|hospital quality of care|hospital quality of care
4994852|NCT01658618|Venous leg ulcer|venous leg ulcer
4994853|NCT01658618|ulcer|ulcer
4994854|NCT01658618|venous stasis|venous stasis
4994855|NCT01658618|compression|compression
4994856|NCT01658618|venous|venous
4994857|NCT01658618|venous stasis ulcer|venous stasis ulcer
4994858|NCT01658618|vlu|vlu
4994859|NCT01658618|hp802-247-09-029|hp802-247-09-029
4994860|NCT01658605|GSK1605786|gsk1605786
4994861|NCT01658605|ulcerative colitis|ulcerative colitis
4994862|NCT01658605|CCR9 antagonist|ccr9 antagonist
4994863|NCT01658605|proof of concept|proof of concept
4994864|NCT01658592|Alcohol Addiction;|alcohol addiction;
4994865|NCT01658592|Deep Brain Stimulation;|deep brain stimulation;
4994866|NCT01658592|Nucleus Accumbens;|nucleus accumbens;
4994867|NCT01658592|Ventral Anterior Internal capsule;|ventral anterior internal capsule;
4994868|NCT01658553|solid tumors|solid tumors
4994869|NCT01658540|Drug Eluting Balloon (DEB) technology|drug eluting balloon (deb) technology
4994870|NCT01658540|long SFA lesions disease|long sfa lesions disease
4994871|NCT01658527|metastatic|metastatic
4994872|NCT01658527|prostate cancer|prostate cancer
4994873|NCT01658488|Iron deficiency anemia|iron deficiency anemia
4994876|NCT01658475|periodontopathic bacteria|periodontopathic bacteria
4994877|NCT01658462|locally recurrent or metastatic breast cancer|locally recurrent or metastatic breast cancer
4994878|NCT01658462|Docetaxel|docetaxel
4994879|NCT01658462|Nintedanib|nintedanib
4994880|NCT01658436|advanced pancreatic neuroendocrine tumor|advanced pancreatic neuroendocrine tumor
4994881|NCT01658436|BEZ235|bez235
4994882|NCT01658436|pNET|pnet
4994883|NCT01658423|pubic hair|pubic hair
4994884|NCT01658423|sprint velocity|sprint velocity
4994885|NCT01658423|vertical jump height|vertical jump height
4994886|NCT01658423|body composition|body composition
4994887|NCT01658423|maximal voluntary torque|maximal voluntary torque
4994888|NCT01658410|Coronary artery disease|coronary artery disease
4994889|NCT01658410|bypass grafting|bypass grafting
4994890|NCT01658397|Healthy subjects|healthy subjects
4994891|NCT01658397|Fasting|fasting
4994892|NCT01658397|Weight loss|weight loss
4994893|NCT01658371|HIV|hiv
4994894|NCT01658358|ErbB receptor|erbb receptor
4994895|NCT01658358|tyrosine kinase inhibitor|tyrosine kinase inhibitor
4994896|NCT01658358|Anthracycline|anthracycline
4994897|NCT01658345|aortic stenosis|aortic stenosis
4994898|NCT01658345|asymptomatic|asymptomatic
4994899|NCT01658345|microvascular dysfunction|microvascular dysfunction
4994900|NCT01658345|Cardiac MRI|cardiac mri
4994901|NCT01658332|lung cancer|lung cancer
4994902|NCT01658332|circulating tumor cells|circulating tumor cells
4994903|NCT01658332|prospective|prospective
4994904|NCT01658332|monocentrique trial|monocentrique trial
4994905|NCT01658306|remote ischemic preconditioning|remote ischemic preconditioning
4994906|NCT01658306|random-controlled|random-controlled
4994907|NCT01658306|double blind|double blind
4994908|NCT01658306|RIPC|ripc
4994909|NCT01658293|stroke|stroke
4994910|NCT01658293|follow up|follow up
4994911|NCT01658293|upper limb|upper limb
4994912|NCT01658293|rehabilitation|rehabilitation
4994913|NCT01658280|transbronchial needle aspiration|transbronchial needle aspiration
4994914|NCT01658280|ultrasound guided transbronchial needle aspiration|ultrasound guided transbronchial needle aspiration
4994915|NCT01658280|sensitivity|sensitivity
4994916|NCT01658280|hilar/mediastinal adenopathy|hilar/mediastinal adenopathy
4994917|NCT01658254|Clinical trials|clinical trials
4994918|NCT01658254|Basic results|basic results
4994919|NCT01658254|Registry|registry
4994920|NCT01658228|Depression|depression
4994921|NCT01658228|Dysthymia|dysthymia
4994922|NCT01658228|Cognitive Impairment|cognitive impairment
4994923|NCT01658228|Cognitive Decline|cognitive decline
4994924|NCT01658228|Memory|memory
4994925|NCT01658215|Smoking cessation|smoking cessation
4994926|NCT01658215|Nicotine|nicotine
4994927|NCT01658215|Tobacco Use Disorder|tobacco use disorder
4994928|NCT01658215|Central Nervous System Agents|central nervous system agents
4994929|NCT01658202|Smoking cessation|smoking cessation
4994930|NCT01658202|Nicotine|nicotine
4994931|NCT01658202|Tobacco Use Disorder|tobacco use disorder
4994932|NCT01658202|Central Nervous System Agents|central nervous system agents
4994933|NCT01658176|Estrogen receptor positive|estrogen receptor positive
4994934|NCT01658176|Her-2 negative|her-2 negative
4994935|NCT01658176|advanced breast cancer|advanced breast cancer
4994936|NCT01658176|Breast Cancer|breast cancer
4994937|NCT01658163|abdominoplasty,|abdominoplasty,
4994938|NCT01658163|skin closure, dressings|skin closure, dressings
4994939|NCT01658150|Cognition|cognition
4994940|NCT01658150|Schizophrenia|schizophrenia
4994941|NCT01658150|Schizoaffective disorder|schizoaffective disorder
4994942|NCT01658137|diet|diet
4994943|NCT01658137|dietary pattern|dietary pattern
4994944|NCT01658137|gene|gene
4994945|NCT01658137|gene expression|gene expression
4994946|NCT01658137|epigenomics|epigenomics
4994947|NCT01658137|diet-gene interaction|diet-gene interaction
4994948|NCT01658137|inflammation|inflammation
4994949|NCT01658137|9p21|9p21
4994950|NCT01658137|fruits|fruits
4994951|NCT01658137|vegetables|vegetables
4994952|NCT01658124|haemorrhage,antifibrinolytic, clinical trial,|haemorrhage,antifibrinolytic, clinical trial,
4994953|NCT01658111|Stroke|stroke
4994954|NCT01658111|Robots|robots
4994955|NCT01658111|EEG|eeg
4994956|NCT01658111|EMG|emg
4994957|NCT01658098|postpartum|postpartum
4994958|NCT01658098|depression|depression
4994959|NCT01658098|edinburgh postpartum depression scale|edinburgh postpartum depression scale
4994960|NCT01658098|mexican population|mexican population
4994961|NCT01658085|Thyroidectomy|thyroidectomy
4994962|NCT01658085|Multinodular goiter|multinodular goiter
4994963|NCT01658085|Harmonic Focus|harmonic focus
4994964|NCT01658085|budget impact|budget impact
4994965|NCT01658085|Harmonic scalpel|harmonic scalpel
4994966|NCT01658072|Total Hip Arthroplasty|total hip arthroplasty
4994967|NCT01658072|Total Hip Replacement|total hip replacement
4994968|NCT01658046|COPD|copd
4994969|NCT01658046|exercise|exercise
4994970|NCT01658046|neuromuscular electrical stimulation|neuromuscular electrical stimulation
4994971|NCT01658033|Metastatic Breast Cancer, Her-2 negative Breast Cancer|metastatic breast cancer, her-2 negative breast cancer
4994972|NCT01658033|Avastin, FOLFOX regimen|avastin, folfox regimen
4994973|NCT01658020|Acute exacerbation of Chronic obstructive pulmonary disease|acute exacerbation of chronic obstructive pulmonary disease
4994974|NCT01658020|Acute Exacerbation|acute exacerbation
4994975|NCT01658020|Chronic obstructive pulmonary disease(COPD)|chronic obstructive pulmonary disease(copd)
4994976|NCT01658020|Zabofloxacin|zabofloxacin
4994977|NCT01658020|Moxifloxacin|moxifloxacin
4994978|NCT01657994|cerebral palsy|cerebral palsy
4994979|NCT01657994|gait training|gait training
4994980|NCT01657994|robotic|robotic
4994981|NCT01657994|functional electrical stimulation|functional electrical stimulation
4994982|NCT01657981|Pharmacokinetics|pharmacokinetics
4994983|NCT01657981|Phase 1|phase 1
4994984|NCT01657981|14C-labeled|14c-labeled
4994985|NCT01657968|Acute tonsillitis|acute tonsillitis
4994986|NCT01657968|Procalcitonin|procalcitonin
4994987|NCT01657968|Streptococcal antigen test|streptococcal antigen test
4994988|NCT01657968|Centor Criteria|centor criteria
4994989|NCT01657968|Infection marker|infection marker
4994990|NCT01657942|MRgFUS|mrgfus
4994991|NCT01657942|Prostate|prostate
4994992|NCT01657942|Intermediate Risk Prostate Lesions|intermediate risk prostate lesions
4994993|NCT01657942|Focal Prostate treatment|focal prostate treatment
4994994|NCT01657942|InSightec|insightec
4994995|NCT01657942|ExAblate|exablate
4994996|NCT01657942|Non-invasive|non-invasive
4994997|NCT01657942|Prostate cancer|prostate cancer
4994998|NCT01657942|Gleason 7|gleason 7
4994999|NCT01657929|Influenza|influenza
4995000|NCT01657929|Avian|avian
4995001|NCT01657929|H5N1|h5n1
4995002|NCT01657929|H5-VLP|h5-vlp
4995003|NCT01657929|GLA|gla
4995004|NCT01657929|GLA-AF|gla-af
4995005|NCT01657916|mid-urethral sling|mid-urethral sling
4995006|NCT01657916|Align urethral support system|align urethral support system
4995007|NCT01657916|tension free vaginal tape|tension free vaginal tape
4995008|NCT01657916|cough stress test|cough stress test
4995009|NCT01657916|pelvic exam|pelvic exam
4995010|NCT01657916|PFDI-20|pfdi-20
4995011|NCT01657916|PFIQ|pfiq
4995012|NCT01657916|SSQ|ssq
4995013|NCT01657916|Urinary retention|urinary retention
4995014|NCT01657916|mesh erosion|mesh erosion
4995015|NCT01657916|urodynamics|urodynamics
4995016|NCT01657890|isavuconazole|isavuconazole
4995017|NCT01657890|BAL8557|bal8557
4995018|NCT01657864|Aseptic Meningitis|aseptic meningitis
4995019|NCT01657864|Epidemiology|epidemiology
4995020|NCT01657864|Bipolar Disorder|bipolar disorder
4995021|NCT01657864|Lamotrigine|lamotrigine
4995022|NCT01657864|Epilepsy|epilepsy
4995023|NCT01657838|Isavuconazole|isavuconazole
4995024|NCT01657838|Ketoconazole|ketoconazole
4995025|NCT01657838|Healthy Volunteers|healthy volunteers
4995026|NCT01657838|BAL8557|bal8557
4995027|NCT01657838|BAL4815|bal4815
4995028|NCT01657825|isavuconazole|isavuconazole
4995029|NCT01657825|warfarin|warfarin
4995030|NCT01657825|Healthy Volunteers|healthy volunteers
4995031|NCT01657825|BAL8557|bal8557
4995032|NCT01657825|Coumadin|coumadin
4995033|NCT01657812|dexmedetomidine|dexmedetomidine
4995034|NCT01657812|Epidural Anesthesia|epidural anesthesia
4995035|NCT01657812|stress response|stress response
4995036|NCT01657812|anesthesia recovery|anesthesia recovery
4995037|NCT01657786|ondanstron|ondanstron
4995038|NCT01657786|gene polymorphism|gene polymorphism
4995039|NCT01657786|postoperative nausea and vomiting|postoperative nausea and vomiting
4995040|NCT01657786|laparoscopic surgery under general anesthesia|laparoscopic surgery under general anesthesia
4995041|NCT01657760|craving|craving
4995042|NCT01657760|dopamine|dopamine
4995043|NCT01657760|citalopram|citalopram
4995044|NCT01657760|ssri|ssri
4995045|NCT01657747|Ovarian carcinoma|ovarian carcinoma
4995046|NCT01657747|Staging|staging
4995047|NCT01657747|Early treatment follow-up|early treatment follow-up
4995048|NCT01657747|Identifying tumor recurrence|identifying tumor recurrence
4995049|NCT01657747|Whole body diffusion-weighted MRI|whole body diffusion-weighted mri
4995050|NCT01657734|therapy-induced inflammatory response with|therapy-induced inflammatory response with
4995051|NCT01657734|magnetic resonance imaging|magnetic resonance imaging
4995052|NCT01657695|HCC|hcc
4995053|NCT01657695|Computed tomography|computed tomography
4995054|NCT01657695|Gene expression|gene expression
4995055|NCT01657695|Fractional growth|fractional growth
4995056|NCT01657682|FLT3|flt3
4995057|NCT01657682|Crenolanib|crenolanib
4995058|NCT01657682|Acute|acute
4995059|NCT01657682|Myeloid|myeloid
4995060|NCT01657682|AML|aml
4995061|NCT01657669|Choroidal neovascularization due to AMD|choroidal neovascularization due to amd
4995062|NCT01657643|Health related quality of life|health related quality of life
4995063|NCT01657643|Functional Status|functional status
4995064|NCT01657630|Insulin Pump Therapy|insulin pump therapy
4995065|NCT01657630|Type 1 Diabetes|type 1 diabetes
4995066|NCT01657630|Treatment Satisfaction|treatment satisfaction
4995067|NCT01657604|CML|cml
4995068|NCT01657604|Tasigna|tasigna
4995069|NCT01657604|Nilotinib|nilotinib
4995070|NCT01657604|Interferon|interferon
4995071|NCT01657591|skin cancer|skin cancer
4995072|NCT01657591|unresectable|unresectable
4995073|NCT01657591|BRAF|braf
4995074|NCT01657578|neonates|neonates
4995075|NCT01657578|reflux disease|reflux disease
4995076|NCT01657578|population pharmacokinetics, omeprazole|population pharmacokinetics, omeprazole
4995077|NCT01657565|LOS|los
4995078|NCT01657565|Ileus|ileus
4995079|NCT01657565|Fever|fever
4995080|NCT01657565|reoperation|reoperation
4995081|NCT01657552|Drug interaction|drug interaction
4995082|NCT01657552|INCIVEK (telaprevir),|incivek (telaprevir),
4995083|NCT01657552|SB-497115 (eltrombopag)|sb-497115 (eltrombopag)
4995084|NCT01657552|Pharmacokinetics|pharmacokinetics
4995085|NCT01657552|Thrombocytopenia|thrombocytopenia
4995086|NCT01657552|VICTRELIS (boceprevir)|victrelis (boceprevir)
4995087|NCT01657526|Healthy adults|healthy adults
4995088|NCT01657526|Safety|safety
4995089|NCT01657526|Reactogenicity|reactogenicity
4995090|NCT01657526|Immunogenicity|immunogenicity
4995091|NCT01657526|Non-typeable H. Influenzae (NTHi)|non-typeable h. influenzae (nthi)
4995092|NCT01657513|psoriasis|psoriasis
4995093|NCT01657513|treatment failure|treatment failure
4995094|NCT01657513|tnf-alfa|tnf-alfa
4995095|NCT01657500|endothelial keratoplasty|endothelial keratoplasty
4995096|NCT01657487|COPD|copd
4995097|NCT01657487|Fluticasone/Salmeterol|fluticasone/salmeterol
4995098|NCT01657487|high dose|high dose
4995099|NCT01657448|Symptom of Dysuria|symptom of dysuria
4995100|NCT01657435|Total hip replacement|total hip replacement
4995101|NCT01657435|Total hip arthroplasty|total hip arthroplasty
4995102|NCT01657435|Hip joint replacement|hip joint replacement
4995103|NCT01657435|Hip prosthesis replacement|hip prosthesis replacement
4995104|NCT01657422|Nutrition|nutrition
4995105|NCT01657422|Physical Activity|physical activity
4995106|NCT01657422|Adolescents|adolescents
4995107|NCT01657409|botulinum toxin|botulinum toxin
4995108|NCT01657409|detrusor overactivity|detrusor overactivity
4995109|NCT01657396|Oral Care|oral care
4995110|NCT01657396|Oral Hygiene|oral hygiene
4995111|NCT01657396|Intensive Care|intensive care
4995112|NCT01657396|Mechanical Ventilation|mechanical ventilation
4995113|NCT01657396|Chlorhexidine|chlorhexidine
4995114|NCT01657331|Hodgkin Lymphoma|hodgkin lymphoma
4995115|NCT01657331|Hodgkin Disease|hodgkin disease
4995116|NCT01657331|Hodgkin's Disease|hodgkin's disease
4995117|NCT01657331|Anaplastic Large Cell Lymphoma|anaplastic large cell lymphoma
4995118|NCT01657331|ALCL|alcl
4995119|NCT01657331|SGN+Benda|sgn+benda
4995120|NCT01657331|Bendamustine|bendamustine
4995121|NCT01657331|Brentuximab Vedotin|brentuximab vedotin
4995122|NCT01657318|diabetic foot|diabetic foot
4995123|NCT01657318|leg ulcer|leg ulcer
4995124|NCT01657305|Split-Thickness Skin Graft (STSG) donor site|split-thickness skin graft (stsg) donor site
4995125|NCT01657305|Split-thickness skin graft|split-thickness skin graft
4995126|NCT01657305|STSG|stsg
4995127|NCT01657305|Wound healing|wound healing
4995128|NCT01657305|Skin grafting|skin grafting
4995129|NCT01657305|Superficial wound|superficial wound
4995130|NCT01657305|Partial-thickness wound|partial-thickness wound
4995131|NCT01657305|Time to wound closure|time to wound closure
4995132|NCT01657292|Wound healing|wound healing
4995133|NCT01657292|Burn wound|burn wound
4995134|NCT01657292|Superficial partial-thickness burn wound|superficial partial-thickness burn wound
4995135|NCT01657292|Grade 2a burn wounds|grade 2a burn wounds
4995136|NCT01657292|Time to wound closure|time to wound closure
4995137|NCT01657279|stroke|stroke
4995138|NCT01657279|risk score|risk score
4995139|NCT01657279|iScore|iscore
4995140|NCT01657279|outcomes|outcomes
4995141|NCT01657279|mortality|mortality
4995142|NCT01657279|disability|disability
4995143|NCT01657279|institutionalization|institutionalization
4995144|NCT01657227|diabetes|diabetes
4995145|NCT01657227|self-management|self-management
4995146|NCT01657227|lifestyle|lifestyle
4995147|NCT01657227|diet|diet
4995148|NCT01657227|physical exercise|physical exercise
4995149|NCT01657227|computer-assisted decision support systems|computer-assisted decision support systems
4995150|NCT01657188|Heart failure, congestive|heart failure, congestive
4995151|NCT01657188|Sleep apnea syndromes|sleep apnea syndromes
4995152|NCT01657188|Adaptive servoventilation|adaptive servoventilation
4995153|NCT01657188|Prognosis|prognosis
4995154|NCT01657188|Cheyne-Stokes respiration|cheyne-stokes respiration
4995155|NCT01657175|Cancer|cancer
4995156|NCT01657175|long-term follow-up|long-term follow-up
4995157|NCT01657175|quality of life|quality of life
4995158|NCT01657175|Surgery|surgery
4995159|NCT01657175|Nursing|nursing
4995160|NCT01657162|BA058|ba058
4995161|NCT01657162|Abaloparatide-SC|abaloparatide-sc
4995162|NCT01657162|abaloparatide|abaloparatide
4995163|NCT01657162|ACTIVExtend|activextend
4995164|NCT01657162|osteoporosis|osteoporosis
4995165|NCT01657162|fracture|fracture
4995166|NCT01657162|bone loss|bone loss
4995167|NCT01657136|Inappropriate sinus tachycardia|inappropriate sinus tachycardia
4995168|NCT01657136|ivabradine|ivabradine
4995169|NCT01657136|beta blockers|beta blockers
4995170|NCT01657123|exercise capacity|exercise capacity
4995171|NCT01657123|Addison's disease|addison's disease
4995172|NCT01657110|acne|acne
4995173|NCT01657110|inflamed lesions|inflamed lesions
4995174|NCT01657110|non-inflamed lesions|non-inflamed lesions
4995175|NCT01657110|complementary medicine|complementary medicine
4995176|NCT01657110|essential oil|essential oil
4995177|NCT01657058|soluble fiber|soluble fiber
4995178|NCT01657058|second meal effect|second meal effect
4995179|NCT01657058|glycemia|glycemia
4995180|NCT01657058|satiety|satiety
4995181|NCT01657058|Individuals|individuals
4995182|NCT01657045|Cicatrix|cicatrix
4995183|NCT01657045|Wound healing|wound healing
4995184|NCT01657032|diarrhea|diarrhea
4995185|NCT01657032|probiotics|probiotics
4995186|NCT01657032|diosmectite|diosmectite
4995187|NCT01657006|Heart rate variability|heart rate variability
4995188|NCT01657006|ischemic heart disease|ischemic heart disease
4995189|NCT01657006|myocardial ischemia|myocardial ischemia
4995190|NCT01656993|Aspirin|aspirin
4995192|NCT01656993|aortopulmonary shunt|aortopulmonary shunt
4995193|NCT01656993|cavopulmonary shunt|cavopulmonary shunt
4995194|NCT01656993|shunt|shunt
4995195|NCT01656993|TEG|teg
4995196|NCT01656993|Antiplatelet|antiplatelet
4995197|NCT01656967|Laryngeal Mask Airway|laryngeal mask airway
4995198|NCT01656967|LMA|lma
4995199|NCT01656967|Intubation|intubation
4995200|NCT01656967|AMBU|ambu
4995201|NCT01656967|AScope|ascope
4995202|NCT01656967|Aura-I|aura-i
4995203|NCT01656967|Fastrach|fastrach
4995204|NCT01656967|Fiberoptic|fiberoptic
4995205|NCT01656967|Disposable Fiberoptic|disposable fiberoptic
4995206|NCT01656967|Blind Intubation|blind intubation
4995207|NCT01656967|Fiberoptic Intubation|fiberoptic intubation
4995208|NCT01656954|stroke volume|stroke volume
4995209|NCT01656954|cardiac output|cardiac output
4995210|NCT01656954|pulse pressure variance|pulse pressure variance
4995211|NCT01656954|stroke volume variance|stroke volume variance
4995212|NCT01656954|passive leg raise|passive leg raise
4995213|NCT01656954|fluid challenge|fluid challenge
4995214|NCT01656954|central venous pressure|central venous pressure
4995215|NCT01656941|neonate|neonate
4995216|NCT01656941|congenital heart disease|congenital heart disease
4995217|NCT01656941|single ventricle cardiac disease|single ventricle cardiac disease
4995218|NCT01656941|hypoplastic left heart syndrome|hypoplastic left heart syndrome
4995219|NCT01656941|hypoplastic right heart syndrome|hypoplastic right heart syndrome
4995220|NCT01656941|d-Transposition of the Great Arteries|d-transposition of the great arteries
4995221|NCT01656915|inflammation|inflammation
4995222|NCT01656915|response|response
4995223|NCT01656915|resilience|resilience
4995224|NCT01656915|cytokines|cytokines
4995225|NCT01656915|pre-diabetes|pre-diabetes
4995226|NCT01656902|Autologous Chondrocyte Transplantation|autologous chondrocyte transplantation
4995227|NCT01656902|NOVOCART 3D plus|novocart 3d plus
4995228|NCT01656902|knee joint pain|knee joint pain
4995229|NCT01656902|safety|safety
4995230|NCT01656902|efficacy|efficacy
4995231|NCT01656902|treatment|treatment
4995232|NCT01656902|TETEC|tetec
4995233|NCT01656902|cartilage|cartilage
4995234|NCT01656902|ACT|act
4995235|NCT01656902|cartilage repair|cartilage repair
4995236|NCT01656902|tissue|tissue
4995237|NCT01656902|MOCART|mocart
4995238|NCT01656889|Venous leg ulcer|venous leg ulcer
4995239|NCT01656889|ulcer|ulcer
4995240|NCT01656889|venous stasis|venous stasis
4995241|NCT01656889|compression|compression
4995242|NCT01656889|venous|venous
4995243|NCT01656889|venous stasis ulcer|venous stasis ulcer
4995244|NCT01656889|vlu|vlu
4995245|NCT01656876|Comparative effectiveness research|comparative effectiveness research
4995246|NCT01656876|Mirror therapy|mirror therapy
4995247|NCT01656876|Stroke rehabilitation|stroke rehabilitation
4995248|NCT01656876|Clinical evaluation|clinical evaluation
4995249|NCT01656876|Kinematic analysis|kinematic analysis
4995250|NCT01656876|Mesh glove|mesh glove
4995251|NCT01656876|Combined therapy|combined therapy
4995252|NCT01656863|Dehydration|dehydration
4995253|NCT01656850|hyperglycemia|hyperglycemia
4995254|NCT01656850|hyperinsulinemia|hyperinsulinemia
4995255|NCT01656837|Substance Abuse|substance abuse
4995256|NCT01656837|Child Maltreatment|child maltreatment
4995257|NCT01656837|Multisystemic Therapy|multisystemic therapy
4995258|NCT01656837|Child Trauma|child trauma
4995259|NCT01656824|Bv8/PK-2|bv8/pk-2
4995260|NCT01656824|MDSC Myeloid Derived Suppressor Cells|mdsc myeloid derived suppressor cells
4995261|NCT01656824|BMDC Bone Marrow Derived Cells|bmdc bone marrow derived cells
4995262|NCT01656824|Angiogenesis|angiogenesis
4995263|NCT01656824|Pancreatic Cancer|pancreatic cancer
4995264|NCT01656785|stroke|stroke
4995265|NCT01656785|cerebrovascular disease|cerebrovascular disease
4995266|NCT01656785|angiogenesis imaging|angiogenesis imaging
4995267|NCT01656785|68Ga-BNOTA-PRGD2|68ga-bnota-prgd2
4995268|NCT01656785|PET/CT|pet/ct
4995269|NCT01656772|magnetic navigation|magnetic navigation
4995270|NCT01656772|robotic control|robotic control
4995271|NCT01656772|RMT ThermoCool catheter|rmt thermocool catheter
4995272|NCT01656759|Blood Loss|blood loss
4995273|NCT01656759|Hemoglobin|hemoglobin
4995274|NCT01656759|Hematocrit|hematocrit
4995275|NCT01656759|Blood Transfusions|blood transfusions
4995276|NCT01656746|Colorectal Disease|colorectal disease
4995277|NCT01656746|SILS|sils
4995278|NCT01656746|colorectal surgery|colorectal surgery
4995279|NCT01656733|Smoking Cessation|smoking cessation
4995280|NCT01656733|Pregnancy|pregnancy
4995281|NCT01656733|Nicotrol Inhaler|nicotrol inhaler
4995282|NCT01656733|Placebo Inhaler|placebo inhaler
4995283|NCT01656733|Nicotine Inhaler|nicotine inhaler
4995284|NCT01656720|Faecal Incontinence|faecal incontinence
4995285|NCT01656720|Suppository|suppository
4995286|NCT01656720|Wexner score|wexner score
4995287|NCT01656707|Adolescents|adolescents
4995288|NCT01656707|Substance Use Disorders|substance use disorders
4995289|NCT01656694|Osteoarthritis|osteoarthritis
4995290|NCT01656694|Knee|knee
4995291|NCT01656694|Replacement|replacement
4995292|NCT01656694|Unicompartmental|unicompartmental
4995293|NCT01656694|DePuy|depuy
4995294|NCT01656694|Sigma HP|sigma hp
4995295|NCT01656668|Chronic|chronic
4995296|NCT01656668|Acute|acute
4995297|NCT01656668|Persistent|persistent
4995298|NCT01656668|Longterm|longterm
4995299|NCT01656668|Cough|cough
4995300|NCT01656655|ptsd, parenting|ptsd, parenting
4995301|NCT01656642|PD-L1|pd-l1
4995302|NCT01656642|PD-1|pd-1
4995303|NCT01656642|PDL1|pdl1
4995304|NCT01656642|antiPD-L1|antipd-l1
4995305|NCT01656642|MPDL3280A|mpdl3280a
4995306|NCT01656642|Melanoma|melanoma
4995307|NCT01656642|BRAF|braf
4995308|NCT01656642|MPDL320A|mpdl320a
4995309|NCT01656616|Pharmacoeconomics|pharmacoeconomics
4995310|NCT01656616|Cost effectiveness|cost effectiveness
4995311|NCT01656616|Cyanide|cyanide
4995312|NCT01656616|Fire|fire
4995313|NCT01656616|Emergency Medical Services|emergency medical services
4995314|NCT01656616|Smoke Inhalation|smoke inhalation
4995315|NCT01656603|cord blood|cord blood
4995316|NCT01656603|transplantation|transplantation
4995317|NCT01656603|stem cells|stem cells
4995318|NCT01656603|adverse event|adverse event
4995319|NCT01656590|Pompe disease|pompe disease
4995320|NCT01656590|Acid Maltase Deficiency|acid maltase deficiency
4995321|NCT01656577|CRF1 antagonist|crf1 antagonist
4995322|NCT01656577|Stress|stress
4995323|NCT01656577|Eating Behavior|eating behavior
4995324|NCT01656577|Food Craving|food craving
4995326|NCT01656564|Pediatric|pediatric
4995327|NCT01656564|ART|art
4995328|NCT01656564|Longitudinal|longitudinal
4995329|NCT01656564|Outcomes|outcomes
4995330|NCT01656551|elderly|elderly
4995331|NCT01656551|chemotherapy|chemotherapy
4995332|NCT01656512|ALL|all
4995333|NCT01656512|zoledronic acid|zoledronic acid
4995334|NCT01656512|Osteoporosis|osteoporosis
4995335|NCT01656486|Pancreas|pancreas
4995336|NCT01656486|Pancreatic fistula|pancreatic fistula
4995337|NCT01656486|Stereotactic radiation|stereotactic radiation
4995338|NCT01656473|Concurrent Disorders|concurrent disorders
4995339|NCT01656473|Adolescents|adolescents
4995340|NCT01656473|Motivational Interviewing|motivational interviewing
4995341|NCT01656473|Dialectical Behaviour Therapy|dialectical behaviour therapy
4995342|NCT01656473|Caregiver Burden|caregiver burden
4995343|NCT01656460|Lung Cancer|lung cancer
4995344|NCT01656447|Scleroderma|scleroderma
4995345|NCT01656447|Scleroderma Registry|scleroderma registry
4995346|NCT01656447|Hospital for Special Surgery Scleroderma|hospital for special surgery scleroderma
4995347|NCT01656434|Combined Oral Contraceptives|combined oral contraceptives
4995348|NCT01656382|ABLC|ablc
4995349|NCT01656382|cryptococcosis|cryptococcosis
4995350|NCT01656369|Delorme operation,incontinence|delorme operation,incontinence
4995351|NCT01656356|Avian Flu|avian flu
4995352|NCT01656356|H5N2|h5n2
4995353|NCT01656330|Healthy|healthy
4995354|NCT01656330|Rivaroxaban|rivaroxaban
4995355|NCT01656330|JNJ-39039039|jnj-39039039
4995356|NCT01656330|BAY59-7939|bay59-7939
4995357|NCT01656330|Prothrombin Complex Concentrate (PCC)|prothrombin complex concentrate (pcc)
4995358|NCT01656317|SAH|sah
4995359|NCT01656317|Early rehabilitation|early rehabilitation
4995360|NCT01656317|Mobilisation|mobilisation
4995361|NCT01656278|Arthritis, Rheumatoid/drug therapy|arthritis, rheumatoid/drug therapy
4995362|NCT01656278|Arthritis, Rheumatoid/pathology|arthritis, rheumatoid/pathology
4995363|NCT01656278|Disease Progression|disease progression
4995364|NCT01656278|Longitudinal Studies|longitudinal studies
4995365|NCT01656278|Prospective Studies|prospective studies
4995366|NCT01656278|Imaging, Magnetic Resonance|imaging, magnetic resonance
4995367|NCT01656278|Remission Induction|remission induction
4995368|NCT01656278|Synovitis/immunology|synovitis/immunology
4995369|NCT01656278|Synovitis/pathology|synovitis/pathology
4995370|NCT01656278|Wrist Joint/pathology|wrist joint/pathology
4995371|NCT01656278|Wrist Joint/physiopathology|wrist joint/physiopathology
4995372|NCT01656252|Acute Leukemia|acute leukemia
4995373|NCT01656252|Complete Remission|complete remission
4995374|NCT01656252|Consolidation|consolidation
4995375|NCT01656252|Consolidation Chemotherapy|consolidation chemotherapy
4995376|NCT01656252|Cytarabine|cytarabine
4995377|NCT01656252|Eltrombopag|eltrombopag
4995378|NCT01656252|Leukemia|leukemia
4995379|NCT01656252|Thrombocytopenia|thrombocytopenia
4995380|NCT01656252|Thrombopoietin|thrombopoietin
4995381|NCT01656239|VA106483, fedovapagon, Nocturia, males, nocturnal voids, anti-diuretic|va106483, fedovapagon, nocturia, males, nocturnal voids, anti-diuretic
4995382|NCT01656226|Actinic Keratosis|actinic keratosis
4995383|NCT01656226|AK|ak
4995384|NCT01656213|Stroke|stroke
4995385|NCT01656213|End Stage Renal Disease|end stage renal disease
4995386|NCT01656213|Recovery|recovery
4995387|NCT01656213|Haemodialysis|haemodialysis
4995388|NCT01656200|Japanese encephalitis|japanese encephalitis
4995389|NCT01656200|Japanese encephalitis vaccine|japanese encephalitis vaccine
4995390|NCT01656200|T lymphocyte|t lymphocyte
4995391|NCT01656200|Immune response|immune response
4995392|NCT01656187|memantine|memantine
4995393|NCT01656187|cognition|cognition
4995394|NCT01656187|corticosteroid|corticosteroid
4995395|NCT01656187|prednisone|prednisone
4995396|NCT01656187|memory|memory
4995397|NCT01656187|hippocampus|hippocampus
4995398|NCT01656148|Multiple sclerosis|multiple sclerosis
4995399|NCT01656148|Walking disablility|walking disablility
4995400|NCT01656148|Mobility|mobility
4995401|NCT01656148|Six Spot Step Test|six spot step test
4995402|NCT01656148|Outcome measures|outcome measures
4995403|NCT01656148|Fampridine-SR|fampridine-sr
4995404|NCT01656148|Fampyra|fampyra
4995405|NCT01656135|gold standard treatment|gold standard treatment
4995406|NCT01656135|immune monitoring|immune monitoring
4995407|NCT01656135|acute rejection|acute rejection
4995408|NCT01656135|graft rejection|graft rejection
4995409|NCT01656135|living-donor|living-donor
4995410|NCT01656135|renal transplantation|renal transplantation
4995411|NCT01656135|kidney transplantation|kidney transplantation
4995412|NCT01656122|pharmacokinetic paramters|pharmacokinetic paramters
4995413|NCT01656122|abacavir|abacavir
4995414|NCT01656122|lamuvidine|lamuvidine
4995415|NCT01656122|HIV-infected children|hiv-infected children
4995416|NCT01656109|pharmacokinetics|pharmacokinetics
4995417|NCT01656109|atazanavir/ritonavir|atazanavir/ritonavir
4995418|NCT01656109|HIV-infected children|hiv-infected children
4995419|NCT01656083|Mobile phone text messaging (SM)|mobile phone text messaging (sm)
4995420|NCT01656083|Varenicline|varenicline
4995421|NCT01656083|The compliance|the compliance
4995422|NCT01656083|The abstinence rate|the abstinence rate
4995423|NCT01656070|HIV|hiv
4995424|NCT01656070|children|children
4995425|NCT01656070|adolescents|adolescents
4995426|NCT01656070|Vitamin D|vitamin d
4995427|NCT01656070|immunity|immunity
4995428|NCT01656070|T cell phenotype|t cell phenotype
4995429|NCT01656057|Bile acids|bile acids
4995430|NCT01656057|Gall bladder emptying|gall bladder emptying
4995431|NCT01656057|Human|human
4995432|NCT01656057|Glucagon like peptide 1|glucagon like peptide 1
4995433|NCT01656057|GLP-1|glp-1
4995434|NCT01656031|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
4995435|NCT01656031|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
4995436|NCT01656031|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
4995437|NCT01656031|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
4995438|NCT01656031|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
4995439|NCT01656031|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
4995440|NCT01656031|adult acute basophilic leukemia|adult acute basophilic leukemia
4995441|NCT01656031|adult acute eosinophilic leukemia|adult acute eosinophilic leukemia
4995442|NCT01656031|adult erythroleukemia (M6a)|adult erythroleukemia (m6a)
4995443|NCT01656031|adult pure erythroid leukemia (M6b)|adult pure erythroid leukemia (m6b)
4995444|NCT01656031|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
4995445|NCT01656031|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
4995446|NCT01656031|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
4995447|NCT01656031|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
4995448|NCT01656031|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
4995449|NCT01656031|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
4995450|NCT01656031|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
4995451|NCT01656018|Healthy|healthy
4995452|NCT01656018|TMC278|tmc278
4995453|NCT01656018|Human Immunodeficiency Virus Type 1|human immunodeficiency virus type 1
4995454|NCT01656018|HIV-1|hiv-1
4995455|NCT01656018|Pharmacokinetics|pharmacokinetics
4995456|NCT01656018|Ex-vivo pharmacodynamics|ex-vivo pharmacodynamics
4995457|NCT01656005|COPD|copd
4995458|NCT01656005|Beta blockers|beta blockers
4995459|NCT01656005|Cardioselective|cardioselective
4995460|NCT01656005|Non-cardioselective|non-cardioselective
4995461|NCT01656005|Impulse oscillometry|impulse oscillometry
4995462|NCT01655992|capecitabine|capecitabine
4995463|NCT01655992|Tegafur，Gimeracil and Oteracil Potassium Capsules|tegafur，gimeracil and oteracil potassium capsules
4995464|NCT01655966|chronic hepatitis c|chronic hepatitis c
4995465|NCT01655966|hcv|hcv
4995466|NCT01655966|vitamin d|vitamin d
4995467|NCT01655927|Neoplasms|neoplasms
4995468|NCT01655927|Tranexamic Acid|tranexamic acid
4995469|NCT01655927|Brain Tumors|brain tumors
4995470|NCT01655901|Active video games|active video games
4995471|NCT01655901|Food intake|food intake
4995472|NCT01655901|Energy balance|energy balance
4995473|NCT01655901|Adolescents|adolescents
4995474|NCT01655888|Tremelimumab|tremelimumab
4995475|NCT01655888|anti-CTLA-4 monoclonal antibody|anti-ctla-4 monoclonal antibody
4995476|NCT01655888|malignant mesothelioma|malignant mesothelioma
4995477|NCT01655875|Allogeneic Blood and Marrow Transplantation|allogeneic blood and marrow transplantation
4995478|NCT01655823|Pain|pain
4995479|NCT01655823|Puffer fish|puffer fish
4995480|NCT01655823|Tetrodotoxin|tetrodotoxin
4995481|NCT01655823|TTX|ttx
4995482|NCT01655823|Neuropathy|neuropathy
4995483|NCT01655823|Chemotherapy|chemotherapy
4995484|NCT01655823|WEX Pharmaceuticals|wex pharmaceuticals
4995485|NCT01655797|insomnia|insomnia
4995486|NCT01655797|cognitive behavior therapy|cognitive behavior therapy
4995487|NCT01655797|primary care|primary care
4995488|NCT01655784|aneurysm|aneurysm
4995489|NCT01655784|intracranial aneurysm|intracranial aneurysm
4995490|NCT01655784|cerebral aneurysm|cerebral aneurysm
4995491|NCT01655784|intracranial embolization|intracranial embolization
4995492|NCT01655784|aneurysm embolization|aneurysm embolization
4995493|NCT01655784|intracranial coil|intracranial coil
4995494|NCT01655784|eighteen coils|eighteen coils
4995495|NCT01655784|bare platinum coils|bare platinum coils
4995496|NCT01655784|GDC Coil|gdc coil
4995497|NCT01655784|Target Coil|target coil
4995498|NCT01655771|Opioid induced constipation|opioid induced constipation
4995499|NCT01655771|Constipation|constipation
4995500|NCT01655758|glaucoma|glaucoma
4995501|NCT01655758|24-hour IOP|24-hour iop
4995502|NCT01655758|outflow drugs|outflow drugs
4995503|NCT01655758|inflow drugs|inflow drugs
4995504|NCT01655745|[18F]|[18f]
4995505|NCT01655745|FDG Positron Emission Tomography-Magnetic Resonance Imaging|fdg positron emission tomography-magnetic resonance imaging
4995506|NCT01655745|FDG-PET-MRI|fdg-pet-mri
4995507|NCT01655745|Muscle-Invasive Bladder Cancer|muscle-invasive bladder cancer
4995508|NCT01655745|Pilot Study|pilot study
4995509|NCT01655745|LCCC 1209|lccc 1209
4995510|NCT01655745|UNC Lineberger|unc lineberger
4995511|NCT01655745|MDCT|mdct
4995512|NCT01655732|Pregnancy|pregnancy
4995513|NCT01655706|major depression|major depression
4995514|NCT01655706|major depressive disorder|major depressive disorder
4995515|NCT01655706|biomarkers|biomarkers
4995516|NCT01655706|escitalopram|escitalopram
4995517|NCT01655706|aripiprazole|aripiprazole
4995518|NCT01655706|MDD|mdd
4995519|NCT01655706|neuroimaging|neuroimaging
4995520|NCT01655706|proteomic|proteomic
4995521|NCT01655706|genomics|genomics
4995522|NCT01655693|Intermediate/advanced hepatocellular carcinoma|intermediate/advanced hepatocellular carcinoma
4995523|NCT01655693|After failure or intolerance to Sorafenib.|after failure or intolerance to sorafenib.
4995524|NCT01655680|Schizophrenia|schizophrenia
4995525|NCT01655667|Diagnosis|diagnosis
4995526|NCT01655667|Primary Care|primary care
4995527|NCT01655667|Comorbidities|comorbidities
4995528|NCT01655667|Healthcare utilisation|healthcare utilisation
4995529|NCT01655654|Hypertension|hypertension
4995530|NCT01655654|Acute hospital staff|acute hospital staff
4995531|NCT01655654|Exercise|exercise
4995532|NCT01655654|Diet|diet
4995533|NCT01655641|Blood transfusion|blood transfusion
4995534|NCT01655641|Bleeding|bleeding
4995535|NCT01655641|Major Gastro-intestinal surgery|major gastro-intestinal surgery
4995536|NCT01655641|Tranexamic Acid|tranexamic acid
4995537|NCT01655628|nasopharyngeal carcinoma|nasopharyngeal carcinoma
4995538|NCT01655628|metastasis|metastasis
4995539|NCT01655628|gemcitabine|gemcitabine
4995540|NCT01655628|CIK cells|cik cells
4995541|NCT01655615|Adolescent cognitive development|adolescent cognitive development
4995542|NCT01655615|mental disorders|mental disorders
4995543|NCT01655615|Mood disorders|mood disorders
4995544|NCT01655615|Alcohol-Related disorders|alcohol-related disorders
4995545|NCT01655615|Mental disorders diagnosed in childhood|mental disorders diagnosed in childhood
4995546|NCT01655615|Substance related disorders|substance related disorders
4995547|NCT01655602|Trichophytic closure|trichophytic closure
4995548|NCT01655602|hair transplantation|hair transplantation
4995549|NCT01655602|donor site|donor site
4995550|NCT01655602|Androgenetic alopecia|androgenetic alopecia
4995551|NCT01655576|drainage|drainage
4995552|NCT01655576|pregnancy|pregnancy
4995553|NCT01655576|active management|active management
4995554|NCT01655576|postpartum hemorrhage|postpartum hemorrhage
4995555|NCT01655563|Transplant|transplant
4995556|NCT01655563|Pediatrics|pediatrics
4995557|NCT01655563|Tacrolimus|tacrolimus
4995558|NCT01655563|Prograf|prograf
4995559|NCT01655537|fibromyalgia|fibromyalgia
4995560|NCT01655537|cognitive dysfunction|cognitive dysfunction
4995561|NCT01655524|Regadenoson|regadenoson
4995562|NCT01655524|Aminophylline|aminophylline
4995563|NCT01655524|ASSUAGE|assuage
4995564|NCT01655524|Myocardial Perfusion Imaging (MPI)|myocardial perfusion imaging (mpi)
4995565|NCT01655511|Pharmacokinetic|pharmacokinetic
4995566|NCT01655511|pharmacodynamic|pharmacodynamic
4995567|NCT01655498|fecal incontinence|fecal incontinence
4995568|NCT01655498|bowel control|bowel control
4995569|NCT01655485|child anxiety|child anxiety
4995570|NCT01655485|challenging behaviors|challenging behaviors
4995571|NCT01655485|time|time
4995572|NCT01655485|Parent anxiety|parent anxiety
4995573|NCT01655472|schizophrenia|schizophrenia
4995574|NCT01655472|imaging|imaging
4995575|NCT01655459|ultrasound, LMA, fiberoptic bronchoscopy|ultrasound, lma, fiberoptic bronchoscopy
4995576|NCT01655446|Comparative effectiveness research|comparative effectiveness research
4995577|NCT01655446|Robotic rehabilitation|robotic rehabilitation
4995578|NCT01655446|Mirror therapy|mirror therapy
4995579|NCT01655446|Functional electrical therapy|functional electrical therapy
4995684|NCT01655056|Ethnicity|ethnicity
4995580|NCT01655446|Combined therapy|combined therapy
4995581|NCT01655446|Stroke rehabilitation|stroke rehabilitation
4995582|NCT01655446|Translational science|translational science
4995583|NCT01655433|ST-elevation MI|st-elevation mi
4995584|NCT01655433|Hypothermia|hypothermia
4995585|NCT01655420|Myopia|myopia
4995586|NCT01655420|Hyperopia|hyperopia
4995587|NCT01655420|Astigmatism|astigmatism
4995588|NCT01655420|Patient-reported outcomes|patient-reported outcomes
4995589|NCT01655420|Patient satisfaction|patient satisfaction
4995590|NCT01655420|Refractive Error|refractive error
4995591|NCT01655420|Emmetropia|emmetropia
4995592|NCT01655420|Dry eyes|dry eyes
4995593|NCT01655420|Glare|glare
4995594|NCT01655420|Halos|halos
4995595|NCT01655420|Patient expectations|patient expectations
4995596|NCT01655407|Split-thickness Autograft|split-thickness autograft
4995597|NCT01655407|Engraftment|engraftment
4995598|NCT01655407|Wound Closure|wound closure
4995599|NCT01655407|Engineered Skin Substitute|engineered skin substitute
4995600|NCT01655407|ESS-W|ess-w
4995601|NCT01655407|Cultured Skin Substitutes|cultured skin substitutes
4995602|NCT01655407|Burn|burn
4995603|NCT01655342|pulpotomy|pulpotomy
4995604|NCT01655342|primary teeth|primary teeth
4995605|NCT01655342|Biodentine®|biodentine®
4995606|NCT01655342|formocresol|formocresol
4995607|NCT01655329|Image Processing|image processing
4995608|NCT01655329|tubes|tubes
4995609|NCT01655329|lines|lines
4995610|NCT01655329|catheters|catheters
4995611|NCT01655329|wires|wires
4995612|NCT01655329|Bedside|bedside
4995613|NCT01655329|chest|chest
4995614|NCT01655329|radiographs|radiographs
4995615|NCT01655264|Stroke|stroke
4995616|NCT01655264|Tele-health|tele-health
4995617|NCT01655264|Rehabilitation|rehabilitation
4995618|NCT01655264|Intervention|intervention
4995619|NCT01655264|Gesture recognition system|gesture recognition system
4995620|NCT01655251|children|children
4995621|NCT01655251|fever|fever
4995622|NCT01655251|emergency department|emergency department
4995623|NCT01655225|Advanced Breast Cancer|advanced breast cancer
4995624|NCT01655225|Advanced Lung Cancer|advanced lung cancer
4995625|NCT01655225|Mesothelioma|mesothelioma
4995626|NCT01655225|Lymphoma|lymphoma
4995627|NCT01655212|Cytomegalovirus|cytomegalovirus
4995628|NCT01655212|Congenital infection|congenital infection
4995629|NCT01655212|Sensorineural hearing loss|sensorineural hearing loss
4995630|NCT01655212|Randomized controlled trial|randomized controlled trial
4995631|NCT01655212|Valganciclovir|valganciclovir
4995632|NCT01655199|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
4995633|NCT01655199|Lung function|lung function
4995634|NCT01655199|Exertional dyspnea|exertional dyspnea
4995635|NCT01655199|Exercise capacity|exercise capacity
4995636|NCT01655199|Pulmonary function|pulmonary function
4995637|NCT01655199|Pleural pressures|pleural pressures
4995638|NCT01655186|Chronic Kidney Disease|chronic kidney disease
4995639|NCT01655186|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
4995640|NCT01655173|Asperger syndrome|asperger syndrome
4995641|NCT01655173|Autistic disorder|autistic disorder
4995642|NCT01655173|Adult|adult
4995643|NCT01655173|Psychotherapy|psychotherapy
4995644|NCT01655160|Stroke rehabilitation|stroke rehabilitation
4995645|NCT01655160|Mirror therapy|mirror therapy
4995646|NCT01655160|Functional performance|functional performance
4995647|NCT01655160|Kinematic analysis|kinematic analysis
4995648|NCT01655160|Functional magnetic resonance image|functional magnetic resonance image
4995649|NCT01655160|Motor recovery|motor recovery
4995650|NCT01655147|Healthy|healthy
4995651|NCT01655147|Pharmacokinetics|pharmacokinetics
4995652|NCT01655147|Abiraterone acetate|abiraterone acetate
4995653|NCT01655147|Abiraterone|abiraterone
4995654|NCT01655147|JNJ-589485|jnj-589485
4995655|NCT01655147|JNJ-212082|jnj-212082
4995656|NCT01655147|Zytiga|zytiga
4995657|NCT01655147|Rifampicin|rifampicin
4995658|NCT01655147|Rifadin|rifadin
4995659|NCT01655147|CYP3A4 inducer|cyp3a4 inducer
4995660|NCT01655134|Heart Failure|heart failure
4995661|NCT01655134|Telemonitoring systems for congestive HF|telemonitoring systems for congestive hf
4995662|NCT01655134|Biomarkers|biomarkers
4995663|NCT01655108|Androgenetic Alopecia|androgenetic alopecia
4995664|NCT01655108|Mesotherapy|mesotherapy
4995665|NCT01655108|Minoxidil|minoxidil
4995666|NCT01655108|Trichogram|trichogram
4995667|NCT01655095|Colon capsule|colon capsule
4995668|NCT01655095|Picosalax|picosalax
4995669|NCT01655095|PEG|peg
4995670|NCT01655095|Prucalopride|prucalopride
4995671|NCT01655082|Smoking cessation|smoking cessation
4995672|NCT01655082|Nicotine|nicotine
4995673|NCT01655082|Tobacco Use Disorder|tobacco use disorder
4995674|NCT01655082|Central Nervous System Agents|central nervous system agents
4995675|NCT01655069|Overactive bladder (OAB)|overactive bladder (oab)
4995676|NCT01655069|Solifenacin succinate suspension|solifenacin succinate suspension
4995677|NCT01655069|Phase 3|phase 3
4995678|NCT01655069|Pediatric|pediatric
4995679|NCT01655056|Pharmacokinetics|pharmacokinetics
4995680|NCT01655056|Pharmacodynamics|pharmacodynamics
4995681|NCT01655056|Phase 1|phase 1
4995682|NCT01655056|YM150|ym150
4995683|NCT01655056|Dose-escalating|dose-escalating
4995685|NCT01655056|Caucasian|caucasian
4995686|NCT01655056|Japanese|japanese
4995687|NCT01655043|Magnetic Resonance Imaging|magnetic resonance imaging
4995688|NCT01655043|regadenoson|regadenoson
4995689|NCT01655017|Obesity|obesity
4995690|NCT01655017|adipose tissue fibrosis|adipose tissue fibrosis
4995691|NCT01655017|Adipose tissue inflammation|adipose tissue inflammation
4995692|NCT01655017|Low grade systemic inflammation|low grade systemic inflammation
4995693|NCT01655017|non invasive device|non invasive device
4995694|NCT01655017|Bariatric surgery|bariatric surgery
4995695|NCT01655004|hormone receptor positive|hormone receptor positive
4995696|NCT01655004|breast cancer|breast cancer
4995697|NCT01654939|HIV|hiv
4995698|NCT01654939|hepatitis C|hepatitis c
4995699|NCT01654926|Feasibility of using the FlexFlowTM ultrafiltration pump in a non hospital environment|feasibility of using the flexflowtm ultrafiltration pump in a non hospital environment
4995700|NCT01654913|hemoglobin determination|hemoglobin determination
4995701|NCT01654913|oxygen|oxygen
4995702|NCT01654887|Comparative Effectiveness|comparative effectiveness
4995703|NCT01654887|Lung Ultrasound versus Chest X-ray|lung ultrasound versus chest x-ray
4995704|NCT01654887|Pneumonia|pneumonia
4995705|NCT01654887|Emergency Department|emergency department
4995706|NCT01654848|liver transplantation|liver transplantation
4995707|NCT01654848|thrombocytes|thrombocytes
4995708|NCT01654848|heparin-induced thrombocytopenia|heparin-induced thrombocytopenia
4995709|NCT01654848|multivariate analysis of associated factors of HIT 2 after OLT|multivariate analysis of associated factors of hit 2 after olt
4995710|NCT01654848|laboratory investigations of HIT-antibodies|laboratory investigations of hit-antibodies
4995711|NCT01654822|HPV|hpv
4995712|NCT01654822|cervix|cervix
4995713|NCT01654796|Depression|depression
4995714|NCT01654796|Treatment Resistant Depression|treatment resistant depression
4995715|NCT01654783|5-ASA, ulcerative colitis, active, remission, adherence|5-asa, ulcerative colitis, active, remission, adherence
4995716|NCT01654770|VCE, DBE,OGIB|vce, dbe,ogib
4995717|NCT01654770|consecutive|consecutive
4995718|NCT01654770|patients|patients
4995719|NCT01654731|PBC|pbc
4995720|NCT01654731|Bezafibrate|bezafibrate
4995721|NCT01654692|metastatic melanoma|metastatic melanoma
4995722|NCT01654692|Ipilimumab|ipilimumab
4995723|NCT01654679|wound infection|wound infection
4995724|NCT01654679|surgery|surgery
4995725|NCT01654679|surgical wound infection rate|surgical wound infection rate
4995726|NCT01654679|wound healing|wound healing
4995727|NCT01654666|Remote ischemic preconditioning|remote ischemic preconditioning
4995728|NCT01654666|Stroke secondary prevention|stroke secondary prevention
4995729|NCT01654666|Carotid artery stenting|carotid artery stenting
4995730|NCT01654666|Carotid stenosis|carotid stenosis
4995731|NCT01654666|Inflammation|inflammation
4995732|NCT01654653|Heart disease|heart disease
4995733|NCT01654653|cardiac surgery|cardiac surgery
4995734|NCT01654653|CABG|cabg
4995735|NCT01654653|Totilac|totilac
4995736|NCT01654653|Voluven|voluven
4995737|NCT01654653|6% HES|6% hes
4995738|NCT01654640|schizophrenia|schizophrenia
4995739|NCT01654640|obesity|obesity
4995740|NCT01654640|clozapine|clozapine
4995741|NCT01654640|metformin|metformin
4995742|NCT01654627|Guided Tissue Regeneration|guided tissue regeneration
4995743|NCT01654627|Dental Implants|dental implants
4995744|NCT01654627|Membrane, Synthetic|membrane, synthetic
4995745|NCT01654614|Keratoconus match index|keratoconus match index
4995746|NCT01654614|keratoconus probability index|keratoconus probability index
4995747|NCT01654614|ocular response analyzer|ocular response analyzer
4995748|NCT01654614|Pentacam|pentacam
4995749|NCT01654614|forme fruste keratoconus|forme fruste keratoconus
4995750|NCT01654601|Schizophrenia|schizophrenia
4995751|NCT01654588|BRONCHIAL CHALLANGE TEST, ASTHMA, METACHLINE, ADENOSINE|bronchial challange test, asthma, metachline, adenosine
4995752|NCT01654575|Methotrexate|methotrexate
4995753|NCT01654575|Knee Osteoarthritis|knee osteoarthritis
4995754|NCT01654575|Synovitis|synovitis
4995755|NCT01654575|Pain reduction|pain reduction
4995756|NCT01654575|Function scores|function scores
4995757|NCT01654549|Steatohepatitis,|steatohepatitis,
4995758|NCT01654549|Helicobacter pylori,|helicobacter pylori,
4995759|NCT01654549|Insulin resistance,|insulin resistance,
4995760|NCT01654549|Alanine aminotransferase,|alanine aminotransferase,
4995761|NCT01654549|Aspartate aminotransferase,|aspartate aminotransferase,
4995762|NCT01654536|PAR|par
4995763|NCT01654523|Trichotillomania|trichotillomania
4995764|NCT01654497|Brain|brain
4995765|NCT01654497|Glioma|glioma
4995766|NCT01654497|glioblastoma|glioblastoma
4995767|NCT01654497|metastases|metastases
4995768|NCT01654497|cancer|cancer
4995769|NCT01654497|ETS2101|ets2101
4995770|NCT01654497|leptomeningeal|leptomeningeal
4995771|NCT01654497|astrocytoma|astrocytoma
4995772|NCT01654497|oligodendroglioma|oligodendroglioma
4995773|NCT01654497|meningioma|meningioma
4995774|NCT01654471|Walking Impairment Questionnaire|walking impairment questionnaire
4995775|NCT01654471|Peripheral arterial occlusive disease|peripheral arterial occlusive disease
4995776|NCT01654471|Korean version|korean version
4995777|NCT01654458|Sexual Dysfunctions, Psychological|sexual dysfunctions, psychological
4995778|NCT01654458|Psychotherapy, Group|psychotherapy, group
4995779|NCT01654458|Genital Neoplasms, Female|genital neoplasms, female
4995877|NCT01653977|trauma|trauma
4995780|NCT01654458|Endometrial Neoplasms|endometrial neoplasms
4995781|NCT01654458|Fallopian Tube Neoplasms|fallopian tube neoplasms
4995782|NCT01654458|Ovarian Neoplasms|ovarian neoplasms
4995783|NCT01654458|Urogenital Neoplasms|urogenital neoplasms
4995784|NCT01654458|Uterine Cervical Neoplasms|uterine cervical neoplasms
4995785|NCT01654458|Uterine Neoplasms|uterine neoplasms
4995786|NCT01654458|Vaginal Neoplasms|vaginal neoplasms
4995787|NCT01654458|Vulvar Neoplasms|vulvar neoplasms
4995788|NCT01654445|Minor stroke|minor stroke
4995789|NCT01654419|sliding jig|sliding jig
4995790|NCT01654419|Class II malocclusion|class ii malocclusion
4995791|NCT01654419|Distalization mechanics|distalization mechanics
4995792|NCT01654419|Intermaxillary elastics|intermaxillary elastics
4995793|NCT01654406|Cesarian scar|cesarian scar
4995794|NCT01654406|Fractional CO2 laser|fractional co2 laser
4995795|NCT01654393|Triage nurse|triage nurse
4995796|NCT01654393|Ottawa ankle rules|ottawa ankle rules
4995797|NCT01654354|Qualitative Evaluation of abdominal CT image using 4 point scale: Excellent(4)/ Good(3) / Fair(2) / Unacceptable(1)|qualitative evaluation of abdominal ct image using 4 point scale: excellent(4)/ good(3) / fair(2) / unacceptable(1)
4995798|NCT01654328|contrast media|contrast media
4995799|NCT01654328|kidney injury|kidney injury
4995800|NCT01654328|hydration|hydration
4995801|NCT01654315|RTP Only Group|rtp only group
4995802|NCT01654315|Myomo Only Group|myomo only group
4995803|NCT01654315|Myom0 + RTP Group|myom0 + rtp group
4995804|NCT01654289|respiratory tract infections|respiratory tract infections
4995805|NCT01654289|common cold|common cold
4995806|NCT01654289|exercise|exercise
4995807|NCT01654289|influenza|influenza
4995808|NCT01654289|meditation|meditation
4995809|NCT01654263|13-valent|13-valent
4995810|NCT01654263|23-valent|23-valent
4995811|NCT01654263|elderly|elderly
4995812|NCT01654263|parent protocol|parent protocol
4995813|NCT01654263|Pneumococcal infections|pneumococcal infections
4995814|NCT01654263|vaccine|vaccine
4995815|NCT01654250|ADHD|adhd
4995816|NCT01654250|methylphenidate extended-release|methylphenidate extended-release
4995817|NCT01654237|work|work
4995818|NCT01654237|WMSD|wmsd
4995819|NCT01654237|prevalence|prevalence
4995820|NCT01654237|occupational risks|occupational risks
4995821|NCT01654237|industry|industry
4995822|NCT01654237|questionnaires|questionnaires
4995823|NCT01654237|musculoskeletal pain|musculoskeletal pain
4995824|NCT01654237|lifestyle|lifestyle
4995825|NCT01654224|Influenza in Long Term Care Setting|influenza in long term care setting
4995826|NCT01654224|High dose Inactivated influenza vaccine|high dose inactivated influenza vaccine
4995827|NCT01654224|Standard dose inactivated influenza vaccine|standard dose inactivated influenza vaccine
4995828|NCT01654172|Diabetes|diabetes
4995829|NCT01654172|peripheral neuropathy|peripheral neuropathy
4995830|NCT01654172|Cocoa flavanols|cocoa flavanols
4995831|NCT01654159|intraocular lenses|intraocular lenses
4995832|NCT01654159|evaluation|evaluation
4995833|NCT01654159|cataract|cataract
4995834|NCT01654146|Ovarian cancer|ovarian cancer
4995835|NCT01654146|Epithelial ovarian carcinoma|epithelial ovarian carcinoma
4995836|NCT01654146|Fallopian tube carcinoma|fallopian tube carcinoma
4995837|NCT01654146|Primary serous peritoneal carcinoma|primary serous peritoneal carcinoma
4995838|NCT01654146|Gynaecological carcinoma|gynaecological carcinoma
4995839|NCT01654146|Randomised controlled trial|randomised controlled trial
4995840|NCT01654133|Aortic Aneurysm, abdominal|aortic aneurysm, abdominal
4995841|NCT01654120|insulin|insulin
4995842|NCT01654120|Type II Diabetes|type ii diabetes
4995843|NCT01654120|liraglutide|liraglutide
4995844|NCT01654120|Glucagon-Like Peptide 1|glucagon-like peptide 1
4995845|NCT01654107|tobacco|tobacco
4995846|NCT01654107|smoking cessation|smoking cessation
4995847|NCT01654107|nicotine dependence|nicotine dependence
4995848|NCT01654081|Lung Cancer|lung cancer
4995849|NCT01654081|POSITIVE NON SMALL CELL CARCINOMA|positive non small cell carcinoma
4995850|NCT01654081|ISG15|isg15
4995851|NCT01654081|IRINOTECAN|irinotecan
4995852|NCT01654068|Female Breast Cancer|female breast cancer
4995853|NCT01654068|Kidney Cancer|kidney cancer
4995854|NCT01654068|Lung Cancer|lung cancer
4995855|NCT01654068|Prostate Cancer|prostate cancer
4995856|NCT01654068|Vertebral metastasis|vertebral metastasis
4995857|NCT01654055|Morphine|morphine
4995858|NCT01654055|Adverse events|adverse events
4995859|NCT01654055|Predictive factors|predictive factors
4995860|NCT01654042|anticoagulation|anticoagulation
4995861|NCT01654042|warfarin|warfarin
4995862|NCT01654042|monitoring|monitoring
4995863|NCT01654042|bleeding|bleeding
4995864|NCT01654042|thromboembolism|thromboembolism
4995865|NCT01654029|Stroke|stroke
4995866|NCT01654029|Communication impairments|communication impairments
4995867|NCT01654029|Nurse-patient communication|nurse-patient communication
4995868|NCT01654029|Patient-centred care|patient-centred care
4995869|NCT01654016|varicose veins|varicose veins
4995870|NCT01654016|inflammation|inflammation
4995871|NCT01654003|Goal-directed therapy|goal-directed therapy
4995872|NCT01654003|severe sepsis|severe sepsis
4995873|NCT01654003|emergency surgery|emergency surgery
4995874|NCT01654003|vasopressor|vasopressor
4995875|NCT01654003|dynamic flow-related parameters|dynamic flow-related parameters
4995876|NCT01653977|Hypovolemic shock|hypovolemic shock
4995878|NCT01653977|emergency|emergency
4995879|NCT01653977|surgery|surgery
4995880|NCT01653977|GDT|gdt
4995881|NCT01653977|Picco|picco
4995882|NCT01653964|suspicious|suspicious
4995883|NCT01653964|lesion|lesion
4995884|NCT01653964|breast|breast
4995885|NCT01653964|cancer|cancer
4995886|NCT01653964|screening|screening
4995887|NCT01653964|mammogram|mammogram
4995888|NCT01653964|negative|negative
4995889|NCT01653938|CHF|chf
4995890|NCT01653925|Prostatic Neoplasms|prostatic neoplasms
4995891|NCT01653925|Low grade prostate cancer|low grade prostate cancer
4995892|NCT01653912|cancer|cancer
4995893|NCT01653912|ovarian|ovarian
4995894|NCT01653912|platinum-resistant|platinum-resistant
4995895|NCT01653899|Type I Diabetes|type i diabetes
4995896|NCT01653886|Palatability|palatability
4995897|NCT01653886|Taste|taste
4995898|NCT01653873|fracture|fracture
4995899|NCT01653873|vertebral column|vertebral column
4995900|NCT01653873|osteoporosis|osteoporosis
4995901|NCT01653873|predictor|predictor
4995902|NCT01653873|vertebroplasty|vertebroplasty
4995903|NCT01653860|Behavior therapy|behavior therapy
4995904|NCT01653860|Group therapy|group therapy
4995905|NCT01653847|transplant|transplant
4995906|NCT01653847|kidney|kidney
4995907|NCT01653847|renal disease|renal disease
4995908|NCT01653834|lymphopenia|lymphopenia
4995909|NCT01653821|carotid body|carotid body
4995910|NCT01653821|heart failure|heart failure
4995911|NCT01653821|chemoreceptor|chemoreceptor
4995912|NCT01653821|hypersensitivity|hypersensitivity
4995913|NCT01653808|CKD dialysis|ckd dialysis
4995914|NCT01653808|hemodialysis|hemodialysis
4995915|NCT01653808|hemodiafiltration|hemodiafiltration
4995916|NCT01653808|Elisio dialyzer|elisio dialyzer
4995917|NCT01653808|efficacy|efficacy
4995918|NCT01653808|biocompatibility|biocompatibility
4995919|NCT01653782|LPB|lpb
4995920|NCT01653782|RCT|rct
4995921|NCT01653782|Intervention study|intervention study
4995922|NCT01653782|Cost effectiveness|cost effectiveness
4995923|NCT01653782|Yoga|yoga
4995924|NCT01653782|evidence based|evidence based
4995925|NCT01653782|advice to stay active|advice to stay active
4995926|NCT01653782|exercise training|exercise training
4995927|NCT01653769|CoSeal|coseal
4995928|NCT01653769|Surgical bleeding|surgical bleeding
4995929|NCT01653769|hemostasis|hemostasis
4995930|NCT01653769|Aortic anastamoses|aortic anastamoses
4995931|NCT01653769|bleeding|bleeding
4995932|NCT01653769|Cardiac surgery|cardiac surgery
4995933|NCT01653769|Aneurysms|aneurysms
4995934|NCT01653769|Aortic Dissection|aortic dissection
4995935|NCT01653756|Asthma|asthma
4995936|NCT01653756|Allergen Challenge|allergen challenge
4995937|NCT01653743|Japanese|japanese
4995938|NCT01653730|portable oxygen concentrator|portable oxygen concentrator
4995939|NCT01653730|6-minute walk test|6-minute walk test
4995940|NCT01653730|chronic obstructive lung disease|chronic obstructive lung disease
4995941|NCT01653730|pulmonary fibrosis|pulmonary fibrosis
4995942|NCT01653730|long term oxygen therapy|long term oxygen therapy
4995943|NCT01653717|Advanced Cancers|advanced cancers
4995944|NCT01653717|Leukemia|leukemia
4995945|NCT01653717|B-cell Chronic Lymphocytic Leukemia|b-cell chronic lymphocytic leukemia
4995946|NCT01653717|B-CLL|b-cll
4995947|NCT01653717|CD19 positivity|cd19 positivity
4995948|NCT01653717|CD19-specific T cells|cd19-specific t cells
4995949|NCT01653717|T-Cell Infusion|t-cell infusion
4995950|NCT01653717|Gene Transfer|gene transfer
4995951|NCT01653717|Leukapheresis|leukapheresis
4995952|NCT01653717|Fludarabine|fludarabine
4995953|NCT01653717|Fludarabine Phosphate|fludarabine phosphate
4995954|NCT01653717|Fludara|fludara
4995955|NCT01653717|Cyclophosphamide|cyclophosphamide
4995956|NCT01653717|Cytoxan|cytoxan
4995957|NCT01653717|Neosar|neosar
4995958|NCT01653691|Pediatric|pediatric
4995959|NCT01653691|Burns|burns
4995960|NCT01653691|Scars|scars
4995961|NCT01653691|Pulse Dye laser|pulse dye laser
4995962|NCT01653678|vitamin D-3|vitamin d-3
4995963|NCT01653678|omega-3 fatty acids|omega-3 fatty acids
4995964|NCT01653678|fish oil|fish oil
4995965|NCT01653678|hypertension|hypertension
4995966|NCT01653678|blood pressure|blood pressure
4995967|NCT01653652|grass pollen|grass pollen
4995968|NCT01653652|allergic rhinitis|allergic rhinitis
4995969|NCT01653652|TNSS|tnss
4995970|NCT01653652|miniRQLQ|minirqlq
4995971|NCT01653639|BAY14-2222|bay14-2222
4995972|NCT01653639|Pharmacokinetics|pharmacokinetics
4995973|NCT01653613|B-cell adult acute lymphoblastic leukemia|b-cell adult acute lymphoblastic leukemia
4995974|NCT01653613|B-cell childhood acute lymphoblastic leukemia|b-cell childhood acute lymphoblastic leukemia
4995975|NCT01653613|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
4995976|NCT01653613|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
4995977|NCT01653600|peripheral arterial disease|peripheral arterial disease
4995978|NCT01653600|atherosclerosis|atherosclerosis
4995979|NCT01653600|nitinol|nitinol
4995980|NCT01653600|stents|stents
4995981|NCT01653587|Transradial Approach|transradial approach
4995982|NCT01653587|Transfemoral Approach|transfemoral approach
4995983|NCT01653587|Vascular Closure Device|vascular closure device
4995984|NCT01653574|Famitinib Malate|famitinib malate
4995985|NCT01653574|Metastatic Breast Cancer|metastatic breast cancer
4995986|NCT01653574|HER-2 negative|her-2 negative
4995987|NCT01653561|Metastatic breast cancer|metastatic breast cancer
4995988|NCT01653561|Apatinib|apatinib
4995989|NCT01653561|non-triple-negative|non-triple-negative
4995990|NCT01653548|emotion dysregulation|emotion dysregulation
4995991|NCT01653548|borderline personality disorder|borderline personality disorder
4995992|NCT01653548|anxiety|anxiety
4995993|NCT01653548|depression|depression
4995994|NCT01653548|negative emotions|negative emotions
4995995|NCT01653548|outpatient interventions for negative emotions|outpatient interventions for negative emotions
4995996|NCT01653548|psychological distress|psychological distress
4995997|NCT01653548|emotion regulation problems|emotion regulation problems
4995998|NCT01653535|Prevention|prevention
4995999|NCT01653535|Health Service Use|health service use
4996000|NCT01653535|Behavioral Intervention|behavioral intervention
4996001|NCT01653535|Conduct Problems|conduct problems
4996002|NCT01653535|Anti-Social Behavior|anti-social behavior
4996003|NCT01653509|cold sore|cold sore
4996004|NCT01653496|Gastric cancer|gastric cancer
4996005|NCT01653496|Perioperative care|perioperative care
4996006|NCT01653496|Enhanced recovery after surgery|enhanced recovery after surgery
4996007|NCT01653496|Multimodal rehabilitation|multimodal rehabilitation
4996008|NCT01653496|Fast track surgery|fast track surgery
4996009|NCT01653496|Gastrectomy|gastrectomy
4996010|NCT01653483|Asthma|asthma
4996011|NCT01653483|Umeclidinium|umeclidinium
4996012|NCT01653483|Adolescent|adolescent
4996013|NCT01653483|Pharmacokinetics|pharmacokinetics
4996014|NCT01653457|Fibromyalgia|fibromyalgia
4996015|NCT01653457|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
4996016|NCT01653457|Memantine|memantine
4996017|NCT01653457|electroencephalic cordance|electroencephalic cordance
4996018|NCT01653405|anticoagulants|anticoagulants
4996019|NCT01653405|pharmacists|pharmacists
4996020|NCT01653405|quality improvement|quality improvement
4996021|NCT01653405|quality of health care|quality of health care
4996022|NCT01653392|Maternal Mortality|maternal mortality
4996023|NCT01653392|Obstetric Labor, Premature|obstetric labor, premature
4996024|NCT01653392|Eclampsia|eclampsia
4996025|NCT01653392|Pre-Eclampsia|pre-eclampsia
4996026|NCT01653392|Abortion, Spontaneous|abortion, spontaneous
4996027|NCT01653392|Diabetes, Gestational|diabetes, gestational
4996028|NCT01653392|Pregnancy, Ectopic|pregnancy, ectopic
4996029|NCT01653392|Hydatidiform Mole|hydatidiform mole
4996030|NCT01653392|Fetal death|fetal death
4996031|NCT01653392|Live birth|live birth
4996032|NCT01653392|Still birth|still birth
4996033|NCT01653392|Premature Birth|premature birth
4996034|NCT01653392|Sex ratio|sex ratio
4996035|NCT01653392|Birth weight|birth weight
4996036|NCT01653366|Breast Cancer|breast cancer
4996037|NCT01653353|nursing home|nursing home
4996038|NCT01653353|vitamin D supplements|vitamin d supplements
4996039|NCT01653353|calcium supplements|calcium supplements
4996040|NCT01653353|guideline adherence|guideline adherence
4996041|NCT01653340|Refractory Chronic Migraine|refractory chronic migraine
4996042|NCT01653340|Medically Intractable Chronic Migraine|medically intractable chronic migraine
4996043|NCT01653340|High Frequency Spinal Cord Stimulator|high frequency spinal cord stimulator
4996044|NCT01653327|mucositis|mucositis
4996045|NCT01653327|head and neck|head and neck
4996046|NCT01653327|cancer|cancer
4996047|NCT01653327|radiation therapy|radiation therapy
4996048|NCT01653327|chemoradiation|chemoradiation
4996049|NCT01653327|oral|oral
4996050|NCT01653327|pain|pain
4996051|NCT01653275|Mediterranean Diet|mediterranean diet
4996052|NCT01653275|Bone turnover|bone turnover
4996053|NCT01653275|postmenopausal women|postmenopausal women
4996054|NCT01653262|Brivaracetam|brivaracetam
4996055|NCT01653262|Levetiracetam|levetiracetam
4996056|NCT01653262|Epilepsy|epilepsy
4996057|NCT01653262|Nonpsychotic behavior|nonpsychotic behavior
4996058|NCT01653249|human papillomavirus (HPV)|human papillomavirus (hpv)
4996059|NCT01653249|vaccine|vaccine
4996060|NCT01653249|treatment|treatment
4996061|NCT01653210|Insulin Pump|insulin pump
4996062|NCT01653210|Continuous Glucose Monitor|continuous glucose monitor
4996063|NCT01653210|Premenopausal women|premenopausal women
4996064|NCT01653184|AMD|amd
4996065|NCT01653184|Vision loss|vision loss
4996066|NCT01653184|omega-3|omega-3
4996067|NCT01653184|supplement|supplement
4996068|NCT01653184|age related macular degeneration|age related macular degeneration
4996069|NCT01653171|Acetylcysteine, Simethicone, Stomach Neoplasms|acetylcysteine, simethicone, stomach neoplasms
4996070|NCT01653158|non-hematologic cancer|non-hematologic cancer
4996071|NCT01653158|advanced solid tumors|advanced solid tumors
4996072|NCT01653158|prostrate cancer|prostrate cancer
4996073|NCT01653145|Appetite|appetite
4996074|NCT01653145|Satiety|satiety
4996075|NCT01653132|PD|pd
4996076|NCT01653119|Acute coronary syndrome|acute coronary syndrome
4996077|NCT01653119|Diabetes mellitus|diabetes mellitus
4996078|NCT01653119|Statins|statins
4996079|NCT01653119|High loading dose|high loading dose
4996080|NCT01653119|Recurrent events|recurrent events
4996081|NCT01653106|cryotherapy|cryotherapy
4996082|NCT01653106|Melphalan|melphalan
4996083|NCT01653106|Mucositis|mucositis
4996084|NCT01653080|Solid Tumor|solid tumor
4996085|NCT01653080|Eye|eye
4996086|NCT01653080|Orbit|orbit
4996087|NCT01653067|Non Hodgkin´s Lymphoma|non hodgkin´s lymphoma
4996088|NCT01653067|Diffuse Large B-Cell Lymphoma|diffuse large b-cell lymphoma
4996089|NCT01653067|Aggressive Lymphoma|aggressive lymphoma
4996090|NCT01653067|Aggressive Non Hodgkin´s Lymphoma|aggressive non hodgkin´s lymphoma
4996091|NCT01653067|NHL|nhl
4996092|NCT01653067|aNHL|anhl
4996093|NCT01653067|Temsirolimus|temsirolimus
4996094|NCT01653067|Torisel|torisel
4996095|NCT01653067|Relapsed Non Hodgkin´s Lymphoma|relapsed non hodgkin´s lymphoma
4996096|NCT01653067|Relapsed Diffuse Large B-Cell Lymphoma|relapsed diffuse large b-cell lymphoma
4996097|NCT01653067|aggressive NHL|aggressive nhl
4996098|NCT01653067|B-NHL|b-nhl
4996099|NCT01653067|aggressive B-NHL|aggressive b-nhl
4996100|NCT01653041|immunosuppression, identical HLA, kidney transplantation, everolimus|immunosuppression, identical hla, kidney transplantation, everolimus
4996101|NCT01653002|Lung cancer|lung cancer
4996102|NCT01653002|EBUS-TBNA|ebus-tbna
4996103|NCT01653002|Epigenetics|epigenetics
4996104|NCT01653002|shox2 protein, human|shox2 protein, human
4996105|NCT01652989|weight loss|weight loss
4996106|NCT01652989|weight loss maintenance|weight loss maintenance
4996107|NCT01652989|community based participatory research|community based participatory research
4996108|NCT01652989|overweight|overweight
4996109|NCT01652976|Metastatic|metastatic
4996110|NCT01652976|Pancreatic Cancer|pancreatic cancer
4996111|NCT01652976|Adenocarcinoma|adenocarcinoma
4996112|NCT01652950|Physical activity|physical activity
4996113|NCT01652950|health-insured|health-insured
4996114|NCT01652950|Financial Incentives|financial incentives
4996115|NCT01652950|Benefits design|benefits design
4996116|NCT01652937|Rheumatoid Arthritis|rheumatoid arthritis
4996117|NCT01652937|DMARD-IR|dmard-ir
4996118|NCT01652924|mechanical ventilation|mechanical ventilation
4996119|NCT01652924|manual ventilation|manual ventilation
4996120|NCT01652911|Islet Transplantation|islet transplantation
4996121|NCT01652911|Cell Pouch|cell pouch
4996122|NCT01652898|PK|pk
4996123|NCT01652885|atopic dermatitis|atopic dermatitis
4996124|NCT01652872|anemia|anemia
4996125|NCT01652872|chronic kidney disease|chronic kidney disease
4996126|NCT01652872|kidney disease|kidney disease
4996127|NCT01652872|renal failure|renal failure
4996128|NCT01652833|Metastatic Colorectal Cancer|metastatic colorectal cancer
4996129|NCT01652820|LUNG|lung
4996130|NCT01652820|DOCETAXEL|docetaxel
4996131|NCT01652820|GEMCITABINE|gemcitabine
4996132|NCT01652820|CARBOPLATIN|carboplatin
4996133|NCT01652820|RADIOTHERAPY|radiotherapy
4996134|NCT01652781|myelodysplastic syndrome|myelodysplastic syndrome
4996135|NCT01652781|azacitidine|azacitidine
4996136|NCT01652781|dosing schedule|dosing schedule
4996137|NCT01652768|Malignant Brain Tumors|malignant brain tumors
4996138|NCT01652768|Malignant Glioma|malignant glioma
4996139|NCT01652768|High-grade Gliomas|high-grade gliomas
4996140|NCT01652768|Oncology|oncology
4996141|NCT01652768|Cancer|cancer
4996142|NCT01652768|Patient Caregiver|patient caregiver
4996143|NCT01652768|Caregiver Stress, Anxiety, Depression|caregiver stress, anxiety, depression
4996144|NCT01652768|Palliative Care Intervention|palliative care intervention
4996145|NCT01652755|cystatin C,acute kidney injury,|cystatin c,acute kidney injury,
4996146|NCT01652729|Diabetes, Type 2, exenatide, Sitagliptin|diabetes, type 2, exenatide, sitagliptin
4996147|NCT01652703|Japanese, hypercholesterolemia, high risk for cardiovascular events|japanese, hypercholesterolemia, high risk for cardiovascular events
4996148|NCT01652677|navigation transcranial magnetic stimulation|navigation transcranial magnetic stimulation
4996149|NCT01652677|stroke rehabilitation|stroke rehabilitation
4996150|NCT01652651|Learning Disorders|learning disorders
4996151|NCT01652638|subjects|subjects
4996152|NCT01652625|Yunnan Baiyao|yunnan baiyao
4996153|NCT01652625|recurrent aphthous stomatitis|recurrent aphthous stomatitis
4996154|NCT01652625|clinical trial|clinical trial
4996155|NCT01652612|positive end expiratory pressure|positive end expiratory pressure
4996156|NCT01652599|Eltrombopag|eltrombopag
4996157|NCT01652599|Dexamethasone|dexamethasone
4996158|NCT01652599|High-dose|high-dose
4996159|NCT01652599|ITP|itp
4996160|NCT01652586|cardiac ablation|cardiac ablation
4996161|NCT01652573|X linked hypophosphatemia|x linked hypophosphatemia
4996162|NCT01652573|calcitonin|calcitonin
4996163|NCT01652573|FGF twenty three|fgf twenty three
4996164|NCT01652560|bevacizumab|bevacizumab
4996165|NCT01652560|neoadjuvant chemotherapy|neoadjuvant chemotherapy
4996166|NCT01652560|HER2-negative breast cancer|her2-negative breast cancer
4996167|NCT01652547|Melanoma|melanoma
4996168|NCT01652547|Merkel cell carcinoma|merkel cell carcinoma
4996169|NCT01652547|Metastatic skin cancer|metastatic skin cancer
4996170|NCT01652534|Freezing of gait|freezing of gait
4996171|NCT01652534|gait dysfunction|gait dysfunction
4996172|NCT01652521|lung compliance|lung compliance
4996173|NCT01652521|pleural effusion|pleural effusion
4996174|NCT01652521|esophageal pressure|esophageal pressure
4996175|NCT01652508|smoking cessation|smoking cessation
4996176|NCT01652508|Acceptance and Commitment Therapy|acceptance and commitment therapy
4996177|NCT01652508|primary care setting|primary care setting
4996382|NCT01651676|LBD|lbd
4996178|NCT01652508|randomised controlled trial|randomised controlled trial
4996179|NCT01652495|rotatory cuff calcific tendonitis|rotatory cuff calcific tendonitis
4996180|NCT01652495|corticosteroids|corticosteroids
4996181|NCT01652495|US guided percutaneous treatment|us guided percutaneous treatment
4996182|NCT01652495|methylprednisolone|methylprednisolone
4996183|NCT01652495|triamcinolone|triamcinolone
4996184|NCT01652495|hypothalamus pituitary adrenal axis|hypothalamus pituitary adrenal axis
4996185|NCT01652469|squamous cell|squamous cell
4996186|NCT01652469|NSCLC|nsclc
4996187|NCT01652469|TKI|tki
4996188|NCT01652469|Erlotinib|erlotinib
4996189|NCT01652469|Docetaxel|docetaxel
4996190|NCT01652469|VeriStrat|veristrat
4996191|NCT01652469|protein signature|protein signature
4996192|NCT01652456|addiction support|addiction support
4996193|NCT01652456|addiction specialist|addiction specialist
4996194|NCT01652456|lung cancer|lung cancer
4996195|NCT01652456|head and neck cancer|head and neck cancer
4996196|NCT01652443|OEF/OIF Veterans|oef/oif veterans
4996197|NCT01652443|Relationships|relationships
4996198|NCT01652430|PTSD|ptsd
4996199|NCT01652430|Suicidal ideation|suicidal ideation
4996200|NCT01652430|Cognitive processes|cognitive processes
4996201|NCT01652417|Methylprednisolone|methylprednisolone
4996202|NCT01652417|prednisone|prednisone
4996203|NCT01652417|renal sarcoidosis treatment|renal sarcoidosis treatment
4996204|NCT01652404|ICU|icu
4996205|NCT01652404|sepsis|sepsis
4996206|NCT01652404|antibiotic therapy|antibiotic therapy
4996207|NCT01652404|procalcitonin|procalcitonin
4996208|NCT01652378|cocaine addiction|cocaine addiction
4996209|NCT01652378|neuroimaging|neuroimaging
4996210|NCT01652378|functional magnetic resonance imaging (fMRI)|functional magnetic resonance imaging (fmri)
4996211|NCT01652365|Malaria Diagnosis|malaria diagnosis
4996212|NCT01652365|Rapid Diagnostic Tests|rapid diagnostic tests
4996213|NCT01652365|RDTs|rdts
4996214|NCT01652365|Private Sector|private sector
4996215|NCT01652365|Retail Sector|retail sector
4996216|NCT01652365|Drug Shops|drug shops
4996217|NCT01652352|Disabled|disabled
4996218|NCT01652352|Disability|disability
4996219|NCT01652352|Power wheelchair|power wheelchair
4996220|NCT01652352|Wheelchair|wheelchair
4996221|NCT01652352|Wheelchair mounted robotic arm|wheelchair mounted robotic arm
4996222|NCT01652352|WMRA|wmra
4996223|NCT01652352|Assistive|assistive
4996224|NCT01652352|Assistive robot|assistive robot
4996225|NCT01652352|Assistive robotics|assistive robotics
4996226|NCT01652352|Rehabilitation robot|rehabilitation robot
4996227|NCT01652352|Rehabilitation engineering|rehabilitation engineering
4996228|NCT01652352|Rehabilitation robotics|rehabilitation robotics
4996229|NCT01652300|Oral health|oral health
4996230|NCT01652300|education|education
4996231|NCT01652300|knowledge|knowledge
4996232|NCT01652300|attitude|attitude
4996233|NCT01652300|performance|performance
4996234|NCT01652274|Child Passenger Safety|child passenger safety
4996235|NCT01652274|Parental perception of vulnerability|parental perception of vulnerability
4996236|NCT01652274|Neonatology|neonatology
4996237|NCT01652274|Newborn|newborn
4996238|NCT01652261|advanced stage|advanced stage
4996239|NCT01652248|Heart failure|heart failure
4996240|NCT01652248|Pacemaker|pacemaker
4996241|NCT01652248|cardiac resynchronization therapy|cardiac resynchronization therapy
4996242|NCT01652235|Abdominal aortic aneurysm|abdominal aortic aneurysm
4996243|NCT01652235|Endovascular|endovascular
4996244|NCT01652235|Fenestration|fenestration
4996245|NCT01652235|Juxtarenal|juxtarenal
4996246|NCT01652235|Off-the-shelf|off-the-shelf
4996247|NCT01652235|Pararenal|pararenal
4996248|NCT01652222|Alzheimer|alzheimer
4996249|NCT01652222|caregiver|caregiver
4996250|NCT01652222|dementia|dementia
4996251|NCT01652222|social support|social support
4996252|NCT01652222|Montessori|montessori
4996253|NCT01652222|Therapeutic game|therapeutic game
4996254|NCT01652196|colorectal cancer|colorectal cancer
4996255|NCT01652196|rectal cancer|rectal cancer
4996256|NCT01652196|FOLFOX|folfox
4996257|NCT01652196|Aflibercept|aflibercept
4996258|NCT01652183|Intravenous paracetamol|intravenous paracetamol
4996259|NCT01652183|catheter related bladder discomfort|catheter related bladder discomfort
4996260|NCT01652183|urologic surgery|urologic surgery
4996261|NCT01652157|prospective|prospective
4996262|NCT01652157|pancreatic insufficiency|pancreatic insufficiency
4996263|NCT01652157|fibrosing colonopathy|fibrosing colonopathy
4996264|NCT01652157|observational|observational
4996265|NCT01652157|pancreatic enzyme replacement therapy|pancreatic enzyme replacement therapy
4996266|NCT01652131|general anesthesia|general anesthesia
4996267|NCT01652131|volume kinetics|volume kinetics
4996268|NCT01652118|bronchopulmonary dysplasia|bronchopulmonary dysplasia
4996269|NCT01652118|clarithromycin|clarithromycin
4996270|NCT01652118|preterm babies|preterm babies
4996271|NCT01652105|Gastric bypass|gastric bypass
4996272|NCT01652105|Preoperative diet|preoperative diet
4996273|NCT01652105|Prodimed|prodimed
4996274|NCT01652092|immunodeficiency disorder|immunodeficiency disorder
4996275|NCT01652092|histiocytic disorder|histiocytic disorder
4996276|NCT01652079|Epithelial|epithelial
4996277|NCT01652079|Primary|primary
4996278|NCT01652053|InterCushion|intercushion
4996279|NCT01652040|Spinal Cord Injury|spinal cord injury
4996280|NCT01652040|Rehabilitation|rehabilitation
4996281|NCT01652040|Electrical Stimulation|electrical stimulation
4996282|NCT01652040|Testosterone|testosterone
4996283|NCT01652040|Body Composition|body composition
4996284|NCT01652040|Lipid and Glucose profile|lipid and glucose profile
4996285|NCT01652040|Ectopic Adiposity|ectopic adiposity
4996286|NCT01652027|FVIII inhibitors|fviii inhibitors
4996287|NCT01652014|Transplantation|transplantation
4996288|NCT01652014|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
4996289|NCT01652001|Xerostomia|xerostomia
4996290|NCT01652001|Antidepressant agents|antidepressant agents
4996291|NCT01652001|Antihypertensive agents|antihypertensive agents
4996292|NCT01651988|ketamine|ketamine
4996293|NCT01651988|propofol anesthesia|propofol anesthesia
4996294|NCT01651975|Dysphagia|dysphagia
4996295|NCT01651975|Thickening liquid|thickening liquid
4996296|NCT01651975|Thickening agent|thickening agent
4996297|NCT01651975|Fluoroscopic swallow study|fluoroscopic swallow study
4996298|NCT01651975|Aspiration|aspiration
4996299|NCT01651975|History of dysphagia|history of dysphagia
4996301|NCT01651975|Age > 18|age > 18
4996302|NCT01651975|comprehensive DSS|comprehensive dss
4996303|NCT01651975|informed consent|informed consent
4996304|NCT01651962|Labor Pain|labor pain
4996305|NCT01651962|Analgesia, Epidural|analgesia, epidural
4996306|NCT01651923|subjects|subjects
4996307|NCT01651910|Cancer Pain|cancer pain
4996308|NCT01651910|Breakthrough Pain|breakthrough pain
4996309|NCT01651910|Unmet Needs|unmet needs
4996310|NCT01651910|Supportive care needs|supportive care needs
4996311|NCT01651897|delirium|delirium
4996312|NCT01651897|emergency department|emergency department
4996313|NCT01651897|natural course|natural course
4996314|NCT01651897|outcomes|outcomes
4996315|NCT01651897|elderly|elderly
4996316|NCT01651884|Stroke|stroke
4996317|NCT01651884|Anomia|anomia
4996318|NCT01651871|Agents, anti allergic|agents, anti allergic
4996319|NCT01651871|Nasal congestion|nasal congestion
4996320|NCT01651871|Sneezing|sneezing
4996321|NCT01651871|Nasal discharge|nasal discharge
4996322|NCT01651871|D prostanoid (DP) receptor antagonist|d prostanoid (dp) receptor antagonist
4996323|NCT01651832|Colorectal Neoplasms/*drug therapy/*secondary|colorectal neoplasms/*drug therapy/*secondary
4996324|NCT01651832|Health Services Accessibility|health services accessibility
4996325|NCT01651832|Humans|humans
4996326|NCT01651832|Supportive Care Needs|supportive care needs
4996327|NCT01651832|Psychooncology|psychooncology
4996328|NCT01651832|Rural Population|rural population
4996329|NCT01651832|Primary Health Care/*methods|primary health care/*methods
4996330|NCT01651832|Treatment Outcome|treatment outcome
4996331|NCT01651832|Socioeconomic Factors|socioeconomic factors
4996332|NCT01651832|Quality Assurance, Health Care|quality assurance, health care
4996333|NCT01651832|Quality of Life|quality of life
4996334|NCT01651832|Adult|adult
4996335|NCT01651832|Aged|aged
4996336|NCT01651832|Aged, 80 and over|aged, 80 and over
4996337|NCT01651819|HTLV-1|htlv-1
4996338|NCT01651819|neurogenic bladder|neurogenic bladder
4996339|NCT01651819|physical therapy|physical therapy
4996340|NCT01651819|Tropical Spastic Paraparesis|tropical spastic paraparesis
4996341|NCT01651806|Blood loss|blood loss
4996342|NCT01651806|transfusion rates|transfusion rates
4996343|NCT01651806|complications|complications
4996344|NCT01651793|cacao|cacao
4996345|NCT01651793|theobromine|theobromine
4996346|NCT01651793|flavanols|flavanols
4996347|NCT01651793|caffeine|caffeine
4996348|NCT01651793|sustained attention|sustained attention
4996349|NCT01651793|vigilance|vigilance
4996350|NCT01651793|vigor|vigor
4996351|NCT01651793|vitality|vitality
4996352|NCT01651793|energy|energy
4996353|NCT01651793|fatigue|fatigue
4996354|NCT01651780|Transcatheter aortic valve replacement|transcatheter aortic valve replacement
4996355|NCT01651780|Aortic valve replacement|aortic valve replacement
4996356|NCT01651780|Severe aortic stenosis|severe aortic stenosis
4996357|NCT01651767|Chronic hepatitis C virus infection|chronic hepatitis c virus infection
4996358|NCT01651767|JNJ-47910382|jnj-47910382
4996359|NCT01651767|Pharmacokinetics|pharmacokinetics
4996360|NCT01651767|Caucasian genotype-1|caucasian genotype-1
4996361|NCT01651767|Non-structural protein 5A (NS5A) inhibitor|non-structural protein 5a (ns5a) inhibitor
4996362|NCT01651741|Intestinal Microbiota|intestinal microbiota
4996363|NCT01651741|Probiotics|probiotics
4996364|NCT01651741|Seaweed|seaweed
4996365|NCT01651741|Healthy Subject|healthy subject
4996366|NCT01651728|Simvastatin|simvastatin
4996367|NCT01651728|Pneumonia|pneumonia
4996368|NCT01651728|Elderly|elderly
4996369|NCT01651728|TNF-α|tnf-α
4996370|NCT01651728|IFN-ϒ|ifn-ϒ
4996371|NCT01651728|PAI-1|pai-1
4996372|NCT01651728|CRP|crp
4996373|NCT01651702|Arrhythmia|arrhythmia
4996374|NCT01651702|Electroanatomical mapping|electroanatomical mapping
4996375|NCT01651689|Scalp biopsy|scalp biopsy
4996376|NCT01651689|Hair count|hair count
4996377|NCT01651689|Vertical section|vertical section
4996378|NCT01651689|Horizontal section|horizontal section
4996379|NCT01651689|Thais|thais
4996380|NCT01651676|VQ11 questionnaire|vq11 questionnaire
4996381|NCT01651676|COPD|copd
4996383|NCT01651663|Influenza|influenza
4996384|NCT01651650|Asthma|asthma
4996385|NCT01651650|PIF|pif
4996386|NCT01651637|Respiratory Distress syndrome|respiratory distress syndrome
4996387|NCT01651637|Complications of prematurity|complications of prematurity
4996388|NCT01651624|Colorectal Cancer|colorectal cancer
4996389|NCT01651624|Screening|screening
4996390|NCT01651624|Fecal Occult Blood Test|fecal occult blood test
4996391|NCT01651624|CT Colonography|ct colonography
4996392|NCT01651624|Virtual Colonoscopy|virtual colonoscopy
4996393|NCT01651624|Colonoscopy|colonoscopy
4996394|NCT01651611|Tobacco Cessation|tobacco cessation
4996395|NCT01651611|Public Housing|public housing
4996396|NCT01651611|Community Health Workers|community health workers
4996397|NCT01651611|Motivational Interviewing|motivational interviewing
4996398|NCT01651611|Patient centered|patient centered
4996399|NCT01651611|Low-income|low-income
4996400|NCT01651611|Tobacco Treatment Advocates|tobacco treatment advocates
4996401|NCT01651611|Social Epidemiology|social epidemiology
4996402|NCT01651611|Smoking cessation predictors|smoking cessation predictors
4996403|NCT01651611|Behavioral Intervention|behavioral intervention
4996404|NCT01651611|Non-pharmacologic|non-pharmacologic
4996405|NCT01651585|viral disease|viral disease
4996406|NCT01651585|cytomegalovirus infection|cytomegalovirus infection
4996407|NCT01651585|is the first cause|is the first cause
4996408|NCT01651585|of congenital|of congenital
4996409|NCT01651585|neurological handicap|neurological handicap
4996410|NCT01651585|of infectious origin.|of infectious origin.
4996411|NCT01651572|Postoperative residual curarization|postoperative residual curarization
4996412|NCT01651572|Residual neuromuscular block|residual neuromuscular block
4996413|NCT01651572|Complications|complications
4996414|NCT01651572|Postoperative|postoperative
4996415|NCT01651572|Neuromuscular function|neuromuscular function
4996416|NCT01651572|Neuromuscular block|neuromuscular block
4996417|NCT01651559|modified PASI|modified pasi
4996418|NCT01651559|narrow band UVB phototherapy|narrow band uvb phototherapy
4996419|NCT01651559|Dead Sea Minerals|dead sea minerals
4996420|NCT01651559|Skin auto-Fluorescence|skin auto-fluorescence
4996421|NCT01651559|Skin wash samples|skin wash samples
4996422|NCT01651546|Clean Intermittent Self Catheterization|clean intermittent self catheterization
4996423|NCT01651546|acceptance|acceptance
4996424|NCT01651546|test|test
4996425|NCT01651533|Mental practice group|mental practice group
4996426|NCT01651533|Active control group|active control group
4996427|NCT01651520|Neurodegeneration|neurodegeneration
4996428|NCT01651520|Disability|disability
4996429|NCT01651520|Cognition|cognition
4996430|NCT01651520|Prognosis|prognosis
4996431|NCT01651507|Pulmonary Langerhans cell histiocytosis|pulmonary langerhans cell histiocytosis
4996432|NCT01651494|DAS181|das181
4996433|NCT01651494|Influenza|influenza
4996434|NCT01651494|inhalation|inhalation
4996435|NCT01651494|inpatient clinic|inpatient clinic
4996436|NCT01651494|Multi-Dose|multi-dose
4996437|NCT01651494|recombinant neuraminidase|recombinant neuraminidase
4996438|NCT01651481|Rhinitis|rhinitis
4996439|NCT01651468|mild bleeding disorder|mild bleeding disorder
4996440|NCT01651455|Cystic Fibrosis|cystic fibrosis
4996441|NCT01651455|Pseudomonas Aeruginosa|pseudomonas aeruginosa
4996442|NCT01651429|Sleep Deprivation|sleep deprivation
4996443|NCT01651416|Home management of malaria|home management of malaria
4996444|NCT01651416|Seasonal malaria chemoprevention|seasonal malaria chemoprevention
4996445|NCT01651403|Hepatitis|hepatitis
4996446|NCT01651403|Hepatitis B|hepatitis b
4996447|NCT01651403|HBV|hbv
4996448|NCT01651390|Restenosis|restenosis
4996449|NCT01651390|Drug coated balloon|drug coated balloon
4996450|NCT01651390|Drug eluting stent|drug eluting stent
4996451|NCT01651390|Paclitaxel|paclitaxel
4996452|NCT01651390|Sirolimus|sirolimus
4996453|NCT01651377|Pramipexole|pramipexole
4996454|NCT01651377|Mirapex|mirapex
4996455|NCT01651377|Cocaine|cocaine
4996456|NCT01651364|Cocaine|cocaine
4996457|NCT01651364|Cabergoline|cabergoline
4996458|NCT01651351|for this study|for this study
4996459|NCT01651351|volunteers|volunteers
4996460|NCT01651351|Focus|focus
4996461|NCT01651351|Condition:|condition:
4996462|NCT01651338|Acupuncture|acupuncture
4996463|NCT01651338|quality of life|quality of life
4996464|NCT01651325|Isavuconazole|isavuconazole
4996465|NCT01651325|dextromethorphan|dextromethorphan
4996466|NCT01651325|dextrorphan|dextrorphan
4996467|NCT01651325|DXM|dxm
4996468|NCT01651325|Healthy Volunteers|healthy volunteers
4996469|NCT01651325|BAL4815|bal4815
4996470|NCT01651312|Radioactivity|radioactivity
4996471|NCT01651312|Excretion rate|excretion rate
4996472|NCT01651312|Human subjects|human subjects
4996473|NCT01651312|Pharmacokinetics|pharmacokinetics
4996474|NCT01651312|YM178|ym178
4996475|NCT01651312|Radio-labeled|radio-labeled
4996476|NCT01651312|Phase 1|phase 1
4996477|NCT01651299|copperhead snake envenomation|copperhead snake envenomation
4996478|NCT01651286|General anesthesia|general anesthesia
4996479|NCT01651286|Positive-pressure ventilation|positive-pressure ventilation
4996480|NCT01651286|Masks|masks
4996481|NCT01651247|Toddlers|toddlers
4996482|NCT01651247|Retrospective|retrospective
4996483|NCT01651247|Porcine circovirus type 1 (PCV-1)|porcine circovirus type 1 (pcv-1)
4996484|NCT01651247|Infants|infants
4996485|NCT01651247|Laboratory evaluations|laboratory evaluations
4996486|NCT01651247|IPV|ipv
4996487|NCT01651221|gustatory response|gustatory response
4996488|NCT01651221|olfactory response|olfactory response
4996489|NCT01651208|Coronary stents|coronary stents
4996490|NCT01651208|Medication adherence|medication adherence
4996491|NCT01651208|Antiplatelet medications|antiplatelet medications
4996492|NCT01651208|Motivational Interviewing|motivational interviewing
4996493|NCT01651182|Blood transfusion|blood transfusion
4996494|NCT01651182|Blood loss|blood loss
4996495|NCT01651182|Postoperative complications|postoperative complications
4996496|NCT01651182|Outcome|outcome
4996497|NCT01651169|Paired Transcranial Magnetic Stimulation|paired transcranial magnetic stimulation
4996498|NCT01651169|Methamphetamine abuse, ADHD, Methylphenidate|methamphetamine abuse, adhd, methylphenidate
4996499|NCT01651169|We study the effect of Methamphetamine abuse on Intracortical Inhibition, in ADHD patients, treated with Methylphenidate.|we study the effect of methamphetamine abuse on intracortical inhibition, in adhd patients, treated with methylphenidate.
4996500|NCT01651130|pregnancy|pregnancy
4996501|NCT01651130|postpartum hemorrhage|postpartum hemorrhage
4996502|NCT01651130|Cesarean delivery|cesarean delivery
4996503|NCT01651130|carbetocin|carbetocin
4996504|NCT01651117|Diabetes Mellitus|diabetes mellitus
4996505|NCT01651117|Mentors|mentors
4996506|NCT01651117|Glucose control|glucose control
4996507|NCT01651117|Hemoglobin A, Glycosylated|hemoglobin a, glycosylated
4996508|NCT01651117|Randomized Controlled Trial|randomized controlled trial
4996509|NCT01651117|Veterans|veterans
4996510|NCT01651104|Influenza, Trivalent, Adjuvanted, Adjuvant, MF59, MF-59, Fluad, Seasonal|influenza, trivalent, adjuvanted, adjuvant, mf59, mf-59, fluad, seasonal
4996511|NCT01651078|Metastatic Brain Tumors|metastatic brain tumors
4996512|NCT01651078|Progression|progression
4996513|NCT01651078|Radiation Necrosis|radiation necrosis
4996514|NCT01651078|Quality of Life|quality of life
4996515|NCT01651052|Aortic valve replacement/regurgitation|aortic valve replacement/regurgitation
4996516|NCT01651039|Panobinostat|panobinostat
4996517|NCT01651039|Lenalidomide|lenalidomide
4996518|NCT01651039|Dexamethasone|dexamethasone
4996519|NCT01651000|Parathyroid Diseases|parathyroid diseases
4996520|NCT01651000|Renal Insufficiency|renal insufficiency
4996521|NCT01651000|Kidney Failure, Chronic|kidney failure, chronic
4996522|NCT01651000|Hyperparathyroidism, Secondary|hyperparathyroidism, secondary
4996523|NCT01651000|Vitamin D|vitamin d
4996524|NCT01651000|Hyperparathyroidism|hyperparathyroidism
4996525|NCT01651000|Kidney Diseases|kidney diseases
4996526|NCT01651000|Kidney Failure|kidney failure
4996527|NCT01651000|Renal Insufficiency, Chronic|renal insufficiency, chronic
4996528|NCT01650987|carcinoma|carcinoma
4996529|NCT01650987|uterus|uterus
4996530|NCT01650987|Not metastatic|not metastatic
4996531|NCT01650974|high flow nasal oxygen therapy|high flow nasal oxygen therapy
4996532|NCT01650974|diagnostic bronchoscopy|diagnostic bronchoscopy
4996533|NCT01650948|age-related macular degeneration|age-related macular degeneration
4996534|NCT01650948|AMD|amd
4996535|NCT01650935|Nephrolithiasis|nephrolithiasis
4996536|NCT01650935|Recurrent stone former|recurrent stone former
4996537|NCT01650935|DASH|dash
4996538|NCT01650935|Urine oxalate|urine oxalate
4996539|NCT01650935|Urine calcium oxalate supersaturation|urine calcium oxalate supersaturation
4996540|NCT01650896|Delirium|delirium
4996541|NCT01650896|Dementia|dementia
4996542|NCT01650896|Instrumental activities of daily living|instrumental activities of daily living
4996543|NCT01650883|Vitamin D3|vitamin d3
4996544|NCT01650883|Vitamin D 25 OH|vitamin d 25 oh
4996545|NCT01650870|Cathartics|cathartics
4996546|NCT01650870|Laxatives|laxatives
4996547|NCT01650870|Lactulose|lactulose
4996548|NCT01650870|Gastrointestinal Agents|gastrointestinal agents
4996549|NCT01650870|Therapeutic Uses|therapeutic uses
4996550|NCT01650870|Pharmacologic Actions|pharmacologic actions
4996551|NCT01650857|Pulmonary hypertension|pulmonary hypertension
4996552|NCT01650857|Rehabilitation|rehabilitation
4996553|NCT01650857|Exercise capacity|exercise capacity
4996554|NCT01650857|Body composition|body composition
4996555|NCT01650857|Health related Quality of Life|health related quality of life
4996556|NCT01650831|Helicobacter Pylori|helicobacter pylori
4996557|NCT01650831|13C Urea Breath Test|13c urea breath test
4996558|NCT01650831|BreathID|breathid
4996559|NCT01650818|Amyotrophic lateral sclerosis|amyotrophic lateral sclerosis
4996560|NCT01650818|Aerobic training|aerobic training
4996561|NCT01650818|Peak oxygen consumption|peak oxygen consumption
4996562|NCT01650818|Quality of life|quality of life
4996563|NCT01650805|Leukemia|leukemia
4996564|NCT01650805|Leukemia, Myeloid|leukemia, myeloid
4996565|NCT01650805|Leukemia, Myelogenous, Chronic, BCR-ABL Positive|leukemia, myelogenous, chronic, bcr-abl positive
4996566|NCT01650805|Neoplasms by Histologic Type|neoplasms by histologic type
4996567|NCT01650805|Neoplasms|neoplasms
4996568|NCT01650805|Lymphoproliferative Disorders|lymphoproliferative disorders
4996569|NCT01650805|Lymphatic Diseases|lymphatic diseases
4996570|NCT01650805|Immunoproliferative Disorders|immunoproliferative disorders
4996571|NCT01650805|Immune System Diseases|immune system diseases
4996572|NCT01650805|Myeloproliferative Disorders|myeloproliferative disorders
4996573|NCT01650805|Bone Marrow Diseases|bone marrow diseases
4996574|NCT01650805|Hematologic Diseases|hematologic diseases
4996575|NCT01650792|Chagas disease|chagas disease
4996576|NCT01650792|Heart failure|heart failure
4996577|NCT01650792|Stroke|stroke
4996578|NCT01650792|Dementia|dementia
4996579|NCT01650779|alpha-galactosidase A|alpha-galactosidase a
4996580|NCT01650779|a-GAL|a-gal
4996581|NCT01650779|Fabry|fabry
4996582|NCT01650779|GL-3|gl-3
4996583|NCT01650779|Fabrazyme|fabrazyme
4996584|NCT01650701|follicular lymphoma|follicular lymphoma
4996585|NCT01650701|non-hodgkins follicular lymphoma|non-hodgkins follicular lymphoma
4996586|NCT01650701|treatment for follicular lymphoma|treatment for follicular lymphoma
4996587|NCT01650701|rituximab treatment|rituximab treatment
4996588|NCT01650701|rituximab and lenalidomide treatment|rituximab and lenalidomide treatment
4996589|NCT01650688|Epiblepharon, general anesthesia, positional change|epiblepharon, general anesthesia, positional change
4996590|NCT01650675|pregnancy|pregnancy
4996591|NCT01650675|screening|screening
4996592|NCT01650675|motivation|motivation
4996593|NCT01650662|Acute Myocardial Infarction|acute myocardial infarction
4996594|NCT01650662|Cyclosporine A|cyclosporine a
4996595|NCT01650662|Reperfusion|reperfusion
4996596|NCT01650662|Clinical Trial|clinical trial
4996597|NCT01650649|lofexidine|lofexidine
4996598|NCT01650649|methadone|methadone
4996599|NCT01650649|interaction|interaction
4996600|NCT01650649|pharmacodynamic|pharmacodynamic
4996601|NCT01650649|ECG|ecg
4996602|NCT01650649|QTc|qtc
4996603|NCT01650636|Videophone-delivered stress management intervention|videophone-delivered stress management intervention
4996604|NCT01650636|Chronic fatigue syndrome|chronic fatigue syndrome
4996605|NCT01650636|Symptoms|symptoms
4996606|NCT01650636|Neuroimmune processes|neuroimmune processes
4996607|NCT01650636|Psychosocial|psychosocial
4996608|NCT01650623|Parkinson´s Disease|parkinson´s disease
4996609|NCT01650623|Rehabilitation|rehabilitation
4996610|NCT01650623|Cognition|cognition
4996611|NCT01650610|Parkinson´s Disease|parkinson´s disease
4996612|NCT01650610|Rehabilitation|rehabilitation
4996613|NCT01650610|Cognition|cognition
4996614|NCT01650597|Healthy volunteers|healthy volunteers
4996615|NCT01650597|Pharmacokinetics|pharmacokinetics
4996616|NCT01650597|Free fatty amides|free fatty amides
4996617|NCT01650558|Malaria|malaria
4996618|NCT01650558|HIV|hiv
4996619|NCT01650558|Prophylaxis|prophylaxis
4996620|NCT01650558|Antiretroviral therapy|antiretroviral therapy
4996621|NCT01650545|case-control study|case-control study
4996622|NCT01650545|aerosolized liposomal cyclosporine A|aerosolized liposomal cyclosporine a
4996623|NCT01650545|bronchiolitis obliterans syndrome|bronchiolitis obliterans syndrome
4996624|NCT01650545|Lung Transplantation|lung transplantation
4996625|NCT01650545|Lung function|lung function
4996626|NCT01650519|knee surgery, arthroscopy; orthopaedic, orthopedic surgery|knee surgery, arthroscopy; orthopaedic, orthopedic surgery
4996627|NCT01650506|Triple Negative|triple negative
4996628|NCT01650506|Basal-like|basal-like
4996629|NCT01650493|remineralization|remineralization
4996630|NCT01650493|demineralzation|demineralzation
4996631|NCT01650493|in situ|in situ
4996632|NCT01650493|dentrifice|dentrifice
4996633|NCT01650480|COPD|copd
4996634|NCT01650480|holistic|holistic
4996635|NCT01650480|pilot|pilot
4996636|NCT01650480|intervention|intervention
4996637|NCT01650467|abl polymorphisms|abl polymorphisms
4996638|NCT01650454|Alzheimer|alzheimer
4996639|NCT01650454|Sleep|sleep
4996640|NCT01650454|Somnolence|somnolence
4996641|NCT01650441|Asthma|asthma
4996642|NCT01650441|NEXThaler®|nexthaler®
4996643|NCT01650441|Formoterol|formoterol
4996644|NCT01650441|Beclomethasone Dipropionate|beclomethasone dipropionate
4996645|NCT01650441|Computational Fluid Dynamics|computational fluid dynamics
4996646|NCT01650441|Functional Imaging|functional imaging
4996647|NCT01650441|Central and Peripheral Airways|central and peripheral airways
4996648|NCT01650441|Asthma Control Test (ACT™)|asthma control test (act™)
4996649|NCT01650441|Asthma Control Questionnaire (ACQ)|asthma control questionnaire (acq)
4996650|NCT01650428|Rectal Cancer|rectal cancer
4996651|NCT01650428|Bevacizumab|bevacizumab
4996652|NCT01650428|Neoadjuvant|neoadjuvant
4996653|NCT01650428|Chemotherapy|chemotherapy
4996654|NCT01650428|Randomised|randomised
4996655|NCT01650415|Cerebral Palsy|cerebral palsy
4996656|NCT01650415|Erythropoietin|erythropoietin
4996657|NCT01650415|Rehabilitation|rehabilitation
4996658|NCT01650402|Hypertension, systolic|hypertension, systolic
4996659|NCT01650402|Elderly (> or equal to 75 years)|elderly (> or equal to 75 years)
4996660|NCT01650402|Cerebrovascular disease|cerebrovascular disease
4996661|NCT01650389|Tuberculosis|tuberculosis
4996662|NCT01650389|HIV|hiv
4996663|NCT01650389|BCG|bcg
4996664|NCT01650389|Infant|infant
4996665|NCT01650376|Ovarian Neoplasms|ovarian neoplasms
4996666|NCT01650376|Cancer of the Ovary|cancer of the ovary
4996667|NCT01650376|Ovarian Cancer|ovarian cancer
4996668|NCT01650376|Uterine Neoplasms|uterine neoplasms
4996669|NCT01650376|Cancer of the Uterus|cancer of the uterus
4996670|NCT01650376|Uterine Cancer|uterine cancer
4996671|NCT01650376|Olaparib|olaparib
4996672|NCT01650376|AZD2281|azd2281
4996673|NCT01650376|Carboplatin|carboplatin
4996674|NCT01650376|Paclitaxel|paclitaxel
4996675|NCT01650376|Relapsed|relapsed
4996780|NCT01649765|safety|safety
4996676|NCT01650363|Complementary and alternative medicine|complementary and alternative medicine
4996677|NCT01650363|Post operative recovery|post operative recovery
4996678|NCT01650363|Cardio- thoracic surgery|cardio- thoracic surgery
4996679|NCT01650350|Melanoma|melanoma
4996680|NCT01650350|Prostate Cancer|prostate cancer
4996681|NCT01650350|Renal Cancer|renal cancer
4996682|NCT01650324|DBPR108|dbpr108
4996683|NCT01650324|DPP4|dpp4
4996684|NCT01650324|Diabetes|diabetes
4996685|NCT01650324|GLP-1|glp-1
4996686|NCT01650324|Incretins|incretins
4996687|NCT01650311|IBD, CD, UC, Serotonin, 5-HT|ibd, cd, uc, serotonin, 5-ht
4996688|NCT01650285|Prostate Cancer|prostate cancer
4996689|NCT01650285|Radical prostatectomy|radical prostatectomy
4996690|NCT01650207|electroacupuncture|electroacupuncture
4996691|NCT01650207|TENS|tens
4996692|NCT01650207|shoulder disorder|shoulder disorder
4996693|NCT01650207|hemiplegia|hemiplegia
4996694|NCT01650194|abiraterone acetate|abiraterone acetate
4996695|NCT01650194|prednisone|prednisone
4996696|NCT01650194|enzalutamide|enzalutamide
4996697|NCT01650194|cancer|cancer
4996698|NCT01650194|prostate|prostate
4996699|NCT01650194|MDV3100|mdv3100
4996700|NCT01650181|nafld, nash, fatty liver|nafld, nash, fatty liver
4996701|NCT01650168|NOMAC-E2|nomac-e2
4996702|NCT01650168|Nomegestrol acetate|nomegestrol acetate
4996703|NCT01650168|Estradiol|estradiol
4996704|NCT01650168|Levonorgestrel|levonorgestrel
4996705|NCT01650168|Safety|safety
4996706|NCT01650142|Neurofibromatosis 1|neurofibromatosis 1
4996707|NCT01650142|Phenotype|phenotype
4996708|NCT01650142|Modifiers|modifiers
4996709|NCT01650116|hypovolemia|hypovolemia
4996710|NCT01650116|renal hypoperfusion|renal hypoperfusion
4996711|NCT01650116|liver transplantation|liver transplantation
4996712|NCT01650116|sodium|sodium
4996713|NCT01650116|chloride|chloride
4996714|NCT01650116|PuCO2|puco2
4996715|NCT01650116|ScvO2|scvo2
4996716|NCT01650116|PiCCO|picco
4996717|NCT01650116|O2-delivery|o2-delivery
4996718|NCT01650116|hemodynamic indexes|hemodynamic indexes
4996719|NCT01650103|hypovolemia|hypovolemia
4996720|NCT01650103|renal hypoperfusion|renal hypoperfusion
4996721|NCT01650103|major surgery|major surgery
4996722|NCT01650103|sodium|sodium
4996723|NCT01650103|potassium|potassium
4996724|NCT01650103|chloride|chloride
4996725|NCT01650103|ScvO2|scvo2
4996726|NCT01650103|hemodynamic indexes|hemodynamic indexes
4996727|NCT01650090|Pulmonary relapse|pulmonary relapse
4996728|NCT01650090|Osteosarcoma|osteosarcoma
4996729|NCT01650090|Lung metastases|lung metastases
4996730|NCT01650090|Pediatric osteosarcoma|pediatric osteosarcoma
4996731|NCT01650090|Inhaled chemotherapy|inhaled chemotherapy
4996732|NCT01650090|Inhaled Lipid Cisplatin|inhaled lipid cisplatin
4996733|NCT01650077|Soft tissue sarcoma|soft tissue sarcoma
4996734|NCT01650077|Yondelis|yondelis
4996735|NCT01650077|Intolerance to doxorubicin/ifosfamide|intolerance to doxorubicin/ifosfamide
4996736|NCT01650077|CHOI criteria|choi criteria
4996737|NCT01650064|Hip fracture|hip fracture
4996738|NCT01650064|Mortality|mortality
4996739|NCT01650038|faecal transplantation|faecal transplantation
4996740|NCT01650038|ulcerative colitis|ulcerative colitis
4996741|NCT01650038|inflammatory bowel disease|inflammatory bowel disease
4996742|NCT01650025|probiotic, obesity, BMI, metabolic profile, metabolomics|probiotic, obesity, bmi, metabolic profile, metabolomics
4996743|NCT01649999|Rheumatoid Arthritis|rheumatoid arthritis
4996744|NCT01649999|ASP015K|asp015k
4996745|NCT01649986|Hyperlipidemia|hyperlipidemia
4996746|NCT01649986|Non-pharmacologic prevention|non-pharmacologic prevention
4996747|NCT01649960|Aging|aging
4996748|NCT01649960|Biomarkers|biomarkers
4996750|NCT01649947|Lung cancer|lung cancer
4996751|NCT01649947|Non-small cell lung cancer|non-small cell lung cancer
4996752|NCT01649947|Advanced non-small cell lung cancer|advanced non-small cell lung cancer
4996753|NCT01649947|Recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
4996754|NCT01649934|Appointments and Schedules|appointments and schedules
4996755|NCT01649921|Sepsis|sepsis
4996756|NCT01649921|SIRS|sirs
4996757|NCT01649921|Septic shock|septic shock
4996758|NCT01649921|Immunoparalysis|immunoparalysis
4996759|NCT01649921|Interferon-gamma|interferon-gamma
4996760|NCT01649895|Obsessive-compulsive disorder|obsessive-compulsive disorder
4996761|NCT01649895|internet|internet
4996762|NCT01649895|cognitive-behaviour therapy|cognitive-behaviour therapy
4996763|NCT01649895|D-Cycloserine|d-cycloserine
4996764|NCT01649882|endotracheal tube position|endotracheal tube position
4996765|NCT01649882|intubation|intubation
4996766|NCT01649869|CMV|cmv
4996767|NCT01649869|Cytomegalovirus|cytomegalovirus
4996768|NCT01649869|Hearing Loss|hearing loss
4996769|NCT01649869|Infants|infants
4996770|NCT01649869|Valganciclovir|valganciclovir
4996771|NCT01649843|Peroral endoscopic myotomy|peroral endoscopic myotomy
4996772|NCT01649843|Esophageal Achalasia|esophageal achalasia
4996773|NCT01649830|low-grade glioma|low-grade glioma
4996774|NCT01649830|radiotherapy|radiotherapy
4996775|NCT01649830|chemotherapy|chemotherapy
4996776|NCT01649765|SLE Flare Index|sle flare index
4996777|NCT01649765|SRI|sri
4996778|NCT01649765|belimumab|belimumab
4996779|NCT01649765|efficacy|efficacy
4996781|NCT01649765|B lymphocyte|b lymphocyte
4996782|NCT01649765|BLyS|blys
4996783|NCT01649765|SELENA SLEDAI|selena sledai
4996784|NCT01649765|BILAG|bilag
4996785|NCT01649765|Lupus|lupus
4996786|NCT01649765|Systemic Lupus Erythematosus (SLE)|systemic lupus erythematosus (sle)
4996787|NCT01649765|PGA|pga
4996788|NCT01649765|Pharmacokinetics|pharmacokinetics
4996789|NCT01649765|placebo|placebo
4996790|NCT01649765|PRINTO|printo
4996791|NCT01649752|Stem cells|stem cells
4996792|NCT01649752|Uterine cavity|uterine cavity
4996793|NCT01649752|Implantation|implantation
4996794|NCT01649752|ICSI|icsi
4996795|NCT01649739|PAH|pah
4996796|NCT01649713|Fluval AB|fluval ab
4996797|NCT01649713|influenza|influenza
4996798|NCT01649713|vaccine|vaccine
4996799|NCT01649713|immunization|immunization
4996800|NCT01649713|infections|infections
4996801|NCT01649661|MRI|mri
4996802|NCT01649661|12-125|12-125
4996803|NCT01649661|premenopausal women|premenopausal women
4996804|NCT01649661|postmenopausal women|postmenopausal women
4996805|NCT01649661|questionnaire|questionnaire
4996806|NCT01649648|Hypoxic ischemic encephalopathy|hypoxic ischemic encephalopathy
4996807|NCT01649648|Autologous cord blood|autologous cord blood
4996808|NCT01649622|Leukemia|leukemia
4996809|NCT01649622|Lymphoma|lymphoma
4996810|NCT01649622|Acute Lymphoblastic Leukemia/Lymphoma|acute lymphoblastic leukemia/lymphoma
4996811|NCT01649622|ALL|all
4996812|NCT01649622|Relapsed or primary refractory B-cell/T-cell|relapsed or primary refractory b-cell/t-cell
4996813|NCT01649622|Bendamustine|bendamustine
4996814|NCT01649622|Bendamustine Hydrochloride|bendamustine hydrochloride
4996815|NCT01649622|Bendamustine HCL|bendamustine hcl
4996816|NCT01649622|CEP-18083|cep-18083
4996817|NCT01649622|SDX-105|sdx-105
4996818|NCT01649622|Treanda|treanda
4996819|NCT01649609|BK Viremia|bk viremia
4996820|NCT01649609|BK Nephropathy|bk nephropathy
4996821|NCT01649609|mTOR inhibitor|mtor inhibitor
4996822|NCT01649609|renal transplant|renal transplant
4996823|NCT01649557|Schizophrenia|schizophrenia
4996824|NCT01649544|Mitral valvulopathy|mitral valvulopathy
4996825|NCT01649544|Atrial Fibrillation|atrial fibrillation
4996826|NCT01649544|Amiodarone|amiodarone
4996827|NCT01649544|Paroxysmal Atrial Fibrillation|paroxysmal atrial fibrillation
4996828|NCT01649544|Chronic Atrial Fibrillation|chronic atrial fibrillation
4996829|NCT01649544|Ultrasound Technique|ultrasound technique
4996830|NCT01649492|diclofenac|diclofenac
4996831|NCT01649492|CYP2C9|cyp2c9
4996832|NCT01649492|bromelain|bromelain
4996833|NCT01649492|pineapple juice|pineapple juice
4996834|NCT01649479|Obstetrical antiphospholipid syndrome|obstetrical antiphospholipid syndrome
4996835|NCT01649479|Thrombophilia|thrombophilia
4996836|NCT01649466|Type 2 diabetes mellitus, diabetes|type 2 diabetes mellitus, diabetes
4996837|NCT01649453|Neoplasms|neoplasms
4996838|NCT01649453|Neoplasm Metastasis|neoplasm metastasis
4996839|NCT01649453|Neoplastic Processes|neoplastic processes
4996840|NCT01649453|Pathologic Processes|pathologic processes
4996841|NCT01649440|Metabolomics|metabolomics
4996842|NCT01649440|serum|serum
4996843|NCT01649440|sepsis|sepsis
4996844|NCT01649440|biomarkers|biomarkers
4996845|NCT01649427|Pharmacokinetics Study|pharmacokinetics study
4996846|NCT01649427|Tacroliums|tacroliums
4996847|NCT01649427|GFR|gfr
4996848|NCT01649427|kdney|kdney
4996849|NCT01649401|nebulizer|nebulizer
4996850|NCT01649401|PARI LC Spring SP|pari lc spring sp
4996851|NCT01649388|Kidney transplant|kidney transplant
4996852|NCT01649388|Delayed tolerance|delayed tolerance
4996853|NCT01649388|Marrow/enriched hematopoetic stem cell transplant|marrow/enriched hematopoetic stem cell transplant
4996854|NCT01649375|Ankylosing spondylitis|ankylosing spondylitis
4996855|NCT01649375|AS|as
4996856|NCT01649375|Chronic inflammatory disease|chronic inflammatory disease
4996857|NCT01649375|Inflammatory back pain|inflammatory back pain
4996858|NCT01649375|Secukinumab|secukinumab
4996859|NCT01649375|Prefilled syringe (PFS)|prefilled syringe (pfs)
4996860|NCT01649375|Subcutaneous injection|subcutaneous injection
4996861|NCT01649375|AIN457|ain457
4996862|NCT01649375|AIN457F|ain457f
4996863|NCT01649375|AIN457F2310|ain457f2310
4996864|NCT01649362|preterm infant|preterm infant
4996865|NCT01649362|feeding difficulties|feeding difficulties
4996866|NCT01649362|prefeeding oral stimulation|prefeeding oral stimulation
4996867|NCT01649310|Chronic obstructive pulmonary disease (COPD)|chronic obstructive pulmonary disease (copd)
4996868|NCT01649310|Muscle strenght|muscle strenght
4996869|NCT01649310|Aged|aged
4996870|NCT01649245|Chronic hepatitis C|chronic hepatitis c
4996871|NCT01649245|Egyptian patients|egyptian patients
4996872|NCT01649245|pegylated interferon|pegylated interferon
4996873|NCT01649245|Ribavirin|ribavirin
4996874|NCT01649245|Reiferon retard|reiferon retard
4996875|NCT01649232|tdcs|tdcs
4996876|NCT01649232|tms|tms
4996877|NCT01649232|qeeg|qeeg
4996878|NCT01649232|neuroplasticity|neuroplasticity
4996879|NCT01649232|brain networks|brain networks
4996880|NCT01649232|add|add
4996881|NCT01649232|adhs|adhs
4996882|NCT01649219|Prediabetes, objectively measured exercise, glucose and lipid metabolism, dose response, muscle metabolism.|prediabetes, objectively measured exercise, glucose and lipid metabolism, dose response, muscle metabolism.
4996883|NCT01649206|Thyroid Nodule|thyroid nodule
4996884|NCT01649206|Radiofrequency Thermal Ablation|radiofrequency thermal ablation
4996885|NCT01649206|Pressure symptoms|pressure symptoms
4996886|NCT01649206|Hyperthyroidism|hyperthyroidism
4996887|NCT01649193|Rehabilitation [E02.831]|rehabilitation [e02.831]
4996888|NCT01649193|Exercise [G11.427.394.380]|exercise [g11.427.394.380]
4996889|NCT01649193|Health Education [I02.233.332]|health education [i02.233.332]
4996890|NCT01649193|[C08]|[c08]
4996891|NCT01649193|[C08.381]|[c08.381]
4996892|NCT01649180|RCC|rcc
4996893|NCT01649180|Clear Cell Renal Cell Carcinoma|clear cell renal cell carcinoma
4996894|NCT01649180|ccRCC|ccrcc
4996895|NCT01649180|Metastatic RCC|metastatic rcc
4996896|NCT01649180|Recurrent RCC|recurrent rcc
4996897|NCT01649180|Kidney Cancer|kidney cancer
4996898|NCT01649180|Kidney Neoplasms|kidney neoplasms
4996899|NCT01649180|Axitinib|axitinib
4996900|NCT01649180|AG-013736|ag-013736
4996901|NCT01649180|Tyrosine Kinase Inhibition|tyrosine kinase inhibition
4996902|NCT01649180|TKI|tki
4996903|NCT01649167|body mass index|body mass index
4996904|NCT01649167|gestational diabetes|gestational diabetes
4996905|NCT01649167|leptin|leptin
4996906|NCT01649167|obesity|obesity
4996907|NCT01649167|pregnancy.|pregnancy.
4996908|NCT01649141|posttraumatic stress disorder|posttraumatic stress disorder
4996909|NCT01649141|trauma-focused cognitive behavioral therapy|trauma-focused cognitive behavioral therapy
4996910|NCT01649141|trauma|trauma
4996911|NCT01649141|child abuse|child abuse
4996912|NCT01649128|preeclampsia|preeclampsia
4996913|NCT01649115|obesity|obesity
4996914|NCT01649115|overweight|overweight
4996915|NCT01649115|childhood obesity|childhood obesity
4996916|NCT01649115|prevention|prevention
4996917|NCT01649115|Z score|z score
4996918|NCT01649115|weight for length|weight for length
4996919|NCT01649115|WFL|wfl
4996920|NCT01649115|body mass index|body mass index
4996921|NCT01649115|BMI|bmi
4996922|NCT01649115|prenatal|prenatal
4996923|NCT01649115|maternal|maternal
4996924|NCT01649115|nutrition education|nutrition education
4996925|NCT01649115|health education|health education
4996926|NCT01649115|health literacy|health literacy
4996927|NCT01649115|health numeracy|health numeracy
4996928|NCT01649115|passport|passport
4996929|NCT01649115|healthy lifestyles|healthy lifestyles
4996931|NCT01649115|growth chart|growth chart
4996932|NCT01649102|Chronic hemodialysis|chronic hemodialysis
4996933|NCT01649102|Tunneled cuffed catheter|tunneled cuffed catheter
4996934|NCT01649102|Catheter-related bloodstream infection|catheter-related bloodstream infection
4996935|NCT01649102|Mechanical catheter dysfunction|mechanical catheter dysfunction
4996936|NCT01649102|impact of catheter design on outcome|impact of catheter design on outcome
4996937|NCT01649063|Uterine contraction;|uterine contraction;
4996938|NCT01649063|Shape; Frequency;|shape; frequency;
4996939|NCT01649063|First stage labor;|first stage labor;
4996940|NCT01649063|Fall|fall
4996941|NCT01649063|Rise ratio.|rise ratio.
4996942|NCT01649050|Spasticity|spasticity
4996943|NCT01649050|Multiple Sclerosis|multiple sclerosis
4996944|NCT01649024|Tremelimumab|tremelimumab
4996945|NCT01649024|Malignant Mesothelioma|malignant mesothelioma
4996946|NCT01649024|anti-CTLA-4 mAb|anti-ctla-4 mab
4996947|NCT01649011|Oswestry Disability Index|oswestry disability index
4996948|NCT01649011|ODI|odi
4996949|NCT01649011|Roland Morris Disability Questionnaire|roland morris disability questionnaire
4996950|NCT01649011|RMDQ|rmdq
4996951|NCT01648998|Mineralocorticoid receptor|mineralocorticoid receptor
4996952|NCT01648998|Fludrocortisone|fludrocortisone
4996953|NCT01648998|Information Processing|information processing
4996954|NCT01648998|Cognition|cognition
4996955|NCT01648998|Depression|depression
4996956|NCT01648946|Strategies of transfusion|strategies of transfusion
4996957|NCT01648946|Red blood cells|red blood cells
4996958|NCT01648946|Liberal|liberal
4996959|NCT01648946|Restrictive|restrictive
4996960|NCT01648946|Oncologic critically ill patients|oncologic critically ill patients
4996961|NCT01648933|sarcoidosis|sarcoidosis
4996962|NCT01648933|heart|heart
4996963|NCT01648933|Rubidium|rubidium
4996964|NCT01648933|PET|pet
4996965|NCT01648920|Asthma|asthma
4996966|NCT01648920|Suspected but undiagnosed asthma|suspected but undiagnosed asthma
4996967|NCT01648907|DESIR|desir
4996968|NCT01648907|SPONDYLARTHRITIS|spondylarthritis
4996969|NCT01648907|EARLY INFLAMMATORY RACHIIALGIA|early inflammatory rachiialgia
4996970|NCT01648907|BACK PAIN|back pain
4996971|NCT01648894|Rectal cancer|rectal cancer
4996972|NCT01648894|radiochemotherapy|radiochemotherapy
4996973|NCT01648894|complete pathological response|complete pathological response
4996974|NCT01648868|TMSAutism|tmsautism
4996975|NCT01648868|Eye-tracking|eye-tracking
4996976|NCT01648868|Social perception|social perception
4996977|NCT01648868|Social cognition|social cognition
4996978|NCT01648855|Circulating antiangiogenic factors|circulating antiangiogenic factors
4996979|NCT01648855|Preeclampsia|preeclampsia
4996980|NCT01648855|Developing lung|developing lung
4996981|NCT01648855|Bronchopulmonary dysplasia|bronchopulmonary dysplasia
4996982|NCT01648842|Preeclampsia|preeclampsia
4996983|NCT01648842|Vitamin D deficiency|vitamin d deficiency
4996984|NCT01648842|Pregnancy|pregnancy
4996985|NCT01648842|First trimester|first trimester
4996986|NCT01648777|Pneumonia|pneumonia
4996987|NCT01648777|Postoperative infection|postoperative infection
4996988|NCT01648777|Cardiac surgery|cardiac surgery
4996989|NCT01648777|Multiperforated catheter|multiperforated catheter
4996990|NCT01648777|Analgesia|analgesia
4996991|NCT01648751|Pelvic organ prolapse|pelvic organ prolapse
4996992|NCT01648751|Pelvic floor physical therapy|pelvic floor physical therapy
4996993|NCT01648751|Vaginal estrogen|vaginal estrogen
4996994|NCT01648751|Placebo|placebo
4996995|NCT01648738|Subacute low back pain|subacute low back pain
4996996|NCT01648738|Chronic low back pain|chronic low back pain
4996997|NCT01648738|Low back pain|low back pain
4996998|NCT01648738|Disability|disability
4996999|NCT01648738|Education|education
4997000|NCT01648738|Exercise|exercise
4997001|NCT01648738|Spa therapy|spa therapy
4997002|NCT01648738|Physiotherapy|physiotherapy
4997003|NCT01648738|Multidisciplinary|multidisciplinary
4997004|NCT01648738|Cost-effectiveness|cost-effectiveness
4997005|NCT01648738|Sick leave|sick leave
4997006|NCT01648725|Hypnosis|hypnosis
4997007|NCT01648725|Anesthesia|anesthesia
4997008|NCT01648725|Propofol|propofol
4997009|NCT01648725|Closed-loop|closed-loop
4997010|NCT01648712|extracorporeal circuit, platelet function|extracorporeal circuit, platelet function
4997011|NCT01648699|Pain|pain
4997012|NCT01648699|Cancer|cancer
4997013|NCT01648699|Osmotic Release Oral System|osmotic release oral system
4997014|NCT01648699|OROS Hydromorphone|oros hydromorphone
4997015|NCT01648699|Jurnista|jurnista
4997016|NCT01648686|Alendronate|alendronate
4997017|NCT01648686|Dental extraction|dental extraction
4997018|NCT01648686|Bone healing|bone healing
4997019|NCT01648686|postmenopausal women|postmenopausal women
4997020|NCT01648686|dental radiography|dental radiography
4997021|NCT01648673|Coronary Artery Disease|coronary artery disease
4997022|NCT01648673|Cardiac Rehabilitation|cardiac rehabilitation
4997023|NCT01648634|Nebivolol|nebivolol
4997024|NCT01648634|beta-blockade treatment|beta-blockade treatment
4997025|NCT01648621|COPD|copd
4997026|NCT01648621|case management|case management
4997027|NCT01648595|Fentanyl|fentanyl
4997028|NCT01648595|analgesia|analgesia
4997029|NCT01648595|duration of the active phase|duration of the active phase
4997030|NCT01648595|pain severity|pain severity
4997031|NCT01648556|Purpura thrombopenic|purpura thrombopenic
4997032|NCT01648556|Medullary cytogenetics|medullary cytogenetics
4997033|NCT01648556|Myelodysplasic syndrome|myelodysplasic syndrome
4997034|NCT01648556|bone marrow biopsy|bone marrow biopsy
4997035|NCT01648517|on-small cell lung carcinoma|on-small cell lung carcinoma
4997036|NCT01648517|chemotherapy naive patient|chemotherapy naive patient
4997037|NCT01648504|Colonoscopy|colonoscopy
4997038|NCT01648504|Screening colonoscopy|screening colonoscopy
4997039|NCT01648504|Electronic education|electronic education
4997040|NCT01648504|Ipad|ipad
4997041|NCT01648504|Patient education|patient education
4997042|NCT01648478|IRAP|irap
4997043|NCT01648478|insulin sensitivity marker|insulin sensitivity marker
4997044|NCT01648465|metastatic|metastatic
4997045|NCT01648465|unresectable|unresectable
4997046|NCT01648465|well or moderately differentiated|well or moderately differentiated
4997047|NCT01648465|advanced|advanced
4997048|NCT01648452|Achromatopsia|achromatopsia
4997049|NCT01648452|Ciliary Neurotrophic Factor|ciliary neurotrophic factor
4997050|NCT01648452|CNTF|cntf
4997051|NCT01648322|Breast Cancer|breast cancer
4997052|NCT01648322|Taxotere Chemotherapy|taxotere chemotherapy
4997053|NCT01648322|Neulasta|neulasta
4997054|NCT01648322|efficacy and safety|efficacy and safety
4997055|NCT01648322|single cycle doses of F-627|single cycle doses of f-627
4997056|NCT01648322|pegfilgrastim|pegfilgrastim
4997057|NCT01648309|aortic stenosis|aortic stenosis
4997058|NCT01648309|TAVI|tavi
4997059|NCT01648309|neuropsychological|neuropsychological
4997060|NCT01648309|cognitive|cognitive
4997061|NCT01648309|candidates for TAVI|candidates for tavi
4997062|NCT01648296|Heart Failure|heart failure
4997063|NCT01648296|Obesity|obesity
4997064|NCT01648296|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
4997065|NCT01648296|Health Normal Volunteer Subjects|health normal volunteer subjects
4997066|NCT01648283|methadone polymorphisms|methadone polymorphisms
4997067|NCT01648270|buprenorphine concentration-effect (miosis) relationship|buprenorphine concentration-effect (miosis) relationship
4997068|NCT01648257|healthy subjects|healthy subjects
4997069|NCT01648257|relative bioavailability|relative bioavailability
4997070|NCT01648257|HIV|hiv
4997071|NCT01648257|GSK1265744|gsk1265744
4997072|NCT01648244|DM, T2DM, Diabetes|dm, t2dm, diabetes
4997073|NCT01648231|Healthy Volunteer|healthy volunteer
4997074|NCT01648218|glucocorticoid|glucocorticoid
4997075|NCT01648218|diabetes mellitus|diabetes mellitus
4997076|NCT01648218|post-transplant|post-transplant
4997077|NCT01648218|insulin|insulin
4997078|NCT01648205|ranolazine|ranolazine
4997079|NCT01648205|clinical trial|clinical trial
4997080|NCT01648179|GSK1322322, relative bioavailability, healthy subjects, open label, food effect, weight effect|gsk1322322, relative bioavailability, healthy subjects, open label, food effect, weight effect
4997081|NCT01648166|trace|trace
4997082|NCT01648166|element|element
4997083|NCT01648166|lung|lung
4997084|NCT01648166|cancer|cancer
4997085|NCT01648166|Appalachia|appalachia
4997086|NCT01648153|Efficacy|efficacy
4997087|NCT01648153|Obese|obese
4997088|NCT01648153|T2DM|t2dm
4997089|NCT01648153|IL-18|il-18
4997090|NCT01648153|Monoclonal antibody (mAb)|monoclonal antibody (mab)
4997091|NCT01648140|Genotype 4|genotype 4
4997092|NCT01648140|GSK2336805|gsk2336805
4997093|NCT01648140|pegylated interferon|pegylated interferon
4997094|NCT01648140|telaprevir|telaprevir
4997095|NCT01648140|Genotype 1|genotype 1
4997096|NCT01648140|chronic hepatitis C|chronic hepatitis c
4997097|NCT01648140|ribavirin|ribavirin
4997098|NCT01648140|NS5A inhibitor|ns5a inhibitor
4997099|NCT01648140|hepatitis C virus (HCV) infection|hepatitis c virus (hcv) infection
4997100|NCT01648127|Ceftaroline|ceftaroline
4997101|NCT01648127|Pharmacokinetics|pharmacokinetics
4997102|NCT01648127|Obesity|obesity
4997103|NCT01648114|breastfeeding|breastfeeding
4997104|NCT01648114|pregnancy|pregnancy
4997105|NCT01648114|antenatal|antenatal
4997106|NCT01648114|exclusive breastfeeding|exclusive breastfeeding
4997107|NCT01648114|education|education
4997108|NCT01648101|Retigabine IR|retigabine ir
4997109|NCT01648101|Asian Subjects|asian subjects
4997110|NCT01648101|Adjunctive Therapy|adjunctive therapy
4997111|NCT01648101|Efficacy|efficacy
4997112|NCT01648101|Drug-Resistant|drug-resistant
4997113|NCT01648101|Safety & tolerability|safety & tolerability
4997114|NCT01648101|Partial-Onset Seizures|partial-onset seizures
4997115|NCT01648101|Epilepsy|epilepsy
4997116|NCT01648088|staphylococcus aureus|staphylococcus aureus
4997117|NCT01648088|prosthetic joint implantation|prosthetic joint implantation
4997118|NCT01648075|caries|caries
4997119|NCT01648075|probiotics|probiotics
4997120|NCT01648075|lactobacilli|lactobacilli
4997121|NCT01648062|Sleep|sleep
4997122|NCT01648062|self-regulation|self-regulation
4997123|NCT01648062|Implementation intentions|implementation intentions
4997124|NCT01648062|intervention|intervention
4997125|NCT01648062|mental simulation|mental simulation
4997126|NCT01648023|LC Bead|lc bead
4997127|NCT01648023|Irinotecan|irinotecan
4997128|NCT01648023|ONCOZENE BEAD|oncozene bead
4997129|NCT01648010|Non Muscle Invasive Bladder Cancer|non muscle invasive bladder cancer
4997130|NCT01648010|Carcinoma of urinary bladder, invasive|carcinoma of urinary bladder, invasive
4997131|NCT01648010|Intravesical instillation|intravesical instillation
4997132|NCT01648010|Mitomycin C|mitomycin c
4997133|NCT01648010|Hydrogel|hydrogel
4997134|NCT01648010|Reverse thermal gelation|reverse thermal gelation
4997135|NCT01648010|Drug retention|drug retention
4997136|NCT01648010|radical cystectomy|radical cystectomy
4997137|NCT01647997|bacterial lipopolysaccharides|bacterial lipopolysaccharides
4997138|NCT01647997|hyperlactatemia|hyperlactatemia
4997139|NCT01647997|muscle lactate|muscle lactate
4997140|NCT01647984|Arrhythmias|arrhythmias
4997141|NCT01647984|Life quality|life quality
4997142|NCT01647971|Lymphoma|lymphoma
4997143|NCT01647971|Rituxan|rituxan
4997144|NCT01647971|Relapsed|relapsed
4997145|NCT01647971|Refractory|refractory
4997146|NCT01647958|TEMPO|tempo
4997147|NCT01647958|TIF|tif
4997148|NCT01647958|Transoral Incisionless Fundoplication|transoral incisionless fundoplication
4997149|NCT01647958|EsophyX System|esophyx system
4997150|NCT01647958|refractory symptoms|refractory symptoms
4997151|NCT01647958|proton pump inhibitors|proton pump inhibitors
4997152|NCT01647958|EndoGastric Solutions|endogastric solutions
4997153|NCT01647958|EGS|egs
4997154|NCT01647958|Acid Reflux|acid reflux
4997155|NCT01647958|Heartburn|heartburn
4997156|NCT01647958|Regurgitation|regurgitation
4997157|NCT01647945|PAH WHO group 1|pah who group 1
4997158|NCT01647932|Heart Failure|heart failure
4997159|NCT01647932|Diuretics|diuretics
4997160|NCT01647932|Diuretic resistance|diuretic resistance
4997161|NCT01647919|Cognition|cognition
4997162|NCT01647919|Attention|attention
4997163|NCT01647919|Memory|memory
4997164|NCT01647919|Mood|mood
4997165|NCT01647867|Met fragments expression|met fragments expression
4997166|NCT01647854|emergency medical service|emergency medical service
4997167|NCT01647854|telemedicine|telemedicine
4997168|NCT01647854|teleconsultation|teleconsultation
4997169|NCT01647854|safety|safety
4997170|NCT01647828|Newly diagnosed Stage IV Pancreatic Cancer|newly diagnosed stage iv pancreatic cancer
4997171|NCT01647815|Axillary vein ultrasound|axillary vein ultrasound
4997172|NCT01647815|Subclavian vein ultrasound|subclavian vein ultrasound
4997173|NCT01647802|standing devices|standing devices
4997174|NCT01647802|transfer devices|transfer devices
4997304|NCT01647204|older|older
4997175|NCT01647789|prostate cancer, castration resistant,|prostate cancer, castration resistant,
4997176|NCT01647776|Colon Neoplasia|colon neoplasia
4997177|NCT01647776|Colorectal carcinoma|colorectal carcinoma
4997178|NCT01647776|colon cancer|colon cancer
4997179|NCT01647776|colon polyp|colon polyp
4997180|NCT01647776|colonoscopy|colonoscopy
4997181|NCT01647776|sDNA test|sdna test
4997182|NCT01647776|FIT tests (fecal immunochemical test)|fit tests (fecal immunochemical test)
4997183|NCT01647776|relating colon neoplasia to obesity, type 2 diabetes|relating colon neoplasia to obesity, type 2 diabetes
4997290|NCT01647243|Total knee arthroplasty|total knee arthroplasty
4997184|NCT01647776|colonoscopy and pathology confirmed advanced adenomas|colonoscopy and pathology confirmed advanced adenomas
4997185|NCT01647763|Hemorrhoids|hemorrhoids
4997186|NCT01647737|Xerostomia|xerostomia
4997187|NCT01647737|Sjogren syndrome|sjogren syndrome
4997188|NCT01647737|dry mouth|dry mouth
4997189|NCT01647724|cervical cancer|cervical cancer
4997190|NCT01647724|prevention|prevention
4997191|NCT01647724|screening|screening
4997192|NCT01647698|Parkinson Disease|parkinson disease
4997193|NCT01647698|near transfer|near transfer
4997194|NCT01647698|far transfer|far transfer
4997195|NCT01647698|working memory|working memory
4997196|NCT01647698|fluid intelligence|fluid intelligence
4997197|NCT01647698|cognitive training|cognitive training
4997198|NCT01647698|dual n-back|dual n-back
4997199|NCT01647685|Vesselwall inflammation|vesselwall inflammation
4997200|NCT01647685|liposomal prednisolone|liposomal prednisolone
4997201|NCT01647659|MEK inhibitor GSK1120212|mek inhibitor gsk1120212
4997202|NCT01647659|pharmacokinetics|pharmacokinetics
4997203|NCT01647659|powder for oral solution|powder for oral solution
4997204|NCT01647659|Solid Tumors|solid tumors
4997205|NCT01647659|pediatric formulation|pediatric formulation
4997206|NCT01647646|asthma|asthma
4997207|NCT01647646|SMART|smart
4997208|NCT01647646|fixed dose|fixed dose
4997209|NCT01647633|rhinitis|rhinitis
4997210|NCT01647633|stuffy nose|stuffy nose
4997211|NCT01647633|congestion|congestion
4997212|NCT01647633|Sneezing|sneezing
4997213|NCT01647607|Breast Cancer|breast cancer
4997214|NCT01647607|Young Women|young women
4997215|NCT01647607|Fertility|fertility
4997216|NCT01647607|Physical Activity|physical activity
4997217|NCT01647607|Survivorship|survivorship
4997218|NCT01647594|Breast cancer|breast cancer
4997219|NCT01647594|Young women|young women
4997220|NCT01647594|Fertility|fertility
4997221|NCT01647594|Physical activity|physical activity
4997222|NCT01647594|Survivorship|survivorship
4997223|NCT01647581|hemoclip|hemoclip
4997224|NCT01647581|colonoscopy|colonoscopy
4997225|NCT01647581|post-polypectomy bleed|post-polypectomy bleed
4997226|NCT01647555|Cetuximab|cetuximab
4997227|NCT01647555|radiotherapy|radiotherapy
4997228|NCT01647555|epidermoid head and neck cancer|epidermoid head and neck cancer
4997229|NCT01647542|Drug therapy|drug therapy
4997230|NCT01647529|Cytomegalovirus|cytomegalovirus
4997231|NCT01647529|uveitis|uveitis
4997232|NCT01647529|endotheliitis|endotheliitis
4997233|NCT01647529|ganciclovir|ganciclovir
4997234|NCT01647503|parathyroid gland|parathyroid gland
4997235|NCT01647503|primary hyperparathyroidism|primary hyperparathyroidism
4997236|NCT01647503|proteins|proteins
4997237|NCT01647477|non treated cancer|non treated cancer
4997238|NCT01647477|oral cavity|oral cavity
4997239|NCT01647477|oropharynx|oropharynx
4997240|NCT01647477|hypopharynx|hypopharynx
4997241|NCT01647477|larynx|larynx
4997242|NCT01647477|first consultation|first consultation
4997243|NCT01647438|South Asians|south asians
4997244|NCT01647438|Diabetes|diabetes
4997245|NCT01647438|Physical Activity|physical activity
4997246|NCT01647438|Coronary Heart Disease|coronary heart disease
4997247|NCT01647438|Lifestyle|lifestyle
4997248|NCT01647425|head and neck cancer|head and neck cancer
4997249|NCT01647425|lung cancer|lung cancer
4997250|NCT01647425|tobacco use disorder|tobacco use disorder
4997251|NCT01647425|alcoholism|alcoholism
4997252|NCT01647412|Crohn's disease|crohn's disease
4997253|NCT01647412|Inflammatory Bowel Disease|inflammatory bowel disease
4997254|NCT01647412|Growth Hormone|growth hormone
4997255|NCT01647412|Nutraceuticals|nutraceuticals
4997256|NCT01647399|Obesity|obesity
4997257|NCT01647399|Asthma|asthma
4997258|NCT01647399|Vitamin D|vitamin d
4997259|NCT01647399|Allergy|allergy
4997260|NCT01647399|Genetic|genetic
4997261|NCT01647399|Childhood|childhood
4997262|NCT01647399|Pediatric|pediatric
4997263|NCT01647399|cohort|cohort
4997264|NCT01647399|observational|observational
4997265|NCT01647399|prospective|prospective
4997266|NCT01647399|molecular|molecular
4997267|NCT01647373|retinal detachment|retinal detachment
4997268|NCT01647373|scleral buckle|scleral buckle
4997269|NCT01647373|silicone sponge|silicone sponge
4997270|NCT01647373|axial length|axial length
4997271|NCT01647373|surgery included silicone sponge scleral buckling|surgery included silicone sponge scleral buckling
4997272|NCT01647373|retina currently attached|retina currently attached
4997273|NCT01647373|at least 6 months after surgery|at least 6 months after surgery
4997274|NCT01647360|Metrorrhagia|metrorrhagia
4997275|NCT01647360|Menorrhagia|menorrhagia
4997276|NCT01647347|bacteria|bacteria
4997277|NCT01647347|bacteremia|bacteremia
4997278|NCT01647347|PVP-iodine|pvp-iodine
4997279|NCT01647347|periodontitis|periodontitis
4997280|NCT01647321|SPMS|spms
4997281|NCT01647295|visual exploration|visual exploration
4997282|NCT01647295|pupil size|pupil size
4997283|NCT01647295|social interactions|social interactions
4997284|NCT01647295|faces|faces
4997285|NCT01647295|human motion|human motion
4997286|NCT01647256|Bioavailability|bioavailability
4997287|NCT01647256|Fed|fed
4997288|NCT01647256|Fasting|fasting
4997289|NCT01647243|Knee osteoarthritis|knee osteoarthritis
4997291|NCT01647243|Preoperative training|preoperative training
4997292|NCT01647243|Strength training|strength training
4997293|NCT01647230|Anaesthesia, spinal|anaesthesia, spinal
4997294|NCT01647230|Cerebral oximetry|cerebral oximetry
4997295|NCT01647230|Blood pressure|blood pressure
4997296|NCT01647230|Heart rate|heart rate
4997297|NCT01647230|Cognitive Symptom|cognitive symptom
4997298|NCT01647217|Blepharitis|blepharitis
4997299|NCT01647217|Demodex|demodex
4997300|NCT01647217|Mites|mites
4997301|NCT01647217|Tea Tree oil|tea tree oil
4997302|NCT01647217|Terpinen|terpinen
4997303|NCT01647204|Nutrition|nutrition
4997305|NCT01647204|hospital|hospital
4997306|NCT01647204|volunteer|volunteer
4997307|NCT01647191|HCV，|hcv，
4997308|NCT01647191|drug users，|drug users，
4997309|NCT01647191|intervention|intervention
4997310|NCT01647165|Maintenance Strategy|maintenance strategy
4997311|NCT01647165|Plasma Cell Neoplasm|plasma cell neoplasm
4997312|NCT01647165|Proteasome Inhibitor|proteasome inhibitor
4997313|NCT01647165|Immunomodulatory Drugs|immunomodulatory drugs
4997314|NCT01647165|Novel Therapy|novel therapy
4997315|NCT01647152|Uveitis|uveitis
4997316|NCT01647152|Ustekinumab|ustekinumab
4997317|NCT01647152|IL 12/23|il 12/23
4997318|NCT01647152|Stelara|stelara
4997319|NCT01646866|autism|autism
4997320|NCT01646866|siblings|siblings
4997321|NCT01646866|genetic test|genetic test
4997322|NCT01646866|screening|screening
4997323|NCT01646840|PF-04958242|pf-04958242
4997324|NCT01646840|bioequivalence|bioequivalence
4997325|NCT01646840|pharmacokinetics|pharmacokinetics
4997326|NCT01646840|Schizophrenia|schizophrenia
4997327|NCT01646827|Schizophrenia, extended release antipsychotic|schizophrenia, extended release antipsychotic
4997328|NCT01646814|Healthy volunteer|healthy volunteer
4997329|NCT01646814|comparison of incidence of|comparison of incidence of
4997330|NCT01646814|treatment groups.|treatment groups.
4997331|NCT01646775|opioid|opioid
4997332|NCT01646775|malignancy|malignancy
4997333|NCT01646775|epidural|epidural
4997334|NCT01646749|Energy intake|energy intake
4997335|NCT01646749|Beef protein|beef protein
4997336|NCT01646749|Satiety|satiety
4997337|NCT01646749|Protein leverage hypothesis|protein leverage hypothesis
4997338|NCT01646736|Lupus Nephritis|lupus nephritis
4997339|NCT01646736|Cyclophosphamide|cyclophosphamide
4997340|NCT01646736|Tripterygium|tripterygium
4997341|NCT01646710|Tool|tool
4997342|NCT01646710|FBR|fbr
4997343|NCT01646710|Advocacy|advocacy
4997344|NCT01646710|Development of a tool|development of a tool
4997345|NCT01646710|advocacy materials|advocacy materials
4997346|NCT01646697|pancreatic cancer|pancreatic cancer
4997347|NCT01646697|adenocarcinoma|adenocarcinoma
4997348|NCT01646697|pancreatic resection|pancreatic resection
4997349|NCT01646684|Prostate cancer, pasireotide LAR, castration resistant prostatate cancer, CRPC, SOM230 LAR|prostate cancer, pasireotide lar, castration resistant prostatate cancer, crpc, som230 lar
4997350|NCT01646671|Hypertension, Severe, LCZ696|hypertension, severe, lcz696
4997351|NCT01646645|CMVpp65 specific T-cells|cmvpp65 specific t-cells
4997352|NCT01646645|Stem Cell Transplantation|stem cell transplantation
4997353|NCT01646645|12-086|12-086
4997354|NCT01646632|institutionalized ADL fitness care-dependency|institutionalized adl fitness care-dependency
4997355|NCT01646619|Hypoxic Ischemic Encephalopathy|hypoxic ischemic encephalopathy
4997356|NCT01646619|Therapeutic Hypothermia|therapeutic hypothermia
4997357|NCT01646619|Therapeutic Hypothermia plus Adjuvant Therapy|therapeutic hypothermia plus adjuvant therapy
4997358|NCT01646619|Cooling|cooling
4997359|NCT01646606|Bronchiolitis|bronchiolitis
4997360|NCT01646606|Length of stay|length of stay
4997361|NCT01646606|Pilot Projects|pilot projects
4997362|NCT01646606|Oxygen saturation monitoring|oxygen saturation monitoring
4997363|NCT01646580|dermatomycoses, tinea, candidiasis, children|dermatomycoses, tinea, candidiasis, children
4997364|NCT01646567|psoriasis|psoriasis
4997365|NCT01646554|Liver metastases|liver metastases
4997366|NCT01646554|Colorectal Cancer|colorectal cancer
4997367|NCT01646554|KRAS mutated|kras mutated
4997368|NCT01646554|FOLFOX|folfox
4997369|NCT01646554|Aflibercept|aflibercept
4997370|NCT01646554|Randomized|randomized
4997371|NCT01646554|Phase II-III|phase ii-iii
4997372|NCT01646554|Perioperative treatment|perioperative treatment
4997373|NCT01646554|Adjuvant|adjuvant
4997374|NCT01646554|Neo-adjuvant|neo-adjuvant
4997375|NCT01646554|Surgery|surgery
4997376|NCT01646554|Progression Free Survival|progression free survival
4997377|NCT01646528|Gastric Intestinal Metaplasia|gastric intestinal metaplasia
4997378|NCT01646528|Confocal Laser Endomicroscopy|confocal laser endomicroscopy
4997379|NCT01646515|systolic heart failure|systolic heart failure
4997380|NCT01646515|udenafil|udenafil
4997381|NCT01646515|exercise capacity|exercise capacity
4997382|NCT01646502|chronic wound|chronic wound
4997383|NCT01646502|treatment|treatment
4997384|NCT01646502|biofilms|biofilms
4997385|NCT01646502|venous insufficiency|venous insufficiency
4997386|NCT01646502|Esp|esp
4997387|NCT01646489|Antisense|antisense
4997388|NCT01646489|miR-122 antagonist|mir-122 antagonist
4997389|NCT01646489|Safety in healthy volunteers|safety in healthy volunteers
4997390|NCT01646489|Hepatitis C|hepatitis c
4997391|NCT01646463|mindfulness|mindfulness
4997392|NCT01646463|stress|stress
4997393|NCT01646463|coping|coping
4997394|NCT01646463|emotion|emotion
4997395|NCT01646463|depression|depression
4997396|NCT01646463|group medical visits|group medical visits
4997397|NCT01646463|prenatal healthcare|prenatal healthcare
4997398|NCT01646463|preterm birth|preterm birth
4997399|NCT01646463|birth weight|birth weight
4997400|NCT01646463|postpartum depression|postpartum depression
4997401|NCT01646463|cortisol|cortisol
4997402|NCT01646463|neuroendocrine function|neuroendocrine function
4997403|NCT01646463|blood pressure|blood pressure
4997404|NCT01646463|health disparities|health disparities
4997405|NCT01646450|NSCLC|nsclc
4997406|NCT01646450|EGFR Mutation|egfr mutation
4997407|NCT01646450|Elder patients|elder patients
4997408|NCT01646424|COPD,|copd,
4997409|NCT01646424|Patient satisfaction,|patient satisfaction,
4997410|NCT01646424|fix combination,|fix combination,
4997411|NCT01646424|NIS Turkey,|nis turkey,
4997412|NCT01646424|turbuhaler,|turbuhaler,
4997413|NCT01646424|FSI-10|fsi-10
4997414|NCT01646411|cytomegalovirus (CMV) IgM &IgG|cytomegalovirus (cmv) igm &igg
4997415|NCT01646411|Lyme|lyme
4997416|NCT01646411|Toxoplasma|toxoplasma
4997417|NCT01646411|Rubella|rubella
4997418|NCT01646411|Rubeola IgM|rubeola igm
4997419|NCT01646411|Rocky mountain Spotted Fever IgM|rocky mountain spotted fever igm
4997420|NCT01646411|Ebv IgM|ebv igm
4997421|NCT01646411|Herpes|herpes
4997422|NCT01646411|Babesia|babesia
4997423|NCT01646411|Measles|measles
4997424|NCT01646411|Tetanus|tetanus
4997425|NCT01646411|Mumps|mumps
4997426|NCT01646411|Mycoplasma|mycoplasma
4997427|NCT01646411|Legionella|legionella
4997428|NCT01646411|Giardia|giardia
4997429|NCT01646411|Syphilis|syphilis
4997430|NCT01646411|Bordetella Pertussis|bordetella pertussis
4997431|NCT01646411|H Pylori|h pylori
4997432|NCT01646411|Antibody Titre|antibody titre
4997433|NCT01646411|Elevated IgG|elevated igg
4997434|NCT01646411|Abnormal IgM|abnormal igm
4997435|NCT01646411|SLE|sle
4997436|NCT01646398|13VPNC|13vpnc
4997437|NCT01646398|23VPS|23vps
4997438|NCT01646385|observational|observational
4997439|NCT01646385|non-interventional|non-interventional
4997440|NCT01646385|cohort|cohort
4997441|NCT01646385|retrospective|retrospective
4997442|NCT01646385|register|register
4997443|NCT01646385|rheumatoid arthritis|rheumatoid arthritis
4997444|NCT01646372|Medical Education|medical education
4997445|NCT01646372|Cognitive Aid|cognitive aid
4997446|NCT01646372|Crisis Resource Management|crisis resource management
4997447|NCT01646372|Advanced Cardiac Life Support|advanced cardiac life support
4997448|NCT01646372|Skills Retention|skills retention
4997449|NCT01646346|Breast Cancer|breast cancer
4997450|NCT01646346|Radiation for Breast Cancer|radiation for breast cancer
4997451|NCT01646333|Parkinson Disease|parkinson disease
4997452|NCT01646333|Mild Cognitive Impairment|mild cognitive impairment
4997453|NCT01646333|Cognition|cognition
4997454|NCT01646333|Executive Function|executive function
4997455|NCT01646333|Learning|learning
4997456|NCT01646333|Memory|memory
4997457|NCT01646333|Problem Solving|problem solving
4997458|NCT01646294|Pharmacokinetics|pharmacokinetics
4997459|NCT01646294|Phase I|phase i
4997460|NCT01646294|YM178|ym178
4997461|NCT01646294|Modified release (Oral Controlled Absorption System (OCAS))|modified release (oral controlled absorption system (ocas))
4997462|NCT01646294|Immediate release (IR)|immediate release (ir)
4997463|NCT01646294|Fasted conditions|fasted conditions
4997464|NCT01646294|Fed conditions|fed conditions
4997465|NCT01646281|Atrial fibrillation|atrial fibrillation
4997466|NCT01646281|Vernakalant|vernakalant
4997467|NCT01646281|Flecainide|flecainide
4997468|NCT01646281|Echocardiography|echocardiography
4997469|NCT01646268|Rotigotine|rotigotine
4997470|NCT01646268|Neupro phase 3|neupro phase 3
4997471|NCT01646268|Early phase|early phase
4997472|NCT01646268|Idiopathic Parkinson's Disease|idiopathic parkinson's disease
4997473|NCT01646255|Rotigotine|rotigotine
4997474|NCT01646255|Neupro phase 3|neupro phase 3
4997475|NCT01646255|Advanced-stage|advanced-stage
4997476|NCT01646255|Idiopathic Parkinson's Disease|idiopathic parkinson's disease
4997477|NCT01646229|Hemoperfusion|hemoperfusion
4997478|NCT01646229|Polymyxin-B|polymyxin-b
4997479|NCT01646229|Emergency abdominal surgery|emergency abdominal surgery
4997480|NCT01646229|Sepsis|sepsis
4997481|NCT01646229|Endotoxin|endotoxin
4997482|NCT01646216|stroke|stroke
4997483|NCT01646216|treadmill|treadmill
4997484|NCT01646216|walking|walking
4997485|NCT01646216|hemiparesis|hemiparesis
4997486|NCT01646216|training|training
4997487|NCT01646203|Advanced Solid Tumors|advanced solid tumors
4997488|NCT01646190|Fast-track|fast-track
4997489|NCT01646190|multimodal perioperative care|multimodal perioperative care
4997490|NCT01646190|enhanced recovery|enhanced recovery
4997491|NCT01646190|colorectal surgery|colorectal surgery
4997492|NCT01646190|elderly patients|elderly patients
4997493|NCT01646190|seniors|seniors
4997494|NCT01646164|Dill seed|dill seed
4997495|NCT01646164|Pattern of uterus contractions|pattern of uterus contractions
4997496|NCT01646164|Active phase of labor|active phase of labor
4997497|NCT01646138|H1N1|h1n1
4997498|NCT01646138|Influenza|influenza
4997499|NCT01646138|Human|human
4997500|NCT01646138|Challenge Study|challenge study
4997501|NCT01646138|Healthy Volunteer|healthy volunteer
4997502|NCT01646125|Non-small cell lung carcinoma (NSCLC)|non-small cell lung carcinoma (nsclc)
4997503|NCT01646125|treatment of lung cancer after first metastasis|treatment of lung cancer after first metastasis
4997504|NCT01646125|lung cancer|lung cancer
4997505|NCT01646125|lung adenocarcinoma|lung adenocarcinoma
4997506|NCT01646125|Squamous cell lung carcinoma|squamous cell lung carcinoma
4997507|NCT01646125|Large-cell lung carcinoma|large-cell lung carcinoma
4997508|NCT01646125|Non small cell lung carcinoma|non small cell lung carcinoma
4997509|NCT01646125|Non small cell lung cancer|non small cell lung cancer
4997510|NCT01646125|Non-small cell lung cancer|non-small cell lung cancer
4997511|NCT01646125|NSCLC|nsclc
4997512|NCT01646125|Large cell lung carcinoma|large cell lung carcinoma
4997513|NCT01646125|Large cell lung cancer|large cell lung cancer
4997514|NCT01646125|HSP90|hsp90
4997515|NCT01646125|AUY922|auy922
4997516|NCT01646125|Pemetrexed|pemetrexed
4997517|NCT01646125|Docetaxel|docetaxel
4997518|NCT01646125|EGFR TKI|egfr tki
4997519|NCT01646125|EGFR mutations|egfr mutations
4997520|NCT01646112|Uncertainty|uncertainty
4997521|NCT01646112|HNPCC|hnpcc
4997522|NCT01646112|Lynch Syndrome|lynch syndrome
4997523|NCT01646112|Genetic Tests|genetic tests
4997524|NCT01646099|Kidney transplant|kidney transplant
4997525|NCT01646099|Renal transplant|renal transplant
4997526|NCT01646099|Sun protection|sun protection
4997527|NCT01646099|Skin cancer|skin cancer
4997528|NCT01646086|Weight Loss|weight loss
4997529|NCT01646086|Self-Weighing|self-weighing
4997530|NCT01646086|Weight Tracking|weight tracking
4997531|NCT01646073|Plaque Psoriasis|plaque psoriasis
4997532|NCT01646073|Psoriasis|psoriasis
4997533|NCT01646073|Placebo Controlled|placebo controlled
4997534|NCT01646073|Skin Disease|skin disease
4997535|NCT01646073|Double Blind|double blind
4997536|NCT01646060|blood|blood
4997537|NCT01646060|loss|loss
4997538|NCT01646060|healthy|healthy
4997539|NCT01646060|volume|volume
4997540|NCT01646060|To evaluate the ability of the Zynex BVM to non-invasively detect blood loss in healthy subjects during a blood draw.|to evaluate the ability of the zynex bvm to non-invasively detect blood loss in healthy subjects during a blood draw.
4997541|NCT01646047|diabetes|diabetes
4997542|NCT01646047|diabetic retinopathy|diabetic retinopathy
4997543|NCT01646047|nutritional supplements|nutritional supplements
4997544|NCT01646047|visual function|visual function
4997545|NCT01646047|macular pigment|macular pigment
4997546|NCT01646047|macular threshold sensitivity|macular threshold sensitivity
4997547|NCT01646047|contrast sensitivity|contrast sensitivity
4997548|NCT01646047|color vision|color vision
4997549|NCT01646047|optical coherence tomography|optical coherence tomography
4997550|NCT01646034|oligo metastatic|oligo metastatic
4997551|NCT01646034|HRD deficiency|hrd deficiency
4997552|NCT01646021|Mantle cell lymphoma|mantle cell lymphoma
4997553|NCT01646021|Relapsed mantle cell lymphoma|relapsed mantle cell lymphoma
4997554|NCT01646021|Refractory mantle cell lymphoma|refractory mantle cell lymphoma
4997555|NCT01646021|Ibrutinib|ibrutinib
4997556|NCT01646021|Bruton's tyrosine kinase inhibitor|bruton's tyrosine kinase inhibitor
4997557|NCT01646021|Temsirolimus|temsirolimus
4997558|NCT01645956|obesity|obesity
4997559|NCT01645956|exercise|exercise
4997560|NCT01645956|energy intake|energy intake
4997561|NCT01645956|physical activity|physical activity
4997562|NCT01645943|Non-ST-elevation acute myocardial infarction|non-st-elevation acute myocardial infarction
4997563|NCT01645943|Comorbidities|comorbidities
4997564|NCT01645930|Relapsed multiple myeloma,|relapsed multiple myeloma,
4997565|NCT01645930|Refractory multiple myeloma,|refractory multiple myeloma,
4997566|NCT01645930|MLN9708,|mln9708,
4997567|NCT01645930|Proteasome inhibitor|proteasome inhibitor
4997568|NCT01645917|paroxysmal atrial fibrillation|paroxysmal atrial fibrillation
4997569|NCT01645904|Hereditary Diseases|hereditary diseases
4997570|NCT01645904|Genetic|genetic
4997571|NCT01645904|Lynch syndrome|lynch syndrome
4997572|NCT01645904|Positive or indeterminate test results for Lynch syndrome|positive or indeterminate test results for lynch syndrome
4997573|NCT01645904|Social media|social media
4997574|NCT01645904|Internet-based program|internet-based program
4997575|NCT01645904|Questionnaire|questionnaire
4997576|NCT01645904|Survey|survey
4997577|NCT01645904|My Family Garden website|my family garden website
4997578|NCT01645904|Interview|interview
4997579|NCT01645904|Focus group|focus group
4997580|NCT01645904|Website Analysis and MeasureMent Inventory|website analysis and measurement inventory
4997581|NCT01645904|WAMMI|wammi
4997582|NCT01645891|Diabetic Foot Ulcer|diabetic foot ulcer
4997583|NCT01645878|Primiparous Mothers|primiparous mothers
4997584|NCT01645878|self-efficacy,|self-efficacy,
4997585|NCT01645878|hands off,|hands off,
4997586|NCT01645878|hands on ,|hands on ,
4997587|NCT01645878|social cognitive theory|social cognitive theory
4997588|NCT01645865|HIV|hiv
4997589|NCT01645865|AIDS|aids
4997590|NCT01645865|PMTCT|pmtct
4997591|NCT01645865|Mobile Phone|mobile phone
4997592|NCT01645865|SMS|sms
4997593|NCT01645839|Leptomeningeal metastasis|leptomeningeal metastasis
4997594|NCT01645839|Intrathecal chemotherapy|intrathecal chemotherapy
4997595|NCT01645839|Depocyte|depocyte
4997596|NCT01645800|Lysozyme hydrochloride|lysozyme hydrochloride
4997597|NCT01645800|COPD|copd
4997598|NCT01645787|Spinal Muscular Atrophy|spinal muscular atrophy
4997599|NCT01645787|4-aminopyridine|4-aminopyridine
4997600|NCT01645787|dalfampridine|dalfampridine
4997601|NCT01645787|Ampyra|ampyra
4997602|NCT01645774|subcutaneous injection heparin|subcutaneous injection heparin
4997603|NCT01645774|injection duration|injection duration
4997604|NCT01645774|bruising pain|bruising pain
4997605|NCT01645774|decrease pain|decrease pain
4997606|NCT01645774|decrease bruising|decrease bruising
4997607|NCT01645761|Helicobacter pylori eradication|helicobacter pylori eradication
4997608|NCT01645761|Peptic ulcer|peptic ulcer
4997609|NCT01645748|head and neck cancer|head and neck cancer
4997610|NCT01645748|docetaxel|docetaxel
4997611|NCT01645748|cisplatin|cisplatin
4997612|NCT01645748|S-1|s-1
4997613|NCT01645735|Infections|infections
4997614|NCT01645735|Teflaro|teflaro
4997615|NCT01645735|cephalosporin|cephalosporin
4997616|NCT01645735|Ceftaroline|ceftaroline
4997617|NCT01645735|antibiotics|antibiotics
4997618|NCT01645735|pneumonia|pneumonia
4997619|NCT01645722|Fat Grafts|fat grafts
4997620|NCT01645722|Autogenous Fat Transfers (AFT)|autogenous fat transfers (aft)
4997621|NCT01645722|Wounded warriors|wounded warriors
4997622|NCT01645722|Amputation pain|amputation pain
4997623|NCT01645696|Diabetes|diabetes
4997624|NCT01645696|Type 1 Diabetes|type 1 diabetes
4997625|NCT01645696|Continuous glucose monitoring|continuous glucose monitoring
4997626|NCT01645696|Blood glucose|blood glucose
4997627|NCT01645696|Blood glucose sensor|blood glucose sensor
4997628|NCT01645696|Glucose Binding Protein (GBP)|glucose binding protein (gbp)
4997629|NCT01645566|cardiopulmonary resuscitation|cardiopulmonary resuscitation
4997630|NCT01645566|stress|stress
4997631|NCT01645566|intervention|intervention
4997632|NCT01645475|enuresis|enuresis
4997633|NCT01645449|Bioequivalence|bioequivalence
4997634|NCT01645449|Atorvastatin calcium|atorvastatin calcium
4997635|NCT01645449|crossover|crossover
4997636|NCT01645436|randomized controlled trial|randomized controlled trial
4997637|NCT01645436|in-hospital exercise|in-hospital exercise
4997638|NCT01645436|children|children
4997639|NCT01645436|cancer|cancer
4997640|NCT01645423|Bioequivalence|bioequivalence
4997641|NCT01645423|Atorvastatin calcium|atorvastatin calcium
4997642|NCT01645423|crossover|crossover
4997643|NCT01645410|Bioequivalence|bioequivalence
4997644|NCT01645410|Atorvastatin calcium|atorvastatin calcium
4997645|NCT01645410|crossover|crossover
4997646|NCT01645397|Asthma|asthma
4997647|NCT01645397|Deep inhalation|deep inhalation
4997648|NCT01645397|Exhaled nitric oxide|exhaled nitric oxide
4997649|NCT01645384|Bioequivalence|bioequivalence
4997650|NCT01645384|Atorvastatin calcium|atorvastatin calcium
4997651|NCT01645384|crossover|crossover
4997652|NCT01645371|opioid-induced constipation|opioid-induced constipation
4997653|NCT01645358|COPD|copd
4997654|NCT01645358|NIV|niv
4997655|NCT01645358|Acute Hypercapnic Respiratory Failure|acute hypercapnic respiratory failure
4997656|NCT01645358|COPD patients with hypercapnic respiratory failure|copd patients with hypercapnic respiratory failure
4997657|NCT01645345|wrinkles|wrinkles
4997658|NCT01645345|acne scars|acne scars
4997659|NCT01645332|DLBS3233|dlbs3233
4997660|NCT01645332|new onset|new onset
4997661|NCT01645332|type-2-diabetes mellitus|type-2-diabetes mellitus
4997662|NCT01645332|oral anti-hyperglycemic agent|oral anti-hyperglycemic agent
4997663|NCT01645280|Active rheumatoid arthritis|active rheumatoid arthritis
4997664|NCT01645280|Ustekinumab|ustekinumab
4997665|NCT01645280|STELARA|stelara
4997666|NCT01645280|CNTO 1959|cnto 1959
4997667|NCT01645254|healthy volunteers|healthy volunteers
4997668|NCT01645254|pharmacokinetics|pharmacokinetics
4997669|NCT01645254|malaria|malaria
4997670|NCT01645254|Argemone mexicana|argemone mexicana
4997671|NCT01645241|Ovarian stimulation|ovarian stimulation
4997672|NCT01645241|Luteal phase|luteal phase
4997673|NCT01645241|Egg donors|egg donors
4997674|NCT01645241|Fertility preservation|fertility preservation
4997675|NCT01645202|Aortic stenosis|aortic stenosis
4997676|NCT01645202|TAVI|tavi
4997677|NCT01645202|Device success|device success
4997678|NCT01645202|Aortic regurgitation|aortic regurgitation
4997679|NCT01645189|Hunter syndrome|hunter syndrome
4997680|NCT01645189|idursulfase-beta|idursulfase-beta
4997681|NCT01645189|Hunterase|hunterase
4997682|NCT01645189|GC1111|gc1111
4997683|NCT01645176|OA|oa
4997684|NCT01645176|Knee|knee
4997685|NCT01645163|mHealth|mhealth
4997686|NCT01645163|Complementary feeding|complementary feeding
4997687|NCT01645163|ICDS|icds
4997688|NCT01645150|physical activity|physical activity
4997689|NCT01645150|exercise|exercise
4997690|NCT01645150|training|training
4997691|NCT01645150|fatigue|fatigue
4997692|NCT01645150|cancer|cancer
4997693|NCT01645150|TKI|tki
4997694|NCT01645150|tyrosine kinase inhibitor|tyrosine kinase inhibitor
4997695|NCT01645137|prematurity|prematurity
4997696|NCT01645137|OMT|omt
4997697|NCT01645137|complementary and alternative medicine|complementary and alternative medicine
4997698|NCT01645137|neonates|neonates
4997699|NCT01645137|length of stay|length of stay
4997700|NCT01645124|Polycythemia|polycythemia
4997701|NCT01645124|Hematocrit|hematocrit
4997702|NCT01645124|Thrombosis|thrombosis
4997703|NCT01645085|R406|r406
4997704|NCT01645085|Fostamatinib|fostamatinib
4997705|NCT01645085|Phase I|phase i
4997706|NCT01645085|Healthy Subjects|healthy subjects
4997707|NCT01645085|Pharmacokinetics|pharmacokinetics
4997708|NCT01645085|Bioequivalence|bioequivalence
4997709|NCT01645072|Drug refractory epilepsy|drug refractory epilepsy
4997710|NCT01645072|Dietary therapy|dietary therapy
4997711|NCT01645072|ketogenic diet|ketogenic diet
4997712|NCT01645072|childhood epilepsy|childhood epilepsy
4997713|NCT01645033|Cognitive Behavioral Therapy|cognitive behavioral therapy
4997714|NCT01645033|computer|computer
4997715|NCT01645020|absorbable mesh|absorbable mesh
4997716|NCT01645020|Partially absorbed Mesh|partially absorbed mesh
4997717|NCT01645020|Prolift|prolift
4997718|NCT01645020|Prolift + M|prolift + m
4997719|NCT01645020|mesh related complications|mesh related complications
4997720|NCT01645007|Hepatitis B|hepatitis b
4997721|NCT01645007|Prevalence|prevalence
4997722|NCT01645007|HBsAg|hbsag
4997723|NCT01645007|Vaccination|vaccination
4997724|NCT01645007|Galilee|galilee
4997725|NCT01644968|metastatic carcinoma|metastatic carcinoma
4997726|NCT01644968|lymphoma|lymphoma
4997727|NCT01644968|sarcoma|sarcoma
4997728|NCT01644968|anti-OX40|anti-ox40
4997729|NCT01644955|Gliomas|gliomas
4997730|NCT01644955|Carboplatin|carboplatin
4997731|NCT01644942|Obese|obese
4997732|NCT01644942|insulin sensitive|insulin sensitive
4997733|NCT01644942|insulin resistant|insulin resistant
4997734|NCT01644942|myotubes|myotubes
4997735|NCT01644942|lipid accumulation|lipid accumulation
4997736|NCT01644929|hemiparesis|hemiparesis
4997737|NCT01644929|bihemispheric transcranial direct current stimulation|bihemispheric transcranial direct current stimulation
4997738|NCT01644929|ischemic stroke|ischemic stroke
4997739|NCT01644929|subacute|subacute
4997740|NCT01644929|rehabilitation|rehabilitation
4997741|NCT01644929|physiotherapy|physiotherapy
4997742|NCT01644929|ergotherapy|ergotherapy
4997743|NCT01644916|COPD|copd
4997744|NCT01644916|Integrated care|integrated care
4997745|NCT01644916|IPCL|ipcl
4997746|NCT01644890|NK105, Paclitaxel, Breast cancer, Micelle|nk105, paclitaxel, breast cancer, micelle
4997747|NCT01644851|veterans|veterans
4997748|NCT01644851|neuropsychology|neuropsychology
4997749|NCT01644851|neuroimaging|neuroimaging
4997750|NCT01644851|attention|attention
4997751|NCT01644851|working memory|working memory
4997752|NCT01644851|inhibition|inhibition
4997753|NCT01644851|magnetic resonance imaging, functional|magnetic resonance imaging, functional
4997754|NCT01644851|trauma|trauma
4997755|NCT01644851|stress|stress
4997756|NCT01644851|anxiety|anxiety
4997757|NCT01644851|emotion|emotion
4997758|NCT01644851|prefrontal cortex|prefrontal cortex
4997759|NCT01644838|Hyoscine,|hyoscine,
4997760|NCT01644838|Promethazine,|promethazine,
4997761|NCT01644838|The first stage of labor,|the first stage of labor,
4997762|NCT01644838|Labor pain|labor pain
4997763|NCT01644825|platinum resistant|platinum resistant
4997764|NCT01644825|platinum refractory|platinum refractory
4997765|NCT01644799|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
4997766|NCT01644799|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
4997767|NCT01644799|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
4997768|NCT01644786|head and neck|head and neck
4997769|NCT01644786|HNSCC|hnscc
4997770|NCT01644786|orophaynx|orophaynx
4997771|NCT01644786|hypopharynx|hypopharynx
4997772|NCT01644786|larynx|larynx
4997773|NCT01644786|nasopharynx|nasopharynx
4997774|NCT01644786|oral cavity|oral cavity
4997775|NCT01644786|prospective study|prospective study
4997776|NCT01644786|predictive models for HNSCC|predictive models for hnscc
4997777|NCT01644786|genomic analyses|genomic analyses
4997778|NCT01644786|outcome prediction|outcome prediction
4997779|NCT01644760|Diaphragmatic excursion|diaphragmatic excursion
4997780|NCT01644760|normality|normality
4997781|NCT01644747|Resistant Depression|resistant depression
4997782|NCT01644747|Moods disorders|moods disorders
4997783|NCT01644747|Unipolar depression|unipolar depression
4997784|NCT01644747|Bipolar disorder|bipolar disorder
4997785|NCT01644747|tDCS|tdcs
4997786|NCT01644721|Child mortality|child mortality
4997787|NCT01644721|Measles vaccine|measles vaccine
4997788|NCT01644721|Non-specific effects|non-specific effects
4997789|NCT01644708|Obesity|obesity
4997790|NCT01644708|Overweight|overweight
4997791|NCT01644708|Individual empowerment|individual empowerment
4997792|NCT01644708|Physical parameters|physical parameters
4997793|NCT01644708|Self esteem|self esteem
4997794|NCT01644695|BARS|bars
4997795|NCT01644695|Bony Anchoring Reinforcement System|bony anchoring reinforcement system
4997796|NCT01644695|Hernia|hernia
4997797|NCT01644695|Incisional|incisional
4997798|NCT01644695|Recurrent|recurrent
4997799|NCT01644695|abdominal wall reconstruction|abdominal wall reconstruction
4997800|NCT01644695|abdominal wall defect|abdominal wall defect
4997801|NCT01644695|mesh|mesh
4997802|NCT01644695|component separation|component separation
4997803|NCT01644682|Visceral leishmaniasis|visceral leishmaniasis
4997804|NCT01644682|insecticide|insecticide
4997805|NCT01644682|wall lining|wall lining
4997806|NCT01644682|KO TAB123|ko tab123
4997807|NCT01644682|Household|household
4997808|NCT01644682|Kala-azar endemic area|kala-azar endemic area
4997809|NCT01644656|portal hypertension|portal hypertension
4997810|NCT01644656|cirrhosis|cirrhosis
4997811|NCT01644656|ARFI|arfi
4997812|NCT01644656|diagnostic study|diagnostic study
4997813|NCT01644643|Ceftazidime,|ceftazidime,
4997814|NCT01644643|avibactam,|avibactam,
4997815|NCT01644643|metronidazone,|metronidazone,
4997816|NCT01644643|Anti-Infectives|anti-infectives
4997817|NCT01644604|Hypertension|hypertension
4997818|NCT01644604|Vascular Diseases|vascular diseases
4997819|NCT01644604|Cardiovascular Diseases|cardiovascular diseases
4997820|NCT01644604|Renal denervation|renal denervation
4997821|NCT01644591|Melanoma|melanoma
4997822|NCT01644591|Malignant melanoma|malignant melanoma
4997823|NCT01644591|Brain Metastases|brain metastases
4997824|NCT01644591|Stereotactic Radiosurgery|stereotactic radiosurgery
4997825|NCT01644591|SRS|srs
4997826|NCT01644591|XRT|xrt
4997827|NCT01644591|Questionnaires|questionnaires
4997828|NCT01644591|Surveys|surveys
4997829|NCT01644578|MRI|mri
4997830|NCT01644578|real-time imaging|real-time imaging
4997831|NCT01644578|workflow|workflow
4997832|NCT01644552|aniridia|aniridia
4997833|NCT01644552|positive angle kappa|positive angle kappa
4997834|NCT01644539|Satiation|satiation
4997835|NCT01644539|Brain activation|brain activation
4997836|NCT01644539|Gut peptides|gut peptides
4997837|NCT01644526|dialysis|dialysis
4997838|NCT01644526|vascular access|vascular access
4997839|NCT01644526|arteriovenous grafts|arteriovenous grafts
4997840|NCT01644526|valve system|valve system
4997841|NCT01644513|Age Related Macular Degeneration|age related macular degeneration
4997842|NCT01644513|Choroidal Neovascular|choroidal neovascular
4997843|NCT01644513|anti-VEGF Therapy|anti-vegf therapy
4997844|NCT01644409|OAB|oab
4997845|NCT01644409|Overactive bladder|overactive bladder
4997846|NCT01644409|Urgency|urgency
4997847|NCT01644409|Incontinence|incontinence
4997848|NCT01644396|Moderate to Severe Plaque Psoriasis|moderate to severe plaque psoriasis
4997849|NCT01644383|meaning of life|meaning of life
4997850|NCT01644383|logotherapy|logotherapy
4997851|NCT01644383|HIV-infected teenagers|hiv-infected teenagers
4997852|NCT01644383|adherence|adherence
4997853|NCT01644370|HIV-infected children|hiv-infected children
4997854|NCT01644370|T cell response|t cell response
4997855|NCT01644370|asthma|asthma
4997856|NCT01644292|Mobility Impairment|mobility impairment
4997857|NCT01644292|Manual Wheelchair|manual wheelchair
4997858|NCT01644292|Older Adults|older adults
4997859|NCT01644279|aging|aging
4997860|NCT01644279|sarcopenia|sarcopenia
4997861|NCT01644279|mitochondria|mitochondria
4997862|NCT01644279|skeletal muscle|skeletal muscle
4997863|NCT01644279|apoptosis|apoptosis
4997864|NCT01644253|chronic lymphocytic leukemia|chronic lymphocytic leukemia
4997865|NCT01644253|CLL|cll
4997866|NCT01644253|previously untreated chronic lymphocytic leukemia|previously untreated chronic lymphocytic leukemia
4997867|NCT01644253|peripheral T-cell lymphoma|peripheral t-cell lymphoma
4997868|NCT01644253|PTCL|ptcl
4997869|NCT01644227|Hip surgery|hip surgery
4997870|NCT01644227|dual mobility cup|dual mobility cup
4997871|NCT01644227|dislocation|dislocation
4997872|NCT01644227|total hip arthroplasty|total hip arthroplasty
4997873|NCT01644214|Pelvic organ prolapse|pelvic organ prolapse
4997874|NCT01644214|Pessary|pessary
4997875|NCT01644162|Non-Invasive Positive-Pressure Ventilation|non-invasive positive-pressure ventilation
4997876|NCT01644162|Disease Exacerbation|disease exacerbation
4997877|NCT01644162|Respiratory Failure|respiratory failure
4997878|NCT01644149|Jet Injector|jet injector
4997879|NCT01644149|Stratis®|stratis®
4997880|NCT01644149|PharmaJet|pharmajet
4997881|NCT01644149|Jet Injection|jet injection
4997882|NCT01644123|Spasticity|spasticity
4997883|NCT01644123|Diagnostic Algorithm|diagnostic algorithm
4997884|NCT01644097|Quality of Life|quality of life
4997885|NCT01644084|albumin|albumin
4997886|NCT01644084|hydroxyethyl starch 130/0.4|hydroxyethyl starch 130/0.4
4997887|NCT01644084|cardiopulmonary bypass|cardiopulmonary bypass
4997888|NCT01644071|violent video games|violent video games
4997889|NCT01644071|serotonergic system|serotonergic system
4997890|NCT01644058|immediate-loading|immediate-loading
4997891|NCT01644058|patient-based outcomes|patient-based outcomes
4997892|NCT01644045|Asthma|asthma
4997893|NCT01644045|COPD|copd
4997894|NCT01644045|emergency medical service|emergency medical service
4997895|NCT01644045|teleconsultation|teleconsultation
4997896|NCT01644045|telemedicine|telemedicine
4997897|NCT01644032|telemedicine|telemedicine
4997898|NCT01644032|teleconsultation|teleconsultation
4997899|NCT01644032|analgesia|analgesia
4997900|NCT01644032|emergency|emergency
4997901|NCT01644032|prehospital|prehospital
4997902|NCT01644019|stroke|stroke
4997903|NCT01644019|teleconsultation|teleconsultation
4997904|NCT01644019|telemedicine|telemedicine
4997905|NCT01644019|emergency medical service|emergency medical service
4998721|NCT01640665|Sorafenib|sorafenib
4997906|NCT01644006|acute coronary syndrome|acute coronary syndrome
4997907|NCT01644006|telemedicine|telemedicine
4997908|NCT01644006|teleconsultation|teleconsultation
4997909|NCT01644006|emergency medical service|emergency medical service
4997910|NCT01643993|IVF|ivf
4997911|NCT01643993|embryo|embryo
4997912|NCT01643967|Ozone|ozone
4997913|NCT01643967|Sunflower oil|sunflower oil
4997914|NCT01643967|diabetes Mellitus|diabetes mellitus
4997915|NCT01643954|prostatectomy|prostatectomy
4997916|NCT01643954|surgery|surgery
4997917|NCT01643954|prostate cancer|prostate cancer
4997918|NCT01643941|Staphylococcus aureus|staphylococcus aureus
4997919|NCT01643941|vaccine|vaccine
4997920|NCT01643941|Staphylococcal infection|staphylococcal infection
4997921|NCT01643928|extension trial|extension trial
4997922|NCT01643928|rheumatoid arthritis|rheumatoid arthritis
4997923|NCT01643928|rituximab|rituximab
4997924|NCT01643915|Audiovisual distraction|audiovisual distraction
4997925|NCT01643915|Pediatric dentistry|pediatric dentistry
4997926|NCT01643902|Stroke|stroke
4997927|NCT01643902|Wake up|wake up
4997928|NCT01643902|IV tPA|iv tpa
4997929|NCT01643902|Thrombolytic|thrombolytic
4997930|NCT01643889|Healthy|healthy
4997931|NCT01643889|Domperidone|domperidone
4997932|NCT01643889|Cardiac Repolarization|cardiac repolarization
4997933|NCT01643876|Denture stomatitis|denture stomatitis
4997934|NCT01643876|Denture Plaque|denture plaque
4997935|NCT01643876|Oral Candidiasis|oral candidiasis
4997936|NCT01643876|Oral Hygiene|oral hygiene
4997937|NCT01643850|Pigmented Villonodular Synovitis|pigmented villonodular synovitis
4997938|NCT01643850|PVNS|pvns
4997939|NCT01643850|Giant cell tumor of the tendon sheath|giant cell tumor of the tendon sheath
4997940|NCT01643850|GCCTS|gccts
4997941|NCT01643850|Tenosynovial giant cell tumor (localized or diffused type)|tenosynovial giant cell tumor (localized or diffused type)
4997942|NCT01643850|GCTS|gcts
4997943|NCT01643850|MCS110|mcs110
4997944|NCT01643837|Mastalgia|mastalgia
4997945|NCT01643837|Breast Pain|breast pain
4997946|NCT01643837|Osteopathic Manipulative Medicine|osteopathic manipulative medicine
4997947|NCT01643837|Osteopathic Manipulative Treatment|osteopathic manipulative treatment
4997948|NCT01643811|early gastric cancer, diabetes, hypertension|early gastric cancer, diabetes, hypertension
4997949|NCT01643785|therapeutic efficacy endonase addictive effect|therapeutic efficacy endonase addictive effect
4997950|NCT01643759|osteoarthritis disorders|osteoarthritis disorders
4997951|NCT01643733|Angioplasty|angioplasty
4997952|NCT01643707|Sick Sinus Syndrome|sick sinus syndrome
4997953|NCT01643707|Bradycardia|bradycardia
4997954|NCT01643616|Sciatic Nerve|sciatic nerve
4997955|NCT01643616|Ultrasound|ultrasound
4997956|NCT01643616|Anesthesia, Regional|anesthesia, regional
4997957|NCT01643616|Orthopedic Surgery|orthopedic surgery
4997958|NCT01643603|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
4997959|NCT01643603|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
4997960|NCT01643603|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
4997961|NCT01643603|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
4997962|NCT01643603|adult acute myeloid leukemia with del(5q)|adult acute myeloid leukemia with del(5q)
4997963|NCT01643603|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
4997964|NCT01643603|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
4997965|NCT01643603|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
4997966|NCT01643603|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
4997967|NCT01643603|adult grade III lymphomatoid granulomatosis|adult grade iii lymphomatoid granulomatosis
4997968|NCT01643603|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
4997969|NCT01643603|anaplastic large cell lymphoma|anaplastic large cell lymphoma
4997970|NCT01643603|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
4997971|NCT01643603|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
4997972|NCT01643603|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
4997973|NCT01643603|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
4997974|NCT01643603|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
4997975|NCT01643603|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
4997976|NCT01643603|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
4997977|NCT01643603|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
4997978|NCT01643603|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
4997979|NCT01643603|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
4997980|NCT01643603|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
4997981|NCT01643603|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
4997982|NCT01643603|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
4997983|NCT01643603|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
4997984|NCT01643603|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
4999005|NCT01639508|12-097|12-097
4997985|NCT01643603|cutaneous B-cell non-Hodgkin lymphoma|cutaneous b-cell non-hodgkin lymphoma
4997986|NCT01643603|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
4997987|NCT01643603|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
4997988|NCT01643603|hepatosplenic T-cell lymphoma|hepatosplenic t-cell lymphoma
4997989|NCT01643603|intraocular lymphoma|intraocular lymphoma
4997990|NCT01643603|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
4997991|NCT01643603|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
4997992|NCT01643603|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
4997993|NCT01643603|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
4997994|NCT01643603|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
4997995|NCT01643603|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
4997996|NCT01643603|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
4997997|NCT01643603|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
4997998|NCT01643603|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
4997999|NCT01643603|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
4998000|NCT01643603|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
4998001|NCT01643603|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
4998002|NCT01643603|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
4998003|NCT01643603|noncutaneous extranodal lymphoma|noncutaneous extranodal lymphoma
4998004|NCT01643603|peripheral T-cell lymphoma|peripheral t-cell lymphoma
4998005|NCT01643603|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
4998006|NCT01643603|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
4998007|NCT01643603|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
4998008|NCT01643603|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
4998009|NCT01643603|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
4998010|NCT01643603|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
4998011|NCT01643603|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
4998012|NCT01643603|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
4998013|NCT01643603|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
4998014|NCT01643603|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
4998015|NCT01643603|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
4998016|NCT01643603|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
4998017|NCT01643603|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
4998018|NCT01643603|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
4998019|NCT01643603|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
4998020|NCT01643603|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
4998021|NCT01643603|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
4998022|NCT01643603|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
4998023|NCT01643603|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
4998024|NCT01643603|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
4998025|NCT01643603|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
4998026|NCT01643603|refractory hairy cell leukemia|refractory hairy cell leukemia
4998027|NCT01643603|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
4998028|NCT01643603|small intestine lymphoma|small intestine lymphoma
4998029|NCT01643603|splenic marginal zone lymphoma|splenic marginal zone lymphoma
4998030|NCT01643603|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
4998031|NCT01643603|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
4998032|NCT01643603|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
4998033|NCT01643603|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
4998034|NCT01643603|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
4998035|NCT01643603|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
4998036|NCT01643603|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
4998037|NCT01643603|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
4998038|NCT01643603|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
4998039|NCT01643603|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
4998040|NCT01643603|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
4998041|NCT01643603|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
4998042|NCT01643603|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
4998043|NCT01643603|stage I mantle cell lymphoma|stage i mantle cell lymphoma
4998044|NCT01643603|stage I marginal zone lymphoma|stage i marginal zone lymphoma
4998045|NCT01643603|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
4998046|NCT01643603|stage IA mycosis fungoides/Sezary syndrome|stage ia mycosis fungoides/sezary syndrome
4998223|NCT01642979|cyclosporine A|cyclosporine a
4998047|NCT01643603|stage IB mycosis fungoides/Sezary syndrome|stage ib mycosis fungoides/sezary syndrome
4998048|NCT01643603|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
4998049|NCT01643603|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
4998050|NCT01643603|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
4998051|NCT01643603|stage IIA mycosis fungoides/Sezary syndrome|stage iia mycosis fungoides/sezary syndrome
4998052|NCT01643603|stage IIB mycosis fungoides/Sezary syndrome|stage iib mycosis fungoides/sezary syndrome
4998053|NCT01643603|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
4998054|NCT01643603|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
4998055|NCT01643603|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
4998056|NCT01643603|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
4998057|NCT01643603|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
4998058|NCT01643603|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
4998059|NCT01643603|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
4998060|NCT01643603|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
4998061|NCT01643603|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
4998062|NCT01643603|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
4998063|NCT01643603|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
4998064|NCT01643603|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
4998065|NCT01643603|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
4998066|NCT01643603|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
4998067|NCT01643603|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
4998068|NCT01643603|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
4998069|NCT01643603|stage IIIA mycosis fungoides/Sezary syndrome|stage iiia mycosis fungoides/sezary syndrome
4998070|NCT01643603|stage IIIB mycosis fungoides/Sezary syndrome|stage iiib mycosis fungoides/sezary syndrome
4998071|NCT01643603|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
4998072|NCT01643603|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
4998073|NCT01643603|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
4998074|NCT01643603|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
4998075|NCT01643603|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
4998076|NCT01643603|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
4998077|NCT01643603|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
4998078|NCT01643603|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
4998079|NCT01643603|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
4998080|NCT01643603|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
4998081|NCT01643603|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
4998082|NCT01643603|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
4998083|NCT01643603|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
4998084|NCT01643603|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
4998085|NCT01643603|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
4998086|NCT01643603|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
4998087|NCT01643603|stage IVA mycosis fungoides/Sezary syndrome|stage iva mycosis fungoides/sezary syndrome
4998088|NCT01643603|stage IVB mycosis fungoides/Sezary syndrome|stage ivb mycosis fungoides/sezary syndrome
4998089|NCT01643603|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
4998090|NCT01643603|testicular lymphoma|testicular lymphoma
4998091|NCT01643603|Waldenström macroglobulinemia|waldenström macroglobulinemia
4998092|NCT01643577|Idiopathic|idiopathic
4998093|NCT01643577|gastroparesis|gastroparesis
4998094|NCT01643577|delayed gastric emptying|delayed gastric emptying
4998095|NCT01643577|nausea|nausea
4998096|NCT01643577|vomiting|vomiting
4998097|NCT01643577|abdominal pain|abdominal pain
4998098|NCT01643577|bloating|bloating
4998099|NCT01643564|Transplant|transplant
4998100|NCT01643564|Cytokines|cytokines
4998101|NCT01643564|Graft Dysfunction|graft dysfunction
4998102|NCT01643551|Heart Failure|heart failure
4998103|NCT01643551|Left Ventricular Assist Device|left ventricular assist device
4998104|NCT01643551|Reperfusion Injury|reperfusion injury
4998105|NCT01643551|Neuron Specific Enolase|neuron specific enolase
4998106|NCT01643538|physical activity|physical activity
4998107|NCT01643538|adults age 65 and older|adults age 65 and older
4998108|NCT01643538|financial incentives|financial incentives
4998109|NCT01643525|Ischemic Stroke|ischemic stroke
4998110|NCT01643486|peritoneal dialysis|peritoneal dialysis
4998111|NCT01643486|phosphate|phosphate
4998112|NCT01643486|iTouch|itouch
4998113|NCT01643473|Hypertension|hypertension
4998114|NCT01643473|Latinos|latinos
4998115|NCT01643473|Medication Adherence|medication adherence
4998116|NCT01643473|Blood Pressure Control|blood pressure control
4998117|NCT01643473|Patient-centered|patient-centered
4998118|NCT01643473|Black|black
4998119|NCT01643460|Intraductal papillary mucinous neoplasms (IPMNs)|intraductal papillary mucinous neoplasms (ipmns)
4998120|NCT01643460|Mucinous cystadenomas [MCN])|mucinous cystadenomas [mcn])
4998224|NCT01642966|ticagrelor|ticagrelor
4999490|NCT01636934|Sugar Pill|sugar pill
4998121|NCT01643460|Invasive IPMNs or mucinous cystadenocarcinomas) tumors|invasive ipmns or mucinous cystadenocarcinomas) tumors
4998122|NCT01643447|Hepatocellular Carcinoma|hepatocellular carcinoma
4998123|NCT01643447|Ulinastatin|ulinastatin
4998124|NCT01643447|Hepatic Failure|hepatic failure
4998125|NCT01643434|Resistant Hypertension|resistant hypertension
4998126|NCT01643408|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
4998127|NCT01643408|Lymphoblastic Lymphoma|lymphoblastic lymphoma
4998128|NCT01643408|Erwinaze|erwinaze
4998129|NCT01643408|asparaginase|asparaginase
4998130|NCT01643408|Eusa Pharma|eusa pharma
4998131|NCT01643408|Pharmacokinetic study|pharmacokinetic study
4998132|NCT01643408|NSAA|nsaa
4998133|NCT01643395|Trauma|trauma
4998134|NCT01643395|vertebral|vertebral
4998135|NCT01643395|compression fracture|compression fracture
4998136|NCT01643395|spinal|spinal
4998137|NCT01643395|acute|acute
4998138|NCT01643395|vertebroplasty|vertebroplasty
4998139|NCT01643395|conservative treatment|conservative treatment
4998140|NCT01643382|diabetes|diabetes
4998141|NCT01643382|kidney transplant|kidney transplant
4998142|NCT01643382|end stage renal disease|end stage renal disease
4998143|NCT01643382|delayed draft function|delayed draft function
4998144|NCT01643369|meditation|meditation
4998145|NCT01643369|compassion|compassion
4998146|NCT01643369|inflammation|inflammation
4998147|NCT01643369|immune system|immune system
4998148|NCT01643356|weight|weight
4998149|NCT01643356|pregnancy|pregnancy
4998150|NCT01643356|behavioral intervention|behavioral intervention
4998151|NCT01643356|obesity|obesity
4998152|NCT01643343|autism spectrum disorders|autism spectrum disorders
4998153|NCT01643343|autism|autism
4998154|NCT01643343|joint attention|joint attention
4998155|NCT01643343|imitation|imitation
4998156|NCT01643343|fluency|fluency
4998157|NCT01643330|Cardiomegaly|cardiomegaly
4998158|NCT01643330|Heart Diseases|heart diseases
4998159|NCT01643330|Cardiovascular Diseases|cardiovascular diseases
4998160|NCT01643304|Menorrhagia|menorrhagia
4998161|NCT01643304|Heavy menstrual bleeding|heavy menstrual bleeding
4998162|NCT01643304|Uterine Hemorrhage|uterine hemorrhage
4998163|NCT01643304|Menstruation Disturbancies|menstruation disturbancies
4998164|NCT01643252|Corneal Ectasia|corneal ectasia
4998165|NCT01643252|Refractive surgery|refractive surgery
4998166|NCT01643252|Cross-Linking|cross-linking
4998167|NCT01643239|Modified constraint-induced therapy|modified constraint-induced therapy
4998168|NCT01643239|Children with cerebral palsy|children with cerebral palsy
4998169|NCT01643239|Kinematic analysis|kinematic analysis
4998170|NCT01643239|Group therapy|group therapy
4998171|NCT01643200|Erectile Dysfunction|erectile dysfunction
4998172|NCT01643200|Male|male
4998173|NCT01643200|Zotarolimus|zotarolimus
4998174|NCT01643200|Stent|stent
4998175|NCT01643200|Stenosis|stenosis
4998176|NCT01643200|Erection|erection
4998177|NCT01643200|PDE5 Inhibitors|pde5 inhibitors
4998178|NCT01643148|biomarker|biomarker
4998179|NCT01643148|BMI|bmi
4998180|NCT01643148|breast cancer|breast cancer
4998181|NCT01643148|CA-15-3|ca-15-3
4998182|NCT01643148|leptin|leptin
4998183|NCT01643135|tranexamic acid|tranexamic acid
4998184|NCT01643135|bleeding|bleeding
4998185|NCT01643135|blood transfusion|blood transfusion
4998186|NCT01643135|spine surgery|spine surgery
4998187|NCT01643122|Endometriosis, Validation study|endometriosis, validation study
4998188|NCT01643109|Cerebral Palsy|cerebral palsy
4998189|NCT01643109|Hemiplegia|hemiplegia
4998190|NCT01643109|Constraint Induced Movement Therapy|constraint induced movement therapy
4998191|NCT01643096|Zataria multiflora Boiss Sumac TEF temperament|zataria multiflora boiss sumac tef temperament
4998192|NCT01643083|Post-prandial distress syndrome|post-prandial distress syndrome
4998193|NCT01643070|Rectal cancer|rectal cancer
4998194|NCT01643070|Liver metastases|liver metastases
4998195|NCT01643070|Capecitabine|capecitabine
4998196|NCT01643070|Oxaliplatin|oxaliplatin
4998197|NCT01643057|Apnea|apnea
4998198|NCT01643057|Prematurity|prematurity
4998199|NCT01643057|Biomarkers|biomarkers
4998200|NCT01643057|Stochastic Resonance|stochastic resonance
4998201|NCT01643057|Neonatal|neonatal
4998202|NCT01643044|pregnancy|pregnancy
4998203|NCT01643044|screening|screening
4998204|NCT01643044|motivation|motivation
4998205|NCT01643031|Diabetes|diabetes
4998206|NCT01643031|Platelets aggregation inhibitors|platelets aggregation inhibitors
4998207|NCT01643031|Platelet function tests|platelet function tests
4998208|NCT01643018|cystic echinococcosis|cystic echinococcosis
4998209|NCT01643018|liver cyst hydatique|liver cyst hydatique
4998210|NCT01643018|treatment|treatment
4998211|NCT01643018|surgery|surgery
4998212|NCT01643018|laparoscopy|laparoscopy
4998213|NCT01643005|HIV|hiv
4998214|NCT01642992|Coronary bifurcation lesion|coronary bifurcation lesion
4998215|NCT01642992|Drug-eluting stent|drug-eluting stent
4998216|NCT01642979|Paroxysmal Nocturnal Hemoglobinuria|paroxysmal nocturnal hemoglobinuria
4998217|NCT01642979|Anemia|anemia
4998218|NCT01642979|Hematologic Diseases|hematologic diseases
4998219|NCT01642979|bone marrow failure|bone marrow failure
4998220|NCT01642979|Immunologic Factors|immunologic factors
4998221|NCT01642979|Physiological Effects of Drugs|physiological effects of drugs
4998222|NCT01642979|Levamisole|levamisole
4998225|NCT01642966|doppler echocardiography|doppler echocardiography
4998226|NCT01642953|Gastric cancer surgery|gastric cancer surgery
4998227|NCT01642953|Early oral feeding|early oral feeding
4998228|NCT01642953|Fast track surgery|fast track surgery
4998229|NCT01642927|LVAD|lvad
4998230|NCT01642927|IABP|iabp
4998231|NCT01642927|Heart Failure|heart failure
4998232|NCT01642927|Thrombosis|thrombosis
4998233|NCT01642927|Hemorrhage|hemorrhage
4998234|NCT01642914|Chronic Constipation|chronic constipation
4998235|NCT01642914|Abdominal Bloating|abdominal bloating
4998236|NCT01642914|Linaclotide|linaclotide
4998237|NCT01642901|spinal cord injury|spinal cord injury
4998238|NCT01642901|bone mineral density|bone mineral density
4998239|NCT01642875|Periampullary tumor|periampullary tumor
4998240|NCT01642875|Chronic pancreatitis|chronic pancreatitis
4998241|NCT01642875|Pancreatoduodenectomy|pancreatoduodenectomy
4998242|NCT01642875|Oral Nutrition|oral nutrition
4998243|NCT01642875|Enteral Nutrition|enteral nutrition
4998244|NCT01642849|high protein diet|high protein diet
4998245|NCT01642849|high carbohydrate diet|high carbohydrate diet
4998246|NCT01642849|weight loss|weight loss
4998247|NCT01642849|oxidative stress|oxidative stress
4998248|NCT01642849|inflammation|inflammation
4998249|NCT01642849|cardiovascular risk factors|cardiovascular risk factors
4998250|NCT01642823|retinoblastoma|retinoblastoma
4998251|NCT01642810|Online treatment for Fibromyalgia Syndrome|online treatment for fibromyalgia syndrome
4998252|NCT01642810|Acceptance-based behavioural treatment|acceptance-based behavioural treatment
4998253|NCT01642797|confocal laser endomicroscopy|confocal laser endomicroscopy
4998254|NCT01642797|gastric intestinal metaplasia|gastric intestinal metaplasia
4998255|NCT01642797|gastric intraepithelial neoplasia|gastric intraepithelial neoplasia
4998256|NCT01642797|gastric carcinoma|gastric carcinoma
4998257|NCT01642784|STEMI|stemi
4998258|NCT01642784|NSTEMI|nstemi
4998259|NCT01642784|revascularization|revascularization
4998260|NCT01642784|stents|stents
4998261|NCT01642771|Triple-negative Breast Cancer|triple-negative breast cancer
4998262|NCT01642771|Post-operative adjuvant Chemotherapy|post-operative adjuvant chemotherapy
4998263|NCT01642771|Docetaxel|docetaxel
4998264|NCT01642771|Capecitabine|capecitabine
4998265|NCT01642771|Epirubicin|epirubicin
4998266|NCT01642771|Cyclophosphamide|cyclophosphamide
4998267|NCT01642771|Fluorouracil|fluorouracil
4998268|NCT01642758|Thalassemia intermedia|thalassemia intermedia
4998269|NCT01642758|Fetal hemoglobin|fetal hemoglobin
4998270|NCT01642758|Hemoglobin|hemoglobin
4998271|NCT01642732|Prostate|prostate
4998272|NCT01642732|Cancer|cancer
4998273|NCT01642732|Everolimus|everolimus
4998274|NCT01642732|Radiation|radiation
4998275|NCT01642719|Sleep disturbance|sleep disturbance
4998276|NCT01642719|Aging|aging
4998277|NCT01642719|Sleep restriction|sleep restriction
4998278|NCT01642719|Health status|health status
4998279|NCT01642719|Glucose tolerance|glucose tolerance
4998280|NCT01642719|Inflammation|inflammation
4998281|NCT01642706|Regulatory B cells|regulatory b cells
4998282|NCT01642706|Rheumatoid arthritis|rheumatoid arthritis
4998283|NCT01642706|Biomarker|biomarker
4998284|NCT01642693|root resorption|root resorption
4998285|NCT01642693|low-power laser|low-power laser
4998286|NCT01642693|orthodontic tooth movement|orthodontic tooth movement
4998287|NCT01642693|pulp changes|pulp changes
4998288|NCT01642680|Physical activity program|physical activity program
4998289|NCT01642680|Chemotherapy|chemotherapy
4998290|NCT01642680|Metabolic syndrome|metabolic syndrome
4998291|NCT01642680|Reducing cardiovascular risk factors|reducing cardiovascular risk factors
4998292|NCT01642680|low physical activity level|low physical activity level
4998293|NCT01642628|Mirror|mirror
4998294|NCT01642628|Body Image|body image
4998295|NCT01642628|Mastectomy|mastectomy
4998296|NCT01642615|Drug therapy|drug therapy
4998297|NCT01642602|Drug Therapy|drug therapy
4998298|NCT01642589|Meningitis|meningitis
4998299|NCT01642589|Meningococcal disease|meningococcal disease
4998300|NCT01642589|Menactra®|menactra®
4998301|NCT01642589|Adacel®|adacel®
4998302|NCT01642576|obesity|obesity
4998303|NCT01642576|men|men
4998304|NCT01642576|sexual function|sexual function
4998305|NCT01642576|urinary tract symptoms|urinary tract symptoms
4998306|NCT01642576|endothelial function|endothelial function
4998307|NCT01642576|inflammation|inflammation
4998308|NCT01642576|quality of life|quality of life
4998309|NCT01642563|Platelet transfusion|platelet transfusion
4998310|NCT01642563|Leukemia|leukemia
4998311|NCT01642563|Transfusion transmissible infections|transfusion transmissible infections
4998312|NCT01642563|Chemotherapy|chemotherapy
4998313|NCT01642563|Allogeneic hemopoietic stem cell transplant|allogeneic hemopoietic stem cell transplant
4998314|NCT01642550|Anorexia nervosa|anorexia nervosa
4998315|NCT01642550|Anorexia|anorexia
4998316|NCT01642550|Eating disorders|eating disorders
4998317|NCT01642524|resuscitation|resuscitation
4998318|NCT01642511|Breast Cancer|breast cancer
4998319|NCT01642511|Sentinel Lymph Node Biopsy|sentinel lymph node biopsy
4998320|NCT01642511|Internal Mammary|internal mammary
4998321|NCT01642511|Lymphoscintigraphy|lymphoscintigraphy
4998322|NCT01642498|High Blood Pressure|high blood pressure
4998323|NCT01642498|Hypertension|hypertension
4998324|NCT01642498|Resistant Hypertension|resistant hypertension
4998325|NCT01642485|Insulin clamp|insulin clamp
4998326|NCT01642485|Glucose clamp|glucose clamp
4998327|NCT01642485|Moxifloxacin|moxifloxacin
4998328|NCT01642485|Fed|fed
4998329|NCT01642485|Fasted|fasted
4998330|NCT01642485|QT/QTC interval|qt/qtc interval
4998331|NCT01642485|TQT|tqt
4998332|NCT01642485|ECG|ecg
4998333|NCT01642485|Meal effects|meal effects
4998334|NCT01642485|C Peptide|c peptide
4998335|NCT01642485|Japanese Caucasian bridging|japanese caucasian bridging
4998336|NCT01642485|TQT bridging|tqt bridging
4998337|NCT01642485|FDA standard breakfast|fda standard breakfast
4998338|NCT01642485|Adaptive study design|adaptive study design
4998339|NCT01642459|arteriovenous fistula|arteriovenous fistula
4998340|NCT01642459|hemodialysis|hemodialysis
4998341|NCT01642459|aneurysm|aneurysm
4998342|NCT01642459|vascular stenosis|vascular stenosis
4998343|NCT01642459|cannulation|cannulation
4998344|NCT01642446|precise hepatectomy|precise hepatectomy
4998345|NCT01642446|hepatocellular carcinoma|hepatocellular carcinoma
4998346|NCT01642446|cirrhotic|cirrhotic
4998347|NCT01642446|portal hypertension|portal hypertension
4998348|NCT01642446|safety|safety
4998349|NCT01642446|combined interventional treatment|combined interventional treatment
4998350|NCT01642394|Diabetes Mellitus|diabetes mellitus
4998351|NCT01642394|Chronic Disease|chronic disease
4998352|NCT01642394|Education|education
4998353|NCT01642394|Primary Care|primary care
4998354|NCT01642394|Self care|self care
4998355|NCT01642394|Self Management|self management
4998356|NCT01642381|Drinking|drinking
4998357|NCT01642381|Alcohol Problems|alcohol problems
4998358|NCT01642381|Alcoholism|alcoholism
4998359|NCT01642381|Moderation-Oriented Treatment|moderation-oriented treatment
4998360|NCT01642381|Controlled Drinking|controlled drinking
4998361|NCT01642381|Reduced Drinking|reduced drinking
4998362|NCT01642381|Heavy Drinking|heavy drinking
4998363|NCT01642381|Problematic Drinking|problematic drinking
4998364|NCT01642381|Non-Abstinence-based Drinking|non-abstinence-based drinking
4998365|NCT01642368|Omega-3 fatty acids|omega-3 fatty acids
4998366|NCT01642368|Omega-3 to omega-6 ratio|omega-3 to omega-6 ratio
4998367|NCT01642368|Cognitive response|cognitive response
4998368|NCT01642368|Physical performance|physical performance
4998369|NCT01642329|Myocardial Infarction|myocardial infarction
4998370|NCT01642329|Angina, Unstable|angina, unstable
4998371|NCT01642316|washback, reading comprehension|washback, reading comprehension
4998372|NCT01642303|vodcasting,listening,language education|vodcasting,listening,language education
4998373|NCT01642277|Overactive Bladder|overactive bladder
4998374|NCT01642277|OAB|oab
4998375|NCT01642277|Urinary Tract Infection|urinary tract infection
4998376|NCT01642277|UTI|uti
4998377|NCT01642277|Microbiome|microbiome
4998378|NCT01642277|Bacteria|bacteria
4998379|NCT01642277|Solifenacin|solifenacin
4998380|NCT01642277|16S rRNA sequence|16s rrna sequence
4998381|NCT01642264|Tobacco Cessation|tobacco cessation
4998382|NCT01642264|Continuing Education|continuing education
4998383|NCT01642264|Pediatric|pediatric
4998384|NCT01642264|Respiratory Therapist|respiratory therapist
4998385|NCT01642264|Nurse|nurse
4998386|NCT01642238|Antiplatelet|antiplatelet
4998387|NCT01642238|ticagrelor|ticagrelor
4998388|NCT01642238|clopidogrel|clopidogrel
4998389|NCT01642238|bivalirudin|bivalirudin
4998390|NCT01642238|thrombosis|thrombosis
4998391|NCT01642212|EoE|eoe
4998392|NCT01642199|obesity|obesity
4998393|NCT01642199|weight loss|weight loss
4998394|NCT01642199|lay health coach|lay health coach
4998395|NCT01642199|peer coach|peer coach
4998396|NCT01642199|mentor coach|mentor coach
4998397|NCT01642199|reduced intensity weight loss program|reduced intensity weight loss program
4998398|NCT01642186|LETROZOLE|letrozole
4998399|NCT01642186|LUPRON DEPOT|lupron depot
4998400|NCT01642186|RAD001 (EVEROLIMUS)|rad001 (everolimus)
4998401|NCT01642186|11-211|11-211
4998402|NCT01642147|Cerebral blood flow|cerebral blood flow
4998403|NCT01642147|Transcranial Doppler|transcranial doppler
4998404|NCT01642147|Emergence from general anesthesia|emergence from general anesthesia
4998405|NCT01642134|Antiplatelet|antiplatelet
4998406|NCT01642134|Anticoagulation|anticoagulation
4998407|NCT01642056|Fibroblasts|fibroblasts
4998408|NCT01642056|Mitochondria|mitochondria
4998409|NCT01642056|Energy|energy
4998410|NCT01642056|Redox|redox
4998411|NCT01642056|Metabolic Disease|metabolic disease
4998412|NCT01642043|greater trochanteric pain syndrome|greater trochanteric pain syndrome
4998413|NCT01642043|trochanteric bursitis|trochanteric bursitis
4998414|NCT01642043|lateral hip pain|lateral hip pain
4998415|NCT01642030|Quantitative sensory testing|quantitative sensory testing
4998416|NCT01642030|Cold pressor test|cold pressor test
4998417|NCT01642030|Opioid dependence|opioid dependence
4998418|NCT01642030|Methadone maintenance|methadone maintenance
4998419|NCT01642030|Buprenorphine maintenance|buprenorphine maintenance
4998420|NCT01642030|Abuse liability|abuse liability
4998421|NCT01642030|Diffuse Noxious Inhibitory Controls (DNIC)|diffuse noxious inhibitory controls (dnic)
4998422|NCT01642030|Temporal Summation|temporal summation
4998423|NCT01642017|Phase I, Pazopanib, Frail elderly patients, Pharmacokinetics|phase i, pazopanib, frail elderly patients, pharmacokinetics
4998424|NCT01641991|Bacillus anthracis, anthrax, vaccine, BioThrax®, dose-sparing|bacillus anthracis, anthrax, vaccine, biothrax®, dose-sparing
4998425|NCT01641913|Eosinophilic Esophagitis|eosinophilic esophagitis
4998426|NCT01641900|sleep|sleep
4998427|NCT01641900|memory|memory
4998428|NCT01641900|schizophrenia|schizophrenia
4998429|NCT01641900|eszopiclone|eszopiclone
4998430|NCT01641887|GERD|gerd
4998431|NCT01641887|Heartburn|heartburn
4998432|NCT01641887|Decision Aid|decision aid
4998433|NCT01641874|Knee|knee
4998434|NCT01641874|Osteoarthritis|osteoarthritis
4998435|NCT01641874|McKenzie system|mckenzie system
4998436|NCT01641874|Exercise|exercise
4998437|NCT01641874|Mechanical Diagnosis and Therapy|mechanical diagnosis and therapy
4998438|NCT01641874|Directional preference|directional preference
4998439|NCT01641861|Chemo-mechanical caries removal|chemo-mechanical caries removal
4998440|NCT01641861|Papacarie®|papacarie®
4998441|NCT01641848|Total Ankle Arthroplasty|total ankle arthroplasty
4998442|NCT01641809|HIV -1|hiv -1
4998443|NCT01641809|GSK1265744|gsk1265744
4998444|NCT01641809|maintenance phase|maintenance phase
4998445|NCT01641809|dose selection|dose selection
4998446|NCT01641796|Cutaneous Leishmaniasis|cutaneous leishmaniasis
4998447|NCT01641796|CL|cl
4998448|NCT01641796|Lesion|lesion
4998449|NCT01641796|Topical|topical
4998450|NCT01641796|Treatment|treatment
4998451|NCT01641796|Cream|cream
4998452|NCT01641796|Expanded Access|expanded access
4998453|NCT01641783|advanced|advanced
4998454|NCT01641783|paclitaxel|paclitaxel
4998455|NCT01641783|capecitabine|capecitabine
4998456|NCT01641783|first line therapy|first line therapy
4998457|NCT01641757|hemodialysis|hemodialysis
4998458|NCT01641757|periodontitis|periodontitis
4998459|NCT01641744|Parent Child Relationship|parent child relationship
4998460|NCT01641744|Maltreatment|maltreatment
4998461|NCT01641744|Risk Behaviors|risk behaviors
4998462|NCT01641744|Social and Emotional Development|social and emotional development
4998463|NCT01641744|Violence and Abuse|violence and abuse
4998464|NCT01641744|Policy|policy
4998465|NCT01641731|cow's milk protein allergy|cow's milk protein allergy
4998466|NCT01641731|oral tolerance induction|oral tolerance induction
4998467|NCT01641718|Hernia, Inguinal|hernia, inguinal
4998468|NCT01641705|rheumatoid arthritis|rheumatoid arthritis
4998469|NCT01641705|respiratory mechanics|respiratory mechanics
4998470|NCT01641705|time of disease|time of disease
4998471|NCT01641692|Asthma|asthma
4998472|NCT01641692|Pharmacokinetics|pharmacokinetics
4998473|NCT01641692|GSK573719|gsk573719
4998474|NCT01641692|Adults|adults
4998475|NCT01641692|Pharmacogenetics|pharmacogenetics
4998476|NCT01641679|Recurrent differentiated thyroid cancer|recurrent differentiated thyroid cancer
4998477|NCT01641679|I124-PET/CT|i124-pet/ct
4998478|NCT01641679|FDG-PET/CT|fdg-pet/ct
4998479|NCT01641653|Nondiabetics undergoing hernia repair.|nondiabetics undergoing hernia repair.
4998480|NCT01641640|HCV genotype 1 (GT-1)|hcv genotype 1 (gt-1)
4998481|NCT01641640|HCV genotype 4 (GT-4)|hcv genotype 4 (gt-4)
4998482|NCT01641640|HCV genotype 5 (GT-5)|hcv genotype 5 (gt-5)
4998483|NCT01641640|HCV genotype 6 (GT-6)|hcv genotype 6 (gt-6)
4998484|NCT01641640|HCV|hcv
4998485|NCT01641640|Sustained Virologic Response|sustained virologic response
4998486|NCT01641640|Direct Acting Antiviral|direct acting antiviral
4998487|NCT01641640|Combination Therapy|combination therapy
4998488|NCT01641640|Treatment-Naïve|treatment-naïve
4998489|NCT01641640|GS-7977|gs-7977
4998490|NCT01641640|Ribavirin|ribavirin
4998491|NCT01641640|RBV|rbv
4998492|NCT01641640|Peginterferon Alfa 2a|peginterferon alfa 2a
4998493|NCT01641640|PEG|peg
4998494|NCT01641627|knee arthritis|knee arthritis
4998495|NCT01641627|muscle atrophy|muscle atrophy
4998496|NCT01641627|proprioceptive stimulation|proprioceptive stimulation
4998497|NCT01641627|vibrations|vibrations
4998498|NCT01641614|Mitral valve|mitral valve
4998499|NCT01641614|valve replacement|valve replacement
4998500|NCT01641614|arrested heart|arrested heart
4998501|NCT01641614|beating heart|beating heart
4998502|NCT01641601|Induction of labor|induction of labor
4998503|NCT01641601|Outpatient cervical ripening|outpatient cervical ripening
4998504|NCT01641588|cognitive executive function|cognitive executive function
4998505|NCT01641588|posture|posture
4998506|NCT01641588|cognitive performance|cognitive performance
4998507|NCT01641588|heart rate|heart rate
4998508|NCT01641588|eeg|eeg
4998509|NCT01641575|CO-1.01|co-1.01
4998510|NCT01641575|CO-101|co-101
4998511|NCT01641575|gemcitabine elaidate|gemcitabine elaidate
4998512|NCT01641575|hENT1|hent1
4998513|NCT01641575|nucleoside equilibrative transporter|nucleoside equilibrative transporter
4998514|NCT01641575|solid tumor|solid tumor
4998515|NCT01641575|non-small-cell lung cancer|non-small-cell lung cancer
4998516|NCT01641575|NSCLC|nsclc
4998517|NCT01641575|lung cancer|lung cancer
4998518|NCT01641562|BREAST CANCER,|breast cancer,
4998519|NCT01641562|TAXANES,|taxanes,
4998520|NCT01641562|SUBCLINICAL CARDIAC DYSFUNCTION ,|subclinical cardiac dysfunction ,
4998521|NCT01641562|DIAGNOSTIC TOOLS,|diagnostic tools,
4998522|NCT01641562|PREDICTIVE MODELS|predictive models
4998648|NCT01641042|Vaccines, conjugate|vaccines, conjugate
4998523|NCT01641549|Prosthetic valve thrombosis|prosthetic valve thrombosis
4998524|NCT01641549|Fibrinolytic therapy|fibrinolytic therapy
4998525|NCT01641549|Emergency surgery|emergency surgery
4998526|NCT01641536|Hepatitis, Chronic|hepatitis, chronic
4998527|NCT01641536|Virus Diseases|virus diseases
4998528|NCT01641536|DNA Virus Infections|dna virus infections
4998529|NCT01641536|Hepatitis B|hepatitis b
4998530|NCT01641536|Liver|liver
4998531|NCT01641536|Chronic Disease|chronic disease
4998532|NCT01641536|HBV|hbv
4998533|NCT01641523|Cranioplasty prosthesis|cranioplasty prosthesis
4998534|NCT01641523|Hydroxyapatite|hydroxyapatite
4998535|NCT01641523|PolyMethylMethacrylate|polymethylmethacrylate
4998536|NCT01641523|Autologous Bone|autologous bone
4998537|NCT01641510|reduced-function CYP2C19 allele|reduced-function cyp2c19 allele
4998538|NCT01641510|high platelet reactivity|high platelet reactivity
4998539|NCT01641510|clopidogrel|clopidogrel
4998540|NCT01641510|prasugrel|prasugrel
4998541|NCT01641497|endometrial cancer|endometrial cancer
4998542|NCT01641497|IMRT|imrt
4998543|NCT01641497|age over 70|age over 70
4998544|NCT01641471|Total Knee Arthroplasty (TKA)|total knee arthroplasty (tka)
4998545|NCT01641471|Transcutaneous Electrical Nerve Stimulation (TENS)|transcutaneous electrical nerve stimulation (tens)
4998546|NCT01641471|Pain|pain
4998547|NCT01641471|Function|function
4998548|NCT01641471|Knee Osteoarthritis|knee osteoarthritis
4998549|NCT01641458|Genotyping|genotyping
4998550|NCT01641458|Area-under-the concentration-time curve|area-under-the concentration-time curve
4998551|NCT01641458|Toxicity|toxicity
4998552|NCT01641458|5-fluorouracil|5-fluorouracil
4998553|NCT01641458|Capecitabine|capecitabine
4998554|NCT01641419|Pain|pain
4998555|NCT01641419|Ropivacaine|ropivacaine
4998556|NCT01641419|sciatic block|sciatic block
4998557|NCT01641419|dexamethasone|dexamethasone
4998558|NCT01641406|NAC Protocol|nac protocol
4998559|NCT01641406|NAC and Oncotype Guided Hormonal therapy for breast cancer|nac and oncotype guided hormonal therapy for breast cancer
4998560|NCT01641406|Neoadjuvant and Oncotype|neoadjuvant and oncotype
4998561|NCT01641406|NAC CCAM 1101|nac ccam 1101
4998562|NCT01641393|Exocrine Pancreatic Insufficiency|exocrine pancreatic insufficiency
4998563|NCT01641393|Cystic Fibrosis|cystic fibrosis
4998564|NCT01641393|Pancreatic Insufficiency|pancreatic insufficiency
4998565|NCT01641380|Depoprovera|depoprovera
4998566|NCT01641380|Contraception|contraception
4998567|NCT01641380|Appointment adherence/attendance|appointment adherence/attendance
4998568|NCT01641380|Pregnancy Prevention|pregnancy prevention
4998569|NCT01641354|Hemiepiphysiodesis|hemiepiphysiodesis
4998570|NCT01641341|Irritable Bowel Syndrome|irritable bowel syndrome
4998571|NCT01641341|Genova Diagnostics kit|genova diagnostics kit
4998572|NCT01641341|Stool test|stool test
4998573|NCT01641341|Rome III|rome iii
4998574|NCT01641341|Practice-based research|practice-based research
4998575|NCT01641341|treatable parasite|treatable parasite
4998576|NCT01641341|Pancreatic insufficiency|pancreatic insufficiency
4998577|NCT01641341|Bowel dysbiosis|bowel dysbiosis
4998578|NCT01641341|High levels of inflammation, C. difficile, or H. pylori|high levels of inflammation, c. difficile, or h. pylori
4998579|NCT01641328|Mild Cognitive Impairment|mild cognitive impairment
4998580|NCT01641328|MCI|mci
4998581|NCT01641328|Meditation|meditation
4998582|NCT01641328|Mindfulness|mindfulness
4998583|NCT01641328|Cognitive Activation|cognitive activation
4998584|NCT01641328|Cognitive Training|cognitive training
4998585|NCT01641328|Tai Chi|tai chi
4998586|NCT01641315|rabies|rabies
4998587|NCT01641315|rabies immunoglobulin|rabies immunoglobulin
4998588|NCT01641289|Falciparum malaria|falciparum malaria
4998589|NCT01641289|Paracetamol|paracetamol
4998590|NCT01641289|Renal function|renal function
4998591|NCT01641289|Oxidative stress|oxidative stress
4998592|NCT01641276|biofeedback response|biofeedback response
4998593|NCT01641263|Depression Prevention|depression prevention
4998594|NCT01641263|Sleep Disturbances|sleep disturbances
4998595|NCT01641263|Inflammatory Markers|inflammatory markers
4998596|NCT01641263|Treatments for Sleep Problems|treatments for sleep problems
4998597|NCT01641224|Irritable bowel syndrome,|irritable bowel syndrome,
4998598|NCT01641224|Pinaverium|pinaverium
4998599|NCT01641224|Herbal medication for IBS,|herbal medication for ibs,
4998600|NCT01641224|Tong Xie Yao Fang (Formula for pain and diarrhea)|tong xie yao fang (formula for pain and diarrhea)
4998601|NCT01641198|Dental implants, bone healing, fixed dental prostheses, implant surface|dental implants, bone healing, fixed dental prostheses, implant surface
4998602|NCT01641185|prostate|prostate
4998603|NCT01641185|IPI|ipi
4998604|NCT01641185|hypofractionation|hypofractionation
4998605|NCT01641185|carbon ions|carbon ions
4998606|NCT01641185|proton|proton
4998607|NCT01641172|taste|taste
4998608|NCT01641172|smell|smell
4998609|NCT01641172|cancer|cancer
4998610|NCT01641172|nutrition|nutrition
4998611|NCT01641159|Cocaine|cocaine
4998612|NCT01641159|Crack|crack
4998613|NCT01641159|Buspirone|buspirone
4998614|NCT01641159|Relapse Prevention|relapse prevention
4998615|NCT01641146|HIV risk reduction|hiv risk reduction
4998616|NCT01641146|Stress reduction|stress reduction
4998617|NCT01641146|Trauma reduction|trauma reduction
4998618|NCT01641146|PTSD|ptsd
4998619|NCT01641133|pneumococcal conjugate vaccine|pneumococcal conjugate vaccine
4998620|NCT01641133|Synflorix™|synflorix™
4998621|NCT01641133|Prevenar 13™|prevenar 13™
4998622|NCT01641133|Pneumococcal diseases|pneumococcal diseases
4998623|NCT01641120|Multiple Sclerosis|multiple sclerosis
4998624|NCT01641120|Intramuscular Injections|intramuscular injections
4998625|NCT01641120|Relapsing Remitting|relapsing remitting
4998626|NCT01641107|Ph+|ph+
4998627|NCT01641107|BCR-ABL+|bcr-abl+
4998628|NCT01641107|ALL|all
4998629|NCT01641107|Ponatinib|ponatinib
4998630|NCT01641107|stem cell transplantation|stem cell transplantation
4998631|NCT01641094|Hepatitis C|hepatitis c
4998632|NCT01641094|Liver|liver
4998633|NCT01641094|Immunology|immunology
4998634|NCT01641094|Genotype 1|genotype 1
4998635|NCT01641094|Treatment|treatment
4998636|NCT01641094|Chronic|chronic
4998637|NCT01641094|RNA Virus Infections|rna virus infections
4998638|NCT01641094|Ribavirin|ribavirin
4998639|NCT01641094|Peginterferon alfa-2a|peginterferon alfa-2a
4998640|NCT01641094|Protease Inhibitors|protease inhibitors
4998641|NCT01641094|Telaprevir|telaprevir
4998642|NCT01641068|Memory|memory
4998643|NCT01641068|Attention|attention
4998644|NCT01641068|Chemo-brain|chemo-brain
4998645|NCT01641068|Survivor|survivor
4998646|NCT01641068|Treatment|treatment
4998647|NCT01641042|Meningococcal vaccines|meningococcal vaccines
4998649|NCT01641042|Neisseria meningitidis|neisseria meningitidis
4998650|NCT01641042|Immunocompromised patient|immunocompromised patient
4998651|NCT01641016|short cycle therapy|short cycle therapy
4998652|NCT01641016|young people|young people
4998653|NCT01641016|HIV|hiv
4998654|NCT01641003|cancer stem cells|cancer stem cells
4998655|NCT01640990|Healthy male volunteers, intravenous infusion, GW328267X, dose escalation,|healthy male volunteers, intravenous infusion, gw328267x, dose escalation,
4998656|NCT01640977|Open PLIF|open plif
4998657|NCT01640977|MAS PLIF|mas plif
4998658|NCT01640977|Lumbar spine|lumbar spine
4998659|NCT01640964|Portal hypertension, cirrhosis, TIPSS, MRI, MRA, portal pressure, portal pressure gradient|portal hypertension, cirrhosis, tipss, mri, mra, portal pressure, portal pressure gradient
4998660|NCT01640951|Psoriasis|psoriasis
4998661|NCT01640951|Plaque|plaque
4998662|NCT01640951|Inflammatory skin disease|inflammatory skin disease
4998663|NCT01640951|Scaly patches|scaly patches
4998664|NCT01640951|AIN457|ain457
4998665|NCT01640951|Secukinumab|secukinumab
4998666|NCT01640951|Moderate to Severe Plaque-type Psoriasis|moderate to severe plaque-type psoriasis
4998667|NCT01640925|nosocomial infection|nosocomial infection
4998668|NCT01640925|hospital acquired infection|hospital acquired infection
4998669|NCT01640925|chlorhexidine|chlorhexidine
4998670|NCT01640925|pneumonia, ventilator-associated|pneumonia, ventilator-associated
4998671|NCT01640925|catheter-related infections|catheter-related infections
4998672|NCT01640925|urinary tract infections, catheter-related|urinary tract infections, catheter-related
4998673|NCT01640925|surgical site infection|surgical site infection
4998674|NCT01640912|Scar|scar
4998675|NCT01640912|Scar prevention|scar prevention
4998676|NCT01640912|Fibrosis|fibrosis
4998677|NCT01640899|Orthotic Devices|orthotic devices
4998678|NCT01640899|Activities of Daily Living|activities of daily living
4998679|NCT01640899|Pain Measurement|pain measurement
4998680|NCT01640899|Lower Extremity|lower extremity
4998681|NCT01640899|Foot|foot
4998682|NCT01640899|Personal Satisfaction|personal satisfaction
4998683|NCT01640886|Staphylococcus aureus|staphylococcus aureus
4998684|NCT01640886|methicillin resistant|methicillin resistant
4998685|NCT01640886|MRSA|mrsa
4998686|NCT01640886|MSSA|mssa
4998687|NCT01640886|Blood Culture|blood culture
4998688|NCT01640886|Diagnostic|diagnostic
4998689|NCT01640873|Type 2 Diabetes|type 2 diabetes
4998690|NCT01640860|docetaxel|docetaxel
4998691|NCT01640860|cisplatin|cisplatin
4998692|NCT01640860|combined modality therapy|combined modality therapy
4998693|NCT01640847|Painful bone metastases|painful bone metastases
4998694|NCT01640847|Bone Cancer|bone cancer
4998695|NCT01640847|Bone Cancer Pain|bone cancer pain
4998696|NCT01640847|Patients with|patients with
4998697|NCT01640821|Health-At-Every-Size intervention|health-at-every-size intervention
4998698|NCT01640782|adenocarcinoma of the stomach|adenocarcinoma of the stomach
4998699|NCT01640782|adenocarcinoma of the gastroesophageal junction|adenocarcinoma of the gastroesophageal junction
4998700|NCT01640769|Cardiomyopathy|cardiomyopathy
4998701|NCT01640769|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
4998702|NCT01640756|Glaucoma Implant|glaucoma implant
4998703|NCT01640756|Trabeculectomy|trabeculectomy
4998704|NCT01640756|POAG|poag
4998705|NCT01640743|Kidney transplantation|kidney transplantation
4998706|NCT01640743|Regulatory T cells|regulatory t cells
4998707|NCT01640743|Tolerance|tolerance
4998708|NCT01640743|Tacrolimus|tacrolimus
4998709|NCT01640743|Rejection|rejection
4998710|NCT01640691|pandemic influenza|pandemic influenza
4998711|NCT01640691|pandemic influenza vaccine|pandemic influenza vaccine
4998712|NCT01640691|Influenza|influenza
4998713|NCT01640691|Orthomyxoviruses|orthomyxoviruses
4998714|NCT01640691|A/H5N1|a/h5n1
4998715|NCT01640665|histologically|histologically
4998716|NCT01640665|unresectable|unresectable
4998717|NCT01640665|metastatic|metastatic
4998718|NCT01640665|Phase 1|phase 1
4998719|NCT01640665|Breast Cancer|breast cancer
4998720|NCT01640665|GI Tumors|gi tumors
4998722|NCT01640665|Capecitabine|capecitabine
4998723|NCT01640639|left ventricular function|left ventricular function
4998724|NCT01640626|Health Education|health education
4998725|NCT01640626|Soil-transmitted helminthiasis|soil-transmitted helminthiasis
4998726|NCT01640626|Ascaris|ascaris
4998727|NCT01640626|Trichuris|trichuris
4998728|NCT01640626|Hookworm|hookworm
4998729|NCT01640626|Prevention and control|prevention and control
4998730|NCT01640613|carotid endarterectomy|carotid endarterectomy
4998731|NCT01640613|regional anaesthesia|regional anaesthesia
4998732|NCT01640613|ultrasound guided block|ultrasound guided block
4998733|NCT01640600|To determine whether 4-8 year-old children exposed to nicotine or antidepressants in utero have more behavioral problems.|to determine whether 4-8 year-old children exposed to nicotine or antidepressants in utero have more behavioral problems.
4998734|NCT01640600|To determine whether 4-8 year-old children exposed to nicotine or antidepressants in utero have more cognitive problems.|to determine whether 4-8 year-old children exposed to nicotine or antidepressants in utero have more cognitive problems.
4998735|NCT01640600|To determine whether 4-8 year-old children exposed to nicotine or antidepressants in utero have poorer motor development.|to determine whether 4-8 year-old children exposed to nicotine or antidepressants in utero have poorer motor development.
4998736|NCT01640587|Uncomplicated falciparum infection|uncomplicated falciparum infection
4998737|NCT01640587|Mefloquine-artesunate|mefloquine-artesunate
4998738|NCT01640587|Dihydroartemisinin-piperaquine|dihydroartemisinin-piperaquine
4998739|NCT01640574|Vivax|vivax
4998740|NCT01640574|Chloroquine|chloroquine
4998741|NCT01640574|Primaquine|primaquine
4998742|NCT01640574|Dihydroartemisinin-Piperaquine|dihydroartemisinin-piperaquine
4998743|NCT01640561|HIV affected|hiv affected
4998744|NCT01640561|Child Neurodevelopment|child neurodevelopment
4998745|NCT01640561|Low and Middle Income Country|low and middle income country
4998746|NCT01640535|PAR|par
4998747|NCT01640522|Hepatocellular carcinoma|hepatocellular carcinoma
4998748|NCT01640522|Cholangio carcinoma|cholangio carcinoma
4998749|NCT01640522|Primary Liver Cancer|primary liver cancer
4998750|NCT01640522|Bile Duct CancerPancreatic Cancer|bile duct cancerpancreatic cancer
4998751|NCT01640522|Gallbladder Cancer|gallbladder cancer
4998752|NCT01640522|Colorectal Carcinoma|colorectal carcinoma
4998753|NCT01640522|Other Primary Cancers with Liver Metastases|other primary cancers with liver metastases
4998754|NCT01640509|Radiotherapy, Targeted|radiotherapy, targeted
4998755|NCT01640496|Ulcerative Colitis|ulcerative colitis
4998756|NCT01640496|Inflammatory Bowel disease|inflammatory bowel disease
4998757|NCT01640496|IBD|ibd
4998758|NCT01640496|Vitamin D|vitamin d
4998759|NCT01640470|assistive technology|assistive technology
4998760|NCT01640470|environmental modification|environmental modification
4998761|NCT01640470|caregiver|caregiver
4998762|NCT01640470|client-centred|client-centred
4998763|NCT01640457|degenerative disc|degenerative disc
4998764|NCT01640457|herniated disc|herniated disc
4998765|NCT01640457|sequestrectomy|sequestrectomy
4998766|NCT01640457|Autologous Disc Chondrocyte Transplantation|autologous disc chondrocyte transplantation
4998767|NCT01640457|nucleotomy|nucleotomy
4998768|NCT01640457|safety|safety
4998769|NCT01640457|efficacy|efficacy
4998770|NCT01640457|treatment|treatment
4998771|NCT01640457|lumbar spine|lumbar spine
4998772|NCT01640457|low back pain|low back pain
4998773|NCT01640457|adjacent degenerative disc|adjacent degenerative disc
4998774|NCT01640457|black disc|black disc
4998775|NCT01640457|NOVOCART|novocart
4998776|NCT01640444|colorectal carcinoma|colorectal carcinoma
4998777|NCT01640444|BRAF and PIK3K|braf and pik3k
4998778|NCT01640444|FOLFIRI -Bevacizumab -Cetuximab|folfiri -bevacizumab -cetuximab
4998779|NCT01640444|circulating tumor cells|circulating tumor cells
4998780|NCT01640431|lumbar disc herniation|lumbar disc herniation
4998781|NCT01640431|clinical trial|clinical trial
4998782|NCT01640431|exercise therapy|exercise therapy
4998783|NCT01640431|TENS|tens
4998784|NCT01640418|pressure ulcer|pressure ulcer
4998785|NCT01640418|dressing|dressing
4998786|NCT01640418|prevention|prevention
4998787|NCT01640418|higher risk patients|higher risk patients
4998788|NCT01640405|colorectal cancer|colorectal cancer
4998789|NCT01640405|FOLFOX|folfox
4998790|NCT01640405|Bevacizumab|bevacizumab
4998791|NCT01640405|FOLFOXIRI|folfoxiri
4998792|NCT01640405|circulating tumor cell|circulating tumor cell
4998793|NCT01640392|Gay men|gay men
4998794|NCT01640392|African American males|african american males
4998795|NCT01640392|Unprotected anal sex|unprotected anal sex
4998796|NCT01640392|HIV risk|hiv risk
4998797|NCT01640392|behavioral intervention|behavioral intervention
4998798|NCT01640392|group-level intervention|group-level intervention
4998799|NCT01640379|Pelvic Inflammatory Disease (PID)|pelvic inflammatory disease (pid)
4998800|NCT01640379|Community Health Nursing|community health nursing
4998801|NCT01640379|Text Messaging|text messaging
4998802|NCT01640379|mobile health (mhealth)|mobile health (mhealth)
4998803|NCT01640379|Adolescents|adolescents
4998804|NCT01640366|surgical incision|surgical incision
4998805|NCT01640366|reduction mammoplasty|reduction mammoplasty
4998806|NCT01640366|healing complications|healing complications
4998807|NCT01640366|negative pressure wound therapy|negative pressure wound therapy
4998808|NCT01640353|si joint|si joint
4998809|NCT01640353|si joint pain|si joint pain
4998810|NCT01640353|si joint injury|si joint injury
4998811|NCT01640353|si joint treatment|si joint treatment
4998812|NCT01640353|si joint injections|si joint injections
4998813|NCT01640353|si joint inflammation|si joint inflammation
4998814|NCT01640353|si joint problems|si joint problems
4998815|NCT01640353|si joint symptoms|si joint symptoms
4998816|NCT01640353|hypermobile si joint|hypermobile si joint
4998817|NCT01640353|si joint arthritis|si joint arthritis
4998818|NCT01640353|si joint pain treatment|si joint pain treatment
4998819|NCT01640353|inflamed si joint|inflamed si joint
4998820|NCT01640353|si joint sclerosis|si joint sclerosis
4998821|NCT01640353|locked si joint|locked si joint
4998822|NCT01640353|si joint injuries|si joint injuries
4998823|NCT01640353|si joint disease|si joint disease
4998824|NCT01640353|si joint infection|si joint infection
4998825|NCT01640353|sacroiliac joint pelvic pain|sacroiliac joint pelvic pain
4998826|NCT01640353|sacroiliac joint arthritis treatment|sacroiliac joint arthritis treatment
4998827|NCT01640340|ondansetron|ondansetron
4998828|NCT01640340|palonosetron|palonosetron
4998829|NCT01640340|emetogenic chemotherapy|emetogenic chemotherapy
4998830|NCT01640340|HEC|hec
4998831|NCT01640327|Interpandemic influenza|interpandemic influenza
4998832|NCT01640327|Adult|adult
4998833|NCT01640327|Elderly|elderly
4998834|NCT01640327|Safety|safety
4998835|NCT01640327|Tolerability|tolerability
4998836|NCT01640327|Immunology|immunology
4998837|NCT01640314|Influenza|influenza
4998838|NCT01640314|Adults|adults
4998839|NCT01640314|Elderly|elderly
4998840|NCT01640314|Immunology|immunology
4998841|NCT01640314|Safety|safety
4998842|NCT01640288|COPD|copd
4998843|NCT01640288|Pulmonary Function Testing|pulmonary function testing
4998844|NCT01640288|MRI|mri
4998845|NCT01640288|Normal Lung Function|normal lung function
4998846|NCT01640288|Current Smoker|current smoker
4998847|NCT01640288|Non Smoker|non smoker
4998848|NCT01640288|Ex Smoker|ex smoker
4998849|NCT01640275|General Anesthesia|general anesthesia
4998850|NCT01640275|Alzheimers Disease|alzheimers disease
4998851|NCT01640275|Cognitive decline|cognitive decline
4998852|NCT01640262|prostate biopsy|prostate biopsy
4998853|NCT01640262|prostate cancer|prostate cancer
4998854|NCT01640262|Magnetic Resonance Imaging|magnetic resonance imaging
4998855|NCT01640262|Neoplasm Staging|neoplasm staging
4998856|NCT01640236|Ocular flare|ocular flare
4998857|NCT01640197|Cognitive performance|cognitive performance
4998858|NCT01640197|Cerebral blood flow|cerebral blood flow
4998859|NCT01640197|Subjective sleep|subjective sleep
4998860|NCT01640197|Subjective mood|subjective mood
4998861|NCT01640197|Subjective health|subjective health
4998862|NCT01640184|hyperparathyroidism|hyperparathyroidism
4998863|NCT01640184|vitamin D|vitamin d
4998864|NCT01640184|ultrasonic ablation|ultrasonic ablation
4998865|NCT01640184|surgery|surgery
4998866|NCT01640171|anesthesia|anesthesia
4998867|NCT01640171|pain|pain
4998868|NCT01640171|intravitreal|intravitreal
4998869|NCT01640171|anti-vegf|anti-vegf
4998870|NCT01640158|mild Traumatic Brain Injury|mild traumatic brain injury
4998871|NCT01640158|Cognitive remediation|cognitive remediation
4998872|NCT01640158|computer|computer
4998873|NCT01640119|metabolic acidosis|metabolic acidosis
4998874|NCT01640119|renal death|renal death
4998875|NCT01640106|Language|language
4998876|NCT01640106|Fatty acids|fatty acids
4998877|NCT01640106|Nutrition|nutrition
4998878|NCT01640106|Developmental delay|developmental delay
4998879|NCT01640093|Healthy participants|healthy participants
4998880|NCT01640093|Bioavailability|bioavailability
4998881|NCT01640093|Pharmacokinetics|pharmacokinetics
4998882|NCT01640093|Abiraterone acetate|abiraterone acetate
4998883|NCT01640093|Abiraterone|abiraterone
4998884|NCT01640080|Major depressive disorder|major depressive disorder
4998885|NCT01640080|Treatment resistant depression|treatment resistant depression
4998886|NCT01640080|Depression|depression
4998887|NCT01640080|Esketamine|esketamine
4998888|NCT01640067|amyotrophic lateral sclerosis|amyotrophic lateral sclerosis
4998889|NCT01640067|motor neuron disease|motor neuron disease
4998890|NCT01640067|stem cells|stem cells
4998891|NCT01640067|safety|safety
4999012|NCT01639469|Quality of Life|quality of life
4998892|NCT01640067|ALS-FRS-Functional scale R and FVC (%) variation|als-frs-functional scale r and fvc (%) variation
4998893|NCT01640067|Survival analysis|survival analysis
4998894|NCT01640067|Changes in quality of life scales|changes in quality of life scales
4998895|NCT01640054|Rheumatoid Arthritis|rheumatoid arthritis
4998896|NCT01640015|Blood pressure|blood pressure
4998897|NCT01640015|eating episode|eating episode
4998898|NCT01640015|eating frequency|eating frequency
4998899|NCT01640015|insulin sensitivity|insulin sensitivity
4998900|NCT01640002|overactive bladder|overactive bladder
4998901|NCT01640002|HTLV-1|htlv-1
4998902|NCT01640002|Propantheline|propantheline
4998903|NCT01640002|anticholinergic|anticholinergic
4998904|NCT01639989|Doppler, Pregnancy|doppler, pregnancy
4998905|NCT01639976|Missed abortion, early pregnancy loss.|missed abortion, early pregnancy loss.
4998906|NCT01639950|Self-Report|self-report
4998907|NCT01639950|Survey Scale|survey scale
4998908|NCT01639950|Validate|validate
4998909|NCT01639950|Pain Severity|pain severity
4998910|NCT01639950|Reliability|reliability
4998911|NCT01639937|Cardiac MRI|cardiac mri
4998912|NCT01639937|Congestive Heart Failure|congestive heart failure
4998913|NCT01639937|Cardiac Fibrosis|cardiac fibrosis
4998914|NCT01639937|Late Gadolinium Enhancement|late gadolinium enhancement
4998915|NCT01639924|Small Bowel Disease|small bowel disease
4998916|NCT01639924|Digestive Disease|digestive disease
4998917|NCT01639924|Gastrointestinal Disease|gastrointestinal disease
4998918|NCT01639924|Lower GI Disease|lower gi disease
4998919|NCT01639911|malignant solid tumor|malignant solid tumor
4998920|NCT01639911|advanced non-hematologic|advanced non-hematologic
4998921|NCT01639898|POEMS|poems
4998922|NCT01639898|VEGF|vegf
4998923|NCT01639898|Free light|free light
4998924|NCT01639898|lenalidomide|lenalidomide
4998925|NCT01639898|dexamethasone|dexamethasone
4998926|NCT01639885|p53 overexpression|p53 overexpression
4998927|NCT01639885|platinum-resistant|platinum-resistant
4998928|NCT01639872|Schizophrenia|schizophrenia
4998929|NCT01639872|Cannabis Abuse|cannabis abuse
4998930|NCT01639872|Cannabis Dependence|cannabis dependence
4998931|NCT01639872|Dual Diagnosis|dual diagnosis
4998932|NCT01639872|Clozapine|clozapine
4998933|NCT01639872|Risperidone|risperidone
4998934|NCT01639859|prostate cancer|prostate cancer
4998935|NCT01639859|elastography|elastography
4998936|NCT01639859|elasticity|elasticity
4998937|NCT01639820|Cervical cancer|cervical cancer
4998938|NCT01639820|early stage carcinoma|early stage carcinoma
4998939|NCT01639820|FIGO IA1 IA2 IB1 IIA|figo ia1 ia2 ib1 iia
4998940|NCT01639820|sentinel lymph node biopsy|sentinel lymph node biopsy
4998941|NCT01639820|pelvic lymphadenectomy|pelvic lymphadenectomy
4998942|NCT01639820|Surgery of uterine cervical carcinoma|surgery of uterine cervical carcinoma
4998943|NCT01639820|medico economic impact|medico economic impact
4998944|NCT01639820|quality of life|quality of life
4998945|NCT01639807|Open Angle Glaucoma or Ocular hypertension|open angle glaucoma or ocular hypertension
4998946|NCT01639794|LUTS (Lower Urinary Tract Symptoms)|luts (lower urinary tract symptoms)
4998947|NCT01639794|Overactive Bladder (OAB)Vesitirim|overactive bladder (oab)vesitirim
4998948|NCT01639794|Solifenacin|solifenacin
4998949|NCT01639794|Anti-muscarinic treatment|anti-muscarinic treatment
4998950|NCT01639794|Cholinergic receptor antagonist|cholinergic receptor antagonist
4998951|NCT01639794|Storage Symptom improvement|storage symptom improvement
4998952|NCT01639781|flavanols|flavanols
4998953|NCT01639781|age related cardiovascular effects|age related cardiovascular effects
4998954|NCT01639768|Sublingual immunotherapy|sublingual immunotherapy
4998955|NCT01639768|Dose range finding|dose range finding
4998956|NCT01639768|Dose tolerability|dose tolerability
4998957|NCT01639768|Birch pollen|birch pollen
4998958|NCT01639768|Allergic rhinitis/rhinoconjunctivitis|allergic rhinitis/rhinoconjunctivitis
4998959|NCT01639768|Safety|safety
4998960|NCT01639768|Immunogenicity|immunogenicity
4998961|NCT01639729|pharmacokinetics|pharmacokinetics
4998962|NCT01639729|area under curve|area under curve
4998963|NCT01639729|time to maximum concentration|time to maximum concentration
4998964|NCT01639716|Survey, interleukin status|survey, interleukin status
4998965|NCT01639703|CT perfusion|ct perfusion
4998966|NCT01639703|Hepatocellular Carcinoma|hepatocellular carcinoma
4998967|NCT01639703|Xenetix|xenetix
4998968|NCT01639703|Contrast agent|contrast agent
4998969|NCT01639690|BUSULFAN|busulfan
4998970|NCT01639690|G-CSF|g-csf
4998971|NCT01639690|CliniMACS-CD34 Reagent System|clinimacs-cd34 reagent system
4998972|NCT01639690|Blood transfusion|blood transfusion
4998973|NCT01639690|10-164|10-164
4998974|NCT01639690|Autologous CD34+ cells transduced with TNS9.3.55, a lentiviral vector encoding the human β-globin gene|autologous cd34+ cells transduced with tns9.3.55, a lentiviral vector encoding the human β-globin gene
4998975|NCT01639677|Obesity|obesity
4998976|NCT01639677|weight loss|weight loss
4998977|NCT01639677|surgery|surgery
4998978|NCT01639677|gastric bypass|gastric bypass
4998979|NCT01639677|VBG|vbg
4998980|NCT01639651|Physical Therapy|physical therapy
4998981|NCT01639651|Glenohumeral Internal Rotation Deficits|glenohumeral internal rotation deficits
4998982|NCT01639651|Joint Mobilization|joint mobilization
4998983|NCT01639651|Posterior capsule|posterior capsule
4998984|NCT01639651|Capsular contracture|capsular contracture
4998985|NCT01639638|Recurrent and non-recurrent genital condyloma|recurrent and non-recurrent genital condyloma
4998986|NCT01639612|Stem Cell|stem cell
4998987|NCT01639612|Grade IV Malignant Glioma|grade iv malignant glioma
4998988|NCT01639599|non-smoker|non-smoker
4998989|NCT01639599|female|female
4998990|NCT01639599|IV PCA|iv pca
4998991|NCT01639599|patient-controlled analgesia|patient-controlled analgesia
4998992|NCT01639573|Patients with Scleroderma|patients with scleroderma
4998993|NCT01639560|smoking|smoking
4998994|NCT01639560|tobacco dependence|tobacco dependence
4998995|NCT01639560|nicotine dependence|nicotine dependence
4998996|NCT01639547|PEGASYS® PLUS RIBAVIRIN|pegasys® plus ribavirin
4998997|NCT01639534|Biomarkers of ischemia|biomarkers of ischemia
4998998|NCT01639534|Carotid Stenting procedure|carotid stenting procedure
4998999|NCT01639534|Levels Xanthine Hypoxanthine and Inosine|levels xanthine hypoxanthine and inosine
4999000|NCT01639534|peripheral blood|peripheral blood
4999001|NCT01639508|Lung|lung
4999002|NCT01639508|XL184 (CABOZANTINIB)|xl184 (cabozantinib)
4999003|NCT01639508|KIF5B/RET Positive|kif5b/ret positive
4999004|NCT01639508|RET Fusion Positive|ret fusion positive
4999006|NCT01639508|Genotypes: ROS1 or NTRK Fusions or Increased MET or AXL Activity|genotypes: ros1 or ntrk fusions or increased met or axl activity
4999007|NCT01639495|Drug refractory|drug refractory
4999008|NCT01639495|Atrial fibrillation|atrial fibrillation
4999009|NCT01639495|Antiarrhythmic drug failure|antiarrhythmic drug failure
4999010|NCT01639495|Atrial tachyarrhythmias|atrial tachyarrhythmias
4999011|NCT01639469|Parkinson Disease|parkinson disease
4999013|NCT01639469|Exercise Therapy|exercise therapy
4999014|NCT01639456|acute myelogenous leukemia|acute myelogenous leukemia
4999015|NCT01639443|quality improvement|quality improvement
4999016|NCT01639443|Organization and Administration|organization and administration
4999017|NCT01639443|Costs and cost analysis|costs and cost analysis
4999018|NCT01639443|Patient satisfaction|patient satisfaction
4999019|NCT01639443|Health plan implementation|health plan implementation
4999020|NCT01639404|Cerebral Palsy|cerebral palsy
4999021|NCT01639404|Umbilical Cord Blood|umbilical cord blood
4999022|NCT01639404|Rehabilitation|rehabilitation
4999023|NCT01639365|Ventricular tachycardia|ventricular tachycardia
4999024|NCT01639365|Catheter ablation|catheter ablation
4999025|NCT01639365|Tissue contact|tissue contact
4999026|NCT01639352|Hepatocellular Carcinoma|hepatocellular carcinoma
4999027|NCT01639352|HCC|hcc
4999028|NCT01639352|SOM230|som230
4999029|NCT01639352|Pasireotide LAR|pasireotide lar
4999030|NCT01639339|Antibodies|antibodies
4999031|NCT01639339|Systemic Lupus Erythematosus|systemic lupus erythematosus
4999032|NCT01639339|Autoimmune Disease|autoimmune disease
4999033|NCT01639339|Glomerulonephritis|glomerulonephritis
4999034|NCT01639339|Belimumab|belimumab
4999035|NCT01639339|Lupus|lupus
4999036|NCT01639339|Nephritis|nephritis
4999037|NCT01639339|Kidney Diseases|kidney diseases
4999038|NCT01639339|SLE|sle
4999039|NCT01639300|Relapsing Forms of Multiple Sclerosis|relapsing forms of multiple sclerosis
4999040|NCT01639300|Progressive Forms of Multiple Sclerosis|progressive forms of multiple sclerosis
4999041|NCT01639300|GNbAC1|gnbac1
4999042|NCT01639300|Monoclonal antibody|monoclonal antibody
4999043|NCT01639300|Multiple Sclerosis Associated Retrovirus (MSRV)|multiple sclerosis associated retrovirus (msrv)
4999044|NCT01639261|steroid-refractory|steroid-refractory
4999045|NCT01639261|bronchiolitis obliterans|bronchiolitis obliterans
4999046|NCT01639261|allogeneic stem cell transplantation|allogeneic stem cell transplantation
4999047|NCT01639261|interferon gamma|interferon gamma
4999048|NCT01639248|Breast Cancer|breast cancer
4999049|NCT01639235|Secondhand Smoke|secondhand smoke
4999050|NCT01639235|Flight Attendants|flight attendants
4999051|NCT01639235|Lung function|lung function
4999052|NCT01639235|Cardiac function|cardiac function
4999053|NCT01639235|Reproductive health|reproductive health
4999054|NCT01639222|Drug therapy|drug therapy
4999055|NCT01639222|Increase in calcium urinary excretion and PTH decrease in serum|increase in calcium urinary excretion and pth decrease in serum
4999056|NCT01639209|Retinal detachment|retinal detachment
4999057|NCT01639209|Pneumatic retinopexy|pneumatic retinopexy
4999058|NCT01639209|Vitrectomy|vitrectomy
4999059|NCT01639196|Chronic pain|chronic pain
4999060|NCT01639196|Psychological adjustment|psychological adjustment
4999061|NCT01639196|Writing|writing
4999062|NCT01639196|Brief intervention|brief intervention
4999063|NCT01639196|Online|online
4999064|NCT01639196|Internet interventions|internet interventions
4999065|NCT01639183|oral inflammation|oral inflammation
4999066|NCT01639183|systemic inflammation|systemic inflammation
4999067|NCT01639183|compliance|compliance
4999068|NCT01639183|power toothbrushing|power toothbrushing
4999069|NCT01639183|nursing home residents|nursing home residents
4999070|NCT01639170|Pneumoperitoneum|pneumoperitoneum
4999071|NCT01639170|Free air|free air
4999072|NCT01639170|Surgery|surgery
4999073|NCT01639170|Perforation|perforation
4999074|NCT01639170|Radiograph|radiograph
4999075|NCT01639144|Infection|infection
4999076|NCT01639144|delayed wound healing|delayed wound healing
4999077|NCT01639144|platelet-rich plasma|platelet-rich plasma
4999078|NCT01639131|Gemcitabine|gemcitabine
4999079|NCT01639131|Docetaxel|docetaxel
4999080|NCT01639131|Filgrastim|filgrastim
4999081|NCT01639131|Pegfilgrastim|pegfilgrastim
4999082|NCT01639118|primary ventral hernia repair with mesh|primary ventral hernia repair with mesh
4999083|NCT01639118|umbilical hernia repair|umbilical hernia repair
4999084|NCT01639118|epigastric hernia repair|epigastric hernia repair
4999085|NCT01639118|C-Qur V-patch|c-qur v-patch
4999086|NCT01639118|Size tailored repair|size tailored repair
4999087|NCT01639118|preperitoneal repair|preperitoneal repair
4999088|NCT01639118|abdominal hernia|abdominal hernia
4999089|NCT01639118|dual sided mesh|dual sided mesh
4999090|NCT01639092|Resistance of Entecavir|resistance of entecavir
4999091|NCT01639079|cigarette smoking behavior|cigarette smoking behavior
4999092|NCT01639079|smoking cessation|smoking cessation
4999093|NCT01639079|Latino smoking cessation|latino smoking cessation
4999094|NCT01639066|Resistance of Adefovir|resistance of adefovir
4999095|NCT01639053|Breast Augmentation|breast augmentation
4999096|NCT01639053|Breast Reconstruction|breast reconstruction
4999097|NCT01639053|Breast Revision|breast revision
4999098|NCT01639053|Silicone breast implants|silicone breast implants
4999099|NCT01639001|Crizotinib|crizotinib
4999100|NCT01639001|ALK positive|alk positive
4999101|NCT01639001|ALK|alk
4999102|NCT01639001|Anaplastic Lymphoma Kinase|anaplastic lymphoma kinase
4999103|NCT01639001|NSCLC|nsclc
4999104|NCT01639001|Non-Small Cell Lung Cancer|non-small cell lung cancer
4999105|NCT01639001|Frontline|frontline
4999106|NCT01639001|1L|1l
4999107|NCT01639001|Previously Untreated|previously untreated
4999108|NCT01639001|East Asian|east asian
4999109|NCT01639001|Non-Squamous|non-squamous
4999110|NCT01638962|Exercise Therapy|exercise therapy
4999111|NCT01638962|Gait|gait
4999112|NCT01638962|Joint load|joint load
4999113|NCT01638962|Knee Joint|knee joint
4999114|NCT01638962|Middle Aged|middle aged
4999115|NCT01638962|Osteoarthritis, Knee/therapy|osteoarthritis, knee/therapy
4999116|NCT01638962|Pain Management|pain management
4999117|NCT01638949|Alzheimer's disease|alzheimer's disease
4999118|NCT01638949|MCI|mci
4999119|NCT01638949|genetic|genetic
4999120|NCT01638949|AV45-PET|av45-pet
4999121|NCT01638936|Combination|combination
4999122|NCT01638936|Multiple Myeloma|multiple myeloma
4999123|NCT01638923|Heavy Menstrual Bleeding|heavy menstrual bleeding
4999124|NCT01638923|Efficacy|efficacy
4999125|NCT01638923|Safety|safety
4999126|NCT01638923|Oral contraceptive|oral contraceptive
4999127|NCT01638923|Estradiol valerate|estradiol valerate
4999128|NCT01638923|Dienogest|dienogest
4999129|NCT01638910|Efficacy|efficacy
4999130|NCT01638910|Safety|safety
4999131|NCT01638910|oral contraception|oral contraception
4999132|NCT01638910|estradiol valerate|estradiol valerate
4999133|NCT01638910|dienogest|dienogest
4999134|NCT01638897|ICD|icd
4999135|NCT01638897|CRTD|crtd
4999136|NCT01638897|DF4|df4
4999137|NCT01638884|Prospective Memory|prospective memory
4999138|NCT01638884|Healthy Aging|healthy aging
4999139|NCT01638884|Alzheimer Disease|alzheimer disease
4999140|NCT01638884|Brain Imaging|brain imaging
4999141|NCT01638832|NASH; coronary artery disease|nash; coronary artery disease
4999142|NCT01638806|Acute Coronary Syndrome|acute coronary syndrome
4999143|NCT01638806|Myocardial infarction|myocardial infarction
4999144|NCT01638806|Angioplasty|angioplasty
4999145|NCT01638806|Prehospital emergency care|prehospital emergency care
4999146|NCT01638806|Biological markers|biological markers
4999147|NCT01638806|Troponin|troponin
4999148|NCT01638806|Point-of-Care systems|point-of-care systems
4999149|NCT01638767|In Vitro Fertilization long protocol|in vitro fertilization long protocol
4999150|NCT01638767|NuvaRing|nuvaring
4999151|NCT01638767|Marvelon|marvelon
4999152|NCT01638767|In vitro fertilization|in vitro fertilization
4999153|NCT01638715|Rheumatoid Arthritis|rheumatoid arthritis
4999154|NCT01638715|Biologic therapies|biologic therapies
4999155|NCT01638715|Biomarker|biomarker
4999156|NCT01638715|Mode of Action|mode of action
4999157|NCT01638702|Catheterisation, Central Venous|catheterisation, central venous
4999158|NCT01638702|Catheters, Indwelling|catheters, indwelling
4999159|NCT01638689|Mechanism of Action of escitalopram|mechanism of action of escitalopram
4999160|NCT01638676|Unresectable melanoma|unresectable melanoma
4999161|NCT01638676|Stage IIIC and Stage IV BRAFV600E+ Melanoma|stage iiic and stage iv brafv600e+ melanoma
4999162|NCT01638663|Tolvaptan|tolvaptan
4999163|NCT01638663|L-NMMA|l-nmma
4999164|NCT01638663|Healthy subjects|healthy subjects
4999165|NCT01638663|Nephrology|nephrology
4999166|NCT01638663|Cardiology|cardiology
4999167|NCT01638624|Propofol|propofol
4999168|NCT01638624|antioxidant capacity|antioxidant capacity
4999169|NCT01638624|total knee arthroplasty|total knee arthroplasty
4999170|NCT01638624|Propofol,antioxidant|propofol,antioxidant
4999171|NCT01638611|Healthy male volunteers|healthy male volunteers
4999172|NCT01638572|Neuroblastoma|neuroblastoma
4999173|NCT01638572|B4GALNT3|b4galnt3
4999174|NCT01638572|Prognosis|prognosis
4999175|NCT01638559|liver transplant|liver transplant
4999176|NCT01638559|allograft function|allograft function
4999177|NCT01638559|anti-rejection|anti-rejection
4999178|NCT01638559|immunosuppression withdrawal|immunosuppression withdrawal
4999179|NCT01638520|Immune Therapy|immune therapy
4999180|NCT01638520|Interleukin 4|interleukin 4
4999181|NCT01638520|monoclonal antibody|monoclonal antibody
4999182|NCT01638507|TARGET LESION REVASCULARIZATION (TLR)|target lesion revascularization (tlr)
4999183|NCT01638507|TARGET VESSEL REVASCULARIZATION (TVR)|target vessel revascularization (tvr)
4999184|NCT01638507|Coronary Artery Disease|coronary artery disease
4999185|NCT01638507|MYOCARDIAL INFARCTION (MI)|myocardial infarction (mi)
4999186|NCT01638507|PERCUTANEOUS CORONARY INTERVENTION (PCI)|percutaneous coronary intervention (pci)
4999187|NCT01638507|STENT THROMBOSIS|stent thrombosis
4999188|NCT01638507|TARGET LESION FAILURE (TLF)|target lesion failure (tlf)
4999189|NCT01638494|25-Hydroxyvitamin D|25-hydroxyvitamin d
4999190|NCT01638494|dietary counseling|dietary counseling
4999191|NCT01638494|pediatrics|pediatrics
4999192|NCT01638494|allergy|allergy
4999193|NCT01638494|bone metabolism|bone metabolism
4999194|NCT01638468|Pulmonary Embolism|pulmonary embolism
4999195|NCT01638468|Acute Pulmonary Embolism|acute pulmonary embolism
4999196|NCT01638468|Sub-massive Pulmonary Embolism|sub-massive pulmonary embolism
4999197|NCT01638468|Massive Pulmonary Embolism|massive pulmonary embolism
4999198|NCT01638468|Pulmonary Thromboembolism|pulmonary thromboembolism
4999199|NCT01638442|Male subjects, healthy|male subjects, healthy
4999200|NCT01638403|narcolepsy|narcolepsy
4999201|NCT01638403|excessive daytime sleepiness|excessive daytime sleepiness
4999202|NCT01638403|cataplexy|cataplexy
4999203|NCT01638377|Back on Track|back on track
4999204|NCT01638377|convicted drinking drivers|convicted drinking drivers
4999205|NCT01638377|naltrexone|naltrexone
4999206|NCT01638377|alcohol dependence|alcohol dependence
4999207|NCT01638351|Diabetes mellitus|diabetes mellitus
4999208|NCT01638351|Resistance exercise|resistance exercise
4999209|NCT01638351|Elderly|elderly
4999210|NCT01638351|Skeletal muscle dysfunction|skeletal muscle dysfunction
4999211|NCT01638351|Metabolomics|metabolomics
4999212|NCT01638338|Alcohol|alcohol
4999213|NCT01638338|Risky drinking|risky drinking
4999214|NCT01638338|Web site|web site
4999215|NCT01638338|Primary Care|primary care
4999216|NCT01638338|General Practice|general practice
4999217|NCT01638338|Local Community|local community
4999218|NCT01638338|Mayors|mayors
4999219|NCT01638312|HIV, fructose|hiv, fructose
4999220|NCT01638299|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
4999221|NCT01638299|Artificial Pancreas|artificial pancreas
4999222|NCT01638273|Pregabalin, GLARS|pregabalin, glars
4999223|NCT01638260|NEAT|neat
4999224|NCT01638260|liraglutide|liraglutide
4999225|NCT01638260|glycemic control|glycemic control
4999226|NCT01638247|Male breast cancer|male breast cancer
4999227|NCT01638247|neoadjuvant, adjuvant or metastatic situation|neoadjuvant, adjuvant or metastatic situation
4999228|NCT01638247|anti-hormonal therapy|anti-hormonal therapy
4999229|NCT01638234|atopic dermatitis|atopic dermatitis
4999230|NCT01638234|eczema|eczema
4999231|NCT01638182|phylloquinone,|phylloquinone,
4999232|NCT01638182|menaquinone-7|menaquinone-7
4999233|NCT01638182|vitamin K-status|vitamin k-status
4999234|NCT01638182|efficacy|efficacy
4999235|NCT01638156|Aortic stenosis|aortic stenosis
4999236|NCT01638143|vitamin K2|vitamin k2
4999237|NCT01638143|menaquinone-7|menaquinone-7
4999238|NCT01638143|bioavailability|bioavailability
4999239|NCT01638091|Narrow band imaging|narrow band imaging
4999240|NCT01638091|Screening colonoscopy|screening colonoscopy
4999241|NCT01638091|Histology|histology
4999242|NCT01638078|coronary restenosis|coronary restenosis
4999243|NCT01638065|vein identification|vein identification
4999244|NCT01638065|vascular access|vascular access
4999245|NCT01638052|Tympanomastoid Surgery|tympanomastoid surgery
4999246|NCT01638052|Cochlear Implant|cochlear implant
4999247|NCT01638052|Mastoidectomy|mastoidectomy
4999248|NCT01638052|Cholesteatoma|cholesteatoma
4999249|NCT01638052|Pediatrics|pediatrics
4999250|NCT01638052|Clonidine|clonidine
4999251|NCT01638052|Bupivacaine|bupivacaine
4999252|NCT01638052|Greater Auricular Nerve Block|greater auricular nerve block
4999253|NCT01638052|Regional Anesthesia|regional anesthesia
4999254|NCT01638026|Gnrh agonist|gnrh agonist
4999255|NCT01638013|Rheumatoid Arthritis|rheumatoid arthritis
4999256|NCT01638013|ASP015K|asp015k
4999257|NCT01638000|Vesitrim|vesitrim
4999258|NCT01638000|Frequency|frequency
4999259|NCT01638000|Urgency|urgency
4999260|NCT01638000|Urgency incontinence|urgency incontinence
4999261|NCT01638000|Urinary incontinence|urinary incontinence
4999262|NCT01638000|Overactive Bladder (OAB)|overactive bladder (oab)
4999263|NCT01638000|Micturition|micturition
4999264|NCT01638000|Mirabegron|mirabegron
4999265|NCT01638000|YM178|ym178
4999266|NCT01638000|Vesicare|vesicare
4999267|NCT01638000|Solifenacin|solifenacin
4999268|NCT01637987|Peripheral intravenous catheter|peripheral intravenous catheter
4999269|NCT01637987|Vein visualization|vein visualization
4999270|NCT01637987|Transillumination|transillumination
4999271|NCT01637987|Near infrared light|near infrared light
4999272|NCT01637948|Chinese medicine|chinese medicine
4999273|NCT01637948|gingivitis|gingivitis
4999274|NCT01637948|cytokine|cytokine
4999275|NCT01637948|microbial|microbial
4999276|NCT01637935|Drug therapy|drug therapy
4999277|NCT01637909|Prehypertension, Hypertension|prehypertension, hypertension
4999278|NCT01637883|benzydamine HCl|benzydamine hcl
4999279|NCT01637883|endotracheal tube|endotracheal tube
4999280|NCT01637883|postoperative sore throat|postoperative sore throat
4999281|NCT01637870|Cesarean delivery|cesarean delivery
4999282|NCT01637870|Postpartum infection|postpartum infection
4999283|NCT01637870|Wound complications|wound complications
4999284|NCT01637870|Wound seroma|wound seroma
4999285|NCT01637870|Wound separation|wound separation
4999286|NCT01637870|Wound infection|wound infection
4999287|NCT01637870|Negative pressure|negative pressure
4999288|NCT01637857|foof hypersensitivity|foof hypersensitivity
4999289|NCT01637857|anal fissures|anal fissures
4999290|NCT01637857|ano-rectal manometry|ano-rectal manometry
4999291|NCT01637844|Pregnant women|pregnant women
4999292|NCT01637844|HBsAg positive|hbsag positive
4999293|NCT01637844|HBeAg positive|hbeag positive
4999294|NCT01637844|Telbivudine|telbivudine
4999295|NCT01637831|Obstructive Sleep Apnea|obstructive sleep apnea
4999296|NCT01637831|Idiopathic Pulmonary Fibrosis|idiopathic pulmonary fibrosis
4999297|NCT01637818|Inguinal hernia repair|inguinal hernia repair
4999298|NCT01637818|long-term follow-up|long-term follow-up
4999299|NCT01637818|Surgical technique|surgical technique
4999300|NCT01637792|peritoneal dialysis|peritoneal dialysis
4999301|NCT01637792|dose|dose
4999302|NCT01637792|residual kidney function|residual kidney function
4999303|NCT01637792|technique survival|technique survival
4999304|NCT01637792|patient survival|patient survival
4999305|NCT01637792|peritonitis|peritonitis
4999306|NCT01637779|randomized controlled trial|randomized controlled trial
4999307|NCT01637779|parent education|parent education
4999308|NCT01637779|pain management|pain management
4999309|NCT01637779|infant|infant
4999310|NCT01637779|immunization|immunization
4999311|NCT01637766|Spinal Metastases|spinal metastases
4999312|NCT01637766|Spinal Metastatic Disease|spinal metastatic disease
4999313|NCT01637766|Cord Compression|cord compression
4999314|NCT01637766|Intra-arterial Chemotherapy|intra-arterial chemotherapy
4999315|NCT01637766|Spinal Tumors|spinal tumors
4999316|NCT01637740|myopia|myopia
4999317|NCT01637740|pseudoexfoliation syndrome|pseudoexfoliation syndrome
4999318|NCT01637740|optical low coherence reflectometry|optical low coherence reflectometry
4999319|NCT01637740|ocular optical components|ocular optical components
4999320|NCT01637740|cataract|cataract
4999321|NCT01637727|Long term effects of gestational diabetes mellitus in a population of parous women|long term effects of gestational diabetes mellitus in a population of parous women
4999322|NCT01637727|Gestational diabetes mellitus- GDM is defined as glucose intolerance diagnosed during pregnancy and not present shortly after birth|gestational diabetes mellitus- gdm is defined as glucose intolerance diagnosed during pregnancy and not present shortly after birth
4999323|NCT01637701|benign prostatic hypertrophy|benign prostatic hypertrophy
4999324|NCT01637701|bipolar transurethral resection of the prostate|bipolar transurethral resection of the prostate
4999325|NCT01637701|plasmakinetic enucleation of the prostate|plasmakinetic enucleation of the prostate
4999326|NCT01637688|cow milk allergy|cow milk allergy
4999327|NCT01637688|amino acid formula|amino acid formula
4999328|NCT01637675|sodium tanshinone IIA sulfonate|sodium tanshinone iia sulfonate
4999329|NCT01637675|pulmonary hypertension|pulmonary hypertension
4999330|NCT01637649|dysphagia,diaphragm, ultrasonography, inspiration, expiration,|dysphagia,diaphragm, ultrasonography, inspiration, expiration,
4999331|NCT01637636|rifampin,|rifampin,
4999332|NCT01637636|ketoconazole,|ketoconazole,
4999333|NCT01637636|CYP3A4,|cyp3a4,
4999334|NCT01637636|tasimelteon,|tasimelteon,
4999335|NCT01637636|VEC-162|vec-162
4999336|NCT01637636|Pharmacokinetics|pharmacokinetics
4999337|NCT01637623|Hypertension|hypertension
4999338|NCT01637623|High Blood Pressure|high blood pressure
4999339|NCT01637623|Sleep Apnea|sleep apnea
4999340|NCT01637623|Obstructive Sleep Apnea|obstructive sleep apnea
4999341|NCT01637623|OSA|osa
4999342|NCT01637610|placental alpha microglobulin-1|placental alpha microglobulin-1
4999343|NCT01637610|AmniSure|amnisure
4999344|NCT01637610|preterm|preterm
4999345|NCT01637610|rupture of fetal membranes|rupture of fetal membranes
4999346|NCT01637597|Non-small cell lung cancer(NSCLC)|non-small cell lung cancer(nsclc)
4999347|NCT01637571|GERD|gerd
4999348|NCT01637571|NCCP|nccp
4999349|NCT01637571|chest pain|chest pain
4999350|NCT01637571|reflux|reflux
4999351|NCT01637571|GERD related non-cardiac chest pain|gerd related non-cardiac chest pain
4999352|NCT01637545|facial bones|facial bones
4999353|NCT01637545|Post operative nasea vomiting|post operative nasea vomiting
4999354|NCT01637545|fractures|fractures
4999355|NCT01637545|reduction|reduction
4999356|NCT01637519|kidney stones|kidney stones
4999357|NCT01637519|ureteral stones|ureteral stones
4999358|NCT01637519|stent|stent
4999359|NCT01637506|urine|urine
4999360|NCT01637506|stool|stool
4999361|NCT01637506|kidney stones|kidney stones
4999362|NCT01637493|Pegylation|pegylation
4999363|NCT01637493|G-CSF|g-csf
4999364|NCT01637493|Pharmacokinetics|pharmacokinetics
4999365|NCT01637493|Pharmacodynamics|pharmacodynamics
4999366|NCT01637467|critical illness|critical illness
4999367|NCT01637467|myopathy|myopathy
4999368|NCT01637467|electrical muscle stimulation|electrical muscle stimulation
4999369|NCT01637454|noradrenaline terlipressin type 2 HRS|noradrenaline terlipressin type 2 hrs
4999370|NCT01637441|bladder prolapse (cystocele)|bladder prolapse (cystocele)
4999371|NCT01637441|Pelvic organ prolapse repair|pelvic organ prolapse repair
4999372|NCT01637441|coelioscopic|coelioscopic
4999373|NCT01637441|prosthetic surgery|prosthetic surgery
4999374|NCT01637441|vaginal approach|vaginal approach
4999375|NCT01637441|Randomized study|randomized study
4999376|NCT01637441|laparoscopic sacropexy|laparoscopic sacropexy
4999377|NCT01637441|vaginal mesh surgery|vaginal mesh surgery
4999378|NCT01637441|Stage II|stage ii
4999379|NCT01637441|Clavien Dindo|clavien dindo
4999380|NCT01637415|alcohol withdrawal syndrome|alcohol withdrawal syndrome
4999381|NCT01637415|prediction|prediction
4999382|NCT01637415|severity|severity
4999383|NCT01637415|alcohol use disorder|alcohol use disorder
4999384|NCT01637415|complicated alcohol withdrawal|complicated alcohol withdrawal
4999385|NCT01637415|alcohol withdrawal seizures|alcohol withdrawal seizures
4999386|NCT01637415|delirium tremens|delirium tremens
4999387|NCT01637415|PAWSS|pawss
4999388|NCT01637402|CRPC|crpc
4999389|NCT01637402|prostate|prostate
4999390|NCT01637402|cancer|cancer
4999391|NCT01637376|Lung neoplasms|lung neoplasms
4999392|NCT01637376|Non Small cell lung carcinoma|non small cell lung carcinoma
4999393|NCT01637376|Non small cell lung cancer|non small cell lung cancer
4999394|NCT01637376|Large cell carcinoma|large cell carcinoma
4999395|NCT01637376|squamous cell carcinoma|squamous cell carcinoma
4999396|NCT01637376|adenocarcinoma|adenocarcinoma
4999397|NCT01637363|Psychoeducation|psychoeducation
4999398|NCT01637363|Stress|stress
4999399|NCT01637363|Sickness absence|sickness absence
4999400|NCT01637363|Psychiatric symptoms|psychiatric symptoms
4999401|NCT01637363|Locus of control|locus of control
4999402|NCT01637363|Self reported health|self reported health
4999403|NCT01637324|To assess VCT and linkage into care|to assess vct and linkage into care
4999404|NCT01637324|nPEP|npep
4999405|NCT01637324|STIs|stis
4999406|NCT01637324|anal dysplasia/cancer|anal dysplasia/cancer
4999407|NCT01637324|hyperlipidemia|hyperlipidemia
4999408|NCT01637324|diabetes|diabetes
4999409|NCT01637324|Proportion of first-time MSM clients attending multidisciplinary services who undergo HIV testing|proportion of first-time msm clients attending multidisciplinary services who undergo hiv testing
4999410|NCT01637324|Proportion of MSM clients who have repeated HIV testing during the first six months after the first negative HIV test|proportion of msm clients who have repeated hiv testing during the first six months after the first negative hiv test
4999411|NCT01637324|Proportion of HIV-positive MSM who receive HIV care within three months after HIV diagnosis or enrolment|proportion of hiv-positive msm who receive hiv care within three months after hiv diagnosis or enrolment
4999412|NCT01637324|Proportion of HIV-positive MSM who still remain in HIV care at six months after enrollment|proportion of hiv-positive msm who still remain in hiv care at six months after enrollment
4999413|NCT01637311|Peroral endoscopic myotomy|peroral endoscopic myotomy
4999414|NCT01637311|Heller myotomy|heller myotomy
4999415|NCT01637311|persistent/recurrent achalasia.|persistent/recurrent achalasia.
4999416|NCT01637298|Histological HGAIN|histological hgain
4999417|NCT01637298|detected biomarkers|detected biomarkers
4999418|NCT01637298|MSM population|msm population
4999419|NCT01637298|HPV subtypes|hpv subtypes
4999420|NCT01637298|AIN study|ain study
4999421|NCT01637298|HIV-positive and HIV-negative MSM|hiv-positive and hiv-negative msm
4999422|NCT01637298|anal cytology and biomarkers|anal cytology and biomarkers
4999423|NCT01637298|likelihood of AIN development at month 12 and yearly thereafter|likelihood of ain development at month 12 and yearly thereafter
4999424|NCT01637272|Dumping syndrome|dumping syndrome
4999425|NCT01637272|SOM230|som230
4999426|NCT01637272|pasireotide LAR|pasireotide lar
4999427|NCT01637259|proteinuria|proteinuria
4999429|NCT01637233|HIV-1 infection|hiv-1 infection
4999430|NCT01637233|neurocognitive function|neurocognitive function
4999431|NCT01637233|switch study|switch study
4999432|NCT01637220|Anaphylaxis|anaphylaxis
4999433|NCT01637220|Neutrophils|neutrophils
4999434|NCT01637220|Platelet activating factor|platelet activating factor
4999435|NCT01637220|Neutrophil Extracellular Traps (NETs)|neutrophil extracellular traps (nets)
4999436|NCT01637168|Disorders of cognitive function|disorders of cognitive function
4999437|NCT01637155|Cholecalciferol|cholecalciferol
4999438|NCT01637129|Childhood stroke|childhood stroke
4999439|NCT01637129|Perinatal stroke|perinatal stroke
4999440|NCT01637129|Pediatric stroke|pediatric stroke
4999441|NCT01637129|Presumed perinatal stroke|presumed perinatal stroke
4999442|NCT01637129|Children who have hemiparesis|children who have hemiparesis
4999443|NCT01637103|Cancer|cancer
4999444|NCT01637103|Depression|depression
4999445|NCT01637103|Anxiety|anxiety
4999446|NCT01637103|Fatigue|fatigue
4999447|NCT01637103|Sleep|sleep
4999448|NCT01637103|Quality of life|quality of life
4999449|NCT01637103|Cognitive therapy|cognitive therapy
4999450|NCT01637103|Bright light therapy|bright light therapy
4999451|NCT01637064|Myositis|myositis
4999452|NCT01637064|Acthar treatment|acthar treatment
4999453|NCT01637038|ischemia/reperfusion injury|ischemia/reperfusion injury
4999454|NCT01637038|remote ischemic postconditioning|remote ischemic postconditioning
4999455|NCT01637012|ALEX|alex
4999456|NCT01637012|coronary stent|coronary stent
4999457|NCT01637012|cobalt-chromium|cobalt-chromium
4999458|NCT01637012|sirolimus|sirolimus
4999459|NCT01637012|OCT|oct
4999460|NCT01636999|Sedara|sedara
4999461|NCT01636999|Nitrous Oxide|nitrous oxide
4999462|NCT01636999|Butorphanol|butorphanol
4999463|NCT01636999|Visual Analog Scale|visual analog scale
4999464|NCT01636986|myopia|myopia
4999465|NCT01636986|contact lenses|contact lenses
4999466|NCT01636986|dry eyes|dry eyes
4999467|NCT01636986|comfort|comfort
4999468|NCT01636986|replacement|replacement
4999469|NCT01636973|Lung cancer|lung cancer
4999470|NCT01636947|chemotherapy|chemotherapy
4999471|NCT01636947|nausea|nausea
4999472|NCT01636947|vomiting|vomiting
4999473|NCT01636947|emetogenic|emetogenic
4999474|NCT01636947|cancer|cancer
4999475|NCT01636947|antiemetics|antiemetics
4999476|NCT01636947|tumor|tumor
4999477|NCT01636934|Lung Cancer|lung cancer
4999478|NCT01636934|Non Small Cell Lung Cancer|non small cell lung cancer
4999479|NCT01636934|NSCLC|nsclc
4999480|NCT01636934|Symptom Burden|symptom burden
4999481|NCT01636934|Chemoradiation|chemoradiation
4999482|NCT01636934|CXRT|cxrt
4999483|NCT01636934|Minocycline|minocycline
4999484|NCT01636934|Dynacin|dynacin
4999485|NCT01636934|Minocin|minocin
4999486|NCT01636934|Minocin PAC|minocin pac
4999487|NCT01636934|Myrac|myrac
4999488|NCT01636934|Solodyn|solodyn
4999489|NCT01636934|Placebo|placebo
4999491|NCT01636934|Questionnaires|questionnaires
4999492|NCT01636934|Surveys|surveys
4999493|NCT01636921|Non-Small Cell Lung Cancer|non-small cell lung cancer
4999494|NCT01636921|Lung Cancer|lung cancer
4999495|NCT01636921|NSCLC|nsclc
4999496|NCT01636921|Radiation Therapy|radiation therapy
4999497|NCT01636921|Sorafenib|sorafenib
4999498|NCT01636921|BAY 43-9006|bay 43-9006
4999499|NCT01636921|Thoracic Radiation|thoracic radiation
4999500|NCT01636895|malaria|malaria
4999501|NCT01636895|pregnancy|pregnancy
4999502|NCT01636895|prevention|prevention
4999503|NCT01636895|treatment|treatment
4999504|NCT01636895|molecular markers|molecular markers
4999505|NCT01636882|Melanoma|melanoma
4999506|NCT01636882|CALM|calm
4999507|NCT01636869|bupivacaine level|bupivacaine level
4999508|NCT01636869|periarticular block|periarticular block
4999509|NCT01636869|total knee arthroplasty|total knee arthroplasty
4999510|NCT01636856|oropharyngeal exercises, obstructive sleep apnea, speech therapy, magnetic resonance, PCRIT, negative expiratory pressure, snore|oropharyngeal exercises, obstructive sleep apnea, speech therapy, magnetic resonance, pcrit, negative expiratory pressure, snore
4999511|NCT01636830|Toothbrushing|toothbrushing
4999512|NCT01636830|gingival recession|gingival recession
4999513|NCT01636804|Quicksite|quicksite
4999514|NCT01636804|Quickflex|quickflex
4999515|NCT01636804|St. Jude Medical|st. jude medical
4999516|NCT01636778|Thrombocytopenia|thrombocytopenia
4999517|NCT01636778|Hepatitis C, chronic|hepatitis c, chronic
4999518|NCT01636739|Intussusceptions|intussusceptions
4999519|NCT01636739|Special Drug Use Investigation|special drug use investigation
4999520|NCT01636739|Rotavirus|rotavirus
4999521|NCT01636726|COPD|copd
4999523|NCT01636726|Asthma|asthma
4999524|NCT01636726|LABAs|labas
4999525|NCT01636700|Tramadol infiltration|tramadol infiltration
4999526|NCT01636700|Analgesic effect|analgesic effect
4999527|NCT01636700|Serum IL-6|serum il-6
4999528|NCT01636687|Psoriasis|psoriasis
4999529|NCT01636687|Moderate to Severe Plaque-type Psoriasis|moderate to severe plaque-type psoriasis
4999530|NCT01636674|positron emission tomography|positron emission tomography
4999531|NCT01636674|computed tomography|computed tomography
4999532|NCT01636674|fluordeoxyglucose|fluordeoxyglucose
4999533|NCT01636674|colon cancer|colon cancer
4999534|NCT01636674|cancer|cancer
4999535|NCT01636674|staging|staging
4999536|NCT01636674|imaging|imaging
4999537|NCT01636648|Aortic Valve Replacement|aortic valve replacement
4999538|NCT01636648|Aortic Valve Bioprosthesis|aortic valve bioprosthesis
4999539|NCT01636622|Advanced Cancers|advanced cancers
4999540|NCT01636622|Advanced Malignancy|advanced malignancy
4999541|NCT01636622|BRAF Mutation|braf mutation
4999542|NCT01636622|Advanced solid tumor|advanced solid tumor
4999543|NCT01636622|Lymphoma|lymphoma
4999544|NCT01636622|Vemurafenib|vemurafenib
4999545|NCT01636622|PLX4032|plx4032
4999546|NCT01636622|RO5185426|ro5185426
4999547|NCT01636622|Carboplatin|carboplatin
4999548|NCT01636622|Paraplatin|paraplatin
4999549|NCT01636622|Paclitaxel|paclitaxel
4999550|NCT01636622|Taxol|taxol
4999551|NCT01636609|Leukemia|leukemia
4999552|NCT01636609|Acute Myeloid Leukemia|acute myeloid leukemia
4999553|NCT01636609|AML|aml
4999554|NCT01636609|Myelodysplastic Syndromes|myelodysplastic syndromes
4999555|NCT01636609|MDS|mds
4999556|NCT01636609|Relapsed|relapsed
4999557|NCT01636609|Refractory|refractory
4999558|NCT01636609|Cytarabine|cytarabine
4999559|NCT01636609|ARA-C|ara-c
4999560|NCT01636609|Cytosar|cytosar
4999561|NCT01636609|DepoCyt|depocyt
4999562|NCT01636609|Cytosine Arabinosine|cytosine arabinosine
4999563|NCT01636609|5-Azacytidine|5-azacytidine
4999564|NCT01636609|Azacitidine|azacitidine
4999565|NCT01636609|5-aza|5-aza
4999566|NCT01636609|Vidaza|vidaza
4999567|NCT01636609|5-AZC|5-azc
4999568|NCT01636609|AZA-CR|aza-cr
4999569|NCT01636609|Ladakamycin|ladakamycin
4999570|NCT01636609|NSC-102816|nsc-102816
4999571|NCT01636609|Tosedostat|tosedostat
4999572|NCT01636596|Alzheimer's Disease|alzheimer's disease
4999573|NCT01636596|Mild Cognitive Impairment|mild cognitive impairment
4999574|NCT01636596|Insulin|insulin
4999575|NCT01636596|Pulsatile|pulsatile
4999576|NCT01636583|zinc|zinc
4999577|NCT01636583|absorption|absorption
4999578|NCT01636583|bio-availability|bio-availability
4999579|NCT01636583|aqueous zinc|aqueous zinc
4999580|NCT01636583|zinc deficiency|zinc deficiency
4999581|NCT01636583|zinc fortification|zinc fortification
4999582|NCT01636570|Vitamin D|vitamin d
4999583|NCT01636570|Cholecalciferol|cholecalciferol
4999584|NCT01636570|Heart Failure|heart failure
4999585|NCT01636570|Congestive heart failure|congestive heart failure
4999586|NCT01636570|Cardiomyopathy|cardiomyopathy
4999587|NCT01636570|Strength|strength
4999588|NCT01636570|Parathyroid Hormone|parathyroid hormone
4999589|NCT01636570|Calcium|calcium
4999590|NCT01636570|Quality of Life|quality of life
4999591|NCT01636570|C reactive protein|c reactive protein
4999592|NCT01636570|Cardiopulmonary exercise testing|cardiopulmonary exercise testing
4999593|NCT01636570|Prognosis|prognosis
4999594|NCT01636557|Rheumatoid arthritis|rheumatoid arthritis
4999595|NCT01636557|sirukumab|sirukumab
4999596|NCT01636557|CNTO 136|cnto 136
4999597|NCT01636557|CYP450 enzyme|cyp450 enzyme
4999598|NCT01636557|anti-interleukin-6 monoclonal antibody|anti-interleukin-6 monoclonal antibody
4999599|NCT01636466|Chronic allograft failure|chronic allograft failure
4999600|NCT01636466|Kidney Transplantation|kidney transplantation
4999601|NCT01636453|wide-neck|wide-neck
4999602|NCT01636453|saccular|saccular
4999603|NCT01636453|intracranial aneurysms|intracranial aneurysms
4999604|NCT01636453|ICA|ica
4999605|NCT01636453|Stent assisted coiling|stent assisted coiling
4999606|NCT01636453|Liberty Stent|liberty stent
4999607|NCT01636440|Conditioned Pain Modulation|conditioned pain modulation
4999608|NCT01636427|myocardial infarction|myocardial infarction
4999609|NCT01636427|coronary angiography|coronary angiography
4999610|NCT01636427|STEMI|stemi
4999611|NCT01636427|NSTEMI|nstemi
4999612|NCT01636414|Total joint arthroplasty, blood loss|total joint arthroplasty, blood loss
4999613|NCT01636388|Relapsed Hodgkins Lymphoma|relapsed hodgkins lymphoma
4999614|NCT01636388|Refractory Hodgkins Lymphoma|refractory hodgkins lymphoma
4999615|NCT01636388|Allogeneic Stem Cell Transplantation|allogeneic stem cell transplantation
4999616|NCT01636388|Adoptive Immunotherapy|adoptive immunotherapy
4999617|NCT01636388|Cellular Therapy|cellular therapy
4999618|NCT01636388|Cytotoxic T cell lymphocytes|cytotoxic t cell lymphocytes
4999619|NCT01636362|Partial-thickness second degree burns|partial-thickness second degree burns
4999620|NCT01636362|Mepitel Ag|mepitel ag
4999621|NCT01636362|Silver dressing|silver dressing
4999622|NCT01636349|Type 2 diabetes|type 2 diabetes
4999623|NCT01636349|hypertension|hypertension
4999624|NCT01636349|obesity|obesity
4999625|NCT01636349|metabolic syndrome|metabolic syndrome
4999626|NCT01636297|Parkinson's disease|parkinson's disease
4999627|NCT01636297|Exercise|exercise
4999628|NCT01636284|Liver Cancer|liver cancer
4999629|NCT01636284|HCC|hcc
4999630|NCT01636284|first line HCC|first line hcc
4999631|NCT01636284|Pexa-Vec|pexa-vec
4999632|NCT01636284|JX-594|jx-594
4999633|NCT01636271|CV Risk|cv risk
4999634|NCT01636271|Cardiovascular Disease|cardiovascular disease
4999635|NCT01636271|Atherosclerosis|atherosclerosis
4999636|NCT01636271|Acute coronary syndrome|acute coronary syndrome
4999637|NCT01636258|Prediabetes|prediabetes
4999638|NCT01636258|Overweight|overweight
4999639|NCT01636258|African American|african american
4999640|NCT01636258|Women|women
4999641|NCT01636258|Cooking|cooking
4999642|NCT01636258|Nutrition|nutrition
4999643|NCT01636258|Exercise|exercise
4999644|NCT01636258|Stress Management|stress management
4999645|NCT01636245|71 vaccine|71 vaccine
4999646|NCT01636245|HFMD|hfmd
4999647|NCT01636245|consistency of three consecutive lots|consistency of three consecutive lots
4999648|NCT01636245|immunogenicity|immunogenicity
4999649|NCT01636232|Vitamin D|vitamin d
4999650|NCT01636232|infection|infection
4999651|NCT01636232|disease severity|disease severity
4999652|NCT01636232|mortality|mortality
4999653|NCT01636232|critically ill|critically ill
4999654|NCT01636232|sepsis|sepsis
4999655|NCT01636219|Spirometry,|spirometry,
4999656|NCT01636219|Cough|cough
4999657|NCT01636193|Rotavirus|rotavirus
4999658|NCT01636193|Rotarix|rotarix
4999659|NCT01636193|Drug Use Investigation|drug use investigation
4999660|NCT01636193|Safety|safety
4999661|NCT01636180|STEMI|stemi
4999662|NCT01636180|NSTEMI|nstemi
4999663|NCT01636180|clopidogrel|clopidogrel
4999664|NCT01636180|Areplex|areplex
4999665|NCT01636180|REL-0609|rel-0609
4999666|NCT01636154|fire-heat syndrome|fire-heat syndrome
4999667|NCT01636154|blood stasis syndrome|blood stasis syndrome
4999668|NCT01636154|method of clearing heat|method of clearing heat
4999669|NCT01636154|method of promoting blood circulation|method of promoting blood circulation
4999670|NCT01636154|medicinal fractions-based herbal combinations|medicinal fractions-based herbal combinations
4999671|NCT01636141|Safety|safety
4999672|NCT01636141|Tolerability|tolerability
4999673|NCT01636141|Pharmacokinetics|pharmacokinetics
4999674|NCT01636141|Dose escalation|dose escalation
4999675|NCT01636141|Randomized|randomized
4999676|NCT01636141|Healthy volunteers|healthy volunteers
4999677|NCT01636141|Topical|topical
4999678|NCT01636141|OLT1177|olt1177
4999679|NCT01636141|Olatec|olatec
4999680|NCT01636141|Pain|pain
4999681|NCT01636141|Inflammation|inflammation
4999682|NCT01636128|Urinary|urinary
4999683|NCT01636128|biomarkers|biomarkers
4999684|NCT01636128|DFMO|dfmo
4999685|NCT01636128|sulindac|sulindac
4999686|NCT01636102|Influenza|influenza
4999687|NCT01636102|Adults|adults
4999688|NCT01636102|Elderly|elderly
4999689|NCT01636102|Immunology|immunology
4999690|NCT01636102|Safety|safety
4999691|NCT01636089|intensive care unit|intensive care unit
4999692|NCT01636076|COPD|copd
4999693|NCT01636063|Induced Abortion|induced abortion
4999694|NCT01636063|Abortion Techniques|abortion techniques
4999695|NCT01636063|Mifepristone|mifepristone
4999696|NCT01636063|Misoprostol|misoprostol
4999697|NCT01636063|Initial Cervical Dilation|initial cervical dilation
4999698|NCT01636050|squat exercise|squat exercise
4999699|NCT01636037|schizophrenia|schizophrenia
4999700|NCT01636037|negative symptoms|negative symptoms
4999701|NCT01636037|deficit syndrome|deficit syndrome
4999702|NCT01636037|SANS|sans
4999703|NCT01636037|Sinemet|sinemet
4999704|NCT01636037|L-dopa|l-dopa
4999705|NCT01636037|levodopa|levodopa
4999706|NCT01636037|carbidopa|carbidopa
4999707|NCT01636037|augmentation|augmentation
4999708|NCT01636037|antipsychotics|antipsychotics
4999709|NCT01636024|Phase 1,|phase 1,
4999710|NCT01636024|healthy volunteers,|healthy volunteers,
4999711|NCT01636024|safety,|safety,
4999712|NCT01636024|tolerability,|tolerability,
4999713|NCT01636024|pharmacokinetics,|pharmacokinetics,
4999714|NCT01636024|pharmacodynamics,|pharmacodynamics,
4999715|NCT01636024|single ascending dose study,|single ascending dose study,
4999716|NCT01636024|multiple|multiple
4999717|NCT01636011|Parkinson's Disease|parkinson's disease
4999718|NCT01636011|Osteopathic Manipulative Medicine|osteopathic manipulative medicine
4999719|NCT01636011|Speech|speech
4999720|NCT01636011|Pulmonary Function|pulmonary function
4999721|NCT01635998|renal sympathetic denervation|renal sympathetic denervation
4999722|NCT01635998|renal catheter ablation|renal catheter ablation
4999723|NCT01635998|hypertension|hypertension
4999724|NCT01635985|Phase I, Healthy male volunteers, pharmacokinetics|phase i, healthy male volunteers, pharmacokinetics
4999725|NCT01635972|Isavuconazole|isavuconazole
4999726|NCT01635972|Bupropion|bupropion
4999727|NCT01635972|Bupropion hydrochloride|bupropion hydrochloride
4999728|NCT01635972|Healthy Volunteers|healthy volunteers
4999729|NCT01635972|BAL8557|bal8557
4999730|NCT01635972|BAL4815|bal4815
4999731|NCT01635972|BAL8728|bal8728
4999732|NCT01635959|upper gastro-intestinal symptoms, GERD|upper gastro-intestinal symptoms, gerd
4999733|NCT01635946|Isavuconazole|isavuconazole
4999734|NCT01635946|Atorvastatin|atorvastatin
4999735|NCT01635946|Healthy Volunteers|healthy volunteers
4999736|NCT01635946|BAL8557|bal8557
4999737|NCT01635946|BAL4815|bal4815
4999738|NCT01635946|BAL8728|bal8728
4999739|NCT01635933|contact lenses|contact lenses
4999740|NCT01635933|color contact lenses|color contact lenses
4999741|NCT01635933|myopia|myopia
4999742|NCT01635920|contact lenses|contact lenses
4999743|NCT01635920|color contact lenses|color contact lenses
4999744|NCT01635920|myopia|myopia
4999745|NCT01635894|female pelvic floor condition|female pelvic floor condition
4999746|NCT01635894|pelvic floor training|pelvic floor training
4999747|NCT01635894|supervised pelvic floor training|supervised pelvic floor training
4999748|NCT01635894|practice nurse|practice nurse
4999749|NCT01635894|nurse specialist|nurse specialist
4999750|NCT01635842|Patient|patient
4999751|NCT01635842|information leaflet|information leaflet
4999752|NCT01635842|informed consent|informed consent
4999753|NCT01635842|awareness|awareness
4999754|NCT01635829|Healthy participants|healthy participants
4999755|NCT01635829|Hepatitis C virus|hepatitis c virus
4999756|NCT01635829|Telaprevir|telaprevir
4999757|NCT01635829|Phenytoin|phenytoin
4999758|NCT01635829|Carbamazepine|carbamazepine
4999759|NCT01635829|HCV|hcv
4999760|NCT01635829|Interaction|interaction
4999761|NCT01635816|Immunogenicity|immunogenicity
4999762|NCT01635816|SA 14-14-2 JE vaccine|sa 14-14-2 je vaccine
4999763|NCT01635816|Bangladesh|bangladesh
4999764|NCT01635803|bevacizumab|bevacizumab
4999765|NCT01635803|ranibizumab|ranibizumab
4999766|NCT01635803|retinal vein occlusions|retinal vein occlusions
4999767|NCT01635803|randomized clinical trial|randomized clinical trial
4999768|NCT01635803|Macular edema|macular edema
4999769|NCT01635790|bevacizumab|bevacizumab
4999770|NCT01635790|ranibizumab|ranibizumab
4999771|NCT01635790|diabetic macular edema|diabetic macular edema
4999772|NCT01635790|randomized clinical trial|randomized clinical trial
4999773|NCT01635777|PKDL|pkdl
4999774|NCT01635777|miltefosine|miltefosine
4999775|NCT01635764|hidradenitis suppurativa|hidradenitis suppurativa
4999776|NCT01635764|open-label|open-label
4999777|NCT01635764|acne inversa|acne inversa
4999778|NCT01635764|PIONEER (OPEN-LABEL EXTENSION)|pioneer (open-label extension)
4999779|NCT01635764|adalimumab|adalimumab
4999780|NCT01635764|HS|hs
4999781|NCT01635764|acne|acne
4999782|NCT01635764|tumor necrosis factor|tumor necrosis factor
4999783|NCT01635764|abscess|abscess
4999784|NCT01635764|inflammatory nodule|inflammatory nodule
4999785|NCT01635751|Pregabalin|pregabalin
4999786|NCT01635751|GLARS|glars
4999787|NCT01635738|Probiotics|probiotics
4999788|NCT01635738|Lactobacillus paracasei GMNL-133|lactobacillus paracasei gmnl-133
4999789|NCT01635738|Lactobacillus fermentum GM-090|lactobacillus fermentum gm-090
4999790|NCT01635738|Atopic dermatitis|atopic dermatitis
4999791|NCT01635738|Asthma|asthma
4999792|NCT01635738|Lactobacillus paracasei|lactobacillus paracasei
4999793|NCT01635738|Lactobacillus fermentum|lactobacillus fermentum
4999794|NCT01635738|efficacy and safety|efficacy and safety
4999795|NCT01635725|colonoscopy|colonoscopy
4999796|NCT01635725|bowel cleanliness|bowel cleanliness
4999797|NCT01635725|bowel rating scale|bowel rating scale
4999798|NCT01635712|Hematological Malignancy|hematological malignancy
4999799|NCT01635712|Hsp90|hsp90
4999800|NCT01635699|DNA oxidation|dna oxidation
4999801|NCT01635699|obstructive sleep apnea|obstructive sleep apnea
4999802|NCT01635699|lipid peroxidation|lipid peroxidation
4999803|NCT01635699|oxidative stresses|oxidative stresses
4999804|NCT01635673|Exercise|exercise
4999805|NCT01635673|Latino|latino
4999806|NCT01635673|Hispanic|hispanic
4999807|NCT01635673|Boys|boys
4999808|NCT01635660|Out-of-hospital|out-of-hospital
4999809|NCT01635660|airway management|airway management
4999810|NCT01635660|intubation|intubation
4999811|NCT01635660|video laryngoscope|video laryngoscope
4999812|NCT01635634|Fibromyalgia|fibromyalgia
4999813|NCT01635634|Cupping|cupping
4999814|NCT01635621|Olokizumab|olokizumab
4999815|NCT01635621|OKZ|okz
4999816|NCT01635621|CDP6038|cdp6038
4999817|NCT01635621|Crohn's Disease|crohn's disease
4999818|NCT01635621|CDAI|cdai
4999819|NCT01635621|IBDQ|ibdq
4999820|NCT01635608|Pharmacokinetics|pharmacokinetics
4999821|NCT01635608|Talinolol|talinolol
4999822|NCT01635608|Amoxicillin|amoxicillin
4999823|NCT01635608|Acetaminophen|acetaminophen
4999824|NCT01635608|Magnetic Resonance Imaging|magnetic resonance imaging
4999825|NCT01635582|Hand exercises|hand exercises
4999826|NCT01635582|Hand function|hand function
4999827|NCT01635582|Computer based exercises|computer based exercises
4999828|NCT01635582|Therapeutic gaming|therapeutic gaming
4999829|NCT01635569|Obsessive-compulsive disorder|obsessive-compulsive disorder
4999830|NCT01635569|Pediatric|pediatric
4999831|NCT01635569|Group-based|group-based
4999832|NCT01635569|Cognitive-behavioural therapy|cognitive-behavioural therapy
4999833|NCT01635556|borderline personality disorder|borderline personality disorder
4999834|NCT01635556|dialectical behavior therapy|dialectical behavior therapy
4999835|NCT01635556|psychological treatment|psychological treatment
4999836|NCT01635517|Diuretics|diuretics
4999837|NCT01635517|Vasopressins|vasopressins
4999838|NCT01635517|Sodium|sodium
4999839|NCT01635504|HIV lipoatrophy|hiv lipoatrophy
4999840|NCT01635504|masseter hypertrophy|masseter hypertrophy
4999841|NCT01635504|parotid enlargement|parotid enlargement
4999842|NCT01635504|botulinum toxin|botulinum toxin
4999843|NCT01635491|Gastrointestinal Motility|gastrointestinal motility
4999844|NCT01635491|Transit time|transit time
4999845|NCT01635426|Aspirin|aspirin
4999846|NCT01635426|Clopidogrel|clopidogrel
4999847|NCT01635426|Unexplained recurrent pregnancy loss|unexplained recurrent pregnancy loss
4999848|NCT01635426|Uterine artery pulsatility index|uterine artery pulsatility index
4999849|NCT01635400|Irinotecan|irinotecan
4999850|NCT01635400|UGT1A1 Gene Polymorphisms|ugt1a1 gene polymorphisms
4999851|NCT01635400|Small Cell Carcinoma of Lung|small cell carcinoma of lung
4999852|NCT01635348|gait speed|gait speed
4999853|NCT01635348|cognitive processing speed|cognitive processing speed
4999854|NCT01635335|HIV prevention|hiv prevention
4999855|NCT01635335|adolescents|adolescents
4999856|NCT01635335|Latinos|latinos
4999857|NCT01635335|Hispanics|hispanics
4999858|NCT01635335|family|family
4999859|NCT01635335|health promotion|health promotion
4999860|NCT01635335|disease prevention|disease prevention
4999861|NCT01635335|family communication|family communication
4999862|NCT01635335|parental supervision|parental supervision
4999863|NCT01635322|deformity|deformity
4999864|NCT01635322|adult|adult
4999865|NCT01635322|lumbar|lumbar
4999866|NCT01635322|thoraco-lumbar|thoraco-lumbar
4999867|NCT01635322|Sagittal vertebral Alignement (SVA)|sagittal vertebral alignement (sva)
4999868|NCT01635322|Oswestry Disability Index (ODI)|oswestry disability index (odi)
4999869|NCT01635257|pulmonary embolism diagnosis|pulmonary embolism diagnosis
4999870|NCT01635257|ultrasound|ultrasound
4999871|NCT01635244|Aortic valve prosthesis|aortic valve prosthesis
4999872|NCT01635244|Aortic valve hemodynamics|aortic valve hemodynamics
4999873|NCT01635244|Prosthesis-patient mismatch|prosthesis-patient mismatch
4999874|NCT01635244|Left ventricular diastolic function|left ventricular diastolic function
4999875|NCT01635244|Left ventricular remodeling|left ventricular remodeling
4999876|NCT01635231|Nephrology|nephrology
4999877|NCT01635231|sodium-channels|sodium-channels
4999878|NCT01635231|water-channels|water-channels
4999879|NCT01635231|BCM|bcm
4999880|NCT01635231|central blood pressure|central blood pressure
4999881|NCT01635218|Depression|depression
4999882|NCT01635218|Perimenopause|perimenopause
4999883|NCT01635218|Postmenopause|postmenopause
4999884|NCT01635218|Homeopathy|homeopathy
4999885|NCT01635205|Paraspinous block|paraspinous block
4999886|NCT01635205|Non-responsive chronic pelvic pain|non-responsive chronic pelvic pain
4999887|NCT01635192|renin|renin
4999888|NCT01635192|angiotensin|angiotensin
4999889|NCT01635192|probiotic|probiotic
4999890|NCT01635192|glucose absorption|glucose absorption
4999891|NCT01635192|intestinal|intestinal
4999892|NCT01635179|Videolaryngoscopy|videolaryngoscopy
4999893|NCT01635179|Bronchial Aspiration|bronchial aspiration
4999894|NCT01635179|Hypoxia|hypoxia
4999895|NCT01635166|Arthroplasty|arthroplasty
4999896|NCT01635166|Replacement|replacement
4999897|NCT01635166|Hip|hip
4999898|NCT01635166|Cementless|cementless
4999899|NCT01635166|Ceramic on Ceramic|ceramic on ceramic
4999900|NCT01635153|HIV|hiv
4999901|NCT01635153|Tuberculosis|tuberculosis
4999902|NCT01635153|Nutrition|nutrition
4999903|NCT01635140|DIPG|dipg
4999904|NCT01635140|Hypofractionated Radiotherapy|hypofractionated radiotherapy
4999905|NCT01635140|Radiotherapy|radiotherapy
4999906|NCT01635140|Median survival|median survival
4999997|NCT01634711|ACL|acl
4999907|NCT01635101|Moderate to severe acute pain following surgery or trauma|moderate to severe acute pain following surgery or trauma
4999908|NCT01635088|Asthma|asthma
4999909|NCT01635088|FEV1 and IOS change after mometasone for asthma|fev1 and ios change after mometasone for asthma
4999910|NCT01635075|psychiatric|psychiatric
4999911|NCT01635075|comorbidity|comorbidity
4999912|NCT01635075|craving|craving
4999913|NCT01635075|tobacco|tobacco
4999914|NCT01635049|in vitro fertilization|in vitro fertilization
4999915|NCT01635049|assisted reproduction techniques|assisted reproduction techniques
4999916|NCT01635049|noninvasive imaging of embryos|noninvasive imaging of embryos
4999917|NCT01635049|time lapse imaging of embryos|time lapse imaging of embryos
4999918|NCT01635049|traditional morphological grading of embryos|traditional morphological grading of embryos
4999919|NCT01635049|prediction of blastocysts|prediction of blastocysts
4999920|NCT01635049|infertility|infertility
4999921|NCT01635049|preimplantation genetic diagnosis|preimplantation genetic diagnosis
4999922|NCT01635049|comprehensive chromosome screening|comprehensive chromosome screening
4999923|NCT01635036|in vitro fertilization|in vitro fertilization
4999924|NCT01635036|assisted reproduction techniques|assisted reproduction techniques
4999925|NCT01635036|noninvasive imaging of embryos|noninvasive imaging of embryos
4999926|NCT01635036|time lapse imaging of embryos|time lapse imaging of embryos
4999927|NCT01635036|traditional morphological grading of embryos|traditional morphological grading of embryos
4999928|NCT01635036|prediction of blastocyst formation|prediction of blastocyst formation
4999929|NCT01635036|infertility|infertility
4999930|NCT01635036|male factor female factor|male factor female factor
4999931|NCT01635036|embryo viability|embryo viability
4999932|NCT01635023|Phase I|phase i
4999933|NCT01635023|healthy volunteers|healthy volunteers
4999934|NCT01635023|AZD6244|azd6244
4999935|NCT01635023|pharmacokinetics|pharmacokinetics
4999936|NCT01635023|AUC|auc
4999937|NCT01635023|Cmax|cmax
4999938|NCT01635023|tmax|tmax
4999939|NCT01635023|AUC(0-t)|auc(0-t)
4999940|NCT01635010|obstructive sleep apnea|obstructive sleep apnea
4999941|NCT01635010|inflammation|inflammation
4999942|NCT01635010|oxidative stress|oxidative stress
4999943|NCT01635010|arterial stiffness|arterial stiffness
4999944|NCT01634997|Screening for Type 2 Diabetes|screening for type 2 diabetes
4999945|NCT01634984|expression of CDK5RAP2|expression of cdk5rap2
4999946|NCT01634971|Postoperative pancreatic fistula(POPF);|postoperative pancreatic fistula(popf);
4999947|NCT01634971|Postpancreatectomy hemorrhage(PPH);|postpancreatectomy hemorrhage(pph);
4999948|NCT01634971|Delayed gastric emptying (DGE);|delayed gastric emptying (dge);
4999949|NCT01634971|Bile leakage after pancreatic surgery;|bile leakage after pancreatic surgery;
4999950|NCT01634971|Anastomotic leakage|anastomotic leakage
4999951|NCT01634958|Allergic Rhinitis|allergic rhinitis
4999952|NCT01634958|Hayfever|hayfever
4999953|NCT01634958|Immunotherapy|immunotherapy
4999954|NCT01634958|Dose-Finding-Study|dose-finding-study
4999955|NCT01634945|anemia|anemia
4999956|NCT01634945|malaria|malaria
4999957|NCT01634945|malnutrition|malnutrition
4999958|NCT01634945|iron fortification|iron fortification
4999959|NCT01634945|intermittent preventive treatment|intermittent preventive treatment
4999960|NCT01634945|subsaharan africa|subsaharan africa
4999961|NCT01634945|ivory coast|ivory coast
4999962|NCT01634945|young children|young children
4999963|NCT01634932|Iron deficiency|iron deficiency
4999964|NCT01634932|Biofortification|biofortification
4999965|NCT01634932|Pearl Millet|pearl millet
4999966|NCT01634932|Benin|benin
4999967|NCT01634919|Chronic hepatitis C|chronic hepatitis c
4999968|NCT01634919|Liver fibrosis|liver fibrosis
4999969|NCT01634919|ARFI(Acoustic radiation force impulse)|arfi(acoustic radiation force impulse)
4999970|NCT01634906|Apolipoprotein B, erythrocytes, statins|apolipoprotein b, erythrocytes, statins
4999971|NCT01634893|Refractory or Relapsed Solid Tumors|refractory or relapsed solid tumors
4999972|NCT01634880|Salivary Gland Malignancies|salivary gland malignancies
4999973|NCT01634880|Panitumumab|panitumumab
4999974|NCT01634880|Postoperative|postoperative
4999975|NCT01634880|Radiotherapy|radiotherapy
4999976|NCT01634841|walnuts|walnuts
4999977|NCT01634841|age related cognitive decline|age related cognitive decline
4999978|NCT01634841|age related macular degeneration|age related macular degeneration
4999979|NCT01634841|healthy elderly subjects|healthy elderly subjects
4999980|NCT01634802|Clinical Decision Support Systems|clinical decision support systems
4999981|NCT01634802|Electronic Medical Record|electronic medical record
4999982|NCT01634802|Resource constrained countries|resource constrained countries
4999983|NCT01634802|HIV|hiv
4999984|NCT01634789|bioavailability|bioavailability
4999985|NCT01634763|Phase I, open-label, dose escalation, oral LDK378, Japanese patients with tumors characterized by ALK genetic alterations|phase i, open-label, dose escalation, oral ldk378, japanese patients with tumors characterized by alk genetic alterations
4999986|NCT01634750|N-Acetyl-D-mannosamine (ManNAc)|n-acetyl-d-mannosamine (mannac)
4999987|NCT01634750|HIBM|hibm
4999988|NCT01634750|GNE Myopathy|gne myopathy
4999989|NCT01634737|shellfish|shellfish
4999990|NCT01634737|tropomyosin|tropomyosin
4999991|NCT01634737|mites|mites
4999992|NCT01634737|food allergy|food allergy
4999993|NCT01634724|GnRH agonist withdrawal|gnrh agonist withdrawal
4999994|NCT01634724|OHSS|ohss
4999995|NCT01634724|E2|e2
4999996|NCT01634724|VEGF|vegf
4999998|NCT01634711|Anterior Cruciate Ligament|anterior cruciate ligament
4999999|NCT01634711|Ligament|ligament
5000000|NCT01634711|Resorbable polymer|resorbable polymer
5000001|NCT01634711|Knee ligament|knee ligament
5000002|NCT01634698|chronic liver disease|chronic liver disease
5000003|NCT01634698|cirrhosis|cirrhosis
5000004|NCT01634698|vitamin A|vitamin a
5000005|NCT01634698|RDR test|rdr test
5000006|NCT01634698|retinol-binding protein|retinol-binding protein
5000007|NCT01634685|Rectal cancer|rectal cancer
5000008|NCT01634685|Bavituximab|bavituximab
5000009|NCT01634685|Capecitabine|capecitabine
5000010|NCT01634685|Radiation Therapy|radiation therapy
5000011|NCT01634672|Gastroesophageal Reflux Disease|gastroesophageal reflux disease
5000012|NCT01634672|peritoneal dialysis|peritoneal dialysis
5000013|NCT01634672|hemodialysis|hemodialysis
5000014|NCT01634659|contact lenses|contact lenses
5000015|NCT01634659|myopia|myopia
5000016|NCT01634646|Observational study|observational study
5000017|NCT01634633|Endometrial nerve fibres|endometrial nerve fibres
5000018|NCT01634620|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
5000019|NCT01634620|Chronic Obstructive Airways Disease|chronic obstructive airways disease
5000020|NCT01634620|Chronic Bronchitis|chronic bronchitis
5000021|NCT01634620|Chronic Emphysema|chronic emphysema
5000022|NCT01634620|Asthma|asthma
5000023|NCT01634607|osteopenia|osteopenia
5000024|NCT01634607|vitamin D deficiency|vitamin d deficiency
5000025|NCT01634607|HIV-infected patients|hiv-infected patients
5000026|NCT01634607|bone health|bone health
5000027|NCT01634607|Bone mineral density (BMD)|bone mineral density (bmd)
5000028|NCT01634607|HIV-uninfected patients|hiv-uninfected patients
5000029|NCT01634607|effects of TDF on the patients' bone|effects of tdf on the patients' bone
5000030|NCT01634594|Deliberate hypotension, QTc, Tp-e, heart rate variability|deliberate hypotension, qtc, tp-e, heart rate variability
5000031|NCT01634555|Advanced Malignant Solid Tumors|advanced malignant solid tumors
5000032|NCT01634516|Diet|diet
5000033|NCT01634516|Pregnant|pregnant
5000034|NCT01634503|3+3 design|3+3 design
5000035|NCT01634503|Phase 1|phase 1
5000036|NCT01634503|Cervical Intraepithelial Neoplasia|cervical intraepithelial neoplasia
5000037|NCT01634503|Adult|adult
5000038|NCT01634503|Safety|safety
5000039|NCT01634503|Dose Finding|dose finding
5000040|NCT01634490|cow's milk allergy|cow's milk allergy
5000041|NCT01634490|formulas|formulas
5000042|NCT01634490|probiotics|probiotics
5000043|NCT01634477|morbidity|morbidity
5000044|NCT01634477|mortality|mortality
5000045|NCT01634477|HIV-infected patients|hiv-infected patients
5000046|NCT01634477|prospective cohort study|prospective cohort study
5000047|NCT01634477|highly active antiretroviral therapy (HAART)|highly active antiretroviral therapy (haart)
5000048|NCT01634477|opportunistic infections|opportunistic infections
5000049|NCT01634477|Non HIV-related illness|non hiv-related illness
5000050|NCT01634477|cardiovascular disease (CVD)|cardiovascular disease (cvd)
5000051|NCT01634477|HIV negative patients|hiv negative patients
5000052|NCT01634477|Thai HIV-infected patients|thai hiv-infected patients
5000053|NCT01634451|Sedation|sedation
5000054|NCT01634451|Quality|quality
5000055|NCT01634438|coronary angiography|coronary angiography
5000056|NCT01634425|NSTEMI|nstemi
5000057|NCT01634425|Point of Care Biomarkers|point of care biomarkers
5000058|NCT01634334|Secondhand smoke|secondhand smoke
5000059|NCT01634295|CKD-828|ckd-828
5000060|NCT01634295|Hypertension|hypertension
5000061|NCT01634295|Stage 2 Hypertension|stage 2 hypertension
5000062|NCT01634295|S-Amlodipine|s-amlodipine
5000063|NCT01634295|Telmisartan|telmisartan
5000064|NCT01634269|Valvular Heart Disease|valvular heart disease
5000065|NCT01634269|Severe Aortic Stenosis|severe aortic stenosis
5000066|NCT01634269|Aortic Valve Replacement|aortic valve replacement
5000067|NCT01634243|SPM 962|spm 962
5000068|NCT01634243|rotigotine|rotigotine
5000069|NCT01634243|Parkinson's disease|parkinson's disease
5000070|NCT01634204|weight reduction|weight reduction
5000071|NCT01634204|web-based intervention|web-based intervention
5000072|NCT01634204|cost-effective|cost-effective
5000073|NCT01634204|overweight|overweight
5000074|NCT01634204|obesity|obesity
5000075|NCT01634204|cardiovascular risk|cardiovascular risk
5000076|NCT01634191|Apremilast|apremilast
5000077|NCT01634191|pharmacokinetic|pharmacokinetic
5000078|NCT01634191|safety|safety
5000079|NCT01634191|Pharmacokinetics and safety in healthy volunteer subjects|pharmacokinetics and safety in healthy volunteer subjects
5000080|NCT01634178|Apremilast,|apremilast,
5000081|NCT01634178|pharmacokinetic|pharmacokinetic
5000082|NCT01634178|safety|safety
5000083|NCT01634178|Safety and pharmacokinetics in healthy volunteer subjects|safety and pharmacokinetics in healthy volunteer subjects
5000084|NCT01634126|Colon|colon
5000085|NCT01634126|Rectal|rectal
5000086|NCT01634126|Cancer|cancer
5000087|NCT01634126|Screening|screening
5000089|NCT01634126|Fecal|fecal
5000090|NCT01634061|Castration-resistant prostate cancer, abiraterone acetate, BEZ235, BKM120, dose escalation, abiraterone acetate failure|castration-resistant prostate cancer, abiraterone acetate, bez235, bkm120, dose escalation, abiraterone acetate failure
5000091|NCT01634048|high protein diet|high protein diet
5000092|NCT01634048|meal replacements|meal replacements
5000093|NCT01634048|low calorie diet|low calorie diet
5000094|NCT01634048|intra hepatocellular lipid|intra hepatocellular lipid
5000095|NCT01634035|glycated hemoglobin|glycated hemoglobin
5000096|NCT01634035|mean plasma glucose|mean plasma glucose
5000097|NCT01634022|Acupuncture|acupuncture
5000098|NCT01634022|Antidepressant|antidepressant
5000099|NCT01634022|Monotherapy|monotherapy
5000100|NCT01634022|Depression|depression
5000101|NCT01634022|Alternative treatments|alternative treatments
5000102|NCT01634009|Severe acute malnutrition|severe acute malnutrition
5000103|NCT01634009|Ready to use therapeutic food|ready to use therapeutic food
5000104|NCT01634009|Soy protein|soy protein
5000105|NCT01634009|Community based management|community based management
5000106|NCT01634009|Efficacy|efficacy
5000107|NCT01634009|Management of Children with SAM in Bangladesh|management of children with sam in bangladesh
5000108|NCT01633996|Acupuncture|acupuncture
5000109|NCT01633996|Antidepressant|antidepressant
5000110|NCT01633996|Augmentation|augmentation
5000111|NCT01633996|Depression|depression
5000112|NCT01633983|Central Serous Chorioretinopathy|central serous chorioretinopathy
5000113|NCT01633983|Methotrexate|methotrexate
5000114|NCT01633957|anticoagulation|anticoagulation
5000115|NCT01633957|bleeding|bleeding
5000116|NCT01633957|CYP2C9|cyp2c9
5000117|NCT01633957|CYP4F2|cyp4f2
5000118|NCT01633957|VKORC1|vkorc1
5000119|NCT01633957|warfarin dosing|warfarin dosing
5000120|NCT01633957|Heart Valve Diseases|heart valve diseases
5000121|NCT01633957|pharmacogenomics|pharmacogenomics
5000122|NCT01633944|CLBP|clbp
5000123|NCT01633944|Chronic Low Back Pain|chronic low back pain
5000124|NCT01633944|Chronic Pain|chronic pain
5000125|NCT01633944|Back Pain|back pain
5000126|NCT01633918|intervention|intervention
5000127|NCT01633918|health education|health education
5000128|NCT01633918|physical activity|physical activity
5000129|NCT01633918|sedentary behavior|sedentary behavior
5000130|NCT01633918|health promotion|health promotion
5000131|NCT01633918|evaluation|evaluation
5000132|NCT01633918|RE-AIM|re-aim
5000133|NCT01633905|alcohol-dependence|alcohol-dependence
5000134|NCT01633905|event-related potentials|event-related potentials
5000135|NCT01633905|emotion|emotion
5000136|NCT01633905|crossmodal|crossmodal
5000137|NCT01633905|peripheral processing|peripheral processing
5000138|NCT01633892|Craniomaxillofacial (CMF)|craniomaxillofacial (cmf)
5000139|NCT01633892|Battle-injured (BI)|battle-injured (bi)
5000140|NCT01633892|Facial Trauma|facial trauma
5000141|NCT01633892|Fat Grafts|fat grafts
5000142|NCT01633892|Autogenous Fat Transfers (AFT)|autogenous fat transfers (aft)
5000143|NCT01633892|Wounded warriors|wounded warriors
5000144|NCT01633892|Adipose Tissue|adipose tissue
5000145|NCT01633879|parenting, prevention, HIV/AIDS, adolescents, Latino|parenting, prevention, hiv/aids, adolescents, latino
5000146|NCT01633866|Magnetic Resonance Imaging|magnetic resonance imaging
5000147|NCT01633853|chronic kidney disease mineral and bone disorder|chronic kidney disease mineral and bone disorder
5000148|NCT01633853|vitamin D2|vitamin d2
5000149|NCT01633853|parathyroid hormone|parathyroid hormone
5000150|NCT01633840|double-blind placebo-controlled food challenges|double-blind placebo-controlled food challenges
5000151|NCT01633840|food allergy|food allergy
5000152|NCT01633840|food hypersensitivity|food hypersensitivity
5000153|NCT01633840|triangle test|triangle test
5000154|NCT01633840|validated recipes|validated recipes
5000155|NCT01633814|Physiological Processes|physiological processes
5000156|NCT01633814|Exercise|exercise
5000157|NCT01633814|Hormone replacement therapy|hormone replacement therapy
5000158|NCT01633775|Refractory primary open angle glaucoma|refractory primary open angle glaucoma
5000159|NCT01633775|trabeculectomy|trabeculectomy
5000160|NCT01633775|ahmed valve implant|ahmed valve implant
5000161|NCT01633749|Influenza|influenza
5000162|NCT01633749|Vaccine|vaccine
5000163|NCT01633749|CHMP criteria|chmp criteria
5000164|NCT01633736|single blinded|single blinded
5000165|NCT01633736|randomised|randomised
5000166|NCT01633736|controlled|controlled
5000167|NCT01633736|physiotherapy|physiotherapy
5000168|NCT01633736|children|children
5000169|NCT01633736|cerebral palsy|cerebral palsy
5000170|NCT01633710|Ankle brachial pressure index|ankle brachial pressure index
5000171|NCT01633710|Colour duplex ultrasound|colour duplex ultrasound
5000172|NCT01633710|Diabetes|diabetes
5000173|NCT01633710|Photoplethysmography|photoplethysmography
5000174|NCT01633697|emphysema|emphysema
5000175|NCT01633697|chronic bronchitis|chronic bronchitis
5000176|NCT01633684|diabetes mellitus|diabetes mellitus
5000177|NCT01633684|bone|bone
5000178|NCT01633671|Misadventures to Patients During Surgical and Medical Care|misadventures to patients during surgical and medical care
5000179|NCT01633671|Pulmonary Embolism Without Acute Cor Pulmonale|pulmonary embolism without acute cor pulmonale
5000180|NCT01633671|Pulmonary Embolism Without Mention of Acute Cor Pulmonale|pulmonary embolism without mention of acute cor pulmonale
5000181|NCT01633658|vitamin D|vitamin d
5000182|NCT01633632|Smoking cessation|smoking cessation
5000183|NCT01633632|Yoga|yoga
5000184|NCT01633632|Cognitive behavioral therapy|cognitive behavioral therapy
5000185|NCT01633619|Prosthetic Joint Infection|prosthetic joint infection
5000186|NCT01633606|severity of illness|severity of illness
5000187|NCT01633606|scoring|scoring
5000188|NCT01633606|medium care|medium care
5000189|NCT01633606|intensive care|intensive care
5000190|NCT01633606|staffing|staffing
5000191|NCT01633580|ICSI|icsi
5000192|NCT01633580|GnRH antagonist|gnrh antagonist
5000193|NCT01633580|corifollitropin alfa|corifollitropin alfa
5000194|NCT01633567|Smoking Cessation|smoking cessation
5000195|NCT01633567|Cigarette Smoking|cigarette smoking
5000196|NCT01633567|Tobacco|tobacco
5000197|NCT01633567|LGBT|lgbt
5000198|NCT01633567|LGBTQ|lgbtq
5000199|NCT01633554|ST-2, IL-33, prediction, fibrosis, hepatitis B|st-2, il-33, prediction, fibrosis, hepatitis b
5000200|NCT01633528|low dose aspirin endometrial thickness pregnancy rate ICSI IVF embryo transfer|low dose aspirin endometrial thickness pregnancy rate icsi ivf embryo transfer
5000201|NCT01633515|Basal cell carcinoma (BCC)|basal cell carcinoma (bcc)
5000202|NCT01633515|Cryotherapy|cryotherapy
5000203|NCT01633515|Cryosurgery|cryosurgery
5000204|NCT01633476|CMV|cmv
5000205|NCT01633476|ANCA associated vasculitis|anca associated vasculitis
5000206|NCT01633476|CD4+CD28- T-cells|cd4+cd28- t-cells
5000207|NCT01633476|Valaciclovir|valaciclovir
5000208|NCT01633463|EMERGENCY CANCER PAIN, ASSESSMENT, TREATMENT ADEQUACY.|emergency cancer pain, assessment, treatment adequacy.
5000209|NCT01633437|tyramine|tyramine
5000210|NCT01633437|MAOI|maoi
5000211|NCT01633437|cheese effect|cheese effect
5000212|NCT01633437|depression|depression
5000213|NCT01633398|Heart Failure|heart failure
5000214|NCT01633398|HF|hf
5000215|NCT01633385|bronchial inflammation|bronchial inflammation
5000216|NCT01633385|Bronchiolitis obliterans|bronchiolitis obliterans
5000217|NCT01633385|Sputum|sputum
5000218|NCT01633385|Blood|blood
5000219|NCT01633385|Inflammation|inflammation
5000220|NCT01633385|adaptive immune system|adaptive immune system
5000221|NCT01633385|innate immune system|innate immune system
5000222|NCT01633372|Primary Myelofibrosis|primary myelofibrosis
5000223|NCT01633372|PMF|pmf
5000224|NCT01633372|Post Polycythemia Vera Fibrosis|post polycythemia vera fibrosis
5000225|NCT01633372|PPV-MF|ppv-mf
5000226|NCT01633372|Post Essential Thrombocythemia Myelofibrosis|post essential thrombocythemia myelofibrosis
5000227|NCT01633372|PET-MF|pet-mf
5000228|NCT01633333|Colonoscopy|colonoscopy
5000229|NCT01633333|Colorectal cancer|colorectal cancer
5000230|NCT01633333|Colorectal adenomas|colorectal adenomas
5000231|NCT01633333|Pain|pain
5000232|NCT01633320|Analgesia/Nociception index|analgesia/nociception index
5000233|NCT01633307|education|education
5000234|NCT01633307|intravenous infusion|intravenous infusion
5000235|NCT01633294|premature rupture of membranes|premature rupture of membranes
5000236|NCT01633294|term pregnancy|term pregnancy
5000237|NCT01633294|chorioamnionitis|chorioamnionitis
5000238|NCT01633294|endometritis|endometritis
5000239|NCT01633294|neonatal sepsis|neonatal sepsis
5000240|NCT01633294|antibiotic prophylaxis|antibiotic prophylaxis
5000241|NCT01633281|peripheral neuropathy|peripheral neuropathy
5000242|NCT01633281|acupuncture|acupuncture
5000243|NCT01633281|Bortezomib|bortezomib
5000244|NCT01633281|Thalidomide|thalidomide
5000245|NCT01633268|MRI (Magnetic Resonance Imaging)|mri (magnetic resonance imaging)
5000246|NCT01633268|Traumatic Brain Injury|traumatic brain injury
5000247|NCT01633255|Anti-Angiogenic|anti-angiogenic
5000248|NCT01633255|Dynamic Contrast Enhanced Magnetic Resonance Imaging|dynamic contrast enhanced magnetic resonance imaging
5000249|NCT01633255|PET/CT Imaging Studies|pet/ct imaging studies
5000250|NCT01633242|MRI|mri
5000251|NCT01633242|Muscular Dystrophy|muscular dystrophy
5000252|NCT01633242|Cardiac|cardiac
5000253|NCT01633242|Myocardium|myocardium
5000254|NCT01633242|Intramyocardial fat|intramyocardial fat
5000255|NCT01633229|Immune Suppression|immune suppression
5000256|NCT01633229|BMSC|bmsc
5000257|NCT01633229|GVHD|gvhd
5000258|NCT01633229|Marrow Failure|marrow failure
5000259|NCT01633229|Regimen Related Toxicity|regimen related toxicity
5000260|NCT01633229|Graft-Versus-Host Disease|graft-versus-host disease
5000261|NCT01633216|poliovirus,|poliovirus,
5000262|NCT01633216|trivalent oral polio vaccine,|trivalent oral polio vaccine,
5000263|NCT01633216|bivalent oral polio vaccine,|bivalent oral polio vaccine,
5000264|NCT01633216|monovalent oral polio vaccine|monovalent oral polio vaccine
5000265|NCT01633203|gastric cancer|gastric cancer
5000266|NCT01633203|combination chemotherapy|combination chemotherapy
5000267|NCT01633203|HER-2 gene|her-2 gene
5000268|NCT01633203|quality of life|quality of life
5000269|NCT01633190|Surveillance|surveillance
5000270|NCT01633190|Rotavirus|rotavirus
5000271|NCT01633190|Gastroenteritis|gastroenteritis
5000272|NCT01633177|vitamin D|vitamin d
5000273|NCT01633177|omega-3 fatty acids|omega-3 fatty acids
5000274|NCT01633177|Type 2 diabetes|type 2 diabetes
5000275|NCT01633177|Oral glucose tolerance test (OGTT)|oral glucose tolerance test (ogtt)
5000276|NCT01633177|Insulin sensitivity|insulin sensitivity
5000277|NCT01633177|Beta-cell function|beta-cell function
5000278|NCT01633164|Spinal Cord Injury|spinal cord injury
5000279|NCT01633164|Self-Efficacy|self-efficacy
5000280|NCT01633164|Life Satisfaction|life satisfaction
5000281|NCT01633164|Community Participation|community participation
5000282|NCT01633138|cognitive remediation therapy|cognitive remediation therapy
5000283|NCT01633138|substance abuse treatment|substance abuse treatment
5000284|NCT01633125|Group music therapy|group music therapy
5000285|NCT01633125|prisoners|prisoners
5000286|NCT01633125|Anxiety|anxiety
5000287|NCT01633125|Depression|depression
5000288|NCT01633125|Self-esteem|self-esteem
5000289|NCT01633099|decitabine|decitabine
5000290|NCT01633099|acute myeloid leukemia|acute myeloid leukemia
5000291|NCT01633099|elderly patient|elderly patient
5000292|NCT01633060|BKM120|bkm120
5000293|NCT01633060|fulvestrant|fulvestrant
5000294|NCT01633060|breast cancer|breast cancer
5000295|NCT01633060|metastatic|metastatic
5000296|NCT01633060|locally advanced|locally advanced
5000297|NCT01633060|AI treated|ai treated
5000298|NCT01633060|mTOR inhibitor|mtor inhibitor
5000299|NCT01633060|PI3K|pi3k
5000300|NCT01633060|PIK3CA|pik3ca
5000301|NCT01633060|PTEN|pten
5000302|NCT01633060|HER2-|her2-
5000303|NCT01633060|HR+|hr+
5000304|NCT01633047|Anterior Cruciate Ligament|anterior cruciate ligament
5000305|NCT01633047|Electric Stimulation Therapy|electric stimulation therapy
5000306|NCT01633034|intervertebral disc degeneration|intervertebral disc degeneration
5000307|NCT01633034|back pain|back pain
5000308|NCT01633034|spine surgery|spine surgery
5000309|NCT01633021|Support|support
5000310|NCT01633021|Cancer|cancer
5000311|NCT01633021|Network|network
5000312|NCT01633021|Sickle Cell Disease|sickle cell disease
5000313|NCT01633021|Sickle Trait|sickle trait
5000314|NCT01633021|Diabetes|diabetes
5000315|NCT01633008|Modified Brief Pain Inventory|modified brief pain inventory
5000316|NCT01633008|Quality of Life|quality of life
5000317|NCT01633008|Pain-Related Coping|pain-related coping
5000318|NCT01633008|Pain-Related Anxiety|pain-related anxiety
5000319|NCT01633008|Depression|depression
5000320|NCT01632982|opioid abuse|opioid abuse
5000321|NCT01632982|substance abuse|substance abuse
5000322|NCT01632982|methadone maintenance treatment|methadone maintenance treatment
5000323|NCT01632982|mobile technology|mobile technology
5000324|NCT01632982|technology-based intervention|technology-based intervention
5000325|NCT01632982|behavioral intervention|behavioral intervention
5000326|NCT01632982|psychosocial treatment|psychosocial treatment
5000327|NCT01632969|12-136|12-136
5000328|NCT01632956|Support Groups|support groups
5000329|NCT01632956|Breast cancer|breast cancer
5000330|NCT01632956|Mandarin speaking|mandarin speaking
5000331|NCT01632956|12-105|12-105
5000332|NCT01632943|Uncontrolled Hypertension|uncontrolled hypertension
5000333|NCT01632930|diagnosis|diagnosis
5000334|NCT01632930|prostate cancer|prostate cancer
5000335|NCT01632930|urine|urine
5000336|NCT01632930|medical economics|medical economics
5000337|NCT01632917|Healthy volunteers|healthy volunteers
5000338|NCT01632904|Polycythemia Vera|polycythemia vera
5000339|NCT01632904|PV|pv
5000340|NCT01632878|Secondary prevention post MI|secondary prevention post mi
5000341|NCT01632865|occlusion|occlusion
5000342|NCT01632865|recanalization|recanalization
5000343|NCT01632865|stenting|stenting
5000344|NCT01632839|PISQ-R|pisq-r
5000345|NCT01632839|new sexuality questionnaire|new sexuality questionnaire
5000346|NCT01632826|Relapsed|relapsed
5000347|NCT01632826|refractory multiple myeloma|refractory multiple myeloma
5000348|NCT01632826|pomalidomide|pomalidomide
5000349|NCT01632813|neurocognitive testing|neurocognitive testing
5000350|NCT01632813|critical illness|critical illness
5000351|NCT01632813|executive function|executive function
5000352|NCT01632813|intelligence|intelligence
5000353|NCT01632800|Magnetic fields discomfort|magnetic fields discomfort
5000354|NCT01632787|Anxiety|anxiety
5000355|NCT01632787|Binocular|binocular
5000356|NCT01632787|Chronic Headache|chronic headache
5000357|NCT01632787|Dizziness|dizziness
5000358|NCT01632787|Vertical Heterophoria|vertical heterophoria
5000359|NCT01632787|Vision Dysfunction|vision dysfunction
5000360|NCT01632761|anemia|anemia
5000361|NCT01632761|vitamin D3|vitamin d3
5000362|NCT01632761|omega-3 fatty acids|omega-3 fatty acids
5000363|NCT01632761|fish oil|fish oil
5000364|NCT01632761|primary prevention|primary prevention
5000365|NCT01632735|Continuing Care|continuing care
5000366|NCT01632735|Youth Substance Abuse|youth substance abuse
5000367|NCT01632735|Recovery Support|recovery support
5000368|NCT01632735|Mobile Texting|mobile texting
5000369|NCT01632722|colorectal cancer, liver metastasis, bevacizumab, perioperative/postoperative chemotherapy|colorectal cancer, liver metastasis, bevacizumab, perioperative/postoperative chemotherapy
5000370|NCT01632696|Antibodies, Monoclonal|antibodies, monoclonal
5000371|NCT01632696|Biologics|biologics
5000372|NCT01632696|F(ab')2|f(ab')2
5000373|NCT01632696|Positron-emission tomography (PET)|positron-emission tomography (pet)
5000374|NCT01632696|Phosphatidylserine (PS)|phosphatidylserine (ps)
5000375|NCT01632696|Solid Tumors|solid tumors
5000376|NCT01632696|Tumor Imaging|tumor imaging
5000377|NCT01632683|difficult airway|difficult airway
5000378|NCT01632683|video laryngoscopy|video laryngoscopy
5000379|NCT01632670|music|music
5000380|NCT01632670|cardiac catheterization|cardiac catheterization
5000381|NCT01632670|endothelial function|endothelial function
5000382|NCT01632631|suitable for endovascular exclusion|suitable for endovascular exclusion
5000383|NCT01632605|ADPKD|adpkd
5000508|NCT01632046|peritoneal dialysis|peritoneal dialysis
5000384|NCT01632605|Autosomal dominant polycystic kidney disease|autosomal dominant polycystic kidney disease
5000385|NCT01632605|Sirolimus|sirolimus
5000386|NCT01632605|Rapamune|rapamune
5000387|NCT01632605|Polycystic liver disease|polycystic liver disease
5000388|NCT01632605|Rapamycin|rapamycin
5000389|NCT01632605|Mammalian target of rapamycin|mammalian target of rapamycin
5000391|NCT01632605|m-TOR inhibition|m-tor inhibition
5000392|NCT01632553|Observation|observation
5000393|NCT01632553|Domestic Violence|domestic violence
5000394|NCT01632553|Partner Abuse|partner abuse
5000395|NCT01632553|Spousal Abuse|spousal abuse
5000396|NCT01632553|Battered Women|battered women
5000397|NCT01632553|Abused Women|abused women
5000398|NCT01632553|Cortisol|cortisol
5000399|NCT01632553|Mental Health|mental health
5000400|NCT01632553|Depression|depression
5000401|NCT01632553|Anxiety|anxiety
5000402|NCT01632553|Posttraumatic Stress Disorders|posttraumatic stress disorders
5000403|NCT01632527|Age-Related Macular Degeneration|age-related macular degeneration
5000404|NCT01632527|Dry AMD with GA|dry amd with ga
5000405|NCT01632527|Geographic Atrophy of Age-Related Macular Degeneration|geographic atrophy of age-related macular degeneration
5000406|NCT01632527|Stem Cell Transplantation|stem cell transplantation
5000407|NCT01632527|Stem Cell transplant|stem cell transplant
5000408|NCT01632527|Stem cells for AMD|stem cells for amd
5000409|NCT01632527|Human neural stem cells|human neural stem cells
5000410|NCT01632527|multipotent stem cells|multipotent stem cells
5000411|NCT01632527|Macular Degeneration|macular degeneration
5000412|NCT01632527|Dry AMD|dry amd
5000413|NCT01632527|Human central nervous system stemcells|human central nervous system stemcells
5000414|NCT01632527|dry age-related macular degeneration|dry age-related macular degeneration
5000415|NCT01632514|hypocalcemia|hypocalcemia
5000416|NCT01632514|vitamin D deficiency|vitamin d deficiency
5000417|NCT01632514|cholecalciferol|cholecalciferol
5000418|NCT01632514|thyroidectomy|thyroidectomy
5000419|NCT01632488|Irritable Bowel Syndrome|irritable bowel syndrome
5000420|NCT01632488|Inflammatory Bowel Disease|inflammatory bowel disease
5000421|NCT01632488|Confocal Laser Endomicroscopy|confocal laser endomicroscopy
5000422|NCT01632475|Human umbilical cord blood-derived mesenchymal stem cells|human umbilical cord blood-derived mesenchymal stem cells
5000423|NCT01632475|Premature infants|premature infants
5000424|NCT01632475|Bronchopulmonary dysplasia|bronchopulmonary dysplasia
5000425|NCT01632475|Lung injury|lung injury
5000426|NCT01632475|Lung diseases|lung diseases
5000427|NCT01632475|Hyperplasia|hyperplasia
5000428|NCT01632475|Ventilator-induced lung injury|ventilator-induced lung injury
5000429|NCT01632475|Respiratory lung diseases|respiratory lung diseases
5000430|NCT01632475|Pathologic Processes|pathologic processes
5000431|NCT01632475|Infant, Premature, Diseases|infant, premature, diseases
5000432|NCT01632475|Infant, Newborn, Diseases|infant, newborn, diseases
5000433|NCT01632462|Crohn's disease|crohn's disease
5000434|NCT01632462|VSL#3|vsl#3
5000435|NCT01632462|probiotics|probiotics
5000436|NCT01632462|metabolic profile|metabolic profile
5000437|NCT01632449|bioequivalence|bioequivalence
5000438|NCT01632436|Hepatic impairment|hepatic impairment
5000439|NCT01632436|Metastatic Cancer|metastatic cancer
5000440|NCT01632410|autonomic nerve system|autonomic nerve system
5000441|NCT01632410|post stroke|post stroke
5000442|NCT01632410|focus of study: to describe the autonomic nerve system function post stroke|focus of study: to describe the autonomic nerve system function post stroke
5000443|NCT01632410|autonomic nervous system|autonomic nervous system
5000444|NCT01632397|PrEP|prep
5000445|NCT01632397|HIV|hiv
5000446|NCT01632397|Adherence|adherence
5000447|NCT01632397|MSM|msm
5000448|NCT01632397|Men having sex with men|men having sex with men
5000449|NCT01632384|Smoker|smoker
5000450|NCT01632384|Non-Smoker|non-smoker
5000451|NCT01632384|Healthy|healthy
5000452|NCT01632384|Drug free|drug free
5000453|NCT01632384|MRI|mri
5000454|NCT01632371|In-stent Restenosis|in-stent restenosis
5000455|NCT01632371|Drug Eluting Stent|drug eluting stent
5000456|NCT01632371|Paclitaxel Coated Balloon|paclitaxel coated balloon
5000457|NCT01632371|Scoring Balloon|scoring balloon
5000458|NCT01632371|Cutting Balloon|cutting balloon
5000459|NCT01632371|Angiographic follow-up|angiographic follow-up
5000460|NCT01632371|Optical coherence tomography (OCT)|optical coherence tomography (oct)
5000461|NCT01632358|safety|safety
5000462|NCT01632358|tolerability|tolerability
5000463|NCT01632358|pharmacokinetics|pharmacokinetics
5000464|NCT01632280|Obesity|obesity
5000465|NCT01632280|Gastric Banding|gastric banding
5000466|NCT01632280|Transcranial Direct Current Stimulation|transcranial direct current stimulation
5000467|NCT01632241|Systemic Lupus Erythematosus|systemic lupus erythematosus
5000468|NCT01632241|African Continental Ancestry Group|african continental ancestry group
5000469|NCT01632241|Autoimmune Disease|autoimmune disease
5000470|NCT01632241|Antibodies|antibodies
5000471|NCT01632241|Minority Groups|minority groups
5000472|NCT01632241|Black Race|black race
5000473|NCT01632241|African Americans|african americans
5000474|NCT01632241|SLE|sle
5000475|NCT01632241|Belimumab|belimumab
5000476|NCT01632241|Lupus|lupus
5000477|NCT01632215|gabapentine|gabapentine
5000478|NCT01632215|postoperative pain|postoperative pain
5000479|NCT01632202|submucosal myomas|submucosal myomas
5000480|NCT01632202|intrauterine adhesions|intrauterine adhesions
5000481|NCT01632202|hysteroscopic myomectomy|hysteroscopic myomectomy
5000482|NCT01632202|seprafilm|seprafilm
5000483|NCT01632189|Varenicline|varenicline
5000484|NCT01632189|PET imaging|pet imaging
5000485|NCT01632189|[11C]-(+)-PHNO PET|[11c]-(+)-phno pet
5000486|NCT01632189|neuroimaging in smokers|neuroimaging in smokers
5000487|NCT01632176|dating abuse|dating abuse
5000488|NCT01632176|dating violence|dating violence
5000489|NCT01632176|domestic violence|domestic violence
5000490|NCT01632176|sexual violence|sexual violence
5000491|NCT01632176|sexual assault|sexual assault
5000492|NCT01632176|youth violence|youth violence
5000493|NCT01632176|underage alcohol use|underage alcohol use
5000494|NCT01632176|alcohol use|alcohol use
5000495|NCT01632098|psychosocial|psychosocial
5000496|NCT01632098|healthcare|healthcare
5000497|NCT01632098|co-morbidities|co-morbidities
5000498|NCT01632098|extremely obese adolescents|extremely obese adolescents
5000499|NCT01632059|ADMA|adma
5000500|NCT01632059|DDAH II|ddah ii
5000501|NCT01632059|SAPS|saps
5000502|NCT01632059|SOFA|sofa
5000503|NCT01632059|Sepsis|sepsis
5000504|NCT01632059|Procalcitonin|procalcitonin
5000505|NCT01632059|ICU|icu
5000506|NCT01632059|mortality|mortality
5000507|NCT01632059|length of stay|length of stay
5000509|NCT01632046|bicarbonate/lactate buffer|bicarbonate/lactate buffer
5000510|NCT01632046|peritoneal transport capacity|peritoneal transport capacity
5000511|NCT01632046|ultrafiltration|ultrafiltration
5000512|NCT01632046|children|children
5000513|NCT01632033|Peripheral artery disease|peripheral artery disease
5000514|NCT01632033|claudication|claudication
5000515|NCT01632033|walking|walking
5000516|NCT01632033|questionnaire|questionnaire
5000517|NCT01632020|colorectal tumor|colorectal tumor
5000518|NCT01632020|colorectal cancer|colorectal cancer
5000519|NCT01632020|colorectal carcinoma|colorectal carcinoma
5000520|NCT01632020|neoplasms, colorectal|neoplasms, colorectal
5000521|NCT01632020|Metformin|metformin
5000522|NCT01631994|metoclopramide video capsule endoscopy gastric transit time|metoclopramide video capsule endoscopy gastric transit time
5000523|NCT01631955|Acute cystitis|acute cystitis
5000524|NCT01631955|Antibiotics|antibiotics
5000525|NCT01631955|Quality of life|quality of life
5000526|NCT01631929|Diabetes|diabetes
5000527|NCT01631929|Ketoacidosis|ketoacidosis
5000528|NCT01631929|Children|children
5000529|NCT01631916|community-acquired pneumonia|community-acquired pneumonia
5000530|NCT01631916|children|children
5000531|NCT01631916|respiratory infections|respiratory infections
5000532|NCT01631864|Hypertension, obesity, insulin sensitivity, lipolysis, LCZ696|hypertension, obesity, insulin sensitivity, lipolysis, lcz696
5000533|NCT01631851|Autism|autism
5000534|NCT01631851|Irritability|irritability
5000535|NCT01631851|Disruptive Behavior|disruptive behavior
5000536|NCT01631851|Aggression|aggression
5000537|NCT01631851|Behavior Therapy|behavior therapy
5000538|NCT01631851|Cognitive Behavioral Therapy|cognitive behavioral therapy
5000539|NCT01631838|Tocotrienols|tocotrienols
5000540|NCT01631838|Platelet aggregation|platelet aggregation
5000541|NCT01631838|Metabolic syndrome|metabolic syndrome
5000542|NCT01631838|Platelet activation|platelet activation
5000543|NCT01631838|Thrombosis|thrombosis
5000544|NCT01631825|SPM 962|spm 962
5000545|NCT01631825|rotigotine|rotigotine
5000546|NCT01631825|Parkinson's disease|parkinson's disease
5000547|NCT01631825|concomitant use of L-dopa|concomitant use of l-dopa
5000548|NCT01631812|SPM 962|spm 962
5000549|NCT01631812|rotigotine|rotigotine
5000550|NCT01631812|Parkinson's disease|parkinson's disease
5000551|NCT01631812|concomitant use of L-dopa|concomitant use of l-dopa
5000552|NCT01631799|epidural anesthesia|epidural anesthesia
5000553|NCT01631799|femoral block|femoral block
5000554|NCT01631799|patient control analgesia|patient control analgesia
5000555|NCT01631786|Ovaries|ovaries
5000556|NCT01631786|Imaging|imaging
5000557|NCT01631786|Ultrasonography|ultrasonography
5000558|NCT01631786|Synchrotron|synchrotron
5000559|NCT01631786|Histology|histology
5000560|NCT01631773|Aspirin-exacerbated respiratory disease|aspirin-exacerbated respiratory disease
5000561|NCT01631773|Nasal polyp|nasal polyp
5000562|NCT01631760|Asthma|asthma
5000563|NCT01631760|Asthma Exacerbations|asthma exacerbations
5000564|NCT01631747|Pregnancy|pregnancy
5000565|NCT01631747|Weight gain|weight gain
5000566|NCT01631747|Obesity|obesity
5000567|NCT01631747|Pregnancy and weight gain|pregnancy and weight gain
5000568|NCT01631721|adolescent couple decision-making|adolescent couple decision-making
5000569|NCT01631721|parenting practices|parenting practices
5000570|NCT01631721|sexual risk behavior|sexual risk behavior
5000571|NCT01631708|Hereditary haemochromatosis|hereditary haemochromatosis
5000572|NCT01631708|Moderate iron overload|moderate iron overload
5000573|NCT01631708|Serum ferritin|serum ferritin
5000574|NCT01631708|Treatment|treatment
5000575|NCT01631682|Posttraumatic Stress Disorder|posttraumatic stress disorder
5000576|NCT01631682|PTSD|ptsd
5000577|NCT01631682|Anxiety|anxiety
5000578|NCT01631682|Fear of spiders|fear of spiders
5000579|NCT01631682|Reconsolidation|reconsolidation
5000580|NCT01631682|Reconsolidation blockade|reconsolidation blockade
5000581|NCT01631669|Ossification|ossification
5000582|NCT01631669|Heterotopic Ossification|heterotopic ossification
5000583|NCT01631656|Rosacea, Laser, Finacea Gel, Azelaic Acid,|rosacea, laser, finacea gel, azelaic acid,
5000584|NCT01631643|Blood glucose monitor|blood glucose monitor
5000585|NCT01631643|Pattern management|pattern management
5000586|NCT01631643|Pattern guide|pattern guide
5000587|NCT01631643|Education|education
5000588|NCT01631630|Alcohol|alcohol
5000589|NCT01631630|Alcohol Dependence|alcohol dependence
5000590|NCT01631630|Alcohol Use|alcohol use
5000591|NCT01631630|Nicotine Dependence|nicotine dependence
5000592|NCT01631630|Nicotine|nicotine
5000593|NCT01631617|Investigator-Blinded|investigator-blinded
5000594|NCT01631617|Skin Biopsy|skin biopsy
5000595|NCT01631617|Randomized|randomized
5000596|NCT01631617|Antibiotics|antibiotics
5000597|NCT01631617|Topical|topical
5000598|NCT01631604|risk of falling|risk of falling
5000599|NCT01631604|gait patterns|gait patterns
5000600|NCT01631604|muscle activity|muscle activity
5000601|NCT01631604|fall prevention|fall prevention
5000602|NCT01631604|motor impairment|motor impairment
5000603|NCT01631578|mitochondrial injection|mitochondrial injection
5000604|NCT01631565|Palliative Care|palliative care
5000605|NCT01631565|Survival|survival
5000606|NCT01631565|Quality of life|quality of life
5000607|NCT01631552|Colorectal (CRC)|colorectal (crc)
5000608|NCT01631552|Gastric adenocarcinoma (GC)|gastric adenocarcinoma (gc)
5000609|NCT01631552|Esophageal cancer (EC)|esophageal cancer (ec)
5000610|NCT01631552|Hepatocellular carcinoma (HCC)|hepatocellular carcinoma (hcc)
5000611|NCT01631552|Non-small cell lung cancer (NSCLC)|non-small cell lung cancer (nsclc)
5000612|NCT01631552|Small cell lung cancer (SCLC)|small cell lung cancer (sclc)
5000613|NCT01631552|Ovarian epithelial cancer (OEC)|ovarian epithelial cancer (oec)
5000614|NCT01631552|Triple-negative breast cancer (TNBC)|triple-negative breast cancer (tnbc)
5000615|NCT01631552|Hormone-refractory prostate cancer (HRPC)|hormone-refractory prostate cancer (hrpc)
5000616|NCT01631552|Pancreatic ductal adenocarcinoma (PDC)|pancreatic ductal adenocarcinoma (pdc)
5000617|NCT01631552|Head and neck cancers- squamous cell (SCCHN)|head and neck cancers- squamous cell (scchn)
5000618|NCT01631552|Renal cell cancer -clear cell (RCC)|renal cell cancer -clear cell (rcc)
5000619|NCT01631552|Bladder cancer|bladder cancer
5000620|NCT01631552|Endometrial Cancer|endometrial cancer
5000621|NCT01631552|Cervical Cancer|cervical cancer
5000622|NCT01631552|Breast cancer|breast cancer
5000623|NCT01631552|Metastatic non-triple negative breast cancer|metastatic non-triple negative breast cancer
5000624|NCT01631552|Glioblastoma multiforme|glioblastoma multiforme
5000625|NCT01631552|Follicular thyroid cancer|follicular thyroid cancer
5000626|NCT01631539|chemoembolization|chemoembolization
5000627|NCT01631539|DC Bead™|dc bead™
5000628|NCT01631539|Irinotecan|irinotecan
5000629|NCT01631539|Cetuximab|cetuximab
5000630|NCT01631539|5FU/LV|5fu/lv
5000631|NCT01631539|KRAS|kras
5000632|NCT01631539|metastatic colorectal cancer|metastatic colorectal cancer
5000633|NCT01631526|Lung cancer|lung cancer
5000634|NCT01631526|vitamin D|vitamin d
5000635|NCT01631526|pharmacokinetics|pharmacokinetics
5000636|NCT01631513|Chronic Low Back Pain|chronic low back pain
5000637|NCT01631513|Osteoarthritis Pain In The Hip or Knee|osteoarthritis pain in the hip or knee
5000638|NCT01631513|Oxycodone|oxycodone
5000639|NCT01631513|Morphine, Hydrocodone|morphine, hydrocodone
5000640|NCT01631513|Tapentadol|tapentadol
5000641|NCT01631513|NUCYNTA ER|nucynta er
5000642|NCT01631500|Integrative medicine|integrative medicine
5000643|NCT01631500|Acupuncture|acupuncture
5000644|NCT01631500|Minor mental health problems|minor mental health problems
5000645|NCT01631500|Medically unexplained symptoms|medically unexplained symptoms
5000646|NCT01631500|Minor mental health problems (e.g. minor depression and anxiety) and Medically unexplained symptoms (e.g. IBS, fibromyalgia, etc)|minor mental health problems (e.g. minor depression and anxiety) and medically unexplained symptoms (e.g. ibs, fibromyalgia, etc)
5000647|NCT01631487|Healthy|healthy
5000648|NCT01631487|JNJ-39439335|jnj-39439335
5000649|NCT01631487|Japanese|japanese
5000650|NCT01631487|Caucasian|caucasian
5000651|NCT01631487|Male|male
5000652|NCT01631474|Intrepid|intrepid
5000653|NCT01631474|acne|acne
5000654|NCT01631474|antiandrogen|antiandrogen
5000655|NCT01631461|pain|pain
5000656|NCT01631461|breast feeding|breast feeding
5000657|NCT01631461|yeast|yeast
5000658|NCT01631461|candida albicance|candida albicance
5000659|NCT01631461|staphylococcus aureus|staphylococcus aureus
5000660|NCT01631461|Signs and symptoms|signs and symptoms
5000661|NCT01631448|Fibrin sealant|fibrin sealant
5000662|NCT01631448|renal transplantation|renal transplantation
5000663|NCT01631448|surgical complication|surgical complication
5000664|NCT01631435|All subjects will have evidence of active symptoms associated with Crohn's disease|all subjects will have evidence of active symptoms associated with crohn's disease
5000665|NCT01631409|clinical research|clinical research
5000666|NCT01631409|coronary heart disease|coronary heart disease
5000667|NCT01631409|cardiac shock wave therapy|cardiac shock wave therapy
5000668|NCT01631409|ischemic heart disease|ischemic heart disease
5000669|NCT01631409|myocardial revascularization|myocardial revascularization
5000670|NCT01631409|observational research|observational research
5000671|NCT01631409|prospective research|prospective research
5000672|NCT01631396|Morbid obesity|morbid obesity
5000673|NCT01631396|Bariatric Surgery|bariatric surgery
5000674|NCT01631396|Neuromuscular block reversal|neuromuscular block reversal
5000675|NCT01631383|Cocaine Use|cocaine use
5000676|NCT01631305|Euthyroid Sick Syndromes|euthyroid sick syndromes
5000677|NCT01631305|Thyroxine|thyroxine
5000678|NCT01631305|Intensive care|intensive care
5000679|NCT01631279|NSCLC|nsclc
5000680|NCT01631279|non-small cell lung cancer|non-small cell lung cancer
5000681|NCT01631279|non-squamous, non-small cell lung cancer|non-squamous, non-small cell lung cancer
5000682|NCT01631279|solid tumors|solid tumors
5000683|NCT01631279|lung cancer|lung cancer
5000684|NCT01631240|Sodium|sodium
5000685|NCT01631240|Potassium|potassium
5000686|NCT01631240|Iodine|iodine
5000687|NCT01631240|Creatinine|creatinine
5000688|NCT01631214|Osteoporosis, Osteoporosis-postmenopausal, Bone Diseases-Metabolic, Bone Diseases, Musculoskeletal Diseases|osteoporosis, osteoporosis-postmenopausal, bone diseases-metabolic, bone diseases, musculoskeletal diseases
5000689|NCT01631201|Chlamydia|chlamydia
5000690|NCT01631188|Minimally Invasive Surgery|minimally invasive surgery
5000691|NCT01631188|Port Access Surgery|port access surgery
5000692|NCT01631188|Heart|heart
5000693|NCT01631188|Pacing|pacing
5000694|NCT01631188|Wire|wire
5000695|NCT01631188|MICS|mics
5000696|NCT01631188|Cardiac Bypass|cardiac bypass
5000697|NCT01631188|Epicardial pacing|epicardial pacing
5000698|NCT01631188|pacing catheter|pacing catheter
5000699|NCT01631188|pacing wire|pacing wire
5000700|NCT01631188|pacing swan|pacing swan
5000701|NCT01631188|pacing pulmonary catheter|pacing pulmonary catheter
5000702|NCT01631188|Pulmonary Endovent|pulmonary endovent
5000703|NCT01631188|Catheter|catheter
5000704|NCT01631188|Aortic Valve Surgery|aortic valve surgery
5000705|NCT01631188|Edwards Lifesciences|edwards lifesciences
5000706|NCT01631175|sarcoma|sarcoma
5000707|NCT01631175|distress|distress
5000708|NCT01631175|tumor|tumor
5000709|NCT01631175|quality of life|quality of life
5000710|NCT01631175|cancer|cancer
5000711|NCT01631162|Asthma|asthma
5000712|NCT01631162|COPD|copd
5000713|NCT01631149|urology|urology
5000714|NCT01631149|muscle relaxation|muscle relaxation
5000715|NCT01631149|laparoscopy|laparoscopy
5000716|NCT01631149|anesthesia|anesthesia
5000717|NCT01631149|rocuronium|rocuronium
5000718|NCT01631136|Non Small Cell Lung Cancer|non small cell lung cancer
5000719|NCT01631136|IFCT|ifct
5000720|NCT01631136|Maintenance|maintenance
5000721|NCT01631136|Switch|switch
5000722|NCT01631123|Twins|twins
5000723|NCT01631123|High carbohydrat diet|high carbohydrat diet
5000724|NCT01631123|High fat diet|high fat diet
5000725|NCT01631123|Isocaloric|isocaloric
5000726|NCT01631123|Nutrigenomics|nutrigenomics
5000727|NCT01631110|Influenza|influenza
5000728|NCT01631110|Virus|virus
5000729|NCT01631110|Vaccination|vaccination
5000730|NCT01631110|Inflexal V|inflexal v
5000731|NCT01631084|Diabetes|diabetes
5000732|NCT01631084|Structured care|structured care
5000733|NCT01631071|Influenza|influenza
5000734|NCT01631071|Virus|virus
5000735|NCT01631071|Vaccination|vaccination
5000736|NCT01631071|Virosomal influenza vaccine|virosomal influenza vaccine
5000737|NCT01631058|kidney transplantation|kidney transplantation
5000738|NCT01631058|chronic renal failure|chronic renal failure
5000739|NCT01631058|immunosuppressive therapy|immunosuppressive therapy
5000740|NCT01631058|elderly|elderly
5000741|NCT01631058|pharmacokinetic|pharmacokinetic
5000742|NCT01631058|tacrolimus|tacrolimus
5000743|NCT01631058|everolimus|everolimus
5000744|NCT01631058|mycophenolate sodium|mycophenolate sodium
5000745|NCT01631058|serious adverse events|serious adverse events
5000746|NCT01631058|biopsy|biopsy
5000747|NCT01631058|Cystatin C|cystatin c
5000748|NCT01631058|metabolic effects|metabolic effects
5000749|NCT01631058|Left Ventricular Mass (LVM)|left ventricular mass (lvm)
5000750|NCT01631058|Left Ventricle Ejection Fraction|left ventricle ejection fraction
5000751|NCT01631045|Obesity|obesity
5000752|NCT01631032|Allergic rhinitis|allergic rhinitis
5000753|NCT01631032|Chinese herbal products|chinese herbal products
5000754|NCT01631032|Qi deficiency|qi deficiency
5000755|NCT01631019|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5000756|NCT01631019|Pulmonary Rehabilitation|pulmonary rehabilitation
5000757|NCT01631019|Mobile phone|mobile phone
5000758|NCT01631019|Biomarker|biomarker
5000759|NCT01631006|CPAP|cpap
5000760|NCT01631006|Hypertrophic cardiomyopathy|hypertrophic cardiomyopathy
5000761|NCT01631006|Blood Pressure|blood pressure
5000762|NCT01631006|The focus of the present study is to evaluate the acute hemodynamic effects of CPAP in patients with non-obstructive and obstructive hypertrophic cardiomyopathy|the focus of the present study is to evaluate the acute hemodynamic effects of cpap in patients with non-obstructive and obstructive hypertrophic cardiomyopathy
5000763|NCT01630993|umbilical cord milking|umbilical cord milking
5000764|NCT01630993|umbilical cord stripping|umbilical cord stripping
5000765|NCT01630993|umbilical cord clamping|umbilical cord clamping
5000766|NCT01630993|placental transfusion|placental transfusion
5000767|NCT01630993|placental residual blood volume|placental residual blood volume
5000768|NCT01630980|Systematic review and meta-analysis|systematic review and meta-analysis
5000769|NCT01630980|Evidence-based medicine (EBM)|evidence-based medicine (ebm)
5000770|NCT01630980|Evidence-based nutrition (EBN)|evidence-based nutrition (ebn)
5000771|NCT01630980|Clinical practice guidelines|clinical practice guidelines
5000772|NCT01630980|Clinical trials|clinical trials
5000773|NCT01630980|Tree nuts|tree nuts
5000774|NCT01630980|Cardiometabolic risk factors|cardiometabolic risk factors
5000775|NCT01630980|Triglycerides|triglycerides
5000776|NCT01630980|Cholesterol|cholesterol
5000777|NCT01630980|Glycemic control|glycemic control
5000778|NCT01630980|Insulin resistance|insulin resistance
5000779|NCT01630980|Body weight|body weight
5000780|NCT01630980|Blood pressure|blood pressure
5000781|NCT01630967|castrate resistance|castrate resistance
5000782|NCT01630967|PSA progression|psa progression
5000783|NCT01630967|LHRH antagonism|lhrh antagonism
5000784|NCT01630954|Hydatidiform mole|hydatidiform mole
5000785|NCT01630954|Molar pregnancy|molar pregnancy
5000786|NCT01630954|H Mole|h mole
5000787|NCT01630954|GTN|gtn
5000788|NCT01630954|GTD|gtd
5000789|NCT01630941|Osteoarthritis of the hip|osteoarthritis of the hip
5000790|NCT01630941|Uncemented Total Hip Arthroplasty|uncemented total hip arthroplasty
5000791|NCT01630941|DXA|dxa
5000792|NCT01630941|BMD|bmd
5000793|NCT01630941|PET|pet
5000794|NCT01630941|CT|ct
5000795|NCT01630941|Biochemical bone markers|biochemical bone markers
5000796|NCT01630928|Renal denervation|renal denervation
5000797|NCT01630928|Resistant Hypertension|resistant hypertension
5000798|NCT01630928|Cardiovascular disease|cardiovascular disease
5000799|NCT01630928|Diabetes|diabetes
5000800|NCT01630928|Quality of LIfe|quality of life
5000801|NCT01630889|Kidney|kidney
5000802|NCT01630889|ESRD|esrd
5000803|NCT01630889|End Stage Renal Disease|end stage renal disease
5000804|NCT01630889|Anemia|anemia
5000805|NCT01630889|Oral anemia treatment|oral anemia treatment
5000806|NCT01630889|Hemoglobin levels|hemoglobin levels
5000807|NCT01630889|Hemodialysis|hemodialysis
5000808|NCT01630889|CKD|ckd
5000809|NCT01630889|Chronic Kidney Disease|chronic kidney disease
5000810|NCT01630889|Peritoneal|peritoneal
5000811|NCT01630889|HD|hd
5000812|NCT01630889|PD|pd
5000813|NCT01630889|Hb|hb
5000814|NCT01630889|Erythropoietin|erythropoietin
5000815|NCT01630889|Blood count|blood count
5000816|NCT01630876|Epiretinal membrane|epiretinal membrane
5000817|NCT01630876|triamcinolone acetonide|triamcinolone acetonide
5000818|NCT01630863|Central serous chorioretinopathy|central serous chorioretinopathy
5000819|NCT01630863|photodynamic therapy|photodynamic therapy
5000820|NCT01630863|safe and effective dose|safe and effective dose
5000821|NCT01630824|education program|education program
5000822|NCT01630824|kidney transplantation|kidney transplantation
5000823|NCT01630824|renal transplantation|renal transplantation
5000824|NCT01630824|evaluation|evaluation
5000825|NCT01630811|Adults|adults
5000826|NCT01630798|barrett's esophgus|barrett's esophgus
5000827|NCT01630798|High grade dysplasia|high grade dysplasia
5000828|NCT01630798|Esophageal adenocarcinoma|esophageal adenocarcinoma
5000829|NCT01630772|women with preeclampsia|women with preeclampsia
5000830|NCT01630772|physical therapy|physical therapy
5000831|NCT01630772|maternal-fetal hemodynamics|maternal-fetal hemodynamics
5000832|NCT01630772|perinatal outcomes|perinatal outcomes
5000833|NCT01630759|Gestational diabetes|gestational diabetes
5000834|NCT01630759|telemonitoring|telemonitoring
5000835|NCT01630759|telehealth|telehealth
5000836|NCT01630759|feasibility study|feasibility study
5000837|NCT01630733|Metastatic|metastatic
5000838|NCT01630733|Stage IV|stage iv
5000839|NCT01630733|Advanced|advanced
5000840|NCT01630733|lung cancer|lung cancer
5000841|NCT01630720|ascorbic acid|ascorbic acid
5000842|NCT01630720|cholecalciferol|cholecalciferol
5000843|NCT01630720|vitamin C|vitamin c
5000844|NCT01630720|vitamin D|vitamin d
5000845|NCT01630720|hypovitaminosis|hypovitaminosis
5000846|NCT01630720|mood|mood
5000847|NCT01630720|distress|distress
5000848|NCT01630694|Difficult airway management|difficult airway management
5000849|NCT01630694|anesthesia|anesthesia
5000850|NCT01630694|difficult intubation|difficult intubation
5000851|NCT01630629|Lactation|lactation
5000852|NCT01630629|Weaning|weaning
5000853|NCT01630629|Bone Density|bone density
5000854|NCT01630629|Endocrine|endocrine
5000855|NCT01630629|Physiological Properties|physiological properties
5000856|NCT01630629|Bone Metabolism|bone metabolism
5000857|NCT01630590|Prostate Cancer|prostate cancer
5000858|NCT01630590|Metastatic Prostate Cancer|metastatic prostate cancer
5000859|NCT01630590|Prostate adenocarcinoma|prostate adenocarcinoma
5000860|NCT01630590|Androgen-Dependent Prostate Cancer|androgen-dependent prostate cancer
5000861|NCT01630590|Cabozantinib|cabozantinib
5000862|NCT01630590|XL 184|xl 184
5000863|NCT01630590|Androgen Ablation|androgen ablation
5000864|NCT01630577|acute circulatory failure|acute circulatory failure
5000865|NCT01630577|hemodynamic stability|hemodynamic stability
5000866|NCT01630577|hypovolemia|hypovolemia
5000867|NCT01630564|Blood And Marrow Transplantation|blood and marrow transplantation
5000868|NCT01630564|Leukemia|leukemia
5000869|NCT01630564|Lymphoma|lymphoma
5000870|NCT01630564|Myeloproliferative Diseases|myeloproliferative diseases
5000871|NCT01630564|Relapsed hematological malignancies|relapsed hematological malignancies
5000872|NCT01630564|Post-Transplant Relapsed Patients|post-transplant relapsed patients
5000873|NCT01630564|Cord Blood Lymphocyte Infusion|cord blood lymphocyte infusion
5000874|NCT01630564|Ex Vivo Expanded Donor Cord Blood T-Lymphocyte Infusion|ex vivo expanded donor cord blood t-lymphocyte infusion
5000875|NCT01630551|tears|tears
5000876|NCT01630551|dry eyes|dry eyes
5000877|NCT01630551|ocular surface disease|ocular surface disease
5000878|NCT01630538|Transplantation|transplantation
5000879|NCT01630525|Alzheimer's disease|alzheimer's disease
5000880|NCT01630525|neurodegenerative signs|neurodegenerative signs
5000881|NCT01630499|Cancer|cancer
5000882|NCT01630499|Breast cancer|breast cancer
5000883|NCT01630499|Breast cancer prevention|breast cancer prevention
5000884|NCT01630499|Breast cancer recurrence|breast cancer recurrence
5000885|NCT01630499|Weight loss|weight loss
5000886|NCT01630499|Weight management|weight management
5000887|NCT01630499|Overweight|overweight
5000888|NCT01630499|Obesity|obesity
5000889|NCT01630486|renal progression|renal progression
5000890|NCT01630486|mortality|mortality
5000891|NCT01630486|complications|complications
5000892|NCT01630486|risk factors|risk factors
5000893|NCT01630486|role of biochemical parameters|role of biochemical parameters
5000894|NCT01630486|genetic influence|genetic influence
5000895|NCT01630473|Tooth crowding|tooth crowding
5000896|NCT01630473|Teeth malpositions|teeth malpositions
5000897|NCT01630473|corticotomy|corticotomy
5000898|NCT01630473|orthodontics|orthodontics
5000899|NCT01630473|tooth movement|tooth movement
5000900|NCT01630473|periodontal parameters|periodontal parameters
5000901|NCT01630460|Craniometaphyseal dysplasia|craniometaphyseal dysplasia
5000902|NCT01630460|bone|bone
5000903|NCT01630460|hyperostosis|hyperostosis
5000904|NCT01630460|osteoblast|osteoblast
5000905|NCT01630460|osteoclast|osteoclast
5000906|NCT01630447|cherubism|cherubism
5000907|NCT01630447|bone|bone
5000908|NCT01630447|autoinflammatory disorder|autoinflammatory disorder
5000909|NCT01630447|osteoblast|osteoblast
5000910|NCT01630447|osteoclast|osteoclast
5000911|NCT01630447|mandible|mandible
5000912|NCT01630447|maxilla|maxilla
5000913|NCT01630421|Aplasia cutis congenita|aplasia cutis congenita
5000914|NCT01630421|bone|bone
5000915|NCT01630421|osteoblast|osteoblast
5000916|NCT01630421|osteoclast|osteoclast
5000917|NCT01630421|skin|skin
5000918|NCT01630408|Preserved ejection fraction|preserved ejection fraction
5000919|NCT01630408|Left ventricular hypertrophy|left ventricular hypertrophy
5000920|NCT01630408|Activated vitamin D|activated vitamin d
5000921|NCT01630408|Cardiac lusitropic effect|cardiac lusitropic effect
5000922|NCT01630408|Hospitalizations|hospitalizations
5000923|NCT01630356|Secondhand Smoke|secondhand smoke
5000924|NCT01630356|Nicotine|nicotine
5000925|NCT01630356|Indoor Air Pollution|indoor air pollution
5000926|NCT01630343|Geriatric hip fracture|geriatric hip fracture
5000927|NCT01630343|pain management|pain management
5000928|NCT01630304|telecommunications|telecommunications
5000929|NCT01630304|Africa|africa
5000930|NCT01630304|randomized controlled trial|randomized controlled trial
5000931|NCT01630278|Prematurity|prematurity
5000932|NCT01630278|patent ductus arteriosus|patent ductus arteriosus
5000933|NCT01630278|ibuprofen|ibuprofen
5000934|NCT01630265|Discharge Instructions|discharge instructions
5000935|NCT01630265|Video Discharge Instructions|video discharge instructions
5000936|NCT01630265|Video|video
5000937|NCT01630265|Emergency Department Discharge Instructions|emergency department discharge instructions
5000938|NCT01630265|ED Discharge|ed discharge
5000939|NCT01630226|BRCA1|brca1
5000940|NCT01630226|pathological complete response|pathological complete response
5000941|NCT01630226|neoadjuvant chemotherapy|neoadjuvant chemotherapy
5000942|NCT01630213|Vitamin D3|vitamin d3
5000943|NCT01630213|Left ventricular mass|left ventricular mass
5000944|NCT01630213|Echocardiography|echocardiography
5000945|NCT01630213|Left ventricular systolic and diastolic function|left ventricular systolic and diastolic function
5000946|NCT01630200|COPD|copd
5000947|NCT01630200|comorbidity|comorbidity
5000948|NCT01630200|arterial stiffness|arterial stiffness
5000949|NCT01630200|roflumilast|roflumilast
5000950|NCT01630187|Carbetocin|carbetocin
5000951|NCT01630187|Uterotonic drug|uterotonic drug
5000952|NCT01630187|elective cesarean section|elective cesarean section
5000953|NCT01630174|IMRT,Pemetrexed,Cisplatin , Esophageal Cancer|imrt,pemetrexed,cisplatin , esophageal cancer
5000954|NCT01630161|relapse|relapse
5000955|NCT01630161|prevention|prevention
5000956|NCT01630161|smoking|smoking
5000957|NCT01630161|habit|habit
5000958|NCT01630161|Forever Free|forever free
5000959|NCT01630148|Thromboprophylaxis|thromboprophylaxis
5000960|NCT01630148|Bemiparin|bemiparin
5000961|NCT01630148|Low Molecular Weight Heparin|low molecular weight heparin
5000962|NCT01630148|Major Gynaecological Surgeries|major gynaecological surgeries
5000963|NCT01630148|Benign Gynaecological Surgeries|benign gynaecological surgeries
5000964|NCT01630122|Trans-thoracic Needle Biopsy (TNB)|trans-thoracic needle biopsy (tnb)
5000965|NCT01630122|Endobronchial Ultrasound Guided Transbronchial Needle Aspiration (EBUS-TBNA)|endobronchial ultrasound guided transbronchial needle aspiration (ebus-tbna)
5000966|NCT01630122|Trans-esophageal Ultrasound Scanning with FNA (EUS-FNA)|trans-esophageal ultrasound scanning with fna (eus-fna)
5000967|NCT01630083|IMAB362|imab362
5000968|NCT01630083|ASP8951|asp8951
5000969|NCT01630083|zolbetuximab|zolbetuximab
5000970|NCT01630070|Critical limb ischemia|critical limb ischemia
5000971|NCT01630070|Rest pain|rest pain
5000972|NCT01630070|Minor tissue loss|minor tissue loss
5000973|NCT01630070|Below the knee|below the knee
5001072|NCT01629511|ATG|atg
5000974|NCT01630031|atrial fibrillation|atrial fibrillation
5000975|NCT01630031|paroxysmal|paroxysmal
5000976|NCT01630031|contact force|contact force
5000977|NCT01630031|radiofrequency|radiofrequency
5000978|NCT01630031|catheter ablation|catheter ablation
5000979|NCT01630031|pulmonary vein isolation|pulmonary vein isolation
5000980|NCT01630031|recurrence|recurrence
5000981|NCT01630031|follow-up|follow-up
5000982|NCT01630018|Epithelial Ovarian Cancer|epithelial ovarian cancer
5000983|NCT01630018|Belotecan|belotecan
5000984|NCT01630018|Topotecan|topotecan
5000985|NCT01629992|Vomiting|vomiting
5000986|NCT01629992|Nausea|nausea
5000987|NCT01629992|Postoperative pain|postoperative pain
5000988|NCT01629992|Feeling|feeling
5000989|NCT01629966|Generalized Anxiety Disorder|generalized anxiety disorder
5000990|NCT01629966|GAD|gad
5000991|NCT01629940|X-linked Hypohidrotic Ectodermal Dysplasia|x-linked hypohidrotic ectodermal dysplasia
5000992|NCT01629940|Hypohidrotic Ectodermal Dysplasia|hypohidrotic ectodermal dysplasia
5000993|NCT01629940|XLHED|xlhed
5000994|NCT01629940|HED|hed
5000995|NCT01629927|X-linked hypohidrotic ectodermal dysplasia|x-linked hypohidrotic ectodermal dysplasia
5000996|NCT01629927|Hypohidrotic ectodermal dysplasia|hypohidrotic ectodermal dysplasia
5000997|NCT01629927|HED|hed
5000998|NCT01629927|XLHED|xlhed
5000999|NCT01629914|Attention-deficit/hyperactivity disorder|attention-deficit/hyperactivity disorder
5001000|NCT01629914|executive functioning|executive functioning
5001001|NCT01629914|mindfulness meditation|mindfulness meditation
5001002|NCT01629914|magnetic resonance imaging|magnetic resonance imaging
5001003|NCT01629914|healthy|healthy
5001004|NCT01629901|Healthy volunteer|healthy volunteer
5001005|NCT01629888|Plant sterol|plant sterol
5001006|NCT01629888|Hypercholesterolemia|hypercholesterolemia
5001007|NCT01629888|dairy|dairy
5001008|NCT01629810|Motion platform at appropriate settings.|motion platform at appropriate settings.
5001009|NCT01629810|Relief of pain.|relief of pain.
5001010|NCT01629810|Improvement in quality of life, cognition, and mood.|improvement in quality of life, cognition, and mood.
5001011|NCT01629810|Effects of WBPA on cognition, mood, behavior, and functioning.|effects of wbpa on cognition, mood, behavior, and functioning.
5001012|NCT01629810|Dose response effect .|dose response effect .
5001013|NCT01629810|Gather data for long-term (2 year) study|gather data for long-term (2 year) study
5001014|NCT01629745|B-cell childhood acute lymphoblastic leukemia|b-cell childhood acute lymphoblastic leukemia
5001015|NCT01629745|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
5001016|NCT01629693|contact lenses|contact lenses
5001017|NCT01629693|myopia|myopia
5001018|NCT01629693|astigmatism|astigmatism
5001019|NCT01629680|moxaverine|moxaverine
5001020|NCT01629680|ocular blood flow|ocular blood flow
5001021|NCT01629654|Poststroke fatigue|poststroke fatigue
5001022|NCT01629654|Health promotion|health promotion
5001023|NCT01629654|Patient education|patient education
5001024|NCT01629641|goniometry|goniometry
5001025|NCT01629641|outcome measures|outcome measures
5001026|NCT01629641|shoulder assessment|shoulder assessment
5001027|NCT01629628|Crohn Disease|crohn disease
5001028|NCT01629628|Colitis Granulomatous|colitis granulomatous
5001029|NCT01629628|Crohn's Disease|crohn's disease
5001030|NCT01629628|Enteritis Regional|enteritis regional
5001031|NCT01629628|Ileitis Regional|ileitis regional
5001032|NCT01629628|Ileitis Terminal|ileitis terminal
5001033|NCT01629628|Ileocolitis|ileocolitis
5001034|NCT01629615|breast cancer|breast cancer
5001035|NCT01629615|metastatic|metastatic
5001036|NCT01629615|triple negative breast cancer|triple negative breast cancer
5001037|NCT01629615|BKM120|bkm120
5001038|NCT01629615|SOLTI|solti
5001039|NCT01629615|PI3K inhibitor|pi3k inhibitor
5001040|NCT01629602|defect;|defect;
5001041|NCT01629602|dorsal branch of the proper digital nerve;|dorsal branch of the proper digital nerve;
5001042|NCT01629602|proper digital nerve;|proper digital nerve;
5001043|NCT01629602|vascularized nerve graft|vascularized nerve graft
5001044|NCT01629589|Adacel® vaccine|adacel® vaccine
5001045|NCT01629589|Tetanus|tetanus
5001046|NCT01629589|Diphtheria|diphtheria
5001047|NCT01629589|whooping cough|whooping cough
5001048|NCT01629589|Pertussis|pertussis
5001049|NCT01629589|BOOSTRIX® vaccine|boostrix® vaccine
5001050|NCT01629537|Post Traumatic Stress Disorder|post traumatic stress disorder
5001051|NCT01629511|Leukemia|leukemia
5001052|NCT01629511|Chronic lymphocytic leukemia|chronic lymphocytic leukemia
5001053|NCT01629511|CLL|cll
5001054|NCT01629511|Allogeneic hematopoietic cell transplantation|allogeneic hematopoietic cell transplantation
5001055|NCT01629511|HCT|hct
5001056|NCT01629511|Methotrexate|methotrexate
5001057|NCT01629511|Filgrastim|filgrastim
5001058|NCT01629511|G-CSF|g-csf
5001059|NCT01629511|Neupogen|neupogen
5001060|NCT01629511|Tacrolimus|tacrolimus
5001061|NCT01629511|Prograf|prograf
5001062|NCT01629511|Busulfan|busulfan
5001063|NCT01629511|Busulfex|busulfex
5001064|NCT01629511|Myleran|myleran
5001065|NCT01629511|Clofarabine|clofarabine
5001066|NCT01629511|Clofarex|clofarex
5001067|NCT01629511|Clolar|clolar
5001068|NCT01629511|Gemcitabine|gemcitabine
5001069|NCT01629511|Gemcitabine Hydrochloride|gemcitabine hydrochloride
5001070|NCT01629511|Gemzar|gemzar
5001071|NCT01629511|Thymoglobulin|thymoglobulin
5001073|NCT01629511|Antithymocyte Globulin|antithymocyte globulin
5001074|NCT01629498|Lung cancer|lung cancer
5001075|NCT01629498|Non-small cell lung cancer|non-small cell lung cancer
5001076|NCT01629498|NSCLC|nsclc
5001077|NCT01629498|Image-guided intensity-modulated scanning beam proton therapy|image-guided intensity-modulated scanning beam proton therapy
5001078|NCT01629498|IMPT|impt
5001079|NCT01629498|Simultaneous integrated boost|simultaneous integrated boost
5001080|NCT01629498|SIB|sib
5001081|NCT01629498|Gross tumor volume|gross tumor volume
5001082|NCT01629498|GTV|gtv
5001083|NCT01629498|Chemotherapy|chemotherapy
5001084|NCT01629498|Questionnaire|questionnaire
5001085|NCT01629498|Survey|survey
5001086|NCT01629485|Mastery Learning|mastery learning
5001087|NCT01629485|Surgical Education|surgical education
5001088|NCT01629485|Laparoscopic Hernia Repair|laparoscopic hernia repair
5001089|NCT01629485|Part vs Whole Task|part vs whole task
5001090|NCT01629485|Contextual Interference|contextual interference
5001091|NCT01629485|laparoscopy|laparoscopy
5001092|NCT01629485|training|training
5001093|NCT01629485|curriculum|curriculum
5001094|NCT01629472|Gender norms|gender norms
5001095|NCT01629472|Financial Autonomy|financial autonomy
5001096|NCT01629472|Economic Well-being|economic well-being
5001097|NCT01629459|exercise|exercise
5001098|NCT01629459|strength|strength
5001099|NCT01629459|training|training
5001100|NCT01629459|barth syndrome|barth syndrome
5001101|NCT01629459|mitochondria|mitochondria
5001102|NCT01629459|amino acid|amino acid
5001103|NCT01629459|protein|protein
5001104|NCT01629446|Phase 1|phase 1
5001105|NCT01629446|Normal healthy volunteers|normal healthy volunteers
5001106|NCT01629446|Mass Balance|mass balance
5001107|NCT01629433|idiopathic detrusor overactivity|idiopathic detrusor overactivity
5001108|NCT01629433|neurogenic dysfunction|neurogenic dysfunction
5001109|NCT01629433|onabotulinumtoxinA|onabotulinumtoxina
5001110|NCT01629420|Gonadotropin-Releasing Hormone (GnRH) antagonist|gonadotropin-releasing hormone (gnrh) antagonist
5001111|NCT01629381|knee arthroscopy|knee arthroscopy
5001112|NCT01629381|venous thromboembolism|venous thromboembolism
5001113|NCT01629381|prevention|prevention
5001114|NCT01629355|Auditory Brainstem Response|auditory brainstem response
5001115|NCT01629355|ABR|abr
5001116|NCT01629355|SD-BERA|sd-bera
5001117|NCT01629329|Headache|headache
5001118|NCT01629329|prochlorperazine|prochlorperazine
5001119|NCT01629329|excedrin migraine|excedrin migraine
5001120|NCT01629329|treatment efficacy|treatment efficacy
5001121|NCT01629329|pain scores|pain scores
5001122|NCT01629316|HIV|hiv
5001123|NCT01629316|prisoners|prisoners
5001124|NCT01629316|test|test
5001125|NCT01629316|treat|treat
5001126|NCT01629316|link coordination|link coordination
5001127|NCT01629316|retain|retain
5001128|NCT01629316|behavioral|behavioral
5001129|NCT01629316|intervention|intervention
5001130|NCT01629316|text reminders|text reminders
5001131|NCT01629316|motivational interviewing|motivational interviewing
5001132|NCT01629316|medication adherence|medication adherence
5001133|NCT01629303|constipation|constipation
5001134|NCT01629303|sacral nerve modulation|sacral nerve modulation
5001135|NCT01629277|Closed-loop insulin delivery|closed-loop insulin delivery
5001136|NCT01629277|Non-compliant behaviours during adolescence|non-compliant behaviours during adolescence
5001137|NCT01629264|Cornea|cornea
5001138|NCT01629264|biomechanics|biomechanics
5001139|NCT01629264|pregnancy|pregnancy
5001140|NCT01629264|keratoconus|keratoconus
5001141|NCT01629264|refractive surgery|refractive surgery
5001142|NCT01629251|Closed-loop insulin delivery|closed-loop insulin delivery
5001143|NCT01629251|Post-prandial hypoglycaemia|post-prandial hypoglycaemia
5001144|NCT01629251|Meal insulin dosing|meal insulin dosing
5001145|NCT01629238|cardiovascular risk|cardiovascular risk
5001146|NCT01629238|dairy enriched product with plant sterols|dairy enriched product with plant sterols
5001147|NCT01629238|general practitioners|general practitioners
5001148|NCT01629238|adults followed by general practitioners|adults followed by general practitioners
5001149|NCT01629225|men and women|men and women
5001150|NCT01629225|in southwestern Han Chinese|in southwestern han chinese
5001151|NCT01629186|CPR|cpr
5001152|NCT01629186|flexible bronchoscope|flexible bronchoscope
5001153|NCT01629186|resuscitation|resuscitation
5001154|NCT01629186|ventilation|ventilation
5001155|NCT01629173|plantar pressure|plantar pressure
5001156|NCT01629173|metatarsalgia|metatarsalgia
5001157|NCT01629173|insole|insole
5001158|NCT01629147|Constipation|constipation
5001159|NCT01629108|Normative Data|normative data
5001160|NCT01629108|Vestibular|vestibular
5001161|NCT01629108|Auditory|auditory
5001162|NCT01629108|Healthy Volunteers|healthy volunteers
5001163|NCT01629108|Hearing|hearing
5001164|NCT01629095|Fatty Liver|fatty liver
5001165|NCT01629095|Liver Transplant|liver transplant
5001166|NCT01629095|Non-Alcoholic Steato-Hepatitis|non-alcoholic steato-hepatitis
5001167|NCT01629095|Steatosis|steatosis
5001168|NCT01629095|Cirrhosis|cirrhosis
5001169|NCT01629095|Cryptogenic Cirrhosis|cryptogenic cirrhosis
5001170|NCT01629095|Liver Failure|liver failure
5001171|NCT01629095|Non-Alcoholic Fatty Liver Disease|non-alcoholic fatty liver disease
5001172|NCT01629082|Myelodysplastic Syndromes|myelodysplastic syndromes
5001173|NCT01629082|Acute Myeloid Leukemia (AML)|acute myeloid leukemia (aml)
5001174|NCT01629082|Chronic Myelomonocytic Leukemia (CMML)|chronic myelomonocytic leukemia (cmml)
5001175|NCT01629069|stress|stress
5001176|NCT01629069|mindfulness|mindfulness
5001177|NCT01629069|coping|coping
5001178|NCT01629056|atrial fibrillation|atrial fibrillation
5001179|NCT01629056|ablation|ablation
5001180|NCT01629056|contact|contact
5001181|NCT01629043|Parkinson's|parkinson's
5001182|NCT01629043|Quality of Care|quality of care
5001183|NCT01629043|Improvement|improvement
5001184|NCT01629043|Mobility|mobility
5001185|NCT01629043|Cognition|cognition
5001186|NCT01629043|Caregiver burden|caregiver burden
5001187|NCT01629043|Center difference|center difference
5001188|NCT01629030|sternal wound infection|sternal wound infection
5001189|NCT01629030|coronary artery bypass graft|coronary artery bypass graft
5001190|NCT01629030|risk factor|risk factor
5001191|NCT01629004|colorectal cancer|colorectal cancer
5001192|NCT01629004|screening|screening
5001193|NCT01629004|fecal occult blood testing|fecal occult blood testing
5001194|NCT01629004|mailed invitation|mailed invitation
5001195|NCT01628991|Behavioral Intervention Program|behavioral intervention program
5001196|NCT01628991|Vaginal Cones|vaginal cones
5001197|NCT01628991|Stress Urinary Incontinence|stress urinary incontinence
5001198|NCT01628991|treatment|treatment
5001199|NCT01628991|Women|women
5001200|NCT01628978|depth of endotracheal tube placement|depth of endotracheal tube placement
5001201|NCT01628978|endotracheal intubation|endotracheal intubation
5001202|NCT01628978|endobronchial intubation|endobronchial intubation
5001203|NCT01628965|SPM 962|spm 962
5001204|NCT01628965|rotigotine|rotigotine
5001205|NCT01628965|Parkinson's disease|parkinson's disease
5001206|NCT01628965|monotherapy|monotherapy
5001207|NCT01628939|low back pain|low back pain
5001208|NCT01628939|facet joint pain|facet joint pain
5001209|NCT01628913|Pancreatic|pancreatic
5001210|NCT01628913|Neuroendocrine tumors|neuroendocrine tumors
5001211|NCT01628913|PNET|pnet
5001212|NCT01628913|BEZ235|bez235
5001213|NCT01628913|Everolimus|everolimus
5001214|NCT01628900|pyelonephritis|pyelonephritis
5001215|NCT01628900|Infection|infection
5001216|NCT01628900|Antibiotic treatment|antibiotic treatment
5001217|NCT01628887|Breast Cancer|breast cancer
5001218|NCT01628874|Lumbar Puncture|lumbar puncture
5001219|NCT01628874|J-Tip|j-tip
5001220|NCT01628874|Jet injection|jet injection
5001221|NCT01628874|Local Analgesia|local analgesia
5001222|NCT01628861|occupation|occupation
5001223|NCT01628861|work|work
5001224|NCT01628861|sitting|sitting
5001225|NCT01628861|sedentary behaviour|sedentary behaviour
5001226|NCT01628861|office worker|office worker
5001227|NCT01628861|adult|adult
5001228|NCT01628861|education|education
5001229|NCT01628861|point-of-choice prompt|point-of-choice prompt
5001230|NCT01628848|SPM 962|spm 962
5001231|NCT01628848|rotigotine|rotigotine
5001232|NCT01628848|Parkinson's disease|parkinson's disease
5001233|NCT01628848|concomitant use of L-dopa|concomitant use of l-dopa
5001234|NCT01628835|overweight|overweight
5001235|NCT01628835|pregnancy|pregnancy
5001236|NCT01628835|diet counselling|diet counselling
5001237|NCT01628835|glycemic|glycemic
5001238|NCT01628822|Fibromyalgia|fibromyalgia
5001239|NCT01628822|Relaxation|relaxation
5001240|NCT01628822|Improving the quality of life|improving the quality of life
5001241|NCT01628809|MBSR|mbsr
5001242|NCT01628809|mindfulness|mindfulness
5001243|NCT01628809|stress|stress
5001244|NCT01628783|Depression|depression
5001245|NCT01628783|emotional processing|emotional processing
5001246|NCT01628783|fMRI|fmri
5001247|NCT01628783|autobiographic memory|autobiographic memory
5001248|NCT01628783|moderator of treatment response|moderator of treatment response
5001249|NCT01628783|mediator of treatment response|mediator of treatment response
5001250|NCT01628770|iron|iron
5001251|NCT01628770|monofer|monofer
5001252|NCT01628770|Pakistan|pakistan
5001253|NCT01628731|loop diuretics|loop diuretics
5001254|NCT01628731|fluid balance|fluid balance
5001255|NCT01628731|urine output|urine output
5001256|NCT01628731|acute renal dysfunction|acute renal dysfunction
5001257|NCT01628718|OEF/OIF|oef/oif
5001258|NCT01628718|Veterans|veterans
5001259|NCT01628718|Psychotherapy|psychotherapy
5001260|NCT01628718|PTSD|ptsd
5001261|NCT01628705|Green tea|green tea
5001262|NCT01628705|oxLDL|oxldl
5001263|NCT01628705|fat mass|fat mass
5001264|NCT01628679|provoked|provoked
5001265|NCT01628679|vulvar|vulvar
5001266|NCT01628679|vestibulodynia|vestibulodynia
5001267|NCT01628679|vestibulitis|vestibulitis
5001268|NCT01628666|Arrhythmia|arrhythmia
5001269|NCT01628666|Device Procedure|device procedure
5001270|NCT01628666|Antibiotics|antibiotics
5001271|NCT01628666|Infection|infection
5001272|NCT01628666|Cluster|cluster
5001273|NCT01628653|Mild cognitive impairment|mild cognitive impairment
5001274|NCT01628653|Cognitive rehabilitation|cognitive rehabilitation
5001275|NCT01628653|Cognitive therapy|cognitive therapy
5001276|NCT01628653|Spaced retrieval Training|spaced retrieval training
5001277|NCT01628653|Alzheimer's disease|alzheimer's disease
5001278|NCT01628653|Memory enhancement|memory enhancement
5001279|NCT01628653|U-healthcare|u-healthcare
5001280|NCT01628627|Diabetic Neuropathy, Painful|diabetic neuropathy, painful
5001281|NCT01628575|periodontally accelerated orthodontics PAO|periodontally accelerated orthodontics pao
5001282|NCT01628562|Remifentanil|remifentanil
5001283|NCT01628562|Esmolol|esmolol
5001284|NCT01628562|Intracranial surgery|intracranial surgery
5001285|NCT01628562|Heart rate|heart rate
5001286|NCT01628562|Blood pressure|blood pressure
5001287|NCT01628549|acne|acne
5001288|NCT01628536|Black Cohosh|black cohosh
5001289|NCT01628536|Ductal Carcinoma in situ|ductal carcinoma in situ
5001290|NCT01628536|Breast Cancer|breast cancer
5001291|NCT01628523|Respiratory failure|respiratory failure
5001292|NCT01628523|Mechanical ventilation|mechanical ventilation
5001293|NCT01628523|Acute lung injury|acute lung injury
5001294|NCT01628510|preterm|preterm
5001295|NCT01628471|Phase I b : advanced solid malignancy|phase i b : advanced solid malignancy
5001296|NCT01628471|Phase II a: stage III b or IV, Non Small Cell Lung Cancer|phase ii a: stage iii b or iv, non small cell lung cancer
5001297|NCT01628458|Pancreatic cancer|pancreatic cancer
5001298|NCT01628458|locally advanced|locally advanced
5001299|NCT01628458|irresectable|irresectable
5001300|NCT01628458|Radiofrequency|radiofrequency
5001301|NCT01628458|RFA|rfa
5001302|NCT01628445|Diabetes|diabetes
5001303|NCT01628445|Insulin|insulin
5001304|NCT01628419|Health promotion|health promotion
5001305|NCT01628419|Intervention|intervention
5001306|NCT01628419|Workplace|workplace
5001307|NCT01628419|Exercise program|exercise program
5001308|NCT01628380|HIPEC|hipec
5001309|NCT01628380|Ovarian Cancer|ovarian cancer
5001310|NCT01628380|Cytoreductive Surgery|cytoreductive surgery
5001311|NCT01628354|Choroidal neovascularization|choroidal neovascularization
5001312|NCT01628354|Lucentis|lucentis
5001313|NCT01628328|colonic stenting|colonic stenting
5001314|NCT01628328|colorectal cancer obstruction|colorectal cancer obstruction
5001315|NCT01628328|circulating tumor cell|circulating tumor cell
5001316|NCT01628315|Multiple Sclerosis|multiple sclerosis
5001317|NCT01628315|ASA|asa
5001318|NCT01628315|MRI|mri
5001319|NCT01628315|Lesion activity|lesion activity
5001320|NCT01628302|Hypertension,plasma renin activity,salt consumption|hypertension,plasma renin activity,salt consumption
5001321|NCT01628289|diabetic retinopathy|diabetic retinopathy
5001322|NCT01628289|screening|screening
5001323|NCT01628289|co-payment|co-payment
5001324|NCT01628289|health service|health service
5001325|NCT01628276|Multiple Sclerosis|multiple sclerosis
5001326|NCT01628276|MRI Scans|mri scans
5001327|NCT01628263|PICU|picu
5001328|NCT01628263|Follow up|follow up
5001329|NCT01628263|PTSD|ptsd
5001330|NCT01628224|Task saturation|task saturation
5001331|NCT01628211|hyperthermic chemotherapy|hyperthermic chemotherapy
5001332|NCT01628211|intraperitoneal chemotherapy|intraperitoneal chemotherapy
5001333|NCT01628211|second-look laparoscopy|second-look laparoscopy
5001334|NCT01628211|peritoneal carcinosis|peritoneal carcinosis
5001335|NCT01628211|mucinous colorectal cancer|mucinous colorectal cancer
5001336|NCT01628198|Hypertension|hypertension
5001337|NCT01628198|renal denervation|renal denervation
5001338|NCT01628198|renal ablation|renal ablation
5001339|NCT01628198|uncontrolled high blood pressure|uncontrolled high blood pressure
5001340|NCT01628172|renal sympathetic denervation|renal sympathetic denervation
5001341|NCT01628172|renal catheter ablation|renal catheter ablation
5001342|NCT01628172|hypertension|hypertension
5001343|NCT01628146|Presbyopia|presbyopia
5001344|NCT01628146|hyperopia|hyperopia
5001345|NCT01628146|Supracor|supracor
5001346|NCT01628146|contrast sensitivity|contrast sensitivity
5001347|NCT01628133|Transfusion|transfusion
5001348|NCT01628133|Neonate|neonate
5001349|NCT01628133|Infant, Very Low Birth Weight|infant, very low birth weight
5001350|NCT01628133|Patent Ductus Arteriosus|patent ductus arteriosus
5001351|NCT01628133|Packed Red Blood Cell|packed red blood cell
5001352|NCT01628120|Chronic renal failure|chronic renal failure
5001353|NCT01628120|Hemodialysis|hemodialysis
5001354|NCT01628107|Chronic renal failure|chronic renal failure
5001355|NCT01628107|hemodialysis|hemodialysis
5001356|NCT01628081|psoriasis|psoriasis
5001357|NCT01628081|Alga Dunaliella Bardawil|alga dunaliella bardawil
5001358|NCT01628068|Left atrial appendage occlusion|left atrial appendage occlusion
5001359|NCT01628068|gastrointestinal bleeding|gastrointestinal bleeding
5001360|NCT01628055|IVIg|ivig
5001361|NCT01628055|Acute Ischemic Stroke|acute ischemic stroke
5001362|NCT01628055|Stroke|stroke
5001363|NCT01628055|CVA|cva
5001364|NCT01628055|Cerebrovascular Accident|cerebrovascular accident
5001365|NCT01628029|Advanced Cancers|advanced cancers
5001366|NCT01628029|Metastatic|metastatic
5001367|NCT01628029|Locally advanced|locally advanced
5001368|NCT01628029|Sleep disturbance|sleep disturbance
5001369|NCT01628029|Sleep problems|sleep problems
5001370|NCT01628029|Litebook|litebook
5001371|NCT01628029|Melatonin|melatonin
5001372|NCT01628029|Methylphenidate|methylphenidate
5001373|NCT01628029|Methylphenidate hydrochloride|methylphenidate hydrochloride
5001374|NCT01628029|Ritalin|ritalin
5001375|NCT01628029|Concerta|concerta
5001376|NCT01628029|Placebo|placebo
5001377|NCT01628029|Supportive counseling|supportive counseling
5001378|NCT01628029|Questionnaires|questionnaires
5001379|NCT01628029|Study Diaries|study diaries
5001380|NCT01628016|depression|depression
5001381|NCT01628016|attention|attention
5001382|NCT01628016|training|training
5001383|NCT01628016|modification|modification
5001384|NCT01628003|Traumatic Brain Injury|traumatic brain injury
5001385|NCT01628003|long-term outcome|long-term outcome
5001386|NCT01628003|Brain Reserves|brain reserves
5001387|NCT01628003|Cognitive Reserves|cognitive reserves
5001388|NCT01628003|Emotional Reserves|emotional reserves
5001389|NCT01628003|Patients 1 year or more after Moderate or Severe Traumatic Brain Injury|patients 1 year or more after moderate or severe traumatic brain injury
5001390|NCT01627990|cytotoxic chemotherapy|cytotoxic chemotherapy
5001391|NCT01627990|G-CSF|g-csf
5001392|NCT01627990|Solid tumour|solid tumour
5001393|NCT01627990|Malignant haematological tumour|malignant haematological tumour
5001394|NCT01627977|chromovitrectomy|chromovitrectomy
5001395|NCT01627977|epiretinal membrane|epiretinal membrane
5001396|NCT01627964|Heart Wall Motion Function|heart wall motion function
5001397|NCT01627951|Plasmodium falciparum|plasmodium falciparum
5001398|NCT01627951|malaria|malaria
5001399|NCT01627938|Multiple Sclerosis|multiple sclerosis
5001400|NCT01627938|MS|ms
5001401|NCT01627938|Mitoxantrone|mitoxantrone
5001402|NCT01627938|Dexrazoxane|dexrazoxane
5001403|NCT01627938|Cardioxane|cardioxane
5001404|NCT01627938|cardiotoxicity|cardiotoxicity
5001405|NCT01627938|cardiac toxicity|cardiac toxicity
5001406|NCT01627938|cardiotoxic side effects|cardiotoxic side effects
5001407|NCT01627938|cardiac MRI|cardiac mri
5001408|NCT01627938|cranial MRI|cranial mri
5001409|NCT01627938|LVEF|lvef
5001410|NCT01627938|neurological outcome|neurological outcome
5001411|NCT01627925|nasal positive airway pressure|nasal positive airway pressure
5001412|NCT01627925|upper airway obstruction|upper airway obstruction
5001413|NCT01627925|mask ventilation|mask ventilation
5001414|NCT01627912|wine|wine
5001415|NCT01627912|inflammation|inflammation
5001416|NCT01627912|oxidative stress|oxidative stress
5001417|NCT01627912|randomized control trial|randomized control trial
5001418|NCT01627912|postprandial intervention|postprandial intervention
5001419|NCT01627912|platelet aggregation|platelet aggregation
5001420|NCT01627912|haemostasis|haemostasis
5001421|NCT01627912|robola|robola
5001422|NCT01627912|cabernet sauvignon|cabernet sauvignon
5001423|NCT01627912|alcohol|alcohol
5001424|NCT01627912|PAF metabolism|paf metabolism
5001425|NCT01627899|Blood glucose monitor|blood glucose monitor
5001426|NCT01627899|Pattern management|pattern management
5001427|NCT01627899|Pattern guide|pattern guide
5001428|NCT01627899|Education|education
5001429|NCT01627886|Bioequivalence|bioequivalence
5001430|NCT01627886|Ibandronate Sodium|ibandronate sodium
5001431|NCT01627886|crossover|crossover
5001432|NCT01627873|Major abdominal surgery|major abdominal surgery
5001433|NCT01627873|analgesic method|analgesic method
5001434|NCT01627873|Fentanyl|fentanyl
5001435|NCT01627873|Remifentanyl|remifentanyl
5001436|NCT01627873|Postoperative cognitive disorder|postoperative cognitive disorder
5001437|NCT01627873|Pro and anti inflammatory cytokines|pro and anti inflammatory cytokines
5001438|NCT01627860|Epilepsy|epilepsy
5001439|NCT01627860|Topiramate|topiramate
5001440|NCT01627860|Neuro-surgical patients|neuro-surgical patients
5001441|NCT01627860|Nervous disorder|nervous disorder
5001442|NCT01627860|Seizures|seizures
5001443|NCT01627847|Bioequivalence|bioequivalence
5001444|NCT01627847|Ropinirole Hydrochloride|ropinirole hydrochloride
5001445|NCT01627847|crossover|crossover
5001446|NCT01627834|Bioequivalence|bioequivalence
5001447|NCT01627834|Ropinirole Hydrochloride|ropinirole hydrochloride
5001448|NCT01627834|crossover|crossover
5001449|NCT01627821|Heart Failure|heart failure
5001450|NCT01627808|intraoperative monitoring|intraoperative monitoring
5001451|NCT01627808|fluid management|fluid management
5001452|NCT01627795|Malignant Mesothelioma|malignant mesothelioma
5001453|NCT01627795|Cancer|cancer
5001454|NCT01627795|Anti cancer agents|anti cancer agents
5001455|NCT01627782|Major depressive disorder|major depressive disorder
5001456|NCT01627782|Treatment-resistant depression|treatment-resistant depression
5001457|NCT01627782|Ketamine|ketamine
5001458|NCT01627769|scars|scars
5001459|NCT01627769|blisters|blisters
5001460|NCT01627769|second degree burns|second degree burns
5001461|NCT01627769|cryosurgery|cryosurgery
5001462|NCT01627769|keloid scars|keloid scars
5001463|NCT01627769|hypertrophic scars|hypertrophic scars
5001464|NCT01627756|Thoracic Surgery|thoracic surgery
5001465|NCT01627756|Endotoxins|endotoxins
5001466|NCT01627756|Respiration, Artificial|respiration, artificial
5001467|NCT01627756|Immune System|immune system
5001468|NCT01627743|CDLM|cdlm
5001469|NCT01627743|visual scale - physician evaluation|visual scale - physician evaluation
5001470|NCT01627743|COPD|copd
5001471|NCT01627743|GOLD group C and D|gold group c and d
5001472|NCT01627717|maraviroc|maraviroc
5001473|NCT01627717|boceprevir|boceprevir
5001474|NCT01627717|HIV|hiv
5001475|NCT01627717|HCV|hcv
5001476|NCT01627717|drug interaction|drug interaction
5001477|NCT01627717|pharmacokinetics|pharmacokinetics
5001780|NCT01626235|strains|strains
5001478|NCT01627704|PET/CT,fluoroestradiol (18F)|pet/ct,fluoroestradiol (18f)
5001479|NCT01627704|breast cancer|breast cancer
5001480|NCT01627704|metastatic|metastatic
5001481|NCT01627704|prediction of response|prediction of response
5001482|NCT01627704|hormone therapy|hormone therapy
5001483|NCT01627678|HIV-1, Vacc-C5|hiv-1, vacc-c5
5001484|NCT01627665|dabigatran|dabigatran
5001485|NCT01627665|rivaroxaban|rivaroxaban
5001486|NCT01627665|PKC|pkc
5001487|NCT01627665|PKD|pkd
5001488|NCT01627665|p-glycoprotein|p-glycoprotein
5001489|NCT01627665|polymorphism|polymorphism
5001490|NCT01627652|hypoxia|hypoxia
5001491|NCT01627626|xerostomia|xerostomia
5001492|NCT01627626|pilocarpine mouthwash|pilocarpine mouthwash
5001493|NCT01627626|minor salivary gland secretion|minor salivary gland secretion
5001494|NCT01627600|stroke|stroke
5001495|NCT01627600|myocardial infarction|myocardial infarction
5001496|NCT01627600|cardiovascular health|cardiovascular health
5001497|NCT01627600|population study|population study
5001498|NCT01627587|preterm labor|preterm labor
5001499|NCT01627574|Pregnancy|pregnancy
5001500|NCT01627574|STI prevention|sti prevention
5001501|NCT01627574|adolescents|adolescents
5001502|NCT01627574|probation|probation
5001503|NCT01627561|Immune response|immune response
5001504|NCT01627561|Human papillomavirus|human papillomavirus
5001505|NCT01627561|HPV vaccine|hpv vaccine
5001506|NCT01627561|Safety|safety
5001507|NCT01627548|PTSD|ptsd
5001508|NCT01627548|Couples|couples
5001509|NCT01627548|Combat Veteran|combat veteran
5001510|NCT01627548|Warfighter|warfighter
5001511|NCT01627548|OEF|oef
5001513|NCT01627548|OND|ond
5001514|NCT01627548|Structured Approach Therapy|structured approach therapy
5001515|NCT01627548|Trauma|trauma
5001516|NCT01627535|Brain Tumor|brain tumor
5001517|NCT01627509|continuous glucose monitoring system|continuous glucose monitoring system
5001518|NCT01627509|hypoglycemia|hypoglycemia
5001519|NCT01627509|insulin regimen|insulin regimen
5001520|NCT01627509|basal bolus therapy|basal bolus therapy
5001521|NCT01627509|modern premixed insulin|modern premixed insulin
5001522|NCT01627509|diabetes control|diabetes control
5001523|NCT01627496|malnutrition|malnutrition
5001524|NCT01627496|elderly care|elderly care
5001525|NCT01627496|quality of life|quality of life
5001526|NCT01627496|hospital|hospital
5001527|NCT01627483|elderly|elderly
5001528|NCT01627483|hip fracture|hip fracture
5001529|NCT01627483|osteoporosis|osteoporosis
5001530|NCT01627483|fall risk|fall risk
5001531|NCT01627483|medication review|medication review
5001532|NCT01627470|non-invasive arterial pressure|non-invasive arterial pressure
5001533|NCT01627470|emergency|emergency
5001534|NCT01627470|intensive care|intensive care
5001535|NCT01627457|Coronary Artery Disease|coronary artery disease
5001536|NCT01627457|Guided Exercise System including ECG Vest with vital signs sensors and PDA|guided exercise system including ecg vest with vital signs sensors and pda
5001537|NCT01627457|Validation Telemedical Device in regard to accuracy and safety of data|validation telemedical device in regard to accuracy and safety of data
5001538|NCT01627457|Homely Rehabilitation|homely rehabilitation
5001539|NCT01627457|Practicability and technical problems at home|practicability and technical problems at home
5001540|NCT01627444|Acupuncture|acupuncture
5001541|NCT01627444|Anxiety|anxiety
5001542|NCT01627444|Human Milk|human milk
5001543|NCT01627444|Very low birth weight infants|very low birth weight infants
5001544|NCT01627444|Mother of very low birth weight infants|mother of very low birth weight infants
5001545|NCT01627431|PAD|pad
5001546|NCT01627431|Peripheral revascularization|peripheral revascularization
5001547|NCT01627431|Antiplatelet therapy|antiplatelet therapy
5001548|NCT01627431|Residual platelet activity|residual platelet activity
5001549|NCT01627418|COPD|copd
5001550|NCT01627418|CORD|cord
5001551|NCT01627418|COAD|coad
5001552|NCT01627379|nonresectable|nonresectable
5001553|NCT01627379|advanced|advanced
5001554|NCT01627379|metastatic esophageal squamous cell cancer|metastatic esophageal squamous cell cancer
5001555|NCT01627379|Panitumumab|panitumumab
5001556|NCT01627353|Hysterectomy|hysterectomy
5001557|NCT01627353|Pain Prevention|pain prevention
5001558|NCT01627353|Wound Infiltration|wound infiltration
5001559|NCT01627340|Engerix™-B|engerix™-b
5001560|NCT01627340|hepatitis B|hepatitis b
5001561|NCT01627340|adults|adults
5001562|NCT01627340|Type 2 diabetes mellitus|type 2 diabetes mellitus
5001563|NCT01627327|Cardiovascular event|cardiovascular event
5001564|NCT01627327|Cardiovascular disease|cardiovascular disease
5001565|NCT01627275|Naive T Cell Depletion|naive t cell depletion
5001566|NCT01627275|Donor Lymphocyte Infusion|donor lymphocyte infusion
5001567|NCT01627275|Allogeneic Hematopoietic Stem Cell Transplant|allogeneic hematopoietic stem cell transplant
5001568|NCT01627262|diverticular disease|diverticular disease
5001569|NCT01627262|colonic diverticulosis|colonic diverticulosis
5001570|NCT01627262|mesalamine|mesalamine
5001571|NCT01627262|placebo|placebo
5001572|NCT01627262|randomized|randomized
5001573|NCT01627249|Diabetic Macular Edema|diabetic macular edema
5001574|NCT01627249|anti-vascular endothelial growth factor|anti-vascular endothelial growth factor
5001575|NCT01627223|Spontaneous Severe Acute Exacerbation of Chronic Hepatitis B|spontaneous severe acute exacerbation of chronic hepatitis b
5001576|NCT01627223|Lamivudine (Zeffix®)|lamivudine (zeffix®)
5001577|NCT01627223|Entecavir (Baraclude®)|entecavir (baraclude®)
5001578|NCT01627210|Diabetes Mellitus|diabetes mellitus
5001579|NCT01627197|Effects of Chemotherapy|effects of chemotherapy
5001580|NCT01627197|intraarterial chemotherapy|intraarterial chemotherapy
5001581|NCT01627145|overactive bladder syndrome|overactive bladder syndrome
5001582|NCT01627145|derusor overactivity|derusor overactivity
5001583|NCT01627145|urodynamic studies|urodynamic studies
5001584|NCT01627145|bladder oversensitivity|bladder oversensitivity
5001585|NCT01627119|CTGF|ctgf
5001586|NCT01627119|Peritoneal metastasis|peritoneal metastasis
5001587|NCT01627093|Head and Neck Cancer|head and neck cancer
5001588|NCT01627093|Head and Neck Malignancies|head and neck malignancies
5001589|NCT01627093|Chart Review|chart review
5001590|NCT01627093|Proton Radiation Therapy|proton radiation therapy
5001591|NCT01627080|Esophagus|esophagus
5001592|NCT01627080|Esophageal Cancer|esophageal cancer
5001593|NCT01627080|Radiation therapy|radiation therapy
5001594|NCT01627080|RT|rt
5001595|NCT01627080|Chemotherapy|chemotherapy
5001596|NCT01627080|Mid thoracic tumor|mid thoracic tumor
5001597|NCT01627080|Distal esophageal tumor|distal esophageal tumor
5001598|NCT01627080|Gastroesophageal junction tumor|gastroesophageal junction tumor
5001599|NCT01627080|Cardiac biomarkers|cardiac biomarkers
5001600|NCT01627067|Breast Cancer|breast cancer
5001601|NCT01627067|Hormone Receptor Positive Metastatic Breast Cancer|hormone receptor positive metastatic breast cancer
5001602|NCT01627067|Hormone-sensitive|hormone-sensitive
5001603|NCT01627067|Postmenopausal|postmenopausal
5001604|NCT01627067|Body Mass Index|body mass index
5001605|NCT01627067|BMI|bmi
5001606|NCT01627067|Everolimus|everolimus
5001607|NCT01627067|Afinitor|afinitor
5001608|NCT01627067|RAD001|rad001
5001609|NCT01627067|Exemestane|exemestane
5001610|NCT01627067|Aromasin|aromasin
5001611|NCT01627067|Metformin|metformin
5001612|NCT01627028|Thai traditional massage|thai traditional massage
5001613|NCT01627028|Bone formation|bone formation
5001614|NCT01627028|Bone resorption|bone resorption
5001615|NCT01627015|Fully formula fed|fully formula fed
5001616|NCT01627002|Phase 1|phase 1
5001617|NCT01627002|First in Human|first in human
5001618|NCT01627002|Healthy Volunteers|healthy volunteers
5001619|NCT01627002|Lipopolysaccharide Challenge|lipopolysaccharide challenge
5001620|NCT01626976|safety|safety
5001621|NCT01626976|tolerability|tolerability
5001622|NCT01626976|pharmacokinetics|pharmacokinetics
5001623|NCT01626976|oral|oral
5001624|NCT01626976|single ascending dose|single ascending dose
5001625|NCT01626976|placebo-controlled|placebo-controlled
5001626|NCT01626976|healthy subjects|healthy subjects
5001627|NCT01626963|single-port access|single-port access
5001628|NCT01626963|laparoscopic surgery|laparoscopic surgery
5001629|NCT01626963|surgical trauma|surgical trauma
5001630|NCT01626950|Breast cancer|breast cancer
5001631|NCT01626950|living conditions|living conditions
5001632|NCT01626950|social fragility|social fragility
5001633|NCT01626937|Acute respiratory failure|acute respiratory failure
5001634|NCT01626937|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
5001635|NCT01626937|Non invasive ventilation|non invasive ventilation
5001636|NCT01626937|Out of hospital|out of hospital
5001637|NCT01626924|Perinatal Asphyxia|perinatal asphyxia
5001638|NCT01626924|Neonatal encephalopathy|neonatal encephalopathy
5001639|NCT01626924|Oxygen shortage at birth|oxygen shortage at birth
5001640|NCT01626924|Antenatal asphyxia|antenatal asphyxia
5001641|NCT01626924|hypoxia-ischaemia|hypoxia-ischaemia
5001642|NCT01626924|birth asphyxia|birth asphyxia
5001643|NCT01626924|asphyxia neonatorum|asphyxia neonatorum
5001644|NCT01626911|severe acute pancreatitis;|severe acute pancreatitis;
5001645|NCT01626911|continuous regional arterial infusion;|continuous regional arterial infusion;
5001646|NCT01626911|low molecular weight heparin|low molecular weight heparin
5001647|NCT01626885|Schizophrenia|schizophrenia
5001648|NCT01626885|Antipsychotic Agents|antipsychotic agents
5001649|NCT01626885|Mental Disorder|mental disorder
5001650|NCT01626885|Psychotropic Drugs|psychotropic drugs
5001651|NCT01626885|Dopamine Agents|dopamine agents
5001652|NCT01626885|Central Nervous System Agents|central nervous system agents
5001653|NCT01626872|Schizophrenia|schizophrenia
5001654|NCT01626872|Antipsychotic Agents|antipsychotic agents
5001655|NCT01626872|Mental Disorder|mental disorder
5001656|NCT01626872|Psychotropic Drugs|psychotropic drugs
5001657|NCT01626872|Dopamine Agents|dopamine agents
5001658|NCT01626872|Risperidone|risperidone
5001659|NCT01626872|Central Nervous System Agents|central nervous system agents
5001660|NCT01626859|Schizophrenia|schizophrenia
5001661|NCT01626859|Antipsychotic Agents|antipsychotic agents
5001662|NCT01626859|Mental Disorder|mental disorder
5001663|NCT01626859|Psychotropic Drugs|psychotropic drugs
5001664|NCT01626859|Dopamine Agents|dopamine agents
5001665|NCT01626859|Central Nervous System Agents|central nervous system agents
5001666|NCT01626846|Neurofibromatosis|neurofibromatosis
5001667|NCT01626833|anorexia nervosa|anorexia nervosa
5001668|NCT01626833|GH|gh
5001669|NCT01626833|Growth velocity|growth velocity
5001670|NCT01626820|Immunogenicity|immunogenicity
5001671|NCT01626820|Influenza|influenza
5001672|NCT01626820|Safety|safety
5001673|NCT01626820|Adults|adults
5001674|NCT01626820|Fluviral|fluviral
5001675|NCT01626807|Safe Routes to School|safe routes to school
5001676|NCT01626807|Walking School Bus|walking school bus
5001677|NCT01626807|Cluster Randomized Controlled Trial|cluster randomized controlled trial
5001678|NCT01626807|Physical Activity|physical activity
5001679|NCT01626807|Obesity|obesity
5001680|NCT01626807|Overweight|overweight
5001681|NCT01626755|Phantom limb pain|phantom limb pain
5001682|NCT01626755|Chronic pain|chronic pain
5001683|NCT01626755|Amputation|amputation
5001684|NCT01626755|Peripheral vascular disease|peripheral vascular disease
5001685|NCT01626729|Food Labeling|food labeling
5001686|NCT01626677|Umbilical Cord Blood|umbilical cord blood
5001687|NCT01626677|Mesenchymal Stem Cells|mesenchymal stem cells
5001688|NCT01626677|Cartilage injury|cartilage injury
5001689|NCT01626677|Osteoarthritis|osteoarthritis
5001690|NCT01626664|Adult T cell Leukemia-Lymphoma (ATL)|adult t cell leukemia-lymphoma (atl)
5001691|NCT01626651|Healthy|healthy
5001692|NCT01626651|Ketoconazole|ketoconazole
5001693|NCT01626651|Ibrutinib|ibrutinib
5001694|NCT01626638|Patients with malignant and pre-malignant pharyngo laryngeal tumors|patients with malignant and pre-malignant pharyngo laryngeal tumors
5001695|NCT01626625|nonunion|nonunion
5001696|NCT01626625|stem cells|stem cells
5001697|NCT01626625|autograft|autograft
5001698|NCT01626625|hydroxyapatite|hydroxyapatite
5001699|NCT01626599|ECG|ecg
5001700|NCT01626599|Accelerometer|accelerometer
5001701|NCT01626599|Device|device
5001702|NCT01626586|Youth|youth
5001703|NCT01626586|Family|family
5001704|NCT01626586|Group Therapy|group therapy
5001705|NCT01626586|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
5001706|NCT01626586|Self-Management|self-management
5001707|NCT01626573|Rheumatoid Arthritis|rheumatoid arthritis
5001708|NCT01626573|RA|ra
5001709|NCT01626573|Active|active
5001710|NCT01626547|symptomatic anameia|symptomatic anameia
5001711|NCT01626508|breast milk|breast milk
5001712|NCT01626508|breast-milk bank|breast-milk bank
5001713|NCT01626508|plasma profile|plasma profile
5001714|NCT01626508|essential fatty acids|essential fatty acids
5001715|NCT01626495|Biological: CART19|biological: cart19
5001716|NCT01626443|PCOS|pcos
5001717|NCT01626443|Metabolic disorders|metabolic disorders
5001718|NCT01626443|Ovarian functionality|ovarian functionality
5001719|NCT01626443|Myo-inositol|myo-inositol
5001720|NCT01626443|D-chiro-inositol|d-chiro-inositol
5001721|NCT01626430|Gamma delta TRF|gamma delta trf
5001722|NCT01626430|Insulin sensitivity|insulin sensitivity
5001723|NCT01626430|Postprandial lipaemia|postprandial lipaemia
5001724|NCT01626430|Inflammatory markers|inflammatory markers
5001725|NCT01626430|NF-κB|nf-κb
5001726|NCT01626417|Stroke|stroke
5001727|NCT01626417|Tibion|tibion
5001728|NCT01626417|Bionics|bionics
5001729|NCT01626417|Rehab|rehab
5001730|NCT01626417|Therapy|therapy
5001731|NCT01626417|Robotics|robotics
5001732|NCT01626417|Intention|intention
5001733|NCT01626404|Thoratec Corporation|thoratec corporation
5001734|NCT01626391|Alzheimer's Disease|alzheimer's disease
5001735|NCT01626391|TRx0237|trx0237
5001736|NCT01626391|Safety Study|safety study
5001737|NCT01626391|AD|ad
5001738|NCT01626378|Behavioral Variant Frontotemporal Dementia|behavioral variant frontotemporal dementia
5001739|NCT01626378|bvFTD|bvftd
5001740|NCT01626378|Frontotemporal Dementia|frontotemporal dementia
5001741|NCT01626365|double-lumen tube|double-lumen tube
5001742|NCT01626365|intubation|intubation
5001743|NCT01626365|thermosoftening|thermosoftening
5001744|NCT01626352|Diffuse Large B-Cell Lymphoma|diffuse large b-cell lymphoma
5001745|NCT01626352|Ofatumumab|ofatumumab
5001746|NCT01626352|Bendamustine|bendamustine
5001747|NCT01626339|Anti vascular endothelial growth factor|anti vascular endothelial growth factor
5001748|NCT01626339|retinal vessels|retinal vessels
5001749|NCT01626326|smoking|smoking
5001750|NCT01626326|smoking cessation|smoking cessation
5001751|NCT01626326|mobile app|mobile app
5001752|NCT01626313|Veteran families|veteran families
5001753|NCT01626313|OEF|oef
5001754|NCT01626313|OIF|oif
5001755|NCT01626313|OND|ond
5001756|NCT01626313|Resiliency|resiliency
5001757|NCT01626313|Psycho educational training|psycho educational training
5001758|NCT01626313|Stress|stress
5001759|NCT01626313|Military|military
5001760|NCT01626287|perineal|perineal
5001761|NCT01626287|postpartum|postpartum
5001763|NCT01626287|treatment|treatment
5001764|NCT01626287|ice and black tea|ice and black tea
5001765|NCT01626287|maternal satisfaction|maternal satisfaction
5001766|NCT01626274|Polysomnography|polysomnography
5001767|NCT01626274|Long term vital signs monitoring|long term vital signs monitoring
5001768|NCT01626274|In-ear sensor system|in-ear sensor system
5001769|NCT01626274|Photoplethysmographic micro-optic device|photoplethysmographic micro-optic device
5001770|NCT01626274|High wearing comfort|high wearing comfort
5001771|NCT01626248|Immunological|immunological
5001772|NCT01626248|biomarkers|biomarkers
5001773|NCT01626248|observational|observational
5001774|NCT01626248|RRMS|rrms
5001775|NCT01626248|Relapsing|relapsing
5001776|NCT01626248|Remitting Multiple Sclerosis|remitting multiple sclerosis
5001777|NCT01626235|pain control|pain control
5001778|NCT01626235|fractures|fractures
5001779|NCT01626235|sprains|sprains
5001781|NCT01626235|dysmenorrhea|dysmenorrhea
5001782|NCT01626235|kidney stones|kidney stones
5001783|NCT01626235|gouty arthritis|gouty arthritis
5001784|NCT01626235|opioids|opioids
5001785|NCT01626235|NSDAIDs|nsdaids
5001786|NCT01626235|Emergency Department|emergency department
5001787|NCT01626235|patient reported outcomes|patient reported outcomes
5001788|NCT01626222|Postmenopausal|postmenopausal
5001789|NCT01626222|Estrogen Receptor Positive|estrogen receptor positive
5001790|NCT01626222|HER2 negative|her2 negative
5001791|NCT01626222|Locally Advanced|locally advanced
5001792|NCT01626222|Metastatic Breast Cancer|metastatic breast cancer
5001793|NCT01626222|Everolimus (RAD001)|everolimus (rad001)
5001794|NCT01626222|Exemestane|exemestane
5001795|NCT01626209|Breast cancer, NSCLC, SCCHN, esophageal cancer|breast cancer, nsclc, scchn, esophageal cancer
5001796|NCT01626183|T-cell childhood acute lymphoblastic leukemia|t-cell childhood acute lymphoblastic leukemia
5001797|NCT01626183|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5001798|NCT01626144|Exemestane|exemestane
5001799|NCT01626144|Metabolism|metabolism
5001800|NCT01626144|Metabolizing enzyme genotype|metabolizing enzyme genotype
5001801|NCT01626144|Breast cancer|breast cancer
5001802|NCT01626131|combat disorders|combat disorders
5001803|NCT01626131|exercise therapy|exercise therapy
5001804|NCT01626105|Hemophilia A|hemophilia a
5001805|NCT01626105|Factor VIII|factor viii
5001806|NCT01626105|Inhibitors|inhibitors
5001807|NCT01626105|Immunogenicity|immunogenicity
5001808|NCT01626105|Pharmacogenetics|pharmacogenetics
5001809|NCT01626105|Mutation|mutation
5001810|NCT01626105|Nonsynonymous Single Nucleotide Polymorphisms|nonsynonymous single nucleotide polymorphisms
5001811|NCT01626105|Class II Human Leukocyte Antigens|class ii human leukocyte antigens
5001812|NCT01626092|bone marrow transplantation|bone marrow transplantation
5001813|NCT01626092|reduced intensity conditioning|reduced intensity conditioning
5001814|NCT01626092|Adrenoleukodystrophy|adrenoleukodystrophy
5001815|NCT01626092|Metachromatic Leukodystrophy|metachromatic leukodystrophy
5001816|NCT01626092|Globoid Cell Leukodystrophy|globoid cell leukodystrophy
5001817|NCT01626092|Wolman's disease|wolman's disease
5001818|NCT01626092|GM1 gangliosidosis|gm1 gangliosidosis
5001819|NCT01626092|Tay Sachs disease|tay sachs disease
5001820|NCT01626092|Sanfilippo syndrome|sanfilippo syndrome
5001821|NCT01626092|Sandhoff disease|sandhoff disease
5001822|NCT01626092|inherited metabolic|inherited metabolic
5001823|NCT01626092|I-cell disease|i-cell disease
5001824|NCT01626092|mucolipidosis II|mucolipidosis ii
5001825|NCT01626079|Functional Mitral Regurgitation|functional mitral regurgitation
5001826|NCT01626079|Mitral Valve Regurgitation|mitral valve regurgitation
5001827|NCT01626079|Symptomatic Heart Failure|symptomatic heart failure
5001828|NCT01626079|Functional MR|functional mr
5001829|NCT01626079|MitraClip|mitraclip
5001830|NCT01626079|Mitral Valve Insufficiency|mitral valve insufficiency
5001831|NCT01626079|Cardiopulmonary exercise testing|cardiopulmonary exercise testing
5001832|NCT01626079|COAPT CAS|coapt cas
5001833|NCT01626079|COAPT Continued Access Study|coapt continued access study
5001834|NCT01626079|MitraClip NT|mitraclip nt
5001835|NCT01626053|psychological|psychological
5001836|NCT01626053|intervention|intervention
5001837|NCT01626053|stages of change|stages of change
5001838|NCT01626053|motivational interviewing|motivational interviewing
5001839|NCT01626053|coping skills|coping skills
5001840|NCT01626053|HbA1C|hba1c
5001841|NCT01626053|psychological testing|psychological testing
5001842|NCT01626053|integrated care|integrated care
5001843|NCT01626053|behavioral health|behavioral health
5001844|NCT01626027|Coronary Heart Disease|coronary heart disease
5001845|NCT01626027|Depression|depression
5001846|NCT01626027|Health Care Services|health care services
5001847|NCT01626014|Stage III ovarian cancer|stage iii ovarian cancer
5001848|NCT01626014|Stage IV ovarian cancer|stage iv ovarian cancer
5001849|NCT01626014|recurrent ovarian cancer|recurrent ovarian cancer
5001850|NCT01626014|primary peritoneal cancer|primary peritoneal cancer
5001851|NCT01626014|fallopian tube cancer|fallopian tube cancer
5001852|NCT01626001|Esophagus Cancer|esophagus cancer
5001853|NCT01626001|Lung Cancer|lung cancer
5001854|NCT01626001|4-dimensional computed tomography|4-dimensional computed tomography
5001855|NCT01626001|4D CT|4d ct
5001856|NCT01625975|Growth modulation|growth modulation
5001857|NCT01625975|Eight plate|eight plate
5001858|NCT01625975|Leg length discrepancy|leg length discrepancy
5001859|NCT01625975|Varus/valgus deformities|varus/valgus deformities
5001860|NCT01625975|Pediatric|pediatric
5001861|NCT01625962|PTSD|ptsd
5001862|NCT01625962|mTBI|mtbi
5001863|NCT01625962|mild TBI|mild tbi
5001864|NCT01625962|extracranial injury|extracranial injury
5001865|NCT01625962|ECI|eci
5001866|NCT01625962|Brain Indices|brain indices
5001867|NCT01625949|myocardial infarction|myocardial infarction
5001868|NCT01625936|metastatic|metastatic
5001869|NCT01625936|locally advanced|locally advanced
5001870|NCT01625936|unresectable|unresectable
5001871|NCT01625923|Gastroparesis|gastroparesis
5001872|NCT01625923|Idiopathic|idiopathic
5001873|NCT01625923|Olanzapine|olanzapine
5001874|NCT01625910|Childhood obesity treatment|childhood obesity treatment
5001875|NCT01625910|Motivational interviewing|motivational interviewing
5001876|NCT01625897|Schizophrenia|schizophrenia
5001877|NCT01625897|Antipsychotic Agents|antipsychotic agents
5001878|NCT01625897|Mental Disorder|mental disorder
5001879|NCT01625897|Psychotropic Drugs|psychotropic drugs
5001880|NCT01625897|Dopamine Agents|dopamine agents
5001881|NCT01625897|Risperidone|risperidone
5001882|NCT01625897|Central Nervous System Agents|central nervous system agents
5001883|NCT01625884|Statin|statin
5001884|NCT01625884|Hypercholesterolemia|hypercholesterolemia
5001885|NCT01625871|malaria|malaria
5001886|NCT01625871|vivax|vivax
5001887|NCT01625871|artemether/lumefantrine|artemether/lumefantrine
5001888|NCT01625871|Sudan|sudan
5001889|NCT01625858|LMA Supreme|lma supreme
5001890|NCT01625845|Major Depressive Disorder|major depressive disorder
5001891|NCT01625845|Depression|depression
5001892|NCT01625845|Depressive Symptoms|depressive symptoms
5001893|NCT01625845|Cardiovascular Disease (CVD)|cardiovascular disease (cvd)
5001894|NCT01625845|Coronary Artery Disease (CAD)|coronary artery disease (cad)
5001895|NCT01625845|Heart Disease|heart disease
5001896|NCT01625845|Endothelial Function|endothelial function
5001897|NCT01625845|Inflammation|inflammation
5001898|NCT01625832|intermittent coronary sinus occlusion|intermittent coronary sinus occlusion
5001899|NCT01625832|collateral flow index|collateral flow index
5001900|NCT01625832|collateral circulation|collateral circulation
5001901|NCT01625832|coronary artery occlusion|coronary artery occlusion
5001902|NCT01625819|Tai Chi|tai chi
5001903|NCT01625793|Hepatitis C|hepatitis c
5001904|NCT01625793|interferon|interferon
5001905|NCT01625793|stress|stress
5001906|NCT01625793|social behavior|social behavior
5001907|NCT01625767|Nicotine|nicotine
5001908|NCT01625767|Smoking|smoking
5001909|NCT01625767|Adolescent|adolescent
5001910|NCT01625767|Tobacco|tobacco
5001911|NCT01625754|Ceramides|ceramides
5001912|NCT01625754|Lipids|lipids
5001913|NCT01625728|Voice|voice
5001914|NCT01625728|aerodynamics|aerodynamics
5001915|NCT01625728|acoustics|acoustics
5001916|NCT01625715|peanut allergy|peanut allergy
5001917|NCT01625702|no-prior chemotherapy|no-prior chemotherapy
5001918|NCT01625689|Influenza vaccines|influenza vaccines
5001919|NCT01625689|Influenza, Human|influenza, human
5001920|NCT01625689|Live Attenuated Influenza Vaccine|live attenuated influenza vaccine
5001921|NCT01625676|Aphasia|aphasia
5001922|NCT01625676|Rehabilitation of Speech and Language Disorders|rehabilitation of speech and language disorders
5001923|NCT01625663|barth syndrome|barth syndrome
5001924|NCT01625663|heart failure|heart failure
5001925|NCT01625663|mitochondria|mitochondria
5001926|NCT01625663|metabolism|metabolism
5001927|NCT01625663|amino acid|amino acid
5001928|NCT01625650|Rheumatoid Arthritis|rheumatoid arthritis
5001929|NCT01625650|Registry|registry
5001930|NCT01625650|RA|ra
5001931|NCT01625650|Biologic|biologic
5001932|NCT01625650|Medications|medications
5001933|NCT01625650|Rheumatology|rheumatology
5001934|NCT01625637|Nicotine|nicotine
5001935|NCT01625637|Smoking|smoking
5001936|NCT01625637|Adolescent|adolescent
5001937|NCT01625637|Tobacco|tobacco
5001938|NCT01625611|Alcohol|alcohol
5001939|NCT01625611|Drinking|drinking
5001940|NCT01625611|Drinkers|drinkers
5001941|NCT01625611|Alcohol Drinking|alcohol drinking
5001942|NCT01625611|Naltrexone|naltrexone
5001943|NCT01625611|Alcohol Dependence|alcohol dependence
5001944|NCT01625611|Alcohol Abuse|alcohol abuse
5001945|NCT01625611|Alcohol-Related Disorders|alcohol-related disorders
5001946|NCT01625611|Ethanol|ethanol
5001947|NCT01625611|Alcoholism|alcoholism
5001948|NCT01625598|Nonproliferative diabetic retinopathy|nonproliferative diabetic retinopathy
5001949|NCT01625598|diabetic macular edema|diabetic macular edema
5001950|NCT01625598|proliferative diabetic retinopathy|proliferative diabetic retinopathy
5001951|NCT01625598|ophthalmologists|ophthalmologists
5001952|NCT01625598|dilated eye exam|dilated eye exam
5001953|NCT01625585|Push-and-Pull Enteroscopy|push-and-pull enteroscopy
5001954|NCT01625585|Single-Balloon-Enteroscopy|single-balloon-enteroscopy
5001955|NCT01625572|general anaesthesia|general anaesthesia
5001956|NCT01625572|epidural catheter|epidural catheter
5001957|NCT01625572|intravenous pain therapy|intravenous pain therapy
5001958|NCT01625546|Major Depressive Disorder|major depressive disorder
5001959|NCT01625546|Whole Body Hyperthermia|whole body hyperthermia
5001960|NCT01625533|Coronary Angiography|coronary angiography
5001961|NCT01625533|Rotational Coronary Angiography|rotational coronary angiography
5001962|NCT01625533|Contrast media|contrast media
5001963|NCT01625533|Radiation|radiation
5001964|NCT01625520|Progressive metastatic|progressive metastatic
5001965|NCT01625520|postoperative persistent|postoperative persistent
5001966|NCT01625468|Secondhand smoke exposure|secondhand smoke exposure
5001967|NCT01625468|Smoke-free homes|smoke-free homes
5001968|NCT01625468|Smoke-free home bans|smoke-free home bans
5001969|NCT01625455|Sezary Syndrome|sezary syndrome
5001970|NCT01625455|Pruritus|pruritus
5001971|NCT01625455|Aprepitant|aprepitant
5001972|NCT01625455|Neurokinin-1|neurokinin-1
5001973|NCT01625442|Metabolic syndrome|metabolic syndrome
5001974|NCT01625442|hypercholesterolemia|hypercholesterolemia
5001975|NCT01625442|hypertriglyceridemia|hypertriglyceridemia
5001976|NCT01625442|hyperglycemia|hyperglycemia
5001977|NCT01625416|Posttraumatic Stress Disorder|posttraumatic stress disorder
5001978|NCT01625416|Depression|depression
5001979|NCT01625416|Suicide|suicide
5001980|NCT01625416|Traumatic Brain Injury|traumatic brain injury
5001981|NCT01625416|Alcohol Use|alcohol use
5001982|NCT01625416|Drug Use|drug use
5001983|NCT01625416|Information Technology|information technology
5001984|NCT01625403|Recombinant BNP|recombinant bnp
5001985|NCT01625403|Diuretics|diuretics
5001986|NCT01625403|Acute decompensated heart failure|acute decompensated heart failure
5001987|NCT01625403|Acute renal injury|acute renal injury
5001988|NCT01625403|Heart function|heart function
5001989|NCT01625403|Renal function|renal function
5001990|NCT01625390|hemophilia, haemophilia, inhibitor, FVIIa, Factor VII activated, bypassing|hemophilia, haemophilia, inhibitor, fviia, factor vii activated, bypassing
5001991|NCT01625377|Everolimus,|everolimus,
5001992|NCT01625377|liver transplantation,|liver transplantation,
5001993|NCT01625377|early introduction,|early introduction,
5001994|NCT01625377|renal function|renal function
5001995|NCT01625364|Health Education|health education
5001996|NCT01625364|Health Counseling|health counseling
5001997|NCT01625364|Patient Education|patient education
5001998|NCT01625338|HCV genotype 2 (GT-2)|hcv genotype 2 (gt-2)
5001999|NCT01625338|HCV genotype 3 (GT-3)|hcv genotype 3 (gt-3)
5002000|NCT01625338|HCV|hcv
5002001|NCT01625338|Sustained Virologic Response|sustained virologic response
5002002|NCT01625338|Direct Acting Antiviral|direct acting antiviral
5002003|NCT01625338|Combination Therapy|combination therapy
5002004|NCT01625338|GS-7977|gs-7977
5002005|NCT01625338|Ribavirin|ribavirin
5002006|NCT01625338|Open Label|open label
5002007|NCT01625325|obesity, adiposity, psychosocial, healthcare, co-morbidities, low key intervention, quality of life|obesity, adiposity, psychosocial, healthcare, co-morbidities, low key intervention, quality of life
5002008|NCT01625299|intestinal permeability|intestinal permeability
5002009|NCT01625299|diet|diet
5002010|NCT01625299|gluten|gluten
5002011|NCT01625299|dairy|dairy
5002012|NCT01625286|advanced breast cancer,|advanced breast cancer,
5002013|NCT01625286|metastatic breast cancer,|metastatic breast cancer,
5002014|NCT01625286|ER+ve breast cancer,|er+ve breast cancer,
5002015|NCT01625286|Estrogen receptor positive breast cancer,|estrogen receptor positive breast cancer,
5002016|NCT01625286|PIK3CA mutated advanced or metastatic breast cancer|pik3ca mutated advanced or metastatic breast cancer
5002017|NCT01625286|AKT inhibitor|akt inhibitor
5002018|NCT01625273|F19|f19
5002019|NCT01625273|Lactobacillus paracasei paracasei|lactobacillus paracasei paracasei
5002020|NCT01625260|cancer|cancer
5002021|NCT01625260|immunotherapy|immunotherapy
5002022|NCT01625260|targeted|targeted
5002023|NCT01625260|non-muscle invasive|non-muscle invasive
5002024|NCT01625260|interleukin-2|interleukin-2
5002025|NCT01625260|antitumor|antitumor
5002026|NCT01625260|TCR|tcr
5002027|NCT01625260|T-cell receptor|t-cell receptor
5002028|NCT01625260|p53|p53
5002029|NCT01625260|p53 gene|p53 gene
5002030|NCT01625260|p53 tumor supressor protein|p53 tumor supressor protein
5002031|NCT01625260|urothelial cancer|urothelial cancer
5002032|NCT01625260|bladder cancer|bladder cancer
5002033|NCT01625260|HLA-A2 positive|hla-a2 positive
5002034|NCT01625260|HLA-A*0201/p53 aa264-272|hla-a*0201/p53 aa264-272
5002035|NCT01625260|HLA complex|hla complex
5002036|NCT01625260|refractory|refractory
5002037|NCT01625260|relapsed|relapsed
5002038|NCT01625260|BCG|bcg
5002039|NCT01625260|multi-focal|multi-focal
5002040|NCT01625260|carcinoma in situ|carcinoma in situ
5002041|NCT01625260|transitional cell carcinoma|transitional cell carcinoma
5002042|NCT01625260|gemcitabine|gemcitabine
5002043|NCT01625234|Cancer|cancer
5002044|NCT01625234|Tumors|tumors
5002045|NCT01625234|ALK|alk
5002046|NCT01625234|NSCLC|nsclc
5002047|NCT01625234|Advanced Malignancies|advanced malignancies
5002048|NCT01625234|Carcinoma, Non-Small-Cell Lung|carcinoma, non-small-cell lung
5002049|NCT01625234|Inflammatory Myofibroblastic Tumors|inflammatory myofibroblastic tumors
5002050|NCT01625221|FENIX|fenix
5002051|NCT01625182|chronic inflammatory demyelinating polyradiculoneuropathy, CIDP, FTY720, fingolimod.|chronic inflammatory demyelinating polyradiculoneuropathy, cidp, fty720, fingolimod.
5002052|NCT01625169|Pharmacokinetics|pharmacokinetics
5002053|NCT01625169|HIV|hiv
5002054|NCT01625169|Breast milk|breast milk
5002055|NCT01625130|sulforaphane|sulforaphane
5002056|NCT01625130|ozone|ozone
5002057|NCT01625130|airway inflammation|airway inflammation
5002058|NCT01625130|broccoli sprouts|broccoli sprouts
5002059|NCT01625130|NRF2|nrf2
5002060|NCT01625130|controls|controls
5002061|NCT01625117|Treatment of ex-combatants|treatment of ex-combatants
5002062|NCT01625117|Narrative Exposure Therapy for ex-combatants|narrative exposure therapy for ex-combatants
5002063|NCT01625117|Appetitive Aggression|appetitive aggression
5002064|NCT01625117|Posttraumatic Stress Disorder|posttraumatic stress disorder
5002065|NCT01625104|Myocardial Infarction|myocardial infarction
5002066|NCT01625104|Time to Treatment|time to treatment
5002067|NCT01625104|Door to Balloon Time|door to balloon time
5002068|NCT01625091|HIV|hiv
5002069|NCT01625091|women|women
5002070|NCT01625091|drinking|drinking
5002071|NCT01625091|Naltrexone|naltrexone
5002072|NCT01625078|Baska Mask|baska mask
5002073|NCT01625078|Supraglottic airway device|supraglottic airway device
5002074|NCT01625078|Children|children
5002075|NCT01625078|Pediatric|pediatric
5002076|NCT01625065|medication compliance|medication compliance
5002077|NCT01625065|adherence|adherence
5002078|NCT01625065|toxicological analyzes|toxicological analyzes
5002079|NCT01625065|GC-MS|gc-ms
5002080|NCT01625065|HPLC|hplc
5002081|NCT01625065|pain patients|pain patients
5002082|NCT01625065|opioid misuse|opioid misuse
5002083|NCT01625065|patients with current pain|patients with current pain
5002084|NCT01625052|mask size|mask size
5002085|NCT01625052|Baska mask|baska mask
5002086|NCT01625052|supraglottic airway|supraglottic airway
5002087|NCT01625052|airway management|airway management
5002088|NCT01625039|Occupational health|occupational health
5002089|NCT01625039|cognitive behavioural therapy|cognitive behavioural therapy
5002090|NCT01625039|physiotherapy|physiotherapy
5002091|NCT01625039|physical activity|physical activity
5002092|NCT01625026|Morbidly obesity|morbidly obesity
5002093|NCT01625026|Gastric bypass|gastric bypass
5002094|NCT01625026|Cholecystolithiasis|cholecystolithiasis
5002095|NCT01625013|osteoarthritis|osteoarthritis
5002096|NCT01625013|viscosupplementation|viscosupplementation
5002097|NCT01625013|Active|active
5002098|NCT01625013|Knee|knee
5002099|NCT01625013|Synvisc-One|synvisc-one
5002100|NCT01625000|Schizophrenia|schizophrenia
5002101|NCT01625000|Antipsychotic Agents|antipsychotic agents
5002102|NCT01625000|Acute Schizophrenia|acute schizophrenia
5002103|NCT01625000|Mental Disorder|mental disorder
5002104|NCT01625000|Psychotropic Drugs|psychotropic drugs
5002105|NCT01625000|Dopamine Agents|dopamine agents
5002106|NCT01625000|Risperidone|risperidone
5002107|NCT01625000|Central Nervous System Agents|central nervous system agents
5002108|NCT01624987|Treatment of ex-combatants|treatment of ex-combatants
5002109|NCT01624987|FORNET for ex-combatants|fornet for ex-combatants
5002110|NCT01624987|Appetitive Aggression|appetitive aggression
5002111|NCT01624987|Post-traumatic Stress Disorder|post-traumatic stress disorder
5002112|NCT01624961|Controlled human malaria infection (CHMI)|controlled human malaria infection (chmi)
5002113|NCT01624961|Malaria challenge|malaria challenge
5002114|NCT01624961|Plasmodium falciparum|plasmodium falciparum
5002115|NCT01624961|PfSPZ Challenge|pfspz challenge
5002116|NCT01624948|BK virus|bk virus
5002117|NCT01624948|Kidney Transplantation|kidney transplantation
5002118|NCT01624948|Immunologic Monitoring|immunologic monitoring
5002119|NCT01624935|PTSD|ptsd
5002120|NCT01624935|earthquake|earthquake
5002121|NCT01624935|disaster|disaster
5002122|NCT01624935|global mental health|global mental health
5002123|NCT01624935|disaster mental health|disaster mental health
5002124|NCT01624935|depression|depression
5002125|NCT01624870|Aortic Valve Stenosis|aortic valve stenosis
5002126|NCT01624870|Valvular Heart Disease|valvular heart disease
5002127|NCT01624870|Transcatheter Aortic Valve Implantation|transcatheter aortic valve implantation
5002128|NCT01624844|ultrasound|ultrasound
5002129|NCT01624831|Psychosis|psychosis
5002130|NCT01624831|schizophrenia|schizophrenia
5002131|NCT01624831|schizoaffective disorder|schizoaffective disorder
5002132|NCT01624831|Bipolar disorder with psychotic features|bipolar disorder with psychotic features
5002133|NCT01624831|Major depression with psychotic features|major depression with psychotic features
5002134|NCT01624831|Psychosis NOS|psychosis nos
5002135|NCT01624831|Social Cognition|social cognition
5002136|NCT01624818|coping|coping
5002137|NCT01624818|physical activity|physical activity
5002138|NCT01624818|psychosocial|psychosocial
5002139|NCT01624818|children|children
5002140|NCT01624818|heart disease|heart disease
5002141|NCT01624818|habilitation|habilitation
5002142|NCT01624805|Leukemia|leukemia
5002143|NCT01624805|Aplastic Anemia|aplastic anemia
5002144|NCT01624805|AA|aa
5002145|NCT01624805|Low/Int-1 Risk Myelodysplastic Syndrome|low/int-1 risk myelodysplastic syndrome
5002146|NCT01624805|MDS|mds
5002147|NCT01624805|hATG|hatg
5002148|NCT01624805|Horse Antithymocyte Globulin|horse antithymocyte globulin
5002149|NCT01624805|ATG|atg
5002150|NCT01624805|Antithymocyte Globulin|antithymocyte globulin
5002151|NCT01624805|Thymoglobulin|thymoglobulin
5002152|NCT01624805|Cyclosporine|cyclosporine
5002153|NCT01624805|Sandimmune|sandimmune
5002154|NCT01624805|CYA|cya
5002155|NCT01624805|Cyclosporin A|cyclosporin a
5002156|NCT01624805|Methylprednisone|methylprednisone
5002157|NCT01624805|Methylprednisolone|methylprednisolone
5002158|NCT01624805|Depo-Medrol|depo-medrol
5002159|NCT01624805|Medrol|medrol
5002160|NCT01624805|Solu-Medrol|solu-medrol
5002161|NCT01624805|pegfilgrastim|pegfilgrastim
5002162|NCT01624805|Neulasta|neulasta
5002163|NCT01624805|PEG-G-CSF|peg-g-csf
5002164|NCT01624805|Filgrastim|filgrastim
5002165|NCT01624805|C-CSF|c-csf
5002166|NCT01624805|Neupogen|neupogen
5002167|NCT01624792|Protein metabolism|protein metabolism
5002168|NCT01624792|casein protein|casein protein
5002169|NCT01624792|EPA|epa
5002170|NCT01624792|Fish oil|fish oil
5002171|NCT01624779|autologous adipose tissue|autologous adipose tissue
5002172|NCT01624766|Advanced Cancers|advanced cancers
5002173|NCT01624766|Advanced Malignancies|advanced malignancies
5002174|NCT01624766|Metastatic Cancers|metastatic cancers
5002175|NCT01624766|Everolimus|everolimus
5002176|NCT01624766|Afinitor|afinitor
5002177|NCT01624766|RAD001|rad001
5002178|NCT01624766|Anakinra|anakinra
5002179|NCT01624766|Kineret|kineret
5002180|NCT01624766|Denosumab|denosumab
5002181|NCT01624766|AMG 162|amg 162
5002182|NCT01624753|interstitial lung disease|interstitial lung disease
5002183|NCT01624753|interstitial pneumonia|interstitial pneumonia
5002184|NCT01624753|idiopathic pulmonary fibrosis|idiopathic pulmonary fibrosis
5002185|NCT01624727|Coronary heart disease|coronary heart disease
5002186|NCT01624727|metabolic syndrome|metabolic syndrome
5002187|NCT01624727|CT angiography|ct angiography
5002188|NCT01624714|Treatment Refractory|treatment refractory
5002189|NCT01624701|Cord blood|cord blood
5002190|NCT01624701|unrelated donor|unrelated donor
5002191|NCT01624701|allogeneic|allogeneic
5002192|NCT01624701|cell dose|cell dose
5002193|NCT01624688|Tattoo|tattoo
5002194|NCT01624688|Tattoo Removal|tattoo removal
5002195|NCT01624675|Autistic disorder in children and adolescents|autistic disorder in children and adolescents
5002196|NCT01624675|Risperidone (R064766)|risperidone (r064766)
5002197|NCT01624675|Children|children
5002198|NCT01624675|Adolescents|adolescents
5002199|NCT01624675|Irritability|irritability
5002200|NCT01624675|Autistic disorder|autistic disorder
5002201|NCT01624649|Attention-deficit hyperactivity disorder|attention-deficit hyperactivity disorder
5002202|NCT01624649|Developmental disorder|developmental disorder
5002203|NCT01624649|Atomoxetine|atomoxetine
5002204|NCT01624649|Methylphenidate|methylphenidate
5002205|NCT01624649|Psychiatric disorder|psychiatric disorder
5002206|NCT01624636|AMD|amd
5002207|NCT01624636|Age-related Macular Degeneration|age-related macular degeneration
5002208|NCT01624636|Wet AMD|wet amd
5002209|NCT01624636|Neovascular AMD|neovascular amd
5002210|NCT01624623|radiation|radiation
5002211|NCT01624623|Calypso|calypso
5002212|NCT01624623|prostatectomy|prostatectomy
5002213|NCT01624610|Irritable bowel syndrome|irritable bowel syndrome
5002214|NCT01624610|Diarrhea|diarrhea
5002215|NCT01624610|abdominal pain|abdominal pain
5002216|NCT01624610|diet|diet
5002217|NCT01624610|nutrition|nutrition
5002218|NCT01624597|Road traffic safety|road traffic safety
5002219|NCT01624584|child|child
5002220|NCT01624584|anxiety|anxiety
5002221|NCT01624584|CBT|cbt
5002222|NCT01624558|malignant hyperthermia|malignant hyperthermia
5002223|NCT01624545|chronic subdural hematoma|chronic subdural hematoma
5002224|NCT01624545|burr hole trepanation|burr hole trepanation
5002225|NCT01624545|radiologic follow-up|radiologic follow-up
5002226|NCT01624545|outcome|outcome
5002227|NCT01624545|recurrence|recurrence
5002228|NCT01624532|Anthrax vaccine|anthrax vaccine
5002229|NCT01624519|Arterial Lactate|arterial lactate
5002230|NCT01624519|Central Venous Lactate|central venous lactate
5002231|NCT01624519|Peripheral Venous Lactate|peripheral venous lactate
5002232|NCT01624506|GERD|gerd
5002233|NCT01624506|Fundoplication|fundoplication
5002234|NCT01624506|Magnetic Sphincter Augmentation|magnetic sphincter augmentation
5002235|NCT01624493|Vascular Disrupting Agents|vascular disrupting agents
5002236|NCT01624493|BNC105P|bnc105p
5002237|NCT01624493|Partially platinum sensitive|partially platinum sensitive
5002238|NCT01624480|Pediatric Narcolepsy|pediatric narcolepsy
5002239|NCT01624467|Advanced Solid Tumors|advanced solid tumors
5002240|NCT01624454|colonoscopy|colonoscopy
5002241|NCT01624454|bowel cleansing|bowel cleansing
5002242|NCT01624428|Tobacco|tobacco
5002243|NCT01624428|Adolescent|adolescent
5002244|NCT01624428|Nicotine|nicotine
5002245|NCT01624428|Magnetic Resonance Imaging|magnetic resonance imaging
5002246|NCT01624428|Varenicline|varenicline
5002247|NCT01624389|[18F]AV-45 PET amyloid binding imaging|[18f]av-45 pet amyloid binding imaging
5002248|NCT01624389|Alzheimer's disease|alzheimer's disease
5002249|NCT01624376|non-invasive management|non-invasive management
5002250|NCT01624376|Fistula|fistula
5002251|NCT01624376|Crohn's Disease|crohn's disease
5002252|NCT01624376|local administration|local administration
5002253|NCT01624376|non-invasive|non-invasive
5002254|NCT01624363|Pancreatic cysts incidentally found during EUS|pancreatic cysts incidentally found during eus
5002255|NCT01624350|Anorectal Fistulas|anorectal fistulas
5002256|NCT01624337|Plasmodium falciparum|plasmodium falciparum
5002257|NCT01624337|Plasmodium vivax|plasmodium vivax
5002258|NCT01624324|aminoglycoside|aminoglycoside
5002259|NCT01624324|KIM-1|kim-1
5002260|NCT01624324|DPOAE|dpoae
5002261|NCT01624324|nephrotoxicity|nephrotoxicity
5002262|NCT01624324|ototoxicity|ototoxicity
5002263|NCT01624311|High ammonia level|high ammonia level
5002264|NCT01624311|Hyperammonemia|hyperammonemia
5002265|NCT01624311|Poor suck|poor suck
5002266|NCT01624311|Lethargy|lethargy
5002267|NCT01624311|Coma|coma
5002268|NCT01624311|Encephalopathy|encephalopathy
5002269|NCT01624311|Seizures|seizures
5002270|NCT01624311|Brain edema|brain edema
5002271|NCT01624311|Urea Cycle Disorder|urea cycle disorder
5002272|NCT01624311|Ornithine Transcarbamylase Deficiency|ornithine transcarbamylase deficiency
5002273|NCT01624311|Carbamoyl Phosphate Synthetase Deficiency|carbamoyl phosphate synthetase deficiency
5002274|NCT01624311|Citrullinemia|citrullinemia
5002275|NCT01624311|Argininosuccinic Aciduria|argininosuccinic aciduria
5002276|NCT01624311|Organic Acidemia|organic acidemia
5002277|NCT01624311|Propionic Aciduria|propionic aciduria
5002278|NCT01624311|Methylmalonic Aciduria|methylmalonic aciduria
5002279|NCT01624311|Isovaleric Aciduria|isovaleric aciduria
5002280|NCT01624298|Randomized controlled trial|randomized controlled trial
5002281|NCT01624298|Traumatized youth|traumatized youth
5002282|NCT01624298|HIV risk|hiv risk
5002283|NCT01624272|Physical Therapy|physical therapy
5002284|NCT01624272|Respiratory Muscle Training|respiratory muscle training
5002285|NCT01624272|Elderly|elderly
5002286|NCT01624220|Spinal tumor|spinal tumor
5002287|NCT01624220|Tumor of the mid or lower spine|tumor of the mid or lower spine
5002288|NCT01624220|Non-small cell lung cancer|non-small cell lung cancer
5002289|NCT01624220|Breast cancer|breast cancer
5002290|NCT01624220|Prostate cancer|prostate cancer
5002291|NCT01624220|Renal cell cancer|renal cell cancer
5002292|NCT01624220|Melanoma|melanoma
5002293|NCT01624220|Gastrointestinal cancer|gastrointestinal cancer
5002294|NCT01624220|Sarcoma|sarcoma
5002295|NCT01624220|Thyroid cancer|thyroid cancer
5002296|NCT01624220|Head and neck primary cancer|head and neck primary cancer
5002297|NCT01624220|Carcinoma of unknown primary|carcinoma of unknown primary
5002298|NCT01624220|Fiducial markers|fiducial markers
5002299|NCT01624220|Gold seed markers|gold seed markers
5002300|NCT01624220|Spinal stereotactic body radiation therapy|spinal stereotactic body radiation therapy
5002301|NCT01624220|Spinal SBRT|spinal sbrt
5002302|NCT01624220|Stereotactic Radiotherapy|stereotactic radiotherapy
5002303|NCT01624207|Atorva|atorva
5002304|NCT01624207|generic|generic
5002305|NCT01624207|atorvastatin|atorvastatin
5002306|NCT01624207|hypercholesterolemia|hypercholesterolemia
5002307|NCT01624181|ion mobility spectrometry|ion mobility spectrometry
5002308|NCT01624181|hospital-acquired pneumonia|hospital-acquired pneumonia
5002309|NCT01624181|microbiological investigation|microbiological investigation
5002310|NCT01624181|intensive care|intensive care
5002311|NCT01624168|anxiety|anxiety
5002312|NCT01624168|sleep quality|sleep quality
5002313|NCT01624168|tai chi chuan|tai chi chuan
5002314|NCT01624168|young adults|young adults
5002315|NCT01624155|teratogens|teratogens
5002316|NCT01624155|contraception|contraception
5002317|NCT01624155|electronic medical record|electronic medical record
5002318|NCT01624142|Hypercholesterolemia|hypercholesterolemia
5002319|NCT01624142|Elevated Cholesterol|elevated cholesterol
5002320|NCT01624142|High Cholesterol|high cholesterol
5002321|NCT01624142|Homozygous Familial Hypercholesterolemia|homozygous familial hypercholesterolemia
5002322|NCT01624142|PCSK9 mutations|pcsk9 mutations
5002323|NCT01624142|Severe Familial Hypercholesterolemia|severe familial hypercholesterolemia
5002324|NCT01624103|Arm Injuries|arm injuries
5002325|NCT01624103|Wounds and Injuries|wounds and injuries
5002326|NCT01624103|Lidocaine|lidocaine
5002327|NCT01624103|Levobupivacaine|levobupivacaine
5002328|NCT01624103|Bupivacaine|bupivacaine
5002329|NCT01624103|Anesthetics|anesthetics
5002330|NCT01624103|Central Nervous System Depressants|central nervous system depressants
5002331|NCT01624103|Physiological Effects of Drugs|physiological effects of drugs
5002332|NCT01624090|Cancer Stem Cell|cancer stem cell
5002333|NCT01624090|Thoracic Malignancies|thoracic malignancies
5002334|NCT01624090|Mythramycin Treatment|mythramycin treatment
5002335|NCT01624090|Lung Tumors|lung tumors
5002336|NCT01624090|Metastatic Lung Tumors|metastatic lung tumors
5002337|NCT01624077|Regulatory T cells|regulatory t cells
5002338|NCT01624077|Liver Transplantation|liver transplantation
5002339|NCT01624077|Rejection|rejection
5002340|NCT01624077|Tolerance|tolerance
5002341|NCT01624077|Cell tolerance|cell tolerance
5002342|NCT01624077|Survival|survival
5002343|NCT01624064|Renal Insufficiency, Chronic|renal insufficiency, chronic
5002344|NCT01624064|Uncertain aetiology|uncertain aetiology
5002345|NCT01624064|ACEI|acei
5002346|NCT01624051|cisplatin based chemotherapy|cisplatin based chemotherapy
5002347|NCT01624051|non-small cell lung cancer|non-small cell lung cancer
5002348|NCT01624051|lean body mass|lean body mass
5002349|NCT01624051|sarcopenia|sarcopenia
5002350|NCT01624038|Hydroxyurea|hydroxyurea
5002351|NCT01624038|Erythropoitin therapy|erythropoitin therapy
5002352|NCT01624038|Thalassemia intermedia|thalassemia intermedia
5002353|NCT01624025|AGC, second-line, docetaxel, epirubicin|agc, second-line, docetaxel, epirubicin
5002354|NCT01624012|NIV NAVA|niv nava
5002355|NCT01624012|non-invasive ventilation|non-invasive ventilation
5002356|NCT01623973|hemiparetic|hemiparetic
5002357|NCT01623973|cognitive|cognitive
5002358|NCT01623973|balance|balance
5002359|NCT01623960|severe haemophilia|severe haemophilia
5002360|NCT01623960|quality of life|quality of life
5002361|NCT01623947|glutamine|glutamine
5002362|NCT01623947|cycling performance|cycling performance
5002363|NCT01623947|mental function|mental function
5002364|NCT01623934|Gestational diabetes|gestational diabetes
5002365|NCT01623934|Adiponectin|adiponectin
5002366|NCT01623934|Leptin|leptin
5002367|NCT01623934|Single Nucleotides Polymorphisms|single nucleotides polymorphisms
5002368|NCT01623934|Insulin resistance|insulin resistance
5002369|NCT01623921|Lung|lung
5002370|NCT01623921|Contusion|contusion
5002371|NCT01623921|Injury|injury
5002372|NCT01623921|Cyclooxygenase|cyclooxygenase
5002373|NCT01623921|Statin|statin
5002374|NCT01623908|Breast neoplasms|breast neoplasms
5002375|NCT01623908|Zoledronate|zoledronate
5002376|NCT01623908|Bone loss|bone loss
5002377|NCT01623882|Diabetes Mellitus|diabetes mellitus
5002378|NCT01623882|Wounds|wounds
5002379|NCT01623882|Ulcers|ulcers
5002380|NCT01623843|FAI|fai
5002381|NCT01623843|randomized|randomized
5002382|NCT01623843|hip arthroscopy|hip arthroscopy
5002383|NCT01623843|lavage|lavage
5002384|NCT01623843|osteochondroplasty|osteochondroplasty
5002385|NCT01623830|reconsolidation|reconsolidation
5002386|NCT01623830|fear of flying|fear of flying
5002387|NCT01623830|virtual reality|virtual reality
5002388|NCT01623830|virtual reality exposure therapy|virtual reality exposure therapy
5002389|NCT01623804|Ultrasound therapy|ultrasound therapy
5002390|NCT01623804|Tibiofemoral joint, medial|tibiofemoral joint, medial
5002391|NCT01623804|Nonsurgical|nonsurgical
5002392|NCT01623791|Pre-eclampsia|pre-eclampsia
5002393|NCT01623791|Proteinuria|proteinuria
5002394|NCT01623791|Protein - creatinine ratio|protein - creatinine ratio
5002395|NCT01623791|Dipstick proteinuria|dipstick proteinuria
5002396|NCT01623791|Severity of disease|severity of disease
5002397|NCT01623778|HBeAg seroconversion|hbeag seroconversion
5002398|NCT01623778|Peginterferon alfa-2a|peginterferon alfa-2a
5002399|NCT01623778|chronic hepatitis B(CHB|chronic hepatitis b(chb
5002400|NCT01623778|Optimal therapy|optimal therapy
5002401|NCT01623778|Response guild treatment(RGT);|response guild treatment(rgt);
5002402|NCT01623765|Endobronchial ultrasound, lung cancer|endobronchial ultrasound, lung cancer
5002403|NCT01623739|Dental implants|dental implants
5002404|NCT01623739|Esthetic score|esthetic score
5002405|NCT01623739|Immediate implants|immediate implants
5002406|NCT01623739|Early placement|early placement
5002407|NCT01623726|Transcranial Direct Current Stimulation|transcranial direct current stimulation
5002408|NCT01623726|Schizophrenia|schizophrenia
5002409|NCT01623713|schizophrenia|schizophrenia
5002410|NCT01623713|iloperidone|iloperidone
5002411|NCT01623713|Risperidone|risperidone
5002412|NCT01623713|Efficacy|efficacy
5002413|NCT01623713|Safety|safety
5002414|NCT01623700|clopidogrel|clopidogrel
5002415|NCT01623700|aspirin|aspirin
5002416|NCT01623700|percutaneous coronary intervention|percutaneous coronary intervention
5002417|NCT01623700|coronary stenting|coronary stenting
5002418|NCT01623700|antiplatelet|antiplatelet
5002419|NCT01623687|total hip arthroplasty|total hip arthroplasty
5002420|NCT01623687|bone metabolism|bone metabolism
5002421|NCT01623687|mineralisation|mineralisation
5002422|NCT01623674|Sleep deprivation in surgeons during night shifts and the effect on performance.|sleep deprivation in surgeons during night shifts and the effect on performance.
5002423|NCT01623661|Nephrology|nephrology
5002424|NCT01623661|chronic kidney disease|chronic kidney disease
5002425|NCT01623661|sodium-channels|sodium-channels
5002426|NCT01623661|water-channels|water-channels
5002427|NCT01623661|BCM|bcm
5002428|NCT01623648|whey protein|whey protein
5002429|NCT01623648|hunger|hunger
5002430|NCT01623609|Phase 1|phase 1
5002431|NCT01623609|Healthy volunteers|healthy volunteers
5002432|NCT01623609|Naloxegol|naloxegol
5002433|NCT01623609|Bioequivalence|bioequivalence
5002434|NCT01623583|lidocaine|lidocaine
5002435|NCT01623583|tetracaine|tetracaine
5002436|NCT01623583|Renal dialysis|renal dialysis
5002437|NCT01623570|Luteinizing Hormone|luteinizing hormone
5002438|NCT01623570|Hypogonadotropic Hypogonadism|hypogonadotropic hypogonadism
5002439|NCT01623570|Ovulation Induction|ovulation induction
5002440|NCT01623570|Chorionic Gonadotropin|chorionic gonadotropin
5002441|NCT01623557|Malaria|malaria
5002442|NCT01623557|Vaccine|vaccine
5002443|NCT01623557|Plasmodium|plasmodium
5002444|NCT01623557|falciparum|falciparum
5002445|NCT01623544|Asthma|asthma
5002446|NCT01623544|Comparative Effectiveness|comparative effectiveness
5002447|NCT01623544|Symbicort|symbicort
5002448|NCT01623531|Fibrinogen|fibrinogen
5002449|NCT01623531|cardiac surgery|cardiac surgery
5002450|NCT01623531|high risk|high risk
5002451|NCT01623531|cardiopulmonary bypass|cardiopulmonary bypass
5002452|NCT01623531|bleeding|bleeding
5002453|NCT01623531|blood transfusion|blood transfusion
5002454|NCT01623505|Smoking Cessation|smoking cessation
5002455|NCT01623505|Psychiatric Illness|psychiatric illness
5002456|NCT01623505|Pharmacotherapy|pharmacotherapy
5002457|NCT01623492|Eisenmenger|eisenmenger
5002458|NCT01623466|PK and Safety|pk and safety
5002459|NCT01623453|crohn's disease|crohn's disease
5002460|NCT01623453|fistula|fistula
5002461|NCT01623453|complex|complex
5002462|NCT01623427|pediatric|pediatric
5002463|NCT01623427|laparoscopy|laparoscopy
5002464|NCT01623427|vacuum|vacuum
5002465|NCT01623427|dressing|dressing
5002466|NCT01623362|Dentifrices|dentifrices
5002467|NCT01623362|Dental Caries|dental caries
5002468|NCT01623362|Fluorides|fluorides
5002469|NCT01623362|Nails|nails
5002470|NCT01623362|pH|ph
5002471|NCT01623349|Recurrent|recurrent
5002472|NCT01623349|High Grade|high grade
5002473|NCT01623349|Serous|serous
5002474|NCT01623349|Triple Negative|triple negative
5002475|NCT01623336|HEPATITIS|hepatitis
5002476|NCT01623336|HEPATITIS C|hepatitis c
5002477|NCT01623336|PEGINTERFERON|peginterferon
5002478|NCT01623336|BIOEQUIVALENCE|bioequivalence
5002479|NCT01623336|TREATMENT|treatment
5002480|NCT01623297|Laparoscopy|laparoscopy
5002481|NCT01623297|Surgery|surgery
5002482|NCT01623297|Acute Phase Reaction|acute phase reaction
5002483|NCT01623297|Aged|aged
5002484|NCT01623297|Aged 80 and over|aged 80 and over
5002485|NCT01623297|Confusion|confusion
5002486|NCT01623297|Inflammation|inflammation
5002487|NCT01623297|Delirium|delirium
5002488|NCT01623284|aphasia|aphasia
5002489|NCT01623284|apraxia of speech|apraxia of speech
5002490|NCT01623284|language|language
5002491|NCT01623271|CRPS I|crps i
5002492|NCT01623232|vaccine|vaccine
5002493|NCT01623232|influenzavirus A|influenzavirus a
5002494|NCT01623232|influenzavirus B|influenzavirus b
5002495|NCT01623232|adjuvant|adjuvant
5002496|NCT01623219|PTSD|ptsd
5002497|NCT01623219|trauma|trauma
5002498|NCT01623219|combat trauma|combat trauma
5002499|NCT01623219|veterans|veterans
5002500|NCT01623219|telemedicine|telemedicine
5002501|NCT01623219|prolonged exposure|prolonged exposure
5002502|NCT01623193|Cardioplegia|cardioplegia
5002503|NCT01623193|Blood transfusion|blood transfusion
5002504|NCT01623193|Cardiac function|cardiac function
5002505|NCT01623193|Myocardial edema|myocardial edema
5002506|NCT01623193|Coronary artery disease|coronary artery disease
5002507|NCT01623193|Valve disease|valve disease
5002508|NCT01623180|DES|des
5002509|NCT01623180|coronary stent|coronary stent
5002510|NCT01623180|bare metal stent|bare metal stent
5002511|NCT01623180|high bleeding|high bleeding
5002512|NCT01623180|MI|mi
5002513|NCT01623180|angina|angina
5002514|NCT01623167|Pancytopenia|pancytopenia
5002515|NCT01623167|Immunosuppression|immunosuppression
5002516|NCT01623167|Hematopoesis|hematopoesis
5002517|NCT01623167|Autoimmunity|autoimmunity
5002518|NCT01623167|Thrombocytopenia|thrombocytopenia
5002519|NCT01623154|Helicobacter pylori|helicobacter pylori
5002520|NCT01623141|CRPS|crps
5002521|NCT01623141|TPBS|tpbs
5002522|NCT01623141|Pressure pain thresholds|pressure pain thresholds
5002523|NCT01623141|limb pain of other origin|limb pain of other origin
5002524|NCT01623128|Breastfeeding initiation|breastfeeding initiation
5002525|NCT01623128|Breastfeeding duration|breastfeeding duration
5002526|NCT01623128|WIC|wic
5002527|NCT01623128|Video education|video education
5002528|NCT01623128|Breastfeeding rates|breastfeeding rates
5002529|NCT01623115|PCSK9|pcsk9
5002530|NCT01623102|Bevacizumab|bevacizumab
5002531|NCT01623102|gemcitabine|gemcitabine
5002532|NCT01623102|cisplatin|cisplatin
5002533|NCT01623102|EGFR wild-type|egfr wild-type
5002534|NCT01623089|severe asthma, phenotype, data|severe asthma, phenotype, data
5002535|NCT01623076|Neuromyelitis Optica|neuromyelitis optica
5002536|NCT01623076|Neuromyelitis Optica Spectrum Disorder|neuromyelitis optica spectrum disorder
5002537|NCT01623076|Transverse Myelitis|transverse myelitis
5002538|NCT01623076|Optic Neuritis|optic neuritis
5002539|NCT01623076|Biorepository|biorepository
5002540|NCT01623063|endometrium|endometrium
5002541|NCT01623063|infertility|infertility
5002542|NCT01623063|uterus|uterus
5002543|NCT01623063|histeroscopy|histeroscopy
5002544|NCT01623037|Lipolysis|lipolysis
5002545|NCT01623037|Cryolipolysis|cryolipolysis
5002546|NCT01623037|Fat Reduction|fat reduction
5002547|NCT01623011|Shoulder|shoulder
5002548|NCT01623011|Sub-acromial|sub-acromial
5002549|NCT01623011|Rotator Cuff|rotator cuff
5002550|NCT01623011|Impingement|impingement
5002551|NCT01622998|Pharmacotherapy|pharmacotherapy
5002552|NCT01622998|Titration|titration
5002553|NCT01622998|Smoking Cessation|smoking cessation
5002554|NCT01622959|emergency departement|emergency departement
5002555|NCT01622959|acute pain|acute pain
5002556|NCT01622959|acupuncture|acupuncture
5002557|NCT01622959|morphine|morphine
5002558|NCT01622946|total hip arthroplasty|total hip arthroplasty
5002559|NCT01622946|tranexamic acid|tranexamic acid
5002560|NCT01622946|postoperative blood loss|postoperative blood loss
5002561|NCT01622933|melanoma|melanoma
5002562|NCT01622933|recurrent|recurrent
5002563|NCT01622933|metastatic|metastatic
5002564|NCT01622920|enamel erosion|enamel erosion
5002565|NCT01622920|ultrasound|ultrasound
5002566|NCT01622920|reproducibility|reproducibility
5002567|NCT01622920|human central incisor|human central incisor
5002568|NCT01622920|reliability|reliability
5002569|NCT01622907|Catheter ablation, radiofrequency|catheter ablation, radiofrequency
5002570|NCT01622907|Epicardially applied radiofrequency ablation|epicardially applied radiofrequency ablation
5002571|NCT01622907|Minimally invasive surgical approach|minimally invasive surgical approach
5002572|NCT01622894|Alzheimer genetics|alzheimer genetics
5002573|NCT01622855|Rape|rape
5002574|NCT01622855|Secondary prevention|secondary prevention
5002575|NCT01622855|Intervention|intervention
5002576|NCT01622842|Impedance|impedance
5002577|NCT01622842|Electrical|electrical
5002578|NCT01622842|Tissue|tissue
5002579|NCT01622842|Excitation frequency|excitation frequency
5002580|NCT01622842|arterial distension|arterial distension
5002581|NCT01622842|distension wave form|distension wave form
5002582|NCT01622777|Rosuvastatin|rosuvastatin
5002583|NCT01622777|Diabetic polyneuropathy|diabetic polyneuropathy
5002584|NCT01622777|Nerve conduction|nerve conduction
5002585|NCT01622777|Oxidative stress|oxidative stress
5002586|NCT01622777|Nerve growth factor|nerve growth factor
5002587|NCT01622764|RO5323441|ro5323441
5002588|NCT01622764|bevacizumab|bevacizumab
5002589|NCT01622764|PET imaging|pet imaging
5002590|NCT01622764|recurrent glioblastoma|recurrent glioblastoma
5002591|NCT01622751|REM sleep|rem sleep
5002592|NCT01622751|Adiponectin|adiponectin
5002593|NCT01622751|Prader-Willi syndrome|prader-willi syndrome
5002594|NCT01622725|ventral hernia|ventral hernia
5002595|NCT01622712|inguinal hernia|inguinal hernia
5002596|NCT01622699|Jaundice|jaundice
5002597|NCT01622699|Neonatal Jaundice|neonatal jaundice
5002598|NCT01622699|Hyperbilirubinemia|hyperbilirubinemia
5002599|NCT01622699|Transcutaneous bilirubin measurement|transcutaneous bilirubin measurement
5002600|NCT01622699|Transcutaneous bilirubinometry|transcutaneous bilirubinometry
5002601|NCT01622699|jaundice meter|jaundice meter
5002602|NCT01622699|Visual assessment of bilirubin|visual assessment of bilirubin
5002603|NCT01622699|Newborn|newborn
5002604|NCT01622686|Prescription Labels|prescription labels
5002605|NCT01622686|Low Health Literacy|low health literacy
5002606|NCT01622686|Limited English Proficiency|limited english proficiency
5002607|NCT01622686|Spanish|spanish
5002608|NCT01622660|URETER|ureter
5002609|NCT01622660|URINARY BLADDER|urinary bladder
5002610|NCT01622660|renal pelvis|renal pelvis
5002611|NCT01622660|GEMCITABINE|gemcitabine
5002612|NCT01622660|GW786034 (PAZOPANIB)|gw786034 (pazopanib)
5002613|NCT01622660|11-191|11-191
5002614|NCT01622647|NCPAP|ncpap
5002615|NCT01622634|cardiovascular disease|cardiovascular disease
5002616|NCT01622634|diabetes mellitus|diabetes mellitus
5002617|NCT01622621|Lung|lung
5002618|NCT01622621|Cancer|cancer
5002619|NCT01622608|Adolescent vaccination|adolescent vaccination
5002620|NCT01622608|Immunization rates|immunization rates
5002621|NCT01622608|Informational kiosk|informational kiosk
5002622|NCT01622608|Tailored health messaging|tailored health messaging
5002623|NCT01622608|Barriers to vaccination|barriers to vaccination
5002624|NCT01622608|Attitudes|attitudes
5002625|NCT01622608|Intentions|intentions
5002626|NCT01622595|Aspergillosis|aspergillosis
5002627|NCT01622595|Candidemia|candidemia
5002628|NCT01622595|Candidiasis|candidiasis
5002629|NCT01622595|C. Difficile|c. difficile
5002630|NCT01622595|cytomegalovirus|cytomegalovirus
5002631|NCT01622595|respiratory syncytial virus (RSV)|respiratory syncytial virus (rsv)
5002632|NCT01622595|Influenza|influenza
5002633|NCT01622595|CONS|cons
5002634|NCT01622582|Multiple Myeloma, Engraftment syndrome|multiple myeloma, engraftment syndrome
5002635|NCT01622556|Chronic Myeloid Leukemia|chronic myeloid leukemia
5002636|NCT01622556|Acute Myeloid Leukemia|acute myeloid leukemia
5002637|NCT01622556|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
5002638|NCT01622556|Non-Hodgkins Lymphoma|non-hodgkins lymphoma
5002639|NCT01622556|Hodgkin's Disease|hodgkin's disease
5002640|NCT01622556|Myelodysplastic Syndromes|myelodysplastic syndromes
5002641|NCT01622556|Myeloproliferative Disorder|myeloproliferative disorder
5002642|NCT01622504|Intranasal|intranasal
5002643|NCT01622504|nasal spray|nasal spray
5002644|NCT01622504|opioid|opioid
5002645|NCT01622504|overdose|overdose
5002646|NCT01622491|H1N1|h1n1
5002647|NCT01622491|pandemic|pandemic
5002648|NCT01622491|influenza|influenza
5002649|NCT01622491|pneumonia|pneumonia
5002650|NCT01622491|vaccine|vaccine
5002651|NCT01622491|effectiveness|effectiveness
5002652|NCT01622491|Manitoba|manitoba
5002653|NCT01622491|Canada|canada
5002654|NCT01622478|sentinel lymph node biopsy|sentinel lymph node biopsy
5002655|NCT01622478|neoadjuvant chemotherapy|neoadjuvant chemotherapy
5002656|NCT01622478|breast cancer|breast cancer
5002657|NCT01622478|locally advanced breast cancer|locally advanced breast cancer
5002658|NCT01622478|positive axillary lymph node|positive axillary lymph node
5002659|NCT01622478|negative conversion|negative conversion
5002660|NCT01622465|Hip arthroplasty|hip arthroplasty
5002661|NCT01622465|Aged|aged
5002662|NCT01622465|Rehabilitation|rehabilitation
5002663|NCT01622465|Exercise therapy|exercise therapy
5002664|NCT01622452|Postoperative cognitive dysfunction|postoperative cognitive dysfunction
5002665|NCT01622452|Cognitive decline|cognitive decline
5002666|NCT01622452|Valve surgery|valve surgery
5002667|NCT01622452|Cardiac surgery|cardiac surgery
5002668|NCT01622452|Diffusion Tensor Imaging|diffusion tensor imaging
5002669|NCT01622452|Brain Morphometry|brain morphometry
5002670|NCT01622452|1H-Magnetic Resonance Spectroscopy|1h-magnetic resonance spectroscopy
5002671|NCT01622439|Lymphoma|lymphoma
5002672|NCT01622439|Diffuse large B-cell lymphoma|diffuse large b-cell lymphoma
5002673|NCT01622439|Valproate|valproate
5002674|NCT01622439|R-CHOP|r-chop
5002675|NCT01622439|CD 20|cd 20
5002676|NCT01622413|lumbar spine|lumbar spine
5002677|NCT01622413|herniated disc|herniated disc
5002678|NCT01622413|slipped disc|slipped disc
5002679|NCT01622413|disc herniation|disc herniation
5002680|NCT01622413|discectomy|discectomy
5002681|NCT01622413|nucleotomy|nucleotomy
5002682|NCT01622413|disc surgery|disc surgery
5002683|NCT01622413|endoscopy|endoscopy
5002684|NCT01622413|spine|spine
5002685|NCT01622400|Cardiovascular risk, Therapeutic education, General practice|cardiovascular risk, therapeutic education, general practice
5003478|NCT01619072|home births|home births
5002686|NCT01622387|Coronary artery bypass surgery|coronary artery bypass surgery
5002687|NCT01622387|Arteries|arteries
5002688|NCT01622387|Veins|veins
5002689|NCT01622387|Conduits|conduits
5002690|NCT01622374|Music|music
5002691|NCT01622374|dental anxiety|dental anxiety
5002692|NCT01622374|"music for the mind"|"music for the mind"
5002693|NCT01622374|mozart|mozart
5002694|NCT01622374|iranian traditional music|iranian traditional music
5002695|NCT01622361|Neoadjuvant|neoadjuvant
5002696|NCT01622361|endocrine therapy|endocrine therapy
5002697|NCT01622361|premenopausal|premenopausal
5002698|NCT01622361|hormone responsive|hormone responsive
5002699|NCT01622361|HER2 negative|her2 negative
5002700|NCT01622361|lymph node positive|lymph node positive
5002701|NCT01622348|Psoriasis|psoriasis
5002702|NCT01622348|Plaque Psoriasis|plaque psoriasis
5002703|NCT01622309|Oxidative Stress|oxidative stress
5002704|NCT01622309|Obesity|obesity
5002705|NCT01622309|Solanum melongena|solanum melongena
5002706|NCT01622218|Medical clown|medical clown
5002707|NCT01622192|Probing|probing
5002708|NCT01622192|manual probe|manual probe
5002709|NCT01622192|automated probe|automated probe
5002710|NCT01622192|Periodontal disease|periodontal disease
5002711|NCT01622179|surgery|surgery
5002712|NCT01622179|suture method|suture method
5002713|NCT01622179|blood supply|blood supply
5002714|NCT01622140|T-SPOT.TB|t-spot.tb
5002715|NCT01622140|QuantiFERON-TB Gold In-Tube|quantiferon-tb gold in-tube
5002716|NCT01622140|Latent tuberculosis infection|latent tuberculosis infection
5002717|NCT01622140|Tuberculin skin test|tuberculin skin test
5002718|NCT01622140|Discordance|discordance
5002719|NCT01622140|Predictive value|predictive value
5002720|NCT01622140|Tuberculosis disease development|tuberculosis disease development
5002721|NCT01622114|Obesity|obesity
5002722|NCT01622114|Weight reduction|weight reduction
5002723|NCT01622114|premenopausal Women|premenopausal women
5002724|NCT01622114|Menstrual cycle|menstrual cycle
5002725|NCT01622114|quality of life|quality of life
5002726|NCT01622114|food cravings|food cravings
5002727|NCT01622101|Energy expenditure|energy expenditure
5002728|NCT01622101|Appetite|appetite
5002729|NCT01622101|Bioactive herbal compounds|bioactive herbal compounds
5002730|NCT01622101|blood pressure|blood pressure
5002731|NCT01622088|ALS, Motor Neuron Disease, Amyotrophic Lateral Sclerosis|als, motor neuron disease, amyotrophic lateral sclerosis
5002732|NCT01622062|Rabies|rabies
5002733|NCT01622062|Verorab®|verorab®
5002734|NCT01622062|Favirab®|favirab®
5002735|NCT01622036|Malnutrition|malnutrition
5002736|NCT01622036|pre-cachexia|pre-cachexia
5002737|NCT01622036|cancer|cancer
5002738|NCT01622036|cachexia|cachexia
5002739|NCT01622036|MNA|mna
5002740|NCT01622036|weight loss|weight loss
5002741|NCT01622023|insemination|insemination
5002742|NCT01622023|donor sperm|donor sperm
5002743|NCT01622023|natural cycle|natural cycle
5002744|NCT01622010|Heart Failure|heart failure
5002745|NCT01622010|Patient Education as Topic|patient education as topic
5002746|NCT01622010|Physical Therapy Specialty|physical therapy specialty
5002747|NCT01621997|peritoneal dialysis|peritoneal dialysis
5002748|NCT01621997|retraining|retraining
5002749|NCT01621997|peritonitis|peritonitis
5002750|NCT01621984|Cerebral palsy|cerebral palsy
5002751|NCT01621984|brain injury|brain injury
5002752|NCT01621984|spinal cord injuries|spinal cord injuries
5002753|NCT01621984|muscular disease|muscular disease
5002754|NCT01621971|inhaled milrinone|inhaled milrinone
5002755|NCT01621971|pulmonary hypertension|pulmonary hypertension
5002756|NCT01621971|mitral regurgitation|mitral regurgitation
5002757|NCT01621971|mitral valve surgery|mitral valve surgery
5002758|NCT01621958|balance loss|balance loss
5002759|NCT01621958|dynamic stability|dynamic stability
5002760|NCT01621958|motor learning|motor learning
5002761|NCT01621958|plasticity|plasticity
5002762|NCT01621945|Neisseria meningitidis B:14, P1-7, 16|neisseria meningitidis b:14, p1-7, 16
5002763|NCT01621945|Serum bactericidal activity|serum bactericidal activity
5002764|NCT01621945|OMV vaccine|omv vaccine
5002765|NCT01621932|Anterior approach|anterior approach
5002766|NCT01621906|Breast|breast
5002767|NCT01621906|brain metastases|brain metastases
5002768|NCT01621906|18F-FLT-PET Imaging|18f-flt-pet imaging
5002769|NCT01621906|FLT(3'DEOXY-3'FLUOROTHYMIDINE)|flt(3'deoxy-3'fluorothymidine)
5002770|NCT01621906|MR Imaging|mr imaging
5002771|NCT01621906|12-039|12-039
5002772|NCT01621893|bone marrow edema|bone marrow edema
5002773|NCT01621893|bone marrow defects|bone marrow defects
5002774|NCT01621880|radiation-induced brain necrosis|radiation-induced brain necrosis
5002775|NCT01621880|nasopharyngeal carcinoma|nasopharyngeal carcinoma
5002776|NCT01621880|Bevacizumab|bevacizumab
5002777|NCT01621880|Methylprednisolone|methylprednisolone
5002778|NCT01621867|Cystic fibrosis|cystic fibrosis
5002779|NCT01621867|Gene therapy|gene therapy
5002780|NCT01621867|CFTR gene|cftr gene
5002781|NCT01621867|Gene expression|gene expression
5002782|NCT01621867|Non-viral|non-viral
5002783|NCT01621867|Multi dose|multi dose
5002784|NCT01621854|cancer|cancer
5002785|NCT01621854|nucleoside analogue|nucleoside analogue
5002786|NCT01621854|advanced solid tumours|advanced solid tumours
5002787|NCT01621828|pre-operative anxiety|pre-operative anxiety
5002788|NCT01621828|multimedia information|multimedia information
5002789|NCT01621828|operating theatre|operating theatre
5002790|NCT01621815|ADHD|adhd
5002791|NCT01621815|Attention Deficit/Hyperactivity Disorder|attention deficit/hyperactivity disorder
5002792|NCT01621815|Conduct|conduct
5002793|NCT01621815|Depression|depression
5002794|NCT01621815|Anxiety|anxiety
5002795|NCT01621815|PDD|pdd
5002796|NCT01621815|Pervasive Developmental Disorders|pervasive developmental disorders
5002797|NCT01621802|Safety|safety
5002798|NCT01621802|Measles, mumps and rubella diseases|measles, mumps and rubella diseases
5002799|NCT01621802|Immunogenicity|immunogenicity
5002800|NCT01621789|lutein|lutein
5002801|NCT01621789|zeaxanthin|zeaxanthin
5002802|NCT01621789|trypan blue|trypan blue
5002803|NCT01621789|dye|dye
5002804|NCT01621776|post-prandial hyperglycemia|post-prandial hyperglycemia
5002805|NCT01621737|oxytocin|oxytocin
5002806|NCT01621724|Gene therapy|gene therapy
5002807|NCT01621724|WT1 TCR|wt1 tcr
5002808|NCT01621724|AML|aml
5002809|NCT01621724|CML|cml
5002810|NCT01621711|substance abuse|substance abuse
5002811|NCT01621711|Substance Dependence|substance dependence
5002812|NCT01621711|Substance, addiction|substance, addiction
5002813|NCT01621711|Alcohol Abuse|alcohol abuse
5002814|NCT01621711|prevention and control|prevention and control
5002815|NCT01621711|preventative health services|preventative health services
5002816|NCT01621711|patient centered care|patient centered care
5002817|NCT01621698|VATS|vats
5002818|NCT01621698|Paravertebral blocks.|paravertebral blocks.
5002819|NCT01621698|Thoracoscopic surgery.|thoracoscopic surgery.
5002820|NCT01621698|Analgesia.|analgesia.
5002821|NCT01621685|Capsaicin|capsaicin
5002822|NCT01621685|Cough|cough
5002823|NCT01621685|Cough reflex|cough reflex
5002824|NCT01621685|Inhalation agents|inhalation agents
5002825|NCT01621685|Inhalation challenge|inhalation challenge
5002826|NCT01621685|TRPV1 receptor|trpv1 receptor
5002827|NCT01621672|Revlimid|revlimid
5002828|NCT01621672|progression free|progression free
5002829|NCT01621672|Lenalidomide|lenalidomide
5002830|NCT01621659|multidisciplinary team|multidisciplinary team
5002831|NCT01621659|exercise|exercise
5002832|NCT01621659|nutrition|nutrition
5002833|NCT01621659|cardiology|cardiology
5002834|NCT01621659|physiotherapy|physiotherapy
5002835|NCT01621659|imaging|imaging
5002836|NCT01621646|lutein|lutein
5002837|NCT01621646|eggs|eggs
5002838|NCT01621646|mild cognitive impairment|mild cognitive impairment
5002839|NCT01621646|elderly|elderly
5002840|NCT01621633|hepatic impairment|hepatic impairment
5002841|NCT01621607|fMRI|fmri
5002842|NCT01621607|Monoamines|monoamines
5002843|NCT01621607|Environment|environment
5002844|NCT01621607|Genes|genes
5002845|NCT01621607|Reward Learning|reward learning
5002846|NCT01621594|Cardiac|cardiac
5002847|NCT01621594|Computed Tomography|computed tomography
5002848|NCT01621594|Radiation Reduction|radiation reduction
5002849|NCT01621594|Iterative Reconstruction|iterative reconstruction
5002850|NCT01621581|Gene Therapy|gene therapy
5002851|NCT01621581|Parkinson's Disease|parkinson's disease
5002852|NCT01621581|Convection-Ehanced Delivery|convection-ehanced delivery
5002853|NCT01621581|Viral Vector|viral vector
5002854|NCT01621568|VEGF|vegf
5002855|NCT01621568|Anti-Angiogenesis|anti-angiogenesis
5002856|NCT01621568|Targeted Agent|targeted agent
5002857|NCT01621555|shoulder surgery|shoulder surgery
5002858|NCT01621555|Pain sensitivity|pain sensitivity
5002859|NCT01621555|Rowe score|rowe score
5002860|NCT01621555|Constant Score|constant score
5002861|NCT01621555|Surgical Outcome|surgical outcome
5002862|NCT01621555|Postoperative pain|postoperative pain
5002863|NCT01621542|Cancer|cancer
5002864|NCT01621542|Vaccine|vaccine
5002865|NCT01621542|Oncology|oncology
5002866|NCT01621542|Malignancies|malignancies
5002867|NCT01621542|Wilms' Tumor|wilms' tumor
5002868|NCT01621542|WT1|wt1
5002869|NCT01621542|Ovarian|ovarian
5002870|NCT01621542|Glioblastoma [GBM]|glioblastoma [gbm]
5002871|NCT01621542|Acute myeloid leukemia [AML]|acute myeloid leukemia [aml]
5002872|NCT01621529|Positron-Emission Tomography|positron-emission tomography
5002873|NCT01621529|PET Scan|pet scan
5002874|NCT01621529|FDG|fdg
5002875|NCT01621529|SUV|suv
5002876|NCT01621529|Invasive Breast cancer|invasive breast cancer
5002877|NCT01621529|Surgery compare|surgery compare
5002878|NCT01621529|Tumor measurement|tumor measurement
5002879|NCT01621516|Beta-cell function|beta-cell function
5002880|NCT01621516|Liver/small bowel transplant|liver/small bowel transplant
5002881|NCT01621516|Donor pancreas|donor pancreas
5002882|NCT01621516|Diabetes|diabetes
5002883|NCT01621516|Long-term immunesuppression|long-term immunesuppression
5002884|NCT01621477|Hematologic malignancy|hematologic malignancy
5002885|NCT01621477|Hematopoietic cell transplant|hematopoietic cell transplant
5002886|NCT01621464|Neuromediated syncope|neuromediated syncope
5002887|NCT01621464|Tilt test|tilt test
5002888|NCT01621464|Pacemaker|pacemaker
5002889|NCT01621464|CLS sensor|cls sensor
5002890|NCT01621438|coronary artery|coronary artery
5002891|NCT01621438|atherosclerosis|atherosclerosis
5002892|NCT01621438|angina pectoris|angina pectoris
5002893|NCT01621425|breast cancer|breast cancer
5002894|NCT01621425|prostate carcinoma|prostate carcinoma
5002895|NCT01621425|docetaxel|docetaxel
5002896|NCT01621425|lean body mass|lean body mass
5002897|NCT01621425|Body Surface Area|body surface area
5002898|NCT01621425|body weight|body weight
5002899|NCT01621425|dexascan|dexascan
5002900|NCT01621412|Medication Adherence|medication adherence
5002901|NCT01621412|HIV infection|hiv infection
5002902|NCT01621412|Disclosure|disclosure
5002903|NCT01621373|neonatology|neonatology
5002904|NCT01621373|intratracheal intubation|intratracheal intubation
5002905|NCT01621373|propofol|propofol
5002906|NCT01621360|Randomized controlled trial|randomized controlled trial
5002907|NCT01621360|Intention to treat|intention to treat
5002908|NCT01621347|HIV|hiv
5002909|NCT01621347|Pregnancy|pregnancy
5002910|NCT01621347|Postpartum|postpartum
5002911|NCT01621347|Women|women
5002912|NCT01621347|Medication Adherence|medication adherence
5002913|NCT01621308|Diabetes Mellitus type 1|diabetes mellitus type 1
5002914|NCT01621308|Intraperitoneal insulin administration|intraperitoneal insulin administration
5002915|NCT01621308|Subcutaneous insulin administration|subcutaneous insulin administration
5002916|NCT01621308|Continuous intraperitoneal insulin infusion|continuous intraperitoneal insulin infusion
5002917|NCT01621282|journal club|journal club
5002918|NCT01621269|Multiple Sclerosis|multiple sclerosis
5002919|NCT01621269|MS|ms
5002920|NCT01621269|Fingolimod|fingolimod
5002921|NCT01621269|Gilenya|gilenya
5002922|NCT01621269|Neutralizing Antibodies|neutralizing antibodies
5002923|NCT01621269|NAb|nab
5002924|NCT01621243|necuparanib|necuparanib
5002925|NCT01621243|gemcitabine|gemcitabine
5002926|NCT01621243|heparin|heparin
5002927|NCT01621243|low molecular weight heparin|low molecular weight heparin
5002928|NCT01621243|nab-Paclitaxel|nab-paclitaxel
5002929|NCT01621230|Bupivacaine|bupivacaine
5002930|NCT01621230|Fentanyl|fentanyl
5002931|NCT01621230|Epidural|epidural
5002932|NCT01621230|Second Stage of Labor|second stage of labor
5002933|NCT01621230|Randomized Controlled Trial|randomized controlled trial
5002934|NCT01621217|Anal cancer|anal cancer
5002935|NCT01621217|Locally advanced anal cancer|locally advanced anal cancer
5002936|NCT01621217|Cetuximab|cetuximab
5002937|NCT01621217|5-fluoruracil|5-fluoruracil
5002938|NCT01621217|Mitomycin C|mitomycin c
5002939|NCT01621217|Radiotherapy|radiotherapy
5002940|NCT01621204|Thrombocytopenia|thrombocytopenia
5002941|NCT01621204|ITP|itp
5002942|NCT01621204|Platelets|platelets
5002943|NCT01621204|Bleeding|bleeding
5002944|NCT01621204|Immune|immune
5002945|NCT01621204|Eltrombopag|eltrombopag
5002946|NCT01621204|IVIG|ivig
5002947|NCT01621165|treatment of bipolar, mania|treatment of bipolar, mania
5002948|NCT01621165|double-blind, placebo-controlled study|double-blind, placebo-controlled study
5002949|NCT01621165|drug intervention|drug intervention
5002950|NCT01621165|add-on study|add-on study
5002951|NCT01621165|prazosin|prazosin
5002952|NCT01621165|alpha-1 adrenergic antagonist|alpha-1 adrenergic antagonist
5002953|NCT01621152|Acute renal failure|acute renal failure
5002954|NCT01621152|acute kidney injury|acute kidney injury
5002955|NCT01621152|electronic surveillance|electronic surveillance
5002956|NCT01621152|AKI|aki
5002957|NCT01621152|sniffer|sniffer
5002958|NCT01621152|AKIN|akin
5002959|NCT01621152|improvement in the process of care and outcomes|improvement in the process of care and outcomes
5002960|NCT01621126|Shoulder instability|shoulder instability
5002961|NCT01621126|Latarjet procedure|latarjet procedure
5002962|NCT01621126|Nerve injury|nerve injury
5002963|NCT01621113|Spinal Cord Injuries|spinal cord injuries
5002964|NCT01621113|4-Aminopyridine|4-aminopyridine
5002965|NCT01621113|Physical Therapy Modalities|physical therapy modalities
5002966|NCT01621113|Randomized Controlled Trial|randomized controlled trial
5002967|NCT01621113|Rehabilitation|rehabilitation
5002968|NCT01621113|Walking|walking
5002969|NCT01621100|Cancer pain|cancer pain
5002970|NCT01621100|OROS|oros
5002971|NCT01621100|Osmotic release oral system|osmotic release oral system
5002972|NCT01621100|Hydromorphone|hydromorphone
5002973|NCT01621100|Painkiller|painkiller
5002974|NCT01621100|Opioid analgesic|opioid analgesic
5002975|NCT01621100|Korean patients|korean patients
5002976|NCT01621061|high altitude illness|high altitude illness
5002977|NCT01621061|pulmonary hypertension|pulmonary hypertension
5002978|NCT01621061|sleep apnea|sleep apnea
5002979|NCT01621061|hypoxia|hypoxia
5002980|NCT01621048|Head and Neck Neoplasmsr|head and neck neoplasmsr
5002981|NCT01621048|Radiotherapy|radiotherapy
5002982|NCT01621048|Xerostomia|xerostomia
5002983|NCT01621048|Deglutition Disorders|deglutition disorders
5002984|NCT01621022|smoking cessation|smoking cessation
5002985|NCT01621022|tobacco dependence|tobacco dependence
5002986|NCT01621009|smoking cessation medications|smoking cessation medications
5002987|NCT01621009|smoking cessation counseling|smoking cessation counseling
5002988|NCT01620996|preintervention and postintervention cohort longitudinal prospective study|preintervention and postintervention cohort longitudinal prospective study
5002989|NCT01620983|arthroplasty|arthroplasty
5002990|NCT01620983|pain|pain
5002991|NCT01620970|Transitional Cell Carcinoma|transitional cell carcinoma
5002992|NCT01620970|Metastatic disease|metastatic disease
5002993|NCT01620970|Bladder tumors, Recurrent|bladder tumors, recurrent
5002994|NCT01620970|Angiogenesis|angiogenesis
5002995|NCT01620970|PF03446962|pf03446962
5002996|NCT01620970|Transforming growth factor beta|transforming growth factor beta
5002997|NCT01620970|Activin receptor like kinase 1|activin receptor like kinase 1
5002998|NCT01620970|Monoclonal Antibody|monoclonal antibody
5002999|NCT01620970|Locally advanced or metastatic disease|locally advanced or metastatic disease
5003000|NCT01620970|Failure of one platinum-based chemotherapy|failure of one platinum-based chemotherapy
5003001|NCT01620970|Measurable disease|measurable disease
5003002|NCT01620957|Default-mode network|default-mode network
5003003|NCT01620957|Difussion tensor imaging|difussion tensor imaging
5003004|NCT01620957|Cortical thickness|cortical thickness
5003005|NCT01620957|Coma|coma
5003006|NCT01620957|Vegetative state|vegetative state
5003007|NCT01620957|Minimally conscious state|minimally conscious state
5003008|NCT01620957|Neural correlate of consciousness|neural correlate of consciousness
5003009|NCT01620892|unicondylar knee arthroplasty|unicondylar knee arthroplasty
5003010|NCT01620892|partial knee replacement|partial knee replacement
5003011|NCT01620866|EMDR|emdr
5003012|NCT01620866|bipolar disorder|bipolar disorder
5003013|NCT01620866|trauma|trauma
5003014|NCT01620866|subsyndromal symptoms|subsyndromal symptoms
5003015|NCT01620866|PTSD|ptsd
5003016|NCT01620853|Non-small cell lung cancer (NSCLC)|non-small cell lung cancer (nsclc)
5003017|NCT01620853|ALK probe|alk probe
5003018|NCT01620853|FISH|fish
5003019|NCT01620853|Chromosomal aberrations|chromosomal aberrations
5003020|NCT01620840|oral administration of Lacosamide is not possible or adequate|oral administration of lacosamide is not possible or adequate
5003021|NCT01620827|follow up|follow up
5003022|NCT01620827|cell phone|cell phone
5003023|NCT01620827|hospital landline|hospital landline
5003024|NCT01620814|misoprostol|misoprostol
5003025|NCT01620814|dinoprostone|dinoprostone
5003026|NCT01620814|cervical ripening|cervical ripening
5003027|NCT01620814|diagnostic hysteroscopy|diagnostic hysteroscopy
5003028|NCT01620801|AAV|aav
5003029|NCT01620801|AAV8|aav8
5003030|NCT01620801|Adeno-associated virus|adeno-associated virus
5003031|NCT01620801|Adeno-associated viral vectors|adeno-associated viral vectors
5003032|NCT01620801|Hemophilia|hemophilia
5003033|NCT01620801|Hemophilia B|hemophilia b
5003034|NCT01620801|Severe hemophilia B|severe hemophilia b
5003035|NCT01620801|Factor IX deficiency|factor ix deficiency
5003036|NCT01620801|Factor IX|factor ix
5003037|NCT01620801|FIX|fix
5003038|NCT01620762|Cat allergy|cat allergy
5003039|NCT01620762|Rhinoconjunctivitis|rhinoconjunctivitis
5003040|NCT01620749|melanoma metastatic diagnosis|melanoma metastatic diagnosis
5003041|NCT01620736|Raltegravir|raltegravir
5003042|NCT01620736|HTLV|htlv
5003043|NCT01620736|Integrase|integrase
5003044|NCT01620723|Breastfeeding|breastfeeding
5003045|NCT01620723|Breastfeeding self efficacy|breastfeeding self efficacy
5003046|NCT01620710|prostatectomy|prostatectomy
5003047|NCT01620658|Occupational Exposure to Radiation|occupational exposure to radiation
5003048|NCT01620632|laparoscopy assisted ERCP|laparoscopy assisted ercp
5003049|NCT01620632|altered gastric anatomy|altered gastric anatomy
5003050|NCT01620619|Shoulder|shoulder
5003051|NCT01620619|Bankart|bankart
5003052|NCT01620619|Anterior Instability|anterior instability
5003053|NCT01620619|Rotator Cuff|rotator cuff
5003054|NCT01620606|FAP|fap
5003055|NCT01620606|RAP|rap
5003056|NCT01620606|Abdominal Pain|abdominal pain
5003057|NCT01620606|IBS|ibs
5003058|NCT01620593|Prostate Cancer|prostate cancer
5003059|NCT01620593|Metformin|metformin
5003060|NCT01620593|Castration therapy|castration therapy
5003061|NCT01620580|sleep disturbance|sleep disturbance
5003062|NCT01620580|tiredness|tiredness
5003063|NCT01620580|itching & numbness|itching & numbness
5003064|NCT01620567|lutein|lutein
5003065|NCT01620567|avocados|avocados
5003066|NCT01620567|chickpeas|chickpeas
5003067|NCT01620567|potatoes|potatoes
5003068|NCT01620567|elderly|elderly
5003069|NCT01620554|Sleep disorder|sleep disorder
5003070|NCT01620554|Obstructive Sleep Apnoea|obstructive sleep apnoea
5003071|NCT01620554|Excessive Daytime Sleepiness|excessive daytime sleepiness
5003072|NCT01620528|Gonadotropin-Releasing Hormone Antagonist|gonadotropin-releasing hormone antagonist
5003073|NCT01620528|Endometriosis associated pain|endometriosis associated pain
5003074|NCT01620528|Dysmenorrhea (DYS)|dysmenorrhea (dys)
5003075|NCT01620528|Non-Menstrual Pelvic Pain (NMPP)|non-menstrual pelvic pain (nmpp)
5003076|NCT01620528|Elagolix|elagolix
5003077|NCT01620515|Prostate|prostate
5003078|NCT01620515|Prostate Cancer|prostate cancer
5003079|NCT01620515|Localized Prostate Cancer|localized prostate cancer
5003080|NCT01620515|T1c Prostate Cancer|t1c prostate cancer
5003081|NCT01620515|Focal Therapy|focal therapy
5003082|NCT01620515|NX-1207|nx-1207
5003083|NCT01620411|Active Duty|active duty
5003084|NCT01620411|Comprehensive Medical Management|comprehensive medical management
5003085|NCT01620411|Spinal Cord Stimulator|spinal cord stimulator
5003086|NCT01620411|Veteran|veteran
5003087|NCT01620411|sustained|sustained
5003088|NCT01620411|military|military
5003089|NCT01620398|cardiovascular diseases|cardiovascular diseases
5003090|NCT01620398|secondary prevention|secondary prevention
5003091|NCT01620398|diet|diet
5003577|NCT01618643|HGD|hgd
5003092|NCT01620385|Cochlear implants|cochlear implants
5003093|NCT01620359|Breast cancer|breast cancer
5003094|NCT01620359|Breast tumor|breast tumor
5003095|NCT01620359|stage 1 disease|stage 1 disease
5003096|NCT01620359|T1 M0 N0|t1 m0 n0
5003097|NCT01620346|advanced maternal age|advanced maternal age
5003098|NCT01620346|infertility|infertility
5003099|NCT01620346|IMSI|imsi
5003100|NCT01620346|ICSI|icsi
5003101|NCT01620346|implantation|implantation
5003102|NCT01620320|Left main coronary artery|left main coronary artery
5003103|NCT01620320|Coronary artery disease|coronary artery disease
5003104|NCT01620320|Stress echography|stress echography
5003105|NCT01620320|Intrastent stenosis|intrastent stenosis
5003106|NCT01620307|H1N1 patients with severe hypoxemia requiring ventilator support|h1n1 patients with severe hypoxemia requiring ventilator support
5003107|NCT01620294|surgical site infection|surgical site infection
5003108|NCT01620294|elective colorectal surgery|elective colorectal surgery
5003109|NCT01620294|level of surgical site infection|level of surgical site infection
5003110|NCT01620294|complication of surgical site infection|complication of surgical site infection
5003111|NCT01620294|type of changed bandage|type of changed bandage
5003112|NCT01620294|frequency of bandage changing|frequency of bandage changing
5003113|NCT01620281|Back Pain|back pain
5003114|NCT01620268|leflunomide|leflunomide
5003115|NCT01620268|orotic acid|orotic acid
5003116|NCT01620268|Polyoma BK Viruria|polyoma bk viruria
5003117|NCT01620268|Polyoma BK Viremia|polyoma bk viremia
5003118|NCT01620268|Polyoma BK Nephropathy|polyoma bk nephropathy
5003119|NCT01620268|Renal Allograft Rejection|renal allograft rejection
5003120|NCT01620242|recurrent or metastatic head and neck cancer|recurrent or metastatic head and neck cancer
5003121|NCT01620242|cabazitaxel|cabazitaxel
5003122|NCT01620203|Premature infants|premature infants
5003123|NCT01620203|Intracranial hemorrhage|intracranial hemorrhage
5003124|NCT01620203|Intraventricular hemorrhage|intraventricular hemorrhage
5003125|NCT01620203|Cerebral oxygenation|cerebral oxygenation
5003126|NCT01620203|Brain function|brain function
5003127|NCT01620203|Cerebral perfusion|cerebral perfusion
5003128|NCT01620177|Cannabis|cannabis
5003129|NCT01620177|Marijuana|marijuana
5003130|NCT01620177|Marihuana|marihuana
5003131|NCT01620177|Alcohol|alcohol
5003132|NCT01620177|Driving|driving
5003133|NCT01620164|three-dimensional vision|three-dimensional vision
5003134|NCT01620164|Parkinson|parkinson
5003135|NCT01620151|Post-operative pain|post-operative pain
5003136|NCT01620151|Wound bleeding requiring exploration|wound bleeding requiring exploration
5003137|NCT01620151|PTH|pth
5003138|NCT01620151|RLN complication|rln complication
5003139|NCT01620151|Hypocalcaemia complication|hypocalcaemia complication
5003140|NCT01620138|Non-functioning pituitary adenomas|non-functioning pituitary adenomas
5003141|NCT01620138|Prolactinomas|prolactinomas
5003142|NCT01620138|Cabergoline|cabergoline
5003143|NCT01620138|Pasireotide|pasireotide
5003144|NCT01620138|somatostatin receptors|somatostatin receptors
5003145|NCT01620138|Dopamine receptors|dopamine receptors
5003146|NCT01620125|Lactobacillus|lactobacillus
5003147|NCT01620125|Gut microbiota|gut microbiota
5003148|NCT01620125|Diabetes mellitus|diabetes mellitus
5003149|NCT01620112|brachial plexus|brachial plexus
5003150|NCT01620112|lidocaine|lidocaine
5003151|NCT01620112|alfa 2 adrenergic receptor clonidine|alfa 2 adrenergic receptor clonidine
5003152|NCT01620112|orthopedic procedure|orthopedic procedure
5003153|NCT01620099|Asthma|asthma
5003154|NCT01620099|Cigarette smoke|cigarette smoke
5003155|NCT01620099|Small airways|small airways
5003156|NCT01620099|Lung function|lung function
5003157|NCT01620099|Asthma control|asthma control
5003158|NCT01620086|Schizophrenia|schizophrenia
5003159|NCT01620086|Auditory hallucinations (AH)|auditory hallucinations (ah)
5003160|NCT01620086|Phantom sound perception|phantom sound perception
5003161|NCT01620086|repetitive transcranial magnetic stimulation (rTMS)|repetitive transcranial magnetic stimulation (rtms)
5003162|NCT01620086|Percent habituation in the P50 amplitude with 250 ms ISI|percent habituation in the p50 amplitude with 250 ms isi
5003163|NCT01620073|Male partner|male partner
5003164|NCT01620073|HIV counseling and testing|hiv counseling and testing
5003165|NCT01620073|Home based|home based
5003166|NCT01620073|Pregnancy|pregnancy
5003167|NCT01620060|Schizophrenia|schizophrenia
5003168|NCT01620060|autism|autism
5003169|NCT01620060|bipolar|bipolar
5003170|NCT01620060|Lurasidone|lurasidone
5003171|NCT01620060|Latuda|latuda
5003172|NCT01620047|Regional Anesthesia|regional anesthesia
5003173|NCT01620047|Post-operative pain management|post-operative pain management
5003174|NCT01620047|Femoral Nerve Block|femoral nerve block
5003175|NCT01620047|Total Knee Replacement|total knee replacement
5003176|NCT01620021|wearable sensors|wearable sensors
5003177|NCT01620021|kinematics|kinematics
5003178|NCT01620021|gait|gait
5003179|NCT01620008|cord clamping (delayed or immediate)|cord clamping (delayed or immediate)
5003180|NCT01620008|Myelin content|myelin content
5003181|NCT01620008|Ferritin|ferritin
5003182|NCT01619995|urge incontinence|urge incontinence
5003183|NCT01619956|dental implants|dental implants
5003184|NCT01619956|osteotome sinus floor elevation|osteotome sinus floor elevation
5003185|NCT01619956|survival rate|survival rate
5003186|NCT01619956|sinus grafting|sinus grafting
5003187|NCT01619956|bone remodeling|bone remodeling
5003189|NCT01619956|radiographic analysis|radiographic analysis
5003190|NCT01619943|Minor head injury|minor head injury
5003191|NCT01619943|CT scan|ct scan
5003192|NCT01619943|Canadian CT Head Rules|canadian ct head rules
5003193|NCT01619943|The New Orleans Criteria|the new orleans criteria
5003194|NCT01619930|Depression|depression
5003195|NCT01619930|Behavioral activation|behavioral activation
5003196|NCT01619917|burn|burn
5003197|NCT01619917|scar|scar
5003198|NCT01619917|laser|laser
5003199|NCT01619917|fractional|fractional
5003200|NCT01619917|vascular|vascular
5003201|NCT01619904|Pancreas Transplantation|pancreas transplantation
5003202|NCT01619904|Goal-directed therapy|goal-directed therapy
5003203|NCT01619904|Outcomes|outcomes
5003204|NCT01619904|Immunometric|immunometric
5003205|NCT01619878|plasmodium|plasmodium
5003206|NCT01619878|P. falciparum|p. falciparum
5003207|NCT01619878|malaria|malaria
5003208|NCT01619878|infant|infant
5003209|NCT01619878|neonate|neonate
5003210|NCT01619865|GA-68|ga-68
5003211|NCT01619865|Gallium 68|gallium 68
5003212|NCT01619865|GA-68 PET|ga-68 pet
5003213|NCT01619852|Surgery|surgery
5003214|NCT01619852|Breast|breast
5003215|NCT01619852|Pain|pain
5003216|NCT01619852|Chronic Pain|chronic pain
5003217|NCT01619852|Lidocaine|lidocaine
5003218|NCT01619852|Anesthesia|anesthesia
5003219|NCT01619852|Gynecologic|gynecologic
5003220|NCT01619852|Urologic|urologic
5003221|NCT01619839|Nektar|nektar
5003222|NCT01619839|NKTR-181|nktr-181
5003223|NCT01619826|physical activity|physical activity
5003224|NCT01619826|fitness|fitness
5003225|NCT01619826|brain health|brain health
5003226|NCT01619826|cognition|cognition
5003227|NCT01619826|scholastic achievement|scholastic achievement
5003228|NCT01619826|preadolescent children|preadolescent children
5003229|NCT01619800|Chronotropic Incompetence|chronotropic incompetence
5003230|NCT01619800|Pacemaker|pacemaker
5003231|NCT01619800|Mount Sinai School of Medicine|mount sinai school of medicine
5003232|NCT01619774|Melanoma|melanoma
5003233|NCT01619774|Metastatic melanoma|metastatic melanoma
5003234|NCT01619774|Refractory or Resistant to BRAF Inhibitor|refractory or resistant to braf inhibitor
5003235|NCT01619774|Advanced melanoma|advanced melanoma
5003236|NCT01619774|GSK2118436|gsk2118436
5003237|NCT01619774|GSK1120212|gsk1120212
5003238|NCT01619761|Leukemia|leukemia
5003239|NCT01619761|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
5003240|NCT01619761|CLL|cll
5003241|NCT01619761|Cord blood|cord blood
5003242|NCT01619761|CB|cb
5003243|NCT01619761|Umbilical cord blood|umbilical cord blood
5003244|NCT01619761|UCB|ucb
5003245|NCT01619761|Natural killer cells|natural killer cells
5003246|NCT01619761|NK|nk
5003247|NCT01619761|Graft versus host disease|graft versus host disease
5003248|NCT01619761|GVHD|gvhd
5003249|NCT01619761|Lenalidomide|lenalidomide
5003250|NCT01619761|CC-5013|cc-5013
5003251|NCT01619761|Revlimid|revlimid
5003252|NCT01619761|Fludarabine|fludarabine
5003253|NCT01619761|Fludarabine Phosphate|fludarabine phosphate
5003254|NCT01619761|Fludara|fludara
5003255|NCT01619761|Melphalan|melphalan
5003256|NCT01619761|Alkeran|alkeran
5003257|NCT01619761|Rituximab|rituximab
5003258|NCT01619761|Rituxan|rituxan
5003259|NCT01619735|Kidney Calculi|kidney calculi
5003260|NCT01619735|Kidney Stones|kidney stones
5003261|NCT01619735|Nephrolithiasis|nephrolithiasis
5003262|NCT01619735|Renal Stones|renal stones
5003263|NCT01619722|PKU|pku
5003264|NCT01619722|Osteoporosis|osteoporosis
5003265|NCT01619722|HMP|hmp
5003266|NCT01619722|Life quality|life quality
5003267|NCT01619722|Neuropsychological|neuropsychological
5003268|NCT01619722|Nutritial evaluation|nutritial evaluation
5003269|NCT01619722|Phenylketonuria|phenylketonuria
5003270|NCT01619722|Hyperphenylalaninemia|hyperphenylalaninemia
5003271|NCT01619709|Intracerebral Hemorrhage|intracerebral hemorrhage
5003272|NCT01619709|Cerebral Amyloid angiopathy|cerebral amyloid angiopathy
5003273|NCT01619709|Amyloid imaging|amyloid imaging
5003274|NCT01619709|18F-AV-45|18f-av-45
5003275|NCT01619696|chemotherapy|chemotherapy
5003276|NCT01619696|rectal adenocarcinoma|rectal adenocarcinoma
5003277|NCT01619696|proctectomy|proctectomy
5003278|NCT01619696|Fmiso TEP|fmiso tep
5003279|NCT01619696|MRI|mri
5003280|NCT01619657|Cystic Fibrosis|cystic fibrosis
5003281|NCT01619657|Hypertonic Saline|hypertonic saline
5003282|NCT01619657|Infant|infant
5003283|NCT01619657|Newborn|newborn
5003284|NCT01619657|Prevention|prevention
5003285|NCT01619644|RTS|rts
5003286|NCT01619644|Rubinstein Taybi|rubinstein taybi
5003287|NCT01619644|explorative phase 2|explorative phase 2
5003288|NCT01619644|clinical approach|clinical approach
5003289|NCT01619644|biological approach|biological approach
5003290|NCT01619644|motor skills|motor skills
5003291|NCT01619631|Depression|depression
5003292|NCT01619631|Tai Chi|tai chi
5003293|NCT01619631|Alternative medicine|alternative medicine
5003294|NCT01619631|Mind body medicine|mind body medicine
5003295|NCT01619618|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
5003578|NCT01618643|IMC|imc
5003296|NCT01619618|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5003297|NCT01619618|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
5003298|NCT01619618|stage IVA squamous cell carcinoma of the larynx|stage iva squamous cell carcinoma of the larynx
5003299|NCT01619618|stage IVB squamous cell carcinoma of the larynx|stage ivb squamous cell carcinoma of the larynx
5003300|NCT01619618|stage IVC squamous cell carcinoma of the larynx|stage ivc squamous cell carcinoma of the larynx
5003301|NCT01619618|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
5003302|NCT01619618|stage IVA squamous cell carcinoma of the lip and oral cavity|stage iva squamous cell carcinoma of the lip and oral cavity
5003303|NCT01619618|stage IVB squamous cell carcinoma of the lip and oral cavity|stage ivb squamous cell carcinoma of the lip and oral cavity
5003304|NCT01619618|stage IVC squamous cell carcinoma of the lip and oral cavity|stage ivc squamous cell carcinoma of the lip and oral cavity
5003305|NCT01619618|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
5003306|NCT01619618|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
5003307|NCT01619618|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
5003308|NCT01619618|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
5003309|NCT01619618|stage IVA squamous cell carcinoma of the oropharynx|stage iva squamous cell carcinoma of the oropharynx
5003310|NCT01619618|stage IVB squamous cell carcinoma of the oropharynx|stage ivb squamous cell carcinoma of the oropharynx
5003311|NCT01619618|stage IVC squamous cell carcinoma of the oropharynx|stage ivc squamous cell carcinoma of the oropharynx
5003312|NCT01619618|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
5003313|NCT01619618|stage IVA squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iva squamous cell carcinoma of the paranasal sinus and nasal cavity
5003314|NCT01619618|stage IVB squamous cell carcinoma of the paranasal sinus and nasal cavity|stage ivb squamous cell carcinoma of the paranasal sinus and nasal cavity
5003315|NCT01619618|stage IVC squamous cell carcinoma of the paranasal sinus and nasal cavity|stage ivc squamous cell carcinoma of the paranasal sinus and nasal cavity
5003316|NCT01619618|recurrent salivary gland cancer|recurrent salivary gland cancer
5003317|NCT01619618|stage IVA salivary gland cancer|stage iva salivary gland cancer
5003318|NCT01619618|stage IVB salivary gland cancer|stage ivb salivary gland cancer
5003319|NCT01619618|stage IVC salivary gland cancer|stage ivc salivary gland cancer
5003320|NCT01619605|tryptases|tryptases
5003321|NCT01619605|anaphylaxis|anaphylaxis
5003322|NCT01619605|shrimp allergy|shrimp allergy
5003323|NCT01619592|patients|patients
5003324|NCT01619592|adaptable|adaptable
5003325|NCT01619592|insulin|insulin
5003326|NCT01619592|schemes|schemes
5003327|NCT01619579|Fibromyalgia|fibromyalgia
5003328|NCT01619579|Pain|pain
5003329|NCT01619579|Non-Invasive|non-invasive
5003330|NCT01619579|Arthritis|arthritis
5003331|NCT01619579|Rheumatoid Disease|rheumatoid disease
5003332|NCT01619566|Fibromyalgia|fibromyalgia
5003333|NCT01619566|Duloxetine|duloxetine
5003334|NCT01619566|Cymbalta|cymbalta
5003335|NCT01619566|Pain|pain
5003336|NCT01619566|Peripheral Nerve|peripheral nerve
5003337|NCT01619566|Biopsy|biopsy
5003338|NCT01619566|Predictive|predictive
5003339|NCT01619553|keloid|keloid
5003340|NCT01619553|fibrosis|fibrosis
5003341|NCT01619553|wound healing|wound healing
5003342|NCT01619553|scar|scar
5003343|NCT01619540|COPD|copd
5003344|NCT01619540|Left Ventricular Failure|left ventricular failure
5003345|NCT01619540|Valsalva Manoeuver|valsalva manoeuver
5003346|NCT01619527|Healthy participants|healthy participants
5003347|NCT01619527|Darunavir|darunavir
5003348|NCT01619527|Cobicistat|cobicistat
5003349|NCT01619527|Bioequivalence|bioequivalence
5003350|NCT01619527|Fixed dose combination|fixed dose combination
5003351|NCT01619527|Pharmacokinetics|pharmacokinetics
5003352|NCT01619527|Human immunodeficiency virus|human immunodeficiency virus
5003353|NCT01619527|Protease inhibitor|protease inhibitor
5003354|NCT01619488|Lap-Band|lap-band
5003355|NCT01619488|morbid obesity|morbid obesity
5003356|NCT01619488|adolescents|adolescents
5003357|NCT01619475|Living Donor|living donor
5003358|NCT01619475|Liver Transplantation|liver transplantation
5003359|NCT01619475|Quality of Life|quality of life
5003360|NCT01619475|Biosamples|biosamples
5003361|NCT01619475|Liver Recipient|liver recipient
5003362|NCT01619462|pneumococcal|pneumococcal
5003363|NCT01619462|vaccine|vaccine
5003364|NCT01619462|papua new guinea|papua new guinea
5003365|NCT01619449|Acute Kidney Injury|acute kidney injury
5003366|NCT01619449|Continuous Renal Replacement Therapy|continuous renal replacement therapy
5003367|NCT01619449|Liver Transplant|liver transplant
5003368|NCT01619423|Metastatic colorectal cancer|metastatic colorectal cancer
5003369|NCT01619423|stage IV|stage iv
5003370|NCT01619423|FOLFOX6|folfox6
5003371|NCT01619423|Chemotherapy|chemotherapy
5003372|NCT01619423|PledOx|pledox
5003373|NCT01619423|Mangafodipir|mangafodipir
5003374|NCT01619423|Febrile neutropenia|febrile neutropenia
5003375|NCT01619423|Oxidative stress|oxidative stress
5003376|NCT01619423|Antioxidant|antioxidant
5003377|NCT01619423|neutropenia|neutropenia
5003378|NCT01619423|neuropathy|neuropathy
5003379|NCT01619397|Condom|condom
5003380|NCT01619397|Medical Device|medical device
5003381|NCT01619384|posttraumatic stress|posttraumatic stress
5003382|NCT01619384|irritable bowel|irritable bowel
5003383|NCT01619371|breast pump|breast pump
5003384|NCT01619371|engorgement|engorgement
5003385|NCT01619371|lactation|lactation
5003386|NCT01619332|Healthy volunteers,|healthy volunteers,
5003387|NCT01619332|Diabetes|diabetes
5003388|NCT01619332|Glucose|glucose
5003389|NCT01619332|Pharmacokinetics|pharmacokinetics
5003390|NCT01619319|schizophrenia prodrome|schizophrenia prodrome
5003391|NCT01619319|clinical high risk of psychosis|clinical high risk of psychosis
5003392|NCT01619293|CCT|cct
5003393|NCT01619293|brain|brain
5003394|NCT01619293|trauma|trauma
5003395|NCT01619293|injury|injury
5003396|NCT01619280|Acute Lung Injury|acute lung injury
5003397|NCT01619280|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
5003398|NCT01619280|Sodium Nitroprusside|sodium nitroprusside
5003399|NCT01619280|adult|adult
5003400|NCT01619280|Safety|safety
5003401|NCT01619280|Dose Finding|dose finding
5003402|NCT01619280|Phase 1|phase 1
5003403|NCT01619280|3 + 3 design|3 + 3 design
5003404|NCT01619280|Nebulizers and Vaporizers|nebulizers and vaporizers
5003405|NCT01619280|High-Frequency Ventilation|high-frequency ventilation
5003406|NCT01619280|nitric oxide|nitric oxide
5003407|NCT01619280|lung injury|lung injury
5003408|NCT01619280|Pulmonary Gas Exchange|pulmonary gas exchange
5003409|NCT01619280|Pulmonary Alveoli|pulmonary alveoli
5003410|NCT01619267|pacemaker defibrillator infection|pacemaker defibrillator infection
5003411|NCT01619254|Intestinal parasitic infections|intestinal parasitic infections
5003412|NCT01619254|Anaemia|anaemia
5003413|NCT01619254|School-aged children|school-aged children
5003414|NCT01619254|Hand washing and nail clipping|hand washing and nail clipping
5003415|NCT01619241|lung cancer|lung cancer
5003416|NCT01619241|F-18 FLT PET/CT|f-18 flt pet/ct
5003417|NCT01619228|premature infant|premature infant
5003418|NCT01619228|neonate|neonate
5003419|NCT01619228|skin maturation|skin maturation
5003420|NCT01619228|stratum corneum maturation|stratum corneum maturation
5003421|NCT01619228|ontogeny of neonatal skin maturation|ontogeny of neonatal skin maturation
5003422|NCT01619228|sunflower oil|sunflower oil
5003423|NCT01619228|effect of Vitamin B3 on premature skin maturation|effect of vitamin b3 on premature skin maturation
5003424|NCT01619228|skin acidity|skin acidity
5003425|NCT01619228|stratum corneum barrier integrity|stratum corneum barrier integrity
5003426|NCT01619228|stratum corneum lipid composition|stratum corneum lipid composition
5003427|NCT01619228|stratum corneum biomarkers|stratum corneum biomarkers
5003428|NCT01619228|stratum corneum cytokines|stratum corneum cytokines
5003429|NCT01619228|stratum corneum structural proteins|stratum corneum structural proteins
5003430|NCT01619202|accident prevention|accident prevention
5003431|NCT01619202|Adolescent|adolescent
5003432|NCT01619202|examination, automobile driver|examination, automobile driver
5003433|NCT01619202|Driving simulator|driving simulator
5003434|NCT01619202|Young drivers|young drivers
5003435|NCT01619202|Driving education|driving education
5003436|NCT01619189|Cell therapy|cell therapy
5003437|NCT01619189|Limbal deficiency|limbal deficiency
5003438|NCT01619189|Limbal stem cell|limbal stem cell
5003439|NCT01619189|Transplantation|transplantation
5003440|NCT01619176|Rheumatoid Arthritis|rheumatoid arthritis
5003441|NCT01619176|blood|blood
5003442|NCT01619176|gut intestinal microbiome|gut intestinal microbiome
5003443|NCT01619163|Prednisolone,|prednisolone,
5003444|NCT01619163|pain,|pain,
5003445|NCT01619163|inflammation,|inflammation,
5003446|NCT01619163|mobility|mobility
5003447|NCT01619163|Function|function
5003448|NCT01619150|knee|knee
5003449|NCT01619150|osteoarthritis|osteoarthritis
5003450|NCT01619150|central sensitization|central sensitization
5003451|NCT01619150|mechanical detection|mechanical detection
5003452|NCT01619150|pain threshold|pain threshold
5003453|NCT01619150|quantitative sensory testing|quantitative sensory testing
5003454|NCT01619150|pain biomarkers|pain biomarkers
5003455|NCT01619150|COX-2 inhibitors|cox-2 inhibitors
5003456|NCT01619150|etoricoxib.|etoricoxib.
5003457|NCT01619137|ununion wound|ununion wound
5003458|NCT01619137|soap|soap
5003459|NCT01619137|irrigation|irrigation
5003460|NCT01619137|Povidone-iodine|povidone-iodine
5003461|NCT01619137|normal salin|normal salin
5003462|NCT01619124|osteonecrosis|osteonecrosis
5003463|NCT01619124|children|children
5003464|NCT01619124|pediatric|pediatric
5003465|NCT01619124|acute lymphoblastic leukaemia|acute lymphoblastic leukaemia
5003466|NCT01619124|lymphoblastic lymphoma|lymphoblastic lymphoma
5003467|NCT01619111|metastatic breast cancer|metastatic breast cancer
5003468|NCT01619111|circulating tumor cells|circulating tumor cells
5003469|NCT01619111|lapatinib|lapatinib
5003470|NCT01619098|Hospital readmission|hospital readmission
5003471|NCT01619098|Care transition|care transition
5003472|NCT01619098|Discharge-transfer intervention|discharge-transfer intervention
5003473|NCT01619098|Community health worker|community health worker
5003474|NCT01619098|Patient Navigatgor|patient navigatgor
5003475|NCT01619072|postpartum hemorrhage|postpartum hemorrhage
5003476|NCT01619072|treatment|treatment
5003477|NCT01619072|misoprostol|misoprostol
5003479|NCT01619046|GreenGene™F, Previously Treated Patients|greengene™f, previously treated patients
5003480|NCT01619033|Renal impairment|renal impairment
5003481|NCT01619020|Healthy|healthy
5003482|NCT01619020|Colon|colon
5003483|NCT01619007|Treatment of Venous Thromboembolism|treatment of venous thromboembolism
5003484|NCT01619007|Thromboembolism|thromboembolism
5003485|NCT01619007|Venous Thromboembolism|venous thromboembolism
5003486|NCT01619007|Embolism and Thrombosis|embolism and thrombosis
5003487|NCT01619007|Vascular Diseases|vascular diseases
5003488|NCT01619007|Cardiovascular Diseases|cardiovascular diseases
5003489|NCT01619007|Thrombosis|thrombosis
5003490|NCT01618994|Robotic Simulator|robotic simulator
5003491|NCT01618994|EBL|ebl
5003492|NCT01618994|Robotic Surgeons|robotic surgeons
5003493|NCT01618994|Intuitive Surgical|intuitive surgical
5003494|NCT01618994|simulation modules|simulation modules
5003495|NCT01618994|benchmarks|benchmarks
5003496|NCT01618994|Morristown Protocol|morristown protocol
5003497|NCT01618994|Study Surgeons|study surgeons
5003498|NCT01618994|Control Surgeons|control surgeons
5003499|NCT01618994|Expert Surgeons|expert surgeons
5003500|NCT01618994|dual-console daVinci system|dual-console davinci system
5003501|NCT01618994|blinded skill assessment|blinded skill assessment
5003502|NCT01618981|Heart failure with preserved ejection fraction|heart failure with preserved ejection fraction
5003503|NCT01618981|atrial dyssynchrony syndrome|atrial dyssynchrony syndrome
5003504|NCT01618981|left atrio-ventricular asynchrony|left atrio-ventricular asynchrony
5003505|NCT01618981|pacemaker|pacemaker
5003506|NCT01618981|left atrial pacing therapy|left atrial pacing therapy
5003507|NCT01618929|Food allergy|food allergy
5003508|NCT01618929|Asthma|asthma
5003509|NCT01618929|Children|children
5003510|NCT01618929|Montelukast|montelukast
5003511|NCT01618929|Inflammation|inflammation
5003512|NCT01618903|Keppra Levetiracetam intravenous|keppra levetiracetam intravenous
5003513|NCT01618903|Oral tablets|oral tablets
5003514|NCT01618903|Bioequivalence|bioequivalence
5003515|NCT01618903|Pharmacokinetics|pharmacokinetics
5003516|NCT01618903|Safety|safety
5003517|NCT01618903|Chinese healthy volunteers|chinese healthy volunteers
5003518|NCT01618890|Prevention|prevention
5003519|NCT01618890|Esophageal variceal bleeding|esophageal variceal bleeding
5003520|NCT01618890|Hepatic Venous Pressure Gradient|hepatic venous pressure gradient
5003521|NCT01618890|Betablocker therapy|betablocker therapy
5003522|NCT01618877|Keppra Levetiracetam intravenous|keppra levetiracetam intravenous
5003523|NCT01618877|Multiple dose|multiple dose
5003524|NCT01618877|Safety|safety
5003525|NCT01618877|Pharmacokinetics|pharmacokinetics
5003526|NCT01618877|Chinese healthy volunteers|chinese healthy volunteers
5003527|NCT01618851|prostate cancer|prostate cancer
5003528|NCT01618838|prostate cancer|prostate cancer
5003529|NCT01618812|Artificial bone graft|artificial bone graft
5003530|NCT01618812|Hydroxyapatite|hydroxyapatite
5003531|NCT01618812|Children|children
5003532|NCT01618812|Osteotomy|osteotomy
5003533|NCT01618812|Pes plano valgus|pes plano valgus
5003534|NCT01618812|Flatfeet|flatfeet
5003535|NCT01618786|Falls|falls
5003536|NCT01618786|Fall injuries|fall injuries
5003537|NCT01618786|Bone fracture|bone fracture
5003538|NCT01618786|Hip fracture|hip fracture
5003539|NCT01618786|Skull fracture|skull fracture
5003540|NCT01618786|Wounds|wounds
5003541|NCT01618786|Closed head injury|closed head injury
5003542|NCT01618786|Traumatic brain injury|traumatic brain injury
5003543|NCT01618786|Concussion|concussion
5003544|NCT01618786|Spinal cord injury|spinal cord injury
5003545|NCT01618786|Trauma|trauma
5003546|NCT01618786|Older adults|older adults
5003547|NCT01618786|Long-term care|long-term care
5003548|NCT01618786|Compliant flooring|compliant flooring
5003549|NCT01618786|Safety floors|safety floors
5003550|NCT01618786|Balance|balance
5003551|NCT01618786|Injury biomechanics|injury biomechanics
5003552|NCT01618786|Biomedical engineering|biomedical engineering
5003553|NCT01618786|Environmental hazards|environmental hazards
5003554|NCT01618786|Environmental interventions|environmental interventions
5003555|NCT01618786|Fall prevention|fall prevention
5003556|NCT01618786|Gerontology|gerontology
5003557|NCT01618773|acne|acne
5003558|NCT01618773|Epiduo|epiduo
5003559|NCT01618773|adapalene/ benzoyl peroxide|adapalene/ benzoyl peroxide
5003560|NCT01618734|Immune Thrombocytopenia|immune thrombocytopenia
5003561|NCT01618734|Thrombopoietin receptor agonist|thrombopoietin receptor agonist
5003562|NCT01618721|Chronic obstructive lung disease;|chronic obstructive lung disease;
5003563|NCT01618721|Interstitial lung disease;|interstitial lung disease;
5003564|NCT01618721|Ultrasound Doppler;|ultrasound doppler;
5003565|NCT01618721|Lung disease diagnosis;|lung disease diagnosis;
5003566|NCT01618695|Partial-onset Seizures|partial-onset seizures
5003567|NCT01618695|partial seizures|partial seizures
5003568|NCT01618695|seizure|seizure
5003569|NCT01618695|epilepsy|epilepsy
5003570|NCT01618682|hand transplant|hand transplant
5003571|NCT01618682|hand replant|hand replant
5003572|NCT01618669|Coronary Artery Disease (CAD)|coronary artery disease (cad)
5003573|NCT01618669|regadenoson|regadenoson
5003574|NCT01618669|pharmacologic stress|pharmacologic stress
5003575|NCT01618643|Barrett's|barrett's
5003576|NCT01618643|High grade dysplasia|high grade dysplasia
5003579|NCT01618643|Intramucosal cancer|intramucosal cancer
5003580|NCT01618643|Acetic acid|acetic acid
5003581|NCT01618643|Chromoendoscopy|chromoendoscopy
5003582|NCT01618630|burn injury|burn injury
5003583|NCT01618630|children|children
5003584|NCT01618630|nutrition|nutrition
5003585|NCT01618630|lipid metabolism|lipid metabolism
5003586|NCT01618630|insulin sensitivity|insulin sensitivity
5003587|NCT01618630|amino acids|amino acids
5003588|NCT01618630|stable isotopes|stable isotopes
5003589|NCT01618617|Constipation|constipation
5003590|NCT01618617|Probiotic|probiotic
5003591|NCT01618617|Randomized Controlled Trial|randomized controlled trial
5003592|NCT01618604|Conditioned Pain Modulation|conditioned pain modulation
5003593|NCT01618604|Quantitative Sensory Testing|quantitative sensory testing
5003594|NCT01618604|duration|duration
5003595|NCT01618604|correlation|correlation
5003596|NCT01618591|diarrhea|diarrhea
5003597|NCT01618591|travelers' diarrhea|travelers' diarrhea
5003598|NCT01618591|watery diarrhea|watery diarrhea
5003599|NCT01618591|enteric illness|enteric illness
5003600|NCT01618591|dysentery|dysentery
5003601|NCT01618591|gastrointestinal|gastrointestinal
5003602|NCT01618578|rubber hand illusion|rubber hand illusion
5003603|NCT01618578|CRPS|crps
5003604|NCT01618578|body image|body image
5003605|NCT01618578|body ownership|body ownership
5003606|NCT01618565|shoulder dystocia|shoulder dystocia
5003607|NCT01618565|training|training
5003608|NCT01618565|To assess the effectiveness of hands-on training versus expert demonstration|to assess the effectiveness of hands-on training versus expert demonstration
5003609|NCT01618552|Chronic disease|chronic disease
5003610|NCT01618552|Cluster randomization|cluster randomization
5003611|NCT01618552|Comorbidity|comorbidity
5003612|NCT01618552|Depression|depression
5003613|NCT01618552|Diabetes|diabetes
5003614|NCT01618552|Medical history taking|medical history taking
5003615|NCT01618552|Office visits|office visits
5003616|NCT01618552|Patient acceptance of health care|patient acceptance of health care
5003617|NCT01618552|Patient compliance|patient compliance
5003618|NCT01618552|Patient simulation|patient simulation
5003619|NCT01618552|Physician patient relations|physician patient relations
5003620|NCT01618552|Primary health care|primary health care
5003621|NCT01618552|Randomized controlled trials|randomized controlled trials
5003622|NCT01618552|Self care|self care
5003623|NCT01618552|Self efficacy|self efficacy
5003624|NCT01618539|Total intravenous anesthesia, Bispectral Index Score|total intravenous anesthesia, bispectral index score
5003625|NCT01618526|Dietary fibers|dietary fibers
5003626|NCT01618526|Butyrate|butyrate
5003627|NCT01618526|Short Chain Fatty Acids|short chain fatty acids
5003628|NCT01618526|Colon|colon
5003629|NCT01618526|Metabolic Syndrome|metabolic syndrome
5003630|NCT01618513|Acromegaly|acromegaly
5003631|NCT01618513|Somatostatin analogs|somatostatin analogs
5003632|NCT01618513|Treatment|treatment
5003633|NCT01618500|Normal Pressure Hydrocephalus|normal pressure hydrocephalus
5003634|NCT01618500|Neuropsychological Test|neuropsychological test
5003635|NCT01618500|Assessment of cognitive disorders/dementia|assessment of cognitive disorders/dementia
5003636|NCT01618500|Neuropsychological assessment|neuropsychological assessment
5003637|NCT01618487|tennis elbow|tennis elbow
5003638|NCT01618487|lateral epicondylitis|lateral epicondylitis
5003639|NCT01618474|gastric cancer|gastric cancer
5003640|NCT01618474|adjuvant chemotherapy|adjuvant chemotherapy
5003641|NCT01618461|Prescription drug information|prescription drug information
5003642|NCT01618461|Medication management|medication management
5003643|NCT01618435|Fusion surgery|fusion surgery
5003644|NCT01618435|Degenerative olisthesis|degenerative olisthesis
5003645|NCT01618435|i-FACTOR|i-factor
5003647|NCT01618435|Spinal stenosis|spinal stenosis
5003648|NCT01618422|DOTS plus|dots plus
5003649|NCT01618422|DOTS|dots
5003650|NCT01618422|multidrug resistant tuberculosis (MDR TB)|multidrug resistant tuberculosis (mdr tb)
5003651|NCT01618409|PictureRx|picturerx
5003652|NCT01618409|Health Literacy|health literacy
5003653|NCT01618409|Limited English Proficiency|limited english proficiency
5003654|NCT01618409|Latinos|latinos
5003655|NCT01618409|Spanish|spanish
5003656|NCT01618396|Microcirculation|microcirculation
5003657|NCT01618396|Hypnotics and Sedatives,|hypnotics and sedatives,
5003658|NCT01618396|Propofol,|propofol,
5003659|NCT01618396|Midazolam|midazolam
5003660|NCT01618383|Parkinson's disease|parkinson's disease
5003661|NCT01618383|gut|gut
5003662|NCT01618383|colon|colon
5003663|NCT01618383|biopsies|biopsies
5003664|NCT01618383|LRRK2|lrrk2
5003665|NCT01618370|Radium 223|radium 223
5003666|NCT01618370|Alpharadin|alpharadin
5003667|NCT01618370|Prostate Cancer|prostate cancer
5003668|NCT01618370|Bone metastases|bone metastases
5003669|NCT01618370|Castrate resistant prostate cancer|castrate resistant prostate cancer
5003670|NCT01618370|Hormone refractory prostate cancer|hormone refractory prostate cancer
5003671|NCT01618357|Veliparib|veliparib
5003672|NCT01618357|ABT-888|abt-888
5003673|NCT01618357|Radiation|radiation
5003674|NCT01618357|POPI|popi
5003675|NCT01618344|neoplasms|neoplasms
5003676|NCT01618344|adolescent|adolescent
5003677|NCT01618344|young adult|young adult
5003678|NCT01618344|medication adherence|medication adherence
5003679|NCT01618331|FSHD|fshd
5003680|NCT01618331|Endurance exercise|endurance exercise
5003681|NCT01618331|Protein supplementation|protein supplementation
5003682|NCT01618331|Placebo RCT|placebo rct
5003683|NCT01618318|Asthma|asthma
5003684|NCT01618318|Allergy|allergy
5003685|NCT01618318|Diagnosis|diagnosis
5003686|NCT01618318|Correlation study|correlation study
5003687|NCT01618292|pelvic organ prolapse|pelvic organ prolapse
5003688|NCT01618292|constipation|constipation
5003689|NCT01618292|bowel dysfunction|bowel dysfunction
5003690|NCT01618292|irritable bowel syndrome (IBS)|irritable bowel syndrome (ibs)
5003691|NCT01618292|CRADI-8|cradi-8
5003692|NCT01618292|CRAIQ-7|craiq-7
5003693|NCT01618292|splinting with defecation|splinting with defecation
5003694|NCT01618292|excessive straining|excessive straining
5003695|NCT01618292|bowel movements|bowel movements
5003696|NCT01618292|fecal incontinence|fecal incontinence
5003697|NCT01618292|bowel symptoms|bowel symptoms
5003698|NCT01618279|tryptase|tryptase
5003699|NCT01618279|coronary|coronary
5003700|NCT01618279|stemi|stemi
5003701|NCT01618279|nstemi|nstemi
5003702|NCT01618253|Transarterial Chemoembolization|transarterial chemoembolization
5003703|NCT01618253|TACE|tace
5003704|NCT01618253|Sorafenib Tosylate|sorafenib tosylate
5003705|NCT01618253|Sorafenib|sorafenib
5003706|NCT01618253|Nexavar|nexavar
5003707|NCT01618253|External Beam Radiation Therapy|external beam radiation therapy
5003708|NCT01618253|Radiation Therapy|radiation therapy
5003709|NCT01618253|Radiotherapy|radiotherapy
5003710|NCT01618253|Radiation|radiation
5003711|NCT01618240|FEES|fees
5003712|NCT01618240|PAS|pas
5003713|NCT01618240|VPSR|vpsr
5003714|NCT01618240|MRC|mrc
5003715|NCT01618201|Inflammation|inflammation
5003716|NCT01618201|Migraine|migraine
5003717|NCT01618201|Headache|headache
5003718|NCT01618175|Bronchiolitis, Viral|bronchiolitis, viral
5003719|NCT01618175|Home oxygen therapy|home oxygen therapy
5003720|NCT01618175|Home Nursing|home nursing
5003721|NCT01618175|Outcome and Process Assessment (Health Care)|outcome and process assessment (health care)
5003722|NCT01618175|bronchiolitis severity score|bronchiolitis severity score
5003723|NCT01618149|osteoarthritis|osteoarthritis
5003724|NCT01618149|periprosthetic bone loss|periprosthetic bone loss
5003725|NCT01618149|dual energy x-ray absorptiometry|dual energy x-ray absorptiometry
5003726|NCT01618136|PARP inhibitors|parp inhibitors
5003727|NCT01618136|Malignant Solid Tumour|malignant solid tumour
5003728|NCT01618136|ovarian cancer|ovarian cancer
5003729|NCT01618136|triple negative breast cancer|triple negative breast cancer
5003730|NCT01618136|advanced melanoma|advanced melanoma
5003731|NCT01618123|Endothelial function|endothelial function
5003732|NCT01618123|Coronary disease|coronary disease
5003733|NCT01618123|Atherosclerosis|atherosclerosis
5003734|NCT01618123|Chest pain|chest pain
5003735|NCT01618110|ADHD|adhd
5003736|NCT01618110|Attention Deficit/Hyperactivity Disorder|attention deficit/hyperactivity disorder
5003737|NCT01618110|TMS|tms
5003738|NCT01618110|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
5003739|NCT01618097|Osteoarthritis|osteoarthritis
5003740|NCT01618097|Decision Aids|decision aids
5003741|NCT01618097|Health Literacy|health literacy
5003742|NCT01618084|hipreplacement|hipreplacement
5003743|NCT01618084|uncemented|uncemented
5003744|NCT01618084|migration|migration
5003745|NCT01618084|boneremodeling|boneremodeling
5003746|NCT01618071|n-3 PUFA|n-3 pufa
5003747|NCT01618071|Endothelial cells|endothelial cells
5003748|NCT01618071|Nitric oxide|nitric oxide
5003749|NCT01618071|Oxidative stress|oxidative stress
5003750|NCT01618071|Blood pressure|blood pressure
5003751|NCT01618071|Vasodilation|vasodilation
5003752|NCT01618071|Lipemia|lipemia
5003753|NCT01618071|Unsaturated dietary fats|unsaturated dietary fats
5003754|NCT01618058|HIV Infections|hiv infections
5003755|NCT01618058|Anti-HIV Agents|anti-hiv agents
5003756|NCT01618058|HIV-1|hiv-1
5003757|NCT01618045|Diabetes|diabetes
5003758|NCT01618045|FPP|fpp
5003759|NCT01618045|fermented papaya preparation|fermented papaya preparation
5003760|NCT01618019|n-3 PUFA|n-3 pufa
5003761|NCT01618019|rheumatoid arthritis|rheumatoid arthritis
5003762|NCT01618019|inflammation|inflammation
5003763|NCT01618019|eicosanoids|eicosanoids
5003764|NCT01618019|bone turnover markers|bone turnover markers
5003765|NCT01617993|in vitro fertilization|in vitro fertilization
5003766|NCT01617993|assisted reproduction|assisted reproduction
5003767|NCT01617993|noninvasive imaging of embryos|noninvasive imaging of embryos
5003768|NCT01617993|time lapse imaging of embryos|time lapse imaging of embryos
5003769|NCT01617993|traditional morphological grading of embryos|traditional morphological grading of embryos
5003770|NCT01617993|prediction of blastocysts|prediction of blastocysts
5003771|NCT01617993|infertility|infertility
5003772|NCT01617993|Genital Diseases, Male|genital diseases, male
5003773|NCT01617993|Genital Diseases, Female|genital diseases, female
5003774|NCT01617980|Hypoxia imaging|hypoxia imaging
5003775|NCT01617980|FMISO-PET|fmiso-pet
5003776|NCT01617980|functional MRI|functional mri
5003777|NCT01617980|Intensity modulated radiation therapy|intensity modulated radiation therapy
5003778|NCT01617967|RNAi therapeutic|rnai therapeutic
5003779|NCT01617941|non-chronic migraine, migraine prevention|non-chronic migraine, migraine prevention
5003780|NCT01617902|Hyperbilirubinemia|hyperbilirubinemia
5003781|NCT01617902|cardiac|cardiac
5003782|NCT01617902|surgery|surgery
5003783|NCT01617902|aorta|aorta
5003784|NCT01617902|prognosis|prognosis
5003785|NCT01617876|Stomach Neoplasms|stomach neoplasms
5003786|NCT01617876|early gastric cancer|early gastric cancer
5003787|NCT01617876|magnifying endoscopy|magnifying endoscopy
5003788|NCT01617876|narrow band imaging|narrow band imaging
5003789|NCT01617876|acetic acid|acetic acid
5003790|NCT01617876|indigocarmine|indigocarmine
5003791|NCT01617837|Postoperative nausea and vomiting|postoperative nausea and vomiting
5003792|NCT01617837|P6 acupressure|p6 acupressure
5003793|NCT01617837|Craniotomy.|craniotomy.
5003794|NCT01617824|Diabetes|diabetes
5003795|NCT01617824|Kidney|kidney
5003796|NCT01617824|Inflammation|inflammation
5003797|NCT01617824|Metabolism|metabolism
5003798|NCT01617772|Non-alcoholic steatohepatitis, Atorvastatin, L-Carnitine|non-alcoholic steatohepatitis, atorvastatin, l-carnitine
5003799|NCT01617746|Asthma|asthma
5003800|NCT01617746|Endothelin|endothelin
5003801|NCT01617746|Airway hyperreactivity|airway hyperreactivity
5003802|NCT01617720|mitral|mitral
5003803|NCT01617720|valve|valve
5003804|NCT01617720|annuloplasty|annuloplasty
5003805|NCT01617720|mitral regurgitation|mitral regurgitation
5003806|NCT01617707|sedation|sedation
5003807|NCT01617707|endoscopy|endoscopy
5003808|NCT01617707|midazolam|midazolam
5003809|NCT01617707|propofol|propofol
5003810|NCT01617707|chronic alcoholics|chronic alcoholics
5003811|NCT01617694|dexmedetomidine|dexmedetomidine
5003812|NCT01617694|remifentanil|remifentanil
5003813|NCT01617694|target-controlled infusion|target-controlled infusion
5003814|NCT01617681|Hypertension; CKD; Pediatric|hypertension; ckd; pediatric
5003815|NCT01617668|Breast cancer,|breast cancer,
5003816|NCT01617668|LCL161,|lcl161,
5003817|NCT01617668|paclitaxel,|paclitaxel,
5003818|NCT01617668|neoadjuvant,|neoadjuvant,
5003819|NCT01617668|triple negative breast cancer|triple negative breast cancer
5003820|NCT01617642|Porphyria|porphyria
5003821|NCT01617642|Inflammation|inflammation
5003822|NCT01617642|Diet|diet
5003823|NCT01617642|Iron status|iron status
5003824|NCT01617629|Cvac|cvac
5003825|NCT01617603|diabetes type 2|diabetes type 2
5003826|NCT01617603|insulin resistance|insulin resistance
5003827|NCT01617603|glycaemic control|glycaemic control
5003828|NCT01617603|Endothelial function|endothelial function
5003829|NCT01617603|Cocoa Polyphenols|cocoa polyphenols
5003830|NCT01617590|RA|ra
5003831|NCT01617590|Leflunomide|leflunomide
5003832|NCT01617590|Methotrexate|methotrexate
5003833|NCT01617577|G-CSF|g-csf
5003834|NCT01617577|granulocyte colony stimulating factor|granulocyte colony stimulating factor
5003835|NCT01617577|Filgrastim|filgrastim
5003836|NCT01617564|medical abortion|medical abortion
5003837|NCT01617564|second trimester|second trimester
5003838|NCT01617564|para cervical blockage|para cervical blockage
5003839|NCT01617564|pain management|pain management
5003840|NCT01617551|Essential hypertension|essential hypertension
5003841|NCT01617551|Nitric oxide|nitric oxide
5003842|NCT01617551|Renal denervation|renal denervation
5003843|NCT01617551|Sodium|sodium
5003844|NCT01617551|GFR|gfr
5003845|NCT01617538|atherosclerosis|atherosclerosis
5003846|NCT01617538|stenosis|stenosis
5003847|NCT01617538|statin therapy|statin therapy
5003848|NCT01617538|Signs and Symptoms|signs and symptoms
5003849|NCT01617538|Circulatory; Change|circulatory; change
5003850|NCT01617499|physical activity|physical activity
5003851|NCT01617499|pedometer|pedometer
5003852|NCT01617499|worksite|worksite
5003853|NCT01617499|wellness|wellness
5003854|NCT01617499|cardiovascular|cardiovascular
5003855|NCT01617499|lifestyle program|lifestyle program
5003856|NCT01617460|Autistic Disorder, children and adolescents|autistic disorder, children and adolescents
5003857|NCT01617460|aripiprazole|aripiprazole
5003858|NCT01617460|Long-term safety study|long-term safety study
5003859|NCT01617460|children and adolescents|children and adolescents
5003860|NCT01617447|Autistic Disorder, children and adolescents|autistic disorder, children and adolescents
5003861|NCT01617447|Aripiprazole|aripiprazole
5003862|NCT01617447|Double-blind|double-blind
5003863|NCT01617447|Randomized|randomized
5003864|NCT01617447|children and adolescents|children and adolescents
5003865|NCT01617421|Yoga|yoga
5003866|NCT01617421|Arthritis|arthritis
5003867|NCT01617408|Theta Burst Stimulation|theta burst stimulation
5003868|NCT01617408|Transcranial Magnetic Stimulation (TMS)|transcranial magnetic stimulation (tms)
5003869|NCT01617408|Visual Cortex|visual cortex
5003870|NCT01617408|Visual Processing|visual processing
5003871|NCT01617395|Multiple Sclerosis|multiple sclerosis
5003872|NCT01617395|Magnetic Resonance Imaging (MRI)|magnetic resonance imaging (mri)
5003873|NCT01617382|HIPEC|hipec
5003874|NCT01617382|Hyperthermic (heated) chemotherapy after debulking|hyperthermic (heated) chemotherapy after debulking
5003875|NCT01617356|TMD|tmd
5003876|NCT01617356|temporomandibular|temporomandibular
5003877|NCT01617356|dextrose|dextrose
5003878|NCT01617356|prolotherapy|prolotherapy
5003879|NCT01617330|Particulate matter|particulate matter
5003880|NCT01617330|Air pollution|air pollution
5003881|NCT01617330|Diesel exhaust|diesel exhaust
5003882|NCT01617330|Allergic rhinitis|allergic rhinitis
5003883|NCT01617317|H1N1 2009|h1n1 2009
5003884|NCT01617317|hyperimmune IVIG|hyperimmune ivig
5003885|NCT01617317|mortality|mortality
5003886|NCT01617317|length of stay|length of stay
5003887|NCT01617317|viral load|viral load
5003888|NCT01617317|cytokine|cytokine
5003889|NCT01617304|advanced glycation end products|advanced glycation end products
5003890|NCT01617304|insulin sensitivity|insulin sensitivity
5003891|NCT01617304|obesity|obesity
5003892|NCT01617304|inflammation|inflammation
5003893|NCT01617304|metabolomics|metabolomics
5003894|NCT01617304|appetite|appetite
5003895|NCT01617304|CVD|cvd
5003896|NCT01617291|Pre-hospital hypothermia|pre-hospital hypothermia
5003897|NCT01617291|Induced therapeutic hypothermia|induced therapeutic hypothermia
5003898|NCT01617291|Cardiac arrest|cardiac arrest
5003899|NCT01617278|Colonoscopy|colonoscopy
5003900|NCT01617278|I Scan|i scan
5003901|NCT01617278|High definition white light|high definition white light
5003902|NCT01617278|Adenomas|adenomas
5003903|NCT01617265|intensive care|intensive care
5003904|NCT01617265|mechanical ventilation|mechanical ventilation
5003905|NCT01617265|sedatives|sedatives
5003906|NCT01617265|morphinics|morphinics
5003907|NCT01617265|oversedation|oversedation
5003908|NCT01617265|mortality|mortality
5003909|NCT01617265|midazolam|midazolam
5003910|NCT01617265|propofol|propofol
5003911|NCT01617265|pain|pain
5003912|NCT01617265|agitation|agitation
5003913|NCT01617252|Cardiac surgery|cardiac surgery
5003914|NCT01617252|Acute respiratory failure|acute respiratory failure
5003915|NCT01617252|High flow oxygen therapy|high flow oxygen therapy
5003916|NCT01617239|Influenza|influenza
5003917|NCT01617239|Vaccination|vaccination
5003918|NCT01617239|Virosomal influenza vaccine|virosomal influenza vaccine
5003919|NCT01617213|Multiple Myeloma|multiple myeloma
5003920|NCT01617174|prostate|prostate
5003921|NCT01617174|pain assessment|pain assessment
5003922|NCT01617174|12-110|12-110
5003923|NCT01617161|Low Risk|low risk
5003924|NCT01617161|Intermediate Risk|intermediate risk
5003925|NCT01617148|Exudative Macular Degeneration|exudative macular degeneration
5003926|NCT01617148|Aflibercept|aflibercept
5003927|NCT01617135|Parkinson's disease|parkinson's disease
5003928|NCT01617135|Motor fluctuations|motor fluctuations
5003929|NCT01617135|levodopa|levodopa
5003930|NCT01617135|inhaled drugs|inhaled drugs
5003931|NCT01617135|"Motor fluctuation (off episodes)"|"motor fluctuation (off episodes)"
5003932|NCT01617122|PID|pid
5003933|NCT01617122|PIDD|pidd
5003934|NCT01617122|antibody deficiency|antibody deficiency
5003935|NCT01617122|CVID|cvid
5003936|NCT01617122|recurrent infections|recurrent infections
5003937|NCT01617109|Vitamin D|vitamin d
5003938|NCT01617109|Calcium|calcium
5003939|NCT01617109|Parathyroid hormone|parathyroid hormone
5003940|NCT01617109|Bone|bone
5003941|NCT01617109|Bone formation|bone formation
5003942|NCT01617109|Bone resorption|bone resorption
5003943|NCT01617109|Micronutrients|micronutrients
5003944|NCT01617109|Trace Elements|trace elements
5003945|NCT01617096|HIV Infections|hiv infections
5003946|NCT01617096|Anti-HIV agents|anti-hiv agents
5003947|NCT01617096|HIV-1|hiv-1
5003948|NCT01617083|PANS|pans
5003949|NCT01617083|PANDAS|pandas
5003950|NCT01617083|OCD|ocd
5003951|NCT01617083|Tics|tics
5003952|NCT01617083|Azithromycin|azithromycin
5003953|NCT01617083|Antibiotic Treatment|antibiotic treatment
5003954|NCT01617070|Tetrahydrobiopterin|tetrahydrobiopterin
5003955|NCT01617070|Kuvan|kuvan
5003956|NCT01617070|Phenylketonuria (PKU)|phenylketonuria (pku)
5003957|NCT01617070|Large Neutral Amino Acids|large neutral amino acids
5003958|NCT01617070|Serotonin|serotonin
5003959|NCT01617070|Dopamine|dopamine
5003960|NCT01617070|Melatonin|melatonin
5003961|NCT01617057|otosclerosis|otosclerosis
5003962|NCT01617057|inner ear|inner ear
5003963|NCT01617057|tiludronic acid|tiludronic acid
5003964|NCT01617044|Iron|iron
5003965|NCT01617044|Deficiency|deficiency
5003966|NCT01617044|Restless|restless
5003967|NCT01617044|Leg|leg
5003968|NCT01617031|aspirin|aspirin
5003969|NCT01617031|diabetes mellitus|diabetes mellitus
5003970|NCT01617031|coronary artery disease|coronary artery disease
5003971|NCT01617018|Psoriasis; Biological therapy; Methotrexate; Cyclosporine|psoriasis; biological therapy; methotrexate; cyclosporine
5003972|NCT01616979|Off-pump coronary artery bypass surgery|off-pump coronary artery bypass surgery
5003973|NCT01616979|Transesophageal echocardiography|transesophageal echocardiography
5003974|NCT01616966|hoarseness|hoarseness
5003975|NCT01616966|sore throat|sore throat
5003976|NCT01616966|vocal cord injuries|vocal cord injuries
5003977|NCT01616953|dental implants|dental implants
5003978|NCT01616940|HIV/AIDS|hiv/aids
5003979|NCT01616940|Peer support|peer support
5003980|NCT01616927|ADPKD|adpkd
5003981|NCT01616927|lanreotide|lanreotide
5003982|NCT01616927|polycystic kidney|polycystic kidney
5003983|NCT01616927|polycystic liver|polycystic liver
5003984|NCT01616914|delirium|delirium
5003985|NCT01616914|outcome|outcome
5003986|NCT01616901|Obese|obese
5003987|NCT01616901|Intensive Care|intensive care
5003988|NCT01616901|Respiratory weaning|respiratory weaning
5003989|NCT01616901|Spontaneous Breathing trial|spontaneous breathing trial
5003990|NCT01616901|Work of breathing|work of breathing
5003991|NCT01616888|drug eluting balloon with paclitaxel|drug eluting balloon with paclitaxel
5003992|NCT01616888|in stent restenosis|in stent restenosis
5003993|NCT01616888|femoropopliteal arteries|femoropopliteal arteries
5003994|NCT01616888|angioplasty|angioplasty
5003995|NCT01616875|Bladder cancer|bladder cancer
5003996|NCT01616875|Transitional cell carcinoma|transitional cell carcinoma
5003997|NCT01616875|Urothelial cancer|urothelial cancer
5003998|NCT01616875|Cisplatin|cisplatin
5003999|NCT01616875|Cabazitaxel|cabazitaxel
5004000|NCT01616875|Chemotherapy|chemotherapy
5004001|NCT01616875|Neo adjuvant chemotherapy|neo adjuvant chemotherapy
5004002|NCT01616862|Pseudomonas aeruginosa|pseudomonas aeruginosa
5004003|NCT01616862|cystic fibrosis|cystic fibrosis
5004004|NCT01616823|Human immunodeficiency virus (HIV) positive women|human immunodeficiency virus (hiv) positive women
5004005|NCT01616810|urinary tract|urinary tract
5004006|NCT01616784|Adult|adult
5004007|NCT01616784|Diabetes Mellitus|diabetes mellitus
5004008|NCT01616784|Type 1|type 1
5004009|NCT01616784|Humans|humans
5004010|NCT01616784|Hypoglycemic Agents|hypoglycemic agents
5004011|NCT01616784|Administration and Dosage|administration and dosage
5004012|NCT01616784|Insulin|insulin
5004013|NCT01616784|Self Care|self care
5004014|NCT01616784|Health Education|health education
5004015|NCT01616784|Insulin Infusion Systems|insulin infusion systems
5004016|NCT01616784|Randomised controlled trial|randomised controlled trial
5004017|NCT01616784|Patient Education as Topic|patient education as topic
5004018|NCT01616784|Hemoglobin A|hemoglobin a
5004019|NCT01616784|Glycosylated|glycosylated
5004020|NCT01616771|laryngoscopes|laryngoscopes
5004021|NCT01616745|NTM Lung disease|ntm lung disease
5004022|NCT01616745|NTM Lung disease patients enrolled in SNUH|ntm lung disease patients enrolled in snuh
5004023|NCT01616693|rotavirus|rotavirus
5004024|NCT01616693|polio|polio
5004025|NCT01616693|zinc supplement|zinc supplement
5004026|NCT01616693|probiotic supplement|probiotic supplement
5004027|NCT01616693|rotavirus vaccine shedding|rotavirus vaccine shedding
5004028|NCT01616667|Controlled Clinical Trial|controlled clinical trial
5004029|NCT01616667|Operative Surgical Procedures|operative surgical procedures
5004030|NCT01616667|Treatment Outcome|treatment outcome
5004031|NCT01616667|Pain Measurement|pain measurement
5004032|NCT01616667|Quality of Life|quality of life
5004033|NCT01616667|Questionnaires/standards|questionnaires/standards
5004034|NCT01616667|Activities of Daily Living|activities of daily living
5004035|NCT01616667|Biomechanics|biomechanics
5004036|NCT01616667|Gait*|gait*
5004037|NCT01616667|Hip Joint/physiology*|hip joint/physiology*
5004038|NCT01616667|Hip Joint/surgery*|hip joint/surgery*
5004039|NCT01616667|Recovery of Function/physiology|recovery of function/physiology
5004040|NCT01616641|rheumatoid arthritis|rheumatoid arthritis
5004041|NCT01616641|bite force|bite force
5004042|NCT01616641|grip strenght|grip strenght
5004043|NCT01616641|oral health|oral health
5004044|NCT01616641|quality of life|quality of life
5004045|NCT01616628|Incentives|incentives
5004046|NCT01616628|Fruit|fruit
5004047|NCT01616628|Vegetables|vegetables
5004048|NCT01616602|patients|patients
5004049|NCT01616602|presenting|presenting
5004050|NCT01616602|elective|elective
5004051|NCT01616602|colonoscopy.|colonoscopy.
5004052|NCT01616589|Fragile X syndrome|fragile x syndrome
5004053|NCT01616589|Fragile X full mutation|fragile x full mutation
5004054|NCT01616589|Fragile X premutation|fragile x premutation
5004055|NCT01616589|Fragile X intermediate|fragile x intermediate
5004056|NCT01616589|CGG repeat length|cgg repeat length
5004057|NCT01616576|cochlear implant|cochlear implant
5004058|NCT01616576|adults|adults
5004059|NCT01616576|HiResolution™|hiresolution™
5004060|NCT01616576|Fidelity 120™|fidelity 120™
5004061|NCT01616576|listening benefits|listening benefits
5004062|NCT01616576|noise|noise
5004063|NCT01616576|cochlear implant benefit|cochlear implant benefit
5004064|NCT01616563|central obesity|central obesity
5004065|NCT01616563|abdominal obesity|abdominal obesity
5004066|NCT01616563|hypertension|hypertension
5004067|NCT01616563|cardiovascular disease|cardiovascular disease
5004068|NCT01616563|high cholesterol|high cholesterol
5004069|NCT01616563|high triglycerides|high triglycerides
5004070|NCT01616563|insulin resistance|insulin resistance
5004071|NCT01616563|diabetes mellitus|diabetes mellitus
5004072|NCT01616550|analgesia|analgesia
5004073|NCT01616550|thoracic surgery|thoracic surgery
5004074|NCT01616537|solid tumors|solid tumors
5004075|NCT01616537|hematological malignancy|hematological malignancy
5004076|NCT01616472|hypertension|hypertension
5004077|NCT01616472|avascular necrosis|avascular necrosis
5004078|NCT01616472|systemic lupus erythematosus|systemic lupus erythematosus
5004079|NCT01616472|osteoporosis|osteoporosis
5004080|NCT01616472|Steroid|steroid
5004081|NCT01616472|diabetes|diabetes
5004082|NCT01616472|cataracts|cataracts
5004083|NCT01616459|Streptococcus pneumoniae|streptococcus pneumoniae
5004084|NCT01616459|Haemophilus influenzae|haemophilus influenzae
5004085|NCT01616459|Pneumococcal vaccine|pneumococcal vaccine
5004086|NCT01616459|Infants|infants
5004087|NCT01616459|Safety|safety
5004088|NCT01616459|Immunogenicity|immunogenicity
5004089|NCT01616446|cyclosporin|cyclosporin
5004090|NCT01616446|nephrotic syndrome|nephrotic syndrome
5004091|NCT01616446|pharmacokinetics|pharmacokinetics
5004092|NCT01616446|children|children
5004093|NCT01616433|Arthritis|arthritis
5004094|NCT01616433|Preventive Behaviors|preventive behaviors
5004095|NCT01616420|prevention|prevention
5004096|NCT01616420|treatment|treatment
5004097|NCT01616420|cost-effectiveness|cost-effectiveness
5004098|NCT01616420|assisted partner notification services|assisted partner notification services
5004099|NCT01616420|Kenya|kenya
5004100|NCT01616420|linkage to HIV care|linkage to hiv care
5004101|NCT01616420|case-finding|case-finding
5004102|NCT01616407|Effects of psychostimulants on emotion recognition and empathy|effects of psychostimulants on emotion recognition and empathy
5004103|NCT01616355|denture, complete;|denture, complete;
5004104|NCT01616355|sodium hypochlorite;|sodium hypochlorite;
5004105|NCT01616355|disinfection;|disinfection;
5004106|NCT01616355|surface roughness;|surface roughness;
5004107|NCT01616355|color stability.|color stability.
5004108|NCT01616329|alloimmunization|alloimmunization
5004109|NCT01616329|RBC|rbc
5004110|NCT01616329|clinicalfactors|clinicalfactors
5004111|NCT01616329|Risk|risk
5004112|NCT01616303|ovarian|ovarian
5004113|NCT01616303|cancer|cancer
5004114|NCT01616303|neoplasm|neoplasm
5004115|NCT01616303|adenocarcinoma|adenocarcinoma
5004116|NCT01616303|CA125|ca125
5004117|NCT01616290|peripheral artery disease|peripheral artery disease
5004118|NCT01616290|PAD|pad
5004119|NCT01616290|claudication|claudication
5004120|NCT01616290|angioplasty|angioplasty
5004121|NCT01616290|percutaneous transluminal angioplasty|percutaneous transluminal angioplasty
5004122|NCT01616290|PTA|pta
5004123|NCT01616290|superficial femoral artery|superficial femoral artery
5004124|NCT01616290|SFA|sfa
5004125|NCT01616290|popliteal artery|popliteal artery
5004126|NCT01616290|PA|pa
5004127|NCT01616290|PRT-201|prt-201
5004128|NCT01616290|restenosis|restenosis
5004129|NCT01616290|vonapanitase|vonapanitase
5004130|NCT01616264|Tuberculosis|tuberculosis
5004131|NCT01616264|Pleural Effusion|pleural effusion
5004132|NCT01616264|Computed Tomography|computed tomography
5004133|NCT01616251|Protein sources|protein sources
5004134|NCT01616251|Appetite|appetite
5004135|NCT01616251|Dietary fibers|dietary fibers
5004136|NCT01616251|Meat|meat
5004137|NCT01616251|Egg|egg
5004138|NCT01616251|Legumes|legumes
5004139|NCT01616225|Infertility|infertility
5004140|NCT01616225|Poor Responder|poor responder
5004141|NCT01616225|In Vitro Fertilization|in vitro fertilization
5004142|NCT01616225|Growth Hormone|growth hormone
5004143|NCT01616212|Teens|teens
5004144|NCT01616212|Parenting|parenting
5004145|NCT01616212|Substance Abuse|substance abuse
5004146|NCT01616212|Treatment Efficacy|treatment efficacy
5004147|NCT01616199|PX-866|px-866
5004148|NCT01616199|BRAF-mutant cancers|braf-mutant cancers
5004149|NCT01616199|Advanced melanoma|advanced melanoma
5004150|NCT01616199|BRAF inhibitor|braf inhibitor
5004151|NCT01616199|Vemurafenib|vemurafenib
5004152|NCT01616199|Zelboraf|zelboraf
5004153|NCT01616199|PI-3K inhibitor|pi-3k inhibitor
5004154|NCT01616186|Renal Cell Carcinoma|renal cell carcinoma
5004155|NCT01616173|Nerve Block|nerve block
5004156|NCT01616173|Anesthesia Recovery Period|anesthesia recovery period
5004157|NCT01616160|Nasal polyps|nasal polyps
5004158|NCT01616147|Intensive Lifestyle Intervention|intensive lifestyle intervention
5004159|NCT01616134|overweight,|overweight,
5004160|NCT01616134|ginseng|ginseng
5004161|NCT01616108|strabismus|strabismus
5004162|NCT01616108|diplopia|diplopia
5004163|NCT01616095|Growth hormone deficiency|growth hormone deficiency
5004164|NCT01616095|hrGH therapy|hrgh therapy
5004165|NCT01616095|metabolic health|metabolic health
5004166|NCT01616095|adipose tissue metabolism|adipose tissue metabolism
5004167|NCT01616095|adipose tissue inflammation|adipose tissue inflammation
5004168|NCT01616095|adipokines|adipokines
5004169|NCT01616082|fatty acid oxidation|fatty acid oxidation
5004170|NCT01616082|Proton magnetic resonance spectroscopy|proton magnetic resonance spectroscopy
5004171|NCT01616069|CABG|cabg
5004172|NCT01616069|Echocardiography|echocardiography
5004173|NCT01616069|Heart Failure|heart failure
5004174|NCT01616069|Heart Function|heart function
5004175|NCT01616056|Chronic graft-versus-host disease|chronic graft-versus-host disease
5004176|NCT01616056|eye|eye
5004177|NCT01616043|scar quality|scar quality
5004178|NCT01616030|Hip fractures|hip fractures
5004179|NCT01616030|Strength training|strength training
5004180|NCT01616017|Cardiac output|cardiac output
5004181|NCT01616017|ultrasound dilution|ultrasound dilution
5004182|NCT01616017|thermodilution|thermodilution
5004183|NCT01615965|prostate cancer|prostate cancer
5004184|NCT01615965|lymph node|lymph node
5004185|NCT01615965|micrometastasis|micrometastasis
5004186|NCT01615952|Supraclavicular Block|supraclavicular block
5004187|NCT01615939|Sciatic Nerve Block|sciatic nerve block
5004188|NCT01615939|Continuous Nerve Block|continuous nerve block
5004189|NCT01615926|dyspnea|dyspnea
5004190|NCT01615926|shortness of breath|shortness of breath
5004891|NCT01612780|Sinusitis|sinusitis
5004191|NCT01615926|respiratory rate|respiratory rate
5004192|NCT01615926|orthopnea|orthopnea
5004193|NCT01615913|onychomycosis|onychomycosis
5004194|NCT01615913|terbinafine|terbinafine
5004195|NCT01615913|ketoconazole|ketoconazole
5004196|NCT01615913|transdermal topical therapy|transdermal topical therapy
5004197|NCT01615900|Renal graft|renal graft
5004198|NCT01615900|Teleconsultation|teleconsultation
5004199|NCT01615900|Kidney transplant failure score|kidney transplant failure score
5004200|NCT01615848|polycystic Ovary syndrome (PCOS)|polycystic ovary syndrome (pcos)
5004201|NCT01615848|diet|diet
5004202|NCT01615848|mediterranean diet|mediterranean diet
5004203|NCT01615848|high protein diet|high protein diet
5004204|NCT01615822|Malaria|malaria
5004205|NCT01615822|PK|pk
5004206|NCT01615822|OZ439|oz439
5004207|NCT01615822|Mefloquine|mefloquine
5004208|NCT01615822|Healthy Volunteers|healthy volunteers
5004209|NCT01615809|Invasive pulmonary aspergillosis|invasive pulmonary aspergillosis
5004210|NCT01615809|IFI|ifi
5004211|NCT01615809|Leukaemia|leukaemia
5004212|NCT01615809|Leukemia|leukemia
5004213|NCT01615809|Pediatric|pediatric
5004214|NCT01615809|Paediatrics|paediatrics
5004215|NCT01615809|Amphotericin B|amphotericin b
5004216|NCT01615809|Aspergillosis|aspergillosis
5004217|NCT01615809|Pulmonary Aspergillosis|pulmonary aspergillosis
5004218|NCT01615809|Invasive Aspergillosis|invasive aspergillosis
5004219|NCT01615809|Antifungal agents|antifungal agents
5004220|NCT01615809|Fungal infections|fungal infections
5004221|NCT01615809|Invasive Fungal Infection|invasive fungal infection
5004222|NCT01615796|GSK2140944|gsk2140944
5004223|NCT01615796|antibiotics|antibiotics
5004224|NCT01615796|first time in human|first time in human
5004225|NCT01615796|pharmacokinetics|pharmacokinetics
5004226|NCT01615796|intravenous|intravenous
5004227|NCT01615796|safety|safety
5004228|NCT01615796|absolute bioavailability|absolute bioavailability
5004229|NCT01615796|Bacterial Type II|bacterial type ii
5004230|NCT01615796|tolerability|tolerability
5004231|NCT01615796|infection|infection
5004232|NCT01615783|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5004233|NCT01615783|Costs|costs
5004234|NCT01615783|Resource utilization|resource utilization
5004235|NCT01615783|Medicaid|medicaid
5004236|NCT01615757|AML|aml
5004237|NCT01615757|Acute Myeloid Leukemia|acute myeloid leukemia
5004238|NCT01615757|Cytarabine dose|cytarabine dose
5004239|NCT01615757|Ara-c dose|ara-c dose
5004240|NCT01615757|Consolidation|consolidation
5004241|NCT01615744|calcaneal fractures|calcaneal fractures
5004242|NCT01615744|surgical treatment|surgical treatment
5004243|NCT01615744|conservative treatment|conservative treatment
5004244|NCT01615744|VAS scoring|vas scoring
5004245|NCT01615744|SF-36|sf-36
5004246|NCT01615744|AOFAS|aofas
5004247|NCT01615744|Olerud-Molander score|olerud-molander score
5004248|NCT01615744|outcome|outcome
5004249|NCT01615731|Mifepristone|mifepristone
5004250|NCT01615731|Induced Abortion|induced abortion
5004251|NCT01615731|Dilation and Evacuation|dilation and evacuation
5004252|NCT01615731|Cervical preparation|cervical preparation
5004253|NCT01615731|Osmotic dilators|osmotic dilators
5004254|NCT01615718|noninvasive stimulation|noninvasive stimulation
5004255|NCT01615718|motor function|motor function
5004256|NCT01615718|transcranial stimulation|transcranial stimulation
5004257|NCT01615718|transcranial ultrasound|transcranial ultrasound
5004258|NCT01615718|brain stimulation|brain stimulation
5004259|NCT01615705|Postphlebitic Syndrome|postphlebitic syndrome
5004260|NCT01615705|Post-Thrombotic Syndrome|post-thrombotic syndrome
5004261|NCT01615705|Biomarkers|biomarkers
5004262|NCT01615705|Markers of Inflammation|markers of inflammation
5004263|NCT01615705|Genetic Thrombophilia|genetic thrombophilia
5004264|NCT01615705|Coagulation Activation|coagulation activation
5004265|NCT01615692|Elastic Stockings|elastic stockings
5004266|NCT01615692|Stockings, Compression|stockings, compression
5004267|NCT01615692|Randomized Controlled Trials|randomized controlled trials
5004268|NCT01615692|Quality of Life|quality of life
5004269|NCT01615679|Non-interventional study|non-interventional study
5004270|NCT01615679|Attention Deficit/Hyperactivity Disorder|attention deficit/hyperactivity disorder
5004271|NCT01615679|ADHD|adhd
5004272|NCT01615666|Alzheimer's disease|alzheimer's disease
5004273|NCT01615666|Mild Cognitive Impairment|mild cognitive impairment
5004274|NCT01615666|Frontotemporal dementia|frontotemporal dementia
5004275|NCT01615666|fMRI|fmri
5004276|NCT01615666|functional neuroimaging|functional neuroimaging
5004277|NCT01615666|Memory|memory
5004278|NCT01615653|Pancreatic cancer|pancreatic cancer
5004279|NCT01615653|Pancreas cancer|pancreas cancer
5004280|NCT01615653|Pain|pain
5004281|NCT01615653|Celiac Plexus|celiac plexus
5004282|NCT01615653|Neurolysis|neurolysis
5004283|NCT01615640|Osteosarcoma|osteosarcoma
5004284|NCT01615640|Response of chemotherapy|response of chemotherapy
5004285|NCT01615640|Dynamic contrast medium examination|dynamic contrast medium examination
5004286|NCT01615640|Diffusion-weighted MR imaging|diffusion-weighted mr imaging
5004287|NCT01615627|Subcutaneous Treprostinil|subcutaneous treprostinil
5004288|NCT01615614|Rilpivirine|rilpivirine
5004289|NCT01615614|Rifabutin|rifabutin
5004290|NCT01615614|Pharmacokinetics|pharmacokinetics
5004291|NCT01615614|Healthy participants|healthy participants
5004292|NCT01615601|Human Immunodeficiency Virus|human immunodeficiency virus
5004293|NCT01615601|HIV|hiv
5004294|NCT01615601|HIV-1|hiv-1
5004295|NCT01615601|HIV type 1|hiv type 1
5004296|NCT01615601|Darunavir|darunavir
5004297|NCT01615601|PREZISTA|prezista
5004298|NCT01615601|Etravirine|etravirine
5004299|NCT01615601|INTELENCE|intelence
5004300|NCT01615601|HIV symptom Distress Module|hiv symptom distress module
5004301|NCT01615601|HIV-SDM|hiv-sdm
5004302|NCT01615601|Antiretroviral therapy|antiretroviral therapy
5004303|NCT01615601|HIV Symptom Index (HSI),|hiv symptom index (hsi),
5004304|NCT01615588|manuka honey|manuka honey
5004305|NCT01615588|glycaemic index|glycaemic index
5004306|NCT01615588|blood glucose control|blood glucose control
5004307|NCT01615588|individuals|individuals
5004308|NCT01615588|current disease|current disease
5004309|NCT01615588|medication use|medication use
5004310|NCT01615562|Polycystic Ovary Syndrome|polycystic ovary syndrome
5004311|NCT01615562|PCOS|pcos
5004312|NCT01615562|Infertility|infertility
5004313|NCT01615549|Cholecystectomy|cholecystectomy
5004314|NCT01615549|Virtual reality device|virtual reality device
5004315|NCT01615549|Training|training
5004316|NCT01615536|chronic rhinosinusitis|chronic rhinosinusitis
5004317|NCT01615536|canine fossa trephine|canine fossa trephine
5004318|NCT01615536|canine fossa puncture|canine fossa puncture
5004319|NCT01615523|Executive functions|executive functions
5004320|NCT01615497|cognitive behavior therapy|cognitive behavior therapy
5004321|NCT01615497|computer assisted instruction|computer assisted instruction
5004322|NCT01615497|alcohol abuse therapy|alcohol abuse therapy
5004323|NCT01615497|educational resource design and development|educational resource design and development
5004324|NCT01615484|Lung Transplant|lung transplant
5004325|NCT01615484|Emphysema|emphysema
5004326|NCT01615484|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
5004327|NCT01615484|Cystic Fibrosis|cystic fibrosis
5004328|NCT01615484|Pulmonary Fibrosis|pulmonary fibrosis
5004329|NCT01615484|Bronchiectasis|bronchiectasis
5004330|NCT01615484|Sarcoidosis|sarcoidosis
5004331|NCT01615484|Pulmonary Hypertension|pulmonary hypertension
5004332|NCT01615484|Alpha-1 Antitrypsin Deficiency|alpha-1 antitrypsin deficiency
5004333|NCT01615471|Obesity|obesity
5004334|NCT01615471|Lifestyle Intervention|lifestyle intervention
5004335|NCT01615471|Group treatment|group treatment
5004336|NCT01615471|Internet Intervention|internet intervention
5004337|NCT01615458|Care Management|care management
5004338|NCT01615458|Implementation|implementation
5004339|NCT01615458|Intervention|intervention
5004340|NCT01615458|Mood Disorders|mood disorders
5004341|NCT01615380|smoking cessation|smoking cessation
5004342|NCT01615380|Aerobic Exercise|aerobic exercise
5004343|NCT01615380|Women|women
5004344|NCT01615380|YMCA|ymca
5004345|NCT01615367|Bipolar disorder|bipolar disorder
5004346|NCT01615367|Nutrition|nutrition
5004347|NCT01615367|Exercise|exercise
5004348|NCT01615367|Symptoms|symptoms
5004349|NCT01615367|Functioning|functioning
5004350|NCT01615341|Kidney transplantation|kidney transplantation
5004351|NCT01615341|Subclinical Viral Infection|subclinical viral infection
5004352|NCT01615341|Renal Allograft Injury|renal allograft injury
5004353|NCT01615328|anterior cervical discectomy and fusion|anterior cervical discectomy and fusion
5004354|NCT01615328|bone graft substitute|bone graft substitute
5004355|NCT01615328|PEEK cage|peek cage
5004356|NCT01615328|hydroxyapatite|hydroxyapatite
5004357|NCT01615328|demineralized bone matrix|demineralized bone matrix
5004358|NCT01615328|b-tricalcium phosphate|b-tricalcium phosphate
5004359|NCT01615328|Bonion|bonion
5004360|NCT01615328|Cervios ChronOs|cervios chronos
5004361|NCT01615315|aspirin|aspirin
5004362|NCT01615315|screening|screening
5004363|NCT01615315|microscopic hematuria|microscopic hematuria
5004364|NCT01615302|Rectal Fistula|rectal fistula
5004365|NCT01615302|Peri-anal Fistula|peri-anal fistula
5004366|NCT01615302|Platelet-Rich Plasma|platelet-rich plasma
5004367|NCT01615302|Mucosa advancement flap|mucosa advancement flap
5004368|NCT01615276|Neuromuscular Electrical Stimulation|neuromuscular electrical stimulation
5004369|NCT01615276|Ageing|ageing
5004370|NCT01615276|Protein ingestion|protein ingestion
5004371|NCT01615263|Video-assisted thoracoscopic surgery (VATS)|video-assisted thoracoscopic surgery (vats)
5004372|NCT01615263|One lung ventilation|one lung ventilation
5004373|NCT01615263|Bronchial blocker|bronchial blocker
5004374|NCT01615263|Lung collapse|lung collapse
5004375|NCT01615263|Double lumen tube|double lumen tube
5004376|NCT01615224|missed abortion|missed abortion
5004377|NCT01615224|miscarriage|miscarriage
5004378|NCT01615211|Abortion|abortion
5004379|NCT01615211|medical abortion|medical abortion
5004380|NCT01615211|termination of pregnancy|termination of pregnancy
5004381|NCT01615211|Mifepristone|mifepristone
5004382|NCT01615211|misoprostol|misoprostol
5004383|NCT01615211|letrozole|letrozole
5004384|NCT01615211|trilostane|trilostane
5004385|NCT01615211|femara|femara
5004386|NCT01615211|Modrenal|modrenal
5004387|NCT01615198|Hypertension, blood pressure, LCZ696, dual inhibitor, neprilysin, NEP inhibition, vasopeptidase, ARNi, angiotensin receptor|hypertension, blood pressure, lcz696, dual inhibitor, neprilysin, nep inhibition, vasopeptidase, arni, angiotensin receptor
5004388|NCT01615185|schizophrenia|schizophrenia
5004389|NCT01615185|amisulpride|amisulpride
5004390|NCT01615185|sulpiride|sulpiride
5004391|NCT01615185|antipsychotic combination|antipsychotic combination
5004392|NCT01615159|Sodium|sodium
5004393|NCT01615159|Diet|diet
5004394|NCT01615159|Urinary sodium excretion|urinary sodium excretion
5004395|NCT01615159|Feeding study|feeding study
5004396|NCT01615159|Diet maintenance|diet maintenance
5004397|NCT01615146|Myelodysplasia|myelodysplasia
5004398|NCT01615146|Leukemia|leukemia
5004399|NCT01615146|Thrombocytopenia|thrombocytopenia
5004400|NCT01615146|Platelet|platelet
5004401|NCT01615146|transfusions|transfusions
5004402|NCT01615146|Outpatient|outpatient
5004403|NCT01615081|Malt extract|malt extract
5004404|NCT01615081|carbohydrate|carbohydrate
5004405|NCT01615081|glucose response|glucose response
5004406|NCT01615081|insulin response|insulin response
5004407|NCT01615081|Appetite|appetite
5004408|NCT01615081|Appetite regulating hormones|appetite regulating hormones
5004409|NCT01615055|Chemotherapy|chemotherapy
5004410|NCT01615055|Cognitive|cognitive
5004411|NCT01615055|Prozac|prozac
5004412|NCT01615055|Fluoxetine|fluoxetine
5004413|NCT01615055|FDG|fdg
5004414|NCT01615055|PET|pet
5004415|NCT01615042|Acute Leukemia|acute leukemia
5004416|NCT01615042|Bone Marrow Transplant|bone marrow transplant
5004417|NCT01615042|High Dose Lenalidomide|high dose lenalidomide
5004418|NCT01615029|Multiple Myeloma|multiple myeloma
5004419|NCT01615029|Daratumumab|daratumumab
5004420|NCT01615029|Lenalidomide|lenalidomide
5004421|NCT01615029|Dexamethasone|dexamethasone
5004422|NCT01615029|Dose-escalation|dose-escalation
5004423|NCT01615029|Relapsed multiple myeloma|relapsed multiple myeloma
5004424|NCT01615029|Relapsed and refractory multiple myeloma|relapsed and refractory multiple myeloma
5004425|NCT01615016|Preterm infant|preterm infant
5004426|NCT01615016|Surfactant application|surfactant application
5004427|NCT01615016|Respiratory Distress Syndrome|respiratory distress syndrome
5004428|NCT01615016|Minimally invasive Surfactant Application|minimally invasive surfactant application
5004429|NCT01615016|INSURE (Intubate-Surfactant-Extubate)|insure (intubate-surfactant-extubate)
5004430|NCT01615003|MicroRNA|microrna
5004431|NCT01615003|coronary heart disease|coronary heart disease
5004432|NCT01615003|unstable angina|unstable angina
5004433|NCT01615003|blood stasis syndrome|blood stasis syndrome
5004434|NCT01615003|Xuesaitong soft capsule|xuesaitong soft capsule
5004435|NCT01614977|nontuberculous mycobacteria|nontuberculous mycobacteria
5004436|NCT01614977|corticosteroids|corticosteroids
5004437|NCT01614977|children|children
5004438|NCT01614977|lymphadeniti|lymphadeniti
5004439|NCT01614977|Therapeutic intervention in immunocompetent children with nontuberculous mycobacterial lymphadenitis.|therapeutic intervention in immunocompetent children with nontuberculous mycobacterial lymphadenitis.
5004440|NCT01614964|Plasmodium falciparum|plasmodium falciparum
5004441|NCT01614964|pharmacokinetics|pharmacokinetics
5004442|NCT01614964|antimalarials (antimalarial drugs)|antimalarials (antimalarial drugs)
5004443|NCT01614964|chloroquine (chloroquine-resistant)|chloroquine (chloroquine-resistant)
5004444|NCT01614964|QT (QTc) interval|qt (qtc) interval
5004445|NCT01614938|Nasopharyngeal carcinoma|nasopharyngeal carcinoma
5004446|NCT01614938|Locally advanced|locally advanced
5004447|NCT01614938|Cetuximab|cetuximab
5004448|NCT01614938|Weekly cisplatin chemotherapy|weekly cisplatin chemotherapy
5004449|NCT01614938|Intensity-modulated radiotherapy|intensity-modulated radiotherapy
5004450|NCT01614886|Rivastigmine, Alzheimer's disease, Transdermal patch|rivastigmine, alzheimer's disease, transdermal patch
5004451|NCT01614873|Breathing Pattern|breathing pattern
5004452|NCT01614873|Mechanical Ventilation|mechanical ventilation
5004453|NCT01614873|Pressure support ventilation|pressure support ventilation
5004454|NCT01614873|Neurally Adjusted Ventilatory Assist|neurally adjusted ventilatory assist
5004455|NCT01614860|Aldosterone|aldosterone
5004456|NCT01614860|Echocardiography|echocardiography
5004457|NCT01614860|Neurohormones|neurohormones
5004458|NCT01614847|dry eye|dry eye
5004459|NCT01614847|artificial tears|artificial tears
5004460|NCT01614847|tear osmolarity|tear osmolarity
5004461|NCT01614847|residence time|residence time
5004462|NCT01614834|urticaria|urticaria
5004463|NCT01614834|disease control|disease control
5004464|NCT01614834|severity|severity
5004465|NCT01614834|test|test
5004466|NCT01614821|Relapsed|relapsed
5004467|NCT01614821|Refractory|refractory
5004468|NCT01614743|Rosacea|rosacea
5004469|NCT01614730|EMS|ems
5004470|NCT01614730|Modified Device|modified device
5004471|NCT01614717|Hypertrophic Obstructive Cardiomyopathy|hypertrophic obstructive cardiomyopathy
5004472|NCT01614717|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
5004473|NCT01614704|Breast cancer|breast cancer
5004474|NCT01614704|Fertility|fertility
5004475|NCT01614678|myopia|myopia
5004476|NCT01614665|Transplant|transplant
5004477|NCT01614665|Prograf|prograf
5004478|NCT01614665|Heart|heart
5004479|NCT01614665|Advagraf|advagraf
5004480|NCT01614665|Tacrolimus|tacrolimus
5004481|NCT01614665|Immunosuppression|immunosuppression
5004482|NCT01614665|Kidney|kidney
5004483|NCT01614665|Liver|liver
5004484|NCT01614665|Pharmacokinetic|pharmacokinetic
5004485|NCT01614665|Pediatric|pediatric
5004486|NCT01614652|Congestive Heart Failure Due to LV Systolic Dysfunction|congestive heart failure due to lv systolic dysfunction
5004487|NCT01614639|Acupuncture|acupuncture
5004488|NCT01614639|fMRI|fmri
5004489|NCT01614639|CLBP|clbp
5004490|NCT01614639|Pain|pain
5004491|NCT01614639|Low Back Pain|low back pain
5004492|NCT01614639|Back Pain|back pain
5004493|NCT01614626|HIV|hiv
5004494|NCT01614626|Alcohol Use|alcohol use
5004495|NCT01614626|Microbial Translocation|microbial translocation
5004496|NCT01614626|Inflammation|inflammation
5004497|NCT01614626|Altered Coagulation|altered coagulation
5004498|NCT01614626|Russia|russia
5004499|NCT01614600|contact lens|contact lens
5004500|NCT01614600|dry eye syndrome|dry eye syndrome
5004501|NCT01614600|symptomatic|symptomatic
5004502|NCT01614600|daily disposable|daily disposable
5004503|NCT01614600|myopia|myopia
5004504|NCT01614587|pelvic organ prolapse|pelvic organ prolapse
5004505|NCT01614587|recurrence of pelvic organ prolapse|recurrence of pelvic organ prolapse
5004506|NCT01614587|genetic predisposition|genetic predisposition
5004507|NCT01614587|SNP microarray analysis|snp microarray analysis
5004508|NCT01614587|pelvic floor|pelvic floor
5004509|NCT01614587|genetic factors|genetic factors
5004510|NCT01614587|adequate prolapse repair|adequate prolapse repair
5004511|NCT01614587|polymorphisms|polymorphisms
5004512|NCT01614587|surgical failure|surgical failure
5004513|NCT01614587|reoperation|reoperation
5004514|NCT01614587|DNA|dna
5004515|NCT01614587|buccal swabs|buccal swabs
5004516|NCT01614587|TaqMan SNP allelic discriminiation assays|taqman snp allelic discriminiation assays
5004517|NCT01614587|duplex real-time PCR|duplex real-time pcr
5004518|NCT01614587|genome-wide SNP microarrays|genome-wide snp microarrays
5004519|NCT01614587|next-generation sequencing|next-generation sequencing
5004520|NCT01614561|Hypercholesterolemia|hypercholesterolemia
5004521|NCT01614561|Lipid lowering drugs|lipid lowering drugs
5004522|NCT01614561|Cholesterol level in blood|cholesterol level in blood
5004523|NCT01614561|Target cholesterol levels guidelines for the management of high blood cholesterol|target cholesterol levels guidelines for the management of high blood cholesterol
5004524|NCT01614548|Prostatic Neoplasms|prostatic neoplasms
5004525|NCT01614548|Prostate Cancer|prostate cancer
5004526|NCT01614548|Disease Management|disease management
5004527|NCT01614548|Rural|rural
5004528|NCT01614548|Urban|urban
5004908|NCT01612702|postoperative pain|postoperative pain
5004529|NCT01614522|Metastatic gastro-oesophageal carcinoma|metastatic gastro-oesophageal carcinoma
5004530|NCT01614522|Recurrent gastro-oesophageal carcinoma|recurrent gastro-oesophageal carcinoma
5004531|NCT01614522|Gastric cancer|gastric cancer
5004533|NCT01614522|HER-2|her-2
5004534|NCT01614509|branch retinal vein occlusion|branch retinal vein occlusion
5004535|NCT01614509|bevacizumab|bevacizumab
5004536|NCT01614509|triamcinolone acetonide|triamcinolone acetonide
5004537|NCT01614483|Vitamin A deficiency|vitamin a deficiency
5004538|NCT01614483|Biofortification|biofortification
5004539|NCT01614483|Cassava|cassava
5004540|NCT01614483|B-carotene|b-carotene
5004541|NCT01614483|School children|school children
5004542|NCT01614483|Kenya|kenya
5004543|NCT01614431|renal function|renal function
5004544|NCT01614431|before and after N acetyl cysteine|before and after n acetyl cysteine
5004545|NCT01614431|Cystinosis patients|cystinosis patients
5004546|NCT01614405|PBC|pbc
5004547|NCT01614392|Resistance Exercise|resistance exercise
5004548|NCT01614392|Physical Activity|physical activity
5004549|NCT01614392|Mobility disability|mobility disability
5004550|NCT01614392|Physical function|physical function
5004551|NCT01614392|Muscle Strength|muscle strength
5004552|NCT01614392|Older Adults|older adults
5004553|NCT01614392|Mobility-Limited|mobility-limited
5004554|NCT01614392|Peak power and strength|peak power and strength
5004555|NCT01614366|amlodipine|amlodipine
5004556|NCT01614366|DMTA07|dmta07
5004557|NCT01614366|hypertension|hypertension
5004558|NCT01614353|Multiple Chronic Conditions|multiple chronic conditions
5004559|NCT01614353|Older Adults|older adults
5004560|NCT01614353|New Prescription|new prescription
5004561|NCT01614340|Home care|home care
5004562|NCT01614340|Cognitive-Behavioral techniques|cognitive-behavioral techniques
5004563|NCT01614340|Physical Therapy|physical therapy
5004564|NCT01614340|Pain|pain
5004565|NCT01614340|Older Adults|older adults
5004566|NCT01614327|Diabetes Type One|diabetes type one
5004567|NCT01614327|Diabetes Type Two|diabetes type two
5004568|NCT01614327|PreDiabetes|prediabetes
5004569|NCT01614327|Retinal Screening|retinal screening
5004570|NCT01614327|RiskAnalyzer|riskanalyzer
5004571|NCT01614327|Retinal Imaging|retinal imaging
5004572|NCT01614327|Algorithm|algorithm
5004573|NCT01614327|Diabetic Retinopathy|diabetic retinopathy
5004574|NCT01614327|Microaneurysms|microaneurysms
5004575|NCT01614327|Neovascularization|neovascularization
5004576|NCT01614327|Intraretinal microvascular abnormalities|intraretinal microvascular abnormalities
5004577|NCT01614314|Preceptorship, simulation, nursing, catheters|preceptorship, simulation, nursing, catheters
5004578|NCT01614301|advanced Melanoma|advanced melanoma
5004579|NCT01614288|HTO|hto
5004580|NCT01614288|Arthroscopy|arthroscopy
5004581|NCT01614288|Quality-of-Life|quality-of-life
5004582|NCT01614288|Gait Analysis|gait analysis
5004583|NCT01614275|Autism|autism
5004584|NCT01614275|Early Intervention|early intervention
5004585|NCT01614275|Parent Training|parent training
5004586|NCT01614275|EIBI|eibi
5004587|NCT01614275|Applied Behavior Analysis|applied behavior analysis
5004588|NCT01614249|Omega-3|omega-3
5004589|NCT01614249|EPA|epa
5004590|NCT01614249|Depression|depression
5004591|NCT01614249|HIV infected|hiv infected
5004592|NCT01614249|Pregnant women|pregnant women
5004593|NCT01614236|pregabalin|pregabalin
5004594|NCT01614236|analgesia|analgesia
5004595|NCT01614236|postoperative pain|postoperative pain
5004596|NCT01614236|orthopedic oncology patients|orthopedic oncology patients
5004597|NCT01614223|Plantar fasciitis|plantar fasciitis
5004598|NCT01614223|Autologous Conditioned Plasma|autologous conditioned plasma
5004599|NCT01614197|Relapse|relapse
5004600|NCT01614197|Lymphoblastic|lymphoblastic
5004601|NCT01614197|Leukemia|leukemia
5004602|NCT01614197|Refractory|refractory
5004603|NCT01614197|Temsirolimus|temsirolimus
5004604|NCT01614197|Acute|acute
5004605|NCT01614197|Childhood|childhood
5004606|NCT01614197|Pediatric|pediatric
5004607|NCT01614197|ALL|all
5004608|NCT01614197|NHL|nhl
5004609|NCT01614197|LL|ll
5004610|NCT01614197|PTL|ptl
5004611|NCT01614171|osteoporosis pseudoglioma|osteoporosis pseudoglioma
5004612|NCT01614171|OPPG|oppg
5004613|NCT01614171|growth hormone|growth hormone
5004614|NCT01614171|osteoporosis|osteoporosis
5004615|NCT01614158|N-AION|n-aion
5004616|NCT01614158|perimetry|perimetry
5004617|NCT01614158|visual field loss|visual field loss
5004618|NCT01614158|Mean Defect|mean defect
5004619|NCT01614158|Total Loss Volume|total loss volume
5004620|NCT01614158|D-BCVA|d-bcva
5004621|NCT01614158|RAPD|rapd
5004622|NCT01614158|retinal nerve fibre thickness/volume|retinal nerve fibre thickness/volume
5004623|NCT01614158|optic nerve head|optic nerve head
5004624|NCT01614132|medulloblastoma|medulloblastoma
5004625|NCT01614132|CNS|cns
5004626|NCT01614132|malignant neoplasm|malignant neoplasm
5004627|NCT01614132|NOA|noa
5004628|NCT01614132|neuroectodermal tumor|neuroectodermal tumor
5004629|NCT01614132|Vincristin|vincristin
5004630|NCT01614132|CCNU|ccnu
5004631|NCT01614132|Cisplatin|cisplatin
5004632|NCT01614119|Cerebral|cerebral
5004633|NCT01614119|Oxygenation|oxygenation
5004634|NCT01614119|Performance|performance
5004635|NCT01614119|Exercise|exercise
5004636|NCT01614106|HIV/AIDS|hiv/aids
5004637|NCT01614106|Drug Users|drug users
5004638|NCT01614106|Crack-Cocaine Use|crack-cocaine use
5004639|NCT01614106|HIV Primary Care|hiv primary care
5004640|NCT01614093|Schizophrenia|schizophrenia
5004641|NCT01614093|Appetite|appetite
5004642|NCT01614093|Oxytocin|oxytocin
5004643|NCT01614080|Stroke|stroke
5004644|NCT01614080|Ischemic stroke|ischemic stroke
5004645|NCT01614080|thrombolysis|thrombolysis
5004646|NCT01614080|toxicity of t-PA|toxicity of t-pa
5004647|NCT01614067|DOR|dor
5004648|NCT01614067|Infertility|infertility
5004649|NCT01614067|IVF|ivf
5004650|NCT01614067|ART|art
5004651|NCT01614067|GnRHa|gnrha
5004652|NCT01614067|GnRH Antagonist Protocol|gnrh antagonist protocol
5004653|NCT01614067|Ganirelix|ganirelix
5004654|NCT01614054|Smoking cessation|smoking cessation
5004655|NCT01614054|Nicotine replacement therapy|nicotine replacement therapy
5004656|NCT01614054|NRT|nrt
5004657|NCT01614054|Inpatient|inpatient
5004658|NCT01614054|General Medicine|general medicine
5004659|NCT01614041|Generalized Anxiety Disorder|generalized anxiety disorder
5004660|NCT01614015|Recording|recording
5004661|NCT01614015|Supervision|supervision
5004662|NCT01614015|Observation|observation
5004663|NCT01614002|carcinoma|carcinoma
5004664|NCT01614002|breast cancer|breast cancer
5004665|NCT01614002|non-small cell lung cancer|non-small cell lung cancer
5004666|NCT01614002|prostata cancer|prostata cancer
5004667|NCT01614002|adenocarcinoma of the stomach|adenocarcinoma of the stomach
5004668|NCT01614002|squamous cell carcinoma of the head and neck region|squamous cell carcinoma of the head and neck region
5004669|NCT01614002|ambulant chemotherapy|ambulant chemotherapy
5004670|NCT01614002|treatment cycles|treatment cycles
5004671|NCT01614002|Docetaxel|docetaxel
5004672|NCT01614002|Doce onkovis|doce onkovis
5004673|NCT01614002|Quantity of Docetaxel|quantity of docetaxel
5004674|NCT01614002|Packaging Sizes|packaging sizes
5004675|NCT01613989|Hip arthroplasty|hip arthroplasty
5004676|NCT01613989|navigation|navigation
5004677|NCT01613976|Myelodysplastic Syndromes|myelodysplastic syndromes
5004679|NCT01613976|Chronic Myelomonocytic Leukemia|chronic myelomonocytic leukemia
5004680|NCT01613976|CMML|cmml
5004681|NCT01613976|Acute Myeloid Leukemia|acute myeloid leukemia
5004682|NCT01613976|AML|aml
5004683|NCT01613976|Panobinostat|panobinostat
5004684|NCT01613976|LBH589|lbh589
5004685|NCT01613976|5-Aza|5-aza
5004686|NCT01613976|Azacitidine|azacitidine
5004687|NCT01613963|Uveitis|uveitis
5004688|NCT01613963|Scleritis|scleritis
5004689|NCT01613950|gastric cancer advanced gastric or metastatic gastric cancer PI3K PIK3CA mutation Her2 amplification HSP90 inhibitor PI3K inhibitor PIK3CA amplification|gastric cancer advanced gastric or metastatic gastric cancer pi3k pik3ca mutation her2 amplification hsp90 inhibitor pi3k inhibitor pik3ca amplification
5004690|NCT01613937|Latinas|latinas
5004691|NCT01613937|Gestational Diabetes|gestational diabetes
5004692|NCT01613937|Prevention|prevention
5004693|NCT01613911|Epilepsy|epilepsy
5004694|NCT01613911|Invasive monitoring|invasive monitoring
5004695|NCT01613911|Human sensory perception|human sensory perception
5004696|NCT01613898|Cerebrotendinous xanthomatosis (CTX),|cerebrotendinous xanthomatosis (ctx),
5004697|NCT01613898|lipoprotein,atherosclerosis,|lipoprotein,atherosclerosis,
5004698|NCT01613898|carotid artery intima-media thickness (cIMT).|carotid artery intima-media thickness (cimt).
5004699|NCT01613833|Alpha2 macroglobulin|alpha2 macroglobulin
5004700|NCT01613833|Osteoarthritis|osteoarthritis
5004701|NCT01613833|plasma and synovium|plasma and synovium
5004702|NCT01613807|gestational diabetes mellitus|gestational diabetes mellitus
5004703|NCT01613807|insulin analogues in pregnancy|insulin analogues in pregnancy
5004704|NCT01613794|Deep vein thrombosis|deep vein thrombosis
5004705|NCT01613794|Pulmonary embolism|pulmonary embolism
5004706|NCT01613794|Rosuvastatin treatment|rosuvastatin treatment
5004707|NCT01613794|Pharmacologic actions|pharmacologic actions
5004708|NCT01613781|hemifacial spasm|hemifacial spasm
5004709|NCT01613781|microvascular decompression|microvascular decompression
5004710|NCT01613781|neuromuscular blockade|neuromuscular blockade
5004711|NCT01613781|electromyography|electromyography
5004712|NCT01613755|Effect Dipyridamole on pharmacokinetics of metformin|effect dipyridamole on pharmacokinetics of metformin
5004713|NCT01613729|Dyslipidemia|dyslipidemia
5004714|NCT01613729|Rosuvastatin|rosuvastatin
5004715|NCT01613729|Efficacy|efficacy
5004716|NCT01613729|Safety|safety
5004717|NCT01613716|Diabetes|diabetes
5004718|NCT01613716|Macular Edema|macular edema
5004719|NCT01613716|Epiretinal Membrane|epiretinal membrane
5004720|NCT01613716|Vitrectomy|vitrectomy
5004721|NCT01613703|ONO-2952|ono-2952
5004722|NCT01613703|Healthy adult subjects|healthy adult subjects
5004723|NCT01613703|single doe|single doe
5004724|NCT01613703|PET study|pet study
5004725|NCT01613703|Safety|safety
5004726|NCT01613703|Tolerability|tolerability
5004727|NCT01613690|Renal impairment|renal impairment
5004728|NCT01613690|NVA237|nva237
5004729|NCT01613690|Pharmacokinetics|pharmacokinetics
5004730|NCT01613677|advanced cervical cancer, BKM 120, progression free survival|advanced cervical cancer, bkm 120, progression free survival
5004731|NCT01613664|obesity|obesity
5004732|NCT01613664|surgical management|surgical management
5004733|NCT01613664|sleeve gastrectomy|sleeve gastrectomy
5004734|NCT01613638|congenital malformation|congenital malformation
5004735|NCT01613638|pollutants|pollutants
5004736|NCT01613586|Interstitial Cystitis|interstitial cystitis
5004737|NCT01613586|Bladder Pain Syndrome|bladder pain syndrome
5004738|NCT01613586|Painful Bladder Syndrome|painful bladder syndrome
5004739|NCT01613586|ASP3652|asp3652
5004740|NCT01613573|pegylated Somatropin|pegylated somatropin
5004741|NCT01613573|PEG-GH|peg-gh
5004742|NCT01613573|Phase 1 study|phase 1 study
5004743|NCT01613573|Pharmacokinetics|pharmacokinetics
5004744|NCT01613534|chronic radiation proctopathy|chronic radiation proctopathy
5004745|NCT01613534|argon plasma coagulation|argon plasma coagulation
5004746|NCT01613534|sucralfate|sucralfate
5004747|NCT01613521|DCE-MRI|dce-mri
5004748|NCT01613521|18F-FMISO PET|18f-fmiso pet
5004749|NCT01613521|11-174|11-174
5004750|NCT01613495|obesity|obesity
5004751|NCT01613469|fluorouracil|fluorouracil
5004752|NCT01613469|leucovorin|leucovorin
5004753|NCT01613469|radiotherapy|radiotherapy
5004754|NCT01613469|neoadjuvant therapy|neoadjuvant therapy
5004755|NCT01613443|Dabigatran, Rivaroxaban, Point of Care-testing|dabigatran, rivaroxaban, point of care-testing
5004756|NCT01613417|Have confirmed or are highly suspected of brain disease|have confirmed or are highly suspected of brain disease
5004757|NCT01613404|Chronic kidney disease|chronic kidney disease
5004758|NCT01613404|Hemodialysis|hemodialysis
5004759|NCT01613404|Eprex|eprex
5004760|NCT01613404|Aranesp|aranesp
5004761|NCT01613404|ESA|esa
5004762|NCT01613404|Anemia|anemia
5004763|NCT01613391|Visfatin|visfatin
5004764|NCT01613391|Resistin|resistin
5004765|NCT01613391|Apelin|apelin
5004766|NCT01613391|roux-en-y gastric bypass|roux-en-y gastric bypass
5004767|NCT01613391|laparoscopic adjustable gastric banding|laparoscopic adjustable gastric banding
5004768|NCT01613391|morbid obesity|morbid obesity
5004769|NCT01613352|Early breast cancer surgery|early breast cancer surgery
5004770|NCT01613352|Psychosocial wellbeing|psychosocial wellbeing
5004771|NCT01613352|Ambulatory surgery|ambulatory surgery
5004772|NCT01613339|stroke|stroke
5004773|NCT01613339|postural control|postural control
5004774|NCT01613339|body awareness therapy|body awareness therapy
5004775|NCT01613326|COPD|copd
5004776|NCT01613313|Lipoma|lipoma
5004777|NCT01613313|Fatty Tumor|fatty tumor
5004778|NCT01613300|hodgkin|hodgkin
5004779|NCT01613300|disease|disease
5004780|NCT01613300|ofatumumab|ofatumumab
5004781|NCT01613287|Pulmonary Hypertension|pulmonary hypertension
5004782|NCT01613287|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
5004783|NCT01613287|TheraSorb|therasorb
5004784|NCT01613287|immunoadsorption|immunoadsorption
5004785|NCT01613274|colon resection|colon resection
5004786|NCT01613261|TAK-733,|tak-733,
5004787|NCT01613261|alisertib,|alisertib,
5004788|NCT01613261|MLN8237,|mln8237,
5004789|NCT01613261|Oral MEK Inhibitor,|oral mek inhibitor,
5004790|NCT01613261|Oral Aurora A Kinase Inhibitor|oral aurora a kinase inhibitor
5004791|NCT01613235|subarachnoid hemorrhage|subarachnoid hemorrhage
5004792|NCT01613235|ischemia|ischemia
5004793|NCT01613235|vasospasm|vasospasm
5004794|NCT01613235|CT|ct
5004795|NCT01613235|perfusion|perfusion
5004796|NCT01613235|induced hypertension|induced hypertension
5004797|NCT01613235|delayed cerebral ischemia|delayed cerebral ischemia
5004798|NCT01613209|Hypertension|hypertension
5004799|NCT01613209|ABPM|abpm
5004800|NCT01613209|office blood pressure|office blood pressure
5004801|NCT01613209|olmesartan|olmesartan
5004802|NCT01613209|amlodipine|amlodipine
5004803|NCT01613209|fixed combination|fixed combination
5004804|NCT01613209|time of intake|time of intake
5004805|NCT01613196|Extrapulmonary tuberculosis|extrapulmonary tuberculosis
5004806|NCT01613196|FDG-TEP|fdg-tep
5004807|NCT01613196|cohorts|cohorts
5004808|NCT01613170|Overactive Bladder|overactive bladder
5004809|NCT01613170|Vaginal Estrogen|vaginal estrogen
5004810|NCT01613170|Anticholinergics|anticholinergics
5004811|NCT01613170|Antimuscarinics|antimuscarinics
5004812|NCT01613157|pharmacokinetics|pharmacokinetics
5004813|NCT01613157|HIV infected women|hiv infected women
5004814|NCT01613118|Primary FSGS|primary fsgs
5004815|NCT01613118|Nephrotic syndrome|nephrotic syndrome
5004816|NCT01613118|Steroid Resistant|steroid resistant
5004817|NCT01613105|Diabetes Mellitus|diabetes mellitus
5004818|NCT01613105|Type-2|type-2
5004819|NCT01613105|Acarbose|acarbose
5004820|NCT01613105|Drug Therapy|drug therapy
5004821|NCT01613105|Combination|combination
5004822|NCT01613092|Arrhythmia|arrhythmia
5004823|NCT01613092|Device Procedure|device procedure
5004824|NCT01613092|High risk patients|high risk patients
5004825|NCT01613092|Antibiotics|antibiotics
5004826|NCT01613092|Infection|infection
5004827|NCT01613092|Cluster|cluster
5004828|NCT01613079|Rheumatoid Arthritis|rheumatoid arthritis
5004829|NCT01613079|Methotrexate|methotrexate
5004830|NCT01613079|Tripterygium|tripterygium
5004831|NCT01613066|Haematological malignancies|haematological malignancies
5004832|NCT01613066|Allogeneic Cord Blood transplantation|allogeneic cord blood transplantation
5004833|NCT01613066|Intrabone|intrabone
5004834|NCT01613053|Gastrointestinal Stromal Tumor, GIST|gastrointestinal stromal tumor, gist
5004835|NCT01613014|Alcohol|alcohol
5004836|NCT01613014|Alcohol Dependence|alcohol dependence
5004837|NCT01613014|Alcohol Abuse|alcohol abuse
5004838|NCT01613014|Alcohol Use Disorders|alcohol use disorders
5004839|NCT01613014|Alcoholism|alcoholism
5004840|NCT01612988|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
5004841|NCT01612988|relapse|relapse
5004842|NCT01612988|Bendamustine|bendamustine
5004843|NCT01612988|Ofatumumab|ofatumumab
5004844|NCT01612988|Méthylprednisolone|méthylprednisolone
5004845|NCT01612975|Chest tubes|chest tubes
5004846|NCT01612975|Length of stay|length of stay
5004847|NCT01612975|Pleural effusion|pleural effusion
5004848|NCT01612975|Lung resection|lung resection
5004849|NCT01612975|Post-operative|post-operative
5004850|NCT01612975|Lung cancer|lung cancer
5004851|NCT01612949|endotracheal intubation|endotracheal intubation
5004852|NCT01612949|facial structure|facial structure
5004853|NCT01612949|Mallampati score|mallampati score
5004854|NCT01612949|computerized facial analysis|computerized facial analysis
5004855|NCT01612936|Asthma|asthma
5004856|NCT01612936|Allergic|allergic
5004857|NCT01612936|Inflammation|inflammation
5004858|NCT01612936|Constriction|constriction
5004859|NCT01612936|Airway|airway
5004860|NCT01612936|Challenge|challenge
5004861|NCT01612936|Chemokines|chemokines
5004862|NCT01612923|abortion|abortion
5004863|NCT01612923|medical abortion|medical abortion
5004864|NCT01612910|estrogen receptor-negative breast cancer|estrogen receptor-negative breast cancer
5004865|NCT01612910|HER2-negative breast cancer|her2-negative breast cancer
5004866|NCT01612910|progesterone receptor-negative breast cancer|progesterone receptor-negative breast cancer
5004867|NCT01612910|recurrent breast cancer|recurrent breast cancer
5004868|NCT01612910|stage II breast cancer|stage ii breast cancer
5004869|NCT01612910|stage IIIA breast cancer|stage iiia breast cancer
5004870|NCT01612910|stage IIIB breast cancer|stage iiib breast cancer
5004871|NCT01612910|stage IIIC breast cancer|stage iiic breast cancer
5004872|NCT01612910|triple-negative breast cancer|triple-negative breast cancer
5004873|NCT01612897|autism|autism
5004874|NCT01612897|well child care|well child care
5004875|NCT01612897|screening|screening
5004876|NCT01612897|computer|computer
5004877|NCT01612897|reminders|reminders
5004878|NCT01612871|Breast cancer,|breast cancer,
5004879|NCT01612871|hormonotherapy,|hormonotherapy,
5004880|NCT01612871|miRNAs,|mirnas,
5004881|NCT01612871|biomarkers|biomarkers
5004882|NCT01612871|hormone therapy|hormone therapy
5004883|NCT01612858|Lipodystrophy|lipodystrophy
5004884|NCT01612858|Insulin resistance|insulin resistance
5004885|NCT01612858|HIV infection|hiv infection
5004886|NCT01612845|rotator cuff|rotator cuff
5004887|NCT01612845|shoulder|shoulder
5004888|NCT01612845|platelet rich plasma|platelet rich plasma
5004889|NCT01612845|fibrin|fibrin
5004890|NCT01612793|COPD|copd
5004892|NCT01612780|Sinus balloon dilation patients|sinus balloon dilation patients
5004893|NCT01612767|de novo coronary lesions|de novo coronary lesions
5004894|NCT01612767|restenotic coronary lesions|restenotic coronary lesions
5004895|NCT01612767|coronary arteries|coronary arteries
5004896|NCT01612754|Reduction of noise pollution|reduction of noise pollution
5004897|NCT01612754|Specifically enforced workplace rules|specifically enforced workplace rules
5004898|NCT01612754|Stress|stress
5004899|NCT01612754|Sound Ears (TM)|sound ears (tm)
5004900|NCT01612754|Error|error
5004901|NCT01612741|Diabetes Mellitus, Type-2|diabetes mellitus, type-2
5004902|NCT01612741|Acarbose|acarbose
5004903|NCT01612741|Drug Therapy|drug therapy
5004904|NCT01612741|Combination|combination
5004905|NCT01612728|Aromatase Inhibitors|aromatase inhibitors
5004906|NCT01612715|Asthma, allergen challenge, T cells, Fel d 1.|asthma, allergen challenge, t cells, fel d 1.
5004907|NCT01612702|postoperative nausea and vomiting|postoperative nausea and vomiting
5004909|NCT01612689|Accelerometer|accelerometer
5004911|NCT01612689|Ambulatory|ambulatory
5004912|NCT01612689|ECG|ecg
5004913|NCT01612689|Heart rate|heart rate
5004914|NCT01612663|Knee pain|knee pain
5004915|NCT01612663|Acupuncture|acupuncture
5004916|NCT01612663|Sham acupuncture|sham acupuncture
5004917|NCT01612650|breast cancer|breast cancer
5004918|NCT01612650|surveillance|surveillance
5004919|NCT01612650|diagnosis|diagnosis
5004920|NCT01612650|2D mammography|2d mammography
5004921|NCT01612650|3D mammography|3d mammography
5004922|NCT01612637|Pelvic organ prolapse|pelvic organ prolapse
5004923|NCT01612637|Pelvic floor muscle training|pelvic floor muscle training
5004924|NCT01612637|Prolapse symptoms|prolapse symptoms
5004925|NCT01612637|Pelvic organ prolapse quantification system|pelvic organ prolapse quantification system
5004926|NCT01612637|Ultrasonography|ultrasonography
5004927|NCT01612637|Predictors|predictors
5004928|NCT01612520|type 2 Diabetes Mellitus|type 2 diabetes mellitus
5004929|NCT01612520|telenursing|telenursing
5004930|NCT01612520|RCT|rct
5004931|NCT01612520|economic analysis|economic analysis
5004932|NCT01612507|Phase 1|phase 1
5004933|NCT01612507|healthy volunteers|healthy volunteers
5004934|NCT01612507|Parallel Group Study|parallel group study
5004935|NCT01612507|ceftaroline fosamil different doses|ceftaroline fosamil different doses
5004936|NCT01612507|safety|safety
5004937|NCT01612507|Cmax|cmax
5004938|NCT01612507|tmax|tmax
5004939|NCT01612507|AUC|auc
5004940|NCT01612481|soft tissue sarcoma|soft tissue sarcoma
5004941|NCT01612481|lung metastasis|lung metastasis
5004942|NCT01612481|surveillance|surveillance
5004943|NCT01612468|Diabetes|diabetes
5004944|NCT01612468|Liraglutide|liraglutide
5004945|NCT01612468|Hypoglycaemia|hypoglycaemia
5004946|NCT01612468|Hyperglycaemia|hyperglycaemia
5004947|NCT01612468|CIMT|cimt
5004948|NCT01612468|PWV|pwv
5004949|NCT01612468|Food preference|food preference
5004950|NCT01612468|Blood pressure|blood pressure
5004951|NCT01612455|HIV|hiv
5004952|NCT01612455|drug addiction|drug addiction
5004953|NCT01612455|Russia|russia
5004954|NCT01612455|case management|case management
5004955|NCT01612442|complementary feeding|complementary feeding
5004956|NCT01612442|mothers|mothers
5004957|NCT01612442|6-24 months children|6-24 months children
5004958|NCT01612442|community health volunteers|community health volunteers
5004959|NCT01612442|nutrition education|nutrition education
5004960|NCT01612442|agricultural education|agricultural education
5004961|NCT01612429|Carbamylation|carbamylation
5004962|NCT01612429|Albumin|albumin
5004963|NCT01612429|Protein structure|protein structure
5004964|NCT01612429|Kidney disease|kidney disease
5004965|NCT01612416|Ganglion Cell complex, Retinal Nerve Fiber Layer,Glaucoma|ganglion cell complex, retinal nerve fiber layer,glaucoma
5004966|NCT01612403|zinc binding protein|zinc binding protein
5004967|NCT01612390|postpartum hemorrhage|postpartum hemorrhage
5004968|NCT01612377|Moderate to Severe|moderate to severe
5004969|NCT01612364|CRPS I|crps i
5004970|NCT01612351|Head and neck cancer|head and neck cancer
5004971|NCT01612351|Squamous Cell Carcinoma|squamous cell carcinoma
5004972|NCT01612351|Phase II|phase ii
5004973|NCT01612351|Transoral Surgery|transoral surgery
5004974|NCT01612351|Induction Chemotherapy|induction chemotherapy
5004975|NCT01612351|Carboplatin|carboplatin
5004976|NCT01612351|Paclitaxel|paclitaxel
5004977|NCT01612351|Lapatinib|lapatinib
5004978|NCT01612338|breast cancer|breast cancer
5004979|NCT01612338|young age of onset|young age of onset
5004980|NCT01612338|family history|family history
5004981|NCT01612338|screening interventions|screening interventions
5004982|NCT01612338|family support|family support
5004983|NCT01612325|liver tumors|liver tumors
5004984|NCT01612312|Non-ST-elevation myocardial infarction|non-st-elevation myocardial infarction
5004985|NCT01612312|thrombectomy|thrombectomy
5004986|NCT01612312|magnetic resonance imaging|magnetic resonance imaging
5004987|NCT01612312|microvascular obstruction|microvascular obstruction
5004988|NCT01612286|Recombinant human endostatin|recombinant human endostatin
5004989|NCT01612286|nasopharyngeal carcinoma|nasopharyngeal carcinoma
5004990|NCT01612286|chemotherapy|chemotherapy
5004991|NCT01612273|Vasospastic syndrome|vasospastic syndrome
5004992|NCT01612273|Vascular dysregulation|vascular dysregulation
5004993|NCT01612260|heart failure|heart failure
5004994|NCT01612260|ventricular premature complex|ventricular premature complex
5004995|NCT01612260|Shensong Yangxin capsule|shensong yangxin capsule
5004996|NCT01612247|Breast Cancer|breast cancer
5004997|NCT01612247|Neoadjuvant therapy|neoadjuvant therapy
5004998|NCT01612234|humans|humans
5004999|NCT01612234|lean|lean
5005000|NCT01612234|obese|obese
5005001|NCT01612234|saturated fat|saturated fat
5005002|NCT01612234|monounsaturated fat|monounsaturated fat
5005003|NCT01612234|insulin sensitivity|insulin sensitivity
5005004|NCT01612234|inflammation|inflammation
5005005|NCT01612234|oxidant stress|oxidant stress
5005006|NCT01612195|anal fistula|anal fistula
5005007|NCT01612195|anal continence|anal continence
5005008|NCT01612195|health-related quality of life|health-related quality of life
5005009|NCT01612182|end-stage renal disease|end-stage renal disease
5005010|NCT01612182|renal replacement therapy|renal replacement therapy
5005011|NCT01612169|HIV patients|hiv patients
5005012|NCT01612169|Hospitalized patients|hospitalized patients
5005013|NCT01612169|Substance Users|substance users
5005014|NCT01612169|Drug Users|drug users
5005015|NCT01612156|Urodynamic testing|urodynamic testing
5005016|NCT01612156|pelvic floor examination|pelvic floor examination
5005017|NCT01612156|Lidocaine gel|lidocaine gel
5005018|NCT01612156|Surgical lubricant|surgical lubricant
5005019|NCT01612156|Pain|pain
5005020|NCT01612156|Embarrassment|embarrassment
5005021|NCT01612117|renal failure|renal failure
5005022|NCT01612117|cardiology|cardiology
5005023|NCT01612117|contrast-induced nephropathy|contrast-induced nephropathy
5005024|NCT01612104|Post Traumatic Stress Disorder|post traumatic stress disorder
5005025|NCT01612104|Anxiety symptoms|anxiety symptoms
5005026|NCT01612104|Depressive symptoms|depressive symptoms
5005027|NCT01612104|Externalizing behavior|externalizing behavior
5005028|NCT01612104|Reduced quality of life|reduced quality of life
5005029|NCT01612091|Expert System|expert system
5005030|NCT01612091|Intensive Care|intensive care
5005031|NCT01612091|Telemedicine|telemedicine
5005032|NCT01612091|Equipment Design|equipment design
5005033|NCT01612065|Office hysteroscopy|office hysteroscopy
5005034|NCT01612065|Cervical priming|cervical priming
5005035|NCT01612065|Misoprostol|misoprostol
5005036|NCT01612052|Vascular Surgery|vascular surgery
5005037|NCT01612039|ulcerative colitis|ulcerative colitis
5005038|NCT01612013|N-acetylcysteine|n-acetylcysteine
5005039|NCT01612013|angiography|angiography
5005040|NCT01612013|contrast medium|contrast medium
5005041|NCT01612013|contrast-induced nephropathy|contrast-induced nephropathy
5005042|NCT01612013|sodium bicarbonate|sodium bicarbonate
5005043|NCT01612000|Influenza|influenza
5005044|NCT01611974|CMV|cmv
5005045|NCT01611974|cytomegalovirus|cytomegalovirus
5005046|NCT01611974|resistant|resistant
5005047|NCT01611974|refractory|refractory
5005048|NCT01611974|transplant|transplant
5005049|NCT01611974|treatment|treatment
5005050|NCT01611961|Docetaxel|docetaxel
5005051|NCT01611961|Lipid Microsphere|lipid microsphere
5005052|NCT01611961|Neoplasms|neoplasms
5005053|NCT01611961|Antineoplastic Agents|antineoplastic agents
5005054|NCT01611961|Pharmacologic Actions|pharmacologic actions
5005055|NCT01611961|Therapeutic Uses|therapeutic uses
5005056|NCT01611935|trauma|trauma
5005057|NCT01611935|shock|shock
5005058|NCT01611935|vasopressin|vasopressin
5005059|NCT01611935|blood transfusion|blood transfusion
5005060|NCT01611922|eye|eye
5005061|NCT01611922|eyelid|eyelid
5005062|NCT01611922|contact lenses|contact lenses
5005063|NCT01611922|dry eye disease|dry eye disease
5005064|NCT01611909|p-menthane-3,8-diol oil extract|p-menthane-3,8-diol oil extract
5005065|NCT01611909|topical therapy|topical therapy
5005066|NCT01611896|Graves' hyperthyroidism|graves' hyperthyroidism
5005067|NCT01611896|Graves' disease|graves' disease
5005068|NCT01611896|Selenium|selenium
5005069|NCT01611896|Quality of Life|quality of life
5005070|NCT01611896|ThyPRO|thypro
5005071|NCT01611896|Autoimmunity|autoimmunity
5005072|NCT01611870|COPD|copd
5005073|NCT01611857|Advanced solid tumors|advanced solid tumors
5005074|NCT01611857|First-Line Metastatic GE cancer|first-line metastatic ge cancer
5005075|NCT01611857|c-Met Inhibitor|c-met inhibitor
5005076|NCT01611857|Tivantinib|tivantinib
5005077|NCT01611857|FOLFOX|folfox
5005078|NCT01611844|delayed-type hypersensitivity reaction to tuberculin intradermal injection|delayed-type hypersensitivity reaction to tuberculin intradermal injection
5005079|NCT01611844|tuberculosis skin test|tuberculosis skin test
5005080|NCT01611844|BD micro-needle|bd micro-needle
5005081|NCT01611844|medical device|medical device
5005082|NCT01611844|spectroscopy|spectroscopy
5005083|NCT01611831|fibromyalgia|fibromyalgia
5005084|NCT01611831|Acceptation & Commitment Therapy|acceptation & commitment therapy
5005085|NCT01611831|randomized controlled trial|randomized controlled trial
5005086|NCT01611818|Depression|depression
5005087|NCT01611818|Computer-delivered psychotherapy|computer-delivered psychotherapy
5005088|NCT01611818|Randomized-controlled trial|randomized-controlled trial
5005089|NCT01611792|Stabilization exercise|stabilization exercise
5005090|NCT01611792|Strength and conditioning exercise|strength and conditioning exercise
5005091|NCT01611792|Physical therapy|physical therapy
5005092|NCT01611792|Rehabilitation|rehabilitation
5005093|NCT01611779|obstructive sleep apnea|obstructive sleep apnea
5005094|NCT01611779|tongue suspension|tongue suspension
5005095|NCT01611766|secondary cytoreductive surgery|secondary cytoreductive surgery
5005096|NCT01611766|Ovarian Cancer|ovarian cancer
5005097|NCT01611766|surgery|surgery
5005098|NCT01611766|recurrence|recurrence
5005099|NCT01611753|Shock, Septic|shock, septic
5005100|NCT01611753|Erythrocyte Transfusion|erythrocyte transfusion
5005101|NCT01611753|Ischemia|ischemia
5005102|NCT01611740|Preterm infant|preterm infant
5005103|NCT01611740|Bacterial infection|bacterial infection
5005104|NCT01611740|Diagnosis of proven or suspected bacterial infection|diagnosis of proven or suspected bacterial infection
5005105|NCT01611727|BRCA1|brca1
5005106|NCT01611727|survival|survival
5005107|NCT01611727|metastatic disease|metastatic disease
5005108|NCT01611727|cisplatin|cisplatin
5005109|NCT01611714|Racial/ethnic disparities|racial/ethnic disparities
5005110|NCT01611714|Imaging|imaging
5005111|NCT01611714|Emergency|emergency
5005112|NCT01611714|Headache|headache
5005113|NCT01611675|Metastatic|metastatic
5005114|NCT01611675|Unresectable|unresectable
5005115|NCT01611675|Clearly progressive|clearly progressive
5005116|NCT01611675|BRAF mutation|braf mutation
5005117|NCT01611649|infant formula|infant formula
5005118|NCT01611649|dairy lipids|dairy lipids
5005119|NCT01611649|omega-3|omega-3
5005120|NCT01611636|allergy|allergy
5005121|NCT01611636|autoimmune diseases|autoimmune diseases
5005122|NCT01611636|rheumatic diseases|rheumatic diseases
5005123|NCT01611623|Solid tumor malignancy|solid tumor malignancy
5005124|NCT01611623|Hsp90|hsp90
5005125|NCT01611610|outcome measures|outcome measures
5005126|NCT01611610|spinal muscular atrophy|spinal muscular atrophy
5005127|NCT01611597|accelerometry|accelerometry
5005128|NCT01611597|neuromuscular disease|neuromuscular disease
5005129|NCT01611584|ALA|ala
5005130|NCT01611584|Florescence|florescence
5005131|NCT01611584|Lung cancer|lung cancer
5005132|NCT01611571|osteoporosis|osteoporosis
5005133|NCT01611571|male|male
5005134|NCT01611545|Pharmacogenomics|pharmacogenomics
5005135|NCT01611545|Pharmacogenetics|pharmacogenetics
5005136|NCT01611545|Clopidogrel|clopidogrel
5005137|NCT01611545|Plavix|plavix
5005138|NCT01611532|Acute pancreatitis|acute pancreatitis
5005139|NCT01611532|Intraabdominal pressure|intraabdominal pressure
5005140|NCT01611532|Critical illness|critical illness
5005141|NCT01611519|urinary bladder|urinary bladder
5005142|NCT01611519|urinary catheterization|urinary catheterization
5005143|NCT01611519|epidural analgesia|epidural analgesia
5005144|NCT01611519|catheters, indwelling|catheters, indwelling
5005145|NCT01611493|Dental Implants|dental implants
5005146|NCT01611493|Jaw, Edentulous, Partially/rehabilitation|jaw, edentulous, partially/rehabilitation
5005147|NCT01611493|Jaw, Edentulous, Partially/surgery|jaw, edentulous, partially/surgery
5005148|NCT01611493|randomised Clinical Trials|randomised clinical trials
5005149|NCT01611493|Humans|humans
5005150|NCT01611467|CC-223|cc-223
5005151|NCT01611467|safety|safety
5005152|NCT01611467|tolerability|tolerability
5005153|NCT01611467|pharmacokinetic|pharmacokinetic
5005154|NCT01611467|AME (Absorption, Metabolism, and Excretion)|ame (absorption, metabolism, and excretion)
5005155|NCT01611467|FE (Food Effect)|fe (food effect)
5005156|NCT01611454|Occupational Exposure to Radiation|occupational exposure to radiation
5005157|NCT01611441|Osteoarthritis of the knee|osteoarthritis of the knee
5005158|NCT01611441|Biomarkers|biomarkers
5005159|NCT01611428|Ipragliflozin|ipragliflozin
5005160|NCT01611428|Healthy|healthy
5005161|NCT01611428|Absolute Bioavailability|absolute bioavailability
5005162|NCT01611428|Pharmacokinetics|pharmacokinetics
5005163|NCT01611415|Phase 1|phase 1
5005164|NCT01611415|Ipragliflozin|ipragliflozin
5005165|NCT01611415|Furosemide|furosemide
5005166|NCT01611415|Pharmacokinetics|pharmacokinetics
5005167|NCT01611415|Pharmacodynamics|pharmacodynamics
5005168|NCT01611402|Tuberculosis|tuberculosis
5005169|NCT01611402|HIV Infection|hiv infection
5005170|NCT01611402|Transcriptional Signature|transcriptional signature
5005171|NCT01611402|IRIS|iris
5005172|NCT01611376|impedance cardiography|impedance cardiography
5005173|NCT01611376|Flotrac/Vigileo|flotrac/vigileo
5005174|NCT01611376|cardiac output|cardiac output
5005175|NCT01611363|Ipragliflozin|ipragliflozin
5005176|NCT01611363|Phase 1|phase 1
5005177|NCT01611363|Healthy|healthy
5005178|NCT01611363|Diabetes Mellitus|diabetes mellitus
5005179|NCT01611363|Pharmacokinetics|pharmacokinetics
5005180|NCT01611363|Pharmacodynamics|pharmacodynamics
5005181|NCT01611350|Indoor Air Pollution|indoor air pollution
5005182|NCT01611350|Marketing Methods for Increasing Technology Adoption|marketing methods for increasing technology adoption
5005183|NCT01611350|Optimal Contracts for Technology Adoption|optimal contracts for technology adoption
5005184|NCT01611337|schizophrenia, insight|schizophrenia, insight
5005185|NCT01611324|Varicose Veins|varicose veins
5005186|NCT01611324|Phlebectomy|phlebectomy
5005187|NCT01611324|Local Anesthesia|local anesthesia
5005188|NCT01611298|allogeneic stem cell transplant|allogeneic stem cell transplant
5005189|NCT01611298|malignant diseases|malignant diseases
5005190|NCT01611298|Acute lymphoblastic leukemia|acute lymphoblastic leukemia
5005191|NCT01611298|acute myelogenous leukemia|acute myelogenous leukemia
5005192|NCT01611298|Chronic myelogenous leukemia|chronic myelogenous leukemia
5005193|NCT01611298|myelodysplastic syndrome|myelodysplastic syndrome
5005194|NCT01611298|Hodgkin lymphoma|hodgkin lymphoma
5005195|NCT01611298|non-Hodgkin lymphoma|non-hodgkin lymphoma
5005196|NCT01611298|myeloproliferative disorder|myeloproliferative disorder
5005197|NCT01611298|non-malignant disease|non-malignant disease
5005198|NCT01611285|UPHOLD|uphold
5005199|NCT01611285|robotic surgery|robotic surgery
5005200|NCT01611285|decision analysis|decision analysis
5005202|NCT01611285|decision node|decision node
5005203|NCT01611285|outcome node|outcome node
5005204|NCT01611272|Unstable angina|unstable angina
5005205|NCT01611259|MALT Lymphoma|malt lymphoma
5005206|NCT01611259|Lenalidomide|lenalidomide
5005207|NCT01611259|Rituximab|rituximab
5005208|NCT01611259|AGMT|agmt
5005209|NCT01611233|metal on metal|metal on metal
5005210|NCT01611233|hip replacement|hip replacement
5005211|NCT01611233|ASR|asr
5005212|NCT01611233|DePuy|depuy
5005213|NCT01611220|Anorexia Nervosa|anorexia nervosa
5005214|NCT01611220|Relapse prevention|relapse prevention
5005215|NCT01611220|Cognitive Dissonance|cognitive dissonance
5005216|NCT01611220|Inpatient treatment|inpatient treatment
5005217|NCT01611220|Cognitive behavior therapy|cognitive behavior therapy
5005218|NCT01611207|wound healing impairments,|wound healing impairments,
5005219|NCT01611207|negative pressure wound therapy,|negative pressure wound therapy,
5005220|NCT01611207|health services research,|health services research,
5005221|NCT01611207|germany|germany
5005222|NCT01611194|HBO2|hbo2
5005223|NCT01611194|HBOT|hbot
5005224|NCT01611194|mTBI|mtbi
5005225|NCT01611194|Brain injury|brain injury
5005226|NCT01611194|PCS|pcs
5005227|NCT01611194|PTSD|ptsd
5005228|NCT01611194|hyperbaric oxygen|hyperbaric oxygen
5005229|NCT01611181|Iron supplementation|iron supplementation
5005230|NCT01611181|Iron deficiency|iron deficiency
5005231|NCT01611181|Hip arthroplasty|hip arthroplasty
5005232|NCT01611181|Knee arthroplasty|knee arthroplasty
5005233|NCT01611142|Monoclonal antibody|monoclonal antibody
5005234|NCT01611142|Peripheral T-cell Lymphoma|peripheral t-cell lymphoma
5005235|NCT01611142|cancer|cancer
5005236|NCT01611142|hematologic malignancy|hematologic malignancy
5005237|NCT01611129|Disability Evaluation|disability evaluation
5005238|NCT01611103|Cognitive Enhancement|cognitive enhancement
5005239|NCT01611103|tDCS|tdcs
5005240|NCT01611103|stimulation|stimulation
5005241|NCT01611103|elderly|elderly
5005242|NCT01611103|older adults|older adults
5005243|NCT01611090|Chronic lymphocytic leukemia|chronic lymphocytic leukemia
5005244|NCT01611090|Small lymphocytic lymphoma|small lymphocytic lymphoma
5005245|NCT01611090|Relapsed or refractory chronic lymphocytic leukemia|relapsed or refractory chronic lymphocytic leukemia
5005246|NCT01611090|Relapsed or refractory small lymphocytic lymphoma|relapsed or refractory small lymphocytic lymphoma
5005247|NCT01611090|Ibrutinib|ibrutinib
5005248|NCT01611090|PCI-32765|pci-32765
5005249|NCT01611090|JNJ-54179060|jnj-54179060
5005250|NCT01611090|Bruton's tyrosine kinase inhibitor|bruton's tyrosine kinase inhibitor
5005251|NCT01611090|Bendamustine|bendamustine
5005252|NCT01611090|Rituximab|rituximab
5005253|NCT01611064|Hand|hand
5005254|NCT01611064|Surgery|surgery
5005255|NCT01611064|Tourniquet|tourniquet
5005256|NCT01611064|Pain|pain
5005257|NCT01611064|Oxygen|oxygen
5005258|NCT01611051|breast cancer|breast cancer
5005259|NCT01611051|neutropenia|neutropenia
5005260|NCT01611051|febrile neutropenia|febrile neutropenia
5005261|NCT01611012|Asthma|asthma
5005262|NCT01611012|Inflammation|inflammation
5005263|NCT01611012|Phenotype|phenotype
5005264|NCT01611012|Sputum|sputum
5005265|NCT01610986|Fructose|fructose
5005266|NCT01610986|Exercise|exercise
5005267|NCT01610986|Lactic acid|lactic acid
5005268|NCT01610986|Monocarboxylic Acid Transporters|monocarboxylic acid transporters
5005269|NCT01610973|Fuch's dystrophy|fuch's dystrophy
5005270|NCT01610973|Corneal graft|corneal graft
5005271|NCT01610960|Non invasive ventilation|non invasive ventilation
5005272|NCT01610960|Helmet|helmet
5005273|NCT01610960|NEXT Helmet|next helmet
5005274|NCT01610960|Work of breathing|work of breathing
5005275|NCT01610960|Intensive care|intensive care
5005276|NCT01610947|Spondyloarthritis|spondyloarthritis
5005277|NCT01610947|Anti-TNF|anti-tnf
5005278|NCT01610947|Adalimumab|adalimumab
5005279|NCT01610947|Etanercept|etanercept
5005280|NCT01610947|Infliximab|infliximab
5005281|NCT01610934|MODY|mody
5005282|NCT01610934|Monogenic diabetes|monogenic diabetes
5005283|NCT01610934|Non-autoimmune diabetes|non-autoimmune diabetes
5005284|NCT01610934|MODY3|mody3
5005285|NCT01610921|asthma|asthma
5005286|NCT01610921|small airways disease|small airways disease
5005287|NCT01610921|inflammation|inflammation
5005288|NCT01610921|provocation|provocation
5005289|NCT01610921|adenosine|adenosine
5005290|NCT01610908|Adolescent|adolescent
5005291|NCT01610908|Idiopathic|idiopathic
5005292|NCT01610908|Scoliosis|scoliosis
5005293|NCT01610908|Schroth|schroth
5005294|NCT01610908|Exercises|exercises
5005295|NCT01610908|Conservative treatment|conservative treatment
5005296|NCT01610895|Colonoscopy|colonoscopy
5005297|NCT01610895|low fibre diet|low fibre diet
5005298|NCT01610895|clear fluids|clear fluids
5005299|NCT01610895|Bowel Preparation|bowel preparation
5005300|NCT01610869|Recurrence|recurrence
5005301|NCT01610869|Ovarian Neoplasms|ovarian neoplasms
5005302|NCT01610869|Ovarian Diseases|ovarian diseases
5005303|NCT01610869|Fallopian Tube Neoplasms|fallopian tube neoplasms
5005304|NCT01610869|Neoplasms|neoplasms
5005305|NCT01610869|Carcinoma|carcinoma
5005306|NCT01610869|Neoplasms by site|neoplasms by site
5005307|NCT01610856|bowel preparation|bowel preparation
5005308|NCT01610856|bowel purgative|bowel purgative
5005309|NCT01610856|bowel cleansing|bowel cleansing
5005310|NCT01610856|colonoscopy|colonoscopy
5005311|NCT01610843|Sarcoidosis|sarcoidosis
5005312|NCT01610843|WISE|wise
5005313|NCT01610843|Sarcoid Study|sarcoid study
5005314|NCT01610843|Worldwide Sarcoidosis Research Study|worldwide sarcoidosis research study
5005315|NCT01610830|Purpura, Schoenlein-Henoch|purpura, schoenlein-henoch
5005316|NCT01610830|adults|adults
5005317|NCT01610830|children|children
5005318|NCT01610830|pronostic factors|pronostic factors
5005319|NCT01610817|Patient information and active participation|patient information and active participation
5005320|NCT01610817|Patient safety|patient safety
5005321|NCT01610817|Health education|health education
5005322|NCT01610817|Adverse drug event|adverse drug event
5005323|NCT01610817|Primary care|primary care
5005324|NCT01610817|Antihypertensive drugs|antihypertensive drugs
5005325|NCT01610765|HSV|hsv
5005326|NCT01610765|pharmacokinetics|pharmacokinetics
5005327|NCT01610765|herpes|herpes
5005328|NCT01610765|neonates|neonates
5005329|NCT01610752|Pregnancy|pregnancy
5005330|NCT01610752|Gestational weight gain|gestational weight gain
5005331|NCT01610726|colon|colon
5005332|NCT01610726|rectum|rectum
5005333|NCT01610726|recovery|recovery
5005334|NCT01610726|surgery|surgery
5005335|NCT01610674|Diabetes mellitus|diabetes mellitus
5005336|NCT01610674|Surgery|surgery
5005337|NCT01610674|Implementation|implementation
5005338|NCT01610674|Quality of care|quality of care
5005339|NCT01610674|Quality indicators|quality indicators
5005340|NCT01610661|carbohydrate|carbohydrate
5005341|NCT01610661|inflammation|inflammation
5005342|NCT01610661|glucose homeostasis|glucose homeostasis
5005343|NCT01610661|gene expression|gene expression
5005344|NCT01610648|OSA|osa
5005345|NCT01610648|metabolic syndrome|metabolic syndrome
5005346|NCT01610648|Apnea-hypopnea index|apnea-hypopnea index
5005347|NCT01610648|Oxygen desaturation index|oxygen desaturation index
5005348|NCT01610635|RCT|rct
5005349|NCT01610635|blood donation frequency|blood donation frequency
5005350|NCT01610635|quality of life|quality of life
5005351|NCT01610635|iron deficiency|iron deficiency
5005352|NCT01610622|Cardiac Output|cardiac output
5005353|NCT01610622|Blood volumes|blood volumes
5005354|NCT01610622|Neonates|neonates
5005355|NCT01610609|Statin treatment|statin treatment
5005356|NCT01610609|Cardiovascular disease|cardiovascular disease
5005357|NCT01610609|High cholesterol|high cholesterol
5005358|NCT01610609|Care management|care management
5005359|NCT01610596|Psoriasis|psoriasis
5005360|NCT01610596|Skin Diseases|skin diseases
5005361|NCT01610596|Halobetasol|halobetasol
5005362|NCT01610596|Vasoconstrictor Agents|vasoconstrictor agents
5005363|NCT01610596|Therapeutic Uses|therapeutic uses
5005364|NCT01610596|Pharmacologic Actions|pharmacologic actions
5005365|NCT01610596|Anti-Inflammatory Agents|anti-inflammatory agents
5005366|NCT01610596|Physiological Effects of Drugs|physiological effects of drugs
5005367|NCT01610583|Genetic Literacy|genetic literacy
5005368|NCT01610583|Latino|latino
5005369|NCT01610570|Dose Limiting Toxicity|dose limiting toxicity
5005370|NCT01610570|Maximum Tolerated Dose|maximum tolerated dose
5005371|NCT01610570|Radiographic Response|radiographic response
5005372|NCT01610570|Time to Progression|time to progression
5005373|NCT01610570|Bone Tumors|bone tumors
5005374|NCT01610557|Diabetic Macular Edema|diabetic macular edema
5005375|NCT01610557|Ranibizumab|ranibizumab
5005376|NCT01610557|Bevacizumab|bevacizumab
5005377|NCT01610544|Thymoma|thymoma
5005378|NCT01610544|Insulin Growth Factor|insulin growth factor
5005379|NCT01610544|Cell Proliferation|cell proliferation
5005380|NCT01610544|Non Small Cell Lung Cancer|non small cell lung cancer
5005381|NCT01610544|PET/CT Imaging Sessions|pet/ct imaging sessions
5005382|NCT01610531|Cohort|cohort
5005383|NCT01610531|Melanoma|melanoma
5005384|NCT01610531|targeted screening|targeted screening
5005385|NCT01610531|risks function|risks function
5005386|NCT01610531|cost effectiveness|cost effectiveness
5005387|NCT01610518|postprandial blood glucose|postprandial blood glucose
5005388|NCT01610518|dietary fiber|dietary fiber
5005389|NCT01610518|beta-glucan|beta-glucan
5005390|NCT01610505|Knee Osteoarthritis|knee osteoarthritis
5005391|NCT01610505|Knee pain|knee pain
5005392|NCT01610505|Arthritis|arthritis
5005393|NCT01610505|KineSpring|kinespring
5005394|NCT01610505|High Tibial Osteotomy|high tibial osteotomy
5005395|NCT01610492|IMGN|imgn
5005396|NCT01610492|anti-PLA2R antibodies|anti-pla2r antibodies
5005397|NCT01610492|pharmacokinetics|pharmacokinetics
5005398|NCT01610492|belimumab|belimumab
5005399|NCT01610492|Benlysta|benlysta
5005400|NCT01610492|Idiopathic Membranous Glomerulonephropathy|idiopathic membranous glomerulonephropathy
5005401|NCT01610492|safety|safety
5005402|NCT01610492|GSK1550188|gsk1550188
5005403|NCT01610492|Lymphostat-B|lymphostat-b
5005404|NCT01610492|membrane attack complex|membrane attack complex
5005405|NCT01610466|Education|education
5005406|NCT01610466|Simulation|simulation
5005407|NCT01610466|Technical skills training|technical skills training
5005408|NCT01610466|Laparoscopy|laparoscopy
5005409|NCT01610466|Bariatric Surgery|bariatric surgery
5005410|NCT01610453|prolonged labor|prolonged labor
5005411|NCT01610453|cesarean section|cesarean section
5005412|NCT01610453|duration of labor|duration of labor
5005413|NCT01610440|Duchenne muscular dystrophy|duchenne muscular dystrophy
5005414|NCT01610440|Human Umbilical Cord Mesenchymal Stem Cells|human umbilical cord mesenchymal stem cells
5005415|NCT01610427|CMI|cmi
5005416|NCT01610427|HIV|hiv
5005417|NCT01610427|Antiretroviral therapy-naïve|antiretroviral therapy-naïve
5005418|NCT01610414|Observer-blind|observer-blind
5005419|NCT01610414|Efficacy|efficacy
5005420|NCT01610414|Immunogenicity|immunogenicity
5005421|NCT01610414|Vaccination|vaccination
5005422|NCT01610414|Safety|safety
5005423|NCT01610414|Adult autologous haematopoietic cell transplant recipients|adult autologous haematopoietic cell transplant recipients
5005424|NCT01610414|Herpes Zoster|herpes zoster
5005425|NCT01610388|healthy subjects|healthy subjects
5005426|NCT01610388|double-blind|double-blind
5005427|NCT01610388|FTIH|ftih
5005428|NCT01610388|dose-escalation|dose-escalation
5005429|NCT01610388|absolute bioavailability|absolute bioavailability
5005430|NCT01610388|GSK1322322|gsk1322322
5005431|NCT01610388|BAL|bal
5005432|NCT01610375|Endometrial cancer|endometrial cancer
5005433|NCT01610362|rabies|rabies
5005434|NCT01610362|immunoglobulin|immunoglobulin
5005435|NCT01610362|dosage|dosage
5005436|NCT01610336|EGFR|egfr
5005437|NCT01610336|c-MET|c-met
5005438|NCT01610336|Lung cancer|lung cancer
5005439|NCT01610336|Gefitinib|gefitinib
5005440|NCT01610336|Erlotinib|erlotinib
5005441|NCT01610323|Pregnancy|pregnancy
5005442|NCT01610323|Obesity|obesity
5005443|NCT01610323|Physical activity|physical activity
5005444|NCT01610323|Cardiorespiratory fitness|cardiorespiratory fitness
5005445|NCT01610323|Muscular Fitness|muscular fitness
5005446|NCT01610323|Weight gain|weight gain
5005447|NCT01610323|Fetal growth|fetal growth
5005448|NCT01610310|SC|sc
5005449|NCT01610310|PEG|peg
5005450|NCT01610310|Inteferon|inteferon
5005451|NCT01610310|PK|pk
5005452|NCT01610310|Subcutaneous|subcutaneous
5005453|NCT01610310|PEGylated|pegylated
5005454|NCT01610310|Autoinjector|autoinjector
5005455|NCT01610310|Injectable|injectable
5005456|NCT01610310|MS|ms
5005457|NCT01610297|hematopoietic stem cell transplantation, beta-thalassemia major, deferasirox, iron overload|hematopoietic stem cell transplantation, beta-thalassemia major, deferasirox, iron overload
5005458|NCT01610284|Breast cancer|breast cancer
5005459|NCT01610284|Hormone receptor positive|hormone receptor positive
5005460|NCT01610284|HER2-negative|her2-negative
5005461|NCT01610284|Metastatic|metastatic
5005462|NCT01610284|Locally advanced|locally advanced
5005463|NCT01610284|PI3K|pi3k
5005464|NCT01610284|Fulvestrant|fulvestrant
5005465|NCT01610284|Refractory|refractory
5005466|NCT01610284|Aromatase inhibitor|aromatase inhibitor
5005467|NCT01610271|Prevention|prevention
5005468|NCT01610271|Surgical Site Infection|surgical site infection
5005469|NCT01610271|Air Barrier System|air barrier system
5005470|NCT01610271|Implant Infection|implant infection
5005471|NCT01610258|pregnancy, chorioamnionitis, PPROM, Treg|pregnancy, chorioamnionitis, pprom, treg
5005472|NCT01610245|Influenza|influenza
5005473|NCT01610232|Infrared LED|infrared led
5005474|NCT01610232|Treadmill Training|treadmill training
5005475|NCT01610232|Strength Muscle|strength muscle
5005476|NCT01610232|Fatigue Muscle|fatigue muscle
5005477|NCT01610232|Aerobic Capacity|aerobic capacity
5005478|NCT01610232|Cellulite|cellulite
5005479|NCT01610232|Osteoporosis|osteoporosis
5005480|NCT01610206|recurrent|recurrent
5005481|NCT01610206|persistent|persistent
5005482|NCT01610193|Pancreatic Stone Protein|pancreatic stone protein
5005483|NCT01610193|Abdominal pain|abdominal pain
5005484|NCT01610193|Acute appendicitis|acute appendicitis
5005485|NCT01610193|Alvarado score|alvarado score
5005486|NCT01610193|Appendectomy|appendectomy
5005487|NCT01610193|Sensitivity and specificity|sensitivity and specificity
5005488|NCT01610180|Eltrombopag|eltrombopag
5005489|NCT01610180|ITP|itp
5005490|NCT01610180|LPD|lpd
5005491|NCT01610180|leukemia|leukemia
5005492|NCT01610180|Immune ThrombocytoPenia|immune thrombocytopenia
5005493|NCT01610154|glucagon|glucagon
5005494|NCT01610154|dipeptidyl peptidase-4 inhibitor|dipeptidyl peptidase-4 inhibitor
5005495|NCT01610141|warfarin metabolism|warfarin metabolism
5005496|NCT01610141|pharmacogenetics|pharmacogenetics
5005497|NCT01610141|CYP2C9|cyp2c9
5005498|NCT01610141|genotyping|genotyping
5005499|NCT01610141|VKORC1|vkorc1
5005500|NCT01610141|CYP4F2|cyp4f2
5005501|NCT01610141|anticoagulation|anticoagulation
5005502|NCT01610141|atrial fibrillation|atrial fibrillation
5005503|NCT01610141|deep vein thrombosis|deep vein thrombosis
5005504|NCT01610141|pulmonary embolism|pulmonary embolism
5005505|NCT01610141|Artificial Heart Valve|artificial heart valve
5005506|NCT01610128|urticaria, patient reported outcome|urticaria, patient reported outcome
5005507|NCT01610115|Pregnancy|pregnancy
5005508|NCT01610102|clinical follow-up|clinical follow-up
5005509|NCT01610102|up to 7 years|up to 7 years
5005510|NCT01610102|all patients enrolled in the main study|all patients enrolled in the main study
5005511|NCT01610089|citrullinemia|citrullinemia
5005512|NCT01610089|argininosuccinate synthetase deficiency|argininosuccinate synthetase deficiency
5005513|NCT01610089|nitric oxide|nitric oxide
5005514|NCT01610089|urea|urea
5005515|NCT01610076|Code Status|code status
5005516|NCT01610076|Do not resuscitate (DNR)|do not resuscitate (dnr)
5005517|NCT01610076|Do not intubate (DNI)|do not intubate (dni)
5005518|NCT01610076|CPR|cpr
5005519|NCT01610076|Cardiopulmonary resuscitation|cardiopulmonary resuscitation
5005520|NCT01610076|video|video
5005521|NCT01610076|advanced directives|advanced directives
5005522|NCT01610063|Algorithm|algorithm
5005523|NCT01610063|Depression|depression
5005524|NCT01610063|Assurex|assurex
5005525|NCT01610063|GeneSight|genesight
5005526|NCT01610050|castration-resistant prostate cancer, advanced breast cancer|castration-resistant prostate cancer, advanced breast cancer
5005527|NCT01610037|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
5005528|NCT01610037|COPD|copd
5005529|NCT01610037|QVA149|qva149
5005530|NCT01610037|QAB149|qab149
5005531|NCT01610037|NVA237|nva237
5005532|NCT01610037|Indacaterol maleate|indacaterol maleate
5005533|NCT01610037|Glycopyronnium bromide|glycopyronnium bromide
5005534|NCT01610011|Schizophrenia|schizophrenia
5005535|NCT01610011|Psychotic Disorders|psychotic disorders
5005536|NCT01610011|N-methyl-D-aspartate receptor|n-methyl-d-aspartate receptor
5005537|NCT01610011|Glycine augmentation|glycine augmentation
5005538|NCT01610011|Glycine|glycine
5005539|NCT01610011|Glycine Pharmacodynamics|glycine pharmacodynamics
5005540|NCT01610011|Glycine Bioavailability|glycine bioavailability
5005541|NCT01610011|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
5005542|NCT01610011|Glycine Decarboxylase|glycine decarboxylase
5005543|NCT01610011|Glycine Decarboxylase Mutation|glycine decarboxylase mutation
5005544|NCT01609998|Influenza A (H1)|influenza a (h1)
5005545|NCT01609998|Influenza A (H3)|influenza a (h3)
5005546|NCT01609998|Influenza B|influenza b
5005547|NCT01609998|DNA Vaccine|dna vaccine
5005548|NCT01609998|Trivalent Inactivated Vaccine (TIV)|trivalent inactivated vaccine (tiv)
5005549|NCT01609998|Healthy Adolescents|healthy adolescents
5005550|NCT01609998|Healthy Children|healthy children
5005551|NCT01609985|Cardiac Resynchronization Therapy Defibrillator (CRT-D) Devices|cardiac resynchronization therapy defibrillator (crt-d) devices
5005552|NCT01609972|Back pain|back pain
5005553|NCT01609972|Spinal Cord Stimulation|spinal cord stimulation
5005554|NCT01609959|Hypertension|hypertension
5005555|NCT01609959|Angiotensin II Receptor Blocker|angiotensin ii receptor blocker
5005556|NCT01609959|Azilsartan|azilsartan
5005557|NCT01609959|Valsartan|valsartan
5005558|NCT01609946|presenting for FNAB or surgery|presenting for fnab or surgery
5005559|NCT01609933|Hepatitis C Virus (HCV)|hepatitis c virus (hcv)
5005560|NCT01609933|Hepatitis C Genotype 1|hepatitis c genotype 1
5005561|NCT01609933|Chronic Hepatitis C|chronic hepatitis c
5005563|NCT01609920|MRI|mri
5005564|NCT01609920|lymph node metastases|lymph node metastases
5005565|NCT01609920|breast cancer|breast cancer
5005566|NCT01609920|gadofosveset|gadofosveset
5005567|NCT01609907|Drug interaction|drug interaction
5005568|NCT01609907|YH14700|yh14700
5005569|NCT01609907|Rosuvastatin|rosuvastatin
5005570|NCT01609907|Valsartan|valsartan
5005571|NCT01609907|Yuhan|yuhan
5005572|NCT01609894|Postnatal development|postnatal development
5005573|NCT01609894|Breast milk fortification|breast milk fortification
5005574|NCT01609894|Composition of breast milk|composition of breast milk
5005575|NCT01609881|Inflammation|inflammation
5005576|NCT01609868|premature infant feeding protein|premature infant feeding protein
5005577|NCT01609855|Adenoma Detection Rate|adenoma detection rate
5005578|NCT01609855|Anti-spasmotic drug|anti-spasmotic drug
5005579|NCT01609842|Acute Coronary Syndrome|acute coronary syndrome
5005580|NCT01609842|adherence|adherence
5005581|NCT01609816|adult grade III lymphomatoid granulomatosis|adult grade iii lymphomatoid granulomatosis
5005582|NCT01609816|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
5005583|NCT01609816|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5005584|NCT01609816|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
5005585|NCT01609816|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
5005586|NCT01609816|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
5005587|NCT01609816|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
5005588|NCT01609816|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
5005589|NCT01609816|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
5005590|NCT01609816|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
5005591|NCT01609816|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
5006328|NCT01607086|properties|properties
5005592|NCT01609816|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
5005593|NCT01609816|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
5005594|NCT01609816|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
5005595|NCT01609816|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
5005596|NCT01609816|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
5005597|NCT01609816|cutaneous B-cell non-Hodgkin lymphoma|cutaneous b-cell non-hodgkin lymphoma
5005598|NCT01609816|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5005599|NCT01609816|hepatosplenic T-cell lymphoma|hepatosplenic t-cell lymphoma
5005600|NCT01609816|intraocular lymphoma|intraocular lymphoma
5005601|NCT01609816|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5005602|NCT01609816|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
5005603|NCT01609816|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5005604|NCT01609816|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
5005605|NCT01609816|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
5005606|NCT01609816|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
5005607|NCT01609816|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
5005608|NCT01609816|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5005609|NCT01609816|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5005610|NCT01609816|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5005611|NCT01609816|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5005612|NCT01609816|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
5005613|NCT01609816|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
5005614|NCT01609816|noncutaneous extranodal lymphoma|noncutaneous extranodal lymphoma
5005615|NCT01609816|peripheral T-cell lymphoma|peripheral t-cell lymphoma
5005616|NCT01609816|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5005617|NCT01609816|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5005618|NCT01609816|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5005619|NCT01609816|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5005620|NCT01609816|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
5005621|NCT01609816|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5005622|NCT01609816|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5005623|NCT01609816|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5005624|NCT01609816|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
5005625|NCT01609816|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5005626|NCT01609816|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5005627|NCT01609816|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5005628|NCT01609816|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5005629|NCT01609816|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5005630|NCT01609816|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5005631|NCT01609816|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5005632|NCT01609816|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5005633|NCT01609816|refractory hairy cell leukemia|refractory hairy cell leukemia
5005634|NCT01609816|refractory multiple myeloma|refractory multiple myeloma
5005635|NCT01609816|small intestine lymphoma|small intestine lymphoma
5005636|NCT01609816|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5005637|NCT01609816|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
5005638|NCT01609816|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
5005639|NCT01609816|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
5005640|NCT01609816|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
5005641|NCT01609816|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
5005642|NCT01609816|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
5005643|NCT01609816|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
5005644|NCT01609816|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
5005645|NCT01609816|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
5005646|NCT01609816|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
5005647|NCT01609816|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
5005648|NCT01609816|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
5005649|NCT01609816|stage I mantle cell lymphoma|stage i mantle cell lymphoma
5005650|NCT01609816|stage I marginal zone lymphoma|stage i marginal zone lymphoma
5005651|NCT01609816|stage I multiple myeloma|stage i multiple myeloma
5005652|NCT01609816|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
5005653|NCT01609816|stage IA mycosis fungoides/Sezary syndrome|stage ia mycosis fungoides/sezary syndrome
5005727|NCT01609673|Chronic Kidney Disease|chronic kidney disease
5005654|NCT01609816|stage IB mycosis fungoides/Sezary syndrome|stage ib mycosis fungoides/sezary syndrome
5005655|NCT01609816|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
5005656|NCT01609816|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
5005657|NCT01609816|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
5005658|NCT01609816|stage II multiple myeloma|stage ii multiple myeloma
5005659|NCT01609816|stage IIA mycosis fungoides/Sezary syndrome|stage iia mycosis fungoides/sezary syndrome
5005660|NCT01609816|stage IIB mycosis fungoides/Sezary syndrome|stage iib mycosis fungoides/sezary syndrome
5005661|NCT01609816|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5005662|NCT01609816|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5005663|NCT01609816|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5005664|NCT01609816|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5005665|NCT01609816|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5005666|NCT01609816|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5005667|NCT01609816|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5005668|NCT01609816|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
5005669|NCT01609816|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
5005670|NCT01609816|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5005671|NCT01609816|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5005672|NCT01609816|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5005673|NCT01609816|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5005674|NCT01609816|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5005675|NCT01609816|stage III multiple myeloma|stage iii multiple myeloma
5005676|NCT01609816|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5005677|NCT01609816|stage IIIA mycosis fungoides/Sezary syndrome|stage iiia mycosis fungoides/sezary syndrome
5005678|NCT01609816|stage IIIB mycosis fungoides/Sezary syndrome|stage iiib mycosis fungoides/sezary syndrome
5005679|NCT01609816|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5005680|NCT01609816|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5005681|NCT01609816|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5005682|NCT01609816|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5005683|NCT01609816|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5005684|NCT01609816|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5005685|NCT01609816|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5005686|NCT01609816|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
5005687|NCT01609816|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
5005688|NCT01609816|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5005689|NCT01609816|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5005690|NCT01609816|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5005691|NCT01609816|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5005692|NCT01609816|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5005693|NCT01609816|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5005694|NCT01609816|stage IVA mycosis fungoides/Sezary syndrome|stage iva mycosis fungoides/sezary syndrome
5005695|NCT01609816|stage IVB mycosis fungoides/Sezary syndrome|stage ivb mycosis fungoides/sezary syndrome
5005696|NCT01609816|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
5005697|NCT01609816|testicular lymphoma|testicular lymphoma
5005698|NCT01609816|Waldenström macroglobulinemia|waldenström macroglobulinemia
5005699|NCT01609751|probiotic|probiotic
5005700|NCT01609751|lactobacillus|lactobacillus
5005701|NCT01609751|colonic diseases|colonic diseases
5005702|NCT01609751|dietary fibre|dietary fibre
5005703|NCT01609738|Cardiac pacing|cardiac pacing
5005704|NCT01609738|Left ventricular septal pacing|left ventricular septal pacing
5005705|NCT01609738|Feasibility and safety|feasibility and safety
5005706|NCT01609738|Lead stability|lead stability
5005707|NCT01609738|Hemodynamics|hemodynamics
5005708|NCT01609738|Left ventricular dyssynchrony|left ventricular dyssynchrony
5005709|NCT01609738|Pacing for heart failure|pacing for heart failure
5005710|NCT01609738|Cardiac resynchronization therapy|cardiac resynchronization therapy
5005711|NCT01609725|Coronary artery disease|coronary artery disease
5005712|NCT01609725|C reactive protein|c reactive protein
5005713|NCT01609725|Periodontitis|periodontitis
5005714|NCT01609725|Periodontal therapy|periodontal therapy
5005715|NCT01609725|Flow-mediated dilation|flow-mediated dilation
5005716|NCT01609712|Improvement of lung function (FEV1, PEF)|improvement of lung function (fev1, pef)
5005717|NCT01609712|Visual Analog Scale|visual analog scale
5005718|NCT01609712|Oswestry Disability Index|oswestry disability index
5005719|NCT01609712|Radiographs pre and post Op|radiographs pre and post op
5005720|NCT01609699|body circumference|body circumference
5005721|NCT01609699|Non-Invasive Reduction|non-invasive reduction
5005722|NCT01609686|cardiac surgery|cardiac surgery
5005723|NCT01609686|renal dysfunction|renal dysfunction
5005724|NCT01609686|pharmacokinetics|pharmacokinetics
5005725|NCT01609686|tranexamic acid|tranexamic acid
5005726|NCT01609673|Immunosuppression|immunosuppression
5006327|NCT01607086|placebo|placebo
5005728|NCT01609673|Renal Transplant|renal transplant
5005729|NCT01609660|probiotics|probiotics
5005730|NCT01609660|cytokine|cytokine
5005731|NCT01609660|short chain fatty acids|short chain fatty acids
5005732|NCT01609660|complications|complications
5005733|NCT01609660|colorectal surgery|colorectal surgery
5005734|NCT01609647|High plate reactivity unit after loading dose of clopidogrel|high plate reactivity unit after loading dose of clopidogrel
5005735|NCT01609634|Healthy|healthy
5005736|NCT01609634|Term infants|term infants
5005737|NCT01609634|Growth|growth
5005738|NCT01609634|Body composition|body composition
5005739|NCT01609595|Thalassemia|thalassemia
5005740|NCT01609595|Anemia|anemia
5005741|NCT01609595|Fetal hemoglobin|fetal hemoglobin
5005742|NCT01609582|Drug therapy|drug therapy
5005743|NCT01609556|FOLR solid tumors|folr solid tumors
5005744|NCT01609530|verruca vulgaris|verruca vulgaris
5005745|NCT01609530|hands|hands
5005746|NCT01609530|feet|feet
5005747|NCT01609530|Nd:YAG|nd:yag
5005748|NCT01609530|laser|laser
5005749|NCT01609530|cryotherapy|cryotherapy
5005750|NCT01609517|Spinal anesthesia|spinal anesthesia
5005751|NCT01609517|determinant|determinant
5005752|NCT01609517|duration|duration
5005753|NCT01609504|Rectal cancer|rectal cancer
5005754|NCT01609504|Radiochemotherapy|radiochemotherapy
5005755|NCT01609504|Transanal Endoscopic Microsurgery|transanal endoscopic microsurgery
5005756|NCT01609504|Laparoscopic Resection|laparoscopic resection
5005757|NCT01609478|asthma|asthma
5005759|NCT01609465|stable angina|stable angina
5005760|NCT01609465|STEMI|stemi
5005761|NCT01609465|NSTEMI|nstemi
5005762|NCT01609465|CVD|cvd
5005763|NCT01609465|secondary prevention|secondary prevention
5005764|NCT01609452|Immune Thrombocytopenic Purpura|immune thrombocytopenic purpura
5005765|NCT01609452|Idiopathic Thrombocytopenic Purpura|idiopathic thrombocytopenic purpura
5005766|NCT01609452|Chronic ITP|chronic itp
5005767|NCT01609439|Permanent|permanent
5005768|NCT01609439|temporary|temporary
5005769|NCT01609439|hypocalcemia|hypocalcemia
5005770|NCT01609426|Proteinuria|proteinuria
5005771|NCT01609426|idiopathic|idiopathic
5005772|NCT01609426|nephrotic syndrome|nephrotic syndrome
5005773|NCT01609426|herpesvirus|herpesvirus
5005774|NCT01609426|epidemiology|epidemiology
5005775|NCT01609426|immune response|immune response
5005776|NCT01609426|interferon|interferon
5005777|NCT01609426|steroid dependency|steroid dependency
5005778|NCT01609426|nephrotic disease: Idiopathic nephrotic syndrome|nephrotic disease: idiopathic nephrotic syndrome
5005779|NCT01609387|Vitamine|vitamine
5005780|NCT01609387|mineral|mineral
5005781|NCT01609387|obese patients|obese patients
5005782|NCT01609387|Vitamine en mineral shortage in obese patients|vitamine en mineral shortage in obese patients
5005783|NCT01609374|Spinal Kinetics|spinal kinetics
5005784|NCT01609374|artificial cervical disc|artificial cervical disc
5005785|NCT01609374|cervical radiculopathy|cervical radiculopathy
5005786|NCT01609374|ACDF|acdf
5005787|NCT01609374|neck pain|neck pain
5005788|NCT01609374|cervical spine|cervical spine
5005789|NCT01609374|degenerative disc disease|degenerative disc disease
5005790|NCT01609361|Rehabilitation program|rehabilitation program
5005791|NCT01609361|Fast track surgery|fast track surgery
5005792|NCT01609361|Laparoscopic colorectal resection|laparoscopic colorectal resection
5005793|NCT01609361|Colorectal cancer|colorectal cancer
5005794|NCT01609361|Morbidity|morbidity
5005795|NCT01609348|Depression|depression
5005796|NCT01609348|Alzheimer's Disease|alzheimer's disease
5005797|NCT01609322|fear of falling|fear of falling
5005798|NCT01609322|agoraphobia|agoraphobia
5005799|NCT01609309|Stomach Neoplasms|stomach neoplasms
5005800|NCT01609309|Laparoscopy|laparoscopy
5005801|NCT01609296|Peripheral Arterial Disease|peripheral arterial disease
5005802|NCT01609296|Drug coated balloon|drug coated balloon
5005803|NCT01609296|Superficial Femoral Artery|superficial femoral artery
5005804|NCT01609296|Popliteal Femoral Artery|popliteal femoral artery
5005805|NCT01609296|Atherosclerosis|atherosclerosis
5005806|NCT01609244|Sleep apnea|sleep apnea
5005807|NCT01609244|central sleep apnea|central sleep apnea
5005808|NCT01609244|bilevel|bilevel
5005809|NCT01609244|servoventilation|servoventilation
5005810|NCT01609244|CPAP|cpap
5005811|NCT01609192|sickle-cell anemia|sickle-cell anemia
5005812|NCT01609192|spermatogenesis|spermatogenesis
5005813|NCT01609192|hydroxyurea|hydroxyurea
5005814|NCT01609166|Hand-foot Syndrome|hand-foot syndrome
5005815|NCT01609166|capecitabine|capecitabine
5005816|NCT01609166|allopurinol|allopurinol
5005817|NCT01609153|schizophrenia|schizophrenia
5005818|NCT01609153|amisulpride|amisulpride
5005819|NCT01609153|olanzapine|olanzapine
5005820|NCT01609153|polypharmacy|polypharmacy
5005821|NCT01609140|Hyperlipidemia|hyperlipidemia
5005822|NCT01609140|Dyslipidemia|dyslipidemia
5005823|NCT01609114|phenomena and mechanism of RT-PK|phenomena and mechanism of rt-pk
5005824|NCT01609114|fact for different anticancer drugs|fact for different anticancer drugs
5005825|NCT01609114|different part in human|different part in human
5005826|NCT01609101|Videolaryngoscopy|videolaryngoscopy
5005827|NCT01609101|Palatopharyngeal distance|palatopharyngeal distance
5005828|NCT01609101|Trauma|trauma
5005829|NCT01609088|endothelium|endothelium
5005830|NCT01609088|diabetes mellitus|diabetes mellitus
5005831|NCT01609088|oxidative stress|oxidative stress
5005832|NCT01609062|Mucopolysaccharidosis IVA Type A|mucopolysaccharidosis iva type a
5005833|NCT01609062|MPS IVA Type A|mps iva type a
5005834|NCT01609062|Mucopolysaccharidosis IVA|mucopolysaccharidosis iva
5005835|NCT01609062|MPS IVA|mps iva
5005836|NCT01609062|Morquio A Syndrome|morquio a syndrome
5005837|NCT01609062|Lysosomal Storage Disorder|lysosomal storage disorder
5005838|NCT01609062|LSD|lsd
5005839|NCT01609062|N-acetylgalactosamine-6-sulfatase|n-acetylgalactosamine-6-sulfatase
5005840|NCT01609062|N-acetylgalactosamine-6-sulfate|n-acetylgalactosamine-6-sulfate
5005841|NCT01609062|sulfatase|sulfatase
5005842|NCT01609062|galactose-6-sulfatase|galactose-6-sulfatase
5005843|NCT01609062|GALNS|galns
5005844|NCT01609062|enzyme replacement therapy|enzyme replacement therapy
5005845|NCT01609062|ERT|ert
5005846|NCT01609062|MOR-008|mor-008
5005847|NCT01609062|CPET|cpet
5005848|NCT01609062|MST|mst
5005849|NCT01609062|muscle strength test|muscle strength test
5005850|NCT01609062|physiological effect|physiological effect
5005851|NCT01608984|remote ischemic preconditioning|remote ischemic preconditioning
5005852|NCT01608984|coronary artery bypass grafting|coronary artery bypass grafting
5005853|NCT01608984|myocardial injury|myocardial injury
5005854|NCT01608971|Protamine|protamine
5005855|NCT01608971|heparin level|heparin level
5005856|NCT01608971|haemostasis|haemostasis
5005857|NCT01608971|thromboelastometry|thromboelastometry
5005858|NCT01608971|cardiac surgery|cardiac surgery
5005859|NCT01608971|Patients undergoing cardiac surgery|patients undergoing cardiac surgery
5005860|NCT01608958|Postpartum hemorrhage|postpartum hemorrhage
5005861|NCT01608958|Oxytocin|oxytocin
5005862|NCT01608958|Third stage of labor|third stage of labor
5005863|NCT01608958|Hemoglobin|hemoglobin
5005864|NCT01608958|Prevention|prevention
5005865|NCT01608958|Intravenous|intravenous
5005866|NCT01608958|Intramuscular|intramuscular
5005867|NCT01608945|steroid|steroid
5005868|NCT01608945|liver function|liver function
5005869|NCT01608945|prognosis|prognosis
5005870|NCT01608906|venous thrombosis|venous thrombosis
5005871|NCT01608906|heparin|heparin
5005872|NCT01608906|pulmonary embolism|pulmonary embolism
5005873|NCT01608906|ICU|icu
5005874|NCT01608867|Phase 1|phase 1
5005875|NCT01608867|dose escalation|dose escalation
5005876|NCT01608867|histologically confirmed|histologically confirmed
5005877|NCT01608867|malignancy|malignancy
5005878|NCT01608867|metastatic|metastatic
5005879|NCT01608854|surgical site infection|surgical site infection
5005880|NCT01608854|spinal surgery|spinal surgery
5005881|NCT01608854|prophylactic antibiotics|prophylactic antibiotics
5005882|NCT01608854|postoperative spinal drains|postoperative spinal drains
5005883|NCT01608815|Salmonella infections|salmonella infections
5005884|NCT01608815|Typhoid fever|typhoid fever
5005885|NCT01608815|Bacterial infections|bacterial infections
5005886|NCT01608815|Typhoid vaccine|typhoid vaccine
5005887|NCT01608802|HIV|hiv
5005888|NCT01608802|Antiretroviral therapy|antiretroviral therapy
5005889|NCT01608802|Palliative care|palliative care
5005890|NCT01608802|Pain|pain
5005891|NCT01608789|Male sling|male sling
5005892|NCT01608789|Stress Urinary Incontinence|stress urinary incontinence
5005893|NCT01608789|Urination Disorders|urination disorders
5005894|NCT01608789|Urologic Diseases|urologic diseases
5005895|NCT01608724|Type 2 DM|type 2 dm
5005896|NCT01608711|Gemcitabine|gemcitabine
5005897|NCT01608711|ASP6182|asp6182
5005898|NCT01608711|AGS-1C4D4|ags-1c4d4
5005899|NCT01608711|Pancreatic Cancer|pancreatic cancer
5005900|NCT01608698|chlormadinone acetate|chlormadinone acetate
5005901|NCT01608698|drospirenone|drospirenone
5005902|NCT01608698|contraceptive pills|contraceptive pills
5005903|NCT01608685|Tuberculosis|tuberculosis
5005904|NCT01608685|Latent tuberculosis infection|latent tuberculosis infection
5005905|NCT01608685|Immunosuppression|immunosuppression
5005906|NCT01608685|Renal transplant recipient|renal transplant recipient
5005907|NCT01608646|S-1|s-1
5005908|NCT01608646|Oxaliplatin|oxaliplatin
5005909|NCT01608646|Dihydropyrimidine Dehydrogenase|dihydropyrimidine dehydrogenase
5005910|NCT01608620|Systematic review and meta-analysis|systematic review and meta-analysis
5005911|NCT01608620|Evidence-based medicine (EBM)|evidence-based medicine (ebm)
5005912|NCT01608620|Evidence-based nutrition (EBN)|evidence-based nutrition (ebn)
5005913|NCT01608620|Clinical practice guidelines|clinical practice guidelines
5005914|NCT01608620|Clinical trials|clinical trials
5005915|NCT01608620|Dietary sugars|dietary sugars
5005916|NCT01608620|Fructose|fructose
5005917|NCT01608620|High fructose corn syrup|high fructose corn syrup
5005918|NCT01608620|Fruit|fruit
5005919|NCT01608620|Isocaloric|isocaloric
5005920|NCT01608620|Hypercaloric|hypercaloric
5005921|NCT01608620|Cardiometabolic risk factors|cardiometabolic risk factors
5005922|NCT01608620|Triglycerides|triglycerides
5005923|NCT01608620|Cholesterol|cholesterol
5005924|NCT01608620|Glycemic control|glycemic control
5005925|NCT01608620|Insulin resistance|insulin resistance
5005926|NCT01608620|Body weight|body weight
5005927|NCT01608620|Uric acid|uric acid
5005928|NCT01608620|Blood pressure|blood pressure
5005929|NCT01608607|Systematic review and meta-analysis|systematic review and meta-analysis
5005930|NCT01608607|Evidence-based medicine (EBM)|evidence-based medicine (ebm)
5005931|NCT01608607|Evidence-based nutrition (EBN)|evidence-based nutrition (ebn)
5005932|NCT01608607|Clinical practice guidelines|clinical practice guidelines
5005933|NCT01608607|Clinical trials|clinical trials
5005934|NCT01608607|Dietary sugars|dietary sugars
5005935|NCT01608607|Fructose|fructose
5005936|NCT01608607|High fructose corn syrup|high fructose corn syrup
5005937|NCT01608607|sucrose|sucrose
5005938|NCT01608607|Isocaloric|isocaloric
5005939|NCT01608607|Hypercaloric|hypercaloric
5005940|NCT01608607|Glycemic control|glycemic control
5005941|NCT01608607|Insulin resistance|insulin resistance
5005942|NCT01608607|Body weight|body weight
5005943|NCT01608607|body mass index|body mass index
5005944|NCT01608607|waist circumference|waist circumference
5005945|NCT01608581|prevention|prevention
5005946|NCT01608581|burn|burn
5005947|NCT01608581|adult|adult
5005948|NCT01608581|health promotion|health promotion
5005949|NCT01608581|evaluation|evaluation
5005950|NCT01608581|media|media
5005951|NCT01608568|Sutures|sutures
5005952|NCT01608568|Pelvic Organ Prolapse|pelvic organ prolapse
5005953|NCT01608568|Sacrocolpopexy|sacrocolpopexy
5005954|NCT01608568|Robotic Assisted Laparoscopy|robotic assisted laparoscopy
5005955|NCT01608555|cystic fibrosis|cystic fibrosis
5005956|NCT01608555|bacterial load|bacterial load
5005957|NCT01608555|inhaled tobramycin|inhaled tobramycin
5005958|NCT01608542|fostamatinib|fostamatinib
5005959|NCT01608542|FosD|fosd
5005960|NCT01608542|Japanese Healthy volunteers|japanese healthy volunteers
5005961|NCT01608542|Phase 1|phase 1
5005962|NCT01608542|Single and Multiple Dose Study|single and multiple dose study
5005963|NCT01608529|Restriction device ventilatory nasal flow|restriction device ventilatory nasal flow
5005964|NCT01608529|oronasal breathing|oronasal breathing
5005965|NCT01608529|nasal breathing.|nasal breathing.
5005966|NCT01608516|PET/CT|pet/ct
5005967|NCT01608516|68Ga-NODAGA-RGD|68ga-nodaga-rgd
5005968|NCT01608516|18F-FDG|18f-fdg
5005969|NCT01608516|MRI|mri
5005970|NCT01608516|US ultrasound|us ultrasound
5005971|NCT01608516|inflammatory atheromatous plaque|inflammatory atheromatous plaque
5005972|NCT01608516|endarterectomy|endarterectomy
5005973|NCT01608503|subclavian vein|subclavian vein
5005974|NCT01608503|ultrasound|ultrasound
5005975|NCT01608503|distance between the subclavian vein and the lung|distance between the subclavian vein and the lung
5005976|NCT01608490|COPD|copd
5005977|NCT01608490|RePneu|repneu
5005978|NCT01608477|Heart transplantation|heart transplantation
5005979|NCT01608477|Medication adherence|medication adherence
5005980|NCT01608477|Behavior system factor|behavior system factor
5005981|NCT01608464|Randomized trial,|randomized trial,
5005982|NCT01608464|Pre-operative chemo-RT with CDDP and 5-FU|pre-operative chemo-rt with cddp and 5-fu
5005983|NCT01608464|Multicenter study|multicenter study
5005984|NCT01608438|Body-machine interface|body-machine interface
5005985|NCT01608438|Customization|customization
5005986|NCT01608438|Upper-body motion|upper-body motion
5005987|NCT01608438|Motor learning|motor learning
5005988|NCT01608438|Assistive Devices|assistive devices
5005989|NCT01608438|Wheelchair|wheelchair
5005990|NCT01608438|Computer keyboard|computer keyboard
5005991|NCT01608425|diabetic foot ulcer|diabetic foot ulcer
5005992|NCT01608425|ulcer monitoring|ulcer monitoring
5005993|NCT01608425|telemedicine consultations|telemedicine consultations
5005994|NCT01608425|cross-sectoral collaboration|cross-sectoral collaboration
5005995|NCT01608412|renal transplantation|renal transplantation
5005996|NCT01608412|everolimus|everolimus
5005997|NCT01608412|tacrolimus|tacrolimus
5005998|NCT01608412|molecular evaluation|molecular evaluation
5005999|NCT01608399|major depressive disorder|major depressive disorder
5006000|NCT01608399|psychotherapy|psychotherapy
5006001|NCT01608399|metacognitive therapy|metacognitive therapy
5006002|NCT01608386|Anterior approach|anterior approach
5006003|NCT01608386|infrahepatic inferior vena cava clamping|infrahepatic inferior vena cava clamping
5006004|NCT01608386|hepatic resection|hepatic resection
5006005|NCT01608373|Pain|pain
5006006|NCT01608373|Lidocaine|lidocaine
5006007|NCT01608373|Intravenous|intravenous
5006008|NCT01608373|Intraperitoneum|intraperitoneum
5006009|NCT01608373|Laparoscopic cholecystectomy|laparoscopic cholecystectomy
5006010|NCT01608360|Pain|pain
5006011|NCT01608360|Lidocaine|lidocaine
5006012|NCT01608360|Intravenous|intravenous
5006013|NCT01608360|Thyroidectomy|thyroidectomy
5006014|NCT01608347|LMWH|lmwh
5006015|NCT01608347|enoxaparin|enoxaparin
5006016|NCT01608347|recurrent miscarriage|recurrent miscarriage
5006017|NCT01608347|continuing fetal viability beyond 20 weeks gestation|continuing fetal viability beyond 20 weeks gestation
5006018|NCT01608321|Chronic Pain|chronic pain
5006019|NCT01608321|Gulf War Illness|gulf war illness
5006020|NCT01608321|Gulf War Syndrome|gulf war syndrome
5006021|NCT01608321|Fibromyalgia|fibromyalgia
5006022|NCT01608321|repetitive Transcranial Magnetic Stimulation|repetitive transcranial magnetic stimulation
5006023|NCT01608321|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
5006024|NCT01608321|Veterans|veterans
5006025|NCT01608308|Chronic Sinusitis|chronic sinusitis
5006026|NCT01608308|Pain Relief|pain relief
5006027|NCT01608308|Post-Operative Opioid Requirement|post-operative opioid requirement
5006028|NCT01608308|IV Acetaminophen|iv acetaminophen
5006029|NCT01608308|Functional Endoscopic Sinus Surgery|functional endoscopic sinus surgery
5006030|NCT01608308|FESS|fess
5006031|NCT01608295|depressed|depressed
5006032|NCT01608295|geriatric|geriatric
5006033|NCT01608295|older adults|older adults
5006034|NCT01608295|antidepressants|antidepressants
5006035|NCT01608295|depression|depression
5006036|NCT01608295|anxious|anxious
5006037|NCT01608295|major depressive disorder|major depressive disorder
5006038|NCT01608295|MDD|mdd
5006039|NCT01608282|Osteoarthritis|osteoarthritis
5006040|NCT01608282|Arthritis|arthritis
5006041|NCT01608282|Knee|knee
5006042|NCT01608282|Exercise|exercise
5006043|NCT01608282|Physical Activity|physical activity
5006044|NCT01608282|Web-based|web-based
5006045|NCT01608256|mild cognitive impairment|mild cognitive impairment
5006046|NCT01608256|Automobile Driving|automobile driving
5006047|NCT01608256|cognitive aspects|cognitive aspects
5006048|NCT01608217|Behavioural disturbances|behavioural disturbances
5006049|NCT01608217|Pain|pain
5006050|NCT01608217|Dementia|dementia
5006051|NCT01608217|Alzheimer's dementia|alzheimer's dementia
5006052|NCT01608217|Vascular dementia|vascular dementia
5006053|NCT01608217|THC|thc
5006054|NCT01608217|Cannabis|cannabis
5006055|NCT01608204|Pharmacokinetics|pharmacokinetics
5006056|NCT01608204|Busulfan|busulfan
5006057|NCT01608204|Polymorphism|polymorphism
5006058|NCT01608204|GST|gst
5006059|NCT01608204|MDR-1(p-Glycoprotein)|mdr-1(p-glycoprotein)
5006060|NCT01608204|Acute Myeloid Leukemia adult patients|acute myeloid leukemia adult patients
5006061|NCT01608178|Pediatric Neurotransmitter Disorders|pediatric neurotransmitter disorders
5006062|NCT01608178|Succinic Semialdehyde Dehydrogenase|succinic semialdehyde dehydrogenase
5006063|NCT01608178|GABA|gaba
5006064|NCT01608178|Epilepsy|epilepsy
5006065|NCT01608165|Small renal cancer mass|small renal cancer mass
5006066|NCT01608152|Leukemia|leukemia
5006067|NCT01608152|Lymphoma|lymphoma
5006068|NCT01608152|Game mechanics|game mechanics
5006069|NCT01608152|Stem cell transplant survivors|stem cell transplant survivors
5006070|NCT01608152|Hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
5006071|NCT01608152|HSCT|hsct
5006072|NCT01608152|Internet-based|internet-based
5006073|NCT01608152|Interactive and personalized intervention|interactive and personalized intervention
5006074|NCT01608152|Questionnaires|questionnaires
5006075|NCT01608152|Focus groups|focus groups
5006076|NCT01608152|Interviews|interviews
5006077|NCT01608139|Advanced Cancers|advanced cancers
5006078|NCT01608139|Advanced Solid Tumors|advanced solid tumors
5006079|NCT01608139|Curcumin|curcumin
5006080|NCT01608139|Sorafenib|sorafenib
5006081|NCT01608139|Nexavar|nexavar
5006082|NCT01608139|Bay 43-9006|bay 43-9006
5006083|NCT01608139|Vorinostat|vorinostat
5006084|NCT01608139|SAHA|saha
5006085|NCT01608139|Suberoylanilide Hydroxamic Acid|suberoylanilide hydroxamic acid
5006086|NCT01608139|MSK-390|msk-390
5006087|NCT01608139|Zolinza|zolinza
5006088|NCT01608126|Ultrasound|ultrasound
5006089|NCT01608126|Cervical Plexus|cervical plexus
5006090|NCT01608126|Anesthesia, Conduction|anesthesia, conduction
5006091|NCT01608126|Surgical Procedures, Elective|surgical procedures, elective
5006092|NCT01608126|Atherectomy|atherectomy
5006093|NCT01608113|neovascular AMD|neovascular amd
5006094|NCT01608113|Optical coherence tomography|optical coherence tomography
5006095|NCT01608113|reading acuity|reading acuity
5006096|NCT01608113|contrast sensitivity|contrast sensitivity
5006097|NCT01608074|BRCA1|brca1
5006098|NCT01608074|BRCA2|brca2
5006099|NCT01608074|Prophylactic surgery|prophylactic surgery
5006100|NCT01608074|Salpingectomy|salpingectomy
5006101|NCT01608074|Fimbriectomy|fimbriectomy
5006102|NCT01608061|Mild probable Alzheimer's Disease|mild probable alzheimer's disease
5006103|NCT01608048|In-vitro Fertilization|in-vitro fertilization
5006104|NCT01608048|transcutaneous electrical acupoint stimulation|transcutaneous electrical acupoint stimulation
5006105|NCT01608035|sciatic catheter|sciatic catheter
5006106|NCT01608035|stump catheter|stump catheter
5006107|NCT01608035|below knee amputation|below knee amputation
5006108|NCT01608009|platinum resistant|platinum resistant
5006109|NCT01608009|ovarian cancer|ovarian cancer
5006110|NCT01607996|Epidural anesthesia|epidural anesthesia
5006111|NCT01607996|pancreatic perfusion|pancreatic perfusion
5006112|NCT01607996|pancreatic necrosectomy|pancreatic necrosectomy
5006113|NCT01607983|nitric oxide|nitric oxide
5006114|NCT01607983|ventricular-arterial coupling|ventricular-arterial coupling
5006115|NCT01607983|congenital heart disease|congenital heart disease
5006116|NCT01607970|Oxytocin|oxytocin
5006117|NCT01607970|Startle|startle
5006118|NCT01607970|moral dilemma|moral dilemma
5006119|NCT01607970|oxytocin receptor gene|oxytocin receptor gene
5006120|NCT01607957|Refractory, metastatic colorectal cancer|refractory, metastatic colorectal cancer
5006121|NCT01607931|Exercise|exercise
5006122|NCT01607931|Physical activity|physical activity
5006123|NCT01607931|Type 2 diabetes|type 2 diabetes
5006124|NCT01607931|Obesity|obesity
5006125|NCT01607931|Incretin effect|incretin effect
5006126|NCT01607931|GLP-1|glp-1
5006127|NCT01607931|GIP|gip
5006128|NCT01607931|Insulin secretion|insulin secretion
5006129|NCT01607931|Glucagon|glucagon
5006130|NCT01607931|Beta-cell function|beta-cell function
5006131|NCT01607931|Disposition Index|disposition index
5006132|NCT01607918|H pylori, eradication|h pylori, eradication
5006133|NCT01607905|Selinexor|selinexor
5006134|NCT01607905|KPT-330|kpt-330
5006135|NCT01607905|Squamous Cell Carcinoma|squamous cell carcinoma
5006136|NCT01607905|Glioblastoma multiforme|glioblastoma multiforme
5006137|NCT01607905|Adenocarcinoma|adenocarcinoma
5006138|NCT01607905|Melanoma|melanoma
5006139|NCT01607892|Selinexor|selinexor
5006140|NCT01607892|KPT-330|kpt-330
5006141|NCT01607892|Multiple Myeloma|multiple myeloma
5006142|NCT01607892|non-Hodgkin Lymphoma|non-hodgkin lymphoma
5006143|NCT01607892|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
5006144|NCT01607892|Waldenström's macroglobulinemia|waldenström's macroglobulinemia
5006145|NCT01607892|Peripheral T-Cell Lymphoma|peripheral t-cell lymphoma
5006146|NCT01607892|Cutaneous T-Cell Lymphoma|cutaneous t-cell lymphoma
5006147|NCT01607892|Chronic Myelocytic Leukemia|chronic myelocytic leukemia
5006148|NCT01607892|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
5006149|NCT01607879|Prostate Cancer|prostate cancer
5006150|NCT01607879|Men|men
5006151|NCT01607879|Androgen Deprivation Therapy|androgen deprivation therapy
5006152|NCT01607879|Elderly|elderly
5006153|NCT01607879|Geriatric|geriatric
5006154|NCT01607879|Nutritional supplementation|nutritional supplementation
5006155|NCT01607840|Schizophrenia|schizophrenia
5006156|NCT01607840|Cognitive Improvement|cognitive improvement
5006157|NCT01607840|tDCS|tdcs
5006158|NCT01607840|stimulation|stimulation
5006159|NCT01607827|polypectomy|polypectomy
5006160|NCT01607827|colonoscopy|colonoscopy
5006161|NCT01607827|polyp miss rate|polyp miss rate
5006162|NCT01607827|surveillance|surveillance
5006163|NCT01607827|colorectal cancer|colorectal cancer
5006164|NCT01607814|cirrhosis|cirrhosis
5006165|NCT01607814|oxidative stress|oxidative stress
5006166|NCT01607814|NADPH oxidase|nadph oxidase
5006167|NCT01607814|isoprostanes|isoprostanes
5006168|NCT01607814|PUFA balance|pufa balance
5006169|NCT01607814|platelet activation|platelet activation
5006170|NCT01607814|coagulation abnormalities|coagulation abnormalities
5006171|NCT01607801|umbilical hernia repair|umbilical hernia repair
5006172|NCT01607801|recurrence|recurrence
5006173|NCT01607801|choice of suture|choice of suture
5006174|NCT01607801|mesh|mesh
5006175|NCT01607801|mesh/non-mesh|mesh/non-mesh
5006176|NCT01607788|Selection criteria|selection criteria
5006177|NCT01607788|Liver transplantation|liver transplantation
5006178|NCT01607788|Hepatocellular carcinoma|hepatocellular carcinoma
5006179|NCT01607762|Healthy|healthy
5006180|NCT01607762|Antipsychotics|antipsychotics
5006181|NCT01607762|Aripiprazole|aripiprazole
5006182|NCT01607762|Paliperidone|paliperidone
5006183|NCT01607762|Risperidone|risperidone
5006184|NCT01607762|Quetiapine|quetiapine
5006185|NCT01607762|Olanzapine|olanzapine
5006186|NCT01607749|Asthma Control|asthma control
5006187|NCT01607749|Quality of life|quality of life
5006188|NCT01607749|Children|children
5006189|NCT01607749|Asthma education|asthma education
5006190|NCT01607736|falls|falls
5006191|NCT01607736|walking|walking
5006192|NCT01607736|healthy older individuals|healthy older individuals
5006193|NCT01607736|virtual gait training|virtual gait training
5006194|NCT01607723|Sleep pattern|sleep pattern
5006195|NCT01607723|Mechanical ventilation|mechanical ventilation
5006196|NCT01607723|weaning|weaning
5006197|NCT01607723|Intensive Care|intensive care
5006198|NCT01607723|NAVA (Neurally Adjusted Ventilatory Assist)|nava (neurally adjusted ventilatory assist)
5006199|NCT01607723|PAV+ (Proportional Assist Ventilation Plus)|pav+ (proportional assist ventilation plus)
5006200|NCT01607710|fMRI|fmri
5006201|NCT01607710|Generalized Anxiety Disorder|generalized anxiety disorder
5006202|NCT01607697|Parkinson's Disease|parkinson's disease
5006203|NCT01607671|Ischemic|ischemic
5006204|NCT01607671|Optic Neuropathy|optic neuropathy
5006205|NCT01607671|Non-Arteritic Anterior Ischemic Optic Neuropathy|non-arteritic anterior ischemic optic neuropathy
5006206|NCT01607671|NAION|naion
5006207|NCT01607671|Ischemic Optic Neuropathy|ischemic optic neuropathy
5006208|NCT01607671|Intraocular Pressure|intraocular pressure
5006209|NCT01607658|Testosterone|testosterone
5006210|NCT01607632|posttraumatic stress|posttraumatic stress
5006211|NCT01607632|depression|depression
5006212|NCT01607619|CRP|crp
5006213|NCT01607593|Retrospective|retrospective
5006214|NCT01607593|Sertraline|sertraline
5006215|NCT01607593|Posttraumatic stress disorder|posttraumatic stress disorder
5006216|NCT01607554|Lung|lung
5006217|NCT01607554|non small cell|non small cell
5006218|NCT01607554|NSCLC|nsclc
5006219|NCT01607554|Irinotecan|irinotecan
5006220|NCT01607541|HIV/AIDS|hiv/aids
5006221|NCT01607541|vulnerable populations|vulnerable populations
5006222|NCT01607541|heterosexuals at high risk|heterosexuals at high risk
5006223|NCT01607541|peer-driven intervention|peer-driven intervention
5006224|NCT01607541|tailored intervention|tailored intervention
5006225|NCT01607541|African-American|african-american
5006226|NCT01607541|Latino/Hispanic|latino/hispanic
5006227|NCT01607541|Seek, test, treat, and retain (STTR)|seek, test, treat, and retain (sttr)
5006228|NCT01607515|Pulmonary hypertension|pulmonary hypertension
5006229|NCT01607515|Cardiac index|cardiac index
5006230|NCT01607515|impedance cardiography|impedance cardiography
5006231|NCT01607502|Pulmonary hypertension|pulmonary hypertension
5006232|NCT01607502|database|database
5006233|NCT01607502|biomarker|biomarker
5006234|NCT01607489|Early diagnosis of pulmonary arterial hypertension|early diagnosis of pulmonary arterial hypertension
5006235|NCT01607489|dynamic dual-energy computed tomography|dynamic dual-energy computed tomography
5006236|NCT01607463|pain|pain
5006237|NCT01607463|transcutaneous electrical nerve stimulation|transcutaneous electrical nerve stimulation
5006238|NCT01607450|Type 2 diabetes mellitus|type 2 diabetes mellitus
5006239|NCT01607450|lean healthy control|lean healthy control
5006240|NCT01607424|cognitive rehabilitation|cognitive rehabilitation
5006241|NCT01607424|schizophrenia|schizophrenia
5006242|NCT01607398|Japan|japan
5006243|NCT01607398|COPD|copd
5006244|NCT01607398|CAT|cat
5006245|NCT01607398|placebo|placebo
5006246|NCT01607398|serum|serum
5006247|NCT01607398|Adoair250|adoair250
5006248|NCT01607398|anti-inflammatory|anti-inflammatory
5006249|NCT01607398|sputum|sputum
5006250|NCT01607385|pharmacokinetic|pharmacokinetic
5006251|NCT01607385|intestinal bile acid transporter inhibitor|intestinal bile acid transporter inhibitor
5006252|NCT01607385|GSK2330672|gsk2330672
5006253|NCT01607385|pharmacodynamic|pharmacodynamic
5006254|NCT01607385|GSK1614235|gsk1614235
5006255|NCT01607385|dose escalation|dose escalation
5006256|NCT01607372|TLR7 agonist, Respiratory Allergies, Allergic Rhinitis, Mild Allergic Asthma, Repeat Dose Safety, Reduction of Allergic Reactivity|tlr7 agonist, respiratory allergies, allergic rhinitis, mild allergic asthma, repeat dose safety, reduction of allergic reactivity
5006257|NCT01607359|atrial fibrillation|atrial fibrillation
5006258|NCT01607359|catheter ablation|catheter ablation
5006259|NCT01607359|dabigatran|dabigatran
5006260|NCT01607359|warfarin|warfarin
5006261|NCT01607359|oral anticoagulation|oral anticoagulation
5006262|NCT01607346|Urinary Retention|urinary retention
5006263|NCT01607333|Antiepileptics|antiepileptics
5006264|NCT01607333|suicidality|suicidality
5006265|NCT01607320|PCOS|pcos
5006266|NCT01607320|Infertility|infertility
5006267|NCT01607320|Anovulation|anovulation
5006268|NCT01607307|daikenchuto|daikenchuto
5006269|NCT01607307|postoperative ileus|postoperative ileus
5006270|NCT01607307|pancreaticoduodenectomy|pancreaticoduodenectomy
5006271|NCT01607281|anatomical landmark|anatomical landmark
5006272|NCT01607281|internal jugular vein canulation|internal jugular vein canulation
5006273|NCT01607268|autonomic failure|autonomic failure
5006274|NCT01607268|mangenetic resonance|mangenetic resonance
5006275|NCT01607268|neurochemistry|neurochemistry
5006276|NCT01607268|neurotransmitter|neurotransmitter
5006277|NCT01607268|glutamate|glutamate
5006278|NCT01607255|adenoma detection|adenoma detection
5006279|NCT01607255|screening colonoscopy|screening colonoscopy
5006280|NCT01607255|water exchange method|water exchange method
5006281|NCT01607255|chromoendoscopy|chromoendoscopy
5006282|NCT01607242|total thyroidectomy|total thyroidectomy
5006283|NCT01607242|voice handicap index|voice handicap index
5006284|NCT01607242|swallowing disorders|swallowing disorders
5006285|NCT01607242|thyroid surgery|thyroid surgery
5006286|NCT01607242|voice disorders|voice disorders
5006287|NCT01607229|multi-frequency|multi-frequency
5006288|NCT01607229|bioelectrical impedance|bioelectrical impedance
5006289|NCT01607229|body composition|body composition
5006290|NCT01607229|hydration|hydration
5006291|NCT01607216|Prematurity|prematurity
5006292|NCT01607216|Respiratory Illness|respiratory illness
5006293|NCT01607216|Lung Function|lung function
5006294|NCT01607216|Lung Disease|lung disease
5006295|NCT01607203|ovarian hyper stimulation syndrome (OHSS)|ovarian hyper stimulation syndrome (ohss)
5006296|NCT01607203|metaphase II oocytes (MII)|metaphase ii oocytes (mii)
5006297|NCT01607203|good quality embryo's|good quality embryo's
5006298|NCT01607203|implantation|implantation
5006299|NCT01607203|pregnancy|pregnancy
5006300|NCT01607190|type 2 diabetes mellitus|type 2 diabetes mellitus
5006301|NCT01607190|nonproliferative diabetic retinopathy|nonproliferative diabetic retinopathy
5006302|NCT01607164|Mood management|mood management
5006303|NCT01607164|self-help|self-help
5006304|NCT01607164|depression|depression
5006305|NCT01607164|prevention|prevention
5006306|NCT01607164|cognitive behavioral|cognitive behavioral
5006307|NCT01607151|hypothermia|hypothermia
5006308|NCT01607151|normothermia|normothermia
5006309|NCT01607151|hyperthermia|hyperthermia
5006310|NCT01607138|laryngectomy|laryngectomy
5006311|NCT01607138|swallowing disturbances|swallowing disturbances
5006312|NCT01607138|speech disturbances|speech disturbances
5006313|NCT01607138|speech intelligibility|speech intelligibility
5006314|NCT01607138|voice prothesis|voice prothesis
5006315|NCT01607112|Influenza|influenza
5006316|NCT01607112|Healthy|healthy
5006317|NCT01607112|Immunogenicity|immunogenicity
5006318|NCT01607112|Elderly|elderly
5006319|NCT01607112|Safety|safety
5006320|NCT01607112|Adults|adults
5006321|NCT01607099|colonoscopy|colonoscopy
5006322|NCT01607099|bowel cleansing|bowel cleansing
5006323|NCT01607099|bowel cleanness|bowel cleanness
5006324|NCT01607099|efficiency|efficiency
5006325|NCT01607099|compatibility|compatibility
5006326|NCT01607086|Lamotrigine|lamotrigine
5006329|NCT01607086|characteristics|characteristics
5006330|NCT01607073|Dravet|dravet
5006331|NCT01607073|seizures|seizures
5006332|NCT01607073|verapamil|verapamil
5006333|NCT01607060|Critically ill patients|critically ill patients
5006334|NCT01607060|intestinal failure|intestinal failure
5006335|NCT01607047|leptospirosis|leptospirosis
5006336|NCT01607047|qPCR|qpcr
5006337|NCT01607047|cohort|cohort
5006338|NCT01607047|french west indies|french west indies
5006339|NCT01607047|blood sample collection|blood sample collection
5006340|NCT01607047|pronostic|pronostic
5006341|NCT01607047|diagnosis|diagnosis
5006342|NCT01607021|Chronic hepatitis C|chronic hepatitis c
5006343|NCT01607021|interleukin 28|interleukin 28
5006344|NCT01607021|Children|children
5006345|NCT01606995|Stroke|stroke
5006346|NCT01606995|Embolism|embolism
5006347|NCT01606995|Atrial fibrillation|atrial fibrillation
5006348|NCT01606982|prostate|prostate
5006349|NCT01606982|MDV3100|mdv3100
5006350|NCT01606982|cancer|cancer
5006351|NCT01606969|Dexmedetomidine|dexmedetomidine
5006352|NCT01606969|epinephrine|epinephrine
5006353|NCT01606969|lidocaine|lidocaine
5006354|NCT01606969|scalp infiltration|scalp infiltration
5006355|NCT01606969|craniotomy|craniotomy
5006356|NCT01606943|Aortic dissection|aortic dissection
5006357|NCT01606943|Risk factor|risk factor
5006358|NCT01606943|Feature|feature
5006359|NCT01606943|Management|management
5006360|NCT01606943|Outcome|outcome
5006361|NCT01606930|Patient Satisfaction|patient satisfaction
5006362|NCT01606930|Patient Doctor Communication|patient doctor communication
5006363|NCT01606930|Shared Decision Making|shared decision making
5006364|NCT01606930|Patient Activation|patient activation
5006365|NCT01606891|preschooler obesity prevention|preschooler obesity prevention
5006366|NCT01606891|community home visiting parents|community home visiting parents
5006367|NCT01606891|preschooler excess BMI gain|preschooler excess bmi gain
5006368|NCT01606891|multi-setting/component intervention|multi-setting/component intervention
5006369|NCT01606852|sedation|sedation
5006370|NCT01606852|mechanical ventilation|mechanical ventilation
5006371|NCT01606852|anxiety|anxiety
5006372|NCT01606852|respiratory failure|respiratory failure
5006373|NCT01606826|Severe|severe
5006374|NCT01606787|Kidney|kidney
5006375|NCT01606787|MANNITOL|mannitol
5006376|NCT01606787|PLACEBO|placebo
5006377|NCT01606787|Partial Nephrectomy|partial nephrectomy
5006378|NCT01606787|12-079|12-079
5006379|NCT01606761|Arthritis, Rheumatoid|arthritis, rheumatoid
5006380|NCT01606761|Active rheumatoid arthritis despite anti-TNF-alpha therapy|active rheumatoid arthritis despite anti-tnf-alpha therapy
5006381|NCT01606761|Sirukumab|sirukumab
5006382|NCT01606761|Human Anti-IL-6 monoclonal antibody|human anti-il-6 monoclonal antibody
5006383|NCT01606748|Advanced Malignant Solid Tumors|advanced malignant solid tumors
5006384|NCT01606748|Solid Cancers|solid cancers
5006385|NCT01606748|Non-small Cell Lung Cancer|non-small cell lung cancer
5006386|NCT01606748|NSCLC|nsclc
5006387|NCT01606748|Breast Cancer|breast cancer
5006388|NCT01606735|cataract surgery|cataract surgery
5006389|NCT01606735|ocular inflammation|ocular inflammation
5006390|NCT01606722|Antiretroviral therapy|antiretroviral therapy
5006391|NCT01606722|Boosted-Darunavir monotherapy|boosted-darunavir monotherapy
5006392|NCT01606722|Resistance|resistance
5006393|NCT01606722|Proviral DNA-HIV|proviral dna-hiv
5006394|NCT01606709|GnRHa trigger|gnrha trigger
5006395|NCT01606709|endometrial gene profile|endometrial gene profile
5006396|NCT01606709|quality of life|quality of life
5006397|NCT01606696|CAD|cad
5006398|NCT01606696|cardiac rehabilitation|cardiac rehabilitation
5006399|NCT01606696|fitness|fitness
5006400|NCT01606683|Acidified milk|acidified milk
5006401|NCT01606683|Beta-palmitate|beta-palmitate
5006402|NCT01606683|Bifidobacteria|bifidobacteria
5006403|NCT01606683|Breastfeeding|breastfeeding
5006404|NCT01606683|Infant formula|infant formula
5006405|NCT01606683|Galacto-oligosaccharides|galacto-oligosaccharides
5006406|NCT01606683|Growth|growth
5006407|NCT01606683|Infants|infants
5006408|NCT01606683|Metabolomics|metabolomics
5006409|NCT01606683|Prebiotics|prebiotics
5006410|NCT01606670|Rotigotine|rotigotine
5006411|NCT01606670|Neupro®|neupro®
5006412|NCT01606657|I&D|i&d
5006413|NCT01606657|Abscess|abscess
5006414|NCT01606657|Irrigation|irrigation
5006415|NCT01606657|Cutaneous Abscess|cutaneous abscess
5006416|NCT01606644|radiation sequelae|radiation sequelae
5006417|NCT01606644|hyperbaric oxygen|hyperbaric oxygen
5006418|NCT01606631|severe sepsis|severe sepsis
5006419|NCT01606631|toxic shock|toxic shock
5006420|NCT01606618|Self-esteem|self-esteem
5006421|NCT01606618|Spina Bifida|spina bifida
5006422|NCT01606618|Spinal cord injury|spinal cord injury
5006423|NCT01606605|Lymphoma|lymphoma
5006424|NCT01606605|Prognosis|prognosis
5006425|NCT01606605|Relapse|relapse
5006426|NCT01606605|Gene|gene
5006427|NCT01606605|microRNA|microrna
5006428|NCT01606579|Leukemia|leukemia
5006429|NCT01606579|acute myeloid leukemia|acute myeloid leukemia
5006430|NCT01606579|AML|aml
5006431|NCT01606579|chronic myeloid leukemia|chronic myeloid leukemia
5006432|NCT01606579|CML|cml
5006433|NCT01606579|MDS|mds
5006434|NCT01606579|myelodysplastic syndrome|myelodysplastic syndrome
5006435|NCT01606579|myeloproliferative neoplasia|myeloproliferative neoplasia
5006436|NCT01606579|MPN|mpn
5006437|NCT01606566|Recurrent|recurrent
5006438|NCT01606566|Head and Neck|head and neck
5006439|NCT01606566|Neoplasms|neoplasms
5006440|NCT01606566|Squamous Cell Carcinoma|squamous cell carcinoma
5006441|NCT01606566|Amphinex|amphinex
5006442|NCT01606566|Cancer|cancer
5006443|NCT01606566|Photodynamic therapy|photodynamic therapy
5006444|NCT01606566|Chemotherapy|chemotherapy
5006445|NCT01606566|Bleomycin|bleomycin
5006446|NCT01606553|chronic heart failure|chronic heart failure
5006447|NCT01606553|respiratory muscle weakness|respiratory muscle weakness
5006448|NCT01606553|inspiratory muscle training|inspiratory muscle training
5006449|NCT01606540|Colles fracture|colles fracture
5006450|NCT01606540|Non-steroid antiinflammatory drugs|non-steroid antiinflammatory drugs
5006451|NCT01606540|Bone healing|bone healing
5006452|NCT01606527|Spectrum of Altitude-associated acute mountain sickness|spectrum of altitude-associated acute mountain sickness
5006453|NCT01606527|hypoxia|hypoxia
5006454|NCT01606527|high altitude headache|high altitude headache
5006455|NCT01606527|high altitude cerebral edemat is.....|high altitude cerebral edemat is.....
5006456|NCT01606488|Postoperative Cognitive Dysfunction|postoperative cognitive dysfunction
5006457|NCT01606488|Postoperative Cognitive Decline|postoperative cognitive decline
5006458|NCT01606488|POCD|pocd
5006459|NCT01606488|Alzheimer's disease|alzheimer's disease
5006460|NCT01606488|Florbetapir F 18 (18F-AV-45)|florbetapir f 18 (18f-av-45)
5006461|NCT01606475|Islet transplant|islet transplant
5006462|NCT01606475|Diabetes Mellitus|diabetes mellitus
5006463|NCT01606475|Hypoglycemia|hypoglycemia
5006464|NCT01606462|oxytocin|oxytocin
5006465|NCT01606462|social cognition|social cognition
5006466|NCT01606462|fMRI|fmri
5006467|NCT01606462|oxytocin receptor gene|oxytocin receptor gene
5006468|NCT01606449|Gastroesophageal reflux diseases|gastroesophageal reflux diseases
5006469|NCT01606449|Hiatal Hernia|hiatal hernia
5006470|NCT01606449|Paraesophageal Hernia|paraesophageal hernia
5006471|NCT01606358|Ovarian Cancer|ovarian cancer
5006472|NCT01606358|Patient with ovarian cancer|patient with ovarian cancer
5006473|NCT01606345|Upper Tract Urothelial Carcinoma|upper tract urothelial carcinoma
5006474|NCT01606345|UTUC|utuc
5006475|NCT01606345|Kidney|kidney
5006476|NCT01606345|Cancer|cancer
5006477|NCT01606345|Renal|renal
5006478|NCT01606319|Asthma|asthma
5006479|NCT01606319|Wheezing|wheezing
5006480|NCT01606319|Ibuprofen|ibuprofen
5006481|NCT01606319|Acetaminophen|acetaminophen
5006482|NCT01606319|exacerbations|exacerbations
5006483|NCT01606319|pain|pain
5006484|NCT01606319|fever|fever
5006485|NCT01606306|Asthma|asthma
5006486|NCT01606306|Wheezing|wheezing
5006487|NCT01606306|Fluticasone|fluticasone
5006488|NCT01606306|Montelukast|montelukast
5006489|NCT01606306|Preschool-age|preschool-age
5006490|NCT01606293|Small cell carcinomas of the cervix|small cell carcinomas of the cervix
5006491|NCT01606293|Large cell carcinomas of the cervix|large cell carcinomas of the cervix
5006492|NCT01606293|Online surveys|online surveys
5006493|NCT01606293|Electronic surveys|electronic surveys
5006494|NCT01606293|Questionnaires|questionnaires
5006495|NCT01606293|Facebook|facebook
5006496|NCT01606293|Social networking support groups|social networking support groups
5006497|NCT01606280|Amyloidosis|amyloidosis
5006498|NCT01606267|Integrated Community Case Management|integrated community case management
5006499|NCT01606267|Pneumonia|pneumonia
5006500|NCT01606267|Ethiopia|ethiopia
5006501|NCT01606254|Schizophrenia|schizophrenia
5006502|NCT01606254|Paliperidone Palmitate|paliperidone palmitate
5006503|NCT01606254|JNS010|jns010
5006504|NCT01606228|Schizophrenia|schizophrenia
5006505|NCT01606228|Paliperidone ER|paliperidone er
5006506|NCT01606228|Treatment naive patients|treatment naive patients
5006507|NCT01606228|Newly diagnosed patients|newly diagnosed patients
5006508|NCT01606215|multiple sclerosis|multiple sclerosis
5006509|NCT01606215|mesenchymal stem cells|mesenchymal stem cells
5006510|NCT01606215|bone marrow|bone marrow
5006511|NCT01606215|rapidly evolving|rapidly evolving
5006512|NCT01606150|neonate|neonate
5006513|NCT01606150|late preterm|late preterm
5006514|NCT01606150|lumbar puncture|lumbar puncture
5006515|NCT01606150|analgesia|analgesia
5006516|NCT01606150|pain|pain
5006517|NCT01606150|lidocaine|lidocaine
5006518|NCT01606098|Surgery|surgery
5006519|NCT01606098|Chemotherapy|chemotherapy
5006520|NCT01606085|Diabetes|diabetes
5006521|NCT01606085|Heart Failure|heart failure
5006522|NCT01606085|Quality of Life|quality of life
5006523|NCT01606085|Self Care|self care
5006524|NCT01606072|DDAVP|ddavp
5006525|NCT01606033|stress|stress
5006526|NCT01606033|Life quality|life quality
5006527|NCT01606033|adjustment strategy|adjustment strategy
5006528|NCT01606033|receiving an antitumor treatment|receiving an antitumor treatment
5006529|NCT01606033|within a clinical trial (case)|within a clinical trial (case)
5006530|NCT01606033|according to a standard treatment (control)|according to a standard treatment (control)
5006531|NCT01606020|effects of sleep deprivation|effects of sleep deprivation
5006532|NCT01606020|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
5006533|NCT01606020|male, healthy volunteers|male, healthy volunteers
5006534|NCT01605981|Nilotinib|nilotinib
5006535|NCT01605981|CML patients|cml patients
5006536|NCT01605981|accelerated phase|accelerated phase
5006537|NCT01605968|Obstetrics|obstetrics
5006538|NCT01605968|Gynecology|gynecology
5006539|NCT01605968|Wound healing|wound healing
5006540|NCT01605955|SPO2|spo2
5006541|NCT01605929|Anesthetics, local/administration & dosage|anesthetics, local/administration & dosage
5006542|NCT01605929|Brachial Plexus/ultrasonography|brachial plexus/ultrasonography
5006543|NCT01605929|Humans|humans
5006544|NCT01605929|Nerve Block/methods|nerve block/methods
5006545|NCT01605929|Upper Extremity/surgery|upper extremity/surgery
5006546|NCT01605929|Catheters, Indwelling|catheters, indwelling
5006547|NCT01605929|Anesthesia, Conduction/methods|anesthesia, conduction/methods
5006548|NCT01605929|Analgesia/methods|analgesia/methods
5006549|NCT01605929|Nerve Block/adverse effects|nerve block/adverse effects
5006550|NCT01605916|Cancer,|cancer,
5006551|NCT01605916|Tumour,|tumour,
5006552|NCT01605916|Metastatic,|metastatic,
5006553|NCT01605916|Lung cancer,|lung cancer,
5006554|NCT01605916|Non-Small Cell Lung Cancer|non-small cell lung cancer
5006555|NCT01605903|Tonsillectomy|tonsillectomy
5006556|NCT01605903|adenoidectomy|adenoidectomy
5006557|NCT01605903|bleeding|bleeding
5006558|NCT01605903|bleeding rates|bleeding rates
5006559|NCT01605903|Tonsillectomy with and without adenoidectomy|tonsillectomy with and without adenoidectomy
5006560|NCT01605890|HIV-2|hiv-2
5006561|NCT01605877|Cataracts|cataracts
5006562|NCT01605877|Intraocular lens|intraocular lens
5006563|NCT01605877|Multifocal|multifocal
5006564|NCT01605877|Presbyopia|presbyopia
5006565|NCT01605864|pneumonia|pneumonia
5006566|NCT01605864|community acquired bacterial pneumonia|community acquired bacterial pneumonia
5006567|NCT01605864|CAP|cap
5006568|NCT01605864|CABP|cabp
5006569|NCT01605864|bacterial pneumonia|bacterial pneumonia
5006570|NCT01605851|PFO|pfo
5006571|NCT01605851|closure|closure
5006572|NCT01605838|TBI|tbi
5006573|NCT01605812|IOL;|iol;
5006574|NCT01605812|capsule；|capsule；
5006575|NCT01605812|PCO;|pco;
5006576|NCT01605812|OCT|oct
5006577|NCT01605799|PTSD|ptsd
5006578|NCT01605799|Mental Health|mental health
5006579|NCT01605799|War|war
5006580|NCT01605799|Veterans|veterans
5006581|NCT01605786|Malaria|malaria
5006582|NCT01605786|Plasmodium falciparum|plasmodium falciparum
5006583|NCT01605786|vaccine|vaccine
5006584|NCT01605786|ADCI|adci
5006585|NCT01605786|sporozoite challenge|sporozoite challenge
5006586|NCT01605786|pre-erythrocytic|pre-erythrocytic
5006587|NCT01605786|erythrocytic|erythrocytic
5006588|NCT01605760|immunotherapy|immunotherapy
5006589|NCT01605760|elderly|elderly
5006590|NCT01605734|hepatocellular carcinoma|hepatocellular carcinoma
5006591|NCT01605734|transarterial chemoembolization|transarterial chemoembolization
5006592|NCT01605734|sorafenib|sorafenib
5006593|NCT01605721|Everolimus|everolimus
5006594|NCT01605721|XIENCE PRIME|xience prime
5006595|NCT01605721|Drug eluting stent|drug eluting stent
5006596|NCT01605708|Itching|itching
5006597|NCT01605695|reference range|reference range
5006598|NCT01605695|plasma|plasma
5006599|NCT01605695|inducible nitric oxide synthase|inducible nitric oxide synthase
5006600|NCT01605695|iNOS|inos
5006601|NCT01605695|healthy adults|healthy adults
5006602|NCT01605682|effect of different berry doses on mood and cognition|effect of different berry doses on mood and cognition
5006603|NCT01605682|adults|adults
5006604|NCT01605669|Auscultation|auscultation
5006605|NCT01605669|Aortic stenosis|aortic stenosis
5006606|NCT01605669|computer assisted auscultation|computer assisted auscultation
5006607|NCT01605669|Aortic Stenosis Acceleration Index|aortic stenosis acceleration index
5006608|NCT01605656|Cancer Prevention|cancer prevention
5006609|NCT01605656|Cervix|cervix
5006610|NCT01605656|Questionnaires|questionnaires
5006611|NCT01605656|Focus groups|focus groups
5006612|NCT01605656|Surveys|surveys
5006613|NCT01605656|Interviews|interviews
5006614|NCT01605643|cancer|cancer
5006615|NCT01605643|tobacco use|tobacco use
5006616|NCT01605643|pregnancy|pregnancy
5006617|NCT01605604|mindfulness EQ adolescents|mindfulness eq adolescents
5006618|NCT01605591|left-side double lumen bronchial tube|left-side double lumen bronchial tube
5006619|NCT01605591|bending type|bending type
5006620|NCT01605591|GlideScope videolaryngoscope|glidescope videolaryngoscope
5006621|NCT01605552|Depression|depression
5006622|NCT01605552|Depressive Symptoms|depressive symptoms
5006623|NCT01605552|Cardiovascular Disease (CVD)|cardiovascular disease (cvd)
5006624|NCT01605552|Coronary Artery Disease (CAD)|coronary artery disease (cad)
5006625|NCT01605552|Heart Disease|heart disease
5006626|NCT01605513|recombinant interferon, tolerated, effective|recombinant interferon, tolerated, effective
5006627|NCT01605500|ICD|icd
5006628|NCT01605474|foley catheter|foley catheter
5006629|NCT01605474|foley bulb|foley bulb
5006630|NCT01605474|induction of labor|induction of labor
5006631|NCT01605474|labor|labor
5006632|NCT01605448|Mild Cognitive Impairment|mild cognitive impairment
5006633|NCT01605448|Alzheimer's disease|alzheimer's disease
5006634|NCT01605448|Meditation|meditation
5006635|NCT01605448|Default Mode Network|default mode network
5006636|NCT01605422|Systematic review and meta-analysis|systematic review and meta-analysis
5006637|NCT01605422|Evidence-based medicine (EBM)|evidence-based medicine (ebm)
5006638|NCT01605422|Evidence-based nutrition (EBN)|evidence-based nutrition (ebn)
5006639|NCT01605422|Clinical practice guidelines|clinical practice guidelines
5006640|NCT01605422|Clinical trials|clinical trials
5006641|NCT01605422|Dietary pulses|dietary pulses
5006642|NCT01605422|legumes|legumes
5006643|NCT01605422|Beans, peas, chickpeas, lentils|beans, peas, chickpeas, lentils
5006644|NCT01605422|glycemic index|glycemic index
5006645|NCT01605422|postprandial glycemia|postprandial glycemia
5006646|NCT01605422|insulin resistance|insulin resistance
5006647|NCT01605422|body weight|body weight
5006648|NCT01605422|appetite|appetite
5006649|NCT01605422|food intake regulation|food intake regulation
5006650|NCT01605422|satiety|satiety
5006651|NCT01605422|satiation|satiation
5006652|NCT01605409|Refractory cardiac arrest|refractory cardiac arrest
5006653|NCT01605409|Emergency cardiopulmonary bypass|emergency cardiopulmonary bypass
5006654|NCT01605409|Extracorporeal life support in cardiac arrest|extracorporeal life support in cardiac arrest
5006655|NCT01605383|Avascular Necrosis of Femur Head|avascular necrosis of femur head
5006656|NCT01605383|Osteonecrosis of the hip|osteonecrosis of the hip
5006657|NCT01605383|Osteonecrosis of the femoral head|osteonecrosis of the femoral head
5006658|NCT01605383|Mesenchymal Stem Cells|mesenchymal stem cells
5006659|NCT01605383|Bone marrow|bone marrow
5006660|NCT01605383|Tissue engineering|tissue engineering
5006661|NCT01605383|Bone Diseases|bone diseases
5006662|NCT01605383|Musculoskeletal Diseases|musculoskeletal diseases
5006663|NCT01605370|Hypertension, Left Ventricular Mass|hypertension, left ventricular mass
5006664|NCT01605357|Brain Injuries|brain injuries
5006665|NCT01605357|Hematoma, subdural|hematoma, subdural
5006666|NCT01605357|Decompressive Craniectomy|decompressive craniectomy
5006667|NCT01605357|Saline solution, hypertonic|saline solution, hypertonic
5006668|NCT01605357|Hypernatremia|hypernatremia
5006669|NCT01605357|Intracranial hemorrhages|intracranial hemorrhages
5006670|NCT01605357|Head Injuries, closed|head injuries, closed
5006671|NCT01605357|Intracranial pressure|intracranial pressure
5006672|NCT01605357|Brain edema|brain edema
5006673|NCT01605357|Critical care|critical care
5006674|NCT01605357|Brain Diseases|brain diseases
5006675|NCT01605357|Central Nervous System Diseases|central nervous system diseases
5006676|NCT01605357|Nervous System Diseases|nervous system diseases
5006677|NCT01605357|Wounds and Injuries|wounds and injuries
5006678|NCT01605357|Physiological Effects of Drugs|physiological effects of drugs
5006679|NCT01605357|Pharmacologic Actions|pharmacologic actions
5006680|NCT01605344|Advanced colon cancer|advanced colon cancer
5006681|NCT01605344|Advanced rectal cancer|advanced rectal cancer
5006682|NCT01605344|Metastatic colon cancer|metastatic colon cancer
5006683|NCT01605344|Metastatic rectal cancer|metastatic rectal cancer
5006684|NCT01605344|Lipitor|lipitor
5006685|NCT01605344|Atorvastatin|atorvastatin
5006686|NCT01605344|FOLFIRI|folfiri
5006687|NCT01605331|Adults|adults
5006688|NCT01605331|GH deficiency|gh deficiency
5006689|NCT01605318|metastatic colorectal cancer|metastatic colorectal cancer
5006690|NCT01605318|colon cancer|colon cancer
5006691|NCT01605318|rectal cancer|rectal cancer
5006692|NCT01605318|previously treated|previously treated
5006693|NCT01605292|Transradial catheterization|transradial catheterization
5006694|NCT01605292|Ultrasound|ultrasound
5006695|NCT01605292|Radial artery|radial artery
5006696|NCT01605279|Low superior vena cava flow|low superior vena cava flow
5006697|NCT01605279|Functional echocardiography|functional echocardiography
5006698|NCT01605266|pediatric|pediatric
5006699|NCT01605266|kidney disease|kidney disease
5006700|NCT01605266|minimal change disease|minimal change disease
5006701|NCT01605266|focal segmental glomerulosclerosis|focal segmental glomerulosclerosis
5006702|NCT01605266|nephrotic syndrome|nephrotic syndrome
5006703|NCT01605253|Post-traumatic stress disorder|post-traumatic stress disorder
5006704|NCT01605253|sleep disturbance|sleep disturbance
5006705|NCT01605253|insomnia|insomnia
5006706|NCT01605253|cytokines|cytokines
5006707|NCT01605253|anxiety|anxiety
5006708|NCT01605253|traumatic event|traumatic event
5006709|NCT01605253|memory|memory
5006710|NCT01605240|Fracture pain|fracture pain
5006711|NCT01605240|Fracture reduction|fracture reduction
5006712|NCT01605240|Analgesia|analgesia
5006713|NCT01605240|Acetaminophen|acetaminophen
5006714|NCT01605240|Ibuprofen|ibuprofen
5006715|NCT01605240|Codeine|codeine
5006716|NCT01605240|Pediatric|pediatric
5006717|NCT01605240|Fracture Pain Analgesia in Pediatric population|fracture pain analgesia in pediatric population
5006718|NCT01605227|prostate cancer|prostate cancer
5006719|NCT01605227|castration resistant prostate cancer|castration resistant prostate cancer
5006720|NCT01605227|bone pain|bone pain
5006721|NCT01605227|CRPC|crpc
5006722|NCT01605214|Extravascular Lung Water|extravascular lung water
5006723|NCT01605214|Transpulmonary Thermodilution|transpulmonary thermodilution
5006724|NCT01605214|Primary Graft Dysfunction|primary graft dysfunction
5006725|NCT01605214|Ischemia Reperfusion Injury|ischemia reperfusion injury
5006726|NCT01605201|Chondral lesions in the knee after traumatic injury|chondral lesions in the knee after traumatic injury
5006727|NCT01605175|Inflammatory Bowel Disease|inflammatory bowel disease
5006728|NCT01605175|Predictors Mucosal Healing|predictors mucosal healing
5006729|NCT01605149|Diabetes|diabetes
5006730|NCT01605136|Erythropoietic Protoporphyria|erythropoietic protoporphyria
5006731|NCT01605136|EPP|epp
5006732|NCT01605136|Afamelanotide|afamelanotide
5006733|NCT01605123|endothelial function|endothelial function
5006734|NCT01605123|children|children
5006735|NCT01605123|obesity|obesity
5006736|NCT01605123|cardiovascular dysfunction|cardiovascular dysfunction
5006737|NCT01605123|carotid intima media thickness|carotid intima media thickness
5006738|NCT01605123|blood pressure|blood pressure
5006739|NCT01605123|oral glucose tolerance test|oral glucose tolerance test
5006740|NCT01605110|blepharoplasty|blepharoplasty
5006741|NCT01605110|hyperbaric|hyperbaric
5006742|NCT01605110|oxygen|oxygen
5006743|NCT01605110|ecchymosis|ecchymosis
5006744|NCT01605110|edema|edema
5006745|NCT01605110|wound|wound
5006746|NCT01605110|healing|healing
5006747|NCT01605097|prostate neoplasms|prostate neoplasms
5006748|NCT01605097|interstitial radiation|interstitial radiation
5006749|NCT01605097|High dose rate prostate brachytherapy|high dose rate prostate brachytherapy
5006750|NCT01605097|dose escalation|dose escalation
5006751|NCT01605071|menopause|menopause
5006752|NCT01605071|estrogen|estrogen
5006753|NCT01605071|insulin sensitivity|insulin sensitivity
5006754|NCT01605071|estrogen receptors|estrogen receptors
5006755|NCT01605045|Cardiac catheterization|cardiac catheterization
5006756|NCT01605045|Radiation|radiation
5006757|NCT01605019|Ventricular Assist Devices|ventricular assist devices
5006758|NCT01605019|Heart assist pumps|heart assist pumps
5006759|NCT01605019|heart pumps|heart pumps
5006760|NCT01605019|sealant agents|sealant agents
5006761|NCT01605006|amyotrophic lateral sclerosis|amyotrophic lateral sclerosis
5006762|NCT01605006|ALS|als
5006763|NCT01605006|motor neuron disease|motor neuron disease
5006764|NCT01605006|diaphragm|diaphragm
5006765|NCT01605006|diaphragm pacing|diaphragm pacing
5006766|NCT01605006|diaphragmatic pacing|diaphragmatic pacing
5006767|NCT01605006|phrenic pacing|phrenic pacing
5006768|NCT01605006|phrenic nerve|phrenic nerve
5006769|NCT01605006|phrenic nerve stimulation|phrenic nerve stimulation
5006770|NCT01605006|NeuRx DPS|neurx dps
5006771|NCT01605006|DPS|dps
5006772|NCT01605006|chronic hypoventilation|chronic hypoventilation
5006773|NCT01605006|respiration|respiration
5006774|NCT01605006|ventilation|ventilation
5006775|NCT01605006|breathing|breathing
5006776|NCT01605006|Humanitarian Device Exemption|humanitarian device exemption
5006777|NCT01605006|HDE|hde
5006778|NCT01605006|post-approval study|post-approval study
5006779|NCT01604993|Dietary Nitrates|dietary nitrates
5006780|NCT01604993|Arterial Stiffness|arterial stiffness
5006781|NCT01604993|Vascular|vascular
5006782|NCT01604993|Blood pressure|blood pressure
5006783|NCT01604954|Food labeling|food labeling
5006784|NCT01604928|Overactive Bladder|overactive bladder
5006785|NCT01604928|YM178|ym178
5006786|NCT01604928|Mirabegron|mirabegron
5006787|NCT01604928|Frequency|frequency
5006788|NCT01604928|Urinary urge incontinence|urinary urge incontinence
5006789|NCT01604928|Urgency|urgency
5006790|NCT01604928|Urinary incontinence|urinary incontinence
5006791|NCT01604928|Micturition|micturition
5006792|NCT01604902|Psoriasis mRNA and miRNA|psoriasis mrna and mirna
5006793|NCT01604889|Melanoma, Skin Cancer, Oncology|melanoma, skin cancer, oncology
5006794|NCT01604876|Parkinson's disease|parkinson's disease
5006795|NCT01604876|depression|depression
5006796|NCT01604876|light therapy|light therapy
5006797|NCT01604876|sleeping problems|sleeping problems
5006798|NCT01604863|Solid Tumors|solid tumors
5006799|NCT01604863|Cancer|cancer
5006800|NCT01604863|Lung Cancer|lung cancer
5006801|NCT01604863|Prostate Cancer|prostate cancer
5006802|NCT01604863|Mesothelioma|mesothelioma
5006803|NCT01604863|Small Cell lung Cancer|small cell lung cancer
5006804|NCT01604850|HCV genotype 2 (GT-2)|hcv genotype 2 (gt-2)
5006805|NCT01604850|HCV genotype 3 (GT-3)|hcv genotype 3 (gt-3)
5006806|NCT01604850|HCV|hcv
5006807|NCT01604850|Sustained Virologic Response|sustained virologic response
5006808|NCT01604850|Direct Acting Antiviral|direct acting antiviral
5006809|NCT01604850|Combination Therapy|combination therapy
5006810|NCT01604850|Treatment Experienced|treatment experienced
5006811|NCT01604850|GS-7977|gs-7977
5006812|NCT01604850|Ribavirin|ribavirin
5006813|NCT01604837|superior hypogastric plexus block|superior hypogastric plexus block
5006814|NCT01604837|pelvic malignancy|pelvic malignancy
5006815|NCT01604837|chronic pelvic pain|chronic pelvic pain
5006816|NCT01604798|proteomics|proteomics
5006817|NCT01604798|serum peptides|serum peptides
5006818|NCT01604798|colorectal cancer|colorectal cancer
5006819|NCT01604798|MALDI-TOF MS|maldi-tof ms
5006820|NCT01604785|Migraine Headache|migraine headache
5006821|NCT01604785|Pediatric|pediatric
5006822|NCT01604759|Mouth Neoplasms|mouth neoplasms
5006823|NCT01604759|Mouth Diseases|mouth diseases
5006824|NCT01604733|Multi-Center Survey|multi-center survey
5006825|NCT01604733|patients currently on lipid-lowering pharmacological treatment|patients currently on lipid-lowering pharmacological treatment
5006826|NCT01604733|level of Control of Hypercholesterolemia in Egypt|level of control of hypercholesterolemia in egypt
5006827|NCT01604720|sample size|sample size
5006828|NCT01604720|liver disease|liver disease
5006829|NCT01604707|stress|stress
5006830|NCT01604707|anxiety|anxiety
5006831|NCT01604707|depression|depression
5006832|NCT01604707|quality of life|quality of life
5006833|NCT01604694|Abdominoplasty|abdominoplasty
5006834|NCT01604694|Transversus Abdominis Plane (TAP) Block|transversus abdominis plane (tap) block
5006835|NCT01604694|levobupivacaine|levobupivacaine
5006836|NCT01604694|Placebo|placebo
5006837|NCT01604681|Linseed Oil|linseed oil
5006838|NCT01604681|Oxidative Stress|oxidative stress
5006839|NCT01604681|Polymorphism, Genetic|polymorphism, genetic
5006840|NCT01604681|Cardiovascular Diseases|cardiovascular diseases
5006841|NCT01604655|Chest pain|chest pain
5006842|NCT01604655|shortness of breath|shortness of breath
5006843|NCT01604655|suspected acute coronary syndrome|suspected acute coronary syndrome
5006844|NCT01604655|stress testing|stress testing
5006845|NCT01604655|coronary computed tomography angiography|coronary computed tomography angiography
5006846|NCT01604629|Spondylarthropathies|spondylarthropathies
5006847|NCT01604629|Persistent clinical remission with anti-TNF therapy|persistent clinical remission with anti-tnf therapy
5006848|NCT01604629|Standardized protocol for dose reduction anti-TNF therapy|standardized protocol for dose reduction anti-tnf therapy
5006849|NCT01604590|Glioblastoma|glioblastoma
5006850|NCT01604590|Imaging Biomarkers|imaging biomarkers
5006851|NCT01604590|Bevacizumab|bevacizumab
5006852|NCT01604590|MRI|mri
5006853|NCT01604577|health literacy|health literacy
5006854|NCT01604577|health numeracy|health numeracy
5006855|NCT01604564|Registry|registry
5006856|NCT01604564|Colitis Ulcerosa (CU)|colitis ulcerosa (cu)
5006857|NCT01604564|Familial Adenomatous Polyposis(FAP)|familial adenomatous polyposis(fap)
5006858|NCT01604564|IPAA|ipaa
5006859|NCT01604512|Brain tumor|brain tumor
5006860|NCT01604512|MRI Perfusion|mri perfusion
5006861|NCT01604512|FDG PET/CT|fdg pet/ct
5006862|NCT01604512|12-067|12-067
5006863|NCT01604499|Healthy eating|healthy eating
5006864|NCT01604499|Incentives|incentives
5006865|NCT01604499|Feedback|feedback
5006866|NCT01604486|Myocardial infarction|myocardial infarction
5006867|NCT01604486|Ischaemic preconditioning|ischaemic preconditioning
5006868|NCT01604486|Myocardial Ischaemia National Audit Project|myocardial ischaemia national audit project
5006869|NCT01604486|General Practice Research Database|general practice research database
5006870|NCT01604486|Hospital Episode Statistics|hospital episode statistics
5006871|NCT01604486|Office for National Statistics|office for national statistics
5006872|NCT01604473|Chronic Kidney Disease|chronic kidney disease
5006873|NCT01604473|CKD|ckd
5006874|NCT01604473|ESRD|esrd
5006875|NCT01604473|AV Fistula|av fistula
5006876|NCT01604473|Arterio-venous fistula|arterio-venous fistula
5006877|NCT01604473|hemodialysis|hemodialysis
5006878|NCT01604460|Hypothermia|hypothermia
5006879|NCT01604460|Newborn|newborn
5006880|NCT01604460|Plastic bag|plastic bag
5006881|NCT01604460|Resuscitation|resuscitation
5006882|NCT01604447|Hypothermia|hypothermia
5006883|NCT01604447|Newborn|newborn
5006884|NCT01604447|Incubator|incubator
5006885|NCT01604447|Plastic bag|plastic bag
5006886|NCT01604447|Normothermia|normothermia
5006887|NCT01604434|Hypothermia|hypothermia
5006888|NCT01604434|Low birth Weight|low birth weight
5006889|NCT01604434|Newborn|newborn
5006890|NCT01604434|Incubator|incubator
5006891|NCT01604434|Plastic bag|plastic bag
5006892|NCT01604421|Hypothermia|hypothermia
5006893|NCT01604421|Low birth weight|low birth weight
5006894|NCT01604421|Newborn|newborn
5006895|NCT01604421|Plastic bag|plastic bag
5006896|NCT01604421|Thermoregulation|thermoregulation
5006897|NCT01604395|GHD|ghd
5006898|NCT01604395|TS|ts
5006899|NCT01604395|CRF|crf
5006900|NCT01604395|SGA|sga
5006901|NCT01604395|ISS|iss
5006902|NCT01604382|Total Knee Arthroplasty (TKA)|total knee arthroplasty (tka)
5006903|NCT01604369|Atrial flutter|atrial flutter
5006904|NCT01604369|Cryoablation|cryoablation
5006905|NCT01604369|Cavotricuspid isthmus|cavotricuspid isthmus
5006906|NCT01604369|Visual analogue scale|visual analogue scale
5006907|NCT01604356|retinitis pigmentosa|retinitis pigmentosa
5006908|NCT01604343|Active rheumatoid arthritis despite disease-modifying antirheumatic drug therapy|active rheumatoid arthritis despite disease-modifying antirheumatic drug therapy
5006909|NCT01604343|Sirukumab|sirukumab
5006910|NCT01604343|Human Anti-IL-6 monoclonal antibody|human anti-il-6 monoclonal antibody
5006911|NCT01604330|High dose baclofen|high dose baclofen
5006912|NCT01604330|Alcoholism|alcoholism
5006913|NCT01604330|Abstinence|abstinence
5006914|NCT01604330|Low risk consumption|low risk consumption
5006915|NCT01604330|Craving|craving
5006916|NCT01604317|Hypothermia|hypothermia
5006917|NCT01604317|Low birth Weight|low birth weight
5006918|NCT01604317|Newborn|newborn
5006919|NCT01604317|Resuscitation|resuscitation
5006920|NCT01604317|Plastic bag|plastic bag
5006921|NCT01604304|stone|stone
5006922|NCT01604304|calculi|calculi
5006923|NCT01604304|kidney|kidney
5006924|NCT01604304|renal treatment|renal treatment
5006925|NCT01604304|flexible ureteroscopy|flexible ureteroscopy
5006926|NCT01604304|extracoporeal shockwave lithotripsy|extracoporeal shockwave lithotripsy
5006927|NCT01604304|retrograde intra renal surgery|retrograde intra renal surgery
5006928|NCT01604278|Indacaterol|indacaterol
5006929|NCT01604278|Glycopyrronium Bromide|glycopyrronium bromide
5006930|NCT01604278|COPD|copd
5006931|NCT01604278|bronchodilation|bronchodilation
5006932|NCT01604239|Osteoarthritis|osteoarthritis
5006933|NCT01604239|Shinbaro|shinbaro
5006934|NCT01604239|Herbal drug|herbal drug
5006935|NCT01604226|total intravenous anesthesia|total intravenous anesthesia
5006936|NCT01604226|Bispectral index monitoring|bispectral index monitoring
5006937|NCT01604226|propofol|propofol
5006938|NCT01604226|remifentanil|remifentanil
5006939|NCT01604213|Type 2 diabetes mellitus|type 2 diabetes mellitus
5006940|NCT01604213|vildagliptin|vildagliptin
5006941|NCT01604213|metformin|metformin
5006942|NCT01604213|atherosclerosis|atherosclerosis
5006943|NCT01604213|inflammation|inflammation
5006944|NCT01604213|interleukin-6|interleukin-6
5006945|NCT01604213|TNF|tnf
5006946|NCT01604213|atherothrombosis|atherothrombosis
5006947|NCT01604213|adiponectin|adiponectin
5006948|NCT01604213|MMP-9|mmp-9
5006949|NCT01604213|hs-CRP|hs-crp
5006950|NCT01604200|hypertension|hypertension
5006951|NCT01604200|dentistry|dentistry
5006952|NCT01604200|blood pressure|blood pressure
5006953|NCT01604200|measurement|measurement
5006954|NCT01604200|screening|screening
5006955|NCT01604200|qualitative research|qualitative research
5006956|NCT01604187|sublingual fentanyl|sublingual fentanyl
5006957|NCT01604187|pain in coloscopy|pain in coloscopy
5006958|NCT01604187|The efficacy and safety of fentanyl transmucosal tablet to placebo in patients having colonoscopy.|the efficacy and safety of fentanyl transmucosal tablet to placebo in patients having colonoscopy.
5006959|NCT01604174|knee|knee
5006960|NCT01604174|osteoarthritis|osteoarthritis
5006961|NCT01604174|arthroplasty|arthroplasty
5006962|NCT01604174|rehabilitation|rehabilitation
5006963|NCT01604148|Holmium Laser Enucleation of Prostate|holmium laser enucleation of prostate
5006964|NCT01604135|Collagen crosslinking|collagen crosslinking
5006965|NCT01604135|Keratoconus|keratoconus
5006966|NCT01604122|Survey|survey
5006967|NCT01604122|burden of illness|burden of illness
5006968|NCT01604122|caregivers|caregivers
5006969|NCT01604122|TTR-FAP|ttr-fap
5006970|NCT01604122|TTR-CM|ttr-cm
5006971|NCT01604122|familial amyloid polyneuropathy|familial amyloid polyneuropathy
5006972|NCT01604122|observational|observational
5006973|NCT01604122|transthyretin familial amyloidosis|transthyretin familial amyloidosis
5006974|NCT01604109|Caries detection/diagnosis/prevention|caries detection/diagnosis/prevention
5006975|NCT01604109|Preventive Dentistry|preventive dentistry
5006976|NCT01604109|Casien Phosphopeptide|casien phosphopeptide
5006977|NCT01604109|Remineralization|remineralization
5006978|NCT01604109|Clinical trial|clinical trial
5006979|NCT01604096|Information|information
5006980|NCT01604096|campaign|campaign
5006981|NCT01604096|antibiotics|antibiotics
5006982|NCT01604096|bacterial resistance|bacterial resistance
5006983|NCT01604096|primary care|primary care
5006984|NCT01604083|transfusion|transfusion
5006985|NCT01604083|packed red blood cells (PRBC)|packed red blood cells (prbc)
5006986|NCT01604083|Transfusion Practice|transfusion practice
5006987|NCT01604083|Transfusion habits|transfusion habits
5006988|NCT01604083|Outcome|outcome
5006989|NCT01604083|elective surgery|elective surgery
5006990|NCT01604083|ETPOS|etpos
5006991|NCT01604083|ESA|esa
5006992|NCT01604083|European Society of Anaesthesiology|european society of anaesthesiology
5006993|NCT01604070|Hammertoe deformity|hammertoe deformity
5006994|NCT01604070|podiatry|podiatry
5006995|NCT01604031|B-CLL|b-cll
5006996|NCT01604031|vaccine|vaccine
5006997|NCT01604031|Lenalidomide|lenalidomide
5006998|NCT01604031|CTL|ctl
5006999|NCT01604018|Cat Allergy|cat allergy
5007000|NCT01604018|Rhinoconjunctivitis|rhinoconjunctivitis
5007001|NCT01604005|Mesothelioma|mesothelioma
5007002|NCT01604005|radiotherapy|radiotherapy
5007003|NCT01604005|prophylactic irradiation of tracts|prophylactic irradiation of tracts
5007004|NCT01603992|Cannabis|cannabis
5007005|NCT01603992|Craving|craving
5007006|NCT01603992|Questionnaire|questionnaire
5007007|NCT01603992|Non-Treatment|non-treatment
5007008|NCT01603992|Drug Use|drug use
5007009|NCT01603979|AV203|av203
5007010|NCT01603979|Solid Tumors|solid tumors
5007011|NCT01603979|ERBB3|erbb3
5007012|NCT01603979|Monoclonal Antibody|monoclonal antibody
5007013|NCT01603979|HER3|her3
5007014|NCT01603966|platelet|platelet
5007015|NCT01603966|aggregation|aggregation
5007016|NCT01603966|aspirin|aspirin
5007017|NCT01603966|inhibition|inhibition
5007018|NCT01603966|reactivity|reactivity
5007019|NCT01603940|Hypertension|hypertension
5007020|NCT01603940|Diabetes Mellitus|diabetes mellitus
5007021|NCT01603940|Vascular stiffness|vascular stiffness
5007022|NCT01603940|Endothelial function|endothelial function
5007023|NCT01603914|burns, catheter related bacteremia,|burns, catheter related bacteremia,
5007024|NCT01603914|infection, central venous catheter,|infection, central venous catheter,
5007025|NCT01603914|catheter-related bloodstream, adult critically ill patients|catheter-related bloodstream, adult critically ill patients
5007026|NCT01603888|children with heart disease|children with heart disease
5007027|NCT01603888|infants|infants
5007028|NCT01603888|healthy newborns|healthy newborns
5007029|NCT01603875|CPRV|cprv
5007030|NCT01603875|SPEEDA|speeda
5007031|NCT01603875|intradermal|intradermal
5007032|NCT01603875|pre-exposure|pre-exposure
5007033|NCT01603875|booster|booster
5007034|NCT01603849|Prophylactic Cranial Irradiation|prophylactic cranial irradiation
5007035|NCT01603849|Lung Cancer|lung cancer
5007036|NCT01603849|Non Small Cell Lung Cancer|non small cell lung cancer
5007037|NCT01603849|Carcinoembryonic Antigen|carcinoembryonic antigen
5007038|NCT01603836|Lumbar spine|lumbar spine
5007039|NCT01603836|Posterolateral fusion|posterolateral fusion
5007040|NCT01603836|Allograft|allograft
5007041|NCT01603836|Bone marrow concentrate|bone marrow concentrate
5007042|NCT01603836|Mesenchymal stem cells|mesenchymal stem cells
5007043|NCT01603836|Fusion rate|fusion rate
5007044|NCT01603784|exercise|exercise
5007045|NCT01603784|cognition|cognition
5007046|NCT01603784|memory|memory
5007047|NCT01603784|adult|adult
5007048|NCT01603771|Adult|adult
5007049|NCT01603771|Exercise|exercise
5007050|NCT01603771|Cognition|cognition
5007051|NCT01603771|MRI|mri
5007052|NCT01603758|Cholesterol|cholesterol
5007053|NCT01603758|Spectrometry, mass|spectrometry, mass
5007054|NCT01603758|Deuterium|deuterium
5007055|NCT01603758|Kinetics|kinetics
5007056|NCT01603758|Cholesterol absorption|cholesterol absorption
5007057|NCT01603758|Coronary Heart Disease|coronary heart disease
5007058|NCT01603732|Strep exposure and heart defects|strep exposure and heart defects
5007059|NCT01603719|infant formula|infant formula
5007060|NCT01603719|prebiotics|prebiotics
5007061|NCT01603719|beta-palmitate|beta-palmitate
5007062|NCT01603719|stool flora|stool flora
5007063|NCT01603719|bifidogenic|bifidogenic
5007064|NCT01603563|Stepped Care|stepped care
5007065|NCT01603563|Trauma-Focused Cognitive Behavioral Therapy|trauma-focused cognitive behavioral therapy
5007066|NCT01603563|Preschool children|preschool children
5007067|NCT01603550|energy restriction|energy restriction
5007068|NCT01603550|sleep deprivation|sleep deprivation
5007069|NCT01603550|cognitive performance|cognitive performance
5007070|NCT01603550|brain function|brain function
5007071|NCT01603537|Traumatic injuries|traumatic injuries
5007072|NCT01603537|Prehospital Trauma Life Support|prehospital trauma life support
5007073|NCT01603537|Traffic accidents|traffic accidents
5007074|NCT01603524|Ottawa Model for Smoking Cessation|ottawa model for smoking cessation
5007075|NCT01603524|Primary Care|primary care
5007076|NCT01603511|rewarming|rewarming
5007077|NCT01603511|core cooling|core cooling
5007078|NCT01603511|afterdrop|afterdrop
5007079|NCT01603511|pre-hospital treatment|pre-hospital treatment
5007080|NCT01603511|hypothermia|hypothermia
5007081|NCT01603498|pain measurement,|pain measurement,
5007082|NCT01603498|edema,|edema,
5007083|NCT01603498|trismus|trismus
5007084|NCT01603407|prednisone|prednisone
5007085|NCT01603407|deflazacort|deflazacort
5007086|NCT01603407|muscular dystrophy|muscular dystrophy
5007087|NCT01603407|neuromuscular disease|neuromuscular disease
5007088|NCT01603407|multi-center|multi-center
5007089|NCT01603823|vitrectomy|vitrectomy
5007090|NCT01603823|cataract|cataract
5007091|NCT01603823|macular edema|macular edema
5007092|NCT01603810|Basal cell carcinoma|basal cell carcinoma
5007093|NCT01603810|Optical Coherence Tomography|optical coherence tomography
5007094|NCT01603797|internetdelivered CBT|internetdelivered cbt
5007095|NCT01603797|chronic pain|chronic pain
5007096|NCT01603797|acceptance and commitment therapy|acceptance and commitment therapy
5007097|NCT01603797|mindfulness|mindfulness
5007098|NCT01603797|guided self help|guided self help
5007099|NCT01603745|PCOS|pcos
5007100|NCT01603706|Heart failure|heart failure
5007101|NCT01603706|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
5007102|NCT01603706|CRT|crt
5007103|NCT01603706|Radial strain echocardiography|radial strain echocardiography
5007104|NCT01603706|Ischemic cardiomyopathy|ischemic cardiomyopathy
5007105|NCT01603693|Guided bone regeneration|guided bone regeneration
5007106|NCT01603693|Bio Oss|bio oss
5007107|NCT01603693|BondBone|bondbone
5007108|NCT01603693|computerized tomography|computerized tomography
5007109|NCT01603693|histological examination|histological examination
5007110|NCT01603680|Ultrasonography|ultrasonography
5007111|NCT01603680|Block nerve|block nerve
5007112|NCT01603680|Anaesthesia|anaesthesia
5007113|NCT01603680|Carpal tunnel syndrome|carpal tunnel syndrome
5007114|NCT01603654|Colon preparation|colon preparation
5007115|NCT01603654|Colonoscopy|colonoscopy
5007116|NCT01603654|Polyethylene glycol|polyethylene glycol
5007117|NCT01603654|Sodium Picosulphate|sodium picosulphate
5007118|NCT01603589|coronary artery disease|coronary artery disease
5007119|NCT01603589|coronary artery bypass grafting|coronary artery bypass grafting
5007120|NCT01603589|cardiopulmonary bypass|cardiopulmonary bypass
5007121|NCT01603589|minimal extracorporeal circulation|minimal extracorporeal circulation
5007122|NCT01603485|Bioavailability|bioavailability
5007123|NCT01603485|Pharmacokinetics|pharmacokinetics
5007124|NCT01603485|Lersivirine|lersivirine
5007125|NCT01603485|Modified-release|modified-release
5007126|NCT01603472|pediatric|pediatric
5007127|NCT01603472|parenteral nutrition|parenteral nutrition
5007128|NCT01603472|bone disease|bone disease
5007129|NCT01603472|long-term PN|long-term pn
5007130|NCT01603446|pediatric|pediatric
5007131|NCT01603446|MELAS|melas
5007132|NCT01603446|mechanism of action of L-arginine|mechanism of action of l-arginine
5007133|NCT01603420|prostate|prostate
5007134|NCT01603420|cancer|cancer
5007135|NCT01603420|radiation|radiation
5007136|NCT01603420|proton|proton
5007137|NCT01603420|chemotherapy|chemotherapy
5007138|NCT01603420|high risk|high risk
5007139|NCT01603368|Probiotics|probiotics
5007140|NCT01603368|Lactobacillus reuteri|lactobacillus reuteri
5007141|NCT01603368|Prematures|prematures
5007142|NCT01603368|Enteral feeding|enteral feeding
5007143|NCT01603368|Motility|motility
5007144|NCT01603368|Necrotizing enterocolitis|necrotizing enterocolitis
5007145|NCT01603368|Sepsis|sepsis
5007146|NCT01603368|Weight|weight
5007147|NCT01603355|JIA|jia
5007148|NCT01603329|medication adherence|medication adherence
5007149|NCT01603329|diabetes|diabetes
5007150|NCT01603329|hypertension|hypertension
5007151|NCT01603329|cholesterol|cholesterol
5007152|NCT01603329|statins|statins
5007153|NCT01603316|Food pantry|food pantry
5007154|NCT01603316|Food voucher|food voucher
5007155|NCT01603316|Grocery delivery|grocery delivery
5007156|NCT01603316|12-099|12-099
5007157|NCT01603303|Breast Cancer|breast cancer
5007158|NCT01603303|Localized breast cancer|localized breast cancer
5007159|NCT01603303|Postmenopausal women|postmenopausal women
5007160|NCT01603303|Aromatase inhibitor|aromatase inhibitor
5007161|NCT01603303|AI|ai
5007162|NCT01603303|Questionnaires|questionnaires
5007163|NCT01603303|Surveys|surveys
5007164|NCT01603303|Luvena|luvena
5007165|NCT01603303|Internet based website|internet based website
5007166|NCT01603303|Phone counseling|phone counseling
5007167|NCT01603303|Water-based vaginal lubricant|water-based vaginal lubricant
5007168|NCT01603303|Hyalo-Gyn|hyalo-gyn
5007169|NCT01603290|Acute leukemia,|acute leukemia,
5007170|NCT01603290|Chemotherapy,|chemotherapy,
5007171|NCT01603290|Cancer-Related Fatigue,|cancer-related fatigue,
5007172|NCT01603290|Physical Fitness|physical fitness
5007173|NCT01603277|Asthma|asthma
5007174|NCT01603277|GM-CSF|gm-csf
5007175|NCT01603277|Moderate-to-Severe Asthma|moderate-to-severe asthma
5007176|NCT01603264|Bioequivalence|bioequivalence
5007177|NCT01603264|Biosimilarity|biosimilarity
5007178|NCT01603264|Similarity|similarity
5007179|NCT01603264|PK|pk
5007180|NCT01603264|Phase I|phase i
5007181|NCT01603264|Trastuzumab|trastuzumab
5007182|NCT01603264|Healthy Male Volunteers|healthy male volunteers
5007183|NCT01603264|Single-dose|single-dose
5007184|NCT01603264|HER-2|her-2
5007185|NCT01603264|Oncology|oncology
5007186|NCT01603251|transmission|transmission
5007187|NCT01603251|anopheles|anopheles
5007188|NCT01603225|Autism|autism
5007189|NCT01603225|tDCS|tdcs
5007190|NCT01603212|Melanoma|melanoma
5007191|NCT01603212|Metastatic melanoma|metastatic melanoma
5007192|NCT01603212|Advanced melanoma|advanced melanoma
5007193|NCT01603212|Vemurafenib|vemurafenib
5007194|NCT01603212|PLX4032|plx4032
5007195|NCT01603212|RO5185426|ro5185426
5007196|NCT01603212|IL-2|il-2
5007197|NCT01603212|Interleukin-2|interleukin-2
5007198|NCT01603212|Aldesleukin|aldesleukin
5007199|NCT01603212|Proleukin|proleukin
5007200|NCT01603212|Interferon Alfa-2b|interferon alfa-2b
5007201|NCT01603212|Intron A|intron a
5007202|NCT01603160|Sickle Cell Disease|sickle cell disease
5007203|NCT01603160|Emergency Department|emergency department
5007204|NCT01603160|Quality Improvement|quality improvement
5007205|NCT01603147|methamphetamine|methamphetamine
5007206|NCT01603147|monoclonal antibody|monoclonal antibody
5007207|NCT01603121|lisofylline|lisofylline
5007208|NCT01603108|Liver Transplant Recipient|liver transplant recipient
5007209|NCT01603108|Recurrent Fibrosis|recurrent fibrosis
5007210|NCT01603095|Achondroplasia|achondroplasia
5007211|NCT01603095|dwarfism|dwarfism
5007212|NCT01603069|Parkinson's disease|parkinson's disease
5007213|NCT01603069|Safety|safety
5007214|NCT01603069|Tolerability|tolerability
5007215|NCT01603056|House dust mite induced allergic rhinitis.|house dust mite induced allergic rhinitis.
5007216|NCT01603043|Geographic Atrophy|geographic atrophy
5007217|NCT01603043|Age-Related Macular Degeneration|age-related macular degeneration
5007218|NCT01603043|Intravitreal injection|intravitreal injection
5007219|NCT01603030|Moxifloxacin|moxifloxacin
5007220|NCT01603030|Prednisolone|prednisolone
5007221|NCT01603030|LASIK|lasik
5007222|NCT01603017|Magnetic Resonance Therapy|magnetic resonance therapy
5007223|NCT01603017|Osteoarthrosis|osteoarthrosis
5007224|NCT01603017|Osteoarthritis|osteoarthritis
5007225|NCT01603004|MRI|mri
5007226|NCT01603004|CT|ct
5007227|NCT01603004|12-058|12-058
5007228|NCT01602991|Obesity|obesity
5007229|NCT01602991|Endoscopy|endoscopy
5007230|NCT01602991|Nasopharyngoesophagogastroscopy|nasopharyngoesophagogastroscopy
5007231|NCT01602991|Bariatric Surgery|bariatric surgery
5007232|NCT01602991|Gastric Bypass Surgery|gastric bypass surgery
5007233|NCT01602965|obesity|obesity
5007234|NCT01602965|counselling|counselling
5007235|NCT01602965|weight loss|weight loss
5007236|NCT01602952|Radotinib|radotinib
5007237|NCT01602952|CML-CP, AP|cml-cp, ap
5007238|NCT01602939|Mast cell|mast cell
5007239|NCT01602939|Mastocytosis|mastocytosis
5007240|NCT01602939|Mast cell disease|mast cell disease
5007241|NCT01602926|hallux valgus|hallux valgus
5007242|NCT01602913|Pravastatin|pravastatin
5007243|NCT01602913|Adverse Events|adverse events
5007244|NCT01602913|Type II Diabetes Mellitus|type ii diabetes mellitus
5007245|NCT01602913|Incidence|incidence
5007246|NCT01602913|Paroxetine|paroxetine
5007247|NCT01602887|BA/BE|ba/be
5007248|NCT01602887|PK|pk
5007249|NCT01602887|PD-0332991|pd-0332991
5007250|NCT01602887|PF-05089326|pf-05089326
5007251|NCT01602887|Breast Cancer|breast cancer
5007252|NCT01602874|children|children
5007253|NCT01602874|pediatry|pediatry
5007254|NCT01602874|pneumonia|pneumonia
5007255|NCT01602874|intra-abdominal|intra-abdominal
5007256|NCT01602874|infection|infection
5007257|NCT01602861|Fibrosis|fibrosis
5007258|NCT01602861|calcineurin inhibitor|calcineurin inhibitor
5007259|NCT01602861|kidney transplant|kidney transplant
5007260|NCT01602861|chronic rejection|chronic rejection
5007261|NCT01602848|Medicaid|medicaid
5007262|NCT01602848|frequent users|frequent users
5007263|NCT01602848|heavy users|heavy users
5007264|NCT01602848|high risk|high risk
5007265|NCT01602848|high cost|high cost
5007266|NCT01602848|intervention to improve care and reduce Medicaid expenditures|intervention to improve care and reduce medicaid expenditures
5007267|NCT01602835|Alport syndrome|alport syndrome
5007268|NCT01602835|proteinuria|proteinuria
5007269|NCT01602835|glomerular disease|glomerular disease
5007270|NCT01602835|hereditary nephropathy|hereditary nephropathy
5007271|NCT01602835|nephropathy|nephropathy
5007272|NCT01602822|HIV Prevention|hiv prevention
5007273|NCT01602822|NPEP|npep
5007274|NCT01602822|PEP|pep
5007275|NCT01602809|Perfusion|perfusion
5007276|NCT01602809|Microvessels|microvessels
5007277|NCT01602809|Ultrasound|ultrasound
5007278|NCT01602809|Sickle Cell Disease|sickle cell disease
5007279|NCT01602783|Radical Prostatectomy|radical prostatectomy
5007280|NCT01602770|Oral contraceptives|oral contraceptives
5007281|NCT01602770|Adverse events|adverse events
5007282|NCT01602770|Safety profile|safety profile
5007283|NCT01602770|Contraceptive Agents|contraceptive agents
5007284|NCT01602744|STOPP screening tool|stopp screening tool
5007285|NCT01602744|START screening tool|start screening tool
5007286|NCT01602744|MIP-medication inappropriate prescription|mip-medication inappropriate prescription
5007287|NCT01602744|PIM-Potentially inappropriate medication|pim-potentially inappropriate medication
5007288|NCT01602731|medication adherence|medication adherence
5007289|NCT01602718|physical activity|physical activity
5007290|NCT01602718|physical performance|physical performance
5007291|NCT01602718|ESRD|esrd
5007292|NCT01602718|home dialysis|home dialysis
5007293|NCT01602705|Feedback (NOT MESH)|feedback (not mesh)
5007294|NCT01602705|Medication errors|medication errors
5007295|NCT01602705|Medication review|medication review
5007296|NCT01602705|Inappropriate medication|inappropriate medication
5007297|NCT01602705|Randomised controlled trial|randomised controlled trial
5007298|NCT01602705|Primary Health Care|primary health care
5007299|NCT01602705|Family Practice|family practice
5007300|NCT01602692|Pain, postoperative|pain, postoperative
5007301|NCT01602692|Postoperative Nausea and Vomiting|postoperative nausea and vomiting
5007302|NCT01602692|Patient Readmission|patient readmission
5007303|NCT01602692|Time to Discharge|time to discharge
5007304|NCT01602640|sedation|sedation
5007305|NCT01602640|critical care|critical care
5007306|NCT01602640|morphine|morphine
5007307|NCT01602640|fentanyl|fentanyl
5007308|NCT01602640|analgesic based sedation|analgesic based sedation
5007309|NCT01602601|Hunter syndrome, immunogenicity, antibodies|hunter syndrome, immunogenicity, antibodies
5007310|NCT01602575|IBS, FMRI, MBSR|ibs, fmri, mbsr
5007311|NCT01602562|Herpes simplex infection|herpes simplex infection
5007312|NCT01602562|valaciclovir|valaciclovir
5007313|NCT01602562|herpes simplex virus|herpes simplex virus
5007314|NCT01602562|hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
5007315|NCT01602536|twitter|twitter
5007316|NCT01602536|quit smoking|quit smoking
5007317|NCT01602536|smoking cessation|smoking cessation
5007318|NCT01602536|social media|social media
5007319|NCT01602536|peer support|peer support
5007320|NCT01602523|Emphysema|emphysema
5007321|NCT01602523|COPD|copd
5007322|NCT01602523|Sleep|sleep
5007323|NCT01602497|Borderline personality disorder|borderline personality disorder
5007324|NCT01602497|repetitive transcranial magnetic stimulation|repetitive transcranial magnetic stimulation
5007325|NCT01602471|Endarterectomy|endarterectomy
5007326|NCT01602471|K5-C200|k5-c200
5007327|NCT01602471|RGD-K5|rgd-k5
5007328|NCT01602471|angiogenesis|angiogenesis
5007329|NCT01602471|Carotid CT Angiogram|carotid ct angiogram
5007330|NCT01602458|Preventative Scar Management|preventative scar management
5007331|NCT01602458|Skin Grafts|skin grafts
5007332|NCT01602458|Silicone Therapy|silicone therapy
5007333|NCT01602458|Silicone Pressure Garment Therapy|silicone pressure garment therapy
5007334|NCT01602445|Venous Thrombosis|venous thrombosis
5007335|NCT01602445|Coagulation factors|coagulation factors
5007336|NCT01602445|Cancer|cancer
5007337|NCT01602445|Blood|blood
5007338|NCT01602432|Venous Thrombosis|venous thrombosis
5007339|NCT01602432|Cancer|cancer
5007340|NCT01602432|Coagulation factors|coagulation factors
5007341|NCT01602432|Blood|blood
5007441|NCT01602029|Simvastatin|simvastatin
5007342|NCT01602406|Advanced HER2-positive Breast cancer or Gastric cancer|advanced her2-positive breast cancer or gastric cancer
5007343|NCT01602380|hormone receptor positive breast cancer|hormone receptor positive breast cancer
5007344|NCT01602380|endocrine|endocrine
5007345|NCT01602380|no hormone therapy|no hormone therapy
5007346|NCT01602380|hormone|hormone
5007347|NCT01602380|breast|breast
5007348|NCT01602380|cancer|cancer
5007349|NCT01602380|neoplasm|neoplasm
5007350|NCT01602380|metastatic|metastatic
5007351|NCT01602380|tumour|tumour
5007352|NCT01602354|Endotoxin Activity Assay|endotoxin activity assay
5007353|NCT01602354|Gram negative|gram negative
5007354|NCT01602354|Septic Shock|septic shock
5007355|NCT01602354|EAA|eaa
5007356|NCT01602341|atopic dermatitis|atopic dermatitis
5007357|NCT01602328|Acute Kidney Injury|acute kidney injury
5007358|NCT01602328|Acute renal failure|acute renal failure
5007359|NCT01602328|Human mesenchymal stem cells|human mesenchymal stem cells
5007360|NCT01602328|Allogeneic stem cells|allogeneic stem cells
5007361|NCT01602315|BYL719|byl719
5007362|NCT01602315|PI3K inhibitor|pi3k inhibitor
5007363|NCT01602315|PIK3CA|pik3ca
5007364|NCT01602315|cetuximab|cetuximab
5007365|NCT01602315|EGFR|egfr
5007366|NCT01602315|HNSCC|hnscc
5007367|NCT01602315|RM HNSCC|rm hnscc
5007368|NCT01602315|platinum-based chemotherapy|platinum-based chemotherapy
5007369|NCT01602315|(RM HNSCC) patients|(rm hnscc) patients
5007370|NCT01602315|resistant or ineligible/intolerant to platinum-based chemotherapy|resistant or ineligible/intolerant to platinum-based chemotherapy
5007371|NCT01602315|swallowing dysfunction|swallowing dysfunction
5007372|NCT01602315|G-tube|g-tube
5007373|NCT01602315|alpelisib|alpelisib
5007374|NCT01602302|rheumatoid arthritis|rheumatoid arthritis
5007375|NCT01602302|ultrasound|ultrasound
5007376|NCT01602302|remission|remission
5007377|NCT01602302|biological DMARD|biological dmard
5007378|NCT01602276|Parkinson's disease|parkinson's disease
5007379|NCT01602276|Lewy body dementia|lewy body dementia
5007380|NCT01602276|Korsakoff's syndrome|korsakoff's syndrome
5007381|NCT01602276|Subcortical Dementia|subcortical dementia
5007382|NCT01602276|Huntington's Disease|huntington's disease
5007383|NCT01602263|Normal cognitive function|normal cognitive function
5007384|NCT01602263|Aphasia|aphasia
5007385|NCT01602263|Autism|autism
5007386|NCT01602263|Schizophrenia|schizophrenia
5007387|NCT01602250|Anesthetics, local|anesthetics, local
5007388|NCT01602250|Toxicity|toxicity
5007389|NCT01602250|Adverse effects|adverse effects
5007390|NCT01602211|stem cell transplant|stem cell transplant
5007391|NCT01602211|cancer survivors|cancer survivors
5007392|NCT01602211|internet|internet
5007393|NCT01602211|social media|social media
5007394|NCT01602211|distress|distress
5007395|NCT01602211|health care adherence|health care adherence
5007396|NCT01602185|NMDA (N-Methyl-D-Aspartate) antagonists|nmda (n-methyl-d-aspartate) antagonists
5007397|NCT01602185|ketamine|ketamine
5007398|NCT01602185|memantine|memantine
5007399|NCT01602185|dextromethorphan|dextromethorphan
5007400|NCT01602185|Neuropathic pain|neuropathic pain
5007401|NCT01602172|alcohol consumption|alcohol consumption
5007402|NCT01602172|inpatients|inpatients
5007403|NCT01602172|risk reduction behavior|risk reduction behavior
5007404|NCT01602172|counseling|counseling
5007405|NCT01602172|nurses|nurses
5007406|NCT01602172|brief intervention|brief intervention
5007407|NCT01602159|Claudication|claudication
5007408|NCT01602159|SFA|sfa
5007409|NCT01602159|Open Bypass|open bypass
5007410|NCT01602159|Angioplasty|angioplasty
5007411|NCT01602159|Stenting|stenting
5007412|NCT01602146|ultramarathon central fatigue,|ultramarathon central fatigue,
5007413|NCT01602133|venous puncture|venous puncture
5007414|NCT01602133|seldinger technique|seldinger technique
5007415|NCT01602133|ultrasound guidance|ultrasound guidance
5007416|NCT01602107|Stress|stress
5007417|NCT01602107|Urinary|urinary
5007418|NCT01602107|Incontinence|incontinence
5007419|NCT01602107|Pelvic|pelvic
5007420|NCT01602107|Physiotherapy|physiotherapy
5007421|NCT01602094|measles|measles
5007422|NCT01602094|antibody|antibody
5007423|NCT01602094|prevalence|prevalence
5007424|NCT01602094|predictors|predictors
5007425|NCT01602094|Donor of National Blood Centre, The Thai Red Cross Society who age 18-30 years old|donor of national blood centre, the thai red cross society who age 18-30 years old
5007426|NCT01602094|Measles antibody levels|measles antibody levels
5007427|NCT01602094|Predictors of adequate measles antibody levels and inadequate measles antibody levels|predictors of adequate measles antibody levels and inadequate measles antibody levels
5007428|NCT01602081|Anal fistula|anal fistula
5007429|NCT01602081|Ligation of the intersphincteric fistula tract|ligation of the intersphincteric fistula tract
5007430|NCT01602081|LIFT|lift
5007431|NCT01602081|Tissue graft|tissue graft
5007432|NCT01602068|Iontophoresis|iontophoresis
5007433|NCT01602068|Cataract Surgery|cataract surgery
5007434|NCT01602068|Ophthalmology|ophthalmology
5007435|NCT01602068|Posterior Chamber Intraocular Lens Implant|posterior chamber intraocular lens implant
5007436|NCT01602042|essential tremor|essential tremor
5007437|NCT01602042|motion sensors|motion sensors
5007438|NCT01602042|tremor|tremor
5007439|NCT01602029|Anti inflammatory|anti inflammatory
5007440|NCT01602029|Schizophrenia|schizophrenia
5007442|NCT01602029|Ondansetron|ondansetron
5007443|NCT01602016|ASD|asd
5007444|NCT01602016|PDD-NOS|pdd-nos
5007445|NCT01601977|COPD|copd
5007446|NCT01601977|Respiratory failure|respiratory failure
5007447|NCT01601977|NIV|niv
5007448|NCT01601977|OSA|osa
5007449|NCT01601964|VEGF, ectopic pregnancy.|vegf, ectopic pregnancy.
5007450|NCT01601951|Osteoarthritis|osteoarthritis
5007451|NCT01601951|Stem Cell Injections|stem cell injections
5007452|NCT01601951|Bone Marrow|bone marrow
5007453|NCT01601951|Autologous|autologous
5007454|NCT01601938|Sepsis|sepsis
5007455|NCT01601938|Shock, Septic|shock, septic
5007456|NCT01601938|Selenium|selenium
5007457|NCT01601938|Survival|survival
5007458|NCT01601912|Whiplash Injuries|whiplash injuries
5007459|NCT01601912|Chronic Pain|chronic pain
5007460|NCT01601912|Exercise|exercise
5007461|NCT01601912|Cognition|cognition
5007462|NCT01601899|trial|trial
5007463|NCT01601899|stavudine|stavudine
5007464|NCT01601899|tenofovir|tenofovir
5007465|NCT01601899|mitochondria|mitochondria
5007466|NCT01601899|insulin resistance|insulin resistance
5007467|NCT01601899|lipids|lipids
5007468|NCT01601899|HOMA|homa
5007469|NCT01601886|Intubation, Intratracheal|intubation, intratracheal
5007470|NCT01601886|Continuous Positive Airway Pressure|continuous positive airway pressure
5007471|NCT01601886|Historical Cohort Studies|historical cohort studies
5007472|NCT01601886|Clinical Trial|clinical trial
5007473|NCT01601873|Arteriovenous graft|arteriovenous graft
5007474|NCT01601873|Propaten|propaten
5007475|NCT01601873|Heparin-bonded|heparin-bonded
5007476|NCT01601873|hemodialysis vascular access|hemodialysis vascular access
5007477|NCT01601873|Surgical|surgical
5007478|NCT01601873|Arteriovenous Shunt|arteriovenous shunt
5007479|NCT01601860|Labor|labor
5007480|NCT01601860|vaginal delivery|vaginal delivery
5007481|NCT01601860|pain|pain
5007482|NCT01601834|Phase 1|phase 1
5007483|NCT01601834|Single Dose|single dose
5007484|NCT01601834|Pharmacokinetics|pharmacokinetics
5007485|NCT01601834|Safety|safety
5007486|NCT01601834|Toleration|toleration
5007487|NCT01601795|Cardioprotection|cardioprotection
5007488|NCT01601769|Cervical preinvasive disease|cervical preinvasive disease
5007489|NCT01601769|Colposcopy|colposcopy
5007490|NCT01601769|Exocolposcopy|exocolposcopy
5007491|NCT01601769|Leep|leep
5007492|NCT01601756|revision knee arthroplasty|revision knee arthroplasty
5007493|NCT01601756|navigation|navigation
5007494|NCT01601756|joint line|joint line
5007495|NCT01601743|Cocaine|cocaine
5007496|NCT01601743|Exercise|exercise
5007497|NCT01601730|Cocaine|cocaine
5007498|NCT01601730|Modafinil|modafinil
5007499|NCT01601730|Escitalopram|escitalopram
5007500|NCT01601717|RTI-336|rti-336
5007501|NCT01601717|Methamphetamine|methamphetamine
5007502|NCT01601704|Body Weight|body weight
5007503|NCT01601704|Bupropion|bupropion
5007504|NCT01601704|Cardiovascular Diseases|cardiovascular diseases
5007505|NCT01601704|Diabetes Mellitus|diabetes mellitus
5007506|NCT01601704|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
5007507|NCT01601704|Endocrine System Diseases|endocrine system diseases
5007508|NCT01601704|Glucose Metabolism Disorders|glucose metabolism disorders
5007509|NCT01601704|Heart Diseases|heart diseases
5007510|NCT01601704|Metabolic Diseases|metabolic diseases
5007511|NCT01601704|Narcotic Antagonists|narcotic antagonists
5007512|NCT01601704|Naltrexone|naltrexone
5007513|NCT01601704|Nutrition Disorders|nutrition disorders
5007514|NCT01601704|Obesity|obesity
5007515|NCT01601704|Overnutrition|overnutrition
5007516|NCT01601704|Overweight|overweight
5007517|NCT01601691|prostate cancer|prostate cancer
5007518|NCT01601691|brachytherapy|brachytherapy
5007519|NCT01601691|spacer|spacer
5007520|NCT01601691|side effect|side effect
5007521|NCT01601678|Achalasia|achalasia
5007522|NCT01601678|Heller Myotomy|heller myotomy
5007523|NCT01601678|Dysphagia|dysphagia
5007524|NCT01601678|Peroral Endoscopic Myotomy|peroral endoscopic myotomy
5007525|NCT01601665|Intraocular lens|intraocular lens
5007526|NCT01601665|Cataracts|cataracts
5007527|NCT01601665|Astigmatism|astigmatism
5007528|NCT01601665|Toric|toric
5007529|NCT01601652|cholestasis|cholestasis
5007530|NCT01601652|PNAC|pnac
5007531|NCT01601652|Parenteral Nutrition Associated Cholestasis|parenteral nutrition associated cholestasis
5007532|NCT01601652|PNALD|pnald
5007533|NCT01601652|Parenteral Nutrition Associated Liver Disease|parenteral nutrition associated liver disease
5007534|NCT01601639|Gastric Antral Vascular Ectasia|gastric antral vascular ectasia
5007535|NCT01601639|Argon plasma Coagulation|argon plasma coagulation
5007536|NCT01601639|Endoscopic Band Ligation|endoscopic band ligation
5007537|NCT01601639|GAVE|gave
5007538|NCT01601587|Introductory Seminar|introductory seminar
5007539|NCT01601587|Waiting list|waiting list
5007540|NCT01601587|Community Mental Health Centre|community mental health centre
5007541|NCT01601574|Type 2 diabetes|type 2 diabetes
5007542|NCT01601574|HbA1c|hba1c
5007543|NCT01601574|Overweight|overweight
5007544|NCT01601574|Obesity|obesity
5007545|NCT01601561|Insulin|insulin
5007546|NCT01601561|Protein metabolism|protein metabolism
5007547|NCT01601561|Stress response|stress response
5007548|NCT01601483|AMD|amd
5007549|NCT01601483|Dry AMD|dry amd
5007550|NCT01601483|Nonexudative AMD|nonexudative amd
5007551|NCT01601483|MC-1101|mc-1101
5007552|NCT01601470|LCZ696, sildenafil, pharmacokinetics, mild to moderate hypertension|lcz696, sildenafil, pharmacokinetics, mild to moderate hypertension
5007553|NCT01601444|To assess pleural effusion by measuring internal thoracic impedance|to assess pleural effusion by measuring internal thoracic impedance
5007554|NCT01601431|Screening colonoscopy|screening colonoscopy
5007555|NCT01601418|YF476|yf476
5007556|NCT01601418|gastrin receptor antagonist|gastrin receptor antagonist
5007557|NCT01601418|pentagastrin|pentagastrin
5007558|NCT01601418|gastric acid|gastric acid
5007559|NCT01601418|healthy subjects|healthy subjects
5007560|NCT01601405|YF476|yf476
5007561|NCT01601405|gastrin receptor antagonist|gastrin receptor antagonist
5007562|NCT01601405|gastrin|gastrin
5007563|NCT01601405|gastric aspiration|gastric aspiration
5007564|NCT01601405|healthy subjects|healthy subjects
5007565|NCT01601392|Ischemic stroke|ischemic stroke
5007566|NCT01601392|direct current stimulation|direct current stimulation
5007567|NCT01601392|motor threshold|motor threshold
5007568|NCT01601392|National institutes of Health Stroke Scale|national institutes of health stroke scale
5007569|NCT01601392|Barthel index scale|barthel index scale
5007570|NCT01601392|Measurement of motor power improvement|measurement of motor power improvement
5007571|NCT01601379|Observational|observational
5007572|NCT01601379|GERD|gerd
5007573|NCT01601379|Gastroesophageal Reflux Disease|gastroesophageal reflux disease
5007574|NCT01601379|Gastro-oesophageal Reflux|gastro-oesophageal reflux
5007575|NCT01601379|Heartburn|heartburn
5007576|NCT01601366|Adenomyosis|adenomyosis
5007577|NCT01601366|Intrauterine levonorgestrel|intrauterine levonorgestrel
5007578|NCT01601366|Dysmenorrhea|dysmenorrhea
5007579|NCT01601366|Oral contraceptives|oral contraceptives
5007580|NCT01601366|Uterus|uterus
5007581|NCT01601353|Erectile Dysfunction|erectile dysfunction
5007582|NCT01601327|hypogonadism|hypogonadism
5007583|NCT01601327|treatment|treatment
5007584|NCT01601327|testis volume|testis volume
5007585|NCT01601301|Limb|limb
5007586|NCT01601301|Lengthening|lengthening
5007587|NCT01601301|PRECICE|precice
5007588|NCT01601301|Ellipse|ellipse
5007589|NCT01601301|Technologies|technologies
5007590|NCT01601301|Distraction|distraction
5007591|NCT01601301|Osteogenesis|osteogenesis
5007592|NCT01601301|Femur|femur
5007593|NCT01601301|Tibia|tibia
5007594|NCT01601301|Intramedullary|intramedullary
5007595|NCT01601301|Nail|nail
5007596|NCT01601301|Device|device
5007597|NCT01601301|Medical|medical
5007598|NCT01601301|Orthopedic|orthopedic
5007599|NCT01601301|Implant|implant
5007600|NCT01601288|obstructive lung disease|obstructive lung disease
5007601|NCT01601288|restrictive lung disease|restrictive lung disease
5007602|NCT01601288|cough|cough
5007603|NCT01601288|dyspnea|dyspnea
5007604|NCT01601275|tuberculosis|tuberculosis
5007605|NCT01601262|ED|ed
5007606|NCT01601262|LI-ESWT|li-eswt
5007607|NCT01601249|IVF, embryo selection, polarized light|ivf, embryo selection, polarized light
5007608|NCT01601236|H.P. Acthar Gel|h.p. acthar gel
5007609|NCT01601236|Acthar|acthar
5007610|NCT01601236|diabetic nephropathy|diabetic nephropathy
5007611|NCT01601236|proteinuria|proteinuria
5007612|NCT01601236|nephrotic syndrome|nephrotic syndrome
5007613|NCT01601223|Ventilatory Management|ventilatory management
5007614|NCT01601223|Mechanical Ventilation|mechanical ventilation
5007615|NCT01601223|Post Operative pulmonary complications|post operative pulmonary complications
5007616|NCT01601223|Intra-operative complications|intra-operative complications
5007617|NCT01601223|General Anesthesia|general anesthesia
5007618|NCT01601223|Surgery|surgery
5007619|NCT01601223|LAS VEGAS|las vegas
5007620|NCT01601223|ESA (European Society of Anaesthesiology)|esa (european society of anaesthesiology)
5007621|NCT01601223|European Society of Anaesthesiology|european society of anaesthesiology
5007622|NCT01601197|immunization|immunization
5007623|NCT01601197|pain management|pain management
5007624|NCT01601197|infants|infants
5007625|NCT01601197|tactile stimulation|tactile stimulation
5007626|NCT01601184|medulloblastoma|medulloblastoma
5007627|NCT01601184|sonic hedgehog pathway|sonic hedgehog pathway
5007628|NCT01601184|vismodegib|vismodegib
5007629|NCT01601171|GnRH deficiency|gnrh deficiency
5007630|NCT01601171|hypogonadism|hypogonadism
5007631|NCT01601171|anosmia|anosmia
5007632|NCT01601171|infertility|infertility
5007633|NCT01601171|cleft lip|cleft lip
5007634|NCT01601171|cleft palate|cleft palate
5007635|NCT01601171|cryptorchidism|cryptorchidism
5007636|NCT01601171|microphallus|microphallus
5007637|NCT01601158|Global developmental delay|global developmental delay
5007638|NCT01601158|Umbilical cord blood|umbilical cord blood
5007639|NCT01601158|Rehabilitation|rehabilitation
5007640|NCT01601145|Lactobacillus Brevis CD2|lactobacillus brevis cd2
5007641|NCT01601145|schoolchildren|schoolchildren
5007642|NCT01601145|dental caries|dental caries
5007643|NCT01601145|Gingivatis|gingivatis
5007644|NCT01601132|pharmacokinetics|pharmacokinetics
5007645|NCT01601132|colchicine|colchicine
5007646|NCT01601132|theophylline|theophylline
5007647|NCT01601119|Multiple Sclerosis|multiple sclerosis
5007648|NCT01601119|Patient reported outcome|patient reported outcome
5007649|NCT01601119|Patient reported experience|patient reported experience
5007650|NCT01601106|Atherosclerosis, inflammation|atherosclerosis, inflammation
5007651|NCT01601093|Respiratory and urinary tract infections|respiratory and urinary tract infections
5007652|NCT01601093|Ceftazidime and Sulbactam Sodium for Injection (2:1)|ceftazidime and sulbactam sodium for injection (2:1)
5007653|NCT01601093|Phase Ⅱ|phase ⅱ
5007654|NCT01601080|Adherence|adherence
5007655|NCT01601080|Multiple Sclerosis|multiple sclerosis
5007656|NCT01601067|posttraumatic stress disorder|posttraumatic stress disorder
5007657|NCT01601067|psychotherapy|psychotherapy
5007658|NCT01601067|alcoholism|alcoholism
5007659|NCT01601054|spine|spine
5007660|NCT01601054|deformity|deformity
5007661|NCT01601054|instrumentation|instrumentation
5007662|NCT01601054|ALIF|alif
5007663|NCT01601041|Urinary Tract Infection|urinary tract infection
5007664|NCT01601041|Bacteriuria|bacteriuria
5007665|NCT01601041|Pyuria|pyuria
5007666|NCT01601041|Prostatitis|prostatitis
5007667|NCT01601041|Intermittent Catheterization|intermittent catheterization
5007668|NCT01601041|Spinal Cord Injuries|spinal cord injuries
5007669|NCT01601041|Residual Urine|residual urine
5007670|NCT01601028|Autoimmune Diseases|autoimmune diseases
5007671|NCT01601028|Sjogren's Syndrome|sjogren's syndrome
5007672|NCT01601028|Hydroxychloroquine|hydroxychloroquine
5007673|NCT01601015|Tension-type headache, Effectiveness, Manual therapy|tension-type headache, effectiveness, manual therapy
5007674|NCT01601002|Mirtazapine|mirtazapine
5007675|NCT01600989|shock septic|shock septic
5007676|NCT01600989|monocytes|monocytes
5007677|NCT01600989|lymphocytes|lymphocytes
5007678|NCT01600989|mitochondria|mitochondria
5007679|NCT01600989|interleukins|interleukins
5007680|NCT01600989|Tumor Necrosis Factor-alpha|tumor necrosis factor-alpha
5007681|NCT01600989|Hypoxia-Inducible Factor 1, alpha Subunit|hypoxia-inducible factor 1, alpha subunit
5007682|NCT01600976|Hepatic impairment|hepatic impairment
5007683|NCT01600976|Hepatitis C|hepatitis c
5007684|NCT01600976|Telaprevir|telaprevir
5007685|NCT01600976|VX-950|vx-950
5007686|NCT01600976|Pharmacokinetics|pharmacokinetics
5007687|NCT01600976|Safety|safety
5007688|NCT01600976|Unbound plasma concentrations|unbound plasma concentrations
5007689|NCT01600976|Child-Pugh score|child-pugh score
5007690|NCT01600963|Multi-drug resistant tuberculosis|multi-drug resistant tuberculosis
5007691|NCT01600963|Pre-extensively drug resistant tuberculosis|pre-extensively drug resistant tuberculosis
5007692|NCT01600963|TMC207|tmc207
5007693|NCT01600963|Background regimen|background regimen
5007694|NCT01600937|diabetes mellitus|diabetes mellitus
5007695|NCT01600937|diabetes education|diabetes education
5007696|NCT01600937|behavioral therapy|behavioral therapy
5007697|NCT01600937|behavior modification|behavior modification
5007698|NCT01600937|physical activity|physical activity
5007699|NCT01600937|supervised exercise|supervised exercise
5007700|NCT01600937|physical fitness|physical fitness
5007701|NCT01600937|HbA1c|hba1c
5007702|NCT01600937|modifiable cardiovascular risk factors|modifiable cardiovascular risk factors
5007703|NCT01600937|quality of life|quality of life
5007704|NCT01600924|diabetes mellitus|diabetes mellitus
5007705|NCT01600924|muscle strength|muscle strength
5007706|NCT01600924|bone strength|bone strength
5007707|NCT01600924|cardiovascular risk factors|cardiovascular risk factors
5007708|NCT01600924|diabetic complications|diabetic complications
5007709|NCT01600911|metabolomics|metabolomics
5007710|NCT01600911|nutri-metabolomics|nutri-metabolomics
5007711|NCT01600911|plant food|plant food
5007712|NCT01600911|blood pressure|blood pressure
5007713|NCT01600898|Asymptomatic carriers of a BMPR2 mutation|asymptomatic carriers of a bmpr2 mutation
5007714|NCT01600898|follow up study|follow up study
5007715|NCT01600885|Guanfacine|guanfacine
5007716|NCT01600885|Ketamine|ketamine
5007717|NCT01600885|Functional Magnetic Resonance Imaging|functional magnetic resonance imaging
5007718|NCT01600885|Prefrontal Cortex Activity|prefrontal cortex activity
5007719|NCT01600885|Receptors, N-Methyl-D-Aspartate|receptors, n-methyl-d-aspartate
5007720|NCT01600885|Receptors, Adrenergic, alpha-2|receptors, adrenergic, alpha-2
5007721|NCT01600885|Memory, Short-Term|memory, short-term
5007722|NCT01600885|Schizophrenia|schizophrenia
5007723|NCT01600872|EDCs|edcs
5007724|NCT01600872|PCOS|pcos
5007726|NCT01600872|TOS|tos
5007727|NCT01600872|ROS|ros
5007728|NCT01600872|Oxidative Stress, Endocrine-Disrupting Chemicals, Polycystic Ovary syndrome|oxidative stress, endocrine-disrupting chemicals, polycystic ovary syndrome
5007729|NCT01600846|Pharmacogenetic testing|pharmacogenetic testing
5007730|NCT01600846|pharmacokinetics|pharmacokinetics
5007731|NCT01600846|Pharmacogenomics|pharmacogenomics
5007732|NCT01600846|genetics|genetics
5007733|NCT01600846|pharmacy|pharmacy
5007734|NCT01600846|drug response|drug response
5007735|NCT01600833|PCOS|pcos
5007736|NCT01600833|Ferritin|ferritin
5007737|NCT01600833|Homocysteine|homocysteine
5007738|NCT01600833|Insulin Resistance|insulin resistance
5007739|NCT01600833|Metabolic Syndrome|metabolic syndrome
5007740|NCT01600820|Plant sterol|plant sterol
5007741|NCT01600820|Hypercholesterolemia|hypercholesterolemia
5007742|NCT01600820|diet|diet
5007743|NCT01600820|dairy|dairy
5007744|NCT01600820|LDL-C|ldl-c
5007745|NCT01600820|Mildly hypercholesterolemic subjects|mildly hypercholesterolemic subjects
5007746|NCT01600807|Metastatic|metastatic
5007747|NCT01600807|Pancreas|pancreas
5007748|NCT01600807|Cancer|cancer
5007749|NCT01600807|Adenocarcinoma|adenocarcinoma
5007750|NCT01600794|In Vitro Fertilization (IVF)|in vitro fertilization (ivf)
5007751|NCT01600794|androgens|androgens
5007752|NCT01600794|ovary function|ovary function
5007753|NCT01600794|This study include the patients who are evaluated by the doctors and are sure to process the In Vitro Fertilization cycle.|this study include the patients who are evaluated by the doctors and are sure to process the in vitro fertilization cycle.
5007754|NCT01600781|Improve the nutritional status|improve the nutritional status
5007755|NCT01600781|QOL|qol
5007756|NCT01600781|children|children
5007757|NCT01600781|enhance immune response|enhance immune response
5007758|NCT01600781|induction chemotherapy|induction chemotherapy
5007759|NCT01600781|fewer side effects|fewer side effects
5007760|NCT01600768|focus of study|focus of study
5007761|NCT01600755|Cell Therapy|cell therapy
5007762|NCT01600755|Autologous Cell Transplantation|autologous cell transplantation
5007763|NCT01600755|Muscle-derived Cell|muscle-derived cell
5007764|NCT01600755|Anal Incontinence|anal incontinence
5007765|NCT01600755|Rectal Diseases|rectal diseases
5007766|NCT01600755|Intestinal Diseases|intestinal diseases
5007767|NCT01600755|Gastrointestinal Diseases|gastrointestinal diseases
5007768|NCT01600755|Urinary Incontinence|urinary incontinence
5007769|NCT01600703|Intestinal lipoprotein|intestinal lipoprotein
5007770|NCT01600703|Apolipoprotein B48 and apolipoprotein B100|apolipoprotein b48 and apolipoprotein b100
5007771|NCT01600703|Pancreatic clamp|pancreatic clamp
5007772|NCT01600703|DPPIV inhibitor|dppiv inhibitor
5007773|NCT01600690|Stem cells|stem cells
5007774|NCT01600690|Regeneration|regeneration
5007775|NCT01600690|Inflammation|inflammation
5007776|NCT01600677|Experimental; Computerized medication delivery unit|experimental; computerized medication delivery unit
5007777|NCT01600664|Type 1 diabetes|type 1 diabetes
5007778|NCT01600664|"My Diabetic friend"|"my diabetic friend"
5007779|NCT01600664|interactive computer game|interactive computer game
5007780|NCT01600651|Receptor for advanced glycation end products (RAGE)|receptor for advanced glycation end products (rage)
5007781|NCT01600651|Soluble RAGE (sRAGE)|soluble rage (srage)
5007782|NCT01600651|Recruitment Maneuver|recruitment maneuver
5007783|NCT01600651|Acute respiratory distress syndrome (ARDS)|acute respiratory distress syndrome (ards)
5007784|NCT01600651|Alveolar epithelium|alveolar epithelium
5007785|NCT01600651|Electrical Impedance Tomography|electrical impedance tomography
5007786|NCT01600651|Mechanical ventilation|mechanical ventilation
5007787|NCT01600651|Intensive Care Unit (ICU)|intensive care unit (icu)
5007788|NCT01600638|Lipolysis|lipolysis
5007789|NCT01600638|Cryolipolysis|cryolipolysis
5007790|NCT01600638|Fat Reduction|fat reduction
5007791|NCT01600625|meibomian gland dysfunction|meibomian gland dysfunction
5007792|NCT01600625|inflammatory tear cytokine|inflammatory tear cytokine
5007793|NCT01600625|minocycline|minocycline
5007794|NCT01600612|postpartum hemorrhage, oxytocin, carbetocin, misopristol|postpartum hemorrhage, oxytocin, carbetocin, misopristol
5007795|NCT01600586|Neonatal Intensive Care Unit (NICU)|neonatal intensive care unit (nicu)
5007796|NCT01600586|Music therapy|music therapy
5007797|NCT01600586|Premature infant|premature infant
5007798|NCT01600586|Oral feeds|oral feeds
5007799|NCT01600586|Non-Nutritive Sucking|non-nutritive sucking
5007800|NCT01600586|Suck rate|suck rate
5007801|NCT01600586|Suck efficiency|suck efficiency
5007802|NCT01600586|Contingent music|contingent music
5007803|NCT01600586|Mother's voice|mother's voice
5007804|NCT01600573|ovarian cancer|ovarian cancer
5007805|NCT01600534|gestational diabetes|gestational diabetes
5007806|NCT01600508|stoma care|stoma care
5007807|NCT01600508|videoconference|videoconference
5007808|NCT01600508|costs|costs
5007809|NCT01600508|quality of life|quality of life
5007810|NCT01600495|pain|pain
5007811|NCT01600495|electric stimulation|electric stimulation
5007812|NCT01600495|nervous|nervous
5007813|NCT01600495|transcutaneous|transcutaneous
5007814|NCT01600495|humanized childbirth|humanized childbirth
5007815|NCT01600482|Hemostasis.|hemostasis.
5007816|NCT01600482|Percutaneous coronary interventions.|percutaneous coronary interventions.
5007817|NCT01600482|Closure Device|closure device
5007818|NCT01600469|Alzheimer's disease|alzheimer's disease
5007819|NCT01600469|mild cognitive impairment|mild cognitive impairment
5007820|NCT01600469|NMDA|nmda
5007821|NCT01600456|PTSD|ptsd
5007822|NCT01600456|Antidepressants|antidepressants
5007823|NCT01600456|Cognitive behavior therapy|cognitive behavior therapy
5007824|NCT01600430|Vitamin D|vitamin d
5007825|NCT01600430|Newborn|newborn
5007826|NCT01600430|Preterm|preterm
5007827|NCT01600430|Supplementation|supplementation
5007828|NCT01600430|Respiratory|respiratory
5007829|NCT01600417|low back pain|low back pain
5007830|NCT01600417|spine|spine
5007831|NCT01600417|lumbar spine|lumbar spine
5007832|NCT01600417|lumbar instability|lumbar instability
5007833|NCT01600417|radiology|radiology
5007834|NCT01600417|functional radiology|functional radiology
5007835|NCT01600404|Mild Cognitive Impairment|mild cognitive impairment
5007836|NCT01600404|Muscarinic Antagonists|muscarinic antagonists
5007837|NCT01600404|Spinal Cord Injuries|spinal cord injuries
5007838|NCT01600404|Urinary Bladder, Neurogenic|urinary bladder, neurogenic
5009220|NCT01594801|insulin|insulin
5007839|NCT01600404|Urinary Bladder, Overactive|urinary bladder, overactive
5007840|NCT01600404|Overactive Detrusor|overactive detrusor
5007841|NCT01600391|Stroke|stroke
5007842|NCT01600391|Visual cues|visual cues
5007843|NCT01600391|Gait rehabilitation|gait rehabilitation
5007844|NCT01600391|Walking adaptability|walking adaptability
5007845|NCT01600391|Turning|turning
5007846|NCT01600391|Overground walking|overground walking
5007847|NCT01600391|Treadmill training|treadmill training
5007848|NCT01600378|diffuse parenchymal lung disease|diffuse parenchymal lung disease
5007849|NCT01600378|interstitial lung disease|interstitial lung disease
5007850|NCT01600378|idiopathic pulmonary fibrosis|idiopathic pulmonary fibrosis
5007851|NCT01600365|Conjunctivitis|conjunctivitis
5007852|NCT01600365|adenovirus.|adenovirus.
5007853|NCT01600352|interstitial lung disease|interstitial lung disease
5007854|NCT01600352|idiopathic pulmonary fibrosis|idiopathic pulmonary fibrosis
5007855|NCT01600313|rice bran oil|rice bran oil
5007856|NCT01600313|diet|diet
5007857|NCT01600313|cardiovascular disease|cardiovascular disease
5007858|NCT01600313|low density lipoprotein|low density lipoprotein
5007859|NCT01600313|total cholesterol|total cholesterol
5007860|NCT01600300|Age-related macular degeneration|age-related macular degeneration
5007861|NCT01600300|electrical stimulation|electrical stimulation
5007862|NCT01600300|randomized|randomized
5007863|NCT01600300|double blind|double blind
5007864|NCT01600287|bispectral index|bispectral index
5007865|NCT01600287|propofol|propofol
5007866|NCT01600287|paediatric cardiac surgery|paediatric cardiac surgery
5007867|NCT01600287|closed loop anaesthesia delivery system|closed loop anaesthesia delivery system
5007868|NCT01600261|without eye disease|without eye disease
5007869|NCT01600248|Chronic Pain|chronic pain
5007870|NCT01600248|Military|military
5007871|NCT01600248|Veteran|veteran
5007872|NCT01600248|Online|online
5007873|NCT01600248|Acceptance|acceptance
5007874|NCT01600235|Stroke, ischemic|stroke, ischemic
5007875|NCT01600235|Progression|progression
5007876|NCT01600235|Induced-hypertension|induced-hypertension
5007877|NCT01600235|Phenylephrine|phenylephrine
5007878|NCT01600209|Cancer|cancer
5007879|NCT01600209|Colorectal Cancer|colorectal cancer
5007880|NCT01600209|Neoplasm|neoplasm
5007881|NCT01600209|Colorectal Neoplasm|colorectal neoplasm
5007882|NCT01600209|Intestinal Neoplasms|intestinal neoplasms
5007883|NCT01600209|Gastrointestinal Neoplasms|gastrointestinal neoplasms
5007884|NCT01600209|Digestive System Neoplasms|digestive system neoplasms
5007885|NCT01600209|Neoplasms by Site|neoplasms by site
5007886|NCT01600209|Neoplasms|neoplasms
5007887|NCT01600209|Digestive System Diseases|digestive system diseases
5007888|NCT01600209|Gastrointestinal Diseases|gastrointestinal diseases
5007889|NCT01600209|Colonic Diseases|colonic diseases
5007890|NCT01600209|Intestinal Diseases|intestinal diseases
5007891|NCT01600209|Rectal Diseases|rectal diseases
5007892|NCT01600196|Hepatectomy|hepatectomy
5007893|NCT01600196|Thrombectomy|thrombectomy
5007894|NCT01600196|Hepatocellular carcinoma|hepatocellular carcinoma
5007895|NCT01600196|Portal vein tumor thrombus|portal vein tumor thrombus
5007896|NCT01600183|MTA|mta
5007897|NCT01600183|metatarsus|metatarsus
5007898|NCT01600183|Metatarsus Adductus, also known as Metatarsus Varus|metatarsus adductus, also known as metatarsus varus
5007899|NCT01600170|HIV|hiv
5007900|NCT01600170|monocytes|monocytes
5007901|NCT01600170|CD16+|cd16+
5007902|NCT01600170|statins|statins
5007903|NCT01600170|mcp1|mcp1
5007904|NCT01600170|inflammation|inflammation
5007905|NCT01600144|data mammography|data mammography
5007906|NCT01600118|tooth mobility|tooth mobility
5007907|NCT01600118|periodontal status|periodontal status
5007908|NCT01600118|irregularity index|irregularity index
5007909|NCT01600118|pulpal blood flow|pulpal blood flow
5007910|NCT01600105|liver fibrosis|liver fibrosis
5007911|NCT01600105|liver cirrhosis|liver cirrhosis
5007912|NCT01600105|chronic hepatitis|chronic hepatitis
5007913|NCT01600105|magnetic resonance imaging|magnetic resonance imaging
5007914|NCT01600079|Varicella-zoster vaccine|varicella-zoster vaccine
5007915|NCT01600079|herpes zoster|herpes zoster
5007916|NCT01600079|shingles|shingles
5007917|NCT01600079|Varicella-zoster virus|varicella-zoster virus
5007918|NCT01600079|postherpetic neuralgia|postherpetic neuralgia
5007919|NCT01600079|Herpesviridae Infections|herpesviridae infections
5007920|NCT01600079|DNA Virus Infections|dna virus infections
5007921|NCT01600079|Virus Diseases|virus diseases
5007922|NCT01600053|Chronic|chronic
5007923|NCT01600053|Lymphocytic|lymphocytic
5007924|NCT01600053|Leukemia|leukemia
5007925|NCT01600040|metastatic|metastatic
5007926|NCT01600027|Fascia iliaca block|fascia iliaca block
5007927|NCT01600027|dexmetomidine|dexmetomidine
5007928|NCT01600027|fracture femur|fracture femur
5007929|NCT01600027|α2 agonist|α2 agonist
5007930|NCT01600001|Chronic Idiopathic Constipation (CIC)|chronic idiopathic constipation (cic)
5007931|NCT01600001|Constipation|constipation
5007932|NCT01600001|Functional gastrointestinal disorders|functional gastrointestinal disorders
5007933|NCT01599975|HAND|hand
5007934|NCT01599975|HIV Associated Neurocognitive Disorder|hiv associated neurocognitive disorder
5007935|NCT01599975|Methylphenidate|methylphenidate
5007936|NCT01599975|HIV Dementia|hiv dementia
5007937|NCT01599949|Mantle cell lymphoma|mantle cell lymphoma
5007938|NCT01599949|Ibrutinib|ibrutinib
5007939|NCT01599949|Bruton's tyrosine kinase inhibitor|bruton's tyrosine kinase inhibitor
5007940|NCT01599949|Rituximab|rituximab
5007941|NCT01599949|Bortezomib|bortezomib
5007942|NCT01599936|scorpion sting|scorpion sting
5007943|NCT01599936|envenomation|envenomation
5007944|NCT01599936|Anascorp|anascorp
5007945|NCT01599923|scorpion|scorpion
5007946|NCT01599923|envenomation|envenomation
5007947|NCT01599923|Alacramyn|alacramyn
5007948|NCT01599910|Scribes|scribes
5007949|NCT01599910|Physician Productivity|physician productivity
5007950|NCT01599910|Electronic Documentation|electronic documentation
5007951|NCT01599897|Tuberculosis|tuberculosis
5007952|NCT01599897|TB|tb
5007953|NCT01599897|Pulmonary|pulmonary
5007954|NCT01599897|Vaccine|vaccine
5007955|NCT01599884|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
5007956|NCT01599884|Chronic bronchitis|chronic bronchitis
5007957|NCT01599884|N-acetylcysteine|n-acetylcysteine
5007958|NCT01599871|COPD|copd
5007959|NCT01599858|YF476|yf476
5007960|NCT01599858|gastrin receptor antagonist|gastrin receptor antagonist
5007961|NCT01599858|gastric pH|gastric ph
5007962|NCT01599858|healthy subjects|healthy subjects
5007963|NCT01599858|omeprazole|omeprazole
5007964|NCT01599845|Lung|lung
5007965|NCT01599845|Alveoli|alveoli
5007966|NCT01599845|Nanoparticles|nanoparticles
5007967|NCT01599845|Particulate matter|particulate matter
5007968|NCT01599845|Exhaled breath condensate|exhaled breath condensate
5007969|NCT01599845|Induced sputum|induced sputum
5007970|NCT01599845|Forced expiratory volume|forced expiratory volume
5007971|NCT01599845|Force vital capacity|force vital capacity
5007972|NCT01599806|Ceftazidime, Avibactam, Doripenem, Ciprofloxacin, sulfamethoxazole/trimethoprim, Anti-Infective Agents, Complicated Urinary Tract Infection,Acute Pyelonephritis|ceftazidime, avibactam, doripenem, ciprofloxacin, sulfamethoxazole/trimethoprim, anti-infective agents, complicated urinary tract infection,acute pyelonephritis
5007973|NCT01599793|castrate resistant prostate cancer|castrate resistant prostate cancer
5007974|NCT01599793|CRPC|crpc
5007975|NCT01599793|cabozantinib|cabozantinib
5007976|NCT01599793|XL184|xl184
5007977|NCT01599780|preterm|preterm
5007978|NCT01599780|premature|premature
5007979|NCT01599780|prematurity|prematurity
5007980|NCT01599780|children|children
5007981|NCT01599780|child|child
5007982|NCT01599780|kid|kid
5007983|NCT01599780|toddler|toddler
5007984|NCT01599780|infant|infant
5007985|NCT01599780|baby|baby
5007986|NCT01599780|language|language
5007987|NCT01599780|development|development
5007988|NCT01599780|skills|skills
5007989|NCT01599780|listening|listening
5007990|NCT01599780|talking|talking
5007991|NCT01599780|communication|communication
5007992|NCT01599780|speech|speech
5007993|NCT01599780|processing|processing
5007994|NCT01599767|transcranial stimulation|transcranial stimulation
5007995|NCT01599767|direct current|direct current
5007996|NCT01599754|renal cell carcinoma|renal cell carcinoma
5007997|NCT01599754|axitinib|axitinib
5007998|NCT01599754|tyrosine kinase inhibitor|tyrosine kinase inhibitor
5007999|NCT01599741|X-rays|x-rays
5008000|NCT01599741|Endovascular angiography|endovascular angiography
5008001|NCT01599741|Image processing|image processing
5008002|NCT01599728|Urocortin 2|urocortin 2
5008003|NCT01599728|Urocortin 3|urocortin 3
5008004|NCT01599728|Forearm venous occlusion plethysmography|forearm venous occlusion plethysmography
5008005|NCT01599728|Heart failure|heart failure
5008006|NCT01599728|Endothelium|endothelium
5008007|NCT01599728|Substance P|substance p
5008008|NCT01599715|Urinary Incontinence|urinary incontinence
5008009|NCT01599715|Weak bladder|weak bladder
5008010|NCT01599715|Frequent urination|frequent urination
5008011|NCT01599715|Overactive bladder|overactive bladder
5008012|NCT01599715|Urine leakage|urine leakage
5008013|NCT01599715|Stress incontinence|stress incontinence
5008014|NCT01599715|Urge Incontinence|urge incontinence
5008015|NCT01599715|Pelvic Floor weakness|pelvic floor weakness
5008016|NCT01599715|Pelvic Floor Muscle Exercises|pelvic floor muscle exercises
5008017|NCT01599715|Kegel exercises|kegel exercises
5008018|NCT01599715|Self-Care|self-care
5008019|NCT01599702|IBD|ibd
5008020|NCT01599702|IDA|ida
5008021|NCT01599702|Subjects|subjects
5008022|NCT01599702|diagnosis|diagnosis
5008023|NCT01599689|Delirium|delirium
5008024|NCT01599689|Delirium, Dementia, Amnestic, Cognitive Disorders|delirium, dementia, amnestic, cognitive disorders
5008025|NCT01599689|Confusion|confusion
5008026|NCT01599689|Neurobehavioral Manifestations|neurobehavioral manifestations
5008027|NCT01599689|Neurologic Manifestations|neurologic manifestations
5008028|NCT01599689|Nervous System Diseases|nervous system diseases
5008029|NCT01599689|Signs and Symptoms|signs and symptoms
5008030|NCT01599689|Mental Disorders|mental disorders
5008031|NCT01599689|Cardiac Surgery|cardiac surgery
5008032|NCT01599689|Mirrors|mirrors
5008033|NCT01599676|Citrulline|citrulline
5008034|NCT01599676|protein-energy malnutrition|protein-energy malnutrition
5008035|NCT01599676|amino acids|amino acids
5008036|NCT01599676|muscle strength|muscle strength
5008037|NCT01599676|resistance training|resistance training
5008038|NCT01599663|Pain management|pain management
5008039|NCT01599663|Pain assessment|pain assessment
5008040|NCT01599663|Intensive care unit|intensive care unit
5008041|NCT01599663|Adult|adult
5008042|NCT01599650|Macular Edema, Branch Retinal Vein Occlusion, visual impairment|macular edema, branch retinal vein occlusion, visual impairment
5008043|NCT01599637|Chronic idiopathic urticaria|chronic idiopathic urticaria
5008044|NCT01599637|CIU|ciu
5008045|NCT01599637|Xolair|xolair
5008046|NCT01599637|IGE025|ige025
5008047|NCT01599637|FcεRI|fcεri
5008048|NCT01599637|IgE|ige
5008049|NCT01599624|Resilience|resilience
5008050|NCT01599624|Perceived stress|perceived stress
5008051|NCT01599624|PTSD symptoms|ptsd symptoms
5008052|NCT01599624|Depression|depression
5008053|NCT01599624|Anxiety|anxiety
5008054|NCT01599624|Sleep quality|sleep quality
5008055|NCT01599624|United States Navy service members|united states navy service members
5008056|NCT01599611|Neonatal hyperbilirubinemia|neonatal hyperbilirubinemia
5008057|NCT01599611|Follow-up|follow-up
5008058|NCT01599611|Motor development|motor development
5008059|NCT01599611|Hearing|hearing
5008060|NCT01599611|Executive function|executive function
5008061|NCT01599598|perceived stress|perceived stress
5008062|NCT01599598|depression|depression
5008063|NCT01599598|anxiety|anxiety
5008064|NCT01599598|posttraumatic stress disorder|posttraumatic stress disorder
5008065|NCT01599598|military|military
5008066|NCT01599598|school|school
5008067|NCT01599598|training environment|training environment
5008068|NCT01599598|heart rate variability|heart rate variability
5008069|NCT01599598|progressive muscle relaxation|progressive muscle relaxation
5008070|NCT01599598|psychophysiological coherence|psychophysiological coherence
5008071|NCT01599598|coherence advantage|coherence advantage
5008072|NCT01599598|stress reduction|stress reduction
5008073|NCT01599598|stress regulation|stress regulation
5008074|NCT01599598|independent duty corpsmen|independent duty corpsmen
5008075|NCT01599585|Depression|depression
5008076|NCT01599585|Behavioral Activation|behavioral activation
5008077|NCT01599585|Tele-medicine|tele-medicine
5008078|NCT01599572|zinc supplementation|zinc supplementation
5008079|NCT01599572|serum zinc concentration|serum zinc concentration
5008080|NCT01599572|lymphocyte proliferation|lymphocyte proliferation
5008081|NCT01599559|previously|previously
5008082|NCT01599559|untreated|untreated
5008083|NCT01599546|Preterm|preterm
5008084|NCT01599546|Full term|full term
5008085|NCT01599546|Reading|reading
5008086|NCT01599546|Dyslexia|dyslexia
5008087|NCT01599546|Brain|brain
5008088|NCT01599546|Diffusion tensor imaging|diffusion tensor imaging
5008089|NCT01599520|cancer|cancer
5008090|NCT01599520|stress|stress
5008091|NCT01599520|stress management|stress management
5008092|NCT01599520|Latinas|latinas
5008093|NCT01599520|Hispanics|hispanics
5008094|NCT01599507|Anemia|anemia
5008095|NCT01599507|Renal|renal
5008096|NCT01599481|Common mental illness|common mental illness
5008097|NCT01599481|Supported Employment|supported employment
5008098|NCT01599481|Anxiety|anxiety
5008099|NCT01599481|Depression|depression
5008100|NCT01599481|Sickness absence|sickness absence
5008101|NCT01599468|post partum hemorrhage|post partum hemorrhage
5008102|NCT01599468|transfusion|transfusion
5008103|NCT01599468|tranexamic acid|tranexamic acid
5008104|NCT01599455|pediatric spinal cord injury|pediatric spinal cord injury
5008105|NCT01599455|blood pressure|blood pressure
5008106|NCT01599455|heart rate|heart rate
5008107|NCT01599455|baseline|baseline
5008108|NCT01599429|AML / LMA|aml / lma
5008109|NCT01599416|Oral Probiotics|oral probiotics
5008110|NCT01599416|HPV DNA Index Test|hpv dna index test
5008111|NCT01599416|Vaginal infection|vaginal infection
5008112|NCT01599403|Rib Fracture|rib fracture
5008113|NCT01599403|Intercostal Nerve Block|intercostal nerve block
5008114|NCT01599403|Paravertebral Nerve Block|paravertebral nerve block
5008115|NCT01599390|United States|united states
5008116|NCT01599390|Burden of Disease|burden of disease
5008117|NCT01599390|Influenza|influenza
5008118|NCT01599364|HIV infection|hiv infection
5008119|NCT01599364|Atazanavir|atazanavir
5008120|NCT01599364|Lamivudine|lamivudine
5008121|NCT01599364|Ritonavir|ritonavir
5008122|NCT01599364|virological suppression|virological suppression
5008123|NCT01599364|non-inferiority|non-inferiority
5008124|NCT01599364|Combined antiretroviral therapy|combined antiretroviral therapy
5008125|NCT01599351|Radiation exposure|radiation exposure
5008126|NCT01599351|ERCP|ercp
5008127|NCT01599338|Liraglutide|liraglutide
5008128|NCT01599338|GLP-1 analogue|glp-1 analogue
5008129|NCT01599338|Food preference|food preference
5008130|NCT01599338|Gustative perception|gustative perception
5008131|NCT01599338|Liking|liking
5008132|NCT01599338|wanting|wanting
5008133|NCT01599338|T2DM|t2dm
5008134|NCT01599338|body mass composition|body mass composition
5008135|NCT01599338|leptin|leptin
5008136|NCT01599338|ghrelin|ghrelin
5008137|NCT01599312|Videolaryngoscopy|videolaryngoscopy
5008138|NCT01599312|Forces|forces
5008139|NCT01599312|Teeth|teeth
5008140|NCT01599299|ultrasound|ultrasound
5008141|NCT01599299|left and right jugular vein|left and right jugular vein
5008142|NCT01599299|comparison|comparison
5008143|NCT01599286|Hyperammonia|hyperammonia
5008144|NCT01599286|Propionic Acidemia (PA)|propionic acidemia (pa)
5008145|NCT01599286|Methylmalonic Acidemia (MMA)|methylmalonic acidemia (mma)
5008146|NCT01599286|Late-Onset CPS1 Deficiency (CPSD)|late-onset cps1 deficiency (cpsd)
5008147|NCT01599286|Late-Onset Ornithine Transcarbamylase Deficiency (OTCD)|late-onset ornithine transcarbamylase deficiency (otcd)
5008148|NCT01599286|Carbaglu|carbaglu
5008149|NCT01599273|thyroid-associated ophthalmopathy|thyroid-associated ophthalmopathy
5008150|NCT01599273|triamcinolone|triamcinolone
5008151|NCT01599273|retraction|retraction
5008152|NCT01599273|swelling|swelling
5008153|NCT01599247|Suicide|suicide
5008154|NCT01599247|Optimism|optimism
5008155|NCT01599247|Hopelessness|hopelessness
5008156|NCT01599221|Femoral fractures|femoral fractures
5008157|NCT01599221|Nail|nail
5008158|NCT01599221|Implant|implant
5008159|NCT01599221|Elderly|elderly
5008160|NCT01599221|Orthopaedics|orthopaedics
5008161|NCT01599195|carotid stenosis|carotid stenosis
5008162|NCT01599195|femoral artery ischemia|femoral artery ischemia
5008163|NCT01599195|carotid bruit asymptomatic|carotid bruit asymptomatic
5008164|NCT01599195|carotid murmur|carotid murmur
5008165|NCT01599169|Burnout syndrome|burnout syndrome
5008166|NCT01599169|Depression work-related|depression work-related
5008167|NCT01599169|Food supplement|food supplement
5008168|NCT01599156|Chronic constipation|chronic constipation
5008169|NCT01599156|Reflexology|reflexology
5008170|NCT01599156|Complementary medicine|complementary medicine
5008171|NCT01599143|Mindfulness|mindfulness
5008172|NCT01599143|Pain Disorder (Chronic physical or mental health complaints:|pain disorder (chronic physical or mental health complaints:
5008173|NCT01599143|Fibromyalgia; Migraines; Back Pain; etc)|fibromyalgia; migraines; back pain; etc)
5008174|NCT01599143|Anxiety Disorder/Anxiety State|anxiety disorder/anxiety state
5008175|NCT01599130|Hepatitis B|hepatitis b
5008176|NCT01599130|sequential peg-interferon-2a to entecavir|sequential peg-interferon-2a to entecavir
5008177|NCT01599117|Heart Failure with Preserved Ejection Fraction|heart failure with preserved ejection fraction
5008178|NCT01599117|Diastolic Heart Failure|diastolic heart failure
5008179|NCT01599117|Exercise Capacity|exercise capacity
5008180|NCT01599117|Cardiopulmonary Exercise Test|cardiopulmonary exercise test
5008181|NCT01599117|Udenafil (Zydena)|udenafil (zydena)
5008182|NCT01599117|Phosphodiesterase Type 5 Inhibitors|phosphodiesterase type 5 inhibitors
5008183|NCT01599104|Essential hypertension|essential hypertension
5008184|NCT01599104|LCZ696|lcz696
5008185|NCT01599091|Fibroblasts|fibroblasts
5008186|NCT01599091|Periodontal ligament|periodontal ligament
5008187|NCT01599091|Gingiva|gingiva
5008188|NCT01599091|Porphyromonas gingivalis|porphyromonas gingivalis
5008189|NCT01599091|Chronic periodontitis|chronic periodontitis
5008190|NCT01599091|( patients undergoing tooth extraction will be asked permission to use extracted tooth and gingiva for periodontal disease basic research)|( patients undergoing tooth extraction will be asked permission to use extracted tooth and gingiva for periodontal disease basic research)
5008191|NCT01599078|Restenosis|restenosis
5008192|NCT01599078|Angioplasty|angioplasty
5008193|NCT01599078|Stent|stent
5008194|NCT01599078|Atherectomy|atherectomy
5008195|NCT01599078|Femoral Artery|femoral artery
5008196|NCT01599078|Popliteal Artery|popliteal artery
5008197|NCT01599078|Paclitaxel|paclitaxel
5008198|NCT01599065|ICD|icd
5008199|NCT01599065|internal cardioverter defibrillator|internal cardioverter defibrillator
5008200|NCT01599065|electrocautery|electrocautery
5008201|NCT01599052|Social Cognition|social cognition
5008202|NCT01599052|Theory of Mind|theory of mind
5008203|NCT01599052|Emotion Recognition|emotion recognition
5008204|NCT01599052|Social competence|social competence
5008205|NCT01599052|Brain Tumour|brain tumour
5008206|NCT01599039|early diagnostics|early diagnostics
5008207|NCT01599039|lymphedema|lymphedema
5008208|NCT01599039|breast cancer|breast cancer
5008209|NCT01599039|breast cancer related lymphedema|breast cancer related lymphedema
5008210|NCT01599039|measuring methods|measuring methods
5008211|NCT01599039|inverse water volumetry|inverse water volumetry
5008212|NCT01599039|prevention|prevention
5008213|NCT01599026|cardiology|cardiology
5008214|NCT01599026|fetus of diabetic mother|fetus of diabetic mother
5008215|NCT01599013|urothelial carcinoma|urothelial carcinoma
5008216|NCT01599013|bladder cancer|bladder cancer
5008217|NCT01599013|vinflunine|vinflunine
5008218|NCT01599013|transitional cell carcinoma|transitional cell carcinoma
5008219|NCT01599013|advanced or metastatic|advanced or metastatic
5008220|NCT01599013|unfit|unfit
5008221|NCT01599013|ineligible to cisplatin|ineligible to cisplatin
5008222|NCT01599013|renal impairment|renal impairment
5008223|NCT01599013|renal insufficiency|renal insufficiency
5008224|NCT01599013|urologic neoplasms|urologic neoplasms
5008225|NCT01599013|urogenital neoplasm|urogenital neoplasm
5008226|NCT01599013|urinary neoplasms|urinary neoplasms
5008227|NCT01599013|cisplatin|cisplatin
5008228|NCT01599013|tubulin inhibitors|tubulin inhibitors
5008229|NCT01599000|malaria|malaria
5008230|NCT01599000|Plasmodium|plasmodium
5008231|NCT01599000|Papua New Guinea|papua new guinea
5008232|NCT01599000|artemether/lumefantrine|artemether/lumefantrine
5008233|NCT01598987|Paediatric liver transplantation|paediatric liver transplantation
5008234|NCT01598987|Everolimus|everolimus
5009221|NCT01594801|injections|injections
5008235|NCT01598987|Reduced calcineurin inhibitor|reduced calcineurin inhibitor
5008236|NCT01598987|Cyclosporine, tacrolimus|cyclosporine, tacrolimus
5008237|NCT01598987|Renal function|renal function
5008238|NCT01598987|Composite efficacy endpoint (treated biopsy proven acute rejection death, graft loss)|composite efficacy endpoint (treated biopsy proven acute rejection death, graft loss)
5008239|NCT01598987|Liver transplant|liver transplant
5008240|NCT01598974|Lower Back Pain|lower back pain
5008241|NCT01598974|Acupuncture|acupuncture
5008242|NCT01598948|hypercholesterolemia|hypercholesterolemia
5008243|NCT01598948|apheresis|apheresis
5008244|NCT01598948|coronary heart disease|coronary heart disease
5008245|NCT01598948|cerebrovascular disease|cerebrovascular disease
5008246|NCT01598948|peripheral arterial disease|peripheral arterial disease
5008247|NCT01598922|Depression|depression
5008248|NCT01598922|Internet Cognitive Behavioral Therapy|internet cognitive behavioral therapy
5008249|NCT01598922|fMRI|fmri
5008250|NCT01598922|Neuroimaging|neuroimaging
5008251|NCT01598909|blepharoplasty|blepharoplasty
5008252|NCT01598909|arnica|arnica
5008253|NCT01598909|homeopathy|homeopathy
5008254|NCT01598896|Cannabis Dependence|cannabis dependence
5008255|NCT01598896|Marijuana Dependence|marijuana dependence
5008256|NCT01598896|Cannabis Use Disorders|cannabis use disorders
5008257|NCT01598896|Cannabis Withdrawal|cannabis withdrawal
5008258|NCT01598896|Dronabinol|dronabinol
5008259|NCT01598896|Clonidine|clonidine
5008260|NCT01598896|Schizophrenia|schizophrenia
5008261|NCT01598870|Spontaneous bacterial peritonitis.|spontaneous bacterial peritonitis.
5008262|NCT01598857|granulomatosis with polyangiitis|granulomatosis with polyangiitis
5008263|NCT01598857|microscopic polyangiitis|microscopic polyangiitis
5008264|NCT01598857|anti-neutrophil cytoplasmic antibodies|anti-neutrophil cytoplasmic antibodies
5008265|NCT01598857|ANCA-associated vasculitis|anca-associated vasculitis
5008266|NCT01598857|Wegener Granulomatosis|wegener granulomatosis
5008267|NCT01598831|sepsis|sepsis
5008268|NCT01598818|Vision Nearsighted|vision nearsighted
5008269|NCT01598818|Vision Farsighted|vision farsighted
5008270|NCT01598805|venous thromboembolism/prevention & control|venous thromboembolism/prevention & control
5008271|NCT01598779|genital warts|genital warts
5008272|NCT01598779|HPV types|hpv types
5008273|NCT01598779|Sexually Transmitted Diseases|sexually transmitted diseases
5008274|NCT01598779|Skin Diseases, Viral|skin diseases, viral
5008275|NCT01598779|Tumor Virus Infections|tumor virus infections
5008276|NCT01598779|Skin Diseases, Infectious|skin diseases, infectious
5008277|NCT01598779|Skin Diseases|skin diseases
5008278|NCT01598779|Papillomavirus Infections|papillomavirus infections
5008279|NCT01598779|DNA Virus Infections|dna virus infections
5008280|NCT01598779|Virus Diseases|virus diseases
5008281|NCT01598779|Sexually Transmitted Diseases, Viral|sexually transmitted diseases, viral
5008282|NCT01598727|parathyroid surgery|parathyroid surgery
5008283|NCT01598701|Acetaminophen|acetaminophen
5008284|NCT01598701|Intravenous Acetaminophen|intravenous acetaminophen
5008285|NCT01598701|Opioid Requirement|opioid requirement
5008286|NCT01598701|Pain|pain
5008287|NCT01598701|Post-Operative Pain|post-operative pain
5008288|NCT01598701|Craniotomy|craniotomy
5008289|NCT01598701|Post-Craniotomy Pain|post-craniotomy pain
5008290|NCT01598688|Bone marrow transplantation|bone marrow transplantation
5008291|NCT01598688|Hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
5008292|NCT01598688|Medication management|medication management
5008293|NCT01598688|Nursing care|nursing care
5008294|NCT01598675|stroke|stroke
5008295|NCT01598675|Gait|gait
5008296|NCT01598675|walking|walking
5008297|NCT01598662|IUD placement|iud placement
5008298|NCT01598662|contraception|contraception
5008299|NCT01598662|postpartum|postpartum
5008300|NCT01598662|intrauterine device|intrauterine device
5008301|NCT01598662|expulsion|expulsion
5008302|NCT01598649|Dietary protein|dietary protein
5008303|NCT01598649|Lupin protein|lupin protein
5008304|NCT01598649|Cholesterol metabolism|cholesterol metabolism
5008305|NCT01598649|Protein metabolism|protein metabolism
5008306|NCT01598649|Hypercholesterolemia|hypercholesterolemia
5008307|NCT01598649|Protein-enriched foods|protein-enriched foods
5008308|NCT01598584|Mirtazapine|mirtazapine
5008309|NCT01598584|gemcitabine|gemcitabine
5008310|NCT01598584|placebo|placebo
5008311|NCT01598584|RCT|rct
5008312|NCT01598584|pancreatic cancer|pancreatic cancer
5008313|NCT01598571|Phase 1|phase 1
5008314|NCT01598571|Healthy male volunteers|healthy male volunteers
5008315|NCT01598571|pharmacokinetics|pharmacokinetics
5008316|NCT01598571|fostamatinib|fostamatinib
5008317|NCT01598571|Bioavailability|bioavailability
5008318|NCT01598571|R406 plasma AUC and Cmax|r406 plasma auc and cmax
5008319|NCT01598571|R406 plasma AUC0-t|r406 plasma auc0-t
5008320|NCT01598571|t1/2λz|t1/2λz
5008321|NCT01598571|tmax|tmax
5008322|NCT01598532|mild traumatic brain injury|mild traumatic brain injury
5008323|NCT01598532|mild TBI|mild tbi
5008324|NCT01598532|mTBI|mtbi
5008325|NCT01598519|school-based|school-based
5008326|NCT01598519|adolescent suicide|adolescent suicide
5008327|NCT01598519|intervention|intervention
5008328|NCT01598519|screening|screening
5008329|NCT01598493|Burns|burns
5008330|NCT01598493|Wound Healing|wound healing
5008331|NCT01598480|Burns|burns
5008332|NCT01598480|Wound Healing|wound healing
5008333|NCT01598467|pelvic organ prolapse|pelvic organ prolapse
5008334|NCT01598467|POP|pop
5008335|NCT01598467|sacrocolpopexy|sacrocolpopexy
5008336|NCT01598467|sacrohysteropexy|sacrohysteropexy
5008337|NCT01598467|promontofixation|promontofixation
5008338|NCT01598467|colpopexy|colpopexy
5008339|NCT01598467|robotic surgery|robotic surgery
5008340|NCT01598467|surgical complications|surgical complications
5008341|NCT01598467|mesh|mesh
5008342|NCT01598467|prolapse repair|prolapse repair
5008343|NCT01598441|pulmonary hypertension, pulmonary hypertensive crisis|pulmonary hypertension, pulmonary hypertensive crisis
5008344|NCT01598428|age related cataract|age related cataract
5008345|NCT01598428|phacoemulsification|phacoemulsification
5008346|NCT01598428|anterior capsule polishing|anterior capsule polishing
5008347|NCT01598428|optical coherence tomography|optical coherence tomography
5008348|NCT01598428|anterior chamber depth|anterior chamber depth
5008349|NCT01598402|LAHNC|lahnc
5008350|NCT01598402|Locally Advanced Head and Neck Cancer|locally advanced head and neck cancer
5008351|NCT01598376|entropion|entropion
5008352|NCT01598376|suture|suture
5008353|NCT01598376|granuloma|granuloma
5008354|NCT01598376|tissue reaction|tissue reaction
5008355|NCT01598350|Gait|gait
5008356|NCT01598350|Orthoses|orthoses
5008357|NCT01598350|Down syndrome|down syndrome
5008358|NCT01598324|magnetic resonance imaging|magnetic resonance imaging
5008359|NCT01598324|magnetic resonance spectroscopy|magnetic resonance spectroscopy
5008360|NCT01598324|depression|depression
5008361|NCT01598324|escitalopram|escitalopram
5008362|NCT01598324|selective serotonin reuptake inhibitor|selective serotonin reuptake inhibitor
5008363|NCT01598324|treatment-resistant depression|treatment-resistant depression
5008364|NCT01598324|ziprasidone|ziprasidone
5008365|NCT01598311|CDAD|cdad
5008366|NCT01598311|Clostridium difficile Associated Diarrhea|clostridium difficile associated diarrhea
5008367|NCT01598311|CDI|cdi
5008368|NCT01598311|Clostridium difficile Infection|clostridium difficile infection
5008369|NCT01598311|Diarrhea|diarrhea
5008370|NCT01598298|estrogen receptor-positive breast cancer|estrogen receptor-positive breast cancer
5008371|NCT01598298|progesterone receptor-positive breast cancer|progesterone receptor-positive breast cancer
5008372|NCT01598298|stage IA breast cancer|stage ia breast cancer
5008373|NCT01598298|stage IB breast cancer|stage ib breast cancer
5008374|NCT01598298|stage II breast cancer|stage ii breast cancer
5008375|NCT01598298|stage IIIA breast cancer|stage iiia breast cancer
5008376|NCT01598298|stage IIIB breast cancer|stage iiib breast cancer
5008377|NCT01598298|stage IIIC breast cancer|stage iiic breast cancer
5008378|NCT01598298|pain|pain
5008379|NCT01598298|musculoskeletal complications|musculoskeletal complications
5008380|NCT01598285|Genome-Wide|genome-wide
5008381|NCT01598285|GWAS|gwas
5008382|NCT01598285|microRNA|microrna
5008383|NCT01598285|miRNA|mirna
5008384|NCT01598285|Bevacizumab Response Predictors|bevacizumab response predictors
5008385|NCT01598285|Metastatic Breast Cancer|metastatic breast cancer
5008386|NCT01598272|Ginseng|ginseng
5008387|NCT01598272|Cordyceps|cordyceps
5008388|NCT01598272|Pomegranate|pomegranate
5008389|NCT01598272|Red Orange|red orange
5008390|NCT01598272|Grape Seed|grape seed
5008391|NCT01598272|Broccoli Seed|broccoli seed
5008392|NCT01598246|Extubation failures|extubation failures
5008393|NCT01598246|Sedation|sedation
5008394|NCT01598220|schizophrenia|schizophrenia
5008395|NCT01598220|cognitive remediation therapy|cognitive remediation therapy
5008396|NCT01598220|cognition|cognition
5008397|NCT01598220|quality of life|quality of life
5008398|NCT01598194|solid pancreatic mass lesions|solid pancreatic mass lesions
5008399|NCT01598194|22-gauge core biopsy needle|22-gauge core biopsy needle
5008400|NCT01598194|reverse bevel design|reverse bevel design
5008401|NCT01598194|endoscopic ultrasound|endoscopic ultrasound
5008402|NCT01598194|EUS|eus
5008403|NCT01598194|guided|guided
5008404|NCT01598194|fine needle aspiration|fine needle aspiration
5008405|NCT01598194|FNA|fna
5008406|NCT01598168|rivaroxaban|rivaroxaban
5008407|NCT01598168|treatment|treatment
5008408|NCT01598168|venous thromboembolism|venous thromboembolism
5008409|NCT01598168|arterial thromboembolism|arterial thromboembolism
5008410|NCT01598168|thrombocytopenia|thrombocytopenia
5008411|NCT01598155|dental biofilm|dental biofilm
5008412|NCT01598155|periodontitis|periodontitis
5008413|NCT01598155|maintenance|maintenance
5008414|NCT01598155|randomized clinical trial|randomized clinical trial
5008415|NCT01598155|biomarkers|biomarkers
5008416|NCT01598155|bacterias|bacterias
5008417|NCT01598155|gingival crevicular fluid|gingival crevicular fluid
5008418|NCT01598142|Endoscopic retrograde cholangiopancreatography (ERCP)|endoscopic retrograde cholangiopancreatography (ercp)
5008419|NCT01598142|Guidewires|guidewires
5008420|NCT01598142|Cannulation|cannulation
5008421|NCT01598142|Single-operator|single-operator
5008422|NCT01598142|C-Hook|c-hook
5008423|NCT01598129|Phase I|phase i
5008424|NCT01598129|Dose escalation|dose escalation
5008425|NCT01598129|oncolytic virus|oncolytic virus
5008426|NCT01598103|Neurogenic detrusor overactivity|neurogenic detrusor overactivity
5008427|NCT01598103|spinal cord lesions|spinal cord lesions
5008428|NCT01598103|spinal cord injury|spinal cord injury
5008429|NCT01598077|Breast cancer, gastric cancer, squamous cell carcinoma of head and neck, esophageal squamous cell carcinoma|breast cancer, gastric cancer, squamous cell carcinoma of head and neck, esophageal squamous cell carcinoma
5008430|NCT01598077|Breast cancer|breast cancer
5008431|NCT01598077|Gastric cancer|gastric cancer
5008432|NCT01598077|Squamous cell carcinoma of head and neck|squamous cell carcinoma of head and neck
5008433|NCT01598077|Esophageal squamous cell carcinoma|esophageal squamous cell carcinoma
5008434|NCT01598051|Xarelto|xarelto
5008435|NCT01598051|SPAF|spaf
5008436|NCT01598051|QOL|qol
5008437|NCT01598038|cancer|cancer
5008438|NCT01598038|renal|renal
5008439|NCT01598038|Afinitor|afinitor
5008440|NCT01598038|pharmacokinetics|pharmacokinetics
5008441|NCT01598025|ANTITHYMOCYTE GLOBULIN:ATG|antithymocyte globulin:atg
5008442|NCT01598025|FLUDARABINE|fludarabine
5008443|NCT01598025|THI0TEPA|thi0tepa
5008444|NCT01598025|CliniMACS-CD34 Reagent System|clinimacs-cd34 reagent system
5008445|NCT01598025|12-053|12-053
5008446|NCT01598012|Ayurved Siriraj Prasaplai|ayurved siriraj prasaplai
5008447|NCT01598012|primary dysmenorrhea|primary dysmenorrhea
5008448|NCT01597986|isavuconazole|isavuconazole
5008449|NCT01597986|ethinyl estradiol|ethinyl estradiol
5008450|NCT01597986|norethindrone|norethindrone
5008451|NCT01597986|contraceptive|contraceptive
5008452|NCT01597986|Healthy Volunteers|healthy volunteers
5008453|NCT01597986|BAL8557|bal8557
5008454|NCT01597986|BAL4815|bal4815
5008455|NCT01597934|Chronic hepatitis B|chronic hepatitis b
5008456|NCT01597934|Partial virologic response|partial virologic response
5008457|NCT01597934|YMDD mutation|ymdd mutation
5008458|NCT01597921|Breast conserving surgery|breast conserving surgery
5008459|NCT01597921|Radiation dermatitis|radiation dermatitis
5008460|NCT01597908|BRAF inhibitor|braf inhibitor
5008461|NCT01597908|Metastatic Melanoma|metastatic melanoma
5008462|NCT01597908|Cancer|cancer
5008463|NCT01597908|MEK inhibitor|mek inhibitor
5008464|NCT01597895|maraviroc|maraviroc
5008465|NCT01597895|boceprevir|boceprevir
5008466|NCT01597895|telaprevir|telaprevir
5008467|NCT01597895|drug interaction|drug interaction
5008468|NCT01597895|pharmacokinetics|pharmacokinetics
5008469|NCT01597895|HIV|hiv
5008470|NCT01597882|case management|case management
5008471|NCT01597882|long term conditions|long term conditions
5008472|NCT01597882|aged sixty five and over|aged sixty five and over
5008473|NCT01597843|education|education
5008474|NCT01597843|self care|self care
5008475|NCT01597843|peer group|peer group
5008476|NCT01597843|Computers|computers
5008477|NCT01597843|Attitude to computers|attitude to computers
5008478|NCT01597830|knee|knee
5008479|NCT01597830|osteoarthritis|osteoarthritis
5008480|NCT01597830|loading|loading
5008481|NCT01597817|Atopic dermatitis|atopic dermatitis
5008482|NCT01597817|Eczema|eczema
5008483|NCT01597817|Textiles|textiles
5008484|NCT01597791|Urinary Retention|urinary retention
5008485|NCT01597791|Urinary Catheter|urinary catheter
5008486|NCT01597791|Bacteriuria|bacteriuria
5008487|NCT01597778|Haplo identical transplant|haplo identical transplant
5008488|NCT01597778|Cord blood transplant|cord blood transplant
5008489|NCT01597778|Reduced intensity conditioning regimen|reduced intensity conditioning regimen
5008490|NCT01597778|Lymphoma|lymphoma
5008491|NCT01597778|Leukemia|leukemia
5008492|NCT01597765|Thalassemia|thalassemia
5008493|NCT01597765|Oxidative stress|oxidative stress
5008494|NCT01597765|antioxidant cocktail|antioxidant cocktail
5008495|NCT01597752|Immunotherapy|immunotherapy
5008496|NCT01597752|Skin prick test|skin prick test
5008497|NCT01597752|Standardization|standardization
5008498|NCT01597752|Blomia tropicalis|blomia tropicalis
5008499|NCT01597739|Active rheumatoid arthritis despite disease-modifying antirheumatic drug therapy|active rheumatoid arthritis despite disease-modifying antirheumatic drug therapy
5008500|NCT01597739|Disease-modifying antirheumatic drugs|disease-modifying antirheumatic drugs
5008501|NCT01597726|Abortion, Induced|abortion, induced
5008502|NCT01597726|Laminaria|laminaria
5008503|NCT01597726|Misoprostol|misoprostol
5008504|NCT01597726|Pregnancy Trimester, Second|pregnancy trimester, second
5008505|NCT01597687|pertussis infection|pertussis infection
5008506|NCT01597687|Prevalence|prevalence
5008507|NCT01597687|health economic burden|health economic burden
5008508|NCT01597687|prolonged cough|prolonged cough
5008509|NCT01597674|YF476|yf476
5008510|NCT01597674|gastrin receptor antagonist|gastrin receptor antagonist
5008511|NCT01597674|gastric pH|gastric ph
5008512|NCT01597674|gastrin|gastrin
5008513|NCT01597674|healthy subjects|healthy subjects
5008514|NCT01597661|first trimester|first trimester
5008515|NCT01597661|left outflow tract obstruction|left outflow tract obstruction
5008516|NCT01597661|Bupropion|bupropion
5008517|NCT01597661|cardiovascular malformation|cardiovascular malformation
5008518|NCT01597661|antidepressants|antidepressants
5008519|NCT01597661|pregnancy|pregnancy
5008520|NCT01597661|cardiovascular defect|cardiovascular defect
5008521|NCT01597661|congenital malformation|congenital malformation
5008522|NCT01597648|Combivir™, HIV, bioequivalence, Combined Formulated Tablet, Combined Formulated Tablet, HIV, bioequivalence, Combivir, Selzentry™, Celsentri™, lamivudine, zidov|combivir™, hiv, bioequivalence, combined formulated tablet, combined formulated tablet, hiv, bioequivalence, combivir, selzentry™, celsentri™, lamivudine, zidov
5008523|NCT01597635|rhACE2|rhace2
5008524|NCT01597635|Acute Respiratory Distress Syndrome (ARDS)|acute respiratory distress syndrome (ards)
5008525|NCT01597635|Acute Lung Injury|acute lung injury
5008526|NCT01597635|GSK2586881|gsk2586881
5008527|NCT01597635|critical care|critical care
5008528|NCT01597622|SELENA|selena
5008529|NCT01597622|belimumab|belimumab
5008530|NCT01597622|Lupus|lupus
5008531|NCT01597622|systemic lupus erythematosus|systemic lupus erythematosus
5008532|NCT01597622|PGA|pga
5008533|NCT01597622|BLys|blys
5008534|NCT01597622|SLE Flare Index|sle flare index
5008535|NCT01597622|continuation|continuation
5008536|NCT01597622|phase III|phase iii
5008537|NCT01597622|BILAG|bilag
5008538|NCT01597622|extension|extension
5008539|NCT01597622|efficacy|efficacy
5008540|NCT01597622|SRI|sri
5008541|NCT01597622|B cell|b cell
5008542|NCT01597622|SLEDAI|sledai
5008543|NCT01597622|safety|safety
5008544|NCT01597622|Asia|asia
5008545|NCT01597622|B lymphocyte|b lymphocyte
5008546|NCT01597557|Atrial Fibrillation|atrial fibrillation
5008547|NCT01597557|Electrical Cardioversion|electrical cardioversion
5008548|NCT01597557|Magnesium Sulfate|magnesium sulfate
5008549|NCT01597544|Voiding dysfunction|voiding dysfunction
5008550|NCT01597544|bladder catheter|bladder catheter
5008551|NCT01597544|prolapse surgery|prolapse surgery
5008552|NCT01597544|patient satisfaction|patient satisfaction
5008553|NCT01597531|Liraglutide|liraglutide
5008554|NCT01597531|Orlistat|orlistat
5008555|NCT01597518|Riluzole|riluzole
5008556|NCT01597518|spinal cord injury|spinal cord injury
5008557|NCT01597518|treatment|treatment
5008558|NCT01597505|CDAD|cdad
5008559|NCT01597505|Clostridium difficile Associated Diarrhea|clostridium difficile associated diarrhea
5008560|NCT01597505|CDI|cdi
5008561|NCT01597505|Clostridium difficile Infection|clostridium difficile infection
5008562|NCT01597505|Diarrhea|diarrhea
5008563|NCT01597492|Antibodies|antibodies
5008564|NCT01597492|Vaccines|vaccines
5008565|NCT01597492|SLE|sle
5008566|NCT01597492|Immune System Diseases|immune system diseases
5008567|NCT01597492|Biological Therapy|biological therapy
5008568|NCT01597492|Autoimmune Diseases|autoimmune diseases
5008569|NCT01597492|Pneumococcal Vaccines|pneumococcal vaccines
5008570|NCT01597492|Lupus|lupus
5008571|NCT01597492|Immunoglobulins|immunoglobulins
5008572|NCT01597492|Vaccination|vaccination
5008573|NCT01597492|Belimumab|belimumab
5008574|NCT01597492|Biological Agents|biological agents
5008575|NCT01597492|Immunization|immunization
5008576|NCT01597479|Ultrasound guided distal peripheral nerve blocks|ultrasound guided distal peripheral nerve blocks
5008577|NCT01597453|Young ischemic stroke|young ischemic stroke
5008578|NCT01597453|Families|families
5008579|NCT01597453|Long-term follow-up|long-term follow-up
5008580|NCT01597440|Propionic acidemia (PA)|propionic acidemia (pa)
5008581|NCT01597440|Methylmalonic acidemia (MMA)|methylmalonic acidemia (mma)
5008582|NCT01597440|Carbaglu NCG|carbaglu ncg
5008583|NCT01597440|Hyperammonia|hyperammonia
5008584|NCT01597427|Clonidine|clonidine
5008585|NCT01597427|Hypertension Pulmonary|hypertension pulmonary
5008586|NCT01597427|Cardiac Surgical Procedures|cardiac surgical procedures
5008587|NCT01597401|Antisickling Agents|antisickling agents
5008588|NCT01597388|Estrogen receptor positive|estrogen receptor positive
5008589|NCT01597388|Advanced metastatic breast cancer|advanced metastatic breast cancer
5008590|NCT01597388|Estrogen receptor positive advanced metastatic breast cancer|estrogen receptor positive advanced metastatic breast cancer
5008591|NCT01597375|Aspirin|aspirin
5008592|NCT01597375|Prasugrel|prasugrel
5008593|NCT01597375|Asthma|asthma
5008594|NCT01597375|AERD|aerd
5008595|NCT01597375|Aspirin challenge|aspirin challenge
5008596|NCT01597375|Aspirin desensitization|aspirin desensitization
5008597|NCT01597375|Aspirin induced asthma|aspirin induced asthma
5008598|NCT01597362|laparoscopy|laparoscopy
5008599|NCT01597362|trocars|trocars
5008600|NCT01597362|veress|veress
5008601|NCT01597362|open|open
5008602|NCT01597362|direct|direct
5008603|NCT01597336|abscess|abscess
5008604|NCT01597336|tPA|tpa
5008605|NCT01597323|Wrinkle Reduction|wrinkle reduction
5008606|NCT01597323|Skin Resurfacing|skin resurfacing
5008607|NCT01597323|Skin Texture Improvement|skin texture improvement
5008608|NCT01597284|Oral therapies|oral therapies
5008609|NCT01597284|Cancer|cancer
5008610|NCT01597284|cognitive function|cognitive function
5008611|NCT01597284|compliance|compliance
5008612|NCT01597258|Safety|safety
5008613|NCT01597258|All cases surveillance in Japan|all cases surveillance in japan
5008614|NCT01597258|ALK-positive unresectable advanced and/or recurrent non-small cell lung cancer|alk-positive unresectable advanced and/or recurrent non-small cell lung cancer
5008615|NCT01597232|Transfusion trigger|transfusion trigger
5008616|NCT01597232|Hemoglobin level|hemoglobin level
5008617|NCT01597219|Haploidentical transplant|haploidentical transplant
5008618|NCT01597219|Haematological malignancy|haematological malignancy
5008619|NCT01597219|Myeloablative|myeloablative
5008620|NCT01597219|Reduced intensity|reduced intensity
5008621|NCT01597206|randomized controlled trial|randomized controlled trial
5008622|NCT01597206|intervention|intervention
5008623|NCT01597206|posterior reduced dental arch|posterior reduced dental arch
5008624|NCT01597206|patient satisfaction|patient satisfaction
5008625|NCT01597206|sequential sampling|sequential sampling
5008626|NCT01597193|enzalutamide|enzalutamide
5008627|NCT01597193|MDV3100|mdv3100
5008628|NCT01597193|breast cancer|breast cancer
5008629|NCT01597180|contraception|contraception
5008630|NCT01597180|HIV|hiv
5008631|NCT01597180|pharmacokinetics|pharmacokinetics
5008632|NCT01597180|pharmacodynamics|pharmacodynamics
5008633|NCT01597167|mild moderate treatment-resistant depression|mild moderate treatment-resistant depression
5008634|NCT01597167|magnesium sulfate|magnesium sulfate
5008635|NCT01597154|Adolescent|adolescent
5008636|NCT01597154|Type 2 Diabetes|type 2 diabetes
5008637|NCT01597154|Peer mentorship|peer mentorship
5008638|NCT01597141|Prodromal|prodromal
5008639|NCT01597141|Schizophrenia|schizophrenia
5008640|NCT01597141|Psychosis|psychosis
5008641|NCT01597141|Family psychoeducation|family psychoeducation
5008642|NCT01597141|Assertive community treatment|assertive community treatment
5008643|NCT01597141|Supported employment|supported employment
5008644|NCT01597141|Supported education|supported education
5008645|NCT01597128|Hernia|hernia
5008646|NCT01597128|human tissue|human tissue
5008647|NCT01597128|mesh|mesh
5008648|NCT01597115|duplex study|duplex study
5008649|NCT01597115|hemodialysis access|hemodialysis access
5008650|NCT01597115|maturation rate|maturation rate
5008651|NCT01597115|endovascular intervention|endovascular intervention
5008652|NCT01597102|encephalopathy, hepatic|encephalopathy, hepatic
5008653|NCT01597102|autoregulation, cerebrovascular|autoregulation, cerebrovascular
5008654|NCT01597102|liver failure|liver failure
5008655|NCT01597102|liver transplantation|liver transplantation
5008656|NCT01597089|Specificity|specificity
5008657|NCT01597089|Bronchoalveolar Lavage|bronchoalveolar lavage
5008658|NCT01597089|Film Array Assay|film array assay
5008659|NCT01597089|Nasopharyngeal Swab|nasopharyngeal swab
5008660|NCT01597089|Sensitivity|sensitivity
5008661|NCT01597076|Morinda citrifolia|morinda citrifolia
5008662|NCT01597076|noni|noni
5008663|NCT01597076|advanced glycation end products|advanced glycation end products
5008664|NCT01597076|oxidative stress|oxidative stress
5008665|NCT01597076|quality of life|quality of life
5008666|NCT01597076|metabolic syndrome|metabolic syndrome
5008667|NCT01597076|safety|safety
5008668|NCT01597050|Discoid Lupus Erythematosus|discoid lupus erythematosus
5008669|NCT01597050|Systemic Lupus Erythematosus|systemic lupus erythematosus
5008670|NCT01597037|Aphasia|aphasia
5008671|NCT01597037|Speech Rehabilitation|speech rehabilitation
5008672|NCT01597024|appetite|appetite
5008673|NCT01597024|food|food
5008674|NCT01597024|gut|gut
5008675|NCT01597024|brain|brain
5008676|NCT01597024|satiety|satiety
5008677|NCT01597024|hunger|hunger
5008678|NCT01597024|gut hormones|gut hormones
5008679|NCT01597011|Hernia, Inguinal|hernia, inguinal
5008680|NCT01597011|Hernia repair|hernia repair
5008681|NCT01597011|Fibrin Tissue Adhesive|fibrin tissue adhesive
5008682|NCT01597011|Tisseel|tisseel
5008683|NCT01597011|Tissucol|tissucol
5008684|NCT01597011|Recurrence|recurrence
5008685|NCT01597011|Chronic Pain|chronic pain
5008686|NCT01597011|Dysejaculation|dysejaculation
5008687|NCT01596998|anesthesia, conduction|anesthesia, conduction
5008688|NCT01596998|transversus abdominis plane block|transversus abdominis plane block
5008689|NCT01596998|Vasoconstrictor Agents|vasoconstrictor agents
5008690|NCT01596998|Ultrasonography|ultrasonography
5008691|NCT01596985|Endometrioma|endometrioma
5008692|NCT01596985|Endometriosis|endometriosis
5008693|NCT01596985|Cystectomy|cystectomy
5008694|NCT01596985|Ablation|ablation
5008695|NCT01596985|Plasma energy|plasma energy
5008696|NCT01596959|atrial flutter|atrial flutter
5008697|NCT01596959|ablation|ablation
5008698|NCT01596959|irrigation|irrigation
5008699|NCT01596959|contact|contact
5008700|NCT01596959|ECI|eci
5008701|NCT01596946|contact tracing|contact tracing
5008702|NCT01596946|home sampling|home sampling
5008703|NCT01596946|cluster randomisation|cluster randomisation
5008704|NCT01596933|head and neck cancer|head and neck cancer
5008705|NCT01596933|omega-3 fatty acid supplementation|omega-3 fatty acid supplementation
5008706|NCT01596933|echium oil|echium oil
5008707|NCT01596933|weight loss|weight loss
5008708|NCT01596933|cancer cachexia|cancer cachexia
5008709|NCT01596933|body composition|body composition
5008710|NCT01596933|biomarker|biomarker
5008711|NCT01596933|quality of life|quality of life
5008712|NCT01596920|Chronic DFUs|chronic dfus
5008713|NCT01596920|Diabetic Foot Ulcers|diabetic foot ulcers
5008714|NCT01596907|resting energy expenditure|resting energy expenditure
5008715|NCT01596907|fat free mass|fat free mass
5008716|NCT01596907|lean body mass|lean body mass
5008717|NCT01596907|bariatric surgery|bariatric surgery
5008718|NCT01596907|morbid obesity|morbid obesity
5008719|NCT01596907|ephedrine|ephedrine
5008720|NCT01596907|caffeine|caffeine
5008721|NCT01596907|Low metabolic rate|low metabolic rate
5008722|NCT01596907|Low lean body mass|low lean body mass
5008723|NCT01596907|Weight loss rate|weight loss rate
5008724|NCT01596894|Pediatric|pediatric
5008725|NCT01596894|Crohn's disease|crohn's disease
5008726|NCT01596894|Azithromycin|azithromycin
5008727|NCT01596894|Metronidazole|metronidazole
5009418|NCT01594177|GBG|gbg
5008728|NCT01596894|Mild to moderate Crohn's Disease|mild to moderate crohn's disease
5008729|NCT01596881|Multiple sclerosis|multiple sclerosis
5008730|NCT01596881|Blood flow|blood flow
5008731|NCT01596881|Optical Coherence Tomography|optical coherence tomography
5008732|NCT01596881|Imaging|imaging
5008733|NCT01596868|Advanced Nasopharyngeal Carcinoma|advanced nasopharyngeal carcinoma
5008734|NCT01596868|treatment|treatment
5008735|NCT01596868|Northwest China|northwest china
5008736|NCT01596855|Anemia|anemia
5008737|NCT01596855|Renal|renal
5008738|NCT01596842|Omega-3 fatty acid|omega-3 fatty acid
5008739|NCT01596842|vitamin D|vitamin d
5008740|NCT01596842|ergocalciferol|ergocalciferol
5008741|NCT01596842|hemodialysis|hemodialysis
5008742|NCT01596829|antibiotic|antibiotic
5008743|NCT01596829|probiotic|probiotic
5008744|NCT01596829|antibiotic-associated diarrhoea|antibiotic-associated diarrhoea
5008745|NCT01596829|faecal microbiota|faecal microbiota
5008746|NCT01596816|prostate cancer|prostate cancer
5008747|NCT01596803|FSHD|fshd
5008748|NCT01596803|Antioxidants|antioxidants
5008749|NCT01596803|Oxidative stress|oxidative stress
5008750|NCT01596803|Muscle function|muscle function
5008751|NCT01596803|Quality of life|quality of life
5008752|NCT01596803|Activity|activity
5008753|NCT01596803|(FSHD;4q35)|(fshd;4q35)
5008754|NCT01596790|Bevacizumab|bevacizumab
5008755|NCT01596790|Circulating tumor cells|circulating tumor cells
5008756|NCT01596790|Treatment efficiency|treatment efficiency
5008757|NCT01596777|Loperamide-induced obstipation|loperamide-induced obstipation
5008758|NCT01596777|Methylnaltrexone|methylnaltrexone
5008759|NCT01596777|oro-cecal transit time|oro-cecal transit time
5008760|NCT01596777|whole gut transit time|whole gut transit time
5008761|NCT01596777|Pharmacokinetics|pharmacokinetics
5008762|NCT01596764|whole-gut transit time|whole-gut transit time
5008763|NCT01596764|oro-cecal transit time|oro-cecal transit time
5008764|NCT01596764|colon transit time|colon transit time
5008765|NCT01596764|loperamide-induced obstipation|loperamide-induced obstipation
5008766|NCT01596764|pharmacokinetics|pharmacokinetics
5008767|NCT01596764|Methylnaltrexone|methylnaltrexone
5008768|NCT01596764|Naloxone|naloxone
5008769|NCT01596751|metastatic|metastatic
5008770|NCT01596751|breast|breast
5008771|NCT01596751|cancer|cancer
5008772|NCT01596751|triple|triple
5008773|NCT01596751|negative|negative
5008774|NCT01596751|PLX|plx
5008775|NCT01596751|Eribulin|eribulin
5008776|NCT01596738|Coronary Artery Disease|coronary artery disease
5008777|NCT01596738|Coronary Artery Bypass Graft|coronary artery bypass graft
5008778|NCT01596738|Platelet Aggregation Inhibitors|platelet aggregation inhibitors
5008779|NCT01596738|Tranexamic Acid|tranexamic acid
5008780|NCT01596712|Allergy,|allergy,
5008781|NCT01596712|Asthma,|asthma,
5008782|NCT01596712|Atopic dermatitis,|atopic dermatitis,
5008783|NCT01596712|Japanese,|japanese,
5008784|NCT01596712|QGE031,|qge031,
5008785|NCT01596712|IgE|ige
5008786|NCT01596699|conditioning|conditioning
5008787|NCT01596699|allogeneic|allogeneic
5008788|NCT01596699|hematopoietic|hematopoietic
5008789|NCT01596699|cell|cell
5008790|NCT01596699|transplantation|transplantation
5008791|NCT01596699|HCT|hct
5008792|NCT01596660|Tap block|tap block
5008793|NCT01596660|laparoscopic hysterectomy|laparoscopic hysterectomy
5008794|NCT01596660|pain|pain
5008795|NCT01596647|cancer, tumors, phase I, drug-drug interaction, pharmacokinetic, probe drug, caffeine, diclofenac, omeprazole, midazolam, CYP1A2, CYP2C9, CYP2C19, CYP3A4|cancer, tumors, phase i, drug-drug interaction, pharmacokinetic, probe drug, caffeine, diclofenac, omeprazole, midazolam, cyp1a2, cyp2c9, cyp2c19, cyp3a4
5008796|NCT01596621|Bendamustine hydrochloride|bendamustine hydrochloride
5008797|NCT01596621|CEP-18083|cep-18083
5008798|NCT01596621|Treanda®|treanda®
5008799|NCT01596621|Non-Hodgkin Lymphoma|non-hodgkin lymphoma
5008800|NCT01596608|Magnetic seizure therapy|magnetic seizure therapy
5008801|NCT01596608|Treatment resistance|treatment resistance
5008802|NCT01596608|Open-label trial|open-label trial
5008803|NCT01596608|Treatment resistant depression|treatment resistant depression
5008804|NCT01596608|Treatment resistant schizophrenia|treatment resistant schizophrenia
5008805|NCT01596608|Treatment resistant obsessive-compulsive disorder|treatment resistant obsessive-compulsive disorder
5008806|NCT01596595|ICD|icd
5008807|NCT01596595|CRT-D|crt-d
5008808|NCT01596595|Defibrillation lead|defibrillation lead
5008809|NCT01596582|Colorectal cancer screening|colorectal cancer screening
5008810|NCT01596582|Shared decision-making|shared decision-making
5008811|NCT01596582|Patient preferences|patient preferences
5008812|NCT01596582|Risk assessment|risk assessment
5008813|NCT01596582|Advanced colorectal neoplasia|advanced colorectal neoplasia
5008814|NCT01596569|Blast Traumatic Brain Injury|blast traumatic brain injury
5008815|NCT01596569|Cognitive Rehabilitation|cognitive rehabilitation
5008816|NCT01596569|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
5008817|NCT01596569|Combined Treatment|combined treatment
5008818|NCT01596556|smoking|smoking
5008819|NCT01596556|exercise|exercise
5008820|NCT01596556|heat tolerance|heat tolerance
5008821|NCT01596556|heat stroke|heat stroke
5008822|NCT01596543|sleep|sleep
5008823|NCT01596543|HTT|htt
5008824|NCT01596543|heat illness|heat illness
5008825|NCT01596530|Breast Neoplasm|breast neoplasm
5008826|NCT01596530|Breast Cancer|breast cancer
5008827|NCT01596530|Breast Tumour|breast tumour
5008828|NCT01596530|Cancer of Breast|cancer of breast
5008829|NCT01596530|Cancer of the Breast|cancer of the breast
5008830|NCT01596491|peripheral nerve injury|peripheral nerve injury
5008831|NCT01596491|postherpetic neuralgia|postherpetic neuralgia
5008832|NCT01596491|PNI|pni
5008833|NCT01596491|PHN|phn
5008834|NCT01596491|Capsaicin|capsaicin
5008835|NCT01596491|QST|qst
5008836|NCT01596491|quantitative sensory testing|quantitative sensory testing
5008837|NCT01596491|sensory profile|sensory profile
5008838|NCT01596491|neuropathic pain|neuropathic pain
5008839|NCT01596478|Gambling|gambling
5008840|NCT01596478|Pathological Gambling|pathological gambling
5008841|NCT01596439|Healthy women|healthy women
5008842|NCT01596439|consisting of a friend or relative of the patient|consisting of a friend or relative of the patient
5008843|NCT01596426|CINV|cinv
5008844|NCT01596413|CINV|cinv
5008845|NCT01596400|CINV|cinv
5008846|NCT01596387|anaesthetics iv|anaesthetics iv
5008847|NCT01596387|propofol|propofol
5008848|NCT01596387|pharmacokinetics|pharmacokinetics
5008849|NCT01596387|pharmacodynamic|pharmacodynamic
5008850|NCT01596348|Exercise|exercise
5008851|NCT01596348|Barriers|barriers
5008852|NCT01596348|Benefits|benefits
5008853|NCT01596348|Preferences|preferences
5008854|NCT01596348|Stages of change|stages of change
5008855|NCT01596335|Infliximab|infliximab
5008856|NCT01596335|REMICADE|remicade
5008857|NCT01596335|TA-650|ta-650
5008858|NCT01596335|intravenous immunoglobulin|intravenous immunoglobulin
5008859|NCT01596335|Kawasaki disease|kawasaki disease
5008860|NCT01596335|IVIG|ivig
5008861|NCT01596322|HIV/AIDS in resource limited setting|hiv/aids in resource limited setting
5008862|NCT01596322|HIV treatment outcomes in resource limited setting|hiv treatment outcomes in resource limited setting
5008863|NCT01596322|Adherence to HIV treatment in resource limited setting|adherence to hiv treatment in resource limited setting
5008864|NCT01596322|ART resistance in resource limited setting|art resistance in resource limited setting
5008865|NCT01596309|cardiovascular risk|cardiovascular risk
5008866|NCT01596309|Elderly population|elderly population
5008867|NCT01596309|cocoa extract|cocoa extract
5008868|NCT01596309|overweight and obesity|overweight and obesity
5008869|NCT01596309|Glycemic profile|glycemic profile
5008870|NCT01596309|lipid profile|lipid profile
5008871|NCT01596309|antioxidant status|antioxidant status
5008872|NCT01596309|inflammatory state|inflammatory state
5008873|NCT01596309|Cardiovascular Risk factors in elder population|cardiovascular risk factors in elder population
5008874|NCT01596296|labor induction|labor induction
5008875|NCT01596296|transcervical foley catheter|transcervical foley catheter
5008876|NCT01596296|dinoprostone|dinoprostone
5008877|NCT01596296|parous women|parous women
5008878|NCT01596283|Perioperative Fluid Management|perioperative fluid management
5008879|NCT01596283|liver resection|liver resection
5008880|NCT01596283|12-056|12-056
5008881|NCT01596257|CliniMACS-CD34 Reagent System|clinimacs-cd34 reagent system
5008882|NCT01596257|Acute Leukemia|acute leukemia
5008883|NCT01596257|Myelodysplastic syndrome|myelodysplastic syndrome
5008884|NCT01596257|Non Hodgkins Lymphoma|non hodgkins lymphoma
5008885|NCT01596257|Hodgkins Disease|hodgkins disease
5008886|NCT01596257|Multiple Myeloma|multiple myeloma
5008887|NCT01596257|12-016|12-016
5008888|NCT01596244|Diabetes Mellitus, Type II|diabetes mellitus, type ii
5008889|NCT01596244|Disease management|disease management
5008890|NCT01596244|Chronic disease|chronic disease
5008891|NCT01596244|Prevention and control|prevention and control
5008892|NCT01596244|Education|education
5008893|NCT01596231|Alcohol consumption|alcohol consumption
5008894|NCT01596231|Kudzu extract|kudzu extract
5008895|NCT01596218|Steroid Refractory|steroid refractory
5008897|NCT01596205|cognitive therapy|cognitive therapy
5008898|NCT01596192|allogeneic transplantation, GVHD|allogeneic transplantation, gvhd
5008899|NCT01596192|Patients with acute GVHD after allogeneic hematopoietic cell transplantation|patients with acute gvhd after allogeneic hematopoietic cell transplantation
5008900|NCT01596179|treatment adherence|treatment adherence
5008901|NCT01596179|fatigue|fatigue
5008902|NCT01596179|symptom management|symptom management
5008903|NCT01596166|migraine|migraine
5008904|NCT01596166|pediatric|pediatric
5008905|NCT01596166|childhood|childhood
5008906|NCT01596166|emergency department|emergency department
5008907|NCT01596166|ketorolac|ketorolac
5008908|NCT01596166|metoclopramide|metoclopramide
5008909|NCT01596166|intravenous|intravenous
5008910|NCT01596140|Vemurafenib|vemurafenib
5008911|NCT01596140|Everolimus|everolimus
5008912|NCT01596140|Afinitor|afinitor
5008913|NCT01596140|RAD001|rad001
5008914|NCT01596140|temsirolimus|temsirolimus
5008915|NCT01596140|BRAF gene mutation|braf gene mutation
5008916|NCT01596140|solid tumor|solid tumor
5008917|NCT01596140|relapsed BRAF mutation positive malignant melanoma|relapsed braf mutation positive malignant melanoma
5008918|NCT01596140|refractory BRAF mutation positive malignant melanoma|refractory braf mutation positive malignant melanoma
5008919|NCT01596127|relapsed CD20+ lymphoid malignancies|relapsed cd20+ lymphoid malignancies
5008920|NCT01596127|refractory CD20+ lymphoid malignancies|refractory cd20+ lymphoid malignancies
5008921|NCT01596127|Rituximab|rituximab
5008922|NCT01596127|Intrathecal Rituximab|intrathecal rituximab
5008923|NCT01596127|CNS|cns
5008924|NCT01596127|Leptomeningeal disease|leptomeningeal disease
5008925|NCT01596127|LMD|lmd
5008926|NCT01596127|central nervous system disease|central nervous system disease
5008927|NCT01596127|Relapsed lymphoid malignancies|relapsed lymphoid malignancies
5008928|NCT01596127|refractory lymphoid malignancies|refractory lymphoid malignancies
5008929|NCT01596127|CNS leukemia|cns leukemia
5008930|NCT01596127|intrathecal chemotherapy|intrathecal chemotherapy
5008931|NCT01596127|cerebrospinal fluid|cerebrospinal fluid
5008932|NCT01596127|CSF|csf
5008933|NCT01596127|lumbar puncture|lumbar puncture
5008934|NCT01596127|LP|lp
5008935|NCT01596114|TKI|tki
5008936|NCT01596114|CML|cml
5008937|NCT01596114|Stopping|stopping
5008938|NCT01596114|chronic phase|chronic phase
5008939|NCT01596114|in remission|in remission
5008940|NCT01596088|Extravasation|extravasation
5008941|NCT01596088|Anthracyclines|anthracyclines
5008942|NCT01596075|Cannabidiol|cannabidiol
5008943|NCT01596075|GVHD|gvhd
5008944|NCT01596075|Allogeneic transplantation|allogeneic transplantation
5008945|NCT01596062|Basiliximab|basiliximab
5008946|NCT01596062|renal transplantation|renal transplantation
5008947|NCT01596062|CNI-free|cni-free
5008948|NCT01596062|everolimus|everolimus
5008949|NCT01596036|cardiac rehabilitation|cardiac rehabilitation
5008950|NCT01596036|referral|referral
5008951|NCT01596036|enrollment|enrollment
5008952|NCT01596036|timing|timing
5008953|NCT01596023|COPD|copd
5008954|NCT01595997|safety tolerability and immunogenicity of two different doses of DLX105 applied intra-dermally into psoriatic lesion of mild-to-moderate psoriatic patients|safety tolerability and immunogenicity of two different doses of dlx105 applied intra-dermally into psoriatic lesion of mild-to-moderate psoriatic patients
5008955|NCT01595984|kidney|kidney
5008956|NCT01595984|transplantation|transplantation
5008957|NCT01595984|graft|graft
5008958|NCT01595984|creatinin|creatinin
5008959|NCT01595971|Asthma|asthma
5008960|NCT01595971|Continuing education|continuing education
5008961|NCT01595971|Primary health care|primary health care
5008962|NCT01595958|Cardiac arrest|cardiac arrest
5008963|NCT01595958|heart arrest|heart arrest
5008964|NCT01595958|cyclosporine A|cyclosporine a
5008965|NCT01595958|post cardiac arrest syndrome|post cardiac arrest syndrome
5008966|NCT01595958|protective agent|protective agent
5008967|NCT01595958|multiple organ failure|multiple organ failure
5008968|NCT01595958|mitochondrial permeability transition pore|mitochondrial permeability transition pore
5008969|NCT01595958|mitochondria|mitochondria
5008970|NCT01595958|cardio-pulmonary resuscitation|cardio-pulmonary resuscitation
5008971|NCT01595958|cardioprotection|cardioprotection
5008972|NCT01595958|ischemia reperfusion|ischemia reperfusion
5008973|NCT01595958|postconditioning|postconditioning
5008974|NCT01595945|Caloric restriction|caloric restriction
5008975|NCT01595945|Obesity|obesity
5008976|NCT01595945|Gastric bypass|gastric bypass
5008977|NCT01595945|Resting metabolic rate|resting metabolic rate
5008978|NCT01595932|irritable bowel syndrome (IBS)|irritable bowel syndrome (ibs)
5008979|NCT01595932|bloating|bloating
5008980|NCT01595932|abdominal distension|abdominal distension
5008981|NCT01595932|flatulence|flatulence
5008982|NCT01595932|α-Galactosidase|α-galactosidase
5008983|NCT01595906|Helmet|helmet
5008984|NCT01595906|Heat Tolerance Test|heat tolerance test
5008985|NCT01595906|ventilation System|ventilation system
5008986|NCT01595893|Polymorphic light eruption|polymorphic light eruption
5008987|NCT01595893|Vitamin D3|vitamin d3
5008988|NCT01595893|Photo provocation|photo provocation
5008989|NCT01595893|Immune function|immune function
5008990|NCT01595867|abuse liability|abuse liability
5008991|NCT01595867|abuse potential|abuse potential
5008992|NCT01595867|morphine|morphine
5008993|NCT01595867|intranasal administration|intranasal administration
5008994|NCT01595867|snorting|snorting
5008995|NCT01595867|opioid abuse|opioid abuse
5008996|NCT01595867|pharmacodynamic|pharmacodynamic
5008997|NCT01595867|recreational drug use|recreational drug use
5008998|NCT01595841|hemodialysis|hemodialysis
5008999|NCT01595841|stenosis|stenosis
5009000|NCT01595841|angioplasty|angioplasty
5009001|NCT01595841|sirolimus|sirolimus
5009002|NCT01595815|Fertilization failure, calcium ionophore, SrCl2|fertilization failure, calcium ionophore, srcl2
5009003|NCT01595802|Cerebral vasospasm|cerebral vasospasm
5009004|NCT01595789|Coronary Artery Disease|coronary artery disease
5009005|NCT01595789|Diabetes Mellitus|diabetes mellitus
5009006|NCT01595789|Left ventricular ejection fraction|left ventricular ejection fraction
5009007|NCT01595789|Beta-cell function|beta-cell function
5009008|NCT01595776|CLI, PAD, Buerger disease|cli, pad, buerger disease
5009009|NCT01595763|Deep vein thrombosis|deep vein thrombosis
5009010|NCT01595763|Primary care|primary care
5009011|NCT01595763|Diagnosis|diagnosis
5009012|NCT01595763|Clinical model|clinical model
5009013|NCT01595750|Post-bronchodilator FEV1<70% reference|post-bronchodilator fev1<70% reference
5009014|NCT01595750|Chronic bronchitis|chronic bronchitis
5009015|NCT01595750|Presence of estavlished CVD,|presence of estavlished cvd,
5009016|NCT01595750|CVD equivalent or diabetes mellitus|cvd equivalent or diabetes mellitus
5009017|NCT01595724|Non-interventional study|non-interventional study
5009018|NCT01595724|Endometriosis,|endometriosis,
5009019|NCT01595724|Quality of life|quality of life
5009020|NCT01595698|Physical exercise|physical exercise
5009021|NCT01595698|IGF-1|igf-1
5009022|NCT01595698|Schizophrenia|schizophrenia
5009023|NCT01595698|neuroplasticity|neuroplasticity
5009024|NCT01595685|HBeAg-positive|hbeag-positive
5009025|NCT01595672|severe acute pancreatitis|severe acute pancreatitis
5009026|NCT01595672|organ failure|organ failure
5009027|NCT01595672|multiple organ dysfunction syndrome|multiple organ dysfunction syndrome
5009028|NCT01595672|systemic complications|systemic complications
5009029|NCT01595672|continuous veno-venous hemofiltration|continuous veno-venous hemofiltration
5009030|NCT01595672|blood purification|blood purification
5009031|NCT01595672|continuous renal replacement therapy|continuous renal replacement therapy
5009032|NCT01595659|Risk|risk
5009033|NCT01595659|Young drivers|young drivers
5009034|NCT01595659|Alcohol|alcohol
5009035|NCT01595659|Passengers|passengers
5009036|NCT01595659|Gender|gender
5009037|NCT01595646|Memory|memory
5009038|NCT01595646|Intranasal insulin|intranasal insulin
5009039|NCT01595646|Alzheimer's disease|alzheimer's disease
5009040|NCT01595646|Mild Cognitive Impairment|mild cognitive impairment
5009041|NCT01595633|nucleoside analogue|nucleoside analogue
5009042|NCT01595633|adefovir|adefovir
5009043|NCT01595633|tenofovir|tenofovir
5009044|NCT01595633|hepatitis B|hepatitis b
5009045|NCT01595620|Cannabis|cannabis
5009046|NCT01595620|THC|thc
5009047|NCT01595620|Pain|pain
5009048|NCT01595594|Periodontal Diseases|periodontal diseases
5009049|NCT01595594|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
5009050|NCT01595594|hemoglobin A1c protein|hemoglobin a1c protein
5009051|NCT01595581|Testosterone|testosterone
5009052|NCT01595581|ACL Reconstruction|acl reconstruction
5009053|NCT01595581|Clinical outcomes|clinical outcomes
5009054|NCT01595581|Lean mass|lean mass
5009055|NCT01595581|Strength|strength
5009056|NCT01595581|Muscle atrophy|muscle atrophy
5009057|NCT01595568|Adolescents|adolescents
5009058|NCT01595568|Dual Diagnosis|dual diagnosis
5009059|NCT01595568|Mental Disorders|mental disorders
5009060|NCT01595568|Substance Use Problems|substance use problems
5009061|NCT01595568|Prevention|prevention
5009062|NCT01595555|stress|stress
5009063|NCT01595555|relaxation|relaxation
5009064|NCT01595555|mindfulness|mindfulness
5009065|NCT01595555|web-based|web-based
5009066|NCT01595555|online|online
5009067|NCT01595555|social media|social media
5009068|NCT01595555|discussion board|discussion board
5009069|NCT01595529|antibiotic therapy|antibiotic therapy
5009070|NCT01595529|antimicrobial resistance|antimicrobial resistance
5009071|NCT01595529|children|children
5009072|NCT01595529|E.coli|e.coli
5009073|NCT01595529|K.pneumoniae|k.pneumoniae
5009074|NCT01595529|parent study|parent study
5009075|NCT01595529|SCOUT Study|scout study
5009076|NCT01595529|spectrum stool bacteria|spectrum stool bacteria
5009077|NCT01595529|stool culture|stool culture
5009078|NCT01595529|urinary tract infections|urinary tract infections
5009079|NCT01595503|Schizophrenia, auditory hallucination|schizophrenia, auditory hallucination
5009080|NCT01595451|Acupuncture|acupuncture
5009081|NCT01595451|Back Pain|back pain
5009082|NCT01595451|Lower Back Pain|lower back pain
5009083|NCT01595451|Brigham and Women's Hospital|brigham and women's hospital
5009084|NCT01595451|Massachusetts General Hospital|massachusetts general hospital
5009085|NCT01595451|Effects of Acupuncture|effects of acupuncture
5009086|NCT01595438|Ceftazidime, Avibactam, Doripenem, Ciprofloxacin, sulfamethoxazole/trimethoprim, Anti-Infective Agents, Complicated Urinary Tract Infection,Acute Pyelonephritis|ceftazidime, avibactam, doripenem, ciprofloxacin, sulfamethoxazole/trimethoprim, anti-infective agents, complicated urinary tract infection,acute pyelonephritis
5009087|NCT01595425|Bioequivalence,|bioequivalence,
5009088|NCT01595425|pharmacokinetics,|pharmacokinetics,
5009089|NCT01595425|safety,|safety,
5009090|NCT01595425|esomeprazole,|esomeprazole,
5009091|NCT01595425|Japanese,|japanese,
5009092|NCT01595425|healthy subject,|healthy subject,
5009093|NCT01595425|homo-EM|homo-em
5009094|NCT01595412|Laparoscopic surgery|laparoscopic surgery
5009095|NCT01595412|Colorectal Surgery|colorectal surgery
5009096|NCT01595412|Quality of Life|quality of life
5009097|NCT01595412|Rectal Prolapse|rectal prolapse
5009098|NCT01595412|Anorectal Physiology|anorectal physiology
5009099|NCT01595399|bradycardia|bradycardia
5009100|NCT01595399|hypoxemia|hypoxemia
5009101|NCT01595399|intubation|intubation
5009102|NCT01595399|premedication|premedication
5009103|NCT01595373|Ghrelin|ghrelin
5009104|NCT01595373|Microdialysis|microdialysis
5009105|NCT01595373|Controls|controls
5009106|NCT01595373|Metabolic effects of ghrelin|metabolic effects of ghrelin
5009107|NCT01595360|TT-173|tt-173
5009108|NCT01595360|Topical Hemostatics|topical hemostatics
5009109|NCT01595360|Hemostasis|hemostasis
5009110|NCT01595347|Pressure Ulcer|pressure ulcer
5009111|NCT01595347|Primary Prevention|primary prevention
5009112|NCT01595347|Fatty Acids|fatty acids
5009113|NCT01595347|Vegetable Fats|vegetable fats
5009114|NCT01595347|Olive oil|olive oil
5009115|NCT01595347|"Pressure Ulcer[prevention and control][Mesh]"|"pressure ulcer[prevention and control][mesh]"
5009116|NCT01595334|IVF-ET|ivf-et
5009117|NCT01595334|ICSI|icsi
5009118|NCT01595334|Gonadotrophins|gonadotrophins
5009119|NCT01595334|rFSH|rfsh
5009120|NCT01595334|rLH|rlh
5009121|NCT01595334|Cetrorelix|cetrorelix
5009122|NCT01595334|Leuprolide acetate|leuprolide acetate
5009123|NCT01595321|Adjuvant therapy|adjuvant therapy
5009124|NCT01595321|Immunotherapy|immunotherapy
5009125|NCT01595321|Cytoxan|cytoxan
5009126|NCT01595321|Cyclophosphamide|cyclophosphamide
5009127|NCT01595321|Pancreatic Vaccine|pancreatic vaccine
5009128|NCT01595321|Stereotactic radiation therapy|stereotactic radiation therapy
5009129|NCT01595321|SBRT|sbrt
5009130|NCT01595321|FOLFIRINOX|folfirinox
5009131|NCT01595308|Male infertility|male infertility
5009132|NCT01595295|CMML|cmml
5009133|NCT01595295|MDS|mds
5009134|NCT01595295|AML|aml
5009135|NCT01595295|registry|registry
5009136|NCT01595295|Vidaza|vidaza
5009137|NCT01595282|pain|pain
5009138|NCT01595282|suction curettage|suction curettage
5009139|NCT01595269|Diabetes|diabetes
5009140|NCT01595269|eHealth|ehealth
5009141|NCT01595269|Type 2 Diabetes|type 2 diabetes
5009142|NCT01595269|Education|education
5009143|NCT01595269|Calgary Health Region|calgary health region
5009144|NCT01595256|colorectal cancer,fatigue,6-minute walking test|colorectal cancer,fatigue,6-minute walking test
5009145|NCT01595243|hepatocellular carcinoma|hepatocellular carcinoma
5009146|NCT01595243|Needs|needs
5009147|NCT01595243|Telephone consultation|telephone consultation
5009148|NCT01595230|Internal Hernias|internal hernias
5009149|NCT01595230|Clips|clips
5009150|NCT01595230|Gastric Bypass|gastric bypass
5009151|NCT01595230|Avoid|avoid
5009152|NCT01595217|Biliary Tract Neoplasm|biliary tract neoplasm
5009153|NCT01595217|Cholangiocarcinoma|cholangiocarcinoma
5009154|NCT01595217|Diffusion magnetic resonance imaging|diffusion magnetic resonance imaging
5009155|NCT01595217|Magnetic resonance imaging|magnetic resonance imaging
5009156|NCT01595217|Magnetic resonance Cholangiopancreatography|magnetic resonance cholangiopancreatography
5009157|NCT01595204|Cancer of Ovary, laparoscopy, operability , score.|cancer of ovary, laparoscopy, operability , score.
5009158|NCT01595178|smoking|smoking
5009159|NCT01595178|drinking|drinking
5009160|NCT01595178|SBIRT|sbirt
5009161|NCT01595178|BNI|bni
5009162|NCT01595178|counseling intervention|counseling intervention
5009163|NCT01595178|emergency department|emergency department
5009164|NCT01595178|adults|adults
5009165|NCT01595165|laparoscopic cholecystectomy|laparoscopic cholecystectomy
5009166|NCT01595165|ultrasound|ultrasound
5009167|NCT01595165|transversus abdominis plane block|transversus abdominis plane block
5009168|NCT01595152|Urgency, urgency incontinence,USIQ|urgency, urgency incontinence,usiq
5009169|NCT01595100|Waist circumference|waist circumference
5009170|NCT01595100|Visceral adipose tissue|visceral adipose tissue
5009171|NCT01595100|Intra-abdominal fat|intra-abdominal fat
5009172|NCT01595100|Pediatrics|pediatrics
5009173|NCT01595087|CRPC|crpc
5009174|NCT01595035|Day surgery|day surgery
5009175|NCT01595035|Orthopedic surgery|orthopedic surgery
5009176|NCT01595035|Breast reconstruction surgery|breast reconstruction surgery
5009177|NCT01594996|Seroquel XR|seroquel xr
5009178|NCT01594996|Quetiapine XR|quetiapine xr
5009179|NCT01594996|Drug utilization|drug utilization
5009180|NCT01594996|Major depressive disorder (MDD)|major depressive disorder (mdd)
5009181|NCT01594983|hypertriglyceridemia|hypertriglyceridemia
5009182|NCT01594983|Non familial Chylocmicronemia Syndrome (non-FCS)|non familial chylocmicronemia syndrome (non-fcs)
5009183|NCT01594957|LCQ908,|lcq908,
5009184|NCT01594957|Hepatic Impairment,|hepatic impairment,
5009185|NCT01594957|Pharmacokinetics|pharmacokinetics
5009186|NCT01594931|malaria|malaria
5009187|NCT01594931|antimalarial|antimalarial
5009188|NCT01594931|artemisinin based combination therapy|artemisinin based combination therapy
5009189|NCT01594918|metastatic|metastatic
5009190|NCT01594918|CRPC|crpc
5009191|NCT01594918|prostate|prostate
5009192|NCT01594918|CAMP|camp
5009193|NCT01594905|To explore|to explore
5009194|NCT01594905|adequate management|adequate management
5009195|NCT01594905|CHB|chb
5009196|NCT01594905|Multidrug resistance|multidrug resistance
5009197|NCT01594892|Spinal metastases|spinal metastases
5009198|NCT01594892|Vertebral metastases|vertebral metastases
5009199|NCT01594892|Radiosurgery|radiosurgery
5009200|NCT01594892|Radiotherapy|radiotherapy
5009201|NCT01594892|Stereotactic body radiotherapy|stereotactic body radiotherapy
5009202|NCT01594892|Pain|pain
5009203|NCT01594879|Endometrial cancer|endometrial cancer
5009204|NCT01594879|LNG-IUS|lng-ius
5009205|NCT01594879|oral MPA|oral mpa
5009206|NCT01594866|Major depressive disorder, remission, escitalopram|major depressive disorder, remission, escitalopram
5009207|NCT01594853|exercise|exercise
5009208|NCT01594853|women|women
5009209|NCT01594853|training|training
5009210|NCT01594853|rehabilitation|rehabilitation
5009211|NCT01594853|leukodystrophy|leukodystrophy
5009212|NCT01594840|language development|language development
5009213|NCT01594840|parental interaction|parental interaction
5009214|NCT01594827|Methicillin-resistant Staphylococcus aureus|methicillin-resistant staphylococcus aureus
5009215|NCT01594827|Vancomycin|vancomycin
5009216|NCT01594814|AVNRT|avnrt
5009217|NCT01594814|AVRT|avrt
5009218|NCT01594814|WPW|wpw
5009219|NCT01594801|DM|dm
5009222|NCT01594762|Diabetic Foot Ulcer Infection|diabetic foot ulcer infection
5009223|NCT01594749|NK-1 Receptor Antagonist, CINV, Emesis, MEC|nk-1 receptor antagonist, cinv, emesis, mec
5009224|NCT01594684|restenosis|restenosis
5009225|NCT01594684|stent|stent
5009226|NCT01594684|drug eltuing balloon|drug eltuing balloon
5009227|NCT01594684|peripheral arterial disease|peripheral arterial disease
5009228|NCT01594671|primary knee arthroplasty|primary knee arthroplasty
5009229|NCT01594671|tranexamic acid|tranexamic acid
5009230|NCT01594671|topical|topical
5009231|NCT01594658|Ultrasound-guided foam sclerotherapy; chronic venous ulcers|ultrasound-guided foam sclerotherapy; chronic venous ulcers
5009232|NCT01594632|AE adverse event|ae adverse event
5009233|NCT01594632|AIDS acquired immunodeficiency syndrome|aids acquired immunodeficiency syndrome
5009234|NCT01594632|ALT (SGPT) alanine aminotransferase|alt (sgpt) alanine aminotransferase
5009235|NCT01594632|ART antiretroviral therapy|art antiretroviral therapy
5009236|NCT01594632|AST (SGOT) aspartate aminotransferase|ast (sgot) aspartate aminotransferase
5009237|NCT01594632|DCF data collection forms|dcf data collection forms
5009238|NCT01594632|DMC Data Monitoring Committee|dmc data monitoring committee
5009239|NCT01594632|FDA (U.S.) Food and Drug Administration|fda (u.s.) food and drug administration
5009240|NCT01594632|GCP Good Clinical Practice guidelines|gcp good clinical practice guidelines
5009241|NCT01594632|HB sAg Hepatitis B surface antigen|hb sag hepatitis b surface antigen
5009242|NCT01594632|ICH International Conference of Harmonization|ich international conference of harmonization
5009243|NCT01594632|IND Investigational New Drug Application|ind investigational new drug application
5009244|NCT01594632|IRB Institutional Review Board|irb institutional review board
5009245|NCT01594632|IU International units|iu international units
5009246|NCT01594632|mg milligram(s)|mg milligram(s)
5009247|NCT01594632|mm3 cubic millimeter(s)|mm3 cubic millimeter(s)
5009248|NCT01594632|PCR polymerase chain reaction|pcr polymerase chain reaction
5009249|NCT01594632|SAE serious adverse event|sae serious adverse event
5009250|NCT01594632|µg microgram|µg microgram
5009251|NCT01594632|ULN upper limit of the normal range|uln upper limit of the normal range
5009252|NCT01594632|WB Western Blot|wb western blot
5009253|NCT01594619|Phase 1|phase 1
5009254|NCT01594619|Healthy male and female volunteers|healthy male and female volunteers
5009255|NCT01594619|Drug-drug interaction|drug-drug interaction
5009256|NCT01594619|Pharmacokinetics|pharmacokinetics
5009257|NCT01594619|Naloxegol|naloxegol
5009258|NCT01594606|Animal-assisted intervention|animal-assisted intervention
5009259|NCT01594606|adjudicated adolescents|adjudicated adolescents
5009260|NCT01594606|empathy|empathy
5009261|NCT01594593|prostate cancer|prostate cancer
5009262|NCT01594593|behavioral|behavioral
5009263|NCT01594593|acceptance and commitment therapy|acceptance and commitment therapy
5009264|NCT01594593|distress|distress
5009265|NCT01594567|Systematic review and meta-analysis|systematic review and meta-analysis
5009266|NCT01594567|Evidence-based medicine (EBM)|evidence-based medicine (ebm)
5009267|NCT01594567|Evidence-based nutrition (EBN)|evidence-based nutrition (ebn)
5009268|NCT01594567|Clinical practice guidelines|clinical practice guidelines
5009269|NCT01594567|Clinical trials|clinical trials
5009270|NCT01594567|Dietary pulses|dietary pulses
5009271|NCT01594567|legumes|legumes
5009272|NCT01594567|Beans, peas, chickpeas, lentils|beans, peas, chickpeas, lentils
5009273|NCT01594567|Cardiometabolic risk factors|cardiometabolic risk factors
5009274|NCT01594567|Triglycerides|triglycerides
5009275|NCT01594567|Cholesterol|cholesterol
5009276|NCT01594567|Glycemic control|glycemic control
5009277|NCT01594567|Insulin resistance|insulin resistance
5009278|NCT01594567|Body weight|body weight
5009279|NCT01594567|Uric acid|uric acid
5009280|NCT01594567|Blood pressure|blood pressure
5009281|NCT01594554|HCV viral genotypes|hcv viral genotypes
5009282|NCT01594554|host genotypes|host genotypes
5009283|NCT01594554|IL28B|il28b
5009284|NCT01594554|Outcome|outcome
5009285|NCT01594554|Follow-Up|follow-up
5009286|NCT01594554|ITPA|itpa
5009287|NCT01594554|RNA|rna
5009288|NCT01594554|China|china
5009289|NCT01594541|hyperhomocysteinemia|hyperhomocysteinemia
5009290|NCT01594541|dementia|dementia
5009291|NCT01594541|depression|depression
5009292|NCT01594541|vitamin B12|vitamin b12
5009293|NCT01594541|mild cognitive impairment|mild cognitive impairment
5009294|NCT01594541|alzheimer's|alzheimer's
5009295|NCT01594528|schizophrenia|schizophrenia
5009296|NCT01594528|major depression|major depression
5009297|NCT01594528|pain|pain
5009298|NCT01594528|behavior|behavior
5009299|NCT01594502|prostate cancer|prostate cancer
5009300|NCT01594502|dutasteride|dutasteride
5009301|NCT01594476|Postpartum|postpartum
5009302|NCT01594476|Contraception|contraception
5009303|NCT01594476|Intrauterine device|intrauterine device
5009304|NCT01594476|Intrauterine system|intrauterine system
5009305|NCT01594476|Mirena|mirena
5009306|NCT01594476|Paragard|paragard
5009307|NCT01594476|Uterine involution|uterine involution
5009308|NCT01594463|Intrauterine growth restriction|intrauterine growth restriction
5009309|NCT01594463|Screening|screening
5009310|NCT01594463|Ultrasound|ultrasound
5009311|NCT01594463|Perinatal morbidity|perinatal morbidity
5009312|NCT01594463|Maternal complications|maternal complications
5009313|NCT01594450|incisional ventral hernia|incisional ventral hernia
5009314|NCT01594450|infected field|infected field
5009315|NCT01594450|biological mesh|biological mesh
5009316|NCT01594437|Cytomegalovirus|cytomegalovirus
5009317|NCT01594437|Monoclonal antibody|monoclonal antibody
5009318|NCT01594424|Donor-Specific Anti-HLA Antibodies|donor-specific anti-hla antibodies
5009319|NCT01594424|Kidney Transplantation|kidney transplantation
5009320|NCT01594411|Corus CAD|corus cad
5009321|NCT01594411|ASGES|asges
5009322|NCT01594411|Age/Sex/Gene Expression Score|age/sex/gene expression score
5009323|NCT01594411|Gene Expression|gene expression
5009324|NCT01594411|GES|ges
5009325|NCT01594411|CAD|cad
5009326|NCT01594411|CVD|cvd
5009327|NCT01594411|CHD|chd
5009328|NCT01594411|Clinical Utility|clinical utility
5009329|NCT01594411|Precision Medicine|precision medicine
5009330|NCT01594411|Primary care|primary care
5009331|NCT01594411|Coronary Artery Disease|coronary artery disease
5009332|NCT01594411|Angina Pectoris|angina pectoris
5009333|NCT01594411|Chest Pain|chest pain
5009334|NCT01594411|Cardiovascular Disease|cardiovascular disease
5009335|NCT01594411|Coronary Heart Disease|coronary heart disease
5009336|NCT01594411|IMPACT|impact
5009337|NCT01594411|IMPACT-PCP|impact-pcp
5009338|NCT01594398|carcinoma,non small cell lung|carcinoma,non small cell lung
5009339|NCT01594398|lung diseases|lung diseases
5009340|NCT01594398|lung neoplasms|lung neoplasms
5009341|NCT01594398|Respiratory|respiratory
5009342|NCT01594398|Carcinoma, Bronchogenic|carcinoma, bronchogenic
5009343|NCT01594398|Bronchial Neoplasms|bronchial neoplasms
5009344|NCT01594398|Respiratory Tract Neoplasms|respiratory tract neoplasms
5009345|NCT01594398|Thoracic Neoplasms|thoracic neoplasms
5009346|NCT01594398|Neoplasms by Site|neoplasms by site
5009347|NCT01594398|Respiratory Tract Diseases|respiratory tract diseases
5009348|NCT01594398|Erlotinib|erlotinib
5009349|NCT01594398|Protein Kinase Inhibitors|protein kinase inhibitors
5009350|NCT01594398|Breast Neoplasms|breast neoplasms
5009351|NCT01594398|Neoplasms|neoplasms
5009352|NCT01594398|Breast Diseases|breast diseases
5009353|NCT01594398|Exemestane|exemestane
5009354|NCT01594398|Aromatase Inhibitors|aromatase inhibitors
5009355|NCT01594385|Open Abdomen|open abdomen
5009356|NCT01594385|Damage Control|damage control
5009357|NCT01594385|Trauma|trauma
5009358|NCT01594385|Wound healing|wound healing
5009359|NCT01594385|Gun shot wounds|gun shot wounds
5009360|NCT01594385|Stab wounds|stab wounds
5009361|NCT01594385|Automobile accidents|automobile accidents
5009362|NCT01594385|Wounds and Injury|wounds and injury
5009363|NCT01594372|Uterine Prolapse|uterine prolapse
5009364|NCT01594372|Laparoscopy|laparoscopy
5009365|NCT01594372|Hysterectomy, vaginal|hysterectomy, vaginal
5009366|NCT01594359|Ferritin|ferritin
5009367|NCT01594346|Vitamin E|vitamin e
5009368|NCT01594346|alpha-tocopherol|alpha-tocopherol
5009369|NCT01594346|cognitive decline|cognitive decline
5009370|NCT01594346|Down syndrome|down syndrome
5009371|NCT01594346|Aging|aging
5009372|NCT01594346|Dementia|dementia
5009373|NCT01594333|Myocardial Infarction|myocardial infarction
5009374|NCT01594333|Stroke|stroke
5009375|NCT01594333|Cardiovascular death|cardiovascular death
5009376|NCT01594333|Type 2 Diabetes|type 2 diabetes
5009377|NCT01594333|Metabolic Syndrome|metabolic syndrome
5009378|NCT01594333|Cardiovascular Inflammation|cardiovascular inflammation
5009379|NCT01594333|Atherothrombosis|atherothrombosis
5009380|NCT01594307|BP|bp
5009381|NCT01594294|CLEAR CARE®|clear care®
5009382|NCT01594294|AOSEPT® Plus|aosept® plus
5009383|NCT01594294|ReNu MultiPlus®|renu multiplus®
5009384|NCT01594294|silicone hydrogel|silicone hydrogel
5009385|NCT01594294|hydrogel|hydrogel
5009386|NCT01594294|ACUVUE® 2®|acuvue® 2®
5009387|NCT01594294|AIR OPTIX® AQUA|air optix® aqua
5009388|NCT01594294|eyelid response|eyelid response
5009389|NCT01594294|wettability|wettability
5009390|NCT01594294|contamination|contamination
5009391|NCT01594294|contact lenses|contact lenses
5009392|NCT01594281|Panretinal photocoagulation|panretinal photocoagulation
5009393|NCT01594281|Ranibizumab|ranibizumab
5009394|NCT01594268|kidney transplant|kidney transplant
5009395|NCT01594268|Certican|certican
5009396|NCT01594255|Healthy volunteer|healthy volunteer
5009397|NCT01594255|QT intervals|qt intervals
5009398|NCT01594255|ECG|ecg
5009399|NCT01594255|QT/QTc interval prolongation and proarrhythmic potential for non-antiarrhythmic drugs|qt/qtc interval prolongation and proarrhythmic potential for non-antiarrhythmic drugs
5009400|NCT01594242|multiple myeloma|multiple myeloma
5009401|NCT01594242|bortezomib|bortezomib
5009402|NCT01594242|proteasome inhibitor|proteasome inhibitor
5009403|NCT01594229|Pharmacokinetics|pharmacokinetics
5009404|NCT01594229|Maximum Tolerated Dose|maximum tolerated dose
5009405|NCT01594229|Safety|safety
5009406|NCT01594229|Bendamustine|bendamustine
5009407|NCT01594229|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
5009408|NCT01594229|Rituximab|rituximab
5009409|NCT01594229|ABT-199|abt-199
5009410|NCT01594229|Cancer|cancer
5009411|NCT01594229|Preliminary Efficacy|preliminary efficacy
5009412|NCT01594216|Postmenopausal female|postmenopausal female
5009413|NCT01594203|Soft Tissue Sarcoma|soft tissue sarcoma
5009414|NCT01594203|Pazopanib|pazopanib
5009415|NCT01594203|F18-FDG PET/CT|f18-fdg pet/ct
5009416|NCT01594177|DAFNE|dafne
5009417|NCT01594177|GBG 70|gbg 70
5009419|NCT01594177|German Breast Group|german breast group
5009420|NCT01594177|GBG Forschungs GmbH|gbg forschungs gmbh
5009421|NCT01594177|Afatinib|afatinib
5009422|NCT01594177|neo-adjuvant|neo-adjuvant
5009423|NCT01594177|HER-2 positive breast cancer|her-2 positive breast cancer
5009424|NCT01594177|BIBW 2992|bibw 2992
5009425|NCT01594177|1200.159|1200.159
5009426|NCT01594164|High Resolution Computed Tomography|high resolution computed tomography
5009427|NCT01594164|Cone Beam Computed Tomography|cone beam computed tomography
5009428|NCT01594164|upper airway|upper airway
5009429|NCT01594164|geometry|geometry
5009430|NCT01594151|asthma|asthma
5009431|NCT01594151|controlled|controlled
5009432|NCT01594151|Cone Beam Computed Tomography|cone beam computed tomography
5009433|NCT01594151|upper airway|upper airway
5009434|NCT01594151|paediatric|paediatric
5009435|NCT01594112|Remote monitoring|remote monitoring
5009436|NCT01594112|Home monitoring|home monitoring
5009437|NCT01594112|Defibrillators, Implantable cardioverter-defibrillator|defibrillators, implantable cardioverter-defibrillator
5009438|NCT01594112|Shock|shock
5009439|NCT01594112|Inappropriate diagnoses and Therapies|inappropriate diagnoses and therapies
5009440|NCT01594112|Corrective actions|corrective actions
5009441|NCT01594112|ID recurrences|id recurrences
5009442|NCT01594112|Medical reaction time|medical reaction time
5009443|NCT01594099|cervical cancer|cervical cancer
5009444|NCT01594099|elderly women|elderly women
5009445|NCT01594099|concurrent chemotherapy|concurrent chemotherapy
5009446|NCT01594086|green tea|green tea
5009447|NCT01594086|aging|aging
5009448|NCT01594086|atherosclerosis|atherosclerosis
5009449|NCT01594086|homocysteine|homocysteine
5009450|NCT01594086|cognitive impairment|cognitive impairment
5009451|NCT01594073|implantable defibrillator|implantable defibrillator
5009452|NCT01594073|ventricular arrhythmias|ventricular arrhythmias
5009453|NCT01594073|cardiac death|cardiac death
5009454|NCT01594047|hyperalgesia|hyperalgesia
5009455|NCT01594047|Patient controlled analgesia|patient controlled analgesia
5009456|NCT01594047|morphine|morphine
5009457|NCT01594047|methadone|methadone
5009458|NCT01594047|ketamine|ketamine
5009459|NCT01594021|propofol|propofol
5009460|NCT01594021|anesthesia, induction|anesthesia, induction
5009461|NCT01594021|hypotension|hypotension
5009462|NCT01594021|cardiac output|cardiac output
5009463|NCT01594008|Toll like receptors|toll like receptors
5009464|NCT01594008|Inflammation|inflammation
5009465|NCT01594008|Anthocyanins|anthocyanins
5009466|NCT01594008|Blueberries|blueberries
5009467|NCT01593995|Erlotinib|erlotinib
5009468|NCT01593995|Skin side effect|skin side effect
5009469|NCT01593995|EGF ointment|egf ointment
5009470|NCT01593982|Repetitive Transcranial Magnetic Stimulation|repetitive transcranial magnetic stimulation
5009471|NCT01593982|Cocaine Dependence|cocaine dependence
5009472|NCT01593982|Cocaine Addicts|cocaine addicts
5009473|NCT01593982|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
5009474|NCT01593982|Cognitive Function|cognitive function
5009475|NCT01593969|Essential Fatty Acid|essential fatty acid
5009476|NCT01593969|Seed oil|seed oil
5009477|NCT01593969|Fish oil|fish oil
5009478|NCT01593969|Dietary deficiency|dietary deficiency
5009479|NCT01593943|contraception|contraception
5009480|NCT01593943|india|india
5009481|NCT01593943|rural|rural
5009482|NCT01593930|Pulp Anesthesia|pulp anesthesia
5009483|NCT01593930|Articaine|articaine
5009484|NCT01593930|Lidocaine|lidocaine
5009485|NCT01593917|Aortic valve|aortic valve
5009486|NCT01593917|Heart valve|heart valve
5009487|NCT01593917|Tissue valve|tissue valve
5009488|NCT01593917|Bioprosthesis|bioprosthesis
5009489|NCT01593904|CCSVI, Flow, Perfusion in MS|ccsvi, flow, perfusion in ms
5009490|NCT01593891|IVUS, CCSVI|ivus, ccsvi
5009491|NCT01593865|Coronary Artery Bypass Grafting|coronary artery bypass grafting
5009492|NCT01593865|Mammary Artery Grafts|mammary artery grafts
5009493|NCT01593865|Bilateral Mammary Artery Grafting|bilateral mammary artery grafting
5009494|NCT01593865|Clinical Outcomes|clinical outcomes
5009495|NCT01593852|X-rays|x-rays
5009496|NCT01593852|Cardiac Electrophysiology|cardiac electrophysiology
5009497|NCT01593852|Image Processing, Computer-Assisted|image processing, computer-assisted
5009498|NCT01593852|Catheter Ablation|catheter ablation
5009499|NCT01593813|Pronator quadratus|pronator quadratus
5009500|NCT01593813|distal radius fracture|distal radius fracture
5009501|NCT01593813|volar plating|volar plating
5009502|NCT01593800|Probiotics|probiotics
5009503|NCT01593800|Lactose|lactose
5009504|NCT01593787|Hypertension|hypertension
5009505|NCT01593787|Renal dysfunction|renal dysfunction
5009506|NCT01593787|LCZ696|lcz696
5009507|NCT01593774|Melatonin|melatonin
5009508|NCT01593774|Olanzapine|olanzapine
5009509|NCT01593774|Metabolic side effects|metabolic side effects
5009510|NCT01593774|Psychosis|psychosis
5009511|NCT01593774|Hyperlipidemia|hyperlipidemia
5009512|NCT01593774|Hyperglycemia|hyperglycemia
5009513|NCT01593774|Weight gain|weight gain
5009514|NCT01593774|Diabetes|diabetes
5009515|NCT01593761|cABSSSI|cabsssi
5009516|NCT01593761|MRSA|mrsa
5009517|NCT01593748|Sarcoma|sarcoma
5009518|NCT01593748|Soft Tissue Sarcoma|soft tissue sarcoma
5009519|NCT01593722|Loa loa|loa loa
5009520|NCT01593722|Immune Response|immune response
5009521|NCT01593722|Therapy|therapy
5009522|NCT01593709|Healthy Volunteers|healthy volunteers
5009523|NCT01593696|CD 19 Expressing B Cells|cd 19 expressing b cells
5009524|NCT01593696|B Cell Lymphoma|b cell lymphoma
5009525|NCT01593696|ALL|all
5009526|NCT01593696|Anti-CD19 Chimeric Antigen Receptor|anti-cd19 chimeric antigen receptor
5009527|NCT01593696|Adoptive Immunotherapy|adoptive immunotherapy
5009528|NCT01593683|Oncology service|oncology service
5009529|NCT01593683|Nursing staff|nursing staff
5009530|NCT01593683|Psychosocial intervention|psychosocial intervention
5009531|NCT01593683|Coping skills|coping skills
5009532|NCT01593670|high risk myelodysplastic syndrome|high risk myelodysplastic syndrome
5009533|NCT01593670|natural killer cells|natural killer cells
5009534|NCT01593644|Dipyridamole/adenosine combination given intravenously|dipyridamole/adenosine combination given intravenously
5009535|NCT01593644|slow bolus and low doses|slow bolus and low doses
5009536|NCT01593644|coronary flow reserve assessment|coronary flow reserve assessment
5009537|NCT01593644|transthoracic echodoppler|transthoracic echodoppler
5009538|NCT01593644|Patients|patients
5009539|NCT01593644|stable|stable
5009540|NCT01593631|lactose malabsorption|lactose malabsorption
5009541|NCT01593631|lactose intolerance|lactose intolerance
5009542|NCT01593631|lactose digestion|lactose digestion
5009543|NCT01593631|lactose maldigestion|lactose maldigestion
5009544|NCT01593631|acid lactase|acid lactase
5009545|NCT01593631|yoghurt bacteria|yoghurt bacteria
5009546|NCT01593618|cancer survivor|cancer survivor
5009547|NCT01593605|Impaired glucose tolerance, pre-diabetes,glycemic control,|impaired glucose tolerance, pre-diabetes,glycemic control,
5009548|NCT01593605|supplements|supplements
5009549|NCT01593592|Helicobacter pylori|helicobacter pylori
5009550|NCT01593592|Lactobacillus reuteri|lactobacillus reuteri
5009551|NCT01593592|dyspeptic patients|dyspeptic patients
5009552|NCT01593592|eradication|eradication
5009553|NCT01593579|melanoma|melanoma
5009554|NCT01593579|autonomic failure|autonomic failure
5009555|NCT01593579|hypotension|hypotension
5009556|NCT01593579|akt therapy|akt therapy
5009557|NCT01593566|femoral nerve block|femoral nerve block
5009558|NCT01593553|Screening|screening
5009559|NCT01593553|Stroke prevention|stroke prevention
5009560|NCT01593553|Cost effectiveness|cost effectiveness
5009561|NCT01593527|Frequent flares|frequent flares
5009562|NCT01593527|Frequent attacks|frequent attacks
5009563|NCT01593527|gout|gout
5009564|NCT01593527|gouty arthritis|gouty arthritis
5009565|NCT01593527|Chronic kidney disease|chronic kidney disease
5009566|NCT01593527|renal impairment|renal impairment
5009567|NCT01593527|Anti-interleukin-1β monoclonal antibody|anti-interleukin-1β monoclonal antibody
5009568|NCT01593527|anti-inflammatory therapy|anti-inflammatory therapy
5009569|NCT01593514|Vaccines|vaccines
5009570|NCT01593514|Meningitis|meningitis
5009571|NCT01593514|Meningococcal|meningococcal
5009572|NCT01593501|vitamin D|vitamin d
5009573|NCT01593501|cholecalciferol|cholecalciferol
5009574|NCT01593501|bone mineral density|bone mineral density
5009575|NCT01593501|Magnesium deficiency|magnesium deficiency
5009576|NCT01593501|Calcium metabolism disorders|calcium metabolism disorders
5009577|NCT01593488|recurrent|recurrent
5009578|NCT01593488|CNS disease|cns disease
5009579|NCT01593488|intrathecal therapy|intrathecal therapy
5009580|NCT01593436|insomnia,menopause, polysomnography, mindfulness|insomnia,menopause, polysomnography, mindfulness
5009581|NCT01593410|Efficacy/Safety|efficacy/safety
5009582|NCT01593410|Lenalidomide and Low-Dose Dexamethasone|lenalidomide and low-dose dexamethasone
5009583|NCT01593410|Chinese Subjects|chinese subjects
5009584|NCT01593410|Relapsed/Refractory Multiple Myeloma|relapsed/refractory multiple myeloma
5009585|NCT01593397|Obesity|obesity
5009586|NCT01593397|Insulin Resistance|insulin resistance
5009587|NCT01593384|Breast Cancer|breast cancer
5009588|NCT01593384|Digital Breast Tomosynthesis (DBT)|digital breast tomosynthesis (dbt)
5009589|NCT01593384|Digital Mammography (DM)|digital mammography (dm)
5009590|NCT01593371|Adipokines|adipokines
5009591|NCT01593371|leptin|leptin
5009592|NCT01593371|chemerin|chemerin
5009593|NCT01593371|omentin|omentin
5009594|NCT01593371|metformin|metformin
5009595|NCT01593371|type 2 diabetes mellitus|type 2 diabetes mellitus
5009596|NCT01593358|CCSVI|ccsvi
5009597|NCT01593345|Elderly|elderly
5009598|NCT01593345|mobility limitations|mobility limitations
5009599|NCT01593345|self-management|self-management
5009600|NCT01593345|exercise|exercise
5009601|NCT01593332|Rituximab|rituximab
5009602|NCT01593332|Rheumatoid arthritis|rheumatoid arthritis
5009603|NCT01593332|Biologics|biologics
5009604|NCT01593332|Anti-tumour necrosis factor|anti-tumour necrosis factor
5009605|NCT01593332|Disease-modifying anti-rheumatic drugs|disease-modifying anti-rheumatic drugs
5009606|NCT01593332|DAS28|das28
5009607|NCT01593332|European League Against Rheumatism response|european league against rheumatism response
5009608|NCT01593293|Elderly patients|elderly patients
5009609|NCT01593293|Non-squamous Non-small Cell Lung Cancer|non-squamous non-small cell lung cancer
5009610|NCT01593293|Pemetrexed|pemetrexed
5009611|NCT01593293|Carboplatin|carboplatin
5009612|NCT01593280|anesthesia|anesthesia
5009613|NCT01593280|regional anesthetic techniques: transversus abdominis plane block,|regional anesthetic techniques: transversus abdominis plane block,
5009614|NCT01593280|pain, postoperative|pain, postoperative
5009615|NCT01593280|surgery, cesarean section|surgery, cesarean section
5009616|NCT01593280|quality of recovery|quality of recovery
5009617|NCT01593267|intracranial aneurysm|intracranial aneurysm
5009618|NCT01593267|subarachnoid hemorrhage|subarachnoid hemorrhage
5009619|NCT01593267|randomized trial|randomized trial
5009620|NCT01593267|coil embolization|coil embolization
5009621|NCT01593267|clip occlusion|clip occlusion
5009622|NCT01593267|vascular disorders|vascular disorders
5009623|NCT01593241|Seminoma IIA/B|seminoma iia/b
5009624|NCT01593241|Carboplatin|carboplatin
5009625|NCT01593241|RT|rt
5009626|NCT01593215|genetics|genetics
5009627|NCT01593215|type 2 diabetes|type 2 diabetes
5009628|NCT01593215|insulin secretion|insulin secretion
5009629|NCT01593189|developmental disabilities|developmental disabilities
5009630|NCT01593189|school readiness|school readiness
5009631|NCT01593189|literacy|literacy
5009632|NCT01593189|social emotional skills|social emotional skills
5009633|NCT01593189|self regulation|self regulation
5009634|NCT01593189|caregiver involvement|caregiver involvement
5009635|NCT01593176|Femur|femur
5009636|NCT01593176|Fracture|fracture
5009637|NCT01593176|Radiostereometric Analysis|radiostereometric analysis
5009638|NCT01593163|Functional echocardiography|functional echocardiography
5009639|NCT01593163|power Doppler cranial ultrasonography|power doppler cranial ultrasonography
5009640|NCT01593163|N-terminal probrain natriuretic peptide|n-terminal probrain natriuretic peptide
5009641|NCT01593163|Patent ductus arteriosus|patent ductus arteriosus
5009642|NCT01593150|Atrial Fibrillation|atrial fibrillation
5009643|NCT01593150|TEE|tee
5009644|NCT01593150|Early versus late DC cardioversion.|early versus late dc cardioversion.
5009645|NCT01593124|Vaginal innate immune and inflammatory responses|vaginal innate immune and inflammatory responses
5009646|NCT01593111|Allergies|allergies
5009647|NCT01593111|Asthma|asthma
5009648|NCT01593111|Environmental|environmental
5009649|NCT01593111|NYC|nyc
5009650|NCT01593111|Manhattan|manhattan
5009651|NCT01593111|Harlem|harlem
5009652|NCT01593111|Bronx|bronx
5009653|NCT01593111|Brooklyn|brooklyn
5009654|NCT01593111|Breathing|breathing
5009655|NCT01593111|eNO|eno
5009656|NCT01593111|IgE|ige
5009657|NCT01593111|Allergens|allergens
5009658|NCT01593111|Cockroach|cockroach
5009659|NCT01593111|Dust mites|dust mites
5009660|NCT01593111|Pets|pets
5009661|NCT01593098|siblings|siblings
5009662|NCT01593098|advanced neoplasm|advanced neoplasm
5009663|NCT01593098|mRNA|mrna
5009664|NCT01593098|TaqMan microRNA expression assays|taqman microrna expression assays
5009665|NCT01593085|palliative cares|palliative cares
5009666|NCT01593085|cancer|cancer
5009667|NCT01593085|suicide risk|suicide risk
5009668|NCT01593072|Multiple Ascending Dose (MAD)|multiple ascending dose (mad)
5009669|NCT01593072|Ebola Virus|ebola virus
5009670|NCT01593072|Post Exposure Prophylaxis|post exposure prophylaxis
5009671|NCT01593072|EHF|ehf
5009672|NCT01593059|International|international
5009673|NCT01593059|Multicenter|multicenter
5009674|NCT01593059|Observational registry|observational registry
5009675|NCT01593059|Orsiro Drug Eluting Stent (DES)|orsiro drug eluting stent (des)
5009676|NCT01593059|Stenting|stenting
5009677|NCT01593059|Treatment of Coronary Artery Disease|treatment of coronary artery disease
5009678|NCT01593059|Coronary revascularization|coronary revascularization
5009679|NCT01593059|Percutaneous Coronary Intervention|percutaneous coronary intervention
5009680|NCT01593059|STEMI|stemi
5009681|NCT01593059|NSTEMI|nstemi
5009682|NCT01593059|Ischemia|ischemia
5009683|NCT01593059|Angina|angina
5009684|NCT01593059|Subgroups|subgroups
5009685|NCT01593059|Acute Myocardial Infarction|acute myocardial infarction
5009686|NCT01593059|Diabetes|diabetes
5009687|NCT01593059|Small Vessels|small vessels
5009688|NCT01593059|Chronic Total Occlusion (CTO)|chronic total occlusion (cto)
5009689|NCT01593046|GSK1265744 LAP|gsk1265744 lap
5009690|NCT01593046|integrase inhibitor|integrase inhibitor
5009691|NCT01593046|healthy subjects|healthy subjects
5009692|NCT01593046|TMC278 LA|tmc278 la
5009693|NCT01593046|GSK1265744LAP|gsk1265744lap
5009694|NCT01593046|long acting retroviral|long acting retroviral
5009695|NCT01593046|HIV-1 infection|hiv-1 infection
5009696|NCT01593020|Breast cancer|breast cancer
5009697|NCT01593020|Early Stage Breast Cancer Not Overexpressing HER-2|early stage breast cancer not overexpressing her-2
5009698|NCT01593020|Primary invasive adenocarcinoma of the breast|primary invasive adenocarcinoma of the breast
5009699|NCT01593020|Paclitaxel|paclitaxel
5009700|NCT01593020|Taxol|taxol
5009701|NCT01593020|Eribulin|eribulin
5009702|NCT01593020|E7389|e7389
5009703|NCT01593020|5-Fluorouracil|5-fluorouracil
5009704|NCT01593020|5-FU|5-fu
5009705|NCT01593020|Adrucil|adrucil
5009706|NCT01593020|Efudex|efudex
5009707|NCT01593020|Epirubicin|epirubicin
5009708|NCT01593020|Ellence|ellence
5009709|NCT01593020|Cyclophosphamide|cyclophosphamide
5009710|NCT01593020|Cytoxan|cytoxan
5009711|NCT01593020|Neosar|neosar
5009712|NCT01593020|Doxorubicin|doxorubicin
5009713|NCT01593020|Doxorubicin hydrochloride|doxorubicin hydrochloride
5009714|NCT01593020|Adriamycin PFS|adriamycin pfs
5009715|NCT01593020|Adriamycin RDF|adriamycin rdf
5009716|NCT01593020|Adriamycin|adriamycin
5009717|NCT01593020|Rubex|rubex
5009718|NCT01593007|Heart failure|heart failure
5009719|NCT01593007|respiratory muscles|respiratory muscles
5009720|NCT01593007|optoelectronic plethysmography|optoelectronic plethysmography
5009721|NCT01592994|HIV|hiv
5009722|NCT01592994|condom use|condom use
5009723|NCT01592994|India|india
5009724|NCT01592994|women|women
5009725|NCT01592981|Waldenstrom's macroglobulinaemia|waldenstrom's macroglobulinaemia
5009726|NCT01592981|bortezomib|bortezomib
5009727|NCT01592981|cyclophosphamide|cyclophosphamide
5009728|NCT01592981|rituximab|rituximab
5009729|NCT01592968|Brain Neoplasms|brain neoplasms
5009730|NCT01592968|Non-melanoma brain metastases|non-melanoma brain metastases
5009731|NCT01592968|Stereotactic radiosurgery|stereotactic radiosurgery
5009732|NCT01592968|SRS|srs
5009733|NCT01592968|Whole brain radiation therapy|whole brain radiation therapy
5009734|NCT01592968|WBRT|wbrt
5009735|NCT01592955|Glaucoma|glaucoma
5009736|NCT01592955|Cyclocoagulation|cyclocoagulation
5009737|NCT01592955|HIFU High Intensity Focused Ultrasound|hifu high intensity focused ultrasound
5009738|NCT01592942|inguinal hernia|inguinal hernia
5009739|NCT01592942|mesh fixation|mesh fixation
5009740|NCT01592942|glue|glue
5009741|NCT01592942|Lichtenstein|lichtenstein
5009742|NCT01592929|Functional Respiratory Imaging|functional respiratory imaging
5009743|NCT01592929|Magnetic Resonance Imaging|magnetic resonance imaging
5009744|NCT01592929|MRI|mri
5009745|NCT01592929|Pharyngometry|pharyngometry
5009746|NCT01592929|Upper Airway|upper airway
5009747|NCT01592929|Mouthpiece of Inhaler|mouthpiece of inhaler
5009748|NCT01592929|Cone Beam Computed Tomography|cone beam computed tomography
5009749|NCT01592929|CBCT|cbct
5009750|NCT01592929|Computed Tomography|computed tomography
5009751|NCT01592929|CT|ct
5009752|NCT01592916|Fibromyalgia|fibromyalgia
5009753|NCT01592916|Pain|pain
5009754|NCT01592916|Women|women
5009755|NCT01592916|Exercise|exercise
5009756|NCT01592916|IGF1|igf1
5009757|NCT01592903|Uterine fibroids|uterine fibroids
5009758|NCT01592903|somatic stem cell|somatic stem cell
5009759|NCT01592903|Side Population|side population
5009760|NCT01592877|UWB|uwb
5009761|NCT01592877|non-contact|non-contact
5009762|NCT01592877|patient monitor|patient monitor
5009763|NCT01592838|Belgium|belgium
5009764|NCT01592838|Quality of hospital care|quality of hospital care
5009765|NCT01592838|Rotavirus vaccination|rotavirus vaccination
5009766|NCT01592825|Breast Cancer|breast cancer
5009767|NCT01592825|Prognostic factor|prognostic factor
5009768|NCT01592825|uPA/PA-1|upa/pa-1
5009769|NCT01592825|cohort|cohort
5009770|NCT01592799|Influenza|influenza
5009771|NCT01592799|Children|children
5009772|NCT01592799|Hospitalizations|hospitalizations
5009773|NCT01592799|Spain|spain
5009774|NCT01592799|Burden|burden
5009775|NCT01592786|Autism Spectrum Disorder (ASD)|autism spectrum disorder (asd)
5009776|NCT01592786|Autism|autism
5009777|NCT01592786|Autistic Disorder|autistic disorder
5009778|NCT01592786|Asperger's Disorder|asperger's disorder
5009779|NCT01592786|Asperger's|asperger's
5009780|NCT01592786|Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)|pervasive developmental disorder not otherwise specified (pdd-nos)
5009781|NCT01592786|Memantine|memantine
5009782|NCT01592786|Pediatric Disorder|pediatric disorder
5009783|NCT01592773|Autistic Disorder|autistic disorder
5009784|NCT01592773|Asperger's Disorder|asperger's disorder
5009785|NCT01592773|Asperger's|asperger's
5009786|NCT01592773|Pediatric Autism|pediatric autism
5009787|NCT01592773|Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)|pervasive developmental disorder not otherwise specified (pdd-nos)
5009788|NCT01592773|Pervasive Child Development Disorder|pervasive child development disorder
5009789|NCT01592760|air-Q SP|air-q sp
5009790|NCT01592760|air-Q|air-q
5009791|NCT01592760|i-gel|i-gel
5009792|NCT01592760|supraglottic airway device|supraglottic airway device
5009793|NCT01592760|laryngeal mask airway|laryngeal mask airway
5009794|NCT01592747|Asperger's|asperger's
5009795|NCT01592747|Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)|pervasive developmental disorder not otherwise specified (pdd-nos)
5009796|NCT01592747|Memantine|memantine
5009797|NCT01592747|Pervasive Child Development Disorder|pervasive child development disorder
5009798|NCT01592747|Pediatric Disorder|pediatric disorder
5009799|NCT01592747|Randomized Controlled Trial|randomized controlled trial
5009800|NCT01592734|chronic constipation|chronic constipation
5009801|NCT01592734|faecal impaction|faecal impaction
5009802|NCT01592734|PEG-only laxative|peg-only laxative
5009803|NCT01592721|Carcinoma|carcinoma
5009804|NCT01592721|Squamous cell carcinoma|squamous cell carcinoma
5009805|NCT01592721|Head and neck neoplasms|head and neck neoplasms
5009806|NCT01592721|Cetuximab|cetuximab
5009807|NCT01592708|orthognathic surgery|orthognathic surgery
5009808|NCT01592708|maxillary osteotomy|maxillary osteotomy
5009809|NCT01592708|post operative nausea vomiting|post operative nausea vomiting
5009810|NCT01592708|post discharge nausea vomiting|post discharge nausea vomiting
5009811|NCT01592708|anesthesia|anesthesia
5009812|NCT01592695|Nicotine dependence|nicotine dependence
5009813|NCT01592695|Smoking cessation|smoking cessation
5009814|NCT01592695|Telehealth|telehealth
5009815|NCT01592695|Alcohol use|alcohol use
5009816|NCT01592695|Depression|depression
5009817|NCT01592695|Body weight|body weight
5009818|NCT01592682|tobacco|tobacco
5009819|NCT01592682|secondhand smoke|secondhand smoke
5009820|NCT01592682|Chinese|chinese
5009821|NCT01592682|NNAL|nnal
5009822|NCT01592669|Passive leg raising, blood pressure, heart rate|passive leg raising, blood pressure, heart rate
5009823|NCT01592656|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5009824|NCT01592656|GOLD stages II, III and IV|gold stages ii, iii and iv
5009825|NCT01592656|Computed Tomography scan|computed tomography scan
5009826|NCT01592656|Functional Respiratory Imaging|functional respiratory imaging
5009827|NCT01592656|Non-Invasive Ventilation|non-invasive ventilation
5009828|NCT01592656|Arterial Blood Gas|arterial blood gas
5009829|NCT01592656|Hypercapnic|hypercapnic
5009830|NCT01592656|Health Related Quality of Life|health related quality of life
5009831|NCT01592656|Lung compliance|lung compliance
5009832|NCT01592643|Corneal shield|corneal shield
5009833|NCT01592643|PRK|prk
5009834|NCT01592643|Myopia|myopia
5009835|NCT01592643|Pain|pain
5009836|NCT01592643|Vision|vision
5009837|NCT01592617|cancer vaccine|cancer vaccine
5009838|NCT01592617|HLA-A*24:02|hla-a*24:02
5009839|NCT01592617|lung cancer|lung cancer
5009840|NCT01592617|CTL|ctl
5009841|NCT01592604|fracture|fracture
5009842|NCT01592604|fifth metatarsal|fifth metatarsal
5009843|NCT01592604|functioanl outcome|functioanl outcome
5009844|NCT01592578|gastroesophgeal variceal bleeding|gastroesophgeal variceal bleeding
5009845|NCT01592578|liver cirrhosis|liver cirrhosis
5009846|NCT01592578|portal hypertension|portal hypertension
5009847|NCT01592552|Alzheimer's Disease|alzheimer's disease
5009848|NCT01592552|Multiple Sclerosis|multiple sclerosis
5009849|NCT01592552|Parkinson's Disease|parkinson's disease
5009850|NCT01592552|Huntington's Disease|huntington's disease
5009851|NCT01592552|Amyotrophic Lateral Sclerosis (ALS)|amyotrophic lateral sclerosis (als)
5009852|NCT01592539|Type 1 Diabetes|type 1 diabetes
5009853|NCT01592539|Bone|bone
5009854|NCT01592526|Systemic inflammatory response.|systemic inflammatory response.
5009855|NCT01592526|Autonomic nervous regulation.|autonomic nervous regulation.
5009856|NCT01592526|Cholinergic antiinflammatory pathway|cholinergic antiinflammatory pathway
5009857|NCT01592500|GHD|ghd
5009858|NCT01592500|r-hGH|r-hgh
5009859|NCT01592500|Long-acting|long-acting
5009860|NCT01592474|Multiple Sclerosis|multiple sclerosis
5009861|NCT01592474|Avonex|avonex
5009862|NCT01592474|Brain atrophy|brain atrophy
5009863|NCT01592474|MRI|mri
5009864|NCT01592474|Interferon-beta 1a|interferon-beta 1a
5009865|NCT01592474|IFN Beta 1-a|ifn beta 1-a
5009866|NCT01592474|Clinically isolated syndrome|clinically isolated syndrome
5009867|NCT01592474|CIS|cis
5009868|NCT01592461|Substance abuse treatment outcomes|substance abuse treatment outcomes
5009869|NCT01592461|Opioid dependence|opioid dependence
5009870|NCT01592461|Suboxone|suboxone
5009871|NCT01592461|Methadone|methadone
5009872|NCT01592448|Acetaminophen|acetaminophen
5009873|NCT01592448|Patient Safety|patient safety
5009874|NCT01592448|Health Literacy|health literacy
5009875|NCT01592422|Small cell lung cancer|small cell lung cancer
5009876|NCT01592422|Maintenance therapy|maintenance therapy
5009877|NCT01592422|Immunotherapy|immunotherapy
5009878|NCT01592422|Autologous cytokine-induced killer cell|autologous cytokine-induced killer cell
5009879|NCT01592409|cannabis impaired driving|cannabis impaired driving
5009880|NCT01592409|driving simulation|driving simulation
5009881|NCT01592409|acute psychopharmacologic effects of cannabis|acute psychopharmacologic effects of cannabis
5009882|NCT01592409|residual effects of cannabis|residual effects of cannabis
5009883|NCT01592409|young drivers|young drivers
5009884|NCT01592396|Tralokinumab|tralokinumab
5009885|NCT01592396|CAT-354|cat-354
5009886|NCT01592396|Asthma|asthma
5009887|NCT01592357|cardiac rehabilitation|cardiac rehabilitation
5009888|NCT01592357|gait speed|gait speed
5009889|NCT01592357|mind body exercise|mind body exercise
5009890|NCT01592357|tai chi|tai chi
5009891|NCT01592357|cardiac disease|cardiac disease
5009892|NCT01592357|frail elderly|frail elderly
5009893|NCT01592344|Chronic pain|chronic pain
5009894|NCT01592344|peripheral nerve|peripheral nerve
5009895|NCT01592344|neuralgia|neuralgia
5009896|NCT01592344|somatosensory nervous system|somatosensory nervous system
5009897|NCT01592266|FLT|flt
5009898|NCT01592266|PET|pet
5009899|NCT01592266|bone marrow|bone marrow
5009900|NCT01592266|AML|aml
5009901|NCT01592240|PF-04950615|pf-04950615
5009902|NCT01592240|RN316|rn316
5009903|NCT01592227|healthy volunteer|healthy volunteer
5009904|NCT01592227|pharmacokinetics|pharmacokinetics
5009905|NCT01592227|paracetamol|paracetamol
5009906|NCT01592214|Staphylococcus aureus, nasal decolonization, XF-73, gel formulation|staphylococcus aureus, nasal decolonization, xf-73, gel formulation
5009907|NCT01592201|Schizophrenia|schizophrenia
5009908|NCT01592201|Paliperidone ER|paliperidone er
5009909|NCT01592201|Antipsychotics|antipsychotics
5009910|NCT01592201|Mental disorder|mental disorder
5009911|NCT01592201|Comparative study|comparative study
5009912|NCT01592188|meditation, inflammation, children, attention|meditation, inflammation, children, attention
5009913|NCT01592149|Appetite|appetite
5009914|NCT01592136|Ponatinib|ponatinib
5009915|NCT01592136|Tyrosine kinase inhibitor|tyrosine kinase inhibitor
5009916|NCT01592123|anxiety|anxiety
5009917|NCT01592123|septal surgery|septal surgery
5009918|NCT01592123|septum deviation|septum deviation
5009919|NCT01592123|sleep|sleep
5009920|NCT01592110|Schizophrenia|schizophrenia
5009921|NCT01592097|Multiple Sclerosis|multiple sclerosis
5009922|NCT01592097|MS|ms
5009923|NCT01592097|Autoimmune|autoimmune
5009924|NCT01592084|lipid lowering therapy|lipid lowering therapy
5009925|NCT01592084|survival|survival
5009926|NCT01592084|ALSFRS|alsfrs
5009927|NCT01592084|age|age
5009928|NCT01592084|BMI|bmi
5009929|NCT01592084|weight|weight
5009930|NCT01592071|food sensitivity|food sensitivity
5009931|NCT01592071|IgG|igg
5009932|NCT01592071|obesity|obesity
5009933|NCT01592071|overweight|overweight
5009934|NCT01592071|body composition|body composition
5009935|NCT01592071|reactive foods|reactive foods
5009936|NCT01592058|weight change|weight change
5009937|NCT01592058|contraception|contraception
5009938|NCT01592058|birth control|birth control
5009939|NCT01592058|progestin|progestin
5009940|NCT01592058|progestin only|progestin only
5009941|NCT01592058|weight gain|weight gain
5009942|NCT01592058|depo|depo
5009943|NCT01592058|Depo Provera|depo provera
5009944|NCT01592058|DMPA|dmpa
5009945|NCT01592058|IUD|iud
5009946|NCT01592058|IUC|iuc
5009947|NCT01592058|Mirena|mirena
5009948|NCT01592058|Paragard|paragard
5009949|NCT01592058|Implanon|implanon
5009950|NCT01592058|implant|implant
5009951|NCT01592032|Antibiotic-lock technique.|antibiotic-lock technique.
5009952|NCT01592032|In vivo antimicrobial concentration.|in vivo antimicrobial concentration.
5009953|NCT01592032|Antimicrobial bioactivity.|antimicrobial bioactivity.
5009954|NCT01592006|hepatitis C virus|hepatitis c virus
5009955|NCT01592006|liver transplant recipient|liver transplant recipient
5009956|NCT01591993|Sensitive skin|sensitive skin
5009957|NCT01591993|Lactic acid test|lactic acid test
5009958|NCT01591993|Transepidermal water loss|transepidermal water loss
5009959|NCT01591993|Colorimetry|colorimetry
5009960|NCT01591993|Capacitance|capacitance
5009961|NCT01591980|post-craniotomy pain|post-craniotomy pain
5009962|NCT01591980|pregabalin|pregabalin
5009963|NCT01591980|chronic post-craniotomy headache|chronic post-craniotomy headache
5009964|NCT01591980|Craniotomy|craniotomy
5009965|NCT01591967|Chiropractic|chiropractic
5009966|NCT01591967|Blood pressure|blood pressure
5009967|NCT01591967|Pulse Rate|pulse rate
5009968|NCT01591967|Thoracic|thoracic
5009969|NCT01591941|ACL, Knee , Injury,|acl, knee , injury,
5009970|NCT01591928|Pediatrics|pediatrics
5009971|NCT01591928|Congenital heart disease|congenital heart disease
5009972|NCT01591928|Heterotaxy syndrome|heterotaxy syndrome
5009973|NCT01591928|Intestinal malrotation|intestinal malrotation
5009974|NCT01591915|Breast cancer, Mindfulness Based Stress Reduction, RCT, mood, cooping, health related quality of life|breast cancer, mindfulness based stress reduction, rct, mood, cooping, health related quality of life
5009975|NCT01591876|exercise|exercise
5009976|NCT01591876|kidney disease|kidney disease
5009977|NCT01591876|vascular function|vascular function
5009978|NCT01591876|haemodialysis|haemodialysis
5009979|NCT01591863|Clostridium difficile-associated diarrhea|clostridium difficile-associated diarrhea
5009980|NCT01591863|CDAD|cdad
5009981|NCT01591863|Pediatric|pediatric
5009982|NCT01591798|Rectal cancer|rectal cancer
5009983|NCT01591798|Robotic surgery|robotic surgery
5009984|NCT01591798|Laparoscopic surgery|laparoscopic surgery
5009985|NCT01591785|Hand|hand
5009986|NCT01591785|Foot|foot
5009987|NCT01591785|Eczema|eczema
5009988|NCT01591785|Atopic Dermatitis|atopic dermatitis
5009989|NCT01591772|FALLOPIAN TUBE|fallopian tube
5009990|NCT01591772|OVARY|ovary
5009991|NCT01591772|PERITONEUM|peritoneum
5009992|NCT01591772|Quality of Life|quality of life
5009993|NCT01591772|structural MRI|structural mri
5009994|NCT01591772|functional MRI|functional mri
5009995|NCT01591772|neuropsychological assessment|neuropsychological assessment
5009996|NCT01591772|12-075|12-075
5009997|NCT01591759|citicoline|citicoline
5009998|NCT01591759|cognitive function|cognitive function
5009999|NCT01591759|function magnetic resonance imaging|function magnetic resonance imaging
5010000|NCT01591759|magnetic resonance spectroscopy|magnetic resonance spectroscopy
5010001|NCT01591759|diffusion tensor imaging|diffusion tensor imaging
5010002|NCT01591746|Mastectomy|mastectomy
5010003|NCT01591746|Mammaplasty|mammaplasty
5010004|NCT01591746|Breast reconstruction|breast reconstruction
5010005|NCT01591746|Tissue expansion|tissue expansion
5010006|NCT01591746|Botulinum toxins, Type A|botulinum toxins, type a
5010007|NCT01591746|Quality of Life|quality of life
5010008|NCT01591746|Acellular dermal matrix|acellular dermal matrix
5010009|NCT01591733|Borderline resectable|borderline resectable
5010010|NCT01591707|autism spectrum disorders|autism spectrum disorders
5010011|NCT01591707|school|school
5010012|NCT01591707|language|language
5010013|NCT01591707|social|social
5010014|NCT01591694|child trauma|child trauma
5010015|NCT01591694|maltreatment|maltreatment
5010016|NCT01591694|physical abuse|physical abuse
5010017|NCT01591694|sexual abuse|sexual abuse
5010018|NCT01591694|emotional abuse|emotional abuse
5010019|NCT01591694|abandonment|abandonment
5010020|NCT01591694|domestic violence|domestic violence
5010021|NCT01591694|community violence|community violence
5010022|NCT01591681|Type 1 Diabetes|type 1 diabetes
5010023|NCT01591681|Hypoglycemia|hypoglycemia
5010024|NCT01591681|Continuous Glucose Monitoring|continuous glucose monitoring
5010025|NCT01591681|Pump Suspension|pump suspension
5010026|NCT01591668|Hepatitis|hepatitis
5010027|NCT01591668|Hepatitis C|hepatitis c
5010028|NCT01591668|Chronic HCV|chronic hcv
5010029|NCT01591668|HCV|hcv
5010030|NCT01591668|Treatment Naive|treatment naive
5010031|NCT01591668|Gilead|gilead
5010032|NCT01591668|GS-9620|gs-9620
5010033|NCT01591642|physical activity|physical activity
5010034|NCT01591642|functional fitness|functional fitness
5010035|NCT01591642|quality of life|quality of life
5010036|NCT01591629|Cannabis|cannabis
5010037|NCT01591629|Marijuana|marijuana
5010038|NCT01591629|Naloxone|naloxone
5010039|NCT01591629|THC|thc
5010040|NCT01591629|Psychotic Disorders|psychotic disorders
5010041|NCT01591590|Colorectal Cancer|colorectal cancer
5010042|NCT01591590|Cancer|cancer
5010043|NCT01591590|Colon Cancer|colon cancer
5010044|NCT01591590|Rectal Cancer|rectal cancer
5010045|NCT01591590|PET|pet
5010046|NCT01591590|PET-CT|pet-ct
5010047|NCT01591590|MRI|mri
5010048|NCT01591590|Diffusion MRI|diffusion mri
5010049|NCT01591590|Apparent Diffusion Coefficient|apparent diffusion coefficient
5010050|NCT01591590|ADC|adc
5010051|NCT01591590|Metabolic Progression Index|metabolic progression index
5010052|NCT01591564|interpersonal psychotherapy|interpersonal psychotherapy
5010053|NCT01591564|severe mood dysregulation|severe mood dysregulation
5010054|NCT01591538|Prevalence|prevalence
5010055|NCT01591538|MDRGNB|mdrgnb
5010056|NCT01591538|Acquisition|acquisition
5010057|NCT01591538|Middle stay|middle stay
5010058|NCT01591538|Endemic area|endemic area
5010059|NCT01591525|Type II Diabetes|type ii diabetes
5010060|NCT01591525|Minorities|minorities
5010061|NCT01591525|Diabetes Mellitus|diabetes mellitus
5010062|NCT01591525|Community based screening|community based screening
5010063|NCT01591512|Small Cell Lung Cancer|small cell lung cancer
5010064|NCT01591512|SCLC|sclc
5010065|NCT01591512|Lung Cancer|lung cancer
5010066|NCT01591512|Subjects diagnosed with SCLC who will undergo treatment|subjects diagnosed with sclc who will undergo treatment
5010067|NCT01591486|Helicobacter pylori (Hp)|helicobacter pylori (hp)
5010068|NCT01591486|ASA users|asa users
5010069|NCT01591486|peptic ulcer bleeding|peptic ulcer bleeding
5010070|NCT01591486|cohorts|cohorts
5010071|NCT01591473|Influenza|influenza
5010072|NCT01591473|Ampligen|ampligen
5010073|NCT01591473|Poly I:Poly C12U|poly i:poly c12u
5010074|NCT01591473|Rintatolimod|rintatolimod
5010075|NCT01591473|FluMist|flumist
5010076|NCT01591408|EEG biofeedback|eeg biofeedback
5010077|NCT01591408|neurofeedback|neurofeedback
5010078|NCT01591408|therapy|therapy
5010079|NCT01591408|adjunct|adjunct
5010080|NCT01591395|inguinal hernia|inguinal hernia
5010081|NCT01591395|laparoscopy|laparoscopy
5010082|NCT01591395|laparoendoscopic single-site surgery|laparoendoscopic single-site surgery
5010083|NCT01591382|Ketamine|ketamine
5010084|NCT01591382|Postoperative pain|postoperative pain
5010085|NCT01591382|Opioid dependent patients|opioid dependent patients
5010086|NCT01591382|Acute pain control|acute pain control
5010087|NCT01591356|Advanced Cancers|advanced cancers
5010088|NCT01591356|Advanced solid tumors|advanced solid tumors
5010089|NCT01591356|siRNA/EphA2|sirna/epha2
5010090|NCT01591343|Specific immunotherapy|specific immunotherapy
5010091|NCT01591343|Allergic rhinitis|allergic rhinitis
5010092|NCT01591343|Allergic rhinoconjunctivitis|allergic rhinoconjunctivitis
5010093|NCT01591343|Asthma|asthma
5010094|NCT01591304|Ulthera® System|ulthera® system
5010095|NCT01591304|Ultherapy™ Treatment|ultherapy™ treatment
5010096|NCT01591304|Ulthera, Inc.|ulthera, inc.
5010097|NCT01591291|alcohol dependence|alcohol dependence
5010098|NCT01591291|alcohol addiction|alcohol addiction
5010099|NCT01591265|Compensatory dental extraction|compensatory dental extraction
5010100|NCT01591265|Children 7-11 years old|children 7-11 years old
5010101|NCT01591252|HIV|hiv
5010102|NCT01591252|Bone mineral density|bone mineral density
5010103|NCT01591252|bone turnover|bone turnover
5010104|NCT01591252|fracture|fracture
5010105|NCT01591252|inflammation|inflammation
5010106|NCT01591239|Adolescent|adolescent
5010107|NCT01591239|Parent|parent
5010108|NCT01591239|Substance Abuse|substance abuse
5010109|NCT01591239|Parent Training|parent training
5010110|NCT01591239|Addiction|addiction
5010111|NCT01591239|Family Intervention|family intervention
5010112|NCT01591239|Brief Intervention|brief intervention
5010113|NCT01591239|Home Intervention|home intervention
5010114|NCT01591226|caffeine|caffeine
5010115|NCT01591226|sodium citrate|sodium citrate
5010116|NCT01591226|exercise performance|exercise performance
5010117|NCT01591226|wheelchair athletes|wheelchair athletes
5010118|NCT01591226|1500m|1500m
5010119|NCT01591213|Cancer education|cancer education
5010120|NCT01591213|Prevention education|prevention education
5010121|NCT01591213|Volunteers|volunteers
5010122|NCT01591200|Alcoholic|alcoholic
5010123|NCT01591200|Liver|liver
5010124|NCT01591200|Cirrhosis|cirrhosis
5010125|NCT01591200|Stem|stem
5010126|NCT01591200|Cells|cells
5010127|NCT01591187|Text messaging|text messaging
5010128|NCT01591187|Secondhand smoke exposure|secondhand smoke exposure
5010129|NCT01591174|Functional Dyspepsia|functional dyspepsia
5010130|NCT01591174|Postprandial Distress Syndrome|postprandial distress syndrome
5010131|NCT01591174|ghrelin|ghrelin
5010132|NCT01591174|C-13 acetate|c-13 acetate
5010133|NCT01591148|Pharmacokinetics|pharmacokinetics
5010134|NCT01591148|Pharmacodynamics|pharmacodynamics
5010135|NCT01591135|Esophageal squamous cell carcinoma|esophageal squamous cell carcinoma
5010136|NCT01591135|chemoradiotherapy|chemoradiotherapy
5010137|NCT01591122|Prostate cancer|prostate cancer
5010138|NCT01591122|Metastatic Castration Resistant Prostate Cancer|metastatic castration resistant prostate cancer
5010139|NCT01591122|Abiraterone acetate|abiraterone acetate
5010140|NCT01591122|Prednisone|prednisone
5010141|NCT01591122|Zytiga|zytiga
5010142|NCT01591096|Stroke|stroke
5010143|NCT01591096|Childhood|childhood
5010144|NCT01591096|Thrombolysis|thrombolysis
5010145|NCT01591083|Peptic ulcer rebleeding, double dose of esomeprazole|peptic ulcer rebleeding, double dose of esomeprazole
5010146|NCT01591070|Facial seborrhoeic dermatitis, tacrolimus|facial seborrhoeic dermatitis, tacrolimus
5010147|NCT01591057|fruit|fruit
5010148|NCT01591057|vegetables|vegetables
5010149|NCT01591057|biomarkers|biomarkers
5010150|NCT01591057|randomised controlled feeding study|randomised controlled feeding study
5010151|NCT01591057|Fruit and vegetable intake biomarkers in healthy adults|fruit and vegetable intake biomarkers in healthy adults
5010152|NCT01591031|laryngeal injuries|laryngeal injuries
5010153|NCT01591031|vocal cord injuries|vocal cord injuries
5010154|NCT01591031|hoarseness|hoarseness
5010155|NCT01591031|sore throat|sore throat
5010156|NCT01591018|sonolysis, brain infarction, prevention, cardiac surgery|sonolysis, brain infarction, prevention, cardiac surgery
5010157|NCT01591005|sonolysis|sonolysis
5010158|NCT01591005|carotid|carotid
5010159|NCT01591005|endarterectomy|endarterectomy
5010160|NCT01591005|stenting|stenting
5010161|NCT01590992|Somatoform disorder|somatoform disorder
5010162|NCT01590992|Functional Somatic Syndrome|functional somatic syndrome
5010163|NCT01590992|Functional Somatic Symptoms|functional somatic symptoms
5010164|NCT01590992|Somatic Symptom Disorder|somatic symptom disorder
5010165|NCT01590992|globus sensation|globus sensation
5010166|NCT01590992|globus pharynges|globus pharynges
5010167|NCT01590992|globus hystericus|globus hystericus
5010168|NCT01590979|Atrial Fibrillation New Onset|atrial fibrillation new onset
5010169|NCT01590979|Ranolazine|ranolazine
5010170|NCT01590979|CABG|cabg
5010171|NCT01590979|valve repair/replacement|valve repair/replacement
5010172|NCT01590979|Cardiac Surgery|cardiac surgery
5010173|NCT01590966|spondyloarthritis|spondyloarthritis
5010174|NCT01590966|Rheumatoid arthritis|rheumatoid arthritis
5010175|NCT01590927|pelvic floor|pelvic floor
5010176|NCT01590927|ultrasonography|ultrasonography
5010177|NCT01590914|Roux-en-Y Bariatric surgery,|roux-en-y bariatric surgery,
5010178|NCT01590914|Gastric banding,|gastric banding,
5010179|NCT01590914|fMRI,|fmri,
5010180|NCT01590914|food cues|food cues
5010181|NCT01590901|Pharmacokinetics|pharmacokinetics
5010182|NCT01590901|Probucol|probucol
5010183|NCT01590901|healthy male subjects|healthy male subjects
5010184|NCT01590875|atrial fibrillation|atrial fibrillation
5010185|NCT01590875|ablation|ablation
5010186|NCT01590875|pulmonary veins|pulmonary veins
5010187|NCT01590875|adenosine|adenosine
5010188|NCT01590862|Obesessive Compulsive Disorder|obesessive compulsive disorder
5010189|NCT01590862|Major Depressive Disorder|major depressive disorder
5010190|NCT01590862|Deep Brain Stimulation|deep brain stimulation
5010191|NCT01590849|contraceptive agents|contraceptive agents
5010192|NCT01590849|autonomic nervous system|autonomic nervous system
5010193|NCT01590849|blood pressure|blood pressure
5010194|NCT01590849|risk|risk
5010195|NCT01590823|pharmacokinetics|pharmacokinetics
5010196|NCT01590784|Depression|depression
5010197|NCT01590784|Schizophrenia|schizophrenia
5010198|NCT01590758|Diabetic Foot Ulcer Infection|diabetic foot ulcer infection
5010199|NCT01590745|Ultrasound therapy|ultrasound therapy
5010200|NCT01590745|Nerve Conduction studies|nerve conduction studies
5010201|NCT01590745|Boston and Levine Questionnaire|boston and levine questionnaire
5010202|NCT01590745|Neutral Angle Wrist Splint|neutral angle wrist splint
5010203|NCT01590745|Canterbury CTS scale|canterbury cts scale
5010204|NCT01590732|Lymphoma|lymphoma
5010205|NCT01590732|Peripheral T-Cell Lymphoma|peripheral t-cell lymphoma
5010206|NCT01590732|PTCL|ptcl
5010207|NCT01590732|Relapsed or refractory T-Cell Lymphoma|relapsed or refractory t-cell lymphoma
5010208|NCT01590732|TCL|tcl
5010209|NCT01590732|Peripheral TCL-NOS|peripheral tcl-nos
5010210|NCT01590732|Angioimmunoblastic TCL|angioimmunoblastic tcl
5010211|NCT01590732|Anaplastic large cell lymphoma|anaplastic large cell lymphoma
5010212|NCT01590732|Hepatosplenic TCL|hepatosplenic tcl
5010213|NCT01590732|Enteropathy-associated TCL|enteropathy-associated tcl
5010214|NCT01590732|Romidepsin|romidepsin
5010215|NCT01590732|Istodax|istodax
5010216|NCT01590732|Depsipeptide|depsipeptide
5010217|NCT01590732|FK228|fk228
5010218|NCT01590732|Etoposide|etoposide
5010219|NCT01590732|VePesid|vepesid
5010220|NCT01590732|Carboplatin|carboplatin
5010221|NCT01590732|Paraplatin|paraplatin
5010222|NCT01590732|Mesna|mesna
5010223|NCT01590732|Mesnex|mesnex
5010224|NCT01590706|Genotype-Phenotype Association|genotype-phenotype association
5010225|NCT01590706|Aged|aged
5010226|NCT01590706|Middle Aged|middle aged
5010227|NCT01590706|Mild Cognitive Impairment|mild cognitive impairment
5010228|NCT01590706|Heart Rate Control|heart rate control
5010229|NCT01590706|Biomarkers|biomarkers
5010230|NCT01590693|Gait|gait
5010231|NCT01590667|Fat excretion|fat excretion
5010232|NCT01590654|Hepatitis|hepatitis
5010233|NCT01590654|Hepatitis B|hepatitis b
5010234|NCT01590654|Hepatitis B Virus|hepatitis b virus
5010235|NCT01590654|HBV|hbv
5010236|NCT01590654|GS-9620|gs-9620
5010237|NCT01590654|Toll-like receptor (TLR)-7 Agonist|toll-like receptor (tlr)-7 agonist
5010238|NCT01590641|Hepatitis|hepatitis
5010239|NCT01590641|Hepatitis B|hepatitis b
5010240|NCT01590641|Hepatitis B Virus|hepatitis b virus
5010241|NCT01590641|HBV|hbv
5010242|NCT01590641|GS-9620|gs-9620
5010243|NCT01590641|Toll-like receptor (TLR)-7 Agonist|toll-like receptor (tlr)-7 agonist
5010244|NCT01590628|Sickle Cell Disease & Thalassemia|sickle cell disease & thalassemia
5010245|NCT01590628|Genetic disorder|genetic disorder
5010246|NCT01590615|Hepatitis|hepatitis
5010247|NCT01590615|Hepatitis B|hepatitis b
5010248|NCT01590615|HBV|hbv
5010249|NCT01590615|OLT|olt
5010250|NCT01590615|MELD|meld
5010251|NCT01590615|Renal Safety|renal safety
5010252|NCT01590615|Liver Transplant|liver transplant
5010253|NCT01590602|Huntington's Disease|huntington's disease
5010254|NCT01590602|European Huntington's Disease Network|european huntington's disease network
5010255|NCT01590602|Juvenile HD|juvenile hd
5010256|NCT01590602|EHDN|ehdn
5010257|NCT01590602|REGISTRY|registry
5010258|NCT01590589|Huntington Disease|huntington disease
5010259|NCT01590589|European HD Network|european hd network
5010260|NCT01590589|Cohort|cohort
5010261|NCT01590589|REGISTRY|registry
5010262|NCT01590589|EHDN|ehdn
5010263|NCT01590576|women|women
5010264|NCT01590550|Pediatric hemodialysis|pediatric hemodialysis
5010265|NCT01590550|Anticoagulation|anticoagulation
5010266|NCT01590537|non-interventional|non-interventional
5010267|NCT01590537|Mirena|mirena
5010268|NCT01590537|Contraception|contraception
5010269|NCT01590537|Russian Federation|russian federation
5010270|NCT01590524|Parent|parent
5010271|NCT01590524|childhood cancer|childhood cancer
5010272|NCT01590524|Complementary and Alternative|complementary and alternative
5010273|NCT01590511|mini fluid challenge|mini fluid challenge
5010274|NCT01590511|subaortic velocity time integral|subaortic velocity time integral
5010275|NCT01590498|Adenocarcinoma|adenocarcinoma
5010276|NCT01590498|Prostatic Neoplasms|prostatic neoplasms
5010277|NCT01590498|Carcinoma|carcinoma
5010278|NCT01590498|Prostatic Diseases|prostatic diseases
5010279|NCT01590485|pain|pain
5010280|NCT01590485|root canal therapy|root canal therapy
5010281|NCT01590472|Genetics of Mesothelioma|genetics of mesothelioma
5010282|NCT01590472|Mesothelioma Consortium|mesothelioma consortium
5010283|NCT01590472|GWAS|gwas
5010284|NCT01590472|Asbestos|asbestos
5010285|NCT01590446|Achondroplasia|achondroplasia
5010286|NCT01590433|Obesity|obesity
5010287|NCT01590433|Overweight|overweight
5010288|NCT01590433|Exenatide|exenatide
5010289|NCT01590433|Diet|diet
5010290|NCT01590433|Women|women
5010291|NCT01590420|OSA|osa
5010292|NCT01590420|Sleep|sleep
5010293|NCT01590420|CPAP|cpap
5010294|NCT01590420|Cost|cost
5010295|NCT01590394|obstruction|obstruction
5010296|NCT01590394|bile duct|bile duct
5010297|NCT01590394|malignant|malignant
5010298|NCT01590342|Pulmonary embolism|pulmonary embolism
5010299|NCT01590342|Right ventricular dysfunction|right ventricular dysfunction
5010300|NCT01590342|Prognosis|prognosis
5010301|NCT01590342|Inflammation|inflammation
5010302|NCT01590329|Skin surgery|skin surgery
5010303|NCT01590329|Micrografting|micrografting
5010304|NCT01590329|Hypo-pigmentation|hypo-pigmentation
5010305|NCT01590316|Brain Injuries|brain injuries
5010306|NCT01590316|Infant, Premature|infant, premature
5010307|NCT01590316|Spectroscopy, Near-Infrared|spectroscopy, near-infrared
5010308|NCT01590316|Randomized Controlled Trial|randomized controlled trial
5010309|NCT01590303|severe sepsis|severe sepsis
5010310|NCT01590264|tinnitus|tinnitus
5010311|NCT01590264|bimodal stimulation|bimodal stimulation
5010312|NCT01590264|rTMS|rtms
5010313|NCT01590264|Repetitive Transcranial Magnetic Stimulation|repetitive transcranial magnetic stimulation
5010314|NCT01590251|Pain|pain
5010315|NCT01590251|Addiction|addiction
5010316|NCT01590251|Buprenorphine|buprenorphine
5010317|NCT01590251|Counseling|counseling
5010318|NCT01590251|Methadone|methadone
5010319|NCT01590251|Yoga|yoga
5010320|NCT01590238|alopecia|alopecia
5010321|NCT01590186|Pain|pain
5010322|NCT01590186|Front foot|front foot
5010323|NCT01590186|Flat foot|flat foot
5010324|NCT01590186|Metatarsalgia|metatarsalgia
5010325|NCT01590173|Low molecular weight heparin|low molecular weight heparin
5010326|NCT01590173|Prednisolone|prednisolone
5010327|NCT01590173|Glucocorticoids|glucocorticoids
5010328|NCT01590173|Recurrent implantation failure|recurrent implantation failure
5010329|NCT01590173|Pregnancy rate|pregnancy rate
5010330|NCT01590134|volunteers|volunteers
5010331|NCT01590134|Pilot study|pilot study
5010332|NCT01590134|There are no pre registration evaluations.|there are no pre registration evaluations.
5010333|NCT01590134|Inclusion criteria: to be a healthy, consenting volunteer not currently receiving iron supplements.|inclusion criteria: to be a healthy, consenting volunteer not currently receiving iron supplements.
5010334|NCT01590134|Exclusion criteria: 1) Needle phobia; 2) Currently receiving iron supplements; 3) Unable to provide informed consent|exclusion criteria: 1) needle phobia; 2) currently receiving iron supplements; 3) unable to provide informed consent
5010335|NCT01590121|Previous flight by aeroplane|previous flight by aeroplane
5010336|NCT01590108|Idiopathic Pulmonary Arterial Hypertension|idiopathic pulmonary arterial hypertension
5010337|NCT01590108|IPAH|ipah
5010338|NCT01590108|Apelin|apelin
5010339|NCT01590108|APJ receptor|apj receptor
5010340|NCT01590095|Chlorine water treatment|chlorine water treatment
5010341|NCT01590095|Point-of-use water treatment|point-of-use water treatment
5010342|NCT01590095|Household water treatment with safe storage|household water treatment with safe storage
5010343|NCT01590095|Hand washing with soap|hand washing with soap
5010344|NCT01590095|Hand hygiene|hand hygiene
5010345|NCT01590095|Latrines|latrines
5010346|NCT01590095|Child potties|child potties
5010347|NCT01590095|Point-of-use fortification|point-of-use fortification
5010348|NCT01590095|Lipid-based nutrient supplement|lipid-based nutrient supplement
5010349|NCT01590095|Environmental enteropathy|environmental enteropathy
5010350|NCT01590095|Tropical enteropathy|tropical enteropathy
5010351|NCT01590095|Gut function|gut function
5010352|NCT01590095|Intestinal parasitic infection|intestinal parasitic infection
5010353|NCT01590095|Soil transmitted helminths|soil transmitted helminths
5010354|NCT01590095|Intestinal protozoans|intestinal protozoans
5010355|NCT01590095|Antibody response|antibody response
5010356|NCT01590095|Water|water
5010357|NCT01590095|Sanitation|sanitation
5010358|NCT01590095|Hand washing|hand washing
5010359|NCT01590095|Breast Feeding|breast feeding
5010360|NCT01590095|Complementary Feeding|complementary feeding
5010361|NCT01590095|Micronutrients|micronutrients
5010362|NCT01590095|Malnutrition|malnutrition
5010363|NCT01590095|Nutrition Disorders|nutrition disorders
5010364|NCT01590095|Diarrhea|diarrhea
5010365|NCT01590095|Child Development|child development
5010366|NCT01590082|Melanoma|melanoma
5010367|NCT01590082|Metastatic Melanoma|metastatic melanoma
5010368|NCT01590082|Advanced melanoma|advanced melanoma
5010369|NCT01590082|Doxycycline|doxycycline
5010370|NCT01590082|Ipilimumab|ipilimumab
5010371|NCT01590082|Yervoy|yervoy
5010372|NCT01590082|MDX010|mdx010
5010373|NCT01590082|BMS-734016|bms-734016
5010374|NCT01590082|Temozolomide|temozolomide
5010375|NCT01590082|Temodar|temodar
5010376|NCT01590069|Sarcoma|sarcoma
5010377|NCT01590069|Solid Tumors|solid tumors
5010378|NCT01590069|Pulmonary Metastases|pulmonary metastases
5010379|NCT01590069|Lung metastases|lung metastases
5010380|NCT01590069|Osteosarcomas|osteosarcomas
5010381|NCT01590069|Ewing sarcoma|ewing sarcoma
5010382|NCT01590069|IL-2|il-2
5010383|NCT01590069|Interleukin-2|interleukin-2
5010384|NCT01590069|Aldesleukin|aldesleukin
5010385|NCT01590069|Proleukin|proleukin
5010386|NCT01590069|Aerosol IL-2|aerosol il-2
5010387|NCT01590069|Spirometry|spirometry
5010388|NCT01590069|Nebulizer|nebulizer
5010389|NCT01590069|Pulse oximeter|pulse oximeter
5010390|NCT01590056|Mapping limbic areas of the STN|mapping limbic areas of the stn
5010391|NCT01590056|neuronal responses to stimuli during surgery|neuronal responses to stimuli during surgery
5010392|NCT01590017|stage IB cervical cancer|stage ib cervical cancer
5010393|NCT01590017|stage IIA cervical cancer|stage iia cervical cancer
5010394|NCT01590017|stage IIB cervical cancer|stage iib cervical cancer
5010395|NCT01590017|stage III cervical cancer|stage iii cervical cancer
5010396|NCT01590017|stage IVA cervical cancer|stage iva cervical cancer
5010397|NCT01590017|cervical adenocarcinoma|cervical adenocarcinoma
5010398|NCT01590017|cervical adenosquamous cell carcinoma|cervical adenosquamous cell carcinoma
5010399|NCT01590017|cervical squamous cell carcinoma|cervical squamous cell carcinoma
5010400|NCT01590017|HIV infection|hiv infection
5010401|NCT01590004|LumbarCool system|lumbarcool system
5010402|NCT01590004|Cooled radiofrequency medial ablation|cooled radiofrequency medial ablation
5010403|NCT01590004|Cooled-RF neurotomy|cooled-rf neurotomy
5010404|NCT01589991|toothpastes|toothpastes
5010405|NCT01589991|bioavailability|bioavailability
5010406|NCT01589991|sodium fluoride|sodium fluoride
5010407|NCT01589991|monofluorphosphate|monofluorphosphate
5010408|NCT01589991|low-fluoride|low-fluoride
5010409|NCT01589978|drug-eluting stent|drug-eluting stent
5010410|NCT01589978|DES|des
5010411|NCT01589978|atherosclerosis|atherosclerosis
5010412|NCT01589978|everolimus|everolimus
5010413|NCT01589965|HIV/AIDS|hiv/aids
5010414|NCT01589965|STIs|stis
5010415|NCT01589965|Lottery|lottery
5010416|NCT01589952|Pegalyted interferon|pegalyted interferon
5010417|NCT01589952|Entecavir|entecavir
5010418|NCT01589939|Reduced Planning Target Volume|reduced planning target volume
5010419|NCT01589939|radiation therapy|radiation therapy
5010420|NCT01589939|Calypso|calypso
5010421|NCT01589913|Implantable Cardioverter Defibrillators|implantable cardioverter defibrillators
5010422|NCT01589913|Heart Failure|heart failure
5010423|NCT01589913|Anxiety|anxiety
5010424|NCT01589913|Depression|depression
5010425|NCT01589913|Quality of Life|quality of life
5010426|NCT01589913|Remote Care|remote care
5010427|NCT01589913|Prevention|prevention
5010428|NCT01589900|colorectal cancer|colorectal cancer
5010429|NCT01589900|invasion|invasion
5010430|NCT01589900|metastasis|metastasis
5010431|NCT01589900|IHC|ihc
5010432|NCT01589874|hepcidin|hepcidin
5010433|NCT01589874|anemia|anemia
5010434|NCT01589874|acute inflammation|acute inflammation
5010435|NCT01589874|IL-6|il-6
5010436|NCT01589874|cytokines|cytokines
5010437|NCT01589848|vWD|vwd
5010438|NCT01589809|Congenital, familial and genetic disorders|congenital, familial and genetic disorders
5010439|NCT01589809|Nervous System Diseases|nervous system diseases
5010440|NCT01589796|anesthesia|anesthesia
5010441|NCT01589796|regional anesthetic techniques: transversus abdominis plane block, ilioinguinal nerve block, iliohypogastric nerve block|regional anesthetic techniques: transversus abdominis plane block, ilioinguinal nerve block, iliohypogastric nerve block
5010442|NCT01589796|surgery, inguinal herniorrhaphy|surgery, inguinal herniorrhaphy
5010443|NCT01589796|pain, postoperative|pain, postoperative
5010444|NCT01589796|surgery, inguinal hernia repair|surgery, inguinal hernia repair
5010445|NCT01589783|Pregnancy|pregnancy
5010446|NCT01589783|Vitamin D|vitamin d
5010447|NCT01589770|rheumatoid arthritis|rheumatoid arthritis
5010448|NCT01589770|inflammation|inflammation
5010449|NCT01589757|"glycaemic index"|"glycaemic index"
5010450|NCT01589757|"glycemic index"|"glycemic index"
5010451|NCT01589757|hyperglycaemia|hyperglycaemia
5010452|NCT01589757|hyperglycemia|hyperglycemia
5010453|NCT01589757|pregnancy|pregnancy
5010454|NCT01589757|"dietary intervention"|"dietary intervention"
5010455|NCT01589757|"education evaluation"|"education evaluation"
5010456|NCT01589757|antioxidant|antioxidant
5010457|NCT01589757|"Impaired Glucose Tolerance of Pregnancy"|"impaired glucose tolerance of pregnancy"
5010458|NCT01589757|"Gestational Diabetes Mellitus"|"gestational diabetes mellitus"
5010459|NCT01589757|"Breast Milk"|"breast milk"
5010460|NCT01589744|medical device|medical device
5010461|NCT01589731|Allergenicity|allergenicity
5010462|NCT01589731|Cow's milk allergy|cow's milk allergy
5010463|NCT01589731|Leukocyte adherence inhibition test|leukocyte adherence inhibition test
5010464|NCT01589731|Polymerization|polymerization
5010465|NCT01589718|Proliferative Diabetic Retinopathy|proliferative diabetic retinopathy
5010466|NCT01589718|Tractional Retinal Detachment|tractional retinal detachment
5010467|NCT01589718|Vitreous Hemorrhage|vitreous hemorrhage
5010468|NCT01589705|Uric acid|uric acid
5010469|NCT01589705|polycystic kidney disease|polycystic kidney disease
5010470|NCT01589692|WRIST|wrist
5010471|NCT01589692|Distal Radius Fracture|distal radius fracture
5010472|NCT01589692|DRF|drf
5010473|NCT01589692|elderly|elderly
5010474|NCT01589692|internal fixation|internal fixation
5010475|NCT01589692|VLPS|vlps
5010476|NCT01589692|External Fixation|external fixation
5010477|NCT01589692|Multi center randomized trial|multi center randomized trial
5010478|NCT01589666|Entegrion|entegrion
5010479|NCT01589666|Spray-dried Solvent/Detergent Plasma|spray-dried solvent/detergent plasma
5010480|NCT01589666|Fresh Frozen Plasma|fresh frozen plasma
5010481|NCT01589666|Transfusion|transfusion
5010482|NCT01589666|Resuscitation|resuscitation
5010483|NCT01589666|Hemorrhage|hemorrhage
5010484|NCT01589666|Coagulopathy|coagulopathy
5010485|NCT01589627|distal radius fracture|distal radius fracture
5010486|NCT01589627|wrist contracture|wrist contracture
5010487|NCT01589627|dynasplint|dynasplint
5010488|NCT01589601|Congestive Heart Failure|congestive heart failure
5010489|NCT01589601|Heart Failure|heart failure
5010490|NCT01589601|Palliative Care|palliative care
5010491|NCT01589601|Palliative Medicine|palliative medicine
5010492|NCT01589588|acute treatment|acute treatment
5010493|NCT01589575|Intensive Care Unit|intensive care unit
5010494|NCT01589549|Acute graft versus host disease|acute graft versus host disease
5010495|NCT01589549|Bone marrow transplantation|bone marrow transplantation
5010496|NCT01589549|Mesenchymal stromal cells|mesenchymal stromal cells
5010497|NCT01589536|psychocardiological|psychocardiological
5010498|NCT01589536|interval intervention|interval intervention
5010499|NCT01589536|disability pension|disability pension
5010500|NCT01589536|risk profile|risk profile
5010501|NCT01589536|mental comorbidity|mental comorbidity
5010502|NCT01589484|Tomography|tomography
5010503|NCT01589484|Urinary Lithiasis|urinary lithiasis
5010504|NCT01589484|Kidney Calculi|kidney calculi
5010505|NCT01589471|Low anterior resection syndrome|low anterior resection syndrome
5010506|NCT01589471|Botulinum toxin A|botulinum toxin a
5010507|NCT01589471|Quality of life|quality of life
5010508|NCT01589471|Incontinence|incontinence
5010509|NCT01589471|Rectal cancer|rectal cancer
5010510|NCT01589471|Anorectal manometry|anorectal manometry
5010511|NCT01589458|toothpastes|toothpastes
5010512|NCT01589458|saliva|saliva
5010513|NCT01589458|dental caries|dental caries
5010514|NCT01589458|fluoride|fluoride
5010515|NCT01589445|Bangladesh|bangladesh
5010516|NCT01589445|T2DM|t2dm
5010517|NCT01589445|Pioglitazone|pioglitazone
5010518|NCT01589445|Metformin|metformin
5010519|NCT01589445|Insulin secretion and Sensitivity|insulin secretion and sensitivity
5010520|NCT01589432|Diabetic peripheral neuropathy|diabetic peripheral neuropathy
5010521|NCT01589419|DLT|dlt
5010522|NCT01589419|radiation|radiation
5010523|NCT01589419|veliparib|veliparib
5010524|NCT01589419|locally advanced rectal cancer|locally advanced rectal cancer
5010525|NCT01589419|ABT-888|abt-888
5010526|NCT01589419|capecitabine|capecitabine
5010527|NCT01589419|MTD|mtd
5010528|NCT01589419|PARP|parp
5010529|NCT01589406|Gynaecological Cancer|gynaecological cancer
5010530|NCT01589406|Quality of Life|quality of life
5010531|NCT01589406|Sexuality|sexuality
5010532|NCT01589393|Trauma|trauma
5010533|NCT01589393|Thromboprophylaxis|thromboprophylaxis
5010534|NCT01589393|Intracranial haemorrhage|intracranial haemorrhage
5010535|NCT01589393|Deep vein Thrombosis|deep vein thrombosis
5010536|NCT01589380|Aortic stenosis|aortic stenosis
5010537|NCT01589380|Exercise performance|exercise performance
5010538|NCT01589380|cardiopulmonary exercise test|cardiopulmonary exercise test
5010539|NCT01589380|fimasartan|fimasartan
5010540|NCT01589367|neoadjuvant endocrine therapy|neoadjuvant endocrine therapy
5010541|NCT01589367|metformin|metformin
5010542|NCT01589367|postmenopausal breast cancer|postmenopausal breast cancer
5010543|NCT01589328|pancreatic cancer|pancreatic cancer
5010544|NCT01589328|biliary tract cancer|biliary tract cancer
5010545|NCT01589328|cancer pain|cancer pain
5010546|NCT01589328|depression|depression
5010547|NCT01589315|ECT|ect
5010548|NCT01589315|FEAST|feast
5010549|NCT01589315|brain stimulation|brain stimulation
5010550|NCT01589315|depression|depression
5010551|NCT01589302|Bruton's Tyrosine Kinase|bruton's tyrosine kinase
5010552|NCT01589302|CLL|cll
5010553|NCT01589302|SLL|sll
5010554|NCT01589302|B-PLL|b-pll
5010555|NCT01589289|Diagnostic research|diagnostic research
5010556|NCT01589289|Rapid diagnostic tests|rapid diagnostic tests
5010557|NCT01589289|Neurological disorders|neurological disorders
5010558|NCT01589289|Neglected Tropical Diseases|neglected tropical diseases
5010559|NCT01589289|Developing countries|developing countries
5010560|NCT01589263|Benign Prostatic Hyperplasia|benign prostatic hyperplasia
5010561|NCT01589263|Lower Urinary Track Symptoms|lower urinary track symptoms
5010562|NCT01589263|BPH|bph
5010563|NCT01589263|LUTS|luts
5010564|NCT01589237|Familial Chylomicronemia Syndrome (FCS) (HLP type I)|familial chylomicronemia syndrome (fcs) (hlp type i)
5010565|NCT01589237|LCQ908|lcq908
5010566|NCT01589211|smoking|smoking
5010567|NCT01589211|cessation|cessation
5010568|NCT01589211|intervention|intervention
5010569|NCT01589211|brief|brief
5010570|NCT01589198|Asthma|asthma
5010571|NCT01589185|Pneumonia|pneumonia
5010572|NCT01589185|Monoclonal antibody|monoclonal antibody
5010573|NCT01589185|Staphylococcus aureus|staphylococcus aureus
5010574|NCT01589146|colon-rectal cancer|colon-rectal cancer
5010575|NCT01589146|heparin|heparin
5010576|NCT01589146|prophylaxis|prophylaxis
5010577|NCT01589146|laparoscopy|laparoscopy
5010578|NCT01589133|Irregular antibody screening|irregular antibody screening
5010579|NCT01589120|CHF|chf
5010580|NCT01589120|video decision aid|video decision aid
5010581|NCT01589094|CISPLATIN|cisplatin
5010582|NCT01589094|GEMCITABINE|gemcitabine
5010583|NCT01589094|GM-CSF|gm-csf
5010584|NCT01589094|radical cystectomy|radical cystectomy
5010585|NCT01589094|12-071|12-071
5010586|NCT01589003|low GI milk mood behaviour cognitive function children|low gi milk mood behaviour cognitive function children
5010587|NCT01588964|HIPEC|hipec
5010588|NCT01588964|ovarian cancer|ovarian cancer
5010589|NCT01588964|recurrence|recurrence
5010590|NCT01588938|radiation therapy|radiation therapy
5010591|NCT01588938|Calypso|calypso
5010592|NCT01588925|Cochlear implantation|cochlear implantation
5010593|NCT01588925|Dexamethasone|dexamethasone
5010594|NCT01588925|Acid, Hyaluronic|acid, hyaluronic
5010595|NCT01588912|chronic hepatitis B|chronic hepatitis b
5010596|NCT01588912|HBeAg positive|hbeag positive
5010597|NCT01588912|telbivudine|telbivudine
5010598|NCT01588912|tenofovir|tenofovir
5010599|NCT01588912|entecavir|entecavir
5010600|NCT01588912|roadmap|roadmap
5010601|NCT01588899|Uterine Leiomyomas|uterine leiomyomas
5010602|NCT01588899|Fibroids|fibroids
5010603|NCT01588899|HIFU|hifu
5010604|NCT01588899|Ablation|ablation
5010605|NCT01588899|High Intensity Focused Ultrasound|high intensity focused ultrasound
5010606|NCT01588886|Proton pump inhibitors|proton pump inhibitors
5010607|NCT01588886|Pneumonia|pneumonia
5010608|NCT01588886|Retrospective cohort study|retrospective cohort study
5010609|NCT01588873|Oral contraceptive pill|oral contraceptive pill
5010610|NCT01588873|Hormonal contraceptive ring|hormonal contraceptive ring
5010611|NCT01588873|Polycystic ovary syndrome|polycystic ovary syndrome
5010612|NCT01588847|perioperative immunoediting|perioperative immunoediting
5010613|NCT01588847|potential predictive biomarkers|potential predictive biomarkers
5010614|NCT01588847|lymph node dissection|lymph node dissection
5010615|NCT01588821|Metastatic|metastatic
5010616|NCT01588821|Refractory|refractory
5010617|NCT01588821|Relapsed|relapsed
5010618|NCT01588808|Immobilization|immobilization
5010619|NCT01588808|Protein supplementation|protein supplementation
5010620|NCT01588795|Diabetic nephropathy|diabetic nephropathy
5010621|NCT01588795|renal denervation|renal denervation
5010622|NCT01588795|nephroprotection|nephroprotection
5010623|NCT01588795|Renal failure|renal failure
5010624|NCT01588795|Renal injury|renal injury
5010625|NCT01588795|End stage renal disease|end stage renal disease
5010626|NCT01588782|Healthy volunteers|healthy volunteers
5010627|NCT01588782|Pharmacology|pharmacology
5010628|NCT01588782|Pharmacokinetics|pharmacokinetics
5010629|NCT01588782|Pharmacodynamics|pharmacodynamics
5010630|NCT01588782|Drug-drug interactions|drug-drug interactions
5010631|NCT01588782|CYP3A4|cyp3a4
5010632|NCT01588782|Abiraterone acetate|abiraterone acetate
5010633|NCT01588782|JNJ-589485|jnj-589485
5010634|NCT01588782|JNJ-212082|jnj-212082
5010635|NCT01588782|Ketoconazole|ketoconazole
5010636|NCT01588769|Glioblastoma Multiforme|glioblastoma multiforme
5010637|NCT01588769|Brain cancer|brain cancer
5010638|NCT01588769|Immunotherapy|immunotherapy
5010639|NCT01588769|Cell based therapy|cell based therapy
5010640|NCT01588769|Autologous cell based therapy|autologous cell based therapy
5010641|NCT01588769|Adoptive immunotherapy|adoptive immunotherapy
5010642|NCT01588769|Cytotoxic T cells|cytotoxic t cells
5010643|NCT01588769|Natural Killer cells|natural killer cells
5010644|NCT01588756|Chronic kidney disease|chronic kidney disease
5010645|NCT01588756|GFR|gfr
5010646|NCT01588756|Inulin|inulin
5010647|NCT01588756|51Cr-EDTA|51cr-edta
5010648|NCT01588756|ASDKP-NH2|asdkp-nh2
5010649|NCT01588756|Healthy male 18-35 yrs old, non smokers, non allergic|healthy male 18-35 yrs old, non smokers, non allergic
5010650|NCT01588756|Or Male/female 18-80 yrs old with chronic Kidney disease|or male/female 18-80 yrs old with chronic kidney disease
5010651|NCT01588730|PF|pf
5010652|NCT01588730|Dynasplint|dynasplint
5010653|NCT01588730|ADFD|adfd
5010654|NCT01588730|AFD|afd
5010655|NCT01588730|Plantar Fasciitis|plantar fasciitis
5010656|NCT01588730|plantar Fasciopathy|plantar fasciopathy
5010657|NCT01588717|Hyperhydrosis|hyperhydrosis
5010658|NCT01588717|Excessive Sweating|excessive sweating
5010659|NCT01588717|Sweating|sweating
5010660|NCT01588717|Depression|depression
5010661|NCT01588717|Antidepressant|antidepressant
5010662|NCT01588704|lung cancer|lung cancer
5010663|NCT01588704|lung adenocarcinoma|lung adenocarcinoma
5010664|NCT01588704|bevacizumab|bevacizumab
5010665|NCT01588704|adjuvant chemotherapy|adjuvant chemotherapy
5010666|NCT01588704|surgical resection rate|surgical resection rate
5010667|NCT01588704|safety|safety
5010668|NCT01588704|feasibility|feasibility
5010669|NCT01588691|Traumatic Brain Injury|traumatic brain injury
5010670|NCT01588678|endometrial|endometrial
5010671|NCT01588678|prostate|prostate
5010672|NCT01588678|breast|breast
5010673|NCT01588678|gastric|gastric
5010674|NCT01588678|cervical|cervical
5010675|NCT01588678|ovarian|ovarian
5010676|NCT01588678|neuroendocrine cancers|neuroendocrine cancers
5010677|NCT01588678|soft-tissue sarcoma|soft-tissue sarcoma
5010678|NCT01588678|squamous cell NSCLC|squamous cell nsclc
5010679|NCT01588678|renal cell carcinoma|renal cell carcinoma
5010680|NCT01588678|non-Hodgkin lymphoma|non-hodgkin lymphoma
5010681|NCT01588665|pregnancy|pregnancy
5010682|NCT01588665|stable isotopes|stable isotopes
5010683|NCT01588665|red blood cell catabolism|red blood cell catabolism
5010684|NCT01588639|Recombinant human insulin|recombinant human insulin
5010685|NCT01588639|T2DM|t2dm
5010686|NCT01588639|Safety|safety
5010687|NCT01588639|Efficacy|efficacy
5010688|NCT01588626|Healthy volunteer|healthy volunteer
5010689|NCT01588626|Japanese males|japanese males
5010690|NCT01588626|PK study|pk study
5010691|NCT01588600|food intake, satiety, fiber|food intake, satiety, fiber
5010692|NCT01588548|Advanced solid malignancies|advanced solid malignancies
5010693|NCT01588548|Malignant lymphoma|malignant lymphoma
5010694|NCT01588535|pain|pain
5010695|NCT01588535|pain measurement|pain measurement
5010696|NCT01588535|ear, middle|ear, middle
5010697|NCT01588535|otitis media|otitis media
5010698|NCT01588522|alopecia|alopecia
5010699|NCT01588509|AMG 785, bone mineral density, alendronate|amg 785, bone mineral density, alendronate
5010700|NCT01588496|hypercholesterolemia|hypercholesterolemia
5010701|NCT01588496|familial hypercholesterolemia|familial hypercholesterolemia
5010702|NCT01588496|homozygous familial hypercholesterolemia|homozygous familial hypercholesterolemia
5010703|NCT01588470|diastolic function|diastolic function
5010704|NCT01588470|mitochondria|mitochondria
5010705|NCT01588470|pioglitazone|pioglitazone
5010706|NCT01588470|pericardial fat|pericardial fat
5010707|NCT01588444|tooth extraction|tooth extraction
5010708|NCT01588444|bone grafting|bone grafting
5010709|NCT01588431|Locally advanced head and neck cancer|locally advanced head and neck cancer
5010710|NCT01588431|Squamous cell carcinoma of the head and neck|squamous cell carcinoma of the head and neck
5010711|NCT01588418|Impaired glucose tolerance (IGT)|impaired glucose tolerance (igt)
5010712|NCT01588418|Diabetes|diabetes
5010713|NCT01588405|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
5010714|NCT01588405|UT-15C SR|ut-15c sr
5010715|NCT01588405|PAH|pah
5010716|NCT01588392|Physical activity|physical activity
5010717|NCT01588392|preschoolers|preschoolers
5010718|NCT01588353|AK160, collagenase clostridium histolyticum|ak160, collagenase clostridium histolyticum
5010719|NCT01588314|Fabry disease|fabry disease
5010720|NCT01588314|neuropathic pain|neuropathic pain
5010721|NCT01588314|gabapentin|gabapentin
5010722|NCT01588301|Cervical Cancer Screening|cervical cancer screening
5010723|NCT01588301|Human Papillomavirus (HPV)|human papillomavirus (hpv)
5010724|NCT01588301|Self-collected vaginal sample|self-collected vaginal sample
5010725|NCT01588301|Cervical Smear|cervical smear
5010726|NCT01588288|Diagnosis|diagnosis
5010727|NCT01588288|Galectin 3|galectin 3
5010728|NCT01588288|Puncture|puncture
5010729|NCT01588288|Goiter, nodular|goiter, nodular
5010730|NCT01588288|Surgery|surgery
5010731|NCT01588275|cost-effectiveness|cost-effectiveness
5010732|NCT01588275|effectiveness|effectiveness
5010733|NCT01588275|treatment|treatment
5010734|NCT01588275|CPAP|cpap
5010735|NCT01588275|MRA|mra
5010736|NCT01588275|compliance|compliance
5010737|NCT01588210|caries|caries
5010738|NCT01588210|sealant|sealant
5010739|NCT01588210|fluoride|fluoride
5010740|NCT01588210|prevention|prevention
5010741|NCT01588210|community dentistry|community dentistry
5010742|NCT01588197|Pain|pain
5010743|NCT01588197|fMRI|fmri
5010744|NCT01588197|real time|real time
5010745|NCT01588171|Deep vein thrombosis|deep vein thrombosis
5010746|NCT01588171|Pulmonary embolism|pulmonary embolism
5010747|NCT01588171|Low molecular weight heparin|low molecular weight heparin
5010748|NCT01588171|Enoxaparin|enoxaparin
5010749|NCT01588171|Bemiparin|bemiparin
5010750|NCT01588158|carpal tunnel syndrome|carpal tunnel syndrome
5010751|NCT01588158|Tylenol|tylenol
5010752|NCT01588158|Vicodin|vicodin
5010753|NCT01588158|pain|pain
5010754|NCT01588145|NSCLC|nsclc
5010755|NCT01588145|HM61713|hm61713
5010756|NCT01588145|EGFR-TKI|egfr-tki
5010757|NCT01588145|Phase II|phase ii
5010758|NCT01588145|olmutinib|olmutinib
5010759|NCT01588041|Microscope mounted SDOCT|microscope mounted sdoct
5010760|NCT01587976|Health related quality of life|health related quality of life
5010761|NCT01587976|Colorectal liver metastasis|colorectal liver metastasis
5010762|NCT01587976|surveillance|surveillance
5010763|NCT01587963|hypovolemic or septic|hypovolemic or septic
5010764|NCT01587950|dentinal sensitivity|dentinal sensitivity
5010765|NCT01587950|potassium nitrate|potassium nitrate
5010766|NCT01587950|dental pain|dental pain
5010767|NCT01587937|Antibiotic stewardship.|antibiotic stewardship.
5010768|NCT01587937|Clostridium difficile infection.|clostridium difficile infection.
5010769|NCT01587937|Antibiotic resistance.|antibiotic resistance.
5010770|NCT01587924|Renal Impairment|renal impairment
5010771|NCT01587924|Anemia|anemia
5010772|NCT01587924|pharmacokinetics|pharmacokinetics
5010773|NCT01587924|hemodialysis|hemodialysis
5010774|NCT01587924|Chronic kidney disease|chronic kidney disease
5010775|NCT01587924|GSK1278863|gsk1278863
5010776|NCT01587924|hemoglobin|hemoglobin
5010777|NCT01587924|Prolyl hydroxylase inhibitor|prolyl hydroxylase inhibitor
5010778|NCT01587924|recombinant human erythropoietin|recombinant human erythropoietin
5010779|NCT01587924|erythropoiesis stimulating agents|erythropoiesis stimulating agents
5010780|NCT01587924|Dialysis, Renal|dialysis, renal
5010781|NCT01587911|Satiety|satiety
5010782|NCT01587911|Food intake regulation|food intake regulation
5010783|NCT01587911|Appetite regulation|appetite regulation
5010784|NCT01587911|Dairy Protein|dairy protein
5010785|NCT01587898|Anemia|anemia
5010786|NCT01587898|Prolyl hydroxylase inhibitor|prolyl hydroxylase inhibitor
5010787|NCT01587898|Hemoglobin|hemoglobin
5010788|NCT01587898|Chronic kidney disease|chronic kidney disease
5010789|NCT01587898|pharmacokinetics|pharmacokinetics
5010790|NCT01587898|recombinant human erythropoietin|recombinant human erythropoietin
5010791|NCT01587898|GSK1278863|gsk1278863
5010792|NCT01587885|Frequent Heartburn|frequent heartburn
5010793|NCT01587885|Omeprazole|omeprazole
5010794|NCT01587885|Omeprazole, sodium bicarbonate drug combination|omeprazole, sodium bicarbonate drug combination
5010795|NCT01587885|Gastrointestinal Agents|gastrointestinal agents
5010796|NCT01587885|Therapeutic Uses|therapeutic uses
5010797|NCT01587885|Pharmacologic Actions|pharmacologic actions
5010798|NCT01587885|Enzyme Inhibitors|enzyme inhibitors
5010799|NCT01587885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
5010800|NCT01587885|Proton Pump Inhibitors|proton pump inhibitors
5010801|NCT01587872|Colonoscopy|colonoscopy
5010802|NCT01587872|Colorectal cancer|colorectal cancer
5010803|NCT01587872|Screening colonoscopy|screening colonoscopy
5010804|NCT01587859|esophagus|esophagus
5010805|NCT01587859|gastro-esophageal reflux disease|gastro-esophageal reflux disease
5010806|NCT01587859|type II-IV hiatal hernia|type ii-iv hiatal hernia
5010807|NCT01587859|esophageal surgery|esophageal surgery
5010808|NCT01587859|minimally invasive surgery|minimally invasive surgery
5010809|NCT01587846|abdominal pain, constipation, Lactobacillus reuteri|abdominal pain, constipation, lactobacillus reuteri
5010810|NCT01587833|Benzodiazepines|benzodiazepines
5010811|NCT01587833|hip/femur fracture|hip/femur fracture
5010812|NCT01587820|cisplatin|cisplatin
5010813|NCT01587820|RADPLAT|radplat
5010814|NCT01587820|intra-arterial chemotherapy|intra-arterial chemotherapy
5010815|NCT01587820|head and neck cancer|head and neck cancer
5010816|NCT01587807|Infection, Quality of Life, lung injury|infection, quality of life, lung injury
5010817|NCT01587794|Rhegmatogenous retinal detachment|rhegmatogenous retinal detachment
5010818|NCT01587794|thickness of retinal layer|thickness of retinal layer
5010819|NCT01587794|outer nuclear layer|outer nuclear layer
5010820|NCT01587794|photoreceptor layer|photoreceptor layer
5010821|NCT01587781|Pharmacokinetics of enoxaparin|pharmacokinetics of enoxaparin
5010822|NCT01587768|Acute liver injury|acute liver injury
5010823|NCT01587768|antibiotics|antibiotics
5010824|NCT01587742|Calcium channel blockers|calcium channel blockers
5010825|NCT01587742|cancer|cancer
5010826|NCT01587729|Hip/femur fracture|hip/femur fracture
5010827|NCT01587729|antidepressants|antidepressants
5010828|NCT01587716|Safety and tolerability, pharmacokinetics, cough, voltage gated sodium channels (VGSC), anaesthesia|safety and tolerability, pharmacokinetics, cough, voltage gated sodium channels (vgsc), anaesthesia
5010829|NCT01587703|BRD3|brd3
5010830|NCT01587703|GSK525762|gsk525762
5010831|NCT01587703|NUT Midline Carcinoma|nut midline carcinoma
5010832|NCT01587703|MYCN-amplified Solid Tumor|mycn-amplified solid tumor
5010833|NCT01587703|BRD4|brd4
5010834|NCT01587703|BET inhibitor|bet inhibitor
5010835|NCT01587703|bromodomains|bromodomains
5010837|NCT01587703|Colorectal C ancer|colorectal c ancer
5010838|NCT01587703|Small Cell Lung Cancer|small cell lung cancer
5010839|NCT01587703|Multiple Myeloma|multiple myeloma
5010840|NCT01587703|Neuroblastoma|neuroblastoma
5010841|NCT01587703|Oncology|oncology
5010842|NCT01587677|Tuberculosis|tuberculosis
5010843|NCT01587664|Swallowing disorders|swallowing disorders
5010844|NCT01587664|Aspiration|aspiration
5010845|NCT01587651|CAD|cad
5010846|NCT01587651|prasugrel|prasugrel
5010847|NCT01587651|ticagrelor|ticagrelor
5010848|NCT01587651|antiplatelet|antiplatelet
5010849|NCT01587651|thienopyridine|thienopyridine
5010850|NCT01587651|P2Y12 Inhibitors|p2y12 inhibitors
5010851|NCT01587638|new-onset diabetes|new-onset diabetes
5010852|NCT01587638|carvedilol|carvedilol
5010853|NCT01587638|claims analysis|claims analysis
5010854|NCT01587638|beta-blocker|beta-blocker
5010855|NCT01587638|Diabetes Mellitus|diabetes mellitus
5010856|NCT01587625|Delayed labour|delayed labour
5010857|NCT01587625|dystocia|dystocia
5010858|NCT01587625|oxytocin augmentation|oxytocin augmentation
5010859|NCT01587625|primiparous women|primiparous women
5010860|NCT01587625|childbirth|childbirth
5010861|NCT01587625|childbirth experience|childbirth experience
5010862|NCT01587625|progress|progress
5010863|NCT01587612|Pain|pain
5010864|NCT01587612|Foot|foot
5010865|NCT01587599|pharmaceutical care|pharmaceutical care
5010866|NCT01587599|drug-related problems|drug-related problems
5010867|NCT01587599|elderly|elderly
5010868|NCT01587599|Pharmaceutical care of elderly patients with diabetes|pharmaceutical care of elderly patients with diabetes
5010869|NCT01587586|Hepatitis C, Chronic|hepatitis c, chronic
5010870|NCT01587586|Interferon-alpha|interferon-alpha
5010871|NCT01587586|Hepatitis C Virus|hepatitis c virus
5010872|NCT01587573|salivary biomarkers|salivary biomarkers
5010873|NCT01587560|Shoulder|shoulder
5010874|NCT01587560|Arthroplasty|arthroplasty
5010875|NCT01587560|Pyrocarbon|pyrocarbon
5010876|NCT01587560|Randomized controlled trial|randomized controlled trial
5010877|NCT01587560|Shoulder resurfacing|shoulder resurfacing
5010878|NCT01587547|ART|art
5010879|NCT01587547|IVF|ivf
5010880|NCT01587547|ICSI|icsi
5010881|NCT01587547|embryo selection|embryo selection
5010882|NCT01587534|Unresectable Pancreatic cancer|unresectable pancreatic cancer
5010883|NCT01587521|Metabolic syndrome|metabolic syndrome
5010884|NCT01587521|Prevalence|prevalence
5010885|NCT01587521|Quality of life|quality of life
5010886|NCT01587521|Depression|depression
5010887|NCT01587521|Antipsychotics|antipsychotics
5010888|NCT01587482|Superficial femoral artery|superficial femoral artery
5010889|NCT01587482|endovascular|endovascular
5010890|NCT01587482|Drug eluting balloon|drug eluting balloon
5010891|NCT01587482|Paclitaxel|paclitaxel
5010892|NCT01587456|Osteoporosis|osteoporosis
5010893|NCT01587430|acute myeloid leukemia|acute myeloid leukemia
5010894|NCT01587430|anthracyclines|anthracyclines
5010895|NCT01587430|high dose cytarabine|high dose cytarabine
5010896|NCT01587430|maintenance|maintenance
5010897|NCT01587404|Atrial Fibrillation|atrial fibrillation
5010898|NCT01587404|Electrogram|electrogram
5010899|NCT01587404|Ablation|ablation
5010900|NCT01587404|Contact Force|contact force
5010901|NCT01587378|miscarriage|miscarriage
5010902|NCT01587378|preterm birth|preterm birth
5010903|NCT01587378|prevention|prevention
5010904|NCT01587326|cytokine, depression, escitalopram|cytokine, depression, escitalopram
5010905|NCT01587313|hydralazine|hydralazine
5010906|NCT01587313|isosorbide|isosorbide
5010907|NCT01587313|bidil|bidil
5010908|NCT01587313|volunteers|volunteers
5010909|NCT01587313|pharmacokinetic profile|pharmacokinetic profile
5010910|NCT01587287|Anterior corneal power|anterior corneal power
5010911|NCT01587287|Placido topographer|placido topographer
5010912|NCT01587287|Scheimpﬂug|scheimpﬂug
5010913|NCT01587287|Precision|precision
5010914|NCT01587287|Agreement|agreement
5010915|NCT01587274|low back pain|low back pain
5010916|NCT01587261|Burns|burns
5010917|NCT01587261|Vitamin C|vitamin c
5010918|NCT01587261|Thermal Injury|thermal injury
5010919|NCT01587261|Fluid Resuscitation|fluid resuscitation
5010920|NCT01587248|Breast cancer,|breast cancer,
5010921|NCT01587248|Harmonic scalpel,|harmonic scalpel,
5010922|NCT01587248|Electrocautery,|electrocautery,
5010923|NCT01587248|Modified Radical Mastectomy,|modified radical mastectomy,
5010924|NCT01587248|Randomized Controlled Trial|randomized controlled trial
5010925|NCT01587209|decompression|decompression
5010926|NCT01587209|intravascular bubbles|intravascular bubbles
5010927|NCT01587209|neutrophil activation|neutrophil activation
5010928|NCT01587196|prescription opiates/medications|prescription opiates/medications
5010929|NCT01587196|vivitrol|vivitrol
5010930|NCT01587196|brain imaging|brain imaging
5010931|NCT01587183|Running|running
5010932|NCT01587183|Blood pressure|blood pressure
5010933|NCT01587170|spasticity|spasticity
5010934|NCT01587170|spinal cord injury|spinal cord injury
5010935|NCT01587170|zolmitriptan|zolmitriptan
5010936|NCT01587144|GBM|gbm
5010937|NCT01587131|Universal Influenza|universal influenza
5010938|NCT01587131|Intradermal DNA-Based Vaccine|intradermal dna-based vaccine
5010939|NCT01587131|Senior|senior
5010940|NCT01587131|Electroporation|electroporation
5010941|NCT01587131|H1|h1
5010942|NCT01587131|Influenza|influenza
5010943|NCT01587131|FVH1|fvh1
5010944|NCT01587118|PTSD|ptsd
5010945|NCT01587118|Posttraumatic Stress Disorder|posttraumatic stress disorder
5010946|NCT01587118|Asenapine|asenapine
5010947|NCT01587118|Adjunctive|adjunctive
5010948|NCT01587118|antidepressant|antidepressant
5010949|NCT01587118|neuroleptic|neuroleptic
5010950|NCT01587092|walking|walking
5010951|NCT01587092|physical activity|physical activity
5010952|NCT01587092|sedentary behavior|sedentary behavior
5010953|NCT01587092|workplace|workplace
5010954|NCT01587079|COPD|copd
5010955|NCT01587027|Altitude Sickness|altitude sickness
5010956|NCT01587027|High Altitude Sickness|high altitude sickness
5010957|NCT01587001|Sarcoidosis|sarcoidosis
5010958|NCT01587001|oxidative stress|oxidative stress
5010959|NCT01587001|anti-oxidant|anti-oxidant
5010960|NCT01586988|HIV|hiv
5010961|NCT01586988|Parenting|parenting
5010962|NCT01586988|self-care|self-care
5010963|NCT01586988|disclosure|disclosure
5010964|NCT01586988|medication adherence|medication adherence
5010965|NCT01586988|mother|mother
5010966|NCT01586988|child|child
5010967|NCT01586988|adolescent|adolescent
5010968|NCT01586962|paracetamol|paracetamol
5010969|NCT01586962|pseudoephedrine|pseudoephedrine
5010970|NCT01586962|syrup|syrup
5010971|NCT01586962|upper respiratory tract infection|upper respiratory tract infection
5010972|NCT01586949|well-being|well-being
5010973|NCT01586949|web-based intervention|web-based intervention
5010974|NCT01586949|social networks|social networks
5010975|NCT01586923|Anemia|anemia
5010976|NCT01586923|Transfusion|transfusion
5010977|NCT01586923|RBC storage age|rbc storage age
5010978|NCT01586923|Tissue oxygenation|tissue oxygenation
5010979|NCT01586923|Malaria|malaria
5010980|NCT01586897|health information technology|health information technology
5010981|NCT01586897|primary care|primary care
5010982|NCT01586897|visit-independent|visit-independent
5010983|NCT01586897|medication monitoring|medication monitoring
5010984|NCT01586884|LV Pacing|lv pacing
5010985|NCT01586884|LV Lead Placement|lv lead placement
5010986|NCT01586884|LV Pacing Site|lv pacing site
5010987|NCT01586884|CRT Device Placement|crt device placement
5010988|NCT01586871|MPS I|mps i
5010989|NCT01586871|MPS II|mps ii
5010990|NCT01586871|MPS VI|mps vi
5010991|NCT01586871|Mucopolysaccharidoses|mucopolysaccharidoses
5010992|NCT01586858|Vasculitis|vasculitis
5010993|NCT01586858|ANCA|anca
5010994|NCT01586858|Rituximab|rituximab
5010995|NCT01586858|Small vessel vasculitis|small vessel vasculitis
5010996|NCT01586845|Randomized Controlled Trials|randomized controlled trials
5010997|NCT01586845|Immunosuppression|immunosuppression
5010998|NCT01586845|Adult|adult
5010999|NCT01586845|Kidney Transplantation|kidney transplantation
5011000|NCT01586845|Treatment Outcome|treatment outcome
5011001|NCT01586832|Hospital Supplies|hospital supplies
5011002|NCT01586832|Stocking of Supplies|stocking of supplies
5011003|NCT01586806|Dexamethasone|dexamethasone
5011004|NCT01586806|Glucocorticoids|glucocorticoids
5011005|NCT01586806|Physiological Effects of Drugs|physiological effects of drugs
5011006|NCT01586806|Therapeutic Uses|therapeutic uses
5011007|NCT01586806|Anterior Cruciate Ligament Reconstruction|anterior cruciate ligament reconstruction
5011008|NCT01586806|Regional Anesthesia, nerve block|regional anesthesia, nerve block
5011009|NCT01586806|Ultrasonic Imaging|ultrasonic imaging
5011010|NCT01586806|Post-Operative Complications: muscle weakness, pain, nausea and vomiting|post-operative complications: muscle weakness, pain, nausea and vomiting
5011011|NCT01586806|Dexamethasone (as local anesthetic additive)|dexamethasone (as local anesthetic additive)
5011012|NCT01586793|Repetitive transcranial magnetic stimulation|repetitive transcranial magnetic stimulation
5011013|NCT01586793|Bipolar depression|bipolar depression
5011014|NCT01586793|Randomized trial|randomized trial
5011015|NCT01586793|rTMS|rtms
5011016|NCT01586793|Neuromodulation|neuromodulation
5011017|NCT01586780|Whey protein|whey protein
5011018|NCT01586780|Soy protein|soy protein
5011019|NCT01586780|Insulinogenic amino acids|insulinogenic amino acids
5011020|NCT01586780|Incretins|incretins
5011021|NCT01586780|Glycaemia|glycaemia
5011022|NCT01586780|Insulinaemia|insulinaemia
5011023|NCT01586767|Nasal cavity|nasal cavity
5011024|NCT01586767|Salivary gland tumors|salivary gland tumors
5011025|NCT01586767|Hard palate|hard palate
5011026|NCT01586767|Sinus|sinus
5011027|NCT01586767|Soft Palate|soft palate
5011028|NCT01586767|Lacrimal Apparatus|lacrimal apparatus
5011029|NCT01586754|metabolic syndrome|metabolic syndrome
5011030|NCT01586754|obesity|obesity
5011031|NCT01586754|endothelial damage|endothelial damage
5011032|NCT01586754|homocysteine|homocysteine
5011033|NCT01586754|microalbumin|microalbumin
5011034|NCT01586754|carotis intima-media thickness|carotis intima-media thickness
5011035|NCT01586728|Cystic fibrosis|cystic fibrosis
5011036|NCT01586728|oxygen therapy|oxygen therapy
5011037|NCT01586728|sleep|sleep
5011038|NCT01586715|Extremely complex perianal fistula|extremely complex perianal fistula
5011039|NCT01586715|Adipose Derived Stem Cells|adipose derived stem cells
5011040|NCT01586702|Stroke, TIA, secondary prevention, support program, multifactorial intervention|stroke, tia, secondary prevention, support program, multifactorial intervention
5011041|NCT01586689|Oxford House|oxford house
5011042|NCT01586689|recovery|recovery
5011043|NCT01586689|substance abuse|substance abuse
5011044|NCT01586689|alcohol abuse|alcohol abuse
5011045|NCT01586689|addiction|addiction
5011046|NCT01586676|supervision|supervision
5011047|NCT01586676|motivational interviewing|motivational interviewing
5011048|NCT01586676|substance abuse|substance abuse
5011049|NCT01586676|dissemination|dissemination
5011050|NCT01586663|Diffuse Systemic Sclerosis|diffuse systemic sclerosis
5011051|NCT01586663|Hand|hand
5011052|NCT01586663|Range of motion|range of motion
5011053|NCT01586663|Splint|splint
5011054|NCT01586650|ankylosing spondylitis|ankylosing spondylitis
5011055|NCT01586650|aerobic exercise|aerobic exercise
5011056|NCT01586637|Fibromyalgia|fibromyalgia
5011057|NCT01586637|Art Therapy|art therapy
5011058|NCT01586637|Pain|pain
5011059|NCT01586637|Quality of life|quality of life
5011060|NCT01586637|Body Image|body image
5011061|NCT01586624|Phase I|phase i
5011062|NCT01586624|Drug evaluation|drug evaluation
5011063|NCT01586624|Oncology|oncology
5011064|NCT01586624|Vandetanib|vandetanib
5011065|NCT01586624|Selumetinib|selumetinib
5011066|NCT01586624|Dose escalation|dose escalation
5011067|NCT01586624|Clinical trial|clinical trial
5011068|NCT01586624|Vascular Endothelial Growth Factor(VEGFR) inhibitor|vascular endothelial growth factor(vegfr) inhibitor
5011069|NCT01586624|Epidermal Growth Factor Receptor(EGFR)inhibitor|epidermal growth factor receptor(egfr)inhibitor
5011070|NCT01586624|Mitogen Activated Kinase (MEK) inhibitor|mitogen activated kinase (mek) inhibitor
5011071|NCT01586624|Non small cell lung cancer|non small cell lung cancer
5011072|NCT01586598|Mandibular Nerve|mandibular nerve
5011073|NCT01586598|Orthognathic Surgery|orthognathic surgery
5011074|NCT01586598|Sagittal Split Osteotomy|sagittal split osteotomy
5011075|NCT01586598|Sensory Retraining|sensory retraining
5011076|NCT01586572|Polio virus type 1,2,3|polio virus type 1,2,3
5011077|NCT01586572|Poliovaccine-Oral|poliovaccine-oral
5011078|NCT01586572|Poliovaccine|poliovaccine
5011079|NCT01586572|Trivalent Oral Polio vaccine|trivalent oral polio vaccine
5011080|NCT01586572|Monovalent oral polio vaccine|monovalent oral polio vaccine
5011081|NCT01586572|Bivalent Oral polio vaccine|bivalent oral polio vaccine
5011082|NCT01586546|Mind-body|mind-body
5011083|NCT01586546|Psychosocial|psychosocial
5011084|NCT01586546|Meditation|meditation
5011085|NCT01586546|Breathing Exercises|breathing exercises
5011086|NCT01586546|Guided Imagery|guided imagery
5011087|NCT01586546|Visualization|visualization
5011088|NCT01586533|ulcerative colitis|ulcerative colitis
5011089|NCT01586533|UC|uc
5011090|NCT01586533|left-sided ulcerative colitis|left-sided ulcerative colitis
5011091|NCT01586533|distal ulcerative colitis|distal ulcerative colitis
5011092|NCT01586533|Zoenasa|zoenasa
5011093|NCT01586533|mesalamine|mesalamine
5011094|NCT01586533|mesalazine|mesalazine
5011095|NCT01586533|5-ASA|5-asa
5011096|NCT01586533|5-aminosalicylic acid|5-aminosalicylic acid
5011097|NCT01586533|N-acetylcysteine|n-acetylcysteine
5011098|NCT01586533|acetylcysteine|acetylcysteine
5011099|NCT01586533|NAC|nac
5011100|NCT01586533|enema|enema
5011101|NCT01586533|rectal gel|rectal gel
5011102|NCT01586520|thyroid cancer, papillary, follicular, proteomics, genetic markers|thyroid cancer, papillary, follicular, proteomics, genetic markers
5011103|NCT01586507|Pain|pain
5011104|NCT01586507|ULTRAM ER|ultram er
5011105|NCT01586507|Tramadol hydrochloride|tramadol hydrochloride
5011106|NCT01586507|Adolescents|adolescents
5011107|NCT01586494|Pain|pain
5011108|NCT01586494|ULTRAM ER|ultram er
5011109|NCT01586494|Tramadol hydrochloride|tramadol hydrochloride
5011110|NCT01586494|Children|children
5011111|NCT01586481|Diabetic foot ulcer|diabetic foot ulcer
5011112|NCT01586481|Off loading|off loading
5011113|NCT01586481|Compliance|compliance
5011114|NCT01586481|Healing duration|healing duration
5011115|NCT01586481|Amputation rate|amputation rate
5011116|NCT01586455|umbilical cord blood|umbilical cord blood
5011117|NCT01586455|stem cell transplantation|stem cell transplantation
5011118|NCT01586455|placental stem cell|placental stem cell
5011119|NCT01586455|inborn errors of metabolism|inborn errors of metabolism
5011120|NCT01586455|marrow failure|marrow failure
5011121|NCT01586455|Severe Combined Immunodeficiency Disease|severe combined immunodeficiency disease
5011122|NCT01586455|AML|aml
5011123|NCT01586455|ALL|all
5011124|NCT01586455|MDS|mds
5011125|NCT01586429|comparing the analgesic efficacy of ultrasound-guided nerve block catheter compared with epidural analgesia|comparing the analgesic efficacy of ultrasound-guided nerve block catheter compared with epidural analgesia
5011126|NCT01586416|Colonic neoplasms|colonic neoplasms
5011127|NCT01586416|Older adults|older adults
5011128|NCT01586416|Psychosocial Intervention|psychosocial intervention
5011129|NCT01586416|Chemotherapy adherence|chemotherapy adherence
5011130|NCT01586403|Melanoma|melanoma
5011131|NCT01586403|Gene Therapy|gene therapy
5011132|NCT01586403|Adoptive T-Cell Transfer|adoptive t-cell transfer
5011133|NCT01586403|IL-2|il-2
5011134|NCT01586390|Ankle Sprain|ankle sprain
5011135|NCT01586390|Ankle Distortion|ankle distortion
5011136|NCT01586390|Functional treatment|functional treatment
5011137|NCT01586390|Brace treatment|brace treatment
5011138|NCT01586377|Complex regional pain syndrome|complex regional pain syndrome
5011139|NCT01586377|Near Infrared Spectroscopy|near infrared spectroscopy
5011140|NCT01586377|Vascular Occlusion Test|vascular occlusion test
5011141|NCT01586364|Menopausal symptoms|menopausal symptoms
5011142|NCT01586364|Vulvar and vaginal atrophy in menopausal women|vulvar and vaginal atrophy in menopausal women
5011143|NCT01586364|Vaginal atrophy|vaginal atrophy
5011144|NCT01586364|Urogenital atrophy|urogenital atrophy
5011145|NCT01586351|Rotator cuff tears|rotator cuff tears
5011146|NCT01586351|ACP|acp
5011147|NCT01586351|DX Reinforcement Matrix|dx reinforcement matrix
5011148|NCT01586325|Chronic hepatitis C infection|chronic hepatitis c infection
5011149|NCT01586325|Asian genotype 1 chronic hepatitis C infection|asian genotype 1 chronic hepatitis c infection
5011150|NCT01586325|JNJ-47910382|jnj-47910382
5011151|NCT01586325|Non-structural protein 5A (NS5A) inhibitor|non-structural protein 5a (ns5a) inhibitor
5011152|NCT01586312|Knee degenerative disease|knee degenerative disease
5011153|NCT01586312|osteoarthritis|osteoarthritis
5011154|NCT01586312|gonarthrosis|gonarthrosis
5011155|NCT01586312|stem cell|stem cell
5011156|NCT01586312|cellular therapy|cellular therapy
5011157|NCT01586312|regenerative therapy|regenerative therapy
5011158|NCT01586312|Mesenchymal stem cells|mesenchymal stem cells
5011159|NCT01586312|Bone marrow|bone marrow
5011160|NCT01586312|musculoskeletal Diseases|musculoskeletal diseases
5011161|NCT01586312|Mesenchymal Stromal Cells (allogenic)|mesenchymal stromal cells (allogenic)
5011162|NCT01586299|pleuropneumonia children|pleuropneumonia children
5011163|NCT01586299|non steroidal anti inflammatory drugs|non steroidal anti inflammatory drugs
5011164|NCT01586299|pleural effusion|pleural effusion
5011165|NCT01586299|severe pneumonia|severe pneumonia
5011166|NCT01586286|Levator Myalgia|levator myalgia
5011167|NCT01586286|Pelvic Pain|pelvic pain
5011168|NCT01586286|Vaginismus|vaginismus
5011169|NCT01586286|Myofascial pain syndromes|myofascial pain syndromes
5011170|NCT01586260|Neuroblastoma in remission|neuroblastoma in remission
5011171|NCT01586260|Relapsed Neuroblastoma|relapsed neuroblastoma
5011172|NCT01586260|Refractory Neuroblastoma|refractory neuroblastoma
5011173|NCT01586234|Fuchs' endothelial dystrophy|fuchs' endothelial dystrophy
5011174|NCT01586234|DSAEK|dsaek
5011175|NCT01586234|Descemet's stripping automated endothelial keratoplasty|descemet's stripping automated endothelial keratoplasty
5011176|NCT01586221|Rehabilitation|rehabilitation
5011177|NCT01586221|Fingers|fingers
5011178|NCT01586221|Grasp|grasp
5011179|NCT01586221|Strength|strength
5011180|NCT01586221|Brain Function|brain function
5011181|NCT01586221|Physiopathology|physiopathology
5011182|NCT01586221|Functional Laterality|functional laterality
5011183|NCT01586221|Psychomotor Performance|psychomotor performance
5011184|NCT01586221|Biomechanis|biomechanis
5011185|NCT01586221|Touch|touch
5011186|NCT01586221|Music Therapy|music therapy
5011187|NCT01586221|Weight-Bearing|weight-bearing
5011188|NCT01586208|refractory status epilepticus|refractory status epilepticus
5011189|NCT01586208|valproic acid|valproic acid
5011190|NCT01586208|phenytoin|phenytoin
5011191|NCT01586208|benzodiazepines|benzodiazepines
5011192|NCT01586208|Valproic acid initial dosage in status treatment|valproic acid initial dosage in status treatment
5011193|NCT01586182|poor prognosis|poor prognosis
5011194|NCT01586169|Albendazole|albendazole
5011195|NCT01586169|Ivermectin|ivermectin
5011196|NCT01586169|Azithromycin|azithromycin
5011197|NCT01586169|Lymphatic filariasis|lymphatic filariasis
5011198|NCT01586169|Trachoma|trachoma
5011199|NCT01586169|Safety|safety
5011200|NCT01586143|Paracetamol by permucosal route,|paracetamol by permucosal route,
5011201|NCT01586143|Paracetamol by intraveinous route,|paracetamol by intraveinous route,
5011202|NCT01586143|Pain.|pain.
5011203|NCT01586143|Patient with minor trauma of lower limb and/or superior limb (sprains, muscle contusions, …).|patient with minor trauma of lower limb and/or superior limb (sprains, muscle contusions, …).
5011204|NCT01586130|Knee Osteoarthritis|knee osteoarthritis
5011205|NCT01586130|Exercise|exercise
5011206|NCT01586130|Isokinetic|isokinetic
5011207|NCT01586130|Muscle strength|muscle strength
5011208|NCT01586130|Rehabilitation|rehabilitation
5011209|NCT01586117|rectal cancer|rectal cancer
5011210|NCT01586117|amifostine|amifostine
5011211|NCT01586117|pre-operative chemo-radiation|pre-operative chemo-radiation
5011212|NCT01586065|type 1 diabetes|type 1 diabetes
5011213|NCT01586065|adolescents|adolescents
5011214|NCT01586065|poor control|poor control
5011215|NCT01586065|CGM|cgm
5011216|NCT01586052|Cerebral Palsy|cerebral palsy
5011217|NCT01586052|Erythropoietin|erythropoietin
5011218|NCT01586052|Rehabilitation|rehabilitation
5011219|NCT01586039|Melatonin|melatonin
5011220|NCT01586039|Sleep|sleep
5011221|NCT01586039|Light|light
5011222|NCT01586039|Alertness|alertness
5011223|NCT01586039|Circadian Rhythms|circadian rhythms
5011224|NCT01586026|Ports|ports
5011225|NCT01586026|Catheters|catheters
5011226|NCT01586026|Distal Valved Catheters|distal valved catheters
5011227|NCT01586026|Maintenance Flush|maintenance flush
5011228|NCT01586026|subjects|subjects
5011229|NCT01586026|routine maintenance flushes|routine maintenance flushes
5011230|NCT01586013|propofol|propofol
5011231|NCT01586013|pharmacodynamic|pharmacodynamic
5011232|NCT01586013|age|age
5011233|NCT01586013|ke0|ke0
5011234|NCT01586000|vaginal ring|vaginal ring
5011235|NCT01585974|Renal Cell Carcinoma|renal cell carcinoma
5011236|NCT01585974|TKI|tki
5011237|NCT01585974|Turkey|turkey
5011238|NCT01585974|Observational|observational
5011239|NCT01585961|Symptomatic paroxysmal|symptomatic paroxysmal
5011240|NCT01585961|Atrial fibrillation|atrial fibrillation
5011241|NCT01585961|Observational|observational
5011242|NCT01585961|Acute procedural outcomes|acute procedural outcomes
5011243|NCT01585961|Ablation|ablation
5011244|NCT01585961|Drug refractory|drug refractory
5011245|NCT01585961|Arrhythmia Recurrent|arrhythmia recurrent
5011246|NCT01585961|Symptomatic|symptomatic
5011247|NCT01585935|Infant, Extremely Low Birth Weight|infant, extremely low birth weight
5011248|NCT01585935|Parenteral Nutrition|parenteral nutrition
5011249|NCT01585935|Fish Oils|fish oils
5011250|NCT01585935|Cholestasis|cholestasis
5011251|NCT01585935|Psychomotor Disorders, Developmental|psychomotor disorders, developmental
5011252|NCT01585922|noninvasive positive pressure ventilation|noninvasive positive pressure ventilation
5011253|NCT01585896|Hoarding|hoarding
5011254|NCT01585896|Compulsive Hoarding|compulsive hoarding
5011255|NCT01585896|Self-Help|self-help
5011256|NCT01585883|Lung cancer|lung cancer
5011257|NCT01585883|Breathlessness|breathlessness
5011258|NCT01585883|Self-management|self-management
5011259|NCT01585870|Safety|safety
5011260|NCT01585870|Tolerability|tolerability
5011261|NCT01585870|Pharmacokinetics|pharmacokinetics
5011262|NCT01585870|Clinical benefit|clinical benefit
5011263|NCT01585870|Sorafenib|sorafenib
5011264|NCT01585870|Eribulin|eribulin
5011265|NCT01585870|advanced metastatic solid tumors|advanced metastatic solid tumors
5011266|NCT01585844|sleep apnea|sleep apnea
5011267|NCT01585844|pregnancy|pregnancy
5011268|NCT01585844|obesity|obesity
5011269|NCT01585831|Klinefelter syndrome|klinefelter syndrome
5011270|NCT01585831|XXY syndrome|xxy syndrome
5011271|NCT01585831|Sex Chromosome Abnormality|sex chromosome abnormality
5011272|NCT01585831|Testosterone replacement therapy|testosterone replacement therapy
5011273|NCT01585818|Glycemic Index|glycemic index
5011274|NCT01585818|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
5011275|NCT01585818|Diet|diet
5011276|NCT01585818|Glucose Variability|glucose variability
5011277|NCT01585818|Metabolic Response|metabolic response
5011278|NCT01585818|Glucose Response|glucose response
5011279|NCT01585766|MAb, B cell, depletion, RMS|mab, b cell, depletion, rms
5011280|NCT01585753|cardiovascular function|cardiovascular function
5011281|NCT01585753|maraviroc|maraviroc
5011282|NCT01585740|Hyperchloraemic metabolic acidosis|hyperchloraemic metabolic acidosis
5011283|NCT01585740|Neonatal acidosis|neonatal acidosis
5011284|NCT01585740|Neonatal hyperchloraemia|neonatal hyperchloraemia
5011285|NCT01585740|Base excess|base excess
5011286|NCT01585740|Metabolic acidosis|metabolic acidosis
5011287|NCT01585740|Caesarean section|caesarean section
5011288|NCT01585740|Normal saline|normal saline
5011289|NCT01585740|Ringer's Lactate|ringer's lactate
5011290|NCT01585740|Postoperative morbidity|postoperative morbidity
5011291|NCT01585727|Rectal cancer|rectal cancer
5011292|NCT01585727|total mesorectal excision|total mesorectal excision
5011293|NCT01585727|pelvic autonomic nerve preservation|pelvic autonomic nerve preservation
5011294|NCT01585727|neurostimulation|neurostimulation
5011295|NCT01585727|urogenital function|urogenital function
5011296|NCT01585727|quality of life|quality of life
5011297|NCT01585701|Phase I|phase i
5011298|NCT01585701|Oncology|oncology
5011299|NCT01585701|AGC Kinase inhibitor|agc kinase inhibitor
5011300|NCT01585701|Protein Kinase inhibitor|protein kinase inhibitor
5011301|NCT01585701|Clinical Trial|clinical trial
5011302|NCT01585701|Multiple protein kinases|multiple protein kinases
5011303|NCT01585688|NHL|nhl
5011304|NCT01585688|CLL|cll
5011305|NCT01585675|Lung Cancer|lung cancer
5011306|NCT01585662|EUS|eus
5011307|NCT01585662|pancreatic pseudocyst|pancreatic pseudocyst
5011308|NCT01585662|drainage|drainage
5011309|NCT01585636|SQ109|sq109
5011310|NCT01585636|Tuberculosis|tuberculosis
5011311|NCT01585610|smoking|smoking
5011312|NCT01585610|smoking cessation|smoking cessation
5011313|NCT01585610|disabled persons|disabled persons
5011314|NCT01585610|behavioral research|behavioral research
5011315|NCT01585597|Ischemic Stoke|ischemic stoke
5011316|NCT01585597|Endovascular Reperfusion|endovascular reperfusion
5011317|NCT01585597|Reperfusion Injury|reperfusion injury
5011318|NCT01585597|Mild hypothermia|mild hypothermia
5011319|NCT01585584|Boceprevir|boceprevir
5011320|NCT01585584|Hepatitis C Genotype 3|hepatitis c genotype 3
5011321|NCT01585571|Balance|balance
5011322|NCT01585571|Posture|posture
5011323|NCT01585571|Virtual Environment|virtual environment
5011324|NCT01585571|Cerebral Palsy|cerebral palsy
5011325|NCT01585571|Adults|adults
5011326|NCT01585558|Menopausal symptoms|menopausal symptoms
5011327|NCT01585558|Urogenital atrophy|urogenital atrophy
5011328|NCT01585558|Vulvar and vaginal atrophy in menopausal women|vulvar and vaginal atrophy in menopausal women
5011329|NCT01585558|Vaginal atrophy|vaginal atrophy
5011330|NCT01585545|CT|ct
5011331|NCT01585545|PET CT|pet ct
5011332|NCT01585545|MRI|mri
5011333|NCT01585545|cancer genomics|cancer genomics
5011334|NCT01585545|Radiomics|radiomics
5011335|NCT01585545|Radiogenomics|radiogenomics
5011336|NCT01585532|Tuberculosis|tuberculosis
5011337|NCT01585532|Urine|urine
5011338|NCT01585532|Nucleic acid|nucleic acid
5011339|NCT01585532|Alere|alere
5011340|NCT01585532|Borstel|borstel
5011341|NCT01585519|High Epicatechin Apples|high epicatechin apples
5011342|NCT01585519|Low Epicatechin Apples|low epicatechin apples
5011343|NCT01585519|Apple Extract|apple extract
5011344|NCT01585519|Apple Granules|apple granules
5011345|NCT01585519|Blood Pressure|blood pressure
5011346|NCT01585519|Cholesterol|cholesterol
5011347|NCT01585493|Lifestyle|lifestyle
5011348|NCT01585493|Smoking|smoking
5011349|NCT01585493|Dietary|dietary
5011350|NCT01585493|Exercise|exercise
5011351|NCT01585480|Obesity|obesity
5011352|NCT01585480|Weight Gain Prevention|weight gain prevention
5011353|NCT01585480|Workplace|workplace
5011354|NCT01585480|Intervention|intervention
5011355|NCT01585480|Diet|diet
5011356|NCT01585480|Exercise|exercise
5011357|NCT01585467|Anterior Shoulder Dislocation|anterior shoulder dislocation
5011358|NCT01585467|Shoulder Dislocation|shoulder dislocation
5011359|NCT01585467|Shoulder Pain|shoulder pain
5011360|NCT01585467|Shoulder Deformity|shoulder deformity
5011361|NCT01585454|Pregnancy|pregnancy
5011362|NCT01585454|Diabetes Mellitus|diabetes mellitus
5011363|NCT01585454|Weight Gain|weight gain
5011364|NCT01585454|Diabetes|diabetes
5011365|NCT01585441|Finasteride|finasteride
5011366|NCT01585441|Central Serous Chorioretinopathy|central serous chorioretinopathy
5011367|NCT01585428|Immunotherapy|immunotherapy
5011368|NCT01585428|HPV-Associated Cancers|hpv-associated cancers
5011369|NCT01585428|Cervical Cancer|cervical cancer
5011370|NCT01585428|Oropharyngeal Cancer|oropharyngeal cancer
5011371|NCT01585428|HPV Infection|hpv infection
5011372|NCT01585415|Tumor Infiltrating Lymphocytes|tumor infiltrating lymphocytes
5011373|NCT01585415|Immunotherapy|immunotherapy
5011374|NCT01585415|Adoptive Cell Therapy|adoptive cell therapy
5011375|NCT01585415|B Raf Inhibitor|b raf inhibitor
5011376|NCT01585402|NT5E|nt5e
5011377|NCT01585402|Biphosphonates|biphosphonates
5011378|NCT01585402|Vascular Calcifications|vascular calcifications
5011379|NCT01585402|Joint Capsule Calcifications|joint capsule calcifications
5011380|NCT01585402|Inherited Disease|inherited disease
5011381|NCT01585389|adult brain tumor|adult brain tumor
5011382|NCT01585389|childhood brain tumor|childhood brain tumor
5011383|NCT01585376|alveolar childhood rhabdomyosarcoma|alveolar childhood rhabdomyosarcoma
5011384|NCT01585376|embryonal childhood rhabdomyosarcoma|embryonal childhood rhabdomyosarcoma
5011385|NCT01585350|melanoma|melanoma
5011386|NCT01585350|peptide vaccine|peptide vaccine
5011387|NCT01585350|polyICLC|polyiclc
5011388|NCT01585350|lipopolysaccharide (LPS)|lipopolysaccharide (lps)
5011389|NCT01585350|immunotherapy|immunotherapy
5011390|NCT01585311|Subarachnoid Hemorrhage (SAH)|subarachnoid hemorrhage (sah)
5011391|NCT01585311|tachycardia|tachycardia
5011392|NCT01585311|Outcome|outcome
5011393|NCT01585298|Multiple Sclerosis|multiple sclerosis
5011394|NCT01585298|MS|ms
5011395|NCT01585298|Fingolimod|fingolimod
5011396|NCT01585298|Gilenya|gilenya
5011397|NCT01585298|ECG|ecg
5011398|NCT01585298|Bradyarrythmia|bradyarrythmia
5011399|NCT01585298|conduction abnormalities|conduction abnormalities
5011400|NCT01585298|first dose observation|first dose observation
5011401|NCT01585285|Coronary artery bypass grafting|coronary artery bypass grafting
5011402|NCT01585285|Left internal mammary artery|left internal mammary artery
5011403|NCT01585285|Composite grafting|composite grafting
5011404|NCT01585285|Multislice Spiral Computed Tomography Scanner|multislice spiral computed tomography scanner
5011405|NCT01585285|Graft patency assessment|graft patency assessment
5011406|NCT01585272|Alzheimer's dementia, AD|alzheimer's dementia, ad
5011407|NCT01585259|anti-platelet;|anti-platelet;
5011408|NCT01585259|safety;|safety;
5011409|NCT01585259|efficacy|efficacy
5011410|NCT01585246|Prostate Cancer|prostate cancer
5011411|NCT01585246|Radiation Therapy|radiation therapy
5011412|NCT01585246|Quality of Life|quality of life
5011413|NCT01585246|Symptom Management|symptom management
5011414|NCT01585233|Moderate Psoriasis|moderate psoriasis
5011415|NCT01585233|Severe Psoriasis|severe psoriasis
5011416|NCT01585233|Skin disease|skin disease
5011417|NCT01585233|ASKP1240|askp1240
5011418|NCT01585233|CD40 antigen|cd40 antigen
5011419|NCT01585233|Anti-CD40 monoclonal antibody|anti-cd40 monoclonal antibody
5011420|NCT01585220|WSRS|wsrs
5011421|NCT01585220|GAIS|gais
5011422|NCT01585220|HA filler|ha filler
5011423|NCT01585220|filler|filler
5011424|NCT01585207|Tourette's Disorder|tourette's disorder
5011425|NCT01585207|vigabatrin|vigabatrin
5011426|NCT01585194|Melanoma|melanoma
5011427|NCT01585194|History of Uveal Melanoma|history of uveal melanoma
5011428|NCT01585194|Metastatic|metastatic
5011429|NCT01585194|Ipilimumab|ipilimumab
5011430|NCT01585194|Yervoy|yervoy
5011431|NCT01585194|BMS-734016|bms-734016
5011432|NCT01585194|MDX010|mdx010
5011433|NCT01585194|Nivolumab|nivolumab
5011434|NCT01585194|BMS-936558|bms-936558
5011435|NCT01585194|Opdivo|opdivo
5011436|NCT01585181|Vaccine, Bacterial disease condition, Cholera|vaccine, bacterial disease condition, cholera
5011437|NCT01585168|Reward Circuitry|reward circuitry
5011438|NCT01585168|Impulsivity|impulsivity
5011439|NCT01585168|Family History of Alcoholism|family history of alcoholism
5011440|NCT01585168|NMDA/DA Interactions|nmda/da interactions
5011441|NCT01585155|Infliximab|infliximab
5011442|NCT01585155|REMICADE|remicade
5011443|NCT01585155|TA-650|ta-650
5011444|NCT01585090|Ankle positions|ankle positions
5011445|NCT01585090|pelvic floor muscles strength|pelvic floor muscles strength
5011446|NCT01585090|relaxation of pelvic floor muscles syndrome|relaxation of pelvic floor muscles syndrome
5011447|NCT01585090|doing strengthening exercises of pelvic floor muscles|doing strengthening exercises of pelvic floor muscles
5011448|NCT01585077|Plasmodium vivax|plasmodium vivax
5011449|NCT01585077|Malaria|malaria
5011450|NCT01585077|Challenge|challenge
5011451|NCT01585077|Anopheles albimanus|anopheles albimanus
5011452|NCT01585064|Rheumatoid Arthritis (RA)|rheumatoid arthritis (ra)
5011453|NCT01585064|Anti-TNF therapy|anti-tnf therapy
5011454|NCT01585064|Adalimumab|adalimumab
5011455|NCT01585064|Disease activity|disease activity
5011456|NCT01585064|Treating to target|treating to target
5011457|NCT01585051|vitamin D|vitamin d
5011458|NCT01585051|blood pressure|blood pressure
5011459|NCT01585051|typ 2 diabetes mellitus|typ 2 diabetes mellitus
5011460|NCT01585051|blood glucose|blood glucose
5011461|NCT01585051|HbA1c|hba1c
5011462|NCT01585038|endothelium|endothelium
5011463|NCT01585038|inflammation|inflammation
5011464|NCT01585038|oxidative stress|oxidative stress
5011465|NCT01585038|HIV-1|hiv-1
5011466|NCT01585025|Primary bile acid malabsorption|primary bile acid malabsorption
5011467|NCT01585025|Secondary bile acid malabsorption|secondary bile acid malabsorption
5011468|NCT01585025|Chronic diarrhoea|chronic diarrhoea
5011469|NCT01585025|Obeticholic acid|obeticholic acid
5011470|NCT01585025|SeHCAT|sehcat
5011471|NCT01585025|FXR|fxr
5011472|NCT01585025|FGF19|fgf19
5011473|NCT01585012|Cervical cap insemination|cervical cap insemination
5011474|NCT01585012|Collection condom|collection condom
5011475|NCT01585012|Instructions for Use|instructions for use
5011476|NCT01585012|Safety during intercourse|safety during intercourse
5011477|NCT01585012|Acceptability of the cervical cap with condom sheath|acceptability of the cervical cap with condom sheath
5011478|NCT01585012|slip|slip
5011479|NCT01585012|break|break
5011480|NCT01585012|ease of conversion|ease of conversion
5011481|NCT01585012|adequate sample collection|adequate sample collection
5011482|NCT01584947|Oral pain|oral pain
5011483|NCT01584947|Local anesthetic|local anesthetic
5011484|NCT01584947|Bupivacaine hydrochloride|bupivacaine hydrochloride
5011485|NCT01584934|fatigue|fatigue
5011486|NCT01584934|sleep quality|sleep quality
5011487|NCT01584934|Chronic, disabling, unexplained fatigue with at least 4 minor criteria for CFS, according to the 1994 Fukuda case definition|chronic, disabling, unexplained fatigue with at least 4 minor criteria for cfs, according to the 1994 fukuda case definition
5011488|NCT01584921|Erythropoietin|erythropoietin
5011489|NCT01584921|Glomerular filtration rate|glomerular filtration rate
5011490|NCT01584921|Tubular reabsorption|tubular reabsorption
5011491|NCT01584921|Renal function|renal function
5011492|NCT01584921|Renal perfusion|renal perfusion
5011493|NCT01584908|kidney transplant recipients|kidney transplant recipients
5011494|NCT01584882|Clinical decision support (CDS)|clinical decision support (cds)
5011495|NCT01584882|Tobacco|tobacco
5011496|NCT01584882|Behavioral|behavioral
5011497|NCT01584882|Dental hygienist|dental hygienist
5011498|NCT01584882|Dentist|dentist
5011499|NCT01584882|Smoking|smoking
5011500|NCT01584882|Electronic health record|electronic health record
5011501|NCT01584869|GI-bleeding|gi-bleeding
5011502|NCT01584869|capsule endoscopy|capsule endoscopy
5011503|NCT01584843|Neuromuscular Agents|neuromuscular agents
5011504|NCT01584843|Strabismus|strabismus
5011505|NCT01584843|Botulinum Toxin Type A|botulinum toxin type a
5011506|NCT01584830|Regorafenib|regorafenib
5011507|NCT01584830|Colorectal|colorectal
5011508|NCT01584830|Metastatic|metastatic
5011509|NCT01584817|colonoscopy|colonoscopy
5011510|NCT01584817|bowel preparation|bowel preparation
5011511|NCT01584817|education|education
5011512|NCT01584804|Su Huang antitussive capsule|su huang antitussive capsule
5011513|NCT01584804|Cough variant asthma|cough variant asthma
5011514|NCT01584804|Placebo|placebo
5011515|NCT01584791|CAD|cad
5011516|NCT01584791|PCI|pci
5011517|NCT01584791|Percutaneous Coronary Intervention|percutaneous coronary intervention
5011518|NCT01584778|Behçet's disease|behçet's disease
5011519|NCT01584778|Eosinophil cationic protein|eosinophil cationic protein
5011520|NCT01584778|Eosinophils|eosinophils
5011521|NCT01584765|liver injury|liver injury
5011522|NCT01584765|Rechallenge|rechallenge
5011523|NCT01584765|Kaiser Permanente California|kaiser permanente california
5011524|NCT01584739|Safety|safety
5011525|NCT01584739|tolerability|tolerability
5011526|NCT01584739|healthy|healthy
5011527|NCT01584739|COPD (chronic obstructive pulmonary disease)|copd (chronic obstructive pulmonary disease)
5011528|NCT01584739|pharmacokinetic|pharmacokinetic
5011529|NCT01584739|pharmacodynamic|pharmacodynamic
5011530|NCT01584739|inhaled|inhaled
5011531|NCT01584726|magnesium|magnesium
5011532|NCT01584726|nebulization|nebulization
5011533|NCT01584726|asthma|asthma
5011534|NCT01584726|sulfate|sulfate
5011535|NCT01584726|children|children
5011536|NCT01584726|pediatric|pediatric
5011537|NCT01584713|Enterocutaneous fistula|enterocutaneous fistula
5011538|NCT01584713|Adipose Derived Stem Cells|adipose derived stem cells
5011539|NCT01584700|NYHA class III or IV|nyha class iii or iv
5011540|NCT01584700|Maximal medical therapy|maximal medical therapy
5011541|NCT01584700|Not eligible for CRT|not eligible for crt
5011542|NCT01584687|asthma|asthma
5011543|NCT01584687|difficult-to-control asthma|difficult-to-control asthma
5011544|NCT01584687|mRNA expression|mrna expression
5011545|NCT01584687|biomarker|biomarker
5011546|NCT01584687|real time PCR|real time pcr
5011547|NCT01584687|ACT|act
5011548|NCT01584687|ACQ|acq
5011549|NCT01584648|Randomized study|randomized study
5011550|NCT01584648|combination therapy|combination therapy
5011551|NCT01584648|BRAF inhibitor|braf inhibitor
5011552|NCT01584648|GSK1120212|gsk1120212
5011553|NCT01584648|BRAF V600E/K mutation-positive cutaneous melanoma|braf v600e/k mutation-positive cutaneous melanoma
5011554|NCT01584648|trametinib|trametinib
5011555|NCT01584648|GSK2118436|gsk2118436
5011556|NCT01584648|MEK inhibitor|mek inhibitor
5011557|NCT01584648|Phase III|phase iii
5011558|NCT01584648|dabrafenib|dabrafenib
5011559|NCT01584635|Less invasive treatment for Achalasia|less invasive treatment for achalasia
5011560|NCT01584609|ischemic stroke|ischemic stroke
5011561|NCT01584609|large vessel occlusion|large vessel occlusion
5011562|NCT01584609|mechanical thrombectomy|mechanical thrombectomy
5011563|NCT01584609|revascularization|revascularization
5011564|NCT01584609|Penumbra System|penumbra system
5011565|NCT01584609|Separator 3D|separator 3d
5011566|NCT01584596|physical activity|physical activity
5011567|NCT01584596|dietary|dietary
5011568|NCT01584596|adults|adults
5011569|NCT01584596|pedometer|pedometer
5011570|NCT01584596|education|education
5011571|NCT01584583|BP|bp
5011572|NCT01584570|dexmedetomidine|dexmedetomidine
5011573|NCT01584570|heart rate variability|heart rate variability
5011574|NCT01584570|QTc interval|qtc interval
5011575|NCT01584544|rectal neoplasms|rectal neoplasms
5011576|NCT01584544|aged|aged
5011577|NCT01584544|chemoradiotherapy|chemoradiotherapy
5011578|NCT01584544|clinical trials, phase I|clinical trials, phase i
5011579|NCT01584544|capecitabine|capecitabine
5011580|NCT01584531|rigosertib sodium|rigosertib sodium
5011581|NCT01584531|rigosertib|rigosertib
5011582|NCT01584531|ON 01910.Na|on 01910.na
5011583|NCT01584531|oral rigosertib|oral rigosertib
5011584|NCT01584505|COPD|copd
5011585|NCT01584479|periodontitis|periodontitis
5011586|NCT01584466|Schizophrenia|schizophrenia
5011587|NCT01584466|Substance Abuse|substance abuse
5011588|NCT01584427|Dietary fibers|dietary fibers
5011589|NCT01584427|Resistent Starch|resistent starch
5011590|NCT01584427|Arabinoxylans|arabinoxylans
5011591|NCT01584427|Postprandial lipaemia|postprandial lipaemia
5011592|NCT01584427|Insulin sensitivity|insulin sensitivity
5011593|NCT01584427|Body composition|body composition
5011594|NCT01584427|Gene expression|gene expression
5011595|NCT01584427|Metabolic rate|metabolic rate
5011596|NCT01584427|Blood pressure|blood pressure
5011597|NCT01584414|Zetiq CellDetect ® stain|zetiq celldetect ® stain
5011598|NCT01584414|distinct red/purple color to the cytoplasm of neoplastic|distinct red/purple color to the cytoplasm of neoplastic
5011599|NCT01584414|distinguishes green/blue stained non-neoplastic cells and tissues|distinguishes green/blue stained non-neoplastic cells and tissues
5011600|NCT01584401|Body temperature|body temperature
5011601|NCT01584401|Thermometers|thermometers
5011602|NCT01584401|Non invasive|non invasive
5011603|NCT01584401|Medisim's non invasive thermometers|medisim's non invasive thermometers
5011604|NCT01584388|Type 1 autoimmune pancreatitis|type 1 autoimmune pancreatitis
5011605|NCT01584388|IgG4-related sclerosing cholangitis|igg4-related sclerosing cholangitis
5011606|NCT01584388|Chronic sclerosing sialadenitis|chronic sclerosing sialadenitis
5011607|NCT01584388|Lacrimal glands|lacrimal glands
5011608|NCT01584388|Orbital pseudotumor|orbital pseudotumor
5011609|NCT01584388|IgG4-related tubulointerstitial nephritis|igg4-related tubulointerstitial nephritis
5011610|NCT01584388|Lymphadenopathy|lymphadenopathy
5011611|NCT01584388|Pachymeningitis|pachymeningitis
5011612|NCT01584388|Aorta|aorta
5011613|NCT01584388|Peri-aortitis|peri-aortitis
5011614|NCT01584388|Retroperitoneal fibrosis|retroperitoneal fibrosis
5011615|NCT01584388|Riedel's thyroiditis|riedel's thyroiditis
5011616|NCT01584375|Intraventricular hemorrhage|intraventricular hemorrhage
5011617|NCT01584375|Preterm infant|preterm infant
5011618|NCT01584375|Midline head position|midline head position
5011619|NCT01584375|Lateral head Position|lateral head position
5011620|NCT01584362|Taenia solium|taenia solium
5011621|NCT01584362|neurocysticercosis|neurocysticercosis
5011622|NCT01584362|oxfendazole|oxfendazole
5011623|NCT01584362|clinical trial, phase 1|clinical trial, phase 1
5011624|NCT01584362|safety|safety
5011625|NCT01584362|pharmacokinetics|pharmacokinetics
5011626|NCT01584336|Gastric cancer, laparoscopy-assisted total gastrectomy|gastric cancer, laparoscopy-assisted total gastrectomy
5011627|NCT01584323|Preterm premature rupture of membranes|preterm premature rupture of membranes
5011628|NCT01584323|pomgranate|pomgranate
5011629|NCT01584323|oxidative stress|oxidative stress
5011630|NCT01584323|pregnant women with Preterm premature rupture of membranes|pregnant women with preterm premature rupture of membranes
5011631|NCT01584310|Nutritional assessment|nutritional assessment
5011632|NCT01584310|children|children
5011633|NCT01584310|malnutrition|malnutrition
5011634|NCT01584297|Granulosa Cell Tumour|granulosa cell tumour
5011635|NCT01584284|Genelux|genelux
5011636|NCT01584284|Genelux Corporation|genelux corporation
5011637|NCT01584284|GL-ONC1|gl-onc1
5011638|NCT01584284|Vaccinia|vaccinia
5011639|NCT01584284|Vaccinia Virus|vaccinia virus
5011640|NCT01584284|Oncolytic virus|oncolytic virus
5011641|NCT01584284|Oncolytic Virotherapy|oncolytic virotherapy
5011642|NCT01584284|Head and Neck Cancer|head and neck cancer
5011643|NCT01584284|Squamous Cell Carcinoma|squamous cell carcinoma
5011644|NCT01584271|AOE|aoe
5011645|NCT01584271|Ear Comfort|ear comfort
5011646|NCT01584271|Dex Otic|dex otic
5011647|NCT01584271|Otidin|otidin
5011648|NCT01584258|Prostate cancer|prostate cancer
5011649|NCT01584258|Prostate adenocarcinoma|prostate adenocarcinoma
5011650|NCT01584258|Early stage prostate cancer|early stage prostate cancer
5011651|NCT01584258|Organ-confined prostate cancer|organ-confined prostate cancer
5011652|NCT01584258|Low-risk prostate cancer|low-risk prostate cancer
5011653|NCT01584258|Intermediate-risk prostate cancer|intermediate-risk prostate cancer
5011654|NCT01584232|Glucagon-like peptide-1 (GLP-1)|glucagon-like peptide-1 (glp-1)
5011655|NCT01584206|Sitosterolemia|sitosterolemia
5011656|NCT01584206|Ezetimibe|ezetimibe
5011657|NCT01584206|Plant sterol|plant sterol
5011658|NCT01584206|Cholesterol|cholesterol
5011659|NCT01584193|central venous access port|central venous access port
5011660|NCT01584193|ultrasound-guided venous puncture|ultrasound-guided venous puncture
5011661|NCT01584193|suclavian vein|suclavian vein
5011662|NCT01584193|cephalic vein|cephalic vein
5011663|NCT01584180|hypothermia|hypothermia
5011664|NCT01584180|induction of hypothermia|induction of hypothermia
5011665|NCT01584180|cold infusion|cold infusion
5011666|NCT01584180|local neck cooling|local neck cooling
5011667|NCT01584180|external cooling|external cooling
5011668|NCT01584180|surface cooling|surface cooling
5011669|NCT01584180|non invasive cooling|non invasive cooling
5011670|NCT01584180|stroke|stroke
5011671|NCT01584180|intracranial hemorrhage|intracranial hemorrhage
5011672|NCT01584180|cerebrovascular disease|cerebrovascular disease
5011673|NCT01584180|neuro intensive care|neuro intensive care
5011674|NCT01584167|hypothermia|hypothermia
5011675|NCT01584167|induction of hypothermia|induction of hypothermia
5011676|NCT01584167|cold infusion|cold infusion
5011677|NCT01584167|whole-body cooling|whole-body cooling
5011678|NCT01584167|external cooling|external cooling
5011679|NCT01584167|surface cooling|surface cooling
5011680|NCT01584167|non invasive cooling|non invasive cooling
5011681|NCT01584167|stroke|stroke
5011682|NCT01584167|intracranial hemorrhage|intracranial hemorrhage
5011683|NCT01584167|cerebrovascular disease|cerebrovascular disease
5011684|NCT01584167|neuro intensive care|neuro intensive care
5011685|NCT01584141|Leukemia|leukemia
5011686|NCT01584141|Lymphoma|lymphoma
5011687|NCT01584141|Occupational Epidemiology|occupational epidemiology
5011688|NCT01584141|Molecular Epidemiology|molecular epidemiology
5011689|NCT01584141|Genetic Polymorphisms|genetic polymorphisms
5011690|NCT01584115|Cancer.|cancer.
5011691|NCT01584115|Melanoma.|melanoma.
5011692|NCT01584115|Ovarian cancer.|ovarian cancer.
5011693|NCT01584115|Lung cancer.|lung cancer.
5011694|NCT01584115|NY-ESO-1.|ny-eso-1.
5011695|NCT01584115|MPLA (monophosphoryl lipid A).|mpla (monophosphoryl lipid a).
5011696|NCT01584115|Tumor antigen.|tumor antigen.
5011697|NCT01584115|Bordetella pertussis.|bordetella pertussis.
5011698|NCT01584102|Randomized controlled trial|randomized controlled trial
5011699|NCT01584102|obesity|obesity
5011700|NCT01584102|community-based participatory research|community-based participatory research
5011701|NCT01584102|minority health|minority health
5011702|NCT01584102|rural health|rural health
5011703|NCT01584102|health promotion|health promotion
5011704|NCT01584076|Amblyopia|amblyopia
5011705|NCT01584076|Donepezil|donepezil
5011706|NCT01584063|Mexican Americans|mexican americans
5011707|NCT01584063|Pregnancy|pregnancy
5011708|NCT01584063|Diabetes Mellitus Type 2|diabetes mellitus type 2
5011709|NCT01584063|Prevention|prevention
5012218|NCT01582074|Tamoxifen|tamoxifen
5011710|NCT01584063|Community health workers|community health workers
5011711|NCT01584063|Community based participatory research|community based participatory research
5011712|NCT01584063|Behavioral Intervention|behavioral intervention
5011713|NCT01584063|Lifestyle Intervention|lifestyle intervention
5011714|NCT01584037|Adenovirus|adenovirus
5011715|NCT01584037|Adenovirus Type 4|adenovirus type 4
5011716|NCT01584037|Adenovirus Type 7|adenovirus type 7
5011717|NCT01584037|Adenovirus Type 4 and Type 7 Vaccine, Live, Oral|adenovirus type 4 and type 7 vaccine, live, oral
5011718|NCT01584024|Dental caries|dental caries
5011719|NCT01584024|Proximal surfaces|proximal surfaces
5011720|NCT01584024|Posterior teeth|posterior teeth
5011721|NCT01584024|Carious lesions|carious lesions
5011722|NCT01584024|Tooth diseases|tooth diseases
5011723|NCT01584024|Preventive therapy|preventive therapy
5011724|NCT01584011|Taste|taste
5011725|NCT01584011|Chorda tympani nerve|chorda tympani nerve
5011726|NCT01583998|Major Depressive Disorder|major depressive disorder
5011727|NCT01583998|MDD|mdd
5011728|NCT01583998|Depression|depression
5011729|NCT01583998|Measurement Based Care|measurement based care
5011730|NCT01583998|MBC|mbc
5011731|NCT01583998|electronic health records|electronic health records
5011732|NCT01583998|EHR|ehr
5011733|NCT01583998|electronic medical records|electronic medical records
5011734|NCT01583998|EMR|emr
5011735|NCT01583985|opioid analgesics|opioid analgesics
5011736|NCT01583985|chronic pain|chronic pain
5011737|NCT01583985|musculoskeletal pain|musculoskeletal pain
5011738|NCT01583972|Vitamin A deficiency|vitamin a deficiency
5011739|NCT01583972|Vitamin A|vitamin a
5011740|NCT01583972|retinyl palmitate|retinyl palmitate
5011741|NCT01583972|malnutrition|malnutrition
5011742|NCT01583972|vaccine|vaccine
5011743|NCT01583972|vaccination|vaccination
5011744|NCT01583972|BCG|bcg
5011745|NCT01583972|tuberculosis|tuberculosis
5011746|NCT01583972|polio virus|polio virus
5011747|NCT01583972|tetanus toxoid|tetanus toxoid
5011748|NCT01583972|hepatitis B virus|hepatitis b virus
5011749|NCT01583972|thymus|thymus
5011750|NCT01583972|T lymphocyte|t lymphocyte
5011751|NCT01583972|B lymphocyte|b lymphocyte
5011752|NCT01583972|antibody|antibody
5011753|NCT01583972|bacterial translocation|bacterial translocation
5011754|NCT01583972|T-cell receptor excision circle|t-cell receptor excision circle
5011755|NCT01583959|rheumatoid arthritis|rheumatoid arthritis
5011756|NCT01583959|folic acid|folic acid
5011757|NCT01583959|methotrexate|methotrexate
5011758|NCT01583946|subjective well-being|subjective well-being
5011759|NCT01583946|life transitions|life transitions
5011760|NCT01583946|health-related quality of life|health-related quality of life
5011761|NCT01583946|health|health
5011762|NCT01583946|healthcare costs|healthcare costs
5011763|NCT01583933|Dental stability|dental stability
5011764|NCT01583933|Occlusal stability|occlusal stability
5011765|NCT01583933|Retainers|retainers
5011766|NCT01583920|prostatic neoplasms|prostatic neoplasms
5011767|NCT01583920|brachytherapy|brachytherapy
5011768|NCT01583920|salvage therapy|salvage therapy
5011769|NCT01583920|recurrent prostate cancer|recurrent prostate cancer
5011770|NCT01583907|cow's milk allergy|cow's milk allergy
5011771|NCT01583881|Patients with diastolic heart failure and hypertension|patients with diastolic heart failure and hypertension
5011772|NCT01583855|Remote catheter ablation|remote catheter ablation
5011773|NCT01583855|Atrial fibrillation|atrial fibrillation
5011774|NCT01583842|neuroblastoma|neuroblastoma
5011775|NCT01583842|imaging|imaging
5011776|NCT01583842|124I-MIBG|124i-mibg
5011777|NCT01583842|131I-MIBG|131i-mibg
5011778|NCT01583842|PET/CT|pet/ct
5011779|NCT01583829|ADHD|adhd
5011780|NCT01583829|neurofeedback|neurofeedback
5011781|NCT01583829|biofeedback|biofeedback
5011782|NCT01583829|computer attention training|computer attention training
5011783|NCT01583816|Actinic Keratosis|actinic keratosis
5011784|NCT01583816|Resiquimod|resiquimod
5011785|NCT01583790|Laparoscopic Sleeve Gastrectomy|laparoscopic sleeve gastrectomy
5011786|NCT01583790|Bariatric surgery|bariatric surgery
5011787|NCT01583790|Morbid Obesity|morbid obesity
5011788|NCT01583777|Belinostat|belinostat
5011789|NCT01583751|pilonidal sinus|pilonidal sinus
5011790|NCT01583751|new technique|new technique
5011791|NCT01583751|videoendoscopic|videoendoscopic
5011792|NCT01583725|Obesity|obesity
5011793|NCT01583725|Bariatric surgery|bariatric surgery
5011794|NCT01583725|Weight loss|weight loss
5011795|NCT01583725|fMRI|fmri
5011796|NCT01583725|gut peptides|gut peptides
5011797|NCT01583712|Confocal laser endomicroscopy|confocal laser endomicroscopy
5011798|NCT01583712|Small bowel imaging|small bowel imaging
5011799|NCT01583712|Graft-versus-host disease|graft-versus-host disease
5011800|NCT01583712|HSCT|hsct
5011801|NCT01583699|MALT-lymphoma|malt-lymphoma
5011802|NCT01583699|Confocal laser endomicroscopy|confocal laser endomicroscopy
5011803|NCT01583699|Gastrointestinal endoscopy|gastrointestinal endoscopy
5011804|NCT01583686|Metastatic Cancer|metastatic cancer
5011805|NCT01583686|Immunotherapy|immunotherapy
5011806|NCT01583686|Gene Therapy|gene therapy
5011807|NCT01583686|Mesothelioma|mesothelioma
5011808|NCT01583686|Pancreatic Cancer|pancreatic cancer
5011809|NCT01583660|NSAIDs|nsaids
5011810|NCT01583660|Anti-inflammatory|anti-inflammatory
5011811|NCT01583660|elderly hip fracture|elderly hip fracture
5011812|NCT01583660|mortality|mortality
5011813|NCT01583608|Drug eluting stent|drug eluting stent
5011814|NCT01583608|Bioabsorbable|bioabsorbable
5011815|NCT01583608|Bioresorbable|bioresorbable
5011816|NCT01583608|Coronary Stent|coronary stent
5011817|NCT01583608|Scaffold|scaffold
5011818|NCT01583608|Stents|stents
5011819|NCT01583608|Angioplasty|angioplasty
5011820|NCT01583608|Coronary Artery Disease|coronary artery disease
5011821|NCT01583608|Stentthrombosis|stentthrombosis
5011822|NCT01583595|Chronic Lung Disease|chronic lung disease
5011823|NCT01583595|Exercise|exercise
5011824|NCT01583595|Self-efficacy|self-efficacy
5011825|NCT01583582|randomized double-blind placebo-controlled study|randomized double-blind placebo-controlled study
5011826|NCT01583582|peptide concentrate|peptide concentrate
5011827|NCT01583582|Coldwater Shrimp|coldwater shrimp
5011828|NCT01583582|antihypertensive effect|antihypertensive effect
5011829|NCT01583582|mild hypertension|mild hypertension
5011830|NCT01583582|moderate hypertension|moderate hypertension
5011831|NCT01583582|blood pressure|blood pressure
5011832|NCT01583569|Complex Dynamic Systems|complex dynamic systems
5011833|NCT01583569|Biomarkers|biomarkers
5011834|NCT01583569|Mood Disorders|mood disorders
5011835|NCT01583556|Adult|adult
5011836|NCT01583556|English speaking|english speaking
5011837|NCT01583556|Fractures|fractures
5011838|NCT01583556|Excellent prognosis|excellent prognosis
5011839|NCT01583556|Upper Extremity|upper extremity
5011840|NCT01583543|Recurrent|recurrent
5011841|NCT01583543|Metastatic|metastatic
5011842|NCT01583530|Belimumab|belimumab
5011843|NCT01583530|Injections, Subcutaneous|injections, subcutaneous
5011844|NCT01583530|Drug Administration Routes|drug administration routes
5011845|NCT01583530|Injections|injections
5011846|NCT01583530|Lupus Erythematosus, Systemic|lupus erythematosus, systemic
5011847|NCT01583530|Lupus|lupus
5011848|NCT01583530|SLE|sle
5011849|NCT01583530|Systemic Lupus Erythematosus|systemic lupus erythematosus
5011850|NCT01583530|Antibodies|antibodies
5011851|NCT01583530|Autoimmune Disease|autoimmune disease
5011852|NCT01583530|Biological Therapy|biological therapy
5011853|NCT01583530|Immune System Diseases|immune system diseases
5011854|NCT01583530|Pharmacokinetics|pharmacokinetics
5011855|NCT01583530|Biological Availability|biological availability
5011856|NCT01583517|Acute pancreatitis|acute pancreatitis
5011857|NCT01583517|ERCP|ercp
5011858|NCT01583517|Sphincterotomy|sphincterotomy
5011859|NCT01583517|Manometry|manometry
5011860|NCT01583517|Sphincter of Oddi dysfunction|sphincter of oddi dysfunction
5011861|NCT01583504|Achilles|achilles
5011862|NCT01583504|Tendinopathy|tendinopathy
5011863|NCT01583504|Tendonitis|tendonitis
5011864|NCT01583504|Injection|injection
5011865|NCT01583491|platelet rich fibrin|platelet rich fibrin
5011866|NCT01583491|mandibular third molar|mandibular third molar
5011867|NCT01583491|periodontal problem|periodontal problem
5011868|NCT01583478|incobotulinumtoxinA|incobotulinumtoxina
5011869|NCT01583478|wrinkles|wrinkles
5011870|NCT01583478|glabellar|glabellar
5011871|NCT01583478|rhytids|rhytids
5011872|NCT01583478|frown|frown
5011873|NCT01583478|lines|lines
5011874|NCT01583465|randomized controlled trial|randomized controlled trial
5011875|NCT01583465|Blood loss, surgical|blood loss, surgical
5011876|NCT01583465|Blood loss, postoperative|blood loss, postoperative
5011877|NCT01583465|Wound healing|wound healing
5011878|NCT01583452|Post operative ileus|post operative ileus
5011879|NCT01583452|Gastrointestinal surgery|gastrointestinal surgery
5011880|NCT01583452|Chewing gum|chewing gum
5011881|NCT01583439|HIV Infections|hiv infections
5011882|NCT01583439|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5011883|NCT01583439|Anti-HIV Agents|anti-hiv agents
5011884|NCT01583439|Sexually Transmitted Diseases, Viral|sexually transmitted diseases, viral
5011885|NCT01583439|Immunologic Deficiency Syndromes|immunologic deficiency syndromes
5011886|NCT01583439|Immune System Diseases|immune system diseases
5011887|NCT01583439|Anti-Retroviral Agents|anti-retroviral agents
5011888|NCT01583439|Antiviral Agents|antiviral agents
5011889|NCT01583426|GeparSepto|geparsepto
5011890|NCT01583426|GBG 69|gbg 69
5011891|NCT01583426|GBG|gbg
5011892|NCT01583426|German Breast Group|german breast group
5011893|NCT01583426|neo-adjuvant|neo-adjuvant
5011894|NCT01583426|GBG Forschungs GmbH|gbg forschungs gmbh
5011895|NCT01583426|Tubular breast cancer stage II|tubular breast cancer stage ii
5011896|NCT01583426|Mucinous breast cancer stage II|mucinous breast cancer stage ii
5011897|NCT01583426|Invasive ductal breast cancer|invasive ductal breast cancer
5011898|NCT01583426|Tubular breast cancer stage III|tubular breast cancer stage iii
5011899|NCT01583426|HER-2 positive breast cancer|her-2 positive breast cancer
5011900|NCT01583426|Inflammatory breast cancer|inflammatory breast cancer
5011901|NCT01583413|Ventilator-associated pneumonia|ventilator-associated pneumonia
5011902|NCT01583400|Depressive Disorder, Major|depressive disorder, major
5011903|NCT01583400|Depressive Disorder, Minor|depressive disorder, minor
5011904|NCT01583400|Dysthymic Disorder|dysthymic disorder
5011905|NCT01583387|healthy adults|healthy adults
5011906|NCT01583387|urinary adducts|urinary adducts
5011907|NCT01583387|water intake|water intake
5011908|NCT01583374|spondylitis|spondylitis
5011909|NCT01583374|spondyloarthritis|spondyloarthritis
5011910|NCT01583374|Spondyloarthropathy|spondyloarthropathy
5011911|NCT01583374|Oral preparation|oral preparation
5011912|NCT01583361|two arms|two arms
5011913|NCT01583361|D2 lymphadenectomy|d2 lymphadenectomy
5011914|NCT01583361|chemotherapy before and after surgery|chemotherapy before and after surgery
5011915|NCT01583361|disease free survival|disease free survival
5011916|NCT01583348|transvaginal|transvaginal
5011917|NCT01583348|NOTES|notes
5011918|NCT01583348|cholecystectomy|cholecystectomy
5011919|NCT01583348|cholangiography|cholangiography
5011920|NCT01583348|symptomatic gallstone disease|symptomatic gallstone disease
5011921|NCT01583335|Overweight|overweight
5011922|NCT01583335|Obesity|obesity
5011923|NCT01583335|Predisposition|predisposition
5011924|NCT01583335|Prevention|prevention
5011925|NCT01583335|Diet|diet
5011926|NCT01583335|Physical activity|physical activity
5011927|NCT01583335|Sleep|sleep
5011928|NCT01583335|Family stress|family stress
5011929|NCT01583322|ovarian cancer|ovarian cancer
5011930|NCT01583322|debulking surgery|debulking surgery
5011931|NCT01583322|interval debulking|interval debulking
5011932|NCT01583322|vargatef|vargatef
5011933|NCT01583322|nintedanib|nintedanib
5011934|NCT01583322|maintenance|maintenance
5011935|NCT01583322|first line|first line
5011936|NCT01583322|paclitaxel|paclitaxel
5011937|NCT01583322|carboplatin|carboplatin
5011938|NCT01583309|blood pressure|blood pressure
5011939|NCT01583309|cardiovascular instability|cardiovascular instability
5011940|NCT01583309|symptomatic hypotension|symptomatic hypotension
5011941|NCT01583309|online hemofiltration|online hemofiltration
5011942|NCT01583309|online hemodiafiltration|online hemodiafiltration
5011943|NCT01583283|Multiple Myeloma|multiple myeloma
5011944|NCT01583283|Relapsed|relapsed
5011945|NCT01583283|Refractory|refractory
5011946|NCT01583283|Histone deacetylase inhibitors|histone deacetylase inhibitors
5011947|NCT01583283|Lenalidomide|lenalidomide
5011948|NCT01583283|Revlimid|revlimid
5011949|NCT01583283|Dexamethasone|dexamethasone
5011950|NCT01583270|Arabinxylan|arabinxylan
5011951|NCT01583270|Rye kernels|rye kernels
5011952|NCT01583270|whole grain|whole grain
5011953|NCT01583270|Dietary fibre|dietary fibre
5011954|NCT01583270|Metabolic syndrome|metabolic syndrome
5011955|NCT01583270|Glycemic response|glycemic response
5011956|NCT01583270|Colon fermentation|colon fermentation
5011957|NCT01583270|Second meal effekt|second meal effekt
5011958|NCT01583270|Satiety|satiety
5011959|NCT01583218|Phase III|phase iii
5011960|NCT01583205|ALS|als
5011961|NCT01583205|Coping Effectiveness Training|coping effectiveness training
5011962|NCT01583205|Distress|distress
5011963|NCT01583205|Care Giver|care giver
5011964|NCT01583192|infection|infection
5011965|NCT01583192|skin preparation|skin preparation
5011966|NCT01583192|fore-foot surgery|fore-foot surgery
5011967|NCT01583192|chloride-hexidine|chloride-hexidine
5011968|NCT01583192|povidine-jodine|povidine-jodine
5011969|NCT01583192|alcohol|alcohol
5011970|NCT01583179|nerve block|nerve block
5011971|NCT01583179|outpatient surgery|outpatient surgery
5011972|NCT01583140|physical activity|physical activity
5011973|NCT01583140|Latinas|latinas
5011974|NCT01583127|Problem Behavior|problem behavior
5011975|NCT01583114|dilated cardiomyopathy|dilated cardiomyopathy
5011976|NCT01583114|heart failure|heart failure
5011977|NCT01583114|genetics|genetics
5011978|NCT01583114|mutation carrier|mutation carrier
5011979|NCT01583114|ACE treatment|ace treatment
5011980|NCT01583114|preclinical|preclinical
5011981|NCT01583088|Amyotrophic lateral sclerosis,|amyotrophic lateral sclerosis,
5011982|NCT01583088|Diaphragm|diaphragm
5011983|NCT01583088|Mechanical ventilation|mechanical ventilation
5011984|NCT01583088|Phrenic nerve stimulation|phrenic nerve stimulation
5011985|NCT01583088|Respiratory insufficiency|respiratory insufficiency
5011986|NCT01583062|Surgical Wound Infection|surgical wound infection
5011987|NCT01583062|Facial Injuries|facial injuries
5011988|NCT01583062|Orbital Fractures|orbital fractures
5011989|NCT01583062|Zygomatic Fractures|zygomatic fractures
5011990|NCT01583062|Mandibular Fractures|mandibular fractures
5011991|NCT01583062|Jaw Injuries|jaw injuries
5011992|NCT01583023|bipolar disorder|bipolar disorder
5011993|NCT01583023|repetitive transcranial magnetic stimulation (rtms)|repetitive transcranial magnetic stimulation (rtms)
5011994|NCT01583023|bupropion|bupropion
5011995|NCT01583023|lithium a/o Epival|lithium a/o epival
5011996|NCT01583010|ultrasound guided regional anaesthesia needle visualization|ultrasound guided regional anaesthesia needle visualization
5011997|NCT01582997|BRAF|braf
5011998|NCT01582997|Advance solid tumors|advance solid tumors
5011999|NCT01582984|consent|consent
5012000|NCT01582984|Patient Understanding|patient understanding
5012001|NCT01582984|Knee Arthroplasty|knee arthroplasty
5012002|NCT01582971|Breast Cancer|breast cancer
5012003|NCT01582971|Reflexology|reflexology
5012004|NCT01582971|Complementary|complementary
5012005|NCT01582958|Osteopathic Manipulative Treatment|osteopathic manipulative treatment
5012006|NCT01582958|Pulmonary Function Tests|pulmonary function tests
5012007|NCT01582958|Biochemical Alterations|biochemical alterations
5012008|NCT01582945|Treatment resistant|treatment resistant
5012423|NCT01581164|system|system
5012009|NCT01582945|suicidal ideation|suicidal ideation
5012010|NCT01582945|major depressive disorder|major depressive disorder
5012011|NCT01582932|plaque psoriasis|plaque psoriasis
5012012|NCT01582932|pediatric|pediatric
5012013|NCT01582932|mild|mild
5012014|NCT01582932|moderate|moderate
5012015|NCT01582919|dementia|dementia
5012016|NCT01582919|Alzheimer's Disease|alzheimer's disease
5012017|NCT01582919|diagnostic|diagnostic
5012018|NCT01582919|biomarkers|biomarkers
5012019|NCT01582919|neuroimaging|neuroimaging
5012020|NCT01582919|PET|pet
5012021|NCT01582919|MRI|mri
5012022|NCT01582919|mild cognitive impairment|mild cognitive impairment
5012023|NCT01582893|inflammation|inflammation
5012024|NCT01582893|dialysis|dialysis
5012025|NCT01582880|Keratoprosthesis|keratoprosthesis
5012026|NCT01582880|sterile cornea ulcer|sterile cornea ulcer
5012027|NCT01582867|Hemodiafiltration|hemodiafiltration
5012028|NCT01582867|Hemodialysis|hemodialysis
5012029|NCT01582867|Sodium|sodium
5012030|NCT01582867|Artis|artis
5012031|NCT01582867|renal failure|renal failure
5012032|NCT01582854|Post-Stroke Cognitive Impairment (PSCI)|post-stroke cognitive impairment (psci)
5012033|NCT01582854|Stroke|stroke
5012034|NCT01582854|Actovegin|actovegin
5012035|NCT01582854|Cognition disorders|cognition disorders
5012036|NCT01582841|Colon Cancer|colon cancer
5012037|NCT01582841|Lynch Syndrome|lynch syndrome
5012038|NCT01582841|Genetic Screening|genetic screening
5012039|NCT01582828|atrial|atrial
5012040|NCT01582828|fibrillation|fibrillation
5012041|NCT01582828|pvi|pvi
5012042|NCT01582828|vats|vats
5012043|NCT01582828|ablation|ablation
5012044|NCT01582828|hybrid|hybrid
5012045|NCT01582815|Major Depressive Disorder|major depressive disorder
5012046|NCT01582815|Depression|depression
5012047|NCT01582815|Anxiety symptoms|anxiety symptoms
5012048|NCT01582815|JNJ-40411813|jnj-40411813
5012049|NCT01582763|Guillain-Barré syndrome|guillain-barré syndrome
5012050|NCT01582763|Polyneuropathy|polyneuropathy
5012051|NCT01582763|Autoimmune Diseases|autoimmune diseases
5012052|NCT01582763|Immune System Diseases|immune system diseases
5012053|NCT01582763|Neuromuscular Diseases|neuromuscular diseases
5012054|NCT01582763|Outcome|outcome
5012055|NCT01582763|Quality of life|quality of life
5012056|NCT01582763|Disability|disability
5012057|NCT01582763|Prognostic Determinants|prognostic determinants
5012058|NCT01582763|Treatment|treatment
5012059|NCT01582763|Immunoglobulins|immunoglobulins
5012060|NCT01582763|Prognosis|prognosis
5012061|NCT01582763|Infections|infections
5012062|NCT01582763|Anti-ganglioside antibodies|anti-ganglioside antibodies
5012063|NCT01582763|Genetic polymorphisms|genetic polymorphisms
5012064|NCT01582763|Electrophysiology|electrophysiology
5012065|NCT01582763|Cerebrospinal Fluid|cerebrospinal fluid
5012066|NCT01582763|Serum|serum
5012067|NCT01582750|endoscopic ultrasound|endoscopic ultrasound
5012068|NCT01582750|pre-operative concurrent chemoradiotherapy|pre-operative concurrent chemoradiotherapy
5012069|NCT01582737|Xarelto|xarelto
5012070|NCT01582737|SPAF|spaf
5012071|NCT01582724|Menstrual pain|menstrual pain
5012072|NCT01582724|Primary dysmenorrhea|primary dysmenorrhea
5012073|NCT01582724|Self-care acupressure|self-care acupressure
5012074|NCT01582711|LTBI|ltbi
5012075|NCT01582711|LTB|ltb
5012076|NCT01582711|Latent TB|latent tb
5012077|NCT01582711|TB infection|tb infection
5012078|NCT01582685|Breast Cancer|breast cancer
5012079|NCT01582685|Obesity|obesity
5012080|NCT01582685|Exercise|exercise
5012081|NCT01582685|Angiogenesis|angiogenesis
5012082|NCT01582672|RCC|rcc
5012083|NCT01582672|Kidney Cancer|kidney cancer
5012084|NCT01582659|constipation|constipation
5012085|NCT01582659|children|children
5012086|NCT01582659|outpatient|outpatient
5012087|NCT01582633|vaccine|vaccine
5012088|NCT01582633|influenza|influenza
5012089|NCT01582633|needle free jet injector|needle free jet injector
5012090|NCT01582633|Intradermal|intradermal
5012091|NCT01582633|sparing dose|sparing dose
5012092|NCT01582620|Cerebrovascular disorders|cerebrovascular disorders
5012093|NCT01582620|Telemedicine|telemedicine
5012094|NCT01582620|remote consultation|remote consultation
5012095|NCT01582620|rural|rural
5012096|NCT01582620|thrombolysis therapy|thrombolysis therapy
5012097|NCT01582620|plasminogen activators|plasminogen activators
5012098|NCT01582620|stroke care|stroke care
5012099|NCT01582620|stroke management|stroke management
5012100|NCT01582594|1000 residual serum/plasma samples|1000 residual serum/plasma samples
5012101|NCT01582594|anti-HCV seronegative or seropositive|anti-hcv seronegative or seropositive
5012102|NCT01582581|mental health|mental health
5012103|NCT01582581|depression|depression
5012104|NCT01582581|behavioral health|behavioral health
5012105|NCT01582581|cognitive behavioral therapy|cognitive behavioral therapy
5012106|NCT01582581|CBT|cbt
5012107|NCT01582581|computer-assisted psychotherapy|computer-assisted psychotherapy
5012108|NCT01582555|mucolysis|mucolysis
5012109|NCT01582555|QOL|qol
5012110|NCT01582555|endoscopy|endoscopy
5012111|NCT01582555|sinus surgery|sinus surgery
5012112|NCT01582529|Developmental Outcomes|developmental outcomes
5012113|NCT01582529|Psychosocial Outcomes|psychosocial outcomes
5012114|NCT01582529|Hypoplastic Left Heart Syndrome|hypoplastic left heart syndrome
5012115|NCT01582529|Congenital Heart Disease|congenital heart disease
5012116|NCT01582516|brain tumor|brain tumor
5012117|NCT01582516|virotherapy|virotherapy
5012118|NCT01582516|glioblastoma|glioblastoma
5012119|NCT01582516|replication competent adenovirus|replication competent adenovirus
5012120|NCT01582490|Mammoplasty|mammoplasty
5012121|NCT01582490|Postoperative pain|postoperative pain
5012122|NCT01582490|Analgesia|analgesia
5012123|NCT01582477|TAP, robot-assisted prostatectomy|tap, robot-assisted prostatectomy
5012124|NCT01582464|Protective Headwear|protective headwear
5012125|NCT01582464|Social Marketing|social marketing
5012126|NCT01582464|Theory of Planned Behavior|theory of planned behavior
5012127|NCT01582425|isavuconazole|isavuconazole
5012128|NCT01582425|methadone|methadone
5012129|NCT01582425|Healthy Volunteers|healthy volunteers
5012130|NCT01582425|BAL8557|bal8557
5012131|NCT01582412|Isavuconazole|isavuconazole
5012132|NCT01582412|Digoxin|digoxin
5012133|NCT01582412|Healthy Volunteers|healthy volunteers
5012134|NCT01582412|BAL8557|bal8557
5012135|NCT01582399|Healthy Volunteers|healthy volunteers
5012136|NCT01582399|CD40 receptor occupancy|cd40 receptor occupancy
5012137|NCT01582399|Co-stimulation blockade|co-stimulation blockade
5012138|NCT01582399|CD40 antigen|cd40 antigen
5012139|NCT01582399|Anti-CD40|anti-cd40
5012140|NCT01582399|ASKP1240|askp1240
5012141|NCT01582360|critical illness|critical illness
5012142|NCT01582360|pharmacokinetics|pharmacokinetics
5012143|NCT01582360|CRRT|crrt
5012144|NCT01582360|CVVH|cvvh
5012145|NCT01582360|CVVHD|cvvhd
5012146|NCT01582360|CVVHDF|cvvhdf
5012147|NCT01582360|antiinfectives|antiinfectives
5012148|NCT01582360|antibiotics|antibiotics
5012149|NCT01582360|minimum inhibitory concentration|minimum inhibitory concentration
5012150|NCT01582360|bacterial killing|bacterial killing
5012151|NCT01582360|pharmacodynamics|pharmacodynamics
5012152|NCT01582360|PK/PD index|pk/pd index
5012153|NCT01582347|Opioid dependence|opioid dependence
5012154|NCT01582334|Growth disorders|growth disorders
5012155|NCT01582334|Saizen|saizen
5012156|NCT01582334|Easypod|easypod
5012157|NCT01582334|Growth hormone|growth hormone
5012158|NCT01582334|Pediatric subject|pediatric subject
5012159|NCT01582321|vascular ultrasound|vascular ultrasound
5012160|NCT01582321|flow cytometry|flow cytometry
5012161|NCT01582321|platelet aggregation|platelet aggregation
5012162|NCT01582295|Bone disease|bone disease
5012163|NCT01582282|Type II NIDDM|type ii niddm
5012164|NCT01582243|Diabetes Mellitus, type 2|diabetes mellitus, type 2
5012165|NCT01582243|vildagliptin|vildagliptin
5012166|NCT01582230|Type 2 diabetes mellitus|type 2 diabetes mellitus
5012167|NCT01582230|Vildagliptin|vildagliptin
5012168|NCT01582217|Bleeding|bleeding
5012169|NCT01582217|Risk Score|risk score
5012170|NCT01582217|Outcomes|outcomes
5012171|NCT01582217|Prasugrel|prasugrel
5012172|NCT01582204|clear cell carcinoma|clear cell carcinoma
5012173|NCT01582204|Kidney|kidney
5012174|NCT01582204|MAB-124I-CG250|mab-124i-cg250
5012175|NCT01582204|PET scan|pet scan
5012176|NCT01582204|CT scan|ct scan
5012177|NCT01582204|sunitinib|sunitinib
5012178|NCT01582204|pazopanib|pazopanib
5012179|NCT01582204|11-134|11-134
5012180|NCT01582191|Advanced Cancers|advanced cancers
5012181|NCT01582191|Advanced solid cancer|advanced solid cancer
5012182|NCT01582191|Metastatic cancer|metastatic cancer
5012183|NCT01582191|Vandetanib|vandetanib
5012184|NCT01582191|ZD 6474|zd 6474
5012185|NCT01582191|Zactima|zactima
5012186|NCT01582191|Caprelsa|caprelsa
5012187|NCT01582191|Everolimus|everolimus
5012188|NCT01582191|Afinitor|afinitor
5012189|NCT01582191|RAD001|rad001
5012190|NCT01582191|Multi-kinase Inhibitor|multi-kinase inhibitor
5012191|NCT01582178|colonoscopy|colonoscopy
5012192|NCT01582178|warm water immersion|warm water immersion
5012193|NCT01582178|cool water immersion|cool water immersion
5012194|NCT01582152|Brain Neoplasms|brain neoplasms
5012195|NCT01582152|Central Nervous System Neoplasms|central nervous system neoplasms
5012196|NCT01582152|Recurrent Glioblastoma|recurrent glioblastoma
5012197|NCT01582152|Glioblastoma multiforme|glioblastoma multiforme
5012198|NCT01582152|GBM|gbm
5012199|NCT01582152|Gliosarcoma|gliosarcoma
5012200|NCT01582152|TPI287|tpi287
5012201|NCT01582152|Bevacizumab|bevacizumab
5012202|NCT01582152|Avastin|avastin
5012203|NCT01582152|Anti-VEGF Monoclonal Antibody|anti-vegf monoclonal antibody
5012204|NCT01582152|rhuMAb-VEGF|rhumab-vegf
5012205|NCT01582139|Artificial Pancreas Project|artificial pancreas project
5012206|NCT01582139|AP Platform|ap platform
5012207|NCT01582139|Insulin Pump|insulin pump
5012208|NCT01582139|Continuous Glucose Monitor|continuous glucose monitor
5012209|NCT01582139|Closed-Loop Control|closed-loop control
5012210|NCT01582139|Control-to-Range|control-to-range
5012211|NCT01582126|multiple sclerosis|multiple sclerosis
5012212|NCT01582126|physical therapy|physical therapy
5012213|NCT01582126|postural control|postural control
5012214|NCT01582087|acute hepatic failure|acute hepatic failure
5012215|NCT01582087|chronic hepatic failure|chronic hepatic failure
5012216|NCT01582087|coma|coma
5012217|NCT01582074|Ultrasound Tomography|ultrasound tomography
5012219|NCT01582074|Breast Cancer|breast cancer
5012220|NCT01582074|Estrogen Receptor Positive|estrogen receptor positive
5012221|NCT01582074|Breast Density|breast density
5012222|NCT01582061|Cushing's disease|cushing's disease
5012223|NCT01582061|Hormone disorder|hormone disorder
5012224|NCT01582061|Cortisol|cortisol
5012225|NCT01582061|Adrenocorticotropic hormone|adrenocorticotropic hormone
5012226|NCT01582061|Pituitary tumor|pituitary tumor
5012227|NCT01582061|SOM230|som230
5012228|NCT01582061|adult|adult
5012229|NCT01582035|Hepatitis C|hepatitis c
5012230|NCT01582035|TMC647055HPC1005|tmc647055hpc1005
5012231|NCT01582035|TMC647055|tmc647055
5012232|NCT01582035|telaprevir|telaprevir
5012233|NCT01581996|Chronic renal failure|chronic renal failure
5012234|NCT01581996|End-stage renal disease|end-stage renal disease
5012235|NCT01581996|Chronic peritoneal dialysis|chronic peritoneal dialysis
5012236|NCT01581996|Serum phosphorus|serum phosphorus
5012237|NCT01581996|Hyperphosphatemia|hyperphosphatemia
5012238|NCT01581996|Phosphate binders|phosphate binders
5012239|NCT01581996|Phosphate|phosphate
5012240|NCT01581970|head and neck cancer|head and neck cancer
5012241|NCT01581970|metastatic squamous cell cancer|metastatic squamous cell cancer
5012242|NCT01581957|Enteral nutrition, critically ill patients|enteral nutrition, critically ill patients
5012243|NCT01581944|myomectomy|myomectomy
5012244|NCT01581944|GnRH|gnrh
5012245|NCT01581944|blood loss|blood loss
5012246|NCT01581905|Hysterectomy|hysterectomy
5012247|NCT01581905|Laparoscopy|laparoscopy
5012248|NCT01581905|Robotics|robotics
5012249|NCT01581892|bone nonunion|bone nonunion
5012250|NCT01581892|bone marrow|bone marrow
5012251|NCT01581892|mononuclear|mononuclear
5012252|NCT01581892|fracture|fracture
5012253|NCT01581879|Bioequivalence|bioequivalence
5012254|NCT01581879|Ziprasidone hydrochloride|ziprasidone hydrochloride
5012255|NCT01581879|crossover|crossover
5012256|NCT01581866|Bioequivalence|bioequivalence
5012257|NCT01581866|Ziprasidone hydrochloride|ziprasidone hydrochloride
5012258|NCT01581866|crossover|crossover
5012259|NCT01581853|HIV|hiv
5012260|NCT01581853|AIDS|aids
5012261|NCT01581853|MONOTHERAPY|monotherapy
5012262|NCT01581853|PILOT|pilot
5012263|NCT01581853|LOPINAVIR/RITONAVIR|lopinavir/ritonavir
5012264|NCT01581840|anus|anus
5012265|NCT01581840|carcinoma|carcinoma
5012266|NCT01581840|panitumumab|panitumumab
5012267|NCT01581840|mitomycine|mitomycine
5012268|NCT01581840|5Fu|5fu
5012269|NCT01581840|radiotherapy|radiotherapy
5012270|NCT01581827|Heart Failure|heart failure
5012271|NCT01581827|BNP|bnp
5012272|NCT01581827|NT-proBNP|nt-probnp
5012273|NCT01581814|PCOS|pcos
5012274|NCT01581801|gastric bypass|gastric bypass
5012275|NCT01581801|sleeve gastrectomy|sleeve gastrectomy
5012276|NCT01581801|reactive hypoglycemia|reactive hypoglycemia
5012277|NCT01581788|Bioequivalence|bioequivalence
5012278|NCT01581788|Divalproex Sodium|divalproex sodium
5012279|NCT01581788|Crossover|crossover
5012280|NCT01581775|Bioequivalence|bioequivalence
5012281|NCT01581775|Divalproex Sodium|divalproex sodium
5012282|NCT01581775|Crossover|crossover
5012283|NCT01581762|EUS, FNA|eus, fna
5012284|NCT01581749|low risk prostate cancer|low risk prostate cancer
5012285|NCT01581749|intermediate risk prostate cancer|intermediate risk prostate cancer
5012286|NCT01581749|stereotactic radiosurgery|stereotactic radiosurgery
5012287|NCT01581736|insulin resistance|insulin resistance
5012288|NCT01581736|mitochondria|mitochondria
5012289|NCT01581723|urinary bladder tumor|urinary bladder tumor
5012290|NCT01581723|monopolar TURBT|monopolar turbt
5012291|NCT01581723|bipolar TURBT|bipolar turbt
5012292|NCT01581710|Leukotriene Antagonists|leukotriene antagonists
5012293|NCT01581710|Bronchodilator response|bronchodilator response
5012294|NCT01581697|oat|oat
5012295|NCT01581697|cholesterol|cholesterol
5012296|NCT01581697|children|children
5012297|NCT01581697|adolescent|adolescent
5012298|NCT01581697|Level reduction of ceric cholesterol|level reduction of ceric cholesterol
5012299|NCT01581645|Parkinson's disease|parkinson's disease
5012300|NCT01581645|Parkinsonism|parkinsonism
5012301|NCT01581645|Gait problems|gait problems
5012302|NCT01581645|Freezing gait|freezing gait
5012303|NCT01581632|atherosclerosis|atherosclerosis
5012304|NCT01581632|endothelial dysfunction|endothelial dysfunction
5012305|NCT01581632|coronary vasospasm|coronary vasospasm
5012306|NCT01581619|Early Invasive N0|early invasive n0
5012307|NCT01581619|Non-Invasive|non-invasive
5012308|NCT01581606|Age Related Macular Degeneration|age related macular degeneration
5012309|NCT01581606|Teleophthalmology|teleophthalmology
5012310|NCT01581606|Screening|screening
5012311|NCT01581606|Diagnosis|diagnosis
5012312|NCT01581606|Timing|timing
5012313|NCT01581606|Treatment|treatment
5012314|NCT01581593|Primary Immunodeficiency|primary immunodeficiency
5012315|NCT01581593|PID|pid
5012316|NCT01581593|Agammaglobulinemia|agammaglobulinemia
5012317|NCT01581593|Hypogammaglobulinemia|hypogammaglobulinemia
5012318|NCT01581593|Antibody deficiency|antibody deficiency
5012319|NCT01581580|Parkinson's Disease|parkinson's disease
5012320|NCT01581580|Deep Brain Stimulation|deep brain stimulation
5012321|NCT01581580|Neurophysiology|neurophysiology
5012322|NCT01581580|Movement Disorder|movement disorder
5012323|NCT01581580|Essential Tremor|essential tremor
5012324|NCT01581580|Parkinson Disease|parkinson disease
5012325|NCT01581567|Storage|storage
5012326|NCT01581567|Repository|repository
5012327|NCT01581567|Samples|samples
5012328|NCT01581567|Data|data
5012329|NCT01581554|Hepatitis B|hepatitis b
5012330|NCT01581554|Treatment|treatment
5012331|NCT01581554|Nucleoside/Nucleotide Analogue|nucleoside/nucleotide analogue
5012332|NCT01581541|Targeted Therapy|targeted therapy
5012333|NCT01581541|Solid Tumors|solid tumors
5012334|NCT01581541|Lymphoma|lymphoma
5012335|NCT01581541|Non-Hodgkin Lymphoma|non-hodgkin lymphoma
5012336|NCT01581541|Solid Tumor|solid tumor
5012337|NCT01581528|T-cell childhood acute lymphoblastic leukemia|t-cell childhood acute lymphoblastic leukemia
5012338|NCT01581528|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
5012339|NCT01581528|T-cell adult acute lymphoblastic leukemia|t-cell adult acute lymphoblastic leukemia
5012340|NCT01581528|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
5012341|NCT01581502|Anticoagulation|anticoagulation
5012342|NCT01581502|Recurrent stroke|recurrent stroke
5012343|NCT01581502|Bleeding|bleeding
5012344|NCT01581489|Cord clamping|cord clamping
5012345|NCT01581489|iron deficiency|iron deficiency
5012346|NCT01581489|Neurodevelopment|neurodevelopment
5012347|NCT01581476|Adolescence|adolescence
5012348|NCT01581463|pharmacokinetics of oral T3|pharmacokinetics of oral t3
5012349|NCT01581450|Hyperalgesia and pain|hyperalgesia and pain
5012350|NCT01581437|atrial fibrillation|atrial fibrillation
5012351|NCT01581437|cardiac ablation|cardiac ablation
5012352|NCT01581424|Fabry disease|fabry disease
5012353|NCT01581424|kidney function|kidney function
5012354|NCT01581424|kidney structure morphometry|kidney structure morphometry
5012355|NCT01581424|Fabry kidney disease|fabry kidney disease
5012356|NCT01581424|Podocytes|podocytes
5012357|NCT01581411|central retinal vein occlusion|central retinal vein occlusion
5012358|NCT01581411|macular edema|macular edema
5012359|NCT01581411|vision loss|vision loss
5012360|NCT01581411|relative afferent papillary defect|relative afferent papillary defect
5012361|NCT01581398|Peginterferon|peginterferon
5012362|NCT01581398|Pegasys|pegasys
5012363|NCT01581398|Sustained virus response|sustained virus response
5012364|NCT01581398|HCV|hcv
5012365|NCT01581385|atherosclerosis|atherosclerosis
5012366|NCT01581385|carotid artery|carotid artery
5012367|NCT01581385|carotid endarterectomy|carotid endarterectomy
5012368|NCT01581359|Endometriosis|endometriosis
5012369|NCT01581359|GnRH treatment|gnrh treatment
5012370|NCT01581359|Infertility|infertility
5012371|NCT01581359|IVF|ivf
5012372|NCT01581346|NSCLC|nsclc
5012373|NCT01581346|exercise intervention|exercise intervention
5012374|NCT01581346|quality of life|quality of life
5012375|NCT01581333|febrile neutropenia|febrile neutropenia
5012376|NCT01581333|antimicrobial treatment|antimicrobial treatment
5012377|NCT01581333|procalcitonin|procalcitonin
5012378|NCT01581307|liver|liver
5012379|NCT01581307|pancreas|pancreas
5012380|NCT01581307|chemotherapy|chemotherapy
5012381|NCT01581307|radiotherapy|radiotherapy
5012382|NCT01581294|Rheumatoid arthritis|rheumatoid arthritis
5012383|NCT01581294|Psoriatic arthritis|psoriatic arthritis
5012384|NCT01581294|Ankylosing spondylitis|ankylosing spondylitis
5012385|NCT01581294|Spondyloarthritis|spondyloarthritis
5012386|NCT01581281|Pediatric|pediatric
5012387|NCT01581281|Children|children
5012388|NCT01581281|Adolescent|adolescent
5012389|NCT01581281|Headache|headache
5012390|NCT01581281|Migraine|migraine
5012391|NCT01581255|acute respiratory distress syndrome|acute respiratory distress syndrome
5012392|NCT01581255|high frequency oscillation ventilation|high frequency oscillation ventilation
5012393|NCT01581255|ventilator-induced lung injury|ventilator-induced lung injury
5012394|NCT01581255|biomarkers|biomarkers
5012395|NCT01581242|Clevudine and Adefovir dipivoxil|clevudine and adefovir dipivoxil
5012396|NCT01581242|pharmacokinetic drug drug interaction|pharmacokinetic drug drug interaction
5012397|NCT01581242|oral administration|oral administration
5012398|NCT01581242|male subjects|male subjects
5012399|NCT01581229|ALI;noninvasive positive pressure ventilation|ali;noninvasive positive pressure ventilation
5012400|NCT01581216|Fatigue|fatigue
5012401|NCT01581216|Palliative Care|palliative care
5012402|NCT01581216|Exercise|exercise
5012403|NCT01581190|Bananas|bananas
5012404|NCT01581190|Exercise|exercise
5012405|NCT01581190|Metabolomics|metabolomics
5012406|NCT01581190|Oxidative stress|oxidative stress
5012407|NCT01581190|Inflammation|inflammation
5012408|NCT01581190|Immune function|immune function
5012409|NCT01581177|asthma|asthma
5012410|NCT01581177|mild-to-moderate persistent asthma|mild-to-moderate persistent asthma
5012411|NCT01581177|mild asthma|mild asthma
5012412|NCT01581177|moderate asthma|moderate asthma
5012413|NCT01581177|persistent asthma|persistent asthma
5012414|NCT01581164|blood|blood
5012415|NCT01581164|hematopoietic|hematopoietic
5012416|NCT01581164|stem|stem
5012417|NCT01581164|cell|cell
5012418|NCT01581164|transplant|transplant
5012419|NCT01581164|vaccine|vaccine
5012420|NCT01581164|vaccination|vaccination
5012421|NCT01581164|recovery|recovery
5012422|NCT01581164|immune|immune
5012424|NCT01581151|retinal vein occlusion|retinal vein occlusion
5012425|NCT01581151|ozurdex|ozurdex
5012426|NCT01581151|lucentis|lucentis
5012427|NCT01581151|BCVA|bcva
5012428|NCT01581151|foveal thickness|foveal thickness
5012429|NCT01581125|Inpatients|inpatients
5012430|NCT01581125|Health Normalcy|health normalcy
5012431|NCT01581125|circadian rhythm|circadian rhythm
5012432|NCT01581099|Atherosclerosis|atherosclerosis
5012433|NCT01581099|Cardiovascular risk factors|cardiovascular risk factors
5012434|NCT01581099|Calorie restriction|calorie restriction
5012435|NCT01581099|Bariatric Surgery|bariatric surgery
5012436|NCT01581086|HIV|hiv
5012437|NCT01581086|COPD|copd
5012438|NCT01581086|Pulmonary disease|pulmonary disease
5012439|NCT01581073|renal anemia|renal anemia
5012440|NCT01581073|erythropoiesis stimulating agent|erythropoiesis stimulating agent
5012441|NCT01581073|hemoglobin|hemoglobin
5012442|NCT01581073|non-diabetes|non-diabetes
5012443|NCT01581073|CKD|ckd
5012444|NCT01581073|Chronic Kidney Disease patients without diabetes|chronic kidney disease patients without diabetes
5012445|NCT01581047|amoxicillin|amoxicillin
5012446|NCT01581047|clavulanic acid|clavulanic acid
5012447|NCT01581047|cefuroxime|cefuroxime
5012448|NCT01581047|Patients in the intensive care unit, with an infection which requires amoxicillin/clavulanic acid or cefuroxime|patients in the intensive care unit, with an infection which requires amoxicillin/clavulanic acid or cefuroxime
5012449|NCT01581034|endothelial function|endothelial function
5012450|NCT01581034|biomarkers|biomarkers
5012451|NCT01581034|autonomic nervous system|autonomic nervous system
5012452|NCT01581034|coronary artery disease|coronary artery disease
5012453|NCT01581021|randomized|randomized
5012454|NCT01581021|controlled|controlled
5012455|NCT01581021|hooks|hooks
5012456|NCT01581021|screws|screws
5012457|NCT01581008|palliative care|palliative care
5012458|NCT01581008|heart failure|heart failure
5012459|NCT01581008|delivery of health care|delivery of health care
5012460|NCT01580995|Chronic hepatitis C infection|chronic hepatitis c infection
5012461|NCT01580982|Oncogenes|oncogenes
5012462|NCT01580982|Lung and Other Thoracic Cancers|lung and other thoracic cancers
5012463|NCT01580969|glioma|glioma
5012464|NCT01580956|Acute respiratory failure|acute respiratory failure
5012465|NCT01580956|Critical illness|critical illness
5012466|NCT01580956|Mechanical ventilation|mechanical ventilation
5012467|NCT01580956|Ventilation weaning|ventilation weaning
5012468|NCT01580956|Intensive Care Unit|intensive care unit
5012469|NCT01580956|Variable (NOISY) PSV|variable (noisy) psv
5012470|NCT01580956|PSV|psv
5012471|NCT01580943|Chlorhexidine|chlorhexidine
5012472|NCT01580943|Cetyl pyridinium chloride|cetyl pyridinium chloride
5012473|NCT01580943|Mouth rinse|mouth rinse
5012474|NCT01580943|Antiplaque Efficacy|antiplaque efficacy
5012475|NCT01580943|Self Efficacy|self efficacy
5012476|NCT01580943|Taste Sweet|taste sweet
5012477|NCT01580943|Side Effects|side effects
5012478|NCT01580930|physical inactivity|physical inactivity
5012479|NCT01580930|exercise training|exercise training
5012480|NCT01580930|sedentary time|sedentary time
5012481|NCT01580930|habitual physical activity|habitual physical activity
5012482|NCT01580917|laser doppler anemometry|laser doppler anemometry
5012483|NCT01580917|dynamic testing of tissue mechanical property|dynamic testing of tissue mechanical property
5012484|NCT01580917|diabetic foot complications|diabetic foot complications
5012485|NCT01580917|ulcer genesis|ulcer genesis
5012486|NCT01580904|Pharmaceutical Care|pharmaceutical care
5012487|NCT01580904|Diabetics patients|diabetics patients
5012488|NCT01580904|Clinical trial|clinical trial
5012489|NCT01580891|Naftifine HCl Cream 1%|naftifine hcl cream 1%
5012490|NCT01580891|Naftin® (Naftifine HCl) Cream 1%|naftin® (naftifine hcl) cream 1%
5012491|NCT01580891|Tinea Pedis|tinea pedis
5012492|NCT01580891|Efficacy and safety|efficacy and safety
5012493|NCT01580878|Butenafine Hydrochloride Cream, 1%|butenafine hydrochloride cream, 1%
5012494|NCT01580878|Lotrimin Ultra® Cream, 1%|lotrimin ultra® cream, 1%
5012495|NCT01580878|Interdigital Tinea Pedis|interdigital tinea pedis
5012496|NCT01580878|Safety and Bioequivalence|safety and bioequivalence
5012497|NCT01580865|Lupus nephritis|lupus nephritis
5012498|NCT01580865|Tacrolimus|tacrolimus
5012499|NCT01580865|Mycophenolate mofetil|mycophenolate mofetil
5012500|NCT01580865|Complete remission|complete remission
5012501|NCT01580839|ischemic stroke|ischemic stroke
5012502|NCT01580839|ischemic penumbra|ischemic penumbra
5012503|NCT01580839|magnetic resonance imaging|magnetic resonance imaging
5012504|NCT01580839|MRI|mri
5012505|NCT01580839|diffusion imaging|diffusion imaging
5012506|NCT01580839|DWI|dwi
5012507|NCT01580839|perfusion imaging|perfusion imaging
5012508|NCT01580839|PWI|pwi
5012509|NCT01580839|thrombolysis|thrombolysis
5012510|NCT01580839|alteplase|alteplase
5012511|NCT01580839|tPA|tpa
5012512|NCT01580839|EPITHET|epithet
5012513|NCT01580826|pasteurization|pasteurization
5012514|NCT01580826|human milk|human milk
5012515|NCT01580826|very low birth weight infants|very low birth weight infants
5012516|NCT01580813|diabetes|diabetes
5012517|NCT01580813|exercise|exercise
5012518|NCT01580813|cardiovascular|cardiovascular
5012519|NCT01580813|heart|heart
5012520|NCT01580813|insulin sensitivity|insulin sensitivity
5012521|NCT01580787|Parkinson´s disease|parkinson´s disease
5012522|NCT01580787|Postural Balance|postural balance
5012523|NCT01580787|virtual reality|virtual reality
5012524|NCT01580735|NSCLC|nsclc
5012525|NCT01580735|c-MET|c-met
5012526|NCT01580735|EGFR mutation-positive|egfr mutation-positive
5012527|NCT01580735|gefitinib|gefitinib
5012528|NCT01580735|erlotinib|erlotinib
5012529|NCT01580735|EGFR-TKI resistance|egfr-tki resistance
5012530|NCT01580722|Anterior Cruciate Ligament,Early,Delay,Reconstruction|anterior cruciate ligament,early,delay,reconstruction
5012531|NCT01580709|stricture|stricture
5012532|NCT01580709|cholangiocarcinoma|cholangiocarcinoma
5012661|NCT01580189|Strength condition|strength condition
5012533|NCT01580709|pancreatic adenocarcinoma|pancreatic adenocarcinoma
5012534|NCT01580709|bile duct|bile duct
5012535|NCT01580709|ERCP|ercp
5012536|NCT01580696|Folate binding protein|folate binding protein
5012537|NCT01580696|E39 vaccine|e39 vaccine
5012538|NCT01580696|Stage I-IV ovarian cancer|stage i-iv ovarian cancer
5012539|NCT01580696|Stage I-IV endometrial cancer|stage i-iv endometrial cancer
5012540|NCT01580683|Atrial Fibrillation|atrial fibrillation
5012541|NCT01580683|Ascorbic Acid|ascorbic acid
5012542|NCT01580683|Thoracic Surgery|thoracic surgery
5012543|NCT01580683|Cardiac Arrhythmias|cardiac arrhythmias
5012544|NCT01580683|Cardiac Surgery|cardiac surgery
5012545|NCT01580683|Vitamin C|vitamin c
5012546|NCT01580683|Postoperative Complications|postoperative complications
5012547|NCT01580683|Antioxidants|antioxidants
5012548|NCT01580683|Inflammation|inflammation
5012549|NCT01580670|Infliximab|infliximab
5012550|NCT01580670|REMICADE|remicade
5012551|NCT01580670|TA-650|ta-650
5012552|NCT01580670|pediatric Crohn's disease|pediatric crohn's disease
5012553|NCT01580657|HIV|hiv
5012554|NCT01580657|Prevention|prevention
5012555|NCT01580657|Methods|methods
5012556|NCT01580657|Assessment reactivity|assessment reactivity
5012557|NCT01580657|South Africa|south africa
5012558|NCT01580657|Youth|youth
5012559|NCT01580631|Narrow band imaging|narrow band imaging
5012560|NCT01580631|Barrett's esophagus|barrett's esophagus
5012561|NCT01580631|Gastroesophageal reflux disease|gastroesophageal reflux disease
5012562|NCT01580618|pleural effusion|pleural effusion
5012563|NCT01580618|malignancy|malignancy
5012564|NCT01580618|loculated|loculated
5012565|NCT01580579|Radiation pneumonitis|radiation pneumonitis
5012566|NCT01580579|locally advanced lung cancer|locally advanced lung cancer
5012567|NCT01580579|Respiratory function tests|respiratory function tests
5012568|NCT01580566|Myocardial Infarction (MI)|myocardial infarction (mi)
5012569|NCT01580566|Kidney function|kidney function
5012570|NCT01580566|bio-markers|bio-markers
5012571|NCT01580553|Heart failure|heart failure
5012572|NCT01580553|L-carnitine|l-carnitine
5012573|NCT01580553|injection|injection
5012574|NCT01580553|safety|safety
5012575|NCT01580553|efficacy|efficacy
5012576|NCT01580527|postoperative artificial nutrition|postoperative artificial nutrition
5012577|NCT01580527|parenteral nutrition|parenteral nutrition
5012578|NCT01580527|enteral nutrition|enteral nutrition
5012579|NCT01580527|postoperative complications|postoperative complications
5012580|NCT01580527|cephalic pancreatoduodenectomy|cephalic pancreatoduodenectomy
5012581|NCT01580514|myocardial infarction|myocardial infarction
5012582|NCT01580514|percutaneous coronary intervention|percutaneous coronary intervention
5012583|NCT01580514|exenatide|exenatide
5012584|NCT01580514|reperfusion injury|reperfusion injury
5012585|NCT01580514|cardiac magnetic resonance|cardiac magnetic resonance
5012586|NCT01580475|glycemic control,|glycemic control,
5012587|NCT01580475|exercise training,|exercise training,
5012588|NCT01580475|detraining,|detraining,
5012589|NCT01580475|retraining,|retraining,
5012590|NCT01580475|body composition,|body composition,
5012591|NCT01580475|strength and fitness|strength and fitness
5012592|NCT01580462|continuous subcutaneous insulin infusion (CSII)|continuous subcutaneous insulin infusion (csii)
5012593|NCT01580462|children|children
5012594|NCT01580462|adolescent|adolescent
5012595|NCT01580436|Tricuspid Valve Insufficiency|tricuspid valve insufficiency
5012596|NCT01580436|Cardiac Valve Annuloplasty|cardiac valve annuloplasty
5012597|NCT01580436|Outcome Assessment (Health Care)|outcome assessment (health care)
5012598|NCT01580423|dyspnea|dyspnea
5012599|NCT01580397|Pancreatic cancer|pancreatic cancer
5012600|NCT01580397|INNO-206|inno-206
5012601|NCT01580397|Doxorubicin-EMCH|doxorubicin-emch
5012602|NCT01580358|cancer|cancer
5012603|NCT01580358|radiotherapy|radiotherapy
5012604|NCT01580358|chemotherapy|chemotherapy
5012605|NCT01580358|Traditional Chinese Medicine|traditional chinese medicine
5012606|NCT01580358|Safety|safety
5012607|NCT01580345|DHA|dha
5012608|NCT01580345|Omega 3 fatty acid|omega 3 fatty acid
5012609|NCT01580345|Decosa hexaenoic acid|decosa hexaenoic acid
5012610|NCT01580345|Pregnancy|pregnancy
5012611|NCT01580345|Newborn outcome|newborn outcome
5012612|NCT01580345|Supplementation|supplementation
5012613|NCT01580345|Birth size|birth size
5012614|NCT01580345|gestational age|gestational age
5012615|NCT01580345|India|india
5012616|NCT01580345|Randomized controlled trial|randomized controlled trial
5012617|NCT01580345|RCT|rct
5012618|NCT01580332|biomarkers|biomarkers
5012619|NCT01580332|lung cancer|lung cancer
5012620|NCT01580332|solitary pulmonary nodules|solitary pulmonary nodules
5012621|NCT01580332|SPN|spn
5012622|NCT01580332|breath analysis|breath analysis
5012623|NCT01580332|VOC|voc
5012624|NCT01580332|volatile organic compounds|volatile organic compounds
5012625|NCT01580332|sputum|sputum
5012626|NCT01580332|auto-antibodies|auto-antibodies
5012627|NCT01580319|obesity|obesity
5012628|NCT01580319|cholesterol|cholesterol
5012629|NCT01580319|cholesterol, LDL|cholesterol, ldl
5012630|NCT01580319|cholesterol, HDL|cholesterol, hdl
5012631|NCT01580319|blood glucose|blood glucose
5012632|NCT01580319|Triglyceride|triglyceride
5012633|NCT01580319|C-Reactive Protein - hs|c-reactive protein - hs
5012634|NCT01580319|blood pressure|blood pressure
5012635|NCT01580319|physical activity|physical activity
5012636|NCT01580319|Sedentary Lifestyle|sedentary lifestyle
5012637|NCT01580293|Hemophilia A, factor VIII, prophylaxis|hemophilia a, factor viii, prophylaxis
5012638|NCT01580280|Cervicogenic|cervicogenic
5012639|NCT01580280|Headache|headache
5012640|NCT01580280|Neck Pain|neck pain
5012641|NCT01580280|Manipulation|manipulation
5012642|NCT01580280|Mobilization|mobilization
5012643|NCT01580280|Exercise|exercise
5012644|NCT01580267|Anemia in trauma|anemia in trauma
5012645|NCT01580254|Latanoprost|latanoprost
5012646|NCT01580254|IOP|iop
5012647|NCT01580215|Valves|valves
5012648|NCT01580215|Endobronchial|endobronchial
5012649|NCT01580215|Endoscopic lung volume reduction|endoscopic lung volume reduction
5012650|NCT01580215|Pulmonx|pulmonx
5012651|NCT01580215|Zephyr|zephyr
5012652|NCT01580215|Chartis|chartis
5012653|NCT01580215|Emphysema|emphysema
5012654|NCT01580215|COPD|copd
5012655|NCT01580202|malignancy|malignancy
5012656|NCT01580202|hepatitis B|hepatitis b
5012657|NCT01580202|lamivudine|lamivudine
5012658|NCT01580202|entecavir|entecavir
5012659|NCT01580202|prophylaxis|prophylaxis
5012660|NCT01580189|Lean tissue|lean tissue
5012662|NCT01580189|Protein|protein
5012663|NCT01580189|Amino Acid|amino acid
5012664|NCT01580163|the opioid dependence in rehabilitation phase|the opioid dependence in rehabilitation phase
5012665|NCT01580163|community|community
5012666|NCT01580150|Berries|berries
5012667|NCT01580150|Starch|starch
5012668|NCT01580150|Sucrose|sucrose
5012669|NCT01580150|Glucose|glucose
5012670|NCT01580150|Insulin|insulin
5012671|NCT01580150|Postprandial|postprandial
5012672|NCT01580137|acute respiratory tract infection|acute respiratory tract infection
5012673|NCT01580137|common cold|common cold
5012674|NCT01580137|acute bacterial rhinosinusitis|acute bacterial rhinosinusitis
5012675|NCT01580137|adult|adult
5012676|NCT01580137|conscript|conscript
5012677|NCT01580111|Blood|blood
5012678|NCT01580111|Storage|storage
5012679|NCT01580111|Age|age
5012680|NCT01580111|Transfusion|transfusion
5012681|NCT01580111|Lactic acidosis|lactic acidosis
5012682|NCT01580085|Sleep disordered breathing|sleep disordered breathing
5012683|NCT01580085|gender|gender
5012684|NCT01580085|hypercoagulability|hypercoagulability
5012685|NCT01580046|Chronic Kidney Disease|chronic kidney disease
5012686|NCT01580046|Coronary Angiography|coronary angiography
5012687|NCT01580046|Contrast Media|contrast media
5012688|NCT01580046|Percutaneous Coronary Intervention|percutaneous coronary intervention
5012689|NCT01580046|Serum Creatinine|serum creatinine
5012690|NCT01580046|Glomerular Filtration Rate|glomerular filtration rate
5012691|NCT01580046|Iodixanol|iodixanol
5012692|NCT01580046|Iopromide|iopromide
5012693|NCT01580033|immunogenicity|immunogenicity
5012694|NCT01580033|safety|safety
5012695|NCT01580033|group A, C polysaccharide meningitis|group a, c polysaccharide meningitis
5012696|NCT01580033|type b haemophilus Influenza|type b haemophilus influenza
5012697|NCT01580020|Macular Degeneration|macular degeneration
5012698|NCT01580020|Macular Edema|macular edema
5012699|NCT01580020|Retinal Vein Occlusion|retinal vein occlusion
5012700|NCT01580020|Choroidal Neovascularization|choroidal neovascularization
5012701|NCT01580020|Signs and Symptoms|signs and symptoms
5012702|NCT01580020|Retinal Degeneration|retinal degeneration
5012703|NCT01580020|Retinal Diseases|retinal diseases
5012704|NCT01580020|Eye Diseases|eye diseases
5012705|NCT01580020|Venous Thrombosis Sensation Disorders|venous thrombosis sensation disorders
5012706|NCT01580020|Dexamethasone acetate|dexamethasone acetate
5012707|NCT01580020|Dexamethasone|dexamethasone
5012708|NCT01580020|Dexamethasone 21-phosphate|dexamethasone 21-phosphate
5012709|NCT01580020|BB 1101|bb 1101
5012710|NCT01580020|Anti-Inflammatory Agents|anti-inflammatory agents
5012711|NCT01580020|Therapeutic Uses|therapeutic uses
5012712|NCT01580020|Vision, Low|vision, low
5012713|NCT01580020|Signs|signs
5012714|NCT01580020|Vision Disorders|vision disorders
5012715|NCT01580007|tuberculosis|tuberculosis
5012716|NCT01580007|phenylbutyrate|phenylbutyrate
5012717|NCT01580007|vitamin D|vitamin d
5012718|NCT01580007|cathelicidin|cathelicidin
5012719|NCT01580007|antimicrobial peptide|antimicrobial peptide
5012720|NCT01580007|in adults|in adults
5012721|NCT01579994|adenocarcinoma|adenocarcinoma
5012722|NCT01579994|Lung|lung
5012723|NCT01579994|Metastatic|metastatic
5012724|NCT01579994|Crizotinib|crizotinib
5012725|NCT01579994|Ganetespib|ganetespib
5012726|NCT01579994|STA-9090|sta-9090
5012922|NCT01579110|Levamisole|levamisole
5012727|NCT01579994|ALK Positive Lung Cancers|alk positive lung cancers
5012728|NCT01579994|12-015|12-015
5012729|NCT01579981|RYGB|rygb
5012730|NCT01579981|Bariatric Surgery|bariatric surgery
5012731|NCT01579981|Glucagon-like-peptide 1|glucagon-like-peptide 1
5012732|NCT01579942|EEG|eeg
5012733|NCT01579942|Biomarker|biomarker
5012734|NCT01579942|Major Depressive Disorder|major depressive disorder
5012735|NCT01579942|Healthy Control|healthy control
5012736|NCT01579929|Extensive Stage Small Cell Lung Cancer (ES-SCLC)|extensive stage small cell lung cancer (es-sclc)
5012737|NCT01579929|CISPLATIN|cisplatin
5012738|NCT01579929|ETOPOSIDE (VP-16)|etoposide (vp-16)
5012739|NCT01579929|LDE-225|lde-225
5012740|NCT01579929|STAR|star
5012741|NCT01579929|Symptom Tracking and Reporting for Patients|symptom tracking and reporting for patients
5012742|NCT01579929|11-206|11-206
5012743|NCT01579916|Trivalent, Influenza, FluMist, Vaccine, Prevention|trivalent, influenza, flumist, vaccine, prevention
5012744|NCT01579903|Hemophilia A|hemophilia a
5012745|NCT01579903|moroctocog alfa (AF-CC)|moroctocog alfa (af-cc)
5012746|NCT01579903|ReFacto AF|refacto af
5012747|NCT01579903|dual-chamber syringe|dual-chamber syringe
5012748|NCT01579903|bioavailability|bioavailability
5012749|NCT01579877|Xerostomia|xerostomia
5012750|NCT01579877|Yukmijihwang-tang|yukmijihwang-tang
5012751|NCT01579877|Yin-Deficiency|yin-deficiency
5012752|NCT01579877|Visual analogue scale|visual analogue scale
5012753|NCT01579877|Dry mouth symptom questionnaire|dry mouth symptom questionnaire
5012754|NCT01579812|Ovarian, Fallopian Tube, and Primary Peritoneal Cancer|ovarian, fallopian tube, and primary peritoneal cancer
5012755|NCT01579786|post operative pain|post operative pain
5012756|NCT01579786|acupuncture|acupuncture
5012757|NCT01579760|radiation|radiation
5012758|NCT01579760|retinopathy|retinopathy
5012759|NCT01579760|macular edema|macular edema
5012760|NCT01579760|anti-VEGF|anti-vegf
5012761|NCT01579760|VEGF-Trap|vegf-trap
5012762|NCT01579760|aflibercept|aflibercept
5012763|NCT01579747|nerve stimulation|nerve stimulation
5012764|NCT01579747|ultrasound|ultrasound
5012765|NCT01579747|sciatic nerve block|sciatic nerve block
5012766|NCT01579747|popliteal block|popliteal block
5012767|NCT01579747|obese|obese
5012768|NCT01579734|breast cancer chemoprevention postmenopause|breast cancer chemoprevention postmenopause
5012769|NCT01579708|Diet|diet
5012770|NCT01579708|Physical activity|physical activity
5012771|NCT01579708|Knowledge|knowledge
5012772|NCT01579708|Attitudes|attitudes
5012773|NCT01579708|Habits|habits
5012774|NCT01579708|Lifestyle|lifestyle
5012775|NCT01579708|School-based|school-based
5012776|NCT01579695|HIV with lipohypertrophy|hiv with lipohypertrophy
5012777|NCT01579682|Eating Disorder|eating disorder
5012778|NCT01579682|Anorexia Nervosa|anorexia nervosa
5012779|NCT01579682|Eating Disorder Not Otherwise Specified|eating disorder not otherwise specified
5012780|NCT01579682|Maudsley|maudsley
5012781|NCT01579682|Family-Based Therapy|family-based therapy
5012782|NCT01579682|FBT|fbt
5012783|NCT01579682|Family Therapy|family therapy
5012784|NCT01579669|Autism Spectrum Disorder|autism spectrum disorder
5012785|NCT01579669|Primary Care Services|primary care services
5012786|NCT01579669|Patient-Provider Communication|patient-provider communication
5012787|NCT01579669|Adults|adults
5012788|NCT01579643|cornea|cornea
5012789|NCT01579643|opacity|opacity
5012790|NCT01579643|congenital|congenital
5012791|NCT01579630|NSCLC|nsclc
5012792|NCT01579630|Nonsquamous|nonsquamous
5012793|NCT01579630|Maintenance therapy|maintenance therapy
5012794|NCT01579617|pregnancy|pregnancy
5012796|NCT01579617|STD|std
5012797|NCT01579604|Loss of upper extremities functions|loss of upper extremities functions
5012798|NCT01579604|Nerve transfer|nerve transfer
5012799|NCT01579578|Metastatic Gastric Cancer who progress following First Line Therapy and are Ineligible for Treatment with trastuzumab by HER2 Status|metastatic gastric cancer who progress following first line therapy and are ineligible for treatment with trastuzumab by her2 status
5012800|NCT01579565|cataract|cataract
5012801|NCT01579565|lens replacement|lens replacement
5012802|NCT01579552|Questionnaires|questionnaires
5012803|NCT01579552|telephone counseling session|telephone counseling session
5012804|NCT01579552|10-104|10-104
5012805|NCT01579552|Childhood Cancer Survivor Women Post Chest Radiation|childhood cancer survivor women post chest radiation
5012806|NCT01579539|Methylprednisolone|methylprednisolone
5012807|NCT01579539|Dry Eye Syndrome|dry eye syndrome
5012808|NCT01579539|Tear Film|tear film
5012809|NCT01579539|Thyroid-associated ophthalmopathy|thyroid-associated ophthalmopathy
5012810|NCT01579526|Safety and Pharmacokinetics of FP01 in Healthy Volunteers|safety and pharmacokinetics of fp01 in healthy volunteers
5012811|NCT01579513|Cardiopulmonary Bypass (CPB)|cardiopulmonary bypass (cpb)
5012812|NCT01579513|System Inflammatory Response|system inflammatory response
5012813|NCT01579513|inflammation|inflammation
5012814|NCT01579513|Methylprednisolone|methylprednisolone
5012815|NCT01579513|Neonates|neonates
5012816|NCT01579513|Steroid|steroid
5012817|NCT01579513|Cardiac Surgical Procedures|cardiac surgical procedures
5012818|NCT01579513|Children|children
5012819|NCT01579513|Infants|infants
5012820|NCT01579513|Pediatrics|pediatrics
5012821|NCT01579513|Glucocorticoid|glucocorticoid
5012822|NCT01579513|Heart Disease|heart disease
5013324|NCT01577368|Pseudomonas|pseudomonas
5012823|NCT01579513|Heart Defects, Congenital|heart defects, congenital
5012824|NCT01579513|Cardiovascular Diseases|cardiovascular diseases
5012825|NCT01579513|Cardiovascular Abnormalities|cardiovascular abnormalities
5012826|NCT01579513|Corticosteroid|corticosteroid
5012827|NCT01579513|methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate
5012828|NCT01579513|Hormones|hormones
5012829|NCT01579513|Physiological Effects of Drugs|physiological effects of drugs
5012830|NCT01579513|Randomized Clinical Trial|randomized clinical trial
5012831|NCT01579487|Lipolysis|lipolysis
5012832|NCT01579487|Cryolipolysis|cryolipolysis
5012833|NCT01579487|Fat Reduction|fat reduction
5012834|NCT01579461|Pharmacokinetics|pharmacokinetics
5012835|NCT01579461|mirabegron|mirabegron
5012836|NCT01579461|hepatic impairment|hepatic impairment
5012837|NCT01579461|Phase 1|phase 1
5012838|NCT01579448|killed oral cholera vaccine|killed oral cholera vaccine
5012839|NCT01579448|boosting vaccine regimen|boosting vaccine regimen
5012840|NCT01579448|safety and immunogenicity|safety and immunogenicity
5012841|NCT01579435|essential tremor|essential tremor
5012842|NCT01579435|primary motor cortex|primary motor cortex
5012843|NCT01579435|cerebellum|cerebellum
5012844|NCT01579435|transcranial direct current stimulation|transcranial direct current stimulation
5012845|NCT01579435|electrophysiology|electrophysiology
5012846|NCT01579422|schizophrenia|schizophrenia
5012847|NCT01579422|treatment|treatment
5012848|NCT01579422|social cognition|social cognition
5012849|NCT01579409|Nutrition|nutrition
5012850|NCT01579409|Arterial stiffness|arterial stiffness
5012851|NCT01579409|Endothelial dysfunction|endothelial dysfunction
5012852|NCT01579409|Microcirculation|microcirculation
5012853|NCT01579409|Cardiac autonomic system.|cardiac autonomic system.
5012854|NCT01579396|septeX|septex
5012855|NCT01579396|high cut-off|high cut-off
5012856|NCT01579396|Thoracic Surgery|thoracic surgery
5012857|NCT01579396|Renal Replacement Therapy|renal replacement therapy
5012858|NCT01579383|Migraine Disorders|migraine disorders
5012859|NCT01579383|Phase 1|phase 1
5012860|NCT01579383|ALD403|ald403
5012861|NCT01579370|healthcare associated infections|healthcare associated infections
5012862|NCT01579370|multidrug resistant organisms|multidrug resistant organisms
5012863|NCT01579370|methicillin resistant staphylococcus aureus|methicillin resistant staphylococcus aureus
5012864|NCT01579370|vancomycin resistant enterococcus|vancomycin resistant enterococcus
5012865|NCT01579370|clostridium difficile|clostridium difficile
5012866|NCT01579370|acinetobacter|acinetobacter
5012867|NCT01579357|colorectal carcinoma|colorectal carcinoma
5012868|NCT01579357|K-ras wild type|k-ras wild type
5012869|NCT01579357|Capecitabine|capecitabine
5012870|NCT01579357|Cetuximab|cetuximab
5012871|NCT01579357|Oxaliplatin|oxaliplatin
5012872|NCT01579357|Pharmacokinetics|pharmacokinetics
5012873|NCT01579357|exclude a possible influence of CETUX|exclude a possible influence of cetux
5012874|NCT01579357|plasma disposition|plasma disposition
5012875|NCT01579357|metabolic activation|metabolic activation
5012876|NCT01579357|CCB|ccb
5012877|NCT01579357|OxPt|oxpt
5012878|NCT01579344|Iodine Radioisotopes|iodine radioisotopes
5012879|NCT01579344|Nasolacrimal Duct|nasolacrimal duct
5012880|NCT01579344|radiation effects|radiation effects
5012881|NCT01579331|IOP|iop
5012882|NCT01579331|Tonometry|tonometry
5012883|NCT01579331|Pascal|pascal
5012884|NCT01579331|Goldmann|goldmann
5012885|NCT01579331|DCT|dct
5012886|NCT01579331|Dynamic Contour|dynamic contour
5012887|NCT01579279|Diabetic neuropathic pain|diabetic neuropathic pain
5012888|NCT01579279|Active controlled phase 2 study|active controlled phase 2 study
5012889|NCT01579266|Writer's Cramp|writer's cramp
5012890|NCT01579266|Focal Hand Dystonia|focal hand dystonia
5012891|NCT01579266|Writer Cramp|writer cramp
5012892|NCT01579266|Dystonia|dystonia
5012893|NCT01579253|Recurrent glioblastoma|recurrent glioblastoma
5012894|NCT01579253|Radiotherapy|radiotherapy
5012895|NCT01579253|PET-MRI|pet-mri
5012896|NCT01579253|FET-PET|fet-pet
5012897|NCT01579240|physical activity|physical activity
5012898|NCT01579240|older adults|older adults
5012899|NCT01579240|Internet|internet
5012900|NCT01579240|sedentary|sedentary
5012901|NCT01579240|multi-week|multi-week
5012902|NCT01579240|internet intervention|internet intervention
5012903|NCT01579227|Healthy participants|healthy participants
5012904|NCT01579214|HIV|hiv
5012905|NCT01579214|Africa south of the sahara|africa south of the sahara
5012906|NCT01579214|Knowledge of results|knowledge of results
5012907|NCT01579214|Communication barriers|communication barriers
5012908|NCT01579214|Cellular Phones|cellular phones
5012909|NCT01579201|Postpartum Hemorrhage|postpartum hemorrhage
5012910|NCT01579201|Uterine Atony|uterine atony
5012911|NCT01579201|Obstetric Anesthesia|obstetric anesthesia
5012912|NCT01579201|Cesarean Section|cesarean section
5012913|NCT01579201|Carbetocin|carbetocin
5012914|NCT01579188|NSCLC|nsclc
5012915|NCT01579162|Hepatitis|hepatitis
5012916|NCT01579162|Fatty Liver|fatty liver
5012917|NCT01579123|Laser atherectomy|laser atherectomy
5012918|NCT01579123|Critical Limb Ischemia|critical limb ischemia
5012919|NCT01579123|Angioplasty|angioplasty
5012920|NCT01579110|autoimmune hemolytic anemia|autoimmune hemolytic anemia
5012921|NCT01579110|hemolytic anemia|hemolytic anemia
5012923|NCT01579110|Treatment of autoimmune hemolytic anemia|treatment of autoimmune hemolytic anemia
5012924|NCT01579110|warm antibody dependant autoimmune hemolytic anemia|warm antibody dependant autoimmune hemolytic anemia
5012925|NCT01579097|(PN) Parenteral nutrition|(pn) parenteral nutrition
5012926|NCT01579097|oral/enteral not possible|oral/enteral not possible
5012927|NCT01579058|aortic stenosis|aortic stenosis
5012928|NCT01579058|beta-blocker|beta-blocker
5012929|NCT01579032|CKD,|ckd,
5012930|NCT01578980|Artificial Pancreas|artificial pancreas
5012931|NCT01578980|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
5012932|NCT01578980|Control-to-Range|control-to-range
5012933|NCT01578980|Closed-Loop Control|closed-loop control
5012934|NCT01578980|Continuous Glucose Monitor|continuous glucose monitor
5012935|NCT01578967|Hodgkin's lymphoma|hodgkin's lymphoma
5012936|NCT01578967|Hodgkin lymphoma|hodgkin lymphoma
5012937|NCT01578954|Leukemia|leukemia
5012938|NCT01578954|Acute Myeloid Leukemia|acute myeloid leukemia
5012939|NCT01578941|menstrual migraine|menstrual migraine
5012940|NCT01578941|migraine|migraine
5012941|NCT01578941|treximet|treximet
5012942|NCT01578928|renal, impairment, endstage renal disease|renal, impairment, endstage renal disease
5012943|NCT01578928|renal|renal
5012944|NCT01578928|impairment|impairment
5012945|NCT01578928|endstage renal disease|endstage renal disease
5012946|NCT01578902|Prostatic Neoplasms|prostatic neoplasms
5012947|NCT01578902|Radiotherapy|radiotherapy
5012948|NCT01578902|Hypofractionation|hypofractionation
5012949|NCT01578902|Low Risk Prostate Cancer|low risk prostate cancer
5012950|NCT01578876|coronary artery disease|coronary artery disease
5012951|NCT01578876|angina pectoris|angina pectoris
5012952|NCT01578876|myocardial ischemia|myocardial ischemia
5012953|NCT01578876|cardiac shock wave therapy|cardiac shock wave therapy
5012954|NCT01578863|Childhood obesity|childhood obesity
5012955|NCT01578863|Adolescence|adolescence
5012956|NCT01578863|Predictors|predictors
5012957|NCT01578863|Success|success
5012958|NCT01578863|Intervention program|intervention program
5012959|NCT01578850|rheumatoid arthritis|rheumatoid arthritis
5012960|NCT01578850|etanercept|etanercept
5012961|NCT01578850|methotrexate|methotrexate
5012962|NCT01578850|DMARDs|dmards
5012963|NCT01578824|Rickets|rickets
5012964|NCT01578824|Vitamin D|vitamin d
5012965|NCT01578824|airway hyperreactivity|airway hyperreactivity
5012966|NCT01578824|Exhaled breath condensate|exhaled breath condensate
5012967|NCT01578772|HIV|hiv
5012968|NCT01578772|Flow-mediated dialation (FMD)|flow-mediated dialation (fmd)
5012969|NCT01578772|Telmisartan|telmisartan
5012970|NCT01578772|Cardiovascular disease (CVD)|cardiovascular disease (cvd)
5012971|NCT01578772|HIV+ men and women age > 50 at risk for heart disease|hiv+ men and women age > 50 at risk for heart disease
5012972|NCT01578759|ovarian function tests|ovarian function tests
5012973|NCT01578746|Coxarthrosis|coxarthrosis
5012974|NCT01578746|Hip arthroplasty|hip arthroplasty
5012975|NCT01578746|Anterior approach|anterior approach
5012976|NCT01578746|Direct lateral approach|direct lateral approach
5012977|NCT01578746|Hardinge approach|hardinge approach
5012978|NCT01578746|Smith-Petersen approach|smith-petersen approach
5012979|NCT01578746|Osteoarthrosis|osteoarthrosis
5012980|NCT01578733|protein requirement|protein requirement
5012981|NCT01578733|female elderly|female elderly
5012982|NCT01578733|healthy female subject's protein requirements|healthy female subject's protein requirements
5012983|NCT01578707|Chronic|chronic
5012984|NCT01578707|SLL|sll
5012985|NCT01578707|CLL|cll
5012986|NCT01578707|Ofatumumab|ofatumumab
5012987|NCT01578707|ibrutinib|ibrutinib
5012988|NCT01578707|RESONATE|resonate
5012989|NCT01578707|Phase III|phase iii
5012990|NCT01578707|Leukemia|leukemia
5012991|NCT01578707|Lymphoma|lymphoma
5012992|NCT01578681|bronchiectasis|bronchiectasis
5012993|NCT01578681|respiratory therapy|respiratory therapy
5012994|NCT01578681|airway clearance|airway clearance
5012995|NCT01578668|lung adenocarcinoma|lung adenocarcinoma
5012996|NCT01578668|brain metastases|brain metastases
5012997|NCT01578668|erlotinib|erlotinib
5012998|NCT01578668|pemetrexed|pemetrexed
5012999|NCT01578655|custirsen sodium|custirsen sodium
5013000|NCT01578655|prostate cancer|prostate cancer
5013001|NCT01578655|metastatic castrate resistant prostate cancer|metastatic castrate resistant prostate cancer
5013002|NCT01578655|overall survival|overall survival
5013003|NCT01578642|GERD|gerd
5013004|NCT01578642|LES Pressure|les pressure
5013005|NCT01578642|Electrical Stimulation|electrical stimulation
5013006|NCT01578629|stroke|stroke
5013007|NCT01578629|ischemia|ischemia
5013008|NCT01578629|TIA|tia
5013009|NCT01578616|Coronary artery disease|coronary artery disease
5013010|NCT01578616|Endothelial function|endothelial function
5013011|NCT01578616|Optical coherence tomography|optical coherence tomography
5013012|NCT01578616|Thin cap fibroatheroma|thin cap fibroatheroma
5013013|NCT01578603|prevention & control|prevention & control
5013014|NCT01578603|Xylitol|xylitol
5013015|NCT01578603|casein phosphopeptide amorphous calcium phosphate complex|casein phosphopeptide amorphous calcium phosphate complex
5013016|NCT01578603|Streptococcus mutans|streptococcus mutans
5013017|NCT01578603|saliva|saliva
5013018|NCT01578603|dental plaque|dental plaque
5013019|NCT01578603|gingivitis|gingivitis
5013020|NCT01578577|Medication Therapy Management|medication therapy management
5013021|NCT01578577|Hypertension|hypertension
5013022|NCT01578577|Health Literacy|health literacy
5013023|NCT01578577|Medication Reconciliation|medication reconciliation
5013024|NCT01578577|Medication Adherence|medication adherence
5013025|NCT01578564|Cancer|cancer
5013026|NCT01578564|Ovarian Cancer|ovarian cancer
5013027|NCT01578564|TRPV6 Calcium channel|trpv6 calcium channel
5013028|NCT01578551|Carcinoma, Non-Small-Cell Lung|carcinoma, non-small-cell lung
5013029|NCT01578551|Lung adenocarcinoma|lung adenocarcinoma
5013030|NCT01578538|hernia, abdominal, strangulation, emergency, wall|hernia, abdominal, strangulation, emergency, wall
5013031|NCT01578525|medication safety|medication safety
5013032|NCT01578525|elderly|elderly
5013033|NCT01578525|pharmaceutical care|pharmaceutical care
5013034|NCT01578525|hospital readmission|hospital readmission
5013035|NCT01578525|drug-related readmission|drug-related readmission
5013036|NCT01578525|Health Services for the Aged|health services for the aged
5013037|NCT01578499|brentuximab vedotin|brentuximab vedotin
5013038|NCT01578499|ALCANZA|alcanza
5013039|NCT01578486|Schizophrenia|schizophrenia
5013040|NCT01578486|Cognition|cognition
5013041|NCT01578486|Metabolism|metabolism
5013042|NCT01578486|Antipsychotics|antipsychotics
5013043|NCT01578486|Psychopathology|psychopathology
5013044|NCT01578473|low testosterone|low testosterone
5013045|NCT01578473|penile curvature|penile curvature
5013046|NCT01578460|Pregnancy|pregnancy
5013047|NCT01578460|Gestational Diabetes|gestational diabetes
5013048|NCT01578460|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
5013049|NCT01578460|Continuous Glucose Monitor|continuous glucose monitor
5013050|NCT01578460|Glucose|glucose
5013051|NCT01578447|injectable contraception|injectable contraception
5013052|NCT01578447|acceptability|acceptability
5013053|NCT01578447|intramuscular|intramuscular
5013054|NCT01578447|subcutaneous|subcutaneous
5013055|NCT01578434|Nutritional Rickets|nutritional rickets
5013056|NCT01578434|Calcium|calcium
5013057|NCT01578434|Vitamin D|vitamin d
5013058|NCT01578408|Femoral neck fractures|femoral neck fractures
5013059|NCT01578408|Uncemented|uncemented
5013060|NCT01578408|Hydroxyapatite|hydroxyapatite
5013061|NCT01578408|Coated|coated
5013062|NCT01578408|Femoral|femoral
5013063|NCT01578408|Stems|stems
5013064|NCT01578408|Hip fractures|hip fractures
5013065|NCT01578408|THA|tha
5013066|NCT01578408|THR|thr
5013067|NCT01578408|Cemented|cemented
5013068|NCT01578408|Fat embolism|fat embolism
5013069|NCT01578408|Cognition|cognition
5013070|NCT01578408|Inflammatory response|inflammatory response
5013071|NCT01578408|Mobilization|mobilization
5013072|NCT01578382|Martorell hypertensive ischemic leg ulcer|martorell hypertensive ischemic leg ulcer
5013073|NCT01578382|Calciphylaxis (calcific uremic arteriolopathy)|calciphylaxis (calcific uremic arteriolopathy)
5013074|NCT01578382|Ischemic subcutaneous arteriolosclerosis|ischemic subcutaneous arteriolosclerosis
5013075|NCT01578382|Hypertension|hypertension
5013076|NCT01578382|Diabetes|diabetes
5013077|NCT01578382|Medial calcinosis|medial calcinosis
5013078|NCT01578382|Wound healing|wound healing
5013079|NCT01578369|Urinary incontinence|urinary incontinence
5013080|NCT01578369|Pregnancy|pregnancy
5013081|NCT01578369|Pelvic floor muscle training|pelvic floor muscle training
5013082|NCT01578356|Prostate cancer|prostate cancer
5013083|NCT01578343|fludarabine|fludarabine
5013084|NCT01578343|mitoxantrone|mitoxantrone
5013085|NCT01578343|dexamethasone|dexamethasone
5013086|NCT01578343|relapsed or refractory mantle cell lymphoma|relapsed or refractory mantle cell lymphoma
5013087|NCT01578343|FND regimen|fnd regimen
5013088|NCT01578343|vorinostat|vorinostat
5013089|NCT01578343|autologous stem cell transplantation|autologous stem cell transplantation
5013090|NCT01578330|Relapsing remitting multiple sclerosis|relapsing remitting multiple sclerosis
5013091|NCT01578330|Fingolimod|fingolimod
5013092|NCT01578330|FTY720|fty720
5013093|NCT01578317|H5N1 Vaccine|h5n1 vaccine
5013094|NCT01578317|H5N1 Immunization|h5n1 immunization
5013095|NCT01578317|AS03 Adjuvant|as03 adjuvant
5013096|NCT01578317|Biologic Sample Collection|biologic sample collection
5013097|NCT01578317|Laboratory Research Specimens|laboratory research specimens
5013098|NCT01578317|Healthy Volunteer|healthy volunteer
5013099|NCT01578317|HV|hv
5013100|NCT01578304|Overactive bladder|overactive bladder
5013101|NCT01578291|Play therapy|play therapy
5013102|NCT01578291|Urinary tract infections|urinary tract infections
5013103|NCT01578291|Children|children
5013104|NCT01578291|Vesicoureteral reflux|vesicoureteral reflux
5013105|NCT01578239|Neuroendocrine tumour|neuroendocrine tumour
5013106|NCT01578239|177Lu-Dota0-Tyr3-octreotate|177lu-dota0-tyr3-octreotate
5013107|NCT01578226|Cirrhosis|cirrhosis
5013108|NCT01578226|Ascites|ascites
5013109|NCT01578226|Decompensation|decompensation
5013110|NCT01578226|Bacterial infection|bacterial infection
5013111|NCT01578226|Sepsis|sepsis
5013112|NCT01578226|Procalcitonin|procalcitonin
5013113|NCT01578226|PCT|pct
5013114|NCT01578200|CKD-MBD|ckd-mbd
5013115|NCT01578200|phosphate-binder|phosphate-binder
5013116|NCT01578200|vascular calcification|vascular calcification
5013117|NCT01578200|mortality|mortality
5013118|NCT01578200|dialysis|dialysis
5013119|NCT01578200|Hemodialysis patients with hyperphosphatemia|hemodialysis patients with hyperphosphatemia
5013120|NCT01578187|hair reduction|hair reduction
5013121|NCT01578187|hair removal|hair removal
5013122|NCT01578187|hair clearance|hair clearance
5013123|NCT01578148|Cervical pain|cervical pain
5013124|NCT01578148|Cervicalgia,|cervicalgia,
5013125|NCT01578148|Cervicodynia|cervicodynia
5013126|NCT01578148|Neck ache|neck ache
5013127|NCT01578148|Neckache|neckache
5013128|NCT01578148|Shoulder pain|shoulder pain
5013129|NCT01578148|Shoulder impingement syndrome|shoulder impingement syndrome
5013130|NCT01578122|post-thrombotic syndrome|post-thrombotic syndrome
5013131|NCT01578122|prevention|prevention
5013132|NCT01578122|deep vein thrombosis|deep vein thrombosis
5013133|NCT01578122|elastic compression stockings|elastic compression stockings
5013134|NCT01578122|compliance|compliance
5013135|NCT01578122|quality of life|quality of life
5013136|NCT01578096|Type 2 Diabetes|type 2 diabetes
5013137|NCT01578083|Chemotherapy|chemotherapy
5013138|NCT01578083|Breast Cancer|breast cancer
5013139|NCT01578083|Cognitive Impairment|cognitive impairment
5013140|NCT01578083|Chemo brain|chemo brain
5013141|NCT01578070|Other and Unspecified Vaccines and Biological Substances Causing Adverse Effects in Therapeutic Use|other and unspecified vaccines and biological substances causing adverse effects in therapeutic use
5013142|NCT01578057|alcohol|alcohol
5013143|NCT01578044|Anti-coagulation|anti-coagulation
5013144|NCT01578031|Sleep Apnea|sleep apnea
5013145|NCT01578031|Obesity|obesity
5013146|NCT01578018|lung cancer|lung cancer
5013147|NCT01578018|smoking|smoking
5013148|NCT01578005|acute coronary syndrome|acute coronary syndrome
5013149|NCT01578005|IVUS|ivus
5013150|NCT01578005|atherosclerotic plaque|atherosclerotic plaque
5013151|NCT01577992|subjective pain|subjective pain
5013152|NCT01577992|Multiple System Atrophy|multiple system atrophy
5013153|NCT01577979|Vaccination|vaccination
5013154|NCT01577979|Medical Home|medical home
5013155|NCT01577979|Adolescents|adolescents
5013156|NCT01577966|Patients with brain tumors associated with seizures|patients with brain tumors associated with seizures
5013157|NCT01577953|Antisense oligonucleotide|antisense oligonucleotide
5013158|NCT01577953|Asthma|asthma
5013159|NCT01577953|Patients with asthma|patients with asthma
5013160|NCT01577953|Phase 1b|phase 1b
5013161|NCT01577953|Transcription factor GATA-3|transcription factor gata-3
5013162|NCT01577953|Oral inhalation|oral inhalation
5013163|NCT01577940|Transversus abdominis plane block|transversus abdominis plane block
5013164|NCT01577940|postoperative pain|postoperative pain
5013165|NCT01577940|Postoperative pain management|postoperative pain management
5013166|NCT01577927|weaning|weaning
5013167|NCT01577927|severe chronic diseases|severe chronic diseases
5013168|NCT01577927|UTIR|utir
5013169|NCT01577901|Pregnancy|pregnancy
5013170|NCT01577862|ACINETOBACTER BAUMANNII|acinetobacter baumannii
5013171|NCT01577862|COLISTIN|colistin
5013172|NCT01577862|RIFAMPICIN|rifampicin
5013173|NCT01577862|THERAPY|therapy
5013174|NCT01577862|RESISTANCE|resistance
5013175|NCT01577836|Radical prostatectomie|radical prostatectomie
5013176|NCT01577836|Robotic assistance|robotic assistance
5013177|NCT01577836|Laparotomy|laparotomy
5013178|NCT01577810|NIRS|nirs
5013179|NCT01577810|near infrared spectroscopy|near infrared spectroscopy
5013180|NCT01577810|heart failure|heart failure
5013181|NCT01577810|cardiac output|cardiac output
5013182|NCT01577810|outpatient|outpatient
5013183|NCT01577810|pediatric|pediatric
5013184|NCT01577797|Methamphetamine|methamphetamine
5013185|NCT01577797|Drug Abuse|drug abuse
5013186|NCT01577797|Substance Abuse|substance abuse
5013187|NCT01577797|Amphetamine|amphetamine
5013188|NCT01577797|Dependence|dependence
5013189|NCT01577797|Addiction|addiction
5013190|NCT01577797|Craving|craving
5013191|NCT01577797|Cognitive Behavioral Therapy|cognitive behavioral therapy
5013192|NCT01577797|Text Messaging|text messaging
5013193|NCT01577784|Advanced renal cell carcinoma|advanced renal cell carcinoma
5013194|NCT01577784|second-line treatment with pazopanib|second-line treatment with pazopanib
5013195|NCT01577784|first line of treatment with a Tyrosine Kinase Inhibitor|first line of treatment with a tyrosine kinase inhibitor
5013196|NCT01577771|Pneumococcal conjugate vaccine|pneumococcal conjugate vaccine
5013197|NCT01577771|Immunogenicity|immunogenicity
5013198|NCT01577771|Reactogenicity|reactogenicity
5013199|NCT01577758|Phase 1,|phase 1,
5013200|NCT01577758|Advanced gastrointestinal malignancies,|advanced gastrointestinal malignancies,
5013201|NCT01577758|MLN0264,|mln0264,
5013202|NCT01577758|Guanylyl Cyclase C(GCC),|guanylyl cyclase c(gcc),
5013203|NCT01577758|Antibody Drug Conjugate(ADC)|antibody drug conjugate(adc)
5013204|NCT01577745|Cancer|cancer
5013205|NCT01577732|booster|booster
5013206|NCT01577732|Infanrix-IPV+HibTM|infanrix-ipv+hibtm
5013207|NCT01577732|DTPa-IPV/Hib|dtpa-ipv/hib
5013208|NCT01577732|Vietnamese toddlers|vietnamese toddlers
5013209|NCT01577719|Cardiovascular|cardiovascular
5013210|NCT01577719|Prevention|prevention
5013211|NCT01577719|Ethnicity|ethnicity
5013212|NCT01577719|Culture|culture
5013213|NCT01577719|Internet|internet
5013214|NCT01577719|Text Message|text message
5013215|NCT01577706|GABA|gaba
5013216|NCT01577706|glutamate|glutamate
5013217|NCT01577706|glutamine|glutamine
5013218|NCT01577706|spectroscopy|spectroscopy
5013219|NCT01577706|brain|brain
5013220|NCT01577706|imaging|imaging
5013221|NCT01577706|alprazolam|alprazolam
5013222|NCT01577706|dextroamphetamine|dextroamphetamine
5013223|NCT01577706|placebo|placebo
5013224|NCT01577693|dutasteride|dutasteride
5013225|NCT01577693|cross over study|cross over study
5013226|NCT01577693|bioavailability|bioavailability
5013227|NCT01577680|healthy subjects|healthy subjects
5013228|NCT01577680|pharmacokinetics|pharmacokinetics
5013229|NCT01577680|vilanterol|vilanterol
5013230|NCT01577680|tolerability|tolerability
5013231|NCT01577680|safety|safety
5013232|NCT01577680|hepatic impairment|hepatic impairment
5013233|NCT01577680|GW642444|gw642444
5013234|NCT01577680|GSK573719|gsk573719
5013235|NCT01577667|automation|automation
5013236|NCT01577667|closed loop|closed loop
5013237|NCT01577667|oxygenation|oxygenation
5013238|NCT01577667|ventilation|ventilation
5013239|NCT01577654|adenocarcinoma|adenocarcinoma
5013240|NCT01577654|squamous|squamous
5013241|NCT01577654|adenosquamous|adenosquamous
5013242|NCT01577654|adenocarcinoma with other NSCLC variants|adenocarcinoma with other nsclc variants
5013243|NCT01577654|EC145|ec145
5013244|NCT01577654|EC20|ec20
5013245|NCT01577654|Vintafolide|vintafolide
5013246|NCT01577654|Etarfolatide|etarfolatide
5013247|NCT01577628|Dermatitis|dermatitis
5013248|NCT01577628|Eczema|eczema
5013249|NCT01577628|Skin diseases|skin diseases
5013250|NCT01577628|Skin barrier|skin barrier
5013251|NCT01577628|Prevention|prevention
5013252|NCT01577628|Infant|infant
5013253|NCT01577628|Moisturizer|moisturizer
5013254|NCT01577628|Emollient|emollient
5013255|NCT01577628|Asthma|asthma
5013256|NCT01577628|Food allergy|food allergy
5013257|NCT01577628|Allergic rhinitis|allergic rhinitis
5013258|NCT01577615|Preterm Infant|preterm infant
5013259|NCT01577615|Neurobehavioral|neurobehavioral
5013260|NCT01577615|Development|development
5013261|NCT01577602|Medication reconciliation|medication reconciliation
5013262|NCT01577602|Self report|self report
5013263|NCT01577602|Electronic medical record medication list|electronic medical record medication list
5013264|NCT01577589|Phase 1|phase 1
5013265|NCT01577589|healthy volunteers|healthy volunteers
5013266|NCT01577589|cross-over study|cross-over study
5013267|NCT01577589|ceftaroline fosamil|ceftaroline fosamil
5013268|NCT01577589|various infusion volumes|various infusion volumes
5013269|NCT01577589|local tolerability|local tolerability
5013270|NCT01577589|Cmax|cmax
5013271|NCT01577589|tmax|tmax
5013272|NCT01577589|AUC|auc
5013273|NCT01577576|Athletes|athletes
5013274|NCT01577576|Sedentary volunteers|sedentary volunteers
5013275|NCT01577563|osteoarthritis (OA)|osteoarthritis (oa)
5013276|NCT01577563|rheumatoid arthritis (RA)|rheumatoid arthritis (ra)
5013277|NCT01577563|ankylosing spondylitis (AS)|ankylosing spondylitis (as)
5013278|NCT01577563|gastrointestinal risk factors|gastrointestinal risk factors
5013279|NCT01577563|NSAIDs|nsaids
5013280|NCT01577550|ABBV-066|abbv-066
5013281|NCT01577550|BI 655066|bi 655066
5013282|NCT01577550|risankizumab|risankizumab
5013283|NCT01577537|SPL7013|spl7013
5013284|NCT01577537|VivaGel|vivagel
5013285|NCT01577537|bacterial vaginosis|bacterial vaginosis
5013286|NCT01577537|BV|bv
5013287|NCT01577511|invasive potential|invasive potential
5013288|NCT01577511|molecular characterisation of circulating cells|molecular characterisation of circulating cells
5013289|NCT01577498|Skeletal age|skeletal age
5013290|NCT01577498|Chronological age|chronological age
5013291|NCT01577498|Adolescent|adolescent
5013292|NCT01577472|female infertility|female infertility
5013293|NCT01577472|poor ovarian response|poor ovarian response
5013294|NCT01577472|controlled ovarian hyperstimulation|controlled ovarian hyperstimulation
5013296|NCT01577472|Antagonist protocol|antagonist protocol
5013297|NCT01577446|CRT|crt
5013298|NCT01577446|heart failure|heart failure
5013299|NCT01577446|narrow QRS|narrow qrs
5013300|NCT01577446|dyssynchrony|dyssynchrony
5013301|NCT01577433|HeartMate II|heartmate ii
5013302|NCT01577433|heart-assist device|heart-assist device
5013303|NCT01577433|left ventricular assist device|left ventricular assist device
5013304|NCT01577433|driveline infection|driveline infection
5013305|NCT01577433|LVAD|lvad
5013306|NCT01577433|HMII LVAS driveline|hmii lvas driveline
5013307|NCT01577433|silicone portion|silicone portion
5013308|NCT01577433|Thoratec Corporation|thoratec corporation
5013309|NCT01577420|Reflexology|reflexology
5013310|NCT01577420|Breast Cancer|breast cancer
5013311|NCT01577420|Complementary|complementary
5013312|NCT01577407|Dyspnea|dyspnea
5013313|NCT01577407|Pain|pain
5013314|NCT01577394|Alzheimer disease|alzheimer disease
5013315|NCT01577394|Lewy Body Disease|lewy body disease
5013316|NCT01577394|Cognitive Disorders|cognitive disorders
5013317|NCT01577394|Neurodegenerative Diseases|neurodegenerative diseases
5013318|NCT01577394|Differential diagnosis|differential diagnosis
5013319|NCT01577394|Eye movement|eye movement
5013320|NCT01577381|Phase 2|phase 2
5013321|NCT01577381|Advanced Dry Age-Related Macular Degeneration|advanced dry age-related macular degeneration
5013322|NCT01577381|Geographic Atrophy|geographic atrophy
5013323|NCT01577381|RN6G|rn6g
5013325|NCT01577368|Piperacillin|piperacillin
5013326|NCT01577368|Beta-lactams|beta-lactams
5013327|NCT01577368|Continuous infusion|continuous infusion
5013328|NCT01577368|Intermittent infusion|intermittent infusion
5013329|NCT01577368|Pharmacokinetics|pharmacokinetics
5013330|NCT01577329|meditation|meditation
5013331|NCT01577329|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5013332|NCT01577329|Mindfulness|mindfulness
5013333|NCT01577329|Anxiety|anxiety
5013334|NCT01577329|Breathing Patterns|breathing patterns
5013335|NCT01577316|vaccination|vaccination
5013336|NCT01577316|Influenza|influenza
5013337|NCT01577316|Immunogenicity|immunogenicity
5013338|NCT01577316|Safety|safety
5013339|NCT01577303|social phobia|social phobia
5013340|NCT01577303|social anxiety|social anxiety
5013341|NCT01577303|cognitive bias modification|cognitive bias modification
5013342|NCT01577290|Anxiety|anxiety
5013343|NCT01577290|Depression|depression
5013344|NCT01577290|Insomnia|insomnia
5013345|NCT01577290|Mindfulness|mindfulness
5013346|NCT01577290|Internet|internet
5013347|NCT01577277|Metabolic Syndrome X|metabolic syndrome x
5013348|NCT01577277|Fatty Acids, Omega-3|fatty acids, omega-3
5013349|NCT01577277|Learning|learning
5013350|NCT01577277|Attention|attention
5013351|NCT01577277|Nutritional Status|nutritional status
5013352|NCT01577277|Nutrition Assessments|nutrition assessments
5013353|NCT01577277|Body Weight|body weight
5013354|NCT01577277|Physical Activity|physical activity
5013355|NCT01577277|Sleep|sleep
5013356|NCT01577277|Child Nutrition Sciences|child nutrition sciences
5013357|NCT01577264|Certolizumab Pegol|certolizumab pegol
5013358|NCT01577264|Cimzia|cimzia
5013359|NCT01577238|SPL7013|spl7013
5013360|NCT01577238|VivaGel|vivagel
5013361|NCT01577238|bacterial vaginosis|bacterial vaginosis
5013362|NCT01577238|BV|bv
5013363|NCT01577225|Clean surgery|clean surgery
5013364|NCT01577212|stage III NSCLC|stage iii nsclc
5013365|NCT01577212|(chemo)radiotherapy|(chemo)radiotherapy
5013366|NCT01577212|individualized dose-escalation|individualized dose-escalation
5013367|NCT01577199|IVF|ivf
5013368|NCT01577199|poor responder|poor responder
5013369|NCT01577199|low ovarian reserve|low ovarian reserve
5013370|NCT01577199|ART|art
5013371|NCT01577199|ovarian stimulation|ovarian stimulation
5013372|NCT01577199|IVF protocols|ivf protocols
5013373|NCT01577186|Schizophrenia|schizophrenia
5013374|NCT01577186|Paliperidone Extended Release|paliperidone extended release
5013375|NCT01577160|Schizophrenia|schizophrenia
5013376|NCT01577160|Paliperidone Extended Release (ER)|paliperidone extended release (er)
5013377|NCT01577147|pregnancy|pregnancy
5013378|NCT01577134|multimorbidity|multimorbidity
5013379|NCT01577134|autonomy|autonomy
5013380|NCT01577134|older adults|older adults
5013381|NCT01577134|physical activity|physical activity
5013382|NCT01577134|intervention|intervention
5013383|NCT01577134|behavior change|behavior change
5013384|NCT01577121|Preterm labor|preterm labor
5013385|NCT01577108|31-32 Weeks of Gestation Completed|31-32 weeks of gestation completed
5013386|NCT01577108|Group B Streptococcal Infection|group b streptococcal infection
5013387|NCT01577108|Streptococcus Group B Infection of the Infant|streptococcus group b infection of the infant
5013388|NCT01577095|electroacupuncture|electroacupuncture
5013389|NCT01577095|rosiglitazone|rosiglitazone
5013390|NCT01577095|plasma glucose|plasma glucose
5013391|NCT01577095|insulin resistance|insulin resistance
5013392|NCT01577095|free fatty acid|free fatty acid
5013393|NCT01577082|Adults, not adequately controlled, pre-dose morning PEF|adults, not adequately controlled, pre-dose morning pef
5013394|NCT01577069|Hepatitis C|hepatitis c
5013395|NCT01577069|Direct Antiviral agent (DAA)|direct antiviral agent (daa)
5013396|NCT01577069|Ultra-deep pyrosequencing|ultra-deep pyrosequencing
5013397|NCT01577069|Single polynucleotide polymorphisms|single polynucleotide polymorphisms
5013398|NCT01577069|Treatment-resistant mutants|treatment-resistant mutants
5013399|NCT01577069|Hepatitis C Virus Protease Inhibitor|hepatitis c virus protease inhibitor
5013400|NCT01577056|Familial hypercholesterolaemia|familial hypercholesterolaemia
5013401|NCT01577056|Postprandial dyslipidaemia|postprandial dyslipidaemia
5013402|NCT01577056|Fish oil treatment|fish oil treatment
5013403|NCT01577056|Cardiovascular disease|cardiovascular disease
5013404|NCT01577043|acute diarrhea|acute diarrhea
5013405|NCT01577043|Racecadotril|racecadotril
5013406|NCT01577043|children|children
5013407|NCT01577017|ovulation induction, clomiphene citrate, letrozole|ovulation induction, clomiphene citrate, letrozole
5013408|NCT01576978|LUMBAR BACK pain|lumbar back pain
5013409|NCT01576978|PELVIC PAIN|pelvic pain
5013410|NCT01576978|PREGNANCY|pregnancy
5013411|NCT01576978|HATHA YOGA|hatha yoga
5013412|NCT01576965|Laparoscopic hysterectomy,laparoscopic sacrocolpopexy,bowel prep|laparoscopic hysterectomy,laparoscopic sacrocolpopexy,bowel prep
5013413|NCT01576926|Sleep apnea, obstructive|sleep apnea, obstructive
5013414|NCT01576926|Deglutition Disorders|deglutition disorders
5013415|NCT01576913|exercise testing|exercise testing
5013416|NCT01576913|music|music
5013417|NCT01576913|VO2 max|vo2 max
5013418|NCT01576900|behavior therapy|behavior therapy
5013419|NCT01576900|nocturia|nocturia
5013420|NCT01576900|polyuria|polyuria
5013421|NCT01576874|nicotine dependence|nicotine dependence
5013422|NCT01576874|hormones|hormones
5013423|NCT01576848|muscle metabolism|muscle metabolism
5013424|NCT01576848|intrinsically labeled protein|intrinsically labeled protein
5013425|NCT01576848|protein synthesis|protein synthesis
5013426|NCT01576848|insulin|insulin
5013427|NCT01576848|perfusion|perfusion
5013428|NCT01576835|Non-contrast|non-contrast
5013429|NCT01576822|Detoxification|detoxification
5013430|NCT01576822|Sauna|sauna
5013431|NCT01576809|Paracetamol|paracetamol
5013432|NCT01576809|acetaminophen|acetaminophen
5013433|NCT01576809|phenylephrine|phenylephrine
5013434|NCT01576809|guaifenesin|guaifenesin
5013435|NCT01576809|syrup|syrup
5013436|NCT01576809|URTI|urti
5013437|NCT01576809|productive cough|productive cough
5013438|NCT01576796|Radiotherapy|radiotherapy
5013439|NCT01576796|Fmiso|fmiso
5013440|NCT01576796|FDG PETSCAN|fdg petscan
5013441|NCT01576796|FMISO PETSCAN|fmiso petscan
5013442|NCT01576796|complement dose|complement dose
5013443|NCT01576796|lung cancer|lung cancer
5013444|NCT01576796|NSCLC|nsclc
5013445|NCT01576796|hypoxic lesion|hypoxic lesion
5013446|NCT01576770|propofol|propofol
5013447|NCT01576770|Pain|pain
5013448|NCT01576770|Synera Patch|synera patch
5013449|NCT01576770|Gebauer's Ethyl Chloride topical anesthetic|gebauer's ethyl chloride topical anesthetic
5013450|NCT01576757|Stem cell therapy|stem cell therapy
5013451|NCT01576744|HE4|he4
5013452|NCT01576744|IVF|ivf
5013453|NCT01576744|Biomarker|biomarker
5013454|NCT01576744|Ovarian cancer|ovarian cancer
5013455|NCT01576744|Infertility|infertility
5013456|NCT01576731|HIV Infection|hiv infection
5013457|NCT01576731|Postexposure prophylaxis|postexposure prophylaxis
5013458|NCT01576718|Dose ranging|dose ranging
5013459|NCT01576718|Fluticasone Propionate|fluticasone propionate
5013460|NCT01576718|Dry Powder Inhaler (DPI)|dry powder inhaler (dpi)
5013461|NCT01576718|High Dose ICS|high dose ics
5013462|NCT01576718|Asthma|asthma
5013463|NCT01576705|Down syndrome|down syndrome
5013464|NCT01576705|Young children|young children
5013465|NCT01576705|Psychomotor development|psychomotor development
5013466|NCT01576705|Thyroid hormone|thyroid hormone
5013467|NCT01576705|Folinic acid|folinic acid
5013468|NCT01576705|Psychometric tests|psychometric tests
5013469|NCT01576705|GMDS|gmds
5013470|NCT01576705|Griffiths|griffiths
5013471|NCT01576705|Genetic factors|genetic factors
5013472|NCT01576705|Biochemical factors|biochemical factors
5013473|NCT01576692|recurrent neuroblastoma|recurrent neuroblastoma
5013474|NCT01576692|refractory neuroblastoma|refractory neuroblastoma
5013475|NCT01576692|natural killer cells|natural killer cells
5013476|NCT01576679|intra-abdominal|intra-abdominal
5013477|NCT01576679|abscess|abscess
5013478|NCT01576679|tPA|tpa
5013479|NCT01576679|alteplase|alteplase
5013480|NCT01576679|cathflo|cathflo
5013481|NCT01576666|Dose escalation|dose escalation
5013482|NCT01576666|Maximum Tolerated Dose|maximum tolerated dose
5013483|NCT01576666|MTD|mtd
5013484|NCT01576666|Safety Expansion|safety expansion
5013485|NCT01576666|Safety|safety
5013486|NCT01576666|Preliminary Efficacy|preliminary efficacy
5013487|NCT01576666|Objective Response Rate|objective response rate
5013488|NCT01576666|Early progression rate|early progression rate
5013489|NCT01576666|PI3K activation|pi3k activation
5013490|NCT01576666|Combination Treatment|combination treatment
5013491|NCT01576666|Hedgehog Signaling Pathway|hedgehog signaling pathway
5013492|NCT01576666|Smoothened inhibitor|smoothened inhibitor
5013493|NCT01576666|Phosphoinositide-3' kinase|phosphoinositide-3' kinase
5013494|NCT01576666|Phosphatase signaling pathway|phosphatase signaling pathway
5013495|NCT01576666|Advanced solid tumors|advanced solid tumors
5013496|NCT01576666|metastatic breast cancer|metastatic breast cancer
5013497|NCT01576666|advanced pancreatic adenocarcinoma|advanced pancreatic adenocarcinoma
5013498|NCT01576666|metastatic colorectal cancer|metastatic colorectal cancer
5013499|NCT01576666|recurrent glioblastoma multiforme|recurrent glioblastoma multiforme
5013500|NCT01576666|gastric cancer|gastric cancer
5013501|NCT01576666|gastroesophageal junction cancer|gastroesophageal junction cancer
5013502|NCT01576666|triple negative metastatic breast cancer|triple negative metastatic breast cancer
5013503|NCT01576666|hormone receptor positive (ER+/PR+, and Her2-) metastatic breast cancer|hormone receptor positive (er+/pr+, and her2-) metastatic breast cancer
5013504|NCT01576653|IFI|ifi
5013505|NCT01576640|Nicotine Dependence|nicotine dependence
5013506|NCT01576640|Smoking Cessation|smoking cessation
5013507|NCT01576640|Relapse Prevention|relapse prevention
5013508|NCT01576640|Cognitive Behavioral Therapy|cognitive behavioral therapy
5013509|NCT01576640|Schizophrenia|schizophrenia
5013510|NCT01576614|Comparing telephone VS RTP in SICU rounding practices|comparing telephone vs rtp in sicu rounding practices
5013511|NCT01576601|pediatrics|pediatrics
5013512|NCT01576601|acute pain|acute pain
5013513|NCT01576601|neurosurgery|neurosurgery
5013514|NCT01576601|Pediatric patients (0-18)|pediatric patients (0-18)
5013515|NCT01576601|postoperative management|postoperative management
5013516|NCT01576588|Chronic lymphocytic leukemia, relapsed, elderly or unfit patients, methylprednisolone, rituximab|chronic lymphocytic leukemia, relapsed, elderly or unfit patients, methylprednisolone, rituximab
5013614|NCT01576237|hemovigilance|hemovigilance
5013615|NCT01576237|hemapheresis|hemapheresis
5013616|NCT01576237|donor vigilance|donor vigilance
5013517|NCT01576575|to determine how people absorb and break down (metabolize) and eliminate buprenorphine and if CYP3A is involved.|to determine how people absorb and break down (metabolize) and eliminate buprenorphine and if cyp3a is involved.
5013518|NCT01576562|Implantable Cardioverter Defibrillator|implantable cardioverter defibrillator
5013519|NCT01576562|Ventricular Assist Device|ventricular assist device
5013520|NCT01576536|Myocardial infarction|myocardial infarction
5013521|NCT01576536|Platelet aggregation|platelet aggregation
5013522|NCT01576536|cold pressor test|cold pressor test
5013523|NCT01576536|Genetics|genetics
5013524|NCT01576497|EUS, EUS-FNA, Pancreatic masses|eus, eus-fna, pancreatic masses
5013525|NCT01576471|T. suis ova|t. suis ova
5013526|NCT01576471|Trichuris suis ova|trichuris suis ova
5013527|NCT01576471|Inflammatory Bowel Disease|inflammatory bowel disease
5013528|NCT01576471|TRUST-I|trust-i
5013529|NCT01576471|TRUSTI|trusti
5013530|NCT01576471|TRUST-1|trust-1
5013531|NCT01576471|TRUST1|trust1
5013532|NCT01576458|ursodeoxycholic acid|ursodeoxycholic acid
5013533|NCT01576458|intrahepatic cholestasis|intrahepatic cholestasis
5013534|NCT01576458|pregnancy|pregnancy
5013535|NCT01576445|Total Knee Arthroplasty|total knee arthroplasty
5013536|NCT01576445|function|function
5013537|NCT01576432|Pain|pain
5013538|NCT01576432|Breastfeeding|breastfeeding
5013539|NCT01576432|Heel prick|heel prick
5013540|NCT01576432|Sucrose|sucrose
5013541|NCT01576432|Skin-to-skin contact|skin-to-skin contact
5013542|NCT01576432|Newborn|newborn
5013543|NCT01576419|PG201|pg201
5013544|NCT01576419|Non-inferiority|non-inferiority
5013545|NCT01576419|100mm pain VAS|100mm pain vas
5013546|NCT01576406|crizotinib|crizotinib
5013547|NCT01576406|xalkori|xalkori
5013548|NCT01576406|PF-02341066|pf-02341066
5013549|NCT01576406|hepatic impairment|hepatic impairment
5013550|NCT01576406|pharmacokinetics|pharmacokinetics
5013551|NCT01576406|advanced cancer|advanced cancer
5013552|NCT01576393|substance abuse|substance abuse
5013553|NCT01576393|treatment|treatment
5013554|NCT01576393|families|families
5013555|NCT01576380|Solid tumors|solid tumors
5013556|NCT01576380|Advanced scirrhous gastric carcinoma|advanced scirrhous gastric carcinoma
5013557|NCT01576380|Gastric Cancer|gastric cancer
5013558|NCT01576380|Second-line or third-line treatment|second-line or third-line treatment
5013559|NCT01576380|VEGF|vegf
5013560|NCT01576380|FGFR|fgfr
5013561|NCT01576380|Neoplasms|neoplasms
5013562|NCT01576380|Gastric Neoplasms|gastric neoplasms
5013563|NCT01576380|Cancer|cancer
5013564|NCT01576380|Carcinoma|carcinoma
5013565|NCT01576380|Gastric Diseases|gastric diseases
5013566|NCT01576380|Female Genital Diseases|female genital diseases
5013567|NCT01576380|Tumors|tumors
5013568|NCT01576380|Oral Administration|oral administration
5013569|NCT01576380|Capsules|capsules
5013570|NCT01576380|TKI258|tki258
5013571|NCT01576380|TKI-258|tki-258
5013572|NCT01576380|TKI 258|tki 258
5013573|NCT01576367|Cryopyrin-associated periodic syndromes (CAPS)|cryopyrin-associated periodic syndromes (caps)
5013574|NCT01576367|Familial Cold Autoinflammatory Syndrome (FCAS)|familial cold autoinflammatory syndrome (fcas)
5013575|NCT01576367|Muckle-Wells Syndrome (MWS)|muckle-wells syndrome (mws)
5013576|NCT01576367|Neonatal Onset Multisystem Inflammatory Disease (NOMID)|neonatal onset multisystem inflammatory disease (nomid)
5013577|NCT01576367|children, systemic autoinflammatory disease|children, systemic autoinflammatory disease
5013578|NCT01576367|CIAS-1 gene|cias-1 gene
5013579|NCT01576367|NALP-3|nalp-3
5013580|NCT01576367|NLRP3|nlrp3
5013581|NCT01576367|ACZ885|acz885
5013582|NCT01576367|canakinumab|canakinumab
5013583|NCT01576367|human monoclonal anti-human interleukin-1 antibody|human monoclonal anti-human interleukin-1 antibody
5013584|NCT01576367|autosomal dominant|autosomal dominant
5013585|NCT01576367|familial autoinflammatory syndrome|familial autoinflammatory syndrome
5013586|NCT01576367|childhood immunizations vaccinations|childhood immunizations vaccinations
5013587|NCT01576354|Multiple Sclerosis|multiple sclerosis
5013588|NCT01576354|walking function|walking function
5013589|NCT01576354|fampridine|fampridine
5013590|NCT01576341|Epoetin alfa, ESA, HX575, CKD|epoetin alfa, esa, hx575, ckd
5013591|NCT01576315|cystic fibrosis|cystic fibrosis
5013592|NCT01576315|Aspergillus|aspergillus
5013593|NCT01576315|itraconazole|itraconazole
5013594|NCT01576315|voriconazole|voriconazole
5013595|NCT01576302|Rumination|rumination
5013596|NCT01576289|Esophagus|esophagus
5013597|NCT01576289|Gastroesophageal reflux|gastroesophageal reflux
5013598|NCT01576289|Reflux esophagitis|reflux esophagitis
5013599|NCT01576289|Barrett's esophagus|barrett's esophagus
5013600|NCT01576289|Stomach|stomach
5013601|NCT01576289|Intestinal metaplasia stomach|intestinal metaplasia stomach
5013602|NCT01576289|Helicobacter pylori infection|helicobacter pylori infection
5013603|NCT01576289|Proton pump inhibitor|proton pump inhibitor
5013604|NCT01576289|Duodenum|duodenum
5013605|NCT01576289|Duodenal bulb|duodenal bulb
5013606|NCT01576289|Celiac disease diagnosis|celiac disease diagnosis
5013607|NCT01576263|Anaesthesia|anaesthesia
5013608|NCT01576263|Infiltration|infiltration
5013609|NCT01576263|Blood transfusion|blood transfusion
5013610|NCT01576263|Autologous|autologous
5013611|NCT01576263|Arthroplasty|arthroplasty
5013612|NCT01576263|Replacement|replacement
5013613|NCT01576263|Ropivacaine|ropivacaine
5013617|NCT01576237|plasmapheresis|plasmapheresis
5013618|NCT01576237|platelet apheresis|platelet apheresis
5013619|NCT01576237|leukapheresis|leukapheresis
5013620|NCT01576237|stem cell apheresis|stem cell apheresis
5013621|NCT01576237|granulocyte apheresis|granulocyte apheresis
5013622|NCT01576237|monocyte apheresis|monocyte apheresis
5013623|NCT01576237|red cell apheresis|red cell apheresis
5013624|NCT01576224|Volar locking plate osteosynthesis|volar locking plate osteosynthesis
5013625|NCT01576224|Early mobilization|early mobilization
5013626|NCT01576224|DASH|dash
5013627|NCT01576211|Wilms tumor and other childhood kidney tumors|wilms tumor and other childhood kidney tumors
5013628|NCT01576198|Wilms tumor and other childhood kidney tumors|wilms tumor and other childhood kidney tumors
5013629|NCT01576159|Biochemical Marker|biochemical marker
5013630|NCT01576159|Fitness Exercises|fitness exercises
5013631|NCT01576159|Impact|impact
5013632|NCT01576159|Articular Cartilage|articular cartilage
5013633|NCT01576146|Clinical Trial, Phase 2|clinical trial, phase 2
5013634|NCT01576146|Renal Dialysis|renal dialysis
5013635|NCT01576146|Secondary Hyperparathyroidism|secondary hyperparathyroidism
5013636|NCT01576146|Chronic kidney disease-mineral and bone disorder|chronic kidney disease-mineral and bone disorder
5013637|NCT01576146|Parathyroid hormone|parathyroid hormone
5013638|NCT01576133|Quality of Life|quality of life
5013639|NCT01576120|Known, active Crohn's disease|known, active crohn's disease
5013640|NCT01576120|Iieocolonic or colonic involvement|iieocolonic or colonic involvement
5013641|NCT01576120|proven patency of the GI tract|proven patency of the gi tract
5013642|NCT01576107|Different cancer entities|different cancer entities
5013643|NCT01576094|congenital heart disease|congenital heart disease
5013644|NCT01576081|bone density|bone density
5013645|NCT01576081|weight bearing|weight bearing
5013646|NCT01576081|muscle atrophy|muscle atrophy
5013647|NCT01576081|vascular degeneration|vascular degeneration
5013648|NCT01576081|gravitational loading|gravitational loading
5013649|NCT01576081|muscular unloading|muscular unloading
5013650|NCT01576068|COPD|copd
5013651|NCT01576068|Pharmacy|pharmacy
5013652|NCT01576068|Spirometry|spirometry
5013653|NCT01576068|Case finding|case finding
5013654|NCT01576055|Peripheral Arterial Disease|peripheral arterial disease
5013655|NCT01576055|Superficial Femoral Artery|superficial femoral artery
5013656|NCT01576055|Proximal Popliteal Artery|proximal popliteal artery
5013657|NCT01576055|PAD|pad
5013658|NCT01576055|SFA|sfa
5013659|NCT01576055|PPA|ppa
5013660|NCT01576055|Stent|stent
5013661|NCT01576055|Gore|gore
5013662|NCT01576055|Bare Metal Stent|bare metal stent
5013663|NCT01576055|LifeStent|lifestent
5013664|NCT01576055|atherosclerosis|atherosclerosis
5013665|NCT01576055|Heparin|heparin
5013666|NCT01576055|claudication|claudication
5013667|NCT01576055|leg pain|leg pain
5013668|NCT01576042|Ischemic heart disease|ischemic heart disease
5013669|NCT01576042|Implantable Cardioverter Defibrillator|implantable cardioverter defibrillator
5013670|NCT01576042|Ventricular Tachycardia|ventricular tachycardia
5013671|NCT01576042|Patient with Implantable Cardioverter Defibrillator (ICD)|patient with implantable cardioverter defibrillator (icd)
5013672|NCT01576016|bradycardia|bradycardia
5013673|NCT01576016|MRI scans|mri scans
5013674|NCT01576003|Short Bowel Syndrome|short bowel syndrome
5013675|NCT01576003|Necrotizing Entercolitis (NEC)|necrotizing entercolitis (nec)
5013676|NCT01576003|Atresia|atresia
5013677|NCT01576003|Parenteral Nutrition|parenteral nutrition
5013678|NCT01576003|Biological Markers|biological markers
5013679|NCT01576003|Growth|growth
5013680|NCT01575990|Colon cancer screening|colon cancer screening
5013681|NCT01575990|Decision support interventions|decision support interventions
5013682|NCT01575990|Health status|health status
5013683|NCT01575990|Patient-centered care|patient-centered care
5013684|NCT01575990|Age|age
5013685|NCT01575990|Randomized controlled trial|randomized controlled trial
5013686|NCT01575990|Double blind|double blind
5013687|NCT01575990|UNC|unc
5013688|NCT01575938|HIV infection|hiv infection
5013689|NCT01575925|Pomalidomide for multiple myeloma|pomalidomide for multiple myeloma
5013690|NCT01575925|renal impairment|renal impairment
5013691|NCT01575925|multiple myeloma patients with renal impairment|multiple myeloma patients with renal impairment
5013692|NCT01575925|Pomalidomide for patients with renal impairment due to multiple myeloma|pomalidomide for patients with renal impairment due to multiple myeloma
5013693|NCT01575925|Pomalidomide|pomalidomide
5013694|NCT01575925|dexamethasone|dexamethasone
5013695|NCT01575925|RRMM|rrmm
5013696|NCT01575925|impaired renal function in multiple myeloma|impaired renal function in multiple myeloma
5013697|NCT01575925|hemodialysis|hemodialysis
5013698|NCT01575925|dialysis|dialysis
5013699|NCT01575925|POM|pom
5013700|NCT01575925|Pomalyst|pomalyst
5013701|NCT01575925|MM|mm
5013702|NCT01575925|severe renal impairment|severe renal impairment
5013703|NCT01575925|CrCl ≤ 30 mL/min|crcl ≤ 30 ml/min
5013704|NCT01575925|Creatinine less than 30|creatinine less than 30
5013705|NCT01575925|clinical trial in subjects with multiple myeloma with renal impairement|clinical trial in subjects with multiple myeloma with renal impairement
5013706|NCT01575912|Schizophrenia|schizophrenia
5013707|NCT01575912|Major depression|major depression
5013708|NCT01575912|Pain|pain
5013709|NCT01575912|Past pain experience|past pain experience
5013710|NCT01575899|Helicobacter pylori|helicobacter pylori
5013711|NCT01575899|Levofloxacin|levofloxacin
5013712|NCT01575899|Amoxicillin/clavulanate|amoxicillin/clavulanate
5013713|NCT01575899|Rabeprazole|rabeprazole
5013714|NCT01575899|Eastern Taiwan|eastern taiwan
5013715|NCT01575886|clinician patient communication|clinician patient communication
5013716|NCT01575886|smoking cessation|smoking cessation
5013717|NCT01575886|weight management|weight management
5013718|NCT01575886|primary care|primary care
5013719|NCT01575886|health behavior change advice|health behavior change advice
5013720|NCT01575873|GIOP, Glucocorticoid, osteporosis, denosumab, BMD, Bone Mineral Density|giop, glucocorticoid, osteporosis, denosumab, bmd, bone mineral density
5013721|NCT01575860|biopsy-proven diagnosis|biopsy-proven diagnosis
5013722|NCT01575860|completed at least 2 cycles of salvage chemotherapy|completed at least 2 cycles of salvage chemotherapy
5013723|NCT01575860|showing PET positive residual lesions|showing pet positive residual lesions
5013724|NCT01575847|Acetaminophen|acetaminophen
5013725|NCT01575847|Acetaminophen Toxicity|acetaminophen toxicity
5013726|NCT01575834|Osteoporosis, Osteoporosis-Postmenopausal, Bone Diseases-Metabolic, Bone Diseases, Musculoskeletal Diseases|osteoporosis, osteoporosis-postmenopausal, bone diseases-metabolic, bone diseases, musculoskeletal diseases
5013727|NCT01575821|children, cough, honey|children, cough, honey
5013728|NCT01575808|Symptomatic PAD|symptomatic pad
5013729|NCT01575808|Stenosis|stenosis
5013730|NCT01575808|Occlusion|occlusion
5013731|NCT01575795|Ticagrelor|ticagrelor
5013732|NCT01575795|ST elevation acute myocardial infarction|st elevation acute myocardial infarction
5013733|NCT01575795|Platelet reactivity|platelet reactivity
5013734|NCT01575782|small cell lung cancer|small cell lung cancer
5013735|NCT01575782|stage I-III|stage i-iii
5013736|NCT01575782|chloroquine|chloroquine
5013737|NCT01575782|Phase I|phase i
5013738|NCT01575730|Peritoneal carcinomatosis from colorectal or appendiceal origin|peritoneal carcinomatosis from colorectal or appendiceal origin
5013739|NCT01575717|Vitamin D|vitamin d
5013740|NCT01575717|hepatocellular carcinoma|hepatocellular carcinoma
5013741|NCT01575717|liver neoplasms|liver neoplasms
5013742|NCT01575717|liver transplantation|liver transplantation
5013743|NCT01575704|Exercise|exercise
5013744|NCT01575704|Hematopoetic cell transplantation|hematopoetic cell transplantation
5013745|NCT01575704|Children|children
5013746|NCT01575691|Combination Chemotherapy|combination chemotherapy
5013747|NCT01575691|MDS|mds
5013748|NCT01575691|High-Risk Myelodysplastic Syndrome|high-risk myelodysplastic syndrome
5013749|NCT01575691|AML|aml
5013750|NCT01575691|Acute myelogenous leukemia|acute myelogenous leukemia
5013751|NCT01575691|valproic acid|valproic acid
5013752|NCT01575691|VPA|vpa
5013753|NCT01575691|Depakene|depakene
5013754|NCT01575691|5-azacytidine|5-azacytidine
5013755|NCT01575691|5-aza|5-aza
5013756|NCT01575691|Azacitidine|azacitidine
5013757|NCT01575691|5-AZC|5-azc
5013758|NCT01575691|Vidaza|vidaza
5013759|NCT01575691|AZA-CR|aza-cr
5013760|NCT01575691|Ladakamycin|ladakamycin
5013761|NCT01575691|NSC-102816|nsc-102816
5013762|NCT01575691|All-trans retinoic acid|all-trans retinoic acid
5013763|NCT01575691|ATRA|atra
5013764|NCT01575691|Tretinoin|tretinoin
5013765|NCT01575691|Vesanoid|vesanoid
5013766|NCT01575678|enuresis|enuresis
5013767|NCT01575678|melatonin|melatonin
5013768|NCT01575678|circadian rhythm|circadian rhythm
5013769|NCT01575678|children|children
5013770|NCT01575678|blood pressure|blood pressure
5013771|NCT01575678|urine production|urine production
5013772|NCT01575678|activity|activity
5013773|NCT01575678|sleep|sleep
5013774|NCT01575665|Hyperventilation|hyperventilation
5013775|NCT01575665|Chronic Idiopathic Hyperventilation|chronic idiopathic hyperventilation
5013776|NCT01575665|Dysfunctional Breathing|dysfunctional breathing
5013777|NCT01575665|Respiratory Alkalosis|respiratory alkalosis
5013778|NCT01575665|Respiratory Acidosis|respiratory acidosis
5013779|NCT01575652|peritoneal dialysis|peritoneal dialysis
5013780|NCT01575652|protein losses|protein losses
5013781|NCT01575613|malaria|malaria
5013782|NCT01575613|heterogeneity|heterogeneity
5013783|NCT01575613|transmission|transmission
5013784|NCT01575613|elimination|elimination
5013785|NCT01575587|Pharmacology|pharmacology
5013786|NCT01575587|Pharmacokinetics|pharmacokinetics
5013787|NCT01575587|Pharmacodynamics|pharmacodynamics
5013788|NCT01575587|Abiraterone acetate|abiraterone acetate
5013789|NCT01575587|Food intake|food intake
5013790|NCT01575587|Caucasion|caucasion
5013791|NCT01575587|Japanese|japanese
5013792|NCT01575587|Healthy|healthy
5013793|NCT01575561|Lurasidone|lurasidone
5013794|NCT01575561|Latuda|latuda
5013795|NCT01575561|Bipolar Disorder|bipolar disorder
5013796|NCT01575535|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
5013797|NCT01575535|adult acute basophilic leukemia|adult acute basophilic leukemia
5013798|NCT01575535|adult acute eosinophilic leukemia|adult acute eosinophilic leukemia
5013799|NCT01575535|adult erythroleukemia (M6a)|adult erythroleukemia (m6a)
5013800|NCT01575535|adult pure erythroid leukemia (M6b)|adult pure erythroid leukemia (m6b)
5013801|NCT01575535|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
5013802|NCT01575535|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
5013891|NCT01574989|magnetic stimulation|magnetic stimulation
5013803|NCT01575535|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
5013804|NCT01575535|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
5013805|NCT01575535|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
5013806|NCT01575535|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
5013807|NCT01575535|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5013808|NCT01575535|adult acute myeloid leukemia with del(5q)|adult acute myeloid leukemia with del(5q)
5013809|NCT01575535|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5013810|NCT01575535|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5013811|NCT01575535|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5013812|NCT01575535|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
5013813|NCT01575496|Tinnitus|tinnitus
5013814|NCT01575496|Transcranial direct current stimulation|transcranial direct current stimulation
5013815|NCT01575496|Transcranial magnetic stimulation|transcranial magnetic stimulation
5013816|NCT01575470|Traumatic Brain Injury|traumatic brain injury
5013817|NCT01575470|TBI|tbi
5013818|NCT01575470|stem cells|stem cells
5013819|NCT01575457|Adolescent Violence Prevention|adolescent violence prevention
5013820|NCT01575444|Pap test|pap test
5013821|NCT01575444|HPV testing|hpv testing
5013822|NCT01575444|cervical cancer|cervical cancer
5013823|NCT01575431|coronary artery disease|coronary artery disease
5013824|NCT01575431|endothelial progenitor cells|endothelial progenitor cells
5013825|NCT01575392|creatinine|creatinine
5013826|NCT01575392|chronic kidney disease|chronic kidney disease
5013827|NCT01575392|creatinine clearance|creatinine clearance
5013828|NCT01575392|estimated glomerular filtration rate|estimated glomerular filtration rate
5013829|NCT01575340|inflammatory markers|inflammatory markers
5013830|NCT01575340|colorectal cancer|colorectal cancer
5013831|NCT01575340|cytokines|cytokines
5013832|NCT01575340|fish oil|fish oil
5013833|NCT01575314|stapling device|stapling device
5013834|NCT01575314|lobectomy|lobectomy
5013835|NCT01575314|cost utility|cost utility
5013836|NCT01575301|GLP-1R agonist|glp-1r agonist
5013837|NCT01575301|biomarker|biomarker
5013838|NCT01575288|arterial function|arterial function
5013839|NCT01575288|cardiovascular|cardiovascular
5013840|NCT01575288|aging|aging
5013841|NCT01575288|endothelial function|endothelial function
5013842|NCT01575288|arterial stiffness|arterial stiffness
5013843|NCT01575288|vascular function|vascular function
5013844|NCT01575288|Trehalose|trehalose
5013845|NCT01575262|behaviour change|behaviour change
5013846|NCT01575262|incentives|incentives
5013847|NCT01575262|nudging|nudging
5013848|NCT01575262|physical activity|physical activity
5013849|NCT01575262|self-monitoring|self-monitoring
5013850|NCT01575249|progression|progression
5013851|NCT01575249|moderate aortic stenosis|moderate aortic stenosis
5013852|NCT01575249|asymptomatic|asymptomatic
5013853|NCT01575249|symptomatic|symptomatic
5013854|NCT01575223|saline irrigation|saline irrigation
5013855|NCT01575223|chronic rhinosinusitis|chronic rhinosinusitis
5013856|NCT01575223|endoscopic sinus surgery|endoscopic sinus surgery
5013857|NCT01575223|high volume saline irrigation|high volume saline irrigation
5013858|NCT01575184|internal jugular vein cannulation|internal jugular vein cannulation
5013859|NCT01575184|common carotid artery|common carotid artery
5013860|NCT01575184|infants|infants
5013861|NCT01575132|Parkinson's Disease|parkinson's disease
5013862|NCT01575132|Stimulation, Deep Brain|stimulation, deep brain
5013863|NCT01575132|Study, Follow-Up|study, follow-up
5013864|NCT01575132|Adverse Effects|adverse effects
5013865|NCT01575119|Cigarette smoker|cigarette smoker
5013866|NCT01575119|Elective surgery|elective surgery
5013867|NCT01575093|Healthy volunteers|healthy volunteers
5013868|NCT01575067|BP|bp
5013869|NCT01575041|sodium|sodium
5013870|NCT01575041|salt|salt
5013871|NCT01575041|potassium|potassium
5013872|NCT01575041|blood pressure|blood pressure
5013873|NCT01575041|flow-mediated dilatation|flow-mediated dilatation
5013874|NCT01575041|endothelial function|endothelial function
5013875|NCT01575041|renal function|renal function
5013876|NCT01575041|controlled feeding study|controlled feeding study
5013877|NCT01575041|dietary intervention|dietary intervention
5013878|NCT01575028|Transversus abdominis plane block|transversus abdominis plane block
5013879|NCT01575028|TAP block|tap block
5013880|NCT01575028|Local anesthetic infiltration|local anesthetic infiltration
5013881|NCT01575028|Appendectomy|appendectomy
5013882|NCT01575028|Laparoscopic appendectomy|laparoscopic appendectomy
5013883|NCT01575015|Liver transplantation (E04.210.650)|liver transplantation (e04.210.650)
5013884|NCT01575015|Renal replacement therapy (E05.196.353)|renal replacement therapy (e05.196.353)
5013885|NCT01575015|Intra-operative period (E04.614.374)|intra-operative period (e04.614.374)
5013886|NCT01575015|Safety (N06.850.135.060.075)|safety (n06.850.135.060.075)
5013887|NCT01575015|Efficacy|efficacy
5013888|NCT01575002|transcranial stimulation|transcranial stimulation
5013889|NCT01575002|direct current stimulation|direct current stimulation
5013890|NCT01574989|direct current stimulation|direct current stimulation
5014093|NCT01574092|Gliomas|gliomas
5013892|NCT01574989|transcranial stimulation|transcranial stimulation
5013893|NCT01574976|ADHD|adhd
5013894|NCT01574976|probabilistic|probabilistic
5013895|NCT01574976|choice|choice
5013896|NCT01574976|feedback|feedback
5013897|NCT01574976|practice|practice
5013898|NCT01574963|Coronary artery disease|coronary artery disease
5013899|NCT01574963|OPG|opg
5013900|NCT01574963|RANKL|rankl
5013901|NCT01574963|bone disease|bone disease
5013902|NCT01574950|Delirium|delirium
5013903|NCT01574937|Castration Resistant|castration resistant
5013904|NCT01574937|Post Chemotherapy|post chemotherapy
5013905|NCT01574924|Personality change|personality change
5013906|NCT01574924|Perfectionism|perfectionism
5013907|NCT01574924|Coping|coping
5013908|NCT01574924|Medical Specialty|medical specialty
5013909|NCT01574924|Medical Residency|medical residency
5013910|NCT01574911|volumetry 3D|volumetry 3d
5013911|NCT01574911|Displacement of water|displacement of water
5013912|NCT01574911|lymphoedema|lymphoedema
5013913|NCT01574911|Venous chronic insufficiency|venous chronic insufficiency
5013914|NCT01574898|Smoking cessation|smoking cessation
5013915|NCT01574898|Nicotine|nicotine
5013916|NCT01574898|Tobacco Use Disorder|tobacco use disorder
5013917|NCT01574898|Central Nervous System Agents|central nervous system agents
5013918|NCT01574885|sleep apnea|sleep apnea
5013919|NCT01574885|adenotonsillar hypertrophy|adenotonsillar hypertrophy
5013920|NCT01574885|salt|salt
5013921|NCT01574885|sodium chloride|sodium chloride
5013922|NCT01574872|psoriasis|psoriasis
5013923|NCT01574872|salt|salt
5013924|NCT01574872|sodium chloride|sodium chloride
5013925|NCT01574859|central hypothyroidism|central hypothyroidism
5013926|NCT01574859|hypopituitarism|hypopituitarism
5013927|NCT01574859|levothyroxine replacement|levothyroxine replacement
5013928|NCT01574859|lipids|lipids
5013929|NCT01574859|body composition|body composition
5013930|NCT01574820|prediabetes|prediabetes
5013931|NCT01574820|coronary artery disease|coronary artery disease
5013932|NCT01574820|insulin resistance|insulin resistance
5013933|NCT01574820|glucose intolerance|glucose intolerance
5013934|NCT01574807|mepivacaine|mepivacaine
5013935|NCT01574807|lidocaine|lidocaine
5013936|NCT01574807|inferior alveolar nerve block|inferior alveolar nerve block
5013937|NCT01574807|pulpal anesthesia|pulpal anesthesia
5013938|NCT01574807|pain of injection|pain of injection
5013939|NCT01574807|mepivacaine/lidocaine|mepivacaine/lidocaine
5013940|NCT01574807|lidocaine/lidocaine|lidocaine/lidocaine
5013941|NCT01574781|Down syndrome|down syndrome
5013942|NCT01574781|Trisomy 13|trisomy 13
5013943|NCT01574781|Trisomy 18|trisomy 18
5013944|NCT01574781|Microdeletions|microdeletions
5013945|NCT01574781|Pregnancy|pregnancy
5013946|NCT01574781|Non-invasive|non-invasive
5013947|NCT01574755|gastric inlet patches|gastric inlet patches
5013948|NCT01574755|argon plasma coagulation|argon plasma coagulation
5013949|NCT01574755|globus sensations|globus sensations
5013950|NCT01574729|p53 gene therapy|p53 gene therapy
5013951|NCT01574729|non-small cell lung cancer|non-small cell lung cancer
5013952|NCT01574729|post-surgery|post-surgery
5013953|NCT01574729|chemotherapy|chemotherapy
5013954|NCT01574703|smoking cessation|smoking cessation
5013955|NCT01574703|psychiatric disease|psychiatric disease
5013956|NCT01574703|cardiovascular events|cardiovascular events
5013957|NCT01574690|central venous pressure|central venous pressure
5013958|NCT01574690|right heart catheter (RHC)|right heart catheter (rhc)
5013959|NCT01574690|non-invasive monitor|non-invasive monitor
5013960|NCT01574690|physical exam of jugular venous pressure|physical exam of jugular venous pressure
5013961|NCT01574690|heart failure (HF)|heart failure (hf)
5013962|NCT01574677|Colorectal cancer|colorectal cancer
5013963|NCT01574677|fecal immunochemical test|fecal immunochemical test
5013964|NCT01574677|Septin 9|septin 9
5013965|NCT01574677|screening|screening
5013966|NCT01574651|QVA149|qva149
5013967|NCT01574651|Health related quality of life|health related quality of life
5013968|NCT01574651|Formoterol|formoterol
5013969|NCT01574651|Tiotropium|tiotropium
5013970|NCT01574651|COPD|copd
5013971|NCT01574612|Xerese|xerese
5013972|NCT01574612|acyclovir hydrocortisone cream|acyclovir hydrocortisone cream
5013973|NCT01574612|herpes labialis|herpes labialis
5013974|NCT01574612|pediatric|pediatric
5013975|NCT01574599|Stroke|stroke
5013976|NCT01574599|weakness|weakness
5013977|NCT01574599|rehabilitation|rehabilitation
5013978|NCT01574599|chronic stroke|chronic stroke
5013979|NCT01574586|True Bifurcation stenosis|true bifurcation stenosis
5013980|NCT01574573|Obesity|obesity
5013981|NCT01574573|GERD|gerd
5013982|NCT01574573|Weight loss|weight loss
5013983|NCT01574560|smoke-free|smoke-free
5013984|NCT01574560|tobacco exposure|tobacco exposure
5013985|NCT01574560|biomarker feedback|biomarker feedback
5013986|NCT01574560|nicotine|nicotine
5013987|NCT01574560|cotinine|cotinine
5013988|NCT01574560|secondhand smoke|secondhand smoke
5013989|NCT01574547|Cat Scratch Colon.|cat scratch colon.
5013990|NCT01574547|Mucosal tears.|mucosal tears.
5013991|NCT01574547|Mucosal erosion.|mucosal erosion.
5013992|NCT01574547|Colonoscopy.|colonoscopy.
5013993|NCT01574508|efficacy|efficacy
5013994|NCT01574508|safety|safety
5013995|NCT01574508|intensive insulin therapy|intensive insulin therapy
5013996|NCT01574495|stroke|stroke
5013997|NCT01574495|error augmentation|error augmentation
5013998|NCT01574495|arm recovery|arm recovery
5013999|NCT01574495|massed practice|massed practice
5014000|NCT01574482|Plant sterol - Hypercholesterolemia - diet - dairy|plant sterol - hypercholesterolemia - diet - dairy
5014001|NCT01574469|Plant sterol - Cholesterol absorption - diet - dairy - LDL|plant sterol - cholesterol absorption - diet - dairy - ldl
5014002|NCT01574443|Epilepsy|epilepsy
5014003|NCT01574417|Plant stanols|plant stanols
5014004|NCT01574417|Gene expression profile|gene expression profile
5014005|NCT01574417|Microbiota|microbiota
5014006|NCT01574404|PGS,PGD, IVF, Polar Body Biopsy, FISH, Microarray analysis|pgs,pgd, ivf, polar body biopsy, fish, microarray analysis
5014007|NCT01574378|Abdominoplasty|abdominoplasty
5014008|NCT01574365|CKD patients with type 2 diabetes|ckd patients with type 2 diabetes
5014009|NCT01574352|Children|children
5014010|NCT01574352|Overweight|overweight
5014011|NCT01574352|Obesity|obesity
5014012|NCT01574352|BMI|bmi
5014013|NCT01574352|Physical activity|physical activity
5014014|NCT01574352|Cognitive function|cognitive function
5014015|NCT01574352|Intervention study|intervention study
5014016|NCT01574352|Randomized controlled trial|randomized controlled trial
5014017|NCT01574352|Day camp|day camp
5014018|NCT01574352|Risk factors|risk factors
5014019|NCT01574339|GERD|gerd
5014020|NCT01574339|LES Pressure|les pressure
5014021|NCT01574339|Electrical Stimulation|electrical stimulation
5014022|NCT01574326|Chronic Kidney Disease|chronic kidney disease
5014023|NCT01574326|Pediatric|pediatric
5014024|NCT01574326|Sevelamer Carbonate|sevelamer carbonate
5014025|NCT01574326|Hyperphosphatemia|hyperphosphatemia
5014026|NCT01574313|stellate ganglion block.|stellate ganglion block.
5014027|NCT01574313|Meniere's disease.|meniere's disease.
5014028|NCT01574313|electrocochleography.|electrocochleography.
5014029|NCT01574313|vertigo.|vertigo.
5014030|NCT01574313|hearing impairment.|hearing impairment.
5014031|NCT01574300|Small Cell Lung Cancer (SCLC)|small cell lung cancer (sclc)
5014032|NCT01574300|Non-Small Cell Lung Cancer (NSCLC)|non-small cell lung cancer (nsclc)
5014033|NCT01574300|M1A or B NSCLC|m1a or b nsclc
5014034|NCT01574261|Polycystic Ovary Syndrome|polycystic ovary syndrome
5014035|NCT01574261|Cardiovascular risk|cardiovascular risk
5014036|NCT01574261|Metabolic Syndrome|metabolic syndrome
5014037|NCT01574248|ACE inhibitor|ace inhibitor
5014038|NCT01574248|Angioedema|angioedema
5014039|NCT01574248|Bradykinin|bradykinin
5014040|NCT01574248|Swelling|swelling
5014041|NCT01574222|Stages IIIB, IV, and recurrent NSCLC|stages iiib, iv, and recurrent nsclc
5014042|NCT01574222|Carcinoma, Non-small cell lung|carcinoma, non-small cell lung
5014043|NCT01574222|Lung Neoplasms|lung neoplasms
5014044|NCT01574222|Carcinoma, Bronchogenic|carcinoma, bronchogenic
5014045|NCT01574222|Thoracic Neoplasms|thoracic neoplasms
5014046|NCT01574222|Neoplasms by Site|neoplasms by site
5014047|NCT01574222|Neoplasms|neoplasms
5014048|NCT01574222|Lung Diseases|lung diseases
5014049|NCT01574209|Celiac disease|celiac disease
5014050|NCT01574209|IBS|ibs
5014051|NCT01574209|Intestinal barrier|intestinal barrier
5014052|NCT01574209|Intestinal permeability|intestinal permeability
5014053|NCT01574209|GI peptides|gi peptides
5014054|NCT01574196|Childhood cancer|childhood cancer
5014055|NCT01574196|Cancer|cancer
5014056|NCT01574196|Sequels|sequels
5014057|NCT01574196|Complications|complications
5014058|NCT01574196|Chemotherapy|chemotherapy
5014059|NCT01574196|Radiotherapy|radiotherapy
5014060|NCT01574196|Surgery|surgery
5014061|NCT01574196|Autonomic nervous system|autonomic nervous system
5014062|NCT01574196|Parasympathetic Nervous System|parasympathetic nervous system
5014063|NCT01574196|Sympathetic Nervous System|sympathetic nervous system
5014064|NCT01574183|Marijuana|marijuana
5014065|NCT01574183|Vilazodone|vilazodone
5014066|NCT01574183|Contingency management|contingency management
5014067|NCT01574183|Motivational enhancement therapy|motivational enhancement therapy
5014068|NCT01574170|Breast cancer,|breast cancer,
5014069|NCT01574170|Third line metastatic|third line metastatic
5014070|NCT01574170|Chemotherapy,|chemotherapy,
5014071|NCT01574170|Overall survival,|overall survival,
5014072|NCT01574170|Quality of life.|quality of life.
5014073|NCT01574144|Heart Failure|heart failure
5014074|NCT01574131|Burn|burn
5014075|NCT01574131|Fenofibrate|fenofibrate
5014076|NCT01574131|PPAR alpha agonist|ppar alpha agonist
5014077|NCT01574131|insulin sensitivity|insulin sensitivity
5014078|NCT01574131|mitochondrial|mitochondrial
5014079|NCT01574118|PTSD|ptsd
5014080|NCT01574118|Posttraumatic Stress Disorder|posttraumatic stress disorder
5014081|NCT01574118|Exposure Therapy|exposure therapy
5014082|NCT01574118|Prolonged Exposure|prolonged exposure
5014083|NCT01574118|Fear Memory Retrieval|fear memory retrieval
5014084|NCT01574118|Compound extinction|compound extinction
5014085|NCT01574118|Deepened extinction|deepened extinction
5014086|NCT01574118|Psychotherapy|psychotherapy
5014087|NCT01574105|Heparin Dose|heparin dose
5014088|NCT01574105|Heparin Resistance|heparin resistance
5014089|NCT01574105|Chest Tube Losses|chest tube losses
5014090|NCT01574105|Transfusion Events|transfusion events
5014091|NCT01574092|Pediatric|pediatric
5014092|NCT01574092|Pediatrics|pediatrics
5014094|NCT01574092|Glioma|glioma
5014095|NCT01574092|Brain tumor|brain tumor
5014096|NCT01574092|Brain cancer|brain cancer
5014097|NCT01574092|Cisplatin|cisplatin
5014098|NCT01574092|Cisplatino|cisplatino
5014099|NCT01574092|Irinotecan|irinotecan
5014100|NCT01574092|Brain stem tumor|brain stem tumor
5014101|NCT01574092|Brainstem gliomas|brainstem gliomas
5014102|NCT01574092|Intrinsic brain stem tumor|intrinsic brain stem tumor
5014103|NCT01574092|PAEDIATRIC HIGH GRADE GLIOMA|paediatric high grade glioma
5014104|NCT01574092|Childhood brain stem glioma|childhood brain stem glioma
5014105|NCT01574066|Community-acquired pneumonia|community-acquired pneumonia
5014106|NCT01574066|Diagnosis|diagnosis
5014107|NCT01574066|Emergency medicine|emergency medicine
5014108|NCT01574066|Chest CT-scan|chest ct-scan
5014109|NCT01574053|Huntington's Disease|huntington's disease
5014110|NCT01574053|Huntington Disease|huntington disease
5014111|NCT01574053|Juvenile Huntington's Disease|juvenile huntington's disease
5014112|NCT01574053|Registry|registry
5014113|NCT01574053|Cohort|cohort
5014114|NCT01574053|CHDI|chdi
5014115|NCT01574040|Lifestyle|lifestyle
5014116|NCT01574040|Lifestyle modification|lifestyle modification
5014117|NCT01574040|Behavior|behavior
5014118|NCT01574040|Primary prevention|primary prevention
5014119|NCT01574040|Healthy staff and visitors of an Academic Hospital|healthy staff and visitors of an academic hospital
5014120|NCT01574027|Assess the efficacy of vitamin D for preventing colorectal cancer and identifying the populations likely (or unlikely) to benefit from vitamin D-based therapy.|assess the efficacy of vitamin d for preventing colorectal cancer and identifying the populations likely (or unlikely) to benefit from vitamin d-based therapy.
5014121|NCT01574027|Evaluate the ability of Vitamin D3 (cholecalciferol) to reduce ACF's in humans.|evaluate the ability of vitamin d3 (cholecalciferol) to reduce acf's in humans.
5014122|NCT01574014|Anxiety Disorder|anxiety disorder
5014123|NCT01574014|Phobic Disorders|phobic disorders
5014124|NCT01574001|ischemic stroke|ischemic stroke
5014125|NCT01574001|smoking cessation|smoking cessation
5014126|NCT01574001|antismoking interventions|antismoking interventions
5014127|NCT01573988|Nutrition|nutrition
5014128|NCT01573988|Eating frequency|eating frequency
5014129|NCT01573988|Food intake|food intake
5014130|NCT01573988|Eating behavior|eating behavior
5014131|NCT01573988|Satiety|satiety
5014132|NCT01573988|Ghrelin|ghrelin
5014133|NCT01573975|Helicobacter pylori|helicobacter pylori
5014134|NCT01573975|antibiotic resistance|antibiotic resistance
5014135|NCT01573975|sequential therapy|sequential therapy
5014136|NCT01573975|Taiwan|taiwan
5014137|NCT01573962|Kidney Renal|kidney renal
5014138|NCT01573949|Heart Failure|heart failure
5014139|NCT01573949|Diabetes|diabetes
5014140|NCT01573949|Pre-diabetes|pre-diabetes
5014141|NCT01573949|Early type II diabetes|early type ii diabetes
5014142|NCT01573949|Metformin|metformin
5014143|NCT01573949|Pharmacotherapy with metformin for prevention of DM in HF patients with pre-diabetes (pre-DM) and glycemic control in HF patients with early type II DM|pharmacotherapy with metformin for prevention of dm in hf patients with pre-diabetes (pre-dm) and glycemic control in hf patients with early type ii dm
5014144|NCT01573936|acquired brain injury|acquired brain injury
5014145|NCT01573936|health-related quality of life|health-related quality of life
5014146|NCT01573936|poliomyelitis survivor|poliomyelitis survivor
5014147|NCT01573936|rehabilitation|rehabilitation
5014148|NCT01573936|spinal cord injury|spinal cord injury
5014149|NCT01573936|completed the WHOQOL-BREF|completed the whoqol-bref
5014150|NCT01573923|Umbilical Mesenchymal Stem Cells; Liver cirrhosis|umbilical mesenchymal stem cells; liver cirrhosis
5014151|NCT01573910|Bacterial conjunctivitis|bacterial conjunctivitis
5014152|NCT01573910|Anti-infective|anti-infective
5014153|NCT01573910|Antibiotics|antibiotics
5014154|NCT01573897|Diabetes|diabetes
5014155|NCT01573897|Sleep apnea|sleep apnea
5014156|NCT01573897|Diabetic foot|diabetic foot
5014157|NCT01573897|Microcirculation|microcirculation
5014158|NCT01573858|Infertility|infertility
5014159|NCT01573858|Polycystic Ovary Syndrome|polycystic ovary syndrome
5014160|NCT01573858|Clomiphene citrate|clomiphene citrate
5014161|NCT01573858|Acupuncture|acupuncture
5014162|NCT01573845|child|child
5014163|NCT01573845|communication|communication
5014164|NCT01573845|diet|diet
5014165|NCT01573845|food|food
5014166|NCT01573845|health communication|health communication
5014167|NCT01573845|nutrition|nutrition
5014168|NCT01573845|parents|parents
5014169|NCT01573845|primary schools|primary schools
5014170|NCT01573845|school age population|school age population
5014171|NCT01573845|school health|school health
5014172|NCT01573819|repeat dose|repeat dose
5014173|NCT01573819|PDE4|pde4
5014174|NCT01573819|healthy volunteers|healthy volunteers
5014175|NCT01573819|GSK356278|gsk356278
5014176|NCT01573806|sepsis|sepsis
5014177|NCT01573806|septic shock|septic shock
5014178|NCT01573806|children|children
5014179|NCT01573806|incretins|incretins
5014180|NCT01573806|exenatide|exenatide
5014181|NCT01573806|pharmacokinetics|pharmacokinetics
5014182|NCT01573806|pharmacodynamics|pharmacodynamics
5014183|NCT01573806|glucose homeostasis|glucose homeostasis
5014184|NCT01573806|inflammation|inflammation
5014185|NCT01573806|cytokines|cytokines
5014186|NCT01573806|health-related quality of life|health-related quality of life
5014187|NCT01573806|functional status|functional status
5014188|NCT01573754|Porphyria, rare disease, orphan disease, iron metabolism|porphyria, rare disease, orphan disease, iron metabolism
5014189|NCT01573741|depressive ketamine antidepressant|depressive ketamine antidepressant
5014190|NCT01573728|Depression|depression
5014191|NCT01573728|Biomarkers|biomarkers
5014192|NCT01573728|Exercise|exercise
5014193|NCT01573702|Non small cell lung cancer|non small cell lung cancer
5014194|NCT01573702|EGFR mutant|egfr mutant
5014195|NCT01573702|Phase II|phase ii
5014196|NCT01573702|erlotinib|erlotinib
5014197|NCT01573702|tarceva|tarceva
5014198|NCT01573702|cyberknife|cyberknife
5014199|NCT01573702|Lineberger|lineberger
5014200|NCT01573689|bereaved children, mutual aid group, death, group intervention.|bereaved children, mutual aid group, death, group intervention.
5014201|NCT01573676|bariatric surgery|bariatric surgery
5014202|NCT01573676|sleep apnea|sleep apnea
5014203|NCT01573676|overweight|overweight
5014204|NCT01573663|Ambroxol|ambroxol
5014205|NCT01573663|Levodropropizine|levodropropizine
5014206|NCT01573663|Drug-drug interaction|drug-drug interaction
5014207|NCT01573637|schizophrenia|schizophrenia
5014208|NCT01573637|negative schizophrenia|negative schizophrenia
5014209|NCT01573637|schizophrenia in post-menopausal women|schizophrenia in post-menopausal women
5014210|NCT01573637|schizophrenia in women|schizophrenia in women
5014211|NCT01573637|ralixifene|ralixifene
5014212|NCT01573637|raloxifen|raloxifen
5014213|NCT01573637|raloxifeno|raloxifeno
5014214|NCT01573637|negative symptoms of schizophrenia|negative symptoms of schizophrenia
5014215|NCT01573637|negative symptoms in schizophrenia|negative symptoms in schizophrenia
5014216|NCT01573637|schizophrenia symptoms|schizophrenia symptoms
5014217|NCT01573637|negative symptoms of psychosis|negative symptoms of psychosis
5014218|NCT01573624|Fluticasone Furoate|fluticasone furoate
5014219|NCT01573624|Vilanterol|vilanterol
5014220|NCT01573624|Adults|adults
5014221|NCT01573624|GSK573719|gsk573719
5014222|NCT01573624|Asthma|asthma
5014223|NCT01573611|mild cognitive impairment|mild cognitive impairment
5014224|NCT01573611|dementia|dementia
5014225|NCT01573611|positron emission tomography (PET)|positron emission tomography (pet)
5014226|NCT01573611|F-18 Fluorodeoxyglucose (FDG)|f-18 fluorodeoxyglucose (fdg)
5014227|NCT01573611|cerebral metabolism|cerebral metabolism
5014228|NCT01573611|dietary supplement|dietary supplement
5014229|NCT01573598|Major Depressive Disorder|major depressive disorder
5014230|NCT01573598|Depression|depression
5014231|NCT01573585|Physical Therapy|physical therapy
5014232|NCT01573585|Exercise therapy|exercise therapy
5014233|NCT01573559|Ambulatory adults with no apparent health conditions|ambulatory adults with no apparent health conditions
5014234|NCT01573533|Treatment Resistant Idiopathic FSGS|treatment resistant idiopathic fsgs
5014235|NCT01573533|Glomerulosclerosis|glomerulosclerosis
5014236|NCT01573533|Proteinuria|proteinuria
5014237|NCT01573533|Rituximab|rituximab
5014238|NCT01573520|compliance|compliance
5014239|NCT01573520|dialysis|dialysis
5014240|NCT01573520|hyperparathyroidism|hyperparathyroidism
5014241|NCT01573507|traumatic brain injury|traumatic brain injury
5014242|NCT01573507|lactate|lactate
5014243|NCT01573507|brain metabolism|brain metabolism
5014244|NCT01573507|cerebral microdialysis|cerebral microdialysis
5014245|NCT01573507|subarachnoid hemorrhage|subarachnoid hemorrhage
5014246|NCT01573507|transcranial doppler|transcranial doppler
5014247|NCT01573494|Cancer|cancer
5014248|NCT01573494|Melanoma|melanoma
5014249|NCT01573494|Circulating Tumor Cells|circulating tumor cells
5014250|NCT01573481|WEANING|weaning
5014251|NCT01573481|PRESSURE CONTROLLED CONTINOUS VENTILATION|pressure controlled continous ventilation
5014252|NCT01573481|PRESSURE VENTILATION SUPPORT|pressure ventilation support
5014253|NCT01573481|SLEEP|sleep
5014254|NCT01573481|POLYGRAPHIC RECORD|polygraphic record
5014255|NCT01573442|hot flashes|hot flashes
5014256|NCT01573442|musculoskeletal complications|musculoskeletal complications
5014257|NCT01573442|sexual dysfunction|sexual dysfunction
5014258|NCT01573442|estrogen receptor-positive breast cancer|estrogen receptor-positive breast cancer
5014259|NCT01573442|progesterone receptor-positive breast cancer|progesterone receptor-positive breast cancer
5014260|NCT01573442|arthralgia|arthralgia
5014261|NCT01573442|stage IA breast cancer|stage ia breast cancer
5014262|NCT01573442|stage IB breast cancer|stage ib breast cancer
5014263|NCT01573442|stage II breast cancer|stage ii breast cancer
5014264|NCT01573442|stage IIIA breast cancer|stage iiia breast cancer
5014265|NCT01573442|stage IIIB breast cancer|stage iiib breast cancer
5014266|NCT01573442|stage IIIC breast cancer|stage iiic breast cancer
5014267|NCT01573429|Biologic Sample Collection|biologic sample collection
5014268|NCT01573429|Metabolism|metabolism
5014269|NCT01573429|Healthy Volunteer|healthy volunteer
5014270|NCT01573429|HV|hv
5014271|NCT01573416|Alcohol|alcohol
5014272|NCT01573416|Abuse|abuse
5014273|NCT01573416|Drugs|drugs
5014274|NCT01573416|Brief intervention|brief intervention
5014275|NCT01573416|ASSIST|assist
5014276|NCT01573403|Proton pump inhibitor (PPI)|proton pump inhibitor (ppi)
5014277|NCT01573403|DLBS2411|dlbs2411
5014278|NCT01573403|gastric pH|gastric ph
5014279|NCT01573390|Non-invasive|non-invasive
5014280|NCT01573390|tissue-oxygenation|tissue-oxygenation
5014281|NCT01573390|hyperspectral|hyperspectral
5014282|NCT01573390|CWC imaging system|cwc imaging system
5014283|NCT01573377|polycystic ovary syndrome|polycystic ovary syndrome
5014284|NCT01573377|insulin resistance|insulin resistance
5014285|NCT01573364|Distal Airways|distal airways
5014286|NCT01573364|Hyperinflation|hyperinflation
5014287|NCT01573364|Reversibility|reversibility
5014288|NCT01573338|Cyclin dependent kinases|cyclin dependent kinases
5014289|NCT01573338|Drug therapy, combination|drug therapy, combination
5014290|NCT01573338|Small cell lung carcinoma|small cell lung carcinoma
5014291|NCT01573338|Etoposide|etoposide
5014292|NCT01573338|Cisplatin|cisplatin
5014293|NCT01573338|Carboplatin|carboplatin
5014294|NCT01573325|Cirrhosis of the liver|cirrhosis of the liver
5014295|NCT01573325|Pre-liver transplant Candidate|pre-liver transplant candidate
5014296|NCT01573325|Depression|depression
5014297|NCT01573325|Poor social support|poor social support
5014298|NCT01573325|Liver disease symptoms|liver disease symptoms
5014299|NCT01573325|Health releated quality of life|health releated quality of life
5014300|NCT01573312|influenza, vaccine, H5N1, monovalent, adjuvant, ASO3|influenza, vaccine, h5n1, monovalent, adjuvant, aso3
5014301|NCT01573299|Cerebral Infarction, Mobilization, Recovery|cerebral infarction, mobilization, recovery
5014302|NCT01573286|Infant Nutrition Disorders|infant nutrition disorders
5014303|NCT01573286|Childhood nutrition disorders|childhood nutrition disorders
5014304|NCT01573286|malnutrition|malnutrition
5014305|NCT01573286|post surgical syndromes|post surgical syndromes
5014306|NCT01573286|necrotising enterocolitis|necrotising enterocolitis
5014307|NCT01573286|intestinal atresia|intestinal atresia
5014308|NCT01573286|gastroschisis|gastroschisis
5014309|NCT01573273|cocaine|cocaine
5014310|NCT01573273|substance abuse|substance abuse
5014311|NCT01573273|drug abuse|drug abuse
5014312|NCT01573273|cocaine dependence|cocaine dependence
5014313|NCT01573273|drug addiction|drug addiction
5014314|NCT01573260|Parkinson's Disease|parkinson's disease
5014315|NCT01573260|Tango|tango
5014316|NCT01573247|Acute myeloid leukemia|acute myeloid leukemia
5014317|NCT01573247|Refractory Acute myeloid leukemia|refractory acute myeloid leukemia
5014318|NCT01573247|FLT3 inhibitor|flt3 inhibitor
5014319|NCT01573247|kinase inhibitor|kinase inhibitor
5014320|NCT01573234|MySkin patch|myskin patch
5014321|NCT01573234|Hydrogel bandage|hydrogel bandage
5014322|NCT01573234|Occlusive dressing|occlusive dressing
5014323|NCT01573208|Knee osteoarthritis|knee osteoarthritis
5014324|NCT01573195|deescalation|deescalation
5014325|NCT01573195|best practice alert|best practice alert
5014326|NCT01573195|antimicrobial stewardship|antimicrobial stewardship
5014327|NCT01573182|Zostavax|zostavax
5014328|NCT01573182|Herpes Zoster|herpes zoster
5014329|NCT01573182|VZV vaccination|vzv vaccination
5014330|NCT01573182|Allogeneic haemopoietic stem cell transplantation|allogeneic haemopoietic stem cell transplantation
5014331|NCT01573169|hemorrhagic stroke|hemorrhagic stroke
5014332|NCT01573169|venous thromboembolism|venous thromboembolism
5014333|NCT01573169|prevention|prevention
5014334|NCT01573156|renal cancer|renal cancer
5014335|NCT01573156|photodynamic therapy|photodynamic therapy
5014336|NCT01573156|wst 11|wst 11
5014337|NCT01573143|Surgical Procedures, Cardiac|surgical procedures, cardiac
5014338|NCT01573143|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors
5014339|NCT01573143|Rosuvastatin|rosuvastatin
5014340|NCT01573143|Post operative atrial fibrillation|post operative atrial fibrillation
5014341|NCT01573130|Depression|depression
5014342|NCT01573130|Physical exercise|physical exercise
5014343|NCT01573130|Internet|internet
5014344|NCT01573117|hypothermia|hypothermia
5014345|NCT01573117|induction of hypothermia|induction of hypothermia
5014346|NCT01573117|cold infusion|cold infusion
5014347|NCT01573117|nasopharyngeal cooling|nasopharyngeal cooling
5014348|NCT01573117|stroke|stroke
5014349|NCT01573117|intracranial hemorrhage|intracranial hemorrhage
5014350|NCT01573117|cerebrovascular disease|cerebrovascular disease
5014351|NCT01573117|neuro intensive care|neuro intensive care
5014352|NCT01573104|Diagnosis|diagnosis
5014353|NCT01573104|Acute Kidney Injury|acute kidney injury
5014354|NCT01573091|Cardiac resynchronization therapy|cardiac resynchronization therapy
5014355|NCT01573091|Heart failure|heart failure
5014356|NCT01573078|Crohn's disease|crohn's disease
5014357|NCT01573078|IBS|ibs
5014358|NCT01573078|Dissociation|dissociation
5014359|NCT01573078|Emotional processing|emotional processing
5014360|NCT01573065|alcohol consumption|alcohol consumption
5014361|NCT01573065|sexual risk behaviors|sexual risk behaviors
5014362|NCT01573065|young, unhealthy drinkers|young, unhealthy drinkers
5014363|NCT01573039|Kidney transplantation|kidney transplantation
5014364|NCT01573039|PCR quantitative|pcr quantitative
5014365|NCT01573039|cytomegalovirus|cytomegalovirus
5014366|NCT01573039|antigenemia|antigenemia
5014367|NCT01573026|Dental Implants|dental implants
5014368|NCT01573026|Dental Implantation|dental implantation
5014369|NCT01573026|Osseointegration|osseointegration
5014370|NCT01573013|iron deficiency|iron deficiency
5014371|NCT01573013|Lead poisoning|lead poisoning
5014372|NCT01573013|cognitive development|cognitive development
5014373|NCT01573013|motor activity|motor activity
5014374|NCT01573000|Bexxar|bexxar
5014375|NCT01573000|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
5014376|NCT01573000|Tositumomab|tositumomab
5014377|NCT01573000|Anti-B1 Antibody|anti-b1 antibody
5014378|NCT01573000|Radioimmunotherapy|radioimmunotherapy
5014379|NCT01573000|Iodine I-131|iodine i-131
5014380|NCT01573000|Iodine-131|iodine-131
5014381|NCT01572987|Barrett's Esophagus|barrett's esophagus
5014382|NCT01572987|Esophageal neoplasms|esophageal neoplasms
5014383|NCT01572987|Radiofrequency ablation|radiofrequency ablation
5014384|NCT01572987|Endoscopic mucosal resection|endoscopic mucosal resection
5014385|NCT01572974|Barrett's esophagus|barrett's esophagus
5014386|NCT01572974|Gastroesophageal reflux disease|gastroesophageal reflux disease
5014387|NCT01572974|Quality of life|quality of life
5014388|NCT01572961|Laser Doppler flowmetry, skin, microcirculation|laser doppler flowmetry, skin, microcirculation
5014389|NCT01572935|childhood obesity prevalence|childhood obesity prevalence
5014390|NCT01572922|Sickle cell disease|sickle cell disease
5014391|NCT01572922|Thalassemia|thalassemia
5014392|NCT01572922|Hemochromatosis|hemochromatosis
5014393|NCT01572922|Cancer|cancer
5014394|NCT01572909|Myocardial Reperfusion|myocardial reperfusion
5014395|NCT01572909|Primary PCI|primary pci
5014396|NCT01572909|Stenting for ST-segment Elevation Myocardial Infarction|stenting for st-segment elevation myocardial infarction
5014397|NCT01572896|adoloescent|adoloescent
5014398|NCT01572896|internet self-management|internet self-management
5014399|NCT01572896|managing JIA|managing jia
5014400|NCT01572883|adjuvant treatment with Radiotherapy and trastuzumab|adjuvant treatment with radiotherapy and trastuzumab
5014401|NCT01572870|Chit1|chit1
5014402|NCT01572870|Cystic Fibrosis|cystic fibrosis
5014403|NCT01572870|Allergic Bronchopulmonary Aspergillosis (ABPA)|allergic bronchopulmonary aspergillosis (abpa)
5014404|NCT01572870|Aspergillus|aspergillus
5014405|NCT01572857|multiple myeloma|multiple myeloma
5014406|NCT01572857|Proteinuria|proteinuria
5014407|NCT01572857|Albuminuria|albuminuria
5014408|NCT01572857|Urinary FLC|urinary flc
5014409|NCT01572857|Urine creatinine|urine creatinine
5014410|NCT01572844|Dermatomyositis|dermatomyositis
5014411|NCT01572844|Superficial calcinosis|superficial calcinosis
5014412|NCT01572844|Fractional carbon dioxide laser|fractional carbon dioxide laser
5014413|NCT01572844|Sodium thiosulfate|sodium thiosulfate
5014414|NCT01572831|antibiotic cessation rules|antibiotic cessation rules
5014415|NCT01572831|procalcitonin|procalcitonin
5014416|NCT01572831|infection|infection
5014417|NCT01572831|critical care|critical care
5014418|NCT01572818|Phlebotomy|phlebotomy
5014419|NCT01572818|Insulin Resistance|insulin resistance
5014420|NCT01572818|Iron Overload|iron overload
5014421|NCT01572805|Post partum haemorrhage|post partum haemorrhage
5014422|NCT01572805|Cesarean|cesarean
5014423|NCT01572805|Pain|pain
5014424|NCT01572792|COPD|copd
5014425|NCT01572792|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5014426|NCT01572792|Chronic Bronchitis|chronic bronchitis
5014427|NCT01572792|Emphysema|emphysema
5014428|NCT01572792|Airflow Obstruction, Chronic|airflow obstruction, chronic
5014429|NCT01572792|Chronic Airflow Obstruction|chronic airflow obstruction
5014430|NCT01572792|Chronic Obstructive Airway Disease|chronic obstructive airway disease
5014431|NCT01572792|Chronic Obstructive Lung Disease|chronic obstructive lung disease
5014432|NCT01572779|dorsavi|dorsavi
5014433|NCT01572779|vimove|vimove
5014434|NCT01572779|biofeedback|biofeedback
5014435|NCT01572779|objective movement data|objective movement data
5014436|NCT01572779|back pain|back pain
5014437|NCT01572766|Osteoporosis|osteoporosis
5014438|NCT01572766|Pharmacist|pharmacist
5014439|NCT01572766|Behavior Change|behavior change
5014440|NCT01572766|FRAX|frax
5014441|NCT01572766|Osteopenia|osteopenia
5014442|NCT01572727|BKM120|bkm120
5014443|NCT01572727|paclitaxel|paclitaxel
5014444|NCT01572727|breast cancer|breast cancer
5014445|NCT01572727|metastatic|metastatic
5014446|NCT01572727|locally advanced|locally advanced
5014447|NCT01572727|PI3K|pi3k
5014448|NCT01572727|PIK3CA|pik3ca
5014449|NCT01572727|PTEN|pten
5014450|NCT01572714|Exercise|exercise
5014451|NCT01572714|Self Care|self care
5014452|NCT01572714|Fatigue|fatigue
5014453|NCT01572675|Pharmacoepidemiological|pharmacoepidemiological
5014454|NCT01572675|Longitudinal|longitudinal
5014455|NCT01572675|Observational|observational
5014456|NCT01572662|Leukemia|leukemia
5014457|NCT01572662|Acute myeloid leukemia|acute myeloid leukemia
5014458|NCT01572662|Acute lymphocytic leukemia|acute lymphocytic leukemia
5014459|NCT01572662|Chronic myeloid leukemia|chronic myeloid leukemia
5014460|NCT01572662|Chronic lymphocytic leukemia|chronic lymphocytic leukemia
5014461|NCT01572662|Myeloproliferative Diseases|myeloproliferative diseases
5014462|NCT01572662|Non-Hodgkins Lymphoma|non-hodgkins lymphoma
5014463|NCT01572662|Hodgkins lymphoma|hodgkins lymphoma
5014464|NCT01572662|Multiple myeloma|multiple myeloma
5014465|NCT01572662|Myelodysplastic syndrome|myelodysplastic syndrome
5014466|NCT01572662|MDS|mds
5014467|NCT01572662|Fludarabine monophosphate|fludarabine monophosphate
5014468|NCT01572662|Fludarabine phosphate|fludarabine phosphate
5014469|NCT01572662|Fludara|fludara
5014470|NCT01572662|Busulfan|busulfan
5014471|NCT01572662|Busulfex|busulfex
5014472|NCT01572662|Myleran|myleran
5014473|NCT01572662|Tacrolimus|tacrolimus
5014474|NCT01572662|Prograf|prograf
5014475|NCT01572662|Methotrexate|methotrexate
5014476|NCT01572662|G-CSF|g-csf
5014477|NCT01572662|Filgrastim|filgrastim
5014478|NCT01572662|Neupogen|neupogen
5014479|NCT01572662|Stem cell transplant|stem cell transplant
5014480|NCT01572662|Allogeneic Transplantation|allogeneic transplantation
5014481|NCT01572636|Hurler Syndrome|hurler syndrome
5014482|NCT01572623|Therapeutic strategies for carotid artery stenting|therapeutic strategies for carotid artery stenting
5014483|NCT01572610|CKD patients with type 2 diabetes|ckd patients with type 2 diabetes
5014484|NCT01572597|Helicobacter pylori|helicobacter pylori
5014485|NCT01572597|antibiotic resistance|antibiotic resistance
5014486|NCT01572597|N-acetylcystein|n-acetylcystein
5014487|NCT01572597|biofilm|biofilm
5014488|NCT01572597|second-line eradication treatment|second-line eradication treatment
5014489|NCT01572584|Pneumothorax|pneumothorax
5014490|NCT01572584|Lung ultrasound|lung ultrasound
5014491|NCT01572584|Chest sonography|chest sonography
5014492|NCT01572571|Emergency ultrasound|emergency ultrasound
5014493|NCT01572571|Focused ultrasound|focused ultrasound
5014494|NCT01572571|Point-of-care ultrasound|point-of-care ultrasound
5014495|NCT01572571|Undifferentiated hypotension|undifferentiated hypotension
5014496|NCT01572558|Appendectomy|appendectomy
5014497|NCT01572558|Nonsurgical treatment with antibiotics|nonsurgical treatment with antibiotics
5014498|NCT01572545|bone turnover|bone turnover
5014499|NCT01572545|denosumab|denosumab
5014500|NCT01572545|postmenopausal osteoporosis|postmenopausal osteoporosis
5014501|NCT01572545|sclerostin|sclerostin
5014502|NCT01572545|zolendronic acid|zolendronic acid
5014503|NCT01572532|Adverse Perinatal Outcomes|adverse perinatal outcomes
5014504|NCT01572532|Treatment of abnormal vaginal flora|treatment of abnormal vaginal flora
5014505|NCT01572519|Relapsed Hodgkin lymphoma|relapsed hodgkin lymphoma
5014506|NCT01572519|Refractory Hodgkin lymphoma|refractory hodgkin lymphoma
5014507|NCT01572519|JNJ-40346527|jnj-40346527
5014508|NCT01572519|Dose-escalation|dose-escalation
5014509|NCT01572519|Pharmacokinetics|pharmacokinetics
5014510|NCT01572506|Anemia|anemia
5014511|NCT01572506|Elderly|elderly
5014512|NCT01572506|Mechanisms|mechanisms
5014513|NCT01572506|Red Cell Survival|red cell survival
5014640|NCT01571973|depression|depression
5014514|NCT01572493|Pharmacokinetics of lL-15|pharmacokinetics of ll-15
5014515|NCT01572493|Cytokine Therapy|cytokine therapy
5014516|NCT01572493|Effects of rhlL-15 on T-cells and NK cells|effects of rhll-15 on t-cells and nk cells
5014517|NCT01572493|Immunotherapy|immunotherapy
5014518|NCT01572480|Proteasome Inhibitor|proteasome inhibitor
5014519|NCT01572480|Immunomodulatory Agents|immunomodulatory agents
5014520|NCT01572480|Combination Therapy|combination therapy
5014521|NCT01572480|Anti-Myeloma Activity|anti-myeloma activity
5014522|NCT01572480|Smoldering Multiple Myeloma|smoldering multiple myeloma
5014523|NCT01572480|SMM|smm
5014524|NCT01572467|Leydig cell tumor|leydig cell tumor
5014525|NCT01572467|ovarian stromal cancer|ovarian stromal cancer
5014526|NCT01572467|childhood malignant testicular germ cell tumor|childhood malignant testicular germ cell tumor
5014527|NCT01572467|childhood malignant ovarian germ cell tumor|childhood malignant ovarian germ cell tumor
5014528|NCT01572454|coronary artery bypass graft|coronary artery bypass graft
5014529|NCT01572454|hypokalemia|hypokalemia
5014530|NCT01572454|cardiac arrhythmia|cardiac arrhythmia
5014531|NCT01572454|dexmedetomidine|dexmedetomidine
5014532|NCT01572454|remifentanil|remifentanil
5014533|NCT01572428|Proximal Colon Cancer|proximal colon cancer
5014534|NCT01572428|Serrated Colon Lesions|serrated colon lesions
5014535|NCT01572428|Narrow Band Imaging|narrow band imaging
5014536|NCT01572415|Screening for Type 2 diabetes|screening for type 2 diabetes
5014537|NCT01572402|Diet|diet
5014538|NCT01572402|Gastrointestinal peptides|gastrointestinal peptides
5014539|NCT01572402|Insulin secretion|insulin secretion
5014540|NCT01572402|Oxidative stress|oxidative stress
5014541|NCT01572402|Plasma lipids|plasma lipids
5014542|NCT01572402|Postprandial|postprandial
5014543|NCT01572402|Type 2 diabetes|type 2 diabetes
5014544|NCT01572389|Diabetes Mellitus|diabetes mellitus
5014545|NCT01572389|Depression|depression
5014546|NCT01572389|Affective Symptoms|affective symptoms
5014547|NCT01572389|Self Care|self care
5014548|NCT01572389|Telemedicine|telemedicine
5014549|NCT01572389|Psychotherapy|psychotherapy
5014550|NCT01572376|Pressure ulcers|pressure ulcers
5014551|NCT01572376|Chronic wounds|chronic wounds
5014552|NCT01572376|Spinal cord injury patients|spinal cord injury patients
5014553|NCT01572376|Bone marrow|bone marrow
5014554|NCT01572376|Mononuclear|mononuclear
5014555|NCT01572376|Debridement|debridement
5014556|NCT01572363|Fontan|fontan
5014557|NCT01572363|Cardiac magnetic resonance imaging|cardiac magnetic resonance imaging
5014558|NCT01572363|Sildenafil|sildenafil
5014559|NCT01572337|NIV|niv
5014560|NCT01572337|acute respiratory failure|acute respiratory failure
5014561|NCT01572337|hypoxia|hypoxia
5014562|NCT01572337|hypercapnia|hypercapnia
5014563|NCT01572337|non-invasive ventilation|non-invasive ventilation
5014564|NCT01572337|hospital ward|hospital ward
5014565|NCT01572324|Cholangiocarcinoma|cholangiocarcinoma
5014566|NCT01572324|gallbladder cancer|gallbladder cancer
5014567|NCT01572324|Infusions|infusions
5014568|NCT01572324|Intra-Arterial|intra-arterial
5014569|NCT01572311|Aerobic exercise|aerobic exercise
5014570|NCT01572311|Cognition|cognition
5014571|NCT01572311|Dual Task|dual task
5014572|NCT01572311|Gait Training|gait training
5014573|NCT01572311|Group-based exercise|group-based exercise
5014574|NCT01572311|Older adults|older adults
5014575|NCT01572285|Hemiplegic|hemiplegic
5014576|NCT01572285|Shoulder Pain|shoulder pain
5014577|NCT01572285|Transforaminal|transforaminal
5014578|NCT01572285|Treatment|treatment
5014579|NCT01572285|Interventional|interventional
5014580|NCT01572272|Distal Capnography|distal capnography
5014581|NCT01572272|CO2|co2
5014582|NCT01572272|neonates|neonates
5014583|NCT01572272|conventional ventilation|conventional ventilation
5014584|NCT01572246|electrosurgery|electrosurgery
5014585|NCT01572246|Cardiac surgical procedures|cardiac surgical procedures
5014586|NCT01572246|Surgical procedures, operative|surgical procedures, operative
5014587|NCT01572246|Defibrillators|defibrillators
5014588|NCT01572233|Fatigue,Physical Activity,Hepatitis C Virus Infection|fatigue,physical activity,hepatitis c virus infection
5014589|NCT01572220|Hospitalized patients|hospitalized patients
5014590|NCT01572207|Multiple Sclerosis|multiple sclerosis
5014591|NCT01572207|Exercise|exercise
5014592|NCT01572207|Physical activity|physical activity
5014593|NCT01572207|Quality of life|quality of life
5014594|NCT01572194|CF|cf
5014595|NCT01572168|Fatigue|fatigue
5014596|NCT01572142|Parkinson disease|parkinson disease
5014597|NCT01572142|smell|smell
5014598|NCT01572142|cognitive|cognitive
5014599|NCT01572116|sufentanil|sufentanil
5014600|NCT01572116|irreversible pulpitis|irreversible pulpitis
5014601|NCT01572116|intra ligament injection|intra ligament injection
5014602|NCT01572090|Body mass index|body mass index
5014603|NCT01572090|Body fat|body fat
5014604|NCT01572090|Obesity|obesity
5014605|NCT01572090|Bariatric surgery|bariatric surgery
5014606|NCT01572090|Conventional dietary treatment|conventional dietary treatment
5014607|NCT01572090|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
5014608|NCT01572090|Cardiometabolic risk factors|cardiometabolic risk factors
5014609|NCT01572090|Inflammation|inflammation
5014610|NCT01572090|Adipokines|adipokines
5014611|NCT01572090|Gastrointestinal hormones|gastrointestinal hormones
5014612|NCT01572090|Comorbidity improvement|comorbidity improvement
5014613|NCT01572090|Energy intake|energy intake
5014614|NCT01572090|Energy expenditure|energy expenditure
5014615|NCT01572090|Physical activity|physical activity
5014616|NCT01572064|MRI|mri
5014617|NCT01572064|liver biopsy|liver biopsy
5014618|NCT01572064|serological markers|serological markers
5014619|NCT01572051|osteoarthritis|osteoarthritis
5014620|NCT01572051|knee osteoarthritis|knee osteoarthritis
5014621|NCT01572051|education|education
5014622|NCT01572012|Pharmacokinetics|pharmacokinetics
5014623|NCT01572012|Safety|safety
5014624|NCT01572012|Healthy Volunteers|healthy volunteers
5014625|NCT01572012|tolerability|tolerability
5014626|NCT01571999|pharmacokinetics|pharmacokinetics
5014627|NCT01571999|GW642444|gw642444
5014628|NCT01571999|GSK573719|gsk573719
5014629|NCT01571999|vilanterol|vilanterol
5014630|NCT01571999|renal impairment|renal impairment
5014631|NCT01571999|safety|safety
5014632|NCT01571999|COPD|copd
5014633|NCT01571986|NIV|niv
5014634|NCT01571986|acute respiratory failure|acute respiratory failure
5014635|NCT01571986|hypoxia|hypoxia
5014636|NCT01571986|hypercapnia|hypercapnia
5014637|NCT01571986|non-invasive ventilation|non-invasive ventilation
5014638|NCT01571986|hospital ward|hospital ward
5014639|NCT01571973|pharmaceutical care|pharmaceutical care
5014641|NCT01571973|compliance|compliance
5014642|NCT01571973|pharmacist's intervention|pharmacist's intervention
5014643|NCT01571973|Dáder|dáder
5014644|NCT01571947|Insulinaemia|insulinaemia
5014645|NCT01571947|inflammatory markers|inflammatory markers
5014646|NCT01571947|gastrointestinal peptides|gastrointestinal peptides
5014647|NCT01571947|SFA|sfa
5014648|NCT01571947|dietary fats|dietary fats
5014649|NCT01571947|carbohydrate|carbohydrate
5014650|NCT01571947|insulin sensitivity|insulin sensitivity
5014651|NCT01571934|Hemophilia A|hemophilia a
5014652|NCT01571908|rocuronium|rocuronium
5014653|NCT01571908|succinylcholine|succinylcholine
5014654|NCT01571908|magnesiumsulphate|magnesiumsulphate
5014655|NCT01571908|intubation conditions|intubation conditions
5014656|NCT01571895|Autoimmune inflammatory blistering disorder|autoimmune inflammatory blistering disorder
5014657|NCT01571882|Plant sterol - Policosanols - Hypercholesterolemia - Dairy|plant sterol - policosanols - hypercholesterolemia - dairy
5014658|NCT01571869|Plant sterol - hypercholesterolemia - dairy - meal|plant sterol - hypercholesterolemia - dairy - meal
5014659|NCT01571856|Acute Diarrhea|acute diarrhea
5014660|NCT01571856|Zinc|zinc
5014661|NCT01571856|Children|children
5014662|NCT01571843|Hyperparathyroidism, Primary|hyperparathyroidism, primary
5014663|NCT01571843|Bone Diseases, Metabolic|bone diseases, metabolic
5014664|NCT01571843|Osteoporosis, Postmenopausal|osteoporosis, postmenopausal
5014665|NCT01571843|Bone Loss, Postmenopausal|bone loss, postmenopausal
5014666|NCT01571830|food allergy|food allergy
5014667|NCT01571830|nutrient intake|nutrient intake
5014668|NCT01571830|growth|growth
5014669|NCT01571817|Insulin Dependent|insulin dependent
5014670|NCT01571804|Anesthesia|anesthesia
5014671|NCT01571804|pregabalin|pregabalin
5014672|NCT01571804|sevoflurane|sevoflurane
5014673|NCT01571804|laparoscopic cholecystectomy|laparoscopic cholecystectomy
5014674|NCT01571791|Ketorolac|ketorolac
5014675|NCT01571791|lidocaine|lidocaine
5014676|NCT01571791|valvular hear diseases|valvular hear diseases
5014677|NCT01571791|cesarean section|cesarean section
5014678|NCT01571778|Hand Hygiene|hand hygiene
5014679|NCT01571778|Non-sterile Glove Use|non-sterile glove use
5014680|NCT01571765|maternal|maternal
5014681|NCT01571765|newborn|newborn
5014682|NCT01571765|child|child
5014683|NCT01571752|Drug Abuse/Dependence|drug abuse/dependence
5014684|NCT01571752|Drug Abuse|drug abuse
5014685|NCT01571752|Drug Dependence|drug dependence
5014686|NCT01571739|Biomarker|biomarker
5014687|NCT01571739|Latent Tuberculosis|latent tuberculosis
5014688|NCT01571739|IGRA|igra
5014689|NCT01571739|Isoniazid|isoniazid
5014690|NCT01571739|TB Lymphadenopathy|tb lymphadenopathy
5014691|NCT01571739|Tuberculosis|tuberculosis
5014692|NCT01571739|TB|tb
5014693|NCT01571726|(18)-Fluciclatide PET/CT|(18)-fluciclatide pet/ct
5014694|NCT01571726|Serum M-Protein|serum m-protein
5014695|NCT01571726|Percentage of Plasma Cells in the Bone Marrow|percentage of plasma cells in the bone marrow
5014696|NCT01571726|Ratio of Normal/Abnormal Percentage of Plasma Cells in the Bone Marrow|ratio of normal/abnormal percentage of plasma cells in the bone marrow
5014697|NCT01571726|Multiple Myeloma|multiple myeloma
5014698|NCT01571700|Mechanical Dysynchrony|mechanical dysynchrony
5014699|NCT01571700|Electrical Dysynchrony|electrical dysynchrony
5014700|NCT01571687|expedition|expedition
5014701|NCT01571687|hypoxia|hypoxia
5014702|NCT01571687|blood coagulation disorders|blood coagulation disorders
5014703|NCT01571687|cell-derived microparticles|cell-derived microparticles
5014704|NCT01571687|oxidative stress|oxidative stress
5014705|NCT01571687|N-Acetylcystein|n-acetylcystein
5014706|NCT01571687|vitamins|vitamins
5014707|NCT01571674|Cervical|cervical
5014708|NCT01571674|Clinical Prediction Rule|clinical prediction rule
5014709|NCT01571674|Exercise|exercise
5014710|NCT01571674|Manipulation|manipulation
5014711|NCT01571674|Manual therapy|manual therapy
5014712|NCT01571674|Mobilization|mobilization
5014713|NCT01571674|Physical Therapy|physical therapy
5014714|NCT01571674|Prognosis|prognosis
5014715|NCT01571674|Shoulder pain|shoulder pain
5014716|NCT01571674|Thoracic|thoracic
5014717|NCT01571661|KGT-1142|kgt-1142
5014718|NCT01571661|safety|safety
5014719|NCT01571661|pharmacokinetics|pharmacokinetics
5014720|NCT01571661|single-dose escalation|single-dose escalation
5014721|NCT01571661|tolerability|tolerability
5014722|NCT01571635|Beta-Thalassaemia|beta-thalassaemia
5014723|NCT01571622|Whey protein|whey protein
5014724|NCT01571622|type 2 diabetes|type 2 diabetes
5014725|NCT01571596|XLH|xlh
5014726|NCT01571583|Chronic HCV infection|chronic hcv infection
5014727|NCT01571583|Genotype 1 chronic HCV|genotype 1 chronic hcv
5014728|NCT01571583|Liver transplantation|liver transplantation
5014729|NCT01571583|Hepatitis C|hepatitis c
5014730|NCT01571583|Hep C|hep c
5014731|NCT01571583|HCV|hcv
5014732|NCT01571583|Telaprevir|telaprevir
5014733|NCT01571583|Pegylated-Interferon-alfa-2a|pegylated-interferon-alfa-2a
5014734|NCT01571583|Ribavirin|ribavirin
5014735|NCT01571570|Healthy volunteers|healthy volunteers
5014736|NCT01571570|Food effect|food effect
5014737|NCT01571570|Capsule|capsule
5014738|NCT01571570|Formulations|formulations
5014739|NCT01571570|Liquid formulation|liquid formulation
5014740|NCT01571570|Concept K|concept k
5014741|NCT01571570|Concept L|concept l
5014742|NCT01571570|Oral suspension|oral suspension
5014743|NCT01571570|Oral solution|oral solution
5014744|NCT01571570|TMC435HPC1002|tmc435hpc1002
5014745|NCT01571570|TMC435|tmc435
5014746|NCT01571570|HPC|hpc
5014747|NCT01571518|G-CSF|g-csf
5014748|NCT01571518|neutropenia|neutropenia
5014749|NCT01571518|TAC|tac
5014750|NCT01571505|Oral vaccines|oral vaccines
5014751|NCT01571505|Vaccine Responsiveness|vaccine responsiveness
5014752|NCT01571505|Tropical Enteropathy|tropical enteropathy
5014753|NCT01571492|Postoperative Pain|postoperative pain
5014754|NCT01571492|Nerve block|nerve block
5014755|NCT01571492|Total Hip Arthroplasty|total hip arthroplasty
5014756|NCT01571492|Postoperative analgesia|postoperative analgesia
5014757|NCT01571492|Lumbar Plexus Catheters|lumbar plexus catheters
5014758|NCT01571492|L2 Paravertebral Catheters|l2 paravertebral catheters
5014759|NCT01571479|laparoscopic cholecystectomy|laparoscopic cholecystectomy
5014760|NCT01571479|mini-instrument|mini-instrument
5014761|NCT01571466|HIV Seronegativity|hiv seronegativity
5014762|NCT01571466|HIV Preventive Vaccine|hiv preventive vaccine
5014763|NCT01571453|MDD|mdd
5014764|NCT01571440|Bone|bone
5014765|NCT01571440|adolescents|adolescents
5014766|NCT01571440|fiber|fiber
5014767|NCT01571440|healthy|healthy
5014768|NCT01571440|boys|boys
5014769|NCT01571440|girls|girls
5014770|NCT01571440|camp|camp
5014771|NCT01571440|calcium|calcium
5014772|NCT01571427|Behavioral intervention|behavioral intervention
5014773|NCT01571427|Social engagement|social engagement
5014774|NCT01571427|Conversational engagement|conversational engagement
5014775|NCT01571427|Social network|social network
5014881|NCT01571011|Prevention|prevention
5014776|NCT01571427|Cognitive Reserve|cognitive reserve
5014777|NCT01571427|Alzheimer's disease|alzheimer's disease
5014778|NCT01571401|Kidney cancer survivors|kidney cancer survivors
5014779|NCT01571401|Randomized Controlled Trial|randomized controlled trial
5014780|NCT01571401|Physical Activity|physical activity
5014781|NCT01571401|Theory of Planned Behaviour|theory of planned behaviour
5014782|NCT01571401|Quality of life|quality of life
5014783|NCT01571388|dacomitinib|dacomitinib
5014784|NCT01571388|PF-00299804|pf-00299804
5014785|NCT01571388|hepatic impairment|hepatic impairment
5014786|NCT01571388|pharmacokinetics|pharmacokinetics
5014787|NCT01571375|Traumatic Brain Injury|traumatic brain injury
5014788|NCT01571375|HEMS|hems
5014789|NCT01571375|Out-of-hospital|out-of-hospital
5014790|NCT01571375|Finland|finland
5014791|NCT01571362|oxycodone|oxycodone
5014792|NCT01571362|naltrexone|naltrexone
5014793|NCT01571362|chronic pain|chronic pain
5014794|NCT01571362|low back pain|low back pain
5014795|NCT01571349|rebalanced hemostasis|rebalanced hemostasis
5014796|NCT01571349|idiopathic thrombocytopenic purpura|idiopathic thrombocytopenic purpura
5014797|NCT01571349|coagulation status|coagulation status
5014798|NCT01571323|post partum haemorrhage at cesarean section|post partum haemorrhage at cesarean section
5014799|NCT01571297|Diabetes Mellitus|diabetes mellitus
5014800|NCT01571297|Delayed Gastric Emptying|delayed gastric emptying
5014801|NCT01571297|Gastroparesis|gastroparesis
5014802|NCT01571297|Gastrointestinal Motility Disorder|gastrointestinal motility disorder
5014803|NCT01571271|biliary|biliary
5014804|NCT01571271|lithotripsy|lithotripsy
5014805|NCT01571271|gall stones|gall stones
5014806|NCT01571271|bile duct|bile duct
5014807|NCT01571271|Biliary stones|biliary stones
5014808|NCT01571258|SMS|sms
5014809|NCT01571258|Obesity|obesity
5014810|NCT01571258|Text Messaging|text messaging
5014811|NCT01571258|Intervention|intervention
5014812|NCT01571258|Mobile Phone|mobile phone
5014813|NCT01571245|Heart rate variability|heart rate variability
5014814|NCT01571245|Attentional Bias|attentional bias
5014815|NCT01571232|Macular Edema|macular edema
5014816|NCT01571232|DME|dme
5014817|NCT01571232|PDR|pdr
5014818|NCT01571232|NPDR|npdr
5014819|NCT01571232|Ozurdex|ozurdex
5014820|NCT01571232|Dexamethasone|dexamethasone
5014821|NCT01571232|Avastin|avastin
5014822|NCT01571232|Bevacizumab|bevacizumab
5014823|NCT01571219|RA|ra
5014824|NCT01571219|Biosimilar|biosimilar
5014825|NCT01571206|AS|as
5014826|NCT01571206|Biosimilar|biosimilar
5014827|NCT01571180|Obesity|obesity
5014828|NCT01571180|Gastric bypass|gastric bypass
5014829|NCT01571180|Medication|medication
5014830|NCT01571180|Medication counseling|medication counseling
5014831|NCT01571180|Dietary pattern|dietary pattern
5014832|NCT01571180|Follow-up of patients|follow-up of patients
5014833|NCT01571167|Methamphetamine|methamphetamine
5014834|NCT01571167|Chantix|chantix
5014835|NCT01571167|Varenicline|varenicline
5014836|NCT01571141|HPV|hpv
5014837|NCT01571141|polyhexamethylene biguanide|polyhexamethylene biguanide
5014838|NCT01571141|intraepithelial lesions|intraepithelial lesions
5014839|NCT01571141|regression rate|regression rate
5014840|NCT01571128|HIV|hiv
5014841|NCT01571128|Prevention & Control|prevention & control
5014842|NCT01571128|Intervention Studies|intervention studies
5014843|NCT01571128|Adolescent|adolescent
5014844|NCT01571128|Gender|gender
5014845|NCT01571128|Combination prevention|combination prevention
5014846|NCT01571128|Pre-Exposure Prophylaxis|pre-exposure prophylaxis
5014847|NCT01571128|Cash Transfer|cash transfer
5014848|NCT01571128|Medical Male Circumcision|medical male circumcision
5014849|NCT01571128|HIV Testing|hiv testing
5014850|NCT01571128|Mobile Health|mobile health
5014851|NCT01571115|insomnia|insomnia
5014852|NCT01571115|resistance physical exercise|resistance physical exercise
5014853|NCT01571115|stretching|stretching
5014854|NCT01571089|Dialectical behavior therapy|dialectical behavior therapy
5014855|NCT01571089|cognitive behavioral therapy|cognitive behavioral therapy
5014856|NCT01571089|emotion regulation|emotion regulation
5014857|NCT01571089|emotion dysregulation|emotion dysregulation
5014858|NCT01571089|anxiety disorders|anxiety disorders
5014859|NCT01571089|skills training|skills training
5014860|NCT01571076|PGS|pgs
5014861|NCT01571076|CGH|cgh
5014862|NCT01571076|Aneuploidy|aneuploidy
5014863|NCT01571076|Advanced maternal age|advanced maternal age
5014864|NCT01571076|Male factor|male factor
5014865|NCT01571050|toothpastes|toothpastes
5014866|NCT01571050|dental fluorosis|dental fluorosis
5014867|NCT01571050|fluoride|fluoride
5014868|NCT01571050|bioavailability|bioavailability
5014869|NCT01571037|mechanical circulatory assist device|mechanical circulatory assist device
5014870|NCT01571024|FOLFOX6|folfox6
5014871|NCT01571024|BKM120|bkm120
5014872|NCT01571024|Advanced Solid Tumors|advanced solid tumors
5014873|NCT01571024|Metastatic|metastatic
5014874|NCT01571024|Colorectal Cancer|colorectal cancer
5014875|NCT01571024|Pancreatic Cancer|pancreatic cancer
5014876|NCT01571011|Adolescent|adolescent
5014877|NCT01571011|Randomized Trial|randomized trial
5014878|NCT01571011|Internet|internet
5014879|NCT01571011|Depressive Disorder|depressive disorder
5014880|NCT01571011|Primary Care|primary care
5014882|NCT01570985|shoulder capsulitis|shoulder capsulitis
5014883|NCT01570985|frozen shoulder|frozen shoulder
5014884|NCT01570985|adhesive capsulitis|adhesive capsulitis
5014885|NCT01570985|distension|distension
5014886|NCT01570985|corticosteroid injection|corticosteroid injection
5014887|NCT01570985|intraarticular injection|intraarticular injection
5014888|NCT01570972|schizophrenia|schizophrenia
5014889|NCT01570972|schizoaffective disorder|schizoaffective disorder
5014890|NCT01570972|bipolar disorder with psychotic features|bipolar disorder with psychotic features
5014891|NCT01570972|major depression with psychotic features|major depression with psychotic features
5014892|NCT01570972|recent-onset psychosis|recent-onset psychosis
5014893|NCT01570972|first-episode psychosis|first-episode psychosis
5014894|NCT01570972|cognitive behavioral therapy|cognitive behavioral therapy
5014895|NCT01570972|multifamily group psychoeducation|multifamily group psychoeducation
5014896|NCT01570946|Lifestyle changes to prevent type 2 diabetes|lifestyle changes to prevent type 2 diabetes
5014897|NCT01570933|cardio-pulmonary bypass|cardio-pulmonary bypass
5014898|NCT01570920|Activity limitations|activity limitations
5014899|NCT01570920|restriction of participation|restriction of participation
5014900|NCT01570920|chronic stroke survival|chronic stroke survival
5014901|NCT01570920|physical activity|physical activity
5014902|NCT01570920|walking|walking
5014903|NCT01570881|postoperative delirium|postoperative delirium
5014904|NCT01570881|melatonin|melatonin
5014905|NCT01570881|sevoflurane|sevoflurane
5014906|NCT01570868|Leukemia|leukemia
5014907|NCT01570868|Chronic Myeloid Leukemia|chronic myeloid leukemia
5014908|NCT01570868|CML|cml
5014909|NCT01570868|Chronic Phase|chronic phase
5014910|NCT01570868|Cytogenetic response|cytogenetic response
5014911|NCT01570868|CCyR|ccyr
5014912|NCT01570868|Major molecular response|major molecular response
5014913|NCT01570868|MMR|mmr
5014914|NCT01570868|Complete molecular response|complete molecular response
5014915|NCT01570868|CMR|cmr
5014916|NCT01570868|Ponatinib|ponatinib
5014917|NCT01570868|AP24534|ap24534
5014918|NCT01570855|Lung cancer|lung cancer
5014919|NCT01570855|chemosensitivity|chemosensitivity
5014920|NCT01570842|Gastroesophageal reflux disease|gastroesophageal reflux disease
5014921|NCT01570842|GERD|gerd
5014922|NCT01570842|Barrett's esophagus|barrett's esophagus
5014923|NCT01570816|stroke|stroke
5014924|NCT01570816|partial paralysis|partial paralysis
5014925|NCT01570816|gait correction|gait correction
5014926|NCT01570816|functional electrical stimulation|functional electrical stimulation
5014927|NCT01570816|paraplegia|paraplegia
5014928|NCT01570816|tetraplegia|tetraplegia
5014929|NCT01570816|spinal cord injury|spinal cord injury
5014930|NCT01570803|peripheral arterial disease,|peripheral arterial disease,
5014931|NCT01570803|atherosclerosis,|atherosclerosis,
5014932|NCT01570803|nitinol,|nitinol,
5014933|NCT01570803|stents|stents
5014934|NCT01570777|Resistant hypertension|resistant hypertension
5014935|NCT01570777|Renal denervation|renal denervation
5014936|NCT01570777|Standardized medication regimen|standardized medication regimen
5014937|NCT01570777|Endovascular|endovascular
5014938|NCT01570777|Primary hypertension|primary hypertension
5014939|NCT01570777|Cardiovascular diseases|cardiovascular diseases
5014940|NCT01570777|Vascular diseases|vascular diseases
5014941|NCT01570764|Systemic sclerosis|systemic sclerosis
5014942|NCT01570764|Interstitial lung disease|interstitial lung disease
5014943|NCT01570764|Worsening|worsening
5014944|NCT01570764|Cyclophosphamide|cyclophosphamide
5014945|NCT01570764|Intravenous|intravenous
5014946|NCT01570738|sleep disorders|sleep disorders
5014947|NCT01570738|sleep apnea|sleep apnea
5014948|NCT01570738|ambulatory device|ambulatory device
5014949|NCT01570738|polysomnography|polysomnography
5014950|NCT01570738|WatchPAT|watchpat
5014951|NCT01570725|Immersive virtual reality|immersive virtual reality
5014952|NCT01570725|e-health|e-health
5014953|NCT01570725|surgery|surgery
5014954|NCT01570725|anxiety|anxiety
5014955|NCT01570725|relaxation|relaxation
5014956|NCT01570725|Patients who undergo ambulatory surgical operations|patients who undergo ambulatory surgical operations
5014957|NCT01570699|Cross-sectional observational study|cross-sectional observational study
5014958|NCT01570699|COMT polymorphism|comt polymorphism
5014959|NCT01570699|Opiate-users|opiate-users
5014960|NCT01570699|Opiate dependence|opiate dependence
5014961|NCT01570686|Food effect, hypertension, aliskiren|food effect, hypertension, aliskiren
5014962|NCT01570673|quality of life|quality of life
5014963|NCT01570673|urinary bladder|urinary bladder
5014964|NCT01570673|symptoms|symptoms
5014965|NCT01570673|children|children
5014966|NCT01570634|Clostridium difficile|clostridium difficile
5014967|NCT01570634|infection|infection
5014968|NCT01570634|diarrhea|diarrhea
5014969|NCT01570634|cramping|cramping
5014970|NCT01570621|achalasia|achalasia
5014971|NCT01570621|peroral endoscopic myotomy|peroral endoscopic myotomy
5014972|NCT01570621|LES pressure|les pressure
5014973|NCT01570621|postoperative complication|postoperative complication
5014974|NCT01570621|symptom relief|symptom relief
5014975|NCT01570621|esophageal barium|esophageal barium
5014976|NCT01570608|Ranibizumab|ranibizumab
5014977|NCT01570608|Bevacizumab|bevacizumab
5014978|NCT01570608|Verteporfin|verteporfin
5015075|NCT01570283|BK virus|bk virus
5014979|NCT01570608|age-related macular degeneration|age-related macular degeneration
5014980|NCT01570595|Tobacco Use Cessation|tobacco use cessation
5014981|NCT01570595|Tobacco Cessation|tobacco cessation
5014982|NCT01570595|Tobacco Use Disorder|tobacco use disorder
5014983|NCT01570595|Tobacco Dependence|tobacco dependence
5014984|NCT01570595|Tobacco-Use Disorder|tobacco-use disorder
5014985|NCT01570595|Virus, Human Immunodeficiency|virus, human immunodeficiency
5014986|NCT01570582|recurrent ovarian|recurrent ovarian
5014987|NCT01570582|ECG|ecg
5014988|NCT01570582|GOG performance|gog performance
5014989|NCT01570582|Hematologic g|hematologic g
5014990|NCT01570582|Blood chemistry and urinalysis h|blood chemistry and urinalysis h
5014991|NCT01570569|Volunteers|volunteers
5014992|NCT01570556|Hemodialysis|hemodialysis
5014993|NCT01570556|Inflammation|inflammation
5014994|NCT01570556|Bacteriuria|bacteriuria
5014995|NCT01570556|Interleukin 6|interleukin 6
5014996|NCT01570556|C reactive protein|c reactive protein
5014997|NCT01570543|implants|implants
5014998|NCT01570543|knee implants|knee implants
5014999|NCT01570543|hip implants|hip implants
5015000|NCT01570543|metallic implants|metallic implants
5015001|NCT01570504|Strongyloidiasis|strongyloidiasis
5015002|NCT01570504|Strongyloides stercoralis|strongyloides stercoralis
5015003|NCT01570504|Ivermectin|ivermectin
5015004|NCT01570465|AML|aml
5015005|NCT01570465|adult|adult
5015006|NCT01570465|AML1310 GIMEMA study|aml1310 gimema study
5015007|NCT01570452|matrilysin|matrilysin
5015008|NCT01570452|MMP-7|mmp-7
5015009|NCT01570452|colorectal cancer|colorectal cancer
5015010|NCT01570452|adenoma|adenoma
5015011|NCT01570452|lymph nodes|lymph nodes
5015012|NCT01570426|Bipolar disorder|bipolar disorder
5015013|NCT01570426|Mood disorders|mood disorders
5015014|NCT01570426|ADHD|adhd
5015015|NCT01570426|Attention Deficit Disorder with Hyperactivity|attention deficit disorder with hyperactivity
5015016|NCT01570426|Attention Deficit Disorder without Hyperactivity|attention deficit disorder without hyperactivity
5015017|NCT01570426|Anxiety disorders|anxiety disorders
5015018|NCT01570426|Generalized anxiety disorder|generalized anxiety disorder
5015019|NCT01570426|Magnetic resonance imaging|magnetic resonance imaging
5015020|NCT01570426|Mental disorders|mental disorders
5015021|NCT01570426|Mental disorders diagnosed in childhood|mental disorders diagnosed in childhood
5015022|NCT01570426|affective neuroscience|affective neuroscience
5015023|NCT01570426|emotion|emotion
5015024|NCT01570426|MRI|mri
5015025|NCT01570426|fMRI|fmri
5015026|NCT01570426|neurocognitive tasks|neurocognitive tasks
5015027|NCT01570426|imaging|imaging
5015028|NCT01570426|Healthy controls|healthy controls
5015029|NCT01570426|typical development|typical development
5015030|NCT01570400|social phobia|social phobia
5015031|NCT01570400|social anxiety|social anxiety
5015032|NCT01570400|cognitive bias modification|cognitive bias modification
5015033|NCT01570374|Cognitive behavioral therapy|cognitive behavioral therapy
5015034|NCT01570374|Internet|internet
5015035|NCT01570374|Anxiety|anxiety
5015036|NCT01570374|Generalized anxiety disorder|generalized anxiety disorder
5015037|NCT01570361|Atrial Fibrillation|atrial fibrillation
5015038|NCT01570361|Arrhythmias, Cardiac|arrhythmias, cardiac
5015039|NCT01570361|Heart Diseases|heart diseases
5015040|NCT01570361|Cardiovascular Diseases|cardiovascular diseases
5015041|NCT01570361|Pathologic Processes|pathologic processes
5015042|NCT01570348|Crohn's Disease|crohn's disease
5015043|NCT01570348|Allogeneic bone marrow transplantation|allogeneic bone marrow transplantation
5015044|NCT01570348|Hematopoietic cell transplantation|hematopoietic cell transplantation
5015045|NCT01570335|SBAR,|sbar,
5015046|NCT01570335|SAQ,|saq,
5015047|NCT01570335|Team Resource Management|team resource management
5015048|NCT01570322|Dementia - Alzheimer - Quality of life|dementia - alzheimer - quality of life
5015049|NCT01570309|vitamin D,|vitamin d,
5015050|NCT01570309|vitamin D deficiency|vitamin d deficiency
5015051|NCT01570309|coronary artery disease|coronary artery disease
5015052|NCT01570309|ergocalciferol|ergocalciferol
5015053|NCT01570309|endothelial function|endothelial function
5015054|NCT01570309|adhesion molecules|adhesion molecules
5015055|NCT01570309|inflammation|inflammation
5015056|NCT01570309|IL-12|il-12
5015057|NCT01570309|interferon-gamma|interferon-gamma
5015058|NCT01570309|CXCL-10|cxcl-10
5015059|NCT01570309|reactive hyperemia peripheral arterial tonometry|reactive hyperemia peripheral arterial tonometry
5015060|NCT01570309|endothelial dysfunction|endothelial dysfunction
5015061|NCT01570309|cytokines|cytokines
5015062|NCT01570309|chemokines|chemokines
5015063|NCT01570296|Advanced Non-Small Cell Lung Cancer|advanced non-small cell lung cancer
5015064|NCT01570296|tumors harbor molecular|tumors harbor molecular
5015065|NCT01570296|alterations of PI3K pathway|alterations of pi3k pathway
5015066|NCT01570296|known to overexpress EGFR|known to overexpress egfr
5015067|NCT01570283|post allogeneic hematopoietic stem cell transplant|post allogeneic hematopoietic stem cell transplant
5015068|NCT01570283|cytotoxic T lymphocytes|cytotoxic t lymphocytes
5015069|NCT01570283|Cytomegalovirus|cytomegalovirus
5015070|NCT01570283|CMV|cmv
5015071|NCT01570283|adenovirus|adenovirus
5015072|NCT01570283|Epstein-Barr virus|epstein-barr virus
5015073|NCT01570283|EBV|ebv
5015074|NCT01570283|Human polyomavirus type I|human polyomavirus type i
5015076|NCT01570283|Human herpesvirus 6|human herpesvirus 6
5015077|NCT01570283|HHV6|hhv6
5015078|NCT01570270|Hypercholesterolemia|hypercholesterolemia
5015079|NCT01570270|Endocannabinoids|endocannabinoids
5015080|NCT01570257|normal pressure hydrocephalus|normal pressure hydrocephalus
5015081|NCT01570257|ventriculoperitoneal shunt|ventriculoperitoneal shunt
5015082|NCT01570257|overdrainage|overdrainage
5015083|NCT01570257|subdural effusion|subdural effusion
5015084|NCT01570231|remote ischemic preconditioning|remote ischemic preconditioning
5015085|NCT01570231|octogenarian|octogenarian
5015086|NCT01570231|intracranial arterial stenosis|intracranial arterial stenosis
5015087|NCT01570231|stroke recurrence|stroke recurrence
5015088|NCT01570218|breast cancer|breast cancer
5015089|NCT01570218|gynecological cancer|gynecological cancer
5015090|NCT01570218|radiotherapy|radiotherapy
5015091|NCT01570218|fatigue|fatigue
5015092|NCT01570218|musicotherapy|musicotherapy
5015093|NCT01570192|gram negative pathogens|gram negative pathogens
5015094|NCT01570192|Pseudomonas aeruginosa|pseudomonas aeruginosa
5015095|NCT01570192|Acinetobacter|acinetobacter
5015096|NCT01570192|HCAP|hcap
5015097|NCT01570192|VABP|vabp
5015098|NCT01570192|HABP|habp
5015099|NCT01570179|bariatric surgery|bariatric surgery
5015100|NCT01570179|residual paralysis|residual paralysis
5015101|NCT01570179|surgical conditions|surgical conditions
5015102|NCT01570166|Hepatocellular Carcinoma|hepatocellular carcinoma
5015103|NCT01570166|RFA|rfa
5015104|NCT01570166|HR|hr
5015105|NCT01570127|Individualized Acupuncture|individualized acupuncture
5015106|NCT01570127|Standardized Acupuncture|standardized acupuncture
5015107|NCT01570127|Low Back Pain|low back pain
5015108|NCT01570127|Randomized Controlled Trial|randomized controlled trial
5015109|NCT01570114|Covered metallic stent|covered metallic stent
5015110|NCT01570114|colon|colon
5015111|NCT01570114|benign stricture|benign stricture
5015112|NCT01570075|Hepatocellular Carcinoma|hepatocellular carcinoma
5015113|NCT01570075|RFA|rfa
5015114|NCT01570075|HR|hr
5015115|NCT01570062|Inflammation|inflammation
5015116|NCT01570062|Pathologic Processes|pathologic processes
5015117|NCT01570049|Single arm|single arm
5015118|NCT01570049|Open label|open label
5015119|NCT01570049|Bendamustine HCl|bendamustine hcl
5015120|NCT01570049|Non-hodgkin's lymphoma|non-hodgkin's lymphoma
5015121|NCT01570036|stage I breast cancer|stage i breast cancer
5015122|NCT01570036|stage II breast cancer|stage ii breast cancer
5015123|NCT01570036|stage IIIA breast cancer|stage iiia breast cancer
5015124|NCT01570036|stage IIIB breast cancer|stage iiib breast cancer
5015125|NCT01570036|stage IIIC breast cancer|stage iiic breast cancer
5015126|NCT01570036|male breast cancer|male breast cancer
5015127|NCT01570023|Deglutition|deglutition
5015128|NCT01570023|Exercise|exercise
5015129|NCT01569997|Dementia|dementia
5015130|NCT01569997|emergency hospitalization|emergency hospitalization
5015131|NCT01569997|nursing home|nursing home
5015132|NCT01569997|multidisciplinary meeting|multidisciplinary meeting
5015133|NCT01569997|cognitive decline|cognitive decline
5015134|NCT01569997|disability|disability
5015135|NCT01569997|residents|residents
5015136|NCT01569997|facilities|facilities
5015137|NCT01569997|long term care unit|long term care unit
5015138|NCT01569997|health policy|health policy
5015139|NCT01569997|general practitioner|general practitioner
5015140|NCT01569997|prevention|prevention
5015141|NCT01569984|Colorectal|colorectal
5015142|NCT01569971|Transition Program|transition program
5015143|NCT01569971|Perspectives|perspectives
5015393|NCT01568840|Posture|posture
5015144|NCT01569932|chemobrain, chemotherapy, cognitive impairments, fcMRI, neurocognitive Assessments|chemobrain, chemotherapy, cognitive impairments, fcmri, neurocognitive assessments
5015145|NCT01569919|Phase II|phase ii
5015146|NCT01569919|Single arm|single arm
5015147|NCT01569919|Vaccine|vaccine
5015148|NCT01569906|Atopic Dermatitis|atopic dermatitis
5015149|NCT01569893|Telemonitoring|telemonitoring
5015150|NCT01569893|Telemedicine|telemedicine
5015151|NCT01569893|Diabetes mellitus|diabetes mellitus
5015152|NCT01569880|Blood gas response|blood gas response
5015153|NCT01569880|Exercise|exercise
5015154|NCT01569880|Gas exchange|gas exchange
5015155|NCT01569880|Hypoxia altitude simulation test|hypoxia altitude simulation test
5015156|NCT01569880|Pulmonary function|pulmonary function
5015157|NCT01569828|LCZ696|lcz696
5015158|NCT01569828|pharmacokinetics|pharmacokinetics
5015159|NCT01569815|Renal Impairment,|renal impairment,
5015160|NCT01569815|LCZ696|lcz696
5015161|NCT01569802|breast cancer screening|breast cancer screening
5015162|NCT01569802|tomosynthesis|tomosynthesis
5015163|NCT01569802|FFDM|ffdm
5015164|NCT01569789|cytokines|cytokines
5015165|NCT01569789|inflammation|inflammation
5015166|NCT01569789|vagus nerve|vagus nerve
5015167|NCT01569789|TNF|tnf
5015168|NCT01569776|Cow milk allergy|cow milk allergy
5015169|NCT01569776|CMA|cma
5015170|NCT01569763|endometrial ablation|endometrial ablation
5015171|NCT01569750|CD20-positive B-cell non-Hodgkin lymphoma|cd20-positive b-cell non-hodgkin lymphoma
5015172|NCT01569750|Diffuse large B-cell lymphoma|diffuse large b-cell lymphoma
5015173|NCT01569750|Mantle cell lymphoma|mantle cell lymphoma
5015174|NCT01569750|Follicular lymphoma|follicular lymphoma
5015175|NCT01569750|Ibrutinib|ibrutinib
5015176|NCT01569750|R-CHOP|r-chop
5015177|NCT01569750|Rituximab|rituximab
5015178|NCT01569750|Cyclophosphamide|cyclophosphamide
5015179|NCT01569750|Doxorubicin|doxorubicin
5015180|NCT01569750|Vincristine|vincristine
5015181|NCT01569750|Prednisone|prednisone
5015182|NCT01569737|ella|ella
5015183|NCT01569737|ulipristal acetate|ulipristal acetate
5015184|NCT01569737|pregnancy|pregnancy
5015185|NCT01569737|emergency contraception|emergency contraception
5015186|NCT01569724|hypertriglyceridemia|hypertriglyceridemia
5015187|NCT01569724|bexarotene|bexarotene
5015188|NCT01569711|chronic and resistant major depressive disorder|chronic and resistant major depressive disorder
5015189|NCT01569711|deep brain stimulation|deep brain stimulation
5015190|NCT01569698|pediatric|pediatric
5015191|NCT01569698|acute renal failure|acute renal failure
5015192|NCT01569698|acute extra renal replacement therapy|acute extra renal replacement therapy
5015193|NCT01569698|Intermittent Hemodialysis|intermittent hemodialysis
5015194|NCT01569698|Continuous Renal Replacement Therapies|continuous renal replacement therapies
5015195|NCT01569698|Peritoneal Dialysis|peritoneal dialysis
5015196|NCT01569685|PTSD|ptsd
5015197|NCT01569685|Traumatic Stress|traumatic stress
5015198|NCT01569685|Depressions|depressions
5015199|NCT01569685|Refugees|refugees
5015200|NCT01569672|Navigator|navigator
5015201|NCT01569659|Schizophrenia|schizophrenia
5015202|NCT01569659|Refractory|refractory
5015203|NCT01569659|Treatment resistant|treatment resistant
5015204|NCT01569659|Lurasidone|lurasidone
5015205|NCT01569646|monocytes|monocytes
5015206|NCT01569646|culprit vessels|culprit vessels
5015207|NCT01569620|Colorectal Cancer Screening|colorectal cancer screening
5015208|NCT01569620|CRC|crc
5015209|NCT01569620|Screening Colonoscopy|screening colonoscopy
5015210|NCT01569620|Hispanics|hispanics
5015211|NCT01569620|Latinos|latinos
5015212|NCT01569607|Neurophysiology|neurophysiology
5015213|NCT01569607|Transcranial Magnetic Stimulation (TMS)|transcranial magnetic stimulation (tms)
5015214|NCT01569607|Neurology|neurology
5015215|NCT01569607|Stroke|stroke
5015216|NCT01569607|Physical Medicine and Rehabilitation|physical medicine and rehabilitation
5015217|NCT01569581|Human Enterovirus 71 (EV71)|human enterovirus 71 (ev71)
5015218|NCT01569581|Hand, Foot and Mouth Disease (HFMD)|hand, foot and mouth disease (hfmd)
5015219|NCT01569581|Inactivated Vaccine|inactivated vaccine
5015220|NCT01569581|Human Diploid cell (KMB17)|human diploid cell (kmb17)
5015221|NCT01569581|Adverse reactions associated with vaccine|adverse reactions associated with vaccine
5015222|NCT01569581|Efficacy|efficacy
5015223|NCT01569568|Neuroimaging|neuroimaging
5015224|NCT01569568|MRI|mri
5015225|NCT01569568|Urea cycle|urea cycle
5015226|NCT01569568|hyperammonemia|hyperammonemia
5015227|NCT01569568|cognitive function|cognitive function
5015228|NCT01569568|ornithine transcarbamylase deficiency|ornithine transcarbamylase deficiency
5015229|NCT01569516|Alzheimer's Disease|alzheimer's disease
5015230|NCT01569516|Octohydroaminoacridine Succinate|octohydroaminoacridine succinate
5015231|NCT01569503|Crohn's Disease|crohn's disease
5015232|NCT01569503|VNS|vns
5015233|NCT01569503|vagus nerve stimulation|vagus nerve stimulation
5015234|NCT01569503|inflammation|inflammation
5015235|NCT01569503|Inflammatory bowel diseases|inflammatory bowel diseases
5015236|NCT01569503|TNF|tnf
5015237|NCT01569464|Rotigotine|rotigotine
5015238|NCT01569464|Restless Legs Syndrome|restless legs syndrome
5015239|NCT01569464|Neupro®|neupro®
5015240|NCT01569451|Multiple Sclerosis|multiple sclerosis
5015241|NCT01569451|Glatiramer Acetate|glatiramer acetate
5015242|NCT01569451|Rituximab|rituximab
5015243|NCT01569451|Relapsing forms of Multiple Sclerosis|relapsing forms of multiple sclerosis
5015244|NCT01569451|Relapsing Multiple Sclerosis|relapsing multiple sclerosis
5015245|NCT01569425|PCOS|pcos
5015246|NCT01569399|Alcohol dependance|alcohol dependance
5015247|NCT01569399|rTMS|rtms
5015248|NCT01569399|craving|craving
5015249|NCT01569399|alcohol consumption|alcohol consumption
5015250|NCT01569386|pulse wave velocity|pulse wave velocity
5015251|NCT01569386|low intensity physical activity|low intensity physical activity
5015252|NCT01569386|hemiplegia|hemiplegia
5015253|NCT01569373|Allogeneic stem cell transplant|allogeneic stem cell transplant
5015254|NCT01569373|Graft versus Host Disease|graft versus host disease
5015255|NCT01569373|GVHD|gvhd
5015256|NCT01569360|Spinal cord injury|spinal cord injury
5015257|NCT01569360|Tetraplegia|tetraplegia
5015258|NCT01569360|Paraplegia|paraplegia
5015259|NCT01569360|Respiratory function|respiratory function
5015260|NCT01569360|Corset|corset
5015261|NCT01569347|Cocaine|cocaine
5015262|NCT01569347|Cocaine-induced psychosis|cocaine-induced psychosis
5015263|NCT01569347|Genetic|genetic
5015264|NCT01569347|Clinical|clinical
5015265|NCT01569347|Biological|biological
5015394|NCT01568840|Muscle Stretching Exercises|muscle stretching exercises
5015395|NCT01568840|Dyskinesias|dyskinesias
5015396|NCT01568840|Neck pain|neck pain
5015266|NCT01569334|identify early non invasive markers that index the endothelial lesion/ regeneration potential in association with CAV in heart transplanted recipients (HTR)|identify early non invasive markers that index the endothelial lesion/ regeneration potential in association with cav in heart transplanted recipients (htr)
5015267|NCT01569308|Cardiac output|cardiac output
5015371|NCT01568944|dendritic|dendritic
5015268|NCT01569308|Pulse pressure variation|pulse pressure variation
5015269|NCT01569308|Fluid responsiveness|fluid responsiveness
5015270|NCT01569308|Low tidal volume|low tidal volume
5015271|NCT01569295|Zydelig|zydelig
5015272|NCT01569295|CLL|cll
5015273|NCT01569295|CAL 101|cal 101
5015274|NCT01569295|CAL-101|cal-101
5015275|NCT01569295|GS 1101|gs 1101
5015276|NCT01569295|GS-1101|gs-1101
5015277|NCT01569295|PI3K|pi3k
5015278|NCT01569295|Rituxan|rituxan
5015279|NCT01569295|Rituximab|rituximab
5015280|NCT01569295|Bendamustine|bendamustine
5015281|NCT01569295|Leukemia|leukemia
5015282|NCT01569295|idelalisib|idelalisib
5015283|NCT01569282|Surgical bypass|surgical bypass
5015284|NCT01569282|Hepaticojejunostomy|hepaticojejunostomy
5015285|NCT01569282|Gastrojejunostomy|gastrojejunostomy
5015286|NCT01569282|Biliary stent|biliary stent
5015287|NCT01569282|Enteral stent|enteral stent
5015288|NCT01569269|chemotherapy induced peripheral neuropathy|chemotherapy induced peripheral neuropathy
5015289|NCT01569269|cancer|cancer
5015290|NCT01569269|psychological distress|psychological distress
5015291|NCT01569269|mindfulness|mindfulness
5015292|NCT01569269|complementary and alternative|complementary and alternative
5015293|NCT01569243|Diabetes mellitus|diabetes mellitus
5015294|NCT01569243|Text messaging|text messaging
5015295|NCT01569243|Physical activity|physical activity
5015296|NCT01569230|Knee osteoarthritis|knee osteoarthritis
5015297|NCT01569230|acupuncture|acupuncture
5015298|NCT01569230|sham acupuncture|sham acupuncture
5015299|NCT01569217|Diaphragm|diaphragm
5015300|NCT01569217|Abdomen|abdomen
5015301|NCT01569217|Breathing pattern|breathing pattern
5015302|NCT01569217|dyspnea|dyspnea
5015303|NCT01569191|Ocular allergy|ocular allergy
5015304|NCT01569191|Tear supplement|tear supplement
5015305|NCT01569191|Cold compress|cold compress
5015306|NCT01569178|stem cells|stem cells
5015307|NCT01569178|acute myocardial infarction|acute myocardial infarction
5015308|NCT01569178|heart failure|heart failure
5015309|NCT01569178|heart attack|heart attack
5015310|NCT01569178|bone marrow|bone marrow
5015311|NCT01569178|intracoronary reinfusion|intracoronary reinfusion
5015312|NCT01569178|bone marrow derived mononuclear cells|bone marrow derived mononuclear cells
5015313|NCT01569178|Left ventricular function improvement|left ventricular function improvement
5015314|NCT01569178|mortality|mortality
5015315|NCT01569165|Acidogenicity|acidogenicity
5015316|NCT01569165|Acidulated phosphate fluoride|acidulated phosphate fluoride
5015317|NCT01569165|dental plaque|dental plaque
5015318|NCT01569165|water rinsing|water rinsing
5015319|NCT01569139|Validation|validation
5015320|NCT01569139|Concordance|concordance
5015321|NCT01569139|Myocardial infarction|myocardial infarction
5015322|NCT01569139|Myocardial Ischaemia National Audit Project|myocardial ischaemia national audit project
5015323|NCT01569139|General Practice Research Database|general practice research database
5015324|NCT01569139|Hospital Episode Statistics|hospital episode statistics
5015325|NCT01569139|ONS mortality|ons mortality
5015326|NCT01569113|ella|ella
5015327|NCT01569113|ellaOne|ellaone
5015328|NCT01569113|quickstart|quickstart
5015329|NCT01569113|contraception|contraception
5015330|NCT01569113|combined oral pill|combined oral pill
5015331|NCT01569113|microgynon|microgynon
5015332|NCT01569087|empegfilgrastim|empegfilgrastim
5015333|NCT01569087|pegylated filgrastim|pegylated filgrastim
5015334|NCT01569087|neutropenia|neutropenia
5015335|NCT01569087|febrile neutropenia|febrile neutropenia
5015336|NCT01569087|chemotherapy-associated neutropenia|chemotherapy-associated neutropenia
5015337|NCT01569087|breast cancer|breast cancer
5015338|NCT01569087|docetaxel|docetaxel
5015339|NCT01569087|doxorubicin|doxorubicin
5015340|NCT01569074|Rheumatoid Arthritis|rheumatoid arthritis
5015341|NCT01569061|overactive bladder|overactive bladder
5015342|NCT01569061|laser therapy|laser therapy
5015343|NCT01569061|urinary incontinence|urinary incontinence
5015344|NCT01569061|urinary urgency|urinary urgency
5015345|NCT01569035|oligohudramnios|oligohudramnios
5015346|NCT01569035|oral anti coagulant|oral anti coagulant
5015347|NCT01569035|Dopplar ultrasound|dopplar ultrasound
5015348|NCT01569022|post traumatic stress disorder|post traumatic stress disorder
5015349|NCT01569022|continuous positive airway pressure|continuous positive airway pressure
5015350|NCT01569022|oral appliance|oral appliance
5015351|NCT01569009|Bronchiectasis|bronchiectasis
5015352|NCT01569009|Physical activity|physical activity
5015353|NCT01569009|Activity monitor|activity monitor
5015354|NCT01569009|Pedometer|pedometer
5015355|NCT01568996|atypical nevi|atypical nevi
5015356|NCT01568996|melanoma|melanoma
5015357|NCT01568996|sulforaphane|sulforaphane
5015358|NCT01568996|broccoli|broccoli
5015359|NCT01568996|lesions|lesions
5015360|NCT01568996|STAT1|stat1
5015361|NCT01568996|STAT3|stat3
5015362|NCT01568970|rehabilitation|rehabilitation
5015363|NCT01568970|return to work|return to work
5015364|NCT01568970|sick leave|sick leave
5015365|NCT01568957|Gait|gait
5015366|NCT01568957|Dual-task|dual-task
5015367|NCT01568957|Obstacle avoidance|obstacle avoidance
5015368|NCT01568957|Attention allocation|attention allocation
5015369|NCT01568944|periodontal|periodontal
5015370|NCT01568944|disease|disease
5015372|NCT01568944|cells|cells
5015373|NCT01568944|antibiotics|antibiotics
5015374|NCT01568931|thrombectomy|thrombectomy
5015375|NCT01568905|smoker|smoker
5015376|NCT01568905|smoking|smoking
5015377|NCT01568905|nicotine levels|nicotine levels
5015378|NCT01568905|tobacco|tobacco
5015379|NCT01568905|nicotine|nicotine
5015380|NCT01568892|ART-experienced|art-experienced
5015381|NCT01568892|GSK1349572|gsk1349572
5015382|NCT01568892|Integrase inhibitor resistance|integrase inhibitor resistance
5015383|NCT01568892|Dolutegravir|dolutegravir
5015384|NCT01568879|Recurrent gout|recurrent gout
5015385|NCT01568879|Tophaceous gout|tophaceous gout
5015386|NCT01568879|Gout flares|gout flares
5015387|NCT01568879|Arthritis|arthritis
5015388|NCT01568879|Joint Diseases|joint diseases
5015389|NCT01568879|Rheumatic Diseases|rheumatic diseases
5015390|NCT01568866|multiple myeloma|multiple myeloma
5015391|NCT01568866|relapsed multiple myeloma|relapsed multiple myeloma
5015392|NCT01568840|Physical Therapy Modalities|physical therapy modalities
5015397|NCT01568814|colonoscopy|colonoscopy
5015398|NCT01568814|bowel preparation|bowel preparation
5015399|NCT01568814|polyethylene glycol|polyethylene glycol
5015400|NCT01568814|low residue meal|low residue meal
5015401|NCT01568801|Integrated Services|integrated services
5015402|NCT01568801|Health Services for the Elderly|health services for the elderly
5015403|NCT01568801|Community Services|community services
5015404|NCT01568788|Respiratory Tract Infections; Orthomyxoviridae Infections|respiratory tract infections; orthomyxoviridae infections
5015405|NCT01568775|End Stage Renal Disease|end stage renal disease
5015406|NCT01568775|Dialysis|dialysis
5015407|NCT01568775|aliskiren|aliskiren
5015408|NCT01568775|SPP100A|spp100a
5015409|NCT01568762|Asthma|asthma
5015410|NCT01568762|VAK694|vak694
5015411|NCT01568762|QAX576|qax576
5015412|NCT01568762|QBX258|qbx258
5015413|NCT01568762|pharmacokinetics|pharmacokinetics
5015414|NCT01568749|otc|otc
5015415|NCT01568749|Analgesia|analgesia
5015416|NCT01568749|Paracetamol|paracetamol
5015417|NCT01568736|Hyper IgD Syndrome (HIDS)|hyper igd syndrome (hids)
5015418|NCT01568736|Mevalonate Kinase Deficiency (MKD)|mevalonate kinase deficiency (mkd)
5015419|NCT01568723|Barrett's esophagus|barrett's esophagus
5015420|NCT01568723|high grade dysplasia|high grade dysplasia
5015421|NCT01568723|ablation|ablation
5015422|NCT01568723|radiofrequency ablation|radiofrequency ablation
5015423|NCT01568723|esophageal cancer|esophageal cancer
5015424|NCT01568710|Blood Flow|blood flow
5015425|NCT01568710|Endothelium|endothelium
5015426|NCT01568710|Nitric Oxide|nitric oxide
5015427|NCT01568710|Oximetry|oximetry
5015428|NCT01568710|Laser Doppler|laser doppler
5015429|NCT01568710|Sickle Cell Disease|sickle cell disease
5015430|NCT01568697|Oral Microbiome|oral microbiome
5015431|NCT01568697|Periodontitis|periodontitis
5015432|NCT01568697|Oral Mucosal Immunity|oral mucosal immunity
5015433|NCT01568697|Oral Infection|oral infection
5015434|NCT01568697|Immune Disorder|immune disorder
5015435|NCT01568697|Periodontal Disease|periodontal disease
5015436|NCT01568697|Gum Disease|gum disease
5015437|NCT01568697|Healthy Volunteer|healthy volunteer
5015438|NCT01568697|HV|hv
5015439|NCT01568684|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
5015440|NCT01568684|Depression|depression
5015441|NCT01568684|Depression Treatment|depression treatment
5015442|NCT01568684|Major Depression|major depression
5015443|NCT01568684|Unipolar Depression|unipolar depression
5015444|NCT01568671|Adult|adult
5015445|NCT01568671|Body Fat Distribution|body fat distribution
5015446|NCT01568671|Healthy|healthy
5015447|NCT01568671|Metabolic Rate|metabolic rate
5015448|NCT01568671|Thermophysiology|thermophysiology
5015449|NCT01568671|Brown Fat|brown fat
5015450|NCT01568671|Healthy Volunteer|healthy volunteer
5015451|NCT01568671|HV|hv
5015452|NCT01568658|Hereditary Myopathies|hereditary myopathies
5015453|NCT01568658|Neuropathology|neuropathology
5015454|NCT01568658|Muscular Dystrophy|muscular dystrophy
5015455|NCT01568658|Inherited Neuromuscular Condition|inherited neuromuscular condition
5015456|NCT01568658|Inherited Neuropathy|inherited neuropathy
5015457|NCT01568658|Inherited Myopathy|inherited myopathy
5015458|NCT01568658|Hereditary Spastic Paraplegia|hereditary spastic paraplegia
5015459|NCT01568658|Healthy Volunteer|healthy volunteer
5015460|NCT01568658|HV|hv
5015461|NCT01568645|Sickle Cell Anemia|sickle cell anemia
5015462|NCT01568645|Tyrosine Kinase Inhibitor|tyrosine kinase inhibitor
5015463|NCT01568645|Platelet Derived Growth Factor|platelet derived growth factor
5015464|NCT01568645|Beta Adrenergic Receptor Blocker|beta adrenergic receptor blocker
5015465|NCT01568645|Pulmonary Vascular Disease|pulmonary vascular disease
5015466|NCT01568645|Sickle Cell Disease|sickle cell disease
5015467|NCT01568645|Pulmonary Hypertension|pulmonary hypertension
5015468|NCT01568632|Dose Limiting Toxicity|dose limiting toxicity
5015469|NCT01568632|Maximum Tolerated Dose|maximum tolerated dose
5015470|NCT01568632|Telomerase Inhibitor|telomerase inhibitor
5015471|NCT01568632|Safety|safety
5015472|NCT01568632|Solid Tumor|solid tumor
5015473|NCT01568632|Lymphoma|lymphoma
5015474|NCT01568619|cardiopulmonary exercise test|cardiopulmonary exercise test
5015475|NCT01568619|cardiac output|cardiac output
5015476|NCT01568606|Heart Failure|heart failure
5015477|NCT01568606|Obesity|obesity
5015478|NCT01568606|Implantable Cardioverter Defibrillator|implantable cardioverter defibrillator
5015479|NCT01568580|Hemophilia A|hemophilia a
5015480|NCT01568580|Factor VIII|factor viii
5015481|NCT01568580|Recombinant|recombinant
5015482|NCT01568567|safety|safety
5015483|NCT01568567|tolerance|tolerance
5015484|NCT01568567|lactobacillus Reuteri|lactobacillus reuteri
5015485|NCT01568541|children|children
5015486|NCT01568541|dentifrice|dentifrice
5015487|NCT01568541|fluoride|fluoride
5015488|NCT01568541|dental fluorosis|dental fluorosis
5015489|NCT01568515|HPV vaccine|hpv vaccine
5015490|NCT01568515|Vaccine adherence|vaccine adherence
5015491|NCT01568515|Vaccine utilization|vaccine utilization
5015492|NCT01568515|Electronic Messaging|electronic messaging
5015493|NCT01568502|dobutamine stress|dobutamine stress
5015494|NCT01568502|inducible ischemia|inducible ischemia
5015495|NCT01568502|CAD|cad
5015496|NCT01568476|Regional anesthesia|regional anesthesia
5015497|NCT01568476|Sciatic nerve block|sciatic nerve block
5015498|NCT01568476|foot surgery|foot surgery
5015499|NCT01568476|ankle surgery|ankle surgery
5015500|NCT01568476|Interneural local anesthetic|interneural local anesthetic
5015501|NCT01568463|Inter-scalene Block|inter-scalene block
5015502|NCT01568463|Regional Anesthesia|regional anesthesia
5015503|NCT01568463|shoulder surgeries|shoulder surgeries
5015504|NCT01568450|Oxycodone, controlled release formulation|oxycodone, controlled release formulation
5015505|NCT01568437|Laparoscopic gastric-bypass surgery|laparoscopic gastric-bypass surgery
5015506|NCT01568437|TAP block|tap block
5015507|NCT01568424|Heart Failure|heart failure
5015508|NCT01568424|Right Ventricular Failure|right ventricular failure
5015509|NCT01568424|Levitronix|levitronix
5015510|NCT01568424|Thoratec Corporation|thoratec corporation
5015511|NCT01568411|None - normal volunteers|none - normal volunteers
5015512|NCT01568398|Gastric or duodenal ulcer|gastric or duodenal ulcer
5015513|NCT01568385|Gastric or duodenal ulcer|gastric or duodenal ulcer
5015514|NCT01568372|pediatric|pediatric
5015515|NCT01568372|tonsillectomy|tonsillectomy
5015516|NCT01568372|pain management|pain management
5015517|NCT01568372|nurse follow-up|nurse follow-up
5015518|NCT01568346|Newly diagnosed|newly diagnosed
5015519|NCT01568346|Early stage|early stage
5015520|NCT01568333|Decitabine|decitabine
5015521|NCT01568333|Immune thrombocytopenia|immune thrombocytopenia
5015522|NCT01568320|Aorta|aorta
5015523|NCT01568320|Thoracic|thoracic
5015524|NCT01568320|Aortic dissection|aortic dissection
5015525|NCT01568320|Rupture|rupture
5015526|NCT01568320|Type B|type b
5015527|NCT01568320|DeBakey type III|debakey type iii
5015528|NCT01568320|Endovascular|endovascular
5015529|NCT01568307|Major depressive disorder|major depressive disorder
5015530|NCT01568307|Serotonin transporter|serotonin transporter
5015531|NCT01568307|Sympathetic nervous system activation|sympathetic nervous system activation
5015532|NCT01568307|Cardiovascular risk factors|cardiovascular risk factors
5015533|NCT01568307|Serotonin re-uptake inhibitor|serotonin re-uptake inhibitor
5015534|NCT01568281|Bioequivalence|bioequivalence
5015535|NCT01568281|pharmacokinetics|pharmacokinetics
5015536|NCT01568281|safety|safety
5015537|NCT01568281|anastrozole|anastrozole
5015538|NCT01568281|Arimidex|arimidex
5015539|NCT01568281|Japanese|japanese
5015540|NCT01568281|healthy subject|healthy subject
5015541|NCT01568268|palonosetron|palonosetron
5015542|NCT01568268|postoperative nausea and vomiting|postoperative nausea and vomiting
5015543|NCT01568255|myopathic symptoms|myopathic symptoms
5015544|NCT01568242|Cataract|cataract
5015545|NCT01568242|Phacoemulsification|phacoemulsification
5015546|NCT01568242|Temperature|temperature
5015547|NCT01568242|Vitreous|vitreous
5015548|NCT01568229|schizophrenia negative symptoms|schizophrenia negative symptoms
5015549|NCT01568216|schizophrenia negative symptoms|schizophrenia negative symptoms
5015550|NCT01568203|single dose, safety, healthy subjects, schizoaffective disorder, AMG 579|single dose, safety, healthy subjects, schizoaffective disorder, amg 579
5015551|NCT01568190|House dust mites sensitisation|house dust mites sensitisation
5015552|NCT01568177|MCD|mcd
5015553|NCT01568164|Epicardial Catheter-based Restoration|epicardial catheter-based restoration
5015554|NCT01568164|Surgical/Left Ventricular Reconstruction|surgical/left ventricular reconstruction
5015555|NCT01568164|Ventricular Remodeling|ventricular remodeling
5015556|NCT01568164|Dor|dor
5015557|NCT01568151|Colorectal Cancer|colorectal cancer
5015558|NCT01568151|Screening|screening
5015559|NCT01568151|Education|education
5015560|NCT01568151|Testing|testing
5015561|NCT01568138|Ventricular Remodeling|ventricular remodeling
5015562|NCT01568112|BG00012|bg00012
5015563|NCT01568112|gastrointestinal events|gastrointestinal events
5015564|NCT01568112|flushing events|flushing events
5015565|NCT01568112|dose titration|dose titration
5015566|NCT01568112|pre-medication|pre-medication
5015567|NCT01568112|aspirin|aspirin
5015568|NCT01568073|Parkinson|parkinson
5015569|NCT01568073|PD|pd
5015570|NCT01568073|Wearing-off|wearing-off
5015571|NCT01568073|Levodopa/DDCI|levodopa/ddci
5015572|NCT01568060|Safety|safety
5015573|NCT01568060|Infanrix-IPV|infanrix-ipv
5015574|NCT01568060|Post-marketing surveillance|post-marketing surveillance
5015760|NCT01567215|granuloma umbilical|granuloma umbilical
5015575|NCT01568060|Diphtheria, tetanus, pertussis and poliomyelitis|diphtheria, tetanus, pertussis and poliomyelitis
5015576|NCT01568047|Parkinson Disease|parkinson disease
5015577|NCT01568047|BIA 9-1067|bia 9-1067
5015578|NCT01568034|Parkinson's Disease|parkinson's disease
5015579|NCT01568034|BIA 9-1067|bia 9-1067
5015580|NCT01567995|eczematous|eczematous
5015581|NCT01567995|dermatitis|dermatitis
5015582|NCT01567982|tDCS|tdcs
5015583|NCT01567982|brain stimulation|brain stimulation
5015584|NCT01567982|addiction|addiction
5015585|NCT01567982|substance dependence|substance dependence
5015586|NCT01567982|craving|craving
5015587|NCT01567982|cognition|cognition
5015588|NCT01567969|mental health services|mental health services
5015589|NCT01567969|child behavior disorders|child behavior disorders
5015590|NCT01567969|child psychiatry|child psychiatry
5015591|NCT01567956|Ulcerative colitis|ulcerative colitis
5015592|NCT01567943|alcohol abuse|alcohol abuse
5015593|NCT01567943|drug abuse|drug abuse
5015594|NCT01567943|schizophrenia|schizophrenia
5015595|NCT01567943|bipolar disorder|bipolar disorder
5015596|NCT01567943|major depressive disorder|major depressive disorder
5015597|NCT01567943|contingency management|contingency management
5015598|NCT01567943|psychosocial treatment|psychosocial treatment
5015599|NCT01567930|Temsirolimus|temsirolimus
5015600|NCT01567930|HCC|hcc
5015601|NCT01567930|Advanced hepatocellular carcinoma|advanced hepatocellular carcinoma
5015602|NCT01567917|Venous thromboembolism|venous thromboembolism
5015603|NCT01567917|Colorectal cancer|colorectal cancer
5015604|NCT01567917|Postoperative period|postoperative period
5015605|NCT01567917|detected on 5th~14th days after surgery (by doppler US) or the follow-up period of postoperative 1 month|detected on 5th~14th days after surgery (by doppler us) or the follow-up period of postoperative 1 month
5015606|NCT01567904|thrombosis|thrombosis
5015607|NCT01567904|Central Venous Line|central venous line
5015608|NCT01567904|CVL|cvl
5015609|NCT01567891|Ovarian Cancer|ovarian cancer
5015610|NCT01567891|Cell Therapy|cell therapy
5015611|NCT01567891|T Cell Therapy|t cell therapy
5015612|NCT01567891|NY-ESO-1|ny-eso-1
5015613|NCT01567891|Immuno-oncology|immuno-oncology
5015614|NCT01567891|Metastatic|metastatic
5015615|NCT01567891|Previously treated|previously treated
5015616|NCT01567891|T Cell Receptor|t cell receptor
5015617|NCT01567878|ultrasound|ultrasound
5015618|NCT01567878|MASEI index|masei index
5015619|NCT01567878|clinical and ultrasound correlation|clinical and ultrasound correlation
5015620|NCT01567878|enthesis ultrasound|enthesis ultrasound
5015621|NCT01567878|articular ultrasound|articular ultrasound
5015622|NCT01567878|ankylosing spondylitis ultrasound|ankylosing spondylitis ultrasound
5015623|NCT01567878|radiographic and ultrasound correlation|radiographic and ultrasound correlation
5015624|NCT01567852|orientation|orientation
5015625|NCT01567852|post-anesthesia recovery|post-anesthesia recovery
5015626|NCT01567852|electroconvulsive therapy|electroconvulsive therapy
5015627|NCT01567839|degree of pulpal anesthesia obtained|degree of pulpal anesthesia obtained
5015628|NCT01567839|primary infiltration in the lower first molar|primary infiltration in the lower first molar
5015629|NCT01567826|YELLO|yello
5015630|NCT01567826|Atorvastatin|atorvastatin
5015631|NCT01567826|Simvastatin|simvastatin
5015632|NCT01567826|Rosuvastatin|rosuvastatin
5015633|NCT01567826|lipid therapy|lipid therapy
5015634|NCT01567826|Statin therapy|statin therapy
5015635|NCT01567826|Coronary artery disease|coronary artery disease
5015636|NCT01567826|CHD|chd
5015637|NCT01567813|Warts|warts
5015638|NCT01567813|Papillomavirus infections|papillomavirus infections
5015639|NCT01567813|DNA virus infections|dna virus infections
5015640|NCT01567813|Virus diseases|virus diseases
5015641|NCT01567813|Skin diseases, viral|skin diseases, viral
5015642|NCT01567813|Tumor virus infections|tumor virus infections
5015643|NCT01567813|Skin diseases, infectious|skin diseases, infectious
5015644|NCT01567813|Skin diseases|skin diseases
5015645|NCT01567800|Procedure/Surgery: 18F-Fluoroazomycin Arabinoside (18F-FAZA)|procedure/surgery: 18f-fluoroazomycin arabinoside (18f-faza)
5015646|NCT01567787|Proton Radiation Therapy|proton radiation therapy
5015647|NCT01567787|Spinal tumors|spinal tumors
5015648|NCT01567787|Neurofibroma(NF1)|neurofibroma(nf1)
5015649|NCT01567787|Malignant peripheral nerve sheath tumor(MPNST)|malignant peripheral nerve sheath tumor(mpnst)
5015650|NCT01567774|Coronary artery disease|coronary artery disease
5015651|NCT01567774|dual antiplatelet therapy|dual antiplatelet therapy
5015652|NCT01567774|atorvastatin|atorvastatin
5015653|NCT01567774|rosuvastatin|rosuvastatin
5015654|NCT01567761|IOP|iop
5015655|NCT01567748|CABG|cabg
5015656|NCT01567748|Coronary Artery Bypass|coronary artery bypass
5015657|NCT01567748|Central Aortic Pressure|central aortic pressure
5015658|NCT01567748|Peripheral Arterial Waveform|peripheral arterial waveform
5015659|NCT01567735|Hepatitis C|hepatitis c
5015660|NCT01567735|TMC435HPC3011|tmc435hpc3011
5015661|NCT01567735|TMC435|tmc435
5015662|NCT01567722|HIV infection|hiv infection
5015663|NCT01567722|adult diffuse large cell lymphoma|adult diffuse large cell lymphoma
5015664|NCT01567722|anal cancer|anal cancer
5015665|NCT01567722|cervical cancer|cervical cancer
5015666|NCT01567722|non-small cell lung cancer|non-small cell lung cancer
5015667|NCT01567722|AIDS-related diffuse large cell lymphoma|aids-related diffuse large cell lymphoma
5015668|NCT01567696|Revision,|revision,
5015669|NCT01567683|Safety and Tolerability of Limtop and vehicle|safety and tolerability of limtop and vehicle
5015670|NCT01567683|of Limtop and vehicle|of limtop and vehicle
5015671|NCT01567657|Sedation in TEE|sedation in tee
5015672|NCT01567657|Blood pressure drop during TEE|blood pressure drop during tee
5015673|NCT01567657|Safety of sedation in TEE|safety of sedation in tee
5015674|NCT01567644|Extracorporeal Shockwave Therapy|extracorporeal shockwave therapy
5015675|NCT01567644|Myocardial Ischemia|myocardial ischemia
5015676|NCT01567644|Refractory Angina|refractory angina
5015677|NCT01567631|Classical Procedure|classical procedure
5015678|NCT01567631|Intrahepatic Glisson's Approach|intrahepatic glisson's approach
5015679|NCT01567631|laparoscopic hepatectomy|laparoscopic hepatectomy
5015680|NCT01567631|Minimal invasive surgery|minimal invasive surgery
5015681|NCT01567631|Endoscopic stapling devices|endoscopic stapling devices
5015682|NCT01567618|Docetaxel|docetaxel
5015683|NCT01567618|Fluorouracil|fluorouracil
5015684|NCT01567618|First line therapy|first line therapy
5015685|NCT01567618|Gastric cancer|gastric cancer
5015686|NCT01567605|spinal cord injury|spinal cord injury
5015687|NCT01567605|autonomic dysreflexia|autonomic dysreflexia
5015688|NCT01567605|blood pressure|blood pressure
5015689|NCT01567605|bowel care management|bowel care management
5015690|NCT01567605|defecation|defecation
5015691|NCT01567592|Extracorporeal Shockwave Therapy|extracorporeal shockwave therapy
5015692|NCT01567592|Myocardial Ischemia|myocardial ischemia
5015693|NCT01567592|Refractory Angina|refractory angina
5015694|NCT01567579|congenital heart defects|congenital heart defects
5015695|NCT01567566|home based daily exercise program|home based daily exercise program
5015696|NCT01567566|local lumbopelvic stabilizer muscles|local lumbopelvic stabilizer muscles
5015697|NCT01567566|hip stabilizer muscles|hip stabilizer muscles
5015698|NCT01567566|real time ultrasound imaging|real time ultrasound imaging
5015699|NCT01567553|inflammatory disease of the central nervous system|inflammatory disease of the central nervous system
5015700|NCT01567553|early clinical deficit|early clinical deficit
5015701|NCT01567553|multiple sclerosis (MS)|multiple sclerosis (ms)
5015702|NCT01567540|Chronic Hepatitis C|chronic hepatitis c
5015703|NCT01567540|Interferon protein 10|interferon protein 10
5015704|NCT01567540|Chemokine gradients|chemokine gradients
5015705|NCT01567540|Sitagliptin|sitagliptin
5015706|NCT01567527|Aripiprazole|aripiprazole
5015707|NCT01567527|Intramuscular (IM) Depot|intramuscular (im) depot
5015708|NCT01567527|Bipolar|bipolar
5015709|NCT01567514|Deep occlusal caries restored with resin composite|deep occlusal caries restored with resin composite
5015710|NCT01567514|on Pit and Fissure Surface Penetrating Into Dentin|on pit and fissure surface penetrating into dentin
5015711|NCT01567488|Advanced|advanced
5015712|NCT01567488|Non functioning|non functioning
5015713|NCT01567488|Well differentiated|well differentiated
5015714|NCT01567462|bladder cancer|bladder cancer
5015715|NCT01567462|transurethral resection of bladder tumors|transurethral resection of bladder tumors
5015716|NCT01567423|Malaria|malaria
5015717|NCT01567423|Plasmodium falciparum|plasmodium falciparum
5015718|NCT01567423|Children|children
5015719|NCT01567423|Efficacy|efficacy
5015720|NCT01567423|Uncomplicated malaria|uncomplicated malaria
5015721|NCT01567410|e-learning|e-learning
5015722|NCT01567410|education|education
5015723|NCT01567384|cancer|cancer
5015724|NCT01567384|neoplasms|neoplasms
5015725|NCT01567384|tumors|tumors
5015726|NCT01567345|Pain|pain
5015727|NCT01567345|cancer|cancer
5015728|NCT01567345|Intrathecal|intrathecal
5015729|NCT01567345|analgesia|analgesia
5015730|NCT01567345|Morphine|morphine
5015731|NCT01567345|Implantable pump|implantable pump
5015732|NCT01567319|Sensitization|sensitization
5015733|NCT01567319|Skin Prick Test|skin prick test
5015734|NCT01567319|Standardization|standardization
5015735|NCT01567319|sources of: D. glomerata, L. perenne, S. cereale and O. europaea|sources of: d. glomerata, l. perenne, s. cereale and o. europaea
5015736|NCT01567306|Allergy|allergy
5015737|NCT01567306|Allergic rhinoconjunctivitis|allergic rhinoconjunctivitis
5015738|NCT01567306|Subcutaneous Immunotherapy|subcutaneous immunotherapy
5015739|NCT01567306|Phleum pratense pollen extract|phleum pratense pollen extract
5015740|NCT01567267|Evidence-based Medicine|evidence-based medicine
5015741|NCT01567267|Good Scientific Practice|good scientific practice
5015742|NCT01567267|Problem-based Learning|problem-based learning
5015743|NCT01567267|Critical health literacy|critical health literacy
5015744|NCT01567267|Educational intervention|educational intervention
5015745|NCT01567254|guided imaginary|guided imaginary
5015746|NCT01567241|clinical hypnosis|clinical hypnosis
5015747|NCT01567241|relaxation music|relaxation music
5015748|NCT01567241|reproduction techniques|reproduction techniques
5015749|NCT01567241|insemination|insemination
5015750|NCT01567241|embryo transfer|embryo transfer
5015751|NCT01567241|pregnancy rate|pregnancy rate
5015752|NCT01567228|obesity|obesity
5015753|NCT01567228|overweight|overweight
5015754|NCT01567228|dental caries|dental caries
5015755|NCT01567228|school problems|school problems
5015756|NCT01567228|school failure|school failure
5015757|NCT01567228|child BMI > 85th percentile|child bmi > 85th percentile
5015758|NCT01567228|Needing dental preventive services|needing dental preventive services
5015759|NCT01567228|Needing academic support for school problems|needing academic support for school problems
5015761|NCT01567202|Brain tumor|brain tumor
5015762|NCT01567202|Glioma|glioma
5015763|NCT01567202|Glioblastoma|glioblastoma
5015764|NCT01567202|Tumor stem cells|tumor stem cells
5015765|NCT01567202|Immunotherapy|immunotherapy
5015767|NCT01567189|Exercise therapy|exercise therapy
5015768|NCT01567189|cost effectiveness|cost effectiveness
5015769|NCT01567189|cardiac rehabilitation|cardiac rehabilitation
5015770|NCT01567189|home-based exercise|home-based exercise
5015771|NCT01567176|Sirtuins|sirtuins
5015772|NCT01567176|Aging|aging
5015773|NCT01567176|Metabolic disease|metabolic disease
5015774|NCT01567163|Advanced Malignant Solid Tumors|advanced malignant solid tumors
5015775|NCT01567124|Schizophrenia|schizophrenia
5015776|NCT01567124|Moxonidine|moxonidine
5015777|NCT01567124|Sympathetic nervous system activation|sympathetic nervous system activation
5015778|NCT01567124|Cardiometabolic side effects of antipsychotics|cardiometabolic side effects of antipsychotics
5015779|NCT01567111|Primary aldosteronism|primary aldosteronism
5015780|NCT01567111|Aldosterone producing adenoma|aldosterone producing adenoma
5015781|NCT01567111|Bilateral adrenal hyperplasia|bilateral adrenal hyperplasia
5015782|NCT01567111|Metomidate-Positron emission tomography|metomidate-positron emission tomography
5015783|NCT01567072|NSAID|nsaid
5015784|NCT01567072|bone fracture|bone fracture
5015785|NCT01567072|heal|heal
5015786|NCT01567033|Diabetes|diabetes
5015787|NCT01567033|Obesity|obesity
5015788|NCT01567033|Home visiting|home visiting
5015789|NCT01567020|Central Auditory Processing|central auditory processing
5015790|NCT01567020|Traumatic Brain Injury|traumatic brain injury
5015791|NCT01567020|Hearing Loss|hearing loss
5015792|NCT01567007|pedometer|pedometer
5015793|NCT01567007|physical activity|physical activity
5015794|NCT01567007|workplace|workplace
5015795|NCT01566994|smoking cessation|smoking cessation
5015796|NCT01566981|Diabetes mellitus tip II|diabetes mellitus tip ii
5015797|NCT01566981|eHealth solution|ehealth solution
5015798|NCT01566981|Health Information Technology|health information technology
5015799|NCT01566981|quality of life|quality of life
5015800|NCT01566981|family medicine|family medicine
5015801|NCT01566981|satisfaction with e-health care|satisfaction with e-health care
5015802|NCT01566981|primary care|primary care
5015803|NCT01566968|COPD|copd
5015804|NCT01566968|Asthma|asthma
5015805|NCT01566968|Healthy volunteers|healthy volunteers
5015806|NCT01566968|Chronic cough|chronic cough
5015807|NCT01566968|Smokers|smokers
5015808|NCT01566968|Cough challenge|cough challenge
5015809|NCT01566968|Cough challenge testing.|cough challenge testing.
5015810|NCT01566955|transgastric|transgastric
5015811|NCT01566955|NOTES|notes
5015812|NCT01566955|Gastrotomy|gastrotomy
5015813|NCT01566955|BRCA 1/2|brca 1/2
5015814|NCT01566942|FOLFIRI|folfiri
5015815|NCT01566942|FOLFOX|folfox
5015816|NCT01566942|adjuvant chemotherapy|adjuvant chemotherapy
5015817|NCT01566942|advanced colorectal cancer|advanced colorectal cancer
5015818|NCT01566929|Obesity|obesity
5015819|NCT01566929|In vitro fertilization|in vitro fertilization
5015820|NCT01566929|Low calorie diet (LCD)|low calorie diet (lcd)
5015821|NCT01566929|Obstetric outcome|obstetric outcome
5015822|NCT01566929|Weight reduction|weight reduction
5015823|NCT01566903|arterial stenosis|arterial stenosis
5015824|NCT01566903|arteriovenous malformations|arteriovenous malformations
5015825|NCT01566903|Post-treatment follow-up|post-treatment follow-up
5015826|NCT01566890|sickle cell|sickle cell
5015827|NCT01566890|sickle cell crisis|sickle cell crisis
5015828|NCT01566890|sickle cell pain crisis|sickle cell pain crisis
5015829|NCT01566890|vaso-occlusive crisis|vaso-occlusive crisis
5015830|NCT01566890|vaso-occlusion|vaso-occlusion
5015831|NCT01566890|sickle cell anemia|sickle cell anemia
5015832|NCT01566890|sickle cell disease|sickle cell disease
5015833|NCT01566890|genetic diseases|genetic diseases
5015834|NCT01566890|adenosine 2A Receptor Agonists|adenosine 2a receptor agonists
5015835|NCT01566890|Lexiscan|lexiscan
5015836|NCT01566890|Regadenoson|regadenoson
5015837|NCT01566890|contrast-enhanced ultrasound|contrast-enhanced ultrasound
5015838|NCT01566890|Hydroxyurea|hydroxyurea
5015839|NCT01566877|Multiple Ascending Dose (MAD)|multiple ascending dose (mad)
5015840|NCT01566877|Marburg Virus|marburg virus
5015841|NCT01566877|Post Exposure Prophylaxis|post exposure prophylaxis
5015842|NCT01566864|hypertension|hypertension
5015843|NCT01566864|disparities|disparities
5015844|NCT01566864|care management|care management
5015845|NCT01566864|provider education|provider education
5015846|NCT01566864|audit and feedback|audit and feedback
5015847|NCT01566864|Omron|omron
5015848|NCT01566864|African Americans|african americans
5015849|NCT01566864|organizational change|organizational change
5015850|NCT01566864|implementation research|implementation research
5015851|NCT01566838|Visual analog pain score|visual analog pain score
5015852|NCT01566838|Length of stay|length of stay
5015853|NCT01566838|Hospital Cost|hospital cost
5015854|NCT01566838|Subpleural pain catheter|subpleural pain catheter
5015855|NCT01566838|Bupivacaine|bupivacaine
5015856|NCT01566825|amitriptyline|amitriptyline
5015857|NCT01566825|sleep dependent memory consolidation|sleep dependent memory consolidation
5015858|NCT01566812|Breast Feeding|breast feeding
5015859|NCT01566812|Cardiovascular Risk|cardiovascular risk
5015860|NCT01566799|Locally advanced breast cancer|locally advanced breast cancer
5015861|NCT01566799|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
5015862|NCT01566799|Metformin|metformin
5015863|NCT01566799|Pathologic Complete Response|pathologic complete response
5015864|NCT01566773|COPD|copd
5015865|NCT01566760|food effect|food effect
5015866|NCT01566760|bioavailability|bioavailability
5015867|NCT01566760|pharmacokinetics|pharmacokinetics
5015868|NCT01566760|fesoterodine|fesoterodine
5015869|NCT01566760|5-hydroxymethyl tolterodine|5-hydroxymethyl tolterodine
5015870|NCT01566760|treatment of overactive bladder|treatment of overactive bladder
5015871|NCT01566734|Surgical Wound Infection|surgical wound infection
5015872|NCT01566734|cefazolin|cefazolin
5015873|NCT01566734|Cesarean Section|cesarean section
5015874|NCT01566708|Acute Tinnitus|acute tinnitus
5015875|NCT01566708|Recent Onset Tinnitus|recent onset tinnitus
5015876|NCT01566708|Music Therapy|music therapy
5015877|NCT01566708|fMRI|fmri
5015878|NCT01566708|Therapy Evaluation|therapy evaluation
5015879|NCT01566682|Lung Lesion|lung lesion
5015880|NCT01566682|Lung Mass|lung mass
5015881|NCT01566682|Lung Nodule|lung nodule
5015882|NCT01566682|Lung Cancer|lung cancer
5015883|NCT01566682|Low-Dose CT|low-dose ct
5015884|NCT01566682|CT|ct
5015885|NCT01566682|Diagnostic|diagnostic
5015886|NCT01566682|Evaluation|evaluation
5015887|NCT01566682|Bioconductance|bioconductance
5015888|NCT01566682|ProLung|prolung
5015889|NCT01566669|Cyclooxygenase inhibitors|cyclooxygenase inhibitors
5015890|NCT01566669|Morphine|morphine
5015891|NCT01566669|Analgesia|analgesia
5015892|NCT01566669|patient-controlled|patient-controlled
5015893|NCT01566669|Gynecologic surgical procedures|gynecologic surgical procedures
5015894|NCT01566656|Allogeneic hematopoietic stem cell transplantation|allogeneic hematopoietic stem cell transplantation
5015895|NCT01566656|Non-myeloablative preparative regimen|non-myeloablative preparative regimen
5015896|NCT01566656|Total lymphoid irradiation|total lymphoid irradiation
5015897|NCT01566656|Anti-thymocyte globulin|anti-thymocyte globulin
5015898|NCT01566656|Lymphoid malignancies|lymphoid malignancies
5015899|NCT01566643|Helicobacter pylori|helicobacter pylori
5015900|NCT01566643|antibiotic resistance|antibiotic resistance
5015901|NCT01566643|sequential-concomitant hybrid therapy|sequential-concomitant hybrid therapy
5015902|NCT01566630|human recombinant RLX030|human recombinant rlx030
5015903|NCT01566630|Pre-eclampsia|pre-eclampsia
5015904|NCT01566630|hemodynamics|hemodynamics
5015905|NCT01566630|Pharmacokinetics|pharmacokinetics
5015906|NCT01566604|Chronic obstructive pulmonary disease (COPD)|chronic obstructive pulmonary disease (copd)
5015907|NCT01566604|NVA237|nva237
5015908|NCT01566591|Bipolar Depression|bipolar depression
5015909|NCT01566552|AMBISOME|ambisome
5015910|NCT01566552|VISCERAL LEISHMANIASIS|visceral leishmaniasis
5015911|NCT01566552|SINGLE DOSE|single dose
5015912|NCT01566539|Social cooperation|social cooperation
5015913|NCT01566539|Oxytocin|oxytocin
5015914|NCT01566539|Vasopressin|vasopressin
5015915|NCT01566539|Prisoner's Dilemma game|prisoner's dilemma game
5015916|NCT01566539|Empathy|empathy
5015917|NCT01566539|fMRI|fmri
5015918|NCT01566513|Peer Support|peer support
5015919|NCT01566513|Cost Effectiveness|cost effectiveness
5015920|NCT01566513|Reducing Hospital use|reducing hospital use
5015921|NCT01566513|Serious Mental Illness|serious mental illness
5015922|NCT01566500|Epilepsy|epilepsy
5015923|NCT01566500|Medication Adherence|medication adherence
5015924|NCT01566487|Bioequivalence|bioequivalence
5015925|NCT01566487|Quetiapine fumarate|quetiapine fumarate
5015926|NCT01566487|crossover|crossover
5015927|NCT01566461|Drug-Coated Angioplasty Balloon|drug-coated angioplasty balloon
5015928|NCT01566461|Drug Coated Angioplasty Balloon|drug coated angioplasty balloon
5015929|NCT01566461|Peripheral Artery Disease|peripheral artery disease
5015930|NCT01566461|Experimental|experimental
5015931|NCT01566461|Percutaneous Transluminal Angioplasty (PTA)|percutaneous transluminal angioplasty (pta)
5015932|NCT01566448|Ketamine|ketamine
5015933|NCT01566448|Mucositis|mucositis
5015934|NCT01566448|Oral ketamine rinse|oral ketamine rinse
5015935|NCT01566409|Constipation|constipation
5015936|NCT01566409|Maintenance treatment|maintenance treatment
5015937|NCT01566409|Ultrasound of rectum|ultrasound of rectum
5015938|NCT01566396|Fractional,|fractional,
5015939|NCT01566396|RF,|rf,
5015940|NCT01566396|Wrinkles|wrinkles
5015941|NCT01566396|Safety|safety
5015942|NCT01566396|Efficacy|efficacy
5015943|NCT01566396|treatment|treatment
5015944|NCT01566370|alcoholism|alcoholism
5015945|NCT01566370|alcohol use disorder|alcohol use disorder
5015946|NCT01566370|alcohol dependence|alcohol dependence
5015947|NCT01566370|alcohol abuse|alcohol abuse
5015948|NCT01566370|bipolar|bipolar
5015949|NCT01566370|anticonvulsant|anticonvulsant
5015950|NCT01566370|zonisamide|zonisamide
5015951|NCT01566357|dental erosion|dental erosion
5015952|NCT01566357|enamel|enamel
5015953|NCT01566357|dentin|dentin
5015954|NCT01566344|Premature Ventricular Complex|premature ventricular complex
5015955|NCT01566344|Cardiomyopathy|cardiomyopathy
5015956|NCT01566344|Left ventricular dysfunction|left ventricular dysfunction
5015957|NCT01566344|Catheter Ablation|catheter ablation
5015958|NCT01566344|Anti-Arrhythmic Agents|anti-arrhythmic agents
5015959|NCT01566344|Randomized Clinical Trial|randomized clinical trial
5015960|NCT01566331|Safe Delivery|safe delivery
5015961|NCT01566331|reduction of pain|reduction of pain
5015962|NCT01566331|reduction stage of labor|reduction stage of labor
5015963|NCT01566318|Depression|depression
5015964|NCT01566318|Anxiety|anxiety
5015965|NCT01566318|Geriatric mental health|geriatric mental health
5015966|NCT01566279|solid tumors|solid tumors
5015967|NCT01566279|all comers|all comers
5015968|NCT01566279|everolimus|everolimus
5015969|NCT01566279|biomarker|biomarker
5015970|NCT01566279|next generation sequencing|next generation sequencing
5015971|NCT01566266|gut flora|gut flora
5015972|NCT01566266|antibiotics|antibiotics
5015973|NCT01566266|lipid metabolism|lipid metabolism
5015974|NCT01566266|LDL cholesterol|ldl cholesterol
5015975|NCT01566253|planned caesarian section, analgesic, PCOA|planned caesarian section, analgesic, pcoa
5015976|NCT01566240|cervical cancer|cervical cancer
5015977|NCT01566240|Chemotherapy|chemotherapy
5015978|NCT01566240|Paclitaxel|paclitaxel
5015979|NCT01566240|Carboplatin|carboplatin
5015980|NCT01566240|Cisplatin|cisplatin
5015981|NCT01566240|Radiotherapy|radiotherapy
5015982|NCT01566240|Chemoradiation|chemoradiation
5015983|NCT01566240|Brachytherapy|brachytherapy
5015984|NCT01566240|Stage IB2 Cervical Cancer|stage ib2 cervical cancer
5015985|NCT01566240|Stage IIA Cervical Cancer|stage iia cervical cancer
5015986|NCT01566240|Stage IIB Cervical Cancer|stage iib cervical cancer
5015987|NCT01566240|Stage IIIB Cervical Cancer|stage iiib cervical cancer
5015988|NCT01566240|Stage IVA Cervical Cancer|stage iva cervical cancer
5015989|NCT01566227|overdenture|overdenture
5015990|NCT01566227|implant|implant
5015991|NCT01566227|edentulism|edentulism
5015992|NCT01566214|coronary heart disease (CHD)|coronary heart disease (chd)
5015993|NCT01566214|myocardial infarction (MI)|myocardial infarction (mi)
5015994|NCT01566214|acute coronary syndromes (ACS)|acute coronary syndromes (acs)
5015995|NCT01566201|Arterial stiffness|arterial stiffness
5015996|NCT01566201|Endothelial function|endothelial function
5015997|NCT01566201|Left ventricular function|left ventricular function
5015998|NCT01566201|Apoptosis|apoptosis
5015999|NCT01566201|Nitrooxidative stress|nitrooxidative stress
5016000|NCT01566175|Neovasc Reducer|neovasc reducer
5016001|NCT01566175|Coronary Sinus|coronary sinus
5016002|NCT01566175|Refractory Angina Pectoris|refractory angina pectoris
5016003|NCT01566175|angina class 3-4|angina class 3-4
5016004|NCT01566162|Lurasidone|lurasidone
5016005|NCT01566162|Latuda|latuda
5016006|NCT01566162|Schizophrenia|schizophrenia
5016007|NCT01566136|hip fracture patients|hip fracture patients
5016008|NCT01566136|cognitive impairment|cognitive impairment
5016009|NCT01566136|rehabilitation model of care|rehabilitation model of care
5016010|NCT01566123|retroperitoneal soft tissue sarcoma|retroperitoneal soft tissue sarcoma
5016011|NCT01566123|IMRT|imrt
5016012|NCT01566123|IORT|iort
5016013|NCT01566110|pediatric|pediatric
5016014|NCT01566110|dietary treatment|dietary treatment
5016015|NCT01566110|celiac disease|celiac disease
5016016|NCT01566110|T1D|t1d
5016017|NCT01566097|Cluster randomized trial|cluster randomized trial
5016018|NCT01566097|Decision aids|decision aids
5016019|NCT01566097|Culturally-appropriate decision aids|culturally-appropriate decision aids
5016020|NCT01566058|Post partum|post partum
5016021|NCT01566058|mother-child relationships|mother-child relationships
5016022|NCT01566045|Prostate Cancer|prostate cancer
5016023|NCT01566045|Biopsy|biopsy
5016024|NCT01566032|pulmonary air leak|pulmonary air leak
5016025|NCT01566032|Thopaz|thopaz
5016026|NCT01566032|analog|analog
5016027|NCT01566032|digital|digital
5016028|NCT01566006|Mycophenolate mofetil (MMF)|mycophenolate mofetil (mmf)
5016029|NCT01566006|Diabetic Nephropathy|diabetic nephropathy
5016030|NCT01566006|proteinuria|proteinuria
5016031|NCT01566006|Diabetic Nephropathy in Chronic Kidney Disease patients stages 2-4|diabetic nephropathy in chronic kidney disease patients stages 2-4
5016032|NCT01565980|Lung cancer|lung cancer
5016033|NCT01565980|mindfulness therapy|mindfulness therapy
5016034|NCT01565980|active treatment (radiation and/or chemotherapy)|active treatment (radiation and/or chemotherapy)
5016035|NCT01565967|AutoLog|autolog
5016036|NCT01565967|Post market release|post market release
5016037|NCT01565967|Non-interventional|non-interventional
5016038|NCT01565954|Sickle Cell Disease|sickle cell disease
5016039|NCT01565954|Respiration Disorders|respiration disorders
5016040|NCT01565954|Polysomnography|polysomnography
5016041|NCT01565941|Cardiovascular|cardiovascular
5016042|NCT01565941|Respiratory|respiratory
5016043|NCT01565941|Failure|failure
5016044|NCT01565941|Heart|heart
5016045|NCT01565941|Lung|lung
5016046|NCT01565941|Continuous glucose monitoring|continuous glucose monitoring
5016047|NCT01565941|Tight glycemic control|tight glycemic control
5016048|NCT01565941|Subcutaneous|subcutaneous
5016049|NCT01565941|Insulin|insulin
5016050|NCT01565941|Algorithm|algorithm
5016051|NCT01565928|Prostate cancer|prostate cancer
5016052|NCT01565928|docetaxel|docetaxel
5016053|NCT01565928|MDV3100|mdv3100
5016054|NCT01565928|enzalutamide|enzalutamide
5016055|NCT01565928|Xtandi|xtandi
5016056|NCT01565902|BAF312|baf312
5016057|NCT01565902|Pharmacokinetics|pharmacokinetics
5016058|NCT01565902|Hepatic impairment|hepatic impairment
5016059|NCT01565876|weight bearing|weight bearing
5016060|NCT01565876|physiological load|physiological load
5016061|NCT01565863|Perceived Disability|perceived disability
5016062|NCT01565863|Mental Wellness|mental wellness
5016063|NCT01565863|Employment|employment
5016064|NCT01565863|Social Integration and Engagement|social integration and engagement
5016065|NCT01565863|Goal Achievement|goal achievement
5016066|NCT01565850|HIV-1|hiv-1
5016067|NCT01565850|HIV|hiv
5016068|NCT01565850|Treatment-Naive|treatment-naive
5016069|NCT01565837|Melanoma|melanoma
5016070|NCT01565837|Malignant Melanoma|malignant melanoma
5016071|NCT01565837|Metastatic|metastatic
5016072|NCT01565837|Oligometastatic|oligometastatic
5016073|NCT01565837|Radiosurgery|radiosurgery
5016074|NCT01565837|Radiosurgery, Stereotactic|radiosurgery, stereotactic
5016075|NCT01565837|Stereotactic Radiosurgery|stereotactic radiosurgery
5016076|NCT01565837|Ipilimumab|ipilimumab
5016077|NCT01565837|Yervoy|yervoy
5016078|NCT01565837|MDX-010|mdx-010
5016079|NCT01565837|Circulating Tumor Cells|circulating tumor cells
5016080|NCT01565811|colon neoplasm, rectal neoplasm, liver metastasis|colon neoplasm, rectal neoplasm, liver metastasis
5016081|NCT01565798|healthcare-acquired infections|healthcare-acquired infections
5016082|NCT01565798|colonization|colonization
5016083|NCT01565798|copper-alloy surfaces|copper-alloy surfaces
5016084|NCT01565785|Child parent home self-management|child parent home self-management
5016085|NCT01565772|Lung cancer|lung cancer
5016086|NCT01565772|Stage III|stage iii
5016087|NCT01565759|Gene expression|gene expression
5016088|NCT01565759|Lithium|lithium
5016089|NCT01565759|Healthy volunteers|healthy volunteers
5016090|NCT01565759|Lymphoblastoid cell lines|lymphoblastoid cell lines
5016091|NCT01565746|BAY88-8223|bay88-8223
5016092|NCT01565746|radium-223 dichloride|radium-223 dichloride
5016093|NCT01565746|prostate cancer|prostate cancer
5016094|NCT01565720|Isavuconazole|isavuconazole
5016095|NCT01565720|Healthy Volunteers|healthy volunteers
5016096|NCT01565720|BAL8557|bal8557
5016097|NCT01565707|Pediatric|pediatric
5016098|NCT01565707|Solifenacin succinate suspension|solifenacin succinate suspension
5016099|NCT01565707|Phase 3|phase 3
5016100|NCT01565707|Pharmacokinetics|pharmacokinetics
5016101|NCT01565707|Overactive bladder (OAB)|overactive bladder (oab)
5016102|NCT01565694|Cognitive Function|cognitive function
5016103|NCT01565694|Phase 3|phase 3
5016104|NCT01565694|Neurogenic Detrusor Overactivity|neurogenic detrusor overactivity
5016105|NCT01565694|Pharmacokinetics|pharmacokinetics
5016106|NCT01565694|Ocular Accommodation|ocular accommodation
5016107|NCT01565694|Urodynamics|urodynamics
5016108|NCT01565681|Healthy Volunteers|healthy volunteers
5016109|NCT01565681|B cell CD40 receptor occupancy|b cell cd40 receptor occupancy
5016110|NCT01565681|anti-CD40 monoclonal antibody|anti-cd40 monoclonal antibody
5016111|NCT01565668|FLT3-ITD positive Acute Myeloid Leukemia (AML)|flt3-itd positive acute myeloid leukemia (aml)
5016112|NCT01565668|AC220|ac220
5016113|NCT01565668|Relapse|relapse
5016114|NCT01565668|Refractory|refractory
5016115|NCT01565655|Rheumatoid Arthritis|rheumatoid arthritis
5016116|NCT01565655|ASP015K|asp015k
5016117|NCT01565642|Dementia, decision making|dementia, decision making
5016118|NCT01565629|Autism|autism
5016119|NCT01565629|Asperger's Syndrome|asperger's syndrome
5016120|NCT01565629|Treatment|treatment
5016121|NCT01565629|Cognitive-behavioral therapy|cognitive-behavioral therapy
5016122|NCT01565629|Anxiety|anxiety
5016123|NCT01565629|Children|children
5016124|NCT01565629|Therapy|therapy
5016125|NCT01565616|Severe Sickle Cell Disease|severe sickle cell disease
5016126|NCT01565616|Hematopoietic cell transplantation (HCT)|hematopoietic cell transplantation (hct)
5016127|NCT01565616|Hematopoietic Stem Cell Therapy|hematopoietic stem cell therapy
5016128|NCT01565616|Bone Marrow Transplant|bone marrow transplant
5016129|NCT01565616|Hematologic Diseases|hematologic diseases
5016130|NCT01565616|Genetic Diseases|genetic diseases
5016131|NCT01565616|Anemia|anemia
5016132|NCT01565616|Hemolytic|hemolytic
5016133|NCT01565616|Congenital|congenital
5016134|NCT01565616|Human Leukocyte Antigen|human leukocyte antigen
5016135|NCT01565616|HLA|hla
5016136|NCT01565603|Hypoxia|hypoxia
5016137|NCT01565603|Exercise|exercise
5016138|NCT01565603|Sleep|sleep
5016139|NCT01565603|Brain|brain
5016140|NCT01565603|Neuromuscular function|neuromuscular function
5016141|NCT01565603|Heart|heart
5016142|NCT01565590|aneurysmal subarachnoid hemorrhage|aneurysmal subarachnoid hemorrhage
5016143|NCT01565590|dexmedetomidine|dexmedetomidine
5016144|NCT01565590|cytokines|cytokines
5016145|NCT01565577|Neisseria meningitidis B:14, P1-7, 16|neisseria meningitidis b:14, p1-7, 16
5016146|NCT01565577|Serum bactericidal activity|serum bactericidal activity
5016147|NCT01565577|Menbvac|menbvac
5016148|NCT01565564|Gestational diabetes mellitus|gestational diabetes mellitus
5016149|NCT01565564|intervention|intervention
5016150|NCT01565564|shared care|shared care
5016151|NCT01565564|pregnancy outcome|pregnancy outcome
5016152|NCT01565564|macrosomia|macrosomia
5016153|NCT01565564|pregnancy-induced hypertension|pregnancy-induced hypertension
5016154|NCT01565551|Traumatic Brain Injury|traumatic brain injury
5016155|NCT01565551|Common Data Elements|common data elements
5016156|NCT01565551|Prognostic Models|prognostic models
5016157|NCT01565551|Neuroimaging|neuroimaging
5016158|NCT01565551|Biomarkers|biomarkers
5016159|NCT01565551|Genetic Variants|genetic variants
5016160|NCT01565551|Concussion|concussion
5016161|NCT01565551|Psychological Health|psychological health
5016162|NCT01565538|Cancer|cancer
5016163|NCT01565538|Non-small-cell lung cancer|non-small-cell lung cancer
5016164|NCT01565538|Adenocarcinoma|adenocarcinoma
5016165|NCT01565538|EGFR gene mutation|egfr gene mutation
5016166|NCT01565538|Chemotherapy|chemotherapy
5016167|NCT01565538|Pemetrexed|pemetrexed
5016168|NCT01565538|Erlotinib|erlotinib
5016169|NCT01565525|well child visit|well child visit
5016170|NCT01565525|anticipatory guidance|anticipatory guidance
5016171|NCT01565525|obesity prevention|obesity prevention
5016172|NCT01565525|infant feeding|infant feeding
5016173|NCT01565512|randomized trial|randomized trial
5016174|NCT01565512|robotic prostatectomy|robotic prostatectomy
5016175|NCT01565512|prostate cancer|prostate cancer
5016176|NCT01565512|foley catheter discomfort|foley catheter discomfort
5016177|NCT01565499|Neoadjuvant nab-paclitaxel luminal breast cancer|neoadjuvant nab-paclitaxel luminal breast cancer
5016178|NCT01565486|operation time|operation time
5016179|NCT01565486|complication rate|complication rate
5016180|NCT01565486|costs|costs
5016181|NCT01565486|admission time|admission time
5016182|NCT01565486|RFS|rfs
5016183|NCT01565486|OS|os
5016184|NCT01565473|non-motor symptoms|non-motor symptoms
5016185|NCT01565460|pancreas|pancreas
5016186|NCT01565460|biliary|biliary
5016187|NCT01565460|stricture|stricture
5016188|NCT01565421|Cancer|cancer
5016189|NCT01565421|Neoplasms|neoplasms
5016190|NCT01565421|Solid Tumor|solid tumor
5016191|NCT01565421|Ovarian Cancer|ovarian cancer
5016192|NCT01565421|Solid Malignancies|solid malignancies
5016193|NCT01565395|ALS|als
5016194|NCT01565395|PD|pd
5016195|NCT01565382|Amyloid imaging|amyloid imaging
5016196|NCT01565382|Positron Emission Tomography|positron emission tomography
5016197|NCT01565382|18F-AV-45|18f-av-45
5016198|NCT01565382|florbetapir F 18|florbetapir f 18
5016199|NCT01565382|Diagnostic imaging|diagnostic imaging
5016200|NCT01565369|Amyloid imaging|amyloid imaging
5016201|NCT01565369|Positron Emission Tomography|positron emission tomography
5016202|NCT01565369|18F-AV-45|18f-av-45
5016203|NCT01565369|florbetapir F 18|florbetapir f 18
5016204|NCT01565369|Diagnostic imaging|diagnostic imaging
5016205|NCT01565356|Amyloid imaging|amyloid imaging
5016206|NCT01565356|Positron Emission Tomography|positron emission tomography
5016207|NCT01565356|18F-AV-45|18f-av-45
5016208|NCT01565356|florbetapir F 18|florbetapir f 18
5016209|NCT01565356|Diagnostic imaging|diagnostic imaging
5016210|NCT01565343|Amyloid imaging|amyloid imaging
5016211|NCT01565343|Positron Emission Tomography|positron emission tomography
5016212|NCT01565343|18F-AV-45|18f-av-45
5016213|NCT01565343|florbetapir F 18|florbetapir f 18
5016214|NCT01565343|Diagnostic imaging|diagnostic imaging
5016215|NCT01565330|Amyloid imaging|amyloid imaging
5016216|NCT01565330|Positron Emission Tomography|positron emission tomography
5016217|NCT01565330|18F-AV-45|18f-av-45
5016218|NCT01565330|florbetapir F 18|florbetapir f 18
5016219|NCT01565330|Diagnostic imaging|diagnostic imaging
5016220|NCT01565304|Teen pregnancy|teen pregnancy
5016221|NCT01565304|Sexually transmitted infections|sexually transmitted infections
5016222|NCT01565304|Sexual risk behaviors|sexual risk behaviors
5016223|NCT01565291|Amyloid imaging|amyloid imaging
5016224|NCT01565291|Positron Emission Tomography|positron emission tomography
5016225|NCT01565291|18F-AV-45|18f-av-45
5016226|NCT01565291|florbetapir F 18|florbetapir f 18
5016227|NCT01565291|Diagnostic imaging|diagnostic imaging
5016228|NCT01565278|Parenteral nutrition|parenteral nutrition
5016229|NCT01565278|fish oil|fish oil
5016230|NCT01565278|liver disease|liver disease
5016231|NCT01565278|Omegaven|omegaven
5016232|NCT01565278|hepatic|hepatic
5016233|NCT01565278|liver biopsy|liver biopsy
5016234|NCT01565278|bilirubin|bilirubin
5016235|NCT01565265|ovarian hyperstimulation|ovarian hyperstimulation
5016236|NCT01565265|GnRH antagonist|gnrh antagonist
5016237|NCT01565265|GnRH agonist|gnrh agonist
5016238|NCT01565265|assisted reproduction|assisted reproduction
5016239|NCT01565265|FSH|fsh
5016240|NCT01565265|LH|lh
5016241|NCT01565252|Egg,Omega 3, Omega 6|egg,omega 3, omega 6
5016242|NCT01565239|Warfarin|warfarin
5016243|NCT01565239|Monitoring|monitoring
5016244|NCT01565239|prothrombin time|prothrombin time
5016245|NCT01565239|Fiix prothrombin time|fiix prothrombin time
5016246|NCT01565239|international normalized ratio (INR)|international normalized ratio (inr)
5016247|NCT01565239|new test|new test
5016248|NCT01565226|Capnography|capnography
5016249|NCT01565226|CO2|co2
5016250|NCT01565226|neonates|neonates
5016251|NCT01565226|High Frequency ventilation (HFV)|high frequency ventilation (hfv)
5016252|NCT01565213|primary health care,common mental disorders,|primary health care,common mental disorders,
5016253|NCT01565213|group therapy|group therapy
5016254|NCT01565200|HER2|her2
5016255|NCT01565200|Metastatic Breast Cancer|metastatic breast cancer
5016256|NCT01565187|Hand Transplantation|hand transplantation
5016257|NCT01565174|cannabis|cannabis
5016258|NCT01565174|THC|thc
5016259|NCT01565174|COMT|comt
5016260|NCT01565174|psychosis|psychosis
5016261|NCT01565174|D2|d2
5016262|NCT01565161|Obesity|obesity
5016263|NCT01565161|Overweight|overweight
5016264|NCT01565148|Diabetic Macular Edema (DME)|diabetic macular edema (dme)
5016265|NCT01565109|NESC|nesc
5016266|NCT01565109|NEOADJUVANT|neoadjuvant
5016267|NCT01565109|GASTRIC|gastric
5016268|NCT01565070|Osteoarthritis|osteoarthritis
5016269|NCT01565070|Pain|pain
5016270|NCT01565070|Quality of life|quality of life
5016271|NCT01565057|emulsion|emulsion
5016272|NCT01565057|emptying|emptying
5016273|NCT01565057|protein|protein
5016274|NCT01565057|layering|layering
5016275|NCT01565044|Stroke|stroke
5016276|NCT01565044|hemiplegia|hemiplegia
5016277|NCT01565044|automatic pilot|automatic pilot
5016278|NCT01565044|upper-limb rehabilitation|upper-limb rehabilitation
5016279|NCT01565031|Asthma|asthma
5016280|NCT01565018|Rotigotine|rotigotine
5016281|NCT01565018|Neupro®|neupro®
5016282|NCT01565018|Transdermal Patch|transdermal patch
5016283|NCT01565018|Bioequivalence|bioequivalence
5016284|NCT01565005|MCPH|mcph
5016285|NCT01565005|FANCONI ANEMIA|fanconi anemia
5016286|NCT01564992|Parkinson's disease|parkinson's disease
5016287|NCT01564992|Pharmacogenetics|pharmacogenetics
5016288|NCT01564992|Genetics|genetics
5016289|NCT01564979|botulinum toxin|botulinum toxin
5016290|NCT01564979|facial nerve|facial nerve
5016291|NCT01564979|hemifacial spasm|hemifacial spasm
5016292|NCT01564979|tears|tears
5016293|NCT01564966|transplantation|transplantation
5016294|NCT01564966|inflammation|inflammation
5016295|NCT01564966|endothelial dysfunction|endothelial dysfunction
5016296|NCT01564953|vitamin D|vitamin d
5016297|NCT01564953|calcium|calcium
5016298|NCT01564953|magnesium|magnesium
5016299|NCT01564953|COPD|copd
5016300|NCT01564953|QoL|qol
5016301|NCT01564940|Cervical cap insemination|cervical cap insemination
5016302|NCT01564940|Usability Study|usability study
5016303|NCT01564927|deqi electroacupuncture|deqi electroacupuncture
5016304|NCT01564927|BP HR HRV|bp hr hrv
5016305|NCT01564875|Simvast CR|simvast cr
5016306|NCT01564875|Zocor|zocor
5016307|NCT01564862|Drug Therapy|drug therapy
5016308|NCT01564849|Pomegranate fruit extract|pomegranate fruit extract
5016309|NCT01564849|Sinusitis|sinusitis
5016310|NCT01564849|rhinitis|rhinitis
5016311|NCT01564849|nasal polyps|nasal polyps
5016312|NCT01564823|Crohn´s disease|crohn´s disease
5016313|NCT01564823|Metronidazole|metronidazole
5016314|NCT01564823|Azathioprine|azathioprine
5016315|NCT01564823|Adalimumab|adalimumab
5016316|NCT01564823|post-chirurgic recurrence|post-chirurgic recurrence
5016317|NCT01564810|liver metastasis|liver metastasis
5016318|NCT01564810|colorectal cancer|colorectal cancer
5016319|NCT01564810|cetuximab|cetuximab
5016320|NCT01564810|chemotherapy|chemotherapy
5016321|NCT01564797|Diabetes|diabetes
5016322|NCT01564797|haemoglobin A1C|haemoglobin a1c
5016323|NCT01564797|Hispanic|hispanic
5016324|NCT01564797|Behavioural Intervention|behavioural intervention
5016325|NCT01564771|Pneumococcal serotypes|pneumococcal serotypes
5016326|NCT01564771|Community Acquired Pneumonia (CAP)|community acquired pneumonia (cap)
5016327|NCT01564758|non-interventional|non-interventional
5016328|NCT01564758|non-comparative|non-comparative
5016329|NCT01564758|open-label study|open-label study
5016330|NCT01564758|safety|safety
5016331|NCT01564758|Linezolid|linezolid
5016332|NCT01564758|gram positive infections|gram positive infections
5016333|NCT01564758|Filipino|filipino
5016334|NCT01564732|morbid obesity|morbid obesity
5016335|NCT01564732|gastric band|gastric band
5016336|NCT01564719|clergy|clergy
5016337|NCT01564719|weight loss|weight loss
5016338|NCT01564719|holistic|holistic
5016339|NCT01564719|stress|stress
5016340|NCT01564719|spiritual|spiritual
5016341|NCT01564706|Amyloid imaging|amyloid imaging
5016342|NCT01564706|Positron Emission Tomography|positron emission tomography
5016343|NCT01564706|18F-AV-45|18f-av-45
5016344|NCT01564706|florbetapir F 18|florbetapir f 18
5016345|NCT01564706|Diagnostic imaging|diagnostic imaging
5016346|NCT01564693|anorexia|anorexia
5016347|NCT01564693|cancer|cancer
5016348|NCT01564693|hypothalamus|hypothalamus
5016349|NCT01564693|inflammation|inflammation
5016350|NCT01564680|Lower abdominal surgery|lower abdominal surgery
5016351|NCT01564680|Paracetamol|paracetamol
5016352|NCT01564680|Lornoxicam|lornoxicam
5016353|NCT01564680|Morphine|morphine
5016354|NCT01564667|PTSD|ptsd
5016355|NCT01564667|Posttraumatic Stress|posttraumatic stress
5016356|NCT01564667|Post Traumatic Stress|post traumatic stress
5016357|NCT01564667|Attention Bias|attention bias
5016358|NCT01564667|Threat Bias|threat bias
5016359|NCT01564667|Combat|combat
5016360|NCT01564667|Warzone|warzone
5016361|NCT01564641|knee|knee
5016362|NCT01564641|osteoarthritis|osteoarthritis
5016363|NCT01564641|bicompartmental|bicompartmental
5016364|NCT01564641|arthroplasty|arthroplasty
5016365|NCT01564641|joint diseases|joint diseases
5016366|NCT01564628|CAD|cad
5016367|NCT01564615|Catheter related bloodstream infection|catheter related bloodstream infection
5016368|NCT01564615|Umbilical venous catheter|umbilical venous catheter
5016369|NCT01564615|Silver|silver
5016370|NCT01564615|Preterm infants|preterm infants
5016371|NCT01564602|2-channel single port laparoscopy|2-channel single port laparoscopy
5016372|NCT01564602|multiple-channel port laparoscopy|multiple-channel port laparoscopy
5016373|NCT01564576|Laparoscopic surgery|laparoscopic surgery
5016374|NCT01564576|Anesthesiology|anesthesiology
5016375|NCT01564576|Neuromuscular blockade|neuromuscular blockade
5016376|NCT01564550|Type 2 diabetes|type 2 diabetes
5016377|NCT01564550|Very-low-density-lipoprotein(VLDL)|very-low-density-lipoprotein(vldl)
5016378|NCT01564550|VLDL1|vldl1
5016379|NCT01564550|VLDL2|vldl2
5016380|NCT01564550|hyperinsulinemia|hyperinsulinemia
5016381|NCT01564550|diet|diet
5016382|NCT01564537|Drug therapy|drug therapy
5016383|NCT01564524|Craniomaxillofacial (CMF) Battle-injured (BI)|craniomaxillofacial (cmf) battle-injured (bi)
5016384|NCT01564524|Facial Trauma|facial trauma
5016385|NCT01564524|Fat Grafts|fat grafts
5016386|NCT01564524|Autogenous Fat Transfers (AFT)|autogenous fat transfers (aft)
5016387|NCT01564524|Wounded warriors|wounded warriors
5016388|NCT01564511|Multiple Sclerosis|multiple sclerosis
5016389|NCT01564511|Robotic Rahabilitation|robotic rahabilitation
5016390|NCT01564511|Fatigue|fatigue
5016391|NCT01564511|Gait disorder|gait disorder
5016392|NCT01564498|anthocyanins|anthocyanins
5016393|NCT01564498|antioxidant|antioxidant
5016394|NCT01564498|polyphenols|polyphenols
5016395|NCT01564498|bioavailability|bioavailability
5016396|NCT01564498|cholesterol|cholesterol
5016397|NCT01564498|insulin sensitivity|insulin sensitivity
5016398|NCT01564498|glucose tolerance|glucose tolerance
5016399|NCT01564498|atherosclerosis|atherosclerosis
5016400|NCT01564498|metabolic syndrome|metabolic syndrome
5016401|NCT01564446|medication|medication
5016402|NCT01564446|discharge|discharge
5016403|NCT01564446|adherence|adherence
5016404|NCT01564446|compliance|compliance
5016405|NCT01564446|secure message|secure message
5016406|NCT01564433|robotics|robotics
5016407|NCT01564433|rehabilitation|rehabilitation
5016408|NCT01564433|gait|gait
5016409|NCT01564433|cerebral palsy|cerebral palsy
5016410|NCT01564420|pharmacokinetic/pharmacodynamic modeling|pharmacokinetic/pharmacodynamic modeling
5016411|NCT01564420|intrathecal morphine|intrathecal morphine
5016412|NCT01564420|postoperative analgesia|postoperative analgesia
5016413|NCT01564420|patient-controlled analgesia device|patient-controlled analgesia device
5016414|NCT01564407|ICX‐RHY‐013|icx‐rhy‐013
5016415|NCT01564407|Restrictive scar contracture|restrictive scar contracture
5016416|NCT01564407|Restrictive hypertrophic scar|restrictive hypertrophic scar
5016417|NCT01564407|Burn Scar|burn scar
5016418|NCT01564407|Burn Scar contractures|burn scar contractures
5016419|NCT01564407|Scar|scar
5016420|NCT01564394|qigong|qigong
5016421|NCT01564394|mindfulness meditation|mindfulness meditation
5016422|NCT01564394|fatigue|fatigue
5016423|NCT01564394|prostate cancer|prostate cancer
5016424|NCT01564381|Cardiovascular disease|cardiovascular disease
5016425|NCT01564368|stage II breast cancer|stage ii breast cancer
5016426|NCT01564368|stage IIIA breast cancer|stage iiia breast cancer
5016427|NCT01564368|stage IIIB breast cancer|stage iiib breast cancer
5016428|NCT01564368|stage IIIC breast cancer|stage iiic breast cancer
5016429|NCT01564368|stage IV breast cancer|stage iv breast cancer
5016430|NCT01564368|HER2-negative breast cancer|her2-negative breast cancer
5016431|NCT01564368|HER2-positive breast cancer|her2-positive breast cancer
5016432|NCT01564342|wound irrigation|wound irrigation
5016433|NCT01564342|tap water irrigation|tap water irrigation
5016434|NCT01564342|wound infection|wound infection
5016435|NCT01564342|wound irrigation solution|wound irrigation solution
5016436|NCT01564329|endostar|endostar
5016437|NCT01564329|CT Perfusion|ct perfusion
5016438|NCT01564329|Advanced Primary Lung Adenocarcinoma|advanced primary lung adenocarcinoma
5016439|NCT01564303|Carnitine|carnitine
5016440|NCT01564303|Phosphodiesterase type 5 (PDE5) inhibitor|phosphodiesterase type 5 (pde5) inhibitor
5016441|NCT01564303|Contrast Media-induced Nephropathy (CMN)|contrast media-induced nephropathy (cmn)
5016442|NCT01564290|acute diarrhea|acute diarrhea
5016443|NCT01564290|probiotics|probiotics
5016444|NCT01564290|children|children
5016445|NCT01564264|Uterine Neoplasms|uterine neoplasms
5016446|NCT01564264|Sentinel Lymph Node Biopsy|sentinel lymph node biopsy
5016447|NCT01564238|calcium retention|calcium retention
5016448|NCT01564238|sodium retention|sodium retention
5016449|NCT01564225|XLHED|xlhed
5016450|NCT01564212|heat loss|heat loss
5016451|NCT01564212|laminar airflow|laminar airflow
5016452|NCT01564212|operating rooms|operating rooms
5016453|NCT01564160|Fish Oil|fish oil
5016454|NCT01564160|EPA|epa
5016455|NCT01564160|DHA|dha
5016456|NCT01564160|Omega-Score|omega-score
5016457|NCT01564160|Omega-3 Fatty Acids|omega-3 fatty acids
5016458|NCT01564160|Green-Lipped Mussel|green-lipped mussel
5016459|NCT01564160|Omega-score < 5.2%|omega-score < 5.2%
5016460|NCT01564147|Therapeutic Education, Rheumatoid Arthritis|therapeutic education, rheumatoid arthritis
5016461|NCT01564134|response vaccination|response vaccination
5016462|NCT01564108|Intravitreal Ranibizumab|intravitreal ranibizumab
5016463|NCT01564108|Non-infectious uveitis|non-infectious uveitis
5016464|NCT01564108|Refractory Cystoid Macular Oedema|refractory cystoid macular oedema
5016465|NCT01564108|Lucentis|lucentis
5016466|NCT01564108|LIMO|limo
5016467|NCT01564095|Liver transplantation|liver transplantation
5016468|NCT01564095|EDC|edc
5016469|NCT01564095|IRI|iri
5016470|NCT01564095|graft survival|graft survival
5016471|NCT01564095|graft function|graft function
5016472|NCT01564095|graft preconditioning|graft preconditioning
5016473|NCT01564095|Tacrolimus rinse|tacrolimus rinse
5016474|NCT01564095|randomised multicenter trial|randomised multicenter trial
5016475|NCT01564082|endotracheal intubation|endotracheal intubation
5016476|NCT01564082|GlideScope|glidescope
5016477|NCT01564069|Chronic pain|chronic pain
5016478|NCT01564069|Intrathecal pain management|intrathecal pain management
5016479|NCT01564056|Adjuvant systemic treatment|adjuvant systemic treatment
5016480|NCT01564056|Breast cancer|breast cancer
5016481|NCT01564056|Elderly patients|elderly patients
5016482|NCT01564030|Pregnancy|pregnancy
5016483|NCT01564030|Respiratory aspiration|respiratory aspiration
5016484|NCT01564030|Gastric contents|gastric contents
5016485|NCT01564030|Ultrasound|ultrasound
5016486|NCT01564017|Allergy|allergy
5016487|NCT01564017|Allergic rhinoconjunctivitis|allergic rhinoconjunctivitis
5016488|NCT01564017|Immunotherapy|immunotherapy
5016489|NCT01564017|D. pteronyssinus|d. pteronyssinus
5016490|NCT01564017|house dust allergy|house dust allergy
5016491|NCT01564004|breech presentation at term|breech presentation at term
5016492|NCT01564004|pregnancy|pregnancy
5016493|NCT01564004|external cephalic version (ECV)|external cephalic version (ecv)
5016494|NCT01564004|clinical hypnosis|clinical hypnosis
5016495|NCT01564004|neuro-linguistic programming (NLP)|neuro-linguistic programming (nlp)
5016496|NCT01563991|surgery|surgery
5016497|NCT01563991|fluid|fluid
5016498|NCT01563991|morbidity|morbidity
5016499|NCT01563978|Rheumatoid Arthritis|rheumatoid arthritis
5016500|NCT01563965|Preoperative fasting|preoperative fasting
5016501|NCT01563965|Acute phase proteins|acute phase proteins
5016502|NCT01563965|Carbohydrates|carbohydrates
5016503|NCT01563965|Protein hydrolizate|protein hydrolizate
5016504|NCT01563965|Inflammatory response|inflammatory response
5016505|NCT01563965|Surgery|surgery
5016506|NCT01563939|Labour analgesia|labour analgesia
5016507|NCT01563939|Pregnancy|pregnancy
5016508|NCT01563939|IVPCA|ivpca
5016509|NCT01563913|Parkinsons disease|parkinsons disease
5016510|NCT01563913|supplement|supplement
5016511|NCT01563913|DHA|dha
5016512|NCT01563913|dyskinesia|dyskinesia
5016513|NCT01563913|abnormal movements|abnormal movements
5016514|NCT01563900|fatigue|fatigue
5016515|NCT01563900|multiple sclerosis|multiple sclerosis
5016516|NCT01563900|sleep apnea|sleep apnea
5016517|NCT01563900|CPAP|cpap
5016518|NCT01563887|Type 1 Diabetes|type 1 diabetes
5016519|NCT01563887|Hypoglycemia|hypoglycemia
5016520|NCT01563887|Driving|driving
5016521|NCT01563887|Driving safety|driving safety
5016522|NCT01563887|Internet|internet
5016523|NCT01563887|Web|web
5016524|NCT01563887|Treatment|treatment
5016525|NCT01563887|Intervention|intervention
5016526|NCT01563874|Antibodies|antibodies
5016527|NCT01563874|Reverse Phase Microarrays|reverse phase microarrays
5016528|NCT01563874|Epigenetics|epigenetics
5016529|NCT01563874|Acetylation|acetylation
5016530|NCT01563874|Methylation|methylation
5016531|NCT01563874|Lymphoma|lymphoma
5016532|NCT01563861|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
5016533|NCT01563861|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5016534|NCT01563861|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5016535|NCT01563861|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5016536|NCT01563835|Termination of pregnancy|termination of pregnancy
5016537|NCT01563835|Epidural|epidural
5016538|NCT01563835|IV PCA|iv pca
5016539|NCT01563822|Follicular Fluid|follicular fluid
5016540|NCT01563822|uterine cavity|uterine cavity
5016541|NCT01563822|Implantation rates|implantation rates
5016542|NCT01563822|ICSI|icsi
5016543|NCT01563796|bladder cancer|bladder cancer
5016544|NCT01563796|TCC|tcc
5016545|NCT01563796|urine|urine
5016546|NCT01563796|protein ELISA|protein elisa
5016547|NCT01563783|Fibroids|fibroids
5016548|NCT01563783|Myomas|myomas
5016549|NCT01563783|leiomyomata|leiomyomata
5016550|NCT01563783|menorrhagia|menorrhagia
5016551|NCT01563783|Acessa Procedure|acessa procedure
5016552|NCT01563783|Radiofrequency Ablation|radiofrequency ablation
5016553|NCT01563783|RFA|rfa
5016554|NCT01563770|Hyperlipidemia|hyperlipidemia
5016555|NCT01563770|Hypertension|hypertension
5016556|NCT01563770|Vasodilation|vasodilation
5016557|NCT01563770|Oxidative stress|oxidative stress
5016558|NCT01563770|Inflammation|inflammation
5016559|NCT01563770|Hemostasis|hemostasis
5016560|NCT01563770|Hemorheology|hemorheology
5016561|NCT01563770|Cardiovascular diseases|cardiovascular diseases
5016562|NCT01563770|Cardiovascular agents|cardiovascular agents
5016563|NCT01563770|Salvia miltiorrhiza|salvia miltiorrhiza
5016564|NCT01563770|Danshen|danshen
5016565|NCT01563770|Danshen root extract|danshen root extract
5016566|NCT01563770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
5016567|NCT01563770|Therapeutic Uses|therapeutic uses
5016568|NCT01563744|colonoscopy|colonoscopy
5016569|NCT01563744|bowel preparation|bowel preparation
5016570|NCT01563744|tolerability|tolerability
5016571|NCT01563744|EGD-assisted|egd-assisted
5016572|NCT01563731|Blood pressure medicines|blood pressure medicines
5016573|NCT01563731|Lipid lowering medicines|lipid lowering medicines
5016574|NCT01563731|Hypertension|hypertension
5016575|NCT01563731|Stroke|stroke
5016576|NCT01563731|Dementia|dementia
5016577|NCT01563731|Heart attack|heart attack
5016578|NCT01563731|Heart failure|heart failure
5016579|NCT01563705|Neuromuscular Disorders|neuromuscular disorders
5016580|NCT01563705|GSD III|gsd iii
5016581|NCT01563705|glycogen storage disease|glycogen storage disease
5016582|NCT01563692|RSV|rsv
5016583|NCT01563692|Immune response|immune response
5016584|NCT01563679|cancer|cancer
5016585|NCT01563679|locoregional therapies|locoregional therapies
5016586|NCT01563679|RFA|rfa
5016587|NCT01563679|Cryoablation|cryoablation
5016588|NCT01563679|Microwave ablation|microwave ablation
5016589|NCT01563679|chemical ablation|chemical ablation
5016590|NCT01563679|Irreversible electroporation|irreversible electroporation
5016591|NCT01563653|predicting surgical success|predicting surgical success
5016592|NCT01563653|simple diagnostic test device|simple diagnostic test device
5016593|NCT01563640|dengue|dengue
5016594|NCT01563588|breast cancer|breast cancer
5016595|NCT01563588|chemotherapy|chemotherapy
5016596|NCT01563588|first line treatment|first line treatment
5016597|NCT01563588|treatments include a chemotherapy|treatments include a chemotherapy
5016598|NCT01563588|last treatment not performed more than 9 months earlier|last treatment not performed more than 9 months earlier
5016599|NCT01563575|Recognition Process|recognition process
5016600|NCT01563575|Health Promotion|health promotion
5016601|NCT01563575|HPH|hph
5016602|NCT01563575|WHO|who
5016603|NCT01563575|Hospitals|hospitals
5016604|NCT01563575|Health Services|health services
5016605|NCT01563575|Health Gain|health gain
5016606|NCT01563575|Service Delivery|service delivery
5016607|NCT01563575|Quality Management|quality management
5016608|NCT01563536|Hepatitis C,Genotype 1|hepatitis c,genotype 1
5016609|NCT01563510|Hepatolithiasis|hepatolithiasis
5016610|NCT01563510|Minimal invasive surgery|minimal invasive surgery
5016611|NCT01563510|Laparoscopic hepatectomy|laparoscopic hepatectomy
5016612|NCT01563510|Choledochoscope|choledochoscope
5016613|NCT01563484|Primary Hepatocellular Carcinoma(HCC)|primary hepatocellular carcinoma(hcc)
5016614|NCT01563484|Transarterial chemoembolization (TACE)|transarterial chemoembolization (tace)
5016615|NCT01563484|Liver function|liver function
5016616|NCT01563484|Renal function|renal function
5016617|NCT01563432|crossover|crossover
5016618|NCT01563432|pharmacokinetic|pharmacokinetic
5016619|NCT01563432|hyperuricemia|hyperuricemia
5016620|NCT01563432|gout|gout
5016621|NCT01563419|Insulin|insulin
5016622|NCT01563419|Diabetes|diabetes
5016623|NCT01563419|Low vision|low vision
5016624|NCT01563406|Needleless connectors|needleless connectors
5016625|NCT01563406|catheter hubs|catheter hubs
5016626|NCT01563393|tool for nutritional evaluation|tool for nutritional evaluation
5016627|NCT01563393|children|children
5016628|NCT01563393|malnutrition|malnutrition
5016629|NCT01563380|total knee arthroplasty|total knee arthroplasty
5016630|NCT01563380|osteoarthritis|osteoarthritis
5016631|NCT01563380|autologous Platelet rich plasma|autologous platelet rich plasma
5016632|NCT01563380|complications|complications
5016633|NCT01563380|blood loss|blood loss
5016634|NCT01563380|Pain|pain
5016635|NCT01563380|functional outcome|functional outcome
5016636|NCT01563367|Anaemia|anaemia
5016637|NCT01563367|Cardiac surgery|cardiac surgery
5016638|NCT01563354|neuroendocrine carcinoma; lung; thymus; pasireotide LAR; everolimus|neuroendocrine carcinoma; lung; thymus; pasireotide lar; everolimus
5016639|NCT01563328|Dolutegravir, GSK1349572, DTG, BCV, TVR, drug interaction|dolutegravir, gsk1349572, dtg, bcv, tvr, drug interaction
5016640|NCT01563315|Community-Acquired Infections|community-acquired infections
5016641|NCT01563315|Pneumonia/microbiology|pneumonia/microbiology
5016642|NCT01563315|Pneumonia/diagnosis|pneumonia/diagnosis
5016643|NCT01563315|Prognosis|prognosis
5016644|NCT01563315|Prospective Studies|prospective studies
5016645|NCT01563302|Advanced Cancers|advanced cancers
5016646|NCT01563302|DLBCL|dlbcl
5016647|NCT01563302|Advanced Lymphoma|advanced lymphoma
5016648|NCT01563276|Progressive Supranuclear Palsy|progressive supranuclear palsy
5016649|NCT01563276|PSP|psp
5016650|NCT01563276|Falls|falls
5016651|NCT01563276|Gait|gait
5016652|NCT01563276|Balance|balance
5016653|NCT01563276|Parkinson's Disease|parkinson's disease
5016654|NCT01563276|PD|pd
5016655|NCT01563263|IC43|ic43
5016656|NCT01563263|Pseudomonas Aeruginosa|pseudomonas aeruginosa
5016657|NCT01563263|mechanically ventilated ICU patients|mechanically ventilated icu patients
5016658|NCT01563263|ICU patients|icu patients
5016659|NCT01563250|Acute Coronary Syndrome|acute coronary syndrome
5016660|NCT01563250|Cardiac Biomarkers|cardiac biomarkers
5016661|NCT01563250|point of care testing|point of care testing
5016662|NCT01563224|GABA-B|gaba-b
5016663|NCT01563211|breast cancer therapy|breast cancer therapy
5016664|NCT01563211|toxicity|toxicity
5016665|NCT01563211|side effect profile|side effect profile
5016867|NCT01562197|recurrent|recurrent
5016666|NCT01563198|MRI departments and facilities|mri departments and facilities
5016667|NCT01563198|Noncompletion of MRI|noncompletion of mri
5016668|NCT01563185|JIA|jia
5016669|NCT01563185|ibuprofen|ibuprofen
5016670|NCT01563185|famotidine|famotidine
5016671|NCT01563185|pediatrics|pediatrics
5016672|NCT01563185|for > 1 month|for > 1 month
5016673|NCT01563159|Belgium|belgium
5016674|NCT01563159|hospitals|hospitals
5016675|NCT01563159|Rotavirus|rotavirus
5016676|NCT01563146|Rotavirus|rotavirus
5016677|NCT01563146|hospitals|hospitals
5016678|NCT01563146|Belgium|belgium
5016679|NCT01563133|endomicroscopy|endomicroscopy
5016680|NCT01563133|needle-based|needle-based
5016681|NCT01563133|pancreatic|pancreatic
5016682|NCT01563133|cyst|cyst
5016683|NCT01563133|mass|mass
5016684|NCT01563133|EUSFNA|eusfna
5016685|NCT01563107|Orthostatic Intolerance|orthostatic intolerance
5016686|NCT01563107|Tachycardia|tachycardia
5016687|NCT01563107|Orthostatic Hypotension|orthostatic hypotension
5016688|NCT01563107|Sodium|sodium
5016689|NCT01563094|Bone Density|bone density
5016690|NCT01563094|Lactation|lactation
5016691|NCT01563094|Bone Turnover Markers|bone turnover markers
5016692|NCT01563081|Allergic rhinitis|allergic rhinitis
5016693|NCT01563081|Pediatric|pediatric
5016694|NCT01563081|Pruritus|pruritus
5016695|NCT01563081|Levocetirizine|levocetirizine
5016696|NCT01563068|plaque psoriasis|plaque psoriasis
5016697|NCT01563068|pediatric|pediatric
5016698|NCT01563068|adolescent|adolescent
5016699|NCT01563042|immunogenicity|immunogenicity
5016700|NCT01563042|GSK2434735|gsk2434735
5016701|NCT01563042|pharmacokinetics (PK)|pharmacokinetics (pk)
5016702|NCT01563042|PK|pk
5016703|NCT01563042|biospecific antibody|biospecific antibody
5016704|NCT01563016|schizophrenia|schizophrenia
5016705|NCT01563016|Psychotic Disorders|psychotic disorders
5016706|NCT01563016|Psychoses|psychoses
5016707|NCT01563003|Autism|autism
5016708|NCT01563003|Asperger's Syndrome|asperger's syndrome
5016709|NCT01563003|Pervasive Developmental Disorder Not Otherwise Specified|pervasive developmental disorder not otherwise specified
5016710|NCT01563003|Treatment|treatment
5016711|NCT01563003|Cognitive-behavioral therapy|cognitive-behavioral therapy
5016712|NCT01563003|Anxiety|anxiety
5016713|NCT01563003|Children|children
5016714|NCT01563003|Therapy|therapy
5016715|NCT01562951|Crohn's disease|crohn's disease
5016716|NCT01562951|mucosal inflammation|mucosal inflammation
5016717|NCT01562951|lesions|lesions
5016718|NCT01562938|Respiratory Syncytial Virus|respiratory syncytial virus
5016719|NCT01562912|radiofrequency|radiofrequency
5016720|NCT01562912|ablation|ablation
5016721|NCT01562912|atrial fibrillation|atrial fibrillation
5016722|NCT01562912|PVAC|pvac
5016723|NCT01562899|MEK162|mek162
5016724|NCT01562899|AMG 479|amg 479
5016725|NCT01562899|Ganitumab|ganitumab
5016726|NCT01562899|colorectal adenocarcinoma|colorectal adenocarcinoma
5016727|NCT01562899|pancreatic adenocarcinoma|pancreatic adenocarcinoma
5016728|NCT01562899|melanoma|melanoma
5016729|NCT01562899|KRAS|kras
5016730|NCT01562899|BRAF|braf
5016731|NCT01562886|Rilpivirine CSF pharmacokinetics|rilpivirine csf pharmacokinetics
5016732|NCT01562873|pSTAT3+|pstat3+
5016733|NCT01562860|median nerve|median nerve
5016734|NCT01562860|carpal tunnel syndrome|carpal tunnel syndrome
5016735|NCT01562860|Pronator Teres Release|pronator teres release
5016736|NCT01562782|Elevated triglycerides|elevated triglycerides
5016737|NCT01562782|Diabetes Mellitus|diabetes mellitus
5016738|NCT01562782|Dyslipidemia|dyslipidemia
5016739|NCT01562782|Lipid Metabolic Disorders|lipid metabolic disorders
5016740|NCT01562782|Body Weight|body weight
5016741|NCT01562730|Coronary Artery Disease|coronary artery disease
5016742|NCT01562730|Myocardial Ischemia|myocardial ischemia
5016743|NCT01562730|Coronary Disease|coronary disease
5016744|NCT01562730|Heart Diseases|heart diseases
5016745|NCT01562730|Cardiovascular Diseases|cardiovascular diseases
5016746|NCT01562730|Arteriosclerosis|arteriosclerosis
5016747|NCT01562730|Arterial Occlusive Diseases|arterial occlusive diseases
5016748|NCT01562730|Vascular Diseases|vascular diseases
5016749|NCT01562730|iECG|iecg
5016750|NCT01562730|12 leads ECG|12 leads ecg
5016751|NCT01562704|mechanism of action of paracetamol in the brain structures|mechanism of action of paracetamol in the brain structures
5016752|NCT01562691|nasal packing|nasal packing
5016753|NCT01562691|nasal airway|nasal airway
5016754|NCT01562691|septoplasty|septoplasty
5016755|NCT01562691|oxygen saturation|oxygen saturation
5016756|NCT01562691|postoperative pain|postoperative pain
5016757|NCT01562678|fMRI|fmri
5016758|NCT01562678|Liraglutide|liraglutide
5016759|NCT01562678|diabetes|diabetes
5016760|NCT01562678|GLP-1|glp-1
5016761|NCT01562665|All patients with NSCLC attending participating hospitals|all patients with nsclc attending participating hospitals
5016762|NCT01562639|maintenance therapy,|maintenance therapy,
5016763|NCT01562639|repeatedly recurring,|repeatedly recurring,
5016764|NCT01562639|relapsing reflux oesophagitis,|relapsing reflux oesophagitis,
5016765|NCT01562639|Nexium|nexium
5016766|NCT01562613|Stroke|stroke
5016767|NCT01562613|Hypertension|hypertension
5016768|NCT01562600|NSAIDs|nsaids
5016868|NCT01562171|Overweight|overweight
5016769|NCT01562600|Gastric ulcer or duodenal ulcer|gastric ulcer or duodenal ulcer
5016770|NCT01562600|Nexium|nexium
5016771|NCT01562548|upper back/neck/shoulder muscle spasm|upper back/neck/shoulder muscle spasm
5016772|NCT01562535|pulled elbow|pulled elbow
5016773|NCT01562535|nursemaid elbow|nursemaid elbow
5016774|NCT01562509|Non-Hodgkin lymphoma (NHL)|non-hodgkin lymphoma (nhl)
5016775|NCT01562509|Quality of health care|quality of health care
5016776|NCT01562509|Oncology Service Hospital|oncology service hospital
5016777|NCT01562509|Patient-centredness|patient-centredness
5016778|NCT01562509|PROMs|proms
5016779|NCT01562496|Parkinson's disease|parkinson's disease
5016780|NCT01562496|Neuroprotective|neuroprotective
5016781|NCT01562496|Intensive exercise|intensive exercise
5016782|NCT01562483|postsurgical pain|postsurgical pain
5016783|NCT01562483|abdominal pain|abdominal pain
5016784|NCT01562483|visceral pain|visceral pain
5016785|NCT01562483|chronic pain|chronic pain
5016786|NCT01562470|cellulite|cellulite
5016787|NCT01562470|reduction|reduction
5016788|NCT01562470|cream|cream
5016789|NCT01562470|thighs|thighs
5016790|NCT01562470|women|women
5016791|NCT01562444|Long term immunogenicity study|long term immunogenicity study
5016792|NCT01562418|Ergonomics|ergonomics
5016793|NCT01562418|musculoskeletal symptoms|musculoskeletal symptoms
5016794|NCT01562418|kinematics|kinematics
5016795|NCT01562405|Relapsed|relapsed
5016796|NCT01562405|Refractory|refractory
5016797|NCT01562392|dietary prevention|dietary prevention
5016798|NCT01562392|cognitive performance|cognitive performance
5016799|NCT01562392|metabolic syndrome|metabolic syndrome
5016800|NCT01562392|colonic fermentation|colonic fermentation
5016801|NCT01562392|sub clinical inflammation|sub clinical inflammation
5016802|NCT01562392|cognition and metabolism|cognition and metabolism
5016803|NCT01562379|complementary food supplements|complementary food supplements
5016804|NCT01562379|stunting|stunting
5016805|NCT01562379|wasting|wasting
5016806|NCT01562379|growth|growth
5016807|NCT01562379|Bangladesh|bangladesh
5016808|NCT01562379|infant feeding|infant feeding
5016809|NCT01562366|Iliotibial Band Release|iliotibial band release
5016810|NCT01562366|Trochanteric Bursectomy|trochanteric bursectomy
5016811|NCT01562366|Micro debridement|micro debridement
5016812|NCT01562353|Opioid Dependence|opioid dependence
5016813|NCT01562353|Opioids for the treatment of pain|opioids for the treatment of pain
5016814|NCT01562340|Hemodialysis|hemodialysis
5016815|NCT01562340|End stage renal disease|end stage renal disease
5016816|NCT01562340|Oxidative stress|oxidative stress
5016817|NCT01562340|Inflammation|inflammation
5016818|NCT01562340|Endothelial dysfunction|endothelial dysfunction
5016819|NCT01562340|Cardiovascular disease|cardiovascular disease
5016820|NCT01562340|Antioxidants|antioxidants
5016821|NCT01562340|Flavonoids|flavonoids
5016822|NCT01562314|Mild to Moderate Ulcerative Colitis|mild to moderate ulcerative colitis
5016823|NCT01562314|GWP42003|gwp42003
5016824|NCT01562301|chemotherapeutic agent toxicity|chemotherapeutic agent toxicity
5016825|NCT01562301|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5016826|NCT01562301|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5016827|NCT01562301|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5016828|NCT01562301|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5016829|NCT01562301|carboplatin|carboplatin
5016830|NCT01562301|Paraplatin|paraplatin
5016831|NCT01562301|docetaxel|docetaxel
5016832|NCT01562301|Taxotere|taxotere
5016833|NCT01562301|Anvirzel|anvirzel
5016834|NCT01562301|nerium oleander|nerium oleander
5016835|NCT01562301|Advanced Non-Small Cell Lung Cancer|advanced non-small cell lung cancer
5016836|NCT01562301|NSCLC|nsclc
5016837|NCT01562288|HER2-positive breast cancer|her2-positive breast cancer
5016838|NCT01562288|HER2-negative breast cancer|her2-negative breast cancer
5016839|NCT01562288|stage IA breast cancer|stage ia breast cancer
5016840|NCT01562288|stage IB breast cancer|stage ib breast cancer
5016841|NCT01562288|stage II breast cancer|stage ii breast cancer
5016842|NCT01562288|stage IIIA breast cancer|stage iiia breast cancer
5016843|NCT01562275|GDC0973|gdc0973
5016844|NCT01562275|MEK|mek
5016845|NCT01562275|MEK inhibitor|mek inhibitor
5016846|NCT01562275|GDC0068|gdc0068
5016847|NCT01562275|Akt|akt
5016848|NCT01562275|Akt inhibitor|akt inhibitor
5016849|NCT01562262|Apnea|apnea
5016850|NCT01562262|PVT|pvt
5016851|NCT01562262|Reaction Time|reaction time
5016852|NCT01562249|clinical evaluation|clinical evaluation
5016853|NCT01562249|controlled clinical trial|controlled clinical trial
5016854|NCT01562249|electromyography|electromyography
5016855|NCT01562249|exercise program|exercise program
5016856|NCT01562249|motor control|motor control
5016857|NCT01562223|stage IIA prostate cancer|stage iia prostate cancer
5016858|NCT01562223|stage IIB prostate cancer|stage iib prostate cancer
5016859|NCT01562223|stage III prostate cancer|stage iii prostate cancer
5016860|NCT01562223|stage IV prostate cancer|stage iv prostate cancer
5016861|NCT01562223|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5016862|NCT01562210|NSCLC|nsclc
5016863|NCT01562210|Olaparib|olaparib
5016864|NCT01562210|CCRT|ccrt
5016865|NCT01562197|axitinib|axitinib
5016866|NCT01562197|glioblastoma|glioblastoma
5016869|NCT01562171|Obese|obese
5016870|NCT01562171|Obesity|obesity
5016871|NCT01562171|Cholesterol|cholesterol
5016872|NCT01562171|Hypercholesterolemia|hypercholesterolemia
5016873|NCT01562171|LDL-Cholesterol|ldl-cholesterol
5016874|NCT01562145|Rotator cuff tear, matrix metalloproteinase, tissue inhibitor of matrix metalloproteinase, partial-thickness tear, full-thickness tear, plasma.|rotator cuff tear, matrix metalloproteinase, tissue inhibitor of matrix metalloproteinase, partial-thickness tear, full-thickness tear, plasma.
5016875|NCT01562132|cryptococcus|cryptococcus
5016876|NCT01562132|HIV|hiv
5016877|NCT01562119|Burns|burns
5016878|NCT01562119|Wound repair|wound repair
5016879|NCT01562119|Skin substitutes|skin substitutes
5016880|NCT01562106|Cancer of Endometrium|cancer of endometrium
5016881|NCT01562106|Cancer of the Endometrium|cancer of the endometrium
5016882|NCT01562106|Carcinoma of Endometrium|carcinoma of endometrium
5016883|NCT01562106|Endometrial Carcinoma|endometrial carcinoma
5016884|NCT01562106|Endometrium Cancer|endometrium cancer
5016885|NCT01562106|Neoplasms, Endometrial|neoplasms, endometrial
5016886|NCT01562093|Adrenal Cortex Hormones|adrenal cortex hormones
5016887|NCT01562093|Spirometry|spirometry
5016888|NCT01562093|Administration, Intranasal|administration, intranasal
5016889|NCT01562093|Nasal blockage|nasal blockage
5016890|NCT01562093|Nasal sprays|nasal sprays
5016891|NCT01562080|hyperlipidemia|hyperlipidemia
5016892|NCT01562080|metabolic syndrome|metabolic syndrome
5016893|NCT01562080|yeast red|yeast red
5016894|NCT01562080|berberine|berberine
5016895|NCT01562080|policosanol|policosanol
5016896|NCT01562080|astaxanthin|astaxanthin
5016897|NCT01562067|Cervical tumors,vascular changes,Sonographic characteristics|cervical tumors,vascular changes,sonographic characteristics
5016898|NCT01562041|Cardiovascular disease|cardiovascular disease
5016899|NCT01562041|Exercise Treadmill Test|exercise treadmill test
5016900|NCT01562041|Ranolazine|ranolazine
5016901|NCT01562041|Angina|angina
5016902|NCT01562041|Myocardial ischemia|myocardial ischemia
5016903|NCT01562028|non small cell lung cancer|non small cell lung cancer
5016904|NCT01562028|advanced|advanced
5016905|NCT01562028|non-squamous|non-squamous
5016906|NCT01562028|EGFR|egfr
5016907|NCT01562028|mutations|mutations
5016908|NCT01562002|limbus|limbus
5016909|NCT01562002|cornea|cornea
5016910|NCT01562002|insufficiency syndrome|insufficiency syndrome
5016911|NCT01562002|stem cell transplant|stem cell transplant
5016912|NCT01561963|Apremilast|apremilast
5016913|NCT01561963|drug interaction|drug interaction
5016914|NCT01561963|pharmacokinetics|pharmacokinetics
5016915|NCT01561911|Clinical Trial|clinical trial
5016916|NCT01561911|Phase I|phase i
5016917|NCT01561911|Antibodies|antibodies
5016918|NCT01561911|Monoclonal|monoclonal
5016919|NCT01561898|Schizophrenia|schizophrenia
5016920|NCT01561898|JNS007ER|jns007er
5016921|NCT01561898|Paliperidone extended-release|paliperidone extended-release
5016922|NCT01561885|Clinical Pathways|clinical pathways
5016923|NCT01561885|Length of Stay|length of stay
5016924|NCT01561885|Patient-Centered Care|patient-centered care
5016925|NCT01561885|Pragmatic Randomized Controlled Trial|pragmatic randomized controlled trial
5016926|NCT01561859|Early Course Schizophrenia|early course schizophrenia
5016927|NCT01561859|Cognitive Enhancement Therapy|cognitive enhancement therapy
5016928|NCT01561859|Enriched Supportive Therapy|enriched supportive therapy
5016929|NCT01561846|Conjugated Linoleic Acid|conjugated linoleic acid
5016930|NCT01561846|LDL-cholesterol|ldl-cholesterol
5016931|NCT01561846|Endocannabinoids|endocannabinoids
5016932|NCT01561833|relapsed or refractory T cell lymphoma|relapsed or refractory t cell lymphoma
5016933|NCT01561820|mild cognitive impairment|mild cognitive impairment
5016934|NCT01561820|cognitive disorders|cognitive disorders
5016935|NCT01561820|exercise|exercise
5016936|NCT01561794|Ciprofloxacin|ciprofloxacin
5016937|NCT01561794|Bacterial pneumonia|bacterial pneumonia
5016938|NCT01561794|Community Acquired Pneumonia (CAP)|community acquired pneumonia (cap)
5016939|NCT01561794|Hospital Acquired Pneumonia (HAP)|hospital acquired pneumonia (hap)
5016940|NCT01561794|Secondary infection of chronic respiratory disease|secondary infection of chronic respiratory disease
5016941|NCT01561794|400 mg BID/TID|400 mg bid/tid
5016942|NCT01561781|Phase 1|phase 1
5016943|NCT01561781|healthy volunteers|healthy volunteers
5016944|NCT01561781|pharmacokinetics|pharmacokinetics
5016945|NCT01561781|vandetanib|vandetanib
5016946|NCT01561781|digoxin|digoxin
5016947|NCT01561755|HIV associated myelopathy|hiv associated myelopathy
5016948|NCT01561742|minocycline, augmentation, schizophrenia|minocycline, augmentation, schizophrenia
5016949|NCT01561729|nasogastric tube|nasogastric tube
5016950|NCT01561729|orogastric tube|orogastric tube
5016951|NCT01561729|RightSpot pH Indicator|rightspot ph indicator
5016952|NCT01561729|suction tube|suction tube
5016953|NCT01561729|RightBio Metrics|rightbio metrics
5016954|NCT01561729|RightLevel|rightlevel
5016955|NCT01561729|RightSpot Infant|rightspot infant
5016956|NCT01561729|NG Tube|ng tube
5016957|NCT01561729|pH|ph
5016958|NCT01561729|Gastric Acidity|gastric acidity
5016959|NCT01561716|video games|video games
5016960|NCT01561716|energy expenditure|energy expenditure
5016961|NCT01561716|physical activity|physical activity
5016962|NCT01561716|exercise physiology|exercise physiology
5016963|NCT01561703|Healthcare utilization|healthcare utilization
5016964|NCT01561703|Tonsillectomy|tonsillectomy
5016965|NCT01561703|Adenoidectomy/Tonsillectomy|adenoidectomy/tonsillectomy
5016966|NCT01561703|Antibiotics|antibiotics
5016967|NCT01561677|obstructive sleep apnea|obstructive sleep apnea
5016968|NCT01561677|syndrome survival|syndrome survival
5016969|NCT01561677|ischemic stroke|ischemic stroke
5016970|NCT01561677|continuous positive airway pressure|continuous positive airway pressure
5016971|NCT01561677|handicap|handicap
5016972|NCT01561664|obesity|obesity
5016973|NCT01561664|insulin resistance|insulin resistance
5016974|NCT01561651|cardiac surgery|cardiac surgery
5016975|NCT01561651|left atrial appendage|left atrial appendage
5016976|NCT01561651|atrial fibrillation|atrial fibrillation
5016977|NCT01561651|stroke|stroke
5016978|NCT01561651|non-CNS systemic embolism|non-cns systemic embolism
5016979|NCT01561638|Pulsed|pulsed
5016980|NCT01561638|radiofrequency|radiofrequency
5016981|NCT01561638|single-dose|single-dose
5016982|NCT01561638|shoulder pain|shoulder pain
5016983|NCT01561638|Pain lasts more than one month|pain lasts more than one month
5016984|NCT01561638|patients referred to the pain clinic from the shoulder clinic|patients referred to the pain clinic from the shoulder clinic
5016985|NCT01561638|Failed all conservative therapies available|failed all conservative therapies available
5016986|NCT01561625|COPD|copd
5016987|NCT01561625|exercise training|exercise training
5016988|NCT01561612|Breastfeeding|breastfeeding
5016989|NCT01561612|Child Health|child health
5016990|NCT01561612|Obesity|obesity
5016991|NCT01561612|Blood Pressure|blood pressure
5016992|NCT01561612|Asthma|asthma
5016993|NCT01561612|Cognitive Development|cognitive development
5016994|NCT01561612|Behavior|behavior
5016995|NCT01561612|Eczema|eczema
5016996|NCT01561612|Lung Function|lung function
5016997|NCT01561612|Spirometry|spirometry
5016998|NCT01561599|hepatocyte growth factor mimetic|hepatocyte growth factor mimetic
5016999|NCT01561599|hepatocyte growth factor(HGF)|hepatocyte growth factor(hgf)
5017000|NCT01561599|Delayed Graft Function (DGF)|delayed graft function (dgf)
5017001|NCT01561599|Kidney transplantation|kidney transplantation
5017002|NCT01561586|Cervical cancer|cervical cancer
5017003|NCT01561586|Concurrent chemoradiation|concurrent chemoradiation
5017004|NCT01561586|Cisplatin|cisplatin
5017005|NCT01561573|Point of Care Ultrasound|point of care ultrasound
5017006|NCT01561573|Emergency Ultrasound|emergency ultrasound
5017007|NCT01561573|Colles Fracture|colles fracture
5017008|NCT01561573|Fracture Reduction|fracture reduction
5017009|NCT01561573|Bedside Ultrasound|bedside ultrasound
5017010|NCT01561560|DAILIES TOTAL1|dailies total1
5017011|NCT01561560|contact lenses|contact lenses
5017012|NCT01561560|myopia|myopia
5017013|NCT01561547|pain|pain
5017014|NCT01561547|preterm neonate|preterm neonate
5017015|NCT01561547|sucrose|sucrose
5017016|NCT01561547|kangaroo mother care|kangaroo mother care
5017017|NCT01561534|fibula flap|fibula flap
5017018|NCT01561534|oral implants|oral implants
5017019|NCT01561534|computer-guided|computer-guided
5017020|NCT01561508|diabetes mellitus|diabetes mellitus
5017021|NCT01561508|children|children
5017022|NCT01561495|scheduled to receive RT either pre- or postoperatively|scheduled to receive rt either pre- or postoperatively
5017023|NCT01561482|Prostate carcinoma|prostate carcinoma
5017024|NCT01561482|Prostate cancer|prostate cancer
5017025|NCT01561482|Prostate Specific Antigen|prostate specific antigen
5017026|NCT01561482|PSA|psa
5017027|NCT01561482|Metformin|metformin
5017028|NCT01561482|Simvastatin|simvastatin
5017029|NCT01561482|Radiation therapy|radiation therapy
5017030|NCT01561482|Prostatectomy|prostatectomy
5017031|NCT01561469|Linezolid|linezolid
5017032|NCT01561469|Vancomycin|vancomycin
5017033|NCT01561469|Ventilator-Associated Pneumonia|ventilator-associated pneumonia
5017034|NCT01561469|Respiratory Tract Infections|respiratory tract infections
5017035|NCT01561456|non-small-cell lung cancer|non-small-cell lung cancer
5017036|NCT01561456|squamous cell carcinoma|squamous cell carcinoma
5017037|NCT01561456|adenocarcinoma of the lung|adenocarcinoma of the lung
5017038|NCT01561456|IGF-1 inhibitor|igf-1 inhibitor
5017039|NCT01561456|docetaxel|docetaxel
5017040|NCT01561456|AXL1717|axl1717
5017041|NCT01561456|NSCLC|nsclc
5017042|NCT01561456|SCC|scc
5017043|NCT01561456|AC|ac
5017044|NCT01561443|Breast cancer,|breast cancer,
5017045|NCT01561443|hormone positive,|hormone positive,
5017046|NCT01561430|beta-secretase inhibitor|beta-secretase inhibitor
5017047|NCT01561326|cervical cancer|cervical cancer
5017048|NCT01561326|follow-up|follow-up
5017049|NCT01561326|Pap test|pap test
5017050|NCT01561326|Medical management|medical management
5017051|NCT01561326|Colposcopy|colposcopy
5017052|NCT01561313|On label Humira users|on label humira users
5017053|NCT01561313|Pain|pain
5017054|NCT01561313|Rheumatoid Arthritis,|rheumatoid arthritis,
5017055|NCT01561300|Black tea|black tea
5017056|NCT01561300|Flow Mediated Dilation|flow mediated dilation
5017057|NCT01561300|Vascular function|vascular function
5017058|NCT01561300|India|india
5017059|NCT01561261|fasciotomy|fasciotomy
5017060|NCT01561261|ACS|acs
5017061|NCT01561248|EHEC|ehec
5017062|NCT01561248|O104:H4|o104:h4
5017063|NCT01561248|German|german
5017064|NCT01561248|outbreak|outbreak
5017065|NCT01561248|polyethylene glycol|polyethylene glycol
5017066|NCT01561248|Bowel lavage|bowel lavage
5017067|NCT01561235|Protein|protein
5017068|NCT01561235|Appetite|appetite
5017069|NCT01561235|Satiety|satiety
5017070|NCT01561235|Energi intake|energi intake
5017071|NCT01561235|Appetite regulating hormones|appetite regulating hormones
5017072|NCT01561235|Dose-response|dose-response
5017073|NCT01561222|calcitrol|calcitrol
5017074|NCT01561222|Bone mineral density|bone mineral density
5017075|NCT01561222|Osteoprotegin|osteoprotegin
5017076|NCT01561222|Vascular calcification|vascular calcification
5017077|NCT01561209|amitryptiline|amitryptiline
5017078|NCT01561209|Chronic pain|chronic pain
5017079|NCT01561209|Neck pain|neck pain
5017080|NCT01561196|arteria cannulation|arteria cannulation
5017081|NCT01561196|Ultrasound|ultrasound
5017082|NCT01561196|pain|pain
5017083|NCT01561196|complications|complications
5017084|NCT01561183|Vital pulp therapy|vital pulp therapy
5017085|NCT01561183|Pulp cap|pulp cap
5017086|NCT01561183|pulpotomy|pulpotomy
5017087|NCT01561183|calcium enriched mixture|calcium enriched mixture
5017088|NCT01561183|CEM cement|cem cement
5017089|NCT01561183|Endodontic|endodontic
5017090|NCT01561170|Electromagnetic|electromagnetic
5017091|NCT01561170|Field therapy|field therapy
5017092|NCT01561170|Chronically venous ulcer|chronically venous ulcer
5017093|NCT01561170|Venous insufficiens|venous insufficiens
5017094|NCT01561157|porphyria|porphyria
5017095|NCT01561157|acute intermittent|acute intermittent
5017096|NCT01561157|coproporphyria|coproporphyria
5017097|NCT01561157|variegate|variegate
5017098|NCT01561157|erythropoietic|erythropoietic
5017099|NCT01561157|protoporphyria|protoporphyria
5017100|NCT01561157|hepatoerythropoietic|hepatoerythropoietic
5017101|NCT01561157|cutanea tarda|cutanea tarda
5017102|NCT01561157|AIP|aip
5017103|NCT01561157|HCP|hcp
5017104|NCT01561157|VP|vp
5017105|NCT01561157|ADP|adp
5017106|NCT01561157|ALAD|alad
5017107|NCT01561157|PCT|pct
5017108|NCT01561157|HEP|hep
5017109|NCT01561157|CEP|cep
5017110|NCT01561157|EPP|epp
5017111|NCT01561157|XLP|xlp
5017112|NCT01561144|Defibrillators, Implantable|defibrillators, implantable
5017113|NCT01561144|Cardiac arrhythmias|cardiac arrhythmias
5017114|NCT01561144|Heart Disease|heart disease
5017115|NCT01561131|Obesity|obesity
5017116|NCT01561131|Protein intake|protein intake
5017117|NCT01561131|Calcium intake|calcium intake
5017118|NCT01561131|Weight loss|weight loss
5017119|NCT01561131|Weight maintenance|weight maintenance
5017120|NCT01561131|Blood lipid profile|blood lipid profile
5017121|NCT01561131|Diet induced thermogenesis|diet induced thermogenesis
5017122|NCT01561118|hemodialysis|hemodialysis
5017123|NCT01561118|dialysis efficacy|dialysis efficacy
5017124|NCT01561118|cardiorespiratory capacity|cardiorespiratory capacity
5017125|NCT01561118|exercise capacity|exercise capacity
5017126|NCT01561118|children and adolescents|children and adolescents
5017127|NCT01561092|Stroke|stroke
5017128|NCT01561092|RCT|rct
5017129|NCT01561092|SSRI|ssri
5017130|NCT01561092|Outcome|outcome
5017131|NCT01561079|Buprenorphine|buprenorphine
5017132|NCT01561079|Methadone|methadone
5017133|NCT01561079|Fetal neurobehavior|fetal neurobehavior
5017134|NCT01561079|Infant neurobehavior|infant neurobehavior
5017135|NCT01561066|Fibrin glue|fibrin glue
5017136|NCT01561066|Platelet|platelet
5017137|NCT01561066|Autologous derivation|autologous derivation
5017138|NCT01561066|Prospective randomized trial|prospective randomized trial
5017139|NCT01561066|Fistulas|fistulas
5017140|NCT01561053|Alzheimer's disease|alzheimer's disease
5017141|NCT01561053|AB peptide|ab peptide
5017142|NCT01561053|Albumin|albumin
5017143|NCT01561053|Intravenous immune globulin|intravenous immune globulin
5017144|NCT01561053|IGIV|igiv
5017145|NCT01561040|Dry Eye syndrome|dry eye syndrome
5017146|NCT01561040|tear film deficiency|tear film deficiency
5017147|NCT01561040|Essential Fatty Acid nutritional supplements|essential fatty acid nutritional supplements
5017148|NCT01561040|Omega three supplements|omega three supplements
5017149|NCT01560988|Asthma|asthma
5017150|NCT01560988|Borage|borage
5017151|NCT01560988|Echium|echium
5017152|NCT01560988|Botanical|botanical
5017153|NCT01560949|Pancreatic Cancer|pancreatic cancer
5017280|NCT01560481|pharmacodynamics|pharmacodynamics
5017154|NCT01560949|Adenocarcinoma of the Pancreas|adenocarcinoma of the pancreas
5017155|NCT01560949|High Risk Resectable|high risk resectable
5017156|NCT01560949|Borderline Resectable|borderline resectable
5017157|NCT01560949|Chemotherapy|chemotherapy
5017158|NCT01560949|Chemoradiation therapy|chemoradiation therapy
5017159|NCT01560949|Oxaliplatin|oxaliplatin
5017160|NCT01560949|Eloxatin|eloxatin
5017161|NCT01560949|Irinotecan|irinotecan
5017162|NCT01560949|CPT-11|cpt-11
5017163|NCT01560949|Camptosar|camptosar
5017164|NCT01560949|5-FU|5-fu
5017165|NCT01560949|5-Fluorouracil|5-fluorouracil
5017166|NCT01560949|Adrucil|adrucil
5017167|NCT01560949|Efudex|efudex
5017168|NCT01560949|Gemcitabine|gemcitabine
5017169|NCT01560949|Gemcitabine Hydrochloride|gemcitabine hydrochloride
5017170|NCT01560949|Gemzar|gemzar
5017171|NCT01560949|Radiation Therapy|radiation therapy
5017172|NCT01560949|XRT|xrt
5017173|NCT01560949|RT|rt
5017174|NCT01560949|External Beam Radiation Therapy|external beam radiation therapy
5017175|NCT01560936|bacterial contamination|bacterial contamination
5017176|NCT01560923|hormone refractory prostate cancer|hormone refractory prostate cancer
5017177|NCT01560910|with or without GERD symptoms|with or without gerd symptoms
5017178|NCT01560910|presenting to gastrointestinal clinic of Maharaj Nakorn Chiangmai Hospital|presenting to gastrointestinal clinic of maharaj nakorn chiangmai hospital
5017179|NCT01560910|November 2009 to November 2010|november 2009 to november 2010
5017180|NCT01560910|GERD|gerd
5017181|NCT01560910|NERD|nerd
5017182|NCT01560871|Heart failure|heart failure
5017183|NCT01560871|inspiratory muscle training|inspiratory muscle training
5017184|NCT01560871|physical activity|physical activity
5017185|NCT01560845|autologous bone marrow stem cells|autologous bone marrow stem cells
5017186|NCT01560845|portal hypertension|portal hypertension
5017187|NCT01560845|surgery|surgery
5017188|NCT01560845|liver cirrhosis|liver cirrhosis
5017189|NCT01560819|ulcerative colitis, gut microbial transplantation|ulcerative colitis, gut microbial transplantation
5017190|NCT01560806|hypertension|hypertension
5017191|NCT01560806|cardiovascular risk factor|cardiovascular risk factor
5017192|NCT01560806|lifestyle|lifestyle
5017193|NCT01560793|Influenza|influenza
5017194|NCT01560793|Vaccines|vaccines
5017195|NCT01560793|H5N1|h5n1
5017196|NCT01560780|Coronary Artery Bypass|coronary artery bypass
5017197|NCT01560780|thrombosis|thrombosis
5017198|NCT01560780|prasugrel|prasugrel
5017199|NCT01560767|Pain relief|pain relief
5017200|NCT01560767|Arthroplasty|arthroplasty
5017201|NCT01560767|periarticular knee infiltration|periarticular knee infiltration
5017202|NCT01560754|Randomized|randomized
5017203|NCT01560754|Placebo-controlled|placebo-controlled
5017204|NCT01560754|Double-blind|double-blind
5017205|NCT01560754|Multi-center|multi-center
5017206|NCT01560754|Disease-modifying potential|disease-modifying potential
5017207|NCT01560754|transdermal nicotine|transdermal nicotine
5017208|NCT01560741|Chronic respiratory failure|chronic respiratory failure
5017209|NCT01560741|Noninvasive Mechanical Ventilation|noninvasive mechanical ventilation
5017210|NCT01560741|Home-care|home-care
5017211|NCT01560741|Telemedicine|telemedicine
5017212|NCT01560741|COPD|copd
5017213|NCT01560728|Post Traumatic Stress Disorder|post traumatic stress disorder
5017214|NCT01560728|Major Depressive Disorder|major depressive disorder
5017215|NCT01560728|Dysthymia|dysthymia
5017216|NCT01560728|Generalized Anxiety Disorder|generalized anxiety disorder
5017217|NCT01560728|Social Phobia|social phobia
5017218|NCT01560728|Panic Disorder|panic disorder
5017219|NCT01560715|Retinitis pigmentosa|retinitis pigmentosa
5017220|NCT01560715|stem cell|stem cell
5017221|NCT01560715|bone marrow|bone marrow
5017222|NCT01560715|retinal dysprophy|retinal dysprophy
5017223|NCT01560702|autologous blood|autologous blood
5017224|NCT01560702|epinephrine|epinephrine
5017225|NCT01560702|endoscopy|endoscopy
5017226|NCT01560702|ulcer|ulcer
5017227|NCT01560702|hemostasis|hemostasis
5017228|NCT01560689|bone marrow transplantation|bone marrow transplantation
5017229|NCT01560689|obstructive lung disease|obstructive lung disease
5017230|NCT01560689|bronchodilators|bronchodilators
5017231|NCT01560689|inhaled steroids|inhaled steroids
5017232|NCT01560689|late-onset pulmonary complication|late-onset pulmonary complication
5017233|NCT01560676|Internet|internet
5017234|NCT01560676|School based|school based
5017235|NCT01560676|Obesity Prevention Program|obesity prevention program
5017236|NCT01560676|Adolescents|adolescents
5017237|NCT01560663|Breast Cancer|breast cancer
5017238|NCT01560663|Neoadjuvant therapy|neoadjuvant therapy
5017239|NCT01560663|Triple negative|triple negative
5017240|NCT01560663|predictor of response|predictor of response
5017241|NCT01560663|predictor of resistance|predictor of resistance
5017242|NCT01560663|Continuous Renal Replacement Therapy|continuous renal replacement therapy
5017243|NCT01560650|CRRT|crrt
5017244|NCT01560650|cardiac surgery associated acute kidney injury|cardiac surgery associated acute kidney injury
5017245|NCT01560650|Intensity|intensity
5017246|NCT01560637|PAH|pah
5017247|NCT01560637|PH|ph
5017248|NCT01560637|FREEDOM|freedom
5017249|NCT01560637|6 minute walk test|6 minute walk test
5017250|NCT01560637|treprostinil|treprostinil
5017251|NCT01560637|open label|open label
5017252|NCT01560624|PAH|pah
5017253|NCT01560624|PH|ph
5017254|NCT01560624|Clinical Worsening|clinical worsening
5017255|NCT01560624|Freedom|freedom
5017256|NCT01560624|Freedom-Ev|freedom-ev
5017257|NCT01560624|Treprostinil|treprostinil
5017258|NCT01560624|UT-15C|ut-15c
5017259|NCT01560624|6 Minute walk test|6 minute walk test
5017260|NCT01560598|GERD|gerd
5017261|NCT01560598|reflux esophagitis|reflux esophagitis
5017262|NCT01560598|adipokine|adipokine
5017263|NCT01560598|especially|especially
5017264|NCT01560598|endoscopically proven|endoscopically proven
5017265|NCT01560585|Isotretinoin|isotretinoin
5017266|NCT01560585|Alzheimer's disease|alzheimer's disease
5017267|NCT01560585|Dementia|dementia
5017268|NCT01560585|Retinoid|retinoid
5017269|NCT01560572|kidney transplantation|kidney transplantation
5017270|NCT01560572|immunosuppression|immunosuppression
5017271|NCT01560572|steroids|steroids
5017272|NCT01560572|tacrolimus OD|tacrolimus od
5017273|NCT01560559|Primary esophageal achalasia|primary esophageal achalasia
5017274|NCT01560559|endoscopic myotomy|endoscopic myotomy
5017275|NCT01560559|high resolution manometry|high resolution manometry
5017276|NCT01560520|acute ischemic stroke|acute ischemic stroke
5017277|NCT01560520|accelerometer|accelerometer
5017278|NCT01560481|metformin glycinate|metformin glycinate
5017279|NCT01560481|pharmacokinetics|pharmacokinetics
5017281|NCT01560468|Hepatitis C Virus Infection|hepatitis c virus infection
5017282|NCT01560468|Liver Transplantation|liver transplantation
5017283|NCT01560455|stent|stent
5017284|NCT01560455|bifurcation|bifurcation
5017285|NCT01560455|coronary|coronary
5017286|NCT01560442|Analgesics, opioids|analgesics, opioids
5017287|NCT01560442|Opiate substitution treatment|opiate substitution treatment
5017288|NCT01560442|Methadone|methadone
5017289|NCT01560442|Buprenorphine|buprenorphine
5017290|NCT01560442|Hyperalgesia|hyperalgesia
5017291|NCT01560442|Pupil|pupil
5017292|NCT01560442|Pain|pain
5017293|NCT01560442|Psychophysics|psychophysics
5017294|NCT01560442|previous illicit drug intake, under a substitution program|previous illicit drug intake, under a substitution program
5017295|NCT01560429|anesthesia and analgesia|anesthesia and analgesia
5017296|NCT01560429|Epidural Anesthesia|epidural anesthesia
5017297|NCT01560429|administration schedules, drug|administration schedules, drug
5017298|NCT01560416|Metastatic|metastatic
5017299|NCT01560416|HR positive|hr positive
5017300|NCT01560416|ER positive|er positive
5017301|NCT01560403|Short bowel syndrome|short bowel syndrome
5017302|NCT01560403|Parenteral nutrition|parenteral nutrition
5017303|NCT01560403|PN|pn
5017304|NCT01560403|HPN|hpn
5017305|NCT01560403|TPN|tpn
5017306|NCT01560403|SBS|sbs
5017307|NCT01560390|Sedation|sedation
5017308|NCT01560390|ICU|icu
5017309|NCT01560390|Ketamine|ketamine
5017310|NCT01560390|Confusion|confusion
5017311|NCT01560390|Hyperalgesia|hyperalgesia
5017312|NCT01560377|Laparoscopic low anterior colon resection|laparoscopic low anterior colon resection
5017313|NCT01560377|Laparoscopic left colectomy|laparoscopic left colectomy
5017314|NCT01560377|Colectomy|colectomy
5017315|NCT01560377|Rectal cancer|rectal cancer
5017316|NCT01560377|Colon cancer|colon cancer
5017317|NCT01560377|Crohn's Disease|crohn's disease
5017318|NCT01560377|Polyp|polyp
5017319|NCT01560377|Procidentia|procidentia
5017320|NCT01560377|Diverticulitis|diverticulitis
5017321|NCT01560364|Renal replacement therapy|renal replacement therapy
5017322|NCT01560364|Hemofilter clotting|hemofilter clotting
5017323|NCT01560364|Clotting risk factor|clotting risk factor
5017324|NCT01560364|Hemofilter clotting prevention|hemofilter clotting prevention
5017325|NCT01560351|Pathological gambling|pathological gambling
5017326|NCT01560351|craving|craving
5017327|NCT01560351|repeated Transcranial Magnetic Stimulation|repeated transcranial magnetic stimulation
5017328|NCT01560351|craving cues|craving cues
5017329|NCT01560338|Pharmacokinetics|pharmacokinetics
5017330|NCT01560338|Midazolam|midazolam
5017331|NCT01560338|Morphine|morphine
5017332|NCT01560338|Cardiac Arrest|cardiac arrest
5017333|NCT01560338|Hypothermia|hypothermia
5017334|NCT01560325|Solid Tumor, Tubulin inhibitor|solid tumor, tubulin inhibitor
5017335|NCT01560312|Renal denervation|renal denervation
5017336|NCT01560312|Resistant hypertension|resistant hypertension
5017337|NCT01560312|Spironolactone|spironolactone
5017338|NCT01560312|Long-term Outcome|long-term outcome
5017339|NCT01560299|hyperthyroidism|hyperthyroidism
5017340|NCT01560299|radio-iodine|radio-iodine
5017341|NCT01560299|I-131|i-131
5017342|NCT01560299|methimazole|methimazole
5017343|NCT01560299|graves disease|graves disease
5017344|NCT01560286|PKU|pku
5017345|NCT01560286|Injections|injections
5017346|NCT01560286|PEG-PAL|peg-pal
5017347|NCT01560286|PAL|pal
5017348|NCT01560247|Stroke|stroke
5017349|NCT01560247|Ischemic Stroke|ischemic stroke
5017350|NCT01560247|Revascularization|revascularization
5017351|NCT01560247|Mechanical thrombectomy|mechanical thrombectomy
5017352|NCT01560247|Neurothrombectomy|neurothrombectomy
5017353|NCT01560234|Safety|safety
5017354|NCT01560234|tolerability|tolerability
5017355|NCT01560234|healthy|healthy
5017356|NCT01560234|pharmacokinetic|pharmacokinetic
5017357|NCT01560234|pharmacodynamic|pharmacodynamic
5017358|NCT01560234|inhaled|inhaled
5017359|NCT01560208|infectious keratitis|infectious keratitis
5017360|NCT01560208|infective keratitis|infective keratitis
5017361|NCT01560208|prospective multicentre study|prospective multicentre study
5017362|NCT01560208|Asia|asia
5017363|NCT01560195|neutropenia|neutropenia
5017364|NCT01560195|febrile neutropenia|febrile neutropenia
5017365|NCT01560195|chemotherapy|chemotherapy
5017366|NCT01560182|Lentiviral vector|lentiviral vector
5017367|NCT01560182|Metachromatic Leukodystrophy|metachromatic leukodystrophy
5017368|NCT01560182|Gene Therapy|gene therapy
5017369|NCT01560169|Celiac Disease|celiac disease
5017370|NCT01560169|Coeliac Disease|coeliac disease
5017371|NCT01560169|Celiac Sprue|celiac sprue
5017372|NCT01560169|Keilakia Disease|keilakia disease
5017373|NCT01560117|AGMT|agmt
5017374|NCT01560117|NHL|nhl
5017375|NCT01560104|Randomized|randomized
5017376|NCT01560104|metastatic|metastatic
5017377|NCT01560104|ABT-888|abt-888
5017378|NCT01560104|paclitaxel|paclitaxel
5017379|NCT01560104|non-small cell lung cancer|non-small cell lung cancer
5017380|NCT01560104|PARP|parp
5017381|NCT01560104|veliparib|veliparib
5017382|NCT01560104|progression free survival|progression free survival
5017383|NCT01560104|carboplatin|carboplatin
5017384|NCT01560091|clearance rate|clearance rate
5017385|NCT01560078|Tuberculosis|tuberculosis
5017386|NCT01560078|Pleural effusion|pleural effusion
5017387|NCT01560078|Category 3|category 3
5017388|NCT01560052|end stage kidney disease|end stage kidney disease
5017389|NCT01560052|IgA nephropathy|iga nephropathy
5017390|NCT01560039|Neuropathic pain|neuropathic pain
5017391|NCT01560039|neurostimulation|neurostimulation
5017392|NCT01560026|ovarian preservation|ovarian preservation
5017393|NCT01560013|Alcohol|alcohol
5017394|NCT01560013|naltrexone|naltrexone
5017395|NCT01560013|cue reactivity|cue reactivity
5017396|NCT01560013|PET|pet
5017397|NCT01560000|The focus of this study is to determine satiety|the focus of this study is to determine satiety
5017398|NCT01559987|plaque removal methods|plaque removal methods
5017399|NCT01559987|oral hygiene devices|oral hygiene devices
5017400|NCT01559974|Peripheral arterial disease|peripheral arterial disease
5017401|NCT01559974|PAOD|paod
5017402|NCT01559974|Vitamin D|vitamin d
5017403|NCT01559974|Walking impairment|walking impairment
5017404|NCT01559961|bladder|bladder
5017405|NCT01559961|cystitis|cystitis
5017406|NCT01559961|frequency|frequency
5017407|NCT01559961|nocturia|nocturia
5017408|NCT01559961|pain|pain
5017409|NCT01559961|urgency|urgency
5017410|NCT01559948|Low back pain|low back pain
5017411|NCT01559948|Sacroiliac joint pain|sacroiliac joint pain
5017412|NCT01559948|Lumbopelvic stabilization program|lumbopelvic stabilization program
5017413|NCT01559948|Pelvic compression belt|pelvic compression belt
5017414|NCT01559948|Deep abdominal muscles|deep abdominal muscles
5017415|NCT01559935|Multiple Myeloma|multiple myeloma
5017416|NCT01559922|Acne|acne
5017417|NCT01559909|Lower limb loss|lower limb loss
5017418|NCT01559909|Leg amputation|leg amputation
5017419|NCT01559909|walking study|walking study
5017420|NCT01559909|socket technology|socket technology
5017421|NCT01559896|egg protein hydrolysate|egg protein hydrolysate
5017422|NCT01559883|cancer|cancer
5017423|NCT01559883|thrombosis|thrombosis
5017424|NCT01559883|pulmonary embolism|pulmonary embolism
5017425|NCT01559883|anticoagulation|anticoagulation
5017426|NCT01559883|low molecular weight heparin|low molecular weight heparin
5017427|NCT01559870|cardiac surgery|cardiac surgery
5017428|NCT01559870|cytokine|cytokine
5017429|NCT01559870|clinical scoring system|clinical scoring system
5017430|NCT01559870|risk factor|risk factor
5017431|NCT01559857|Depression|depression
5017432|NCT01559857|Insulin resistance|insulin resistance
5017433|NCT01559857|Mood disorder|mood disorder
5017434|NCT01559844|Hepatitis|hepatitis
5017435|NCT01559844|Chronic|chronic
5017436|NCT01559844|hepatocellular carcinoma|hepatocellular carcinoma
5017437|NCT01559844|HCC|hcc
5017438|NCT01559844|transplant|transplant
5017439|NCT01559831|Japanese Encephalitis|japanese encephalitis
5017440|NCT01559831|IXIARO|ixiaro
5017441|NCT01559831|Japanese Encephalitis Vaccine|japanese encephalitis vaccine
5017442|NCT01559805|HIV|hiv
5017443|NCT01559805|Viral Load|viral load
5017444|NCT01559805|Risk|risk
5017445|NCT01559805|Patient Compliance|patient compliance
5017446|NCT01559805|Homosexuality, Male|homosexuality, male
5017447|NCT01559805|Anti-Retroviral Agents|anti-retroviral agents
5017448|NCT01559779|Obesity|obesity
5017449|NCT01559779|Roux-en-Y gastric bypass|roux-en-y gastric bypass
5017450|NCT01559779|Incretin hormones|incretin hormones
5017451|NCT01559779|Beta cell function|beta cell function
5017452|NCT01559766|Vitamin A|vitamin a
5017453|NCT01559766|Dietary requirement|dietary requirement
5017454|NCT01559766|Dietary records|dietary records
5017455|NCT01559766|Deuterated retinol dilution technique|deuterated retinol dilution technique
5017456|NCT01559766|Chinese children|chinese children
5017457|NCT01559766|Dietary intake of vitamin A|dietary intake of vitamin a
5017458|NCT01559766|Vitamin A liver reserves|vitamin a liver reserves
5017459|NCT01559753|Antibiotic|antibiotic
5017460|NCT01559753|treatment|treatment
5017461|NCT01559753|ventilator associated pneumonia|ventilator associated pneumonia
5017462|NCT01559753|duration|duration
5017463|NCT01559740|regional anesthesia|regional anesthesia
5017464|NCT01559740|children|children
5017465|NCT01559740|postoperative pain relief|postoperative pain relief
5017466|NCT01559727|heart failure|heart failure
5017467|NCT01559727|diuresis|diuresis
5017468|NCT01559727|prednisone|prednisone
5017469|NCT01559714|Troponin|troponin
5017470|NCT01559714|Exercise|exercise
5017471|NCT01559714|MRI|mri
5017472|NCT01559701|Safety|safety
5017473|NCT01559701|PF-00345439|pf-00345439
5017474|NCT01559701|Remoxy|remoxy
5017475|NCT01559701|PTI-821|pti-821
5017476|NCT01559675|Corticosteroids|corticosteroids
5017477|NCT01559675|perioperative|perioperative
5017478|NCT01559675|colorectal surgery|colorectal surgery
5017479|NCT01559662|chewing gum|chewing gum
5017480|NCT01559662|ileus|ileus
5017481|NCT01559662|gastrointestinal function|gastrointestinal function
5017482|NCT01559662|colorectal surgery|colorectal surgery
5017483|NCT01559662|abdominal surgery|abdominal surgery
5017484|NCT01559649|Stroke|stroke
5017485|NCT01559649|Deglutition|deglutition
5017486|NCT01559649|Deglutition Disorders|deglutition disorders
5017487|NCT01559649|Nurse Screening|nurse screening
5017488|NCT01559636|seroconversion|seroconversion
5017489|NCT01559636|oral polio vaccine|oral polio vaccine
5017490|NCT01559636|OPV|opv
5017491|NCT01559636|poliomyelitis|poliomyelitis
5017492|NCT01559636|diarrhea|diarrhea
5017493|NCT01559636|seroimmunity|seroimmunity
5017494|NCT01559610|cardiac surgery|cardiac surgery
5017495|NCT01559610|orientation|orientation
5017496|NCT01559610|nursing|nursing
5017497|NCT01559597|controlled temperature chain|controlled temperature chain
5017498|NCT01559597|outside the cold chain|outside the cold chain
5017499|NCT01559597|vaccination|vaccination
5017500|NCT01559597|prevention of mother to child transmission|prevention of mother to child transmission
5017501|NCT01559584|Alopecia|alopecia
5017502|NCT01559584|Areata|areata
5017503|NCT01559584|Phototherapy|phototherapy
5017504|NCT01559584|Phototoxic|phototoxic
5017505|NCT01559584|Ultraviolet A|ultraviolet a
5017506|NCT01559584|Randomized controlled trial|randomized controlled trial
5017507|NCT01559584|Interferon gamma|interferon gamma
5017508|NCT01559584|Transforming growth factor beta-1|transforming growth factor beta-1
5017509|NCT01559584|Insulin like growth factor-1|insulin like growth factor-1
5017510|NCT01559571|Retinopathy of Prematurity|retinopathy of prematurity
5017511|NCT01559545|Clostridium difficile associated diarrhea|clostridium difficile associated diarrhea
5017512|NCT01559545|Metronidazole|metronidazole
5017513|NCT01559545|CDAD|cdad
5017514|NCT01559532|Deep vein thrombosis|deep vein thrombosis
5017515|NCT01559532|Thromboembolism|thromboembolism
5017516|NCT01559532|Tourniquet|tourniquet
5017517|NCT01559532|Knee prosthesis.|knee prosthesis.
5017518|NCT01559519|TIPS|tips
5017519|NCT01559519|albumin|albumin
5017520|NCT01559519|hepatic encephalopathy|hepatic encephalopathy
5017521|NCT01559519|hyponatremia|hyponatremia
5017522|NCT01559519|hypovolemia|hypovolemia
5017523|NCT01559519|cirrhosis|cirrhosis
5017524|NCT01559506|CFU|cfu
5017525|NCT01559506|surgery site|surgery site
5017526|NCT01559493|atherosclerotic lesion assessment|atherosclerotic lesion assessment
5017527|NCT01559480|Endometriosis|endometriosis
5017528|NCT01559480|Desogestrel|desogestrel
5017529|NCT01559480|Placebo|placebo
5017530|NCT01559467|Myocardial infarction|myocardial infarction
5017531|NCT01559467|Randomized Controlled Trial|randomized controlled trial
5017532|NCT01559467|Magnetic Resonance Imaging|magnetic resonance imaging
5017533|NCT01559467|Coronary Angiography|coronary angiography
5017534|NCT01559467|Tomography, X-Ray Computed|tomography, x-ray computed
5017535|NCT01559467|Mortality|mortality
5017536|NCT01559467|Complications|complications
5017537|NCT01559467|Quality of Life|quality of life
5017538|NCT01559467|Cost-Benefit Analysis|cost-benefit analysis
5017539|NCT01559454|chronic pain|chronic pain
5017540|NCT01559454|opioid dependence|opioid dependence
5017541|NCT01559454|methadone|methadone
5017542|NCT01559454|buprenorphine|buprenorphine
5017543|NCT01559454|substance use disorder|substance use disorder
5017544|NCT01559441|beetroot juice|beetroot juice
5017545|NCT01559441|nitrate|nitrate
5017546|NCT01559441|vascular activity|vascular activity
5017547|NCT01559441|postprandial state|postprandial state
5017548|NCT01559428|Plant sterols|plant sterols
5017549|NCT01559428|Plant stanols|plant stanols
5017550|NCT01559428|Oxyphytosterols|oxyphytosterols
5017551|NCT01559428|Cardiovascular Disease|cardiovascular disease
5017552|NCT01559415|Adipocytes|adipocytes
5017553|NCT01559389|Urge Urinary Incontinence|urge urinary incontinence
5017554|NCT01559389|Vesicare|vesicare
5017555|NCT01559389|Urinary Incontinence|urinary incontinence
5017556|NCT01559389|Sexual function|sexual function
5017557|NCT01559350|OPCAB|opcab
5017558|NCT01559337|defect|defect
5017559|NCT01559337|dorsal branch of the proper digital nerve|dorsal branch of the proper digital nerve
5017560|NCT01559337|proper digital nerve|proper digital nerve
5017561|NCT01559337|nerve transfer|nerve transfer
5017562|NCT01559337|finger sensory reconstruction|finger sensory reconstruction
5017563|NCT01559311|Bradycardia|bradycardia
5017564|NCT01559298|Transcatheter aortic valve implantation|transcatheter aortic valve implantation
5017565|NCT01559298|Antithrombotic treatment|antithrombotic treatment
5017566|NCT01559298|Clopidogrel|clopidogrel
5017567|NCT01559298|Aspirin|aspirin
5017568|NCT01559298|Myocardial Infarction|myocardial infarction
5017569|NCT01559298|Ischemic stroke|ischemic stroke
5017570|NCT01559298|Major bleeding|major bleeding
5017571|NCT01559285|epidural, local, ropivacaine|epidural, local, ropivacaine
5017572|NCT01559285|epidural administration|epidural administration
5017573|NCT01559285|stroke volume variability|stroke volume variability
5017574|NCT01559272|Schizophrenia|schizophrenia
5017575|NCT01559272|Paliperidone palmitate|paliperidone palmitate
5017576|NCT01559272|R092670|r092670
5017577|NCT01559272|Paliperidone|paliperidone
5017578|NCT01559272|3-month formulation|3-month formulation
5017579|NCT01559272|Pharmacokinetics|pharmacokinetics
5017580|NCT01559259|ibuprofen|ibuprofen
5017581|NCT01559259|acetaminophen|acetaminophen
5017582|NCT01559259|pain|pain
5017583|NCT01559259|molar extraction|molar extraction
5017584|NCT01559246|Cardiac Arrhythmia Monitoring|cardiac arrhythmia monitoring
5017585|NCT01559246|Holter Monitoring|holter monitoring
5017586|NCT01559246|Continuous ECG monitoring|continuous ecg monitoring
5017587|NCT01559246|Event monitoring|event monitoring
5017588|NCT01559246|Observational|observational
5017589|NCT01559207|nucleosome|nucleosome
5017590|NCT01559207|plasma nucleosome concentrations|plasma nucleosome concentrations
5017591|NCT01559207|free DNA|free dna
5017592|NCT01559207|plasma free DNA concentrations|plasma free dna concentrations
5017593|NCT01559181|Offspring of mothers with type 1 diabetes|offspring of mothers with type 1 diabetes
5017594|NCT01559181|Pregnancy and programing|pregnancy and programing
5017595|NCT01559181|Intrauterine hyperglycaemia|intrauterine hyperglycaemia
5017596|NCT01559181|Study focuses on offspring of mothers with type 1 diabetes|study focuses on offspring of mothers with type 1 diabetes
5017597|NCT01559155|proteasomes|proteasomes
5017598|NCT01559155|proteasome concentration|proteasome concentration
5017599|NCT01559155|disease activity|disease activity
5017600|NCT01559155|proteolytic activity|proteolytic activity
5017601|NCT01559155|autoantibodies|autoantibodies
5017602|NCT01559155|proteasome autoantibody|proteasome autoantibody
5017603|NCT01559142|Crohn Disease|crohn disease
5017604|NCT01559142|infliximab|infliximab
5017605|NCT01559142|azathioprine|azathioprine
5017606|NCT01559103|Rheumatoid Arthritis|rheumatoid arthritis
5017607|NCT01559103|Phase I|phase i
5017608|NCT01559103|Biologic|biologic
5017609|NCT01559090|Japan|japan
5017610|NCT01559090|Phase2|phase2
5017611|NCT01559090|Safety|safety
5017612|NCT01559090|Tolerability|tolerability
5017613|NCT01559090|Systemic Lupus Erythematosus|systemic lupus erythematosus
5017614|NCT01559090|SLE, MEDI-546|sle, medi-546
5017615|NCT01559077|ATTR|attr
5017616|NCT01559051|COPD|copd
5017617|NCT01559051|Pulmonary|pulmonary
5017618|NCT01559051|Lungs|lungs
5017619|NCT01559038|Assessing Effectiveness in Psoriatic Arthritis|assessing effectiveness in psoriatic arthritis
5017620|NCT01559025|Type 1 diabetes|type 1 diabetes
5017621|NCT01559025|Vildagliptin|vildagliptin
5017622|NCT01559025|Galvus|galvus
5017623|NCT01559012|Hyperemesis Gravidarum|hyperemesis gravidarum
5017624|NCT01559012|treatment|treatment
5017625|NCT01559012|transdermal clonidine|transdermal clonidine
5017626|NCT01558986|Antibiotic prophylaxis|antibiotic prophylaxis
5017627|NCT01558986|surgical site infection|surgical site infection
5017628|NCT01558986|modified radical mastectomy|modified radical mastectomy
5017629|NCT01558986|Prevention of surgical site infection (SSI) in patients undergoing MRM for breast cancer|prevention of surgical site infection (ssi) in patients undergoing mrm for breast cancer
5017630|NCT01558960|Retinoblastoma|retinoblastoma
5017631|NCT01558947|gastric cancer|gastric cancer
5017632|NCT01558947|Peri-operative chemotherapy|peri-operative chemotherapy
5017633|NCT01558934|lofexidine|lofexidine
5017634|NCT01558934|methadone|methadone
5017635|NCT01558934|interaction|interaction
5017636|NCT01558934|pharmacodynamic|pharmacodynamic
5017637|NCT01558934|ECG|ecg
5017638|NCT01558934|QTc|qtc
5017639|NCT01558921|rectal cancer|rectal cancer
5017640|NCT01558921|radiotherapy|radiotherapy
5017641|NCT01558921|chemotherapy|chemotherapy
5017642|NCT01558921|5x5|5x5
5017643|NCT01558921|capecitbine|capecitbine
5017644|NCT01558921|oxaliplatin|oxaliplatin
5017645|NCT01558921|CAPOX|capox
5017646|NCT01558921|FOLFOX|folfox
5017647|NCT01558921|folinic acid|folinic acid
5017648|NCT01558921|fluorouracil|fluorouracil
5017649|NCT01558908|critical limb ischemia|critical limb ischemia
5017650|NCT01558895|Infrared ray heat treatment|infrared ray heat treatment
5017651|NCT01558895|liver cirrhosis|liver cirrhosis
5017652|NCT01558895|refractory ascites|refractory ascites
5017653|NCT01558882|Essure|essure
5017654|NCT01558882|Change in uterine cytokines|change in uterine cytokines
5017655|NCT01558882|Change in uterine natural killer cells|change in uterine natural killer cells
5017656|NCT01558882|cytokine|cytokine
5017657|NCT01558882|natural killer cell|natural killer cell
5017658|NCT01558856|refractory overactive bladder|refractory overactive bladder
5017659|NCT01558856|neuromodulation|neuromodulation
5017660|NCT01558856|sacral nerves|sacral nerves
5017661|NCT01558843|Sodium Management|sodium management
5017662|NCT01558843|Neurointensive Care|neurointensive care
5017663|NCT01558843|Hyponatremia|hyponatremia
5017664|NCT01558830|amiodarone|amiodarone
5017665|NCT01558830|ranolazine|ranolazine
5017666|NCT01558830|safety|safety
5017667|NCT01558830|arrhythmia|arrhythmia
5017668|NCT01558817|CPR|cpr
5017669|NCT01558817|Palliative|palliative
5017670|NCT01558817|Outcome|outcome
5017671|NCT01558804|Streptococcus pyogenes|streptococcus pyogenes
5017672|NCT01558804|Streptococcus|streptococcus
5017673|NCT01558791|PTSD|ptsd
5017674|NCT01558791|patient education handout|patient education handout
5017675|NCT01558765|Rehabilitation|rehabilitation
5017676|NCT01558765|Integrated rehabilitation programme|integrated rehabilitation programme
5017677|NCT01558765|Exercise training|exercise training
5017678|NCT01558765|Psycho-educational care|psycho-educational care
5017679|NCT01558752|Total hip replacement|total hip replacement
5017680|NCT01558752|Bone mineral density (BMD)|bone mineral density (bmd)
5017681|NCT01558739|Ruxolitinib|ruxolitinib
5017682|NCT01558739|INC424|inc424
5017683|NCT01558739|myelofibrosis|myelofibrosis
5017684|NCT01558739|PMF|pmf
5017685|NCT01558739|post polycythemia myelofibrosis|post polycythemia myelofibrosis
5017686|NCT01558739|PPV MF|ppv mf
5017687|NCT01558739|post-essential thrombocythemia myelofibrosis|post-essential thrombocythemia myelofibrosis
5017688|NCT01558739|PET-MF|pet-mf
5017689|NCT01558739|Primary Myelofibrosis|primary myelofibrosis
5017690|NCT01558739|Polycythemia|polycythemia
5017691|NCT01558739|Thrombocythemia|thrombocythemia
5017692|NCT01558739|Essential Thrombocytosis|essential thrombocytosis
5017693|NCT01558739|myeloproliferative Disorders|myeloproliferative disorders
5017694|NCT01558739|Bone Marrow Diseases|bone marrow diseases
5017695|NCT01558739|Haematologic Diseases|haematologic diseases
5017696|NCT01558739|Blood Coagulation Disorders|blood coagulation disorders
5017697|NCT01558739|Blood Platelet Disorders|blood platelet disorders
5017698|NCT01558739|Haemorrhagic Disorders|haemorrhagic disorders
5017699|NCT01558726|Case Management|case management
5017700|NCT01558726|Crack abuse/dependents|crack abuse/dependents
5017701|NCT01558726|Evaluation|evaluation
5017702|NCT01558726|Inpatient|inpatient
5017703|NCT01558726|ASI|asi
5017704|NCT01558726|Treatment retention|treatment retention
5017705|NCT01558726|Abstinence|abstinence
5017706|NCT01558713|parturient|parturient
5017707|NCT01558700|osteoarthritis|osteoarthritis
5017708|NCT01558700|pain|pain
5017709|NCT01558700|brain|brain
5017710|NCT01558700|gray matter|gray matter
5017711|NCT01558687|Oncology|oncology
5017712|NCT01558687|newly diagnosed inoperable glioblastoma|newly diagnosed inoperable glioblastoma
5017713|NCT01558687|temolozomide|temolozomide
5017714|NCT01558687|radiotherapy|radiotherapy
5017715|NCT01558687|dynamic MRI|dynamic mri
5017716|NCT01558687|Positron emission tomography|positron emission tomography
5017717|NCT01558687|[18]FET tracer|[18]fet tracer
5017718|NCT01558687|cilengitide|cilengitide
5017719|NCT01558687|World Health Organization [WHO] Grade IV|world health organization [who] grade iv
5017720|NCT01558661|axitinib (AG-013736)|axitinib (ag-013736)
5017721|NCT01558661|recurrent|recurrent
5017722|NCT01558661|metastatic|metastatic
5017723|NCT01558661|12-004|12-004
5017724|NCT01558648|Minimally Invasive Esophagectomy|minimally invasive esophagectomy
5017725|NCT01558648|Open Esophagectomy|open esophagectomy
5017726|NCT01558648|Quality of Life|quality of life
5017727|NCT01558648|12-003|12-003
5017728|NCT01558635|Atrial Fibrillation|atrial fibrillation
5017729|NCT01558635|Surgical ablation|surgical ablation
5017730|NCT01558635|Maze procedure|maze procedure
5017731|NCT01558635|AF|af
5017732|NCT01558622|postoperative analgesia|postoperative analgesia
5017733|NCT01558622|dexketoprofen trometamol|dexketoprofen trometamol
5017734|NCT01558622|tramadol hydrochloride|tramadol hydrochloride
5017735|NCT01558622|pethidine|pethidine
5017736|NCT01558622|laparoscopic Nissen fundoplication|laparoscopic nissen fundoplication
5017737|NCT01558583|Colon|colon
5017738|NCT01558583|Prostate|prostate
5017739|NCT01558583|Cancer|cancer
5017740|NCT01558544|Ovarian tissue cryopreservation|ovarian tissue cryopreservation
5017741|NCT01558544|Ovarian tissue transplantation|ovarian tissue transplantation
5017742|NCT01558544|Fertility preservation|fertility preservation
5017743|NCT01558544|Risk of premature ovarian failure|risk of premature ovarian failure
5017744|NCT01558531|peripheral arterial disease|peripheral arterial disease
5017745|NCT01558531|drug-eluting balloon|drug-eluting balloon
5017746|NCT01558531|restenosis|restenosis
5017747|NCT01558518|Handheld echocardiography|handheld echocardiography
5017748|NCT01558518|V-scan|v-scan
5017749|NCT01558518|Handheld ultrasound|handheld ultrasound
5017750|NCT01558518|Portable ultrasound|portable ultrasound
5017751|NCT01558505|critical limb ischemia|critical limb ischemia
5017752|NCT01558505|drug-eluting balloon|drug-eluting balloon
5017753|NCT01558505|restenosis|restenosis
5017754|NCT01558492|Metastatic Castrate Resistant Prostate Cancer|metastatic castrate resistant prostate cancer
5017755|NCT01558492|CRPC|crpc
5017756|NCT01558479|Parkinson's Disease|parkinson's disease
5017757|NCT01558479|Genetics|genetics
5017758|NCT01558479|Family Research|family research
5017759|NCT01558479|Hereditary Neurodegenerative Diseases|hereditary neurodegenerative diseases
5017760|NCT01558466|newborn|newborn
5017761|NCT01558466|INO|ino
5017762|NCT01558466|Sildenafil|sildenafil
5017763|NCT01558466|PPHN|pphn
5017764|NCT01558440|Nutrition rehabilitation|nutrition rehabilitation
5017765|NCT01558440|severe malnutrition|severe malnutrition
5017766|NCT01558440|infant formula|infant formula
5017767|NCT01558440|F-100|f-100
5017768|NCT01558414|Cholecystectomy|cholecystectomy
5017769|NCT01558414|Minimally invasive surgery|minimally invasive surgery
5017770|NCT01558414|Laparoscopic surgery|laparoscopic surgery
5017771|NCT01558414|Single incision surgery|single incision surgery
5017772|NCT01558401|physical activity|physical activity
5017773|NCT01558401|elderly|elderly
5017774|NCT01558401|women|women
5017775|NCT01558401|efficiency|efficiency
5017776|NCT01558362|myocardial perfusion imaging|myocardial perfusion imaging
5017777|NCT01558362|single photon emission tomography|single photon emission tomography
5017778|NCT01558362|Coronary artery disease|coronary artery disease
5017976|NCT01557582|APAH HIV|apah hiv
5017779|NCT01558362|gamma camera imaging|gamma camera imaging
5017780|NCT01558362|Phase 1 clinical trial|phase 1 clinical trial
5017781|NCT01558362|cyclotron|cyclotron
5017782|NCT01558349|Epispot|epispot
5017783|NCT01558349|CellSearch|cellsearch
5017784|NCT01558349|Circulating melanoma cells|circulating melanoma cells
5017785|NCT01558349|circulating cells|circulating cells
5017786|NCT01558336|Schistosoma haematobium|schistosoma haematobium
5017787|NCT01558336|schoolchildren|schoolchildren
5017788|NCT01558336|Central Sudan|central sudan
5017789|NCT01558336|Praziquantel|praziquantel
5017790|NCT01558323|LCQ908, Renal Impairment, Pharmacokinetics|lcq908, renal impairment, pharmacokinetics
5017791|NCT01558284|Irritable bowel syndrome|irritable bowel syndrome
5017792|NCT01558284|Neu-P11|neu-p11
5017793|NCT01558284|Melatonin|melatonin
5017794|NCT01558284|D-IBS|d-ibs
5017795|NCT01558271|GLP-1|glp-1
5017796|NCT01558245|ischemic stroke; in-stent restenosis; tissue kallikrein;|ischemic stroke; in-stent restenosis; tissue kallikrein;
5017797|NCT01558245|the middle cerebral artery; atherosclerotic stenosis|the middle cerebral artery; atherosclerotic stenosis
5017798|NCT01558232|Stroke|stroke
5017799|NCT01558232|Tibion|tibion
5017800|NCT01558232|Bionics|bionics
5017801|NCT01558232|Rehab|rehab
5017802|NCT01558232|Therapy|therapy
5017803|NCT01558232|Robotics|robotics
5017804|NCT01558232|Intention|intention
5017805|NCT01558219|Metastatic prostate cancer|metastatic prostate cancer
5017806|NCT01558206|PTE|pte
5017807|NCT01558206|Emergency bedside ultrasonography|emergency bedside ultrasonography
5017808|NCT01558206|pulmonary CT Angiography|pulmonary ct angiography
5017809|NCT01558206|Pulmonary Wedge infarction|pulmonary wedge infarction
5017810|NCT01558206|Pulmonary Thromboembolism|pulmonary thromboembolism
5017811|NCT01558193|Aggression DHA|aggression dha
5017812|NCT01558193|Docosahexaenoic acid|docosahexaenoic acid
5017813|NCT01558193|Impulsivity|impulsivity
5017814|NCT01558193|Minerals|minerals
5017815|NCT01558193|Vitamins|vitamins
5017816|NCT01558167|Dose limiting toxicity of Lenalidomide|dose limiting toxicity of lenalidomide
5017817|NCT01558167|Chronic lymphocytic leukemia|chronic lymphocytic leukemia
5017818|NCT01558154|depression|depression
5017819|NCT01558154|Chinese herb|chinese herb
5017820|NCT01558154|acupuncture|acupuncture
5017821|NCT01558154|Psychotherapy|psychotherapy
5017822|NCT01558154|Transcranial magnetic stimulation|transcranial magnetic stimulation
5017823|NCT01558141|IVF stimulation.|ivf stimulation.
5017824|NCT01558141|Poor responders.|poor responders.
5017825|NCT01558141|IVF patients with poor response to stimulation|ivf patients with poor response to stimulation
5017826|NCT01558115|Columbia University|columbia university
5017827|NCT01558115|Primary hyperparathyroidism|primary hyperparathyroidism
5017828|NCT01558115|Low bone density|low bone density
5017829|NCT01558115|Denosumab|denosumab
5017830|NCT01558115|Prolia|prolia
5017831|NCT01558102|brain aneurysm PED Pipeline|brain aneurysm ped pipeline
5017832|NCT01558076|Sickle cell anemia|sickle cell anemia
5017833|NCT01558076|exercise testing|exercise testing
5017834|NCT01558076|cardiopulmonary disease|cardiopulmonary disease
5017835|NCT01558063|Ketamine|ketamine
5017836|NCT01558063|Major Depressive Disorder|major depressive disorder
5017837|NCT01558063|Treatment|treatment
5017838|NCT01558063|Depression|depression
5017839|NCT01558037|transplant|transplant
5017840|NCT01558037|solid organ transplant|solid organ transplant
5017841|NCT01558037|kidney transplant|kidney transplant
5017842|NCT01558037|liver transplant|liver transplant
5017843|NCT01558037|pancreas transplant|pancreas transplant
5017844|NCT01558037|heart transplant|heart transplant
5017845|NCT01558037|CMV|cmv
5017846|NCT01558037|Cytomegalovirus|cytomegalovirus
5017847|NCT01558024|compression stockings|compression stockings
5017848|NCT01558024|physiopathology|physiopathology
5017849|NCT01558011|gastric adenocarcinoma|gastric adenocarcinoma
5017850|NCT01558011|Capecitabine and oxaliplatin (XELOX)|capecitabine and oxaliplatin (xelox)
5017851|NCT01558011|Docetaxel and capecitabine (TX)|docetaxel and capecitabine (tx)
5017852|NCT01558011|Using genetic polymorphisms|using genetic polymorphisms
5017853|NCT01558011|drug metabolism and immunohistochemical stain|drug metabolism and immunohistochemical stain
5017854|NCT01558011|predict the efficacy|predict the efficacy
5017855|NCT01557998|Test and linkage to care|test and linkage to care
5017856|NCT01557998|Injecting drug user (IDU)|injecting drug user (idu)
5017857|NCT01557998|Prevention with positives|prevention with positives
5017858|NCT01557998|ART adherence|art adherence
5017859|NCT01557998|point of care CD4 counts|point of care cd4 counts
5017860|NCT01557998|Peer case management|peer case management
5017861|NCT01557998|Conditional cash transfer|conditional cash transfer
5017862|NCT01557985|children|children
5017863|NCT01557985|regional anesthesia|regional anesthesia
5017864|NCT01557985|postoperative pain management|postoperative pain management
5017865|NCT01557985|local anesthetic solution|local anesthetic solution
5017866|NCT01557985|toxicity|toxicity
5017867|NCT01557933|ECT|ect
5017868|NCT01557933|Bipolar Disorder|bipolar disorder
5017869|NCT01557920|apnea|apnea
5017870|NCT01557920|airway collapsibility|airway collapsibility
5017871|NCT01557920|healthy|healthy
5017872|NCT01557920|hypercapnia|hypercapnia
5017873|NCT01557920|general anesthesia|general anesthesia
5017874|NCT01557920|breathing-swallow coordination|breathing-swallow coordination
5017875|NCT01557920|aspiration|aspiration
5017876|NCT01557907|Diabetes|diabetes
5017877|NCT01557907|Diabetes Mellitus|diabetes mellitus
5017878|NCT01557907|Type 1 diabetes|type 1 diabetes
5017879|NCT01557907|Insulin Pump users|insulin pump users
5017880|NCT01557907|Intradermal insulin|intradermal insulin
5017881|NCT01557894|Social anxiety disorders|social anxiety disorders
5017882|NCT01557894|Social phobia|social phobia
5017883|NCT01557894|Anxiety sensitivity|anxiety sensitivity
5017884|NCT01557894|Irrational thinking|irrational thinking
5017885|NCT01557894|Guided self-help|guided self-help
5017886|NCT01557894|Internet-delivered treatment|internet-delivered treatment
5017887|NCT01557855|Corus CAD|corus cad
5017888|NCT01557855|ASGES|asges
5017889|NCT01557855|Age/Sex/Gene Expression Score|age/sex/gene expression score
5017890|NCT01557855|Gene Expression|gene expression
5017891|NCT01557855|GES|ges
5017892|NCT01557855|CAD|cad
5017893|NCT01557855|CVD|cvd
5017894|NCT01557855|CHD|chd
5017895|NCT01557855|Precision Medicine|precision medicine
5017896|NCT01557855|Clinical Utility|clinical utility
5017897|NCT01557855|Registry|registry
5017898|NCT01557855|Coronary Artery Disease|coronary artery disease
5017899|NCT01557855|Coronary Heart Disease|coronary heart disease
5017900|NCT01557855|Cardiovascular Disease|cardiovascular disease
5017901|NCT01557855|Angina Pectoris|angina pectoris
5017902|NCT01557855|Chest Pain|chest pain
5017903|NCT01557855|Registry I|registry i
5017904|NCT01557855|Registry-I|registry-i
5017905|NCT01557842|Ischemic|ischemic
5017906|NCT01557842|Ventricular Tachycardia|ventricular tachycardia
5017907|NCT01557842|Implantable Cardioverter Defibrillators|implantable cardioverter defibrillators
5017908|NCT01557842|Antiarrhythmic Drug Therapy|antiarrhythmic drug therapy
5017909|NCT01557842|Ablation|ablation
5017910|NCT01557842|Electrophysiology|electrophysiology
5017911|NCT01557829|spondylolisthesis|spondylolisthesis
5017912|NCT01557829|disc degeneration|disc degeneration
5017913|NCT01557829|lumbar interbody fusion|lumbar interbody fusion
5017914|NCT01557829|randomized controlled trial|randomized controlled trial
5017915|NCT01557829|ceramic interbody spacer|ceramic interbody spacer
5017916|NCT01557816|osteoarthritis|osteoarthritis
5017917|NCT01557816|knee|knee
5017918|NCT01557816|Naproxen|naproxen
5017919|NCT01557803|Immune reconstitution inflammatory syndrome|immune reconstitution inflammatory syndrome
5017920|NCT01557803|Biomarkers|biomarkers
5017921|NCT01557803|HIV|hiv
5017922|NCT01557803|ART|art
5017923|NCT01557803|predictive factors|predictive factors
5017924|NCT01557803|epidemiological pattern|epidemiological pattern
5017925|NCT01557803|Gabon|gabon
5017926|NCT01557790|Adult male|adult male
5017927|NCT01557790|18 years or older|18 years or older
5017928|NCT01557790|clinical diagnosis|clinical diagnosis
5017929|NCT01557751|Total knee arthroplasty|total knee arthroplasty
5017930|NCT01557751|Total knee replacement|total knee replacement
5017931|NCT01557751|Genetics of pain|genetics of pain
5017932|NCT01557738|Exercise|exercise
5017933|NCT01557738|Blood Flow|blood flow
5017934|NCT01557738|Nitric Oxide|nitric oxide
5017935|NCT01557738|Aging|aging
5017936|NCT01557738|Antioxidant|antioxidant
5017937|NCT01557738|Flavanol|flavanol
5017938|NCT01557738|Young (18-30 yrs)|young (18-30 yrs)
5017939|NCT01557738|Aging (60 - 80 yrs)|aging (60 - 80 yrs)
5017940|NCT01557725|Knee Replacement, Total|knee replacement, total
5017941|NCT01557725|Hip Replacement, Total|hip replacement, total
5017942|NCT01557725|Thromboembolism, Venous|thromboembolism, venous
5017943|NCT01557725|prophylaxis|prophylaxis
5017944|NCT01557725|Enhanced recovery|enhanced recovery
5017945|NCT01557686|Cancer Related fatigue|cancer related fatigue
5017946|NCT01557686|Quality of Life|quality of life
5017947|NCT01557686|Psychosocial Intervention|psychosocial intervention
5017948|NCT01557686|Rehabilitation|rehabilitation
5017949|NCT01557686|Physical Fitness|physical fitness
5017950|NCT01557686|Physical Activity|physical activity
5017951|NCT01557686|Exercise Therapy|exercise therapy
5017952|NCT01557686|Exercise|exercise
5017953|NCT01557686|Hematologic|hematologic
5017954|NCT01557686|Hematological|hematological
5017955|NCT01557686|Leukemia, Myeloid, Acute|leukemia, myeloid, acute
5017956|NCT01557686|Acute Myeloid Leukemia|acute myeloid leukemia
5017957|NCT01557686|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
5017958|NCT01557686|Acute Leukemia|acute leukemia
5017959|NCT01557673|Nasogastric|nasogastric
5017960|NCT01557673|Small bowel water|small bowel water
5017961|NCT01557673|Diarrhoea|diarrhoea
5017962|NCT01557673|Mesenteric blood flow|mesenteric blood flow
5017963|NCT01557673|Enteral feeding|enteral feeding
5017964|NCT01557621|Immunization reminder/recall|immunization reminder/recall
5017965|NCT01557621|Reminder/Recall systems|reminder/recall systems
5017966|NCT01557621|Population based Recall|population based recall
5017967|NCT01557621|Practice based Recall|practice based recall
5017968|NCT01557608|cancer|cancer
5017969|NCT01557608|chemotherapy|chemotherapy
5017970|NCT01557608|photon stimulation|photon stimulation
5017971|NCT01557608|neuropathy|neuropathy
5017972|NCT01557608|pain|pain
5017973|NCT01557582|IPAH|ipah
5017974|NCT01557582|HPAH|hpah
5017975|NCT01557582|APAH CTD|apah ctd
5017977|NCT01557582|APAH PoPH|apah poph
5017978|NCT01557582|APAH Drugs/Toxins|apah drugs/toxins
5017979|NCT01557582|APAH CHD repaired|apah chd repaired
5017980|NCT01557582|APAH CHD unrepaired|apah chd unrepaired
5017981|NCT01557569|methamphetamine|methamphetamine
5017982|NCT01557569|addiction|addiction
5017983|NCT01557569|relapse|relapse
5017984|NCT01557569|atomoxetine|atomoxetine
5017985|NCT01557556|CRH Antagonist|crh antagonist
5017986|NCT01557556|Nicotine|nicotine
5017987|NCT01557556|Nicotine Dependence|nicotine dependence
5017988|NCT01557556|Smoking|smoking
5017989|NCT01557556|Stress|stress
5017990|NCT01557543|Coronary Artery Bypass Grafting|coronary artery bypass grafting
5017991|NCT01557543|Coronary Artery Disease|coronary artery disease
5017992|NCT01557543|Transmyocardial Revascularization|transmyocardial revascularization
5017993|NCT01557543|Bone Marrow Stromal Cells|bone marrow stromal cells
5017994|NCT01557517|cGVHD|cgvhd
5017995|NCT01557517|Oral cGVHD|oral cgvhd
5017996|NCT01557517|Topical|topical
5017997|NCT01557517|Oral Rinse|oral rinse
5017998|NCT01557517|Clobetasol|clobetasol
5017999|NCT01557517|Oral Graft-Versus-Host Disease|oral graft-versus-host disease
5018000|NCT01557517|GVHD|gvhd
5018001|NCT01557491|Alopecia|alopecia
5018002|NCT01557491|Coronal Incision|coronal incision
5018003|NCT01557491|Scar Quality|scar quality
5018004|NCT01557478|breast cancer|breast cancer
5018005|NCT01557478|melatonin|melatonin
5018006|NCT01557478|adjuvant therapy|adjuvant therapy
5018007|NCT01557478|quality of life|quality of life
5018008|NCT01557478|pain|pain
5018009|NCT01557478|sleep|sleep
5018010|NCT01557478|survival|survival
5018011|NCT01557478|adverse events|adverse events
5018012|NCT01557452|JIA|jia
5018013|NCT01557426|skin|skin
5018014|NCT01557426|soft tissue|soft tissue
5018015|NCT01557426|infection|infection
5018016|NCT01557426|cellulitis|cellulitis
5018017|NCT01557426|abscess|abscess
5018018|NCT01557413|Humerus|humerus
5018019|NCT01557413|fracture|fracture
5018020|NCT01557413|nail|nail
5018021|NCT01557413|plate|plate
5018022|NCT01557413|tuberosity|tuberosity
5018023|NCT01557400|Duchenne muscular dystrophy|duchenne muscular dystrophy
5018024|NCT01557400|Becker muscular dystrophy|becker muscular dystrophy
5018025|NCT01557400|Nonsense mutation|nonsense mutation
5018026|NCT01557400|Premature stop codon|premature stop codon
5018027|NCT01557400|DMD|dmd
5018028|NCT01557400|BMD|bmd
5018029|NCT01557400|nmDBMD|nmdbmd
5018030|NCT01557400|DBMD|dbmd
5018031|NCT01557400|Ataluren|ataluren
5018032|NCT01557400|PTC124|ptc124
5018033|NCT01557387|Pseudopolyp|pseudopolyp
5018034|NCT01557387|Inflammatory bowel disease|inflammatory bowel disease
5018035|NCT01557374|Rheumatoid arthritis|rheumatoid arthritis
5018036|NCT01557374|Disease activity|disease activity
5018037|NCT01557374|Remission|remission
5018038|NCT01557374|Lowest Effective DOse|lowest effective dose
5018039|NCT01557374|Abatacept Tocilizumab|abatacept tocilizumab
5018040|NCT01557374|ACR-EULAR 2010|acr-eular 2010
5018041|NCT01557361|renal replacement therapy|renal replacement therapy
5018042|NCT01557361|dialysis|dialysis
5018043|NCT01557361|acute kidney injury|acute kidney injury
5018044|NCT01557361|hemodialysis|hemodialysis
5018045|NCT01557361|critical illness|critical illness
5018046|NCT01557335|To evaluate adenosine diphosphate (ADP)-induced platelet aggregation|to evaluate adenosine diphosphate (adp)-induced platelet aggregation
5018047|NCT01557309|traumatic rotator cuff tear|traumatic rotator cuff tear
5018048|NCT01557309|arthroscopic rotator cuff repair|arthroscopic rotator cuff repair
5018049|NCT01557309|age|age
5018050|NCT01557309|early rotator cuff repair|early rotator cuff repair
5018051|NCT01557296|Diet|diet
5018052|NCT01557296|Dietary treatment|dietary treatment
5018053|NCT01557296|Particle size|particle size
5018054|NCT01557296|Gastroparesis|gastroparesis
5018055|NCT01557296|Diabetes Mellitus|diabetes mellitus
5018056|NCT01557257|single- and multiple-dose pharmacokinetics|single- and multiple-dose pharmacokinetics
5018057|NCT01557257|ALO-02|alo-02
5018058|NCT01557257|OxyContin|oxycontin
5018059|NCT01557244|neurogenic detrusor overactivity|neurogenic detrusor overactivity
5018060|NCT01557244|neurogenic bladder|neurogenic bladder
5018061|NCT01557244|neuropathic bladder|neuropathic bladder
5018062|NCT01557244|neurologic disease|neurologic disease
5018063|NCT01557244|fesoterodine|fesoterodine
5018064|NCT01557231|OA|oa
5018065|NCT01557231|osteoarthritis|osteoarthritis
5018066|NCT01557231|pain|pain
5018067|NCT01557231|variability|variability
5018068|NCT01557231|activity|activity
5018069|NCT01557231|treatment|treatment
5018070|NCT01557218|Dietary variety|dietary variety
5018071|NCT01557218|Vegetable intake|vegetable intake
5018072|NCT01557218|Fruit intake|fruit intake
5018073|NCT01557205|optical coherence tomography|optical coherence tomography
5018074|NCT01557205|cell imaging|cell imaging
5018075|NCT01557192|Depression|depression
5018076|NCT01557192|Bipolar Depression|bipolar depression
5018077|NCT01557192|LFMS|lfms
5018078|NCT01557192|Electromagnetic Stimulation|electromagnetic stimulation
5018079|NCT01557166|OSA|osa
5018080|NCT01557153|Late-life Unremitted Depression|late-life unremitted depression
5018081|NCT01557140|Chagas cardiomyopathy,|chagas cardiomyopathy,
5018082|NCT01557140|Renin-angiotensin system,|renin-angiotensin system,
5018083|NCT01557140|Beta-blockers,|beta-blockers,
5018084|NCT01557140|Enalapril,|enalapril,
5018085|NCT01557140|Carvedilol,|carvedilol,
5018086|NCT01557140|Renin-angiotensin system inhibitors,|renin-angiotensin system inhibitors,
5018087|NCT01557140|Brain natriuretic peptide level,|brain natriuretic peptide level,
5018088|NCT01557140|Left ventricular ejection fraction,|left ventricular ejection fraction,
5018089|NCT01557140|Chemokines|chemokines
5018090|NCT01557127|Renal cell carcinoma,|renal cell carcinoma,
5018091|NCT01557127|Sorafenib|sorafenib
5018092|NCT01557127|Dosing|dosing
5018093|NCT01557114|unresectable Stage III or stage IV advanced malignant melanoma|unresectable stage iii or stage iv advanced malignant melanoma
5018094|NCT01557088|coronary artery disease|coronary artery disease
5018095|NCT01557088|coronary artery spasm|coronary artery spasm
5018096|NCT01557088|small vessel coronary artery disease|small vessel coronary artery disease
5018097|NCT01557075|High dose statin|high dose statin
5018098|NCT01557062|Fibromyalgia|fibromyalgia
5018099|NCT01557062|Hydrotherapy|hydrotherapy
5018100|NCT01557062|Sleep|sleep
5018101|NCT01557062|Pain|pain
5018102|NCT01557062|Body Temperature|body temperature
5018103|NCT01557049|chronic low back pain|chronic low back pain
5018104|NCT01557049|Postural global reeducation|postural global reeducation
5018105|NCT01557049|randomized|randomized
5018106|NCT01557049|physical rehabilitation|physical rehabilitation
5018107|NCT01557036|Brain Aneurysm|brain aneurysm
5018108|NCT01556997|Hypertension|hypertension
5018109|NCT01556997|Essential Hypertension|essential hypertension
5018110|NCT01556984|diabetic foot|diabetic foot
5018111|NCT01556984|digital subtraction angiography|digital subtraction angiography
5018112|NCT01556984|endothelial function|endothelial function
5018113|NCT01556984|Patients with diabetes|patients with diabetes
5018114|NCT01556984|Age 40 to 70 years old|age 40 to 70 years old
5018115|NCT01556984|Endothelial function are determined|endothelial function are determined
5018116|NCT01556945|P. falciparum|p. falciparum
5018117|NCT01556945|vaccine|vaccine
5018118|NCT01556945|healthy volunteers|healthy volunteers
5018119|NCT01556919|GERD|gerd
5018120|NCT01556919|Esophagitis|esophagitis
5018121|NCT01556893|Flap Creation|flap creation
5018122|NCT01556893|Femtosecond Laser|femtosecond laser
5018123|NCT01556893|corneal flap prior to LASIK procedure|corneal flap prior to lasik procedure
5018124|NCT01556880|Drivers|drivers
5018125|NCT01556880|Chinese|chinese
5018126|NCT01556880|Short Message Service|short message service
5018127|NCT01556880|Cellular Phone|cellular phone
5018128|NCT01556867|Umbilical cord care|umbilical cord care
5018129|NCT01556867|dry cord care|dry cord care
5018130|NCT01556867|antiseptic|antiseptic
5018131|NCT01556867|Omphalitis|omphalitis
5018132|NCT01556867|umbilical cord drop|umbilical cord drop
5018133|NCT01556867|hospitalized in maternity hospital|hospitalized in maternity hospital
5018134|NCT01556854|ginkgo leaves|ginkgo leaves
5018135|NCT01556854|butylphthalide|butylphthalide
5018136|NCT01556854|edaravone|edaravone
5018137|NCT01556854|citicoline|citicoline
5018138|NCT01556854|cerebrolysin|cerebrolysin
5018139|NCT01556854|piracetam|piracetam
5018140|NCT01556854|Neuroprotectants|neuroprotectants
5018141|NCT01556841|Randomised|randomised
5018142|NCT01556841|Controlled|controlled
5018143|NCT01556841|Trovax|trovax
5018144|NCT01556841|MVA-5T4|mva-5t4
5018145|NCT01556841|5T4|5t4
5018146|NCT01556841|Immunotherapy|immunotherapy
5018147|NCT01556841|Relapsed|relapsed
5018148|NCT01556841|Asymptomatic|asymptomatic
5018149|NCT01556841|Epithelial|epithelial
5018150|NCT01556841|Ovarian|ovarian
5018151|NCT01556841|Fallopian|fallopian
5018152|NCT01556841|Peritoneal|peritoneal
5018153|NCT01556815|Hepatocellular Carcinoma|hepatocellular carcinoma
5018154|NCT01556815|Sorafenib|sorafenib
5018155|NCT01556815|Transarterial Chemoembolization|transarterial chemoembolization
5018156|NCT01556815|HBV|hbv
5018157|NCT01556802|stroke|stroke
5018158|NCT01556802|sequelaes|sequelaes
5018159|NCT01556802|minocicline|minocicline
5018160|NCT01556789|ONT-10|ont-10
5018161|NCT01556789|MUC1|muc1
5018162|NCT01556789|Vaccine|vaccine
5018163|NCT01556789|Phase 1|phase 1
5018164|NCT01556789|Solid Tumors|solid tumors
5018165|NCT01556789|Dose escalation|dose escalation
5018166|NCT01556776|CLL|cll
5018167|NCT01556776|High Risk|high risk
5018168|NCT01556776|Maintenance|maintenance
5018169|NCT01556763|Schizophrenia|schizophrenia
5018170|NCT01556763|Schizoaffective|schizoaffective
5018171|NCT01556763|CNS|cns
5018172|NCT01556737|isoflavone|isoflavone
5018173|NCT01556737|supplement|supplement
5018174|NCT01556737|daidzein|daidzein
5018175|NCT01556737|genistein|genistein
5018176|NCT01556737|gene expression|gene expression
5018177|NCT01556724|Peripheral nerve blocks|peripheral nerve blocks
5018178|NCT01556724|Ropivacaine concentrations in lumbar plexus catheters|ropivacaine concentrations in lumbar plexus catheters
5018179|NCT01556724|Postoperative pain|postoperative pain
5018180|NCT01556724|Total hip replacement|total hip replacement
5018181|NCT01556711|Head Injury|head injury
5018182|NCT01556711|Head Trauma|head trauma
5018183|NCT01556711|TBI (Traumatic Brain Injury)|tbi (traumatic brain injury)
5018489|NCT01555489|Erlotinib|erlotinib
5018184|NCT01556711|Emergency Department|emergency department
5018185|NCT01556698|Acne Vulgaris|acne vulgaris
5018186|NCT01556698|Acne|acne
5018187|NCT01556672|small bowel lesions|small bowel lesions
5018188|NCT01556672|Crohn's Disease|crohn's disease
5018189|NCT01556672|Plaque psoriasis|plaque psoriasis
5018190|NCT01556672|adalimumab|adalimumab
5018191|NCT01556672|capsule endoscopy|capsule endoscopy
5018192|NCT01556659|Left ventricular thrombus|left ventricular thrombus
5018193|NCT01556659|Acute myocardial infarction|acute myocardial infarction
5018194|NCT01556659|Anticoagulation|anticoagulation
5018195|NCT01556646|Cirrhosis|cirrhosis
5018196|NCT01556646|Hepatic Encephalopathy|hepatic encephalopathy
5018197|NCT01556646|Hyponatremia|hyponatremia
5018198|NCT01556646|Brain MRI|brain mri
5018199|NCT01556646|Health-related quality of life|health-related quality of life
5018200|NCT01556646|cognitive function|cognitive function
5018201|NCT01556620|PtiO2|ptio2
5018202|NCT01556620|NIRS|nirs
5018203|NCT01556607|Respiratory Syncytial Virus Infection|respiratory syncytial virus infection
5018204|NCT01556607|RSV|rsv
5018205|NCT01556594|Hypoglycemia|hypoglycemia
5018206|NCT01556594|Diabetes mellitus|diabetes mellitus
5018207|NCT01556581|back pain|back pain
5018208|NCT01556581|primary care|primary care
5018209|NCT01556581|physical therapy|physical therapy
5018210|NCT01556568|Noonan Syndrome, hypertrophic cardiomyopathy.|noonan syndrome, hypertrophic cardiomyopathy.
5018211|NCT01556555|Sclerosing cholangitis|sclerosing cholangitis
5018212|NCT01556555|Spyglass|spyglass
5018213|NCT01556555|Endoscopic retrograde cholangiopancreaticography|endoscopic retrograde cholangiopancreaticography
5018214|NCT01556542|peripheral arterial disease|peripheral arterial disease
5018215|NCT01556542|drug-eluting balloon|drug-eluting balloon
5018216|NCT01556542|restenosis|restenosis
5018217|NCT01556477|MDS|mds
5018218|NCT01556477|AML|aml
5018219|NCT01556477|Azacitidine|azacitidine
5018220|NCT01556477|Lenalidomide|lenalidomide
5018221|NCT01556477|del5q|del5q
5018222|NCT01556464|Obstructive sleep apnea|obstructive sleep apnea
5018223|NCT01556464|CPAP|cpap
5018224|NCT01556425|opioid use disorder|opioid use disorder
5018225|NCT01556425|treatment|treatment
5018226|NCT01556425|heroin|heroin
5018227|NCT01556425|extended-release naltrexone|extended-release naltrexone
5018228|NCT01556425|incentives|incentives
5018229|NCT01556425|cotningency management|cotningency management
5018230|NCT01556425|employment-based reinforcement|employment-based reinforcement
5018231|NCT01556425|therapeutic workplace|therapeutic workplace
5018232|NCT01556412|endoscopic ultrasound|endoscopic ultrasound
5018233|NCT01556412|primary sclerosing cholangitis|primary sclerosing cholangitis
5018234|NCT01556412|EUS|eus
5018235|NCT01556412|cholestatic hepatopathy|cholestatic hepatopathy
5018236|NCT01556399|Duodenal adenoma|duodenal adenoma
5018237|NCT01556399|Ampullary adenoma|ampullary adenoma
5018238|NCT01556386|acute lymphoblastic leukemia|acute lymphoblastic leukemia
5018239|NCT01556386|single nucleotide polymorphism|single nucleotide polymorphism
5018240|NCT01556373|acute systemic inflammation|acute systemic inflammation
5018241|NCT01556373|arterial stiffness|arterial stiffness
5018242|NCT01556373|Carotid-femoral pulse wave velocity|carotid-femoral pulse wave velocity
5018243|NCT01556360|genetic hemochromatosis|genetic hemochromatosis
5018244|NCT01556360|Iron overload|iron overload
5018245|NCT01556360|C282 homozygosity|c282 homozygosity
5018246|NCT01556347|alloantibody|alloantibody
5018247|NCT01556347|immunologic|immunologic
5018248|NCT01556347|memory|memory
5018249|NCT01556347|heart|heart
5018250|NCT01556347|transplant|transplant
5018251|NCT01556347|desensitization|desensitization
5018252|NCT01556334|premature ruptured membranes|premature ruptured membranes
5018253|NCT01556334|azithromycin|azithromycin
5018254|NCT01556334|erythromycin|erythromycin
5018255|NCT01556334|latency|latency
5018256|NCT01556334|antibiotics|antibiotics
5018257|NCT01556321|Obesity|obesity
5018258|NCT01556321|Body weight|body weight
5018259|NCT01556321|Gut flora|gut flora
5018260|NCT01556321|Fat absorption|fat absorption
5018261|NCT01556308|Dowling Meara|dowling meara
5018262|NCT01556308|Epidermolysis bullosa|epidermolysis bullosa
5018263|NCT01556308|inflammation|inflammation
5018264|NCT01556295|Nurses|nurses
5018265|NCT01556295|Low back pain|low back pain
5018266|NCT01556295|Gesture behavior|gesture behavior
5018267|NCT01556295|Knowlegde|knowlegde
5018268|NCT01556282|Hepatocellular Carcinoma|hepatocellular carcinoma
5018269|NCT01556282|portal vein thrombosis|portal vein thrombosis
5018270|NCT01556282|HCC|hcc
5018271|NCT01556243|stage IA breast cancer|stage ia breast cancer
5018272|NCT01556243|stage IB breast cancer|stage ib breast cancer
5018273|NCT01556243|stage II breast cancer|stage ii breast cancer
5018274|NCT01556243|ductal breast carcinoma in situ|ductal breast carcinoma in situ
5018275|NCT01556243|lobular breast carcinoma in situ|lobular breast carcinoma in situ
5018276|NCT01556230|pituitary gland|pituitary gland
5018277|NCT01556230|pituitary adenoma|pituitary adenoma
5018278|NCT01556230|pituitary tumor|pituitary tumor
5018279|NCT01556230|hypophysis|hypophysis
5018280|NCT01556230|endocrine|endocrine
5018281|NCT01556230|neuroendocrine|neuroendocrine
5018282|NCT01556230|hormone|hormone
5018283|NCT01556217|Healthy volunteers|healthy volunteers
5018284|NCT01556217|JNJ-39393406-aaa|jnj-39393406-aaa
5018285|NCT01556217|Pharmacokinetics|pharmacokinetics
5018286|NCT01556217|Central brain penetrance|central brain penetrance
5018287|NCT01556217|Cerebral spinal fluid|cerebral spinal fluid
5018288|NCT01556204|Endometriosis|endometriosis
5018289|NCT01556191|lung cancer|lung cancer
5018290|NCT01556191|women|women
5018291|NCT01556178|Hydrocephalus|hydrocephalus
5018292|NCT01556178|Survivin|survivin
5018293|NCT01556178|miRNA|mirna
5018294|NCT01556165|Rasagiline|rasagiline
5018295|NCT01556165|Azilect|azilect
5018296|NCT01556165|Parkinson´s Disease|parkinson´s disease
5018297|NCT01556165|Motor fluctuations|motor fluctuations
5018298|NCT01556139|Endurance|endurance
5018299|NCT01556139|exercise training|exercise training
5018300|NCT01556139|6-min walking test|6-min walking test
5018301|NCT01556126|Coronary artery disease|coronary artery disease
5018302|NCT01556126|Drug Eluting Stent|drug eluting stent
5018303|NCT01556126|All comers patients|all comers patients
5018304|NCT01556113|fatty liver|fatty liver
5018305|NCT01556113|hypertriglyceridemia|hypertriglyceridemia
5018306|NCT01556113|elevated liver enzymes|elevated liver enzymes
5018307|NCT01556100|18F-DTBZ AV-133 imaging|18f-dtbz av-133 imaging
5018308|NCT01556087|opioids|opioids
5018309|NCT01556087|distress tolerance|distress tolerance
5018310|NCT01556087|buprenorphine|buprenorphine
5018311|NCT01556074|Post traumatic stress disorder|post traumatic stress disorder
5018312|NCT01556074|PTSD|ptsd
5018313|NCT01556074|Insomnia|insomnia
5018314|NCT01556074|Sleep|sleep
5018315|NCT01556074|Yoga|yoga
5018316|NCT01556074|Meditation|meditation
5018317|NCT01556074|Mental Health|mental health
5018318|NCT01556074|Sleep Quality|sleep quality
5018319|NCT01556074|Actigraphy|actigraphy
5018320|NCT01556074|Sleep Diaries|sleep diaries
5018321|NCT01556074|Autonomic|autonomic
5018322|NCT01556074|Social Health|social health
5018323|NCT01556074|Interoception|interoception
5018324|NCT01556074|Attention Regulation|attention regulation
5018325|NCT01556074|Emotion Regulation|emotion regulation
5018326|NCT01556061|Laryngoscopy|laryngoscopy
5018327|NCT01556061|Airway Management|airway management
5018328|NCT01556061|Intubation|intubation
5018329|NCT01556048|Behavior therapy|behavior therapy
5018330|NCT01556048|Bereavement|bereavement
5018331|NCT01556048|Complicated grief|complicated grief
5018332|NCT01556048|Depression|depression
5018333|NCT01556048|Posttraumatic Stress Disorder|posttraumatic stress disorder
5018334|NCT01556035|oncodermatology|oncodermatology
5018335|NCT01556035|hematology|hematology
5018336|NCT01556035|cutaneous B cell lymphoma|cutaneous b cell lymphoma
5018337|NCT01556035|lenalidomide|lenalidomide
5018338|NCT01556022|Ischemic heart disease|ischemic heart disease
5018339|NCT01556022|Coronary artery disease|coronary artery disease
5018340|NCT01556022|Chronic heart failure|chronic heart failure
5018341|NCT01556022|Cardiovascular disease|cardiovascular disease
5018342|NCT01556022|Adult stem cells|adult stem cells
5018343|NCT01556022|Adipose derived regenerative cells|adipose derived regenerative cells
5018344|NCT01556009|Basal Cell Carcinoma|basal cell carcinoma
5018345|NCT01556009|Photodynamic Therapy|photodynamic therapy
5018346|NCT01555996|older|older
5018347|NCT01555996|delirium|delirium
5018348|NCT01555996|cognitive status|cognitive status
5018349|NCT01555996|occupational therapy|occupational therapy
5018350|NCT01555996|critically ill patients|critically ill patients
5018351|NCT01555983|cannabis|cannabis
5018352|NCT01555983|central neuropathic pain|central neuropathic pain
5018353|NCT01555983|analgesia|analgesia
5018354|NCT01555970|Obsessive-compulsive disorder|obsessive-compulsive disorder
5018355|NCT01555970|Treatment|treatment
5018356|NCT01555970|Glutamate|glutamate
5018357|NCT01555970|N-Acetylcysteine|n-acetylcysteine
5018358|NCT01555918|Pharmacokinetics|pharmacokinetics
5018359|NCT01555918|Healthy volunteers|healthy volunteers
5018360|NCT01555918|Isavuconazole|isavuconazole
5018361|NCT01555918|BAL4815|bal4815
5018362|NCT01555918|BAL8728|bal8728
5018363|NCT01555918|BAL8557|bal8557
5018364|NCT01555905|Respiratory Muscle Strength|respiratory muscle strength
5018365|NCT01555892|EBV|ebv
5018366|NCT01555892|Hodgkin's Lymphoma|hodgkin's lymphoma
5018367|NCT01555892|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
5018368|NCT01555892|Lymphoma Relapse|lymphoma relapse
5018369|NCT01555892|Autologous or Syngeneic Stem Cell Transplant|autologous or syngeneic stem cell transplant
5018370|NCT01555892|T/NK-lymphoproliferative disease|t/nk-lymphoproliferative disease
5018371|NCT01555892|LMP|lmp
5018372|NCT01555892|BARF1|barf1
5018373|NCT01555892|EBNA1|ebna1
5018374|NCT01555879|Retrospective|retrospective
5018375|NCT01555879|Database|database
5018376|NCT01555879|Data warehouse|data warehouse
5018377|NCT01555879|Data mining|data mining
5018378|NCT01555879|Collaborative effectiveness|collaborative effectiveness
5018379|NCT01555879|Comparative effectiveness|comparative effectiveness
5018380|NCT01555879|Outcome based medicine|outcome based medicine
5018381|NCT01555879|Evidence based medicine|evidence based medicine
5018382|NCT01555866|isavuconazole|isavuconazole
5018383|NCT01555866|BAL4815|bal4815
5018384|NCT01555866|BAL8557|bal8557
5018385|NCT01555866|BAL8728|bal8728
5018386|NCT01555840|Magnetically guided capsule endoscopy (MGCE)|magnetically guided capsule endoscopy (mgce)
5018387|NCT01555840|Gastroscopy|gastroscopy
5018388|NCT01555827|Retina|retina
5018389|NCT01555827|ALzheimer's disease|alzheimer's disease
5018390|NCT01555827|neurodegenerative signs|neurodegenerative signs
5018391|NCT01555814|dopamine|dopamine
5018392|NCT01555814|first episode|first episode
5018393|NCT01555814|reward|reward
5018394|NCT01555814|cognition|cognition
5018395|NCT01555814|MRI|mri
5018396|NCT01555814|fMRI|fmri
5018397|NCT01555814|PPI|ppi
5018398|NCT01555814|P300|p300
5018399|NCT01555814|P50 gating|p50 gating
5018400|NCT01555814|endophenotypes|endophenotypes
5018401|NCT01555801|esophageal cancer|esophageal cancer
5018402|NCT01555801|early cancer|early cancer
5018403|NCT01555801|ultrasonography (EUS)|ultrasonography (eus)
5018404|NCT01555801|stage|stage
5018405|NCT01555788|type 1 diabetes,|type 1 diabetes,
5018406|NCT01555788|diaport,|diaport,
5018407|NCT01555788|artificial pancreas,|artificial pancreas,
5018408|NCT01555788|zone mpc algorithm,|zone mpc algorithm,
5018409|NCT01555788|ap system,|ap system,
5018410|NCT01555788|intraperitoneal insulin|intraperitoneal insulin
5018411|NCT01555775|exercise-induced muscle damage|exercise-induced muscle damage
5018412|NCT01555775|nutritional recovery|nutritional recovery
5018413|NCT01555775|nutritional supplement|nutritional supplement
5018414|NCT01555775|natural food|natural food
5018415|NCT01555736|allergic rhinitis|allergic rhinitis
5018416|NCT01555736|perennial immunotherapy|perennial immunotherapy
5018417|NCT01555736|preseasonal immunotherapy|preseasonal immunotherapy
5018418|NCT01555697|Schizophrenia|schizophrenia
5018419|NCT01555697|prepulse inhibition|prepulse inhibition
5018420|NCT01555697|neurocognition|neurocognition
5018421|NCT01555697|working memory|working memory
5018422|NCT01555697|memantine|memantine
5018548|NCT01555255|pregnancy|pregnancy
5018423|NCT01555697|MATRICS Consensus Cognitive Battery|matrics consensus cognitive battery
5018424|NCT01555684|MS|ms
5018425|NCT01555684|CCSVI|ccsvi
5018426|NCT01555671|labor,|labor,
5018427|NCT01555671|meperidine,|meperidine,
5018428|NCT01555671|active phase,|active phase,
5018429|NCT01555671|duration of labor|duration of labor
5018430|NCT01555658|Long Lesions|long lesions
5018431|NCT01555658|Stent Implantation|stent implantation
5018432|NCT01555645|Breast cancer|breast cancer
5018433|NCT01555645|Stress management|stress management
5018434|NCT01555645|Stepped care|stepped care
5018435|NCT01555645|Randomized|randomized
5018436|NCT01555619|Left heart pacing lead|left heart pacing lead
5018437|NCT01555619|Cardiac resynchronization therapy (CRT)|cardiac resynchronization therapy (crt)
5018438|NCT01555619|Heart Failure|heart failure
5018439|NCT01555619|Quadripolar pacing|quadripolar pacing
5018440|NCT01555606|Psoriasis|psoriasis
5018441|NCT01555606|Patient-reported outcome|patient-reported outcome
5018442|NCT01555606|Quality of Life|quality of life
5018443|NCT01555593|COPD|copd
5018444|NCT01555593|FeNO|feno
5018445|NCT01555593|Bronchial inflammation|bronchial inflammation
5018446|NCT01555593|Small airways|small airways
5018447|NCT01555593|Decubitus|decubitus
5018448|NCT01555580|myasthenia gravis|myasthenia gravis
5018449|NCT01555580|autoimmune|autoimmune
5018450|NCT01555580|GM-CSF|gm-csf
5018451|NCT01555567|ACL|acl
5018452|NCT01555567|muscle|muscle
5018453|NCT01555567|quadriceps|quadriceps
5018454|NCT01555567|strength|strength
5018455|NCT01555554|Post-traumatic stress disorder|post-traumatic stress disorder
5018456|NCT01555554|Propranolol|propranolol
5018457|NCT01555554|surgery|surgery
5018458|NCT01555554|anesthesia|anesthesia
5018459|NCT01555541|relapsed|relapsed
5018460|NCT01555541|refractory|refractory
5018461|NCT01555541|DLBCL|dlbcl
5018462|NCT01555541|lymphoma|lymphoma
5018463|NCT01555541|B-cell|b-cell
5018464|NCT01555541|diffuse|diffuse
5018465|NCT01555528|Growth disorders|growth disorders
5018466|NCT01555528|Saizen|saizen
5018467|NCT01555528|Easypod|easypod
5018468|NCT01555528|Growth hormone|growth hormone
5018469|NCT01555528|Pediatric subject|pediatric subject
5018470|NCT01555489|Pancreatic Neoplasms|pancreatic neoplasms
5018471|NCT01555489|Pancreatic Cancer cells|pancreatic cancer cells
5018472|NCT01555489|Digestive System Neoplasms|digestive system neoplasms
5018473|NCT01555489|Neoplasms by Site|neoplasms by site
5018474|NCT01555489|Neoplasms|neoplasms
5018475|NCT01555489|Endocrine Gland Neoplasms|endocrine gland neoplasms
5018476|NCT01555489|Digestive System Diseases|digestive system diseases
5018477|NCT01555489|Pancreatic Diseases|pancreatic diseases
5018478|NCT01555489|Endocrine System Diseases|endocrine system diseases
5018479|NCT01555489|Ascorbic Acid|ascorbic acid
5018480|NCT01555489|Gemcitabine Vitamins|gemcitabine vitamins
5018481|NCT01555489|Vitamin C|vitamin c
5018482|NCT01555489|Antioxidants|antioxidants
5018483|NCT01555489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
5018484|NCT01555489|Pharmacologic Actions|pharmacologic actions
5018485|NCT01555489|Protective Agents|protective agents
5018486|NCT01555489|Physiological Effects of Drugs|physiological effects of drugs
5018487|NCT01555489|Micronutrients|micronutrients
5018488|NCT01555489|Growth Substances|growth substances
5018490|NCT01555489|Integrative Medicine|integrative medicine
5018491|NCT01555489|Alternative Medicine|alternative medicine
5018492|NCT01555489|Complementary Medicine|complementary medicine
5018493|NCT01555476|Pharmacokinetics|pharmacokinetics
5018494|NCT01555463|Rosacea|rosacea
5018495|NCT01555450|Colorectal cancer screening|colorectal cancer screening
5018496|NCT01555450|Social inequalities|social inequalities
5018497|NCT01555450|Patient Navigator|patient navigator
5018498|NCT01555437|capsule endoscopy scoring index|capsule endoscopy scoring index
5018499|NCT01555437|Harvey-Bradshaw index|harvey-bradshaw index
5018500|NCT01555437|C-reactive protein|c-reactive protein
5018501|NCT01555437|serum albumin|serum albumin
5018502|NCT01555437|hemoglobin|hemoglobin
5018503|NCT01555424|25-hydroxyvitamin D|25-hydroxyvitamin d
5018504|NCT01555424|Institutionalized seniors|institutionalized seniors
5018505|NCT01555424|SF-36 survey|sf-36 survey
5018506|NCT01555424|Winter|winter
5018507|NCT01555411|Cardiovascular epidemiology|cardiovascular epidemiology
5018508|NCT01555411|Prospective, observational cohort study|prospective, observational cohort study
5018509|NCT01555411|Biomarkers|biomarkers
5018510|NCT01555411|Cardio- and cerebrovascular imaging|cardio- and cerebrovascular imaging
5018511|NCT01555398|Fenofibric acid|fenofibric acid
5018512|NCT01555398|HIP0901|hip0901
5018513|NCT01555398|food effect|food effect
5018514|NCT01555385|Mental workload|mental workload
5018515|NCT01555385|Multitasking|multitasking
5018516|NCT01555385|Protein|protein
5018517|NCT01555385|Tryptophan|tryptophan
5018518|NCT01555372|unstable distal clavicular fractures (Neer 2b)|unstable distal clavicular fractures (neer 2b)
5018519|NCT01555372|Study Protocol|study protocol
5018520|NCT01555372|Fracture Fixation|fracture fixation
5018521|NCT01555346|Down syndrome|down syndrome
5018522|NCT01555346|fetal aneuploidy|fetal aneuploidy
5018523|NCT01555346|trisomy|trisomy
5018524|NCT01555346|noninvasive prenatal test|noninvasive prenatal test
5018525|NCT01555307|total hip arthroplasty|total hip arthroplasty
5018526|NCT01555307|total knee arthroplasty|total knee arthroplasty
5018527|NCT01555307|balance exercises|balance exercises
5018528|NCT01555307|force plate|force plate
5018529|NCT01555307|berg balance scale|berg balance scale
5018530|NCT01555307|timed up and go test|timed up and go test
5018531|NCT01555294|(subclinical)atherosclerosis|(subclinical)atherosclerosis
5018532|NCT01555294|non-invasive measurements|non-invasive measurements
5018533|NCT01555294|intima-media thickness|intima-media thickness
5018534|NCT01555294|flow-mediated dilation|flow-mediated dilation
5018535|NCT01555294|pulse wave velocity and analysis|pulse wave velocity and analysis
5018536|NCT01555294|fatal and non-fatal cardiovascular events|fatal and non-fatal cardiovascular events
5018537|NCT01555294|ankle-brachial index (at rest and after exercise)|ankle-brachial index (at rest and after exercise)
5018538|NCT01555294|general population|general population
5018539|NCT01555294|Familial Combined Hyperlipidemia|familial combined hyperlipidemia
5018540|NCT01555281|Multiple Myeloma|multiple myeloma
5018541|NCT01555281|Kahler Disease|kahler disease
5018542|NCT01555281|Lenalidomide|lenalidomide
5018543|NCT01555281|Revlimid|revlimid
5018544|NCT01555281|Nelfinavir|nelfinavir
5018545|NCT01555281|Viracept|viracept
5018546|NCT01555281|Dexamethasone|dexamethasone
5018547|NCT01555255|malaria|malaria
5018549|NCT01555255|placental malaria|placental malaria
5018550|NCT01555255|malaria in pregnancy|malaria in pregnancy
5018551|NCT01555255|birth weight|birth weight
5018552|NCT01555255|anemia|anemia
5018553|NCT01555242|Advanced Cancer|advanced cancer
5018554|NCT01555242|Lymphoma|lymphoma
5018555|NCT01555242|Refractory|refractory
5018556|NCT01555229|Secretion drainage|secretion drainage
5018557|NCT01555229|Ventilator-associated pneumonia|ventilator-associated pneumonia
5018558|NCT01555229|Tracheal fibroscopy|tracheal fibroscopy
5018559|NCT01555216|Forefoot surgery|forefoot surgery
5018560|NCT01555190|myo-inositol|myo-inositol
5018561|NCT01555190|folic acid|folic acid
5018562|NCT01555177|Peri-operative myocardial infarction|peri-operative myocardial infarction
5018563|NCT01555177|Non-ST elevation myocardial infarction|non-st elevation myocardial infarction
5018564|NCT01555177|Optical coherence tomography|optical coherence tomography
5018565|NCT01555151|Asthma|asthma
5018566|NCT01555138|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5018567|NCT01555138|Indacaterol|indacaterol
5018568|NCT01555138|Salmeterol/fluticasone propionate|salmeterol/fluticasone propionate
5018569|NCT01555125|Psoriasis|psoriasis
5018570|NCT01555099|COPD, FEV1, AZD5423|copd, fev1, azd5423
5018571|NCT01555086|Lymphadenectomy|lymphadenectomy
5018572|NCT01555086|Prostate cancer|prostate cancer
5018573|NCT01555060|hemoglobin recovery|hemoglobin recovery
5018574|NCT01555060|iron recovery|iron recovery
5018575|NCT01555060|iron supplements|iron supplements
5018576|NCT01555034|obesity|obesity
5018577|NCT01555034|movement therapy|movement therapy
5018578|NCT01555034|exercise|exercise
5018579|NCT01555034|behaviour|behaviour
5018580|NCT01554995|LCB01-0371|lcb01-0371
5018581|NCT01554982|Participation Limited|participation limited
5018582|NCT01554982|Long Term|long term
5018583|NCT01554982|Safety Extension|safety extension
5018584|NCT01554956|Plasminogen Deficiency|plasminogen deficiency
5018585|NCT01554956|Ligneous Conjunctivitis|ligneous conjunctivitis
5018586|NCT01554956|Plasminogen|plasminogen
5018587|NCT01554956|Ligneous Conjunctivitis in Plasminogen Deficient Patients|ligneous conjunctivitis in plasminogen deficient patients
5018588|NCT01554943|CMF|cmf
5018589|NCT01554943|HEC|hec
5018590|NCT01554943|EC|ec
5018591|NCT01554943|node positive|node positive
5018592|NCT01554943|breast cancer|breast cancer
5018593|NCT01554930|HFMD|hfmd
5018594|NCT01554930|Traditional Chinese Medicine|traditional chinese medicine
5018595|NCT01554930|Xiyanping|xiyanping
5018596|NCT01554917|Rheumatoid Arthritis|rheumatoid arthritis
5018597|NCT01554917|Iguratimod|iguratimod
5018598|NCT01554904|Sleep Study|sleep study
5018599|NCT01554904|Snoring|snoring
5018600|NCT01554904|Sleep Apnea|sleep apnea
5018601|NCT01554904|Muscle Laxity|muscle laxity
5018602|NCT01554904|Oral Appliance|oral appliance
5018603|NCT01554904|Facial Muscles|facial muscles
5018604|NCT01554904|Neck Muscles|neck muscles
5018605|NCT01554904|Upper Airway|upper airway
5018606|NCT01554904|Muscle Strength|muscle strength
5018607|NCT01554904|Dynamic Resistance|dynamic resistance
5018608|NCT01554904|Oral Exercise|oral exercise
5018609|NCT01554904|Facial Toning|facial toning
5018610|NCT01554904|Facial Muscle Strength|facial muscle strength
5018611|NCT01554904|Strap Muscles of the Neck|strap muscles of the neck
5018612|NCT01554904|Apnea-Hypopnea|apnea-hypopnea
5018613|NCT01554891|brain injuries, traumatic|brain injuries, traumatic
5018614|NCT01554891|military personnel|military personnel
5018615|NCT01554891|classification|classification
5018616|NCT01554891|diagnosis|diagnosis
5018617|NCT01554891|instrumentation|instrumentation
5018618|NCT01554878|osteochondral defect of the knee|osteochondral defect of the knee
5018619|NCT01554865|obesity|obesity
5018620|NCT01554865|men|men
5018621|NCT01554865|sexual function|sexual function
5018622|NCT01554865|urinary tract symptoms|urinary tract symptoms
5018623|NCT01554865|endothelial function|endothelial function
5018624|NCT01554865|inflammation|inflammation
5018625|NCT01554865|quality of life|quality of life
5018626|NCT01554852|myeloma|myeloma
5018627|NCT01554852|lenalidomide|lenalidomide
5018628|NCT01554852|Revlimid|revlimid
5018629|NCT01554852|cyclophosphamide|cyclophosphamide
5018630|NCT01554852|dexamethasone|dexamethasone
5018631|NCT01554852|bortezomib|bortezomib
5018632|NCT01554852|Velcade|velcade
5018633|NCT01554852|vorinostat|vorinostat
5018634|NCT01554852|Zolinza|zolinza
5018635|NCT01554852|stem cell|stem cell
5018636|NCT01554852|carfilzomib|carfilzomib
5018637|NCT01554852|Kyprolis|kyprolis
5018638|NCT01554826|Pediatric influenza vaccine|pediatric influenza vaccine
5018639|NCT01554813|Influenza Vaccine, Vaccination,|influenza vaccine, vaccination,
5018640|NCT01554800|Lecithin Cholesterol Acyl Transferase|lecithin cholesterol acyl transferase
5018641|NCT01554800|LCAT|lcat
5018642|NCT01554800|rhLCAT|rhlcat
5018643|NCT01554800|Enzyme replacement therapy|enzyme replacement therapy
5018644|NCT01554800|High-Density Lipoprotein (HDL)|high-density lipoprotein (hdl)
5018645|NCT01554800|Cholesterol|cholesterol
5018646|NCT01554800|Cholesterol ester|cholesterol ester
5018647|NCT01554800|LCAT Deficiency|lcat deficiency
5018648|NCT01554787|After stroke with fatigue|after stroke with fatigue
5018649|NCT01554774|COPD|copd
5018650|NCT01554774|PVR|pvr
5018651|NCT01554761|astigmatism|astigmatism
5018652|NCT01554761|pseudophakia|pseudophakia
5018653|NCT01554748|total joint arthroplasty|total joint arthroplasty
5018654|NCT01554748|thumb|thumb
5018655|NCT01554748|trapeziometacarpal joint|trapeziometacarpal joint
5018656|NCT01554748|osteoarthritis|osteoarthritis
5018657|NCT01554735|obesity|obesity
5018658|NCT01554735|men|men
5018659|NCT01554735|sexual function|sexual function
5018660|NCT01554735|urinary tract symptoms|urinary tract symptoms
5018661|NCT01554735|endothelial function|endothelial function
5018662|NCT01554735|inflammation|inflammation
5018663|NCT01554735|quality of life|quality of life
5018664|NCT01554722|Ultrasound guidance|ultrasound guidance
5018665|NCT01554722|Femoral nerve block|femoral nerve block
5018666|NCT01554722|Needle placement|needle placement
5018667|NCT01554722|Intraneural needle insertion|intraneural needle insertion
5018668|NCT01554709|bypass|bypass
5018669|NCT01554709|cannula|cannula
5018670|NCT01554696|Rheumatoid Arthritis|rheumatoid arthritis
5018671|NCT01554696|ASP015K|asp015k
5018672|NCT01554683|Alzheimer's Disease|alzheimer's disease
5018673|NCT01554683|Seizures|seizures
5018674|NCT01554683|Memory|memory
5018675|NCT01554683|Executive|executive
5018676|NCT01554670|Arthroscopic subacromial decompression|arthroscopic subacromial decompression
5018677|NCT01554670|Bipolar radiofrequency|bipolar radiofrequency
5018678|NCT01554670|Tendon debridement|tendon debridement
5018679|NCT01554670|Shoulder surgery|shoulder surgery
5018680|NCT01554657|Pneumonia, Bacterial|pneumonia, bacterial
5018681|NCT01554644|Cleansing|cleansing
5018682|NCT01554644|Chronic Leg Ulcers|chronic leg ulcers
5018683|NCT01554644|Diabetic Patients|diabetic patients
5018684|NCT01554631|Bioequivalence|bioequivalence
5018685|NCT01554631|Acarbose|acarbose
5018686|NCT01554631|ODT|odt
5018687|NCT01554618|exenatide|exenatide
5018688|NCT01554618|type 2 diabetes|type 2 diabetes
5018689|NCT01554618|GLP-1 receptor agonist|glp-1 receptor agonist
5018690|NCT01554592|Heart Failure|heart failure
5018691|NCT01554592|Statin withdrawal|statin withdrawal
5018692|NCT01554566|honey|honey
5018693|NCT01554566|diabetes|diabetes
5018694|NCT01554566|lipids|lipids
5018695|NCT01554566|c-peptide|c-peptide
5018696|NCT01554553|Sleeve gastrectomy|sleeve gastrectomy
5018697|NCT01554553|Posterior crural repair|posterior crural repair
5018698|NCT01554540|Treprostinil|treprostinil
5018699|NCT01554540|Scleroderma|scleroderma
5018700|NCT01554540|Iontophoresis|iontophoresis
5018701|NCT01554527|polysomnography|polysomnography
5018702|NCT01554527|child|child
5018703|NCT01554527|continuous positive airway pressure|continuous positive airway pressure
5018704|NCT01554527|tonsillectomy|tonsillectomy
5018705|NCT01554527|neuropsychological tests|neuropsychological tests
5018706|NCT01554527|cognition|cognition
5018707|NCT01554527|sleepiness|sleepiness
5018708|NCT01554527|behavior|behavior
5018709|NCT01554514|ADAMTS13|adamts13
5018710|NCT01554514|Rituximab|rituximab
5018711|NCT01554514|Thrombotic thrombocytopenic purpura|thrombotic thrombocytopenic purpura
5018712|NCT01554514|TTP|ttp
5018713|NCT01554514|Plasma exchange|plasma exchange
5018714|NCT01554501|stress|stress
5018715|NCT01554501|self-control|self-control
5018716|NCT01554501|emotion regulation|emotion regulation
5018717|NCT01554501|health|health
5018718|NCT01554488|asthma|asthma
5018719|NCT01554488|COPD|copd
5018720|NCT01554488|sleep apnea, obstructive|sleep apnea, obstructive
5018721|NCT01554475|herbal drugs|herbal drugs
5018722|NCT01554475|dietary supplements|dietary supplements
5018723|NCT01554475|drug interactions|drug interactions
5018724|NCT01554462|Attention|attention
5018725|NCT01554462|Cognitive control|cognitive control
5018726|NCT01554462|ADHD|adhd
5018727|NCT01554462|Healthy|healthy
5018728|NCT01554462|EPA|epa
5018729|NCT01554462|Eicosapentaenoic acid|eicosapentaenoic acid
5018730|NCT01554462|DHA|dha
5018731|NCT01554462|Docosahexaenoic acid|docosahexaenoic acid
5018732|NCT01554462|PUFA|pufa
5018733|NCT01554462|Omega-3|omega-3
5018734|NCT01554449|Stroke|stroke
5018735|NCT01554449|Upper arm|upper arm
5018736|NCT01554449|Rehabilitation|rehabilitation
5018737|NCT01554449|Motor function|motor function
5018738|NCT01554449|Video games|video games
5018739|NCT01554449|Virtual reality|virtual reality
5018740|NCT01554449|Occupational Therapy|occupational therapy
5018741|NCT01554449|Functional MRI|functional mri
5018742|NCT01554436|Smoking|smoking
5018743|NCT01554436|Neuropsychology|neuropsychology
5018744|NCT01554436|Abstinence|abstinence
5018745|NCT01554436|Prognosis|prognosis
5018746|NCT01554436|Nicotine Dependence, Cigarettes, with Other Nicotine-induced Disorders|nicotine dependence, cigarettes, with other nicotine-induced disorders
5018747|NCT01554423|HIV Prevention Intervention|hiv prevention intervention
5018748|NCT01554410|Cervical|cervical
5018749|NCT01554410|Carcinoma|carcinoma
5018750|NCT01554410|Gemcitabine|gemcitabine
5018751|NCT01554410|Gemzar|gemzar
5018752|NCT01554410|Cisplatin|cisplatin
5018753|NCT01554410|IMRT|imrt
5018754|NCT01554410|Radiation|radiation
5018755|NCT01554410|External Beam|external beam
5018756|NCT01554410|Brachytherapy|brachytherapy
5018757|NCT01554397|Cervical|cervical
5018758|NCT01554397|Carcinoma|carcinoma
5018759|NCT01554397|Cisplatin|cisplatin
5018760|NCT01554397|IMRT|imrt
5018761|NCT01554397|Radiation|radiation
5018762|NCT01554397|INTERTECC|intertecc
5018763|NCT01554397|International|international
5018764|NCT01554397|External Beam|external beam
5018765|NCT01554397|Brachytherapy|brachytherapy
5018766|NCT01554397|LDR|ldr
5018767|NCT01554397|HDR|hdr
5018768|NCT01554397|IGRT|igrt
5018769|NCT01554397|CBCT|cbct
5018770|NCT01554384|Tuberculosis|tuberculosis
5018771|NCT01554384|diagnosis|diagnosis
5018772|NCT01554384|Xpert MTB/RIF|xpert mtb/rif
5018773|NCT01554384|point-of-treatment|point-of-treatment
5018774|NCT01554384|randomized controlled trial|randomized controlled trial
5018775|NCT01554371|Solid tumor|solid tumor
5018776|NCT01554371|Metastatic breast cancer|metastatic breast cancer
5018777|NCT01554371|Unresectable or metastatic carcinoma|unresectable or metastatic carcinoma
5018778|NCT01554371|Neuropathy|neuropathy
5018779|NCT01554371|Eribulin|eribulin
5018780|NCT01554371|Cyclophosphamide|cyclophosphamide
5018781|NCT01554358|Gestational diabetes mellitus|gestational diabetes mellitus
5018782|NCT01554358|Lifestyle intervention|lifestyle intervention
5018783|NCT01554332|Motor Cortex Stimulation|motor cortex stimulation
5018784|NCT01554332|Neuropathic pain|neuropathic pain
5018785|NCT01554319|Antisense oligonucleotide|antisense oligonucleotide
5018786|NCT01554319|Asthma|asthma
5018787|NCT01554319|Healthy subjects|healthy subjects
5018788|NCT01554319|Phase 1|phase 1
5018789|NCT01554319|Transcription factor GATA-3|transcription factor gata-3
5018790|NCT01554319|Oral inhalation|oral inhalation
5018791|NCT01554280|Stricture|stricture
5018792|NCT01554280|Dysphagia|dysphagia
5018793|NCT01554267|Mastectomy skin flap necrosis|mastectomy skin flap necrosis
5018794|NCT01554267|Breast reconstruction|breast reconstruction
5018795|NCT01554267|Indocyanine Green Dye|indocyanine green dye
5018796|NCT01554254|Cord blood transplant|cord blood transplant
5018899|NCT01553734|pneumonia|pneumonia
5018797|NCT01554254|hematological malignancy|hematological malignancy
5018798|NCT01554254|inherited metabolic disease|inherited metabolic disease
5018799|NCT01554254|Mucositis|mucositis
5018800|NCT01554254|Neutrophil engraftment|neutrophil engraftment
5018801|NCT01554254|Platelet recovery|platelet recovery
5018802|NCT01554254|Immune reconstitution|immune reconstitution
5018803|NCT01554241|vitamin D3|vitamin d3
5018804|NCT01554241|D3|d3
5018805|NCT01554241|cholecalciferol|cholecalciferol
5018806|NCT01554241|25-OH vitamin D|25-oh vitamin d
5018807|NCT01554241|elderly|elderly
5018808|NCT01554241|nursing home resident|nursing home resident
5018809|NCT01554215|parenting|parenting
5018810|NCT01554215|child behavior|child behavior
5018811|NCT01554215|attachment|attachment
5018812|NCT01554202|Alzheimer's disease|alzheimer's disease
5018813|NCT01554202|MCI|mci
5018814|NCT01554202|genetic|genetic
5018815|NCT01554202|AV45-PET|av45-pet
5018816|NCT01554176|Current depressive episode|current depressive episode
5018817|NCT01554176|moderate to severe|moderate to severe
5018818|NCT01554163|Osteoarthritis|osteoarthritis
5018819|NCT01554163|Celecoxib|celecoxib
5018820|NCT01554163|Etoricoxib|etoricoxib
5018821|NCT01554150|Primary Health Care|primary health care
5018822|NCT01554150|Mental Health|mental health
5018823|NCT01554150|Cognitive Therapy|cognitive therapy
5018824|NCT01554124|Meningitis|meningitis
5018825|NCT01554124|Neonates|neonates
5018826|NCT01554124|Meropenem|meropenem
5018827|NCT01554111|Bowel Evacuants|bowel evacuants
5018828|NCT01554111|Purgatives|purgatives
5018829|NCT01554098|Polyp detection|polyp detection
5018830|NCT01554098|Supine|supine
5018831|NCT01554098|Colonoscope withdrawal|colonoscope withdrawal
5018832|NCT01554098|Patient position|patient position
5018833|NCT01554098|Dynamic position change|dynamic position change
5018834|NCT01554072|home-based|home-based
5018835|NCT01554072|pulmonary rehabilitation|pulmonary rehabilitation
5018836|NCT01554072|COPD|copd
5018837|NCT01554059|Rectal cancer|rectal cancer
5018838|NCT01554059|Adenocarcinoma|adenocarcinoma
5018839|NCT01554059|Bevacizumab|bevacizumab
5018840|NCT01554059|Chemoradiation|chemoradiation
5018841|NCT01554046|Attention Deficit Hyperactivity Disorder (ADHD)|attention deficit hyperactivity disorder (adhd)
5018842|NCT01554046|Methylphenidate- RITALIN IR (Immediate Release)|methylphenidate- ritalin ir (immediate release)
5018843|NCT01554033|European Huntington's Disease Network|european huntington's disease network
5018844|NCT01554033|Huntington patients in KOREA|huntington patients in korea
5018845|NCT01554020|Blood glucose|blood glucose
5018846|NCT01554020|Insulin sensitivity|insulin sensitivity
5018847|NCT01554020|Oral glucose tolerance|oral glucose tolerance
5018848|NCT01554007|Crohn's disease|crohn's disease
5018849|NCT01553981|Interstitial lung disease|interstitial lung disease
5018850|NCT01553981|Scleroderma|scleroderma
5018851|NCT01553955|PRP,|prp,
5018852|NCT01553955|Platelet|platelet
5018853|NCT01553955|Manual|manual
5018854|NCT01553942|NSCLC|nsclc
5018855|NCT01553929|MCI|mci
5018856|NCT01553903|Hormonal therapy|hormonal therapy
5018857|NCT01553903|Breast Cancer|breast cancer
5018858|NCT01553903|AEBS|aebs
5018859|NCT01553903|Oxysterols|oxysterols
5018860|NCT01553890|SSc= scleroderma|ssc= scleroderma
5018861|NCT01553890|ICF+ informed consent form|icf+ informed consent form
5018862|NCT01553890|age 18 to 85|age 18 to 85
5018863|NCT01553890|healthy|healthy
5018864|NCT01553838|prostate biopsy|prostate biopsy
5018865|NCT01553838|MRI guided biopsy|mri guided biopsy
5018866|NCT01553838|TRUS guided biopsy|trus guided biopsy
5018867|NCT01553812|forced oscillation technique|forced oscillation technique
5018868|NCT01553812|COPD|copd
5018869|NCT01553812|elderly|elderly
5018870|NCT01553812|airway resistance|airway resistance
5018871|NCT01553812|airtrapping|airtrapping
5018872|NCT01553786|T-cell lymphoma|t-cell lymphoma
5018873|NCT01553786|CHOp|chop
5018874|NCT01553786|lenalidomide|lenalidomide
5018875|NCT01553773|Hyaluroic acid|hyaluroic acid
5018876|NCT01553773|Estradiol|estradiol
5018877|NCT01553773|Isoflavone|isoflavone
5018878|NCT01553773|Skin|skin
5018879|NCT01553773|Postmenopause|postmenopause
5018880|NCT01553760|Cataract|cataract
5018881|NCT01553760|TRI-MICS|tri-mics
5018882|NCT01553760|ACM|acm
5018883|NCT01553760|MICS|mics
5018884|NCT01553760|phacoemulsification|phacoemulsification
5018885|NCT01553747|Irritable bowel syndrome with diarrhea|irritable bowel syndrome with diarrhea
5018886|NCT01553747|Irritable bowel syndrome|irritable bowel syndrome
5018887|NCT01553747|Diarrhea predominant irritable bowel syndrome|diarrhea predominant irritable bowel syndrome
5018888|NCT01553747|Colonic diseases|colonic diseases
5018889|NCT01553747|Colonic diseases, functional|colonic diseases, functional
5018890|NCT01553747|Digestive system disease|digestive system disease
5018891|NCT01553747|Gastrointestinal disease|gastrointestinal disease
5018892|NCT01553747|Intestinal disease|intestinal disease
5018893|NCT01553747|Colonic pseudo-obstruction|colonic pseudo-obstruction
5018894|NCT01553747|Diarrhea|diarrhea
5018895|NCT01553747|Signs and symptoms, Digestive|signs and symptoms, digestive
5018896|NCT01553734|QT prolongation|qt prolongation
5018897|NCT01553734|Azithromycin|azithromycin
5018898|NCT01553734|macrolide|macrolide
5018900|NCT01553734|ECG changes|ecg changes
5018901|NCT01553708|Wound healing|wound healing
5018902|NCT01553708|Epithelialization|epithelialization
5018903|NCT01553708|Safety|safety
5018904|NCT01553695|Touble|touble
5018905|NCT01553695|deficit|deficit
5018906|NCT01553695|attention|attention
5018907|NCT01553695|hyperactivity|hyperactivity
5018908|NCT01553695|Touble deficit attention with hyperactivity|touble deficit attention with hyperactivity
5018909|NCT01553682|HIV|hiv
5018910|NCT01553682|STDs|stds
5018911|NCT01553682|African American Females|african american females
5018912|NCT01553682|Alcohol|alcohol
5018913|NCT01553656|Advanced cancer|advanced cancer
5018914|NCT01553656|Metastatic|metastatic
5018915|NCT01553656|NSCLC|nsclc
5018916|NCT01553643|Huang-Chi-Wu-Wu-Tang|huang-chi-wu-wu-tang
5018917|NCT01553643|Intracranial arterial prominent stenosis|intracranial arterial prominent stenosis
5018918|NCT01553630|Fractures|fractures
5018919|NCT01553630|distal femur fractures|distal femur fractures
5018920|NCT01553630|distal tibial fracures|distal tibial fracures
5018921|NCT01553604|breast prosthesis implantation|breast prosthesis implantation
5018922|NCT01553604|bandages|bandages
5018923|NCT01553604|skin colonization|skin colonization
5018924|NCT01553604|surgical site infection|surgical site infection
5018925|NCT01553604|augmentation mammaplasty|augmentation mammaplasty
5018926|NCT01553604|dressing wear time|dressing wear time
5018927|NCT01553591|Irritable bowel syndrome with diarrhea|irritable bowel syndrome with diarrhea
5018928|NCT01553591|Irritable bowel syndrome|irritable bowel syndrome
5018929|NCT01553591|Diarrhea Predominant Irritable Bowel Syndrome|diarrhea predominant irritable bowel syndrome
5018930|NCT01553591|Colonic diseases|colonic diseases
5018931|NCT01553591|Colonic diseases, functional|colonic diseases, functional
5018932|NCT01553591|Digestive system disease|digestive system disease
5018933|NCT01553591|Gastrointestinal disease|gastrointestinal disease
5018934|NCT01553591|Intestinal disease|intestinal disease
5018935|NCT01553591|Colonic pseudo-obstruction|colonic pseudo-obstruction
5018936|NCT01553591|Diarrhea|diarrhea
5018937|NCT01553591|Signs and symptoms, Digestive|signs and symptoms, digestive
5018938|NCT01553565|10 mm in diameter|10 mm in diameter
5018939|NCT01553565|antithrombotic agents|antithrombotic agents
5018940|NCT01553552|Schistosoma haematobium|schistosoma haematobium
5018941|NCT01553552|schistosoma mansoni|schistosoma mansoni
5018942|NCT01553552|Anemia|anemia
5018943|NCT01553552|Underweight|underweight
5018944|NCT01553552|stunting|stunting
5018945|NCT01553552|Blastocystis|blastocystis
5018946|NCT01553526|International|international
5018947|NCT01553526|Multicenter|multicenter
5018948|NCT01553526|Observational registry|observational registry
5018949|NCT01553526|All-comers open label registry|all-comers open label registry
5018950|NCT01553526|Orsiro Drug Eluting Stent (DES)|orsiro drug eluting stent (des)
5018951|NCT01553526|Stenting|stenting
5018952|NCT01553526|Treatment of Coronary Artery Disease|treatment of coronary artery disease
5018953|NCT01553526|Coronary revascularization|coronary revascularization
5018954|NCT01553526|Percutaneous Coronary Intervention|percutaneous coronary intervention
5018955|NCT01553526|STEMI|stemi
5018956|NCT01553526|NSTEMI|nstemi
5018957|NCT01553526|Ischemia|ischemia
5018958|NCT01553526|Angina|angina
5018959|NCT01553526|Subgroups|subgroups
5018960|NCT01553526|Acute Myocardial Infarction|acute myocardial infarction
5018961|NCT01553526|Diabetes|diabetes
5018962|NCT01553526|Small Vessels|small vessels
5018963|NCT01553526|Chronic Total Occlusion (CTO)|chronic total occlusion (cto)
5018964|NCT01553513|PET|pet
5018965|NCT01553513|Coronary Artery Disease|coronary artery disease
5018966|NCT01553513|Inflammation|inflammation
5018967|NCT01553513|Plaque|plaque
5018968|NCT01553513|Atherosclerosis|atherosclerosis
5018969|NCT01553500|NAFLD|nafld
5018970|NCT01553500|insulin resistance|insulin resistance
5018971|NCT01553500|children|children
5018972|NCT01553487|vibration|vibration
5018973|NCT01553487|muscle strength|muscle strength
5018974|NCT01553487|bone loss|bone loss
5018975|NCT01553487|immobilization|immobilization
5018976|NCT01553487|fracture|fracture
5018977|NCT01553474|Age-Related Macular Degeneration (AMD)|age-related macular degeneration (amd)
5018978|NCT01553474|Eye Diseases|eye diseases
5018979|NCT01553461|Transplant|transplant
5018980|NCT01553461|Umbilical Cord Blood|umbilical cord blood
5018981|NCT01553461|Graft Rejection|graft rejection
5018982|NCT01553461|Graft Versus Host Disease|graft versus host disease
5018983|NCT01553448|disseminated neuroblastoma|disseminated neuroblastoma
5018984|NCT01553448|hereditary neuroblastoma|hereditary neuroblastoma
5018985|NCT01553448|localized resectable neuroblastoma|localized resectable neuroblastoma
5018986|NCT01553448|localized unresectable neuroblastoma|localized unresectable neuroblastoma
5018987|NCT01553448|stage 4S neuroblastoma|stage 4s neuroblastoma
5018988|NCT01553435|Dextromethorphan|dextromethorphan
5018989|NCT01553435|Morphine|morphine
5018990|NCT01553435|Fentanyl|fentanyl
5018991|NCT01553435|Opioid|opioid
5018992|NCT01553435|analgesia|analgesia
5018993|NCT01553435|Efficacy|efficacy
5018994|NCT01553422|Intrabdominal Pressure|intrabdominal pressure
5018995|NCT01553422|Emergency Bedside Ultrasonography|emergency bedside ultrasonography
5018996|NCT01553422|Abdominal Compartment Syndrome|abdominal compartment syndrome
5018997|NCT01553409|Hypertension|hypertension
5018998|NCT01553409|Ferritin|ferritin
5018999|NCT01553409|Phlebotomy|phlebotomy
5019000|NCT01553409|Blood donation|blood donation
5019001|NCT01553383|OSA|osa
5019002|NCT01553357|Plasma cell leukemia|plasma cell leukemia
5019003|NCT01553357|Lenalidomide|lenalidomide
5019004|NCT01553357|Dexamethasone|dexamethasone
5019005|NCT01553357|Multiple myeloma|multiple myeloma
5019006|NCT01553357|Bortezomib|bortezomib
5019007|NCT01553357|Stem cell transplantation|stem cell transplantation
5019008|NCT01553344|sclerostin|sclerostin
5019009|NCT01553344|osteomalacia|osteomalacia
5019010|NCT01553344|vitamin D deficiency|vitamin d deficiency
5019011|NCT01553331|laparoscopic cholecystectomy|laparoscopic cholecystectomy
5019012|NCT01553318|Fibromyalgia|fibromyalgia
5019013|NCT01553318|FMS|fms
5019014|NCT01553305|exercise programme|exercise programme
5019015|NCT01553292|Respiratory distress syndrome|respiratory distress syndrome
5019016|NCT01553292|Preterm infants|preterm infants
5019017|NCT01553292|Vascular catheter|vascular catheter
5019018|NCT01553292|Surfactant|surfactant
5019019|NCT01553292|CPAP|cpap
5019020|NCT01553292|ECALMIST|ecalmist
5019021|NCT01553266|Diabetes Mellitus|diabetes mellitus
5019022|NCT01553266|diabetes care|diabetes care
5019023|NCT01553266|diabetes self-management education|diabetes self-management education
5019024|NCT01553266|primary care physicians|primary care physicians
5019025|NCT01553266|interprofessional collaboration|interprofessional collaboration
5019026|NCT01553266|diabetes education programs|diabetes education programs
5019027|NCT01553266|qualitative|qualitative
5019028|NCT01553266|quantitative|quantitative
5019029|NCT01553266|implementation|implementation
5019030|NCT01553266|evaluation|evaluation
5019031|NCT01553266|health services|health services
5019032|NCT01553266|coordinated care|coordinated care
5019033|NCT01553266|integrated care|integrated care
5019034|NCT01553266|patient care processes|patient care processes
5019035|NCT01553253|Postcholecystectomy Pain|postcholecystectomy pain
5019036|NCT01553253|Chronic Postoperative Pain|chronic postoperative pain
5019037|NCT01553253|Visceral Pain|visceral pain
5019038|NCT01553253|Referred pain|referred pain
5019039|NCT01553253|Somatic pain|somatic pain
5019040|NCT01553253|Quantitative Sensory Testing|quantitative sensory testing
5019041|NCT01553240|TMS|tms
5019042|NCT01553240|functional MRI|functional mri
5019043|NCT01553240|Supplementary motor cortex|supplementary motor cortex
5019044|NCT01553240|Right Temporoparietal junction( RTPJ)|right temporoparietal junction( rtpj)
5019045|NCT01553227|OSAHS: Obstructive Sleep Apnea hypopnea Syndrome|osahs: obstructive sleep apnea hypopnea syndrome
5019046|NCT01553227|OHS: Obesity Hypoventilation Syndrome|ohs: obesity hypoventilation syndrome
5019047|NCT01553227|Auto-trilevel ventilation|auto-trilevel ventilation
5019048|NCT01553227|BiPAP ventilation|bipap ventilation
5019049|NCT01553214|Healthy Volunteers|healthy volunteers
5019050|NCT01553214|Granulocyte Transfusion|granulocyte transfusion
5019051|NCT01553214|Granulocytapheresis|granulocytapheresis
5019052|NCT01553214|Leukapheresis|leukapheresis
5019053|NCT01553214|Cytokine Stimulation|cytokine stimulation
5019054|NCT01553214|Healthy Volunteer|healthy volunteer
5019055|NCT01553214|HV|hv
5019056|NCT01553201|Quality of Life|quality of life
5019057|NCT01553201|Endometriosis|endometriosis
5019058|NCT01553201|Botulinum Toxin A|botulinum toxin a
5019059|NCT01553201|Pelvic Pain Spasm|pelvic pain spasm
5019060|NCT01553201|Chronic Pelvic Pain|chronic pelvic pain
5019061|NCT01553188|Anti-Angiogenesis|anti-angiogenesis
5019062|NCT01553188|Ang 1|ang 1
5019063|NCT01553188|Ang 2|ang 2
5019064|NCT01553188|Peptide-Fc fusion protein|peptide-fc fusion protein
5019065|NCT01553188|Small Molecule|small molecule
5019066|NCT01553175|childhood atypical teratoid/rhabdoid tumor|childhood atypical teratoid/rhabdoid tumor
5019067|NCT01553175|rhabdoid tumor of the kidney|rhabdoid tumor of the kidney
5019068|NCT01553162|B-cell childhood acute lymphoblastic leukemia|b-cell childhood acute lymphoblastic leukemia
5019069|NCT01553162|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
5019070|NCT01553136|alcohol-related disorders|alcohol-related disorders
5019071|NCT01553136|Cholinergic Drugs|cholinergic drugs
5019072|NCT01553136|varenicline|varenicline
5019073|NCT01553136|Chantix|chantix
5019074|NCT01553123|Leiomyomas|leiomyomas
5019075|NCT01553110|Cold|cold
5019076|NCT01553110|Acute Rhinosinusitis|acute rhinosinusitis
5019077|NCT01553110|Allergic Rhinitis|allergic rhinitis
5019078|NCT01553097|Breast Cancer|breast cancer
5019079|NCT01553097|Neurocognitive Impairment|neurocognitive impairment
5019080|NCT01553097|Quality of Life|quality of life
5019081|NCT01553097|Cytokines|cytokines
5019082|NCT01553084|Smoking Cessation|smoking cessation
5019083|NCT01553084|Smoking|smoking
5019084|NCT01553084|Nicotine|nicotine
5019085|NCT01553071|Malignancy, Relapsed|malignancy, relapsed
5019086|NCT01553071|Chemotherapy, Intravenous|chemotherapy, intravenous
5019087|NCT01553058|Psoriasis|psoriasis
5019088|NCT01553058|Cardiovascular Disease|cardiovascular disease
5019089|NCT01553058|FDG/PET-CT|fdg/pet-ct
5019090|NCT01553058|NB-UVB Phototherapy|nb-uvb phototherapy
5019091|NCT01553058|Vascular Inflammation|vascular inflammation
5019092|NCT01553058|Lipid Biomarkers|lipid biomarkers
5019498|NCT01551290|IBD|ibd
5019093|NCT01553045|symptom burden|symptom burden
5019094|NCT01553045|atrial fibrillation|atrial fibrillation
5019095|NCT01553045|biomarkers|biomarkers
5019096|NCT01553045|intracardiac pressures|intracardiac pressures
5019097|NCT01553032|Immuno-(Chemo-)and Radiotherapy|immuno-(chemo-)and radiotherapy
5019098|NCT01553032|Erbitux®|erbitux®
5019099|NCT01553032|Skin changes in Head and neck cancer|skin changes in head and neck cancer
5019100|NCT01553019|Proton radiation|proton radiation
5019101|NCT01553019|Chemotherapy|chemotherapy
5019102|NCT01553019|Pancreatic cancer|pancreatic cancer
5019103|NCT01553019|Postoperative|postoperative
5019104|NCT01553006|rhinosinusitis|rhinosinusitis
5019105|NCT01553006|cefditoren pivoxil|cefditoren pivoxil
5019106|NCT01552993|prematurity|prematurity
5019107|NCT01552993|retinopathy|retinopathy
5019108|NCT01552993|pain|pain
5019109|NCT01552993|acetaminophen|acetaminophen
5019110|NCT01552980|Gastric cancer|gastric cancer
5019111|NCT01552980|Adenocarcinoma|adenocarcinoma
5019112|NCT01552980|SOX|sox
5019113|NCT01552967|Colorectal cancer|colorectal cancer
5019114|NCT01552967|Adenocarcinoma|adenocarcinoma
5019115|NCT01552967|XELOX|xelox
5019116|NCT01552954|hypertension|hypertension
5019117|NCT01552954|Chronic kidney disease|chronic kidney disease
5019118|NCT01552954|albuminuria|albuminuria
5019119|NCT01552954|low salt diet|low salt diet
5019120|NCT01552954|Angiotensin II receptor blocker|angiotensin ii receptor blocker
5019121|NCT01552941|Vagus Nerve|vagus nerve
5019122|NCT01552941|Vagal Nerve Stimulation|vagal nerve stimulation
5019123|NCT01552941|Rheumatoid Arthritis|rheumatoid arthritis
5019124|NCT01552941|Implantable Medical Device|implantable medical device
5019125|NCT01552915|ADHD|adhd
5019126|NCT01552902|ADHD|adhd
5019127|NCT01552863|pharmacokinetics|pharmacokinetics
5019128|NCT01552863|bioavailability|bioavailability
5019129|NCT01552863|oxycodone.|oxycodone.
5019130|NCT01552850|pharmacokinetics|pharmacokinetics
5019131|NCT01552850|relative bioavailability|relative bioavailability
5019132|NCT01552850|oxycodone|oxycodone
5019133|NCT01552837|Diffusion Tensor Imaging,|diffusion tensor imaging,
5019134|NCT01552837|quetiapine|quetiapine
5019135|NCT01552837|Bipolar Disorder|bipolar disorder
5019136|NCT01552837|hippocampus|hippocampus
5019137|NCT01552837|Volume Brain Morphometry|volume brain morphometry
5019138|NCT01552837|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
5019139|NCT01552837|effect of quetiapine on hippocampal neurogenesis|effect of quetiapine on hippocampal neurogenesis
5019140|NCT01552824|LUTO|luto
5019141|NCT01552824|posterior urethral valves|posterior urethral valves
5019142|NCT01552824|urethral atresia|urethral atresia
5019143|NCT01552772|Safety|safety
5019144|NCT01552772|Tolerability|tolerability
5019145|NCT01552772|Schizophrenia|schizophrenia
5019146|NCT01552772|Aripiprazole|aripiprazole
5019147|NCT01552759|Appetite Hormones|appetite hormones
5019148|NCT01552759|Binge Eating Disorder|binge eating disorder
5019149|NCT01552759|Obesity|obesity
5019150|NCT01552759|Cortisol|cortisol
5019151|NCT01552759|Stress|stress
5019152|NCT01552746|Postoperative shoulder pain|postoperative shoulder pain
5019153|NCT01552746|Persisting postoperative pain|persisting postoperative pain
5019154|NCT01552720|aorta|aorta
5019155|NCT01552720|dissection|dissection
5019156|NCT01552720|feature|feature
5019157|NCT01552707|Spondylolisthesis|spondylolisthesis
5019158|NCT01552707|Degenerative discopathy|degenerative discopathy
5019159|NCT01552707|Mesenchymal Stem Cells|mesenchymal stem cells
5019160|NCT01552707|Bone marrow|bone marrow
5019161|NCT01552707|Tissue engineering|tissue engineering
5019162|NCT01552707|Spinal fusion|spinal fusion
5019163|NCT01552694|cardiometabolic complications|cardiometabolic complications
5019164|NCT01552681|baminercept treatment|baminercept treatment
5019165|NCT01552668|Clostridium difficile infection|clostridium difficile infection
5019166|NCT01552668|fidaxomicin|fidaxomicin
5019167|NCT01552655|Dual-time PET/CT|dual-time pet/ct
5019168|NCT01552655|Breast cancer recurrence|breast cancer recurrence
5019169|NCT01552655|Bone scintigraphy|bone scintigraphy
5019170|NCT01552655|CT thorax upper abdomen|ct thorax upper abdomen
5019171|NCT01552642|Comprehensive Health Enhancement Support System (CHESS)|comprehensive health enhancement support system (chess)
5019172|NCT01552629|Atopic dermatitis|atopic dermatitis
5019173|NCT01552629|Atopic eczema|atopic eczema
5019174|NCT01552629|Skin Diseases|skin diseases
5019175|NCT01552629|QGE031|qge031
5019176|NCT01552603|glucose sensors|glucose sensors
5019177|NCT01552603|artificial pancreas|artificial pancreas
5019178|NCT01552603|Diabetes Mellitus|diabetes mellitus
5019179|NCT01552577|Post-Concussion Syndrome|post-concussion syndrome
5019180|NCT01552577|Concussion|concussion
5019181|NCT01552577|Brain Injury|brain injury
5019182|NCT01552577|TBI|tbi
5019183|NCT01552577|Military Personnel|military personnel
5019184|NCT01552577|Eye-tracking|eye-tracking
5019185|NCT01552577|Neurocognitive Function|neurocognitive function
5019186|NCT01552577|Assessment|assessment
5019187|NCT01552551|Falls|falls
5019188|NCT01552551|exercise|exercise
5019189|NCT01552551|safety|safety
5019190|NCT01552551|injury|injury
5019191|NCT01552551|Older adults|older adults
5019192|NCT01552538|Rheumatoid Arthritis|rheumatoid arthritis
5019193|NCT01552538|Vagus Nerve|vagus nerve
5019194|NCT01552538|Vagal Nerve Stimulation|vagal nerve stimulation
5019195|NCT01552525|acute kidney injury|acute kidney injury
5019196|NCT01552525|asymmetric dimethylarginine|asymmetric dimethylarginine
5019197|NCT01552525|symmetric dimethylarginine|symmetric dimethylarginine
5019198|NCT01552525|l-arginine|l-arginine
5019199|NCT01552525|arterial stiffness|arterial stiffness
5019200|NCT01552525|augmentation index|augmentation index
5019201|NCT01552525|pulse wave velocity|pulse wave velocity
5019202|NCT01552512|Stunting|stunting
5019203|NCT01552512|Hidden Hunger|hidden hunger
5019204|NCT01552512|Diarrhea|diarrhea
5019205|NCT01552512|Vitamin A Deficiency|vitamin a deficiency
5019206|NCT01552486|chiropractic|chiropractic
5019207|NCT01552486|manipulation|manipulation
5019208|NCT01552486|radiculopathy|radiculopathy
5019209|NCT01552486|sciatica|sciatica
5019210|NCT01552486|lumbar|lumbar
5019211|NCT01552486|disc|disc
5019212|NCT01552486|herniation|herniation
5019213|NCT01552486|protrusion|protrusion
5019214|NCT01552473|TBI|tbi
5019215|NCT01552473|Traumatic Brain Injury|traumatic brain injury
5019216|NCT01552473|combat related injury|combat related injury
5019217|NCT01552473|blast injury|blast injury
5019218|NCT01552473|concussion|concussion
5019219|NCT01552473|sleep problems|sleep problems
5019220|NCT01552473|attention problems|attention problems
5019221|NCT01552473|memory problems|memory problems
5019222|NCT01552473|headaches|headaches
5019223|NCT01552473|dizziness|dizziness
5019224|NCT01552473|OEF|oef
5019225|NCT01552473|OIF|oif
5019226|NCT01552473|Veterans|veterans
5019227|NCT01552473|Civilian|civilian
5019228|NCT01552460|Autism Spectrum Disorders|autism spectrum disorders
5019229|NCT01552460|Brain Imaging|brain imaging
5019230|NCT01552460|Genetics|genetics
5019231|NCT01552434|Advanced Cancers|advanced cancers
5019232|NCT01552434|Advanced Malignancy|advanced malignancy
5019233|NCT01552434|Metastatic cancer|metastatic cancer
5019234|NCT01552434|Temsirolimus|temsirolimus
5019235|NCT01552434|CCI-779|cci-779
5019236|NCT01552434|Torisel|torisel
5019237|NCT01552434|Bevacizumab|bevacizumab
5019238|NCT01552434|Avastin|avastin
5019239|NCT01552434|rhuMAb-VEGF|rhumab-vegf
5019240|NCT01552434|Anti-VEGF Monoclonal Antibody|anti-vegf monoclonal antibody
5019241|NCT01552434|Cetuximab|cetuximab
5019242|NCT01552434|C225|c225
5019243|NCT01552434|Erbitux|erbitux
5019244|NCT01552434|IMC-C225|imc-c225
5019245|NCT01552434|Valproic Acid|valproic acid
5019246|NCT01552434|Depakene|depakene
5019247|NCT01552421|Cholecystectomy|cholecystectomy
5019248|NCT01552421|Natural Orifice Transluminal Endoscopic Surgery|natural orifice transluminal endoscopic surgery
5019249|NCT01552421|Transvaginal cholecystectomy|transvaginal cholecystectomy
5019250|NCT01552421|Postoperative outcome|postoperative outcome
5019251|NCT01552408|Non Proliferative Diabetic Retinopathy|non proliferative diabetic retinopathy
5019252|NCT01552408|Diabetic Retinopathy|diabetic retinopathy
5019253|NCT01552408|Macular Edema|macular edema
5019254|NCT01552408|Background Diabetic Retinopathy|background diabetic retinopathy
5019255|NCT01552408|Pre Proliferative Diabetic Retinopathy|pre proliferative diabetic retinopathy
5019256|NCT01552382|vitamin D|vitamin d
5019257|NCT01552382|25-hydroxyvitamin D|25-hydroxyvitamin d
5019258|NCT01552382|MACCE|macce
5019259|NCT01552382|mortality|mortality
5019260|NCT01552382|cardiac|cardiac
5019261|NCT01552382|cerebrovascular|cerebrovascular
5019262|NCT01552369|CMV|cmv
5019263|NCT01552369|cytomegalovirus infections|cytomegalovirus infections
5019264|NCT01552369|ganciclovir|ganciclovir
5019265|NCT01552369|liver transplant|liver transplant
5019266|NCT01552369|preemptive therapy|preemptive therapy
5019267|NCT01552369|prophylaxis|prophylaxis
5019268|NCT01552369|valganciclovir|valganciclovir
5019269|NCT01552330|Primaquine|primaquine
5019270|NCT01552330|Pyronaridine-artesunate|pyronaridine-artesunate
5019271|NCT01552317|chronic kidney disease|chronic kidney disease
5019272|NCT01552304|Obstructive sleep apnea|obstructive sleep apnea
5019273|NCT01552304|Oxygen therapy|oxygen therapy
5019274|NCT01552304|Surgery|surgery
5019275|NCT01552304|Anesthesia|anesthesia
5019276|NCT01552291|Malnourishment|malnourishment
5019277|NCT01552291|Gastrointestinal tumors|gastrointestinal tumors
5019278|NCT01552291|Immunocompetence|immunocompetence
5019279|NCT01552265|Mild Cognitive Impairment|mild cognitive impairment
5019280|NCT01552265|Alzheimer's Disease|alzheimer's disease
5019281|NCT01552252|POs-Ca|pos-ca
5019282|NCT01552252|calcium additives|calcium additives
5019283|NCT01552252|drink|drink
5019284|NCT01552239|Soft tissue sarcoma|soft tissue sarcoma
5019285|NCT01552239|Intensity-Modulated Radiation Therapy (IMRT)|intensity-modulated radiation therapy (imrt)
5019286|NCT01552239|Tomotherapy|tomotherapy
5019287|NCT01552239|Safety Margins|safety margins
5019288|NCT01552239|Image-guided Radiation Therapy|image-guided radiation therapy
5019289|NCT01552239|Brachytherapy|brachytherapy
5019290|NCT01552239|interstitial|interstitial
5019291|NCT01552200|Colorectal Cancer|colorectal cancer
5019292|NCT01552200|Polyp|polyp
5019293|NCT01552200|Adenoma|adenoma
5019294|NCT01552200|Detection Rate|detection rate
5019295|NCT01552200|Colonoscopy|colonoscopy
5019296|NCT01552200|NaviAid™ G-Eye procedure|naviaid™ g-eye procedure
5019798|NCT01550094|orthopedics|orthopedics
5019297|NCT01552200|NaviAid™ G-Eye system|naviaid™ g-eye system
5019298|NCT01552200|G-Eye procedure|g-eye procedure
5019299|NCT01552200|G-Eye system|g-eye system
5019300|NCT01552187|cardiac surgery|cardiac surgery
5019301|NCT01552187|post-pericardiotomy syndrome|post-pericardiotomy syndrome
5019302|NCT01552187|atrial fibrillation|atrial fibrillation
5019303|NCT01552187|pericardial effusion|pericardial effusion
5019304|NCT01552187|pleural effusion|pleural effusion
5019305|NCT01552187|prevention|prevention
5019306|NCT01552187|colchicine|colchicine
5019307|NCT01552174|MGD|mgd
5019308|NCT01552174|ocular surface pathologies|ocular surface pathologies
5019309|NCT01552161|Angiography|angiography
5019310|NCT01552161|Atherosclerosis|atherosclerosis
5019311|NCT01552161|Asthma|asthma
5019312|NCT01552161|Tryptase|tryptase
5019313|NCT01552161|Eosinophil cationic protein|eosinophil cationic protein
5019314|NCT01552135|titanium dioxide|titanium dioxide
5019315|NCT01552135|nanoparticles|nanoparticles
5019316|NCT01552135|skin|skin
5019317|NCT01552135|penetrate|penetrate
5019318|NCT01552109|symptomatic stable angina|symptomatic stable angina
5019319|NCT01552109|subjects with symptomatic stable angina visiting non-interventional consulting physicians for treatment and meets the inclusion/exclusion criteria|subjects with symptomatic stable angina visiting non-interventional consulting physicians for treatment and meets the inclusion/exclusion criteria
5019320|NCT01552096|Anaesthesia|anaesthesia
5019321|NCT01552096|tonsillectomy|tonsillectomy
5019322|NCT01552096|inflammatory response|inflammatory response
5019323|NCT01552096|stress response|stress response
5019324|NCT01552096|tramadol|tramadol
5019325|NCT01552096|lidocaine|lidocaine
5019326|NCT01552083|sleep apnea|sleep apnea
5019327|NCT01552083|screening|screening
5019328|NCT01552083|community pharmacy|community pharmacy
5019329|NCT01552044|retina|retina
5019330|NCT01552031|COPD exacerbations|copd exacerbations
5019331|NCT01552031|FOT variability|fot variability
5019332|NCT01551992|Sutures|sutures
5019333|NCT01551992|Pelvic Organ Prolapse|pelvic organ prolapse
5019334|NCT01551992|Sacrocolpopexy|sacrocolpopexy
5019335|NCT01551992|Laparoscopy|laparoscopy
5019336|NCT01551979|Schizophrenia|schizophrenia
5019337|NCT01551979|repetitive Transcranial Magnetic Stimulation|repetitive transcranial magnetic stimulation
5019338|NCT01551966|Esophageal varices|esophageal varices
5019339|NCT01551966|Portal hypertension in children|portal hypertension in children
5019340|NCT01551966|Wireless capsule endoscopy|wireless capsule endoscopy
5019341|NCT01551953|chronic bronchitis|chronic bronchitis
5019342|NCT01551953|emphysema|emphysema
5019343|NCT01551953|pulmonary|pulmonary
5019344|NCT01551953|COPD|copd
5019345|NCT01551940|Sialorrhea|sialorrhea
5019346|NCT01551940|Amyotrophic lateral sclerosis|amyotrophic lateral sclerosis
5019347|NCT01551940|Botulinum toxin|botulinum toxin
5019348|NCT01551927|expectations|expectations
5019349|NCT01551914|Ultrasonic scissors|ultrasonic scissors
5019350|NCT01551914|thyroidectomy|thyroidectomy
5019351|NCT01551901|Back pain|back pain
5019352|NCT01551901|Spinal fusion|spinal fusion
5019353|NCT01551901|Degenerative disc disease (DDD)|degenerative disc disease (ddd)
5019354|NCT01551901|Lower back pain|lower back pain
5019355|NCT01551901|Fusion|fusion
5019356|NCT01551888|COPD|copd
5019357|NCT01551888|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5019358|NCT01551888|Chronic Bronchitis|chronic bronchitis
5019359|NCT01551888|Emphysema|emphysema
5019360|NCT01551888|Airflow Obstruction, Chronic|airflow obstruction, chronic
5019361|NCT01551888|Chronic Airflow Obstruction|chronic airflow obstruction
5019362|NCT01551888|Chronic Obstructive Airway Disease|chronic obstructive airway disease
5019363|NCT01551888|Chronic Obstructive Lung Disease|chronic obstructive lung disease
5019364|NCT01551875|CIMT|cimt
5019365|NCT01551875|cardiovascular disease|cardiovascular disease
5019366|NCT01551875|correlation with cardiovascular Risk factors|correlation with cardiovascular risk factors
5019367|NCT01551862|lower body lift|lower body lift
5019368|NCT01551862|body contouring surgery|body contouring surgery
5019369|NCT01551862|massive weight loss|massive weight loss
5019370|NCT01551836|pharmacokinetics|pharmacokinetics
5019371|NCT01551836|paracetamol|paracetamol
5019372|NCT01551823|Influenza Virus Vaccine (Split Virion, Inactivated)|influenza virus vaccine (split virion, inactivated)
5019373|NCT01551823|Influenza|influenza
5019374|NCT01551810|Influenza Virus Vaccine (Split Virion, Inactivated)|influenza virus vaccine (split virion, inactivated)
5019375|NCT01551810|Influenza|influenza
5019376|NCT01551784|Statin treatment|statin treatment
5019377|NCT01551784|Cardiovascular disease|cardiovascular disease
5019378|NCT01551784|Statin treatment induced HDL changes and the effect on cardiovascular disease|statin treatment induced hdl changes and the effect on cardiovascular disease
5019379|NCT01551771|CCR3 antagonist|ccr3 antagonist
5019380|NCT01551758|Exacerbation|exacerbation
5019381|NCT01551758|Adult|adult
5019382|NCT01551758|COPD|copd
5019383|NCT01551758|Respiratory|respiratory
5019384|NCT01551745|Papillary Serous Ovarian Cancer|papillary serous ovarian cancer
5019385|NCT01551745|Endometrioid Ovarian Cancer|endometrioid ovarian cancer
5019386|NCT01551745|Epithelial Ovarian Cancer|epithelial ovarian cancer
5019387|NCT01551732|Anger|anger
5019388|NCT01551732|Aggression|aggression
5019389|NCT01551732|Biofeedback|biofeedback
5019390|NCT01551732|Videogame|videogame
5019391|NCT01551719|Bacterial infection of skin or soft tissues|bacterial infection of skin or soft tissues
5019392|NCT01551706|Total antioxidant capacity|total antioxidant capacity
5019394|NCT01551706|8-OHdG|8-ohdg
5019395|NCT01551706|8-isoprostane|8-isoprostane
5019396|NCT01551706|oxLDL|oxldl
5019397|NCT01551693|Stage III|stage iii
5019398|NCT01551693|Stage IV|stage iv
5019399|NCT01551693|Unresectable|unresectable
5019400|NCT01551693|Metastatic|metastatic
5019401|NCT01551667|S. aureus|s. aureus
5019402|NCT01551654|Pain|pain
5019403|NCT01551654|Colonoscopy|colonoscopy
5019404|NCT01551654|TENS|tens
5019405|NCT01551654|Acupuncture|acupuncture
5019406|NCT01551641|Esophageal Cancer|esophageal cancer
5019407|NCT01551641|Chemoradiotherapy|chemoradiotherapy
5019408|NCT01551641|VEGF|vegf
5019409|NCT01551641|Thalidomide|thalidomide
5019410|NCT01551615|Phase 1|phase 1
5019411|NCT01551615|healthy volunteers|healthy volunteers
5019412|NCT01551615|pharmacokinetics|pharmacokinetics
5019413|NCT01551615|vandetanib|vandetanib
5019414|NCT01551615|metformin|metformin
5019415|NCT01551615|AUC(0-t)|auc(0-t)
5019416|NCT01551615|t1/2|t1/2
5019417|NCT01551615|tmax|tmax
5019418|NCT01551615|CL/F|cl/f
5019419|NCT01551615|Vz/F|vz/f
5019420|NCT01551615|Cmax|cmax
5019421|NCT01551602|AK159|ak159
5019422|NCT01551602|teriparatide acetate|teriparatide acetate
5019423|NCT01551589|Esophageal squamous cell carcinoma|esophageal squamous cell carcinoma
5019424|NCT01551589|Concurrent chemoradiotherapy|concurrent chemoradiotherapy
5019425|NCT01551589|Clinical target volume|clinical target volume
5019426|NCT01551589|Safety|safety
5019427|NCT01551589|Prognosis|prognosis
5019428|NCT01551550|Glaucoma Drainage Device, Tube Exposure, Amniotic Membrane|glaucoma drainage device, tube exposure, amniotic membrane
5019429|NCT01551537|Healthy females|healthy females
5019430|NCT01551537|Post-marketing surveillance (PMS)|post-marketing surveillance (pms)
5019431|NCT01551537|Human papillomavirus vaccine|human papillomavirus vaccine
5019432|NCT01551537|Sri Lanka|sri lanka
5019433|NCT01551537|Cervarix|cervarix
5019434|NCT01551524|Leukemia|leukemia
5019435|NCT01551524|Lymphoma|lymphoma
5019436|NCT01551524|C240588.448|c240588.448
5019437|NCT01551524|C115.378.400|c115.378.400
5019438|NCT01551511|chronic pancreatitis|chronic pancreatitis
5019439|NCT01551511|abdominal pain|abdominal pain
5019440|NCT01551511|visceral pain|visceral pain
5019441|NCT01551511|chronic pain|chronic pain
5019442|NCT01551498|Hashimoto Disease|hashimoto disease
5019443|NCT01551498|Thyroiditis|thyroiditis
5019444|NCT01551459|Uveal|uveal
5019445|NCT01551459|Melanoma|melanoma
5019446|NCT01551459|Metastatic|metastatic
5019447|NCT01551459|Sunitinib|sunitinib
5019448|NCT01551433|esophagectomy|esophagectomy
5019449|NCT01551433|ESOPHAGUS|esophagus
5019450|NCT01551433|Wipox instrument|wipox instrument
5019451|NCT01551433|Tissue Oxygenation|tissue oxygenation
5019452|NCT01551433|Anastomotic Leak|anastomotic leak
5019453|NCT01551433|11-192|11-192
5019454|NCT01551420|Amputation|amputation
5019455|NCT01551420|Prosthetic Design|prosthetic design
5019456|NCT01551420|Upper Extremity|upper extremity
5019457|NCT01551407|Hexvix|hexvix
5019458|NCT01551407|bladder cancer|bladder cancer
5019459|NCT01551407|cystoscopy|cystoscopy
5019460|NCT01551407|Patients with known or suspicion of bladder cancer|patients with known or suspicion of bladder cancer
5019461|NCT01551394|sepsis|sepsis
5019462|NCT01551394|neonates|neonates
5019463|NCT01551394|meropenem|meropenem
5019464|NCT01551381|Safety|safety
5019465|NCT01551381|Tolerability|tolerability
5019466|NCT01551381|Pharmacokinetics|pharmacokinetics
5019467|NCT01551381|Pharmacodynamics|pharmacodynamics
5019468|NCT01551368|male factor|male factor
5019469|NCT01551368|intrauterine insemination|intrauterine insemination
5019470|NCT01551368|LH surge|lh surge
5019471|NCT01551368|controlled ovarian stimulation|controlled ovarian stimulation
5019472|NCT01551368|clomiphene citrate|clomiphene citrate
5019473|NCT01551368|letrozole|letrozole
5019474|NCT01551368|human menopausal gonadotropins|human menopausal gonadotropins
5019475|NCT01551355|behavioral modification|behavioral modification
5019476|NCT01551355|health communication|health communication
5019477|NCT01551355|prevention|prevention
5019478|NCT01551342|bladder cancer|bladder cancer
5019479|NCT01551342|Transitional cell carcinoma (TCC)|transitional cell carcinoma (tcc)
5019480|NCT01551329|depression|depression
5019481|NCT01551329|alcohol|alcohol
5019482|NCT01551329|comorbidity|comorbidity
5019483|NCT01551329|ketamine|ketamine
5019484|NCT01551329|glutamate|glutamate
5019485|NCT01551329|NMDA|nmda
5019486|NCT01551316|safety|safety
5019487|NCT01551316|pharmacokinetics|pharmacokinetics
5019488|NCT01551316|spirometry|spirometry
5019489|NCT01551290|Ulcerative colitis|ulcerative colitis
5019490|NCT01551290|UC|uc
5019491|NCT01551290|Remicade|remicade
5019492|NCT01551290|Infliximab|infliximab
5019493|NCT01551290|Chinese patients|chinese patients
5019494|NCT01551290|Mayo score|mayo score
5019495|NCT01551290|Mucosal healing|mucosal healing
5019496|NCT01551290|Rectal bleeding|rectal bleeding
5019497|NCT01551290|Inflammatory bowel disease|inflammatory bowel disease
5019499|NCT01551238|Energy expenditure|energy expenditure
5019500|NCT01551238|Sleep|sleep
5019501|NCT01551238|Protein|protein
5019502|NCT01551238|Carbohydrate|carbohydrate
5019503|NCT01551225|Randomized controlled trial|randomized controlled trial
5019504|NCT01551225|Escitalopram|escitalopram
5019505|NCT01551225|Irritable bowel syndrome|irritable bowel syndrome
5019506|NCT01551225|Panic disorder|panic disorder
5019507|NCT01551212|Liver transplantation|liver transplantation
5019508|NCT01551212|everolimus|everolimus
5019509|NCT01551212|kidney function|kidney function
5019510|NCT01551186|Probiotics|probiotics
5019511|NCT01551173|Dyslipidemias|dyslipidemias
5019512|NCT01551173|Fluvastatin sodium|fluvastatin sodium
5019513|NCT01551173|Chinese|chinese
5019514|NCT01551160|Non-technical skills|non-technical skills
5019515|NCT01551160|Crisis resource management|crisis resource management
5019516|NCT01551160|Medical Emergency Team|medical emergency team
5019517|NCT01551160|Rapid Response Team|rapid response team
5019518|NCT01551147|asthma|asthma
5019519|NCT01551147|ONO-6950|ono-6950
5019520|NCT01551147|asthma in adult patients|asthma in adult patients
5019521|NCT01551134|Gastroesophageal Reflux|gastroesophageal reflux
5019522|NCT01551134|Fundoplication|fundoplication
5019523|NCT01551134|Randomized Controlled Trial|randomized controlled trial
5019524|NCT01551134|General Surgery|general surgery
5019525|NCT01551134|Child|child
5019526|NCT01551134|Laparoscopy|laparoscopy
5019527|NCT01551108|Children|children
5019528|NCT01551108|physical activity|physical activity
5019529|NCT01551095|PEGJ|pegj
5019530|NCT01551095|PEG-J|peg-j
5019531|NCT01551095|percutaneous endoscopic gastrostomy|percutaneous endoscopic gastrostomy
5019532|NCT01551095|feeding tube|feeding tube
5019533|NCT01551095|gastroparesis|gastroparesis
5019534|NCT01551095|acute pancreatitis|acute pancreatitis
5019535|NCT01551095|stroke|stroke
5019536|NCT01551095|respiratory failure|respiratory failure
5019537|NCT01551095|GERD|gerd
5019538|NCT01551095|balloon|balloon
5019539|NCT01551095|self-propelled|self-propelled
5019540|NCT01551043|adult patients|adult patients
5019541|NCT01551043|aged 18|aged 18
5019542|NCT01551043|CD19+ ALL relapsed|cd19+ all relapsed
5019543|NCT01551043|after allogeneic SCT|after allogeneic sct
5019544|NCT01551030|KIDNEY|kidney
5019545|NCT01551030|URETER|ureter
5019546|NCT01551030|URINARY BLADDER|urinary bladder
5019547|NCT01551030|Buparlisib|buparlisib
5019548|NCT01551030|11-060|11-060
5019549|NCT01551017|total knee endoprostheses|total knee endoprostheses
5019550|NCT01551017|swelling|swelling
5019551|NCT01551017|mobilisation|mobilisation
5019552|NCT01551004|C. diff|c. diff
5019553|NCT01551004|C. difficile|c. difficile
5019554|NCT01551004|Clostridium difficile|clostridium difficile
5019555|NCT01551004|CRS3123|crs3123
5019556|NCT01550965|Quality of Life|quality of life
5019557|NCT01550965|Costs of Ulcerative Colitis|costs of ulcerative colitis
5019558|NCT01550965|Health Care Utilization|health care utilization
5019559|NCT01550939|Biometry of the Eye|biometry of the eye
5019560|NCT01550939|Intraocular Lens Implantation|intraocular lens implantation
5019561|NCT01550939|IOL|iol
5019562|NCT01550926|orlistat|orlistat
5019563|NCT01550926|overweight|overweight
5019564|NCT01550926|bioequivalence|bioequivalence
5019565|NCT01550913|Substance use|substance use
5019566|NCT01550913|perinatal depression|perinatal depression
5019567|NCT01550913|pregnant|pregnant
5019568|NCT01550900|Colorectum|colorectum
5019569|NCT01550900|Metachronous ctalColonic Neoplastic Polyps|metachronous ctalcolonic neoplastic polyps
5019570|NCT01550900|Chemoprevention|chemoprevention
5019571|NCT01550900|Colonic adenoma(s)|colonic adenoma(s)
5019572|NCT01550900|Pre-cancerous tumor(s) on the colon|pre-cancerous tumor(s) on the colon
5019573|NCT01550900|Metformin ER|metformin er
5019574|NCT01550900|Extended Release|extended release
5019575|NCT01550900|Placebo|placebo
5019576|NCT01550900|Sugar pill|sugar pill
5019577|NCT01550874|Physical Activity|physical activity
5019578|NCT01550874|Epilepsy|epilepsy
5019579|NCT01550874|Children|children
5019580|NCT01550874|Motivation|motivation
5019581|NCT01550861|infertility|infertility
5019582|NCT01550861|in vitro maturation (IVM)|in vitro maturation (ivm)
5019583|NCT01550861|in vitro fertilization (IVF)|in vitro fertilization (ivf)
5019584|NCT01550861|natural cycle|natural cycle
5019585|NCT01550835|Symptomatic carotid artery stenosis|symptomatic carotid artery stenosis
5019586|NCT01550822|stroke, lifestyle habits|stroke, lifestyle habits
5019587|NCT01550809|T1DM|t1dm
5019588|NCT01550809|CSII|csii
5019590|NCT01550809|postprandial control|postprandial control
5019591|NCT01550809|glycemic variability|glycemic variability
5019592|NCT01550809|Prandial insulin dosing in Type 1 diabetes treated with continuous subcutaneous insulin infusion|prandial insulin dosing in type 1 diabetes treated with continuous subcutaneous insulin infusion
5019593|NCT01550796|Tinnitus|tinnitus
5019594|NCT01550796|Brain Fitness Program|brain fitness program
5019595|NCT01550796|Posit Science|posit science
5019596|NCT01550796|D-cycloserine|d-cycloserine
5019597|NCT01550796|Cognitive Training|cognitive training
5019598|NCT01550783|Cervical cancer|cervical cancer
5019599|NCT01550783|Atypical squamous cells of undetermined significance|atypical squamous cells of undetermined significance
5019600|NCT01550783|Stage 0 cervical cancer|stage 0 cervical cancer
5019601|NCT01550783|Cervical intraepithelial neoplasia grade 1|cervical intraepithelial neoplasia grade 1
5019602|NCT01550783|Cervical|cervical
5019603|NCT01550783|intraepithelial neoplasia grade 2|intraepithelial neoplasia grade 2
5019604|NCT01550783|Cervical intraepithelial neoplasia grade 3|cervical intraepithelial neoplasia grade 3
5019605|NCT01550783|Human papillomavirus|human papillomavirus
5019606|NCT01550783|HPV|hpv
5019607|NCT01550744|Psoriasis|psoriasis
5019608|NCT01550744|Ustekinumab|ustekinumab
5019609|NCT01550744|STELARA|stelara
5019610|NCT01550744|Skin disease|skin disease
5019611|NCT01550744|Monoclonal|monoclonal
5019612|NCT01550731|advance care planning|advance care planning
5019613|NCT01550731|health communication|health communication
5019614|NCT01550731|aging|aging
5019615|NCT01550718|Aerobic Exercise|aerobic exercise
5019616|NCT01550718|Alzheimer's Disease|alzheimer's disease
5019617|NCT01550718|Burden and Stress|burden and stress
5019618|NCT01550718|Caregiving Issues|caregiving issues
5019619|NCT01550718|Quality of Life|quality of life
5019620|NCT01550718|Early Stage Memory Loss|early stage memory loss
5019621|NCT01550705|Protoporphyria|protoporphyria
5019622|NCT01550705|Porphyria|porphyria
5019623|NCT01550705|Porphyrins|porphyrins
5019624|NCT01550666|negative symptoms|negative symptoms
5019625|NCT01550653|Memory|memory
5019626|NCT01550653|GLP-1|glp-1
5019627|NCT01550653|Liraglutide|liraglutide
5019628|NCT01550653|energy output|energy output
5019629|NCT01550653|Memory facilitation|memory facilitation
5019630|NCT01550653|GLP-1 analogue|glp-1 analogue
5019631|NCT01550640|remifentanil|remifentanil
5019632|NCT01550640|Caesarean operation|caesarean operation
5019633|NCT01550640|general anaesthesia|general anaesthesia
5019634|NCT01550640|hypertension|hypertension
5019635|NCT01550640|newborn's adaptation|newborn's adaptation
5019636|NCT01550640|pharmacogenetics|pharmacogenetics
5019637|NCT01550627|preterm infants < 32 weeks of gestation|preterm infants < 32 weeks of gestation
5019638|NCT01550614|Angina Pectoris|angina pectoris
5019639|NCT01550614|Myocardial Ischemia|myocardial ischemia
5019640|NCT01550614|Chest Pain|chest pain
5019641|NCT01550614|Coronary Artery Disease|coronary artery disease
5019642|NCT01550614|Heart Diseases|heart diseases
5019643|NCT01550614|Cardiovascular Diseases|cardiovascular diseases
5019644|NCT01550614|Myocardial Perfusion|myocardial perfusion
5019645|NCT01550614|Reversible Perfusion Defect Size|reversible perfusion defect size
5019646|NCT01550614|SPECT-MIBI|spect-mibi
5019647|NCT01550614|Anti-Anginal Medication|anti-anginal medication
5019648|NCT01550614|Quality of Life|quality of life
5019649|NCT01550601|morbid obesity|morbid obesity
5019650|NCT01550601|gastrectomy|gastrectomy
5019651|NCT01550601|gastrinaemia|gastrinaemia
5019652|NCT01550601|comorbidity|comorbidity
5019653|NCT01550601|gastric antrum|gastric antrum
5019654|NCT01550588|PFO|pfo
5019655|NCT01550588|Stroke|stroke
5019656|NCT01550549|Amyloid imaging|amyloid imaging
5019657|NCT01550549|Positron Emission Tomography|positron emission tomography
5019658|NCT01550549|18F-AV-45|18f-av-45
5019659|NCT01550549|florbetapir F 18|florbetapir f 18
5019660|NCT01550549|Diagnostic imaging|diagnostic imaging
5019661|NCT01550536|basal metabolic rate|basal metabolic rate
5019662|NCT01550536|resting energy expenditure|resting energy expenditure
5019663|NCT01550536|menopause|menopause
5019664|NCT01550536|physical activity|physical activity
5019665|NCT01550536|metabolic syndrome|metabolic syndrome
5019666|NCT01550523|Brain Tumor|brain tumor
5019667|NCT01550510|Stage IV Colorectal cancer|stage iv colorectal cancer
5019668|NCT01550510|Colorectal Neoplasms|colorectal neoplasms
5019669|NCT01550510|Intestinal Neoplasms|intestinal neoplasms
5019670|NCT01550510|Gastrointestinal Neoplasms|gastrointestinal neoplasms
5019671|NCT01550510|Digestive System Neoplasms|digestive system neoplasms
5019672|NCT01550510|Neoplasms by Site|neoplasms by site
5019673|NCT01550510|Neoplasms|neoplasms
5019674|NCT01550510|Digestive System Diseases|digestive system diseases
5019675|NCT01550510|Gastrointestinal Diseases|gastrointestinal diseases
5019676|NCT01550510|Colonic Diseases|colonic diseases
5019677|NCT01550510|Intestinal Diseases|intestinal diseases
5019678|NCT01550510|Rectal Diseases|rectal diseases
5019679|NCT01550510|Ascorbic Acid|ascorbic acid
5019680|NCT01550510|Vitamins|vitamins
5019681|NCT01550510|Irinotecan|irinotecan
5019682|NCT01550510|Integrative Medicine|integrative medicine
5019683|NCT01550510|Complementary Medicine|complementary medicine
5019684|NCT01550510|Alternative Medicine Antioxidants|alternative medicine antioxidants
5019685|NCT01550510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
5019686|NCT01550510|Pharmacologic Actions|pharmacologic actions
5019687|NCT01550510|Protective Agents|protective agents
5019688|NCT01550510|Physiological Effects of Drugs|physiological effects of drugs
5019689|NCT01550510|Micronutrients|micronutrients
5019690|NCT01550510|Growth Substances|growth substances
5019691|NCT01550510|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic
5019692|NCT01550510|Antineoplastic Agents|antineoplastic agents
5019693|NCT01550510|Therapeutic Uses|therapeutic uses
5019694|NCT01550510|Radiation-Sensitizing Agents|radiation-sensitizing agents
5019695|NCT01550510|Topoisomerase I Inhibitors|topoisomerase i inhibitors
5019696|NCT01550510|Topoisomerase Inhibitors|topoisomerase inhibitors
5019697|NCT01550510|Enzyme Inhibitors|enzyme inhibitors
5019698|NCT01550497|back pain|back pain
5019699|NCT01550497|scoliosis|scoliosis
5019700|NCT01550497|home exercise program|home exercise program
5019701|NCT01550471|Mild asthma and allergic rhinitis|mild asthma and allergic rhinitis
5019702|NCT01550458|Clinical Trial, Phase I|clinical trial, phase i
5019703|NCT01550458|Human Volunteers|human volunteers
5019704|NCT01550458|Healthy Volunteers|healthy volunteers
5019705|NCT01550458|mibefradil|mibefradil
5019706|NCT01550458|Posicor®|posicor®
5019707|NCT01550445|Steroid withdrawal, Kidney transplantation|steroid withdrawal, kidney transplantation
5019708|NCT01550419|Ventilator-associated pneumonia|ventilator-associated pneumonia
5019709|NCT01550419|Ischemic stroke|ischemic stroke
5019710|NCT01550419|Atorvastatin|atorvastatin
5019711|NCT01550419|Morbidity|morbidity
5019712|NCT01550419|Mortality|mortality
5019713|NCT01550406|Pancreatic fistula|pancreatic fistula
5019714|NCT01550406|distal Pancreatectomy|distal pancreatectomy
5019715|NCT01550393|stage II Wilms tumor|stage ii wilms tumor
5019716|NCT01550393|stage III Wilms tumor|stage iii wilms tumor
5019717|NCT01550393|recurrent Wilms tumor and other childhood kidney tumors|recurrent wilms tumor and other childhood kidney tumors
5019718|NCT01550380|Endometrial cancer|endometrial cancer
5019719|NCT01550341|HIV|hiv
5019720|NCT01550341|AIDS|aids
5019721|NCT01550341|Opiate Addiction|opiate addiction
5019722|NCT01550341|Drug Dependence|drug dependence
5019723|NCT01550341|Buprenorphine|buprenorphine
5019724|NCT01550328|Screening for Type 2 diabetes|screening for type 2 diabetes
5019725|NCT01550315|POTS|pots
5019726|NCT01550315|endothelial function|endothelial function
5019727|NCT01550315|high salt vs low salt diet|high salt vs low salt diet
5019728|NCT01550315|PAT protocol|pat protocol
5019729|NCT01550315|Calf blood flow|calf blood flow
5019730|NCT01550315|forearm mediated dilation|forearm mediated dilation
5019731|NCT01550302|Superficial Cervical Plexus Block|superficial cervical plexus block
5019732|NCT01550302|Thoracic Surgery|thoracic surgery
5019733|NCT01550302|Thoracotomy|thoracotomy
5019734|NCT01550302|Video-Assisted Thoracoscopic Surgery|video-assisted thoracoscopic surgery
5019735|NCT01550289|Dengue Fever|dengue fever
5019736|NCT01550289|Dengue Hemorrhagic Fever|dengue hemorrhagic fever
5019737|NCT01550289|CYD Dengue Vaccine|cyd dengue vaccine
5019738|NCT01550289|Dengue Virus|dengue virus
5019739|NCT01550289|Flavivirus|flavivirus
5019740|NCT01550276|Effectiveness|effectiveness
5019741|NCT01550276|Tension-type headache|tension-type headache
5019742|NCT01550276|Manual therapy|manual therapy
5019743|NCT01550263|Hip Preservation|hip preservation
5019744|NCT01550263|Hip Arthroscopy|hip arthroscopy
5019745|NCT01550263|Hip Pain|hip pain
5019746|NCT01550263|Psychological distress|psychological distress
5019747|NCT01550250|Breast cancer|breast cancer
5019748|NCT01550250|Arm lymphedema|arm lymphedema
5019749|NCT01550250|Compression therapy|compression therapy
5019750|NCT01550237|radiotherapy, image-guided|radiotherapy, image-guided
5019751|NCT01550237|adverse effects|adverse effects
5019752|NCT01550237|position verification|position verification
5019753|NCT01550237|safety margins|safety margins
5019754|NCT01550198|newborn|newborn
5019755|NCT01550198|shock|shock
5019756|NCT01550198|hemodynamics|hemodynamics
5019757|NCT01550198|cardiac output|cardiac output
5019758|NCT01550198|blood pressure|blood pressure
5019759|NCT01550172|dementia caregivers|dementia caregivers
5019760|NCT01550172|caregivers|caregivers
5019761|NCT01550172|Alzheimer's caregivers|alzheimer's caregivers
5019762|NCT01550172|caregiver sleep|caregiver sleep
5019763|NCT01550172|heart disease risk|heart disease risk
5019764|NCT01550172|dementia|dementia
5019765|NCT01550172|Alzheimer's Disease|alzheimer's disease
5019766|NCT01550159|Postoperative Cognitive Dysfunction|postoperative cognitive dysfunction
5019767|NCT01550159|Cardiac Surgery|cardiac surgery
5019768|NCT01550159|General Anesthesia|general anesthesia
5019769|NCT01550159|Neuropsychological Tests|neuropsychological tests
5019770|NCT01550146|Fractured neck of femur|fractured neck of femur
5019771|NCT01550146|Dexamethasone|dexamethasone
5019772|NCT01550133|Peptides|peptides
5019773|NCT01550133|Hormones|hormones
5019774|NCT01550133|Appetite|appetite
5019775|NCT01550133|Humans|humans
5019776|NCT01550133|Obese|obese
5019777|NCT01550133|Beverage|beverage
5019778|NCT01550133|Solid food|solid food
5019779|NCT01550133|cephalic phase|cephalic phase
5019780|NCT01550120|taste|taste
5019781|NCT01550120|fat|fat
5019782|NCT01550120|threshold|threshold
5019783|NCT01550120|sensitivity|sensitivity
5019784|NCT01550120|human|human
5019785|NCT01550107|Sarcopenia|sarcopenia
5019786|NCT01550107|Allopurinol|allopurinol
5019787|NCT01550107|Xanthine Oxidase|xanthine oxidase
5019788|NCT01550107|MR Spectroscopy|mr spectroscopy
5019789|NCT01550094|obese|obese
5019790|NCT01550094|regional anesthesia|regional anesthesia
5019791|NCT01550094|anesthesia|anesthesia
5019792|NCT01550094|anesthesiology|anesthesiology
5019793|NCT01550094|surgery|surgery
5019794|NCT01550094|foot|foot
5019795|NCT01550094|foot surgery|foot surgery
5019796|NCT01550094|ankle|ankle
5019797|NCT01550094|ankle surgery|ankle surgery
5019799|NCT01550094|orthopedic surgery|orthopedic surgery
5019800|NCT01550094|sports medicine|sports medicine
5019801|NCT01550094|sports medicine surgery|sports medicine surgery
5019802|NCT01550094|Ochsner Hospital|ochsner hospital
5019803|NCT01550094|Ochsner Clinic|ochsner clinic
5019804|NCT01550094|New Orleans|new orleans
5019805|NCT01550094|Louisiana|louisiana
5019806|NCT01550094|Jefferson|jefferson
5019807|NCT01550094|Soberon|soberon
5019808|NCT01550081|exercise intensity|exercise intensity
5019809|NCT01550081|aerobic interval training|aerobic interval training
5019810|NCT01550081|cardiac rehabilitation|cardiac rehabilitation
5019811|NCT01550081|group exercise|group exercise
5019812|NCT01550068|Rheumatic Heart Disease|rheumatic heart disease
5019813|NCT01550055|KRAS wild-type|kras wild-type
5019814|NCT01550055|Metastatic Colorectal Cancer|metastatic colorectal cancer
5019815|NCT01550055|CMAB009 Plus Irinotecan|cmab009 plus irinotecan
5019816|NCT01550055|Phase II/III|phase ii/iii
5019817|NCT01550029|Smoking|smoking
5019818|NCT01550029|Tobacco|tobacco
5019819|NCT01550029|Nicotine|nicotine
5019820|NCT01550029|Bipolar|bipolar
5019821|NCT01550016|dengue warning signs|dengue warning signs
5019822|NCT01550016|latin america|latin america
5019823|NCT01550016|south east asia|south east asia
5019824|NCT01550016|other febrile illnesses|other febrile illnesses
5019825|NCT01550016|dengue classification|dengue classification
5019826|NCT01550003|Cimzia|cimzia
5019827|NCT01550003|JIA|jia
5019828|NCT01550003|Polyarticular|polyarticular
5019829|NCT01550003|Oligoarticular|oligoarticular
5019830|NCT01550003|Enthesitis-related-Arthritis|enthesitis-related-arthritis
5019831|NCT01550003|Juvenile Idiopathic Arthritis|juvenile idiopathic arthritis
5019832|NCT01550003|Juvenile Psoriatic Arthritis|juvenile psoriatic arthritis
5019833|NCT01550003|Certolizumab Pegol|certolizumab pegol
5019834|NCT01550003|PASCAL|pascal
5019835|NCT01550003|CDP870|cdp870
5019836|NCT01549977|Drug Therapy|drug therapy
5019837|NCT01549964|Drug Therapy|drug therapy
5019838|NCT01549951|Metastatic castrate resistant prostate cancer, mCRPC, orteronel, TAK-700, Phase 2, QT, QTc|metastatic castrate resistant prostate cancer, mcrpc, orteronel, tak-700, phase 2, qt, qtc
5019839|NCT01549938|Vitamin D|vitamin d
5019840|NCT01549938|Cholecalciferol|cholecalciferol
5019841|NCT01549938|Respiratory tract infection|respiratory tract infection
5019842|NCT01549912|Rotator Cuff Tears|rotator cuff tears
5019843|NCT01549912|Dislocation|dislocation
5019844|NCT01549912|Shoulder Dislocation|shoulder dislocation
5019845|NCT01549899|Insomnia|insomnia
5019846|NCT01549899|Cognitive|cognitive
5019847|NCT01549899|Behavioral|behavioral
5019848|NCT01549899|Therapy|therapy
5019849|NCT01549899|Internet|internet
5019850|NCT01549899|Depression|depression
5019851|NCT01549899|Substance Use|substance use
5019852|NCT01549899|Post-Tramatic Stress Disorder|post-tramatic stress disorder
5019853|NCT01549886|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
5019854|NCT01549886|Zevalin|zevalin
5019855|NCT01549886|Motexafin Gadolinium|motexafin gadolinium
5019856|NCT01549860|Venous Insufficiency|venous insufficiency
5019857|NCT01549860|Reflux|reflux
5019858|NCT01549860|Lower Extremity Ulcer|lower extremity ulcer
5019859|NCT01549847|Postpoliomyelitis Syndrome|postpoliomyelitis syndrome
5019860|NCT01549847|Piracetam|piracetam
5019861|NCT01549847|L-Carnitine|l-carnitine
5019862|NCT01549808|ADL|adl
5019863|NCT01549808|activities of daily living|activities of daily living
5019864|NCT01549808|level of function|level of function
5019865|NCT01549795|Liver transplantation|liver transplantation
5019866|NCT01549795|Neoadjuvant radio- chemo-therapy|neoadjuvant radio- chemo-therapy
5019867|NCT01549782|Prebiotics|prebiotics
5019868|NCT01549782|Microbiota|microbiota
5019869|NCT01549782|Radiotherapy|radiotherapy
5019870|NCT01549782|Gynaecological Cancer|gynaecological cancer
5019871|NCT01549756|stage 4 stomach cancer|stage 4 stomach cancer
5019872|NCT01549756|stage 4 gastric cancer|stage 4 gastric cancer
5019873|NCT01549717|Early warning score|early warning score
5019874|NCT01549717|Physiological score|physiological score
5019875|NCT01549717|Track and trigger score|track and trigger score
5019876|NCT01549717|Scoring system|scoring system
5019877|NCT01549717|Physiological model|physiological model
5019878|NCT01549717|Monitoring|monitoring
5019879|NCT01549717|Patient monitoring|patient monitoring
5019880|NCT01549717|Wireless monitoring|wireless monitoring
5019881|NCT01549717|Wearable monitor|wearable monitor
5019882|NCT01549704|Total knee arthroplasty|total knee arthroplasty
5019883|NCT01549704|Adductor canal blockade (ACB)|adductor canal blockade (acb)
5019884|NCT01549704|High pain responders|high pain responders
5019885|NCT01549704|US-guided nerve block|us-guided nerve block
5019886|NCT01549691|Premedication|premedication
5019887|NCT01549691|Benzodiazepine|benzodiazepine
5019888|NCT01549691|Anti-anxiety agents|anti-anxiety agents
5019889|NCT01549691|Anxiety|anxiety
5019890|NCT01549691|Surgery|surgery
5019891|NCT01549691|Adult|adult
5019892|NCT01549691|Human|human
5019893|NCT01549678|Plantar fasciitis|plantar fasciitis
5019894|NCT01549678|foot pain|foot pain
5019895|NCT01549678|insoles|insoles
5019896|NCT01549678|foot function|foot function
5019897|NCT01549678|electronic baropodometer|electronic baropodometer
5019898|NCT01549678|plantar pressure|plantar pressure
5019899|NCT01549678|gait analysis|gait analysis
5019900|NCT01549665|Graft-Versus-Host Disease|graft-versus-host disease
5019901|NCT01549665|GVHD|gvhd
5019902|NCT01549665|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
5019903|NCT01549665|Stem Cell Transplantation|stem cell transplantation
5019904|NCT01549665|Allogeneic hematopoietic transplant|allogeneic hematopoietic transplant
5019905|NCT01549665|Mesenchymal Stem Cells|mesenchymal stem cells
5019906|NCT01549665|Unrelated Donors|unrelated donors
5019907|NCT01549665|Cord Blood Stem Cell Transplantation|cord blood stem cell transplantation
5019908|NCT01549639|Propofol|propofol
5019909|NCT01549639|Target controlled infusion|target controlled infusion
5019910|NCT01549639|General anaesthesia|general anaesthesia
5019911|NCT01549626|Flaxseed|flaxseed
5019912|NCT01549626|Women|women
5019913|NCT01549626|Obesity|obesity
5019914|NCT01549626|No smokers|no smokers
5019915|NCT01549574|crizotinib|crizotinib
5019916|NCT01549574|pharmacokinetics|pharmacokinetics
5019917|NCT01549574|esomeprazole|esomeprazole
5019918|NCT01549574|proton pump inhibitor|proton pump inhibitor
5019919|NCT01549574|drug drug interaction|drug drug interaction
5019920|NCT01549574|healthy volunteers|healthy volunteers
5019921|NCT01549561|behavior problems|behavior problems
5019922|NCT01549561|foster care|foster care
5019923|NCT01549561|parent training|parent training
5019924|NCT01549561|youth skills training|youth skills training
5019925|NCT01549548|CML|cml
5019926|NCT01549522|patients or caregivers|patients or caregivers
5019927|NCT01549522|for caregivers, loved one must still be living|for caregivers, loved one must still be living
5019928|NCT01549496|HCV|hcv
5019929|NCT01549496|pharmacokinetics|pharmacokinetics
5019930|NCT01549496|boceprevir|boceprevir
5019931|NCT01549496|hypertension|hypertension
5019932|NCT01549496|amlodipine|amlodipine
5019933|NCT01549496|diltiazem|diltiazem
5019934|NCT01549483|asthma|asthma
5019935|NCT01549483|airway hyperresponsiveness|airway hyperresponsiveness
5019936|NCT01549483|asymptomatic airway hyperresponsiveness|asymptomatic airway hyperresponsiveness
5019937|NCT01549483|small airways|small airways
5019938|NCT01549457|latent tuberculosis|latent tuberculosis
5019939|NCT01549457|text message interventions|text message interventions
5019940|NCT01549457|medication adherence|medication adherence
5019942|NCT01549444|aldosterone|aldosterone
5019943|NCT01549444|neonate|neonate
5019944|NCT01549431|Multiple Myeloma|multiple myeloma
5019945|NCT01549418|Gastrointestinal bleeding|gastrointestinal bleeding
5019946|NCT01549418|Lower gastrointestinal bleeding (LGIB)|lower gastrointestinal bleeding (lgib)
5019947|NCT01549418|Polypectomy|polypectomy
5019948|NCT01549418|Large colorectal polyps|large colorectal polyps
5019949|NCT01549418|ASA|asa
5019950|NCT01549418|Aspirin|aspirin
5019951|NCT01549418|Acetylsalicylic acid|acetylsalicylic acid
5019952|NCT01549418|Colorectal Neoplasms|colorectal neoplasms
5019953|NCT01549418|Intestinal Neoplasms|intestinal neoplasms
5019954|NCT01549418|Gastrointestinal Neoplasms|gastrointestinal neoplasms
5019955|NCT01549418|Digestive System Neoplasms|digestive system neoplasms
5019956|NCT01549418|Neoplasms by Site|neoplasms by site
5019957|NCT01549418|Neoplasms|neoplasms
5019958|NCT01549418|Digestive System Diseases|digestive system diseases
5019959|NCT01549418|Gastrointestinal Diseases|gastrointestinal diseases
5019960|NCT01549418|Colonic Diseases|colonic diseases
5019961|NCT01549418|Intestinal Diseases|intestinal diseases
5019962|NCT01549418|Rectal Diseases|rectal diseases
5019963|NCT01549405|percutanous nephrolitotomy,intercostal nerve block, Ultrasound|percutanous nephrolitotomy,intercostal nerve block, ultrasound
5019964|NCT01549392|dynamic enhanced ct scan|dynamic enhanced ct scan
5019965|NCT01549392|mri spectroscopy|mri spectroscopy
5019966|NCT01549392|recurrent gliomas|recurrent gliomas
5019967|NCT01549379|Head and neck cancer|head and neck cancer
5019968|NCT01549379|Radiation|radiation
5019969|NCT01549379|Chemotherapy|chemotherapy
5019970|NCT01549379|Surgery|surgery
5019971|NCT01549379|Dynamic contrast enhanced computed tomography|dynamic contrast enhanced computed tomography
5019972|NCT01549340|Rhinitis|rhinitis
5019973|NCT01549340|Allergen immunotherapy|allergen immunotherapy
5019974|NCT01549327|Virtual Patient Navigation|virtual patient navigation
5019975|NCT01549327|Randomized Clinical Trial|randomized clinical trial
5019976|NCT01549327|Empowerment|empowerment
5019977|NCT01549327|Cost-Effectiveness|cost-effectiveness
5019978|NCT01549327|Cancer Information Preferences|cancer information preferences
5019979|NCT01549314|Cystic fibrosis related bone disease|cystic fibrosis related bone disease
5019980|NCT01549314|Cystic fibrosis|cystic fibrosis
5019981|NCT01549314|Ivacaftor|ivacaftor
5019982|NCT01549249|cone outer segment tips line|cone outer segment tips line
5019983|NCT01549249|inner segment/outer segment junction line|inner segment/outer segment junction line
5019984|NCT01549249|optical coherence tomography|optical coherence tomography
5019985|NCT01549249|epiretinal membrane|epiretinal membrane
5019986|NCT01549236|Chagas Disease|chagas disease
5019987|NCT01549236|Trypanosoma Cruzi|trypanosoma cruzi
5019988|NCT01549236|T.Cruzi|t.cruzi
5019989|NCT01549223|Uterine Atony|uterine atony
5019990|NCT01549223|Hypotension|hypotension
5019991|NCT01549223|Cesarean Delivery|cesarean delivery
5019992|NCT01549223|Hemorrhage|hemorrhage
5019993|NCT01549223|Phenylephrine|phenylephrine
5019994|NCT01549223|Ephedrine|ephedrine
5019995|NCT01549210|gout|gout
5019996|NCT01549210|gouty arthritis|gouty arthritis
5019997|NCT01549197|PTSD|ptsd
5019998|NCT01549184|secondary ITP|secondary itp
5019999|NCT01549184|hydroxychloroquine|hydroxychloroquine
5020000|NCT01549184|Systemic Lupus Erythematosus|systemic lupus erythematosus
5020001|NCT01549171|Human ART|human art
5020002|NCT01549171|Prostacyclin|prostacyclin
5020003|NCT01549171|Iloprost|iloprost
5020004|NCT01549171|Pregnancy|pregnancy
5020005|NCT01549158|loop diuretics|loop diuretics
5020006|NCT01549158|torasemide prolonged release|torasemide prolonged release
5020007|NCT01549158|torasemide immediate release|torasemide immediate release
5020008|NCT01549158|Sutril Neo|sutril neo
5020009|NCT01549158|pharmacodynamic profile of Torasemide-PR|pharmacodynamic profile of torasemide-pr
5020010|NCT01549145|Severe|severe
5020011|NCT01549145|Ongoing|ongoing
5020012|NCT01549145|Unilateral|unilateral
5020013|NCT01549145|present for more than 6 months|present for more than 6 months
5020014|NCT01549132|Clinically significant macular oedema|clinically significant macular oedema
5020015|NCT01549132|Retinal Oximetry|retinal oximetry
5020016|NCT01549132|Spectral imaging|spectral imaging
5020017|NCT01549132|Retinal Laser therapy|retinal laser therapy
5020018|NCT01549132|Intravitreal Anti-VEGF Injection therapy|intravitreal anti-vegf injection therapy
5020019|NCT01549119|HIV-1|hiv-1
5020020|NCT01549119|HIV|hiv
5020021|NCT01549119|immunotherapy|immunotherapy
5020022|NCT01549119|active immunotherapy|active immunotherapy
5020023|NCT01549119|vaccine|vaccine
5020024|NCT01549119|virulence|virulence
5020025|NCT01549119|innate immunity|innate immunity
5020026|NCT01549119|NK cells|nk cells
5020027|NCT01549093|Non-small cell lung cancer|non-small cell lung cancer
5020028|NCT01549093|Endostar|endostar
5020029|NCT01549093|Continued Pumping into|continued pumping into
5020030|NCT01549093|Gemcitabine|gemcitabine
5020031|NCT01549093|Carboplatin|carboplatin
5020032|NCT01549080|traditional chinese medicine and thalassemia|traditional chinese medicine and thalassemia
5020033|NCT01549067|Advanced|advanced
5020034|NCT01549067|Colorectal Cancer|colorectal cancer
5020035|NCT01549067|Targeted chemotherapy|targeted chemotherapy
5020036|NCT01549067|Surgery|surgery
5020037|NCT01549067|Radiotherapy|radiotherapy
5020038|NCT01549041|schizophrenia|schizophrenia
5020039|NCT01549041|asenapine|asenapine
5020040|NCT01549041|Once daily|once daily
5020041|NCT01549041|twice daily|twice daily
5020042|NCT01549015|Urea Cycle Defects|urea cycle defects
5020043|NCT01549015|CPSD|cpsd
5020044|NCT01549015|OTCD|otcd
5020045|NCT01549015|ASSD|assd
5020046|NCT01549015|ASLD|asld
5020047|NCT01549002|Abscess|abscess
5020048|NCT01549002|Pain|pain
5020049|NCT01549002|Administration intranasal|administration intranasal
5020050|NCT01549002|Infusions intravenous|infusions intravenous
5020051|NCT01548989|linguistic validation of a new questionnaire|linguistic validation of a new questionnaire
5020052|NCT01548976|linguistic validation of the PISQ-R questionnaire|linguistic validation of the pisq-r questionnaire
5020053|NCT01548963|Tight glycemia control|tight glycemia control
5020054|NCT01548963|Model Predictive Control algorithm|model predictive control algorithm
5020055|NCT01548963|Cardiac surgery patients|cardiac surgery patients
5020056|NCT01548950|Congenital heart disease|congenital heart disease
5020057|NCT01548950|Pulmonary arterial hypertension|pulmonary arterial hypertension
5020058|NCT01548950|Sildenafil|sildenafil
5020059|NCT01548950|Bosentan|bosentan
5020060|NCT01548950|Pediatric cardiac surgery|pediatric cardiac surgery
5020061|NCT01548937|I-123 ADAM Serotonin transporter imaging|i-123 adam serotonin transporter imaging
5020062|NCT01548924|Patients with malignant solid tumors of any histologically confirmed, not susceptible of cure, which have received the standard treatment available|patients with malignant solid tumors of any histologically confirmed, not susceptible of cure, which have received the standard treatment available
5020063|NCT01548872|HTk solution|htk solution
5020064|NCT01548872|Cardioplegia|cardioplegia
5020065|NCT01548872|myocardial protection|myocardial protection
5020066|NCT01548872|pediatric cardiac surgery|pediatric cardiac surgery
5020067|NCT01548859|Myocardial protection|myocardial protection
5020068|NCT01548859|Myocardial injury|myocardial injury
5020069|NCT01548859|Anaesthetic preconditioning|anaesthetic preconditioning
5020070|NCT01548859|Pediatric cardiac surgery|pediatric cardiac surgery
5020071|NCT01548859|Troponin I|troponin i
5020072|NCT01548859|Sevoflurane|sevoflurane
5020073|NCT01548859|Midazolam|midazolam
5020074|NCT01548846|tomotherapy|tomotherapy
5020075|NCT01548846|xerostomy|xerostomy
5020076|NCT01548846|head and neck squamous cell carcinoma|head and neck squamous cell carcinoma
5020077|NCT01548833|Myopia|myopia
5020078|NCT01548833|Contact Lenses|contact lenses
5020079|NCT01548820|Hepatitis B virus|hepatitis b virus
5020080|NCT01548820|Lamivudine|lamivudine
5020081|NCT01548820|Resistance to treatment|resistance to treatment
5020082|NCT01548794|spinal anesthesia|spinal anesthesia
5020083|NCT01548794|bupivacaine|bupivacaine
5020084|NCT01548794|lidocaine|lidocaine
5020085|NCT01548794|local infiltration anesthesia|local infiltration anesthesia
5020086|NCT01548794|recovery|recovery
5020087|NCT01548794|duration of anesthesia|duration of anesthesia
5020286|NCT01547988|Dual-Task|dual-task
5020088|NCT01548794|outpatient herniorrhaphy|outpatient herniorrhaphy
5020089|NCT01548781|arm|arm
5020090|NCT01548781|strength|strength
5020091|NCT01548781|coordination|coordination
5020092|NCT01548781|physical therapy|physical therapy
5020093|NCT01548781|robotics|robotics
5020094|NCT01548781|stroke|stroke
5020095|NCT01548781|synergy|synergy
5020096|NCT01548768|Rheumatoid Arthritis|rheumatoid arthritis
5020097|NCT01548768|Cardiovascular disease|cardiovascular disease
5020098|NCT01548768|Myocardium|myocardium
5020099|NCT01548768|TNF-alpha inhibitors|tnf-alpha inhibitors
5020100|NCT01548768|ESCAPE|escape
5020101|NCT01548768|Co-morbidities|co-morbidities
5020102|NCT01548768|RHYTHM|rhythm
5020103|NCT01548755|Home monitoring|home monitoring
5020104|NCT01548755|cardiomessenger|cardiomessenger
5020105|NCT01548755|ICD|icd
5020106|NCT01548742|Meditation|meditation
5020107|NCT01548729|Cystic Fibrosis|cystic fibrosis
5020108|NCT01548729|Diabetes Related Cystic Fibrosis|diabetes related cystic fibrosis
5020109|NCT01548729|Lung transplantation|lung transplantation
5020110|NCT01548729|Pancreatic islets|pancreatic islets
5020111|NCT01548716|Pruritis in hemodialysis patients|pruritis in hemodialysis patients
5020112|NCT01548716|25-Vitamin D in chronic kidney disease|25-vitamin d in chronic kidney disease
5020113|NCT01548703|metabotropic glutamate receptors 2 and 3|metabotropic glutamate receptors 2 and 3
5020114|NCT01548703|antagonist|antagonist
5020115|NCT01548703|mGluR|mglur
5020116|NCT01548703|ketamine|ketamine
5020117|NCT01548703|BDNF|bdnf
5020118|NCT01548703|Depression|depression
5020119|NCT01548703|Major Depressive Disorder|major depressive disorder
5020120|NCT01548703|Treatment Resistant Depression|treatment resistant depression
5020121|NCT01548703|Mood Disorder|mood disorder
5020122|NCT01548703|Phase 1 safety, tolerability and pharmacokinetics study|phase 1 safety, tolerability and pharmacokinetics study
5020123|NCT01548690|ornithine|ornithine
5020124|NCT01548690|phenylacetate|phenylacetate
5020125|NCT01548690|acetaminophen toxicity|acetaminophen toxicity
5020126|NCT01548690|acute liver failure|acute liver failure
5020127|NCT01548690|hepatitis B|hepatitis b
5020128|NCT01548690|autoimmune hepatitis|autoimmune hepatitis
5020129|NCT01548690|drug-induced liver injury|drug-induced liver injury
5020130|NCT01548677|Circulating Tumour Cells|circulating tumour cells
5020131|NCT01548677|HER2 negative primary breast cancer|her2 negative primary breast cancer
5020132|NCT01548677|HER2 positive CTC|her2 positive ctc
5020133|NCT01548677|Trastuzumab|trastuzumab
5020134|NCT01548664|Total knee replacement|total knee replacement
5020135|NCT01548664|Outpatient|outpatient
5020136|NCT01548664|Randomized controlled trial|randomized controlled trial
5020137|NCT01548664|Video games|video games
5020138|NCT01548638|Tobacco|tobacco
5020139|NCT01548638|Smoking|smoking
5020140|NCT01548638|Galantamine|galantamine
5020141|NCT01548625|risk of cardiovascular events|risk of cardiovascular events
5020142|NCT01548612|Schizophrenia|schizophrenia
5020143|NCT01548612|Nitric oxide|nitric oxide
5020144|NCT01548612|Sodium nitroprusside|sodium nitroprusside
5020145|NCT01548599|HIV|hiv
5020146|NCT01548599|Malnutrition|malnutrition
5020147|NCT01548599|Food Security|food security
5020148|NCT01548599|Kenya|kenya
5020149|NCT01548586|tDCS|tdcs
5020150|NCT01548586|Diaphragm|diaphragm
5020151|NCT01548586|Cortical Excitability|cortical excitability
5020152|NCT01548586|MEPs|meps
5020153|NCT01548586|TMS|tms
5020154|NCT01548573|multiple myeloma|multiple myeloma
5020155|NCT01548573|POEMS (Polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy, and skin changes)|poems (polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy, and skin changes)
5020156|NCT01548573|amyloidosis|amyloidosis
5020157|NCT01548573|bone marrow transplant|bone marrow transplant
5020158|NCT01548573|autologous|autologous
5020159|NCT01548560|HIV Infections|hiv infections
5020160|NCT01548560|Anti-HIV agents|anti-hiv agents
5020161|NCT01548560|HIV-1|hiv-1
5020162|NCT01548547|intravenous line|intravenous line
5020163|NCT01548547|simulation education|simulation education
5020164|NCT01548534|Metastatic Breast Cancer|metastatic breast cancer
5020165|NCT01548534|First-Line chemotherapy|first-line chemotherapy
5020166|NCT01548534|Taxane or Anthracycline|taxane or anthracycline
5020167|NCT01548534|DHA|dha
5020168|NCT01548534|PUFA|pufa
5020169|NCT01548534|Dietary supplementation|dietary supplementation
5020170|NCT01548534|First-Line Taxane or Anthracycline based chemotherapy|first-line taxane or anthracycline based chemotherapy
5020171|NCT01548521|Prader-Willi, neonates, poor suckling|prader-willi, neonates, poor suckling
5020172|NCT01548508|Advanced Chronic Heart Failure, physical therapy, Exercise|advanced chronic heart failure, physical therapy, exercise
5020173|NCT01548495|MDS|mds
5020174|NCT01548495|Autoantibodies|autoantibodies
5020175|NCT01548495|Erythropoietin|erythropoietin
5020176|NCT01548495|Autoantibodies in MDS patients treated with EPO|autoantibodies in mds patients treated with epo
5020177|NCT01548469|Mild periodontitis|mild periodontitis
5020178|NCT01548469|Bio Mineral toothpaste|bio mineral toothpaste
5020179|NCT01548469|Geumjin Thermal Water|geumjin thermal water
5020180|NCT01548456|femur fracture|femur fracture
5020181|NCT01548456|internal fixation|internal fixation
5020182|NCT01548456|intramedullary nailing|intramedullary nailing
5020183|NCT01548443|Wound Healing|wound healing
5020184|NCT01548443|hydrocolloid|hydrocolloid
5020185|NCT01548443|Wound Dressing|wound dressing
5020186|NCT01548443|Medifoam H|medifoam h
5020187|NCT01548443|Duoderm THIN|duoderm thin
5020188|NCT01548443|Mild Acute Trauma|mild acute trauma
5020189|NCT01548417|Alcohol|alcohol
5020190|NCT01548417|Relapse|relapse
5020191|NCT01548378|HGF|hgf
5020192|NCT01548378|Gene|gene
5020193|NCT01548378|Critical Limb Ischemia|critical limb ischemia
5020194|NCT01548365|Nursing Services|nursing services
5020195|NCT01548365|Catheterization, Central Venous|catheterization, central venous
5020196|NCT01548365|Catheters Indwelling|catheters indwelling
5020197|NCT01548365|Catheterization, Peripheral|catheterization, peripheral
5020198|NCT01548352|Syncope|syncope
5020199|NCT01548352|Unconsciousness|unconsciousness
5020200|NCT01548352|Syncope, vasovagal, neurally-mediated|syncope, vasovagal, neurally-mediated
5020201|NCT01548352|Syncope, cardiogenic|syncope, cardiogenic
5020202|NCT01548352|Cardiac arrhythmia|cardiac arrhythmia
5020203|NCT01548352|Sudden cardiac death|sudden cardiac death
5020204|NCT01548352|Syncopal episode|syncopal episode
5020205|NCT01548326|Vaccination Failure|vaccination failure
5020206|NCT01548326|Nonresponder|nonresponder
5020207|NCT01548326|Hepatitis B virus|hepatitis b virus
5020208|NCT01548326|Atorvastatin|atorvastatin
5020209|NCT01548326|Immunization against viral Hepatitis|immunization against viral hepatitis
5020210|NCT01548313|human milk|human milk
5020211|NCT01548313|nutrition|nutrition
5020212|NCT01548313|breastfed child|breastfed child
5020213|NCT01548313|microbiota|microbiota
5020214|NCT01548313|fatty acids|fatty acids
5020215|NCT01548313|intestinal microbiota|intestinal microbiota
5020216|NCT01548313|probiotics|probiotics
5020217|NCT01548300|cardiometabolic disease|cardiometabolic disease
5020218|NCT01548287|Mild Cognitive Impairment|mild cognitive impairment
5020219|NCT01548287|Mild Alzheimer's disease|mild alzheimer's disease
5020220|NCT01548287|Safety|safety
5020221|NCT01548287|Tolerability|tolerability
5020222|NCT01548274|endothelial progenitor cells|endothelial progenitor cells
5020223|NCT01548261|obtain the oral mucosal tissue from healthy donors|obtain the oral mucosal tissue from healthy donors
5020224|NCT01548222|type 2 diabetes|type 2 diabetes
5020225|NCT01548222|continuous glucose|continuous glucose
5020226|NCT01548222|basal insulin|basal insulin
5020227|NCT01548196|nephrolithotomy|nephrolithotomy
5020228|NCT01548170|Pharmacokinetic|pharmacokinetic
5020229|NCT01548170|Sunitinib|sunitinib
5020230|NCT01548170|Ketoconazol|ketoconazol
5020231|NCT01548170|interaction, Phase I|interaction, phase i
5020232|NCT01548157|HCP1007|hcp1007
5020233|NCT01548157|Rosuvastatin|rosuvastatin
5020234|NCT01548157|Omega-3|omega-3
5020235|NCT01548144|Advanced Cancers|advanced cancers
5020236|NCT01548144|Advanced Malignancies|advanced malignancies
5020237|NCT01548144|Crizotinib|crizotinib
5020238|NCT01548144|PF-02341066|pf-02341066
5020239|NCT01548144|Pazopanib|pazopanib
5020240|NCT01548144|Gw786034|gw786034
5020241|NCT01548144|Pemetrexed|pemetrexed
5020242|NCT01548144|LY231514|ly231514
5020243|NCT01548144|Alimta|alimta
5020244|NCT01548144|MTA|mta
5020245|NCT01548144|Multitargeted Antifolate|multitargeted antifolate
5020246|NCT01548144|NSC-698037|nsc-698037
5020247|NCT01548131|fear of childbirth|fear of childbirth
5020248|NCT01548131|delivery mode|delivery mode
5020249|NCT01548131|delivery satisfaction|delivery satisfaction
5020250|NCT01548118|Human papillomavirus|human papillomavirus
5020251|NCT01548118|vaccine|vaccine
5020252|NCT01548118|cervical infection|cervical infection
5020253|NCT01548118|cervical cancer|cervical cancer
5020254|NCT01548105|Pelvic organ prolapse|pelvic organ prolapse
5020255|NCT01548105|smoking and collagen metabolism|smoking and collagen metabolism
5020256|NCT01548092|Recto-vaginal fistula|recto-vaginal fistula
5020257|NCT01548092|Adipose Derived Stem Cells|adipose derived stem cells
5020258|NCT01548079|ursodeoxycholic acid|ursodeoxycholic acid
5020259|NCT01548079|fatty liver disease|fatty liver disease
5020260|NCT01548079|morbid obesity|morbid obesity
5020261|NCT01548079|bariatric surgery|bariatric surgery
5020262|NCT01548079|NAFLD|nafld
5020263|NCT01548053|Primary care|primary care
5020264|NCT01548053|Dementia|dementia
5020265|NCT01548053|Knowledge translation|knowledge translation
5020266|NCT01548053|Quality of care|quality of care
5020267|NCT01548053|Qualitative methods|qualitative methods
5020268|NCT01548053|Alzheimer's disease|alzheimer's disease
5020269|NCT01548040|NMES|nmes
5020270|NCT01548040|Muscle|muscle
5020271|NCT01548040|strength|strength
5020272|NCT01548040|TKA|tka
5020273|NCT01548040|Focus to show shorter muscle recovery after Knee operation|focus to show shorter muscle recovery after knee operation
5020274|NCT01548027|TAP block|tap block
5020275|NCT01548027|postoperative analgesia|postoperative analgesia
5020276|NCT01548014|Crohn's disease|crohn's disease
5020277|NCT01548014|VSL #3|vsl #3
5020278|NCT01548014|infliximab|infliximab
5020279|NCT01548001|Rheumatoid Arthritis|rheumatoid arthritis
5020280|NCT01548001|Iguratimod|iguratimod
5020281|NCT01548001|Methotrexate|methotrexate
5020282|NCT01547988|Aging|aging
5020283|NCT01547988|Falls|falls
5020284|NCT01547988|Balance Control|balance control
5020285|NCT01547988|Voluntary Step Execution Test|voluntary step execution test
5020287|NCT01547988|Self-reported function|self-reported function
5020288|NCT01547975|surgical outcomes after corneal transplantation|surgical outcomes after corneal transplantation
5020289|NCT01547975|Retrospective analysis|retrospective analysis
5020290|NCT01547975|corneal transplantation|corneal transplantation
5020291|NCT01547949|pain|pain
5020292|NCT01547949|inflammation|inflammation
5020293|NCT01547949|muscle damage|muscle damage
5020294|NCT01547923|Colorectal Cancer|colorectal cancer
5020295|NCT01547923|DihydroPyrimidine Dehydrogenase|dihydropyrimidine dehydrogenase
5020296|NCT01547923|Lethal toxicity|lethal toxicity
5020297|NCT01547923|Fluoropyrimidine|fluoropyrimidine
5020298|NCT01547910|fatty liver|fatty liver
5020299|NCT01547910|hepatitis|hepatitis
5020300|NCT01547910|insulin resistance|insulin resistance
5020301|NCT01547910|unsaturated fatty acids|unsaturated fatty acids
5020302|NCT01547910|NAFLD, children|nafld, children
5020303|NCT01547884|Immune Responses|immune responses
5020304|NCT01547884|Mycobacterial Antigens|mycobacterial antigens
5020305|NCT01547884|Tissue-invasive Helminth Parasites|tissue-invasive helminth parasites
5020306|NCT01547871|Natural History Study|natural history study
5020435|NCT01547468|Ochsner Clinic|ochsner clinic
5020307|NCT01547871|Spinal Muscular Atrophy (SMA)|spinal muscular atrophy (sma)
5020308|NCT01547871|Natural History|natural history
5020309|NCT01547858|Hematotoxicity|hematotoxicity
5020310|NCT01547858|Formaldehyde|formaldehyde
5020311|NCT01547858|Cross-Sectional Study|cross-sectional study
5020312|NCT01547858|Occupational Exposure|occupational exposure
5020313|NCT01547845|Disparities|disparities
5020314|NCT01547845|Patient Reported Outcomes|patient reported outcomes
5020315|NCT01547845|Symptoms|symptoms
5020316|NCT01547845|Symptom Surveillance|symptom surveillance
5020317|NCT01547832|Cholesterol|cholesterol
5020318|NCT01547832|Early Onset Parkinson's Disease|early onset parkinson's disease
5020319|NCT01547832|Fat Metabolism|fat metabolism
5020320|NCT01547832|Insulin Resistance|insulin resistance
5020321|NCT01547832|PARK2 Mutations|park2 mutations
5020322|NCT01547819|TBI|tbi
5020323|NCT01547819|Magnetic Resonance Imaging (MRI)|magnetic resonance imaging (mri)
5020324|NCT01547819|PTSD|ptsd
5020325|NCT01547819|PET Imaging|pet imaging
5020326|NCT01547819|11C-Flumazenil|11c-flumazenil
5020327|NCT01547806|Autologous Hematopoietic Cell Transplantation|autologous hematopoietic cell transplantation
5020328|NCT01547806|Plasma Cell Myeloma|plasma cell myeloma
5020329|NCT01547806|Mobilization|mobilization
5020330|NCT01547806|Apheresis|apheresis
5020331|NCT01547806|Plerixafor|plerixafor
5020332|NCT01547793|Hemolytic Severity|hemolytic severity
5020333|NCT01547793|Erythrocyte|erythrocyte
5020334|NCT01547793|Sickle Cell Disease|sickle cell disease
5020335|NCT01547793|SD|sd
5020336|NCT01547780|MRI|mri
5020337|NCT01547780|Positron Emission Tomograhy (PET)|positron emission tomograhy (pet)
5020338|NCT01547780|Inflammation|inflammation
5020339|NCT01547780|Microglial Activation|microglial activation
5020340|NCT01547780|Traumatic Brain Injury|traumatic brain injury
5020341|NCT01547780|TBI|tbi
5020342|NCT01547767|Metabolism|metabolism
5020343|NCT01547767|Muscle|muscle
5020344|NCT01547767|Mutation|mutation
5020345|NCT01547767|ISCU Myopathy|iscu myopathy
5020346|NCT01547767|Myopathy|myopathy
5020347|NCT01547754|Neuroinflammation|neuroinflammation
5020348|NCT01547754|HIV|hiv
5020349|NCT01547754|Positron Emission Tomograhy (PET)|positron emission tomograhy (pet)
5020350|NCT01547754|Mild Neurocognitive Disorder|mild neurocognitive disorder
5020351|NCT01547754|P-Glycoprotein|p-glycoprotein
5020352|NCT01547754|Mild Cognitive Disorder|mild cognitive disorder
5020353|NCT01547754|Healthy Volunteer|healthy volunteer
5020354|NCT01547754|HV|hv
5020355|NCT01547741|estrogen receptor-negative breast cancer|estrogen receptor-negative breast cancer
5020356|NCT01547741|estrogen receptor-positive breast cancer|estrogen receptor-positive breast cancer
5020357|NCT01547741|HER2-negative breast cancer|her2-negative breast cancer
5020358|NCT01547741|progesterone receptor-negative breast cancer|progesterone receptor-negative breast cancer
5020359|NCT01547741|progesterone receptor-positive breast cancer|progesterone receptor-positive breast cancer
5020360|NCT01547741|stage IA breast cancer|stage ia breast cancer
5020361|NCT01547741|stage IB breast cancer|stage ib breast cancer
5020362|NCT01547741|stage II breast cancer|stage ii breast cancer
5020363|NCT01547741|stage IIIA breast cancer|stage iiia breast cancer
5020364|NCT01547741|stage IIIC breast cancer|stage iiic breast cancer
5020365|NCT01547728|antithrombin|antithrombin
5020366|NCT01547728|Heparin Resistant|heparin resistant
5020367|NCT01547728|Cardiac Surgery|cardiac surgery
5020368|NCT01547715|Meningococcal,|meningococcal,
5020369|NCT01547715|ACWY,|acwy,
5020370|NCT01547715|bacterial meningitis,|bacterial meningitis,
5020371|NCT01547715|conjugate vaccine,|conjugate vaccine,
5020372|NCT01547715|healthy, children,|healthy, children,
5020373|NCT01547715|adolescents,|adolescents,
5020374|NCT01547715|adults,|adults,
5020375|NCT01547715|India|india
5020376|NCT01547702|ADHD|adhd
5020377|NCT01547702|attention|attention
5020378|NCT01547702|inattention|inattention
5020379|NCT01547702|hyperactivity|hyperactivity
5020380|NCT01547702|classroom intervention|classroom intervention
5020381|NCT01547702|teacher education|teacher education
5020382|NCT01547702|web-based intervention|web-based intervention
5020383|NCT01547663|pain scale|pain scale
5020384|NCT01547663|craniotomy|craniotomy
5020385|NCT01547637|Obturator nerve block|obturator nerve block
5020386|NCT01547637|Regional anesthesia|regional anesthesia
5020387|NCT01547637|TURBT|turbt
5020388|NCT01547624|Neck|neck
5020389|NCT01547624|Spine|spine
5020390|NCT01547624|Muscles|muscles
5020391|NCT01547624|Activity|activity
5020392|NCT01547624|Coordination|coordination
5020393|NCT01547611|Rehabilitation|rehabilitation
5020394|NCT01547611|Cervical Spine|cervical spine
5020395|NCT01547611|Radiculopathy|radiculopathy
5020396|NCT01547611|Disc|disc
5020397|NCT01547611|Surgery|surgery
5020398|NCT01547585|Cholesterol|cholesterol
5020399|NCT01547585|Cardiovascular disease|cardiovascular disease
5020400|NCT01547585|Soy|soy
5020401|NCT01547585|Dose-response|dose-response
5020402|NCT01547572|Video education|video education
5020403|NCT01547572|Enhanced recovery|enhanced recovery
5020404|NCT01547572|Reducing hospital stay|reducing hospital stay
5020405|NCT01547572|Improving patient satisfaction|improving patient satisfaction
5020406|NCT01547533|Chagas disease|chagas disease
5020407|NCT01547533|lactation|lactation
5020408|NCT01547533|breastmilk|breastmilk
5020409|NCT01547533|postpartum period|postpartum period
5020410|NCT01547533|infants|infants
5020411|NCT01547533|pediatric clinical pharmacology|pediatric clinical pharmacology
5020412|NCT01547533|developmental clinical pharmacology|developmental clinical pharmacology
5020413|NCT01547533|parasitology|parasitology
5020414|NCT01547533|trypanosoma cruzi|trypanosoma cruzi
5020415|NCT01547520|meperidine|meperidine
5020416|NCT01547520|esophagogastroduodenoscopy|esophagogastroduodenoscopy
5020417|NCT01547520|unsedated|unsedated
5020418|NCT01547520|minimal sedation|minimal sedation
5020419|NCT01547507|hemodynamics|hemodynamics
5020420|NCT01547507|respiratory|respiratory
5020421|NCT01547494|Migraines|migraines
5020422|NCT01547494|Diet, Vegetarian|diet, vegetarian
5020423|NCT01547494|Diet, Fat-Restricted|diet, fat-restricted
5020424|NCT01547494|Pain|pain
5020425|NCT01547468|hip fracture|hip fracture
5020426|NCT01547468|elderly|elderly
5020427|NCT01547468|delirium|delirium
5020428|NCT01547468|broken hip|broken hip
5020429|NCT01547468|hip|hip
5020430|NCT01547468|surgery|surgery
5020431|NCT01547468|orthopedic|orthopedic
5020432|NCT01547468|orthopedic surgery|orthopedic surgery
5020433|NCT01547468|pain|pain
5020434|NCT01547468|anesthesia|anesthesia
5020436|NCT01547468|Ochsner Hospital|ochsner hospital
5020437|NCT01547468|Leslie Thomas MD|leslie thomas md
5020438|NCT01547468|New Orleans|new orleans
5020439|NCT01547468|Louisiana|louisiana
5020440|NCT01547455|Statin|statin
5020441|NCT01547455|kidney function|kidney function
5020442|NCT01547455|antiinflammatory effect|antiinflammatory effect
5020443|NCT01547442|aphakia|aphakia
5020444|NCT01547442|secondary intraocular lens|secondary intraocular lens
5020445|NCT01547442|congenital cataract|congenital cataract
5020446|NCT01547442|marfan syndrome|marfan syndrome
5020447|NCT01547442|pediatric cataract|pediatric cataract
5020448|NCT01547442|ectopia lentis|ectopia lentis
5020449|NCT01547442|subluxated lens|subluxated lens
5020450|NCT01547429|aphakia|aphakia
5020451|NCT01547429|secondary intraocular lens|secondary intraocular lens
5020452|NCT01547416|Diaphragmatic dysfunction|diaphragmatic dysfunction
5020453|NCT01547416|General anesthesia|general anesthesia
5020454|NCT01547416|Epidural Anesthesia|epidural anesthesia
5020455|NCT01547403|Screening for Type 2 Diabetes|screening for type 2 diabetes
5020456|NCT01547390|preeclampsia|preeclampsia
5020457|NCT01547390|Aspirin|aspirin
5020458|NCT01547377|atherosclerosis|atherosclerosis
5020459|NCT01547377|zinc and selenium status|zinc and selenium status
5020460|NCT01547377|rosuvastatin|rosuvastatin
5020461|NCT01547377|oxidative stress biomarkers|oxidative stress biomarkers
5020462|NCT01547377|inflammation biomarkers|inflammation biomarkers
5020463|NCT01547364|Caudal|caudal
5020464|NCT01547364|Epidural|epidural
5020465|NCT01547364|Dextrose|dextrose
5020466|NCT01547364|Analgesia|analgesia
5020467|NCT01547364|TRVP1|trvp1
5020468|NCT01547351|Relapse in multiple sclerosis|relapse in multiple sclerosis
5020469|NCT01547351|Psychometric properties of the patient self-report questionnaire|psychometric properties of the patient self-report questionnaire
5020470|NCT01547351|Evaluation of ARMS questionnaire|evaluation of arms questionnaire
5020471|NCT01547338|Breast|breast
5020472|NCT01547338|Reconstruction|reconstruction
5020473|NCT01547299|prostate cancer|prostate cancer
5020474|NCT01547299|prostatectomy|prostatectomy
5020475|NCT01547299|neoadjuvant|neoadjuvant
5020476|NCT01547286|Asthma|asthma
5020477|NCT01547286|Allergen Challenge|allergen challenge
5020478|NCT01547286|Cat allergen|cat allergen
5020479|NCT01547286|Dust mite allergen|dust mite allergen
5020480|NCT01547286|Airway Hyper-responsiveness|airway hyper-responsiveness
5020481|NCT01547286|Positron Emission Tomography - Computed Tomography|positron emission tomography - computed tomography
5020482|NCT01547286|Nitrogen isotopes|nitrogen isotopes
5020483|NCT01547286|Blood flow|blood flow
5020484|NCT01547247|colonoscopy|colonoscopy
5020485|NCT01547247|cap-assisted colonoscopy|cap-assisted colonoscopy
5020486|NCT01547247|water immersion colonoscopy|water immersion colonoscopy
5020487|NCT01547234|Multiple Sclerosis|multiple sclerosis
5020488|NCT01547234|ambulation|ambulation
5020489|NCT01547234|manual function|manual function
5020490|NCT01547234|Fampridine|fampridine
5020491|NCT01547221|otomycosis|otomycosis
5020492|NCT01547221|3% boric acid|3% boric acid
5020493|NCT01547221|1% clotrimazole ear drop|1% clotrimazole ear drop
5020494|NCT01547208|ICD shocks|icd shocks
5020495|NCT01547208|Ventricular tachycardias ablation|ventricular tachycardias ablation
5020496|NCT01547208|Timing of ablation|timing of ablation
5020497|NCT01547208|Electrical storm|electrical storm
5020498|NCT01547208|Arrhythmic storm|arrhythmic storm
5020499|NCT01547195|fibromyalgia|fibromyalgia
5020500|NCT01547195|swimming|swimming
5020501|NCT01547169|memory|memory
5020502|NCT01547169|intranasal insulin|intranasal insulin
5020503|NCT01547169|Alzheimer's disease|alzheimer's disease
5020504|NCT01547156|patient decision support|patient decision support
5020505|NCT01547156|telemonitoring|telemonitoring
5020506|NCT01547156|self-management|self-management
5020507|NCT01547156|remote patient monitoring|remote patient monitoring
5020508|NCT01547156|active assistance technology|active assistance technology
5020509|NCT01547156|selfcare|selfcare
5020510|NCT01547143|Secondary hemophagocytic lymphohistiocytosis of adults|secondary hemophagocytic lymphohistiocytosis of adults
5020511|NCT01547130|Colonoscopy|colonoscopy
5020512|NCT01547130|Yoga|yoga
5020513|NCT01547130|Complementary and alternative medicine|complementary and alternative medicine
5020514|NCT01547130|Bowel cleansing|bowel cleansing
5020515|NCT01547130|Large bowel preparation|large bowel preparation
5020516|NCT01547130|Cancer screening|cancer screening
5020517|NCT01547130|Colorectal cancer|colorectal cancer
5020518|NCT01547117|POTS|pots
5020519|NCT01547117|Orthostatic Intolerance|orthostatic intolerance
5020520|NCT01547117|Orthostatic Tachycardia|orthostatic tachycardia
5020521|NCT01547091|Mesenchymal Stem Cells|mesenchymal stem cells
5020522|NCT01547091|Rheumatoid Arthritis|rheumatoid arthritis
5020523|NCT01547065|TEE and renal resistive index|tee and renal resistive index
5020524|NCT01547052|DBT, child, emotion regulation, behavior problems|dbt, child, emotion regulation, behavior problems
5020525|NCT01547039|Carotid endarterectomy|carotid endarterectomy
5020526|NCT01547039|Transcranial doppler|transcranial doppler
5020527|NCT01547039|Micro embolic signals|micro embolic signals
5020528|NCT01547039|Platelets|platelets
5020529|NCT01547039|Aspirin|aspirin
5020530|NCT01547026|schizophrenia|schizophrenia
5020531|NCT01547026|exercise|exercise
5020532|NCT01547026|sport|sport
5020533|NCT01547026|weight control|weight control
5020534|NCT01547026|fitness|fitness
5020535|NCT01547000|Tourette Syndrome|tourette syndrome
5020536|NCT01547000|Tourette Disorder|tourette disorder
5020537|NCT01547000|Tics|tics
5020538|NCT01547000|Motor tics|motor tics
5020539|NCT01547000|Vocal tics|vocal tics
5020540|NCT01547000|Intuniv|intuniv
5020541|NCT01547000|Guanfacine|guanfacine
5020542|NCT01547000|Medication|medication
5020543|NCT01547000|Drug|drug
5020544|NCT01547000|Placebo|placebo
5020545|NCT01547000|Child|child
5020546|NCT01547000|Children|children
5020547|NCT01547000|Adolescent|adolescent
5020548|NCT01546987|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5020549|NCT01546987|stage I prostate cancer|stage i prostate cancer
5020550|NCT01546987|stage IIA prostate cancer|stage iia prostate cancer
5020551|NCT01546987|stage IIB prostate cancer|stage iib prostate cancer
5020552|NCT01546987|stage III prostate cancer|stage iii prostate cancer
5020553|NCT01546987|stage IV prostate cancer|stage iv prostate cancer
5020554|NCT01546974|Mechanical Ventilation|mechanical ventilation
5020555|NCT01546974|Humidification system|humidification system
5020556|NCT01546974|Patients submitted to mechanical ventilation for at least 48 hours|patients submitted to mechanical ventilation for at least 48 hours
5020557|NCT01546961|Chloroquine|chloroquine
5020558|NCT01546961|Uncomplicated vivax malaria|uncomplicated vivax malaria
5020559|NCT01546948|Methadone|methadone
5020560|NCT01546948|Hydromorphone|hydromorphone
5020561|NCT01546948|Hepatobiliary surgery|hepatobiliary surgery
5020562|NCT01546948|Postoperative pain|postoperative pain
5020563|NCT01546935|Influenza|influenza
5020564|NCT01546935|Oseltamivir|oseltamivir
5020565|NCT01546935|Lower tract respiratory infection|lower tract respiratory infection
5020566|NCT01546922|Hydrocortisone|hydrocortisone
5020567|NCT01546922|Cognition|cognition
5020568|NCT01546922|Adrenal insufficiency|adrenal insufficiency
5020569|NCT01546922|Quality of Life|quality of life
5020570|NCT01546922|Common Somatic Complaints|common somatic complaints
5020571|NCT01546922|Cardiovascular/Metabolic Profile|cardiovascular/metabolic profile
5020572|NCT01546922|Somatosensation|somatosensation
5020573|NCT01546883|Atrial fibrillation|atrial fibrillation
5020574|NCT01546883|MRI|mri
5020575|NCT01546857|orthopedic pain|orthopedic pain
5020576|NCT01546844|SMS|sms
5020577|NCT01546844|text|text
5020578|NCT01546844|text messages|text messages
5020579|NCT01546844|text messaging|text messaging
5020580|NCT01546844|diabetes|diabetes
5020581|NCT01546844|diabetes mellitus|diabetes mellitus
5020582|NCT01546844|type II diabetes|type ii diabetes
5020583|NCT01546844|type II diabetes mellitus|type ii diabetes mellitus
5020584|NCT01546844|type 2 diabetes|type 2 diabetes
5020585|NCT01546844|type 2 diabetes mellitus|type 2 diabetes mellitus
5020586|NCT01546844|Beacon|beacon
5020587|NCT01546818|HIV|hiv
5020588|NCT01546818|Vaccine|vaccine
5020589|NCT01546818|HIV-1 infections|hiv-1 infections
5020590|NCT01546805|Blepharospasm|blepharospasm
5020591|NCT01546805|Hemifacial spasm|hemifacial spasm
5020592|NCT01546805|Botox|botox
5020593|NCT01546805|Zinc|zinc
5020594|NCT01546792|exercise|exercise
5020595|NCT01546792|diet|diet
5020596|NCT01546792|lifestyle|lifestyle
5020597|NCT01546792|sleep apnoea|sleep apnoea
5020598|NCT01546792|obesity|obesity
5020599|NCT01546766|Diabetes|diabetes
5020600|NCT01546766|Pupillary response|pupillary response
5020601|NCT01546766|Retinal disorders|retinal disorders
5020602|NCT01546766|Midperipheral ischemia|midperipheral ischemia
5020603|NCT01546766|Fundus photography|fundus photography
5020604|NCT01546766|Optical coherence tomography|optical coherence tomography
5020605|NCT01546753|Walnut hypersensitivity|walnut hypersensitivity
5020606|NCT01546753|Tree nut hypersensitivity|tree nut hypersensitivity
5020607|NCT01546753|Oral immunotherapy|oral immunotherapy
5020608|NCT01546753|Food allergy|food allergy
5020609|NCT01546753|Walnut allergy|walnut allergy
5020610|NCT01546753|tree nut allergy|tree nut allergy
5020611|NCT01546740|Glaucoma, Compliance, Prevalence|glaucoma, compliance, prevalence
5020612|NCT01546727|Preschoolers|preschoolers
5020613|NCT01546727|Obesity|obesity
5020614|NCT01546727|Behavioral Treatment|behavioral treatment
5020615|NCT01546675|Amputation|amputation
5020616|NCT01546675|Prosthesis Design|prosthesis design
5020617|NCT01546675|Biomechanics|biomechanics
5020618|NCT01546662|Rhinitis|rhinitis
5020619|NCT01546636|Cerebral desaturation events|cerebral desaturation events
5020620|NCT01546636|Cerebral oximetry|cerebral oximetry
5020621|NCT01546636|Beach chair position|beach chair position
5020622|NCT01546610|Rheumatoid foot|rheumatoid foot
5020623|NCT01546610|foot pain|foot pain
5020624|NCT01546610|insoles|insoles
5020625|NCT01546610|foot function|foot function
5020626|NCT01546610|electronic baropodometer|electronic baropodometer
5020627|NCT01546610|plantar pressure|plantar pressure
5020628|NCT01546610|gait analysis|gait analysis
5020629|NCT01546597|Metformin|metformin
5020630|NCT01546597|Ranolazine|ranolazine
5020631|NCT01546597|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
5020632|NCT01546558|Metformin|metformin
5020633|NCT01546558|Ranolazine|ranolazine
5020634|NCT01546558|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
5020635|NCT01546532|Heart failure|heart failure
5020636|NCT01546532|RLX030|rlx030
5020637|NCT01546532|hemodynamics|hemodynamics
5020638|NCT01546532|cardiovascular diseases|cardiovascular diseases
5020639|NCT01546480|Chronic postoperative pain|chronic postoperative pain
5020640|NCT01546480|Postcholecystectomy pain|postcholecystectomy pain
5020641|NCT01546480|Inflammation|inflammation
5020642|NCT01546480|Interleukines|interleukines
5020643|NCT01546467|Schizophrenia|schizophrenia
5020644|NCT01546467|Schizoaffective disorder|schizoaffective disorder
5020645|NCT01546467|Psychosis|psychosis
5020646|NCT01546467|Early phase|early phase
5020647|NCT01546467|Cognitive remediation|cognitive remediation
5020648|NCT01546467|Functional outcome|functional outcome
5020649|NCT01546454|Premenopausal women|premenopausal women
5020650|NCT01546454|coronary heart disease|coronary heart disease
5020651|NCT01546454|menstrual cycle|menstrual cycle
5020652|NCT01546454|lipids|lipids
5020653|NCT01546441|primary care|primary care
5020654|NCT01546441|aging|aging
5020655|NCT01546441|interprofessional care|interprofessional care
5020656|NCT01546441|multimorbidity|multimorbidity
5020657|NCT01546428|c-MET|c-met
5020658|NCT01546428|Advanced solid tumor|advanced solid tumor
5020659|NCT01546415|Phase 4|phase 4
5020660|NCT01546415|Desferasirox|desferasirox
5020661|NCT01546415|Iron Overload|iron overload
5020662|NCT01546415|Aplastic Anemia|aplastic anemia
5020663|NCT01546389|Malaria, vaccine, PfSPZ, challenge|malaria, vaccine, pfspz, challenge
5020664|NCT01546350|infertility, recurrent pregnancy loss, miscarriage|infertility, recurrent pregnancy loss, miscarriage
5020665|NCT01546337|anemia|anemia
5020666|NCT01546337|non-myeloid haemopathy|non-myeloid haemopathy
5020667|NCT01546337|myelodysplastic syndrome|myelodysplastic syndrome
5020668|NCT01546337|Erythropoiesis stimulating agents|erythropoiesis stimulating agents
5020669|NCT01546337|predictive markers|predictive markers
5020670|NCT01546324|Maternal Blood|maternal blood
5020671|NCT01546324|PGD|pgd
5020672|NCT01546324|PGS|pgs
5020673|NCT01546324|Natera|natera
5020674|NCT01546324|Gene Security Network|gene security network
5020675|NCT01546324|Non-invasive prenatal diagnosis|non-invasive prenatal diagnosis
5020676|NCT01546311|prosthetic socket|prosthetic socket
5020677|NCT01546311|residual limb volume fluctuation|residual limb volume fluctuation
5020678|NCT01546311|instantaneous bladder|instantaneous bladder
5020679|NCT01546298|Contact Dermatitis|contact dermatitis
5020680|NCT01546285|The focus of this study is to demonstrate that DINAMAP® SuperSTATTM NIBP algorithm has been implemented correctly without performance losses to the B40 monitor|the focus of this study is to demonstrate that dinamap® superstattm nibp algorithm has been implemented correctly without performance losses to the b40 monitor
5020681|NCT01546272|Subcutaneous resorbable sutures|subcutaneous resorbable sutures
5020682|NCT01546272|Tolerance / effectiveness of subcutaneous suture|tolerance / effectiveness of subcutaneous suture
5020683|NCT01546272|Reduced operative time and anesthesia time|reduced operative time and anesthesia time
5020684|NCT01546272|Medico-economic evaluation|medico-economic evaluation
5020685|NCT01546272|Accidental exposure to blood|accidental exposure to blood
5020686|NCT01546259|colonoscopy|colonoscopy
5020687|NCT01546259|water|water
5020688|NCT01546259|female|female
5020689|NCT01546259|BMI|bmi
5020690|NCT01546259|unsedated|unsedated
5020691|NCT01546259|low BMI female patients|low bmi female patients
5020692|NCT01546259|Intubation|intubation
5020693|NCT01546246|colonoscopy|colonoscopy
5020694|NCT01546246|water|water
5020695|NCT01546246|incomplete|incomplete
5020696|NCT01546246|failed|failed
5020697|NCT01546246|unsedated|unsedated
5020698|NCT01546233|Lung cancer|lung cancer
5020699|NCT01546233|Chemotherapy|chemotherapy
5020700|NCT01546233|Multidisciplinary self care programme|multidisciplinary self care programme
5020701|NCT01546233|Fatigue|fatigue
5020702|NCT01546220|colonoscopy|colonoscopy
5020703|NCT01546220|elder patient|elder patient
5020704|NCT01546220|water|water
5020705|NCT01546220|unsedated|unsedated
5020706|NCT01546207|ventricular tachycardia|ventricular tachycardia
5020707|NCT01546207|catheter ablation|catheter ablation
5020708|NCT01546207|VT|vt
5020709|NCT01546194|Informed consent|informed consent
5020710|NCT01546194|Perioperative period|perioperative period
5020711|NCT01546194|Morning of surgery|morning of surgery
5020712|NCT01546194|Anesthesiology|anesthesiology
5020713|NCT01546181|photoreceptors|photoreceptors
5020714|NCT01546181|retinal pigment epithelium|retinal pigment epithelium
5020715|NCT01546181|adaptive optics|adaptive optics
5020716|NCT01546168|Atrial Fibrillation ablation|atrial fibrillation ablation
5020717|NCT01546168|Esophageal Deviation|esophageal deviation
5020718|NCT01546168|AF|af
5020719|NCT01546116|adefovir|adefovir
5020720|NCT01546116|lamivudine|lamivudine
5020721|NCT01546116|entecavir resistance|entecavir resistance
5020722|NCT01546103|Vitamin D deficiency|vitamin d deficiency
5020723|NCT01546090|Alprazolam|alprazolam
5020724|NCT01546090|benzodiazepines|benzodiazepines
5020725|NCT01546090|Inferior alveolar nerve block|inferior alveolar nerve block
5020726|NCT01546090|irreversible pulpitis|irreversible pulpitis
5020727|NCT01546090|local anesthesia|local anesthesia
5020728|NCT01546064|Bile duct anastomosis|bile duct anastomosis
5020729|NCT01546064|Biliary complications|biliary complications
5020730|NCT01546051|metabotropic glutamate receptors 2 and 3|metabotropic glutamate receptors 2 and 3
5020731|NCT01546051|antagonist|antagonist
5020732|NCT01546051|mGluR|mglur
5020733|NCT01546051|ketamine|ketamine
5020734|NCT01546051|BDNF|bdnf
5020735|NCT01546051|Depression|depression
5020736|NCT01546051|Major Depressive Disorder|major depressive disorder
5020737|NCT01546051|Mood Disorder|mood disorder
5020738|NCT01546051|Treatment Resistant Depression|treatment resistant depression
5020739|NCT01546051|Phase 1 safety, tolerability and pharmacokinetics study|phase 1 safety, tolerability and pharmacokinetics study
5020740|NCT01546038|Hedgehog Inhibitor|hedgehog inhibitor
5020741|NCT01546038|Acute Myeloid Leukemia|acute myeloid leukemia
5020742|NCT01546038|Myelodysplastic syndrome|myelodysplastic syndrome
5020743|NCT01546038|Intensive chemotherapy|intensive chemotherapy
5020744|NCT01546038|LDAC|ldac
5020745|NCT01546038|glasdegib|glasdegib
5020746|NCT01545999|Transcranial Magnetic Stimulation (TMS)|transcranial magnetic stimulation (tms)
5020747|NCT01545999|Dorsolateral Prefrontal Cortex (DLPFC)|dorsolateral prefrontal cortex (dlpfc)
5020748|NCT01545999|Schizophrenia|schizophrenia
5020749|NCT01545999|Working Memory|working memory
5020750|NCT01545999|Paired Associative Stimulation (PAS)|paired associative stimulation (pas)
5020751|NCT01545999|Electroencephalography (EEG)|electroencephalography (eeg)
5020752|NCT01545999|Cognition|cognition
5020753|NCT01545986|Joint Replacement|joint replacement
5020754|NCT01545986|Exercise|exercise
5020755|NCT01545986|Power training|power training
5020756|NCT01545947|Neoplasms|neoplasms
5020757|NCT01545947|Pulmonary|pulmonary
5020758|NCT01545947|Lung Cancer|lung cancer
5020759|NCT01545947|Cancer of the Lung|cancer of the lung
5020760|NCT01545947|Stage IIIB Non-Small Cell Lung Cancer|stage iiib non-small cell lung cancer
5020761|NCT01545947|IV Non-Small Cell Lung Cancer|iv non-small cell lung cancer
5020762|NCT01545947|Non-Small Cell Lung Cancer|non-small cell lung cancer
5020763|NCT01545934|Overweight|overweight
5020764|NCT01545934|Obese|obese
5020765|NCT01545934|Pregnancy|pregnancy
5020766|NCT01545934|Weight Gain|weight gain
5020767|NCT01545921|Quality Of Life|quality of life
5020768|NCT01545921|Cancer|cancer
5020769|NCT01545921|End of life|end of life
5020770|NCT01545921|palliative setting|palliative setting
5020771|NCT01545908|Fecal transplant|fecal transplant
5020772|NCT01545908|induction of remission|induction of remission
5020773|NCT01545908|active ulcerative colitis|active ulcerative colitis
5020774|NCT01545882|prostate|prostate
5020775|NCT01545882|hormone-resistant|hormone-resistant
5020776|NCT01545882|degarelix|degarelix
5020777|NCT01545882|firmagon|firmagon
5020778|NCT01545882|anti-androgens|anti-androgens
5020779|NCT01545882|total androgen blockade|total androgen blockade
5020780|NCT01545882|injection|injection
5020781|NCT01545869|carbon dioxide laser|carbon dioxide laser
5020782|NCT01545869|fractional resurfacing|fractional resurfacing
5020783|NCT01545869|freckles|freckles
5020784|NCT01545869|melanosis|melanosis
5020785|NCT01545856|Parkinson's Disease|parkinson's disease
5020786|NCT01545856|cardiovascular events|cardiovascular events
5020787|NCT01545856|Levodopa|levodopa
5020788|NCT01545843|depression|depression
5020789|NCT01545843|sleep|sleep
5020790|NCT01545843|treatment|treatment
5020791|NCT01545830|Metabolic syndrome|metabolic syndrome
5020792|NCT01545830|Insulin resistance|insulin resistance
5020793|NCT01545830|Vitamin D deficiency|vitamin d deficiency
5020794|NCT01545817|Renal cell carcinoma|renal cell carcinoma
5020795|NCT01545817|GW786034|gw786034
5020796|NCT01545817|Everolimus|everolimus
5020797|NCT01545817|Pazopanib|pazopanib
5020798|NCT01545804|Hepatocellular carcinoma|hepatocellular carcinoma
5020799|NCT01545778|Substance abuse detection|substance abuse detection
5020800|NCT01545778|Opioids abuse|opioids abuse
5020801|NCT01545778|Tapentadol immediate-release (IR)|tapentadol immediate-release (ir)
5020802|NCT01545778|Oxycodone immediate-release (IR)|oxycodone immediate-release (ir)
5020803|NCT01545765|Healthy volunteers|healthy volunteers
5020804|NCT01545752|elearning|elearning
5020805|NCT01545752|CD-based education|cd-based education
5020806|NCT01545739|Pacemaker therapy|pacemaker therapy
5020911|NCT01545531|cystatin C.|cystatin c.
5020807|NCT01545739|Cardiac resynchronisation therapy (CRT)|cardiac resynchronisation therapy (crt)
5020808|NCT01545726|Asthma|asthma
5020809|NCT01545726|Sputum eosinophilia|sputum eosinophilia
5020810|NCT01545726|CRTH2 receptor|crth2 receptor
5020811|NCT01545726|PGD2 antagonist|pgd2 antagonist
5020812|NCT01545713|renal|renal
5020813|NCT01545713|kidney|kidney
5020814|NCT01545713|transplant|transplant
5020815|NCT01545713|living donor|living donor
5020816|NCT01545700|dexamethasone|dexamethasone
5020817|NCT01545700|hyperglycemia|hyperglycemia
5020818|NCT01545700|gynecologic surgery|gynecologic surgery
5020819|NCT01545687|pain|pain
5020820|NCT01545687|oral complications of radiation therapy|oral complications of radiation therapy
5020821|NCT01545687|weight changes|weight changes
5020822|NCT01545687|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
5020823|NCT01545687|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
5020824|NCT01545687|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
5020825|NCT01545687|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
5020826|NCT01545687|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
5020827|NCT01545687|stage I squamous cell carcinoma of the hypopharynx|stage i squamous cell carcinoma of the hypopharynx
5020828|NCT01545687|stage I squamous cell carcinoma of the larynx|stage i squamous cell carcinoma of the larynx
5020829|NCT01545687|stage I squamous cell carcinoma of the nasopharynx|stage i squamous cell carcinoma of the nasopharynx
5020830|NCT01545687|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
5020831|NCT01545687|stage I verrucous carcinoma of the larynx|stage i verrucous carcinoma of the larynx
5020832|NCT01545687|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
5020833|NCT01545687|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
5020834|NCT01545687|stage II squamous cell carcinoma of the nasopharynx|stage ii squamous cell carcinoma of the nasopharynx
5020835|NCT01545687|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
5020836|NCT01545687|stage II verrucous carcinoma of the larynx|stage ii verrucous carcinoma of the larynx
5020837|NCT01545687|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
5020838|NCT01545687|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
5020839|NCT01545687|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
5020840|NCT01545687|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
5020841|NCT01545687|stage III verrucous carcinoma of the larynx|stage iii verrucous carcinoma of the larynx
5020842|NCT01545687|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5020843|NCT01545687|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
5020844|NCT01545687|stage IVA squamous cell carcinoma of the larynx|stage iva squamous cell carcinoma of the larynx
5020845|NCT01545687|stage IVA squamous cell carcinoma of the oropharynx|stage iva squamous cell carcinoma of the oropharynx
5020846|NCT01545687|stage IVA verrucous carcinoma of the larynx|stage iva verrucous carcinoma of the larynx
5020847|NCT01545687|stage IVB squamous cell carcinoma of the larynx|stage ivb squamous cell carcinoma of the larynx
5020848|NCT01545687|stage IVB squamous cell carcinoma of the oropharynx|stage ivb squamous cell carcinoma of the oropharynx
5020849|NCT01545687|stage IVB verrucous carcinoma of the larynx|stage ivb verrucous carcinoma of the larynx
5020850|NCT01545687|stage IVC squamous cell carcinoma of the larynx|stage ivc squamous cell carcinoma of the larynx
5020851|NCT01545687|stage IVC squamous cell carcinoma of the oropharynx|stage ivc squamous cell carcinoma of the oropharynx
5020852|NCT01545687|stage IVC verrucous carcinoma of the larynx|stage ivc verrucous carcinoma of the larynx
5020853|NCT01545687|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
5020949|NCT01545427|Pilot study|pilot study
5020854|NCT01545687|stage I verrucous carcinoma of the oral cavity|stage i verrucous carcinoma of the oral cavity
5020855|NCT01545687|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
5020856|NCT01545687|stage II verrucous carcinoma of the oral cavity|stage ii verrucous carcinoma of the oral cavity
5020857|NCT01545687|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
5020858|NCT01545687|stage III verrucous carcinoma of the oral cavity|stage iii verrucous carcinoma of the oral cavity
5020859|NCT01545687|stage IVA squamous cell carcinoma of the lip and oral cavity|stage iva squamous cell carcinoma of the lip and oral cavity
5020860|NCT01545687|stage IVA verrucous carcinoma of the oral cavity|stage iva verrucous carcinoma of the oral cavity
5020861|NCT01545687|stage IVB squamous cell carcinoma of the lip and oral cavity|stage ivb squamous cell carcinoma of the lip and oral cavity
5020862|NCT01545687|stage IVB verrucous carcinoma of the oral cavity|stage ivb verrucous carcinoma of the oral cavity
5020863|NCT01545687|stage IVC squamous cell carcinoma of the lip and oral cavity|stage ivc squamous cell carcinoma of the lip and oral cavity
5020864|NCT01545687|stage IVC verrucous carcinoma of the oral cavity|stage ivc verrucous carcinoma of the oral cavity
5020865|NCT01545687|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
5020866|NCT01545687|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
5020867|NCT01545674|Aneuploidy|aneuploidy
5020868|NCT01545674|Non-invasive Prenatal Diagnosis|non-invasive prenatal diagnosis
5020869|NCT01545674|Prenatal Blood Test|prenatal blood test
5020870|NCT01545674|Prenatal Aneuploidy Screening|prenatal aneuploidy screening
5020871|NCT01545674|Trisomy 13|trisomy 13
5020872|NCT01545674|Trisomy 18|trisomy 18
5020873|NCT01545674|Trisomy 21|trisomy 21
5020874|NCT01545674|Trisomy|trisomy
5020875|NCT01545674|Down Syndrome|down syndrome
5020876|NCT01545674|Turner Syndrome|turner syndrome
5020877|NCT01545674|Edwards Syndrome|edwards syndrome
5020878|NCT01545661|Tuberculosis|tuberculosis
5020879|NCT01545661|diagnosis|diagnosis
5020880|NCT01545661|sputum induction|sputum induction
5020881|NCT01545661|primary care|primary care
5020882|NCT01545648|breast|breast
5020883|NCT01545648|cancer|cancer
5020884|NCT01545648|early|early
5020886|NCT01545648|disseminated|disseminated
5020887|NCT01545648|tumor|tumor
5020888|NCT01545648|cells|cells
5020889|NCT01545635|Major trauma|major trauma
5020890|NCT01545635|Injury Severity Score|injury severity score
5020891|NCT01545635|ISS > 15|iss > 15
5020892|NCT01545635|clinical signs|clinical signs
5020893|NCT01545635|risk of blood loss|risk of blood loss
5020894|NCT01545635|coagulopathy|coagulopathy
5020895|NCT01545635|rotational thrombelastometry|rotational thrombelastometry
5020896|NCT01545635|ROTEM|rotem
5020897|NCT01545609|Text messaging|text messaging
5020898|NCT01545609|birth control|birth control
5020899|NCT01545609|adolescents|adolescents
5020900|NCT01545596|Intraoperative Monitoring|intraoperative monitoring
5020901|NCT01545596|Decision Support Systems|decision support systems
5020902|NCT01545596|anesthesia outcomes|anesthesia outcomes
5020903|NCT01545557|Volume loss|volume loss
5020904|NCT01545544|B-Cell Non Hodgkin Lymphomas|b-cell non hodgkin lymphomas
5020905|NCT01545544|Hepatitis C|hepatitis c
5020906|NCT01545531|glomerular filtration rate|glomerular filtration rate
5020907|NCT01545531|iohexol|iohexol
5020908|NCT01545531|hematopoietic cell transplant|hematopoietic cell transplant
5020909|NCT01545531|kidney function|kidney function
5020910|NCT01545531|gold standard measure|gold standard measure
5020912|NCT01545518|Refractory epilepsy|refractory epilepsy
5020913|NCT01545518|Cryptogenic epilepsy|cryptogenic epilepsy
5020914|NCT01545518|Autoimmune disorders|autoimmune disorders
5020915|NCT01545518|IVIG|ivig
5020916|NCT01545518|Immunomodulatory therapy|immunomodulatory therapy
5020917|NCT01545518|Autoantibodies|autoantibodies
5020918|NCT01545492|CHIPS|chips
5020919|NCT01545492|famine|famine
5020920|NCT01545492|reprogramming|reprogramming
5020921|NCT01545492|developmental|developmental
5020922|NCT01545492|blood|blood
5020923|NCT01545492|pressure|pressure
5020924|NCT01545492|randomised|randomised
5020925|NCT01545492|randomized|randomized
5020926|NCT01545492|hypertension|hypertension
5020927|NCT01545492|anthropometry|anthropometry
5020928|NCT01545492|measurement|measurement
5020929|NCT01545492|genetics|genetics
5020930|NCT01545492|epigenetics|epigenetics
5020931|NCT01545492|methylation|methylation
5020932|NCT01545492|cortisol|cortisol
5020933|NCT01545492|stress|stress
5020934|NCT01545492|DNA|dna
5020935|NCT01545492|growth|growth
5020936|NCT01545492|weight|weight
5020937|NCT01545492|length|length
5020938|NCT01545492|height|height
5020939|NCT01545479|ECA|eca
5020940|NCT01545479|BOLD-MRI|bold-mri
5020941|NCT01545479|kidney|kidney
5020942|NCT01545466|Migraines|migraines
5020943|NCT01545466|Behavioral|behavioral
5020944|NCT01545466|Complementary and Alternative Medicine|complementary and alternative medicine
5020945|NCT01545466|Mindfulness Meditation|mindfulness meditation
5020946|NCT01545466|Mindfulness Based Stress Reduction|mindfulness based stress reduction
5020947|NCT01545427|Scleroderma|scleroderma
5020948|NCT01545427|Randomized controled trial|randomized controled trial
5020950|NCT01545427|Gleevec (imatinib)|gleevec (imatinib)
5020951|NCT01545427|Biomarkers|biomarkers
5020952|NCT01545414|Self-help treatment|self-help treatment
5020953|NCT01545414|Internet treatment|internet treatment
5020954|NCT01545414|Cognitive Behavioral Therapy|cognitive behavioral therapy
5020955|NCT01545414|Internet-based Cognitive Behavioral Therapy|internet-based cognitive behavioral therapy
5020956|NCT01545401|chronic disease management|chronic disease management
5020957|NCT01545401|Chronic Care Model|chronic care model
5020958|NCT01545401|multifaceted intervention|multifaceted intervention
5020959|NCT01545401|primary care|primary care
5020960|NCT01545401|type 2 diabetes mellitus|type 2 diabetes mellitus
5020961|NCT01545401|hypertension|hypertension
5020962|NCT01545375|nasopharyngeal carriage|nasopharyngeal carriage
5020963|NCT01545375|safety|safety
5020964|NCT01545375|immunogenicity|immunogenicity
5020965|NCT01545375|US|us
5020966|NCT01545375|Pneumococcal vaccine|pneumococcal vaccine
5020967|NCT01545375|efficacy|efficacy
5020968|NCT01545375|Streptococcus pneumoniae|streptococcus pneumoniae
5020969|NCT01545375|infants|infants
5020970|NCT01545349|LGG|lgg
5020971|NCT01545349|Immune response|immune response
5020972|NCT01545349|Influenza vaccine|influenza vaccine
5020973|NCT01545349|Elderly|elderly
5020974|NCT01545349|Healthy|healthy
5020975|NCT01545349|Microbiome|microbiome
5020976|NCT01545323|Netherton syndrome|netherton syndrome
5020977|NCT01545323|Gene therapy|gene therapy
5020978|NCT01545323|SPINK5|spink5
5020979|NCT01545297|dexmedetomidine|dexmedetomidine
5020980|NCT01545297|conscious sedation|conscious sedation
5020981|NCT01545297|awake craniotomy|awake craniotomy
5020982|NCT01545297|brain mapping|brain mapping
5020983|NCT01545284|chronic hand dermatitis|chronic hand dermatitis
5020984|NCT01545284|acitretin|acitretin
5020985|NCT01545284|PGA|pga
5020986|NCT01545271|Xenon|xenon
5020987|NCT01545271|Hypothermia|hypothermia
5020988|NCT01545271|Hypoxic Ischemic Encephalopathy|hypoxic ischemic encephalopathy
5020989|NCT01545271|Newborn|newborn
5020990|NCT01545271|Term|term
5020991|NCT01545271|Neuroprotection|neuroprotection
5020992|NCT01545271|Cooling|cooling
5020993|NCT01545271|HIE|hie
5020994|NCT01545245|atopic asthma|atopic asthma
5020995|NCT01545245|recurrent wheezing|recurrent wheezing
5020996|NCT01545245|preterm infants|preterm infants
5020997|NCT01545245|palivizumab|palivizumab
5020998|NCT01545245|respiratory syncytial virus|respiratory syncytial virus
5020999|NCT01545245|RSV|rsv
5021000|NCT01545232|Massive Transfusion|massive transfusion
5021001|NCT01545232|Trauma|trauma
5021002|NCT01545232|Coagulopathy|coagulopathy
5021003|NCT01545232|Trauma Induced Coagulopathy|trauma induced coagulopathy
5021004|NCT01545232|Plasma|plasma
5021005|NCT01545232|Platelets|platelets
5021006|NCT01545232|Red Blood Cells|red blood cells
5021007|NCT01545232|Mortality|mortality
5021008|NCT01545232|Wounds and Injuries|wounds and injuries
5021009|NCT01545232|Shock, Hemorrhagic|shock, hemorrhagic
5021010|NCT01545232|Shock|shock
5021011|NCT01545232|Pathologic Processes|pathologic processes
5021012|NCT01545232|Hemorrhage|hemorrhage
5021013|NCT01545232|Hemostatics|hemostatics
5021014|NCT01545232|Coagulation|coagulation
5021015|NCT01545232|Transfusion-related acute lung injury (TRALI)|transfusion-related acute lung injury (trali)
5021016|NCT01545232|Inflammation|inflammation
5021017|NCT01545193|Elderly|elderly
5021018|NCT01545193|Residual neuromuscular blockade|residual neuromuscular blockade
5021019|NCT01545180|Observatory|observatory
5021020|NCT01545180|Heart failure|heart failure
5021021|NCT01545180|Post-capillary pulmonary hypertension|post-capillary pulmonary hypertension
5021022|NCT01545180|HTPcap|htpcap
5021023|NCT01545167|African Americans|african americans
5021024|NCT01545167|pancreatitis|pancreatitis
5021025|NCT01545167|controls|controls
5021026|NCT01545141|metastatic|metastatic
5021027|NCT01545141|recurrent|recurrent
5021028|NCT01545141|peritoneal metastasis|peritoneal metastasis
5021029|NCT01545141|cytoreductive surgery|cytoreductive surgery
5021030|NCT01545141|hyperthermic intraperitoneal chemoperfusion|hyperthermic intraperitoneal chemoperfusion
5021031|NCT01545141|HIPEC|hipec
5021032|NCT01545141|hepatic metastasis|hepatic metastasis
5021033|NCT01545141|extrahepatic metastasis|extrahepatic metastasis
5021034|NCT01545141|vaccine|vaccine
5021035|NCT01545128|COPD|copd
5021036|NCT01545128|Pulmonary rehabilitation|pulmonary rehabilitation
5021037|NCT01545115|Children|children
5021038|NCT01545115|Immunity|immunity
5021039|NCT01545115|Sub-Saharan|sub-saharan
5021040|NCT01545115|Pertussis|pertussis
5021041|NCT01545115|Malaria|malaria
5021042|NCT01545115|Nutrition|nutrition
5021043|NCT01545115|antibodies|antibodies
5021044|NCT01545011|Inspiratory muscle training|inspiratory muscle training
5021045|NCT01545011|COPD|copd
5021046|NCT01545011|Conventional respiratory rehabilitation|conventional respiratory rehabilitation
5021047|NCT01545011|Dyspnea scale|dyspnea scale
5021048|NCT01544985|pediatrics|pediatrics
5021049|NCT01544985|emergency medicine|emergency medicine
5021050|NCT01544985|pain|pain
5021051|NCT01544985|bladder catheterization|bladder catheterization
5021052|NCT01544972|Patent Ductus Arteriosus|patent ductus arteriosus
5021053|NCT01544972|Paracetamol|paracetamol
5021054|NCT01544972|Ibuprofen|ibuprofen
5021055|NCT01544972|Serum levels|serum levels
5021056|NCT01544972|Preterm infant|preterm infant
5021057|NCT01544959|Narcotic|narcotic
5021058|NCT01544959|Opioid|opioid
5021059|NCT01544959|betablocking drug|betablocking drug
5021060|NCT01544959|postoperative pain|postoperative pain
5021061|NCT01544959|postoperative nausea and vomiting|postoperative nausea and vomiting
5021062|NCT01544959|breast cancer|breast cancer
5021063|NCT01544959|hyperalgesia|hyperalgesia
5021064|NCT01544959|cancer recurrence|cancer recurrence
5021065|NCT01544959|anesthesia|anesthesia
5021066|NCT01544959|mastectomy|mastectomy
5021067|NCT01544959|chronic postsurgical pain syndrome|chronic postsurgical pain syndrome
5021068|NCT01544959|acute postoperative pain|acute postoperative pain
5021069|NCT01544959|postmastectomy pain syndrome|postmastectomy pain syndrome
5021070|NCT01544959|pain|pain
5021071|NCT01544959|ambulatory surgery|ambulatory surgery
5021072|NCT01544946|pediatrics|pediatrics
5021073|NCT01544946|emergency medicine|emergency medicine
5021074|NCT01544946|pain|pain
5021075|NCT01544946|nasopharyngeal aspiration|nasopharyngeal aspiration
5021076|NCT01544933|spinal fractures|spinal fractures
5021077|NCT01544933|Thoracic vertebrae|thoracic vertebrae
5021078|NCT01544933|spinal canal|spinal canal
5021079|NCT01544933|kyphosis|kyphosis
5021080|NCT01544907|Drug Eluting Balloon|drug eluting balloon
5021081|NCT01544907|Arteriovenous fistula or graft stenosis|arteriovenous fistula or graft stenosis
5021082|NCT01544894|Postmenopausal osteoporosis|postmenopausal osteoporosis
5021083|NCT01544894|Compliance|compliance
5021084|NCT01544894|Bone mineral density|bone mineral density
5021085|NCT01544894|Bonemarkers|bonemarkers
5021086|NCT01544881|Pharmacokinetics|pharmacokinetics
5021087|NCT01544881|Pharmacodynamics|pharmacodynamics
5021088|NCT01544881|Hyperglycemia|hyperglycemia
5021089|NCT01544881|Insulin|insulin
5021090|NCT01544868|Total Energy Expenditure|total energy expenditure
5021091|NCT01544868|Protein Balance|protein balance
5021092|NCT01544868|Burns|burns
5021093|NCT01544855|Health young participants|health young participants
5021094|NCT01544842|Oral lichen planus|oral lichen planus
5021095|NCT01544842|Tacrolimus ointment|tacrolimus ointment
5021096|NCT01544842|Triamcinolone paste|triamcinolone paste
5021097|NCT01544829|theobromine|theobromine
5021098|NCT01544829|heart rate|heart rate
5021099|NCT01544829|blood lipids|blood lipids
5021100|NCT01544803|Randomized Controlled Trial|randomized controlled trial
5021101|NCT01544803|Alcohol|alcohol
5021102|NCT01544803|Internet|internet
5021103|NCT01544803|Screening|screening
5021104|NCT01544803|Brief intervention|brief intervention
5021105|NCT01544803|Personalized feedback|personalized feedback
5021106|NCT01544790|Esophageal carcinoma|esophageal carcinoma
5021107|NCT01544790|Esophageal cancer|esophageal cancer
5021108|NCT01544790|Robotic surgery|robotic surgery
5021109|NCT01544790|Esophagectomy|esophagectomy
5021110|NCT01544790|Minimally invasive|minimally invasive
5021111|NCT01544777|Aphakia|aphakia
5021112|NCT01544777|Cataract|cataract
5021113|NCT01544764|Diphtheria-Tetanus-Pertussis Vaccine|diphtheria-tetanus-pertussis vaccine
5021114|NCT01544764|Measles-Mumps-Rubella Vaccine|measles-mumps-rubella vaccine
5021115|NCT01544764|Meningococcal Vaccines|meningococcal vaccines
5021116|NCT01544764|Hepatitis B Vaccines|hepatitis b vaccines
5021117|NCT01544764|Chickenpox Vaccine|chickenpox vaccine
5021118|NCT01544764|Papillomavirus Vaccines|papillomavirus vaccines
5021119|NCT01544751|NAFLD|nafld
5021120|NCT01544751|metformin|metformin
5021121|NCT01544751|atorvastatin|atorvastatin
5021122|NCT01544751|metabolic syndrome|metabolic syndrome
5021123|NCT01544738|Parkinson Disease|parkinson disease
5021124|NCT01544738|sensory stimulation|sensory stimulation
5021125|NCT01544738|Bradykinesia|bradykinesia
5021126|NCT01544725|Procedural sedation|procedural sedation
5021127|NCT01544725|Ketamine-propofol|ketamine-propofol
5021128|NCT01544725|Ketamine|ketamine
5021129|NCT01544712|osteonecrosis|osteonecrosis
5021130|NCT01544712|cell-based therapy|cell-based therapy
5021131|NCT01544712|bone marrow|bone marrow
5021132|NCT01544712|mesenchymal stem cell|mesenchymal stem cell
5021134|NCT01544712|core decompression|core decompression
5021135|NCT01544699|stroke|stroke
5021136|NCT01544686|neutropenia|neutropenia
5021137|NCT01544686|cancer|cancer
5021138|NCT01544686|fever|fever
5021139|NCT01544686|central venous catheter|central venous catheter
5021140|NCT01544686|infection|infection
5021141|NCT01544660|spine and hip scan|spine and hip scan
5021142|NCT01544660|BMD|bmd
5021143|NCT01544647|Knee osteoarthritis|knee osteoarthritis
5021144|NCT01544647|spa therapy|spa therapy
5021145|NCT01544647|spa modalities|spa modalities
5021146|NCT01544634|Asthma|asthma
5021147|NCT01544634|Propranolol|propranolol
5021148|NCT01544634|Inhaled corticosteroids|inhaled corticosteroids
5021149|NCT01544634|Steroid sparing agent|steroid sparing agent
5021150|NCT01544634|Airway hyper-responsiveness|airway hyper-responsiveness
5021151|NCT01544621|Real life smoking cessation. NON-drug NON-intervention study|real life smoking cessation. non-drug non-intervention study
5021152|NCT01544608|Acute psychotic episode of Schizophrenia|acute psychotic episode of schizophrenia
5021153|NCT01544595|Psoriasis, inflammatory skin disease|psoriasis, inflammatory skin disease
5021154|NCT01544595|scaly patches|scaly patches
5021155|NCT01544595|secukinumab (AIN457)|secukinumab (ain457)
5021156|NCT01544595|Psoriasis Area and Severity Index (PASI)|psoriasis area and severity index (pasi)
5021157|NCT01544595|Investigator Global Assessment (IGA) mod 2011|investigator global assessment (iga) mod 2011
5021158|NCT01544582|Pegylated Interferon|pegylated interferon
5021159|NCT01544582|boceprevir|boceprevir
5021160|NCT01544582|telaprevir|telaprevir
5021161|NCT01544569|rhabdoid tumor of the kidney|rhabdoid tumor of the kidney
5021162|NCT01544556|abdominoplasty|abdominoplasty
5021163|NCT01544543|COPD|copd
5021164|NCT01544530|Brain-death|brain-death
5021165|NCT01544530|organ donation|organ donation
5021166|NCT01544517|Helicobacter pylori|helicobacter pylori
5021167|NCT01544517|Concomitant therapy|concomitant therapy
5021168|NCT01544517|Sequential therapy|sequential therapy
5021169|NCT01544517|levofloxacin|levofloxacin
5021170|NCT01544504|Radiodermatitis|radiodermatitis
5021171|NCT01544504|Prevention|prevention
5021172|NCT01544504|Radiotherapy|radiotherapy
5021173|NCT01544504|Breast|breast
5021174|NCT01544504|Radiation Dermatitis|radiation dermatitis
5021175|NCT01544491|Paediatric kidney transplantation|paediatric kidney transplantation
5021176|NCT01544491|Early MMF to everolimus conversion|early mmf to everolimus conversion
5021177|NCT01544491|Composite efficacy (biopsy-proven acute rejection, graft loss or death)|composite efficacy (biopsy-proven acute rejection, graft loss or death)
5021178|NCT01544491|Renal function|renal function
5021179|NCT01544465|Parkinson's disease|parkinson's disease
5021180|NCT01544465|Sleep Quality|sleep quality
5021181|NCT01544465|Daytime sleepiness|daytime sleepiness
5021182|NCT01544465|physical therapy|physical therapy
5021183|NCT01544465|exercise|exercise
5021184|NCT01544452|MR|mr
5021185|NCT01544452|CT|ct
5021186|NCT01544452|ultrasonography|ultrasonography
5021187|NCT01544452|MR colonography|mr colonography
5021188|NCT01544452|MR rectum|mr rectum
5021189|NCT01544452|MR liver|mr liver
5021190|NCT01544439|Temporomandibular joint disorders|temporomandibular joint disorders
5021191|NCT01544439|Stress psychological|stress psychological
5021192|NCT01544439|Depression|depression
5021193|NCT01544439|Quality of Life|quality of life
5021194|NCT01544426|Office hysteroscopy,|office hysteroscopy,
5021195|NCT01544426|intrauterine insemination|intrauterine insemination
5021196|NCT01544426|endometrial scrap|endometrial scrap
5021197|NCT01544413|laparoscopic sentinel lymph node biopsy|laparoscopic sentinel lymph node biopsy
5021198|NCT01544413|quality control study|quality control study
5021199|NCT01544413|early gastric cancer|early gastric cancer
5021200|NCT01544400|reverse anorexia,|reverse anorexia,
5021201|NCT01544400|anorexia athletics|anorexia athletics
5021202|NCT01544387|Preterm Premature Rupture Of Membranes|preterm premature rupture of membranes
5021203|NCT01544387|PPROM|pprom
5021204|NCT01544387|Pregnancy|pregnancy
5021205|NCT01544387|Bed rest.|bed rest.
5021206|NCT01544374|Breast Cancer|breast cancer
5021207|NCT01544374|Treatment Disparities|treatment disparities
5021208|NCT01544374|Tracking and Feedback|tracking and feedback
5021209|NCT01544374|Registry|registry
5021210|NCT01544374|Cancer Therapy Disparities|cancer therapy disparities
5021211|NCT01544374|Adjuvant Treatment|adjuvant treatment
5021212|NCT01544374|Racial Disparities|racial disparities
5021213|NCT01544374|Underuse of Adjuvant Treatment|underuse of adjuvant treatment
5021214|NCT01544361|Healthy subjects|healthy subjects
5021215|NCT01544361|MEDI7814|medi7814
5021216|NCT01544361|FTiH|ftih
5021217|NCT01544348|Allergic|allergic
5021218|NCT01544348|Atopic Dermatitis|atopic dermatitis
5021219|NCT01544348|MEDI4212|medi4212
5021220|NCT01544322|solid tumors|solid tumors
5021221|NCT01544322|recurrent|recurrent
5021222|NCT01544322|advanced|advanced
5021223|NCT01544322|metastatic|metastatic
5021224|NCT01544322|refractory|refractory
5021225|NCT01544283|Shoulder Pain|shoulder pain
5021226|NCT01544283|Shoulder Impingement Syndrome|shoulder impingement syndrome
5021227|NCT01544270|milk protein|milk protein
5021228|NCT01544270|probiotics|probiotics
5021229|NCT01544270|stress|stress
5021230|NCT01544270|cortisol|cortisol
5021231|NCT01544270|heart beat|heart beat
5021232|NCT01544257|Osteopathic manipulative treatment|osteopathic manipulative treatment
5021233|NCT01544257|alternative medicine|alternative medicine
5021234|NCT01544257|complementary medicine|complementary medicine
5021235|NCT01544257|neonatology|neonatology
5021236|NCT01544257|neonatal care|neonatal care
5021237|NCT01544257|prematurity|prematurity
5021238|NCT01544257|allied health care|allied health care
5021239|NCT01544244|comparison of physical therapy strategies|comparison of physical therapy strategies
5021240|NCT01544231|Neutrophil Gelatinase Associated Lipocalin|neutrophil gelatinase associated lipocalin
5021241|NCT01544231|predicting acute kidney failure|predicting acute kidney failure
5021242|NCT01544231|emergency room|emergency room
5021243|NCT01544218|Alcohol related disorders|alcohol related disorders
5021244|NCT01544192|Antioxidant|antioxidant
5021245|NCT01544192|α−tocopherol|α−tocopherol
5021246|NCT01544192|Vitamin E|vitamin e
5021247|NCT01544192|Gingko Biloba|gingko biloba
5021248|NCT01544192|Glaucoma|glaucoma
5021249|NCT01544192|Neuroprotection|neuroprotection
5021250|NCT01544192|Retina|retina
5021251|NCT01544179|Non Small Cell Lung Cancer|non small cell lung cancer
5021252|NCT01544179|Gefitinib|gefitinib
5021253|NCT01544179|Pemetrexed|pemetrexed
5021254|NCT01544179|Treatment Beyond Progression|treatment beyond progression
5021255|NCT01544166|Gadolinium, Pediatrics, MRI, contrast|gadolinium, pediatrics, mri, contrast
5021256|NCT01544153|Web based behavioral intervention|web based behavioral intervention
5021257|NCT01544153|Adherence|adherence
5021258|NCT01544153|Smoking cessation|smoking cessation
5021259|NCT01544153|Social network|social network
5021260|NCT01544153|Nicotine replacement therapy|nicotine replacement therapy
5021261|NCT01544153|Social support|social support
5021262|NCT01544140|Phase 1|phase 1
5021263|NCT01544140|healthy volunteers|healthy volunteers
5021264|NCT01544140|pharmacokinetics|pharmacokinetics
5021265|NCT01544140|vandetanib|vandetanib
5021266|NCT01544140|midazolam|midazolam
5021267|NCT01544127|Veterans|veterans
5021268|NCT01544127|Motivational Interviewing|motivational interviewing
5021269|NCT01544127|Inpatients|inpatients
5021270|NCT01544127|Suicide, Attempted|suicide, attempted
5021271|NCT01544101|Rheumatoid Arthritis|rheumatoid arthritis
5021272|NCT01544101|Diet, Vegetarian|diet, vegetarian
5021273|NCT01544101|Diet, Fat-Restricted|diet, fat-restricted
5021274|NCT01544101|Pain|pain
5021275|NCT01544088|randomized controlled trial|randomized controlled trial
5021276|NCT01544088|PTSD|ptsd
5021277|NCT01544088|cognitive behavioral treatment|cognitive behavioral treatment
5021278|NCT01544088|group treatment|group treatment
5021279|NCT01544062|Cardiac surgery|cardiac surgery
5021280|NCT01544062|Acute Pain|acute pain
5021281|NCT01544062|Wound Hyperalgesia|wound hyperalgesia
5021282|NCT01544062|Intravenous Acetaminophen|intravenous acetaminophen
5021283|NCT01544062|Patient Satisfaction|patient satisfaction
5021284|NCT01544049|fallopian tube removal|fallopian tube removal
5021285|NCT01544049|salpingectomy|salpingectomy
5021286|NCT01544049|ovarian cancer prevention|ovarian cancer prevention
5021287|NCT01544036|AKI|aki
5021288|NCT01544036|contrast nephropathy|contrast nephropathy
5021289|NCT01544036|renal blood flow|renal blood flow
5021290|NCT01544023|breast reconstruction|breast reconstruction
5021291|NCT01544023|mesh|mesh
5021292|NCT01544023|implant reconstruction|implant reconstruction
5021293|NCT01544023|acellular dermal matrix|acellular dermal matrix
5021294|NCT01544023|titanized polypropylene mesh|titanized polypropylene mesh
5021295|NCT01544023|TiLOOP Bra|tiloop bra
5021296|NCT01544023|TiLOOP|tiloop
5021297|NCT01544023|implant based breast reconstruction|implant based breast reconstruction
5021298|NCT01544010|Transtheoretical Model|transtheoretical model
5021299|NCT01544010|Tailored Print Intervention|tailored print intervention
5021300|NCT01544010|Population-based|population-based
5021301|NCT01544010|Behavioral Intervention|behavioral intervention
5021302|NCT01543984|health care workers|health care workers
5021303|NCT01543984|tailored physical activity|tailored physical activity
5021304|NCT01543984|prevention|prevention
5021305|NCT01543984|spine|spine
5021306|NCT01543984|upper body|upper body
5021307|NCT01543984|pain related to Spine or Upper body|pain related to spine or upper body
5021308|NCT01543971|Peripheral blood stem cell mobilization|peripheral blood stem cell mobilization
5021309|NCT01543971|CD34+ count|cd34+ count
5021310|NCT01543945|Postoperative Nausea and Vomiting|postoperative nausea and vomiting
5021311|NCT01543945|Ambulatory|ambulatory
5021312|NCT01543945|Gynecologic laparoscopy|gynecologic laparoscopy
5021313|NCT01543945|Incidence of postoperative nausea and vomiting.|incidence of postoperative nausea and vomiting.
5021314|NCT01543932|antiplatelet effect|antiplatelet effect
5021315|NCT01543932|prasugrel|prasugrel
5021316|NCT01543932|clopidogrel|clopidogrel
5021317|NCT01543932|stable angina|stable angina
5021318|NCT01543893|neck pain|neck pain
5021319|NCT01543893|shoulder pain|shoulder pain
5021320|NCT01543893|resistance training|resistance training
5021321|NCT01543854|Heart failure|heart failure
5021322|NCT01543854|RLX030|rlx030
5021323|NCT01543854|Hemodynamics|hemodynamics
5021324|NCT01543854|Cardiovascular Diseases|cardiovascular diseases
5021325|NCT01543841|advanced cancer|advanced cancer
5021326|NCT01543841|healthy|healthy
5021327|NCT01543841|blood sample|blood sample
5021328|NCT01543841|TEM|tem
5021329|NCT01543841|TIE-2 expressing monocytes|tie-2 expressing monocytes
5021330|NCT01543841|ANG1|ang1
5021331|NCT01543841|ANG2|ang2
5021332|NCT01543828|COPD|copd
5021333|NCT01543828|Indacatarol|indacatarol
5021334|NCT01543828|placebo|placebo
5021335|NCT01543828|crossover|crossover
5021336|NCT01543828|patient perception|patient perception
5021337|NCT01543815|Psychological Distress|psychological distress
5021338|NCT01543815|Depression|depression
5021339|NCT01543815|Anxiety|anxiety
5021340|NCT01543815|Well-Being Therapy|well-being therapy
5021341|NCT01543815|Heart Failure|heart failure
5021342|NCT01543815|Quality of Life|quality of life
5021343|NCT01543815|Adherence|adherence
5021344|NCT01543802|soft-tissue sarcoma|soft-tissue sarcoma
5021345|NCT01543802|pazopanib|pazopanib
5021346|NCT01543802|antiangiogenetic treatment|antiangiogenetic treatment
5021347|NCT01543802|endothelial progenitor cells|endothelial progenitor cells
5021348|NCT01543802|preoperative therapy|preoperative therapy
5021349|NCT01543789|Umbilical Hernia|umbilical hernia
5021350|NCT01543763|metastatic|metastatic
5021351|NCT01543763|solid|solid
5021352|NCT01543763|sarcoma|sarcoma
5021353|NCT01543763|progression|progression
5021354|NCT01543750|episodic ataxia|episodic ataxia
5021355|NCT01543750|CACNA1A mutations|cacna1a mutations
5021356|NCT01543724|Lithium|lithium
5021357|NCT01543724|Bipolar disorder|bipolar disorder
5021358|NCT01543724|Multimodal Brain Imaging|multimodal brain imaging
5021359|NCT01543711|Breast cancer|breast cancer
5021360|NCT01543711|persistent pain|persistent pain
5021361|NCT01543711|neuropathic pain|neuropathic pain
5021362|NCT01543711|lymphedema|lymphedema
5021363|NCT01543698|Advanced solid tumor,|advanced solid tumor,
5021364|NCT01543698|BRAF V600 mutation|braf v600 mutation
5021365|NCT01543672|lung|lung
5021366|NCT01543672|SBRT|sbrt
5021367|NCT01543672|MLD|mld
5021368|NCT01543672|toxicity|toxicity
5021369|NCT01543659|89Zr-DFO-huJ591|89zr-dfo-huj591
5021370|NCT01543659|prostate|prostate
5021371|NCT01543659|Pet scan|pet scan
5021372|NCT01543659|11-126|11-126
5021373|NCT01543646|Hepatology|hepatology
5021374|NCT01543646|Liver Cirrhosis|liver cirrhosis
5021375|NCT01543646|Fatty Liver|fatty liver
5021376|NCT01543620|kidney safety|kidney safety
5021377|NCT01543620|biomarkers|biomarkers
5021378|NCT01543620|serum creatinine|serum creatinine
5021379|NCT01543620|BUN|bun
5021380|NCT01543620|cystic fibrosis|cystic fibrosis
5021381|NCT01543620|head and neck cancer|head and neck cancer
5021382|NCT01543620|renal injury|renal injury
5021383|NCT01543620|drug induced acute kidney injury|drug induced acute kidney injury
5021384|NCT01543620|aminoglycoside|aminoglycoside
5021385|NCT01543620|cisplatin|cisplatin
5021386|NCT01543620|nephrotoxicity|nephrotoxicity
5021387|NCT01543620|biomarker qualification|biomarker qualification
5021388|NCT01543607|Bile duct|bile duct
5021389|NCT01543607|Cholangiocarcinoma|cholangiocarcinoma
5021390|NCT01543607|Bile duct stenosis|bile duct stenosis
5021391|NCT01543607|Malignant bile duct obstruction|malignant bile duct obstruction
5021392|NCT01543607|Malignant bile duct stricture|malignant bile duct stricture
5021393|NCT01543607|Radiofrequency ablation|radiofrequency ablation
5021394|NCT01543607|RFA|rfa
5021395|NCT01543607|Endoscopic RFA catheter|endoscopic rfa catheter
5021396|NCT01543607|EndoHPB|endohpb
5021397|NCT01543594|Rheumatoid arthritis|rheumatoid arthritis
5021398|NCT01543594|Seronegative polyarthritis|seronegative polyarthritis
5021399|NCT01543594|Biologic drugs|biologic drugs
5021400|NCT01543594|Safety efficacy biologics polyarthritis|safety efficacy biologics polyarthritis
5021401|NCT01543581|Basal Cell Carcinoma|basal cell carcinoma
5021402|NCT01543581|Treatment of Skin Cancer|treatment of skin cancer
5021403|NCT01543568|Age related Macular Degeneration|age related macular degeneration
5021404|NCT01543568|Recalcitrant Age Related Macular Degeneration|recalcitrant age related macular degeneration
5021405|NCT01543555|myocardial infarction|myocardial infarction
5021406|NCT01543555|statin|statin
5021407|NCT01543555|perioperative care|perioperative care
5021408|NCT01543555|peripheral vascular diseases|peripheral vascular diseases
5021409|NCT01543555|anesthesiology|anesthesiology
5021410|NCT01543542|1-3 brain metastases from any primary cancer|1-3 brain metastases from any primary cancer
5021411|NCT01543516|Asthma|asthma
5021412|NCT01543516|Sputum|sputum
5021413|NCT01543516|Blood|blood
5021414|NCT01543516|Inflammation|inflammation
5021415|NCT01543516|adaptive immune system|adaptive immune system
5021416|NCT01543516|innate immune system|innate immune system
5021417|NCT01543464|Indeolamine 2,3 dioxygenase|indeolamine 2,3 dioxygenase
5021418|NCT01543464|Survivin|survivin
5021419|NCT01543464|Montanide|montanide
5021420|NCT01543464|Imiquimod|imiquimod
5021421|NCT01543464|GMCSF|gmcsf
5021422|NCT01543438|ED utilization|ed utilization
5021423|NCT01543438|video education|video education
5021424|NCT01543438|mobile health|mobile health
5021425|NCT01543438|streaming media|streaming media
5021426|NCT01543438|underserved populations|underserved populations
5021427|NCT01543425|Neuropathic Pain|neuropathic pain
5021428|NCT01543425|Adenocorticotrophic axis|adenocorticotrophic axis
5021429|NCT01543425|Psychological state|psychological state
5021430|NCT01543412|FOLFIRI|folfiri
5021431|NCT01543412|Metastases|metastases
5021432|NCT01543412|pancreatic adenocarcinoma|pancreatic adenocarcinoma
5021433|NCT01543412|locally advanced or metastatic pancreatic adenocarcinoma|locally advanced or metastatic pancreatic adenocarcinoma
5021434|NCT01543399|Tibolone|tibolone
5021435|NCT01543399|climacteric|climacteric
5021436|NCT01543399|Doppler|doppler
5021437|NCT01543399|hormone replacement therapy|hormone replacement therapy
5021438|NCT01543386|Polyphenol|polyphenol
5021439|NCT01543386|Curcumin|curcumin
5021440|NCT01543386|Endothelium, vascular|endothelium, vascular
5021441|NCT01543386|Endothelium-dependant relaxing factor|endothelium-dependant relaxing factor
5021442|NCT01543386|Smoking|smoking
5021443|NCT01543386|Transcriptome|transcriptome
5021444|NCT01543373|Coronary artery disease|coronary artery disease
5021445|NCT01543373|Optical Coherence Tomography|optical coherence tomography
5021446|NCT01543373|Tissue coverage|tissue coverage
5021447|NCT01543373|DES|des
5021448|NCT01543360|axillary vein|axillary vein
5021449|NCT01543360|sub clavian vein|sub clavian vein
5021550|NCT01542892|Sarcopenia|sarcopenia
5021450|NCT01543360|comparison of strategies|comparison of strategies
5021451|NCT01543347|UTI|uti
5021452|NCT01543347|ESBL|esbl
5021453|NCT01543347|AmpC Enterobacteriaceae|ampc enterobacteriaceae
5021454|NCT01543334|intensive care|intensive care
5021455|NCT01543334|antibiotic levels in blood samples|antibiotic levels in blood samples
5021456|NCT01543321|tetrabenazine|tetrabenazine
5021457|NCT01543321|movement disorders|movement disorders
5021458|NCT01543321|tardive disorders|tardive disorders
5021459|NCT01543295|Non-Treponemal|non-treponemal
5021460|NCT01543295|Treponemal|treponemal
5021461|NCT01543282|endoscopic ultrasonography|endoscopic ultrasonography
5021462|NCT01543282|fine needle aspiration cytology|fine needle aspiration cytology
5021463|NCT01543282|22 gauge|22 gauge
5021464|NCT01543282|25 gauge|25 gauge
5021465|NCT01543269|Obesity|obesity
5021466|NCT01543269|Lipid disorders|lipid disorders
5021467|NCT01543256|benign biliary strictures secondary to chronic pancreatitis|benign biliary strictures secondary to chronic pancreatitis
5021468|NCT01543243|postural balance|postural balance
5021469|NCT01543243|strength|strength
5021470|NCT01543230|Non-Inflammatory Degenerative Joint Disease|non-inflammatory degenerative joint disease
5021471|NCT01543217|COPD|copd
5021472|NCT01543204|plaque psoriasis|plaque psoriasis
5021473|NCT01543204|etanercept|etanercept
5021474|NCT01543204|adalimumab|adalimumab
5021475|NCT01543191|Lung Diseases|lung diseases
5021476|NCT01543191|Respiratory Tract Diseases|respiratory tract diseases
5021477|NCT01543191|Fibrosis|fibrosis
5021478|NCT01543178|IBS|ibs
5021479|NCT01543178|IBS-D|ibs-d
5021480|NCT01543178|IBS with diarrhea|ibs with diarrhea
5021481|NCT01543178|Diarrhea|diarrhea
5021482|NCT01543178|Irritable bowel syndrome with diarrhea|irritable bowel syndrome with diarrhea
5021483|NCT01543165|Renal colic|renal colic
5021484|NCT01543165|Analgesia|analgesia
5021485|NCT01543165|Nefopam|nefopam
5021486|NCT01543165|Ketorolac|ketorolac
5021487|NCT01543152|HIV|hiv
5021488|NCT01543152|autologous cell therapy|autologous cell therapy
5021489|NCT01543152|cyclophosphamide|cyclophosphamide
5021490|NCT01543139|Bipolar Depression|bipolar depression
5021491|NCT01543139|Magnetic resonance spectroscopy|magnetic resonance spectroscopy
5021492|NCT01543139|Cytidine-|cytidine-
5021493|NCT01543139|Creatine-|creatine-
5021494|NCT01543113|melanoma|melanoma
5021495|NCT01543113|white-caucasian population|white-caucasian population
5021496|NCT01543100|MGUS|mgus
5021497|NCT01543074|HDAC|hdac
5021498|NCT01543074|histone acetylation|histone acetylation
5021499|NCT01543074|broccoli sprout extract|broccoli sprout extract
5021500|NCT01543074|garlic oil|garlic oil
5021501|NCT01543074|PBMCs|pbmcs
5021502|NCT01543048|Human Papilloma Virus (HPV)|human papilloma virus (hpv)
5021503|NCT01543048|Virological tests|virological tests
5021504|NCT01543048|CIN3|cin3
5021505|NCT01543048|Cervical cancer|cervical cancer
5021506|NCT01543048|Conization|conization
5021507|NCT01543048|within women treated by conization for a CIN3|within women treated by conization for a cin3
5021508|NCT01543035|HIV infection|hiv infection
5021509|NCT01543035|lipid lowering drugs|lipid lowering drugs
5021510|NCT01543035|etravirine|etravirine
5021511|NCT01543035|patient|patient
5021512|NCT01543035|statin treatment|statin treatment
5021513|NCT01543035|EFV or boosted PI antiretroviral treatment|efv or boosted pi antiretroviral treatment
5021514|NCT01543009|child|child
5021515|NCT01543009|venipuncture|venipuncture
5021516|NCT01543009|pain|pain
5021517|NCT01542983|breast cancer|breast cancer
5021518|NCT01542983|bright light|bright light
5021519|NCT01542983|insomnia|insomnia
5021520|NCT01542983|fatigue|fatigue
5021521|NCT01542970|intervention|intervention
5021522|NCT01542970|lactobacillus reuteri|lactobacillus reuteri
5021523|NCT01542970|omega-3 fatty acids|omega-3 fatty acids
5021524|NCT01542970|pregnancy|pregnancy
5021525|NCT01542970|lactation|lactation
5021526|NCT01542970|allergic symptoms|allergic symptoms
5021527|NCT01542970|IgE associated disease|ige associated disease
5021528|NCT01542970|gastrointestinal function|gastrointestinal function
5021529|NCT01542957|Major Depressive Disorder|major depressive disorder
5021530|NCT01542957|Dysthymic Disorder|dysthymic disorder
5021531|NCT01542957|Depression|depression
5021532|NCT01542957|Cognitive Behavior Therapy|cognitive behavior therapy
5021533|NCT01542957|Personal Construct Theory|personal construct theory
5021534|NCT01542957|Repertory Grid Technique|repertory grid technique
5021535|NCT01542957|Cognitive Conflicts|cognitive conflicts
5021536|NCT01542957|Personal dilemmas|personal dilemmas
5021537|NCT01542944|Acute myeloid leukemia|acute myeloid leukemia
5021538|NCT01542944|Myelodysplastic syndrome|myelodysplastic syndrome
5021539|NCT01542944|Stem Cell Mobilization|stem cell mobilization
5021540|NCT01542944|Allogeneic Stem Cell Transplantation|allogeneic stem cell transplantation
5021541|NCT01542931|Oral squamous cell carcinoma|oral squamous cell carcinoma
5021542|NCT01542931|Induction chemotherapy|induction chemotherapy
5021543|NCT01542931|Surgery|surgery
5021544|NCT01542931|Radiotherapy|radiotherapy
5021545|NCT01542918|Recurrent|recurrent
5021546|NCT01542918|Refractory|refractory
5021547|NCT01542918|CNS|cns
5021548|NCT01542918|Intraocular|intraocular
5021549|NCT01542918|Lymphoma|lymphoma
5021551|NCT01542892|Nutrition|nutrition
5021552|NCT01542892|Vitamin D|vitamin d
5021553|NCT01542892|Exercise|exercise
5021554|NCT01542866|ranibizumab|ranibizumab
5021555|NCT01542866|Age related Macular Degeneration|age related macular degeneration
5021556|NCT01542866|AMD|amd
5021557|NCT01542866|Health Management Tool|health management tool
5021558|NCT01542866|HMT|hmt
5021559|NCT01542866|Best Corrected Visual Acuity|best corrected visual acuity
5021560|NCT01542866|Investigator's Clinical Judgement of Change|investigator's clinical judgement of change
5021561|NCT01542866|Choroidal Neovascularization|choroidal neovascularization
5021562|NCT01542866|Central Retinal Subfield Thickness|central retinal subfield thickness
5021563|NCT01542866|visual function self test|visual function self test
5021564|NCT01542840|surgery|surgery
5021565|NCT01542840|orthopedic surgery|orthopedic surgery
5021566|NCT01542840|foot surgery|foot surgery
5021567|NCT01542840|leg surgery|leg surgery
5021568|NCT01542840|ankle surgery|ankle surgery
5021569|NCT01542840|leg|leg
5021570|NCT01542840|foot|foot
5021571|NCT01542840|ankle|ankle
5021572|NCT01542840|anesthesia|anesthesia
5021573|NCT01542840|local anesthesia|local anesthesia
5021574|NCT01542840|regional anesthesia|regional anesthesia
5021575|NCT01542840|Ochsner Clinic|ochsner clinic
5021576|NCT01542840|Ochsner Hospital|ochsner hospital
5021577|NCT01542840|New Orleans|new orleans
5021578|NCT01542840|Louisiana|louisiana
5021579|NCT01542840|Kristie Osteen, MD|kristie osteen, md
5021580|NCT01542827|neck pain|neck pain
5021581|NCT01542827|menthol|menthol
5021582|NCT01542814|Screening Mammogram|screening mammogram
5021583|NCT01542814|Diagnostic Mammogram|diagnostic mammogram
5021584|NCT01542814|Benign|benign
5021585|NCT01542814|Malignant|malignant
5021586|NCT01542814|BI-RADS Categories|bi-rads categories
5021587|NCT01542801|Effect of Preventive Antibiotics|effect of preventive antibiotics
5021588|NCT01542788|HCV genotype 2 (GT-2)|hcv genotype 2 (gt-2)
5021589|NCT01542788|HCV genotype 3 (GT-3)|hcv genotype 3 (gt-3)
5021590|NCT01542788|HCV|hcv
5021591|NCT01542788|Sustained Virologic Response|sustained virologic response
5021592|NCT01542788|Direct Acting Antiviral|direct acting antiviral
5021593|NCT01542788|Combination Therapy|combination therapy
5021594|NCT01542788|Interferon intolerant|interferon intolerant
5021595|NCT01542788|Interferon ineligible|interferon ineligible
5021596|NCT01542788|GS-7977|gs-7977
5021597|NCT01542788|Ribavirin|ribavirin
5021598|NCT01542762|Deep venous thrombosis|deep venous thrombosis
5021599|NCT01542762|Pulmonary Embolism|pulmonary embolism
5021600|NCT01542762|Lower leg Cast immobilization|lower leg cast immobilization
5021601|NCT01542749|BVA-100 Blood volume analyzer|bva-100 blood volume analyzer
5021602|NCT01542749|Human serum albumin labeled with Iodine 131|human serum albumin labeled with iodine 131
5021603|NCT01542723|Deep venous thrombosis|deep venous thrombosis
5021604|NCT01542723|Pulmonary Embolism|pulmonary embolism
5021605|NCT01542723|Arthroscopy of the knee|arthroscopy of the knee
5021606|NCT01542697|magnesium sulpahate|magnesium sulpahate
5021607|NCT01542697|postoperative analgesia|postoperative analgesia
5021608|NCT01542684|Leukemia|leukemia
5021609|NCT01542684|Myelodysplastic Syndrome|myelodysplastic syndrome
5021610|NCT01542684|MDS|mds
5021611|NCT01542684|Azacytidine|azacytidine
5021612|NCT01542684|5-Azacytidine|5-azacytidine
5021613|NCT01542684|5-AZA|5-aza
5021614|NCT01542684|Vidaza|vidaza
5021615|NCT01542684|5-AZC|5-azc
5021616|NCT01542684|Aza-CR|aza-cr
5021617|NCT01542684|Ladakamycin|ladakamycin
5021618|NCT01542684|NSC-102816|nsc-102816
5021619|NCT01542684|GM-CSF|gm-csf
5021620|NCT01542684|Sargramostim|sargramostim
5021621|NCT01542684|Leukine|leukine
5021622|NCT01542671|lifestyle change|lifestyle change
5021623|NCT01542671|obesity treatment|obesity treatment
5021624|NCT01542671|physical activity|physical activity
5021625|NCT01542671|primary care|primary care
5021626|NCT01542671|quality of life|quality of life
5021627|NCT01542645|Fentanyl|fentanyl
5021628|NCT01542645|Methadone|methadone
5021629|NCT01542645|Thoracic Surgery|thoracic surgery
5021630|NCT01542632|safety and immunogenicity of dengue vaccine|safety and immunogenicity of dengue vaccine
5021631|NCT01542606|PH|ph
5021632|NCT01542606|SCREENING|screening
5021633|NCT01542606|EARLY WARNING|early warning
5021634|NCT01542606|VAGINAL HEALTH|vaginal health
5021635|NCT01542606|VAGINAL SECRETION|vaginal secretion
5021636|NCT01542606|VAGINAL PH|vaginal ph
5021637|NCT01542580|Revision surgery|revision surgery
5021638|NCT01542567|Diclofenac|diclofenac
5021639|NCT01542567|BCG|bcg
5021640|NCT01542567|BLADDER IRRIGATIONS|bladder irrigations
5021641|NCT01542554|Diabetes mellitus|diabetes mellitus
5021642|NCT01542554|Chinese|chinese
5021643|NCT01542554|Glycaemic index|glycaemic index
5021644|NCT01542528|ADHD|adhd
5021645|NCT01542528|Executive function|executive function
5021646|NCT01542528|Inhibitory control|inhibitory control
5021647|NCT01542528|Computer games|computer games
5021648|NCT01542528|Sports activities|sports activities
5021649|NCT01542528|Good Behavior Game|good behavior game
5021650|NCT01542515|Allograft|allograft
5021651|NCT01542515|Arthroplasty|arthroplasty
5021652|NCT01542515|Basal Joint|basal joint
5021653|NCT01542515|carpometacarpal joint|carpometacarpal joint
5021654|NCT01542515|Thumb|thumb
5021655|NCT01542515|meniscus|meniscus
5021656|NCT01542515|osteoarthritis|osteoarthritis
5021657|NCT01542515|Patients with Stages I - III arthritis of the the thumb carpometacarpal joint|patients with stages i - iii arthritis of the the thumb carpometacarpal joint
5021658|NCT01542502|Heart failure with preserved ejection fraction|heart failure with preserved ejection fraction
5021659|NCT01542502|Diastolic heart failure|diastolic heart failure
5021660|NCT01542502|Aerobic exercise performance|aerobic exercise performance
5021661|NCT01542437|Non-Small Cell Lung Cancer|non-small cell lung cancer
5021662|NCT01542398|community-based|community-based
5021663|NCT01542398|war-affected|war-affected
5021664|NCT01542398|psychosocial support|psychosocial support
5021665|NCT01542398|family-focused|family-focused
5021666|NCT01542398|psychological distress|psychological distress
5021667|NCT01542398|adolescents|adolescents
5021668|NCT01542398|Democratic Republic of Congo|democratic republic of congo
5021669|NCT01542398|family functioning|family functioning
5021670|NCT01542398|community functioning|community functioning
5021671|NCT01542398|daily functioning|daily functioning
5021672|NCT01542385|Delayed stenting|delayed stenting
5021673|NCT01542385|Deferred stenting|deferred stenting
5021674|NCT01542385|Late stenting|late stenting
5021675|NCT01542385|postponed stenting|postponed stenting
5021676|NCT01542385|Thrombectomy|thrombectomy
5021677|NCT01542385|Percutaneous coronary intervention|percutaneous coronary intervention
5021678|NCT01542385|PCI|pci
5021679|NCT01542385|Angioplasty|angioplasty
5021680|NCT01542385|STEMI|stemi
5021681|NCT01542385|acute myocardial infarction|acute myocardial infarction
5021682|NCT01542372|PTSD|ptsd
5021683|NCT01542372|Cognitive behavioral therapy (CBT)|cognitive behavioral therapy (cbt)
5021684|NCT01542372|Medication augmentation|medication augmentation
5021685|NCT01542372|Treatment-resistant PTSD|treatment-resistant ptsd
5021686|NCT01542372|Cambodian refugees|cambodian refugees
5021687|NCT01542372|Culturally sensitive treatment|culturally sensitive treatment
5021688|NCT01542359|Yoga, Hypertension|yoga, hypertension
5021689|NCT01542359|Blood Pressure|blood pressure
5021690|NCT01542359|Autonomic Nervous system|autonomic nervous system
5021691|NCT01542346|Wound closure|wound closure
5021692|NCT01542346|cosmetic outcome|cosmetic outcome
5021693|NCT01542333|recurrent Wilms tumor and other childhood kidney tumors|recurrent wilms tumor and other childhood kidney tumors
5021694|NCT01542333|stage I Wilms tumor|stage i wilms tumor
5021695|NCT01542333|stage II Wilms tumor|stage ii wilms tumor
5021696|NCT01542333|stage III Wilms tumor|stage iii wilms tumor
5021697|NCT01542333|stage IV Wilms tumor|stage iv wilms tumor
5021698|NCT01542333|stage V Wilms tumor|stage v wilms tumor
5021699|NCT01542320|probiotic|probiotic
5021700|NCT01542320|Lactobacillus reuteri DSM 17938|lactobacillus reuteri dsm 17938
5021701|NCT01542320|healthy infants|healthy infants
5021702|NCT01542307|migraine|migraine
5021703|NCT01542307|oxygen therapy|oxygen therapy
5021704|NCT01542294|gastric cancer|gastric cancer
5021705|NCT01542294|S-1|s-1
5021706|NCT01542294|oxaliplatin|oxaliplatin
5021707|NCT01542294|adjuvant chemotherapy|adjuvant chemotherapy
5021708|NCT01542281|liver resection|liver resection
5021709|NCT01542281|hepatectomy|hepatectomy
5021710|NCT01542281|pre-habilitation|pre-habilitation
5021711|NCT01542268|pentoxifylline|pentoxifylline
5021712|NCT01542268|tight junction signalling|tight junction signalling
5021713|NCT01542268|intestinal epithelial barrier|intestinal epithelial barrier
5021714|NCT01542268|irritable bowel syndrome|irritable bowel syndrome
5021715|NCT01542255|Metronomic Therapy|metronomic therapy
5021716|NCT01542255|Metastatic Melanoma|metastatic melanoma
5021717|NCT01542255|Vinblastine|vinblastine
5021718|NCT01542255|Cyclophosphamide|cyclophosphamide
5021719|NCT01542255|Dacarbazine|dacarbazine
5021720|NCT01542242|Diabetes Mellitus Type 2|diabetes mellitus type 2
5021721|NCT01542242|Prader Willi Syndrome|prader willi syndrome
5021722|NCT01542229|Post Traumatic Stress Disorder|post traumatic stress disorder
5021723|NCT01542229|Severe Mental Illness|severe mental illness
5021724|NCT01542203|doxorubicin|doxorubicin
5021725|NCT01542203|cyclophosphamide|cyclophosphamide
5021726|NCT01542203|Breast Cancer|breast cancer
5021727|NCT01542203|BMI|bmi
5021728|NCT01542190|cataract surgery|cataract surgery
5021729|NCT01542190|cystoid macular edema|cystoid macular edema
5021730|NCT01542190|angiography|angiography
5021731|NCT01542177|hypoxia|hypoxia
5021732|NCT01542177|pancreas|pancreas
5021733|NCT01542177|cancer|cancer
5021734|NCT01542177|pancreatic cancer|pancreatic cancer
5021735|NCT01542177|18F-FAZA|18f-faza
5021736|NCT01542177|18F-Fluoroazomycin Arabinoside|18f-fluoroazomycin arabinoside
5021737|NCT01542177|Positron Emission Tomography|positron emission tomography
5021738|NCT01542177|PET|pet
5021739|NCT01542164|Calcium intake|calcium intake
5021740|NCT01542164|Fat excretion|fat excretion
5021741|NCT01542164|Energy excretion|energy excretion
5021742|NCT01542164|Gut micro flora|gut micro flora
5021743|NCT01542151|Labor, induced|labor, induced
5021744|NCT01542151|Sleep|sleep
5021745|NCT01542151|Fatigue|fatigue
5021746|NCT01542151|Patient satisfaction|patient satisfaction
5021747|NCT01542151|Circadian rhythm|circadian rhythm
5021748|NCT01542138|Inflammatory hyperpigmentation, axillar pigmentation|inflammatory hyperpigmentation, axillar pigmentation
5021749|NCT01542125|Patients aged 3 to 16 years presenting for|patients aged 3 to 16 years presenting for
5021750|NCT01542125|removal of smooth percutaneous interosseus pins|removal of smooth percutaneous interosseus pins
5021751|NCT01542125|after orthopeadic surgery|after orthopeadic surgery
5021752|NCT01542112|Patient-Centered Care|patient-centered care
5021753|NCT01542112|Patient Satisfaction|patient satisfaction
5021754|NCT01542112|Interventional study|interventional study
5021755|NCT01542112|Patient Expectations|patient expectations
5021756|NCT01542112|Hospitalization|hospitalization
5021757|NCT01542086|intermediate pre-test|intermediate pre-test
5021758|NCT01542086|probability of significant coronary heart disease|probability of significant coronary heart disease
5021759|NCT01542073|myocardial infarction|myocardial infarction
5021760|NCT01542073|angiogenesis|angiogenesis
5021761|NCT01542073|integrin receptor imaging|integrin receptor imaging
5021762|NCT01542073|68Ga-BNOTA-PRGD2|68ga-bnota-prgd2
5021763|NCT01542047|Metastatic|metastatic
5021764|NCT01542047|Solid tumors|solid tumors
5021765|NCT01542047|carboplatin|carboplatin
5021766|NCT01542047|Paraplatin|paraplatin
5021767|NCT01542047|Pazopanib|pazopanib
5021768|NCT01542047|Votrient|votrient
5021769|NCT01542047|Alkylating agent|alkylating agent
5021770|NCT01542047|Tyrosine kinase inhibitor|tyrosine kinase inhibitor
5021771|NCT01542047|Metastatic disease|metastatic disease
5021772|NCT01542021|prostate|prostate
5021773|NCT01542021|Degarelix|degarelix
5021774|NCT01542021|injections|injections
5021775|NCT01542021|radical prostatectomy|radical prostatectomy
5021776|NCT01542021|11-182|11-182
5021777|NCT01541995|contrast medium enhanced post mortem CT|contrast medium enhanced post mortem ct
5021778|NCT01541995|virtual autopsy|virtual autopsy
5021779|NCT01541995|To evaluate the value of contrast medium enhanced post-mortem CT in virtual autopsy focussing on thromboembolic and vascular conditions|to evaluate the value of contrast medium enhanced post-mortem ct in virtual autopsy focussing on thromboembolic and vascular conditions
5021780|NCT01541969|Ear|ear
5021781|NCT01541969|Hearing|hearing
5021782|NCT01541956|type 2 diabetes;|type 2 diabetes;
5021783|NCT01541956|vildagliptin;|vildagliptin;
5021784|NCT01541956|metformin;|metformin;
5021785|NCT01541943|Atorvastatin|atorvastatin
5021786|NCT01541943|Losartan|losartan
5021787|NCT01541943|Essential Hypertension|essential hypertension
5021788|NCT01541943|Hyperlipidemia|hyperlipidemia
5021789|NCT01541904|Ocular Allergy.|ocular allergy.
5021790|NCT01541904|Seasonal Allergic Conjunctivitis|seasonal allergic conjunctivitis
5021791|NCT01541904|Perennial Allergic Conjunctivitis|perennial allergic conjunctivitis
5021792|NCT01541904|Conjunctivitis, Allergic|conjunctivitis, allergic
5021793|NCT01541904|Ocular Antihistamines.|ocular antihistamines.
5021794|NCT01541891|PRO-148|pro-148
5021795|NCT01541891|Dry eye syndrome|dry eye syndrome
5021796|NCT01541865|hypertension, renal denervation, uncontrolled hypertension, medication resistant hypertension|hypertension, renal denervation, uncontrolled hypertension, medication resistant hypertension
5021797|NCT01541852|Vascular Inflammation|vascular inflammation
5021798|NCT01541852|FDG PET-CT|fdg pet-ct
5021799|NCT01541852|COPD|copd
5021800|NCT01541852|Atherosclerosis|atherosclerosis
5021801|NCT01541852|p38 MAP kinase inhibitor|p38 map kinase inhibitor
5021802|NCT01541839|Nasal septum|nasal septum
5021803|NCT01541839|Nasal surgical procedures|nasal surgical procedures
5021804|NCT01541826|aronia|aronia
5021805|NCT01541826|LDL cholesterol|ldl cholesterol
5021806|NCT01541826|polyphenols|polyphenols
5021807|NCT01541826|bioavailability|bioavailability
5021808|NCT01541826|oxidative stress|oxidative stress
5021809|NCT01541813|Rare iron overload|rare iron overload
5021810|NCT01541813|hepcidin|hepcidin
5021811|NCT01541774|Atherectomy|atherectomy
5021812|NCT01541774|Atherosclerosis|atherosclerosis
5021813|NCT01541774|Peripheral artery disease|peripheral artery disease
5021814|NCT01541761|Obesity|obesity
5021815|NCT01541761|Child|child
5021816|NCT01541761|Hispanic|hispanic
5021817|NCT01541761|Prevention|prevention
5021818|NCT01541761|Nutrition|nutrition
5021819|NCT01541761|Parenting|parenting
5021820|NCT01541735|Diabetes|diabetes
5021821|NCT01541735|Insulin|insulin
5021822|NCT01541735|Pantoprazole|pantoprazole
5021823|NCT01541722|Urea cycle disorders|urea cycle disorders
5021824|NCT01541709|This is a single-center|this is a single-center
5021825|NCT01541709|prospective|prospective
5021826|NCT01541709|single-arm|single-arm
5021827|NCT01541709|open-label phase II study|open-label phase ii study
5021828|NCT01541696|zinc|zinc
5021829|NCT01541696|zn|zn
5021830|NCT01541696|EZP (exchangeable zinc pools)multivitamin MN|ezp (exchangeable zinc pools)multivitamin mn
5021831|NCT01541683|PEG-electrolyte solution|peg-electrolyte solution
5021832|NCT01541683|bowel cleansing|bowel cleansing
5021833|NCT01541683|Mentholyptus drops|mentholyptus drops
5021834|NCT01541683|Palatability|palatability
5021835|NCT01541657|Ankle Instability|ankle instability
5021836|NCT01541657|Sensorimotor Control|sensorimotor control
5021837|NCT01541657|Sensory|sensory
5021838|NCT01541657|Postural Control|postural control
5021839|NCT01541657|Balance|balance
5021840|NCT01541657|Gait|gait
5021841|NCT01541644|Acupuncture Therapy|acupuncture therapy
5021842|NCT01541644|bortezomib-induced peripheral neuropathy|bortezomib-induced peripheral neuropathy
5022324|NCT01539291|CLL|cll
5021843|NCT01541631|Human Immunodeficiency Virus-1|human immunodeficiency virus-1
5021844|NCT01541631|Schistosoma mansoni|schistosoma mansoni
5021845|NCT01541631|Anemia|anemia
5021846|NCT01541631|Immune response|immune response
5021847|NCT01541631|Opportunistic infections|opportunistic infections
5021848|NCT01541631|Tanzania|tanzania
5021849|NCT01541618|MS|ms
5021850|NCT01541618|RRMS|rrms
5021851|NCT01541618|RR Multiple Sclerosis|rr multiple sclerosis
5021852|NCT01541592|Insulin resistance|insulin resistance
5021853|NCT01541592|Endothelial dysfunction|endothelial dysfunction
5021854|NCT01541592|saturated fat|saturated fat
5021855|NCT01541592|monounsaturated fat|monounsaturated fat
5021856|NCT01541592|polyunsaturated fat|polyunsaturated fat
5021857|NCT01541579|Perianal fistulising Crohn's disease.|perianal fistulising crohn's disease.
5021858|NCT01541566|arterial hypertension|arterial hypertension
5021859|NCT01541566|metabolic syndrome|metabolic syndrome
5021860|NCT01541566|home blood pressure|home blood pressure
5021861|NCT01541566|ambulatory blood pressure|ambulatory blood pressure
5021862|NCT01541566|office blood pressure|office blood pressure
5021863|NCT01541566|telemedicine|telemedicine
5021864|NCT01541527|non neutralizing antibody|non neutralizing antibody
5021865|NCT01541527|Epitopic profile|epitopic profile
5021866|NCT01541527|Clinical relevance|clinical relevance
5021867|NCT01541501|Central Corneal Thickness|central corneal thickness
5021868|NCT01541501|Pachymetry|pachymetry
5021869|NCT01541462|mechanical ventilation|mechanical ventilation
5021870|NCT01541462|weaning|weaning
5021871|NCT01541462|pressure support|pressure support
5021872|NCT01541462|spontaneous breathing|spontaneous breathing
5021873|NCT01541462|Long-term acute care facility|long-term acute care facility
5021874|NCT01541462|mortality|mortality
5021875|NCT01541449|AMD|amd
5021876|NCT01541449|PLAQUENIL|plaquenil
5021877|NCT01541449|CNV|cnv
5021878|NCT01541436|Remote Ischemic Preconditioning|remote ischemic preconditioning
5021879|NCT01541436|Nociception|nociception
5021880|NCT01541436|Central Sensitization|central sensitization
5021881|NCT01541436|Peripheral Sensitization|peripheral sensitization
5021882|NCT01541397|Hyperphenylalaninemia|hyperphenylalaninemia
5021883|NCT01541397|Phenylketonuria|phenylketonuria
5021884|NCT01541397|Adults|adults
5021885|NCT01541397|Bone Mineral Density|bone mineral density
5021886|NCT01541384|Kidney transplant|kidney transplant
5021887|NCT01541384|Adherence|adherence
5021888|NCT01541384|Electronic pill bottles|electronic pill bottles
5021889|NCT01541371|Schizophrenia|schizophrenia
5021890|NCT01541371|Paliperidone extended-release tablets|paliperidone extended-release tablets
5021891|NCT01541332|relapsed refractory|relapsed refractory
5021892|NCT01541332|multiple myeloma|multiple myeloma
5021893|NCT01541332|pomalidomide|pomalidomide
5021894|NCT01541332|Doxil|doxil
5021895|NCT01541332|dexamethasone|dexamethasone
5021896|NCT01541332|Oncotherapeutics|oncotherapeutics
5021897|NCT01541319|Cardiac Surgery|cardiac surgery
5021898|NCT01541319|Erythrocyte Transfusion|erythrocyte transfusion
5021899|NCT01541306|C-type natriuretic peptide|c-type natriuretic peptide
5021900|NCT01541306|dwarfism|dwarfism
5021901|NCT01541306|growth|growth
5021902|NCT01541306|achondroplasia|achondroplasia
5021903|NCT01541306|hypochondroplasia|hypochondroplasia
5021904|NCT01541306|biomarker|biomarker
5021905|NCT01541293|Abortion, Induced|abortion, induced
5021906|NCT01541293|Laminaria|laminaria
5021907|NCT01541293|Pain management|pain management
5021908|NCT01541293|Cervical preparation|cervical preparation
5021909|NCT01541293|Dilation and Evacuation|dilation and evacuation
5021910|NCT01541280|Allogreffe, LAM , MDS|allogreffe, lam , mds
5021911|NCT01541280|Azacitidine (VidazaÒ)|azacitidine (vidazaò)
5021912|NCT01541280|Injection de lymphocytes de donneur (DLI)|injection de lymphocytes de donneur (dli)
5021913|NCT01541267|aliskiren|aliskiren
5021914|NCT01541267|eplerenon|eplerenon
5021915|NCT01541267|telmisartan|telmisartan
5021916|NCT01541267|direct renin inhibitor|direct renin inhibitor
5021917|NCT01541267|ACE inhibitor|ace inhibitor
5021918|NCT01541267|mineralocorticoid inhibitor|mineralocorticoid inhibitor
5021919|NCT01541267|proteinuria|proteinuria
5021920|NCT01541267|chronic kidney diseases|chronic kidney diseases
5021921|NCT01541267|renin-angiotensin-aldosterone system|renin-angiotensin-aldosterone system
5021922|NCT01541254|intracranial aneurysm|intracranial aneurysm
5021923|NCT01541254|wide-neck|wide-neck
5021924|NCT01541254|saccular|saccular
5021925|NCT01541254|endovascular treatment|endovascular treatment
5021926|NCT01541254|coil embolization|coil embolization
5021927|NCT01541254|stent|stent
5021928|NCT01541254|bare platinum|bare platinum
5021929|NCT01541241|Intrauterine contraceptive device (IUD) is one of the most frequently used methods of birth control around the world|intrauterine contraceptive device (iud) is one of the most frequently used methods of birth control around the world
5021930|NCT01541241|Uterine Hemodynamic changes|uterine hemodynamic changes
5021931|NCT01541228|actinic keratosis|actinic keratosis
5021932|NCT01541228|photodynamic therapy|photodynamic therapy
5021933|NCT01541228|5-aminolevulinic acid|5-aminolevulinic acid
5021934|NCT01541202|chronic heart failure|chronic heart failure
5021935|NCT01541202|neuregulin|neuregulin
5021936|NCT01541202|mortality|mortality
5021937|NCT01541189|hypertension|hypertension
5021938|NCT01541189|valsartan|valsartan
5021939|NCT01541176|Corticotherapy|corticotherapy
5021940|NCT01541176|Fibrosis|fibrosis
5021941|NCT01541176|Numerical reading|numerical reading
5021942|NCT01541176|18-70 years|18-70 years
5021943|NCT01541176|first renal transplant was lost due to rejection|first renal transplant was lost due to rejection
5021944|NCT01541176|first or second renal transplant|first or second renal transplant
5021945|NCT01541163|Ischemia|ischemia
5021946|NCT01541163|Brain Infarction|brain infarction
5021947|NCT01541163|Acute Stroke|acute stroke
5021948|NCT01541163|Heart Diseases|heart diseases
5021949|NCT01541163|Myocardial Infarction|myocardial infarction
5021950|NCT01541150|Pedophilia|pedophilia
5021951|NCT01541150|Impaired Decision making|impaired decision making
5021952|NCT01541150|Insight|insight
5021953|NCT01541150|Cognitive Distorsions|cognitive distorsions
5021954|NCT01541150|Impulsiveness|impulsiveness
5021955|NCT01541137|thoracotomy|thoracotomy
5021956|NCT01541137|pain|pain
5021957|NCT01541137|NSAID|nsaid
5021958|NCT01541137|PCA|pca
5021959|NCT01541137|TEA|tea
5021960|NCT01541137|chronic|chronic
5021961|NCT01541124|cancer pain|cancer pain
5021962|NCT01541124|analgesia|analgesia
5021963|NCT01541124|morphine|morphine
5021964|NCT01541111|Cancer pain|cancer pain
5021965|NCT01541111|Magnesiun|magnesiun
5021966|NCT01541085|Human Immunodeficiency Virus; HIV; Highly Active Antiretroviral Therapy; HAART; Darunavir; Ritonavir; Efavirenz; Kinetics; Immunological Recovery|human immunodeficiency virus; hiv; highly active antiretroviral therapy; haart; darunavir; ritonavir; efavirenz; kinetics; immunological recovery
5021967|NCT01541072|Lymphoma, B-cell|lymphoma, b-cell
5021968|NCT01541072|Lymphocyte reconstitution|lymphocyte reconstitution
5021969|NCT01541072|Lymphocyte subsets|lymphocyte subsets
5021970|NCT01541072|Peripheral stem cell transplantation|peripheral stem cell transplantation
5021971|NCT01541072|Induction chemotherapy|induction chemotherapy
5021972|NCT01541072|growth factor|growth factor
5021973|NCT01541072|Granulocyte Colony-stimulating factor|granulocyte colony-stimulating factor
5021974|NCT01541072|Pegfilgrastim|pegfilgrastim
5021975|NCT01541072|Filgrastim|filgrastim
5021976|NCT01541059|Third molar extraction|third molar extraction
5021977|NCT01541059|local anesthesia|local anesthesia
5021978|NCT01541059|ropivacaine|ropivacaine
5021979|NCT01541046|pediatric|pediatric
5021980|NCT01541046|infantile colic|infantile colic
5021981|NCT01541046|probiotic treatment|probiotic treatment
5021982|NCT01541033|autism|autism
5021983|NCT01541033|children|children
5021984|NCT01541007|Prostate Cancer|prostate cancer
5021985|NCT01541007|Metastatic|metastatic
5021986|NCT01541007|Castration Resistant|castration resistant
5021987|NCT01540994|Neoplasms|neoplasms
5021988|NCT01540994|Urogenital neoplasm|urogenital neoplasm
5021989|NCT01540994|Genital neoplasms, male|genital neoplasms, male
5021990|NCT01540955|Reduce Cognitive Complaints|reduce cognitive complaints
5021991|NCT01540955|improve cognitive function|improve cognitive function
5021992|NCT01540955|post-treatment breast cancer patients|post-treatment breast cancer patients
5021993|NCT01540942|Crohn's disease|crohn's disease
5021994|NCT01540942|Nutrition|nutrition
5021995|NCT01540942|Bowel resection|bowel resection
5021996|NCT01540942|Postoperative recurrence|postoperative recurrence
5021997|NCT01540942|complication|complication
5021998|NCT01540942|Active disease|active disease
5021999|NCT01540929|Smallpox|smallpox
5022000|NCT01540929|ACAM2000®|acam2000®
5022001|NCT01540929|Smallpox vaccine|smallpox vaccine
5022002|NCT01540916|acid-base equilibrium|acid-base equilibrium
5022003|NCT01540916|renal system|renal system
5022004|NCT01540916|urinary electrolytes|urinary electrolytes
5022005|NCT01540903|Malaria Challenge|malaria challenge
5022006|NCT01540903|Plasmodium falciparum|plasmodium falciparum
5022007|NCT01540903|PfSPZ Challenge|pfspz challenge
5022008|NCT01540903|Controlled|controlled
5022009|NCT01540903|human|human
5022010|NCT01540903|malaria infection|malaria infection
5022011|NCT01540864|Obesity|obesity
5022012|NCT01540864|Overweight|overweight
5022013|NCT01540864|Body Mass Index|body mass index
5022014|NCT01540851|Osteoarthritis|osteoarthritis
5022015|NCT01540851|Total Knee Replacement|total knee replacement
5022016|NCT01540851|total Knee Arthroplasty|total knee arthroplasty
5022017|NCT01540851|Post operative recovery, TKA|post operative recovery, tka
5022018|NCT01540851|Post-operative recovery TKR|post-operative recovery tkr
5022019|NCT01540851|Care Navigator|care navigator
5022020|NCT01540838|Bacterial meningitis|bacterial meningitis
5022021|NCT01540838|infusion|infusion
5022022|NCT01540838|bolus|bolus
5022023|NCT01540838|paracetamol|paracetamol
5022024|NCT01540812|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
5022025|NCT01540799|Migraine|migraine
5022026|NCT01540799|High disability migraine|high disability migraine
5022027|NCT01540799|Sphenopalatine ganglion|sphenopalatine ganglion
5022028|NCT01540799|Neuromodulation|neuromodulation
5022029|NCT01540799|Neurostimulation|neurostimulation
5022030|NCT01540799|Autonomic nervous system|autonomic nervous system
5022031|NCT01540786|OAB|oab
5022032|NCT01540786|High Resolution Urodynamics|high resolution urodynamics
5022033|NCT01540773|growth hormone|growth hormone
5022034|NCT01540747|intrafollicular melatonin|intrafollicular melatonin
5022035|NCT01540747|PCOS|pcos
5022036|NCT01540747|embryos quality|embryos quality
5022037|NCT01540747|oocytes quality|oocytes quality
5022038|NCT01540734|paracetamol|paracetamol
5022039|NCT01540734|pharmacokinetic|pharmacokinetic
5022040|NCT01540721|paracetamol|paracetamol
5022041|NCT01540721|pharmacokinetics|pharmacokinetics
5022042|NCT01540708|Asthma|asthma
5022043|NCT01540708|Respiratory|respiratory
5022044|NCT01540708|COPD|copd
5022045|NCT01540695|Any patient with a routine basal cell or squamous cell carcinoma|any patient with a routine basal cell or squamous cell carcinoma
5022046|NCT01540695|of the skin diagnosed on frozen histology during a Mohs procedure|of the skin diagnosed on frozen histology during a mohs procedure
5022047|NCT01540682|Male and female patients with HNSCC of the oral cavity, oropharynx, hypopharynx, larynx,|male and female patients with hnscc of the oral cavity, oropharynx, hypopharynx, larynx,
5022048|NCT01540682|nasopharynx or paranasal sinuses that is considered appropriate|nasopharynx or paranasal sinuses that is considered appropriate
5022049|NCT01540682|for definitive cetuximab-based radiation therapy.|for definitive cetuximab-based radiation therapy.
5022050|NCT01540669|constipation|constipation
5022051|NCT01540669|functional constipation|functional constipation
5022052|NCT01540669|polydextrose|polydextrose
5022053|NCT01540669|whole gut transit time|whole gut transit time
5022054|NCT01540656|Stress incontinence|stress incontinence
5022055|NCT01540656|Incontinence|incontinence
5022056|NCT01540656|prostate cancer|prostate cancer
5022057|NCT01540656|Radical Prostatectomy vibration|radical prostatectomy vibration
5022058|NCT01540656|nerve stimulation|nerve stimulation
5022059|NCT01540643|abdominal aortic aneurysm|abdominal aortic aneurysm
5022060|NCT01540643|iliac leg graft|iliac leg graft
5022061|NCT01540617|Low back pain|low back pain
5022062|NCT01540617|Proprioception|proprioception
5022063|NCT01540617|Postural control|postural control
5022064|NCT01540617|Spine|spine
5022065|NCT01540617|Variability|variability
5022066|NCT01540617|MRI|mri
5022067|NCT01540617|Vibration|vibration
5022068|NCT01540617|Brain|brain
5022069|NCT01540604|DMD|dmd
5022070|NCT01540604|BMD|bmd
5022071|NCT01540604|symptomatic carriers|symptomatic carriers
5022072|NCT01540591|repeated implantation failure|repeated implantation failure
5022073|NCT01540591|intralipid|intralipid
5022074|NCT01540552|lung cancer|lung cancer
5022075|NCT01540552|precancerous condition|precancerous condition
5022076|NCT01540552|lung nodules|lung nodules
5022077|NCT01540552|CT Scan|ct scan
5022078|NCT01540500|Pharmacokinetics|pharmacokinetics
5022079|NCT01540500|Drug Interaction|drug interaction
5022080|NCT01540474|Interference of malaria infection|interference of malaria infection
5022081|NCT01540461|HCC|hcc
5022082|NCT01540435|Colorectal cancer|colorectal cancer
5022083|NCT01540435|Liver metastases|liver metastases
5022084|NCT01540435|Perioperative treatment|perioperative treatment
5022085|NCT01540435|Liver resection|liver resection
5022086|NCT01540422|vein grafts|vein grafts
5022087|NCT01540422|coronary bypass|coronary bypass
5022088|NCT01540422|endoscopic harvest|endoscopic harvest
5022089|NCT01540422|endoscopic vein harvest|endoscopic vein harvest
5022090|NCT01540409|DMD, Duchenne, Eteplirsen, dystrophy, dystrophin, exon 51|dmd, duchenne, eteplirsen, dystrophy, dystrophin, exon 51
5022091|NCT01540396|Gestational Diabetes|gestational diabetes
5022092|NCT01540383|Communication|communication
5022093|NCT01540383|Language|language
5022094|NCT01540383|Treatment|treatment
5022095|NCT01540383|Intervention|intervention
5022096|NCT01540383|Therapy|therapy
5022097|NCT01540383|Efficacy|efficacy
5022098|NCT01540383|Maintenance|maintenance
5022099|NCT01540383|Recovery|recovery
5022100|NCT01540383|Outcome|outcome
5022101|NCT01540383|Rehabilitation|rehabilitation
5022102|NCT01540383|Treatment Intensity|treatment intensity
5022103|NCT01540383|Language Impairment|language impairment
5022104|NCT01540383|Intensive Language Therapy|intensive language therapy
5022105|NCT01540383|Functional Communication|functional communication
5022106|NCT01540383|Functional Improvement|functional improvement
5022107|NCT01540383|Evidence-Based Intervention|evidence-based intervention
5022108|NCT01540383|High-Frequency|high-frequency
5022109|NCT01540357|mindfulness-based therapy|mindfulness-based therapy
5022110|NCT01540357|chronic tinnitus;|chronic tinnitus;
5022111|NCT01540344|peritoneal carcinomatosis|peritoneal carcinomatosis
5022112|NCT01540344|cytoreductive surgery|cytoreductive surgery
5022113|NCT01540344|HIPEC|hipec
5022114|NCT01540344|colorectal cancer|colorectal cancer
5022115|NCT01540318|ultrasonography|ultrasonography
5022116|NCT01540318|Abdominal Injuries|abdominal injuries
5022117|NCT01540318|Trauma|trauma
5022118|NCT01540305|Obsessive Compulsive Disorder|obsessive compulsive disorder
5022119|NCT01540305|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
5022120|NCT01540305|Treatment|treatment
5022121|NCT01540292|Crohn's disease|crohn's disease
5022122|NCT01540292|Mesenchymal Stem Cell|mesenchymal stem cell
5022123|NCT01540292|Cell therapy|cell therapy
5022124|NCT01540292|Allogeneic|allogeneic
5022125|NCT01540292|Inflammatory disorders|inflammatory disorders
5022126|NCT01540292|Autoimmune disorders|autoimmune disorders
5022127|NCT01540266|physician-patient communication|physician-patient communication
5022128|NCT01540266|information structuring|information structuring
5022129|NCT01540266|emergency department|emergency department
5022130|NCT01540240|HIV treatment|hiv treatment
5022131|NCT01540240|zidovudine|zidovudine
5022132|NCT01540240|dose reduction|dose reduction
5022133|NCT01540240|anaemia|anaemia
5022134|NCT01540240|safety and efficacy comparison|safety and efficacy comparison
5022135|NCT01540227|Syphilis|syphilis
5022136|NCT01540227|Penicillin|penicillin
5022137|NCT01540214|Urinary Bladder, Overactive|urinary bladder, overactive
5022138|NCT01540214|Pelvic Organ Prolapse|pelvic organ prolapse
5022139|NCT01540214|Gynecologic Surgical Procedures|gynecologic surgical procedures
5022140|NCT01540214|Urodynamics|urodynamics
5022141|NCT01540201|one lung ventilation|one lung ventilation
5022142|NCT01540201|gas exchange|gas exchange
5022143|NCT01540201|inverse-ratio ventilation|inverse-ratio ventilation
5022144|NCT01540188|Drug user|drug user
5022145|NCT01540188|Family member|family member
5022146|NCT01540188|Intervention|intervention
5022147|NCT01540188|Community|community
5022148|NCT01540188|Support|support
5022149|NCT01540175|Autologous stem cell transplant|autologous stem cell transplant
5022150|NCT01540175|Immune reconstitution|immune reconstitution
5022151|NCT01540162|preterm newborn|preterm newborn
5022152|NCT01540162|neonatology|neonatology
5022153|NCT01540162|EcN|ecn
5022154|NCT01540162|Nissle|nissle
5022155|NCT01540162|Mutaflor|mutaflor
5022156|NCT01540162|prophylaxis|prophylaxis
5022157|NCT01540162|infection|infection
5022158|NCT01540110|Locally Advanced or Node Positive Primary Breast Cancer|locally advanced or node positive primary breast cancer
5022159|NCT01540084|Cocktail sedation|cocktail sedation
5022160|NCT01540084|ERCP|ercp
5022411|NCT01539083|Consolidation therapy|consolidation therapy
5022161|NCT01540071|Hormone refractory prostate cancer|hormone refractory prostate cancer
5022162|NCT01540071|HRPC|hrpc
5022163|NCT01540071|Androgen independent prostate cancer|androgen independent prostate cancer
5022164|NCT01540071|CRPC|crpc
5022165|NCT01540071|Castration and Taxane Resistant Prostate Cancer|castration and taxane resistant prostate cancer
5022166|NCT01540045|Non-Small Cell Lung Cancer|non-small cell lung cancer
5022167|NCT01540045|Dysgeusia|dysgeusia
5022168|NCT01540045|Antineoplastic Combined Chemotherapy Protocols|antineoplastic combined chemotherapy protocols
5022169|NCT01540045|Paclitaxel|paclitaxel
5022170|NCT01540045|Cisplatin|cisplatin
5022171|NCT01540019|anorexia|anorexia
5022172|NCT01540019|Paullinia cupana|paullinia cupana
5022173|NCT01540019|loss of weight|loss of weight
5022174|NCT01539993|Hepatocellular carcinoma|hepatocellular carcinoma
5022175|NCT01539993|Liver metastases|liver metastases
5022176|NCT01539993|Cholangiocarcinoma|cholangiocarcinoma
5022177|NCT01539993|Percutaneous treatments|percutaneous treatments
5022178|NCT01539993|RFA|rfa
5022179|NCT01539993|TACE|tace
5022180|NCT01539993|DEB|deb
5022181|NCT01539980|Sericin scaffold|sericin scaffold
5022182|NCT01539980|Wound healing|wound healing
5022183|NCT01539980|Skin graft donor|skin graft donor
5022184|NCT01539967|Laparoscopic Sleeve Gastrectomy|laparoscopic sleeve gastrectomy
5022185|NCT01539967|Obesity follow-up|obesity follow-up
5022186|NCT01539954|Alcohol related disorders|alcohol related disorders
5022187|NCT01539941|Co-occurring adolescent substance use and ADHD|co-occurring adolescent substance use and adhd
5022188|NCT01539928|Dual time PET/CT|dual time pet/ct
5022189|NCT01539928|glucose-6-phosphatase|glucose-6-phosphatase
5022190|NCT01539915|Psoriasis|psoriasis
5022191|NCT01539915|Stable plaque psoriasis|stable plaque psoriasis
5022192|NCT01539915|lesions|lesions
5022193|NCT01539915|TNF-alpha|tnf-alpha
5022194|NCT01539915|BCT194|bct194
5022195|NCT01539902|MSC for the treatment of Lupus Nephritis|msc for the treatment of lupus nephritis
5022196|NCT01539876|locally advanced breast cancer patients|locally advanced breast cancer patients
5022197|NCT01539850|obesity|obesity
5022198|NCT01539850|gastric stimulation|gastric stimulation
5022199|NCT01539850|morbid obesity|morbid obesity
5022200|NCT01539837|Parkinson's disease|parkinson's disease
5022201|NCT01539837|Brain Iron|brain iron
5022202|NCT01539837|Iron chelation|iron chelation
5022203|NCT01539837|Oxidative stress|oxidative stress
5022204|NCT01539811|Foot Infections|foot infections
5022205|NCT01539811|Diabetes|diabetes
5022206|NCT01539811|Antibiotic|antibiotic
5022207|NCT01539798|Saline solution|saline solution
5022208|NCT01539798|Sodium Chloride|sodium chloride
5022209|NCT01539798|Hypoalbuminemia|hypoalbuminemia
5022210|NCT01539798|Weight Gain|weight gain
5022211|NCT01539785|HIPEC|hipec
5022212|NCT01539785|Hyperthermic|hyperthermic
5022213|NCT01539785|ovarian cancer|ovarian cancer
5022214|NCT01539785|recurrence|recurrence
5022215|NCT01539759|Postpartum Contraception|postpartum contraception
5022216|NCT01539759|Intrauterine Devices|intrauterine devices
5022217|NCT01539746|Aortic stenosis|aortic stenosis
5022218|NCT01539746|Transcatheter aortic valve implantation|transcatheter aortic valve implantation
5022219|NCT01539746|TAVI|tavi
5022220|NCT01539746|Predilation|predilation
5022221|NCT01539746|Balloon valvuloplasty|balloon valvuloplasty
5022222|NCT01539746|BAV|bav
5022223|NCT01539746|CoreValve|corevalve
5022224|NCT01539720|emergency contraception|emergency contraception
5022225|NCT01539720|Ella|ella
5022226|NCT01539720|Mirena IUD|mirena iud
5022227|NCT01539720|post-coital contraception|post-coital contraception
5022228|NCT01539720|Liletta IUD|liletta iud
5022229|NCT01539707|Neurogenic Detrusor Overactivity|neurogenic detrusor overactivity
5022230|NCT01539707|Solifenacin succinate suspension|solifenacin succinate suspension
5022231|NCT01539707|Pharmacokinetics|pharmacokinetics
5022232|NCT01539707|Phase 1|phase 1
5022233|NCT01539681|Hepatocellular Carcinoma|hepatocellular carcinoma
5022234|NCT01539681|Cancer, Liver|cancer, liver
5022235|NCT01539681|Sorafenib|sorafenib
5022236|NCT01539681|Nexavar|nexavar
5022237|NCT01539668|Cervical Cancer|cervical cancer
5022238|NCT01539668|HPV|hpv
5022239|NCT01539668|Secondary prevention|secondary prevention
5022240|NCT01539655|Phase 1|phase 1
5022241|NCT01539655|healthy volunteers|healthy volunteers
5022242|NCT01539655|pharmacokinetics|pharmacokinetics
5022243|NCT01539655|vandetanib|vandetanib
5022244|NCT01539655|omeprazole|omeprazole
5022245|NCT01539655|ranitidine|ranitidine
5022246|NCT01539642|In patient, post operative pain|in patient, post operative pain
5022247|NCT01539642|Adult post-operative inpatients who are expected to require parenteral opioid analgesia for at least 48 hours after open abdominal surgery|adult post-operative inpatients who are expected to require parenteral opioid analgesia for at least 48 hours after open abdominal surgery
5022248|NCT01539629|Heart failure|heart failure
5022249|NCT01539629|Autothreshold|autothreshold
5022250|NCT01539629|Pacing|pacing
5022251|NCT01539629|CRT-D recipients|crt-d recipients
5022252|NCT01539629|Left Ventricular evoked response signals|left ventricular evoked response signals
5022253|NCT01539616|Hypertriglyceridemia|hypertriglyceridemia
5022254|NCT01539616|Dyslipidemia|dyslipidemia
5022255|NCT01539603|drug eluting balloon|drug eluting balloon
5022256|NCT01539603|bare metal stent|bare metal stent
5022257|NCT01539603|drug eluting stent|drug eluting stent
5022258|NCT01539603|coronary artery disease|coronary artery disease
5022259|NCT01539590|hepatocyte growth factor mimetic|hepatocyte growth factor mimetic
5022260|NCT01539590|hepatocyte growth factor(HGF)|hepatocyte growth factor(hgf)
5022261|NCT01539590|Myocardial Infarction|myocardial infarction
5022262|NCT01539590|Acute ST Segment Elevation Myocardial Infarction (STEMI)|acute st segment elevation myocardial infarction (stemi)
5022263|NCT01539590|Percutaneous Coronary Intervention (PCI)|percutaneous coronary intervention (pci)
5022264|NCT01539538|Adult post-operative inpatients who|adult post-operative inpatients who
5022265|NCT01539538|are expected to require parenteral|are expected to require parenteral
5022266|NCT01539538|opioid analgesia for at least 48|opioid analgesia for at least 48
5022267|NCT01539538|hours after open abdominal surgery|hours after open abdominal surgery
5022268|NCT01539538|or hip/knee replacement surgery|or hip/knee replacement surgery
5022269|NCT01539512|CLL|cll
5022270|NCT01539512|CAL-101|cal-101
5022271|NCT01539512|GS 1101|gs 1101
5022272|NCT01539512|PI3K|pi3k
5022273|NCT01539512|GS-US-312-0117|gs-us-312-0117
5022274|NCT01539512|idelalisib|idelalisib
5022275|NCT01539460|Axillary osmidrosis|axillary osmidrosis
5022276|NCT01539460|liposuction|liposuction
5022277|NCT01539460|minimally invasive surgery|minimally invasive surgery
5022278|NCT01539447|Hip arthroscopy|hip arthroscopy
5022279|NCT01539447|Femoroacetabular impingement|femoroacetabular impingement
5022280|NCT01539447|Heterotopic ossification|heterotopic ossification
5022412|NCT01539083|Subcutaneous|subcutaneous
5022281|NCT01539447|Heterotopic bone formation|heterotopic bone formation
5022282|NCT01539434|COPD|copd
5022283|NCT01539434|Behavioral intervention|behavioral intervention
5022284|NCT01539434|Physical capacity|physical capacity
5022285|NCT01539434|Physical activity|physical activity
5022286|NCT01539421|COPD|copd
5022287|NCT01539421|exercise endurance|exercise endurance
5022288|NCT01539395|Relapsing Remitting|relapsing remitting
5022289|NCT01539395|MS|ms
5022290|NCT01539382|cardiac surgery|cardiac surgery
5022291|NCT01539382|neurocognitive assessment|neurocognitive assessment
5022292|NCT01539382|neurocognitive function|neurocognitive function
5022293|NCT01539369|dietary intervention|dietary intervention
5022294|NCT01539369|dietary fibre|dietary fibre
5022295|NCT01539369|weight loss|weight loss
5022296|NCT01539369|weight maintenance|weight maintenance
5022297|NCT01539356|Hepcidin|hepcidin
5022298|NCT01539356|Preterm Infants|preterm infants
5022299|NCT01539356|Anemia|anemia
5022300|NCT01539356|Sepsis|sepsis
5022301|NCT01539356|Ferritin|ferritin
5022302|NCT01539343|Infection|infection
5022303|NCT01539343|Catheter-related bloodstream infection|catheter-related bloodstream infection
5022304|NCT01539343|CRBSI|crbsi
5022305|NCT01539343|Antimicrobial Lock Therapy|antimicrobial lock therapy
5022306|NCT01539343|ALT|alt
5022307|NCT01539343|Central Line Associated Bloodstream Infection|central line associated bloodstream infection
5022308|NCT01539343|CLABSI|clabsi
5022309|NCT01539343|Central Venous Catheter|central venous catheter
5022310|NCT01539343|CVC|cvc
5022311|NCT01539343|Quantitative blood cultures|quantitative blood cultures
5022312|NCT01539343|QBC|qbc
5022313|NCT01539330|voriconazole|voriconazole
5022314|NCT01539330|microdialysis|microdialysis
5022315|NCT01539330|sequence therapy|sequence therapy
5022316|NCT01539330|pharmacokinetics|pharmacokinetics
5022317|NCT01539330|Target Site Pharmacokinetics|target site pharmacokinetics
5022318|NCT01539317|Vulvodynia|vulvodynia
5022319|NCT01539317|Dyspareunia|dyspareunia
5022320|NCT01539317|Breast Cancer|breast cancer
5022321|NCT01539317|Menopause|menopause
5022322|NCT01539317|Vaginal dryness|vaginal dryness
5022323|NCT01539317|Painful intercourse|painful intercourse
5022325|NCT01539291|CAL-101|cal-101
5022326|NCT01539291|CAL 101|cal 101
5022327|NCT01539291|GS-1101|gs-1101
5022328|NCT01539291|GS 1101|gs 1101
5022329|NCT01539291|PI3K|pi3k
5022330|NCT01539291|Leukemia|leukemia
5022331|NCT01539291|GS-US-312-0116|gs-us-312-0116
5022332|NCT01539291|idelalisib|idelalisib
5022333|NCT01539278|Sleep Apnea, Obstructive|sleep apnea, obstructive
5022334|NCT01539278|Child|child
5022335|NCT01539278|Tonsillectomy|tonsillectomy
5022336|NCT01539278|Adenoidectomy|adenoidectomy
5022337|NCT01539265|urinary calculus|urinary calculus
5022338|NCT01539265|ureteral stones|ureteral stones
5022339|NCT01539265|medical expulsive therapy|medical expulsive therapy
5022340|NCT01539252|hemodialysis|hemodialysis
5022341|NCT01539252|adequacy|adequacy
5022342|NCT01539252|phosphate clearance|phosphate clearance
5022343|NCT01539252|double dialyzer|double dialyzer
5022344|NCT01539252|two dialyzers in parallel|two dialyzers in parallel
5022345|NCT01539239|Glaucoma|glaucoma
5022346|NCT01539239|POAG|poag
5022347|NCT01539239|Cataract|cataract
5022348|NCT01539226|HIV Infections|hiv infections
5022349|NCT01539226|Anti-HIV agents|anti-hiv agents
5022350|NCT01539226|HIV-1|hiv-1
5022351|NCT01539213|Psoriasis|psoriasis
5022352|NCT01539213|interstitial fluid|interstitial fluid
5022353|NCT01539213|open flow microperfusion|open flow microperfusion
5022354|NCT01539213|IL-17|il-17
5022355|NCT01539213|inflammatory skin disease|inflammatory skin disease
5022356|NCT01539213|scaly patches|scaly patches
5022357|NCT01539213|Healthy volunteers and psoriasis patients|healthy volunteers and psoriasis patients
5022358|NCT01539187|uterine fibroid RF ablation|uterine fibroid rf ablation
5022359|NCT01539187|intrauterine ultrasound|intrauterine ultrasound
5022360|NCT01539187|VizAblate|vizablate
5022361|NCT01539161|Chagas Disease|chagas disease
5022362|NCT01539161|Chagasic|chagasic
5022363|NCT01539161|Reveal XT|reveal xt
5022364|NCT01539161|Implantable Cardiac Monitor|implantable cardiac monitor
5022365|NCT01539161|ICM|icm
5022366|NCT01539148|Quality of Life|quality of life
5022367|NCT01539148|Qol|qol
5022368|NCT01539148|Questionnaire|questionnaire
5022369|NCT01539148|Survey|survey
5022370|NCT01539148|Insulin Potentiation Targeted Low Dose Chemotherapy|insulin potentiation targeted low dose chemotherapy
5022371|NCT01539148|IPTLD|iptld
5022372|NCT01539148|Nutritional Therapy|nutritional therapy
5022373|NCT01539148|Chemotherapy|chemotherapy
5022374|NCT01539148|Cancer Treatment|cancer treatment
5022375|NCT01539148|Kotsanis Institute|kotsanis institute
5022376|NCT01539148|The Best Answer for Cancer Foundation|the best answer for cancer foundation
5022377|NCT01539148|Liberty IRB|liberty irb
5022378|NCT01539148|Texas|texas
5022379|NCT01539135|Aspiration, Respiratory|aspiration, respiratory
5022380|NCT01539122|osteoarthritis|osteoarthritis
5022381|NCT01539122|shoulder replacement|shoulder replacement
5022382|NCT01539109|Incomplete Spinal Cord Injury|incomplete spinal cord injury
5022383|NCT01539109|Quadriplegia|quadriplegia
5022384|NCT01539109|Tetraplegia|tetraplegia
5022385|NCT01539109|SCI|sci
5022386|NCT01539109|Spinal Cord Disease|spinal cord disease
5022387|NCT01539109|Spinal Cord Injury|spinal cord injury
5022388|NCT01539109|iSCI|isci
5022389|NCT01539109|Transcranial Direct Current Stimulation|transcranial direct current stimulation
5022390|NCT01539109|tDCS|tdcs
5022391|NCT01539109|SCI recovery|sci recovery
5022392|NCT01539109|brain stimulation|brain stimulation
5022393|NCT01539109|rehabilitation|rehabilitation
5022394|NCT01539096|Stroke|stroke
5022395|NCT01539096|Rehabilitation|rehabilitation
5022396|NCT01539096|Paresis|paresis
5022397|NCT01539096|Paralysis|paralysis
5022398|NCT01539096|Recovery|recovery
5022399|NCT01539096|tDCS|tdcs
5022400|NCT01539096|Transcranial Direct Current Stimulation|transcranial direct current stimulation
5022401|NCT01539096|CIMT|cimt
5022402|NCT01539096|Constraint Induced Movement Therapy|constraint induced movement therapy
5022403|NCT01539096|Stroke therapy|stroke therapy
5022404|NCT01539096|MRI|mri
5022405|NCT01539096|Hand|hand
5022406|NCT01539096|CVA|cva
5022407|NCT01539096|Cerebrovascular accident|cerebrovascular accident
5022408|NCT01539083|Multiple Myeloma|multiple myeloma
5022409|NCT01539083|Bortezomib|bortezomib
5022410|NCT01539083|VELCADE|velcade
5022413|NCT01539083|Thalidomide|thalidomide
5022414|NCT01539083|Prednisolone|prednisolone
5022415|NCT01539083|Autologous stem cell transplant (ASCT)|autologous stem cell transplant (asct)
5022416|NCT01539083|VELCADE, cyclophosphamide, dexamethasone (VCD) induction therapy|velcade, cyclophosphamide, dexamethasone (vcd) induction therapy
5022417|NCT01539070|Nutritional intervention|nutritional intervention
5022418|NCT01539070|Childhood obesity|childhood obesity
5022419|NCT01539070|Physical activity|physical activity
5022420|NCT01539070|Feeding practices|feeding practices
5022421|NCT01539057|Liver|liver
5022422|NCT01539057|Surgery|surgery
5022423|NCT01539057|hemostasis|hemostasis
5022424|NCT01539057|coagulation|coagulation
5022425|NCT01539057|Fibrinogen|fibrinogen
5022426|NCT01539044|reversal|reversal
5022427|NCT01539044|muscle relaxant|muscle relaxant
5022428|NCT01539044|sugammadex|sugammadex
5022429|NCT01539031|Alzheimer Disease|alzheimer disease
5022430|NCT01539031|Dementia|dementia
5022431|NCT01539031|Delirium|delirium
5022432|NCT01539031|Amnestic|amnestic
5022433|NCT01539031|Cognitive Disorders|cognitive disorders
5022434|NCT01539031|Donepezil|donepezil
5022435|NCT01539031|Brain Diseases|brain diseases
5022436|NCT01539031|Central Nervous System Diseases|central nervous system diseases
5022437|NCT01539031|Nervous System Diseases|nervous system diseases
5022438|NCT01539031|Tauopathies|tauopathies
5022439|NCT01539031|Neurodegenerative Diseases|neurodegenerative diseases
5022440|NCT01539031|Mental Disorders|mental disorders
5022441|NCT01539031|Cholinesterase Inhibitors|cholinesterase inhibitors
5022442|NCT01539031|Enzy|enzy
5022443|NCT01539005|Recurrence|recurrence
5022444|NCT01539005|Tuberculosis|tuberculosis
5022445|NCT01538992|renal denervation|renal denervation
5022446|NCT01538992|heart failure|heart failure
5022447|NCT01538979|Grass pollen allergy|grass pollen allergy
5022448|NCT01538979|Immunotherapy|immunotherapy
5022449|NCT01538979|Recombinant vaccine|recombinant vaccine
5022450|NCT01538979|Rhinitis, allergic, seasonal|rhinitis, allergic, seasonal
5022451|NCT01538966|acromegaly|acromegaly
5022452|NCT01538966|pituitary|pituitary
5022453|NCT01538966|pegvisomant|pegvisomant
5022454|NCT01538966|somavert|somavert
5022455|NCT01538966|lanreotide|lanreotide
5022456|NCT01538966|octreotide|octreotide
5022457|NCT01538953|diarrhea|diarrhea
5022458|NCT01538953|handwashing|handwashing
5022459|NCT01538953|point-of-use water treatment|point-of-use water treatment
5022460|NCT01538953|diarrhea longitudinal prevalence|diarrhea longitudinal prevalence
5022461|NCT01538940|Influenza|influenza
5022462|NCT01538940|Vaccine|vaccine
5022463|NCT01538940|Thailand|thailand
5022464|NCT01538927|fibrin sealant|fibrin sealant
5022465|NCT01538927|tissue adhesive|tissue adhesive
5022466|NCT01538927|wound healing|wound healing
5022467|NCT01538927|interleukin 1 beta|interleukin 1 beta
5022468|NCT01538927|interleukin 8|interleukin 8
5022469|NCT01538901|actinic keratoses|actinic keratoses
5022470|NCT01538901|organ transplant recipients|organ transplant recipients
5022471|NCT01538901|photodynamic therapy|photodynamic therapy
5022472|NCT01538901|imiquimod|imiquimod
5022473|NCT01538888|WHOLE BODY VIBRATION|whole body vibration
5022474|NCT01538888|AGED|aged
5022475|NCT01538888|VO2|vo2
5022476|NCT01538888|muscle strength|muscle strength
5022477|NCT01538875|Hypertension, pregnancy induced|hypertension, pregnancy induced
5022478|NCT01538875|Hydralazine|hydralazine
5022479|NCT01538875|Labetalol|labetalol
5022480|NCT01538823|Surgery, Renal Cell Cancer|surgery, renal cell cancer
5022481|NCT01538810|CT imaging|ct imaging
5022482|NCT01538797|YF476|yf476
5022483|NCT01538797|gastrin receptor antagonist|gastrin receptor antagonist
5022484|NCT01538797|gastric pH|gastric ph
5022485|NCT01538797|healthy subjects|healthy subjects
5022486|NCT01538797|ranitidine|ranitidine
5022487|NCT01538784|YF476|yf476
5022488|NCT01538784|gastrin receptor antagonist|gastrin receptor antagonist
5022489|NCT01538784|gastric pH|gastric ph
5022490|NCT01538784|healthy subjects|healthy subjects
5022491|NCT01538771|Myocardial infarction|myocardial infarction
5022492|NCT01538771|Erythropoietin|erythropoietin
5022493|NCT01538771|Myocardial reperfusion injury|myocardial reperfusion injury
5022494|NCT01538758|calcifying tendinitis|calcifying tendinitis
5022495|NCT01538758|rotator cuff|rotator cuff
5022496|NCT01538745|Pain|pain
5022497|NCT01538745|Emergency Department|emergency department
5022498|NCT01538745|Morphine|morphine
5022499|NCT01538745|Ketamine|ketamine
5022500|NCT01538706|Hospital-based home care|hospital-based home care
5022501|NCT01538706|Pediatric oncology|pediatric oncology
5022502|NCT01538693|BDNF|bdnf
5022503|NCT01538693|serotonin|serotonin
5022504|NCT01538693|high-intensity|high-intensity
5022505|NCT01538693|exercise|exercise
5022506|NCT01538667|Lung|lung
5022507|NCT01538667|Scintigraphy|scintigraphy
5022508|NCT01538667|Pharmacokinetics|pharmacokinetics
5022509|NCT01538667|Inhalation|inhalation
5022510|NCT01538667|Ciprofloxacin|ciprofloxacin
5022511|NCT01538654|obesity|obesity
5022512|NCT01538654|PSMF ( protein sparing modified fast)|psmf ( protein sparing modified fast)
5022513|NCT01538654|Enteral nutrition|enteral nutrition
5022514|NCT01538654|Tube feeding|tube feeding
5022515|NCT01538654|VLCD ( very low calorie diet)|vlcd ( very low calorie diet)
5022516|NCT01538654|Pulmonary function tests|pulmonary function tests
5022517|NCT01538654|body composition|body composition
5022518|NCT01538654|FFM ( fat free mass)|ffm ( fat free mass)
5022519|NCT01538654|Body fat|body fat
5022520|NCT01538654|Handgripstregth|handgripstregth
5022521|NCT01538628|Prostate cancer|prostate cancer
5022522|NCT01538628|Spacer|spacer
5022523|NCT01538615|Family meals|family meals
5022524|NCT01538615|Home food environment|home food environment
5022525|NCT01538615|Electronic media|electronic media
5022526|NCT01538602|PCOS|pcos
5022527|NCT01538602|cardiovascular disorders|cardiovascular disorders
5022528|NCT01538563|ON 01910.Na|on 01910.na
5022529|NCT01538563|rigosertib sodium|rigosertib sodium
5022530|NCT01538563|rogosertib|rogosertib
5022531|NCT01538550|cancer|cancer
5022532|NCT01538550|colon|colon
5022533|NCT01538550|rectum|rectum
5022534|NCT01538550|adenoma|adenoma
5022535|NCT01538550|screening|screening
5022536|NCT01538550|iFOBT|ifobt
5022537|NCT01538550|flexible sigmoidoscopy|flexible sigmoidoscopy
5022538|NCT01538550|randomized trial|randomized trial
5022539|NCT01538537|ON 01910.Na|on 01910.na
5022540|NCT01538537|rigosertib Sodium|rigosertib sodium
5022541|NCT01538537|rigosertib|rigosertib
5022542|NCT01538498|PCI|pci
5022543|NCT01538498|Ovarian cancer|ovarian cancer
5022544|NCT01538485|Vitamin D|vitamin d
5022545|NCT01538485|regulatory T cells|regulatory t cells
5022546|NCT01538485|GUT|gut
5022547|NCT01538472|Lymphoma|lymphoma
5022548|NCT01538472|Relapse B-cell CD20+ non-Hodgkin's lymphoma|relapse b-cell cd20+ non-hodgkin's lymphoma
5022549|NCT01538472|High-dose BEAM chemotherapy|high-dose beam chemotherapy
5022550|NCT01538472|Y Zevalin|y zevalin
5022551|NCT01538472|In Zevalin|in zevalin
5022552|NCT01538472|Rituxan|rituxan
5022553|NCT01538472|Rituximab|rituximab
5022554|NCT01538472|BCNU|bcnu
5022555|NCT01538472|1,3-bis(2-chloroethyl)-1-nitrosourea bis-chloronitrosourea|1,3-bis(2-chloroethyl)-1-nitrosourea bis-chloronitrosourea
5022556|NCT01538472|Carmustine|carmustine
5022557|NCT01538472|BiCNU|bicnu
5022558|NCT01538472|VP-16|vp-16
5022559|NCT01538472|Ara-C|ara-c
5022560|NCT01538472|Cytarabine|cytarabine
5022561|NCT01538472|Cytosar|cytosar
5022562|NCT01538472|DepoCyt|depocyt
5022563|NCT01538472|Cytosine Arabinosine Hydrochloride|cytosine arabinosine hydrochloride
5022564|NCT01538472|Melphalan|melphalan
5022565|NCT01538472|Alkeran|alkeran
5022566|NCT01538472|G-CSF|g-csf
5022567|NCT01538472|Filgrastim|filgrastim
5022568|NCT01538472|Neupogen|neupogen
5022569|NCT01538472|Stem cell infusion|stem cell infusion
5022570|NCT01538472|Autologous stem cell transplantation|autologous stem cell transplantation
5022571|NCT01538459|Blood Glucose|blood glucose
5022572|NCT01538459|Bupivacaine|bupivacaine
5022573|NCT01538459|Interscalene Nerve Block|interscalene nerve block
5022574|NCT01538459|Regional Anesthesia|regional anesthesia
5022575|NCT01538459|Pain Blockade|pain blockade
5022576|NCT01538459|Arthroscopic Surgery|arthroscopic surgery
5022577|NCT01538459|Arthroscopic rotator cuff repair|arthroscopic rotator cuff repair
5022578|NCT01538459|Dexamethasone|dexamethasone
5022579|NCT01538459|Anti-Inflammatory Agents|anti-inflammatory agents
5022580|NCT01538459|Therapeutic Uses|therapeutic uses
5022581|NCT01538459|Physiological Effects of Drugs|physiological effects of drugs
5022582|NCT01538459|Glucocorticoids|glucocorticoids
5022583|NCT01538459|Anesthetics, Local|anesthetics, local
5022584|NCT01538459|Anesthetics|anesthetics
5022585|NCT01538459|Sensory System Agents|sensory system agents
5022586|NCT01538459|Adjuvants, Anesthesia|adjuvants, anesthesia
5022587|NCT01538459|Anesthesiology|anesthesiology
5022588|NCT01538459|Injections|injections
5022589|NCT01538459|Adult|adult
5022590|NCT01538459|Analgesia/methods|analgesia/methods
5022591|NCT01538459|Brachial Plexus/drug effects|brachial plexus/drug effects
5022592|NCT01538459|Brachial Plexus/surgery|brachial plexus/surgery
5022593|NCT01538459|Brachial Plexus/ultrasonography|brachial plexus/ultrasonography
5022594|NCT01538459|Bupivacaine/administration & dosage|bupivacaine/administration & dosage
5022595|NCT01538459|Dexamethasone/administration & dosage|dexamethasone/administration & dosage
5022596|NCT01538459|Drug Therapy, Combination|drug therapy, combination
5022597|NCT01538459|Female|female
5022598|NCT01538459|Humans|humans
5022599|NCT01538459|Male|male
5022600|NCT01538459|Nerve Block/methods|nerve block/methods
5022601|NCT01538459|Pain, Postoperative/etiology|pain, postoperative/etiology
5022602|NCT01538459|Pain, Postoperative/prevention & control|pain, postoperative/prevention & control
5022603|NCT01538459|Prospective Studies|prospective studies
5022604|NCT01538459|Time Factors|time factors
5022605|NCT01538446|Elderly|elderly
5022606|NCT01538446|Acute coronary syndrome|acute coronary syndrome
5022607|NCT01538446|Percutaneous coronary intervention|percutaneous coronary intervention
5022608|NCT01538446|Prasugrel|prasugrel
5022609|NCT01538446|Platelet function test|platelet function test
5022610|NCT01538433|diagnosis|diagnosis
5022611|NCT01538433|IgA nephropathy|iga nephropathy
5022612|NCT01538420|Safety|safety
5022613|NCT01538420|Tolerability|tolerability
5022614|NCT01538420|Pharmacokinetics|pharmacokinetics
5022615|NCT01538420|Pharmacodynamics|pharmacodynamics
5022616|NCT01538407|Strength training|strength training
5022617|NCT01538407|Biomechanics|biomechanics
5022618|NCT01538407|Quadriceps|quadriceps
5022619|NCT01538407|Gait|gait
5022620|NCT01538394|smoking cessation|smoking cessation
5022621|NCT01538394|abstinence|abstinence
5022622|NCT01538394|clinical trial|clinical trial
5022623|NCT01538394|varenicline|varenicline
5022624|NCT01538394|nicotine|nicotine
5022625|NCT01538381|Neoadjuvant targeted therapy|neoadjuvant targeted therapy
5022626|NCT01538381|Preoperative targeted therapy|preoperative targeted therapy
5022627|NCT01538381|Afatinib|afatinib
5022628|NCT01538368|MRCP|mrcp
5022629|NCT01538368|ERCP|ercp
5022630|NCT01538368|EUS|eus
5022631|NCT01538368|Image interpretation|image interpretation
5022632|NCT01538368|MRCP findings|mrcp findings
5022633|NCT01538368|endoscopic intervention(s)|endoscopic intervention(s)
5022634|NCT01538355|multiple sclerosis|multiple sclerosis
5022635|NCT01538355|diet|diet
5022636|NCT01538355|prolonged fasting|prolonged fasting
5022637|NCT01538355|caloric restriction|caloric restriction
5022638|NCT01538355|ketogenic low glycemic load treatment|ketogenic low glycemic load treatment
5022639|NCT01538355|health related quality of life|health related quality of life
5022640|NCT01538355|ketogenic diet|ketogenic diet
5022641|NCT01538355|neurodegeneration|neurodegeneration
5022642|NCT01538355|neuroinflammation|neuroinflammation
5022643|NCT01538329|Dyskinesia|dyskinesia
5022644|NCT01538329|L-DOPA|l-dopa
5022645|NCT01538329|Early introduced treatment|early introduced treatment
5022646|NCT01538329|Amantadine|amantadine
5022647|NCT01538316|Prostate cancer|prostate cancer
5022648|NCT01538316|dietary supplements|dietary supplements
5022649|NCT01538316|quercetin|quercetin
5022650|NCT01538316|genistein|genistein
5022651|NCT01538316|prostate-specific antigen|prostate-specific antigen
5022652|NCT01538316|oxidative Status|oxidative status
5022653|NCT01538303|STEMI|stemi
5022654|NCT01538303|absolute flow|absolute flow
5022655|NCT01538303|microvascular resistance|microvascular resistance
5022656|NCT01538290|Calibration|calibration
5022657|NCT01538290|Validation|validation
5022658|NCT01538290|Transfer function|transfer function
5022659|NCT01538290|SphygmoCor|sphygmocor
5022660|NCT01538290|Arteriograph|arteriograph
5022661|NCT01538277|contact force catheter|contact force catheter
5022662|NCT01538277|loop recorder|loop recorder
5022663|NCT01538251|ulcerative colitis|ulcerative colitis
5022664|NCT01538251|propionyl-l-carnitine|propionyl-l-carnitine
5022665|NCT01538225|Spasticity|spasticity
5022666|NCT01538212|Alzheimer's disease|alzheimer's disease
5022667|NCT01538212|retrospective|retrospective
5022668|NCT01538212|Axona|axona
5022669|NCT01538199|Device study|device study
5022670|NCT01538199|Depression|depression
5022671|NCT01538199|Major Depression|major depression
5022672|NCT01538199|Major Depressive Disorder|major depressive disorder
5022673|NCT01538199|MDD|mdd
5022674|NCT01538199|Device for depression|device for depression
5022675|NCT01538199|Alternatives to medication for depression|alternatives to medication for depression
5022676|NCT01538199|Massachusetts General Hospital|massachusetts general hospital
5022677|NCT01538199|Boston|boston
5022678|NCT01538186|Coronary intervention|coronary intervention
5022679|NCT01538186|PCI of the side branch|pci of the side branch
5022680|NCT01538173|surgical side infection|surgical side infection
5022681|NCT01538173|breast reduction|breast reduction
5022682|NCT01538173|reduction mammaplasty|reduction mammaplasty
5022683|NCT01538173|prospective trial|prospective trial
5022684|NCT01538173|microcirculation|microcirculation
5022685|NCT01538173|breast surgery|breast surgery
5022686|NCT01538160|recombinant factor VIIa|recombinant factor viia
5022687|NCT01538160|factor XI deficiency|factor xi deficiency
5022688|NCT01538147|Restless Leg Syndrome|restless leg syndrome
5022689|NCT01538147|Severe Preeclampsia|severe preeclampsia
5022690|NCT01538134|Antibodies, anticardiolipin|antibodies, anticardiolipin
5022691|NCT01538134|Antibodies, B2 Glycoprotein I|antibodies, b2 glycoprotein i
5022692|NCT01538134|Lupus Anticoagulant|lupus anticoagulant
5022693|NCT01538134|Fetal Growth Restriction|fetal growth restriction
5022694|NCT01538121|Antibodies, anticardiolipin|antibodies, anticardiolipin
5022695|NCT01538121|Antibodies, B2 Glycoprotein I|antibodies, b2 glycoprotein i
5022696|NCT01538121|Lupus Anticoagulant|lupus anticoagulant
5022697|NCT01538121|Severe Preeclampsia|severe preeclampsia
5022698|NCT01538082|Anxiety disorders|anxiety disorders
5022699|NCT01538082|Depressive disorders|depressive disorders
5022700|NCT01538082|Metabolic syndrome|metabolic syndrome
5022701|NCT01538082|Stress disorders|stress disorders
5022702|NCT01538082|Primary care|primary care
5022703|NCT01538069|Heart failure|heart failure
5022704|NCT01538069|Sleep apnea syndromes|sleep apnea syndromes
5022705|NCT01538069|Exercise|exercise
5022706|NCT01538069|Continuous Positive Airway Pressure|continuous positive airway pressure
5022707|NCT01538056|AAA|aaa
5022708|NCT01538043|Cost-effectiveness analysis|cost-effectiveness analysis
5022709|NCT01538043|Cost-utility analysis|cost-utility analysis
5022710|NCT01538043|Osteoarthritis|osteoarthritis
5022711|NCT01538043|Spa therapy|spa therapy
5022712|NCT01538043|Randomized clinical trial|randomized clinical trial
5022713|NCT01538043|Mechanisms of action|mechanisms of action
5022714|NCT01538030|Fetal membranes, premature rupture|fetal membranes, premature rupture
5022715|NCT01538030|Cesarean section|cesarean section
5022716|NCT01538030|Perinatal mortality|perinatal mortality
5022717|NCT01538030|Neonatal sepsis|neonatal sepsis
5022718|NCT01538030|Amniotic Fluid Volume|amniotic fluid volume
5022719|NCT01538004|Blood pressure determination|blood pressure determination
5022720|NCT01538004|Primary health care|primary health care
5022721|NCT01538004|Office visits|office visits
5022722|NCT01538004|Reproducibility of results|reproducibility of results
5022723|NCT01537991|radiotherapy|radiotherapy
5022724|NCT01537991|non small cell lung cancer|non small cell lung cancer
5022725|NCT01537991|isotoxic|isotoxic
5022726|NCT01537978|spinal cord injury, video gaming, functional improvement|spinal cord injury, video gaming, functional improvement
5022727|NCT01537965|hepatitis|hepatitis
5022728|NCT01537965|fibrosis|fibrosis
5022729|NCT01537965|elastography|elastography
5022835|NCT01537393|endothelial keratoplasty|endothelial keratoplasty
5022730|NCT01537952|facial paralysis, facial nerve, borreliosis, Bell's palsy|facial paralysis, facial nerve, borreliosis, bell's palsy
5022731|NCT01537939|Physical Activity|physical activity
5022732|NCT01537939|Walking|walking
5022733|NCT01537939|Pedometer|pedometer
5022734|NCT01537939|Body Composition|body composition
5022735|NCT01537939|Aerobic Fitness|aerobic fitness
5022736|NCT01537926|HALT|halt
5022737|NCT01537926|HCM|hcm
5022738|NCT01537874|Secondhand smoke|secondhand smoke
5022739|NCT01537874|Pediatric disease|pediatric disease
5022740|NCT01537848|EUS|eus
5022741|NCT01537848|Endoscopic ultrasound|endoscopic ultrasound
5022742|NCT01537848|abdominal collection|abdominal collection
5022743|NCT01537848|post-operative|post-operative
5022744|NCT01537848|post-surgical|post-surgical
5022745|NCT01537835|healthcare|healthcare
5022746|NCT01537835|worker|worker
5022747|NCT01537835|uniforms|uniforms
5022748|NCT01537835|bacterial|bacterial
5022749|NCT01537835|contamination|contamination
5022750|NCT01537822|intrauterine polyps|intrauterine polyps
5022751|NCT01537822|myomas|myomas
5022752|NCT01537822|residual placental tissue|residual placental tissue
5022753|NCT01537809|Vitamin D|vitamin d
5022754|NCT01537809|Vitamin D Deficiency|vitamin d deficiency
5022755|NCT01537809|Avitaminosis|avitaminosis
5022756|NCT01537809|Deficiency Diseases|deficiency diseases
5022757|NCT01537809|Blood lipids|blood lipids
5022758|NCT01537796|Obesity|obesity
5022759|NCT01537796|Exercise|exercise
5022760|NCT01537783|abscess|abscess
5022761|NCT01537770|Vertebroplasty|vertebroplasty
5022762|NCT01537770|Low energy osteoporotic vertebral fractures|low energy osteoporotic vertebral fractures
5022763|NCT01537770|of the thoracic and/or lumbar spine|of the thoracic and/or lumbar spine
5022764|NCT01537744|expansion cohort|expansion cohort
5022765|NCT01537705|Medical food|medical food
5022766|NCT01537705|Neuropathy|neuropathy
5022767|NCT01537705|Diabetes|diabetes
5022768|NCT01537705|Neuropathic Pain|neuropathic pain
5022769|NCT01537679|Caregiver|caregiver
5022770|NCT01537679|meditation|meditation
5022771|NCT01537679|relaxation|relaxation
5022772|NCT01537679|stress|stress
5022773|NCT01537627|Motor activity|motor activity
5022774|NCT01537627|Exercise|exercise
5022775|NCT01537627|Rehabilitation|rehabilitation
5022776|NCT01537601|Posterior urethral valves|posterior urethral valves
5022777|NCT01537601|Febrile urinary tract infection|febrile urinary tract infection
5022778|NCT01537601|Circumcision|circumcision
5022779|NCT01537601|Antibioprophylaxis|antibioprophylaxis
5022780|NCT01537601|Impact on family|impact on family
5022781|NCT01537588|anterior cruciate ligament|anterior cruciate ligament
5022782|NCT01537588|hamstring|hamstring
5022783|NCT01537588|semitendinosus|semitendinosus
5022784|NCT01537588|gracilis|gracilis
5022785|NCT01537588|graft|graft
5022786|NCT01537562|Copper IUD|copper iud
5022787|NCT01537562|LNG-IUS|lng-ius
5022788|NCT01537562|intrauterine contraception|intrauterine contraception
5022789|NCT01537562|medical abortion|medical abortion
5022790|NCT01537562|postabortion contraception|postabortion contraception
5022791|NCT01537549|Progressive supranuclear palsy|progressive supranuclear palsy
5022792|NCT01537549|alpha-lipoic acid|alpha-lipoic acid
5022793|NCT01537549|L-acetyl carnitine|l-acetyl carnitine
5022794|NCT01537549|antioxidant|antioxidant
5022795|NCT01537549|magnetic resonance spectroscopy|magnetic resonance spectroscopy
5022796|NCT01537549|neurodegeneration|neurodegeneration
5022797|NCT01537549|glutathione|glutathione
5022798|NCT01537536|Breast cancer|breast cancer
5022799|NCT01537536|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
5022800|NCT01537536|EndoTAG-1|endotag-1
5022801|NCT01537523|physical|physical
5022802|NCT01537523|psychological|psychological
5022803|NCT01537523|fracture hip|fracture hip
5022804|NCT01537497|Phase 1|phase 1
5022805|NCT01537497|Single Doses|single doses
5022806|NCT01537497|Pharmacodynamics|pharmacodynamics
5022807|NCT01537497|Healthy Volunteers|healthy volunteers
5022808|NCT01537484|massage|massage
5022809|NCT01537484|osteoarthritis|osteoarthritis
5022810|NCT01537484|light touch|light touch
5022811|NCT01537484|Swedish|swedish
5022813|NCT01537471|Meclizine|meclizine
5022814|NCT01537471|Startle|startle
5022815|NCT01537471|Sensory processing|sensory processing
5022816|NCT01537471|antihistamines|antihistamines
5022817|NCT01537445|Diabetes Mellitus|diabetes mellitus
5022818|NCT01537445|Pancreas|pancreas
5022819|NCT01537445|Renal failure|renal failure
5022820|NCT01537445|Transplantation|transplantation
5022821|NCT01537432|Psoriasis, Plaque-type psoriasis|psoriasis, plaque-type psoriasis
5022822|NCT01537432|Plaque|plaque
5022823|NCT01537432|Secukinumab|secukinumab
5022824|NCT01537432|AIN457A|ain457a
5022825|NCT01537432|PASI|pasi
5022826|NCT01537432|DLQI|dlqi
5022827|NCT01537432|IGA|iga
5022828|NCT01537419|Suicide|suicide
5022829|NCT01537419|Depression|depression
5022830|NCT01537419|Family Relationships|family relationships
5022831|NCT01537406|BREAST IRRADIATION USING INTENSITY MODULATED RADIATION THERAPY|breast irradiation using intensity modulated radiation therapy
5022832|NCT01537393|cornea|cornea
5022833|NCT01537393|transplant|transplant
5022834|NCT01537393|preservation|preservation
5023621|NCT01533818|Management|management
5022836|NCT01537367|Human immunodeficiency virus|human immunodeficiency virus
5022837|NCT01537367|HIV primary care|hiv primary care
5022838|NCT01537328|Total knee arthroplasty|total knee arthroplasty
5022839|NCT01537328|quadriceps|quadriceps
5022840|NCT01537328|muscle|muscle
5022841|NCT01537328|arthroplasty|arthroplasty
5022842|NCT01537328|joint diseases|joint diseases
5022843|NCT01537328|musculoskeletal diseases|musculoskeletal diseases
5022844|NCT01537315|Kidney Failure, Chronic|kidney failure, chronic
5022845|NCT01537315|Cardiovascular Disease|cardiovascular disease
5022846|NCT01537315|Arteriosclerosis|arteriosclerosis
5022847|NCT01537302|Chronic Total Occlusion|chronic total occlusion
5022848|NCT01537302|Optimal Coherence Tomography|optimal coherence tomography
5022849|NCT01537302|Lumivascular|lumivascular
5022850|NCT01537289|Trauma|trauma
5022851|NCT01537289|Pneumothorax|pneumothorax
5022852|NCT01537276|hysterosalpingography|hysterosalpingography
5022853|NCT01537276|Fluoroscopy|fluoroscopy
5022854|NCT01537276|diagnostic accuracy|diagnostic accuracy
5022855|NCT01537263|Aneurysmal Subarachnoid Hemorrhage|aneurysmal subarachnoid hemorrhage
5022856|NCT01537263|SAB|sab
5022857|NCT01537263|SAH|sah
5022858|NCT01537263|Ultrasound|ultrasound
5022859|NCT01537263|Perfusion imaging|perfusion imaging
5022860|NCT01537250|CAP|cap
5022861|NCT01537237|Atrial Fibrillation|atrial fibrillation
5022862|NCT01537237|Catheter-based ablation|catheter-based ablation
5022863|NCT01537237|Pulmonary vein isolation|pulmonary vein isolation
5022864|NCT01537237|Electro-anatomical mapping|electro-anatomical mapping
5022865|NCT01537237|Rotational angiography|rotational angiography
5022866|NCT01537224|Electrophysiology|electrophysiology
5022867|NCT01537224|Subthalamic nucleus|subthalamic nucleus
5022868|NCT01537224|Parkinson|parkinson
5022869|NCT01537211|Dysvascular|dysvascular
5022870|NCT01537211|amputation|amputation
5022871|NCT01537211|above knee|above knee
5022872|NCT01537211|ambulation|ambulation
5022873|NCT01537198|Postmarketing Drug Surveillance|postmarketing drug surveillance
5022874|NCT01537172|ONO-4053 healthy subjects|ono-4053 healthy subjects
5022875|NCT01537172|3 part adaptive design|3 part adaptive design
5022876|NCT01537159|AML|aml
5022877|NCT01537146|unicompartmental|unicompartmental
5022878|NCT01537146|osteoarthritis|osteoarthritis
5022879|NCT01537146|varus|varus
5022880|NCT01537146|malalignment|malalignment
5022881|NCT01537146|opening wedge|opening wedge
5022882|NCT01537146|HTO|hto
5022883|NCT01537146|high|high
5022884|NCT01537146|tibia|tibia
5022885|NCT01537146|osteotomy|osteotomy
5022886|NCT01537094|low vitamin c|low vitamin c
5022887|NCT01537094|reduced growth hormone secretion|reduced growth hormone secretion
5022888|NCT01537068|Dysthymic disorder|dysthymic disorder
5022889|NCT01537068|Dysthymia|dysthymia
5022890|NCT01537068|Chronic non-major depression|chronic non-major depression
5022891|NCT01537068|Non-major chronic depression|non-major chronic depression
5022892|NCT01537068|Chronic depressive disorder|chronic depressive disorder
5022893|NCT01537068|Antidepressant treatment|antidepressant treatment
5022894|NCT01537055|H pylori eradication|h pylori eradication
5022895|NCT01537042|Rotigotine|rotigotine
5022896|NCT01537042|Neupro|neupro
5022897|NCT01537042|Restless Legs Syndrome|restless legs syndrome
5022898|NCT01537042|RLS|rls
5022899|NCT01537042|End-Stage Renal Disease|end-stage renal disease
5022900|NCT01537029|Breast cancer|breast cancer
5022901|NCT01537029|Pharmacokinetics|pharmacokinetics
5022902|NCT01537029|Obesity|obesity
5022903|NCT01537029|Doxorubicin|doxorubicin
5022904|NCT01537029|Cyclophosphamide|cyclophosphamide
5022905|NCT01537029|Weight|weight
5022906|NCT01536977|quality of life|quality of life
5022907|NCT01536925|Behavioral Economics|behavioral economics
5022908|NCT01536925|Drug self administration|drug self administration
5022909|NCT01536925|Opioid|opioid
5022910|NCT01536912|HIV positive|hiv positive
5022911|NCT01536899|HIV positive|hiv positive
5022912|NCT01536899|Medical Marijuana|medical marijuana
5022913|NCT01536873|treatment experienced patients|treatment experienced patients
5022914|NCT01536873|Integrase resistance|integrase resistance
5022915|NCT01536834|Verruca|verruca
5022916|NCT01536834|Plantar Wart|plantar wart
5022917|NCT01536834|Medical Device|medical device
5022918|NCT01536834|Podiatry|podiatry
5022919|NCT01536834|Footcare|footcare
5022920|NCT01536821|Parkinson disease|parkinson disease
5022921|NCT01536821|Parkinson's Disease|parkinson's disease
5022922|NCT01536821|PD|pd
5022923|NCT01536821|LRRK2|lrrk2
5022924|NCT01536821|genetics|genetics
5022925|NCT01536821|genes|genes
5022926|NCT01536808|Diabetes mellitus|diabetes mellitus
5022927|NCT01536808|accelerated aging|accelerated aging
5022928|NCT01536808|cellular senescence|cellular senescence
5022929|NCT01536808|diabetic cardiomyopathy|diabetic cardiomyopathy
5022930|NCT01536808|strain imaging|strain imaging
5022931|NCT01536808|strain rate imaging,|strain rate imaging,
5022932|NCT01536808|echocardiography|echocardiography
5022933|NCT01536795|Ointment to treat leishmania skin lesions|ointment to treat leishmania skin lesions
5022934|NCT01536782|head and neck cancer|head and neck cancer
5022935|NCT01536782|chemoradiation therapy|chemoradiation therapy
5022936|NCT01536782|bolus feeding|bolus feeding
5022937|NCT01536782|gravity feeding|gravity feeding
5022938|NCT01536782|pump feeding|pump feeding
5022939|NCT01536782|optimal enteral feeding method|optimal enteral feeding method
5022940|NCT01536782|To determine the optimal tube feeding method by analyzing percent weigtht loss.|to determine the optimal tube feeding method by analyzing percent weigtht loss.
5022941|NCT01536782|To determine the optimal tube feeding method by analyzing tolerance of enteral feeds.|to determine the optimal tube feeding method by analyzing tolerance of enteral feeds.
5022942|NCT01536782|To determine the optimal tube feeding method by analyzing percent met of estimated calories and protein.|to determine the optimal tube feeding method by analyzing percent met of estimated calories and protein.
5022943|NCT01536769|Metagenomic analysis|metagenomic analysis
5022944|NCT01536769|Microbiota|microbiota
5022945|NCT01536756|Depressive disorder|depressive disorder
5022946|NCT01536756|exercise|exercise
5022947|NCT01536756|pain|pain
5022948|NCT01536756|physical|physical
5022949|NCT01536756|psychological|psychological
5022950|NCT01536756|Chinese|chinese
5022951|NCT01536756|mild to severe depressive disorders|mild to severe depressive disorders
5022952|NCT01536717|atrial septal defect|atrial septal defect
5022953|NCT01536717|mitral valve annuloplasty|mitral valve annuloplasty
5022954|NCT01536717|aortic valve annuloplasty|aortic valve annuloplasty
5022955|NCT01536717|open heart surgery|open heart surgery
5022956|NCT01536717|oxycodone consumption|oxycodone consumption
5022957|NCT01536717|articain|articain
5022958|NCT01536717|bupivacaine|bupivacaine
5022959|NCT01536717|pain after sternotomy|pain after sternotomy
5022960|NCT01536717|postoperative pain|postoperative pain
5022961|NCT01536717|wound infusion|wound infusion
5022962|NCT01536704|nicotine lozenge|nicotine lozenge
5022963|NCT01536704|nicotine|nicotine
5022964|NCT01536704|nicotine replacement therapy|nicotine replacement therapy
5022965|NCT01536691|ramosetron|ramosetron
5022966|NCT01536691|ondansetron|ondansetron
5022967|NCT01536691|aprepitant|aprepitant
5022968|NCT01536691|chemotherapy induced nausea & vomiting|chemotherapy induced nausea & vomiting
5022969|NCT01536587|influence of bronchodilatation with salmeterol on the autonomic nervous systems in COPD patients will be measured using MSNA.|influence of bronchodilatation with salmeterol on the autonomic nervous systems in copd patients will be measured using msna.
5022970|NCT01536587|Relation of COPD and sympathetic nerve activity is to be evaluated,|relation of copd and sympathetic nerve activity is to be evaluated,
5022971|NCT01536561|Tositumomab and/or Iodine I 131 Tositumomab|tositumomab and/or iodine i 131 tositumomab
5022972|NCT01536561|B-cell non-Hodgkin's lymphoma|b-cell non-hodgkin's lymphoma
5022973|NCT01536561|Dose-limiting toxicity|dose-limiting toxicity
5022974|NCT01536561|Bexxar|bexxar
5022975|NCT01536548|hemodialysis|hemodialysis
5022976|NCT01536548|cannulation|cannulation
5022977|NCT01536548|AV-fistula|av-fistula
5022978|NCT01536548|buttonhole technique|buttonhole technique
5022979|NCT01536535|Ulcerative Colitis|ulcerative colitis
5022980|NCT01536535|mesalamine|mesalamine
5022981|NCT01536535|corticosteroids|corticosteroids
5022982|NCT01536535|PROTECT|protect
5022983|NCT01536522|Asthma|asthma
5022984|NCT01536522|Allergic Asthma|allergic asthma
5022985|NCT01536522|Non-allergic Asthma|non-allergic asthma
5022986|NCT01536496|trauma|trauma
5022987|NCT01536496|hemorrhagic shock|hemorrhagic shock
5022988|NCT01536496|thrombelastography|thrombelastography
5022989|NCT01536496|coagulopathy|coagulopathy
5022990|NCT01536496|transfusion|transfusion
5022991|NCT01536496|resuscitation|resuscitation
5022992|NCT01536483|Butyrate|butyrate
5022993|NCT01536483|Preterms|preterms
5022994|NCT01536483|Very Low Birth Weight (<1250g)|very low birth weight (<1250g)
5022995|NCT01536483|Rectocolonic enemas|rectocolonic enemas
5022996|NCT01536483|Digestive maturation|digestive maturation
5022997|NCT01536483|Parenteral nutrition weaning|parenteral nutrition weaning
5022998|NCT01536483|ECUN|ecun
5022999|NCT01536483|Whole gut transit time|whole gut transit time
5023000|NCT01536470|Intraoperative hemodynamic|intraoperative hemodynamic
5023001|NCT01536470|Arterial pressure|arterial pressure
5023002|NCT01536470|Postoperative complications|postoperative complications
5023003|NCT01536470|Intraoperative fluids|intraoperative fluids
5023004|NCT01536470|Noradrenaline|noradrenaline
5023005|NCT01536457|asthma|asthma
5023006|NCT01536457|children|children
5023007|NCT01536457|gastroesophageal reflux|gastroesophageal reflux
5023008|NCT01536457|retrospective|retrospective
5023009|NCT01536457|data analysis|data analysis
5023010|NCT01536444|Mohs surgery|mohs surgery
5023011|NCT01536444|Excisional skin surgery|excisional skin surgery
5023012|NCT01536444|Micrografting|micrografting
5023013|NCT01536431|Diabetes|diabetes
5023014|NCT01536418|Crohn's disease, chemokine receptor 9 antagonist, Crohn's Disease Activity Index|crohn's disease, chemokine receptor 9 antagonist, crohn's disease activity index
5023015|NCT01536418|active treatment|active treatment
5023016|NCT01536392|Cancer of the Cervix|cancer of the cervix
5023017|NCT01536392|Anti-emetic therapy|anti-emetic therapy
5023018|NCT01536392|Granisetron|granisetron
5023019|NCT01536392|Transdermal patch|transdermal patch
5023020|NCT01536392|Ondansetron|ondansetron
5023021|NCT01536392|Zofran|zofran
5023022|NCT01536392|Questionnaires|questionnaires
5023023|NCT01536392|Surveys|surveys
5023024|NCT01536392|Study Drug Diary|study drug diary
5023025|NCT01536379|Infection|infection
5023026|NCT01536379|Quality of Life|quality of life
5023027|NCT01536366|Parkinson Disease|parkinson disease
5023028|NCT01536366|BIA 9-1067|bia 9-1067
5023029|NCT01536340|post discharge adverse events|post discharge adverse events
5023030|NCT01536340|discontinuities in care|discontinuities in care
5023031|NCT01536340|medical injury|medical injury
5023032|NCT01536327|leukodystrophies|leukodystrophies
5023033|NCT01536327|Metachromatic Leukodystrophy Disease|metachromatic leukodystrophy disease
5023034|NCT01536314|Pre-emptive administration|pre-emptive administration
5023035|NCT01536314|Post-operative administration|post-operative administration
5023036|NCT01536314|Prophylaxis|prophylaxis
5023037|NCT01536314|Memantine|memantine
5023038|NCT01536314|Post-mastectomy/tumorectomy|post-mastectomy/tumorectomy
5023039|NCT01536314|Neuropathic pain|neuropathic pain
5023040|NCT01536301|oxycodone|oxycodone
5023041|NCT01536301|morphine|morphine
5023042|NCT01536301|hip replacement|hip replacement
5023043|NCT01536301|analgesia|analgesia
5023044|NCT01536301|post operative analgesia|post operative analgesia
5023045|NCT01536288|acute mountain sickness|acute mountain sickness
5023046|NCT01536288|AMS|ams
5023047|NCT01536288|Rhodiola Crenulata|rhodiola crenulata
5023048|NCT01536288|mountaineering|mountaineering
5023049|NCT01536288|pulse oximetry|pulse oximetry
5023050|NCT01536288|oxygen saturation|oxygen saturation
5023051|NCT01536275|critical illness|critical illness
5023052|NCT01536275|children|children
5023053|NCT01536275|nutrition|nutrition
5023054|NCT01536275|metabolism|metabolism
5023055|NCT01536236|Diabetes|diabetes
5023056|NCT01536236|Polyneuropathy|polyneuropathy
5023057|NCT01536236|Spinal cord stimulation|spinal cord stimulation
5023058|NCT01536223|Nasopharyngeal Carcinoma (NPC)|nasopharyngeal carcinoma (npc)
5023059|NCT01536223|cisplatin and 5-fluorouracil (PF)|cisplatin and 5-fluorouracil (pf)
5023060|NCT01536223|docetaxel,cisplatin and 5-fluorouracil(TPF)|docetaxel,cisplatin and 5-fluorouracil(tpf)
5023061|NCT01536223|Neoadjuvant Chemotherapy|neoadjuvant chemotherapy
5023062|NCT01536223|intensity modulated radiotherapy(IMRT)|intensity modulated radiotherapy(imrt)
5023063|NCT01536210|ADHD(attention Deficit Hyperactivity Disorder)|adhd(attention deficit hyperactivity disorder)
5023064|NCT01536197|obesity|obesity
5023065|NCT01536197|gastric bypass|gastric bypass
5023066|NCT01536197|gastric banding|gastric banding
5023067|NCT01536197|sleeve gastrectomy|sleeve gastrectomy
5023068|NCT01536197|weight loss|weight loss
5023069|NCT01536197|taste perception|taste perception
5023070|NCT01536184|Fetal Alcohol Spectrum Disorder|fetal alcohol spectrum disorder
5023071|NCT01536184|FASD|fasd
5023072|NCT01536171|runners|runners
5023073|NCT01536171|mid-foot strike|mid-foot strike
5023074|NCT01536171|fore foot strike|fore foot strike
5023075|NCT01536171|metabolic costs|metabolic costs
5023076|NCT01536171|trained runners (men,women) with a FM strike|trained runners (men,women) with a fm strike
5023077|NCT01536171|shod running|shod running
5023078|NCT01536171|barefoot running|barefoot running
5023079|NCT01536158|Patent Ductus Arteriosus|patent ductus arteriosus
5023080|NCT01536158|Paracetamol|paracetamol
5023081|NCT01536158|Ibuprofen|ibuprofen
5023082|NCT01536158|Preterm infant|preterm infant
5023083|NCT01536145|IGF-1R inhibitor|igf-1r inhibitor
5023084|NCT01536145|CP-751871|cp-751871
5023085|NCT01536145|multiple myeloma|multiple myeloma
5023086|NCT01536132|Levosimendan|levosimendan
5023087|NCT01536132|chronic heart failure|chronic heart failure
5023088|NCT01536132|inotropic drug|inotropic drug
5023089|NCT01536119|Breastfeeding|breastfeeding
5023090|NCT01536119|Coparenting|coparenting
5023091|NCT01536119|Infant feeding|infant feeding
5023092|NCT01536119|Fathers' support|fathers' support
5023093|NCT01536119|Breastfeeding support|breastfeeding support
5023094|NCT01536119|Breastfeeding support intervention|breastfeeding support intervention
5023095|NCT01536119|clinical trial|clinical trial
5023096|NCT01536106|Cell therapy, Bone marrow stem cells, cardiac cell therapy|cell therapy, bone marrow stem cells, cardiac cell therapy
5023097|NCT01536041|asthma|asthma
5023098|NCT01536041|Adult|adult
5023099|NCT01536015|Rotigotine|rotigotine
5023100|NCT01536015|Neupro®|neupro®
5023101|NCT01536015|Levodopa|levodopa
5023102|NCT01536015|Gastrointestinal Dysfunction|gastrointestinal dysfunction
5023103|NCT01536002|Bariatric surgery|bariatric surgery
5023104|NCT01536002|Anesthetics, intravenous|anesthetics, intravenous
5023105|NCT01536002|Propofol|propofol
5023106|NCT01536002|Pharmacokinetics|pharmacokinetics
5023107|NCT01535989|B-cell Non Hodgkin's Lymphomas|b-cell non hodgkin's lymphomas
5023108|NCT01535989|CD22 positive|cd22 positive
5023109|NCT01535950|Age-related macular degeneration|age-related macular degeneration
5023110|NCT01535950|intravitreal, neovascular|intravitreal, neovascular
5023111|NCT01535950|anti-vascular endothelial growth factor|anti-vascular endothelial growth factor
5023112|NCT01535950|wet AMD|wet amd
5023113|NCT01535950|Age-related|age-related
5023114|NCT01535950|Macular degeneration|macular degeneration
5023115|NCT01535950|Intravitreal|intravitreal
5023116|NCT01535950|Neovascular|neovascular
5023117|NCT01535924|Hodgkin's Lymphoma|hodgkin's lymphoma
5023118|NCT01535924|relapsed|relapsed
5023119|NCT01535924|refractory|refractory
5023120|NCT01535911|ketogenic diet|ketogenic diet
5023121|NCT01535911|brain tumors|brain tumors
5023122|NCT01535898|MRI|mri
5023622|NCT01533818|Amoxicillin|amoxicillin
5023123|NCT01535898|MR imaging Pulse Sequence|mr imaging pulse sequence
5023124|NCT01535898|High Resolution Diffusion-weighted|high resolution diffusion-weighted
5023125|NCT01535898|Questionnaire|questionnaire
5023126|NCT01535898|12-033|12-033
5023127|NCT01535885|Cytoxic T Lymphocytes(CTL)|cytoxic t lymphocytes(ctl)
5023128|NCT01535885|T-cell Depleted|t-cell depleted
5023129|NCT01535885|Allogeneic Transplant|allogeneic transplant
5023130|NCT01535885|Epstein Barr Virus|epstein barr virus
5023131|NCT01535885|Adenovirus|adenovirus
5023132|NCT01535885|Cytomegalovirus|cytomegalovirus
5023133|NCT01535885|Hematopoietic progenitor cell transplantation|hematopoietic progenitor cell transplantation
5023134|NCT01535846|taste|taste
5023135|NCT01535846|mindful eating|mindful eating
5023136|NCT01535846|intuitive eating|intuitive eating
5023137|NCT01535846|attitude|attitude
5023138|NCT01535846|behavior|behavior
5023139|NCT01535833|robotic sacral colpopexy|robotic sacral colpopexy
5023140|NCT01535833|Learning curve|learning curve
5023141|NCT01535833|Pelvic Organ Prolapse|pelvic organ prolapse
5023142|NCT01535833|Robotic Surgery|robotic surgery
5023143|NCT01535820|Healthy volunteers|healthy volunteers
5023144|NCT01535820|ORTHO EVRA|ortho evra
5023145|NCT01535820|Contraceptive hormones|contraceptive hormones
5023146|NCT01535820|Transdermal patch|transdermal patch
5023147|NCT01535820|Progestin norelgestromin (NGMN)|progestin norelgestromin (ngmn)
5023148|NCT01535820|Estrogen ethinyl estradiol (EE)|estrogen ethinyl estradiol (ee)
5023149|NCT01535820|JNJ-93964|jnj-93964
5023150|NCT01535820|JNJ-622206|jnj-622206
5023151|NCT01535807|Atrial Fibrillation|atrial fibrillation
5023152|NCT01535807|Cardiac surgery|cardiac surgery
5023153|NCT01535807|Coronary Artery Bypass Graft|coronary artery bypass graft
5023154|NCT01535807|CorMatrix extra cellular matrix|cormatrix extra cellular matrix
5023155|NCT01535807|Heart surgery|heart surgery
5023156|NCT01535807|Inflammatory Biomarkers|inflammatory biomarkers
5023157|NCT01535807|Myocardial Infarction|myocardial infarction
5023158|NCT01535807|identify proteomic inflammatory biomarkers|identify proteomic inflammatory biomarkers
5023159|NCT01535794|HPV vaccine|hpv vaccine
5023160|NCT01535794|acceptability|acceptability
5023161|NCT01535794|males|males
5023162|NCT01535794|men who have sex with men|men who have sex with men
5023163|NCT01535781|pertrochanteric fracture|pertrochanteric fracture
5023164|NCT01535781|tranexamic acid|tranexamic acid
5023165|NCT01535781|postoperative blood loss|postoperative blood loss
5023166|NCT01535781|blood loss|blood loss
5023167|NCT01535781|hidden blood loss|hidden blood loss
5023168|NCT01535781|blood transfusions|blood transfusions
5023169|NCT01535755|noninvasive mechanical ventilation|noninvasive mechanical ventilation
5023170|NCT01535755|ventilator weaning|ventilator weaning
5023171|NCT01535742|laryngeal mask airway|laryngeal mask airway
5023172|NCT01535742|children|children
5023173|NCT01535742|tracheal intubation|tracheal intubation
5023174|NCT01535742|fiberoptic bronchoscopy|fiberoptic bronchoscopy
5023175|NCT01535690|Laser|laser
5023176|NCT01535690|Clinical trial|clinical trial
5023177|NCT01535690|Non-surgical periodontal therapy|non-surgical periodontal therapy
5023178|NCT01535690|Periodontitis|periodontitis
5023179|NCT01535690|bleeding on probing and radiographic bone loss|bleeding on probing and radiographic bone loss
5023180|NCT01535690|minimum of 2 teeth with probing depth (PD) ≥ 7 mm and|minimum of 2 teeth with probing depth (pd) ≥ 7 mm and
5023181|NCT01535690|2 other teeth with PD ≥ 5 mm|2 other teeth with pd ≥ 5 mm
5023182|NCT01535690|mininum 16 teeth in both jaws|mininum 16 teeth in both jaws
5023183|NCT01535677|Phase 1|phase 1
5023184|NCT01535677|healthy volunteers|healthy volunteers
5023185|NCT01535677|cross-over study|cross-over study
5023186|NCT01535677|Bioavailability|bioavailability
5023187|NCT01535677|Bioequivalence|bioequivalence
5023188|NCT01535677|Cmax|cmax
5023189|NCT01535677|tmax|tmax
5023190|NCT01535677|AUC|auc
5023191|NCT01535677|AUC(0-t)|auc(0-t)
5023192|NCT01535677|λz|λz
5023193|NCT01535677|tlast|tlast
5023194|NCT01535664|Multiple Sclerosis|multiple sclerosis
5023195|NCT01535664|MS|ms
5023196|NCT01535625|Coronary artery disease|coronary artery disease
5023197|NCT01535625|Atherosclerosis|atherosclerosis
5023198|NCT01535625|CAD|cad
5023199|NCT01535599|Acute Otitis Externa|acute otitis externa
5023200|NCT01535586|CPAP|cpap
5023201|NCT01535586|MAD|mad
5023202|NCT01535586|sleep apnea|sleep apnea
5023203|NCT01535586|PTSD|ptsd
5023204|NCT01535573|Cocaine|cocaine
5023205|NCT01535573|citalopram|citalopram
5023206|NCT01535573|treatment|treatment
5023207|NCT01535573|serotonin|serotonin
5023208|NCT01535560|Acute otitis externa|acute otitis externa
5023209|NCT01535547|isavuconazole|isavuconazole
5023210|NCT01535547|tacrolimus|tacrolimus
5023211|NCT01535547|Healthy Volunteers|healthy volunteers
5023212|NCT01535547|BAL8557|bal8557
5023213|NCT01535534|sepsis|sepsis
5023214|NCT01535534|inflammation|inflammation
5023215|NCT01535534|diagnosis|diagnosis
5023216|NCT01535534|prognosis|prognosis
5023217|NCT01535534|survival|survival
5023218|NCT01535534|mortality|mortality
5023219|NCT01535495|beta-antagonist|beta-antagonist
5023220|NCT01535495|propranolol|propranolol
5023221|NCT01535495|diabetic retinopathy|diabetic retinopathy
5023222|NCT01535495|diabetes|diabetes
5023223|NCT01535495|angiogenesis|angiogenesis
5023224|NCT01535495|neovascularization|neovascularization
5023225|NCT01535482|Cognitive therapy|cognitive therapy
5023226|NCT01535482|Suicide|suicide
5023227|NCT01535482|Older men|older men
5023228|NCT01535482|suicide ideation|suicide ideation
5023229|NCT01535469|cryptococcal meningitis|cryptococcal meningitis
5023230|NCT01535469|hiv|hiv
5023231|NCT01535469|aids|aids
5023232|NCT01535469|implementation science|implementation science
5023233|NCT01535469|stepped wedge design|stepped wedge design
5023234|NCT01535469|retention-in-care|retention-in-care
5023235|NCT01535456|MDS|mds
5023236|NCT01535456|AML|aml
5023237|NCT01535456|5 azacitidine|5 azacitidine
5023238|NCT01535456|FLT PET|flt pet
5023239|NCT01535443|PRO-155|pro-155
5023240|NCT01535443|Ocular NSAIDs|ocular nsaids
5023241|NCT01535443|Safety and tolerability|safety and tolerability
5023242|NCT01535443|Ocular Inflammation|ocular inflammation
5023243|NCT01535443|Ocular Paint|ocular paint
5023244|NCT01535430|brain mapping|brain mapping
5023245|NCT01535430|brain tumor|brain tumor
5023246|NCT01535417|Osteoarthritis|osteoarthritis
5023247|NCT01535391|Chronic Myeloid Leukemia,|chronic myeloid leukemia,
5023248|NCT01535391|Nilotinib,|nilotinib,
5023249|NCT01535391|Philadelphia positive,|philadelphia positive,
5023250|NCT01535391|BCR-ABL+|bcr-abl+
5023251|NCT01535391|Early chronic phase|early chronic phase
5023252|NCT01535365|muscular sprain|muscular sprain
5023253|NCT01535365|acute back pain|acute back pain
5023254|NCT01535365|acute neck pain|acute neck pain
5023255|NCT01535365|heat treatment|heat treatment
5023256|NCT01535365|cold treatment|cold treatment
5023257|NCT01535339|mild Traumatic Brain Injury|mild traumatic brain injury
5023258|NCT01535339|mTBI|mtbi
5023259|NCT01535339|Concussion|concussion
5023260|NCT01535326|colonoscopy|colonoscopy
5023261|NCT01535300|Ultrasound|ultrasound
5023262|NCT01535300|Minimal transverse tracheal diameter|minimal transverse tracheal diameter
5023263|NCT01535300|Endotracheal tube size|endotracheal tube size
5023264|NCT01535300|Paediatric age-based formulas|paediatric age-based formulas
5023265|NCT01535300|Sonographic measurement of the trachea|sonographic measurement of the trachea
5023266|NCT01535287|Dexmedetomidine|dexmedetomidine
5023267|NCT01535287|Emergence Agitation|emergence agitation
5023268|NCT01535287|Myringotomy|myringotomy
5023269|NCT01535287|Children|children
5023270|NCT01535287|General Anesthesia|general anesthesia
5023271|NCT01535274|Cerebral oxygenation|cerebral oxygenation
5023272|NCT01535274|Beach chair position|beach chair position
5023273|NCT01535274|General anesthetic technique|general anesthetic technique
5023274|NCT01535274|Inspired oxygen fraction|inspired oxygen fraction
5023275|NCT01535274|End tidal carbon dioxide|end tidal carbon dioxide
5023276|NCT01535261|Ophthalmology|ophthalmology
5023277|NCT01535261|Ranibizumab|ranibizumab
5023278|NCT01535261|Central Retinal Vein Occlusion|central retinal vein occlusion
5023279|NCT01535248|ERCP|ercp
5023280|NCT01535248|Transthoracic Echocardiography|transthoracic echocardiography
5023281|NCT01535248|Air Embolus|air embolus
5023282|NCT01535248|ERCP associated air embolus|ercp associated air embolus
5023283|NCT01535235|HIV|hiv
5023284|NCT01535235|Lymphoid fibrosis|lymphoid fibrosis
5023285|NCT01535222|cardiac surgery|cardiac surgery
5023286|NCT01535222|coronary artery bypass graft|coronary artery bypass graft
5023287|NCT01535222|cardiopulmonary bypass|cardiopulmonary bypass
5023288|NCT01535222|haemostasis modulator|haemostasis modulator
5023289|NCT01535222|blood loss|blood loss
5023290|NCT01535222|direct inhibitor of plasmin and plasma kallikrein|direct inhibitor of plasmin and plasma kallikrein
5023291|NCT01535222|CABG|cabg
5023292|NCT01535222|CPB|cpb
5023293|NCT01535209|Stereotactic radiotherapy|stereotactic radiotherapy
5023294|NCT01535209|Whole-brain radiotherapy|whole-brain radiotherapy
5023295|NCT01535209|Resection cavity|resection cavity
5023296|NCT01535196|vitamin D|vitamin d
5023297|NCT01535196|heart failure|heart failure
5023298|NCT01535183|irinotecan|irinotecan
5023299|NCT01535183|brain tumor|brain tumor
5023300|NCT01535183|pediatrics|pediatrics
5023301|NCT01535183|salvage therapy|salvage therapy
5023302|NCT01535183|chemotherapy|chemotherapy
5023303|NCT01535170|lactoferrin|lactoferrin
5023304|NCT01535170|selective decontamination of digestive tract|selective decontamination of digestive tract
5023305|NCT01535170|antimicrobial activity|antimicrobial activity
5023306|NCT01535170|prolonged mechanical ventilation|prolonged mechanical ventilation
5023307|NCT01535170|respiratory care center|respiratory care center
5023308|NCT01535157|Chemotherapy|chemotherapy
5023309|NCT01535131|otitis media|otitis media
5023310|NCT01535131|cleft palate|cleft palate
5023311|NCT01535118|Allergies|allergies
5023312|NCT01535118|Immunotherapy|immunotherapy
5023313|NCT01535092|HCV recurrence|hcv recurrence
5023314|NCT01535092|HCV reinfection|hcv reinfection
5023315|NCT01535092|Liver transplantation|liver transplantation
5023316|NCT01535092|Legalon SIL|legalon sil
5023317|NCT01535092|silibinin|silibinin
5023318|NCT01535092|viral load|viral load
5023319|NCT01535079|sore throat pain|sore throat pain
5023320|NCT01535079|tonsillopharyngitis|tonsillopharyngitis
5023321|NCT01535079|upper respiratory tract infection|upper respiratory tract infection
5023518|NCT01534364|acute kidney injury|acute kidney injury
5023322|NCT01535066|estrogen receptor-positive breast cancer|estrogen receptor-positive breast cancer
5023323|NCT01535066|progesterone receptor-positive breast cancer|progesterone receptor-positive breast cancer
5023324|NCT01535066|stage IA breast cancer|stage ia breast cancer
5023325|NCT01535066|stage IB breast cancer|stage ib breast cancer
5023326|NCT01535066|stage II breast cancer|stage ii breast cancer
5023327|NCT01535066|stage IIIA breast cancer|stage iiia breast cancer
5023328|NCT01535066|stage IIIB breast cancer|stage iiib breast cancer
5023329|NCT01535066|stage IIIC breast cancer|stage iiic breast cancer
5023330|NCT01535066|pain|pain
5023331|NCT01535040|cancer survivor|cancer survivor
5023332|NCT01535040|stage I non-small cell lung cancer|stage i non-small cell lung cancer
5023333|NCT01535040|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
5023334|NCT01535040|tobacco use disorder|tobacco use disorder
5023335|NCT01535040|stage IA breast cancer|stage ia breast cancer
5023336|NCT01535040|stage IB breast cancer|stage ib breast cancer
5023337|NCT01535040|stage II breast cancer|stage ii breast cancer
5023338|NCT01535040|stage IIIA breast cancer|stage iiia breast cancer
5023339|NCT01535040|stage IIIB breast cancer|stage iiib breast cancer
5023340|NCT01535040|stage IIIC breast cancer|stage iiic breast cancer
5023341|NCT01535040|stage I prostate cancer|stage i prostate cancer
5023342|NCT01535040|stage IIA prostate cancer|stage iia prostate cancer
5023343|NCT01535040|stage IIB prostate cancer|stage iib prostate cancer
5023344|NCT01535040|stage III prostate cancer|stage iii prostate cancer
5023345|NCT01535040|stage I colon cancer|stage i colon cancer
5023346|NCT01535040|stage IIA colon cancer|stage iia colon cancer
5023347|NCT01535040|stage IIB colon cancer|stage iib colon cancer
5023348|NCT01535040|stage IIC colon cancer|stage iic colon cancer
5023349|NCT01535040|stage IIIA colon cancer|stage iiia colon cancer
5023350|NCT01535040|stage IIIB colon cancer|stage iiib colon cancer
5023351|NCT01535040|stage IIIC colon cancer|stage iiic colon cancer
5023352|NCT01535040|stage I rectal cancer|stage i rectal cancer
5023353|NCT01535040|stage IIA rectal cancer|stage iia rectal cancer
5023354|NCT01535040|stage IIB rectal cancer|stage iib rectal cancer
5023355|NCT01535040|stage IIC rectal cancer|stage iic rectal cancer
5023356|NCT01535040|stage IIIA rectal cancer|stage iiia rectal cancer
5023357|NCT01535040|stage IIIB rectal cancer|stage iiib rectal cancer
5023358|NCT01535040|stage IIIC rectal cancer|stage iiic rectal cancer
5023359|NCT01535027|teriparatide|teriparatide
5023360|NCT01535027|alendronate|alendronate
5023361|NCT01535027|raloxifene|raloxifene
5023362|NCT01535027|bone mineral density|bone mineral density
5023363|NCT01535001|Osteoarthritis, Knee|osteoarthritis, knee
5023364|NCT01535001|Treatment Outcome|treatment outcome
5023365|NCT01535001|Time Factors|time factors
5023366|NCT01535001|Rehabilitation|rehabilitation
5023367|NCT01535001|Combined Modality Therapy|combined modality therapy
5023368|NCT01535001|Middle Aged|middle aged
5023369|NCT01535001|Aged|aged
5023370|NCT01535001|Aged, 80 and over|aged, 80 and over
5023371|NCT01535001|Male|male
5023372|NCT01535001|Female|female
5023373|NCT01535001|Humans|humans
5023374|NCT01535001|Analysis of Variance|analysis of variance
5023375|NCT01534975|cardiac CT|cardiac ct
5023376|NCT01534975|enhancement|enhancement
5023377|NCT01534975|contrast|contrast
5023378|NCT01534975|safety|safety
5023379|NCT01534975|image quality|image quality
5023380|NCT01534962|Atrial Fibrillation|atrial fibrillation
5023381|NCT01534962|Ranolazine|ranolazine
5023382|NCT01534962|Arrhythmias, Cardiac|arrhythmias, cardiac
5023383|NCT01534962|Antiarrhythmic Agents|antiarrhythmic agents
5023384|NCT01534962|Cardiac Electroversion|cardiac electroversion
5023385|NCT01534962|Ranexa|ranexa
5023386|NCT01534949|DLBCL, Biosimilar|dlbcl, biosimilar
5023387|NCT01534936|schizophrenia|schizophrenia
5023388|NCT01534936|atypical antipsychotics|atypical antipsychotics
5023389|NCT01534936|depressive symptoms|depressive symptoms
5023390|NCT01534923|Doctor-Patient Communication|doctor-patient communication
5023391|NCT01534923|questionnaire|questionnaire
5023392|NCT01534923|survey|survey
5023393|NCT01534923|12-017|12-017
5023394|NCT01534910|garlic|garlic
5023395|NCT01534910|ct angiography|ct angiography
5023396|NCT01534910|atherosclerosis|atherosclerosis
5023397|NCT01534910|carotid IMT|carotid imt
5023398|NCT01534897|thyroid cancer|thyroid cancer
5023399|NCT01534897|Tall cell PTC|tall cell ptc
5023400|NCT01534897|Poorly differentiated thyroid carcinoma|poorly differentiated thyroid carcinoma
5023401|NCT01534897|metastatic|metastatic
5023402|NCT01534884|RA, Biosimilar|ra, biosimilar
5023403|NCT01534871|Cardiac rehabilitation|cardiac rehabilitation
5023404|NCT01534871|Exercise|exercise
5023405|NCT01534871|Systemic inflammation|systemic inflammation
5023406|NCT01534871|Cardiovascular disease risk|cardiovascular disease risk
5023407|NCT01534858|polyhexanide, polihexanide, PHMB, Prontosan, burns, wounds|polyhexanide, polihexanide, phmb, prontosan, burns, wounds
5023408|NCT01534832|surgical smoke|surgical smoke
5023409|NCT01534832|laparoscopic surgery|laparoscopic surgery
5023410|NCT01534832|impaired vision|impaired vision
5023411|NCT01534819|Abdominal aortic aneurysm|abdominal aortic aneurysm
5023413|NCT01534819|Endograft|endograft
5023414|NCT01534819|interventional treatment of AAA|interventional treatment of aaa
5023415|NCT01534806|Migraine|migraine
5023416|NCT01534793|Quality assessment|quality assessment
5023417|NCT01534793|Benign Prostatic Hyperplasia|benign prostatic hyperplasia
5023418|NCT01534793|Enucleation of the prostate|enucleation of the prostate
5023419|NCT01534793|LUMENIS|lumenis
5023420|NCT01534793|Laser|laser
5023421|NCT01534793|Learning Curve|learning curve
5023422|NCT01534728|Hepatitis C|hepatitis c
5023423|NCT01534728|CD8 epitopes|cd8 epitopes
5023424|NCT01534702|Acute Myeloid Leukemia|acute myeloid leukemia
5023425|NCT01534702|chemotherapy|chemotherapy
5023426|NCT01534702|clofarabine|clofarabine
5023427|NCT01534676|iron|iron
5023428|NCT01534676|transfusion|transfusion
5023429|NCT01534676|red blood cells|red blood cells
5023430|NCT01534676|sickle cell disease|sickle cell disease
5023431|NCT01534676|thalassemia|thalassemia
5023432|NCT01534676|blood donors|blood donors
5023433|NCT01534663|Heart Failure|heart failure
5023434|NCT01534663|Skeletal Muscle Function|skeletal muscle function
5023435|NCT01534663|Metabolism|metabolism
5023436|NCT01534663|Inflammation|inflammation
5023437|NCT01534663|Glutamine|glutamine
5023438|NCT01534663|Fish oil|fish oil
5023439|NCT01534663|Muscle Function|muscle function
5023440|NCT01534650|motion sensors|motion sensors
5023441|NCT01534650|tremor|tremor
5023442|NCT01534650|bradykinesia|bradykinesia
5023443|NCT01534650|gait|gait
5023444|NCT01534650|balance|balance
5023445|NCT01534650|dyskinesia|dyskinesia
5023446|NCT01534624|Induced Pluripotent Stem Cell (iPS) Cell Lines|induced pluripotent stem cell (ips) cell lines
5023447|NCT01534624|Addiction|addiction
5023448|NCT01534624|Addiction-Associated Human Gene Variants|addiction-associated human gene variants
5023449|NCT01534624|Dopamine Transporter|dopamine transporter
5023450|NCT01534598|DNA Methylation|dna methylation
5023451|NCT01534598|Advanced Cancer|advanced cancer
5023452|NCT01534598|Methyltransferase Inhibitor|methyltransferase inhibitor
5023453|NCT01534598|Epigenetics|epigenetics
5023454|NCT01534598|Gene Re-Expression|gene re-expression
5023455|NCT01534598|Cancer|cancer
5023456|NCT01534598|Solid Tumor|solid tumor
5023457|NCT01534585|nasopharyngeal carcinoma(NPC)|nasopharyngeal carcinoma(npc)
5023458|NCT01534585|Icotinib|icotinib
5023459|NCT01534585|Intensity Modulation Radiation Therapy(IMRT)|intensity modulation radiation therapy(imrt)
5023460|NCT01534546|neoadjuvant chemotherapy|neoadjuvant chemotherapy
5023461|NCT01534546|adjuvant chemotherapy|adjuvant chemotherapy
5023462|NCT01534546|DFS|dfs
5023463|NCT01534546|OS|os
5023464|NCT01534546|safety|safety
5023465|NCT01534546|resectable locally advanced gastric carcinoma|resectable locally advanced gastric carcinoma
5023466|NCT01534546|potentially resectable locally advanced gastric carcinoma|potentially resectable locally advanced gastric carcinoma
5023467|NCT01534533|early atherosclerosis|early atherosclerosis
5023468|NCT01534533|serum lutein|serum lutein
5023469|NCT01534533|serum lycopene|serum lycopene
5023470|NCT01534533|intima-media thickness|intima-media thickness
5023471|NCT01534533|arterial stiffness|arterial stiffness
5023472|NCT01534533|combined effect|combined effect
5023473|NCT01534520|Intrauterine Device|intrauterine device
5023474|NCT01534520|Pain|pain
5023475|NCT01534520|Lidocaine|lidocaine
5023476|NCT01534494|alcohol dependence|alcohol dependence
5023477|NCT01534494|psilocybin|psilocybin
5023478|NCT01534494|clinical trial|clinical trial
5023479|NCT01534494|motivational enhancement therapy|motivational enhancement therapy
5023480|NCT01534481|NICHD Neonatal Research Network|nichd neonatal research network
5023481|NCT01534481|Extremely Low Birth Weight (ELBW)|extremely low birth weight (elbw)
5023482|NCT01534481|Prematurity|prematurity
5023483|NCT01534481|Neurodevelopmental Impairment|neurodevelopmental impairment
5023484|NCT01534481|Donor Breast Milk|donor breast milk
5023485|NCT01534481|Preterm Formula|preterm formula
5023486|NCT01534455|German Breast Group|german breast group
5023487|NCT01534455|GBG Forschungs GmbH|gbg forschungs gmbh
5023488|NCT01534455|GBG|gbg
5023489|NCT01534455|GBG 64|gbg 64
5023490|NCT01534455|E-VITA|e-vita
5023491|NCT01534455|Breast Cancer|breast cancer
5023492|NCT01534455|Metastatic Breast Cancer|metastatic breast cancer
5023493|NCT01534455|Eribulin|eribulin
5023494|NCT01534455|Lapatinib|lapatinib
5023495|NCT01534455|Halaven|halaven
5023496|NCT01534455|Tyverb|tyverb
5023497|NCT01534429|pain|pain
5023498|NCT01534416|Paracervical Block|paracervical block
5023499|NCT01534416|Laparoscopic Surgery|laparoscopic surgery
5023500|NCT01534416|Postoperative Pain|postoperative pain
5023501|NCT01534416|Bupivacaine|bupivacaine
5023502|NCT01534416|Hysterectomy|hysterectomy
5023503|NCT01534416|Myomectomy|myomectomy
5023504|NCT01534416|Randomized Trial|randomized trial
5023505|NCT01534403|Lupus|lupus
5023506|NCT01534403|Monoclonal antibody|monoclonal antibody
5023507|NCT01534403|B-cell immunotherapy|b-cell immunotherapy
5023508|NCT01534403|Epratuzumab|epratuzumab
5023509|NCT01534390|microparticles|microparticles
5023510|NCT01534390|in-line microfilters|in-line microfilters
5023511|NCT01534390|systemic inflammation|systemic inflammation
5023512|NCT01534390|organ failure|organ failure
5023513|NCT01534390|critical illness|critical illness
5023514|NCT01534390|adult|adult
5023515|NCT01534377|Depression|depression
5023516|NCT01534377|Adolescents|adolescents
5023517|NCT01534364|acute renal failure|acute renal failure
5023519|NCT01534364|diet|diet
5023520|NCT01534364|caloric restriction|caloric restriction
5023521|NCT01534364|cardiac surgery|cardiac surgery
5023522|NCT01534364|cardiothoracic surgery|cardiothoracic surgery
5023523|NCT01534338|Sleep|sleep
5023524|NCT01534338|inflammation|inflammation
5023525|NCT01534338|mindfulness|mindfulness
5023526|NCT01534338|meditation|meditation
5023527|NCT01534338|randomized controlled trial|randomized controlled trial
5023528|NCT01534312|Glycopeptides|glycopeptides
5023529|NCT01534312|Dietary proteins|dietary proteins
5023530|NCT01534286|Prescription Medical Food|prescription medical food
5023531|NCT01534286|Theramine|theramine
5023532|NCT01534286|Knee surgery|knee surgery
5023533|NCT01534273|Mild Cognitive Impairment|mild cognitive impairment
5023534|NCT01534247|Phase I|phase i
5023535|NCT01534247|drug to drug|drug to drug
5023536|NCT01534247|CAZ-AVI|caz-avi
5023537|NCT01534247|Healthy volunteer|healthy volunteer
5023538|NCT01534247|pharmacokinetics|pharmacokinetics
5023539|NCT01534247|open label|open label
5023540|NCT01534247|metronidazole|metronidazole
5023541|NCT01534247|safety|safety
5023542|NCT01534234|CRT-D device|crt-d device
5023543|NCT01534234|Severe HF (NYHA Class III or ambulatory IV)|severe hf (nyha class iii or ambulatory iv)
5023544|NCT01534234|stable, optimal drug regimen|stable, optimal drug regimen
5023545|NCT01534234|sinus rhythm|sinus rhythm
5023546|NCT01534221|Ischemic Heart Disease|ischemic heart disease
5023547|NCT01534182|Relapsing Remitting Multiple Sclerosis (RRMS)|relapsing remitting multiple sclerosis (rrms)
5023548|NCT01534182|Fingolimod|fingolimod
5023549|NCT01534182|Disease Modifying Therapy (DMT)|disease modifying therapy (dmt)
5023550|NCT01534182|TSQM-9|tsqm-9
5023551|NCT01534169|Graves' disease|graves' disease
5023552|NCT01534169|Dexamethasone|dexamethasone
5023553|NCT01534169|Function of regulatory T cells|function of regulatory t cells
5023554|NCT01534169|The proportion of Th1 and Th2 cells|the proportion of th1 and th2 cells
5023555|NCT01534130|Chronic Fatigue Syndrome|chronic fatigue syndrome
5023556|NCT01534130|Sleep Disorder, Adjustment|sleep disorder, adjustment
5023557|NCT01534130|Acupuncture|acupuncture
5023558|NCT01534104|fMRI|fmri
5023559|NCT01534104|DTI|dti
5023560|NCT01534104|DSI|dsi
5023561|NCT01534104|tractography|tractography
5023562|NCT01534104|neurological/physical testing|neurological/physical testing
5023563|NCT01534104|Motor and Language Pathways|motor and language pathways
5023564|NCT01534104|resting state fMRI|resting state fmri
5023565|NCT01534104|12-008|12-008
5023566|NCT01534091|overweight|overweight
5023567|NCT01534091|obese|obese
5023568|NCT01534091|children|children
5023569|NCT01534091|exercise|exercise
5023570|NCT01534091|physical activity|physical activity
5023571|NCT01534091|pedometer|pedometer
5023572|NCT01534078|non-bulky|non-bulky
5023573|NCT01534078|limited stage|limited stage
5023574|NCT01534065|Hernia|hernia
5023575|NCT01534065|Intervertebral Disk Displacement|intervertebral disk displacement
5023576|NCT01534065|Pathological Conditions, Anatomical|pathological conditions, anatomical
5023577|NCT01534065|Spinal Diseases|spinal diseases
5023578|NCT01534065|Bone Diseases|bone diseases
5023579|NCT01534065|Musculoskeletal Diseases|musculoskeletal diseases
5023580|NCT01534052|Prostate Cancer|prostate cancer
5023581|NCT01534052|Castration-Resistant Prostate Cancer (CRPC)|castration-resistant prostate cancer (crpc)
5023582|NCT01534052|MDV3100|mdv3100
5023583|NCT01534052|Androgen receptor signaling inhibitor|androgen receptor signaling inhibitor
5023584|NCT01534013|Closed loop insulin delivery|closed loop insulin delivery
5023585|NCT01534000|Cardiac CT|cardiac ct
5023586|NCT01534000|Ischemic heat disease|ischemic heat disease
5023587|NCT01534000|Stress test|stress test
5023588|NCT01533987|Male|male
5023589|NCT01533987|Overweight|overweight
5023590|NCT01533987|Juice Plus|juice plus
5023591|NCT01533961|neglected disease|neglected disease
5023592|NCT01533961|africa|africa
5023593|NCT01533961|new drug|new drug
5023594|NCT01533961|oral drug|oral drug
5023595|NCT01533961|parasite|parasite
5023596|NCT01533896|Obesity prevention|obesity prevention
5023597|NCT01533896|Primary care|primary care
5023598|NCT01533896|Education|education
5023599|NCT01533883|Mitral|mitral
5023600|NCT01533883|Valve|valve
5023601|NCT01533883|Annuloplasty|annuloplasty
5023602|NCT01533883|Transatrial|transatrial
5023603|NCT01533883|Transapical|transapical
5023604|NCT01533883|Transfemoral|transfemoral
5023605|NCT01533883|Mitral valve insufficiency|mitral valve insufficiency
5023606|NCT01533870|Phase 1|phase 1
5023607|NCT01533870|Healthy male and female volunteers|healthy male and female volunteers
5023608|NCT01533870|Drug-drug interaction|drug-drug interaction
5023609|NCT01533870|Pharmacokinetics|pharmacokinetics
5023610|NCT01533870|NKTR-118|nktr-118
5023611|NCT01533870|Bioavailability|bioavailability
5023612|NCT01533870|Plasma AUC and Cmax|plasma auc and cmax
5023613|NCT01533870|Plasma AUC0-t and t1/2λz and tmax|plasma auc0-t and t1/2λz and tmax
5023614|NCT01533857|Black tea|black tea
5023615|NCT01533857|phenolic acids|phenolic acids
5023616|NCT01533844|CDAD|cdad
5023617|NCT01533844|Neonates|neonates
5023618|NCT01533844|Clostridium difficile|clostridium difficile
5023619|NCT01533818|Fast breathing|fast breathing
5023620|NCT01533818|Young infants|young infants
5023623|NCT01533818|Placebo|placebo
5023624|NCT01533805|Lumbago|lumbago
5023625|NCT01533805|Exercise therapy|exercise therapy
5023626|NCT01533805|Spine|spine
5023627|NCT01533792|Treatment|treatment
5023628|NCT01533792|pregnant women|pregnant women
5023629|NCT01533792|periodontitis|periodontitis
5023630|NCT01533792|dental scaling|dental scaling
5023631|NCT01533792|dental plaque|dental plaque
5023632|NCT01533779|children|children
5023633|NCT01533779|malignancy|malignancy
5023634|NCT01533779|neutrophil|neutrophil
5023635|NCT01533779|neutrophil extracellular traps|neutrophil extracellular traps
5023636|NCT01533779|superoxide production|superoxide production
5023637|NCT01533779|hydrogen peroxide production|hydrogen peroxide production
5023638|NCT01533779|chemotaxis|chemotaxis
5023639|NCT01533779|myeloperoxidase|myeloperoxidase
5023640|NCT01533779|immunosurveillance|immunosurveillance
5023641|NCT01533779|cancer cell lines|cancer cell lines
5023642|NCT01533753|hot flashes|hot flashes
5023643|NCT01533753|prostate cancer|prostate cancer
5023644|NCT01533727|Cytokine-Induced Killer Cell|cytokine-induced killer cell
5023645|NCT01533727|NSCLC|nsclc
5023646|NCT01533727|adjuvant therapy|adjuvant therapy
5023647|NCT01533714|Rheumatoid Arthritis|rheumatoid arthritis
5023648|NCT01533714|Monoclonal antibody|monoclonal antibody
5023649|NCT01533714|Interleukin-6|interleukin-6
5023650|NCT01533714|Olokizumab|olokizumab
5023651|NCT01533714|CDP6038|cdp6038
5023652|NCT01533701|Hypoxia|hypoxia
5023653|NCT01533701|Fetal blood sampling|fetal blood sampling
5023654|NCT01533701|Lactate|lactate
5023655|NCT01533701|pH|ph
5023656|NCT01533701|base deficit|base deficit
5023657|NCT01533701|angiogenic factors|angiogenic factors
5023658|NCT01533701|suspected fetal hypoxia|suspected fetal hypoxia
5023659|NCT01533675|suture, tensile strength, wound care, saline, hydrogen peroxide, skin closure, wounds, wound healing, wound cleansing, antiseptics|suture, tensile strength, wound care, saline, hydrogen peroxide, skin closure, wounds, wound healing, wound cleansing, antiseptics
5023660|NCT01533662|phenylephrine|phenylephrine
5023661|NCT01533662|hypotension|hypotension
5023662|NCT01533662|spinal anesthesia|spinal anesthesia
5023663|NCT01533662|lower limb orthopedic surgery|lower limb orthopedic surgery
5023664|NCT01533649|Behavioral intervention|behavioral intervention
5023665|NCT01533649|Seizure self-efficacy|seizure self-efficacy
5023666|NCT01533649|Psychosocial outcomes|psychosocial outcomes
5023667|NCT01533649|Quality of Life in Epilepsy|quality of life in epilepsy
5023668|NCT01533636|Cystic Fibrosis, Healthy|cystic fibrosis, healthy
5023669|NCT01533610|Post-Traumatic Stress disorder|post-traumatic stress disorder
5023670|NCT01533610|Stellate ganglion|stellate ganglion
5023671|NCT01533610|cervical plexus|cervical plexus
5023672|NCT01533610|local anesthesia|local anesthesia
5023673|NCT01533610|anxiety|anxiety
5023674|NCT01533597|Overactive bladder|overactive bladder
5023675|NCT01533597|Solifenacin succinate|solifenacin succinate
5023676|NCT01533597|Tamsulosin|tamsulosin
5023677|NCT01533571|Guided Bone Regeneration|guided bone regeneration
5023678|NCT01533571|Dental Implant|dental implant
5023679|NCT01533571|Alveolar Ridge Augmentation|alveolar ridge augmentation
5023680|NCT01533571|Socket graft|socket graft
5023681|NCT01533558|caspofungin|caspofungin
5023682|NCT01533558|pharmacokinetics|pharmacokinetics
5023683|NCT01533558|invasive fungal infection|invasive fungal infection
5023684|NCT01533558|candidiasis|candidiasis
5023685|NCT01533558|aspergillosis|aspergillosis
5023686|NCT01533558|intensive care|intensive care
5023687|NCT01533545|Mepivacaine|mepivacaine
5023688|NCT01533545|Epinephrine|epinephrine
5023689|NCT01533545|Brachial plexus block|brachial plexus block
5023690|NCT01533545|Renal insufficiency|renal insufficiency
5023691|NCT01533532|Gonadotropin-Releasing Hormone (GnRH) antagonist|gonadotropin-releasing hormone (gnrh) antagonist
5023692|NCT01533519|Neuropeptide Y|neuropeptide y
5023693|NCT01533519|Intranasal Administration|intranasal administration
5023694|NCT01533519|PTSD|ptsd
5023695|NCT01533519|Trauma|trauma
5023696|NCT01533506|treatment with stiripentol|treatment with stiripentol
5023697|NCT01533493|ADHD|adhd
5023698|NCT01533493|Executive Function|executive function
5023699|NCT01533493|Namenda|namenda
5023700|NCT01533493|Concerta|concerta
5023701|NCT01533480|Adenovirus|adenovirus
5023702|NCT01533480|Conjunctivitis|conjunctivitis
5023703|NCT01533480|keratoconjunctivitis|keratoconjunctivitis
5023704|NCT01533480|viral shedding|viral shedding
5023705|NCT01533480|subepithelial infiltrate|subepithelial infiltrate
5023706|NCT01533480|bulbar injection|bulbar injection
5023707|NCT01533467|Delivery rupture|delivery rupture
5023708|NCT01533467|perineal protection device|perineal protection device
5023709|NCT01533467|reduce perineal tears|reduce perineal tears
5023710|NCT01533454|Obesity|obesity
5023711|NCT01533454|Weight loss|weight loss
5023712|NCT01533454|Incentives|incentives
5023713|NCT01533454|Motivation|motivation
5023714|NCT01533441|anticoagulant therapy|anticoagulant therapy
5023715|NCT01533441|INR|inr
5023716|NCT01533441|vitamin K2|vitamin k2
5023717|NCT01533441|vitamin K antagonist|vitamin k antagonist
5023718|NCT01533428|Painful Diabetic Peripheral Neuropathy,|painful diabetic peripheral neuropathy,
5023719|NCT01533428|Capsaicin 8% transdermal delivery system|capsaicin 8% transdermal delivery system
5023720|NCT01533415|Anxiety|anxiety
5023721|NCT01533415|Anxiety Disorders|anxiety disorders
5023722|NCT01533402|Cognitive behavior therapy|cognitive behavior therapy
5023723|NCT01533402|Internet|internet
5023724|NCT01533402|Anxiety disorders|anxiety disorders
5023725|NCT01533402|Children|children
5023726|NCT01533376|Sturge Weber|sturge weber
5023727|NCT01533376|SWS|sws
5023728|NCT01533376|Timolol|timolol
5023729|NCT01533376|Port wine mark|port wine mark
5023730|NCT01533363|Hemorrhoids|hemorrhoids
5023731|NCT01533363|Surgery|surgery
5023732|NCT01533363|Hemorrhoidopexy|hemorrhoidopexy
5023733|NCT01533363|Milligan Morgan|milligan morgan
5023734|NCT01533350|Ultrasonography|ultrasonography
5023735|NCT01533350|late follicle phase|late follicle phase
5023736|NCT01533350|homogeneous endometrium|homogeneous endometrium
5023737|NCT01533350|receptivity|receptivity
5023738|NCT01533350|biochemical factor|biochemical factor
5023739|NCT01533350|ultrastructure|ultrastructure
5023740|NCT01533350|endometrial echo pattern|endometrial echo pattern
5023741|NCT01533337|dorsal digital free flap|dorsal digital free flap
5023742|NCT01533337|dorsal branch of proper digital nerve|dorsal branch of proper digital nerve
5023743|NCT01533337|dorsal branch of proper digital artery|dorsal branch of proper digital artery
5023744|NCT01533337|proper digital artery|proper digital artery
5023745|NCT01533324|hepatocellular carcinoma|hepatocellular carcinoma
5023746|NCT01533324|S-1|s-1
5023747|NCT01533324|Leucovorin|leucovorin
5023748|NCT01533324|fluorouracil|fluorouracil
5023749|NCT01533311|nonpolypoid colorectal neoplasms(NP-CRN)|nonpolypoid colorectal neoplasms(np-crn)
5023750|NCT01533311|prevalence|prevalence
5023751|NCT01533311|histology|histology
5023752|NCT01533285|Major depressive disorder|major depressive disorder
5023753|NCT01533285|MDD|mdd
5023754|NCT01533285|Psychiatry disorders|psychiatry disorders
5023755|NCT01533285|Psychosocial stressor|psychosocial stressor
5023756|NCT01533285|Psychosocial stress|psychosocial stress
5023757|NCT01533285|Typhoid vaccination|typhoid vaccination
5023758|NCT01533285|Typhoid vaccine|typhoid vaccine
5023759|NCT01533272|HIV infection|hiv infection
5023760|NCT01533272|Postexposure prophylaxis|postexposure prophylaxis
5023761|NCT01533259|HIV-1|hiv-1
5023762|NCT01533259|HIV|hiv
5023763|NCT01533259|Treatment Experienced|treatment experienced
5023764|NCT01533233|thoracoscopy|thoracoscopy
5023765|NCT01533233|lung cancer|lung cancer
5023766|NCT01533233|lobectomy|lobectomy
5023767|NCT01533233|epidural anesthesia|epidural anesthesia
5023768|NCT01533220|nasal and nasopharyngeal congestion|nasal and nasopharyngeal congestion
5023769|NCT01533168|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
5023770|NCT01533168|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5023771|NCT01533168|B-cell childhood acute lymphoblastic leukemia|b-cell childhood acute lymphoblastic leukemia
5023772|NCT01533155|Phase 1|phase 1
5023773|NCT01533155|Healthy male and female volunteers|healthy male and female volunteers
5023774|NCT01533155|Drug-drug interaction|drug-drug interaction
5023775|NCT01533155|Pharmacokinetics|pharmacokinetics
5023776|NCT01533155|NKTR-118|nktr-118
5023777|NCT01533142|lipids|lipids
5023778|NCT01533129|Hypogonadism|hypogonadism
5023779|NCT01533129|Endothelial dysfunction|endothelial dysfunction
5023780|NCT01533129|Inflammation|inflammation
5023781|NCT01533129|Insulin resistance|insulin resistance
5023782|NCT01533129|Testosterone replacement therapy|testosterone replacement therapy
5023783|NCT01533116|Parkinson Disease|parkinson disease
5023784|NCT01533116|BIA 9-1067|bia 9-1067
5023785|NCT01533077|Parkinson Disease|parkinson disease
5023786|NCT01533077|BIA 9-1067|bia 9-1067
5023787|NCT01533051|Chronic hepatitis B|chronic hepatitis b
5023788|NCT01533051|Nucleos(t)ide analogue|nucleos(t)ide analogue
5023789|NCT01533051|Antiviral treatment|antiviral treatment
5023790|NCT01533051|Korea|korea
5023791|NCT01533025|anterior cruciate ligament|anterior cruciate ligament
5023792|NCT01533025|Achilles|achilles
5023793|NCT01533025|free tendon|free tendon
5023794|NCT01533025|bone-tendon|bone-tendon
5023795|NCT01533025|free tendon Achilles allograft|free tendon achilles allograft
5023796|NCT01533025|Achilles allograft with calcaneal bone block on its end|achilles allograft with calcaneal bone block on its end
5023797|NCT01532999|Posttraumatic Stress Disorder|posttraumatic stress disorder
5023798|NCT01532999|Meditation|meditation
5023799|NCT01532999|Present Centered Group Therapy|present centered group therapy
5023800|NCT01532999|mindfulness|mindfulness
5023801|NCT01532999|MBSR|mbsr
5023802|NCT01532999|complementary alternative medicine|complementary alternative medicine
5023803|NCT01532986|Quality of Health Care|quality of health care
5023804|NCT01532986|Nursing Care Management|nursing care management
5023805|NCT01532986|Care Coordination|care coordination
5023806|NCT01532986|Randomized Trials|randomized trials
5023807|NCT01532960|breast cancer|breast cancer
5023808|NCT01532960|peptide vaccine|peptide vaccine
5023809|NCT01532960|immunotherapy|immunotherapy
5023810|NCT01532934|substance use|substance use
5023811|NCT01532934|psychopathy|psychopathy
5023812|NCT01532934|motivational enhancement|motivational enhancement
5023813|NCT01532934|criminal recidivism|criminal recidivism
5023814|NCT01532908|Liver Transplantation|liver transplantation
5023815|NCT01532895|Pain|pain
5023816|NCT01532895|Cancer pain|cancer pain
5023817|NCT01532895|Hydromorphone|hydromorphone
5023818|NCT01532895|Hydromorphone OROS|hydromorphone oros
5023819|NCT01532895|Narcotic analgesics|narcotic analgesics
5023820|NCT01532895|Opioid-naive|opioid-naive
5023821|NCT01532856|multiple myeloma|multiple myeloma
5023822|NCT01532856|thalidomide|thalidomide
5023823|NCT01532856|comparative|comparative
5023824|NCT01532856|elderly|elderly
5023825|NCT01532843|Hepatitis B|hepatitis b
5023826|NCT01532843|sustained response|sustained response
5023827|NCT01532843|peginterferon|peginterferon
5023828|NCT01532843|nucleos(t)ide analogues|nucleos(t)ide analogues
5023829|NCT01532830|vagus nerve stimulation|vagus nerve stimulation
5023830|NCT01532830|vagal nerve stimulation|vagal nerve stimulation
5023831|NCT01532830|nVNS|nvns
5023832|NCT01532830|VNS|vns
5023833|NCT01532830|migraine|migraine
5023834|NCT01532830|non invasive|non invasive
5023835|NCT01532830|gammacore|gammacore
5023836|NCT01532804|Unresectable metastases|unresectable metastases
5023837|NCT01532791|MELAS|melas
5023838|NCT01532791|mitochondrial DNA mutation|mitochondrial dna mutation
5023839|NCT01532791|mtDNA mutation|mtdna mutation
5023840|NCT01532791|mitochondrial DNA|mitochondrial dna
5023841|NCT01532791|mitochondria|mitochondria
5023842|NCT01532791|m.3243A>G mutation|m.3243a>g mutation
5023843|NCT01532765|Internal limiting membrane|internal limiting membrane
5023844|NCT01532765|Indocyanine green dye|indocyanine green dye
5023845|NCT01532739|Mild Cognitive Impairment|mild cognitive impairment
5023846|NCT01532739|Aging|aging
5023847|NCT01532739|Memory|memory
5023848|NCT01532739|Executive Function|executive function
5023849|NCT01532739|Cognitive Intervention|cognitive intervention
5023850|NCT01532739|Memory Training|memory training
5023851|NCT01532739|Mental Health|mental health
5023852|NCT01532726|Partial-Onset Seizures|partial-onset seizures
5023853|NCT01532726|Eslicarbazepine Acetate|eslicarbazepine acetate
5023854|NCT01532726|ESL|esl
5023855|NCT01532726|BIA 2-093|bia 2-093
5023856|NCT01532726|BIAL|bial
5023857|NCT01532661|TRAUMA|trauma
5023858|NCT01532661|HAEMORRHAGIC|haemorrhagic
5023859|NCT01532661|rVIIa|rviia
5023860|NCT01532661|Complication of Trauma hemorrhage|complication of trauma hemorrhage
5023861|NCT01532661|bleeding|bleeding
5023862|NCT01532661|rFVIIa administration for hemorrhage after trauma|rfviia administration for hemorrhage after trauma
5023863|NCT01532648|Ulcerative Colitis|ulcerative colitis
5023864|NCT01532635|hematologic malignancy|hematologic malignancy
5023865|NCT01532635|leukemia|leukemia
5023866|NCT01532635|Acute lymphoblastic leukemia|acute lymphoblastic leukemia
5023867|NCT01532635|ALL|all
5023868|NCT01532635|Acute myelogenous leukemia|acute myelogenous leukemia
5023869|NCT01532635|AML|aml
5023870|NCT01532635|Chronic lymphocytic leukemia|chronic lymphocytic leukemia
5023871|NCT01532635|CLL|cll
5023872|NCT01532635|lymphoma|lymphoma
5023873|NCT01532635|hodgkin's lymphoma|hodgkin's lymphoma
5023874|NCT01532635|non-hodgkin's lymphoma|non-hodgkin's lymphoma
5023875|NCT01532635|myeloma|myeloma
5023876|NCT01532635|allogeneic stem cell transplant|allogeneic stem cell transplant
5023877|NCT01532635|TJU 2-step|tju 2-step
5023878|NCT01532635|Hematopoietic stem cell transplant|hematopoietic stem cell transplant
5023879|NCT01532635|HSCT|hsct
5023880|NCT01532635|bone marrow transplant|bone marrow transplant
5023881|NCT01532635|Cyclophosphamide|cyclophosphamide
5023882|NCT01532635|MMF|mmf
5023883|NCT01532635|Mycophenolate Mofetil|mycophenolate mofetil
5023884|NCT01532622|Blueberry|blueberry
5023885|NCT01532609|Methadone maintenance therapy|methadone maintenance therapy
5023886|NCT01532609|Behavioral intervention|behavioral intervention
5023887|NCT01532609|Service provider|service provider
5023888|NCT01532609|Drug use|drug use
5023889|NCT01532570|Behcet's disease|behcet's disease
5023890|NCT01532570|intestinal Behcet's disease|intestinal behcet's disease
5023891|NCT01532570|neuro-Behcet's disease|neuro-behcet's disease
5023892|NCT01532570|vascular Behcet's disease|vascular behcet's disease
5023893|NCT01532544|Severe pneumonia|severe pneumonia
5023894|NCT01532531|Collateral Meridian Therapy|collateral meridian therapy
5023895|NCT01532531|Knee Osteoarthritis|knee osteoarthritis
5023896|NCT01532518|Feeding intolerance|feeding intolerance
5023897|NCT01532518|Infant|infant
5023898|NCT01532518|tachykinin antagonist|tachykinin antagonist
5023899|NCT01532518|Infant colic|infant colic
5023900|NCT01532518|Nepadutant|nepadutant
5023901|NCT01532505|cardiopulmonary bypass|cardiopulmonary bypass
5023902|NCT01532505|Postcardiotomy vasodilatory shock|postcardiotomy vasodilatory shock
5023903|NCT01532505|Microcirculation|microcirculation
5023904|NCT01532505|Catecholamines|catecholamines
5023905|NCT01532505|Vasopressin|vasopressin
5023906|NCT01532492|Questionnaire|questionnaire
5023907|NCT01532492|WORC|worc
5023908|NCT01532492|Rotator cuff|rotator cuff
5023909|NCT01532492|Reliability|reliability
5023910|NCT01532492|Validity|validity
5023911|NCT01532492|Responsiveness|responsiveness
5023912|NCT01532479|Osteoradionecrosis|osteoradionecrosis
5023913|NCT01532479|Xerostomia|xerostomia
5023914|NCT01532466|fentanyl-induced coughing, rocuronium|fentanyl-induced coughing, rocuronium
5023915|NCT01532401|Blood pressure|blood pressure
5023916|NCT01532388|Randomized Controlled Trial|randomized controlled trial
5023918|NCT01532388|Drugs|drugs
5023919|NCT01532388|Internet|internet
5023920|NCT01532388|Screening|screening
5023921|NCT01532388|Brief intervention|brief intervention
5023922|NCT01532375|Kochujang,|kochujang,
5023923|NCT01532375|visceral fat|visceral fat
5023924|NCT01532375|population|population
5023925|NCT01532349|chronic kidney disease|chronic kidney disease
5023926|NCT01532349|anemia|anemia
5023927|NCT01532336|adenovirus|adenovirus
5023928|NCT01532336|conjunctivitis|conjunctivitis
5023929|NCT01532336|pinkeye|pinkeye
5023930|NCT01532323|Oral disorders|oral disorders
5023931|NCT01532310|systemic lupus erythematosus|systemic lupus erythematosus
5023932|NCT01532310|belimumab|belimumab
5023933|NCT01532310|pregnancy|pregnancy
5023934|NCT01532297|citrate dialysate|citrate dialysate
5023935|NCT01532297|dialysis|dialysis
5023936|NCT01532297|calcium|calcium
5023937|NCT01532284|aneuploid oocytes|aneuploid oocytes
5023938|NCT01532284|ICSI|icsi
5023939|NCT01532284|IVF|ivf
5023940|NCT01532284|Polar Body Biopsy|polar body biopsy
5023941|NCT01532271|mild Traumatic Brain Injury|mild traumatic brain injury
5023942|NCT01532271|mTBI|mtbi
5023943|NCT01532271|Concussion|concussion
5023944|NCT01532258|BMI|bmi
5023945|NCT01532258|Weight loss|weight loss
5023946|NCT01532258|Nutrition|nutrition
5023947|NCT01532258|Diet|diet
5023948|NCT01532258|Mediterranean diet|mediterranean diet
5023949|NCT01532258|Online program|online program
5023950|NCT01532258|web-based program|web-based program
5023951|NCT01532258|Oxidative stress|oxidative stress
5023952|NCT01532258|F2 isoprostanes|f2 isoprostanes
5023953|NCT01532232|PLACEBO|placebo
5023954|NCT01532232|VARENICLINE (CHANTIX)|varenicline (chantix)
5023955|NCT01532232|Self-reported cigarettes smokers|self-reported cigarettes smokers
5023956|NCT01532232|Smoking Cessation|smoking cessation
5023957|NCT01532232|11-136|11-136
5023958|NCT01532206|Remote ischemic preconditioning|remote ischemic preconditioning
5023959|NCT01532206|inflammation|inflammation
5023960|NCT01532180|Obstructive sleep apnea, neurostimulation, hypoglossal nerve|obstructive sleep apnea, neurostimulation, hypoglossal nerve
5023961|NCT01532141|Parkinson Disease|parkinson disease
5023962|NCT01532141|BIA 9-1067|bia 9-1067
5023963|NCT01532128|Parkinson Disease|parkinson disease
5023964|NCT01532128|BIA 9-1067|bia 9-1067
5023965|NCT01532115|Parkinson Disease|parkinson disease
5023966|NCT01532115|BIA 9-1067|bia 9-1067
5023967|NCT01532102|Genital warts|genital warts
5023968|NCT01532102|Anogenital warts|anogenital warts
5023969|NCT01532102|HPV|hpv
5023970|NCT01532102|Human papillomavirus|human papillomavirus
5023971|NCT01532102|Antiviral|antiviral
5023972|NCT01532076|osteoporosis|osteoporosis
5023973|NCT01532076|prox. humeral fracture|prox. humeral fracture
5023974|NCT01532076|geriatric trauma|geriatric trauma
5023975|NCT01532076|mesenchymal stem cells|mesenchymal stem cells
5023976|NCT01532063|Difficult intubation|difficult intubation
5023977|NCT01532063|Intensive care units|intensive care units
5023978|NCT01532063|Risk factors|risk factors
5023979|NCT01532063|Incidence|incidence
5023980|NCT01532063|Complications|complications
5023981|NCT01532063|Intubation in Intensive Care Unit|intubation in intensive care unit
5023982|NCT01532063|More than 2 attempts of intubation|more than 2 attempts of intubation
5023983|NCT01532063|Intubation attempts lasting more than 10 minutes|intubation attempts lasting more than 10 minutes
5023984|NCT01532050|OSAS|osas
5023985|NCT01532050|American Academy of Sleep Medicine Task Force|american academy of sleep medicine task force
5023986|NCT01532037|Randomised controlled trial|randomised controlled trial
5023987|NCT01532037|Multiple Sclerosis|multiple sclerosis
5023988|NCT01532037|Fatigue|fatigue
5023989|NCT01532037|Cognitive Behavioural Therapy|cognitive behavioural therapy
5023990|NCT01532037|Self Help|self help
5023991|NCT01532024|Optical Imaging|optical imaging
5023992|NCT01532024|Neutrophil|neutrophil
5023993|NCT01532024|Elastase|elastase
5023994|NCT01532024|Molecular Imaging|molecular imaging
5023995|NCT01532024|Acute Lung Injury|acute lung injury
5023996|NCT01532024|ARDS|ards
5023997|NCT01532011|Advanced Cancers|advanced cancers
5023998|NCT01532011|Solid Tumors|solid tumors
5023999|NCT01532011|Erlotinib|erlotinib
5024000|NCT01532011|Erlotinib Hydrochloride|erlotinib hydrochloride
5024001|NCT01532011|OSI-774|osi-774
5024002|NCT01532011|Tarceva|tarceva
5024003|NCT01532011|Pralatrexate|pralatrexate
5024004|NCT01532011|Folotyn|folotyn
5024005|NCT01532011|PDX-010|pdx-010
5024006|NCT01531998|Myeloma|myeloma
5024007|NCT01531998|Multiple Myeloma|multiple myeloma
5024008|NCT01531998|MM|mm
5024009|NCT01531998|Newly diagnosed|newly diagnosed
5024010|NCT01531998|Lenalidomide|lenalidomide
5024011|NCT01531998|CC-5013|cc-5013
5024012|NCT01531998|Revlimid|revlimid
5024013|NCT01531998|Bortezomib|bortezomib
5024014|NCT01531998|Velcade|velcade
5024015|NCT01531998|LDP-341|ldp-341
5024016|NCT01531998|MLN341|mln341
5024017|NCT01531998|PS-341|ps-341
5024018|NCT01531998|Siltuximab|siltuximab
5024019|NCT01531998|CNTO 328|cnto 328
5024020|NCT01531998|Anti-IL-6 Antibody|anti-il-6 antibody
5024021|NCT01531998|Dexamethasone|dexamethasone
5024022|NCT01531998|Decadron|decadron
5024128|NCT01531517|Diabetic|diabetic
5024023|NCT01531998|M. D. Anderson Symptom Inventory Module|m. d. anderson symptom inventory module
5024024|NCT01531998|MDASI-MM|mdasi-mm
5024025|NCT01531998|Questionnaires|questionnaires
5024026|NCT01531998|Surveys|surveys
5024027|NCT01531985|Congenital Heart Disease|congenital heart disease
5024028|NCT01531985|Acute Kidney Injury|acute kidney injury
5024029|NCT01531985|Cardiopulmonary Bypass|cardiopulmonary bypass
5024030|NCT01531985|Biomarkers|biomarkers
5024031|NCT01531972|Single-photon Emission Computed Tomography|single-photon emission computed tomography
5024032|NCT01531972|Healthy Volunteers|healthy volunteers
5024033|NCT01531972|Tomography|tomography
5024034|NCT01531959|Midodrine|midodrine
5024035|NCT01531959|Hypotension|hypotension
5024036|NCT01531959|Intensive care unit|intensive care unit
5024037|NCT01531959|IV vasopressors|iv vasopressors
5024038|NCT01531959|ICU discharge|icu discharge
5024039|NCT01531946|Diffusion Tensor Imaging|diffusion tensor imaging
5024040|NCT01531933|Prediabetic|prediabetic
5024041|NCT01531933|Primary prevention|primary prevention
5024042|NCT01531933|Type 2 diabetes mellitus|type 2 diabetes mellitus
5024043|NCT01531907|GLP2|glp2
5024044|NCT01531907|Obesity|obesity
5024045|NCT01531907|Premenopausal|premenopausal
5024046|NCT01531907|Bone|bone
5024047|NCT01531907|Formation|formation
5024048|NCT01531907|Resorption|resorption
5024049|NCT01531894|solid tumor|solid tumor
5024050|NCT01531894|GSK2110183|gsk2110183
5024051|NCT01531894|hematologic malignancy|hematologic malignancy
5024052|NCT01531894|AKT inhibitor|akt inhibitor
5024053|NCT01531894|cancer|cancer
5024054|NCT01531894|safety|safety
5024055|NCT01531868|Decision making|decision making
5024056|NCT01531868|Carotid stenosis|carotid stenosis
5024057|NCT01531855|T1DM, Exercise|t1dm, exercise
5024058|NCT01531842|Conjunctival bacterial flora|conjunctival bacterial flora
5024059|NCT01531842|prophylactic topical antibiotic|prophylactic topical antibiotic
5024060|NCT01531842|injection|injection
5024061|NCT01531842|intravitreal injection|intravitreal injection
5024062|NCT01531842|bacterial resistance|bacterial resistance
5024063|NCT01531842|serial injection|serial injection
5024064|NCT01531842|serial intravitreal injections|serial intravitreal injections
5024066|NCT01531842|CRVO|crvo
5024067|NCT01531842|AMD|amd
5024068|NCT01531842|BRVO|brvo
5024069|NCT01531829|pulmonary embolism|pulmonary embolism
5024070|NCT01531829|right ventricular dysfunction|right ventricular dysfunction
5024071|NCT01531829|Thrombolysis|thrombolysis
5024072|NCT01531829|Heparin|heparin
5024073|NCT01531816|Pediatrics,|pediatrics,
5024074|NCT01531816|Critically ill Children|critically ill children
5024075|NCT01531816|immobility|immobility
5024076|NCT01531790|Endostar|endostar
5024077|NCT01531790|Carboplatin|carboplatin
5024078|NCT01531790|Pemetrexed|pemetrexed
5024079|NCT01531790|NSCLC|nsclc
5024080|NCT01531790|Phase I|phase i
5024081|NCT01531777|Advanced Colorectal Cancer|advanced colorectal cancer
5024082|NCT01531764|Metastatic breast cancer|metastatic breast cancer
5024083|NCT01531764|intermediate HER2 expression|intermediate her2 expression
5024084|NCT01531764|Afatinib|afatinib
5024085|NCT01531751|HCO-HD|hco-hd
5024086|NCT01531751|survival|survival
5024087|NCT01531751|cardiac biomarkers|cardiac biomarkers
5024088|NCT01531751|AL amyloidosis|al amyloidosis
5024089|NCT01531751|Light Chain Amyloidosis|light chain amyloidosis
5024090|NCT01531738|Taste|taste
5024091|NCT01531738|bariatric surgery|bariatric surgery
5024092|NCT01531738|food preferences|food preferences
5024093|NCT01531738|reward|reward
5024094|NCT01531738|progressive ratio task|progressive ratio task
5024095|NCT01531725|Stents|stents
5024096|NCT01531712|neoadjuvant treatment|neoadjuvant treatment
5024097|NCT01531712|borderline resectability|borderline resectability
5024098|NCT01531686|intraosseous vascular access|intraosseous vascular access
5024099|NCT01531686|CT examination|ct examination
5024100|NCT01531634|Borderline Personality Disorder|borderline personality disorder
5024101|NCT01531634|Women|women
5024102|NCT01531634|Dynamic Cognitive Intervention|dynamic cognitive intervention
5024103|NCT01531634|Recovery|recovery
5024104|NCT01531634|Hope Scale|hope scale
5024105|NCT01531621|metastatic colorectal cancer|metastatic colorectal cancer
5024106|NCT01531608|melanoma|melanoma
5024107|NCT01531608|imaging|imaging
5024108|NCT01531608|sentinel node|sentinel node
5024109|NCT01531608|biopsy|biopsy
5024110|NCT01531595|metastatic colorectal cancer|metastatic colorectal cancer
5024111|NCT01531582|Angelman|angelman
5024112|NCT01531582|Minocycline|minocycline
5024113|NCT01531582|cognitive|cognitive
5024114|NCT01531582|children|children
5024115|NCT01531582|tetracycline|tetracycline
5024116|NCT01531569|Flaxseed|flaxseed
5024117|NCT01531569|Lignans|lignans
5024118|NCT01531569|Pharmacokinetics|pharmacokinetics
5024119|NCT01531543|Vacuum Assisted Closure (VAC)|vacuum assisted closure (vac)
5024120|NCT01531543|Laparostomy|laparostomy
5024121|NCT01531543|Severe peritonitis|severe peritonitis
5024122|NCT01531530|Shigella|shigella
5024123|NCT01531530|Vaccine|vaccine
5024124|NCT01531530|Mucosal immunity|mucosal immunity
5024125|NCT01531517|Pedyphar|pedyphar
5024126|NCT01531517|Ointment|ointment
5024127|NCT01531517|Healing|healing
5024129|NCT01531517|Foot Ulcer|foot ulcer
5024130|NCT01531504|hysterectomies|hysterectomies
5024131|NCT01531504|uterine manipulator|uterine manipulator
5024132|NCT01531491|Emergence|emergence
5024133|NCT01531491|Hypercapnia|hypercapnia
5024134|NCT01531491|Hypocapnia|hypocapnia
5024135|NCT01531491|Propofol|propofol
5024136|NCT01531478|Childhood cancer|childhood cancer
5024137|NCT01531478|Cancer|cancer
5024138|NCT01531478|Sequels|sequels
5024139|NCT01531478|Complications|complications
5024140|NCT01531478|Chemotherapy|chemotherapy
5024141|NCT01531478|Radiotherapy|radiotherapy
5024142|NCT01531478|Surgery|surgery
5024143|NCT01531465|Respiratory insufficiency|respiratory insufficiency
5024144|NCT01531465|Infants|infants
5024145|NCT01531465|High Flow Nasal Cannula (HFNC)|high flow nasal cannula (hfnc)
5024146|NCT01531465|Nasal Continuous Positive Airway Pressure (NCPAP)|nasal continuous positive airway pressure (ncpap)
5024147|NCT01531452|Stomach Neoplasms|stomach neoplasms
5024148|NCT01531452|drug therapy|drug therapy
5024149|NCT01531452|oxaliplatin|oxaliplatin
5024150|NCT01531452|s1|s1
5024151|NCT01531439|Narcotic Antagonists|narcotic antagonists
5024152|NCT01531439|Naloxone infusion|naloxone infusion
5024153|NCT01531439|Postoperative pruritis|postoperative pruritis
5024154|NCT01531439|Patient controlled analgesia|patient controlled analgesia
5024155|NCT01531439|Pediatric|pediatric
5024156|NCT01531439|Children|children
5024157|NCT01531426|resuscitation|resuscitation
5024158|NCT01531426|hypothermia|hypothermia
5024159|NCT01531426|outcome|outcome
5024160|NCT01531387|Phase III|phase iii
5024161|NCT01531387|Sickle cell anemia|sickle cell anemia
5024162|NCT01531387|Conditional transcranial doppler velocities|conditional transcranial doppler velocities
5024163|NCT01531387|Reduce risk of conversion to abnormally high transcranial doppler velocities|reduce risk of conversion to abnormally high transcranial doppler velocities
5024164|NCT01531387|Pediatric patients|pediatric patients
5024165|NCT01531374|Valvular Heart Disease|valvular heart disease
5024166|NCT01531374|Critical Aortic Stenosis|critical aortic stenosis
5024167|NCT01531374|Severe Aortic Stenosis|severe aortic stenosis
5024168|NCT01531374|Extreme Risk|extreme risk
5024169|NCT01531374|High Risk|high risk
5024170|NCT01531374|Aortic Valve Replacement|aortic valve replacement
5024171|NCT01531361|Advanced Cancers|advanced cancers
5024172|NCT01531361|Advanced Malignancies|advanced malignancies
5024173|NCT01531361|Metastatic cancers|metastatic cancers
5024174|NCT01531361|Vemurafenib|vemurafenib
5024175|NCT01531361|PLX4032|plx4032
5024176|NCT01531361|R05185426|r05185426
5024177|NCT01531361|Sorafenib|sorafenib
5024178|NCT01531361|Nexavar|nexavar
5024179|NCT01531361|Bay 43-9006|bay 43-9006
5024180|NCT01531361|Crizotinib|crizotinib
5024181|NCT01531361|PF-02341066|pf-02341066
5024182|NCT01531361|Xalkori|xalkori
5024183|NCT01531361|Maximum tolerated dose|maximum tolerated dose
5024184|NCT01531361|MTD|mtd
5024185|NCT01531361|Dose limiting toxicity|dose limiting toxicity
5024186|NCT01531361|DLT|dlt
5024187|NCT01531348|Retinitis pigmentosa|retinitis pigmentosa
5024188|NCT01531348|Bone marrow-derived mesenchymal stem cells|bone marrow-derived mesenchymal stem cells
5024189|NCT01531348|Intravitreal injection|intravitreal injection
5024190|NCT01531335|adults|adults
5024191|NCT01531322|13vPnC|13vpnc
5024192|NCT01531322|Healthy subjects|healthy subjects
5024193|NCT01531322|China|china
5024194|NCT01531309|Liver impairment|liver impairment
5024195|NCT01531309|Major Depression Disorder|major depression disorder
5024196|NCT01531309|Sublingual tablet|sublingual tablet
5024197|NCT01531296|MRI|mri
5024198|NCT01531296|Lower Extremity Rotational|lower extremity rotational
5024199|NCT01531296|Femoral Version|femoral version
5024200|NCT01531296|Tibial Torsion|tibial torsion
5024201|NCT01531283|unacylated ghrelin|unacylated ghrelin
5024202|NCT01531283|beta cell function|beta cell function
5024203|NCT01531231|heart disease|heart disease
5024204|NCT01531231|unstable angina|unstable angina
5024205|NCT01531231|myocardial infarction|myocardial infarction
5024206|NCT01531231|behavioral|behavioral
5024207|NCT01531231|cardiovascular|cardiovascular
5024208|NCT01531231|emotions|emotions
5024209|NCT01531218|Campylobacter|campylobacter
5024210|NCT01531218|concisus|concisus
5024211|NCT01531218|diarrhea|diarrhea
5024212|NCT01531218|fever|fever
5024213|NCT01531218|abdominal pain|abdominal pain
5024214|NCT01531218|vomiting|vomiting
5024215|NCT01531205|recurrent|recurrent
5024216|NCT01531205|high risk|high risk
5024217|NCT01531192|Lactobacillus reuteri|lactobacillus reuteri
5024218|NCT01531192|Nystatin|nystatin
5024219|NCT01531192|Very Low Birth Weight Infants|very low birth weight infants
5024220|NCT01531192|Candida Colonization|candida colonization
5024221|NCT01531166|Chronic hepatitis B|chronic hepatitis b
5024222|NCT01531166|pegylated Interferon-alpha 2a|pegylated interferon-alpha 2a
5024223|NCT01531166|Korean|korean
5024224|NCT01531153|Cocaine use decreases, increases or stays the same|cocaine use decreases, increases or stays the same
5024225|NCT01531140|colonoscopy cleansing|colonoscopy cleansing
5024226|NCT01531140|PEG|peg
5024227|NCT01531140|sennosides|sennosides
5024228|NCT01531140|children|children
5024229|NCT01531114|Diabetes mellitus|diabetes mellitus
5024636|NCT01529515|R092670|r092670
5024230|NCT01531114|antiplatelet effect|antiplatelet effect
5024231|NCT01531114|prasugrel|prasugrel
5024232|NCT01531114|ticagrelor|ticagrelor
5024233|NCT01531114|STEMI|stemi
5024234|NCT01531114|Insulin|insulin
5024235|NCT01531101|Transference work|transference work
5024236|NCT01531101|Psychodynamic|psychodynamic
5024237|NCT01531101|Depression|depression
5024238|NCT01531101|Treatment|treatment
5024239|NCT01531101|Adolescent|adolescent
5024240|NCT01531088|Nursing Home|nursing home
5024241|NCT01531075|HBV, Inflammatory bowel disease, immunosuppressor|hbv, inflammatory bowel disease, immunosuppressor
5024242|NCT01531062|nigella sativa|nigella sativa
5024243|NCT01531062|dyslipidemia|dyslipidemia
5024244|NCT01531062|elderly|elderly
5024245|NCT01531049|smoking cessation|smoking cessation
5024246|NCT01531049|young adults|young adults
5024247|NCT01531049|motivational counselling|motivational counselling
5024248|NCT01531049|smoking|smoking
5024249|NCT01531049|nicotine replacement therapy|nicotine replacement therapy
5024250|NCT01531049|therapy|therapy
5024251|NCT01531023|Extended-Spectrum Beta-lactamase Producing Bacteria|extended-spectrum beta-lactamase producing bacteria
5024252|NCT01531010|Neonate|neonate
5024253|NCT01531010|Premature|premature
5024254|NCT01531010|Pressure limited ventilation|pressure limited ventilation
5024255|NCT01531010|Volume ventilation|volume ventilation
5024256|NCT01530997|Human Papilloma Virus|human papilloma virus
5024257|NCT01530997|Oropharynx|oropharynx
5024258|NCT01530997|Oropharyngeal Squamous Cell Carcinoma|oropharyngeal squamous cell carcinoma
5024259|NCT01530997|Squamous Cell Carcinoma|squamous cell carcinoma
5024260|NCT01530997|Radiation Therapy|radiation therapy
5024261|NCT01530997|Chemotherapy|chemotherapy
5024262|NCT01530997|p16|p16
5024263|NCT01530984|prostate cancer|prostate cancer
5024264|NCT01530984|metastatic castrate resistant prostate cancer|metastatic castrate resistant prostate cancer
5024265|NCT01530984|Chemotherapy-naïve patients|chemotherapy-naïve patients
5024266|NCT01530984|Anti-CTLA4 blockade|anti-ctla4 blockade
5024267|NCT01530984|systemic GM-CSF|systemic gm-csf
5024268|NCT01530984|Ipilimumab|ipilimumab
5024269|NCT01530971|oxygen|oxygen
5024270|NCT01530971|pregnancy|pregnancy
5024271|NCT01530971|caesarean section|caesarean section
5024272|NCT01530971|anesthetic techniques|anesthetic techniques
5024273|NCT01530958|CKD|ckd
5024274|NCT01530958|Automated Telephone Self Management|automated telephone self management
5024275|NCT01530958|Registry|registry
5024276|NCT01530958|CKD awareness|ckd awareness
5024277|NCT01530958|Self efficacy|self efficacy
5024278|NCT01530932|sepsis|sepsis
5024279|NCT01530932|tissue oxygenation|tissue oxygenation
5024280|NCT01530932|tissue perfusion|tissue perfusion
5024281|NCT01530932|immune reaction|immune reaction
5024282|NCT01530906|Eating disorders|eating disorders
5024283|NCT01530906|Bulimia|bulimia
5024284|NCT01530906|rTMS|rtms
5024285|NCT01530906|Treatment|treatment
5024286|NCT01530893|flavonoids|flavonoids
5024287|NCT01530893|vascular function|vascular function
5024288|NCT01530893|randomised controlled trial|randomised controlled trial
5024289|NCT01530893|placebo controlled|placebo controlled
5024290|NCT01530880|Fever reduction|fever reduction
5024291|NCT01530880|Fever burden|fever burden
5024292|NCT01530880|intravenous ibuprofen|intravenous ibuprofen
5024293|NCT01530867|Dietary Supplements|dietary supplements
5024294|NCT01530867|Physician-patient communication|physician-patient communication
5024295|NCT01530867|Qualitative study|qualitative study
5024296|NCT01530867|Audio recorded office visits|audio recorded office visits
5024297|NCT01530854|sepsis|sepsis
5024298|NCT01530854|free fatty acids|free fatty acids
5024299|NCT01530854|emergency department|emergency department
5024300|NCT01530841|Myotonic dystrophy type 1|myotonic dystrophy type 1
5024301|NCT01530841|Home ventilation|home ventilation
5024302|NCT01530841|Respiratory insufficiency|respiratory insufficiency
5024303|NCT01530841|Neuromuscular|neuromuscular
5024304|NCT01530828|Immunoreactive Trypsinogen|immunoreactive trypsinogen
5024305|NCT01530828|Nectrotizing Enterocolitis|nectrotizing enterocolitis
5024306|NCT01530828|Premature Infants|premature infants
5024307|NCT01530828|Serial IRT|serial irt
5024308|NCT01530802|laparoscopic myomectomy, leiomyoma, blood loss, uterine artery|laparoscopic myomectomy, leiomyoma, blood loss, uterine artery
5024309|NCT01530789|Telemedecine|telemedecine
5024310|NCT01530789|Telemedecine nurse|telemedecine nurse
5024311|NCT01530789|Delegation of tasks|delegation of tasks
5024312|NCT01530789|Type 1 diabetes|type 1 diabetes
5024313|NCT01530776|Pregnancy|pregnancy
5024314|NCT01530776|Postpartum|postpartum
5024315|NCT01530776|Weight Retention|weight retention
5024316|NCT01530776|Behavioral|behavioral
5024317|NCT01530776|Electronically-mediated|electronically-mediated
5024318|NCT01530763|Infections|infections
5024319|NCT01530763|Pediatrics|pediatrics
5024320|NCT01530763|Teflaro|teflaro
5024321|NCT01530763|cephalosporin|cephalosporin
5024322|NCT01530750|postoperative atrial fibrillation|postoperative atrial fibrillation
5024323|NCT01530750|internal loop recorder|internal loop recorder
5024324|NCT01530750|risk factors|risk factors
5024325|NCT01530750|coronary artery bypass surgery|coronary artery bypass surgery
5024326|NCT01530737|pediatric|pediatric
5024327|NCT01530737|Antithrombin|antithrombin
5024927|NCT01528384|Arginine|arginine
5024328|NCT01530737|anticoagulation efficiency|anticoagulation efficiency
5024329|NCT01530737|cardiac surgery|cardiac surgery
5024330|NCT01530724|abdominal obesity|abdominal obesity
5024331|NCT01530698|dendritic cell vaccination|dendritic cell vaccination
5024332|NCT01530698|melanoma|melanoma
5024333|NCT01530698|toll like receptor ligands|toll like receptor ligands
5024334|NCT01530698|mRNA electroporation|mrna electroporation
5024335|NCT01530698|vaccines|vaccines
5024336|NCT01530685|cinnamon|cinnamon
5024337|NCT01530685|chromium|chromium
5024338|NCT01530685|prediabete|prediabete
5024339|NCT01530685|overweight|overweight
5024340|NCT01530672|HIV|hiv
5024341|NCT01530672|Syphilis|syphilis
5024342|NCT01530672|Combination|combination
5024343|NCT01530672|POC|poc
5024344|NCT01530672|point-of-care|point-of-care
5024345|NCT01530672|MBIO|mbio
5024346|NCT01530659|Retinitis pigmentosa|retinitis pigmentosa
5024347|NCT01530659|Usher syndrome type 2|usher syndrome type 2
5024348|NCT01530659|Usher syndrome type 3|usher syndrome type 3
5024349|NCT01530659|Cone photoreceptor|cone photoreceptor
5024350|NCT01530659|Vision|vision
5024351|NCT01530659|Blind|blind
5024352|NCT01530646|obesity|obesity
5024353|NCT01530646|overweight|overweight
5024354|NCT01530646|muscle|muscle
5024355|NCT01530646|protein|protein
5024356|NCT01530646|muscle protein synthesis|muscle protein synthesis
5024357|NCT01530646|muscle protein breakdown|muscle protein breakdown
5024358|NCT01530646|whey|whey
5024359|NCT01530646|soy|soy
5024360|NCT01530646|caloric restriction|caloric restriction
5024361|NCT01530620|Antimuscarinics|antimuscarinics
5024362|NCT01530620|Neurogenic bladder|neurogenic bladder
5024363|NCT01530620|Propiverine|propiverine
5024364|NCT01530620|Urodynamics|urodynamics
5024365|NCT01530607|Early Stage Breast Cancer|early stage breast cancer
5024366|NCT01530607|Reduce Ovarian Failure Following Chemotherapy|reduce ovarian failure following chemotherapy
5024367|NCT01530594|Untreated|untreated
5024368|NCT01530594|Without intent for immediate autologous stem cell transplant|without intent for immediate autologous stem cell transplant
5024369|NCT01530568|Intensive care, TB, tracheal aspirates, Gene Xpert|intensive care, tb, tracheal aspirates, gene xpert
5024370|NCT01530542|bioavailability|bioavailability
5024371|NCT01530542|food effect|food effect
5024372|NCT01530542|oxycodone|oxycodone
5024373|NCT01530542|management of acute and chronic moderate to severe pain|management of acute and chronic moderate to severe pain
5024374|NCT01530529|PF-05180999|pf-05180999
5024375|NCT01530529|safety|safety
5024376|NCT01530529|pharmacokinetics|pharmacokinetics
5024377|NCT01530529|relative bioavailability|relative bioavailability
5024378|NCT01530529|Mental Disorders|mental disorders
5024379|NCT01530529|Schizophrenia and Disorders with Psychotic Features|schizophrenia and disorders with psychotic features
5024380|NCT01530529|Schizophrenia|schizophrenia
5024381|NCT01530516|Malocclusion, Angle Class II|malocclusion, angle class ii
5024382|NCT01530503|biliary tract cancer|biliary tract cancer
5024383|NCT01530503|advanced disease|advanced disease
5024384|NCT01530503|chemotherapy|chemotherapy
5024385|NCT01530490|IVF|ivf
5024386|NCT01530490|ovarian hyperstimulation syndrome|ovarian hyperstimulation syndrome
5024387|NCT01530490|cabergoline|cabergoline
5024388|NCT01530490|hydroxyethyl starch|hydroxyethyl starch
5024389|NCT01530490|prevention|prevention
5024390|NCT01530477|Bone mineral density|bone mineral density
5024391|NCT01530477|weight|weight
5024392|NCT01530477|body composition|body composition
5024393|NCT01530477|DEXA|dexa
5024394|NCT01530477|DXA|dxa
5024395|NCT01530464|High altitude induced fatigue|high altitude induced fatigue
5024396|NCT01530464|High altitude induced pulmonary Hypertension|high altitude induced pulmonary hypertension
5024397|NCT01530451|Nocturia|nocturia
5024398|NCT01530451|Obstructive sleep Apnoea|obstructive sleep apnoea
5024399|NCT01530451|Desmopressin|desmopressin
5024400|NCT01530438|Amyotrophic lateral sclerosis|amyotrophic lateral sclerosis
5024401|NCT01530425|pediatric wheelchairs|pediatric wheelchairs
5024402|NCT01530425|low-income|low-income
5024403|NCT01530425|comparisons|comparisons
5024404|NCT01530412|Quality of Life|quality of life
5024405|NCT01530412|Free-living activity|free-living activity
5024406|NCT01530412|Exacerbation|exacerbation
5024407|NCT01530412|Rehabilitation|rehabilitation
5024408|NCT01530386|Lacosamide|lacosamide
5024409|NCT01530386|Vimpat|vimpat
5024410|NCT01530373|hot flashes|hot flashes
5024411|NCT01530373|breast cancer|breast cancer
5024412|NCT01530373|aromatase inhibitors|aromatase inhibitors
5024413|NCT01530373|solifenacin|solifenacin
5024414|NCT01530373|clonidine|clonidine
5024415|NCT01530373|quality of life|quality of life
5024416|NCT01530347|Glucose monitoring|glucose monitoring
5024417|NCT01530347|non-invasive glucometer|non-invasive glucometer
5024418|NCT01530347|Self glucose monitoring|self glucose monitoring
5024419|NCT01530321|cervicogenic headache|cervicogenic headache
5024420|NCT01530321|spinal manipulation|spinal manipulation
5024421|NCT01530321|chiropractic|chiropractic
5024422|NCT01530321|randomized controlled trial|randomized controlled trial
5024423|NCT01530321|dose-response|dose-response
5024424|NCT01530321|efficacy|efficacy
5024425|NCT01530308|Delirium|delirium
5024426|NCT01530282|Respiratory Insufficiency [C08.618.846]|respiratory insufficiency [c08.618.846]
5024427|NCT01530269|intermediate|intermediate
5024428|NCT01530269|high|high
5024429|NCT01530269|risk|risk
5024430|NCT01530269|radiation|radiation
5024431|NCT01530269|therapy|therapy
5024432|NCT01530269|planning|planning
5024433|NCT01530269|surgical|surgical
5024434|NCT01530269|immunotherapy|immunotherapy
5024435|NCT01530269|chemotherapy|chemotherapy
5024436|NCT01530269|hormone|hormone
5024437|NCT01530256|allograph|allograph
5024438|NCT01530256|steroid refractory|steroid refractory
5024439|NCT01530230|cesarean section|cesarean section
5024440|NCT01530230|electrocardiography|electrocardiography
5024441|NCT01530230|heart|heart
5024442|NCT01530230|hypotension|hypotension
5024443|NCT01530230|ischemia|ischemia
5024444|NCT01530230|oxytocin|oxytocin
5024445|NCT01530230|preeclampsia|preeclampsia
5024446|NCT01530230|regional anesthesia|regional anesthesia
5024447|NCT01530230|ECG changes suggestive of myocardial ischemia|ecg changes suggestive of myocardial ischemia
5024448|NCT01530217|Analgesics|analgesics
5024449|NCT01530217|Ibuprofen|ibuprofen
5024450|NCT01530217|Inflammation|inflammation
5024451|NCT01530217|Tooth Bleaching|tooth bleaching
5024452|NCT01530204|knee arthritis|knee arthritis
5024453|NCT01530204|knee osteoarthritis|knee osteoarthritis
5024454|NCT01530204|knee pain|knee pain
5024455|NCT01530204|cognitive behavioral therapy|cognitive behavioral therapy
5024456|NCT01530204|physical therapy|physical therapy
5024457|NCT01530204|depression prevention|depression prevention
5024458|NCT01530191|depression|depression
5024459|NCT01530191|anxiety|anxiety
5024460|NCT01530191|pelvic organ prolapse|pelvic organ prolapse
5024461|NCT01530191|POP|pop
5024462|NCT01530178|Diabetes Mellitus, Type 1|diabetes mellitus, type 1
5024463|NCT01530165|IFG|ifg
5024464|NCT01530165|IGTT|igtt
5024465|NCT01530152|Truwiev PCD laryngoscope|truwiev pcd laryngoscope
5024466|NCT01530152|Macintosh laryngoscope|macintosh laryngoscope
5024467|NCT01530126|periodontitis|periodontitis
5024468|NCT01530113|Childhood sexual abuse|childhood sexual abuse
5024469|NCT01530113|Vaginismus|vaginismus
5024470|NCT01530113|Partial vaginismus|partial vaginismus
5024471|NCT01530113|Labor dystocia|labor dystocia
5024472|NCT01530113|Depression|depression
5024473|NCT01530100|Edema|edema
5024474|NCT01530100|Pain|pain
5024475|NCT01530100|Lower laser therapy|lower laser therapy
5024476|NCT01530100|orthognathics surgery|orthognathics surgery
5024477|NCT01530087|colostomy|colostomy
5024478|NCT01530087|ileostomy|ileostomy
5024479|NCT01530087|irritant dermatitis|irritant dermatitis
5024480|NCT01530087|two piece barrier|two piece barrier
5024481|NCT01530074|Mandibular nerve|mandibular nerve
5024482|NCT01530074|Mental nerve|mental nerve
5024483|NCT01530074|Mandibular incisive nerve|mandibular incisive nerve
5024484|NCT01530074|Local anesthesia|local anesthesia
5024485|NCT01530074|None, only healthy subjects will be enrolled in this study|none, only healthy subjects will be enrolled in this study
5024486|NCT01530035|cardiac|cardiac
5024487|NCT01530035|vascular|vascular
5024488|NCT01530035|muscular|muscular
5024489|NCT01530035|adaptations|adaptations
5024490|NCT01530035|soccer training|soccer training
5024491|NCT01530035|strength training|strength training
5024492|NCT01530022|Lacosamide|lacosamide
5024493|NCT01530022|Vimpat|vimpat
5024494|NCT01530022|Cognition|cognition
5024495|NCT01530022|Mental Processes|mental processes
5024496|NCT01530022|Adverse Effects|adverse effects
5024497|NCT01530009|Antroduodenal manometry|antroduodenal manometry
5024498|NCT01530009|Child|child
5024499|NCT01530009|Adolescent|adolescent
5024500|NCT01530009|Amoxicillin|amoxicillin
5024501|NCT01530009|Gastrointestinal Motility|gastrointestinal motility
5024502|NCT01529957|Volunteers|volunteers
5024503|NCT01529918|Diabetes|diabetes
5024504|NCT01529918|Self-screening|self-screening
5024505|NCT01529918|Web-based technology|web-based technology
5024506|NCT01529918|follow-up clinical care|follow-up clinical care
5024507|NCT01529918|randomized control trial|randomized control trial
5024508|NCT01529905|depression|depression
5024509|NCT01529905|mania|mania
5024510|NCT01529905|bipolar|bipolar
5024511|NCT01529905|outcome|outcome
5024512|NCT01529905|cognitive|cognitive
5024513|NCT01529879|edentulism|edentulism
5024514|NCT01529879|dental implants|dental implants
5024515|NCT01529879|clinical study|clinical study
5024516|NCT01529879|Nanotite Certain Tapered implant|nanotite certain tapered implant
5024517|NCT01529879|randomized|randomized
5024518|NCT01529879|crestal bone level|crestal bone level
5024519|NCT01529866|clinical study|clinical study
5024520|NCT01529866|edentulism|edentulism
5024521|NCT01529866|dental implants|dental implants
5024522|NCT01529866|Nanotite Certain Tapered implant|nanotite certain tapered implant
5024523|NCT01529866|randomized|randomized
5024524|NCT01529866|crestal bone level|crestal bone level
5024525|NCT01529866|immediate loading|immediate loading
5024526|NCT01529814|edentulism|edentulism
5024527|NCT01529814|dental implants|dental implants
5024528|NCT01529814|clinical study|clinical study
5024529|NCT01529814|Nanotite Certain Tapered implant|nanotite certain tapered implant
5024530|NCT01529814|randomized|randomized
5024531|NCT01529814|crestal bone level|crestal bone level
5024532|NCT01529814|early loading|early loading
5024533|NCT01529801|edentulism|edentulism
5024534|NCT01529801|dental implants|dental implants
5024535|NCT01529801|clinical study|clinical study
5024536|NCT01529801|randomized|randomized
5024537|NCT01529801|Osseotite Certain Tapered|osseotite certain tapered
5024538|NCT01529801|Crestal bone level|crestal bone level
5024539|NCT01529788|abobotulinum toxin lateral orbital lines|abobotulinum toxin lateral orbital lines
5024540|NCT01529788|BotoxCosmetic|botoxcosmetic
5024541|NCT01529788|Dysport|dysport
5024542|NCT01529788|onabotulinum toxin|onabotulinum toxin
5024543|NCT01529788|wrinkles|wrinkles
5024544|NCT01529788|lateral orbital lines|lateral orbital lines
5024545|NCT01529775|partial edentulism|partial edentulism
5024546|NCT01529775|dental implants|dental implants
5024547|NCT01529775|Osseotite Certain Prevail Tapered|osseotite certain prevail tapered
5024548|NCT01529775|Osseotite Certain Tapered|osseotite certain tapered
5024549|NCT01529775|Crestal bone level|crestal bone level
5024550|NCT01529775|randomized|randomized
5024551|NCT01529775|clinical study|clinical study
5024552|NCT01529762|edentulism|edentulism
5024553|NCT01529762|dental implants|dental implants
5024554|NCT01529762|Osseotite Certain Tapered|osseotite certain tapered
5024555|NCT01529762|randomized|randomized
5024556|NCT01529762|clinical study|clinical study
5024557|NCT01529762|partial edentulism|partial edentulism
5024558|NCT01529762|immediate loading|immediate loading
5024559|NCT01529762|crestal bone level|crestal bone level
5024560|NCT01529736|edentulism|edentulism
5024561|NCT01529736|dental implants|dental implants
5024562|NCT01529736|early loading|early loading
5024563|NCT01529736|crestal bone level|crestal bone level
5024564|NCT01529736|high torque insertion|high torque insertion
5024565|NCT01529736|low torque insertion|low torque insertion
5024566|NCT01529736|randomized|randomized
5024567|NCT01529736|Osseotite|osseotite
5024568|NCT01529736|clinical study|clinical study
5024569|NCT01529723|Stroke|stroke
5024570|NCT01529723|Dysphagia screening|dysphagia screening
5024571|NCT01529710|Schistosomiasis hematobium|schistosomiasis hematobium
5024572|NCT01529710|Schistosomiasis mansoni|schistosomiasis mansoni
5024573|NCT01529697|Asthma|asthma
5024574|NCT01529697|Inhaler use|inhaler use
5024575|NCT01529684|Cancer, solid tumors|cancer, solid tumors
5024576|NCT01529684|oncology patients|oncology patients
5024577|NCT01529684|OSI-906|osi-906
5024578|NCT01529684|mass balance|mass balance
5024579|NCT01529684|Absorption, Metabolism, and Excretion of OSI-906|absorption, metabolism, and excretion of osi-906
5024580|NCT01529684|Metabolic profile of 906|metabolic profile of 906
5024581|NCT01529684|Pharmacokinetics of 14C-OSI-906|pharmacokinetics of 14c-osi-906
5024582|NCT01529658|Renal function|renal function
5024583|NCT01529658|Renal hypothermia|renal hypothermia
5024584|NCT01529658|Nephrology|nephrology
5024585|NCT01529658|Nephrectomy|nephrectomy
5024586|NCT01529658|Renal tumor|renal tumor
5024587|NCT01529658|Urology|urology
5024588|NCT01529658|Kidney|kidney
5024589|NCT01529645|pertussis|pertussis
5024590|NCT01529645|booster vaccine|booster vaccine
5024591|NCT01529645|tetanus|tetanus
5024592|NCT01529645|diphtheria in adults|diphtheria in adults
5024593|NCT01529632|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
5024594|NCT01529632|COPD|copd
5024595|NCT01529632|QVA149|qva149
5024596|NCT01529632|QAB149|qab149
5024597|NCT01529632|NVA237|nva237
5024598|NCT01529632|indacaterol|indacaterol
5024599|NCT01529632|glycopyrronium bromide|glycopyrronium bromide
5024600|NCT01529619|Rivastigmine|rivastigmine
5024601|NCT01529619|Alzheimer's disease|alzheimer's disease
5024602|NCT01529619|Transdermal patch|transdermal patch
5024603|NCT01529606|dental restoration|dental restoration
5024604|NCT01529606|dental caries|dental caries
5024605|NCT01529606|tooth cavity|tooth cavity
5024606|NCT01529593|Advanced Cancers|advanced cancers
5024607|NCT01529593|Metastatic cancer|metastatic cancer
5024608|NCT01529593|Tumor response|tumor response
5024609|NCT01529593|Dose limiting toxicity|dose limiting toxicity
5024610|NCT01529593|DLT|dlt
5024611|NCT01529593|Maximum tolerated dose|maximum tolerated dose
5024612|NCT01529593|MTD|mtd
5024613|NCT01529593|Temsirolimus|temsirolimus
5024614|NCT01529593|CCI-779|cci-779
5024615|NCT01529593|Torisel|torisel
5024616|NCT01529593|Metformin|metformin
5024617|NCT01529580|Autism Spectrum Disorder|autism spectrum disorder
5024618|NCT01529580|language|language
5024619|NCT01529580|intervention|intervention
5024620|NCT01529580|school-age|school-age
5024621|NCT01529554|Acute Coronary Syndromes|acute coronary syndromes
5024622|NCT01529554|ST-Elevation Myocardial Infarction|st-elevation myocardial infarction
5024623|NCT01529554|Infarct size|infarct size
5024624|NCT01529554|inflammation|inflammation
5024625|NCT01529554|everolimus|everolimus
5024626|NCT01529541|CWP-0403|cwp-0403
5024627|NCT01529541|Sitagliptin|sitagliptin
5024628|NCT01529541|Metformin|metformin
5024629|NCT01529541|type 2 DM|type 2 dm
5024630|NCT01529528|CWP-0403|cwp-0403
5024631|NCT01529528|type 2 DM|type 2 dm
5024632|NCT01529528|Efficacy|efficacy
5024633|NCT01529528|Safety|safety
5024634|NCT01529528|Phase 3|phase 3
5024635|NCT01529515|Schizophrenia|schizophrenia
5024637|NCT01529515|Paliperidone Palmitate|paliperidone palmitate
5024638|NCT01529515|Paliperidone palmitate 3 month formulation (PP3M)|paliperidone palmitate 3 month formulation (pp3m)
5024639|NCT01529502|Blood Transfusion, Autologous|blood transfusion, autologous
5024640|NCT01529502|Blood Preservation/adverse effects|blood preservation/adverse effects
5024641|NCT01529502|Blood Transfusion/adverse effects|blood transfusion/adverse effects
5024642|NCT01529502|Endothelium, Vascular/physiopathology|endothelium, vascular/physiopathology
5024643|NCT01529502|Hemoglobins|hemoglobins
5024644|NCT01529502|Nitric Oxide|nitric oxide
5024645|NCT01529502|Pulmonary Hypertension|pulmonary hypertension
5024646|NCT01529489|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5024647|NCT01529489|Physical training|physical training
5024648|NCT01529489|Oxygen uptake kinetic|oxygen uptake kinetic
5024649|NCT01529489|Heart rate kinetic|heart rate kinetic
5024650|NCT01529476|Ofloxacin|ofloxacin
5024651|NCT01529476|Levofloxacin|levofloxacin
5024652|NCT01529476|Ofloxacin hydrochloride|ofloxacin hydrochloride
5024653|NCT01529463|Congestive Heart Failure|congestive heart failure
5024654|NCT01529450|basal cell carcinoma, sonidegib, smoothened inhibitor, hedgehog|basal cell carcinoma, sonidegib, smoothened inhibitor, hedgehog
5024655|NCT01529437|allergy|allergy
5024656|NCT01529437|immunology|immunology
5024657|NCT01529437|immune tolerance|immune tolerance
5024658|NCT01529437|immunotherapy|immunotherapy
5024659|NCT01529424|Hypertriglyceridemia|hypertriglyceridemia
5024660|NCT01529411|urothelium|urothelium
5024661|NCT01529411|transitional|transitional
5024662|NCT01529411|carcinoma|carcinoma
5024663|NCT01529411|cancer|cancer
5024664|NCT01529411|metastatic|metastatic
5024665|NCT01529411|tract|tract
5024666|NCT01529398|knee osteoarthritis|knee osteoarthritis
5024667|NCT01529398|exercise therapy|exercise therapy
5024668|NCT01529398|resistance training|resistance training
5024669|NCT01529398|proprioception|proprioception
5024670|NCT01529385|swollen leg|swollen leg
5024671|NCT01529385|diabetes|diabetes
5024672|NCT01529385|compression stockings|compression stockings
5024673|NCT01529385|edema|edema
5024674|NCT01529372|Hypertension|hypertension
5024675|NCT01529372|Blood pressure|blood pressure
5024676|NCT01529372|Renal denervation|renal denervation
5024677|NCT01529359|Irritable Bowel Syndrome|irritable bowel syndrome
5024678|NCT01529359|Probiotics|probiotics
5024679|NCT01529346|Postoperative dental pain|postoperative dental pain
5024680|NCT01529307|Biologic,|biologic,
5024681|NCT01529307|solid tumors,|solid tumors,
5024682|NCT01529307|Death Receptor 5 agonist,|death receptor 5 agonist,
5024683|NCT01529307|caspase-8|caspase-8
5024684|NCT01529294|Hepatic impairment|hepatic impairment
5024685|NCT01529294|Iloperidone|iloperidone
5024686|NCT01529294|ILO522D|ilo522d
5024687|NCT01529294|Pharmacokinetics|pharmacokinetics
5024688|NCT01529268|Nonalcoholic Fatty Liver Disease (NAFLD)|nonalcoholic fatty liver disease (nafld)
5024689|NCT01529268|Cysteamine bitartrate delayed release|cysteamine bitartrate delayed release
5024690|NCT01529268|Children|children
5024691|NCT01529255|Chronic Hepatitis B|chronic hepatitis b
5024692|NCT01529255|Compensated Chronic hepatitis B|compensated chronic hepatitis b
5024693|NCT01529216|DIAMOND System|diamond system
5024694|NCT01529216|T2DM|t2dm
5024695|NCT01529216|Randomized study|randomized study
5024696|NCT01529216|Electrical stimulation|electrical stimulation
5024697|NCT01529216|Fundus|fundus
5024698|NCT01529190|pregabalin|pregabalin
5024699|NCT01529190|postoperative pain control|postoperative pain control
5024700|NCT01529190|interleukin-6|interleukin-6
5024701|NCT01529190|acute pain|acute pain
5024702|NCT01529177|Metformin|metformin
5024703|NCT01529177|Insulin resistance|insulin resistance
5024704|NCT01529177|male infertility|male infertility
5024705|NCT01529177|unexplained Oligozspermia|unexplained oligozspermia
5024706|NCT01529177|Clomiphene citrate|clomiphene citrate
5024707|NCT01529177|Unexplained azoospermia|unexplained azoospermia
5024708|NCT01529164|endostatin|endostatin
5024709|NCT01529164|chemotherapy|chemotherapy
5024710|NCT01529164|antiangiogenesis agent|antiangiogenesis agent
5024711|NCT01529164|colorectal cancer|colorectal cancer
5024712|NCT01529151|Dizziness|dizziness
5024713|NCT01529151|Vertigo|vertigo
5024714|NCT01529151|Benign Paroxysmal Positional Vertigo|benign paroxysmal positional vertigo
5024715|NCT01529151|Labyrinthitis|labyrinthitis
5024716|NCT01529151|Osteopathic Manipulative Treatment|osteopathic manipulative treatment
5024717|NCT01529151|Vestibular Rehabilitation Therapy|vestibular rehabilitation therapy
5024718|NCT01529138|Cancer|cancer
5024719|NCT01529112|Locally Advanced|locally advanced
5024720|NCT01529112|Metastatic Non-Squamous Non-Small Cell Lung Cancer|metastatic non-squamous non-small cell lung cancer
5024721|NCT01529099|Osteoarthritis|osteoarthritis
5024722|NCT01529099|Knee|knee
5024723|NCT01529099|Knee replacement|knee replacement
5024724|NCT01529099|Knee implant|knee implant
5024725|NCT01529099|Knee arthroplasty|knee arthroplasty
5024726|NCT01529099|Unicompartmental|unicompartmental
5024727|NCT01529099|Primary|primary
5024728|NCT01529099|Partial|partial
5024729|NCT01529099|Patellofemoral|patellofemoral
5024730|NCT01529099|Medial|medial
5024731|NCT01529099|Lateral|lateral
5024732|NCT01529099|Bicompartmental|bicompartmental
5024733|NCT01529099|Cemented|cemented
5024734|NCT01529099|Post-traumatic arthritis of the tibio-femoral and/or patellofemoral articular surfaces|post-traumatic arthritis of the tibio-femoral and/or patellofemoral articular surfaces
5024735|NCT01529099|History of Gout or pseudo-gout.|history of gout or pseudo-gout.
5024736|NCT01529086|prostate cancer|prostate cancer
5024737|NCT01529086|dutasteride|dutasteride
5024738|NCT01529086|for cause prostate biopsy|for cause prostate biopsy
5024739|NCT01529073|HIV|hiv
5024740|NCT01529073|genotype 4 HCV|genotype 4 hcv
5024741|NCT01529073|pegylated interferon|pegylated interferon
5024742|NCT01529073|ribavirin|ribavirin
5024743|NCT01529073|nitazoxanide|nitazoxanide
5024744|NCT01529060|phenylbutyrate|phenylbutyrate
5024745|NCT01529060|MSUD|msud
5024746|NCT01529060|Buphenyl-TM|buphenyl-tm
5024747|NCT01529034|Epilepsy|epilepsy
5024748|NCT01529034|seizure clusters|seizure clusters
5024749|NCT01529034|acute repetitive seizures|acute repetitive seizures
5024750|NCT01529034|rescue treatment|rescue treatment
5024751|NCT01529021|Pain management|pain management
5024752|NCT01529021|vaccination|vaccination
5024753|NCT01529021|immunization|immunization
5024754|NCT01529021|pediatric|pediatric
5024755|NCT01529021|robotics|robotics
5024756|NCT01529021|human-robot interaction|human-robot interaction
5024757|NCT01529008|Osteonecrosis|osteonecrosis
5024758|NCT01529008|Femoral Head|femoral head
5024759|NCT01529008|Hip|hip
5024760|NCT01529008|Orthopedics|orthopedics
5024761|NCT01529008|Bone|bone
5024762|NCT01529008|Musculoskeletal Disorders|musculoskeletal disorders
5024763|NCT01528995|fecal incontinence|fecal incontinence
5024764|NCT01528995|anal incontinence|anal incontinence
5024765|NCT01528995|obstetric sphincter injuries|obstetric sphincter injuries
5024766|NCT01528995|OASIS|oasis
5024767|NCT01528995|double incontinence|double incontinence
5024768|NCT01528995|urinary incontinence|urinary incontinence
5024769|NCT01528995|sexual function|sexual function
5024770|NCT01528995|sacral nerve modulation|sacral nerve modulation
5024771|NCT01528995|sacral nerve stimulation|sacral nerve stimulation
5024772|NCT01528995|Interstim|interstim
5024773|NCT01528995|anal bulking injections|anal bulking injections
5024774|NCT01528995|Permacol|permacol
5024775|NCT01528969|oral microbiota|oral microbiota
5024776|NCT01528969|mutans streptococci|mutans streptococci
5024777|NCT01528969|xylitol|xylitol
5024778|NCT01528956|adrenocortical carcinoma|adrenocortical carcinoma
5024779|NCT01528943|prostacycline, endothel integrity and abdominal surgery|prostacycline, endothel integrity and abdominal surgery
5024780|NCT01528930|Lung Diseases|lung diseases
5024781|NCT01528930|Anti-Infective Agents|anti-infective agents
5024782|NCT01528930|Therapeutic Uses|therapeutic uses
5024783|NCT01528930|Amikacin|amikacin
5024784|NCT01528917|Lysosomal Storage Disease|lysosomal storage disease
5024785|NCT01528917|Late Onset Lysosomal Acid Lipase (LAL) Deficiency|late onset lysosomal acid lipase (lal) deficiency
5024786|NCT01528917|Acid cholesteryl ester hydrolase deficiency, type 2|acid cholesteryl ester hydrolase deficiency, type 2
5024787|NCT01528917|Acid lipase disease|acid lipase disease
5024788|NCT01528917|Cholesterol ester hydrolase deficiency|cholesterol ester hydrolase deficiency
5024789|NCT01528917|LAL Deficiency|lal deficiency
5024790|NCT01528917|LIPA Deficiency|lipa deficiency
5024791|NCT01528917|Wolman disease|wolman disease
5024792|NCT01528904|pregnancy|pregnancy
5024793|NCT01528904|autoimmune thyroid disease|autoimmune thyroid disease
5024794|NCT01528904|fetal thyroid hormones|fetal thyroid hormones
5024795|NCT01528904|antithyroid antibodies|antithyroid antibodies
5024796|NCT01528904|ultrasound parameters|ultrasound parameters
5024797|NCT01528891|tonsillectomy|tonsillectomy
5024798|NCT01528891|emergence agitation|emergence agitation
5024799|NCT01528878|Liver Cancer|liver cancer
5024800|NCT01528878|Hepatocellular Carcinoma|hepatocellular carcinoma
5024801|NCT01528878|HCC|hcc
5024802|NCT01528878|Metastatic Cancer to Liver|metastatic cancer to liver
5024803|NCT01528878|Metastatic Colon Cancer|metastatic colon cancer
5024804|NCT01528878|Metastatic Colo-rectal Cancer|metastatic colo-rectal cancer
5024805|NCT01528878|mCRC|mcrc
5024806|NCT01528878|Liver Function|liver function
5024807|NCT01528878|Child-Pugh|child-pugh
5024808|NCT01528865|virus|virus
5024809|NCT01528865|K(HML2)[HERV-K(HML2)]|k(hml2)[herv-k(hml2)]
5024810|NCT01528865|Lymphoma|lymphoma
5024811|NCT01528865|Human endogenous retrovirus-K(HLM2)[HERV-K(HML2)]|human endogenous retrovirus-k(hlm2)[herv-k(hml2)]
5024812|NCT01528852|neonatal Mortality|neonatal mortality
5024813|NCT01528852|chlorhexidine cord care|chlorhexidine cord care
5024814|NCT01528852|cord infections|cord infections
5024815|NCT01528852|african settings|african settings
5024816|NCT01528852|clinical trials|clinical trials
5024817|NCT01528839|Bipolar disorder|bipolar disorder
5024818|NCT01528839|Bipolar depression|bipolar depression
5024819|NCT01528839|Thyroid abnormality|thyroid abnormality
5024820|NCT01528839|mood stabilizer|mood stabilizer
5024821|NCT01528839|antidepressants|antidepressants
5024822|NCT01528839|currently depressed|currently depressed
5024823|NCT01528826|metastatic triple-negative breast cancer|metastatic triple-negative breast cancer
5024824|NCT01528826|vinorebine|vinorebine
5024825|NCT01528826|oxaliplatin|oxaliplatin
5024826|NCT01528813|Erbium-doped yttrium aluminium garnet laser|erbium-doped yttrium aluminium garnet laser
5024827|NCT01528813|Er:YAG|er:yag
5024828|NCT01528813|Amorolfine lacquer|amorolfine lacquer
5024829|NCT01528813|Dermatophytes|dermatophytes
5024830|NCT01528813|Subungual distal lateral onychomycosis|subungual distal lateral onychomycosis
5024831|NCT01528813|Drug delivery|drug delivery
5024832|NCT01528800|Vitamin K|vitamin k
5024833|NCT01528800|Chronic kidney disease|chronic kidney disease
5024834|NCT01528800|vascular calcification|vascular calcification
5024835|NCT01528800|hemodialysis|hemodialysis
5024836|NCT01528800|coronary artery calcification|coronary artery calcification
5024837|NCT01528787|Intraocular pressure|intraocular pressure
5024838|NCT01528787|visual field|visual field
5024839|NCT01528787|Ocular hypertension or open angle glaucoma|ocular hypertension or open angle glaucoma
5024840|NCT01528774|Melanoma|melanoma
5024841|NCT01528774|Circulating Tumor Cells|circulating tumor cells
5024842|NCT01528774|Prostate cancer|prostate cancer
5024843|NCT01528774|Sarcoma|sarcoma
5024844|NCT01528774|Renal Cancer|renal cancer
5024845|NCT01528774|Pancreatic neuroendocrine cancer|pancreatic neuroendocrine cancer
5024846|NCT01528774|Other solid tumor|other solid tumor
5024847|NCT01528761|physical activity|physical activity
5024848|NCT01528761|older adults|older adults
5024849|NCT01528761|physical function|physical function
5024850|NCT01528761|health-related quality of life|health-related quality of life
5024851|NCT01528761|prosocial behavior|prosocial behavior
5024852|NCT01528761|social cognitive theory|social cognitive theory
5024853|NCT01528722|Emergency laparoscopic cholecystectomy|emergency laparoscopic cholecystectomy
5024854|NCT01528722|Pain scores|pain scores
5024855|NCT01528722|Intraperitoneal local anaesthesia|intraperitoneal local anaesthesia
5024856|NCT01528722|Cholecystitis|cholecystitis
5024857|NCT01528709|Statin,|statin,
5024858|NCT01528709|CABG,|cabg,
5024859|NCT01528709|saphenous vein graft,|saphenous vein graft,
5024860|NCT01528709|graft occlusion,|graft occlusion,
5024861|NCT01528709|lipids|lipids
5024862|NCT01528696|Obesity|obesity
5024863|NCT01528696|Cesarean Section|cesarean section
5024864|NCT01528696|Wound care|wound care
5024865|NCT01528657|Sick Sinus Syndrome|sick sinus syndrome
5024866|NCT01528657|Ventricular pacing|ventricular pacing
5024867|NCT01528657|Minimal ventricular pacing|minimal ventricular pacing
5024868|NCT01528657|Ventricular pacing suppression|ventricular pacing suppression
5024869|NCT01528657|Intrinsic rhythm support|intrinsic rhythm support
5024870|NCT01528657|Long term AV|long term av
5024871|NCT01528644|iron|iron
5024872|NCT01528644|fortification|fortification
5024873|NCT01528644|alginate|alginate
5024874|NCT01528644|iron deficiency|iron deficiency
5024875|NCT01528618|Advanced Nasopharyngeal Carcinoma|advanced nasopharyngeal carcinoma
5024876|NCT01528618|treatment|treatment
5024877|NCT01528605|lutein|lutein
5024878|NCT01528605|zeaxanthin|zeaxanthin
5024879|NCT01528605|age-related macular degeneration|age-related macular degeneration
5024880|NCT01528605|supplementation|supplementation
5024881|NCT01528605|macular pigment optical density|macular pigment optical density
5024882|NCT01528605|visual function|visual function
5024883|NCT01528605|serum concentration|serum concentration
5024884|NCT01528579|Whiplash|whiplash
5024885|NCT01528579|Rehabilitation|rehabilitation
5024886|NCT01528579|Physiotherapy|physiotherapy
5024887|NCT01528579|Exercises|exercises
5024888|NCT01528566|osteoarthritis, knee|osteoarthritis, knee
5024889|NCT01528566|Cognitive impairment|cognitive impairment
5024890|NCT01528566|Tai Chi|tai chi
5024891|NCT01528553|genu valgus|genu valgus
5024892|NCT01528553|lower limb|lower limb
5024893|NCT01528553|paediatric|paediatric
5024894|NCT01528553|epiphysiodesis|epiphysiodesis
5024895|NCT01528540|chronic pancreatitis|chronic pancreatitis
5024896|NCT01528540|pregabalin|pregabalin
5024897|NCT01528540|antioxidant|antioxidant
5024898|NCT01528514|Myocardial infarction|myocardial infarction
5024899|NCT01528514|Coronary artery bypass grafting|coronary artery bypass grafting
5024900|NCT01528514|Anti-oxidant|anti-oxidant
5024901|NCT01528514|Curcuminoids|curcuminoids
5024902|NCT01528475|Therapeutic Hypothermia|therapeutic hypothermia
5024903|NCT01528475|Cardiac arrest|cardiac arrest
5024904|NCT01528462|Stroke|stroke
5024905|NCT01528462|Ischemic Attack, Transient|ischemic attack, transient
5024906|NCT01528462|Sleep Disorders|sleep disorders
5024907|NCT01528462|Sleep Apnea Syndromes|sleep apnea syndromes
5024908|NCT01528462|Restless Legs Syndrome|restless legs syndrome
5024909|NCT01528462|Chronobiology Disorders|chronobiology disorders
5024910|NCT01528449|babesia|babesia
5024911|NCT01528449|blood donation|blood donation
5024912|NCT01528449|transfusion transmitted babesiosis|transfusion transmitted babesiosis
5024913|NCT01528436|Cerebral Palsy|cerebral palsy
5024914|NCT01528436|Umbilical Cord Blood|umbilical cord blood
5024915|NCT01528436|Rehabilitation|rehabilitation
5024916|NCT01528423|XtremeCT|xtremect
5024917|NCT01528423|Density|density
5024918|NCT01528423|pQCT|pqct
5024919|NCT01528423|Turnover|turnover
5024920|NCT01528423|Bone|bone
5024921|NCT01528423|short-term reproducibility|short-term reproducibility
5024922|NCT01528397|defect|defect
5024923|NCT01528397|dorsal branch of the proper digital nerve|dorsal branch of the proper digital nerve
5024924|NCT01528397|proper digital nerve|proper digital nerve
5024925|NCT01528397|second dorsal metacarpal artery|second dorsal metacarpal artery
5024926|NCT01528397|pedicled nerve graft.|pedicled nerve graft.
5024928|NCT01528384|Arginine deiminase|arginine deiminase
5024929|NCT01528384|Argininosuccinate synthetase|argininosuccinate synthetase
5024930|NCT01528384|Phase 1|phase 1
5024931|NCT01528384|Pediatric|pediatric
5024932|NCT01528384|Failed other treatments|failed other treatments
5024933|NCT01528384|Pediatric patients|pediatric patients
5024934|NCT01528371|Intravenous sedation|intravenous sedation
5024935|NCT01528371|Midazolam|midazolam
5024936|NCT01528371|Dental treatment|dental treatment
5024937|NCT01528371|White-coat hypertension|white-coat hypertension
5024938|NCT01528371|STAI|stai
5024939|NCT01528371|Dental patients|dental patients
5024940|NCT01528371|Transient hypertension|transient hypertension
5024941|NCT01528358|sepsis|sepsis
5024942|NCT01528358|tissue oximetry|tissue oximetry
5024943|NCT01528358|NIRS|nirs
5024944|NCT01528358|VOT|vot
5024945|NCT01528345|Breast Cancer|breast cancer
5024946|NCT01528345|HER2-, HR+|her2-, hr+
5024947|NCT01528345|post-menopausal|post-menopausal
5024948|NCT01528345|Locally advanced or metastatic Breast Cancer (HER2-, HR+)|locally advanced or metastatic breast cancer (her2-, hr+)
5024949|NCT01528332|Musculoskeletal pain|musculoskeletal pain
5024950|NCT01528332|Back pain|back pain
5024951|NCT01528332|Chronic pain|chronic pain
5024952|NCT01528319|Arthroscopic Bankart repair|arthroscopic bankart repair
5024953|NCT01528319|Suture anchor|suture anchor
5024954|NCT01528319|Shoulder dislocation|shoulder dislocation
5024955|NCT01528306|HP802-247|hp802-247
5024956|NCT01528306|EB (epidermolysis bullosa)|eb (epidermolysis bullosa)
5024957|NCT01528280|Shift work|shift work
5024958|NCT01528280|Hepatitis A vaccination|hepatitis a vaccination
5024959|NCT01528280|humoral response|humoral response
5024960|NCT01528280|cellular response|cellular response
5024961|NCT01528267|Emphysema, lung volume reduction, autologous blood|emphysema, lung volume reduction, autologous blood
5024962|NCT01528254|Type 2 Diabetes Mellitus,|type 2 diabetes mellitus,
5024963|NCT01528254|Vildagliptin,|vildagliptin,
5024964|NCT01528254|Elderly Patients|elderly patients
5024965|NCT01528241|ABP688|abp688
5024966|NCT01528241|Tracer|tracer
5024967|NCT01528241|Depression|depression
5024968|NCT01528202|Sleep, circadian cycle, melatonin|sleep, circadian cycle, melatonin
5024969|NCT01528189|Insulin, surgery, infection|insulin, surgery, infection
5024970|NCT01528176|FGF-23, CKD, Cyp24, 24,25(OH)2D, vitamin D metabolism|fgf-23, ckd, cyp24, 24,25(oh)2d, vitamin d metabolism
5024971|NCT01528163|Head and neck|head and neck
5024972|NCT01528163|Squamous cell carcinoma|squamous cell carcinoma
5024973|NCT01528163|Randomized|randomized
5024974|NCT01528163|palliative treatment|palliative treatment
5024975|NCT01528098|polyethylene glycol|polyethylene glycol
5024976|NCT01528098|bisacodyl|bisacodyl
5024977|NCT01528085|Philadelphia chromsome|philadelphia chromsome
5024978|NCT01528085|BCR-ABL|bcr-abl
5024979|NCT01528085|ALL|all
5024980|NCT01528085|acute lymphoblastic leukemia|acute lymphoblastic leukemia
5024981|NCT01528085|Nilotinib|nilotinib
5024982|NCT01528085|Tasigna|tasigna
5024983|NCT01528072|Dynesys Dynamic Stabilization System|dynesys dynamic stabilization system
5024984|NCT01528072|Spondylolithesis|spondylolithesis
5024985|NCT01528072|pseudoarthrosis|pseudoarthrosis
5024986|NCT01528072|neurologic impairment|neurologic impairment
5024987|NCT01528072|failed fusion|failed fusion
5024988|NCT01528059|Diabetes|diabetes
5024989|NCT01528059|Gastric cancer|gastric cancer
5024990|NCT01528059|Gastric bypass|gastric bypass
5024991|NCT01528046|central nervous system (CNS)|central nervous system (cns)
5024992|NCT01528046|malignancy|malignancy
5024993|NCT01528046|relapsed|relapsed
5024994|NCT01528046|refractory|refractory
5024995|NCT01528046|pediatric|pediatric
5024996|NCT01528046|recurrent|recurrent
5024997|NCT01528033|surgical wound|surgical wound
5024998|NCT01528033|wound healing disorder|wound healing disorder
5024999|NCT01528033|Wound healing impairment|wound healing impairment
5025000|NCT01528033|post surgical wound healing disorder|post surgical wound healing disorder
5025001|NCT01528033|abdominal wound healing impairment|abdominal wound healing impairment
5025002|NCT01528033|Vacuum Assisted Closure|vacuum assisted closure
5025003|NCT01528033|negative pressure wound therapy|negative pressure wound therapy
5025004|NCT01528007|Pathological gambling|pathological gambling
5025005|NCT01528007|Treatment intervention|treatment intervention
5025006|NCT01527994|Aprepitant|aprepitant
5025007|NCT01527994|Intravenous heroin dependence|intravenous heroin dependence
5025008|NCT01527981|Depression|depression
5025009|NCT01527981|Diabetes|diabetes
5025010|NCT01527981|Adherence|adherence
5025011|NCT01527981|Medication|medication
5025012|NCT01527981|Glucose|glucose
5025013|NCT01527981|Insulin|insulin
5025014|NCT01527955|Kelee|kelee
5025015|NCT01527955|Meditation|meditation
5025016|NCT01527955|Stress|stress
5025017|NCT01527955|Anxiety|anxiety
5025018|NCT01527955|Depression|depression
5025019|NCT01527955|Brain|brain
5025020|NCT01527955|Mind|mind
5025021|NCT01527942|Pain Management|pain management
5025022|NCT01527903|propofol|propofol
5025023|NCT01527903|midazolam|midazolam
5025024|NCT01527903|sedation|sedation
5025025|NCT01527903|ICU|icu
5025026|NCT01527890|intravenous patient-controlled analgesia|intravenous patient-controlled analgesia
5025027|NCT01527890|IV PCA|iv pca
5025028|NCT01527877|BKM120|bkm120
5025029|NCT01527877|head and neck cancer|head and neck cancer
5025030|NCT01527877|squamous cell carcinoma|squamous cell carcinoma
5025031|NCT01527864|NSCLC|nsclc
5025032|NCT01527851|Post-bariatric surgery|post-bariatric surgery
5025033|NCT01527851|Excess skin|excess skin
5025034|NCT01527851|Physical fitness|physical fitness
5025035|NCT01527851|Physical activity|physical activity
5025036|NCT01527851|Barriers to physical activity|barriers to physical activity
5025037|NCT01527851|Plastic surgery|plastic surgery
5025038|NCT01527851|Quality of life|quality of life
5025039|NCT01527851|Self-esteem|self-esteem
5025040|NCT01527838|Hematologic malignancies|hematologic malignancies
5025041|NCT01527799|Sickle cell anemia|sickle cell anemia
5025042|NCT01527799|Exercise testing|exercise testing
5025043|NCT01527799|Cardiopulmonary disease|cardiopulmonary disease
5025044|NCT01527786|Major Depressive Disorder, Postpartum Onset|major depressive disorder, postpartum onset
5025045|NCT01527773|COPD|copd
5025046|NCT01527773|Cardiovascular disease|cardiovascular disease
5025047|NCT01527773|Phenotypes|phenotypes
5025048|NCT01527760|Essential Hypertension|essential hypertension
5025049|NCT01527760|Viscum album mother tincture|viscum album mother tincture
5025050|NCT01527760|one group pretest post-test study|one group pretest post-test study
5025051|NCT01527747|Type 2 Diabetes|type 2 diabetes
5025052|NCT01527747|Hypertriglyceridemia|hypertriglyceridemia
5025053|NCT01527747|dipeptidyl peptidase-4 (DPP-4)|dipeptidyl peptidase-4 (dpp-4)
5025054|NCT01527747|glucagon-like peptide-1 (glp-1)|glucagon-like peptide-1 (glp-1)
5025055|NCT01527734|Comparison study|comparison study
5025056|NCT01527721|keratoconus|keratoconus
5025057|NCT01527721|CxL|cxl
5025058|NCT01527721|CxL combined with t-PRK|cxl combined with t-prk
5025059|NCT01527695|Phase IIa|phase iia
5025060|NCT01527695|AZD3241|azd3241
5025061|NCT01527695|microglia activation|microglia activation
5025062|NCT01527695|safety|safety
5025063|NCT01527695|Pharmacodynamics and pharmacokinetics analyses|pharmacodynamics and pharmacokinetics analyses
5025064|NCT01527695|Parkinson patients|parkinson patients
5025065|NCT01527682|Intraocular pressure|intraocular pressure
5025066|NCT01527682|Latanoprost|latanoprost
5025067|NCT01527682|Dorzolamide|dorzolamide
5025068|NCT01527669|Red yeast rice|red yeast rice
5025069|NCT01527669|lovastatin|lovastatin
5025070|NCT01527669|Pharmacokinetics|pharmacokinetics
5025071|NCT01527578|Healthy children|healthy children
5025072|NCT01527578|Healthy adults|healthy adults
5025073|NCT01527578|individuals ages 7-60|individuals ages 7-60
5025074|NCT01527526|DMPA|dmpa
5025075|NCT01527526|insulin resistance|insulin resistance
5025076|NCT01527526|cardiovascular disease|cardiovascular disease
5025077|NCT01527526|BMI|bmi
5025078|NCT01527526|weight gain|weight gain
5025079|NCT01527526|thrombosis|thrombosis
5025080|NCT01527513|Partial Epilepsy|partial epilepsy
5025081|NCT01527513|eslicarbazepine acetate|eslicarbazepine acetate
5025082|NCT01527513|Children|children
5025083|NCT01527500|AMD|amd
5025084|NCT01527500|Age-related Macular Degeneration|age-related macular degeneration
5025085|NCT01527500|geographic atrophy|geographic atrophy
5025086|NCT01527500|GA|ga
5025087|NCT01527500|Dry AMD|dry amd
5025088|NCT01527500|Blindness|blindness
5025089|NCT01527500|Drusen|drusen
5025090|NCT01527500|GA lesion|ga lesion
5025091|NCT01527487|breast cancer|breast cancer
5025092|NCT01527487|eribulin|eribulin
5025093|NCT01527487|Halaven|halaven
5025094|NCT01527487|taxotere|taxotere
5025095|NCT01527474|postpartum|postpartum
5025096|NCT01527474|postpartum depression|postpartum depression
5025097|NCT01527474|PPD|ppd
5025098|NCT01527474|escitalopram|escitalopram
5025099|NCT01527461|lung neoplasms|lung neoplasms
5025100|NCT01527461|dogs|dogs
5025101|NCT01527461|sweat|sweat
5025102|NCT01527461|smell|smell
5025103|NCT01527448|postpartum|postpartum
5025104|NCT01527448|postpartum depression|postpartum depression
5025105|NCT01527448|PPD|ppd
5025106|NCT01527448|quetiapine XR|quetiapine xr
5025107|NCT01527448|quetiapine|quetiapine
5025108|NCT01527448|seroquel|seroquel
5025109|NCT01527448|bipolar|bipolar
5025110|NCT01527448|bipolar disorder|bipolar disorder
5025111|NCT01527448|bipolar disorder, type II|bipolar disorder, type ii
5025112|NCT01527435|Best corrected visual acuity|best corrected visual acuity
5025113|NCT01527435|Slit lamp examination|slit lamp examination
5025114|NCT01527435|Ophthalmoscopy with contact lens/indirect ophthalmoscope|ophthalmoscopy with contact lens/indirect ophthalmoscope
5025115|NCT01527435|OCT assessment|oct assessment
5025116|NCT01527435|Fundus photos, fluorescein angiogram, ICG angiogram|fundus photos, fluorescein angiogram, icg angiogram
5025117|NCT01527422|Aggressive Non-Hodgkin's Lymphoma|aggressive non-hodgkin's lymphoma
5025118|NCT01527409|Exercise|exercise
5025119|NCT01527409|Diet|diet
5025120|NCT01527409|Posttraumatic growth|posttraumatic growth
5025121|NCT01527396|endometrial cancer|endometrial cancer
5025122|NCT01527396|lymph node metastasis|lymph node metastasis
5025123|NCT01527396|lymphadenectomy|lymphadenectomy
5025124|NCT01527396|risk criteria|risk criteria
5025125|NCT01527383|Shingles|shingles
5025126|NCT01527357|fibrin sealant|fibrin sealant
5025127|NCT01527357|thrombin|thrombin
5025128|NCT01527357|fibrinogen|fibrinogen
5025129|NCT01527357|hemostasis|hemostasis
5025130|NCT01527344|OCT|oct
5025131|NCT01527344|IVUS|ivus
5025132|NCT01527344|CAV|cav
5025133|NCT01527318|NLSDM|nlsdm
5025134|NCT01527318|Lipid accumulation|lipid accumulation
5025135|NCT01527305|Schizophrenia|schizophrenia
5025136|NCT01527305|Antipsychotics|antipsychotics
5025137|NCT01527305|Paliperidone Palmitate|paliperidone palmitate
5025138|NCT01527305|Paliperidone|paliperidone
5025139|NCT01527305|Invega|invega
5025140|NCT01527305|Sustenna|sustenna
5025141|NCT01527305|Psychotic disorder|psychotic disorder
5025142|NCT01527305|Psychosis|psychosis
5025143|NCT01527292|Vertebral Metastasis|vertebral metastasis
5025144|NCT01527292|pain control|pain control
5025145|NCT01527292|VAP|vap
5025146|NCT01527292|SRT+VAP|srt+vap
5025147|NCT01527279|atrial fibrillation|atrial fibrillation
5025148|NCT01527279|paroxysmal|paroxysmal
5025149|NCT01527279|cardioversion|cardioversion
5025150|NCT01527279|antazoline|antazoline
5025151|NCT01527266|carbohydrate|carbohydrate
5025152|NCT01527266|performance|performance
5025153|NCT01527266|cycling|cycling
5025154|NCT01527253|Cardiometabolic risk|cardiometabolic risk
5025155|NCT01527253|Metabolic syndrome|metabolic syndrome
5025156|NCT01527253|Prebiotics|prebiotics
5025157|NCT01527253|Legumes|legumes
5025158|NCT01527253|Wholegrain cereal|wholegrain cereal
5025159|NCT01527253|Functional diet|functional diet
5025160|NCT01527253|Low glycemic index diet|low glycemic index diet
5025161|NCT01527240|Volume of cerebral infarction|volume of cerebral infarction
5025162|NCT01527240|Stroke|stroke
5025163|NCT01527240|CsA|csa
5025164|NCT01527240|NIHSS|nihss
5025165|NCT01527227|Children of mentally ill|children of mentally ill
5025166|NCT01527214|Lung cancer|lung cancer
5025167|NCT01527214|early detection|early detection
5025168|NCT01527214|CT scan|ct scan
5025169|NCT01527214|General Practice|general practice
5025170|NCT01527214|Effect of Computed Tomography scans|effect of computed tomography scans
5025171|NCT01527214|Clinical medical education|clinical medical education
5025172|NCT01527201|Arthroscopy|arthroscopy
5025173|NCT01527201|Debridement|debridement
5025174|NCT01527188|HDM|hdm
5025175|NCT01527188|allergic rhinitis|allergic rhinitis
5025176|NCT01527162|Cerebral palsy|cerebral palsy
5025177|NCT01527162|orthotics|orthotics
5025178|NCT01527162|solid ankle foot orthoses|solid ankle foot orthoses
5025179|NCT01527123|GSK2585823, benzoic acid, hippuric acid, acne vulgaris, pharmacokinetics|gsk2585823, benzoic acid, hippuric acid, acne vulgaris, pharmacokinetics
5025180|NCT01527110|zanamivir|zanamivir
5025181|NCT01527110|Seasonal Influenza|seasonal influenza
5025182|NCT01527110|H1N1|h1n1
5025183|NCT01527110|intravenous|intravenous
5025184|NCT01527110|neuraminidase inhibitor|neuraminidase inhibitor
5025185|NCT01527110|Pandemic|pandemic
5025186|NCT01527110|Relenza|relenza
5025187|NCT01527110|Influenza B virus|influenza b virus
5025188|NCT01527110|Influenza A virus|influenza a virus
5025189|NCT01527097|Cardiovascular Diseases|cardiovascular diseases
5025190|NCT01527097|Pharmacologic Actions|pharmacologic actions
5025191|NCT01527097|Endothelial Function|endothelial function
5025192|NCT01527097|Dermatology|dermatology
5025193|NCT01527097|Inflammatory Disease|inflammatory disease
5025194|NCT01527097|Skin Disease|skin disease
5025195|NCT01527058|lung cancer|lung cancer
5025196|NCT01527058|integrin receptor|integrin receptor
5025197|NCT01527058|68Ga-BNOTA-PRGD2|68ga-bnota-prgd2
5025198|NCT01527058|PET/CT|pet/ct
5025199|NCT01527058|efficacy and safety|efficacy and safety
5025200|NCT01527032|amyloidosis|amyloidosis
5025201|NCT01527032|stem cell transplant|stem cell transplant
5025202|NCT01527019|Acute Cystitis|acute cystitis
5025203|NCT01526967|ostomy|ostomy
5025204|NCT01526967|peristomal skin breakdown|peristomal skin breakdown
5025205|NCT01526967|ConvaTec Moldable Skin Barriers|convatec moldable skin barriers
5025206|NCT01526928|cancer|cancer
5025207|NCT01526928|metastatic|metastatic
5025208|NCT01526928|locally advanced|locally advanced
5025209|NCT01526928|lung|lung
5025210|NCT01526928|non-small cell lung cancer|non-small cell lung cancer
5025211|NCT01526928|NSCLC|nsclc
5025212|NCT01526928|epidermal growth factor receptor|epidermal growth factor receptor
5025213|NCT01526928|EGFR|egfr
5025214|NCT01526928|T790M|t790m
5025215|NCT01526928|CO-1686|co-1686
5025216|NCT01526928|unresectable|unresectable
5025217|NCT01526928|recurrent|recurrent
5025218|NCT01526928|EGFR-directed therapy|egfr-directed therapy
5025219|NCT01526928|irreversible EGFR inhibitor|irreversible egfr inhibitor
5025220|NCT01526928|TIGER|tiger
5025221|NCT01526928|Rociletinib|rociletinib
5025222|NCT01526915|PRF|prf
5025223|NCT01526915|PLATELET RICH FIBRIN|platelet rich fibrin
5025224|NCT01526915|BISPHOSPHONATES|bisphosphonates
5025225|NCT01526902|contact lenses|contact lenses
5025226|NCT01526889|Non-infectious uveitis|non-infectious uveitis
5025227|NCT01526889|Panuveitis|panuveitis
5025228|NCT01526889|Vitreous haze|vitreous haze
5025229|NCT01526889|Visual acuity|visual acuity
5025230|NCT01526876|Intracranial Pressure|intracranial pressure
5025231|NCT01526876|Cerebral Perfusion Pressure|cerebral perfusion pressure
5025232|NCT01526876|Clevidipine Butyrate|clevidipine butyrate
5025233|NCT01526863|Allergy|allergy
5025234|NCT01526863|Egg|egg
5025235|NCT01526850|cGVHD|cgvhd
5025236|NCT01526837|Brain tumor|brain tumor
5025237|NCT01526837|GBM|gbm
5025238|NCT01526837|Brain cancer|brain cancer
5025239|NCT01526811|Endurant|endurant
5025240|NCT01526811|Stent Graft|stent graft
5025241|NCT01526811|Abdominal Aortic Aneurysm|abdominal aortic aneurysm
5025242|NCT01526798|End-Stage Renal Disease (ESRD)|end-stage renal disease (esrd)
5025243|NCT01526798|chronic Inflammation|chronic inflammation
5025244|NCT01526798|EPO Resistance|epo resistance
5025245|NCT01526798|ESA Resistance|esa resistance
5025246|NCT01526798|high cut-off dialysis|high cut-off dialysis
5025247|NCT01526798|hemodialysis|hemodialysis
5025248|NCT01526772|Transnasal|transnasal
5025249|NCT01526772|Transoral|transoral
5025250|NCT01526772|Roux en Y gastric bypass|roux en y gastric bypass
5025251|NCT01526772|Upper Endoscopy|upper endoscopy
5025252|NCT01526772|Obesity|obesity
5025253|NCT01526759|dietary fiber|dietary fiber
5025254|NCT01526759|energy intake|energy intake
5025255|NCT01526759|satiety|satiety
5025256|NCT01526759|physicochemical properties|physicochemical properties
5025257|NCT01526759|men and women|men and women
5025258|NCT01526759|Healthy adults|healthy adults
5025259|NCT01526746|End stage renal disease|end stage renal disease
5025260|NCT01526746|ESRD|esrd
5025261|NCT01526746|kidney disease|kidney disease
5025262|NCT01526746|renal impairment|renal impairment
5025263|NCT01526746|renal|renal
5025264|NCT01526733|Type 1 Diabetes|type 1 diabetes
5025265|NCT01526733|Continuous Subcutaneous Insulin Infusion (CSII)|continuous subcutaneous insulin infusion (csii)
5025266|NCT01526720|Type 2 diabetes mellitus|type 2 diabetes mellitus
5025267|NCT01526720|Beta cell function|beta cell function
5025268|NCT01526720|Insulin sensitivity|insulin sensitivity
5025269|NCT01526720|Genetics of diabetes|genetics of diabetes
5025270|NCT01526707|To identify changes in FKBP51 expression with inhaled steroid treatment in asthma|to identify changes in fkbp51 expression with inhaled steroid treatment in asthma
5025271|NCT01526694|relapsed or refractory multiple myeloma|relapsed or refractory multiple myeloma
5025272|NCT01526681|Sensory Nerve|sensory nerve
5025273|NCT01526681|Mixed Nerve|mixed nerve
5025274|NCT01526681|Motor Nerve|motor nerve
5025275|NCT01526668|Benign gynecological disease|benign gynecological disease
5025276|NCT01526668|Surgery|surgery
5025277|NCT01526668|Postoperative follow-up strategy|postoperative follow-up strategy
5025278|NCT01526668|Pain threshold|pain threshold
5025279|NCT01526668|Chronic pelvic pain|chronic pelvic pain
5025280|NCT01526668|[E04.950.300.399]|[e04.950.300.399]
5025281|NCT01526668|[C13.351.500]|[c13.351.500]
5025282|NCT01526668|[F02.463.593.710.560]|[f02.463.593.710.560]
5025283|NCT01526668|[N02.421.585.722.700]|[n02.421.585.722.700]
5025284|NCT01526668|Postoperative Care|postoperative care
5025285|NCT01526655|Endometrial cancer|endometrial cancer
5025286|NCT01526655|Robot assisted laparoscopy|robot assisted laparoscopy
5025287|NCT01526655|Abdominal hysterectomy|abdominal hysterectomy
5025288|NCT01526655|Fast track program|fast track program
5025289|NCT01526629|ICD|icd
5025290|NCT01526629|Remote follow-up|remote follow-up
5025291|NCT01526616|PCOS|pcos
5025292|NCT01526616|metformin|metformin
5025293|NCT01526616|spironolactone|spironolactone
5025294|NCT01526616|metabolic syndrome|metabolic syndrome
5025295|NCT01526616|hyperandrogenism|hyperandrogenism
5025296|NCT01526603|peripheral blood stem cell transplantation|peripheral blood stem cell transplantation
5025297|NCT01526603|autologous stem cell transplant|autologous stem cell transplant
5025298|NCT01526577|phase1|phase1
5025299|NCT01526577|healthy subjects|healthy subjects
5025300|NCT01526577|antiplatelet agent|antiplatelet agent
5025301|NCT01526564|Chemotherapy-induced peripheral neuropathy (CIPN)|chemotherapy-induced peripheral neuropathy (cipn)
5025302|NCT01526551|Human Papillomavirus|human papillomavirus
5025303|NCT01526525|tramadol|tramadol
5025304|NCT01526525|ketamine|ketamine
5025305|NCT01526525|parecoxib|parecoxib
5025306|NCT01526525|paracetamol|paracetamol
5025307|NCT01526525|numerical rating scale (NRS)|numerical rating scale (nrs)
5025308|NCT01526525|McGill (SF-MPQ)|mcgill (sf-mpq)
5025309|NCT01526525|electronic pressure algometer|electronic pressure algometer
5025310|NCT01526525|Spielberger State Trait Anxiety Inventory STAI Y-6 item|spielberger state trait anxiety inventory stai y-6 item
5025311|NCT01526512|Metronomic cyclophosphamide|metronomic cyclophosphamide
5025312|NCT01526512|Metronomic capecitabine|metronomic capecitabine
5025313|NCT01526512|HER2-negative breast cancer|her2-negative breast cancer
5025314|NCT01526499|Metronomic cyclophosphamide|metronomic cyclophosphamide
5025315|NCT01526499|metastatic breast cancer|metastatic breast cancer
5025316|NCT01526499|first line|first line
5025317|NCT01526499|docetaxel|docetaxel
5025318|NCT01526486|melanoma|melanoma
5025320|NCT01526486|inguinal|inguinal
5025321|NCT01526486|lymph nodes|lymph nodes
5025322|NCT01526486|groin|groin
5025323|NCT01526486|lymphadenectomy|lymphadenectomy
5025324|NCT01526486|groin dissection|groin dissection
5025325|NCT01526486|skin cancer|skin cancer
5025326|NCT01526486|penile cancer|penile cancer
5025327|NCT01526486|urethral cancer|urethral cancer
5025328|NCT01526486|scrotal cancer|scrotal cancer
5025329|NCT01526486|Paget's disease|paget's disease
5025330|NCT01526473|Alphavirus|alphavirus
5025331|NCT01526473|Vaccine|vaccine
5025332|NCT01526473|Immunotherapy|immunotherapy
5025333|NCT01526473|HER2|her2
5025334|NCT01526460|Platelet|platelet
5025335|NCT01526460|Atorvastatin|atorvastatin
5025336|NCT01526460|Rosuvastatin|rosuvastatin
5025337|NCT01526460|Multiplate|multiplate
5025338|NCT01526460|reactivity|reactivity
5025339|NCT01526447|Neck Pain|neck pain
5025340|NCT01526447|Craniosacral Manipulation|craniosacral manipulation
5025341|NCT01526447|Complementary Therapies|complementary therapies
5025342|NCT01526447|Randomized Controlled Trial|randomized controlled trial
5025343|NCT01526447|Sensory Thresholds|sensory thresholds
5025344|NCT01526447|Quality of Life|quality of life
5025345|NCT01526434|Cimzia|cimzia
5025346|NCT01526434|Non-interventional|non-interventional
5025347|NCT01526434|Multicenter|multicenter
5025348|NCT01526434|Postmarketing|postmarketing
5025349|NCT01526434|Local|local
5025350|NCT01526421|HIV|hiv
5025351|NCT01526421|Antiretroviral therapy, highly active|antiretroviral therapy, highly active
5025352|NCT01526408|Meniere's Disease|meniere's disease
5025353|NCT01526408|Vertigo|vertigo
5025354|NCT01526408|Hearing loss|hearing loss
5025355|NCT01526408|Tinnitus|tinnitus
5025356|NCT01526408|Anti-viral|anti-viral
5025357|NCT01526408|Famciclovir|famciclovir
5025358|NCT01526395|electroconvulsive therapy|electroconvulsive therapy
5025359|NCT01526395|ECT|ect
5025360|NCT01526395|unmodified|unmodified
5025361|NCT01526395|anesthesia|anesthesia
5025362|NCT01526395|propofol|propofol
5025363|NCT01526382|septic shock|septic shock
5025364|NCT01526382|acute respiratory distress syndrome|acute respiratory distress syndrome
5025365|NCT01526382|transpulmonary thermodilution technique|transpulmonary thermodilution technique
5025366|NCT01526382|mortality|mortality
5025367|NCT01526369|HER2-positive metastatic breast cancer.|her2-positive metastatic breast cancer.
5025368|NCT01526356|Angiofibroma|angiofibroma
5025369|NCT01526356|Tuberous Sclerosis|tuberous sclerosis
5025370|NCT01526356|Rapamycin|rapamycin
5025371|NCT01526356|Sirolimus|sirolimus
5025372|NCT01526356|mTOR|mtor
5025373|NCT01526343|Patients|patients
5025374|NCT01526330|Degenerative disc disease|degenerative disc disease
5025375|NCT01526330|YH14618|yh14618
5025376|NCT01526330|Penial 2000|penial 2000
5025377|NCT01526330|Penial 2K|penial 2k
5025378|NCT01526317|Drug interaction|drug interaction
5025379|NCT01526317|Rosuvastatin|rosuvastatin
5025380|NCT01526317|Metformin SR|metformin sr
5025381|NCT01526317|Pharmacokinetic|pharmacokinetic
5025382|NCT01526291|Myopia|myopia
5025383|NCT01526291|Hyperopia|hyperopia
5025384|NCT01526291|Astigmatism|astigmatism
5025385|NCT01526291|Patient-reported outcomes|patient-reported outcomes
5025386|NCT01526291|Patient satisfaction|patient satisfaction
5025387|NCT01526291|Refractive Error|refractive error
5025388|NCT01526291|Emmetropia|emmetropia
5025389|NCT01526291|Dry eyes|dry eyes
5025390|NCT01526291|glare|glare
5025391|NCT01526291|halos|halos
5025392|NCT01526291|patient expectations|patient expectations
5025393|NCT01526278|alendronate|alendronate
5025394|NCT01526278|Maxmarvil®|maxmarvil®
5025395|NCT01526265|Smoking Cessation|smoking cessation
5025396|NCT01526265|Work-site|work-site
5025397|NCT01526265|Incentives|incentives
5025398|NCT01526265|Health Behavior|health behavior
5025399|NCT01526265|Smoking|smoking
5025400|NCT01526252|speckle tracking echocardiography|speckle tracking echocardiography
5025401|NCT01526252|database|database
5025402|NCT01526239|Colorectal cancer screening|colorectal cancer screening
5025403|NCT01526239|colon cancer screening|colon cancer screening
5025404|NCT01526239|colonoscopy|colonoscopy
5025405|NCT01526226|High flow nasal cannula|high flow nasal cannula
5025406|NCT01526226|Discomfort|discomfort
5025407|NCT01526200|CLM|clm
5025408|NCT01526187|Public Health and Epidemiology|public health and epidemiology
5025409|NCT01526187|Bacteriology|bacteriology
5025410|NCT01526187|Infectious and Tropical|infectious and tropical
5025411|NCT01526174|autoimmune|autoimmune
5025412|NCT01526174|hearing loss|hearing loss
5025413|NCT01526174|bilateral hearing loss|bilateral hearing loss
5025414|NCT01526174|steroid-dependent|steroid-dependent
5025415|NCT01526161|Asthma|asthma
5025416|NCT01526161|Children|children
5025417|NCT01526161|Therapy|therapy
5025418|NCT01526161|Fluticasone|fluticasone
5025419|NCT01526161|Salmeterol|salmeterol
5025420|NCT01526161|Montelukast|montelukast
5025421|NCT01526135|National multicentric phase III superiority trial|national multicentric phase iii superiority trial
5025422|NCT01526122|Clopidogrel|clopidogrel
5025423|NCT01526122|Aspirin|aspirin
5025424|NCT01526122|coadministration|coadministration
5025425|NCT01526109|elderly|elderly
5025426|NCT01526109|quality of life|quality of life
5025427|NCT01526109|functional capacity|functional capacity
5025428|NCT01526109|cognitive function|cognitive function
5025429|NCT01526109|physical exercise|physical exercise
5025430|NCT01526083|Male Healthy Volunteers|male healthy volunteers
5025431|NCT01526057|rheumatoid arthritis|rheumatoid arthritis
5025432|NCT01526057|rituximab|rituximab
5025433|NCT01526057|methotrexate|methotrexate
5025434|NCT01526057|anti-TNF|anti-tnf
5025435|NCT01526044|hyperglycemia|hyperglycemia
5025436|NCT01526044|hypoglycemia|hypoglycemia
5025437|NCT01526044|insulin|insulin
5025536|NCT01525524|tDCS|tdcs
5025438|NCT01526044|critical illness|critical illness
5025439|NCT01526044|intensive insulin therapy|intensive insulin therapy
5025440|NCT01526044|continuous glucose monitoring|continuous glucose monitoring
5025441|NCT01526044|CGM|cgm
5025442|NCT01526044|interstitial fluid glucose|interstitial fluid glucose
5025443|NCT01526044|intensive care unit|intensive care unit
5025444|NCT01526044|Blood glucose|blood glucose
5025445|NCT01526031|frozen shoulder|frozen shoulder
5025446|NCT01526031|bee venom acupuncture|bee venom acupuncture
5025447|NCT01526018|Intake|intake
5025448|NCT01526018|Formula feeding|formula feeding
5025449|NCT01525992|Community Pharmacy Services|community pharmacy services
5025450|NCT01525992|Pharmacists|pharmacists
5025451|NCT01525992|Diabetes Mellitus|diabetes mellitus
5025452|NCT01525992|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
5025453|NCT01525992|Self Care|self care
5025454|NCT01525992|Randomized Controlled Trial|randomized controlled trial
5025455|NCT01525979|Stroke rehabilitation|stroke rehabilitation
5025456|NCT01525979|Unilateral arm training|unilateral arm training
5025457|NCT01525979|Bilateral arm training|bilateral arm training
5025458|NCT01525979|Robot-assisted arm training|robot-assisted arm training
5025459|NCT01525979|Kinematic analysis|kinematic analysis
5025460|NCT01525979|Functional magnetic resonance image|functional magnetic resonance image
5025461|NCT01525979|Motor recovery|motor recovery
5025462|NCT01525979|Quality of life|quality of life
5025463|NCT01525953|esophageal cancer|esophageal cancer
5025464|NCT01525953|radiochemotherapy|radiochemotherapy
5025465|NCT01525953|prognosis|prognosis
5025466|NCT01525940|colon capsule endoscopy|colon capsule endoscopy
5025467|NCT01525940|CT-colonography|ct-colonography
5025468|NCT01525940|Patients|patients
5025469|NCT01525940|incomplete colonoscopy|incomplete colonoscopy
5025470|NCT01525927|Oropharyngeal Neoplasms|oropharyngeal neoplasms
5025471|NCT01525927|Neoplasms, Oropharyngeal|neoplasms, oropharyngeal
5025472|NCT01525927|Oropharynx Neoplasms|oropharynx neoplasms
5025473|NCT01525914|prostate cancer|prostate cancer
5025474|NCT01525914|PSA kinetics|psa kinetics
5025475|NCT01525914|PSA doubling time|psa doubling time
5025476|NCT01525914|active surveillance|active surveillance
5025477|NCT01525901|SHANK3|shank3
5025478|NCT01525901|IGF-1|igf-1
5025479|NCT01525901|Autism|autism
5025480|NCT01525888|Contrast induced nephropathy|contrast induced nephropathy
5025481|NCT01525875|pseudoxanthoma elasticum|pseudoxanthoma elasticum
5025482|NCT01525875|calcification|calcification
5025483|NCT01525836|Purpura|purpura
5025484|NCT01525836|Idiopathic Thrombocytopenic Purpura|idiopathic thrombocytopenic purpura
5025485|NCT01525797|Liver Transplant|liver transplant
5025486|NCT01525784|rtCGMS|rtcgms
5025487|NCT01525784|glycemic control|glycemic control
5025488|NCT01525784|type 1 diabetes mellitus|type 1 diabetes mellitus
5025489|NCT01525784|youth|youth
5025490|NCT01525771|Advanced Gastric cancer|advanced gastric cancer
5025491|NCT01525771|Xeloda (Capecitabine)|xeloda (capecitabine)
5025492|NCT01525771|Cisplatin|cisplatin
5025493|NCT01525771|Taxotere (Docetaxel)|taxotere (docetaxel)
5025494|NCT01525732|Achalasia, Hypertensive LES|achalasia, hypertensive les
5025495|NCT01525719|cholangiocarcinoma|cholangiocarcinoma
5025496|NCT01525719|RAD001|rad001
5025497|NCT01525719|everolimus|everolimus
5025498|NCT01525706|Endoscopic Ultrasound|endoscopic ultrasound
5025499|NCT01525706|Pancreatic Mucinous Cystic Neoplasm|pancreatic mucinous cystic neoplasm
5025500|NCT01525706|Fine Needle Injection|fine needle injection
5025501|NCT01525706|Ethanol Ablation|ethanol ablation
5025502|NCT01525706|Paclitaxel Ablation|paclitaxel ablation
5025503|NCT01525693|diabetes|diabetes
5025504|NCT01525693|diabetics|diabetics
5025505|NCT01525693|high glucose|high glucose
5025506|NCT01525693|Chinese patients|chinese patients
5025507|NCT01525680|PTSD|ptsd
5025508|NCT01525667|THA|tha
5025509|NCT01525667|Muscle injury|muscle injury
5025510|NCT01525654|Rheumatoid Arthritis|rheumatoid arthritis
5025511|NCT01525654|peer support|peer support
5025512|NCT01525654|self-efficacy|self-efficacy
5025513|NCT01525654|medication adherence|medication adherence
5025514|NCT01525602|advanced, incurable solid tumors|advanced, incurable solid tumors
5025515|NCT01525589|Breast cancer|breast cancer
5025516|NCT01525589|PM01183|pm01183
5025517|NCT01525589|lurbinectedin|lurbinectedin
5025518|NCT01525589|Pharma Mar|pharma mar
5025519|NCT01525576|booster program|booster program
5025520|NCT01525576|internet|internet
5025521|NCT01525576|cbt|cbt
5025522|NCT01525576|Study the specific effects of adding a booster program|study the specific effects of adding a booster program
5025523|NCT01525563|Duphaston Study|duphaston study
5025524|NCT01525550|neuroendocrine tumors|neuroendocrine tumors
5025525|NCT01525550|adenoma islet cells|adenoma islet cells
5025526|NCT01525550|carcinoma islet cells|carcinoma islet cells
5025527|NCT01525550|pancreatic neoplasms|pancreatic neoplasms
5025528|NCT01525550|angiogenesis inhibitors|angiogenesis inhibitors
5025529|NCT01525550|sunitinib|sunitinib
5025530|NCT01525550|neoplasms|neoplasms
5025531|NCT01525550|carcinoma|carcinoma
5025532|NCT01525550|adenoma|adenoma
5025533|NCT01525537|Anesthesia General|anesthesia general
5025534|NCT01525537|Anesthetics Inhalation|anesthetics inhalation
5025535|NCT01525537|Diagnostic techniques and procedures|diagnostic techniques and procedures
5025537|NCT01525524|Major Depression|major depression
5025538|NCT01525524|Stroke|stroke
5025539|NCT01525498|Pelvic Organ Prolapse|pelvic organ prolapse
5025540|NCT01525498|Catheterization|catheterization
5025541|NCT01525498|Urinary tract infection|urinary tract infection
5025542|NCT01525498|Urinary retention|urinary retention
5025543|NCT01525472|obesity|obesity
5025544|NCT01525472|adipose tissue|adipose tissue
5025545|NCT01525472|angiogenesis|angiogenesis
5025546|NCT01525472|senecence|senecence
5025547|NCT01525459|Glioma|glioma
5025548|NCT01525459|PBMC subpopulations|pbmc subpopulations
5025549|NCT01525459|Gene expression|gene expression
5025550|NCT01525459|Metabolomics|metabolomics
5025551|NCT01525459|Immunological status|immunological status
5025552|NCT01525459|miRNA|mirna
5025553|NCT01525459|Proteomics|proteomics
5025554|NCT01525446|NSCLC|nsclc
5025555|NCT01525446|Lung Cancer|lung cancer
5025556|NCT01525394|lymphomas|lymphomas
5025557|NCT01525394|Refractory solid tumors|refractory solid tumors
5025558|NCT01525368|mild cognitive impairment|mild cognitive impairment
5025559|NCT01525368|Alzheimer's disease|alzheimer's disease
5025560|NCT01525368|cognitive intervention|cognitive intervention
5025561|NCT01525368|cognitive reserve|cognitive reserve
5025562|NCT01525355|EUS|eus
5025563|NCT01525355|ERCP|ercp
5025564|NCT01525355|Intraoperative cholangiogram|intraoperative cholangiogram
5025565|NCT01525355|Cholecystectomy|cholecystectomy
5025566|NCT01525355|Common Bile Duct Stones|common bile duct stones
5025567|NCT01525355|Strictures|strictures
5025568|NCT01525355|Stenosis|stenosis
5025569|NCT01525355|Duodenum|duodenum
5025570|NCT01525355|Dilated Bile duct|dilated bile duct
5025571|NCT01525355|Non-filling of the duodenum by contrast|non-filling of the duodenum by contrast
5025572|NCT01525329|Actinic Keratosis|actinic keratosis
5025573|NCT01525329|Photodynamic Therapy|photodynamic therapy
5025574|NCT01525316|Late Onset Neonatal Sepsis|late onset neonatal sepsis
5025575|NCT01525316|Neonates|neonates
5025576|NCT01525316|Lactoferrin|lactoferrin
5025577|NCT01525316|Infections|infections
5025578|NCT01525316|Prevention|prevention
5025579|NCT01525316|Neurodevelopment|neurodevelopment
5025580|NCT01525303|headaches|headaches
5025581|NCT01525303|behavioral treatment|behavioral treatment
5025582|NCT01525303|physical activity|physical activity
5025583|NCT01525290|wake-up stroke|wake-up stroke
5025584|NCT01525290|thrombolysis|thrombolysis
5025585|NCT01525290|magnetic resonance imaging (MRI)|magnetic resonance imaging (mri)
5025586|NCT01525290|diffusion weighted imaging (DWI)|diffusion weighted imaging (dwi)
5025587|NCT01525290|fluid attenuated inversion recovery (FLAIR)|fluid attenuated inversion recovery (flair)
5025588|NCT01525264|Mammography|mammography
5025589|NCT01525251|primary caregiver|primary caregiver
5025590|NCT01525251|neuroblastoma|neuroblastoma
5025591|NCT01525251|support group|support group
5025592|NCT01525251|posttraumatic stress|posttraumatic stress
5025593|NCT01525251|uncertainty|uncertainty
5025594|NCT01525199|Non-Small Cell Lung Cancer,|non-small cell lung cancer,
5025595|NCT01525199|Epidermal Growth Factor Receptor mutation,|epidermal growth factor receptor mutation,
5025596|NCT01525199|Lung cancer,|lung cancer,
5025597|NCT01525199|Lung adenocarcinoma|lung adenocarcinoma
5025598|NCT01525186|Weight|weight
5025599|NCT01525186|Food intakes|food intakes
5025600|NCT01525186|Feeding|feeding
5025601|NCT01525160|Clot structure|clot structure
5025602|NCT01525160|Haemostasis|haemostasis
5025603|NCT01525160|Gel point|gel point
5025604|NCT01525160|Fractal dimension|fractal dimension
5025605|NCT01525160|serum amyloid A|serum amyloid a
5025606|NCT01525160|C-reactive protein|c-reactive protein
5025607|NCT01525160|vascular cell adhesion molecule-1|vascular cell adhesion molecule-1
5025608|NCT01525160|intercellular adhesion molecule-1|intercellular adhesion molecule-1
5025609|NCT01525134|Tests, Diagnostic|tests, diagnostic
5025610|NCT01525134|Mycobacterium tuberculosis|mycobacterium tuberculosis
5025611|NCT01525134|Mycobacterium tuberculosis antigens|mycobacterium tuberculosis antigens
5025612|NCT01525134|TB|tb
5025613|NCT01525134|Tuberculosis|tuberculosis
5025614|NCT01525134|Tuberculosis, Pulmonary|tuberculosis, pulmonary
5025615|NCT01525134|Tuberculosis, Miliary|tuberculosis, miliary
5025616|NCT01525134|Lipoarabinomannan|lipoarabinomannan
5025617|NCT01525121|mechanical ventilation|mechanical ventilation
5025618|NCT01525121|chest physiotherapy|chest physiotherapy
5025619|NCT01525121|critical care|critical care
5025620|NCT01525121|pneumonia|pneumonia
5025621|NCT01525121|Mechanically ventilated patients with pulmonary infection.|mechanically ventilated patients with pulmonary infection.
5025622|NCT01525108|Medication adherence|medication adherence
5025623|NCT01525108|Blood pressure|blood pressure
5025624|NCT01525108|Home-based blood pressure measurement|home-based blood pressure measurement
5025625|NCT01525108|Blood Pressure Determination|blood pressure determination
5025626|NCT01525108|Blood Pressure Monitors|blood pressure monitors
5025627|NCT01525108|Blood Pressure Monitoring, Ambulatory|blood pressure monitoring, ambulatory
5025628|NCT01525095|Candida|candida
5025629|NCT01525095|Diagnostic Assay|diagnostic assay
5025630|NCT01525095|Blood culture|blood culture
5025631|NCT01525095|Sepsis|sepsis
5025632|NCT01525095|T2 Magnetic Relaxation|t2 magnetic relaxation
5025633|NCT01525056|rectal cancer|rectal cancer
5025634|NCT01525056|imaging|imaging
5025635|NCT01525056|PET|pet
5025636|NCT01525056|MRI|mri
5025637|NCT01525043|Epicondylitis|epicondylitis
5025638|NCT01525004|Solid organ transplant|solid organ transplant
5025639|NCT01525004|Flu vaccine|flu vaccine
5025640|NCT01524965|Locking Plate|locking plate
5025641|NCT01524965|Physiotherapy|physiotherapy
5025642|NCT01524926|Phase 2|phase 2
5025643|NCT01524926|Crizotinib|crizotinib
5025644|NCT01524926|Anaplastic large cell lymphoma|anaplastic large cell lymphoma
5025645|NCT01524926|Inflammatory myofibroblastic tumor|inflammatory myofibroblastic tumor
5025646|NCT01524926|Papillary renal cell carcinoma type 1|papillary renal cell carcinoma type 1
5025647|NCT01524926|Alveolar soft part sarcoma|alveolar soft part sarcoma
5025648|NCT01524926|Clear cell sarcoma|clear cell sarcoma
5025649|NCT01524926|Alveolar rhabdomyosarcoma|alveolar rhabdomyosarcoma
5025650|NCT01524874|vitamin d|vitamin d
5025651|NCT01524874|cholecalciferol|cholecalciferol
5025652|NCT01524874|nutritional supplements|nutritional supplements
5025653|NCT01524874|hypovitaminosis d|hypovitaminosis d
5025654|NCT01524874|klotho|klotho
5025655|NCT01524874|toll like receptor 4|toll like receptor 4
5025656|NCT01524861|Tako-Tsubo|tako-tsubo
5025657|NCT01524861|Sympathetic heart innervation|sympathetic heart innervation
5025658|NCT01524861|MIBG|mibg
5025659|NCT01524861|Alpha-lipoic acid|alpha-lipoic acid
5025660|NCT01524861|L-acetyl carnitine|l-acetyl carnitine
5025661|NCT01524848|Clinical trial|clinical trial
5025662|NCT01524848|Investigational drugs|investigational drugs
5025663|NCT01524848|Gastrointestinal stromal tumors|gastrointestinal stromal tumors
5025664|NCT01524848|Pazopanib|pazopanib
5025665|NCT01524835|Tissue Donors|tissue donors
5025666|NCT01524835|Lung|lung
5025667|NCT01524835|Transplants|transplants
5025668|NCT01524835|Transplantation|transplantation
5025669|NCT01524822|Military|military
5025670|NCT01524822|Traumatic Brain Injury|traumatic brain injury
5025671|NCT01524822|Cognitive Testing|cognitive testing
5025672|NCT01524822|Neuroimaging|neuroimaging
5025673|NCT01524822|Brain Function|brain function
5025674|NCT01524796|Real-life|real-life
5025675|NCT01524796|non-interventional|non-interventional
5025676|NCT01524796|observational|observational
5025677|NCT01524796|peripheral neuropathic pain|peripheral neuropathic pain
5025678|NCT01524796|Lyrica|lyrica
5025679|NCT01524796|pregabalin|pregabalin
5025680|NCT01524783|Neuroendocrine tumor|neuroendocrine tumor
5025681|NCT01524783|NET|net
5025682|NCT01524783|progressive|progressive
5025683|NCT01524783|advanced|advanced
5025684|NCT01524783|gastrointestinal|gastrointestinal
5025685|NCT01524783|GI or lung origin|gi or lung origin
5025686|NCT01524783|nonfunctional|nonfunctional
5025687|NCT01524783|everolimus|everolimus
5025688|NCT01524783|Advanced NET of GI origin|advanced net of gi origin
5025689|NCT01524783|Advanced NET of lung origin|advanced net of lung origin
5025690|NCT01524744|oral lichen planus treatment pimecrolimus|oral lichen planus treatment pimecrolimus
5025691|NCT01524718|radiation|radiation
5025692|NCT01524718|time surgery|time surgery
5025693|NCT01524705|Pilot Study|pilot study
5025694|NCT01524705|Prospective Randomized Trial|prospective randomized trial
5025695|NCT01524705|Comparative Effectiveness|comparative effectiveness
5025696|NCT01524705|Glycemic Variability|glycemic variability
5025697|NCT01524705|insulin glargine|insulin glargine
5025698|NCT01524705|exenatide|exenatide
5025699|NCT01524705|basal insulin|basal insulin
5025700|NCT01524705|bolus insulin|bolus insulin
5025701|NCT01524679|chronic hepatitis B|chronic hepatitis b
5025702|NCT01524653|VTE|vte
5025703|NCT01524653|DVT|dvt
5025704|NCT01524653|Chemo|chemo
5025705|NCT01524653|Metastatic|metastatic
5025706|NCT01524653|Advanced|advanced
5025707|NCT01524653|Systemic therapy|systemic therapy
5025708|NCT01524653|statin|statin
5025709|NCT01524653|biomarkers|biomarkers
5025710|NCT01524640|oral cholera vaccine|oral cholera vaccine
5025711|NCT01524640|safety and immunogenicity|safety and immunogenicity
5025712|NCT01524640|bridging study|bridging study
5025713|NCT01524640|ethiopia|ethiopia
5025714|NCT01524627|Smokers|smokers
5025715|NCT01524627|fMRI|fmri
5025716|NCT01524627|varenicline|varenicline
5025717|NCT01524614|continuous positive airway pressure|continuous positive airway pressure
5025718|NCT01524614|nasal mask|nasal mask
5025719|NCT01524614|upper airway obstruction|upper airway obstruction
5025720|NCT01524601|Immunosuppression|immunosuppression
5025721|NCT01524601|Everolimus|everolimus
5025722|NCT01524601|rosuvastatin|rosuvastatin
5025723|NCT01524601|fluvastatin|fluvastatin
5025724|NCT01524601|Lipid lowering|lipid lowering
5025725|NCT01524588|Genotype|genotype
5025726|NCT01524588|Phenotype|phenotype
5025727|NCT01524588|Genotypic Variation Between Patients|genotypic variation between patients
5025728|NCT01524588|Genotypic Phenotypic Relationships|genotypic phenotypic relationships
5025729|NCT01524575|pancreatic cancer|pancreatic cancer
5025730|NCT01524575|ERCC1|ercc1
5025731|NCT01524575|oxaliplatin|oxaliplatin
5025732|NCT01524575|gemcitabine|gemcitabine
5025733|NCT01524562|Fibrosis|fibrosis
5025734|NCT01524562|Cirrhosis|cirrhosis
5025735|NCT01524562|Africa|africa
5025736|NCT01524562|Schistosomiasis|schistosomiasis
5025737|NCT01524562|Aflatoxin|aflatoxin
5025738|NCT01524562|Liver Disease|liver disease
5025739|NCT01524549|Cardiovascular|cardiovascular
5025740|NCT01524549|P450s|p450s
5025741|NCT01524549|Flow-Mediated Dilatation|flow-mediated dilatation
5025742|NCT01524549|Brachial Artery Ultrasound|brachial artery ultrasound
5025743|NCT01524549|Endothelial Cell Function|endothelial cell function
5025744|NCT01524549|Healthy Volunteer|healthy volunteer
5025745|NCT01524549|HV|hv
5025746|NCT01524536|Hypereosinophilia|hypereosinophilia
5025747|NCT01524536|Hypereosinophilic Syndrome|hypereosinophilic syndrome
5025748|NCT01524536|Corticosteroids|corticosteroids
5025749|NCT01524536|Therapy|therapy
5025750|NCT01524536|HES|hes
5025751|NCT01524523|Gene Expression|gene expression
5025752|NCT01524523|Acute Pain|acute pain
5025753|NCT01524523|Nitric Oxide|nitric oxide
5025754|NCT01524523|Pain|pain
5025755|NCT01524523|Bone Marrow|bone marrow
5025756|NCT01524510|OSAS|osas
5025757|NCT01524510|AHI|ahi
5025758|NCT01524510|MRA|mra
5025759|NCT01524510|CFD|cfd
5025760|NCT01524497|losing interest and feelings of guilt|losing interest and feelings of guilt
5025761|NCT01524497|poor concentration|poor concentration
5025762|NCT01524497|loss of appetite|loss of appetite
5025763|NCT01524497|suicide|suicide
5025764|NCT01524484|Data quality|data quality
5025765|NCT01524484|Anesthesia|anesthesia
5025766|NCT01524484|Quality assurance|quality assurance
5025767|NCT01524471|Hypertensive LES|hypertensive les
5025768|NCT01524445|Bortezomib|bortezomib
5025769|NCT01524445|Velcade|velcade
5025770|NCT01524445|multiple myeloma|multiple myeloma
5025771|NCT01524445|retrospective study, response rate, medical resource utilization|retrospective study, response rate, medical resource utilization
5025772|NCT01524432|Clotrimazole|clotrimazole
5025773|NCT01524432|Microcapsules|microcapsules
5025774|NCT01524419|spontaneous labor|spontaneous labor
5025775|NCT01524419|term|term
5025776|NCT01524419|surgical|surgical
5025777|NCT01524419|mechanical|mechanical
5025778|NCT01524419|fetal or maternal complications|fetal or maternal complications
5025779|NCT01524406|Muscle Atrophy|muscle atrophy
5025780|NCT01524393|Assisted Reproductive Techniques|assisted reproductive techniques
5025781|NCT01524393|Pregnancy|pregnancy
5025782|NCT01524393|Pulmonary Embolism|pulmonary embolism
5025783|NCT01524393|Venous Thromboembolism|venous thromboembolism
5025784|NCT01524380|Schizophrenia|schizophrenia
5025785|NCT01524380|clinical trial|clinical trial
5025786|NCT01524380|risperidone|risperidone
5025787|NCT01524380|ginkgo biloba extract|ginkgo biloba extract
5025788|NCT01524380|antioxidant|antioxidant
5025789|NCT01524354|depth of anesthesia|depth of anesthesia
5025790|NCT01524354|valve surgery|valve surgery
5025791|NCT01524341|Acute malaria|acute malaria
5025792|NCT01524341|KAE609|kae609
5025793|NCT01524328|Complementary and alternative medicine|complementary and alternative medicine
5025794|NCT01524328|HRQoL, Inflammatory bowel disease|hrqol, inflammatory bowel disease
5025795|NCT01524315|Thiamine|thiamine
5025796|NCT01524315|Vitamin B1|vitamin b1
5025797|NCT01524315|Thiamine Deficiency|thiamine deficiency
5025798|NCT01524315|Thiamine supplementation|thiamine supplementation
5025799|NCT01524315|Cardiac surgery|cardiac surgery
5025800|NCT01524315|Lactic Acid|lactic acid
5025801|NCT01524302|pneumonia|pneumonia
5025802|NCT01524302|ceftaroline|ceftaroline
5025803|NCT01524302|community-aquired|community-aquired
5025804|NCT01524250|Multiple Sclerosis|multiple sclerosis
5025805|NCT01524250|relapse|relapse
5025806|NCT01524250|demyelination|demyelination
5025807|NCT01524250|treatment|treatment
5025808|NCT01524250|corticosteroids|corticosteroids
5025809|NCT01524224|Metastases|metastases
5025810|NCT01524224|Neoplasm|neoplasm
5025811|NCT01524224|Advanced Cancer|advanced cancer
5025812|NCT01524224|Metastatic Cancer|metastatic cancer
5025813|NCT01524211|Aortic Aneurysms|aortic aneurysms
5025814|NCT01524185|childhood trauma|childhood trauma
5025815|NCT01524185|intergenerational trauma|intergenerational trauma
5025816|NCT01524185|child neglect|child neglect
5025817|NCT01524185|child maltreatment|child maltreatment
5025818|NCT01524185|mental health|mental health
5025819|NCT01524172|child trauma exposure|child trauma exposure
5025820|NCT01524172|mental health|mental health
5025821|NCT01524172|yoga|yoga
5025822|NCT01524172|mood regulation|mood regulation
5025823|NCT01524172|child maltreatment|child maltreatment
5025824|NCT01524159|cardiovascular disease|cardiovascular disease
5025825|NCT01524146|Unresectable Cholangiocarcinoma|unresectable cholangiocarcinoma
5025826|NCT01524146|Biliary obstruction|biliary obstruction
5025827|NCT01524146|Stent obstruction|stent obstruction
5025828|NCT01524146|Biliary stricture|biliary stricture
5025829|NCT01524146|Photodynamic therapy|photodynamic therapy
5025830|NCT01524146|PDT|pdt
5025831|NCT01524146|Ablation|ablation
5025832|NCT01524133|combat-related PTSD|combat-related ptsd
5025833|NCT01524133|Posttraumatic stress disorder|posttraumatic stress disorder
5025834|NCT01524133|prolonged exposure therapy|prolonged exposure therapy
5025835|NCT01524133|sertraline|sertraline
5025836|NCT01524133|military|military
5025837|NCT01524133|veterans|veterans
5025838|NCT01524133|VA hospital|va hospital
5025839|NCT01524133|mental illness|mental illness
5025840|NCT01524120|Mucosal healing|mucosal healing
5025841|NCT01524107|Prophylaxis Antibiotics|prophylaxis antibiotics
5025842|NCT01524107|Maternal Complications|maternal complications
5025843|NCT01524107|Neonatal Complications|neonatal complications
5025844|NCT01524107|Cord Prolapse|cord prolapse
5025845|NCT01524107|Elective Caesarian Section|elective caesarian section
5025846|NCT01524107|Maternal Morbidity|maternal morbidity
5025847|NCT01524107|Neonatal Morbidity|neonatal morbidity
5025848|NCT01524094|colorectal cancer|colorectal cancer
5025849|NCT01524094|cytoreductive surgery|cytoreductive surgery
5025850|NCT01524094|intraperitoneal chemotherapy|intraperitoneal chemotherapy
5025851|NCT01524094|systemic chemotherapy|systemic chemotherapy
5025852|NCT01524094|Peritoneal Metastatic Disease From the Colon or Rectum|peritoneal metastatic disease from the colon or rectum
5025853|NCT01524081|antibiotic prophylaxis|antibiotic prophylaxis
5025854|NCT01524081|emergent surgery|emergent surgery
5025855|NCT01524081|surgical site infection|surgical site infection
5025856|NCT01524068|Acute Idiopathic Pulmonary Fibrosis Exacerbations|acute idiopathic pulmonary fibrosis exacerbations
5025857|NCT01524068|Idiopathic Pulmonary Fibrosis|idiopathic pulmonary fibrosis
5025858|NCT01524068|IPF|ipf
5025859|NCT01524042|Satisfaction|satisfaction
5025860|NCT01524042|colonoscopy|colonoscopy
5025861|NCT01524042|double pants|double pants
5025862|NCT01524042|single pants|single pants
5025863|NCT01524029|Digital Breast Tomosynthesis|digital breast tomosynthesis
5025864|NCT01524029|Digital Mammography|digital mammography
5025865|NCT01524029|Breast cancer detection|breast cancer detection
5025866|NCT01524016|Oncogenic osteomalacia|oncogenic osteomalacia
5025867|NCT01524016|mesenchymal tumor|mesenchymal tumor
5025868|NCT01524016|Somatostatin receptor|somatostatin receptor
5025869|NCT01524016|68Ga-DOTATATE|68ga-dotatate
5025870|NCT01524016|PET/CT|pet/ct
5025871|NCT01524003|community based participatory research|community based participatory research
5025872|NCT01523977|ALL|all
5025873|NCT01523977|pediatric|pediatric
5025874|NCT01523977|relapse|relapse
5025875|NCT01523964|DMD|dmd
5025876|NCT01523964|EIM|eim
5025877|NCT01523964|Duchenne Muscular Dystrophy|duchenne muscular dystrophy
5025878|NCT01523964|electrical impedance myography|electrical impedance myography
5025879|NCT01523951|topical local anaesthesia|topical local anaesthesia
5025880|NCT01523951|cooling|cooling
5025881|NCT01523951|capsaicin 8%|capsaicin 8%
5025882|NCT01523951|epidermal nerve fiber density|epidermal nerve fiber density
5025883|NCT01523951|treatment pain|treatment pain
5025884|NCT01523925|Functional electrical therapy|functional electrical therapy
5025885|NCT01523925|Bilateral arm training|bilateral arm training
5025886|NCT01523925|Constraint induced therapy|constraint induced therapy
5025887|NCT01523925|Stroke rehabilitation|stroke rehabilitation
5025888|NCT01523925|Clinical evaluation|clinical evaluation
5025889|NCT01523925|Kinematic analysis|kinematic analysis
5025890|NCT01523912|radiofrequency ablation|radiofrequency ablation
5025891|NCT01523912|gastric dysplasia|gastric dysplasia
5025892|NCT01523912|gastric neoplasia|gastric neoplasia
5025893|NCT01523899|SSTI|ssti
5025894|NCT01523899|cutaneous abscess|cutaneous abscess
5025895|NCT01523899|boil|boil
5025896|NCT01523847|Hodgkin Lymphoma|hodgkin lymphoma
5025897|NCT01523847|Cardiopathic|cardiopathic
5025898|NCT01523847|elderly|elderly
5025899|NCT01523847|Myocet|myocet
5025900|NCT01523834|Diffuse Large B-cell Lymphoma (DLBCL)|diffuse large b-cell lymphoma (dlbcl)
5025901|NCT01523834|Panobinostat|panobinostat
5025902|NCT01523834|Patients with relapsed/refractory DLBCL.|patients with relapsed/refractory dlbcl.
5025903|NCT01523808|pancreatic cancer|pancreatic cancer
5025904|NCT01523808|asparaginase|asparaginase
5025905|NCT01523795|Energy intake|energy intake
5025906|NCT01523795|Video games|video games
5025907|NCT01523795|Television|television
5025908|NCT01523795|Physical activity|physical activity
5025909|NCT01523795|Obesity|obesity
5025910|NCT01523782|Acute Lymphoblastic leukemia|acute lymphoblastic leukemia
5025911|NCT01523782|Elderly patient|elderly patient
5025912|NCT01523782|Asparaginase|asparaginase
5025913|NCT01523769|prematurity|prematurity
5025914|NCT01523769|umbilical cord milking|umbilical cord milking
5025915|NCT01523769|delayed cord clamping|delayed cord clamping
5025916|NCT01523769|neonatal transfusion|neonatal transfusion
5025917|NCT01523730|Schizophrenia|schizophrenia
5025918|NCT01523730|Nicotine|nicotine
5025919|NCT01523730|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
5025920|NCT01523730|Cognition|cognition
5025921|NCT01523730|EEG|eeg
5025922|NCT01523717|procalcitonin|procalcitonin
5025923|NCT01523717|decrease over 72 hours|decrease over 72 hours
5025924|NCT01523717|severe sepsis|severe sepsis
5025925|NCT01523717|septic shock|septic shock
5025926|NCT01523691|Healthy individuals|healthy individuals
5025927|NCT01523678|Ovarian Cancer|ovarian cancer
5025928|NCT01523678|Endometrial Cancer|endometrial cancer
5025929|NCT01523678|Endometrial Carcinoma|endometrial carcinoma
5025930|NCT01523678|Uterine Cervical Cancer|uterine cervical cancer
5025931|NCT01523678|Paclitaxel|paclitaxel
5025932|NCT01523678|Carboplatin|carboplatin
5025933|NCT01523678|Neupogen|neupogen
5025934|NCT01523678|Filgrastim|filgrastim
5025935|NCT01523678|Ovarian Diseases|ovarian diseases
5025936|NCT01523678|Peritoneal Diseases|peritoneal diseases
5025937|NCT01523678|Fallopian Tube Diseases|fallopian tube diseases
5025938|NCT01523678|Endocrine System Diseases|endocrine system diseases
5025939|NCT01523678|Endometrial Diseases|endometrial diseases
5025940|NCT01523678|Uterine Cervical Diseases|uterine cervical diseases
5025941|NCT01523678|Neoplasms|neoplasms
5025942|NCT01523678|Neoplasms, Glandular and Epithelial|neoplasms, glandular and epithelial
5025943|NCT01523678|Ovarian Neoplasms|ovarian neoplasms
5025944|NCT01523678|Peritoneal Neoplasms|peritoneal neoplasms
5025945|NCT01523678|Fallopian Tube Neoplasms|fallopian tube neoplasms
5025946|NCT01523678|Neoplasms, Endometrial|neoplasms, endometrial
5025947|NCT01523678|Cervical Neoplasms|cervical neoplasms
5025948|NCT01523678|Genital Neoplasms, Female|genital neoplasms, female
5025949|NCT01523678|Urogenital Neoplasms|urogenital neoplasms
5025950|NCT01523678|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic
5025951|NCT01523678|Genital Diseases, Female|genital diseases, female
5025952|NCT01523639|liver injury|liver injury
5025953|NCT01523639|steatosis|steatosis
5025954|NCT01523639|KRAS-Wild-Type|kras-wild-type
5025955|NCT01523639|metastatic colorectal cancer|metastatic colorectal cancer
5025956|NCT01523639|metformin|metformin
5025957|NCT01523639|placebo|placebo
5025958|NCT01523639|chemotherapy|chemotherapy
5025959|NCT01523626|Trauma|trauma
5025960|NCT01523626|Injur*|injur*
5025961|NCT01523626|Emergen*|emergen*
5025962|NCT01523626|Computed Tomography|computed tomography
5025963|NCT01523626|Total body|total body
5025964|NCT01523626|TBCT|tbct
5025965|NCT01523626|Whole body|whole body
5025966|NCT01523626|WBCT|wbct
5025967|NCT01523626|Full body|full body
5025968|NCT01523626|Pan CT|pan ct
5025969|NCT01523613|Dental caries|dental caries
5025970|NCT01523613|Proximal surfaces|proximal surfaces
5025971|NCT01523613|Posterior teeth|posterior teeth
5025972|NCT01523613|Carious lesions|carious lesions
5025973|NCT01523613|Tooth diseases|tooth diseases
5025974|NCT01523613|Dental restorations|dental restorations
5025975|NCT01523613|Glass-ionomer|glass-ionomer
5025976|NCT01523600|whole body vibration|whole body vibration
5025977|NCT01523600|physical functioning|physical functioning
5025978|NCT01523600|falls|falls
5025979|NCT01523600|older people|older people
5025980|NCT01523600|prevention|prevention
5025981|NCT01523574|oxaliplatin|oxaliplatin
5025982|NCT01523574|vitamin e|vitamin e
5025983|NCT01523574|neuropathy|neuropathy
5025984|NCT01523574|peripheral|peripheral
5025985|NCT01523574|prophylaxis|prophylaxis
5025986|NCT01523561|dance|dance
5025987|NCT01523561|intervention|intervention
5025988|NCT01523561|adolescent|adolescent
5025989|NCT01523561|girls|girls
5025990|NCT01523548|Carbon Monoxide|carbon monoxide
5025991|NCT01523548|Hypertension, Pulmonary|hypertension, pulmonary
5025992|NCT01523522|Fecal incontinence|fecal incontinence
5025993|NCT01523522|Myoblast|myoblast
5025994|NCT01523522|Surgery|surgery
5025995|NCT01523509|Dental Caries|dental caries
5025996|NCT01523509|Radiography, Dental|radiography, dental
5025997|NCT01523509|Contrast media|contrast media
5025998|NCT01523509|Tooth|tooth
5026000|NCT01523496|Vitamin D Deficiency|vitamin d deficiency
5026001|NCT01523483|preterm birth|preterm birth
5026002|NCT01523483|preterm labor|preterm labor
5026003|NCT01523483|progesterone|progesterone
5026004|NCT01523483|uterine electromyography|uterine electromyography
5026005|NCT01523483|cervical length|cervical length
5026006|NCT01523470|non-invasive ventilator|non-invasive ventilator
5026007|NCT01523457|metastatic pancreatic cancer|metastatic pancreatic cancer
5026008|NCT01523457|locally advanced pancreatic cancer|locally advanced pancreatic cancer
5026009|NCT01523457|FOLFIRINOX|folfirinox
5026010|NCT01523457|phase II|phase ii
5026011|NCT01523457|progression free survival|progression free survival
5026012|NCT01523444|Adolescents|adolescents
5026013|NCT01523444|Screening|screening
5026014|NCT01523444|Advice|advice
5026015|NCT01523444|Referral|referral
5026016|NCT01523431|Colorectal cancer|colorectal cancer
5026017|NCT01523431|Irinotecan|irinotecan
5026018|NCT01523431|UGT1A1 genotype|ugt1a1 genotype
5026019|NCT01523431|Neutropenia|neutropenia
5026020|NCT01523431|diarrhea|diarrhea
5026021|NCT01523431|response|response
5026022|NCT01523431|pharmacokinetic|pharmacokinetic
5026023|NCT01523418|Xarelto|xarelto
5026024|NCT01523418|Thromboembolism, Venous|thromboembolism, venous
5026025|NCT01523418|Orthopedic surgery|orthopedic surgery
5026026|NCT01523418|Factor Xa inhibitor|factor xa inhibitor
5026027|NCT01523418|Observational study|observational study
5026028|NCT01523405|Non Interventional Study, Type II Diabetes Mellitus, Quality of Life|non interventional study, type ii diabetes mellitus, quality of life
5026029|NCT01523392|Stable Coronary Artery Disease, CAD|stable coronary artery disease, cad
5026030|NCT01523379|Causalgia|causalgia
5026031|NCT01523379|CRPS|crps
5026032|NCT01523379|complex regional pain syndrome|complex regional pain syndrome
5026033|NCT01523379|Dynastat|dynastat
5026034|NCT01523379|Parecoxib|parecoxib
5026035|NCT01523366|Stable Coronary Artery Disease, CAD|stable coronary artery disease, cad
5026036|NCT01523353|Prehabilitation|prehabilitation
5026037|NCT01523353|Exercise|exercise
5026038|NCT01523353|Colorectal Cancer|colorectal cancer
5026039|NCT01523353|Surgery|surgery
5026040|NCT01523327|Uric acid|uric acid
5026041|NCT01523314|diabetic macular edema|diabetic macular edema
5026042|NCT01523314|intravitreal injection|intravitreal injection
5026043|NCT01523314|dexamethasone|dexamethasone
5026044|NCT01523314|Cyclodextrin|cyclodextrin
5026045|NCT01523314|eye drops|eye drops
5026046|NCT01523314|bevacizumab|bevacizumab
5026047|NCT01523314|macular laser|macular laser
5026048|NCT01523301|Rotigotine|rotigotine
5026049|NCT01523301|Neupro|neupro
5026050|NCT01523301|Depressive Symptom|depressive symptom
5026051|NCT01523301|Idiopathic Parkinson's disease|idiopathic parkinson's disease
5026052|NCT01523275|mitomycin-C|mitomycin-c
5026053|NCT01523275|laryngotracheal stenosis|laryngotracheal stenosis
5026054|NCT01523275|subglottic stenosis|subglottic stenosis
5026055|NCT01523275|tracheal stenosis|tracheal stenosis
5026056|NCT01523275|endoscopic airway surgery|endoscopic airway surgery
5026057|NCT01523262|preconditioning|preconditioning
5026058|NCT01523262|aortic aneurysm|aortic aneurysm
5026059|NCT01523249|3D ultrasonography|3d ultrasonography
5026060|NCT01523249|epidural|epidural
5026061|NCT01523249|neuraxial anesthesia|neuraxial anesthesia
5026062|NCT01523249|neuraxial analgesia|neuraxial analgesia
5026063|NCT01523249|pregnant woman|pregnant woman
5026064|NCT01523249|parturients|parturients
5026065|NCT01523236|Allergic Rhinitis|allergic rhinitis
5026066|NCT01523236|Bioequivalence|bioequivalence
5026067|NCT01523210|spasticity|spasticity
5026068|NCT01523210|Diffusor tensor imaging|diffusor tensor imaging
5026069|NCT01523210|distribution|distribution
5026070|NCT01523210|botulinum toxin|botulinum toxin
5026071|NCT01523210|physiotherapy|physiotherapy
5026072|NCT01523197|Obstructive Sleep Apnea hypopnea Syndrome|obstructive sleep apnea hypopnea syndrome
5026073|NCT01523197|COPD|copd
5026074|NCT01523197|overlap syndrome|overlap syndrome
5026075|NCT01523197|Auto-trilevel ventilation|auto-trilevel ventilation
5026076|NCT01523197|BiPAP ventilation|bipap ventilation
5026077|NCT01523184|Chronic constipation (CC)|chronic constipation (cc)
5026078|NCT01523184|Functional Constipation (FC)|functional constipation (fc)
5026079|NCT01523184|Gastric Emptying|gastric emptying
5026080|NCT01523184|Colon Transit|colon transit
5026081|NCT01523184|multiple doses of YKP10811|multiple doses of ykp10811
5026082|NCT01523184|gastrointestinal transit|gastrointestinal transit
5026083|NCT01523184|colonic transit|colonic transit
5026084|NCT01523158|Allergic Rhinitis|allergic rhinitis
5026085|NCT01523158|Immunotherapy|immunotherapy
5026086|NCT01523145|Atrial fibrillation|atrial fibrillation
5026087|NCT01523145|Radio Frequency Ablation|radio frequency ablation
5026088|NCT01523145|Rehabilitation|rehabilitation
5026089|NCT01523145|Physical capacity|physical capacity
5026090|NCT01523145|Quality of life|quality of life
5026091|NCT01523145|Integrated rehabilitation|integrated rehabilitation
5026092|NCT01523106|Crohn's disease|crohn's disease
5026093|NCT01523106|carnitine|carnitine
5026094|NCT01523067|Vasomera|vasomera
5026095|NCT01523067|PB1046|pb1046
5026096|NCT01523067|Hypertension|hypertension
5026097|NCT01523054|metoprolol, acute myocardial infarction, pharmacokinetics, pharmacodynamics|metoprolol, acute myocardial infarction, pharmacokinetics, pharmacodynamics
5026098|NCT01523015|Adenocarcinoma|adenocarcinoma
5026099|NCT01523015|esophago-gastric cancer|esophago-gastric cancer
5026100|NCT01523015|chemotherapy|chemotherapy
5026101|NCT01523015|chemoradiotherapy|chemoradiotherapy
5026102|NCT01523015|surgery|surgery
5026103|NCT01522989|Cancer|cancer
5026104|NCT01522989|Advanced|advanced
5026105|NCT01522989|Refractory|refractory
5026106|NCT01522950|hypertension|hypertension
5026107|NCT01522950|prevention|prevention
5026108|NCT01522950|endothelial function|endothelial function
5026109|NCT01522924|tobacco cessation treatment|tobacco cessation treatment
5026110|NCT01522924|standardized patients|standardized patients
5026111|NCT01522924|dental students|dental students
5026112|NCT01522924|tobacco cessation treatment education|tobacco cessation treatment education
5026113|NCT01522898|Heart Failure|heart failure
5026114|NCT01522898|Atrial Fibrillation|atrial fibrillation
5026115|NCT01522885|Chest tube|chest tube
5026116|NCT01522885|placement|placement
5026117|NCT01522885|mal positioning|mal positioning
5026118|NCT01522872|TH-302|th-302
5026119|NCT01522872|Relapsed/Refractory Multiple Myeloma|relapsed/refractory multiple myeloma
5026120|NCT01522872|Bortezomib|bortezomib
5026121|NCT01522872|Phase 1/2|phase 1/2
5026122|NCT01522872|Hypoxia|hypoxia
5026123|NCT01522872|Myeloma|myeloma
5026124|NCT01522872|Evofosfamide|evofosfamide
5026125|NCT01522872|Pomalidomide|pomalidomide
5026126|NCT01522872|Pimonidazole|pimonidazole
5026127|NCT01522859|COPD|copd
5026128|NCT01522859|Telehealth|telehealth
5026129|NCT01522859|health related quality of life|health related quality of life
5026130|NCT01522833|NSLCL|nslcl
5026131|NCT01522833|Erlotinib|erlotinib
5026132|NCT01522833|Tarceva|tarceva
5026133|NCT01522807|Phase 1|phase 1
5026134|NCT01522807|Single Doses|single doses
5026135|NCT01522807|Biocomparison|biocomparison
5026136|NCT01522807|Pharmacokinetics|pharmacokinetics
5026137|NCT01522807|Healthy Volunteers|healthy volunteers
5026138|NCT01522768|ESOPHAGUS|esophagus
5026139|NCT01522768|STOMACH|stomach
5026140|NCT01522768|Afatinib|afatinib
5026141|NCT01522768|paclitaxel|paclitaxel
5026142|NCT01522768|trastuzumab|trastuzumab
5026143|NCT01522768|11-166|11-166
5026144|NCT01522755|Pacing lead|pacing lead
5026145|NCT01522755|implant|implant
5026146|NCT01522755|pacemaker|pacemaker
5026147|NCT01522742|psoriasis|psoriasis
5026148|NCT01522742|cardiovascular disease risk|cardiovascular disease risk
5026149|NCT01522742|atherosclerosis|atherosclerosis
5026150|NCT01522742|etanercept (enbrel)|etanercept (enbrel)
5026151|NCT01522729|Chronic pulmonary obstructive disease|chronic pulmonary obstructive disease
5026152|NCT01522729|Muscle dysfunction|muscle dysfunction
5026153|NCT01522729|Exercise intolerance|exercise intolerance
5026154|NCT01522729|Muscle afferents|muscle afferents
5026155|NCT01522729|Ventilation|ventilation
5026156|NCT01522703|asthma|asthma
5026157|NCT01522703|allergic rhinitis|allergic rhinitis
5026158|NCT01522703|dietary interventions|dietary interventions
5026159|NCT01522703|mouse allergy|mouse allergy
5026160|NCT01522690|Accelerometer|accelerometer
5026161|NCT01522690|gait analysis|gait analysis
5026162|NCT01522690|Healthy subjects|healthy subjects
5026163|NCT01522677|tumor immunology|tumor immunology
5026164|NCT01522677|neoadjuvant|neoadjuvant
5026165|NCT01522677|colonoscopy|colonoscopy
5026166|NCT01522677|photosensitization|photosensitization
5026167|NCT01522651|Atrial Fibrillation|atrial fibrillation
5026168|NCT01522651|Ranolazine|ranolazine
5026169|NCT01522651|Dronedarone|dronedarone
5026170|NCT01522651|Dual Chamber Pacemakers|dual chamber pacemakers
5026171|NCT01522625|chronic hepatitis B|chronic hepatitis b
5026172|NCT01522625|hepatitis B viral DNA|hepatitis b viral dna
5026173|NCT01522625|antiviral therapy|antiviral therapy
5026174|NCT01522625|Tenofovir|tenofovir
5026175|NCT01522612|KRAS Wild Type|kras wild type
5026176|NCT01522612|Frail Elderly|frail elderly
5026177|NCT01522612|QLQ-C30|qlq-c30
5026178|NCT01522612|QLQ-ELD14|qlq-eld14
5026179|NCT01522612|CGA|cga
5026180|NCT01522612|EGFR|egfr
5026181|NCT01522612|Cetuximab|cetuximab
5026182|NCT01522612|5-FU|5-fu
5026183|NCT01522599|ARDS: Acute Respiratory Distress Syndrome|ards: acute respiratory distress syndrome
5026184|NCT01522599|LOW FLOW ECCO2-R: EXTRA-CORPOREAL CO2 REMOVAL|low flow ecco2-r: extra-corporeal co2 removal
5026185|NCT01522599|VILI: Ventilator Induced Lung Injury|vili: ventilator induced lung injury
5026186|NCT01522573|Cholangiocarcinoma|cholangiocarcinoma
5026187|NCT01522573|Pancreatic Cancer|pancreatic cancer
5026188|NCT01522573|Bile Duct Cancer|bile duct cancer
5026189|NCT01522573|Biliary Stricture|biliary stricture
5026190|NCT01522573|Biliary obstruction|biliary obstruction
5026191|NCT01522573|Stent obstruction|stent obstruction
5026192|NCT01522573|Proximal duct stricture|proximal duct stricture
5026193|NCT01522573|Distal duct stricture|distal duct stricture
5026194|NCT01522573|Ampullary Cancer|ampullary cancer
5026195|NCT01522573|Biliary sphincter stenosis|biliary sphincter stenosis
5026196|NCT01522573|Impacted stones|impacted stones
5026197|NCT01522573|Chronic pancreatitis|chronic pancreatitis
5026198|NCT01522573|Peri-ampullary diverticula|peri-ampullary diverticula
5026199|NCT01522573|Altered anatomy|altered anatomy
5026200|NCT01522573|Endoscopic ultrasound|endoscopic ultrasound
5026201|NCT01522573|Endoscopic Retrograde Cholangiopancreatography|endoscopic retrograde cholangiopancreatography
5026202|NCT01522573|Multicenter|multicenter
5026203|NCT01522560|CA2 and CA3 residents|ca2 and ca3 residents
5026204|NCT01522560|Pediatric Anesthesia|pediatric anesthesia
5026205|NCT01522547|Pomalidomide|pomalidomide
5026206|NCT01522547|Sickle Cell Disease|sickle cell disease
5026207|NCT01522547|Fetal Hemoglobin|fetal hemoglobin
5026208|NCT01522534|injuries|injuries
5026209|NCT01522534|pain|pain
5026210|NCT01522534|Block, Nerve|block, nerve
5026211|NCT01522534|morphine|morphine
5026212|NCT01522534|Prehospital Emergency Care|prehospital emergency care
5026213|NCT01522521|AK156|ak156
5026214|NCT01522508|Analgesia|analgesia
5026215|NCT01522508|Anesthetics|anesthetics
5026216|NCT01522508|Diagnostic Techniques and Procedures|diagnostic techniques and procedures
5026217|NCT01522482|fatty acids|fatty acids
5026218|NCT01522482|cardiovascular disease|cardiovascular disease
5026219|NCT01522482|genotype|genotype
5026220|NCT01522482|apoE|apoe
5026221|NCT01522469|FLT3|flt3
5026222|NCT01522469|Crenolanib|crenolanib
5026223|NCT01522469|Acute|acute
5026224|NCT01522469|myeloid|myeloid
5026225|NCT01522469|leukemia|leukemia
5026226|NCT01522469|relapsed|relapsed
5026227|NCT01522469|refractory|refractory
5026228|NCT01522443|prostate cancer|prostate cancer
5026229|NCT01522443|castration resistant prostate cancer|castration resistant prostate cancer
5026230|NCT01522443|bone pain|bone pain
5026231|NCT01522443|CRPC|crpc
5026232|NCT01522430|Resistant hypertension|resistant hypertension
5026233|NCT01522430|Renal denervation|renal denervation
5026234|NCT01522430|Ambulatory blood pressure|ambulatory blood pressure
5026235|NCT01522430|Renal function|renal function
5026236|NCT01522430|Simplicity catheter|simplicity catheter
5026237|NCT01522430|Sham procedure|sham procedure
5026238|NCT01522404|Mild Cognitive Impairment|mild cognitive impairment
5026239|NCT01522404|Memory Loss|memory loss
5026240|NCT01522404|Alzheimer's Disease|alzheimer's disease
5026241|NCT01522378|cardiac resynchronization therapy|cardiac resynchronization therapy
5026441|NCT01521416|Cost|cost
5026242|NCT01522365|Dental implants|dental implants
5026243|NCT01522365|XiVE CAD/CAM bridge|xive cad/cam bridge
5026244|NCT01522352|Bioprosthesis,|bioprosthesis,
5026245|NCT01522352|aortic valve replacement|aortic valve replacement
5026246|NCT01522352|Magna Ease|magna ease
5026247|NCT01522352|Mitroflow|mitroflow
5026248|NCT01522352|Trifecta|trifecta
5026249|NCT01522339|NICU|nicu
5026250|NCT01522339|MRI|mri
5026251|NCT01522339|Neonatal|neonatal
5026252|NCT01522339|Safety|safety
5026253|NCT01522339|Efficacy|efficacy
5026254|NCT01522339|Cincinnati|cincinnati
5026255|NCT01522326|Acute Mountain Sickness|acute mountain sickness
5026256|NCT01522326|High Altitude Headache|high altitude headache
5026257|NCT01522326|Lake Louise AMS Score|lake louise ams score
5026258|NCT01522326|Visual Analog Scale|visual analog scale
5026259|NCT01522326|Ibuprofen|ibuprofen
5026260|NCT01522326|Metoclopramide|metoclopramide
5026261|NCT01522326|Nepal|nepal
5026262|NCT01522300|Tomosynthesis|tomosynthesis
5026263|NCT01522300|breast cancer|breast cancer
5026264|NCT01522300|specificity|specificity
5026265|NCT01522300|sensitivity|sensitivity
5026266|NCT01522300|To assess efficacy of Tomosynthesis by evaluating its sensitivity and specificity in detecting the multicentricity of mammary tumor|to assess efficacy of tomosynthesis by evaluating its sensitivity and specificity in detecting the multicentricity of mammary tumor
5026267|NCT01522287|Obsessive Compulsive Disorder|obsessive compulsive disorder
5026268|NCT01522287|Computer Assisted Therapy|computer assisted therapy
5026269|NCT01522287|Cognitive Behavior Therapy|cognitive behavior therapy
5026270|NCT01522287|Cognitive Therapy|cognitive therapy
5026271|NCT01522261|Mechanical Bowel Prep|mechanical bowel prep
5026272|NCT01522248|influenza vaccine|influenza vaccine
5026273|NCT01522248|cytokines|cytokines
5026274|NCT01522248|chemokines|chemokines
5026275|NCT01522248|symptoms|symptoms
5026276|NCT01522235|Autoimmune autonomic neuropathy|autoimmune autonomic neuropathy
5026277|NCT01522235|Orthostatic hypotension|orthostatic hypotension
5026278|NCT01522235|Dysautonomia|dysautonomia
5026279|NCT01522235|Autonomic failure|autonomic failure
5026280|NCT01522235|Peripheral autonomic neuropathy|peripheral autonomic neuropathy
5026281|NCT01522222|cardiopulmonary bypass surgery|cardiopulmonary bypass surgery
5026282|NCT01522222|CABG|cabg
5026283|NCT01522222|PEEP|peep
5026284|NCT01522209|CRLM|crlm
5026285|NCT01522209|Primovist MRI|primovist mri
5026286|NCT01522209|CEIOUS|ceious
5026287|NCT01522196|SCD|scd
5026288|NCT01522183|Atypical Hemolytic-Uremic Syndrome|atypical hemolytic-uremic syndrome
5026289|NCT01522183|aHUS|ahus
5026290|NCT01522183|Thrombotic Microangiopathy|thrombotic microangiopathy
5026291|NCT01522183|TMA|tma
5026292|NCT01522170|Atypical Hemolytic Uremic Syndrome|atypical hemolytic uremic syndrome
5026293|NCT01522170|aHUS|ahus
5026294|NCT01522170|Eculizumab|eculizumab
5026295|NCT01522157|Diet|diet
5026296|NCT01522157|Low-carbohydrate|low-carbohydrate
5026297|NCT01522157|Postprandial|postprandial
5026298|NCT01522157|Type 2 diabetes mellitus|type 2 diabetes mellitus
5026299|NCT01522131|bioresorbable membrane|bioresorbable membrane
5026300|NCT01522118|Prostate Cancer|prostate cancer
5026301|NCT01522118|High Intensity Focused Ultrasound|high intensity focused ultrasound
5026302|NCT01522118|Magnetic Resonance guided Focused Ultrasound|magnetic resonance guided focused ultrasound
5026303|NCT01522118|Non-invasive therapy|non-invasive therapy
5026304|NCT01522118|Focal Disease|focal disease
5026305|NCT01522105|Meningitis|meningitis
5026306|NCT01522105|Central Nervous System Infections|central nervous system infections
5026307|NCT01522105|Pediatrics|pediatrics
5026308|NCT01522105|Daptomycin|daptomycin
5026309|NCT01522105|Anti-Bacterial Agents|anti-bacterial agents
5026310|NCT01522105|Therapeutic Use|therapeutic use
5026311|NCT01522105|Pharmacologic Actions|pharmacologic actions
5026312|NCT01522092|Exacerbations|exacerbations
5026313|NCT01522079|spinal muscular atrophy|spinal muscular atrophy
5026314|NCT01522079|heart rate variability|heart rate variability
5026315|NCT01522079|posture|posture
5026316|NCT01522079|air stacking|air stacking
5026317|NCT01522040|Asthma|asthma
5026318|NCT01522040|Magnesium|magnesium
5026319|NCT01522040|Adrenergic Receptor|adrenergic receptor
5026320|NCT01522014|Joint Replacement|joint replacement
5026321|NCT01522014|Health Related Quality of Life|health related quality of life
5026322|NCT01522014|Functional Outcomes|functional outcomes
5026323|NCT01522014|Revision Rate|revision rate
5026324|NCT01522001|Acute Coronary Syndrome|acute coronary syndrome
5026325|NCT01522001|Myocardial Ischemia|myocardial ischemia
5026326|NCT01522001|Shared Care|shared care
5026327|NCT01522001|Rehabilitation|rehabilitation
5026328|NCT01522001|Community|community
5026329|NCT01522001|Cardiac Rehabilitation|cardiac rehabilitation
5026330|NCT01522001|Hospital|hospital
5026331|NCT01521988|Atrial flutter|atrial flutter
5026332|NCT01521988|Atrial fibrillation|atrial fibrillation
5026333|NCT01521988|Catheter ablation|catheter ablation
5026334|NCT01521975|HBV DNA|hbv dna
5026336|NCT01521975|ADV|adv
5026337|NCT01521975|HBeAg negative hepatitis|hbeag negative hepatitis
5026338|NCT01521975|CHB|chb
5026339|NCT01521949|Prostate Cancer|prostate cancer
5026340|NCT01521949|Nutraceutical|nutraceutical
5026341|NCT01521949|Acai Juice|acai juice
5026442|NCT01521416|UK|uk
5026342|NCT01521923|Certolizumab Pegol - Cimzia|certolizumab pegol - cimzia
5026343|NCT01521923|Rheumatoid Arthritis|rheumatoid arthritis
5026344|NCT01521910|survival|survival
5026345|NCT01521910|protein restriction|protein restriction
5026346|NCT01521910|diabetic nephropathy|diabetic nephropathy
5026347|NCT01521910|type 1 diabetes|type 1 diabetes
5026348|NCT01521910|GFR|gfr
5026349|NCT01521910|ESRD|esrd
5026350|NCT01521910|progressive renal disease|progressive renal disease
5026351|NCT01521897|Pneumococcal Vaccine|pneumococcal vaccine
5026352|NCT01521897|Prevenar|prevenar
5026353|NCT01521897|7-valent|7-valent
5026354|NCT01521897|Special Use-result surveillance|special use-result surveillance
5026355|NCT01521871|Tissue glue|tissue glue
5026356|NCT01521871|Cyanoacrylate|cyanoacrylate
5026357|NCT01521871|Wound closure|wound closure
5026358|NCT01521871|Living donor nephrectomy|living donor nephrectomy
5026359|NCT01521871|Surgical wound closure|surgical wound closure
5026360|NCT01521845|elective percutaneous coronary intervention|elective percutaneous coronary intervention
5026361|NCT01521845|hs-CRP|hs-crp
5026362|NCT01521845|CKMB and troponin I|ckmb and troponin i
5026363|NCT01521819|AMD|amd
5026364|NCT01521819|V-Ped|v-ped
5026365|NCT01521819|Vascularized Pigment Epithelial Detachment|vascularized pigment epithelial detachment
5026366|NCT01521819|Iray|iray
5026367|NCT01521819|radiation|radiation
5026368|NCT01521819|retina|retina
5026369|NCT01521819|macula|macula
5026370|NCT01521819|radiotherapy|radiotherapy
5026371|NCT01521806|insulin sensitivity|insulin sensitivity
5026372|NCT01521806|resistant starch|resistant starch
5026373|NCT01521780|hepatocellular carcinoma|hepatocellular carcinoma
5026374|NCT01521780|MRI|mri
5026375|NCT01521780|pharmacogenomics|pharmacogenomics
5026376|NCT01521780|beta-catenin|beta-catenin
5026377|NCT01521767|pharmacokinetics|pharmacokinetics
5026378|NCT01521767|relative bioavailability|relative bioavailability
5026379|NCT01521767|tolterodine microspheres in powder blend|tolterodine microspheres in powder blend
5026380|NCT01521767|Overactive Urinary Bladder|overactive urinary bladder
5026381|NCT01521741|Breast Cancer|breast cancer
5026382|NCT01521741|Lymphedema|lymphedema
5026383|NCT01521741|symptoms|symptoms
5026384|NCT01521728|ALS|als
5026385|NCT01521728|Exercise|exercise
5026386|NCT01521728|Resistance|resistance
5026387|NCT01521728|Endurance|endurance
5026388|NCT01521702|adenocarcinoma|adenocarcinoma
5026389|NCT01521702|pancreatic head|pancreatic head
5026390|NCT01521689|MRD negative CR|mrd negative cr
5026391|NCT01521676|breast cancer|breast cancer
5026392|NCT01521663|Moderate to severe idiopathic RLS|moderate to severe idiopathic rls
5026393|NCT01521650|Probiotics|probiotics
5026394|NCT01521650|Anaesthesia|anaesthesia
5026395|NCT01521650|Intubation|intubation
5026396|NCT01521650|Pathogenic bacteria|pathogenic bacteria
5026397|NCT01521611|Radioimmunotherapy|radioimmunotherapy
5026398|NCT01521611|Transplant|transplant
5026399|NCT01521611|BMT|bmt
5026400|NCT01521611|yttrium|yttrium
5026401|NCT01521611|indium|indium
5026402|NCT01521598|Diabetic Peripheral Neuropathy|diabetic peripheral neuropathy
5026403|NCT01521572|chronic obstructive pulmonary disease,|chronic obstructive pulmonary disease,
5026404|NCT01521572|bronchial reversibility,|bronchial reversibility,
5026405|NCT01521572|bronchodilator,|bronchodilator,
5026406|NCT01521572|respiratory impedance,|respiratory impedance,
5026407|NCT01521572|forced oscillation technique,|forced oscillation technique,
5026408|NCT01521572|plethysmography,|plethysmography,
5026409|NCT01521572|spirometry|spirometry
5026410|NCT01521572|Diagnostic Techniques, Respiratory System|diagnostic techniques, respiratory system
5026411|NCT01521546|Duchenne muscular dystrophy|duchenne muscular dystrophy
5026412|NCT01521546|cardiomyopathy|cardiomyopathy
5026413|NCT01521546|aldosterone antagonist|aldosterone antagonist
5026414|NCT01521533|Relapsed Multiple Myeloma|relapsed multiple myeloma
5026415|NCT01521533|NOX-A12|nox-a12
5026416|NCT01521533|Velcade|velcade
5026417|NCT01521533|Dexamethasone|dexamethasone
5026418|NCT01521533|Spiegelmer|spiegelmer
5026419|NCT01521533|Chemosensitization|chemosensitization
5026420|NCT01521533|Stromal cell-derived factor-1 (SDF-1)|stromal cell-derived factor-1 (sdf-1)
5026421|NCT01521533|CXCL12|cxcl12
5026422|NCT01521520|type 1 diabetes|type 1 diabetes
5026423|NCT01521520|magnetic resonance imaging|magnetic resonance imaging
5026424|NCT01521520|insulitis|insulitis
5026425|NCT01521520|ferumoxytol|ferumoxytol
5026426|NCT01521494|Hemodialysis|hemodialysis
5026427|NCT01521494|Hyperphosphatemia|hyperphosphatemia
5026428|NCT01521468|Coronary artery disease|coronary artery disease
5026429|NCT01521468|Diagnostic accuracy|diagnostic accuracy
5026430|NCT01521468|CT coronary angiography|ct coronary angiography
5026431|NCT01521468|Positron emission tomography|positron emission tomography
5026432|NCT01521468|Single photon emission tomography|single photon emission tomography
5026433|NCT01521468|Noninvasive techniques|noninvasive techniques
5026434|NCT01521468|Cardiac catheterization|cardiac catheterization
5026435|NCT01521468|Fractional flow reserve|fractional flow reserve
5026436|NCT01521442|PTSD|ptsd
5026437|NCT01521442|Yoga|yoga
5026438|NCT01521442|Complementary and Alternative Medicine (CAM)|complementary and alternative medicine (cam)
5026439|NCT01521416|Illness|illness
5026440|NCT01521416|Influenza|influenza
5026443|NCT01521403|Blastocystis hominis|blastocystis hominis
5026444|NCT01521403|Metronidazole|metronidazole
5026445|NCT01521377|LAMA|lama
5026446|NCT01521377|Respiratory|respiratory
5026447|NCT01521377|COPD|copd
5026448|NCT01521377|Tolerability|tolerability
5026449|NCT01521377|Beta-2 Agonist|beta-2 agonist
5026450|NCT01521377|Safety|safety
5026451|NCT01521377|Pharmacokinetics|pharmacokinetics
5026452|NCT01521377|Pharmacodynamics|pharmacodynamics
5026453|NCT01521377|LABA|laba
5026454|NCT01521377|Muscarinic Receptor Agonist|muscarinic receptor agonist
5026455|NCT01521377|Healthy subjects|healthy subjects
5026456|NCT01521377|Moxifloxacin|moxifloxacin
5026457|NCT01521377|Anticholinergic|anticholinergic
5026458|NCT01521377|GW642444|gw642444
5026459|NCT01521377|GSK573719|gsk573719
5026460|NCT01521377|QTc|qtc
5026461|NCT01521364|pharmacokinetic|pharmacokinetic
5026462|NCT01521364|drug-interaction|drug-interaction
5026463|NCT01521364|linezolid|linezolid
5026464|NCT01521364|clarithromycin|clarithromycin
5026465|NCT01521364|Mycobacterium tuberculosis|mycobacterium tuberculosis
5026466|NCT01521351|microwave radiometry|microwave radiometry
5026467|NCT01521351|cardiovascular events|cardiovascular events
5026468|NCT01521351|carotid artery disease|carotid artery disease
5026469|NCT01521351|stroke|stroke
5026470|NCT01521351|myocardial infarction|myocardial infarction
5026471|NCT01521338|Cystic Fibrosis|cystic fibrosis
5026472|NCT01521338|G551D|g551d
5026473|NCT01521338|G551D Mutation|g551d mutation
5026474|NCT01521312|Impaired glucose tolerance|impaired glucose tolerance
5026475|NCT01521312|Saxagliptin|saxagliptin
5026476|NCT01521312|Cardiovascular risk integrators|cardiovascular risk integrators
5026477|NCT01521312|Vago-sympathetic activity|vago-sympathetic activity
5026478|NCT01521312|Arterial stiffness|arterial stiffness
5026479|NCT01521312|Endothelial function|endothelial function
5026480|NCT01521299|hydroxyurea|hydroxyurea
5026481|NCT01521299|S phase|s phase
5026482|NCT01521299|G2 phase|g2 phase
5026483|NCT01521299|pharmacokinetics|pharmacokinetics
5026484|NCT01521286|Spain|spain
5026485|NCT01521286|cost|cost
5026486|NCT01521286|complications|complications
5026487|NCT01521286|incidence|incidence
5026488|NCT01521286|adults|adults
5026489|NCT01521286|quality of life|quality of life
5026490|NCT01521286|Herpes Zoster|herpes zoster
5026491|NCT01521286|Surveillance|surveillance
5026492|NCT01521273|beans|beans
5026493|NCT01521273|biofortification|biofortification
5026494|NCT01521273|phytic acid|phytic acid
5026495|NCT01521273|iron|iron
5026496|NCT01521273|iron isotopes|iron isotopes
5026497|NCT01521273|different phytic acid concentrations|different phytic acid concentrations
5026498|NCT01521260|dental implants|dental implants
5026499|NCT01521260|microbiology|microbiology
5026500|NCT01521260|chlorhexidine|chlorhexidine
5026501|NCT01521247|Asthma|asthma
5026502|NCT01521247|Transition program|transition program
5026503|NCT01521247|Pediatric|pediatric
5026504|NCT01521247|Adult|adult
5026505|NCT01521208|Out-of-Hospital cardiac arrest (OHCA)|out-of-hospital cardiac arrest (ohca)
5026506|NCT01521208|Chest compressions|chest compressions
5026507|NCT01521208|LUCAS device|lucas device
5026508|NCT01521195|pediatric|pediatric
5026509|NCT01521195|ECMO|ecmo
5026510|NCT01521195|extracorporeal blood flow|extracorporeal blood flow
5026511|NCT01521195|VO2|vo2
5026512|NCT01521182|Probiotic - dairy product - influenza vaccination - healthy elderly|probiotic - dairy product - influenza vaccination - healthy elderly
5026513|NCT01521169|Plant sterol - Hypercholesterolemia - Diet - Dairy|plant sterol - hypercholesterolemia - diet - dairy
5026514|NCT01521156|Plant sterols - Hypercholesterolemia - Diet - Dairy|plant sterols - hypercholesterolemia - diet - dairy
5026515|NCT01521143|EOC|eoc
5026516|NCT01521130|Benign Childhood Epilepsy With Centrotemporal Spikes|benign childhood epilepsy with centrotemporal spikes
5026517|NCT01521130|Benign Rolandic Epilepsy|benign rolandic epilepsy
5026518|NCT01521117|donepezil|donepezil
5026519|NCT01521117|parkinson's disease|parkinson's disease
5026520|NCT01521117|balance|balance
5026521|NCT01521117|cholinesterase inhibitor|cholinesterase inhibitor
5026522|NCT01521104|narrow band imaging（NBI）|narrow band imaging（nbi）
5026523|NCT01521104|colorectal lesions|colorectal lesions
5026524|NCT01521104|predicting histology|predicting histology
5026525|NCT01521091|narrow band imaging（NBI）|narrow band imaging（nbi）
5026526|NCT01521091|indigo carmine|indigo carmine
5026527|NCT01521091|acetic acid|acetic acid
5026528|NCT01521091|colorectal lesions|colorectal lesions
5026529|NCT01521091|predicting histology|predicting histology
5026530|NCT01521065|AMD|amd
5026531|NCT01521065|Wet AMD|wet amd
5026532|NCT01521039|aGVHD|agvhd
5026533|NCT01521039|Acute Graft-versus-Host Disease|acute graft-versus-host disease
5026534|NCT01521039|allogeneic stem cell transplantation|allogeneic stem cell transplantation
5026535|NCT01521039|Hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
5026536|NCT01521039|MicroRNA Expression|microrna expression
5026537|NCT01521000|Breast Cancer|breast cancer
5026538|NCT01521000|Lymphedema|lymphedema
5026539|NCT01521000|Sentinel Node Biopsy|sentinel node biopsy
5026540|NCT01521000|Axillary Dissection|axillary dissection
5026541|NCT01520987|Parkinson Disease|parkinson disease
5026542|NCT01520987|BIA 9-1067|bia 9-1067
5026543|NCT01520961|Partial Hip Arthroplasty|partial hip arthroplasty
5026544|NCT01520948|Parkinson disease|parkinson disease
5026545|NCT01520948|Incontinence|incontinence
5026546|NCT01520935|Office of National Statistics|office of national statistics
5026547|NCT01520935|Burden of Disease|burden of disease
5026548|NCT01520935|Influenza|influenza
5026549|NCT01520935|Hospital Episode Statistics|hospital episode statistics
5026550|NCT01520935|General Practitioners Research Database|general practitioners research database
5026551|NCT01520922|Relapsed or Refractory Chronic Lymphocytic Leukemia|relapsed or refractory chronic lymphocytic leukemia
5026552|NCT01520922|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
5026553|NCT01520922|CLL|cll
5026554|NCT01520922|Cancer|cancer
5026555|NCT01520922|Lymphoid leukemia|lymphoid leukemia
5026556|NCT01520922|Lymphoblastic leukemia|lymphoblastic leukemia
5026557|NCT01520909|immune thrombocytopenic purpura|immune thrombocytopenic purpura
5026558|NCT01520909|pediatrics|pediatrics
5026559|NCT01520909|chronic ITP|chronic itp
5026560|NCT01520909|idiopathic thrombocytopenic purpura|idiopathic thrombocytopenic purpura
5026561|NCT01520909|eltrombopag|eltrombopag
5026808|NCT01519986|Vitamin D|vitamin d
5026562|NCT01520909|Chronic Immune Thrombocytopenia|chronic immune thrombocytopenia
5026563|NCT01520909|platelet disorder|platelet disorder
5026564|NCT01520909|thrombocytopenia|thrombocytopenia
5026565|NCT01520896|Phase 1|phase 1
5026566|NCT01520896|Healthy male and female volunteers|healthy male and female volunteers
5026567|NCT01520896|Drug-drug interaction|drug-drug interaction
5026568|NCT01520896|Pharmacokinetics|pharmacokinetics
5026569|NCT01520896|NKTR-118|nktr-118
5026570|NCT01520870|Dacomitinib|dacomitinib
5026571|NCT01520870|PF-299804|pf-299804
5026572|NCT01520870|Glioblastoma, Recurrent|glioblastoma, recurrent
5026573|NCT01520870|EGFR|egfr
5026574|NCT01520857|Laparoscopic inguinal hernia repair|laparoscopic inguinal hernia repair
5026575|NCT01520857|TAPP|tapp
5026576|NCT01520857|Spinal Anesthesia|spinal anesthesia
5026577|NCT01520857|General Anesthesia|general anesthesia
5026578|NCT01520805|acute myeloid leukemia|acute myeloid leukemia
5026579|NCT01520805|myelodysplastic syndrome|myelodysplastic syndrome
5026580|NCT01520805|refractory|refractory
5026581|NCT01520805|relapsed|relapsed
5026582|NCT01520805|hypomethylating agents|hypomethylating agents
5026583|NCT01520792|pharmacogenetic of paracetamol|pharmacogenetic of paracetamol
5026584|NCT01520792|Pain threshold|pain threshold
5026585|NCT01520779|Hepatocellular cacinoma|hepatocellular cacinoma
5026586|NCT01520779|Radiofrequancy ablation|radiofrequancy ablation
5026587|NCT01520779|Intrahepatic recurrence|intrahepatic recurrence
5026588|NCT01520766|glass fiber posts|glass fiber posts
5026589|NCT01520766|titanium posts|titanium posts
5026590|NCT01520766|postendodontic restoration|postendodontic restoration
5026591|NCT01520766|self-adhesive resin cement|self-adhesive resin cement
5026592|NCT01520740|Gold Stage III|gold stage iii
5026593|NCT01520740|Gold Stage IV|gold stage iv
5026594|NCT01520740|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5026595|NCT01520740|COPD|copd
5026596|NCT01520740|Lung Volume Reduction Surgery|lung volume reduction surgery
5026597|NCT01520740|LVRS|lvrs
5026598|NCT01520740|Bronchoscopic Lung Volume Reduction|bronchoscopic lung volume reduction
5026599|NCT01520740|BLVR|blvr
5026600|NCT01520740|Upper Lobe Predominant|upper lobe predominant
5026601|NCT01520740|ULP|ulp
5026602|NCT01520740|Heterogeneous|heterogeneous
5026603|NCT01520740|Homogeneous|homogeneous
5026604|NCT01520727|BIA 9-1067|bia 9-1067
5026605|NCT01520714|Congestive Heart Failure (CHF)|congestive heart failure (chf)
5026606|NCT01520714|Cardiac Resynchronization Therapy (CRT)|cardiac resynchronization therapy (crt)
5026607|NCT01520714|BiVentricular Implantable Cardioverter Defibrillator (BiVICD)|biventricular implantable cardioverter defibrillator (bivicd)
5026608|NCT01520714|Fraction|fraction
5026609|NCT01520701|head and neck cancer|head and neck cancer
5026610|NCT01520701|Hydrotac®|hydrotac®
5026611|NCT01520701|radiodermatitis|radiodermatitis
5026612|NCT01520701|algia|algia
5026613|NCT01520701|radiotherapy|radiotherapy
5026614|NCT01520688|Mild persistent or mild intermittent asthma|mild persistent or mild intermittent asthma
5026615|NCT01520675|chronic pancreatitis|chronic pancreatitis
5026616|NCT01520675|randomized controlled trial|randomized controlled trial
5026617|NCT01520675|endoscopic therapy|endoscopic therapy
5026618|NCT01520675|surgery|surgery
5026619|NCT01520675|ESWL|eswl
5026620|NCT01520662|patient-centered care|patient-centered care
5026621|NCT01520662|wellness|wellness
5026622|NCT01520662|preventive services|preventive services
5026623|NCT01520662|primary care|primary care
5026624|NCT01520662|To accomplish Aim 2, we will conduct a nine-month pre-post|to accomplish aim 2, we will conduct a nine-month pre-post
5026625|NCT01520662|randomized controlled trial (RCT) in four primary care|randomized controlled trial (rct) in four primary care
5026626|NCT01520662|practices. The study will focus on the impact of a patient|practices. the study will focus on the impact of a patient
5026627|NCT01520662|Wellness Portal on the quantity and quality of preventive|wellness portal on the quantity and quality of preventive
5026628|NCT01520662|care patients receive in primary care practices.|care patients receive in primary care practices.
5026629|NCT01520649|Neurogenesis|neurogenesis
5026630|NCT01520649|hippocampal stem cells|hippocampal stem cells
5026631|NCT01520649|depression|depression
5026632|NCT01520649|stroke|stroke
5026633|NCT01520636|stroke|stroke
5026634|NCT01520636|early rehabilitation|early rehabilitation
5026635|NCT01520636|motor recovery|motor recovery
5026636|NCT01520636|functional recovery|functional recovery
5026637|NCT01520623|Allogeneic haematopoietic stem cell transplantation (HSCT)|allogeneic haematopoietic stem cell transplantation (hsct)
5026638|NCT01520623|Myeloablative conditioning for an haematological malignancy|myeloablative conditioning for an haematological malignancy
5026639|NCT01520623|Graft-versus-host disease (GvHD)|graft-versus-host disease (gvhd)
5026640|NCT01520623|Activation of complement system|activation of complement system
5026641|NCT01520623|Gut GVHD|gut gvhd
5026642|NCT01520610|Tako-TSUBO Cardiomyopathy|tako-tsubo cardiomyopathy
5026643|NCT01520610|Stress Cardiomyopathy|stress cardiomyopathy
5026644|NCT01520610|Myocardiopathies|myocardiopathies
5026645|NCT01520610|Acute Coronary Syndrome|acute coronary syndrome
5026646|NCT01520610|Gene|gene
5026647|NCT01520597|Multicentric|multicentric
5026648|NCT01520597|National|national
5026649|NCT01520597|Prospective on|prospective on
5026650|NCT01520597|Listeriosis|listeriosis
5026651|NCT01520597|Listeria|listeria
5026652|NCT01520571|Computer Assistance|computer assistance
5026653|NCT01520571|Total Knee Arthroplasty|total knee arthroplasty
5026654|NCT01520571|conventional|conventional
5026655|NCT01520558|Acute Myeloid Leukemia|acute myeloid leukemia
5026656|NCT01520558|High Risk Relapse|high risk relapse
5026657|NCT01520558|Complete Remission|complete remission
5026658|NCT01520558|Allogeneic Natural Killer Cells|allogeneic natural killer cells
5026659|NCT01520545|Gablofen|gablofen
5026660|NCT01520545|baclofen injection|baclofen injection
5026661|NCT01520519|Leukemia|leukemia
5026662|NCT01520519|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
5026663|NCT01520519|CLL|cll
5026664|NCT01520519|Small Lymphocytic Lymphoma|small lymphocytic lymphoma
5026665|NCT01520519|SLL|sll
5026666|NCT01520519|Rituximab|rituximab
5026667|NCT01520519|Rituxan|rituxan
5026668|NCT01520519|PCI-32765|pci-32765
5026669|NCT01520506|Hypertension|hypertension
5026670|NCT01520506|Kidney Diseases|kidney diseases
5026671|NCT01520506|Kidney Failure, Chronic|kidney failure, chronic
5026672|NCT01520506|Vascular Diseases|vascular diseases
5026673|NCT01520506|Cardiovascular Diseases|cardiovascular diseases
5026674|NCT01520506|Urologic Diseases|urologic diseases
5026675|NCT01520506|Renal Insufficiency, Chronic|renal insufficiency, chronic
5026676|NCT01520506|Renal Insufficiency|renal insufficiency
5026677|NCT01520493|pulmonary arterial hypertension|pulmonary arterial hypertension
5026678|NCT01520493|skeletal muscle microcirculation|skeletal muscle microcirculation
5026679|NCT01520493|exercise induced blood flow|exercise induced blood flow
5026680|NCT01520480|survival after surgery|survival after surgery
5026681|NCT01520480|Pathological Subtrochanteric Fractures|pathological subtrochanteric fractures
5026682|NCT01520467|SRS|srs
5026683|NCT01520467|PWS|pws
5026684|NCT01520467|pathological adrenarche|pathological adrenarche
5026685|NCT01520467|aromatase inhibitor|aromatase inhibitor
5026686|NCT01520467|Children|children
5026687|NCT01520454|Leptin resistance|leptin resistance
5026688|NCT01520454|Free fatty acids|free fatty acids
5026689|NCT01520454|Lipotoxicity|lipotoxicity
5026690|NCT01520441|Botulinum Toxin|botulinum toxin
5026691|NCT01520441|Prostate Cancer|prostate cancer
5026692|NCT01520441|BPH|bph
5026693|NCT01520441|LUTS|luts
5026694|NCT01520402|Genetic Determinants of Warfarin Dose Variability|genetic determinants of warfarin dose variability
5026695|NCT01520389|cancer|cancer
5026696|NCT01520389|solid tumors|solid tumors
5026697|NCT01520389|oncology|oncology
5026698|NCT01520389|Phase I|phase i
5026699|NCT01520389|EGFR|egfr
5026700|NCT01520389|EGF receptor (ErbB1)|egf receptor (erbb1)
5026701|NCT01520389|irinotecan|irinotecan
5026702|NCT01520363|Rett syndrome|rett syndrome
5026703|NCT01520363|RTT|rtt
5026704|NCT01520363|MECP2|mecp2
5026705|NCT01520363|dextromethorphan|dextromethorphan
5026706|NCT01520363|DM|dm
5026707|NCT01520311|Coronary Artery Disease|coronary artery disease
5026708|NCT01520311|Myocardial Ischemia|myocardial ischemia
5026709|NCT01520311|Coronary Disease|coronary disease
5026710|NCT01520311|Heart Diseases|heart diseases
5026711|NCT01520311|Cardiovascular Diseases|cardiovascular diseases
5026712|NCT01520311|Arteriosclerosis|arteriosclerosis
5026713|NCT01520311|Arterial Occlusive Diseases|arterial occlusive diseases
5026714|NCT01520311|Vascular Diseases|vascular diseases
5026715|NCT01520311|CABG|cabg
5026716|NCT01520311|SVG|svg
5026717|NCT01520311|eSVS Mesh|esvs mesh
5026718|NCT01520311|Bypass Grafting|bypass grafting
5026719|NCT01520285|hypertension|hypertension
5026720|NCT01520285|Blood pressure decrease|blood pressure decrease
5026721|NCT01520285|efficacy|efficacy
5026722|NCT01520272|HPV18 Immunogenicity|hpv18 immunogenicity
5026723|NCT01520272|HPV16 Immunogenicity|hpv16 immunogenicity
5026724|NCT01520272|Bivalent HPV16/18 Vaccine|bivalent hpv16/18 vaccine
5026725|NCT01520272|Less than 3 Dosed of the Bivalent HPV Vaccine|less than 3 dosed of the bivalent hpv vaccine
5026726|NCT01520272|HP Vaccine|hp vaccine
5026727|NCT01520259|Gallbaldder|gallbaldder
5026728|NCT01520259|Gallstones|gallstones
5026729|NCT01520259|Inflammation|inflammation
5026730|NCT01520259|Cholecystectomy|cholecystectomy
5026731|NCT01520259|Cancer|cancer
5026732|NCT01520259|Gallbaldder Cancer|gallbaldder cancer
5026733|NCT01520246|adult acute lymphoblastic leukemia|adult acute lymphoblastic leukemia
5026734|NCT01520246|childhood acute lymphoblastic leukemia|childhood acute lymphoblastic leukemia
5026735|NCT01520246|adult T-cell leukemia/lymphoma|adult t-cell leukemia/lymphoma
5026736|NCT01520233|disseminated neuroblastoma|disseminated neuroblastoma
5026737|NCT01520233|localized unresectable neuroblastoma|localized unresectable neuroblastoma
5026738|NCT01520233|recurrent neuroblastoma|recurrent neuroblastoma
5026739|NCT01520233|regional neuroblastoma|regional neuroblastoma
5026740|NCT01520233|stage 4S neuroblastoma|stage 4s neuroblastoma
5026741|NCT01520194|genital warts|genital warts
5026742|NCT01520194|HPV|hpv
5026743|NCT01520194|psychosocial burden|psychosocial burden
5026744|NCT01520194|economic burden|economic burden
5026745|NCT01520194|female genital warts|female genital warts
5026746|NCT01520168|Incisional hernia|incisional hernia
5026747|NCT01520168|Mesh|mesh
5026748|NCT01520168|Surgery|surgery
5026749|NCT01520168|Composix Kugel|composix kugel
5026750|NCT01520168|IPOM technique|ipom technique
5026751|NCT01520155|lupus erythematosus|lupus erythematosus
5026752|NCT01520155|cardiovascular risk|cardiovascular risk
5026753|NCT01520142|Healthy participants|healthy participants
5026754|NCT01520142|Pharmacodynamic|pharmacodynamic
5026755|NCT01520142|Pharmacokinetics|pharmacokinetics
5026756|NCT01520142|Intravenous Endotoxin-Induced Model|intravenous endotoxin-induced model
5026757|NCT01520142|Acute Inflammation|acute inflammation
5026758|NCT01520142|JNJ-26528398|jnj-26528398
5026759|NCT01520142|Anti-inflammatory|anti-inflammatory
5026760|NCT01520129|Bipolar Disorder|bipolar disorder
5026761|NCT01520129|Bipolar NOS|bipolar nos
5026762|NCT01520129|Bipolar Depression|bipolar depression
5026763|NCT01520103|Metastatic breast cancer|metastatic breast cancer
5026764|NCT01520103|locally advanced breast cancer|locally advanced breast cancer
5026765|NCT01520103|Her2/new negative|her2/new negative
5026766|NCT01520103|HER2 negative|her2 negative
5026767|NCT01520090|contraception|contraception
5026768|NCT01520090|family planning|family planning
5026769|NCT01520090|egyptian|egyptian
5026770|NCT01520090|knowledge|knowledge
5026771|NCT01520077|alopecia areata|alopecia areata
5026772|NCT01520077|vytorin|vytorin
5026773|NCT01520077|statin|statin
5026774|NCT01520077|hair growth|hair growth
5026775|NCT01520064|Emphysema|emphysema
5026776|NCT01520064|GOLD Stage III|gold stage iii
5026777|NCT01520064|GOLD Stage IV|gold stage iv
5026778|NCT01520064|AeriSeal System|aeriseal system
5026779|NCT01520064|Homogeneous|homogeneous
5026780|NCT01520064|Heterogeneous|heterogeneous
5026781|NCT01520064|Upper Lobe Predominant|upper lobe predominant
5026782|NCT01520064|ULP|ulp
5026783|NCT01520064|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5026784|NCT01520064|COPD|copd
5026785|NCT01520064|Lung Volume Reduction Surgery|lung volume reduction surgery
5026786|NCT01520064|LVRS|lvrs
5026787|NCT01520064|Bronchoscopic Lung Volume Reduction|bronchoscopic lung volume reduction
5026788|NCT01520064|BLVR|blvr
5026789|NCT01520051|Asthma|asthma
5026790|NCT01520051|Viral|viral
5026791|NCT01520051|Infection|infection
5026792|NCT01520051|Inflammation|inflammation
5026793|NCT01520051|Mepolizumab|mepolizumab
5026794|NCT01520051|Eosinophilia|eosinophilia
5026795|NCT01520025|Radiopharmaceutical|radiopharmaceutical
5026796|NCT01520025|18FDG PET|18fdg pet
5026797|NCT01520025|CTA|cta
5026798|NCT01520025|Multi-modality imaging|multi-modality imaging
5026799|NCT01520025|Metabolic Imaging of Ischemia|metabolic imaging of ischemia
5026800|NCT01520025|Myocardial blood flow|myocardial blood flow
5026801|NCT01520025|Myocardial blood flow reserve|myocardial blood flow reserve
5026802|NCT01519999|Shared decision making|shared decision making
5026803|NCT01519999|Ambulatory Care|ambulatory care
5026804|NCT01519999|Patient-Centered Care|patient-centered care
5026805|NCT01519999|Community-wide intervention|community-wide intervention
5026806|NCT01519999|Intervention Study|intervention study
5026807|NCT01519999|Longitudinal Studies|longitudinal studies
5026809|NCT01519986|Cholecalciferol|cholecalciferol
5026810|NCT01519986|Supplementation|supplementation
5026811|NCT01519986|Dietary Supplements|dietary supplements
5026812|NCT01519986|Dietary Fats|dietary fats
5026813|NCT01519986|25-hydroxyvitamin D|25-hydroxyvitamin d
5026814|NCT01519973|Diagnostic imaging|diagnostic imaging
5026815|NCT01519973|Single Photon Emission Computed Tomography|single photon emission computed tomography
5026816|NCT01519973|Positron emission tomography|positron emission tomography
5026817|NCT01519973|Computed tomography|computed tomography
5026818|NCT01519973|Attenuation|attenuation
5026819|NCT01519973|Resolution|resolution
5026820|NCT01519973|Scatter|scatter
5026821|NCT01519973|Radiopharmaceutical|radiopharmaceutical
5026822|NCT01519934|Ulthera® System|ulthera® system
5026823|NCT01519934|Ultherapy™ Treatment|ultherapy™ treatment
5026824|NCT01519934|Ulthera, Inc.|ulthera, inc.
5026825|NCT01519934|Ultrasound treatment for skin tightening|ultrasound treatment for skin tightening
5026826|NCT01519908|cardiac resynchronization therapy|cardiac resynchronization therapy
5026827|NCT01519908|biomarkers|biomarkers
5026828|NCT01519908|response|response
5026829|NCT01519895|quality of life|quality of life
5026830|NCT01519895|anxiety|anxiety
5026831|NCT01519895|stress|stress
5026832|NCT01519895|carers|carers
5026833|NCT01519895|colorectal or colon cancer|colorectal or colon cancer
5026834|NCT01519882|Rotigotine|rotigotine
5026835|NCT01519882|Neupro|neupro
5026836|NCT01519882|Polysomnography|polysomnography
5026837|NCT01519882|Sleep efficiency|sleep efficiency
5026838|NCT01519882|Advanced Idiopathic Parkinson's Disease|advanced idiopathic parkinson's disease
5026839|NCT01519882|Sleep Disorder|sleep disorder
5026840|NCT01519869|peritoneal|peritoneal
5026841|NCT01519869|carcinoma|carcinoma
5026842|NCT01519869|ovarian|ovarian
5026843|NCT01519869|fallopian tube|fallopian tube
5026844|NCT01519869|neoadjuvant chemotherapy|neoadjuvant chemotherapy
5026845|NCT01519869|surgical debulking|surgical debulking
5026846|NCT01519856|open|open
5026847|NCT01519856|non-intervention|non-intervention
5026848|NCT01519856|observational|observational
5026849|NCT01519843|stroke|stroke
5026850|NCT01519830|Anemia, Iron-Deficiency|anemia, iron-deficiency
5026851|NCT01519830|Blood Donors|blood donors
5026852|NCT01519817|Vaccine Therapy|vaccine therapy
5026853|NCT01519817|Dose-Limiting Toxicity|dose-limiting toxicity
5026854|NCT01519817|Maximum Tolerated Dose|maximum tolerated dose
5026855|NCT01519817|Clinical Response|clinical response
5026856|NCT01519817|Immune Response|immune response
5026857|NCT01519817|Cancer|cancer
5026858|NCT01519817|Solid Tumor|solid tumor
5026859|NCT01519791|Certolizumab Pegol - Cimzia|certolizumab pegol - cimzia
5026860|NCT01519791|Methotrexate|methotrexate
5026861|NCT01519791|Rheumatoid Arthritis|rheumatoid arthritis
5026862|NCT01519752|Tinea Pedis|tinea pedis
5026863|NCT01519713|Meningitis|meningitis
5026864|NCT01519713|Meningococcal Meningitis|meningococcal meningitis
5026865|NCT01519713|Meningococcal Infections|meningococcal infections
5026866|NCT01519713|Meningococcal conjugate Vaccine|meningococcal conjugate vaccine
5026867|NCT01519713|Menactra®|menactra®
5026868|NCT01519700|Filgrastim|filgrastim
5026869|NCT01519700|G-CSF, neutropenia|g-csf, neutropenia
5026870|NCT01519700|supportive care|supportive care
5026871|NCT01519700|breast cancer|breast cancer
5026872|NCT01519687|hyperuricemia|hyperuricemia
5026873|NCT01519687|gout|gout
5026874|NCT01519687|levotofisopam|levotofisopam
5026875|NCT01519661|Tobramycin Inhalation powder|tobramycin inhalation powder
5026876|NCT01519661|Cystic fibrosis|cystic fibrosis
5026877|NCT01519661|Lung disease|lung disease
5026878|NCT01519661|Anti-bacterial agents|anti-bacterial agents
5026879|NCT01519648|Invasive fungal infection|invasive fungal infection
5026880|NCT01519648|Acute leukemia (AL)|acute leukemia (al)
5026881|NCT01519648|Hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
5026882|NCT01519648|Antifungal stewardship|antifungal stewardship
5026883|NCT01519648|Neutropenia|neutropenia
5026884|NCT01519648|Hematological malignancies|hematological malignancies
5026885|NCT01519635|Kidney oxygenation|kidney oxygenation
5026886|NCT01519635|Stage 1 or 2 hypertension|stage 1 or 2 hypertension
5026887|NCT01519635|BOLD-IRM|bold-irm
5026888|NCT01519622|End of life decisions|end of life decisions
5026889|NCT01519622|Perception of illness|perception of illness
5026890|NCT01519609|Bowel prep|bowel prep
5026891|NCT01519609|Safety|safety
5026892|NCT01519609|Efficacy|efficacy
5026893|NCT01519583|walking|walking
5026894|NCT01519583|physical activity|physical activity
5026895|NCT01519583|sedentary behavior|sedentary behavior
5026896|NCT01519570|Herpes Zoster vaccine|herpes zoster vaccine
5026897|NCT01519570|Electronic patient portal|electronic patient portal
5026898|NCT01519570|Electronic medical record|electronic medical record
5026899|NCT01519570|Primary care|primary care
5026900|NCT01519570|Immunizations|immunizations
5026901|NCT01519544|Sleep|sleep
5026902|NCT01519544|High Altitude|high altitude
5026903|NCT01519544|High-altitude Sleep Disturbance|high-altitude sleep disturbance
5026904|NCT01519544|Acute Mountain Sickness|acute mountain sickness
5026905|NCT01519544|Difficulty Sleeping at High Altitude|difficulty sleeping at high altitude
5026906|NCT01519544|Periodic Breathing|periodic breathing
5026907|NCT01519544|Actigraphy|actigraphy
5026908|NCT01519544|Acetazolamide|acetazolamide
5026909|NCT01519544|Temazepam|temazepam
5026910|NCT01519544|Groningen Sleep Quality Questionnaire survey|groningen sleep quality questionnaire survey
5026911|NCT01519544|Stanford Sleepiness Scale|stanford sleepiness scale
5026912|NCT01519544|Lake Louise Acute Mountain Sickness Score|lake louise acute mountain sickness score
5026913|NCT01519518|ST elevation myocardial infarction|st elevation myocardial infarction
5026914|NCT01519518|Primary percutaneous coronary intervention|primary percutaneous coronary intervention
5026915|NCT01519518|Unfractionated heparin|unfractionated heparin
5026916|NCT01519518|Bivalirudin|bivalirudin
5026917|NCT01519518|primary angioplasty|primary angioplasty
5026918|NCT01519505|Prevention|prevention
5026919|NCT01519505|Diabetes mellitus|diabetes mellitus
5026920|NCT01519505|Lifestyle changes|lifestyle changes
5026921|NCT01519505|Cardiovascular risk|cardiovascular risk
5026922|NCT01519505|Cost-effectiveness|cost-effectiveness
5026923|NCT01519492|Skin and Subcutaneous Tissue Bacterial Infections|skin and subcutaneous tissue bacterial infections
5026924|NCT01519479|Congestive Heart Failure|congestive heart failure
5026925|NCT01519479|Heart Failure|heart failure
5026926|NCT01519479|Palliative Care|palliative care
5026927|NCT01519479|Palliative Medicine|palliative medicine
5026928|NCT01519466|Diabetes|diabetes
5026929|NCT01519466|SMBG|smbg
5026930|NCT01519466|Insulin calculator|insulin calculator
5026931|NCT01519453|Asthma|asthma
5026932|NCT01519453|Preschool|preschool
5026933|NCT01519453|Health Disparities|health disparities
5026934|NCT01519453|Implementation|implementation
5026935|NCT01519440|unintended extension|unintended extension
5026936|NCT01519440|blunt|blunt
5026937|NCT01519440|sharp|sharp
5026938|NCT01519440|maternal blood loss|maternal blood loss
5026939|NCT01519401|PCOS|pcos
5026940|NCT01519401|drospirenone ethinylestradiol|drospirenone ethinylestradiol
5026941|NCT01519401|androgens|androgens
5026942|NCT01519401|metabolism|metabolism
5026943|NCT01519388|Neuromuscular disorder|neuromuscular disorder
5026944|NCT01519388|Respiratory failure|respiratory failure
5026945|NCT01519388|Swallowing|swallowing
5026946|NCT01519388|Mechanical ventilation|mechanical ventilation
5026947|NCT01519375|Osteoarthritis|osteoarthritis
5026948|NCT01519375|Rheumatoid Arthritis|rheumatoid arthritis
5026949|NCT01519375|Ankylosing Spondylitis|ankylosing spondylitis
5026950|NCT01519362|Polyacrylamide hydrogel|polyacrylamide hydrogel
5026951|NCT01519362|leukocytopenia|leukocytopenia
5026952|NCT01519362|migration|migration
5026953|NCT01519362|complication|complication
5026954|NCT01519362|epicranial aponeurosis|epicranial aponeurosis
5026955|NCT01519362|PAAG injection|paag injection
5026956|NCT01519349|Becker muscular dystrophy|becker muscular dystrophy
5026957|NCT01519349|BMD|bmd
5026958|NCT01519349|muscular dystrophy|muscular dystrophy
5026959|NCT01519349|inclusion body myositis|inclusion body myositis
5026960|NCT01519349|IBM|ibm
5026961|NCT01519349|Follistatin|follistatin
5026962|NCT01519310|choline metabolism|choline metabolism
5026963|NCT01519310|gut flora|gut flora
5026964|NCT01519310|phosphatidylcholine|phosphatidylcholine
5026965|NCT01519310|lecithin|lecithin
5026966|NCT01519297|Preeclampsia|preeclampsia
5026967|NCT01519297|Pregnancy Induced Hypertension|pregnancy induced hypertension
5026968|NCT01519284|Parkinson Disease|parkinson disease
5026969|NCT01519284|BIA 9-1067|bia 9-1067
5026970|NCT01519271|Parkinson's Disease|parkinson's disease
5026971|NCT01519271|Mild Cognitive Impairment|mild cognitive impairment
5026972|NCT01519271|Cognition|cognition
5026973|NCT01519271|Memory|memory
5026974|NCT01519271|Attention|attention
5026975|NCT01519271|Exelon|exelon
5026976|NCT01519271|Rivastigmine|rivastigmine
5026977|NCT01519258|ARDS|ards
5026978|NCT01519245|coronary artery bypass grafting|coronary artery bypass grafting
5026979|NCT01519245|tranexamic acid|tranexamic acid
5026980|NCT01519245|antifibrinolytic|antifibrinolytic
5026981|NCT01519245|administration, topical|administration, topical
5026982|NCT01519245|operative blood salvage|operative blood salvage
5026983|NCT01519232|hepatocellular carcinoma|hepatocellular carcinoma
5026984|NCT01519219|hepatic irradiation|hepatic irradiation
5026985|NCT01519219|IC-GREEN|ic-green
5026986|NCT01519206|Ulthera® System|ulthera® system
5026987|NCT01519206|Ultherapy™ Treatment|ultherapy™ treatment
5026988|NCT01519206|Ulthera, Inc.|ulthera, inc.
5026989|NCT01519193|Aggressive Behavior|aggressive behavior
5026990|NCT01519193|Appetitive Aggression|appetitive aggression
5026991|NCT01519193|Post-Traumatic Stress Disorder|post-traumatic stress disorder
5026992|NCT01519180|gastroparesis|gastroparesis
5026993|NCT01519180|gastric emptying|gastric emptying
5026994|NCT01519180|antro-duodenal manometry|antro-duodenal manometry
5026995|NCT01519154|deep sedation|deep sedation
5026996|NCT01519154|propofol|propofol
5026997|NCT01519154|ketamine|ketamine
5026998|NCT01519154|child|child
5026999|NCT01519154|preschool child|preschool child
5027000|NCT01519154|infant|infant
5027001|NCT01519154|recovery and quality of sedation|recovery and quality of sedation
5027002|NCT01519141|Human Immunodeficiency Virus|human immunodeficiency virus
5027003|NCT01519141|Atherosclerosis|atherosclerosis
5027004|NCT01519141|Inflammation|inflammation
5027005|NCT01519141|Endothelial Function|endothelial function
5027006|NCT01519141|Thrombosis|thrombosis
5027007|NCT01519128|Healthy|healthy
5027008|NCT01519128|TMC278|tmc278
5027009|NCT01519128|TMC278IFD1001|tmc278ifd1001
5027010|NCT01519128|Human immunodeficiency virus - type 1|human immunodeficiency virus - type 1
5027011|NCT01519128|Pharmacokinetics|pharmacokinetics
5027012|NCT01519128|Digoxin|digoxin
5027013|NCT01519115|deep cervical flexors|deep cervical flexors
5027014|NCT01519115|spine stabilization|spine stabilization
5027015|NCT01519115|posture|posture
5027016|NCT01519115|function|function
5027017|NCT01519115|neck pain|neck pain
5027018|NCT01519089|chronic|chronic
5027019|NCT01519089|severe|severe
5027020|NCT01519089|moderate|moderate
5027021|NCT01519089|treatment|treatment
5027022|NCT01519089|safety|safety
5027023|NCT01519089|efficacy|efficacy
5027024|NCT01519089|CP-690|cp-690
5027025|NCT01519089|550|550
5027026|NCT01519089|Plaque psoriasis|plaque psoriasis
5027027|NCT01519089|Psoriasis Vulgaris|psoriasis vulgaris
5027028|NCT01519089|Psoriatic Arthritis|psoriatic arthritis
5027029|NCT01519089|tofacitinib|tofacitinib
5027030|NCT01519089|Xeljanz|xeljanz
5027031|NCT01519076|stroke|stroke
5027032|NCT01519063|Alcohol|alcohol
5027033|NCT01519063|Drinking|drinking
5027034|NCT01519063|Drinkers|drinkers
5027035|NCT01519063|Alcohol Drinking|alcohol drinking
5027036|NCT01519063|Memantine|memantine
5027037|NCT01519063|Naltrexone|naltrexone
5027038|NCT01519063|Alcohol Dependence|alcohol dependence
5027039|NCT01519063|Alcohol Abuse|alcohol abuse
5027040|NCT01519063|Alcohol-Related Disorders|alcohol-related disorders
5027041|NCT01519063|Ethanol|ethanol
5027042|NCT01519063|Alcoholism|alcoholism
5027043|NCT01519037|calcimimetic agent|calcimimetic agent
5027044|NCT01519037|RAAS|raas
5027045|NCT01519037|renin|renin
5027046|NCT01519037|aldosterone|aldosterone
5027047|NCT01519024|hypertrophy|hypertrophy
5027048|NCT01519024|breast|breast
5027049|NCT01519024|postural balance|postural balance
5027050|NCT01519011|Myelodysplastic Syndromes|myelodysplastic syndromes
5027051|NCT01519011|MDS|mds
5027052|NCT01519011|Chronic Myelomonocytic Leukemia|chronic myelomonocytic leukemia
5027053|NCT01519011|CMML|cmml
5027054|NCT01519011|Acute Myeloid Leukemia|acute myeloid leukemia
5027055|NCT01519011|AML|aml
5027056|NCT01519011|Vidaza|vidaza
5027057|NCT01519011|oral azacitidine|oral azacitidine
5027058|NCT01519011|aza|aza
5027059|NCT01519011|oral aza|oral aza
5027060|NCT01519011|pharmacokinetics|pharmacokinetics
5027061|NCT01519011|hematology|hematology
5027062|NCT01519011|myeloid disease|myeloid disease
5027063|NCT01519011|PK|pk
5027064|NCT01518998|Fimasartan|fimasartan
5027065|NCT01518998|Amlodipine|amlodipine
5027066|NCT01518998|antihypertension|antihypertension
5027067|NCT01518972|Alcohol|alcohol
5027068|NCT01518972|Abuse|abuse
5027069|NCT01518972|Use|use
5027070|NCT01518972|Disorder|disorder
5027071|NCT01518972|Dependence|dependence
5027072|NCT01518972|Symptoms|symptoms
5027073|NCT01518972|Alcoholic|alcoholic
5027074|NCT01518972|Alcoholism|alcoholism
5027075|NCT01518972|Prazosin|prazosin
5027076|NCT01518972|Drug|drug
5027077|NCT01518972|Medicine|medicine
5027078|NCT01518972|Medication|medication
5027079|NCT01518972|Treatment|treatment
5027080|NCT01518972|Study|study
5027081|NCT01518972|Placebo|placebo
5027082|NCT01518972|Medical|medical
5027083|NCT01518972|Management|management
5027084|NCT01518972|Craving|craving
5027085|NCT01518972|Consumption|consumption
5027086|NCT01518972|Binge|binge
5027087|NCT01518972|Drinking|drinking
5027088|NCT01518972|Drink|drink
5027089|NCT01518972|Heavy|heavy
5027090|NCT01518972|PTSD|ptsd
5027091|NCT01518972|Trauma|trauma
5027092|NCT01518972|Post|post
5027093|NCT01518972|Posttraumatic|posttraumatic
5027094|NCT01518946|Symptomatic Orthostatic Hypotension|symptomatic orthostatic hypotension
5027095|NCT01518933|HCV recurrence|hcv recurrence
5027096|NCT01518933|stable liver transplanted patients|stable liver transplanted patients
5027097|NCT01518920|Age related sensorineural hearing loss|age related sensorineural hearing loss
5027098|NCT01518920|PF-04958242|pf-04958242
5027099|NCT01518907|cellulite|cellulite
5027100|NCT01518907|Xiaflex|xiaflex
5027101|NCT01518894|PF-04958242|pf-04958242
5027102|NCT01518894|multiple dose|multiple dose
5027103|NCT01518894|Safety|safety
5027104|NCT01518894|schizophrenia|schizophrenia
5027105|NCT01518842|ischemic retinopathy, stem cell,bone marrow|ischemic retinopathy, stem cell,bone marrow
5027106|NCT01518829|hepatocellular carcinom|hepatocellular carcinom
5027107|NCT01518829|postablation syndrom|postablation syndrom
5027108|NCT01518829|procalcitonin|procalcitonin
5027109|NCT01518816|antioxidant preterm labor|antioxidant preterm labor
5027110|NCT01518803|Obesity|obesity
5027111|NCT01518803|Adolescence|adolescence
5027112|NCT01518803|Lipid metabolism|lipid metabolism
5027113|NCT01518803|Mediterranean diet|mediterranean diet
5027114|NCT01518803|Chylomicron|chylomicron
5027115|NCT01518803|Macrophages|macrophages
5027116|NCT01518790|PEG 3350|peg 3350
5027117|NCT01518790|boston bowel preparation scale|boston bowel preparation scale
5027118|NCT01518790|colonoscopy cleanout|colonoscopy cleanout
5027119|NCT01518790|bowel preparation|bowel preparation
5027120|NCT01518790|miralax|miralax
5027121|NCT01518790|gatorade|gatorade
5027122|NCT01518790|cleanout efficacy|cleanout efficacy
5027123|NCT01518790|Focus of study is efficacy of PEG 3350 cleanout for improving diagnostic yield of colonoscopy.|focus of study is efficacy of peg 3350 cleanout for improving diagnostic yield of colonoscopy.
5027124|NCT01518777|Coronary Artery Disease|coronary artery disease
5027125|NCT01518725|Muscle Power|muscle power
5027126|NCT01518725|Vitamin D|vitamin d
5027127|NCT01518725|Vitamins|vitamins
5027128|NCT01518725|Cholecalciferol|cholecalciferol
5027129|NCT01518712|Healthy Volunteers|healthy volunteers
5027130|NCT01518712|Bioequivalence|bioequivalence
5027131|NCT01518712|Canagliflozin (JNJ-28431754)|canagliflozin (jnj-28431754)
5027132|NCT01518712|Metformin IR|metformin ir
5027133|NCT01518686|Norm values|norm values
5027134|NCT01518686|semi-automated kinetic perimetry|semi-automated kinetic perimetry
5027135|NCT01518686|isopters|isopters
5027136|NCT01518686|mathematical model|mathematical model
5027137|NCT01518686|luminance|luminance
5027138|NCT01518686|test-retest reliability|test-retest reliability
5027139|NCT01518686|deviation|deviation
5027140|NCT01518686|age dependance|age dependance
5027141|NCT01518686|different age groups|different age groups
5027142|NCT01518686|Healthy subjects|healthy subjects
5027143|NCT01518660|Resistance Training|resistance training
5027144|NCT01518660|Strength Training|strength training
5027145|NCT01518647|Bodily Distress Syndrome|bodily distress syndrome
5027146|NCT01518647|Medically unexplained symptoms|medically unexplained symptoms
5027147|NCT01518647|Functional somatic symptoms|functional somatic symptoms
5027148|NCT01518647|Functional somatic syndromes|functional somatic syndromes
5027149|NCT01518647|Treatment|treatment
5027150|NCT01518647|Acceptance and Commitment Therapy|acceptance and commitment therapy
5027151|NCT01518634|Bodily Distress Syndrome|bodily distress syndrome
5027152|NCT01518634|Medically unexplained symptoms|medically unexplained symptoms
5027153|NCT01518634|Functional somatic symptoms|functional somatic symptoms
5027154|NCT01518634|Functional somatic syndromes|functional somatic syndromes
5027155|NCT01518634|Treatment|treatment
5027156|NCT01518634|Imipramine|imipramine
5027157|NCT01518634|Tricyclic antidepressant|tricyclic antidepressant
5027158|NCT01518608|Alfentanil|alfentanil
5027159|NCT01518608|Tracheal intubation|tracheal intubation
5027160|NCT01518608|Rapid sequence induction|rapid sequence induction
5027161|NCT01518595|patients|patients
5027162|NCT01518582|Cervicobrachial|cervicobrachial
5027163|NCT01518582|neuralgia|neuralgia
5027164|NCT01518582|symptomatic cervical discopathy|symptomatic cervical discopathy
5027165|NCT01518569|ulinastatin|ulinastatin
5027166|NCT01518569|systemic inflammation|systemic inflammation
5027167|NCT01518569|cardiac surgery|cardiac surgery
5027168|NCT01518569|cardiopulmonary bypass|cardiopulmonary bypass
5027169|NCT01518556|Idarubicin|idarubicin
5027170|NCT01518556|Remission Induction|remission induction
5027171|NCT01518556|Maximum Tolerated Dose|maximum tolerated dose
5027172|NCT01518556|Survival|survival
5027173|NCT01518543|arthrodesis|arthrodesis
5027174|NCT01518543|arthrodesis in the following joints:Ankle, 1st MTP, Metatarso - Cuneiform (1st), Navicular - Cuneiform, Talo-Navicular, Calcaneum - Cuboid;|arthrodesis in the following joints:ankle, 1st mtp, metatarso - cuneiform (1st), navicular - cuneiform, talo-navicular, calcaneum - cuboid;
5027175|NCT01518530|Chronic Neck Pain, Occiflex, Computerized Mobilization|chronic neck pain, occiflex, computerized mobilization
5027176|NCT01518517|acute lymphoblastic leukemia|acute lymphoblastic leukemia
5027177|NCT01518517|relapse|relapse
5027178|NCT01518517|asparaginase|asparaginase
5027179|NCT01518504|Thoracic|thoracic
5027180|NCT01518504|Manipulation|manipulation
5027181|NCT01518504|Manual Therapy|manual therapy
5027182|NCT01518504|Mobilization|mobilization
5027183|NCT01518504|Shoulder|shoulder
5027184|NCT01518504|Range of Motion|range of motion
5027185|NCT01518452|working memory training, computerized|working memory training, computerized
5027186|NCT01518452|clinical assessment|clinical assessment
5027187|NCT01518452|quantitative EEG|quantitative eeg
5027188|NCT01518452|child, preschool|child, preschool
5027189|NCT01518439|neuromuscular|neuromuscular
5027190|NCT01518439|cough|cough
5027191|NCT01518439|restrictive|restrictive
5027192|NCT01518426|Brain computer interface|brain computer interface
5027193|NCT01518426|EEG recording|eeg recording
5027194|NCT01518426|Electrodes|electrodes
5027195|NCT01518413|Sora./Irino. combination therapy|sora./irino. combination therapy
5027196|NCT01518400|Pediatric Cancer|pediatric cancer
5027197|NCT01518400|Cancer Late Effects|cancer late effects
5027198|NCT01518400|Cancer Survivor|cancer survivor
5027199|NCT01518400|Cancer Survivorship|cancer survivorship
5027200|NCT01518387|Hyperphosphatemia in ESRD (End Stage Renal Disease) patients on dialysis|hyperphosphatemia in esrd (end stage renal disease) patients on dialysis
5027201|NCT01518374|Male or female subjects at least 18 years of age|male or female subjects at least 18 years of age
5027202|NCT01518374|AD|ad
5027203|NCT01518374|MCI|mci
5027204|NCT01518348|Patch Test|patch test
5027205|NCT01518348|Contact Dermatitis|contact dermatitis
5027206|NCT01518348|Allergy|allergy
5027207|NCT01518348|Children|children
5027208|NCT01518348|PREA|prea
5027209|NCT01518335|platelet rich plasma|platelet rich plasma
5027210|NCT01518335|ankle|ankle
5027211|NCT01518335|sprain|sprain
5027212|NCT01518335|injection|injection
5027213|NCT01518335|Platelet Rich Plasma therapy|platelet rich plasma therapy
5027214|NCT01518335|focal, invasive therapy for sprains|focal, invasive therapy for sprains
5027215|NCT01518322|Asthma|asthma
5027216|NCT01518322|Fractional Exhaled Nitric Oxide|fractional exhaled nitric oxide
5027217|NCT01518322|Respiratory Symptoms|respiratory symptoms
5027218|NCT01518322|NIOX MINO|niox mino
5027219|NCT01518322|Inhaled corticosteroids|inhaled corticosteroids
5027220|NCT01518322|Nitric Oxide|nitric oxide
5027221|NCT01518296|Pelvic Organ Prolapse Quantification (POPQ)|pelvic organ prolapse quantification (popq)
5027222|NCT01518296|POPQ|popq
5027223|NCT01518296|Urodynamic test|urodynamic test
5027224|NCT01518283|Weekly cabazitaxel.|weekly cabazitaxel.
5027225|NCT01518283|Advanced Hormone-refractory prostate Cancer.|advanced hormone-refractory prostate cancer.
5027226|NCT01518283|Unfit patients.|unfit patients.
5027227|NCT01518244|Primary open angle-glaucoma|primary open angle-glaucoma
5027228|NCT01518244|Ocular hypertension|ocular hypertension
5027229|NCT01518244|Pigment dispersion glaucoma|pigment dispersion glaucoma
5027230|NCT01518231|stroke|stroke
5027231|NCT01518231|hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
5027232|NCT01518218|Sickle cell disease|sickle cell disease
5027233|NCT01518218|laying-on-of-hands|laying-on-of-hands
5027234|NCT01518218|morbidity|morbidity
5027235|NCT01518218|mortality|mortality
5027236|NCT01518205|diabetic foot ulcers,|diabetic foot ulcers,
5027237|NCT01518205|peripheral arterial disease,|peripheral arterial disease,
5027238|NCT01518205|heparin-induced extracorporal lipid apheresis.|heparin-induced extracorporal lipid apheresis.
5027239|NCT01518205|inflammatory markers|inflammatory markers
5027240|NCT01518205|type 2 diabetes|type 2 diabetes
5027241|NCT01518205|LDL-cholesterol|ldl-cholesterol
5027242|NCT01518192|erythema migrans|erythema migrans
5027243|NCT01518192|doxycycline|doxycycline
5027244|NCT01518192|cefuroxime axetil|cefuroxime axetil
5027245|NCT01518192|post-Lyme disease symptoms|post-lyme disease symptoms
5027246|NCT01518192|background symptoms in general population|background symptoms in general population
5027247|NCT01518179|Colles' Fracture|colles' fracture
5027248|NCT01518179|Compression Bandages|compression bandages
5027249|NCT01518179|Occupational therapy|occupational therapy
5027250|NCT01518179|Rehabilitation|rehabilitation
5027251|NCT01518179|Smith's fracture|smith's fracture
5027252|NCT01518153|Blood and Marrow Transplantation|blood and marrow transplantation
5027253|NCT01518153|Lymphoma|lymphoma
5027254|NCT01518153|Myeloma|myeloma
5027255|NCT01518153|Myeloproliferative Diseases|myeloproliferative diseases
5027256|NCT01518153|Leukemia|leukemia
5027257|NCT01518153|Myelodysplastic syndrome|myelodysplastic syndrome
5027258|NCT01518153|MDS|mds
5027259|NCT01518153|Hodgkin disease|hodgkin disease
5027260|NCT01518153|Multiple myeloma|multiple myeloma
5027261|NCT01518153|Fludarabine|fludarabine
5027262|NCT01518153|Fludarabine Phosphate|fludarabine phosphate
5027263|NCT01518153|Fludara|fludara
5027264|NCT01518153|Melphalan|melphalan
5027265|NCT01518153|Alkeran|alkeran
5027266|NCT01518153|Tacrolimus|tacrolimus
5027267|NCT01518153|Prograf|prograf
5027268|NCT01518153|Methotrexate|methotrexate
5027269|NCT01518153|G-CSF|g-csf
5027270|NCT01518153|Filgrastim|filgrastim
5027271|NCT01518153|NeupogenTM|neupogentm
5027272|NCT01518153|Donor Lymphocyte Infusion|donor lymphocyte infusion
5027273|NCT01518153|DLI|dli
5027274|NCT01518153|Allogeneic Stem Cell Transplantation|allogeneic stem cell transplantation
5027275|NCT01518153|Graft-vs-host disease|graft-vs-host disease
5027276|NCT01518153|GvHD|gvhd
5027277|NCT01518153|T-lymphocytes|t-lymphocytes
5027278|NCT01518153|T-cells|t-cells
5027279|NCT01518153|Alemtuzumab|alemtuzumab
5027280|NCT01518153|CAMPATH-1H|campath-1h
5027281|NCT01518153|Campath|campath
5027282|NCT01518140|Advanced Cancers|advanced cancers
5027283|NCT01518140|Locally advanced|locally advanced
5027284|NCT01518140|Recurrent|recurrent
5027285|NCT01518140|Metastatic disease|metastatic disease
5027286|NCT01518140|Oxygen Delivery Modalities|oxygen delivery modalities
5027287|NCT01518140|Shortness of breath|shortness of breath
5027288|NCT01518140|Dyspnea|dyspnea
5027289|NCT01518140|VapoTherm|vapotherm
5027290|NCT01518140|Bilevel positive airway pressure|bilevel positive airway pressure
5027291|NCT01518140|BiPAP|bipap
5027292|NCT01518140|Non-rebreather mask|non-rebreather mask
5027293|NCT01518127|Macular Degeneration|macular degeneration
5027294|NCT01518114|Hypertrophic Cardiomyopathy|hypertrophic cardiomyopathy
5027295|NCT01518114|Exercise Training|exercise training
5027296|NCT01518114|Cardiac Rehabilitation|cardiac rehabilitation
5027297|NCT01518114|Heart Failure|heart failure
5027298|NCT01518101|patient preference|patient preference
5027299|NCT01518101|vildagliptin|vildagliptin
5027300|NCT01518101|liraglutide|liraglutide
5027301|NCT01518075|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5027302|NCT01518075|Non invasive mechanical ventilation|non invasive mechanical ventilation
5027303|NCT01518075|Breathing-swallowing interaction|breathing-swallowing interaction
5027304|NCT01518075|Intensive Care Unit|intensive care unit
5027305|NCT01518049|Affective Disorders, Psychotic|affective disorders, psychotic
5027306|NCT01518049|Psychometrics|psychometrics
5027307|NCT01518049|Biological Markers|biological markers
5027308|NCT01518023|diabetes mellitus|diabetes mellitus
5027309|NCT01518023|prediabetes|prediabetes
5027310|NCT01518023|fasting blood glucose|fasting blood glucose
5027311|NCT01518023|HbA1c|hba1c
5027312|NCT01518023|Roux en Y gastric bypass|roux en y gastric bypass
5027313|NCT01518023|Cancer gastrectomy|cancer gastrectomy
5027314|NCT01518023|Cancer colorectal surgery|cancer colorectal surgery
5027315|NCT01518010|Brain injury|brain injury
5027316|NCT01518010|Cognitive rehabilitation|cognitive rehabilitation
5027317|NCT01518010|Video game|video game
5027318|NCT01517997|Drug coated balloons|drug coated balloons
5027319|NCT01517997|Drug eluting stents|drug eluting stents
5027320|NCT01517984|recipients of living-donor kidney allografts|recipients of living-donor kidney allografts
5027321|NCT01517984|antithymocyte globulin (ATG) induction|antithymocyte globulin (atg) induction
5027322|NCT01517984|calcineurin inhibitors (CNIs)|calcineurin inhibitors (cnis)
5027323|NCT01517984|CNI withdrawal|cni withdrawal
5027324|NCT01517971|stage IA non-small cell lung cancer|stage ia non-small cell lung cancer
5027325|NCT01517971|stage IB non-small cell lung cancer|stage ib non-small cell lung cancer
5027425|NCT01517529|Hepatitis C|hepatitis c
5027326|NCT01517971|adenocarcinoma of the lung|adenocarcinoma of the lung
5027327|NCT01517971|squamous cell lung cancer|squamous cell lung cancer
5027328|NCT01517958|Transient tachypnea of the newborn|transient tachypnea of the newborn
5027329|NCT01517958|Respiratory Distress Syndrome|respiratory distress syndrome
5027330|NCT01517958|Lung Ultrasound|lung ultrasound
5027331|NCT01517958|Neonates|neonates
5027332|NCT01517945|Survivors|survivors
5027333|NCT01517945|Quality of Life|quality of life
5027334|NCT01517945|Questionnaire|questionnaire
5027335|NCT01517945|11-204|11-204
5027336|NCT01517919|peer support|peer support
5027337|NCT01517919|peer leader|peer leader
5027338|NCT01517919|community health worker|community health worker
5027339|NCT01517919|empowerment|empowerment
5027340|NCT01517919|self-management|self-management
5027341|NCT01517906|eating disorder behaviors|eating disorder behaviors
5027342|NCT01517906|well being|well being
5027343|NCT01517906|functional health|functional health
5027344|NCT01517893|vitiligo|vitiligo
5027345|NCT01517893|simvastatin|simvastatin
5027346|NCT01517880|Hereditary Inclusion Body Myopathy (HIBM)|hereditary inclusion body myopathy (hibm)
5027347|NCT01517880|GNE myopathies|gne myopathies
5027348|NCT01517880|distal myopathy with rimmed vacuoles [DMRV]|distal myopathy with rimmed vacuoles [dmrv]
5027349|NCT01517880|Nonaka disease|nonaka disease
5027350|NCT01517867|preschool children behavior problems|preschool children behavior problems
5027351|NCT01517867|child between 2 and 5 years old|child between 2 and 5 years old
5027352|NCT01517841|peritoneal dialysis|peritoneal dialysis
5027353|NCT01517841|modality choice|modality choice
5027354|NCT01517841|kidney disease|kidney disease
5027355|NCT01517828|Intubation|intubation
5027356|NCT01517828|Delivery room|delivery room
5027357|NCT01517828|Sedation|sedation
5027358|NCT01517828|Analgesia|analgesia
5027359|NCT01517815|Septic shock|septic shock
5027360|NCT01517815|overweight|overweight
5027361|NCT01517815|critically ill|critically ill
5027362|NCT01517815|pharmacokinetic|pharmacokinetic
5027363|NCT01517815|doripenem|doripenem
5027364|NCT01517815|piperacillin-tazobactam|piperacillin-tazobactam
5027365|NCT01517802|Metastatic castration-resistant prostate cancer|metastatic castration-resistant prostate cancer
5027366|NCT01517802|Metastatic breast cancer|metastatic breast cancer
5027367|NCT01517802|Abiraterone acetate|abiraterone acetate
5027368|NCT01517802|Low-dose corticosteroid treatment|low-dose corticosteroid treatment
5027369|NCT01517802|Long-term access|long-term access
5027370|NCT01517789|Surgery|surgery
5027371|NCT01517789|Optic Nerve and Pathway Injury|optic nerve and pathway injury
5027372|NCT01517789|visual event-related potential|visual event-related potential
5027373|NCT01517776|High grade glioma|high grade glioma
5027374|NCT01517776|Glioblastoma multiforme|glioblastoma multiforme
5027375|NCT01517776|Anaplastic astrocytoma|anaplastic astrocytoma
5027376|NCT01517776|Diffuse intrinsic pontine glioma|diffuse intrinsic pontine glioma
5027377|NCT01517776|Relapse|relapse
5027378|NCT01517776|refractory tumour disease|refractory tumour disease
5027379|NCT01517776|Relapsed or refractory high grade gliomas and diffuse intrinsic pontine gliomas|relapsed or refractory high grade gliomas and diffuse intrinsic pontine gliomas
5027380|NCT01517763|Obstructive Sleep Apnea|obstructive sleep apnea
5027381|NCT01517763|Humidification|humidification
5027382|NCT01517763|Continuous Positive Airway Pressure|continuous positive airway pressure
5027383|NCT01517763|ICON|icon
5027384|NCT01517763|ThermoSmart|thermosmart
5027385|NCT01517763|SensAwake|sensawake
5027386|NCT01517750|Obstructive Sleep Apnea|obstructive sleep apnea
5027387|NCT01517750|Humidification|humidification
5027388|NCT01517750|Continuous Positive Airway Pressure|continuous positive airway pressure
5027389|NCT01517750|ICON|icon
5027390|NCT01517750|ThermoSmart|thermosmart
5027392|NCT01517724|HDT|hdt
5027393|NCT01517724|ASCT|asct
5027394|NCT01517724|consolidation|consolidation
5027395|NCT01517724|bortezomib|bortezomib
5027396|NCT01517711|pharmacotherapy|pharmacotherapy
5027397|NCT01517711|combat disorders|combat disorders
5027398|NCT01517685|Eicosapentaenoic acid|eicosapentaenoic acid
5027399|NCT01517685|EPA|epa
5027400|NCT01517685|Docosahexaenoic acid|docosahexaenoic acid
5027401|NCT01517685|DHA|dha
5027402|NCT01517685|Omega 3 fat|omega 3 fat
5027403|NCT01517685|alpha-linoleic acid|alpha-linoleic acid
5027404|NCT01517685|ALA|ala
5027405|NCT01517685|fish oil|fish oil
5027406|NCT01517685|flax seed oil|flax seed oil
5027407|NCT01517672|PTSD|ptsd
5027408|NCT01517672|domestic violence|domestic violence
5027409|NCT01517672|intimate partner violence|intimate partner violence
5027410|NCT01517672|functional MRI|functional mri
5027411|NCT01517672|neuroimaging|neuroimaging
5027412|NCT01517659|Lipolysis|lipolysis
5027413|NCT01517659|Cryolipolysis|cryolipolysis
5027414|NCT01517659|Fat Reduction|fat reduction
5027415|NCT01517646|Lipolysis|lipolysis
5027416|NCT01517646|Cryolipolysis|cryolipolysis
5027417|NCT01517646|Fat Reduction|fat reduction
5027418|NCT01517633|Amniotic fluid leakage|amniotic fluid leakage
5027419|NCT01517633|Urinary incontinence|urinary incontinence
5027420|NCT01517581|Brown adipose tissue|brown adipose tissue
5027421|NCT01517542|diet|diet
5027422|NCT01517542|DASH|dash
5027423|NCT01517542|Stroke|stroke
5027424|NCT01517542|Nutritional counseling|nutritional counseling
5027426|NCT01517529|HCV|hcv
5027427|NCT01517516|fMRI|fmri
5027428|NCT01517516|resting state|resting state
5027429|NCT01517516|structural MRI|structural mri
5027430|NCT01517516|functional MRI|functional mri
5027431|NCT01517477|Open angle|open angle
5027432|NCT01517477|Glaucoma|glaucoma
5027433|NCT01517477|surgery|surgery
5027434|NCT01517477|Glaucoma, Open-Angle|glaucoma, open-angle
5027435|NCT01517477|Ocular Hypertension|ocular hypertension
5027436|NCT01517477|Eye Diseases|eye diseases
5027437|NCT01517464|neoplasm|neoplasm
5027438|NCT01517464|bladder cancer|bladder cancer
5027439|NCT01517464|advances solid tumors|advances solid tumors
5027440|NCT01517438|agitation, desflurane, children|agitation, desflurane, children
5027441|NCT01517399|Oncology|oncology
5027442|NCT01517399|pharmacokinetics|pharmacokinetics
5027443|NCT01517399|PK interaction in advanced solid tumors with our drug and other drugs|pk interaction in advanced solid tumors with our drug and other drugs
5027444|NCT01517386|paravertebral space|paravertebral space
5027445|NCT01517386|needle placement|needle placement
5027446|NCT01517386|tissue identification|tissue identification
5027447|NCT01517386|regional|regional
5027448|NCT01517373|T2DM|t2dm
5027449|NCT01517373|PF-04937319|pf-04937319
5027450|NCT01517373|Phase 2|phase 2
5027451|NCT01517360|Schizophrenia|schizophrenia
5027452|NCT01517360|Social Cognition|social cognition
5027453|NCT01517360|Oxytocin|oxytocin
5027454|NCT01517347|IL2|il2
5027455|NCT01517347|relapse|relapse
5027456|NCT01517347|GVHD|gvhd
5027457|NCT01517347|survival|survival
5027458|NCT01517347|allogeneic stem cell transplantation|allogeneic stem cell transplantation
5027459|NCT01517347|MRD|mrd
5027460|NCT01517347|CR|cr
5027461|NCT01517308|HCV|hcv
5027462|NCT01517308|Hepatitis|hepatitis
5027463|NCT01517308|Genotype 2 or 3|genotype 2 or 3
5027464|NCT01517308|Pegylated Interferon|pegylated interferon
5027465|NCT01517308|Duration|duration
5027466|NCT01517295|Pharmacokinetics|pharmacokinetics
5027467|NCT01517295|Hydromorphone|hydromorphone
5027468|NCT01517295|Hydrocodone|hydrocodone
5027469|NCT01517295|APAP|apap
5027470|NCT01517269|Parent education|parent education
5027471|NCT01517256|Chronic pain|chronic pain
5027472|NCT01517256|Primary care|primary care
5027473|NCT01517256|Multidisciplinary group therapy|multidisciplinary group therapy
5027474|NCT01517256|Embedded mixed-methods study|embedded mixed-methods study
5027475|NCT01517243|Metastatic Renal Cell Carcinoma|metastatic renal cell carcinoma
5027476|NCT01517243|sunitinib|sunitinib
5027477|NCT01517243|alternating|alternating
5027478|NCT01517243|temsirolimus|temsirolimus
5027479|NCT01517230|Cluster-randomised trial|cluster-randomised trial
5027480|NCT01517230|Comprehensive mass media campaign|comprehensive mass media campaign
5027481|NCT01517230|Rural community radio|rural community radio
5027482|NCT01517230|Under-five child mortality|under-five child mortality
5027483|NCT01517230|Preventive and curative behaviours|preventive and curative behaviours
5027484|NCT01517230|Burkina Faso|burkina faso
5027485|NCT01517230|Health care seeking behavior|health care seeking behavior
5027486|NCT01517230|Childbirth|childbirth
5027487|NCT01517217|girdle|girdle
5027488|NCT01517217|laparotomy|laparotomy
5027489|NCT01517217|pulmonary function|pulmonary function
5027490|NCT01517217|postoperative pain|postoperative pain
5027491|NCT01517217|mobilisation|mobilisation
5027492|NCT01517204|Trachway(R) intubating stylet|trachway(r) intubating stylet
5027493|NCT01517204|Left sided double lumen endobronchial tube|left sided double lumen endobronchial tube
5027494|NCT01517204|Efficacy|efficacy
5027495|NCT01517204|Intubation complication|intubation complication
5027496|NCT01517191|Influenza|influenza
5027497|NCT01517191|Respiratory Infection|respiratory infection
5027498|NCT01517165|Opioid Dependence|opioid dependence
5027499|NCT01517165|Pioglitazone|pioglitazone
5027500|NCT01517165|Buprenorphine|buprenorphine
5027501|NCT01517152|Symptoms|symptoms
5027502|NCT01517152|Patient-Reported Outcomes|patient-reported outcomes
5027503|NCT01517152|Linguistic Validation|linguistic validation
5027504|NCT01517152|Toxicity|toxicity
5027505|NCT01517152|PRO-CTCAE|pro-ctcae
5027506|NCT01517152|Adverse Events|adverse events
5027507|NCT01517152|Translation|translation
5027508|NCT01517152|Questionnaire|questionnaire
5027509|NCT01517139|Diet and Nutrition|diet and nutrition
5027510|NCT01517139|Pregnancy Folic Acid|pregnancy folic acid
5027511|NCT01517139|In Utero Exposure|in utero exposure
5027512|NCT01517139|DNA Methylation|dna methylation
5027513|NCT01517139|Physical Activity|physical activity
5027514|NCT01517126|Youth Suicide|youth suicide
5027515|NCT01517126|Suicide Screening|suicide screening
5027516|NCT01517126|Developmental Delay|developmental delay
5027517|NCT01517126|Intellectual Disability|intellectual disability
5027518|NCT01517126|Assessment Instrument|assessment instrument
5027519|NCT01517126|Mental Retardation|mental retardation
5027520|NCT01517126|Suicidal Thoughts|suicidal thoughts
5027521|NCT01517126|Suicidal Behavior|suicidal behavior
5027522|NCT01517113|Endothelial Dysfunction|endothelial dysfunction
5027523|NCT01517113|Hepatic|hepatic
5027524|NCT01517113|Adiposity|adiposity
5027525|NCT01517113|Cytokines|cytokines
5027526|NCT01517113|Muscle Mass|muscle mass
5027527|NCT01517113|Coronary Artery Disease|coronary artery disease
5027528|NCT01517113|Aging|aging
5027529|NCT01517113|Inflammation|inflammation
5027530|NCT01517100|Glucose|glucose
5027531|NCT01517100|Insulin Secretion|insulin secretion
5027532|NCT01517100|Insulin Action|insulin action
5027533|NCT01517100|Endocannabinoids|endocannabinoids
5027534|NCT01517100|Insulin|insulin
5027535|NCT01517100|Metabolism|metabolism
5027536|NCT01517087|Motor Function|motor function
5027537|NCT01517087|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
5027538|NCT01517087|Transcranial Magnetic Stimulation (TMS)|transcranial magnetic stimulation (tms)
5027539|NCT01517087|Diffusion Tensor Imaging|diffusion tensor imaging
5027540|NCT01517087|Functional Magnetic Resonance Imaging (fMRI)|functional magnetic resonance imaging (fmri)
5027541|NCT01517087|Healthy Volunteer|healthy volunteer
5027542|NCT01517087|HV|hv
5027543|NCT01517074|Sirolimus|sirolimus
5027544|NCT01517074|Scleritis|scleritis
5027545|NCT01517074|Autoimmune Scleritis|autoimmune scleritis
5027546|NCT01517061|Phantom Limb Pain|phantom limb pain
5027547|NCT01517061|Genetic Polymorphisms|genetic polymorphisms
5027548|NCT01517061|Genetic Susceptibility|genetic susceptibility
5027549|NCT01517061|Amputation|amputation
5027550|NCT01517048|Body Composition|body composition
5027551|NCT01517048|Obesity|obesity
5027552|NCT01517048|Overweight|overweight
5027553|NCT01517048|Energy Homeostasis|energy homeostasis
5027554|NCT01517048|Nociception|nociception
5027555|NCT01517048|Prader-Willi Syndrome|prader-willi syndrome
5027556|NCT01517048|Genetic Disorder|genetic disorder
5027557|NCT01517048|Healthy Volunteer|healthy volunteer
5027558|NCT01517048|HV|hv
5027680|NCT01516528|emphysema|emphysema
5027559|NCT01517035|Peripheral Blood Stem Cell Transplantation|peripheral blood stem cell transplantation
5027560|NCT01517035|Stem Cell Transplant|stem cell transplant
5027561|NCT01517035|Transplant|transplant
5027562|NCT01517035|Myelodyplastic Syndrome|myelodyplastic syndrome
5027563|NCT01517035|MDS|mds
5027564|NCT01517035|Leukemia|leukemia
5027565|NCT01517022|smoking cessation|smoking cessation
5027566|NCT01517022|early sputum smear conversion|early sputum smear conversion
5027567|NCT01517009|Neo-adjuvant chemotherapy|neo-adjuvant chemotherapy
5027568|NCT01517009|D1extra-resection|d1extra-resection
5027569|NCT01516996|Neoadjuvant|neoadjuvant
5027570|NCT01516996|Concurrent Chemoradiotherapy,CCRT|concurrent chemoradiotherapy,ccrt
5027571|NCT01516996|Nimotuzumab|nimotuzumab
5027572|NCT01516996|Locoregionally Advanced Oropharynx|locoregionally advanced oropharynx
5027573|NCT01516996|Hypopharynx cancer|hypopharynx cancer
5027574|NCT01516996|Randomized|randomized
5027575|NCT01516996|Multicenter|multicenter
5027576|NCT01516983|Safety|safety
5027577|NCT01516983|EGFR-TKI|egfr-tki
5027578|NCT01516983|NSCLC|nsclc
5027579|NCT01516983|Icotinib|icotinib
5027580|NCT01516983|WBRT|wbrt
5027581|NCT01516970|Human Immunodeficiency Virus (HIV) Post exposure prophylaxis|human immunodeficiency virus (hiv) post exposure prophylaxis
5027582|NCT01516970|DRV/r|drv/r
5027583|NCT01516970|Occupational injury|occupational injury
5027584|NCT01516970|Non-occupational exposure|non-occupational exposure
5027585|NCT01516970|Prezista|prezista
5027586|NCT01516970|Darunavir/r|darunavir/r
5027587|NCT01516957|Psoriatic Arthritis|psoriatic arthritis
5027588|NCT01516957|IL-17|il-17
5027589|NCT01516957|AMG 827|amg 827
5027590|NCT01516957|AMG827|amg827
5027591|NCT01516957|Musculoskeletal Disease|musculoskeletal disease
5027592|NCT01516957|Spondylarthropathy|spondylarthropathy
5027593|NCT01516944|Tegafur，Gimeracil and Oteracil Potassium Capsules|tegafur，gimeracil and oteracil potassium capsules
5027594|NCT01516944|Capecitabine|capecitabine
5027595|NCT01516944|Oxaliplatin|oxaliplatin
5027596|NCT01516944|perioperative Chemotherapy|perioperative chemotherapy
5027597|NCT01516944|Gastric Cancer|gastric cancer
5027598|NCT01516931|repetitive Transcranial Magnetic Stimulation (rTMS)|repetitive transcranial magnetic stimulation (rtms)
5027599|NCT01516931|Depression|depression
5027600|NCT01516931|Venlafaxine|venlafaxine
5027601|NCT01516931|Relapse|relapse
5027602|NCT01516879|Cholesterol|cholesterol
5027603|NCT01516879|High Cholesterol|high cholesterol
5027604|NCT01516879|Elevated Cholesterol|elevated cholesterol
5027605|NCT01516879|Raised Cholesterol|raised cholesterol
5027606|NCT01516866|Androgen receptor-directed therapy|androgen receptor-directed therapy
5027607|NCT01516866|NaF PET/CT|naf pet/ct
5027608|NCT01516866|antimicrotubule directed chemotherapy|antimicrotubule directed chemotherapy
5027609|NCT01516840|acute symptomatic deep vein thrombosis|acute symptomatic deep vein thrombosis
5027610|NCT01516827|PTSD|ptsd
5027611|NCT01516827|Children and Adolescents|children and adolescents
5027612|NCT01516827|Post-Traumatic Stress Disorder in Children and Adolescents|post-traumatic stress disorder in children and adolescents
5027613|NCT01516814|acute symptomatic pulmonary embolism|acute symptomatic pulmonary embolism
5027614|NCT01516801|Prostate Cancer Screening|prostate cancer screening
5027615|NCT01516801|Pragmatic Trial|pragmatic trial
5027616|NCT01516801|Health Literacy|health literacy
5027617|NCT01516775|preoperative care|preoperative care
5027618|NCT01516775|preoperative period|preoperative period
5027619|NCT01516775|fasting|fasting
5027620|NCT01516762|Radium 223|radium 223
5027621|NCT01516762|Alpharadin|alpharadin
5027622|NCT01516762|Prostate Cancer|prostate cancer
5027623|NCT01516762|Bone metastases|bone metastases
5027624|NCT01516762|Castrate resistant prostate cancer|castrate resistant prostate cancer
5027625|NCT01516762|Hormone refractory prostate cancer|hormone refractory prostate cancer
5027626|NCT01516749|hidradenitis suppurativa|hidradenitis suppurativa
5027627|NCT01516749|anakinra|anakinra
5027628|NCT01516736|Pegfilgrastim|pegfilgrastim
5027629|NCT01516736|G-CSF|g-csf
5027630|NCT01516736|neutropenia|neutropenia
5027631|NCT01516736|breast cancer|breast cancer
5027632|NCT01516736|myelosuppressive chemotherapy|myelosuppressive chemotherapy
5027633|NCT01516723|drug-eluting stent|drug-eluting stent
5027634|NCT01516723|chronic total occlusion|chronic total occlusion
5027635|NCT01516723|hybrid sirolimus-eluting stent|hybrid sirolimus-eluting stent
5027636|NCT01516723|everolimus-eluting stent|everolimus-eluting stent
5027637|NCT01516710|Open liver resection|open liver resection
5027638|NCT01516710|Laparoscopic liver resection|laparoscopic liver resection
5027639|NCT01516710|Colorectal cancer liver metastases|colorectal cancer liver metastases
5027640|NCT01516697|thoracic electric bioimpedance|thoracic electric bioimpedance
5027641|NCT01516697|cardiac output monitoring|cardiac output monitoring
5027642|NCT01516697|cesarean section|cesarean section
5027643|NCT01516697|spinal anesthesia|spinal anesthesia
5027644|NCT01516671|Subarachnoid hemorrhage|subarachnoid hemorrhage
5027645|NCT01516671|Cerebral vasospasm|cerebral vasospasm
5027646|NCT01516671|Neuroinflammation|neuroinflammation
5027647|NCT01516671|Bilateral Bispectral Index|bilateral bispectral index
5027648|NCT01516658|intracranial aneurysm|intracranial aneurysm
5027649|NCT01516658|endovascular therapy|endovascular therapy
5027650|NCT01516658|detachable coil|detachable coil
5027651|NCT01516658|recanalization|recanalization
5027652|NCT01516645|Squamous cell type tumor|squamous cell type tumor
5027653|NCT01516632|Cellular Phone|cellular phone
5027654|NCT01516632|Mobile Phone|mobile phone
5027655|NCT01516632|Cognitive Behavior Therapy|cognitive behavior therapy
5027656|NCT01516632|Technology|technology
5027657|NCT01516632|Smoking cessation|smoking cessation
5027658|NCT01516632|young adults|young adults
5027659|NCT01516619|NHL|nhl
5027660|NCT01516619|chemotherapy-induced grade-4 thrombocytopenia|chemotherapy-induced grade-4 thrombocytopenia
5027661|NCT01516606|MALT|malt
5027662|NCT01516606|refractory|refractory
5027663|NCT01516606|relapsed|relapsed
5027664|NCT01516606|extranodal|extranodal
5027665|NCT01516606|relapsed or refractory extranodal marginal zone lymphoma|relapsed or refractory extranodal marginal zone lymphoma
5027666|NCT01516593|HIV|hiv
5027667|NCT01516593|Burkitt's lymphoma|burkitt's lymphoma
5027668|NCT01516593|intensive|intensive
5027669|NCT01516593|short term|short term
5027670|NCT01516593|immuno-chemotherapy|immuno-chemotherapy
5027671|NCT01516593|HIV-positive patients with Burkitt's lymphoma|hiv-positive patients with burkitt's lymphoma
5027672|NCT01516554|Multiple Sclerosis|multiple sclerosis
5027673|NCT01516554|Fatigue|fatigue
5027674|NCT01516528|COPD|copd
5027675|NCT01516528|exacerbation|exacerbation
5027676|NCT01516528|comorbidities|comorbidities
5027677|NCT01516528|lung function|lung function
5027678|NCT01516528|burden|burden
5027679|NCT01516528|chronic bronchitis|chronic bronchitis
5027681|NCT01516528|prevalence|prevalence
5027682|NCT01516528|cardiovascular disease|cardiovascular disease
5027683|NCT01516515|Actinic Keratosis|actinic keratosis
5027685|NCT01516502|laser therapy|laser therapy
5027686|NCT01516502|myofascial pain syndrome|myofascial pain syndrome
5027687|NCT01516502|acupoint|acupoint
5027688|NCT01516502|trigger point|trigger point
5027689|NCT01516502|range of motion|range of motion
5027690|NCT01516489|screening|screening
5027691|NCT01516489|colon cancer|colon cancer
5027692|NCT01516489|incentives|incentives
5027693|NCT01516489|behavioral economics|behavioral economics
5027694|NCT01516463|burn|burn
5027695|NCT01516463|partial thickness burn|partial thickness burn
5027696|NCT01516463|second degree burn|second degree burn
5027697|NCT01516463|minor burn|minor burn
5027698|NCT01516463|scar|scar
5027699|NCT01516463|Santyl|santyl
5027700|NCT01516463|Bacitracin|bacitracin
5027701|NCT01516463|outpatient burn center|outpatient burn center
5027702|NCT01516463|scar appearance|scar appearance
5027703|NCT01516463|Kansas City|kansas city
5027704|NCT01516463|University of Kansas Medical Center|university of kansas medical center
5027705|NCT01516463|KUMC|kumc
5027706|NCT01516450|GSK1550188, belimumab, SLE, healthy, Japanese, pharmacokinetics, safety|gsk1550188, belimumab, sle, healthy, japanese, pharmacokinetics, safety
5027707|NCT01516437|Chronic Obstructive Pulmonary disease (COPD)|chronic obstructive pulmonary disease (copd)
5027708|NCT01516424|Blonanserin|blonanserin
5027709|NCT01516411|Health Promotion|health promotion
5027710|NCT01516411|Physical Activity|physical activity
5027711|NCT01516411|Sedentary Time|sedentary time
5027712|NCT01516411|Smartphones|smartphones
5027713|NCT01516385|spinal cord injury|spinal cord injury
5027714|NCT01516385|biomarkers|biomarkers
5027715|NCT01516385|rehabilitation|rehabilitation
5027716|NCT01516385|functional independence|functional independence
5027717|NCT01516385|prognosis|prognosis
5027718|NCT01516372|GEn, moxifloxacin, cardiac repolarisation, QT/QTc|gen, moxifloxacin, cardiac repolarisation, qt/qtc
5027719|NCT01516346|Heart Failure|heart failure
5027819|NCT01515930|Care|care
5027720|NCT01516346|Heart failure with preserved ejection fraction (HFpEF)|heart failure with preserved ejection fraction (hfpef)
5027721|NCT01516346|Vasodilators|vasodilators
5027722|NCT01516346|Isosorbide dinitrate|isosorbide dinitrate
5027723|NCT01516346|Hydralazine|hydralazine
5027724|NCT01516346|wave reflections|wave reflections
5027725|NCT01516346|arterial stiffness|arterial stiffness
5027726|NCT01516346|hemodynamics|hemodynamics
5027727|NCT01516333|glycemic Index|glycemic index
5027728|NCT01516320|Type 2 Diabetes|type 2 diabetes
5027729|NCT01516320|Gastric Bypass|gastric bypass
5027730|NCT01516320|Laparoscopic Banding|laparoscopic banding
5027731|NCT01516320|Vertical Sleeve Gastrectomy|vertical sleeve gastrectomy
5027732|NCT01516294|AMD|amd
5027733|NCT01516294|PCV|pcv
5027734|NCT01516294|Iray|iray
5027735|NCT01516294|radiation|radiation
5027736|NCT01516294|retina|retina
5027737|NCT01516294|macula|macula
5027738|NCT01516294|radiotherapy|radiotherapy
5027739|NCT01516281|TBI|tbi
5027740|NCT01516281|PD|pd
5027741|NCT01516268|Cesarean Delivery|cesarean delivery
5027742|NCT01516268|TAP block|tap block
5027743|NCT01516268|sufentanyl|sufentanyl
5027744|NCT01516268|Narcotic dosages|narcotic dosages
5027745|NCT01516216|previously untreated|previously untreated
5027746|NCT01516203|AZD5847,dose-ranging,Mycobacterium tuberculosis,Rifafour,tuberculosis|azd5847,dose-ranging,mycobacterium tuberculosis,rifafour,tuberculosis
5027747|NCT01516190|stage I-III breast cancer|stage i-iii breast cancer
5027748|NCT01516177|Kidney Transplantation|kidney transplantation
5027749|NCT01516177|kidney transplant|kidney transplant
5027750|NCT01516177|renal transplant|renal transplant
5027751|NCT01516177|immunosuppression|immunosuppression
5027752|NCT01516164|Laryngoscopy|laryngoscopy
5027753|NCT01516164|Videolaryngoscopy|videolaryngoscopy
5027754|NCT01516164|Ease of Intubation|ease of intubation
5027755|NCT01516151|Hypertriglyceridemia|hypertriglyceridemia
5027756|NCT01516138|Glucose-insulin-potassium|glucose-insulin-potassium
5027757|NCT01516138|Cardiac surgery|cardiac surgery
5027758|NCT01516125|healthy adult|healthy adult
5027759|NCT01516125|genetic variation|genetic variation
5027760|NCT01516125|botanical oils|botanical oils
5027761|NCT01516125|polyunsaturated fatty acid|polyunsaturated fatty acid
5027762|NCT01516125|fish oil|fish oil
5027763|NCT01516125|fat metabolism|fat metabolism
5027764|NCT01516125|Genetic variation of fat metabolism in healthy adults|genetic variation of fat metabolism in healthy adults
5027765|NCT01516112|ICD, home monitoring, cardiomessenger, implant|icd, home monitoring, cardiomessenger, implant
5027766|NCT01516099|Physical activity counselor|physical activity counselor
5027767|NCT01516099|Active and healthy lifestyle|active and healthy lifestyle
5027768|NCT01516099|General Practitioner|general practitioner
5027769|NCT01516099|Social-cultural Organization|social-cultural organization
5027770|NCT01516086|Controlled|controlled
5027771|NCT01516086|uncontrolled|uncontrolled
5027772|NCT01516073|partially controlled|partially controlled
5027773|NCT01516073|uncontrolled|uncontrolled
5027774|NCT01516047|Hepatic impairment|hepatic impairment
5027775|NCT01516047|Pharmacology|pharmacology
5027776|NCT01516047|Pharmacokinetics|pharmacokinetics
5027777|NCT01516047|Pharmacodynamics|pharmacodynamics
5027778|NCT01516047|Abiraterone acetate suspension|abiraterone acetate suspension
5027779|NCT01516047|JNJ-212082|jnj-212082
5027780|NCT01516034|Tattoo removal|tattoo removal
5027781|NCT01516034|ultrasound|ultrasound
5027782|NCT01516021|Fat ingestion|fat ingestion
5027783|NCT01516021|hypothalamus|hypothalamus
5027784|NCT01516021|insula|insula
5027785|NCT01516021|fMRI|fmri
5027786|NCT01516021|CBF|cbf
5027787|NCT01516008|Hallux Valgus|hallux valgus
5027788|NCT01516008|Bunionectomy|bunionectomy
5027789|NCT01516008|Bunion|bunion
5027790|NCT01516008|Acute pain|acute pain
5027791|NCT01516008|Tapentadol|tapentadol
5027792|NCT01516008|Tapentadol IR|tapentadol ir
5027793|NCT01515995|Magnesium sulfate|magnesium sulfate
5027794|NCT01515995|Childhood asthma|childhood asthma
5027795|NCT01515995|Emergency department|emergency department
5027796|NCT01515982|Alzheimer's disease|alzheimer's disease
5027797|NCT01515982|Aerobic exercise|aerobic exercise
5027798|NCT01515982|Physical training|physical training
5027799|NCT01515982|Cognitive function|cognitive function
5027800|NCT01515982|Functional capacity.|functional capacity.
5027801|NCT01515956|Mucopolysaccharidosis IVA type A|mucopolysaccharidosis iva type a
5027802|NCT01515956|MPS IVA Type A|mps iva type a
5027803|NCT01515956|Mucopolysaccharidosis IVA|mucopolysaccharidosis iva
5027804|NCT01515956|MPS IVA|mps iva
5027805|NCT01515956|Morquio A Syndrome|morquio a syndrome
5027806|NCT01515956|Lysosomal Storage Disorder|lysosomal storage disorder
5027808|NCT01515956|N-acetylgalactosamine-6-sulfatase|n-acetylgalactosamine-6-sulfatase
5027809|NCT01515956|N-acetylgalactosamine-6-sulfate|n-acetylgalactosamine-6-sulfate
5027810|NCT01515956|sulfatase|sulfatase
5027811|NCT01515956|galactose-6-sulfatase|galactose-6-sulfatase
5027812|NCT01515956|GALNS|galns
5027813|NCT01515956|enzyme replacement therapy|enzyme replacement therapy
5027814|NCT01515956|ERT|ert
5027815|NCT01515943|Convergence insufficiency|convergence insufficiency
5027816|NCT01515930|Parenting|parenting
5027817|NCT01515930|Parental Monitoring|parental monitoring
5027818|NCT01515930|Diabetes|diabetes
5027820|NCT01515917|Veterans|veterans
5027821|NCT01515917|Traumatic Brain Injury|traumatic brain injury
5027822|NCT01515917|TBI|tbi
5027823|NCT01515917|Substance Abuse|substance abuse
5027824|NCT01515917|Substance Dependence|substance dependence
5027825|NCT01515917|Veterans with traumatic brain injury (TBI)|veterans with traumatic brain injury (tbi)
5027826|NCT01515917|Veterans with substance abuse or dependence|veterans with substance abuse or dependence
5027827|NCT01515904|obesity management|obesity management
5027828|NCT01515904|adolescents|adolescents
5027829|NCT01515904|body mass index|body mass index
5027830|NCT01515904|treatment outcomes|treatment outcomes
5027831|NCT01515904|program evaluation|program evaluation
5027832|NCT01515891|Parkinson Disease|parkinson disease
5027833|NCT01515891|BIA 9-1067|bia 9-1067
5027834|NCT01515852|stress level|stress level
5027835|NCT01515852|stereotactic biopsy|stereotactic biopsy
5027836|NCT01515852|brain lesion|brain lesion
5027837|NCT01515852|general anesthesia|general anesthesia
5027838|NCT01515852|local anesthesia|local anesthesia
5027839|NCT01515839|SPECT|spect
5027840|NCT01515839|Imaging|imaging
5027841|NCT01515839|Football|football
5027842|NCT01515839|Traumatic brain injury|traumatic brain injury
5027843|NCT01515839|Regional cerebral blood flow|regional cerebral blood flow
5027844|NCT01515826|Cataract surgery|cataract surgery
5027845|NCT01515826|Topical therapy|topical therapy
5027846|NCT01515826|Prevention of inflammation|prevention of inflammation
5027847|NCT01515826|Inflammation of infection|inflammation of infection
5027848|NCT01515800|estrogen receptor-positive breast cancer|estrogen receptor-positive breast cancer
5027849|NCT01515800|progesterone receptor-positive breast cancer|progesterone receptor-positive breast cancer
5027850|NCT01515800|stage IA breast cancer|stage ia breast cancer
5027851|NCT01515800|stage IB breast cancer|stage ib breast cancer
5027852|NCT01515800|stage II breast cancer|stage ii breast cancer
5027853|NCT01515800|stage IIIA breast cancer|stage iiia breast cancer
5027854|NCT01515787|stage IIA rectal cancer|stage iia rectal cancer
5027855|NCT01515787|stage IIIA rectal cancer|stage iiia rectal cancer
5027856|NCT01515787|stage IIIB rectal cancer|stage iiib rectal cancer
5027857|NCT01515774|Parkinson's disease|parkinson's disease
5027858|NCT01515774|Pramipexole|pramipexole
5027859|NCT01515722|Medication Persistence|medication persistence
5027860|NCT01515722|Compliance|compliance
5027861|NCT01515722|Health Education Intervention (HEI)|health education intervention (hei)
5027862|NCT01515709|Cohort Studies|cohort studies
5027863|NCT01515709|Longitudinal Studies|longitudinal studies
5027864|NCT01515696|VLBW infant|vlbw infant
5027865|NCT01515696|Meconium|meconium
5027866|NCT01515696|Enteral nutrition|enteral nutrition
5027867|NCT01515696|Meconium passage|meconium passage
5027868|NCT01515683|Nervousness before anesthesia|nervousness before anesthesia
5027869|NCT01515670|THA|tha
5027870|NCT01515670|TKA|tka
5027871|NCT01515670|Fast-track|fast-track
5027872|NCT01515670|Enhanced recovery|enhanced recovery
5027873|NCT01515670|preoperative co-morbidity|preoperative co-morbidity
5027874|NCT01515670|postoperative morbidity|postoperative morbidity
5027875|NCT01515670|Arthroplasty|arthroplasty
5027876|NCT01515670|Replacement|replacement
5027877|NCT01515670|Hip|hip
5027878|NCT01515670|Knee|knee
5027879|NCT01515670|Morbidity|morbidity
5027880|NCT01515644|Healthy infants|healthy infants
5027881|NCT01515644|Infant formula|infant formula
5027882|NCT01515644|Prebiotics|prebiotics
5027883|NCT01515566|Advanced Cancer|advanced cancer
5027884|NCT01515566|Dyspnea|dyspnea
5027885|NCT01515566|Exercise-induced breakthrough dyspnea|exercise-induced breakthrough dyspnea
5027886|NCT01515566|Shortness of breath|shortness of breath
5027887|NCT01515566|Fentanyl|fentanyl
5027888|NCT01515566|Sublimaze|sublimaze
5027889|NCT01515566|Placebo|placebo
5027890|NCT01515566|Normal saline|normal saline
5027891|NCT01515566|NS|ns
5027892|NCT01515566|Questionnaires|questionnaires
5027893|NCT01515566|Surveys|surveys
5027894|NCT01515566|Walk test|walk test
5027895|NCT01515540|chronic back pain|chronic back pain
5027896|NCT01515540|placebo|placebo
5027897|NCT01515540|fmri|fmri
5027898|NCT01515540|brain imaging|brain imaging
5027899|NCT01515527|Leukemia|leukemia
5027900|NCT01515527|Acute myeloid leukemia|acute myeloid leukemia
5027901|NCT01515527|AML|aml
5027902|NCT01515527|myelodysplastic syndrome|myelodysplastic syndrome
5027903|NCT01515527|MDS|mds
5027904|NCT01515527|Cytarabine|cytarabine
5027905|NCT01515527|Ara-C|ara-c
5027906|NCT01515527|Cytosar|cytosar
5027907|NCT01515527|DepoCyt|depocyt
5027908|NCT01515527|Cytosine Arabinosine Hydrochloride|cytosine arabinosine hydrochloride
5027909|NCT01515527|Decitabine|decitabine
5027910|NCT01515527|Dacogen|dacogen
5027911|NCT01515527|Cladribine|cladribine
5027912|NCT01515527|Leustatin|leustatin
5027913|NCT01515527|2-CdA|2-cda
5027914|NCT01515514|polyps|polyps
5027915|NCT01515514|inflammatory bowel disease|inflammatory bowel disease
5027916|NCT01515514|associated neoplasia|associated neoplasia
5027917|NCT01515501|Constipation|constipation
5027918|NCT01515501|Hirschsprung Disease|hirschsprung disease
5027919|NCT01515488|Triage|triage
5027920|NCT01515488|Automated|automated
5027921|NCT01515488|Admitting|admitting
5027922|NCT01515488|Pediatric ED|pediatric ed
5027923|NCT01515475|Hyperopia|hyperopia
5027924|NCT01515475|Glasses|glasses
5027925|NCT01515462|Lentiviral vector|lentiviral vector
5027926|NCT01515462|Gene therapy|gene therapy
5027927|NCT01515462|Wiskott-Aldrich Syndrome|wiskott-aldrich syndrome
5027928|NCT01515436|Rolandic Epilepsy|rolandic epilepsy
5027929|NCT01515436|Benign Childhood Epilepsy with Centrotemporal Spikes (BCECTS)|benign childhood epilepsy with centrotemporal spikes (bcects)
5027930|NCT01515436|Epilepsy|epilepsy
5027931|NCT01515436|Seizures|seizures
5027932|NCT01515436|Music|music
5027933|NCT01515436|Mozart|mozart
5027934|NCT01515436|Beethoven|beethoven
5027935|NCT01515423|Schizophrenia|schizophrenia
5027936|NCT01515423|R092670|r092670
5027937|NCT01515423|Paliperidone Palmitate|paliperidone palmitate
5027938|NCT01515423|Paliperidone palmitate 1 month formulation (PP1M)|paliperidone palmitate 1 month formulation (pp1m)
5027939|NCT01515423|Paliperidone palmitate 3 month formulation (PP3M)|paliperidone palmitate 3 month formulation (pp3m)
5027940|NCT01515410|Parkinson's disease|parkinson's disease
5027941|NCT01515410|PD|pd
5027942|NCT01515410|stage2/3Parkinson's|stage2/3parkinson's
5027943|NCT01515410|Advanced Parkinson's Disease with Motor Fluctuations|advanced parkinson's disease with motor fluctuations
5027944|NCT01515345|clopidogrel-nonresponder|clopidogrel-nonresponder
5027945|NCT01515345|stent thrombosis|stent thrombosis
5027946|NCT01515319|Obesity|obesity
5027947|NCT01515319|Peptide YY|peptide yy
5027948|NCT01515319|Food intake|food intake
5027949|NCT01515319|Safety|safety
5027950|NCT01515319|Pharmacokinetics|pharmacokinetics
5027951|NCT01515306|Advanced Malignant Solid Tumors|advanced malignant solid tumors
5027952|NCT01515280|chronic cough|chronic cough
5027953|NCT01515267|EF|ef
5027954|NCT01515267|EDV|edv
5027955|NCT01515267|ESV|esv
5027956|NCT01515267|Biplane|biplane
5027957|NCT01515267|Echocardiography|echocardiography
5027958|NCT01515254|Children|children
5027959|NCT01515254|Obesity Prevention|obesity prevention
5027960|NCT01515254|Child Overweight|child overweight
5027961|NCT01515254|Eating Behavior|eating behavior
5027962|NCT01515254|Energy Compensation|energy compensation
5027963|NCT01515254|Food Intake|food intake
5027964|NCT01515254|Parenting Behavior|parenting behavior
5027965|NCT01515241|Heterozygous Familial Hypercholesterolemia|heterozygous familial hypercholesterolemia
5027966|NCT01515241|Familial Hypercholesterolemia|familial hypercholesterolemia
5027967|NCT01515241|HDL mimetic|hdl mimetic
5027968|NCT01515241|ApoA-1|apoa-1
5027969|NCT01515228|requiring drug eluting stents|requiring drug eluting stents
5027970|NCT01515215|Major Depression Disorder|major depression disorder
5027971|NCT01515215|Treatment Resistance|treatment resistance
5027972|NCT01515215|repetitive Transcranial Magnetic Stimulation|repetitive transcranial magnetic stimulation
5027973|NCT01515150|diverticulitis|diverticulitis
5027974|NCT01515150|Out-patient management|out-patient management
5027975|NCT01515150|Antibiotics|antibiotics
5027976|NCT01515137|Head and Neck|head and neck
5027977|NCT01515137|Locally Advanced Head and Neck Squamous Cell Carcinoma|locally advanced head and neck squamous cell carcinoma
5027978|NCT01515124|Lymphedema|lymphedema
5027979|NCT01515124|Strength training intervention|strength training intervention
5027980|NCT01515124|Weight loss intervention|weight loss intervention
5027981|NCT01515124|Breast cancer recurrence|breast cancer recurrence
5027982|NCT01515124|Cost Effectiveness|cost effectiveness
5027983|NCT01515111|Non-communicable diseases|non-communicable diseases
5027984|NCT01515111|Preventive services|preventive services
5027985|NCT01515111|Medical education|medical education
5027986|NCT01515111|Guatemala|guatemala
5027987|NCT01515072|Remote Ischemic Preconditioning|remote ischemic preconditioning
5027988|NCT01515072|Brain death organ donors|brain death organ donors
5027989|NCT01515072|Delayed graft function|delayed graft function
5027990|NCT01515072|Donor management|donor management
5027991|NCT01515072|Pulsatile perfusion|pulsatile perfusion
5027992|NCT01515059|obesity|obesity
5027993|NCT01515059|diabetes|diabetes
5027994|NCT01515059|bariatric surgery|bariatric surgery
5027995|NCT01515059|gastric bypass|gastric bypass
5027996|NCT01515059|insulin|insulin
5027997|NCT01515059|glucose|glucose
5027998|NCT01515059|incretins|incretins
5027999|NCT01515059|leptin|leptin
5028000|NCT01515059|ghrelin|ghrelin
5028001|NCT01515046|Vitamins|vitamins
5028002|NCT01515046|Complementary medicine|complementary medicine
5028003|NCT01515046|Pancreatic cancer|pancreatic cancer
5028004|NCT01515046|Ascorbate|ascorbate
5028005|NCT01515046|Ascorbic Acid|ascorbic acid
5028006|NCT01515046|Antioxidants|antioxidants
5028007|NCT01515046|Gemcitabine|gemcitabine
5028008|NCT01515046|Pharmacologic actions|pharmacologic actions
5028009|NCT01515033|Coronary artery disease|coronary artery disease
5028010|NCT01515033|Exercise|exercise
5028011|NCT01515033|Ventilatory efficiency|ventilatory efficiency
5028012|NCT01515020|bacteremia|bacteremia
5028013|NCT01515020|meticillin-resistant Staphylococcus aureus|meticillin-resistant staphylococcus aureus
5028014|NCT01515020|nosocomial infection|nosocomial infection
5028015|NCT01515020|healthcare-associated infection|healthcare-associated infection
5028016|NCT01515020|rapid molecular diagnostic test|rapid molecular diagnostic test
5028017|NCT01515007|Bronchiectasis, non-CF, Ciprofloxacin, Liposome|bronchiectasis, non-cf, ciprofloxacin, liposome
5028018|NCT01514981|Asthma|asthma
5028019|NCT01514942|PCOS|pcos
5028020|NCT01514942|Insulin resistance|insulin resistance
5028021|NCT01514942|Myo-inositol|myo-inositol
5028022|NCT01514942|D-chiro-inositol|d-chiro-inositol
5028023|NCT01514929|Thorough QT|thorough qt
5028024|NCT01514903|anti erectile dysfunction agent|anti erectile dysfunction agent
5028025|NCT01514877|tumors metastatic to brain|tumors metastatic to brain
5028026|NCT01514877|non-small cell lung cancer|non-small cell lung cancer
5028027|NCT01514877|Icotinib|icotinib
5028028|NCT01514851|Hyperphosphatemia in ESRD (End Stage Renal Disease) patients on dialysis|hyperphosphatemia in esrd (end stage renal disease) patients on dialysis
5028029|NCT01514838|ASP1941|asp1941
5028030|NCT01514838|ipragliflozin|ipragliflozin
5028031|NCT01514838|plasma glucose|plasma glucose
5028032|NCT01514838|urine glucose|urine glucose
5028033|NCT01514825|YM150|ym150
5028034|NCT01514825|Plasma concentration|plasma concentration
5028035|NCT01514825|darexaban|darexaban
5028036|NCT01514825|Healthy elderly subject|healthy elderly subject
5028037|NCT01514825|Pharmacokinetics of YM150|pharmacokinetics of ym150
5028038|NCT01514812|YM150|ym150
5028039|NCT01514812|digoxin|digoxin
5028040|NCT01514812|drug-drug interaction|drug-drug interaction
5028041|NCT01514812|Plasma concentration|plasma concentration
5028042|NCT01514812|darexaban|darexaban
5028043|NCT01514812|Pharmacokinetics of digoxin|pharmacokinetics of digoxin
5028044|NCT01514799|gastric bypass|gastric bypass
5028045|NCT01514799|morbid obesity|morbid obesity
5028046|NCT01514799|gut function|gut function
5028047|NCT01514799|weight loss|weight loss
5028048|NCT01514786|Colorectal Cancer|colorectal cancer
5028049|NCT01514786|Screening|screening
5028050|NCT01514786|Prevention|prevention
5028051|NCT01514773|left ventricular systolic dysfunction|left ventricular systolic dysfunction
5028052|NCT01514773|implantable cardioverter defibrillator|implantable cardioverter defibrillator
5028053|NCT01514773|systolic heart failure|systolic heart failure
5028054|NCT01514773|congestive heart failure|congestive heart failure
5028055|NCT01514773|Ischemic cardiomyopathy|ischemic cardiomyopathy
5028056|NCT01514773|Nonischemic cardiomyopathy|nonischemic cardiomyopathy
5028057|NCT01514773|ICD|icd
5028058|NCT01514773|ICD utilization|icd utilization
5028059|NCT01514773|ICD implantation|icd implantation
5028060|NCT01514773|defibrillator|defibrillator
5028061|NCT01514773|defibrillator therapy|defibrillator therapy
5028062|NCT01514773|sudden cardiac death|sudden cardiac death
5028063|NCT01514760|Adolescents|adolescents
5028064|NCT01514760|Mobile based applications|mobile based applications
5028065|NCT01514760|Asthma action plan|asthma action plan
5028066|NCT01514760|Self Efficacy|self efficacy
5028067|NCT01514734|Primary open-angle glaucoma|primary open-angle glaucoma
5028068|NCT01514734|Ocular hypertension|ocular hypertension
5028069|NCT01514734|Pigment dispersion glaucoma|pigment dispersion glaucoma
5028070|NCT01514721|Open-angle glaucoma|open-angle glaucoma
5028071|NCT01514721|Ocular hypertension|ocular hypertension
5028072|NCT01514721|Pigment dispersion glaucoma|pigment dispersion glaucoma
5028073|NCT01514708|Influenza|influenza
5028074|NCT01514708|Vaccination|vaccination
5028075|NCT01514708|Vaccine|vaccine
5028076|NCT01514708|Pregnancy|pregnancy
5028077|NCT01514695|endoscopy|endoscopy
5028078|NCT01514695|sedation|sedation
5028079|NCT01514695|opioid|opioid
5028080|NCT01514695|narcotic|narcotic
5028081|NCT01514682|schizophrenia|schizophrenia
5028082|NCT01514682|anti-inflammatory|anti-inflammatory
5028083|NCT01514682|salsalate|salsalate
5028084|NCT01514682|statins|statins
5028085|NCT01514682|omega-3-fatty acids|omega-3-fatty acids
5028086|NCT01514643|tibial plateau fracture|tibial plateau fracture
5028087|NCT01514643|tibial plafond fracture|tibial plafond fracture
5028088|NCT01514643|inflammatory cytokine profile|inflammatory cytokine profile
5028089|NCT01514643|synovial fluid|synovial fluid
5028090|NCT01514643|blood serum|blood serum
5028091|NCT01514643|Post-traumatic osteoarthritis (PTOA)|post-traumatic osteoarthritis (ptoa)
5028092|NCT01514617|Leiomyoma|leiomyoma
5028093|NCT01514617|Diffusion weighted MRI|diffusion weighted mri
5028094|NCT01514617|Perfusion MRI|perfusion mri
5028095|NCT01514617|Uterine artery embolization|uterine artery embolization
5028096|NCT01514617|Volumetric Response|volumetric response
5028097|NCT01514617|Women with symptomatic leiomyomas|women with symptomatic leiomyomas
5028098|NCT01514604|Anesthesia and analgesia|anesthesia and analgesia
5028099|NCT01514604|ultrasonography|ultrasonography
5028100|NCT01514604|education|education
5028101|NCT01514578|safety|safety
5028102|NCT01514578|tolerability|tolerability
5028103|NCT01514578|TRV130A|trv130a
5028104|NCT01514565|Triple negative Breast Cancer|triple negative breast cancer
5028105|NCT01514565|RB|rb
5028106|NCT01514565|PTEN|pten
5028107|NCT01514565|Chemotherapy|chemotherapy
5028108|NCT01514565|Neoadjuvant|neoadjuvant
5028109|NCT01514552|Functional food|functional food
5028110|NCT01514552|Strawberries|strawberries
5028111|NCT01514552|Gummies|gummies
5028112|NCT01514552|Smoker|smoker
5028113|NCT01514552|Nonsmoker|nonsmoker
5028114|NCT01514539|Human milk, Ghrelin,PYY and maternal obesity.|human milk, ghrelin,pyy and maternal obesity.
5028115|NCT01514526|Adrenocortical carcinoma|adrenocortical carcinoma
5028221|NCT01514006|functional outcomes|functional outcomes
5028116|NCT01514461|Hyperlipoproteinemia (HLP Type I)|hyperlipoproteinemia (hlp type i)
5028117|NCT01514461|Fasting Triglycerides|fasting triglycerides
5028118|NCT01514448|Kidney cancer|kidney cancer
5028119|NCT01514448|mRCC|mrcc
5028120|NCT01514448|metastic renal cell carcinoma|metastic renal cell carcinoma
5028121|NCT01514448|everolimus|everolimus
5028122|NCT01514448|sunitinib|sunitinib
5028123|NCT01514448|pazopanib|pazopanib
5028124|NCT01514435|depression|depression
5028125|NCT01514435|FDG-PET|fdg-pet
5028126|NCT01514435|Electroconvulsive therapy|electroconvulsive therapy
5028127|NCT01514435|glucose metabolism|glucose metabolism
5028128|NCT01514422|Bipolar disorder|bipolar disorder
5028129|NCT01514422|depression|depression
5028130|NCT01514422|minocycline|minocycline
5028131|NCT01514422|mood disorders|mood disorders
5028132|NCT01514422|bipolar depression|bipolar depression
5028133|NCT01514409|5-hydroxytryptophan|5-hydroxytryptophan
5028134|NCT01514409|Mood|mood
5028135|NCT01514409|Emotional Processing|emotional processing
5028136|NCT01514409|Emotional Cognition|emotional cognition
5028137|NCT01514409|Nutritional Supplement|nutritional supplement
5028138|NCT01514409|Low mood|low mood
5028139|NCT01514396|Pediatric|pediatric
5028140|NCT01514396|Wounds|wounds
5028141|NCT01514383|wounds|wounds
5028142|NCT01514370|Multiple Sclerosis|multiple sclerosis
5028143|NCT01514370|Relapsing|relapsing
5028144|NCT01514370|Interferon beta 1a|interferon beta 1a
5028145|NCT01514370|Curcumin|curcumin
5028146|NCT01514344|OAL|oal
5028147|NCT01514344|MALT|malt
5028148|NCT01514344|conjunctiva|conjunctiva
5028149|NCT01514344|indolent|indolent
5028150|NCT01514344|CD20+|cd20+
5028151|NCT01514331|Ventilator Induced Lung Injury|ventilator induced lung injury
5028152|NCT01514331|Neonatal respiratory distress|neonatal respiratory distress
5028153|NCT01514331|Mechanical ventilation|mechanical ventilation
5028154|NCT01514279|Overweight|overweight
5028155|NCT01514279|Obese|obese
5028156|NCT01514279|Over Nutrition|over nutrition
5028157|NCT01514279|Nutrition Disorders|nutrition disorders
5028158|NCT01514279|Body weight|body weight
5028159|NCT01514279|Signs and Symptoms|signs and symptoms
5028160|NCT01514266|proven diagnosis|proven diagnosis
5028161|NCT01514266|COPD|copd
5028162|NCT01514266|sputum|sputum
5028163|NCT01514253|glucose|glucose
5028164|NCT01514253|analgesic|analgesic
5028165|NCT01514253|newborns|newborns
5028166|NCT01514240|mild to moderate active Crohn's disease|mild to moderate active crohn's disease
5028167|NCT01514240|affecting ileum|affecting ileum
5028168|NCT01514240|ileocecal region|ileocecal region
5028169|NCT01514240|ascending colon|ascending colon
5028170|NCT01514240|score of 180-400 on the CDAI|score of 180-400 on the cdai
5028171|NCT01514214|ERCP|ercp
5028172|NCT01514214|biliary stricture|biliary stricture
5028173|NCT01514214|viaduct|viaduct
5028174|NCT01514214|cancer|cancer
5028175|NCT01514188|sarcoma|sarcoma
5028176|NCT01514188|soft-tissue sarcoma|soft-tissue sarcoma
5028177|NCT01514188|Metastatic,locally advanced, or unresectable soft tissue sarcoma|metastatic,locally advanced, or unresectable soft tissue sarcoma
5028178|NCT01514175|Ketorolac|ketorolac
5028179|NCT01514175|Caldolor|caldolor
5028180|NCT01514175|Chronic Pelvic Pain|chronic pelvic pain
5028181|NCT01514162|Trifecta Valve|trifecta valve
5028182|NCT01514149|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
5028183|NCT01514149|T2DM|t2dm
5028184|NCT01514149|diabetes|diabetes
5028185|NCT01514149|ConjuChem|conjuchem
5028186|NCT01514149|GLP-1|glp-1
5028187|NCT01514149|Glucagon-like peptide-1|glucagon-like peptide-1
5028188|NCT01514149|exendin-4|exendin-4
5028189|NCT01514149|modified exendin-4|modified exendin-4
5028190|NCT01514123|VGX-100|vgx-100
5028191|NCT01514123|Bevacizumab|bevacizumab
5028192|NCT01514123|VEGF-C|vegf-c
5028193|NCT01514123|First-In-Human|first-in-human
5028194|NCT01514123|Dose Escalation|dose escalation
5028195|NCT01514123|Advanced Solid Tumors|advanced solid tumors
5028196|NCT01514123|Angiogenesis Inhibitors|angiogenesis inhibitors
5028197|NCT01514123|Angiogenesis Modulating Agents|angiogenesis modulating agents
5028198|NCT01514123|Pharmacologic Actions|pharmacologic actions
5028199|NCT01514123|Antibodies, Monoclonal|antibodies, monoclonal
5028200|NCT01514123|Phase 1|phase 1
5028201|NCT01514123|Oncology|oncology
5028202|NCT01514123|Advanced malignancy|advanced malignancy
5028203|NCT01514097|emergency|emergency
5028204|NCT01514097|pediatric|pediatric
5028205|NCT01514097|fracture|fracture
5028206|NCT01514097|pain|pain
5028207|NCT01514084|laceration|laceration
5028208|NCT01514084|emergency|emergency
5028209|NCT01514084|cosmetic outcomes|cosmetic outcomes
5028210|NCT01514084|patient satisfaction|patient satisfaction
5028211|NCT01514084|suture|suture
5028212|NCT01514071|head injury|head injury
5028213|NCT01514071|CT|ct
5028214|NCT01514071|emergency|emergency
5028215|NCT01514071|radiation|radiation
5028216|NCT01514045|Quality of Life|quality of life
5028217|NCT01514019|SLCO2B1 genotype|slco2b1 genotype
5028218|NCT01514019|effect of apple juice|effect of apple juice
5028219|NCT01514006|Primary hip arthroplasty|primary hip arthroplasty
5028220|NCT01514006|postoperative anemia|postoperative anemia
5028222|NCT01513993|CHF|chf
5028223|NCT01513993|Telemonitoring|telemonitoring
5028224|NCT01513980|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5028225|NCT01513980|Telemonitoring|telemonitoring
5028226|NCT01513967|Alzheimer,|alzheimer,
5028227|NCT01513967|dementia|dementia
5028228|NCT01513954|Infertility|infertility
5028229|NCT01513941|Chronic hepatitis C|chronic hepatitis c
5028230|NCT01513941|Genotype 1 chronic hepatitis C|genotype 1 chronic hepatitis c
5028231|NCT01513941|Treatment experienced with HCV-1/HIV-1 coinfection|treatment experienced with hcv-1/hiv-1 coinfection
5028232|NCT01513941|Telaprevir|telaprevir
5028233|NCT01513941|Pegylated-Interferon-alfa-2a|pegylated-interferon-alfa-2a
5028234|NCT01513941|Ribavirin|ribavirin
5028235|NCT01513941|HCV-1/HIV-1 coinfection|hcv-1/hiv-1 coinfection
5028236|NCT01513941|Hepatitis C|hepatitis c
5028237|NCT01513928|pharmacokinetics|pharmacokinetics
5028238|NCT01513928|relative bioavailability|relative bioavailability
5028239|NCT01513928|formulation comparison|formulation comparison
5028240|NCT01513915|parents|parents
5028241|NCT01513915|group cognitive behavioral intervention|group cognitive behavioral intervention
5028242|NCT01513915|anxiety disorder|anxiety disorder
5028243|NCT01513915|children|children
5028244|NCT01513915|FRIENDS program|friends program
5028245|NCT01513902|Arthritis|arthritis
5028246|NCT01513902|Pediatric|pediatric
5028247|NCT01513902|Tofacitinib|tofacitinib
5028248|NCT01513902|JIA|jia
5028249|NCT01513850|Liver Transplantation|liver transplantation
5028250|NCT01513850|HBV|hbv
5028251|NCT01513850|HBV Recurrence|hbv recurrence
5028252|NCT01513850|HBsAg Positive|hbsag positive
5028253|NCT01513824|stress|stress
5028254|NCT01513824|biofeed back guided treatment|biofeed back guided treatment
5028255|NCT01513824|acupressure|acupressure
5028256|NCT01513824|ischemic heart disease|ischemic heart disease
5028257|NCT01513811|bowel preparation|bowel preparation
5028258|NCT01513811|constipation|constipation
5028259|NCT01513811|polyethylene glycol|polyethylene glycol
5028260|NCT01513811|itopride|itopride
5028261|NCT01513798|Diet Therapy|diet therapy
5028262|NCT01513798|Exercise Therapy|exercise therapy
5028263|NCT01513798|Insulin Resistance|insulin resistance
5028264|NCT01513785|H. pylori|h. pylori
5028265|NCT01513785|Dual therapy|dual therapy
5028266|NCT01513785|Amoxicillin|amoxicillin
5028267|NCT01513785|Rabeprazole|rabeprazole
5028268|NCT01513759|Fibrinolysis|fibrinolysis
5028269|NCT01513759|catheter directed fibrinolysis|catheter directed fibrinolysis
5028270|NCT01513759|ultrasound accelerated fibrinolysis|ultrasound accelerated fibrinolysis
5028271|NCT01513759|recombinant t-PA|recombinant t-pa
5028272|NCT01513759|Activase|activase
5028273|NCT01513746|Type 1 Diabetes|type 1 diabetes
5028274|NCT01513746|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
5028275|NCT01513746|Eating Disorders|eating disorders
5028276|NCT01513746|Insulin Omission|insulin omission
5028277|NCT01513720|Bioequivalence|bioequivalence
5028278|NCT01513720|Lamotrigine|lamotrigine
5028279|NCT01513720|crossover|crossover
5028280|NCT01513707|kidney transplantation|kidney transplantation
5028281|NCT01513707|hemodialysis|hemodialysis
5028282|NCT01513707|peritoneal dialysis|peritoneal dialysis
5028283|NCT01513694|Mesenchymal Stem Cells|mesenchymal stem cells
5028284|NCT01513694|Stem Cells|stem cells
5028285|NCT01513694|Intervertebral disc disease|intervertebral disc disease
5028286|NCT01513681|Bioequivalence|bioequivalence
5028287|NCT01513681|Lamotrigine|lamotrigine
5028288|NCT01513681|crossover|crossover
5028289|NCT01513655|COPD|copd
5028290|NCT01513655|Home NIV|home niv
5028291|NCT01513655|NIV|niv
5028292|NCT01513642|physiotherapy|physiotherapy
5028293|NCT01513642|cardiac surgery|cardiac surgery
5028294|NCT01513642|breath Stacking|breath stacking
5028295|NCT01513629|Autism spectrum disorders|autism spectrum disorders
5028296|NCT01513629|structural connectivity|structural connectivity
5028297|NCT01513629|diffusion spectrum imaging|diffusion spectrum imaging
5028298|NCT01513629|sibling|sibling
5028299|NCT01513629|endophenotype|endophenotype
5028300|NCT01513616|COPD|copd
5028301|NCT01513616|dyspnea|dyspnea
5028302|NCT01513616|exercise|exercise
5028303|NCT01513616|measurement|measurement
5028304|NCT01513616|respiratory physiology|respiratory physiology
5028305|NCT01513577|Lumbar fusion|lumbar fusion
5028306|NCT01513577|Pedicular screws|pedicular screws
5028307|NCT01513577|Minimal invasive technique|minimal invasive technique
5028308|NCT01513577|Randomized controlled trial|randomized controlled trial
5028309|NCT01513564|Disc disease|disc disease
5028310|NCT01513564|Spondylolisthesis|spondylolisthesis
5028311|NCT01513538|Pacemaker programming|pacemaker programming
5028312|NCT01513538|Bradyarrhythmia|bradyarrhythmia
5028313|NCT01513499|Eating behavior|eating behavior
5028314|NCT01513499|Appetite|appetite
5028315|NCT01513499|Oxytocin|oxytocin
5028316|NCT01513499|Neuropeptide|neuropeptide
5028317|NCT01513460|Chronic Obstructive Pulmonary Disease,|chronic obstructive pulmonary disease,
5028318|NCT01513460|NVA 237,|nva 237,
5028319|NCT01513460|glycopyrronium,|glycopyrronium,
5028320|NCT01513460|COPD|copd
5028321|NCT01513447|sterile water injections|sterile water injections
5028322|NCT01513447|back labor|back labor
5028323|NCT01513421|Infected|infected
5028324|NCT01513421|Intra-abdominal|intra-abdominal
5028325|NCT01513421|Collection|collection
5028326|NCT01513421|Drainage|drainage
5028327|NCT01513421|Percutaneous|percutaneous
5028328|NCT01513408|breast cancer|breast cancer
5028329|NCT01513408|CD8+|cd8+
5028330|NCT01513408|Foxp3|foxp3
5028331|NCT01513408|neoadjuvant chemotherapy|neoadjuvant chemotherapy
5028332|NCT01513395|Cervical assessment|cervical assessment
5028333|NCT01513395|Focal myometrial contractions|focal myometrial contractions
5028334|NCT01513382|Pilonidal sinus|pilonidal sinus
5028335|NCT01513382|Methylene blue|methylene blue
5028336|NCT01513382|Histopathology|histopathology
5028337|NCT01513382|Surgery|surgery
5028338|NCT01513369|Diabetes|diabetes
5028339|NCT01513369|iron deficiency|iron deficiency
5028340|NCT01513356|breast|breast
5028341|NCT01513356|cancer|cancer
5028342|NCT01513356|BKM120|bkm120
5028343|NCT01513317|Myelodysplastic Syndrome|myelodysplastic syndrome
5028344|NCT01513317|MDS|mds
5028345|NCT01513317|Blood and lymphatic diseases|blood and lymphatic diseases
5028346|NCT01513317|Siltuximab|siltuximab
5028347|NCT01513317|Anemic|anemic
5028348|NCT01513265|reduction polypharmacy|reduction polypharmacy
5028349|NCT01513265|clinical outcomes|clinical outcomes
5028350|NCT01513265|pharmaceutical care|pharmaceutical care
5028351|NCT01513265|clinical pharmacy|clinical pharmacy
5028352|NCT01513265|geriatrics|geriatrics
5028353|NCT01513265|medication review|medication review
5028354|NCT01513265|potentially inappropriate drugs|potentially inappropriate drugs
5028355|NCT01513252|Cognitive decline|cognitive decline
5028356|NCT01513252|prevention|prevention
5028357|NCT01513252|omega-3 fatty acids|omega-3 fatty acids
5028358|NCT01513252|nutrition exercise|nutrition exercise
5028359|NCT01513252|cognitive training|cognitive training
5028360|NCT01513252|social activities|social activities
5028361|NCT01513252|frailty|frailty
5028362|NCT01513239|Clostridium difficile|clostridium difficile
5028363|NCT01513239|Clostridium difficile infection (CDI)|clostridium difficile infection (cdi)
5028364|NCT01513239|recurrent Clostridium difficile|recurrent clostridium difficile
5028365|NCT01513239|vancomycin|vancomycin
5028366|NCT01513239|metronidazole|metronidazole
5028367|NCT01513239|monoclonal antibody|monoclonal antibody
5028368|NCT01513226|cycled light|cycled light
5028369|NCT01513226|dim light|dim light
5028370|NCT01513226|circadian rhythm|circadian rhythm
5028371|NCT01513226|actigraphy, sleep|actigraphy, sleep
5028372|NCT01513226|premature infant|premature infant
5028373|NCT01513213|Arterial cannulation|arterial cannulation
5028374|NCT01513213|Blood gas|blood gas
5028375|NCT01513213|Carbon dioxide|carbon dioxide
5028376|NCT01513213|Arterial blood|arterial blood
5028377|NCT01513213|Oxygen|oxygen
5028378|NCT01513213|Oxygen fractions|oxygen fractions
5028379|NCT01513187|Advanced renal cell carcinoma|advanced renal cell carcinoma
5028380|NCT01513187|SOGUG|sogug
5028381|NCT01513187|Pazopanib|pazopanib
5028382|NCT01513187|Pazopanib in combination with interferon alpha 2A|pazopanib in combination with interferon alpha 2a
5028383|NCT01513174|GOAL|goal
5028384|NCT01513174|Lung|lung
5028385|NCT01513174|Non small cell lung cancer|non small cell lung cancer
5028386|NCT01513174|EGFR mutations|egfr mutations
5028387|NCT01513161|pruritus|pruritus
5028388|NCT01513135|HIV,|hiv,
5028389|NCT01513135|HAART-treated|haart-treated
5028390|NCT01513135|participants|participants
5028391|NCT01513135|Tat protein,|tat protein,
5028392|NCT01513135|Therapeutic immunization|therapeutic immunization
5028393|NCT01513109|WT1 positive Acute Myeloid Leukemia|wt1 positive acute myeloid leukemia
5028394|NCT01513109|Antigen specific cancer immunotherapeutic|antigen specific cancer immunotherapeutic
5028395|NCT01513109|Ex vivo regulatory T cell depletion|ex vivo regulatory t cell depletion
5028396|NCT01513109|In vivo regulatory T cell depletion|in vivo regulatory t cell depletion
5028397|NCT01513096|colonoscopy|colonoscopy
5028398|NCT01513096|bowel preparation|bowel preparation
5028399|NCT01513096|PEG|peg
5028400|NCT01513096|Prokinetics|prokinetics
5028401|NCT01513070|Quick-Acting Heart Reliever|quick-acting heart reliever
5028402|NCT01513070|Coronary Artery Stenosis|coronary artery stenosis
5028403|NCT01513070|Coronary Heart Disease|coronary heart disease
5028404|NCT01513070|Suxiao Jiuxin Pill|suxiao jiuxin pill
5028405|NCT01513070|Chinese Herbal Drugs|chinese herbal drugs
5028406|NCT01513070|Traditional Chinese Medicine|traditional chinese medicine
5028407|NCT01513070|Chinese Medicine|chinese medicine
5028408|NCT01513070|Angina Pectoris|angina pectoris
5028409|NCT01513070|Isosorbide Dinitrate|isosorbide dinitrate
5028410|NCT01513070|Myocardial Perfusion Imaging|myocardial perfusion imaging
5028411|NCT01513070|Clinical Trial|clinical trial
5028412|NCT01513057|bioequivalence|bioequivalence
5028413|NCT01513057|Mycophenolate Mofetil|mycophenolate mofetil
5028414|NCT01513057|crossover|crossover
5028415|NCT01513044|bioequivalence|bioequivalence
5028416|NCT01513044|Mycophenolate Mofetil|mycophenolate mofetil
5028417|NCT01513044|crossover|crossover
5028418|NCT01513031|Atrial fibrillation|atrial fibrillation
5028419|NCT01513031|Anti-arrhythmic medication|anti-arrhythmic medication
5028420|NCT01513031|Medication adherence|medication adherence
5028421|NCT01513018|OLV|olv
5028422|NCT01513018|one lung ventilation|one lung ventilation
5028423|NCT01513005|Laparoscopic Sleeve Gastrectomy|laparoscopic sleeve gastrectomy
5028424|NCT01513005|obesity management|obesity management
5028425|NCT01512966|Diabetic Macular Edema|diabetic macular edema
5028426|NCT01512966|DME|dme
5028427|NCT01512966|VEGF Trap-Eye|vegf trap-eye
5028428|NCT01512966|best-corrected visual acuity (BCVA)|best-corrected visual acuity (bcva)
5028429|NCT01512953|PPI|ppi
5028430|NCT01512953|clopidogrel|clopidogrel
5028431|NCT01512953|2C19|2c19
5028432|NCT01512953|Lansoprazole|lansoprazole
5028433|NCT01512940|obesity|obesity
5028434|NCT01512940|Laparoscopic Greater Curvature Plication|laparoscopic greater curvature plication
5028560|NCT01512485|crossover|crossover
5028435|NCT01512940|Percent Excess weight Loss|percent excess weight loss
5028436|NCT01512940|comorbidities|comorbidities
5028437|NCT01512940|BMI|bmi
5028438|NCT01512940|Bariatric Surgery|bariatric surgery
5028439|NCT01512927|electronic stethoscope|electronic stethoscope
5028440|NCT01512927|arteriovenous fistula|arteriovenous fistula
5028441|NCT01512927|hemodialysis,|hemodialysis,
5028442|NCT01512914|Gynecologic laparoscopic surgery|gynecologic laparoscopic surgery
5028443|NCT01512914|Postoperative pain|postoperative pain
5028444|NCT01512914|Nebulization|nebulization
5028445|NCT01512914|Ropivacaine|ropivacaine
5028446|NCT01512888|SCID|scid
5028447|NCT01512888|SCID-X1|scid-x1
5028448|NCT01512888|X-linked SCID|x-linked scid
5028449|NCT01512888|immunodeficiency|immunodeficiency
5028450|NCT01512888|gene therapy|gene therapy
5028451|NCT01512875|Helicobacter pylori|helicobacter pylori
5028452|NCT01512875|water contamination|water contamination
5028453|NCT01512875|Lima, Peru|lima, peru
5028454|NCT01512862|Calcitriol|calcitriol
5028455|NCT01512862|Off-label|off-label
5028456|NCT01512849|TA-7284|ta-7284
5028457|NCT01512849|JNJ-28431754|jnj-28431754
5028458|NCT01512849|Canagliflozin|canagliflozin
5028459|NCT01512849|Renal Impairment|renal impairment
5028460|NCT01512849|Sodium Glucose Co-transporter2 (SGLT2) inhibitor|sodium glucose co-transporter2 (sglt2) inhibitor
5028461|NCT01512836|COPD|copd
5028462|NCT01512836|Case management|case management
5028463|NCT01512836|CEA|cea
5028464|NCT01512836|Health economy|health economy
5028465|NCT01512836|Quality of Life|quality of life
5028466|NCT01512823|randomised controlled trial|randomised controlled trial
5028467|NCT01512823|educational intervention|educational intervention
5028468|NCT01512823|occupational therapy|occupational therapy
5028469|NCT01512810|Endometrial|endometrial
5028470|NCT01512810|Cancer|cancer
5028471|NCT01512810|Intraoperative Consultation|intraoperative consultation
5028472|NCT01512797|Januvia|januvia
5028473|NCT01512797|Sitagliptin|sitagliptin
5028474|NCT01512797|Diabetes|diabetes
5028475|NCT01512797|Gastric-Bypass|gastric-bypass
5028476|NCT01512784|Quadrivalent Human Papillomavirus Vaccine (HPV) Gardasil|quadrivalent human papillomavirus vaccine (hpv) gardasil
5028477|NCT01512784|HIV infection|hiv infection
5028478|NCT01512784|Evaluation of quadrivalent HPV vaccine in adolescents and young adults.|evaluation of quadrivalent hpv vaccine in adolescents and young adults.
5028479|NCT01512758|East Asian Patients|east asian patients
5028480|NCT01512758|Advanced solid tumors|advanced solid tumors
5028481|NCT01512758|Lymphomas|lymphomas
5028482|NCT01512758|MLN8237|mln8237
5028483|NCT01512758|Alisertib|alisertib
5028484|NCT01512758|Aurora A Kinase Inhibitor|aurora a kinase inhibitor
5028485|NCT01512706|Human Enterovirus 71 (EV71)|human enterovirus 71 (ev71)
5028486|NCT01512706|Hand, Foot and Mouth Disease|hand, foot and mouth disease
5028487|NCT01512706|Inactivated Vaccine|inactivated vaccine
5028488|NCT01512706|Human Diploid cell|human diploid cell
5028489|NCT01512706|Safety|safety
5028490|NCT01512706|Immunogenicity|immunogenicity
5028491|NCT01512706|Adverse reactions associated with vaccine|adverse reactions associated with vaccine
5028492|NCT01512680|Functional Insulin Thearpy|functional insulin thearpy
5028493|NCT01512680|Carbs counting|carbs counting
5028494|NCT01512680|Type 1 diabetes mellitus|type 1 diabetes mellitus
5028495|NCT01512680|Insulin pump|insulin pump
5028496|NCT01512680|Treatment by external insulin pump|treatment by external insulin pump
5028497|NCT01512654|diabetes|diabetes
5028498|NCT01512654|diadvisor|diadvisor
5028499|NCT01512654|type 1 diabetes|type 1 diabetes
5028500|NCT01512654|type 2 diabetes|type 2 diabetes
5028501|NCT01512654|glucose prediction|glucose prediction
5028502|NCT01512654|cgm prediction|cgm prediction
5028503|NCT01512654|algorithm|algorithm
5028504|NCT01512654|therapy advices|therapy advices
5028505|NCT01512641|children dissociative disorders schizophrenia|children dissociative disorders schizophrenia
5028506|NCT01512615|Rehabilitation|rehabilitation
5028507|NCT01512615|Exercise training|exercise training
5028508|NCT01512615|Psycho-educational care|psycho-educational care
5028509|NCT01512602|Borderline Personality Disorder traits|borderline personality disorder traits
5028510|NCT01512602|Suicide prevention|suicide prevention
5028511|NCT01512602|Self-harm|self-harm
5028512|NCT01512602|Dialectical Behavior Therapy|dialectical behavior therapy
5028513|NCT01512602|DBT|dbt
5028514|NCT01512602|Collaborative Assessment and Management of Suicidology|collaborative assessment and management of suicidology
5028515|NCT01512602|CAMS|cams
5028516|NCT01512589|Proton Beam Therapy|proton beam therapy
5028517|NCT01512589|PBT|pbt
5028518|NCT01512589|Intensity-Modulated Radiation Therapy|intensity-modulated radiation therapy
5028519|NCT01512589|IMRT|imrt
5028520|NCT01512589|Esophageal cancer|esophageal cancer
5028521|NCT01512589|Adenocarcinoma|adenocarcinoma
5028522|NCT01512589|Squamous cell carcinoma|squamous cell carcinoma
5028523|NCT01512589|Cervical esophagus|cervical esophagus
5028524|NCT01512589|Thoracic esophagus|thoracic esophagus
5028525|NCT01512589|Gastroesophageal junction|gastroesophageal junction
5028526|NCT01512589|Cardia of stomach|cardia of stomach
5028527|NCT01512589|Questionnaires|questionnaires
5028528|NCT01512589|Surveys|surveys
5028529|NCT01512589|Symptom scores|symptom scores
5028530|NCT01512589|Quality of life|quality of life
5028531|NCT01512589|QOL|qol
5028532|NCT01512576|whiplash|whiplash
5028533|NCT01512576|chronic pain|chronic pain
5028534|NCT01512576|sensitization|sensitization
5028535|NCT01512576|treatment|treatment
5028536|NCT01512576|acupuncture|acupuncture
5028537|NCT01512576|relaxation|relaxation
5028538|NCT01512563|paclitaxel|paclitaxel
5028539|NCT01512563|drug eluting stent|drug eluting stent
5028540|NCT01512550|Radiostereometric Analysis (RSA)|radiostereometric analysis (rsa)
5028541|NCT01512550|Total hip arthroplasty (THA)|total hip arthroplasty (tha)
5028542|NCT01512550|Hip anatomy|hip anatomy
5028543|NCT01512550|Hip biomechanics|hip biomechanics
5028544|NCT01512537|Vitamin D|vitamin d
5028545|NCT01512537|UVB|uvb
5028546|NCT01512537|Vitamin D supplementation|vitamin d supplementation
5028547|NCT01512524|Traumatic Brain Injury|traumatic brain injury
5028548|NCT01512524|Quality of Life (QoL)|quality of life (qol)
5028549|NCT01512524|hypopituitarism,GH|hypopituitarism,gh
5028550|NCT01512511|laparoscopic cholecystectomy|laparoscopic cholecystectomy
5028551|NCT01512511|pneumoperitoneum|pneumoperitoneum
5028552|NCT01512511|nitrous oxide|nitrous oxide
5028553|NCT01512511|carbon dioxide|carbon dioxide
5028554|NCT01512498|VV GVHD|vv gvhd
5028555|NCT01512498|girls|girls
5028556|NCT01512498|adolescents|adolescents
5028557|NCT01512498|HSCT|hsct
5028558|NCT01512485|Bioequivalence|bioequivalence
5028559|NCT01512485|Clopidogrel|clopidogrel
5028561|NCT01512472|localized prostate cancer|localized prostate cancer
5028562|NCT01512472|degarelix|degarelix
5028563|NCT01512472|intermittent androgen deprivation therapy|intermittent androgen deprivation therapy
5028564|NCT01512459|Bioavailability|bioavailability
5028565|NCT01512459|Venlafaxine|venlafaxine
5028566|NCT01512459|two way crossover|two way crossover
5028567|NCT01512446|Osteoporosis|osteoporosis
5028568|NCT01512446|Osteoporotic fractures|osteoporotic fractures
5028569|NCT01512446|Bisphosphonate|bisphosphonate
5028570|NCT01512446|Pretreatment with bisphosphonates|pretreatment with bisphosphonates
5028571|NCT01512433|acupuncture|acupuncture
5028572|NCT01512433|methadone|methadone
5028573|NCT01512407|Hepatocellular Carcinoma|hepatocellular carcinoma
5028574|NCT01512407|Randomised controlled trial|randomised controlled trial
5028575|NCT01512407|Transarterial chemoembolisation|transarterial chemoembolisation
5028576|NCT01512394|bowel preparation|bowel preparation
5028577|NCT01512381|heart failure|heart failure
5028578|NCT01512381|CRT|crt
5028579|NCT01512381|atrial fibrillation|atrial fibrillation
5028580|NCT01512381|AV junction ablation|av junction ablation
5028581|NCT01512368|Fibroblast growth factor 21 (FGF21)|fibroblast growth factor 21 (fgf21)
5028582|NCT01512368|Exercise|exercise
5028583|NCT01512368|Metabolic equivalents (METs)|metabolic equivalents (mets)
5028584|NCT01512368|Lipolysis|lipolysis
5028585|NCT01512368|Glucose|glucose
5028586|NCT01512368|Free fatty acids (FFAs)|free fatty acids (ffas)
5028587|NCT01512368|Epinephrine|epinephrine
5028588|NCT01512342|pacing|pacing
5028589|NCT01512342|activity management|activity management
5028590|NCT01512342|relaxation|relaxation
5028591|NCT01512342|physiotherapy|physiotherapy
5028592|NCT01512342|occupational therapy|occupational therapy
5028593|NCT01512342|autonomic nervous system|autonomic nervous system
5028594|NCT01512329|neurology|neurology
5028595|NCT01512329|physiotherapy|physiotherapy
5028596|NCT01512329|physical therapy|physical therapy
5028597|NCT01512329|occupational therapy|occupational therapy
5028598|NCT01512329|stress management|stress management
5028599|NCT01512329|activity management|activity management
5028600|NCT01512329|treatment|treatment
5028601|NCT01512316|Fear|fear
5028602|NCT01512316|Cycloserine|cycloserine
5028603|NCT01512316|Conditioning|conditioning
5028604|NCT01512316|Functional neuroimaging|functional neuroimaging
5028605|NCT01512316|Anxiety disorders|anxiety disorders
5028606|NCT01512303|PTSD|ptsd
5028607|NCT01512303|Veterans' Health|veterans' health
5028608|NCT01512303|Meditation|meditation
5028609|NCT01512303|MRI, Functional|mri, functional
5028610|NCT01512290|Auditory verbal hallucinations|auditory verbal hallucinations
5028611|NCT01512290|Transcranial Magnetic stimulation|transcranial magnetic stimulation
5028612|NCT01512290|Theta Burst frequency|theta burst frequency
5028613|NCT01512277|vaccines|vaccines
5028614|NCT01512277|safety|safety
5028615|NCT01512277|drug tolerance|drug tolerance
5028616|NCT01512277|immunogenic protein|immunogenic protein
5028617|NCT01512277|antibody response|antibody response
5028618|NCT01512277|cytokine|cytokine
5028619|NCT01512264|Aphasia|aphasia
5028620|NCT01512264|Stroke|stroke
5028621|NCT01512264|functional Magnetic resonance imaging|functional magnetic resonance imaging
5028622|NCT01512264|fMRI|fmri
5028623|NCT01512264|Language recovery after stroke|language recovery after stroke
5028624|NCT01512264|constraint induced aphasia therapy|constraint induced aphasia therapy
5028625|NCT01512264|CIAT|ciat
5028626|NCT01512264|Repetitive transcranial magnetic stimulation|repetitive transcranial magnetic stimulation
5028627|NCT01512264|rTMS|rtms
5028628|NCT01512251|BKM120|bkm120
5028629|NCT01512251|BRAF|braf
5028630|NCT01512251|Melanoma|melanoma
5028631|NCT01512251|PI3K|pi3k
5028632|NCT01512238|Medicine adherence|medicine adherence
5028633|NCT01512238|Drug substitution|drug substitution
5028634|NCT01512238|Herb-drug interaction|herb-drug interaction
5028635|NCT01512238|Herbal medicine|herbal medicine
5028636|NCT01512238|Dietary supplements|dietary supplements
5028637|NCT01512238|Over-the-counter products|over-the-counter products
5028638|NCT01512238|On-line prescription records|on-line prescription records
5028639|NCT01512238|Personal electronic medicine profile|personal electronic medicine profile
5028640|NCT01512238|Intentional non-adherence|intentional non-adherence
5028641|NCT01512238|Unintentional non-adherence|unintentional non-adherence
5028642|NCT01512225|breastmilk|breastmilk
5028643|NCT01512225|domperidone|domperidone
5028644|NCT01512225|preterm|preterm
5028645|NCT01512212|thyroid|thyroid
5028646|NCT01512212|fine|fine
5028647|NCT01512212|needle|needle
5028648|NCT01512212|aspiration|aspiration
5028649|NCT01512212|biopsy|biopsy
5028650|NCT01512212|new|new
5028651|NCT01512212|technique|technique
5028652|NCT01512199|U3-1287|u3-1287
5028653|NCT01512199|Trastuzumab|trastuzumab
5028654|NCT01512199|Paclitaxel|paclitaxel
5028655|NCT01512199|newly diagnosed HER-2 positive|newly diagnosed her-2 positive
5028656|NCT01512199|breast cancer|breast cancer
5028657|NCT01512199|metastatic|metastatic
5028658|NCT01512186|Clear cell renal cancer|clear cell renal cancer
5028659|NCT01512173|Propranolol gel|propranolol gel
5028660|NCT01512173|Hemangioma|hemangioma
5028661|NCT01512173|capillary neoplasm|capillary neoplasm
5028662|NCT01512173|vascular tissue|vascular tissue
5028663|NCT01512173|neoplasm by histologic type|neoplasm by histologic type
5028664|NCT01512173|neoplasm|neoplasm
5028665|NCT01512173|therapeutic uses|therapeutic uses
5028666|NCT01512173|pharmacologic actions|pharmacologic actions
5028667|NCT01512173|adrenergic beta-antagonists|adrenergic beta-antagonists
5028668|NCT01512173|adrenergic antagonist|adrenergic antagonist
5028669|NCT01512173|adrenergics agent|adrenergics agent
5028670|NCT01512173|neurotransmitter agent|neurotransmitter agent
5028671|NCT01512173|molecular mechanism of pharmacological action|molecular mechanism of pharmacological action
5028672|NCT01512173|physiological effects of drugs|physiological effects of drugs
5028673|NCT01512160|Post-surgical dental pain|post-surgical dental pain
5028674|NCT01512147|SSEP measurements|ssep measurements
5028675|NCT01512147|MEP measurements|mep measurements
5028676|NCT01512147|Pediatric Patients|pediatric patients
5028677|NCT01512147|Neurosurgery|neurosurgery
5028678|NCT01512147|General Anesthesia|general anesthesia
5028679|NCT01512134|Obesity|obesity
5028680|NCT01512134|DBS|dbs
5028681|NCT01512082|Pain|pain
5028682|NCT01512082|Delayed onset muscle soreness|delayed onset muscle soreness
5028683|NCT01512082|Pulsed electromagnetic field|pulsed electromagnetic field
5028684|NCT01512082|Marathon|marathon
5028685|NCT01512069|randomized controlled trial|randomized controlled trial
5028686|NCT01512069|internet|internet
5028687|NCT01512069|diet|diet
5028688|NCT01512069|exercise|exercise
5028689|NCT01512069|health planning|health planning
5028690|NCT01512069|the TTM|the ttm
5028691|NCT01512056|Influenza vaccine|influenza vaccine
5028692|NCT01512056|dialysis|dialysis
5028693|NCT01512056|vaccine|vaccine
5028694|NCT01512056|Seroprotection|seroprotection
5028695|NCT01512056|Seroresponse|seroresponse
5028696|NCT01512056|Seroconversion|seroconversion
5028697|NCT01512056|Safety of the vaccine|safety of the vaccine
5028698|NCT01512043|Breathlessness|breathlessness
5028699|NCT01512043|Symptoms|symptoms
5028700|NCT01512043|Quality of life|quality of life
5028701|NCT01512017|skin lesions or defects|skin lesions or defects
5028702|NCT01512004|Overactive Bladder|overactive bladder
5028703|NCT01512004|urgent micturition|urgent micturition
5028704|NCT01512004|frequent micturition|frequent micturition
5028705|NCT01512004|urge urinary incontinence|urge urinary incontinence
5028706|NCT01511991|cardiac surgery|cardiac surgery
5028707|NCT01511991|sevoflurane|sevoflurane
5028708|NCT01511991|tissue Doppler|tissue doppler
5028709|NCT01511978|Lambert-Eaton|lambert-eaton
5028710|NCT01511978|Eaton-Lambert|eaton-lambert
5028711|NCT01511978|myasthenia|myasthenia
5028712|NCT01511978|myasthenic|myasthenic
5028713|NCT01511978|LEMS|lems
5028714|NCT01511978|LES|les
5028715|NCT01511978|DAP|dap
5028716|NCT01511978|diaminopyridine|diaminopyridine
5028717|NCT01511978|3,4-diaminopyridine|3,4-diaminopyridine
5028718|NCT01511978|3,4-DAP|3,4-dap
5028719|NCT01511952|music therapy|music therapy
5028720|NCT01511952|entrainment|entrainment
5028721|NCT01511952|premature infants|premature infants
5028722|NCT01511952|live music intervention|live music intervention
5028723|NCT01511952|parent preferred lullabies|parent preferred lullabies
5028724|NCT01511939|Knee pain|knee pain
5028725|NCT01511939|Anticoagulant|anticoagulant
5028726|NCT01511939|Warfarin|warfarin
5028727|NCT01511939|Dabigatran|dabigatran
5028728|NCT01511939|Clopidogrel|clopidogrel
5028729|NCT01511939|Aspirin|aspirin
5028730|NCT01511939|Topical NSAID|topical nsaid
5028731|NCT01511939|Osteoarthritis|osteoarthritis
5028732|NCT01511926|Vimovo™ treated patients and prescribing patterns|vimovo™ treated patients and prescribing patterns
5028733|NCT01511926|Risk of gastrointestinal side effects|risk of gastrointestinal side effects
5028734|NCT01511913|Unresectable or metastatic cutaneous melanoma|unresectable or metastatic cutaneous melanoma
5028735|NCT01511887|Patent Ductus Arteriosus|patent ductus arteriosus
5028736|NCT01511887|PDA|pda
5028737|NCT01511887|Term newborns|term newborns
5028738|NCT01511887|Ibuprofen|ibuprofen
5028739|NCT01511874|ELIGARD|eligard
5028740|NCT01511874|Prostate cancer|prostate cancer
5028741|NCT01511848|Iron chelation|iron chelation
5028742|NCT01511848|Iron balance|iron balance
5028743|NCT01511848|Secondary iron overload|secondary iron overload
5028744|NCT01511848|deferoxamine|deferoxamine
5028745|NCT01511848|deferasirox|deferasirox
5028746|NCT01511848|Deferiprone|deferiprone
5028747|NCT01511848|1- Beta-thalassemia major patients;|1- beta-thalassemia major patients;
5028748|NCT01511848|Patients with high iron stores|patients with high iron stores
5028749|NCT01511848|Serum ferritin consistently > 2500 mcg/l and or increasing trend over previous 12 months|serum ferritin consistently > 2500 mcg/l and or increasing trend over previous 12 months
5028750|NCT01511848|Liver iron >14 mg/g dry weight- by R2 MRI|liver iron >14 mg/g dry weight- by r2 mri
5028751|NCT01511848|2- Sickle cell disease|2- sickle cell disease
5028752|NCT01511848|3- Other causes of transfusional iron hemosiderosis|3- other causes of transfusional iron hemosiderosis
5028753|NCT01511835|diabetes|diabetes
5028754|NCT01511835|pregnancy|pregnancy
5028755|NCT01511835|myo-inositol|myo-inositol
5028756|NCT01511822|PCOS|pcos
5028757|NCT01511822|Insulin resistance|insulin resistance
5028758|NCT01511822|Hyperandrogenism|hyperandrogenism
5028759|NCT01511822|Myo-inositol|myo-inositol
5028760|NCT01511809|HIV-1|hiv-1
5028761|NCT01511796|stroke|stroke
5028762|NCT01511796|upper limb rehabilitation function|upper limb rehabilitation function
5028763|NCT01511770|Bioequivalence|bioequivalence
5028764|NCT01511770|Fluconazole|fluconazole
5028765|NCT01511770|Crossover|crossover
5028766|NCT01511757|Bioequivalence|bioequivalence
5028767|NCT01511757|Fluconazole|fluconazole
5028768|NCT01511757|Crossover|crossover
5028769|NCT01511744|Respiratory Tract Infections; Orthomyxoviridae Infections|respiratory tract infections; orthomyxoviridae infections
5028770|NCT01511731|Bioequivalence|bioequivalence
5028771|NCT01511731|famotidine|famotidine
5028772|NCT01511731|Crossover|crossover
5028773|NCT01511718|Bioequivalence|bioequivalence
5028774|NCT01511718|Ondansetron|ondansetron
5028775|NCT01511718|crossover|crossover
5028776|NCT01511705|Bioequivalence|bioequivalence
5028777|NCT01511705|Ondansetron|ondansetron
5028778|NCT01511705|crossover|crossover
5028779|NCT01511679|Alcohol abuse|alcohol abuse
5028780|NCT01511666|cardiac arrest|cardiac arrest
5028781|NCT01511666|mechanical chest compressions|mechanical chest compressions
5028782|NCT01511666|intraarrest cooling|intraarrest cooling
5028783|NCT01511666|ECLS|ecls
5028784|NCT01511653|screening colonoscopy|screening colonoscopy
5028785|NCT01511653|colon cancer early detection|colon cancer early detection
5028786|NCT01511653|rectal cancer early detection|rectal cancer early detection
5028787|NCT01511653|colorectal cancer prevention|colorectal cancer prevention
5028788|NCT01511653|biomarker validation|biomarker validation
5028789|NCT01511640|marijuana|marijuana
5028790|NCT01511640|addiction|addiction
5028791|NCT01511640|treatment|treatment
5028792|NCT01511640|pharmacotherapy|pharmacotherapy
5028793|NCT01511640|cannabinoid|cannabinoid
5028794|NCT01511614|fMRI|fmri
5028795|NCT01511614|Nicotine Withdrawal|nicotine withdrawal
5028796|NCT01511601|Apheresis|apheresis
5028797|NCT01511601|Leukocytes|leukocytes
5028798|NCT01511601|Plasma|plasma
5028799|NCT01511601|Plamodium Falciparum Malaria|plamodium falciparum malaria
5028800|NCT01511601|Immunology|immunology
5028801|NCT01511588|Kallmann Syndrome|kallmann syndrome
5028802|NCT01511588|Delayed Puberty|delayed puberty
5028803|NCT01511588|GnRH Deficiency|gnrh deficiency
5028804|NCT01511588|Infertility|infertility
5028805|NCT01511588|Hypogonadotropic Hypogonadism|hypogonadotropic hypogonadism
5028806|NCT01511588|Amenorrhea|amenorrhea
5028807|NCT01511588|Hypogonadism|hypogonadism
5028808|NCT01511575|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
5028809|NCT01511575|childhood acute myeloid leukemia/other myeloid malignancies|childhood acute myeloid leukemia/other myeloid malignancies
5028810|NCT01511575|childhood acute megakaryocytic leukemia (M7)|childhood acute megakaryocytic leukemia (m7)
5028811|NCT01511562|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
5028812|NCT01511562|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
5028813|NCT01511562|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5028814|NCT01511562|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
5028815|NCT01511562|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5029308|NCT01509469|Casein|casein
5028816|NCT01511562|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5028817|NCT01511523|Liver|liver
5028818|NCT01511523|Fatty|fatty
5028819|NCT01511523|Non Alcoholic|non alcoholic
5028820|NCT01511523|Vitamin E|vitamin e
5028821|NCT01511523|Silymarin|silymarin
5028822|NCT01511523|Carnitine|carnitine
5028823|NCT01511523|Supplement|supplement
5028824|NCT01511523|NAFLD|nafld
5028825|NCT01511510|PF-04958242|pf-04958242
5028826|NCT01511510|multiple dose|multiple dose
5028827|NCT01511510|safety|safety
5028828|NCT01511510|schizophrenia|schizophrenia
5028829|NCT01511497|Phase 1|phase 1
5028830|NCT01511497|PF-04427429|pf-04427429
5028831|NCT01511484|fruit|fruit
5028832|NCT01511484|vegetables|vegetables
5028833|NCT01511484|appearance|appearance
5028834|NCT01511484|skin color|skin color
5028835|NCT01511484|carotenoids|carotenoids
5028836|NCT01511484|diet|diet
5028837|NCT01511471|Ticagrelor|ticagrelor
5028838|NCT01511471|platelet reactivity|platelet reactivity
5028839|NCT01511471|clopidogrel|clopidogrel
5028840|NCT01511471|haemodialysis|haemodialysis
5028841|NCT01511458|Pregnancy|pregnancy
5028842|NCT01511458|Fetal aneuploidy|fetal aneuploidy
5028843|NCT01511458|Trisomy 21|trisomy 21
5028844|NCT01511458|Down Syndrome|down syndrome
5028845|NCT01511458|Prenatal screening|prenatal screening
5028846|NCT01511458|Non-invasive prenatal testing|non-invasive prenatal testing
5028847|NCT01511458|First trimester|first trimester
5028848|NCT01511458|Combined screening|combined screening
5028849|NCT01511458|Nuchal translucency|nuchal translucency
5028850|NCT01511458|PAPP-A|papp-a
5028851|NCT01511458|hCG|hcg
5028852|NCT01511458|cell free DNA|cell free dna
5028853|NCT01511458|cf DNA|cf dna
5028854|NCT01511458|DNA|dna
5028855|NCT01511458|Performance characteristics of non-invasive first trimester screening|performance characteristics of non-invasive first trimester screening
5028856|NCT01511458|Harmony Prenatal Test|harmony prenatal test
5028857|NCT01511445|Cervicobrachial pain|cervicobrachial pain
5028858|NCT01511445|radicular pain|radicular pain
5028859|NCT01511445|arm pain|arm pain
5028860|NCT01511445|myelopathy|myelopathy
5028861|NCT01511445|radiculitis|radiculitis
5028862|NCT01511445|Radiating pain with or without signs of myelopathy.|radiating pain with or without signs of myelopathy.
5028863|NCT01511432|Relative bioavailability|relative bioavailability
5028864|NCT01511432|telaprevir formulations|telaprevir formulations
5028865|NCT01511419|Influenza|influenza
5028866|NCT01511419|Vaccine|vaccine
5028867|NCT01511419|Pandemic|pandemic
5028868|NCT01511419|H7N3|h7n3
5028869|NCT01511406|Psychosis|psychosis
5028870|NCT01511406|Schizophrenia|schizophrenia
5028871|NCT01511406|Cognitive behavioral therapy|cognitive behavioral therapy
5028872|NCT01511406|Self esteem|self esteem
5028873|NCT01511406|Depression|depression
5028874|NCT01511393|GLP1|glp1
5028875|NCT01511393|Glucagon like peptide|glucagon like peptide
5028876|NCT01511393|liraglutide|liraglutide
5028877|NCT01511393|exenatide extended release|exenatide extended release
5028878|NCT01511393|albiglutide|albiglutide
5028879|NCT01511393|dulaglutide|dulaglutide
5028880|NCT01511380|juvenile|juvenile
5028881|NCT01511380|randomized trial|randomized trial
5028882|NCT01511380|substance abuse|substance abuse
5028883|NCT01511380|sexual risk|sexual risk
5028884|NCT01511380|contingency management|contingency management
5028885|NCT01511367|moderate to severe persistent reversible asthma|moderate to severe persistent reversible asthma
5028886|NCT01511354|critically ill children|critically ill children
5028887|NCT01511354|ICU|icu
5028888|NCT01511354|24hr protein balance|24hr protein balance
5028889|NCT01511354|stable isotopes|stable isotopes
5028890|NCT01511354|fed state|fed state
5028891|NCT01511341|Telenursing|telenursing
5028892|NCT01511341|Children|children
5028893|NCT01511341|Chronic Illness|chronic illness
5028894|NCT01511341|Nursing|nursing
5028895|NCT01511328|HPV testing|hpv testing
5028896|NCT01511328|Primary screening|primary screening
5028897|NCT01511328|Cervical Cancer|cervical cancer
5028898|NCT01511315|Moderate to severe psoriasis|moderate to severe psoriasis
5028899|NCT01511289|Radotinib|radotinib
5028900|NCT01511289|CML-CP|cml-cp
5028901|NCT01511289|Chronic Myeloid Leukemia, chronic phase|chronic myeloid leukemia, chronic phase
5028902|NCT01511276|Breast cancer|breast cancer
5028903|NCT01511276|Sex hormones|sex hormones
5028904|NCT01511276|Physical activity|physical activity
5028905|NCT01511263|Epigallocatechin gallate|epigallocatechin gallate
5028906|NCT01511263|AL amyloidosis|al amyloidosis
5028907|NCT01511250|Normal healthy adults and children|normal healthy adults and children
5028908|NCT01511250|Safety and tolerability|safety and tolerability
5028909|NCT01511250|Active vaccine|active vaccine
5028910|NCT01511250|Placebo|placebo
5028911|NCT01511250|Dengue virus vaccine|dengue virus vaccine
5028912|NCT01511250|Immune response|immune response
5028913|NCT01511237|HIV-1 infection|hiv-1 infection
5028914|NCT01511237|Prophylaxis|prophylaxis
5028915|NCT01511237|Mother-to-child transmission HIV-1|mother-to-child transmission hiv-1
5028916|NCT01511237|Thailand|thailand
5028917|NCT01511237|Developing Countries|developing countries
5028918|NCT01511224|Bloodstream infections|bloodstream infections
5028919|NCT01511224|Acinetobacter|acinetobacter
5028920|NCT01511224|Drug resistant Acinetobacter baumannii bacteremia|drug resistant acinetobacter baumannii bacteremia
5028921|NCT01511211|Dexamethasone|dexamethasone
5028922|NCT01511211|lower limb block|lower limb block
5028923|NCT01511211|ultrasound guided femoral nerve block|ultrasound guided femoral nerve block
5028924|NCT01511211|ultrasound guided obturator nerve block|ultrasound guided obturator nerve block
5028925|NCT01511211|ultrasound guided sciatic nerve block|ultrasound guided sciatic nerve block
5028926|NCT01511211|ropivacaine|ropivacaine
5028927|NCT01511211|total knee arthroplasty|total knee arthroplasty
5028928|NCT01511211|Post surgical pain after total knee arthroplasty|post surgical pain after total knee arthroplasty
5028929|NCT01511146|oxaliplatin|oxaliplatin
5028930|NCT01511146|mitomycin|mitomycin
5028931|NCT01511146|gemcitabine|gemcitabine
5028932|NCT01511146|intrahepatic|intrahepatic
5028933|NCT01511146|liver metastasis|liver metastasis
5028934|NCT01511146|response in liver metastasis|response in liver metastasis
5028935|NCT01511146|downsized to operation|downsized to operation
5028936|NCT01511133|Laboratory evaluations|laboratory evaluations
5028937|NCT01511133|infants|infants
5028938|NCT01511133|Porcine circovirus type 1 (PCV-1)|porcine circovirus type 1 (pcv-1)
5028939|NCT01511133|serologic response|serologic response
5028940|NCT01511133|human rotavirus (HRV) vaccine|human rotavirus (hrv) vaccine
5028941|NCT01511107|acute otitis media|acute otitis media
5028942|NCT01511107|ear infection|ear infection
5028943|NCT01511107|antimicrobial therapy|antimicrobial therapy
5028944|NCT01511107|antimicrobial resistance|antimicrobial resistance
5028945|NCT01511094|ab-interno trabeculectomy,|ab-interno trabeculectomy,
5028946|NCT01511094|intraocular pressure,|intraocular pressure,
5028947|NCT01511094|open angle glaucoma|open angle glaucoma
5028948|NCT01511094|trabeculectomy|trabeculectomy
5028949|NCT01511094|Goniocurettage|goniocurettage
5028950|NCT01511094|Non-Filtering Surgery|non-filtering surgery
5028951|NCT01511081|Non-small-cell lung cancer|non-small-cell lung cancer
5028952|NCT01511081|NSCLC|nsclc
5028953|NCT01511081|Centrally-located|centrally-located
5028954|NCT01511081|Recurrent|recurrent
5028955|NCT01511081|Squamous cell carcinoma|squamous cell carcinoma
5028956|NCT01511081|Adenocarcinoma|adenocarcinoma
5028957|NCT01511081|Large cell carcinoma|large cell carcinoma
5028958|NCT01511081|Bronchioloalveolar cell carcinoma|bronchioloalveolar cell carcinoma
5028959|NCT01511081|Non-small cell carcinoma not otherwise specified|non-small cell carcinoma not otherwise specified
5028960|NCT01511081|Stereotactic Body Radiotherapy|stereotactic body radiotherapy
5028961|NCT01511081|SBRT|sbrt
5028962|NCT01511081|Stereotactic Body Proton Therapy|stereotactic body proton therapy
5028963|NCT01511081|SBPT|sbpt
5028964|NCT01511068|PAP|pap
5028965|NCT01511055|Ovarian Cancer|ovarian cancer
5028966|NCT01511016|lipid kinetics|lipid kinetics
5028967|NCT01511016|fat oxidation|fat oxidation
5028968|NCT01511003|calcineurin inhibitor|calcineurin inhibitor
5028969|NCT01511003|Prograf|prograf
5028970|NCT01511003|Rheumatoid arthritis (RA)|rheumatoid arthritis (ra)
5028971|NCT01511003|Tacrolimus|tacrolimus
5028972|NCT01510990|Non-small cell lung cancer|non-small cell lung cancer
5028973|NCT01510990|Gefitinib|gefitinib
5028974|NCT01510990|FDG-PET|fdg-pet
5028975|NCT01510977|colonoscopy|colonoscopy
5028976|NCT01510977|bowel preparation|bowel preparation
5028977|NCT01510964|Breast cancer|breast cancer
5028978|NCT01510964|Patient involvement|patient involvement
5028979|NCT01510964|Question prompt-sheet|question prompt-sheet
5028980|NCT01510964|Doctor-patient communication|doctor-patient communication
5028981|NCT01510964|RCT|rct
5028982|NCT01510951|AMGEN|amgen
5028983|NCT01510951|PSORIASIS|psoriasis
5028984|NCT01510951|SAFETY|safety
5028985|NCT01510938|Children|children
5028986|NCT01510938|Respiratory Tract Infections|respiratory tract infections
5028987|NCT01510938|Prevention|prevention
5028988|NCT01510886|MDD, management, Andalusia, Database, PismaEP|mdd, management, andalusia, database, pismaep
5028989|NCT01510873|Health-related quality of life|health-related quality of life
5028990|NCT01510873|Fatigue|fatigue
5028991|NCT01510873|pITO|pito
5028992|NCT01510873|Primary Immune Thrombocytopenic Purpura|primary immune thrombocytopenic purpura
5028993|NCT01510834|Computerized Tailored Intervention|computerized tailored intervention
5028994|NCT01510834|CTI|cti
5028995|NCT01510834|Post Traumatic Stress Disorder|post traumatic stress disorder
5028996|NCT01510834|PTSD|ptsd
5028997|NCT01510834|Smoking|smoking
5028998|NCT01510834|Anxiety|anxiety
5028999|NCT01510834|Depression|depression
5029000|NCT01510821|endoscopic vein harvest|endoscopic vein harvest
5029001|NCT01510821|saphenous vein graft|saphenous vein graft
5029002|NCT01510821|endothelial function|endothelial function
5029003|NCT01510808|aggressive periodontitis orthodontic stability|aggressive periodontitis orthodontic stability
5029004|NCT01510795|Kidney transplantation|kidney transplantation
5029005|NCT01510795|Mineralocorticoid receptors|mineralocorticoid receptors
5029006|NCT01510795|Spironolactone|spironolactone
5029007|NCT01510743|open heart surgery|open heart surgery
5029008|NCT01510743|lung surgery|lung surgery
5029009|NCT01510743|spine surgery|spine surgery
5029010|NCT01510743|hepatobiliary surgery|hepatobiliary surgery
5029011|NCT01510730|gastric tumor|gastric tumor
5029012|NCT01510730|Helicobacter pylori|helicobacter pylori
5029013|NCT01510730|endoscopic resection|endoscopic resection
5029014|NCT01510730|metachronous neoplasms|metachronous neoplasms
5029015|NCT01510717|Intraocular Lens|intraocular lens
5029016|NCT01510717|Monofocal|monofocal
5029017|NCT01510717|Multifocal|multifocal
5029018|NCT01510691|Oxygenation of the retinal vessels|oxygenation of the retinal vessels
5029019|NCT01510691|vitroretinal surgery|vitroretinal surgery
5029020|NCT01510678|Diet Quality|diet quality
5029021|NCT01510665|Weight gain in pregnancy|weight gain in pregnancy
5029022|NCT01510665|Metabolic and Inflammatory markers|metabolic and inflammatory markers
5029023|NCT01510652|Cardiac Resynchronization therapy,|cardiac resynchronization therapy,
5029024|NCT01510652|Heart Failure,|heart failure,
5029025|NCT01510652|Left Ventricular Lead,|left ventricular lead,
5029026|NCT01510652|Quadripolar Left ventricular Lead,|quadripolar left ventricular lead,
5029027|NCT01510652|Phrenic Nerve Stimulation,|phrenic nerve stimulation,
5029028|NCT01510652|Intra and post operative related complications|intra and post operative related complications
5029029|NCT01510626|Multiple food allergies|multiple food allergies
5029030|NCT01510613|Pomalidomide|pomalidomide
5029031|NCT01510613|Dexamethasone|dexamethasone
5029032|NCT01510613|treatment|treatment
5029033|NCT01510613|AL amyloidosis|al amyloidosis
5029034|NCT01510600|stage 4S neuroblastoma|stage 4s neuroblastoma
5029035|NCT01510600|localized resectable neuroblastoma|localized resectable neuroblastoma
5029036|NCT01510600|localized unresectable neuroblastoma|localized unresectable neuroblastoma
5029037|NCT01510600|recurrent neuroblastoma|recurrent neuroblastoma
5029038|NCT01510600|regional neuroblastoma|regional neuroblastoma
5029039|NCT01510587|obesity|obesity
5029040|NCT01510587|prevention|prevention
5029041|NCT01510587|preteen|preteen
5029042|NCT01510587|nutrition|nutrition
5029043|NCT01510587|physical activity|physical activity
5029044|NCT01510587|body image|body image
5029045|NCT01510587|family dynamics|family dynamics
5029046|NCT01510574|postpartum hemorrhage, PPH, misoprostol|postpartum hemorrhage, pph, misoprostol
5029047|NCT01510561|metastatic pancreatic adenocarcinoma|metastatic pancreatic adenocarcinoma
5029048|NCT01510561|pancreatic cancer|pancreatic cancer
5029049|NCT01510561|metastatic pancreatic cancer|metastatic pancreatic cancer
5029050|NCT01510548|Disc prolapse|disc prolapse
5029051|NCT01510548|Pain|pain
5029052|NCT01510548|Disability|disability
5029053|NCT01510535|Osteoartritis|osteoartritis
5029054|NCT01510535|Knee|knee
5029055|NCT01510535|LBSA0103|lbsa0103
5029056|NCT01510535|Hyruan Plus Inj.|hyruan plus inj.
5029057|NCT01510522|Diabetes|diabetes
5029058|NCT01510522|Glucophage|glucophage
5029059|NCT01510522|Metformin|metformin
5029060|NCT01510522|sachets|sachets
5029061|NCT01510522|tablets|tablets
5029062|NCT01510509|Drug Eluting Stent|drug eluting stent
5029063|NCT01510509|Bioactive Bare Metal Stent|bioactive bare metal stent
5029064|NCT01510496|Chronic pain|chronic pain
5029065|NCT01510496|genetic polymorphisms|genetic polymorphisms
5029066|NCT01510496|postoperative pain|postoperative pain
5029067|NCT01510483|obesity prevention|obesity prevention
5029068|NCT01510483|tobacco prevention|tobacco prevention
5029069|NCT01510483|nutrition|nutrition
5029070|NCT01510483|physical activity|physical activity
5029071|NCT01510483|sedentary activity|sedentary activity
5029072|NCT01510483|tobacco use|tobacco use
5029073|NCT01510483|tobacco exposure|tobacco exposure
5029074|NCT01510483|prevention|prevention
5029075|NCT01510483|clinician intervention|clinician intervention
5029076|NCT01510483|preteen|preteen
5029077|NCT01510483|adolescents|adolescents
5029078|NCT01510470|AstraTech Osseospeed Profile Implant|astratech osseospeed profile implant
5029079|NCT01510470|Marginal bone level|marginal bone level
5029080|NCT01510470|soft tissue|soft tissue
5029081|NCT01510470|soft tissue responds|soft tissue responds
5029082|NCT01510457|Knee Osteoarthritis|knee osteoarthritis
5029083|NCT01510457|Degenerative Joint Disease|degenerative joint disease
5029084|NCT01510457|Chronic Pain|chronic pain
5029085|NCT01510457|Knee Pain|knee pain
5029086|NCT01510418|Hemophilia|hemophilia
5029087|NCT01510418|Spouse|spouse
5029088|NCT01510418|Significant Other|significant other
5029089|NCT01510418|Quality of Life|quality of life
5029090|NCT01510405|Subjects undergoing or who have undergone thoracic surgery for presumed lung cancer.|subjects undergoing or who have undergone thoracic surgery for presumed lung cancer.
5029091|NCT01510405|The following procedures are allowed: Wedge resection, lobectomy, bilobectomy, segmentectomy and pneumonectomy thoracic surgical operations are permitted.|the following procedures are allowed: wedge resection, lobectomy, bilobectomy, segmentectomy and pneumonectomy thoracic surgical operations are permitted.
5029092|NCT01510392|Optical coherence tomography|optical coherence tomography
5029093|NCT01510392|Glaucoma|glaucoma
5029094|NCT01510392|Macula|macula
5029095|NCT01510392|Keratoconus|keratoconus
5029096|NCT01510392|Screening|screening
5029097|NCT01510379|nausea|nausea
5029098|NCT01510379|vomiting|vomiting
5029099|NCT01510379|post-operative|post-operative
5029100|NCT01510379|foregut surgery|foregut surgery
5029101|NCT01510366|Inactivated Poliomyelitis Vaccine|inactivated poliomyelitis vaccine
5029102|NCT01510366|Sabin Strains|sabin strains
5029103|NCT01510366|poliomyelitis|poliomyelitis
5029104|NCT01510340|adherence|adherence
5029105|NCT01510340|HIV|hiv
5029106|NCT01510340|antiretroviral therapy|antiretroviral therapy
5029309|NCT01509469|Sucrose|sucrose
5029107|NCT01510340|tailored web intervention|tailored web intervention
5029108|NCT01510327|drug-eluting stents|drug-eluting stents
5029109|NCT01510327|DES|des
5029110|NCT01510327|atherosclerotic|atherosclerotic
5029111|NCT01510301|Self-report|self-report
5029112|NCT01510301|Self-management|self-management
5029113|NCT01510301|Hypertension|hypertension
5029114|NCT01510301|Adherence|adherence
5029115|NCT01510301|Cell phone|cell phone
5029116|NCT01510301|Drug treatment|drug treatment
5029117|NCT01510301|Medical Adherence|medical adherence
5029118|NCT01510288|GVAX|gvax
5029119|NCT01510288|Ipilimumab|ipilimumab
5029120|NCT01510288|prostate cancer|prostate cancer
5029121|NCT01510275|cardio-thoracic surgery|cardio-thoracic surgery
5029122|NCT01510275|patients|patients
5029123|NCT01510275|pulmonary volume|pulmonary volume
5029124|NCT01510275|respiratory muscle performance|respiratory muscle performance
5029125|NCT01510262|Repeat STI patients|repeat sti patients
5029126|NCT01510262|HIV|hiv
5029127|NCT01510262|Cost effectiveness|cost effectiveness
5029128|NCT01510262|Resource scarce|resource scarce
5029129|NCT01510262|Urban clinics|urban clinics
5029130|NCT01510249|calcaneal spur|calcaneal spur
5029131|NCT01510249|shock wave therapy|shock wave therapy
5029132|NCT01510249|ultrasound therapy|ultrasound therapy
5029133|NCT01510236|Adolescence|adolescence
5029134|NCT01510236|Cancer|cancer
5029135|NCT01510236|Depression|depression
5029136|NCT01510236|Anxiety|anxiety
5029137|NCT01510236|Self-help via internet|self-help via internet
5029138|NCT01510223|Fats|fats
5029139|NCT01510223|Macronutrients|macronutrients
5029140|NCT01510223|appetite|appetite
5029141|NCT01510223|gastric emptying|gastric emptying
5029142|NCT01510223|Gastrointestinal transit|gastrointestinal transit
5029143|NCT01510210|Atrial Fibrillation|atrial fibrillation
5029144|NCT01510210|Arrhythmia|arrhythmia
5029145|NCT01510210|Rhythm control|rhythm control
5029146|NCT01510197|Atrial Fibrillation|atrial fibrillation
5029147|NCT01510197|Arrhythmia|arrhythmia
5029148|NCT01510197|Rhythm control|rhythm control
5029149|NCT01510171|platelet inhibitor|platelet inhibitor
5029150|NCT01510171|ST-segment elevation myocardial infarction|st-segment elevation myocardial infarction
5029151|NCT01510171|stent|stent
5029152|NCT01510171|prasugrel|prasugrel
5029153|NCT01510171|ticagrelor|ticagrelor
5029154|NCT01510145|Glaucoma|glaucoma
5029155|NCT01510145|Open-angle glaucoma|open-angle glaucoma
5029156|NCT01510145|Ocular hypertension|ocular hypertension
5029157|NCT01510145|Hypertension|hypertension
5029158|NCT01510145|Eye Diseases|eye diseases
5029159|NCT01510145|Vascular Diseases|vascular diseases
5029160|NCT01510145|Cardiovascular Diseases|cardiovascular diseases
5029161|NCT01510145|Travoprost|travoprost
5029162|NCT01510145|Antihypertensive Agents|antihypertensive agents
5029163|NCT01510145|Cardiovascular Agents|cardiovascular agents
5029164|NCT01510145|Therapeutic Uses|therapeutic uses
5029165|NCT01510145|Pharmacologic Actions|pharmacologic actions
5029166|NCT01510132|OAG|oag
5029167|NCT01510132|OHT|oht
5029168|NCT01510093|type 2 diabetes mellitus, endogenous insulin|type 2 diabetes mellitus, endogenous insulin
5029169|NCT01510080|Computer-assisted live supervision|computer-assisted live supervision
5029170|NCT01510080|"Bug-in-the-eye supervision"|"bug-in-the-eye supervision"
5029171|NCT01510080|Delayed video-based supervision|delayed video-based supervision
5029172|NCT01510080|Cognitive behavioral therapy supervision|cognitive behavioral therapy supervision
5029173|NCT01510067|CLE|cle
5029174|NCT01510067|Lupus|lupus
5029175|NCT01510067|Lupus Erythematosus|lupus erythematosus
5029176|NCT01510054|miRNA in endometrium|mirna in endometrium
5029177|NCT01510041|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
5029178|NCT01510041|Physical therapy|physical therapy
5029179|NCT01510041|Dyspnea|dyspnea
5029180|NCT01510041|Inspiratory muscle training|inspiratory muscle training
5029181|NCT01510041|Activities of daily living|activities of daily living
5029182|NCT01510028|Intrathecal Drug Delivery Device (IDDD)|intrathecal drug delivery device (iddd)
5029183|NCT01510028|Recombinant human arylsulfatase A (rhASA)|recombinant human arylsulfatase a (rhasa)
5029184|NCT01510028|Metachromatic Leukodystrophy (MLD)|metachromatic leukodystrophy (mld)
5029185|NCT01510015|cannabis|cannabis
5029186|NCT01510015|psychostimulants|psychostimulants
5029187|NCT01510015|psychosis|psychosis
5029188|NCT01510002|papillary thyroid cancer|papillary thyroid cancer
5029189|NCT01510002|central neck dissection|central neck dissection
5029190|NCT01510002|survival|survival
5029191|NCT01510002|locoregional control|locoregional control
5029192|NCT01510002|morbidity|morbidity
5029193|NCT01509989|Adherence|adherence
5029194|NCT01509989|Compliance|compliance
5029195|NCT01509989|Systemic Lupus Erythematosus|systemic lupus erythematosus
5029196|NCT01509989|Hydroxychloroquine|hydroxychloroquine
5029197|NCT01509989|Blood monitoring|blood monitoring
5029198|NCT01509989|Flares|flares
5029199|NCT01509976|Triclosan|triclosan
5029200|NCT01509976|Triclocarban|triclocarban
5029201|NCT01509976|Microbial flora|microbial flora
5029202|NCT01509976|Obesity|obesity
5029203|NCT01509963|MSKCC nomogram|mskcc nomogram
5029204|NCT01509963|Tenon score|tenon score
5029205|NCT01509963|metastatic SN|metastatic sn
5029206|NCT01509963|low risk of metastatic non-SN|low risk of metastatic non-sn
5029207|NCT01509963|additional ALND|additional alnd
5029208|NCT01509937|end stage renal disease|end stage renal disease
5029209|NCT01509937|maintenance hemodialysis|maintenance hemodialysis
5029210|NCT01509937|dry weight|dry weight
5029211|NCT01509937|bioimpedance spectroscopy analysis|bioimpedance spectroscopy analysis
5029212|NCT01509937|body composition monitor|body composition monitor
5029213|NCT01509937|Fresenius BCM|fresenius bcm
5029214|NCT01509937|Ultrafiltration|ultrafiltration
5029215|NCT01509924|Walking capacity|walking capacity
5029216|NCT01509924|Mental Fatigue|mental fatigue
5029217|NCT01509924|Quality of Life|quality of life
5029218|NCT01509924|Cognition|cognition
5029219|NCT01509924|Motor activity|motor activity
5029220|NCT01509924|Exercise|exercise
5029221|NCT01509872|Trauma-Focused Cognitive Behavior Therapy|trauma-focused cognitive behavior therapy
5029222|NCT01509872|War-affected Children|war-affected children
5029223|NCT01509872|Post-traumatic Stress Symptoms|post-traumatic stress symptoms
5029224|NCT01509872|Psychosocial Distress|psychosocial distress
5029225|NCT01509859|proximal femur nail|proximal femur nail
5029226|NCT01509859|pfna|pfna
5029227|NCT01509859|intertan|intertan
5029228|NCT01509859|weight bearing|weight bearing
5029229|NCT01509859|pertrochanteric fracture|pertrochanteric fracture
5029230|NCT01509859|femur neck fracture|femur neck fracture
5029231|NCT01509846|Shigella|shigella
5029232|NCT01509846|vaccine|vaccine
5029233|NCT01509846|shigellosis|shigellosis
5029234|NCT01509846|dysentery|dysentery
5029235|NCT01509846|whole cell|whole cell
5029236|NCT01509833|ICSI Ovarian stimulation|icsi ovarian stimulation
5029237|NCT01509833|hCG low dose|hcg low dose
5029238|NCT01509833|Oocyte maturity|oocyte maturity
5029239|NCT01509833|poor respond|poor respond
5029240|NCT01509807|Ileostomy reversal|ileostomy reversal
5029241|NCT01509794|CME|cme
5029242|NCT01509794|Simulation|simulation
5029243|NCT01509794|Affective engagement|affective engagement
5029244|NCT01509794|Cognitive performance|cognitive performance
5029245|NCT01509781|simple mastectomy|simple mastectomy
5029246|NCT01509781|modified radical mastectomy|modified radical mastectomy
5029247|NCT01509781|wound care|wound care
5029248|NCT01509781|suction drain|suction drain
5029249|NCT01509781|adaptive suture|adaptive suture
5029250|NCT01509768|MPS IIIB|mps iiib
5029251|NCT01509729|Knee|knee
5029252|NCT01509729|Arthroscopy|arthroscopy
5029253|NCT01509729|Lidocaine patch|lidocaine patch
5029254|NCT01509729|Pain management after knee arthroscopy|pain management after knee arthroscopy
5029255|NCT01509716|Predialysis|predialysis
5029256|NCT01509703|COPD|copd
5029257|NCT01509703|Nasal High Flow Therapy|nasal high flow therapy
5029258|NCT01509703|tracheotomy stent|tracheotomy stent
5029259|NCT01509703|tracheotomy|tracheotomy
5029260|NCT01509690|Incident|incident
5029261|NCT01509690|Hemodialysis|hemodialysis
5029262|NCT01509677|Roflumilast|roflumilast
5029263|NCT01509677|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5029264|NCT01509677|COPD|copd
5029265|NCT01509651|antagonists neuromuscular block|antagonists neuromuscular block
5029266|NCT01509651|neuromuscular block, monitoring|neuromuscular block, monitoring
5029267|NCT01509651|neuromuscular function|neuromuscular function
5029268|NCT01509638|Ileostomy reversal|ileostomy reversal
5029269|NCT01509625|Fulvestrant|fulvestrant
5029270|NCT01509625|Faslodex|faslodex
5029271|NCT01509612|cancer|cancer
5029272|NCT01509612|additive homeopathy|additive homeopathy
5029273|NCT01509612|patients with advanced malignant tumors|patients with advanced malignant tumors
5029274|NCT01509599|Venous disease|venous disease
5029275|NCT01509599|Venous disorders|venous disorders
5029276|NCT01509599|Venous insufficiency|venous insufficiency
5029277|NCT01509599|Venous ulcers|venous ulcers
5029278|NCT01509599|Cryotherapy|cryotherapy
5029279|NCT01509586|smoking|smoking
5029280|NCT01509586|smoking cessation|smoking cessation
5029281|NCT01509586|Potentially Reduced Exposure Products (PREPs)|potentially reduced exposure products (preps)
5029282|NCT01509573|prevention therapy|prevention therapy
5029283|NCT01509573|depressive symptoms|depressive symptoms
5029284|NCT01509573|anxiety|anxiety
5029285|NCT01509573|parenting|parenting
5029286|NCT01509573|family functioning|family functioning
5029287|NCT01509573|resilience, psychological|resilience, psychological
5029288|NCT01509573|Developing countries|developing countries
5029289|NCT01509573|Rwanda|rwanda
5029290|NCT01509573|HIV/AIDS|hiv/aids
5029291|NCT01509534|pacemaker|pacemaker
5029292|NCT01509534|implantable loop recorder|implantable loop recorder
5029293|NCT01509534|syncope|syncope
5029294|NCT01509521|Spectroscopy, Near-Infrared|spectroscopy, near-infrared
5029295|NCT01509521|Fetal heartrate|fetal heartrate
5029296|NCT01509521|Ephedrine|ephedrine
5029297|NCT01509521|Phenylephrine|phenylephrine
5029298|NCT01509508|HIV|hiv
5029299|NCT01509508|Prevention|prevention
5029300|NCT01509508|Treatment|treatment
5029301|NCT01509508|South Africa|south africa
5029302|NCT01509495|Heart Failure|heart failure
5029303|NCT01509495|HF|hf
5029304|NCT01509482|insulin resistance|insulin resistance
5029305|NCT01509482|unexplained azoospermia|unexplained azoospermia
5029306|NCT01509482|unexplained oligospermia|unexplained oligospermia
5029307|NCT01509469|Ileal brake|ileal brake
5029310|NCT01509469|Ileal infusion|ileal infusion
5029311|NCT01509456|bone metabolism|bone metabolism
5029312|NCT01509456|potassium bicarbonate|potassium bicarbonate
5029313|NCT01509456|alkaline salt|alkaline salt
5029314|NCT01509456|acid base balance|acid base balance
5029315|NCT01509456|bed rest|bed rest
5029316|NCT01509443|Asthma|asthma
5029317|NCT01509443|Obesity|obesity
5029318|NCT01509443|Breathing exercise|breathing exercise
5029319|NCT01509417|pyloric stenosis|pyloric stenosis
5029320|NCT01509404|CMV|cmv
5029321|NCT01509404|cytomegalovirus|cytomegalovirus
5029322|NCT01509404|transplant|transplant
5029323|NCT01509378|ICD|icd
5029324|NCT01509378|ATP therapy|atp therapy
5029325|NCT01509378|Rescue Shock therapy|rescue shock therapy
5029326|NCT01509365|cardiovascular disease|cardiovascular disease
5029327|NCT01509365|maintenance dose|maintenance dose
5029328|NCT01509365|clopidogrel|clopidogrel
5029329|NCT01509365|overweight|overweight
5029330|NCT01509365|antiplatelet agents|antiplatelet agents
5029331|NCT01509352|fundoplication|fundoplication
5029332|NCT01509352|gastric reflux|gastric reflux
5029333|NCT01509339|Vancomycin|vancomycin
5029334|NCT01509339|Inhalation|inhalation
5029335|NCT01509339|Nebulization|nebulization
5029336|NCT01509339|Pharmacokinetics|pharmacokinetics
5029337|NCT01509326|headache|headache
5029338|NCT01509326|chiropractic|chiropractic
5029339|NCT01509326|manipulation|manipulation
5029340|NCT01509326|acupressure|acupressure
5029341|NCT01509326|self-care|self-care
5029342|NCT01509313|endometrial polyps|endometrial polyps
5029343|NCT01509313|uterine polyps|uterine polyps
5029344|NCT01509313|morcellator|morcellator
5029345|NCT01509313|hysteroscopy|hysteroscopy
5029346|NCT01509300|TBI|tbi
5029347|NCT01509300|Fludarabine|fludarabine
5029348|NCT01509300|CD3 depletion|cd3 depletion
5029349|NCT01509300|Children and adolescents|children and adolescents
5029350|NCT01509300|Haploidentical hematopoietic stem cell transplantation|haploidentical hematopoietic stem cell transplantation
5029351|NCT01509287|Donnai-Barrow Syndrome (DBS)|donnai-barrow syndrome (dbs)
5029352|NCT01509287|metabolic testing|metabolic testing
5029353|NCT01509287|genes|genes
5029354|NCT01509287|genetic|genetic
5029355|NCT01509274|Plantar fasciitis|plantar fasciitis
5029356|NCT01509274|Plasma|plasma
5029357|NCT01509274|PRP|prp
5029358|NCT01509274|Heel pain|heel pain
5029359|NCT01509261|Erosive Esophagitis|erosive esophagitis
5029360|NCT01509261|Ilaprazole|ilaprazole
5029361|NCT01509261|GERD|gerd
5029362|NCT01509248|Theophylline|theophylline
5029363|NCT01509235|cystic fibrosis|cystic fibrosis
5029364|NCT01509235|Lung function|lung function
5029365|NCT01509235|physical exercise|physical exercise
5029366|NCT01509222|Health promotion|health promotion
5029367|NCT01509222|Dietary Counseling|dietary counseling
5029368|NCT01509209|vasomotor|vasomotor
5029369|NCT01509209|pseudoephedrine|pseudoephedrine
5029370|NCT01509209|levocetirizine|levocetirizine
5029371|NCT01509196|Fenofibric acid|fenofibric acid
5029372|NCT01509196|HIP0901|hip0901
5029373|NCT01509196|Lipidilsupra|lipidilsupra
5029374|NCT01509183|asthma|asthma
5029375|NCT01509183|healthcare utilization costs|healthcare utilization costs
5029376|NCT01509157|Type 1 diabetes|type 1 diabetes
5029377|NCT01509157|Continuous Glucose Monitoring|continuous glucose monitoring
5029378|NCT01509157|Nocturnal Hypoglycemia|nocturnal hypoglycemia
5029379|NCT01509144|Safety of this HIV vaccine|safety of this hiv vaccine
5029380|NCT01509092|traumatic macular hole|traumatic macular hole
5029381|NCT01509092|vitrectomy|vitrectomy
5029382|NCT01509092|observation|observation
5029383|NCT01509066|vegetarian|vegetarian
5029384|NCT01509066|vegan|vegan
5029385|NCT01509066|low calorie|low calorie
5029386|NCT01509066|infertility|infertility
5029387|NCT01509066|PCOS|pcos
5029388|NCT01509053|Schizophrenia|schizophrenia
5029389|NCT01509040|Resuscitated from Out-of-Hospital Cardiac Arrest|resuscitated from out-of-hospital cardiac arrest
5029390|NCT01509027|hemodialysis|hemodialysis
5029391|NCT01509027|hyperphoshatemia|hyperphoshatemia
5029392|NCT01509027|compliance|compliance
5029393|NCT01509014|Statins|statins
5029394|NCT01509014|Adherence|adherence
5029395|NCT01509014|Pharmacists|pharmacists
5029396|NCT01509001|type 2 diabetes|type 2 diabetes
5029397|NCT01509001|metformin|metformin
5029398|NCT01509001|glimepiride|glimepiride
5029399|NCT01509001|glucose control|glucose control
5029400|NCT01509001|vascular reactivity|vascular reactivity
5029401|NCT01509001|Adverse Reaction to Other Drugs and Medicines|adverse reaction to other drugs and medicines
5029402|NCT01508988|ONO-9054|ono-9054
5029403|NCT01508988|adult healthy volunteers|adult healthy volunteers
5029404|NCT01508988|single dose|single dose
5029405|NCT01508988|phase 1|phase 1
5029406|NCT01508975|satiety|satiety
5029407|NCT01508975|obesity|obesity
5029408|NCT01508975|food intake|food intake
5029409|NCT01508962|Disease onset|disease onset
5029410|NCT01508962|Disease progression|disease progression
5029411|NCT01508884|intradermal|intradermal
5029412|NCT01508884|influenza|influenza
5029413|NCT01508884|vaccination|vaccination
5029414|NCT01508845|vitamin D|vitamin d
5029415|NCT01508845|vitamin D absorption|vitamin d absorption
5029516|NCT01508416|Thrombosis|thrombosis
5029416|NCT01508845|vitamin D deficiency|vitamin d deficiency
5029417|NCT01508819|Patients over 75|patients over 75
5029418|NCT01508819|acute pathology|acute pathology
5029419|NCT01508819|ICU admission|icu admission
5029420|NCT01508793|Sleep|sleep
5029421|NCT01508793|Obesity|obesity
5029422|NCT01508793|Children|children
5029423|NCT01508793|Eating behaviors|eating behaviors
5029424|NCT01508793|Activity|activity
5029425|NCT01508754|Continuous positive airway pressure|continuous positive airway pressure
5029426|NCT01508754|Ambulatory blood pressures|ambulatory blood pressures
5029427|NCT01508741|Insomnia|insomnia
5029428|NCT01508741|Frequent Nocturnal Awakening|frequent nocturnal awakening
5029429|NCT01508741|Irritability|irritability
5029430|NCT01508741|Moody|moody
5029431|NCT01508741|Moodiness|moodiness
5029432|NCT01508741|Coping Ability|coping ability
5029433|NCT01508741|Coping Behavior|coping behavior
5029434|NCT01508741|Stress|stress
5029435|NCT01508741|Feeling Overwhelmed|feeling overwhelmed
5029436|NCT01508728|unoperated severe sprain of the knee with partial or total rupture of the anterior|unoperated severe sprain of the knee with partial or total rupture of the anterior
5029437|NCT01508728|cruciate ligament and medial or lateral collateral ligament|cruciate ligament and medial or lateral collateral ligament
5029438|NCT01508715|subacromial|subacromial
5029439|NCT01508715|rotator cuff|rotator cuff
5029440|NCT01508715|impingement|impingement
5029441|NCT01508715|physical therapy|physical therapy
5029442|NCT01508715|eccentric exercise|eccentric exercise
5029443|NCT01508715|concentric exercise|concentric exercise
5029444|NCT01508702|Gout|gout
5029445|NCT01508689|Cereal bar|cereal bar
5029446|NCT01508689|Calcium-fortified|calcium-fortified
5029447|NCT01508689|Calcium intake|calcium intake
5029448|NCT01508676|neuropathic pain|neuropathic pain
5029449|NCT01508676|postherpetic neuralgia|postherpetic neuralgia
5029450|NCT01508676|complex regional pain syndrome|complex regional pain syndrome
5029451|NCT01508676|reflex sympathetic dystrophy|reflex sympathetic dystrophy
5029452|NCT01508663|Coronary artery disease 75years of age or older|coronary artery disease 75years of age or older
5029453|NCT01508650|heart failure|heart failure
5029454|NCT01508637|air pollution|air pollution
5029455|NCT01508637|vasoconstriction|vasoconstriction
5029456|NCT01508637|blood pressure|blood pressure
5029457|NCT01508637|diesel exhaust|diesel exhaust
5029458|NCT01508624|Randomised controlled trial|randomised controlled trial
5029459|NCT01508624|Pain|pain
5029460|NCT01508624|Recovery|recovery
5029461|NCT01508624|Office based surgery|office based surgery
5029462|NCT01508611|dental caries|dental caries
5029463|NCT01508611|permanent teeth|permanent teeth
5029464|NCT01508611|silver diamine fluoride|silver diamine fluoride
5029465|NCT01508611|tooth eruption|tooth eruption
5029466|NCT01508598|Pediatric|pediatric
5029467|NCT01508598|Obesity|obesity
5029468|NCT01508598|Bariatric surgery|bariatric surgery
5029469|NCT01508598|Cardiovascular disease|cardiovascular disease
5029470|NCT01508585|Bariatric surgery|bariatric surgery
5029471|NCT01508585|Cognitive Behavioral Therapy|cognitive behavioral therapy
5029472|NCT01508585|Telephone based CBT|telephone based cbt
5029473|NCT01508585|Obesity|obesity
5029474|NCT01508572|breast cancer|breast cancer
5029475|NCT01508572|VEGF|vegf
5029476|NCT01508572|optical imaging|optical imaging
5029477|NCT01508559|HIV|hiv
5029478|NCT01508559|Neurocognitive|neurocognitive
5029479|NCT01508546|breast cancer|breast cancer
5029480|NCT01508546|axillary dissection|axillary dissection
5029481|NCT01508533|Disease burden|disease burden
5029482|NCT01508533|Rotavirus gastroenteritis|rotavirus gastroenteritis
5029483|NCT01508520|early gastric cancer|early gastric cancer
5029484|NCT01508520|stomach neoplasms|stomach neoplasms
5029485|NCT01508520|magnifying endoscopy|magnifying endoscopy
5029486|NCT01508520|narrow band imaging|narrow band imaging
5029487|NCT01508507|Oral|oral
5029488|NCT01508507|Cholera|cholera
5029489|NCT01508507|Vaccine|vaccine
5029490|NCT01508507|Herd|herd
5029491|NCT01508507|Risk|risk
5029492|NCT01508507|population|population
5029493|NCT01508507|Matched|matched
5029494|NCT01508507|Control|control
5029495|NCT01508507|Case|case
5029496|NCT01508507|Bias|bias
5029497|NCT01508494|modification of fMRI maps after galantamine/placebo|modification of fmri maps after galantamine/placebo
5029498|NCT01508481|Vitamin D|vitamin d
5029499|NCT01508481|Diabetes|diabetes
5029500|NCT01508481|pancreas beta cell function|pancreas beta cell function
5029501|NCT01508481|insulin resistance|insulin resistance
5029502|NCT01508481|Deficiency of Vitamin D3|deficiency of vitamin d3
5029503|NCT01508468|Rituximab|rituximab
5029504|NCT01508468|membranous nephropathy|membranous nephropathy
5029505|NCT01508468|anti-PLA2R antibody|anti-pla2r antibody
5029506|NCT01508429|Postpartum hemorrhage|postpartum hemorrhage
5029507|NCT01508429|PPH|pph
5029508|NCT01508429|misoprostol|misoprostol
5029509|NCT01508429|home deliveries|home deliveries
5029510|NCT01508416|Multiple Myeloma|multiple myeloma
5029511|NCT01508416|Newly diagnosed|newly diagnosed
5029512|NCT01508416|Thrombin generation|thrombin generation
5029513|NCT01508416|TFPI|tfpi
5029514|NCT01508416|Tissue Factor pathway inhibitor|tissue factor pathway inhibitor
5029515|NCT01508416|Protein S|protein s
5029517|NCT01508416|Chemotherapy|chemotherapy
5029518|NCT01508390|prostate|prostate
5029519|NCT01508377|posttraumatic stress disorder|posttraumatic stress disorder
5029520|NCT01508377|internet-based psychotherapy|internet-based psychotherapy
5029521|NCT01508377|cognitive restructuring|cognitive restructuring
5029522|NCT01508377|exposure|exposure
5029523|NCT01508364|renal cell carcinoma, first targeted therapy, observational study|renal cell carcinoma, first targeted therapy, observational study
5029524|NCT01508351|Propofol|propofol
5029525|NCT01508351|Induction|induction
5029526|NCT01508351|Hypotension|hypotension
5029527|NCT01508351|General population|general population
5029528|NCT01508338|HMB beta-hydroxy-beta-methylbutyrate|hmb beta-hydroxy-beta-methylbutyrate
5029529|NCT01508338|ATP (adenosine-triphosphate)|atp (adenosine-triphosphate)
5029530|NCT01508338|trained athletes|trained athletes
5029531|NCT01508325|Bisoprolol|bisoprolol
5029532|NCT01508325|Hypertension|hypertension
5029533|NCT01508325|Blood pressure|blood pressure
5029534|NCT01508325|Heart rate|heart rate
5029535|NCT01508312|CARBOPLATIN|carboplatin
5029536|NCT01508312|ETOPOSIDE (VP-16)|etoposide (vp-16)
5029537|NCT01508312|IFOSFAMIDE|ifosfamide
5029538|NCT01508312|SGN-35 (BRENTUXIMAB VEDOTIN)|sgn-35 (brentuximab vedotin)
5029539|NCT01508312|11-142|11-142
5029540|NCT01508299|skin test|skin test
5029541|NCT01508299|raw food|raw food
5029542|NCT01508299|commercial extract|commercial extract
5029543|NCT01508286|telaprevir|telaprevir
5029544|NCT01508286|hepatitis C|hepatitis c
5029545|NCT01508286|early access program|early access program
5029546|NCT01508273|Breast Cancer|breast cancer
5029547|NCT01508273|Breast Cancer Survivors|breast cancer survivors
5029548|NCT01508273|High risk cancer survivors|high risk cancer survivors
5029549|NCT01508273|Stage II to IIIC breast cancer|stage ii to iiic breast cancer
5029550|NCT01508273|African American|african american
5029551|NCT01508273|AA|aa
5029552|NCT01508273|Hispanic|hispanic
5029553|NCT01508273|Non-Hispanic White|non-hispanic white
5029554|NCT01508273|Operable invasive breast carcinoma|operable invasive breast carcinoma
5029555|NCT01508273|Aerobic and resistance training|aerobic and resistance training
5029556|NCT01508273|Pedometer|pedometer
5029557|NCT01508273|Telephone Counseling Calls|telephone counseling calls
5029558|NCT01508273|Physical activity report|physical activity report
5029559|NCT01508273|PAR|par
5029560|NCT01508273|Functional Assessment of Cancer Therapy-Breast|functional assessment of cancer therapy-breast
5029561|NCT01508273|FACT-B|fact-b
5029562|NCT01508273|Health related quality of life|health related quality of life
5029564|NCT01508260|Leukemia|leukemia
5029565|NCT01508260|Aquapheresis|aquapheresis
5029566|NCT01508260|Ultrafiltration|ultrafiltration
5029567|NCT01508260|Aquadex pump|aquadex pump
5029568|NCT01508260|Severe Fluid Overload|severe fluid overload
5029569|NCT01508260|Diuretic therapy|diuretic therapy
5029570|NCT01508260|Dyspnea|dyspnea
5029571|NCT01508260|Orthopnea|orthopnea
5029572|NCT01508260|Paroxysmal nocturnal dyspnea|paroxysmal nocturnal dyspnea
5029573|NCT01508260|PND|pnd
5029574|NCT01508260|Peripheral edema|peripheral edema
5029575|NCT01508260|Rales|rales
5029576|NCT01508260|Jugular venous distension|jugular venous distension
5029577|NCT01508260|JVD|jvd
5029578|NCT01508260|Hypoxia|hypoxia
5029579|NCT01508260|Pulmonary edema by chest X-ray|pulmonary edema by chest x-ray
5029580|NCT01508260|Furosemide|furosemide
5029581|NCT01508260|Lasix|lasix
5029582|NCT01508247|efficacy|efficacy
5029583|NCT01508247|safety|safety
5029584|NCT01508247|inactivated vaccine (Vero Cell) against EV71|inactivated vaccine (vero cell) against ev71
5029585|NCT01508247|EV71-associated diseases|ev71-associated diseases
5029586|NCT01508221|brain metastasis|brain metastasis
5029587|NCT01508208|Hypertension|hypertension
5029588|NCT01508208|24 hour urine protein|24 hour urine protein
5029589|NCT01508208|Protein/creatinine ratio|protein/creatinine ratio
5029590|NCT01508195|Healthy Volunteers|healthy volunteers
5029591|NCT01508195|Bioequivalence|bioequivalence
5029592|NCT01508195|Canagliflozin (JNJ-28431754)|canagliflozin (jnj-28431754)
5029593|NCT01508195|Metformin IR|metformin ir
5029594|NCT01508182|Healthy Volunteers|healthy volunteers
5029595|NCT01508182|Bioequivalence|bioequivalence
5029596|NCT01508182|Canagliflozin (JNJ-28431754)|canagliflozin (jnj-28431754)
5029597|NCT01508182|Metformin IR|metformin ir
5029598|NCT01508169|elderly|elderly
5029599|NCT01508169|balance|balance
5029600|NCT01508169|insole|insole
5029601|NCT01508169|foot orthosis|foot orthosis
5029602|NCT01508169|orthotics|orthotics
5029603|NCT01508156|Hepatitis C|hepatitis c
5029604|NCT01508156|HCV|hcv
5029605|NCT01508156|treatment-naive|treatment-naive
5029606|NCT01508143|Abortion|abortion
5029607|NCT01508143|Pregnancy|pregnancy
5029608|NCT01508143|Termination|termination
5029609|NCT01508143|Misoprostol|misoprostol
5029610|NCT01508117|GBM|gbm
5029611|NCT01508117|brain tumor|brain tumor
5029612|NCT01508104|solid tumor|solid tumor
5029613|NCT01508104|glioblastoma multiforme|glioblastoma multiforme
5029614|NCT01508104|GBM|gbm
5029615|NCT01508104|brain tumor|brain tumor
5029616|NCT01508104|neuroendocrine tumor|neuroendocrine tumor
5029617|NCT01508091|Obesity|obesity
5029618|NCT01508091|ageing|ageing
5029619|NCT01508052|core temperature|core temperature
5029620|NCT01508052|sequential compression device|sequential compression device
5029621|NCT01508052|total intravenous anesthesia|total intravenous anesthesia
5029622|NCT01508039|Intranasal|intranasal
5029623|NCT01508039|Chitin Micro-particles|chitin micro-particles
5029624|NCT01508039|Immunological Effects|immunological effects
5029625|NCT01508039|Nasal mucosa|nasal mucosa
5029626|NCT01508039|Cytokines|cytokines
5029627|NCT01508039|Immunological Effects from Intranasal Chitin Micro-Particles|immunological effects from intranasal chitin micro-particles
5029628|NCT01508026|Stage 1|stage 1
5029629|NCT01508026|Stage 2|stage 2
5029630|NCT01508026|Hypertension|hypertension
5029631|NCT01508013|Melanoma|melanoma
5029632|NCT01508013|Basal Cell Carcinoma|basal cell carcinoma
5029633|NCT01508013|Squamous Cell Carcinoma|squamous cell carcinoma
5029634|NCT01508000|Liver metastases|liver metastases
5029635|NCT01508000|Colorectal Cancer|colorectal cancer
5029636|NCT01508000|KRAS wild type|kras wild type
5029637|NCT01508000|FOLFOX|folfox
5029638|NCT01508000|Bevacizumab|bevacizumab
5029639|NCT01508000|Panitumumab|panitumumab
5029640|NCT01508000|Randomized|randomized
5029641|NCT01508000|Phase II|phase ii
5029642|NCT01508000|Perioperative treatment|perioperative treatment
5029643|NCT01508000|Adjuvant|adjuvant
5029644|NCT01508000|Neo-adjuvant|neo-adjuvant
5029645|NCT01508000|Surgery|surgery
5029646|NCT01508000|Progression Free Survival|progression free survival
5029647|NCT01507987|Externalized Conductors, visual lead an|externalized conductors, visual lead an
5029648|NCT01507974|preventive|preventive
5029649|NCT01507974|antibiotic treatment|antibiotic treatment
5029650|NCT01507974|urinary tract infection|urinary tract infection
5029651|NCT01507974|pregnancy|pregnancy
5029652|NCT01507974|puerperium|puerperium
5029653|NCT01507948|Posttraumatic Stress Disorder (PTSD)|posttraumatic stress disorder (ptsd)
5029654|NCT01507948|Psychotherapy|psychotherapy
5029655|NCT01507948|non-medication treatment|non-medication treatment
5029656|NCT01507948|Prolonged Exposure|prolonged exposure
5029657|NCT01507948|Transcranial Magnetic Stimulation (TMS)|transcranial magnetic stimulation (tms)
5029658|NCT01507948|Anxiety Disorders|anxiety disorders
5029659|NCT01507948|emotion|emotion
5029660|NCT01507948|emotion regulation|emotion regulation
5029661|NCT01507948|functional MRI|functional mri
5029662|NCT01507948|Affective Symptoms|affective symptoms
5029663|NCT01507935|Healthy infants|healthy infants
5029664|NCT01507935|Infant formula|infant formula
5029665|NCT01507935|Prebiotics oligosaccharides|prebiotics oligosaccharides
5029666|NCT01507935|Colonisation Resistance|colonisation resistance
5029667|NCT01507935|Gut Microbiota|gut microbiota
5029668|NCT01507922|Fenoverine|fenoverine
5029669|NCT01507922|Irritable Bowel Syndrome|irritable bowel syndrome
5029670|NCT01507922|Abdominal pain|abdominal pain
5029671|NCT01507922|BSS|bss
5029672|NCT01507909|EEG|eeg
5029673|NCT01507909|related visual|related visual
5029674|NCT01507909|and verbal cues|and verbal cues
5029675|NCT01507883|Supervision|supervision
5029676|NCT01507883|embryos|embryos
5029677|NCT01507883|Resulting|resulting
5029678|NCT01507870|body mass index|body mass index
5029679|NCT01507857|EV71 vaccine|ev71 vaccine
5029680|NCT01507857|HFMD|hfmd
5029681|NCT01507857|efficacy|efficacy
5029682|NCT01507857|EV71 associated disease|ev71 associated disease
5029683|NCT01507844|COPD|copd
5029684|NCT01507844|CPAP|cpap
5029685|NCT01507844|Sham|sham
5029686|NCT01507844|FEV1|fev1
5029687|NCT01507844|IC|ic
5029688|NCT01507844|RV/TLC|rv/tlc
5029689|NCT01507818|Arthroscopic Rotator Cuff Repair|arthroscopic rotator cuff repair
5029690|NCT01507818|Electromagnetic field treatment|electromagnetic field treatment
5029691|NCT01507818|Pulsed Radio Frequency treatment|pulsed radio frequency treatment
5029692|NCT01507818|Non-invasive|non-invasive
5029693|NCT01507818|Non-thermal|non-thermal
5029694|NCT01507805|Electroacupuncture|electroacupuncture
5029695|NCT01507805|preconditioning|preconditioning
5029696|NCT01507805|Non-cardiac surgery|non-cardiac surgery
5029697|NCT01507805|Coronary heart disease|coronary heart disease
5029698|NCT01507792|Cough|cough
5029699|NCT01507792|Laryngismus|laryngismus
5029700|NCT01507792|Bronchial spasm|bronchial spasm
5029701|NCT01507792|Deficiency diseases|deficiency diseases
5029702|NCT01507766|severe acute pancreatitis|severe acute pancreatitis
5029703|NCT01507766|intra-abdominal pressure|intra-abdominal pressure
5029704|NCT01507766|enteral nutrition|enteral nutrition
5029705|NCT01507753|childhood bipolar disorder|childhood bipolar disorder
5029706|NCT01507727|hyponatremia|hyponatremia
5029707|NCT01507727|Non-hypovolemic and Non-acute hyponatremia|non-hypovolemic and non-acute hyponatremia
5029708|NCT01507727|Tolvaptan|tolvaptan
5029709|NCT01507714|Preventive|preventive
5029710|NCT01507714|tvt-o|tvt-o
5029711|NCT01507714|stress incontinence|stress incontinence
5029712|NCT01507701|adolescents|adolescents
5029713|NCT01507688|Stroke|stroke
5029714|NCT01507675|suicide|suicide
5029715|NCT01507675|psychometric properties|psychometric properties
5029716|NCT01507675|military|military
5029717|NCT01507675|veterans|veterans
5029718|NCT01507675|Interpersonal needs questionnaire|interpersonal needs questionnaire
5029719|NCT01507675|Acquired capability for suicide|acquired capability for suicide
5029720|NCT01507675|mental health|mental health
5029721|NCT01507675|Survey of Life Principles|survey of life principles
5029722|NCT01507675|Risk assessment|risk assessment
5029723|NCT01507662|Bone Density|bone density
5029724|NCT01507662|Absorptiometry, Photon|absorptiometry, photon
5029725|NCT01507662|Osteoporosis|osteoporosis
5029726|NCT01507662|Bone, Diseases, Metabolic|bone, diseases, metabolic
5029727|NCT01507662|Patient Education as Topic|patient education as topic
5029728|NCT01507662|Fractures, Bone/Prevention and Control|fractures, bone/prevention and control
5029729|NCT01507649|postnatal depression|postnatal depression
5029730|NCT01507649|quality of life|quality of life
5029731|NCT01507636|apraxia|apraxia
5029732|NCT01507636|occupational therapy|occupational therapy
5029733|NCT01507636|multiple sclerosis|multiple sclerosis
5029734|NCT01507636|manual dexterity|manual dexterity
5029735|NCT01507623|NAPS|naps
5029736|NCT01507623|Hypoxia|hypoxia
5029737|NCT01507623|Propofol|propofol
5029738|NCT01507623|capnography|capnography
5029739|NCT01507623|endoscopy|endoscopy
5029740|NCT01507623|Sedation|sedation
5029741|NCT01507610|sumatriptan|sumatriptan
5029742|NCT01507610|bioavailability|bioavailability
5029743|NCT01507597|Glucagon-like peptide-1|glucagon-like peptide-1
5029744|NCT01507597|Glucagon|glucagon
5029745|NCT01507597|Normal physiology|normal physiology
5029746|NCT01507597|T2DM|t2dm
5029747|NCT01507597|T1DM|t1dm
5029748|NCT01507571|Incurable cancer|incurable cancer
5029749|NCT01507571|Palliative care|palliative care
5029750|NCT01507571|Dignity Therapy|dignity therapy
5029751|NCT01507571|Loss of dignity|loss of dignity
5029752|NCT01507571|Patient Dignity Intventory|patient dignity intventory
5029753|NCT01507571|Eortc QLQ-C15-PAL|eortc qlq-c15-pal
5029754|NCT01507571|Structured Interview for Symptoms and Concerns|structured interview for symptoms and concerns
5029755|NCT01507571|Hospital Anxiety and Depression Scale|hospital anxiety and depression scale
5029756|NCT01507558|Peripheral Arterial Disease|peripheral arterial disease
5029757|NCT01507558|Femoral popliteal lesions|femoral popliteal lesions
5029758|NCT01507545|mCRC|mcrc
5029759|NCT01507545|chemorefractory metastatic colorectal cancer|chemorefractory metastatic colorectal cancer
5029760|NCT01507506|Glioblastoma|glioblastoma
5029761|NCT01507506|Radiotherapy|radiotherapy
5029762|NCT01507506|Intensity modulated radiation therapy (IMRT)|intensity modulated radiation therapy (imrt)
5029763|NCT01507506|Magnetic resonance spectroscopic imaging (MRSI)|magnetic resonance spectroscopic imaging (mrsi)
5029764|NCT01507493|gene polymorphism|gene polymorphism
5029765|NCT01507493|SCN9A|scn9a
5029766|NCT01507493|pain perception|pain perception
5029767|NCT01507493|postoperative pain|postoperative pain
5029768|NCT01507480|Hemorrhagic Hereditary Telangiectasia (HHT)|hemorrhagic hereditary telangiectasia (hht)
5029769|NCT01507480|Antiangiogenic therapies|antiangiogenic therapies
5029770|NCT01507480|Bevacizumab|bevacizumab
5029771|NCT01507467|Head and neck carcinoma|head and neck carcinoma
5029772|NCT01507467|Accelerated radiotherapy|accelerated radiotherapy
5029773|NCT01507467|Hypoxic modification with Nimorazole|hypoxic modification with nimorazole
5029774|NCT01507441|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
5029775|NCT01507441|childhood acute myeloid leukemia/other myeloid malignancies|childhood acute myeloid leukemia/other myeloid malignancies
5029776|NCT01507441|childhood acute megakaryocytic leukemia (M7)|childhood acute megakaryocytic leukemia (m7)
5029777|NCT01507415|Cohort Studies|cohort studies
5029778|NCT01507415|Longitudinal Studies|longitudinal studies
5029779|NCT01507415|Patient Readmission|patient readmission
5029780|NCT01507415|Hospitalization|hospitalization
5029781|NCT01507415|Disability Evaluation|disability evaluation
5029782|NCT01507376|Ovulation induction|ovulation induction
5029783|NCT01507376|urinary|urinary
5029784|NCT01507376|hCG|hcg
5029785|NCT01507376|recombinant hCG|recombinant hcg
5029786|NCT01507350|obesity related glmerulopathy|obesity related glmerulopathy
5029787|NCT01507350|51 Cr-EDTA clearance|51 cr-edta clearance
5029788|NCT01507350|impaired renal function|impaired renal function
5029789|NCT01507350|gastric band|gastric band
5029790|NCT01507350|GFR measurement|gfr measurement
5029791|NCT01507350|gastric bypass|gastric bypass
5029792|NCT01507350|sleeve gastrectomy|sleeve gastrectomy
5029793|NCT01507298|Physical activity|physical activity
5029794|NCT01507298|Accelerometry|accelerometry
5029795|NCT01507298|Oesophageal pH|oesophageal ph
5029796|NCT01507298|Capsule endoscopy|capsule endoscopy
5029797|NCT01507259|Determine effect on cerebral vasculature|determine effect on cerebral vasculature
5029798|NCT01507246|open colectomy|open colectomy
5029799|NCT01507233|open colectomy|open colectomy
5029800|NCT01507233|colectomy|colectomy
5029801|NCT01507220|open colectomy|open colectomy
5029802|NCT01507207|Dysphagia|dysphagia
5029803|NCT01507207|aspiration|aspiration
5029804|NCT01507207|pediatric|pediatric
5029805|NCT01507207|injection laryngoplasty|injection laryngoplasty
5029806|NCT01507181|suicidal ideation|suicidal ideation
5029807|NCT01507181|major depression|major depression
5029808|NCT01507181|treatment resistant|treatment resistant
5029809|NCT01507181|ketamine|ketamine
5029810|NCT01507181|glutamate|glutamate
5029811|NCT01507155|Major|major
5029812|NCT01507155|Depressive|depressive
5029813|NCT01507155|Disorder|disorder
5029814|NCT01507155|Depression|depression
5029815|NCT01507155|MDD|mdd
5029816|NCT01507155|Treatment Resistant|treatment resistant
5029817|NCT01507155|Anxiety|anxiety
5029818|NCT01507155|GAD|gad
5029819|NCT01507142|saliva|saliva
5029820|NCT01507142|diagnostics|diagnostics
5029821|NCT01507142|HIV|hiv
5029822|NCT01507142|AIDS|aids
5029823|NCT01507129|dehydration|dehydration
5029824|NCT01507129|plasma|plasma
5029825|NCT01507129|osmolality|osmolality
5029826|NCT01507129|saliva|saliva
5029827|NCT01507129|urine|urine
5029828|NCT01507129|biomarkers|biomarkers
5029829|NCT01507129|hypertonic|hypertonic
5029830|NCT01507129|isotonic|isotonic
5029831|NCT01507129|hydration|hydration
5029832|NCT01507103|Tecemotide (L-BLP25)|tecemotide (l-blp25)
5029833|NCT01507103|Cyclophosphamide (CPA)|cyclophosphamide (cpa)
5029834|NCT01507103|Mode of action|mode of action
5029835|NCT01507103|Neoplasms|neoplasms
5029836|NCT01507103|Neoplasms by Site|neoplasms by site
5029837|NCT01507103|Carcinomas|carcinomas
5029838|NCT01507103|Antineoplastic Agents|antineoplastic agents
5029839|NCT01507103|Neoadjuvant|neoadjuvant
5029840|NCT01507103|Radiotherapy Pharmacologic Actions|radiotherapy pharmacologic actions
5029841|NCT01507103|Immunosuppressive Agents|immunosuppressive agents
5029842|NCT01507103|Immunologic Function|immunologic function
5029843|NCT01507103|Therapeutic Uses|therapeutic uses
5029844|NCT01507103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
5029845|NCT01507090|children for whom there is no scale to determine weight|children for whom there is no scale to determine weight
5029846|NCT01507077|Obese|obese
5029847|NCT01507077|Obesity|obesity
5029848|NCT01507077|Overweight|overweight
5029849|NCT01507064|hepatocellular carcinoma|hepatocellular carcinoma
5029850|NCT01507064|sorafenib|sorafenib
5029851|NCT01507064|laser ablation|laser ablation
5029852|NCT01507051|Rivaroxaban|rivaroxaban
5029853|NCT01507051|Xa-Factors|xa-factors
5029854|NCT01507051|Warfarin|warfarin
5029855|NCT01507051|Thrombosis|thrombosis
5029856|NCT01507051|Embolism|embolism
5029857|NCT01507038|Diabetes Mellitus|diabetes mellitus
5029858|NCT01507038|YH14617|yh14617
5029859|NCT01507038|Exenatide|exenatide
5029860|NCT01507038|Yuhan|yuhan
5029861|NCT01507025|hinge position|hinge position
5029862|NCT01507025|dry eye|dry eye
5029863|NCT01507012|Berry phenolics|berry phenolics
5029864|NCT01507012|mood|mood
5029865|NCT01507012|cognition|cognition
5029866|NCT01507012|adults|adults
5029867|NCT01506999|Angina Pectoris|angina pectoris
5029868|NCT01506999|SNPs|snps
5029869|NCT01506999|Genetic|genetic
5029870|NCT01506999|Myocardial Infarction|myocardial infarction
5029871|NCT01506999|Cardiovascular Risk Factors|cardiovascular risk factors
5029872|NCT01506986|Ulcer bleeding|ulcer bleeding
5029873|NCT01506986|Aspirin|aspirin
5029874|NCT01506986|Helicobacter pylori|helicobacter pylori
5029875|NCT01506986|H. pylori|h. pylori
5029876|NCT01506986|Hospitalisation for ulcer bleeding|hospitalisation for ulcer bleeding
5029877|NCT01506973|histologically or cytologically documented|histologically or cytologically documented
5029878|NCT01506947|Hemodialysis|hemodialysis
5029879|NCT01506947|Chronic kidney disease|chronic kidney disease
5029880|NCT01506947|Secondary hyperparathyroidism,|secondary hyperparathyroidism,
5029881|NCT01506921|racemic ketamine|racemic ketamine
5029882|NCT01506921|S-ketamine|s-ketamine
5029883|NCT01506921|Cerebral blood flow|cerebral blood flow
5029884|NCT01506921|Magnetic resonance imaging|magnetic resonance imaging
5029885|NCT01506921|arterial spin labeling|arterial spin labeling
5029886|NCT01506921|healthy volunteers|healthy volunteers
5029887|NCT01506908|craving|craving
5029888|NCT01506895|Diabetic Macular Edema|diabetic macular edema
5029889|NCT01506856|Epithelial ovarian cancer|epithelial ovarian cancer
5029890|NCT01506856|Fallopian tube cancer|fallopian tube cancer
5029891|NCT01506856|peritoneal cancer|peritoneal cancer
5029892|NCT01506856|intraperitoneal therapy|intraperitoneal therapy
5029893|NCT01506856|Carboplatin|carboplatin
5029894|NCT01506856|Paclitaxel|paclitaxel
5029895|NCT01506843|IgA antibody|iga antibody
5029896|NCT01506843|IgE antibody|ige antibody
5029897|NCT01506843|IgG1/IgG4 subclasses|igg1/igg4 subclasses
5029898|NCT01506843|Mite allergy|mite allergy
5029899|NCT01506843|Sublingual immunotherapy|sublingual immunotherapy
5029900|NCT01506843|Saliva|saliva
5029901|NCT01506830|Adhesives.|adhesives.
5029902|NCT01506830|Composites.|composites.
5029903|NCT01506830|Noncarious cervical lesions.|noncarious cervical lesions.
5029904|NCT01506830|Clinical performance.|clinical performance.
5029905|NCT01506830|Treatment|treatment
5029906|NCT01506817|fibromyalgia|fibromyalgia
5029907|NCT01506817|DCE-MRI|dce-mri
5029908|NCT01506817|neurogenic inflammation|neurogenic inflammation
5029909|NCT01506817|contrast-enhancement patterns|contrast-enhancement patterns
5029910|NCT01506804|Shoulder|shoulder
5029911|NCT01506804|Impingement|impingement
5029912|NCT01506804|Ultrasound|ultrasound
5029913|NCT01506804|injection of glucocorticosteroid|injection of glucocorticosteroid
5029914|NCT01506804|exercise|exercise
5029915|NCT01506791|Bioequivalence|bioequivalence
5029916|NCT01506791|Desloratadine and pseudoephedrine|desloratadine and pseudoephedrine
5029917|NCT01506791|crossover|crossover
5030021|NCT01506453|Vincristine|vincristine
5029918|NCT01506778|Endometrial Sampling Procedure|endometrial sampling procedure
5029919|NCT01506778|Likert Scala|likert scala
5029920|NCT01506778|Pipelle|pipelle
5029921|NCT01506778|Tenaculum|tenaculum
5029922|NCT01506778|Visual Analog Pain Scala|visual analog pain scala
5029923|NCT01506765|Schizophrenia|schizophrenia
5029924|NCT01506765|glutathione|glutathione
5029925|NCT01506765|NAC|nac
5029926|NCT01506765|Neurological scales|neurological scales
5029927|NCT01506765|Magnetic Resonance Spectroscopy (MRS)|magnetic resonance spectroscopy (mrs)
5029928|NCT01506765|EEG/evoked potentials|eeg/evoked potentials
5029929|NCT01506765|fibroblasts|fibroblasts
5029930|NCT01506765|patients who receive NAC|patients who receive nac
5029931|NCT01506765|patients who receive placebo|patients who receive placebo
5029932|NCT01506752|Bioequivalence|bioequivalence
5029933|NCT01506752|Healthy Subjects|healthy subjects
5029934|NCT01506752|Donepezil|donepezil
5029935|NCT01506739|Bioequivalence|bioequivalence
5029936|NCT01506739|Healthy Subjects|healthy subjects
5029937|NCT01506739|Donepezil|donepezil
5029938|NCT01506726|anemia|anemia
5029939|NCT01506726|unexplained anemia|unexplained anemia
5029940|NCT01506726|elderly|elderly
5029941|NCT01506726|geriatric|geriatric
5029942|NCT01506726|older adults|older adults
5029943|NCT01506726|UAE|uae
5029944|NCT01506726|over 65|over 65
5029945|NCT01506726|salsalate|salsalate
5029946|NCT01506726|PACTTE|pactte
5029947|NCT01506726|pactee|pactee
5029948|NCT01506726|aging|aging
5029949|NCT01506726|aged|aged
5029950|NCT01506726|old|old
5029951|NCT01506726|older|older
5029952|NCT01506687|Colorectal cancer screening|colorectal cancer screening
5029953|NCT01506687|50 years or older|50 years or older
5029954|NCT01506661|Rheumatoid arthritis|rheumatoid arthritis
5029955|NCT01506661|vaccination|vaccination
5029956|NCT01506661|immune response|immune response
5029957|NCT01506661|varicella zoster|varicella zoster
5029958|NCT01506609|PARP|parp
5029959|NCT01506609|TMZ|tmz
5029960|NCT01506609|Temodal|temodal
5029961|NCT01506609|Carboplatin|carboplatin
5029962|NCT01506609|veliparib|veliparib
5029963|NCT01506609|BRCA2 mutation carrier|brca2 mutation carrier
5029964|NCT01506609|Breast cancer|breast cancer
5029965|NCT01506609|Metastatic breast cancer|metastatic breast cancer
5029966|NCT01506609|temozolomide|temozolomide
5029967|NCT01506609|BRCA1 mutation carrier|brca1 mutation carrier
5029968|NCT01506609|ABT-888|abt-888
5029969|NCT01506609|Paclitaxel|paclitaxel
5029970|NCT01506609|Recurrent breast cancer|recurrent breast cancer
5029971|NCT01506609|Temodar|temodar
5029972|NCT01506609|Locally recurrent|locally recurrent
5029973|NCT01506596|Liposarcoma|liposarcoma
5029974|NCT01506583|cough|cough
5029975|NCT01506583|myalgia|myalgia
5029976|NCT01506583|nasal obstruction|nasal obstruction
5029977|NCT01506583|sore throat|sore throat
5029978|NCT01506583|headache|headache
5029979|NCT01506583|fatigue|fatigue
5029980|NCT01506583|feverishness|feverishness
5029981|NCT01506583|Patients who exhibit flu-like symptoms during a flu season, including cough, myalgia, nasal obstruction, sore throat, headache, fatigue, and/or feverishness.|patients who exhibit flu-like symptoms during a flu season, including cough, myalgia, nasal obstruction, sore throat, headache, fatigue, and/or feverishness.
5029982|NCT01506557|vitamin D|vitamin d
5029983|NCT01506557|vitamin D deficiency|vitamin d deficiency
5029984|NCT01506557|breastfeeding|breastfeeding
5029985|NCT01506557|body composition|body composition
5029986|NCT01506557|bone mineral content|bone mineral content
5029987|NCT01506544|HU|hu
5029988|NCT01506544|Hydroxyurea|hydroxyurea
5029989|NCT01506544|Sickle cell|sickle cell
5029990|NCT01506544|Pediatric|pediatric
5029991|NCT01506531|gastroschisis|gastroschisis
5029992|NCT01506531|silo|silo
5029993|NCT01506531|primary closure|primary closure
5029994|NCT01506518|Muscular Dystrophy, Duchenne|muscular dystrophy, duchenne
5029995|NCT01506518|Ultrasound|ultrasound
5029996|NCT01506518|Imaging|imaging
5029997|NCT01506518|Acoustic Radiation Force|acoustic radiation force
5029998|NCT01506518|Double Push|double push
5029999|NCT01506505|Cardiovascular prevention|cardiovascular prevention
5030000|NCT01506505|Polypill|polypill
5030001|NCT01506505|Combination therapy|combination therapy
5030002|NCT01506492|Randomized controlled trial|randomized controlled trial
5030003|NCT01506492|Depression|depression
5030004|NCT01506492|Cancer|cancer
5030005|NCT01506492|Psychotherapy|psychotherapy
5030006|NCT01506492|Quality of life|quality of life
5030007|NCT01506479|Parkinson Disease|parkinson disease
5030008|NCT01506479|Basal Ganglia Disease|basal ganglia disease
5030009|NCT01506479|Central Nervous System Diseases|central nervous system diseases
5030010|NCT01506479|Nervous System Diseases|nervous system diseases
5030011|NCT01506479|Movement Disorders|movement disorders
5030012|NCT01506479|Neurodegenerative Diseases|neurodegenerative diseases
5030013|NCT01506479|Brain Diseases|brain diseases
5030014|NCT01506466|chemotherapy|chemotherapy
5030015|NCT01506466|metabolism|metabolism
5030016|NCT01506466|weight|weight
5030017|NCT01506466|body composition|body composition
5030018|NCT01506453|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
5030019|NCT01506453|Neuropathy|neuropathy
5030020|NCT01506453|Neuropathic Pain|neuropathic pain
5030022|NCT01506453|TOTAL XVI Protocol|total xvi protocol
5030023|NCT01506427|Newly Diagnosed|newly diagnosed
5030024|NCT01506427|Head and Neck Cancer|head and neck cancer
5030025|NCT01506427|PET Imaging|pet imaging
5030026|NCT01506414|Purpura|purpura
5030027|NCT01506414|Idiopathic Thrombocytopenic Purpura|idiopathic thrombocytopenic purpura
5030028|NCT01506401|ARDS|ards
5030029|NCT01506401|ventilator-induced lung injury|ventilator-induced lung injury
5030030|NCT01506401|lung protective ventilation|lung protective ventilation
5030031|NCT01506401|high frequency oscillation|high frequency oscillation
5030032|NCT01506388|labour induction|labour induction
5030033|NCT01506388|Foley catheter|foley catheter
5030034|NCT01506388|misoprostol|misoprostol
5030035|NCT01506388|isosorbide mononitrate|isosorbide mononitrate
5030036|NCT01506375|seasonal allergic rhinoconjunctivitis|seasonal allergic rhinoconjunctivitis
5030037|NCT01506375|grass pollen|grass pollen
5030038|NCT01506375|allergen specific immunotherapy|allergen specific immunotherapy
5030039|NCT01506362|Ulcerative Colitis|ulcerative colitis
5030040|NCT01506362|IBD|ibd
5030041|NCT01506349|celiac disease|celiac disease
5030042|NCT01506349|gluten|gluten
5030043|NCT01506349|fog|fog
5030044|NCT01506349|attention|attention
5030045|NCT01506336|GIST|gist
5030046|NCT01506336|resistant|resistant
5030047|NCT01506336|imatinib|imatinib
5030048|NCT01506336|gastro intestinal stromal tumor resistant to imatinib|gastro intestinal stromal tumor resistant to imatinib
5030049|NCT01506323|Complementary Therapy|complementary therapy
5030050|NCT01506323|Stress Disorders, Post-Traumatic|stress disorders, post-traumatic
5030051|NCT01506323|Veterans Health|veterans health
5030052|NCT01506323|Clinical Trials, Randomized|clinical trials, randomized
5030053|NCT01506323|Mindfulness|mindfulness
5030054|NCT01506323|Spirituality|spirituality
5030055|NCT01506323|Meditation|meditation
5030056|NCT01506323|Mind-body therapy|mind-body therapy
5030057|NCT01506310|gestational diabetes mellitus|gestational diabetes mellitus
5030058|NCT01506310|fasting glucose|fasting glucose
5030059|NCT01506310|insulin resistance|insulin resistance
5030060|NCT01506310|birth-weight|birth-weight
5030061|NCT01506310|Glucose values|glucose values
5030062|NCT01506310|Insulin concentrations|insulin concentrations
5030063|NCT01506310|Cesarean sections|cesarean sections
5030064|NCT01506297|obesity|obesity
5030065|NCT01506297|satiety|satiety
5030066|NCT01506297|body weight management|body weight management
5030067|NCT01506284|Forced oscillatory technique|forced oscillatory technique
5030068|NCT01506284|Laser interferometry|laser interferometry
5030069|NCT01506284|Intravenous anesthesia|intravenous anesthesia
5030070|NCT01506284|Mechanical ventilation|mechanical ventilation
5030071|NCT01506284|Pressure controlled ventilation|pressure controlled ventilation
5030072|NCT01506284|Airways mechanical properties|airways mechanical properties
5030073|NCT01506284|Respiratory system reactance|respiratory system reactance
5030074|NCT01506284|Oscillatory mechanics|oscillatory mechanics
5030075|NCT01506284|Atelectasis|atelectasis
5030076|NCT01506271|Complicated Intra-abdominal Infections|complicated intra-abdominal infections
5030077|NCT01506258|CD34+|cd34+
5030078|NCT01506258|perinatal hypoxia|perinatal hypoxia
5030079|NCT01506258|autologous hematopoietic stem cells|autologous hematopoietic stem cells
5030080|NCT01506258|cord and placental blood|cord and placental blood
5030081|NCT01506258|cerebral palsy|cerebral palsy
5030082|NCT01506245|Obesity|obesity
5030083|NCT01506245|Children|children
5030084|NCT01506245|Behavior|behavior
5030085|NCT01506245|Family|family
5030086|NCT01506245|Exercise|exercise
5030087|NCT01506232|ADHD|adhd
5030088|NCT01506232|Pediatric Bipolar Disorder|pediatric bipolar disorder
5030089|NCT01506232|Autism|autism
5030090|NCT01506232|Autism Spectrum Disorders|autism spectrum disorders
5030091|NCT01506232|EEG|eeg
5030092|NCT01506232|Brain Flow Analyses|brain flow analyses
5030093|NCT01506219|Randomized controlled trial|randomized controlled trial
5030094|NCT01506219|Comprehensive geriatric care|comprehensive geriatric care
5030095|NCT01506219|Activity of daily living|activity of daily living
5030096|NCT01506219|Quality of life|quality of life
5030097|NCT01506219|Healthcare utilization|healthcare utilization
5030098|NCT01506219|Community rehabilitation unit|community rehabilitation unit
5030099|NCT01506219|Medication adjustment|medication adjustment
5030100|NCT01506206|Deep Brain Stimulation|deep brain stimulation
5030101|NCT01506206|Impulsivity|impulsivity
5030102|NCT01506193|safety|safety
5030103|NCT01506193|healthy|healthy
5030104|NCT01506193|conjugated|conjugated
5030105|NCT01506193|immunogenicity|immunogenicity
5030106|NCT01506193|children|children
5030107|NCT01506193|MenC vaccine|menc vaccine
5030108|NCT01506193|MMRV vaccine|mmrv vaccine
5030109|NCT01506180|acute medical care|acute medical care
5030110|NCT01506180|comprehensive geriatric assessment|comprehensive geriatric assessment
5030111|NCT01506180|Health Services for the Aged|health services for the aged
5030112|NCT01506180|Geriatric Assessment|geriatric assessment
5030113|NCT01506180|Geriatrics|geriatrics
5030114|NCT01506180|Aged|aged
5030115|NCT01506154|bursitis/tendonitis and/or subdeltoid bursitis|bursitis/tendonitis and/or subdeltoid bursitis
5030116|NCT01506141|MPS II|mps ii
5030117|NCT01506141|MPS 2|mps 2
5030118|NCT01506141|lysosomal storage disorder|lysosomal storage disorder
5030119|NCT01506141|mps symptoms|mps symptoms
5030120|NCT01506141|enlarged adenoids|enlarged adenoids
5030121|NCT01506141|elaprase|elaprase
5030122|NCT01506141|hunter's syndrome|hunter's syndrome
5030123|NCT01506141|MPS2|mps2
5030124|NCT01506141|hunters disease|hunters disease
5030125|NCT01506141|hunter's disease treatment|hunter's disease treatment
5030126|NCT01506141|hunter syndrome therapy|hunter syndrome therapy
5030127|NCT01506141|iduronate sulfatase|iduronate sulfatase
5030128|NCT01506141|mps society|mps society
5030129|NCT01506141|MPSII|mpsii
5030130|NCT01506141|hunter syndrome treatment|hunter syndrome treatment
5030131|NCT01506141|hunter's disease|hunter's disease
5030132|NCT01506141|iduronate 2 sulfatase|iduronate 2 sulfatase
5030133|NCT01506141|mucopolysaccharides|mucopolysaccharides
5030134|NCT01506141|mps diagnosis|mps diagnosis
5030135|NCT01506141|chronic ear infection|chronic ear infection
5030136|NCT01506141|hunters syndrome|hunters syndrome
5030137|NCT01506141|ert treatment|ert treatment
5030138|NCT01506141|lysosomal storage disease|lysosomal storage disease
5030139|NCT01506141|hunter disease|hunter disease
5030140|NCT01506141|enzyme replacement therapy|enzyme replacement therapy
5030141|NCT01506141|idursulfase|idursulfase
5030142|NCT01506141|hunter's syndrome treatment|hunter's syndrome treatment
5030143|NCT01506128|HPV|hpv
5030144|NCT01506128|Menstrual blood|menstrual blood
5030145|NCT01506128|HPV detection using menstrual blood|hpv detection using menstrual blood
5030146|NCT01506115|Hepatocellular carcinoma|hepatocellular carcinoma
5030147|NCT01506115|Obstructive jaundice|obstructive jaundice
5030148|NCT01506115|Photodynamic therapy|photodynamic therapy
5030149|NCT01506089|IVF|ivf
5030150|NCT01506089|infertility|infertility
5030151|NCT01506089|PGD|pgd
5030152|NCT01506089|embryo|embryo
5030153|NCT01506089|temperature|temperature
5030154|NCT01506089|incubator|incubator
5030155|NCT01506089|CCS|ccs
5030156|NCT01506089|culture|culture
5030157|NCT01506089|incubator-36 degrees Celsius|incubator-36 degrees celsius
5030158|NCT01506089|incubator-37 degrees Celsius|incubator-37 degrees celsius
5030159|NCT01506063|Bioequivalence|bioequivalence
5030160|NCT01506063|Levocetirizine|levocetirizine
5030161|NCT01506063|Crossover|crossover
5030162|NCT01506050|Bioequivalence|bioequivalence
5030163|NCT01506050|Desloratadine|desloratadine
5030164|NCT01506050|crossover|crossover
5030165|NCT01506037|Bioequivalence|bioequivalence
5030166|NCT01506037|Desloratadine|desloratadine
5030167|NCT01506037|crossover|crossover
5030168|NCT01506024|Arthroplasty, Replacement, Hip|arthroplasty, replacement, hip
5030169|NCT01506024|Surgical Procedures, Operative|surgical procedures, operative
5030170|NCT01506024|Surgical Procedures, Minimally Invasive|surgical procedures, minimally invasive
5030171|NCT01505985|Hip fracture|hip fracture
5030172|NCT01505985|SPPB|sppb
5030173|NCT01505985|Functional recovery|functional recovery
5030174|NCT01505972|screening colonoscopy|screening colonoscopy
5030175|NCT01505972|attendance|attendance
5030176|NCT01505972|response|response
5030177|NCT01505972|colorectal cancer|colorectal cancer
5030178|NCT01505959|Obstructive Sleep Apnea Syndrome|obstructive sleep apnea syndrome
5030179|NCT01505959|Apnea|apnea
5030180|NCT01505959|Sleep Apnea|sleep apnea
5030181|NCT01505959|Telemedicine|telemedicine
5030182|NCT01505959|CPAP compliance|cpap compliance
5030183|NCT01505946|Thrombin|thrombin
5030184|NCT01505946|Hemophilia|hemophilia
5030185|NCT01505946|Inhibitors|inhibitors
5030186|NCT01505946|Immunotolerance|immunotolerance
5030187|NCT01505946|Haemostatic|haemostatic
5030188|NCT01505946|FVIII|fviii
5030189|NCT01505946|Epitopes|epitopes
5030190|NCT01505946|Moderately severe Hemophilia A with inhibitor|moderately severe hemophilia a with inhibitor
5030191|NCT01505933|upper|upper
5030192|NCT01505933|airway|airway
5030193|NCT01505933|dimensions|dimensions
5030194|NCT01505933|propofol|propofol
5030195|NCT01505933|dexmedetomidine|dexmedetomidine
5030196|NCT01505907|Pharmacokinetics|pharmacokinetics
5030197|NCT01505907|Safety|safety
5030198|NCT01505907|Healthy Males|healthy males
5030199|NCT01505868|Prostate Cancer|prostate cancer
5030200|NCT01505868|Metastatic Castration-Resistant Prostate Cancer|metastatic castration-resistant prostate cancer
5030201|NCT01505868|mCRPC|mcrpc
5030202|NCT01505868|Prior treatment with docetaxel|prior treatment with docetaxel
5030203|NCT01505868|Cabazitaxel|cabazitaxel
5030204|NCT01505868|Jevtana|jevtana
5030205|NCT01505868|Carboplatin|carboplatin
5030206|NCT01505868|Paraplatin|paraplatin
5030207|NCT01505868|Prednisone|prednisone
5030208|NCT01505855|Crohn's disease|crohn's disease
5030209|NCT01505855|Pneumococcal vaccination|pneumococcal vaccination
5030210|NCT01505842|Ulcerative colitis|ulcerative colitis
5030211|NCT01505842|Crohn's disease|crohn's disease
5030212|NCT01505842|Chromoendoscopy|chromoendoscopy
5030213|NCT01505842|Dysplasia|dysplasia
5030214|NCT01505842|Neoplasia|neoplasia
5030215|NCT01505842|Inflammatory Bowel Disease|inflammatory bowel disease
5030216|NCT01505816|Cataract|cataract
5030217|NCT01505816|Vision|vision
5030218|NCT01505816|Intraocular lens|intraocular lens
5030219|NCT01505816|Multifocal|multifocal
5030220|NCT01505816|Toric|toric
5030221|NCT01505803|Type 2 diabetes mellitus|type 2 diabetes mellitus
5030222|NCT01505803|Dietary supplements|dietary supplements
5030223|NCT01505803|Hyperglycemia|hyperglycemia
5030224|NCT01505803|Insulin resistance|insulin resistance
5030225|NCT01505803|Dyslipidemia|dyslipidemia
5030226|NCT01505803|Inflammation|inflammation
5030227|NCT01505803|Oxidative stress|oxidative stress
5030228|NCT01505803|Zinc|zinc
5030229|NCT01505803|Omega 3|omega 3
5030230|NCT01505777|irritable bowel syndrome without predominant diarrhea|irritable bowel syndrome without predominant diarrhea
5030231|NCT01505777|Probiotics(Medirac) 10/mosapride 10mg|probiotics(medirac) 10/mosapride 10mg
5030232|NCT01505777|Probiotics(Medirac) 15/mosapride 10mg|probiotics(medirac) 15/mosapride 10mg
5030233|NCT01505777|Probiotics(Medirac) 15/mosapride 15mg|probiotics(medirac) 15/mosapride 15mg
5030234|NCT01505777|Probiotics(Medirac) 30/mosapride 15mg|probiotics(medirac) 30/mosapride 15mg
5030235|NCT01505777|Probiotics(Medirac) placebo/mosapride placebo|probiotics(medirac) placebo/mosapride placebo
5030236|NCT01505764|Cachexia|cachexia
5030237|NCT01505751|Outcome of cervical cancer|outcome of cervical cancer
5030238|NCT01505725|Nicotine Reinforcement|nicotine reinforcement
5030239|NCT01505725|Tobacco Craving|tobacco craving
5030240|NCT01505725|Behavior Genetics|behavior genetics
5030241|NCT01505725|Smoking|smoking
5030242|NCT01505712|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
5030243|NCT01505712|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
5030244|NCT01505712|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5030245|NCT01505712|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5030246|NCT01505699|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5030247|NCT01505699|B-cell adult acute lymphoblastic leukemia|b-cell adult acute lymphoblastic leukemia
5030248|NCT01505673|Insulin|insulin
5030249|NCT01505673|Glucagon-like peptide|glucagon-like peptide
5030250|NCT01505673|Liraglutide|liraglutide
5030251|NCT01505673|Beta-Cell|beta-cell
5030252|NCT01505673|pancreatic steatosis|pancreatic steatosis
5030253|NCT01505673|hepatic steatosis|hepatic steatosis
5030254|NCT01505660|Adherence|adherence
5030255|NCT01505660|Depression|depression
5030256|NCT01505660|Care management|care management
5030257|NCT01505660|Stepped care|stepped care
5030258|NCT01505660|HIV|hiv
5030259|NCT01505660|Patient reported outcomes|patient reported outcomes
5030260|NCT01505660|Antiretroviral medication adherence|antiretroviral medication adherence
5030261|NCT01505621|Aging|aging
5030262|NCT01505621|Protein accumulation|protein accumulation
5030263|NCT01505621|Protein damage|protein damage
5030264|NCT01505569|autologous transplantation|autologous transplantation
5030265|NCT01505569|high risk solid tumor|high risk solid tumor
5030266|NCT01505569|relapsed solid tumor|relapsed solid tumor
5030267|NCT01505478|Sepsis|sepsis
5030268|NCT01505478|Clinical Prediction Rule|clinical prediction rule
5030269|NCT01505478|Clinical Informatics|clinical informatics
5030270|NCT01505478|Machine Learning|machine learning
5030271|NCT01505465|Total Knee Replacement|total knee replacement
5030272|NCT01505465|Pain|pain
5030273|NCT01505465|Confusion|confusion
5030274|NCT01505465|Sleep|sleep
5030275|NCT01505439|solifenacin|solifenacin
5030276|NCT01505439|bladder symptom|bladder symptom
5030277|NCT01505426|ASP1941|asp1941
5030278|NCT01505426|ipragliflozin|ipragliflozin
5030279|NCT01505426|metformin|metformin
5030280|NCT01505426|plasma glucose|plasma glucose
5030281|NCT01505426|urine glucose|urine glucose
5030282|NCT01505413|advanced unresectable or metastatic Pancreatic Cancer|advanced unresectable or metastatic pancreatic cancer
5030283|NCT01505400|Molecular profiling|molecular profiling
5030284|NCT01505400|Advanced cancer|advanced cancer
5030285|NCT01505400|Breast cancer|breast cancer
5030286|NCT01505400|Non-small cell lung cancer|non-small cell lung cancer
5030287|NCT01505400|Colorectal cancer|colorectal cancer
5030288|NCT01505400|Genitourinary cancer|genitourinary cancer
5030289|NCT01505400|Pancreatobiliary gastrointestinal cancer|pancreatobiliary gastrointestinal cancer
5030290|NCT01505400|Upper aerodigestive tract cancer|upper aerodigestive tract cancer
5030291|NCT01505400|Gynecological cancers|gynecological cancers
5030292|NCT01505400|Phase I|phase i
5030293|NCT01505400|Phase I Clinical Trial Candidates|phase i clinical trial candidates
5030294|NCT01505400|melanoma cancer|melanoma cancer
5030295|NCT01505400|rare cancer|rare cancer
5030296|NCT01505400|unknown primary cancer|unknown primary cancer
5030297|NCT01505387|Weight maintenance|weight maintenance
5030298|NCT01505387|Overweight|overweight
5030299|NCT01505387|Obese|obese
5030300|NCT01505387|Weight management|weight management
5030301|NCT01505374|Bilateral total knee replacement|bilateral total knee replacement
5030302|NCT01505374|Femoral Nerve Block|femoral nerve block
5030303|NCT01505374|Saphenous Nerve Block|saphenous nerve block
5030304|NCT01505361|probiotic|probiotic
5030305|NCT01505361|Lactobacillus salivarius|lactobacillus salivarius
5030306|NCT01505361|mastitis|mastitis
5030307|NCT01505361|prevention|prevention
5030308|NCT01505361|group B streptococci|group b streptococci
5030309|NCT01505361|intrapartum prophylaxis|intrapartum prophylaxis
5030310|NCT01505348|feeding patterns|feeding patterns
5030311|NCT01505348|aerobic exercise|aerobic exercise
5030312|NCT01505348|osteoclasts|osteoclasts
5030313|NCT01505335|alveolar nerve, inferior|alveolar nerve, inferior
5030314|NCT01505335|ultrasound|ultrasound
5030315|NCT01505335|digital radiography, dental|digital radiography, dental
5030316|NCT01505335|nerve injury|nerve injury
5030317|NCT01505322|daily activities|daily activities
5030318|NCT01505309|Aortic Diseases|aortic diseases
5030319|NCT01505309|Vascular Diseases|vascular diseases
5030320|NCT01505309|Cardiovascular Diseases|cardiovascular diseases
5030321|NCT01505309|Treatment Outcome|treatment outcome
5030322|NCT01505309|Aorta Dissection|aorta dissection
5030323|NCT01505309|Aorta Aneurysm|aorta aneurysm
5030324|NCT01505309|Aorta pseudoaneurysm|aorta pseudoaneurysm
5030325|NCT01505309|Endovascular aortic repair|endovascular aortic repair
5030326|NCT01505296|Catheter ablation|catheter ablation
5030327|NCT01505257|Delirium|delirium
5030328|NCT01505257|Dementia|dementia
5030329|NCT01505257|Confusion Assessment Method|confusion assessment method
5030330|NCT01505231|Shock|shock
5030331|NCT01505231|norepinephrine|norepinephrine
5030332|NCT01505231|vasopressin|vasopressin
5030333|NCT01505231|cardiac surgery|cardiac surgery
5030334|NCT01505218|Sedation|sedation
5030335|NCT01505218|propofol|propofol
5030336|NCT01505218|patient-controlled|patient-controlled
5030337|NCT01505218|safety|safety
5030338|NCT01505205|Gist,c-KIT,PDGFRA,DOG1,mutation|gist,c-kit,pdgfra,dog1,mutation
5030339|NCT01505192|Those in Labor, Delivery and the Puerperium|those in labor, delivery and the puerperium
5030340|NCT01505179|HFPEF|hfpef
5030341|NCT01505179|Heart Failure|heart failure
5030342|NCT01505179|HF w/ preserved EF|hf w/ preserved ef
5030343|NCT01505179|Preserved EF|preserved ef
5030344|NCT01505179|Preserved Ejection Fraction|preserved ejection fraction
5030345|NCT01505179|Diastolic Dysfunction|diastolic dysfunction
5030346|NCT01505166|colorectal carcinoma|colorectal carcinoma
5030347|NCT01505166|colon cancer|colon cancer
5030348|NCT01505166|liver metastases|liver metastases
5030349|NCT01505153|Advanced cancer|advanced cancer
5030350|NCT01505153|Metastatic cancer|metastatic cancer
5030351|NCT01505153|solid tumors|solid tumors
5030352|NCT01505153|Melanoma|melanoma
5030353|NCT01505140|Andrology|andrology
5030354|NCT01505140|Fertility|fertility
5030355|NCT01505140|Reproduction|reproduction
5030356|NCT01505140|Diet|diet
5030357|NCT01505140|Nutritional Sciences|nutritional sciences
5030358|NCT01505140|Fatty Acids|fatty acids
5030359|NCT01505140|Antioxidants|antioxidants
5030360|NCT01505140|Body weight changes|body weight changes
5030361|NCT01505127|Drug Therapy|drug therapy
5030362|NCT01505114|HIV Prevention|hiv prevention
5030363|NCT01505114|PrEP|prep
5030364|NCT01505114|Maraviroc|maraviroc
5030365|NCT01505088|Iontophoresis|iontophoresis
5030366|NCT01505088|Non-Infectious Anterior Segment Uveitis|non-infectious anterior segment uveitis
5030367|NCT01505088|Ophthalmology|ophthalmology
5030368|NCT01505075|prostatic neoplasms|prostatic neoplasms
5030369|NCT01505075|radiotherapy|radiotherapy
5030370|NCT01505075|hypofractionated|hypofractionated
5030371|NCT01505075|high risk prostate cancer|high risk prostate cancer
5030372|NCT01505062|Usher Syndrome Retinitis Pigmentosa|usher syndrome retinitis pigmentosa
5030373|NCT01505062|Usher Syndrome associated Retinitis Pigmentosa|usher syndrome associated retinitis pigmentosa
5030374|NCT01505049|immunology|immunology
5030375|NCT01505049|vaccination|vaccination
5030376|NCT01505049|human papillomavirus|human papillomavirus
5030377|NCT01505036|Diabetes Mellitus|diabetes mellitus
5030378|NCT01505036|smart-care|smart-care
5030379|NCT01505036|U-health care|u-health care
5030380|NCT01505010|Treatment-resistant hypertension|treatment-resistant hypertension
5030381|NCT01505010|Renal denervation|renal denervation
5030382|NCT01505010|Sympathetic nervous system|sympathetic nervous system
5030383|NCT01504997|DaVinci|davinci
5030384|NCT01504997|Robot assisted surgery|robot assisted surgery
5030385|NCT01504997|Gastrectomy|gastrectomy
5030386|NCT01504997|Safety|safety
5030387|NCT01504997|Gastric Cancer|gastric cancer
5030388|NCT01504984|Evaluation of the pharmacokinetics equivalence|evaluation of the pharmacokinetics equivalence
5030389|NCT01504984|Healthy volunteers|healthy volunteers
5030390|NCT01504984|Single dose over the period I and II(crossover)|single dose over the period i and ii(crossover)
5030391|NCT01504984|Healthy male volunteers|healthy male volunteers
5030392|NCT01504971|Gastroesophageal Reflux;|gastroesophageal reflux;
5030393|NCT01504971|Endoscopy;|endoscopy;
5030394|NCT01504971|Esophageal pH monitoring;|esophageal ph monitoring;
5030395|NCT01504971|Narrow band imaging;|narrow band imaging;
5030396|NCT01504971|Autofluorescence imaging;|autofluorescence imaging;
5030397|NCT01504971|White light imaging;|white light imaging;
5030398|NCT01504958|Alzheimer's disease|alzheimer's disease
5030399|NCT01504958|Cognitive Training|cognitive training
5030400|NCT01504958|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
5030401|NCT01504945|chronic coronary artery disease|chronic coronary artery disease
5030402|NCT01504932|black raspberry lozenges|black raspberry lozenges
5030403|NCT01504932|Appalachian|appalachian
5030404|NCT01504932|Oral Cancer|oral cancer
5030405|NCT01504919|Psychosocial|psychosocial
5030406|NCT01504919|Behavioral intervention|behavioral intervention
5030407|NCT01504919|Nicotine patch|nicotine patch
5030408|NCT01504919|Latinos|latinos
5030409|NCT01504919|Mexican American|mexican american
5030410|NCT01504919|Motivation and Problem Solving|motivation and problem solving
5030411|NCT01504919|MAPS|maps
5030412|NCT01504919|Cancer risk reduction|cancer risk reduction
5030413|NCT01504919|Smoking cessation|smoking cessation
5030414|NCT01504919|Overweight/obese smokers|overweight/obese smokers
5030415|NCT01504919|BMI greater than or equal to 25|bmi greater than or equal to 25
5030416|NCT01504919|Wellness program|wellness program
5030417|NCT01504919|Questionnaires|questionnaires
5030418|NCT01504919|Surveys|surveys
5030419|NCT01504919|Self-help materials|self-help materials
5030420|NCT01504919|Pamphlets|pamphlets
5030421|NCT01504906|Phase 1|phase 1
5030422|NCT01504906|Healthy male volunteers|healthy male volunteers
5030423|NCT01504906|pharmacokinetics|pharmacokinetics
5030424|NCT01504906|cyclosporine|cyclosporine
5030425|NCT01504906|ticagrelor|ticagrelor
5030426|NCT01504906|Bioavailability (plasma AUC, Cmax, plasma AUC0-t, t1/2λz, tmax)|bioavailability (plasma auc, cmax, plasma auc0-t, t1/2λz, tmax)
5030427|NCT01504893|ventilation|ventilation
5030428|NCT01504893|PEEP|peep
5030429|NCT01504893|Acute Lung Injury|acute lung injury
5030430|NCT01504893|pneumonectomy|pneumonectomy
5030431|NCT01504893|ARDS|ards
5030432|NCT01504880|Mitral Regurgitation|mitral regurgitation
5030433|NCT01504880|Tricuspid Regurgitation|tricuspid regurgitation
5030434|NCT01504880|Vena Contracta|vena contracta
5030435|NCT01504867|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
5030436|NCT01504867|Acute Lung Injury|acute lung injury
5030437|NCT01504867|ARDS|ards
5030438|NCT01504867|ALI|ali
5030439|NCT01504867|aspirin|aspirin
5030440|NCT01504867|prevention|prevention
5030441|NCT01504854|Alzheimer's disease|alzheimer's disease
5030442|NCT01504854|Dementia|dementia
5030443|NCT01504854|Brain diseases|brain diseases
5030444|NCT01504854|Resveratrol|resveratrol
5030445|NCT01504854|Memory problems|memory problems
5030446|NCT01504854|Mental disorders|mental disorders
5030447|NCT01504854|Cognitive disorders|cognitive disorders
5030448|NCT01504828|Energy Metabolism|energy metabolism
5030449|NCT01504828|Ageing|ageing
5030450|NCT01504828|left ventricle|left ventricle
5030451|NCT01504828|energetics|energetics
5030452|NCT01504828|function|function
5030453|NCT01504815|advanced head and neck cancer|advanced head and neck cancer
5030454|NCT01504815|adaptive radiotherapy|adaptive radiotherapy
5030455|NCT01504815|cisplatinum|cisplatinum
5030456|NCT01504802|Growth hormone|growth hormone
5030457|NCT01504802|C-type natriuretic peptide|c-type natriuretic peptide
5030458|NCT01504802|amino-terminal propeptide of C-type natriuretic peptide|amino-terminal propeptide of c-type natriuretic peptide
5030459|NCT01504802|insulin-like growth factor-I|insulin-like growth factor-i
5030460|NCT01504802|bone specific alkaline phosphatase|bone specific alkaline phosphatase
5030461|NCT01504802|leptin|leptin
5030462|NCT01504802|deoxypyridinoline|deoxypyridinoline
5030463|NCT01504802|growth velocity|growth velocity
5030464|NCT01504802|pharmacodynamic|pharmacodynamic
5030465|NCT01504802|biomarker|biomarker
5030466|NCT01504789|Breast Cancer|breast cancer
5030467|NCT01504789|Breast Cancer Survivors|breast cancer survivors
5030468|NCT01504789|Exercise|exercise
5030469|NCT01504789|Hispanic|hispanic
5030470|NCT01504789|Mexican-American|mexican-american
5030471|NCT01504789|Puerto Rican|puerto rican
5030472|NCT01504789|Culturally tailored exercise|culturally tailored exercise
5030473|NCT01504789|Fitness tests|fitness tests
5030474|NCT01504789|Questionnaires|questionnaires
5030475|NCT01504789|Surveys|surveys
5030476|NCT01504789|Culturally tailored written material|culturally tailored written material
5030477|NCT01504776|MCL|mcl
5030478|NCT01504776|Lymphoma|lymphoma
5030479|NCT01504776|Panobinostat|panobinostat
5030480|NCT01504763|Massage|massage
5030481|NCT01504763|Chair massage|chair massage
5030482|NCT01504763|Relaxation|relaxation
5030483|NCT01504763|Nurses|nurses
5030484|NCT01504750|Length of Stay [E02.760.400.480]|length of stay [e02.760.400.480]
5030485|NCT01504750|Activities of Daily Living [I03.050]|activities of daily living [i03.050]
5030486|NCT01504737|Exercise|exercise
5030487|NCT01504737|Physical Activity|physical activity
5030488|NCT01504737|Physiotherapy|physiotherapy
5030489|NCT01504737|Exercise test|exercise test
5030490|NCT01504737|Quality of Life|quality of life
5030491|NCT01504737|Aortic Valve Replacement|aortic valve replacement
5030492|NCT01504724|central macular thickness|central macular thickness
5030493|NCT01504698|Manipulative treatment|manipulative treatment
5030494|NCT01504698|Children|children
5030495|NCT01504698|Neck pain|neck pain
5030496|NCT01504698|Back pain|back pain
5030497|NCT01504698|Effect|effect
5030498|NCT01504698|Adolescence|adolescence
5030499|NCT01504698|Advise|advise
5030500|NCT01504698|Exercise|exercise
5030501|NCT01504685|Morbid obesity|morbid obesity
5030502|NCT01504685|Obesity surgery|obesity surgery
5030503|NCT01504685|Gastric bypass|gastric bypass
5030504|NCT01504685|Banded gastric bypass|banded gastric bypass
5030505|NCT01504672|Drug related problems|drug related problems
5030506|NCT01504659|bipolar disorder|bipolar disorder
5030507|NCT01504659|treatment resistance|treatment resistance
5030508|NCT01504659|depression|depression
5030509|NCT01504659|ketamine|ketamine
5030510|NCT01504659|intranasal|intranasal
5030511|NCT01504659|child|child
5030512|NCT01504646|Asthma|asthma
5030787|NCT01503489|Switch.|switch.
5030513|NCT01504646|Exercise-Induced Bronchoconstriction|exercise-induced bronchoconstriction
5030514|NCT01504646|lipids|lipids
5030515|NCT01504646|n-3 PUFA|n-3 pufa
5030516|NCT01504646|airway inflammation|airway inflammation
5030517|NCT01504646|Bronchoconstriction|bronchoconstriction
5030518|NCT01504633|cognitive function|cognitive function
5030519|NCT01504633|omega-3 PUFA (DHA)|omega-3 pufa (dha)
5030520|NCT01504633|iron|iron
5030521|NCT01504633|nutrigenomics|nutrigenomics
5030522|NCT01504633|under-two year old children|under-two year old children
5030523|NCT01504633|Indonesia|indonesia
5030524|NCT01504620|diabetes mellitus|diabetes mellitus
5030525|NCT01504620|blood glucose self-assessment|blood glucose self-assessment
5030526|NCT01504620|Accuracy|accuracy
5030527|NCT01504620|Intra-Assay precision|intra-assay precision
5030528|NCT01504620|Hematocrit interference|hematocrit interference
5030529|NCT01504607|corneal endothelium|corneal endothelium
5030530|NCT01504607|congenital cataract surgery|congenital cataract surgery
5030531|NCT01504607|IOL implantation|iol implantation
5030532|NCT01504594|Dilated cardiomyopathy|dilated cardiomyopathy
5030533|NCT01504594|Idiopathic|idiopathic
5030534|NCT01504594|Bone Marrow|bone marrow
5030535|NCT01504594|Stem Cells|stem cells
5030536|NCT01504594|CD34 +|cd34 +
5030537|NCT01504594|Autologous|autologous
5030538|NCT01504555|hypercortisolism, dexamethasone, alcoholism,obesity.|hypercortisolism, dexamethasone, alcoholism,obesity.
5030539|NCT01504542|Immunotherapy|immunotherapy
5030540|NCT01504529|Rotigotine (Neupro)|rotigotine (neupro)
5030541|NCT01504529|Non-Motor Symptoms|non-motor symptoms
5030542|NCT01504529|Advanced Parkinson's Disease|advanced parkinson's disease
5030543|NCT01504529|Local study|local study
5030544|NCT01504529|Spain|spain
5030545|NCT01504529|Observational study|observational study
5030546|NCT01504529|Non-interventional study|non-interventional study
5030547|NCT01504529|Retrospective study|retrospective study
5030548|NCT01504529|Post-marketing study|post-marketing study
5030549|NCT01504529|Multicenter study|multicenter study
5030550|NCT01504516|Bioequivalence|bioequivalence
5030551|NCT01504516|Donepezil|donepezil
5030552|NCT01504516|crossover|crossover
5030553|NCT01504503|Bioequivalence|bioequivalence
5030554|NCT01504503|Donepezil|donepezil
5030555|NCT01504503|crossover|crossover
5030556|NCT01504490|Advanced cancer|advanced cancer
5030557|NCT01504477|colorectal cancer|colorectal cancer
5030558|NCT01504477|relapsed|relapsed
5030559|NCT01504477|refractory|refractory
5030560|NCT01504477|Kras wild type|kras wild type
5030561|NCT01504464|knee joint osteoarthritis mesenchymal stem cell|knee joint osteoarthritis mesenchymal stem cell
5030562|NCT01504451|Atrial fibrillation|atrial fibrillation
5030563|NCT01504451|Ablation|ablation
5030564|NCT01504451|Implantable loop recorder|implantable loop recorder
5030565|NCT01504412|Pain|pain
5030566|NCT01504412|Diabetic Peripheral Neuropathy|diabetic peripheral neuropathy
5030567|NCT01504399|Pituitary surgery|pituitary surgery
5030568|NCT01504399|Transsphenoidal surgery|transsphenoidal surgery
5030569|NCT01504399|Anterior skull base surgery|anterior skull base surgery
5030570|NCT01504399|Endoscopic surgery|endoscopic surgery
5030571|NCT01504399|Patient survey|patient survey
5030572|NCT01504399|Nasal complications|nasal complications
5030573|NCT01504373|NAVA|nava
5030574|NCT01504373|neurally adjusted ventilatory support|neurally adjusted ventilatory support
5030575|NCT01504373|lung injury|lung injury
5030576|NCT01504373|ventilation|ventilation
5030577|NCT01504373|lung volume distribution|lung volume distribution
5030578|NCT01504373|oxygen cost of breathing|oxygen cost of breathing
5030579|NCT01504360|sarcoma|sarcoma
5030580|NCT01504360|radiation therapy|radiation therapy
5030581|NCT01504360|predictive essay|predictive essay
5030582|NCT01504321|Polycystic Ovary syndrome|polycystic ovary syndrome
5030583|NCT01504321|PCOS|pcos
5030584|NCT01504321|sympathetic nervous system|sympathetic nervous system
5030585|NCT01504321|moxonidine|moxonidine
5030586|NCT01504308|uterine fibroids|uterine fibroids
5030587|NCT01504308|uterine leiomyomas|uterine leiomyomas
5030588|NCT01504308|magnetic resonance imaging|magnetic resonance imaging
5030589|NCT01504308|focused ultrasound|focused ultrasound
5030590|NCT01504256|Adenocarcinoma|adenocarcinoma
5030591|NCT01504256|Esophagogastric Junction|esophagogastric junction
5030592|NCT01504256|Peritoneal Carcinomatosis|peritoneal carcinomatosis
5030593|NCT01504256|Catumaxomab|catumaxomab
5030594|NCT01504256|AIO-STO-0110|aio-sto-0110
5030595|NCT01504243|CD163;|cd163;
5030596|NCT01504243|SNPs;|snps;
5030597|NCT01504243|prognosis;|prognosis;
5030598|NCT01504243|control（normal person）|control（normal person）
5030599|NCT01504230|To ascertain the mechanisms for effectively controlling balance in seniors with osteoporosis and to provide a basis for developing fall prevention programs.|to ascertain the mechanisms for effectively controlling balance in seniors with osteoporosis and to provide a basis for developing fall prevention programs.
5030600|NCT01504230|To develop biomechanical models that control the entire body's center of mass (CoM) during upright quiet stance in seniors with osteoporosis.|to develop biomechanical models that control the entire body's center of mass (com) during upright quiet stance in seniors with osteoporosis.
5030601|NCT01504230|To identify the mechanism to control the entire body's CoM after receiving a balance perturbation in seniors with osteoporosis.|to identify the mechanism to control the entire body's com after receiving a balance perturbation in seniors with osteoporosis.
5030602|NCT01504217|Healthy older people over 65 years old|healthy older people over 65 years old
5030603|NCT01504204|adherence|adherence
5030604|NCT01504204|adapalene|adapalene
5030605|NCT01504204|benzoyl peroxide|benzoyl peroxide
5030606|NCT01504204|sample|sample
5030607|NCT01504204|topical treatment|topical treatment
5030608|NCT01504191|myocardial infarction|myocardial infarction
5030609|NCT01504191|depression|depression
5030610|NCT01504191|anxiety|anxiety
5030611|NCT01504191|Internet‐based CBT|internet‐based cbt
5030612|NCT01504191|genetic disposition|genetic disposition
5030613|NCT01504178|Noradrenergic system and pain in Parkinson's disease|noradrenergic system and pain in parkinson's disease
5030614|NCT01504165|Renal impairment|renal impairment
5030615|NCT01504165|Pharmacokinetic|pharmacokinetic
5030616|NCT01504165|cilengitide|cilengitide
5030617|NCT01504165|subjects with mild|subjects with mild
5030618|NCT01504165|moderate or severe renal impairment compared to subjects with normal renal function|moderate or severe renal impairment compared to subjects with normal renal function
5030619|NCT01504152|International travel|international travel
5030620|NCT01504152|cancer patients|cancer patients
5030621|NCT01504152|HSCT|hsct
5030622|NCT01504152|Quality of Life|quality of life
5030623|NCT01504152|questionnaire|questionnaire
5030624|NCT01504152|11-176|11-176
5030625|NCT01504126|Ovarian Cancer|ovarian cancer
5030626|NCT01504126|Primary peritoneal carcinoma|primary peritoneal carcinoma
5030627|NCT01504126|Fallopian tube cancer|fallopian tube cancer
5030628|NCT01504126|Invasive epithelial ovarian cancer|invasive epithelial ovarian cancer
5030629|NCT01504126|Serous adenocarcinoma|serous adenocarcinoma
5030630|NCT01504126|Endometrioid adenocarcinoma|endometrioid adenocarcinoma
5030631|NCT01504126|Mucinous adenocarcinoma|mucinous adenocarcinoma
5030632|NCT01504126|Undifferentiated carcinoma|undifferentiated carcinoma
5030633|NCT01504126|Clear cell carcinoma|clear cell carcinoma
5030634|NCT01504126|Mixed epithelial carcinoma|mixed epithelial carcinoma
5030635|NCT01504126|Adenocarcinoma not otherwise specified|adenocarcinoma not otherwise specified
5030636|NCT01504126|Primary Müllerian epithelial adenocarcinoma|primary müllerian epithelial adenocarcinoma
5030637|NCT01504126|Propranolol|propranolol
5030638|NCT01504126|Beta-blocker|beta-blocker
5030639|NCT01504113|Target therapy|target therapy
5030640|NCT01504113|Biologics|biologics
5030641|NCT01504113|Psoriasis|psoriasis
5030642|NCT01504113|Latent virus|latent virus
5030643|NCT01504113|Human papillomaviruses|human papillomaviruses
5030644|NCT01504113|Cytomegalovirus|cytomegalovirus
5030645|NCT01504113|Epstein-Barr virus|epstein-barr virus
5030646|NCT01504113|Tumor necrosis factor|tumor necrosis factor
5030647|NCT01504087|patient in critical care|patient in critical care
5030648|NCT01504074|Irvine Gass syndrome|irvine gass syndrome
5030649|NCT01504074|multimodal imaging|multimodal imaging
5030650|NCT01504074|SD-OCT|sd-oct
5030651|NCT01504074|CME secondary to cataract surgery|cme secondary to cataract surgery
5030652|NCT01504074|in vivo correlation of morphology and function|in vivo correlation of morphology and function
5030653|NCT01504061|surgical|surgical
5030654|NCT01504061|scars|scars
5030655|NCT01504061|Mederma|mederma
5030656|NCT01504048|Microscopic colitis|microscopic colitis
5030657|NCT01504048|Intestinal Diseases|intestinal diseases
5030658|NCT01504048|Inflammatory Bowel Diseases|inflammatory bowel diseases
5030659|NCT01504035|Donor site pain|donor site pain
5030660|NCT01504035|Iliac crest|iliac crest
5030661|NCT01504035|Bone graft|bone graft
5030662|NCT01504035|Hemostatic putty|hemostatic putty
5030663|NCT01504035|lidocaine|lidocaine
5030664|NCT01504035|Donor site pain following harvest of iliac crest bone grafts|donor site pain following harvest of iliac crest bone grafts
5030665|NCT01504022|Hypertension|hypertension
5030666|NCT01504022|self-monitoring|self-monitoring
5030667|NCT01504022|internet|internet
5030668|NCT01504022|lifestyle modification|lifestyle modification
5030669|NCT01504009|Nervous System Disease|nervous system disease
5030670|NCT01504009|Neurodegenerative Disease|neurodegenerative disease
5030671|NCT01504009|Motor Neuron Disease|motor neuron disease
5030672|NCT01504009|ALS|als
5030673|NCT01504009|Muscle training|muscle training
5030674|NCT01504009|Muscle atrophy|muscle atrophy
5030675|NCT01503996|dehydration|dehydration
5030676|NCT01503996|risk factor|risk factor
5030677|NCT01503996|glaucoma|glaucoma
5030678|NCT01503996|Controls|controls
5030679|NCT01503983|Gastric Cancer with Metastasis|gastric cancer with metastasis
5030680|NCT01503983|HER2-positive|her2-positive
5030681|NCT01503970|chondral lesions|chondral lesions
5030682|NCT01503970|knee|knee
5030683|NCT01503957|Allergic rhinitis|allergic rhinitis
5030684|NCT01503957|Allergen|allergen
5030685|NCT01503957|Allergy|allergy
5030686|NCT01503957|Dustmite|dustmite
5030687|NCT01503931|alcohol dependence, functional magnetic resonance imaging, genetics, endophenotypes, dopamine,|alcohol dependence, functional magnetic resonance imaging, genetics, endophenotypes, dopamine,
5030688|NCT01503931|glutamate|glutamate
5030689|NCT01503918|Critical Illness|critical illness
5030690|NCT01503918|Critical Care|critical care
5030691|NCT01503918|Valganciclovir|valganciclovir
5030692|NCT01503918|Ganciclovir|ganciclovir
5030693|NCT01503918|Aciclovir|aciclovir
5030694|NCT01503918|Valaciclovir|valaciclovir
5030695|NCT01503918|Cytomegalovirus|cytomegalovirus
5030696|NCT01503905|breast cancer|breast cancer
5030697|NCT01503905|neoadjuvant chemotherapy|neoadjuvant chemotherapy
5030698|NCT01503905|amenorrhea|amenorrhea
5030699|NCT01503892|Small Fiber Neuropathy|small fiber neuropathy
5030700|NCT01503892|Metanx Effect on Small Fiber Neuropathy|metanx effect on small fiber neuropathy
5030701|NCT01503892|Metanx Effect on Diabetic Peripheral Neuropathy|metanx effect on diabetic peripheral neuropathy
5030702|NCT01503879|general anaesthesia|general anaesthesia
5030703|NCT01503879|invasive mechanical ventilation|invasive mechanical ventilation
5030704|NCT01503879|DLCO|dlco
5030706|NCT01503853|Medical Costs|medical costs
5030707|NCT01503853|Health Care|health care
5030708|NCT01503853|Focus Groups|focus groups
5030709|NCT01503827|Whole Brain Radiotherapy|whole brain radiotherapy
5030710|NCT01503827|Brain metastases|brain metastases
5030711|NCT01503827|Melanoma|melanoma
5030712|NCT01503827|Stage IV Metastatic Melanoma|stage iv metastatic melanoma
5030713|NCT01503827|Neurocognitive function|neurocognitive function
5030714|NCT01503827|Quality of life|quality of life
5030715|NCT01503814|hypertension|hypertension
5030716|NCT01503814|primary care|primary care
5030717|NCT01503814|cardiovascular disease prevention|cardiovascular disease prevention
5030718|NCT01503814|high cardiovascular risk|high cardiovascular risk
5030719|NCT01503814|diuretics|diuretics
5030720|NCT01503814|aspirin|aspirin
5030721|NCT01503814|smoking cessation|smoking cessation
5030722|NCT01503814|salt reduction|salt reduction
5030723|NCT01503814|Tibet|tibet
5030724|NCT01503801|Preterm neonates|preterm neonates
5030725|NCT01503801|Bronchopulmonary dysplasia|bronchopulmonary dysplasia
5030726|NCT01503801|Chronic lung disease|chronic lung disease
5030727|NCT01503801|Inhaled nitric oxide|inhaled nitric oxide
5030728|NCT01503801|Respiratory therapy|respiratory therapy
5030729|NCT01503775|intracranial|intracranial
5030730|NCT01503775|ruptured|ruptured
5030731|NCT01503775|non-ruptured|non-ruptured
5030732|NCT01503775|aneurysms|aneurysms
5030733|NCT01503775|Intracranial ruptured or non-ruptured aneurysms|intracranial ruptured or non-ruptured aneurysms
5030734|NCT01503762|Hand Flexor tendon Injuries|hand flexor tendon injuries
5030735|NCT01503762|hand Extensor Tendon Injuries|hand extensor tendon injuries
5030736|NCT01503762|Hand Joint Dislocations and subluxation|hand joint dislocations and subluxation
5030737|NCT01503736|Kidney Diseases|kidney diseases
5030738|NCT01503736|Kidney Failure, Chronic|kidney failure, chronic
5030739|NCT01503736|Hyperphosphatemia|hyperphosphatemia
5030740|NCT01503736|Urologic Diseases|urologic diseases
5030741|NCT01503736|Renal Insufficiency, Chronic|renal insufficiency, chronic
5030742|NCT01503736|Renal Insufficiency|renal insufficiency
5030743|NCT01503736|Phosphorus Metabolism Disorders|phosphorus metabolism disorders
5030744|NCT01503710|Proteinuria predict outcome|proteinuria predict outcome
5030745|NCT01503710|BNP and NGAL predict outcome|bnp and ngal predict outcome
5030746|NCT01503710|Pre-operative GFR and proteinuria|pre-operative gfr and proteinuria
5030747|NCT01503697|Breast Cancer|breast cancer
5030748|NCT01503697|High Risk|high risk
5030749|NCT01503697|Imaging|imaging
5030750|NCT01503697|Angiogenesis|angiogenesis
5030751|NCT01503684|sepsis|sepsis
5030752|NCT01503671|left ventricular diastolic function|left ventricular diastolic function
5030753|NCT01503671|inflammation|inflammation
5030754|NCT01503671|peritoneal dialysis|peritoneal dialysis
5030755|NCT01503671|LV diastolic function changes after statin intervention|lv diastolic function changes after statin intervention
5030756|NCT01503658|Clopidogrel,|clopidogrel,
5030757|NCT01503658|Aspirin,|aspirin,
5030758|NCT01503658|Pharmacogenomics|pharmacogenomics
5030759|NCT01503645|kidney diseases|kidney diseases
5030760|NCT01503645|drugs, Chinese herbal|drugs, chinese herbal
5030761|NCT01503645|aristolochic acid|aristolochic acid
5030762|NCT01503645|polymorphism, genetic|polymorphism, genetic
5030763|NCT01503619|small cell lung cancer|small cell lung cancer
5030764|NCT01503606|preterm premature rupture of membrane|preterm premature rupture of membrane
5030765|NCT01503606|antibiotics|antibiotics
5030766|NCT01503606|duration|duration
5030767|NCT01503606|cefazolin|cefazolin
5030768|NCT01503606|clarithromycin|clarithromycin
5030769|NCT01503541|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5030770|NCT01503541|adult acute myeloid leukemia with del(5q)|adult acute myeloid leukemia with del(5q)
5030771|NCT01503541|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5030772|NCT01503541|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5030773|NCT01503541|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5030774|NCT01503541|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5030775|NCT01503541|adult acute myeloid leukemia|adult acute myeloid leukemia
5030776|NCT01503528|arthroplasty|arthroplasty
5030777|NCT01503528|wound|wound
5030778|NCT01503528|catheter|catheter
5030779|NCT01503528|local|local
5030780|NCT01503528|anesthesia|anesthesia
5030781|NCT01503528|infiltration|infiltration
5030782|NCT01503528|Total Knee Arthroplasty|total knee arthroplasty
5030783|NCT01503502|Myelogenous Leukemia|myelogenous leukemia
5030784|NCT01503502|chronce|chronce
5030785|NCT01503502|Philadelphia Chromosome Positive|philadelphia chromosome positive
5030786|NCT01503502|Flumatinib|flumatinib
5030788|NCT01503476|gastro esophageal reflux disease|gastro esophageal reflux disease
5030789|NCT01503463|Congestive Heart Failure|congestive heart failure
5030790|NCT01503463|Telemedicine|telemedicine
5030791|NCT01503385|Celecoxib|celecoxib
5030792|NCT01503385|phase II|phase ii
5030793|NCT01503359|glutamic acid|glutamic acid
5030794|NCT01503359|sarcosine|sarcosine
5030795|NCT01503359|NMDA|nmda
5030796|NCT01503359|schizophrenia|schizophrenia
5030797|NCT01503346|Appetite Loss|appetite loss
5030798|NCT01503333|exercise|exercise
5030799|NCT01503333|adolescent|adolescent
5030800|NCT01503333|intervention|intervention
5030801|NCT01503333|female|female
5030802|NCT01503333|counseling|counseling
5030803|NCT01503320|To evaluate|to evaluate
5030804|NCT01503320|efficacy|efficacy
5030805|NCT01503320|enteral glutamine|enteral glutamine
5030806|NCT01503307|prenatal chd diagnosis|prenatal chd diagnosis
5030807|NCT01503307|postpartum chd diagnosis|postpartum chd diagnosis
5030808|NCT01503307|parenting|parenting
5030809|NCT01503307|internal working models|internal working models
5030810|NCT01503294|Temporal artery thermometer|temporal artery thermometer
5030811|NCT01503294|Pulmonary artery thermistor|pulmonary artery thermistor
5030812|NCT01503281|Children|children
5030813|NCT01503281|Physical activity|physical activity
5030814|NCT01503281|Home-based treatment|home-based treatment
5030815|NCT01503281|Body mass index (z-BMI)|body mass index (z-bmi)
5030816|NCT01503281|Percentage body fat|percentage body fat
5030817|NCT01503281|Waist circumference|waist circumference
5030818|NCT01503268|Atrial fibrillation|atrial fibrillation
5030819|NCT01503268|Ablation|ablation
5030820|NCT01503268|Percutaneous ablation|percutaneous ablation
5030821|NCT01503268|Minimally-invasive thoracoscopic ablation|minimally-invasive thoracoscopic ablation
5030822|NCT01503268|Implantable loop recorder|implantable loop recorder
5030823|NCT01503255|CBT|cbt
5030824|NCT01503255|alcohol|alcohol
5030825|NCT01503255|HIV|hiv
5030826|NCT01503255|Kenya|kenya
5030827|NCT01503255|paraprofessional|paraprofessional
5030828|NCT01503216|randomized controlled trial|randomized controlled trial
5030829|NCT01503216|vitamin D|vitamin d
5030830|NCT01503216|bioavailability|bioavailability
5030831|NCT01503203|Older|older
5030832|NCT01503203|virtual systems|virtual systems
5030833|NCT01503203|low back pain|low back pain
5030834|NCT01503203|postural balance|postural balance
5030835|NCT01503190|Breast Cancer|breast cancer
5030836|NCT01503190|Young Women|young women
5030837|NCT01503190|Pregnancy Associated Breast Cancer|pregnancy associated breast cancer
5030838|NCT01503190|Pregnancy|pregnancy
5030839|NCT01503190|Premenopausal Breast Cancer|premenopausal breast cancer
5030840|NCT01503164|Obstructive sleep apnea|obstructive sleep apnea
5030841|NCT01503164|Sleep Apnea|sleep apnea
5030842|NCT01503164|Sleep-disordered breathing|sleep-disordered breathing
5030843|NCT01503164|Insulin sensitivity|insulin sensitivity
5030844|NCT01503164|Glucose tolerance|glucose tolerance
5030845|NCT01503164|Type 2 diabetes|type 2 diabetes
5030846|NCT01503151|attention bias modification treatment|attention bias modification treatment
5030847|NCT01503151|interpretive bias modification|interpretive bias modification
5030848|NCT01503151|cognitive bias modification|cognitive bias modification
5030849|NCT01503151|attention training|attention training
5030850|NCT01503151|social anxiety|social anxiety
5030851|NCT01503138|Intimate Partner Violence|intimate partner violence
5030852|NCT01503138|Depressive Symptoms|depressive symptoms
5030853|NCT01503138|Intervention|intervention
5030854|NCT01503138|Randomized Controlled Trial|randomized controlled trial
5030855|NCT01503138|Mainland Chinese|mainland chinese
5030856|NCT01503138|Immigrants|immigrants
5030857|NCT01503138|Women|women
5030858|NCT01503125|GAN|gan
5030859|NCT01503125|Giant Axonal Neuropathy|giant axonal neuropathy
5030860|NCT01503125|Neuromuscular Disease|neuromuscular disease
5030861|NCT01503125|Natural History Study|natural history study
5030862|NCT01503125|Observational Study|observational study
5030863|NCT01503112|Glucagon-Like Peptide 1, DPP4 protein, Therapeutics, Hypoglycemic Agents, C-Peptide, Type 2 Diabetes Mellitus,|glucagon-like peptide 1, dpp4 protein, therapeutics, hypoglycemic agents, c-peptide, type 2 diabetes mellitus,
5030864|NCT01503099|ITB|itb
5030865|NCT01503099|PTB|ptb
5030866|NCT01503099|CD|cd
5030867|NCT01503073|stroke|stroke
5030868|NCT01503060|pediatrics|pediatrics
5030869|NCT01503060|Pain|pain
5030870|NCT01503060|Immunization|immunization
5030871|NCT01503034|Pregnant women|pregnant women
5030872|NCT01503021|Soluble ferric pyrophosphate|soluble ferric pyrophosphate
5030873|NCT01503021|Chronic kidney disease|chronic kidney disease
5030874|NCT01503021|Chronic hemodialysis|chronic hemodialysis
5030875|NCT01503021|Ferric pyrophosphate citrate|ferric pyrophosphate citrate
5030876|NCT01502995|Assistive devices|assistive devices
5030877|NCT01502995|Freezing of gait|freezing of gait
5030878|NCT01502995|Gait disorders|gait disorders
5030879|NCT01502995|Gait hesitation|gait hesitation
5030880|NCT01502995|Gait ignition failure|gait ignition failure
5030881|NCT01502995|Laser light|laser light
5030882|NCT01502995|Parkinson's disease|parkinson's disease
5030883|NCT01502995|Rolling walker|rolling walker
5030884|NCT01502995|Visual Cue|visual cue
5030885|NCT01502995|Walker|walker
5030886|NCT01502982|DLBCL|dlbcl
5030887|NCT01502982|high risk|high risk
5030888|NCT01502982|young|young
5030889|NCT01502969|diarrhea|diarrhea
5030890|NCT01502969|fever|fever
5030891|NCT01502969|nausea|nausea
5030892|NCT01502969|vomit|vomit
5030893|NCT01502969|irritability|irritability
5030894|NCT01502956|Refractory Urinary Urge Incontinence|refractory urinary urge incontinence
5030895|NCT01502956|Botox A®|botox a®
5030896|NCT01502956|Interstim® Device|interstim® device
5030897|NCT01502943|Complementary Therapies|complementary therapies
5030898|NCT01502943|Traditional Chinese Medicine|traditional chinese medicine
5030899|NCT01502943|Quality of life|quality of life
5030900|NCT01502943|Seattle angina questionnaire (SAQ)|seattle angina questionnaire (saq)
5030901|NCT01502943|SF-12|sf-12
5030902|NCT01502943|Measure Your Medical Outcome Profile (MYMOP)|measure your medical outcome profile (mymop)
5030903|NCT01502943|Phlegm and blood stasis Syndrome|phlegm and blood stasis syndrome
5030904|NCT01502943|Qi deficiency and blood stasis Syndrome|qi deficiency and blood stasis syndrome
5030905|NCT01502943|Invigorating Spleen to Remove Phlegm or replenish Qi|invigorating spleen to remove phlegm or replenish qi
5030906|NCT01502943|Activating blood and dissolving stasis|activating blood and dissolving stasis
5030907|NCT01502943|Traditional Chinese medicine SYndrome Scale (TCMsys)|traditional chinese medicine syndrome scale (tcmsys)
5030908|NCT01502943|Patients Report Outcomes(PRO)|patients report outcomes(pro)
5030909|NCT01502943|clinical efficacy|clinical efficacy
5030910|NCT01502943|evaluative index|evaluative index
5030911|NCT01502917|Brain stem glioma|brain stem glioma
5030912|NCT01502917|CNS|cns
5030913|NCT01502917|MAB 124I-8H9|mab 124i-8h9
5030914|NCT01502917|infusion cannula|infusion cannula
5030915|NCT01502917|DIPG|dipg
5030916|NCT01502917|Diffuse Intrinsic Pontine Glioma|diffuse intrinsic pontine glioma
5030917|NCT01502917|11-011|11-011
5030918|NCT01502904|SES vs BES|ses vs bes
5030919|NCT01502891|Comparative Effectiveness Research|comparative effectiveness research
5030920|NCT01502891|Decision Support Techniques|decision support techniques
5030921|NCT01502891|Decision Making|decision making
5030922|NCT01502878|Nut allergy|nut allergy
5031049|NCT01502306|Self-help|self-help
5030923|NCT01502878|Double-blind placebo-controlled (DBPC) oral nut challenge|double-blind placebo-controlled (dbpc) oral nut challenge
5030924|NCT01502878|Nut oral immunotherapy (OIT)|nut oral immunotherapy (oit)
5030925|NCT01502878|Nut oral desensitization|nut oral desensitization
5030926|NCT01502852|OEF/OIF Veterans|oef/oif veterans
5030927|NCT01502852|Traumatic Brain Injury|traumatic brain injury
5030928|NCT01502852|Community Mental Health|community mental health
5030929|NCT01502826|Childhood obesity|childhood obesity
5030930|NCT01502826|Endothelial dysfunction|endothelial dysfunction
5030931|NCT01502826|Inflammation|inflammation
5030932|NCT01502826|Insulin resistance|insulin resistance
5030933|NCT01502813|Neuropsychological testing|neuropsychological testing
5030934|NCT01502813|Dietary supplements|dietary supplements
5030935|NCT01502800|Metastatic|metastatic
5030936|NCT01502800|Unresectable|unresectable
5030937|NCT01502800|Recurrent advanced|recurrent advanced
5030938|NCT01502787|hypertension|hypertension
5030939|NCT01502787|blood pressure|blood pressure
5030940|NCT01502787|blood pressure medications|blood pressure medications
5030941|NCT01502787|metoprolol|metoprolol
5030942|NCT01502787|nebivolol|nebivolol
5030943|NCT01502787|handgrip exercise|handgrip exercise
5030944|NCT01502787|lower body negative pressure|lower body negative pressure
5030945|NCT01502787|angiotensin II|angiotensin ii
5030946|NCT01502787|sympathetic nerve activity|sympathetic nerve activity
5030947|NCT01502787|flow mediated dilation|flow mediated dilation
5030948|NCT01502787|nitric oxide|nitric oxide
5030949|NCT01502787|microneurography|microneurography
5030950|NCT01502774|STEMI|stemi
5030951|NCT01502774|cyclosporine|cyclosporine
5030952|NCT01502774|reperfusion injury|reperfusion injury
5030953|NCT01502761|stroke|stroke
5030954|NCT01502761|Magnesium|magnesium
5030955|NCT01502761|endovascular|endovascular
5030956|NCT01502748|stroke|stroke
5030957|NCT01502748|Magnesium|magnesium
5030958|NCT01502748|Endovascular|endovascular
5030959|NCT01502735|dengue|dengue
5030960|NCT01502735|dengue fever|dengue fever
5030961|NCT01502735|monovalent dengue vaccine|monovalent dengue vaccine
5030962|NCT01502709|Single blind|single blind
5030963|NCT01502709|Randomized|randomized
5030964|NCT01502709|Controlled clinical trial|controlled clinical trial
5030965|NCT01502696|ulcerated primary cutaneous melanoma|ulcerated primary cutaneous melanoma
5030966|NCT01502696|Stage II|stage ii
5030967|NCT01502696|PEG IFN alfa-2b|peg ifn alfa-2b
5030968|NCT01502696|T(2-4)bN0M0|t(2-4)bn0m0
5030969|NCT01502683|Stroke|stroke
5030970|NCT01502683|neurocognitive dysfunction|neurocognitive dysfunction
5030971|NCT01502683|cerebral embolic events|cerebral embolic events
5030972|NCT01502670|Pulmonary nodules|pulmonary nodules
5030973|NCT01502657|percutaneous tracheostomy|percutaneous tracheostomy
5030974|NCT01502657|ultrasonography|ultrasonography
5030975|NCT01502657|echography|echography
5030976|NCT01502657|critical care|critical care
5030977|NCT01502644|low back pain|low back pain
5030978|NCT01502644|opioids|opioids
5030979|NCT01502644|mood symptoms|mood symptoms
5031080|NCT01502202|Intercalation administration|intercalation administration
5030980|NCT01502618|Adolescent Medicine Trials Network for HIV/AIDS Interventions|adolescent medicine trials network for hiv/aids interventions
5030981|NCT01502618|Human Immunodeficiency Virus|human immunodeficiency virus
5030982|NCT01502605|5-ALA|5-ala
5030983|NCT01502605|Aminolevulinic Acid|aminolevulinic acid
5030984|NCT01502605|Craniotomy|craniotomy
5030985|NCT01502605|Brain Tumor|brain tumor
5030986|NCT01502605|Surgical Resection|surgical resection
5030987|NCT01502605|Neurosurgery|neurosurgery
5030988|NCT01502592|MDX-010 (Ipilimumab)|mdx-010 (ipilimumab)
5030989|NCT01502592|Cryoablation|cryoablation
5030990|NCT01502592|Total mastectomy planned|total mastectomy planned
5030991|NCT01502592|11-202|11-202
5030992|NCT01502579|IgA nephropathy|iga nephropathy
5030993|NCT01502566|educational intervention|educational intervention
5030994|NCT01502566|dentals caries|dentals caries
5030995|NCT01502566|population|population
5030996|NCT01502566|new populational caries prevention strategies.|new populational caries prevention strategies.
5030997|NCT01502553|blood pressure|blood pressure
5030998|NCT01502553|heart rate|heart rate
5030999|NCT01502540|pain|pain
5031000|NCT01502540|craniotomy|craniotomy
5031001|NCT01502527|Vulvo vaginal atrophy|vulvo vaginal atrophy
5031002|NCT01502527|Femarelle|femarelle
5031003|NCT01502514|CHF|chf
5031004|NCT01502514|ischemia|ischemia
5031005|NCT01502514|Heart Failure|heart failure
5031006|NCT01502501|CHF|chf
5031007|NCT01502501|Heart Failure|heart failure
5031008|NCT01502501|Non-Ischemic|non-ischemic
5031009|NCT01502501|nonischemic|nonischemic
5031010|NCT01502501|nonischemia|nonischemia
5031011|NCT01502488|Autistic|autistic
5031012|NCT01502488|ASC therapy|asc therapy
5031013|NCT01502488|ADSC|adsc
5031014|NCT01502475|Complementary Alternative Medicine|complementary alternative medicine
5031015|NCT01502475|Veteran|veteran
5031016|NCT01502475|Attitudes|attitudes
5031017|NCT01502475|Beliefs|beliefs
5031018|NCT01502462|Clinical course and prognostic factors in patients with severe isolated TR|clinical course and prognostic factors in patients with severe isolated tr
5031019|NCT01502449|telemedicine, telephonic, PTSD|telemedicine, telephonic, ptsd
5031020|NCT01502436|posttraumatic stress disorder|posttraumatic stress disorder
5031021|NCT01502436|traumatic brain injury|traumatic brain injury
5031022|NCT01502436|Suicide Attempt|suicide attempt
5031023|NCT01502436|Veterans|veterans
5031024|NCT01502423|On label Humira users|on label humira users
5031025|NCT01502423|Rheumatoid Arthritis|rheumatoid arthritis
5031026|NCT01502423|Pain|pain
5031027|NCT01502397|hepatitis B|hepatitis b
5031028|NCT01502397|anti-HBc|anti-hbc
5031029|NCT01502397|HBsAg|hbsag
5031030|NCT01502397|rituximab|rituximab
5031031|NCT01502397|occult HBV|occult hbv
5031032|NCT01502384|healthy 1st degree relatives of pd patients|healthy 1st degree relatives of pd patients
5031033|NCT01502371|Asthma|asthma
5031034|NCT01502371|Children|children
5031035|NCT01502371|Persistent|persistent
5031036|NCT01502358|dengue|dengue
5031037|NCT01502358|dengue fever|dengue fever
5031038|NCT01502358|dengue disease|dengue disease
5031039|NCT01502358|tetravalent dengue vaccine|tetravalent dengue vaccine
5031040|NCT01502358|Vaxfectin®|vaxfectin®
5031041|NCT01502345|HFRS|hfrs
5031042|NCT01502332|Mechanical ventilation|mechanical ventilation
5031043|NCT01502332|Open lung approach|open lung approach
5031044|NCT01502332|Blood gases|blood gases
5031045|NCT01502332|Cardiac surgery|cardiac surgery
5031046|NCT01502332|Pulmonary complications|pulmonary complications
5031047|NCT01502306|Smoking cessation|smoking cessation
5031048|NCT01502306|Telephone|telephone
5031050|NCT01502306|Smoking abstinence|smoking abstinence
5031051|NCT01502306|Incentives|incentives
5031052|NCT01502306|Nicotine-replacement therapy|nicotine-replacement therapy
5031053|NCT01502306|Medi-Cal|medi-cal
5031054|NCT01502306|Medicaid|medicaid
5031055|NCT01502280|extent of resection|extent of resection
5031056|NCT01502280|Glioma|glioma
5031057|NCT01502280|5-ALA|5-ala
5031058|NCT01502280|tumor fluorescence|tumor fluorescence
5031059|NCT01502280|confocal microscopy|confocal microscopy
5031060|NCT01502267|Waiting list|waiting list
5031061|NCT01502267|Deceased donor kidney transplantation|deceased donor kidney transplantation
5031062|NCT01502267|Desensitization|desensitization
5031063|NCT01502267|anti HLA antibody|anti hla antibody
5031064|NCT01502254|Informed consent|informed consent
5031065|NCT01502254|Cancer clinical trials|cancer clinical trials
5031066|NCT01502254|Patient information|patient information
5031067|NCT01502254|Knowledge|knowledge
5031068|NCT01502254|Questionnaire|questionnaire
5031069|NCT01502254|Patient Eligible for a Phase II or III Cancer Clinical Trial|patient eligible for a phase ii or iii cancer clinical trial
5031070|NCT01502254|Scheduled Clinical Visit for Information About a Trial|scheduled clinical visit for information about a trial
5031071|NCT01502241|elderly|elderly
5031072|NCT01502241|brain tumors|brain tumors
5031073|NCT01502241|MGMT|mgmt
5031074|NCT01502241|chemotherapy|chemotherapy
5031075|NCT01502241|Newly diagnosed|newly diagnosed
5031076|NCT01502241|patients > 65 years|patients > 65 years
5031077|NCT01502202|lung adenocarcinoma|lung adenocarcinoma
5031078|NCT01502202|never smoker|never smoker
5031079|NCT01502202|1st line treatment|1st line treatment
5031081|NCT01502202|Gefitinib|gefitinib
5031082|NCT01502202|never smokers|never smokers
5031083|NCT01502189|patient education as topic|patient education as topic
5031084|NCT01502189|representational approach|representational approach
5031085|NCT01502189|parents|parents
5031086|NCT01502189|childhood cancer|childhood cancer
5031087|NCT01502189|paediatric oncology|paediatric oncology
5031088|NCT01502189|nursing|nursing
5031089|NCT01502189|parents of children with cancer|parents of children with cancer
5031090|NCT01502189|Stress|stress
5031091|NCT01502189|Health Knowledge|health knowledge
5031092|NCT01502189|Attitudes|attitudes
5031093|NCT01502189|Practice|practice
5031094|NCT01502176|atrial fibrillation|atrial fibrillation
5031095|NCT01502176|registry|registry
5031096|NCT01502163|perioperative hypothermia|perioperative hypothermia
5031097|NCT01502163|prewarming|prewarming
5031098|NCT01502163|forced air warming|forced air warming
5031099|NCT01502163|insulation|insulation
5031100|NCT01502150|Pediatric Cancer|pediatric cancer
5031101|NCT01502150|Proton Radiation Therapy|proton radiation therapy
5031102|NCT01502150|Proton beam radiotherapy|proton beam radiotherapy
5031103|NCT01502150|PBT|pbt
5031104|NCT01502150|Data Collection|data collection
5031105|NCT01502150|Database|database
5031106|NCT01502150|Acute and late normal tissue toxicities|acute and late normal tissue toxicities
5031107|NCT01502150|Dosimetric data|dosimetric data
5031108|NCT01502150|Toxicity data|toxicity data
5031109|NCT01502111|decreased level of consciousness|decreased level of consciousness
5031110|NCT01502111|hypoxemia|hypoxemia
5031111|NCT01502111|ineffective ventilation|ineffective ventilation
5031112|NCT01502111|airway obstruction|airway obstruction
5031113|NCT01502111|combative or unresponsive|combative or unresponsive
5031114|NCT01502111|relief of pain or distress|relief of pain or distress
5031115|NCT01502111|cardiopulmonary arrest|cardiopulmonary arrest
5031116|NCT01502085|multiple myeloma lenalidomide|multiple myeloma lenalidomide
5031117|NCT01502072|Ribavirin|ribavirin
5031118|NCT01502072|Ribavirin Aerosol|ribavirin aerosol
5031119|NCT01502072|Respiratory Syncytial Virus|respiratory syncytial virus
5031120|NCT01502072|RSV|rsv
5031121|NCT01502072|upper respiratory tract infection|upper respiratory tract infection
5031122|NCT01502072|URI|uri
5031123|NCT01502072|Lower respiratory tract Infection|lower respiratory tract infection
5031124|NCT01502072|LRI|lri
5031125|NCT01502072|pneumonia|pneumonia
5031126|NCT01502072|aerosolized ribavirin|aerosolized ribavirin
5031127|NCT01502072|HSCT|hsct
5031128|NCT01502072|Hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
5031129|NCT01502072|oral ribavirin therapy|oral ribavirin therapy
5031130|NCT01502059|Pilates|pilates
5031131|NCT01502059|Exercise|exercise
5031132|NCT01502059|Treatment|treatment
5031133|NCT01502059|Low back pain|low back pain
5031134|NCT01502059|Pain|pain
5031135|NCT01502059|Function|function
5031136|NCT01502046|Huntington's disease, cannabinoids|huntington's disease, cannabinoids
5031137|NCT01502033|Adolescent Depression|adolescent depression
5031138|NCT01502033|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
5031139|NCT01502020|actinic keratoses|actinic keratoses
5031140|NCT01502020|actinic keratosis|actinic keratosis
5031141|NCT01502020|imiquimod, 3.75%|imiquimod, 3.75%
5031142|NCT01502020|imiquimod|imiquimod
5031143|NCT01502020|Zyclara|zyclara
5031144|NCT01502020|Actinic keratoses of the face or balding scalp|actinic keratoses of the face or balding scalp
5031145|NCT01502007|Activity Level|activity level
5031146|NCT01502007|Overweight|overweight
5031147|NCT01502007|Obesity|obesity
5031148|NCT01501994|Activity level|activity level
5031149|NCT01501994|Weight|weight
5031150|NCT01501994|Body Fat|body fat
5031151|NCT01501994|Well Being|well being
5031152|NCT01501981|heart failure|heart failure
5031153|NCT01501981|MR-proANP|mr-proanp
5031154|NCT01501981|MR-proADM|mr-proadm
5031155|NCT01501981|decompensation|decompensation
5031156|NCT01501981|Copeptin|copeptin
5031157|NCT01501981|CT-proET1|ct-proet1
5031158|NCT01501981|NT-proBNP|nt-probnp
5031159|NCT01501968|Colistin|colistin
5031160|NCT01501968|ascorbic acid|ascorbic acid
5031161|NCT01501968|renal toxicity|renal toxicity
5031162|NCT01501955|Osteoarthritis|osteoarthritis
5031163|NCT01501942|Asthma|asthma
5031164|NCT01501942|Allergen induced asthma|allergen induced asthma
5031165|NCT01501942|ATS Criteria (1)|ats criteria (1)
5031166|NCT01501929|hypertension|hypertension
5031167|NCT01501929|blood pressure|blood pressure
5031168|NCT01501929|blood pressure medications|blood pressure medications
5031169|NCT01501929|metoprolol|metoprolol
5031170|NCT01501929|nebivolol|nebivolol
5031171|NCT01501929|vascular oxidative stress|vascular oxidative stress
5031172|NCT01501929|nitric oxide|nitric oxide
5031173|NCT01501929|nitric oxide synthase (eNOS)|nitric oxide synthase (enos)
5031174|NCT01501929|endothelium|endothelium
5031175|NCT01501929|endothelial dysfunction|endothelial dysfunction
5031176|NCT01501929|endothelial cell protein expression|endothelial cell protein expression
5031177|NCT01501929|microvascular blood flow|microvascular blood flow
5031178|NCT01501929|flow mediated dilation|flow mediated dilation
5031179|NCT01501929|handgrip exercise|handgrip exercise
5031180|NCT01501929|endothelial cell collection|endothelial cell collection
5031181|NCT01501929|microbubbles|microbubbles
5031182|NCT01501929|Definity|definity
5031183|NCT01501890|Threatened Abortion|threatened abortion
5031184|NCT01501890|Progesterone|progesterone
5031185|NCT01501890|Subchorionic Hematoma|subchorionic hematoma
5031186|NCT01501890|Pre-Eclampsia|pre-eclampsia
5031187|NCT01501890|Abruptio Placentae|abruptio placentae
5031188|NCT01501890|Fetal Growth Retardation|fetal growth retardation
5031189|NCT01501890|Premature Birth|premature birth
5031190|NCT01501877|Smoking|smoking
5031191|NCT01501877|Type 2 Diabetes|type 2 diabetes
5031192|NCT01501877|Smoking cessation|smoking cessation
5031193|NCT01501864|HIV prevention|hiv prevention
5031194|NCT01501864|HSV-2|hsv-2
5031195|NCT01501864|Schooling|schooling
5031196|NCT01501864|Kenya|kenya
5031197|NCT01501864|Orphans|orphans
5031198|NCT01501864|School support|school support
5031199|NCT01501799|acne|acne
5031200|NCT01501799|adapalene/benzoyl peroxide|adapalene/benzoyl peroxide
5031201|NCT01501799|Epiduo|epiduo
5031202|NCT01501799|Mild to severe acne vulgaris|mild to severe acne vulgaris
5031203|NCT01501786|children|children
5031204|NCT01501786|sedation|sedation
5031205|NCT01501786|propofol|propofol
5031206|NCT01501786|ketamine|ketamine
5031207|NCT01501773|Acute ischemic stroke|acute ischemic stroke
5031208|NCT01501747|Placebo effect|placebo effect
5031209|NCT01501747|drug half life|drug half life
5031210|NCT01501747|pharmacokinetics|pharmacokinetics
5031211|NCT01501734|CHF|chf
5031212|NCT01501734|watch-pat|watch-pat
5031213|NCT01501734|embletta x|embletta x
5031214|NCT01501734|endothelial function|endothelial function
5031215|NCT01501721|prevention|prevention
5031216|NCT01501721|workers|workers
5031217|NCT01501721|clinical trials|clinical trials
5031218|NCT01501721|obesity|obesity
5031219|NCT01501708|caspofungin|caspofungin
5031220|NCT01501708|IFI|ifi
5031221|NCT01501708|allogeneic hematopoietic stem cell transplantation|allogeneic hematopoietic stem cell transplantation
5031222|NCT01501695|tic disorder|tic disorder
5031223|NCT01501695|pediatric|pediatric
5031224|NCT01501682|ventralex|ventralex
5031225|NCT01501682|ventral hernia|ventral hernia
5031226|NCT01501669|irinotecan|irinotecan
5031227|NCT01501669|capecitabine|capecitabine
5031228|NCT01501669|metastatic breast cancer|metastatic breast cancer
5031229|NCT01501643|Non invasive positive pressure ventilation|non invasive positive pressure ventilation
5031230|NCT01501643|Spirometry|spirometry
5031231|NCT01501643|Acute chest syndrome|acute chest syndrome
5031232|NCT01501643|Sickle cell disease|sickle cell disease
5031233|NCT01501643|Vaso-occlusive crisis|vaso-occlusive crisis
5031234|NCT01501630|Comparison of imaging modalities|comparison of imaging modalities
5031235|NCT01501630|Impact on patient management|impact on patient management
5031236|NCT01501630|Optimisation of cost of the diagnostic strategy|optimisation of cost of the diagnostic strategy
5031237|NCT01501617|Hair Loss|hair loss
5031238|NCT01501617|Androgenetic Alopecia|androgenetic alopecia
5031239|NCT01501617|Baldness|baldness
5031240|NCT01501617|Male pattern baldness|male pattern baldness
5031241|NCT01501617|Male pattern hair loss|male pattern hair loss
5031242|NCT01501617|Hair Regrowth|hair regrowth
5031243|NCT01501617|Alopecia|alopecia
5031244|NCT01501617|Hair growth|hair growth
5031245|NCT01501617|Regrow Hair|regrow hair
5031246|NCT01501604|PIK3CA mutation|pik3ca mutation
5031247|NCT01501604|Advanced solid tumors|advanced solid tumors
5031248|NCT01501591|Placebo effect|placebo effect
5031249|NCT01501591|placebo drug interaction|placebo drug interaction
5031250|NCT01501591|placebo -controlled clinical trials|placebo -controlled clinical trials
5031251|NCT01501578|Pulmonary fibrosis|pulmonary fibrosis
5031252|NCT01501578|Telomerase mutation|telomerase mutation
5031253|NCT01501565|Postoperative pain|postoperative pain
5031254|NCT01501565|Transverse abdominal blockade|transverse abdominal blockade
5031255|NCT01501565|Efficacy|efficacy
5031256|NCT01501565|Safety|safety
5031257|NCT01501565|Urology|urology
5031258|NCT01501552|Primary health care|primary health care
5031259|NCT01501552|Identification and Brief Intervention Programmes|identification and brief intervention programmes
5031260|NCT01501552|Hazardous and harmful alcohol consumption|hazardous and harmful alcohol consumption
5031261|NCT01501539|Hypergranulation tissue|hypergranulation tissue
5031262|NCT01501539|Gastrostomy tube|gastrostomy tube
5031263|NCT01501539|Hydrocolloid dressing|hydrocolloid dressing
5031264|NCT01501539|Silver hydrocolloid dressing|silver hydrocolloid dressing
5031265|NCT01501539|Gastrostomy tube dislodgement|gastrostomy tube dislodgement
5031266|NCT01501539|Wound infection|wound infection
5031267|NCT01501539|Peristomal skin breakdown|peristomal skin breakdown
5031268|NCT01501526|herpes esophagitis|herpes esophagitis
5031269|NCT01501526|dysphagia|dysphagia
5031270|NCT01501526|vocal fold palsy|vocal fold palsy
5031271|NCT01501526|immunocompetent|immunocompetent
5031272|NCT01501526|husky voice|husky voice
5031273|NCT01501513|colonoscopy|colonoscopy
5031274|NCT01501513|bowel preparation|bowel preparation
5031275|NCT01501513|endoscopy|endoscopy
5031276|NCT01501500|botulinum toxin type A|botulinum toxin type a
5031277|NCT01501500|hallux valgus angle|hallux valgus angle
5031278|NCT01501500|foot function index|foot function index
5031279|NCT01501500|VAS pain scale|vas pain scale
5031280|NCT01501487|breast cancer|breast cancer
5031281|NCT01501487|neo adjuvant therapy|neo adjuvant therapy
5031282|NCT01501474|Confocal|confocal
5031283|NCT01501474|malignant biliary stricture|malignant biliary stricture
5031284|NCT01501474|Sensitivity, specificity and accuracy of CholangioFlex in malignant biliary stricture diagnosis|sensitivity, specificity and accuracy of cholangioflex in malignant biliary stricture diagnosis
5031285|NCT01501474|sensitivity, specificity and accuracy of Fluorescent in situ Hybridization(FISH) in malignant biliary stricture diagnosis|sensitivity, specificity and accuracy of fluorescent in situ hybridization(fish) in malignant biliary stricture diagnosis
5031286|NCT01501435|Safety|safety
5031287|NCT01501435|Pharmacokinetics|pharmacokinetics
5031288|NCT01501422|postmenopause|postmenopause
5031289|NCT01501422|sleep quality|sleep quality
5031290|NCT01501422|estrogen|estrogen
5031291|NCT01501422|objective sleep quality|objective sleep quality
5031292|NCT01501422|actigraph|actigraph
5031293|NCT01501409|Sodium lauryl sulfate (SLS)|sodium lauryl sulfate (sls)
5031294|NCT01501409|recurrent aphthous stomatitis (RAS)|recurrent aphthous stomatitis (ras)
5031295|NCT01501409|dentifrice|dentifrice
5031296|NCT01501409|pain|pain
5031297|NCT01501370|Myeloma|myeloma
5031298|NCT01501370|Biochemical relapse|biochemical relapse
5031299|NCT01501357|caries|caries
5031300|NCT01501357|primary molars|primary molars
5031301|NCT01501357|plaque|plaque
5031302|NCT01501357|toothbrushing|toothbrushing
5031303|NCT01501344|osteoporosis|osteoporosis
5031304|NCT01501344|postmenopausal women|postmenopausal women
5031305|NCT01501344|bone remodelling|bone remodelling
5031306|NCT01501344|bone turnover markers|bone turnover markers
5031307|NCT01501331|Congestive Heart Failure|congestive heart failure
5031308|NCT01501331|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
5031309|NCT01501331|Internal Cardioverter Defibrillators|internal cardioverter defibrillators
5031310|NCT01501318|SBIRT|sbirt
5031311|NCT01501318|brief intervention|brief intervention
5031312|NCT01501318|alcohol|alcohol
5031313|NCT01501318|drug abuse|drug abuse
5031314|NCT01501305|influence|influence
5031315|NCT01501305|carob powder|carob powder
5031316|NCT01501305|probiotics|probiotics
5031317|NCT01501305|duration|duration
5031318|NCT01501279|pudendal nerve block|pudendal nerve block
5031319|NCT01501279|postoperative pain|postoperative pain
5031320|NCT01501279|bladder spasm|bladder spasm
5031321|NCT01501266|postmenopausal breast cancer|postmenopausal breast cancer
5031322|NCT01501266|Faslodex|faslodex
5031323|NCT01501266|cohort|cohort
5031324|NCT01501253|CKD-828|ckd-828
5031325|NCT01501253|Hypertension|hypertension
5031326|NCT01501253|Primary Hypertension|primary hypertension
5031327|NCT01501253|S-Amlodipine|s-amlodipine
5031328|NCT01501253|Telmisartan|telmisartan
5031329|NCT01501253|Non-Responder|non-responder
5031330|NCT01501240|Magnetic resonance image|magnetic resonance image
5031331|NCT01501240|gadoxetic acid|gadoxetic acid
5031332|NCT01501240|hepatocellular carcinoma|hepatocellular carcinoma
5031333|NCT01501240|liver cirrhosis|liver cirrhosis
5031334|NCT01501227|ventilator associated pneumonia|ventilator associated pneumonia
5031335|NCT01501214|atosiban|atosiban
5031336|NCT01501214|in vitro fertilization|in vitro fertilization
5031337|NCT01501214|subfertility|subfertility
5031338|NCT01501201|Obesity|obesity
5031339|NCT01501201|Diabetes|diabetes
5031340|NCT01501201|Bariatric Surgery|bariatric surgery
5031341|NCT01501188|Chronic Venous Insufficiency|chronic venous insufficiency
5031342|NCT01501188|Kinesio Taping|kinesio taping
5031343|NCT01501188|Electromyography|electromyography
5031344|NCT01501188|Range of ankle motion|range of ankle motion
5031345|NCT01501175|superficial vein thrombosis|superficial vein thrombosis
5031346|NCT01501175|Saint Etienne region|saint etienne region
5031347|NCT01501162|hepatitis, alcohol|hepatitis, alcohol
5031348|NCT01501149|NK/T cell lymphoma|nk/t cell lymphoma
5031349|NCT01501149|chemotherapy|chemotherapy
5031350|NCT01501149|clinical trial|clinical trial
5031351|NCT01501149|RR|rr
5031352|NCT01501149|PFS|pfs
5031353|NCT01501149|OS|os
5031354|NCT01501136|NK/T cell lymphoma|nk/t cell lymphoma
5031355|NCT01501136|chemotherapy|chemotherapy
5031356|NCT01501136|clinical trial|clinical trial
5031357|NCT01501136|RR|rr
5031358|NCT01501136|PFS|pfs
5031359|NCT01501136|OS|os
5031360|NCT01501123|Time to sedation of agitated patients|time to sedation of agitated patients
5031361|NCT01501110|Euthyroid Sick Syndrome|euthyroid sick syndrome
5031362|NCT01501110|low T3 syndrome|low t3 syndrome
5031363|NCT01501110|deiodases|deiodases
5031364|NCT01501110|oxidative stress|oxidative stress
5031365|NCT01501110|ischemic heart disease|ischemic heart disease
5031366|NCT01501084|functional MRI|functional mri
5031367|NCT01501084|Structural MRI|structural mri
5031368|NCT01501084|obesity|obesity
5031369|NCT01501084|resting state networks|resting state networks
5031370|NCT01501071|Laparoscopic Nissen fundoplication|laparoscopic nissen fundoplication
5031371|NCT01501071|Esophageal calibration|esophageal calibration
5031372|NCT01501071|Postoperative dysphagia|postoperative dysphagia
5031373|NCT01501045|TMS|tms
5031374|NCT01501045|CPM|cpm
5031375|NCT01501045|headache|headache
5031376|NCT01501045|migraine|migraine
5031377|NCT01501045|EEG|eeg
5031378|NCT01501045|psychophysics|psychophysics
5031379|NCT01501032|Diabetes Type 1|diabetes type 1
5031380|NCT01501032|Artificial Pancreas|artificial pancreas
5031381|NCT01501006|Physicians|physicians
5031382|NCT01500993|Rectal cancer|rectal cancer
5031383|NCT01500993|Chemoradiotherapy|chemoradiotherapy
5031384|NCT01500993|Capecitabine|capecitabine
5031385|NCT01500993|phase-III trial|phase-iii trial
5031386|NCT01500980|malaria|malaria
5031387|NCT01500980|challenge|challenge
5031388|NCT01500980|P. falciparum|p. falciparum
5031389|NCT01500980|prevention|prevention
5031390|NCT01500928|Insulin Pump|insulin pump
5031391|NCT01500928|Glycemic Control|glycemic control
5031392|NCT01500928|Type 1 Diabetes|type 1 diabetes
5031393|NCT01500915|AMD|amd
5031394|NCT01500915|ranibizumab|ranibizumab
5031395|NCT01500915|antiVEGF|antivegf
5031396|NCT01500915|regimen of injections|regimen of injections
5031397|NCT01500915|anti VEGF regimen|anti vegf regimen
5031398|NCT01500915|PRN|prn
5031399|NCT01500915|treat and extend|treat and extend
5031400|NCT01500902|Acute Coronary Syndrome (ACS)|acute coronary syndrome (acs)
5031401|NCT01500902|Percutaneous Intervention (PCI)|percutaneous intervention (pci)
5031402|NCT01500902|Coronary Stent (CStent)|coronary stent (cstent)
5031403|NCT01500902|Percutaneous Transluminal Coronary Angioplasty (PTCA)|percutaneous transluminal coronary angioplasty (ptca)
5031404|NCT01500902|stent placement|stent placement
5031405|NCT01500902|balloon angioplasty|balloon angioplasty
5031406|NCT01500889|Anal fissure|anal fissure
5031407|NCT01500889|Advancement flap|advancement flap
5031408|NCT01500889|Internal sphincterotomy|internal sphincterotomy
5031409|NCT01500876|lung cancer|lung cancer
5031410|NCT01500863|endometrial receptivity|endometrial receptivity
5031411|NCT01500863|gene arrays|gene arrays
5031412|NCT01500863|agonist triggering|agonist triggering
5031413|NCT01500863|Endometrial gene expression|endometrial gene expression
5031414|NCT01500863|OHSS|ohss
5031415|NCT01500850|Type 2 Diabetes mellitus|type 2 diabetes mellitus
5031416|NCT01500850|NPH insulin|nph insulin
5031417|NCT01500850|Insulin Glargine|insulin glargine
5031418|NCT01500850|cardiovascular biomarkers|cardiovascular biomarkers
5031419|NCT01500850|hsCRP, adiponectin|hscrp, adiponectin
5031420|NCT01500850|intact proinsulin|intact proinsulin
5031421|NCT01500850|cardiovascular risk|cardiovascular risk
5031422|NCT01500837|Staphylococcus aureus|staphylococcus aureus
5031423|NCT01500837|osteoarticular infection|osteoarticular infection
5031424|NCT01500837|clindamycin|clindamycin
5031425|NCT01500837|serum concentration|serum concentration
5031426|NCT01500837|orthopedic surgery|orthopedic surgery
5031427|NCT01500824|Crizotinib|crizotinib
5031428|NCT01500824|ALK|alk
5031429|NCT01500824|NSCLC|nsclc
5031430|NCT01500824|Non-Small Cell Lung Cancer|non-small cell lung cancer
5031431|NCT01500824|Asian|asian
5031432|NCT01500811|chondrocyte hip osteoarthritis intra articular injection|chondrocyte hip osteoarthritis intra articular injection
5031433|NCT01500772|Hepatitis C|hepatitis c
5031434|NCT01500772|PI treatment failure|pi treatment failure
5031435|NCT01500759|chronic heart failure|chronic heart failure
5031436|NCT01500759|heart failure|heart failure
5031437|NCT01500759|hf|hf
5031438|NCT01500759|sleep-disordered breathing|sleep-disordered breathing
5031439|NCT01500759|sdb|sdb
5031440|NCT01500759|nyha|nyha
5031441|NCT01500759|lvef|lvef
5031442|NCT01500759|cheyne stokes|cheyne stokes
5031443|NCT01500759|central sleep apnoea|central sleep apnoea
5031444|NCT01500759|sleep apnoea|sleep apnoea
5031445|NCT01500746|chronic wound treatment|chronic wound treatment
5031446|NCT01500746|pulse lavage|pulse lavage
5031447|NCT01500746|serial pulse lavage|serial pulse lavage
5031448|NCT01500746|wounds|wounds
5031449|NCT01500746|bacterial colonization of wounds|bacterial colonization of wounds
5031450|NCT01500733|Treatment|treatment
5031451|NCT01500733|CLL (Chronic Lymphocytic Leukemia)|cll (chronic lymphocytic leukemia)
5031452|NCT01500733|SLL (Small Lymphocytic Lymphoma)|sll (small lymphocytic lymphoma)
5031453|NCT01500733|Leukemia|leukemia
5031454|NCT01500733|Lymphocytic Leukemia|lymphocytic leukemia
5031455|NCT01500733|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
5031456|NCT01500733|CLL|cll
5031457|NCT01500733|Small Lymphocytic Leukemia|small lymphocytic leukemia
5031458|NCT01500733|SLL|sll
5031459|NCT01500668|Botox|botox
5031460|NCT01500668|catocholamine|catocholamine
5031461|NCT01500668|shock|shock
5031462|NCT01500668|vasomotor|vasomotor
5031463|NCT01500668|Vasopressin|vasopressin
5031464|NCT01500668|botulinum toxin|botulinum toxin
5031465|NCT01500655|burn|burn
5031466|NCT01500655|skin graft donor site|skin graft donor site
5031467|NCT01500655|analgesia for donor site|analgesia for donor site
5031468|NCT01500629|Allergic Rhinitis|allergic rhinitis
5031469|NCT01500629|Hayfever|hayfever
5031470|NCT01500629|Pollen Allergy|pollen allergy
5031471|NCT01500616|Chronic Hepatitis C Infection|chronic hepatitis c infection
5031472|NCT01500616|Chronic Hepatitis C Co-Infected Patients|chronic hepatitis c co-infected patients
5031473|NCT01500616|Hepatitis C|hepatitis c
5031474|NCT01500616|Severe Fibrosis|severe fibrosis
5031475|NCT01500616|Compensated Cirrhosis|compensated cirrhosis
5031476|NCT01500616|VX-950HPC3005|vx-950hpc3005
5031477|NCT01500603|post-radical prostatectomy|post-radical prostatectomy
5031478|NCT01500603|stress urinary incontinence|stress urinary incontinence
5032072|NCT01498094|Prongs|prongs
5031479|NCT01500603|periurethral Pro-ACT balloons|periurethral pro-act balloons
5031480|NCT01500603|AdvanceXP retrourethral male sling|advancexp retrourethral male sling
5031481|NCT01500590|Diabetes|diabetes
5031482|NCT01500590|hypertensive|hypertensive
5031483|NCT01500590|without albuminuria|without albuminuria
5031484|NCT01500577|Prevention|prevention
5031485|NCT01500577|Breast Cancer|breast cancer
5031486|NCT01500577|Proliferation|proliferation
5031487|NCT01500577|Breast Cancer Prevention|breast cancer prevention
5031488|NCT01500564|Stroke|stroke
5031489|NCT01500564|transcranial direct current stimulation (tDCS)|transcranial direct current stimulation (tdcs)
5031490|NCT01500564|motor function|motor function
5031491|NCT01500551|Arthritis|arthritis
5031492|NCT01500551|Pediatric|pediatric
5031493|NCT01500551|Tofacitinib|tofacitinib
5031494|NCT01500551|Long-term|long-term
5031495|NCT01500551|JIA|jia
5031496|NCT01500551|CP-690,550|cp-690,550
5031497|NCT01500551|Xeljanz|xeljanz
5031498|NCT01500538|Follicular lymphoma|follicular lymphoma
5031499|NCT01500538|Marginal zone lymphoma|marginal zone lymphoma
5031500|NCT01500538|Mantle cell lymphoma|mantle cell lymphoma
5031501|NCT01500538|thrombocytopenia|thrombocytopenia
5031502|NCT01500538|eltrombopag|eltrombopag
5031503|NCT01500538|vorinostat|vorinostat
5031504|NCT01500538|lymphoma|lymphoma
5031505|NCT01500525|asthma|asthma
5031506|NCT01500525|children|children
5031507|NCT01500525|accuracy of bronchodilator response|accuracy of bronchodilator response
5031508|NCT01500499|adult acute myeloid leukemia|adult acute myeloid leukemia
5031509|NCT01500499|childhood acute myeloid leukemia/other myeloid malignancies|childhood acute myeloid leukemia/other myeloid malignancies
5031510|NCT01500447|Hypogonadotropic Hypogonadism|hypogonadotropic hypogonadism
5031511|NCT01500447|Kallmann Syndrome|kallmann syndrome
5031512|NCT01500447|Delayed Puberty|delayed puberty
5031513|NCT01500447|Infertility|infertility
5031514|NCT01500447|Hypothalamic Amenorrhea|hypothalamic amenorrhea
5031515|NCT01500447|Early Puberty|early puberty
5031516|NCT01500447|Late Puberty|late puberty
5031517|NCT01500447|Hypogonadism|hypogonadism
5031518|NCT01500447|Amenorrhea|amenorrhea
5031519|NCT01500447|Endocrine Diseases|endocrine diseases
5031520|NCT01500434|drug-eluting stents|drug-eluting stents
5031521|NCT01500434|DES|des
5031522|NCT01500434|atherosclerotic|atherosclerotic
5031523|NCT01500421|Hypothermia, Induced|hypothermia, induced
5031524|NCT01500395|Aortic Diseases|aortic diseases
5031525|NCT01500395|Vascular Diseases|vascular diseases
5031526|NCT01500395|Cardiovascular Diseases|cardiovascular diseases
5031527|NCT01500395|Treatment Outcome|treatment outcome
5031528|NCT01500395|Aorta Dissection|aorta dissection
5031529|NCT01500395|Aorta Aneurysm|aorta aneurysm
5031530|NCT01500395|Aorta pseudoaneurysm|aorta pseudoaneurysm
5031531|NCT01500395|Endovascular aortic repair|endovascular aortic repair
5031532|NCT01500395|Hybrid operation|hybrid operation
5031533|NCT01500395|Debranching|debranching
5031534|NCT01500369|atrial fibrillation|atrial fibrillation
5031535|NCT01500369|remote ischemic conditioning|remote ischemic conditioning
5031536|NCT01500356|cardiovascular disease|cardiovascular disease
5031537|NCT01500356|obesity|obesity
5031538|NCT01500356|exercise|exercise
5031539|NCT01500343|heart failure|heart failure
5031540|NCT01500343|probiotics|probiotics
5031541|NCT01500343|Saccharomyces boulardii|saccharomyces boulardii
5031542|NCT01500343|cardio-intestinal syndrome|cardio-intestinal syndrome
5031543|NCT01500343|gut|gut
5031544|NCT01500343|inflammation|inflammation
5031545|NCT01500317|tapentadol|tapentadol
5031546|NCT01500317|oxycodone|oxycodone
5031547|NCT01500317|mu-opiate|mu-opiate
5031548|NCT01500317|stomach|stomach
5031549|NCT01500317|small intestine|small intestine
5031550|NCT01500317|colon|colon
5031551|NCT01500317|motility|motility
5031552|NCT01500317|nausea|nausea
5031553|NCT01500317|constipation|constipation
5031554|NCT01500304|Melanoma|melanoma
5031555|NCT01500304|Lymph Nodes|lymph nodes
5031556|NCT01500304|Lymph Node Dissection|lymph node dissection
5031557|NCT01500304|Minimally invasive|minimally invasive
5031558|NCT01500291|anesthesia stress|anesthesia stress
5031559|NCT01500278|Certolizumab Pegol|certolizumab pegol
5031560|NCT01500278|Cimzia|cimzia
5031561|NCT01500278|Adalimumab|adalimumab
5031562|NCT01500278|Humira|humira
5031563|NCT01500278|Rheumatoid Arthritis|rheumatoid arthritis
5031564|NCT01500265|hepatitis B virus|hepatitis b virus
5031565|NCT01500265|early screening tools|early screening tools
5031566|NCT01500265|renal proximal tubular tolerance|renal proximal tubular tolerance
5031567|NCT01500252|Total Knee Replacement|total knee replacement
5031568|NCT01500252|Patellar Resurfacing|patellar resurfacing
5031569|NCT01500252|Health Related Quality of Life|health related quality of life
5031570|NCT01500226|Rolapitant|rolapitant
5031571|NCT01500226|Nausea|nausea
5031572|NCT01500226|Vomiting|vomiting
5031573|NCT01500226|CINV|cinv
5031574|NCT01500226|Chemotherapy|chemotherapy
5031575|NCT01500213|Rolapitant|rolapitant
5031576|NCT01500213|Nausea|nausea
5031577|NCT01500213|Vomiting|vomiting
5031578|NCT01500213|CINV|cinv
5031579|NCT01500213|Chemotherapy|chemotherapy
5031580|NCT01500187|white spot lesions|white spot lesions
5032275|NCT01497184|Lymphoma|lymphoma
5031581|NCT01500187|fixed orthodontic brackets|fixed orthodontic brackets
5031582|NCT01500187|fluoride varnish|fluoride varnish
5031583|NCT01500187|fluoride gel|fluoride gel
5031584|NCT01500174|skin|skin
5031585|NCT01500174|decubitus|decubitus
5031586|NCT01500174|pressure|pressure
5031587|NCT01500174|sore|sore
5031588|NCT01500174|spinal cord injury|spinal cord injury
5031589|NCT01500161|Leukemia|leukemia
5031590|NCT01500161|Lymphoma|lymphoma
5031591|NCT01500161|Myeloma|myeloma
5031592|NCT01500161|Aplastic Anemia|aplastic anemia
5031593|NCT01500161|Myelodysplasia|myelodysplasia
5031595|NCT01500161|ALL|all
5031596|NCT01500161|CLL|cll
5031597|NCT01500161|CML|cml
5031598|NCT01500148|Mitral Valve Prolapse|mitral valve prolapse
5031599|NCT01500148|Mitral Valve Disease|mitral valve disease
5031600|NCT01500148|Mitral Valve Regurgitation|mitral valve regurgitation
5031601|NCT01500148|Mitral Valve Insufficiency|mitral valve insufficiency
5031602|NCT01500148|Mitral Valve Incompetence|mitral valve incompetence
5031603|NCT01500148|Percutaneous Mitral Valve Repair|percutaneous mitral valve repair
5031604|NCT01500148|Posterior leaflet prolapse|posterior leaflet prolapse
5031605|NCT01500148|Mitral valve degeneration|mitral valve degeneration
5031606|NCT01500135|Vascular Surgery|vascular surgery
5031607|NCT01500135|Secondary treatment of needle hole bleeding|secondary treatment of needle hole bleeding
5031608|NCT01500135|Subjects undergoing vascular surgery and who need supportive treatment in order to control bleeding|subjects undergoing vascular surgery and who need supportive treatment in order to control bleeding
5031609|NCT01500109|cleft palate surgery|cleft palate surgery
5031610|NCT01500109|post-operative pain management|post-operative pain management
5031611|NCT01500109|Acetaminophen|acetaminophen
5031612|NCT01500096|Fatigue|fatigue
5031613|NCT01500096|HIV/AIDS|hiv/aids
5031614|NCT01500096|American ginseng|american ginseng
5031615|NCT01500096|Panax quinquefolius|panax quinquefolius
5031616|NCT01500096|Fatigue Severity Scale|fatigue severity scale
5031617|NCT01500096|CD4 count|cd4 count
5031618|NCT01500096|plasma HIV RNA|plasma hiv rna
5031619|NCT01500096|cytokines|cytokines
5031620|NCT01500096|IL-6|il-6
5031621|NCT01500096|sTNFR1|stnfr1
5031622|NCT01500096|sTNFR2|stnfr2
5031623|NCT01500083|iNHL|inhl
5031624|NCT01500083|CLL|cll
5031625|NCT01500070|Peripheral Arterial Disease|peripheral arterial disease
5031626|NCT01500070|Claudication|claudication
5031627|NCT01500070|Drug-Eluting Stent|drug-eluting stent
5031628|NCT01500070|BTK|btk
5031629|NCT01500070|Everolimus|everolimus
5031630|NCT01500070|CLI|cli
5031631|NCT01500057|enlarged prostate|enlarged prostate
5031632|NCT01500044|Radiculopathy|radiculopathy
5031633|NCT01500044|Rehabilitation|rehabilitation
5031634|NCT01500044|Mobilization|mobilization
5031635|NCT01500044|Exercise|exercise
5031636|NCT01500044|Physical Therapy|physical therapy
5031637|NCT01500018|Phase I|phase i
5031638|NCT01500018|healthy recreational polydrug users|healthy recreational polydrug users
5031639|NCT01500018|abuse liability|abuse liability
5031640|NCT01500018|TC-5214|tc-5214
5031641|NCT01500018|Single dose crossover study to evaluate the abuse potential of TC-5214|single dose crossover study to evaluate the abuse potential of tc-5214
5031642|NCT01499992|Shoulder rehabilitation|shoulder rehabilitation
5031643|NCT01499992|Rotator cuff tear|rotator cuff tear
5031644|NCT01499992|Physiotherapy|physiotherapy
5031645|NCT01499992|aqua therapy|aqua therapy
5031646|NCT01499992|Therapy dosage|therapy dosage
5031647|NCT01499992|adjunctive aquatic physical therapy|adjunctive aquatic physical therapy
5031648|NCT01499979|Ischemia-reperfusion injury|ischemia-reperfusion injury
5031649|NCT01499979|In situ hypothermic perfusion|in situ hypothermic perfusion
5031650|NCT01499979|In situ hypothermic preservation|in situ hypothermic preservation
5031651|NCT01499966|Lateral Ankle Sprain|lateral ankle sprain
5031652|NCT01499966|Plaster of Paris|plaster of paris
5031653|NCT01499966|Tubigrip|tubigrip
5031654|NCT01499953|superficial vein thrombosis|superficial vein thrombosis
5031655|NCT01499953|thrombosis|thrombosis
5031656|NCT01499953|SVT|svt
5031657|NCT01499940|peripheral neuropathy|peripheral neuropathy
5031658|NCT01499940|vitamin D status|vitamin d status
5031659|NCT01499940|oxaliplatin|oxaliplatin
5031660|NCT01499927|Early reassessment of intravenous antiinfective therapy|early reassessment of intravenous antiinfective therapy
5031661|NCT01499914|vaccination H1N1|vaccination h1n1
5031662|NCT01499914|cystic fibrosis|cystic fibrosis
5031663|NCT01499901|deafness|deafness
5031664|NCT01499901|unilateral implantation|unilateral implantation
5031665|NCT01499901|bilateral|bilateral
5031666|NCT01499901|auditory perception|auditory perception
5031667|NCT01499888|Sickle Cell Disease|sickle cell disease
5031668|NCT01499888|Subtype Hgb SS|subtype hgb ss
5031669|NCT01499888|Subtype Hgb SC|subtype hgb sc
5031670|NCT01499888|Subtype Hgb SB|subtype hgb sb
5031671|NCT01499888|Chronic Transfusion Therapy|chronic transfusion therapy
5031672|NCT01499888|Prior Stroke|prior stroke
5031673|NCT01499888|Allogeneic|allogeneic
5031674|NCT01499888|Stem Cell Transplantation|stem cell transplantation
5031675|NCT01499888|Alemtuzumab|alemtuzumab
5031676|NCT01499888|Sirolimus|sirolimus
5031677|NCT01499888|Total Body Irradiation|total body irradiation
5031678|NCT01499888|Hydroxyurea Intolerant|hydroxyurea intolerant
5031679|NCT01499875|Pharmacokinetic|pharmacokinetic
5031680|NCT01499875|Pharmacodynamic|pharmacodynamic
5031681|NCT01499875|Phenoxymethylpenicillin|phenoxymethylpenicillin
5031682|NCT01499875|Children|children
5031683|NCT01499862|Stroke|stroke
5031684|NCT01499862|Tibion|tibion
5031685|NCT01499862|Bionics|bionics
5031686|NCT01499862|Rehab|rehab
5031687|NCT01499862|Therapy|therapy
5031688|NCT01499862|Robotics|robotics
5031689|NCT01499862|Intention|intention
5031690|NCT01499849|Rolapitant|rolapitant
5031691|NCT01499849|Nausea|nausea
5031692|NCT01499849|Vomiting|vomiting
5031693|NCT01499849|CINV|cinv
5031694|NCT01499849|Chemotherapy|chemotherapy
5031695|NCT01499823|Permeability Map|permeability map
5031696|NCT01499823|High-Grade Glioma|high-grade glioma
5031697|NCT01499810|Hypertension|hypertension
5031698|NCT01499810|Radiofrequency Catheter Ablation|radiofrequency catheter ablation
5031699|NCT01499810|Renal Artery|renal artery
5031700|NCT01499810|Sympathetic Nerve Block|sympathetic nerve block
5031701|NCT01499797|frailty|frailty
5031702|NCT01499797|frail elders|frail elders
5031703|NCT01499797|multicomponent intervention|multicomponent intervention
5031704|NCT01499797|overall functioning|overall functioning
5031705|NCT01499797|cost-effectiveness|cost-effectiveness
5031706|NCT01499797|integrated care|integrated care
5031707|NCT01499797|primary care|primary care
5031708|NCT01499797|community dwelling|community dwelling
5031709|NCT01499745|Idiopathic pulmonary fibrosis (IPF) patients|idiopathic pulmonary fibrosis (ipf) patients
5031710|NCT01499732|Premature endothelial dysfunction|premature endothelial dysfunction
5031711|NCT01499732|Early Rheumatoid Arthritis|early rheumatoid arthritis
5031712|NCT01499732|established rheumatoid arthritis|established rheumatoid arthritis
5031713|NCT01499732|Premature endothelial dysfunction in early rheumatoid arthritis|premature endothelial dysfunction in early rheumatoid arthritis
5031714|NCT01499732|Premature endothelial dysfunction in established rheumatoid arthritis|premature endothelial dysfunction in established rheumatoid arthritis
5031715|NCT01499732|Endothelial function in healthy subjects|endothelial function in healthy subjects
5031716|NCT01499719|Sinusitis|sinusitis
5031717|NCT01499719|Disease|disease
5031718|NCT01499719|Chronic|chronic
5031719|NCT01499719|Sinonasal|sinonasal
5031720|NCT01499706|Motivational Interviewing|motivational interviewing
5031721|NCT01499706|Telephone|telephone
5031722|NCT01499706|HIV|hiv
5031723|NCT01499706|AIDS|aids
5031724|NCT01499706|Older Adults|older adults
5031725|NCT01499693|Proton Pump Inhibitors|proton pump inhibitors
5031726|NCT01499693|gastric pH|gastric ph
5031727|NCT01499680|Degenerative Lumbar Conditions|degenerative lumbar conditions
5031728|NCT01499667|Relapsing remitting multiple sclerosis|relapsing remitting multiple sclerosis
5031729|NCT01499667|multiple sclerosis (MS)|multiple sclerosis (ms)
5031730|NCT01499667|safety|safety
5031731|NCT01499667|tolerability|tolerability
5031732|NCT01499667|health outcomes|health outcomes
5031733|NCT01499667|fingolimod|fingolimod
5031734|NCT01499667|disease control|disease control
5031735|NCT01499667|MRI|mri
5031736|NCT01499654|SPECT MPI|spect mpi
5031737|NCT01499654|Tomography, Emission-Computed, Single-Photon|tomography, emission-computed, single-photon
5031738|NCT01499654|Wide Beam Reconstruction|wide beam reconstruction
5031739|NCT01499641|discectomy|discectomy
5031740|NCT01499641|methylprednisolone|methylprednisolone
5031741|NCT01499641|randomized control trial|randomized control trial
5031742|NCT01499615|adverse events|adverse events
5031743|NCT01499615|adverse cardiovascular events|adverse cardiovascular events
5031744|NCT01499615|early warning|early warning
5031745|NCT01499602|Endometrial hyperplasia,|endometrial hyperplasia,
5031746|NCT01499602|LNG-IUS,|lng-ius,
5031747|NCT01499602|Progestin|progestin
5031748|NCT01499589|anesthesia-controlled time|anesthesia-controlled time
5031749|NCT01499589|turnover time|turnover time
5031750|NCT01499576|Mass Screening|mass screening
5031751|NCT01499576|Endoscopy, Gastrointestinal|endoscopy, gastrointestinal
5031752|NCT01499576|Stomach Neoplasms|stomach neoplasms
5031753|NCT01499576|Metaplasia|metaplasia
5031754|NCT01499576|Diagnosis|diagnosis
5031755|NCT01499576|Acetic acid|acetic acid
5031756|NCT01499576|Chromoendoscopy|chromoendoscopy
5031757|NCT01499550|transnasal high flow therapy|transnasal high flow therapy
5031758|NCT01499550|COPD|copd
5031759|NCT01499537|Stenosis of biliary ways|stenosis of biliary ways
5031760|NCT01499524|ICP, GDM|icp, gdm
5031761|NCT01499511|Hypertension|hypertension
5031762|NCT01499511|Mortality|mortality
5031763|NCT01499511|Morbidity|morbidity
5031764|NCT01499511|Coronary Heart Disease|coronary heart disease
5031765|NCT01499511|Stroke|stroke
5031766|NCT01499511|Diabetes|diabetes
5031767|NCT01499498|Healthy volunteers|healthy volunteers
5031768|NCT01499485|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
5031769|NCT01499485|Obesity Hypoventilation Syndrome|obesity hypoventilation syndrome
5031770|NCT01499485|Alkalosis|alkalosis
5031771|NCT01499485|Respiration, Artificial|respiration, artificial
5031772|NCT01499485|Acetazolamide|acetazolamide
5031773|NCT01499485|Intensive care|intensive care
5031774|NCT01499485|Adult|adult
5031775|NCT01499459|liver cirrhosis|liver cirrhosis
5031776|NCT01499459|autologous mesenchymal stem cell transplantation|autologous mesenchymal stem cell transplantation
5031777|NCT01499342|Stent|stent
5031778|NCT01499342|Atherosclerotic occlusive disease|atherosclerotic occlusive disease
5031779|NCT01499342|Peripheral arterial disease|peripheral arterial disease
5031780|NCT01499342|Superficial femoral artery|superficial femoral artery
5031781|NCT01499342|SFA|sfa
5031782|NCT01499329|Stent therapy|stent therapy
5031783|NCT01499316|Coronary artery disease|coronary artery disease
5031784|NCT01499316|Fractional flow reserve|fractional flow reserve
5031785|NCT01499303|lymphoma|lymphoma
5031786|NCT01499303|DLBCL|dlbcl
5031787|NCT01499303|fostamatinib|fostamatinib
5031788|NCT01499303|Diffuse Large B-Cell Lymphoma (DLBCL)|diffuse large b-cell lymphoma (dlbcl)
5031789|NCT01499290|Ceftazidime|ceftazidime
5031790|NCT01499290|Meropenem|meropenem
5031791|NCT01499290|Metronidazole|metronidazole
5031792|NCT01499290|Anti-Bacterial Agents|anti-bacterial agents
5031793|NCT01499290|Anti-Infective Agents|anti-infective agents
5031794|NCT01499290|Antiprotozoal Agents|antiprotozoal agents
5031795|NCT01499290|Antiparasitic Agents|antiparasitic agents
5031796|NCT01499290|cIAI, Complicated Intra-Abdominal Infection|ciai, complicated intra-abdominal infection
5031797|NCT01499277|complicated skin and soft tissue infections (cSSTI)|complicated skin and soft tissue infections (cssti)
5031798|NCT01499277|skin infection|skin infection
5031799|NCT01499277|ceftaroline|ceftaroline
5031800|NCT01499277|wound infection|wound infection
5031801|NCT01499277|cellulitis|cellulitis
5031802|NCT01499277|burn infection|burn infection
5031803|NCT01499277|bacterial infection|bacterial infection
5031804|NCT01499277|vancomycin|vancomycin
5031805|NCT01499264|MySkin patch|myskin patch
5031806|NCT01499251|glioblastoma|glioblastoma
5031807|NCT01499238|Efficacy|efficacy
5031808|NCT01499238|safety|safety
5031809|NCT01499238|nasal SIMV|nasal simv
5031810|NCT01499238|nasal CPAP|nasal cpap
5031811|NCT01499238|infants who are >35 gestational week with wet lung|infants who are >35 gestational week with wet lung
5031812|NCT01499199|cerebrospinal fluid (CSF)|cerebrospinal fluid (csf)
5031813|NCT01499199|ART-naive|art-naive
5031814|NCT01499199|integrase inhibitor|integrase inhibitor
5031815|NCT01499199|dolutegravir|dolutegravir
5031816|NCT01499199|antiretroviral therapy naive|antiretroviral therapy naive
5031817|NCT01499186|Local vibration, elderly, bone, muscle, functionality|local vibration, elderly, bone, muscle, functionality
5031818|NCT01499160|endocrine resistant|endocrine resistant
5031819|NCT01499160|everolimus|everolimus
5031820|NCT01499160|lapatinib|lapatinib
5031821|NCT01499160|letrozole|letrozole
5031822|NCT01499147|Acute myeloid leukemia|acute myeloid leukemia
5031823|NCT01499147|First remission|first remission
5031824|NCT01499147|Acute lymphocytic leukemia|acute lymphocytic leukemia
5031825|NCT01499147|Acute leukemia|acute leukemia
5031826|NCT01499147|Second remission|second remission
5031827|NCT01499147|Early relapse|early relapse
5031828|NCT01499147|Partial remission|partial remission
5031829|NCT01499147|Accelerated phase|accelerated phase
5031830|NCT01499147|Blast-crisis|blast-crisis
5031831|NCT01499147|Chronic myelogenous leukemia|chronic myelogenous leukemia
5031832|NCT01499147|Chronic phase|chronic phase
5031833|NCT01499147|Recurrent malignant lymphoma|recurrent malignant lymphoma
5031834|NCT01499147|Refractory malignant lymphoma|refractory malignant lymphoma
5031835|NCT01499147|Hodgkin's disease|hodgkin's disease
5031836|NCT01499147|Multiple myeloma.|multiple myeloma.
5031837|NCT01499147|Chronic lymphocytic leukemia|chronic lymphocytic leukemia
5031838|NCT01499147|Myeloproliferative disorder|myeloproliferative disorder
5031839|NCT01499147|Polycythemia vera|polycythemia vera
5031840|NCT01499147|Myelofibrosis|myelofibrosis
5031841|NCT01499147|Severe aplastic anemia|severe aplastic anemia
5031842|NCT01499108|type 2 diabetes|type 2 diabetes
5031843|NCT01499108|hypertension|hypertension
5031844|NCT01499108|liraglutide|liraglutide
5031845|NCT01499108|kidney function|kidney function
5031846|NCT01499056|osteoarthritis|osteoarthritis
5031847|NCT01499056|hip joint|hip joint
5031848|NCT01499056|mesenchymal stem cell|mesenchymal stem cell
5031849|NCT01499043|CRPC|crpc
5031850|NCT01499043|Prostate Cancer|prostate cancer
5031851|NCT01499043|Bone metastasis|bone metastasis
5031852|NCT01499043|Advanced Castration-Resistant Prostate Cancer (CRPC)|advanced castration-resistant prostate cancer (crpc)
5031853|NCT01499017|Single Ascending Dose Study in healthy subjects|single ascending dose study in healthy subjects
5031854|NCT01499004|tofacitinib|tofacitinib
5031855|NCT01499004|CP-690|cp-690
5031856|NCT01499004|550|550
5031857|NCT01499004|relative bioavailability|relative bioavailability
5031858|NCT01499004|modified release|modified release
5031859|NCT01499004|Phase 1|phase 1
5031860|NCT01498991|Incomplete Spinal Cord Injury|incomplete spinal cord injury
5031861|NCT01498991|Rehabilitation|rehabilitation
5031862|NCT01498991|AMES device|ames device
5031863|NCT01498991|Lower Extremity|lower extremity
5031864|NCT01498991|Gait|gait
5031865|NCT01498991|Paraplegia|paraplegia
5031866|NCT01498965|food allergy|food allergy
5031867|NCT01498965|eczema|eczema
5031868|NCT01498965|Vitamin D status|vitamin d status
5031869|NCT01498965|body composition|body composition
5031870|NCT01498965|obesity|obesity
5031871|NCT01498965|neurodevelopmental and behavioural outcome|neurodevelopmental and behavioural outcome
5031872|NCT01498952|HCC, liver cancer, hepatocellular carcinoma, MEDI-573, anti-IGF|hcc, liver cancer, hepatocellular carcinoma, medi-573, anti-igf
5031873|NCT01498887|Multiple Sclerosis|multiple sclerosis
5031874|NCT01498887|Relapsing Remitting Multiple Sclerosis|relapsing remitting multiple sclerosis
5031875|NCT01498887|Fingolimod|fingolimod
5031876|NCT01498887|Early multiple sclerosis|early multiple sclerosis
5031877|NCT01498887|Naive patients|naive patients
5031878|NCT01498874|Acne|acne
5031879|NCT01498874|Acne Vulgaris|acne vulgaris
5031880|NCT01498835|Soft tissue sarcoma|soft tissue sarcoma
5031881|NCT01498835|Radiation therapy|radiation therapy
5031882|NCT01498835|Sunitinib|sunitinib
5031883|NCT01498822|Levetiracetam|levetiracetam
5031884|NCT01498822|Oxcarbazepine|oxcarbazepine
5031885|NCT01498822|treatment failure|treatment failure
5031886|NCT01498822|partial epilepsy|partial epilepsy
5031887|NCT01498809|Orthostatic intolerance in people with spinal cord injury|orthostatic intolerance in people with spinal cord injury
5031888|NCT01498744|Skin and Soft Tissue Abscess|skin and soft tissue abscess
5031889|NCT01498744|Methicillin-resistant Staphylococcus aureus (MRSA)|methicillin-resistant staphylococcus aureus (mrsa)
5031890|NCT01498744|Incision and Drainage|incision and drainage
5031891|NCT01498744|Clindamycin|clindamycin
5031892|NCT01498744|Trimethoprim-sulfamethoxazole|trimethoprim-sulfamethoxazole
5031893|NCT01498744|Skin Infection|skin infection
5031894|NCT01498731|Copeptin|copeptin
5031895|NCT01498731|Troponin|troponin
5031896|NCT01498731|Acute Coronary Syndrome|acute coronary syndrome
5031897|NCT01498731|Rule-out of acute myocardial infarction|rule-out of acute myocardial infarction
5031898|NCT01498731|Emergency Medicine|emergency medicine
5031899|NCT01498718|Influenza A (H1N1)|influenza a (h1n1)
5031900|NCT01498718|Influenza A (H3N2)|influenza a (h3n2)
5031901|NCT01498718|Influenza B|influenza b
5031902|NCT01498718|Trivalent Inactivated Vaccine (TIV)|trivalent inactivated vaccine (tiv)
5031903|NCT01498718|Healthy Adults|healthy adults
5031904|NCT01498705|Intraventricular Hemorrhage|intraventricular hemorrhage
5031905|NCT01498705|Intracerebral Hemorrhage|intracerebral hemorrhage
5031906|NCT01498705|Cerebrovascular Disorders|cerebrovascular disorders
5031907|NCT01498705|Brain Diseases|brain diseases
5031908|NCT01498705|Central Nervous System Diseases|central nervous system diseases
5031909|NCT01498705|Nervous System Diseases|nervous system diseases
5031910|NCT01498705|Vascular Diseases|vascular diseases
5031911|NCT01498705|Procalcitonin Level|procalcitonin level
5031912|NCT01498692|drug-eluting stents|drug-eluting stents
5031913|NCT01498692|DES|des
5031914|NCT01498692|atherosclerotic|atherosclerotic
5031915|NCT01498640|XIAFLEX|xiaflex
5031916|NCT01498640|XIAPEX|xiapex
5031917|NCT01498640|Dupuytren's disease|dupuytren's disease
5031918|NCT01498640|contracture|contracture
5031919|NCT01498627|Autoimmune diseases (AIDs)|autoimmune diseases (aids)
5031920|NCT01498627|Cervarix|cervarix
5031921|NCT01498627|PGRx information system|pgrx information system
5031922|NCT01498614|Diabetes mellitus|diabetes mellitus
5031923|NCT01498614|depression|depression
5031924|NCT01498614|anxiety|anxiety
5031925|NCT01498614|negative self image|negative self image
5031926|NCT01498614|alexithymia|alexithymia
5031927|NCT01498614|metabolic control|metabolic control
5031928|NCT01498614|diabetes complications|diabetes complications
5031929|NCT01498601|oral hygiene|oral hygiene
5031930|NCT01498601|tracheostomy|tracheostomy
5031931|NCT01498601|deglutition disorders|deglutition disorders
5031932|NCT01498601|enteral nutrition|enteral nutrition
5031933|NCT01498601|brain injury|brain injury
5031934|NCT01498601|coma|coma
5031935|NCT01498588|Breast Neoplasms|breast neoplasms
5031936|NCT01498588|Breast Cancer|breast cancer
5031937|NCT01498588|Breast Tumors|breast tumors
5031938|NCT01498588|Cancer of the Breast|cancer of the breast
5031939|NCT01498588|Neoplasms, Breast|neoplasms, breast
5031940|NCT01498588|Tumors, Breast|tumors, breast
5031941|NCT01498575|Teen driving|teen driving
5031942|NCT01498575|Behind the wheel practice driving|behind the wheel practice driving
5031943|NCT01498575|Parent supervision|parent supervision
5031944|NCT01498549|Abstinent cocaine users|abstinent cocaine users
5031945|NCT01498549|cognitive testing|cognitive testing
5031946|NCT01498523|Camel milk|camel milk
5031947|NCT01498523|Postprandial glycaemic response|postprandial glycaemic response
5031948|NCT01498523|postprandial insulinaemic response|postprandial insulinaemic response
5031949|NCT01498523|Glycaemic index|glycaemic index
5031950|NCT01498510|chronic pain|chronic pain
5031951|NCT01498510|cognitive behavior therapy|cognitive behavior therapy
5031952|NCT01498510|web-based intervention|web-based intervention
5031953|NCT01498484|EBV-specific T-cell lines|ebv-specific t-cell lines
5031954|NCT01498484|11-130|11-130
5031955|NCT01498458|German Breast Group|german breast group
5031956|NCT01498458|GBG Forschungs GmbH|gbg forschungs gmbh
5031958|NCT01498458|GBG 62|gbg 62
5031959|NCT01498458|PazoX|pazox
5031960|NCT01498458|Breast Cancer|breast cancer
5031961|NCT01498458|Metastatic Breast Cancer|metastatic breast cancer
5031962|NCT01498458|Pazopanib|pazopanib
5031963|NCT01498458|Abraxane|abraxane
5031964|NCT01498458|Capecitabine|capecitabine
5031965|NCT01498458|Xeloda|xeloda
5031966|NCT01498445|Leukemia|leukemia
5031967|NCT01498445|Chronic myelogenous leukemia|chronic myelogenous leukemia
5031968|NCT01498445|Chronic myeloid leukemia|chronic myeloid leukemia
5031969|NCT01498445|CML|cml
5031970|NCT01498445|Accelerated phase|accelerated phase
5031971|NCT01498445|Blastic phase|blastic phase
5031972|NCT01498445|Dasatinib|dasatinib
5031973|NCT01498445|BMS-354825|bms-354825
5031974|NCT01498445|Sprycel|sprycel
5031975|NCT01498445|Decitabine|decitabine
5031976|NCT01498445|Dacogen|dacogen
5031977|NCT01498419|Tuberculosis|tuberculosis
5031978|NCT01498419|Serial Sputum Colony Counts|serial sputum colony counts
5031979|NCT01498419|Colony Forming Units|colony forming units
5031980|NCT01498419|Time to Sputum Culture Positivity|time to sputum culture positivity
5031981|NCT01498419|PA824|pa824
5031982|NCT01498419|pretomanid|pretomanid
5031983|NCT01498406|cutaneous lupus erythematosus|cutaneous lupus erythematosus
5031984|NCT01498406|vitamin D|vitamin d
5031985|NCT01498406|quality of life|quality of life
5031986|NCT01498393|fungal nail|fungal nail
5031987|NCT01498380|Dexmedetomidine|dexmedetomidine
5031988|NCT01498380|Precedex|precedex
5031989|NCT01498380|TIVA|tiva
5031990|NCT01498380|Rapid bolus|rapid bolus
5031991|NCT01498367|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
5031992|NCT01498367|Telemedicine|telemedicine
5031993|NCT01498354|Transanal endoscopic microsurgery|transanal endoscopic microsurgery
5031994|NCT01498354|Transanal endoscopic operations|transanal endoscopic operations
5031995|NCT01498354|Rectal adenomas|rectal adenomas
5031996|NCT01498354|Transanal endoscopic surgery|transanal endoscopic surgery
5031997|NCT01498354|"Rectal adenocarcinomas in situ"|"rectal adenocarcinomas in situ"
5031998|NCT01498341|Hypoparathyroidism|hypoparathyroidism
5031999|NCT01498341|Epidemiology|epidemiology
5032000|NCT01498341|Prognosis|prognosis
5032001|NCT01498341|Symptoms|symptoms
5032002|NCT01498328|EGFRvIII|egfrviii
5032003|NCT01498328|Glioblastoma|glioblastoma
5032004|NCT01498328|Rindopepimut|rindopepimut
5032005|NCT01498328|CDX-110|cdx-110
5032006|NCT01498328|Small cell|small cell
5032007|NCT01498328|Giant cell|giant cell
5032008|NCT01498328|Brain Cancer|brain cancer
5032009|NCT01498328|Brain Tumor|brain tumor
5032010|NCT01498328|Gliosarcoma|gliosarcoma
5032011|NCT01498328|oligodendroglial|oligodendroglial
5032012|NCT01498328|radiotherapy|radiotherapy
5032013|NCT01498328|chemoradiation|chemoradiation
5032014|NCT01498328|Tumor|tumor
5032015|NCT01498328|Bevacizumab|bevacizumab
5032016|NCT01498328|Relapsed|relapsed
5032017|NCT01498328|Returned|returned
5032018|NCT01498328|Recurrent|recurrent
5032019|NCT01498328|EGFR variant III|egfr variant iii
5032020|NCT01498302|childhood acute myeloid leukemia/other myeloid malignancies|childhood acute myeloid leukemia/other myeloid malignancies
5032021|NCT01498289|recurrent esophageal cancer|recurrent esophageal cancer
5032022|NCT01498289|stage IV esophageal cancer|stage iv esophageal cancer
5032023|NCT01498289|recurrent gastric cancer|recurrent gastric cancer
5032024|NCT01498289|stage IV gastric cancer|stage iv gastric cancer
5032025|NCT01498289|adenocarcinoma of the gastroesophageal junction|adenocarcinoma of the gastroesophageal junction
5032026|NCT01498289|stage IIIB gastric cancer|stage iiib gastric cancer
5032027|NCT01498289|stage IIIC gastric cancer|stage iiic gastric cancer
5032028|NCT01498289|stage IIIB esophageal cancer|stage iiib esophageal cancer
5032029|NCT01498289|stage IIIC esophageal cancer|stage iiic esophageal cancer
5032030|NCT01498289|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
5032031|NCT01498289|adenocarcinoma of the stomach|adenocarcinoma of the stomach
5032032|NCT01498276|Family History|family history
5032033|NCT01498276|Family Health History|family health history
5032034|NCT01498276|Disease Risk Assessment|disease risk assessment
5032035|NCT01498263|Genetic Condition|genetic condition
5032036|NCT01498263|Family Network|family network
5032037|NCT01498263|Social Support|social support
5032038|NCT01498263|Alzheimer's Disease|alzheimer's disease
5032039|NCT01498263|AD|ad
5032040|NCT01498263|Family Systems|family systems
5032041|NCT01498237|Photoacoustic endoscopy|photoacoustic endoscopy
5032042|NCT01498224|Cataract surgery|cataract surgery
5032043|NCT01498211|volunteer|volunteer
5032044|NCT01498198|Rotator Cuff|rotator cuff
5032045|NCT01498198|WCB|wcb
5032046|NCT01498172|Non muscle invasive bladder cancer|non muscle invasive bladder cancer
5032047|NCT01498159|Diabetes Mellitus|diabetes mellitus
5032048|NCT01498159|Pharmacists|pharmacists
5032049|NCT01498159|Community Health Aides|community health aides
5032050|NCT01498146|cryptogenic stroke|cryptogenic stroke
5032051|NCT01498146|atrial fibrillation|atrial fibrillation
5032052|NCT01498146|longterm monitoring|longterm monitoring
5032053|NCT01498146|loop recorder|loop recorder
5032054|NCT01498133|Skin-to-skin contact|skin-to-skin contact
5032055|NCT01498133|Decolonization|decolonization
5032056|NCT01498133|MRSA|mrsa
5032057|NCT01498120|Rotigotine|rotigotine
5032058|NCT01498120|Restless Legs Syndrome|restless legs syndrome
5032059|NCT01498120|RLS|rls
5032060|NCT01498120|Long-term|long-term
5032061|NCT01498120|Adolescents|adolescents
5032062|NCT01498107|online intervention|online intervention
5032063|NCT01498107|computerized CBT|computerized cbt
5032064|NCT01498107|e-health|e-health
5032065|NCT01498094|Bronchiolitis|bronchiolitis
5032066|NCT01498094|High|high
5032067|NCT01498094|Flow|flow
5032068|NCT01498094|Oxygen|oxygen
5032069|NCT01498094|Therapy|therapy
5032070|NCT01498094|Nasal|nasal
5032071|NCT01498094|Cannulae|cannulae
5032073|NCT01498081|COPD, pulmonary disease|copd, pulmonary disease
5032074|NCT01498068|Genotype 1 chronic Hepatitis C|genotype 1 chronic hepatitis c
5032075|NCT01498068|VX-950HPC3007|vx-950hpc3007
5032076|NCT01498068|VX-950|vx-950
5032077|NCT01498068|Hepatitis C|hepatitis c
5032078|NCT01498068|Telaprevir|telaprevir
5032079|NCT01498068|HCV|hcv
5032080|NCT01498055|lung cancer|lung cancer
5032081|NCT01498055|CIK cells|cik cells
5032082|NCT01498055|therapy|therapy
5032083|NCT01498029|Cartilage, Articular|cartilage, articular
5032084|NCT01498016|acute leukemia|acute leukemia
5032085|NCT01498016|allogeneic stem cell transplantation|allogeneic stem cell transplantation
5032086|NCT01498016|busulfan|busulfan
5032087|NCT01498003|coronary disease|coronary disease
5032088|NCT01498003|stents|stents
5032089|NCT01498003|thrombosis|thrombosis
5032090|NCT01498003|myocardial infarction|myocardial infarction
5032091|NCT01498003|prognosis|prognosis
5032092|NCT01497990|Burns|burns
5032093|NCT01497990|Ertapenem|ertapenem
5032094|NCT01497990|Pharmacokinetics|pharmacokinetics
5032095|NCT01497977|phytoestrogens|phytoestrogens
5032096|NCT01497977|postmenopause|postmenopause
5032097|NCT01497977|serum lipids|serum lipids
5032098|NCT01497925|Arginine deiminase|arginine deiminase
5032099|NCT01497925|Arginine|arginine
5032100|NCT01497925|Solid tumors|solid tumors
5032101|NCT01497925|Prostate cancer|prostate cancer
5032102|NCT01497925|Phase 1 study|phase 1 study
5032103|NCT01497899|HIV-1|hiv-1
5032104|NCT01497899|HIV|hiv
5032105|NCT01497899|Treatment-Naive|treatment-naive
5032106|NCT01497886|Stroke|stroke
5032107|NCT01497886|Children|children
5032108|NCT01497886|Hip Hop Stroke|hip hop stroke
5032109|NCT01497886|New York City|new york city
5032110|NCT01497873|Small Cell Lung Cancer|small cell lung cancer
5032111|NCT01497873|Belotecan|belotecan
5032112|NCT01497873|Topotecan|topotecan
5032113|NCT01497860|pediatric|pediatric
5032114|NCT01497860|children|children
5032115|NCT01497860|glioma|glioma
5032116|NCT01497860|low-grade|low-grade
5032117|NCT01497860|vinorelbine|vinorelbine
5032118|NCT01497860|recurrent|recurrent
5032119|NCT01497860|progressive|progressive
5032120|NCT01497847|Post-Infectious Irritable Bowel Syndrome|post-infectious irritable bowel syndrome
5032121|NCT01497847|PI-IBS|pi-ibs
5032122|NCT01497834|Hepatitis C Virus Infection|hepatitis c virus infection
5032123|NCT01497821|Amgen|amgen
5032124|NCT01497821|Phase 1|phase 1
5032125|NCT01497821|First in Human|first in human
5032126|NCT01497821|Relapsed / Refractory Renal Cell Carcinoma (RCC)|relapsed / refractory renal cell carcinoma (rcc)
5032127|NCT01497821|Kidney Cancer|kidney cancer
5032128|NCT01497821|Clinical Trial|clinical trial
5032129|NCT01497821|Antibody drug conjugate (ADC)|antibody drug conjugate (adc)
5032130|NCT01497821|Open-label|open-label
5032131|NCT01497821|Oncology|oncology
5032132|NCT01497808|previously untreated|previously untreated
5032133|NCT01497808|previously treated|previously treated
5032134|NCT01497808|bone, lung, liver or subcutaneous involvement|bone, lung, liver or subcutaneous involvement
5032135|NCT01497808|nodal involvement|nodal involvement
5032136|NCT01497808|without evidence of brain involvement|without evidence of brain involvement
5032137|NCT01497782|virtual reality, simulator, feedback, laparoscopy, training|virtual reality, simulator, feedback, laparoscopy, training
5032138|NCT01497769|vaccine|vaccine
5032139|NCT01497769|immunogenicity|immunogenicity
5032140|NCT01497743|Scleroderma|scleroderma
5032141|NCT01497743|gastrointestinal|gastrointestinal
5032142|NCT01497743|bloating|bloating
5032143|NCT01497743|reflux|reflux
5032144|NCT01497730|Arthroplasty, Replacement, Knee,|arthroplasty, replacement, knee,
5032145|NCT01497704|Cancer|cancer
5032146|NCT01497704|Tumor|tumor
5032147|NCT01497704|Oncology|oncology
5032148|NCT01497704|Antiangiogenesis|antiangiogenesis
5032149|NCT01497691|Asthma|asthma
5032150|NCT01497691|Pediatrics|pediatrics
5032151|NCT01497691|BiPAP|bipap
5032152|NCT01497691|Noninvasive Positive Pressure Ventilation|noninvasive positive pressure ventilation
5032153|NCT01497678|MTURR|mturr
5032154|NCT01497678|ECM|ecm
5032155|NCT01497678|Muscle Loss|muscle loss
5032156|NCT01497678|Tendon|tendon
5032157|NCT01497678|Tendon Repair|tendon repair
5032158|NCT01497678|Muscle Repair|muscle repair
5032159|NCT01497678|Soft Tissue Repair|soft tissue repair
5032160|NCT01497678|Scaffold|scaffold
5032161|NCT01497678|Extracellular Matrix|extracellular matrix
5032162|NCT01497665|GRN1005|grn1005
5032163|NCT01497665|ANG1005|ang1005
5032164|NCT01497665|LRP-1|lrp-1
5032165|NCT01497665|Targeted Therapy|targeted therapy
5032166|NCT01497665|Brain Tumor|brain tumor
5032167|NCT01497665|Blood Brain Barrier|blood brain barrier
5032168|NCT01497665|Peptide-Drug Conjugate (PDC)|peptide-drug conjugate (pdc)
5032169|NCT01497665|Brain Metastases|brain metastases
5032170|NCT01497665|Paclitaxel|paclitaxel
5032171|NCT01497665|Taxol|taxol
5032172|NCT01497665|NSCLC|nsclc
5032173|NCT01497665|Non-Small Cell Lung Cancer|non-small cell lung cancer
5032174|NCT01497652|Parkinson's Disease|parkinson's disease
5032175|NCT01497652|Cognition|cognition
5032176|NCT01497652|Rasagiline|rasagiline
5032177|NCT01497652|MoCA|moca
5032472|NCT01496378|Parents|parents
5032178|NCT01497652|Mild Cognitive Impairment in Parkinson's Disease|mild cognitive impairment in parkinson's disease
5032179|NCT01497639|dystonia|dystonia
5032180|NCT01497639|pallidal stimulation|pallidal stimulation
5032181|NCT01497639|deep brain stimulation|deep brain stimulation
5032182|NCT01497639|deep brain stimulation of GPi|deep brain stimulation of gpi
5032183|NCT01497639|GPi|gpi
5032184|NCT01497639|interleaving stimulation|interleaving stimulation
5032185|NCT01497626|Advanced cancer|advanced cancer
5032186|NCT01497626|Solid tumor|solid tumor
5032187|NCT01497613|Socialization|socialization
5032188|NCT01497613|Well-being|well-being
5032189|NCT01497613|Quality of Life|quality of life
5032190|NCT01497613|Connectivity|connectivity
5032191|NCT01497548|Depression|depression
5032192|NCT01497548|cancer|cancer
5032193|NCT01497548|methylphenidate|methylphenidate
5032194|NCT01497548|pharmacotherapy|pharmacotherapy
5032195|NCT01497522|Vildagliptin|vildagliptin
5032196|NCT01497522|Type 2 diabetes|type 2 diabetes
5032197|NCT01497522|HbA1c|hba1c
5032198|NCT01497522|Fasting plasma glucose|fasting plasma glucose
5032199|NCT01497496|leukemia|leukemia
5032200|NCT01497496|lymphoma|lymphoma
5032201|NCT01497496|consolidative therapy|consolidative therapy
5032202|NCT01497496|combination regimen|combination regimen
5032203|NCT01497496|Chronic Lymphocytic Leukemia (CLL)|chronic lymphocytic leukemia (cll)
5032204|NCT01497496|Small Lymphocytic Lymphoma (SLL)|small lymphocytic lymphoma (sll)
5032205|NCT01497470|paclitaxel|paclitaxel
5032206|NCT01497470|carboplatin|carboplatin
5032207|NCT01497470|custirsen|custirsen
5032208|NCT01497470|drug-drug interaction|drug-drug interaction
5032209|NCT01497470|pharmacokinetics|pharmacokinetics
5032210|NCT01497470|cancer|cancer
5032211|NCT01497444|recurrent adult primary liver cancer|recurrent adult primary liver cancer
5032212|NCT01497444|recurrent renal cell cancer|recurrent renal cell cancer
5032213|NCT01497444|advanced adult primary liver cancer|advanced adult primary liver cancer
5032214|NCT01497444|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
5032215|NCT01497444|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
5032216|NCT01497405|Gender-based Violence|gender-based violence
5032217|NCT01497405|HIV|hiv
5032218|NCT01497405|Randomized Controlled Trial|randomized controlled trial
5032219|NCT01497405|Sexually Transmitted Diseases|sexually transmitted diseases
5032220|NCT01497405|Substance Abuse Detection|substance abuse detection
5032221|NCT01497405|Test, Treat and Retain|test, treat and retain
5032222|NCT01497379|Hereditary retinal|hereditary retinal
5032223|NCT01497379|degeneration outer|degeneration outer
5032224|NCT01497379|retinal layers|retinal layers
5032225|NCT01497379|photoreceptor rods cones|photoreceptor rods cones
5032226|NCT01497379|Retinitis pigmentosa|retinitis pigmentosa
5032227|NCT01497379|blindness|blindness
5032228|NCT01497379|reading ability|reading ability
5032229|NCT01497379|retina implant|retina implant
5032230|NCT01497379|subretinal|subretinal
5032231|NCT01497366|HCV genotype 2 (GT-2)|hcv genotype 2 (gt-2)
5032232|NCT01497366|HCV genotype 3 (GT-3)|hcv genotype 3 (gt-3)
5032233|NCT01497353|Cord clamping|cord clamping
5032234|NCT01497353|newborn|newborn
5032235|NCT01497353|Skin contact|skin contact
5032236|NCT01497353|Placental transfusion|placental transfusion
5032237|NCT01497353|Delivery room|delivery room
5032238|NCT01497340|Cord clamping|cord clamping
5032239|NCT01497340|newborn|newborn
5032240|NCT01497340|Placental trasfusion|placental trasfusion
5032241|NCT01497340|Delivery room|delivery room
5032242|NCT01497327|HEPATITIS C, CHRONIC|hepatitis c, chronic
5032243|NCT01497327|HCV|hcv
5032244|NCT01497327|hepatic impairment|hepatic impairment
5032245|NCT01497314|healthy term infants|healthy term infants
5032246|NCT01497314|growth|growth
5032247|NCT01497314|infant formula|infant formula
5032248|NCT01497301|Diabetes|diabetes
5032249|NCT01497301|Group Visit|group visit
5032250|NCT01497301|Shared Medical Appointment|shared medical appointment
5032251|NCT01497288|Intranasal fentanyl spray|intranasal fentanyl spray
5032252|NCT01497288|Population PK|population pk
5032253|NCT01497262|Multiple Sclerosis|multiple sclerosis
5032254|NCT01497262|Relapsing-Remitting|relapsing-remitting
5032255|NCT01497249|Dietary Fiber|dietary fiber
5032256|NCT01497249|Blood glucose control|blood glucose control
5032257|NCT01497249|Fermentability|fermentability
5032258|NCT01497249|Tolerability|tolerability
5032259|NCT01497223|Phase II|phase ii
5032260|NCT01497223|Double-Blind|double-blind
5032261|NCT01497223|Placebo-Controlled|placebo-controlled
5032262|NCT01497223|Vulvovaginal Candidiasis|vulvovaginal candidiasis
5032263|NCT01497223|Moderate to Severe|moderate to severe
5032264|NCT01497223|Acute|acute
5032265|NCT01497223|Treatment of Moderate to Severe Vulvovaginal Candidiasis|treatment of moderate to severe vulvovaginal candidiasis
5032266|NCT01497197|Reproduction Techniques|reproduction techniques
5032267|NCT01497197|Reproductive Medicine|reproductive medicine
5032268|NCT01497197|Assisted Reproductive Technics|assisted reproductive technics
5032269|NCT01497197|Pregnancy Rate|pregnancy rate
5032270|NCT01497197|Ovulation Induction|ovulation induction
5032271|NCT01497197|Ovarian Stimulation|ovarian stimulation
5032272|NCT01497197|Oocytes|oocytes
5032273|NCT01497197|Implantation|implantation
5032274|NCT01497184|Leukemia|leukemia
5032276|NCT01497184|Allogeneic donor lymphocyte infusion|allogeneic donor lymphocyte infusion
5032277|NCT01497184|DLI|dli
5032278|NCT01497184|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
5032279|NCT01497184|HSCT|hsct
5032280|NCT01497184|Bone marrow transplant|bone marrow transplant
5032281|NCT01497184|CD19-specific T cells|cd19-specific t cells
5032282|NCT01497184|T cell infusion|t cell infusion
5032283|NCT01497184|B-Lineage lymphoid malignancies|b-lineage lymphoid malignancies
5032284|NCT01497184|CD19+ lymphoid malignancies|cd19+ lymphoid malignancies
5032285|NCT01497184|Acute lymphoblastic leukemia|acute lymphoblastic leukemia
5032286|NCT01497184|ALL|all
5032287|NCT01497184|Biphenotypic leukemia CD19+ in advanced remission|biphenotypic leukemia cd19+ in advanced remission
5032288|NCT01497184|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
5032289|NCT01497184|NHL|nhl
5032290|NCT01497184|Diffuse large B-cell lymphoma|diffuse large b-cell lymphoma
5032291|NCT01497184|Small lymphocytic lymphoma|small lymphocytic lymphoma
5032292|NCT01497184|Follicular lymphoma|follicular lymphoma
5032293|NCT01497184|Mantle cell lymphoma with active disease at time of transplant|mantle cell lymphoma with active disease at time of transplant
5032294|NCT01497171|Cystocele|cystocele
5032295|NCT01497171|Bladder prolapse|bladder prolapse
5032296|NCT01497171|Anterior prolapse|anterior prolapse
5032297|NCT01497171|Vaginal prolapse|vaginal prolapse
5032298|NCT01497171|Uterine prolapse|uterine prolapse
5032299|NCT01497171|Urinary incontinence|urinary incontinence
5032300|NCT01497158|tobacco cessation|tobacco cessation
5032301|NCT01497119|Moderate atopic dermatitis|moderate atopic dermatitis
5032302|NCT01497119|JNJ-39758979|jnj-39758979
5032303|NCT01497119|Japanese patients|japanese patients
5032304|NCT01497106|Insulin resistance|insulin resistance
5032305|NCT01497106|Abdominal obesity|abdominal obesity
5032306|NCT01497106|Calorie restriction|calorie restriction
5032307|NCT01497093|Myeloma|myeloma
5032308|NCT01497093|Multiple Myeloma|multiple myeloma
5032309|NCT01497093|Relapsed Multiple Myeloma|relapsed multiple myeloma
5032310|NCT01497093|Relapsed and Refractory Multiple Myeloma|relapsed and refractory multiple myeloma
5032311|NCT01497093|Refractory Myeloma|refractory myeloma
5032312|NCT01497093|Resistant Multiple Myeloma|resistant multiple myeloma
5032313|NCT01497093|Treatment-resistant Multiple Myeloma|treatment-resistant multiple myeloma
5032314|NCT01497093|Pomalidomide|pomalidomide
5032315|NCT01497093|Lenalidomide-resistant|lenalidomide-resistant
5032316|NCT01497080|distal radius fracture|distal radius fracture
5032317|NCT01497080|Condition|condition
5032318|NCT01497080|risk factors|risk factors
5032319|NCT01497080|adverse activity transitions following DRF|adverse activity transitions following drf
5032320|NCT01497080|optimal assessment approach|optimal assessment approach
5032321|NCT01497054|B type natriuretic peptide|b type natriuretic peptide
5032322|NCT01497054|Patent Ductus Arteriosus|patent ductus arteriosus
5032323|NCT01497054|Preterm infant|preterm infant
5032324|NCT01497028|Co-morbid disease resolution|co-morbid disease resolution
5032325|NCT01497002|AML|aml
5032326|NCT01496989|HIV|hiv
5032327|NCT01496989|AIDS|aids
5032328|NCT01496989|HIV vaccine|hiv vaccine
5032329|NCT01496989|HIV prevention|hiv prevention
5032330|NCT01496976|leukemia|leukemia
5032331|NCT01496976|lymphoma|lymphoma
5032332|NCT01496976|consolidative therapy|consolidative therapy
5032333|NCT01496976|combination regimen|combination regimen
5032334|NCT01496976|CLL|cll
5032335|NCT01496976|SLL|sll
5032336|NCT01496963|Thalassemia|thalassemia
5032337|NCT01496963|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
5032338|NCT01496950|migraine|migraine
5032339|NCT01496924|Dysphagia|dysphagia
5032340|NCT01496924|Intensive care units|intensive care units
5032341|NCT01496924|Deglutition disorders|deglutition disorders
5032342|NCT01496924|Rehabilitation|rehabilitation
5032343|NCT01496911|Diving|diving
5032344|NCT01496911|Drugs|drugs
5032345|NCT01496911|Antihistamines|antihistamines
5032346|NCT01496911|Performance|performance
5032347|NCT01496898|Microflora|microflora
5032348|NCT01496898|Vaginal|vaginal
5032349|NCT01496898|Cervical|cervical
5032350|NCT01496898|Uterine|uterine
5032351|NCT01496898|Inflammation|inflammation
5032352|NCT01496898|Cytokine|cytokine
5032353|NCT01496898|Intrauterine Device|intrauterine device
5032354|NCT01496898|Levonorgestrel|levonorgestrel
5032355|NCT01496885|stroke|stroke
5032356|NCT01496872|Newborn cranial somatic dysfunction|newborn cranial somatic dysfunction
5032357|NCT01496872|Newborn observational study|newborn observational study
5032358|NCT01496872|Somatic dysfunction|somatic dysfunction
5032359|NCT01496872|Cranial strain pattern|cranial strain pattern
5032360|NCT01496872|Osteopathy|osteopathy
5032361|NCT01496859|Baska mask|baska mask
5032362|NCT01496859|supraglottic airway|supraglottic airway
5032363|NCT01496859|airway management|airway management
5032364|NCT01496846|Articaine|articaine
5032365|NCT01496846|Lidocaine|lidocaine
5032366|NCT01496846|Anesthesia, Local|anesthesia, local
5032367|NCT01496846|Endodontics|endodontics
5032368|NCT01496846|Molar|molar
5032369|NCT01496846|Dental Pulp Diseases|dental pulp diseases
5032370|NCT01496833|Aortic Diseases|aortic diseases
5032371|NCT01496833|Vascular Diseases|vascular diseases
5032372|NCT01496833|Cardiovascular Diseases|cardiovascular diseases
5032373|NCT01496833|Treatment Outcome|treatment outcome
5032374|NCT01496833|Aorta Dissection|aorta dissection
5032375|NCT01496833|Aorta Aneurysm|aorta aneurysm
5032376|NCT01496833|Aorta pseudoaneurysm|aorta pseudoaneurysm
5032377|NCT01496833|Endovascular aortic repair|endovascular aortic repair
5032378|NCT01496807|unresectable|unresectable
5032379|NCT01496807|stage 3|stage 3
5032380|NCT01496807|stage 4|stage 4
5032381|NCT01496807|autoimmune|autoimmune
5032382|NCT01496807|antibodies|antibodies
5032383|NCT01496781|Endoscopic Hemostasis|endoscopic hemostasis
5032384|NCT01496781|metallic hemoclip|metallic hemoclip
5032385|NCT01496781|EndoClot Absorbable Polysaccharide Hemostat|endoclot absorbable polysaccharide hemostat
5032386|NCT01496781|Colonic Polyps|colonic polyps
5032387|NCT01496729|Kidney transplantation|kidney transplantation
5032388|NCT01496729|Transversus abdominis plane (TAP) block|transversus abdominis plane (tap) block
5032389|NCT01496716|Osteoarthritis|osteoarthritis
5032390|NCT01496716|obesity|obesity
5032391|NCT01496716|quality of life|quality of life
5032392|NCT01496703|reasons for MMF dose reduction|reasons for mmf dose reduction
5032393|NCT01496690|Anxiety-comorbidity to schizophrenia|anxiety-comorbidity to schizophrenia
5032394|NCT01496690|Double-blinded randomized placebo controlled trial|double-blinded randomized placebo controlled trial
5032395|NCT01496690|Pregabalin|pregabalin
5032396|NCT01496677|volunteer|volunteer
5032397|NCT01496651|Percutaneous coronary intervention|percutaneous coronary intervention
5032398|NCT01496651|Coronary artery bypass graft operation|coronary artery bypass graft operation
5032399|NCT01496651|Left Main|left main
5032400|NCT01496638|PCI|pci
5032401|NCT01496638|Bifurcation lesion|bifurcation lesion
5032402|NCT01496625|Biological Specimens|biological specimens
5032403|NCT01496625|Retinal Disease|retinal disease
5032404|NCT01496625|Phenotype|phenotype
5032405|NCT01496625|Phenotype-Genotype correlation|phenotype-genotype correlation
5032406|NCT01496625|Age-Related Macular Degeneration (AMD)|age-related macular degeneration (amd)
5032407|NCT01496625|AMD|amd
5032408|NCT01496625|Diabetic Retinopathy|diabetic retinopathy
5032409|NCT01496625|Healthy Volunteer|healthy volunteer
5032410|NCT01496625|HV|hv
5032411|NCT01496612|Epilepsy|epilepsy
5032412|NCT01496612|Temporal Lobe Epilepsy|temporal lobe epilepsy
5032413|NCT01496612|Serotonin 1A Receptor|serotonin 1a receptor
5032414|NCT01496612|Seizures|seizures
5032415|NCT01496599|Brain Imaging|brain imaging
5032416|NCT01496599|Parkinson's Disease|parkinson's disease
5032417|NCT01496599|Parkinsonism|parkinsonism
5032418|NCT01496599|Parkinson Disease|parkinson disease
5032419|NCT01496599|PD|pd
5032420|NCT01496599|Healthy Volunteer|healthy volunteer
5032421|NCT01496599|HV|hv
5032422|NCT01496586|Fatigue|fatigue
5032423|NCT01496586|Traumatic Brain Injury|traumatic brain injury
5032424|NCT01496586|Motivational Incentive|motivational incentive
5032425|NCT01496586|TBI|tbi
5032426|NCT01496560|colonoscopy|colonoscopy
5032427|NCT01496560|pain|pain
5032428|NCT01496560|rectal balloon|rectal balloon
5032429|NCT01496547|feasibility, effective and safety|feasibility, effective and safety
5032430|NCT01496547|intensive chemotherapy|intensive chemotherapy
5032431|NCT01496547|RIC regimen|ric regimen
5032432|NCT01496547|refractory or relapse leukemia|refractory or relapse leukemia
5032433|NCT01496547|allogeneic stem cell transplantation|allogeneic stem cell transplantation
5032434|NCT01496534|advanced solid tumors|advanced solid tumors
5032435|NCT01496534|bladder cancer|bladder cancer
5032436|NCT01496534|gemcitabine|gemcitabine
5032437|NCT01496534|cisplatin|cisplatin
5032438|NCT01496534|carboplatin|carboplatin
5032439|NCT01496534|solid tumors|solid tumors
5032440|NCT01496521|Aspirin|aspirin
5032441|NCT01496521|polyphenols|polyphenols
5032442|NCT01496521|Chemoprevention|chemoprevention
5032443|NCT01496508|high-frequency oscillatory ventilation|high-frequency oscillatory ventilation
5032444|NCT01496508|respiratory distress syndrome|respiratory distress syndrome
5032445|NCT01496508|preterm infants|preterm infants
5032446|NCT01496508|neurodevelopment|neurodevelopment
5032447|NCT01496508|preterm infants with severe respiratory distress syndrome|preterm infants with severe respiratory distress syndrome
5032448|NCT01496482|Dry eye Syndromes|dry eye syndromes
5032449|NCT01496469|Drug Therapy|drug therapy
5032450|NCT01496456|Dental caries|dental caries
5032451|NCT01496456|Proximal surfaces|proximal surfaces
5032452|NCT01496456|Posterior teeth|posterior teeth
5032453|NCT01496456|Carious lesions|carious lesions
5032454|NCT01496456|Tooth diseases|tooth diseases
5032455|NCT01496456|Preventive therapy|preventive therapy
5032456|NCT01496443|Drug Therapy|drug therapy
5032457|NCT01496430|Drug Therapy|drug therapy
5032458|NCT01496430|Hypertension and Diabetes|hypertension and diabetes
5032459|NCT01496417|Kidney Transplantation|kidney transplantation
5032460|NCT01496417|Biopsy|biopsy
5032461|NCT01496417|Belatacept|belatacept
5032462|NCT01496404|Electrocautery|electrocautery
5032463|NCT01496391|imaging|imaging
5032464|NCT01496391|renal function|renal function
5032465|NCT01496391|I-123 OIH|i-123 oih
5032466|NCT01496391|Tc-99m MAG 3|tc-99m mag 3
5032467|NCT01496378|Chronic Pain|chronic pain
5032468|NCT01496378|Abdominal Pain|abdominal pain
5032469|NCT01496378|Headache|headache
5032470|NCT01496378|Adolescents|adolescents
5032471|NCT01496378|Children|children
5032473|NCT01496378|Problem-Solving Skills Training|problem-solving skills training
5032474|NCT01496365|Keywords: pain, diabetes, neuropathy|keywords: pain, diabetes, neuropathy
5032475|NCT01496352|Surgical site infection|surgical site infection
5032476|NCT01496352|Colorectal surgery|colorectal surgery
5032477|NCT01496326|Osteoarthritis|osteoarthritis
5032478|NCT01496326|knee pain|knee pain
5032479|NCT01496313|medullary thyroid cancer|medullary thyroid cancer
5032480|NCT01496313|metastatic|metastatic
5032481|NCT01496313|thyroid cancer|thyroid cancer
5032482|NCT01496313|carcinoma of the thyroid|carcinoma of the thyroid
5032483|NCT01496313|receptor tyrosine kinase inhibitor|receptor tyrosine kinase inhibitor
5032484|NCT01496313|VEGFR|vegfr
5032485|NCT01496313|Unresectable locally advanced thyroid cancer|unresectable locally advanced thyroid cancer
5032486|NCT01496300|Navigation OrthoPilot Hip TEP THA|navigation orthopilot hip tep tha
5032487|NCT01496261|Clopidogrel|clopidogrel
5032488|NCT01496261|Aspirin|aspirin
5032489|NCT01496261|Combination|combination
5032490|NCT01496261|Pharmacokinetics|pharmacokinetics
5032491|NCT01496261|Phase 1|phase 1
5032492|NCT01496248|Major depressive disorder|major depressive disorder
5032493|NCT01496248|Residual symptoms|residual symptoms
5032494|NCT01496248|Korean red ginseng|korean red ginseng
5032495|NCT01496222|mild cognitive impairment|mild cognitive impairment
5032496|NCT01496222|Montreal Cognitive Assessment test|montreal cognitive assessment test
5032497|NCT01496209|Infarction|infarction
5032498|NCT01496209|Myocardial Infarction|myocardial infarction
5032499|NCT01496209|Ventricular Dysfunction, Left|ventricular dysfunction, left
5032500|NCT01496209|Heart Disease|heart disease
5032501|NCT01496209|Cardiovascular Disease|cardiovascular disease
5032502|NCT01496209|Chronic Ischemia|chronic ischemia
5032503|NCT01496196|hemoptisis|hemoptisis
5032504|NCT01496196|bleeding|bleeding
5032505|NCT01496196|tranexamic acid|tranexamic acid
5032506|NCT01496157|Primary Prostate Cancer|primary prostate cancer
5032507|NCT01496144|Chronic non specific low back pain|chronic non specific low back pain
5032508|NCT01496144|Manual therapy|manual therapy
5032509|NCT01496144|Active exercises|active exercises
5032510|NCT01496144|Pain|pain
5032511|NCT01496144|Disability|disability
5032512|NCT01496131|Tecemotide|tecemotide
5032513|NCT01496131|Prostate Cancer|prostate cancer
5032514|NCT01496131|Goserelin|goserelin
5032515|NCT01496131|Cyclophosphamide|cyclophosphamide
5032516|NCT01496131|Radiotherapy|radiotherapy
5032517|NCT01496118|Relapsed/Refractory Multiple Myeloma|relapsed/refractory multiple myeloma
5032518|NCT01496118|carfilzomib|carfilzomib
5032519|NCT01496118|panobinostat|panobinostat
5032520|NCT01496092|Keto Acid|keto acid
5032521|NCT01496092|Peritoneal dialysis|peritoneal dialysis
5032522|NCT01496092|Insulin resistance|insulin resistance
5032523|NCT01496079|Maternal immunization|maternal immunization
5032524|NCT01496079|Infant immunization|infant immunization
5032525|NCT01496079|Influenza vaccine|influenza vaccine
5032526|NCT01496079|Passive transfer of immunity|passive transfer of immunity
5032527|NCT01496053|Cytokine levels in blood|cytokine levels in blood
5032528|NCT01496053|Calprotectin in feces|calprotectin in feces
5032529|NCT01496053|Clinical symptom score.|clinical symptom score.
5032530|NCT01496027|cerebral oxygenation|cerebral oxygenation
5032531|NCT01496027|NIRS|nirs
5032532|NCT01496027|tissue oximeters|tissue oximeters
5032533|NCT01496027|near infrared spectroscopy|near infrared spectroscopy
5032534|NCT01496027|newborn|newborn
5032535|NCT01496014|open fracture wounds|open fracture wounds
5032536|NCT01496014|infections|infections
5032537|NCT01496014|tibia fractures|tibia fractures
5032538|NCT01496014|antibiotic therapies in severe fractures|antibiotic therapies in severe fractures
5032539|NCT01496014|All severe open fracture of the tibia bone|all severe open fracture of the tibia bone
5032540|NCT01496001|Early unilateral breast cancer|early unilateral breast cancer
5032541|NCT01495988|Metastatic melanoma|metastatic melanoma
5032542|NCT01495988|BRAF-mutant|braf-mutant
5032543|NCT01495988|Stage IV melanoma|stage iv melanoma
5032544|NCT01495988|Vemurafenib|vemurafenib
5032545|NCT01495988|Bevacizumab|bevacizumab
5032546|NCT01495988|Cobimetinib|cobimetinib
5032547|NCT01495975|Diabetes Mellitus|diabetes mellitus
5032548|NCT01495975|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
5032549|NCT01495975|Hospitalization|hospitalization
5032550|NCT01495975|Patient Discharge|patient discharge
5032551|NCT01495962|Damage Control Laparotomy|damage control laparotomy
5032552|NCT01495962|Open Abdomen|open abdomen
5032553|NCT01495962|Botulinum Toxin A|botulinum toxin a
5032554|NCT01495962|Primary Fascial Closure|primary fascial closure
5032555|NCT01495949|etomidate|etomidate
5032556|NCT01495949|cortisol level|cortisol level
5032557|NCT01495949|inotrope|inotrope
5032558|NCT01495949|cardiac patients|cardiac patients
5032559|NCT01495936|One Lung Ventilation (OLV)|one lung ventilation (olv)
5032560|NCT01495936|Continuous Positive Airway Pressure (CPAP)|continuous positive airway pressure (cpap)
5032561|NCT01495936|Positive End Expiratory Pressure (PEEP)|positive end expiratory pressure (peep)
5032562|NCT01495936|Lung recruitment maneuver|lung recruitment maneuver
5032563|NCT01495936|Hypoxia|hypoxia
5032564|NCT01495923|low back pain|low back pain
5032565|NCT01495923|radiculopathy|radiculopathy
5032566|NCT01495923|injection|injection
5032670|NCT01495585|Treatment|treatment
5032567|NCT01495910|21-hydroxylase deficiency|21-hydroxylase deficiency
5032568|NCT01495910|Androstenedione|androstenedione
5032569|NCT01495910|Abiraterone acetate|abiraterone acetate
5032570|NCT01495910|Pharmacokinetics|pharmacokinetics
5032571|NCT01495910|Pharmacodynamics|pharmacodynamics
5032572|NCT01495910|Dose-finding|dose-finding
5032573|NCT01495897|Dystonia|dystonia
5032574|NCT01495897|Cerebellar|cerebellar
5032575|NCT01495897|ocular movements|ocular movements
5032576|NCT01495897|DYT 11|dyt 11
5032577|NCT01495897|sensorimotor integration|sensorimotor integration
5032578|NCT01495858|Naproxen sodium|naproxen sodium
5032579|NCT01495858|Diphenhydramine|diphenhydramine
5032580|NCT01495845|pharmacogenomics|pharmacogenomics
5032581|NCT01495845|feasibility|feasibility
5032582|NCT01495845|community pharmacy|community pharmacy
5032583|NCT01495845|personalized medicine|personalized medicine
5032584|NCT01495845|clopidogrel|clopidogrel
5032585|NCT01495845|Plavix|plavix
5032586|NCT01495832|Adult Obesity|adult obesity
5032587|NCT01495832|Cardiometabolic health|cardiometabolic health
5032588|NCT01495832|Pulse Foods|pulse foods
5032589|NCT01495832|Beans, Peas, Lentils|beans, peas, lentils
5032590|NCT01495832|Cognitive Function|cognitive function
5032591|NCT01495819|Nicotine|nicotine
5032592|NCT01495819|smokers|smokers
5032593|NCT01495819|vitals associated with smoking|vitals associated with smoking
5032594|NCT01495806|functional dyspepsia|functional dyspepsia
5032595|NCT01495806|irritable bowel syndrome|irritable bowel syndrome
5032596|NCT01495806|functional abdominal pain|functional abdominal pain
5032597|NCT01495793|Rotigotine|rotigotine
5032598|NCT01495793|Restless Legs Syndrome|restless legs syndrome
5032599|NCT01495793|RLS|rls
5032600|NCT01495793|Children|children
5032601|NCT01495793|Adolescents|adolescents
5032602|NCT01495780|Behavioral|behavioral
5032603|NCT01495780|Remote monitoring|remote monitoring
5032604|NCT01495767|childhood uveitis|childhood uveitis
5032605|NCT01495767|health-related quality of life|health-related quality of life
5032606|NCT01495767|gender|gender
5032607|NCT01495754|coffee|coffee
5032608|NCT01495754|overweight/obese|overweight/obese
5032609|NCT01495754|appetite|appetite
5032610|NCT01495754|energy intake|energy intake
5032611|NCT01495754|inflammation|inflammation
5032612|NCT01495754|glucose metabolism|glucose metabolism
5032613|NCT01495754|randomized controlled trial|randomized controlled trial
5032614|NCT01495741|Mania|mania
5032615|NCT01495741|Manic|manic
5032616|NCT01495741|Depressive|depressive
5032617|NCT01495741|Manic Depressive|manic depressive
5032618|NCT01495728|Cervical Radiculopathy|cervical radiculopathy
5032619|NCT01495728|Neck Pain|neck pain
5032620|NCT01495728|Manipulation|manipulation
5032621|NCT01495702|HIV-1|hiv-1
5032622|NCT01495702|HIV|hiv
5032623|NCT01495702|Treatment Experienced|treatment experienced
5032624|NCT01495689|Smoking Cessation|smoking cessation
5032625|NCT01495689|respirology Out-patient setting|respirology out-patient setting
5032626|NCT01495689|SmartCard|smartcard
5032627|NCT01495676|Bladder cancer|bladder cancer
5032628|NCT01495676|Organ-conserving strategy|organ-conserving strategy
5032629|NCT01495676|Radiochemotherapy|radiochemotherapy
5032630|NCT01495676|non metastatic|non metastatic
5032631|NCT01495663|refractory|refractory
5032632|NCT01495663|relapsed|relapsed
5032633|NCT01495663|non-small cell lung cancer|non-small cell lung cancer
5032634|NCT01495663|triple-negative breast cancer|triple-negative breast cancer
5032635|NCT01495663|soft tissue sarcoma|soft tissue sarcoma
5032636|NCT01495663|colorectal cancer|colorectal cancer
5032637|NCT01495663|esophageal cancer|esophageal cancer
5032638|NCT01495663|prostate cancer|prostate cancer
5032639|NCT01495663|ovarian cancer|ovarian cancer
5032640|NCT01495650|Comprehensive Adjuvant Care|comprehensive adjuvant care
5032641|NCT01495650|Cancer-related fatigue|cancer-related fatigue
5032642|NCT01495650|Therapeutic patient education|therapeutic patient education
5032643|NCT01495650|Physical Activity|physical activity
5032644|NCT01495650|Nutritional counselling|nutritional counselling
5032645|NCT01495650|Rehabilitation|rehabilitation
5032646|NCT01495637|pediatric|pediatric
5032647|NCT01495637|trauma|trauma
5032648|NCT01495637|critical|critical
5032649|NCT01495637|GM-CSF|gm-csf
5032650|NCT01495637|immune|immune
5032651|NCT01495624|rotator cuff repair|rotator cuff repair
5032652|NCT01495624|capsular shift|capsular shift
5032653|NCT01495624|shoulder arthroplasty|shoulder arthroplasty
5032654|NCT01495624|subacromial decompression|subacromial decompression
5032655|NCT01495624|18 and 75 years|18 and 75 years
5032656|NCT01495611|postoperative,|postoperative,
5032657|NCT01495611|pediatric|pediatric
5032658|NCT01495611|pharmacogenetic|pharmacogenetic
5032659|NCT01495611|opioid|opioid
5032660|NCT01495611|morphine|morphine
5032661|NCT01495611|perioperative|perioperative
5032662|NCT01495611|respiratory depression|respiratory depression
5032663|NCT01495598|Human Herpesvirus-8/HHV8|human herpesvirus-8/hhv8
5032664|NCT01495598|Immune Modulation|immune modulation
5032665|NCT01495598|CC-4047|cc-4047
5032666|NCT01495598|IMiD|imid
5032667|NCT01495598|Kaposi Sarcoma|kaposi sarcoma
5032668|NCT01495585|Hepatitis|hepatitis
5032669|NCT01495585|Delta|delta
5032671|NCT01495585|Lonafarnib|lonafarnib
5032672|NCT01495585|Hepatitis D|hepatitis d
5032673|NCT01495572|Malignant Melanoma|malignant melanoma
5032674|NCT01495572|Immunotherapy|immunotherapy
5032675|NCT01495572|Cell Therapy|cell therapy
5032676|NCT01495572|HLA-A2 Positive|hla-a2 positive
5032677|NCT01495572|Skin Cancer|skin cancer
5032678|NCT01495546|total hip arthroplasty|total hip arthroplasty
5032679|NCT01495546|THA|tha
5032680|NCT01495546|prosthesis type Lepine|prosthesis type lepine
5032681|NCT01495520|Arrhythmias|arrhythmias
5032682|NCT01495520|palpitations|palpitations
5032683|NCT01495494|Nasal Strip|nasal strip
5032684|NCT01495481|Supraventricular Tachycardia|supraventricular tachycardia
5032685|NCT01495481|SVT|svt
5032686|NCT01495481|Reentrant Tachycardia|reentrant tachycardia
5032687|NCT01495481|Dexmedetomidine|dexmedetomidine
5032688|NCT01495481|Adenosine|adenosine
5032689|NCT01495468|pegylated somatropin|pegylated somatropin
5032690|NCT01495468|PEG-rhGH|peg-rhgh
5032691|NCT01495468|growth hormone|growth hormone
5032692|NCT01495468|Growth Hormone Deficiency|growth hormone deficiency
5032693|NCT01495468|phase III study|phase iii study
5032694|NCT01495429|catheter related large vein thrombosis|catheter related large vein thrombosis
5032695|NCT01495429|upper extremity deep venous thrombosis|upper extremity deep venous thrombosis
5032696|NCT01495429|central venous catheters|central venous catheters
5032697|NCT01495429|upper extremity catheter related large vein thrombosis|upper extremity catheter related large vein thrombosis
5032698|NCT01495403|liver cirrhosis|liver cirrhosis
5032699|NCT01495403|muscle cramps|muscle cramps
5032700|NCT01495390|Biomarkers|biomarkers
5032701|NCT01495390|Biological Markers|biological markers
5032702|NCT01495390|Surrogate Markers|surrogate markers
5032703|NCT01495390|Clinical Markers|clinical markers
5032704|NCT01495390|Plasma|plasma
5032705|NCT01495390|Cerebrospinal Fluid|cerebrospinal fluid
5032706|NCT01495390|DNA|dna
5032707|NCT01495390|Serum|serum
5032708|NCT01495390|RNA|rna
5032709|NCT01495377|swallowing difficulties|swallowing difficulties
5032710|NCT01495377|remifentanil|remifentanil
5032711|NCT01495377|pulmonary aspiration|pulmonary aspiration
5032712|NCT01495377|scintigraphy|scintigraphy
5032713|NCT01495364|STEMI|stemi
5032714|NCT01495325|Firefighter|firefighter
5032715|NCT01495325|Woodsmoke|woodsmoke
5032716|NCT01495325|Vascular function|vascular function
5032717|NCT01495325|Air Pollution|air pollution
5032718|NCT01495325|Endothelial function|endothelial function
5032719|NCT01495325|Thrombosis|thrombosis
5032720|NCT01495312|IOP fluctuations|iop fluctuations
5032721|NCT01495312|during two 24-hour periods|during two 24-hour periods
5032722|NCT01495299|relationship|relationship
5032723|NCT01495299|IOP fluctuations|iop fluctuations
5032724|NCT01495299|glaucoma|glaucoma
5032725|NCT01495299|cataract surgery|cataract surgery
5032726|NCT01495299|SENSIMED Triggerfish|sensimed triggerfish
5032727|NCT01495286|newborn infant|newborn infant
5032728|NCT01495286|acupuncture|acupuncture
5032729|NCT01495286|safety|safety
5032730|NCT01495286|pain|pain
5032731|NCT01495260|XALD|xald
5032732|NCT01495260|AMN|amn
5032733|NCT01495247|Locally advanced|locally advanced
5032734|NCT01495247|metastatic|metastatic
5032735|NCT01495247|breast cancer|breast cancer
5032736|NCT01495247|HER2 negative|her2 negative
5032737|NCT01495247|PI3K pathway|pi3k pathway
5032738|NCT01495247|paclitaxel|paclitaxel
5032739|NCT01495247|mTOR inhibitor|mtor inhibitor
5032740|NCT01495234|Spinal degeneration|spinal degeneration
5032741|NCT01495195|Acetylcholine|acetylcholine
5032742|NCT01495195|Cholinesterases|cholinesterases
5032743|NCT01495195|Cocaine|cocaine
5032744|NCT01495195|Self-Administration|self-administration
5032745|NCT01495182|Dietary fiber|dietary fiber
5032746|NCT01495182|Gastrointestinal toleration|gastrointestinal toleration
5032747|NCT01495182|Fecal weight|fecal weight
5032748|NCT01495169|Antipsychotic|antipsychotic
5032749|NCT01495169|Schizophrenia|schizophrenia
5032750|NCT01495169|Bipolar disorder|bipolar disorder
5032751|NCT01495169|Iloperidone|iloperidone
5032752|NCT01495143|Glucose|glucose
5032753|NCT01495143|Lactate pyruvate ratio|lactate pyruvate ratio
5032754|NCT01495143|Glycerol|glycerol
5032755|NCT01495143|Paraspinal muscle|paraspinal muscle
5032756|NCT01495143|Microdialysis|microdialysis
5032757|NCT01495117|surgical site infection|surgical site infection
5032758|NCT01495117|chlorhexidine gluconate|chlorhexidine gluconate
5032759|NCT01495117|povidone iodine|povidone iodine
5032760|NCT01495091|coronary artery disease|coronary artery disease
5032761|NCT01495091|cardiovascular disease|cardiovascular disease
5032762|NCT01495091|exercise stress testing|exercise stress testing
5032763|NCT01495091|biomarkers|biomarkers
5032764|NCT01495091|NT-pro-BNP|nt-pro-bnp
5032765|NCT01495078|telemonitoring|telemonitoring
5032766|NCT01495078|heart failure|heart failure
5032767|NCT01495065|GSK2251052, healthy volunteer, safety, tolerability, pharmacokinetics, single|gsk2251052, healthy volunteer, safety, tolerability, pharmacokinetics, single
5032768|NCT01495052|naked oat (Avena nuda L.)|naked oat (avena nuda l.)
5032769|NCT01495052|diabetes mellitus|diabetes mellitus
5032770|NCT01495052|RCT|rct
5032771|NCT01495026|Healthy male subjects|healthy male subjects
5032772|NCT01495026|North-East Asian ancestry|north-east asian ancestry
5032773|NCT01495026|Bioequivalence|bioequivalence
5032774|NCT01495026|Food effect|food effect
5032775|NCT01495026|Tamsulosin hydrochloride|tamsulosin hydrochloride
5032776|NCT01495026|Cross-over design|cross-over design
5032777|NCT01495026|Pilot bioequivalence|pilot bioequivalence
5032778|NCT01495026|Dutasteride (GI198745)|dutasteride (gi198745)
5032779|NCT01495013|non-inferiority|non-inferiority
5032780|NCT01495013|glimepiride|glimepiride
5032781|NCT01495013|LDL cholesterol|ldl cholesterol
5032782|NCT01495013|fixed dose combination|fixed dose combination
5032783|NCT01495013|atorvastatin|atorvastatin
5032784|NCT01495013|Diabetes Mellitus|diabetes mellitus
5032785|NCT01495000|India|india
5032786|NCT01495000|dual energy x-ray absorptiometry|dual energy x-ray absorptiometry
5032787|NCT01495000|bone mineral density|bone mineral density
5032788|NCT01495000|denosumab|denosumab
5032789|NCT01494987|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
5032790|NCT01494974|Glaucoma|glaucoma
5032791|NCT01494974|Pediatric|pediatric
5032792|NCT01494974|Ahmed|ahmed
5032793|NCT01494974|Congenital|congenital
5032794|NCT01494974|FP7|fp7
5032795|NCT01494974|FP8|fp8
5032796|NCT01494961|Partner HIV testing|partner hiv testing
5032797|NCT01494961|Couple HIV counseling|couple hiv counseling
5032798|NCT01494961|Couple communication on sexual and reproductive health|couple communication on sexual and reproductive health
5032799|NCT01494961|HIV incidence|hiv incidence
5032800|NCT01494961|Incidence of pregnancies|incidence of pregnancies
5032801|NCT01494961|Disclosure|disclosure
5032802|NCT01494961|Condom use|condom use
5032803|NCT01494922|Skin scarring|skin scarring
5032804|NCT01494922|cicatrix|cicatrix
5032805|NCT01494922|hypertrophic scar|hypertrophic scar
5032806|NCT01494922|hypertrophic scar prevention|hypertrophic scar prevention
5032807|NCT01494909|protein digestion|protein digestion
5032808|NCT01494909|fat absorption|fat absorption
5032809|NCT01494909|gut function|gut function
5032810|NCT01494909|glucose absorption|glucose absorption
5032811|NCT01494909|CF|cf
5032812|NCT01494909|pancreatic intake|pancreatic intake
5032813|NCT01494909|feeding|feeding
5032814|NCT01494896|Pulmonary Hypertension|pulmonary hypertension
5032815|NCT01494896|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
5032816|NCT01494896|COPD|copd
5032817|NCT01494896|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5032818|NCT01494896|Tyvaso|tyvaso
5032819|NCT01494896|Inhaled Treprostinil Sodium|inhaled treprostinil sodium
5032820|NCT01494896|Ventilation Perfusion Matching|ventilation perfusion matching
5032821|NCT01494896|HO Group 1 Pulmonary Arterial Hypertension|ho group 1 pulmonary arterial hypertension
5032822|NCT01494896|Concomitant Chronic Obstructive Pulmonary Disease|concomitant chronic obstructive pulmonary disease
5032823|NCT01494883|Mindfulness Based Stress Reduction|mindfulness based stress reduction
5032824|NCT01494883|lung cancer|lung cancer
5032825|NCT01494883|psychological distress|psychological distress
5032826|NCT01494883|caretakers|caretakers
5032827|NCT01494870|acute coronary syndrome|acute coronary syndrome
5032828|NCT01494870|percutaneous coronary intervention|percutaneous coronary intervention
5032829|NCT01494870|left bundle branch block|left bundle branch block
5032830|NCT01494857|Ulcerative colitis|ulcerative colitis
5032831|NCT01494857|biological treatment|biological treatment
5032832|NCT01494857|anti-TNF|anti-tnf
5032833|NCT01494844|Patient Monitoring|patient monitoring
5032834|NCT01494844|Capnography|capnography
5032835|NCT01494844|Human Engineering|human engineering
5032836|NCT01494818|Contact lenses|contact lenses
5032837|NCT01494818|Contact lens solutions|contact lens solutions
5032838|NCT01494805|Age-related Macular Degeneration|age-related macular degeneration
5032839|NCT01494805|AAV|aav
5032840|NCT01494805|AMD|amd
5032841|NCT01494805|Wet AMD|wet amd
5032842|NCT01494805|Neovascular AMD|neovascular amd
5032843|NCT01494805|Gene Therapy|gene therapy
5032844|NCT01494805|Ocular|ocular
5032845|NCT01494805|Ocular Gene Therapy|ocular gene therapy
5032846|NCT01494805|Eye diseases|eye diseases
5032847|NCT01494805|Macular Degeneration|macular degeneration
5032848|NCT01494805|Retinal Degeneration|retinal degeneration
5032849|NCT01494805|Retinal Neovascularization|retinal neovascularization
5032850|NCT01494805|Wet Macular Degeneration|wet macular degeneration
5032851|NCT01494805|Retinal Diseases|retinal diseases
5032852|NCT01494779|children|children
5032853|NCT01494766|RLS|rls
5032854|NCT01494740|H1N1|h1n1
5032855|NCT01494740|Vaccine|vaccine
5032856|NCT01494740|Immunogenicity|immunogenicity
5032857|NCT01494740|Safety|safety
5032858|NCT01494740|infants|infants
5032859|NCT01494727|Safety|safety
5032860|NCT01494727|Pharmacokinetics|pharmacokinetics
5032861|NCT01494714|Healthy volunteers|healthy volunteers
5032862|NCT01494714|JNJ 10229570-AAA|jnj 10229570-aaa
5032863|NCT01494714|Skin irritation|skin irritation
5032864|NCT01494714|Skin photo irritation|skin photo irritation
5032865|NCT01494701|Spinal Muscular Atrophy|spinal muscular atrophy
5032866|NCT01494701|SMA|sma
5032867|NCT01494701|SMN|smn
5032868|NCT01494701|SMNRx|smnrx
5032869|NCT01494701|ISIS-SMNRx|isis-smnrx
5032870|NCT01494701|ISIS-SMN Rx|isis-smn rx
5032871|NCT01494701|ISIS 396443|isis 396443
5032872|NCT01494701|IONIS-SMNRx|ionis-smnrx
5032873|NCT01494701|IONIS-SMN Rx|ionis-smn rx
5032874|NCT01494701|Spinraza|spinraza
5032875|NCT01494675|procalcitonin|procalcitonin
5032876|NCT01494675|duration of the antibiotic therapy|duration of the antibiotic therapy
5032877|NCT01494675|sepsis|sepsis
5032878|NCT01494662|HER2 Positive|her2 positive
5032879|NCT01494662|BrCa|brca
5032880|NCT01494649|dentinal|dentinal
5032881|NCT01494649|hypersensitivity|hypersensitivity
5032882|NCT01494636|Capsaicin Challenge|capsaicin challenge
5032883|NCT01494636|Pharmacodynamics|pharmacodynamics
5032884|NCT01494636|Safety|safety
5032885|NCT01494636|Pharmacokinetics|pharmacokinetics
5032886|NCT01494636|Oral GSK2339345|oral gsk2339345
5032887|NCT01494636|Tolerability|tolerability
5032888|NCT01494636|FTIH|ftih
5032889|NCT01494636|Chronic Cough|chronic cough
5032890|NCT01494623|working memory|working memory
5032891|NCT01494623|schizophrenia|schizophrenia
5032892|NCT01494623|cognition|cognition
5032893|NCT01494623|rTMS|rtms
5032894|NCT01494610|safety|safety
5032895|NCT01494610|replicated cross-over design|replicated cross-over design
5032896|NCT01494610|pharmacodynamics|pharmacodynamics
5032897|NCT01494610|Fluticasone propionate/Salmeterol|fluticasone propionate/salmeterol
5032898|NCT01494610|capsule-based inhaler|capsule-based inhaler
5032899|NCT01494610|COPD|copd
5032900|NCT01494610|asthma|asthma
5032901|NCT01494610|multi dose dry powder inhaler|multi dose dry powder inhaler
5032902|NCT01494610|bioavailability|bioavailability
5032903|NCT01494610|pharmacokinetics|pharmacokinetics
5032904|NCT01494597|Isavuconazole|isavuconazole
5032905|NCT01494597|Cyclosporine|cyclosporine
5032906|NCT01494597|Healthy Volunteers|healthy volunteers
5032907|NCT01494597|BAL8557|bal8557
5032908|NCT01494597|Pharmacokinetics of isavuconazole|pharmacokinetics of isavuconazole
5032909|NCT01494597|Pharmacokinetics of cyclosporine|pharmacokinetics of cyclosporine
5032910|NCT01494558|Overall survival|overall survival
5032911|NCT01494545|DAILIES TOTAL1|dailies total1
5032912|NCT01494545|Alcon|alcon
5032913|NCT01494545|contact lens|contact lens
5032914|NCT01494519|External ring fixation|external ring fixation
5032915|NCT01494519|internal fixation|internal fixation
5032916|NCT01494519|traumatic tibia fracture|traumatic tibia fracture
5032917|NCT01494506|Pancreatic cancer|pancreatic cancer
5032918|NCT01494506|MM-398|mm-398
5032919|NCT01494506|PEP02|pep02
5032920|NCT01494506|Metastatic pancreatic cancer|metastatic pancreatic cancer
5032921|NCT01494506|Gemcitabine refractory pancreatic cancer|gemcitabine refractory pancreatic cancer
5032922|NCT01494506|Second line pancreatic cancer treatment|second line pancreatic cancer treatment
5032923|NCT01494506|Pancreatic cancer post gemcitabine therapy|pancreatic cancer post gemcitabine therapy
5032924|NCT01494493|symptomatic degenerative disc disease|symptomatic degenerative disc disease
5032925|NCT01494480|ALS|als
5032926|NCT01494480|stem cell|stem cell
5032927|NCT01494467|PPR|ppr
5032928|NCT01494454|Lumbar degenerative disc disease|lumbar degenerative disc disease
5032929|NCT01494441|lumbar degenerative disc disease|lumbar degenerative disc disease
5032930|NCT01494428|symptomatic degenerative disc disease|symptomatic degenerative disc disease
5032931|NCT01494415|Squamous Cell Lung Cancer|squamous cell lung cancer
5032932|NCT01494415|radiation therapy|radiation therapy
5032933|NCT01494415|chemotherapy|chemotherapy
5032934|NCT01494402|Healthy volunteer, Japanese males, homo-EM|healthy volunteer, japanese males, homo-em
5032935|NCT01494389|CD4+T lymphocyte subsets|cd4+t lymphocyte subsets
5032936|NCT01494389|sepsis|sepsis
5032937|NCT01494389|immunoparalysis|immunoparalysis
5032938|NCT01494350|cutaneous leishmaniasis|cutaneous leishmaniasis
5032939|NCT01494350|topical treatment|topical treatment
5032940|NCT01494350|Tunisia|tunisia
5032941|NCT01494337|LASER|laser
5032942|NCT01494337|BPH|bph
5032943|NCT01494337|Prostate surgery|prostate surgery
5032944|NCT01494337|HOLEP|holep
5032945|NCT01494337|Green light PVP|green light pvp
5032946|NCT01494324|Liver|liver
5032947|NCT01494324|Thermal Ablation|thermal ablation
5032948|NCT01494324|Dynamic CT|dynamic ct
5032949|NCT01494324|09-122|09-122
5032950|NCT01494311|Arterial catheter|arterial catheter
5032951|NCT01494311|arterial cannula|arterial cannula
5032952|NCT01494311|Rapydan|rapydan
5032953|NCT01494311|lidocaine/tetracaine patch|lidocaine/tetracaine patch
5032954|NCT01494311|topical anaesthesia|topical anaesthesia
5032955|NCT01494298|Type 2 diabetes|type 2 diabetes
5032956|NCT01494298|African American|african american
5032957|NCT01494298|cholesterol|cholesterol
5032958|NCT01494298|lipoprotein|lipoprotein
5032959|NCT01494298|apolipoprotein|apolipoprotein
5032960|NCT01494285|Acne Vulgaris|acne vulgaris
5032961|NCT01494285|Topical|topical
5032962|NCT01494285|Foam|foam
5032963|NCT01494272|caudal epidural analgesia|caudal epidural analgesia
5032964|NCT01494272|elective circumcision|elective circumcision
5032965|NCT01494272|elective inguinal herniorrhaphy|elective inguinal herniorrhaphy
5032966|NCT01494259|immediate breast reconstruction|immediate breast reconstruction
5032967|NCT01494259|pain control|pain control
5032968|NCT01494259|post mastectomy pain control|post mastectomy pain control
5032969|NCT01494246|Adult|adult
5032970|NCT01494246|computer-assisted instruction|computer-assisted instruction
5032971|NCT01494246|electronic mail|electronic mail
5032972|NCT01494246|program evaluation|program evaluation
5032973|NCT01494246|smoking cessation/methods|smoking cessation/methods
5032974|NCT01494246|continued abstinence|continued abstinence
5032975|NCT01494220|Bispectral index; anesthesia|bispectral index; anesthesia
5032976|NCT01494220|liver transplantation|liver transplantation
5032977|NCT01494220|independent factors|independent factors
5032978|NCT01494220|outcome|outcome
5032979|NCT01494220|Living donor liver transplantation|living donor liver transplantation
5032980|NCT01494207|worksite|worksite
5032981|NCT01494207|interventions|interventions
5032982|NCT01494207|motivational interviewing|motivational interviewing
5032983|NCT01494207|physical activity|physical activity
5032984|NCT01494194|Mold sensitized|mold sensitized
5032985|NCT01494181|obstructive sleep apnea|obstructive sleep apnea
5032986|NCT01494181|vascular events|vascular events
5032987|NCT01494168|Hypertension|hypertension
5032988|NCT01494168|Arterial stiffness|arterial stiffness
5032989|NCT01494168|Obesity|obesity
5032990|NCT01494168|Bariatric surgery|bariatric surgery
5032991|NCT01494155|resectable pancreatic cancer|resectable pancreatic cancer
5032992|NCT01494155|pancreaticoduodenectomy|pancreaticoduodenectomy
5032993|NCT01494142|Registry|registry
5032994|NCT01494142|Atopic Dermatitis|atopic dermatitis
5032995|NCT01494142|Eczema Herpeticum|eczema herpeticum
5032996|NCT01494142|GWAS|gwas
5032997|NCT01494142|Staphylococcus aureus|staphylococcus aureus
5032998|NCT01494116|Pediatrics|pediatrics
5032999|NCT01494116|Fluid|fluid
5033000|NCT01494116|Bolus|bolus
5033001|NCT01494116|Resuscitation|resuscitation
5033002|NCT01494116|Shock|shock
5033003|NCT01494103|Acute lymphoblastic leukemia|acute lymphoblastic leukemia
5033004|NCT01494103|Myelodysplastic syndrome|myelodysplastic syndrome
5033005|NCT01494103|Acute myeloid leukemia|acute myeloid leukemia
5033006|NCT01494103|Chronic myelogenous leukemia|chronic myelogenous leukemia
5033007|NCT01494103|Non Hodgkin lymphoma|non hodgkin lymphoma
5033008|NCT01494103|Hemophagocytic lymphohistiocytosis|hemophagocytic lymphohistiocytosis
5033009|NCT01494103|Familial hemophagocytic lymphohistiocytosis|familial hemophagocytic lymphohistiocytosis
5033010|NCT01494103|Hemophagocytic syndrome|hemophagocytic syndrome
5033011|NCT01494103|Epstein Barr virus infection|epstein barr virus infection
5033012|NCT01494103|X-linked lymphoproliferative disease|x-linked lymphoproliferative disease
5033013|NCT01494090|Venous thromboembolism|venous thromboembolism
5033014|NCT01494090|Hip fracture|hip fracture
5033015|NCT01494090|Cardiovascular events|cardiovascular events
5033016|NCT01494090|Statin|statin
5033017|NCT01494077|Pancreatic Cyst Fluid|pancreatic cyst fluid
5033018|NCT01494077|Dilution|dilution
5033019|NCT01494077|Carcinoembryonic Antigen (CEA)|carcinoembryonic antigen (cea)
5033020|NCT01494051|fatty acid oxidation disorders|fatty acid oxidation disorders
5033021|NCT01494025|Diabetes|diabetes
5033022|NCT01494025|Pre-diabetes|pre-diabetes
5033023|NCT01494025|Obese|obese
5033024|NCT01493999|Clopidogrel|clopidogrel
5033025|NCT01493999|prasugrel|prasugrel
5033026|NCT01493999|HPR|hpr
5033027|NCT01493999|loading dose|loading dose
5033028|NCT01493999|maintenance dose|maintenance dose
5033029|NCT01493999|stent thrombosis|stent thrombosis
5033030|NCT01493999|platelet reactivity|platelet reactivity
5033031|NCT01493999|Coronary intervention|coronary intervention
5033032|NCT01493999|stent implantation|stent implantation
5033033|NCT01493986|Ropivacaine|ropivacaine
5033034|NCT01493986|Brachial plexus|brachial plexus
5033035|NCT01493973|Erythropoietin|erythropoietin
5033036|NCT01493973|EPO|epo
5033037|NCT01493973|Friedreich|friedreich
5033038|NCT01493973|Ataxia|ataxia
5033039|NCT01493973|Epoetin alfa|epoetin alfa
5033040|NCT01493973|VO2 max|vo2 max
5033041|NCT01493973|SARA|sara
5033042|NCT01493973|EQ-5D|eq-5d
5033043|NCT01493973|frataxin|frataxin
5033044|NCT01493960|Colitis, Ulcerative|colitis, ulcerative
5033045|NCT01493960|Gastrointestinal Diseases|gastrointestinal diseases
5033046|NCT01493960|Inflammatory Bowel Diseases|inflammatory bowel diseases
5033047|NCT01493960|Immunomodulatory Therapy|immunomodulatory therapy
5033048|NCT01493960|Glucocorticoids|glucocorticoids
5033049|NCT01493960|Anti-Inflammatory Agents|anti-inflammatory agents
5033050|NCT01493960|Therapeutic uses|therapeutic uses
5033051|NCT01493934|metabolic syndrome|metabolic syndrome
5033052|NCT01493934|type 2 diabetes mellitus|type 2 diabetes mellitus
5033053|NCT01493934|insulin resistance|insulin resistance
5033054|NCT01493934|Scintigraphy|scintigraphy
5033055|NCT01493921|SR-T100 Clinical treatment against Actinic Keratosis|sr-t100 clinical treatment against actinic keratosis
5033056|NCT01493921|Actinic keratosis skin lesion treatment with SR-T100 gel|actinic keratosis skin lesion treatment with sr-t100 gel
5033057|NCT01493921|Skin lesion treatment with SR-T100 gel|skin lesion treatment with sr-t100 gel
5033058|NCT01493921|SR-T100 gel treatment against skin lesion|sr-t100 gel treatment against skin lesion
5033059|NCT01493921|Clinical efficacy study of SR-T100 gel|clinical efficacy study of sr-t100 gel
5033060|NCT01493908|Placebo effect;|placebo effect;
5033061|NCT01493908|Pain; Analgesic;|pain; analgesic;
5033062|NCT01493908|Electrical shock|electrical shock
5033063|NCT01493908|control in healthy volunteers|control in healthy volunteers
5033064|NCT01493882|Uncontrolled Persistent Asthma, Dyspnea, Wheezing|uncontrolled persistent asthma, dyspnea, wheezing
5033065|NCT01493869|Normal healthy adult subjects|normal healthy adult subjects
5033066|NCT01493869|Adult subjects with hepatic impairment|adult subjects with hepatic impairment
5033067|NCT01493830|neuroblastoma|neuroblastoma
5033068|NCT01493804|Near Infrared Spectroscopy|near infrared spectroscopy
5033069|NCT01493804|EEG|eeg
5033070|NCT01493804|Brain Connectivity|brain connectivity
5033071|NCT01493804|Healthy Volunteer|healthy volunteer
5033072|NCT01493804|HV|hv
5033073|NCT01493791|CDB-2914|cdb-2914
5033074|NCT01493791|Abnormal Urine Bleeding|abnormal urine bleeding
5033075|NCT01493791|Abnormal Uterine Bleeding|abnormal uterine bleeding
5033076|NCT01493700|heated circuit|heated circuit
5033077|NCT01493700|body temperature|body temperature
5033078|NCT01493674|folate|folate
5033079|NCT01493674|homocysteine|homocysteine
5033080|NCT01493674|cognitive function|cognitive function
5033081|NCT01493674|eating disorders|eating disorders
5033082|NCT01493674|depression.|depression.
5033083|NCT01493661|Sleep|sleep
5033084|NCT01493661|Polysomnography|polysomnography
5033085|NCT01493661|Reaction Time|reaction time
5033086|NCT01493661|Sleep Deprivation|sleep deprivation
5033087|NCT01493661|Psychophysiology|psychophysiology
5033088|NCT01493661|Chronic sleep restriction|chronic sleep restriction
5033089|NCT01493661|healthy|healthy
5033090|NCT01493661|without sleep complaints|without sleep complaints
5033091|NCT01493648|statins|statins
5033092|NCT01493648|side effects|side effects
5033093|NCT01493648|muscle|muscle
5033094|NCT01493648|vitamin D|vitamin d
5033095|NCT01493648|biopsy|biopsy
5033096|NCT01493648|strength|strength
5033097|NCT01493648|fatigue|fatigue
5033098|NCT01493622|Schizophrenia minocycline cognition|schizophrenia minocycline cognition
5033099|NCT01493596|Safety|safety
5033100|NCT01493596|Tolerability|tolerability
5033101|NCT01493583|severely obese|severely obese
5033102|NCT01493583|Roux-en Y gastric bypass surgery (RYGB)|roux-en y gastric bypass surgery (rygb)
5033103|NCT01493583|brain activity by fMRI|brain activity by fmri
5033104|NCT01493583|visual presentation of food and non-food-related pictures|visual presentation of food and non-food-related pictures
5033105|NCT01493544|COPD|copd
5033106|NCT01493544|smokers|smokers
5033107|NCT01493544|primary care|primary care
5033108|NCT01493531|Gout|gout
5033109|NCT01493518|SAFETY|safety
5033110|NCT01493518|ADULT|adult
5033111|NCT01493518|PSORIASIS|psoriasis
5033112|NCT01493518|INFLAMMATION|inflammation
5033113|NCT01493505|Primary Peritoneal Cancer|primary peritoneal cancer
5033114|NCT01493492|proteomics,urinary,sepsis,prognosis|proteomics,urinary,sepsis,prognosis
5033115|NCT01493466|proteomics,|proteomics,
5033116|NCT01493466|serum,|serum,
5033117|NCT01493466|sepsis,|sepsis,
5033118|NCT01493466|potential biomarkers,|potential biomarkers,
5033119|NCT01493466|dynamic changes|dynamic changes
5033120|NCT01493466|normal|normal
5033121|NCT01493440|atosiban|atosiban
5033122|NCT01493440|clinical pregnancy|clinical pregnancy
5033123|NCT01493440|implantation rate|implantation rate
5033124|NCT01493440|uterine contractility|uterine contractility
5033125|NCT01493440|IVF-ET|ivf-et
5033126|NCT01493427|Glaucoma|glaucoma
5033127|NCT01493427|OAG|oag
5033128|NCT01493427|OHT|oht
5033129|NCT01493414|Myelofibrosis|myelofibrosis
5033130|NCT01493414|Primary myelofibrosis|primary myelofibrosis
5033131|NCT01493414|PMF|pmf
5033132|NCT01493414|Post polycythemia myelofibrosis|post polycythemia myelofibrosis
5033133|NCT01493414|PPV MF|ppv mf
5033134|NCT01493414|Post-essential thrombocythemia myelofibrosis|post-essential thrombocythemia myelofibrosis
5033135|NCT01493414|PET-MF|pet-mf
5033136|NCT01493414|INC424|inc424
5033137|NCT01493414|Ruxolitinib|ruxolitinib
5033138|NCT01493375|Contamination, hip operation, knee operation|contamination, hip operation, knee operation
5033139|NCT01493362|Bulimia Nervosa|bulimia nervosa
5033140|NCT01493362|PET Imaging|pet imaging
5033141|NCT01493362|Dopamine|dopamine
5033142|NCT01493349|Colonic diverticula|colonic diverticula
5033143|NCT01493349|Diverticulitis|diverticulitis
5033144|NCT01493323|Psychic pain|psychic pain
5033145|NCT01493323|Social exclusion|social exclusion
5033146|NCT01493323|Mood disorders|mood disorders
5033147|NCT01493323|Suicide, attempted|suicide, attempted
5033148|NCT01493323|Magnetic Resonance Imaging, Functional|magnetic resonance imaging, functional
5033149|NCT01493323|Genetic|genetic
5033150|NCT01493323|Physic pain|physic pain
5033151|NCT01493297|Retinyl palmitate, beta-carotene, stable isotopes, radio isotopes|retinyl palmitate, beta-carotene, stable isotopes, radio isotopes
5033152|NCT01493284|aortic stenosis|aortic stenosis
5033153|NCT01493284|aortic valve stenosis|aortic valve stenosis
5033154|NCT01493284|valvular heart disease|valvular heart disease
5033155|NCT01493284|aortic valve replacement|aortic valve replacement
5033156|NCT01493284|transcatheter aortic valve implantation|transcatheter aortic valve implantation
5033157|NCT01493284|TAVI|tavi
5033158|NCT01493258|Diabetes|diabetes
5033159|NCT01493258|Comparative Effectiveness Research|comparative effectiveness research
5033160|NCT01493258|Interactive computer-assisted education|interactive computer-assisted education
5033161|NCT01493258|Informatics|informatics
5033162|NCT01493245|Chronic Pain|chronic pain
5033163|NCT01493245|JNS020QD|jns020qd
5033164|NCT01493245|Fentanyl|fentanyl
5033165|NCT01493245|Opioid analgesics|opioid analgesics
5033166|NCT01493232|Lingualized occlusion|lingualized occlusion
5033167|NCT01493232|Complete denture occlusion|complete denture occlusion
5033168|NCT01493232|Fully bilateral balanced occlusion|fully bilateral balanced occlusion
5033169|NCT01493232|Patient satisfaction of complete denture|patient satisfaction of complete denture
5033170|NCT01493219|Glioblastoma|glioblastoma
5033171|NCT01493219|Glioblastoma Multiforme|glioblastoma multiforme
5033172|NCT01493219|Astrocytoma|astrocytoma
5033173|NCT01493219|Gliosarcoma|gliosarcoma
5033174|NCT01493219|Glioma WHO grade IV|glioma who grade iv
5033303|NCT01492608|preterm birth|preterm birth
5033175|NCT01493206|intraoperative radiotherapy|intraoperative radiotherapy
5033176|NCT01493167|cast|cast
5033177|NCT01493167|splint|splint
5033178|NCT01493167|circumferential casting|circumferential casting
5033179|NCT01493167|casting techniques|casting techniques
5033180|NCT01493167|fracture in extremity|fracture in extremity
5033181|NCT01493154|HPV|hpv
5033182|NCT01493154|Head and Neck Cancer|head and neck cancer
5033183|NCT01493154|Vaccine|vaccine
5033184|NCT01493154|Immunotherapy|immunotherapy
5033185|NCT01493154|Cyclophosphamide|cyclophosphamide
5033186|NCT01493154|Sexually Transmitted Diseases, Viral|sexually transmitted diseases, viral
5033187|NCT01493141|MOMHR|momhr
5033188|NCT01493141|THA|tha
5033189|NCT01493141|Osteoarthritis|osteoarthritis
5033190|NCT01493128|atrial fibrillation|atrial fibrillation
5033191|NCT01493128|atrial cells|atrial cells
5033192|NCT01493128|myocardial tissue|myocardial tissue
5033193|NCT01493128|t-tubules|t-tubules
5033194|NCT01493128|immunofluorescence|immunofluorescence
5033195|NCT01493102|septic shock|septic shock
5033196|NCT01493102|norepinephrine|norepinephrine
5033197|NCT01493102|vasopressin|vasopressin
5033198|NCT01493102|hypotension|hypotension
5033199|NCT01493076|ERCP|ercp
5033200|NCT01493076|Cannulation|cannulation
5033201|NCT01493076|Precut|precut
5033202|NCT01493076|Mini-spincterotome|mini-spincterotome
5033203|NCT01493063|preterm infant|preterm infant
5033204|NCT01493050|Diabetic Nephropathy|diabetic nephropathy
5033205|NCT01493050|Sevelamer Carbonate|sevelamer carbonate
5033206|NCT01493037|STEMI|stemi
5033207|NCT01493037|PICSO|picso
5033208|NCT01493037|Coronary Sinus|coronary sinus
5033209|NCT01493037|Involving Left Anterior Descending Coronary Artery|involving left anterior descending coronary artery
5033210|NCT01492998|Hepatitis C virus|hepatitis c virus
5033211|NCT01492998|Biliary salts|biliary salts
5033212|NCT01492998|Farnesoid X receptor|farnesoid x receptor
5033213|NCT01492998|Guggulsterone|guggulsterone
5033214|NCT01492972|Prostate|prostate
5033215|NCT01492972|proton|proton
5033216|NCT01492972|radiation|radiation
5033217|NCT01492972|intermediate risk|intermediate risk
5033218|NCT01492946|Malnutrition|malnutrition
5033219|NCT01492946|Post-operative outcome|post-operative outcome
5033220|NCT01492946|Phase angle|phase angle
5033221|NCT01492946|MUST|must
5033222|NCT01492946|Clavien Dindo classification|clavien dindo classification
5033223|NCT01492946|Bioelectrical impedance analysis|bioelectrical impedance analysis
5033224|NCT01492933|Ethanol|ethanol
5033225|NCT01492933|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
5033226|NCT01492933|Spectroscopy|spectroscopy
5033227|NCT01492933|Alcohol Use|alcohol use
5033228|NCT01492907|Heterocyclic amine carcinogens|heterocyclic amine carcinogens
5033229|NCT01492907|meat-borne carcinogens|meat-borne carcinogens
5033230|NCT01492881|relapsed multiple myeloma|relapsed multiple myeloma
5033231|NCT01492881|refractory multiple myeloma|refractory multiple myeloma
5033232|NCT01492881|vorinostat|vorinostat
5033233|NCT01492881|bortezomib|bortezomib
5033234|NCT01492881|doxil|doxil
5033235|NCT01492868|sinusitis|sinusitis
5033236|NCT01492868|upper respiratory infection|upper respiratory infection
5033237|NCT01492855|Meniscal lesions|meniscal lesions
5033238|NCT01492855|MRI|mri
5033239|NCT01492855|arthroscopic treatment|arthroscopic treatment
5033240|NCT01492829|HIV prevention|hiv prevention
5033241|NCT01492829|sexually transmitted infection prevention|sexually transmitted infection prevention
5033242|NCT01492829|HIV knowledge|hiv knowledge
5033243|NCT01492829|relationship power|relationship power
5033244|NCT01492829|depression|depression
5033245|NCT01492829|coping|coping
5033246|NCT01492829|social support|social support
5033247|NCT01492829|internally displaced persons|internally displaced persons
5033248|NCT01492829|community health worker|community health worker
5033249|NCT01492829|HIV/STI educational video|hiv/sti educational video
5033250|NCT01492829|substance use|substance use
5033251|NCT01492829|women's health|women's health
5033252|NCT01492816|HIV prevention|hiv prevention
5033253|NCT01492816|HIV positive communities|hiv positive communities
5033254|NCT01492803|HIV infection|hiv infection
5033255|NCT01492803|Probiotics|probiotics
5033256|NCT01492764|Ventricular Tachyarrhythmia|ventricular tachyarrhythmia
5033257|NCT01492764|Ablation|ablation
5033258|NCT01492764|Electrophysiology|electrophysiology
5033259|NCT01492764|Human|human
5033260|NCT01492764|Mapping|mapping
5033261|NCT01492751|Prostatic Neoplasms|prostatic neoplasms
5033262|NCT01492751|Radiotherapy conformal|radiotherapy conformal
5033263|NCT01492751|brachytherapy|brachytherapy
5033264|NCT01492751|radical prostatectomy|radical prostatectomy
5033265|NCT01492751|Quality of life|quality of life
5033371|NCT01492361|simvastatin|simvastatin
5033266|NCT01492751|biochemical relapse|biochemical relapse
5033267|NCT01492751|biochemical failure|biochemical failure
5033268|NCT01492751|survival|survival
5033269|NCT01492751|Clinically localized prostate cancer|clinically localized prostate cancer
5033270|NCT01492738|Acupuncture|acupuncture
5033271|NCT01492738|anxiety|anxiety
5033272|NCT01492738|memory|memory
5033273|NCT01492712|Propofol|propofol
5033274|NCT01492712|Pharmacokinetics|pharmacokinetics
5033275|NCT01492712|Pharmacodynamics|pharmacodynamics
5033276|NCT01492712|Infusion Pumps|infusion pumps
5033277|NCT01492699|PTSD|ptsd
5033278|NCT01492699|Post Traumatic Stress Disorder|post traumatic stress disorder
5033279|NCT01492686|Amyotrophic Lateral Sclerosis (ALS)|amyotrophic lateral sclerosis (als)
5033280|NCT01492673|Ewing's sarcoma|ewing's sarcoma
5033281|NCT01492673|BEVACIZUMAB (AVASTIN)|bevacizumab (avastin)
5033282|NCT01492673|CYCLOPHOSPHAMIDE (CYTOXAN)|cyclophosphamide (cytoxan)
5033283|NCT01492673|TOPOTECAN|topotecan
5033284|NCT01492673|11-183|11-183
5033285|NCT01492673|POETIC|poetic
5033286|NCT01492660|Ultrasonography|ultrasonography
5033287|NCT01492660|nerve block|nerve block
5033288|NCT01492660|catheters|catheters
5033289|NCT01492660|needle|needle
5033290|NCT01492660|anesthesia|anesthesia
5033291|NCT01492647|Acne vulgaris|acne vulgaris
5033292|NCT01492647|JNJ 10229570-AAA|jnj 10229570-aaa
5033293|NCT01492647|Japanese patients|japanese patients
5033294|NCT01492647|Topical treatment|topical treatment
5033295|NCT01492634|bioimpedance|bioimpedance
5033296|NCT01492634|overhydration|overhydration
5033297|NCT01492634|dry weight|dry weight
5033298|NCT01492621|major depression|major depression
5033299|NCT01492621|DTI|dti
5033300|NCT01492621|inflammatory markers|inflammatory markers
5033301|NCT01492621|cognition|cognition
5033302|NCT01492608|magnesium sulphate|magnesium sulphate
5033304|NCT01492608|cerebral palsy|cerebral palsy
5033305|NCT01492595|contact|contact
5033306|NCT01492556|Recurrent|recurrent
5033307|NCT01492556|Metastatic|metastatic
5033308|NCT01492556|Breast cancer|breast cancer
5033309|NCT01492543|Advanced|advanced
5033310|NCT01492543|Metastatic|metastatic
5033311|NCT01492543|Breast cancer|breast cancer
5033312|NCT01492530|Men who have sex with Men and Women|men who have sex with men and women
5033313|NCT01492530|HIV Prevention|hiv prevention
5033314|NCT01492530|Behavioral Intervention|behavioral intervention
5033315|NCT01492530|Condom use|condom use
5033316|NCT01492530|African American MSMW|african american msmw
5033317|NCT01492517|Controlled Human exposure study|controlled human exposure study
5033318|NCT01492517|Air Pollution|air pollution
5033319|NCT01492517|Gene expression|gene expression
5033320|NCT01492517|Epigenetic|epigenetic
5033321|NCT01492517|Cardiovascular|cardiovascular
5033322|NCT01492491|SUPRA-HFR|supra-hfr
5033323|NCT01492491|adsorpition|adsorpition
5033324|NCT01492491|vitamins|vitamins
5033325|NCT01492491|large toxins|large toxins
5033326|NCT01492465|Type 2 diabetes|type 2 diabetes
5033327|NCT01492452|guidelines for nursing|guidelines for nursing
5033328|NCT01492452|anxiety|anxiety
5033329|NCT01492452|cardiac surgery|cardiac surgery
5033330|NCT01492452|pediatrics|pediatrics
5033331|NCT01492439|Psychosis|psychosis
5033332|NCT01492439|Psychosis NOS|psychosis nos
5033333|NCT01492439|Schizophrenia|schizophrenia
5033334|NCT01492439|Schizoaffective Disorder|schizoaffective disorder
5033335|NCT01492439|Bipolar Disorder|bipolar disorder
5033336|NCT01492426|Hepatitis C Virus|hepatitis c virus
5033337|NCT01492413|Overweight|overweight
5033338|NCT01492413|Obesity|obesity
5033339|NCT01492387|community-acquired pneumonia|community-acquired pneumonia
5033340|NCT01492387|healthcare-associated pneumonia|healthcare-associated pneumonia
5033341|NCT01492387|antibiotic therapy|antibiotic therapy
5033342|NCT01492387|Duration of therapy|duration of therapy
5033343|NCT01492361|Coronary Artery Disease|coronary artery disease
5033344|NCT01492361|Myocardial Ischemia|myocardial ischemia
5033345|NCT01492361|Coronary Disease|coronary disease
5033346|NCT01492361|Heart Diseases|heart diseases
5033347|NCT01492361|Acute Coronary Syndrome|acute coronary syndrome
5033348|NCT01492361|Cardiovascular Diseases|cardiovascular diseases
5033349|NCT01492361|Arteriosclerosis|arteriosclerosis
5033350|NCT01492361|Arterial Occlusive Diseases|arterial occlusive diseases
5033351|NCT01492361|Vascular Diseases|vascular diseases
5033352|NCT01492361|Angina Pectoris|angina pectoris
5033353|NCT01492361|Chest Pain|chest pain
5033354|NCT01492361|Anticholesteremic Agents|anticholesteremic agents
5033355|NCT01492361|Hypolipidemic Agents|hypolipidemic agents
5033356|NCT01492361|Lipid Regulating Agents|lipid regulating agents
5033357|NCT01492361|hypertriglyceridemia|hypertriglyceridemia
5033358|NCT01492361|omega-3 fatty acids|omega-3 fatty acids
5033359|NCT01492361|statin|statin
5033360|NCT01492361|triglycerides|triglycerides
5033361|NCT01492361|EPA|epa
5033362|NCT01492361|docosahexaenoic acid|docosahexaenoic acid
5033363|NCT01492361|fish|fish
5033364|NCT01492361|fatty acids|fatty acids
5033365|NCT01492361|fibrates|fibrates
5033366|NCT01492361|niacin|niacin
5033367|NCT01492361|lipids|lipids
5033368|NCT01492361|lipoprotein|lipoprotein
5033369|NCT01492361|atorvastatin|atorvastatin
5033370|NCT01492361|Lovaza|lovaza
5033372|NCT01492361|lovastatin|lovastatin
5033373|NCT01492361|pravastatin|pravastatin
5033374|NCT01492361|fluvastatin|fluvastatin
5033375|NCT01492361|rosuvastatin|rosuvastatin
5033376|NCT01492361|Trilipix|trilipix
5033377|NCT01492361|Vytorin|vytorin
5033378|NCT01492361|Simcor|simcor
5033379|NCT01492361|ezetimibe|ezetimibe
5033380|NCT01492361|Zetia|zetia
5033381|NCT01492361|ethyl-EPA|ethyl-epa
5033382|NCT01492361|ethyl icosapentate|ethyl icosapentate
5033383|NCT01492361|Crestor|crestor
5033384|NCT01492361|Zocor|zocor
5033385|NCT01492361|Lipitor|lipitor
5033386|NCT01492361|LDL|ldl
5033387|NCT01492361|HDL|hdl
5033388|NCT01492361|cholesterol|cholesterol
5033389|NCT01492361|dyslipidemia|dyslipidemia
5033390|NCT01492361|AMR101|amr101
5033391|NCT01492361|Cardiovascular Disease, Unspecified|cardiovascular disease, unspecified
5033392|NCT01492361|VASCEPA|vascepa
5033393|NCT01492361|icosapent ethyl|icosapent ethyl
5033394|NCT01492348|collaborative care|collaborative care
5033395|NCT01492348|PTSD|ptsd
5033396|NCT01492348|military|military
5033397|NCT01492348|Depression|depression
5033398|NCT01492348|primary care|primary care
5033399|NCT01492348|care management|care management
5033400|NCT01492348|stepped care|stepped care
5033401|NCT01492348|telehealth|telehealth
5033402|NCT01492348|OIF|oif
5033403|NCT01492348|OEF|oef
5033404|NCT01492348|preference-based treatment|preference-based treatment
5033405|NCT01492348|cost effectiveness|cost effectiveness
5033406|NCT01492348|web-based treatment|web-based treatment
5033407|NCT01492348|telephonic CBT|telephonic cbt
5033408|NCT01492348|evidence-based treatment|evidence-based treatment
5033409|NCT01492335|Cognitive decline|cognitive decline
5033410|NCT01492335|Cognitive impairment|cognitive impairment
5033411|NCT01492322|Smoker|smoker
5033412|NCT01492322|SPECT|spect
5033413|NCT01492322|Dopamine|dopamine
5033414|NCT01492322|Nicotine Sated condition|nicotine sated condition
5033415|NCT01492322|Nicotine withdrawal condition|nicotine withdrawal condition
5033416|NCT01492309|Major Depressive Disorder|major depressive disorder
5033417|NCT01492309|Pregnancy|pregnancy
5033418|NCT01492309|Brain Derived Neurotrophic Factor|brain derived neurotrophic factor
5033419|NCT01492309|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
5033420|NCT01492283|NAFLD|nafld
5033421|NCT01492283|Incretin hormones|incretin hormones
5033422|NCT01492270|Prostate Cancer|prostate cancer
5033423|NCT01492270|Multi parametric MRI|multi parametric mri
5033424|NCT01492270|Prostate HistoScanning|prostate histoscanning
5033425|NCT01492270|Transperineal prostate mapping biopsy|transperineal prostate mapping biopsy
5033426|NCT01492257|shared decision making|shared decision making
5033427|NCT01492257|decision aids|decision aids
5033428|NCT01492257|total joint arthroplasty|total joint arthroplasty
5033429|NCT01492257|osteoarthritis|osteoarthritis
5033430|NCT01492244|Knee pain|knee pain
5033431|NCT01492244|map|map
5033432|NCT01492244|questionnaire|questionnaire
5033433|NCT01492244|survey|survey
5033434|NCT01492231|gastroenterology|gastroenterology
5033435|NCT01492231|Endoscopy, Digestive System|endoscopy, digestive system
5033436|NCT01492231|Endosonography|endosonography
5033437|NCT01492231|Endoscopic Retrograde Cholangiopancreatography|endoscopic retrograde cholangiopancreatography
5033438|NCT01492231|gastrointestinal endoscopy|gastrointestinal endoscopy
5033439|NCT01492192|Angiogenesis|angiogenesis
5033440|NCT01492192|PET-CT|pet-ct
5033441|NCT01492192|Perfusion-CT|perfusion-ct
5033442|NCT01492179|Surgery: Abdominal hysterectomy|surgery: abdominal hysterectomy
5033443|NCT01492179|Anesthetics: Local|anesthetics: local
5033444|NCT01492179|Postoperative: Pain|postoperative: pain
5033445|NCT01492179|Drugs: Morphine|drugs: morphine
5033446|NCT01492127|Hepatocellular carcinoma|hepatocellular carcinoma
5033447|NCT01492127|cirrhosis|cirrhosis
5033448|NCT01492127|proteasome|proteasome
5033449|NCT01492127|alpha-fetoprotein|alpha-fetoprotein
5033450|NCT01492114|C-reactive protein|c-reactive protein
5033451|NCT01492114|Resveratrol|resveratrol
5033452|NCT01492114|Redox index|redox index
5033453|NCT01492088|Pediatric|pediatric
5033454|NCT01492088|Lymphoma|lymphoma
5033455|NCT01492088|Hodgkin|hodgkin
5033456|NCT01492088|Anaplastic Large-cell|anaplastic large-cell
5033457|NCT01492088|Relapsed|relapsed
5033458|NCT01492088|Refractory|refractory
5033459|NCT01492088|Drug therapy|drug therapy
5033460|NCT01492075|Postoperative pain|postoperative pain
5033461|NCT01492075|Anesthetics: Local anesthetics|anesthetics: local anesthetics
5033462|NCT01492075|Surgery: Hysterectomy|surgery: hysterectomy
5033463|NCT01492062|Type 1 diabetes mellitus|type 1 diabetes mellitus
5033464|NCT01492062|artificial pancreas|artificial pancreas
5033465|NCT01492062|closed-loop|closed-loop
5033466|NCT01492049|Colorectal Neoplasms|colorectal neoplasms
5033467|NCT01492049|Promoting Health Literacy|promoting health literacy
5033468|NCT01492049|Patient education program|patient education program
5033469|NCT01492049|Colorectal Cancer Screening|colorectal cancer screening
5033470|NCT01492049|CRCS|crcs
5033471|NCT01492049|Patient decision aid|patient decision aid
5033472|NCT01492049|PtDA|ptda
5033473|NCT01492049|Video|video
5033474|NCT01492049|Questionnaires|questionnaires
5033475|NCT01492049|Surveys|surveys
5033476|NCT01492036|Replication-Competent Retrovirus|replication-competent retrovirus
5033477|NCT01492036|RCR|rcr
5033478|NCT01492036|Gene transfer therapy|gene transfer therapy
5033479|NCT01492036|Registry|registry
5033480|NCT01492036|Medical information database|medical information database
5033481|NCT01492036|Vector or vector-treated cells|vector or vector-treated cells
5033482|NCT01492036|Blood draw|blood draw
5033483|NCT01492036|Computed tomography|computed tomography
5033484|NCT01492036|CT|ct
5033485|NCT01492036|Questionnaires|questionnaires
5033486|NCT01492036|Surveys|surveys
5033487|NCT01492036|Gene Transfer Research|gene transfer research
5033488|NCT01492036|National Gene Vector Biorepository and Coordinating Center|national gene vector biorepository and coordinating center
5033489|NCT01492036|NGVB|ngvb
5033490|NCT01492023|neuropsychological|neuropsychological
5033491|NCT01492023|rehabilitation|rehabilitation
5033492|NCT01492023|multiple sclerosis|multiple sclerosis
5033493|NCT01492023|RCT study|rct study
5033494|NCT01492010|skeletal muscle|skeletal muscle
5033495|NCT01492010|FSR|fsr
5033496|NCT01492010|resistance exercise|resistance exercise
5033497|NCT01492010|leucine|leucine
5033498|NCT01492010|protein|protein
5033499|NCT01491958|Leukemia|leukemia
5033500|NCT01491958|AML|aml
5033501|NCT01491958|ALL|all
5033502|NCT01491958|MDS|mds
5033503|NCT01491945|Abdominal aortic aneurysm|abdominal aortic aneurysm
5033504|NCT01491945|Renal stent|renal stent
5033505|NCT01491945|Juxtarenal|juxtarenal
5033506|NCT01491945|Pararenal|pararenal
5033507|NCT01491945|Endovascular|endovascular
5033508|NCT01491932|Parkinson Disease|parkinson disease
5033509|NCT01491932|L-dopa|l-dopa
5033510|NCT01491932|Levodopa|levodopa
5033511|NCT01491932|Dyskinesia|dyskinesia
5033512|NCT01491919|High Blood Pressure|high blood pressure
5033513|NCT01491919|Hypertension|hypertension
5033514|NCT01491919|Renal Transplantation|renal transplantation
5033515|NCT01491919|Kidney Transplantation|kidney transplantation
5033516|NCT01491893|GBM|gbm
5033517|NCT01491893|Brain Tumor|brain tumor
5033518|NCT01491893|Poliovirus Vaccine|poliovirus vaccine
5033519|NCT01491893|WHO Grade IV Malignant Glioma|who grade iv malignant glioma
5033520|NCT01491880|cognitive behavior therapy|cognitive behavior therapy
5033521|NCT01491880|telemedicine|telemedicine
5033522|NCT01491880|rural|rural
5033523|NCT01491880|Latinos|latinos
5033524|NCT01491880|children|children
5033525|NCT01491867|intraocular pressure|intraocular pressure
5033526|NCT01491854|Long-term|long-term
5033527|NCT01491854|safety|safety
5033528|NCT01491854|follow-up|follow-up
5033529|NCT01491854|growth hormone treatment|growth hormone treatment
5033530|NCT01491854|short children|short children
5033531|NCT01491854|Small for Gestational Age|small for gestational age
5033532|NCT01491854|Somatropin|somatropin
5033533|NCT01491828|Apnea|apnea
5033534|NCT01491828|Sleep apnea|sleep apnea
5033535|NCT01491828|Snoring|snoring
5033536|NCT01491828|Hypoglossal nerve stimulation|hypoglossal nerve stimulation
5033537|NCT01491828|Laynx stimulation|laynx stimulation
5033538|NCT01491802|COPD|copd
5033539|NCT01491802|Combination therapy|combination therapy
5033540|NCT01491802|Anticholinergic|anticholinergic
5033541|NCT01491802|Beta2-agonist|beta2-agonist
5033542|NCT01491802|Exercise|exercise
5033543|NCT01491802|Dyspnea|dyspnea
5033544|NCT01491802|Respiratory mechanics|respiratory mechanics
5033545|NCT01491789|spinal cord injury|spinal cord injury
5033546|NCT01491789|Virtual sailing|virtual sailing
5033547|NCT01491789|Vsail|vsail
5033548|NCT01491776|Group A Streptococcus|group a streptococcus
5033549|NCT01491776|Strep A|strep a
5033550|NCT01491776|Rapid Test|rapid test
5033551|NCT01491776|Pharyngitis|pharyngitis
5033552|NCT01491750|SURGERY|surgery
5033553|NCT01491750|TOTAL JOINT REPLACEMENT|total joint replacement
5033554|NCT01491750|TOTAL KNEE REPLACEMENT|total knee replacement
5033555|NCT01491750|GUIDED IMAGERY|guided imagery
5033556|NCT01491750|COMPLEMENTARY AND ALTERNATIVE THERAPY|complementary and alternative therapy
5033557|NCT01491711|Superficial basal cell carcinoma|superficial basal cell carcinoma
5033558|NCT01491711|Carcinoma, Basal Cell|carcinoma, basal cell
5033559|NCT01491711|Skin diseases|skin diseases
5033560|NCT01491711|Connective tissue diseases|connective tissue diseases
5033561|NCT01491711|Treatment|treatment
5033562|NCT01491711|Drug therapy|drug therapy
5033563|NCT01491711|Efficacy|efficacy
5033564|NCT01491711|Photodynamic therapy|photodynamic therapy
5033565|NCT01491711|Photosensitizing Agents/therapeutic use|photosensitizing agents/therapeutic use
5033566|NCT01491711|Aminolevulinic acid|aminolevulinic acid
5033567|NCT01491711|Methylaminolevulinate|methylaminolevulinate
5033568|NCT01491711|Pain measurement|pain measurement
5033569|NCT01491711|Health Care Economics and Organizations|health care economics and organizations
5033570|NCT01491698|stomach|stomach
5033571|NCT01491698|surgery|surgery
5033572|NCT01491698|Total Gastrectomy|total gastrectomy
5033573|NCT01491698|Roux-En-Y Pouch Reconstruction|roux-en-y pouch reconstruction
5033574|NCT01491698|Conventional Roux-En-Y Reconstruction|conventional roux-en-y reconstruction
5033575|NCT01491698|Quality of Life|quality of life
5033576|NCT01491698|11-170|11-170
5033577|NCT01491672|Metastatic Renal Cell Carcinoma|metastatic renal cell carcinoma
5033578|NCT01491672|Second Line|second line
5033579|NCT01491672|Everolimus|everolimus
5033580|NCT01491672|RAD001|rad001
5033581|NCT01491646|pulmonary hypertension|pulmonary hypertension
5033582|NCT01491646|cardiac magnetic resonance imaging|cardiac magnetic resonance imaging
5033583|NCT01491646|Characterize and quantify RV vortex flow|characterize and quantify rv vortex flow
5033584|NCT01491646|Assess feasibility of cardiac MR for RVDD diagnosis|assess feasibility of cardiac mr for rvdd diagnosis
5033585|NCT01491646|Biomarker information to help diagnose|biomarker information to help diagnose
5033586|NCT01491633|Lung cancer|lung cancer
5033587|NCT01491633|NSCLC|nsclc
5033588|NCT01491633|Stage IIIB|stage iiib
5033589|NCT01491633|Stage IV|stage iv
5033590|NCT01491620|poikiloderma of Civatte|poikiloderma of civatte
5033591|NCT01491620|red dyschromia|red dyschromia
5033592|NCT01491620|brown dyschromia|brown dyschromia
5033593|NCT01491620|sun damage|sun damage
5033594|NCT01491620|neck|neck
5033595|NCT01491620|chest|chest
5033596|NCT01491620|dyschromia|dyschromia
5033597|NCT01491620|pigmentation disorders|pigmentation disorders
5033598|NCT01491620|erythema|erythema
5033599|NCT01491620|photosensitivity disorders|photosensitivity disorders
5033600|NCT01491620|sun exposure|sun exposure
5033601|NCT01491620|telangiectasia|telangiectasia
5033602|NCT01491620|hyperpigmentation|hyperpigmentation
5033603|NCT01491620|hypopigmentation|hypopigmentation
5033604|NCT01491607|post-exposure prophylaxis|post-exposure prophylaxis
5033605|NCT01491607|toxin neutralization assay|toxin neutralization assay
5033606|NCT01491594|Metastatic sarcoma|metastatic sarcoma
5033607|NCT01491594|Bone sarcoma|bone sarcoma
5033608|NCT01491581|anthropometry|anthropometry
5033609|NCT01491581|zinc|zinc
5033610|NCT01491581|iodine|iodine
5033611|NCT01491581|vitamin D|vitamin d
5033612|NCT01491581|calcium|calcium
5033613|NCT01491581|school children|school children
5033614|NCT01491581|food supplement|food supplement
5033615|NCT01491568|symptomatic degenerative disc disease at two levels|symptomatic degenerative disc disease at two levels
5033616|NCT01491555|Duchenne Muscular Dystrophy|duchenne muscular dystrophy
5033617|NCT01491555|DMD|dmd
5033618|NCT01491555|controls|controls
5033619|NCT01491555|EIM|eim
5033620|NCT01491555|QUS|qus
5033621|NCT01491542|Symptomatic Degenerative Disc Disease|symptomatic degenerative disc disease
5033622|NCT01491529|Parkinson Disease|parkinson disease
5033623|NCT01491529|L-dopa|l-dopa
5033624|NCT01491529|Levodopa|levodopa
5033625|NCT01491529|Dyskinesia|dyskinesia
5033626|NCT01491529|Amantadine|amantadine
5033627|NCT01491516|Lumbar degenerative disc disease|lumbar degenerative disc disease
5033628|NCT01491503|montelukast|montelukast
5033629|NCT01491503|levocetirizine|levocetirizine
5033630|NCT01491503|interaction|interaction
5033631|NCT01491490|Schizophrenia|schizophrenia
5033632|NCT01491490|Functional psychosis|functional psychosis
5033633|NCT01491490|Schizophreniform|schizophreniform
5033634|NCT01491490|Acute psychosis|acute psychosis
5033635|NCT01491464|symptomatic degenerative disc disease|symptomatic degenerative disc disease
5033636|NCT01491451|Degenerative lumbar disc disease|degenerative lumbar disc disease
5033637|NCT01491425|symptomatic degenerative disc disease|symptomatic degenerative disc disease
5033638|NCT01491412|Schizophrenia|schizophrenia
5033639|NCT01491412|antipsychotics|antipsychotics
5033640|NCT01491412|real life treatment|real life treatment
5033641|NCT01491412|non-interventional|non-interventional
5033642|NCT01491386|symptomatic degenerative disc disease|symptomatic degenerative disc disease
5033643|NCT01491373|Degenerative Disc Disease|degenerative disc disease
5033644|NCT01491373|Symptomatic Degenerative Disc Disease|symptomatic degenerative disc disease
5033645|NCT01491360|Presbyopia|presbyopia
5033646|NCT01491360|sclera|sclera
5033647|NCT01491360|LaserACE|laserace
5033648|NCT01491347|BDNF|bdnf
5033649|NCT01491347|withdrawal|withdrawal
5033650|NCT01491347|alcohol|alcohol
5033651|NCT01491347|psychiatry|psychiatry
5033652|NCT01491334|POP|pop
5033653|NCT01491334|Pelvic Floor|pelvic floor
5033654|NCT01491334|Pelvic Organ Prolapse|pelvic organ prolapse
5033655|NCT01491321|chronic low back pain|chronic low back pain
5033656|NCT01491321|bee venom acupuncture|bee venom acupuncture
5033657|NCT01491295|Lamivudine|lamivudine
5033658|NCT01491295|adefovir add on treatment|adefovir add on treatment
5033659|NCT01491295|tenofovir|tenofovir
5033660|NCT01491295|chronic hepatitis B|chronic hepatitis b
5033661|NCT01491282|human brown adipose tissue activity|human brown adipose tissue activity
5033662|NCT01491282|obesity|obesity
5033663|NCT01491282|energy metabolism|energy metabolism
5033664|NCT01491282|adaptive thermogenesis|adaptive thermogenesis
5033665|NCT01491269|chronic pain|chronic pain
5033666|NCT01491269|internet delivered CBT|internet delivered cbt
5033667|NCT01491269|tertiary intervention|tertiary intervention
5033668|NCT01491269|mindfulness|mindfulness
5033669|NCT01491269|applied relaxation|applied relaxation
5033670|NCT01491269|guided self help|guided self help
5033671|NCT01491256|Index of microcirculatory resistance|index of microcirculatory resistance
5033672|NCT01491256|atorvastatin|atorvastatin
5033673|NCT01491256|drug-eluting stent|drug-eluting stent
5033674|NCT01491256|acute coronary syndrome|acute coronary syndrome
5033675|NCT01491243|contrast-induced nephropathy|contrast-induced nephropathy
5033676|NCT01491230|cancer|cancer
5033677|NCT01491230|neutrophil extracellular traps|neutrophil extracellular traps
5033678|NCT01491230|autologous hematopoietic stem cell transplantation|autologous hematopoietic stem cell transplantation
5033679|NCT01491230|allogeneic hematopoietic stem cell transplantation|allogeneic hematopoietic stem cell transplantation
5033680|NCT01491230|chemotaxis|chemotaxis
5033681|NCT01491230|superoxide production|superoxide production
5033682|NCT01491230|hydrogen peroxide production|hydrogen peroxide production
5033683|NCT01491230|myeloperoxidase|myeloperoxidase
5033684|NCT01491217|Oraxol®|oraxol®
5033685|NCT01491217|oral paclitaxel|oral paclitaxel
5033686|NCT01491217|paclitaxel|paclitaxel
5033687|NCT01491217|HM30181A|hm30181a
5033689|NCT01491217|DLT|dlt
5033690|NCT01491217|RD|rd
5033691|NCT01491191|surgical pain|surgical pain
5033692|NCT01491191|chronic pain|chronic pain
5033693|NCT01491191|prevention|prevention
5033694|NCT01491191|palmitoylethanolamide|palmitoylethanolamide
5033695|NCT01491165|umbilical cord mesenchyma stem cell|umbilical cord mesenchyma stem cell
5033696|NCT01491152|Cerebral Palsy|cerebral palsy
5033697|NCT01491152|Whole Body Vibration|whole body vibration
5033698|NCT01491152|Infant|infant
5033699|NCT01491152|Motor development|motor development
5033700|NCT01491152|Physiotherapy|physiotherapy
5033701|NCT01491139|Radiotherapy|radiotherapy
5033702|NCT01491139|Biomarkers, pharmacological|biomarkers, pharmacological
5033703|NCT01491139|Pharmacokinetics|pharmacokinetics
5033704|NCT01491139|Genetic Markers|genetic markers
5033705|NCT01491139|Cisplatin|cisplatin
5033706|NCT01491139|Poly(ADP-ribose) Polymerases|poly(adp-ribose) polymerases
5033707|NCT01491139|AZD 2281|azd 2281
5033708|NCT01491139|Radiotherapy, Intensity-Modulated|radiotherapy, intensity-modulated
5033709|NCT01491139|Head and Neck|head and neck
5033710|NCT01491139|Chemoradiotherapy|chemoradiotherapy
5033711|NCT01491139|SCC|scc
5033712|NCT01491126|Gastroscopy|gastroscopy
5033713|NCT01491126|Colonoscopy|colonoscopy
5033714|NCT01491126|Anesthesia|anesthesia
5033715|NCT01491126|Recovery|recovery
5033716|NCT01491113|Levetiracetam|levetiracetam
5033717|NCT01491113|Oral administration|oral administration
5033718|NCT01491113|Japanese|japanese
5033719|NCT01491113|Non-epileptic|non-epileptic
5033720|NCT01491113|Healthy|healthy
5033721|NCT01491113|Renal impaired subjects|renal impaired subjects
5033722|NCT01491100|Cognition|cognition
5033723|NCT01491100|Physical Activity|physical activity
5033724|NCT01491100|Relapsing Remitting Multiple Sclerosis|relapsing remitting multiple sclerosis
5033725|NCT01491087|Pentaxim®|pentaxim®
5033726|NCT01491087|Whole-cell Pertussis vaccine|whole-cell pertussis vaccine
5033727|NCT01491087|Acellular Pertussis vaccine|acellular pertussis vaccine
5033728|NCT01491087|Haemophilus influenzae type b polysaccharide|haemophilus influenzae type b polysaccharide
5033729|NCT01491087|Inactivated Polio vaccine|inactivated polio vaccine
5033730|NCT01491087|Pentavac®|pentavac®
5033731|NCT01491061|periprocedural myocardial infarction|periprocedural myocardial infarction
5033732|NCT01491061|ranolazine|ranolazine
5033733|NCT01491048|Hip osteoarthritis|hip osteoarthritis
5033734|NCT01491048|Physiotherapy|physiotherapy
5033735|NCT01491048|THA|tha
5033736|NCT01491035|Children|children
5033737|NCT01491035|Adolescents|adolescents
5033738|NCT01491035|Pharmacokinetic|pharmacokinetic
5033739|NCT01491035|Pharmacodynamic|pharmacodynamic
5033740|NCT01491022|parkinson's|parkinson's
5033741|NCT01491022|gait dysfunction|gait dysfunction
5033742|NCT01491022|ampyra|ampyra
5033743|NCT01491022|4-aminopyridine|4-aminopyridine
5033744|NCT01491009|Dexmedetomidine|dexmedetomidine
5033745|NCT01491009|midazolam|midazolam
5033746|NCT01491009|remifentanil|remifentanil
5033747|NCT01491009|mini-mental state examination|mini-mental state examination
5033748|NCT01491009|monitored anaesthesia care|monitored anaesthesia care
5033749|NCT01491009|cystoscopy|cystoscopy
5033750|NCT01491009|sedation|sedation
5033751|NCT01490996|Curcumin|curcumin
5033752|NCT01490996|Colorectal cancer|colorectal cancer
5033753|NCT01490996|metastases|metastases
5033754|NCT01490996|FOLFOX|folfox
5033755|NCT01490983|Chronic Myeloid Leukemia|chronic myeloid leukemia
5033756|NCT01490983|Chronic Phase CML|chronic phase cml
5033757|NCT01490970|Sarcoma Database|sarcoma database
5033758|NCT01490957|HD|hd
5033759|NCT01490957|NHL|nhl
5033760|NCT01490931|acute pain|acute pain
5033761|NCT01490931|dental pain|dental pain
5033762|NCT01490931|intranasal ketorolac|intranasal ketorolac
5033763|NCT01490931|dental implant surgery|dental implant surgery
5033764|NCT01490918|Type-II diabetes mellitus|type-ii diabetes mellitus
5033765|NCT01490918|Acarbose|acarbose
5033766|NCT01490918|ACADEMIC|academic
5033767|NCT01490905|Medical food|medical food
5033768|NCT01490905|Theramine|theramine
5033769|NCT01490905|Ibuprofen|ibuprofen
5033770|NCT01490905|Amino acids|amino acids
5033771|NCT01490905|Convenience Pack Kit|convenience pack kit
5033772|NCT01490892|breast abnormality|breast abnormality
5033773|NCT01490892|ultrasound imaging|ultrasound imaging
5033774|NCT01490892|ultrasound contrast agent|ultrasound contrast agent
5033775|NCT01490892|subharmonic imaging|subharmonic imaging
5033776|NCT01490879|DFU|dfu
5033777|NCT01490879|Diabetic Foot Ulcer|diabetic foot ulcer
5033778|NCT01490879|Ulcers|ulcers
5033779|NCT01490879|Foot Ulcers|foot ulcers
5033780|NCT01490879|chronic wound|chronic wound
5033781|NCT01490879|wounds|wounds
5033782|NCT01490879|Nexagon|nexagon
5033783|NCT01490879|CoDa|coda
5033784|NCT01490866|Colorectal Cancer|colorectal cancer
5033785|NCT01490866|Axitinib|axitinib
5033786|NCT01490866|FOLFOX/Bevacizumab|folfox/bevacizumab
5033787|NCT01490853|Ph pos CML|ph pos cml
5033788|NCT01490853|Philadelphia positive Chronic Myeloid Leukemia|philadelphia positive chronic myeloid leukemia
5033789|NCT01490840|Fatigue|fatigue
5033790|NCT01490840|MS|ms
5033791|NCT01490840|Multiple Sclerosis|multiple sclerosis
5033792|NCT01490840|Exercise|exercise
5033793|NCT01490840|Physical activity|physical activity
5033794|NCT01490840|Physical training|physical training
5033795|NCT01490840|Fingolimod|fingolimod
5033796|NCT01490814|PAF|paf
5033797|NCT01490814|two episodes within the last twelve months one episode documented|two episodes within the last twelve months one episode documented
5033798|NCT01490814|Documented treatment failure of at least one antiarrhythmic|documented treatment failure of at least one antiarrhythmic
5033799|NCT01490814|drug AAD Type I or III including β-blocker and AAD intolerance|drug aad type i or iii including β-blocker and aad intolerance
5033800|NCT01490801|childhood Hodgkin lymphoma|childhood hodgkin lymphoma
5033801|NCT01490801|childhood mixed cellularity Hodgkin lymphoma|childhood mixed cellularity hodgkin lymphoma
5033802|NCT01490801|hemophagocytic lymphohistiocytosis|hemophagocytic lymphohistiocytosis
5033803|NCT01490801|Epstein-Barr virus infection|epstein-barr virus infection
5033804|NCT01490775|Chronic Myeloid Leukemia|chronic myeloid leukemia
5033805|NCT01490762|PK|pk
5033806|NCT01490762|PD|pd
5033807|NCT01490749|Esophageal Cancer|esophageal cancer
5033808|NCT01490749|Neoplasms, Esophageal|neoplasms, esophageal
5033809|NCT01490736|Acne|acne
5033810|NCT01490736|Sebum gland disease|sebum gland disease
5033811|NCT01490723|Leukemia|leukemia
5033812|NCT01490723|Chronic lymphocytic leukemia|chronic lymphocytic leukemia
5033813|NCT01490723|Lymphoma|lymphoma
5033814|NCT01490723|CD20+ lymphoid malignancies|cd20+ lymphoid malignancies
5033815|NCT01490723|Diffuse large B-cell lymphoma|diffuse large b-cell lymphoma
5033816|NCT01490723|Allogeneic transplantation|allogeneic transplantation
5033817|NCT01490723|Rituximab|rituximab
5033818|NCT01490723|Rituxan|rituxan
5033819|NCT01490723|In ibritumomab|in ibritumomab
5033820|NCT01490723|Y ibritumomab|y ibritumomab
5033821|NCT01490723|Zevalin|zevalin
5033822|NCT01490723|Fludarabine Phosphate|fludarabine phosphate
5033823|NCT01490723|Fludara|fludara
5033824|NCT01490723|Bendamustine Hydrochloride|bendamustine hydrochloride
5033825|NCT01490723|Bendamustine HCL|bendamustine hcl
5033826|NCT01490723|CEP-18083|cep-18083
5033827|NCT01490723|SDX-105|sdx-105
5033828|NCT01490723|Treanda|treanda
5033829|NCT01490723|Stem Cell Transplantation|stem cell transplantation
5033830|NCT01490723|Planar Scintigraphy|planar scintigraphy
5033831|NCT01490723|Spect Scan|spect scan
5033832|NCT01490723|Single Photon Emission-Computed Tomography|single photon emission-computed tomography
5033833|NCT01490723|CT Scan|ct scan
5033834|NCT01490723|Computed Tomography|computed tomography
5033835|NCT01490723|G-CSF|g-csf
5033836|NCT01490723|Filgrastim|filgrastim
5033837|NCT01490723|Neupogen|neupogen
5033838|NCT01490723|Thymoglobulin|thymoglobulin
5033839|NCT01490723|ATG|atg
5033840|NCT01490723|Antithymocyte Globulin|antithymocyte globulin
5033841|NCT01490723|Methotrexate|methotrexate
5033842|NCT01490723|Mycophenolate|mycophenolate
5033843|NCT01490723|MMF|mmf
5033844|NCT01490723|Mycophenolate Mofetil|mycophenolate mofetil
5033845|NCT01490723|CellCept|cellcept
5033846|NCT01490723|Tacrolimus|tacrolimus
5033847|NCT01490723|Prograf|prograf
5033848|NCT01490710|NAVA|nava
5033849|NCT01490710|Hemodynamic|hemodynamic
5033850|NCT01490710|Cardiac Index|cardiac index
5033851|NCT01490710|Children with admission weight > 5kg|children with admission weight > 5kg
5033852|NCT01490697|stress disorders|stress disorders
5033853|NCT01490697|posttraumatic|posttraumatic
5033854|NCT01490697|memory|memory
5033855|NCT01490697|mifepristone|mifepristone
5033856|NCT01490697|d-cycloserine|d-cycloserine
5033857|NCT01490697|psychophysiology|psychophysiology
5033858|NCT01490684|candidiasis|candidiasis
5033859|NCT01490684|critically ill|critically ill
5033860|NCT01490684|outcomes|outcomes
5033861|NCT01490645|ACS patients participating in a SCP|acs patients participating in a scp
5033862|NCT01490645|QoL after ACS|qol after acs
5033863|NCT01490645|ASC Patients's needs|asc patients's needs
5033864|NCT01490632|Moderate|moderate
5033865|NCT01490632|Severe|severe
5033866|NCT01490632|Plaque|plaque
5033867|NCT01490632|Chronic|chronic
5033868|NCT01490619|Type 1 diabetes|type 1 diabetes
5033869|NCT01490619|Adolescent|adolescent
5033870|NCT01490619|Resilience|resilience
5033871|NCT01490619|Prevention|prevention
5033872|NCT01490619|Depression|depression
5033873|NCT01490593|Canadian|canadian
5033874|NCT01490593|Eye|eye
5033875|NCT01490593|Injury|injury
5033876|NCT01490593|Registry|registry
5033877|NCT01490580|Pain|pain
5033878|NCT01490580|Newborn|newborn
5033879|NCT01490580|Anaesthesia|anaesthesia
5033880|NCT01490580|opioids|opioids
5033881|NCT01490580|propofol|propofol
5033882|NCT01490580|neuromuscular blocker|neuromuscular blocker
5033883|NCT01490580|atropine|atropine
5033884|NCT01490567|Impaired Cognition Schizophrenia|impaired cognition schizophrenia
5033885|NCT01490554|Skin aging|skin aging
5033886|NCT01490554|fibroblasts|fibroblasts
5033887|NCT01490554|transplantation|transplantation
5033888|NCT01490554|autologous|autologous
5033889|NCT01490541|Gastric intestinal metaplasia|gastric intestinal metaplasia
5033890|NCT01490528|Pediatric IBD|pediatric ibd
5033891|NCT01490515|non-invasive,|non-invasive,
5033892|NCT01490515|metabolomics,|metabolomics,
5033893|NCT01490515|morphology,|morphology,
5033894|NCT01490515|embryo selection,|embryo selection,
5033895|NCT01490515|implantation rates|implantation rates
5033896|NCT01490489|EG-VEGF|eg-vegf
5033897|NCT01490489|Endocrine Gland-derived Vascular Endothelial Growth Factor|endocrine gland-derived vascular endothelial growth factor
5033898|NCT01490489|Pre-eclampsia|pre-eclampsia
5033899|NCT01490489|intra-uterine growth retardation|intra-uterine growth retardation
5033900|NCT01490489|prognosis|prognosis
5033901|NCT01490476|Neurofibromatosis Type 2 with Vestibular Schwannoma|neurofibromatosis type 2 with vestibular schwannoma
5033902|NCT01490476|Vestibular Schwannoma|vestibular schwannoma
5033903|NCT01490476|Peripheral Nervous System Diseases|peripheral nervous system diseases
5033904|NCT01490476|Otorhinolaryngologic Diseases|otorhinolaryngologic diseases
5033905|NCT01490476|Vestibulocochlear Nerve Diseases|vestibulocochlear nerve diseases
5033906|NCT01490463|Treatment of|treatment of
5033907|NCT01490437|Advanced urothelial carcinoma|advanced urothelial carcinoma
5033908|NCT01490424|TREM-1;|trem-1;
5033909|NCT01490424|SNPs;|snps;
5033910|NCT01490424|prognosis|prognosis
5033911|NCT01490424|control（normal person）|control（normal person）
5033912|NCT01490411|Specific immunotherapy|specific immunotherapy
5033913|NCT01490411|SIT|sit
5033914|NCT01490411|SCIT|scit
5033915|NCT01490411|recombinant|recombinant
5033916|NCT01490398|Hypertension|hypertension
5033917|NCT01490398|Rosuvastatin|rosuvastatin
5033918|NCT01490398|Coronary flow reserve|coronary flow reserve
5033919|NCT01490359|human immunodeficiency virus|human immunodeficiency virus
5033920|NCT01490359|randomized controlled trial|randomized controlled trial
5033921|NCT01490359|intervention studies|intervention studies
5033922|NCT01490359|South Africa|south africa
5033923|NCT01490359|men|men
5033924|NCT01490359|sexually behavior|sexually behavior
5033925|NCT01490359|social cognitive theory|social cognitive theory
5033926|NCT01490346|HIV 1|hiv 1
5033927|NCT01490346|Pharmacokinetics|pharmacokinetics
5033928|NCT01490346|Drug levels|drug levels
5033929|NCT01490346|Treatment naive|treatment naive
5033930|NCT01490320|Violence prevention|violence prevention
5033931|NCT01490320|Media|media
5033932|NCT01490320|Primary care|primary care
5033933|NCT01490320|Parenting|parenting
5033934|NCT01490307|parenting intervention|parenting intervention
5033935|NCT01490307|Family Check-Up|family check-up
5033936|NCT01490307|Anxiety Disorders|anxiety disorders
5033937|NCT01490307|Depression|depression
5033938|NCT01490307|Depressive Disorder|depressive disorder
5033939|NCT01490307|Conduct Disorder|conduct disorder
5033940|NCT01490307|Mental Disorders|mental disorders
5033941|NCT01490307|Behavioral Symptoms|behavioral symptoms
5033942|NCT01490307|Mood Disorders|mood disorders
5033943|NCT01490307|Mental Disorders Diagnosed in Childhood|mental disorders diagnosed in childhood
5033944|NCT01490307|Substance-Related Disorders|substance-related disorders
5033945|NCT01490294|Cardiac MRI|cardiac mri
5033946|NCT01490294|gadobutrol|gadobutrol
5033947|NCT01490281|Fibromyalgia|fibromyalgia
5033948|NCT01490281|exercise|exercise
5033949|NCT01490281|physical activity|physical activity
5033950|NCT01490281|pain|pain
5033951|NCT01490268|Pharmacokinetic-pharmacodynamic modeling|pharmacokinetic-pharmacodynamic modeling
5033952|NCT01490268|Patient-controlled analgesia|patient-controlled analgesia
5033953|NCT01490268|Target-controlled infusion|target-controlled infusion
5033954|NCT01490268|Hydromorphone|hydromorphone
5033955|NCT01490268|Sufentanil|sufentanil
5033956|NCT01490268|after thoracotomy|after thoracotomy
5033957|NCT01490268|cardiac surgery|cardiac surgery
5033958|NCT01490255|platelet reactivity|platelet reactivity
5033959|NCT01490255|aspirin|aspirin
5033960|NCT01490255|clopidogrel|clopidogrel
5033961|NCT01490229|nutraceuticals|nutraceuticals
5033962|NCT01490229|statin|statin
5033963|NCT01490216|cocaine|cocaine
5033964|NCT01490216|lisdexamfetamine|lisdexamfetamine
5033965|NCT01490216|vyvanse|vyvanse
5033966|NCT01490203|Gd-EOB-DTPA|gd-eob-dtpa
5033967|NCT01490203|MRI|mri
5033968|NCT01490203|Hepatectomy|hepatectomy
5033969|NCT01490203|Hepatocellular Carcinoma|hepatocellular carcinoma
5033970|NCT01490203|Liver Function Tests|liver function tests
5033971|NCT01490177|Multiple food allergies|multiple food allergies
5033972|NCT01490151|Hormone|hormone
5033973|NCT01490151|Diabetes|diabetes
5033974|NCT01490151|Mellitus|mellitus
5033975|NCT01490151|Type 1|type 1
5033976|NCT01490151|Immune|immune
5033977|NCT01490151|Metabolic disorder|metabolic disorder
5033978|NCT01490138|β-D-Glucan test|β-d-glucan test
5033979|NCT01490138|IFI|ifi
5033980|NCT01490125|COPD|copd
5033981|NCT01490125|Dyspnea|dyspnea
5033982|NCT01490125|QVA149|qva149
5033983|NCT01490125|tiotropium|tiotropium
5033984|NCT01490073|Intrauterine device|intrauterine device
5033985|NCT01490073|Pain|pain
5033986|NCT01490073|Contraception|contraception
5033987|NCT01490073|Nitroglycerin|nitroglycerin
5033988|NCT01490073|Nitric oxide donor|nitric oxide donor
5033989|NCT01490073|Intrauterine device insertion|intrauterine device insertion
5033990|NCT01490060|cancer|cancer
5033991|NCT01490060|fosaprepitant|fosaprepitant
5033992|NCT01490060|Ifosfamide-based Multi-day Chemotherapy|ifosfamide-based multi-day chemotherapy
5033993|NCT01490060|Chemotherapy-induced nausea and vomiting|chemotherapy-induced nausea and vomiting
5033994|NCT01490060|CINV|cinv
5033995|NCT01490060|multi-day chemotherapy regimens|multi-day chemotherapy regimens
5033996|NCT01490060|antiemetics|antiemetics
5033997|NCT01490060|adverse effect|adverse effect
5033998|NCT01490060|doxorubicin plus ifosfamide|doxorubicin plus ifosfamide
5033999|NCT01490060|AI|ai
5034000|NCT01490060|AI and vincristine|ai and vincristine
5034001|NCT01490060|VAI|vai
5034002|NCT01490060|aprepitant|aprepitant
5034003|NCT01490060|prevention|prevention
5034004|NCT01490060|nausea|nausea
5034005|NCT01490060|vomiting|vomiting
5034006|NCT01490060|emetogenic chemotherapy|emetogenic chemotherapy
5034007|NCT01490034|obesity|obesity
5034008|NCT01490034|energy intake|energy intake
5034009|NCT01490034|appetite|appetite
5034010|NCT01490034|food form|food form
5034011|NCT01490034|beverage|beverage
5034012|NCT01490034|learning|learning
5034013|NCT01490034|dietary compensation|dietary compensation
5034014|NCT01490021|Healthy young men|healthy young men
5034015|NCT01489995|Food effect|food effect
5034016|NCT01489995|GR181413A|gr181413a
5034017|NCT01489995|AT1001|at1001
5034018|NCT01489995|migalastat hydrochloride|migalastat hydrochloride
5034019|NCT01489995|Lysosomal storage disorders|lysosomal storage disorders
5034020|NCT01489995|Pharmacokinetics|pharmacokinetics
5034021|NCT01489982|Parkinson's disease|parkinson's disease
5034022|NCT01489982|insomnia|insomnia
5034023|NCT01489969|sleep latency|sleep latency
5034024|NCT01489969|Sleep maintenance|sleep maintenance
5034025|NCT01489969|Sleep fragmentation|sleep fragmentation
5034026|NCT01489969|Polysomnography|polysomnography
5034027|NCT01489956|Keyhole Limpet Hemocyanin (KLH)|keyhole limpet hemocyanin (klh)
5034028|NCT01489956|Immucothel|immucothel
5034029|NCT01489956|Native KLH|native klh
5034030|NCT01489956|Healthy volunteers|healthy volunteers
5034031|NCT01489956|Oral tolerance|oral tolerance
5034032|NCT01489956|Immunogenicity|immunogenicity
5034033|NCT01489956|Autoimmune diseases|autoimmune diseases
5034034|NCT01489930|Exercise|exercise
5034035|NCT01489930|Aging|aging
5034036|NCT01489930|Sarcopenia|sarcopenia
5034037|NCT01489930|Mitochondria|mitochondria
5034038|NCT01489917|radial artery occlusion|radial artery occlusion
5034039|NCT01489917|hemostasis|hemostasis
5034040|NCT01489917|coronary intervention|coronary intervention
5034041|NCT01489917|radial approach|radial approach
5034042|NCT01489904|drooling|drooling
5034043|NCT01489904|cerebral palsy|cerebral palsy
5034044|NCT01489891|Esophagogastroduodenoscopy|esophagogastroduodenoscopy
5034045|NCT01489891|Lidocaine|lidocaine
5034046|NCT01489891|Propofol|propofol
5034047|NCT01489878|Coagulase-negative staphylococci|coagulase-negative staphylococci
5034048|NCT01489878|Staphylococcus epidermidis|staphylococcus epidermidis
5034049|NCT01489878|Staphylococcus aureus|staphylococcus aureus
5034050|NCT01489878|Anti-bacterial agents|anti-bacterial agents
5034051|NCT01489878|Drug resistance, Microbial|drug resistance, microbial
5034052|NCT01489878|Methicillin resistance|methicillin resistance
5034053|NCT01489878|Β-lactams|β-lactams
5034054|NCT01489878|Fluoroquinolones|fluoroquinolones
5034055|NCT01489878|Macrolides|macrolides
5034056|NCT01489878|Synergistin|synergistin
5034057|NCT01489878|General practitioners|general practitioners
5034058|NCT01489878|Antibiotic selection pressure|antibiotic selection pressure
5034059|NCT01489878|Ambulatory antibiotherapy|ambulatory antibiotherapy
5034060|NCT01489878|Community patients|community patients
5034061|NCT01489865|Pancreas cancer|pancreas cancer
5034062|NCT01489865|Veliparib|veliparib
5034063|NCT01489865|oxaliplatin|oxaliplatin
5034064|NCT01489852|Assisted reproductive treatment|assisted reproductive treatment
5034065|NCT01489852|GnRH antagonist|gnrh antagonist
5034066|NCT01489852|Estrogen pre-treatment|estrogen pre-treatment
5034067|NCT01489852|Ovarian stimulation|ovarian stimulation
5034068|NCT01489839|periodontal disease|periodontal disease
5034069|NCT01489839|biomarkers|biomarkers
5034070|NCT01489839|periodontal treatment|periodontal treatment
5034071|NCT01489839|clinical attachment level|clinical attachment level
5034072|NCT01489826|Cancer|cancer
5034073|NCT01489800|feeding|feeding
5034074|NCT01489800|complications|complications
5034075|NCT01489800|radical cystectomy|radical cystectomy
5034076|NCT01489787|Surgery|surgery
5034077|NCT01489787|Ultrasonic therapy|ultrasonic therapy
5034078|NCT01489787|Liver|liver
5034079|NCT01489761|long lesions|long lesions
5034080|NCT01489761|drug eluting stents|drug eluting stents
5034081|NCT01489735|GERD|gerd
5034082|NCT01489735|GERD Q QUESTIONNAIRE|gerd q questionnaire
5034083|NCT01489722|Leukemia|leukemia
5034084|NCT01489722|AML|aml
5034085|NCT01489722|AZD1208|azd1208
5034086|NCT01489709|overactive bladder|overactive bladder
5034087|NCT01489709|solifenacin|solifenacin
5034088|NCT01489709|Overactive bladder questionnaire|overactive bladder questionnaire
5034089|NCT01489709|Overactive Bladder Symptom Score|overactive bladder symptom score
5034090|NCT01489709|satisfaction score|satisfaction score
5034091|NCT01489696|Pharmacokinetics|pharmacokinetics
5034092|NCT01489696|Mirabegron|mirabegron
5034093|NCT01489696|Tamsulosin|tamsulosin
5034094|NCT01489696|Phase 1|phase 1
5034095|NCT01489683|intubating conditions|intubating conditions
5034096|NCT01489683|propofol|propofol
5034097|NCT01489683|remifentanil|remifentanil
5034098|NCT01489683|topical lidocaine|topical lidocaine
5034099|NCT01489657|Obesity|obesity
5034100|NCT01489657|Bariatric Surgery|bariatric surgery
5034101|NCT01489657|Sleeve Gastrectomy|sleeve gastrectomy
5034102|NCT01489657|Metabolite Profiling|metabolite profiling
5034103|NCT01489631|Epidural|epidural
5034104|NCT01489631|Local infiltration|local infiltration
5034105|NCT01489631|Knee|knee
5034106|NCT01489631|Arthroplasty|arthroplasty
5034107|NCT01489618|Common variable immunodeficiency|common variable immunodeficiency
5034108|NCT01489618|pneumococcal vaccine|pneumococcal vaccine
5034109|NCT01489618|prime boost|prime boost
5034110|NCT01489605|Orotracheal intubation, videolaryngoscopy|orotracheal intubation, videolaryngoscopy
5034111|NCT01489566|Hepatocellular,Carcinoma,recurrence|hepatocellular,carcinoma,recurrence
5034112|NCT01489553|Egg hypersensitivity|egg hypersensitivity
5034113|NCT01489553|egg allergy|egg allergy
5034114|NCT01489553|egg protein allergy|egg protein allergy
5034115|NCT01489540|Burn|burn
5034116|NCT01489540|Depth|depth
5034117|NCT01489540|Diagnosis|diagnosis
5034118|NCT01489540|Laser Doppler Imaging|laser doppler imaging
5034119|NCT01489527|Vaccine|vaccine
5034120|NCT01489527|Placebo|placebo
5034121|NCT01489527|sexually transmitted infection (STI)|sexually transmitted infection (sti)
5034122|NCT01489527|HIV|hiv
5034123|NCT01489527|Human Immunodeficiency|human immunodeficiency
5034124|NCT01489527|Gardasil|gardasil
5034125|NCT01489527|HPV|hpv
5034126|NCT01489527|human papillomavirus|human papillomavirus
5034127|NCT01489514|peanut allergy|peanut allergy
5034128|NCT01489514|hypoallergenic peanut extracts|hypoallergenic peanut extracts
5034129|NCT01489514|epicutaneous skin prick testing|epicutaneous skin prick testing
5034130|NCT01489501|Caomecs, Transplantation, Limbal stem cell deficiency,|caomecs, transplantation, limbal stem cell deficiency,
5034131|NCT01489488|Relative bioavailability study|relative bioavailability study
5034132|NCT01489475|children|children
5034133|NCT01489475|congenital heart defects|congenital heart defects
5034134|NCT01489475|cardiopulmonary bypass|cardiopulmonary bypass
5034135|NCT01489475|modified ultrafiltration|modified ultrafiltration
5034136|NCT01489475|angiopoietins|angiopoietins
5034137|NCT01489475|cytokines|cytokines
5034138|NCT01489462|Arthritis|arthritis
5034139|NCT01489462|Osteoarthritis|osteoarthritis
5034140|NCT01489462|Strength Training|strength training
5034141|NCT01489449|drug coated balloon|drug coated balloon
5034142|NCT01489449|NSTEMI|nstemi
5034143|NCT01489436|gallstone disease|gallstone disease
5034144|NCT01489436|cholecystectomy|cholecystectomy
5034145|NCT01489436|minimally invasive|minimally invasive
5034146|NCT01489436|surgical|surgical
5034147|NCT01489436|laparoscopic|laparoscopic
5034148|NCT01489436|single port|single port
5034149|NCT01489436|cytokine|cytokine
5034150|NCT01489423|stage IIIC melanoma|stage iiic melanoma
5034151|NCT01489423|stage IV melanoma|stage iv melanoma
5034152|NCT01489423|recurrent melanoma|recurrent melanoma
5034153|NCT01489397|Confocol laser endomicroscopy|confocol laser endomicroscopy
5034154|NCT01489397|Feasibility of Confocol laser endomicroscopy|feasibility of confocol laser endomicroscopy
5034155|NCT01489384|Rheumatoid arthritis|rheumatoid arthritis
5034156|NCT01489384|DAS28|das28
5034157|NCT01489358|Vaccine-Mediated Protection|vaccine-mediated protection
5034158|NCT01489358|Antibody Response|antibody response
5034159|NCT01489358|Chikungunya Virus|chikungunya virus
5034160|NCT01489358|Immune Response|immune response
5034161|NCT01489358|Healthy Volunteer|healthy volunteer
5034162|NCT01489358|Humoral Inmunity|humoral inmunity
5034163|NCT01489358|Virus-like Particles|virus-like particles
5034164|NCT01489345|ONO-2952|ono-2952
5034165|NCT01489345|Healthy adult subjects|healthy adult subjects
5034166|NCT01489345|Multiple dose|multiple dose
5034167|NCT01489345|Safety|safety
5034168|NCT01489345|Tolerability|tolerability
5034169|NCT01489345|Pharmacokinetics|pharmacokinetics
5034170|NCT01489332|rectal cancer|rectal cancer
5034171|NCT01489332|capecitabine|capecitabine
5034172|NCT01489332|radiotherapy|radiotherapy
5034173|NCT01489332|locally advanced rectal cancer|locally advanced rectal cancer
5034174|NCT01489319|inflammation|inflammation
5034175|NCT01489319|body composition|body composition
5034176|NCT01489319|hyperandrogenism|hyperandrogenism
5034177|NCT01489319|insulin resistance|insulin resistance
5034178|NCT01489306|Respiratory Syncytial Virus Infection|respiratory syncytial virus infection
5034179|NCT01489306|RSV|rsv
5034180|NCT01489280|Temple Touch Pro|temple touch pro
5034181|NCT01489280|Medisim|medisim
5034182|NCT01489280|temperature|temperature
5034183|NCT01489280|surgery|surgery
5034184|NCT01489267|cerebellar ataxia|cerebellar ataxia
5034185|NCT01489267|hereditary disease|hereditary disease
5034186|NCT01489267|stem cell|stem cell
5034187|NCT01489254|Multiple Sclerosis,|multiple sclerosis,
5034188|NCT01489254|Relapsing-Remitting Multiple Sclerosis,|relapsing-remitting multiple sclerosis,
5034189|NCT01489254|glatiramer acetate,|glatiramer acetate,
5034190|NCT01489254|MRI,|mri,
5034191|NCT01489254|lesions,|lesions,
5034192|NCT01489254|MS relapse rate,|ms relapse rate,
5034193|NCT01489254|Copaxone|copaxone
5034194|NCT01489241|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
5034195|NCT01489241|Telemedicine|telemedicine
5034196|NCT01489228|Chagas Disease|chagas disease
5034197|NCT01489202|drug-eluting stent|drug-eluting stent
5034198|NCT01489202|percutaneous coronary intervention|percutaneous coronary intervention
5034199|NCT01489176|Stress Echocardiography|stress echocardiography
5034200|NCT01489176|Real-Time Perfusion Imaging|real-time perfusion imaging
5034201|NCT01489176|Regadenoson|regadenoson
5034202|NCT01489176|Optison|optison
5034203|NCT01489163|Gestational Diabetes|gestational diabetes
5034204|NCT01489163|Weight Loss|weight loss
5034205|NCT01489163|Physical Activity|physical activity
5034206|NCT01489163|Pregnancy|pregnancy
5034207|NCT01489163|Postpartum|postpartum
5034208|NCT01489163|Intervention|intervention
5034209|NCT01489150|Acute respiratory failure|acute respiratory failure
5034210|NCT01489150|Hypercapnia|hypercapnia
5034211|NCT01489150|Non invasive ventilation|non invasive ventilation
5034212|NCT01489150|End-tidal CO2|end-tidal co2
5034213|NCT01489124|Infection|infection
5034214|NCT01489124|Imipenem|imipenem
5034215|NCT01489124|Ventilator-Associated Pneumonia|ventilator-associated pneumonia
5034216|NCT01489124|pharmacokinetic|pharmacokinetic
5034217|NCT01489124|pharmacodynamic|pharmacodynamic
5034218|NCT01489098|Body composition|body composition
5034219|NCT01489098|Protein Metabolism|protein metabolism
5034220|NCT01489085|ventilation|ventilation
5034221|NCT01489085|automated|automated
5034222|NCT01489033|Allergic rhinitis|allergic rhinitis
5034223|NCT01489033|Phleum pratense|phleum pratense
5034224|NCT01489033|Timothy grass pollen allergy|timothy grass pollen allergy
5034225|NCT01489033|subcutaneous immunotherapy|subcutaneous immunotherapy
5034226|NCT01489020|Allergy|allergy
5034227|NCT01489020|Immunotherapy|immunotherapy
5034228|NCT01489020|Allergic Rhinoconjunctivitis|allergic rhinoconjunctivitis
5034229|NCT01489020|D. pteronyssinus|d. pteronyssinus
5034230|NCT01489020|house dust allergy|house dust allergy
5034231|NCT01489007|vegetarian|vegetarian
5034232|NCT01489007|children|children
5034233|NCT01489007|iron|iron
5034234|NCT01489007|iron absorption|iron absorption
5034235|NCT01488981|Radio Frequency Microstimulator|radio frequency microstimulator
5034236|NCT01488981|Traumatic Brain Injury|traumatic brain injury
5034237|NCT01488981|TBI|tbi
5034238|NCT01488981|Arm Rehabilitation|arm rehabilitation
5034239|NCT01488981|electrical stimulation|electrical stimulation
5034240|NCT01488981|FES|fes
5034241|NCT01488968|high risk prostate cancer|high risk prostate cancer
5034242|NCT01488968|hypofractionated radiation treatment|hypofractionated radiation treatment
5034243|NCT01488968|higher biological doses|higher biological doses
5034244|NCT01488968|acceptable rectal toxicity|acceptable rectal toxicity
5034245|NCT01488968|Radiation Treatment|radiation treatment
5034246|NCT01488955|bacterial infection|bacterial infection
5034247|NCT01488942|HIV|hiv
5034248|NCT01488942|reinforcement|reinforcement
5034249|NCT01488942|medication adherence|medication adherence
5034250|NCT01488942|patient compliance|patient compliance
5034251|NCT01488942|antiretroviral therapy, highly active|antiretroviral therapy, highly active
5034252|NCT01488916|Vitamin D|vitamin d
5034253|NCT01488916|Postprandial Glucose|postprandial glucose
5034254|NCT01488916|Type 2 Diabetes|type 2 diabetes
5034255|NCT01488903|genetic susceptibility|genetic susceptibility
5034256|NCT01488903|obesity|obesity
5034257|NCT01488903|body composition|body composition
5034258|NCT01488903|the metabolic syndrome|the metabolic syndrome
5034259|NCT01488903|women|women
5034260|NCT01488890|Dengue fever|dengue fever
5034261|NCT01488890|Dengue Hemorrhagic Fever|dengue hemorrhagic fever
5034262|NCT01488890|CYD dengue vaccine|cyd dengue vaccine
5034263|NCT01488890|Yellow Fever|yellow fever
5034264|NCT01488890|Flavivirus|flavivirus
5034265|NCT01488877|Type 2 diabetes mellitus. albuminuria.|type 2 diabetes mellitus. albuminuria.
5034266|NCT01488864|Hot flashes|hot flashes
5034267|NCT01488864|Vasomotor symptoms|vasomotor symptoms
5034268|NCT01488864|Menopause|menopause
5034269|NCT01488864|Applied Relaxation|applied relaxation
5034270|NCT01488864|Health Related Quality of Life|health related quality of life
5034271|NCT01488864|Salivary cortisol|salivary cortisol
5034272|NCT01488851|Osteo necrosis of the Jaw|osteo necrosis of the jaw
5034273|NCT01488812|Hip-fracture|hip-fracture
5034274|NCT01488799|Anxiety|anxiety
5034275|NCT01488799|Generalized Anxiety Disorder|generalized anxiety disorder
5034276|NCT01488799|Motivational Interviewing|motivational interviewing
5034277|NCT01488799|Cognitive Behavioural Therapy|cognitive behavioural therapy
5034278|NCT01488799|Psychotherapy|psychotherapy
5034279|NCT01488786|Assistive Technology|assistive technology
5034280|NCT01488786|Non-Surgical Visual Prosthetic|non-surgical visual prosthetic
5034281|NCT01488786|Sensory Substitution|sensory substitution
5034282|NCT01488773|asthma|asthma
5034283|NCT01488773|asthma control|asthma control
5034284|NCT01488773|inhaled glucocorticosteroid|inhaled glucocorticosteroid
5034285|NCT01488773|ICS|ics
5034286|NCT01488773|leukotriene antagonist|leukotriene antagonist
5034287|NCT01488773|LTRA|ltra
5034288|NCT01488773|montelukast|montelukast
5034289|NCT01488773|fluticasone|fluticasone
5034290|NCT01488773|salmeterol|salmeterol
5034291|NCT01488773|observational study|observational study
5034292|NCT01488773|repeated measures|repeated measures
5034293|NCT01488773|retrospective|retrospective
5034294|NCT01488747|Omega-3 fatty acids|omega-3 fatty acids
5034295|NCT01488747|Phospholipid fatty acids|phospholipid fatty acids
5034296|NCT01488747|chymlomicron fatty acids|chymlomicron fatty acids
5034297|NCT01488747|Bioavailability fo fish oil supplements in healthy adults|bioavailability fo fish oil supplements in healthy adults
5034298|NCT01488734|Vitamin D|vitamin d
5034299|NCT01488734|Mushroom|mushroom
5034300|NCT01488734|Cholecalciferol|cholecalciferol
5034301|NCT01488734|Prediabetes|prediabetes
5034302|NCT01488734|Metabolic Syndrome|metabolic syndrome
5034303|NCT01488708|Lupus|lupus
5034304|NCT01488708|SLE|sle
5034305|NCT01488708|Systemic Lupus Erythematosus|systemic lupus erythematosus
5034306|NCT01488708|Immune System Disease|immune system disease
5034307|NCT01488695|intubation|intubation
5034308|NCT01488695|double lumen tube|double lumen tube
5034309|NCT01488682|Head and neck cancer|head and neck cancer
5034310|NCT01488682|Neck dissection|neck dissection
5034311|NCT01488682|Harmonic scalpel|harmonic scalpel
5034312|NCT01488669|head and neck neoplasms|head and neck neoplasms
5034313|NCT01488669|neck dissection|neck dissection
5034314|NCT01488669|robotics|robotics
5034315|NCT01488656|Antioxidants|antioxidants
5034316|NCT01488656|Dietary supplements|dietary supplements
5034317|NCT01488656|Forced vital lung capacity|forced vital lung capacity
5034318|NCT01488656|Exhaled nitric oxide|exhaled nitric oxide
5034319|NCT01488656|Air pollution|air pollution
5034320|NCT01488643|Bronchospasm|bronchospasm
5034321|NCT01488643|Laparoscopic Gastrectomy|laparoscopic gastrectomy
5034322|NCT01488643|Obesity|obesity
5034323|NCT01488630|substance abuse|substance abuse
5034324|NCT01488630|alcohol|alcohol
5034325|NCT01488630|drug|drug
5034326|NCT01488630|smoking|smoking
5034327|NCT01488630|HIV screening|hiv screening
5034328|NCT01488617|Surgery|surgery
5034329|NCT01488617|Psychosocial Factors|psychosocial factors
5034330|NCT01488617|Psychological Distress|psychological distress
5034331|NCT01488617|Outcome Assessment (Health Care)|outcome assessment (health care)
5034332|NCT01488578|Overactive Bladder|overactive bladder
5034333|NCT01488578|Japanese|japanese
5034334|NCT01488578|Tolterodine|tolterodine
5034335|NCT01488578|Detrusitol|detrusitol
5034336|NCT01488578|Detrol|detrol
5034337|NCT01488578|Postmarketing commitment plan.|postmarketing commitment plan.
5034338|NCT01488552|pancreatic cancer|pancreatic cancer
5034339|NCT01488552|pancreatic adenocarcinoma|pancreatic adenocarcinoma
5034340|NCT01488552|Stage IV pancreatic cancer|stage iv pancreatic cancer
5034341|NCT01488552|pancreas|pancreas
5034342|NCT01488552|pancreatic|pancreatic
5034343|NCT01488539|Stress Disorders, Post-Traumatic|stress disorders, post-traumatic
5034344|NCT01488539|PTSD|ptsd
5034345|NCT01488539|Adult Survivors of Child Abuse|adult survivors of child abuse
5034346|NCT01488539|Women|women
5034347|NCT01488539|Interpersonal violence|interpersonal violence
5034348|NCT01488539|psychological trauma|psychological trauma
5034349|NCT01488526|Hepatitis B|hepatitis b
5034350|NCT01488526|Vertical transmission|vertical transmission
5034351|NCT01488526|Pregnancy|pregnancy
5034352|NCT01488526|Antiviral treatment|antiviral treatment
5034353|NCT01488513|ABC294640|abc294640
5034354|NCT01488513|RedHill Biopharma, Ltd.|redhill biopharma, ltd.
5034355|NCT01488513|ABC-101|abc-101
5034356|NCT01488513|Medical University of South Carolina|medical university of south carolina
5034357|NCT01488513|Apogee Biotechnology Corporation|apogee biotechnology corporation
5034358|NCT01488500|Wood smoke|wood smoke
5034359|NCT01488500|inflammation|inflammation
5034360|NCT01488500|lung function|lung function
5034361|NCT01488500|arterial stiffness|arterial stiffness
5034362|NCT01488500|heart rate variability|heart rate variability
5034363|NCT01488500|Respiratory and systemic inflammation following exposure to woodsmoke in healthy volunteers|respiratory and systemic inflammation following exposure to woodsmoke in healthy volunteers
5034364|NCT01488487|HCC|hcc
5034365|NCT01488487|Advanced Hepatocellular Carcinoma|advanced hepatocellular carcinoma
5034366|NCT01488487|Metastatic Hepatocellular Carcinoma|metastatic hepatocellular carcinoma
5034367|NCT01488487|Liver Cancer|liver cancer
5034368|NCT01488474|regional anesthesia|regional anesthesia
5034369|NCT01488474|peripheral nerve stimulation|peripheral nerve stimulation
5034370|NCT01488474|diabetes|diabetes
5034371|NCT01488474|diabetic neuropathy|diabetic neuropathy
5034372|NCT01488461|Congenital cerebellar ataxias|congenital cerebellar ataxias
5034373|NCT01488461|Genetics|genetics
5034374|NCT01488461|Gene ATCAY|gene atcay
5034375|NCT01488461|Gene ABC7|gene abc7
5034376|NCT01488461|Cerebellar atrophy|cerebellar atrophy
5034377|NCT01488448|Hypertonic saline|hypertonic saline
5034378|NCT01488448|Bronchiolitis|bronchiolitis
5034379|NCT01488448|Infants|infants
5034380|NCT01488448|Wheezing|wheezing
5034381|NCT01488448|Nebulized|nebulized
5034382|NCT01488448|Bronchodilator|bronchodilator
5034383|NCT01488396|Cyclosporin|cyclosporin
5034384|NCT01488396|Stevens-Johnson syndrome|stevens-johnson syndrome
5034385|NCT01488396|Dry eye|dry eye
5034386|NCT01488383|Hyperglycemia|hyperglycemia
5034387|NCT01488383|Diabetes|diabetes
5034388|NCT01488383|Blood glucose|blood glucose
5034389|NCT01488383|Hypertension|hypertension
5034390|NCT01488383|Anti hypertensive agents|anti hypertensive agents
5034391|NCT01488383|Anti hypertensive drugs|anti hypertensive drugs
5034392|NCT01488383|Anti hypertensive|anti hypertensive
5034393|NCT01488370|breathing tube placement|breathing tube placement
5034394|NCT01488357|Breast cancer|breast cancer
5034395|NCT01488357|UNC|unc
5034396|NCT01488357|Lineberger|lineberger
5034397|NCT01488357|Breast Reconstruction|breast reconstruction
5034398|NCT01488357|Mastectomy|mastectomy
5034399|NCT01488318|Cetuximab|cetuximab
5034400|NCT01488318|Dasatinib|dasatinib
5034401|NCT01488318|Squamous Cell|squamous cell
5034402|NCT01488318|Head and Neck|head and neck
5034403|NCT01488318|After Cetuximab Containing Chemoradiotherapy|after cetuximab containing chemoradiotherapy
5034404|NCT01488318|Recurrent|recurrent
5034405|NCT01488318|Metastatic|metastatic
5034406|NCT01488305|MNP|mnp
5034407|NCT01488305|AAMA program|aama program
5034408|NCT01488305|Nepal|nepal
5034409|NCT01488305|HFP|hfp
5034410|NCT01488305|IYCF|iycf
5034411|NCT01488305|BCC|bcc
5034412|NCT01488292|mental health|mental health
5034413|NCT01488292|social skills|social skills
5034414|NCT01488279|Pre-diabetes|pre-diabetes
5034415|NCT01488279|Impaired fasting glucose|impaired fasting glucose
5034416|NCT01488279|Impaired glucose tolerance|impaired glucose tolerance
5034417|NCT01488279|Steroid-induced hyperglycemia|steroid-induced hyperglycemia
5034418|NCT01488266|depression|depression
5034419|NCT01488266|depressive|depressive
5034420|NCT01488266|major|major
5034421|NCT01488266|aripiprazole|aripiprazole
5034422|NCT01488266|switching|switching
5034423|NCT01488266|augmentation|augmentation
5034424|NCT01488266|antidepressant|antidepressant
5034425|NCT01488253|Hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
5034426|NCT01488253|Graft vs Host disease|graft vs host disease
5034427|NCT01488253|Prevention|prevention
5034428|NCT01488253|Sirolimus|sirolimus
5034429|NCT01488253|Tacrolimus|tacrolimus
5034430|NCT01488240|burn|burn
5034431|NCT01488240|scar|scar
5034432|NCT01488240|laser|laser
5034433|NCT01488227|Vitamin D status in athletes|vitamin d status in athletes
5034434|NCT01488227|Vitamin D|vitamin d
5034435|NCT01488227|25(OH)D|25(oh)d
5034436|NCT01488227|athletes|athletes
5034437|NCT01488227|body composition|body composition
5034438|NCT01488227|inflammatory markers|inflammatory markers
5034439|NCT01488227|illness|illness
5034440|NCT01488227|injury|injury
5034441|NCT01488214|Systemic Sclerosis|systemic sclerosis
5034442|NCT01488214|neuropsychiatric manifestations|neuropsychiatric manifestations
5034443|NCT01488214|magnetic resonance imaging|magnetic resonance imaging
5034444|NCT01488201|Psoriasis|psoriasis
5034445|NCT01488188|Influenza vaccine|influenza vaccine
5034446|NCT01488188|nasal route|nasal route
5034447|NCT01488188|sublingual route|sublingual route
5034448|NCT01488188|immunogenicity|immunogenicity
5034449|NCT01488188|safety|safety
5034450|NCT01488175|TKA|tka
5034451|NCT01488175|RSA|rsa
5034452|NCT01488175|Tourniquet|tourniquet
5034453|NCT01488175|Arthroplasty|arthroplasty
5034454|NCT01488175|Knee|knee
5034455|NCT01488149|Fentanyl|fentanyl
5034456|NCT01488149|Bupivacaine|bupivacaine
5034457|NCT01488149|Nalbuphine|nalbuphine
5034458|NCT01488136|Type 1 diabetes|type 1 diabetes
5034459|NCT01488136|Hypoglycaemia|hypoglycaemia
5034460|NCT01488136|Diazoxide|diazoxide
5034461|NCT01488123|Breast, Cancer, Survivorship, Integrative, Complementary|breast, cancer, survivorship, integrative, complementary
5034462|NCT01488097|Enzyme replacement therapy (ERT)|enzyme replacement therapy (ert)
5034463|NCT01488097|Lysosomal storage disease|lysosomal storage disease
5034464|NCT01488097|Late onset lysosomal acid lipase (LAL) deficiency|late onset lysosomal acid lipase (lal) deficiency
5034465|NCT01488097|Acid cholesteryl ester hydrolase deficiency, type 2|acid cholesteryl ester hydrolase deficiency, type 2
5034466|NCT01488097|Acid lipase disease|acid lipase disease
5034467|NCT01488097|Cholesterol ester hydrolase deficiency|cholesterol ester hydrolase deficiency
5034468|NCT01488097|LAL deficiency|lal deficiency
5034469|NCT01488097|LIPA enzyme deficiency|lipa enzyme deficiency
5034470|NCT01488084|Saphenous vein graft patency|saphenous vein graft patency
5034471|NCT01488084|Coronary artery bypass surgery|coronary artery bypass surgery
5034472|NCT01488084|Coronary artery disease|coronary artery disease
5034473|NCT01488071|Depression|depression
5034474|NCT01488071|Multimodal antidepressant|multimodal antidepressant
5034475|NCT01488045|Colonoscopy|colonoscopy
5034476|NCT01488045|Propofol|propofol
5034477|NCT01488045|Cancer Screening|cancer screening
5034478|NCT01488006|Primary Glenohumeral Osteoarthritis|primary glenohumeral osteoarthritis
5034479|NCT01488006|Total shoulder arthroplasty|total shoulder arthroplasty
5035359|NCT01484496|Lupus|lupus
5034480|NCT01488006|Total shoulder replacement|total shoulder replacement
5034481|NCT01488006|Osteoarthritis|osteoarthritis
5034482|NCT01488006|Multicenter study|multicenter study
5034483|NCT01487993|Obesity|obesity
5034484|NCT01487993|Children|children
5034485|NCT01487993|Adolescents|adolescents
5034486|NCT01487993|Metformin|metformin
5034487|NCT01487993|Insulin resistance|insulin resistance
5034488|NCT01487967|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
5034489|NCT01487967|ADHD|adhd
5034490|NCT01487967|Preferences|preferences
5034491|NCT01487967|Goals|goals
5034492|NCT01487967|Decision Making|decision making
5034493|NCT01487954|skin reactions secondary to radiation therapy|skin reactions secondary to radiation therapy
5034494|NCT01487928|breastfed|breastfed
5034495|NCT01487928|human milk cream|human milk cream
5034496|NCT01487928|human milk fat|human milk fat
5034497|NCT01487928|caloric supplement|caloric supplement
5034498|NCT01487915|Cisplatin-unfit condition|cisplatin-unfit condition
5034499|NCT01487902|Chemotherapy-naive|chemotherapy-naive
5034500|NCT01487876|DNA vaccine|dna vaccine
5034501|NCT01487876|HBV|hbv
5034502|NCT01487876|Chronic hepatitis B (CHB)|chronic hepatitis b (chb)
5034503|NCT01487876|T-cell|t-cell
5034504|NCT01487863|prostate cancer|prostate cancer
5034505|NCT01487863|prostate|prostate
5034506|NCT01487863|androgen independent prostate cancer (AIPC)|androgen independent prostate cancer (aipc)
5034507|NCT01487863|androgen-independent|androgen-independent
5034508|NCT01487863|androgen independent|androgen independent
5034509|NCT01487863|hormone insensitive|hormone insensitive
5034510|NCT01487863|hormone-insensitive|hormone-insensitive
5034511|NCT01487863|prostate specific antigen (PSA)|prostate specific antigen (psa)
5034512|NCT01487863|prostatic adenocarcinoma|prostatic adenocarcinoma
5034513|NCT01487863|hormone-refractory|hormone-refractory
5034514|NCT01487863|hormone refractory|hormone refractory
5034515|NCT01487863|hormone refractory prostate cancer (HRPC)|hormone refractory prostate cancer (hrpc)
5034516|NCT01487863|immune therapy|immune therapy
5034517|NCT01487863|immunotherapy|immunotherapy
5034518|NCT01487863|vaccine|vaccine
5034519|NCT01487863|dendritic cells|dendritic cells
5034520|NCT01487863|antigen-presenting cells|antigen-presenting cells
5034521|NCT01487863|antigen presenting cells|antigen presenting cells
5034522|NCT01487863|cancer vaccine|cancer vaccine
5034523|NCT01487863|therapeutic vaccine|therapeutic vaccine
5034524|NCT01487863|therapeutic cancer vaccine|therapeutic cancer vaccine
5034525|NCT01487863|recombinant|recombinant
5034526|NCT01487863|biological|biological
5034527|NCT01487863|biopharmaceutical|biopharmaceutical
5034528|NCT01487863|biotechnology|biotechnology
5034529|NCT01487863|biotech|biotech
5034530|NCT01487863|castration resistant prostate cancer (CRPC)|castration resistant prostate cancer (crpc)
5034531|NCT01487863|castration-resistant prostate cancer (CRPC)|castration-resistant prostate cancer (crpc)
5034532|NCT01487863|castration-resistance|castration-resistance
5034533|NCT01487863|sipuleucel-T|sipuleucel-t
5034534|NCT01487863|abiraterone|abiraterone
5034535|NCT01487863|prednisone|prednisone
5034536|NCT01487863|sequence|sequence
5034537|NCT01487863|sequencing|sequencing
5034538|NCT01487850|wind instruments|wind instruments
5034539|NCT01487850|molds|molds
5034540|NCT01487850|hypersensitivity pneumonitis|hypersensitivity pneumonitis
5034541|NCT01487850|fungal contamination of wind instruments|fungal contamination of wind instruments
5034542|NCT01487850|specific antibodies against molds in musicians' sera|specific antibodies against molds in musicians' sera
5034543|NCT01487850|musicians|musicians
5034544|NCT01487837|Fibrinogen|fibrinogen
5034545|NCT01487837|Blood coagulation disorders|blood coagulation disorders
5034546|NCT01487837|Postoperative bleeding|postoperative bleeding
5034547|NCT01487837|Transfusions|transfusions
5034548|NCT01487785|metastatic pancreatic cancer|metastatic pancreatic cancer
5034549|NCT01487785|LDE225|lde225
5034550|NCT01487785|gemcitabine|gemcitabine
5034551|NCT01487785|locally advanced|locally advanced
5034552|NCT01487785|adenocarcinoma|adenocarcinoma
5034553|NCT01487746|APLA|apla
5034554|NCT01487746|APS|aps
5034555|NCT01487746|Stroke|stroke
5034556|NCT01487746|minor anti body|minor anti body
5034557|NCT01487746|major anti body|major anti body
5034558|NCT01487746|APLA antibodies in Serum|apla antibodies in serum
5034559|NCT01487733|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
5034560|NCT01487733|metastatic squamous neck cancer with occult primary|metastatic squamous neck cancer with occult primary
5034561|NCT01487733|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
5034562|NCT01487733|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
5034563|NCT01487733|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
5034564|NCT01487733|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
5034565|NCT01487733|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
5034566|NCT01487733|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
5034567|NCT01487733|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
5034568|NCT01487733|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
5034569|NCT01487733|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
5034570|NCT01487733|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
5034571|NCT01487733|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
5034572|NCT01487733|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
5034573|NCT01487733|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
5034574|NCT01487733|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
5034575|NCT01487733|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5034576|NCT01487733|stage IVA squamous cell carcinoma of the larynx|stage iva squamous cell carcinoma of the larynx
5034577|NCT01487733|stage IVA squamous cell carcinoma of the lip and oral cavity|stage iva squamous cell carcinoma of the lip and oral cavity
5034578|NCT01487733|stage IVA squamous cell carcinoma of the oropharynx|stage iva squamous cell carcinoma of the oropharynx
5034579|NCT01487733|stage IVA squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iva squamous cell carcinoma of the paranasal sinus and nasal cavity
5034580|NCT01487733|stage IVB squamous cell carcinoma of the larynx|stage ivb squamous cell carcinoma of the larynx
5034581|NCT01487733|stage IVB squamous cell carcinoma of the lip and oral cavity|stage ivb squamous cell carcinoma of the lip and oral cavity
5034582|NCT01487733|stage IVB squamous cell carcinoma of the oropharynx|stage ivb squamous cell carcinoma of the oropharynx
5034583|NCT01487733|stage IVB squamous cell carcinoma of the paranasal sinus and nasal cavity|stage ivb squamous cell carcinoma of the paranasal sinus and nasal cavity
5034584|NCT01487733|stage IVC squamous cell carcinoma of the larynx|stage ivc squamous cell carcinoma of the larynx
5034585|NCT01487733|stage IVC squamous cell carcinoma of the lip and oral cavity|stage ivc squamous cell carcinoma of the lip and oral cavity
5034586|NCT01487733|stage IVC squamous cell carcinoma of the oropharynx|stage ivc squamous cell carcinoma of the oropharynx
5034587|NCT01487733|stage IVC squamous cell carcinoma of the paranasal sinus and nasal cavity|stage ivc squamous cell carcinoma of the paranasal sinus and nasal cavity
5034588|NCT01487733|recurrent salivary gland cancer|recurrent salivary gland cancer
5034589|NCT01487733|stage III salivary gland cancer|stage iii salivary gland cancer
5034590|NCT01487733|stage IVA salivary gland cancer|stage iva salivary gland cancer
5034591|NCT01487733|stage IVB salivary gland cancer|stage ivb salivary gland cancer
5034592|NCT01487733|stage IVC salivary gland cancer|stage ivc salivary gland cancer
5034593|NCT01487720|Castration-resistant prostate cancer|castration-resistant prostate cancer
5034594|NCT01487720|Docetaxel-refractory status|docetaxel-refractory status
5034595|NCT01487707|pregnancy|pregnancy
5034596|NCT01487707|maternal mortality|maternal mortality
5034597|NCT01487707|neonatal mortality|neonatal mortality
5034598|NCT01487707|community intervention|community intervention
5034599|NCT01487707|voluntary health worker|voluntary health worker
5034600|NCT01487707|safe birth kit|safe birth kit
5034601|NCT01487707|maternal child health|maternal child health
5034602|NCT01487694|back cohosh|back cohosh
5034603|NCT01487694|cimicifuga racemosa|cimicifuga racemosa
5034604|NCT01487694|menopausal symptoms|menopausal symptoms
5034605|NCT01487694|hot flashes|hot flashes
5034606|NCT01487694|Kupperman index|kupperman index
5034607|NCT01487694|MENQOL|menqol
5034608|NCT01487668|chronic mental disorders|chronic mental disorders
5034609|NCT01487668|cardiovascular disease|cardiovascular disease
5034610|NCT01487668|behavior change|behavior change
5034611|NCT01487655|Open-angle glaucoma|open-angle glaucoma
5034612|NCT01487655|Low tension glaucoma|low tension glaucoma
5034613|NCT01487655|Color Doppler Imaging|color doppler imaging
5034614|NCT01487629|Diabetic Retinopathy|diabetic retinopathy
5034615|NCT01487629|Macular Edema|macular edema
5034616|NCT01487629|Bevacizumab|bevacizumab
5034617|NCT01487629|Ranibizumab|ranibizumab
5034618|NCT01487616|Mullerian anomalies|mullerian anomalies
5034619|NCT01487616|Congenital uterine malformations or anomalies|congenital uterine malformations or anomalies
5034620|NCT01487616|Arcuate|arcuate
5034621|NCT01487616|Septate|septate
5034622|NCT01487616|Subseptate|subseptate
5034623|NCT01487616|Bicornuate|bicornuate
5034624|NCT01487616|Unicornuate|unicornuate
5034625|NCT01487616|Didelphys|didelphys
5034626|NCT01487616|T-shaped|t-shaped
5034627|NCT01487603|Patients|patients
5034628|NCT01487603|undiagnosed enlarged|undiagnosed enlarged
5034629|NCT01487603|lymph nodes|lymph nodes
5034630|NCT01487590|pregnancy|pregnancy
5034631|NCT01487590|breech|breech
5034632|NCT01487590|acupuncture|acupuncture
5034633|NCT01487590|moxibustion|moxibustion
5034634|NCT01487590|version|version
5034635|NCT01487577|Allogeneic blood and marrow transplantation (BMT)|allogeneic blood and marrow transplantation (bmt)
5034636|NCT01487577|Graft versus host disease|graft versus host disease
5034637|NCT01487577|Mycophenolate mofetil|mycophenolate mofetil
5034638|NCT01487577|Pharmacokinetics|pharmacokinetics
5034639|NCT01487564|Healthy volunteers|healthy volunteers
5034640|NCT01487564|Pharmacokinetics|pharmacokinetics
5034641|NCT01487564|OROS Hydromorphone|oros hydromorphone
5034642|NCT01487564|Hydromorphone|hydromorphone
5034643|NCT01487564|Taiwan|taiwan
5034644|NCT01487564|UGT2B7 Gene|ugt2b7 gene
5034645|NCT01487551|Systemic sclerosis|systemic sclerosis
5034646|NCT01487551|Biomarkers|biomarkers
5034647|NCT01487525|symptomatic knee osteoarthritis|symptomatic knee osteoarthritis
5034648|NCT01487525|partial blood flow restriction|partial blood flow restriction
5034649|NCT01487525|knee extensor strength|knee extensor strength
5034650|NCT01487512|Healthy Volunteers|healthy volunteers
5034651|NCT01487512|Dose Proportionality|dose proportionality
5034652|NCT01487512|Pharmacokinetics|pharmacokinetics
5034653|NCT01487512|OROS Hydromorphone|oros hydromorphone
5034654|NCT01487512|Hydromorphone|hydromorphone
5034655|NCT01487512|Taiwan|taiwan
5034656|NCT01487486|Polycystic Ovary Syndrome|polycystic ovary syndrome
5034657|NCT01487486|PCOS|pcos
5034658|NCT01487486|Follicular Fluid|follicular fluid
5034659|NCT01487486|Proteomics|proteomics
5034660|NCT01487486|Glyco-proteomics|glyco-proteomics
5034661|NCT01487473|Meditation|meditation
5034662|NCT01487473|Mindfulness|mindfulness
5034663|NCT01487473|Attention|attention
5034664|NCT01487473|Chronic Pain|chronic pain
5034665|NCT01487473|Depression|depression
5034666|NCT01487473|Anxiety|anxiety
5034667|NCT01487473|Stress|stress
5034668|NCT01487473|Acceptance|acceptance
5034669|NCT01487473|Pain intensity|pain intensity
5034670|NCT01487473|Pain disability|pain disability
5034671|NCT01487460|High cholesterol levels|high cholesterol levels
5034672|NCT01487460|Hyperlipidemia|hyperlipidemia
5034673|NCT01487460|High-density Lipoprotein|high-density lipoprotein
5034674|NCT01487460|Low-density Lipoprotein|low-density lipoprotein
5034675|NCT01487460|Simvastatin|simvastatin
5034676|NCT01487434|Attendance|attendance
5034677|NCT01487434|Truancy|truancy
5034678|NCT01487434|Student engagement|student engagement
5034679|NCT01487434|Mentoring|mentoring
5034680|NCT01487434|Monitoring|monitoring
5034681|NCT01487434|Case management|case management
5034682|NCT01487395|Alzheimer|alzheimer
5034683|NCT01487395|Donepezil|donepezil
5034684|NCT01487395|biomarkers|biomarkers
5034685|NCT01487395|battery|battery
5034686|NCT01487395|cognition|cognition
5034687|NCT01487395|imaging|imaging
5034688|NCT01487395|neurophysiological|neurophysiological
5034689|NCT01487356|Colonoscopy|colonoscopy
5034690|NCT01487356|quality assurance|quality assurance
5034691|NCT01487356|withdrawal time|withdrawal time
5034692|NCT01487356|polyp detection rate|polyp detection rate
5034693|NCT01487343|Oral Chemotherapy|oral chemotherapy
5034694|NCT01487343|capecitabine|capecitabine
5034695|NCT01487343|questionnaire|questionnaire
5034696|NCT01487343|breast|breast
5034697|NCT01487343|gastric|gastric
5034698|NCT01487343|11-194|11-194
5034699|NCT01487330|aortic stenosis|aortic stenosis
5034700|NCT01487330|aortic valve stenosis|aortic valve stenosis
5034701|NCT01487330|valvular heart disease|valvular heart disease
5034702|NCT01487330|aortic valve replacement|aortic valve replacement
5034703|NCT01487330|transcatheter aortic valve implantation|transcatheter aortic valve implantation
5034704|NCT01487330|TAVI|tavi
5034705|NCT01487330|TAVR|tavr
5034706|NCT01487317|Delirium|delirium
5034707|NCT01487317|acetylcholinesterase inhibitor|acetylcholinesterase inhibitor
5034708|NCT01487317|Elderly|elderly
5034709|NCT01487317|Emergency department|emergency department
5034710|NCT01487291|Thrombophilia tests|thrombophilia tests
5034711|NCT01487291|Hypofibrinolysis|hypofibrinolysis
5034712|NCT01487291|Fibrinolysis|fibrinolysis
5034713|NCT01487278|postpartum hemorrhage|postpartum hemorrhage
5034714|NCT01487278|prevention|prevention
5034715|NCT01487278|misoprostol|misoprostol
5034716|NCT01487278|Uniject|uniject
5034717|NCT01487278|oxytocin|oxytocin
5034718|NCT01487265|Erlotinib|erlotinib
5034719|NCT01487265|BKM120|bkm120
5034720|NCT01487265|NSCLC|nsclc
5034721|NCT01487226|Cervical cancer|cervical cancer
5034722|NCT01487213|Medical abortion|medical abortion
5034723|NCT01487213|Termination of pregnancy|termination of pregnancy
5034724|NCT01487213|Mifepristone|mifepristone
5034725|NCT01487213|Misoprostol|misoprostol
5034726|NCT01487213|Urine hCG|urine hcg
5034727|NCT01487213|Follow Up|follow up
5034728|NCT01487213|Termination of unwanted pregnancy. Self assessment (follow up) after medical abortion|termination of unwanted pregnancy. self assessment (follow up) after medical abortion
5034729|NCT01487200|Osteoarthritis|osteoarthritis
5034730|NCT01487200|Knee|knee
5034731|NCT01487200|Steroid|steroid
5034732|NCT01487200|intra-articular|intra-articular
5034733|NCT01487200|injection|injection
5034734|NCT01487187|Cord-milking|cord-milking
5034735|NCT01487187|hemodynamic|hemodynamic
5034736|NCT01487187|preterm infants|preterm infants
5034737|NCT01487161|osteoarthritis|osteoarthritis
5034738|NCT01487161|knee|knee
5034739|NCT01487161|pain|pain
5034740|NCT01487161|corticosteroid|corticosteroid
5034741|NCT01487161|intra-articular|intra-articular
5034742|NCT01487161|injection|injection
5034743|NCT01487135|Thorough QT (TQT)|thorough qt (tqt)
5034744|NCT01487135|EVP-6124|evp-6124
5034745|NCT01487122|Diathermy|diathermy
5034746|NCT01487122|Neck Pain|neck pain
5034747|NCT01487109|Type 2 diabetes|type 2 diabetes
5034748|NCT01487109|chronic kidney disease|chronic kidney disease
5034749|NCT01487083|schizophrenia|schizophrenia
5034750|NCT01487083|LY2140023|ly2140023
5034751|NCT01487083|pomaglumetad methionil|pomaglumetad methionil
5034752|NCT01487057|thyroid cancer|thyroid cancer
5034753|NCT01487057|dislipidemia|dislipidemia
5034754|NCT01487057|cardiovascular risk|cardiovascular risk
5034755|NCT01487044|DME|dme
5034756|NCT01487031|Autologous Stem Cell Transplantation|autologous stem cell transplantation
5034757|NCT01487031|multiple myeloma|multiple myeloma
5034758|NCT01487031|non-Hodgkin|non-hodgkin
5034759|NCT01487031|Hodgkin lymphoma|hodgkin lymphoma
5034760|NCT01487031|Music Therapy|music therapy
5034761|NCT01487031|Nausea|nausea
5034762|NCT01487031|Pain|pain
5034763|NCT01487018|Zygomatic Fractures|zygomatic fractures
5034764|NCT01487018|Surgery, Computer-Assisted|surgery, computer-assisted
5034765|NCT01487018|Facial Asymmetry|facial asymmetry
5034766|NCT01487005|ozone|ozone
5034767|NCT01487005|air pollution|air pollution
5034768|NCT01487005|vascular function|vascular function
5034769|NCT01487005|cardiac function|cardiac function
5034770|NCT01487005|inflammation|inflammation
5034771|NCT01486953|respiratory resistance|respiratory resistance
5034772|NCT01486953|lung compliance|lung compliance
5034773|NCT01486953|desflurane|desflurane
5034774|NCT01486953|sevoflurane|sevoflurane
5034775|NCT01486836|Cardiac disease (ICD indication)|cardiac disease (icd indication)
5034776|NCT01486810|cocaine|cocaine
5034777|NCT01486810|lisdexamfetamine|lisdexamfetamine
5034778|NCT01486797|Relapsed Chronic Lymphocytic Leukemia (CLL)|relapsed chronic lymphocytic leukemia (cll)
5034779|NCT01486797|NOX-A12|nox-a12
5034780|NCT01486797|Bendamustine|bendamustine
5034781|NCT01486797|Rituximab|rituximab
5034782|NCT01486797|Spiegelmer|spiegelmer
5034783|NCT01486797|Chemosensitization|chemosensitization
5034784|NCT01486797|Stromal cell-derived factor-1 (SDF-1)|stromal cell-derived factor-1 (sdf-1)
5034785|NCT01486797|CXCL12|cxcl12
5034786|NCT01486784|equal to or greater than age 60 years|equal to or greater than age 60 years
5034787|NCT01486784|non-M3 AML|non-m3 aml
5034788|NCT01486784|relapsed disease|relapsed disease
5034789|NCT01486784|primary refractory disease|primary refractory disease
5034790|NCT01486784|not appropriate or willing candidates for aggressive therapy|not appropriate or willing candidates for aggressive therapy
5034791|NCT01486784|AML|aml
5034792|NCT01486771|Proliferative Diabetic Retinopathy|proliferative diabetic retinopathy
5034793|NCT01486732|Cerebral Palsy|cerebral palsy
5034794|NCT01486732|Umbilical Cord Blood|umbilical cord blood
5034795|NCT01486732|FLT-PET|flt-pet
5034796|NCT01486719|Finger pulp reconstruction|finger pulp reconstruction
5034797|NCT01486719|dorsal branch|dorsal branch
5034798|NCT01486719|proper digital nerve|proper digital nerve
5034799|NCT01486719|palmar arterial arch|palmar arterial arch
5034800|NCT01486719|dorsal digital island flap|dorsal digital island flap
5034801|NCT01486706|Overactive Bladder|overactive bladder
5034802|NCT01486706|Gabapentin|gabapentin
5034803|NCT01486706|Quality of Life|quality of life
5034804|NCT01486706|Urodynamic|urodynamic
5034805|NCT01486706|safety|safety
5034806|NCT01486706|Efficacy|efficacy
5034807|NCT01486693|cytomegalovirus|cytomegalovirus
5034808|NCT01486693|uveitis|uveitis
5034809|NCT01486680|Gastric bypass|gastric bypass
5034810|NCT01486680|Silastic ring gastric bypass|silastic ring gastric bypass
5034811|NCT01486680|Roux-en-Y gastric bypass|roux-en-y gastric bypass
5034812|NCT01486680|Sleeve gastrectomy|sleeve gastrectomy
5034813|NCT01486680|Body composition analysis|body composition analysis
5034814|NCT01486667|focus of study instead|focus of study instead
5034815|NCT01486654|Cortical stimulation|cortical stimulation
5034816|NCT01486654|Ischemic Stroke|ischemic stroke
5034817|NCT01486654|Aphasia|aphasia
5034818|NCT01486654|Speech and Language Rehabilitation|speech and language rehabilitation
5034819|NCT01486641|femoral neck fracture|femoral neck fracture
5034820|NCT01486641|arthroplasty|arthroplasty
5034821|NCT01486641|surgical approach|surgical approach
5034822|NCT01486641|anterolateral|anterolateral
5034823|NCT01486641|posterolateral|posterolateral
5034824|NCT01486615|premedication|premedication
5034825|NCT01486615|premedicants|premedicants
5034826|NCT01486615|preoperative anxiety|preoperative anxiety
5034827|NCT01486615|melatonin|melatonin
5034828|NCT01486615|alprazolam|alprazolam
5034829|NCT01486602|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5034830|NCT01486602|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5034831|NCT01486589|emergency care|emergency care
5034832|NCT01486589|cardiac autonomic function|cardiac autonomic function
5034833|NCT01486589|deceleration capacity|deceleration capacity
5034834|NCT01486537|samples|samples
5034835|NCT01486537|children|children
5034836|NCT01486537|the age group 3-13 years|the age group 3-13 years
5034837|NCT01486524|pharmacogenomic biomarker|pharmacogenomic biomarker
5034838|NCT01486524|predictive marker|predictive marker
5034839|NCT01486524|prospective-retrospective|prospective-retrospective
5034840|NCT01486524|propensity score|propensity score
5034841|NCT01486524|matched-patients trial|matched-patients trial
5034842|NCT01486511|Liver disease|liver disease
5034843|NCT01486511|Pulmonary embolism|pulmonary embolism
5034844|NCT01486511|Thrombophilia|thrombophilia
5034845|NCT01486511|Death|death
5034846|NCT01486485|renal replacement therapy|renal replacement therapy
5034847|NCT01486472|Adjuvant chemotherapy|adjuvant chemotherapy
5034848|NCT01486446|IEM|iem
5034849|NCT01486446|EM|em
5035657|NCT01483014|stromal,|stromal,
5034850|NCT01486446|Erythromelalgia|erythromelalgia
5034851|NCT01486446|Erythermalgia|erythermalgia
5034852|NCT01486446|Red neuralgia|red neuralgia
5034853|NCT01486446|Peripheral Vascular Disease|peripheral vascular disease
5034854|NCT01486446|Vascular Disease|vascular disease
5034855|NCT01486446|Cardiovascular Disease|cardiovascular disease
5034856|NCT01486433|eicosapentaenoic acid|eicosapentaenoic acid
5034857|NCT01486433|docosapentaenoic acid|docosapentaenoic acid
5034858|NCT01486433|arachidonic acid|arachidonic acid
5034859|NCT01486433|hypertriglyceridemia|hypertriglyceridemia
5034860|NCT01486433|simvastatin|simvastatin
5034861|NCT01486420|Quinell grade|quinell grade
5034862|NCT01486420|Open surgery|open surgery
5034863|NCT01486420|corticosteroid injections|corticosteroid injections
5034864|NCT01486420|randomized controlled trial|randomized controlled trial
5034865|NCT01486420|Trigger finger|trigger finger
5034866|NCT01486407|Airway management|airway management
5034867|NCT01486355|Mortality|mortality
5034868|NCT01486355|Morbidity|morbidity
5034869|NCT01486355|Hospitalisations/consultations|hospitalisations/consultations
5034870|NCT01486355|Growth|growth
5034871|NCT01486355|Measles infection|measles infection
5034872|NCT01486329|Pancreatic cancer|pancreatic cancer
5034873|NCT01486329|Cancer vaccine|cancer vaccine
5034874|NCT01486329|Gemcitabine|gemcitabine
5034875|NCT01486329|Inoperable|inoperable
5034876|NCT01486329|Gemcitabine chemotherapy|gemcitabine chemotherapy
5034877|NCT01486329|Locally advanced|locally advanced
5034878|NCT01486303|Facial Cosmetic acupuncture|facial cosmetic acupuncture
5034879|NCT01486303|Skin Rejuvenation|skin rejuvenation
5034880|NCT01486303|Skin Aging|skin aging
5034881|NCT01486290|Intervention|intervention
5034882|NCT01486290|Cost Effective|cost effective
5034883|NCT01486290|Elderly|elderly
5034884|NCT01486290|Glycemic Control|glycemic control
5034885|NCT01486277|Lymphoma, T-Cell, Cutaneous|lymphoma, t-cell, cutaneous
5034886|NCT01486277|T-cell lymphoma|t-cell lymphoma
5034887|NCT01486277|Lymphoma|lymphoma
5034888|NCT01486277|Histone Deacetylase Inhibitor|histone deacetylase inhibitor
5034889|NCT01486277|JNJ-26481585|jnj-26481585
5034890|NCT01486238|Diabetic Macular Edema|diabetic macular edema
5034891|NCT01486212|Ischemia-reperfusion injury|ischemia-reperfusion injury
5034892|NCT01486212|Oxidative markers|oxidative markers
5034893|NCT01486212|Inflammatory markers|inflammatory markers
5034894|NCT01486199|cystic fibrosis|cystic fibrosis
5034895|NCT01486199|mucociliary clearance|mucociliary clearance
5034896|NCT01486199|airway surface liquid|airway surface liquid
5034897|NCT01486199|nuclear medicine|nuclear medicine
5034898|NCT01486186|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
5034899|NCT01486186|Double-Blind Method|double-blind method
5034900|NCT01486186|Medicine, Chinese Traditional|medicine, chinese traditional
5034901|NCT01486186|Humans|humans
5034902|NCT01486186|Treatment Outcome|treatment outcome
5034903|NCT01486173|PUFA|pufa
5034904|NCT01486173|Iron|iron
5034905|NCT01486173|Neurological development|neurological development
5034906|NCT01486173|Premature infant|premature infant
5034907|NCT01486147|Food labeling|food labeling
5034908|NCT01486147|Nutrition|nutrition
5034909|NCT01486147|Memory|memory
5034910|NCT01486147|Diet|diet
5034911|NCT01486134|Hepatocellular carcinoma|hepatocellular carcinoma
5034912|NCT01486134|Radiofrequency ablation|radiofrequency ablation
5034913|NCT01486134|Multipolar mode|multipolar mode
5034914|NCT01486134|Recurrence|recurrence
5034915|NCT01486134|Cirrhosis|cirrhosis
5034916|NCT01486134|MR temperature monitoring|mr temperature monitoring
5034917|NCT01486134|large tumor|large tumor
5034918|NCT01486121|Surgery|surgery
5034919|NCT01486121|Critical illness|critical illness
5034920|NCT01486121|Mechanical ventilation|mechanical ventilation
5034921|NCT01486121|Organ dysfunction syndrome|organ dysfunction syndrome
5034922|NCT01486121|Intensive Care Units Sedation|intensive care units sedation
5034923|NCT01486121|Analgesia|analgesia
5034924|NCT01486121|Treatment protocol|treatment protocol
5034925|NCT01486121|Nursing protocol|nursing protocol
5034926|NCT01486121|Outcome|outcome
5034927|NCT01486121|Pain|pain
5034928|NCT01486121|Neurological disorders|neurological disorders
5034929|NCT01486121|Delirium|delirium
5034930|NCT01486121|Muscular weakness|muscular weakness
5034931|NCT01486121|Psychological disorders|psychological disorders
5034932|NCT01486121|Anxiety|anxiety
5034933|NCT01486121|Depression|depression
5034934|NCT01486121|Stress disorders|stress disorders
5034935|NCT01486121|Post-Traumatic|post-traumatic
5034936|NCT01486108|tonic, burst and placebo stimulation|tonic, burst and placebo stimulation
5034937|NCT01486082|OCA 10|oca 10
5034938|NCT01486082|Antibiogram|antibiogram
5034939|NCT01486082|Eradication|eradication
5034940|NCT01486069|Dentofacial Deformity|dentofacial deformity
5034941|NCT01486069|Orthognathic Surgery|orthognathic surgery
5034942|NCT01486069|Mandible|mandible
5034943|NCT01486069|Orthognathic Surgical Procedures|orthognathic surgical procedures
5034944|NCT01486056|epilepsy|epilepsy
5034945|NCT01486056|ECG|ecg
5034946|NCT01486056|device placement|device placement
5034947|NCT01486043|Induction chemotherapy|induction chemotherapy
5034948|NCT01486043|Transient hyperglycemia|transient hyperglycemia
5034949|NCT01486043|Metformin|metformin
5034950|NCT01486043|Acute lymphoblastic leukemia|acute lymphoblastic leukemia
5034951|NCT01486043|Insulin resistance|insulin resistance
5034952|NCT01486043|Hyperglycemia|hyperglycemia
5034953|NCT01486043|Insulin|insulin
5034954|NCT01486030|Atherosclerosis|atherosclerosis
5034955|NCT01486030|Corus CAD|corus cad
5034956|NCT01486030|Age/Sex/Gene Expression Score|age/sex/gene expression score
5034957|NCT01486030|ASGES|asges
5034958|NCT01486030|Gene Expression|gene expression
5034959|NCT01486030|GES|ges
5034960|NCT01486030|CAD|cad
5034961|NCT01486030|CVD|cvd
5034962|NCT01486030|CHD|chd
5034963|NCT01486030|Precision Medicine|precision medicine
5034964|NCT01486030|Exercise Stress Test|exercise stress test
5034965|NCT01486030|Coronary Artery Disease|coronary artery disease
5034966|NCT01486030|Angina Pectoris|angina pectoris
5034967|NCT01486030|Chest Pain|chest pain
5034968|NCT01486030|Cardiovascular Disease|cardiovascular disease
5034969|NCT01486030|Coronary Heart Disease|coronary heart disease
5034970|NCT01486030|EXERCISE|exercise
5034971|NCT01486017|ASP015K|asp015k
5034972|NCT01486017|healthy subjects|healthy subjects
5034973|NCT01486017|bioavailability|bioavailability
5034974|NCT01486017|rheumatoid arthritis|rheumatoid arthritis
5034975|NCT01486017|psoriasis|psoriasis
5034976|NCT01486017|transplantation|transplantation
5034977|NCT01486004|Hepatitis C Virus|hepatitis c virus
5034978|NCT01486004|TMC435|tmc435
5034979|NCT01486004|TMC435-TiDP16-C124|tmc435-tidp16-c124
5034980|NCT01486004|TMC435-C124|tmc435-c124
5034981|NCT01486004|HCV|hcv
5034982|NCT01486004|Hepatitis C|hepatitis c
5034983|NCT01486004|Hep C|hep c
5034984|NCT01486004|Healthy participants|healthy participants
5034985|NCT01485991|Hepatitis C|hepatitis c
5034986|NCT01485991|TMC435HPC3001|tmc435hpc3001
5034987|NCT01485991|TMC435|tmc435
5034988|NCT01485991|Hepatitis C Virus (HCV)|hepatitis c virus (hcv)
5034989|NCT01485991|HEP C|hep c
5034990|NCT01485991|Genotype 1|genotype 1
5034991|NCT01485991|Treatment experienced|treatment experienced
5034992|NCT01485991|Null responders|null responders
5034993|NCT01485991|Partial responders|partial responders
5034994|NCT01485978|Alport Syndrome|alport syndrome
5034995|NCT01485978|chronic kidney disease|chronic kidney disease
5034996|NCT01485978|renal fibrosis|renal fibrosis
5034997|NCT01485978|nephroprotection|nephroprotection
5034998|NCT01485978|pediatric study|pediatric study
5034999|NCT01485965|Huntington Disease|huntington disease
5035000|NCT01485965|Basal Ganglia Diseases|basal ganglia diseases
5035001|NCT01485965|Brain Diseases|brain diseases
5035002|NCT01485965|Central Nervous System Diseases|central nervous system diseases
5035003|NCT01485965|Nervous System Diseases|nervous system diseases
5035004|NCT01485965|Dementia|dementia
5035005|NCT01485965|Chorea|chorea
5035006|NCT01485965|Dyskinesias|dyskinesias
5035007|NCT01485965|Movement Disorders|movement disorders
5035008|NCT01485965|Heredodegenerative Disorders, Nervous System|heredodegenerative disorders, nervous system
5035009|NCT01485965|Neurodegenerative Diseases|neurodegenerative diseases
5035010|NCT01485965|Genetic Diseases, Inborn|genetic diseases, inborn
5035011|NCT01485965|Cognition Disorders|cognition disorders
5035012|NCT01485965|Mental Disorders|mental disorders
5035013|NCT01485952|Huntington Disease|huntington disease
5035014|NCT01485952|Basal Ganglia Diseases|basal ganglia diseases
5035015|NCT01485952|Brain Diseases|brain diseases
5035016|NCT01485952|Central Nervous System Diseases|central nervous system diseases
5035017|NCT01485952|Nervous System Diseases|nervous system diseases
5035018|NCT01485952|Dementia|dementia
5035019|NCT01485952|Chorea|chorea
5035020|NCT01485952|Dyskinesias|dyskinesias
5035021|NCT01485952|Movement Disorders|movement disorders
5035022|NCT01485952|Heredodegenerative Disorders, Nervous System|heredodegenerative disorders, nervous system
5035023|NCT01485952|Neurodegenerative Diseases|neurodegenerative diseases
5035024|NCT01485952|Genetic Diseases, Inborn|genetic diseases, inborn
5035025|NCT01485952|Cognition Disorders|cognition disorders
5035026|NCT01485952|Mental Disorders|mental disorders
5035027|NCT01485939|lidocaine patch|lidocaine patch
5035028|NCT01485939|laparoscopic cholecystectomy|laparoscopic cholecystectomy
5035029|NCT01485913|Education|education
5035030|NCT01485913|Diabetes|diabetes
5035031|NCT01485913|Prevention complications|prevention complications
5035032|NCT01485913|Prevention of complications of diabetes|prevention of complications of diabetes
5035033|NCT01485887|Venlafaxine ER|venlafaxine er
5035034|NCT01485887|long-term extension|long-term extension
5035035|NCT01485887|Japan|japan
5035036|NCT01485874|BIBF 1120|bibf 1120
5035037|NCT01485835|Multiple Myeloma|multiple myeloma
5035038|NCT01485835|Bortezomib|bortezomib
5035039|NCT01485835|Velcade|velcade
5035040|NCT01485835|Ganetespib|ganetespib
5035041|NCT01485822|Glaucoma|glaucoma
5035042|NCT01485822|Travatan|travatan
5035043|NCT01485822|Trabeculectomy|trabeculectomy
5035044|NCT01485796|PIDD|pidd
5035045|NCT01485783|Hypertension|hypertension
5035046|NCT01485757|patients|patients
5035047|NCT01485744|metastatic|metastatic
5035048|NCT01485744|untreated|untreated
5035049|NCT01485744|advanced|advanced
5035050|NCT01485731|Cervical|cervical
5035051|NCT01485731|Cancer|cancer
5035052|NCT01485731|Uterine Cervix|uterine cervix
5035053|NCT01485731|Squamous Cell|squamous cell
5035054|NCT01485731|Adenocarcinoma|adenocarcinoma
5035055|NCT01485718|Obesity|obesity
5035056|NCT01485718|Overweight|overweight
5035057|NCT01485718|Weight loss|weight loss
5035058|NCT01485705|severe bacterial infection|severe bacterial infection
5035059|NCT01485692|Violence|violence
5035060|NCT01485692|Aggression|aggression
5035061|NCT01485692|Psychiatric emergencies|psychiatric emergencies
5035062|NCT01485692|Psychomotor agitation|psychomotor agitation
5035063|NCT01485692|Violent patient|violent patient
5035064|NCT01485679|18 fluoro deoxy glucose positrons emission tomography combined with computed tomography,|18 fluoro deoxy glucose positrons emission tomography combined with computed tomography,
5035065|NCT01485679|Patients with intraductal papillary mucinous tumor of the pancreas|patients with intraductal papillary mucinous tumor of the pancreas
5035066|NCT01485679|intraductal papillary mucinous|intraductal papillary mucinous
5035067|NCT01485679|pancreas|pancreas
5035068|NCT01485666|Thoratec|thoratec
5035069|NCT01485666|HeartMate II|heartmate ii
5035070|NCT01485666|heart-assist devices|heart-assist devices
5035071|NCT01485666|driveline or percutaneous lead management|driveline or percutaneous lead management
5035072|NCT01485666|HeartMate II Percutaneous Lead Management|heartmate ii percutaneous lead management
5035073|NCT01485653|Brachial Plexus|brachial plexus
5035074|NCT01485653|Mepivacaine|mepivacaine
5035075|NCT01485653|Ultrasound|ultrasound
5035076|NCT01485653|Axillary|axillary
5035077|NCT01485653|Block|block
5035078|NCT01485640|Schizophrenia|schizophrenia
5035079|NCT01485640|bipolar disorder|bipolar disorder
5035080|NCT01485640|Lurasidone|lurasidone
5035081|NCT01485640|Latuda|latuda
5035082|NCT01485627|Cancer|cancer
5035083|NCT01485627|Communication|communication
5035084|NCT01485627|prognosis|prognosis
5035085|NCT01485575|Chromovitrectomy|chromovitrectomy
5035086|NCT01485575|Indocyanine green|indocyanine green
5035087|NCT01485575|ICG|icg
5035088|NCT01485575|Brilliant Blue G|brilliant blue g
5035089|NCT01485575|BBG|bbg
5035090|NCT01485575|Trypan blue|trypan blue
5035091|NCT01485575|TB|tb
5035092|NCT01485575|Internal limiting membrane|internal limiting membrane
5035093|NCT01485575|ILM|ilm
5035094|NCT01485562|postpartum haemorrhage|postpartum haemorrhage
5035095|NCT01485562|misoprostol|misoprostol
5035096|NCT01485562|treatment|treatment
5035097|NCT01485562|prophylaxis|prophylaxis
5035098|NCT01485562|home births|home births
5035099|NCT01485549|Multiple system atrophy (MSA)|multiple system atrophy (msa)
5035100|NCT01485549|alpha-synucleinopathies|alpha-synucleinopathies
5035101|NCT01485549|biological markers|biological markers
5035102|NCT01485549|cerebrospinal fluid|cerebrospinal fluid
5035103|NCT01485549|plasma|plasma
5035104|NCT01485536|Lymphoma|lymphoma
5035105|NCT01485536|Relapsed/refractory lymphoma|relapsed/refractory lymphoma
5035106|NCT01485536|AUY922|auy922
5035107|NCT01485523|Allergic rhinitis|allergic rhinitis
5035108|NCT01485523|Nasal provocation test|nasal provocation test
5035109|NCT01485510|Maltreatment|maltreatment
5035110|NCT01485510|Infant Mental Health|infant mental health
5035111|NCT01485510|Infant mental health in maltreated children|infant mental health in maltreated children
5035112|NCT01485497|APNEA|apnea
5035113|NCT01485471|Middle Ear Infection|middle ear infection
5035114|NCT01485458|Incomplete spinal cord injury|incomplete spinal cord injury
5035115|NCT01485458|Cervical canal stenosis|cervical canal stenosis
5035116|NCT01485458|Ossification of the posterior longitudinal ligament|ossification of the posterior longitudinal ligament
5035117|NCT01485458|Surgery|surgery
5035118|NCT01485458|Decompression|decompression
5035119|NCT01485445|bioequivalence|bioequivalence
5035120|NCT01485445|pharmacokinetics|pharmacokinetics
5035121|NCT01485445|Fluticasone Furoate|fluticasone furoate
5035122|NCT01485445|Vilanterol|vilanterol
5035123|NCT01485432|Renal transplant surgery|renal transplant surgery
5035124|NCT01485432|hemodynamic management|hemodynamic management
5035125|NCT01485432|PiCCO|picco
5035126|NCT01485432|delayed graft function|delayed graft function
5035127|NCT01485419|Sex hormones|sex hormones
5035128|NCT01485419|Testosterone|testosterone
5035129|NCT01485419|Estradiol|estradiol
5035130|NCT01485406|Haemophilus influenzae|haemophilus influenzae
5035131|NCT01485406|Safety|safety
5035132|NCT01485406|Pneumococcal vaccine|pneumococcal vaccine
5035133|NCT01485406|Streptococcus pneumoniae|streptococcus pneumoniae
5035134|NCT01485406|Immunogenicity|immunogenicity
5035135|NCT01485406|Toddlers|toddlers
5035136|NCT01485380|Dexmedetomidine|dexmedetomidine
5035137|NCT01485380|Sleep|sleep
5035138|NCT01485380|MRI-PET|mri-pet
5035139|NCT01485380|EEG|eeg
5035140|NCT01485367|Senile Purpura|senile purpura
5035141|NCT01485367|Adapalene 0.3%|adapalene 0.3%
5035142|NCT01485354|Stroke|stroke
5035143|NCT01485354|Rehabilitation|rehabilitation
5035144|NCT01485341|gluten sensitivity|gluten sensitivity
5035145|NCT01485328|Dyspepsia|dyspepsia
5035146|NCT01485328|Flatulence|flatulence
5035147|NCT01485328|Aerophagia|aerophagia
5035148|NCT01485328|Constipation|constipation
5035149|NCT01485302|mild to moderate Alzheimer's Disease|mild to moderate alzheimer's disease
5035150|NCT01485276|Parkinson's Disease|parkinson's disease
5035151|NCT01485276|Deep Brain Stimulation|deep brain stimulation
5035152|NCT01485276|Gait|gait
5035153|NCT01485276|Electrophysiology|electrophysiology
5035154|NCT01485276|Parkinson Disease|parkinson disease
5035155|NCT01485276|PD|pd
5035156|NCT01485263|Deep Brain Stimulation|deep brain stimulation
5035157|NCT01485263|OCD|ocd
5035158|NCT01485250|Healthy Volunteers|healthy volunteers
5035159|NCT01485250|Motivations|motivations
5035160|NCT01485250|Decision Making|decision making
5035161|NCT01485250|Motivation|motivation
5035162|NCT01485224|Hereditary hemorrhagic telangiectasia|hereditary hemorrhagic telangiectasia
5035163|NCT01485224|Epistaxis|epistaxis
5035164|NCT01485224|Thalidomide|thalidomide
5035165|NCT01485211|progressive keratoconus|progressive keratoconus
5035166|NCT01485211|thin corneas|thin corneas
5035167|NCT01485211|cross-linking|cross-linking
5035168|NCT01485211|hypo-osmolar riboflavin|hypo-osmolar riboflavin
5035169|NCT01485198|osteoarthritis|osteoarthritis
5035170|NCT01485198|knee|knee
5035171|NCT01485198|stem cell therapy|stem cell therapy
5035172|NCT01485198|bone marrow|bone marrow
5035173|NCT01485198|G-CSF|g-csf
5035174|NCT01485185|Donepezil|donepezil
5035175|NCT01485185|allodynia|allodynia
5035176|NCT01485185|Gabapentin|gabapentin
5035177|NCT01485185|Sural nerve stimulation|sural nerve stimulation
5035178|NCT01485185|Electrical hyperalgesia|electrical hyperalgesia
5035179|NCT01485159|prevalence|prevalence
5035180|NCT01485159|COPD|copd
5035181|NCT01485159|emphysema|emphysema
5035182|NCT01485159|co-morbidities|co-morbidities
5035183|NCT01485159|ischemic heart disease|ischemic heart disease
5035184|NCT01485159|chronic bronchitis|chronic bronchitis
5035185|NCT01485159|spirometry|spirometry
5035186|NCT01485159|burden|burden
5035187|NCT01485133|colonoscopy|colonoscopy
5035188|NCT01485133|water|water
5035189|NCT01485133|surgery|surgery
5035190|NCT01485133|unsedated|unsedated
5035191|NCT01485120|Blood pressure (low, normal, high)|blood pressure (low, normal, high)
5035192|NCT01485107|Ulthera® System|ulthera® system
5035193|NCT01485107|Ultherapy™ treatment|ultherapy™ treatment
5035194|NCT01485107|Ulthera, Inc.|ulthera, inc.
5035195|NCT01485107|Ultrasound treatment for skin tightening|ultrasound treatment for skin tightening
5035196|NCT01485094|neuralgia|neuralgia
5035197|NCT01485094|postherpetic|postherpetic
5035198|NCT01485081|Bifurcation|bifurcation
5035199|NCT01485081|Drug-eluting balloon|drug-eluting balloon
5035200|NCT01485081|Paclitaxel-eluting balloon|paclitaxel-eluting balloon
5035201|NCT01485081|Angioplasty|angioplasty
5035202|NCT01485081|Coronary artery disease|coronary artery disease
5035203|NCT01485081|Coronary artery stenosis|coronary artery stenosis
5035204|NCT01485068|Restenosis|restenosis
5035205|NCT01485068|Paclitaxel-eluting balloon|paclitaxel-eluting balloon
5035206|NCT01485068|Angioplasty|angioplasty
5035207|NCT01485068|Coronary artery disease|coronary artery disease
5035208|NCT01485068|Coronary artery stenosis|coronary artery stenosis
5035209|NCT01485055|aGVHD|agvhd
5035210|NCT01485055|GVHD|gvhd
5035211|NCT01485055|Graft versus host disease|graft versus host disease
5035212|NCT01485055|Acute graft versus host disease|acute graft versus host disease
5035213|NCT01485055|Steroid refractory graft versus host disease|steroid refractory graft versus host disease
5035214|NCT01485055|Bone marrow transplant|bone marrow transplant
5035215|NCT01485055|BMT|bmt
5035216|NCT01485055|HSCT|hsct
5035217|NCT01485055|infliximab|infliximab
5035218|NCT01485055|basiliximab|basiliximab
5035219|NCT01485055|Monoclonal antibody treatment|monoclonal antibody treatment
5035220|NCT01485042|Phase 1|phase 1
5035221|NCT01485042|pazopanib|pazopanib
5035222|NCT01485042|TH-302|th-302
5035223|NCT01485042|advanced solid tumors|advanced solid tumors
5035224|NCT01485016|epilepsy|epilepsy
5035225|NCT01485016|ECG|ecg
5035226|NCT01485016|accelerometer|accelerometer
5035227|NCT01484990|Parkinson's Disease|parkinson's disease
5035228|NCT01484990|levodopa|levodopa
5035229|NCT01484990|carbidopa|carbidopa
5035230|NCT01484990|Duodopa|duodopa
5035231|NCT01484990|intestinal gel|intestinal gel
5035232|NCT01484977|Lacosamide|lacosamide
5035233|NCT01484977|Epilepsy|epilepsy
5035234|NCT01484977|Levetiracetam|levetiracetam
5035235|NCT01484977|Sodium Channel Blockers|sodium channel blockers
5035236|NCT01484964|ASP015K|asp015k
5035237|NCT01484964|healthy subjects|healthy subjects
5035238|NCT01484964|bioavailability|bioavailability
5035239|NCT01484964|food effect|food effect
5035240|NCT01484964|rheumatoid arthritis|rheumatoid arthritis
5035241|NCT01484964|psoriasis|psoriasis
5035242|NCT01484964|transplantation|transplantation
5035243|NCT01484951|Open-angle glaucoma|open-angle glaucoma
5035244|NCT01484951|Ocular hypertension|ocular hypertension
5035245|NCT01484951|Pigment dispersion glaucoma|pigment dispersion glaucoma
5035246|NCT01484938|Soft contact lenses|soft contact lenses
5035247|NCT01484938|Multi-purpose solution|multi-purpose solution
5035248|NCT01484938|Corneal staining|corneal staining
5035249|NCT01484925|Barrett's esophagus|barrett's esophagus
5035250|NCT01484912|Green tea polyphenols|green tea polyphenols
5035251|NCT01484912|Chronic Stable Angina|chronic stable angina
5035252|NCT01484899|Pulmonary arterial Hypertension|pulmonary arterial hypertension
5035253|NCT01484899|Chronic thromboembolic pulmonary hypertension|chronic thromboembolic pulmonary hypertension
5035254|NCT01484899|smoking|smoking
5035255|NCT01484886|Hemoglobin|hemoglobin
5035256|NCT01484886|Congenital heart disease|congenital heart disease
5035257|NCT01484886|Cardiac surgery|cardiac surgery
5035258|NCT01484886|Red blood cell transfusion|red blood cell transfusion
5035259|NCT01484886|Number of red blood cell transfusions|number of red blood cell transfusions
5035260|NCT01484873|Exenatide|exenatide
5035261|NCT01484873|Byetta|byetta
5035262|NCT01484873|Hypothalamic Obesity|hypothalamic obesity
5035263|NCT01484873|Obesity|obesity
5035264|NCT01484873|Craniopharyngioma|craniopharyngioma
5035265|NCT01484860|AUY922|auy922
5035266|NCT01484860|Pancreas|pancreas
5035267|NCT01484860|Pancreatic cancer|pancreatic cancer
5035268|NCT01484860|Adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
5035269|NCT01484860|Cancer of the pancreas|cancer of the pancreas
5035270|NCT01484860|Metastatic|metastatic
5035271|NCT01484860|Advanced|advanced
5035272|NCT01484860|Advanced disease|advanced disease
5035273|NCT01484860|Prior systemic anticancer therapy|prior systemic anticancer therapy
5035274|NCT01484847|advanced|advanced
5035275|NCT01484847|PF-00299804|pf-00299804
5035276|NCT01484847|head and neck|head and neck
5035277|NCT01484847|pharmacokinetic|pharmacokinetic
5035278|NCT01484847|squamous cell carcinoma|squamous cell carcinoma
5035279|NCT01484847|gastrojejunostomy|gastrojejunostomy
5035280|NCT01484847|feeding tube|feeding tube
5035281|NCT01484834|Physical Activity|physical activity
5035282|NCT01484834|Occupational Health|occupational health
5035283|NCT01484834|Quality of Life|quality of life
5035284|NCT01484834|Health Promotion|health promotion
5035285|NCT01484821|Sarcopenia|sarcopenia
5035286|NCT01484821|ARFI|arfi
5035287|NCT01484821|DEXA|dexa
5035288|NCT01484821|Cancer|cancer
5035289|NCT01484808|PSA Density|psa density
5035290|NCT01484808|Prostate Cancer|prostate cancer
5035291|NCT01484808|Prostate Biopsy|prostate biopsy
5035292|NCT01484808|PSA|psa
5035293|NCT01484795|noninvasive ventilation|noninvasive ventilation
5035294|NCT01484795|autonomic nervous system|autonomic nervous system
5035295|NCT01484782|Hypertension|hypertension
5035296|NCT01484782|Telephone Care Management|telephone care management
5035297|NCT01484782|Blood pressure|blood pressure
5035298|NCT01484782|Medication adherence|medication adherence
5035299|NCT01484782|Interactive Voice Response (IVR)|interactive voice response (ivr)
5035300|NCT01484782|Cloud computing|cloud computing
5035301|NCT01484756|respiratory infection|respiratory infection
5035302|NCT01484756|independent elderly|independent elderly
5035303|NCT01484756|zinc|zinc
5035304|NCT01484756|vitamins|vitamins
5035305|NCT01484743|recurrence|recurrence
5035306|NCT01484743|readmission|readmission
5035307|NCT01484743|reoperation|reoperation
5035308|NCT01484743|mortality|mortality
5035309|NCT01484743|morbidity|morbidity
5035310|NCT01484704|Carcinoma ductale mammae|carcinoma ductale mammae
5035311|NCT01484678|Duchenne Muscular Dystrophy|duchenne muscular dystrophy
5035312|NCT01484678|Magnetic Resonance Imaging|magnetic resonance imaging
5035313|NCT01484678|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
5035315|NCT01484665|PSA screening|psa screening
5035316|NCT01484665|Decision aids|decision aids
5035317|NCT01484652|Moderate Post-Operative Pain|moderate post-operative pain
5035318|NCT01484652|Severe Post-Operative Pain|severe post-operative pain
5035319|NCT01484652|Bunionectomy|bunionectomy
5035320|NCT01484639|transfusion|transfusion
5035321|NCT01484639|cardiac surgery|cardiac surgery
5035322|NCT01484626|Relapsed Multiple Myeloma|relapsed multiple myeloma
5035323|NCT01484626|Refractory Multiple Myeloma|refractory multiple myeloma
5035324|NCT01484626|Bendamustine|bendamustine
5035325|NCT01484626|Bortezomib|bortezomib
5035326|NCT01484626|Lenalidomide|lenalidomide
5035327|NCT01484626|Dexamethasone|dexamethasone
5035328|NCT01484626|Treanda|treanda
5035329|NCT01484626|Velcade|velcade
5035330|NCT01484626|Revlimid|revlimid
5035331|NCT01484613|Hear Failure|hear failure
5035332|NCT01484613|Cardiac resynchronization|cardiac resynchronization
5035333|NCT01484613|CRT-D|crt-d
5035334|NCT01484613|quadripolar|quadripolar
5035335|NCT01484600|Volunteers|volunteers
5035336|NCT01484587|Moderate to Severe Plaque-Type Psoriasis|moderate to severe plaque-type psoriasis
5035337|NCT01484587|Psoriasis|psoriasis
5035338|NCT01484587|Plaque-type psoriasis|plaque-type psoriasis
5035339|NCT01484587|CNTO 1959|cnto 1959
5035340|NCT01484587|Japanese participants|japanese participants
5035341|NCT01484574|Critical limb ischemia|critical limb ischemia
5035342|NCT01484574|Buerger's disease|buerger's disease
5035343|NCT01484574|Critical limb ischemia due to Buerger's disease|critical limb ischemia due to buerger's disease
5035344|NCT01484561|Phase 1|phase 1
5035345|NCT01484522|Influenza|influenza
5035346|NCT01484522|Perinatal|perinatal
5035347|NCT01484522|immunogenicity|immunogenicity
5035348|NCT01484522|Monovalent vaccine|monovalent vaccine
5035349|NCT01484522|Children|children
5035350|NCT01484522|Youth|youth
5035351|NCT01484522|H1N1|h1n1
5035352|NCT01484522|Adolescent|adolescent
5035353|NCT01484522|Flu|flu
5035354|NCT01484509|walking impairment|walking impairment
5035355|NCT01484509|claudication|claudication
5035356|NCT01484509|treadmill|treadmill
5035357|NCT01484509|questionnaire|questionnaire
5035358|NCT01484496|Subcutaneous|subcutaneous
5035360|NCT01484496|Systemic Lupus Erythematosus|systemic lupus erythematosus
5035361|NCT01484496|SLE|sle
5035362|NCT01484496|Belimumab|belimumab
5035363|NCT01484496|Autoimmune Disease|autoimmune disease
5035364|NCT01484496|Antibodies|antibodies
5035365|NCT01484470|Stem cell transplantation|stem cell transplantation
5035366|NCT01484470|Stem Cell expansion|stem cell expansion
5035367|NCT01484470|Elderly|elderly
5035368|NCT01484457|Diabetes Mellitus|diabetes mellitus
5035369|NCT01484457|Closed Loop|closed loop
5035370|NCT01484457|Artificial Pancreas|artificial pancreas
5035371|NCT01484418|Chronic Low Back Pain|chronic low back pain
5035372|NCT01484418|Cognitive Behavioural Therapy|cognitive behavioural therapy
5035373|NCT01484418|Exposure|exposure
5035374|NCT01484418|Fear avoidance|fear avoidance
5035375|NCT01484418|Cognitive Behavioural Therapy in chronic low back pain|cognitive behavioural therapy in chronic low back pain
5035376|NCT01484418|Exposure in vivo in chronic low back pain|exposure in vivo in chronic low back pain
5035377|NCT01484405|surgical approach for total hip arthroplasty|surgical approach for total hip arthroplasty
5035378|NCT01484392|open angle glaucoma|open angle glaucoma
5035379|NCT01484392|compliance|compliance
5035380|NCT01484392|adherence|adherence
5035381|NCT01484379|Primary Hyperparathyroidism|primary hyperparathyroidism
5035382|NCT01484379|multigland disease|multigland disease
5035383|NCT01484379|neck exploration|neck exploration
5035384|NCT01484379|elderly|elderly
5035385|NCT01484366|fractures of both radius and ulna|fractures of both radius and ulna
5035386|NCT01484353|Diabetes|diabetes
5035387|NCT01484340|smoking|smoking
5035388|NCT01484340|administration, cutaneous|administration, cutaneous
5035389|NCT01484327|Heart Failure|heart failure
5035390|NCT01484327|Acute Myocardial Infarction|acute myocardial infarction
5035391|NCT01484327|LVEF|lvef
5035392|NCT01484314|Relapsed|relapsed
5035393|NCT01484301|Chronic pain|chronic pain
5035394|NCT01484301|Opioids|opioids
5035395|NCT01484301|Tolerability|tolerability
5035396|NCT01484275|High-risk smoldering multiple myeloma|high-risk smoldering multiple myeloma
5035397|NCT01484275|Multiple myeloma|multiple myeloma
5035398|NCT01484275|Siltuximab|siltuximab
5035399|NCT01484249|embolic|embolic
5035400|NCT01484249|filters|filters
5035401|NCT01484249|brachiocephalic|brachiocephalic
5035402|NCT01484249|neurovasculature|neurovasculature
5035403|NCT01484249|debris|debris
5035404|NCT01484236|Lymphangioleiomyomatosis|lymphangioleiomyomatosis
5035405|NCT01484223|Primary Health Care|primary health care
5035406|NCT01484223|Somatization symptoms|somatization symptoms
5035407|NCT01484223|Cognitive Behavioral Therapy|cognitive behavioral therapy
5035408|NCT01484223|Nursing intervention|nursing intervention
5035409|NCT01484197|Asthma|asthma
5035410|NCT01484197|Indacaterol|indacaterol
5035411|NCT01484197|QAB149|qab149
5035412|NCT01484184|Completely paralyzed|completely paralyzed
5035413|NCT01484184|Chronically injured|chronically injured
5035414|NCT01484184|Central Pattern Generator|central pattern generator
5035415|NCT01484184|Locomotion|locomotion
5035416|NCT01484184|Secondary complications|secondary complications
5035417|NCT01484184|Activity-based training|activity-based training
5035418|NCT01484184|Treadmill training|treadmill training
5035419|NCT01484184|Spinal cord injury|spinal cord injury
5035420|NCT01484184|Paraplegia|paraplegia
5035421|NCT01484184|Tetraplegia|tetraplegia
5035422|NCT01484171|Acute Myeloid Leukemia|acute myeloid leukemia
5035423|NCT01484171|idarubicin|idarubicin
5035424|NCT01484171|Microtransplantation|microtransplantation
5035425|NCT01484158|Myocardial Infarction|myocardial infarction
5035426|NCT01484145|Onychomycosis|onychomycosis
5035427|NCT01484145|Nail fungus|nail fungus
5035428|NCT01484145|Tinea Unguium|tinea unguium
5035429|NCT01484132|Dental Caries|dental caries
5035430|NCT01484132|Dental Restorative Materials|dental restorative materials
5035431|NCT01484132|Dental Composite|dental composite
5035432|NCT01484132|Bisphenol-A|bisphenol-a
5035433|NCT01484119|seasonal allergic rhinitis|seasonal allergic rhinitis
5035434|NCT01484093|CYCLOPHOSPHAMIDE (CYTOXAN)|cyclophosphamide (cytoxan)
5035435|NCT01484093|CYTARABINE (ARA-C)|cytarabine (ara-c)
5035436|NCT01484093|DOXORUBICIN/ADRIAMYCIN|doxorubicin/adriamycin
5035437|NCT01484093|PREDNISONE|prednisone
5035438|NCT01484093|RITUXIMAB|rituximab
5035439|NCT01484093|TOSITUMOMAB (BEXXAR)|tositumomab (bexxar)
5035440|NCT01484093|Iodine|iodine
5035441|NCT01484093|VINCRISTIN|vincristin
5035442|NCT01484093|Lymphoma|lymphoma
5035443|NCT01484093|Chemo-Radioimmunotherapy|chemo-radioimmunotherapy
5035444|NCT01484093|Autologous Transplantation|autologous transplantation
5035445|NCT01484093|Untreated|untreated
5035446|NCT01484093|11-095|11-095
5035447|NCT01484067|Herpes Simplex Virus|herpes simplex virus
5035448|NCT01484041|Breast cancer|breast cancer
5035449|NCT01484041|postmenopausal|postmenopausal
5035450|NCT01484002|Hip replacement|hip replacement
5035451|NCT01484002|Crosslinked and conventional polyethylene|crosslinked and conventional polyethylene
5035452|NCT01484002|Oxidation|oxidation
5035453|NCT01484002|Crosslink density|crosslink density
5035454|NCT01484002|Outcome|outcome
5035455|NCT01483989|Dry Eye|dry eye
5035456|NCT01483989|Epithelial changes|epithelial changes
5035457|NCT01483950|Dyslipidemia|dyslipidemia
5035458|NCT01483950|Statins|statins
5035459|NCT01483950|Total Cholesterol|total cholesterol
5035460|NCT01483950|Low density lipoprotein (LDL) cholesterol|low density lipoprotein (ldl) cholesterol
5035461|NCT01483950|High density lipoprotein (HDL) cholesterol|high density lipoprotein (hdl) cholesterol
5035462|NCT01483937|Keywords provided by BalanceSense, LLC:|keywords provided by balancesense, llc:
5035463|NCT01483937|Physical Therapy|physical therapy
5035464|NCT01483937|Rehabilitation|rehabilitation
5035465|NCT01483937|Disequilibrium|disequilibrium
5035466|NCT01483937|Balance dysfunction or disorder|balance dysfunction or disorder
5035467|NCT01483937|Vestibular|vestibular
5035468|NCT01483937|Mild Traumatic Brain Injury (mTBI)|mild traumatic brain injury (mtbi)
5035469|NCT01483937|Vibrotactile|vibrotactile
5035470|NCT01483924|Mild to Moderate Chronic Plaque Psoriasis|mild to moderate chronic plaque psoriasis
5035471|NCT01483898|critical limb ischemia|critical limb ischemia
5035472|NCT01483898|REVIVE|revive
5035473|NCT01483898|peripheral vascular disease|peripheral vascular disease
5035474|NCT01483898|CLI|cli
5035475|NCT01483898|PAD|pad
5035476|NCT01483898|MSC|msc
5035477|NCT01483898|stem cells|stem cells
5035478|NCT01483898|cell therapy|cell therapy
5035479|NCT01483872|salvage infected hemodialysis catheters|salvage infected hemodialysis catheters
5035480|NCT01483872|novel catheter lock solution|novel catheter lock solution
5035481|NCT01483846|Neuropathic Pain|neuropathic pain
5035482|NCT01483846|Capsaicin Induced Pain|capsaicin induced pain
5035483|NCT01483807|speech|speech
5035484|NCT01483807|speech therapy|speech therapy
5035485|NCT01483807|apraxia of speech|apraxia of speech
5035486|NCT01483794|genital warts|genital warts
5035487|NCT01483781|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
5035488|NCT01483781|Plasma Volume|plasma volume
5035489|NCT01483781|Canagliflozin|canagliflozin
5035490|NCT01483781|Metformin|metformin
5035491|NCT01483781|Hemoglobin A1c|hemoglobin a1c
5035492|NCT01483781|Hypertension|hypertension
5035493|NCT01483781|Angiotensin-Converting Enzyme Inhibitors (ACEIs)|angiotensin-converting enzyme inhibitors (aceis)
5035494|NCT01483781|Angiotensin Receptor Blockers (ARBs)|angiotensin receptor blockers (arbs)
5035495|NCT01483781|Pharmacodynamics|pharmacodynamics
5035496|NCT01483781|Pharmacokinetics|pharmacokinetics
5035497|NCT01483768|Sleeve gastrectomy|sleeve gastrectomy
5035498|NCT01483768|Obesity surgery|obesity surgery
5035499|NCT01483768|Iron deficiency|iron deficiency
5035500|NCT01483768|HEPCIDINE|hepcidine
5035501|NCT01483755|Myocardial infarction|myocardial infarction
5035502|NCT01483755|Postconditioning|postconditioning
5035503|NCT01483690|Relapse|relapse
5035504|NCT01483690|Lymphoblastic|lymphoblastic
5035505|NCT01483690|Leukemia|leukemia
5035506|NCT01483690|Decitabine|decitabine
5035507|NCT01483690|Vorinostat|vorinostat
5035508|NCT01483690|Refractory|refractory
5035509|NCT01483690|Acute|acute
5035510|NCT01483690|Childhood|childhood
5035511|NCT01483690|Pediatric|pediatric
5035512|NCT01483690|ALL|all
5035513|NCT01483677|Laparoscopy|laparoscopy
5035514|NCT01483677|video games|video games
5035515|NCT01483677|Nintendo Wii|nintendo wii
5035516|NCT01483677|Playstation|playstation
5035517|NCT01483664|patient outcomes|patient outcomes
5035518|NCT01483664|Survivorship|survivorship
5035519|NCT01483664|Communication Skills|communication skills
5035520|NCT01483664|Communication strategies|communication strategies
5035521|NCT01483664|Physicians communication|physicians communication
5035522|NCT01483664|11-180|11-180
5035523|NCT01483651|diabetes|diabetes
5035524|NCT01483651|glucagon|glucagon
5035525|NCT01483651|insulin|insulin
5035526|NCT01483651|dideuterated glucose|dideuterated glucose
5035527|NCT01483638|duration of disease response|duration of disease response
5035528|NCT01483638|axitinib|axitinib
5035529|NCT01483612|Body Weight|body weight
5035530|NCT01483612|Female|female
5035531|NCT01483612|Infertility, Female/therapy|infertility, female/therapy
5035532|NCT01483612|Infertility, Female/physiopathology|infertility, female/physiopathology
5035533|NCT01483612|Obesity/physiopathology|obesity/physiopathology
5035534|NCT01483612|Polycystic ovary syndrome|polycystic ovary syndrome
5035535|NCT01483612|Pregnancy|pregnancy
5035536|NCT01483612|Pregnancy Outcome|pregnancy outcome
5035537|NCT01483612|Weight Loss|weight loss
5035538|NCT01483599|Moderate to Severe Plaque-Type Psoriasis|moderate to severe plaque-type psoriasis
5035539|NCT01483599|Psoriasis|psoriasis
5035540|NCT01483599|Plaque-type psoriasis|plaque-type psoriasis
5035541|NCT01483599|CNTO 1959|cnto 1959
5035542|NCT01483599|adalimumab|adalimumab
5035543|NCT01483573|low back pain|low back pain
5035544|NCT01483573|straight leg raise|straight leg raise
5035545|NCT01483560|REMOVAL|removal
5035546|NCT01483560|metformin|metformin
5035547|NCT01483560|carotid IMT|carotid imt
5035548|NCT01483560|LDL Cholesterol|ldl cholesterol
5035549|NCT01483560|endothelial function|endothelial function
5035550|NCT01483560|retinopathy|retinopathy
5035551|NCT01483560|HbA1c|hba1c
5035552|NCT01483534|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5035553|NCT01483534|Pulmonary|pulmonary
5035554|NCT01483534|Intervention|intervention
5035555|NCT01483534|Device|device
5035556|NCT01483534|Denervation|denervation
5035557|NCT01483534|Lung|lung
5035558|NCT01483534|Holaira, Inc.|holaira, inc.
5035559|NCT01483534|Innovative Pulmonary Solutions, Inc.|innovative pulmonary solutions, inc.
5035560|NCT01483521|Randomized|randomized
5035561|NCT01483521|Home visitation|home visitation
5035562|NCT01483521|Externalizing disorder|externalizing disorder
5035563|NCT01483521|Parenting stress|parenting stress
5035564|NCT01483521|Childhood externalizing disorders|childhood externalizing disorders
5035565|NCT01483521|Positional defiant|positional defiant
5035566|NCT01483508|flavanols|flavanols
5035567|NCT01483508|procyanidins|procyanidins
5035568|NCT01483508|absorption|absorption
5035569|NCT01483508|cocoa polyphenols|cocoa polyphenols
5035570|NCT01483508|Flavanol and procyanidin absorption in healthy volunteers|flavanol and procyanidin absorption in healthy volunteers
5035571|NCT01483482|clavicle fractures|clavicle fractures
5035572|NCT01483482|midshaft clavicle fractures|midshaft clavicle fractures
5035573|NCT01483482|conservative treatment|conservative treatment
5035574|NCT01483482|surgical treatment|surgical treatment
5035575|NCT01483482|functional outcome|functional outcome
5035576|NCT01483482|clinical assessment|clinical assessment
5035577|NCT01483482|adults|adults
5035578|NCT01483456|Accidental falls|accidental falls
5035579|NCT01483456|safety management|safety management
5035580|NCT01483456|aged|aged
5035581|NCT01483456|inpatient|inpatient
5035582|NCT01483456|stepped wedge design|stepped wedge design
5035583|NCT01483443|oophrectomy|oophrectomy
5035584|NCT01483443|survival|survival
5035585|NCT01483430|Blood pressure|blood pressure
5035586|NCT01483430|Korea red ginseng|korea red ginseng
5035587|NCT01483430|Ambulatory blood pressure|ambulatory blood pressure
5035588|NCT01483430|Pulse wave velocity|pulse wave velocity
5035589|NCT01483417|SILS|sils
5035590|NCT01483417|Laparoscopic hysterectomy|laparoscopic hysterectomy
5035591|NCT01483417|Cosmetic outcome|cosmetic outcome
5035592|NCT01483417|Pain|pain
5035593|NCT01483404|microcirculation|microcirculation
5035594|NCT01483404|caput femoris|caput femoris
5035595|NCT01483391|Bipolar disorder|bipolar disorder
5035596|NCT01483391|Major depressive disorder|major depressive disorder
5035597|NCT01483391|Mania|mania
5035598|NCT01483391|Depression|depression
5035599|NCT01483391|Cyclothymic Disorder|cyclothymic disorder
5035600|NCT01483313|Anesthestics|anesthestics
5035601|NCT01483313|Minor surgery|minor surgery
5035602|NCT01483313|Wechsler Intelligence Scale for Children|wechsler intelligence scale for children
5035603|NCT01483313|Cognitiion|cognitiion
5035604|NCT01483300|breast cancer|breast cancer
5035605|NCT01483300|gemcitabine|gemcitabine
5035606|NCT01483300|lobaplatin|lobaplatin
5035607|NCT01483300|cisplatin|cisplatin
5035608|NCT01483287|Gastrointestinal Symptoms|gastrointestinal symptoms
5035609|NCT01483287|Bloating|bloating
5035610|NCT01483287|Distention|distention
5035611|NCT01483274|AML|aml
5035612|NCT01483274|vaccine|vaccine
5035613|NCT01483261|Trauma-Focused Cognitive Behavior Therapy|trauma-focused cognitive behavior therapy
5035614|NCT01483261|Sexually Exploited Girls|sexually exploited girls
5035615|NCT01483261|Post-traumatic Stress Symptoms|post-traumatic stress symptoms
5035616|NCT01483261|Psychosocial Distress|psychosocial distress
5035617|NCT01483248|Menstrual blood|menstrual blood
5035618|NCT01483248|Mesenchymal stem cell|mesenchymal stem cell
5035619|NCT01483248|Liver cirrhosis|liver cirrhosis
5035620|NCT01483235|cardiac rehabilitation|cardiac rehabilitation
5035621|NCT01483235|prevention|prevention
5035622|NCT01483235|exercise capacity|exercise capacity
5035623|NCT01483222|Low Back Pain|low back pain
5035624|NCT01483222|Braces|braces
5035625|NCT01483222|Prevention|prevention
5035626|NCT01483209|Digital ischemia|digital ischemia
5035627|NCT01483209|Vasopressor|vasopressor
5035628|NCT01483183|Atrial fibrillation|atrial fibrillation
5035629|NCT01483183|Paroxysmal Atrial fibrillation|paroxysmal atrial fibrillation
5035630|NCT01483183|Persistent Atrial fibrillation|persistent atrial fibrillation
5035631|NCT01483183|A-fib|a-fib
5035632|NCT01483144|Familial Adenomatous Polyposis|familial adenomatous polyposis
5035633|NCT01483144|Eflornithine|eflornithine
5035634|NCT01483144|Sulindac|sulindac
5035635|NCT01483118|PCOS|pcos
5035636|NCT01483118|Insulin resistance|insulin resistance
5035637|NCT01483118|Cinnamon extract|cinnamon extract
5035638|NCT01483118|Irregular menstrual cycles|irregular menstrual cycles
5035639|NCT01483118|Ovarian cysts|ovarian cysts
5035640|NCT01483105|VCUG|vcug
5035641|NCT01483105|Child|child
5035642|NCT01483105|Hypnosis|hypnosis
5035643|NCT01483105|Relaxation|relaxation
5035644|NCT01483105|Voiding cystourethrography|voiding cystourethrography
5035645|NCT01483079|donor human milk products|donor human milk products
5035646|NCT01483079|post-discharge|post-discharge
5035647|NCT01483079|growth|growth
5035648|NCT01483079|development|development
5035649|NCT01483053|Major depressive disorder|major depressive disorder
5035650|NCT01483053|Sympathetic nervous system activation|sympathetic nervous system activation
5035651|NCT01483053|Cardiovascular risk factors|cardiovascular risk factors
5035652|NCT01483053|Agomelatine|agomelatine
5035653|NCT01483053|Escitalopram|escitalopram
5035654|NCT01483040|wide angle view colonoscopy|wide angle view colonoscopy
5035655|NCT01483040|PeerScope B System™|peerscope b system™
5035656|NCT01483014|Gastrointestinal,|gastrointestinal,
5035658|NCT01483014|neoadjuvant,|neoadjuvant,
5035659|NCT01483014|imatinib,|imatinib,
5035660|NCT01483014|mesylate,|mesylate,
5035661|NCT01483014|pre-operatory|pre-operatory
5035662|NCT01483001|Cancer Stem Cells|cancer stem cells
5035663|NCT01483001|Chemo-Sensitivity Assay|chemo-sensitivity assay
5035664|NCT01483001|Cancer Treatment|cancer treatment
5035665|NCT01482988|prevalence of the Dectin-1 polymorphism (Tyr238X)|prevalence of the dectin-1 polymorphism (tyr238x)
5035666|NCT01482975|tobacco|tobacco
5035667|NCT01482975|alcohol|alcohol
5035668|NCT01482975|diet|diet
5035669|NCT01482975|exercise|exercise
5035670|NCT01482962|Drug Therapy|drug therapy
5035671|NCT01482949|RCC|rcc
5035672|NCT01482949|Kidney Cancer|kidney cancer
5035673|NCT01482949|Renal Cancer|renal cancer
5035674|NCT01482949|Arcelis|arcelis
5035675|NCT01482923|Tobacco Use Assessment|tobacco use assessment
5035676|NCT01482923|smoke tobacco|smoke tobacco
5035677|NCT01482923|quit smoking|quit smoking
5035678|NCT01482923|tobacco cessation|tobacco cessation
5035679|NCT01482923|HIV/AIDS|hiv/aids
5035680|NCT01482923|Community-Based Service Organizations|community-based service organizations
5035681|NCT01482923|11-173|11-173
5035682|NCT01482923|Low-Income Persons Living with HIV/AIDS|low-income persons living with hiv/aids
5035683|NCT01482897|Discal sciatica, infiltrations|discal sciatica, infiltrations
5035684|NCT01482897|Subjects|subjects
5035685|NCT01482897|evolving|evolving
5035686|NCT01482884|tralokinumab|tralokinumab
5035687|NCT01482884|inflammatory bowel disease|inflammatory bowel disease
5035688|NCT01482884|moderate to severe ulcerative colitis|moderate to severe ulcerative colitis
5035689|NCT01482871|Diabetic Macular Edema|diabetic macular edema
5035690|NCT01482832|Randomized trial|randomized trial
5035691|NCT01482832|Postpartum depression|postpartum depression
5035692|NCT01482832|Adolescent pregnancy|adolescent pregnancy
5035693|NCT01482832|Interpersonal psychotherapy|interpersonal psychotherapy
5035694|NCT01482806|Depression|depression
5035695|NCT01482806|Anxiety|anxiety
5035696|NCT01482806|Primary care|primary care
5035697|NCT01482806|Cognitive Behavioral Therapy|cognitive behavioral therapy
5035698|NCT01482806|Internet|internet
5035699|NCT01482806|Support groups|support groups
5035700|NCT01482806|Technology assisted|technology assisted
5035701|NCT01482741|Quality of Life|quality of life
5035702|NCT01482741|Focus groups|focus groups
5035703|NCT01482741|Risks of Ionizing Radiation|risks of ionizing radiation
5035704|NCT01482741|Risk of medical imaging|risk of medical imaging
5035705|NCT01482741|11-185|11-185
5035706|NCT01482715|gBRCA ovarian cancer|gbrca ovarian cancer
5035707|NCT01482715|platinum sensitive|platinum sensitive
5035708|NCT01482715|PARP Inhibitor|parp inhibitor
5035709|NCT01482715|Rucaparib|rucaparib
5035710|NCT01482715|CO-338|co-338
5035711|NCT01482715|PF 01367338|pf 01367338
5035712|NCT01482715|AG 14699|ag 14699
5035713|NCT01482715|BRCA1|brca1
5035714|NCT01482715|BRCA2|brca2
5035715|NCT01482715|platinum sensitive ovarian cancer|platinum sensitive ovarian cancer
5035716|NCT01482715|platinum sensitive gBRCA ovarian cancer|platinum sensitive gbrca ovarian cancer
5035717|NCT01482715|gynecological cancer|gynecological cancer
5035718|NCT01482715|relapsed disease|relapsed disease
5035719|NCT01482715|homologous recombination deficiency|homologous recombination deficiency
5035720|NCT01482715|HRD|hrd
5035721|NCT01482702|breast cancer survivor|breast cancer survivor
5035722|NCT01482702|weight loss|weight loss
5035723|NCT01482702|postmenopausal|postmenopausal
5035724|NCT01482702|Weight loss for overweight postmenopausal breast cancer survivors|weight loss for overweight postmenopausal breast cancer survivors
5035725|NCT01482689|Bioavailability|bioavailability
5035726|NCT01482689|Vitamin D metabolism|vitamin d metabolism
5035727|NCT01482689|Bone turnover|bone turnover
5035728|NCT01482663|Hand eczema|hand eczema
5035729|NCT01482663|Hand dermatitis|hand dermatitis
5035730|NCT01482663|Chronic hand eczema|chronic hand eczema
5035731|NCT01482663|Chronic hand dermatitis|chronic hand dermatitis
5035732|NCT01482663|Contact dermatitis|contact dermatitis
5035733|NCT01482663|Skin disease|skin disease
5035734|NCT01482663|Self-management|self-management
5035735|NCT01482650|Baska mask|baska mask
5035736|NCT01482650|LMA|lma
5035737|NCT01482650|laryngeal mask airway|laryngeal mask airway
5035738|NCT01482650|supraglottic airway device|supraglottic airway device
5035739|NCT01482624|hyaluronan|hyaluronan
5035740|NCT01482624|hyaluronic acid|hyaluronic acid
5035741|NCT01482611|Hepatitis C Virus|hepatitis c virus
5035742|NCT01482611|JNJ-47910382|jnj-47910382
5035743|NCT01482611|47910382HPC1001|47910382hpc1001
5035744|NCT01482611|HCV|hcv
5035745|NCT01482611|Hepatitis C|hepatitis c
5035746|NCT01482611|Hep C|hep c
5035747|NCT01482611|Healthy participants|healthy participants
5035748|NCT01482611|Japanese|japanese
5035749|NCT01482611|Caucasians|caucasians
5035750|NCT01482598|Heart Failure|heart failure
5035751|NCT01482598|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
5035752|NCT01482598|Remote Care|remote care
5035753|NCT01482598|Disease Management|disease management
5035754|NCT01482585|lung adenocarcinoma|lung adenocarcinoma
5035755|NCT01482585|prognosis|prognosis
5035756|NCT01482585|tumor aggressiveness|tumor aggressiveness
5035757|NCT01482585|imaging biomarker|imaging biomarker
5035758|NCT01482585|genetic biomarker|genetic biomarker
5035759|NCT01482572|biopsy|biopsy
5035760|NCT01482572|needle aspiration|needle aspiration
5035761|NCT01482572|mutational analysis|mutational analysis
5035762|NCT01482559|Dopamine|dopamine
5035763|NCT01482559|Intraventricular haemorrhage|intraventricular haemorrhage
5035764|NCT01482559|Periventricular Leukomalacia|periventricular leukomalacia
5035765|NCT01482559|Neurodisability|neurodisability
5035766|NCT01482559|Infant|infant
5035767|NCT01482546|colonoscopy|colonoscopy
5035768|NCT01482546|trainees|trainees
5035769|NCT01482546|water|water
5035770|NCT01482546|adenoma detection rate|adenoma detection rate
5035771|NCT01482546|cecal intubation rate|cecal intubation rate
5035772|NCT01482494|Myopathies|myopathies
5035773|NCT01482494|Pompe disease|pompe disease
5035774|NCT01482494|Polymyositis|polymyositis
5035775|NCT01482494|Respiratory Insufficiency|respiratory insufficiency
5035776|NCT01482481|Patient Care Planning|patient care planning
5035777|NCT01482481|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
5035778|NCT01482481|Cardiovascular Risk Factors|cardiovascular risk factors
5035779|NCT01482481|Primary Health Care|primary health care
5035780|NCT01482481|Spain|spain
5035781|NCT01482455|Insulin resistance|insulin resistance
5035782|NCT01482455|vascular impairment|vascular impairment
5035783|NCT01482455|diabetes|diabetes
5035784|NCT01482442|Liver, HCC|liver, hcc
5035785|NCT01482442|Liver, interventional procedures|liver, interventional procedures
5035786|NCT01482442|Liver, randomized studies|liver, randomized studies
5035787|NCT01482442|Liver, targeted therapy|liver, targeted therapy
5035788|NCT01482442|Liver, RADIOEMBOLIZATION|liver, radioembolization
5035789|NCT01482429|ventilator weaning|ventilator weaning
5035790|NCT01482429|protocol|protocol
5035791|NCT01482416|hormone replacement therapy|hormone replacement therapy
5035792|NCT01482416|Doppler velocimetry|doppler velocimetry
5035793|NCT01482416|Flow-mediated dilation|flow-mediated dilation
5035794|NCT01482416|menopause|menopause
5035795|NCT01482364|HOTMAN System|hotman system
5035796|NCT01482364|Hemodynamic integrated management|hemodynamic integrated management
5035797|NCT01482351|apnea|apnea
5035798|NCT01482351|cognition|cognition
5035799|NCT01482351|memory|memory
5035800|NCT01482351|function|function
5035801|NCT01482351|amnestic mild cognitive impairment|amnestic mild cognitive impairment
5035802|NCT01482351|older adults|older adults
5035803|NCT01482351|Alzheimer's Disease|alzheimer's disease
5035804|NCT01482338|PMS|pms
5035805|NCT01482338|Low-dose combine contraceptives pills|low-dose combine contraceptives pills
5035806|NCT01482338|COC|coc
5035807|NCT01482299|pS6 Ser 240/4|ps6 ser 240/4
5035808|NCT01482299|RAD001 (everolimus)|rad001 (everolimus)
5035809|NCT01482299|second-line treatment|second-line treatment
5035810|NCT01482299|advanced gastric cancer|advanced gastric cancer
5035811|NCT01482286|Exercise|exercise
5035812|NCT01482286|Diet|diet
5035813|NCT01482286|Insulin resistance|insulin resistance
5035814|NCT01482286|Weight|weight
5035815|NCT01482273|catheter-directed thrombolysis|catheter-directed thrombolysis
5035816|NCT01482273|ilio-femoral deep vein thrombosis|ilio-femoral deep vein thrombosis
5035817|NCT01482273|Postthrombotic syndrome|postthrombotic syndrome
5035818|NCT01482273|Phlebographic scores|phlebographic scores
5035819|NCT01482273|Phlebography|phlebography
5035820|NCT01482273|Catheters|catheters
5035821|NCT01482234|physical activity|physical activity
5035822|NCT01482234|exercise|exercise
5035823|NCT01482234|walking|walking
5035824|NCT01482234|pedometers|pedometers
5035825|NCT01482234|goal setting|goal setting
5035826|NCT01482234|text messages|text messages
5035827|NCT01482234|motivation|motivation
5035828|NCT01482234|intrinsic motivation|intrinsic motivation
5035829|NCT01482234|extrinsic motivation|extrinsic motivation
5035830|NCT01482234|self determination theory|self determination theory
5035831|NCT01482234|prompts|prompts
5035832|NCT01482221|Major Depressive Disorder|major depressive disorder
5035833|NCT01482221|MDD|mdd
5035834|NCT01482221|Inadequate Response to Antidepressant Therapy|inadequate response to antidepressant therapy
5035835|NCT01482221|Channel blocker of the NMDA class of glutamate receptors|channel blocker of the nmda class of glutamate receptors
5035836|NCT01482208|Dehydration|dehydration
5035837|NCT01482208|Hydration|hydration
5035838|NCT01482208|Muscle composition|muscle composition
5035839|NCT01482208|Diarrhea|diarrhea
5035840|NCT01482208|Pediatrics|pediatrics
5035841|NCT01482208|Neonatology|neonatology
5035842|NCT01482208|Ultrasound|ultrasound
5035843|NCT01482195|Retinal Disease|retinal disease
5035844|NCT01482182|Non-small cell lung cancer|non-small cell lung cancer
5035845|NCT01482182|Diffusion-weighted MRI|diffusion-weighted mri
5035846|NCT01482182|18F-FDG PET|18f-fdg pet
5035847|NCT01482182|Treatment response|treatment response
5035848|NCT01482182|Prognosis|prognosis
5035849|NCT01482169|Left heart catheterization|left heart catheterization
5035850|NCT01482169|Fractional flow reserve|fractional flow reserve
5035851|NCT01482169|Adenoscan®|adenoscan®
5035852|NCT01482169|Regadenoson|regadenoson
5035853|NCT01482156|Advanced solid tumors|advanced solid tumors
5035854|NCT01482156|Metastatic renal cell carcinoma (mRCC)|metastatic renal cell carcinoma (mrcc)
5035855|NCT01482156|ER+/HER2-Metastatic breast cancer (MBC)|er+/her2-metastatic breast cancer (mbc)
5035856|NCT01482156|Dose finding study|dose finding study
5035857|NCT01482156|mTOR|mtor
5035858|NCT01482156|Pl3K|pl3k
5035859|NCT01482156|BEZ235|bez235
5035860|NCT01482156|RAD001|rad001
5035861|NCT01482156|Everolimus|everolimus
5035862|NCT01482156|Afinitor®|afinitor®
5035863|NCT01482156|ER+/HER2- metastatic breast cancer|er+/her2- metastatic breast cancer
5035864|NCT01482143|Fragile X Syndrome|fragile x syndrome
5035865|NCT01482143|pharmacokinetics|pharmacokinetics
5035866|NCT01482143|safety and tolerability|safety and tolerability
5035867|NCT01482130|Exercise|exercise
5035868|NCT01482130|osteoporosis|osteoporosis
5035869|NCT01482130|prevention|prevention
5035870|NCT01482117|CYP2C19|cyp2c19
5035871|NCT01482117|CYP3A5|cyp3a5
5035872|NCT01482117|Clopidogrel|clopidogrel
5035873|NCT01482117|Cilostazol|cilostazol
5035874|NCT01482117|Healthy|healthy
5035875|NCT01482104|Photochemotherapy|photochemotherapy
5035876|NCT01482104|methyl 5-aminolevulinate|methyl 5-aminolevulinate
5035877|NCT01482091|fentanyl|fentanyl
5035878|NCT01482091|intranasal|intranasal
5035879|NCT01482091|sickle cell|sickle cell
5035880|NCT01482091|vasoocclusive crisis|vasoocclusive crisis
5035881|NCT01482091|pain crisis|pain crisis
5035882|NCT01482091|pediatrics|pediatrics
5035883|NCT01482078|Magnesium Sulphate|magnesium sulphate
5035884|NCT01482078|Neuroprotection|neuroprotection
5035885|NCT01482078|Neuraxial Anesthesia|neuraxial anesthesia
5035886|NCT01482078|Sedation|sedation
5035887|NCT01482078|Respiratory function|respiratory function
5035888|NCT01482078|Cesarean Section|cesarean section
5035889|NCT01482078|Obstetrical Anesthesia|obstetrical anesthesia
5035890|NCT01482065|Non Alcoholic Fatty Liver Disease|non alcoholic fatty liver disease
5035891|NCT01482065|NAFLD|nafld
5035892|NCT01482065|Continuous Positive Airway Pressure|continuous positive airway pressure
5035893|NCT01482065|CPAP|cpap
5035894|NCT01482065|CPAP Therapy|cpap therapy
5035895|NCT01482065|Apnea Hypopnea Index|apnea hypopnea index
5035896|NCT01482065|Non alcoholic steatohepatitis|non alcoholic steatohepatitis
5035897|NCT01482065|NASH|nash
5035898|NCT01482065|OSA|osa
5035899|NCT01482065|Obstructive Sleep Apnea|obstructive sleep apnea
5035900|NCT01482065|AHI|ahi
5035901|NCT01482052|Central Nervous System Infections|central nervous system infections
5035902|NCT01482052|Meningitis|meningitis
5035903|NCT01482052|toxoid|toxoid
5035904|NCT01482052|Meningococcal vaccine|meningococcal vaccine
5035905|NCT01482052|conjugate vaccines|conjugate vaccines
5035906|NCT01482039|short cervix|short cervix
5035907|NCT01482039|cervical shortening|cervical shortening
5035908|NCT01482039|preterm birth|preterm birth
5035909|NCT01482026|Epilepsy|epilepsy
5035910|NCT01482026|Attention deficit|attention deficit
5035911|NCT01482026|ADHD rating scale IV|adhd rating scale iv
5035912|NCT01482000|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
5035913|NCT01482000|Adult|adult
5035914|NCT01482000|therapeutic use|therapeutic use
5035915|NCT01482000|Humans|humans
5035916|NCT01482000|Treatment Outcome|treatment outcome
5035917|NCT01482000|daoyin therapy|daoyin therapy
5035918|NCT01481987|Microperimetry|microperimetry
5035919|NCT01481987|OCT|oct
5035920|NCT01481987|idiopathic epiretinal membrane|idiopathic epiretinal membrane
5035921|NCT01481974|liver transplantation|liver transplantation
5035922|NCT01481974|treprostinil|treprostinil
5035923|NCT01481961|Alzheimer's disease|alzheimer's disease
5035924|NCT01481961|rTMS|rtms
5035925|NCT01481961|cognition|cognition
5035926|NCT01481948|physical activity|physical activity
5035927|NCT01481948|fruit and vegetable|fruit and vegetable
5035928|NCT01481948|water|water
5035929|NCT01481948|girls|girls
5035930|NCT01481948|African American|african american
5035931|NCT01481948|online|online
5035932|NCT01481935|Antibiotic resistant bacteria|antibiotic resistant bacteria
5035933|NCT01481935|Colonization|colonization
5035934|NCT01481935|Hospital cleaning|hospital cleaning
5035935|NCT01481935|Environmental cleaning|environmental cleaning
5035936|NCT01481935|Infection Control|infection control
5035937|NCT01481922|Lumbar puncture|lumbar puncture
5035938|NCT01481922|Flow rate|flow rate
5035939|NCT01481922|Backache|backache
5035940|NCT01481922|Pain|pain
5035941|NCT01481922|Undifferentiated headache|undifferentiated headache
5035942|NCT01481922|Post-lumbar puncture headache|post-lumbar puncture headache
5035943|NCT01481909|Assessment of wheal and flare development|assessment of wheal and flare development
5035944|NCT01481909|Assessment of life quality|assessment of life quality
5035945|NCT01481896|Hip replacement|hip replacement
5035946|NCT01481896|Metal-on-metal bearings|metal-on-metal bearings
5035947|NCT01481896|Osteolysis|osteolysis
5035948|NCT01481896|Metal ion levels|metal ion levels
5035949|NCT01481896|Outcome|outcome
5035950|NCT01481883|Schizophrenia|schizophrenia
5035951|NCT01481883|Mental Illness|mental illness
5035952|NCT01481883|SERM|serm
5035953|NCT01481883|Raloxifene|raloxifene
5035954|NCT01481870|renal cell carcinoma|renal cell carcinoma
5035955|NCT01481870|sorafenib|sorafenib
5035956|NCT01481870|sunitinib|sunitinib
5035957|NCT01481870|crossover|crossover
5035958|NCT01481844|sequential therapy|sequential therapy
5035959|NCT01481844|second line treatment|second line treatment
5035960|NCT01481844|H pylori|h pylori
5035961|NCT01481792|Keratorefractive Surgical Procedures|keratorefractive surgical procedures
5035962|NCT01481766|child development|child development
5035963|NCT01481766|screening|screening
5035964|NCT01481766|Non-anemic iron deficiency|non-anemic iron deficiency
5035965|NCT01481766|primary care pediatrics|primary care pediatrics
5035966|NCT01481766|prevention and health promotion|prevention and health promotion
5035967|NCT01481740|spinal induced hypotension|spinal induced hypotension
5035968|NCT01481740|nausea and vomiting|nausea and vomiting
5035969|NCT01481740|cesarean delivery|cesarean delivery
5035970|NCT01481727|acute exacerbation of COPD number|acute exacerbation of copd number
5035971|NCT01481727|acute exacerbation of COPD severity|acute exacerbation of copd severity
5035972|NCT01481714|Sodium picosulphate|sodium picosulphate
5035973|NCT01481714|Split-dose|split-dose
5035974|NCT01481714|Bowel cleansing|bowel cleansing
5035975|NCT01481714|colonoscopy|colonoscopy
5035976|NCT01481714|Degree of bowel cleansing during colonoscopy|degree of bowel cleansing during colonoscopy
5035977|NCT01481701|ovarian carcinoma|ovarian carcinoma
5035978|NCT01481701|Bordet|bordet
5035979|NCT01481701|relapse|relapse
5035980|NCT01481688|Dialysis adequacy|dialysis adequacy
5035981|NCT01481688|Urea clearance|urea clearance
5035982|NCT01481688|Phosphate clearance|phosphate clearance
5035983|NCT01481688|Beta 2 microglobulin clearance|beta 2 microglobulin clearance
5035984|NCT01481688|Intradialytic exercise|intradialytic exercise
5035985|NCT01481688|Haemodialysis patients|haemodialysis patients
5035986|NCT01481675|biliopancreatic diversion|biliopancreatic diversion
5035987|NCT01481675|sleeve gastrectomy|sleeve gastrectomy
5035988|NCT01481675|diabetes mellitus|diabetes mellitus
5035989|NCT01481675|weight loss|weight loss
5035990|NCT01481675|ghrelin|ghrelin
5035992|NCT01481675|GLP-1|glp-1
5035993|NCT01481662|SUSAC's Syndrome|susac's syndrome
5035994|NCT01481662|encephalopathy|encephalopathy
5035995|NCT01481662|hearing loss|hearing loss
5035996|NCT01481662|retinal artery branch occlusions|retinal artery branch occlusions
5035997|NCT01481662|Diffusion tensor MRI|diffusion tensor mri
5035998|NCT01481649|hepatitis B|hepatitis b
5035999|NCT01481649|anti-HBc|anti-hbc
5036000|NCT01481649|HBsAg|hbsag
5036001|NCT01481649|HSCT|hsct
5036002|NCT01481649|recipients|recipients
5036003|NCT01481636|Obstructive sleep apnea|obstructive sleep apnea
5036004|NCT01481636|correlation|correlation
5036005|NCT01481636|AHI|ahi
5036006|NCT01481636|symptoms|symptoms
5036007|NCT01481636|mechanisms|mechanisms
5036008|NCT01481623|Diabetes|diabetes
5036009|NCT01481623|neonatal|neonatal
5036010|NCT01481623|consanguinity|consanguinity
5036011|NCT01481623|monogenic|monogenic
5036012|NCT01481623|metabolism|metabolism
5036013|NCT01481610|Kidney Failure, Chronic|kidney failure, chronic
5036014|NCT01481610|Arthralgia|arthralgia
5036015|NCT01481610|NSAID|nsaid
5036016|NCT01481610|Diclofenac|diclofenac
5036017|NCT01481610|Lumiracoxib|lumiracoxib
5036018|NCT01481610|Safety|safety
5036019|NCT01481597|deuteporfin|deuteporfin
5036020|NCT01481597|safety|safety
5036021|NCT01481597|tolerability|tolerability
5036022|NCT01481597|pharmacokinetics|pharmacokinetics
5036023|NCT01481597|healthy volunteers|healthy volunteers
5036024|NCT01481584|Dietary protein|dietary protein
5036025|NCT01481584|Canola protein|canola protein
5036026|NCT01481584|Protein metabolism|protein metabolism
5036027|NCT01481584|Protein-enriched drinks|protein-enriched drinks
5036028|NCT01481584|Nitrogen balance|nitrogen balance
5036029|NCT01481571|Media for vitrification/warming of human oocytes|media for vitrification/warming of human oocytes
5036030|NCT01481558|Apathy|apathy
5036031|NCT01481558|Alzheimer's Disease|alzheimer's disease
5036032|NCT01481558|Dementia|dementia
5036033|NCT01481545|locally advanced|locally advanced
5036034|NCT01481545|high risk|high risk
5036035|NCT01481545|preoperative therapy|preoperative therapy
5036036|NCT01481532|Antineoplastic agent|antineoplastic agent
5036037|NCT01481519|Conjunctivitis|conjunctivitis
5036038|NCT01481519|Ocular diseases|ocular diseases
5036039|NCT01481519|Artificial tears|artificial tears
5036040|NCT01481493|rheumatoid arthritis|rheumatoid arthritis
5036041|NCT01481480|shoulder|shoulder
5036042|NCT01481480|rotator cuff|rotator cuff
5036043|NCT01481480|tendon transfer|tendon transfer
5036044|NCT01481480|arthroscopic repair|arthroscopic repair
5036045|NCT01481467|influenza vaccination|influenza vaccination
5036046|NCT01481467|intervention mapping|intervention mapping
5036047|NCT01481467|hospital care|hospital care
5036048|NCT01481467|respiratory infections|respiratory infections
5036049|NCT01481467|vaccination|vaccination
5036050|NCT01481454|Influenza|influenza
5036051|NCT01481454|Quadrivalent Inactivated Influenza Vaccine|quadrivalent inactivated influenza vaccine
5036052|NCT01481454|Trivalent Inactivated Influenza Vaccine|trivalent inactivated influenza vaccine
5036053|NCT01481441|Contrast Enhanced Ultrasound (CEUS)|contrast enhanced ultrasound (ceus)
5036054|NCT01481441|Prostate cancer|prostate cancer
5036055|NCT01481441|Quantification|quantification
5036056|NCT01481441|Prostate biopsies|prostate biopsies
5036057|NCT01481441|Transrectal ultrasound (TRUS)|transrectal ultrasound (trus)
5036058|NCT01481441|Microbubbles|microbubbles
5036059|NCT01481428|High risk behavior|high risk behavior
5036060|NCT01481428|Drug court clients|drug court clients
5036061|NCT01481428|Substance abuse|substance abuse
5036062|NCT01481428|HIV intervention|hiv intervention
5036063|NCT01481428|Treatment Court Clients|treatment court clients
5036064|NCT01481415|left atrial|left atrial
5036065|NCT01481415|three-dimensional echocardioraphy|three-dimensional echocardioraphy
5036066|NCT01481415|left atrial function|left atrial function
5036067|NCT01481402|Heart failure|heart failure
5036068|NCT01481402|Liothyronine|liothyronine
5036069|NCT01481402|Low T3 syndrome|low t3 syndrome
5036070|NCT01481389|Blood lipids|blood lipids
5036071|NCT01481389|risk factor for cardiovascular diseases|risk factor for cardiovascular diseases
5036072|NCT01481376|Parietex™ ProGrip™|parietex™ progrip™
5036073|NCT01481376|Laparoscopic Transabdominal preperitoneal|laparoscopic transabdominal preperitoneal
5036074|NCT01481376|TAPP|tapp
5036075|NCT01481376|Inguinal hernia repair|inguinal hernia repair
5036076|NCT01481363|dementia|dementia
5036077|NCT01481363|communication|communication
5036078|NCT01481363|carers|carers
5036079|NCT01481363|caregivers|caregivers
5036080|NCT01481363|psychosocial support systems|psychosocial support systems
5036081|NCT01481363|education|education
5036082|NCT01481337|colon|colon
5036083|NCT01481337|endoscopy|endoscopy
5036084|NCT01481337|resection|resection
5036085|NCT01481324|Clubfoot|clubfoot
5036086|NCT01481324|Compliance|compliance
5036087|NCT01481324|Brace wear|brace wear
5036088|NCT01481285|Bioelectrical Impedance Measurement|bioelectrical impedance measurement
5036089|NCT01481285|Adults|adults
5036090|NCT01481272|Salvage therapy in DLBCL|salvage therapy in dlbcl
5036091|NCT01481259|Nonsquamous non-small cell lung cancer|nonsquamous non-small cell lung cancer
5036092|NCT01481259|Maintenance therapy|maintenance therapy
5036093|NCT01481259|Immunotherapy|immunotherapy
5036094|NCT01481259|Autologous cytokine-induced killer cell|autologous cytokine-induced killer cell
5036095|NCT01481259|Pemetrexed|pemetrexed
5036096|NCT01481246|neurorehabilitation|neurorehabilitation
5036097|NCT01481246|cognition|cognition
5036098|NCT01481246|aging|aging
5036099|NCT01481246|MCI|mci
5036100|NCT01481246|cognitive decline|cognitive decline
5036101|NCT01481233|oral colchicine|oral colchicine
5036102|NCT01481233|castrate-resistant prostate cancer|castrate-resistant prostate cancer
5036103|NCT01481233|failed taxotere based chemotherapy|failed taxotere based chemotherapy
5036104|NCT01481220|Myelodysplastic syndrome|myelodysplastic syndrome
5036105|NCT01481220|azacitidine|azacitidine
5036106|NCT01481220|Eltrombopag|eltrombopag
5036107|NCT01481220|Thrombopoietin-receptor agonist|thrombopoietin-receptor agonist
5036108|NCT01481220|Thrombocytopenia|thrombocytopenia
5036109|NCT01481220|Transfusion dependency|transfusion dependency
5036110|NCT01481220|Safety study|safety study
5036111|NCT01481207|magnetic resonance spectroscopy|magnetic resonance spectroscopy
5036112|NCT01481207|magnetic resonance imaging|magnetic resonance imaging
5036113|NCT01481194|Multiple Myeloma|multiple myeloma
5036114|NCT01481181|zinc water diarrhoea growth preschool children|zinc water diarrhoea growth preschool children
5036115|NCT01481155|actinic keratosis|actinic keratosis
5036116|NCT01481155|field cancerisation|field cancerisation
5036117|NCT01481116|Drug Therapy|drug therapy
5036118|NCT01481103|Over the counter medication|over the counter medication
5036119|NCT01481103|Acupuncture|acupuncture
5036120|NCT01481090|Infertility|infertility
5036121|NCT01481090|acupuncture|acupuncture
5036122|NCT01481090|frozen embryos|frozen embryos
5036123|NCT01481090|endometrium|endometrium
5036124|NCT01481090|TCM|tcm
5036125|NCT01481064|Patient centredness|patient centredness
5036126|NCT01481064|Quality of life|quality of life
5036127|NCT01481064|Multifaceted approach|multifaceted approach
5036128|NCT01481064|Fertility care|fertility care
5036129|NCT01481038|early detection|early detection
5036130|NCT01481038|CRBSI|crbsi
5036131|NCT01481025|Climacteric|climacteric
5036132|NCT01481025|Depression|depression
5036133|NCT01481025|Herbal treatment|herbal treatment
5036134|NCT01481012|Heart transplantation|heart transplantation
5036135|NCT01481012|Coronary artery bypass graft (CABG) surgery|coronary artery bypass graft (cabg) surgery
5036136|NCT01481012|Left ventricular assist device implantation surgeries|left ventricular assist device implantation surgeries
5036137|NCT01480999|Laparotomy|laparotomy
5036138|NCT01480999|Open Surgery|open surgery
5036139|NCT01480999|Laparoscopy|laparoscopy
5036140|NCT01480999|Robotic surgery|robotic surgery
5036141|NCT01480960|lung transplantation|lung transplantation
5036142|NCT01480960|whole body vibration|whole body vibration
5036143|NCT01480960|exercise training|exercise training
5036144|NCT01480960|pulmonary rehabilitation|pulmonary rehabilitation
5036145|NCT01480947|probiotics|probiotics
5036146|NCT01480947|pediatric|pediatric
5036147|NCT01480947|salmonella|salmonella
5036148|NCT01480947|rotavirus|rotavirus
5036149|NCT01480947|gastroenteritis|gastroenteritis
5036150|NCT01480934|Diabetes,posterior capsule opacification,case control study|diabetes,posterior capsule opacification,case control study
5036151|NCT01480921|heart failure|heart failure
5036152|NCT01480921|health related quality of life|health related quality of life
5036153|NCT01480921|exercise capacity|exercise capacity
5036154|NCT01480921|home based exercise training|home based exercise training
5036155|NCT01480921|supervised exercise training|supervised exercise training
5036156|NCT01480908|Right bundle branch block|right bundle branch block
5036157|NCT01480908|Ventricular septal defect|ventricular septal defect
5036158|NCT01480908|Echocardiography|echocardiography
5036159|NCT01480908|MRI|mri
5036160|NCT01480908|Exercise testing|exercise testing
5036161|NCT01480895|Diabetes Mellitus Type 2|diabetes mellitus type 2
5036162|NCT01480895|Gestational Diabetes Mellitus|gestational diabetes mellitus
5036163|NCT01480895|Glucose Intolerance|glucose intolerance
5036164|NCT01480895|Physical exercise|physical exercise
5036165|NCT01480895|Nutritional Habits|nutritional habits
5036166|NCT01480895|Dyslipidemia|dyslipidemia
5036167|NCT01480882|Manual percussion|manual percussion
5036168|NCT01480882|Mechanical percussion|mechanical percussion
5036169|NCT01480882|Chronic bronchiectasis|chronic bronchiectasis
5036170|NCT01480882|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5036171|NCT01480882|Wet sputum weight|wet sputum weight
5036172|NCT01480882|Dry sputum weight|dry sputum weight
5036173|NCT01480869|Breast cancer|breast cancer
5036174|NCT01480869|Vitamin D supplementation|vitamin d supplementation
5036175|NCT01480869|in neoadjuvant|in neoadjuvant
5036176|NCT01480869|adjuvant setting|adjuvant setting
5036177|NCT01480843|simplification|simplification
5036178|NCT01480843|glargine|glargine
5036179|NCT01480843|elderly|elderly
5036180|NCT01480830|Quality|quality
5036181|NCT01480830|indicators|indicators
5036182|NCT01480804|Barriers|barriers
5036183|NCT01480804|Intervention|intervention
5036184|NCT01480804|Elderly|elderly
5036185|NCT01480804|glycemic control|glycemic control
5036186|NCT01480791|resistance arteries|resistance arteries
5036187|NCT01480791|endothelial dysfunction|endothelial dysfunction
5036188|NCT01480791|aortic stiffness|aortic stiffness
5036189|NCT01480778|hormonal response, levonorgestrel, ethinyl estradiol|hormonal response, levonorgestrel, ethinyl estradiol
5036190|NCT01480752|In the patients with symptomatic Irreversible Pulpitis|in the patients with symptomatic irreversible pulpitis
5036191|NCT01480739|Phase 1, AZD5069, safety and tolerability, healthy volunteer,|phase 1, azd5069, safety and tolerability, healthy volunteer,
5036192|NCT01480713|HIV-1|hiv-1
5036193|NCT01480713|protease inhibitors|protease inhibitors
5036194|NCT01480713|integrase inhibitors|integrase inhibitors
5036195|NCT01480713|raltegravir|raltegravir
5036196|NCT01480713|viral replication|viral replication
5036197|NCT01480713|treatment intensification|treatment intensification
5036198|NCT01480713|viral pathogenesis|viral pathogenesis
5036199|NCT01480713|immune activation|immune activation
5036200|NCT01480700|eggs|eggs
5036201|NCT01480700|Optical Macular Pigment|optical macular pigment
5036202|NCT01480700|Age Macular Degeneration|age macular degeneration
5036203|NCT01480700|study for the Age Macular Degeneration prevention|study for the age macular degeneration prevention
5036204|NCT01480687|Hypertension|hypertension
5036205|NCT01480687|Endothelial dysfunction|endothelial dysfunction
5036206|NCT01480687|Vascular stiffness|vascular stiffness
5036207|NCT01480661|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
5036208|NCT01480661|Computed Tomography scan|computed tomography scan
5036209|NCT01480661|Functional Respiratory Imaging|functional respiratory imaging
5036210|NCT01480661|Roflumilast|roflumilast
5036211|NCT01480661|Health Related Quality of Life|health related quality of life
5036212|NCT01480635|Incomplete Colonoscopy|incomplete colonoscopy
5036213|NCT01480635|Efficacy of PillCam Colon2|efficacy of pillcam colon2
5036214|NCT01480622|healthy subjects|healthy subjects
5036215|NCT01480622|Tenofovir disoproxil fumarate|tenofovir disoproxil fumarate
5036216|NCT01480622|hepatitis|hepatitis
5036217|NCT01480622|pharmacokinetics|pharmacokinetics
5036218|NCT01480583|GRN1005|grn1005
5036219|NCT01480583|ANG1005|ang1005
5036220|NCT01480583|Peptide-Drug Conjugate (PDC)|peptide-drug conjugate (pdc)
5036221|NCT01480583|LRP-1|lrp-1
5036222|NCT01480583|Targeted Therapy|targeted therapy
5036223|NCT01480583|Breast Cancer|breast cancer
5036224|NCT01480583|Brain Metastases|brain metastases
5036225|NCT01480583|Brain Tumor|brain tumor
5036226|NCT01480583|Blood Brain Barrier|blood brain barrier
5036227|NCT01480583|Trastuzumab|trastuzumab
5036228|NCT01480583|Herceptin|herceptin
5036229|NCT01480583|Paclitaxel|paclitaxel
5036230|NCT01480583|Taxol|taxol
5036231|NCT01480583|Breast cancer with brain metastases|breast cancer with brain metastases
5036232|NCT01480557|cataract|cataract
5036233|NCT01480557|phacoemulsification|phacoemulsification
5036234|NCT01480557|liquefaction|liquefaction
5036235|NCT01480557|torsional ip|torsional ip
5036236|NCT01480557|endothelial cell count|endothelial cell count
5036237|NCT01480557|central corneal edema|central corneal edema
5036238|NCT01480557|central corneal sensitivity|central corneal sensitivity
5036239|NCT01480544|Institutional Deliveries|institutional deliveries
5036240|NCT01480544|Maternal Health|maternal health
5036241|NCT01480544|Infant Health|infant health
5036242|NCT01480544|Private Medical Providers|private medical providers
5036243|NCT01480544|Provider Incentives|provider incentives
5036244|NCT01480544|Randomized Control Trial|randomized control trial
5036245|NCT01480531|aorta|aorta
5036246|NCT01480531|aneurysm|aneurysm
5036247|NCT01480531|dissection|dissection
5036248|NCT01480518|localized Ewing sarcoma/peripheral primitive neuroectodermal tumor|localized ewing sarcoma/peripheral primitive neuroectodermal tumor
5036249|NCT01480505|Retinal detachment|retinal detachment
5036250|NCT01480505|high myopia|high myopia
5036251|NCT01480505|macular hole|macular hole
5036252|NCT01480505|axial length|axial length
5036253|NCT01480505|Scleral buckling|scleral buckling
5036254|NCT01480505|Vitrectomy|vitrectomy
5036255|NCT01480505|Visual acuity|visual acuity
5036256|NCT01480505|fundus examination results|fundus examination results
5036257|NCT01480492|HBV|hbv
5036258|NCT01480492|Immune|immune
5036259|NCT01480492|antiviral therapy|antiviral therapy
5036260|NCT01480479|EGFRvIII|egfrviii
5036261|NCT01480479|Glioblastoma|glioblastoma
5036262|NCT01480479|Small cell|small cell
5036263|NCT01480479|Giant cell|giant cell
5036264|NCT01480479|Gliosarcoma|gliosarcoma
5036265|NCT01480479|oligodendroglial|oligodendroglial
5036266|NCT01480479|Brain Cancer|brain cancer
5036267|NCT01480479|Brain Tumor|brain tumor
5036268|NCT01480479|radiotherapy|radiotherapy
5036269|NCT01480479|chemoradiation|chemoradiation
5036270|NCT01480479|Tumor|tumor
5036271|NCT01480479|temozolomide|temozolomide
5036272|NCT01480479|EGFR variant III|egfr variant iii
5036273|NCT01480466|Overweight|overweight
5036274|NCT01480466|Obesity|obesity
5036275|NCT01480466|Body mass index|body mass index
5036276|NCT01480466|Weight|weight
5036277|NCT01480466|Primary care|primary care
5036278|NCT01480453|Osteoarthritis|osteoarthritis
5036279|NCT01480453|Rheumatoid arthritis|rheumatoid arthritis
5036280|NCT01480453|Post-traumatic arthritis|post-traumatic arthritis
5036281|NCT01480453|Ununited humeral head fracture|ununited humeral head fracture
5036282|NCT01480453|Irreducible 3- and 4-part proximal humeral fractures|irreducible 3- and 4-part proximal humeral fractures
5036283|NCT01480453|Avascular necrosis|avascular necrosis
5036284|NCT01480440|Reverse Total Shoulder Arthroplasty|reverse total shoulder arthroplasty
5036285|NCT01480440|Reverse TSA|reverse tsa
5036286|NCT01480440|Osteoarthritis|osteoarthritis
5036287|NCT01480440|Rheumatoid Arthritis|rheumatoid arthritis
5036288|NCT01480440|Post-traumatic arthritis|post-traumatic arthritis
5036289|NCT01480440|Ununited humeral head fracture|ununited humeral head fracture
5036290|NCT01480440|Irreducible 3-and 4-part proximal humeral fractures|irreducible 3-and 4-part proximal humeral fractures
5036291|NCT01480440|Avascular necrosis|avascular necrosis
5036292|NCT01480440|Gross rotator cuff deficiency|gross rotator cuff deficiency
5036293|NCT01480440|Failed total shoulder arthroplasty (both glenoid and humeral components require revision|failed total shoulder arthroplasty (both glenoid and humeral components require revision
5036294|NCT01480427|Children aged 0-12 years|children aged 0-12 years
5036295|NCT01480427|IgE mediated food allergy|ige mediated food allergy
5036296|NCT01480414|bone marrow mono nuclear stem cell ischemic ulcer|bone marrow mono nuclear stem cell ischemic ulcer
5036297|NCT01480401|Patients with stable heart failure|patients with stable heart failure
5036298|NCT01480388|Rheumatoid arthritis|rheumatoid arthritis
5036299|NCT01480388|Swollen and tender joints|swollen and tender joints
5036300|NCT01480388|Dose range finding study|dose range finding study
5036301|NCT01480388|Concurrent treatment with methotrexate|concurrent treatment with methotrexate
5036302|NCT01480375|prostate cancer detection|prostate cancer detection
5036303|NCT01480375|prostate biopsy|prostate biopsy
5036304|NCT01480375|3d navigation|3d navigation
5036305|NCT01480375|trans rectal ultrasound|trans rectal ultrasound
5036306|NCT01480362|Diabetic foot wound|diabetic foot wound
5036307|NCT01480362|Amputation wound|amputation wound
5036308|NCT01480362|Chronic wound|chronic wound
5036309|NCT01480349|Post-Hemorrhagic Hydrocephalus|post-hemorrhagic hydrocephalus
5036310|NCT01480349|Intraventricular Hemorrhage|intraventricular hemorrhage
5036311|NCT01480349|Low Birth Weight Premature Infants|low birth weight premature infants
5036312|NCT01480336|Arrhythmia|arrhythmia
5036313|NCT01480323|Malignant melanoma|malignant melanoma
5036314|NCT01480297|Pain|pain
5036315|NCT01480297|Neuropathy|neuropathy
5036316|NCT01480297|Diabetes type 1|diabetes type 1
5036317|NCT01480284|Tenofovir Disoproxil Fumarate|tenofovir disoproxil fumarate
5036318|NCT01480284|Chronic Hepatitis B|chronic hepatitis b
5036319|NCT01480271|Allergic Rhinitis|allergic rhinitis
5036320|NCT01480271|Healthy Volunteers|healthy volunteers
5036321|NCT01480271|Single Dose Escalation|single dose escalation
5036322|NCT01480271|TLR7 agonist|tlr7 agonist
5036323|NCT01480271|First Time in Human Study|first time in human study
5036324|NCT01480258|combination vaccine|combination vaccine
5036325|NCT01480258|diphtheria|diphtheria
5036326|NCT01480258|pertussis|pertussis
5036327|NCT01480258|tetanus|tetanus
5036328|NCT01480258|hepatitis B|hepatitis b
5036329|NCT01480258|Hep B|hep b
5036330|NCT01480258|Haemophilus influenzae b|haemophilus influenzae b
5036331|NCT01480258|Hib|hib
5036332|NCT01480258|polio|polio
5036333|NCT01480258|poliovirus|poliovirus
5036334|NCT01480245|968|968
5036335|NCT01480245|Duchenne|duchenne
5036336|NCT01480245|DMD|dmd
5036337|NCT01480245|drisapersen|drisapersen
5036338|NCT01480219|voriconazole|voriconazole
5036339|NCT01480219|non-melanoma skin cancer|non-melanoma skin cancer
5036340|NCT01480219|confounding|confounding
5036341|NCT01480219|statistical adjustment|statistical adjustment
5036342|NCT01480219|risk adjustment|risk adjustment
5036343|NCT01480219|lung transplant|lung transplant
5036344|NCT01480219|heart/lung transplant|heart/lung transplant
5036345|NCT01480219|immunosuppression|immunosuppression
5036346|NCT01480193|Tinnitus|tinnitus
5036347|NCT01480167|VCF|vcf
5036348|NCT01480167|Osteoporosis|osteoporosis
5036349|NCT01480167|Minimally Invasive|minimally invasive
5036350|NCT01480167|Non-operative management|non-operative management
5036351|NCT01480167|Medical Management|medical management
5036352|NCT01480128|Single-port|single-port
5036353|NCT01480128|Laparoscopy|laparoscopy
5036354|NCT01480128|colectomy|colectomy
5036355|NCT01480128|Single port|single port
5036356|NCT01480128|colon cancer|colon cancer
5036357|NCT01480128|minimally invasive surgery|minimally invasive surgery
5036358|NCT01480115|antral follicle count|antral follicle count
5036359|NCT01480115|automated antral follicle count|automated antral follicle count
5036360|NCT01480115|ovarian reserve|ovarian reserve
5036361|NCT01480102|Percutaneous nephrolithotomy|percutaneous nephrolithotomy
5036362|NCT01480102|Paravertebral block|paravertebral block
5036363|NCT01480102|bupivacaine|bupivacaine
5036364|NCT01480089|Surgical Pain Management|surgical pain management
5036365|NCT01480089|Robotic surgery|robotic surgery
5036366|NCT01480089|Ropivacaine|ropivacaine
5036367|NCT01480076|Quality of Life|quality of life
5036368|NCT01480076|Multiple Sclerosis|multiple sclerosis
5036369|NCT01480050|adult giant cell glioblastoma|adult giant cell glioblastoma
5036370|NCT01480050|adult glioblastoma|adult glioblastoma
5036371|NCT01480050|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5036372|NCT01480050|adult anaplastic ependymoma|adult anaplastic ependymoma
5036373|NCT01480050|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
5036374|NCT01480050|adult mixed glioma|adult mixed glioma
5036375|NCT01480050|recurrent adult brain tumor|recurrent adult brain tumor
5036376|NCT01480024|healthy women|healthy women
5036377|NCT01480024|oocytes|oocytes
5036378|NCT01480024|in vitro fertilization|in vitro fertilization
5036379|NCT01480024|pregnancy|pregnancy
5036380|NCT01480024|childbearing-age|childbearing-age
5036381|NCT01480011|Lactobacillus CD2 lozenges|lactobacillus cd2 lozenges
5036382|NCT01480011|high-dose chemotherapy induced|high-dose chemotherapy induced
5036383|NCT01480011|hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
5036384|NCT01479998|smoking cessation|smoking cessation
5036385|NCT01479998|NRT nicotine replacement therapy|nrt nicotine replacement therapy
5036386|NCT01479998|CBT cognitive behavioral therapy|cbt cognitive behavioral therapy
5036387|NCT01479998|contingency management|contingency management
5036388|NCT01479972|Tuberculosis|tuberculosis
5036389|NCT01479972|Vaccine|vaccine
5036390|NCT01479972|Live vaccine|live vaccine
5036391|NCT01479972|rBCG|rbcg
5036392|NCT01479959|Tracheostomy|tracheostomy
5036393|NCT01479959|positive end expiratory pressure|positive end expiratory pressure
5036394|NCT01479959|speech|speech
5036395|NCT01479959|respiratory failure|respiratory failure
5036396|NCT01479959|ventilation|ventilation
5036397|NCT01479959|neuromuscular disorders|neuromuscular disorders
5036398|NCT01479933|vitamin D|vitamin d
5036399|NCT01479933|cholecalciferol|cholecalciferol
5036400|NCT01479933|supplementation|supplementation
5036401|NCT01479933|prediabetic state|prediabetic state
5036402|NCT01479933|obesity|obesity
5036403|NCT01479933|glucose metabolism|glucose metabolism
5036404|NCT01479933|gene expression|gene expression
5036405|NCT01479933|transcriptomics|transcriptomics
5036406|NCT01479933|epigenomics|epigenomics
5036407|NCT01479933|immunological function|immunological function
5036408|NCT01479933|insulin sensitivity|insulin sensitivity
5036409|NCT01479933|peripheral mononuclear cells|peripheral mononuclear cells
5036410|NCT01479920|Depressive Disorder|depressive disorder
5036411|NCT01479920|Depressive Symptoms|depressive symptoms
5036412|NCT01479920|Depressive Syndrome|depressive syndrome
5036413|NCT01479920|Emotional Depression|emotional depression
5036414|NCT01479881|Hepatitis C Virus|hepatitis c virus
5036415|NCT01479881|TMC435|tmc435
5036416|NCT01479881|TMC435-TiDP16-C120|tmc435-tidp16-c120
5036417|NCT01479881|TMC435-C120|tmc435-c120
5036418|NCT01479881|HCV|hcv
5036419|NCT01479881|Hepatitis C|hepatitis c
5036420|NCT01479881|Hep C|hep c
5036421|NCT01479881|Healthy participants|healthy participants
5036422|NCT01479868|Hepatitis C virus genotype-1|hepatitis c virus genotype-1
5036423|NCT01479868|Human immunodeficiency virus-type 1|human immunodeficiency virus-type 1
5036424|NCT01479868|HCV-1|hcv-1
5036425|NCT01479868|HIV-1|hiv-1
5036426|NCT01479868|TMC435|tmc435
5036427|NCT01479868|Pegylated interferon alpha-2a|pegylated interferon alpha-2a
5036428|NCT01479868|PegIFNα-2a|pegifnα-2a
5036429|NCT01479868|Pegasys|pegasys
5036430|NCT01479868|Ribavirin|ribavirin
5036431|NCT01479868|RBV|rbv
5036432|NCT01479868|Copegus|copegus
5036433|NCT01479855|Mild Cognitive Impairment (MCI)|mild cognitive impairment (mci)
5036434|NCT01479855|Alzheimers disease|alzheimers disease
5036435|NCT01479855|Vitamines|vitamines
5036436|NCT01479855|Nutrients|nutrients
5036437|NCT01479829|Bipolar depression|bipolar depression
5036438|NCT01479829|Celecoxib|celecoxib
5036439|NCT01479829|Escitalopram|escitalopram
5036440|NCT01479829|Inflammation|inflammation
5036441|NCT01479816|continence|continence
5036442|NCT01479816|index|index
5036443|NCT01479790|Visante AS-OCT|visante as-oct
5036444|NCT01479790|Cirrus AS-OCT|cirrus as-oct
5036445|NCT01479790|Thermography|thermography
5036446|NCT01479790|Tear evaporation|tear evaporation
5036447|NCT01479790|Tear evaporimetry|tear evaporimetry
5036448|NCT01479777|Spinal Cord Injury|spinal cord injury
5036449|NCT01479777|Functional electrical stimulation|functional electrical stimulation
5036450|NCT01479777|Rehabilitation|rehabilitation
5036451|NCT01479751|Rocuronium|rocuronium
5036452|NCT01479751|magnesium|magnesium
5036453|NCT01479751|priming|priming
5036454|NCT01479751|ketamine|ketamine
5036455|NCT01479751|intubation|intubation
5036456|NCT01479738|arthroplasty|arthroplasty
5036457|NCT01479738|graft|graft
5036458|NCT01479738|capitate|capitate
5036459|NCT01479738|artery|artery
5036460|NCT01479725|interstitial cystitis|interstitial cystitis
5036461|NCT01479712|Irrigation|irrigation
5036462|NCT01479712|Cesarean Section|cesarean section
5036463|NCT01479712|Nausea|nausea
5036464|NCT01479712|Infection|infection
5036465|NCT01479699|Olive leaf extract|olive leaf extract
5036466|NCT01479699|Polyphenols|polyphenols
5036467|NCT01479699|Vascular function|vascular function
5036468|NCT01479699|Bioavailability|bioavailability
5036469|NCT01479699|Cytokines|cytokines
5036470|NCT01479686|GLIOMA|glioma
5036471|NCT01479686|NEURONAVIGATION|neuronavigation
5036472|NCT01479686|INTERVENTIONAL MRI|interventional mri
5036473|NCT01479673|Enteral Nutrition|enteral nutrition
5036474|NCT01479673|Parenteral Nutrition|parenteral nutrition
5036475|NCT01479673|Indirect Calorimetry|indirect calorimetry
5036476|NCT01479673|Intravenous Feeding|intravenous feeding
5036477|NCT01479660|Probiotics|probiotics
5036478|NCT01479660|ulcerative colitis|ulcerative colitis
5036479|NCT01479660|inflammatory bowel disease|inflammatory bowel disease
5036480|NCT01479634|HIV|hiv
5036481|NCT01479634|ART|art
5036482|NCT01479621|Dose Ranging|dose ranging
5036483|NCT01479621|Fluticasone Propionate|fluticasone propionate
5036484|NCT01479621|Dry Powder Inhaler (DPI)|dry powder inhaler (dpi)
5036485|NCT01479621|Non-steroidal|non-steroidal
5036486|NCT01479621|Asthma|asthma
5036487|NCT01479595|Asthma|asthma
5036488|NCT01479595|Interleukin|interleukin
5036489|NCT01479595|QBX258|qbx258
5036490|NCT01479595|QAX576|qax576
5036491|NCT01479595|VAK694|vak694
5036492|NCT01479582|Adult and Pediatric|adult and pediatric
5036493|NCT01479582|Unlicensed Cord Blood Unit IND|unlicensed cord blood unit ind
5036494|NCT01479582|NMDP|nmdp
5036495|NCT01479582|Transplant|transplant
5036496|NCT01479582|Hematologic Malignancies|hematologic malignancies
5036497|NCT01479582|Leukemia|leukemia
5036498|NCT01479582|Multiple Myeloma|multiple myeloma
5036499|NCT01479582|Non-Hodgkin Lymphoma|non-hodgkin lymphoma
5036500|NCT01479582|CML|cml
5036501|NCT01479582|Chronic Myelogenous Leukemia|chronic myelogenous leukemia
5036502|NCT01479582|Myelodyplastic Syndrome|myelodyplastic syndrome
5036503|NCT01479582|MDS|mds
5036504|NCT01479582|Thalassemia|thalassemia
5036505|NCT01479582|Lysosomal Storage Diseases|lysosomal storage diseases
5036506|NCT01479569|MRI Catheterization|mri catheterization
5036507|NCT01479569|Pericardiocentesis|pericardiocentesis
5036508|NCT01479569|MRI Safety|mri safety
5036509|NCT01479569|Cardiac Magnetic Resonance Imaging|cardiac magnetic resonance imaging
5036510|NCT01479556|Pregabalin|pregabalin
5036511|NCT01479556|Neuropathic pain|neuropathic pain
5036512|NCT01479556|At-level neuropathic pain|at-level neuropathic pain
5036513|NCT01479556|Non-evoked neuropathic pain|non-evoked neuropathic pain
5036514|NCT01479556|Evoked neuropathic pain|evoked neuropathic pain
5036515|NCT01479556|Sub-acute spinal cord injury|sub-acute spinal cord injury
5036516|NCT01479543|Probiotic|probiotic
5036517|NCT01479543|Immunity|immunity
5036518|NCT01479543|Gastrointestinal symptoms|gastrointestinal symptoms
5036519|NCT01479530|Rasagiline|rasagiline
5036520|NCT01479530|Azilect|azilect
5036521|NCT01479530|Parkinson´s Disease|parkinson´s disease
5036522|NCT01479530|Motor fluctuations|motor fluctuations
5036523|NCT01479517|operative|operative
5036524|NCT01479517|dental procedure|dental procedure
5036525|NCT01479504|Nasopharyngeal Carcinoma|nasopharyngeal carcinoma
5036526|NCT01479504|neoadjuvant chemotherapy|neoadjuvant chemotherapy
5036527|NCT01479504|concurrent chemoradiotherapy|concurrent chemoradiotherapy
5036528|NCT01479504|Nedaplatin|nedaplatin
5036529|NCT01479491|Japan|japan
5036530|NCT01479491|Retrospective|retrospective
5036531|NCT01479491|Observational|observational
5036532|NCT01479491|Epidemiological study|epidemiological study
5036533|NCT01479491|Children aged < 12 months|children aged < 12 months
5036534|NCT01479491|Intussusception|intussusception
5036535|NCT01479465|GSI|gsi
5036536|NCT01479465|Gilead|gilead
5036537|NCT01479465|Gilead Sciences|gilead sciences
5036538|NCT01479465|GS-6624|gs-6624
5036539|NCT01479465|Colorectal Cancer|colorectal cancer
5036540|NCT01479465|KRAS|kras
5036541|NCT01479465|Oncology|oncology
5036542|NCT01479465|monoclonal antibody|monoclonal antibody
5036543|NCT01479452|obesity|obesity
5036544|NCT01479452|bariatric surgery|bariatric surgery
5036545|NCT01479452|weight loss|weight loss
5036546|NCT01479426|Erectile dysfunction|erectile dysfunction
5036547|NCT01479426|Korean Red Ginseng|korean red ginseng
5036548|NCT01479426|IIEF|iief
5036549|NCT01479426|MSHQ|mshq
5036550|NCT01479413|Schizophrenia|schizophrenia
5036551|NCT01479413|Oxidative stress|oxidative stress
5036552|NCT01479413|Mitochondria|mitochondria
5036553|NCT01479400|antipsychotic|antipsychotic
5036554|NCT01479400|schizophrenia|schizophrenia
5036555|NCT01479400|infant development|infant development
5036556|NCT01479387|Zevalin|zevalin
5036557|NCT01479387|CD20+|cd20+
5036558|NCT01479387|Non-Hodgkin's lymphoma|non-hodgkin's lymphoma
5036559|NCT01479387|Mantle cell lymphoma|mantle cell lymphoma
5036560|NCT01479374|Allergic Conjunctivitis|allergic conjunctivitis
5036561|NCT01479374|Ocular Allergy|ocular allergy
5036562|NCT01479361|Atovaquone|atovaquone
5036563|NCT01479361|Drug Interaction|drug interaction
5036564|NCT01479361|Pharmacokinetics|pharmacokinetics
5036565|NCT01479361|Efavirenz|efavirenz
5036566|NCT01479361|Atazanavir-Ritonavir|atazanavir-ritonavir
5036567|NCT01479361|HIV|hiv
5036568|NCT01479348|Imaging|imaging
5036569|NCT01479348|Radiopharmaceutical|radiopharmaceutical
5036570|NCT01479348|Safety|safety
5036571|NCT01479348|Dosimetry|dosimetry
5036572|NCT01479348|Drug Distribution|drug distribution
5036573|NCT01479348|Cancer|cancer
5036574|NCT01479322|Intima-media thickness|intima-media thickness
5036575|NCT01479322|Ghrelin|ghrelin
5036576|NCT01479322|Prader-Willi syndrome|prader-willi syndrome
5036577|NCT01479309|Advanced Malignancies|advanced malignancies
5036578|NCT01479309|Solid Tumors|solid tumors
5036579|NCT01479309|Melanoma|melanoma
5036580|NCT01479309|Renal Cell Carcinoma|renal cell carcinoma
5036581|NCT01479309|Phase I Studies|phase i studies
5036582|NCT01479309|Sodium Stibogluconate|sodium stibogluconate
5036583|NCT01479309|Interferon Alpha-2b|interferon alpha-2b
5036584|NCT01479309|Intron A|intron a
5036585|NCT01479309|SSG|ssg
5036586|NCT01479283|Infection|infection
5036587|NCT01479283|Bone Neoplasms|bone neoplasms
5036588|NCT01479283|Prosthesis|prosthesis
5036589|NCT01479283|Anti-Bacterial Agents|anti-bacterial agents
5036590|NCT01479283|Randomized|randomized
5036591|NCT01479270|recovery|recovery
5036592|NCT01479270|postoperative|postoperative
5036593|NCT01479270|pain|pain
5036594|NCT01479270|laparoscopy|laparoscopy
5036595|NCT01479270|hysterectomy|hysterectomy
5036596|NCT01479270|ropivacaine|ropivacaine
5036597|NCT01479270|TAP block|tap block
5036598|NCT01479270|local anesthesia|local anesthesia
5036599|NCT01479257|Cancer|cancer
5036600|NCT01479257|Risk factors|risk factors
5036601|NCT01479257|Latinos|latinos
5036602|NCT01479257|Hispanic Americans|hispanic americans
5036603|NCT01479257|Hispanics|hispanics
5036604|NCT01479257|Latino resident|latino resident
5036605|NCT01479257|Houston metropolitan area|houston metropolitan area
5036606|NCT01479257|Spanish speaking|spanish speaking
5036607|NCT01479257|Cancer risk behaviors|cancer risk behaviors
5036608|NCT01479257|Questionnaires|questionnaires
5036609|NCT01479257|Surveys|surveys
5036610|NCT01479257|Accelerometer|accelerometer
5036611|NCT01479244|HER2|her2
5036612|NCT01479244|low or intermediate|low or intermediate
5036613|NCT01479244|breast cancer|breast cancer
5036614|NCT01479244|node-positive tumors|node-positive tumors
5036615|NCT01479231|GERD|gerd
5036616|NCT01479231|Eosinophilic esophagitis|eosinophilic esophagitis
5036617|NCT01479231|Proton pump inhibitor|proton pump inhibitor
5036618|NCT01479231|dysphagia|dysphagia
5036619|NCT01479205|specific immunotherapy|specific immunotherapy
5036620|NCT01479205|bronchial allergen provocation|bronchial allergen provocation
5036621|NCT01479205|specific IgE|specific ige
5036622|NCT01479205|specific IgG|specific igg
5036623|NCT01479205|specific IgG4|specific igg4
5036624|NCT01479205|SIT|sit
5036625|NCT01479192|breast|breast
5036626|NCT01479192|cancer|cancer
5036627|NCT01479192|prevention|prevention
5036628|NCT01479192|fenretinide|fenretinide
5036629|NCT01479179|Breast Cancer|breast cancer
5036630|NCT01479179|Metastatic Breast Cancer|metastatic breast cancer
5036631|NCT01479179|HER-2-overexpressing breast cancer|her-2-overexpressing breast cancer
5036632|NCT01479179|Human epidermal growth factor receptor|human epidermal growth factor receptor
5036633|NCT01479179|AMG 479|amg 479
5036634|NCT01479179|Trastuzumab|trastuzumab
5036635|NCT01479179|Herceptin|herceptin
5036636|NCT01479166|cystic fibrosis|cystic fibrosis
5036637|NCT01479166|HRCT|hrct
5036638|NCT01479166|Sputum|sputum
5036639|NCT01479166|Blood|blood
5036640|NCT01479166|Inflammation|inflammation
5036641|NCT01479166|adaptive immune system|adaptive immune system
5036642|NCT01479166|innate immune system|innate immune system
5036643|NCT01479153|Central venous catheterization|central venous catheterization
5036644|NCT01479153|Major complications|major complications
5036645|NCT01479153|Internal Jugular|internal jugular
5036646|NCT01479153|Femoral|femoral
5036647|NCT01479153|Subclavian|subclavian
5036648|NCT01479140|myocardial infarction|myocardial infarction
5036649|NCT01479140|dissection|dissection
5036650|NCT01479140|coronary Fibromuscular Dysplasia|coronary fibromuscular dysplasia
5036651|NCT01479140|coronary ectasia|coronary ectasia
5036652|NCT01479140|atherosclerotic Coronary Artery Disease|atherosclerotic coronary artery disease
5036653|NCT01479140|coronary vasculitis|coronary vasculitis
5036654|NCT01479140|coronary embolism|coronary embolism
5036655|NCT01479140|congenital coronary anomaly|congenital coronary anomaly
5036656|NCT01479127|Levodopa-carbidopa intestinal gel|levodopa-carbidopa intestinal gel
5036657|NCT01479127|Advanced Parkinson's disease|advanced parkinson's disease
5036658|NCT01479127|Severe motor fluctuations|severe motor fluctuations
5036659|NCT01479127|Dyskinesia|dyskinesia
5036660|NCT01479101|neo adjuvant, breast cancer|neo adjuvant, breast cancer
5036661|NCT01479088|Cinacalcet|cinacalcet
5036662|NCT01479088|PK|pk
5036663|NCT01479088|Secondary Hyperparathyroidism|secondary hyperparathyroidism
5036664|NCT01479088|Paediatric|paediatric
5036665|NCT01479088|Chronic Kidney Disease|chronic kidney disease
5036666|NCT01479088|Dialysis|dialysis
5036667|NCT01479075|central insulin|central insulin
5036668|NCT01479075|insulin resistance|insulin resistance
5036669|NCT01479075|energy metabolism|energy metabolism
5036670|NCT01479062|behavior change|behavior change
5036671|NCT01479062|pre-diabetes|pre-diabetes
5036672|NCT01479062|prevention|prevention
5036673|NCT01479062|diabetes prevention|diabetes prevention
5036674|NCT01479062|Hemoglobin A1c|hemoglobin a1c
5036675|NCT01479062|glucose|glucose
5036676|NCT01479062|physical activity|physical activity
5036677|NCT01479062|nutrition|nutrition
5036678|NCT01479062|email|email
5036679|NCT01479062|web|web
5036680|NCT01479062|obesity|obesity
5036681|NCT01479049|congenital heart disease|congenital heart disease
5036682|NCT01479049|cardiac surgery|cardiac surgery
5036683|NCT01479049|cardiopulmonary bypass|cardiopulmonary bypass
5036684|NCT01479049|cardioplegia|cardioplegia
5036685|NCT01479036|breast cancer|breast cancer
5036686|NCT01479036|neoadjuvant chemotherapy|neoadjuvant chemotherapy
5036687|NCT01479036|recombinant human endostatin (endostar)|recombinant human endostatin (endostar)
5036688|NCT01479036|docetaxel|docetaxel
5036689|NCT01479036|epirubicin|epirubicin
5036690|NCT01478984|NSTEMI|nstemi
5036691|NCT01478984|PCI|pci
5036692|NCT01478984|onestage|onestage
5036693|NCT01478984|multistaged|multistaged
5036694|NCT01478971|Anemia|anemia
5036695|NCT01478971|Chronic Renal Failure|chronic renal failure
5036696|NCT01478971|CRF|crf
5036697|NCT01478971|Chronic Kidney Disease|chronic kidney disease
5036698|NCT01478971|CKD|ckd
5036699|NCT01478971|Erythropoietin|erythropoietin
5036700|NCT01478971|Hematide|hematide
5036701|NCT01478971|Peginesatide|peginesatide
5036702|NCT01478971|Hemoglobin|hemoglobin
5036703|NCT01478971|Hgb|hgb
5036704|NCT01478971|Red Blood Cell|red blood cell
5036705|NCT01478971|Red Blood Cell Production|red blood cell production
5036706|NCT01478971|Dialysis|dialysis
5036707|NCT01478958|fatty acids|fatty acids
5036708|NCT01478958|cardiovascular disease|cardiovascular disease
5036709|NCT01478958|vascular function|vascular function
5036710|NCT01478958|microparticles|microparticles
5036711|NCT01478945|vitiligo|vitiligo
5036712|NCT01478945|early vitiligo|early vitiligo
5036713|NCT01478945|focal vitiligo|focal vitiligo
5036714|NCT01478932|dyspnea|dyspnea
5036715|NCT01478932|diaphragmatic breathing|diaphragmatic breathing
5036716|NCT01478932|Heart failure|heart failure
5036717|NCT01478919|Endoscopic Mucosal Resection|endoscopic mucosal resection
5036718|NCT01478919|Laterally Spreading Tumor|laterally spreading tumor
5036719|NCT01478919|Local Residual Neoplasia|local residual neoplasia
5036720|NCT01478919|Colonoscopy|colonoscopy
5036721|NCT01478919|Therapy|therapy
5036722|NCT01478893|nicotine vaccine|nicotine vaccine
5036723|NCT01478893|smoking vaccine|smoking vaccine
5036724|NCT01478893|smoking cessation|smoking cessation
5036725|NCT01478893|SEL-068|sel-068
5036726|NCT01478867|celiac disease|celiac disease
5036727|NCT01478867|gluten-free diet|gluten-free diet
5036728|NCT01478867|gluten peptides|gluten peptides
5036729|NCT01478867|feces|feces
5036730|NCT01478841|insulin resistance|insulin resistance
5036731|NCT01478841|type 2 diabetes (T2D)|type 2 diabetes (t2d)
5036732|NCT01478841|cardiovascular complications|cardiovascular complications
5036733|NCT01478841|polyphenolic compounds derived from red grape marc extracts|polyphenolic compounds derived from red grape marc extracts
5036734|NCT01478841|oxidative stress|oxidative stress
5036735|NCT01478802|Mechanical Ventilation|mechanical ventilation
5036736|NCT01478802|High frequency oscillation|high frequency oscillation
5036737|NCT01478802|Acute Respiratory Distress syndrome|acute respiratory distress syndrome
5036738|NCT01478776|ASP|asp
5036739|NCT01478776|LCN2|lcn2
5036740|NCT01478776|RBP4|rbp4
5036741|NCT01478776|C5L2|c5l2
5036742|NCT01478763|PDRP|pdrp
5036743|NCT01478763|vitreous|vitreous
5036744|NCT01478763|protein|protein
5036745|NCT01478763|vitrectomy|vitrectomy
5036746|NCT01478750|obesity|obesity
5036747|NCT01478750|fat|fat
5036748|NCT01478750|appetite|appetite
5036749|NCT01478750|digestion|digestion
5036750|NCT01478737|PDRP|pdrp
5036751|NCT01478737|vitreous hemorrhage|vitreous hemorrhage
5036752|NCT01478737|vitrectomy|vitrectomy
5036753|NCT01478698|peritoneal dialysis|peritoneal dialysis
5036754|NCT01478698|peritoneal dialysis, continuous ambulatory|peritoneal dialysis, continuous ambulatory
5036755|NCT01478698|peritonitis|peritonitis
5036756|NCT01478685|Relapsed or Refractory Solid Tumors|relapsed or refractory solid tumors
5036757|NCT01478672|Promotion health|promotion health
5036758|NCT01478659|Diet|diet
5036759|NCT01478659|Fiber|fiber
5036760|NCT01478659|Adult|adult
5036761|NCT01478659|Fructooligosaccharide|fructooligosaccharide
5036762|NCT01478646|breathing therapy|breathing therapy
5036763|NCT01478646|reflective breathing therapy|reflective breathing therapy
5036764|NCT01478646|COPD|copd
5036765|NCT01478646|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
5036766|NCT01478633|Alzheimer's disease|alzheimer's disease
5036767|NCT01478633|Dementia|dementia
5036768|NCT01478633|Galantamine|galantamine
5036769|NCT01478633|Donepezil|donepezil
5036770|NCT01478607|Painful Diabetic Peripheral Neuropathy|painful diabetic peripheral neuropathy
5036771|NCT01478607|Qutenza|qutenza
5036772|NCT01478594|metastatic colorectal cancer|metastatic colorectal cancer
5036773|NCT01478594|Avastin|avastin
5036774|NCT01478594|bevacizumab|bevacizumab
5036775|NCT01478594|tivozanib|tivozanib
5036776|NCT01478594|mFOLFOX6|mfolfox6
5036777|NCT01478594|BATON-CRC|baton-crc
5036778|NCT01478594|AV951|av951
5036779|NCT01478594|ASP4130|asp4130
5036780|NCT01478581|PCI-32765|pci-32765
5036781|NCT01478581|Multiple Myeloma|multiple myeloma
5036782|NCT01478581|Relapsed Refractory Multiple Myeloma|relapsed refractory multiple myeloma
5036783|NCT01478581|Bruton's Tyrosine Kinase|bruton's tyrosine kinase
5036784|NCT01478568|Pharmacokinetics|pharmacokinetics
5036785|NCT01478568|Mirabegron|mirabegron
5036786|NCT01478568|Phase 1|phase 1
5036787|NCT01478555|Dry Eye|dry eye
5036788|NCT01478542|DLBCL|dlbcl
5036789|NCT01478542|Liposomal Vincristine (Marqibo)|liposomal vincristine (marqibo)
5036790|NCT01478542|Optimised Rituximab|optimised rituximab
5036791|NCT01478542|Toxicity|toxicity
5036792|NCT01478542|Elderly Patients|elderly patients
5036793|NCT01478542|FDG-PET|fdg-pet
5036794|NCT01478542|Bulky Disease|bulky disease
5036795|NCT01478542|Radiation|radiation
5036796|NCT01478542|age >60 years|age >60 years
5036797|NCT01478542|First line Therapy|first line therapy
5036798|NCT01478542|Vitamin D|vitamin d
5036799|NCT01478529|Pharmacokinetics|pharmacokinetics
5036800|NCT01478529|Mirabegron|mirabegron
5036801|NCT01478529|Phase 1|phase 1
5036802|NCT01478516|autologous plasmin|autologous plasmin
5036803|NCT01478516|macular edema|macular edema
5036804|NCT01478516|vitreous|vitreous
5036805|NCT01478503|Pharmacokinetics|pharmacokinetics
5036806|NCT01478503|Mirabegron|mirabegron
5036807|NCT01478503|Phase 1|phase 1
5036808|NCT01478503|Dose-Escalation|dose-escalation
5036809|NCT01478490|Pharmacokinetics,|pharmacokinetics,
5036810|NCT01478490|Mirabegron|mirabegron
5036811|NCT01478490|Metoprolol|metoprolol
5036812|NCT01478490|CYP2D6|cyp2d6
5036813|NCT01478490|Phase 1|phase 1
5036814|NCT01478477|Breast Cancer|breast cancer
5036815|NCT01478451|DOMS|doms
5036816|NCT01478438|Unifocal|unifocal
5036817|NCT01478438|20mm in diameter|20mm in diameter
5036818|NCT01478438|measures|measures
5036819|NCT01478438|5mm away from the skin and chest|5mm away from the skin and chest
5036820|NCT01478425|Prevention|prevention
5036821|NCT01478425|Pollen|pollen
5036822|NCT01478425|Allergy|allergy
5036823|NCT01478425|Rhinitis|rhinitis
5036824|NCT01478412|Prostate cancer|prostate cancer
5036825|NCT01478412|Low risk|low risk
5036826|NCT01478412|Intermediate risk|intermediate risk
5036827|NCT01478412|T1|t1
5036828|NCT01478412|T2a|t2a
5036829|NCT01478412|T2b|t2b
5036830|NCT01478412|Gleason 6|gleason 6
5036831|NCT01478412|Gleason 7|gleason 7
5036832|NCT01478412|PSA 10|psa 10
5036833|NCT01478412|PSA 20|psa 20
5036834|NCT01478373|GIST|gist
5036835|NCT01478373|Dovitinib|dovitinib
5036836|NCT01478360|Asthma|asthma
5036837|NCT01478360|Secukinumab|secukinumab
5036838|NCT01478360|Therapeutic Uses|therapeutic uses
5036839|NCT01478360|Respiratory|respiratory
5036840|NCT01478360|Lung|lung
5036841|NCT01478360|Pulmonary|pulmonary
5036842|NCT01478360|inhaled|inhaled
5036843|NCT01478360|corticosteroids|corticosteroids
5036844|NCT01478347|Neisseria, Meningitis, Group B, Vaccine, At-risk, Adults|neisseria, meningitis, group b, vaccine, at-risk, adults
5036845|NCT01478334|High intensity exercise|high intensity exercise
5036846|NCT01478334|cardiovascular risk factors|cardiovascular risk factors
5036847|NCT01478321|Information Not Provided|information not provided
5036848|NCT01478308|prostate|prostate
5036849|NCT01478308|castration resistant|castration resistant
5036850|NCT01478308|hormone resistant|hormone resistant
5036851|NCT01478308|CRPC|crpc
5036852|NCT01478295|Nursing intervention|nursing intervention
5036853|NCT01478295|Primary Health care|primary health care
5036854|NCT01478295|caregiver|caregiver
5036855|NCT01478295|strain|strain
5036856|NCT01478282|dabigatran|dabigatran
5036857|NCT01478282|rivaroxaban|rivaroxaban
5036858|NCT01478282|oral anticoagulants|oral anticoagulants
5036859|NCT01478282|coagulation|coagulation
5036860|NCT01478282|bleeding|bleeding
5036861|NCT01478282|plasma concentrates|plasma concentrates
5036862|NCT01478269|Aggressive B-cell lymphoma|aggressive b-cell lymphoma
5036863|NCT01478269|R-CHOP|r-chop
5036864|NCT01478256|blepharitis|blepharitis
5036865|NCT01478256|topical erythromycin|topical erythromycin
5036866|NCT01478256|topical besifloxocin|topical besifloxocin
5036867|NCT01478243|Keloid|keloid
5036868|NCT01478230|Pharmacokinetics|pharmacokinetics
5036869|NCT01478217|lung ultrasonography|lung ultrasonography
5036870|NCT01478217|pressure-volume loops|pressure-volume loops
5036871|NCT01478217|ARDS|ards
5036872|NCT01478204|Alzheimer's disease|alzheimer's disease
5036873|NCT01478204|Sleep quality|sleep quality
5036874|NCT01478204|Anticholinesterase drugs|anticholinesterase drugs
5036875|NCT01478191|Hodgkin's Lymphoma|hodgkin's lymphoma
5036876|NCT01478191|Ifosfamide, Gemcitabine and Vinorelbine (IGEV)|ifosfamide, gemcitabine and vinorelbine (igev)
5036877|NCT01478191|High Dose Chemotherapy (HDCT)|high dose chemotherapy (hdct)
5036878|NCT01478191|Autologous Hematopoietic Stem Cells Transplantation (AHSCT)|autologous hematopoietic stem cells transplantation (ahsct)
5036879|NCT01478178|Glioma|glioma
5036880|NCT01478178|Glioblastoma|glioblastoma
5036881|NCT01478178|Glioblastoma multiforme|glioblastoma multiforme
5036882|NCT01478178|GBM|gbm
5036883|NCT01478178|brain tumor|brain tumor
5036884|NCT01478178|brain cancer|brain cancer
5036885|NCT01478178|recurrent brain tumor|recurrent brain tumor
5036886|NCT01478178|recurrent brain cancer|recurrent brain cancer
5036887|NCT01478178|refractory brain tumor|refractory brain tumor
5036888|NCT01478178|refractory brain cancer|refractory brain cancer
5036889|NCT01478178|recurrent GBM|recurrent gbm
5036890|NCT01478178|refractory GBM|refractory gbm
5036891|NCT01478178|recurrent glioma|recurrent glioma
5036892|NCT01478178|refractory glioma|refractory glioma
5036893|NCT01478178|recurrent glioblastoma|recurrent glioblastoma
5036894|NCT01478178|refractory glioblastoma|refractory glioblastoma
5036895|NCT01478178|recurrent glioblastoma multiforme|recurrent glioblastoma multiforme
5036896|NCT01478178|refractory glioblastoma multiforme|refractory glioblastoma multiforme
5036897|NCT01478178|failed temodar|failed temodar
5036898|NCT01478178|failed temozolomide|failed temozolomide
5036899|NCT01478178|temodar refractory|temodar refractory
5036900|NCT01478178|temozolomide refractory|temozolomide refractory
5036901|NCT01478178|failed avastin|failed avastin
5036902|NCT01478178|avastin refractory|avastin refractory
5036903|NCT01478178|failed bevacizumab|failed bevacizumab
5036904|NCT01478178|bevacizumab refractory|bevacizumab refractory
5036905|NCT01478178|avastin failure|avastin failure
5036906|NCT01478178|bevacizumab failure|bevacizumab failure
5036907|NCT01478178|temodar failure|temodar failure
5036908|NCT01478178|temozolomide failure|temozolomide failure
5036909|NCT01478165|Palonosetron|palonosetron
5036910|NCT01478165|PONV(postoperative nausea and vomiting)|ponv(postoperative nausea and vomiting)
5036911|NCT01478165|TIVA(Total intravenous anesthesia)|tiva(total intravenous anesthesia)
5036912|NCT01478152|Asthma|asthma
5036913|NCT01478152|Ectoin|ectoin
5036914|NCT01478152|Ectoine|ectoine
5036915|NCT01478152|FeNO|feno
5036916|NCT01478152|Metacholin|metacholin
5036917|NCT01478152|sRaw|sraw
5036918|NCT01478139|anorectal fistula|anorectal fistula
5036919|NCT01478139|acellular dermal matrix|acellular dermal matrix
5036920|NCT01478139|ligation of intersphincteric fistula tract|ligation of intersphincteric fistula tract
5036921|NCT01478139|ligation of intersphincteric fistula tract and plug|ligation of intersphincteric fistula tract and plug
5036922|NCT01478139|complications of treatment|complications of treatment
5036923|NCT01478139|recurrence|recurrence
5036924|NCT01478113|Major Depressive Disorder|major depressive disorder
5036925|NCT01478113|Therapy|therapy
5036926|NCT01478113|Medication study|medication study
5036927|NCT01478113|Depression|depression
5036928|NCT01478113|Therapy study|therapy study
5036929|NCT01478100|Coronary artery disease|coronary artery disease
5036930|NCT01478100|CT|ct
5036931|NCT01478100|Computational flow dynamics|computational flow dynamics
5036932|NCT01478074|Acute Myeloid Leukemia|acute myeloid leukemia
5036933|NCT01478074|Relapsed leukemia|relapsed leukemia
5036934|NCT01478074|Refractory leukemia|refractory leukemia
5036935|NCT01478074|Natural Killer Cells|natural killer cells
5036936|NCT01478074|Adoptive immunotherapy|adoptive immunotherapy
5036937|NCT01478074|NK cell infusion|nk cell infusion
5036938|NCT01478074|Haploidentical|haploidentical
5036939|NCT01478074|KIR mismatch|kir mismatch
5036940|NCT01478074|Fludarabine|fludarabine
5036941|NCT01478074|Cytarabine|cytarabine
5036942|NCT01478074|Ara-C|ara-c
5036943|NCT01478074|ALT-801|alt-801
5036944|NCT01478048|Relapsed/Refractory Multiple Myeloma|relapsed/refractory multiple myeloma
5036945|NCT01478035|Phenytoin prophylaxis|phenytoin prophylaxis
5036946|NCT01478035|Pneumococcal meningitis|pneumococcal meningitis
5036947|NCT01478035|Randomized|randomized
5036948|NCT01478035|Placebo-controlled|placebo-controlled
5036949|NCT01478035|Double blind|double blind
5036950|NCT01478035|Patient 50 years or older|patient 50 years or older
5036951|NCT01478022|DMD|dmd
5036952|NCT01478022|Duchenne|duchenne
5036953|NCT01478022|Muscular Dystrophy|muscular dystrophy
5036954|NCT01477996|intravitreal therapy|intravitreal therapy
5036955|NCT01477996|pain scales|pain scales
5036956|NCT01477996|gauge|gauge
5036957|NCT01477996|Pain Scores|pain scores
5036958|NCT01477996|Visual Analog Scale|visual analog scale
5036959|NCT01477983|atrial fibrillation|atrial fibrillation
5036960|NCT01477983|catheter ablation|catheter ablation
5036961|NCT01477983|adenosine triphosphate|adenosine triphosphate
5036962|NCT01477983|antiarrhythmic drugs|antiarrhythmic drugs
5036963|NCT01477970|GnRH antagonists|gnrh antagonists
5036964|NCT01477970|OHSS|ohss
5036965|NCT01477970|ovarian stimulation|ovarian stimulation
5036966|NCT01477957|weight loss after bariatric surgery|weight loss after bariatric surgery
5036967|NCT01477957|Insulin sensitivity|insulin sensitivity
5036968|NCT01477957|insulin resistance|insulin resistance
5036969|NCT01477944|Statins pattern of use|statins pattern of use
5036970|NCT01477944|Hypercholesterolemic patients|hypercholesterolemic patients
5036971|NCT01477944|Statins|statins
5036972|NCT01477931|Bupropion hydrochloride extended release|bupropion hydrochloride extended release
5036973|NCT01477931|Wellbutrin XL|wellbutrin xl
5036974|NCT01477931|Major Depressive Disorder with Atypical Features|major depressive disorder with atypical features
5036975|NCT01477918|prevalence|prevalence
5036976|NCT01477918|Korea|korea
5036977|NCT01477905|priming|priming
5036978|NCT01477905|remifentanil|remifentanil
5036979|NCT01477905|target-controlled infusion|target-controlled infusion
5036980|NCT01477840|Misoprostol|misoprostol
5036981|NCT01477840|Oxytocin|oxytocin
5036982|NCT01477840|Cesarean Delivery|cesarean delivery
5036983|NCT01477840|Blood Loss|blood loss
5036984|NCT01477814|colorectal cancer|colorectal cancer
5036985|NCT01477814|screening|screening
5036986|NCT01477814|colonoscopy|colonoscopy
5036987|NCT01477814|fecal immunochemical test|fecal immunochemical test
5036988|NCT01477814|clinical guidelines|clinical guidelines
5036989|NCT01477788|pelvic mass|pelvic mass
5036990|NCT01477788|ovarian mass|ovarian mass
5036991|NCT01477788|ultrasound|ultrasound
5036992|NCT01477788|serum markers|serum markers
5036993|NCT01477788|ovarian malignancy|ovarian malignancy
5036994|NCT01477775|myocardial infarction|myocardial infarction
5036995|NCT01477775|coronary stent|coronary stent
5036996|NCT01477775|Oral P2Y12 receptor blocker|oral p2y12 receptor blocker
5036997|NCT01477775|Platelet reactivity units (PRU)|platelet reactivity units (pru)
5036998|NCT01477762|startle response|startle response
5036999|NCT01477762|fear conditioning|fear conditioning
5037000|NCT01477762|PTSD|ptsd
5037001|NCT01477749|prostate cancer|prostate cancer
5037002|NCT01477749|prostate|prostate
5037003|NCT01477749|immune therapy|immune therapy
5037004|NCT01477749|immunotherapy|immunotherapy
5037005|NCT01477749|vaccine|vaccine
5037006|NCT01477749|dendritic cells|dendritic cells
5037007|NCT01477749|antigen-presenting cells|antigen-presenting cells
5037008|NCT01477749|antigen presenting cells|antigen presenting cells
5037009|NCT01477749|cancer vaccine|cancer vaccine
5037010|NCT01477749|PSA|psa
5037011|NCT01477749|prostatic adenocarcinoma|prostatic adenocarcinoma
5037012|NCT01477736|Neurogenic bladder|neurogenic bladder
5037013|NCT01477736|Urodynamic|urodynamic
5037014|NCT01477736|Quality of life|quality of life
5037015|NCT01477710|Mechanical ventilation|mechanical ventilation
5037016|NCT01477710|Tidal volume|tidal volume
5037017|NCT01477710|Respiratory rate|respiratory rate
5037018|NCT01477697|Trauma|trauma
5037019|NCT01477671|Dengue|dengue
5037020|NCT01477671|Dengue Fever|dengue fever
5037021|NCT01477671|Dengue Hemorrhagic Fever|dengue hemorrhagic fever
5037022|NCT01477658|Congenital Complete Atrioventricular Heart Block|congenital complete atrioventricular heart block
5037023|NCT01477658|Pacemaker|pacemaker
5037024|NCT01477658|Cardiac pacing|cardiac pacing
5037025|NCT01477658|Children|children
5037026|NCT01477658|Heart failure|heart failure
5037027|NCT01477658|Ventricular dyssynchrony|ventricular dyssynchrony
5037028|NCT01477658|Echocardiography|echocardiography
5037029|NCT01477658|Quality of life|quality of life
5037030|NCT01477658|Six-minute walk test|six-minute walk test
5037031|NCT01477658|Young adults|young adults
5037032|NCT01477619|Pharmacokinetics|pharmacokinetics
5037033|NCT01477606|Acute myeloid leukemia|acute myeloid leukemia
5037034|NCT01477606|FLT3-ITD|flt3-itd
5037035|NCT01477606|midostaurin (PKC412)|midostaurin (pkc412)
5037036|NCT01477593|circumcision, chinese children, pain|circumcision, chinese children, pain
5037037|NCT01477554|Women|women
5037038|NCT01477554|Maternal morbidity|maternal morbidity
5037039|NCT01477554|Maternal mortality|maternal mortality
5037040|NCT01477554|Perinatal mortality|perinatal mortality
5037041|NCT01477554|Perinatal morbidity|perinatal morbidity
5037042|NCT01477554|Training|training
5037043|NCT01477554|Obstetric Emergency|obstetric emergency
5037044|NCT01477554|Medical team|medical team
5037045|NCT01477554|Simulation|simulation
5037046|NCT01477541|Prenatal care|prenatal care
5037047|NCT01477541|Maternal mortality|maternal mortality
5037048|NCT01477541|Perinatal mortality|perinatal mortality
5037049|NCT01477541|Perinatal|perinatal
5037050|NCT01477541|Puerperium|puerperium
5037051|NCT01477541|Puerperium care|puerperium care
5037052|NCT01477541|Midwives|midwives
5037053|NCT01477541|Midwife|midwife
5037054|NCT01477541|Obstetric|obstetric
5037055|NCT01477541|Nurse|nurse
5037056|NCT01477541|Integration|integration
5037057|NCT01477541|Alternative personnel|alternative personnel
5037058|NCT01477541|Skilled attendant|skilled attendant
5037059|NCT01477541|Birth attendant|birth attendant
5037060|NCT01477541|Delivery|delivery
5037061|NCT01477541|Delivery services|delivery services
5037062|NCT01477541|Best practices|best practices
5037063|NCT01477541|Rural|rural
5037064|NCT01477528|HeartMate II|heartmate ii
5037065|NCT01477528|Anticoagulation|anticoagulation
5037066|NCT01477528|Thoratec Corporation|thoratec corporation
5037067|NCT01477502|urinary tract infection|urinary tract infection
5037068|NCT01477502|spinal cord injury|spinal cord injury
5037069|NCT01477502|homeopathy|homeopathy
5037070|NCT01477502|prevention|prevention
5037072|NCT01477476|Diabetes|diabetes
5037073|NCT01477476|Type I Diabetes|type i diabetes
5037074|NCT01477463|quality of life|quality of life
5037075|NCT01477450|Hypobaric hypoxemia|hypobaric hypoxemia
5037076|NCT01477450|Altitude|altitude
5037077|NCT01477450|Oxygen|oxygen
5037078|NCT01477450|oxygen concentrator|oxygen concentrator
5037079|NCT01477437|teens|teens
5037080|NCT01477437|adolescents|adolescents
5037081|NCT01477437|Internet intervention|internet intervention
5037082|NCT01477437|Hemophilia|hemophilia
5037083|NCT01477424|Drug-drug interaction|drug-drug interaction
5037084|NCT01477424|Pharmacokinetics|pharmacokinetics
5037085|NCT01477424|PA21|pa21
5037086|NCT01477411|Drug-drug interaction|drug-drug interaction
5037087|NCT01477411|Pharmacokinetics|pharmacokinetics
5037088|NCT01477411|PA21|pa21
5037089|NCT01477385|dental caries|dental caries
5037090|NCT01477385|primary teeth|primary teeth
5037091|NCT01477385|permanent teeth|permanent teeth
5037092|NCT01477385|silver diamine fluoride|silver diamine fluoride
5037093|NCT01477372|Pregnancy|pregnancy
5037094|NCT01477372|Exercise|exercise
5037095|NCT01477372|Excessive weight gain|excessive weight gain
5037096|NCT01477372|Outcomes|outcomes
5037097|NCT01477372|Urinary incontinence|urinary incontinence
5037098|NCT01477359|Sarcoidosis|sarcoidosis
5037099|NCT01477333|Tyvaso|tyvaso
5037100|NCT01477333|UT-15C SR|ut-15c sr
5037101|NCT01477333|PAH|pah
5037102|NCT01477320|Enteral Nutrition|enteral nutrition
5037103|NCT01477320|Stress Ulcer Prophylaxis|stress ulcer prophylaxis
5037104|NCT01477320|Critically Ill Patients|critically ill patients
5037105|NCT01477320|Overt and significant GI bleeding|overt and significant gi bleeding
5037106|NCT01477320|Stress gastropathy|stress gastropathy
5037107|NCT01477320|Clostridium Difficile pseudomembranous colitis|clostridium difficile pseudomembranous colitis
5037108|NCT01477320|Vital AF|vital af
5037109|NCT01477320|Small peptide fish oil structured lipids|small peptide fish oil structured lipids
5037110|NCT01477320|Fructose oligosaccharide|fructose oligosaccharide
5037111|NCT01477307|obesity|obesity
5037112|NCT01477307|non-alcoholic fatty liver disease|non-alcoholic fatty liver disease
5037113|NCT01477294|Total|total
5037114|NCT01477294|Intra and Extracellular Water|intra and extracellular water
5037115|NCT01477294|Energy Expenditure, Physical Activity|energy expenditure, physical activity
5037116|NCT01477294|Body Composition|body composition
5037117|NCT01477294|Dilution Techniques|dilution techniques
5037118|NCT01477281|chronic venous insufficiency|chronic venous insufficiency
5037119|NCT01477281|Daflon|daflon
5037120|NCT01477281|Venaflon|venaflon
5037121|NCT01477268|antidepressants|antidepressants
5037122|NCT01477268|depression|depression
5037123|NCT01477268|zoloft|zoloft
5037124|NCT01477268|psychiatry|psychiatry
5037125|NCT01477268|psychology|psychology
5037126|NCT01477255|daily assessment|daily assessment
5037127|NCT01477255|electronic diary|electronic diary
5037128|NCT01477255|coping strategies|coping strategies
5037129|NCT01477255|resiliency of cancer patients|resiliency of cancer patients
5037130|NCT01477255|psychology|psychology
5037131|NCT01477242|vomiting|vomiting
5037132|NCT01477242|anti-emetics|anti-emetics
5037133|NCT01477242|ketamine|ketamine
5037134|NCT01477242|sedation|sedation
5037135|NCT01477229|Rectal cancer|rectal cancer
5037136|NCT01477229|Quality of Life|quality of life
5037137|NCT01477229|Abdominoperineal Resection|abdominoperineal resection
5037138|NCT01477229|Anterior Resection|anterior resection
5037139|NCT01477229|Palliative cancer treatment|palliative cancer treatment
5037140|NCT01477229|Radio chemotherapy|radio chemotherapy
5037141|NCT01477216|Glycemic index|glycemic index
5037142|NCT01477216|Glycemic responses|glycemic responses
5037143|NCT01477216|Insulin responses|insulin responses
5037144|NCT01477216|Insulinemic index|insulinemic index
5037145|NCT01477216|Carbohydrates|carbohydrates
5037146|NCT01477216|Methodology|methodology
5037147|NCT01477216|Glucose metabolism|glucose metabolism
5037148|NCT01477177|Barrett's esophagus dysplasia|barrett's esophagus dysplasia
5037149|NCT01477164|Exercise|exercise
5037150|NCT01477164|Aging|aging
5037151|NCT01477164|Sarcopenia|sarcopenia
5037152|NCT01477164|Muscle function|muscle function
5037153|NCT01477151|isoflurane|isoflurane
5037154|NCT01477151|sevoflurane|sevoflurane
5037155|NCT01477151|troponin|troponin
5037156|NCT01477151|anesthesia|anesthesia
5037157|NCT01477151|cardioprotection|cardioprotection
5037158|NCT01477151|preconditioning|preconditioning
5037159|NCT01477151|cardiac surgery|cardiac surgery
5037160|NCT01477151|cardiac anesthesia|cardiac anesthesia
5037161|NCT01477138|Sick Sinus Syndrome|sick sinus syndrome
5037162|NCT01477138|Cardiac Pacing, Artificial|cardiac pacing, artificial
5037163|NCT01477138|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
5037164|NCT01477138|Pacemaker, Artificial|pacemaker, artificial
5037165|NCT01477138|SSS|sss
5037166|NCT01477125|adhd|adhd
5037167|NCT01477125|adults|adults
5037168|NCT01477125|working memory|working memory
5037169|NCT01477125|training|training
5037170|NCT01477125|RCT|rct
5037171|NCT01477112|Type 2 diabetes|type 2 diabetes
5037172|NCT01477112|β-carotene|β-carotene
5037173|NCT01477112|Oxidative balance|oxidative balance
5037174|NCT01477112|Oxidants|oxidants
5037175|NCT01477112|Antioxidants|antioxidants
5037176|NCT01477086|Sarcopenia|sarcopenia
5037177|NCT01477086|Hip fracture|hip fracture
5037178|NCT01477086|Frailty|frailty
5037179|NCT01477073|in-vitro fertilization|in-vitro fertilization
5037180|NCT01477073|reproductive disorder|reproductive disorder
5037181|NCT01477034|Vitamin D deficiency|vitamin d deficiency
5037182|NCT01477034|Obesity|obesity
5037183|NCT01477034|Inflammation|inflammation
5037184|NCT01477034|Low-grade, chronic inflammation|low-grade, chronic inflammation
5037185|NCT01477034|Adipose tissue inflammation|adipose tissue inflammation
5037186|NCT01477034|Diabetes|diabetes
5037187|NCT01477034|Type 2 diabetes mellitus|type 2 diabetes mellitus
5037188|NCT01477034|Insulin resistance|insulin resistance
5037189|NCT01477034|Intestinal permeability|intestinal permeability
5037190|NCT01477008|Knee|knee
5037191|NCT01477008|Cartilage repair|cartilage repair
5037192|NCT01477008|Cartilage regeneration|cartilage regeneration
5037193|NCT01477008|Chondral|chondral
5037194|NCT01477008|Osteochondral|osteochondral
5037195|NCT01477008|Biphasic scaffold|biphasic scaffold
5037196|NCT01477008|Medical device|medical device
5037197|NCT01477008|Autologous|autologous
5037198|NCT01477008|Synthetic|synthetic
5037199|NCT01477008|Medial condyle|medial condyle
5037200|NCT01477008|Lateral condyle|lateral condyle
5037201|NCT01477008|Trochlea|trochlea
5037202|NCT01476995|Cardiovascular system|cardiovascular system
5037203|NCT01476995|gastrointestinal system|gastrointestinal system
5037204|NCT01476995|kidneys|kidneys
5037205|NCT01476995|liver|liver
5037206|NCT01476995|lungs|lungs
5037207|NCT01476969|Ischemia reperfusion injury|ischemia reperfusion injury
5037208|NCT01476969|Cardiopulmonary bypass|cardiopulmonary bypass
5037209|NCT01476969|Remote Ischemic Postconditioning|remote ischemic postconditioning
5037210|NCT01476969|Other Functional Disturbances Following Cardiac Surgery|other functional disturbances following cardiac surgery
5037211|NCT01476930|migraine|migraine
5037212|NCT01476930|prophylactic treatment|prophylactic treatment
5037213|NCT01476930|cupping|cupping
5037214|NCT01476930|serkangabin|serkangabin
5037215|NCT01476904|Asthma|asthma
5037216|NCT01476904|Bronchial Asthma|bronchial asthma
5037217|NCT01476904|Shortness of breath|shortness of breath
5037218|NCT01476891|MBSR|mbsr
5037219|NCT01476891|Cancer|cancer
5037220|NCT01476891|Online|online
5037221|NCT01476891|Mindfulness Meditation|mindfulness meditation
5037222|NCT01476891|Randomized Waitlist Controlled Trial|randomized waitlist controlled trial
5037223|NCT01476878|Radiosurgery|radiosurgery
5037224|NCT01476878|Frameless radiosurgery|frameless radiosurgery
5037225|NCT01476878|Accuracy|accuracy
5037226|NCT01476800|Drugs, Investigational|drugs, investigational
5037227|NCT01476800|pharmacokinetics|pharmacokinetics
5037228|NCT01476800|Urinary Bladder, Overactive|urinary bladder, overactive
5037229|NCT01476800|YM178|ym178
5037230|NCT01476800|Mirabegron|mirabegron
5037231|NCT01476787|Follicular lymphoma|follicular lymphoma
5037232|NCT01476787|Non-Hodgkins Follicular Lymphoma|non-hodgkins follicular lymphoma
5037233|NCT01476787|treatment for Follicular Lymphoma|treatment for follicular lymphoma
5037234|NCT01476787|rituximab treatment|rituximab treatment
5037235|NCT01476787|rituximab and lenalidomide treatment|rituximab and lenalidomide treatment
5037236|NCT01476761|Surgical tissue resection|surgical tissue resection
5037237|NCT01476761|Tissue dissection|tissue dissection
5037238|NCT01476761|Tissue transection|tissue transection
5037239|NCT01476761|Anastomosis of gastrointestina tissue|anastomosis of gastrointestina tissue
5037240|NCT01476722|Silicone Hydrogel|silicone hydrogel
5037241|NCT01476722|Soft Contact Lenses|soft contact lenses
5037242|NCT01476722|Multi-Purpose Solution|multi-purpose solution
5037243|NCT01476709|Puncture; Instrument|puncture; instrument
5037244|NCT01476709|Optics and Photonics|optics and photonics
5037245|NCT01476709|Pain|pain
5037246|NCT01476696|Sickle cell disease|sickle cell disease
5037247|NCT01476696|pediatrics|pediatrics
5037248|NCT01476696|SCD|scd
5037249|NCT01476696|children|children
5037250|NCT01476696|child|child
5037251|NCT01476696|kids|kids
5037252|NCT01476696|pain crisis|pain crisis
5037253|NCT01476696|sickle cell anemia|sickle cell anemia
5037254|NCT01476696|sickle cell pain|sickle cell pain
5037255|NCT01476683|Antidiarrheals|antidiarrheals
5037256|NCT01476670|Posterior fossa brain tumor|posterior fossa brain tumor
5037257|NCT01476670|Cerebral blood flow|cerebral blood flow
5037258|NCT01476670|Cerebral autoregulation|cerebral autoregulation
5037259|NCT01476670|Carbon dioxide reactivity|carbon dioxide reactivity
5037260|NCT01476670|Transcranial Doppler|transcranial doppler
5037261|NCT01476657|Phase 1|phase 1
5037262|NCT01476644|Health related quality of life|health related quality of life
5037263|NCT01476644|Clinical measures of vision|clinical measures of vision
5037264|NCT01476618|Provider Perspectives|provider perspectives
5037265|NCT01476618|Barriers|barriers
5037266|NCT01476618|OIF/OEF Veterans|oif/oef veterans
5037267|NCT01476605|prolotherapy|prolotherapy
5037268|NCT01476605|Platelet rich plasma|platelet rich plasma
5037269|NCT01476605|tennis elbow|tennis elbow
5037270|NCT01476605|lateral epicondylosis|lateral epicondylosis
5037271|NCT01476592|gastrointestinal neuroendocrine tumor|gastrointestinal neuroendocrine tumor
5037272|NCT01476579|Coronary CT|coronary ct
5037273|NCT01476579|Sensitivity|sensitivity
5037274|NCT01476579|Specificity|specificity
5037275|NCT01476579|Radiation|radiation
5037276|NCT01476579|Tomography, X-Ray Computed|tomography, x-ray computed
5037277|NCT01476579|Coronary angiography|coronary angiography
5037278|NCT01476566|aged|aged
5037279|NCT01476566|family practice|family practice
5037280|NCT01476553|gastric cancer|gastric cancer
5037281|NCT01476553|extensive intraperitoneal lavage|extensive intraperitoneal lavage
5037282|NCT01476553|EIPL|eipl
5037283|NCT01476553|intraperitoneal tumor cells|intraperitoneal tumor cells
5037284|NCT01476553|peritoneal carcinomatosis|peritoneal carcinomatosis
5037285|NCT01476514|Hyperekplexia|hyperekplexia
5037286|NCT01476514|Pain modulation|pain modulation
5037287|NCT01476514|Glycine receptors|glycine receptors
5037288|NCT01476514|Hyperalgesia|hyperalgesia
5037289|NCT01476514|Spinal inhibitory interneurons|spinal inhibitory interneurons
5037290|NCT01476501|vitamin D|vitamin d
5037291|NCT01476501|bone health|bone health
5037292|NCT01476501|diabetes|diabetes
5037293|NCT01476501|nephropathy|nephropathy
5037294|NCT01476462|Acute lymphoblastic leukemia|acute lymphoblastic leukemia
5037295|NCT01476462|Ponte-di-Legno consortium|ponte-di-legno consortium
5037296|NCT01476462|Second cancer|second cancer
5037297|NCT01476462|Survival|survival
5037298|NCT01476449|Diabetic Macular Edema|diabetic macular edema
5037299|NCT01476449|Diabetic Retinal Swelling|diabetic retinal swelling
5037300|NCT01476449|DIabetic Eye Disease|diabetic eye disease
5037301|NCT01476436|Cardio vascular risk factors|cardio vascular risk factors
5037302|NCT01476423|Glanzmann's Thrombasthenia|glanzmann's thrombasthenia
5037303|NCT01476397|full-term|full-term
5037304|NCT01476397|formula-fed infants|formula-fed infants
5037305|NCT01476384|Glucose|glucose
5037306|NCT01476384|insulin|insulin
5037307|NCT01476384|Glycocalyx|glycocalyx
5037308|NCT01476384|Muscle|muscle
5037309|NCT01476384|Vascularisation|vascularisation
5037310|NCT01476384|young|young
5037311|NCT01476384|elderly|elderly
5037312|NCT01476371|Group treatment|group treatment
5037313|NCT01476371|Mindfulness|mindfulness
5037314|NCT01476371|Minor mental disorders|minor mental disorders
5037315|NCT01476371|Inflammation|inflammation
5037316|NCT01476332|eyes|eyes
5037317|NCT01476332|cis-urocanic acid|cis-urocanic acid
5037318|NCT01476332|safety|safety
5037319|NCT01476332|tolerability|tolerability
5037320|NCT01476332|pharmacokinetics|pharmacokinetics
5037321|NCT01476306|feasibility|feasibility
5037322|NCT01476306|effectiveness|effectiveness
5037323|NCT01476306|Parkinson disease care|parkinson disease care
5037324|NCT01476306|care via telemedicine|care via telemedicine
5037325|NCT01476293|Infiltration|infiltration
5037326|NCT01476293|Extravasation|extravasation
5037327|NCT01476293|Leaking|leaking
5037328|NCT01476293|PIV Infiltration|piv infiltration
5037329|NCT01476293|IV Infiltration|iv infiltration
5037330|NCT01476293|Optical Detection of Infiltration|optical detection of infiltration
5037331|NCT01476293|Optical Monitoring|optical monitoring
5037332|NCT01476280|antiemetics|antiemetics
5037333|NCT01476280|ramosetron|ramosetron
5037334|NCT01476280|palonosetron|palonosetron
5037335|NCT01476280|PONV(postoperative nausea and vomiting)|ponv(postoperative nausea and vomiting)
5037336|NCT01476254|Postoperative pulmonary complications|postoperative pulmonary complications
5037337|NCT01476254|Laparoscopic surgery|laparoscopic surgery
5037338|NCT01476215|paracetamol|paracetamol
5037339|NCT01476202|craving, provoked craving, smoking cessation, nicotine replacement therapy, NRT|craving, provoked craving, smoking cessation, nicotine replacement therapy, nrt
5037340|NCT01476189|pharmacokinetic|pharmacokinetic
5037341|NCT01476189|paracetamol|paracetamol
5037342|NCT01476189|Healthy volunteer|healthy volunteer
5037343|NCT01476189|steady state|steady state
5037344|NCT01476176|Bioequivalence|bioequivalence
5037345|NCT01476176|Pharmacokinetics|pharmacokinetics
5037346|NCT01476176|Healthy volunteers|healthy volunteers
5037347|NCT01476176|paracetamol|paracetamol
5037348|NCT01476176|caffeine|caffeine
5037349|NCT01476163|AT1001|at1001
5037350|NCT01476163|Lysosomal storage disease|lysosomal storage disease
5037351|NCT01476163|Lysosomal Storage Disorder|lysosomal storage disorder
5037352|NCT01476163|migalastat|migalastat
5037353|NCT01476163|Fabry disease|fabry disease
5037354|NCT01476163|Fabry|fabry
5037355|NCT01476163|Amicus|amicus
5037356|NCT01476137|oncology|oncology
5037357|NCT01476137|solid tumors|solid tumors
5037358|NCT01476137|multiple myeloma|multiple myeloma
5037359|NCT01476137|AKT inhibitor|akt inhibitor
5037360|NCT01476137|MEK inhibitor|mek inhibitor
5037361|NCT01476111|tumor antigens|tumor antigens
5037362|NCT01476111|observational|observational
5037363|NCT01476111|breast cancer|breast cancer
5037364|NCT01476111|biomarkers|biomarkers
5037365|NCT01476111|Neoadjuvant|neoadjuvant
5037766|NCT01474486|pyridoxine|pyridoxine
5037366|NCT01476059|Treatment compliance|treatment compliance
5037367|NCT01476059|Pediatric|pediatric
5037368|NCT01476059|Asthma|asthma
5037369|NCT01476046|Acute Lung Injury (ALI)|acute lung injury (ali)
5037370|NCT01476046|Acute Respiratory Distress Syndrome (ARDS)|acute respiratory distress syndrome (ards)
5037371|NCT01476033|Oxidative stress|oxidative stress
5037372|NCT01476033|inflammation|inflammation
5037373|NCT01476033|blood flow|blood flow
5037374|NCT01476020|Drug eluting stent|drug eluting stent
5037375|NCT01476020|Dual antiplatelet therapy|dual antiplatelet therapy
5037376|NCT01476020|bleeding|bleeding
5037377|NCT01476020|stent thrombosis|stent thrombosis
5037378|NCT01476020|follow-up of the drug eluting stent|follow-up of the drug eluting stent
5037379|NCT01476007|primary health care|primary health care
5037380|NCT01476007|Vitamin B 12 Deficiency|vitamin b 12 deficiency
5037381|NCT01475981|JTK-853|jtk-853
5037382|NCT01475981|single dose|single dose
5037383|NCT01475942|elderly|elderly
5037384|NCT01475942|probiotic|probiotic
5037385|NCT01475942|bowel function|bowel function
5037386|NCT01475942|pathogen|pathogen
5037387|NCT01475942|constipation|constipation
5037388|NCT01475942|diarrhoea|diarrhoea
5037389|NCT01475942|Subclinical levels|subclinical levels
5037390|NCT01475929|irritable bowel syndrome|irritable bowel syndrome
5037391|NCT01475929|probiotic|probiotic
5037392|NCT01475916|Asthma|asthma
5037393|NCT01475916|Educational program|educational program
5037394|NCT01475916|Quality of life|quality of life
5037395|NCT01475916|School-aged children|school-aged children
5037396|NCT01475903|Obesity|obesity
5037397|NCT01475903|Sleeve gastrectomy|sleeve gastrectomy
5037398|NCT01475903|Nutritional impact|nutritional impact
5037399|NCT01475903|Vitamin deficiency|vitamin deficiency
5037400|NCT01475890|HIV/AIDS|hiv/aids
5037401|NCT01475890|Nutrition|nutrition
5037402|NCT01475877|bromfenac|bromfenac
5037403|NCT01475877|nepafenac|nepafenac
5037404|NCT01475877|PRK|prk
5037405|NCT01475877|epithelial healing,|epithelial healing,
5037406|NCT01475864|Choledocholithiasis|choledocholithiasis
5037407|NCT01475864|metal stents|metal stents
5037408|NCT01475864|biliary duct stent|biliary duct stent
5037409|NCT01475851|Tenofovir disoproxil fumarate, compensated chronic hepatitis B|tenofovir disoproxil fumarate, compensated chronic hepatitis b
5037410|NCT01475838|HIV-1|hiv-1
5037411|NCT01475838|HIV|hiv
5037412|NCT01475838|Treatment Experienced|treatment experienced
5037413|NCT01475812|COPD|copd
5037414|NCT01475812|activities of daily living|activities of daily living
5037415|NCT01475812|pulmonary hyperinflation|pulmonary hyperinflation
5037416|NCT01475812|exercise|exercise
5037417|NCT01475786|nerve pain|nerve pain
5037418|NCT01475786|diabetic nerve pain|diabetic nerve pain
5037419|NCT01475786|throbbing|throbbing
5037420|NCT01475786|burning|burning
5037421|NCT01475786|painful feet|painful feet
5037422|NCT01475786|tingling|tingling
5037423|NCT01475786|numbness|numbness
5037424|NCT01475773|self-esteem|self-esteem
5037425|NCT01475773|personality|personality
5037426|NCT01475773|quality of life|quality of life
5037427|NCT01475773|malocclusion|malocclusion
5037428|NCT01475773|orthodontics|orthodontics
5037429|NCT01475760|chronic kidney disease|chronic kidney disease
5037430|NCT01475760|serum phosphorus|serum phosphorus
5037431|NCT01475760|salivary phosphorus|salivary phosphorus
5037432|NCT01475760|FGF23|fgf23
5037433|NCT01475734|glucose clamp|glucose clamp
5037434|NCT01475734|hypoglycemia|hypoglycemia
5037435|NCT01475721|ADVAIR|advair
5037436|NCT01475721|Asthma|asthma
5037437|NCT01475721|safety|safety
5037438|NCT01475721|FLOVENT|flovent
5037439|NCT01475708|Lyme borreliosis|lyme borreliosis
5037440|NCT01475708|Erythema migrans|erythema migrans
5037441|NCT01475708|Doxycycline|doxycycline
5037442|NCT01475708|Subjective symptoms|subjective symptoms
5037443|NCT01475708|Outcome|outcome
5037444|NCT01475695|Mass balance|mass balance
5037445|NCT01475695|intravenous|intravenous
5037446|NCT01475695|GSK2251052|gsk2251052
5037447|NCT01475695|Healthy volunteer|healthy volunteer
5037448|NCT01475695|Antimicrobial|antimicrobial
5037449|NCT01475695|Radiolabel|radiolabel
5037450|NCT01475682|Obstructive sleep apnea|obstructive sleep apnea
5037451|NCT01475682|cardiometabolic complications|cardiometabolic complications
5037452|NCT01475682|Effects of CPAP treatment|effects of cpap treatment
5037453|NCT01475643|Pediatric cataract|pediatric cataract
5037454|NCT01475630|temporomandibular joint|temporomandibular joint
5037455|NCT01475630|rehabilitation medicine|rehabilitation medicine
5037456|NCT01475630|joint diseases|joint diseases
5037457|NCT01475630|physical therapy|physical therapy
5037458|NCT01475604|Pulsed Radio Frequency, Electromagnetic Field therapy|pulsed radio frequency, electromagnetic field therapy
5037459|NCT01475591|persistent neuromusculoskeletal pain|persistent neuromusculoskeletal pain
5037461|NCT01475591|shoulder|shoulder
5037462|NCT01475591|back-area|back-area
5037463|NCT01475591|risk|risk
5037464|NCT01475591|longlasting|longlasting
5037465|NCT01475591|pain syndrome|pain syndrome
5037466|NCT01475578|Vascular Dementia|vascular dementia
5037467|NCT01475565|polycystic ovary syndrome (PCOS)|polycystic ovary syndrome (pcos)
5037468|NCT01475565|insulin sensitivity|insulin sensitivity
5037767|NCT01474486|vitamin D|vitamin d
5037469|NCT01475565|insulin resistance|insulin resistance
5037470|NCT01475565|gestational diabetes|gestational diabetes
5037471|NCT01475565|pregnancy|pregnancy
5037472|NCT01475565|estrogen|estrogen
5037473|NCT01475565|glucose intolerance|glucose intolerance
5037474|NCT01475565|obesity|obesity
5037475|NCT01475565|ovulatory disorder|ovulatory disorder
5037476|NCT01475565|racial differences|racial differences
5037477|NCT01475565|hyperandrogenism|hyperandrogenism
5037478|NCT01475552|platelet reactivity|platelet reactivity
5037479|NCT01475552|platelet function assay|platelet function assay
5037480|NCT01475552|abciximab|abciximab
5037481|NCT01475552|tailored therapy|tailored therapy
5037482|NCT01475539|Polio|polio
5037483|NCT01475539|Poliovirus|poliovirus
5037484|NCT01475539|Oral poliovirus vaccine|oral poliovirus vaccine
5037485|NCT01475539|IMOVAX Polio®|imovax polio®
5037486|NCT01475526|grocery store|grocery store
5037487|NCT01475526|nutrition|nutrition
5037488|NCT01475526|Latino|latino
5037489|NCT01475526|Hispanic|hispanic
5037490|NCT01475513|oral contraceptive|oral contraceptive
5037491|NCT01475513|birth control pill|birth control pill
5037492|NCT01475513|women|women
5037493|NCT01475513|healthy volunteer|healthy volunteer
5037494|NCT01475513|insulin sensitivity|insulin sensitivity
5037495|NCT01475513|insulin resistance|insulin resistance
5037496|NCT01475513|cardiovascular risk factors|cardiovascular risk factors
5037497|NCT01475513|endothelial function|endothelial function
5037498|NCT01475513|estrogen metabolism|estrogen metabolism
5037499|NCT01475513|racial difference|racial difference
5037500|NCT01475513|glucose intolerance|glucose intolerance
5037501|NCT01475474|incontinence|incontinence
5037502|NCT01475474|bowel|bowel
5037503|NCT01475474|movement|movement
5037504|NCT01475474|fecal|fecal
5037505|NCT01475474|anal|anal
5037506|NCT01475474|diarrhea|diarrhea
5037507|NCT01475474|stool|stool
5037508|NCT01475474|rectal|rectal
5037509|NCT01475474|feces|feces
5037510|NCT01475474|uncontrolled|uncontrolled
5037511|NCT01475474|loose|loose
5037512|NCT01475474|leakage|leakage
5037513|NCT01475474|rectum|rectum
5037514|NCT01475474|BM|bm
5037515|NCT01475474|watery|watery
5037516|NCT01475474|urgent|urgent
5037517|NCT01475474|flatulence|flatulence
5037518|NCT01475474|gas|gas
5037519|NCT01475461|Phase 2|phase 2
5037520|NCT01475461|type 2 diabetes mellitus|type 2 diabetes mellitus
5037521|NCT01475461|PF-04937319|pf-04937319
5037522|NCT01475448|biomechanics|biomechanics
5037523|NCT01475448|motor control|motor control
5037524|NCT01475448|movement|movement
5037525|NCT01475448|walking|walking
5037526|NCT01475448|running|running
5037527|NCT01475448|sedentarism|sedentarism
5037528|NCT01475448|joint moment|joint moment
5037529|NCT01475409|anti-TNF|anti-tnf
5037530|NCT01475409|tuberculosis|tuberculosis
5037531|NCT01475409|QuantiFERON-TB Gold In-Tube|quantiferon-tb gold in-tube
5037532|NCT01475409|tuberculin skin test|tuberculin skin test
5037533|NCT01475409|rheumatoid arthritis|rheumatoid arthritis
5037534|NCT01475409|spondyloarthritis|spondyloarthritis
5037535|NCT01475396|exercise|exercise
5037536|NCT01475396|physical activity|physical activity
5037537|NCT01475396|cognition|cognition
5037538|NCT01475396|brain|brain
5037539|NCT01475396|aging|aging
5037540|NCT01475396|BDNF|bdnf
5037541|NCT01475383|Tourette's Syndrome in adults|tourette's syndrome in adults
5037542|NCT01475383|Safety and Efficacy|safety and efficacy
5037543|NCT01475383|Randomized|randomized
5037544|NCT01475383|Placebo Control|placebo control
5037545|NCT01475383|Cross-over|cross-over
5037546|NCT01475370|Acute myeloid leukemia|acute myeloid leukemia
5037547|NCT01475370|WT1|wt1
5037548|NCT01475357|congenital heart defects|congenital heart defects
5037549|NCT01475357|growth failure|growth failure
5037550|NCT01475344|Trauma patient with major bleeding|trauma patient with major bleeding
5037551|NCT01475331|pancreatic cyst|pancreatic cyst
5037552|NCT01475331|chemotherapy|chemotherapy
5037553|NCT01475331|ethanol|ethanol
5037554|NCT01475331|ablation|ablation
5037555|NCT01475318|complete abortion rate|complete abortion rate
5037556|NCT01475318|side effects|side effects
5037557|NCT01475318|induction-to-abortion interval|induction-to-abortion interval
5037558|NCT01475305|Respiratory Syncytial Virus (RSV)|respiratory syncytial virus (rsv)
5037559|NCT01475305|Healthy adults|healthy adults
5037560|NCT01475305|MEDI-557|medi-557
5037561|NCT01475305|Intranasal challenge|intranasal challenge
5037562|NCT01475305|Human model|human model
5037563|NCT01475292|COPD|copd
5037564|NCT01475279|Warfarin|warfarin
5037565|NCT01475279|Dantonic|dantonic
5037566|NCT01475279|Pharmacodynamics|pharmacodynamics
5037567|NCT01475279|Pharmacokinetics|pharmacokinetics
5037568|NCT01475279|Interaction|interaction
5037569|NCT01475266|Bladder Cancer|bladder cancer
5037570|NCT01475266|NMIBC|nmibc
5037571|NCT01475266|TURBT|turbt
5037572|NCT01475266|Apaziquone|apaziquone
5037573|NCT01475266|EOquin|eoquin
5037574|NCT01475266|Immediate instillation|immediate instillation
5037575|NCT01475240|HIV|hiv
5037576|NCT01475227|HIV|hiv
5037577|NCT01475227|Bilirubin|bilirubin
5037578|NCT01475214|potassium bicarbonate|potassium bicarbonate
5037579|NCT01475214|urinary N-telopeptide|urinary n-telopeptide
5037580|NCT01475214|urinary nitrogen|urinary nitrogen
5037581|NCT01475214|net acid excretion|net acid excretion
5037582|NCT01475201|Type 2 diabetes|type 2 diabetes
5037583|NCT01475201|Hypertension|hypertension
5037584|NCT01475201|Primary Care|primary care
5037585|NCT01475201|Physical Activity|physical activity
5037586|NCT01475201|Behavioural Intervention|behavioural intervention
5037587|NCT01475201|Pedometer|pedometer
5037588|NCT01475201|Accelerometer|accelerometer
5037589|NCT01475201|Arterial Stiffness|arterial stiffness
5037590|NCT01475201|Carotid femoral pulse wave velocity|carotid femoral pulse wave velocity
5037591|NCT01475201|Vascular disease risk|vascular disease risk
5037592|NCT01475201|Vascular disease prevention|vascular disease prevention
5037593|NCT01475201|Intervention|intervention
5037594|NCT01475188|specific subcutaneous immunotherapy|specific subcutaneous immunotherapy
5037595|NCT01475188|seasonal allergic rhinitis|seasonal allergic rhinitis
5037596|NCT01475188|regulatory lymphocytes|regulatory lymphocytes
5037597|NCT01475188|signal transduction|signal transduction
5037598|NCT01475188|histamine receptor|histamine receptor
5037599|NCT01475162|acute Graft versus Host Disease (aGVHD)|acute graft versus host disease (agvhd)
5037600|NCT01475162|steroid refractory acute Graft versus Host Disease (aGVHD)|steroid refractory acute graft versus host disease (agvhd)
5037601|NCT01475162|chronic Graft versus Host Disease (cGVHD)|chronic graft versus host disease (cgvhd)
5037602|NCT01475162|corticosteroids|corticosteroids
5037603|NCT01475162|allogeneic hematopoietic stem cell transplantation|allogeneic hematopoietic stem cell transplantation
5037604|NCT01475149|Antiphospholipid syndrome|antiphospholipid syndrome
5037605|NCT01475149|Antiphospholipid antibodies|antiphospholipid antibodies
5037606|NCT01475149|Systemic lupus erythematosus|systemic lupus erythematosus
5037607|NCT01475149|Annexin A5 and Annexin A5 resistance assay|annexin a5 and annexin a5 resistance assay
5037608|NCT01475123|Nicorandil|nicorandil
5037609|NCT01475123|Randomized control study|randomized control study
5037610|NCT01475123|Hemodialysis|hemodialysis
5037611|NCT01475123|Coronary Artery Disease|coronary artery disease
5037612|NCT01475110|Imatinib|imatinib
5037613|NCT01475110|Chronic Myeloid Leukaemia|chronic myeloid leukaemia
5037614|NCT01475110|Nilotinib|nilotinib
5037615|NCT01475110|Adult patients|adult patients
5037616|NCT01475110|Imatinib resistant|imatinib resistant
5037617|NCT01475097|AE - Adverse event|ae - adverse event
5037618|NCT01475097|Arteriography|arteriography
5037619|NCT01475097|IA - Intra-arterial|ia - intra-arterial
5037620|NCT01475097|IOCM - Iso-Osmolar Contrast Medium|iocm - iso-osmolar contrast medium
5037621|NCT01475097|LOCM - Low-Osmolar Contrast Medium|locm - low-osmolar contrast medium
5037622|NCT01475097|Patient Comfort|patient comfort
5037623|NCT01475097|Body Image Disturbance|body image disturbance
5037624|NCT01475097|Patient|patient
5037625|NCT01475084|Flex-rigid pleuroscopy|flex-rigid pleuroscopy
5037626|NCT01475084|cryobiopsy|cryobiopsy
5037627|NCT01475084|pleural biopsy|pleural biopsy
5037628|NCT01475084|pleural effusion|pleural effusion
5037629|NCT01475084|safety|safety
5037630|NCT01475084|thoracoscopy|thoracoscopy
5037631|NCT01475045|COPD|copd
5037632|NCT01475032|Asthma|asthma
5037633|NCT01475032|children|children
5037634|NCT01475032|chronic treatment|chronic treatment
5037635|NCT01475019|Obesity|obesity
5037636|NCT01475019|Polycystic Ovaries Syndrome|polycystic ovaries syndrome
5037637|NCT01475019|Orlistat|orlistat
5037638|NCT01475019|Sibutramine|sibutramine
5037639|NCT01475019|Androgen levels|androgen levels
5037640|NCT01475019|Insulin resistance|insulin resistance
5037641|NCT01475006|Epidermal Growth Factor Receptor Variant III|epidermal growth factor receptor variant iii
5037642|NCT01475006|EGFRvIII|egfrviii
5037643|NCT01475006|Glioma|glioma
5037644|NCT01475006|Anaplastic Astrocytomas|anaplastic astrocytomas
5037645|NCT01475006|Glioblastoma Multiforme|glioblastoma multiforme
5037646|NCT01475006|Antibody drug conjugate|antibody drug conjugate
5037647|NCT01475006|brain tumor|brain tumor
5037648|NCT01474980|Congenital Myasthenic Syndrome|congenital myasthenic syndrome
5037649|NCT01474980|Pregnancy|pregnancy
5037650|NCT01474980|Outcome|outcome
5037651|NCT01474967|polycystic ovary syndrome|polycystic ovary syndrome
5037652|NCT01474967|lipid profile|lipid profile
5037653|NCT01474967|metformin|metformin
5037654|NCT01474954|HIV|hiv
5037655|NCT01474954|Antiretroviral Medication|antiretroviral medication
5037656|NCT01474954|Cardiovascular Disease Risk|cardiovascular disease risk
5037657|NCT01474941|Multiple Dose Study Overweight Healthy Subjects Body Weight Modified-Release Formulation|multiple dose study overweight healthy subjects body weight modified-release formulation
5037658|NCT01474928|Asthma|asthma
5037659|NCT01474928|Community-based participatory research|community-based participatory research
5037660|NCT01474928|Educational intervention|educational intervention
5037661|NCT01474928|Ethno-cultural community|ethno-cultural community
5037662|NCT01474928|Video recording|video recording
5037663|NCT01474928|Patient education handout|patient education handout
5037664|NCT01474915|Neurosurgery|neurosurgery
5037665|NCT01474902|pediatric|pediatric
5037666|NCT01474902|asymptotic venous thrombosis|asymptotic venous thrombosis
5037667|NCT01474902|Enoxaparin|enoxaparin
5037668|NCT01474902|pediatric cardiac surgery|pediatric cardiac surgery
5037669|NCT01474889|Hypoglycemia, Unawareness, RT-CGM, Type 1 Diabetes|hypoglycemia, unawareness, rt-cgm, type 1 diabetes
5037670|NCT01474876|Post-marketing observational study (PMOS) Protocol|post-marketing observational study (pmos) protocol
5037671|NCT01474876|Effectiveness of Adalimumab (HUMIRA®)|effectiveness of adalimumab (humira®)
5037672|NCT01474876|Psoriatic Arthritis|psoriatic arthritis
5037673|NCT01474876|Ankylosing Spondylitis|ankylosing spondylitis
5037674|NCT01474850|mechanical ventilation|mechanical ventilation
5037675|NCT01474850|pressure control ventilation|pressure control ventilation
5037676|NCT01474850|lung recruitment|lung recruitment
5037677|NCT01474850|positive end expiratory pressure|positive end expiratory pressure
5037678|NCT01474850|opto-electronic plethysmography|opto-electronic plethysmography
5037679|NCT01474850|chest wall volume variation|chest wall volume variation
5037680|NCT01474850|intravenous anesthesia|intravenous anesthesia
5037681|NCT01474837|depressive disorders|depressive disorders
5037682|NCT01474837|exercise therapy|exercise therapy
5037683|NCT01474824|Cardiac output|cardiac output
5037684|NCT01474824|Stroke volume|stroke volume
5037685|NCT01474811|Hepatitis|hepatitis
5037686|NCT01474811|Hepatitis C|hepatitis c
5037687|NCT01474811|HCV-TARGET|hcv-target
5037688|NCT01474811|HCV|hcv
5037689|NCT01474811|Observational Study|observational study
5037690|NCT01474798|Acne Vulgaris|acne vulgaris
5037691|NCT01474785|Obesity|obesity
5037692|NCT01474785|Bariatric surgery|bariatric surgery
5037693|NCT01474785|Nashville, Tennessee|nashville, tennessee
5037694|NCT01474772|Diabetic Peripheral Neuropathy|diabetic peripheral neuropathy
5037695|NCT01474772|Pain on Walking|pain on walking
5037696|NCT01474772|Pregabalin|pregabalin
5037697|NCT01474746|Fragile X Syndrome|fragile x syndrome
5037698|NCT01474746|Pediatrics|pediatrics
5037699|NCT01474746|sertraline|sertraline
5037700|NCT01474746|autism|autism
5037701|NCT01474733|resident education|resident education
5037702|NCT01474733|health literacy|health literacy
5037703|NCT01474733|curriculum|curriculum
5037704|NCT01474720|Systemic Lupus Erythematosus|systemic lupus erythematosus
5037705|NCT01474720|Lupus|lupus
5037706|NCT01474720|SLE|sle
5037707|NCT01474720|Zostavax|zostavax
5037708|NCT01474720|shingles|shingles
5037709|NCT01474707|COPD|copd
5037710|NCT01474707|Educational materials|educational materials
5037711|NCT01474707|Cultural background|cultural background
5037712|NCT01474707|Instructional videos|instructional videos
5037713|NCT01474707|Patient education handouts|patient education handouts
5037714|NCT01474707|Lung age|lung age
5037715|NCT01474694|prospective study|prospective study
5037716|NCT01474694|multicenter trial|multicenter trial
5037717|NCT01474694|analysis, computer assisted image|analysis, computer assisted image
5037718|NCT01474694|CE marked|ce marked
5037719|NCT01474694|medical devices|medical devices
5037720|NCT01474694|catheter ablation|catheter ablation
5037721|NCT01474681|hematologic malignancies|hematologic malignancies
5037722|NCT01474681|leukemia|leukemia
5037723|NCT01474681|lymphoma|lymphoma
5037724|NCT01474655|epiretinal membrane|epiretinal membrane
5037725|NCT01474655|visual acuity|visual acuity
5037726|NCT01474655|metamorphopsia|metamorphopsia
5037727|NCT01474655|thickness of retinal layers|thickness of retinal layers
5037728|NCT01474655|spectral domain optical coherence tomography|spectral domain optical coherence tomography
5037729|NCT01474642|Advanced or recurrent esophageal squamous cell carcinoma|advanced or recurrent esophageal squamous cell carcinoma
5037730|NCT01474642|Randomizes phase II trial|randomizes phase ii trial
5037731|NCT01474642|Capecitabine|capecitabine
5037732|NCT01474642|Cisplatin|cisplatin
5037733|NCT01474642|Genexol|genexol
5037734|NCT01474629|oxidative stress|oxidative stress
5037735|NCT01474629|inflammation|inflammation
5037736|NCT01474629|endotoxemia|endotoxemia
5037737|NCT01474629|strenuous exercise|strenuous exercise
5037738|NCT01474616|Aging|aging
5037739|NCT01474616|Health Services|health services
5037740|NCT01474616|Knowledge Translation|knowledge translation
5037741|NCT01474616|Long-Term Care Facilities|long-term care facilities
5037742|NCT01474616|Mobility|mobility
5037743|NCT01474616|Psychosocial And Health Behaviours|psychosocial and health behaviours
5037744|NCT01474603|observational study|observational study
5037745|NCT01474577|stress test|stress test
5037746|NCT01474577|cardiac issues|cardiac issues
5037747|NCT01474577|Rb-82 PET Myocardial Perfusion Imaging|rb-82 pet myocardial perfusion imaging
5037748|NCT01474577|11-150|11-150
5037749|NCT01474577|one or more 82Rb myocardial perfusion stress tests|one or more 82rb myocardial perfusion stress tests
5037750|NCT01474564|Blood draw|blood draw
5037751|NCT01474564|pancreas|pancreas
5037752|NCT01474564|Tumorigenic Cells|tumorigenic cells
5037753|NCT01474564|11-141|11-141
5037754|NCT01474551|Vemurafenib|vemurafenib
5037755|NCT01474551|skin cancer|skin cancer
5037756|NCT01474551|Stage IV|stage iv
5037757|NCT01474551|advanced stage III|advanced stage iii
5037758|NCT01474551|11-091|11-091
5037759|NCT01474538|diabetes|diabetes
5037760|NCT01474538|type 2 diabetes|type 2 diabetes
5037761|NCT01474538|insulin pump|insulin pump
5037762|NCT01474538|continuous subcutaneous insulin infusion|continuous subcutaneous insulin infusion
5037763|NCT01474538|CSII|csii
5037764|NCT01474538|A1C|a1c
5037765|NCT01474486|thiamin|thiamin
5037768|NCT01474486|zinc|zinc
5037769|NCT01474486|congestive heart failure (CHF)|congestive heart failure (chf)
5037770|NCT01474486|ischemic cardiomyopathy|ischemic cardiomyopathy
5037771|NCT01474486|nutritional injury|nutritional injury
5037772|NCT01474486|quality of life|quality of life
5037773|NCT01474473|CACIPLIQ20|cacipliq20
5037774|NCT01474473|Matrix Therapy|matrix therapy
5037775|NCT01474473|Diabetic foot|diabetic foot
5037776|NCT01474460|warfarin|warfarin
5037777|NCT01474460|phytonadione|phytonadione
5037778|NCT01474460|INR|inr
5037779|NCT01474447|low back pain|low back pain
5037780|NCT01474434|coronary artery disease,|coronary artery disease,
5037781|NCT01474434|LCQ908,|lcq908,
5037782|NCT01474434|hyperlipidemia,|hyperlipidemia,
5037783|NCT01474434|hypertriglyceridemia,|hypertriglyceridemia,
5037784|NCT01474434|pradigastat|pradigastat
5037785|NCT01474421|Parkinson's disease|parkinson's disease
5037786|NCT01474421|Dyskinesia|dyskinesia
5037787|NCT01474421|Movement disorders|movement disorders
5037788|NCT01474421|L-dopa|l-dopa
5037789|NCT01474408|Coronary artery bypass|coronary artery bypass
5037790|NCT01474408|Exercise therapy|exercise therapy
5037791|NCT01474408|Revascularization (PCI)|revascularization (pci)
5037792|NCT01474395|schizophrenia|schizophrenia
5037793|NCT01474395|cognitive remediation|cognitive remediation
5037794|NCT01474395|NMDA|nmda
5037795|NCT01474382|OraVerse|oraverse
5037796|NCT01474382|Safety|safety
5037797|NCT01474382|Efficacy|efficacy
5037798|NCT01474382|Pediatric|pediatric
5037799|NCT01474382|Reversal of dental anesthesia|reversal of dental anesthesia
5037800|NCT01474369|Drug Therapy|drug therapy
5037801|NCT01474356|brachytherapy|brachytherapy
5037802|NCT01474356|interstitial hyperthermia|interstitial hyperthermia
5037803|NCT01474356|cervical cancer|cervical cancer
5037804|NCT01474356|side effects|side effects
5037805|NCT01474356|Locally advanced cervical cancer patients|locally advanced cervical cancer patients
5037806|NCT01474343|Neurodegenerative Diseases|neurodegenerative diseases
5037807|NCT01474343|Nervous System Diseases|nervous system diseases
5037808|NCT01474343|Genetic Diseases, Inborn|genetic diseases, inborn
5037809|NCT01474343|Metabolic Diseases|metabolic diseases
5037810|NCT01474343|Gene Therapy|gene therapy
5037811|NCT01474343|Adenovirus Associated Vector|adenovirus associated vector
5037812|NCT01474330|Pomalidomide|pomalidomide
5037813|NCT01474330|safety|safety
5037814|NCT01474330|tolerability|tolerability
5037815|NCT01474330|pharmacokinetics|pharmacokinetics
5037816|NCT01474304|craniotomy|craniotomy
5037817|NCT01474304|tumor resection|tumor resection
5037818|NCT01474304|aneurysm|aneurysm
5037819|NCT01474304|revascularization|revascularization
5037820|NCT01474304|opioid|opioid
5037821|NCT01474304|nausea|nausea
5037822|NCT01474304|vomiting|vomiting
5037823|NCT01474304|acetaminophen|acetaminophen
5037824|NCT01474265|smoking cessation|smoking cessation
5037825|NCT01474265|varenicline|varenicline
5037826|NCT01474265|sympathovagal balance|sympathovagal balance
5037827|NCT01474265|quit attempts|quit attempts
5037828|NCT01474265|MSNA|msna
5037829|NCT01474226|lysine|lysine
5037830|NCT01474226|rice|rice
5037831|NCT01474226|bioavailability|bioavailability
5037832|NCT01474213|dexmedetomidine|dexmedetomidine
5037833|NCT01474213|remifentanil|remifentanil
5037834|NCT01474213|awake nasotracheal fibreoptic intubation|awake nasotracheal fibreoptic intubation
5037835|NCT01474213|oral maxillofacial surgery|oral maxillofacial surgery
5037836|NCT01474213|difficult airway|difficult airway
5037837|NCT01474213|adult|adult
5037838|NCT01474200|Ultrafiltration|ultrafiltration
5037839|NCT01474200|Aquapheresis|aquapheresis
5037840|NCT01474200|Diuretics|diuretics
5037841|NCT01474200|Loop Diuretics|loop diuretics
5037842|NCT01474200|Aquadex Flexflow System|aquadex flexflow system
5037843|NCT01474200|Gambro UF Solutions|gambro uf solutions
5037844|NCT01474187|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
5037845|NCT01474187|rectal cancer|rectal cancer
5037846|NCT01474187|phase I study|phase i study
5037847|NCT01474187|irinotecan|irinotecan
5037848|NCT01474148|paraplegia|paraplegia
5037849|NCT01474148|tetraplegia|tetraplegia
5037850|NCT01474148|Spinal cord injured|spinal cord injured
5037851|NCT01474148|FES|fes
5037852|NCT01474135|Glaucoma|glaucoma
5037853|NCT01474135|Ocular Hypertension|ocular hypertension
5037854|NCT01474122|digital ulcers|digital ulcers
5037855|NCT01474122|systemic sclerosis|systemic sclerosis
5037856|NCT01474109|systemic sclerosis|systemic sclerosis
5037857|NCT01474109|digital ulcers|digital ulcers
5037858|NCT01474096|clinical practice guideline-primary health care|clinical practice guideline-primary health care
5037859|NCT01474083|Type 2 diabetes mellitus|type 2 diabetes mellitus
5037860|NCT01474083|pharmacokinetics|pharmacokinetics
5037861|NCT01474083|pharmacodynamics|pharmacodynamics
5037862|NCT01474070|Glaucoma|glaucoma
5037863|NCT01474070|Goldmann Tonometry|goldmann tonometry
5037864|NCT01474070|Dynamic Contour Tonometry|dynamic contour tonometry
5037865|NCT01474057|PTSD|ptsd
5037866|NCT01474057|combat trauma|combat trauma
5037867|NCT01474057|telemedicine|telemedicine
5037868|NCT01474057|primary care interventions|primary care interventions
5037869|NCT01474057|CBT|cbt
5038060|NCT01473264|BPD|bpd
5037870|NCT01474057|self-managed treatment|self-managed treatment
5037871|NCT01474057|web-based intervention|web-based intervention
5037872|NCT01474057|internet treatment|internet treatment
5037873|NCT01474031|total hip arthroplasty|total hip arthroplasty
5037874|NCT01474031|biomechanics|biomechanics
5037875|NCT01474031|direct anterior approach|direct anterior approach
5037876|NCT01474005|laryngectomy|laryngectomy
5037877|NCT01474005|artificial larynx|artificial larynx
5037878|NCT01474005|breathing|breathing
5037879|NCT01474005|swallowing|swallowing
5037880|NCT01474005|upper airway|upper airway
5037881|NCT01473979|cardiac surgery|cardiac surgery
5037882|NCT01473979|poststernotomy wound infections|poststernotomy wound infections
5037883|NCT01473979|delayed secondary closure of sternum|delayed secondary closure of sternum
5037884|NCT01473927|Inflammatory bowel diseases|inflammatory bowel diseases
5037885|NCT01473927|Crohn disease|crohn disease
5037886|NCT01473927|Ficolin-2|ficolin-2
5037887|NCT01473927|C-Reactive Protein|c-reactive protein
5037888|NCT01473927|Calprotectin|calprotectin
5037889|NCT01473927|Inflammatory markers|inflammatory markers
5037890|NCT01473927|SES-CD|ses-cd
5037891|NCT01473901|BKM120|bkm120
5037892|NCT01473901|temozolomide|temozolomide
5037893|NCT01473901|glioblastoma multiforme|glioblastoma multiforme
5037894|NCT01473901|GBM|gbm
5037895|NCT01473901|Newly diagnosed|newly diagnosed
5037896|NCT01473888|T89(Dantonic®)|t89(dantonic®)
5037897|NCT01473888|Cooperstown 5+1 cocktail probes|cooperstown 5+1 cocktail probes
5037898|NCT01473888|CYP450|cyp450
5037899|NCT01473875|LIPA|lipa
5037900|NCT01473875|Wolman Disease|wolman disease
5037901|NCT01473875|Wolman Phenotype|wolman phenotype
5037902|NCT01473875|Acid Lipase Deficiency|acid lipase deficiency
5037903|NCT01473875|Acid Cholesteryl Hydrolase|acid cholesteryl hydrolase
5037904|NCT01473875|Acid Lipase Disease Deficiency, type 2|acid lipase disease deficiency, type 2
5037905|NCT01473875|Cholesteryl Ester Storage Disease (CESD)|cholesteryl ester storage disease (cesd)
5037906|NCT01473875|Cholesteryl Ester Hydrolase Deficiency|cholesteryl ester hydrolase deficiency
5037907|NCT01473875|Early Onset LAL-Deficiency (Wolman Disease)|early onset lal-deficiency (wolman disease)
5037908|NCT01473875|LAL Deficiency|lal deficiency
5037909|NCT01473875|Late Onset Lysosomal Acid Lipase Deficiency (CESD)|late onset lysosomal acid lipase deficiency (cesd)
5037910|NCT01473875|Wolman Disease (early onset LAL Deficiency)|wolman disease (early onset lal deficiency)
5037911|NCT01473875|Related Disorders:|related disorders:
5037912|NCT01473875|Non-alcoholic Fatty Liver Disease (NAFLD)|non-alcoholic fatty liver disease (nafld)
5037913|NCT01473875|Non-alcoholic Steatohepatitis (NASH)|non-alcoholic steatohepatitis (nash)
5037914|NCT01473875|Alcoholic Liver Disease|alcoholic liver disease
5037915|NCT01473875|Cryptogenic Cirrhosis|cryptogenic cirrhosis
5037916|NCT01473875|Niemann-Pick Disease (NPD) Type C|niemann-pick disease (npd) type c
5037917|NCT01473875|Chanarin Dorfman Syndrome|chanarin dorfman syndrome
5037918|NCT01473862|adolescent|adolescent
5037919|NCT01473862|bereavement|bereavement
5037920|NCT01473862|cancer|cancer
5037921|NCT01473862|coping skills|coping skills
5037922|NCT01473849|Cytomegalovirus|cytomegalovirus
5037923|NCT01473849|Liver transplantation|liver transplantation
5037924|NCT01473849|Hepatitis C virus|hepatitis c virus
5037925|NCT01473849|Patients who underwent first liver transplantation due to hepatopathy caused by HCV,confirmed by detection of HCV RNA previously to transplantation|patients who underwent first liver transplantation due to hepatopathy caused by hcv,confirmed by detection of hcv rna previously to transplantation
5037926|NCT01473836|Metronidazole|metronidazole
5037927|NCT01473836|intra-abdominal infection|intra-abdominal infection
5037928|NCT01473836|pelvic inflammatory disease|pelvic inflammatory disease
5037929|NCT01473836|anaerobe|anaerobe
5037930|NCT01473823|food allergy|food allergy
5037931|NCT01473823|eczema|eczema
5037932|NCT01473823|sensitisation|sensitisation
5037933|NCT01473823|omega-3 long chain polyunsaturated fatty acids|omega-3 long chain polyunsaturated fatty acids
5037934|NCT01473823|prevention|prevention
5037935|NCT01473823|asthma|asthma
5037936|NCT01473810|HIV|hiv
5037937|NCT01473810|vaccination|vaccination
5037938|NCT01473810|T cells|t cells
5037939|NCT01473810|mucosal immunity|mucosal immunity
5037940|NCT01473810|safety|safety
5037941|NCT01473810|nasal administration|nasal administration
5037942|NCT01473810|DTH skin test|dth skin test
5037943|NCT01473771|Suicide|suicide
5037944|NCT01473771|Suicide, Attempted|suicide, attempted
5037945|NCT01473758|COPD|copd
5037946|NCT01473758|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
5037947|NCT01473758|Roflumilast|roflumilast
5037948|NCT01473745|Alar Base Suture; Nasolabial Change; 3D stereogrammetry|alar base suture; nasolabial change; 3d stereogrammetry
5037949|NCT01473732|CNI toxicity|cni toxicity
5037950|NCT01473732|CAI|cai
5037951|NCT01473719|alcohol use|alcohol use
5037952|NCT01473719|marijuana use|marijuana use
5037953|NCT01473719|STI|sti
5037954|NCT01473706|Malnutrition|malnutrition
5037955|NCT01473706|Nutrition status|nutrition status
5037956|NCT01473706|Elderly|elderly
5037957|NCT01473706|Nutrition screening|nutrition screening
5037958|NCT01473693|Quality of Life|quality of life
5037959|NCT01473693|Lung cancer|lung cancer
5037960|NCT01473693|MRI|mri
5037961|NCT01473693|Surgery|surgery
5037962|NCT01473693|induction chemotherapy|induction chemotherapy
5037963|NCT01473693|11-145|11-145
5037964|NCT01473680|minority breast cancer patients|minority breast cancer patients
5037965|NCT01473680|EEG|eeg
5037966|NCT01473680|Evaluation|evaluation
5037967|NCT01473680|Questionnaires|questionnaires
5037968|NCT01473680|11-139|11-139
5037969|NCT01473641|Etonogestrel|etonogestrel
5037970|NCT01473641|Contraceptive implant|contraceptive implant
5037971|NCT01473641|Safety|safety
5037972|NCT01473628|early stage follicular lymphoma|early stage follicular lymphoma
5037973|NCT01473628|indolent non-Hodgkin's lymphomas|indolent non-hodgkin's lymphomas
5037974|NCT01473628|Lymphoma|lymphoma
5037975|NCT01473628|Follicular Lymphoma|follicular lymphoma
5037976|NCT01473628|FL|fl
5037977|NCT01473628|Rituximab|rituximab
5037978|NCT01473628|Rituxan|rituxan
5037979|NCT01473628|Radiation|radiation
5037980|NCT01473628|Radiation Therapy|radiation therapy
5037981|NCT01473628|XRT|xrt
5037982|NCT01473576|type II diabetes|type ii diabetes
5037983|NCT01473576|protein synthesis|protein synthesis
5037984|NCT01473576|nitrate|nitrate
5037985|NCT01473576|elderly|elderly
5037986|NCT01473550|Mental Health|mental health
5037987|NCT01473550|Smart Technology|smart technology
5037988|NCT01473550|Mood disorder|mood disorder
5037989|NCT01473550|Psychotic disorder|psychotic disorder
5037990|NCT01473537|dental caries/prevention and control|dental caries/prevention and control
5037991|NCT01473537|oral health|oral health
5037992|NCT01473537|cariostatic agents|cariostatic agents
5037993|NCT01473524|Primary Biliary Cholangitis|primary biliary cholangitis
5037994|NCT01473524|Primary Biliary Cirrhosis|primary biliary cirrhosis
5037995|NCT01473524|PBC|pbc
5037996|NCT01473524|Cirrhosis|cirrhosis
5037997|NCT01473524|Liver|liver
5037998|NCT01473511|Behavioural intervention|behavioural intervention
5037999|NCT01473511|Distance intervention|distance intervention
5038000|NCT01473511|Parenting intervention|parenting intervention
5038001|NCT01473498|Sepsis|sepsis
5038002|NCT01473498|Acute kidney injury|acute kidney injury
5038003|NCT01473498|Mean arterial pressure|mean arterial pressure
5038004|NCT01473498|Catecholamines|catecholamines
5038005|NCT01473498|Renal doppler|renal doppler
5038006|NCT01473485|Brain Tumor|brain tumor
5038007|NCT01473485|Glioma|glioma
5038008|NCT01473485|Brain Cancer|brain cancer
5038009|NCT01473485|Metastatic Brain Cancer|metastatic brain cancer
5038010|NCT01473472|Prophylaxis|prophylaxis
5038011|NCT01473472|HIV infection|hiv infection
5038012|NCT01473472|tenofovir|tenofovir
5038013|NCT01473472|emtricitabine|emtricitabine
5038014|NCT01473472|men who have sex with men|men who have sex with men
5038015|NCT01473459|best fertility protocol|best fertility protocol
5038016|NCT01473459|(BMI > 30)|(bmi > 30)
5038017|NCT01473459|women|women
5038018|NCT01473459|PCOS|pcos
5038019|NCT01473446|Goal directed fluid therapy|goal directed fluid therapy
5038020|NCT01473446|perioperative fluid therapy|perioperative fluid therapy
5038021|NCT01473446|LiDCOrapid|lidcorapid
5038022|NCT01473446|Postoperative outcome|postoperative outcome
5038023|NCT01473446|Open abdominal surgery|open abdominal surgery
5038024|NCT01473433|Regenerative medicine|regenerative medicine
5038025|NCT01473433|Myocardial infarction|myocardial infarction
5038026|NCT01473394|Major depressive disorder|major depressive disorder
5038027|NCT01473394|Depression|depression
5038028|NCT01473381|Major Depressive Disorder|major depressive disorder
5038029|NCT01473381|Depression|depression
5038030|NCT01473368|human Gut Microbiota|human gut microbiota
5038031|NCT01473368|gut microbiota|gut microbiota
5038032|NCT01473368|gut microbiome|gut microbiome
5038033|NCT01473368|probiotic|probiotic
5038034|NCT01473368|antibiotic|antibiotic
5038035|NCT01473368|antibiotic-associated diarrhea|antibiotic-associated diarrhea
5038036|NCT01473368|intestinal bacterial overgrowth|intestinal bacterial overgrowth
5038037|NCT01473342|Healthy survivorship|healthy survivorship
5038038|NCT01473342|Smartphones|smartphones
5038039|NCT01473342|Treatment|treatment
5038040|NCT01473329|diabetes care|diabetes care
5038041|NCT01473329|diabetes education|diabetes education
5038042|NCT01473329|diabetes control|diabetes control
5038043|NCT01473303|stage IV pancreatic cancer|stage iv pancreatic cancer
5038044|NCT01473303|duct cell adenocarcinoma of the pancreas|duct cell adenocarcinoma of the pancreas
5038045|NCT01473290|diarrhea|diarrhea
5038046|NCT01473290|constipation, impaction, and bowel obstruction|constipation, impaction, and bowel obstruction
5038047|NCT01473290|gastrointestinal complications|gastrointestinal complications
5038048|NCT01473290|fatigue|fatigue
5038049|NCT01473290|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
5038050|NCT01473290|cognitive/functional effects|cognitive/functional effects
5038051|NCT01473290|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5038052|NCT01473277|Hemiplegic shoulder pain|hemiplegic shoulder pain
5038053|NCT01473277|Botulinum toxin type A (BT-A)|botulinum toxin type a (bt-a)
5038054|NCT01473277|Steroid|steroid
5038055|NCT01473277|Intra-articular injection|intra-articular injection
5038056|NCT01473277|Pain score of 45 or greater on a 0-100 mm VAS|pain score of 45 or greater on a 0-100 mm vas
5038057|NCT01473277|Duration of HSP for at least one month|duration of hsp for at least one month
5038058|NCT01473277|Pain refractoriness to conventional treatment|pain refractoriness to conventional treatment
5038059|NCT01473264|CC10|cc10
5038061|NCT01473264|Bronchopulmonary dysplasia|bronchopulmonary dysplasia
5038062|NCT01473264|premature infants|premature infants
5038063|NCT01473264|neonates|neonates
5038064|NCT01473264|pulmonary inflammation|pulmonary inflammation
5038065|NCT01473264|lung function|lung function
5038066|NCT01473264|RDS|rds
5038067|NCT01473238|Desktop computer|desktop computer
5038068|NCT01473238|Mobile|mobile
5038069|NCT01473238|iPad|ipad
5038070|NCT01473238|Evaluation|evaluation
5038071|NCT01473238|User experience|user experience
5038072|NCT01473238|Benefits|benefits
5038073|NCT01473238|Cost analysis|cost analysis
5038074|NCT01473199|focal defect|focal defect
5038075|NCT01473199|focal lesion|focal lesion
5038076|NCT01473199|chondral lesion|chondral lesion
5038077|NCT01473199|osteochondral lesion|osteochondral lesion
5038078|NCT01473186|morbid obesity|morbid obesity
5038079|NCT01473186|endometrial pathology|endometrial pathology
5038080|NCT01473186|menstrual irregularities|menstrual irregularities
5038082|NCT01473173|Tolerability|tolerability
5038083|NCT01473173|Pharmacokinetics|pharmacokinetics
5038084|NCT01473173|Pharmacodynamics|pharmacodynamics
5038085|NCT01473147|GLP-1 analogue|glp-1 analogue
5038086|NCT01473147|CSII|csii
5038087|NCT01473147|insulin|insulin
5038088|NCT01473147|type 2 diabetes mellitus|type 2 diabetes mellitus
5038089|NCT01473121|Hepatocellular carcinoma|hepatocellular carcinoma
5038090|NCT01473121|Registry|registry
5038091|NCT01473121|Turkey|turkey
5038092|NCT01473108|Healthy volunteers, proof-of-concept trial, PK and PD|healthy volunteers, proof-of-concept trial, pk and pd
5038093|NCT01473095|AKT|akt
5038094|NCT01473095|ARQ 092|arq 092
5038095|NCT01473095|Targeted therapy|targeted therapy
5038096|NCT01473095|Molecular therapy|molecular therapy
5038097|NCT01473095|Biomarker|biomarker
5038098|NCT01473095|Phase 1|phase 1
5038099|NCT01473095|Phase I|phase i
5038100|NCT01473095|Endometrial cancer|endometrial cancer
5038101|NCT01473095|Lymphoma|lymphoma
5038102|NCT01473095|AKT pathway|akt pathway
5038103|NCT01473095|AKT signaling|akt signaling
5038104|NCT01473095|AKT inhibitor|akt inhibitor
5038105|NCT01473095|AKT pan inhibitor|akt pan inhibitor
5038106|NCT01473095|AKT1|akt1
5038107|NCT01473095|AKT2|akt2
5038108|NCT01473095|AKT3|akt3
5038109|NCT01473095|AKT1 mutation|akt1 mutation
5038110|NCT01473095|AKT1-E17K|akt1-e17k
5038111|NCT01473095|AKT1-E17K mutation|akt1-e17k mutation
5038112|NCT01473095|AKT 2 inhibitor|akt 2 inhibitor
5038113|NCT01473095|AKT 3 inhibitor|akt 3 inhibitor
5038114|NCT01473095|AKT 3 amplification|akt 3 amplification
5038115|NCT01473095|PI3K AKT mTOR signalling pathway|pi3k akt mtor signalling pathway
5038116|NCT01473095|mTOR inhibitor|mtor inhibitor
5038117|NCT01473095|PI3K inhibitor|pi3k inhibitor
5038118|NCT01473095|Clinical oncology|clinical oncology
5038119|NCT01473095|Tumor|tumor
5038120|NCT01473095|Tumour|tumour
5038121|NCT01473095|PIK3CA H1047R mutation|pik3ca h1047r mutation
5038122|NCT01473069|JTK-853|jtk-853
5038123|NCT01473069|Healthy subjects|healthy subjects
5038124|NCT01473056|Hepatitis C|hepatitis c
5038125|NCT01473056|JTK-853|jtk-853
5038126|NCT01473043|Axitinib|axitinib
5038127|NCT01473043|metastatic renal cell carcinoma|metastatic renal cell carcinoma
5038128|NCT01473030|Benign prostate|benign prostate
5038129|NCT01473030|serum DHT|serum dht
5038130|NCT01473030|Dutasteride|dutasteride
5038131|NCT01473030|PSA|psa
5038132|NCT01473030|Avodart|avodart
5038133|NCT01473004|Sir-spheres|sir-spheres
5038134|NCT01473004|Liver Metastases|liver metastases
5038135|NCT01473004|Selective internal radiation|selective internal radiation
5038136|NCT01473004|Yttrium-90|yttrium-90
5038137|NCT01473004|Uveal|uveal
5038138|NCT01473004|Melanoma|melanoma
5038139|NCT01473004|Ocular melanoma|ocular melanoma
5038140|NCT01472991|ADHD|adhd
5038141|NCT01472978|C. difficile|c. difficile
5038142|NCT01472965|central line|central line
5038143|NCT01472965|adolescents|adolescents
5038144|NCT01472965|children|children
5038145|NCT01472965|bloodstream infection|bloodstream infection
5038146|NCT01472965|antibiotic lock therapy|antibiotic lock therapy
5038147|NCT01472965|catheter lock therapy|catheter lock therapy
5038148|NCT01472965|ethanol lock therapy|ethanol lock therapy
5038149|NCT01472952|sepsis|sepsis
5038150|NCT01472952|immune cells|immune cells
5038151|NCT01472952|immune reaction|immune reaction
5038152|NCT01472952|trauma|trauma
5038153|NCT01472952|Immune activation|immune activation
5038154|NCT01472926|acute ischaemic stroke|acute ischaemic stroke
5038155|NCT01472926|stroke|stroke
5038156|NCT01472926|thrombolysis|thrombolysis
5038157|NCT01472926|thrombolytic drug therapy|thrombolytic drug therapy
5038158|NCT01472926|CT perfusion|ct perfusion
5038159|NCT01472926|CT angiography|ct angiography
5038160|NCT01472926|brain imaging|brain imaging
5038161|NCT01472913|Prospective randomised double-blind study|prospective randomised double-blind study
5038162|NCT01472913|Fibrin sealant|fibrin sealant
5038163|NCT01472913|Bilateral simultaneous total knee arthroplasty|bilateral simultaneous total knee arthroplasty
5038164|NCT01472913|Blood loss|blood loss
5038165|NCT01472913|Postoperative pain|postoperative pain
5038166|NCT01472913|Complications|complications
5038167|NCT01472900|acne vulgaris|acne vulgaris
5038168|NCT01472874|Wilson Disease|wilson disease
5038169|NCT01472874|Trientine|trientine
5038170|NCT01472874|One Daily Dosage|one daily dosage
5038171|NCT01472861|coculture|coculture
5038172|NCT01472861|endometrial biopsy|endometrial biopsy
5038173|NCT01472861|IVF poor responders|ivf poor responders
5038174|NCT01472835|sedation|sedation
5038175|NCT01472835|sensitivity|sensitivity
5038176|NCT01472835|specificity|specificity
5038177|NCT01472835|validity|validity
5038178|NCT01472835|diagnostic injection|diagnostic injection
5038179|NCT01472822|Omija|omija
5038180|NCT01472822|knee osteoarthritis|knee osteoarthritis
5038181|NCT01472809|ZYGK1|zygk1
5038182|NCT01472809|Cadila|cadila
5038183|NCT01472809|Zydus|zydus
5038184|NCT01472809|ZRC|zrc
5038185|NCT01472809|Zydus Research Center|zydus research center
5038186|NCT01472809|Phase 1|phase 1
5038187|NCT01472809|Diabetes|diabetes
5038188|NCT01472796|African American|african american
5038189|NCT01472796|Vitamin D deficient|vitamin d deficient
5038190|NCT01472783|BRCA1 mutation|brca1 mutation
5038191|NCT01472783|BRCA2 mutation|brca2 mutation
5038192|NCT01472783|Ovarian cancer|ovarian cancer
5038193|NCT01472783|PARP inhibitor|parp inhibitor
5038194|NCT01472770|Colorectal cancer|colorectal cancer
5038195|NCT01472770|Metastatic|metastatic
5038196|NCT01472770|Treatment resistant|treatment resistant
5038197|NCT01472744|Executive function|executive function
5038198|NCT01472744|Aging|aging
5038199|NCT01472744|Physical activity|physical activity
5038200|NCT01472731|GC1008|gc1008
5038201|NCT01472731|PET imaging|pet imaging
5038202|NCT01472731|primary brain tumors|primary brain tumors
5038203|NCT01472731|recurrent high grade glioma's|recurrent high grade glioma's
5038204|NCT01472705|drug-eluting coronary stent|drug-eluting coronary stent
5038205|NCT01472705|percutaneous coronary intervention|percutaneous coronary intervention
5038206|NCT01472692|Prehypertension|prehypertension
5038207|NCT01472692|Gout|gout
5038208|NCT01472692|Puls Wave Velocity|puls wave velocity
5038209|NCT01472692|Hypertension|hypertension
5038210|NCT01472692|24 hour blood pressure|24 hour blood pressure
5038211|NCT01472679|fat mass|fat mass
5038212|NCT01472679|fat free mass|fat free mass
5038213|NCT01472679|body mass index|body mass index
5038214|NCT01472666|Medium chain fatty acids|medium chain fatty acids
5038215|NCT01472666|Saturated fatty acids|saturated fatty acids
5038216|NCT01472666|Whey protein|whey protein
5038217|NCT01472666|Casein protein|casein protein
5038218|NCT01472666|Metabolic syndrome|metabolic syndrome
5038219|NCT01472666|Type 2 diabetes|type 2 diabetes
5038220|NCT01472666|Cardiovascular disease|cardiovascular disease
5038221|NCT01472666|Dairy products|dairy products
5038222|NCT01472666|Dietary intervention|dietary intervention
5038223|NCT01472653|Head and neck Cancer|head and neck cancer
5038224|NCT01472653|Radiochemotherapy|radiochemotherapy
5038225|NCT01472653|Radioimmunotherapy|radioimmunotherapy
5038226|NCT01472653|Skin rush|skin rush
5038227|NCT01472653|locoregional control|locoregional control
5038228|NCT01472653|Survival|survival
5038229|NCT01472653|Toxicity|toxicity
5038230|NCT01472640|CHF, Diabetes; Liraglutid, Ecco|chf, diabetes; liraglutid, ecco
5038232|NCT01472627|Bortezomib|bortezomib
5038233|NCT01472627|Velcade|velcade
5038234|NCT01472614|Type-2 diabetes mellitus|type-2 diabetes mellitus
5038235|NCT01472614|Add-on therapy|add-on therapy
5038236|NCT01472575|rotavirus|rotavirus
5038237|NCT01472575|gastroenteritis|gastroenteritis
5038238|NCT01472575|vaccination|vaccination
5038239|NCT01472575|hospitalisation|hospitalisation
5038240|NCT01472562|mantle cell lymphoma|mantle cell lymphoma
5038241|NCT01472549|Preoperative|preoperative
5038242|NCT01472549|Antiseptics|antiseptics
5038243|NCT01472549|Comparative|comparative
5038244|NCT01472549|Cost|cost
5038245|NCT01472549|Effectiveness|effectiveness
5038246|NCT01472536|Influenza|influenza
5038247|NCT01472536|Non pharmaceutical intervention|non pharmaceutical intervention
5038248|NCT01472536|Sequestration|sequestration
5038249|NCT01472536|Social network|social network
5038250|NCT01472510|Diabetic|diabetic
5038251|NCT01472510|Macular|macular
5038252|NCT01472510|Edema|edema
5038253|NCT01472510|Ranibizumab|ranibizumab
5038254|NCT01472510|anti-VEGF|anti-vegf
5038255|NCT01472497|hypertension|hypertension
5038256|NCT01472497|insulin resistance|insulin resistance
5038257|NCT01472497|oral glucose tolerance test|oral glucose tolerance test
5038258|NCT01472497|AGE|age
5038259|NCT01472497|inflammatory cytokine|inflammatory cytokine
5038260|NCT01472484|beans|beans
5038261|NCT01472484|lpa mutant|lpa mutant
5038262|NCT01472484|polyphenols|polyphenols
5038263|NCT01472484|phytic acid|phytic acid
5038264|NCT01472484|stable iron isotopes|stable iron isotopes
5038265|NCT01472471|Childhood Asthma|childhood asthma
5038266|NCT01472471|Oxidative stress|oxidative stress
5038267|NCT01472471|Urinary 8-isoprostane|urinary 8-isoprostane
5038268|NCT01472458|Cardiac arrest|cardiac arrest
5038269|NCT01472458|Hypothermia|hypothermia
5038270|NCT01472458|Post Cardiac Arrest Care|post cardiac arrest care
5038271|NCT01472458|Survivors of cardiac arrest|survivors of cardiac arrest
5038272|NCT01472445|Vitamin D|vitamin d
5038273|NCT01472445|Obesity|obesity
5038274|NCT01472432|type 2 diabetes|type 2 diabetes
5038275|NCT01472432|healing|healing
5038276|NCT01472432|foot ulcers|foot ulcers
5038277|NCT01472432|vildagliptin|vildagliptin
5038278|NCT01472419|metastatic esophageal squamous cell carcinoma|metastatic esophageal squamous cell carcinoma
5038279|NCT01472419|Fluoropyrimidine/platinum-based first-line chemotherapy|fluoropyrimidine/platinum-based first-line chemotherapy
5038280|NCT01472419|prognosis|prognosis
5038281|NCT01472406|type 1 diabetes mellitus|type 1 diabetes mellitus
5038282|NCT01472406|closed-loop artificial pancreas|closed-loop artificial pancreas
5038283|NCT01472393|creatine supplementation|creatine supplementation
5038284|NCT01472393|bone mass|bone mass
5038285|NCT01472393|postmenopausal women|postmenopausal women
5038286|NCT01472393|muscle function|muscle function
5038287|NCT01472393|bone markers|bone markers
5038288|NCT01472354|HIV|hiv
5038289|NCT01472354|Hepatitis C|hepatitis c
5038290|NCT01472354|Decision-Making|decision-making
5038291|NCT01472354|chronic|chronic
5038292|NCT01472328|Oxidative stress|oxidative stress
5038293|NCT01472328|Insulin resistance|insulin resistance
5038294|NCT01472315|sleep apnea|sleep apnea
5038295|NCT01472315|women|women
5038296|NCT01472315|postmenopause|postmenopause
5038297|NCT01472315|hormone treatment|hormone treatment
5038298|NCT01472289|CLI|cli
5038299|NCT01472289|Peripheral arterial disease|peripheral arterial disease
5038300|NCT01472276|Behaviour change|behaviour change
5038301|NCT01472276|Weight loss|weight loss
5038302|NCT01472276|Cardiovascular risk|cardiovascular risk
5038303|NCT01472276|Diet|diet
5038304|NCT01472276|Physical activity|physical activity
5038305|NCT01472276|Overweight|overweight
5038306|NCT01472276|Obesity|obesity
5038307|NCT01472276|Internet|internet
5038308|NCT01472263|HTLV-1|htlv-1
5038309|NCT01472263|tropical spastic paraparesis|tropical spastic paraparesis
5038310|NCT01472263|Immune System Diseases|immune system diseases
5038311|NCT01472263|Physical disability|physical disability
5038312|NCT01472263|pentoxifylline|pentoxifylline
5038313|NCT01472250|Advanced Gastric Cancer|advanced gastric cancer
5038314|NCT01472250|chemotherapy|chemotherapy
5038315|NCT01472250|quality of life|quality of life
5038316|NCT01472250|treatment expense|treatment expense
5038317|NCT01472250|patients accepted first-line chemotherapy|patients accepted first-line chemotherapy
5038318|NCT01472224|Transcranial ultrasound|transcranial ultrasound
5038319|NCT01472224|Haematoma expansion|haematoma expansion
5038320|NCT01472198|GSI|gsi
5038321|NCT01472198|Gilead|gilead
5038322|NCT01472198|Gilead Sciences|gilead sciences
5038323|NCT01472198|Pancreatic Cancer|pancreatic cancer
5038324|NCT01472198|PC|pc
5038325|NCT01472198|Gemcitabine|gemcitabine
5038326|NCT01472198|Phase 2|phase 2
5038327|NCT01472198|Phase II|phase ii
5038328|NCT01472198|GS-6624|gs-6624
5038329|NCT01472198|Oncology|oncology
5038330|NCT01472198|Monoclonal Antibody|monoclonal antibody
5038331|NCT01472185|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
5038332|NCT01472172|Flex-rigid pleuroscopy|flex-rigid pleuroscopy
5038333|NCT01472172|cryobiopsy|cryobiopsy
5038334|NCT01472172|pleural biopsy|pleural biopsy
5038335|NCT01472172|pleural effusion|pleural effusion
5038336|NCT01472172|safety|safety
5038337|NCT01472172|thoracoscopy|thoracoscopy
5038338|NCT01472146|Neoadjuvant therapy|neoadjuvant therapy
5038339|NCT01472146|Breast cancer HER2 positive|breast cancer her2 positive
5038340|NCT01472146|zolendronic acid|zolendronic acid
5038341|NCT01472133|Respiration Rate|respiration rate
5038342|NCT01472133|ECG|ecg
5038343|NCT01472133|Pulse oximetry|pulse oximetry
5038344|NCT01472133|Photoplethysmograph|photoplethysmograph
5038345|NCT01472133|PPG|ppg
5038346|NCT01472133|Physiology|physiology
5038347|NCT01472107|Pregnancy|pregnancy
5038348|NCT01472107|APL female patients|apl female patients
5038349|NCT01472068|Incontinence|incontinence
5038350|NCT01472068|NMES|nmes
5038351|NCT01472055|Hematopoietic stem cell transplantation with fludarabine based conditioning|hematopoietic stem cell transplantation with fludarabine based conditioning
5038352|NCT01472042|Traumatic Brain Injury|traumatic brain injury
5038353|NCT01472042|Sport Concussion|sport concussion
5038354|NCT01472042|Head Injury|head injury
5038355|NCT01472042|Sports Injury|sports injury
5038356|NCT01472029|Adenocarcinoma|adenocarcinoma
5038357|NCT01472029|Gastroesophageal junction|gastroesophageal junction
5038358|NCT01472029|Stomach|stomach
5038359|NCT01472029|HER2|her2
5038360|NCT01472016|c-Met overexpression|c-met overexpression
5038361|NCT01472016|MET amplification|met amplification
5038362|NCT01472016|Neoplasms|neoplasms
5038363|NCT01472016|h224G11|h224g11
5038364|NCT01471990|PACAP38|pacap38
5038365|NCT01471990|MMA|mma
5038366|NCT01471990|migraine|migraine
5038367|NCT01471990|angiography|angiography
5038368|NCT01471990|VIP|vip
5038369|NCT01471990|vasodilatation|vasodilatation
5038370|NCT01471912|Macular Holes|macular holes
5038371|NCT01471912|spectral domain optical coherence tomography|spectral domain optical coherence tomography
5038372|NCT01471912|elongation of foveal tissue|elongation of foveal tissue
5038373|NCT01471912|M-score|m-score
5038374|NCT01471873|Posterior corneal surface elevation|posterior corneal surface elevation
5038684|NCT01470833|treatment|treatment
5038375|NCT01471873|Pentacam-Scheimpflung imaging|pentacam-scheimpflung imaging
5038376|NCT01471873|variability|variability
5038377|NCT01471873|progressive keratoconus|progressive keratoconus
5038378|NCT01471873|corneal cross-linking|corneal cross-linking
5038379|NCT01471847|Locally advanced|locally advanced
5038380|NCT01471847|metastatic|metastatic
5038381|NCT01471847|breast cancer|breast cancer
5038382|NCT01471847|HER2 positive|her2 positive
5038383|NCT01471847|PI3K|pi3k
5038384|NCT01471847|mTOR|mtor
5038385|NCT01471847|trastuzumab|trastuzumab
5038386|NCT01471847|targeted therapy|targeted therapy
5038387|NCT01471847|LABC|labc
5038388|NCT01471847|MBC|mbc
5038389|NCT01471782|ALL|all
5038390|NCT01471782|relapsed, refractory B-precursor ALL|relapsed, refractory b-precursor all
5038391|NCT01471782|Leukemia|leukemia
5038392|NCT01471782|Leukemia, Lymphoid|leukemia, lymphoid
5038393|NCT01471782|Precursor Cell Lymphoblastic Leukemia|precursor cell lymphoblastic leukemia
5038394|NCT01471782|Neoplasms by Histologic Type|neoplasms by histologic type
5038395|NCT01471782|Neoplasms|neoplasms
5038396|NCT01471782|Lymphoproliferative Disorders|lymphoproliferative disorders
5038397|NCT01471782|Lymphatic Diseases|lymphatic diseases
5038398|NCT01471782|Immunoproliferative Disorders|immunoproliferative disorders
5038399|NCT01471782|Antibodies, Bispecific|antibodies, bispecific
5038400|NCT01471769|pediatric|pediatric
5038401|NCT01471769|pain|pain
5038402|NCT01471756|sessile neoplasms|sessile neoplasms
5038403|NCT01471756|flat neoplasms|flat neoplasms
5038404|NCT01471756|gastric cancer|gastric cancer
5038405|NCT01471743|nutrition|nutrition
5038406|NCT01471743|surgery|surgery
5038407|NCT01471743|immune|immune
5038408|NCT01471730|Transfusions|transfusions
5038409|NCT01471730|Fresh Frozen Plasma|fresh frozen plasma
5038410|NCT01471730|Fibrinogen|fibrinogen
5038411|NCT01471730|Prothrombin complex|prothrombin complex
5038412|NCT01471717|PK|pk
5038413|NCT01471717|pharmacokinetics|pharmacokinetics
5038414|NCT01471717|INX08189|inx08189
5038415|NCT01471717|Victrelis|victrelis
5038416|NCT01471717|Inhibitex|inhibitex
5038417|NCT01471704|Pharmacokinetics|pharmacokinetics
5038418|NCT01471704|PK|pk
5038419|NCT01471704|INX08189|inx08189
5038420|NCT01471704|Verapamil|verapamil
5038421|NCT01471704|Inhibitex|inhibitex
5038422|NCT01471678|Cross-over design|cross-over design
5038423|NCT01471678|Pilot bioequivalence|pilot bioequivalence
5038424|NCT01471678|North east Asian ancestry|north east asian ancestry
5038425|NCT01471678|GI198745|gi198745
5038426|NCT01471678|Tamsulosin hydrochloride|tamsulosin hydrochloride
5038427|NCT01471678|healthy male subjects|healthy male subjects
5038428|NCT01471678|Bioequivalence|bioequivalence
5038429|NCT01471678|Dutasteride|dutasteride
5038430|NCT01471561|Osmolarity|osmolarity
5038431|NCT01471561|Cataract|cataract
5038432|NCT01471561|Dry Eye|dry eye
5038433|NCT01471548|tumor|tumor
5038434|NCT01471548|cancer|cancer
5038435|NCT01471548|phase1|phase1
5038436|NCT01471548|TKI258|tki258
5038437|NCT01471418|TMJ|tmj
5038438|NCT01471418|orofacial pain|orofacial pain
5038439|NCT01471418|synovitis|synovitis
5038440|NCT01471418|arthroscopy|arthroscopy
5038441|NCT01471379|Irritable Bowel Syndrome|irritable bowel syndrome
5038442|NCT01471379|IBS|ibs
5038443|NCT01471379|Savella|savella
5038444|NCT01471379|Milnacipran|milnacipran
5038445|NCT01471379|Abdominal Pain|abdominal pain
5038446|NCT01471366|Hyperlipidemias|hyperlipidemias
5038447|NCT01471366|Dyslipidemias|dyslipidemias
5038448|NCT01471366|Fatty Acids, Omega-3|fatty acids, omega-3
5038449|NCT01471366|Fish Oils|fish oils
5038450|NCT01471353|Metastatic|metastatic
5038451|NCT01471353|Colon Cancer|colon cancer
5038452|NCT01471353|Rectal Cancer|rectal cancer
5038453|NCT01471652|myalgic encephalopathy|myalgic encephalopathy
5038454|NCT01471652|chronic fatigue syndrome|chronic fatigue syndrome
5038455|NCT01471652|post viral infection|post viral infection
5038456|NCT01471652|fatigue|fatigue
5038457|NCT01471652|muscle pain|muscle pain
5038458|NCT01471652|unrefreshing sleep|unrefreshing sleep
5038459|NCT01471652|fuzzy thought|fuzzy thought
5038460|NCT01471652|poor memory|poor memory
5038461|NCT01471652|forgetfulness|forgetfulness
5038462|NCT01471639|18 years and older,|18 years and older,
5038463|NCT01471639|previously healthy|previously healthy
5038464|NCT01471639|men and nonpregnant women|men and nonpregnant women
5038465|NCT01471639|emergency department|emergency department
5038466|NCT01471626|sleep apnea|sleep apnea
5038467|NCT01471626|polysomnography|polysomnography
5038468|NCT01471626|telemedicine|telemedicine
5038469|NCT01471613|spinal cord injury|spinal cord injury
5038470|NCT01471613|umbilical cord blood cell|umbilical cord blood cell
5038471|NCT01471613|cell transplant|cell transplant
5038472|NCT01471613|lithium carbonate|lithium carbonate
5038473|NCT01471600|upper gastrointestinal endoscopy|upper gastrointestinal endoscopy
5038474|NCT01471600|general anesthesia|general anesthesia
5038475|NCT01471535|chronic hepatitis B|chronic hepatitis b
5038476|NCT01471509|Glycemic Index|glycemic index
5038477|NCT01471509|LoBAG Diet|lobag diet
5038478|NCT01471509|Insulin|insulin
5038479|NCT01471509|Glucagon|glucagon
5038480|NCT01471496|duodenal ulcer|duodenal ulcer
5038481|NCT01471496|upper gastrointestinal system bleeding|upper gastrointestinal system bleeding
5038482|NCT01471496|injection therapy|injection therapy
5038483|NCT01471483|Geriatric Assessment|geriatric assessment
5038484|NCT01471483|Quality of Life|quality of life
5038485|NCT01471483|11-164|11-164
5038486|NCT01471483|Fallopian Tubes|fallopian tubes
5038487|NCT01471470|Advanced gastric cancer|advanced gastric cancer
5038488|NCT01471470|Neoadjuvant|neoadjuvant
5038489|NCT01471470|Bevacizumab|bevacizumab
5038490|NCT01471457|bacterial|bacterial
5038491|NCT01471457|vaginosis|vaginosis
5038492|NCT01471457|pessary|pessary
5038493|NCT01471457|discharge|discharge
5038494|NCT01471444|Blood And Marrow Transplantation|blood and marrow transplantation
5038495|NCT01471444|Leukemia|leukemia
5038496|NCT01471444|Allogeneic hematopoietic stem cell transplantation|allogeneic hematopoietic stem cell transplantation
5038497|NCT01471444|Acute myeloid leukemia|acute myeloid leukemia
5038498|NCT01471444|AML|aml
5038499|NCT01471444|Myelodysplastic syndrome|myelodysplastic syndrome
5038500|NCT01471444|MDS|mds
5038501|NCT01471444|Progression free survival|progression free survival
5038502|NCT01471444|Rate of engraftment|rate of engraftment
5038503|NCT01471444|Toxicity|toxicity
5038504|NCT01471444|Relapse rate|relapse rate
5038505|NCT01471444|Graft-vs-host disease|graft-vs-host disease
5038506|NCT01471444|GvHD|gvhd
5038507|NCT01471444|Progression-free survival|progression-free survival
5038508|NCT01471444|PFS|pfs
5038509|NCT01471444|Overall survival|overall survival
5038510|NCT01471444|OS|os
5038511|NCT01471444|Fludarabine|fludarabine
5038512|NCT01471444|Fludarabine Phosphate|fludarabine phosphate
5038513|NCT01471444|Fludara|fludara
5038514|NCT01471444|Clofarabine|clofarabine
5038515|NCT01471444|Clofarex|clofarex
5038516|NCT01471444|Clolar|clolar
5038517|NCT01471444|Busulfan|busulfan
5038518|NCT01471444|Busulfex|busulfex
5038519|NCT01471444|Myleran|myleran
5038520|NCT01471444|Thymoglobulin|thymoglobulin
5038521|NCT01471444|ATG|atg
5038522|NCT01471444|Antithymocyte Globulin|antithymocyte globulin
5038523|NCT01471444|Methotrexate|methotrexate
5038524|NCT01471444|Tacrolimus|tacrolimus
5038525|NCT01471444|Prograf|prograf
5038526|NCT01471392|Identigene|identigene
5038527|NCT01471392|STD Test|std test
5038528|NCT01471392|Chlamydia|chlamydia
5038529|NCT01471392|Gonorrhoeae|gonorrhoeae
5038530|NCT01471392|APTIMA|aptima
5038531|NCT01471392|Sexually Transmitted Disease|sexually transmitted disease
5038532|NCT01471301|systemic lupus erythematosus|systemic lupus erythematosus
5038533|NCT01471301|rheumatoid arthritis|rheumatoid arthritis
5038534|NCT01471288|well differentiated thyroid cancer|well differentiated thyroid cancer
5038535|NCT01471288|Carum Carvi|carum carvi
5038536|NCT01471288|Normal controls|normal controls
5038537|NCT01471275|type 2 diabetes|type 2 diabetes
5038538|NCT01471275|obesity|obesity
5038539|NCT01471275|hypertriglyceridemia|hypertriglyceridemia
5038540|NCT01471262|Complications|complications
5038541|NCT01471262|Mortality|mortality
5038542|NCT01471262|Liver|liver
5038543|NCT01471262|Failure|failure
5038544|NCT01471249|esophageal stenting|esophageal stenting
5038545|NCT01471249|palliative|palliative
5038546|NCT01471249|dysphagia|dysphagia
5038547|NCT01471236|cartilage|cartilage
5038548|NCT01471236|bone|bone
5038549|NCT01471184|Allergic Rhinitis|allergic rhinitis
5038550|NCT01471184|Conjunctivitis|conjunctivitis
5038551|NCT01471184|Bitop|bitop
5038552|NCT01471184|Eye|eye
5038553|NCT01471184|Eye Drops|eye drops
5038554|NCT01471184|Nasal Spray|nasal spray
5038555|NCT01471184|Total Nasal Symptom Score|total nasal symptom score
5038556|NCT01471184|Total Ocular Symptom Score|total ocular symptom score
5038557|NCT01471184|AUC|auc
5038558|NCT01471171|COPD|copd
5038559|NCT01471171|Antimuscarinic|antimuscarinic
5038560|NCT01471158|Primary open-angle glaucoma|primary open-angle glaucoma
5038561|NCT01471158|ocular hypertension|ocular hypertension
5038562|NCT01471158|pigment dispersion glaucoma|pigment dispersion glaucoma
5038563|NCT01471145|opioid dependence|opioid dependence
5038564|NCT01471145|heroin dependence|heroin dependence
5038565|NCT01471145|extended release depot naltrexone|extended release depot naltrexone
5038566|NCT01471145|functional Magnetic Resonance Imaging|functional magnetic resonance imaging
5038567|NCT01471145|dopamine transporter|dopamine transporter
5038568|NCT01471145|Single Photon Emission Computed Tomography|single photon emission computed tomography
5038569|NCT01471119|sublingual immunotherapy|sublingual immunotherapy
5038570|NCT01471119|atopic dermatitis|atopic dermatitis
5038571|NCT01471119|Dermatophagoides Farinae Drops|dermatophagoides farinae drops
5038572|NCT01471106|Breast Cancer|breast cancer
5038573|NCT01471106|Estrogen Receptor Negative Breast Cancer|estrogen receptor negative breast cancer
5038574|NCT01471106|Biomarker studies|biomarker studies
5038575|NCT01471106|Ki-67|ki-67
5038576|NCT01471106|Dasatinib|dasatinib
5038577|NCT01471106|BMS-354825|bms-354825
5038578|NCT01471106|Sprycel|sprycel
5038579|NCT01471080|laparoscopic hepatectomy|laparoscopic hepatectomy
5038580|NCT01471080|radio-frequency ablation|radio-frequency ablation
5038581|NCT01471080|giant cavernous hemangiomas|giant cavernous hemangiomas
5038582|NCT01471080|liver|liver
5038685|NCT01470820|Neonates|neonates
5038583|NCT01471067|Blood And Marrow Transplantation|blood and marrow transplantation
5038584|NCT01471067|Leukemia|leukemia
5038585|NCT01471067|Lymphoma|lymphoma
5038586|NCT01471067|Pediatrics|pediatrics
5038587|NCT01471067|Cord blood transplant|cord blood transplant
5038588|NCT01471067|Cord Blood Fucosylation|cord blood fucosylation
5038589|NCT01471067|Hematologic Malignancies|hematologic malignancies
5038590|NCT01471067|Acute Myelogenous Leukemia|acute myelogenous leukemia
5038591|NCT01471067|AML|aml
5038592|NCT01471067|Myelodysplastic Syndrome|myelodysplastic syndrome
5038593|NCT01471067|MDS|mds
5038594|NCT01471067|High-risk cytogenetics|high-risk cytogenetics
5038595|NCT01471067|Secondary leukemia from prior chemotherapy|secondary leukemia from prior chemotherapy
5038596|NCT01471067|Langerhan's cell histiocytosis|langerhan's cell histiocytosis
5038597|NCT01471067|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
5038598|NCT01471067|ALL|all
5038599|NCT01471067|complete remission|complete remission
5038600|NCT01471067|Philadelphia chromosome|philadelphia chromosome
5038601|NCT01471067|translocation 4;11|translocation 4;11
5038602|NCT01471067|Hypodiploidy|hypodiploidy
5038603|NCT01471067|Chronic Myeloid Leukemia|chronic myeloid leukemia
5038604|NCT01471067|CML|cml
5038605|NCT01471067|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
5038606|NCT01471067|NHL|nhl
5038607|NCT01471067|Hodgkin's Disease|hodgkin's disease
5038608|NCT01471067|HD|hd
5038609|NCT01471067|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
5038610|NCT01471067|CLL|cll
5038611|NCT01471067|Melphalan|melphalan
5038612|NCT01471067|Alkeran|alkeran
5038613|NCT01471067|Thiotepa|thiotepa
5038614|NCT01471067|Fludarabine|fludarabine
5038615|NCT01471067|Fludarabine Phosphate|fludarabine phosphate
5038616|NCT01471067|Fludara|fludara
5038617|NCT01471067|Mycophenolate Mofetil|mycophenolate mofetil
5038618|NCT01471067|MMF|mmf
5038619|NCT01471067|CellCept|cellcept
5038620|NCT01471067|Tacrolimus|tacrolimus
5038621|NCT01471067|Prograf|prograf
5038622|NCT01471067|Rituximab|rituximab
5038623|NCT01471067|Rituxan|rituxan
5038624|NCT01471067|ATG|atg
5038625|NCT01471067|Antithymocyte Globulin|antithymocyte globulin
5038626|NCT01471067|Thymoglobulin|thymoglobulin
5038627|NCT01471054|Plaque radiotherapy|plaque radiotherapy
5038628|NCT01471054|Brachytherapy|brachytherapy
5038629|NCT01471054|Macular edema|macular edema
5038630|NCT01471054|Cystoid macular edema|cystoid macular edema
5038631|NCT01471054|Uveal melanoma|uveal melanoma
5038632|NCT01471054|Radiation maculopathy|radiation maculopathy
5038633|NCT01471054|Radiation retinopathy|radiation retinopathy
5038634|NCT01471054|Ozurdex|ozurdex
5038635|NCT01471054|Dexamethasone intravitreal implant|dexamethasone intravitreal implant
5038636|NCT01471041|End Stage Renal Disease|end stage renal disease
5038637|NCT01471041|Hemodialysis|hemodialysis
5038638|NCT01471041|AV fistula|av fistula
5038639|NCT01471041|Kidney failure|kidney failure
5038640|NCT01471028|Acute alcoholic hepatitis|acute alcoholic hepatitis
5038641|NCT01471028|alcoholic|alcoholic
5038642|NCT01471028|hepatitis|hepatitis
5038643|NCT01471028|liver|liver
5038644|NCT01471015|Hypoxic Ischemic Encephalopathy|hypoxic ischemic encephalopathy
5038645|NCT01471015|Cooling Therapy|cooling therapy
5038646|NCT01471015|HIE|hie
5038647|NCT01470989|gouty arthritis|gouty arthritis
5038648|NCT01470976|Goal-directed therapy|goal-directed therapy
5038649|NCT01470976|Hemodynamic optimization|hemodynamic optimization
5038650|NCT01470976|Cardiac surgery|cardiac surgery
5038651|NCT01470963|Referral|referral
5038652|NCT01470963|Quality of Health Care|quality of health care
5038653|NCT01470950|Functional Electrical Stimulation|functional electrical stimulation
5038654|NCT01470950|Signalling Pathways|signalling pathways
5038655|NCT01470937|diabetes acarbose alphaglucosidase prevention|diabetes acarbose alphaglucosidase prevention
5038656|NCT01470924|acute lymphoblastic leukemia|acute lymphoblastic leukemia
5038657|NCT01470924|relapse|relapse
5038658|NCT01470924|salvage|salvage
5038659|NCT01470924|prognostic|prognostic
5038660|NCT01470911|Antisense oligonucleotide|antisense oligonucleotide
5038661|NCT01470911|Asthma|asthma
5038662|NCT01470911|Healthy subjects|healthy subjects
5038663|NCT01470911|Phase 1|phase 1
5038664|NCT01470911|Transcription factor GATA-3|transcription factor gata-3
5038665|NCT01470911|Oral inhalation|oral inhalation
5038666|NCT01470898|bispectral index monitoring|bispectral index monitoring
5038667|NCT01470898|extubation|extubation
5038668|NCT01470898|analgesia|analgesia
5038669|NCT01470898|abdominal surgery|abdominal surgery
5038670|NCT01470885|glucose|glucose
5038671|NCT01470885|prognosis|prognosis
5038672|NCT01470885|glycated hemoglobin|glycated hemoglobin
5038673|NCT01470859|De Novo parkinson's disease|de novo parkinson's disease
5038674|NCT01470859|initial treatment|initial treatment
5038675|NCT01470859|pramipexole|pramipexole
5038676|NCT01470859|Levodopa|levodopa
5038677|NCT01470859|Parkinson's disease-related spatial covariance pattern|parkinson's disease-related spatial covariance pattern
5038678|NCT01470846|epidural analgesia|epidural analgesia
5038679|NCT01470846|morphin analgesia|morphin analgesia
5038680|NCT01470846|laparotomy|laparotomy
5038681|NCT01470833|Achilles tendon|achilles tendon
5038682|NCT01470833|rupture|rupture
5038683|NCT01470833|non-operative|non-operative
5038686|NCT01470820|Hyperbilirubinemia|hyperbilirubinemia
5038687|NCT01470820|Phototherapy|phototherapy
5038688|NCT01470820|Light irradiance|light irradiance
5038689|NCT01470820|Saturation point|saturation point
5038690|NCT01470807|Artificial Pancreas|artificial pancreas
5038691|NCT01470807|Insulin Pump|insulin pump
5038692|NCT01470807|Continuous Glucose Monitor|continuous glucose monitor
5038693|NCT01470807|Closed Loop|closed loop
5038694|NCT01470794|GBM|gbm
5038695|NCT01470794|HGG|hgg
5038696|NCT01470794|High grade glioma|high grade glioma
5038697|NCT01470794|Malignant glioma|malignant glioma
5038698|NCT01470794|Grade III glioma|grade iii glioma
5038699|NCT01470794|Grad IV glioma|grad iv glioma
5038700|NCT01470794|glioma|glioma
5038701|NCT01470794|glioblastoma|glioblastoma
5038702|NCT01470794|Grade IV astrocytoma|grade iv astrocytoma
5038703|NCT01470794|brain cancer|brain cancer
5038704|NCT01470794|recurrent glioblastoma|recurrent glioblastoma
5038705|NCT01470794|AA|aa
5038706|NCT01470794|AOD|aod
5038707|NCT01470794|anaplastic astrocytoma|anaplastic astrocytoma
5038708|NCT01470794|Anaplastic oligodendroglioma|anaplastic oligodendroglioma
5038709|NCT01470794|Anaplastic oligoastrocytoma|anaplastic oligoastrocytoma
5038710|NCT01470781|Bipolar Disorder|bipolar disorder
5038711|NCT01470781|Psychosis|psychosis
5038712|NCT01470781|Cognition|cognition
5038713|NCT01470781|Cognitive Remediation|cognitive remediation
5038714|NCT01470755|Pediatrics|pediatrics
5038715|NCT01470755|Bronchial wheeze|bronchial wheeze
5038716|NCT01470755|bronchodilator|bronchodilator
5038717|NCT01470755|lung function|lung function
5038718|NCT01470755|airway resistance|airway resistance
5038719|NCT01470729|Spinocerebellar ataxia, energy metabolism, NMR spectroscopy|spinocerebellar ataxia, energy metabolism, nmr spectroscopy
5038720|NCT01470716|EGFR mutation|egfr mutation
5038721|NCT01470716|NSCLC|nsclc
5038722|NCT01470703|Acute Respiratory Distress Syndrome,|acute respiratory distress syndrome,
5038723|NCT01470703|ECMO, Extracorporeal Membrane Oxygenation|ecmo, extracorporeal membrane oxygenation
5038724|NCT01470703|Randomized controlled trial|randomized controlled trial
5038725|NCT01470703|Positive-Pressure ventilation|positive-pressure ventilation
5038726|NCT01470703|Survival Rate|survival rate
5038727|NCT01470690|HVC infection|hvc infection
5038728|NCT01470690|gastric acid-related disorders|gastric acid-related disorders
5038729|NCT01470690|proton pump inhibitor|proton pump inhibitor
5038730|NCT01470690|interaction|interaction
5038731|NCT01470690|pharmacokinetics|pharmacokinetics
5038732|NCT01470690|boceprevir|boceprevir
5038733|NCT01470690|omeprazole|omeprazole
5038734|NCT01470677|lymph cyst|lymph cyst
5038735|NCT01470677|lymphocele|lymphocele
5038736|NCT01470677|fibrin|fibrin
5038737|NCT01470677|collagen|collagen
5038738|NCT01470677|prevention|prevention
5038739|NCT01470677|cancer|cancer
5038740|NCT01470651|HCV+|hcv+
5038741|NCT01470651|HCV treatment|hcv treatment
5038742|NCT01470651|Fatigue|fatigue
5038743|NCT01470651|patients starting alpha interferon/ribavirin treatment|patients starting alpha interferon/ribavirin treatment
5038744|NCT01470638|Flt3-L|flt3-l
5038745|NCT01470638|CSF|csf
5038746|NCT01470625|Dying|dying
5038747|NCT01470625|Patients|patients
5038748|NCT01470625|Hospice|hospice
5038749|NCT01470625|Liverpool Care Pathways|liverpool care pathways
5038750|NCT01470612|Ulcerative colitis|ulcerative colitis
5038751|NCT01470612|open-label|open-label
5038752|NCT01470612|long term treatment|long term treatment
5038753|NCT01470586|Colorectal cancer|colorectal cancer
5038754|NCT01470586|Surgical resection|surgical resection
5038755|NCT01470586|Oxidative Stress Markers|oxidative stress markers
5038756|NCT01470586|Controls|controls
5038757|NCT01470560|Mindfulness|mindfulness
5038758|NCT01470560|Mindfulness-Based Stress Reduction|mindfulness-based stress reduction
5038759|NCT01470560|Meditation|meditation
5038760|NCT01470560|Yoga|yoga
5038761|NCT01470547|Liver Cirrhosis|liver cirrhosis
5038762|NCT01470547|Portal Vein Thrombosis|portal vein thrombosis
5038763|NCT01470547|Cirrhosis Complications|cirrhosis complications
5038764|NCT01470547|Registry|registry
5038765|NCT01470547|Italian|italian
5038766|NCT01470534|Dietary supplement|dietary supplement
5038767|NCT01470534|Carbohydrate loading|carbohydrate loading
5038768|NCT01470534|Insulin resistance|insulin resistance
5038769|NCT01470534|Surgery|surgery
5038770|NCT01470521|Multiple sclerosis|multiple sclerosis
5038771|NCT01470521|Hookworm larvae|hookworm larvae
5038772|NCT01470521|Necator americanus|necator americanus
5038773|NCT01470521|Treg cells|treg cells
5038774|NCT01470508|Bulimia|bulimia
5038775|NCT01470508|Binge-Eating Disorder|binge-eating disorder
5038776|NCT01470508|Eating Disorders|eating disorders
5038777|NCT01470482|Total knee|total knee
5038778|NCT01470482|Tourniquet|tourniquet
5038779|NCT01470482|Blood loss|blood loss
5038780|NCT01470482|pain|pain
5038781|NCT01470482|range of motion|range of motion
5038782|NCT01470391|Adductor-Canal-Blockade|adductor-canal-blockade
5038783|NCT01470391|Femoral Nerve Block|femoral nerve block
5038784|NCT01470391|Postoperative Pain|postoperative pain
5038785|NCT01470391|Total Knee Arthroplasty|total knee arthroplasty
5038786|NCT01470378|Lymphedema|lymphedema
5038787|NCT01470378|Magnetic Resonance Imaging|magnetic resonance imaging
5038788|NCT01470378|Plastic Surgery|plastic surgery
5038789|NCT01470352|migraine|migraine
5038790|NCT01470352|pain|pain
5038791|NCT01470352|CPM|cpm
5038792|NCT01470352|offset analgesia|offset analgesia
5038793|NCT01470352|fMRI|fmri
5038794|NCT01470339|endogenous pain modulation|endogenous pain modulation
5038795|NCT01470339|migraine|migraine
5038796|NCT01470339|fMRI|fmri
5038797|NCT01470339|duloxetine|duloxetine
5038798|NCT01470339|preventive migraine treatment|preventive migraine treatment
5038799|NCT01470326|Osteoporosis|osteoporosis
5038800|NCT01470326|Post menopausal women|post menopausal women
5038801|NCT01470326|SERM|serm
5038802|NCT01470326|Japanese|japanese
5038803|NCT01470326|Viviant|viviant
5038804|NCT01470326|Regulatory Post Marketing Commitment Plan|regulatory post marketing commitment plan
5038805|NCT01470326|Long term treatment|long term treatment
5038806|NCT01470313|Safety and tolerability|safety and tolerability
5038807|NCT01470313|cutaneous lupus erythematosus|cutaneous lupus erythematosus
5038808|NCT01470313|efficacy|efficacy
5038809|NCT01470287|Infants,|infants,
5038810|NCT01470287|Immunogenicity,|immunogenicity,
5038811|NCT01470287|Safety|safety
5038812|NCT01470274|Blood volume|blood volume
5038813|NCT01470274|CO-rebreathing|co-rebreathing
5038814|NCT01470274|COPD|copd
5038815|NCT01470274|CVD|cvd
5038816|NCT01470261|methylphenidate|methylphenidate
5038817|NCT01470261|ritalin|ritalin
5038818|NCT01470261|Attention Deficit Disorder|attention deficit disorder
5038819|NCT01470248|Lung Cancer|lung cancer
5038820|NCT01470248|Carcinoma, small cell|carcinoma, small cell
5038821|NCT01470248|Trisenox|trisenox
5038822|NCT01470248|Arsenic trioxide|arsenic trioxide
5038823|NCT01470248|phase II trial|phase ii trial
5038824|NCT01470235|screening|screening
5038825|NCT01470235|genetic|genetic
5038826|NCT01470235|cancer|cancer
5038827|NCT01470222|Worksite|worksite
5038828|NCT01470222|group weight loss|group weight loss
5038829|NCT01470222|behavioral components|behavioral components
5038830|NCT01470209|lung cancer with activated mTOR/PI3K pathway|lung cancer with activated mtor/pi3k pathway
5038831|NCT01470209|alterations in PIK3CA, NF1, TSC1/TSC2, mTOR, KRAS, LKB1, PTEN|alterations in pik3ca, nf1, tsc1/tsc2, mtor, kras, lkb1, pten
5038832|NCT01470196|WM|wm
5038833|NCT01470196|untreated|untreated
5038834|NCT01470196|symptomatic|symptomatic
5038835|NCT01470183|Lupus Nephritis|lupus nephritis
5038836|NCT01470170|Sedative bronchoscope|sedative bronchoscope
5038837|NCT01470170|Alfentanil doses|alfentanil doses
5038838|NCT01470170|Propofol|propofol
5038839|NCT01470170|Targeted controlled infusion|targeted controlled infusion
5038840|NCT01470170|Hypoxemia|hypoxemia
5038841|NCT01470131|multiple myeloma|multiple myeloma
5038842|NCT01470131|relapse|relapse
5038843|NCT01470131|second line therapy|second line therapy
5038844|NCT01470131|bortezomib|bortezomib
5038845|NCT01470131|dexamethasone|dexamethasone
5038846|NCT01470105|questionnaire|questionnaire
5038847|NCT01470105|11-121|11-121
5038848|NCT01470092|Menopause|menopause
5038849|NCT01470092|Depression|depression
5038850|NCT01470066|peripheral T cell lymphomas|peripheral t cell lymphomas
5038851|NCT01470066|interim PET/CT|interim pet/ct
5038852|NCT01470066|prognosis|prognosis
5038853|NCT01470066|Positron-emission tomography/Computerized tomography|positron-emission tomography/computerized tomography
5038854|NCT01470053|mometasone furoate|mometasone furoate
5038855|NCT01470053|azelastine HCl|azelastine hcl
5038856|NCT01470053|perennial allergic rhinitis|perennial allergic rhinitis
5038857|NCT01470040|traumatic brain injury|traumatic brain injury
5038858|NCT01470040|chronic subdural hematoma|chronic subdural hematoma
5038859|NCT01470040|aspirin|aspirin
5038860|NCT01470040|antiplatelet therapy|antiplatelet therapy
5038861|NCT01470027|magnetic resonance spectroscopy|magnetic resonance spectroscopy
5038862|NCT01470027|N-acetylcysteine|n-acetylcysteine
5038863|NCT01470027|antioxidant|antioxidant
5038864|NCT01470027|glutathione|glutathione
5038865|NCT01470014|isolated left ventricular non-compaction|isolated left ventricular non-compaction
5038866|NCT01470014|cardiac computed tomography|cardiac computed tomography
5038867|NCT01470014|cardiac magnet resonance imaging|cardiac magnet resonance imaging
5038868|NCT01470014|echocardiography|echocardiography
5038869|NCT01469975|cancer|cancer
5038870|NCT01469975|relapse or refractory|relapse or refractory
5038871|NCT01469962|morbid obesity|morbid obesity
5038872|NCT01469962|bariatric surgery|bariatric surgery
5038873|NCT01469962|NASH|nash
5038874|NCT01469962|Liver fibrosis|liver fibrosis
5038875|NCT01469962|Fibrotest|fibrotest
5038876|NCT01469949|Improvement of the accuracy of Lumbar repositioning|improvement of the accuracy of lumbar repositioning
5038877|NCT01469936|Fibromyalgia|fibromyalgia
5038878|NCT01469936|Irritable Bowel Syndrome|irritable bowel syndrome
5038879|NCT01469923|Phase 1|phase 1
5038880|NCT01469923|obese|obese
5038881|NCT01469923|healthy male volunteers|healthy male volunteers
5038882|NCT01469923|multiple doses|multiple doses
5038883|NCT01469923|dose escalation|dose escalation
5038884|NCT01469923|pharmacokinetics|pharmacokinetics
5038885|NCT01469923|pharmakodynamics|pharmakodynamics
5038886|NCT01469897|JIA|jia
5038887|NCT01469897|Juvenile Idiopathic Arthritis|juvenile idiopathic arthritis
5038888|NCT01469897|Cost of Care|cost of care
5038889|NCT01469897|Quality of Life|quality of life
5038890|NCT01469897|QOL|qol
5038891|NCT01469884|Renal allograft recipients|renal allograft recipients
5038892|NCT01469884|Hepatitis C virus (HCV)|hepatitis c virus (hcv)
5038893|NCT01469884|Certican|certican
5038894|NCT01469884|Calcineurin inhibitor(tacrolimus or cyclosporin)|calcineurin inhibitor(tacrolimus or cyclosporin)
5038895|NCT01469871|Dressing|dressing
5038896|NCT01469871|Blisters|blisters
5038897|NCT01469871|Silicone|silicone
5038898|NCT01469845|hospital admissions|hospital admissions
5038899|NCT01469845|acute bronchiolitis|acute bronchiolitis
5038900|NCT01469845|under one year old|under one year old
5038901|NCT01469845|requiring oxygen therapy|requiring oxygen therapy
5038902|NCT01469832|fundus flavimaculatus|fundus flavimaculatus
5038903|NCT01469832|Retinal Diseases|retinal diseases
5038904|NCT01469832|Macular Degeneration|macular degeneration
5038905|NCT01469832|SMD|smd
5038906|NCT01469832|juvenile macular dystrophy|juvenile macular dystrophy
5038907|NCT01469819|chronic constipation|chronic constipation
5038908|NCT01469819|constipation|constipation
5038909|NCT01469819|idiopathic constipation|idiopathic constipation
5038910|NCT01469819|SmartPill|smartpill
5038911|NCT01469819|Wireless Motility Capsule|wireless motility capsule
5038912|NCT01469819|lubiprostone (Amitiza)|lubiprostone (amitiza)
5038913|NCT01469819|small intestinal bacterial overgrowth|small intestinal bacterial overgrowth
5038914|NCT01469780|Pain|pain
5038915|NCT01469780|Health behavior change|health behavior change
5038916|NCT01469780|Coronary angioplasty|coronary angioplasty
5038917|NCT01469780|Cardiovascular disease|cardiovascular disease
5038918|NCT01469780|Outcomes|outcomes
5038919|NCT01469780|Morbidity|morbidity
5038920|NCT01469780|Mortality|mortality
5038921|NCT01469767|eczema|eczema
5038922|NCT01469767|itch|itch
5038923|NCT01469767|scratching|scratching
5038924|NCT01469767|actigraphy|actigraphy
5038925|NCT01469767|adherence|adherence
5038926|NCT01469754|lymphoma|lymphoma
5038927|NCT01469754|survivors|survivors
5038928|NCT01469754|posttraumatic growth|posttraumatic growth
5038929|NCT01469754|posttraumatic stress|posttraumatic stress
5038930|NCT01469754|longitudinal|longitudinal
5038931|NCT01469728|VATS|vats
5038932|NCT01469728|awake thoracic surgery|awake thoracic surgery
5038933|NCT01469728|pleurodesis|pleurodesis
5038934|NCT01469728|talc|talc
5038935|NCT01469728|TEA|tea
5038936|NCT01469728|epidural anesthesia|epidural anesthesia
5038937|NCT01469728|Video-Assisted|video-assisted
5038938|NCT01469728|Anesthesia Epidural|anesthesia epidural
5038939|NCT01469715|Continuous Glucose Monitor|continuous glucose monitor
5038940|NCT01469702|cat-scratch disease|cat-scratch disease
5038941|NCT01469702|Bartonella henselae|bartonella henselae
5038942|NCT01469702|corticosteroids|corticosteroids
5038943|NCT01469702|treatment|treatment
5038944|NCT01469689|People|people
5038945|NCT01469689|living|living
5038946|NCT01469689|community|community
5038947|NCT01469676|Coronary Artery Bypass Surgery|coronary artery bypass surgery
5038948|NCT01469676|Cardiopulmonary Bypass|cardiopulmonary bypass
5038949|NCT01469676|Leukocyte Reduction Filtrations|leukocyte reduction filtrations
5038950|NCT01469676|Pulmonary Function|pulmonary function
5038951|NCT01469676|Systemic Inflammatory Response|systemic inflammatory response
5038952|NCT01469663|Borderline Personality Disorder|borderline personality disorder
5038953|NCT01469663|Major Depression|major depression
5038954|NCT01469663|Electroencephalogram|electroencephalogram
5038955|NCT01469663|N2|n2
5038956|NCT01469663|Error Related Negativity|error related negativity
5038957|NCT01469663|Emotional Processing|emotional processing
5038958|NCT01469663|Levels of Emotional Awareness|levels of emotional awareness
5038959|NCT01469650|vitamin D3|vitamin d3
5038960|NCT01469650|prematurity|prematurity
5038961|NCT01469650|parathyroid hormone|parathyroid hormone
5038962|NCT01469650|25(OH)D|25(oh)d
5038963|NCT01469650|NICU hospitalization|nicu hospitalization
5038964|NCT01469624|Contrast Induced Nephropathy|contrast induced nephropathy
5038965|NCT01469624|Pentoxifylline|pentoxifylline
5038966|NCT01469624|PCI|pci
5038967|NCT01469611|advanced/metastatic colorectal carcinoma|advanced/metastatic colorectal carcinoma
5038968|NCT01469585|continuous oral contraceptives|continuous oral contraceptives
5038969|NCT01469585|MMP expression|mmp expression
5038970|NCT01469572|Neuroendocrine hepatic tumors|neuroendocrine hepatic tumors
5038971|NCT01469572|Liver cancer|liver cancer
5038972|NCT01469572|Metastatic liver cancer|metastatic liver cancer
5038973|NCT01469559|Insulin|insulin
5038974|NCT01469559|Diabetic neuropathy|diabetic neuropathy
5038975|NCT01469559|Intranasal administration|intranasal administration
5038976|NCT01469559|Pilot project|pilot project
5038977|NCT01469546|Squamous Cell Carcinoma of the Head and Neck|squamous cell carcinoma of the head and neck
5038978|NCT01469533|Spine|spine
5038979|NCT01469533|Manipulation|manipulation
5038980|NCT01469533|Pain Threshold|pain threshold
5038981|NCT01469533|Electromyography.|electromyography.
5038982|NCT01469520|HIV|hiv
5038983|NCT01469520|AIDS|aids
5038984|NCT01469520|Treatment|treatment
5038985|NCT01469494|DIEP flap|diep flap
5038986|NCT01469494|SIEA flap|siea flap
5038987|NCT01469494|breast reconstruction|breast reconstruction
5038988|NCT01469494|objective isokinetic abdominal strength testing|objective isokinetic abdominal strength testing
5038989|NCT01469494|fat necrosis|fat necrosis
5038990|NCT01469494|flap loss|flap loss
5038991|NCT01469494|seroma rate|seroma rate
5038992|NCT01469494|abdominal wound breakdown|abdominal wound breakdown
5038993|NCT01469494|Breast-Q|breast-q
5038994|NCT01469494|abdominal wall outcome questionnaire|abdominal wall outcome questionnaire
5038995|NCT01469481|diabetes mellitus|diabetes mellitus
5038996|NCT01469481|ADME|adme
5038997|NCT01469455|Local metastatic melanoma|local metastatic melanoma
5038998|NCT01469455|relapsed cutaneous/subcutaneous tumors|relapsed cutaneous/subcutaneous tumors
5038999|NCT01469455|melanoma-in-transit|melanoma-in-transit
5039000|NCT01469442|Biliary fistula|biliary fistula
5039001|NCT01469442|prevention|prevention
5039002|NCT01469442|hepatectomy|hepatectomy
5039003|NCT01469442|external stent|external stent
5039004|NCT01469442|Hepatectomy of more 2 segments|hepatectomy of more 2 segments
5039005|NCT01469442|Not emergency or laparoscopy surgery|not emergency or laparoscopy surgery
5039006|NCT01469429|oral cancer|oral cancer
5039007|NCT01469416|rosuvastatin|rosuvastatin
5039008|NCT01469416|clopidogrel|clopidogrel
5039009|NCT01469416|pharmacokinetics|pharmacokinetics
5039010|NCT01469416|drug interaction|drug interaction
5039011|NCT01469416|healthy volunteer|healthy volunteer
5039012|NCT01469416|drug transporter|drug transporter
5039013|NCT01469403|Osteoarthritis, knee|osteoarthritis, knee
5039014|NCT01469403|Obesity|obesity
5039015|NCT01469403|Weight Loss|weight loss
5039016|NCT01469403|Arthroplasty|arthroplasty
5039017|NCT01469377|Major depressive disorder|major depressive disorder
5039018|NCT01469377|Depression|depression
5039019|NCT01469364|Lung Transplant|lung transplant
5039020|NCT01469364|Lung Transplant Recipient|lung transplant recipient
5039021|NCT01469351|Alzheimers disease|alzheimers disease
5039022|NCT01469325|Repetitive Transcranial Magnetic Stimulation|repetitive transcranial magnetic stimulation
5039023|NCT01469325|Depression|depression
5039024|NCT01469325|left prefrontal|left prefrontal
5039025|NCT01469312|Low Biologically Available Glucose Diet (LoBAG diet)|low biologically available glucose diet (lobag diet)
5039026|NCT01469312|Diabetes|diabetes
5039027|NCT01469312|Glycemic Index|glycemic index
5039028|NCT01469299|Ligament Balance, Total Knee Arthroplasty, Intra-operative Sensors|ligament balance, total knee arthroplasty, intra-operative sensors
5039029|NCT01469286|delayed gastric emptying|delayed gastric emptying
5039030|NCT01469286|nausea|nausea
5039031|NCT01469286|vomiting|vomiting
5039032|NCT01469286|abdominal discomfort|abdominal discomfort
5039033|NCT01469273|Diarrhea|diarrhea
5039034|NCT01469273|EcN|ecn
5039035|NCT01469273|E. coli strain Nissle 1917|e. coli strain nissle 1917
5039036|NCT01469273|Gastrointestinal infection|gastrointestinal infection
5039037|NCT01469273|Infant|infant
5039038|NCT01469273|Newborn|newborn
5039039|NCT01469273|Probiotic drug|probiotic drug
5039040|NCT01469273|Prevention|prevention
5039041|NCT01469273|Prophylaxis|prophylaxis
5039042|NCT01469260|Overweight|overweight
5039043|NCT01469260|Obesity|obesity
5039044|NCT01469260|Pregnancy|pregnancy
5039045|NCT01469260|Weight gain|weight gain
5039046|NCT01469260|Pedometer|pedometer
5039047|NCT01469260|Exercise|exercise
5039048|NCT01469247|Brain cancer|brain cancer
5039049|NCT01469247|Recurrent or progressive brainstem glioma|recurrent or progressive brainstem glioma
5039050|NCT01469247|Diffuse Intrinsic Pontine Glioma|diffuse intrinsic pontine glioma
5039051|NCT01469247|DIPG|dipg
5039052|NCT01469247|Reirradiation|reirradiation
5039053|NCT01469247|ReRT|rert
5039054|NCT01469247|Photon radiation therapy|photon radiation therapy
5039055|NCT01469247|XRT|xrt
5039056|NCT01469221|Bladder Cancer|bladder cancer
5039057|NCT01469221|Non-Muscle Invasive Bladder Cancer|non-muscle invasive bladder cancer
5039058|NCT01469221|NMIBC|nmibc
5039059|NCT01469221|Apaziquone|apaziquone
5039060|NCT01469221|EOquin|eoquin
5039061|NCT01469221|GU Cancer|gu cancer
5039062|NCT01469221|TURBT|turbt
5039063|NCT01469208|Gastroschisis|gastroschisis
5039064|NCT01469208|NICU inpatients|nicu inpatients
5039065|NCT01469208|Post surgical repair|post surgical repair
5039066|NCT01469208|Music Therapy|music therapy
5039067|NCT01469195|lead rectangle|lead rectangle
5039068|NCT01469195|radiation exposure|radiation exposure
5039069|NCT01469195|operators|operators
5039070|NCT01469195|radial approach|radial approach
5039071|NCT01469195|coronary procedures|coronary procedures
5039072|NCT01469195|percutaneous coronary intervention|percutaneous coronary intervention
5039073|NCT01469182|Immunology|immunology
5039074|NCT01469169|Iloprost|iloprost
5039075|NCT01469169|Inhalation|inhalation
5039076|NCT01469169|Pulmonary Hypertension|pulmonary hypertension
5039077|NCT01469169|Pulmonary Artery Hypertension|pulmonary artery hypertension
5039078|NCT01469169|Japanese Patients|japanese patients
5039079|NCT01469156|polypoidal choroidal vasculopathy|polypoidal choroidal vasculopathy
5039080|NCT01469156|choroidal neovascularization|choroidal neovascularization
5039081|NCT01469156|ranibizumab|ranibizumab
5039082|NCT01469156|Lucentis|lucentis
5039083|NCT01469130|MEK, Advanced solid tumor|mek, advanced solid tumor
5039084|NCT01469117|Developmental disabilities|developmental disabilities
5039085|NCT01469117|Enteral Nutrition|enteral nutrition
5039086|NCT01469117|Tube feeding|tube feeding
5039087|NCT01469117|Nutrition support|nutrition support
5039088|NCT01469104|Diabetes|diabetes
5039089|NCT01469091|Acute admittance|acute admittance
5039090|NCT01469091|Current smoker|current smoker
5039091|NCT01469078|Chronic Kidney Disease|chronic kidney disease
5039092|NCT01469078|CKD stage 5|ckd stage 5
5039093|NCT01469078|Iron deficiency|iron deficiency
5039094|NCT01469065|inpatient|inpatient
5039095|NCT01469065|diabetes|diabetes
5039096|NCT01469065|phase 1|phase 1
5039097|NCT01469039|Alkermes|alkermes
5039098|NCT01469039|schizophrenia|schizophrenia
5039099|NCT01469039|ALKS 9072|alks 9072
5039100|NCT01469039|ALKS 9070|alks 9070
5039101|NCT01469039|aripiprazole lauroxil|aripiprazole lauroxil
5039102|NCT01468948|Essential Tremor|essential tremor
5039103|NCT01468948|Tremor|tremor
5039104|NCT01468948|Octanol|octanol
5039105|NCT01468948|Octanoic Acid|octanoic acid
5039106|NCT01468935|Uterus|uterus
5039107|NCT01468935|Endometrium|endometrium
5039108|NCT01468935|Bone Marrow Transplant|bone marrow transplant
5039109|NCT01468935|Gynecology|gynecology
5039110|NCT01468935|Healthy Volunteer|healthy volunteer
5039111|NCT01468935|HV|hv
5039112|NCT01468935|Stem Cell Transplant|stem cell transplant
5039113|NCT01468935|Endometriosis|endometriosis
5039114|NCT01468922|Pazopanib|pazopanib
5039115|NCT01468922|Tivantinib|tivantinib
5039116|NCT01468922|MET Inhibitor|met inhibitor
5039117|NCT01468922|Advanced Cancer|advanced cancer
5039118|NCT01468922|Anti-Angiogenesis|anti-angiogenesis
5039119|NCT01468922|Cancer|cancer
5039120|NCT01468922|Solid Tumor|solid tumor
5039121|NCT01468922|Sarcoma|sarcoma
5039122|NCT01468883|Breast Cancer|breast cancer
5039123|NCT01468883|Surgery|surgery
5039124|NCT01468883|Radiation|radiation
5039125|NCT01468857|Clinical Stress Markers|clinical stress markers
5039126|NCT01468857|Chronic Stress|chronic stress
5039127|NCT01468857|Allogeneic Hematopoietic Stem Cell Transplant|allogeneic hematopoietic stem cell transplant
5039128|NCT01468857|HSCT Caregivers|hsct caregivers
5039129|NCT01468857|Cancer Caregivers|cancer caregivers
5039130|NCT01468857|Stress|stress
5039131|NCT01468857|Family Caregivers|family caregivers
5039132|NCT01468844|Central Retinal Vein Occlusion|central retinal vein occlusion
5039133|NCT01468844|Minocycline|minocycline
5039134|NCT01468844|Retinal Vein Occlusion|retinal vein occlusion
5039135|NCT01468844|CRVO|crvo
5039136|NCT01468831|Branch Retinal Vein Occlusion|branch retinal vein occlusion
5039137|NCT01468831|Minocycline|minocycline
5039138|NCT01468831|Macular Edema|macular edema
5039139|NCT01468831|Retinal Vein Occlusion|retinal vein occlusion
5039140|NCT01468831|BRVO|brvo
5039141|NCT01468818|Metastatic Melanoma|metastatic melanoma
5039142|NCT01468818|Adoptive Cell Therapy|adoptive cell therapy
5039143|NCT01468818|Skin Cancer|skin cancer
5039144|NCT01468805|Environmental Intervention|environmental intervention
5039145|NCT01468805|Indoor Allergens|indoor allergens
5039146|NCT01468805|Cockroach|cockroach
5039147|NCT01468805|Health Disparities|health disparities
5039148|NCT01468805|Multi-Center|multi-center
5039149|NCT01468805|Asthma|asthma
5039150|NCT01468805|Environment|environment
5039151|NCT01468792|systemic sclerosis|systemic sclerosis
5039152|NCT01468792|pulmonary arterial hypertension|pulmonary arterial hypertension
5039153|NCT01468779|Periampullary cancer|periampullary cancer
5039154|NCT01468779|Surgery|surgery
5039155|NCT01468779|Dietary supplementation|dietary supplementation
5039156|NCT01468779|Nutritional assessment|nutritional assessment
5039157|NCT01468753|Conception in HIV Discordant Couples|conception in hiv discordant couples
5039158|NCT01468753|Reproduction in HIV Discordant Couples|reproduction in hiv discordant couples
5039159|NCT01468753|Vaginal Insemination|vaginal insemination
5039160|NCT01468727|dental caries|dental caries
5039161|NCT01468727|mutans streptococci|mutans streptococci
5039162|NCT01468727|lactobacilli|lactobacilli
5039163|NCT01468727|bacterial transmission|bacterial transmission
5039164|NCT01468727|bacterial colonization|bacterial colonization
5039165|NCT01468714|Drug Interaction|drug interaction
5039166|NCT01468714|pharmacokinetics|pharmacokinetics
5039167|NCT01468714|ketoconazole|ketoconazole
5039168|NCT01468714|CYP3A|cyp3a
5039169|NCT01468688|Imatinib mesylate|imatinib mesylate
5039170|NCT01468688|BKM120|bkm120
5039171|NCT01468688|GIST|gist
5039172|NCT01468649|Breast Cancer|breast cancer
5039173|NCT01468649|Sentinel Lymph Node Mapping|sentinel lymph node mapping
5039174|NCT01468649|Intraoperative Imaging|intraoperative imaging
5039175|NCT01468636|Warts|warts
5039176|NCT01468636|HPV|hpv
5039177|NCT01468636|Zinc|zinc
5039178|NCT01468623|Colorectal cancer, metastatic|colorectal cancer, metastatic
5039179|NCT01468623|FOLFOX6|folfox6
5039180|NCT01468623|5-FU|5-fu
5039181|NCT01468623|First line|first line
5039182|NCT01468623|bevacizumab|bevacizumab
5039183|NCT01468610|depression|depression
5039184|NCT01468610|cognition|cognition
5039185|NCT01468610|occupational functioning|occupational functioning
5039186|NCT01468610|productivity|productivity
5039187|NCT01468610|neuropsychology|neuropsychology
5039188|NCT01468610|desvenlafaxine|desvenlafaxine
5039189|NCT01468610|antidepressants|antidepressants
5039190|NCT01468597|Emergent|emergent
5039191|NCT01468597|Cardiac surgery|cardiac surgery
5039192|NCT01468597|On-pump|on-pump
5039193|NCT01468597|Platelet function|platelet function
5039194|NCT01468584|Genotype 2|genotype 2
5039195|NCT01468571|Potassium Sparing Diuretics|potassium sparing diuretics
5039196|NCT01468571|Right-sided heart failure|right-sided heart failure
5039197|NCT01468571|Edema|edema
5039198|NCT01468558|Drug Drug Interaction Study in Normal Healthy Volunteers|drug drug interaction study in normal healthy volunteers
5039199|NCT01468545|Education|education
5039200|NCT01468545|Ventavis|ventavis
5039201|NCT01468545|Adherence|adherence
5039202|NCT01468545|PAH|pah
5039203|NCT01468545|Pulmonary artery hypertension|pulmonary artery hypertension
5039204|NCT01468519|Diabetes mellitus, type 2|diabetes mellitus, type 2
5039205|NCT01468519|Erectile dysfunction|erectile dysfunction
5039206|NCT01468519|continuous subcutaneous insulin infusion|continuous subcutaneous insulin infusion
5039207|NCT01468519|CSII|csii
5039208|NCT01468519|insulin|insulin
5039209|NCT01468506|Chronic Kidney Disease|chronic kidney disease
5039210|NCT01468506|arteriovenous fistula|arteriovenous fistula
5039211|NCT01468493|FSGS|fsgs
5039212|NCT01468493|suPAR|supar
5039213|NCT01468480|direct pulp capping|direct pulp capping
5039214|NCT01468480|MTA|mta
5039215|NCT01468480|Single visit pulp cap|single visit pulp cap
5039216|NCT01468480|Multical|multical
5039217|NCT01468467|AC220|ac220
5039218|NCT01468467|Acute Myeloid Leukemia (AML)|acute myeloid leukemia (aml)
5039219|NCT01468467|Transplantation|transplantation
5039220|NCT01468467|Stem Cell Transplantation|stem cell transplantation
5039221|NCT01468467|Allogeneic Transplantation|allogeneic transplantation
5039222|NCT01468467|FMS-like tyrosine kinase (FLT3)|fms-like tyrosine kinase (flt3)
5039223|NCT01468467|FMS-like tyrosine kinase (FLT3) Inhibitor|fms-like tyrosine kinase (flt3) inhibitor
5039224|NCT01468467|Kinase|kinase
5039225|NCT01468467|Kinase Inhibitor|kinase inhibitor
5039226|NCT01468467|Pharmacokinetics|pharmacokinetics
5039227|NCT01468467|ASP2689|asp2689
5039228|NCT01468467|quizartinib|quizartinib
5039229|NCT01468454|Congenital Hyperinsulinism (CHI)|congenital hyperinsulinism (chi)
5039230|NCT01468454|hyperinsulinism|hyperinsulinism
5039231|NCT01468454|Persistent Hyperinsulinemic Hypoglycemia of Infancy (PHHI)|persistent hyperinsulinemic hypoglycemia of infancy (phhi)
5039232|NCT01468454|CHI|chi
5039233|NCT01468454|PHHI|phhi
5039234|NCT01468454|Pancreatectomy|pancreatectomy
5039235|NCT01468454|18F-DOPA|18f-dopa
5039236|NCT01468454|PET/CT scan|pet/ct scan
5039237|NCT01468441|ovarian stimulation|ovarian stimulation
5039238|NCT01468441|GnRH agonist|gnrh agonist
5039239|NCT01468441|GnRH antagonist|gnrh antagonist
5039240|NCT01468441|hCG microdose|hcg microdose
5039241|NCT01468441|ICSI|icsi
5039242|NCT01468415|Methylprednisolone|methylprednisolone
5039243|NCT01468415|trans sacral block|trans sacral block
5039244|NCT01468415|phenol|phenol
5039245|NCT01468402|Leiomyoma|leiomyoma
5039246|NCT01468402|uterine artery embolization|uterine artery embolization
5039247|NCT01468402|magnetic resonance imaging|magnetic resonance imaging
5039248|NCT01468389|Gastric Cancer|gastric cancer
5039249|NCT01468389|capecitabine|capecitabine
5039250|NCT01468389|maintenance treatment|maintenance treatment
5039251|NCT01468376|impaired glucose tolerance|impaired glucose tolerance
5039252|NCT01468376|pre-diabetes|pre-diabetes
5039253|NCT01468363|Dry weight|dry weight
5039254|NCT01468363|Body composition monitor|body composition monitor
5039255|NCT01468363|Hemodialysis|hemodialysis
5039256|NCT01468363|Zonguldak|zonguldak
5039257|NCT01468337|Central Serous Chorioretinopathy|central serous chorioretinopathy
5039258|NCT01468337|Interferon-Gamma (IFN-Gamma)|interferon-gamma (ifn-gamma)
5039259|NCT01468337|Jakstat|jakstat
5039260|NCT01468337|Retinal Eye Disease|retinal eye disease
5039261|NCT01468337|Macular Eye Disease|macular eye disease
5039262|NCT01468337|CSC|csc
5039263|NCT01468324|Brain|brain
5039264|NCT01468324|Angiogenesis|angiogenesis
5039265|NCT01468324|Radiotherapy|radiotherapy
5039266|NCT01468324|Malignant|malignant
5039267|NCT01468324|Tumor|tumor
5039268|NCT01468324|Glioma|glioma
5039269|NCT01468324|Glioblastoma Multiforme|glioblastoma multiforme
5039270|NCT01468324|Brain Tumor|brain tumor
5039271|NCT01468311|Immunotherapy|immunotherapy
5039272|NCT01468311|Resistant Hodgkins Lymphoma|resistant hodgkins lymphoma
5039273|NCT01468311|Auto Stem Cell Transplant|auto stem cell transplant
5039274|NCT01468311|Combination Chemo and Radiolabeled Monoclonal Antibody|combination chemo and radiolabeled monoclonal antibody
5039275|NCT01468311|Hodgkin Lymphoma|hodgkin lymphoma
5039276|NCT01468298|back pain|back pain
5039277|NCT01468298|physical therapy|physical therapy
5039278|NCT01468298|spine|spine
5039279|NCT01468298|rehabilitation|rehabilitation
5039280|NCT01468298|exercise|exercise
5039281|NCT01468285|interventional,placebo controlled|interventional,placebo controlled
5039282|NCT01468272|asthma children NEXT DPI LABA ICS inhalation|asthma children next dpi laba ics inhalation
5039283|NCT01468246|Breast Cancer|breast cancer
5039284|NCT01468246|Cohort|cohort
5039285|NCT01468246|Young Women|young women
5039286|NCT01468246|Survivorship|survivorship
5039287|NCT01468246|Fertility|fertility
5039288|NCT01468233|placebo controlled|placebo controlled
5039289|NCT01468233|double blind|double blind
5039290|NCT01468233|adalimumab|adalimumab
5039291|NCT01468233|TNF|tnf
5039292|NCT01468233|psoriasis|psoriasis
5039293|NCT01468233|HS|hs
5039294|NCT01468233|PIONEER II|pioneer ii
5039295|NCT01468233|hidradenitis suppurativa|hidradenitis suppurativa
5039296|NCT01468233|acne inversa|acne inversa
5039297|NCT01468233|boil|boil
5039298|NCT01468233|acne|acne
5039299|NCT01468220|tissue metabolism|tissue metabolism
5039300|NCT01468220|skeletal muscle|skeletal muscle
5039301|NCT01468220|adipose tissue|adipose tissue
5039302|NCT01468220|HIF|hif
5039303|NCT01468207|acne|acne
5039304|NCT01468207|psoriasis|psoriasis
5039305|NCT01468207|hidradenitis suppurativa|hidradenitis suppurativa
5039306|NCT01468207|TNF|tnf
5039307|NCT01468207|HS|hs
5039308|NCT01468207|PIONEER I|pioneer i
5039309|NCT01468207|acne inversa|acne inversa
5039310|NCT01468207|boil|boil
5039311|NCT01468207|placebo controlled|placebo controlled
5039312|NCT01468207|Double blind|double blind
5039313|NCT01468207|adalimumab|adalimumab
5039314|NCT01468194|AMS|ams
5039315|NCT01468194|HAPE|hape
5039316|NCT01468194|high altitude|high altitude
5039317|NCT01468194|oxygen|oxygen
5039318|NCT01468194|saturation|saturation
5039319|NCT01468194|mountain|mountain
5039320|NCT01468194|climbing|climbing
5039321|NCT01468194|breathing|breathing
5039322|NCT01468181|Type 2 diabetes mellitus|type 2 diabetes mellitus
5039323|NCT01468181|Oral antihyperglycemic medications|oral antihyperglycemic medications
5039324|NCT01468181|Long-Term Safety|long-term safety
5039325|NCT01468181|GLP 1|glp 1
5039326|NCT01468181|Glucagon like peptide 1|glucagon like peptide 1
5039327|NCT01468155|PVA|pva
5039328|NCT01468155|peri procedural bleeding complications|peri procedural bleeding complications
5039329|NCT01468116|Type 2 diabetes|type 2 diabetes
5039330|NCT01468116|Gastric bypass surgery|gastric bypass surgery
5039331|NCT01468116|Obesity|obesity
5039332|NCT01468116|Mitochondrial function|mitochondrial function
5039333|NCT01468103|intraocular pressure|intraocular pressure
5039334|NCT01468103|Peripheral anterior synechiae|peripheral anterior synechiae
5039335|NCT01468090|Inflammatory bowel disease|inflammatory bowel disease
5039336|NCT01468090|Crohn's disease|crohn's disease
5039337|NCT01468090|Ulcerative colitis|ulcerative colitis
5039338|NCT01468090|Disease course|disease course
5039339|NCT01468090|Phenotype|phenotype
5039340|NCT01468090|Biological treatment|biological treatment
5039341|NCT01468064|Central Nervous System Diseases|central nervous system diseases
5039342|NCT01468064|Stroke|stroke
5039343|NCT01468064|Infarction, Middle Cerebral Artery|infarction, middle cerebral artery
5039344|NCT01468064|Cerebral Infarction|cerebral infarction
5039345|NCT01468064|Cerebrovascular Accident|cerebrovascular accident
5039346|NCT01468064|Stem Cell Transplantation|stem cell transplantation
5039347|NCT01468064|Mesenchymal Stem Cell Transplantation|mesenchymal stem cell transplantation
5039348|NCT01468064|Bone marrow stromal cells|bone marrow stromal cells
5039349|NCT01468064|Mesenchymal Stem Cells|mesenchymal stem cells
5039350|NCT01468064|Endothelial progenitor cells|endothelial progenitor cells
5039351|NCT01468064|Adult Stem Cells|adult stem cells
5039352|NCT01468064|Cell Therapy|cell therapy
5039353|NCT01468051|predialysed|predialysed
5039354|NCT01468051|chronic|chronic
5039355|NCT01468051|renal failure patients|renal failure patients
5039356|NCT01468025|NSAIDs|nsaids
5039357|NCT01468025|Theramine|theramine
5039358|NCT01468025|naproxen|naproxen
5039359|NCT01468025|Low back pain|low back pain
5039360|NCT01468025|amino acids|amino acids
5039361|NCT01468025|CRP|crp
5039362|NCT01468025|Medical Food|medical food
5039363|NCT01468012|cocaine dependence|cocaine dependence
5039364|NCT01468012|levodopa|levodopa
5039365|NCT01468012|carbidopa|carbidopa
5039366|NCT01468012|entacapone|entacapone
5039367|NCT01467999|cannabis dependence|cannabis dependence
5039368|NCT01467999|marijuana dependence|marijuana dependence
5039369|NCT01467999|guanfacine|guanfacine
5039370|NCT01467986|neuroblastoma|neuroblastoma
5039371|NCT01467986|molecular targeted therapy|molecular targeted therapy
5039372|NCT01467986|protein kinase inhibitor|protein kinase inhibitor
5039373|NCT01467986|mTOR Inhibitor|mtor inhibitor
5039374|NCT01467986|cytostatic topoisomerase-I-inhibitor|cytostatic topoisomerase-i-inhibitor
5039375|NCT01467986|temozolomide|temozolomide
5039376|NCT01467986|irinotecan|irinotecan
5039377|NCT01467986|dasatinib|dasatinib
5039378|NCT01467986|rapamycin|rapamycin
5039379|NCT01467973|Heart Failure|heart failure
5039380|NCT01467973|Heart Failure, Diastolic|heart failure, diastolic
5039381|NCT01467973|Heart Failure, Systolic|heart failure, systolic
5039382|NCT01467973|Middle-East|middle-east
5039383|NCT01467908|Diagnosed vegetative state after stroke or traumatic brain injury|diagnosed vegetative state after stroke or traumatic brain injury
5039384|NCT01467869|abnormal semen|abnormal semen
5039385|NCT01467869|assisted conception|assisted conception
5039386|NCT01467856|Tetraplegia|tetraplegia
5039387|NCT01467843|Cognitive Behavioral Therapy|cognitive behavioral therapy
5039388|NCT01467843|Mindfulness Based Stress Reduction|mindfulness based stress reduction
5039389|NCT01467830|absorbable sutures efficacy|absorbable sutures efficacy
5039390|NCT01467830|reducing Adverse effect to be caused from surgery|reducing adverse effect to be caused from surgery
5039391|NCT01467830|Inguinal Hernia repair with mesh|inguinal hernia repair with mesh
5039392|NCT01467817|body mass|body mass
5039393|NCT01467817|abdominal fat|abdominal fat
5039394|NCT01467817|whole body lean mass|whole body lean mass
5039395|NCT01467817|insulin resistance|insulin resistance
5039396|NCT01467817|caloric intake|caloric intake
5039397|NCT01467817|expenditure|expenditure
5039398|NCT01467817|endurance|endurance
5039399|NCT01467817|Strength|strength
5039400|NCT01467817|TC:HDL ratio|tc:hdl ratio
5039401|NCT01467817|LDL:HDL ratio|ldl:hdl ratio
5039402|NCT01467817|area under the TG response curve|area under the tg response curve
5039403|NCT01467817|feeding challenge|feeding challenge
5039404|NCT01467817|fasting and post-prandial whole body fat oxidation|fasting and post-prandial whole body fat oxidation
5039405|NCT01467817|HRQoL|hrqol
5039406|NCT01467804|efficacy,|efficacy,
5039407|NCT01467804|safety,|safety,
5039408|NCT01467804|JWXYJN|jwxyjn
5039409|NCT01467791|ambrisentan|ambrisentan
5039410|NCT01467791|Bosentan|bosentan
5039411|NCT01467791|Iloprost|iloprost
5039412|NCT01467778|skin|skin
5039413|NCT01467752|reconstruction|reconstruction
5039414|NCT01467752|metacarpophalangeal joint|metacarpophalangeal joint
5039415|NCT01467752|bone graft|bone graft
5039416|NCT01467752|MCP joint|mcp joint
5039417|NCT01467726|Alzheimer's disease|alzheimer's disease
5039418|NCT01467726|Elderly|elderly
5039419|NCT01467713|Drug Therapy|drug therapy
5039420|NCT01467700|Drug Therapy|drug therapy
5039421|NCT01467674|Diabetes mellitus|diabetes mellitus
5039422|NCT01467674|Chronic periodontitis|chronic periodontitis
5039423|NCT01467674|Malondialdehyde|malondialdehyde
5039424|NCT01467674|Glutathione peroxidase|glutathione peroxidase
5039425|NCT01467674|Paraoxonase|paraoxonase
5039426|NCT01467648|Infection|infection
5039427|NCT01467648|Doripenem|doripenem
5039428|NCT01467648|Ventilator-Associated Pneumonia|ventilator-associated pneumonia
5039429|NCT01467648|pharmacokinetic|pharmacokinetic
5039430|NCT01467648|pharmacodynamic|pharmacodynamic
5039431|NCT01467635|Endobronchial ultrasound|endobronchial ultrasound
5039432|NCT01467635|Transbronchial needle aspiration|transbronchial needle aspiration
5039433|NCT01467635|Transbronchial biopsy forceps|transbronchial biopsy forceps
5039434|NCT01467635|Mediastinal lymphadenopathy|mediastinal lymphadenopathy
5039435|NCT01467635|Hilar lymphadenopathy|hilar lymphadenopathy
5039436|NCT01467622|chest tube drainage|chest tube drainage
5039437|NCT01467622|pulmonary air leak|pulmonary air leak
5039438|NCT01467622|lung resection|lung resection
5039439|NCT01467609|Pillcam colon capsule endoscopy|pillcam colon capsule endoscopy
5039440|NCT01467609|conventional colonoscopy|conventional colonoscopy
5039441|NCT01467609|ulcerative colitis|ulcerative colitis
5039442|NCT01467609|endoscopic manifestation|endoscopic manifestation
5039443|NCT01467609|colonoscopy|colonoscopy
5039444|NCT01467596|Ultrasound|ultrasound
5039445|NCT01467596|Brachial block|brachial block
5039446|NCT01467596|Levobupivacaine|levobupivacaine
5039447|NCT01467596|Minimum|minimum
5039448|NCT01467596|Volume|volume
5039449|NCT01467596|Minimum volume of Levobupivacaine 0,5%|minimum volume of levobupivacaine 0,5%
5039450|NCT01467583|Fondaparinux|fondaparinux
5039451|NCT01467583|Renal Failure|renal failure
5039452|NCT01467583|Critically Ill|critically ill
5039453|NCT01467570|diarrhea|diarrhea
5039454|NCT01467557|adverse events|adverse events
5039455|NCT01467544|Tai Chi|tai chi
5039456|NCT01467531|HIV, GSK1265744, GSK1349572, dolutegravir, rilpivirine, drug interaction, pharmacokinetics|hiv, gsk1265744, gsk1349572, dolutegravir, rilpivirine, drug interaction, pharmacokinetics
5039457|NCT01467518|methadone|methadone
5039458|NCT01467518|Opiate-dependent|opiate-dependent
5039459|NCT01467492|VX-950, Incivek|vx-950, incivek
5039460|NCT01467466|renal|renal
5039461|NCT01467466|cardiovascular|cardiovascular
5039462|NCT01467466|kidney|kidney
5039463|NCT01467466|heart|heart
5039464|NCT01467466|clinical trial|clinical trial
5039465|NCT01467466|double-blind|double-blind
5039466|NCT01467466|multi-site trial|multi-site trial
5039467|NCT01467466|randomized|randomized
5039468|NCT01467466|drug treatment|drug treatment
5039469|NCT01467466|IV solutions|iv solutions
5039470|NCT01467466|antioxidant|antioxidant
5039471|NCT01467440|Glaucoma and Ocular Hypertension|glaucoma and ocular hypertension
5039472|NCT01467388|patients with glaucoma or ocular hypertension|patients with glaucoma or ocular hypertension
5039473|NCT01467362|xerosis|xerosis
5039474|NCT01467362|dry skin|dry skin
5039475|NCT01467362|dermatitis|dermatitis
5039476|NCT01467362|pruritus|pruritus
5039477|NCT01467362|eczema|eczema
5039478|NCT01467362|emollient|emollient
5039479|NCT01467362|corticosteroid|corticosteroid
5039480|NCT01467349|Raltegravir|raltegravir
5039481|NCT01467349|efficacy|efficacy
5039482|NCT01467349|safety|safety
5039483|NCT01467349|raltegravir-containing regimens|raltegravir-containing regimens
5039484|NCT01467349|HIV urban clinic setting|hiv urban clinic setting
5039485|NCT01467310|GSK1120212|gsk1120212
5039486|NCT01467310|TNBC|tnbc
5039487|NCT01467310|Triple Negative Breast Cancer|triple negative breast cancer
5039488|NCT01467310|Surgical Resection|surgical resection
5039489|NCT01467297|Chronic bronchitis|chronic bronchitis
5039490|NCT01467297|exacerbations|exacerbations
5039491|NCT01467297|treatment|treatment
5039492|NCT01467297|ceftidoren|ceftidoren
5039493|NCT01467297|levofloxacin|levofloxacin
5039494|NCT01467297|inflammation|inflammation
5039495|NCT01467284|Obesity|obesity
5039496|NCT01467284|Workplace|workplace
5039497|NCT01467284|Intervention|intervention
5039498|NCT01467284|Diet|diet
5039499|NCT01467284|Exercise|exercise
5039500|NCT01467245|Thoracoscopy|thoracoscopy
5039501|NCT01467245|congenital diaphragmatic hernia|congenital diaphragmatic hernia
5039502|NCT01467245|oesophageal atresia|oesophageal atresia
5039503|NCT01467245|hypercapnia|hypercapnia
5039504|NCT01467245|acidosis|acidosis
5039505|NCT01467245|cerebral oxygenation|cerebral oxygenation
5039506|NCT01467245|neonates|neonates
5039507|NCT01467219|early|early
5039508|NCT01467219|high risk|high risk
5039509|NCT01467206|Stroke|stroke
5039510|NCT01467206|Physiotherapy|physiotherapy
5039511|NCT01467206|Motor training|motor training
5039512|NCT01467206|Rehabilitation|rehabilitation
5039513|NCT01467180|septeX|septex
5039514|NCT01467180|CVVH|cvvh
5039515|NCT01467180|CVHD|cvhd
5039516|NCT01467180|myoglobin|myoglobin
5039517|NCT01467167|Anesthesia|anesthesia
5039518|NCT01467167|Smart Pilot View|smart pilot view
5039519|NCT01467167|Pain control|pain control
5039520|NCT01467167|Recovery|recovery
5039521|NCT01467128|Elderly|elderly
5039522|NCT01467128|Hospital|hospital
5039523|NCT01467128|Adverse Drug|adverse drug
5039524|NCT01467128|Pharmacist|pharmacist
5039525|NCT01467128|Prevention|prevention
5039526|NCT01467115|loco regionally advanced|loco regionally advanced
5039527|NCT01467115|head and neck cancer|head and neck cancer
5039528|NCT01467115|chemotherapy|chemotherapy
5039529|NCT01467115|radiation|radiation
5039530|NCT01467102|chronic post surgical pain|chronic post surgical pain
5039531|NCT01467102|Pain|pain
5039532|NCT01467102|Risk factors of chronic post surgical pain|risk factors of chronic post surgical pain
5039533|NCT01467102|predictive risk factors|predictive risk factors
5039534|NCT01467102|chronic post-surgical pain (CPSP)|chronic post-surgical pain (cpsp)
5039535|NCT01467102|international level|international level
5039536|NCT01467102|epidemiology of CPSP|epidemiology of cpsp
5039537|NCT01467102|Europe|europe
5039538|NCT01467102|observational|observational
5039539|NCT01467102|prospective|prospective
5039540|NCT01467089|Schizophrenia|schizophrenia
5039541|NCT01467089|Extrapyramidal symptoms|extrapyramidal symptoms
5039542|NCT01467089|Tardive dyskinesia|tardive dyskinesia
5039543|NCT01467089|Two Way Video Assessment|two way video assessment
5039544|NCT01467063|Type I Diabetes|type i diabetes
5039545|NCT01467063|Insulin Resistance|insulin resistance
5039546|NCT01467063|Glutamine|glutamine
5039547|NCT01467063|Amino Acids|amino acids
5039548|NCT01467063|Glucagon like peptide 1|glucagon like peptide 1
5039549|NCT01467063|Glutathione|glutathione
5039550|NCT01467063|Citrulline|citrulline
5039551|NCT01467063|Arginine|arginine
5039552|NCT01467063|Nitric Oxide|nitric oxide
5039553|NCT01467050|Adverse drug event|adverse drug event
5039554|NCT01467050|Adverse drug reaction|adverse drug reaction
5039555|NCT01467050|Inappropriate prescribing|inappropriate prescribing
5039556|NCT01467050|Elderly|elderly
5039557|NCT01467050|Hospital-acquired|hospital-acquired
5039558|NCT01467037|Rotavirus|rotavirus
5039559|NCT01467037|Gastroenteritis|gastroenteritis
5039560|NCT01467037|Vaccination|vaccination
5039561|NCT01467037|Pediatrics|pediatrics
5039562|NCT01467024|HTLV|htlv
5039563|NCT01467024|Confirmatory|confirmatory
5039564|NCT01467024|Supplemental|supplemental
5039565|NCT01467024|Blot|blot
5039566|NCT01467024|HTLV-I|htlv-i
5039567|NCT01467024|HTLV-II|htlv-ii
5039568|NCT01467011|Myfortic|myfortic
5039569|NCT01467011|Mycophenolic acid|mycophenolic acid
5039570|NCT01467011|Prograf|prograf
5039571|NCT01467011|Tacrolimus|tacrolimus
5039572|NCT01467011|Liver transplantation|liver transplantation
5039573|NCT01466972|Advanced|advanced
5039574|NCT01466972|Breast|breast
5039575|NCT01466972|Cancer|cancer
5039576|NCT01466972|Hormone Resistance|hormone resistance
5039577|NCT01466972|Pazopanib|pazopanib
5039578|NCT01466972|anastrozole|anastrozole
5039579|NCT01466972|arimidex|arimidex
5039580|NCT01466972|letrozole|letrozole
5039581|NCT01466972|femara|femara
5039582|NCT01466959|hemodialysis|hemodialysis
5039583|NCT01466959|dialysate|dialysate
5039584|NCT01466959|acetate based dialysate|acetate based dialysate
5039585|NCT01466959|citrasate dialysate|citrasate dialysate
5039586|NCT01466959|heparin anticoagulation|heparin anticoagulation
5039587|NCT01466959|hemodynamic stability|hemodynamic stability
5039588|NCT01466946|lung cancer|lung cancer
5039589|NCT01466946|Hispanic/Latino patients|hispanic/latino patients
5039590|NCT01466946|interviews|interviews
5039591|NCT01466946|11-109|11-109
5039592|NCT01466933|parenting intervention|parenting intervention
5039593|NCT01466933|child development|child development
5039594|NCT01466933|low and middle income countries|low and middle income countries
5039595|NCT01466920|Total knee arthroplasty|total knee arthroplasty
5039596|NCT01466907|complication|complication
5039597|NCT01466907|depression|depression
5039598|NCT01466907|follow-up|follow-up
5039599|NCT01466907|intervention|intervention
5039600|NCT01466907|nurse-led|nurse-led
5039601|NCT01466907|outcome|outcome
5039602|NCT01466907|secondary prevention|secondary prevention
5039603|NCT01466907|stroke|stroke
5039604|NCT01466894|Nonalcoholic fatty liver disease|nonalcoholic fatty liver disease
5039605|NCT01466894|NAFLD|nafld
5039606|NCT01466894|Fatty liver|fatty liver
5039607|NCT01466894|NASH|nash
5039608|NCT01466868|Diffuse Large B cell Lymphoma|diffuse large b cell lymphoma
5039609|NCT01466868|AKT|akt
5039610|NCT01466868|MK 2206|mk 2206
5039611|NCT01466868|objective response rate|objective response rate
5039612|NCT01466868|progression free survival|progression free survival
5039613|NCT01466868|overall survival|overall survival
5039614|NCT01466868|safety|safety
5039615|NCT01466855|Retinoblastoma|retinoblastoma
5039616|NCT01466829|sternotomy|sternotomy
5039617|NCT01466829|parathyroid hormone|parathyroid hormone
5039618|NCT01466829|bone healing|bone healing
5039619|NCT01466816|Lipid metabolism|lipid metabolism
5039620|NCT01466803|Buprenorphine|buprenorphine
5039621|NCT01466803|Vorikonazole|vorikonazole
5039622|NCT01466803|Interactions|interactions
5039623|NCT01466803|Pharmacokinetics|pharmacokinetics
5039624|NCT01466803|Pharmacodynamics|pharmacodynamics
5039625|NCT01466803|Voriconazole|voriconazole
5039626|NCT01466790|Hepatitis C|hepatitis c
5039627|NCT01466790|TMC435|tmc435
5039628|NCT01466790|PSI-7977|psi-7977
5039629|NCT01466790|GS7977|gs7977
5039630|NCT01466790|Ribavirin|ribavirin
5039631|NCT01466790|HCV|hcv
5039632|NCT01466790|Hep C|hep c
5039633|NCT01466790|Genotype 1|genotype 1
5039634|NCT01466777|Endometrium cancer|endometrium cancer
5039635|NCT01466777|Robotic-assisted laparoscopy|robotic-assisted laparoscopy
5039636|NCT01466777|Traditional laparoscopy|traditional laparoscopy
5039637|NCT01466777|Laparoscopic surgery|laparoscopic surgery
5039638|NCT01466777|Treatment|treatment
5039639|NCT01466777|Operation time|operation time
5039640|NCT01466777|Bleeding|bleeding
5039641|NCT01466777|Complications|complications
5039642|NCT01466777|Conversions|conversions
5039643|NCT01466777|Pelvic lymph node|pelvic lymph node
5039644|NCT01466764|biomarkers|biomarkers
5039645|NCT01466751|Computerized neurobehavioral intervention|computerized neurobehavioral intervention
5039646|NCT01466738|Healthy volunteer|healthy volunteer
5039647|NCT01466738|Rhinovirus|rhinovirus
5039648|NCT01466738|Cold virus|cold virus
5039649|NCT01466738|HRV-16|hrv-16
5039650|NCT01466725|Lupus|lupus
5039651|NCT01466725|Discoid Lupus|discoid lupus
5039652|NCT01466725|DLE|dle
5039653|NCT01466725|Cutaneous Lupus|cutaneous lupus
5039654|NCT01466686|Recurrent Glioblastoma Multiforme|recurrent glioblastoma multiforme
5039655|NCT01466686|Recurrent Anaplastic Astrocytoma|recurrent anaplastic astrocytoma
5039656|NCT01466686|Surgery|surgery
5039657|NCT01466686|Adjuvant Radiation|adjuvant radiation
5039658|NCT01466686|Adjuvant Temozolomide|adjuvant temozolomide
5039659|NCT01466673|Acne Vulgaris|acne vulgaris
5039660|NCT01466673|Ethinyl estradiol|ethinyl estradiol
5039661|NCT01466673|Norgestimate|norgestimate
5039662|NCT01466673|Desogestrel|desogestrel
5039663|NCT01466673|Tricilest|tricilest
5039664|NCT01466673|Oilezz|oilezz
5039665|NCT01466647|NSCLC|nsclc
5039666|NCT01466621|cardiac resynchronization therapy|cardiac resynchronization therapy
5039667|NCT01466621|heart failure|heart failure
5039668|NCT01466621|mortality|mortality
5039669|NCT01466608|OATP1B1|oatp1b1
5039670|NCT01466608|Rosuvastatin|rosuvastatin
5039671|NCT01466608|lipidomics|lipidomics
5039672|NCT01466608|pharmacodynamics|pharmacodynamics
5039673|NCT01466582|HIV-1-infection|hiv-1-infection
5039674|NCT01466582|comorbidity|comorbidity
5039675|NCT01466582|ageing|ageing
5039676|NCT01466569|Advanced Solid Tumor|advanced solid tumor
5039677|NCT01466569|Gastric Cancer|gastric cancer
5039678|NCT01466569|Oncology|oncology
5039679|NCT01466569|monoclonal Antibody|monoclonal antibody
5039680|NCT01466543|Vascular dementia|vascular dementia
5039681|NCT01466543|Subcortical vascular dementia|subcortical vascular dementia
5039682|NCT01466543|Phosphodiesterase 5|phosphodiesterase 5
5039683|NCT01466543|Udenafil|udenafil
5039684|NCT01466530|Full term pregnancy > 36 weeks|full term pregnancy > 36 weeks
5039685|NCT01466530|Cesarean delivery|cesarean delivery
5039686|NCT01466530|General anesthesia|general anesthesia
5039687|NCT01466517|Relative Bioavailability Study|relative bioavailability study
5039688|NCT01466517|Ibuprofen|ibuprofen
5039689|NCT01466517|Alivium|alivium
5039690|NCT01466504|P63|p63
5039691|NCT01466504|Sorafenib|sorafenib
5039692|NCT01466504|Regorafenib|regorafenib
5039693|NCT01466504|rash|rash
5039694|NCT01466504|skin toxicity|skin toxicity
5039695|NCT01466504|RCC|rcc
5039696|NCT01466504|HCC|hcc
5039697|NCT01466504|colorectal carcinoma|colorectal carcinoma
5039698|NCT01466491|Pain during first-trimester surgical abortion|pain during first-trimester surgical abortion
5039699|NCT01466465|Vitamin D|vitamin d
5039700|NCT01466465|SIT|sit
5039701|NCT01466465|Grass pollen|grass pollen
5039702|NCT01466465|allergic rhinoconjunctivitis|allergic rhinoconjunctivitis
5039703|NCT01466439|rTMS|rtms
5039704|NCT01466439|P50|p50
5039705|NCT01466439|inhibitory|inhibitory
5039706|NCT01466439|facilitatory|facilitatory
5039707|NCT01466439|physiological process|physiological process
5039708|NCT01466439|brain changes|brain changes
5039709|NCT01466426|Venous thromboembolic disease|venous thromboembolic disease
5039710|NCT01466426|Deep veinous thrombosis|deep veinous thrombosis
5039711|NCT01466426|Pulmonary embolism|pulmonary embolism
5039712|NCT01466413|Intrinsic Aging of Skin|intrinsic aging of skin
5039713|NCT01466400|health benefits of infant formula|health benefits of infant formula
5039714|NCT01466387|Adults|adults
5039715|NCT01466387|international travel vaccination|international travel vaccination
5039716|NCT01466387|Meningococcal disease|meningococcal disease
5039717|NCT01466387|meningococcal meningitis|meningococcal meningitis
5039718|NCT01466387|typhoid|typhoid
5039719|NCT01466387|yellow fever|yellow fever
5039720|NCT01466387|rabies|rabies
5039721|NCT01466387|Japanese encephalitis|japanese encephalitis
5039722|NCT01466361|Nicotine|nicotine
5039723|NCT01466361|Nicotine craving|nicotine craving
5039724|NCT01466348|Paracetomol|paracetomol
5039725|NCT01466348|Caffeine|caffeine
5039726|NCT01466348|Common cold|common cold
5039727|NCT01466322|Healthy volunteers|healthy volunteers
5039728|NCT01466322|GSK2018682|gsk2018682
5039729|NCT01466322|Pharmacokinetics|pharmacokinetics
5039730|NCT01466322|Relapsing Remitting Multiple Sclerosis|relapsing remitting multiple sclerosis
5039731|NCT01466322|Pharmacodynamics|pharmacodynamics
5039732|NCT01466309|AHI|ahi
5039733|NCT01466309|ESS|ess
5039734|NCT01466309|VAS|vas
5039735|NCT01466309|FOSQ|fosq
5039736|NCT01466309|SF-36|sf-36
5039737|NCT01466296|CERBRAL PALSY|cerbral palsy
5039738|NCT01466296|Poststroke/CVA Paresis|poststroke/cva paresis
5039739|NCT01466296|REHABILITATION|rehabilitation
5039740|NCT01466296|WALKING|walking
5039741|NCT01466296|PERUTURBATION|peruturbation
5039742|NCT01466283|childhood rhabdomyosarcoma|childhood rhabdomyosarcoma
5039743|NCT01466270|fatigue|fatigue
5039744|NCT01466270|sleep disorders|sleep disorders
5039745|NCT01466270|depression|depression
5039746|NCT01466270|anxiety disorder|anxiety disorder
5039747|NCT01466270|cognitive/functional effects|cognitive/functional effects
5039748|NCT01466270|breast cancer|breast cancer
5039749|NCT01466270|cancer survivor|cancer survivor
5039750|NCT01466257|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
5039751|NCT01466257|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
5039752|NCT01466257|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
5039753|NCT01466257|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
5039754|NCT01466257|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
5039755|NCT01466257|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
5039756|NCT01466257|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
5039757|NCT01466257|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
5039758|NCT01466257|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
5039759|NCT01466257|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
5039760|NCT01466257|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
5039761|NCT01466257|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
5039762|NCT01466257|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5039763|NCT01466257|stage IVA squamous cell carcinoma of the larynx|stage iva squamous cell carcinoma of the larynx
5039764|NCT01466257|stage IVA squamous cell carcinoma of the lip and oral cavity|stage iva squamous cell carcinoma of the lip and oral cavity
5039765|NCT01466257|stage IVA squamous cell carcinoma of the oropharynx|stage iva squamous cell carcinoma of the oropharynx
5039766|NCT01466257|stage IVA squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iva squamous cell carcinoma of the paranasal sinus and nasal cavity
5039767|NCT01466257|stage IVB squamous cell carcinoma of the larynx|stage ivb squamous cell carcinoma of the larynx
5039768|NCT01466257|stage IVB squamous cell carcinoma of the lip and oral cavity|stage ivb squamous cell carcinoma of the lip and oral cavity
5039769|NCT01466257|stage IVB squamous cell carcinoma of the oropharynx|stage ivb squamous cell carcinoma of the oropharynx
5039770|NCT01466257|stage IVB squamous cell carcinoma of the paranasal sinus and nasal cavity|stage ivb squamous cell carcinoma of the paranasal sinus and nasal cavity
5039771|NCT01466257|stage IVC squamous cell carcinoma of the larynx|stage ivc squamous cell carcinoma of the larynx
5039772|NCT01466257|stage IVC squamous cell carcinoma of the lip and oral cavity|stage ivc squamous cell carcinoma of the lip and oral cavity
5039773|NCT01466257|stage IVC squamous cell carcinoma of the oropharynx|stage ivc squamous cell carcinoma of the oropharynx
5039774|NCT01466257|stage IVC squamous cell carcinoma of the paranasal sinus and nasal cavity|stage ivc squamous cell carcinoma of the paranasal sinus and nasal cavity
5039775|NCT01466257|untreated metastatic squamous neck cancer with occult primary|untreated metastatic squamous neck cancer with occult primary
5039776|NCT01466244|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
5039848|NCT01466088|Dementia|dementia
5039777|NCT01466244|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
5039778|NCT01466244|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
5039779|NCT01466244|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
5039780|NCT01466244|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
5039781|NCT01466244|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
5039782|NCT01466244|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
5039783|NCT01466244|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
5039784|NCT01466244|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
5039785|NCT01466244|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
5039786|NCT01466244|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
5039787|NCT01466244|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
5039788|NCT01466244|stage IVA squamous cell carcinoma of the larynx|stage iva squamous cell carcinoma of the larynx
5039789|NCT01466244|stage IVA squamous cell carcinoma of the lip and oral cavity|stage iva squamous cell carcinoma of the lip and oral cavity
5039790|NCT01466244|stage IVA squamous cell carcinoma of the oropharynx|stage iva squamous cell carcinoma of the oropharynx
5039791|NCT01466244|stage IVA squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iva squamous cell carcinoma of the paranasal sinus and nasal cavity
5039792|NCT01466244|stage IVB squamous cell carcinoma of the larynx|stage ivb squamous cell carcinoma of the larynx
5039793|NCT01466244|stage IVB squamous cell carcinoma of the lip and oral cavity|stage ivb squamous cell carcinoma of the lip and oral cavity
5039794|NCT01466244|stage IVB squamous cell carcinoma of the oropharynx|stage ivb squamous cell carcinoma of the oropharynx
5039795|NCT01466244|stage IVB squamous cell carcinoma of the paranasal sinus and nasal cavity|stage ivb squamous cell carcinoma of the paranasal sinus and nasal cavity
5039796|NCT01466244|stage IVC squamous cell carcinoma of the larynx|stage ivc squamous cell carcinoma of the larynx
5039797|NCT01466244|stage IVC squamous cell carcinoma of the lip and oral cavity|stage ivc squamous cell carcinoma of the lip and oral cavity
5039798|NCT01466244|stage IVC squamous cell carcinoma of the oropharynx|stage ivc squamous cell carcinoma of the oropharynx
5039799|NCT01466244|stage IVC squamous cell carcinoma of the paranasal sinus and nasal cavity|stage ivc squamous cell carcinoma of the paranasal sinus and nasal cavity
5039800|NCT01466244|untreated metastatic squamous neck cancer with occult primary|untreated metastatic squamous neck cancer with occult primary
5039801|NCT01466231|refractory germ cell cancer|refractory germ cell cancer
5039802|NCT01466231|everolimus|everolimus
5039803|NCT01466218|pulmonary function abnormalities|pulmonary function abnormalities
5039804|NCT01466218|pulmonary disease|pulmonary disease
5039805|NCT01466218|cardiac disease|cardiac disease
5039806|NCT01466218|cardiopulmonary disease|cardiopulmonary disease
5039807|NCT01466218|obstructive sleep apnea|obstructive sleep apnea
5039808|NCT01466218|OSA|osa
5039809|NCT01466218|cardiovascular disease|cardiovascular disease
5039810|NCT01466218|CVD|cvd
5039811|NCT01466218|particulate matter|particulate matter
5039812|NCT01466205|schizotypal personality disorder|schizotypal personality disorder
5039813|NCT01466205|cognitive impairment|cognitive impairment
5039814|NCT01466205|working memory|working memory
5039815|NCT01466192|Genotype 2|genotype 2
5039816|NCT01466179|B-ALL|b-all
5039817|NCT01466179|relapsed ALL|relapsed all
5039818|NCT01466179|refractory ALL|refractory all
5039819|NCT01466179|adult ALL|adult all
5039820|NCT01466179|Leukemia|leukemia
5039821|NCT01466179|Leukemia, Lymphoid|leukemia, lymphoid
5039822|NCT01466179|precursor cell lymphoblastic leukemia-lymphoma|precursor cell lymphoblastic leukemia-lymphoma
5039823|NCT01466179|Lymphatic diseases|lymphatic diseases
5039824|NCT01466179|Lymphoproliferative disorders|lymphoproliferative disorders
5039825|NCT01466179|bispecific antibody|bispecific antibody
5039826|NCT01466179|anti-CD19|anti-cd19
5039827|NCT01466179|Immunotherapeutic treatment|immunotherapeutic treatment
5039828|NCT01466179|immunoproliferative disorders|immunoproliferative disorders
5039829|NCT01466153|Chronic lymphocytic leukemia; leukemia; B-Cell malignancy; anti-CD19; monoclonal antibody; CLL; Refractory; Relapse; Non-Hodgkin's Lymphoma|chronic lymphocytic leukemia; leukemia; b-cell malignancy; anti-cd19; monoclonal antibody; cll; refractory; relapse; non-hodgkin's lymphoma
5039830|NCT01466140|Patient Satisfaction|patient satisfaction
5039831|NCT01466140|Request for help|request for help
5039832|NCT01466140|General practice|general practice
5039833|NCT01466127|Effect of oxytocin on learning|effect of oxytocin on learning
5039834|NCT01466114|multiple sclerosis|multiple sclerosis
5039835|NCT01466114|MS|ms
5039836|NCT01466114|relapsing remitting multiple sclerosis|relapsing remitting multiple sclerosis
5039837|NCT01466114|RRMS|rrms
5039838|NCT01466114|secondary progressive multiple sclerosis|secondary progressive multiple sclerosis
5039839|NCT01466114|SPMS|spms
5039840|NCT01466114|primary progressive multiple sclerosis|primary progressive multiple sclerosis
5039841|NCT01466114|estrogen|estrogen
5039842|NCT01466114|estriol|estriol
5039843|NCT01466101|Hysterectomy|hysterectomy
5039844|NCT01466101|Pain|pain
5039845|NCT01466101|Pregabalin|pregabalin
5039846|NCT01466088|Alzheimer's Disease|alzheimer's disease
5039847|NCT01466088|AD|ad
5039849|NCT01466062|Immunocompromised medical conditions|immunocompromised medical conditions
5039850|NCT01466062|Respiratory Syncytial Virus Infection|respiratory syncytial virus infection
5039851|NCT01466062|Infant|infant
5039852|NCT01466062|Newborn|newborn
5039853|NCT01466062|Young children|young children
5039854|NCT01466049|Ovarian Cancer|ovarian cancer
5039855|NCT01466049|Adnexal Mass|adnexal mass
5039856|NCT01466049|Pelvic Mass|pelvic mass
5039857|NCT01466036|metastatic|metastatic
5039858|NCT01466023|thyroid metabolism during pregnancy|thyroid metabolism during pregnancy
5039859|NCT01466023|impact on neonate|impact on neonate
5039860|NCT01466010|osteoma, osteoid|osteoma, osteoid
5039861|NCT01466010|surgical procedures, operative|surgical procedures, operative
5039862|NCT01466010|bone neoplasms|bone neoplasms
5039863|NCT01465997|Lacosamide|lacosamide
5039864|NCT01465984|Paracetamol|paracetamol
5039865|NCT01465984|Morphine sulfates|morphine sulfates
5039866|NCT01465984|Acute pain|acute pain
5039867|NCT01465971|high|high
5039868|NCT01465971|altitude|altitude
5039869|NCT01465971|acute|acute
5039870|NCT01465971|mountain|mountain
5039871|NCT01465971|sickness|sickness
5039872|NCT01465971|sleep|sleep
5039873|NCT01465971|disorder|disorder
5039874|NCT01465971|periodic|periodic
5039875|NCT01465971|breathing|breathing
5039876|NCT01465971|hyperventilation|hyperventilation
5039877|NCT01465971|apnea|apnea
5039878|NCT01465945|TEM for rectal lesions|tem for rectal lesions
5039879|NCT01465945|Sutured defect|sutured defect
5039880|NCT01465945|Unsutured defect|unsutured defect
5039881|NCT01465932|Nursing staff|nursing staff
5039882|NCT01465932|Physical Therapy (Specialty)|physical therapy (specialty)
5039883|NCT01465919|depression|depression
5039884|NCT01465919|interferon|interferon
5039885|NCT01465919|chronic hepatitis C|chronic hepatitis c
5039886|NCT01465919|mirtazapine|mirtazapine
5039887|NCT01465906|COPD|copd
5039888|NCT01465893|vitamin d|vitamin d
5039889|NCT01465880|Smoking research study|smoking research study
5039890|NCT01465867|Selenium|selenium
5039891|NCT01465867|Pregnancy|pregnancy
5039892|NCT01465867|Auto-immune thyroiditis|auto-immune thyroiditis
5039893|NCT01465867|Post-partum thyroiditis|post-partum thyroiditis
5039894|NCT01465867|Miscarriage|miscarriage
5039895|NCT01465867|Pre-eclampsia|pre-eclampsia
5039896|NCT01465867|Implantation and Pregnancy rate|implantation and pregnancy rate
5039897|NCT01465867|Infertility|infertility
5039898|NCT01465854|lung cancer|lung cancer
5039899|NCT01465854|smoking|smoking
5039900|NCT01465854|molecular epidemiology|molecular epidemiology
5039901|NCT01465854|genetic polymorphism|genetic polymorphism
5039902|NCT01465854|risk factors|risk factors
5039903|NCT01465854|never smokers|never smokers
5039904|NCT01465854|histologically/cytologically confirmed|histologically/cytologically confirmed
5039905|NCT01465841|intracranial aneurysms|intracranial aneurysms
5039906|NCT01465841|Peripheral aneurysms|peripheral aneurysms
5039907|NCT01465841|acute treatment|acute treatment
5039908|NCT01465841|PC 400 System|pc 400 system
5039909|NCT01465841|packing density|packing density
5039910|NCT01465828|antiplatelet effect|antiplatelet effect
5039911|NCT01465828|prasugrel|prasugrel
5039912|NCT01465828|clopidogrel|clopidogrel
5039913|NCT01465828|ACS|acs
5039914|NCT01465802|non-small cell lung cancer|non-small cell lung cancer
5039915|NCT01465802|advanced|advanced
5039916|NCT01465802|previously treated|previously treated
5039917|NCT01465776|SCC of the oral cavity|scc of the oral cavity
5039918|NCT01465776|black raspberries|black raspberries
5039919|NCT01465763|tofacitinib|tofacitinib
5039920|NCT01465763|CP-690|cp-690
5039921|NCT01465763|550|550
5039922|NCT01465763|Moderate to severe ulcerative colitis|moderate to severe ulcerative colitis
5039923|NCT01465763|phase 3 clinical trial|phase 3 clinical trial
5039924|NCT01465763|Mayo score|mayo score
5039925|NCT01465737|epidemiology|epidemiology
5039926|NCT01465737|uterine cancer|uterine cancer
5039927|NCT01465737|Taiwan|taiwan
5039928|NCT01465724|Insulin resistance|insulin resistance
5039929|NCT01465724|Insulin sensitivity|insulin sensitivity
5039930|NCT01465724|HOMA-IR|homa-ir
5039931|NCT01465724|blood pressure|blood pressure
5039932|NCT01465724|Renal denervation|renal denervation
5039933|NCT01465724|renal sympathetic denervation|renal sympathetic denervation
5039934|NCT01465724|renal ablation|renal ablation
5039935|NCT01465711|Peritonitis|peritonitis
5039936|NCT01465711|Sepsis|sepsis
5039937|NCT01465711|General Surgery|general surgery
5039938|NCT01465711|Intensive Care Units|intensive care units
5039939|NCT01465711|Sensitivity and Specificity|sensitivity and specificity
5039940|NCT01465698|exercise|exercise
5039941|NCT01465698|counseling|counseling
5039942|NCT01465698|movement control|movement control
5039943|NCT01465698|fear avoidance|fear avoidance
5039944|NCT01465685|MDMA|mdma
5039945|NCT01465685|pharmacokinetics|pharmacokinetics
5039946|NCT01465685|pharmacodynamics|pharmacodynamics
5039947|NCT01465685|emotions|emotions
5039948|NCT01465685|Mechanism of action of MDMA|mechanism of action of mdma
5039949|NCT01465685|Interaction study|interaction study
5040073|NCT01465191|genetics|genetics
5039950|NCT01465685|Effect of MDMA and methylphenidate on emotions|effect of mdma and methylphenidate on emotions
5039951|NCT01465672|copeptin|copeptin
5039952|NCT01465672|SIADH|siadh
5039953|NCT01465672|Diabetes insipidus|diabetes insipidus
5039954|NCT01465672|transphenoidal pituitary adenoma resection|transphenoidal pituitary adenoma resection
5039955|NCT01465672|pituitary adenoma|pituitary adenoma
5039956|NCT01465672|tumors close to pituitary gland|tumors close to pituitary gland
5039957|NCT01465672|tumors close to hypothalamus|tumors close to hypothalamus
5039958|NCT01465646|levothyroxine|levothyroxine
5039959|NCT01465646|bioavailability|bioavailability
5039960|NCT01465633|bioavailability|bioavailability
5039961|NCT01465633|levothyroxine|levothyroxine
5039962|NCT01465620|Peripheral Nervous System Diseases|peripheral nervous system diseases
5039963|NCT01465620|Diabetic Polyneuropathy|diabetic polyneuropathy
5039964|NCT01465620|Metabolic Syndrome X|metabolic syndrome x
5039965|NCT01465607|Condom use|condom use
5039966|NCT01465594|Pain Measurement|pain measurement
5039967|NCT01465581|incontinence|incontinence
5039968|NCT01465581|dysfunctional voiding|dysfunctional voiding
5039969|NCT01465581|neurogenic bladder disturbance|neurogenic bladder disturbance
5039970|NCT01465581|filum terminale|filum terminale
5039971|NCT01465581|spinal cord tethering|spinal cord tethering
5039972|NCT01465581|conus|conus
5039973|NCT01465568|osteoporosis|osteoporosis
5039974|NCT01465568|denosumab|denosumab
5039975|NCT01465568|RANKL|rankl
5039976|NCT01465568|glucocorticoids|glucocorticoids
5039977|NCT01465555|Clinical Alert|clinical alert
5039978|NCT01465555|Cognitive Behavioral Intervention|cognitive behavioral intervention
5039979|NCT01465555|Web-based|web-based
5039980|NCT01465555|Substance Abuse Treatment|substance abuse treatment
5039981|NCT01465542|Acetaminophen Toxicity|acetaminophen toxicity
5039982|NCT01465542|Acetaminophen Overdose|acetaminophen overdose
5039983|NCT01465542|N-acetylcysteine|n-acetylcysteine
5039984|NCT01465542|Liver Toxicity|liver toxicity
5039985|NCT01465503|bleeding|bleeding
5039986|NCT01465503|percutaneous coronary intervention|percutaneous coronary intervention
5039987|NCT01465503|heparin|heparin
5039988|NCT01465503|bivalirudin|bivalirudin
5039989|NCT01465490|Monitoring|monitoring
5039990|NCT01465490|Feedback|feedback
5039991|NCT01465490|Substance Abuse Treatment|substance abuse treatment
5039992|NCT01465477|Fibromyalgia|fibromyalgia
5039993|NCT01465477|Influenza vaccination|influenza vaccination
5039994|NCT01465451|colorectal cancer|colorectal cancer
5039995|NCT01465451|curative resection|curative resection
5039996|NCT01465451|intra-operative chemotherapy|intra-operative chemotherapy
5039997|NCT01465451|5-fluorouracil|5-fluorouracil
5039998|NCT01465451|chemotherapy|chemotherapy
5039999|NCT01465425|extracolonic findings|extracolonic findings
5040000|NCT01465425|ECFs|ecfs
5040001|NCT01465425|CT colonography|ct colonography
5040002|NCT01465425|computed tomography colonography|computed tomography colonography
5040003|NCT01465425|National CT Colonography Trial|national ct colonography trial
5040004|NCT01465425|ACRIN 6664|acrin 6664
5040005|NCT01465412|Parkinson disease|parkinson disease
5040006|NCT01465373|In-Vitro Fertilization|in-vitro fertilization
5040007|NCT01465373|Donor Egg IVF|donor egg ivf
5040008|NCT01465360|Alzheimer's disease|alzheimer's disease
5040010|NCT01465360|Non AD dementia|non ad dementia
5040011|NCT01465360|Mild Cognitive Impairment|mild cognitive impairment
5040012|NCT01465360|MCI|mci
5040013|NCT01465360|Vascular dementia|vascular dementia
5040014|NCT01465360|Fronto-temporal dementia|fronto-temporal dementia
5040015|NCT01465360|Primary progressive aphasia|primary progressive aphasia
5040016|NCT01465360|Parkinson's Disease dementia|parkinson's disease dementia
5040017|NCT01465360|Mixed dementia|mixed dementia
5040018|NCT01465360|Blood signature|blood signature
5040019|NCT01465360|Diagnosis|diagnosis
5040020|NCT01465360|AclarusDx|aclarusdx
5040021|NCT01465360|Alzheimer's Disease and other non-AD dementia|alzheimer's disease and other non-ad dementia
5040022|NCT01465360|Exonhit|exonhit
5040023|NCT01465347|Primary brain tumor|primary brain tumor
5040024|NCT01465347|Glioblastoma|glioblastoma
5040025|NCT01465347|Glioma|glioma
5040026|NCT01465347|GBM|gbm
5040027|NCT01465347|Radiation therapy|radiation therapy
5040028|NCT01465334|17p Deletion CLL|17p deletion cll
5040029|NCT01465308|head and neck cancer|head and neck cancer
5040030|NCT01465308|radiotherapy induced xerostomia|radiotherapy induced xerostomia
5040031|NCT01465308|radiotherapy induced oral mucositis|radiotherapy induced oral mucositis
5040032|NCT01465308|RCT|rct
5040033|NCT01465308|symptom management|symptom management
5040034|NCT01465295|Scoliosis|scoliosis
5040035|NCT01465295|Adolescent Idiopathic Scoliosis (AIS)|adolescent idiopathic scoliosis (ais)
5040036|NCT01465295|Scoliosis treatment|scoliosis treatment
5040037|NCT01465295|Fusionless spinal surgery|fusionless spinal surgery
5040038|NCT01465295|Vertebral stapling|vertebral stapling
5040039|NCT01465295|Spinal stapling|spinal stapling
5040040|NCT01465295|Non-fusion|non-fusion
5040041|NCT01465295|Spinal curvature|spinal curvature
5040042|NCT01465295|Curvature of the spine|curvature of the spine
5040043|NCT01465295|Spinal bracing alternative|spinal bracing alternative
5040044|NCT01465295|HemiBridge|hemibridge
5040045|NCT01465295|SpineForm|spineform
5040046|NCT01465295|Dr. Eric Wall|dr. eric wall
5040047|NCT01465295|Dr. George Thompson|dr. george thompson
5040048|NCT01465295|Spinal clip|spinal clip
5040049|NCT01465295|Cincinnati Children's Hospital Medical Center|cincinnati children's hospital medical center
5040050|NCT01465295|University Hospitals Case Medical Center, Rainbow Babies|university hospitals case medical center, rainbow babies
5040051|NCT01465282|psoriasis vulgaris|psoriasis vulgaris
5040052|NCT01465282|topical ointment|topical ointment
5040053|NCT01465269|TBI|tbi
5040054|NCT01465269|Social Competence|social competence
5040055|NCT01465256|Aspirin|aspirin
5040056|NCT01465256|Colon polypectomy|colon polypectomy
5040057|NCT01465256|Bleeding|bleeding
5040058|NCT01465243|Efficacy|efficacy
5040059|NCT01465243|Safety|safety
5040060|NCT01465243|EGFR-TKI|egfr-tki
5040061|NCT01465243|phase IV|phase iv
5040062|NCT01465243|NSCLC|nsclc
5040063|NCT01465243|Dose escalation|dose escalation
5040064|NCT01465230|chronic lymphocytic leukemia|chronic lymphocytic leukemia
5040065|NCT01465230|maintenance therapy|maintenance therapy
5040066|NCT01465217|medication adherence|medication adherence
5040067|NCT01465217|African Americans|african americans
5040068|NCT01465204|Behavior Change|behavior change
5040069|NCT01465204|Hygiene & Sanitation Marketing|hygiene & sanitation marketing
5040070|NCT01465191|cesarean|cesarean
5040071|NCT01465191|postoperative|postoperative
5040072|NCT01465191|morphine|morphine
5040074|NCT01465191|opioid|opioid
5040075|NCT01465178|hypovitaminosis D|hypovitaminosis d
5040076|NCT01465178|vitamin D insufficiency|vitamin d insufficiency
5040077|NCT01465178|low vitamin D|low vitamin d
5040078|NCT01465165|Depression|depression
5040079|NCT01465165|Positron emission tomography|positron emission tomography
5040080|NCT01465165|Magnetic resonance spectroscopy|magnetic resonance spectroscopy
5040081|NCT01465165|glucose metabolism|glucose metabolism
5040082|NCT01465165|ATP|atp
5040083|NCT01465165|phosphocreatine|phosphocreatine
5040084|NCT01465113|Barrett's Esophagus|barrett's esophagus
5040085|NCT01465113|Vitamin D3|vitamin d3
5040086|NCT01465113|cholecalciferol|cholecalciferol
5040087|NCT01465113|15-Prostaglandin Dehydrogenase Expression|15-prostaglandin dehydrogenase expression
5040088|NCT01465113|metformin|metformin
5040089|NCT01465100|phenylketonuria|phenylketonuria
5040090|NCT01465100|hepatocyte|hepatocyte
5040091|NCT01465087|Multiple Sclerosis|multiple sclerosis
5040092|NCT01465087|Breath|breath
5040093|NCT01465087|Diagnosis|diagnosis
5040094|NCT01465087|Discrimination MS/healthy subj. via exhaled breath samples|discrimination ms/healthy subj. via exhaled breath samples
5040095|NCT01465087|Discrimination MS/other neurological and autoimmune diseases|discrimination ms/other neurological and autoimmune diseases
5040096|NCT01465074|nicotine|nicotine
5040097|NCT01465074|memory|memory
5040098|NCT01465074|plasticity|plasticity
5040099|NCT01465074|TMS|tms
5040100|NCT01465074|Paired Associative Stimulation|paired associative stimulation
5040101|NCT01465061|Online social network|online social network
5040102|NCT01465061|Psoriasis|psoriasis
5040103|NCT01465061|Filipino|filipino
5040104|NCT01465048|Malaria|malaria
5040105|NCT01465048|Protozoan Infections|protozoan infections
5040106|NCT01465048|Parasitic Diseases|parasitic diseases
5040107|NCT01465048|Malaria Challenge|malaria challenge
5040108|NCT01465022|Breastfeeding rates|breastfeeding rates
5040109|NCT01465022|Contraceptive continuation|contraceptive continuation
5040110|NCT01465022|Birth control pills|birth control pills
5040111|NCT01465022|Lactation|lactation
5040112|NCT01465009|Sore Throat|sore throat
5040113|NCT01464996|non-carious cervical lesions|non-carious cervical lesions
5040114|NCT01464996|bonded restorations|bonded restorations
5040115|NCT01464996|composites|composites
5040116|NCT01464996|adhesives|adhesives
5040117|NCT01464970|DIEP perfusion|diep perfusion
5040118|NCT01464970|Zone IV|zone iv
5040119|NCT01464970|Free Flap|free flap
5040120|NCT01464970|Breast Cancer Reconstruction|breast cancer reconstruction
5040121|NCT01464970|Perfusion of Zone IV of DIEP flaps|perfusion of zone iv of diep flaps
5040122|NCT01464957|skin cancer prevention|skin cancer prevention
5040123|NCT01464957|precaution adoption process model|precaution adoption process model
5040124|NCT01464957|semi-tailored newsletter|semi-tailored newsletter
5040125|NCT01464957|pediatric|pediatric
5040126|NCT01464957|behavioral intervention|behavioral intervention
5040127|NCT01464944|Upper Respiratory Tract Infections|upper respiratory tract infections
5040128|NCT01464918|gastric cancer|gastric cancer
5040129|NCT01464918|colon cancer|colon cancer
5040130|NCT01464918|endoscopic submucosal dissection|endoscopic submucosal dissection
5040131|NCT01464905|RRMS|rrms
5040132|NCT01464892|Imagery rescripting|imagery rescripting
5040133|NCT01464892|Imagery rescripting and reprocessing therapy|imagery rescripting and reprocessing therapy
5040134|NCT01464892|Skills Training in affective and interpersonal regulation|skills training in affective and interpersonal regulation
5040135|NCT01464892|Post-traumatic Stress Disorder|post-traumatic stress disorder
5040136|NCT01464892|Childhood abuse|childhood abuse
5040137|NCT01464892|Childhood sexual abuse|childhood sexual abuse
5040138|NCT01464840|Pregnancy|pregnancy
5040139|NCT01464840|Cesarean section|cesarean section
5040140|NCT01464840|Antibiotic|antibiotic
5040141|NCT01464827|Hepatitis C Genotype 1|hepatitis c genotype 1
5040142|NCT01464827|Hepatitis C|hepatitis c
5040143|NCT01464827|Interferon-Free|interferon-free
5040144|NCT01464827|HCV|hcv
5040145|NCT01464827|Chronic Hepatitis C|chronic hepatitis c
5040146|NCT01464814|probiotic|probiotic
5040147|NCT01464814|fish oil|fish oil
5040148|NCT01464814|digestion|digestion
5040149|NCT01464814|viability|viability
5040150|NCT01464801|Non-alcoholic Fatty Liver Disease|non-alcoholic fatty liver disease
5040151|NCT01464801|Non-alcoholic Steatohepatitis|non-alcoholic steatohepatitis
5040152|NCT01464801|Resveratrol|resveratrol
5040153|NCT01464801|Human study|human study
5040154|NCT01464788|stroke|stroke
5040155|NCT01464788|Argatroban|argatroban
5040156|NCT01464788|thrombin-inhibition|thrombin-inhibition
5040157|NCT01464788|thrombolysis|thrombolysis
5040158|NCT01464788|anticoagulation|anticoagulation
5040159|NCT01464775|Endometriosis|endometriosis
5040160|NCT01464775|Laparoscopy|laparoscopy
5040161|NCT01464775|Narrow Band Imaging|narrow band imaging
5040162|NCT01464762|Tuberculosis|tuberculosis
5040163|NCT01464762|TMC207TBC3001|tmc207tbc3001
5040164|NCT01464762|TMC207|tmc207
5040165|NCT01464762|Early access|early access
5040166|NCT01464762|TB|tb
5040167|NCT01464762|Drug resistant|drug resistant
5040168|NCT01464762|Multi drug-resistant|multi drug-resistant
5040169|NCT01464762|Extensively drug-resistant|extensively drug-resistant
5040170|NCT01464749|multiple sclerosis|multiple sclerosis
5040171|NCT01464749|gait rehabilitation|gait rehabilitation
5040172|NCT01464736|aerobic exercise|aerobic exercise
5040173|NCT01464736|noninvasive ventilation|noninvasive ventilation
5040174|NCT01464736|functionality|functionality
5040175|NCT01464697|hot flushes/hot flashes|hot flushes/hot flashes
5040176|NCT01464697|night sweats|night sweats
5040177|NCT01464697|sleep problems|sleep problems
5040178|NCT01464697|negative mood|negative mood
5040179|NCT01464697|anxiety|anxiety
5040180|NCT01464697|perimenopause|perimenopause
5040181|NCT01464697|progesterone|progesterone
5040182|NCT01464697|vasomotor symptoms|vasomotor symptoms
5040183|NCT01464697|premenopause|premenopause
5040184|NCT01464671|Coronary Artery Disease|coronary artery disease
5040185|NCT01464671|Stable Angina|stable angina
5040186|NCT01464671|Percutaneous Coronary Intervention|percutaneous coronary intervention
5040187|NCT01464658|panniculitis|panniculitis
5040188|NCT01464658|panniculectomy|panniculectomy
5040189|NCT01464632|medial knee replacement|medial knee replacement
5040190|NCT01464619|Parenting|parenting
5040191|NCT01464619|Early Child Development|early child development
5040192|NCT01464606|pleuropulmonary blastoma|pleuropulmonary blastoma
5040193|NCT01464606|pediatric|pediatric
5040194|NCT01464606|lung cysts|lung cysts
5040195|NCT01464593|Colorectal Liver Metastasis|colorectal liver metastasis
5040196|NCT01464593|Colon Cancer|colon cancer
5040197|NCT01464593|Liver Cancer|liver cancer
5040198|NCT01464593|Liver Metastasis|liver metastasis
5040199|NCT01464593|Liver metastases|liver metastases
5040200|NCT01464567|Weaning|weaning
5040201|NCT01464567|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5040202|NCT01464567|Spontaneous Breathing Trial|spontaneous breathing trial
5040203|NCT01464554|adolescents|adolescents
5040204|NCT01464554|alcohol|alcohol
5040205|NCT01464554|drugs|drugs
5040206|NCT01464554|delinquency|delinquency
5040207|NCT01464554|intervention|intervention
5040208|NCT01464541|Orbit|orbit
5040209|NCT01464541|Fracture|fracture
5040210|NCT01464541|measurement|measurement
5040211|NCT01464541|CT|ct
5040212|NCT01464541|intraoperative|intraoperative
5040213|NCT01464528|hysteroscopy|hysteroscopy
5040214|NCT01464528|postoperative complications|postoperative complications
5040215|NCT01464528|adhesions|adhesions
5040216|NCT01464528|hyaluronic gel|hyaluronic gel
5040217|NCT01464528|prevention|prevention
5040218|NCT01464515|Mild Cognitive Impairment, So Stated|mild cognitive impairment, so stated
5040219|NCT01464515|Deep Transcranial Magnetic Stimulation|deep transcranial magnetic stimulation
5040220|NCT01464502|Heart failure|heart failure
5040221|NCT01464502|Cardiac resynchronisation therapy|cardiac resynchronisation therapy
5040222|NCT01464502|Acute haemodynamic response|acute haemodynamic response
5040223|NCT01464502|Responder|responder
5040224|NCT01464489|Intubation time|intubation time
5040225|NCT01464489|Atropine|atropine
5040226|NCT01464489|Propofol anesthesia|propofol anesthesia
5040227|NCT01464463|Depression|depression
5040228|NCT01464463|Exercise|exercise
5040229|NCT01464463|Psychoneuroimmunology|psychoneuroimmunology
5040230|NCT01464463|Cognitive Behavioral Therapy|cognitive behavioral therapy
5040231|NCT01464463|CBASP|cbasp
5040232|NCT01464450|Pharmacokinetics|pharmacokinetics
5040233|NCT01464450|Bioavailability|bioavailability
5040234|NCT01464450|Healthy Participants|healthy participants
5040235|NCT01464437|diabetes|diabetes
5040236|NCT01464437|mellitus|mellitus
5040237|NCT01464437|metformin|metformin
5040238|NCT01464424|Glaucoma|glaucoma
5040239|NCT01464424|Ocular Hypertension|ocular hypertension
5040240|NCT01464424|Open-Angle Glaucoma|open-angle glaucoma
5040241|NCT01464424|Intraocular Pressure|intraocular pressure
5040242|NCT01464411|chronic myelogenous leukemia|chronic myelogenous leukemia
5040243|NCT01464411|chronic phase|chronic phase
5040244|NCT01464411|Phase II|phase ii
5040245|NCT01464411|dasatinib|dasatinib
5040246|NCT01464398|Polycystic Ovary Syndrome|polycystic ovary syndrome
5040247|NCT01464398|stress|stress
5040248|NCT01464398|mindfulness|mindfulness
5040249|NCT01464398|meditation|meditation
5040250|NCT01464398|health education|health education
5040251|NCT01464398|women|women
5040252|NCT01464398|overweight|overweight
5040253|NCT01464398|obesity|obesity
5040254|NCT01464372|Urinary Incontinence, Urge|urinary incontinence, urge
5040255|NCT01464372|Peripheral Nerve Stimulation|peripheral nerve stimulation
5040256|NCT01464359|umbilical cord blood transplant|umbilical cord blood transplant
5040257|NCT01464346|diabetes|diabetes
5040258|NCT01464346|glucose sensor|glucose sensor
5040259|NCT01464346|CGM|cgm
5040260|NCT01464333|Crohn's Disease|crohn's disease
5040261|NCT01464320|Safety|safety
5040262|NCT01464320|Type 2 diabetes|type 2 diabetes
5040263|NCT01464320|Kidney disease|kidney disease
5040264|NCT01464294|CAD/CAM|cad/cam
5040265|NCT01464294|crowns|crowns
5040266|NCT01464294|onlays|onlays
5040267|NCT01464294|composite block|composite block
5040268|NCT01464294|milled restorations|milled restorations
5040269|NCT01464281|nucleoside|nucleoside
5040270|NCT01464281|peginterferon alfa-2a|peginterferon alfa-2a
5040271|NCT01464268|Keratoconus|keratoconus
5040272|NCT01464268|Corneal Ectasia|corneal ectasia
5040273|NCT01464268|Collagen Crosslinking|collagen crosslinking
5040274|NCT01464268|Riboflavin|riboflavin
5040275|NCT01464255|contact lenses|contact lenses
5040276|NCT01464242|Cutaneous Leishmaniasis|cutaneous leishmaniasis
5040277|NCT01464242|pentoxifylline|pentoxifylline
5040278|NCT01464242|immunomodulation|immunomodulation
5040279|NCT01464216|Functional Magnetic Resonance Imaging|functional magnetic resonance imaging
5040280|NCT01464216|Prostate cancer|prostate cancer
5040281|NCT01464216|FACBC PET|facbc pet
5040282|NCT01464216|Hypoxia imaging|hypoxia imaging
5040283|NCT01464203|Computed tomographic coronary angiography|computed tomographic coronary angiography
5040284|NCT01464203|multi-slice CT|multi-slice ct
5040285|NCT01464203|angina|angina
5040286|NCT01464203|cost-effectiveness|cost-effectiveness
5040287|NCT01464190|PA21|pa21
5040288|NCT01464190|Phosphate Binder|phosphate binder
5040289|NCT01464177|malignant glioma|malignant glioma
5040290|NCT01464177|glioblastoma|glioblastoma
5040291|NCT01464177|radiotherapy|radiotherapy
5040292|NCT01464177|randomized|randomized
5040293|NCT01464164|Diamond Blackfan anemia|diamond blackfan anemia
5040294|NCT01464164|DBA|dba
5040295|NCT01464164|Blackfan Diamond anemia|blackfan diamond anemia
5040296|NCT01464164|Congenital pure red cell aplasia|congenital pure red cell aplasia
5040297|NCT01464164|Aase-Smith II Syndrome|aase-smith ii syndrome
5040298|NCT01464164|Aase Syndrome|aase syndrome
5040299|NCT01464164|Anemia, Congenital Pure Red Cell|anemia, congenital pure red cell
5040300|NCT01464164|Aplasia, Congenital Pure Red Cell|aplasia, congenital pure red cell
5040301|NCT01464164|BDA|bda
5040302|NCT01464164|Congenital Hypoplastic Anemia|congenital hypoplastic anemia
5040303|NCT01464164|Erythrogenesis Imperfecta|erythrogenesis imperfecta
5040304|NCT01464164|Hypoplastic Congenital Anemia|hypoplastic congenital anemia
5040305|NCT01464164|Inherited Erythroblastopenia|inherited erythroblastopenia
5040306|NCT01464164|pure red cell aplasia|pure red cell aplasia
5040307|NCT01464164|bone marrow failure syndrome|bone marrow failure syndrome
5040308|NCT01464151|IBD|ibd
5040309|NCT01464151|colitis|colitis
5040310|NCT01464151|dysplasia|dysplasia
5040311|NCT01464151|colorectal cancer|colorectal cancer
5040312|NCT01464138|Malaria|malaria
5040313|NCT01464125|Malaria|malaria
5040314|NCT01464125|Plasmodium falciparum|plasmodium falciparum
5040315|NCT01464125|acute uncomplicated|acute uncomplicated
5040316|NCT01464112|Multiple myeloma that has relapsed or is progressive following prior therapy|multiple myeloma that has relapsed or is progressive following prior therapy
5040317|NCT01464112|Relapsed Multiple Myeloma|relapsed multiple myeloma
5040318|NCT01464112|JNJ 26481585|jnj 26481585
5040319|NCT01464112|VELCADE|velcade
5040320|NCT01464112|Bortezomib|bortezomib
5040321|NCT01464112|Dexamethasone|dexamethasone
5040322|NCT01464086|patients with Li Fraumeni syndrome|patients with li fraumeni syndrome
5040323|NCT01464073|NIDDM|niddm
5040324|NCT01464073|obesity|obesity
5040325|NCT01464073|lifestyle intervention|lifestyle intervention
5040326|NCT01464073|physical exercise|physical exercise
5040327|NCT01464073|diet|diet
5040328|NCT01464073|LIPOXmax|lipoxmax
5040329|NCT01464073|FATmax|fatmax
5040330|NCT01464073|fat oxydation rate|fat oxydation rate
5040331|NCT01464060|Helicobacter pylori|helicobacter pylori
5040332|NCT01464060|Quadruple therapy|quadruple therapy
5040333|NCT01464060|Clarithromycin resistance|clarithromycin resistance
5040334|NCT01464021|Study|study
5040335|NCT01464021|prospective|prospective
5040336|NCT01464021|Rheumatoid|rheumatoid
5040337|NCT01464021|Observational study|observational study
5040338|NCT01464021|Arthritis|arthritis
5040339|NCT01464021|Adalimumab|adalimumab
5040340|NCT01463995|severe neurological diseases|severe neurological diseases
5040341|NCT01463995|neurological intensive care unit|neurological intensive care unit
5040342|NCT01463995|prediction|prediction
5040343|NCT01463995|long-term outcome|long-term outcome
5040344|NCT01463995|biomarkers|biomarkers
5040345|NCT01463995|prediction of long-term outcome|prediction of long-term outcome
5040346|NCT01463982|Advanced solid cancer|advanced solid cancer
5040347|NCT01463969|PCOS and PTX3 levels|pcos and ptx3 levels
5040348|NCT01463956|Boceprevir|boceprevir
5040349|NCT01463956|HCV infection|hcv infection
5040350|NCT01463956|Antiviral therapy|antiviral therapy
5040351|NCT01463956|Liver transplantation|liver transplantation
5040352|NCT01463930|Total Knee Replacement|total knee replacement
5040353|NCT01463930|Expectations|expectations
5040354|NCT01463930|Audiovisual videodisc|audiovisual videodisc
5040355|NCT01463917|Coronary Artery Bypass|coronary artery bypass
5040356|NCT01463917|Off-Pump|off-pump
5040357|NCT01463917|Saline Solution|saline solution
5040358|NCT01463917|Hypertonic|hypertonic
5040359|NCT01463904|Morbid obesity|morbid obesity
5040360|NCT01463904|duodenal switch|duodenal switch
5040361|NCT01463904|diabetes|diabetes
5040362|NCT01463904|decrease in cardiac risk|decrease in cardiac risk
5040363|NCT01463904|remission of T2DM|remission of t2dm
5040364|NCT01463891|Eribulin Mesylate|eribulin mesylate
5040365|NCT01463891|inoperable or recurrent breast cancer|inoperable or recurrent breast cancer
5040366|NCT01463878|glycemic control|glycemic control
5040367|NCT01463878|glycemic variability|glycemic variability
5040368|NCT01463878|mean blood glucose level|mean blood glucose level
5040369|NCT01463852|vincristine|vincristine
5040370|NCT01463852|JNK|jnk
5040371|NCT01463852|phosphorylation|phosphorylation
5040372|NCT01463852|cll|cll
5040373|NCT01463852|vinca alkaloid|vinca alkaloid
5040374|NCT01463852|apoptosis|apoptosis
5040375|NCT01463839|sleep disorder|sleep disorder
5040376|NCT01463839|malocclusion|malocclusion
5040377|NCT01463839|children|children
5040378|NCT01463826|bruxism|bruxism
5040379|NCT01463826|children|children
5040380|NCT01463826|oral breathing|oral breathing
5040381|NCT01463826|dental caries|dental caries
5040382|NCT01463813|bone density conservation agents|bone density conservation agents
5040383|NCT01463813|cancer|cancer
5040384|NCT01463813|cardiovascular disease|cardiovascular disease
5040385|NCT01463813|cholecalciferol|cholecalciferol
5040386|NCT01463813|diabetes mellitus, type 2|diabetes mellitus, type 2
5040387|NCT01463813|dietary supplements|dietary supplements
5040388|NCT01463813|primary prevention|primary prevention
5040389|NCT01463813|vitamin D|vitamin d
5040390|NCT01463800|Heart Defects, congenital|heart defects, congenital
5040391|NCT01463787|Infertility|infertility
5040392|NCT01463787|varicocelectomy|varicocelectomy
5040393|NCT01463787|microsurgery|microsurgery
5040394|NCT01463787|Chinese men|chinese men
5040395|NCT01463787|pregnancy rate|pregnancy rate
5040396|NCT01463774|Healthy Volunteers|healthy volunteers
5040397|NCT01463774|Bioequivalence|bioequivalence
5040398|NCT01463774|Canagliflozin (JNJ-28431754)|canagliflozin (jnj-28431754)
5040399|NCT01463774|Metformin|metformin
5040400|NCT01463761|High-level athlete|high-level athlete
5040401|NCT01463761|ANS activity|ans activity
5040402|NCT01463761|Overtraining|overtraining
5040403|NCT01463735|Cirrhotic patients|cirrhotic patients
5040404|NCT01463722|Respiratory distress syndrome|respiratory distress syndrome
5040405|NCT01463722|Lung maturity|lung maturity
5040406|NCT01463722|lamellar body|lamellar body
5040407|NCT01463709|basal cell carcinoma|basal cell carcinoma
5040408|NCT01463709|Basal Cell Nevus Syndrome|basal cell nevus syndrome
5040409|NCT01463709|Electric Field|electric field
5040410|NCT01463709|Nanosecond pulse|nanosecond pulse
5040411|NCT01463670|LENALIDOMIDE (CC-5013)|lenalidomide (cc-5013)
5040412|NCT01463670|BONE MARROW|bone marrow
5040413|NCT01463670|11-107|11-107
5040414|NCT01463657|Aging|aging
5040415|NCT01463644|Mepolizumab|mepolizumab
5040416|NCT01463644|COPD|copd
5040417|NCT01463644|eosinophilic bronchitis|eosinophilic bronchitis
5040418|NCT01463644|exacerbation|exacerbation
5040419|NCT01463644|anti-interleukin 5 (IL5)|anti-interleukin 5 (il5)
5040420|NCT01463605|radiotherapy|radiotherapy
5040421|NCT01463605|targeted therapy|targeted therapy
5040422|NCT01463605|esophageal cancer|esophageal cancer
5040423|NCT01463605|older|older
5040424|NCT01463592|Renessans|renessans
5040425|NCT01463592|HCV|hcv
5040426|NCT01463579|Intensive Care Unit|intensive care unit
5040427|NCT01463579|Critical Illness|critical illness
5040428|NCT01463579|Rehabilitation|rehabilitation
5040429|NCT01463579|Exercise Programme|exercise programme
5040430|NCT01463566|arthritis|arthritis
5040431|NCT01463553|primary spontaneous pneumothorax|primary spontaneous pneumothorax
5040432|NCT01463553|VATS|vats
5040433|NCT01463553|pleurodesis|pleurodesis
5040434|NCT01463553|recurrence rate|recurrence rate
5040435|NCT01463540|Enteral nutrition|enteral nutrition
5040436|NCT01463540|Gastrostomy, adverse effects|gastrostomy, adverse effects
5040437|NCT01463540|Gastrostomy, nursing|gastrostomy, nursing
5040438|NCT01463540|Endoscopy,gastrointestinal|endoscopy,gastrointestinal
5040439|NCT01463540|Surgical wound infection|surgical wound infection
5040440|NCT01463527|Hypoventilation during sedation|hypoventilation during sedation
5040441|NCT01463527|Hypoxia associated with hypoventilation|hypoxia associated with hypoventilation
5040442|NCT01463514|Pulmonary Hypertension,|pulmonary hypertension,
5040443|NCT01463514|NIRS,|nirs,
5040444|NCT01463514|Near-infrared spectroscopy,|near-infrared spectroscopy,
5040445|NCT01463514|cerebral tissue oxygenation,|cerebral tissue oxygenation,
5040446|NCT01463514|cerebral blood flow|cerebral blood flow
5040447|NCT01463501|Esophageal cancer|esophageal cancer
5040448|NCT01463501|Resectable|resectable
5040449|NCT01463501|Neoadjuvant chemoradiotherapy|neoadjuvant chemoradiotherapy
5040450|NCT01463501|Adjuvant chemoradiotherapy|adjuvant chemoradiotherapy
5040451|NCT01463475|MSC|msc
5040452|NCT01463475|Allogeneic|allogeneic
5040453|NCT01463475|Bone marrow cells|bone marrow cells
5040454|NCT01463475|Healthy subject donors|healthy subject donors
5040455|NCT01463475|Collection of MSC from bone marrow aspirate|collection of msc from bone marrow aspirate
5040456|NCT01463475|Bronchiolitis obliterans syndrome (BOS)|bronchiolitis obliterans syndrome (bos)
5040457|NCT01463449|Obesity|obesity
5040458|NCT01463449|Soluble-CD163|soluble-cd163
5040459|NCT01463449|Macrophage|macrophage
5040460|NCT01463449|Inflammation|inflammation
5040461|NCT01463436|endothelial function|endothelial function
5040462|NCT01463436|postmenopausal|postmenopausal
5040463|NCT01463436|soy isoflavone supplementation|soy isoflavone supplementation
5040464|NCT01463436|osteoporosis|osteoporosis
5040465|NCT01463384|Magnetic Resonance Imaging|magnetic resonance imaging
5040466|NCT01463384|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
5040467|NCT01463384|Neuroinflammation|neuroinflammation
5040468|NCT01463384|Mild Cognitive Impairment|mild cognitive impairment
5040469|NCT01463384|Alzheimer's Disease|alzheimer's disease
5040470|NCT01463384|Minocycline|minocycline
5040471|NCT01463371|Bronchiectasis|bronchiectasis
5040472|NCT01463371|Oxidative stress markers|oxidative stress markers
5040473|NCT01463371|Airway inflammation|airway inflammation
5040474|NCT01463358|Syncope|syncope
5040475|NCT01463358|Bifascicular block|bifascicular block
5040476|NCT01463358|Bradycardia pacing|bradycardia pacing
5040477|NCT01463345|Blood conservation|blood conservation
5040478|NCT01463345|Transfusion|transfusion
5040479|NCT01463345|Hemoglobin trigger|hemoglobin trigger
5040480|NCT01463345|Transfusion trigger|transfusion trigger
5040481|NCT01463345|Cardiac surgery|cardiac surgery
5040482|NCT01463345|Transfusion triggers post cardiac surgery|transfusion triggers post cardiac surgery
5040483|NCT01463332|Propofol|propofol
5040484|NCT01463332|Pain|pain
5040485|NCT01463332|Dexmedetomidine|dexmedetomidine
5040486|NCT01463319|colonoscopy|colonoscopy
5040487|NCT01463319|warm water method|warm water method
5040488|NCT01463319|hydrocolonoscopy|hydrocolonoscopy
5040489|NCT01463319|unsedated colonoscopy|unsedated colonoscopy
5040490|NCT01463306|safety|safety
5040491|NCT01463306|partial onset seizures|partial onset seizures
5040492|NCT01463306|primary generalized tonic-clonic seizures|primary generalized tonic-clonic seizures
5040493|NCT01463306|pregabalin|pregabalin
5040494|NCT01463306|pediatric|pediatric
5040495|NCT01463306|adult|adult
5040496|NCT01463306|open-label|open-label
5040497|NCT01463306|long term|long term
5040498|NCT01463293|constipation|constipation
5040499|NCT01463293|probiotic|probiotic
5040500|NCT01463293|functional constipation|functional constipation
5040501|NCT01463293|IBS-C|ibs-c
5040502|NCT01463280|Platelets|platelets
5040503|NCT01463280|Inhibition|inhibition
5040504|NCT01463280|Lidocaine|lidocaine
5040505|NCT01463280|Thromboembolism|thromboembolism
5040506|NCT01463280|Prevention|prevention
5040507|NCT01463280|Lidocaine effects on platelets|lidocaine effects on platelets
5040508|NCT01463267|Heart Failure|heart failure
5040509|NCT01463254|Femplant|femplant
5040510|NCT01463254|AE adverse event|ae adverse event
5040511|NCT01463254|AIDS acquired immunodeficiency syndrome|aids acquired immunodeficiency syndrome
5040512|NCT01463254|ALT (SGPT) alanine aminotransferase|alt (sgpt) alanine aminotransferase
5040513|NCT01463254|ART antiretroviral therapy|art antiretroviral therapy
5040514|NCT01463254|AST (SGOT) aspartate aminotransferase|ast (sgot) aspartate aminotransferase
5040515|NCT01463254|DCF data collection forms|dcf data collection forms
5040516|NCT01463254|DMC Data Monitoring Committee|dmc data monitoring committee
5040517|NCT01463254|FDA (U.S.) Food and Drug Administration|fda (u.s.) food and drug administration
5040518|NCT01463254|GCP Good Clinical Practice guidelines|gcp good clinical practice guidelines
5040519|NCT01463254|HB sAg Hepatitis B surface antigen|hb sag hepatitis b surface antigen
5040520|NCT01463254|ICH International Conference of Harmonisation|ich international conference of harmonisation
5040521|NCT01463254|IND Investigational New Drug Application|ind investigational new drug application
5040522|NCT01463254|IRB Institutional Review Board|irb institutional review board
5040523|NCT01463254|IU international units|iu international units
5040524|NCT01463254|mg milligram(s)|mg milligram(s)
5040525|NCT01463254|mm3 cubic millimeter(s)|mm3 cubic millimeter(s)
5040526|NCT01463254|PCR polymerase chain reaction|pcr polymerase chain reaction
5040527|NCT01463254|SAE serious adverse event|sae serious adverse event
5040528|NCT01463254|µg microgram|µg microgram
5040529|NCT01463254|ULN upper limit of the normal range|uln upper limit of the normal range
5040530|NCT01463254|WB Western Blot|wb western blot
5040531|NCT01463228|Healthy Volunteers|healthy volunteers
5040532|NCT01463228|Bioequivalence|bioequivalence
5040533|NCT01463228|Canagliflozin (JNJ-28431754)|canagliflozin (jnj-28431754)
5040534|NCT01463228|Metformin IR|metformin ir
5040535|NCT01463215|Ambroxol|ambroxol
5040536|NCT01463215|Type I Gaucher Disease|type i gaucher disease
5040537|NCT01463202|Postpartum contraception|postpartum contraception
5040538|NCT01463202|Contraceptive continuation|contraceptive continuation
5040539|NCT01463202|Breastfeeding|breastfeeding
5040646|NCT01462825|tomatoes|tomatoes
5040540|NCT01463202|Postpartum depression|postpartum depression
5040541|NCT01463202|Progestins|progestins
5040542|NCT01463189|arthritis|arthritis
5040543|NCT01463189|self management|self management
5040544|NCT01463176|Music Therapy|music therapy
5040545|NCT01463176|Child Psychology|child psychology
5040546|NCT01463176|Vaccination|vaccination
5040547|NCT01463163|Platelet reactivity|platelet reactivity
5040548|NCT01463163|Ticagrelor|ticagrelor
5040549|NCT01463163|Prasugrel|prasugrel
5040550|NCT01463150|Platelet reactivity|platelet reactivity
5040551|NCT01463150|Clopidogrel|clopidogrel
5040552|NCT01463150|Prasugrel|prasugrel
5040553|NCT01463137|social phobia|social phobia
5040554|NCT01463137|anxiety|anxiety
5040555|NCT01463124|School Nurse|school nurse
5040556|NCT01463124|Overweight|overweight
5040557|NCT01463124|Obesity|obesity
5040558|NCT01463124|Counseling|counseling
5040559|NCT01463124|Intervention|intervention
5040560|NCT01463124|Exercise|exercise
5040561|NCT01463111|Bipolar|bipolar
5040562|NCT01463111|Manic depression|manic depression
5040563|NCT01463111|Mood stabilizer|mood stabilizer
5040564|NCT01463111|Decision|decision
5040565|NCT01463111|Neuroeconomics|neuroeconomics
5040566|NCT01463059|Rheumatoid Arthritis|rheumatoid arthritis
5040567|NCT01463059|Monoclonal Antibody|monoclonal antibody
5040568|NCT01463059|Interleukin-6|interleukin-6
5040569|NCT01463059|Olokizumab|olokizumab
5040570|NCT01463059|CDP6038|cdp6038
5040571|NCT01463046|leukemia|leukemia
5040572|NCT01463046|AML|aml
5040573|NCT01463046|AMS|ams
5040574|NCT01463046|panobinostat|panobinostat
5040575|NCT01463046|cytarabine|cytarabine
5040576|NCT01463046|daunorubicin|daunorubicin
5040577|NCT01463046|HDAC|hdac
5040578|NCT01463033|Post-Traumatic epilepsy|post-traumatic epilepsy
5040579|NCT01463033|Traumatic brain injury|traumatic brain injury
5040580|NCT01463033|Epilepsy prevention|epilepsy prevention
5040581|NCT01463033|Levetiracetam|levetiracetam
5040582|NCT01463020|Depression|depression
5040583|NCT01463020|Smartphone|smartphone
5040584|NCT01463020|Behavioural activation|behavioural activation
5040585|NCT01463020|Mindfulness|mindfulness
5040586|NCT01463007|invasive ductal cancer|invasive ductal cancer
5040587|NCT01463007|tubular breast cancer|tubular breast cancer
5040588|NCT01463007|breast cancer|breast cancer
5040589|NCT01463007|colloid|colloid
5040590|NCT01463007|ER positive|er positive
5040591|NCT01463007|radiation|radiation
5040592|NCT01462994|Patients with GIST treated with standard therapy harboring activating mutations of CKIT and PDGFRA|patients with gist treated with standard therapy harboring activating mutations of ckit and pdgfra
5040593|NCT01462968|Heparin treatment during cardiac surgery|heparin treatment during cardiac surgery
5040594|NCT01462968|Heparin reversal after cardiac surgery|heparin reversal after cardiac surgery
5040595|NCT01462968|Thrombin generation|thrombin generation
5040596|NCT01462968|Endogenous Thrombin potential|endogenous thrombin potential
5040597|NCT01462942|COPD|copd
5040598|NCT01462942|Bronchitis|bronchitis
5040599|NCT01462942|Chronic|chronic
5040600|NCT01462942|Emphysema|emphysema
5040601|NCT01462929|COPD|copd
5040602|NCT01462929|antimuscarinic|antimuscarinic
5040603|NCT01462916|honey|honey
5040604|NCT01462916|mucositis|mucositis
5040605|NCT01462916|bee products|bee products
5040606|NCT01462903|TIL|til
5040607|NCT01462903|NPC|npc
5040608|NCT01462903|hepatocellular carcinoma|hepatocellular carcinoma
5040609|NCT01462903|immunotherapy|immunotherapy
5040610|NCT01462890|Ovarian Carcinoma|ovarian carcinoma
5040611|NCT01462890|Bevacizumab|bevacizumab
5040612|NCT01462890|Paclitaxel|paclitaxel
5040613|NCT01462890|Carboplatin|carboplatin
5040614|NCT01462877|Lipid Regulating Agents|lipid regulating agents
5040615|NCT01462877|Drug Therapy|drug therapy
5040616|NCT01462877|cardiovascular diseases|cardiovascular diseases
5040617|NCT01462877|hypertriglyceridemia|hypertriglyceridemia
5040618|NCT01462877|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors
5040619|NCT01462877|fenofibrate|fenofibrate
5040620|NCT01462877|Dyslipidemias|dyslipidemias
5040621|NCT01462877|Combination|combination
5040622|NCT01462864|Polycystic Ovary Syndrome|polycystic ovary syndrome
5040623|NCT01462864|Lifestyle|lifestyle
5040624|NCT01462864|Structured Education|structured education
5040625|NCT01462864|Walking Activity|walking activity
5040626|NCT01462864|Exercise|exercise
5040627|NCT01462864|Overweight|overweight
5040628|NCT01462864|Impaired Glucose Regulation|impaired glucose regulation
5040629|NCT01462864|Diabetes Prevention|diabetes prevention
5040630|NCT01462851|healthy volunteer|healthy volunteer
5040631|NCT01462851|safety|safety
5040632|NCT01462851|pharmacokinetic|pharmacokinetic
5040633|NCT01462851|pharmacodynamic|pharmacodynamic
5040634|NCT01462838|advanced HPV-|advanced hpv-
5040635|NCT01462838|p16INK4a-positive|p16ink4a-positive
5040636|NCT01462838|cervical|cervical
5040637|NCT01462838|vulvar,|vulvar,
5040638|NCT01462838|vaginal|vaginal
5040639|NCT01462838|penile|penile
5040640|NCT01462838|anal|anal
5040641|NCT01462838|head|head
5040642|NCT01462838|neck|neck
5040643|NCT01462825|Inflammation|inflammation
5040644|NCT01462825|cytokines|cytokines
5040645|NCT01462825|chemotaxis|chemotaxis
5040647|NCT01462825|cardiovascular disease|cardiovascular disease
5040648|NCT01462812|Migraine|migraine
5040649|NCT01462812|Headache|headache
5040650|NCT01462812|Sumatriptan|sumatriptan
5040651|NCT01462799|PBL|pbl
5040652|NCT01462799|patient education|patient education
5040653|NCT01462799|coronary heart disease|coronary heart disease
5040654|NCT01462799|empowerment|empowerment
5040655|NCT01462799|self-efficacy|self-efficacy
5040656|NCT01462799|self-care|self-care
5040657|NCT01462799|Focus on to determine the long term effectiveness of PBL in patient education by comparison of standardized homesent information in patients with CHD.|focus on to determine the long term effectiveness of pbl in patient education by comparison of standardized homesent information in patients with chd.
5040658|NCT01462799|Further focus is on patients' self-care goals, beliefs, self-efficacy and empowerment to make lifestyle changes.|further focus is on patients' self-care goals, beliefs, self-efficacy and empowerment to make lifestyle changes.
5040659|NCT01462773|malignant|malignant
5040660|NCT01462773|melanoma|melanoma
5040661|NCT01462708|Parkinson Disease|parkinson disease
5040662|NCT01462708|Molecular NeuroImaging|molecular neuroimaging
5040663|NCT01462682|focus group study|focus group study
5040664|NCT01462682|sleep deprivation|sleep deprivation
5040665|NCT01462682|surgery|surgery
5040666|NCT01462669|Ezogabine|ezogabine
5040667|NCT01462669|Pharmacokinetics|pharmacokinetics
5040668|NCT01462669|Retigabine|retigabine
5040669|NCT01462656|anti-epileptic drug|anti-epileptic drug
5040670|NCT01462656|ezogabine|ezogabine
5040671|NCT01462656|AED polytherapy|aed polytherapy
5040672|NCT01462656|epilepsy|epilepsy
5040673|NCT01462656|AED monotherapy|aed monotherapy
5040674|NCT01462656|retigabine|retigabine
5040675|NCT01462656|urinary retention|urinary retention
5040676|NCT01462643|Psoriasis Plaque Test|psoriasis plaque test
5040677|NCT01462643|topical|topical
5040678|NCT01462643|ointment|ointment
5040679|NCT01462591|wave reflection|wave reflection
5040680|NCT01462591|augmentation Index|augmentation index
5040681|NCT01462591|heart rate variability|heart rate variability
5040682|NCT01462591|wasted left ventricular energy|wasted left ventricular energy
5040683|NCT01462578|Neoplasms benign, malignant and unspecified|neoplasms benign, malignant and unspecified
5040684|NCT01462578|Acute myeloid leukemia|acute myeloid leukemia
5040685|NCT01462578|AML|aml
5040686|NCT01462578|Myelodysplastic syndrome|myelodysplastic syndrome
5040687|NCT01462578|MDS|mds
5040688|NCT01462565|flolan|flolan
5040689|NCT01462565|pulmonary arterial hypertension|pulmonary arterial hypertension
5040690|NCT01462565|thermo stable formulation|thermo stable formulation
5040691|NCT01462565|epoprostenol sodium|epoprostenol sodium
5040692|NCT01462565|modified sterile diluent|modified sterile diluent
5040693|NCT01462552|liver function testing|liver function testing
5040694|NCT01462552|Breast cancer|breast cancer
5040695|NCT01462552|lapatanib|lapatanib
5040696|NCT01462513|Colon carcinoma|colon carcinoma
5040697|NCT01462513|Rectum carcinoma|rectum carcinoma
5040698|NCT01462513|Liver metastases|liver metastases
5040699|NCT01462500|Miltefosine|miltefosine
5040700|NCT01462500|pharmacokinetics|pharmacokinetics
5040701|NCT01462500|cutaneous leishmaniasis|cutaneous leishmaniasis
5040702|NCT01462487|Pregnancy safety|pregnancy safety
5040703|NCT01462487|zanamivir|zanamivir
5040704|NCT01462487|influenza|influenza
5040705|NCT01462474|Concurrent Chemoradiotherapy|concurrent chemoradiotherapy
5040706|NCT01462461|Phantom Limb|phantom limb
5040707|NCT01462461|Amputation, Traumatic|amputation, traumatic
5040708|NCT01462461|Electromyography|electromyography
5040709|NCT01462461|Visual Analog Pain Scale|visual analog pain scale
5040710|NCT01462448|Phantom Limb|phantom limb
5040711|NCT01462448|Genetic Variation|genetic variation
5040712|NCT01462448|DNA Sequence Analysis|dna sequence analysis
5040713|NCT01462448|Amputation, Traumatic|amputation, traumatic
5040714|NCT01462448|Single Nucleotide Polymorphism|single nucleotide polymorphism
5040715|NCT01462448|Visual Analog Pain Scale|visual analog pain scale
5040716|NCT01462448|Brain-Derived Neurotrophic Factor|brain-derived neurotrophic factor
5040717|NCT01462448|Inflammatory Antibody|inflammatory antibody
5040718|NCT01462448|Peripheral Nerve Damage|peripheral nerve damage
5040719|NCT01462422|Postpartum hemorrhage|postpartum hemorrhage
5040720|NCT01462422|Prevention|prevention
5040721|NCT01462422|Misoprostol|misoprostol
5040722|NCT01462422|Developing countries|developing countries
5040723|NCT01462422|Nurse midwife|nurse midwife
5040724|NCT01462409|obstructive sleep apnea|obstructive sleep apnea
5040725|NCT01462409|humidification|humidification
5040726|NCT01462409|mask|mask
5040727|NCT01462409|heated tubing|heated tubing
5040728|NCT01462396|Neuroblastoma|neuroblastoma
5040729|NCT01462396|Relapsed|relapsed
5040730|NCT01462396|Refractory|refractory
5040731|NCT01462383|Advanced Cancer|advanced cancer
5040732|NCT01462383|Malignancy|malignancy
5040733|NCT01462383|Cardiac complications|cardiac complications
5040734|NCT01462383|Electrocardiograms|electrocardiograms
5040735|NCT01462383|ECG|ecg
5040736|NCT01462383|Chart Review|chart review
5040737|NCT01462383|Data Review|data review
5040738|NCT01462383|Data Analysis|data analysis
5040739|NCT01462383|Phase I|phase i
5040740|NCT01462383|Clinical Research Study|clinical research study
5040741|NCT01462357|Human papillomavirus|human papillomavirus
5040742|NCT01462357|Safety|safety
5040743|NCT01462357|HPV vaccine|hpv vaccine
5040744|NCT01462357|Immune response|immune response
5040745|NCT01462344|pediatric|pediatric
5040746|NCT01462344|ADVAIR|advair
5040747|NCT01462344|FLOVENT|flovent
5040748|NCT01462344|asthma|asthma
5040749|NCT01462331|Isomaltooligosaccharide|isomaltooligosaccharide
5040750|NCT01462331|Human Consumption|human consumption
5040751|NCT01462331|Dose tolerance|dose tolerance
5040752|NCT01462331|Prebiotic|prebiotic
5040753|NCT01462331|Short chain fatty acids|short chain fatty acids
5040754|NCT01462331|Blood glucose|blood glucose
5040755|NCT01462331|Dose tolerance and prebiotic effect|dose tolerance and prebiotic effect
5040756|NCT01462318|Pre-filled syringe|pre-filled syringe
5040757|NCT01462318|Pharmacokinetic|pharmacokinetic
5040758|NCT01462318|Daclizumab High Yield Process|daclizumab high yield process
5040759|NCT01462318|immunogenicity|immunogenicity
5040760|NCT01462305|SAD|sad
5040761|NCT01462305|Seasonal Affective Disorder|seasonal affective disorder
5040762|NCT01462305|Winter Blues|winter blues
5040763|NCT01462305|Seasonal Depression|seasonal depression
5040764|NCT01462292|968|968
5040765|NCT01462292|Duchenne Muscular Dystrophy|duchenne muscular dystrophy
5040766|NCT01462292|GSK2402968|gsk2402968
5040767|NCT01462292|DMD|dmd
5040768|NCT01462292|Duchenne|duchenne
5040769|NCT01462292|GSK|gsk
5040770|NCT01462279|acute respiratory failure|acute respiratory failure
5040771|NCT01462279|thiamine|thiamine
5040772|NCT01462279|oxygen consumption|oxygen consumption
5040773|NCT01462279|VO2|vo2
5040774|NCT01462253|Adult patients|adult patients
5040775|NCT01462253|Refractory|refractory
5040776|NCT01462253|Relapsed|relapsed
5040777|NCT01462253|clofarabine|clofarabine
5040778|NCT01462253|cyclophosphamide|cyclophosphamide
5040779|NCT01462253|refractory and relapsed acute lymphoblastic leukemia|refractory and relapsed acute lymphoblastic leukemia
5040780|NCT01462253|ALL|all
5040781|NCT01462240|arthritis|arthritis
5040782|NCT01462227|Hypoglycemia|hypoglycemia
5040783|NCT01462227|Type 1 diabetes|type 1 diabetes
5040784|NCT01462201|focused ultrasound|focused ultrasound
5040785|NCT01462201|mechanical fat destruction|mechanical fat destruction
5040786|NCT01462201|Body Sculpting|body sculpting
5040787|NCT01462188|ST-segment elevation myocardial infarction|st-segment elevation myocardial infarction
5040788|NCT01462188|Primary angioplasty|primary angioplasty
5040789|NCT01462188|stent|stent
5040790|NCT01462136|PK study|pk study
5040791|NCT01462097|Chronic kidney disease|chronic kidney disease
5040792|NCT01462097|Exercise|exercise
5040793|NCT01462097|Aerobic capacity|aerobic capacity
5040794|NCT01462097|Learning and memory|learning and memory
5040795|NCT01462097|Executive function|executive function
5040796|NCT01462097|Endothelial function|endothelial function
5040797|NCT01462084|sleeping|sleeping
5040798|NCT01462084|opioid medications|opioid medications
5040799|NCT01462084|positive airway pressure|positive airway pressure
5040800|NCT01462058|SPAQ|spaq
5040801|NCT01462058|Sigh-SAD|sigh-sad
5040802|NCT01462058|Hamilton 29|hamilton 29
5040803|NCT01462058|Vitamin D3|vitamin d3
5040804|NCT01462058|p25(OH)D|p25(oh)d
5040805|NCT01462045|Exercise|exercise
5040806|NCT01462045|Stress|stress
5040807|NCT01462045|PTSD|ptsd
5040808|NCT01462045|Mindfulness|mindfulness
5040809|NCT01462045|Breathing|breathing
5040810|NCT01462045|Cortisol|cortisol
5040811|NCT01462032|Preschool Children|preschool children
5040812|NCT01462032|ADHD|adhd
5040813|NCT01462032|Treatment|treatment
5040814|NCT01462032|Non-pharmacological|non-pharmacological
5040815|NCT01462019|nipple trauma|nipple trauma
5040816|NCT01462019|breast feeding|breast feeding
5040817|NCT01462019|phototherapy|phototherapy
5040818|NCT01462019|wound healing|wound healing
5040819|NCT01461993|vaccine|vaccine
5040820|NCT01461993|rLP2086|rlp2086
5040821|NCT01461993|Gardasil|gardasil
5040822|NCT01461993|HPV|hpv
5040823|NCT01461993|meningitis B|meningitis b
5040824|NCT01461993|N. meningitidis serogroup B|n. meningitidis serogroup b
5040825|NCT01461993|adolescents|adolescents
5040826|NCT01461993|single-blind|single-blind
5040827|NCT01461993|Meningococcal Vaccines|meningococcal vaccines
5040828|NCT01461980|vaccine|vaccine
5040829|NCT01461980|rLP2086|rlp2086
5040830|NCT01461980|MCV4|mcv4
5040831|NCT01461980|Tdap|tdap
5040832|NCT01461980|meningitis B|meningitis b
5040833|NCT01461980|N. meningitidis serogroup B|n. meningitidis serogroup b
5040834|NCT01461980|adolescents|adolescents
5040835|NCT01461980|observer-blind|observer-blind
5040836|NCT01461941|Dermatitis|dermatitis
5040837|NCT01461941|Atopic|atopic
5040838|NCT01461915|Pancreatic Cancer|pancreatic cancer
5040839|NCT01461902|traumatic brain injury|traumatic brain injury
5040840|NCT01461902|brain injury|brain injury
5040841|NCT01461902|head injury|head injury
5040842|NCT01461902|vasospasm|vasospasm
5040843|NCT01461889|transfusion-related acute lung injury|transfusion-related acute lung injury
5040844|NCT01461889|Blood Component Transfusion|blood component transfusion
5040845|NCT01461889|Gastrointestinal Hemorrhage|gastrointestinal hemorrhage
5040846|NCT01461889|Cirrhosis|cirrhosis
5040847|NCT01461889|Fresh frozen plasma|fresh frozen plasma
5041149|NCT01460602|bortezomib|bortezomib
5040848|NCT01461837|sickle cell disease|sickle cell disease
5040849|NCT01461837|stem cell transplantation|stem cell transplantation
5040850|NCT01461837|haploidentical|haploidentical
5040851|NCT01461824|Birth Control|birth control
5040852|NCT01461824|Contraceptive Methods|contraceptive methods
5040853|NCT01461824|Female Contraception|female contraception
5040854|NCT01461824|Weight Gain|weight gain
5040855|NCT01461824|Bone Density|bone density
5040856|NCT01461811|toric|toric
5040857|NCT01461811|contact lenses|contact lenses
5040858|NCT01461811|daily disposable contact lenses|daily disposable contact lenses
5040859|NCT01461811|astigmatism|astigmatism
5040860|NCT01461811|soft contact lenses|soft contact lenses
5040861|NCT01461811|contact lens comfort|contact lens comfort
5040862|NCT01461798|plant stanols|plant stanols
5040863|NCT01461798|lipids|lipids
5040864|NCT01461798|cardiovascular disease|cardiovascular disease
5040865|NCT01461785|Platelet rich plasma|platelet rich plasma
5040866|NCT01461785|Dermal improvement|dermal improvement
5040867|NCT01461785|Graft survival|graft survival
5040868|NCT01461733|atrial fibrillation|atrial fibrillation
5040869|NCT01461733|amiodarone|amiodarone
5040870|NCT01461720|Bone marrow|bone marrow
5040871|NCT01461720|Autologous|autologous
5040872|NCT01461720|Mesenchymal stem cells|mesenchymal stem cells
5040873|NCT01461720|Unilateral middle cerebral artery infarct|unilateral middle cerebral artery infarct
5040874|NCT01461707|Cellular phone|cellular phone
5040875|NCT01461707|exercise|exercise
5040876|NCT01461707|pregnant women|pregnant women
5040877|NCT01461707|obesity|obesity
5040878|NCT01461707|overweight|overweight
5040879|NCT01461707|physical activity|physical activity
5040880|NCT01461694|Hirsutism|hirsutism
5040881|NCT01461694|Laser|laser
5040882|NCT01461694|Hair Reduction|hair reduction
5040883|NCT01461694|IPL|ipl
5040884|NCT01461694|Intense Pulsed Light|intense pulsed light
5040885|NCT01461681|Palliative care|palliative care
5040886|NCT01461681|Symptom management|symptom management
5040887|NCT01461681|Heart failure|heart failure
5040888|NCT01461668|MRSA|mrsa
5040889|NCT01461668|MRSA resistant to mupirocin|mrsa resistant to mupirocin
5040890|NCT01461642|Asthma|asthma
5040891|NCT01461642|ICT Support|ict support
5040892|NCT01461642|ACT|act
5040893|NCT01461642|PEF|pef
5040894|NCT01461629|cognitive impairment|cognitive impairment
5040895|NCT01461629|cognitive function|cognitive function
5040896|NCT01461629|hospitalization|hospitalization
5040897|NCT01461629|self-management|self-management
5040898|NCT01461629|cardiac disease|cardiac disease
5040899|NCT01461629|heart failure|heart failure
5040900|NCT01461616|Diabetes Mellitus, Type 1|diabetes mellitus, type 1
5040901|NCT01461603|critical illness|critical illness
5040902|NCT01461603|protein metabolism|protein metabolism
5040903|NCT01461603|pharmaconutrients|pharmaconutrients
5040904|NCT01461564|screening|screening
5040905|NCT01461564|colonoscopy|colonoscopy
5040906|NCT01461564|carbon dioxide|carbon dioxide
5040907|NCT01461564|air|air
5040908|NCT01461564|pain score|pain score
5040909|NCT01461564|complications|complications
5040910|NCT01461551|troponin I|troponin i
5040911|NCT01461551|creatine kinase mb|creatine kinase mb
5040912|NCT01461551|hospital days|hospital days
5040913|NCT01461551|lymphocyte apoptosis|lymphocyte apoptosis
5040914|NCT01461551|intensive care unit days|intensive care unit days
5040915|NCT01461538|Acute Lymphoid Leukemia|acute lymphoid leukemia
5040916|NCT01461538|Myelodysplastic Syndrome|myelodysplastic syndrome
5040917|NCT01461538|Acute Myeloid Leukemia|acute myeloid leukemia
5040918|NCT01461538|Solid Tumors|solid tumors
5040919|NCT01461538|Anemia, Refractory, with Excess of Blasts|anemia, refractory, with excess of blasts
5040920|NCT01461538|Antibodies, Monoclonal|antibodies, monoclonal
5040921|NCT01461538|Antibody-Drug Conjugate|antibody-drug conjugate
5040922|NCT01461538|Antigens, CD30|antigens, cd30
5040923|NCT01461538|Drug Therapy|drug therapy
5040924|NCT01461538|Hematologic Diseases|hematologic diseases
5040925|NCT01461538|Immunotherapy|immunotherapy
5040926|NCT01461538|Monomethyl Auristatin E|monomethyl auristatin e
5040927|NCT01461525|Low Rectal Cancer|low rectal cancer
5040928|NCT01461525|Sphincter preservation|sphincter preservation
5040929|NCT01461525|Abdominoperineal resection|abdominoperineal resection
5040930|NCT01461525|Quality of life|quality of life
5040931|NCT01461525|Sexual function|sexual function
5040932|NCT01461525|Urinary function|urinary function
5040933|NCT01461525|Oncologic outcome|oncologic outcome
5040934|NCT01461499|Hypertension|hypertension
5040935|NCT01461499|Albuminuria|albuminuria
5040936|NCT01461499|Direct renin inhibitor|direct renin inhibitor
5040937|NCT01461499|Angiotensin receptor blocker|angiotensin receptor blocker
5040938|NCT01461499|Type 2 diabetes|type 2 diabetes
5040939|NCT01461486|Continuous positive airway pressure|continuous positive airway pressure
5040940|NCT01461486|Oral appliance|oral appliance
5040941|NCT01461486|mild Obstructive Sleep Apnea Syndrome|mild obstructive sleep apnea syndrome
5040942|NCT01461473|Obstructive Sleep Apnea|obstructive sleep apnea
5040943|NCT01461473|Obstructive Sleep Apnea Syndrome|obstructive sleep apnea syndrome
5040944|NCT01461473|Sleep Apnea Syndrome, Obstructive|sleep apnea syndrome, obstructive
5040945|NCT01461473|Syndrome, Obstructive Sleep Apnea|syndrome, obstructive sleep apnea
5041150|NCT01460602|Nipent|nipent
5040946|NCT01461473|Syndrome, Sleep Apnea, Obstructive|syndrome, sleep apnea, obstructive
5040947|NCT01461473|Syndrome, Upper Airway Resistance, Sleep Apnea|syndrome, upper airway resistance, sleep apnea
5040948|NCT01461473|Upper Airway Resistance Sleep Apnea Syndrome|upper airway resistance sleep apnea syndrome
5040949|NCT01461460|volunteer|volunteer
5040950|NCT01461434|atrial fibrillation|atrial fibrillation
5040951|NCT01461434|biomarkers|biomarkers
5040952|NCT01461434|stroke prevention|stroke prevention
5040953|NCT01461434|implantable loop recorder|implantable loop recorder
5040954|NCT01461421|Obesity|obesity
5040955|NCT01461421|Primary Care|primary care
5040956|NCT01461421|Behavior Modification|behavior modification
5040957|NCT01461408|HPV Vaccination|hpv vaccination
5040958|NCT01461408|Beauty Salons|beauty salons
5040959|NCT01461408|Health Education|health education
5040960|NCT01461408|Sexual Health|sexual health
5040961|NCT01461395|IVF|ivf
5040962|NCT01461343|pulmonary hypertension, PET imaging, CT/PET|pulmonary hypertension, pet imaging, ct/pet
5040963|NCT01461330|diabetes|diabetes
5040964|NCT01461330|exercise|exercise
5040965|NCT01461330|DASH diet|dash diet
5040966|NCT01461330|ABPM|abpm
5040967|NCT01461304|fatty acid oxidation|fatty acid oxidation
5040968|NCT01461304|triheptanoin|triheptanoin
5040969|NCT01461304|long-chain fatty acid oxidation disorders|long-chain fatty acid oxidation disorders
5040970|NCT01461304|LCHADD|lchadd
5040971|NCT01461304|VLCADD|vlcadd
5040972|NCT01461304|CPT1|cpt1
5040973|NCT01461304|CPT2|cpt2
5040974|NCT01461304|TFP|tfp
5040975|NCT01461304|Glycogen Storage Disorders|glycogen storage disorders
5040976|NCT01461304|GSD|gsd
5040977|NCT01461304|Pyruvate Carboxylase|pyruvate carboxylase
5040978|NCT01461304|PC|pc
5040979|NCT01461304|ACAD9|acad9
5040980|NCT01461304|Barth|barth
5040981|NCT01461291|Primary open-angle glaucoma|primary open-angle glaucoma
5040982|NCT01461291|POAG|poag
5040983|NCT01461291|Trabecular meshwork|trabecular meshwork
5040984|NCT01461291|iStent inject|istent inject
5040985|NCT01461278|Primary open-angle glaucoma|primary open-angle glaucoma
5040986|NCT01461278|POAG|poag
5040987|NCT01461278|Cataract surgery|cataract surgery
5040988|NCT01461278|Suprachoroidal space|suprachoroidal space
5040989|NCT01461278|Suprachoroidal stent|suprachoroidal stent
5040990|NCT01461278|iStent supra|istent supra
5040991|NCT01461265|Painful bone metastases|painful bone metastases
5040992|NCT01461265|Bone metastases|bone metastases
5040993|NCT01461265|Metastatic bone tumors|metastatic bone tumors
5040994|NCT01461265|Metastatic bone pain|metastatic bone pain
5040995|NCT01461265|Cryoablation|cryoablation
5040996|NCT01461265|Cryotherapy|cryotherapy
5040997|NCT01461265|Cryosurgery|cryosurgery
5040998|NCT01461252|Painful bone metastases|painful bone metastases
5040999|NCT01461252|Bone metastases|bone metastases
5041000|NCT01461252|Metastatic bone tumors|metastatic bone tumors
5041001|NCT01461252|Metastatic bone pain|metastatic bone pain
5041002|NCT01461252|Cryoablation|cryoablation
5041003|NCT01461252|Cryotherapy|cryotherapy
5041004|NCT01461252|Cryosurgery|cryosurgery
5041005|NCT01461252|Radiation therapy|radiation therapy
5041006|NCT01461252|Radiotherapy|radiotherapy
5041007|NCT01461239|survival|survival
5041008|NCT01461239|debonding|debonding
5041009|NCT01461239|endodontic treated teeth|endodontic treated teeth
5041010|NCT01461226|overweight|overweight
5041011|NCT01461226|cardiovascular risk factors|cardiovascular risk factors
5041012|NCT01461226|exercise training|exercise training
5041013|NCT01461226|endothelial function|endothelial function
5041014|NCT01461226|endothelium|endothelium
5041015|NCT01461226|endothelial progenitor cells|endothelial progenitor cells
5041016|NCT01461213|Tapetoretinal degeneration, choroideraemia, X-linked|tapetoretinal degeneration, choroideraemia, x-linked
5041017|NCT01461213|retinitis pigmentosa|retinitis pigmentosa
5041018|NCT01461187|Exercise|exercise
5041019|NCT01461187|Pregnancy|pregnancy
5041020|NCT01461187|Childbirth|childbirth
5041021|NCT01461187|Vaginal|vaginal
5041022|NCT01461187|Cesarean section|cesarean section
5041023|NCT01461174|Sleep deprivation|sleep deprivation
5041024|NCT01461174|Cognitive Functions|cognitive functions
5041025|NCT01461174|young male|young male
5041026|NCT01461148|UICC stage III/IV MSI-H colorectal cancer|uicc stage iii/iv msi-h colorectal cancer
5041027|NCT01461109|Parkinson Disease|parkinson disease
5041028|NCT01461109|Alzheimer Disease|alzheimer disease
5041029|NCT01461109|[18F] CFPyPB|[18f] cfpypb
5041030|NCT01461109|GlyT1|glyt1
5041031|NCT01461083|Parkinson Disease|parkinson disease
5041032|NCT01461083|[18F]MPPF|[18f]mppf
5041033|NCT01461070|Breast Cancer|breast cancer
5041034|NCT01461070|Post Menopausal Estrogens|post menopausal estrogens
5041035|NCT01461070|Fecal Microbes|fecal microbes
5041036|NCT01461031|pain|pain
5041037|NCT01461031|orthognathic|orthognathic
5041038|NCT01461018|Immune globulin subcutaneous|immune globulin subcutaneous
5041039|NCT01461018|SCIG|scig
5041040|NCT01461018|Primary immunodeficiency|primary immunodeficiency
5041041|NCT01461018|PID|pid
5041042|NCT01461005|Spondylolisthesis|spondylolisthesis
5041043|NCT01461005|Neurologic impairment|neurologic impairment
5041044|NCT01461005|Kyphosis|kyphosis
5041045|NCT01461005|Pseudarthrosis|pseudarthrosis
5041046|NCT01460992|Pacemaker therapy|pacemaker therapy
5041047|NCT01460992|Magnetic Resonance Imaging (MRI)|magnetic resonance imaging (mri)
5041048|NCT01460992|EVIA/ENTOVIS|evia/entovis
5041049|NCT01460979|Ovarian Cancer|ovarian cancer
5041050|NCT01460979|Endometrial Carcinoma|endometrial carcinoma
5041051|NCT01460979|Temsirolimus|temsirolimus
5041052|NCT01460966|Distal protection device|distal protection device
5041053|NCT01460966|Thrombus aspiration|thrombus aspiration
5041054|NCT01460966|Coronary Artery Disease|coronary artery disease
5041055|NCT01460966|Coronary Disease|coronary disease
5041056|NCT01460966|Acute Coronary Syndrome|acute coronary syndrome
5041057|NCT01460953|curriculum|curriculum
5041058|NCT01460953|training|training
5041059|NCT01460953|Medical student Knowledge|medical student knowledge
5041060|NCT01460940|refractory Hodgkin's lymphoma|refractory hodgkin's lymphoma
5041061|NCT01460940|panobinostat|panobinostat
5041062|NCT01460940|lenalidomide|lenalidomide
5041063|NCT01460914|ECP|ecp
5041064|NCT01460914|CTCL|ctcl
5041065|NCT01460914|Extracorporeal photopheresis|extracorporeal photopheresis
5041066|NCT01460914|Cutaneous T Cell Lymphoma|cutaneous t cell lymphoma
5041067|NCT01460914|GVHD|gvhd
5041068|NCT01460914|Graft versus host disease|graft versus host disease
5041069|NCT01460901|Neuroblastoma|neuroblastoma
5041070|NCT01460901|Relapsed|relapsed
5041071|NCT01460901|Refractory|refractory
5041072|NCT01460875|high risk melanoma|high risk melanoma
5041073|NCT01460875|lymph node disease|lymph node disease
5041074|NCT01460862|Asthma|asthma
5041075|NCT01460862|Omalizumab|omalizumab
5041076|NCT01460849|Cystic fibrosis|cystic fibrosis
5041077|NCT01460836|Cystic fibrosis|cystic fibrosis
5041078|NCT01460823|Hearing loss|hearing loss
5041079|NCT01460823|Cochlear Implantation|cochlear implantation
5041080|NCT01460823|Image guided surgery|image guided surgery
5041081|NCT01460797|Glycemic index|glycemic index
5041082|NCT01460797|Caloric restriction|caloric restriction
5041083|NCT01460797|Energy intake|energy intake
5041084|NCT01460797|Glucose|glucose
5041085|NCT01460797|Lipid Metabolism|lipid metabolism
5041086|NCT01460797|Cholesterol|cholesterol
5041087|NCT01460797|HDL Cholesterol|hdl cholesterol
5041088|NCT01460797|LDL Cholesterol|ldl cholesterol
5041089|NCT01460797|Obesity|obesity
5041090|NCT01460797|Metformin|metformin
5041091|NCT01460784|Metabolic dysfunction|metabolic dysfunction
5041092|NCT01460784|Insulin resistance|insulin resistance
5041093|NCT01460784|Brown adipose tissue|brown adipose tissue
5041094|NCT01460784|Dyslipidemia|dyslipidemia
5041095|NCT01460771|childhood dystonia|childhood dystonia
5041096|NCT01460758|Depression|depression
5041097|NCT01460758|Transcranial magnetic stimulation|transcranial magnetic stimulation
5041098|NCT01460758|rTMS|rtms
5041099|NCT01460758|DLPFC|dlpfc
5041100|NCT01460758|medial frontal cortex|medial frontal cortex
5041101|NCT01460758|anterior cingulate complex|anterior cingulate complex
5041102|NCT01460745|Erbitux|erbitux
5041103|NCT01460745|CRC|crc
5041104|NCT01460745|mCRC|mcrc
5041105|NCT01460745|Liver|liver
5041106|NCT01460745|Metastases|metastases
5041107|NCT01460732|Hypertension|hypertension
5041108|NCT01460732|Nocturnal BP dipping|nocturnal bp dipping
5041109|NCT01460732|Home Blood pressure Monitoring|home blood pressure monitoring
5041110|NCT01460732|Ambulatory Blood Pressure Monitoring|ambulatory blood pressure monitoring
5041111|NCT01460706|Glioma|glioma
5041112|NCT01460706|68Ga-DOTATOC|68ga-dotatoc
5041113|NCT01460706|PET/CT|pet/ct
5041114|NCT01460706|Somatostatin receptor|somatostatin receptor
5041115|NCT01460693|Leukemia|leukemia
5041116|NCT01460693|Myeloid|myeloid
5041117|NCT01460693|Chronic|chronic
5041118|NCT01460693|Chronic-Phase|chronic-phase
5041119|NCT01460693|CML|cml
5041120|NCT01460680|Fibromyalgia|fibromyalgia
5041121|NCT01460680|Systemic Lupus Erythematosus|systemic lupus erythematosus
5041122|NCT01460680|Omega-3 Fatty acids|omega-3 fatty acids
5041123|NCT01460680|Magnesium|magnesium
5041124|NCT01460667|Laparoscopic Roux-en-Y Gastric Bypass|laparoscopic roux-en-y gastric bypass
5041125|NCT01460667|Post-Operative Pain|post-operative pain
5041126|NCT01460667|IV Acetaminophen|iv acetaminophen
5041127|NCT01460667|Post-Operative Nausea and Vomiting|post-operative nausea and vomiting
5041128|NCT01460628|fatigue|fatigue
5041129|NCT01460628|menopausal symptoms|menopausal symptoms
5041130|NCT01460628|hot flashes|hot flashes
5041131|NCT01460628|Vasomotor symptoms|vasomotor symptoms
5041132|NCT01460628|perimenopause|perimenopause
5041133|NCT01460628|related Quality of life|related quality of life
5041134|NCT01460615|Postoperative pancreatitis|postoperative pancreatitis
5041135|NCT01460615|Postoperative complications|postoperative complications
5041136|NCT01460615|Delayed gastric emptying|delayed gastric emptying
5041137|NCT01460615|Leakage|leakage
5041138|NCT01460615|Fistula|fistula
5041139|NCT01460615|Acinar cell|acinar cell
5041140|NCT01460615|Risk patient|risk patient
5041141|NCT01460615|Pancreaticoduodenectomy|pancreaticoduodenectomy
5041142|NCT01460615|Whipple|whipple
5041143|NCT01460615|Cortisone|cortisone
5041144|NCT01460602|Lymphoma|lymphoma
5041145|NCT01460602|Follicular|follicular
5041146|NCT01460602|Marginal Zone|marginal zone
5041147|NCT01460602|Mantle Cell|mantle cell
5041148|NCT01460602|Velcade|velcade
5041151|NCT01460602|pentastatin|pentastatin
5041152|NCT01460602|Rituxan|rituxan
5041153|NCT01460602|rituximab|rituximab
5041154|NCT01460602|Turturro|turturro
5041155|NCT01460602|Shreveport|shreveport
5041156|NCT01460589|colon cancer|colon cancer
5041157|NCT01460589|Chemotherapy|chemotherapy
5041158|NCT01460589|adjuvant|adjuvant
5041159|NCT01460576|prematurity|prematurity
5041160|NCT01460576|respiratory disease|respiratory disease
5041161|NCT01460576|bronchopulmonary dysplasia|bronchopulmonary dysplasia
5041162|NCT01460563|craniotomy|craniotomy
5041163|NCT01460563|sodium valproate|sodium valproate
5041164|NCT01460563|rocuronium|rocuronium
5041165|NCT01460550|delayed gastric emptying(DGE)|delayed gastric emptying(dge)
5041166|NCT01460550|pancreaticoduodenectomy(PD)|pancreaticoduodenectomy(pd)
5041167|NCT01460550|randomized controlled trial(RCT)|randomized controlled trial(rct)
5041168|NCT01460550|gastro- or duodeno- jejunostomy reconstruction|gastro- or duodeno- jejunostomy reconstruction
5041169|NCT01460550|morbidity|morbidity
5041170|NCT01460537|phase I|phase i
5041171|NCT01460537|phosphatidylinositol-3 kinase inhibitor|phosphatidylinositol-3 kinase inhibitor
5041172|NCT01460537|gemcitabine|gemcitabine
5041173|NCT01460537|cisplatin|cisplatin
5041174|NCT01460537|maximum tolerated dose|maximum tolerated dose
5041175|NCT01460524|bronchiolitis|bronchiolitis
5041176|NCT01460524|saline|saline
5041177|NCT01460524|nebulization|nebulization
5041178|NCT01460524|hypertonic|hypertonic
5041179|NCT01460511|Mild bronchial asthma|mild bronchial asthma
5041180|NCT01460498|Leukemia|leukemia
5041181|NCT01460498|Chronic Myeloid Leukemia|chronic myeloid leukemia
5041182|NCT01460498|CML|cml
5041183|NCT01460498|Complete cytogenetic remission|complete cytogenetic remission
5041184|NCT01460498|CCyR|ccyr
5041185|NCT01460498|Minimal residual disease|minimal residual disease
5041186|NCT01460498|Philadelphia chromosome (Ph)-|philadelphia chromosome (ph)-
5041187|NCT01460498|BCR/ABL-positive|bcr/abl-positive
5041188|NCT01460498|Tyrosine kinase inhibitor|tyrosine kinase inhibitor
5041189|NCT01460498|TKI|tki
5041190|NCT01460498|Azacitidine|azacitidine
5041191|NCT01460498|5-Azacytidine|5-azacytidine
5041192|NCT01460498|5-AZA|5-aza
5041193|NCT01460498|Vidaza|vidaza
5041194|NCT01460498|5-AZC|5-azc
5041195|NCT01460498|AZA-CR|aza-cr
5041196|NCT01460498|Ladakamycin|ladakamycin
5041197|NCT01460498|NSC-102816|nsc-102816
5041198|NCT01460472|NSCLC|nsclc
5041199|NCT01460472|Lung cancer, small-cell|lung cancer, small-cell
5041200|NCT01460472|advanced lung cancer|advanced lung cancer
5041201|NCT01460472|therapeutic vaccine|therapeutic vaccine
5041202|NCT01460472|anti-idiotypic vaccine|anti-idiotypic vaccine
5041203|NCT01460472|1E10|1e10
5041204|NCT01460459|diabetes|diabetes
5041205|NCT01460459|self-monitoring of blood glucose|self-monitoring of blood glucose
5041206|NCT01460459|frequency|frequency
5041207|NCT01460433|HIV 1|hiv 1
5041208|NCT01460433|Herpes Simplex Type 2|herpes simplex type 2
5041209|NCT01460433|Treatment experienced|treatment experienced
5041210|NCT01460420|Allogeneic transplantation|allogeneic transplantation
5041211|NCT01460420|Hematologic malignancies|hematologic malignancies
5041212|NCT01460420|Multiple myeloma|multiple myeloma
5041213|NCT01460420|RIC (Reduced Intensity Conditioning)|ric (reduced intensity conditioning)
5041214|NCT01460394|Healthy|healthy
5041215|NCT01460394|Control|control
5041216|NCT01460355|strabismus surgery|strabismus surgery
5041217|NCT01460355|botulinum toxin|botulinum toxin
5041218|NCT01460355|esotropia|esotropia
5041219|NCT01460355|exotropia|exotropia
5041220|NCT01460355|blepharoptosis|blepharoptosis
5041221|NCT01460342|Prostatic hyperplasia|prostatic hyperplasia
5041222|NCT01460342|Benign prostatic hyperplasia|benign prostatic hyperplasia
5041223|NCT01460342|Lower urinary tract|lower urinary tract
5041224|NCT01460329|intensive care units|intensive care units
5041225|NCT01460329|pediatric|pediatric
5041226|NCT01460329|cardiac index|cardiac index
5041227|NCT01460329|Doppler Ultrasonography|doppler ultrasonography
5041228|NCT01460316|Conotruncal cardiac defects|conotruncal cardiac defects
5041229|NCT01460316|methylation|methylation
5041230|NCT01460316|genotype|genotype
5041231|NCT01460316|cobalamin|cobalamin
5041232|NCT01460316|folates|folates
5041233|NCT01460316|nutrition|nutrition
5041234|NCT01460303|Transurethral catheterization|transurethral catheterization
5041235|NCT01460303|Urinary retention|urinary retention
5041236|NCT01460303|Bladder dysfunction|bladder dysfunction
5041237|NCT01460303|Patient comfort|patient comfort
5041238|NCT01460303|Pelvic Reconstructive Surgery|pelvic reconstructive surgery
5041239|NCT01460303|Postoperative bladder dysfunction|postoperative bladder dysfunction
5041240|NCT01460303|Postoperative urinary retention|postoperative urinary retention
5041241|NCT01460277|hemiplegic|hemiplegic
5041242|NCT01460277|balance|balance
5041243|NCT01460277|hydrotherapy|hydrotherapy
5041244|NCT01460264|Prospective Cohort Study|prospective cohort study
5041245|NCT01460264|Respiratory Function Tests|respiratory function tests
5041246|NCT01460264|Computed Tomography|computed tomography
5041247|NCT01460264|Electrocardiography|electrocardiography
5041248|NCT01460264|Peripheral Arterial Disease|peripheral arterial disease
5041249|NCT01460251|type 1 diabetes|type 1 diabetes
5041250|NCT01460251|beta cell|beta cell
5041251|NCT01460251|immunomodulation|immunomodulation
5041252|NCT01460251|immunointervention|immunointervention
5041253|NCT01460238|Lipoprotein Lipase|lipoprotein lipase
5041254|NCT01460238|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
5041255|NCT01460238|CLL|cll
5041256|NCT01460225|constipation|constipation
5041257|NCT01460225|chronic idiopathic constipation|chronic idiopathic constipation
5041258|NCT01460225|no prior history of surgery to the colon|no prior history of surgery to the colon
5041259|NCT01460225|not on any type of medication that could alter gastrointestinal motility or transit|not on any type of medication that could alter gastrointestinal motility or transit
5041260|NCT01460212|Cognitive-Behavior Therapy|cognitive-behavior therapy
5041261|NCT01460212|Magnetic Resonance Imaging|magnetic resonance imaging
5041262|NCT01460212|major depressive disorder|major depressive disorder
5041263|NCT01460186|Germ line polymorphisms|germ line polymorphisms
5041264|NCT01460173|alertness test|alertness test
5041265|NCT01460173|sleepiness|sleepiness
5041266|NCT01460173|vigilance|vigilance
5041267|NCT01460173|Sleep Apnea, Obstructive|sleep apnea, obstructive
5041268|NCT01460147|Hemophilia|hemophilia
5041269|NCT01460134|CD27 expressing Hematologic Malignancies|cd27 expressing hematologic malignancies
5041270|NCT01460134|CD27 expressing Solid Tumors|cd27 expressing solid tumors
5041271|NCT01460134|chronic lymphocytic leukemia|chronic lymphocytic leukemia
5041272|NCT01460134|Burkett's lymphoma|burkett's lymphoma
5041273|NCT01460134|mantle cell lymphoma|mantle cell lymphoma
5041274|NCT01460134|primary lymphoma of the central nervous system|primary lymphoma of the central nervous system
5041275|NCT01460134|marginal zone B cell lymphoma|marginal zone b cell lymphoma
5041276|NCT01460134|solid tumor|solid tumor
5041277|NCT01460134|metastatic melanoma|metastatic melanoma
5041278|NCT01460134|renal (clear) cell carcinoma|renal (clear) cell carcinoma
5041279|NCT01460134|hormone-refractory prostate adenocarcinoma|hormone-refractory prostate adenocarcinoma
5041280|NCT01460134|ovarian cancer|ovarian cancer
5041281|NCT01460134|colorectal adenocarcinoma|colorectal adenocarcinoma
5041282|NCT01460134|non-small cell lung cancer|non-small cell lung cancer
5041283|NCT01460121|Phobic Postural Vertigo|phobic postural vertigo
5041284|NCT01460121|Visual Vertigo|visual vertigo
5041285|NCT01460121|Chronic Subjective Dizziness|chronic subjective dizziness
5041286|NCT01460121|Motion and Space Discomfort|motion and space discomfort
5041287|NCT01460121|SpotOn|spoton
5041288|NCT01460108|PLVR|plvr
5041289|NCT01460108|AeriSeal|aeriseal
5041290|NCT01460108|Treatment|treatment
5041291|NCT01460108|Device|device
5041292|NCT01460108|Breathing|breathing
5041293|NCT01460108|COPD|copd
5041294|NCT01460108|emphysema|emphysema
5041295|NCT01460108|polymeric lung volume reduction|polymeric lung volume reduction
5041296|NCT01460108|heterogeneous|heterogeneous
5041297|NCT01460108|homogeneous|homogeneous
5041298|NCT01460108|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5041299|NCT01460095|diabetes|diabetes
5041300|NCT01460095|translational research|translational research
5041301|NCT01460095|HbA1c|hba1c
5041302|NCT01460095|education|education
5041303|NCT01460082|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
5041304|NCT01460082|acute exacerbation|acute exacerbation
5041305|NCT01460082|endothelial dysfunction|endothelial dysfunction
5041306|NCT01460082|flow mediated dilation|flow mediated dilation
5041307|NCT01460082|systemic inflammation|systemic inflammation
5041308|NCT01460069|psoriasis|psoriasis
5041309|NCT01460069|liraglutide|liraglutide
5041310|NCT01460069|morbidity|morbidity
5041311|NCT01460069|PASI|pasi
5041312|NCT01460069|DLQI|dlqi
5041313|NCT01460056|peritoneal dialysis|peritoneal dialysis
5041314|NCT01460056|endotoxin-associated sterile peritonitis|endotoxin-associated sterile peritonitis
5041315|NCT01460030|Hypercalcemia in patients with parathyroid carcinoma or intractable PHPT|hypercalcemia in patients with parathyroid carcinoma or intractable phpt
5041316|NCT01460004|patellar tendinopathy|patellar tendinopathy
5041317|NCT01460004|jumper's knee|jumper's knee
5041318|NCT01459991|walnut|walnut
5041319|NCT01459991|mediterranean|mediterranean
5041320|NCT01459978|CUmulative SUM (CUSUM)|cumulative sum (cusum)
5041321|NCT01459978|quality indicators|quality indicators
5041322|NCT01459978|obstetrics|obstetrics
5041323|NCT01459965|Jaundice|jaundice
5041324|NCT01459965|Biliary stents|biliary stents
5041325|NCT01459965|Palliation|palliation
5041326|NCT01459965|Quality of Life|quality of life
5041327|NCT01459965|Endoscopic Retrograde Cholangiography|endoscopic retrograde cholangiography
5041328|NCT01459952|occurences of flu|occurences of flu
5041329|NCT01459952|occurences of common cold|occurences of common cold
5041330|NCT01459939|Osteoarthritis|osteoarthritis
5041331|NCT01459926|Opioid induced constipation|opioid induced constipation
5041332|NCT01459926|OIC|oic
5041333|NCT01459926|Constipation|constipation
5041334|NCT01459926|Opioid side effects|opioid side effects
5041335|NCT01459926|Morphine induced constipation|morphine induced constipation
5041336|NCT01459926|Opioid therapy|opioid therapy
5041337|NCT01459913|VX-950|vx-950
5041338|NCT01459913|INCIVEK|incivek
5041339|NCT01459913|INCIVO|incivo
5041340|NCT01459900|Treatment Resistant Hypertension|treatment resistant hypertension
5041341|NCT01459887|untreated, CD20-positive|untreated, cd20-positive
5041342|NCT01459874|Home Monitoring|home monitoring
5041343|NCT01459874|Remote monitoring|remote monitoring
5041344|NCT01459874|Telecardiology|telecardiology
5041345|NCT01459874|Organizational model|organizational model
5041346|NCT01459874|Patient indicated for pacemaker, ICD, CRT-P, or CRT-D|patient indicated for pacemaker, icd, crt-p, or crt-d
5041347|NCT01459861|early ambulation|early ambulation
5041348|NCT01459861|knee arthroplasty|knee arthroplasty
5041349|NCT01459848|Salivary cortisol measured after DVD watching or block play|salivary cortisol measured after dvd watching or block play
5041350|NCT01459835|TV|tv
5041351|NCT01459835|Violence|violence
5041352|NCT01459835|DVDs|dvds
5041353|NCT01459835|Behavior|behavior
5041354|NCT01459835|Preschool children|preschool children
5041355|NCT01459822|sepsis|sepsis
5041356|NCT01459822|miRNA|mirna
5041357|NCT01459783|Caregivers|caregivers
5041358|NCT01459783|Comparative Effectiveness Research|comparative effectiveness research
5041359|NCT01459783|Cost Effectiveness|cost effectiveness
5041360|NCT01459783|Patient Care Management|patient care management
5041361|NCT01459783|Social Work|social work
5041362|NCT01459770|glomerular filtration rate|glomerular filtration rate
5041363|NCT01459770|albuminuria|albuminuria
5041364|NCT01459770|medical therapy|medical therapy
5041365|NCT01459770|hospital discharge|hospital discharge
5041366|NCT01459770|hospital readmission|hospital readmission
5041367|NCT01459770|CKD complications|ckd complications
5041368|NCT01459770|CKD risk factors|ckd risk factors
5041369|NCT01459757|Retrospective|retrospective
5041370|NCT01459757|GIST|gist
5041371|NCT01459757|sunitinib|sunitinib
5041372|NCT01459757|mutational|mutational
5041373|NCT01459744|Heart failure|heart failure
5041374|NCT01459744|Palliative care|palliative care
5041375|NCT01459744|Communication|communication
5041376|NCT01459718|Severe cardiac iron overload|severe cardiac iron overload
5041377|NCT01459718|deferasirox|deferasirox
5041378|NCT01459718|β-thalassaemia|β-thalassaemia
5041379|NCT01459718|cardiac dysfunction|cardiac dysfunction
5041380|NCT01459705|Combat Disorders|combat disorders
5041381|NCT01459705|Exposure Therapy|exposure therapy
5041382|NCT01459705|Army Personnel|army personnel
5041383|NCT01459692|Seizures|seizures
5041384|NCT01459692|Epilepsy|epilepsy
5041385|NCT01459692|Auditory Stimulation|auditory stimulation
5041386|NCT01459692|Music|music
5041387|NCT01459666|Scar|scar
5041388|NCT01459666|Forehead|forehead
5041389|NCT01459666|Skin Cancer|skin cancer
5041390|NCT01459666|MOHS Surgery|mohs surgery
5041391|NCT01459666|Dermatology|dermatology
5041392|NCT01459653|Febrile neutropenia|febrile neutropenia
5041393|NCT01459653|cancer|cancer
5041394|NCT01459653|chemotherapy,|chemotherapy,
5041395|NCT01459653|primary prophylaxis|primary prophylaxis
5041396|NCT01459653|secondary prophylaxis|secondary prophylaxis
5041397|NCT01459653|filgrastim|filgrastim
5041398|NCT01459653|granulocyte colony stimulating factor|granulocyte colony stimulating factor
5041399|NCT01459653|observational study|observational study
5041400|NCT01459653|noninterventional study|noninterventional study
5041401|NCT01459640|Osteoarthritis|osteoarthritis
5041402|NCT01459640|Bone marrow|bone marrow
5041403|NCT01459640|Mesenchymal stem cells|mesenchymal stem cells
5041404|NCT01459640|Autologous|autologous
5041405|NCT01459640|Mild osteoarthritis|mild osteoarthritis
5041406|NCT01459640|Moderate osteoarthritis|moderate osteoarthritis
5041407|NCT01459627|DAPT- Dual Antiplatelet Therapy|dapt- dual antiplatelet therapy
5041408|NCT01459627|STEMI|stemi
5041409|NCT01459601|diabetes mellitus|diabetes mellitus
5041410|NCT01459601|FBS|fbs
5041411|NCT01459601|HbA1C|hba1c
5041412|NCT01459601|Cabergoline|cabergoline
5041413|NCT01459575|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5041414|NCT01459575|antiretroviral therapy|antiretroviral therapy
5041415|NCT01459575|China|china
5041416|NCT01459549|hepatolithiasis|hepatolithiasis
5041417|NCT01459549|sphincter of oddi laxity|sphincter of oddi laxity
5041418|NCT01459549|choledochojejunostomy|choledochojejunostomy
5041419|NCT01459536|Aging|aging
5041420|NCT01459523|Peripheral Nerve Block|peripheral nerve block
5041421|NCT01459523|Perineural Catheter|perineural catheter
5041422|NCT01459523|Orthopedic Surgery|orthopedic surgery
5041423|NCT01459523|Ultrasound|ultrasound
5041424|NCT01459510|Violence prevention|violence prevention
5041425|NCT01459510|Parenting|parenting
5041426|NCT01459510|Discipline|discipline
5041427|NCT01459497|non-small cell lung cancer|non-small cell lung cancer
5041428|NCT01459497|Stages II or III non-small cell lung cancer|stages ii or iii non-small cell lung cancer
5041429|NCT01459484|Non metastatic extremities high grade osteosarcoma|non metastatic extremities high grade osteosarcoma
5041430|NCT01459458|intimate partner violence|intimate partner violence
5041431|NCT01459458|gender-based violence|gender-based violence
5041432|NCT01459458|domestic violence|domestic violence
5041433|NCT01459458|unintended pregnancy|unintended pregnancy
5041434|NCT01459445|ethinylestradiol 30µg-drospirenone|ethinylestradiol 30µg-drospirenone
5041435|NCT01459445|flow-mediated dilatation|flow-mediated dilatation
5041436|NCT01459445|endothelial dysfunction|endothelial dysfunction
5041437|NCT01459445|hsCRP|hscrp
5041438|NCT01459445|metformin|metformin
5041439|NCT01459445|polycystic ovary syndrome|polycystic ovary syndrome
5041440|NCT01459406|Gastrointestinal physiology|gastrointestinal physiology
5041441|NCT01459406|Gastrointestinal response to sugars|gastrointestinal response to sugars
5041442|NCT01459406|MRI|mri
5041443|NCT01459406|gastrointestinal|gastrointestinal
5041444|NCT01459406|stomach|stomach
5041445|NCT01459406|small bowel|small bowel
5041446|NCT01459406|colon|colon
5041447|NCT01459406|glucose|glucose
5041448|NCT01459406|fructose|fructose
5041449|NCT01459406|fructan|fructan
5041450|NCT01459406|FODMAP|fodmap
5041451|NCT01459393|Actinic keratosis|actinic keratosis
5041452|NCT01459393|Photodynamic therapy|photodynamic therapy
5041453|NCT01459393|5-aminolevulinic acid|5-aminolevulinic acid
5041454|NCT01459393|Cryotherapy|cryotherapy
5041455|NCT01459367|Drug Therapy|drug therapy
5041456|NCT01459341|CLI Critical limb ischemia|cli critical limb ischemia
5041457|NCT01459341|PVD peripheral vascular disease|pvd peripheral vascular disease
5041458|NCT01459341|NIRS near infrared spectroscopy|nirs near infrared spectroscopy
5041459|NCT01459341|TCPO2 - transcutaneous oxygen pressure|tcpo2 - transcutaneous oxygen pressure
5041460|NCT01459328|rectal carcinoma|rectal carcinoma
5041461|NCT01459328|long course chemo-radiation|long course chemo-radiation
5041462|NCT01459328|short course chemo-rdiation|short course chemo-rdiation
5041463|NCT01459328|Locally Advanced Rectal Carcinoma|locally advanced rectal carcinoma
5041464|NCT01459315|Healthy|healthy
5041465|NCT01459315|Male|male
5041466|NCT01459315|GSK1349572|gsk1349572
5041467|NCT01459315|Dolutegravir|dolutegravir
5041468|NCT01459315|DTG|dtg
5041469|NCT01459315|Integrase|integrase
5041470|NCT01459315|HIV|hiv
5041471|NCT01459302|FALS|fals
5041472|NCT01459302|ALS|als
5041473|NCT01459302|SALS|sals
5041474|NCT01459302|MND|mnd
5041475|NCT01459302|SOD1|sod1
5041476|NCT01459302|ALS GENES|als genes
5041477|NCT01459302|PLS|pls
5041478|NCT01459302|PMA|pma
5041479|NCT01459302|ALS/FTD|als/ftd
5041480|NCT01459302|FAMILIAL ALS|familial als
5041481|NCT01459302|SPORADIC ALS|sporadic als
5041482|NCT01459302|GENETICS|genetics
5041483|NCT01459302|FTD|ftd
5041484|NCT01459302|Miyoshi myopathy|miyoshi myopathy
5041485|NCT01459276|seasonal|seasonal
5041486|NCT01459276|prevention|prevention
5041487|NCT01459276|influenza|influenza
5041488|NCT01459276|infection|infection
5041489|NCT01459276|influenza vaccine|influenza vaccine
5041490|NCT01459276|vaccine|vaccine
5041491|NCT01459276|influenza in humans|influenza in humans
5041492|NCT01459263|GSV|gsv
5041493|NCT01459263|insufficiency|insufficiency
5041494|NCT01459263|ClariVein device|clarivein device
5041495|NCT01459263|safety|safety
5041496|NCT01459263|efficacy|efficacy
5041497|NCT01459263|QOL|qol
5041498|NCT01459250|AGO178C,|ago178c,
5041499|NCT01459250|renal impairment,|renal impairment,
5041500|NCT01459250|ESRD,|esrd,
5041501|NCT01459250|pharmacokinetics|pharmacokinetics
5041502|NCT01459237|Cushing's Disease|cushing's disease
5041503|NCT01459237|Microadenoma|microadenoma
5041504|NCT01459237|PET Imaging|pet imaging
5041505|NCT01459237|Cushing Disease Tumor|cushing disease tumor
5041506|NCT01459237|Pituitary Tumors|pituitary tumors
5041507|NCT01459211|CLL|cll
5041508|NCT01459185|Non-small cell lung cancer|non-small cell lung cancer
5041509|NCT01459185|Adjuvant chemotherapy|adjuvant chemotherapy
5041510|NCT01459185|oral fluoropyrimidine|oral fluoropyrimidine
5041511|NCT01459185|S-1|s-1
5041512|NCT01459185|Feasibility study|feasibility study
5041513|NCT01459185|Surgery|surgery
5041514|NCT01459172|breast cancer prevention|breast cancer prevention
5041515|NCT01459159|Hematology|hematology
5041516|NCT01459159|MDS|mds
5041517|NCT01459159|Myelodysplastic Syndrome|myelodysplastic syndrome
5041518|NCT01459159|Low risk MDS|low risk mds
5041519|NCT01459159|Int-1 risk MDS|int-1 risk mds
5041520|NCT01459159|Transfusion dependence|transfusion dependence
5041521|NCT01459159|Telintra|telintra
5041522|NCT01459159|ezatiostat|ezatiostat
5041523|NCT01459159|ezatiostat hydrochloride|ezatiostat hydrochloride
5041524|NCT01459159|TLK199|tlk199
5041525|NCT01459159|Glutathione|glutathione
5041526|NCT01459159|Glutathione analog|glutathione analog
5041527|NCT01459159|Glutathione Transferase|glutathione transferase
5041528|NCT01459159|Glutathione Transferase P1-1 inhibitor|glutathione transferase p1-1 inhibitor
5041529|NCT01459159|GST P1-1 inhibitor|gst p1-1 inhibitor
5041530|NCT01459159|Apoptosis|apoptosis
5041531|NCT01459159|Differentiation|differentiation
5041532|NCT01459159|Enzyme inhibitor|enzyme inhibitor
5041533|NCT01459159|non-del (5q)|non-del (5q)
5041534|NCT01459159|non-deletion 5q|non-deletion 5q
5041535|NCT01459146|IPT|ipt
5041536|NCT01459146|malaria|malaria
5041537|NCT01459146|ACT|act
5041538|NCT01459146|schistosomiasis|schistosomiasis
5041539|NCT01459146|Hemoglobin|hemoglobin
5041540|NCT01459146|Anemia|anemia
5041541|NCT01459146|Sustained attention|sustained attention
5041542|NCT01459146|Recall|recall
5041543|NCT01459146|Schoolchildren|schoolchildren
5041544|NCT01459146|Kassena-Nankana|kassena-nankana
5041545|NCT01459133|investigational|investigational
5041546|NCT01459133|inhaled insulin product|inhaled insulin product
5041547|NCT01459120|Home-based HIV-testing|home-based hiv-testing
5041548|NCT01459120|Voluntary Counseling and Testing|voluntary counseling and testing
5041549|NCT01459120|Community based testing|community based testing
5041550|NCT01459120|HIV/AIDS|hiv/aids
5041551|NCT01459120|Lesotho|lesotho
5041552|NCT01459107|Hand Transplant|hand transplant
5041553|NCT01459107|Composite Tissue Allotransplantation (CTA)|composite tissue allotransplantation (cta)
5041554|NCT01459107|Vascularized Composite Allotransplantation (VCA)|vascularized composite allotransplantation (vca)
5041555|NCT01459107|Composite Tissue|composite tissue
5041556|NCT01459107|Amputation|amputation
5041557|NCT01459107|Upper limb|upper limb
5041558|NCT01459107|Immunosuppression|immunosuppression
5041559|NCT01459094|Healthy Volunteers|healthy volunteers
5041560|NCT01459094|Oral bioavailability|oral bioavailability
5041561|NCT01459094|Canagliflozin (JNJ-28431754)|canagliflozin (jnj-28431754)
5041562|NCT01459094|Metformin IR|metformin ir
5041563|NCT01459029|Schizophrenia|schizophrenia
5041564|NCT01459029|NMDA receptor|nmda receptor
5041565|NCT01459029|D-serine|d-serine
5041566|NCT01459029|Recent onset|recent onset
5041567|NCT01459029|Negative symptoms|negative symptoms
5041568|NCT01459029|Cognition|cognition
5041569|NCT01459016|Mild Cognitive Impairment|mild cognitive impairment
5041570|NCT01459016|Brain Imaging Biomarkers|brain imaging biomarkers
5041571|NCT01459016|Magnetic resonance imaging biomarker|magnetic resonance imaging biomarker
5041572|NCT01459016|Positron Emission Tomography|positron emission tomography
5041573|NCT01458977|Lípid-lowering effect|lípid-lowering effect
5041574|NCT01458977|Tenofovir|tenofovir
5041575|NCT01458977|Dyslipidemia|dyslipidemia
5041576|NCT01458964|Fibromyalgia|fibromyalgia
5041577|NCT01458951|Tofacitinib|tofacitinib
5041578|NCT01458951|CP-690|cp-690
5041579|NCT01458951|550|550
5041580|NCT01458951|Moderate to severe ulcerative colitis|moderate to severe ulcerative colitis
5041581|NCT01458951|phase 3 clinical trial|phase 3 clinical trial
5041582|NCT01458951|Mayo score|mayo score
5041583|NCT01458925|Colorectal cancer|colorectal cancer
5041584|NCT01458925|Colonic polyps|colonic polyps
5041585|NCT01458899|Phase 1|phase 1
5041586|NCT01458899|healthy male|healthy male
5041587|NCT01458899|nonpregnant female|nonpregnant female
5041588|NCT01458899|volunteers|volunteers
5041589|NCT01458899|pharmacokinetics|pharmacokinetics
5041590|NCT01458899|TC 5214|tc 5214
5041591|NCT01458899|The effect of food on the pharmacokinetics of TC-5214|the effect of food on the pharmacokinetics of tc-5214
5041592|NCT01458873|infiltration|infiltration
5041593|NCT01458873|extravasation|extravasation
5041594|NCT01458847|bladder cancer|bladder cancer
5041595|NCT01458847|cis-urocanic acid|cis-urocanic acid
5041596|NCT01458847|primary|primary
5041597|NCT01458847|recurrent|recurrent
5041598|NCT01458847|non-muscle|non-muscle
5041599|NCT01458834|Smoking|smoking
5041600|NCT01458834|Attentional bias|attentional bias
5041601|NCT01458834|Craving|craving
5041602|NCT01458821|Tinnitus|tinnitus
5041603|NCT01458808|salt|salt
5041604|NCT01458808|inflammation|inflammation
5041605|NCT01458808|hypervolemia|hypervolemia
5041606|NCT01458808|diet|diet
5041607|NCT01458782|Cartilage repair|cartilage repair
5041608|NCT01458782|Chondrocytes|chondrocytes
5041609|NCT01458782|Stemcells|stemcells
5041610|NCT01458756|liver transplant patients|liver transplant patients
5041611|NCT01458756|hepatic transplantation|hepatic transplantation
5041612|NCT01458743|pharmacokinetics|pharmacokinetics
5041613|NCT01458730|PCNSL|pcnsl
5041614|NCT01458730|Immunochemotherapy|immunochemotherapy
5041615|NCT01458730|Intraspinal Depocyt|intraspinal depocyt
5041616|NCT01458730|Maintenance temozolomide|maintenance temozolomide
5041617|NCT01458717|pancreas|pancreas
5041618|NCT01458717|cancer|cancer
5041619|NCT01458717|borderline resectable|borderline resectable
5041620|NCT01458717|locally advanced|locally advanced
5041621|NCT01458717|resectability|resectability
5041622|NCT01458717|chemotherapy|chemotherapy
5041623|NCT01458717|radiation|radiation
5041624|NCT01458717|chemoradiation|chemoradiation
5041625|NCT01458717|neoadjuvant|neoadjuvant
5041626|NCT01458717|survival|survival
5041627|NCT01458717|prognosis|prognosis
5041628|NCT01458717|recurrence|recurrence
5041629|NCT01458717|response rate|response rate
5041630|NCT01458652|AST-120|ast-120
5041631|NCT01458652|HDF|hdf
5041632|NCT01458652|Replacement Volume described above|replacement volume described above
5041633|NCT01458639|Pulmonary embolism|pulmonary embolism
5041634|NCT01458639|PE|pe
5041635|NCT01458626|mirtazapine|mirtazapine
5041636|NCT01458626|paroxetine|paroxetine
5041637|NCT01458626|major depression|major depression
5041638|NCT01458626|early improvement|early improvement
5041639|NCT01458613|Maroteaux-Lamy Disease|maroteaux-lamy disease
5041640|NCT01458613|Biomarker|biomarker
5041641|NCT01458600|ophthalmopathy|ophthalmopathy
5041642|NCT01458600|prevention|prevention
5041643|NCT01458600|diclofenac|diclofenac
5041644|NCT01458587|Actinic keratosis|actinic keratosis
5041645|NCT01458574|Janus kinase inhibitor|janus kinase inhibitor
5041646|NCT01458574|JAK 3 inhibitor|jak 3 inhibitor
5041647|NCT01458574|inflammatory bowel disease|inflammatory bowel disease
5041648|NCT01458574|ulcerative colitis|ulcerative colitis
5041649|NCT01458574|OCTAVE|octave
5041650|NCT01458574|CP-690|cp-690
5041651|NCT01458574|550|550
5041652|NCT01458574|tofacitinib|tofacitinib
5041653|NCT01458574|Xeljanz|xeljanz
5041654|NCT01458561|Hemostatic agent|hemostatic agent
5041655|NCT01458561|Liver surgery|liver surgery
5041656|NCT01458561|Hemostasis|hemostasis
5041657|NCT01458548|1st-line therapy|1st-line therapy
5041658|NCT01458548|single agent rituximab|single agent rituximab
5041659|NCT01458548|CHOP|chop
5041660|NCT01458548|PTLD|ptld
5041661|NCT01458535|Genotype 1|genotype 1
5041662|NCT01458535|Genotype 2|genotype 2
5041663|NCT01458535|Genotype 3|genotype 3
5041664|NCT01458535|Hepatitis C Virus|hepatitis c virus
5041665|NCT01458535|ABT-450/r|abt-450/r
5041666|NCT01458535|Ribavirin|ribavirin
5041667|NCT01458535|ABT-267|abt-267
5041668|NCT01458535|Ombitasvir|ombitasvir
5041669|NCT01458535|Paritaprevir|paritaprevir
5041670|NCT01458522|Nonconvulsive Seizures|nonconvulsive seizures
5041671|NCT01458509|Quality of Life|quality of life
5041672|NCT01458509|patient outcomes|patient outcomes
5041673|NCT01458509|questionaires|questionaires
5041674|NCT01458509|11-101|11-101
5041675|NCT01458470|huntington|huntington
5041676|NCT01458470|huntingtin|huntingtin
5041677|NCT01458470|memantine|memantine
5041678|NCT01458470|ebixa|ebixa
5041679|NCT01458470|namenda|namenda
5041680|NCT01458444|Respiratory Insufficiency|respiratory insufficiency
5041681|NCT01458444|Cardiothoracic Surgery|cardiothoracic surgery
5041682|NCT01458444|Ventilation system|ventilation system
5041683|NCT01458431|cesarean section|cesarean section
5041684|NCT01458431|wound infusion|wound infusion
5041685|NCT01458431|Local anesthetic levobupivacaine|local anesthetic levobupivacaine
5041686|NCT01458431|Pain management|pain management
5041687|NCT01458418|Eosinophil|eosinophil
5041688|NCT01458418|Esophagitis|esophagitis
5041689|NCT01458405|Myocardial Infarction|myocardial infarction
5041690|NCT01458405|Heart Attack|heart attack
5041691|NCT01458405|Stem cell|stem cell
5041692|NCT01458405|Left ventricular dysfunction|left ventricular dysfunction
5041693|NCT01458405|Congestive heart failure|congestive heart failure
5041694|NCT01458366|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
5041695|NCT01458366|Lymphoma|lymphoma
5041696|NCT01458366|B-Cell Lymphoma|b-cell lymphoma
5041697|NCT01458353|Right-sided colon cancer|right-sided colon cancer
5041698|NCT01458353|Ileocolonic anastomosis|ileocolonic anastomosis
5041699|NCT01458353|stapled anastomosis|stapled anastomosis
5041700|NCT01458353|handsewn anastomosis|handsewn anastomosis
5041701|NCT01458353|peritoneal contamination|peritoneal contamination
5041702|NCT01458353|microbiological spectrum|microbiological spectrum
5041703|NCT01458340|Adult ADHD|adult adhd
5041704|NCT01458340|Attention-Deficit/Hyperactivity Disorder|attention-deficit/hyperactivity disorder
5041705|NCT01458327|MDMA|mdma
5041706|NCT01458327|PTSD|ptsd
5041707|NCT01458327|psychotherapy|psychotherapy
5041708|NCT01458314|Physical exercise|physical exercise
5041709|NCT01458314|Rehabilitation|rehabilitation
5041710|NCT01458314|NIV|niv
5041711|NCT01458301|Drug Therapy|drug therapy
5041712|NCT01458275|Seasonal Allergic Rhinitis|seasonal allergic rhinitis
5041713|NCT01458275|Ciclesonide|ciclesonide
5041714|NCT01458275|Ciclesonide Nasal Aerosol|ciclesonide nasal aerosol
5041715|NCT01458262|cerebral oxymetry|cerebral oxymetry
5041716|NCT01458262|systemic oxymetry|systemic oxymetry
5041717|NCT01458262|hepatic surgery|hepatic surgery
5041718|NCT01458262|liver transplantation|liver transplantation
5041719|NCT01458249|Soft Tissue Sarcoma|soft tissue sarcoma
5041720|NCT01458223|spine surgery|spine surgery
5041721|NCT01458223|postoperative infection|postoperative infection
5041722|NCT01458223|postoperative antibiotics|postoperative antibiotics
5041723|NCT01458197|Overactive Bladder|overactive bladder
5041724|NCT01458197|Tarafenacin|tarafenacin
5041725|NCT01458184|risk factors for complications|risk factors for complications
5041726|NCT01458184|precarious medical situations|precarious medical situations
5041727|NCT01458171|Immune globulin subcutaneous|immune globulin subcutaneous
5041728|NCT01458171|SCIG|scig
5041729|NCT01458171|Primary immunodeficiency|primary immunodeficiency
5041730|NCT01458171|PID|pid
5041731|NCT01458158|Gelatinases|gelatinases
5041732|NCT01458158|kidney disease|kidney disease
5041733|NCT01458158|diabetes mellitus type 2|diabetes mellitus type 2
5041734|NCT01458132|subject follow-up|subject follow-up
5041735|NCT01458132|HIV infection|hiv infection
5041736|NCT01458132|registry|registry
5041737|NCT01458132|seizures|seizures
5041738|NCT01458132|GSK2248761|gsk2248761
5041739|NCT01458119|Fabry disease|fabry disease
5041740|NCT01458119|Lysosomal storage disease|lysosomal storage disease
5041741|NCT01458119|migalastat HCl|migalastat hcl
5041742|NCT01458119|AT1001|at1001
5041743|NCT01458080|ENABLE|enable
5041744|NCT01458080|invasive procedures|invasive procedures
5041745|NCT01458080|Thrombocytopenia|thrombocytopenia
5041746|NCT01458080|Thromboembolic events|thromboembolic events
5041747|NCT01458080|Eltrombopag|eltrombopag
5041748|NCT01458080|Hepatitis C|hepatitis c
5041749|NCT01458080|HCV|hcv
5041750|NCT01458054|pharmacokinetics|pharmacokinetics
5041751|NCT01458054|omeprazole|omeprazole
5041752|NCT01458054|ritonavir|ritonavir
5041753|NCT01458054|healthy subjects|healthy subjects
5041754|NCT01458054|drug interaction|drug interaction
5041755|NCT01458041|Critical limb ischaemia|critical limb ischaemia
5041756|NCT01458041|Iloprost|iloprost
5041757|NCT01458041|Quality of life|quality of life
5041758|NCT01458041|Visual analogue scale|visual analogue scale
5041759|NCT01458028|BAY85-3934|bay85-3934
5041760|NCT01458028|pharmacokinetics|pharmacokinetics
5041761|NCT01458028|age|age
5041762|NCT01458028|gender|gender
5041763|NCT01458015|QST|qst
5041764|NCT01458015|neuropathic pain|neuropathic pain
5041765|NCT01458015|tapentadol pr|tapentadol pr
5041766|NCT01458015|oxycodone|oxycodone
5041767|NCT01457989|retention rate|retention rate
5041768|NCT01457989|epilepsy|epilepsy
5041769|NCT01457989|responder rate|responder rate
5041770|NCT01457989|seizure freedom|seizure freedom
5041771|NCT01457989|discontinuation rate|discontinuation rate
5041772|NCT01457989|safety assessment|safety assessment
5041773|NCT01457989|reduction in seizure frequency|reduction in seizure frequency
5041774|NCT01457989|open-label|open-label
5041775|NCT01457976|cancer|cancer
5041776|NCT01457976|obesity|obesity
5041777|NCT01457976|personal responsibility|personal responsibility
5041778|NCT01457950|denosumab|denosumab
5041779|NCT01457950|Republic of Korea|republic of korea
5041780|NCT01457950|dual energy x-ray absorptiometry|dual energy x-ray absorptiometry
5041781|NCT01457937|HCV|hcv
5041782|NCT01457937|Menopause|menopause
5041783|NCT01457937|Peg IFN|peg ifn
5041784|NCT01457937|Ribavirin|ribavirin
5041785|NCT01457937|Boceprevir|boceprevir
5041786|NCT01457924|Relapsing Remitting Multiple Sclerosis|relapsing remitting multiple sclerosis
5041787|NCT01457924|Ofatumumab|ofatumumab
5041788|NCT01457898|Cardiac surgery|cardiac surgery
5041789|NCT01457898|Non-invasive ventilation|non-invasive ventilation
5041790|NCT01457885|AML|aml
5041791|NCT01457872|Heroin addiction|heroin addiction
5041792|NCT01457872|Substance use disorders|substance use disorders
5041793|NCT01457872|Substitution treatment|substitution treatment
5041794|NCT01457872|Syringe exchange|syringe exchange
5041795|NCT01457846|gastro-oesophageal junction cancer|gastro-oesophageal junction cancer
5041796|NCT01457846|gastric cancer|gastric cancer
5041797|NCT01457846|lower third oesophageal cancer|lower third oesophageal cancer
5041798|NCT01457846|polysomy|polysomy
5041799|NCT01457846|amplification|amplification
5041800|NCT01457846|FGFR|fgfr
5041801|NCT01457820|Allopurinol|allopurinol
5041802|NCT01457820|Angina|angina
5041803|NCT01457820|Acute coronary syndrome|acute coronary syndrome
5041804|NCT01457807|Phase 1|phase 1
5041805|NCT01457807|Parkinson's disease|parkinson's disease
5041806|NCT01457807|pharmacodynamic|pharmacodynamic
5041807|NCT01457807|biomarkers|biomarkers
5041808|NCT01457807|pharmacokinetics|pharmacokinetics
5041809|NCT01457807|extended release formulation|extended release formulation
5041810|NCT01457794|Metabolic Syndrome X|metabolic syndrome x
5041811|NCT01457794|Fatty Acids, Omega-3|fatty acids, omega-3
5041812|NCT01457794|Learning|learning
5041813|NCT01457794|Attention|attention
5041814|NCT01457794|Nutritional Status|nutritional status
5041815|NCT01457794|Nutrition Assessments|nutrition assessments
5041816|NCT01457794|Body Weight|body weight
5041817|NCT01457794|Physical Activity|physical activity
5041818|NCT01457794|Sleep|sleep
5041819|NCT01457794|Child Nutrition Sciences|child nutrition sciences
5041820|NCT01457781|Inhaled nitric oxide|inhaled nitric oxide
5041821|NCT01457781|pulmonary arterial hypertension|pulmonary arterial hypertension
5041822|NCT01457781|pulmonary hypertension|pulmonary hypertension
5041823|NCT01457781|PAH|pah
5041824|NCT01457768|Hepatitis C|hepatitis c
5041825|NCT01457768|HCV|hcv
5041826|NCT01457768|Sustained Virologic Response|sustained virologic response
5041827|NCT01457768|Direct Acting Antiviral|direct acting antiviral
5041828|NCT01457768|Combination Therapy|combination therapy
5041829|NCT01457768|Tegobuvir|tegobuvir
5041830|NCT01457768|Registry|registry
5041831|NCT01457768|HCV RNA|hcv rna
5041832|NCT01457768|Treatment experienced|treatment experienced
5041833|NCT01457768|Treatment naive|treatment naive
5041834|NCT01457768|GS 9451|gs 9451
5041835|NCT01457768|GS 5885|gs 5885
5041836|NCT01457768|Sequence|sequence
5041837|NCT01457768|GS 5816|gs 5816
5041838|NCT01457768|GS 7977|gs 7977
5041839|NCT01457768|Sofosbuvir|sofosbuvir
5041840|NCT01457768|Sovaldi™|sovaldi™
5041841|NCT01457768|SOF|sof
5041842|NCT01457768|Ledipasvir|ledipasvir
5041843|NCT01457768|LDV|ldv
5041844|NCT01457755|Hepatitis C|hepatitis c
5041845|NCT01457755|HCV|hcv
5041846|NCT01457755|Sustained Virologic Response|sustained virologic response
5041847|NCT01457755|Direct Acting Antiviral|direct acting antiviral
5041848|NCT01457755|Combination Therapy|combination therapy
5041849|NCT01457755|Tegobuvir|tegobuvir
5041850|NCT01457755|Registry|registry
5041851|NCT01457755|HCV RNA|hcv rna
5041852|NCT01457755|Treatment experienced|treatment experienced
5041853|NCT01457755|Treatment naive|treatment naive
5041854|NCT01457755|GS 9451|gs 9451
5041855|NCT01457755|GS 5885|gs 5885
5041856|NCT01457755|GS 7977|gs 7977
5041857|NCT01457755|GS 5816|gs 5816
5041858|NCT01457755|Sofosbuvir|sofosbuvir
5041859|NCT01457755|Sovaldi™|sovaldi™
5041860|NCT01457755|SOF|sof
5041861|NCT01457755|Ledipasvir|ledipasvir
5041862|NCT01457755|LDV|ldv
5041863|NCT01457742|Osteoarthritis|osteoarthritis
5041864|NCT01457729|ergometer|ergometer
5041865|NCT01457729|training|training
5041866|NCT01457729|motivation|motivation
5041867|NCT01457729|telemonitoring|telemonitoring
5041868|NCT01457729|sleep apnea|sleep apnea
5041869|NCT01457716|Healthy volunteer study|healthy volunteer study
5041870|NCT01457703|LH pulsatility|lh pulsatility
5041871|NCT01457703|Obesity|obesity
5041872|NCT01457703|Reproduction|reproduction
5041873|NCT01457690|Vitamin E pegylated|vitamin e pegylated
5041874|NCT01457690|chylomicron retention|chylomicron retention
5041875|NCT01457690|Familial Hypocholesterolemia|familial hypocholesterolemia
5041876|NCT01457690|Hypobetalipoproteinemias|hypobetalipoproteinemias
5041877|NCT01457651|Recruitment|recruitment
5041878|NCT01457651|Coronary artery bypass grafting|coronary artery bypass grafting
5041879|NCT01457651|Postoperative period|postoperative period
5041880|NCT01457638|nasal obstruction|nasal obstruction
5041881|NCT01457638|rhinoplasty|rhinoplasty
5041882|NCT01457638|turbinate surgery|turbinate surgery
5041883|NCT01457638|quality of life|quality of life
5041884|NCT01457638|acoustic rhinometry|acoustic rhinometry
5041885|NCT01457625|fetuin A liver fat content visceral obesity mortality|fetuin a liver fat content visceral obesity mortality
5041886|NCT01457612|Insulin Resistant|insulin resistant
5041887|NCT01457612|Dietary Supplements|dietary supplements
5041888|NCT01457612|Nutrition|nutrition
5041889|NCT01457612|Antioxidant|antioxidant
5041890|NCT01457612|Inflammation|inflammation
5041891|NCT01457599|liver-colorectal metastases-computertomography-guided-wire-chemotherapy-complete response|liver-colorectal metastases-computertomography-guided-wire-chemotherapy-complete response
5041892|NCT01457599|Feasibility, safety|feasibility, safety
5041893|NCT01457586|Heart Surgery|heart surgery
5041894|NCT01457586|Blood Transfusion|blood transfusion
5041895|NCT01457586|Postoperative Complications|postoperative complications
5041896|NCT01457560|Oral polio vaccine (OPV)|oral polio vaccine (opv)
5041897|NCT01457560|DTPa-HBV-IPV/Hib vaccine|dtpa-hbv-ipv/hib vaccine
5041898|NCT01457547|HEXAVACTM|hexavactm
5041899|NCT01457547|InfanrixTM HEXA|infanrixtm hexa
5041900|NCT01457547|DTPa-HBV-IPV-Hib|dtpa-hbv-ipv-hib
5041901|NCT01457547|DTPa-HBV-IPV/Hib|dtpa-hbv-ipv/hib
5041902|NCT01457521|pain|pain
5041903|NCT01457521|medical abortion|medical abortion
5041904|NCT01457508|combination vaccine|combination vaccine
5041905|NCT01457508|DTPa-HBV-IPV|dtpa-hbv-ipv
5041906|NCT01457508|Hib|hib
5041907|NCT01457495|Infants|infants
5041908|NCT01457495|combined vaccine|combined vaccine
5041909|NCT01457495|DTPa-HBV-IPV/Hib|dtpa-hbv-ipv/hib
5041910|NCT01457495|DTPa-IPV/Hib|dtpa-ipv/hib
5041911|NCT01457495|safety|safety
5041912|NCT01457495|Immunogenicity|immunogenicity
5041913|NCT01457495|HBV|hbv
5041914|NCT01457482|Fear|fear
5041915|NCT01457482|Childbirth|childbirth
5041916|NCT01457482|Art therapy|art therapy
5041917|NCT01457482|Therapeutic conversations|therapeutic conversations
5041918|NCT01457482|W-DEQ|w-deq
5041919|NCT01457456|Biomarker|biomarker
5041920|NCT01457456|Morquio Disease|morquio disease
5041921|NCT01457443|Pompe Disease|pompe disease
5041922|NCT01457443|Biomarker|biomarker
5041923|NCT01457417|Cancer|cancer
5041924|NCT01457417|Oncology|oncology
5041925|NCT01457404|integrated cognitive behavioral therapy|integrated cognitive behavioral therapy
5041926|NCT01457404|cognitive behavioral therapy|cognitive behavioral therapy
5041927|NCT01457404|addiction|addiction
5041928|NCT01457404|posttraumatic stress disorder (PTSD)|posttraumatic stress disorder (ptsd)
5041929|NCT01457391|cognitive behavioral therapy|cognitive behavioral therapy
5041930|NCT01457391|addiction|addiction
5041931|NCT01457391|posttraumatic stress disorder (PTSD)|posttraumatic stress disorder (ptsd)
5041932|NCT01457378|Gastrointestinal symptoms|gastrointestinal symptoms
5041933|NCT01457378|healthy subjects|healthy subjects
5041934|NCT01457378|IBS|ibs
5041935|NCT01457378|HRQoL|hrqol
5041936|NCT01457378|questionnaires|questionnaires
5041937|NCT01457352|Baclofen, spasticity|baclofen, spasticity
5041938|NCT01457339|Schizophrenia|schizophrenia
5041939|NCT01457326|Immersion therapy|immersion therapy
5041940|NCT01457326|early weight bearing physical therapy|early weight bearing physical therapy
5041941|NCT01457300|Rehabilitation outcome|rehabilitation outcome
5041942|NCT01457300|Aged|aged
5041943|NCT01457300|Aged, 80 and over|aged, 80 and over
5041944|NCT01457300|Activities of daily living|activities of daily living
5041945|NCT01457274|AMBULATORY CARE|ambulatory care
5041946|NCT01457274|AWARENESS AND RECALL|awareness and recall
5041947|NCT01457274|Propofol|propofol
5041948|NCT01457274|Patient Safety and Satisfaction|patient safety and satisfaction
5041949|NCT01457274|Colonoscopy|colonoscopy
5041950|NCT01457274|Elective outpatient colonoscopy|elective outpatient colonoscopy
5041951|NCT01457274|Procedural sedation|procedural sedation
5041952|NCT01457261|interstitial lung disease|interstitial lung disease
5041953|NCT01457261|drug deposition|drug deposition
5041954|NCT01457261|lung imaging|lung imaging
5041955|NCT01457261|respiratory|respiratory
5041956|NCT01457248|after aortic surgery|after aortic surgery
5041957|NCT01457235|Bipolar disorder|bipolar disorder
5041958|NCT01457235|Cognitive Remediation|cognitive remediation
5041959|NCT01457235|Cognition|cognition
5041960|NCT01457235|Cognitive function|cognitive function
5041961|NCT01457235|Mood disorders|mood disorders
5041962|NCT01457235|Affective disorders|affective disorders
5041963|NCT01457222|Mindfulness|mindfulness
5041964|NCT01457222|Stress|stress
5041965|NCT01457222|Cognition|cognition
5041966|NCT01457222|Psychological health|psychological health
5041967|NCT01457222|Primary prevention|primary prevention
5041968|NCT01457209|PCOS|pcos
5041969|NCT01457209|Insulin resistance|insulin resistance
5041970|NCT01457209|Acupuncture|acupuncture
5041971|NCT01457196|Cancer Genetics|cancer genetics
5041972|NCT01457183|pulsed lavage|pulsed lavage
5041973|NCT01457183|evaluate containment|evaluate containment
5041974|NCT01457183|evaluate tolerability|evaluate tolerability
5041975|NCT01457170|Pulmonary Hypertension|pulmonary hypertension
5041976|NCT01457170|Heart Failure|heart failure
5041977|NCT01457170|Apelin|apelin
5041978|NCT01457170|Haemodynamics|haemodynamics
5041979|NCT01457170|pulmonary vascular resistance|pulmonary vascular resistance
5041980|NCT01457170|cardiac output|cardiac output
5041981|NCT01457144|Mantle cell lymphoma|mantle cell lymphoma
5041982|NCT01457144|Rituximab|rituximab
5041983|NCT01457144|bendamustine|bendamustine
5041984|NCT01457144|Velcade|velcade
5041985|NCT01457144|Dexamethasone|dexamethasone
5041986|NCT01457131|Metastatic Cancer|metastatic cancer
5041987|NCT01457131|Immunotherapy|immunotherapy
5041988|NCT01457131|Gene Therapy|gene therapy
5041989|NCT01457131|Metastatic Melanoma|metastatic melanoma
5041990|NCT01457131|Metastatic Kidney Cancer|metastatic kidney cancer
5041991|NCT01457118|Open Label multicenter extension study advanced solid tumors|open label multicenter extension study advanced solid tumors
5041992|NCT01457105|Malignant strictures of the main biliary duct|malignant strictures of the main biliary duct
5041993|NCT01457092|benign biliary strictures|benign biliary strictures
5041994|NCT01457092|chronic pancreatitis|chronic pancreatitis
5041995|NCT01457079|Keloid|keloid
5041996|NCT01457079|Radiation Therapy|radiation therapy
5041997|NCT01457079|Hypertrophic Scar|hypertrophic scar
5041998|NCT01457053|Acute decompensated heart failure|acute decompensated heart failure
5041999|NCT01457053|Myocardial blood flow|myocardial blood flow
5042000|NCT01457053|Coronary flow reserve|coronary flow reserve
5042001|NCT01457053|Ultrafiltration|ultrafiltration
5042002|NCT01457053|Diuretics|diuretics
5042003|NCT01457040|Acute Lymphoblastic leukemia|acute lymphoblastic leukemia
5042004|NCT01457040|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
5042005|NCT01457027|Influenza|influenza
5042006|NCT01457027|Virus|virus
5042007|NCT01457027|Vaccination|vaccination
5042008|NCT01457027|Immunisation|immunisation
5042009|NCT01457014|chronic pain|chronic pain
5042010|NCT01457014|sleep disordered breathing|sleep disordered breathing
5042011|NCT01457014|Opioids|opioids
5042012|NCT01457001|chronic haemodialysis|chronic haemodialysis
5042013|NCT01457001|25-OH-D vitamin|25-oh-d vitamin
5042014|NCT01456975|Ascending aorta aneurism|ascending aorta aneurism
5042015|NCT01456975|Aortic insufficiency|aortic insufficiency
5042016|NCT01456962|Immune reconstitution|immune reconstitution
5042017|NCT01456962|CD4+ T cells|cd4+ t cells
5042018|NCT01456949|Atrial fibrillation (AF)|atrial fibrillation (af)
5042019|NCT01456949|Paroxysmal atrial fibrillation (PAF)|paroxysmal atrial fibrillation (paf)
5042020|NCT01456949|Arrythmias|arrythmias
5042021|NCT01456949|Cardiac Arrythmias|cardiac arrythmias
5042022|NCT01456949|Cardiac ablation|cardiac ablation
5042023|NCT01456949|Cryoablation|cryoablation
5042024|NCT01456936|smoking cessation|smoking cessation
5042025|NCT01456936|psychiatric disease|psychiatric disease
5042026|NCT01456923|DNA damaging agents|dna damaging agents
5042027|NCT01456910|Physical education|physical education
5042028|NCT01456910|People with mental disabilities|people with mental disabilities
5042029|NCT01456910|muscular strength dynamometer|muscular strength dynamometer
5042030|NCT01456910|Performance Evaluation|performance evaluation
5042031|NCT01456910|Occupational health|occupational health
5042032|NCT01456884|Music therapy|music therapy
5042033|NCT01456884|Infants|infants
5042034|NCT01456884|Children|children
5042035|NCT01456884|Adolescents|adolescents
5042036|NCT01456884|pediatric|pediatric
5042037|NCT01456884|palliative care|palliative care
5042038|NCT01456884|neurological impairment|neurological impairment
5042039|NCT01456884|metabolic condition|metabolic condition
5042040|NCT01456884|pain management|pain management
5042041|NCT01456871|Mechanoreceptors|mechanoreceptors
5042042|NCT01456871|PIP joint|pip joint
5042043|NCT01456871|Ligamento-muscular reflexes|ligamento-muscular reflexes
5042044|NCT01456858|Malaria Prevention Refugee Emergency|malaria prevention refugee emergency
5042045|NCT01456858|Malaria, Falciparum C03.752.530.650|malaria, falciparum c03.752.530.650
5042046|NCT01456845|Plasma levels|plasma levels
5042047|NCT01456845|isoniazid|isoniazid
5042048|NCT01456845|rifampicin|rifampicin
5042049|NCT01456845|pyrazinamide|pyrazinamide
5042050|NCT01456845|hepatoxicity|hepatoxicity
5042051|NCT01456832|hyponatremia|hyponatremia
5042052|NCT01456832|renal transplant|renal transplant
5042053|NCT01456819|autologous|autologous
5042054|NCT01456819|bone marrow|bone marrow
5042055|NCT01456819|critical limb ischemia|critical limb ischemia
5042056|NCT01456819|efficacy|efficacy
5042057|NCT01456819|mesenchymal stem cells|mesenchymal stem cells
5042058|NCT01456819|mononuclear cells|mononuclear cells
5042059|NCT01456806|T2DM|t2dm
5042060|NCT01456806|Cardiovascular risk factors|cardiovascular risk factors
5042061|NCT01456806|Metabolic control|metabolic control
5042062|NCT01456806|Well-being|well-being
5042063|NCT01456806|Cost|cost
5042064|NCT01456806|Cost-consequence|cost-consequence
5042065|NCT01456793|Pregnancy prevention|pregnancy prevention
5042066|NCT01456793|Pregnancy|pregnancy
5042067|NCT01456793|Birth|birth
5042068|NCT01456793|Contraceptive use|contraceptive use
5042069|NCT01456793|Adolescents|adolescents
5042070|NCT01456780|Meibomian gland dysfunction|meibomian gland dysfunction
5042071|NCT01456780|Blepharitis|blepharitis
5042072|NCT01456780|Dry Eye|dry eye
5042073|NCT01456780|Ocular Inflammation|ocular inflammation
5042075|NCT01456780|Zylet|zylet
5042076|NCT01456780|Lotemax|lotemax
5042077|NCT01456780|Artificial Tear|artificial tear
5042078|NCT01456754|Insulin Metabolism|insulin metabolism
5042079|NCT01456754|Glucose Metabolism|glucose metabolism
5042080|NCT01456754|Substrate Partitioning|substrate partitioning
5042081|NCT01456754|Muscle Biopsies|muscle biopsies
5042082|NCT01456754|Feeding Frequency|feeding frequency
5042083|NCT01456754|Insulin|insulin
5042084|NCT01456741|endobronchial needle aspiration (EBNA)|endobronchial needle aspiration (ebna)
5042085|NCT01456741|transbronchial needle aspiration (TBNA)|transbronchial needle aspiration (tbna)
5042086|NCT01456741|rapid on-site evaluation (ROSE)|rapid on-site evaluation (rose)
5042087|NCT01456741|lung cancer|lung cancer
5042088|NCT01456728|Helicobacter pylori|helicobacter pylori
5042089|NCT01456728|Progastria|progastria
5042090|NCT01456728|Lactobacillus reuteri|lactobacillus reuteri
5042091|NCT01456728|omeprazole|omeprazole
5042092|NCT01456728|triple therapy|triple therapy
5042093|NCT01456728|probiotic|probiotic
5042094|NCT01456715|Human Papillomavirus Vaccines|human papillomavirus vaccines
5042095|NCT01456715|Immunogenicity Gardasil Cervarix|immunogenicity gardasil cervarix
5042096|NCT01456715|Booster dose|booster dose
5042097|NCT01456702|SVV|svv
5042098|NCT01456702|hemodynamic monitoring|hemodynamic monitoring
5042099|NCT01456702|goal-directed volume therapie|goal-directed volume therapie
5042100|NCT01456689|Myeloma|myeloma
5042101|NCT01456689|Multiple Myeloma|multiple myeloma
5042102|NCT01456689|MM|mm
5042103|NCT01456676|LDE225|lde225
5042104|NCT01456676|nilotinib|nilotinib
5042105|NCT01456676|Chronic myeloid leukemia|chronic myeloid leukemia
5042106|NCT01456676|CML|cml
5042107|NCT01456676|Philadelphia positive|philadelphia positive
5042108|NCT01456676|Ph+|ph+
5042109|NCT01456676|resistant|resistant
5042110|NCT01456676|Resistant Philadelphia chromosome positive chronic myeloid leukemia (Ph+ CML) in chronic phase (CP)|resistant philadelphia chromosome positive chronic myeloid leukemia (ph+ cml) in chronic phase (cp)
5042111|NCT01456663|AFQ056|afq056
5042112|NCT01456663|Hepatic impairment|hepatic impairment
5042113|NCT01456663|Hepatic impaired|hepatic impaired
5042114|NCT01456650|Type 2 diabetes|type 2 diabetes
5042115|NCT01456650|ABCA1 alleles|abca1 alleles
5042116|NCT01456650|Glyburide|glyburide
5042117|NCT01456637|Insomnia|insomnia
5042118|NCT01456637|Intervention|intervention
5042119|NCT01456637|Self-help|self-help
5042120|NCT01456637|Internet|internet
5042121|NCT01456598|Stomach neoplasm|stomach neoplasm
5042122|NCT01456598|Laparoscopy|laparoscopy
5042123|NCT01456585|Histological documentation|histological documentation
5042124|NCT01456585|primary adenocarcinoma of the pancreas|primary adenocarcinoma of the pancreas
5042125|NCT01456585|surgically eligible|surgically eligible
5042126|NCT01456585|tumor resection|tumor resection
5042127|NCT01456585|curative intent|curative intent
5042128|NCT01456572|glucagon-like peptide-1|glucagon-like peptide-1
5042129|NCT01456572|peptide tyrosine tyrosine|peptide tyrosine tyrosine
5042130|NCT01456572|ghrelin|ghrelin
5042131|NCT01456572|stomach|stomach
5042132|NCT01456572|small intestine|small intestine
5042133|NCT01456572|gastric emptying|gastric emptying
5042134|NCT01456559|Hypovolemia|hypovolemia
5042135|NCT01456559|Lower body negative pressure|lower body negative pressure
5042136|NCT01456559|Photoplethysmography|photoplethysmography
5042137|NCT01456546|CYP2C19*17|cyp2c19*17
5042138|NCT01456546|Pharmacokinetics|pharmacokinetics
5042139|NCT01456546|Pharmacodynamics|pharmacodynamics
5042140|NCT01456533|hyponatremia|hyponatremia
5042141|NCT01456533|hypernatremia|hypernatremia
5042142|NCT01456520|pharmacokinetics|pharmacokinetics
5042143|NCT01456520|bioequivalence|bioequivalence
5042144|NCT01456520|hydrocodone|hydrocodone
5042145|NCT01456520|acetaminophen|acetaminophen
5042146|NCT01456520|moderate to moderately severe pain|moderate to moderately severe pain
5042147|NCT01456507|Food effect|food effect
5042148|NCT01456507|bioavailability|bioavailability
5042149|NCT01456507|oxycodone|oxycodone
5042150|NCT01456507|sequestered Naltrexone|sequestered naltrexone
5042151|NCT01456507|management of moderate to severe pain|management of moderate to severe pain
5042152|NCT01456494|Obstructive Lung Disease|obstructive lung disease
5042153|NCT01456494|COPD|copd
5042154|NCT01456494|Asthma|asthma
5042155|NCT01456494|Inhaler|inhaler
5042156|NCT01456494|Metered-Dose Inhaler|metered-dose inhaler
5042157|NCT01456494|Education|education
5042158|NCT01456494|Hospital-based education|hospital-based education
5042159|NCT01456481|reflex fainting|reflex fainting
5042160|NCT01456481|vasovagal syncope|vasovagal syncope
5042161|NCT01456481|midodrine|midodrine
5042162|NCT01456468|Cholangitis, Sclerosing|cholangitis, sclerosing
5042163|NCT01456468|Tretinoin|tretinoin
5042164|NCT01456468|Ursodeoxycholic Acid|ursodeoxycholic acid
5042165|NCT01456455|Central nervous system|central nervous system
5042166|NCT01456455|pathological markers|pathological markers
5042167|NCT01456429|invasive staging|invasive staging
5042168|NCT01456429|mediastinal lymph nodes|mediastinal lymph nodes
5042169|NCT01456429|endosonography|endosonography
5042170|NCT01456429|surgical staging|surgical staging
5042171|NCT01456429|lung cancer|lung cancer
5042172|NCT01456416|RRMS|rrms
5042173|NCT01456416|Multiple Sclerosis|multiple sclerosis
5042174|NCT01456416|Glatiramer Acetate|glatiramer acetate
5042175|NCT01456416|Autoimmune Comorbidities|autoimmune comorbidities
5042176|NCT01456416|Psoriasis|psoriasis
5042177|NCT01456416|Autoimmune Thyroiditis|autoimmune thyroiditis
5042178|NCT01456416|Vasculitis|vasculitis
5042179|NCT01456416|Rheumatoid Arthritis|rheumatoid arthritis
5042180|NCT01456403|Carotid|carotid
5042181|NCT01456403|endarterectomy|endarterectomy
5042182|NCT01456403|vulnerable plaque|vulnerable plaque
5042183|NCT01456403|Ultrasound|ultrasound
5042184|NCT01456403|MRI|mri
5042185|NCT01456403|PET/CT|pet/ct
5042186|NCT01456390|Open angle glaucoma|open angle glaucoma
5042187|NCT01456390|Prior trabeculectomy|prior trabeculectomy
5042188|NCT01456377|lumbar stenosis|lumbar stenosis
5042189|NCT01456377|systemic corticosteroids|systemic corticosteroids
5042190|NCT01456377|outcome|outcome
5042191|NCT01456377|security|security
5042192|NCT01456364|clopidogrel low response|clopidogrel low response
5042193|NCT01456364|ticagrelor|ticagrelor
5042194|NCT01456364|prasugrel|prasugrel
5042195|NCT01456364|platelet aggregation|platelet aggregation
5042196|NCT01456351|Event free survival|event free survival
5042197|NCT01456351|Remission rates|remission rates
5042198|NCT01456351|Toxicity|toxicity
5042199|NCT01456351|Overall survival|overall survival
5042200|NCT01456351|Efficiency costs|efficiency costs
5042201|NCT01456351|Recurrent low grade|recurrent low grade
5042202|NCT01456338|cognitive behavior therapy|cognitive behavior therapy
5042203|NCT01456338|addiction|addiction
5042204|NCT01456338|posttraumatic stress disorder (PTSD)|posttraumatic stress disorder (ptsd)
5042205|NCT01456312|Peginterferon alfa 2a|peginterferon alfa 2a
5042206|NCT01456312|Entecavir|entecavir
5042207|NCT01456312|Response Guided Therapy|response guided therapy
5042208|NCT01456312|Chronic Hepatitis B|chronic hepatitis b
5042209|NCT01456299|laryngeal mask airway|laryngeal mask airway
5042210|NCT01456299|insertion|insertion
5042211|NCT01456299|sevoflurane|sevoflurane
5042212|NCT01456299|remifentanil|remifentanil
5042213|NCT01456273|biopsychosocial model|biopsychosocial model
5042214|NCT01456273|biomedical model|biomedical model
5042215|NCT01456273|functional dyspepsia|functional dyspepsia
5042216|NCT01456260|Drug Therapy|drug therapy
5042217|NCT01456247|Drug Therapy|drug therapy
5042218|NCT01456221|Obesity|obesity
5042219|NCT01456221|Insulin resistance|insulin resistance
5042220|NCT01456221|Omega3 long chain polyunsaturated fatty acids|omega3 long chain polyunsaturated fatty acids
5042221|NCT01456195|Drug Therapy|drug therapy
5042222|NCT01456169|High Blood Pressure|high blood pressure
5042223|NCT01456169|Drug Therapy|drug therapy
5042224|NCT01456156|hepatocellular carcinoma|hepatocellular carcinoma
5042225|NCT01456156|postoperative radiotherapy|postoperative radiotherapy
5042226|NCT01456143|Squamous Cell Carcinoma|squamous cell carcinoma
5042227|NCT01456143|Neoplasia|neoplasia
5042228|NCT01456143|Optical imaging|optical imaging
5042229|NCT01456143|Head and Neck Cancer|head and neck cancer
5042230|NCT01456143|Oropharynx|oropharynx
5042231|NCT01456143|Larynx|larynx
5042232|NCT01456143|Oral Cavity|oral cavity
5042233|NCT01456117|Drug Therapy|drug therapy
5042234|NCT01456117|pharmacodynamics|pharmacodynamics
5042235|NCT01456117|pharmacokinetics|pharmacokinetics
5042236|NCT01456104|vaccine|vaccine
5042237|NCT01456104|stage IIB|stage iib
5042238|NCT01456104|stage IIC|stage iic
5042239|NCT01456104|stage III|stage iii
5042240|NCT01456104|stage IV (MIa)|stage iv (mia)
5042241|NCT01456104|Langerhans-type dendritic cells|langerhans-type dendritic cells
5042242|NCT01456104|Immune Responses|immune responses
5042243|NCT01456104|10-229|10-229
5042244|NCT01456091|adolescent pregnancy|adolescent pregnancy
5042245|NCT01456091|adolescent birth|adolescent birth
5042246|NCT01456091|rapid repeat pregnancy|rapid repeat pregnancy
5042247|NCT01456091|rapid repeat birth|rapid repeat birth
5042248|NCT01456091|youth development|youth development
5042249|NCT01456091|Pregnancy in Adolescence|pregnancy in adolescence
5042250|NCT01456078|Neuroendocrine tumor|neuroendocrine tumor
5042251|NCT01456078|Liver metastases|liver metastases
5042252|NCT01456078|177Lu-DOTA-TATE|177lu-dota-tate
5042253|NCT01456078|Safety|safety
5042254|NCT01456078|Kidney dosimetry|kidney dosimetry
5042255|NCT01456078|Dose escalation|dose escalation
5042256|NCT01456078|Neuroendocrine tumors, with liver metastases.|neuroendocrine tumors, with liver metastases.
5042257|NCT01456026|Diabetes|diabetes
5042258|NCT01456026|Advanced glycation endproducts|advanced glycation endproducts
5042259|NCT01456026|Endothelium|endothelium
5042260|NCT01456000|atrial fibrillation|atrial fibrillation
5042261|NCT01456000|AF|af
5042262|NCT01456000|PAF|paf
5042263|NCT01456000|PVI|pvi
5042264|NCT01456000|ablation|ablation
5042265|NCT01456000|paroxysmal atrial fibrillation|paroxysmal atrial fibrillation
5042266|NCT01456000|pulmonary vein isolation|pulmonary vein isolation
5042267|NCT01455987|Osteochondritis dissecans|osteochondritis dissecans
5042268|NCT01455987|Juvenile osteochondritis dissecans|juvenile osteochondritis dissecans
5042269|NCT01455987|Knee|knee
5042270|NCT01455987|Osteochondral|osteochondral
5042271|NCT01455987|Outcome|outcome
5042272|NCT01455974|hypertension|hypertension
5042273|NCT01455974|arterial stiffness|arterial stiffness
5042274|NCT01455974|left ventricular hypertrophy|left ventricular hypertrophy
5042275|NCT01455961|Real life setting|real life setting
5042276|NCT01455961|Bipolar Disorder|bipolar disorder
5042277|NCT01455961|Registry based Data Base Audit|registry based data base audit
5042278|NCT01455948|sinusitis|sinusitis
5042279|NCT01455948|chronic|chronic
5042280|NCT01455948|Functional endoscopic sinus surgery|functional endoscopic sinus surgery
5042281|NCT01455948|balloon sinuplasty|balloon sinuplasty
5042282|NCT01455844|Hypertriglyceridemia|hypertriglyceridemia
5042283|NCT01455792|Biopsy|biopsy
5042284|NCT01455792|MRI and ultrasound soft image fusion|mri and ultrasound soft image fusion
5042285|NCT01455792|Gold standard TRUS biopsy|gold standard trus biopsy
5042286|NCT01455779|Stress Urinary Incontinence|stress urinary incontinence
5042287|NCT01455779|Incontinence|incontinence
5042288|NCT01455779|SUI|sui
5042289|NCT01455779|Renessa|renessa
5042290|NCT01455766|postpneumonectomy pulmonary edema|postpneumonectomy pulmonary edema
5042291|NCT01455766|extravascular lung water|extravascular lung water
5042292|NCT01455753|Influenza|influenza
5042293|NCT01455753|Proximity|proximity
5042294|NCT01455740|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5042295|NCT01455740|HIV|hiv
5042296|NCT01455740|Commitment|commitment
5042297|NCT01455740|Financial Incentives|financial incentives
5042298|NCT01455727|Pharmaceutical care|pharmaceutical care
5042299|NCT01455727|Diabetes Mellitus|diabetes mellitus
5042300|NCT01455714|hypertenion|hypertenion
5042301|NCT01455714|exertional dyspnoea|exertional dyspnoea
5042302|NCT01455714|heart failure|heart failure
5042303|NCT01455714|biomarkers|biomarkers
5042304|NCT01455688|critically ill patients|critically ill patients
5042305|NCT01455688|HIV infection|hiv infection
5042306|NCT01455688|HAART|haart
5042307|NCT01455688|mortality|mortality
5042308|NCT01455675|cystic fibrosis|cystic fibrosis
5042309|NCT01455662|cardiac arrest|cardiac arrest
5042310|NCT01455649|Kidney|kidney
5042311|NCT01455649|Transplant|transplant
5042312|NCT01455649|Immunosuppression|immunosuppression
5042313|NCT01455649|Everolimus|everolimus
5042314|NCT01455649|Graft function|graft function
5042315|NCT01455636|pediatric|pediatric
5042316|NCT01455636|micronutrient powder|micronutrient powder
5042317|NCT01455636|hand hygiene|hand hygiene
5042318|NCT01455636|low birth weight|low birth weight
5042319|NCT01455636|infant feeding|infant feeding
5042320|NCT01455636|hand sanitizers|hand sanitizers
5042321|NCT01455623|CMT|cmt
5042322|NCT01455610|Computed tomography|computed tomography
5042323|NCT01455610|Contrast enhancement|contrast enhancement
5042324|NCT01455610|Pancreas|pancreas
5042325|NCT01455610|Cancer|cancer
5042326|NCT01455610|Resectability|resectability
5042327|NCT01455597|Postmenopausal Women|postmenopausal women
5042328|NCT01455597|Vaginal Dryness|vaginal dryness
5042329|NCT01455597|Postmenopausal Vulvovaginal Atrophy|postmenopausal vulvovaginal atrophy
5042330|NCT01455584|HM781-36B|hm781-36b
5042331|NCT01455558|Pharmacokinetics|pharmacokinetics
5042332|NCT01455545|Asthma|asthma
5042333|NCT01455545|Degree of Control|degree of control
5042334|NCT01455545|Exhaled Nitric Oxide|exhaled nitric oxide
5042335|NCT01455545|Asthma Control Test|asthma control test
5042336|NCT01455519|Low Back Pain|low back pain
5042337|NCT01455519|Back Pain|back pain
5042338|NCT01455519|Chronic back pain|chronic back pain
5042339|NCT01455506|Acute Myeloid Leukemia (AML)|acute myeloid leukemia (aml)
5042340|NCT01455506|Myelodysplastic Syndrome (MDS)|myelodysplastic syndrome (mds)
5042341|NCT01455506|Bone Marrow Transplant|bone marrow transplant
5042342|NCT01455506|Stem Cell Transplant|stem cell transplant
5042343|NCT01455480|Second Degree Burn|second degree burn
5042344|NCT01455480|partial thickness burns|partial thickness burns
5042345|NCT01455467|Open angle glaucoma|open angle glaucoma
5042346|NCT01455467|Pigmentary glaucoma|pigmentary glaucoma
5042347|NCT01455467|Pseudoexfoliative glaucoma|pseudoexfoliative glaucoma
5042348|NCT01455441|GLP-1|glp-1
5042349|NCT01455441|Training|training
5042350|NCT01455441|Exercise|exercise
5042351|NCT01455441|Type 2 Diabetes|type 2 diabetes
5042352|NCT01455428|Pregabalin|pregabalin
5042353|NCT01455428|Postherpetic Neuralgia ( PHN )|postherpetic neuralgia ( phn )
5042354|NCT01455402|Respiratory Syncytial Virus, Chronic Obstructive Pulmonary Disease, Congestive Heart Failure, Observational|respiratory syncytial virus, chronic obstructive pulmonary disease, congestive heart failure, observational
5042355|NCT01455389|Lung Cancer|lung cancer
5042356|NCT01455389|Non-small cell lung cancer|non-small cell lung cancer
5042357|NCT01455389|NSCLC|nsclc
5042358|NCT01455389|FUS1-nanoparticles|fus1-nanoparticles
5042359|NCT01455389|DOTAP:Chol-fus1|dotap:chol-fus1
5042360|NCT01455389|DOTAP:Cholesterol-Fus1 Liposome Complex|dotap:cholesterol-fus1 liposome complex
5042361|NCT01455389|Erlotinib|erlotinib
5042362|NCT01455389|Erlotinib Hydrochloride|erlotinib hydrochloride
5042363|NCT01455389|OSI-774|osi-774
5042364|NCT01455389|Tarceva|tarceva
5042365|NCT01455389|Dexamethasone|dexamethasone
5042366|NCT01455389|Decadron|decadron
5042367|NCT01455389|Diphenhydramine|diphenhydramine
5042368|NCT01455389|Benadryl|benadryl
5042369|NCT01455389|Benylin Cough SyrupPharmacokinetic|benylin cough syruppharmacokinetic
5042370|NCT01455389|PK|pk
5042371|NCT01455376|brain injury|brain injury
5042372|NCT01455376|cognitive function|cognitive function
5042373|NCT01455376|sodium lactate|sodium lactate
5042374|NCT01455376|MMSE score|mmse score
5042375|NCT01455350|provoked vestibulodynia|provoked vestibulodynia
5042376|NCT01455350|multimodal physiotherapy|multimodal physiotherapy
5042377|NCT01455350|lidocaine|lidocaine
5042378|NCT01455337|severe alcoholic hepatitis|severe alcoholic hepatitis
5042379|NCT01455324|prosthetic socket|prosthetic socket
5042380|NCT01455324|residual limb volume fluctuation|residual limb volume fluctuation
5042381|NCT01455324|conformable socket liner|conformable socket liner
5042382|NCT01455311|cystic pancreatic tumors|cystic pancreatic tumors
5042383|NCT01455311|cystic pancreatic lesions|cystic pancreatic lesions
5042384|NCT01455311|gastrointestinal|gastrointestinal
5042385|NCT01455311|GI|gi
5042386|NCT01455311|EUS-FNA|eus-fna
5042387|NCT01455311|EchoBrush®|echobrush®
5042388|NCT01455311|cytology brush|cytology brush
5042389|NCT01455311|endoscopic|endoscopic
5042390|NCT01455298|Alpha-1 AT deficiency|alpha-1 at deficiency
5042391|NCT01455298|liver injury|liver injury
5042392|NCT01455298|Transient Elastography|transient elastography
5042393|NCT01455298|FibroTest|fibrotest
5042394|NCT01455285|dysmenorrhea|dysmenorrhea
5042395|NCT01455285|transcutaneous electrical nerve stimulation (TENS|transcutaneous electrical nerve stimulation (tens
5042396|NCT01455285|analgesia|analgesia
5042397|NCT01455285|pain visual analog scale|pain visual analog scale
5042398|NCT01455285|McGill pain questionnaire|mcgill pain questionnaire
5042399|NCT01455259|AdCD40L|adcd40l
5042400|NCT01455259|Adenoviral vector|adenoviral vector
5042401|NCT01455259|CD40L|cd40l
5042402|NCT01455259|CD154|cd154
5042403|NCT01455259|malignant melanoma|malignant melanoma
5042404|NCT01455246|Cirrhosis|cirrhosis
5042405|NCT01455246|Nosocomial Spontaneous Bacterial Peritonitis|nosocomial spontaneous bacterial peritonitis
5042406|NCT01455246|Ascites|ascites
5042407|NCT01455246|Daptomycin|daptomycin
5042408|NCT01455246|Meropenem|meropenem
5042409|NCT01455246|Ceftazidime|ceftazidime
5042410|NCT01455246|Nosocomial infection|nosocomial infection
5042411|NCT01455246|Multi drug resistant bacteria|multi drug resistant bacteria
5042412|NCT01455246|Sepsis|sepsis
5042413|NCT01455246|Albumin|albumin
5042414|NCT01455233|cornea|cornea
5042415|NCT01455233|ocular antibiotic|ocular antibiotic
5042416|NCT01455233|cataract surgery|cataract surgery
5042417|NCT01455220|Multiple Sclerosis|multiple sclerosis
5042418|NCT01455220|Sexual Dysfunction|sexual dysfunction
5042419|NCT01455220|Quality of Life|quality of life
5042420|NCT01455207|Magnetic Resonance Imaging|magnetic resonance imaging
5042421|NCT01455207|Positon Emission Tomography|positon emission tomography
5042422|NCT01455207|Behavior|behavior
5042423|NCT01455194|ciclesonide|ciclesonide
5042424|NCT01455194|asthma|asthma
5042425|NCT01455181|Hypoparathyroidism|hypoparathyroidism
5042426|NCT01455181|NPSP558|npsp558
5042427|NCT01455181|Parathyroid Hormone 1-84|parathyroid hormone 1-84
5042428|NCT01455181|PTH 1-84|pth 1-84
5042429|NCT01455168|anterior capsule shrinkage|anterior capsule shrinkage
5042430|NCT01455168|capsular tension ring|capsular tension ring
5042431|NCT01455168|exfoliation syndrome|exfoliation syndrome
5042432|NCT01455168|phacoemulsification and aspiration|phacoemulsification and aspiration
5042433|NCT01455155|stroke|stroke
5042434|NCT01455155|Art therapy|art therapy
5042435|NCT01455155|Music therapy|music therapy
5042436|NCT01455155|Creative therapy|creative therapy
5042437|NCT01455155|Efficacy|efficacy
5042438|NCT01455129|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
5042439|NCT01455129|COPD|copd
5042440|NCT01455129|COPD exacerbation|copd exacerbation
5042441|NCT01455129|treatment|treatment
5042442|NCT01455129|tiotropium|tiotropium
5042443|NCT01455129|anticholinergic|anticholinergic
5042444|NCT01455129|acute exacerbation of COPD (AECOPD)|acute exacerbation of copd (aecopd)
5042445|NCT01455116|Sepsis|sepsis
5042446|NCT01455116|Multi organ dysfunction syndrome|multi organ dysfunction syndrome
5042447|NCT01455116|Mild Induced Hypothermia|mild induced hypothermia
5042448|NCT01455077|obesity|obesity
5042449|NCT01455077|sleep apnea|sleep apnea
5042450|NCT01455077|portable monitoring|portable monitoring
5042451|NCT01455025|Plerixafor granulocyte-colony stimulating factor|plerixafor granulocyte-colony stimulating factor
5042452|NCT01455025|Chemotherapy in relapse|chemotherapy in relapse
5042453|NCT01455025|Acute Myeloid Leukemia|acute myeloid leukemia
5042454|NCT01455012|Rotigotine|rotigotine
5042455|NCT01455012|Neupro|neupro
5042456|NCT01455012|RLS|rls
5042457|NCT01455012|Cardiovascular Risk|cardiovascular risk
5042458|NCT01455012|Nocturnal Blood Pressure|nocturnal blood pressure
5042459|NCT01454999|veteran|veteran
5042460|NCT01454999|smoking|smoking
5042461|NCT01454999|stage of change|stage of change
5042462|NCT01454999|cell phone|cell phone
5042463|NCT01454999|computerized tailored intervention|computerized tailored intervention
5042464|NCT01454986|Healthy subjects|healthy subjects
5042465|NCT01454973|type 2 diabetes|type 2 diabetes
5042466|NCT01454973|beta cell function|beta cell function
5042467|NCT01454973|meal tolerance test|meal tolerance test
5042468|NCT01454973|maximum stimulation test|maximum stimulation test
5042469|NCT01454973|method standardization|method standardization
5042470|NCT01454973|insulin secretion|insulin secretion
5042471|NCT01454960|Antibiotics|antibiotics
5042472|NCT01454960|Inappropriate Prescribing|inappropriate prescribing
5042473|NCT01454960|Respiratory Tract Infections|respiratory tract infections
5042474|NCT01454960|Behavioral Research|behavioral research
5042475|NCT01454947|Antibiotics|antibiotics
5042476|NCT01454947|Inappropriate Prescribing|inappropriate prescribing
5042477|NCT01454947|Respiratory Tract Infections|respiratory tract infections
5042478|NCT01454947|Behavioral Research|behavioral research
5042479|NCT01454921|HIV|hiv
5042480|NCT01454921|Adolescent Trials Network|adolescent trials network
5042481|NCT01454908|partial knee arthroplasty|partial knee arthroplasty
5042482|NCT01454895|noise-induced hearing loss|noise-induced hearing loss
5042483|NCT01454895|prevention|prevention
5042484|NCT01454895|farmers|farmers
5042485|NCT01454882|Direct calorimetry|direct calorimetry
5042486|NCT01454882|Indirect calorimetry|indirect calorimetry
5042487|NCT01454882|Energy Expenditure|energy expenditure
5042488|NCT01454869|heparin|heparin
5042489|NCT01454843|Myopia|myopia
5042490|NCT01454843|Astigmatism|astigmatism
5042491|NCT01454843|Aberrations|aberrations
5042492|NCT01454843|Wavefront|wavefront
5042493|NCT01454843|LASIK|lasik
5042494|NCT01454843|Wavefront LASIK|wavefront lasik
5042495|NCT01454830|Social support|social support
5042496|NCT01454830|Cognition|cognition
5042497|NCT01454830|Adaptation, psychological|adaptation, psychological
5042498|NCT01454830|Health behavior|health behavior
5042499|NCT01454830|Patient education|patient education
5042500|NCT01454817|Quality of Life|quality of life
5042501|NCT01454817|Implantable Cardiac Defibrillators|implantable cardiac defibrillators
5042502|NCT01454817|ICDs|icds
5042503|NCT01454804|Advanced Cancers|advanced cancers
5042504|NCT01454804|Solid Tumors|solid tumors
5042505|NCT01454804|Pazopanib|pazopanib
5042506|NCT01454804|GW786034|gw786034
5042507|NCT01454804|Lapatinib|lapatinib
5042508|NCT01454804|Tykerb|tykerb
5042509|NCT01454804|GW572016|gw572016
5042510|NCT01454804|Trastuzumab|trastuzumab
5042511|NCT01454804|Herceptin|herceptin
5042512|NCT01454791|multiple sclerosis|multiple sclerosis
5042513|NCT01454791|diclofenac|diclofenac
5042514|NCT01454791|subcutaneous injection|subcutaneous injection
5042515|NCT01454791|glatiramer acetate|glatiramer acetate
5042516|NCT01454791|Copaxone|copaxone
5042517|NCT01454778|restenosis|restenosis
5042518|NCT01454778|peripheral vascular disease|peripheral vascular disease
5042519|NCT01454778|lower extremity ischemia|lower extremity ischemia
5042520|NCT01454778|claudication|claudication
5042521|NCT01454752|malaria|malaria
5042522|NCT01454752|anaemia|anaemia
5042523|NCT01454752|cognition|cognition
5042524|NCT01454752|intermittent preventive treatment|intermittent preventive treatment
5042525|NCT01454752|children|children
5042526|NCT01454752|schools|schools
5042527|NCT01454752|insecticide-treated nets|insecticide-treated nets
5042528|NCT01454739|rFVIIIFc|rfviiifc
5042529|NCT01454739|A-LONG Extension|a-long extension
5042530|NCT01454726|Dizziness|dizziness
5042531|NCT01454726|Meniere's disease|meniere's disease
5042532|NCT01454726|Diaoshi Jifa therapy|diaoshi jifa therapy
5042533|NCT01454700|Type 1 diabetes mellitus|type 1 diabetes mellitus
5042534|NCT01454700|Albuminuria|albuminuria
5042535|NCT01454700|Late diabetes complications|late diabetes complications
5042536|NCT01454700|CSII|csii
5042537|NCT01454700|CGM|cgm
5042538|NCT01454700|Glycaemic control|glycaemic control
5042539|NCT01454661|Probiotics|probiotics
5042540|NCT01454661|Premature infant|premature infant
5042541|NCT01454661|Intestinal microbiota|intestinal microbiota
5042542|NCT01454661|Intestinal immunity|intestinal immunity
5042543|NCT01454661|Breastfeeding|breastfeeding
5042544|NCT01454648|Traumatic Brain Injury|traumatic brain injury
5042545|NCT01454648|EMS|ems
5042546|NCT01454648|Out-of-Hospital|out-of-hospital
5042547|NCT01454635|depression|depression
5042548|NCT01454635|treatment response|treatment response
5042549|NCT01454635|selective serotonin reuptake inhibitor|selective serotonin reuptake inhibitor
5042550|NCT01454622|Healthy Volunteers|healthy volunteers
5042551|NCT01454622|Bioequivalence|bioequivalence
5042552|NCT01454622|Canagliflozin (JNJ-28431754)|canagliflozin (jnj-28431754)
5042553|NCT01454622|Metformin IR|metformin ir
5042554|NCT01454609|cervical plexus block|cervical plexus block
5042555|NCT01454609|thyroidectomy|thyroidectomy
5042556|NCT01454609|postoperative analgesia|postoperative analgesia
5042557|NCT01454596|Cell Therapy|cell therapy
5042558|NCT01454596|Gene Therapy|gene therapy
5042559|NCT01454596|Immunotherapy|immunotherapy
5042560|NCT01454596|Brain Cancer|brain cancer
5042561|NCT01454596|Glioma|glioma
5042562|NCT01454596|Glioblastoma|glioblastoma
5042563|NCT01454583|renin inhibitor|renin inhibitor
5042564|NCT01454583|ACE inhibitor|ace inhibitor
5042565|NCT01454583|ARB (AT1 receptor blockers)|arb (at1 receptor blockers)
5042566|NCT01454583|RAS blockade|ras blockade
5042567|NCT01454570|exoskeleton walking system|exoskeleton walking system
5042568|NCT01454570|paraplegia|paraplegia
5042569|NCT01454570|paralysis|paralysis
5042570|NCT01454557|Acquired Brain Injury|acquired brain injury
5042571|NCT01454557|Heart Rate Variability (HRV)|heart rate variability (hrv)
5042572|NCT01454557|Auditory Stimuli|auditory stimuli
5042573|NCT01454557|Physical Activity|physical activity
5042574|NCT01454518|hip arthroscopy|hip arthroscopy
5042575|NCT01454518|post operative analgesia|post operative analgesia
5042576|NCT01454505|Healthy subjects|healthy subjects
5042577|NCT01454505|Nasal allergies|nasal allergies
5042578|NCT01454505|Allergies|allergies
5042579|NCT01454505|Environmental Exposure Chamber|environmental exposure chamber
5042580|NCT01454505|EEC|eec
5042581|NCT01454505|Ragweed|ragweed
5042582|NCT01454492|Allergy rhinitis|allergy rhinitis
5042583|NCT01454492|Geographic tongue|geographic tongue
5042584|NCT01454479|Lapatinib|lapatinib
5042585|NCT01454479|Ixabepilone|ixabepilone
5042586|NCT01454479|HER-2|her-2
5042587|NCT01454479|Endometrial Carcinoma|endometrial carcinoma
5042588|NCT01454466|prevention|prevention
5042589|NCT01454466|retinal break|retinal break
5042590|NCT01454466|vitrectomy|vitrectomy
5042591|NCT01454466|partial posterior hyaloidectomy|partial posterior hyaloidectomy
5042592|NCT01454453|amisulpride|amisulpride
5042593|NCT01454453|receptor occupancy|receptor occupancy
5042594|NCT01454453|antipsychotic sensitivity|antipsychotic sensitivity
5042595|NCT01454440|Coronary artery disease|coronary artery disease
5042596|NCT01454440|Eptifibatide|eptifibatide
5042597|NCT01454440|Percutaneous coronary intervention|percutaneous coronary intervention
5042598|NCT01454440|stable coronary artery disease|stable coronary artery disease
5042599|NCT01454440|percutaneous coronary intervention (PCI)|percutaneous coronary intervention (pci)
5042600|NCT01454440|DES|des
5042601|NCT01454375|Smoking|smoking
5042602|NCT01454362|nicotine|nicotine
5042603|NCT01454362|inhalator|inhalator
5042604|NCT01454362|electronic cigarette|electronic cigarette
5042605|NCT01454362|tobacco|tobacco
5042606|NCT01454349|Benign prostatic hyperplasia|benign prostatic hyperplasia
5042607|NCT01454349|BPH|bph
5042608|NCT01454349|Enlarged prostate|enlarged prostate
5042609|NCT01454349|Lower urinary tract symptoms (LUTS)|lower urinary tract symptoms (luts)
5042610|NCT01454336|MSCs|mscs
5042611|NCT01454336|Pioglitazon|pioglitazon
5042612|NCT01454336|fibrosis|fibrosis
5042613|NCT01454336|liver|liver
5042614|NCT01454323|Chronic Myocardial Ischemia|chronic myocardial ischemia
5042615|NCT01454323|Cell therapy|cell therapy
5042616|NCT01454323|Bone marrow mononuclear cells|bone marrow mononuclear cells
5042617|NCT01454310|Skin substitutes|skin substitutes
5042618|NCT01454310|Split-thickness skin graft|split-thickness skin graft
5042619|NCT01454310|Burn wound|burn wound
5042620|NCT01454310|Scar formation|scar formation
5042621|NCT01454310|Skin quality|skin quality
5042622|NCT01454297|Myeloma|myeloma
5042623|NCT01454297|Multiple Myeloma|multiple myeloma
5042624|NCT01454297|Observational|observational
5042625|NCT01454297|Longitudinal|longitudinal
5042626|NCT01454271|Total Hip arthroplasty|total hip arthroplasty
5042627|NCT01454271|Hip Osteoarthritis|hip osteoarthritis
5042628|NCT01454271|Infection after Total Hip Arthroplasty|infection after total hip arthroplasty
5042629|NCT01454245|39439335EDI1013|39439335edi1013
5042630|NCT01454245|Bioavailability|bioavailability
5042631|NCT01454245|Pharmacokinetics|pharmacokinetics
5042632|NCT01454232|Obesity|obesity
5042633|NCT01454232|adipose tissue inflammation|adipose tissue inflammation
5042634|NCT01454232|Low grade systemic inflammation|low grade systemic inflammation
5042635|NCT01454232|gut microbiota|gut microbiota
5042636|NCT01454232|Bariatric surgery|bariatric surgery
5042637|NCT01454206|cannabis abuse|cannabis abuse
5042638|NCT01454206|alcohol abuse|alcohol abuse
5042639|NCT01454206|substance abuse|substance abuse
5042640|NCT01454180|Therapeutic targets in Pancreas|therapeutic targets in pancreas
5042641|NCT01454167|vacum drains|vacum drains
5042642|NCT01454167|operational wounds|operational wounds
5042643|NCT01454167|infections|infections
5042644|NCT01454167|seroma|seroma
5042645|NCT01454167|acid base|acid base
5042646|NCT01454167|glucose|glucose
5042647|NCT01454167|lactate|lactate
5042648|NCT01454154|TBI|tbi
5042649|NCT01454154|Traumatic Brain Injury|traumatic brain injury
5042650|NCT01454141|Depressed mood|depressed mood
5042651|NCT01454128|exercise base rehabilitation|exercise base rehabilitation
5042652|NCT01454128|heart failure|heart failure
5042653|NCT01454128|periodic breathing|periodic breathing
5042654|NCT01454128|aerobic fitness|aerobic fitness
5042655|NCT01454089|bladder|bladder
5042656|NCT01454089|urinary tract|urinary tract
5042657|NCT01454089|transitional cell carcinoma|transitional cell carcinoma
5042658|NCT01454089|metastatic bladder cancer|metastatic bladder cancer
5042659|NCT01454089|chemotherapy|chemotherapy
5043754|NCT01449669|cefazolin|cefazolin
5042660|NCT01454076|Cmax: maximum plasma concentration|cmax: maximum plasma concentration
5042661|NCT01454076|AUC0-tlast: area under the plasma concentration-time curve from time zero to the time of the last quantifiable concentration|auc0-tlast: area under the plasma concentration-time curve from time zero to the time of the last quantifiable concentration
5042662|NCT01454063|cataract|cataract
5042663|NCT01454063|lens replacement|lens replacement
5042664|NCT01454050|ICD therapy|icd therapy
5042665|NCT01454050|RV/LV Capture Control|rv/lv capture control
5042666|NCT01454050|Safety and Efficacy|safety and efficacy
5042667|NCT01454011|hypogonadism|hypogonadism
5042668|NCT01454011|testosterone|testosterone
5042669|NCT01454011|HDL cholesterol subgroups|hdl cholesterol subgroups
5042670|NCT01454011|hsCRP|hscrp
5042671|NCT01454011|HOMA-IR|homa-ir
5042672|NCT01453972|Exercise|exercise
5042673|NCT01453972|High-intensity|high-intensity
5042674|NCT01453972|Interval training|interval training
5042675|NCT01453959|hypertension|hypertension
5042676|NCT01453959|salt sensitivity|salt sensitivity
5042677|NCT01453959|fludrocortisone|fludrocortisone
5042678|NCT01453946|Crohn's Disease|crohn's disease
5042679|NCT01453933|Anti-HIV Agents|anti-hiv agents
5042680|NCT01453933|Anti-Retroviral Agents|anti-retroviral agents
5042681|NCT01453933|Antiviral Agents|antiviral agents
5042682|NCT01453933|Anti-Infective Agents|anti-infective agents
5042683|NCT01453933|Lopinavir/ritonavir|lopinavir/ritonavir
5042684|NCT01453920|Age Related Macular Degeneration|age related macular degeneration
5042685|NCT01453920|Choroidal Neovascular Membrane|choroidal neovascular membrane
5042686|NCT01453894|Colorectal Cancer Screening|colorectal cancer screening
5042687|NCT01453894|Fecal Occult Blood Testing|fecal occult blood testing
5042688|NCT01453881|Asthma|asthma
5042689|NCT01453881|pMDI|pmdi
5042690|NCT01453881|Beclomethasone|beclomethasone
5042691|NCT01453881|Formoterol|formoterol
5042692|NCT01453881|Efficacy|efficacy
5042693|NCT01453868|Multiple Sclerosis|multiple sclerosis
5042694|NCT01453868|non impact aerobics|non impact aerobics
5042695|NCT01453855|Open-Angle Glaucoma|open-angle glaucoma
5042696|NCT01453855|Ocular Hypertension|ocular hypertension
5042697|NCT01453842|Glucagon-like peptide-1|glucagon-like peptide-1
5042698|NCT01453842|Glucose-dependant insulinotropic polypeptide|glucose-dependant insulinotropic polypeptide
5042699|NCT01453842|Glucagon|glucagon
5042700|NCT01453842|Peptide PYY|peptide pyy
5042701|NCT01453842|2-oleyl glycerol|2-oleyl glycerol
5042702|NCT01453816|Renal insufficiency|renal insufficiency
5042703|NCT01453816|kidney failure|kidney failure
5042704|NCT01453803|Liposuction|liposuction
5042705|NCT01453803|ADSC|adsc
5042706|NCT01453803|ASC|asc
5042707|NCT01453803|stem cell|stem cell
5042708|NCT01453803|Parkinson's Disease|parkinson's disease
5042709|NCT01453803|Parkinson's|parkinson's
5042710|NCT01453803|therapy|therapy
5042711|NCT01453790|depression|depression
5042712|NCT01453790|treatment|treatment
5042713|NCT01453790|motivation to seek follow up|motivation to seek follow up
5042714|NCT01453777|diffuse brain lesion|diffuse brain lesion
5042715|NCT01453751|Diabetes|diabetes
5042716|NCT01453751|Type 2 Diabetes|type 2 diabetes
5042717|NCT01453738|Osteoarthritis|osteoarthritis
5042718|NCT01453738|Knee|knee
5042719|NCT01453738|Stem cells|stem cells
5042720|NCT01453738|Mesenchymal Stem Cells|mesenchymal stem cells
5042721|NCT01453712|coronary artery disease|coronary artery disease
5042722|NCT01453712|coronary CT angiography|coronary ct angiography
5042723|NCT01453712|radiation dose|radiation dose
5042724|NCT01453712|iterative image reconstruction|iterative image reconstruction
5042725|NCT01453712|detection|detection
5042726|NCT01453699|Bereavement|bereavement
5042727|NCT01453699|early parental death|early parental death
5042728|NCT01453699|grief|grief
5042729|NCT01453699|affective disorders|affective disorders
5042730|NCT01453699|depression, depressive symptoms|depression, depressive symptoms
5042731|NCT01453699|socioeconomic factors|socioeconomic factors
5042732|NCT01453699|suicide|suicide
5042733|NCT01453699|attempted suicide|attempted suicide
5042734|NCT01453699|antidepressive agents|antidepressive agents
5042735|NCT01453699|cardiovascular diseases|cardiovascular diseases
5042736|NCT01453699|quality of life|quality of life
5042737|NCT01453699|Long-term health effects|long-term health effects
5042738|NCT01453699|Socioeconomic outcomes|socioeconomic outcomes
5042739|NCT01453699|Psychosocial well-being|psychosocial well-being
5042740|NCT01453686|Alopecia Areata|alopecia areata
5042741|NCT01453686|Hydrocortisone|hydrocortisone
5042742|NCT01453686|Clobetasol Propionate|clobetasol propionate
5042743|NCT01453686|Randomized Controlled Trial|randomized controlled trial
5042744|NCT01453673|knee|knee
5042745|NCT01453673|Cruciate Ligament|cruciate ligament
5042746|NCT01453673|Meniscus|meniscus
5042747|NCT01453660|Endothelial Function|endothelial function
5042748|NCT01453660|Endo-PAT2000 system|endo-pat2000 system
5042749|NCT01453660|11-140|11-140
5042750|NCT01453647|Fibromyalgia|fibromyalgia
5042751|NCT01453647|self-efficacy|self-efficacy
5042752|NCT01453647|fatigue|fatigue
5042753|NCT01453647|stress|stress
5042754|NCT01453647|cytokine|cytokine
5042755|NCT01453634|chronic kidney disease (CKD)|chronic kidney disease (ckd)
5042756|NCT01453634|secondary hyperparathyroidism (SHPT)|secondary hyperparathyroidism (shpt)
5042757|NCT01453634|hemodialysis (HD)|hemodialysis (hd)
5042758|NCT01453621|prediction rules|prediction rules
5042759|NCT01453621|computerized clinical decision support|computerized clinical decision support
5042760|NCT01453621|traumatic brain injury|traumatic brain injury
5042761|NCT01453621|blunt head trauma|blunt head trauma
5042762|NCT01453595|Kidney|kidney
5042763|NCT01453595|renal cell carcinoma|renal cell carcinoma
5042764|NCT01453595|BEZ235|bez235
5042765|NCT01453595|11-080|11-080
5042766|NCT01453582|Chest stuffiness of TCM|chest stuffiness of tcm
5042767|NCT01453582|Qi deficiency and blood stasis of TCM|qi deficiency and blood stasis of tcm
5042768|NCT01453556|Laparoscopic surgery|laparoscopic surgery
5042769|NCT01453556|Right colectomy|right colectomy
5042770|NCT01453556|Mechanical anastomosis|mechanical anastomosis
5042771|NCT01453556|Post-operative ileum|post-operative ileum
5042772|NCT01453530|Recovery|recovery
5042773|NCT01453530|Street fitness|street fitness
5042774|NCT01453530|Sugammadex|sugammadex
5042775|NCT01453530|Alertness|alertness
5042776|NCT01453530|Ambulatory surgery|ambulatory surgery
5042777|NCT01453517|bariatric|bariatric
5042778|NCT01453517|obesity|obesity
5042779|NCT01453517|post-surgery|post-surgery
5042780|NCT01453517|intervention|intervention
5042781|NCT01453452|weight changes|weight changes
5042782|NCT01453452|fatigue|fatigue
5042783|NCT01453452|depression|depression
5042784|NCT01453452|anxiety disorder|anxiety disorder
5042785|NCT01453452|pain|pain
5042786|NCT01453452|cognitive/functional effects|cognitive/functional effects
5042787|NCT01453452|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
5042788|NCT01453452|cancer survivor|cancer survivor
5042789|NCT01453452|stage IA breast cancer|stage ia breast cancer
5042790|NCT01453452|stage IB breast cancer|stage ib breast cancer
5042791|NCT01453452|stage II breast cancer|stage ii breast cancer
5042792|NCT01453452|stage IIIA breast cancer|stage iiia breast cancer
5042793|NCT01453452|stage IIIB breast cancer|stage iiib breast cancer
5042794|NCT01453452|stage IIIC breast cancer|stage iiic breast cancer
5042795|NCT01453452|stage I colon cancer|stage i colon cancer
5042796|NCT01453452|stage IIA colon cancer|stage iia colon cancer
5042797|NCT01453452|stage IIB colon cancer|stage iib colon cancer
5042798|NCT01453452|stage IIC colon cancer|stage iic colon cancer
5042799|NCT01453452|stage IIIA colon cancer|stage iiia colon cancer
5042800|NCT01453452|stage IIIB colon cancer|stage iiib colon cancer
5042801|NCT01453452|stage IIIC colon cancer|stage iiic colon cancer
5042802|NCT01453452|stage I rectal cancer|stage i rectal cancer
5042803|NCT01453452|stage IIA rectal cancer|stage iia rectal cancer
5042804|NCT01453452|stage IIB rectal cancer|stage iib rectal cancer
5042805|NCT01453452|stage IIC rectal cancer|stage iic rectal cancer
5042806|NCT01453452|stage IIIA rectal cancer|stage iiia rectal cancer
5042807|NCT01453452|stage IIIB rectal cancer|stage iiib rectal cancer
5042808|NCT01453452|stage IIIC rectal cancer|stage iiic rectal cancer
5042809|NCT01453439|Body dysmorphic disorder|body dysmorphic disorder
5042810|NCT01453439|Obsessive compulsive spectrum disorder|obsessive compulsive spectrum disorder
5042811|NCT01453439|Body image|body image
5042812|NCT01453439|Appearance concerns|appearance concerns
5042813|NCT01453400|aspirin|aspirin
5042814|NCT01453400|acetylsalicylic acid|acetylsalicylic acid
5042815|NCT01453400|pharyngitis|pharyngitis
5042816|NCT01453400|sore throat|sore throat
5042817|NCT01453387|MEK inhibitor|mek inhibitor
5042818|NCT01453387|Solid Tumor|solid tumor
5042819|NCT01453387|Phase I|phase i
5042820|NCT01453374|opioid dependence|opioid dependence
5042821|NCT01453374|VIVITROL|vivitrol
5042822|NCT01453374|criminal justice|criminal justice
5042823|NCT01453361|FANG|fang
5042824|NCT01453361|Melanoma|melanoma
5042825|NCT01453361|Vigil|vigil
5042826|NCT01453348|meningococcal|meningococcal
5042827|NCT01453348|conjugate|conjugate
5042828|NCT01453348|vaccine|vaccine
5042829|NCT01453348|adults|adults
5042830|NCT01453335|Veins|veins
5042831|NCT01453335|Catheter Segments|catheter segments
5042832|NCT01453335|Vascular Access|vascular access
5042833|NCT01453335|VeinViewer Vision|veinviewer vision
5042834|NCT01453322|Veins|veins
5042835|NCT01453322|Vascular Access|vascular access
5042836|NCT01453322|IV complications|iv complications
5042837|NCT01453322|VeinViewer Vision|veinviewer vision
5042838|NCT01453309|lumbar fusion|lumbar fusion
5042839|NCT01453309|transfusion|transfusion
5042840|NCT01453309|cell-saver|cell-saver
5042841|NCT01453309|cost-effectiveness|cost-effectiveness
5042842|NCT01453296|Asthma|asthma
5042843|NCT01453296|Tolerability|tolerability
5042844|NCT01453296|Safety|safety
5042845|NCT01453296|Pharmacokinetics|pharmacokinetics
5042846|NCT01453296|GW642444|gw642444
5042847|NCT01453283|DNA Repair|dna repair
5042848|NCT01453283|Nucleotide Excision Repair|nucleotide excision repair
5042849|NCT01453283|Trabectedine|trabectedine
5042850|NCT01453283|Phase I|phase i
5042851|NCT01453283|Sarcoma|sarcoma
5042852|NCT01453283|Cytotoxic|cytotoxic
5042853|NCT01453283|Chemotherapy|chemotherapy
5042854|NCT01453283|Solid Tumor|solid tumor
5042855|NCT01453283|Malignant Tumor|malignant tumor
5042856|NCT01453283|Rhabdomyosarcoma|rhabdomyosarcoma
5042857|NCT01453283|Ewing Sarcoma|ewing sarcoma
5042858|NCT01453283|Neuroblastoma|neuroblastoma
5042859|NCT01453283|Wilm's Tumor|wilm's tumor
5042860|NCT01453283|Hepatic Tumor|hepatic tumor
5042861|NCT01453283|Brain Tumor|brain tumor
5042862|NCT01453270|Sepsis|sepsis
5042863|NCT01453270|Emergency medicine|emergency medicine
5042864|NCT01453270|Cardiac output|cardiac output
5042865|NCT01453270|Stroke volume|stroke volume
5042866|NCT01453270|Lactate|lactate
5042867|NCT01453257|Molecular Targets|molecular targets
5042868|NCT01453257|Personalize Treatment|personalize treatment
5042869|NCT01453257|Colon Cancer|colon cancer
5042870|NCT01453257|Complete Response Rate|complete response rate
5042871|NCT01453244|Chronic hepatitis C|chronic hepatitis c
5042872|NCT01453244|Pharmacogenomics|pharmacogenomics
5042873|NCT01453244|IL28B|il28b
5042874|NCT01453244|ITPA|itpa
5042875|NCT01453231|bariatric surgery|bariatric surgery
5042876|NCT01453231|plastic surgery|plastic surgery
5042877|NCT01453231|thigh|thigh
5042878|NCT01453231|obesity|obesity
5042879|NCT01453231|body image|body image
5042880|NCT01453231|quality of life|quality of life
5042881|NCT01453218|Renal insufficiency|renal insufficiency
5042882|NCT01453218|Liver transplant|liver transplant
5042883|NCT01453218|Acute rejection|acute rejection
5042884|NCT01453218|Infections|infections
5042885|NCT01453218|Hepatitis C recurrence|hepatitis c recurrence
5042886|NCT01453205|Lymphoma, Non-Hodgkin's Lymphoma, Diffuse Large B-Cell Lymphoma, DLBCL, B-Cell Malignancy, anti-CD19, monoclonal antibody, second line, ASCT, Refractory|lymphoma, non-hodgkin's lymphoma, diffuse large b-cell lymphoma, dlbcl, b-cell malignancy, anti-cd19, monoclonal antibody, second line, asct, refractory
5042887|NCT01453192|Raltegravir|raltegravir
5042888|NCT01453192|Renal transplantation|renal transplantation
5042889|NCT01453192|HIV-1|hiv-1
5042890|NCT01453192|Acute renal graft rejection|acute renal graft rejection
5042891|NCT01453179|actinic keratosis|actinic keratosis
5042892|NCT01453179|invasive SCC|invasive scc
5042893|NCT01453179|in situ SCC|in situ scc
5042894|NCT01453179|histological classification|histological classification
5042895|NCT01453179|histological progression|histological progression
5042896|NCT01453179|clinical clearance|clinical clearance
5042897|NCT01453179|cryotherapy|cryotherapy
5042898|NCT01453153|pancreatic|pancreatic
5042899|NCT01453153|Cancer|cancer
5042900|NCT01453153|Stage IV|stage iv
5042901|NCT01453153|untreated|untreated
5042902|NCT01453127|dementia|dementia
5042903|NCT01453127|parkinsonism|parkinsonism
5042904|NCT01453127|mild cognitive impairment|mild cognitive impairment
5042905|NCT01453127|REM sleep behavior disorder|rem sleep behavior disorder
5042906|NCT01453114|Cognitive Behavioral Therapy|cognitive behavioral therapy
5042907|NCT01453114|CBT|cbt
5042908|NCT01453114|relapse|relapse
5042909|NCT01453114|postpartum depression|postpartum depression
5042910|NCT01453114|depression recurrence|depression recurrence
5042911|NCT01453114|depression relapse|depression relapse
5042912|NCT01453101|Multiple Myeloma|multiple myeloma
5042913|NCT01453101|Transplant|transplant
5042914|NCT01453088|multiple myeloma|multiple myeloma
5042915|NCT01453088|transplant|transplant
5042916|NCT01453075|hepatitis C|hepatitis c
5042917|NCT01453075|herpes simplex type 2|herpes simplex type 2
5042918|NCT01453075|veterans|veterans
5042919|NCT01453062|Ofatumumab|ofatumumab
5042920|NCT01453062|Chronic lymphocytic leukemia (CLL)|chronic lymphocytic leukemia (cll)
5042921|NCT01453062|Arzerra|arzerra
5042922|NCT01453049|rosiglitazone/glimepiride, fix dose, type 2 diabetes|rosiglitazone/glimepiride, fix dose, type 2 diabetes
5042923|NCT01453036|Peptic ulcer|peptic ulcer
5042924|NCT01453036|Helicobacter pylori|helicobacter pylori
5042925|NCT01453036|Clarithromycin|clarithromycin
5042926|NCT01453036|23S rRNA|23s rrna
5042927|NCT01453036|Resistance|resistance
5042928|NCT01453023|pediatric ages 5 to 11 years|pediatric ages 5 to 11 years
5042929|NCT01453010|SaeboFlex|saeboflex
5042930|NCT01453010|Stroke rehabilitation|stroke rehabilitation
5042931|NCT01453010|Upper Limb Rehabilitation|upper limb rehabilitation
5042932|NCT01453010|Acute Stroke|acute stroke
5042933|NCT01452997|mosquito|mosquito
5042934|NCT01452997|allergy|allergy
5042935|NCT01452997|bite|bite
5042936|NCT01452997|ant-inflammatory|ant-inflammatory
5042937|NCT01452997|Aedes aegypti mosquito bite|aedes aegypti mosquito bite
5042938|NCT01452984|Non-Melanoma skin cancer patients who have undergone or about to undergo Mohs surgery|non-melanoma skin cancer patients who have undergone or about to undergo mohs surgery
5042939|NCT01452984|who are treated within the University of Pennsylvania Health System|who are treated within the university of pennsylvania health system
5042940|NCT01452971|tumor susceptibility gene|tumor susceptibility gene
5042941|NCT01452971|glycine N-methyltransferase (GNMT)|glycine n-methyltransferase (gnmt)
5042942|NCT01452971|polycyclic aromatic hydrocarbons (PAHs)|polycyclic aromatic hydrocarbons (pahs)
5042943|NCT01452971|lung cancer|lung cancer
5042944|NCT01452958|Endotoxin|endotoxin
5042945|NCT01452958|LPS|lps
5042946|NCT01452958|TNF-α|tnf-α
5042947|NCT01452958|insulin resistance|insulin resistance
5042948|NCT01452958|metabolism|metabolism
5042949|NCT01452932|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
5042950|NCT01452932|Dyspnea|dyspnea
5042951|NCT01452932|Exercise test|exercise test
5042952|NCT01452932|Endurance training|endurance training
5042953|NCT01452919|schizophrenia, LY2140023, pomaglumetad methionil|schizophrenia, ly2140023, pomaglumetad methionil
5042954|NCT01452906|Drug-drug interaction|drug-drug interaction
5042955|NCT01452906|Pharmacokinetics|pharmacokinetics
5042956|NCT01452906|PA21|pa21
5042957|NCT01452906|Drug Interaction Potentiation|drug interaction potentiation
5042958|NCT01452880|Remifentanil|remifentanil
5042959|NCT01452880|Lithotripsy|lithotripsy
5042960|NCT01452880|Conscious Sedation|conscious sedation
5042961|NCT01452867|Airway|airway
5042962|NCT01452867|Bag-Valve -Mask- Ventilation|bag-valve -mask- ventilation
5042963|NCT01452867|Laryngeal Mask - Ventilation|laryngeal mask - ventilation
5042964|NCT01452867|Laryngeal Tube - Ventilation|laryngeal tube - ventilation
5042965|NCT01452854|LGG|lgg
5042966|NCT01452854|Temozolomide|temozolomide
5042967|NCT01452854|Temodar|temodar
5042968|NCT01452854|Ovarian Aging|ovarian aging
5042969|NCT01452854|Infertility|infertility
5042970|NCT01452854|Chemotherapy|chemotherapy
5042971|NCT01452841|grapefruit|grapefruit
5042972|NCT01452841|weight loss|weight loss
5042973|NCT01452841|blood pressure|blood pressure
5042974|NCT01452841|lipids|lipids
5042975|NCT01452841|inflammation|inflammation
5042976|NCT01452828|Renal Impairment|renal impairment
5042977|NCT01452815|diabetic gastroparesis|diabetic gastroparesis
5042978|NCT01452815|delayed gastric emptying|delayed gastric emptying
5042979|NCT01452815|gastroparesis|gastroparesis
5042980|NCT01452815|diabetes mellitus, Type 1|diabetes mellitus, type 1
5042981|NCT01452815|diabetes mellitus, Type 2|diabetes mellitus, type 2
5042982|NCT01452802|HeartMate II|heartmate ii
5042983|NCT01452802|heart-assist device|heart-assist device
5042984|NCT01452802|medical management|medical management
5042985|NCT01452802|optimal medical management|optimal medical management
5042986|NCT01452802|Heart Failure NYHA Class IIIB/IV|heart failure nyha class iiib/iv
5042987|NCT01452802|Thoratec Corporation|thoratec corporation
5042988|NCT01452789|neonatal abstinence syndrome|neonatal abstinence syndrome
5042989|NCT01452789|buprenorphine|buprenorphine
5042990|NCT01452789|morphine|morphine
5042991|NCT01452789|pharmacokinetics|pharmacokinetics
5042992|NCT01452776|Drug Therapy|drug therapy
5042993|NCT01452763|Drug Therapy|drug therapy
5042994|NCT01452750|Drug Therapy|drug therapy
5042995|NCT01452737|colonoscopy|colonoscopy
5042996|NCT01452737|bowel preparation|bowel preparation
5042997|NCT01452737|Golytely|golytely
5042998|NCT01452724|Drug Therapy|drug therapy
5042999|NCT01452711|Drug Therapy|drug therapy
5043000|NCT01452698|Drug Therapy|drug therapy
5043001|NCT01452685|Drug Therapy|drug therapy
5043002|NCT01452672|Breast cancer|breast cancer
5043003|NCT01452672|Radiotherapy|radiotherapy
5043004|NCT01452672|Post-mastectomy|post-mastectomy
5043005|NCT01452672|Molecular characterization|molecular characterization
5043006|NCT01452659|Drug Therapy|drug therapy
5043007|NCT01452646|acute myeloid leukemia|acute myeloid leukemia
5043008|NCT01452646|risk-adapted therapy|risk-adapted therapy
5043009|NCT01452646|MRD-directed therapy|mrd-directed therapy
5043010|NCT01452646|young adults|young adults
5043011|NCT01452633|pain|pain
5043012|NCT01452633|laparoscopy|laparoscopy
5043013|NCT01452633|reduction|reduction
5043014|NCT01452620|Endovascular Abdominal Aortic Aneurysm Repair (EVAR)|endovascular abdominal aortic aneurysm repair (evar)
5043015|NCT01452620|Abdominal Aortic aneurysm (AAA)|abdominal aortic aneurysm (aaa)
5043016|NCT01452607|Ebselen|ebselen
5043017|NCT01452581|Transfusion|transfusion
5043018|NCT01452581|Red blood cells|red blood cells
5043019|NCT01452581|Postoperative|postoperative
5043020|NCT01452581|Dizziness|dizziness
5043021|NCT01452581|Hip Arthroplasty|hip arthroplasty
5043022|NCT01452568|Thromboembolic complications|thromboembolic complications
5043023|NCT01452568|Bleeding complications|bleeding complications
5043024|NCT01452568|Haemorrhagic complications|haemorrhagic complications
5043025|NCT01452568|Anticoagulant therapy|anticoagulant therapy
5043026|NCT01452568|Aspirin|aspirin
5043027|NCT01452568|biological Aorta Valve|biological aorta valve
5043028|NCT01452555|HIV|hiv
5043029|NCT01452555|HIV Prevention|hiv prevention
5043030|NCT01452555|HIV testing|hiv testing
5043031|NCT01452555|HIV Rapid Test|hiv rapid test
5043032|NCT01452542|Genz-112638|genz-112638
5043033|NCT01452529|Pain|pain
5043034|NCT01452529|Opioid|opioid
5043035|NCT01452516|PLF|plf
5043036|NCT01452516|lumbar fusion|lumbar fusion
5043037|NCT01452516|bone graft|bone graft
5043038|NCT01452516|biologics|biologics
5043039|NCT01452503|AE adverse event|ae adverse event
5043040|NCT01452503|AIDS acquired immunodeficiency syndrome|aids acquired immunodeficiency syndrome
5043041|NCT01452503|ALT (SGPT) alanine aminotransferase|alt (sgpt) alanine aminotransferase
5043042|NCT01452503|ART antiretroviral therapy|art antiretroviral therapy
5043043|NCT01452503|AST (SGOT) aspartate aminotransferase|ast (sgot) aspartate aminotransferase
5043044|NCT01452503|DCF data collection forms|dcf data collection forms
5043045|NCT01452503|DMC Data Monitoring Committee|dmc data monitoring committee
5043046|NCT01452503|FDA (U.S.) Food and Drug Administration|fda (u.s.) food and drug administration
5043047|NCT01452503|GCP Good Clinical Practice guidelines|gcp good clinical practice guidelines
5043048|NCT01452503|HB sAg Hepatitis B surface antigen|hb sag hepatitis b surface antigen
5043049|NCT01452503|ICH International Conference of Harmonization|ich international conference of harmonization
5044254|NCT01447602|Dysthymia|dysthymia
5043050|NCT01452503|IND Investigational New Drug Application|ind investigational new drug application
5043051|NCT01452503|IRB Institutional Review Board|irb institutional review board
5043052|NCT01452503|IU International units|iu international units
5043053|NCT01452503|mg milligram(s)|mg milligram(s)
5043054|NCT01452503|mm3 cubic millimeter(s)|mm3 cubic millimeter(s)
5043055|NCT01452503|PCR polymerase chain reaction|pcr polymerase chain reaction
5043056|NCT01452503|SAE serious adverse event|sae serious adverse event
5043057|NCT01452503|µg microgram|µg microgram
5043058|NCT01452503|ULN upper limit of the normal range|uln upper limit of the normal range
5043059|NCT01452503|WB Western Blot|wb western blot
5043060|NCT01452490|Onychomycosis|onychomycosis
5043061|NCT01452490|Toenail Fungus|toenail fungus
5043062|NCT01452477|Polycystic Ovary Syndrome|polycystic ovary syndrome
5043063|NCT01452477|Cryptotanshinone|cryptotanshinone
5043064|NCT01452464|observational|observational
5043065|NCT01452464|serogroup A, B, Y, W|serogroup a, b, y, w
5043066|NCT01452464|meningococcal meningitis|meningococcal meningitis
5043067|NCT01452464|meningococcal vaccines|meningococcal vaccines
5043068|NCT01452464|safety|safety
5043069|NCT01452464|MenACYW-CRM|menacyw-crm
5043070|NCT01452464|post-marketing|post-marketing
5043071|NCT01452464|adolescents|adolescents
5043072|NCT01452438|observational|observational
5043073|NCT01452438|serogroup A, B, Y, W|serogroup a, b, y, w
5043074|NCT01452438|meningococcal meningitis|meningococcal meningitis
5043075|NCT01452438|meningococcal vaccines|meningococcal vaccines
5043076|NCT01452438|safety|safety
5043077|NCT01452438|MenACYW-CRM|menacyw-crm
5043078|NCT01452438|post-marketing|post-marketing
5043079|NCT01452438|children|children
5043080|NCT01452425|Human volunteers|human volunteers
5043081|NCT01452412|Alkali|alkali
5043082|NCT01452412|Sodium bicarbonate|sodium bicarbonate
5043083|NCT01452412|Kidney disease|kidney disease
5043084|NCT01452412|Acidosis|acidosis
5043085|NCT01452386|Constipation|constipation
5043086|NCT01452386|Stimulation Treatment|stimulation treatment
5043087|NCT01452373|Hot flush(es)|hot flush(es)
5043088|NCT01452373|Hot flash(es)|hot flash(es)
5043089|NCT01452373|Vasomotor symptoms|vasomotor symptoms
5043090|NCT01452373|Dehydroepiandrosterone (DHEA)|dehydroepiandrosterone (dhea)
5043091|NCT01452373|Prasterone|prasterone
5043092|NCT01452373|Acolbifene|acolbifene
5043093|NCT01452373|Selective estrogen receptor modulator (SERM)|selective estrogen receptor modulator (serm)
5043094|NCT01452373|Antiestrogen|antiestrogen
5043095|NCT01452373|Menopause|menopause
5043096|NCT01452373|Postmenopausal women|postmenopausal women
5043097|NCT01452360|chronic kidney disease|chronic kidney disease
5043098|NCT01452321|Transcranial Magnetic Stimulation;|transcranial magnetic stimulation;
5043099|NCT01452321|Postpartum Depression;|postpartum depression;
5043100|NCT01452321|Clinical Performance;|clinical performance;
5043101|NCT01452321|Cognitive Performance;|cognitive performance;
5043102|NCT01452321|Social Performance|social performance
5043103|NCT01452308|Gilead|gilead
5043104|NCT01452308|Gilead Sciences|gilead sciences
5043105|NCT01452308|GSI|gsi
5043106|NCT01452308|Liver Fibrosis|liver fibrosis
5043107|NCT01452308|Liver|liver
5043108|NCT01452308|Fibrosis|fibrosis
5043109|NCT01452295|liver|liver
5043110|NCT01452295|liver failure|liver failure
5043111|NCT01452295|acute liver failure|acute liver failure
5043112|NCT01452295|ELAD|elad
5043113|NCT01452295|alcoholic hepatitis|alcoholic hepatitis
5043114|NCT01452295|acute on chronic hepatitis|acute on chronic hepatitis
5043115|NCT01452282|Ankle Brachial Index|ankle brachial index
5043116|NCT01452282|Perioperative care|perioperative care
5043117|NCT01452282|General Surgery|general surgery
5043118|NCT01452282|Acute Coronary Syndromes|acute coronary syndromes
5043119|NCT01452282|Cardiovascular Complications|cardiovascular complications
5043120|NCT01452243|Vitamin D|vitamin d
5043121|NCT01452243|Calcium|calcium
5043122|NCT01452243|Elderly|elderly
5043123|NCT01452230|Bariatric Surgery Candidate|bariatric surgery candidate
5043124|NCT01452230|Severely obese|severely obese
5043125|NCT01452230|Bariatric surgery|bariatric surgery
5043126|NCT01452230|Physical activity|physical activity
5043127|NCT01452230|Physical fitness|physical fitness
5043128|NCT01452230|Comorbidities|comorbidities
5043129|NCT01452230|Quality of life|quality of life
5043130|NCT01452230|Surgical complications|surgical complications
5043131|NCT01452217|Pancreas|pancreas
5043132|NCT01452217|Chronic pancreatitis|chronic pancreatitis
5043133|NCT01452217|Perfusion|perfusion
5043134|NCT01452217|Blood flow|blood flow
5043135|NCT01452217|Magnetic resonance imaging|magnetic resonance imaging
5043136|NCT01452204|PEMF|pemf
5043137|NCT01452204|magneto|magneto
5043138|NCT01452204|shoulder|shoulder
5043139|NCT01452204|impingement|impingement
5043140|NCT01452191|Cluster Randomised Controlled Trial|cluster randomised controlled trial
5043141|NCT01452191|Community Health Services|community health services
5043142|NCT01452191|prevention & control|prevention & control
5043143|NCT01452191|Accidents, Home|accidents, home
5043144|NCT01452191|Child Health Services|child health services
5043145|NCT01452178|Cardiovascular diseases|cardiovascular diseases
5043146|NCT01452178|Glucometabolic disorders|glucometabolic disorders
5043147|NCT01452178|Type-D personality|type-d personality
5043148|NCT01452165|Cardiovascular diseases|cardiovascular diseases
5043149|NCT01452165|Hypertrophy, Left ventricle|hypertrophy, left ventricle
5043150|NCT01452165|Echocardiography|echocardiography
5043151|NCT01452165|Prognosis|prognosis
5043152|NCT01452152|Pharmacogenomics|pharmacogenomics
5043153|NCT01452152|Platelet Aggregation Inhibitors|platelet aggregation inhibitors
5043154|NCT01452139|STEMI|stemi
5043155|NCT01452139|Pharmacogenetics|pharmacogenetics
5043156|NCT01452139|Prasugrel|prasugrel
5043157|NCT01452139|Clopidogrel|clopidogrel
5043158|NCT01452139|Percutaneous Coronary Intervention|percutaneous coronary intervention
5043159|NCT01452113|Diabetes Mellitus|diabetes mellitus
5043160|NCT01452113|DPP-IV protein|dpp-iv protein
5043161|NCT01452113|Glucagon-Like Peptide 1|glucagon-like peptide 1
5043162|NCT01452113|autonomic neuropathy|autonomic neuropathy
5043163|NCT01452100|embolism|embolism
5043164|NCT01452100|cholesterol cristal|cholesterol cristal
5043165|NCT01452100|creatinine|creatinine
5043166|NCT01452100|renal insufficiency|renal insufficiency
5043167|NCT01452100|prednisone|prednisone
5043168|NCT01452100|systemic atheroembolism|systemic atheroembolism
5043169|NCT01452087|insulin sensitivity|insulin sensitivity
5043170|NCT01452087|exercise|exercise
5043171|NCT01452074|Insulin Sensitivity|insulin sensitivity
5043172|NCT01452074|Exercise Training|exercise training
5043173|NCT01452074|Weight Loss|weight loss
5043174|NCT01452074|Fat Metabolism|fat metabolism
5043175|NCT01452061|Autism Spectrum Disorder|autism spectrum disorder
5043176|NCT01452061|Attention Deficit/Hyperactivity Disorder|attention deficit/hyperactivity disorder
5043177|NCT01452061|Developmental Delay|developmental delay
5043178|NCT01452048|insulin sensitivity|insulin sensitivity
5043179|NCT01452048|fatty acid metabolism|fatty acid metabolism
5043180|NCT01452035|insulin sensitivity|insulin sensitivity
5043181|NCT01452035|fatty acid metabolism|fatty acid metabolism
5043182|NCT01452035|exercise|exercise
5043183|NCT01452022|inductigraft|inductigraft
5043184|NCT01452022|osteoinductive|osteoinductive
5043185|NCT01452022|synthetic bone graft|synthetic bone graft
5043186|NCT01452022|posterolateral lumbar fusion|posterolateral lumbar fusion
5043187|NCT01452022|post market|post market
5043188|NCT01452022|lumbar spinal stenosis|lumbar spinal stenosis
5043189|NCT01452009|open angle glaucoma|open angle glaucoma
5043190|NCT01452009|ocular hypertension|ocular hypertension
5043191|NCT01451996|direct-to-consumer advertising|direct-to-consumer advertising
5043192|NCT01451983|Autism|autism
5043193|NCT01451983|PTEN|pten
5043194|NCT01451983|macrocephaly|macrocephaly
5043195|NCT01451970|high fat diet treatment|high fat diet treatment
5043196|NCT01451970|insulin sensitivity|insulin sensitivity
5043197|NCT01451957|exercise|exercise
5043198|NCT01451957|fatty acid metabolism|fatty acid metabolism
5043199|NCT01451957|insulin sensitivity|insulin sensitivity
5043200|NCT01451944|Asthma|asthma
5043201|NCT01451944|Home Health Nursing|home health nursing
5043202|NCT01451944|Patient education|patient education
5043203|NCT01451931|kidney stone|kidney stone
5043204|NCT01451931|urolithiasis|urolithiasis
5043205|NCT01451931|urinary tract infection|urinary tract infection
5043206|NCT01451931|ultrasound|ultrasound
5043207|NCT01451931|computed tomography|computed tomography
5043208|NCT01451931|safety|safety
5043209|NCT01451931|cost|cost
5043210|NCT01451931|accuracy|accuracy
5043211|NCT01451918|Dyslipidaemia|dyslipidaemia
5043212|NCT01451918|Insulin resistance|insulin resistance
5043213|NCT01451918|Type 2 Diabetes|type 2 diabetes
5043214|NCT01451892|Obesity|obesity
5043215|NCT01451892|dance|dance
5043216|NCT01451892|gait|gait
5043217|NCT01451892|balance|balance
5043218|NCT01451892|posture|posture
5043219|NCT01451892|dance therapy|dance therapy
5043220|NCT01451879|Pompe Disease|pompe disease
5043221|NCT01451879|Infusion Associated Reaction|infusion associated reaction
5043222|NCT01451879|Immune-modulation regimen|immune-modulation regimen
5043223|NCT01451866|resistance training|resistance training
5043224|NCT01451866|Healthy People Programs|healthy people programs
5043225|NCT01451853|Lung Cancer|lung cancer
5043226|NCT01451853|Head and Neck Cancer|head and neck cancer
5043227|NCT01451853|Hearing Loss|hearing loss
5043228|NCT01451853|Ototoxicity|ototoxicity
5043229|NCT01451853|Tinnitus|tinnitus
5043230|NCT01451853|Deafness|deafness
5043231|NCT01451853|SPI-1005|spi-1005
5043232|NCT01451853|Cisplatin|cisplatin
5043233|NCT01451853|Carboplatin|carboplatin
5043234|NCT01451853|Ebselen|ebselen
5043235|NCT01451827|Kidney Disease|kidney disease
5043236|NCT01451827|Polycystic Kidney Disease|polycystic kidney disease
5043237|NCT01451827|Autosomal Dominant Polycystic Kidney Disease|autosomal dominant polycystic kidney disease
5043238|NCT01451827|PKD|pkd
5043239|NCT01451827|ADPKD|adpkd
5043240|NCT01451814|smoking cessation|smoking cessation
5043241|NCT01451801|Hepatitis B|hepatitis b
5043242|NCT01451801|non responders|non responders
5043243|NCT01451801|cellular immune response|cellular immune response
5043244|NCT01451801|cytokines|cytokines
5043245|NCT01451801|predictors|predictors
5043246|NCT01451801|HBsAg|hbsag
5043247|NCT01451788|RCT|rct
5043248|NCT01451788|Gelatin matrix|gelatin matrix
5043249|NCT01451788|thrombin|thrombin
5044740|NCT01445691|Gliomas|gliomas
5043250|NCT01451788|idiopathic scoliosis|idiopathic scoliosis
5043251|NCT01451788|Surgery|surgery
5043252|NCT01451762|pain|pain
5043253|NCT01451762|anesthesia|anesthesia
5043254|NCT01451762|surgery|surgery
5043255|NCT01451762|postoperative|postoperative
5043256|NCT01451749|Mild cognitive impairment|mild cognitive impairment
5043257|NCT01451736|First-episode Schizophrenia|first-episode schizophrenia
5043258|NCT01451736|Schizoaffective Disorder, Depressed Type (recent-onset)|schizoaffective disorder, depressed type (recent-onset)
5043259|NCT01451736|Schizophreniform Disorder|schizophreniform disorder
5043260|NCT01451736|oral risperidone|oral risperidone
5043261|NCT01451736|long-acting injectable paliperidone palmitate|long-acting injectable paliperidone palmitate
5043262|NCT01451736|functional outcome|functional outcome
5043263|NCT01451723|Multiple Sclerosis|multiple sclerosis
5043264|NCT01451723|Polyphenon E|polyphenon e
5043265|NCT01451723|Green tea|green tea
5043266|NCT01451723|EGCG|egcg
5043267|NCT01451723|Epigallocatechin-galleate|epigallocatechin-galleate
5043268|NCT01451723|Placebo|placebo
5043269|NCT01451723|Randomized controlled trial|randomized controlled trial
5043270|NCT01451710|enough steroids|enough steroids
5043271|NCT01451710|MCD|mcd
5043272|NCT01451710|efficacy|efficacy
5043273|NCT01451684|pregnancy|pregnancy
5043274|NCT01451684|fetus|fetus
5043275|NCT01451684|euploid|euploid
5043276|NCT01451671|fetal|fetal
5043277|NCT01451671|aneuploidy|aneuploidy
5043278|NCT01451671|non-invasive|non-invasive
5043279|NCT01451671|prenatal|prenatal
5043280|NCT01451671|cell free DNA|cell free dna
5043281|NCT01451658|Variceal bleeding|variceal bleeding
5043282|NCT01451658|portal hypertension|portal hypertension
5043283|NCT01451658|hepatocellular carcinoma|hepatocellular carcinoma
5043284|NCT01451658|endoscopic variceal ligation|endoscopic variceal ligation
5043285|NCT01451658|non-selective beta-blocker|non-selective beta-blocker
5043286|NCT01451658|rebleeding|rebleeding
5043287|NCT01451645|Gout|gout
5043288|NCT01451632|Metastatic Colorectal cancer|metastatic colorectal cancer
5043289|NCT01451632|Kras wild-type|kras wild-type
5043290|NCT01451632|Squamous cell head and neck cancer|squamous cell head and neck cancer
5043291|NCT01451632|Non-small cell lung cancer|non-small cell lung cancer
5043292|NCT01451632|Triple negative breast cancer|triple negative breast cancer
5043293|NCT01451632|EGFR|egfr
5043294|NCT01451632|ErbB3|erbb3
5043295|NCT01451632|MM-121|mm-121
5043296|NCT01451632|Cetuximab|cetuximab
5043297|NCT01451632|Irinotecan|irinotecan
5043298|NCT01451606|Chronic Pelvic Pain (CPP)|chronic pelvic pain (cpp)
5043299|NCT01451606|Pelvic Pain|pelvic pain
5043300|NCT01451593|Optic neuritis|optic neuritis
5043301|NCT01451593|Multiple sclerosis|multiple sclerosis
5043302|NCT01451593|Retinal nerve fibre layer|retinal nerve fibre layer
5043303|NCT01451593|Axonal loss|axonal loss
5043304|NCT01451593|Neuroprotection|neuroprotection
5043305|NCT01451593|Phenytoin|phenytoin
5043306|NCT01451593|MRI|mri
5043307|NCT01451593|Optical coherence tomography|optical coherence tomography
5043308|NCT01451593|Sodium Channel Blockers|sodium channel blockers
5043309|NCT01451580|Phase II|phase ii
5043310|NCT01451580|Metastatic Breast Cancer|metastatic breast cancer
5043311|NCT01451567|Nurses, Workload, Musculoskeletal System, Intervention|nurses, workload, musculoskeletal system, intervention
5043312|NCT01451554|weight|weight
5043313|NCT01451554|body mass index|body mass index
5043314|NCT01451554|obesity|obesity
5043315|NCT01451554|portion control plate|portion control plate
5043316|NCT01451554|diet|diet
5043317|NCT01451554|exercise|exercise
5043318|NCT01451528|Umbilical Cord Blood|umbilical cord blood
5043319|NCT01451528|Allogeneic|allogeneic
5043320|NCT01451528|Traumatic Brain Injury|traumatic brain injury
5043321|NCT01451515|Lymphoblastic lymphoma|lymphoblastic lymphoma
5043322|NCT01451502|umbilical cord blood|umbilical cord blood
5043323|NCT01451489|FSGS|fsgs
5043324|NCT01451489|FK506|fk506
5043325|NCT01451489|CTX|ctx
5043326|NCT01451476|Ageing|ageing
5043327|NCT01451463|Huntington's Disease|huntington's disease
5043328|NCT01451463|Chorea|chorea
5043329|NCT01451463|Gait|gait
5043330|NCT01451463|Balance|balance
5043331|NCT01451450|Peanut Allergy|peanut allergy
5043332|NCT01451411|Serum Sodium|serum sodium
5043333|NCT01451411|Euvolemia|euvolemia
5043334|NCT01451411|Hypervolemia|hypervolemia
5043335|NCT01451411|Vaprisol®|vaprisol®
5043336|NCT01451411|Conivaptan|conivaptan
5043337|NCT01451411|YM087|ym087
5043338|NCT01451372|Diabetes|diabetes
5043339|NCT01451372|CGM|cgm
5043340|NCT01451372|CSII|csii
5043341|NCT01451346|Pilot study|pilot study
5043342|NCT01451333|HIV|hiv
5043343|NCT01451333|Efavirenz|efavirenz
5043344|NCT01451333|Central Nervous System (CNS)|central nervous system (cns)
5043345|NCT01451333|Lumbar puncture|lumbar puncture
5043346|NCT01451333|Dose reduction|dose reduction
5043347|NCT01451320|Prosthetic valve|prosthetic valve
5043348|NCT01451320|thrombosis|thrombosis
5043349|NCT01451320|TROIA|troia
5043350|NCT01451320|tPA|tpa
5043351|NCT01451320|TEE|tee
5043352|NCT01451307|Congenital abnormalities|congenital abnormalities
5043353|NCT01451307|Digestive system abnormalities|digestive system abnormalities
5043354|NCT01451307|Neonatal surgery|neonatal surgery
5043355|NCT01451307|Neonatal anesthesia|neonatal anesthesia
5043356|NCT01451307|Bayley Scales of Infant Development II|bayley scales of infant development ii
5043357|NCT01451294|Cerebral autoregulation|cerebral autoregulation
5043358|NCT01451281|Ultrasonography|ultrasonography
5043359|NCT01451281|Muscular Dystrophy|muscular dystrophy
5043360|NCT01451281|Neuromuscular Disease|neuromuscular disease
5043361|NCT01451281|Oligonucleotide|oligonucleotide
5043362|NCT01451281|Magnetic Resonance Imaging (MRI)|magnetic resonance imaging (mri)
5043363|NCT01451281|Duchenne Muscular Dystrophy|duchenne muscular dystrophy
5043364|NCT01451281|DND|dnd
5043365|NCT01451268|60 to 150 Days After Allogeneic Stem Cell Transplantation|60 to 150 days after allogeneic stem cell transplantation
5043366|NCT01451268|High Risk MDS|high risk mds
5043367|NCT01451268|MDS|mds
5043368|NCT01451268|AML|aml
5043369|NCT01451255|pulsatility|pulsatility
5043370|NCT01451255|normal subjects|normal subjects
5043371|NCT01451255|mild pulmonary hypertension|mild pulmonary hypertension
5043372|NCT01451255|exercise-associated pulmonary hypertension|exercise-associated pulmonary hypertension
5043373|NCT01451242|Heart Rate Variability|heart rate variability
5043374|NCT01451242|Acquired Brain Injury|acquired brain injury
5043375|NCT01451242|Physical Activity|physical activity
5043376|NCT01451229|pharmacokinetics|pharmacokinetics
5043377|NCT01451229|pharmacodynamics|pharmacodynamics
5043378|NCT01451216|Acquired brain injury|acquired brain injury
5043379|NCT01451216|Balance control|balance control
5043380|NCT01451216|Functional reach|functional reach
5043381|NCT01451203|Cimzia|cimzia
5043382|NCT01451203|Early RA|early ra
5043383|NCT01451203|Certolizumab Pegol|certolizumab pegol
5043384|NCT01451190|Androgenetic Alopecia|androgenetic alopecia
5043385|NCT01451190|Male Pattern Baldness|male pattern baldness
5043386|NCT01451190|Female Pattern Baldness|female pattern baldness
5043387|NCT01451190|Hair Loss|hair loss
5043388|NCT01451190|Baldness|baldness
5043389|NCT01451177|Androgenetic Alopecia|androgenetic alopecia
5043390|NCT01451177|Male Pattern Baldness|male pattern baldness
5043391|NCT01451177|Female Pattern Baldness|female pattern baldness
5043392|NCT01451177|Hair Loss|hair loss
5043393|NCT01451177|Baldness|baldness
5043394|NCT01451151|Androgenetic Alopecia|androgenetic alopecia
5043395|NCT01451151|Male Pattern Baldness|male pattern baldness
5043396|NCT01451151|Female Pattern Baldness|female pattern baldness
5043397|NCT01451151|Hair Loss|hair loss
5043398|NCT01451151|Baldness|baldness
5043399|NCT01451138|Androgenetic Alopecia|androgenetic alopecia
5043400|NCT01451138|Male Pattern Baldness|male pattern baldness
5043401|NCT01451138|Female Pattern Baldness|female pattern baldness
5043402|NCT01451138|Hair Loss|hair loss
5043403|NCT01451138|Baldness|baldness
5043404|NCT01451125|Androgenetic Alopecia|androgenetic alopecia
5043405|NCT01451125|Male Pattern Baldness|male pattern baldness
5043406|NCT01451125|Female Pattern Baldness|female pattern baldness
5043407|NCT01451125|Hair Loss Baldness|hair loss baldness
5043408|NCT01451112|Androgenetic Alopecia|androgenetic alopecia
5043409|NCT01451112|Male Pattern Baldness|male pattern baldness
5043410|NCT01451112|Female Pattern Baldness|female pattern baldness
5043411|NCT01451112|Hair Loss|hair loss
5043412|NCT01451112|Baldness|baldness
5043413|NCT01451099|Androgenetic Alopecia|androgenetic alopecia
5043414|NCT01451099|Male Pattern Baldness|male pattern baldness
5043415|NCT01451099|Female Pattern Baldness|female pattern baldness
5043416|NCT01451099|Hair Loss|hair loss
5043417|NCT01451099|Baldness|baldness
5043418|NCT01451086|Safety|safety
5043419|NCT01451086|Immunogenicity|immunogenicity
5043420|NCT01451086|Pneumococcal vaccine|pneumococcal vaccine
5043421|NCT01451073|Androgenetic Alopecia|androgenetic alopecia
5043422|NCT01451073|Male Pattern Baldness|male pattern baldness
5043423|NCT01451073|Female Pattern Baldness|female pattern baldness
5043424|NCT01451073|Hair Loss|hair loss
5043425|NCT01451073|Baldness|baldness
5043426|NCT01451060|vasopressors|vasopressors
5043427|NCT01451060|cesarean anesthesia|cesarean anesthesia
5043428|NCT01451060|hypotension|hypotension
5043429|NCT01451047|Androgenetic Alopecia|androgenetic alopecia
5043430|NCT01451047|Male Pattern Baldness|male pattern baldness
5043431|NCT01451047|Female Pattern Baldness|female pattern baldness
5043432|NCT01451047|Hair Loss|hair loss
5043433|NCT01451047|Baldness|baldness
5043434|NCT01451034|WHYX lesion|whyx lesion
5043435|NCT01451034|endoscopic resection|endoscopic resection
5043436|NCT01451034|complete resection|complete resection
5043437|NCT01451034|complete resection rate|complete resection rate
5043438|NCT01451034|endoscopic feature|endoscopic feature
5043439|NCT01451034|Average size discrepancy|average size discrepancy
5043440|NCT01451021|Androgenetic Alopecia|androgenetic alopecia
5043441|NCT01451021|Male Pattern Baldness|male pattern baldness
5043442|NCT01451021|Female Pattern Baldness|female pattern baldness
5043443|NCT01451021|Hair Loss|hair loss
5043444|NCT01451021|Baldness|baldness
5043445|NCT01451008|Anastomosis|anastomosis
5043446|NCT01451008|Compression|compression
5043447|NCT01451008|Colon|colon
5043448|NCT01450995|Migraine|migraine
5043449|NCT01450995|Headache, Migraine|headache, migraine
5043450|NCT01450982|Rheumatoid Arthritis|rheumatoid arthritis
5043451|NCT01450982|JNJ-38518168|jnj-38518168
5043452|NCT01450982|Methotrexate|methotrexate
5043453|NCT01450969|Operator Comfort Assessment|operator comfort assessment
5043454|NCT01450969|Radiation protection|radiation protection
5043455|NCT01450969|Measurement of Radiation Exposure|measurement of radiation exposure
5043456|NCT01450969|Endovascular Interventional Radiology|endovascular interventional radiology
5043457|NCT01450956|congenital heart diseases|congenital heart diseases
5043458|NCT01450956|cardiopulmonary bypass|cardiopulmonary bypass
5043459|NCT01450956|Pediatric|pediatric
5043460|NCT01450956|sevoflurane|sevoflurane
5043461|NCT01450943|Diabetic Foot Ulcer|diabetic foot ulcer
5043462|NCT01450943|Chronic wounds|chronic wounds
5043463|NCT01450943|Chronic ulcers|chronic ulcers
5043464|NCT01450943|Oasis|oasis
5043465|NCT01450943|Dermagraft|dermagraft
5043466|NCT01450943|Adaptic|adaptic
5043467|NCT01450930|Adrenal insufficiency|adrenal insufficiency
5043468|NCT01450930|Addison's disease|addison's disease
5043469|NCT01450891|Alzheimer's disease|alzheimer's disease
5043470|NCT01450891|Diagnosis|diagnosis
5043471|NCT01450891|Costs|costs
5043472|NCT01450891|Benefits|benefits
5043473|NCT01450891|subjective and/or objective memory complaints|subjective and/or objective memory complaints
5043474|NCT01450878|high dose of EPO|high dose of epo
5043475|NCT01450878|transplant kidney|transplant kidney
5043476|NCT01450878|cadaveric organ donor|cadaveric organ donor
5043477|NCT01450878|mono-organ (kidney) retrieval|mono-organ (kidney) retrieval
5043478|NCT01450878|patient|patient
5043479|NCT01450878|kidney graft|kidney graft
5043480|NCT01450865|neuropathy|neuropathy
5043481|NCT01450865|axonal excitability|axonal excitability
5043482|NCT01450865|myelinated nerve|myelinated nerve
5043483|NCT01450865|human|human
5043484|NCT01450865|ectopic discharge|ectopic discharge
5043485|NCT01450865|flupirtine|flupirtine
5043486|NCT01450852|Melanocortin Receptor|melanocortin receptor
5043487|NCT01450852|Monocyte|monocyte
5043488|NCT01450852|Resistance Training|resistance training
5043489|NCT01450852|Inflammation|inflammation
5043490|NCT01450852|Markers of Inflammation|markers of inflammation
5043491|NCT01450839|Transdermal Administration|transdermal administration
5043492|NCT01450839|Japanese|japanese
5043493|NCT01450839|elderly|elderly
5043494|NCT01450839|male|male
5043495|NCT01450839|volunteers|volunteers
5043496|NCT01450826|Chemotherapy induced nausea and vomiting|chemotherapy induced nausea and vomiting
5043497|NCT01450826|CINV|cinv
5043498|NCT01450826|Glioma|glioma
5043499|NCT01450826|Temozolomide|temozolomide
5043500|NCT01450826|Temodar|temodar
5043501|NCT01450826|Aprepitant|aprepitant
5043502|NCT01450826|Emend|emend
5043503|NCT01450826|Ondansetron|ondansetron
5043504|NCT01450826|Zofran|zofran
5043505|NCT01450826|Pro00031206|pro00031206
5043506|NCT01450826|Affronti|affronti
5043507|NCT01450826|Peters|peters
5043508|NCT01450826|Duke|duke
5043509|NCT01450826|Preston Robert Tisch Brain Tumor Center|preston robert tisch brain tumor center
5043510|NCT01450800|urinary tract infection|urinary tract infection
5043511|NCT01450800|gynecologic surgery|gynecologic surgery
5043512|NCT01450800|post-operative complications|post-operative complications
5043513|NCT01450800|nitrofurantoin|nitrofurantoin
5043514|NCT01450787|dry eyes|dry eyes
5043515|NCT01450787|diabetes|diabetes
5043516|NCT01450748|sodium alginate|sodium alginate
5043517|NCT01450748|laryngopharyngeal reflux|laryngopharyngeal reflux
5043518|NCT01450748|combined impedance-pH monitoring|combined impedance-ph monitoring
5043519|NCT01450722|Chronic lower limb ischemia|chronic lower limb ischemia
5043520|NCT01450722|claudication|claudication
5043521|NCT01450722|chronic critical ischemia|chronic critical ischemia
5043522|NCT01450709|Probiotics|probiotics
5043523|NCT01450709|Kibow Biotics|kibow biotics
5043524|NCT01450709|Dialysis|dialysis
5043525|NCT01450709|Gut based uremic toxin removal|gut based uremic toxin removal
5043526|NCT01450670|Probiotics|probiotics
5043527|NCT01450670|Kibow Biotics|kibow biotics
5043528|NCT01450670|Dialysis|dialysis
5043529|NCT01450670|Gut based uremic toxin removal|gut based uremic toxin removal
5043530|NCT01450657|Chronic Kidney failure stage three and four|chronic kidney failure stage three and four
5043531|NCT01450657|Probiotics|probiotics
5043532|NCT01450657|Kibow Biotics|kibow biotics
5043533|NCT01450657|Dialysis|dialysis
5043534|NCT01450657|Gut based uremic toxin removal|gut based uremic toxin removal
5043535|NCT01450644|Advanced|advanced
5043536|NCT01450644|Progressive|progressive
5043537|NCT01450644|Idiopathic Fibrotic Interstitial Lung Disease|idiopathic fibrotic interstitial lung disease
5043538|NCT01450644|Palliative Care|palliative care
5043539|NCT01450644|Randomised|randomised
5043540|NCT01450644|Controlled|controlled
5043541|NCT01450631|surgical site infection|surgical site infection
5043542|NCT01450631|nosocomial infection|nosocomial infection
5043543|NCT01450631|post-operative complication|post-operative complication
5043544|NCT01450631|surgical incision risk|surgical incision risk
5043545|NCT01450631|surgical incision infection|surgical incision infection
5043546|NCT01450631|negative pressure wound therapy|negative pressure wound therapy
5043547|NCT01450631|wound management|wound management
5043548|NCT01450631|cesarean section surgery|cesarean section surgery
5043549|NCT01450631|wound dehiscence|wound dehiscence
5045252|NCT01443728|vitamin D|vitamin d
5043550|NCT01450631|wound infection|wound infection
5043551|NCT01450631|surgical closure|surgical closure
5043552|NCT01450631|wound disruption|wound disruption
5043553|NCT01450631|subcutaneous approximation|subcutaneous approximation
5043554|NCT01450631|wound separation|wound separation
5043555|NCT01450631|seroma|seroma
5043556|NCT01450631|hematoma|hematoma
5043557|NCT01450631|subcutaneous closure|subcutaneous closure
5043558|NCT01450631|obesity|obesity
5043559|NCT01450631|cesarean|cesarean
5043560|NCT01450631|incision|incision
5043561|NCT01450631|massive obesity|massive obesity
5043562|NCT01450631|obese|obese
5043563|NCT01450631|pregnancy|pregnancy
5043564|NCT01450631|cesarean delivery|cesarean delivery
5043565|NCT01450631|superobesity|superobesity
5043566|NCT01450631|wound complication|wound complication
5043567|NCT01450592|Carbohydrate, Dietary|carbohydrate, dietary
5043568|NCT01450579|Recombinant Influenza HA vaccine|recombinant influenza ha vaccine
5043569|NCT01450579|Immunogenicity of ASP7373|immunogenicity of asp7373
5043570|NCT01450566|ureteroscopy (URS)|ureteroscopy (urs)
5043571|NCT01450566|ureteral stent placement|ureteral stent placement
5043572|NCT01450566|Ureteral Calculi|ureteral calculi
5043573|NCT01450566|Renal Calculi|renal calculi
5043574|NCT01450553|Tissue Collection|tissue collection
5043575|NCT01450553|Lung Cancer|lung cancer
5043576|NCT01450553|Non-Small Cell Lung Cancer|non-small cell lung cancer
5043577|NCT01450553|Early Stage Lung Cancer|early stage lung cancer
5043578|NCT01450527|Etiology and outcomes of ARDS|etiology and outcomes of ards
5043579|NCT01450488|primary progressive multiple sclerosis|primary progressive multiple sclerosis
5043580|NCT01450488|relapse-free secondary progressive multiple sclerosis|relapse-free secondary progressive multiple sclerosis
5043581|NCT01450449|GBM, fractionation, short course, standard course|gbm, fractionation, short course, standard course
5043582|NCT01450423|Epilepsy|epilepsy
5043583|NCT01450423|Physical activity|physical activity
5043584|NCT01450423|Cardio exercise|cardio exercise
5043585|NCT01450423|Physical fitness|physical fitness
5043586|NCT01450423|Cognitive function|cognitive function
5043587|NCT01450410|Dyslipemia, HDL composition|dyslipemia, hdl composition
5043588|NCT01450397|Dupuytren's Contracture|dupuytren's contracture
5043589|NCT01450384|protocol specific|protocol specific
5043590|NCT01450371|Autonomic Nervous System|autonomic nervous system
5043591|NCT01450371|Neuromodulation|neuromodulation
5043592|NCT01450371|Blood flow control|blood flow control
5043593|NCT01450371|Exercise|exercise
5043594|NCT01450358|Sepsis|sepsis
5043595|NCT01450358|Real time PCR|real time pcr
5043596|NCT01450358|Blood culture|blood culture
5043597|NCT01450358|Bacteremia diagnosis|bacteremia diagnosis
5043598|NCT01450358|Fungemia diagnosis|fungemia diagnosis
5043599|NCT01450345|Clinical diagnosis of inguinal hernia|clinical diagnosis of inguinal hernia
5043600|NCT01450345|Patient undergo operation under daycare basis|patient undergo operation under daycare basis
5043601|NCT01450345|ASA I-II|asa i-ii
5043602|NCT01450345|Written consent|written consent
5043603|NCT01450332|ACL|acl
5043604|NCT01450332|arthroscopy|arthroscopy
5043605|NCT01450332|ligament|ligament
5043606|NCT01450332|rupture|rupture
5043607|NCT01450332|reconstruction|reconstruction
5043608|NCT01450332|ACLR|aclr
5043609|NCT01450332|accelerated rehabilitation program|accelerated rehabilitation program
5043610|NCT01450319|K-RAS|k-ras
5043611|NCT01450319|FcγRII/IIIa genotypes|fcγrii/iiia genotypes
5043612|NCT01450319|CRC|crc
5043613|NCT01450319|Colorectal cancer|colorectal cancer
5043614|NCT01450293|Immune response|immune response
5043615|NCT01450267|Cystic Fibrosis|cystic fibrosis
5043616|NCT01450267|Glutathione|glutathione
5043617|NCT01450254|Hip Osteoarthritis|hip osteoarthritis
5043618|NCT01450254|Gait Patterns|gait patterns
5043619|NCT01450254|Neuromuscular retraining|neuromuscular retraining
5043620|NCT01450241|Febrile neutropenia|febrile neutropenia
5043621|NCT01450241|Unexplained fever|unexplained fever
5043622|NCT01450241|Duration|duration
5043623|NCT01450241|Short-term antibiotic treatment|short-term antibiotic treatment
5043624|NCT01450228|primary insomnia|primary insomnia
5043625|NCT01450215|Relapsed and refractory Multiple Myeloma|relapsed and refractory multiple myeloma
5043626|NCT01450202|Carbon dioxide insufflation|carbon dioxide insufflation
5043627|NCT01450202|Colonoscopy|colonoscopy
5043628|NCT01450202|Esophagogastroduodenoscopy|esophagogastroduodenoscopy
5043629|NCT01450202|Bowel insufflation|bowel insufflation
5043630|NCT01450202|Postprocedure pain|postprocedure pain
5043631|NCT01450202|Pain Due to Certain Specified Procedures|pain due to certain specified procedures
5043632|NCT01450189|Acute HIV|acute hiv
5043633|NCT01450189|Transmission Prevention|transmission prevention
5043634|NCT01450189|Randomized Pilot study|randomized pilot study
5043635|NCT01450176|eye|eye
5043636|NCT01450176|itching|itching
5043637|NCT01450176|allergies|allergies
5043638|NCT01450163|Neuropathic pain|neuropathic pain
5043639|NCT01450163|prevention|prevention
5043640|NCT01450163|prophylaxis|prophylaxis
5043641|NCT01450163|chemotherapy|chemotherapy
5043642|NCT01450163|neuropathy|neuropathy
5043643|NCT01450163|Oxaliplatin|oxaliplatin
5043644|NCT01450163|pregabalin|pregabalin
5043645|NCT01450150|Major Depression|major depression
5043646|NCT01450150|Transcranial Direct Current Stimulation|transcranial direct current stimulation
5043647|NCT01450150|Randomized, Sham-Controlled Trial|randomized, sham-controlled trial
5043648|NCT01450150|tDCS|tdcs
5043649|NCT01450137|Giant Cell Arteritis|giant cell arteritis
5043650|NCT01450137|Tocilizumab|tocilizumab
5043651|NCT01450137|Antibodies, Monoclonal|antibodies, monoclonal
5043652|NCT01450137|Glucocorticoids|glucocorticoids
5043653|NCT01450111|Lacosamide|lacosamide
5043654|NCT01450059|Human Immunodeficiency Virus|human immunodeficiency virus
5043655|NCT01450059|Microchimerism|microchimerism
5043656|NCT01450059|Maternal-Fetal Exchange|maternal-fetal exchange
5043657|NCT01450059|Gestation|gestation
5043658|NCT01450059|HiV-vertical transmission|hiv-vertical transmission
5043659|NCT01450046|pancreas|pancreas
5043660|NCT01450046|gastrointestinal|gastrointestinal
5043661|NCT01450046|GI|gi
5043662|NCT01450046|prevention|prevention
5043663|NCT01450046|vitamin E|vitamin e
5043664|NCT01450033|kidney|kidney
5043665|NCT01450033|renal|renal
5043666|NCT01450033|transplant|transplant
5043667|NCT01450033|transplantation|transplantation
5043668|NCT01450033|adolescent|adolescent
5043669|NCT01450033|pediatric|pediatric
5043670|NCT01450033|mentor|mentor
5043671|NCT01450033|mentoring|mentoring
5043672|NCT01450033|medication|medication
5043673|NCT01450033|adherence|adherence
5043674|NCT01450033|immunosuppressant|immunosuppressant
5043675|NCT01450033|heart|heart
5043676|NCT01450033|liver|liver
5043677|NCT01450020|cancer survivor|cancer survivor
5043678|NCT01450007|Pain blockade|pain blockade
5043679|NCT01450007|Ropivacaine|ropivacaine
5043680|NCT01450007|Dexamethasone|dexamethasone
5043681|NCT01449994|knee|knee
5043682|NCT01449994|hip|hip
5043683|NCT01449994|ankle|ankle
5043684|NCT01449994|foot|foot
5043685|NCT01449994|pain|pain
5043686|NCT01449994|lower limb|lower limb
5043687|NCT01449994|activator|activator
5043688|NCT01449994|instrumental|instrumental
5043689|NCT01449994|chiropractic|chiropractic
5043690|NCT01449994|Painful functional conditions of the lower extremity|painful functional conditions of the lower extremity
5043691|NCT01449981|Adolescents|adolescents
5043692|NCT01449981|Alcohol Abuse|alcohol abuse
5043693|NCT01449981|Alcohol Dependence|alcohol dependence
5043694|NCT01449981|Drug Abuse|drug abuse
5043695|NCT01449981|Drug Dependence|drug dependence
5043696|NCT01449981|Substance Use Disorder|substance use disorder
5043697|NCT01449981|Alcoholics Anonymous|alcoholics anonymous
5043698|NCT01449981|Motivational Enhancement Therapy|motivational enhancement therapy
5043699|NCT01449981|Cognitive Behavioral Therapy|cognitive behavioral therapy
5043700|NCT01449955|PTSD|ptsd
5043701|NCT01449942|Nasopharyngeal carcinoma|nasopharyngeal carcinoma
5043702|NCT01449942|EBV|ebv
5043703|NCT01449942|LMP1|lmp1
5043704|NCT01449929|ritonavir|ritonavir
5043705|NCT01449929|HIV|hiv
5043706|NCT01449929|HAART|haart
5043707|NCT01449929|darunavir|darunavir
5043708|NCT01449929|antiretroviral|antiretroviral
5043709|NCT01449929|dolutegravir|dolutegravir
5043710|NCT01449929|GSK1349572|gsk1349572
5043711|NCT01449916|Sepsis|sepsis
5043712|NCT01449916|Severe Sepsis|severe sepsis
5043713|NCT01449916|Protocol|protocol
5043714|NCT01449916|Zambia|zambia
5043715|NCT01449890|follow up care|follow up care
5043716|NCT01449890|e-mail|e-mail
5043717|NCT01449890|effectiveness|effectiveness
5043718|NCT01449890|depressive disorders|depressive disorders
5043719|NCT01449877|Ocular Toxoplasmosis|ocular toxoplasmosis
5043720|NCT01449877|Retinochoroiditis|retinochoroiditis
5043721|NCT01449877|Prophylaxis|prophylaxis
5043722|NCT01449864|upper GI malignancies|upper gi malignancies
5043723|NCT01449864|concurrent chemoradiation with continuous infusion 5-Fluorouracil chemotherapy|concurrent chemoradiation with continuous infusion 5-fluorouracil chemotherapy
5043724|NCT01449825|hepatic safety|hepatic safety
5043725|NCT01449825|prescriber compliance|prescriber compliance
5043726|NCT01449825|pazopanib|pazopanib
5043727|NCT01449825|epidemiology|epidemiology
5043728|NCT01449812|combination vaccine|combination vaccine
5043729|NCT01449812|booster vaccination|booster vaccination
5043730|NCT01449786|Mal d 1, Bet v 1, sublingual immunotherapy,|mal d 1, bet v 1, sublingual immunotherapy,
5043731|NCT01449760|Ankle sprain|ankle sprain
5043732|NCT01449760|Balance|balance
5043733|NCT01449760|Gait|gait
5043734|NCT01449747|Type 2 diabetes mellitus|type 2 diabetes mellitus
5043735|NCT01449747|Dipeptidyl peptidase IV inhibitors|dipeptidyl peptidase iv inhibitors
5043736|NCT01449747|Glucagon-like peptide 1|glucagon-like peptide 1
5043737|NCT01449721|Sepsis|sepsis
5043738|NCT01449721|Multiple organ failure|multiple organ failure
5043739|NCT01449721|Resuscitation|resuscitation
5043740|NCT01449708|Bariatric Surgery|bariatric surgery
5043741|NCT01449708|TIVA|tiva
5043742|NCT01449708|PONV|ponv
5043743|NCT01449708|non-opioid|non-opioid
5043744|NCT01449708|OSA|osa
5043745|NCT01449695|PAD|pad
5043746|NCT01449695|CVA|cva
5043747|NCT01449695|ACS|acs
5043748|NCT01449682|BRVO|brvo
5043749|NCT01449682|CRVO|crvo
5043750|NCT01449682|Macular Edema|macular edema
5043751|NCT01449682|Anti-VEGF|anti-vegf
5043752|NCT01449682|Ozurdex|ozurdex
5043753|NCT01449669|pharmacokinetics|pharmacokinetics
5043755|NCT01449669|microdialysis sampling|microdialysis sampling
5043756|NCT01449669|interstitial fluid|interstitial fluid
5043757|NCT01449669|skeletal muscle|skeletal muscle
5043758|NCT01449669|plasma|plasma
5043759|NCT01449669|children|children
5043760|NCT01449643|Obesity|obesity
5043761|NCT01449643|Diaphragm|diaphragm
5043762|NCT01449643|Inspiratory muscular training|inspiratory muscular training
5043763|NCT01449617|Carotid stenosis|carotid stenosis
5043764|NCT01449617|Aspirin plus Clopidogrel|aspirin plus clopidogrel
5043765|NCT01449617|Residual platelet reactivity|residual platelet reactivity
5043766|NCT01449604|Stereotactic radiotherapy|stereotactic radiotherapy
5043767|NCT01449604|SRS|srs
5043768|NCT01449604|SRT|srt
5043769|NCT01449604|vestibular schwannoma|vestibular schwannoma
5043770|NCT01449591|BFH772|bfh772
5043771|NCT01449591|rosacea|rosacea
5043772|NCT01449591|erythemato-telangiectatic rosacea|erythemato-telangiectatic rosacea
5043773|NCT01449565|methamphetamine|methamphetamine
5043774|NCT01449565|high-risk sexual behavior|high-risk sexual behavior
5043775|NCT01449565|HIV prevention|hiv prevention
5043776|NCT01449539|Hyperbaric oxygen|hyperbaric oxygen
5043777|NCT01449539|mobilize|mobilize
5043778|NCT01449539|stem cells|stem cells
5043779|NCT01449539|growth factor|growth factor
5043780|NCT01449526|contact lens|contact lens
5043781|NCT01449500|Dyspeptic H.pylori-infection|dyspeptic h.pylori-infection
5043782|NCT01449487|Experimental pain|experimental pain
5043783|NCT01449487|IBS|ibs
5043784|NCT01449487|Rectum|rectum
5043785|NCT01449448|pain relief|pain relief
5043786|NCT01449448|Hypermobility, Joint|hypermobility, joint
5043787|NCT01449448|increased strength|increased strength
5043788|NCT01449448|increased patient satisfaction|increased patient satisfaction
5043789|NCT01449435|Asthma|asthma
5043790|NCT01449435|children|children
5043791|NCT01449435|predictors of exacerbation|predictors of exacerbation
5043792|NCT01449435|Methacholine challenge|methacholine challenge
5043793|NCT01449435|Pulmonary function testing|pulmonary function testing
5043794|NCT01449409|Uncontrolled asthma|uncontrolled asthma
5043795|NCT01449409|Asthma risk|asthma risk
5043796|NCT01449409|Asthma impairment|asthma impairment
5043797|NCT01449409|Real time asthma outreach program|real time asthma outreach program
5043798|NCT01449396|acupuncture|acupuncture
5043799|NCT01449396|in vitro fertilization|in vitro fertilization
5043800|NCT01449396|embryo transfer|embryo transfer
5043801|NCT01449383|cross over|cross over
5043802|NCT01449383|dietary intervention|dietary intervention
5043803|NCT01449383|fibre|fibre
5043804|NCT01449383|red meat|red meat
5043805|NCT01449383|microbiota|microbiota
5043806|NCT01449370|INK1117|ink1117
5043807|NCT01449370|PIK3CA|pik3ca
5043808|NCT01449370|KINASE|kinase
5043809|NCT01449370|TUMOR|tumor
5043810|NCT01449370|CANCER|cancer
5043811|NCT01449370|Locally advanced or metastatic solid tumors|locally advanced or metastatic solid tumors
5043812|NCT01449370|not eligible for standard of care therapy|not eligible for standard of care therapy
5043813|NCT01449357|NSCLC|nsclc
5043814|NCT01449357|Zalutumumab|zalutumumab
5043815|NCT01449357|Efficacy|efficacy
5043816|NCT01449357|Safety|safety
5043817|NCT01449344|relapsed|relapsed
5043818|NCT01449344|refractory|refractory
5043819|NCT01449318|Pain|pain
5043820|NCT01449318|quantitative sensory testing|quantitative sensory testing
5043821|NCT01449292|PLVR|plvr
5043822|NCT01449292|ELVR|elvr
5043823|NCT01449292|AeriSeal System|aeriseal system
5043824|NCT01449292|foam sealant|foam sealant
5043825|NCT01449292|emphysematous lung sealant|emphysematous lung sealant
5043826|NCT01449292|ELS|els
5043827|NCT01449292|COPD|copd
5043828|NCT01449292|emphysema|emphysema
5043829|NCT01449292|polymeric lung volume reduction|polymeric lung volume reduction
5043830|NCT01449292|heterogeneous|heterogeneous
5043831|NCT01449292|Respiratory Tract Diseases|respiratory tract diseases
5043832|NCT01449292|Lung Diseases|lung diseases
5043833|NCT01449292|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5043834|NCT01449266|Dotarem|dotarem
5043835|NCT01449266|Dialyses|dialyses
5043836|NCT01449266|Dialysed|dialysed
5043837|NCT01449266|Safety|safety
5043838|NCT01449266|Safety and dialysability of Dotarem in dialysed patients|safety and dialysability of dotarem in dialysed patients
5043839|NCT01449240|Hunter syndrome|hunter syndrome
5043840|NCT01449240|Mucopolysaccharidosis II|mucopolysaccharidosis ii
5043841|NCT01449240|Iduronate 2-Sulfatase Deficiency|iduronate 2-sulfatase deficiency
5043842|NCT01449240|Lumbar puncture|lumbar puncture
5043843|NCT01449240|Cerebrospinal fluid (CSF)|cerebrospinal fluid (csf)
5043844|NCT01449240|Pediatric|pediatric
5043845|NCT01449240|Adult|adult
5043846|NCT01449240|Biomarkers|biomarkers
5043847|NCT01449227|adhesive capsulitis|adhesive capsulitis
5043848|NCT01449227|hip|hip
5043849|NCT01449214|Thoracic epidural|thoracic epidural
5043850|NCT01449214|Epidural anesthesia|epidural anesthesia
5043851|NCT01449214|Ultrasound|ultrasound
5043852|NCT01449214|Palpation|palpation
5043853|NCT01449214|Thoracic spine|thoracic spine
5043854|NCT01449201|PF-00299804, head and neck cancer, squamous cell carcinoma|pf-00299804, head and neck cancer, squamous cell carcinoma
5043855|NCT01449188|ondansetron|ondansetron
5043856|NCT01449188|moxifloxacin|moxifloxacin
5043858|NCT01449188|thorough QT study|thorough qt study
5043859|NCT01449188|IV|iv
5043860|NCT01449175|AeriSeal|aeriseal
5043861|NCT01449175|treatment|treatment
5043862|NCT01449175|device|device
5043863|NCT01449175|breathing|breathing
5043864|NCT01449175|COPD|copd
5043865|NCT01449175|emphysema|emphysema
5043866|NCT01449175|polymeric lung volume reduction (PLVR)|polymeric lung volume reduction (plvr)
5043867|NCT01449175|biologic lung volume reduction (BLVR)|biologic lung volume reduction (blvr)
5043868|NCT01449175|heterogeneous|heterogeneous
5043869|NCT01449175|homogeneous|homogeneous
5043870|NCT01449175|Respiratory Tract Diseases|respiratory tract diseases
5043871|NCT01449175|Lung Diseases|lung diseases
5043872|NCT01449175|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
5043873|NCT01449162|severe persistent asthma|severe persistent asthma
5043874|NCT01449162|patients treated with oral corticosteroids|patients treated with oral corticosteroids
5043875|NCT01449149|Age 18 or greater|age 18 or greater
5043876|NCT01449149|No prior radiation|no prior radiation
5043877|NCT01449136|Antibacterial agents|antibacterial agents
5043878|NCT01449136|Deciduous Teeth|deciduous teeth
5043879|NCT01449136|Clinical Trial|clinical trial
5043880|NCT01449123|Asthma|asthma
5043881|NCT01449123|mannitol challenge test|mannitol challenge test
5043882|NCT01449123|Sweden|sweden
5043883|NCT01449123|primary care|primary care
5043884|NCT01449110|Primary prevention|primary prevention
5043885|NCT01449110|Secondary prevention|secondary prevention
5043886|NCT01449110|Resveratrol|resveratrol
5043887|NCT01449110|Grape|grape
5043888|NCT01449110|Cardiovascular|cardiovascular
5043889|NCT01449110|Nutraceutical|nutraceutical
5043890|NCT01449110|Food complement|food complement
5043891|NCT01449097|Adductor-Canal-blockade,|adductor-canal-blockade,
5043892|NCT01449097|human volunteers,|human volunteers,
5043893|NCT01449097|US-guided nerve block|us-guided nerve block
5043894|NCT01449097|femoral nerve block|femoral nerve block
5043895|NCT01449084|Pancreatic duct stenting|pancreatic duct stenting
5043896|NCT01449084|Post-endoscopic pancreatitis|post-endoscopic pancreatitis
5043897|NCT01449071|Lupus|lupus
5043898|NCT01449071|Monoclonal antibody|monoclonal antibody
5043899|NCT01449071|B-cell immunotherapy|b-cell immunotherapy
5043900|NCT01449071|Epratuzumab|epratuzumab
5043901|NCT01449058|Advanced solid tumor,|advanced solid tumor,
5043902|NCT01449058|AML|aml
5043903|NCT01449058|high risk and very high risk MDS|high risk and very high risk mds
5043904|NCT01449058|dose escalation,|dose escalation,
5043905|NCT01449058|RAS/BRAF mutation,|ras/braf mutation,
5043906|NCT01449058|PI3K inhibitor,|pi3k inhibitor,
5043907|NCT01449058|MEK inhibitor,|mek inhibitor,
5043908|NCT01449058|BYL719,|byl719,
5043909|NCT01449058|MEK162|mek162
5043910|NCT01449045|IPTc|iptc
5043911|NCT01449045|Community Case Management|community case management
5043912|NCT01449045|Home Management for malaria|home management for malaria
5043913|NCT01449032|Patients|patients
5043914|NCT01449019|GLP-1|glp-1
5043915|NCT01449019|Exendin(9-39)|exendin(9-39)
5043916|NCT01449019|Insulin|insulin
5043917|NCT01449019|Glucagon|glucagon
5043918|NCT01449019|T2DM|t2dm
5043919|NCT01449019|incretin effect|incretin effect
5043920|NCT01449019|human physiology|human physiology
5043921|NCT01449006|HIV|hiv
5043922|NCT01449006|HAND|hand
5043923|NCT01449006|Maraviroc|maraviroc
5043924|NCT01449006|Neurocognitive|neurocognitive
5043925|NCT01449006|Neurology|neurology
5043926|NCT01449006|Human Immunodeficiency Virus|human immunodeficiency virus
5043927|NCT01449006|HIV Associated Neurocognitive Disorders|hiv associated neurocognitive disorders
5043928|NCT01448980|massage|massage
5043929|NCT01448980|stroke spasticity|stroke spasticity
5043930|NCT01448928|Zevalin|zevalin
5043931|NCT01448928|CD20+|cd20+
5043932|NCT01448928|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
5043933|NCT01448928|Mantle Cell Lymphoma|mantle cell lymphoma
5043934|NCT01448915|HIV|hiv
5043935|NCT01448915|Human immunodeficiency virus|human immunodeficiency virus
5043936|NCT01448915|Acquired Immune Deficiency Syndrome Virus|acquired immune deficiency syndrome virus
5043937|NCT01448915|AIDS virus|aids virus
5043938|NCT01448915|Immunodeficiency Virus, Human|immunodeficiency virus, human
5043939|NCT01448915|Virus, Human Immunodeficiency|virus, human immunodeficiency
5043940|NCT01448915|Hepatitis C|hepatitis c
5043941|NCT01448915|Hepatitis C, chronic|hepatitis c, chronic
5043942|NCT01448915|Hepatitis C virus|hepatitis c virus
5043943|NCT01448915|Hepatitis C antibodies|hepatitis c antibodies
5043944|NCT01448915|Hepatitis C antigens|hepatitis c antigens
5043945|NCT01448902|Allergic rhinitis|allergic rhinitis
5043946|NCT01448902|CRTH2|crth2
5043947|NCT01448889|contrast induced nephropathy|contrast induced nephropathy
5043948|NCT01448889|oxigen|oxigen
5043949|NCT01448889|coronary angiography|coronary angiography
5043950|NCT01448876|Chlamydia trachomatis|chlamydia trachomatis
5043951|NCT01448876|anorectal|anorectal
5043952|NCT01448876|cervicovaginal|cervicovaginal
5043953|NCT01448876|MSM|msm
5043954|NCT01448876|women|women
5043955|NCT01448876|treatment|treatment
5043956|NCT01448876|RNA|rna
5043957|NCT01448876|bacterial load|bacterial load
5043958|NCT01448876|sexual behaviour|sexual behaviour
5043959|NCT01448876|Azythromycin treated|azythromycin treated
5043960|NCT01448850|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
5043961|NCT01448850|MEDI8968|medi8968
5043962|NCT01448824|Low High-density Lipoprotein (HDL)|low high-density lipoprotein (hdl)
5043963|NCT01448824|Cholesterol (HDL-C)|cholesterol (hdl-c)
5043964|NCT01448798|radical prostatectomy|radical prostatectomy
5043965|NCT01448798|robotic surgery|robotic surgery
5043966|NCT01448798|erectile dysfunction|erectile dysfunction
5043967|NCT01448798|continence|continence
5043968|NCT01448785|obesity|obesity
5043969|NCT01448785|gastric stimulation|gastric stimulation
5043970|NCT01448785|morbid obesity|morbid obesity
5043971|NCT01448772|Dronabinol|dronabinol
5043972|NCT01448772|fasting|fasting
5043973|NCT01448759|Patients receiving docetaxel or paclitaxel. All tumors.|patients receiving docetaxel or paclitaxel. all tumors.
5043974|NCT01448746|gastric cancer|gastric cancer
5043975|NCT01448746|VTE|vte
5043976|NCT01448746|incidence|incidence
5043977|NCT01448733|acne vulgaris|acne vulgaris
5043978|NCT01448720|Schizophrenia|schizophrenia
5043979|NCT01448720|Paliperidone palmitate|paliperidone palmitate
5043980|NCT01448720|Long-acting injectable antipsychotic medication|long-acting injectable antipsychotic medication
5043981|NCT01448707|Darunavir (DRV)|darunavir (drv)
5043982|NCT01448707|TMC114|tmc114
5043983|NCT01448707|Prezista|prezista
5043985|NCT01448707|virologic response|virologic response
5043986|NCT01448707|neurocognitive function|neurocognitive function
5043987|NCT01448694|Hemorrhage|hemorrhage
5043988|NCT01448681|Intracranial Hypertension|intracranial hypertension
5043989|NCT01448681|Elevated ICP (Intracranial Pressure)|elevated icp (intracranial pressure)
5043990|NCT01448668|pancreatic cancer|pancreatic cancer
5043991|NCT01448668|mistletoe|mistletoe
5043992|NCT01448668|supportive treatment|supportive treatment
5043993|NCT01448668|long-term study|long-term study
5043994|NCT01448668|non-interventional cohort study|non-interventional cohort study
5043995|NCT01448668|controlled study with parallel groups|controlled study with parallel groups
5043996|NCT01448655|colorectal cancer|colorectal cancer
5043997|NCT01448655|mistletoe|mistletoe
5043998|NCT01448655|supportive treatment|supportive treatment
5043999|NCT01448655|long-term study|long-term study
5044000|NCT01448655|non-interventional cohort study|non-interventional cohort study
5044001|NCT01448655|controlled study with parallel groups|controlled study with parallel groups
5044002|NCT01448603|Ragweed allergy|ragweed allergy
5044003|NCT01448603|ToleroMune ragweed|toleromune ragweed
5044004|NCT01448603|immunotherapy|immunotherapy
5044005|NCT01448590|post dural puncture headache|post dural puncture headache
5044006|NCT01448590|accidental dural puncture|accidental dural puncture
5044007|NCT01448590|PDPH|pdph
5044008|NCT01448590|ADP|adp
5044009|NCT01448590|spinal catheter|spinal catheter
5044010|NCT01448590|epidural catheter|epidural catheter
5044011|NCT01448590|intrathecal catheter|intrathecal catheter
5044012|NCT01448590|dural puncture|dural puncture
5044013|NCT01448590|systemic review|systemic review
5044014|NCT01448564|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5044015|NCT01448564|Fatigue|fatigue
5044016|NCT01448564|laser therapy|laser therapy
5044017|NCT01448551|Obesity|obesity
5044018|NCT01448551|Treatment|treatment
5044019|NCT01448551|Adolescents|adolescents
5044020|NCT01448551|Text Messages|text messages
5044021|NCT01448551|Mobile phones|mobile phones
5044022|NCT01448551|Multidisciplinary|multidisciplinary
5044023|NCT01448538|Medication Non-Adherence|medication non-adherence
5044024|NCT01448538|Medication Persistence|medication persistence
5044025|NCT01448538|wet macular degeneration|wet macular degeneration
5044026|NCT01448512|HIV|hiv
5044027|NCT01448512|Pregnancy|pregnancy
5044028|NCT01448512|Prevention|prevention
5044029|NCT01448512|Couples|couples
5044030|NCT01448499|schizophrenia|schizophrenia
5044031|NCT01448499|clozapine|clozapine
5044032|NCT01448499|amisulpride|amisulpride
5044033|NCT01448499|combination|combination
5044034|NCT01448499|treatment resistant|treatment resistant
5044035|NCT01448486|HIV|hiv
5044036|NCT01448486|HAND|hand
5044037|NCT01448486|Human Immunodeficiency Virus|human immunodeficiency virus
5044038|NCT01448486|Raltegravir|raltegravir
5044039|NCT01448486|HIV Associated Neurocognitive Disorders|hiv associated neurocognitive disorders
5044040|NCT01448486|Neuro-HAART|neuro-haart
5044041|NCT01448486|Neurocognitive|neurocognitive
5044042|NCT01448486|Neurology|neurology
5044043|NCT01448473|Head trauma|head trauma
5044044|NCT01448473|Children|children
5044045|NCT01448473|Radiography|radiography
5044046|NCT01448434|Osteoarthritis|osteoarthritis
5044047|NCT01448434|Knee|knee
5044048|NCT01448434|Stem cell|stem cell
5044049|NCT01448434|MSC|msc
5044050|NCT01448421|TAVR|tavr
5044051|NCT01448408|Forme Fruste Keratoconus|forme fruste keratoconus
5044052|NCT01448408|Corneal Biomechanical properties|corneal biomechanical properties
5044053|NCT01448408|Anterior Segment Parameters|anterior segment parameters
5044054|NCT01448408|Diagnostic Capacity|diagnostic capacity
5044055|NCT01448395|Mass Balance|mass balance
5044056|NCT01448395|Metabolite Identification and Profiling|metabolite identification and profiling
5044057|NCT01448395|Metabolite profile and Identification of [14C]NXL104|metabolite profile and identification of [14c]nxl104
5044058|NCT01448395|Mass Balance Recovery|mass balance recovery
5044059|NCT01448369|meibomian gland dysfunction|meibomian gland dysfunction
5044060|NCT01448369|hot compress|hot compress
5044061|NCT01448369|eyelid warming|eyelid warming
5044062|NCT01448369|meibum|meibum
5044063|NCT01448356|Controlled adverse chamber|controlled adverse chamber
5044064|NCT01448356|tear film stability|tear film stability
5044065|NCT01448356|tear film evaporation|tear film evaporation
5044066|NCT01448356|tear film break up time|tear film break up time
5044067|NCT01448356|humidity|humidity
5044068|NCT01448356|temperature|temperature
5044069|NCT01448343|transfusion|transfusion
5044070|NCT01448343|potassium|potassium
5044071|NCT01448330|clopidogrel|clopidogrel
5044072|NCT01448330|aspinin|aspinin
5044073|NCT01448330|combination|combination
5044074|NCT01448291|Contraception|contraception
5044075|NCT01448291|Nuvaring|nuvaring
5044076|NCT01448291|Vaginal inflammation|vaginal inflammation
5044077|NCT01448291|Bacterial vaginosis|bacterial vaginosis
5044078|NCT01448291|Nugent score|nugent score
5044079|NCT01448278|Anterior cruciate ligament|anterior cruciate ligament
5044080|NCT01448278|Arthroscopy|arthroscopy
5044081|NCT01448278|Incomplete bone tunnels|incomplete bone tunnels
5044082|NCT01448278|Anterior cruciate ligament reconstruction|anterior cruciate ligament reconstruction
5044083|NCT01448265|atrial fibrillation|atrial fibrillation
5044084|NCT01448265|catheter ablation|catheter ablation
5044085|NCT01448265|circular mapping catheter|circular mapping catheter
5044086|NCT01448265|cryoballoon|cryoballoon
5044087|NCT01448252|T cell vaccination|t cell vaccination
5044088|NCT01448252|Immunotherapy|immunotherapy
5044089|NCT01448252|Tolerance|tolerance
5044090|NCT01448252|safety|safety
5044091|NCT01448252|clinical efficacy|clinical efficacy
5044092|NCT01448213|DMEK|dmek
5044093|NCT01448213|Rejection|rejection
5044094|NCT01448213|Corticosteroid|corticosteroid
5044095|NCT01448200|hepatitis C|hepatitis c
5044096|NCT01448200|NS5A inhibitor|ns5a inhibitor
5044097|NCT01448200|Phase 1|phase 1
5044098|NCT01448200|genotype-1|genotype-1
5044099|NCT01448200|genotype-2|genotype-2
5044100|NCT01448200|genotype-3|genotype-3
5044101|NCT01448187|Lung cancer, France|lung cancer, france
5044102|NCT01448174|salusin-alpha|salusin-alpha
5044103|NCT01448174|atorvastatin|atorvastatin
5044104|NCT01448174|CD36|cd36
5044105|NCT01448174|Hemodialysis|hemodialysis
5044106|NCT01448161|Pediatric|pediatric
5044107|NCT01448161|Adult|adult
5044108|NCT01448161|ICU|icu
5044109|NCT01448148|Mild cognitive impairment|mild cognitive impairment
5044110|NCT01448122|Prevention of pigmentation|prevention of pigmentation
5044111|NCT01448109|Sepsis|sepsis
5044112|NCT01448109|Corticosteroid|corticosteroid
5044113|NCT01448096|primary breast diffuse large B cell lymphoma|primary breast diffuse large b cell lymphoma
5044114|NCT01448096|rituximab|rituximab
5044115|NCT01448096|prophylactic intrathecal chemotherapy|prophylactic intrathecal chemotherapy
5044116|NCT01448096|CNS recurrence|cns recurrence
5044117|NCT01448083|I-131 MIBG therapy|i-131 mibg therapy
5044118|NCT01448083|whole body I-123 MIBG scintigraphy|whole body i-123 mibg scintigraphy
5044119|NCT01448057|Paracetamol|paracetamol
5044120|NCT01448057|dimethindene maleate|dimethindene maleate
5044121|NCT01448057|phenylephrine hydrochloride|phenylephrine hydrochloride
5044122|NCT01448057|cold and flu symptoms|cold and flu symptoms
5044123|NCT01448044|hepatitis C virus|hepatitis c virus
5044124|NCT01448031|Acetyl Salicylic Acid|acetyl salicylic acid
5044125|NCT01448031|Bioavailability|bioavailability
5044126|NCT01448031|Healthy Volunteers|healthy volunteers
5044127|NCT01448005|Coronary Artery Bypass Grafting|coronary artery bypass grafting
5044128|NCT01448005|Resuscitation|resuscitation
5044129|NCT01448005|Sudden Cardiac Death|sudden cardiac death
5044130|NCT01448005|Ventricular Dysfunction|ventricular dysfunction
5044131|NCT01447992|Artificial Pancreas|artificial pancreas
5044132|NCT01447992|Insulin Pump|insulin pump
5044133|NCT01447992|Continuous Glucose Monitor|continuous glucose monitor
5044134|NCT01447992|Closed Loop|closed loop
5044135|NCT01447979|Artificial Pancreas|artificial pancreas
5044136|NCT01447979|Insulin Pump|insulin pump
5044137|NCT01447979|Continuous Glucose Monitor|continuous glucose monitor
5044138|NCT01447979|Closed Loop|closed loop
5044139|NCT01447966|OCD|ocd
5044140|NCT01447966|Obsessive Compulsive Disorder|obsessive compulsive disorder
5044141|NCT01447966|Child|child
5044142|NCT01447966|Pediatric|pediatric
5044143|NCT01447966|CBT|cbt
5044144|NCT01447966|Therapy|therapy
5044145|NCT01447966|ERP|erp
5044146|NCT01447966|Exposure Response Prevention|exposure response prevention
5044147|NCT01447966|Preschool|preschool
5044148|NCT01447966|Cognitive Behavioral|cognitive behavioral
5044149|NCT01447953|Activity|activity
5044150|NCT01447953|disability|disability
5044151|NCT01447953|life-role|life-role
5044152|NCT01447953|multimodal rehabilitation|multimodal rehabilitation
5044153|NCT01447953|primary health care|primary health care
5044154|NCT01447953|persistent pain|persistent pain
5044155|NCT01447953|randomized controlled trial|randomized controlled trial
5044156|NCT01447953|Musculoskeletal back pain|musculoskeletal back pain
5044157|NCT01447940|Telemedicine|telemedicine
5044158|NCT01447940|Type 1 diabetes|type 1 diabetes
5045253|NCT01443715|MDD|mdd
5044159|NCT01447940|economic cost of Type 1 diabetes|economic cost of type 1 diabetes
5044160|NCT01447940|ePortal Meos|eportal meos
5044161|NCT01447914|c-Met Inhibitor ARQ-197|c-met inhibitor arq-197
5044162|NCT01447914|tivantinib|tivantinib
5044163|NCT01447914|multiple myeloma|multiple myeloma
5044164|NCT01447914|plasma cell proliferative disorder|plasma cell proliferative disorder
5044165|NCT01447914|Hypercalcemia|hypercalcemia
5044166|NCT01447914|hematologic malignancy|hematologic malignancy
5044167|NCT01447914|plasma cell dyscrasia|plasma cell dyscrasia
5044168|NCT01447914|cast nephropathy|cast nephropathy
5044169|NCT01447914|amyloidosis|amyloidosis
5044170|NCT01447914|osteolysis|osteolysis
5044171|NCT01447914|Renal insufficiency|renal insufficiency
5044172|NCT01447914|Anemia|anemia
5044173|NCT01447914|Bone lytic lesions|bone lytic lesions
5044174|NCT01447914|severe osteopenia|severe osteopenia
5044175|NCT01447914|pathologic fractures|pathologic fractures
5044176|NCT01447914|biopsy-proven plasmacytoma|biopsy-proven plasmacytoma
5044177|NCT01447901|Hyperlipoproteinemia Type I|hyperlipoproteinemia type i
5044178|NCT01447888|Spine surgery|spine surgery
5044179|NCT01447888|Chronic pain|chronic pain
5044180|NCT01447888|Opioid tolerant|opioid tolerant
5044181|NCT01447888|Pain management in spine surgery patients|pain management in spine surgery patients
5044182|NCT01447862|recent-onset|recent-onset
5044183|NCT01447849|Chronic Constipation|chronic constipation
5044184|NCT01447836|indocyanine green|indocyanine green
5044185|NCT01447836|sepsis|sepsis
5044186|NCT01447836|liver injury|liver injury
5044187|NCT01447836|abdominal perfusion pressure|abdominal perfusion pressure
5044188|NCT01447823|Oesophageal bolus obstruction|oesophageal bolus obstruction
5044189|NCT01447823|Gastroscopy|gastroscopy
5044190|NCT01447823|phmetry|phmetry
5044191|NCT01447810|Constraint-Induced Movement therapy|constraint-induced movement therapy
5044192|NCT01447810|Pediatric|pediatric
5044193|NCT01447810|Hemiplegia|hemiplegia
5044194|NCT01447810|Brain Tumor|brain tumor
5044195|NCT01447810|Rehabilitation|rehabilitation
5044196|NCT01447797|Irbesartan|irbesartan
5044197|NCT01447797|Atorvastatin|atorvastatin
5044198|NCT01447797|combination|combination
5044199|NCT01447784|HDM allergy|hdm allergy
5044200|NCT01447784|Rhinoconunctivitis|rhinoconunctivitis
5044201|NCT01447784|Environmental Exposure Chamber|environmental exposure chamber
5044202|NCT01447784|Immunotherapy|immunotherapy
5044203|NCT01447784|ToleroMune HDM|toleromune hdm
5044204|NCT01447771|Decision making|decision making
5044205|NCT01447771|Decisional aide|decisional aide
5044206|NCT01447745|Visceral obesity|visceral obesity
5044207|NCT01447745|Cardiometabolic risk|cardiometabolic risk
5044208|NCT01447745|Atherosclerosis|atherosclerosis
5044209|NCT01447745|Ectopic fat|ectopic fat
5044210|NCT01447745|Carotid plaque|carotid plaque
5044211|NCT01447745|Magnetic resonance imaging (MRI)|magnetic resonance imaging (mri)
5044212|NCT01447745|Computed tomography (CT)|computed tomography (ct)
5044213|NCT01447732|Monoclonal antibody (Mab)|monoclonal antibody (mab)
5044214|NCT01447732|Antibody dependent cellular cytotoxicity (ADCC)|antibody dependent cellular cytotoxicity (adcc)
5044215|NCT01447732|Complement-dependent toxicity (CDC)|complement-dependent toxicity (cdc)
5044216|NCT01447732|Non-fucosylated immunoglobulin G|non-fucosylated immunoglobulin g
5044217|NCT01447706|Ovarian Cancer|ovarian cancer
5044218|NCT01447706|Platinum-resistant|platinum-resistant
5044219|NCT01447706|Platinum-refractory|platinum-refractory
5044220|NCT01447706|Fallopian tube cancer|fallopian tube cancer
5044221|NCT01447706|Peritoneal Cancer|peritoneal cancer
5044222|NCT01447706|Paclitaxel|paclitaxel
5044223|NCT01447706|ErbB3|erbb3
5044224|NCT01447706|Phase II|phase ii
5044225|NCT01447706|locally advanced/metastatic or recurrent|locally advanced/metastatic or recurrent
5044226|NCT01447693|uremia|uremia
5044227|NCT01447693|pruritus|pruritus
5044228|NCT01447693|oliva-omega 3|oliva-omega 3
5044229|NCT01447680|HIV infection|hiv infection
5044230|NCT01447680|HCV infection|hcv infection
5044231|NCT01447680|SMARTube|smartube
5044232|NCT01447680|SMARTplasma|smartplasma
5044233|NCT01447667|Hepatic fibrosis|hepatic fibrosis
5044234|NCT01447667|Magnetic resonance elastography|magnetic resonance elastography
5044235|NCT01447667|Hepatocellular carcinoma|hepatocellular carcinoma
5044236|NCT01447667|Recurrence|recurrence
5044237|NCT01447654|Hypertrophic cardiomyopathy|hypertrophic cardiomyopathy
5044238|NCT01447654|Hypertrophic obstructive cardiomyopathy|hypertrophic obstructive cardiomyopathy
5044239|NCT01447654|Hypertrophy|hypertrophy
5044240|NCT01447654|Losartan|losartan
5044241|NCT01447654|Angiotensin II receptor antagonist|angiotensin ii receptor antagonist
5044242|NCT01447641|Cluster Headache|cluster headache
5044243|NCT01447641|Trigeminal Autonomic Cephalalgias|trigeminal autonomic cephalalgias
5044244|NCT01447641|Sleep|sleep
5044245|NCT01447641|Circadian Rhythms|circadian rhythms
5044246|NCT01447628|Idiopathic pulmonary arterial hypertension (IPAH)|idiopathic pulmonary arterial hypertension (ipah)
5044247|NCT01447628|Iron deficiency|iron deficiency
5044248|NCT01447615|Orphaned children and youth|orphaned children and youth
5044249|NCT01447615|Economic empowerment|economic empowerment
5044250|NCT01447615|Uganda|uganda
5044251|NCT01447615|HIV/AIDS|hiv/aids
5044252|NCT01447615|Sub-Saharan Africa|sub-saharan africa
5044253|NCT01447602|Major Depressive Disorder (MDD)|major depressive disorder (mdd)
5044255|NCT01447602|Depressive Disorder Not Otherwise Specified (DDNOS)|depressive disorder not otherwise specified (ddnos)
5044256|NCT01447589|Radiosensitiser|radiosensitiser
5044257|NCT01447563|Bioequivalence|bioequivalence
5044258|NCT01447563|Bioavailability|bioavailability
5044259|NCT01447550|Bosentan|bosentan
5044260|NCT01447550|Buerguer disease|buerguer disease
5044261|NCT01447537|Cirrhosis|cirrhosis
5044262|NCT01447537|Exercise|exercise
5044263|NCT01447537|Relaxation|relaxation
5044264|NCT01447537|Muscle mass|muscle mass
5044265|NCT01447537|Effort tolerance|effort tolerance
5044266|NCT01447511|Drug Interactions|drug interactions
5044267|NCT01447511|Warfarin|warfarin
5044268|NCT01447511|Genetics|genetics
5044269|NCT01447511|CYP2C9|cyp2c9
5044270|NCT01447511|Healthy Volunteers|healthy volunteers
5044271|NCT01447485|Hypertension, chronic kidney disease|hypertension, chronic kidney disease
5044272|NCT01447485|nephrotic syndrome|nephrotic syndrome
5044273|NCT01447485|pharmacokinetics|pharmacokinetics
5044274|NCT01447472|MDMA,|mdma,
5044275|NCT01447472|pharmacokinetics,|pharmacokinetics,
5044276|NCT01447472|pharmacodynamics,|pharmacodynamics,
5044277|NCT01447472|CYP2D6, COMT,|cyp2d6, comt,
5044278|NCT01447472|SERT, 5-HTTLPR, gender,|sert, 5-httlpr, gender,
5044279|NCT01447472|dextromethorphan,|dextromethorphan,
5044280|NCT01447472|caffeine.|caffeine.
5044281|NCT01447459|Asthma|asthma
5044282|NCT01447459|Asthma Education|asthma education
5044283|NCT01447433|Calcium Carbonate|calcium carbonate
5044284|NCT01447433|Vitamin D|vitamin d
5044285|NCT01447433|Body weight|body weight
5044286|NCT01447433|Body fat|body fat
5044287|NCT01447433|Metabolic parameters|metabolic parameters
5044288|NCT01447433|Energy restriction|energy restriction
5044289|NCT01447433|Very-low calcium consumers|very-low calcium consumers
5044290|NCT01447433|Obesity|obesity
5044291|NCT01447433|Overweight|overweight
5044292|NCT01447407|Staphylococcal infections|staphylococcal infections
5044293|NCT01447407|Yeast infections|yeast infections
5044294|NCT01447407|Candidiasis|candidiasis
5044295|NCT01447368|chronic kidney disease|chronic kidney disease
5044296|NCT01447368|peritoneal dialysis|peritoneal dialysis
5044297|NCT01447368|secondary hyperparathyroidism|secondary hyperparathyroidism
5044298|NCT01447368|parathyroidectomy|parathyroidectomy
5044299|NCT01447368|vascular calcification|vascular calcification
5044300|NCT01447368|cinacalcet|cinacalcet
5044301|NCT01447329|pain|pain
5044302|NCT01447329|acupuncture|acupuncture
5044303|NCT01447329|knee|knee
5044304|NCT01447329|debridement|debridement
5044305|NCT01447329|surgery|surgery
5044306|NCT01447329|arthroscopic knee surgery debridement|arthroscopic knee surgery debridement
5044307|NCT01447316|body composition|body composition
5044308|NCT01447316|gait|gait
5044309|NCT01447316|quality of life|quality of life
5044310|NCT01447316|Patients|patients
5044311|NCT01447316|undergoing|undergoing
5044312|NCT01447316|bariatric surgery.|bariatric surgery.
5044313|NCT01447303|knee|knee
5044314|NCT01447303|osteoarthritis|osteoarthritis
5044315|NCT01447303|hyaluronic acid|hyaluronic acid
5044316|NCT01447303|viscosupplementation|viscosupplementation
5044317|NCT01447290|preeclampsia|preeclampsia
5044318|NCT01447290|protein|protein
5044319|NCT01447290|creatinine|creatinine
5044320|NCT01447290|protein:creatinine ratio|protein:creatinine ratio
5044321|NCT01447277|ACL reconstruction|acl reconstruction
5044322|NCT01447277|Femoral Block|femoral block
5044323|NCT01447277|Sciatic Block|sciatic block
5044324|NCT01447264|Rheumatoid arthritis|rheumatoid arthritis
5044325|NCT01447264|Muscle strength|muscle strength
5044326|NCT01447264|Body composition|body composition
5044327|NCT01447264|Physical activity|physical activity
5044328|NCT01447264|Water exercises|water exercises
5044329|NCT01447264|Hydrotherapy|hydrotherapy
5044330|NCT01447264|Randomized controlled clinical trial|randomized controlled clinical trial
5044331|NCT01447251|Obstructive Sleep Apnea|obstructive sleep apnea
5044332|NCT01447251|Diabetes Mellitus type 2|diabetes mellitus type 2
5044333|NCT01447251|DM2|dm2
5044334|NCT01447251|OSA|osa
5044335|NCT01447251|CPAP|cpap
5044336|NCT01447251|continuous positive airway pressure|continuous positive airway pressure
5044337|NCT01447238|pancreatic cysts|pancreatic cysts
5044338|NCT01447238|EUS/FNA|eus/fna
5044339|NCT01447238|Needle-based Confocal Laser Endomicroscopy (nCLE)|needle-based confocal laser endomicroscopy (ncle)
5044340|NCT01447238|fiber optic imaging|fiber optic imaging
5044341|NCT01447238|EUS/FNA of pancreatic cysts|eus/fna of pancreatic cysts
5044342|NCT01447225|Advanced-stage|advanced-stage
5044343|NCT01447225|Solid Tumors|solid tumors
5044344|NCT01447225|MM-121|mm-121
5044345|NCT01447225|Carboplatin|carboplatin
5044346|NCT01447225|Pemetrexed|pemetrexed
5044347|NCT01447225|Gemcitabine|gemcitabine
5044348|NCT01447225|Cabazitaxel|cabazitaxel
5044349|NCT01447225|ErbB3|erbb3
5044350|NCT01447225|Phase I|phase i
5044351|NCT01447225|Cancer|cancer
5044352|NCT01447212|Opioid Dependence|opioid dependence
5044353|NCT01447212|Long-term Opioid Injectors|long-term opioid injectors
5044354|NCT01447212|Opioid Substitution Treatment|opioid substitution treatment
5044355|NCT01447212|Hydromorphone|hydromorphone
5044356|NCT01447212|Diamorphine|diamorphine
5045254|NCT01443715|Dysthymia|dysthymia
5044357|NCT01447212|Diacetylmorphine|diacetylmorphine
5044358|NCT01447199|Bladder cancer|bladder cancer
5044359|NCT01447199|Colorectal cancer|colorectal cancer
5044360|NCT01447199|Endometrial cancer|endometrial cancer
5044361|NCT01447199|Kidney cancer|kidney cancer
5044362|NCT01447199|Skin cancer|skin cancer
5044363|NCT01447199|Uterus cancer|uterus cancer
5044364|NCT01447199|Molecular Predisposition|molecular predisposition
5044365|NCT01447199|Hereditary Nonpolyposis Colon Cancer|hereditary nonpolyposis colon cancer
5044366|NCT01447199|HNPCC|hnpcc
5044367|NCT01447199|Molecular genetic testing|molecular genetic testing
5044368|NCT01447199|Gene mutations|gene mutations
5044369|NCT01447199|Mutation analyses|mutation analyses
5044370|NCT01447199|Genetic polymorphisms|genetic polymorphisms
5044371|NCT01447199|Family history of cancer|family history of cancer
5044372|NCT01447199|Early age of cancer onset|early age of cancer onset
5044373|NCT01447199|Little/no personal or family history of cancer|little/no personal or family history of cancer
5044374|NCT01447199|Spouses|spouses
5044375|NCT01447199|Questionnaires|questionnaires
5044376|NCT01447199|Blood sample|blood sample
5044377|NCT01447199|Saliva Sample|saliva sample
5044378|NCT01447186|Prostate cancer screening|prostate cancer screening
5044379|NCT01447186|Prostate Cancer|prostate cancer
5044380|NCT01447186|Patient Decision Aid|patient decision aid
5044381|NCT01447186|Spanish Speaking Men|spanish speaking men
5044382|NCT01447186|Spanish-language slide set|spanish-language slide set
5044383|NCT01447186|Focus group|focus group
5044384|NCT01447186|Interview|interview
5044385|NCT01447186|Survey|survey
5044386|NCT01447173|Asthma|asthma
5044387|NCT01447173|Pulmonary Function Test|pulmonary function test
5044388|NCT01447173|Vitamin D|vitamin d
5044389|NCT01447160|facet joint|facet joint
5044390|NCT01447160|back pain|back pain
5044391|NCT01447160|osteoarthritis|osteoarthritis
5044392|NCT01447160|infiltration|infiltration
5044393|NCT01447108|Trigeminal Neuralgia|trigeminal neuralgia
5044394|NCT01447108|Tic Douloureux|tic douloureux
5044395|NCT01447108|Low Intensity Low Frequency Surface Acoustic Wave Ultrasound|low intensity low frequency surface acoustic wave ultrasound
5044396|NCT01447095|Subarachnoid hemorrhage|subarachnoid hemorrhage
5044397|NCT01447095|vasospasm|vasospasm
5044398|NCT01447095|prostacyclin|prostacyclin
5044399|NCT01447082|atypical|atypical
5044400|NCT01447082|antipsychotics|antipsychotics
5044401|NCT01447082|quetiapine|quetiapine
5044402|NCT01447069|heart failure stage 3|heart failure stage 3
5044403|NCT01447069|beta 2 agonist|beta 2 agonist
5044404|NCT01447069|N-terminal pro-brain natriuretic peptide|n-terminal pro-brain natriuretic peptide
5044405|NCT01447069|ejection fraction <35%|ejection fraction <35%
5044406|NCT01447056|Hodgkin lymphoma|hodgkin lymphoma
5044407|NCT01447056|Non-Hodgkin lymphoma|non-hodgkin lymphoma
5044408|NCT01447056|Lymphoproliferative disorder|lymphoproliferative disorder
5044409|NCT01447056|Nasopharyngeal carcinoma|nasopharyngeal carcinoma
5044410|NCT01447056|Leiomyosarcoma|leiomyosarcoma
5044411|NCT01447056|EBV Cytotoxic T Lymphocytes|ebv cytotoxic t lymphocytes
5044412|NCT01447043|retrospective studies|retrospective studies
5044413|NCT01447030|Biliary strictur|biliary strictur
5044414|NCT01447030|Hepatojejunostomy|hepatojejunostomy
5044415|NCT01447030|Iatrogenic major bile duct injury|iatrogenic major bile duct injury
5044416|NCT01446991|prostate neoplasm|prostate neoplasm
5044417|NCT01446991|brachytherapy|brachytherapy
5044418|NCT01446991|androgen ablation|androgen ablation
5044419|NCT01446991|benign prostatic hypertrophy|benign prostatic hypertrophy
5044420|NCT01446991|prostate size reduction|prostate size reduction
5044421|NCT01446991|localized prostate cancer with prostate volume > 40 cc|localized prostate cancer with prostate volume > 40 cc
5044422|NCT01446978|hepatitis A vaccine|hepatitis a vaccine
5044423|NCT01446978|TNF-alfa inhibitory drugs|tnf-alfa inhibitory drugs
5044424|NCT01446978|Rheumatoid arthritis|rheumatoid arthritis
5044425|NCT01446978|methotrexate|methotrexate
5044426|NCT01446965|myocardial infarction, acute|myocardial infarction, acute
5044427|NCT01446965|myocardial infarction|myocardial infarction
5044428|NCT01446965|ventricular dysfunction|ventricular dysfunction
5044429|NCT01446965|death, sudden, cardiac|death, sudden, cardiac
5044430|NCT01446965|death, sudden|death, sudden
5044431|NCT01446965|death|death
5044432|NCT01446965|ventricular tachycardia|ventricular tachycardia
5044433|NCT01446965|ventricular fibrillation|ventricular fibrillation
5044434|NCT01446965|defibrillation, electric|defibrillation, electric
5044435|NCT01446965|cardioversion, electric|cardioversion, electric
5044436|NCT01446965|electric countershock|electric countershock
5044437|NCT01446965|defibrillators, external|defibrillators, external
5044438|NCT01446952|prevention|prevention
5044439|NCT01446952|pancreas|pancreas
5044440|NCT01446939|MRI|mri
5044441|NCT01446939|Parkinson's disease|parkinson's disease
5044442|NCT01446939|Essential tremor|essential tremor
5044443|NCT01446939|Ultrasonography|ultrasonography
5044444|NCT01446939|Diagnosis|diagnosis
5044445|NCT01446926|Pneumonia|pneumonia
5044446|NCT01446926|Pneumococcal Infections|pneumococcal infections
5044447|NCT01446926|Streptococcus pneumoniae Infections|streptococcus pneumoniae infections
5044448|NCT01446926|Pneumococcal vaccines|pneumococcal vaccines
5044449|NCT01446913|Sleep Apnea|sleep apnea
5044450|NCT01446913|CPAP adherence|cpap adherence
5044451|NCT01446913|behavioral adherence|behavioral adherence
5044452|NCT01446913|stroke|stroke
5044453|NCT01446900|Rituximab|rituximab
5044454|NCT01446900|Cladribine|cladribine
5044455|NCT01446900|Chronic Lymphocytic Leukaemia|chronic lymphocytic leukaemia
5044456|NCT01446900|Small Lymphocytic Lymphoma|small lymphocytic lymphoma
5044457|NCT01446887|Deep Vein Thrombosis|deep vein thrombosis
5044458|NCT01446887|total hip arthroplasty|total hip arthroplasty
5044459|NCT01446887|prophylactic anticoagulation|prophylactic anticoagulation
5044460|NCT01446887|randomized study|randomized study
5044461|NCT01446874|Incidence of post-operative pneumonia in patients undergoing surgery for primary lung cancer or primary esophageal cancer|incidence of post-operative pneumonia in patients undergoing surgery for primary lung cancer or primary esophageal cancer
5044462|NCT01446861|Cystic fibrosis|cystic fibrosis
5044463|NCT01446861|Pancreas|pancreas
5044464|NCT01446861|Exocrine function|exocrine function
5044465|NCT01446861|Ultrasound|ultrasound
5044466|NCT01446861|Contrast ultrasound|contrast ultrasound
5044467|NCT01446848|iron deficiency|iron deficiency
5044468|NCT01446848|pulmonary hypertension|pulmonary hypertension
5044469|NCT01446848|iron supplements|iron supplements
5044470|NCT01446848|ferrous sulfate|ferrous sulfate
5044471|NCT01446822|urinary bladder neoplasm|urinary bladder neoplasm
5044472|NCT01446822|bipolar transurethral resection|bipolar transurethral resection
5044473|NCT01446822|monopolar transurethral resection|monopolar transurethral resection
5044474|NCT01446822|obturator nerve|obturator nerve
5044475|NCT01446796|Ventricular assist device|ventricular assist device
5044476|NCT01446783|COL5A1|col5a1
5044477|NCT01446783|Collagen disorders|collagen disorders
5044478|NCT01446783|IGF-I|igf-i
5044479|NCT01446783|Collagen synthesis|collagen synthesis
5044480|NCT01446757|quality of life|quality of life
5044481|NCT01446757|feeling of security|feeling of security
5044482|NCT01446757|costs|costs
5044483|NCT01446757|multiprofessional team|multiprofessional team
5044484|NCT01446757|geriatric competence|geriatric competence
5044485|NCT01446731|Prostate cancer|prostate cancer
5044486|NCT01446718|quadrivalent vaccine|quadrivalent vaccine
5044487|NCT01446718|Human Papillomavirus|human papillomavirus
5044488|NCT01446692|Major depressive disorder|major depressive disorder
5044489|NCT01446692|primary care|primary care
5044490|NCT01446692|real-world evidence|real-world evidence
5044491|NCT01446692|database|database
5044492|NCT01446679|Lipitor|lipitor
5044493|NCT01446679|HMG-CoA reductase inhibitor|hmg-coa reductase inhibitor
5044494|NCT01446666|hepatocellular carcinoma|hepatocellular carcinoma
5044495|NCT01446666|surveillance|surveillance
5044496|NCT01446666|gadoxetic acid|gadoxetic acid
5044497|NCT01446666|MRI|mri
5044498|NCT01446653|Fetal Alcohol Spectrum Disorders|fetal alcohol spectrum disorders
5044499|NCT01446653|FASDs|fasds
5044500|NCT01446653|AEP risk|aep risk
5044501|NCT01446653|binge drinking|binge drinking
5044502|NCT01446653|ineffective contraception|ineffective contraception
5044503|NCT01446627|Absorbable vicryl subcuticular staples|absorbable vicryl subcuticular staples
5044504|NCT01446627|metal staples|metal staples
5044505|NCT01446627|wound healing|wound healing
5044506|NCT01446627|cesarean section|cesarean section
5044507|NCT01446601|Apnea|apnea
5044508|NCT01446601|OSA|osa
5044509|NCT01446601|Sleep Apnea Syndromes|sleep apnea syndromes
5044510|NCT01446601|Sleep Apnea, Obstructive|sleep apnea, obstructive
5044511|NCT01446601|Hypoglossal Nerve Stimulation|hypoglossal nerve stimulation
5044512|NCT01446601|Sleep Disorders|sleep disorders
5044513|NCT01446601|Tongue|tongue
5044514|NCT01446536|Quality|quality
5044515|NCT01446536|Improvement|improvement
5044516|NCT01446523|endotoxins HE|endotoxins he
5044517|NCT01446510|VTE|vte
5044518|NCT01446510|DVT|dvt
5044519|NCT01446510|PE|pe
5044520|NCT01446510|Risk assessment|risk assessment
5044521|NCT01446510|risk score|risk score
5044522|NCT01446510|risk analysis|risk analysis
5044523|NCT01446510|Venous thromboembolism risk|venous thromboembolism risk
5044524|NCT01446497|Normal tension glaucoma|normal tension glaucoma
5044525|NCT01446497|Antiglaucoma ophthalmic solution|antiglaucoma ophthalmic solution
5044526|NCT01446497|Brimonidine|brimonidine
5044527|NCT01446497|Timolol|timolol
5044528|NCT01446497|Combination drugs|combination drugs
5044529|NCT01446484|Renal transplantation|renal transplantation
5044530|NCT01446484|Kidney transplantation|kidney transplantation
5044531|NCT01446484|CD4+CD25+CD127lowFoxP3+ T Regulatory Cells|cd4+cd25+cd127lowfoxp3+ t regulatory cells
5044532|NCT01446484|T reg|t reg
5044533|NCT01446484|Campath|campath
5044534|NCT01446471|Bedside Ultrasound|bedside ultrasound
5044535|NCT01446471|Point of care ultrasound|point of care ultrasound
5044536|NCT01446471|cardiac arrest|cardiac arrest
5044537|NCT01446458|Cancer of Pancreas|cancer of pancreas
5044538|NCT01446458|Cancer of the Pancreas|cancer of the pancreas
5044539|NCT01446458|Neoplasms, Pancreatic|neoplasms, pancreatic
5044540|NCT01446458|Pancreas Cancer|pancreas cancer
5044541|NCT01446458|Pancreas Neoplasms|pancreas neoplasms
5044542|NCT01446458|Entry Term Pancreatic Cancer|entry term pancreatic cancer
5044543|NCT01446445|Cytomegalovirus|cytomegalovirus
5044544|NCT01446445|renal transplant|renal transplant
5044545|NCT01446432|Dupuytren's Contracture|dupuytren's contracture
5044546|NCT01446419|chronic axial low back pain|chronic axial low back pain
5044547|NCT01446419|vertebrogenic pain|vertebrogenic pain
5044548|NCT01446419|Radio frequency ablation|radio frequency ablation
5044549|NCT01446406|Bipolar disorder|bipolar disorder
5044550|NCT01446406|Electronic daily monitoring|electronic daily monitoring
5044551|NCT01446406|Affective episodes|affective episodes
5044552|NCT01446354|Blood component transfusion|blood component transfusion
5044553|NCT01446354|Hypothermic|hypothermic
5044554|NCT01446341|Ankle sprain|ankle sprain
5044555|NCT01446341|Functional rehabilitation|functional rehabilitation
5044556|NCT01446341|Immobilization|immobilization
5044557|NCT01446328|Antipsychotic Drugs|antipsychotic drugs
5044558|NCT01446328|Randomized Controlled Trial|randomized controlled trial
5044559|NCT01446328|Treatment Effectiveness|treatment effectiveness
5044560|NCT01446328|Translational Research|translational research
5044561|NCT01446315|asthma|asthma
5044562|NCT01446315|asthma care system|asthma care system
5044563|NCT01446315|effectiveness|effectiveness
5044564|NCT01446315|primary care|primary care
5044565|NCT01446315|practice based research network|practice based research network
5044566|NCT01446302|Dialysis|dialysis
5044567|NCT01446302|Protein-energy wasting|protein-energy wasting
5044568|NCT01446302|Insulin-Like Growth Factor I|insulin-like growth factor i
5044569|NCT01446302|Insulin-Like Growth Factor Binding Protein 1|insulin-like growth factor binding protein 1
5044570|NCT01446302|Inflammation|inflammation
5044571|NCT01446289|Group B streptococcus|group b streptococcus
5044572|NCT01446289|GBS|gbs
5044573|NCT01446289|Vaccine|vaccine
5044574|NCT01446289|Prevention of group B streptococcus infection|prevention of group b streptococcus infection
5044575|NCT01446276|Obesity|obesity
5044576|NCT01446276|Resveratrol|resveratrol
5044577|NCT01446276|Nonalcoholic fatty liver disease|nonalcoholic fatty liver disease
5044578|NCT01446276|Insulin sensitivity|insulin sensitivity
5044579|NCT01446276|Lipid turnover|lipid turnover
5044580|NCT01446276|Liver fat content|liver fat content
5044581|NCT01446263|Radial access|radial access
5044582|NCT01446263|Femoral access|femoral access
5044583|NCT01446263|Coronary angiography|coronary angiography
5044584|NCT01446263|Coronary artery bypass graft|coronary artery bypass graft
5044585|NCT01446250|Chronic hepatitis C|chronic hepatitis c
5044586|NCT01446250|Cyclophilin inhibitor|cyclophilin inhibitor
5044587|NCT01446224|adverse events|adverse events
5044588|NCT01446224|pazopanib|pazopanib
5044589|NCT01446224|Torsades des Pointes|torsades des pointes
5044590|NCT01446224|renal cell carcinoma|renal cell carcinoma
5044591|NCT01446224|anti-VEGF agents|anti-vegf agents
5044592|NCT01446224|observational data|observational data
5044593|NCT01446224|cardiac ischemia|cardiac ischemia
5044594|NCT01446211|gusperimus|gusperimus
5044595|NCT01446211|Wegeners granulomatosis|wegeners granulomatosis
5044596|NCT01446211|relapse|relapse
5044597|NCT01446198|HPV|hpv
5044722|NCT01445717|GBS, Streptococcus, .|gbs, streptococcus, .
5044598|NCT01446185|HR+, N- or pN1(mi), Her2- breast cancer adjuvant population|hr+, n- or pn1(mi), her2- breast cancer adjuvant population
5044599|NCT01446185|Early Breast cancer|early breast cancer
5044600|NCT01446185|Gene Expression|gene expression
5044601|NCT01446185|Node-Negative|node-negative
5044602|NCT01446185|treatment options|treatment options
5044603|NCT01446185|Hormone receptor positive|hormone receptor positive
5044604|NCT01446172|Long term outcome|long term outcome
5044605|NCT01446159|MEDI-573, breast cancer, metastatic, aromatase inhibitor, anti-IGF|medi-573, breast cancer, metastatic, aromatase inhibitor, anti-igf
5044606|NCT01446146|Posttraumatic Stress Disorder|posttraumatic stress disorder
5044607|NCT01446146|PTSD Treatment|ptsd treatment
5044608|NCT01446146|Decision making|decision making
5044609|NCT01446146|Veterans|veterans
5044610|NCT01446133|Leukemia|leukemia
5044611|NCT01446133|Lymphoma|lymphoma
5044612|NCT01446133|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
5044613|NCT01446133|CLL|cll
5044614|NCT01446133|Small Lymphocytic Lymphoma|small lymphocytic lymphoma
5044615|NCT01446133|SLL|sll
5044616|NCT01446133|Initial Treatment|initial treatment
5044617|NCT01446133|Subsequent Therapy|subsequent therapy
5044618|NCT01446133|Rituximab|rituximab
5044619|NCT01446133|Rituxan|rituxan
5044620|NCT01446133|Lenalidomide|lenalidomide
5044621|NCT01446133|CC-5013|cc-5013
5044622|NCT01446133|Revlimid|revlimid
5044623|NCT01446120|this is phase one study. The study population are healthy volunteers.|this is phase one study. the study population are healthy volunteers.
5044624|NCT01446107|tooth decay|tooth decay
5044625|NCT01446107|fluoride|fluoride
5044626|NCT01446107|sealant|sealant
5044627|NCT01446107|prevention|prevention
5044628|NCT01446094|Coronary artery disease|coronary artery disease
5044629|NCT01446081|chemotherapy|chemotherapy
5044630|NCT01446081|exercise|exercise
5044631|NCT01446081|quality of life|quality of life
5044632|NCT01446081|cancer-related fatigue|cancer-related fatigue
5044633|NCT01446081|elderly|elderly
5044634|NCT01446081|physical fitness|physical fitness
5044635|NCT01446055|Peripheral arterial disease|peripheral arterial disease
5044636|NCT01446055|Buerger's disease|buerger's disease
5044637|NCT01446055|atherosclerotic arterial occlusion|atherosclerotic arterial occlusion
5044638|NCT01446055|bone marrow mononuclear cell|bone marrow mononuclear cell
5044639|NCT01446055|chronic limb ischemia|chronic limb ischemia
5044640|NCT01446029|Telemonitoring|telemonitoring
5044641|NCT01446029|Chronic Kidney Disease|chronic kidney disease
5044642|NCT01446016|Breast Cancer|breast cancer
5044643|NCT01446016|Breast Tumors|breast tumors
5044644|NCT01446016|Cancer of Breast|cancer of breast
5044645|NCT01446016|Cancer of the Breast|cancer of the breast
5044646|NCT01446016|Human Mammary Carcinoma|human mammary carcinoma
5044647|NCT01446016|Mammary Carcinoma, Human|mammary carcinoma, human
5044648|NCT01446016|Mammary Neoplasm, Human|mammary neoplasm, human
5044649|NCT01446016|Mammary Neoplasms, Human|mammary neoplasms, human
5044650|NCT01446016|Neoplasms, Breast|neoplasms, breast
5044651|NCT01446016|Tumors, Breast|tumors, breast
5044652|NCT01446016|Chloroquine|chloroquine
5044653|NCT01446016|Paclitaxel|paclitaxel
5044654|NCT01446016|Taxol|taxol
5044655|NCT01446016|Ixabepilone|ixabepilone
5044656|NCT01446016|Abraxane|abraxane
5044657|NCT01446016|Metastatic Breast Cancer|metastatic breast cancer
5044658|NCT01446016|Advanced Breast Cancer|advanced breast cancer
5044659|NCT01446016|Anthracycline|anthracycline
5044660|NCT01445990|free tissue flaps|free tissue flaps
5044661|NCT01445990|lactic acid|lactic acid
5044662|NCT01445990|glucose|glucose
5044663|NCT01445990|thrombosis|thrombosis
5044664|NCT01445990|diagnostic test|diagnostic test
5044665|NCT01445990|Pedicle postoperative complications diagnosis|pedicle postoperative complications diagnosis
5044666|NCT01445977|Sonitus Medical|sonitus medical
5044667|NCT01445977|SoundBite|soundbite
5044668|NCT01445977|Single Sided Deafness|single sided deafness
5044669|NCT01445977|Conductive Hearing Loss|conductive hearing loss
5044670|NCT01445977|Unilateral Hearing Loss|unilateral hearing loss
5044671|NCT01445964|SLCO2B1 genotype|slco2b1 genotype
5044672|NCT01445964|effect of apple juice|effect of apple juice
5044673|NCT01445886|Nail Psoriasis|nail psoriasis
5044674|NCT01445886|Indigo Naturalis|indigo naturalis
5044675|NCT01445886|Indirubin|indirubin
5044676|NCT01445886|Calcipotriol|calcipotriol
5044677|NCT01445886|Nail Psoriasis Severity Index|nail psoriasis severity index
5044678|NCT01445873|Pulmonary arterial hypertension|pulmonary arterial hypertension
5044679|NCT01445873|sitaxentan sodium|sitaxentan sodium
5044680|NCT01445873|Thelin|thelin
5044681|NCT01445860|DDI|ddi
5044682|NCT01445860|pharmacokinetics|pharmacokinetics
5044683|NCT01445847|Laryngospasm|laryngospasm
5044684|NCT01445847|Lidocaine|lidocaine
5044685|NCT01445834|outcome of pelvic floor muscle physiotherapy|outcome of pelvic floor muscle physiotherapy
5044686|NCT01445834|female|female
5044687|NCT01445834|stress urinary incontinence|stress urinary incontinence
5044688|NCT01445834|urgency urinary incontinence|urgency urinary incontinence
5044689|NCT01445834|mixed urinary incontinence|mixed urinary incontinence
5044690|NCT01445821|Autologous Stem Cell Transplantation|autologous stem cell transplantation
5044691|NCT01445808|psychodynamic psychotherapy|psychodynamic psychotherapy
5044692|NCT01445808|coronary heart disease|coronary heart disease
5044693|NCT01445808|physical activity|physical activity
5044694|NCT01445808|secondary prevention|secondary prevention
5044695|NCT01445795|Inhibitex|inhibitex
5044696|NCT01445795|Chronic Hepatitis|chronic hepatitis
5044697|NCT01445795|Hepatitis C Virus|hepatitis c virus
5044698|NCT01445782|Safety|safety
5044699|NCT01445782|tolerability|tolerability
5044700|NCT01445782|healthy|healthy
5044701|NCT01445782|inhaled|inhaled
5044702|NCT01445769|Myelofibrosis|myelofibrosis
5044703|NCT01445769|Primary Myelofibrosis|primary myelofibrosis
5044704|NCT01445769|PMF|pmf
5044705|NCT01445769|Post-Polycythemia Vera Myelofibrosis|post-polycythemia vera myelofibrosis
5044706|NCT01445769|PPV-MF|ppv-mf
5044707|NCT01445769|Post-Essential Thrombocythemia Myelofibrosis|post-essential thrombocythemia myelofibrosis
5044708|NCT01445769|PET-MF|pet-mf
5044709|NCT01445769|Open label|open label
5044710|NCT01445769|Ruxolitinib|ruxolitinib
5044711|NCT01445769|18424|18424
5044712|NCT01445769|Jak inhibitor|jak inhibitor
5044713|NCT01445756|Intrauterine Device|intrauterine device
5044714|NCT01445743|Tdap Vaccine|tdap vaccine
5044715|NCT01445743|Pregnant woman|pregnant woman
5044716|NCT01445743|Pertussis|pertussis
5044717|NCT01445730|fructose|fructose
5044718|NCT01445730|hypertriglyceridemia|hypertriglyceridemia
5044719|NCT01445730|postprandial lipids|postprandial lipids
5044720|NCT01445730|de novo lipogenesis|de novo lipogenesis
5044721|NCT01445730|stable isotopes|stable isotopes
5044723|NCT01445717|Group B|group b
5044724|NCT01445704|Weight loss|weight loss
5044725|NCT01445704|Probiotics|probiotics
5044726|NCT01445704|Gastric Bypass|gastric bypass
5044727|NCT01445691|Benign Neoplasms, Brain|benign neoplasms, brain
5044728|NCT01445691|Brain Cancer|brain cancer
5044729|NCT01445691|Brain Neoplasms, Benign|brain neoplasms, benign
5044730|NCT01445691|Brain Neoplasms, Malignant|brain neoplasms, malignant
5044731|NCT01445691|Brain Tumor, Primary|brain tumor, primary
5044732|NCT01445691|Brain Tumor, Recurrent|brain tumor, recurrent
5044733|NCT01445691|Brain Tumors|brain tumors
5044734|NCT01445691|Intracranial Neoplasms|intracranial neoplasms
5044735|NCT01445691|Neoplasms, Brain|neoplasms, brain
5044736|NCT01445691|Neoplasms, Intracranial|neoplasms, intracranial
5044737|NCT01445691|Primary Brain Neoplasms|primary brain neoplasms
5044738|NCT01445691|Primary Malignant Brain Neoplasms|primary malignant brain neoplasms
5044739|NCT01445691|Primary Malignant Brain Tumors|primary malignant brain tumors
5044741|NCT01445691|Glioblastoma|glioblastoma
5044742|NCT01445691|Surgery|surgery
5044743|NCT01445691|5-ALA|5-ala
5044744|NCT01445691|Aminolevulinic acid|aminolevulinic acid
5044745|NCT01445691|Fluorescence|fluorescence
5044746|NCT01445678|cIAI|ciai
5044747|NCT01445639|dexmedetomidine|dexmedetomidine
5044748|NCT01445639|sedation|sedation
5044749|NCT01445639|neurosurgery|neurosurgery
5044750|NCT01445639|postoperative care|postoperative care
5044751|NCT01445613|Carotid|carotid
5044752|NCT01445613|Stent|stent
5044753|NCT01445613|Carotid Endarterectomy|carotid endarterectomy
5044754|NCT01445600|Impetigo|impetigo
5044755|NCT01445600|secondarily-infected traumatic lesions|secondarily-infected traumatic lesions
5044756|NCT01445600|retapamulin|retapamulin
5044757|NCT01445587|bortezomib|bortezomib
5044758|NCT01445587|AKT inhibitor|akt inhibitor
5044759|NCT01445587|multiple myeloma|multiple myeloma
5044760|NCT01445587|GSK2110183|gsk2110183
5044761|NCT01445587|hematologic malignancies|hematologic malignancies
5044762|NCT01445561|Interleukin-2|interleukin-2
5044763|NCT01445561|IL-2|il-2
5044764|NCT01445561|Stem Cells|stem cells
5044765|NCT01445561|Regulatory T Cells (T regs)|regulatory t cells (t regs)
5044766|NCT01445561|Natural Killer Cells (NK cells)|natural killer cells (nk cells)
5044767|NCT01445561|Healthy Volunteer|healthy volunteer
5044768|NCT01445561|HV|hv
5044769|NCT01445548|Age-Related Macular Degeneration (AMD)|age-related macular degeneration (amd)
5044770|NCT01445548|Geographic Atrophy|geographic atrophy
5044771|NCT01445548|Bilateral Geographic Atrophy|bilateral geographic atrophy
5044772|NCT01445548|Sirolimus|sirolimus
5044773|NCT01445548|Age Related Macular Degeneration|age related macular degeneration
5044774|NCT01445548|AMD|amd
5044775|NCT01445535|CD2 Positive|cd2 positive
5044776|NCT01445535|Toxicity|toxicity
5044777|NCT01445535|EBV Lymphoma|ebv lymphoma
5044778|NCT01445535|Chemotherapy Naive|chemotherapy naive
5044779|NCT01445535|Maximum Tolerated Dose|maximum tolerated dose
5044780|NCT01445535|Lymphoma|lymphoma
5044781|NCT01445535|T-Cell Lymphoma|t-cell lymphoma
5044782|NCT01445535|NK T-Cell Lymphoma|nk t-cell lymphoma
5044783|NCT01445522|PARP Inhibitor|parp inhibitor
5044784|NCT01445522|DNA Damage|dna damage
5044785|NCT01445522|Chemotherapy|chemotherapy
5044786|NCT01445522|Advanced Cancer|advanced cancer
5044787|NCT01445522|DNA Repair|dna repair
5044788|NCT01445509|Angiogenesis|angiogenesis
5044789|NCT01445509|VEGF|vegf
5044790|NCT01445509|SRC|src
5044791|NCT01445509|Targeted Therapy|targeted therapy
5044792|NCT01445509|Cancer|cancer
5044793|NCT01445509|Solid Tumor|solid tumor
5044794|NCT01445483|Cancer|cancer
5044795|NCT01445483|Radiation|radiation
5044796|NCT01445483|Brain|brain
5044797|NCT01445483|Neuropsychological Outcome|neuropsychological outcome
5044798|NCT01445483|Metastasis|metastasis
5044799|NCT01445483|Brain Metastasis|brain metastasis
5044800|NCT01445444|Habit Reversal Training|habit reversal training
5044801|NCT01445444|Hair Pulling|hair pulling
5044802|NCT01445444|Children|children
5044803|NCT01445444|Trich|trich
5044804|NCT01445444|cognitive behavioral therapy|cognitive behavioral therapy
5044805|NCT01445444|TTM|ttm
5044806|NCT01445444|psychotherapy|psychotherapy
5044807|NCT01445418|Genetic|genetic
5044808|NCT01445418|BRCA|brca
5044809|NCT01445418|Ovarian Cancer, sporadic epithelial ovarian cancer|ovarian cancer, sporadic epithelial ovarian cancer
5044810|NCT01445418|Breast Cancer, triple negative breast cancer|breast cancer, triple negative breast cancer
5044811|NCT01445418|Metastatic|metastatic
5044812|NCT01445418|Breast Cancer|breast cancer
5044813|NCT01445418|Ovarian Cancer|ovarian cancer
5044814|NCT01445405|Proteasome|proteasome
5044815|NCT01445405|Bortezomib|bortezomib
5044816|NCT01445405|NF-kappaB|nf-kappab
5044817|NCT01445405|Cetuximab|cetuximab
5044818|NCT01445405|Epidermal Growth Factor|epidermal growth factor
5044819|NCT01445405|Head and Neck Cancer|head and neck cancer
5044820|NCT01445405|Squamous Cell Carcinoma|squamous cell carcinoma
5044821|NCT01445405|Oral Cancer|oral cancer
5044822|NCT01445392|Recombinant Immunotoxin|recombinant immunotoxin
5044823|NCT01445392|Monoclonal Antibody|monoclonal antibody
5044824|NCT01445392|Pseudomonas Exotoxin|pseudomonas exotoxin
5044825|NCT01445392|Targeted Therapy|targeted therapy
5044826|NCT01445392|Pleural Mesothelioma|pleural mesothelioma
5044827|NCT01445392|Mesothelioma|mesothelioma
5044828|NCT01445392|Epithelial Pleural Mesothelioma|epithelial pleural mesothelioma
5044829|NCT01445379|Solid Tumor|solid tumor
5044830|NCT01445379|Monoclonal Antibody|monoclonal antibody
5044831|NCT01445379|Pediatrics|pediatrics
5044832|NCT01445379|Pharmacokinetics|pharmacokinetics
5044833|NCT01445379|Immunotherapy|immunotherapy
5044834|NCT01445379|Sarcoma|sarcoma
5044835|NCT01445379|Lymphoma|lymphoma
5044836|NCT01445379|Neuroblastoma|neuroblastoma
5044837|NCT01445340|Topical Depsi|topical depsi
5044838|NCT01445340|Cutaneous T Cell Lymphoma|cutaneous t cell lymphoma
5044839|NCT01445340|CTCL|ctcl
5044840|NCT01445340|Mycosis Fungoides|mycosis fungoides
5044841|NCT01445327|Blood|blood
5044842|NCT01445327|Urine|urine
5044843|NCT01445327|Stool|stool
5044844|NCT01445327|Tumor Marker|tumor marker
5044845|NCT01445327|Radiation Therapy|radiation therapy
5044846|NCT01445327|Gastrointestinal Cancer|gastrointestinal cancer
5044847|NCT01445327|Esophageal Cancer|esophageal cancer
5044848|NCT01445327|Stomach|stomach
5044849|NCT01445327|Pancreatic Cancer|pancreatic cancer
5044850|NCT01445314|Stored Data|stored data
5044851|NCT01445314|Neurobehavioral|neurobehavioral
5044852|NCT01445314|Behavior|behavior
5044853|NCT01445314|Quality of Life|quality of life
5044854|NCT01445301|twice daily|twice daily
5044855|NCT01445301|once daily|once daily
5044856|NCT01445301|CLDM 1%-BPO 3% gel|cldm 1%-bpo 3% gel
5044857|NCT01445301|Clindamycin (CLDM)|clindamycin (cldm)
5044858|NCT01445301|benzoyl peroxide (BPO)|benzoyl peroxide (bpo)
5044859|NCT01445301|inflammatory lesion|inflammatory lesion
5044860|NCT01445301|non-inflammatory lesion|non-inflammatory lesion
5044861|NCT01445301|acne vulgaris|acne vulgaris
5044862|NCT01445288|Neurotoxicity|neurotoxicity
5044863|NCT01445288|Brain Tumor|brain tumor
5044864|NCT01445288|Children|children
5044865|NCT01445288|Angiogenesis|angiogenesis
5044866|NCT01445288|Imaging|imaging
5044867|NCT01445288|Central Nervous System Tumor|central nervous system tumor
5044868|NCT01445288|CNS Tumor|cns tumor
5044869|NCT01445249|regional anaesthetic techniques|regional anaesthetic techniques
5044870|NCT01445249|surgery orthopaedic|surgery orthopaedic
5044871|NCT01445236|Operational tolerance|operational tolerance
5044872|NCT01445236|Biomarkers|biomarkers
5044873|NCT01445236|Liver Transplantation|liver transplantation
5044874|NCT01445223|HIV|hiv
5044875|NCT01445223|Antiretroviral therapy|antiretroviral therapy
5044876|NCT01445223|efavirenz|efavirenz
5044877|NCT01445223|lopinavir|lopinavir
5044878|NCT01445223|atazanavir|atazanavir
5044879|NCT01445223|randomised controlled clinical trial|randomised controlled clinical trial
5044880|NCT01445210|Postoperative pain|postoperative pain
5044881|NCT01445210|Major ankle surgery|major ankle surgery
5044882|NCT01445210|Continuous nerve block|continuous nerve block
5044883|NCT01445210|Saphenous nerve|saphenous nerve
5044884|NCT01445210|Ropivacaine|ropivacaine
5044885|NCT01445171|Aortic Valve Replacement|aortic valve replacement
5044886|NCT01445158|ShopTalk|shoptalk
5044887|NCT01445158|Comprehension|comprehension
5044888|NCT01445158|Donors|donors
5044889|NCT01445158|Education|education
5044890|NCT01445158|Stem Cell Transplant|stem cell transplant
5044891|NCT01445158|Sibling Donor|sibling donor
5044892|NCT01445145|End-of-Life|end-of-life
5044893|NCT01445145|Advance Directive|advance directive
5044894|NCT01445145|Pediatric Cancer|pediatric cancer
5044895|NCT01445145|Adolescents|adolescents
5044896|NCT01445145|Young Adults|young adults
5044897|NCT01445132|Adoptive Immunotherapy|adoptive immunotherapy
5044898|NCT01445132|Tumor Infiltrating Lymphocytes|tumor infiltrating lymphocytes
5044899|NCT01445132|Refractory Tumor|refractory tumor
5044900|NCT01445132|Resection|resection
5044901|NCT01445132|B-Cell Malignancies|b-cell malignancies
5044902|NCT01445132|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
5044903|NCT01445132|BCL|bcl
5044904|NCT01445132|B-Cell Lymphoid Malignancy|b-cell lymphoid malignancy
5044905|NCT01445119|Brain|brain
5044906|NCT01445119|Tumor|tumor
5044907|NCT01445119|Radiation|radiation
5044908|NCT01445119|Antiangiogenesis|antiangiogenesis
5044909|NCT01445119|Chemotherapy|chemotherapy
5044910|NCT01445119|Brain Tumor|brain tumor
5044911|NCT01445119|Glioma|glioma
5044912|NCT01445106|HIV Protease Inhibitor|hiv protease inhibitor
5044913|NCT01445106|Drug Repositioning|drug repositioning
5044914|NCT01445106|Akt/Mtor Inhibitor|akt/mtor inhibitor
5044915|NCT01445106|Targeted Therapy|targeted therapy
5044916|NCT01445106|Off - Label Drugs|off - label drugs
5044917|NCT01445106|Nelfinavir|nelfinavir
5044918|NCT01445106|Protease Inhibitor|protease inhibitor
5044919|NCT01445106|Solid Tumor|solid tumor
5044920|NCT01445106|Phase I|phase i
5044921|NCT01445106|Malignant Tumor|malignant tumor
5044922|NCT01445080|MTD|mtd
5044923|NCT01445080|Phase I/II|phase i/ii
5044924|NCT01445080|Pediatric|pediatric
5044925|NCT01445080|Solid Tumor|solid tumor
5044926|NCT01445080|Leukemia|leukemia
5044927|NCT01445080|Chronic Myelogenous Leukemia|chronic myelogenous leukemia
5044928|NCT01445080|CML|cml
5044929|NCT01445080|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
5044930|NCT01445080|ALL|all
5044931|NCT01445080|Acute Myeloid Leukemia|acute myeloid leukemia
5044932|NCT01445080|AML|aml
5044933|NCT01445080|Juevenile Myelomoncytic Leukemia|juevenile myelomoncytic leukemia
5044934|NCT01445080|JMML|jmml
5044935|NCT01445054|111 Indium Trastuzumab Imaging|111 indium trastuzumab imaging
5044936|NCT01445054|PET|pet
5044937|NCT01445054|Optimal Scanning Strategy|optimal scanning strategy
5044938|NCT01445054|Breast Cancer|breast cancer
5044939|NCT01445041|Hypoplastic Left Heart Syndrome|hypoplastic left heart syndrome
5044940|NCT01445041|Autologous Umbilical Cord Blood|autologous umbilical cord blood
5044941|NCT01445041|Newborn Infants|newborn infants
5044942|NCT01445015|adolescents|adolescents
5044943|NCT01445002|grass pollen allergy|grass pollen allergy
5044944|NCT01445002|immunotherapy|immunotherapy
5044945|NCT01445002|recombinant vaccine|recombinant vaccine
5044946|NCT01444989|"Sun spots"|"sun spots"
5044947|NCT01444989|"Pre-cancerous skin lesion"|"pre-cancerous skin lesion"
5044948|NCT01444976|age range of 18-83|age range of 18-83
5044949|NCT01444924|Pain control|pain control
5044950|NCT01444924|Gynecologic Oncology|gynecologic oncology
5044951|NCT01444924|Surgery|surgery
5044952|NCT01444911|Sexual Dysfunction|sexual dysfunction
5044953|NCT01444911|Gynecologic cancer|gynecologic cancer
5044954|NCT01444911|Cancer survivor|cancer survivor
5044955|NCT01444911|Vaginal dilator|vaginal dilator
5044956|NCT01444898|Prader-Willi Syndrome|prader-willi syndrome
5044957|NCT01444898|Obesity|obesity
5044958|NCT01444898|Weight|weight
5044959|NCT01444898|Exenatide|exenatide
5044960|NCT01444898|Byetta|byetta
5044961|NCT01444898|Pediatrics|pediatrics
5044962|NCT01444898|Adolescents|adolescents
5044963|NCT01444885|Variant angina|variant angina
5044964|NCT01444885|Cilostazol|cilostazol
5044965|NCT01444846|Temporary Auditory Threshold Shift|temporary auditory threshold shift
5044966|NCT01444846|Hearing Loss|hearing loss
5044967|NCT01444846|Deafness|deafness
5044968|NCT01444846|SPI-1005|spi-1005
5044969|NCT01444846|Ebselen|ebselen
5044970|NCT01444833|hypertension|hypertension
5044971|NCT01444833|obesity|obesity
5044972|NCT01444833|metabolism|metabolism
5044973|NCT01444833|angiotensin|angiotensin
5044974|NCT01444820|radiation therapy|radiation therapy
5044975|NCT01444820|hypofractionation|hypofractionation
5044976|NCT01444820|hormonal therapy|hormonal therapy
5044977|NCT01444820|high risk adenocarcinoma of the prostate|high risk adenocarcinoma of the prostate
5044978|NCT01444807|sorafenib|sorafenib
5044979|NCT01444807|metastatic renal cell carcinoma|metastatic renal cell carcinoma
5044980|NCT01444807|metastasectomy|metastasectomy
5044981|NCT01444794|Lower limb spasticity|lower limb spasticity
5044982|NCT01444781|Diphtheria|diphtheria
5044983|NCT01444781|Tetanus|tetanus
5044984|NCT01444781|Whooping Cough|whooping cough
5044985|NCT01444781|Hepatitis B|hepatitis b
5044986|NCT01444781|Poliomyelitis|poliomyelitis
5044987|NCT01444781|Pediatric combined vaccine|pediatric combined vaccine
5044988|NCT01444781|Invasive Hib infections|invasive hib infections
5044989|NCT01444768|Alert Systems, Medication|alert systems, medication
5044990|NCT01444768|Computerized Physician Order Entry System|computerized physician order entry system
5044991|NCT01444768|CPOE|cpoe
5044992|NCT01444768|Medication Alert Systems|medication alert systems
5044993|NCT01444768|Medical Order Entry Systems|medical order entry systems
5044994|NCT01444755|Locally advanced gastric cancer|locally advanced gastric cancer
5044995|NCT01444755|neoadjuvant chemotherapy|neoadjuvant chemotherapy
5044996|NCT01444742|Leukemia|leukemia
5044997|NCT01444742|Myeloproliferative Diseases|myeloproliferative diseases
5044998|NCT01444742|Myelodysplastic Syndrome|myelodysplastic syndrome
5044999|NCT01444742|(MDS)|(mds)
5045000|NCT01444742|Relapsing|relapsing
5045001|NCT01444742|Refractory|refractory
5045002|NCT01444742|Clofarabine|clofarabine
5045003|NCT01444742|Clofarex|clofarex
5045004|NCT01444742|Clolar|clolar
5045005|NCT01444742|Cytarabine|cytarabine
5045006|NCT01444742|Ara-C|ara-c
5045007|NCT01444742|Cytosar|cytosar
5045008|NCT01444742|DepoCyt|depocyt
5045009|NCT01444742|Cytosine Arabinosine Hydrochloride|cytosine arabinosine hydrochloride
5045010|NCT01444729|'Dupuytren's contracture'|'dupuytren's contracture'
5045011|NCT01444729|'xiapex'|'xiapex'
5045012|NCT01444729|'surgery'|'surgery'
5045013|NCT01444716|Advanced Cancers|advanced cancers
5045014|NCT01444716|Leukemia|leukemia
5045015|NCT01444716|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
5045016|NCT01444716|CLL|cll
5045017|NCT01444716|Elderly|elderly
5045018|NCT01444716|Ofatumumab|ofatumumab
5045019|NCT01444716|Arzerra|arzerra
5045020|NCT01444703|Thoracic surgery|thoracic surgery
5045021|NCT01444703|double-lumen endotracheal tube|double-lumen endotracheal tube
5045022|NCT01444703|intubation|intubation
5045023|NCT01444703|extubation|extubation
5045024|NCT01444703|sore throat|sore throat
5045025|NCT01444703|prevention of post-extubation sore throat|prevention of post-extubation sore throat
5045026|NCT01444690|Antiretroviral therapy|antiretroviral therapy
5045027|NCT01444690|Acquired Immunodeficiency Syndrome/complications*|acquired immunodeficiency syndrome/complications*
5045028|NCT01444690|Anti-HIV Agents/adverse effects|anti-hiv agents/adverse effects
5045029|NCT01444677|Safety|safety
5045030|NCT01444677|Tolerability|tolerability
5045031|NCT01444677|Pharmacokinetic|pharmacokinetic
5045032|NCT01444651|Tadalafil|tadalafil
5045033|NCT01444651|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors
5045034|NCT01444651|Cyclic Guanylyl Monophosphate Pathway|cyclic guanylyl monophosphate pathway
5045035|NCT01444651|Pharmacologic Actions|pharmacologic actions
5045036|NCT01444651|Vasodilator Agents|vasodilator agents
5045037|NCT01444651|Cardiovascular Agents|cardiovascular agents
5045038|NCT01444651|Obesity|obesity
5045039|NCT01444651|Glycemic Traits|glycemic traits
5045040|NCT01444651|Insulin Resistance|insulin resistance
5045041|NCT01444651|Glucose Metabolism|glucose metabolism
5045042|NCT01444638|pregnancy|pregnancy
5045043|NCT01444638|Caesarian|caesarian
5045044|NCT01444638|section|section
5045045|NCT01444638|spinal|spinal
5045046|NCT01444625|UV radiation|uv radiation
5045047|NCT01444625|photoprotection|photoprotection
5045048|NCT01444625|flavanols rich chocolate|flavanols rich chocolate
5045049|NCT01444612|cancer surgery|cancer surgery
5046145|NCT01440231|Phase II|phase ii
5045050|NCT01444612|venous thromboembolism|venous thromboembolism
5045051|NCT01444612|hospitalization|hospitalization
5045052|NCT01444612|anticoagulants|anticoagulants
5045053|NCT01444612|costs and cost analysis|costs and cost analysis
5045054|NCT01444612|thromboprophylaxis|thromboprophylaxis
5045055|NCT01444599|coronary atherosclerosis|coronary atherosclerosis
5045056|NCT01444599|virtual histology intravascular ultrasound|virtual histology intravascular ultrasound
5045057|NCT01444599|fractional flow reserve|fractional flow reserve
5045058|NCT01444586|non-interventional|non-interventional
5045059|NCT01444586|Xarelto|xarelto
5045060|NCT01444586|knee replacement|knee replacement
5045061|NCT01444586|hip replecement|hip replecement
5045062|NCT01444586|Russia|russia
5045063|NCT01444573|Rate control|rate control
5045064|NCT01444573|ILR|ilr
5045065|NCT01444547|esophageal cancer|esophageal cancer
5045066|NCT01444547|paclitaxel|paclitaxel
5045067|NCT01444547|cisplatin|cisplatin
5045068|NCT01444534|mobile phone application|mobile phone application
5045069|NCT01444534|diabetes type 1|diabetes type 1
5045070|NCT01444534|self-management|self-management
5045071|NCT01444534|telemedicin|telemedicin
5045072|NCT01444521|advanced gastric cancer|advanced gastric cancer
5045073|NCT01444521|irinotecan|irinotecan
5045074|NCT01444521|cisplatin|cisplatin
5045075|NCT01444495|rectal cancer|rectal cancer
5045076|NCT01444495|radiotherapy|radiotherapy
5045077|NCT01444495|overall survival|overall survival
5045078|NCT01444495|recurrence rate|recurrence rate
5045079|NCT01444495|downstaging|downstaging
5045080|NCT01444469|Asthma exacerbations|asthma exacerbations
5045081|NCT01444469|Respiratory disease|respiratory disease
5045082|NCT01444469|Viral infection|viral infection
5045083|NCT01444469|Macrolide/ketolide antibiotics|macrolide/ketolide antibiotics
5045084|NCT01444469|Mycoplasma pneumoniae (M. pneumoniae)|mycoplasma pneumoniae (m. pneumoniae)
5045085|NCT01444469|Chlamydophila pneumoniae (C. pneumoniae)|chlamydophila pneumoniae (c. pneumoniae)
5045086|NCT01444456|Breast Cancer|breast cancer
5045087|NCT01444456|Lung Cancer|lung cancer
5045088|NCT01444456|Ovarian Cancer|ovarian cancer
5045089|NCT01444456|Prostate Cancer|prostate cancer
5045090|NCT01444456|Colorectal Cancer|colorectal cancer
5045091|NCT01444456|Aranesp|aranesp
5045092|NCT01444456|Chemotherapy induced anaemia|chemotherapy induced anaemia
5045093|NCT01444456|Chemotherapy|chemotherapy
5045094|NCT01444456|Bladder Cancer|bladder cancer
5045095|NCT01444456|Endometrial Cancer|endometrial cancer
5045096|NCT01444456|Renal Cancer|renal cancer
5045097|NCT01444456|Pancreatic Cancer|pancreatic cancer
5045098|NCT01444456|Esophageal Cancer|esophageal cancer
5045099|NCT01444456|Gastric Cancer|gastric cancer
5045100|NCT01444443|Type 1 diabetes|type 1 diabetes
5045101|NCT01444443|Glucose control|glucose control
5045102|NCT01444443|Closed-loop|closed-loop
5045103|NCT01444443|Insulin pump|insulin pump
5045104|NCT01444443|Glucose sensor|glucose sensor
5045105|NCT01444430|Symbicort pMDI|symbicort pmdi
5045106|NCT01444430|Asthma|asthma
5045107|NCT01444430|safety|safety
5045108|NCT01444430|budesonide|budesonide
5045109|NCT01444417|Immune (Idiopathic) Thrombocytopenic Purpura|immune (idiopathic) thrombocytopenic purpura
5045110|NCT01444417|Pediatric Immune (Idiopathic) Thrombocytopenic Purpura|pediatric immune (idiopathic) thrombocytopenic purpura
5045111|NCT01444417|Immune Thrombocytopenia|immune thrombocytopenia
5045112|NCT01444404|Solid Tumors|solid tumors
5045113|NCT01444404|Phase 1|phase 1
5045114|NCT01444404|Clinical Trial|clinical trial
5045115|NCT01444391|Tympanostomy tube placement|tympanostomy tube placement
5045116|NCT01444391|iontophoresis|iontophoresis
5045117|NCT01444378|Atherosclerosis|atherosclerosis
5045118|NCT01444378|Claudication|claudication
5045119|NCT01444378|Peripheral Arterial Occlusive Disease|peripheral arterial occlusive disease
5045120|NCT01444378|Stent|stent
5045121|NCT01444365|Osteoarthritis of the knee|osteoarthritis of the knee
5045122|NCT01444352|Pneumococcal infections|pneumococcal infections
5045123|NCT01444352|Streptococcus pneumoniae Infections|streptococcus pneumoniae infections
5045124|NCT01444352|Pneumococcal Vaccines|pneumococcal vaccines
5045125|NCT01444339|Pneumococcal Infections|pneumococcal infections
5045126|NCT01444339|Streptococcus Pneumoniae Infections|streptococcus pneumoniae infections
5045127|NCT01444339|Pneumococcal Vaccine|pneumococcal vaccine
5045128|NCT01444326|Keywords;|keywords;
5045129|NCT01444326|Cardiovascular disease|cardiovascular disease
5045130|NCT01444326|Dairy|dairy
5045131|NCT01444326|Inflammation|inflammation
5045132|NCT01444326|Blood lipids|blood lipids
5045133|NCT01444300|multiple sclerosis|multiple sclerosis
5045134|NCT01444300|postural balance|postural balance
5045135|NCT01444300|gait|gait
5045136|NCT01444300|fatigue|fatigue
5045137|NCT01444261|iron deficiency|iron deficiency
5045138|NCT01444261|anemia|anemia
5045139|NCT01444248|Amaryl MEX|amaryl mex
5045140|NCT01444235|CAD, ACVB|cad, acvb
5045141|NCT01444222|Myocardial contractility|myocardial contractility
5045142|NCT01444222|Quantification of regurgitant flow|quantification of regurgitant flow
5045143|NCT01444222|exercise capacity|exercise capacity
5045144|NCT01444209|pituitary gland|pituitary gland
5045145|NCT01444196|ACU|acu
5045146|NCT01444196|acquired cold urticaria|acquired cold urticaria
5045147|NCT01444183|Epilepsy|epilepsy
5045148|NCT01444183|seizures|seizures
5045149|NCT01444183|stress reduction|stress reduction
5045150|NCT01444170|eccentric exercise|eccentric exercise
5045151|NCT01444170|exercise induce muscle damage|exercise induce muscle damage
5045152|NCT01444170|isometric strength|isometric strength
5045153|NCT01444170|range of motion|range of motion
5045154|NCT01444170|self report symptoms|self report symptoms
5045155|NCT01444170|mechanical pain threshold|mechanical pain threshold
5045156|NCT01444144|Ankle|ankle
5045157|NCT01444144|Fracture|fracture
5045158|NCT01444144|Elderly|elderly
5045159|NCT01444144|At-risk Population|at-risk population
5045160|NCT01444144|Ankle Fracture in at-risk elderly population|ankle fracture in at-risk elderly population
5045161|NCT01444131|Smoking|smoking
5045162|NCT01444131|Smoking cessation|smoking cessation
5045163|NCT01444131|Pharmaceutical aids|pharmaceutical aids
5045164|NCT01444105|Open angle glaucoma|open angle glaucoma
5045165|NCT01444105|Pseudoexfoliative glaucoma|pseudoexfoliative glaucoma
5045166|NCT01444079|Liver transplantation|liver transplantation
5045167|NCT01444079|Rejection|rejection
5045168|NCT01444079|Tolerance|tolerance
5045169|NCT01444040|Open angle glaucoma|open angle glaucoma
5045170|NCT01444040|POAG|poag
5045171|NCT01444040|Ocular hypertension|ocular hypertension
5045172|NCT01444040|Pseudoexfoliative glaucoma|pseudoexfoliative glaucoma
5045173|NCT01444040|Naïve to treatment|naïve to treatment
5045174|NCT01444014|YF476|yf476
5045175|NCT01444014|netazepide|netazepide
5045176|NCT01444014|hypergastrinaemia|hypergastrinaemia
5045177|NCT01444014|gastric carcinoids|gastric carcinoids
5045178|NCT01444001|Pneumococcal Infections|pneumococcal infections
5045179|NCT01444001|Pneumococcal Vaccines|pneumococcal vaccines
5045180|NCT01444001|pneumococcal protein|pneumococcal protein
5045181|NCT01443988|Open angle glaucoma|open angle glaucoma
5045182|NCT01443988|POAG|poag
5045183|NCT01443988|Ocular hypertension|ocular hypertension
5045184|NCT01443988|Pseudoexfoliative glaucoma|pseudoexfoliative glaucoma
5045185|NCT01443988|Naïve to treatment|naïve to treatment
5045186|NCT01443975|Total Hip Arthroplasty|total hip arthroplasty
5045187|NCT01443975|Osteoarthritis|osteoarthritis
5045188|NCT01443962|laparoscopic cholecystectomy|laparoscopic cholecystectomy
5045189|NCT01443962|PEEP|peep
5045190|NCT01443962|rSO2|rso2
5045191|NCT01443949|fMRI|fmri
5045192|NCT01443949|Reward|reward
5045193|NCT01443949|Adolescents|adolescents
5045194|NCT01443949|Impulse Control|impulse control
5045195|NCT01443949|Cabergoline|cabergoline
5045196|NCT01443936|Influenza Vaccine|influenza vaccine
5045197|NCT01443936|H5N1 Influenza|h5n1 influenza
5045198|NCT01443936|Normal Volunteer|normal volunteer
5045199|NCT01443936|Adenovirus|adenovirus
5045200|NCT01443936|Live Virus Vaccine|live virus vaccine
5045201|NCT01443936|Healthy Volunteer|healthy volunteer
5045202|NCT01443936|HV|hv
5045203|NCT01443923|Hepatitis|hepatitis
5045204|NCT01443923|Immunological Response|immunological response
5045205|NCT01443923|Virological Response|virological response
5045206|NCT01443923|Resistance Mutations|resistance mutations
5045207|NCT01443923|Viral Kinetics|viral kinetics
5045208|NCT01443923|Hepatitis C|hepatitis c
5045209|NCT01443923|HCV|hcv
5045210|NCT01443910|Body Weight|body weight
5045211|NCT01443910|Immersive Virtual Enviroment Technology|immersive virtual enviroment technology
5045212|NCT01443897|Vitamin D|vitamin d
5045213|NCT01443871|Volunteer|volunteer
5045214|NCT01443858|Smoking Cessation|smoking cessation
5045215|NCT01443858|Cigarette Smoking|cigarette smoking
5045216|NCT01443858|Meclizine|meclizine
5045217|NCT01443858|Nicotine Patch|nicotine patch
5045218|NCT01443845|COPD|copd
5045219|NCT01443845|Exacerbations|exacerbations
5045220|NCT01443845|Roflumilast|roflumilast
5045221|NCT01443845|Daliresp|daliresp
5045222|NCT01443832|ferrous sulfate|ferrous sulfate
5045223|NCT01443832|iron absorption|iron absorption
5045224|NCT01443832|Beninese women|beninese women
5045225|NCT01443832|fonio|fonio
5045226|NCT01443819|Radiculopathy|radiculopathy
5045227|NCT01443819|Transforaminal|transforaminal
5045228|NCT01443819|Disc Protrusion|disc protrusion
5045229|NCT01443806|oseltamivir metabolism|oseltamivir metabolism
5045230|NCT01443806|Carboxylesterase 1|carboxylesterase 1
5045231|NCT01443780|Selenium|selenium
5045232|NCT01443780|Q10|q10
5045233|NCT01443780|dietary supplement|dietary supplement
5045234|NCT01443780|elderly population|elderly population
5045235|NCT01443780|intervention|intervention
5045236|NCT01443780|All-cause mortality|all-cause mortality
5045237|NCT01443780|cardiac function|cardiac function
5045238|NCT01443767|Cardiac Output|cardiac output
5045239|NCT01443767|esCCO|escco
5045240|NCT01443767|Pulse Wave Transit Time|pulse wave transit time
5045241|NCT01443767|PiCCO|picco
5045242|NCT01443767|Pulse Contour Analysis|pulse contour analysis
5045243|NCT01443767|Non-invasive Monitoring|non-invasive monitoring
5045244|NCT01443767|Partial Liver Resection|partial liver resection
5045245|NCT01443741|FIT Therapy|fit therapy
5045246|NCT01443741|Diabetes mellitus|diabetes mellitus
5045247|NCT01443741|Insulin pump|insulin pump
5045248|NCT01443741|Pediatric|pediatric
5045249|NCT01443728|sickle cell disease|sickle cell disease
5045250|NCT01443728|acute chest syndrome|acute chest syndrome
5045251|NCT01443728|respiratory complications|respiratory complications
5045255|NCT01443715|Depressive Disorder Not Otherwise Specified (DDNOS)|depressive disorder not otherwise specified (ddnos)
5045256|NCT01443702|Kidney Calculi|kidney calculi
5045257|NCT01443702|Iranian traditional medicine|iranian traditional medicine
5045258|NCT01443702|Lapis judaicus|lapis judaicus
5045259|NCT01443689|Extensive Burn|extensive burn
5045260|NCT01443689|Human Cord Blood Mononuclear Cells|human cord blood mononuclear cells
5045261|NCT01443689|Human Umbilical Cord Mesenchymal Stem Cells|human umbilical cord mesenchymal stem cells
5045262|NCT01443637|Coronary Artery Disease|coronary artery disease
5045263|NCT01443637|CAD|cad
5045264|NCT01443637|Atherosclerosis|atherosclerosis
5045265|NCT01443637|Myocardial Infarction|myocardial infarction
5045266|NCT01443637|MI|mi
5045267|NCT01443637|CONFIRM|confirm
5045268|NCT01443637|Coronary Computed Tomographic Angiography|coronary computed tomographic angiography
5045269|NCT01443637|CCTA|ccta
5045270|NCT01443624|iron|iron
5045271|NCT01443624|critical illness|critical illness
5045272|NCT01443624|oxidative stress|oxidative stress
5045273|NCT01443611|Infants|infants
5045274|NCT01443598|Pulmonary arterial hypertension,|pulmonary arterial hypertension,
5045275|NCT01443598|Interstitial lung disease at HRCT|interstitial lung disease at hrct
5045276|NCT01443585|Progressive Addition Lens|progressive addition lens
5045277|NCT01443585|Multifocal|multifocal
5045278|NCT01443585|Presbyopia|presbyopia
5045279|NCT01443572|Kasai operation under general anesthesia|kasai operation under general anesthesia
5045280|NCT01443559|Xenogenic|xenogenic
5045281|NCT01443546|oocyte donor|oocyte donor
5045282|NCT01443546|oocyte recipient|oocyte recipient
5045283|NCT01443546|ovulation trigger|ovulation trigger
5045284|NCT01443533|Contraception|contraception
5045285|NCT01443533|Contraception behavior|contraception behavior
5045286|NCT01443533|Postnatal care|postnatal care
5045287|NCT01443533|Health education|health education
5045288|NCT01443533|Randomized controlled trial|randomized controlled trial
5045289|NCT01443520|Pharmacokinetics|pharmacokinetics
5045290|NCT01443520|Pharmacodynamics|pharmacodynamics
5045291|NCT01443507|aerobic capacity|aerobic capacity
5045292|NCT01443507|maximal oxygen uptake|maximal oxygen uptake
5045293|NCT01443507|aerobic endurance|aerobic endurance
5045294|NCT01443507|work economy|work economy
5045295|NCT01443507|lactate threshold|lactate threshold
5045296|NCT01443507|endurance training|endurance training
5045297|NCT01443507|exercise intensity|exercise intensity
5045298|NCT01443494|septic shock|septic shock
5045299|NCT01443494|microcirculation|microcirculation
5045300|NCT01443494|norepinephrine|norepinephrine
5045301|NCT01443494|fluid|fluid
5045302|NCT01443481|solid tumors|solid tumors
5045303|NCT01443481|hepatic impairment|hepatic impairment
5045304|NCT01443481|Child-Pugh classification|child-pugh classification
5045305|NCT01443481|pharmacokinetics|pharmacokinetics
5045306|NCT01443481|PK|pk
5045307|NCT01443481|RECIST 1.1|recist 1.1
5045308|NCT01443468|Tp53|tp53
5045309|NCT01443468|Cancer|cancer
5045310|NCT01443468|Hereditary|hereditary
5045311|NCT01443468|Genetic Testing|genetic testing
5045312|NCT01443468|Screening|screening
5045313|NCT01443468|Li-Fraumeni Syndrome|li-fraumeni syndrome
5045314|NCT01443468|LFS|lfs
5045315|NCT01443455|menopause|menopause
5045316|NCT01443455|sedentary|sedentary
5045317|NCT01443455|overweight|overweight
5045318|NCT01443442|Conjunctivitis|conjunctivitis
5045319|NCT01443442|Allergic|allergic
5045320|NCT01443442|Bepotastine besilate|bepotastine besilate
5045321|NCT01443442|Loteprednol etabonate|loteprednol etabonate
5045322|NCT01443429|TRK-100STP|trk-100stp
5045323|NCT01443429|PK|pk
5045324|NCT01443429|beraprost sodium|beraprost sodium
5045325|NCT01443429|Japanese males and females|japanese males and females
5045326|NCT01443429|Subjects with mild/moderate/severe patients|subjects with mild/moderate/severe patients
5045327|NCT01443429|renal impairment|renal impairment
5045328|NCT01443416|pneumococcal conjugate vaccine|pneumococcal conjugate vaccine
5045329|NCT01443416|invasive pneumococcal disease|invasive pneumococcal disease
5045330|NCT01443416|vaccination|vaccination
5045331|NCT01443416|children|children
5045332|NCT01443403|Opioid Therapy|opioid therapy
5045333|NCT01443403|Non-Malignant Chronic Pain|non-malignant chronic pain
5045334|NCT01443403|Opioid-Induced Constipation|opioid-induced constipation
5045335|NCT01443390|Whole genome sequencing|whole genome sequencing
5045336|NCT01443390|Advanced Refractory Cancer|advanced refractory cancer
5045337|NCT01443377|Neorec|neorec
5045338|NCT01443377|rectal cancer|rectal cancer
5045339|NCT01443377|KRAS|kras
5045340|NCT01443377|Panitumumab|panitumumab
5045341|NCT01443377|neoadjuvant|neoadjuvant
5045342|NCT01443377|Radiochemotherapy|radiochemotherapy
5045343|NCT01443377|antibody|antibody
5045344|NCT01443377|locally advanced KRAS wild type rectal cancer|locally advanced kras wild type rectal cancer
5045345|NCT01443364|Certolizumab pegol - Cimzia|certolizumab pegol - cimzia
5045346|NCT01443364|Rheumatoid Arthritis|rheumatoid arthritis
5045347|NCT01443364|Power Doppler Ultrasonography|power doppler ultrasonography
5045348|NCT01443364|Italy|italy
5045349|NCT01443364|Moderate-severe Rheumatoid Arthritis|moderate-severe rheumatoid arthritis
5045350|NCT01443351|ITP|itp
5045351|NCT01443351|romiplostim|romiplostim
5045352|NCT01443351|eltrombopag|eltrombopag
5045353|NCT01443351|bone marrow fibrosis|bone marrow fibrosis
5045354|NCT01443351|long-term safety|long-term safety
5045355|NCT01443338|Triptergium wilfordii|triptergium wilfordii
5045356|NCT01443338|Acitretin|acitretin
5045357|NCT01443338|psoriasis vulgaris|psoriasis vulgaris
5045358|NCT01443325|Persistent Postherniorrhaphy inguinal Pain|persistent postherniorrhaphy inguinal pain
5045359|NCT01443312|Beta globin gene|beta globin gene
5045360|NCT01443312|Alfa globin gene|alfa globin gene
5045361|NCT01443312|xmn1 polymorphism|xmn1 polymorphism
5045362|NCT01443273|Newborns|newborns
5045363|NCT01443260|oncolytic virus|oncolytic virus
5045364|NCT01443260|oncolytic|oncolytic
5045365|NCT01443260|GL-ONC1|gl-onc1
5045366|NCT01443260|Vaccinia|vaccinia
5045367|NCT01443260|Vaccinia virus|vaccinia virus
5045368|NCT01443260|Genelux|genelux
5045369|NCT01443260|Genelux GmbH|genelux gmbh
5045370|NCT01443260|peritoneal|peritoneal
5045371|NCT01443260|peritoneal carcinomatosis|peritoneal carcinomatosis
5045372|NCT01443260|cancer|cancer
5045373|NCT01443260|abdominal cancer|abdominal cancer
5045374|NCT01443260|imaging|imaging
5045375|NCT01443234|Depression|depression
5045376|NCT01443234|Cognitive Bias|cognitive bias
5045377|NCT01443234|Internet|internet
5045378|NCT01443221|mitiglinide|mitiglinide
5045379|NCT01443221|metformin|metformin
5045380|NCT01443221|Pharmacokinetics|pharmacokinetics
5045381|NCT01443221|Safety|safety
5045382|NCT01443208|pharmacokinetics|pharmacokinetics
5045383|NCT01443208|safety|safety
5045384|NCT01443208|desvenlafaxine|desvenlafaxine
5045385|NCT01443208|Korean healthy subjects|korean healthy subjects
5045386|NCT01443169|Pharmacokinetic|pharmacokinetic
5045387|NCT01443169|relative oral bioavailability|relative oral bioavailability
5045388|NCT01443169|pregabalin|pregabalin
5045389|NCT01443156|Diet|diet
5045390|NCT01443156|Sleep deficiency|sleep deficiency
5045391|NCT01443156|Cancer|cancer
5045392|NCT01443156|Obesity|obesity
5045393|NCT01443156|Diabetes|diabetes
5045394|NCT01443156|Shift work|shift work
5045395|NCT01443156|Work schedule|work schedule
5045396|NCT01443156|Cardiovascular disease|cardiovascular disease
5045397|NCT01443156|Body composition|body composition
5045398|NCT01443156|Body mass index|body mass index
5045399|NCT01443156|Body fat percentage|body fat percentage
5045400|NCT01443143|Diabetes|diabetes
5045401|NCT01443143|Obesity|obesity
5045402|NCT01443143|Glycemic|glycemic
5045403|NCT01443143|Portion-control|portion-control
5045404|NCT01443143|Commercial diet|commercial diet
5045405|NCT01443130|malaria,Malawi,pregnancy|malaria,malawi,pregnancy
5045406|NCT01443104|coronary artery disease|coronary artery disease
5045407|NCT01443104|drug-eluting stents|drug-eluting stents
5045408|NCT01443104|polymers|polymers
5045409|NCT01443091|very low birth weight infants|very low birth weight infants
5045410|NCT01443091|VLBW infants|vlbw infants
5045411|NCT01443091|colostrum|colostrum
5045412|NCT01443078|Carboplatin|carboplatin
5045413|NCT01443078|Cisplatin|cisplatin
5045414|NCT01443078|Pemetrexed (Altima)|pemetrexed (altima)
5045415|NCT01443078|Taxotere (Docetaxel)|taxotere (docetaxel)
5045416|NCT01443078|Vinorelbine Tartrate (Navelbine)|vinorelbine tartrate (navelbine)
5045417|NCT01443078|Stage IB-III|stage ib-iii
5045418|NCT01443078|non squamous|non squamous
5045419|NCT01443078|non-small cell lung cancer|non-small cell lung cancer
5045420|NCT01443078|11-106|11-106
5045421|NCT01443065|Adenocarcinoma|adenocarcinoma
5045422|NCT01443065|Locally advanced (non operable) or metastatic|locally advanced (non operable) or metastatic
5045423|NCT01443065|First line treatment|first line treatment
5045424|NCT01443052|Gait stability|gait stability
5045425|NCT01443052|Spatiotemporal parameters|spatiotemporal parameters
5045426|NCT01443052|Walking|walking
5045427|NCT01443052|Elderly people|elderly people
5045428|NCT01443052|Stroke|stroke
5045429|NCT01443052|Fallers|fallers
5045430|NCT01443039|drug metabolizing enzymes and drug transporter|drug metabolizing enzymes and drug transporter
5045431|NCT01443039|Roux-en Y-Gastric Bypass|roux-en y-gastric bypass
5045432|NCT01443039|Obesity|obesity
5045433|NCT01443039|Drug Availability|drug availability
5045434|NCT01443039|BMI over 35kg/m² and comorbidities or >40kg/m²|bmi over 35kg/m² and comorbidities or >40kg/m²
5045435|NCT01443026|Intraepithelial Prostatic Neoplasia|intraepithelial prostatic neoplasia
5045436|NCT01443026|Prostatic neoplasms|prostatic neoplasms
5045437|NCT01443026|Male urogenital disease|male urogenital disease
5045438|NCT01443026|Prostate|prostate
5045439|NCT01443013|Tolerance|tolerance
5045440|NCT01443013|Renal Transplantation|renal transplantation
5045441|NCT01443013|Chronic allograft nephropathy|chronic allograft nephropathy
5045442|NCT01443000|Observational study|observational study
5045443|NCT01443000|IOIS|iois
5045444|NCT01443000|Orbital Pseudotumor|orbital pseudotumor
5045445|NCT01443000|Outcome|outcome
5045446|NCT01443000|Treatment|treatment
5045447|NCT01442987|Irbesartan|irbesartan
5045448|NCT01442987|Atorvastatin|atorvastatin
5045449|NCT01442987|Hypertension|hypertension
5045450|NCT01442987|Hyperlipidemia|hyperlipidemia
5045451|NCT01442974|nab-paclitaxel|nab-paclitaxel
5045452|NCT01442974|neoadjuvant treatment|neoadjuvant treatment
5045453|NCT01442974|SPARC|sparc
5045454|NCT01442974|Pancreatic Cancer|pancreatic cancer
5045455|NCT01442961|pain, postoperative|pain, postoperative
5045456|NCT01442961|hysterectomy, vaginal|hysterectomy, vaginal
5045457|NCT01442961|surgery, gynecological|surgery, gynecological
5045458|NCT01442948|-CD16+ monocytes|-cd16+ monocytes
5045459|NCT01442935|Adenocarcinoma|adenocarcinoma
5045460|NCT01442935|Non-resectable hepatic metastases|non-resectable hepatic metastases
5045461|NCT01442935|First-line treatment|first-line treatment
5045462|NCT01442922|L3-L4|l3-l4
5045463|NCT01442922|L4-L5|l4-l5
5045464|NCT01442922|L5-S1|l5-s1
5045465|NCT01442922|Human Meniscus Allograft|human meniscus allograft
5045466|NCT01442922|Nucleus pulposus|nucleus pulposus
5045467|NCT01442922|Minimally invasive surgery|minimally invasive surgery
5045468|NCT01442922|Degeneration of L3-L4 Intervertebral Disc|degeneration of l3-l4 intervertebral disc
5045469|NCT01442922|Degeneration of L4-L5 Intervertebral Disc|degeneration of l4-l5 intervertebral disc
5045470|NCT01442922|Degeneration of L5-S1 Intervertebral Disc|degeneration of l5-s1 intervertebral disc
5045471|NCT01442909|lung cancer|lung cancer
5045472|NCT01442909|docetaxel|docetaxel
5045473|NCT01442909|pemetrexed|pemetrexed
5045474|NCT01442883|Treatment Resistant|treatment resistant
5045475|NCT01442857|Magnetic Resonance Imaging|magnetic resonance imaging
5045476|NCT01442857|Nerve Net|nerve net
5045477|NCT01442857|Brachial Plexus|brachial plexus
5045478|NCT01442857|Nerve block|nerve block
5045479|NCT01442844|Mohs|mohs
5045480|NCT01442844|Scalp|scalp
5045481|NCT01442831|metabolic profile of TR-700 in plasma urine|metabolic profile of tr-700 in plasma urine
5045482|NCT01442818|vaginal reconstructive surgery|vaginal reconstructive surgery
5045483|NCT01442805|Cognitive Behavior Therapy|cognitive behavior therapy
5045484|NCT01442805|Virtual Reality Exposure Therapy|virtual reality exposure therapy
5045485|NCT01442805|Psychophysiological Measures|psychophysiological measures
5045486|NCT01442805|Driving Phobia|driving phobia
5045487|NCT01442805|Flying Phobia|flying phobia
5045488|NCT01442792|Angioplasty, Balloon, Coronary|angioplasty, balloon, coronary
5045489|NCT01442779|Idiopathic Pulmonary Fibrosis|idiopathic pulmonary fibrosis
5045490|NCT01442779|Interferon alpha|interferon alpha
5045491|NCT01442766|cholinesterase inhibitor|cholinesterase inhibitor
5045492|NCT01442766|donepezil|donepezil
5045493|NCT01442766|motor|motor
5045494|NCT01442766|stroke|stroke
5045495|NCT01442753|Spanish speaking|spanish speaking
5045496|NCT01442740|Functional Endoscopic Sinus Surgery|functional endoscopic sinus surgery
5045497|NCT01442740|Reverse Trendelenburg Position|reverse trendelenburg position
5045498|NCT01442727|arsenical melanosis|arsenical melanosis
5045499|NCT01442727|arsenical melanoses|arsenical melanoses
5045500|NCT01442727|arsenical keratosis|arsenical keratosis
5045501|NCT01442727|arsenical keratoses|arsenical keratoses
5045502|NCT01442727|arsenical cancer|arsenical cancer
5045503|NCT01442727|arsenic cancers|arsenic cancers
5045504|NCT01442727|arsenic|arsenic
5045505|NCT01442727|arsenicosis|arsenicosis
5045506|NCT01442727|arsenic exposure|arsenic exposure
5045507|NCT01442727|arsenic toxicity|arsenic toxicity
5045508|NCT01442727|arsenic poisoning|arsenic poisoning
5045509|NCT01442727|drinking water|drinking water
5045510|NCT01442727|selenium|selenium
5045511|NCT01442727|selenite|selenite
5045512|NCT01442727|sodium selenite|sodium selenite
5045513|NCT01442675|Meningitis|meningitis
5045514|NCT01442675|Meningococcal Infection|meningococcal infection
5045515|NCT01442675|Menactra®|menactra®
5045516|NCT01442662|Metastatic or relapsed uterine or soft tissue leiomyosarcoma|metastatic or relapsed uterine or soft tissue leiomyosarcoma
5045517|NCT01442649|Adenocarcinoma|adenocarcinoma
5045518|NCT01442649|Metastatic|metastatic
5045519|NCT01442649|Second-line treatment|second-line treatment
5045520|NCT01442649|Progressive disease after first-line treatment with bevacizumab|progressive disease after first-line treatment with bevacizumab
5045521|NCT01442649|Non-mutated (wild-type) KRAS.|non-mutated (wild-type) kras.
5045522|NCT01442623|Vestibular Rehabilitation|vestibular rehabilitation
5045523|NCT01442623|Balance|balance
5045524|NCT01442623|Virtual Reality|virtual reality
5045525|NCT01442623|Gait|gait
5045526|NCT01442623|Dizziness|dizziness
5045527|NCT01442610|Rasagiline|rasagiline
5045528|NCT01442610|Sleep disorder|sleep disorder
5045529|NCT01442610|Parkinson's disease|parkinson's disease
5045530|NCT01442610|Sleep Disturbances in patients with parkinsons's disease|sleep disturbances in patients with parkinsons's disease
5045531|NCT01442597|cognitive behavior therapy|cognitive behavior therapy
5045532|NCT01442597|computer assisted instruction|computer assisted instruction
5045533|NCT01442597|drug abuse therapy|drug abuse therapy
5045534|NCT01442597|educational resource design and development|educational resource design and development
5045535|NCT01442584|ovary|ovary
5045536|NCT01442584|cortex|cortex
5045537|NCT01442584|transplantation|transplantation
5045538|NCT01442571|Adult Men and Women, who underwent arthroscopy of the knee with cartilage injury of ICRS grade 2 or higher|adult men and women, who underwent arthroscopy of the knee with cartilage injury of icrs grade 2 or higher
5045539|NCT01442558|relief|relief
5045540|NCT01442558|Intra-operative|intra-operative
5045541|NCT01442545|Rheumatoid Arthritis|rheumatoid arthritis
5045542|NCT01442545|JNJ-39758979|jnj-39758979
5045543|NCT01442545|Methotrexate|methotrexate
5045544|NCT01442532|Healthy male volunteer|healthy male volunteer
5045545|NCT01442532|JNJ-38518168|jnj-38518168
5045546|NCT01442532|Midazolam|midazolam
5045547|NCT01442519|non-muscle invasive urothelial bladder cancer|non-muscle invasive urothelial bladder cancer
5045548|NCT01442519|intravesical therapy|intravesical therapy
5045549|NCT01442519|BCG|bcg
5045550|NCT01442519|mitomycin|mitomycin
5045551|NCT01442519|electromotive drug administration|electromotive drug administration
5045552|NCT01442519|Bladder Cancer Stage 0, Without Cancer in Situ|bladder cancer stage 0, without cancer in situ
5045553|NCT01442506|acetic acid|acetic acid
5045554|NCT01442506|virtual chromoendosopy|virtual chromoendosopy
5045555|NCT01442493|Methadone Treatment|methadone treatment
5045556|NCT01442493|Opiate dependence|opiate dependence
5045557|NCT01442493|Services research|services research
5045558|NCT01442480|air pollution|air pollution
5045559|NCT01442480|fatty acid supplementation|fatty acid supplementation
5045560|NCT01442467|mitral annular calcification|mitral annular calcification
5045561|NCT01442467|MAC|mac
5045562|NCT01442467|left atrial pressure|left atrial pressure
5045563|NCT01442467|LAP|lap
5045564|NCT01442467|left ventricular end diastolic pressure|left ventricular end diastolic pressure
5045565|NCT01442467|LVEDP|lvedp
5045566|NCT01442467|Echocardiogram|echocardiogram
5045567|NCT01442454|chronic pancreatitis|chronic pancreatitis
5045568|NCT01442441|chronic pancreatitis|chronic pancreatitis
5045569|NCT01442428|TB|tb
5045570|NCT01442428|AIDS|aids
5045571|NCT01442428|HIV|hiv
5045572|NCT01442428|IRIS|iris
5045573|NCT01442428|immune reconstitution inflammatory syndrome|immune reconstitution inflammatory syndrome
5045574|NCT01442428|anti-inflammatory|anti-inflammatory
5045575|NCT01442428|treatment|treatment
5045576|NCT01442376|Prevention of Chemotherapy-Induced Nausea and Vomiting|prevention of chemotherapy-induced nausea and vomiting
5045577|NCT01442376|Palonosetron|palonosetron
5045578|NCT01442376|Ondansetron|ondansetron
5045579|NCT01442376|Pediatric|pediatric
5045580|NCT01442363|Crohn's disease|crohn's disease
5045581|NCT01442363|perianal|perianal
5045582|NCT01442363|inflammatory bowel disease|inflammatory bowel disease
5045583|NCT01442363|fistula|fistula
5045584|NCT01442350|Fabry disease|fabry disease
5045585|NCT01442350|annexin 5|annexin 5
5045586|NCT01442350|miosin|miosin
5045587|NCT01442350|sarcoma|sarcoma
5045588|NCT01442350|alfa-galactosidase|alfa-galactosidase
5045589|NCT01442350|fibrosis|fibrosis
5045590|NCT01442350|apoptosis|apoptosis
5045591|NCT01442350|biomarkers|biomarkers
5045592|NCT01442350|NT-proBNP|nt-probnp
5045593|NCT01442337|de novo kidney transplant|de novo kidney transplant
5045594|NCT01442337|kidney transplant|kidney transplant
5045595|NCT01442337|ASP8597|asp8597
5045596|NCT01442337|diannexin|diannexin
5045597|NCT01442337|ischemia-reperfusion injury|ischemia-reperfusion injury
5045598|NCT01442324|Laparotomic surgery|laparotomic surgery
5045599|NCT01442324|Laparoscopic surgery|laparoscopic surgery
5045600|NCT01442324|Percutaneos tumour ablation|percutaneos tumour ablation
5045601|NCT01442324|Irreversible electroporation (IRE)|irreversible electroporation (ire)
5045602|NCT01442311|Hepatitis C Virus|hepatitis c virus
5045603|NCT01442311|Chronic Hepatitis C|chronic hepatitis c
5045604|NCT01442311|Methadone|methadone
5045605|NCT01442311|Injection Drug User|injection drug user
5045606|NCT01442311|Adherence|adherence
5045607|NCT01442311|Directly Observed Treatment|directly observed treatment
5045608|NCT01442298|bloodless field|bloodless field
5045609|NCT01442298|cuff pressure|cuff pressure
5045610|NCT01442298|limb occlusion pressure|limb occlusion pressure
5045611|NCT01442259|Renal impairment,|renal impairment,
5045612|NCT01442259|pharmacokinetics,|pharmacokinetics,
5045613|NCT01442259|safety|safety
5045614|NCT01442246|Benefit of|benefit of
5045615|NCT01442246|adjuvant|adjuvant
5045616|NCT01442246|treatment|treatment
5045617|NCT01442246|prostatectomy|prostatectomy
5045618|NCT01442233|multiple sclerosis|multiple sclerosis
5045619|NCT01442233|plasma exchange|plasma exchange
5045620|NCT01442207|Premature Birth|premature birth
5045621|NCT01442207|Placenta Previa|placenta previa
5045622|NCT01442194|Multiple sclerosis|multiple sclerosis
5045623|NCT01442194|fingolimod|fingolimod
5045624|NCT01442194|observational study|observational study
5045625|NCT01442168|Uncomplicated Falciparum Malaria|uncomplicated falciparum malaria
5045626|NCT01442168|Plasmodium falciparum|plasmodium falciparum
5045627|NCT01442168|Antimalarial treatment|antimalarial treatment
5045628|NCT01442168|Sevuparin/DF02|sevuparin/df02
5045629|NCT01442168|Adjuvant therapy|adjuvant therapy
5045630|NCT01442168|Malanil|malanil
5045631|NCT01442168|Peripheral blood parasitemia|peripheral blood parasitemia
5045632|NCT01442168|Rosette formation|rosette formation
5045633|NCT01442168|Maximum tolerated dose|maximum tolerated dose
5045634|NCT01442155|Colorectal cancer|colorectal cancer
5045635|NCT01442155|Adjuvant setting|adjuvant setting
5045636|NCT01442155|Capecitabine|capecitabine
5045637|NCT01442155|Oxaliplatin|oxaliplatin
5045638|NCT01442142|obesity|obesity
5045639|NCT01442142|pediatric|pediatric
5045640|NCT01442142|childhood|childhood
5045641|NCT01442142|overweight|overweight
5045642|NCT01442129|Heart Failure|heart failure
5045643|NCT01442129|Left Ventricular Assist Device|left ventricular assist device
5045644|NCT01442129|Heart Transplantation|heart transplantation
5045645|NCT01442129|Cardiomyopathy|cardiomyopathy
5045646|NCT01442129|Destination Therapy|destination therapy
5045647|NCT01442129|Cell Therapy|cell therapy
5045648|NCT01442064|CNV|cnv
5045649|NCT01442064|Lucentis|lucentis
5045650|NCT01442064|AMD|amd
5045651|NCT01442064|Age-related macular degeneration|age-related macular degeneration
5045652|NCT01442064|RVO|rvo
5045653|NCT01442064|Macular edema secondary to retinal vein occlusion|macular edema secondary to retinal vein occlusion
5045654|NCT01442051|Acute Normovolemic Hemodilution|acute normovolemic hemodilution
5045655|NCT01442051|Cytoreductive Surgery|cytoreductive surgery
5045656|NCT01442051|laparotomy|laparotomy
5045657|NCT01442051|11-149|11-149
5045658|NCT01442051|advanced primary epithelial ovarian cancer|advanced primary epithelial ovarian cancer
5045659|NCT01442025|Crohn's Disease|crohn's disease
5045660|NCT01442025|IFX trough level|ifx trough level
5045661|NCT01442012|PONV|ponv
5045662|NCT01442012|ACUPUNCTURE|acupuncture
5045663|NCT01441999|Rigid rods|rigid rods
5045664|NCT01441999|less rigid rods|less rigid rods
5045665|NCT01441999|prevent kyphosis|prevent kyphosis
5045666|NCT01441999|long constructs|long constructs
5045667|NCT01441986|dextromethorphan|dextromethorphan
5045668|NCT01441986|amantadine|amantadine
5045669|NCT01441986|blood glucose lowering effect|blood glucose lowering effect
5045670|NCT01441986|oral glucose tolerance test|oral glucose tolerance test
5045671|NCT01441960|Succinylcholine|succinylcholine
5045672|NCT01441960|Rocuronium|rocuronium
5045673|NCT01441960|ECT|ect
5045674|NCT01441947|ER+|er+
5045675|NCT01441947|PR+|pr+
5045676|NCT01441947|Human Epidermal Growth Factor Receptor (HER) 2 negative|human epidermal growth factor receptor (her) 2 negative
5045677|NCT01441947|metastatic|metastatic
5045678|NCT01441921|pistachio intake|pistachio intake
5045679|NCT01441921|insulin resistance|insulin resistance
5045680|NCT01441921|type 2 diabetes mellitus|type 2 diabetes mellitus
5045681|NCT01441908|Cardiovascular|cardiovascular
5045682|NCT01441908|Multi-analyte|multi-analyte
5045683|NCT01441908|Statin|statin
5045684|NCT01441908|Dyslipidemia|dyslipidemia
5045685|NCT01441895|Refractive Cataract Extraction|refractive cataract extraction
5045686|NCT01441895|Femtosecond laser|femtosecond laser
5045687|NCT01441895|arcuate relaxing incisions|arcuate relaxing incisions
5045688|NCT01441895|Dry Eye post cataract refraction|dry eye post cataract refraction
5045689|NCT01441869|Phase 1, Healthy male volunteers, pharmacokinetics, saxagliptin/ metformin , Diabex|phase 1, healthy male volunteers, pharmacokinetics, saxagliptin/ metformin , diabex
5045690|NCT01441856|Open|open
5045691|NCT01441856|Laparoscopic|laparoscopic
5045692|NCT01441856|Hemihepatectomy|hemihepatectomy
5045693|NCT01441856|Enhanced Recovery After Surgery|enhanced recovery after surgery
5045694|NCT01441856|Functional recovery|functional recovery
5045695|NCT01441843|quality of life|quality of life
5045696|NCT01441843|lorazepam|lorazepam
5045697|NCT01441843|anxiety|anxiety
5045698|NCT01441843|premedication|premedication
5045699|NCT01441843|surgery|surgery
5045700|NCT01441843|Adult patients|adult patients
5045701|NCT01441843|Ambulatory Surgical Procedures|ambulatory surgical procedures
5045702|NCT01441843|Postoperative Period|postoperative period
5045703|NCT01441830|shoulder|shoulder
5045704|NCT01441830|subacromial|subacromial
5045705|NCT01441830|impingement|impingement
5045706|NCT01441830|tendinopathy|tendinopathy
5045707|NCT01441830|rESWT|reswt
5045708|NCT01441830|shock wave|shock wave
5045709|NCT01441830|ESWT|eswt
5045710|NCT01441830|RSWT|rswt
5045711|NCT01441791|PEEP|peep
5045712|NCT01441791|Positive end-expiratory pressure|positive end-expiratory pressure
5045713|NCT01441791|Recruitment maneuver|recruitment maneuver
5045714|NCT01441791|Open lung approach|open lung approach
5045715|NCT01441791|Post-operative complications|post-operative complications
5045716|NCT01441791|Open abdominal surgery|open abdominal surgery
5045717|NCT01441778|nasal irrigation|nasal irrigation
5045718|NCT01441778|allergic rhinitis|allergic rhinitis
5045719|NCT01441778|children|children
5045720|NCT01441765|Kidney|kidney
5045721|NCT01441765|Metastatic|metastatic
5045722|NCT01441765|Stage IV|stage iv
5045723|NCT01441726|Advanced dementia|advanced dementia
5045724|NCT01441726|Quality|quality
5045725|NCT01441726|Terminal care|terminal care
5045726|NCT01441713|Hormone treatment|hormone treatment
5045727|NCT01441713|castration|castration
5045728|NCT01441713|Orchiectomy|orchiectomy
5045729|NCT01441713|treatment frequency|treatment frequency
5045730|NCT01441713|treatment satisfaction|treatment satisfaction
5045731|NCT01441713|side effects|side effects
5045732|NCT01441700|Prone emergence|prone emergence
5045733|NCT01441700|supine emergence|supine emergence
5045734|NCT01441700|coughing|coughing
5045735|NCT01441700|haemodynamic stimulation|haemodynamic stimulation
5045736|NCT01441700|lumbar surgery|lumbar surgery
5045737|NCT01441687|Health status unknown|health status unknown
5045738|NCT01441687|healthy,no evidence of disease|healthy,no evidence of disease
5045739|NCT01441674|Occupational Therapy|occupational therapy
5045740|NCT01441661|Sunitinib|sunitinib
5045741|NCT01441661|kidney diseases|kidney diseases
5045742|NCT01441661|urogenital neoplasms|urogenital neoplasms
5045743|NCT01441661|kidney cancer|kidney cancer
5045744|NCT01441648|conjunctival injection|conjunctival injection
5045745|NCT01441648|conjunctival papillary hypertrophy|conjunctival papillary hypertrophy
5045746|NCT01441648|pannus formation|pannus formation
5045747|NCT01441648|corneal epitheliopathy|corneal epitheliopathy
5045748|NCT01441648|Schirmer test|schirmer test
5045749|NCT01441648|Impression cytology|impression cytology
5045750|NCT01441648|confocal microscopy|confocal microscopy
5045751|NCT01441648|Scanning electronmicroscopy (SEM)|scanning electronmicroscopy (sem)
5045752|NCT01441648|bacterial adhesion determination|bacterial adhesion determination
5045753|NCT01441635|Elagolix|elagolix
5045754|NCT01441635|Uterine Fibroids|uterine fibroids
5045755|NCT01441635|Elagolix sodium|elagolix sodium
5045756|NCT01441635|Leiomyomata|leiomyomata
5045757|NCT01441635|Heavy Uterine Bleeding|heavy uterine bleeding
5045758|NCT01441635|Menorrhagia|menorrhagia
5045759|NCT01441635|ABT-620|abt-620
5045760|NCT01441622|Continuous Positive Airway Pressure (CPAP)|continuous positive airway pressure (cpap)
5045761|NCT01441622|AL539|al539
5045762|NCT01441622|Home-monitoring|home-monitoring
5045763|NCT01441609|Th9 cells|th9 cells
5045765|NCT01441609|non/poor responsiveness to hepatitis B|non/poor responsiveness to hepatitis b
5045766|NCT01441609|collect blood samples after vaccination|collect blood samples after vaccination
5045767|NCT01441583|pacemaker, CRT-P, auto threshold|pacemaker, crt-p, auto threshold
5045768|NCT01441570|kidney|kidney
5045769|NCT01441570|transplant|transplant
5045770|NCT01441570|hypertension|hypertension
5045771|NCT01441570|nebivolol|nebivolol
5045772|NCT01441570|metoprolol|metoprolol
5045773|NCT01441570|bystolic|bystolic
5045774|NCT01441570|toprol|toprol
5045775|NCT01441557|mechanical ventilation|mechanical ventilation
5045776|NCT01441544|active video games|active video games
5045777|NCT01441544|Energy expenditure|energy expenditure
5045778|NCT01441531|narcotic use|narcotic use
5045779|NCT01441531|Other Acute Pain|other acute pain
5045780|NCT01441492|Distal pancreatectomy|distal pancreatectomy
5045781|NCT01441492|Pancreas resection|pancreas resection
5045782|NCT01441466|bronchiolitis|bronchiolitis
5045783|NCT01441466|RSV|rsv
5045784|NCT01441453|Hepatocellular carcinoma|hepatocellular carcinoma
5045785|NCT01441453|Cirrhosis|cirrhosis
5045786|NCT01441453|Liver resection|liver resection
5045787|NCT01441453|FibroScan|fibroscan
5045788|NCT01441440|venlafaxine ER|venlafaxine er
5045789|NCT01441440|Major depressive disorder|major depressive disorder
5045790|NCT01441440|Japan|japan
5045791|NCT01441440|placebo-controlled|placebo-controlled
5045792|NCT01441427|feeding intolerance|feeding intolerance
5045793|NCT01441427|recombinant growth factors|recombinant growth factors
5045794|NCT01441427|G-CSF|g-csf
5045795|NCT01441427|EPO|epo
5045796|NCT01441427|necrotizing enterocolitis|necrotizing enterocolitis
5045797|NCT01441414|CVX-060|cvx-060
5045798|NCT01441414|PF-04856884|pf-04856884
5045799|NCT01441414|AG-013736|ag-013736
5045800|NCT01441414|axitinib|axitinib
5045801|NCT01441414|mRCC|mrcc
5045802|NCT01441414|metastatic renal cell cancer|metastatic renal cell cancer
5045803|NCT01441414|second line|second line
5045804|NCT01441414|anti-angiogenic|anti-angiogenic
5045805|NCT01441414|Ang-2|ang-2
5045806|NCT01441401|Gabapentin|gabapentin
5045807|NCT01441401|Epilepsies|epilepsies
5045808|NCT01441401|safety|safety
5045809|NCT01441388|Phase 1b|phase 1b
5045810|NCT01441388|crizotinib|crizotinib
5045811|NCT01441388|sunitinib|sunitinib
5045812|NCT01441388|axitinib|axitinib
5045813|NCT01441388|sorafenib|sorafenib
5045814|NCT01441388|bevacizumab|bevacizumab
5045815|NCT01441388|cMET inhibitor|cmet inhibitor
5045816|NCT01441388|VEGF inhibitor|vegf inhibitor
5045817|NCT01441388|crizotinib combination|crizotinib combination
5045818|NCT01441375|Sickle cell anemia|sickle cell anemia
5045819|NCT01441362|during double-lumen|during double-lumen
5045820|NCT01441362|tube intubation|tube intubation
5045821|NCT01441349|Simvastatin|simvastatin
5045822|NCT01441349|SCLC|sclc
5045823|NCT01441349|Extensive Disease|extensive disease
5045824|NCT01441323|Obesity|obesity
5045825|NCT01441323|Type 2 Diabetes|type 2 diabetes
5045826|NCT01441323|Cardiovascular Risk|cardiovascular risk
5045827|NCT01441323|Cancer|cancer
5045828|NCT01441323|African American|african american
5045829|NCT01441323|Adolescents|adolescents
5045830|NCT01441323|Strength Training|strength training
5045831|NCT01441323|Nutrition|nutrition
5045832|NCT01441310|Gastric cancer|gastric cancer
5045833|NCT01441310|Sentinel node navigation surgery|sentinel node navigation surgery
5045834|NCT01441310|Dual method|dual method
5045835|NCT01441310|Recurrence|recurrence
5045836|NCT01441297|recurrent small cell lung cancer|recurrent small cell lung cancer
5045837|NCT01441284|pramipexole|pramipexole
5045838|NCT01441284|essential tremor|essential tremor
5045839|NCT01441284|cross-over|cross-over
5045840|NCT01441245|acute heart failure|acute heart failure
5045841|NCT01441245|diuretics|diuretics
5045842|NCT01441245|BNP|bnp
5045843|NCT01441245|Renal function|renal function
5045844|NCT01441245|acute decompensated Heart Failure,|acute decompensated heart failure,
5045845|NCT01441245|volume overload|volume overload
5045846|NCT01441206|rifampin|rifampin
5045847|NCT01441206|infants|infants
5045848|NCT01441193|HIV|hiv
5045849|NCT01441193|preventive vaccine|preventive vaccine
5045850|NCT01441193|Tat|tat
5045851|NCT01441193|Env|env
5045852|NCT01441180|Direct Acting Antiviral|direct acting antiviral
5045853|NCT01441180|Liver|liver
5045854|NCT01441180|Hepatitis C|hepatitis c
5045855|NCT01441180|HCV|hcv
5045856|NCT01441167|Healthy Subjects|healthy subjects
5045857|NCT01441167|Immunogenicity|immunogenicity
5045858|NCT01441167|Vaccine-Mediated Protection|vaccine-mediated protection
5045859|NCT01441167|Sporozoites|sporozoites
5045860|NCT01441167|Parasitemia|parasitemia
5045861|NCT01441167|Healthy Volunteer|healthy volunteer
5045862|NCT01441167|HV|hv
5045863|NCT01441154|Hypothyroidism|hypothyroidism
5045864|NCT01441154|Thyroid Cancer|thyroid cancer
5045865|NCT01441154|Triiodothyronine (T3)|triiodothyronine (t3)
5045866|NCT01441154|Energy Expenditure|energy expenditure
5045867|NCT01441154|Thyroid Hormone|thyroid hormone
5045868|NCT01441141|GCH1|gch1
5045869|NCT01441141|Pain Sensitivity|pain sensitivity
5045870|NCT01441141|Quantitative Sensory Testing (QST)|quantitative sensory testing (qst)
5045871|NCT01441141|Genetic Variation|genetic variation
5045872|NCT01441141|Sickle Cell Anemia|sickle cell anemia
5045873|NCT01441128|Lung Neoplasms|lung neoplasms
5045874|NCT01441128|Epithelial-Mesenchymal Transition Factor (c-Met)|epithelial-mesenchymal transition factor (c-met)
5045875|NCT01441128|Tyrosine Kinase Inhibitor|tyrosine kinase inhibitor
5045876|NCT01441128|Hepatocyte Growth Factor Receptor|hepatocyte growth factor receptor
5045877|NCT01441128|Epidermal Growth Factor Receptor|epidermal growth factor receptor
5045878|NCT01441128|Non Small Cell Lung Cancer|non small cell lung cancer
5045879|NCT01441128|NSCLC|nsclc
5045880|NCT01441115|Metastasis|metastasis
5045881|NCT01441115|Cancer|cancer
5045882|NCT01441115|Radiation Therapy|radiation therapy
5045883|NCT01441115|Locally Advanced|locally advanced
5045884|NCT01441115|Palliation|palliation
5045885|NCT01441115|Metastatic Cancer|metastatic cancer
5045886|NCT01441102|Diabetic Macular Edema|diabetic macular edema
5045887|NCT01441102|Microglia|microglia
5045888|NCT01441102|Dextromethorphan|dextromethorphan
5045889|NCT01441089|Pharmacogenetics|pharmacogenetics
5045890|NCT01441089|Pharmacokinetics|pharmacokinetics
5045891|NCT01441089|Pharmacodynamics|pharmacodynamics
5045892|NCT01441089|Clinical Outcome|clinical outcome
5045893|NCT01441089|Drug Metabolism and Transport|drug metabolism and transport
5045894|NCT01441089|Cancer|cancer
5045895|NCT01441076|Behcet's Disease|behcet's disease
5045896|NCT01441076|Aphthous Ulcer|aphthous ulcer
5045897|NCT01441076|Uveitis|uveitis
5045898|NCT01441076|IL-1|il-1
5045899|NCT01441076|Autoinflammation|autoinflammation
5045900|NCT01441076|BD|bd
5045901|NCT01441063|Kaposi Sarcoma Herpesvirus|kaposi sarcoma herpesvirus
5045902|NCT01441063|Human Immunodeficiency Virus|human immunodeficiency virus
5045903|NCT01441063|Tocilizumab|tocilizumab
5045904|NCT01441063|Multicentric Castleman Disease|multicentric castleman disease
5045905|NCT01441063|Interleukin-6|interleukin-6
5045906|NCT01441063|Castleman Disease|castleman disease
5045907|NCT01441037|Aplastic Anemia|aplastic anemia
5045908|NCT01441037|Androgen|androgen
5045909|NCT01441037|Telomeres|telomeres
5045910|NCT01441037|Sex hormone|sex hormone
5045911|NCT01441037|Pulmonary fibrosis|pulmonary fibrosis
5045912|NCT01441037|Liver cirrhosis|liver cirrhosis
5045913|NCT01441024|Immunocompromised|immunocompromised
5045914|NCT01441024|Respiratory Tract Disease|respiratory tract disease
5045915|NCT01441024|Viral Shedding|viral shedding
5045916|NCT01441024|Fever|fever
5045917|NCT01441024|Pharmacokinetics|pharmacokinetics
5045918|NCT01441024|Parainfluenza Infection|parainfluenza infection
5045919|NCT01441024|Flu|flu
5045920|NCT01441011|weight loss|weight loss
5045921|NCT01441011|breast cancer|breast cancer
5045922|NCT01441011|obesity|obesity
5045923|NCT01441011|overweight|overweight
5045924|NCT01441011|rural women|rural women
5045925|NCT01441011|community based|community based
5045926|NCT01441011|Secondary Prevention|secondary prevention
5045927|NCT01440985|Tooth Staining|tooth staining
5045928|NCT01440972|knee osteoarthritis|knee osteoarthritis
5045929|NCT01440972|symptomatic knee osteoarthritis|symptomatic knee osteoarthritis
5045930|NCT01440972|isotonic leg-press strength|isotonic leg-press strength
5045931|NCT01440972|isokinetic knee extensor strength|isokinetic knee extensor strength
5045932|NCT01440972|quadriceps volume|quadriceps volume
5045933|NCT01440959|This is a single-center|this is a single-center
5045934|NCT01440959|prospective|prospective
5045935|NCT01440959|single-arm|single-arm
5045936|NCT01440959|open-label phase II study|open-label phase ii study
5045937|NCT01440933|sugammadex|sugammadex
5045938|NCT01440933|rocuronium|rocuronium
5045939|NCT01440933|magnesiumsulphate|magnesiumsulphate
5045940|NCT01440933|neuromuscular monitoring|neuromuscular monitoring
5045941|NCT01440920|Acute myeloid leukemia|acute myeloid leukemia
5045942|NCT01440920|WT1|wt1
5045943|NCT01440907|Health Information Technology|health information technology
5045944|NCT01440907|Health Records, Personal|health records, personal
5045945|NCT01440907|Hospital Information Systems|hospital information systems
5045946|NCT01440907|Patient Access to Records|patient access to records
5045947|NCT01440907|Medical Records|medical records
5045948|NCT01440907|Medical Record Systems, Computerized|medical record systems, computerized
5045949|NCT01440894|weight|weight
5045950|NCT01440894|body fat|body fat
5045951|NCT01440894|total body water|total body water
5045952|NCT01440894|bone mass|bone mass
5045953|NCT01440894|muscle mass|muscle mass
5045954|NCT01440881|renal failure|renal failure
5045955|NCT01440881|cardiopulmonary bypass|cardiopulmonary bypass
5045956|NCT01440868|Respiratory Distress Syndrome, Newborn|respiratory distress syndrome, newborn
5045957|NCT01440868|Delivery Rooms|delivery rooms
5045958|NCT01440868|Resuscitation|resuscitation
5045959|NCT01440868|Premature Birth|premature birth
5045960|NCT01440868|Infant, Newborn|infant, newborn
5045961|NCT01440868|Respiration, Artificial|respiration, artificial
5045962|NCT01440855|Survivorship|survivorship
5045963|NCT01440855|cancer control|cancer control
5045964|NCT01440855|psychosocial interventions|psychosocial interventions
5045965|NCT01440855|Facing Forward|facing forward
5045966|NCT01440842|Stress hyperglycaemia|stress hyperglycaemia
5045967|NCT01440829|Transjugular Intrahepatic Portosystemic Shunt|transjugular intrahepatic portosystemic shunt
5045968|NCT01440829|TIPS|tips
5045969|NCT01440829|Liver Cirrhosis|liver cirrhosis
5045970|NCT01440829|LOLA|lola
5045971|NCT01440829|L-ornithine-L-aspartate|l-ornithine-l-aspartate
5045972|NCT01440829|Refractory Ascites|refractory ascites
5045973|NCT01440803|osteoporosis|osteoporosis
5045974|NCT01440803|premenopausal|premenopausal
5045975|NCT01440803|forteo|forteo
5045976|NCT01440803|idiopathic|idiopathic
5045977|NCT01440803|Idiopathic Osteoporosis in Premenopausal Women|idiopathic osteoporosis in premenopausal women
5045978|NCT01440777|Insomnia|insomnia
5045979|NCT01440777|Sleep|sleep
5045980|NCT01440777|Stress|stress
5045981|NCT01440777|Online program|online program
5045982|NCT01440777|Web-based program|web-based program
5045983|NCT01440777|Cognitive Behavioral Therapy for Insomnia (CBT-i)|cognitive behavioral therapy for insomnia (cbt-i)
5045984|NCT01440764|dyspnea|dyspnea
5045985|NCT01440764|Laboratory model of dyspnea in healthy subjects|laboratory model of dyspnea in healthy subjects
5045986|NCT01440751|ologen collagen matrix|ologen collagen matrix
5045987|NCT01440751|mitomycin-C|mitomycin-c
5045988|NCT01440751|trabeculectomy|trabeculectomy
5045989|NCT01440751|glaucoma|glaucoma
5045990|NCT01440751|filtering surgery|filtering surgery
5045991|NCT01440738|general population|general population
5045992|NCT01440725|muscle|muscle
5045993|NCT01440725|injuries|injuries
5045994|NCT01440725|platelet-rich plasma|platelet-rich plasma
5045995|NCT01440725|autologous|autologous
5045996|NCT01440725|haematoma|haematoma
5045997|NCT01440712|Gastrografin|gastrografin
5045998|NCT01440712|Postoperative ileus|postoperative ileus
5045999|NCT01440712|Colo-rectal surgery|colo-rectal surgery
5046000|NCT01440712|Effects on morbidity and mortality of postoperative ileus|effects on morbidity and mortality of postoperative ileus
5046001|NCT01440699|Crohn's fistula|crohn's fistula
5046002|NCT01440686|Pharmacokinetics|pharmacokinetics
5046003|NCT01440686|Pharmacodynamics|pharmacodynamics
5046004|NCT01440686|Safety|safety
5046005|NCT01440686|Male|male
5046006|NCT01440673|Postoperative Nausea and Vomiting|postoperative nausea and vomiting
5046007|NCT01440647|Respiration, Artificial|respiration, artificial
5046008|NCT01440647|Infant, Premature|infant, premature
5046009|NCT01440647|Bronchopulmonary Dysplasia|bronchopulmonary dysplasia
5046010|NCT01440647|Continuous Positive Airway Pressure|continuous positive airway pressure
5046011|NCT01440647|Non-Invasive Positive-Pressure Ventilation|non-invasive positive-pressure ventilation
5046012|NCT01440647|Intermittent Positive-Pressure Ventilation|intermittent positive-pressure ventilation
5046013|NCT01440647|High-Frequency Ventilation|high-frequency ventilation
5046014|NCT01440634|Peripheral arterial disease|peripheral arterial disease
5046015|NCT01440634|Community Medicine|community medicine
5046016|NCT01440634|Exercise Test|exercise test
5046017|NCT01440634|Exercise Therapy|exercise therapy
5046018|NCT01440621|Cancer related fatigue|cancer related fatigue
5046019|NCT01440621|Quality of life|quality of life
5046020|NCT01440621|Modafinil|modafinil
5046021|NCT01440621|Radiation therapy|radiation therapy
5046022|NCT01440621|Radiotherapy|radiotherapy
5046023|NCT01440582|Myeloma|myeloma
5046024|NCT01440582|Multiple Myeloma|multiple myeloma
5046025|NCT01440582|MM|mm
5046026|NCT01440582|Newly diagnosed|newly diagnosed
5046027|NCT01440582|Transplant eligible|transplant eligible
5046028|NCT01440582|Panobinostat|panobinostat
5046029|NCT01440582|LBH589B|lbh589b
5046030|NCT01440582|Bortezomib|bortezomib
5046031|NCT01440582|Velcade|velcade
5046032|NCT01440582|LDP-341|ldp-341
5046033|NCT01440582|MLN341|mln341
5046034|NCT01440582|PS-341|ps-341
5046035|NCT01440582|Lenalidomide|lenalidomide
5046036|NCT01440582|CC-5013|cc-5013
5046037|NCT01440582|Revlimid|revlimid
5046038|NCT01440582|Dexamethasone|dexamethasone
5046039|NCT01440582|Decadron|decadron
5046040|NCT01440582|Symptom questionnaire|symptom questionnaire
5046041|NCT01440582|Survey|survey
5046042|NCT01440569|HIV-1|hiv-1
5046043|NCT01440569|HIV|hiv
5046044|NCT01440569|Treatment Naïve|treatment naïve
5046045|NCT01440569|Treatment Experienced|treatment experienced
5046046|NCT01440556|Allogeneic bone marrow transplantation|allogeneic bone marrow transplantation
5046047|NCT01440556|Multiple myeloma|multiple myeloma
5046048|NCT01440543|colonoscopy|colonoscopy
5046049|NCT01440543|water immersion|water immersion
5046050|NCT01440543|CO2 insufflation|co2 insufflation
5046051|NCT01440543|patients referred for diagnostic outpatient colonoscopy|patients referred for diagnostic outpatient colonoscopy
5046052|NCT01440543|(screening, surveillance, symptoms)|(screening, surveillance, symptoms)
5046053|NCT01440543|patient discomfort associated with diagnostic colonoscopy|patient discomfort associated with diagnostic colonoscopy
5046054|NCT01440530|Diabetes Internet Education|diabetes internet education
5046055|NCT01440530|Diabetes Education|diabetes education
5046056|NCT01440530|Diabetes Self-Care|diabetes self-care
5046057|NCT01440530|Diabetes Self-Management|diabetes self-management
5046058|NCT01440530|Diabetes Behavior Intervention|diabetes behavior intervention
5046059|NCT01440517|CE-MRI - Contrast-enhanced magnetic resonance imaging|ce-mri - contrast-enhanced magnetic resonance imaging
5046060|NCT01440517|DM - Diabetes mellitus|dm - diabetes mellitus
5046061|NCT01440517|EKG - Echocardiography|ekg - echocardiography
5046062|NCT01440517|HFPEF - Heart failure preserved left ventricular ejection fraction|hfpef - heart failure preserved left ventricular ejection fraction
5046063|NCT01440517|LVEF - Left Ventricular Ejection Fraction|lvef - left ventricular ejection fraction
5046064|NCT01440504|Cancer|cancer
5046065|NCT01440504|Ovarian|ovarian
5046066|NCT01440504|chemotherapy|chemotherapy
5046067|NCT01440504|BH3-mimetic|bh3-mimetic
5046068|NCT01440504|platin|platin
5046069|NCT01440504|ex-vivo|ex-vivo
5046070|NCT01440491|low back pain|low back pain
5046071|NCT01440491|exercise|exercise
5046072|NCT01440491|booklet|booklet
5046073|NCT01440465|chemotherapy|chemotherapy
5046074|NCT01440465|cancer|cancer
5046075|NCT01440465|nausea|nausea
5046076|NCT01440465|vomiting|vomiting
5046077|NCT01440452|TM|tm
5046078|NCT01440452|MS|ms
5046079|NCT01440452|Spinal Cord Injury|spinal cord injury
5046080|NCT01440452|Functional electrical stimulation|functional electrical stimulation
5046081|NCT01440452|Rehabilitation|rehabilitation
5046082|NCT01440452|Growth factors|growth factors
5046083|NCT01440452|Cytokines|cytokines
5046084|NCT01440439|insulin glargine|insulin glargine
5046085|NCT01440439|insulin detemir|insulin detemir
5046086|NCT01440439|hypoglycaemia|hypoglycaemia
5046087|NCT01440439|metabolism|metabolism
5046088|NCT01440439|Exercise|exercise
5046089|NCT01440426|gingival recession|gingival recession
5046090|NCT01440426|root coverage|root coverage
5046091|NCT01440426|periodontal surgery|periodontal surgery
5046092|NCT01440426|collagen matrix|collagen matrix
5046093|NCT01440426|mucograft|mucograft
5046094|NCT01440426|multiple exposed teeth|multiple exposed teeth
5046095|NCT01440413|anti-tumor immune response|anti-tumor immune response
5046096|NCT01440413|neo-adjuvant chemotherapy|neo-adjuvant chemotherapy
5046097|NCT01440413|relapse|relapse
5046098|NCT01440413|long term survival|long term survival
5046099|NCT01440413|histo-pathological response|histo-pathological response
5046100|NCT01440413|tumor cell death|tumor cell death
5046101|NCT01440413|tumor associated antigens|tumor associated antigens
5046102|NCT01440413|Calreticulin|calreticulin
5046103|NCT01440413|Localized breast cancer|localized breast cancer
5046104|NCT01440400|Ultrasound|ultrasound
5046105|NCT01440400|Spinal anesthesia|spinal anesthesia
5046106|NCT01440400|Cesarean section|cesarean section
5046107|NCT01440387|Influenza|influenza
5046108|NCT01440387|Phase III|phase iii
5046109|NCT01440387|Seasonal influenza|seasonal influenza
5046110|NCT01440374|acute myeloid leukemia (AML)|acute myeloid leukemia (aml)
5046111|NCT01440374|acute myelogenous leukemia (AML)|acute myelogenous leukemia (aml)
5046112|NCT01440374|acute non lymphocytic leukemia (ANLL)|acute non lymphocytic leukemia (anll)
5046113|NCT01440374|myeloproliferative disease (MDS)|myeloproliferative disease (mds)
5046114|NCT01440374|myelodysplastic syndrome ( secondary acute myeloid leukemia)|myelodysplastic syndrome ( secondary acute myeloid leukemia)
5046115|NCT01440374|refractory acute myeloid leukemia|refractory acute myeloid leukemia
5046116|NCT01440348|Achilles allograft|achilles allograft
5046117|NCT01440348|cruciate ligament|cruciate ligament
5046118|NCT01440348|reconstruction|reconstruction
5046119|NCT01440335|Fenoterol|fenoterol
5046120|NCT01440335|Pharmacodynamics|pharmacodynamics
5046121|NCT01440335|Pharmacokinetics|pharmacokinetics
5046122|NCT01440335|Safety|safety
5046123|NCT01440335|Beta Adrenergic Agonist|beta adrenergic agonist
5046124|NCT01440322|Myopia|myopia
5046125|NCT01440322|Contact lenses|contact lenses
5046126|NCT01440309|biliary cirrhosis|biliary cirrhosis
5046127|NCT01440283|Neuroblastoma|neuroblastoma
5046128|NCT01440283|Radiation Therapy|radiation therapy
5046129|NCT01440270|Oral cancer|oral cancer
5046130|NCT01440270|Oropharyngeal cancer|oropharyngeal cancer
5046131|NCT01440270|Induction chemotherapy|induction chemotherapy
5046132|NCT01440270|Targeted chemotherapy|targeted chemotherapy
5046133|NCT01440270|Surgery|surgery
5046134|NCT01440270|Radiotherapy|radiotherapy
5046135|NCT01440270|Effects of Chemotherapy|effects of chemotherapy
5046136|NCT01440244|mediastinoscopy|mediastinoscopy
5046137|NCT01440244|pleural evaluation|pleural evaluation
5046138|NCT01440244|pleural biopsy|pleural biopsy
5046139|NCT01440244|pleurodesis|pleurodesis
5046140|NCT01440231|Rheumatology|rheumatology
5046141|NCT01440231|Double-Blind|double-blind
5046142|NCT01440231|Placebo-Controlled|placebo-controlled
5046143|NCT01440231|Multidose|multidose
5046144|NCT01440231|Dose-Response|dose-response
5046146|NCT01440231|Systemic Lupus Erythematosus|systemic lupus erythematosus
5046147|NCT01440231|SLE|sle
5046148|NCT01440231|Atacicept|atacicept
5046149|NCT01440218|Idiopathic diseases|idiopathic diseases
5046150|NCT01440218|family member of the affected individual|family member of the affected individual
5046151|NCT01440218|unknown etiology|unknown etiology
5046152|NCT01440205|Flu Shot|flu shot
5046153|NCT01440192|Sarcoidosis|sarcoidosis
5046154|NCT01440192|Stem cells|stem cells
5046155|NCT01440192|PDA001|pda001
5046156|NCT01440192|Celgene|celgene
5046157|NCT01440192|Human Placenta-Derived cells|human placenta-derived cells
5046158|NCT01440192|Cenplacel-L|cenplacel-l
5046159|NCT01440166|Human healthy volunteers|human healthy volunteers
5046160|NCT01440153|Dance|dance
5046161|NCT01440153|Injury|injury
5046162|NCT01440153|Physical condition|physical condition
5046163|NCT01440153|Exercise|exercise
5046164|NCT01440114|emergence agitation|emergence agitation
5046165|NCT01440114|pediatric patient|pediatric patient
5046166|NCT01440114|fentanyl|fentanyl
5046167|NCT01440114|incidence of emergence agitation|incidence of emergence agitation
5046168|NCT01440114|severity of emergence agitation|severity of emergence agitation
5046169|NCT01440114|adverse outcome from intervention|adverse outcome from intervention
5046170|NCT01440088|TH-302|th-302
5046171|NCT01440088|TH-CR-406|th-cr-406
5046172|NCT01440088|SARC021|sarc021
5046173|NCT01440088|Locally Advanced Soft Tissue Sarcoma|locally advanced soft tissue sarcoma
5046174|NCT01440088|Metastatic Soft Tissue Sarcoma|metastatic soft tissue sarcoma
5046175|NCT01440088|Sarcoma|sarcoma
5046176|NCT01440088|Doxorubicin|doxorubicin
5046177|NCT01440088|Evofosfamide|evofosfamide
5046178|NCT01440075|Kawasaki disease|kawasaki disease
5046179|NCT01440049|patients with MI- on top of treatment add Eplerenone - assess LVEF and BP|patients with mi- on top of treatment add eplerenone - assess lvef and bp
5046180|NCT01440036|carotid artery|carotid artery
5046181|NCT01440036|Atherosclerotic plaque|atherosclerotic plaque
5046182|NCT01440036|paraoxygenase 1 PON1|paraoxygenase 1 pon1
5046183|NCT01440036|Patients undergoing carotid artery endarterectomy CEA for carotid artery stenosis|patients undergoing carotid artery endarterectomy cea for carotid artery stenosis
5046184|NCT01440023|tic disorder|tic disorder
5046185|NCT01440023|tourette syndrome|tourette syndrome
5046186|NCT01440023|habit reversal|habit reversal
5046187|NCT01440023|response inhibition|response inhibition
5046188|NCT01440023|cognitive retraining|cognitive retraining
5046189|NCT01440010|IORT|iort
5046190|NCT01440010|Boost|boost
5046191|NCT01440010|Breast cancer|breast cancer
5046192|NCT01440010|Local recurrence|local recurrence
5046193|NCT01440010|Toxicity|toxicity
5046194|NCT01440010|LENT SOMA|lent soma
5046195|NCT01440010|TARGIT|targit
5046196|NCT01440010|Quality Control Registry|quality control registry
5046197|NCT01439997|Nocturnal polyuria|nocturnal polyuria
5046198|NCT01439984|PE|pe
5046199|NCT01439984|IELT|ielt
5046200|NCT01439984|DCIT|dcit
5046201|NCT01439971|Phase 1|phase 1
5046202|NCT01439971|Safety|safety
5046203|NCT01439971|Pharmacokinetic|pharmacokinetic
5046204|NCT01439971|Pharmacodynamic|pharmacodynamic
5046205|NCT01439958|Inhalation|inhalation
5046206|NCT01439958|Lung Transplantation|lung transplantation
5046207|NCT01439958|Cyclosporine|cyclosporine
5046208|NCT01439945|hot flashes|hot flashes
5046209|NCT01439945|cancer survivor|cancer survivor
5046210|NCT01439945|breast cancer|breast cancer
5046211|NCT01439932|plantar fasciitis|plantar fasciitis
5046212|NCT01439932|heel pain|heel pain
5046213|NCT01439932|manual treatment|manual treatment
5046214|NCT01439932|dorsi flexion|dorsi flexion
5046215|NCT01439906|Degenerative scoliosis|degenerative scoliosis
5046216|NCT01439906|Pain|pain
5046217|NCT01439906|Deformity correction|deformity correction
5046218|NCT01439906|Instrumented arthrodesis|instrumented arthrodesis
5046219|NCT01439893|Chronic heart failure|chronic heart failure
5046220|NCT01439893|rhNRG-1|rhnrg-1
5046221|NCT01439893|Cardiac remodeling|cardiac remodeling
5046222|NCT01439880|High cholesterol|high cholesterol
5046223|NCT01439880|Raised cholesterol|raised cholesterol
5046224|NCT01439880|Cholesterol|cholesterol
5046225|NCT01439880|Elevated Cholesterol|elevated cholesterol
5046226|NCT01439867|Dialysis|dialysis
5046227|NCT01439867|Sensipar|sensipar
5046228|NCT01439867|Mimpara|mimpara
5046229|NCT01439867|Hemodialysis|hemodialysis
5046230|NCT01439867|Peritoneal Dialysis|peritoneal dialysis
5046231|NCT01439867|Renal|renal
5046232|NCT01439867|Parathyroid hormone|parathyroid hormone
5046233|NCT01439867|Pediatric|pediatric
5046234|NCT01439854|Insulin sensitivity|insulin sensitivity
5046235|NCT01439854|Mitochondrial function|mitochondrial function
5046236|NCT01439854|Glucose toxicity|glucose toxicity
5046237|NCT01439854|Glucosuria|glucosuria
5046238|NCT01439841|HIV|hiv
5046239|NCT01439841|microbial translocation|microbial translocation
5046240|NCT01439841|immune activation|immune activation
5046241|NCT01439841|probiotics|probiotics
5046242|NCT01439828|Cannabis|cannabis
5046243|NCT01439828|N-Acetylcystein|n-acetylcystein
5046244|NCT01439828|Dependence|dependence
5046245|NCT01439828|Abuse|abuse
5046246|NCT01439828|Craving|craving
5046247|NCT01439828|Genetic|genetic
5046248|NCT01439802|Postpartum IUD|postpartum iud
5046249|NCT01439802|Cesarean Delivery|cesarean delivery
5046250|NCT01439802|6 months postpartum|6 months postpartum
5046251|NCT01439802|satisfaction|satisfaction
5046252|NCT01439789|Chronic Heart Failure|chronic heart failure
5046253|NCT01439789|rhNRG-1|rhnrg-1
5046254|NCT01439789|NT-proBNP|nt-probnp
5046255|NCT01439776|chronic hepatitis C|chronic hepatitis c
5046256|NCT01439776|SVR|svr
5046257|NCT01439776|Vit D|vit d
5046258|NCT01439776|Peginterferon alfa 2a|peginterferon alfa 2a
5046259|NCT01439776|Ribavirin|ribavirin
5046260|NCT01439763|Bullies|bullies
5046261|NCT01439763|Bully victims|bully victims
5046262|NCT01439763|Psychiatric symptoms|psychiatric symptoms
5046263|NCT01439750|mantle cell lymphoma|mantle cell lymphoma
5046264|NCT01439750|lymphoma|lymphoma
5046265|NCT01439737|Asthma|asthma
5046266|NCT01439737|metabolomics|metabolomics
5046267|NCT01439737|exhaled breath condensate|exhaled breath condensate
5046268|NCT01439724|Oral mucositis|oral mucositis
5046269|NCT01439724|Low Level Laser Therapy|low level laser therapy
5046270|NCT01439724|Head and neck cancer|head and neck cancer
5046271|NCT01439711|ductal breast carcinoma in situ|ductal breast carcinoma in situ
5046272|NCT01439711|estrogen receptor-positive breast cancer|estrogen receptor-positive breast cancer
5046273|NCT01439698|Cholangiocarcinoma|cholangiocarcinoma
5046274|NCT01439698|Pancreatic Cancer|pancreatic cancer
5046275|NCT01439698|Bile Duct Cancer|bile duct cancer
5046276|NCT01439698|Biliary Stricture|biliary stricture
5046277|NCT01439698|Bile duct obstruction|bile duct obstruction
5046278|NCT01439698|ENDOHPB|endohpb
5046279|NCT01439698|Radio Frequency Ablation|radio frequency ablation
5046280|NCT01439698|RFA|rfa
5046281|NCT01439698|ERCP|ercp
5046282|NCT01439698|Endoscopic Retrograde Cholangiopancreatography|endoscopic retrograde cholangiopancreatography
5046283|NCT01439698|Registry|registry
5046284|NCT01439698|Multicenter|multicenter
5046285|NCT01439685|Cholangiocarcinoma|cholangiocarcinoma
5046286|NCT01439685|PDT|pdt
5046287|NCT01439685|Photodynamic Therapy|photodynamic therapy
5046288|NCT01439685|Bile Duct|bile duct
5046289|NCT01439685|Bile Duct Obstruction|bile duct obstruction
5046290|NCT01439685|Jaundice|jaundice
5046291|NCT01439685|Biliary Stent|biliary stent
5046292|NCT01439685|ERCP|ercp
5046293|NCT01439685|Obstructive Jaundice|obstructive jaundice
5046294|NCT01439672|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
5046295|NCT01439659|Ovarian Cancer|ovarian cancer
5046296|NCT01439659|Epithelial ovarian cancer|epithelial ovarian cancer
5046297|NCT01439659|First clinical remission|first clinical remission
5046298|NCT01439659|Nutritional Supplements|nutritional supplements
5046299|NCT01439659|Juice Plus +|juice plus +
5046300|NCT01439659|Juice Plus + Complete|juice plus + complete
5046301|NCT01439659|Dietary counseling|dietary counseling
5046302|NCT01439646|empirical|empirical
5046303|NCT01439646|ICU|icu
5046304|NCT01439646|high risk patient|high risk patient
5046305|NCT01439633|Barrett's Esophagus|barrett's esophagus
5046306|NCT01439633|Esophagus|esophagus
5046307|NCT01439633|OCT|oct
5046308|NCT01439633|Imaging|imaging
5046309|NCT01439620|Biliary Stricture|biliary stricture
5046310|NCT01439620|OCT|oct
5046311|NCT01439620|Imaging|imaging
5046312|NCT01439607|Gaucher disease|gaucher disease
5046313|NCT01439594|Barrett's Esophagus|barrett's esophagus
5046314|NCT01439594|Esophagus|esophagus
5046315|NCT01439594|OCT|oct
5046316|NCT01439594|Imaging|imaging
5046317|NCT01439594|Radiofrequency Ablation|radiofrequency ablation
5046318|NCT01439594|BARRX|barrx
5046319|NCT01439581|patients|patients
5046320|NCT01439581|susceptible to|susceptible to
5046321|NCT01439581|hospital|hospital
5046322|NCT01439581|acquired pressure|acquired pressure
5046323|NCT01439568|Cancer|cancer
5046324|NCT01439568|Lung|lung
5046325|NCT01439568|Metastasis|metastasis
5046326|NCT01439555|Early Alzheimer|early alzheimer
5046327|NCT01439555|Mild Cognitive Impairment|mild cognitive impairment
5046328|NCT01439555|Drug treatment|drug treatment
5046329|NCT01439555|Cerebral blood flow|cerebral blood flow
5046330|NCT01439555|Endothelial facilitation|endothelial facilitation
5046331|NCT01439555|Cognitive improvement|cognitive improvement
5046332|NCT01439542|High risk prostate cancer|high risk prostate cancer
5046333|NCT01439529|Cardiac|cardiac
5046334|NCT01439529|Resynchronization|resynchronization
5046335|NCT01439529|Therapy|therapy
5046336|NCT01439477|exercise|exercise
5046337|NCT01439477|healthy eating|healthy eating
5046338|NCT01439477|heart disease|heart disease
5046339|NCT01439477|prevention & control|prevention & control
5046340|NCT01439477|Middle aged|middle aged
5046341|NCT01439477|Women|women
5046342|NCT01439477|Health promotion|health promotion
5046343|NCT01439451|Balance control|balance control
5046344|NCT01439451|Aging|aging
5046345|NCT01439451|Balance reactions|balance reactions
5046346|NCT01439451|Perturbation|perturbation
5046347|NCT01439451|above seventy years old|above seventy years old
5046348|NCT01439425|psoriasis|psoriasis
5046349|NCT01439425|obesity|obesity
5046350|NCT01439425|body mass index|body mass index
5046351|NCT01439425|disease remission|disease remission
5046352|NCT01439425|diet|diet
5046353|NCT01439412|Low back pain|low back pain
5046354|NCT01439412|Acupuncture|acupuncture
5046355|NCT01439412|General practice|general practice
5046356|NCT01439399|postoperative pain|postoperative pain
5046357|NCT01439399|postoperative care|postoperative care
5046358|NCT01439399|intravenous lidocaine|intravenous lidocaine
5046359|NCT01439399|intravenous ketamine|intravenous ketamine
5046360|NCT01439399|morphine consumption|morphine consumption
5046361|NCT01439373|chronic hepatitis C|chronic hepatitis c
5046362|NCT01439373|NS5A inhibitor|ns5a inhibitor
5046363|NCT01439373|ribavirin|ribavirin
5046364|NCT01439373|pegylated interferon|pegylated interferon
5046365|NCT01439373|GSK2336805|gsk2336805
5046366|NCT01439360|Vaccine|vaccine
5046367|NCT01439360|Seasonal Flu|seasonal flu
5046368|NCT01439360|Efficacy|efficacy
5046369|NCT01439360|Children|children
5046370|NCT01439347|Marqibo|marqibo
5046371|NCT01439347|HALLMARQ|hallmarq
5046372|NCT01439347|leukemia|leukemia
5046373|NCT01439347|front-line|front-line
5046374|NCT01439347|ALL|all
5046375|NCT01439347|acute lymphoblastic leukemia|acute lymphoblastic leukemia
5046376|NCT01439334|Brief|brief
5046377|NCT01439334|Online|online
5046378|NCT01439334|Image|image
5046379|NCT01439334|Interactive|interactive
5046380|NCT01439334|Young Adult|young adult
5046381|NCT01439334|Primary Care|primary care
5046382|NCT01439321|treatment satisfaction|treatment satisfaction
5046383|NCT01439321|romiplostim|romiplostim
5046384|NCT01439321|eltrombopag|eltrombopag
5046385|NCT01439321|chronic immune thrombocytopenic pupura|chronic immune thrombocytopenic pupura
5046386|NCT01439308|NAR|nar
5046387|NCT01439308|Capsaicin challenge|capsaicin challenge
5046388|NCT01439295|Ascorbyl peroxide|ascorbyl peroxide
5046389|NCT01439295|Bronchopulmonary dysplasia|bronchopulmonary dysplasia
5046390|NCT01439295|Redox status|redox status
5046391|NCT01439295|Necrotising entercolitis|necrotising entercolitis
5046392|NCT01439295|Retinopathy of prematurity|retinopathy of prematurity
5046393|NCT01439295|Patent ductus arteriosus|patent ductus arteriosus
5046394|NCT01439295|Intraventricular hemorrhage|intraventricular hemorrhage
5046395|NCT01439295|Periventricular leucomalacia|periventricular leucomalacia
5046396|NCT01439282|Estrogen Receptor-Positive Early Stage Breast Cancer|estrogen receptor-positive early stage breast cancer
5046397|NCT01439269|Separation stress|separation stress
5046398|NCT01439269|Family Nurture|family nurture
5046399|NCT01439269|Maternal Confidence|maternal confidence
5046400|NCT01439269|Maternal Competence|maternal competence
5046401|NCT01439269|Calming Cycle|calming cycle
5046402|NCT01439269|Kangaroo Care|kangaroo care
5046403|NCT01439269|Infant Neurodevelopment|infant neurodevelopment
5046404|NCT01439269|Infant Psychological Development|infant psychological development
5046405|NCT01439269|Post-partum depression|post-partum depression
5046406|NCT01439269|Mother-infant Co-regulation|mother-infant co-regulation
5046407|NCT01439243|Bioequivalence|bioequivalence
5046408|NCT01439243|Healthy Subjects|healthy subjects
5046409|NCT01439243|Donepezil|donepezil
5046410|NCT01439230|Bioequivalence|bioequivalence
5046411|NCT01439230|Healthy Subjects|healthy subjects
5046412|NCT01439230|Donepezil|donepezil
5046413|NCT01439217|Acute lymphoblastic leukemia|acute lymphoblastic leukemia
5046414|NCT01439217|Survivor|survivor
5046415|NCT01439217|Sibling control|sibling control
5046416|NCT01439191|HER2-Overexpressed|her2-overexpressed
5046417|NCT01439165|Adacel vaccine|adacel vaccine
5046418|NCT01439165|Tetanus|tetanus
5046419|NCT01439165|Diphtheria|diphtheria
5046420|NCT01439165|whooping cough|whooping cough
5046421|NCT01439152|Oncology|oncology
5046422|NCT01439152|Solid tumors|solid tumors
5046423|NCT01439152|Antibody drug conjugate (ADC)|antibody drug conjugate (adc)
5046424|NCT01439152|Treatment Emergent Adverse Events|treatment emergent adverse events
5046425|NCT01439152|Mesothelin|mesothelin
5046426|NCT01439139|Osteoporosis|osteoporosis
5046427|NCT01439139|ultrasound|ultrasound
5046428|NCT01439139|sonometer|sonometer
5046429|NCT01439139|DXA|dxa
5046430|NCT01439126|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
5046431|NCT01439113|Ultrasound, Difficult access|ultrasound, difficult access
5046432|NCT01439100|Parkinson's disease|parkinson's disease
5046433|NCT01439100|severe pain|severe pain
5046434|NCT01439100|OXN PR|oxn pr
5046435|NCT01439100|randomised|randomised
5046436|NCT01439087|Colonic Polyps|colonic polyps
5046437|NCT01439087|OCT|oct
5046438|NCT01439087|Imaging|imaging
5046439|NCT01439087|Colon|colon
5046440|NCT01439087|Polyp|polyp
5046441|NCT01439074|Burn injuries|burn injuries
5046442|NCT01439074|Mepilex Ag|mepilex ag
5046443|NCT01439074|SSD Ag|ssd ag
5046444|NCT01439074|Partial thickness|partial thickness
5046445|NCT01439061|Growth disorders|growth disorders
5046446|NCT01439061|Saizen|saizen
5046447|NCT01439061|Easypod|easypod
5046448|NCT01439061|Growth hormone|growth hormone
5046449|NCT01439061|Pediatric subject|pediatric subject
5046450|NCT01439048|Placenta|placenta
5046451|NCT01439048|Cord Blood|cord blood
5046452|NCT01439048|PAH|pah
5046453|NCT01439048|Environmental Markers|environmental markers
5046454|NCT01439048|Toll-Like Receptors|toll-like receptors
5046455|NCT01439035|Celiac Disease|celiac disease
5046456|NCT01439035|Duodenal|duodenal
5046457|NCT01439035|OCT|oct
5046458|NCT01439035|Imaging|imaging
5046459|NCT01439022|Parkinson's Disease|parkinson's disease
5046460|NCT01439022|Exercise|exercise
5046461|NCT01439022|Treatment Outcome|treatment outcome
5046462|NCT01439022|Patient Adherence|patient adherence
5046463|NCT01439009|Heart failure|heart failure
5046464|NCT01439009|Volume overload|volume overload
5046465|NCT01439009|Tolvaptan|tolvaptan
5046466|NCT01439009|loop diuretics|loop diuretics
5046467|NCT01438996|Typhoid fever|typhoid fever
5046468|NCT01438996|Glycoconjugate vaccine|glycoconjugate vaccine
5046469|NCT01438996|Vi polysaccharide|vi polysaccharide
5046470|NCT01438996|Immunogenicity|immunogenicity
5046471|NCT01438957|Dexmedetomidine|dexmedetomidine
5046472|NCT01438957|Sedation|sedation
5046473|NCT01438957|Non-intubation|non-intubation
5046474|NCT01438957|epidural anesthesia|epidural anesthesia
5046475|NCT01438957|spinal anesthesia|spinal anesthesia
5046476|NCT01438944|NRT|nrt
5046477|NCT01438944|Patch|patch
5046478|NCT01438944|smoking|smoking
5046479|NCT01438944|addiction|addiction
5046480|NCT01438931|Dexmedetomidine|dexmedetomidine
5046481|NCT01438931|Sedation|sedation
5046482|NCT01438931|Non-intubation|non-intubation
5046483|NCT01438931|local anesthesia|local anesthesia
5046484|NCT01438918|Knee|knee
5046485|NCT01438918|Osteoarthritis|osteoarthritis
5046486|NCT01438918|X-ray|x-ray
5046487|NCT01438918|Joint Space Narrowing|joint space narrowing
5046488|NCT01438905|Ankle Sprain|ankle sprain
5046489|NCT01438905|Chronic Ankle Instability|chronic ankle instability
5046490|NCT01438905|Ankle Mobilization|ankle mobilization
5046491|NCT01438905|Talocrural Joint Mobilization|talocrural joint mobilization
5046492|NCT01438905|Cortical Muscle Activation|cortical muscle activation
5046493|NCT01438905|Spinal Muscle Activation|spinal muscle activation
5046494|NCT01438892|rheumatoid arthritis|rheumatoid arthritis
5046495|NCT01438892|therapy compliance|therapy compliance
5046496|NCT01438879|CSF|csf
5046497|NCT01438879|PCR|pcr
5046498|NCT01438879|lymphocytic herpesvirus|lymphocytic herpesvirus
5046499|NCT01438879|CNS|cns
5046500|NCT01438866|Dental caries|dental caries
5046501|NCT01438866|Fissure sealant|fissure sealant
5046502|NCT01438866|Fluoride varnish|fluoride varnish
5046503|NCT01438866|Primary molar|primary molar
5046504|NCT01438853|Sepsis|sepsis
5046505|NCT01438853|Acute Lung Injury|acute lung injury
5046506|NCT01438853|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
5046507|NCT01438853|ALI/ARDS|ali/ards
5046508|NCT01438853|Lung Disease|lung disease
5046509|NCT01438840|Chronic Immune Thrombocytopenia|chronic immune thrombocytopenia
5046510|NCT01438788|Bethlem myopathy|bethlem myopathy
5046511|NCT01438788|Ullrich congenital muscular dystrophy|ullrich congenital muscular dystrophy
5046512|NCT01438788|Low protein diet|low protein diet
5046513|NCT01438788|Autophagy|autophagy
5046514|NCT01438788|Pilot clinical trial|pilot clinical trial
5046515|NCT01438775|Benign prostatic hyperplasia|benign prostatic hyperplasia
5046516|NCT01438775|BPH|bph
5046517|NCT01438775|Enlarged prostate|enlarged prostate
5046518|NCT01438775|Lower urinary tract symptoms|lower urinary tract symptoms
5046519|NCT01438775|LUTS|luts
5046520|NCT01438775|LUTS secondary to BPH|luts secondary to bph
5046521|NCT01438775|LUTS/BPH|luts/bph
5046522|NCT01438775|Benign prostatic obstruction|benign prostatic obstruction
5046523|NCT01438775|BPO|bpo
5046524|NCT01438775|Bladder outlet obstruction|bladder outlet obstruction
5046525|NCT01438775|BOO|boo
5046526|NCT01438762|Anterior Knee Pain|anterior knee pain
5046527|NCT01438736|Focus:|focus:
5046528|NCT01438736|preceding|preceding
5046529|NCT01438736|desogestrel predicts|desogestrel predicts
5046530|NCT01438736|pattern of following|pattern of following
5046531|NCT01438736|etonogestrel implant|etonogestrel implant
5046532|NCT01438723|ischemia reperfusion injury|ischemia reperfusion injury
5046533|NCT01438723|CABG|cabg
5046534|NCT01438723|metformin|metformin
5046535|NCT01438723|Hs-troponin-I|hs-troponin-i
5046536|NCT01438697|sleep|sleep
5046537|NCT01438697|insomnia|insomnia
5046538|NCT01438697|internet|internet
5046539|NCT01438697|CBT|cbt
5046540|NCT01438684|chronic vegetative state|chronic vegetative state
5046541|NCT01438684|functional MRI|functional mri
5046542|NCT01438671|WiiFit|wiifit
5046543|NCT01438671|Standing Balance|standing balance
5046544|NCT01438671|Neurological Population|neurological population
5046545|NCT01438658|uveal melanoma|uveal melanoma
5046546|NCT01438658|metastatic uveal melanoma|metastatic uveal melanoma
5046547|NCT01438645|Colonoscopy|colonoscopy
5046548|NCT01438645|Colon cancer screening|colon cancer screening
5046549|NCT01438632|Insulin action|insulin action
5046550|NCT01438632|Jet injector|jet injector
5046551|NCT01438632|Diabetes Mellitus|diabetes mellitus
5046552|NCT01438632|Pharmacodynamics|pharmacodynamics
5046553|NCT01438632|Pharmacokinetics|pharmacokinetics
5046554|NCT01438632|Insulin analogs|insulin analogs
5046555|NCT01438632|Insulin aspart|insulin aspart
5046556|NCT01438619|sodium|sodium
5046557|NCT01438619|blood pressure|blood pressure
5046558|NCT01438619|pulse wave velocity|pulse wave velocity
5046559|NCT01438619|random digit dialling|random digit dialling
5046560|NCT01438593|Stroke|stroke
5046561|NCT01438593|Brain disease|brain disease
5046562|NCT01438593|Ischemia|ischemia
5046563|NCT01438593|Cerebral infraction|cerebral infraction
5046564|NCT01438593|Cord Blood|cord blood
5046565|NCT01438580|atrial ﬁbrillation|atrial ﬁbrillation
5046566|NCT01438580|stroke|stroke
5046567|NCT01438580|warfarin|warfarin
5046568|NCT01438580|aspirin|aspirin
5046569|NCT01438567|oxycodone naloxone combination|oxycodone naloxone combination
5046570|NCT01438567|severe chronic and non-malignant pain|severe chronic and non-malignant pain
5046571|NCT01438567|Malignant and non-malignant pain that requires around-the clock opioid therapy|malignant and non-malignant pain that requires around-the clock opioid therapy
5046572|NCT01438567|Opioid related constipation|opioid related constipation
5046573|NCT01438541|No skin breakdown|no skin breakdown
5046574|NCT01438541|Prevention|prevention
5046575|NCT01438541|protection of the skin|protection of the skin
5046576|NCT01438528|Growth disorders|growth disorders
5046577|NCT01438528|Saizen|saizen
5046578|NCT01438528|Easypod|easypod
5046579|NCT01438528|Growth hormone|growth hormone
5046580|NCT01438528|Pediatric subject|pediatric subject
5046581|NCT01438515|MRSA|mrsa
5046582|NCT01438515|doxycycline|doxycycline
5046583|NCT01438515|rifampin|rifampin
5046584|NCT01438515|mupirocin|mupirocin
5046585|NCT01438515|chlorhexidine gluconate|chlorhexidine gluconate
5046586|NCT01438515|decolonization|decolonization
5046587|NCT01438515|methicillin-resistant staphylococcus aureus|methicillin-resistant staphylococcus aureus
5046588|NCT01438502|cardiac surgery|cardiac surgery
5046589|NCT01438502|cardio-pulmonary-bypass|cardio-pulmonary-bypass
5046590|NCT01438489|MEDI-546|medi-546
5046591|NCT01438489|Anifrolumab|anifrolumab
5046592|NCT01438489|Systemic Lupus Erythematosus|systemic lupus erythematosus
5046593|NCT01438476|Liver Cancer|liver cancer
5046594|NCT01438476|Pancreatic Cancer|pancreatic cancer
5046595|NCT01438476|Thoracic epidural analgesia|thoracic epidural analgesia
5046596|NCT01438476|TEA|tea
5046597|NCT01438476|Intravenous patient-controlled analgesia|intravenous patient-controlled analgesia
5046598|NCT01438476|IVPCA|ivpca
5046599|NCT01438476|Pain control|pain control
5046600|NCT01438476|Quality of life|quality of life
5046601|NCT01438476|QOL|qol
5046602|NCT01438476|Surgical resection|surgical resection
5046603|NCT01438463|non-seasonal allergy|non-seasonal allergy
5046604|NCT01438463|house dust mite|house dust mite
5046605|NCT01438463|immunotherapy|immunotherapy
5046606|NCT01438463|dose response|dose response
5046607|NCT01438450|Thalidomide|thalidomide
5046608|NCT01438450|Capecitabine|capecitabine
5046609|NCT01438450|Advanced hepatocellular carcinoma|advanced hepatocellular carcinoma
5046610|NCT01438450|Therapy|therapy
5046611|NCT01438450|Supportive care|supportive care
5046612|NCT01438437|Hepatocellular carcinoma|hepatocellular carcinoma
5046613|NCT01438437|Radiofrequency ablation|radiofrequency ablation
5046614|NCT01438437|Percutaneous acetic acid ablation|percutaneous acetic acid ablation
5046615|NCT01438437|Tumour response|tumour response
5046616|NCT01438411|Cholic Acid|cholic acid
5046617|NCT01438411|Inborn Error|inborn error
5046618|NCT01438411|Bile Acid Metabolism|bile acid metabolism
5046619|NCT01438411|Inborn Error of Bile Acid Synthesis|inborn error of bile acid synthesis
5046620|NCT01438398|Submucosal endoscopic myotomy|submucosal endoscopic myotomy
5046621|NCT01438398|Per Oral Endoscopic Myotomy|per oral endoscopic myotomy
5046622|NCT01438398|Natural Orifice Transluminal Endoscopic Surgery|natural orifice transluminal endoscopic surgery
5046623|NCT01438385|Pancreatico-biliary|pancreatico-biliary
5046624|NCT01438385|Biliary|biliary
5046625|NCT01438385|Bile Duct|bile duct
5046626|NCT01438385|Gastrointestinal disorder|gastrointestinal disorder
5046627|NCT01438385|Esophageal disorder|esophageal disorder
5046628|NCT01438372|Iron Deficiency Anemia|iron deficiency anemia
5046629|NCT01438372|Inflammatory Bowel Disease|inflammatory bowel disease
5046630|NCT01438372|Children|children
5046631|NCT01438359|Drug-drug interaction|drug-drug interaction
5046632|NCT01438359|Pharmacokinetics|pharmacokinetics
5046633|NCT01438359|PA21|pa21
5046634|NCT01438359|Drug Interaction Potentiation|drug interaction potentiation
5046635|NCT01438346|Substance Abuse|substance abuse
5046636|NCT01438346|Substance Addiction|substance addiction
5046637|NCT01438346|Substance Dependence|substance dependence
5046638|NCT01438346|Treatment program|treatment program
5046639|NCT01438333|Chronic Peridodontitis|chronic peridodontitis
5046640|NCT01438333|probiotics|probiotics
5046641|NCT01438333|lactobacillus brevis|lactobacillus brevis
5046642|NCT01438333|full mouth disinfection|full mouth disinfection
5046643|NCT01438320|Treatment naive|treatment naive
5046644|NCT01438320|Contraindications to standard therapies|contraindications to standard therapies
5046645|NCT01438320|Alternative hepatitis C therapy|alternative hepatitis c therapy
5046646|NCT01438307|Non-small cell lung cancer|non-small cell lung cancer
5046647|NCT01438307|Cabazitaxel-XRP6258|cabazitaxel-xrp6258
5046648|NCT01438307|P-glycoprotein|p-glycoprotein
5046649|NCT01438307|taxane|taxane
5046650|NCT01438307|Advanced NSCLC|advanced nsclc
5046651|NCT01438294|Asthma|asthma
5046652|NCT01438294|childhood|childhood
5046653|NCT01438294|exercise|exercise
5046654|NCT01438281|ocular pain|ocular pain
5046655|NCT01438281|dry eye|dry eye
5046656|NCT01438281|siRNA|sirna
5046657|NCT01438242|Major|major
5046658|NCT01438242|Depressive|depressive
5046659|NCT01438242|Disorder|disorder
5046660|NCT01438242|Depression|depression
5046661|NCT01438242|Treatment Resistant|treatment resistant
5046662|NCT01438229|Catheter-based renal artery ablation|catheter-based renal artery ablation
5046663|NCT01438229|Hypertension|hypertension
5046664|NCT01438229|Resistant to Conventional Therapy|resistant to conventional therapy
5046665|NCT01438216|Pharmacokinetics|pharmacokinetics
5046666|NCT01438216|Intensive Care|intensive care
5046667|NCT01438216|Candidemia|candidemia
5046668|NCT01438216|Invasive candidiasis|invasive candidiasis
5046669|NCT01438216|Anidulafungin|anidulafungin
5046670|NCT01438203|manipulation|manipulation
5046671|NCT01438203|mobilization|mobilization
5046672|NCT01438203|low back pain|low back pain
5046673|NCT01438203|treatment|treatment
5046674|NCT01438177|myeloma|myeloma
5046675|NCT01438177|multiple myeloma|multiple myeloma
5046676|NCT01438177|relapsed myeloma|relapsed myeloma
5046677|NCT01438177|refractory myeloma|refractory myeloma
5046678|NCT01438164|FDG-PET|fdg-pet
5046679|NCT01438164|cancer|cancer
5046680|NCT01438164|staging|staging
5046681|NCT01438164|Evaluate the cost impact in the evaluation of oncologic patients.|evaluate the cost impact in the evaluation of oncologic patients.
5046682|NCT01438151|Crohn's disease|crohn's disease
5046683|NCT01438151|Remicade|remicade
5046684|NCT01438151|infliximab|infliximab
5046685|NCT01438138|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
5046686|NCT01438138|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5046687|NCT01438138|untreated childhood acute myeloid leukemia and other myeloid malignancies|untreated childhood acute myeloid leukemia and other myeloid malignancies
5046688|NCT01438138|childhood acute basophilic leukemia|childhood acute basophilic leukemia
5046689|NCT01438138|childhood acute eosinophilic leukemia|childhood acute eosinophilic leukemia
5046690|NCT01438138|childhood acute erythroleukemia (M6)|childhood acute erythroleukemia (m6)
5046691|NCT01438138|childhood acute megakaryocytic leukemia (M7)|childhood acute megakaryocytic leukemia (m7)
5046692|NCT01438138|childhood acute monoblastic leukemia (M5a)|childhood acute monoblastic leukemia (m5a)
5046693|NCT01438138|childhood acute monocytic leukemia (M5b)|childhood acute monocytic leukemia (m5b)
5046694|NCT01438138|childhood acute myeloblastic leukemia with maturation (M2)|childhood acute myeloblastic leukemia with maturation (m2)
5046695|NCT01438138|childhood acute myeloblastic leukemia without maturation (M1)|childhood acute myeloblastic leukemia without maturation (m1)
5046696|NCT01438138|childhood acute myelomonocytic leukemia (M4)|childhood acute myelomonocytic leukemia (m4)
5046697|NCT01438138|childhood acute minimally differentiated myeloid leukemia (M0)|childhood acute minimally differentiated myeloid leukemia (m0)
5046698|NCT01438112|cancer|cancer
5046699|NCT01438112|bladder cancer|bladder cancer
5046700|NCT01438112|transitional cell|transitional cell
5046701|NCT01438112|virus|virus
5046702|NCT01438112|oncolytic|oncolytic
5046703|NCT01438112|GM-CSF|gm-csf
5046704|NCT01438112|adenovirus|adenovirus
5046705|NCT01438112|intravesical|intravesical
5046706|NCT01438112|neoadjuvant|neoadjuvant
5046707|NCT01438112|cystectomy|cystectomy
5046708|NCT01438112|gene therapy|gene therapy
5046709|NCT01438112|oncolytic virus|oncolytic virus
5046710|NCT01438112|carcinoma in situ|carcinoma in situ
5046711|NCT01438112|carcinoma in situ concurrent with papillary tumors|carcinoma in situ concurrent with papillary tumors
5046712|NCT01438099|epidural analgesia|epidural analgesia
5046713|NCT01438099|ultrasound|ultrasound
5046714|NCT01438099|labor analgesia|labor analgesia
5046715|NCT01438099|labor|labor
5046716|NCT01438086|Heart Failure|heart failure
5046717|NCT01438086|Myocardial Infarction|myocardial infarction
5046718|NCT01438047|Port Wine Stain|port wine stain
5046719|NCT01438021|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5046720|NCT01438008|Sucrose|sucrose
5046721|NCT01438008|Pain|pain
5046722|NCT01437995|Asthma|asthma
5046723|NCT01437995|Step down therapy|step down therapy
5046724|NCT01437995|Inhaled corticosteroids|inhaled corticosteroids
5046725|NCT01437995|Long-acting beta agonists|long-acting beta agonists
5046726|NCT01437995|Fluticasone Salmeterol|fluticasone salmeterol
5046727|NCT01437982|post-operative inflammation|post-operative inflammation
5046728|NCT01437982|conjunctivitis|conjunctivitis
5046729|NCT01437982|safety|safety
5046730|NCT01437982|Seasonal allergic conjunctivitis|seasonal allergic conjunctivitis
5046731|NCT01437982|Giant papillary conjunctivitis|giant papillary conjunctivitis
5046732|NCT01437969|Possible association|possible association
5046733|NCT01437969|between severity|between severity
5046734|NCT01437969|IL28B genetic variants|il28b genetic variants
5046735|NCT01437969|patients|patients
5046736|NCT01437969|different HCV genotypes|different hcv genotypes
5046737|NCT01437956|Calcineurin|calcineurin
5046738|NCT01437956|Bronchiolitis|bronchiolitis
5046739|NCT01437956|Epithelial lung injury|epithelial lung injury
5046740|NCT01437956|Rhinovirus|rhinovirus
5046741|NCT01437956|Respiratory Syncytial Virus|respiratory syncytial virus
5046742|NCT01437956|Asthma|asthma
5046743|NCT01437943|Transplant|transplant
5046744|NCT01437943|Failure|failure
5046745|NCT01437943|Kidney|kidney
5046746|NCT01437930|n-3 LC-PUFA|n-3 lc-pufa
5046747|NCT01437930|hypertriglyceridemic|hypertriglyceridemic
5046748|NCT01437930|human|human
5046749|NCT01437930|TAG|tag
5046750|NCT01437917|glycemic index|glycemic index
5046751|NCT01437904|Renal Calculi|renal calculi
5046752|NCT01437904|Percutaneous nephrolithotomy (PCNL)|percutaneous nephrolithotomy (pcnl)
5046753|NCT01437891|PTSD|ptsd
5046754|NCT01437891|Military veteran|military veteran
5046755|NCT01437891|Gulf War|gulf war
5046756|NCT01437891|Fibromyalgia|fibromyalgia
5046757|NCT01437891|Gulf War Syndrome|gulf war syndrome
5046758|NCT01437878|PH|ph
5046759|NCT01437878|COPD|copd
5046760|NCT01437865|MRI|mri
5046761|NCT01437865|lymph node metastases|lymph node metastases
5046762|NCT01437865|breast cancer|breast cancer
5046763|NCT01437865|gadofosveset|gadofosveset
5046764|NCT01437839|Food effect study|food effect study
5046765|NCT01437839|Pharmacokinetics|pharmacokinetics
5046766|NCT01437839|Apixaban|apixaban
5046767|NCT01437826|chemoprevention|chemoprevention
5046768|NCT01437826|colorectal cancer|colorectal cancer
5046769|NCT01437826|metachronous adenoma|metachronous adenoma
5046770|NCT01437826|randomized trial|randomized trial
5046771|NCT01437813|DM2|dm2
5046772|NCT01437813|glimepiride|glimepiride
5046773|NCT01437813|metformin extended release|metformin extended release
5046774|NCT01437800|DM2|dm2
5046775|NCT01437800|glimepiride|glimepiride
5046776|NCT01437800|metformin extended release|metformin extended release
5046777|NCT01437774|Acute ischemic stroke|acute ischemic stroke
5046778|NCT01437748|Small Airways|small airways
5046779|NCT01437748|Closing volume|closing volume
5046780|NCT01437748|Closing Capacity|closing capacity
5046781|NCT01437748|Tiotropium|tiotropium
5046782|NCT01437748|Indacaterol|indacaterol
5046783|NCT01437748|COPD|copd
5046784|NCT01437735|Asthma|asthma
5046785|NCT01437735|QAW039|qaw039
5046786|NCT01437722|BV|bv
5046787|NCT01437722|Bacterial vaginosis|bacterial vaginosis
5046788|NCT01437722|recurrent|recurrent
5046789|NCT01437722|SPL7013 Gel|spl7013 gel
5046790|NCT01437722|VivaGel|vivagel
5046791|NCT01437709|Bendamustine HCL|bendamustine hcl
5046792|NCT01437709|Ofatumumab (GSK 1841157)|ofatumumab (gsk 1841157)
5046793|NCT01437709|Immunotherapy|immunotherapy
5046794|NCT01437709|Chemoimmunotherapy|chemoimmunotherapy
5046795|NCT01437709|11-050|11-050
5046796|NCT01437696|Aging|aging
5046797|NCT01437696|Vitamin D|vitamin d
5046798|NCT01437696|Bone health|bone health
5046799|NCT01437696|Inflammation|inflammation
5046800|NCT01437696|Men|men
5046801|NCT01437683|Craniocerebral Trauma|craniocerebral trauma
5046802|NCT01437683|Quality of life|quality of life
5046803|NCT01437683|Long term outcome|long term outcome
5046804|NCT01437683|Activities of Daily Living|activities of daily living
5046805|NCT01437683|Cognitive Deficiency|cognitive deficiency
5046806|NCT01437683|Health Care Quality, Access, and Evaluation|health care quality, access, and evaluation
5046807|NCT01437644|Cerebral Palsy|cerebral palsy
5046808|NCT01437644|Hip displacement|hip displacement
5046809|NCT01437644|Hip surgery|hip surgery
5046810|NCT01437644|Post-operative pain|post-operative pain
5046811|NCT01437644|Botulinum Toxin|botulinum toxin
5046812|NCT01437631|colon polyp|colon polyp
5046813|NCT01437631|endoscopic polypectomy|endoscopic polypectomy
5046814|NCT01437631|postpolypectomy bleeding|postpolypectomy bleeding
5046815|NCT01437631|prophylactic clip application|prophylactic clip application
5046816|NCT01437605|Resected|resected
5046817|NCT01437605|Skin|skin
5046818|NCT01437605|Stage IV|stage iv
5046819|NCT01437579|interstitial cystitis|interstitial cystitis
5046820|NCT01437579|bladder pain syndrome|bladder pain syndrome
5046821|NCT01437579|intratrigonal injection|intratrigonal injection
5046822|NCT01437579|botulinum toxin|botulinum toxin
5046823|NCT01437553|IVUS|ivus
5046824|NCT01437553|iMAP|imap
5046825|NCT01437553|Catheterization|catheterization
5046826|NCT01437553|Acute Coronary Syndrome|acute coronary syndrome
5046827|NCT01437540|COPD|copd
5046828|NCT01437540|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5046829|NCT01437540|Chronic Bronchitis|chronic bronchitis
5046830|NCT01437540|Emphysema|emphysema
5046831|NCT01437540|Airflow Obstruction, Chronic|airflow obstruction, chronic
5046832|NCT01437540|Chronic Airflow Obstruction|chronic airflow obstruction
5046833|NCT01437540|Chronic Obstructive Airway Disease|chronic obstructive airway disease
5046834|NCT01437540|Chronic Obstructive Lung Disease|chronic obstructive lung disease
5046835|NCT01437527|anorexia nervosa|anorexia nervosa
5046836|NCT01437527|CMME-TCA Unit|cmme-tca unit
5046837|NCT01437527|Centre Hospitalier Sainte Anne|centre hospitalier sainte anne
5046838|NCT01437514|rectal cancer|rectal cancer
5046839|NCT01437514|Endosonography|endosonography
5046840|NCT01437514|preoperative short-course radiotherapy|preoperative short-course radiotherapy
5046841|NCT01437514|preoperative adjuvant therapy|preoperative adjuvant therapy
5046842|NCT01437514|neoadjuvant therapy|neoadjuvant therapy
5046843|NCT01437514|short-term high-dose preoperative radiotherapy|short-term high-dose preoperative radiotherapy
5046844|NCT01437514|total mesorectal excision|total mesorectal excision
5046845|NCT01437514|circumferential resection margin|circumferential resection margin
5046846|NCT01437514|local recurrence|local recurrence
5046847|NCT01437514|overall survival|overall survival
5046848|NCT01437514|metastasis|metastasis
5046849|NCT01437514|complication|complication
5046850|NCT01437501|glucoraphanin|glucoraphanin
5046851|NCT01437501|sulforaphane|sulforaphane
5046852|NCT01437501|pharmacokinetics|pharmacokinetics
5046853|NCT01437501|pharmacodynamics|pharmacodynamics
5046854|NCT01437501|broccoli sprout|broccoli sprout
5046855|NCT01437501|carcinogens, environment|carcinogens, environment
5046856|NCT01437488|Urothelial carcinoma|urothelial carcinoma
5046857|NCT01437488|Urothelial cancer|urothelial cancer
5046858|NCT01437475|HBV|hbv
5046859|NCT01437475|HIV|hiv
5046860|NCT01437475|Immunization|immunization
5046861|NCT01437475|HBV Immunization rate among HIV positive individuals|hbv immunization rate among hiv positive individuals
5046862|NCT01437462|Pain, Postoperative|pain, postoperative
5046863|NCT01437462|Anesthetics, intravenous|anesthetics, intravenous
5046864|NCT01437462|Anesthetics, inhalation|anesthetics, inhalation
5046865|NCT01437462|Otherwise healthy adults undergoing general anesthesia for gynecological disease.|otherwise healthy adults undergoing general anesthesia for gynecological disease.
5046866|NCT01437449|Quality of Life|quality of life
5046867|NCT01437436|otitis media|otitis media
5046868|NCT01437436|obesity|obesity
5046869|NCT01437436|ventilation tube|ventilation tube
5046870|NCT01437423|Diphtheria|diphtheria
5046871|NCT01437423|Tetanus|tetanus
5046872|NCT01437423|Pertussis|pertussis
5046873|NCT01437423|Poliomyelitis|poliomyelitis
5046874|NCT01437423|TETRAXIM™|tetraxim™
5046875|NCT01437397|COPD|copd
5046876|NCT01437397|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5046877|NCT01437397|Chronic Bronchitis|chronic bronchitis
5046878|NCT01437397|Emphysema|emphysema
5046879|NCT01437397|Airflow Obstruction, Chronic|airflow obstruction, chronic
5046880|NCT01437397|Chronic Airflow Obstruction|chronic airflow obstruction
5046881|NCT01437397|Chronic Obstructive Airway Disease|chronic obstructive airway disease
5046882|NCT01437397|Chronic Obstructive Lung Disease|chronic obstructive lung disease
5046883|NCT01437371|Heart failure|heart failure
5046884|NCT01437371|Aged and over 80|aged and over 80
5046885|NCT01437371|clinical trial|clinical trial
5046886|NCT01437371|quality of life|quality of life
5046887|NCT01437358|Epidural catheter|epidural catheter
5046888|NCT01437358|Epidural analgesia|epidural analgesia
5046889|NCT01437358|Intensive care unit|intensive care unit
5046890|NCT01437358|Safety|safety
5046891|NCT01437306|lofexidine|lofexidine
5046892|NCT01437306|food effect|food effect
5046893|NCT01437306|pharmacokinetics|pharmacokinetics
5046894|NCT01437306|healthy volunteer|healthy volunteer
5046895|NCT01437293|cocaine|cocaine
5046896|NCT01437280|Tumors|tumors
5046897|NCT01437280|Solid Tumors|solid tumors
5046898|NCT01437254|99mTc Pertechnetate|99mtc pertechnetate
5046899|NCT01437254|thyroidectomy|thyroidectomy
5046900|NCT01437241|HIV-infection|hiv-infection
5046901|NCT01437241|Etravirine|etravirine
5046902|NCT01437241|Treatment|treatment
5046903|NCT01437241|Non-nucleoside reverse-transcriptase inhibitor|non-nucleoside reverse-transcriptase inhibitor
5046904|NCT01437215|aneurysm|aneurysm
5046905|NCT01437215|renal stent|renal stent
5046906|NCT01437215|juxtarenal|juxtarenal
5046907|NCT01437215|pararenal|pararenal
5046908|NCT01437202|imatinib|imatinib
5046909|NCT01437202|drug resistance|drug resistance
5046910|NCT01437202|pharmacogenetics|pharmacogenetics
5046911|NCT01437189|Parkinson's disease|parkinson's disease
5046912|NCT01437189|depression|depression
5046913|NCT01437189|sertraline|sertraline
5046914|NCT01437189|intervention|intervention
5046915|NCT01437176|surgery|surgery
5046916|NCT01437176|fixation|fixation
5046917|NCT01437176|intramedullary nail|intramedullary nail
5046918|NCT01437150|surgery|surgery
5046919|NCT01437150|fixation|fixation
5046920|NCT01437150|bone plate|bone plate
5046921|NCT01437137|elective surgery of short duration (less than 2 hr) undergoing general anesthesia using supraglottic airway|elective surgery of short duration (less than 2 hr) undergoing general anesthesia using supraglottic airway
5046922|NCT01437111|Osteoporosis|osteoporosis
5046923|NCT01437111|Postmenopausal|postmenopausal
5046924|NCT01437098|Valvular Heart Disease|valvular heart disease
5046925|NCT01437098|Severe Aortic Stenosis|severe aortic stenosis
5046926|NCT01437098|Aortic Valve Replacement|aortic valve replacement
5046927|NCT01437085|Needle deflection|needle deflection
5046928|NCT01437085|Prostate Deformation|prostate deformation
5046929|NCT01437085|Prostate Brachytherapy|prostate brachytherapy
5046930|NCT01437085|Needles|needles
5046931|NCT01437046|Alcohol drinking|alcohol drinking
5046932|NCT01437046|Alcohol craving|alcohol craving
5046933|NCT01437033|Breath Tests|breath tests
5046934|NCT01437033|Human Volunteers|human volunteers
5046935|NCT01437033|Pilot Study|pilot study
5046936|NCT01437033|Breath Test|breath test
5046937|NCT01437020|IL-10|il-10
5046938|NCT01437020|Leishmaniasis|leishmaniasis
5046939|NCT01437020|Immunotherapy|immunotherapy
5046940|NCT01437007|SNALP|snalp
5046941|NCT01437007|Regional Therapy|regional therapy
5046942|NCT01437007|Stage IV Disease|stage iv disease
5046943|NCT01437007|Adenocarcinoma|adenocarcinoma
5046944|NCT01437007|Unresectable|unresectable
5046945|NCT01437007|Liver Metastases|liver metastases
5046946|NCT01437007|Colorectal Cancer|colorectal cancer
5046947|NCT01437007|Stomach Cancer|stomach cancer
5046948|NCT01437007|Gastric Cancer|gastric cancer
5046949|NCT01437007|Breast Cancer|breast cancer
5046950|NCT01437007|Ovarian Cancer|ovarian cancer
5046951|NCT01437007|Pancreatic Cancer|pancreatic cancer
5046952|NCT01437007|Liver Cancer|liver cancer
5046953|NCT01436994|thyrotoxic|thyrotoxic
5046954|NCT01436994|thyrotoxicosis|thyrotoxicosis
5046955|NCT01436994|paediatric|paediatric
5046956|NCT01436994|endocrinology|endocrinology
5046957|NCT01436994|block and replace|block and replace
5046958|NCT01436994|dose titration|dose titration
5046959|NCT01436994|carbimazole|carbimazole
5046960|NCT01436981|papaverine|papaverine
5046961|NCT01436981|pharmacokinetic|pharmacokinetic
5046962|NCT01436981|CABG|cabg
5046963|NCT01436981|Injury of Internal Mammary Artery|injury of internal mammary artery
5046964|NCT01436981|Complications Due to Coronary Artery Bypass Graft|complications due to coronary artery bypass graft
5046965|NCT01436968|immunotherapy, cytotoxicity, tumor vaccine, prostate cancer, radiotherapy|immunotherapy, cytotoxicity, tumor vaccine, prostate cancer, radiotherapy
5046966|NCT01436929|silymarin|silymarin
5046967|NCT01436929|hepatotoxicity|hepatotoxicity
5046968|NCT01436929|tuberculosis|tuberculosis
5046969|NCT01436929|HREZ|hrez
5046970|NCT01436916|prediabetes|prediabetes
5046971|NCT01436916|oral cholecalciferol|oral cholecalciferol
5046972|NCT01436903|menorrhagia|menorrhagia
5046973|NCT01436903|dysfunctional uterine bleeding|dysfunctional uterine bleeding
5046974|NCT01436903|endometrial ablation|endometrial ablation
5046975|NCT01436903|cavatermTM|cavatermtm
5046976|NCT01436903|probe|probe
5046977|NCT01436890|Chronic Persistent Asthma|chronic persistent asthma
5046978|NCT01436877|BPH|bph
5046979|NCT01436877|bladder neck obstruction|bladder neck obstruction
5046980|NCT01436877|Bladder neck obstruction secondary to BPH|bladder neck obstruction secondary to bph
5046981|NCT01436864|Recombinant Human VEGF Receptor-Fc Fusion Protein (KH902|recombinant human vegf receptor-fc fusion protein (kh902
5046982|NCT01436864|)|)
5046983|NCT01436864|age-related macular degeneration (AMD)|age-related macular degeneration (amd)
5046984|NCT01436864|choroidal neovascularization (CNV)|choroidal neovascularization (cnv)
5046985|NCT01436864|intravitreal injection|intravitreal injection
5046986|NCT01436864|best corrected visual acuity (BCVA)|best corrected visual acuity (bcva)
5046987|NCT01436864|central retinal thickness|central retinal thickness
5046988|NCT01436851|rhinitis|rhinitis
5046989|NCT01436851|allergy|allergy
5046990|NCT01436851|occupational|occupational
5046991|NCT01436851|storage mites|storage mites
5046992|NCT01436851|nasal lavage|nasal lavage
5046993|NCT01436851|challenge test|challenge test
5046995|NCT01436851|alfa2Macroglobuline|alfa2macroglobuline
5046996|NCT01436838|Relapsing-Remitting Multiple Sclerosis|relapsing-remitting multiple sclerosis
5046997|NCT01436838|Secondary Progressive Multiple Sclerosis|secondary progressive multiple sclerosis
5046998|NCT01436825|Haemophilia A|haemophilia a
5046999|NCT01436825|Factor VIII|factor viii
5047000|NCT01436825|Pharmacokinetic|pharmacokinetic
5047001|NCT01436825|Computer Tool validation|computer tool validation
5047002|NCT01436812|cerebral oxymetry|cerebral oxymetry
5047003|NCT01436812|laparoscopy|laparoscopy
5047004|NCT01436812|PEEP|peep
5047005|NCT01436799|propofol|propofol
5047006|NCT01436799|desflurane|desflurane
5047007|NCT01436799|cerebrovascular circulation|cerebrovascular circulation
5047008|NCT01436799|sitting|sitting
5047009|NCT01436786|cytokines|cytokines
5047010|NCT01436786|Guided imagery|guided imagery
5047011|NCT01436760|IBS|ibs
5047012|NCT01436747|Kidney transplantation|kidney transplantation
5047013|NCT01436747|Proteinuria|proteinuria
5047014|NCT01436747|Albuminuria|albuminuria
5047015|NCT01436747|Vitamin D|vitamin d
5047016|NCT01436747|Paricalcitol|paricalcitol
5047017|NCT01436721|Effectiveness|effectiveness
5047018|NCT01436721|Device success|device success
5047019|NCT01436721|Hepatectomy|hepatectomy
5047020|NCT01436708|pelvic organ prolapse|pelvic organ prolapse
5047021|NCT01436708|urinary symptoms|urinary symptoms
5047022|NCT01436708|sexual function|sexual function
5047023|NCT01436695|seizure early detection|seizure early detection
5047024|NCT01436682|Nerve Blocks|nerve blocks
5047025|NCT01436656|BRAF mutant,|braf mutant,
5047026|NCT01436656|BRAF mutated,|braf mutated,
5047027|NCT01436656|melanoma,|melanoma,
5047028|NCT01436656|metastatic,|metastatic,
5047029|NCT01436656|advanced,|advanced,
5047030|NCT01436656|RAF kinase inhibitor|raf kinase inhibitor
5047031|NCT01436656|BRAF V600 mutation|braf v600 mutation
5047032|NCT01436643|Depression|depression
5047033|NCT01436643|Multiple Sclerosis|multiple sclerosis
5047034|NCT01436643|Fingolimod|fingolimod
5047035|NCT01436643|Venlafaxine|venlafaxine
5047036|NCT01436643|Fluoxetine|fluoxetine
5047037|NCT01436630|Exercise Tolerance|exercise tolerance
5047038|NCT01436630|Step Test|step test
5047039|NCT01436630|Stroke|stroke
5047040|NCT01436630|Walking|walking
5047041|NCT01436617|cancer|cancer
5047042|NCT01436617|colon|colon
5047043|NCT01436617|Head and neck|head and neck
5047044|NCT01436617|cetuximab|cetuximab
5047045|NCT01436617|anti-cetuximab dosage|anti-cetuximab dosage
5047046|NCT01436604|cardiac MRI|cardiac mri
5047047|NCT01436604|Cancer|cancer
5047048|NCT01436604|Breast|breast
5047049|NCT01436604|Herceptin|herceptin
5047050|NCT01436604|LV dysfunction|lv dysfunction
5047051|NCT01436591|Cancer|cancer
5047052|NCT01436591|Breast|breast
5047053|NCT01436591|18FDG|18fdg
5047054|NCT01436591|Axillary|axillary
5047055|NCT01436591|Positron Emission Tomography|positron emission tomography
5047056|NCT01436552|MCI|mci
5047057|NCT01436552|Depression|depression
5047058|NCT01436552|Alzheimer|alzheimer
5047059|NCT01436552|Life events|life events
5047060|NCT01436526|Bioequivalence|bioequivalence
5047061|NCT01436513|bioequivalence|bioequivalence
5047062|NCT01436513|menometrorrhagia|menometrorrhagia
5047063|NCT01436513|climacteric disturbance|climacteric disturbance
5047064|NCT01436513|Estrogen Replacement Therapy|estrogen replacement therapy
5047065|NCT01436513|Estrogens Conjugated|estrogens conjugated
5047066|NCT01436500|Hepatorenal Syndrome|hepatorenal syndrome
5047067|NCT01436500|HRS|hrs
5047068|NCT01436500|ifetroban|ifetroban
5047069|NCT01436487|ischemic stroke|ischemic stroke
5047070|NCT01436487|adult stem cells|adult stem cells
5047071|NCT01436474|Varenicline|varenicline
5047072|NCT01436474|Chantix|chantix
5047073|NCT01436474|Chronic Pain|chronic pain
5047074|NCT01436474|Opioid dependence|opioid dependence
5047075|NCT01436448|efficacy|efficacy
5047076|NCT01436448|Lactobacillus Rhamnosus|lactobacillus rhamnosus
5047077|NCT01436448|glucose intolerance|glucose intolerance
5047078|NCT01436448|feasibility|feasibility
5047079|NCT01436448|compliance and safety|compliance and safety
5047080|NCT01436448|reducing glucose intolerance during and after pregnancy|reducing glucose intolerance during and after pregnancy
5047081|NCT01436435|PAD|pad
5047082|NCT01436435|peripheral artery disease|peripheral artery disease
5047083|NCT01436435|atherectomy|atherectomy
5047084|NCT01436422|Dengue Virus|dengue virus
5047085|NCT01436422|Dengue Fever|dengue fever
5047086|NCT01436422|Dengue Vaccine|dengue vaccine
5047087|NCT01436422|Dengue Hemorrhagic Fever|dengue hemorrhagic fever
5047088|NCT01436422|Dengue Shock Syndrome|dengue shock syndrome
5047089|NCT01436409|vaginal touch|vaginal touch
5047090|NCT01436409|deliveries assisted|deliveries assisted
5047091|NCT01436409|echography|echography
5047092|NCT01436409|assisted delivery|assisted delivery
5047093|NCT01436396|Dengue|dengue
5047094|NCT01436396|Dengue Hemorrhagic Fever|dengue hemorrhagic fever
5047095|NCT01436396|CYD Dengue Vaccines|cyd dengue vaccines
5047096|NCT01436396|Yellow Fever|yellow fever
5047097|NCT01436396|Stamaril®|stamaril®
5047098|NCT01436396|Flavivirus Infections|flavivirus infections
5047099|NCT01436383|high altitude|high altitude
5047100|NCT01436383|hypobaric hypoxia|hypobaric hypoxia
5047101|NCT01436383|metabolomics|metabolomics
5047102|NCT01436383|oxidative stress|oxidative stress
5047103|NCT01436383|acute mountain sickness|acute mountain sickness
5047104|NCT01436370|influenza, rheumatoid arthritis, TNF-alpha-inhibitor, Fluzone®, Fluzone® High Dose|influenza, rheumatoid arthritis, tnf-alpha-inhibitor, fluzone®, fluzone® high dose
5047105|NCT01436357|AdCh3NSmut1|adch3nsmut1
5047106|NCT01436357|Hepatitis C|hepatitis c
5047107|NCT01436357|MVA-NSmut|mva-nsmut
5047108|NCT01436357|vaccine|vaccine
5047109|NCT01436344|esophageal electrocardiography|esophageal electrocardiography
5047110|NCT01436344|electrocardiography|electrocardiography
5047111|NCT01436344|atrial electrogram|atrial electrogram
5047112|NCT01436344|atrial function, left|atrial function, left
5047113|NCT01436331|First episode psychosis|first episode psychosis
5047114|NCT01436331|Early Psychosis|early psychosis
5047115|NCT01436331|Cognitive Behavioural therapy|cognitive behavioural therapy
5047116|NCT01436331|Psychosocial Intervention|psychosocial intervention
5047117|NCT01436331|Assertive Community treatment|assertive community treatment
5047118|NCT01436331|Family Intervention|family intervention
5047119|NCT01436331|Mental Disorders|mental disorders
5047120|NCT01436331|Psychotic Disorders|psychotic disorders
5047121|NCT01436331|Schizophrenia and Disorders with Psychotic Features|schizophrenia and disorders with psychotic features
5047122|NCT01436331|Affective Disorders, Psychotic|affective disorders, psychotic
5047123|NCT01436318|Healthy Kids|healthy kids
5047124|NCT01436318|Respiratory|respiratory
5047125|NCT01436318|Volunteers|volunteers
5047126|NCT01436305|immunosuppressive (IS) regimens|immunosuppressive (is) regimens
5047127|NCT01436305|long-term graft function|long-term graft function
5047128|NCT01436305|CNI (calcineurin Inhibitor )-free IS regimen|cni (calcineurin inhibitor )-free is regimen
5047129|NCT01436305|CNI (calcineurin Inhibitor ) IS regimen|cni (calcineurin inhibitor ) is regimen
5047130|NCT01436305|corticosteroids|corticosteroids
5047131|NCT01436292|Hypoalbuminemia|hypoalbuminemia
5047132|NCT01436292|Burns|burns
5047133|NCT01436292|Albumin|albumin
5047134|NCT01436292|Organ dysfunction|organ dysfunction
5047135|NCT01436292|Outcome|outcome
5047136|NCT01436240|Patient-Reported Outcomes|patient-reported outcomes
5047137|NCT01436240|Common Terminology Criteria for Adverse Events|common terminology criteria for adverse events
5047138|NCT01436240|PRO-CTCAE|pro-ctcae
5047139|NCT01436240|Native Spanish Speaking|native spanish speaking
5047140|NCT01436240|Spanish Translation|spanish translation
5047141|NCT01436240|Cognitive Interview|cognitive interview
5047142|NCT01436240|Questionnaire|questionnaire
5047143|NCT01436240|11-133|11-133
5047144|NCT01436240|Adverse Events|adverse events
5047145|NCT01436240|chemotherapy|chemotherapy
5047146|NCT01436240|radiation therapy|radiation therapy
5047147|NCT01436240|treatment in previous 6 months|treatment in previous 6 months
5047148|NCT01436227|Von Hippel-Lindau Syndrome|von hippel-lindau syndrome
5047149|NCT01436227|VHL|vhl
5047150|NCT01436227|Von Hippel-Lindau related lesion|von hippel-lindau related lesion
5047151|NCT01436227|Pazopanib|pazopanib
5047152|NCT01436227|GW786034|gw786034
5047153|NCT01436188|Biological Markers|biological markers
5047154|NCT01436188|Healthy Volunteer|healthy volunteer
5047155|NCT01436188|Alzheimer's Disease (AD)|alzheimer's disease (ad)
5047156|NCT01436188|Mild Cognitive Impairment (MCI)|mild cognitive impairment (mci)
5047157|NCT01436188|Cerebrospinal fluid (CSF)|cerebrospinal fluid (csf)
5047158|NCT01436188|CSF proteins|csf proteins
5047159|NCT01436136|Cardiovascular disease|cardiovascular disease
5047160|NCT01436136|HIV|hiv
5047161|NCT01436136|Antiretroviral treatment|antiretroviral treatment
5047162|NCT01436136|team interventions|team interventions
5047163|NCT01436136|Framingham risk score|framingham risk score
5047164|NCT01436123|Plasmonic Photothermal Therapy|plasmonic photothermal therapy
5047165|NCT01436123|Nanoparticles|nanoparticles
5047166|NCT01436123|Stem cells|stem cells
5047167|NCT01436123|Atherosclerosis|atherosclerosis
5047168|NCT01436123|Bioengineering|bioengineering
5047169|NCT01436123|Biodegradable stenting|biodegradable stenting
5047170|NCT01436123|Repair disease|repair disease
5047171|NCT01436097|Healthy Eating|healthy eating
5047172|NCT01436097|Health Behavior|health behavior
5047173|NCT01436097|Incentive|incentive
5047174|NCT01436097|Work-site|work-site
5047175|NCT01436084|Leukemia|leukemia
5047176|NCT01436084|Myelodysplastic syndrome|myelodysplastic syndrome
5047177|NCT01436084|MDS|mds
5047178|NCT01436084|SB1518|sb1518
5047179|NCT01436058|side effect|side effect
5047180|NCT01436058|mesenchymal stem cell|mesenchymal stem cell
5047181|NCT01436058|ankle|ankle
5047182|NCT01436058|osteoarthritis|osteoarthritis
5047183|NCT01436045|Memory|memory
5047184|NCT01436045|Insulin glulisine|insulin glulisine
5047185|NCT01436045|Alzheimer's Disease|alzheimer's disease
5047186|NCT01436019|Juvenile idiopathic arthritis|juvenile idiopathic arthritis
5047187|NCT01436019|Rheumatic diseases|rheumatic diseases
5047188|NCT01436019|Antibodies|antibodies
5047189|NCT01436019|Biological therapy|biological therapy
5047190|NCT01436006|MDCT|mdct
5047191|NCT01436006|radiation|radiation
5047192|NCT01436006|dose|dose
5047193|NCT01435993|Multiple Sclerosis, Secondary-Progressive with relapses|multiple sclerosis, secondary-progressive with relapses
5047194|NCT01435980|type 2 diabetes|type 2 diabetes
5047195|NCT01435980|Gastric Bypass|gastric bypass
5047196|NCT01435980|GLP-1|glp-1
5047197|NCT01435980|adiponectin|adiponectin
5047198|NCT01435967|Rotarix™|rotarix™
5047199|NCT01435967|Observational|observational
5047200|NCT01435967|ecological|ecological
5047201|NCT01435954|benign prostatic hyperplasia|benign prostatic hyperplasia
5047202|NCT01435954|surgery|surgery
5047203|NCT01435954|5-alpha-reductase inhibitor|5-alpha-reductase inhibitor
5047204|NCT01435954|enlarged prostate|enlarged prostate
5047205|NCT01435954|acute urinary retention|acute urinary retention
5047206|NCT01435941|mailed survey|mailed survey
5047207|NCT01435941|non-steroidal anti-inflammatory drug|non-steroidal anti-inflammatory drug
5047208|NCT01435941|migraine disorders|migraine disorders
5047209|NCT01435941|headache|headache
5047210|NCT01435928|Schizophrenia|schizophrenia
5047211|NCT01435928|Lurasidone|lurasidone
5047212|NCT01435928|Latuda|latuda
5047213|NCT01435902|exercise-induced bronchospasm|exercise-induced bronchospasm
5047214|NCT01435902|Activity/Exercise induced bronchospasm|activity/exercise induced bronchospasm
5047215|NCT01435902|asthma|asthma
5047216|NCT01435889|Acute respiratory distress syndrome|acute respiratory distress syndrome
5047217|NCT01435889|Children|children
5047218|NCT01435889|Long term respiratory sequelae|long term respiratory sequelae
5047219|NCT01435889|Pulmonary function tests|pulmonary function tests
5047220|NCT01435889|Computed tomography, lung|computed tomography, lung
5047221|NCT01435850|hip arthroplasty|hip arthroplasty
5047222|NCT01435850|primary stability|primary stability
5047223|NCT01435850|secondary stability|secondary stability
5047224|NCT01435850|EBRA|ebra
5047225|NCT01435837|Voice|voice
5047226|NCT01435837|aerodynamics|aerodynamics
5047227|NCT01435837|acoustics|acoustics
5047228|NCT01435824|healthy adult volunteers|healthy adult volunteers
5047229|NCT01435824|comparative bioavailability|comparative bioavailability
5047230|NCT01435824|amoxicillin|amoxicillin
5047231|NCT01435824|breast milk|breast milk
5047232|NCT01435824|Amoxicillin Bioavailability in breast milk|amoxicillin bioavailability in breast milk
5047233|NCT01435811|Norovirus|norovirus
5047234|NCT01435798|chronic pain|chronic pain
5047235|NCT01435798|central neuropathic pain|central neuropathic pain
5047236|NCT01435798|spinal cord injury|spinal cord injury
5047237|NCT01435798|dextromethorphan|dextromethorphan
5047238|NCT01435798|lidocaine|lidocaine
5047239|NCT01435798|combination therapy|combination therapy
5047240|NCT01435798|analgesia|analgesia
5047241|NCT01435785|PKPD|pkpd
5047242|NCT01435785|Propofol|propofol
5047243|NCT01435785|TCI|tci
5047244|NCT01435785|Elderly patients|elderly patients
5047245|NCT01435746|liver transplantation|liver transplantation
5047246|NCT01435746|intensive care|intensive care
5047247|NCT01435746|red blood cell transfusion|red blood cell transfusion
5047248|NCT01435733|ASD|asd
5047249|NCT01435733|Divorce|divorce
5047250|NCT01435720|Multiple myeloma|multiple myeloma
5047251|NCT01435720|B cell lymphoma|b cell lymphoma
5047252|NCT01435720|Hematologic disease|hematologic disease
5047253|NCT01435720|Blood protein disorder|blood protein disorder
5047254|NCT01435720|Neoplasm, plasma cell|neoplasm, plasma cell
5047255|NCT01435720|Mantle Cell Lymphoma|mantle cell lymphoma
5047256|NCT01435720|Diffuse Large B Cell Lymphoma|diffuse large b cell lymphoma
5047257|NCT01435720|Plasma Cell Leukemia|plasma cell leukemia
5047258|NCT01435720|B cell malignancy|b cell malignancy
5047259|NCT01435707|epidural steroid injection|epidural steroid injection
5047260|NCT01435707|triamcinolone|triamcinolone
5047261|NCT01435707|fasting blood glucose|fasting blood glucose
5047262|NCT01435707|diabetes mellitus|diabetes mellitus
5047263|NCT01435694|multiple sclerosis|multiple sclerosis
5047264|NCT01435694|gait rehabilitation|gait rehabilitation
5047265|NCT01435681|DYT-1|dyt-1
5047266|NCT01435681|DYT1|dyt1
5047267|NCT01435681|DYT 1|dyt 1
5047268|NCT01435681|dystonia|dystonia
5047269|NCT01435681|DBS|dbs
5047270|NCT01435681|deep brain stimulation|deep brain stimulation
5047271|NCT01435681|TMS|tms
5047272|NCT01435681|transcranial magnetic stimulation|transcranial magnetic stimulation
5047273|NCT01435668|alcohol|alcohol
5047274|NCT01435668|hazardous or harmful drinking|hazardous or harmful drinking
5047275|NCT01435668|emergency department (ED)|emergency department (ed)
5047276|NCT01435616|diabetes mellitus|diabetes mellitus
5047277|NCT01435616|type 2 diabetes mellitus|type 2 diabetes mellitus
5047278|NCT01435616|insulin naive|insulin naive
5047279|NCT01435616|insulin treatment|insulin treatment
5047280|NCT01435603|Prevention & Control|prevention & control
5047281|NCT01435603|Hyperglycemia|hyperglycemia
5047282|NCT01435603|Obesity|obesity
5047283|NCT01435603|Diabetes Mellitus|diabetes mellitus
5047284|NCT01435603|Cost Benefit Analysis|cost benefit analysis
5047285|NCT01435577|Bunionectomy|bunionectomy
5047286|NCT01435577|Postsurgical Pain|postsurgical pain
5047287|NCT01435577|Acute Pain|acute pain
5047288|NCT01435564|Mobile phone|mobile phone
5047289|NCT01435564|Sedentary lifestyle|sedentary lifestyle
5047290|NCT01435564|Physical activity|physical activity
5047291|NCT01435564|Prevention|prevention
5047292|NCT01435564|Health Promotion|health promotion
5047293|NCT01435564|Exercise|exercise
5047294|NCT01435564|eHealth|ehealth
5047295|NCT01435564|Electronic diary|electronic diary
5047296|NCT01435551|Alzheimer|alzheimer
5047297|NCT01435551|Dementia|dementia
5047298|NCT01435538|interprofessional teamwork|interprofessional teamwork
5047299|NCT01435538|care pathways|care pathways
5047300|NCT01435538|team communication|team communication
5047301|NCT01435538|team coordination|team coordination
5047302|NCT01435538|Chronic Obstructive Pulmonary Disease Teams|chronic obstructive pulmonary disease teams
5047303|NCT01435538|Proximal Femur Fracture Teams|proximal femur fracture teams
5047304|NCT01435525|triple therapy|triple therapy
5047305|NCT01435525|Helicobacter pylori|helicobacter pylori
5047306|NCT01435525|eradication|eradication
5047307|NCT01435525|Nexium|nexium
5047308|NCT01435512|PTSD|ptsd
5047309|NCT01435512|CBT|cbt
5047310|NCT01435512|Intimate Partner Violence|intimate partner violence
5047311|NCT01435512|Treatment|treatment
5047312|NCT01435499|immunotherapy|immunotherapy
5047313|NCT01435499|vaccine|vaccine
5047314|NCT01435499|GVAX|gvax
5047315|NCT01435499|GM-CSF|gm-csf
5047316|NCT01435486|caffeine|caffeine
5047317|NCT01435486|apnea|apnea
5047318|NCT01435486|bronchiolitis|bronchiolitis
5047319|NCT01435473|pediatrics|pediatrics
5047320|NCT01435473|thrombosis|thrombosis
5047321|NCT01435473|thromboembolic complications|thromboembolic complications
5047322|NCT01435473|pediatric cardiac surgery|pediatric cardiac surgery
5047323|NCT01435460|ocular allergy|ocular allergy
5047324|NCT01435447|efficacy|efficacy
5047325|NCT01435447|safety|safety
5047326|NCT01435447|conditioning|conditioning
5047327|NCT01435447|fludarabine|fludarabine
5047328|NCT01435447|busulfan|busulfan
5047329|NCT01435447|cyclophosphamide|cyclophosphamide
5047330|NCT01435447|adult|adult
5047331|NCT01435434|subjects sustaining Non union/delayed fractures and requiring surgical intervention for treatment|subjects sustaining non union/delayed fractures and requiring surgical intervention for treatment
5047332|NCT01435408|STEMI|stemi
5047333|NCT01435408|Ischemic postconditioning|ischemic postconditioning
5047334|NCT01435408|Deferred stenting|deferred stenting
5047335|NCT01435408|Primary PCI|primary pci
5047336|NCT01435382|PF-04950615|pf-04950615
5047337|NCT01435382|RN316|rn316
5047338|NCT01435356|Urinary Bladder neoplasms|urinary bladder neoplasms
5047339|NCT01435356|Lymphoproliferative Disorders|lymphoproliferative disorders
5047340|NCT01435356|Immune System Diseases|immune system diseases
5047341|NCT01435356|Cystectomy|cystectomy
5047342|NCT01435356|Adjuvants, Immunologic|adjuvants, immunologic
5047343|NCT01435356|Immunologic Factors|immunologic factors
5047344|NCT01435330|Safety|safety
5047345|NCT01435330|BVS857|bvs857
5047346|NCT01435330|insulin resistance|insulin resistance
5047347|NCT01435317|Acoustic CR®-neuromodulation|acoustic cr®-neuromodulation
5047348|NCT01435317|ANM T30 CR®-System|anm t30 cr®-system
5047349|NCT01435278|Weight maintenance|weight maintenance
5047350|NCT01435278|BMI|bmi
5047351|NCT01435278|Body weight|body weight
5047352|NCT01435278|Overweight|overweight
5047353|NCT01435278|Obesity|obesity
5047354|NCT01435278|Satiety|satiety
5047355|NCT01435265|Psoriasis|psoriasis
5047356|NCT01435265|Dermatology|dermatology
5047357|NCT01435265|Phase IV|phase iv
5047358|NCT01435265|Nurse Education|nurse education
5047359|NCT01435265|Adalimumab|adalimumab
5047360|NCT01435265|Humira|humira
5047361|NCT01435226|Hepatitis C|hepatitis c
5047362|NCT01435226|HCV|hcv
5047363|NCT01435226|Rapid Virologic Response|rapid virologic response
5047364|NCT01435226|Sustained Virologic Response|sustained virologic response
5047365|NCT01435226|Direct Acting Antiviral|direct acting antiviral
5047366|NCT01435226|Combination Therapy|combination therapy
5047367|NCT01435226|Tegobuvir|tegobuvir
5047368|NCT01435226|Treatment Experienced|treatment experienced
5047369|NCT01435226|HCV RNA|hcv rna
5047370|NCT01435226|Polymerase inhibitor|polymerase inhibitor
5047371|NCT01435226|Protease inhibitor|protease inhibitor
5047372|NCT01435226|Interferon intolerant|interferon intolerant
5047373|NCT01435226|Interferon ineligible|interferon ineligible
5047374|NCT01435226|GS-9190|gs-9190
5047375|NCT01435226|GS-9451|gs-9451
5047376|NCT01435226|GS-5885|gs-5885
5047377|NCT01435226|Chronic Genotype 1a or 1b|chronic genotype 1a or 1b
5047378|NCT01435213|alpha2-adrenoceptor|alpha2-adrenoceptor
5047379|NCT01435213|receptor occupancy|receptor occupancy
5047380|NCT01435213|positron emission tomography|positron emission tomography
5047381|NCT01435213|[11C]ORM-13070|[11c]orm-13070
5047382|NCT01435213|striatum|striatum
5047383|NCT01435213|brain|brain
5047384|NCT01435213|noradrenaline|noradrenaline
5047385|NCT01435213|norepinephrine|norepinephrine
5047386|NCT01435213|endogenous|endogenous
5047387|NCT01435213|binding|binding
5047388|NCT01435213|Validation studies|validation studies
5047389|NCT01435200|Intravenous iron|intravenous iron
5047390|NCT01435200|gynecologic cancer blood transfusion|gynecologic cancer blood transfusion
5047391|NCT01435174|ranolazine|ranolazine
5047392|NCT01435174|end-stage renal disease|end-stage renal disease
5047393|NCT01435174|pharmacokinetics|pharmacokinetics
5047394|NCT01435174|cardiovascular disease|cardiovascular disease
5047395|NCT01435161|paroxysmal atrial fibrillation, hypertension|paroxysmal atrial fibrillation, hypertension
5047396|NCT01435148|Deep Brain Stimulation|deep brain stimulation
5047397|NCT01435148|Treatment Resistant Depression|treatment resistant depression
5047398|NCT01435122|progressive advanced carcinoid tumors|progressive advanced carcinoid tumors
5047399|NCT01435122|advanced|advanced
5047400|NCT01435122|unresectable|unresectable
5047401|NCT01435122|metastatic|metastatic
5047402|NCT01435122|cancerous tumors|cancerous tumors
5047403|NCT01435122|neuroendocrine|neuroendocrine
5047404|NCT01435122|digestive tract|digestive tract
5047405|NCT01435122|lungs|lungs
5047406|NCT01435122|renal|renal
5047407|NCT01435122|ovarian|ovarian
5047408|NCT01435122|thymic|thymic
5047409|NCT01435122|hepatic|hepatic
5047410|NCT01435109|Osteoarthritis|osteoarthritis
5047411|NCT01435109|Exercise|exercise
5047412|NCT01435109|Diet|diet
5047413|NCT01435109|Coping Skills|coping skills
5047414|NCT01435109|Education, Medical|education, medical
5047415|NCT01435083|Nocturia|nocturia
5047416|NCT01435070|Colles' fracture|colles' fracture
5047417|NCT01435070|Radius fracture|radius fracture
5047418|NCT01435070|grip strength|grip strength
5047419|NCT01435070|pinch strength|pinch strength
5047420|NCT01435070|range of movement|range of movement
5047421|NCT01435070|PRWE|prwe
5047422|NCT01435070|DASH|dash
5047423|NCT01435070|EQ-5D|eq-5d
5047424|NCT01435070|Kirschner wire|kirschner wire
5047425|NCT01435070|Volar locking plate|volar locking plate
5047426|NCT01435057|Abdominal Obesity|abdominal obesity
5047427|NCT01435057|training|training
5047428|NCT01435057|fat|fat
5047429|NCT01435057|insulin|insulin
5047430|NCT01435057|glucose|glucose
5047431|NCT01435057|diet|diet
5047432|NCT01435044|Hepatitis C|hepatitis c
5047433|NCT01435044|Chronic|chronic
5047434|NCT01435044|HCV|hcv
5047435|NCT01435031|Angioplasty|angioplasty
5047436|NCT01435031|Chronic Total Occlusion (CTO)|chronic total occlusion (cto)
5047437|NCT01435031|Chronic total coronary occlusions|chronic total coronary occlusions
5047438|NCT01435031|Coronary Artery Disease (CAD)|coronary artery disease (cad)
5047439|NCT01435031|Coronary artery stenosis|coronary artery stenosis
5047440|NCT01435031|Total coronary occlusion|total coronary occlusion
5047441|NCT01435005|Prevention and control|prevention and control
5047442|NCT01435005|Exercise|exercise
5047443|NCT01435005|Sedentary lifestyle|sedentary lifestyle
5047444|NCT01435005|Biological markers|biological markers
5047445|NCT01434966|Lumbopelvic Manipulation|lumbopelvic manipulation
5047446|NCT01434966|Lumbosacral Manipulation|lumbosacral manipulation
5047447|NCT01434966|Sacroiliac Manipulation|sacroiliac manipulation
5047448|NCT01434966|TENS Spine|tens spine
5047449|NCT01434966|TENS Knee|tens knee
5047450|NCT01434966|Knee Pain|knee pain
5047451|NCT01434966|Chronic Knee Pain|chronic knee pain
5047452|NCT01434953|Prehypertension|prehypertension
5047453|NCT01434953|Blood pressure screening|blood pressure screening
5047454|NCT01434953|White coat effect|white coat effect
5047455|NCT01434940|Alzheimer disease|alzheimer disease
5047456|NCT01434940|Depression|depression
5047457|NCT01434940|Differential diagnosis|differential diagnosis
5047458|NCT01434940|Eye movement|eye movement
5047459|NCT01434914|Ulcus cruris|ulcus cruris
5047460|NCT01434914|chronic wounds|chronic wounds
5047461|NCT01434914|octenisept®|octenisept®
5047462|NCT01434901|Diabetes|diabetes
5047463|NCT01434901|Blood Sugar|blood sugar
5047464|NCT01434901|Xenin-25|xenin-25
5047465|NCT01434901|GIP|gip
5047466|NCT01434901|Muscarinic|muscarinic
5047467|NCT01434888|pharmacokinetics|pharmacokinetics
5047468|NCT01434862|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
5047469|NCT01434849|infantile hemangioma|infantile hemangioma
5047470|NCT01434849|very low birth weight infants|very low birth weight infants
5047471|NCT01434849|premature infants|premature infants
5047472|NCT01434836|Anti-depressant effects|anti-depressant effects
5047473|NCT01434823|nocturnal staffing|nocturnal staffing
5047474|NCT01434823|intensivist staffing|intensivist staffing
5047475|NCT01434823|intensivist coverage|intensivist coverage
5047476|NCT01434823|ICU patient-centered outcomes|icu patient-centered outcomes
5047477|NCT01434823|ICU resource utilization|icu resource utilization
5047478|NCT01434823|patients admitted to the medical intensive care unit|patients admitted to the medical intensive care unit
5047479|NCT01434823|Sleep Deprivation|sleep deprivation
5047480|NCT01434823|Inattention|inattention
5047481|NCT01434823|Work Hours|work hours
5047482|NCT01434810|Hyperbilirubinemia, Neonatal|hyperbilirubinemia, neonatal
5047483|NCT01434797|Infection|infection
5047484|NCT01434797|Permanent central venous catheter|permanent central venous catheter
5047485|NCT01434797|Device Related|device related
5047486|NCT01434784|lung cancer|lung cancer
5047487|NCT01434784|quality of life|quality of life
5047488|NCT01434758|Mycobacterium tuberculosis|mycobacterium tuberculosis
5047489|NCT01434758|Culture yield|culture yield
5047490|NCT01434745|SLOS|slos
5047616|NCT01434368|HV|hv
5047491|NCT01434745|Cholesterol Supplementation|cholesterol supplementation
5047492|NCT01434745|Simvastatin|simvastatin
5047493|NCT01434732|Superior vena cava flow|superior vena cava flow
5047494|NCT01434732|umbilical cord milking|umbilical cord milking
5047495|NCT01434732|hemodynamics|hemodynamics
5047496|NCT01434732|systemic blood flow|systemic blood flow
5047497|NCT01434719|Streptococcus suis|streptococcus suis
5047498|NCT01434719|Sepsis|sepsis
5047499|NCT01434719|Porcine Respiratory and Reproductive System virus|porcine respiratory and reproductive system virus
5047500|NCT01434719|Pig disease|pig disease
5047501|NCT01434719|Epidemiology|epidemiology
5047502|NCT01434706|HIV|hiv
5047503|NCT01434706|acute infection|acute infection
5047504|NCT01434706|primary infection|primary infection
5047505|NCT01434706|seroconverters|seroconverters
5047506|NCT01434693|T. suis ova|t. suis ova
5047507|NCT01434693|Crohn's disease|crohn's disease
5047508|NCT01434680|Meningococcal disease|meningococcal disease
5047509|NCT01434680|vaccines|vaccines
5047510|NCT01434680|toddlers|toddlers
5047511|NCT01434680|prevention|prevention
5047512|NCT01434680|Meningitis|meningitis
5047513|NCT01434667|Mild Cognitive Impairment (MCI)|mild cognitive impairment (mci)
5047514|NCT01434667|Alzheimer's disease (AD)|alzheimer's disease (ad)
5047515|NCT01434667|APOE|apoe
5047516|NCT01434667|genetics|genetics
5047517|NCT01434667|risk assessment|risk assessment
5047518|NCT01434667|education|education
5047519|NCT01434667|genetic counseling|genetic counseling
5047520|NCT01434667|Mild Cognitive Impairment, So Stated|mild cognitive impairment, so stated
5047521|NCT01434654|HAND|hand
5047522|NCT01434654|HIV|hiv
5047523|NCT01434654|Neurology|neurology
5047524|NCT01434654|Neurocognitive|neurocognitive
5047525|NCT01434654|Neuro-HAART|neuro-haart
5047526|NCT01434654|HIV Associated Neurocognitive Disorders (HAND)|hiv associated neurocognitive disorders (hand)
5047527|NCT01434641|myocardial perfusion SPECT|myocardial perfusion spect
5047528|NCT01434641|wide beam reconstruction|wide beam reconstruction
5047529|NCT01434641|Tc-99m sestamibi|tc-99m sestamibi
5047530|NCT01434628|Male Circumcision|male circumcision
5047531|NCT01434628|HIV Prevention|hiv prevention
5047532|NCT01434628|HIV Infections|hiv infections
5047533|NCT01434615|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
5047534|NCT01434615|Moderate to advanced|moderate to advanced
5047535|NCT01434615|patients|patients
5047536|NCT01434615|current consensus guidelines|current consensus guidelines
5047537|NCT01434602|Chemotherapy|chemotherapy
5047538|NCT01434602|Brain Tumor|brain tumor
5047539|NCT01434602|Glioblastoma|glioblastoma
5047540|NCT01434602|Anaplastic Glioma|anaplastic glioma
5047541|NCT01434589|internet addiction|internet addiction
5047542|NCT01434589|computer game addiction|computer game addiction
5047543|NCT01434589|STICA|stica
5047544|NCT01434589|short-term treatment|short-term treatment
5047545|NCT01434589|psychotherapy|psychotherapy
5047546|NCT01434589|internet and computer game addiction|internet and computer game addiction
5047547|NCT01434563|HIV|hiv
5047548|NCT01434563|neurocognitive disorder|neurocognitive disorder
5047549|NCT01434563|primary care|primary care
5047550|NCT01434563|HIV negative|hiv negative
5047551|NCT01434563|HAND|hand
5047552|NCT01434563|CNS|cns
5047553|NCT01434550|pancreas|pancreas
5047554|NCT01434550|pancreatic cancer|pancreatic cancer
5047555|NCT01434550|SBRT|sbrt
5047556|NCT01434550|stereotactic body radiation|stereotactic body radiation
5047557|NCT01434550|radiation therapy|radiation therapy
5047558|NCT01434550|unresectable|unresectable
5047559|NCT01434550|non-metastatic|non-metastatic
5047560|NCT01434550|tissue, blood, research imaging|tissue, blood, research imaging
5047561|NCT01434550|TBRI|tbri
5047562|NCT01434537|pediatric anesthesia|pediatric anesthesia
5047563|NCT01434537|venepuncture|venepuncture
5047564|NCT01434537|peripheral venous access|peripheral venous access
5047565|NCT01434511|hemophilia A|hemophilia a
5047566|NCT01434511|haemophilia A|haemophilia a
5047567|NCT01434511|blood coagulation disorders|blood coagulation disorders
5047568|NCT01434511|hemorrhagic disorders|hemorrhagic disorders
5047569|NCT01434511|coagulation protein disorder|coagulation protein disorder
5047570|NCT01434511|hematologic diseases|hematologic diseases
5047571|NCT01434511|congenital hemophilia A|congenital hemophilia a
5047572|NCT01434498|Hepatitis C|hepatitis c
5047573|NCT01434498|HCV|hcv
5047574|NCT01434498|Rapid Virologic Response|rapid virologic response
5047575|NCT01434498|Sustained Virologic Response|sustained virologic response
5047576|NCT01434498|Direct Acting Antiviral|direct acting antiviral
5047577|NCT01434498|Combination Therapy|combination therapy
5047578|NCT01434498|Tegobuvir|tegobuvir
5047579|NCT01434498|Treatment naïve|treatment naïve
5047580|NCT01434498|HCV RNA|hcv rna
5047581|NCT01434498|Polymerase inhibitor|polymerase inhibitor
5047582|NCT01434498|Protease inhibitor|protease inhibitor
5047583|NCT01434498|Interferon intolerant|interferon intolerant
5047584|NCT01434498|Interferon ineligible|interferon ineligible
5047585|NCT01434498|GS-9190|gs-9190
5047586|NCT01434498|GS-9451|gs-9451
5047587|NCT01434498|GS-5885|gs-5885
5047588|NCT01434485|gastric ulcer, duodenal ulcer, anastomotic ulcer, reflux oesophagitis, non-erosive reflux disease, Zollinger-Ellison syndrome, Nexium|gastric ulcer, duodenal ulcer, anastomotic ulcer, reflux oesophagitis, non-erosive reflux disease, zollinger-ellison syndrome, nexium
5047589|NCT01434459|Pancreatic neoplasms|pancreatic neoplasms
5047590|NCT01434459|Cholangiocarcinoma|cholangiocarcinoma
5047591|NCT01434420|triple negative breast cancer|triple negative breast cancer
5047592|NCT01434407|Advanced glycation endproducts|advanced glycation endproducts
5047593|NCT01434407|Satiety|satiety
5047594|NCT01434407|Obesity|obesity
5047595|NCT01434407|Inflammation|inflammation
5047596|NCT01434407|Insulin resistance|insulin resistance
5047597|NCT01434394|Oral cancer|oral cancer
5047598|NCT01434394|Oropharyngeal cancer|oropharyngeal cancer
5047599|NCT01434394|Induction chemotherapy|induction chemotherapy
5047600|NCT01434394|Targeted chemotherapy|targeted chemotherapy
5047601|NCT01434394|Surgery|surgery
5047602|NCT01434394|Radiotherapy|radiotherapy
5047603|NCT01434381|Recombinant|recombinant
5047604|NCT01434381|Proteins|proteins
5047605|NCT01434381|Antigen|antigen
5047606|NCT01434381|Membrane|membrane
5047607|NCT01434381|Assay|assay
5047608|NCT01434381|Malaria|malaria
5047609|NCT01434368|Functional Magnetic Resonance Imaging (fMRI)|functional magnetic resonance imaging (fmri)
5047610|NCT01434368|Normal Development|normal development
5047611|NCT01434368|Puberty|puberty
5047612|NCT01434368|Brain Function|brain function
5047613|NCT01434368|Gonadal Steroids|gonadal steroids
5047614|NCT01434368|Brain Structure|brain structure
5047615|NCT01434368|Healthy Volunteer|healthy volunteer
5047617|NCT01434342|stage IA non-small cell lung cancer|stage ia non-small cell lung cancer
5047618|NCT01434342|stage IB non-small cell lung cancer|stage ib non-small cell lung cancer
5047619|NCT01434342|stage IIA non-small cell lung cancer|stage iia non-small cell lung cancer
5047620|NCT01434342|stage IIB non-small cell lung cancer|stage iib non-small cell lung cancer
5047621|NCT01434342|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5047622|NCT01434342|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5047623|NCT01434342|limited stage small cell lung cancer|limited stage small cell lung cancer
5047624|NCT01434342|tobacco use disorder|tobacco use disorder
5047625|NCT01434342|Breast Cancer|breast cancer
5047626|NCT01434342|Cervical Cancer|cervical cancer
5047627|NCT01434342|head & neck cancer|head & neck cancer
5047628|NCT01434342|Prostate Cancer|prostate cancer
5047629|NCT01434342|All histologies|all histologies
5047630|NCT01434329|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
5047631|NCT01434290|radiation toxicity|radiation toxicity
5047632|NCT01434290|sexual dysfunction|sexual dysfunction
5047633|NCT01434290|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
5047634|NCT01434290|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5047635|NCT01434290|stage I prostate cancer|stage i prostate cancer
5047636|NCT01434290|stage IIA prostate cancer|stage iia prostate cancer
5047637|NCT01434277|Preservative|preservative
5047638|NCT01434277|Eye Drops|eye drops
5047639|NCT01434264|rehabilitation|rehabilitation
5047640|NCT01434251|Hypotension|hypotension
5047641|NCT01434251|premature infants|premature infants
5047642|NCT01434251|near infrared spectroscopy|near infrared spectroscopy
5047643|NCT01434238|infant feeding|infant feeding
5047644|NCT01434238|HIV|hiv
5047645|NCT01434238|growth|growth
5047646|NCT01434238|anemia|anemia
5047647|NCT01434225|Neonatal seizures|neonatal seizures
5047648|NCT01434225|Hypoxic Ischemic Encephalopathy|hypoxic ischemic encephalopathy
5047649|NCT01434225|Electroencephalography|electroencephalography
5047650|NCT01434225|Bumetanide|bumetanide
5047651|NCT01434212|HCV dynamics|hcv dynamics
5047652|NCT01434212|Mathematical model|mathematical model
5047653|NCT01434212|Interferon|interferon
5047654|NCT01434212|Predict|predict
5047655|NCT01434212|Hepatitis C Virus|hepatitis c virus
5047656|NCT01434199|magnetic endoscope imaging|magnetic endoscope imaging
5047657|NCT01434199|colonoscopy|colonoscopy
5047658|NCT01434199|caecal intubation|caecal intubation
5047659|NCT01434173|Liver Diseases|liver diseases
5047660|NCT01434173|Anti-Bacterial Agents|anti-bacterial agents
5047661|NCT01434173|Fluoroquinolones|fluoroquinolones
5047662|NCT01434173|Amoxicillin|amoxicillin
5047663|NCT01434173|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination
5047664|NCT01434173|Clarithromycin|clarithromycin
5047665|NCT01434173|Doxycycline|doxycycline
5047666|NCT01434173|Cefuroxime|cefuroxime
5047667|NCT01434173|Case-Control Studies|case-control studies
5047668|NCT01434173|Retrospective Studies|retrospective studies
5047669|NCT01434173|Cohort Studies|cohort studies
5047670|NCT01434173|Epidemiologic Research Design|epidemiologic research design
5047671|NCT01434173|Epidemiologic Studies|epidemiologic studies
5047672|NCT01434173|HealthCore Integrated Research Database (non-MESH)|healthcore integrated research database (non-mesh)
5047673|NCT01434173|United States|united states
5047674|NCT01434173|Human|human
5047675|NCT01434173|Insurance Claim Review|insurance claim review
5047676|NCT01434160|Intrauterine|intrauterine
5047677|NCT01434160|contraception|contraception
5047678|NCT01434160|adolescent|adolescent
5047679|NCT01434147|locally advanced rectal cancer|locally advanced rectal cancer
5047680|NCT01434147|preoperative induction chemotherapy chemoradiotherapy|preoperative induction chemotherapy chemoradiotherapy
5047681|NCT01434134|Anthracyclines|anthracyclines
5047682|NCT01434134|Trastuzumab|trastuzumab
5047683|NCT01434108|cirrhosis, gastrointestinal bleeding|cirrhosis, gastrointestinal bleeding
5047684|NCT01434095|microperimetry|microperimetry
5047685|NCT01434095|fixation point|fixation point
5047686|NCT01434095|retinal sensitivity|retinal sensitivity
5047687|NCT01434095|photodynamic therapy|photodynamic therapy
5047688|NCT01434095|chronic central serous chorioretinopathy|chronic central serous chorioretinopathy
5047689|NCT01434082|sleep|sleep
5047690|NCT01434082|school-age children|school-age children
5047691|NCT01434082|Children with and without arthritis|children with and without arthritis
5047692|NCT01434069|colon|colon
5047693|NCT01434069|rectum|rectum
5047694|NCT01434069|small bowel|small bowel
5047695|NCT01434069|pancreas|pancreas
5047696|NCT01434069|gastric|gastric
5047697|NCT01434069|esophageal|esophageal
5047698|NCT01434069|metastatic|metastatic
5047699|NCT01434069|unresectable|unresectable
5047700|NCT01434069|GI|gi
5047701|NCT01434069|combination therapy|combination therapy
5047702|NCT01434069|dose escalation|dose escalation
5047703|NCT01434069|solid tumor|solid tumor
5047704|NCT01434056|Liver disease|liver disease
5047705|NCT01434056|Hepatic encephalopathy|hepatic encephalopathy
5047706|NCT01434056|MELD|meld
5047707|NCT01434056|Liver transplantation|liver transplantation
5047708|NCT01434043|Cardiac CT perfusion|cardiac ct perfusion
5047709|NCT01434043|Positron emission tomography perfusion|positron emission tomography perfusion
5047710|NCT01434043|Quantitative perfusion|quantitative perfusion
5047711|NCT01434017|PONV|ponv
5047712|NCT01434017|Dexamethasone|dexamethasone
5047713|NCT01434017|Droperidol|droperidol
5047714|NCT01434017|Ondansetron|ondansetron
5047715|NCT01434017|Tonsillectomy|tonsillectomy
5047716|NCT01434004|prostate cancer|prostate cancer
5047717|NCT01433965|Bone marrow transplantation|bone marrow transplantation
5047718|NCT01433965|Maintenance lenalidomide|maintenance lenalidomide
5047719|NCT01433939|colonoscopy|colonoscopy
5047720|NCT01433939|position changes|position changes
5047721|NCT01433939|patient comfort|patient comfort
5047722|NCT01433926|Breast cancer.|breast cancer.
5047723|NCT01433926|Trastuzumab.|trastuzumab.
5047724|NCT01433926|Complete remission.|complete remission.
5047725|NCT01433900|glaucoma|glaucoma
5047726|NCT01433900|intraocular pressure|intraocular pressure
5047727|NCT01433900|ocular surface|ocular surface
5047728|NCT01433900|benzalkonium chloride|benzalkonium chloride
5047729|NCT01433887|Peginterferon alfa-2a|peginterferon alfa-2a
5047730|NCT01433887|ribavirin|ribavirin
5047731|NCT01433874|Shoulder pain|shoulder pain
5047732|NCT01433874|Upper abdominal pain|upper abdominal pain
5047733|NCT01433874|Laparoscopic surgery|laparoscopic surgery
5047734|NCT01433874|Abdominal fullness|abdominal fullness
5047735|NCT01433861|gastric cancer|gastric cancer
5047736|NCT01433861|proximal gastrectomy|proximal gastrectomy
5047737|NCT01433861|total gastrectomy|total gastrectomy
5047738|NCT01433861|laparoscopy|laparoscopy
5047739|NCT01433861|reflux esophagitis|reflux esophagitis
5047740|NCT01433861|double tract reconstruction|double tract reconstruction
5047741|NCT01433835|Cytomegalovirus|cytomegalovirus
5047742|NCT01433835|Antiviral|antiviral
5047743|NCT01433835|Safety|safety
5047744|NCT01433835|Healthy|healthy
5047745|NCT01433809|thyroid cancer|thyroid cancer
5047746|NCT01433809|thyroid neoplasm|thyroid neoplasm
5047747|NCT01433809|thyroid adenoma|thyroid adenoma
5047748|NCT01433796|antiretroviral therapy|antiretroviral therapy
5047749|NCT01433796|tuberculosis|tuberculosis
5047750|NCT01433796|health centres|health centres
5047751|NCT01433796|Ethiopia|ethiopia
5047752|NCT01433757|dystonia|dystonia
5047753|NCT01433757|DYT-1|dyt-1
5047754|NCT01433757|AMPICILLIN|ampicillin
5047755|NCT01433744|C-Reactive protein|c-reactive protein
5047756|NCT01433744|risk|risk
5047757|NCT01433731|CTCL|ctcl
5047758|NCT01433731|Cutaneous T-Cell Lymphoma|cutaneous t-cell lymphoma
5047759|NCT01433718|Effectivness|effectivness
5047760|NCT01433718|Neuromuscular Training|neuromuscular training
5047761|NCT01433718|Resistance Training|resistance training
5047762|NCT01433718|Modification|modification
5047763|NCT01433718|Anterior Cruciate Ligament Risk Factors|anterior cruciate ligament risk factors
5047764|NCT01433718|Drop-Jump|drop-jump
5047765|NCT01433718|Knee Separation|knee separation
5047766|NCT01433718|Resistance training program|resistance training program
5047767|NCT01433705|heart|heart
5047768|NCT01433705|perfusion|perfusion
5047769|NCT01433705|glucose|glucose
5047770|NCT01433692|Addictions|addictions
5047771|NCT01433692|Adolescents|adolescents
5047772|NCT01433692|Primary Health Care|primary health care
5047773|NCT01433692|Brief Intervention|brief intervention
5047774|NCT01433679|Health Behavior|health behavior
5047775|NCT01433679|Exercise|exercise
5047776|NCT01433679|Adolescent Behavior|adolescent behavior
5047777|NCT01433679|Motivation|motivation
5047778|NCT01433679|Biological Markers|biological markers
5047779|NCT01433653|Comorbid|comorbid
5047780|NCT01433653|Complicated|complicated
5047781|NCT01433640|image on multi-modalities|image on multi-modalities
5047782|NCT01433640|visualize cancer lesions|visualize cancer lesions
5047783|NCT01433640|highly suspicious lesions|highly suspicious lesions
5047784|NCT01433627|acute coronary syndromes|acute coronary syndromes
5047785|NCT01433627|myocardial infarction|myocardial infarction
5047786|NCT01433627|access site|access site
5047787|NCT01433627|bivalirudin|bivalirudin
5047788|NCT01433627|bleedings|bleedings
5047789|NCT01433601|Adherence|adherence
5047790|NCT01433601|Peer support|peer support
5047791|NCT01433601|Treatment failure|treatment failure
5047792|NCT01433588|Managing infant pain|managing infant pain
5047793|NCT01433588|27 - 36+6 weeks gestation|27 - 36+6 weeks gestation
5047794|NCT01433588|Preterm infants|preterm infants
5047795|NCT01433562|breast cancer|breast cancer
5047796|NCT01433562|neoadjuvant therapy|neoadjuvant therapy
5047797|NCT01433562|Stage II/III|stage ii/iii
5047798|NCT01433536|cranial trauma with or without high velocity fracture to inferior limb|cranial trauma with or without high velocity fracture to inferior limb
5047799|NCT01433536|spinal trauma with or without high velocity fracture to inferior limb|spinal trauma with or without high velocity fracture to inferior limb
5047800|NCT01433536|high velocity fracture to inferior limb|high velocity fracture to inferior limb
5047801|NCT01433523|HDM|hdm
5047802|NCT01433523|AIT|ait
5047803|NCT01433523|asthma|asthma
5047804|NCT01433523|asthma exacerbation|asthma exacerbation
5047805|NCT01433523|House dust mite induced asthma|house dust mite induced asthma
5047806|NCT01433510|Allergic|allergic
5047807|NCT01433510|Rhinoconjunctivitis|rhinoconjunctivitis
5047808|NCT01433510|Immunotherapy|immunotherapy
5047809|NCT01433497|multiple sclerosis|multiple sclerosis
5047810|NCT01433497|primary progressive|primary progressive
5047811|NCT01433497|relapse-free|relapse-free
5047812|NCT01433497|secondary progressive|secondary progressive
5047813|NCT01433484|cardiovascular disease|cardiovascular disease
5047814|NCT01433484|coronary heart disease|coronary heart disease
5047815|NCT01433484|obesity|obesity
5047816|NCT01433484|weight loss|weight loss
5047817|NCT01433484|genomics|genomics
5047818|NCT01433471|Ulcerative Colitis|ulcerative colitis
5047819|NCT01433471|Trichuris Suis Ova|trichuris suis ova
5047820|NCT01433471|Inflammatory Bowel Disease|inflammatory bowel disease
5047821|NCT01433471|Mucus|mucus
5047822|NCT01433458|Hepatic impairment|hepatic impairment
5047823|NCT01433458|healthy volunteers|healthy volunteers
5047824|NCT01433458|RLX030|rlx030
5047825|NCT01433458|pharmacokinetics|pharmacokinetics
5047826|NCT01433445|Myelofibrosis|myelofibrosis
5047827|NCT01433445|Panobinostat|panobinostat
5047828|NCT01433445|Ruxolitinib|ruxolitinib
5047829|NCT01433445|MF|mf
5047830|NCT01433445|PMF|pmf
5047831|NCT01433445|PPV|ppv
5047832|NCT01433445|PPV-MF|ppv-mf
5047833|NCT01433445|PET|pet
5047834|NCT01433445|PET-MF|pet-mf
5047835|NCT01433445|JAK2|jak2
5047836|NCT01433445|DACi|daci
5047837|NCT01433432|Crohn's Disease|crohn's disease
5047838|NCT01433419|Drug Therapy|drug therapy
5047839|NCT01433406|Drug Therapy|drug therapy
5047840|NCT01433393|Drug Therapy|drug therapy
5047841|NCT01433380|Phase 1|phase 1
5047842|NCT01433380|Single Doses|single doses
5047843|NCT01433380|Pharmacodynamics|pharmacodynamics
5047844|NCT01433380|Healthy Volunteers|healthy volunteers
5047845|NCT01433367|total disc replacement|total disc replacement
5047846|NCT01433367|cervical disc disease|cervical disc disease
5047847|NCT01433354|Fragile X Syndrome|fragile x syndrome
5047848|NCT01433354|Martin-Bell Syndrome|martin-bell syndrome
5047849|NCT01433354|Genetic Diseases|genetic diseases
5047850|NCT01433354|X-Linked|x-linked
5047851|NCT01433354|Escalante's syndrome|escalante's syndrome
5047852|NCT01433341|Normal young athletes|normal young athletes
5047853|NCT01433328|Remodulin|remodulin
5047854|NCT01433328|Treprostinil|treprostinil
5047855|NCT01433315|sleep deprivation|sleep deprivation
5047856|NCT01433315|sleep restriction|sleep restriction
5047857|NCT01433302|Breast cancer|breast cancer
5047858|NCT01433302|Genitourinary cancer|genitourinary cancer
5047859|NCT01433302|Gynecological cancer|gynecological cancer
5047860|NCT01433302|Malignant Female Reproductive System Neoplasm|malignant female reproductive system neoplasm
5047861|NCT01433302|Melanoma|melanoma
5047862|NCT01433302|Sarcoma|sarcoma
5047863|NCT01433302|Inflammatory Response|inflammatory response
5047864|NCT01433302|Inflammatory proteins|inflammatory proteins
5047865|NCT01433302|Tissue Fibrosis|tissue fibrosis
5047866|NCT01433302|Lymphatico-venous Bypass Surgery|lymphatico-venous bypass surgery
5047867|NCT01433302|Punch biopsy|punch biopsy
5047868|NCT01433302|Lab collections|lab collections
5047869|NCT01433302|Th2 immune phenotype|th2 immune phenotype
5047870|NCT01433302|Lymphedema|lymphedema
5047871|NCT01433289|HIV|hiv
5047872|NCT01433289|safety|safety
5047873|NCT01433289|toxicity|toxicity
5047874|NCT01433289|pharmacokinetics|pharmacokinetics
5047875|NCT01433289|Polyphenon E|polyphenon e
5047876|NCT01433289|EGCG|egcg
5047877|NCT01433289|green tea|green tea
5047878|NCT01433289|CD4|cd4
5047879|NCT01433289|viral load|viral load
5047880|NCT01433276|Fluid resuscitation|fluid resuscitation
5047881|NCT01433276|hemorrhagic shock|hemorrhagic shock
5047882|NCT01433276|Totilac|totilac
5047883|NCT01433276|Ringer's|ringer's
5047884|NCT01433276|trauma|trauma
5047885|NCT01433263|Wasting syndrome|wasting syndrome
5047886|NCT01433263|emaciation|emaciation
5047887|NCT01433263|lung cancer|lung cancer
5047888|NCT01433263|adenocarcinoma|adenocarcinoma
5047889|NCT01433263|pancreatic cancer|pancreatic cancer
5047890|NCT01433250|Multiple Sclerosis,|multiple sclerosis,
5047891|NCT01433250|demyelinating autoimmune diseases,|demyelinating autoimmune diseases,
5047892|NCT01433250|interleukin-17,|interleukin-17,
5047893|NCT01433250|monoclonal human antibody|monoclonal human antibody
5047894|NCT01433237|embryonal childhood rhabdomyosarcoma|embryonal childhood rhabdomyosarcoma
5047895|NCT01433237|adult rhabdomyosarcoma|adult rhabdomyosarcoma
5047896|NCT01433237|alveolar childhood rhabdomyosarcoma|alveolar childhood rhabdomyosarcoma
5047897|NCT01433237|adult soft tissue sarcoma|adult soft tissue sarcoma
5047898|NCT01433237|childhood rhabdomyosarcoma|childhood rhabdomyosarcoma
5047899|NCT01433224|recurrent childhood malignant germ cell tumor|recurrent childhood malignant germ cell tumor
5047900|NCT01433224|recurrent extragonadal germ cell tumor|recurrent extragonadal germ cell tumor
5047901|NCT01433224|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
5047902|NCT01433224|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
5047903|NCT01433185|PMTCT|pmtct
5047904|NCT01433185|SMS|sms
5047905|NCT01433185|HIV Infections|hiv infections
5047906|NCT01433185|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5047907|NCT01433185|Prevention & Control|prevention & control
5047908|NCT01433185|Patient Compliance|patient compliance
5047909|NCT01433185|Cellular Phone|cellular phone
5047910|NCT01433185|Randomized Controlled Trial|randomized controlled trial
5047911|NCT01433172|stage IV|stage iv
5047912|NCT01433172|adenocarcinoma|adenocarcinoma
5047913|NCT01433172|vaccine therapy|vaccine therapy
5047914|NCT01433172|immunology|immunology
5047915|NCT01433172|tumor vaccine|tumor vaccine
5047916|NCT01433172|colony stimulating factor(CSF)|colony stimulating factor(csf)
5047917|NCT01433172|granulocyte-macrophage colony-stimulating factor (GM-CSF)|granulocyte-macrophage colony-stimulating factor (gm-csf)
5047918|NCT01433172|CC chemokine ligand 21 (CCL21)|cc chemokine ligand 21 (ccl21)
5047919|NCT01433172|Chemokine [C-C motif] ligand 21 (CCL21)|chemokine [c-c motif] ligand 21 (ccl21)
5047920|NCT01433172|human leukocyte antigen serotype (HLA)|human leukocyte antigen serotype (hla)
5047921|NCT01433159|Pressure Ulcers|pressure ulcers
5047922|NCT01433159|Spinal Cord Injury|spinal cord injury
5047923|NCT01433159|Healthpoint|healthpoint
5047924|NCT01433159|Xenaderm|xenaderm
5047925|NCT01433159|011-101|011-101
5047926|NCT01433146|Temperament|temperament
5047927|NCT01433146|Anxiety|anxiety
5047928|NCT01433146|Depression|depression
5047929|NCT01433146|Colorectal Cancer|colorectal cancer
5047930|NCT01433120|Obesity|obesity
5047931|NCT01433120|Insulin resistance|insulin resistance
5047932|NCT01433120|Microbiota|microbiota
5047933|NCT01433120|Probiotic|probiotic
5047934|NCT01433120|Prebiotic|prebiotic
5047935|NCT01433107|Tinea pedis|tinea pedis
5047936|NCT01433107|Terbinafine film forming solution|terbinafine film forming solution
5047937|NCT01433094|Adherence|adherence
5047938|NCT01433094|Psychoeducation|psychoeducation
5047939|NCT01433094|Pharmacotherapy|pharmacotherapy
5047940|NCT01433094|Schizophrenia|schizophrenia
5047941|NCT01433094|Family support|family support
5048445|NCT01431235|ADHD|adhd
5047942|NCT01433068|Adult Soft Tissue Sarcoma of the extremities and Trunk wall|adult soft tissue sarcoma of the extremities and trunk wall
5047943|NCT01433055|Schizophrenia|schizophrenia
5047944|NCT01433055|Cognitive Symptoms|cognitive symptoms
5047945|NCT01433055|Clozapine|clozapine
5047946|NCT01433042|small bowel disease|small bowel disease
5047947|NCT01433029|Surgical Procedure|surgical procedure
5047948|NCT01433029|Assessment|assessment
5047949|NCT01433029|Cardiothoracic Surgery|cardiothoracic surgery
5047950|NCT01433029|Coronary artery bypass|coronary artery bypass
5047951|NCT01433029|CAB|cab
5047952|NCT01433029|Video recordings|video recordings
5047953|NCT01433029|Global rating scale|global rating scale
5047954|NCT01433029|GRS|grs
5047955|NCT01433029|Cardiothoracic surgeon|cardiothoracic surgeon
5047956|NCT01433029|Surgical trainees|surgical trainees
5047957|NCT01433016|HCC Hepatocellular carcinoma|hcc hepatocellular carcinoma
5047958|NCT01433016|OBT Octanoate Breath Test|obt octanoate breath test
5047959|NCT01433003|Thrombotic thrombocytopenia purpura|thrombotic thrombocytopenia purpura
5047960|NCT01433003|hemolytic uremic syndrome|hemolytic uremic syndrome
5047961|NCT01433003|plasma exchange|plasma exchange
5047962|NCT01433003|Improve treatment response|improve treatment response
5047963|NCT01433003|TTP/HUS|ttp/hus
5047964|NCT01432990|SCI|sci
5047965|NCT01432990|gait|gait
5047966|NCT01432990|rehabilitation|rehabilitation
5047967|NCT01432990|robotic|robotic
5047968|NCT01432964|Orbital Fractures|orbital fractures
5047969|NCT01432964|Fracture Fixation|fracture fixation
5047970|NCT01432964|Blow-out Fractures|blow-out fractures
5047971|NCT01432964|Surgical Mesh|surgical mesh
5047972|NCT01432964|Titanium|titanium
5047973|NCT01432964|Computer-assisted Image Processing|computer-assisted image processing
5047974|NCT01432925|Buruli ulcer|buruli ulcer
5047975|NCT01432925|Mycobacterium ulcerans|mycobacterium ulcerans
5047976|NCT01432925|Streptomycin|streptomycin
5047977|NCT01432925|Rifampicin|rifampicin
5047978|NCT01432925|Functional limitations|functional limitations
5047979|NCT01432925|surgery|surgery
5047980|NCT01432925|Bénin|bénin
5047981|NCT01432899|Neurophysiology|neurophysiology
5047982|NCT01432899|Hemidystonia|hemidystonia
5047983|NCT01432899|Childhood-onset|childhood-onset
5047984|NCT01432899|Motion Analysis|motion analysis
5047985|NCT01432899|Neuroimaging|neuroimaging
5047986|NCT01432899|Childhood Onset Hemidystonia|childhood onset hemidystonia
5047987|NCT01432899|Healthy Volunteer|healthy volunteer
5047988|NCT01432899|HV|hv
5047989|NCT01432886|Breast Cancer|breast cancer
5047990|NCT01432873|BMT|bmt
5047991|NCT01432873|HSCT|hsct
5047992|NCT01432860|Skin Self Examination|skin self examination
5047993|NCT01432847|Best Disease|best disease
5047994|NCT01432847|Late-Onset Retinal Degeneration (L-ORD)|late-onset retinal degeneration (l-ord)
5047995|NCT01432847|Age-Related Macular Degeneration (AMD)|age-related macular degeneration (amd)
5047996|NCT01432847|Induced Pluripotent Stem Cell (iPS) Cell Lines|induced pluripotent stem cell (ips) cell lines
5047997|NCT01432847|Retinal Degeneration|retinal degeneration
5047998|NCT01432847|Age-Related Macular Degeneration|age-related macular degeneration
5047999|NCT01432847|AMD|amd
5048000|NCT01432834|non-anterior astigmatism correction|non-anterior astigmatism correction
5048001|NCT01432834|Allegretto Wave excimer laser|allegretto wave excimer laser
5048002|NCT01432834|wavefront optimized ablation profile (WFO)|wavefront optimized ablation profile (wfo)
5048003|NCT01432834|LASIK|lasik
5048004|NCT01432834|PRK|prk
5048005|NCT01432821|Epilepsy,|epilepsy,
5048006|NCT01432821|dopamine|dopamine
5048007|NCT01432821|yawning,|yawning,
5048008|NCT01432821|blinking eyelids,|blinking eyelids,
5048009|NCT01432821|electroencephalography|electroencephalography
5048010|NCT01432795|chronic venous insufficiency|chronic venous insufficiency
5048011|NCT01432795|post-thrombotic syndrome|post-thrombotic syndrome
5048012|NCT01432795|medical compression therapy|medical compression therapy
5048013|NCT01432795|compression stocking|compression stocking
5048014|NCT01432795|gliding aid|gliding aid
5048015|NCT01432795|stocking butler|stocking butler
5048016|NCT01432795|adherence to treatment|adherence to treatment
5048017|NCT01432782|Weight loss|weight loss
5048018|NCT01432782|Dysphagia|dysphagia
5048019|NCT01432782|Esophageal hypermotility|esophageal hypermotility
5048020|NCT01432782|Chest Pain|chest pain
5048021|NCT01432769|enteral nutrition|enteral nutrition
5048022|NCT01432769|malnutrition|malnutrition
5048023|NCT01432769|cardiac surgery|cardiac surgery
5048024|NCT01432756|HIV|hiv
5048025|NCT01432743|3D mapping|3d mapping
5048026|NCT01432743|Image integration|image integration
5048027|NCT01432743|Atrial fibrillation|atrial fibrillation
5048028|NCT01432743|Catheter Ablation|catheter ablation
5048029|NCT01432704|MS|ms
5048030|NCT01432704|vitamin D|vitamin d
5048031|NCT01432704|environment|environment
5048032|NCT01432691|Hip-fracture|hip-fracture
5048033|NCT01432691|RSA|rsa
5048034|NCT01432678|vitamin D|vitamin d
5048035|NCT01432678|asthma|asthma
5048036|NCT01432665|HSDD|hsdd
5048037|NCT01432639|Myocardial infarction|myocardial infarction
5048038|NCT01432639|Autonomic function|autonomic function
5048039|NCT01432639|Arterial Stiffness|arterial stiffness
5048040|NCT01432639|Endothelial function|endothelial function
5048041|NCT01432639|Inflammation|inflammation
5048042|NCT01432639|Rehabilitation program|rehabilitation program
5048043|NCT01432639|Exercise|exercise
5048044|NCT01432626|stress induced cardiomyopathy|stress induced cardiomyopathy
5048045|NCT01432626|broken heart syndrome|broken heart syndrome
5048046|NCT01432626|Takotsubo cardiomyopathy|takotsubo cardiomyopathy
5048047|NCT01432626|transient apical ballooning syndrome|transient apical ballooning syndrome
5048048|NCT01432626|apical ballooning cardiomyopathy|apical ballooning cardiomyopathy
5048049|NCT01432626|stress cardiomyopathy|stress cardiomyopathy
5048050|NCT01432626|non-ischemic cardiomyopathy|non-ischemic cardiomyopathy
5048051|NCT01432613|Myositis|myositis
5048052|NCT01432613|Magnetic Resonance Imaging|magnetic resonance imaging
5048053|NCT01432613|Muscle biopsy|muscle biopsy
5048054|NCT01432613|Sensitivity and Specificity|sensitivity and specificity
5048055|NCT01432600|Multiple Myeloma|multiple myeloma
5048056|NCT01432600|Relapsed|relapsed
5048057|NCT01432600|Refractory|refractory
5048058|NCT01432600|Corticosteroids|corticosteroids
5048059|NCT01432587|Amyloidosis|amyloidosis
5048060|NCT01432587|Transthyretin|transthyretin
5048061|NCT01432587|Neuropathies|neuropathies
5048062|NCT01432587|Diflunisal|diflunisal
5048063|NCT01432587|Familial|familial
5048064|NCT01432574|HPV|hpv
5048065|NCT01432561|Lysosomal Storage Diseases|lysosomal storage diseases
5048066|NCT01432561|Metabolic Diseases|metabolic diseases
5048067|NCT01432561|Metabolism, Inborn Errors|metabolism, inborn errors
5048068|NCT01432548|Ischemic|ischemic
5048069|NCT01432548|preconditioning|preconditioning
5048070|NCT01432548|liver|liver
5048071|NCT01432548|resection|resection
5048072|NCT01432522|Intranasal epinephrine|intranasal epinephrine
5048073|NCT01432522|Plasma epinephrine level|plasma epinephrine level
5048074|NCT01432509|Pre-diabetes|pre-diabetes
5048075|NCT01432509|Type 2 diabetes|type 2 diabetes
5048076|NCT01432509|Biomarkers|biomarkers
5048077|NCT01432509|Cohort|cohort
5048078|NCT01432509|Diabetes Risk Score|diabetes risk score
5048079|NCT01432509|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
5048080|NCT01432509|Glucose Intolerance|glucose intolerance
5048081|NCT01432509|Prediabetic State|prediabetic state
5048082|NCT01432509|Glucose Metabolism Disorders|glucose metabolism disorders
5048083|NCT01432509|Metabolic Diseases|metabolic diseases
5048084|NCT01432509|Endocrine System Diseases|endocrine system diseases
5048085|NCT01432509|Hyperglycemia|hyperglycemia
5048086|NCT01432496|Laparoscopic|laparoscopic
5048087|NCT01432496|Colectomy|colectomy
5048088|NCT01432496|Nebulization|nebulization
5048089|NCT01432496|Ropivacaine|ropivacaine
5048090|NCT01432483|Cancer|cancer
5048091|NCT01432483|ONTAK|ontak
5048092|NCT01432483|Denileukin diftitox|denileukin diftitox
5048093|NCT01432483|persistent or recurrent disease|persistent or recurrent disease
5048094|NCT01432483|requiring continued delivery of essential cancer therapy|requiring continued delivery of essential cancer therapy
5048095|NCT01432470|vaginal atrophy|vaginal atrophy
5048096|NCT01432444|Schizophrenia|schizophrenia
5048097|NCT01432418|rehabilitation|rehabilitation
5048098|NCT01432418|wheelchairs|wheelchairs
5048099|NCT01432418|safety|safety
5048100|NCT01432418|disability evaluation|disability evaluation
5048101|NCT01432418|motor skills|motor skills
5048102|NCT01432405|Diabetes|diabetes
5048103|NCT01432392|gastroesophageal reflux disease|gastroesophageal reflux disease
5048104|NCT01432392|GERD questionnaire|gerd questionnaire
5048105|NCT01432392|primary care setting|primary care setting
5048106|NCT01432340|Influenza|influenza
5048107|NCT01432340|Influenza vaccine|influenza vaccine
5048108|NCT01432340|Influenza vaccine effectiveness study|influenza vaccine effectiveness study
5048109|NCT01432327|motor activity|motor activity
5048110|NCT01432327|randomized controlled trial|randomized controlled trial
5048111|NCT01432327|feedback|feedback
5048112|NCT01432314|patient's survival|patient's survival
5048113|NCT01432314|tumor response|tumor response
5048114|NCT01432314|safety|safety
5048115|NCT01432301|fluorouracil overdose|fluorouracil overdose
5048116|NCT01432301|fluorouracil toxicity|fluorouracil toxicity
5048117|NCT01432301|capecitabine overdose|capecitabine overdose
5048118|NCT01432301|capecitabine toxicity|capecitabine toxicity
5048119|NCT01432275|Diabetes|diabetes
5048120|NCT01432275|SMBG|smbg
5048121|NCT01432275|Insulin calculator|insulin calculator
5048122|NCT01432262|prevention of pneumococcal diseases|prevention of pneumococcal diseases
5048123|NCT01432249|pediatric psoriasis|pediatric psoriasis
5048124|NCT01432249|enbrel|enbrel
5048125|NCT01432249|safety|safety
5048126|NCT01432249|efficacy|efficacy
5048127|NCT01432236|Pregabalin|pregabalin
5048128|NCT01432236|Lyrica|lyrica
5048129|NCT01432236|depression|depression
5048130|NCT01432223|Trastuzumab|trastuzumab
5048131|NCT01432223|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
5048132|NCT01432223|Primary chemotherapy|primary chemotherapy
5048133|NCT01432210|post-prandial absorption|post-prandial absorption
5048134|NCT01432210|provitamin A carotenoids|provitamin a carotenoids
5048135|NCT01432210|vitamin A|vitamin a
5048136|NCT01432210|avocado|avocado
5048137|NCT01432210|tomato|tomato
5048138|NCT01432210|carrot|carrot
5048139|NCT01432197|HRQOL|hrqol
5048140|NCT01432197|Occupational therapy|occupational therapy
5048446|NCT01431235|SUD|sud
5048141|NCT01432197|ADL intervention|adl intervention
5048142|NCT01432197|Cancer patients|cancer patients
5048143|NCT01432184|cerebral|cerebral
5048144|NCT01432184|hypoxia|hypoxia
5048145|NCT01432171|Brain cancer|brain cancer
5048146|NCT01432171|Central nervous system|central nervous system
5048147|NCT01432171|Seizure prophylaxis|seizure prophylaxis
5048148|NCT01432171|High-Grade Gliomas|high-grade gliomas
5048149|NCT01432171|HGG|hgg
5048150|NCT01432171|Supratentorial high-grade glioma|supratentorial high-grade glioma
5048151|NCT01432171|Malignant glioma|malignant glioma
5048152|NCT01432171|Lacosamide|lacosamide
5048153|NCT01432171|Vimpat|vimpat
5048154|NCT01432171|Placebo|placebo
5048155|NCT01432171|Sugar pill|sugar pill
5048156|NCT01432158|Invasive pneumococcal disease|invasive pneumococcal disease
5048157|NCT01432145|BRCA defective|brca defective
5048158|NCT01432132|Head and Neck Cancer|head and neck cancer
5048159|NCT01432132|Body Image Adaptation|body image adaptation
5048160|NCT01432132|Post surgical body image|post surgical body image
5048161|NCT01432132|Audio-recorded interview|audio-recorded interview
5048162|NCT01432132|Questionnaire|questionnaire
5048163|NCT01432132|Survey|survey
5048164|NCT01432119|Advanced Cancers|advanced cancers
5048165|NCT01432119|Advanced Malignancies|advanced malignancies
5048166|NCT01432119|Liver Metastases|liver metastases
5048167|NCT01432119|SIR-Spheres|sir-spheres
5048168|NCT01432119|Selective internal radiation|selective internal radiation
5048169|NCT01432119|Yttrium-90|yttrium-90
5048170|NCT01432119|Cetuximab|cetuximab
5048171|NCT01432119|C225|c225
5048172|NCT01432119|Erbitux|erbitux
5048173|NCT01432119|Erlotinib|erlotinib
5048174|NCT01432119|Erlotinib Hydrochloride|erlotinib hydrochloride
5048175|NCT01432119|Tarceva|tarceva
5048176|NCT01432119|OSI-774|osi-774
5048177|NCT01432106|Hypertension|hypertension
5048178|NCT01432106|Metabolic Syndrome|metabolic syndrome
5048179|NCT01432106|African American|african american
5048180|NCT01432093|liver transplant|liver transplant
5048181|NCT01432093|high blood sugars|high blood sugars
5048182|NCT01432093|hospital hyperglycemia|hospital hyperglycemia
5048183|NCT01432093|post-transplant hyperglycemia|post-transplant hyperglycemia
5048184|NCT01432093|post liver transplant|post liver transplant
5048185|NCT01432093|post liver-kidney transplant|post liver-kidney transplant
5048186|NCT01432080|Pulmonary disease, chronic obstructive|pulmonary disease, chronic obstructive
5048187|NCT01432080|Viral respiratory tract infections|viral respiratory tract infections
5048188|NCT01432080|Respiratory syncytial viruses|respiratory syncytial viruses
5048189|NCT01432080|Influenza virus A|influenza virus a
5048190|NCT01432080|Influenza virus B|influenza virus b
5048191|NCT01432080|Transplantation, Allogeneic|transplantation, allogeneic
5048192|NCT01432067|cancer|cancer
5048193|NCT01432067|geriatry|geriatry
5048194|NCT01432067|curative care|curative care
5048195|NCT01432067|physical activity|physical activity
5048196|NCT01432054|Human Tissue Repository|human tissue repository
5048197|NCT01432041|Injury prevention|injury prevention
5048198|NCT01432041|smoke alarms|smoke alarms
5048199|NCT01432041|car seats|car seats
5048200|NCT01432015|aprepitant|aprepitant
5048201|NCT01432015|fosaprepitant|fosaprepitant
5048202|NCT01432015|gynecologic cancer|gynecologic cancer
5048203|NCT01432015|emesis|emesis
5048204|NCT01432002|breast carcinoma|breast carcinoma
5048205|NCT01432002|FDG|fdg
5048206|NCT01432002|PET/CT|pet/ct
5048207|NCT01432002|PET/IRM|pet/irm
5048208|NCT01431950|fluticasone furoate|fluticasone furoate
5048209|NCT01431937|Pharmacodynamics|pharmacodynamics
5048210|NCT01431937|Pharmacokinetics|pharmacokinetics
5048211|NCT01431924|outcomes|outcomes
5048212|NCT01431924|observational|observational
5048213|NCT01431924|retrospective|retrospective
5048214|NCT01431924|database|database
5048215|NCT01431924|asthma|asthma
5048216|NCT01431898|HCV RNA|hcv rna
5048217|NCT01431898|Polymerase inhibitor|polymerase inhibitor
5048218|NCT01431898|Treatment naïve and Treatment experienced|treatment naïve and treatment experienced
5048219|NCT01431898|GS-9669|gs-9669
5048220|NCT01431898|Hepatitis C|hepatitis c
5048221|NCT01431898|HCV|hcv
5048222|NCT01431885|fibronectin|fibronectin
5048223|NCT01431885|cervical length|cervical length
5048224|NCT01431872|Aromatase Inhibitors|aromatase inhibitors
5048225|NCT01431859|pollen|pollen
5048226|NCT01431859|allergy|allergy
5048227|NCT01431859|food|food
5048228|NCT01431859|immunotherapy|immunotherapy
5048229|NCT01431833|Hepatic Impairment|hepatic impairment
5048230|NCT01431833|Matched control subjects|matched control subjects
5048231|NCT01431820|Onychomycosis|onychomycosis
5048232|NCT01431820|Toenail Fungus|toenail fungus
5048233|NCT01431820|luliconazole|luliconazole
5048234|NCT01431820|Antifungal|antifungal
5048235|NCT01431820|Topical|topical
5048236|NCT01431794|Pancreatic ductal adenocarcinoma (PDA)Neoplasms|pancreatic ductal adenocarcinoma (pda)neoplasms
5048237|NCT01431794|LDE225|lde225
5048238|NCT01431794|nab-paclitaxel|nab-paclitaxel
5048239|NCT01431794|abraxane|abraxane
5048240|NCT01431794|gemcitabine|gemcitabine
5048241|NCT01431794|neoadjuvant|neoadjuvant
5048242|NCT01431794|cytotoxic|cytotoxic
5048243|NCT01431794|hedgehog (Hh) inhibitors|hedgehog (hh) inhibitors
5048244|NCT01431794|stromal cells|stromal cells
5048245|NCT01431794|resectable PDA|resectable pda
5048246|NCT01431794|Pancreatic Diseases|pancreatic diseases
5048247|NCT01431794|Carcinoma|carcinoma
5048248|NCT01431768|Influenza|influenza
5048249|NCT01431768|Human|human
5048250|NCT01431768|Orthomyxoviridae infections|orthomyxoviridae infections
5048251|NCT01431768|RNA Virus Infections|rna virus infections
5048252|NCT01431768|Virus Diseases|virus diseases
5048253|NCT01431768|Respiratory Tract infections|respiratory tract infections
5048254|NCT01431768|Respiratory Tract Diseases|respiratory tract diseases
5048255|NCT01431742|buccal soluble film|buccal soluble film
5048256|NCT01431742|Pain|pain
5048257|NCT01431742|Back Pain|back pain
5048258|NCT01431742|Low Back Pain|low back pain
5048259|NCT01431742|Buprenorphine|buprenorphine
5048260|NCT01431742|Analgesics, Opioid|analgesics, opioid
5048261|NCT01431742|Analgesics|analgesics
5048262|NCT01431703|narrow band imaging|narrow band imaging
5048263|NCT01431703|learning curve|learning curve
5048264|NCT01431703|colorectal|colorectal
5048265|NCT01431703|differential diagnosis|differential diagnosis
5048266|NCT01431703|with colorectal lesion|with colorectal lesion
5048267|NCT01431703|NBI with magnification|nbi with magnification
5048268|NCT01431690|Eicosapentaenoic Acid|eicosapentaenoic acid
5048269|NCT01431690|Docosahexaenoic Acid|docosahexaenoic acid
5048270|NCT01431690|Warfarin|warfarin
5048271|NCT01431690|Hypertriglyceridemia|hypertriglyceridemia
5048272|NCT01431690|Omega-3 free fatty acids|omega-3 free fatty acids
5048273|NCT01431690|Omega-3 ethyl ester acids|omega-3 ethyl ester acids
5048274|NCT01431690|Epanova|epanova
5048275|NCT01431690|Lovaza|lovaza
5048276|NCT01431690|pharmacokinetics|pharmacokinetics
5048277|NCT01431690|low-fat meal|low-fat meal
5048278|NCT01431677|Muscle|muscle
5048279|NCT01431677|Biopsy|biopsy
5048280|NCT01431677|Energetics|energetics
5048281|NCT01431677|Sarcopenia|sarcopenia
5048282|NCT01431677|Frailty|frailty
5048283|NCT01431664|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5048284|NCT01431664|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5048285|NCT01431664|acute leukemias of ambiguous lineage|acute leukemias of ambiguous lineage
5048286|NCT01431664|acute undifferentiated leukemia|acute undifferentiated leukemia
5048287|NCT01431664|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5048288|NCT01431651|Food and beverages|food and beverages
5048289|NCT01431651|Food|food
5048290|NCT01431651|Dietary supplements|dietary supplements
5048291|NCT01431638|Gout|gout
5048292|NCT01431638|arthritis|arthritis
5048293|NCT01431638|gout flare|gout flare
5048294|NCT01431638|acute gout|acute gout
5048295|NCT01431638|gouty|gouty
5048296|NCT01431638|rheumatic disease|rheumatic disease
5048297|NCT01431638|uric acid|uric acid
5048298|NCT01431638|podagra|podagra
5048299|NCT01431625|COPD|copd
5048300|NCT01431625|Exercise Training|exercise training
5048301|NCT01431612|Pharmacokinetics, kidney;|pharmacokinetics, kidney;
5048302|NCT01431612|Receptors, adrenergic;|receptors, adrenergic;
5048303|NCT01431612|Fluids, i.v.;|fluids, i.v.;
5048304|NCT01431612|Sympathetic nervous system, esmolol;|sympathetic nervous system, esmolol;
5048305|NCT01431612|Sympathetic nervous system, phenylephrine|sympathetic nervous system, phenylephrine
5048306|NCT01431599|Locally advanced rectal cancer|locally advanced rectal cancer
5048307|NCT01431586|JDTic|jdtic
5048308|NCT01431586|cocaine dependence|cocaine dependence
5048309|NCT01431586|kappa-opioid antagonist|kappa-opioid antagonist
5048310|NCT01431573|Depression|depression
5048311|NCT01431560|ankle|ankle
5048312|NCT01431560|metallic|metallic
5048313|NCT01431560|biodegradable|biodegradable
5048314|NCT01431560|Freedom|freedom
5048315|NCT01431508|Hypertension|hypertension
5048316|NCT01431495|platelet agregation|platelet agregation
5048317|NCT01431495|clopidogrel|clopidogrel
5048318|NCT01431495|major adverse cardiac events (MACE)|major adverse cardiac events (mace)
5048319|NCT01431482|skin symptoms|skin symptoms
5048320|NCT01431456|Prevention|prevention
5048321|NCT01431456|venous thromboembolism after knee arthroplasty|venous thromboembolism after knee arthroplasty
5048322|NCT01431443|Randomized double blind trial|randomized double blind trial
5048323|NCT01431443|Cocoa flavonoids|cocoa flavonoids
5048324|NCT01431443|Endothelial function|endothelial function
5048325|NCT01431443|Blood pressure|blood pressure
5048326|NCT01431443|Pregnant women|pregnant women
5048327|NCT01431443|Preeclampsia|preeclampsia
5048328|NCT01431443|Uterine artery flow|uterine artery flow
5048329|NCT01431443|Pulsatility index|pulsatility index
5048330|NCT01431430|Vitamine D|vitamine d
5048331|NCT01431430|renal transplantation|renal transplantation
5048332|NCT01431430|diabetes mellitus|diabetes mellitus
5048333|NCT01431430|cancer|cancer
5048334|NCT01431430|cardiovascular complications|cardiovascular complications
5048335|NCT01431417|Shoulder|shoulder
5048336|NCT01431417|Outcome treatment|outcome treatment
5048337|NCT01431417|Validation Studies as topic|validation studies as topic
5048338|NCT01431417|Biomechanics|biomechanics
5048339|NCT01431417|Shoulder, Joint Instability|shoulder, joint instability
5048340|NCT01431391|Immune therapy|immune therapy
5048341|NCT01431391|Cancer vaccine|cancer vaccine
5048342|NCT01431391|Therapeutic vaccine|therapeutic vaccine
5048343|NCT01431391|Therapeutic cancer vaccine|therapeutic cancer vaccine
5048344|NCT01431391|Vaccine|vaccine
5048345|NCT01431391|Dendritic cells|dendritic cells
5048346|NCT01431391|PSA|psa
5048347|NCT01431391|Androgen deprivation therapy|androgen deprivation therapy
5048348|NCT01431391|Prostatic Neoplasms|prostatic neoplasms
5048349|NCT01431391|Genital Neoplasms, Male|genital neoplasms, male
5048350|NCT01431391|Urogenital Neoplasms|urogenital neoplasms
5048351|NCT01431391|Neoplasms|neoplasms
5048352|NCT01431391|Prostatic Diseases|prostatic diseases
5048353|NCT01431391|Androgens|androgens
5048354|NCT01431391|Hormones|hormones
5048355|NCT01431391|Adenocarcinoma|adenocarcinoma
5048356|NCT01431391|Carcinoma|carcinoma
5048357|NCT01431391|Neoplasms, Glandular and Epithelial|neoplasms, glandular and epithelial
5048358|NCT01431391|Immunology|immunology
5048359|NCT01431391|Hormone therapy|hormone therapy
5048360|NCT01431391|Immunotherapy|immunotherapy
5048361|NCT01431391|Luteinizing hormone-releasing hormone (LHRH)|luteinizing hormone-releasing hormone (lhrh)
5048362|NCT01431378|CT scan|ct scan
5048363|NCT01431378|CNS|cns
5048364|NCT01431378|Thorax|thorax
5048365|NCT01431378|Abdomen|abdomen
5048366|NCT01431378|staging of a known or suspected lung cancer|staging of a known or suspected lung cancer
5048367|NCT01431378|suspected urolithiasis|suspected urolithiasis
5048368|NCT01431378|known or suspected focal liver lesion|known or suspected focal liver lesion
5048369|NCT01431365|exercise|exercise
5048370|NCT01431365|topography|topography
5048371|NCT01431365|cravings|cravings
5048372|NCT01431365|smoking behaviour|smoking behaviour
5048373|NCT01431352|Polycystic ovary syndrome|polycystic ovary syndrome
5048374|NCT01431352|Randomized controlled trial|randomized controlled trial
5048375|NCT01431352|Chinese herbal medicine|chinese herbal medicine
5048376|NCT01431352|Chinese herbal medicine granules|chinese herbal medicine granules
5048377|NCT01431352|Letrozole|letrozole
5048378|NCT01431352|Live birth|live birth
5048379|NCT01431326|adenovirus|adenovirus
5048380|NCT01431326|anaesthetic|anaesthetic
5048381|NCT01431326|anesthesia|anesthesia
5048382|NCT01431326|anticoagulant|anticoagulant
5048383|NCT01431326|anti-epileptic|anti-epileptic
5048384|NCT01431326|anti-inflammatory|anti-inflammatory
5048385|NCT01431326|antimicrobial|antimicrobial
5048386|NCT01431326|anti-psychotic|anti-psychotic
5048387|NCT01431326|antiviral|antiviral
5048388|NCT01431326|anxiety|anxiety
5048389|NCT01431326|anxiolysis|anxiolysis
5048390|NCT01431326|anxiolytic|anxiolytic
5048391|NCT01431326|autism|autism
5048392|NCT01431326|autistic disorder|autistic disorder
5048393|NCT01431326|benzodiazepine|benzodiazepine
5048394|NCT01431326|bipolar disorder|bipolar disorder
5048395|NCT01431326|convulsions|convulsions
5048396|NCT01431326|epilepsy|epilepsy
5048397|NCT01431326|headaches|headaches
5048398|NCT01431326|herpes simplex virus|herpes simplex virus
5048399|NCT01431326|herpes simplex virus (HSV)|herpes simplex virus (hsv)
5048400|NCT01431326|hypertension|hypertension
5048401|NCT01431326|infantile hemangioma|infantile hemangioma
5048402|NCT01431326|infection|infection
5048403|NCT01431326|inflammation|inflammation
5048404|NCT01431326|influenza|influenza
5048405|NCT01431326|lower respiratory tract infection (LRTI)|lower respiratory tract infection (lrti)
5048406|NCT01431326|meningitis|meningitis
5048407|NCT01431326|migraines|migraines
5048408|NCT01431326|muscle spasms|muscle spasms
5048409|NCT01431326|pain|pain
5048410|NCT01431326|pneumonia|pneumonia
5048411|NCT01431326|prophylaxis|prophylaxis
5048412|NCT01431326|retinitis|retinitis
5048413|NCT01431326|schizophrenia|schizophrenia
5048414|NCT01431326|sedation|sedation
5048415|NCT01431326|sedative|sedative
5048416|NCT01431326|seizures|seizures
5048417|NCT01431326|septicemia|septicemia
5048418|NCT01431326|swelling|swelling
5048419|NCT01431326|thromboprophylaxis|thromboprophylaxis
5048420|NCT01431326|thrombosis|thrombosis
5048421|NCT01431326|urinary tract infection|urinary tract infection
5048422|NCT01431326|urinary tract infection (UTI)|urinary tract infection (uti)
5048423|NCT01431326|withdrawal|withdrawal
5048424|NCT01431326|empiric therapy|empiric therapy
5048425|NCT01431326|staphylococci|staphylococci
5048426|NCT01431313|pulmonary hypertension|pulmonary hypertension
5048427|NCT01431300|central veins|central veins
5048428|NCT01431300|thorax|thorax
5048429|NCT01431300|superior vena cava|superior vena cava
5048430|NCT01431300|Central vein imaging|central vein imaging
5048431|NCT01431261|Chronic neck pain|chronic neck pain
5048432|NCT01431261|Whiplash|whiplash
5048433|NCT01431261|Whiplash Associated Disorders|whiplash associated disorders
5048434|NCT01431261|Chronic Pain|chronic pain
5048435|NCT01431261|Neck exercises|neck exercises
5048436|NCT01431261|Training|training
5048437|NCT01431261|Pacing|pacing
5048438|NCT01431261|Patient Education|patient education
5048439|NCT01431261|Pain Management|pain management
5048440|NCT01431261|Whiplash Injuries|whiplash injuries
5048441|NCT01431261|Musculoskeletal|musculoskeletal
5048442|NCT01431248|Preterm Premature Rupture of Membranes|preterm premature rupture of membranes
5048443|NCT01431248|Erythromycin|erythromycin
5048444|NCT01431248|Azithromycin|azithromycin
5048447|NCT01431235|cognitive behavioral therapy|cognitive behavioral therapy
5048448|NCT01431222|severe mitral regurgitation|severe mitral regurgitation
5048449|NCT01431222|interventional mitral valve reconstruction|interventional mitral valve reconstruction
5048450|NCT01431222|inoperable|inoperable
5048451|NCT01431222|EuroSCORE|euroscore
5048452|NCT01431222|STS Risk Score|sts risk score
5048453|NCT01431222|MitraClip|mitraclip
5048454|NCT01431222|fluoroscopy|fluoroscopy
5048455|NCT01431222|echocardiography|echocardiography
5048456|NCT01431222|percutaneous treatment of mitral regurgitation|percutaneous treatment of mitral regurgitation
5048457|NCT01431196|breast cancer|breast cancer
5048458|NCT01431196|neoadjuvant chemotherapy|neoadjuvant chemotherapy
5048459|NCT01431196|autologous dendritic cell vaccination|autologous dendritic cell vaccination
5048460|NCT01431183|influenza|influenza
5048461|NCT01431183|vaccine|vaccine
5048462|NCT01431183|reminder / recall|reminder / recall
5048463|NCT01431183|immunization registry|immunization registry
5048464|NCT01431183|immunization information systems|immunization information systems
5048465|NCT01431157|Sleep Apnea Syndrome|sleep apnea syndrome
5048466|NCT01431157|Heart Failure|heart failure
5048467|NCT01431157|Oxygen Inhalation Therapy|oxygen inhalation therapy
5048468|NCT01431144|soft tissue thickness|soft tissue thickness
5048469|NCT01431144|dental implant|dental implant
5048470|NCT01431144|soft tissue recession|soft tissue recession
5048471|NCT01431144|implant exposure|implant exposure
5048472|NCT01431131|graft placement|graft placement
5048473|NCT01431131|bone resorption|bone resorption
5048474|NCT01431118|iron metabolism|iron metabolism
5048475|NCT01431118|hepcidin|hepcidin
5048476|NCT01431118|dragon boating|dragon boating
5048477|NCT01431118|sport-specific stress|sport-specific stress
5048478|NCT01431118|iron|iron
5048479|NCT01431118|anaemia|anaemia
5048480|NCT01431118|sport|sport
5048481|NCT01431105|Kawasaki disease|kawasaki disease
5048482|NCT01431079|HPV|hpv
5048483|NCT01431079|College men|college men
5048484|NCT01431079|HPV vaccine|hpv vaccine
5048485|NCT01431079|Health belief model|health belief model
5048486|NCT01431079|HPV vaccine acceptance|hpv vaccine acceptance
5048487|NCT01431053|exemestane|exemestane
5048488|NCT01431053|aspirin|aspirin
5048489|NCT01431053|quality of life|quality of life
5048490|NCT01431040|Bowel Prep|bowel prep
5048491|NCT01431040|No bowel prep|no bowel prep
5048492|NCT01431040|Vaginal reconstructive or obliterative surgery|vaginal reconstructive or obliterative surgery
5048493|NCT01431027|Heart Failure|heart failure
5048494|NCT01431027|Diastolic Heart Failure|diastolic heart failure
5048495|NCT01431027|Heart Failure with Normal Ejection Fraction|heart failure with normal ejection fraction
5048496|NCT01431014|orthognathic surgery|orthognathic surgery
5048497|NCT01431014|steroid|steroid
5048498|NCT01431014|swelling|swelling
5048499|NCT01431014|3-dimensional photogrammetry|3-dimensional photogrammetry
5048500|NCT01431001|Depression|depression
5048501|NCT01431001|MDD|mdd
5048502|NCT01431001|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
5048503|NCT01431001|Depressive Disorder|depressive disorder
5048504|NCT01431001|TMS|tms
5048505|NCT01430988|Head Injuries|head injuries
5048506|NCT01430988|Head Trauma|head trauma
5048507|NCT01430988|TBI (Traumatic Brain Injury)|tbi (traumatic brain injury)
5048508|NCT01430988|Emergency Department|emergency department
5048509|NCT01430988|Accident & Emergency|accident & emergency
5048510|NCT01430975|Radiation Exposure|radiation exposure
5048511|NCT01430975|Rubidium 82|rubidium 82
5048512|NCT01430975|Strontium 82|strontium 82
5048513|NCT01430975|Strontium 85|strontium 85
5048514|NCT01430962|EBUS|ebus
5048515|NCT01430962|mediastinal lymph nodes|mediastinal lymph nodes
5048516|NCT01430962|mediastinal masses|mediastinal masses
5048517|NCT01430962|anesthesia|anesthesia
5048518|NCT01430962|moderate sedation|moderate sedation
5048519|NCT01430949|Paroxysmal Atrial Fibrillation|paroxysmal atrial fibrillation
5048520|NCT01430949|Catheter Ablation|catheter ablation
5048521|NCT01430949|Pulmonary Vein Isolation|pulmonary vein isolation
5048522|NCT01430949|Radio Frequency Ablation|radio frequency ablation
5048523|NCT01430936|Vascular Diseases|vascular diseases
5048524|NCT01430936|Hypertension|hypertension
5048525|NCT01430936|Chronic Kidney Disease|chronic kidney disease
5048526|NCT01430936|COPD|copd
5048527|NCT01430923|Refrigeration free latanoprost|refrigeration free latanoprost
5048528|NCT01430910|Phase 1|phase 1
5048529|NCT01430910|open label|open label
5048530|NCT01430910|ceftazidime|ceftazidime
5048531|NCT01430910|pharmacokinetics|pharmacokinetics
5048532|NCT01430910|urinary tract infection|urinary tract infection
5048533|NCT01430910|intra-abdominal infection|intra-abdominal infection
5048534|NCT01430897|d-TGA|d-tga
5048535|NCT01430897|dextro Transposition of the great arteries|dextro transposition of the great arteries
5048536|NCT01430897|systemic right ventricle|systemic right ventricle
5048537|NCT01430897|right ventricular failure|right ventricular failure
5048538|NCT01430897|Atrial switch procedure|atrial switch procedure
5048539|NCT01430884|coronary aspirate blood|coronary aspirate blood
5048540|NCT01430884|particular debris / microemboli|particular debris / microemboli
5048541|NCT01430884|distal occlusion device|distal occlusion device
5048542|NCT01430858|Fracture|fracture
5048543|NCT01430858|Anabolic|anabolic
5048544|NCT01430858|Vibration|vibration
5048545|NCT01430858|Strain Gauge|strain gauge
5048546|NCT01430858|Focus - Osteoporosis|focus - osteoporosis
5048547|NCT01430845|GDD|gdd
5048548|NCT01430845|CP|cp
5048549|NCT01430845|MR|mr
5048550|NCT01430845|PDD|pdd
5048551|NCT01430845|ASD|asd
5048552|NCT01430845|BSID|bsid
5048553|NCT01430832|PTSD|ptsd
5048554|NCT01430832|Preterm|preterm
5048555|NCT01430832|Premature|premature
5048556|NCT01430832|VLBW|vlbw
5048557|NCT01430819|Influenza|influenza
5048558|NCT01430819|Influenza Virus Vaccine|influenza virus vaccine
5048559|NCT01430819|Fluzone® 2011-2012 Formulation|fluzone® 2011-2012 formulation
5048560|NCT01430819|Fluzone® High-Dose 2011-2012 Formulation|fluzone® high-dose 2011-2012 formulation
5048561|NCT01430819|Trivalent Inactivated Influenza Vaccine|trivalent inactivated influenza vaccine
5048562|NCT01430780|Coronary artery disease|coronary artery disease
5048563|NCT01430780|nitrate|nitrate
5048564|NCT01430780|endothelium|endothelium
5048565|NCT01430767|adherence|adherence
5048566|NCT01430754|Blindness|blindness
5048567|NCT01430754|Eye Diseases|eye diseases
5048568|NCT01430754|Nap Disorders|nap disorders
5048569|NCT01430754|Circadian Rhythm Disorders|circadian rhythm disorders
5048570|NCT01430754|Sleep Disorders|sleep disorders
5048571|NCT01430754|Circadian Rhythm Sleep Disorders|circadian rhythm sleep disorders
5048572|NCT01430754|Dyssomnias|dyssomnias
5048573|NCT01430754|Nervous System Diseases|nervous system diseases
5048574|NCT01430741|Implementation Science|implementation science
5048575|NCT01430741|Supportive Housing|supportive housing
5048576|NCT01430741|Co-occurring disorders|co-occurring disorders
5048577|NCT01430741|Cluster randomized controlled trial|cluster randomized controlled trial
5048578|NCT01430741|Hybrid implementation-effectiveness trial|hybrid implementation-effectiveness trial
5048579|NCT01430715|active video game|active video game
5048580|NCT01430715|video gaming|video gaming
5048581|NCT01430715|accelerometery|accelerometery
5048582|NCT01430715|MVPA|mvpa
5048583|NCT01430715|outdoor play|outdoor play
5048584|NCT01430715|children|children
5048585|NCT01430715|unstructured|unstructured
5048586|NCT01430715|energy expenditure|energy expenditure
5048587|NCT01430689|Influenza|influenza
5048588|NCT01430689|Pregnancy|pregnancy
5048589|NCT01430689|Neonates|neonates
5048590|NCT01430676|Incisional hernia|incisional hernia
5048591|NCT01430676|recurrence|recurrence
5048592|NCT01430676|longterm|longterm
5048593|NCT01430663|aspergillosis|aspergillosis
5048594|NCT01430663|bronchoalveolar lavage|bronchoalveolar lavage
5048595|NCT01430663|galactomannan|galactomannan
5048596|NCT01430663|pcr|pcr
5048597|NCT01430663|hematological patients|hematological patients
5048598|NCT01430650|Oral estrogens|oral estrogens
5048599|NCT01430650|transdermal estrogens|transdermal estrogens
5048600|NCT01430650|endometrial priming|endometrial priming
5048601|NCT01430637|childhood desmoplastic small round cell tumor|childhood desmoplastic small round cell tumor
5048602|NCT01430637|metastatic childhood soft tissue sarcoma|metastatic childhood soft tissue sarcoma
5048603|NCT01430637|nonmetastatic childhood soft tissue sarcoma|nonmetastatic childhood soft tissue sarcoma
5048604|NCT01430637|recurrent childhood soft tissue sarcoma|recurrent childhood soft tissue sarcoma
5048605|NCT01430637|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
5048606|NCT01430637|stage I adult soft tissue sarcoma|stage i adult soft tissue sarcoma
5048607|NCT01430637|stage II adult soft tissue sarcoma|stage ii adult soft tissue sarcoma
5048608|NCT01430637|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
5048609|NCT01430637|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
5048610|NCT01430637|adult desmoplastic small round cell tumor|adult desmoplastic small round cell tumor
5048611|NCT01430624|Rape|rape
5048612|NCT01430624|Secondary prevention|secondary prevention
5048613|NCT01430624|Intervention|intervention
5048614|NCT01430611|Meningitis|meningitis
5048615|NCT01430611|Neisseria meningitidis|neisseria meningitidis
5048616|NCT01430611|Meningo A+C®|meningo a+c®
5048617|NCT01430611|Meng Ling Kang®|meng ling kang®
5048618|NCT01430598|Full Thickness Rotator Cuff Tear and Acromial Spur|full thickness rotator cuff tear and acromial spur
5048619|NCT01430585|Ki-67|ki-67
5048620|NCT01430585|postmenopausal early breast cancer|postmenopausal early breast cancer
5048621|NCT01430585|ER positive/HER2 negative early breast cancer|er positive/her2 negative early breast cancer
5048622|NCT01430572|Advanced Cancers|advanced cancers
5048623|NCT01430572|Solid Tumors|solid tumors
5048624|NCT01430572|PI3KCA Mutation Positive/PTEN|pi3kca mutation positive/pten
5048625|NCT01430572|Refractory to standard therapy|refractory to standard therapy
5048626|NCT01430572|Relapsed after standard therapy|relapsed after standard therapy
5048627|NCT01430572|Pazopanib|pazopanib
5048628|NCT01430572|GW786034|gw786034
5048629|NCT01430572|Everolimus|everolimus
5048630|NCT01430572|Afinitor|afinitor
5048631|NCT01430572|RAD001|rad001
5048632|NCT01430559|Validation of the WOMAC in Chinese subjects with osteoarthritis of the knee|validation of the womac in chinese subjects with osteoarthritis of the knee
5048633|NCT01430546|Relapsed and Refractory Multiple Myeloma|relapsed and refractory multiple myeloma
5048634|NCT01430533|dermal sensitization potential|dermal sensitization potential
5048635|NCT01430507|Anti-inflammatory drugs, DMARD|anti-inflammatory drugs, dmard
5048636|NCT01430481|rosehip|rosehip
5048637|NCT01430481|osteoarthritis|osteoarthritis
5048638|NCT01430481|pain|pain
5048639|NCT01430481|knee|knee
5048640|NCT01430481|RCT|rct
5048641|NCT01430468|Glenoid component position|glenoid component position
5048642|NCT01430468|patient specific instruments|patient specific instruments
5048643|NCT01430455|Major Depressive Episode|major depressive episode
5048644|NCT01430455|Depression NOS|depression nos
5048645|NCT01430455|Bipolar Disorder|bipolar disorder
5048646|NCT01430455|Bipolar Disorder I|bipolar disorder i
5048647|NCT01430455|Bipolar Disorder II|bipolar disorder ii
5048648|NCT01430455|Bipolar Depression|bipolar depression
5048649|NCT01430455|Major Depression|major depression
5048650|NCT01430416|Uveal melanoma|uveal melanoma
5048651|NCT01430416|phase 1|phase 1
5048652|NCT01430416|AEB071|aeb071
5048653|NCT01430416|Metastatic|metastatic
5048654|NCT01430403|persistent allergic asthma|persistent allergic asthma
5048655|NCT01430403|asthma exacerbations reduction|asthma exacerbations reduction
5048656|NCT01430403|Xolair® (omalizumab)|xolair® (omalizumab)
5048657|NCT01430403|Flovent® Diskus® (fluticasone)|flovent® diskus® (fluticasone)
5048658|NCT01430403|placebo|placebo
5048659|NCT01430403|inhaled corticosteroid therapy|inhaled corticosteroid therapy
5048660|NCT01430403|anti-immunoglobulin E therapy|anti-immunoglobulin e therapy
5048661|NCT01430403|anti-IgE therapy|anti-ige therapy
5048662|NCT01430390|In Vitro Expanded Allogeneic Epstein-Barr Virus Specific Cytotoxic|in vitro expanded allogeneic epstein-barr virus specific cytotoxic
5048663|NCT01430390|T-Lymphocytes (EBV-CTLs)|t-lymphocytes (ebv-ctls)
5048664|NCT01430390|CD19 specific T-cells|cd19 specific t-cells
5048665|NCT01430390|11-038|11-038
5048666|NCT01430377|periprocedural myonecrosis|periprocedural myonecrosis
5048667|NCT01430377|procedure time|procedure time
5048668|NCT01430377|fluoroscopy time|fluoroscopy time
5048669|NCT01430364|coronary bifurcation stenosis|coronary bifurcation stenosis
5048670|NCT01430364|dedicated bifurcation stent|dedicated bifurcation stent
5048671|NCT01430364|sirolymus|sirolymus
5048672|NCT01430364|PTS|pts
5048673|NCT01430364|BiOSS Lym|bioss lym
5048674|NCT01430351|Brain cancer|brain cancer
5048675|NCT01430351|Central nervous system|central nervous system
5048676|NCT01430351|Glioblastoma Multiforme|glioblastoma multiforme
5048677|NCT01430351|GBM|gbm
5048678|NCT01430351|Post Radiation Therapy|post radiation therapy
5048679|NCT01430351|Post-RT|post-rt
5048680|NCT01430351|External beam radiotherapy|external beam radiotherapy
5048681|NCT01430351|XRT|xrt
5048682|NCT01430351|Supratentorial glioblastoma|supratentorial glioblastoma
5048683|NCT01430351|Gliosarcoma|gliosarcoma
5048684|NCT01430351|Grade IV astrocytoma|grade iv astrocytoma
5048685|NCT01430351|Temozolomide|temozolomide
5048686|NCT01430351|Temodar|temodar
5048687|NCT01430351|Memantine|memantine
5048688|NCT01430351|Namenda|namenda
5048689|NCT01430351|Mefloquine|mefloquine
5048690|NCT01430351|Apo-Mefloquine|apo-mefloquine
5048691|NCT01430351|Lariam|lariam
5048692|NCT01430351|Metformin|metformin
5048693|NCT01430325|Hyperbaric oxygen|hyperbaric oxygen
5048694|NCT01430312|dermal irritative potential|dermal irritative potential
5048695|NCT01430286|Caregivers|caregivers
5048696|NCT01430286|Alzheimer Disease|alzheimer disease
5048697|NCT01430286|Psychological stress|psychological stress
5048698|NCT01430286|Psychological adaptation|psychological adaptation
5048699|NCT01430286|Self-efficacy|self-efficacy
5048700|NCT01430286|Randomized controlled trial|randomized controlled trial
5048701|NCT01430273|Antiplatelet therapy|antiplatelet therapy
5048702|NCT01430273|Surgery|surgery
5048703|NCT01430273|Bleeding|bleeding
5048704|NCT01430273|Platelet aggregation|platelet aggregation
5048705|NCT01430260|efficacy|efficacy
5048706|NCT01430260|ciclesonide|ciclesonide
5048707|NCT01430260|levocetirizine|levocetirizine
5048708|NCT01430260|allergic rhinitis|allergic rhinitis
5048709|NCT01430247|amblyopia|amblyopia
5048710|NCT01430247|amblyogenic factors|amblyogenic factors
5048711|NCT01430247|screening|screening
5048712|NCT01430247|preschool children|preschool children
5048713|NCT01430247|visual acuity|visual acuity
5048714|NCT01430247|prevalence|prevalence
5048715|NCT01430234|Chronic pancreatitis|chronic pancreatitis
5048716|NCT01430234|Exocrine insufficiency|exocrine insufficiency
5048717|NCT01430234|Pancreatic enzyme replacement therapy|pancreatic enzyme replacement therapy
5048718|NCT01430234|Self-administration|self-administration
5048719|NCT01430221|prediabetes|prediabetes
5048720|NCT01430221|severity of depressive symptoms|severity of depressive symptoms
5048721|NCT01430221|mindfulness|mindfulness
5048722|NCT01430221|personalized health planning|personalized health planning
5048723|NCT01430221|cardiometabolic diseases prevention|cardiometabolic diseases prevention
5048724|NCT01430208|endometrial pathology|endometrial pathology
5048725|NCT01430195|vitiligo|vitiligo
5048726|NCT01430195|depigmentation|depigmentation
5048727|NCT01430195|phototherapy|phototherapy
5048728|NCT01430195|non-segmental vitiligo|non-segmental vitiligo
5048729|NCT01430182|Adult|adult
5048730|NCT01430182|Female|female
5048731|NCT01430182|Humans|humans
5048732|NCT01430182|Intraoperative Care/methods|intraoperative care/methods
5048733|NCT01430182|Male|male
5048734|NCT01430182|Methadone/administration & dosage|methadone/administration & dosage
5048928|NCT01429350|rtPA|rtpa
5048735|NCT01430182|Analgesics/therapeutic use|analgesics/therapeutic use
5048736|NCT01430182|Methadone/therapeutic use|methadone/therapeutic use
5048737|NCT01430182|Morphine/therapeutic use|morphine/therapeutic use
5048738|NCT01430182|Middle Aged|middle aged
5048739|NCT01430182|Pain Measurement/drug effects|pain measurement/drug effects
5048740|NCT01430182|Pain Measurement/methods|pain measurement/methods
5048741|NCT01430182|Pain, Postoperative/prevention & control|pain, postoperative/prevention & control
5048742|NCT01430182|Prospective Studies|prospective studies
5048743|NCT01430182|Double-Blind Method|double-blind method
5048744|NCT01430182|Tibial Fractures/surgery|tibial fractures/surgery
5048745|NCT01430182|Young Adult|young adult
5048746|NCT01430182|Orthopedics|orthopedics
5048747|NCT01430169|Xiaflex|xiaflex
5048748|NCT01430169|Xiapex|xiapex
5048749|NCT01430169|Collagenase clostridium histolyticum|collagenase clostridium histolyticum
5048750|NCT01430156|Renal Transplantation|renal transplantation
5048751|NCT01430156|Ischemia-reperfusion injury|ischemia-reperfusion injury
5048752|NCT01430156|Heme-oxygenase 1|heme-oxygenase 1
5048753|NCT01430156|Heme arginate|heme arginate
5048754|NCT01430143|Exercise|exercise
5048755|NCT01430130|scar|scar
5048756|NCT01430130|incision|incision
5048757|NCT01430130|wound healing|wound healing
5048758|NCT01430130|scarring|scarring
5048759|NCT01430130|scar revision|scar revision
5048760|NCT01430117|Immunotherapy|immunotherapy
5048761|NCT01430117|Skin prick test|skin prick test
5048762|NCT01430117|Standardization|standardization
5048763|NCT01430117|Poa pratensis|poa pratensis
5048764|NCT01430078|ASP015K|asp015k
5048765|NCT01430078|Healthy subjects|healthy subjects
5048766|NCT01430078|Pharmacokinetics of ASP015K|pharmacokinetics of asp015k
5048767|NCT01430065|transplant|transplant
5048768|NCT01430065|ASP015K|asp015k
5048769|NCT01430065|tacrolimus|tacrolimus
5048770|NCT01430065|Prograf|prograf
5048771|NCT01430065|healthy volunteers|healthy volunteers
5048772|NCT01430039|Crohn's disease|crohn's disease
5048773|NCT01430039|ulcerative colitis|ulcerative colitis
5048774|NCT01430039|Syndecan-1|syndecan-1
5048775|NCT01430026|chronic sinusitis|chronic sinusitis
5048776|NCT01430026|gentamicin nasal irrigation|gentamicin nasal irrigation
5048777|NCT01429987|Chronic Idiopathic Constipation|chronic idiopathic constipation
5048778|NCT01429987|Constipation|constipation
5048779|NCT01429987|Sign and Symptoms: Digestive|sign and symptoms: digestive
5048780|NCT01429974|amniotic fluid|amniotic fluid
5048781|NCT01429974|post term pregnancies|post term pregnancies
5048782|NCT01429948|Stroke, Ischemic|stroke, ischemic
5048783|NCT01429948|Patent foramen ovale|patent foramen ovale
5048784|NCT01429948|Magnetic resonance imaging|magnetic resonance imaging
5048785|NCT01429948|Paradoxical embolism|paradoxical embolism
5048786|NCT01429948|Transcranial Doppler|transcranial doppler
5048787|NCT01429948|Silent cerebral infarct|silent cerebral infarct
5048788|NCT01429935|dental pain model|dental pain model
5048789|NCT01429935|Ginger powder|ginger powder
5048790|NCT01429935|CRP|crp
5048791|NCT01429909|Functional magnetic resonance imaging|functional magnetic resonance imaging
5048792|NCT01429909|T2*|t2*
5048793|NCT01429909|cortex and basal ganglia|cortex and basal ganglia
5048794|NCT01429909|Parkinson's disease|parkinson's disease
5048795|NCT01429896|peanut allergy|peanut allergy
5048796|NCT01429896|food allergy|food allergy
5048797|NCT01429896|thresholds|thresholds
5048798|NCT01429896|anaphylaxis|anaphylaxis
5048799|NCT01429896|food labelling|food labelling
5048800|NCT01429896|food challenges|food challenges
5048801|NCT01429896|peanut challenges|peanut challenges
5048802|NCT01429857|Troponin concentration in heart failure|troponin concentration in heart failure
5048803|NCT01429844|Calcineurin inhibitors|calcineurin inhibitors
5048804|NCT01429844|Bronchiolitis obliterans|bronchiolitis obliterans
5048805|NCT01429844|Lung transplantation|lung transplantation
5048806|NCT01429844|Cyclosporine|cyclosporine
5048807|NCT01429844|Tacrolimus|tacrolimus
5048808|NCT01429844|Mycophenolate|mycophenolate
5048809|NCT01429844|Steroids|steroids
5048810|NCT01429844|Chronic rejection|chronic rejection
5048811|NCT01429844|Acute rejection|acute rejection
5048812|NCT01429844|Obliterative bronchiolitis|obliterative bronchiolitis
5048813|NCT01429818|Endothelial dysfunction|endothelial dysfunction
5048814|NCT01429818|Diabetes mellitus|diabetes mellitus
5048815|NCT01429818|glimepiride|glimepiride
5048816|NCT01429818|metformin|metformin
5048817|NCT01429805|Hip arthroscopy|hip arthroscopy
5048818|NCT01429779|General surgery|general surgery
5048819|NCT01429766|Breath holding times|breath holding times
5048820|NCT01429766|Phases of respiration|phases of respiration
5048821|NCT01429766|Radiotherapy|radiotherapy
5048822|NCT01429753|Cardiac resychronisation therapy|cardiac resychronisation therapy
5048823|NCT01429753|Heart failure|heart failure
5048824|NCT01429753|Imaging guided LV lead placement|imaging guided lv lead placement
5048825|NCT01429740|PF 05180999|pf 05180999
5048826|NCT01429740|safety|safety
5048827|NCT01429740|pharmacokinetics|pharmacokinetics
5048828|NCT01429727|Spontaneous coronary artery dissection|spontaneous coronary artery dissection
5048829|NCT01429727|SCAD|scad
5048830|NCT01429727|coronary artery disease|coronary artery disease
5048831|NCT01429727|myocardial infarction|myocardial infarction
5049128|NCT01428726|NT-KO-003|nt-ko-003
5048832|NCT01429727|coronary dissection|coronary dissection
5048833|NCT01429714|Elastic Compression Stockings|elastic compression stockings
5048834|NCT01429714|Deep Venous Thrombosis|deep venous thrombosis
5048835|NCT01429714|Post Thrombotic Syndrome|post thrombotic syndrome
5048836|NCT01429701|Dermatitis|dermatitis
5048837|NCT01429701|Dermatitis, Atopic|dermatitis, atopic
5048838|NCT01429662|postmenopause|postmenopause
5048839|NCT01429662|hypertension|hypertension
5048840|NCT01429662|relaxation|relaxation
5048841|NCT01429662|SBP 140-159 mmHg|sbp 140-159 mmhg
5048842|NCT01429662|DBP 90-99 mmHg|dbp 90-99 mmhg
5048843|NCT01429662|stage 1 or mild hypertension|stage 1 or mild hypertension
5048844|NCT01429649|pure pulmonary ground glass opacity|pure pulmonary ground glass opacity
5048845|NCT01429636|perimenopause|perimenopause
5048846|NCT01429636|postmenopause|postmenopause
5048847|NCT01429636|vasomotor symptoms|vasomotor symptoms
5048848|NCT01429636|relaxation|relaxation
5048849|NCT01429623|Mild Cognitive Impairment|mild cognitive impairment
5048850|NCT01429623|Early Stage Dementia|early stage dementia
5048851|NCT01429623|Conversion to Alzheimer's disease|conversion to alzheimer's disease
5048852|NCT01429623|Memory Impairment|memory impairment
5048853|NCT01429610|acute lymphoblastic leukemia|acute lymphoblastic leukemia
5048854|NCT01429610|rituximab|rituximab
5048855|NCT01429610|VPDL|vpdl
5048856|NCT01429610|CD20|cd20
5048857|NCT01429597|Cerebrovascular Accident|cerebrovascular accident
5048858|NCT01429597|Cerebrovascular Accident, Acute|cerebrovascular accident, acute
5048859|NCT01429597|Fabry Disease|fabry disease
5048860|NCT01429597|Fabry´s Disease|fabry´s disease
5048861|NCT01429597|Anderson-Fabry Disease|anderson-fabry disease
5048862|NCT01429597|CVA (Cerebrovascular Accident)|cva (cerebrovascular accident)
5048863|NCT01429597|Stroke, Acute|stroke, acute
5048864|NCT01429597|Cerebral Stroke|cerebral stroke
5048865|NCT01429584|bupivacaine concentration|bupivacaine concentration
5048866|NCT01429584|interscalene nerve block|interscalene nerve block
5048867|NCT01429584|diaphragm function|diaphragm function
5048868|NCT01429584|diaphragm weakness|diaphragm weakness
5048869|NCT01429558|treatment resistant obsessive-compulsive disorder|treatment resistant obsessive-compulsive disorder
5048870|NCT01429545|Tocolysis|tocolysis
5048871|NCT01429545|atosiban|atosiban
5048872|NCT01429545|nifedipine|nifedipine
5048873|NCT01429545|combination|combination
5048874|NCT01429532|Cataract|cataract
5048875|NCT01429519|chronic wound|chronic wound
5048876|NCT01429519|ulcerated wound|ulcerated wound
5048877|NCT01429519|venous insufficiency|venous insufficiency
5048878|NCT01429519|lymphatic insufficiency|lymphatic insufficiency
5048879|NCT01429519|neuropathic wound|neuropathic wound
5048880|NCT01429519|diabetic ulcer|diabetic ulcer
5048881|NCT01429519|post- operative|post- operative
5048882|NCT01429519|post-traumatic chronic wound|post-traumatic chronic wound
5048883|NCT01429506|Sleeve gastrectomy|sleeve gastrectomy
5048884|NCT01429506|Intensive medical management|intensive medical management
5048885|NCT01429480|Analgesia, postoperative|analgesia, postoperative
5048886|NCT01429467|Glucose Variability|glucose variability
5048887|NCT01429467|Continuous Glucose Monitoring|continuous glucose monitoring
5048888|NCT01429467|Hypoxia-inducible Factor (HIF)|hypoxia-inducible factor (hif)
5048889|NCT01429467|Vascular Endothelial Growth Factor (VEGF)|vascular endothelial growth factor (vegf)
5048890|NCT01429467|Erythropoietin|erythropoietin
5048891|NCT01429467|Cortisol|cortisol
5048892|NCT01429454|Prodromal|prodromal
5048893|NCT01429454|Schizophrenia|schizophrenia
5048894|NCT01429454|Psychosis|psychosis
5048895|NCT01429454|Omega|omega
5048896|NCT01429428|Cellulitis|cellulitis
5048897|NCT01429428|Skin ultra-sound images|skin ultra-sound images
5048898|NCT01429428|Treatment|treatment
5048899|NCT01429428|Infra-red light|infra-red light
5048900|NCT01429415|pediatric|pediatric
5048901|NCT01429415|Acute Asthma|acute asthma
5048902|NCT01429415|Inhaled Magnesium|inhaled magnesium
5048903|NCT01429402|Botulinum toxin A.|botulinum toxin a.
5048904|NCT01429402|Cleft lip scar|cleft lip scar
5048905|NCT01429389|Down syndrome|down syndrome
5048906|NCT01429389|fetal aneuploidy|fetal aneuploidy
5048907|NCT01429389|trisomy|trisomy
5048908|NCT01429389|noninvasive screening test|noninvasive screening test
5048909|NCT01429376|Chronic heart failure|chronic heart failure
5048910|NCT01429376|Pulmonary function abnormalities/impairment|pulmonary function abnormalities/impairment
5048911|NCT01429376|Restriction|restriction
5048912|NCT01429376|Airway obstruction|airway obstruction
5048913|NCT01429376|Diffusion impairment|diffusion impairment
5048914|NCT01429376|Pulmonary function tests|pulmonary function tests
5048915|NCT01429376|Chronic obstructive pulmonary disease (COPD)|chronic obstructive pulmonary disease (copd)
5048916|NCT01429376|Prevalence|prevalence
5048917|NCT01429376|Overdiagnosis|overdiagnosis
5048918|NCT01429376|Underdiagnosis|underdiagnosis
5048919|NCT01429376|Systemic inflammation|systemic inflammation
5048920|NCT01429376|Diagnostic Errors|diagnostic errors
5048921|NCT01429363|contained herniated lumbar discs|contained herniated lumbar discs
5048922|NCT01429363|TDD|tdd
5048923|NCT01429363|Case series|case series
5048924|NCT01429363|RCT|rct
5048925|NCT01429350|ischemic stroke|ischemic stroke
5048926|NCT01429350|acute intervention|acute intervention
5048927|NCT01429350|thrombolysis|thrombolysis
5048929|NCT01429350|internal carotid artery|internal carotid artery
5048930|NCT01429350|middle cerebral artery|middle cerebral artery
5048931|NCT01429350|mechanical thrombectomy|mechanical thrombectomy
5048932|NCT01429350|Penumbra System|penumbra system
5048933|NCT01429350|clot length|clot length
5048934|NCT01429350|mRS|mrs
5048935|NCT01429350|NIHSS|nihss
5048936|NCT01429337|Pharmacokinetics|pharmacokinetics
5048937|NCT01429337|Hepatic impaired patients|hepatic impaired patients
5048938|NCT01429337|Healthy volunteers|healthy volunteers
5048939|NCT01429337|Varying degrees of hepatic impairment|varying degrees of hepatic impairment
5048940|NCT01429324|Near infrared spectroscopy|near infrared spectroscopy
5048941|NCT01429324|neuromonitoring|neuromonitoring
5048942|NCT01429324|aortic arch surgery|aortic arch surgery
5048943|NCT01429311|Atopic Dermatitis|atopic dermatitis
5048944|NCT01429311|Eczema herpeticum|eczema herpeticum
5048945|NCT01429311|Interferon gamma|interferon gamma
5048946|NCT01429311|IFNγ|ifnγ
5048947|NCT01429298|Acute|acute
5048948|NCT01429298|Pain|pain
5048949|NCT01429298|Emergency Department|emergency department
5048950|NCT01429298|Hydromorphone|hydromorphone
5048951|NCT01429298|Protocol|protocol
5048952|NCT01429285|Pain|pain
5048953|NCT01429285|Hydromorphone|hydromorphone
5048954|NCT01429285|Acute|acute
5048955|NCT01429285|Emergency Department|emergency department
5048956|NCT01429272|Bipolar Disorder|bipolar disorder
5048957|NCT01429272|Minocycline|minocycline
5048958|NCT01429259|Cystic Fibrosis|cystic fibrosis
5048959|NCT01429259|Acute Pulmonary Exacerbations|acute pulmonary exacerbations
5048960|NCT01429259|Pseudomonas aeruginosa|pseudomonas aeruginosa
5048961|NCT01429246|Hypertension|hypertension
5048962|NCT01429246|Diet Therapy|diet therapy
5048963|NCT01429246|Sodium Chloride, Dietary|sodium chloride, dietary
5048964|NCT01429246|Tibet|tibet
5048965|NCT01429246|Aged|aged
5048966|NCT01429233|Observational|observational
5048967|NCT01429233|Colombia|colombia
5048968|NCT01429220|deep brain stimulation|deep brain stimulation
5048969|NCT01429220|monopolar review|monopolar review
5048970|NCT01429220|motion sensors|motion sensors
5048971|NCT01429220|tremor|tremor
5048972|NCT01429220|bradykinesia|bradykinesia
5048973|NCT01429207|levodopa|levodopa
5048974|NCT01429207|tremor|tremor
5048975|NCT01429207|bradykinesia|bradykinesia
5048976|NCT01429207|motion sensors|motion sensors
5048977|NCT01429194|Weight Loss|weight loss
5048978|NCT01429194|Trans-oral Endoscopic Procedure|trans-oral endoscopic procedure
5048979|NCT01429194|Gastric Plication|gastric plication
5048980|NCT01429181|Peripheral Neuropathic Pain|peripheral neuropathic pain
5048981|NCT01429155|End stage liver disease|end stage liver disease
5048982|NCT01429155|Living donor liver transplantation|living donor liver transplantation
5048983|NCT01429155|Hepatitis C|hepatitis c
5048984|NCT01429155|Interleukin 28B|interleukin 28b
5048985|NCT01429129|Smoking|smoking
5048986|NCT01429129|Nicotine|nicotine
5048987|NCT01429129|Nicotine Replacement Therapy|nicotine replacement therapy
5048988|NCT01429129|Nicotine Patch|nicotine patch
5048989|NCT01429129|Nicoderm|nicoderm
5048990|NCT01429129|Mass Distribution|mass distribution
5048991|NCT01429129|Tobacco Control|tobacco control
5048992|NCT01429129|Randomized Controlled Trial|randomized controlled trial
5048993|NCT01429116|Blindness|blindness
5048994|NCT01429116|Eye Diseases|eye diseases
5048995|NCT01429116|Nap Disorders|nap disorders
5048996|NCT01429116|Circadian Rhythm Disorders|circadian rhythm disorders
5048997|NCT01429116|Sleep Disorders|sleep disorders
5048998|NCT01429116|Circadian Rhythm Sleep Disorders|circadian rhythm sleep disorders
5048999|NCT01429116|Dyssomnias|dyssomnias
5049000|NCT01429116|Nervous System Diseases|nervous system diseases
5049001|NCT01429090|Pharmacokinetics|pharmacokinetics
5049002|NCT01429090|Accommodation, Ocular|accommodation, ocular
5049003|NCT01429090|Reflex, Pupillary|reflex, pupillary
5049004|NCT01429090|Salivation|salivation
5049005|NCT01429077|Levodopa|levodopa
5049006|NCT01429077|Ischemic Stroke|ischemic stroke
5049007|NCT01429077|Aphasia|aphasia
5049008|NCT01429077|Speech Rehabilitation|speech rehabilitation
5049009|NCT01429051|Break through pain|break through pain
5049010|NCT01429051|BTP|btp
5049011|NCT01429051|Cancer|cancer
5049012|NCT01429051|Intranasal Fentanyl Spray|intranasal fentanyl spray
5049013|NCT01429051|INFS|infs
5049014|NCT01429051|cancer patients|cancer patients
5049015|NCT01429038|end-stage|end-stage
5049016|NCT01429038|liver diseases|liver diseases
5049017|NCT01429038|cirrhosis|cirrhosis
5049018|NCT01429038|cancer|cancer
5049019|NCT01429038|fulminant hepatic failure|fulminant hepatic failure
5049020|NCT01429038|metabolic hepatic diseases|metabolic hepatic diseases
5049021|NCT01429038|congenital hepatic diseases|congenital hepatic diseases
5049022|NCT01429038|renal diseases|renal diseases
5049023|NCT01429025|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5049024|NCT01429025|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5049025|NCT01429025|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5049026|NCT01429025|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5049129|NCT01428726|RRMS|rrms
5049130|NCT01428726|efficacy|efficacy
5049131|NCT01428726|safety|safety
5049027|NCT01429025|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5049028|NCT01429025|Waldenström macroglobulinemia|waldenström macroglobulinemia
5049029|NCT01429025|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5049030|NCT01429025|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5049031|NCT01429012|bone|bone
5049032|NCT01429012|nonunion fracture|nonunion fracture
5049033|NCT01429012|atrophic nonunion fracture|atrophic nonunion fracture
5049034|NCT01429012|callus|callus
5049035|NCT01429012|mesenchymal stem cells|mesenchymal stem cells
5049036|NCT01429012|cell therapy|cell therapy
5049037|NCT01429012|autologous|autologous
5049038|NCT01429012|indium|indium
5049039|NCT01429012|Pet-scan|pet-scan
5049040|NCT01428999|probiotics|probiotics
5049041|NCT01428999|gastrointestinal function|gastrointestinal function
5049042|NCT01428999|intestinal bacteria flora|intestinal bacteria flora
5049043|NCT01428986|maraviroc|maraviroc
5049044|NCT01428986|osteoclasts|osteoclasts
5049045|NCT01428986|Receptors, CCR5|receptors, ccr5
5049046|NCT01428986|Chemokine CCL5|chemokine ccl5
5049047|NCT01428973|Allogeneic hematopoeitic cell transplantation|allogeneic hematopoeitic cell transplantation
5049048|NCT01428973|Graft-Versus-Host Disease|graft-versus-host disease
5049049|NCT01428973|Prophylaxis|prophylaxis
5049050|NCT01428973|Reduced-intensity conditioning|reduced-intensity conditioning
5049051|NCT01428973|Immunosuppressive regimen|immunosuppressive regimen
5049052|NCT01428973|HLA-matched donor|hla-matched donor
5049053|NCT01428973|Progression free survival|progression free survival
5049054|NCT01428973|Overall survival|overall survival
5049055|NCT01428960|Palm mid fraction|palm mid fraction
5049056|NCT01428960|Shea butter|shea butter
5049057|NCT01428960|sn-1, sn-3 fatty acids|sn-1, sn-3 fatty acids
5049058|NCT01428960|Cholesterol|cholesterol
5049059|NCT01428960|Postprandial lipemia,|postprandial lipemia,
5049060|NCT01428960|Inflammatory markers|inflammatory markers
5049061|NCT01428960|Satiety|satiety
5049062|NCT01428960|Gut hormone|gut hormone
5049063|NCT01428960|Insulin|insulin
5049064|NCT01428921|Long-term efficacy|long-term efficacy
5049065|NCT01428921|Education programme|education programme
5049066|NCT01428921|Adherence|adherence
5049067|NCT01428921|OSA|osa
5049068|NCT01428921|CPAP|cpap
5049069|NCT01428908|immunogenicity|immunogenicity
5049070|NCT01428908|safety|safety
5049071|NCT01428908|group A, C polysaccharide meningitis|group a, c polysaccharide meningitis
5049072|NCT01428908|type b haemophilus Influenza|type b haemophilus influenza
5049073|NCT01428908|conjugate vaccine|conjugate vaccine
5049074|NCT01428895|Bone Metastases|bone metastases
5049075|NCT01428895|Femoral Metastases|femoral metastases
5049076|NCT01428882|Propofol|propofol
5049077|NCT01428882|Midazolam|midazolam
5049078|NCT01428882|Moderate sedation|moderate sedation
5049079|NCT01428882|Deep sedation|deep sedation
5049080|NCT01428882|Colonoscopy|colonoscopy
5049081|NCT01428869|Statins|statins
5049082|NCT01428869|acetylsalicylic acid|acetylsalicylic acid
5049083|NCT01428869|dutasteride|dutasteride
5049084|NCT01428869|Prostate Cancer|prostate cancer
5049085|NCT01428869|Lower urinary tract symptoms|lower urinary tract symptoms
5049086|NCT01428869|prevention|prevention
5049087|NCT01428869|drug interactions|drug interactions
5049088|NCT01428843|Inflammatory Bowel Disease|inflammatory bowel disease
5049089|NCT01428843|Anemia|anemia
5049090|NCT01428843|Anti-TNF alpha theray|anti-tnf alpha theray
5049091|NCT01428843|Ferrisat perfusion|ferrisat perfusion
5049092|NCT01428830|fistula|fistula
5049093|NCT01428830|catheter|catheter
5049094|NCT01428830|surgery|surgery
5049095|NCT01428830|obstetrics|obstetrics
5049096|NCT01428830|gynecology|gynecology
5049097|NCT01428830|urology|urology
5049098|NCT01428817|pregnancy|pregnancy
5049099|NCT01428817|postpartum hemorrhage|postpartum hemorrhage
5049100|NCT01428817|Cesarean delivery|cesarean delivery
5049101|NCT01428817|carbetocin|carbetocin
5049102|NCT01428804|Resistant Major Depression|resistant major depression
5049103|NCT01428804|Mood disorders|mood disorders
5049104|NCT01428804|tDCS|tdcs
5049105|NCT01428791|Geriatrics|geriatrics
5049106|NCT01428791|Older adults|older adults
5049107|NCT01428791|Health Disparities|health disparities
5049108|NCT01428791|Health Services for the Aged|health services for the aged
5049109|NCT01428791|Interdisciplinary Health Team|interdisciplinary health team
5049110|NCT01428791|Depressive symptoms|depressive symptoms
5049111|NCT01428791|Metabolic Syndrome X|metabolic syndrome x
5049112|NCT01428791|Overweight|overweight
5049113|NCT01428791|Obesity|obesity
5049114|NCT01428791|Hypertension|hypertension
5049115|NCT01428791|Hyperglycemia|hyperglycemia
5049116|NCT01428791|Dyslipidemias|dyslipidemias
5049117|NCT01428778|Marathon running|marathon running
5049118|NCT01428778|Brain MRI|brain mri
5049119|NCT01428778|ECG recording|ecg recording
5049120|NCT01428778|Blood tests|blood tests
5049121|NCT01428752|colonoscopy|colonoscopy
5049122|NCT01428752|colorectal neoplasms|colorectal neoplasms
5049123|NCT01428752|screening|screening
5049124|NCT01428752|family history|family history
5049125|NCT01428739|cancer|cancer
5049126|NCT01428739|MRS|mrs
5049127|NCT01428739|Treatment response|treatment response
5049132|NCT01428726|Phase IIa|phase iia
5049133|NCT01428713|menorrhagia|menorrhagia
5049134|NCT01428713|oral contraceptives|oral contraceptives
5049135|NCT01428713|oral tranexamic acid|oral tranexamic acid
5049136|NCT01428687|Weight loss|weight loss
5049137|NCT01428687|Sleep duration|sleep duration
5049138|NCT01428674|Interpersonal mindful compassion|interpersonal mindful compassion
5049139|NCT01428674|Loving kindness meditation|loving kindness meditation
5049140|NCT01428674|Autonomic Nervous System|autonomic nervous system
5049141|NCT01428674|Heart rate variability|heart rate variability
5049142|NCT01428674|Respiratory rate|respiratory rate
5049143|NCT01428674|Relaxation|relaxation
5049144|NCT01428661|tasimelteon|tasimelteon
5049145|NCT01428661|Major Depressive Disorder|major depressive disorder
5049146|NCT01428661|MDD|mdd
5049147|NCT01428661|depression|depression
5049148|NCT01428648|Parkinson|parkinson
5049149|NCT01428648|ballroom dancing|ballroom dancing
5049150|NCT01428635|Leukemia|leukemia
5049151|NCT01428635|Thrombocytopenia|thrombocytopenia
5049152|NCT01428635|Tyrosine kinase therapy|tyrosine kinase therapy
5049153|NCT01428635|TKI|tki
5049154|NCT01428635|Chronic myeloid leukemia|chronic myeloid leukemia
5049155|NCT01428635|CML|cml
5049156|NCT01428635|Platelet count|platelet count
5049157|NCT01428635|Clonal evolution|clonal evolution
5049158|NCT01428635|Eltrombopag|eltrombopag
5049159|NCT01428635|Promacta|promacta
5049160|NCT01428635|Myelofibrosis|myelofibrosis
5049161|NCT01428635|MF|mf
5049162|NCT01428609|Amalgam|amalgam
5049163|NCT01428609|Mercury|mercury
5049164|NCT01428609|Endodontics|endodontics
5049165|NCT01428609|Apicoectomy|apicoectomy
5049166|NCT01428596|HIV-1|hiv-1
5049167|NCT01428596|therapeutic vaccine|therapeutic vaccine
5049168|NCT01428596|immunotherapy|immunotherapy
5049169|NCT01428596|AIDS|aids
5049170|NCT01428583|Chronic noncancer pain|chronic noncancer pain
5049171|NCT01428583|oxycodone|oxycodone
5049172|NCT01428583|naltrexone|naltrexone
5049173|NCT01428570|sleep apnea, obstructive|sleep apnea, obstructive
5049174|NCT01428570|intubation|intubation
5049175|NCT01428557|Heart Failure|heart failure
5049176|NCT01428557|Epidemiology|epidemiology
5049177|NCT01428557|Evidence-Based Practice|evidence-based practice
5049178|NCT01428492|AKT Inhibitor|akt inhibitor
5049179|NCT01428492|hematologic malignancies|hematologic malignancies
5049180|NCT01428492|GSK2110183|gsk2110183
5049181|NCT01428492|bortezomib|bortezomib
5049182|NCT01428492|multiple myeloma|multiple myeloma
5049183|NCT01428492|dexamethasone|dexamethasone
5049184|NCT01428453|Alzheimer's disease|alzheimer's disease
5049185|NCT01428427|Gemcitabine|gemcitabine
5049186|NCT01428427|MEK inhibitor|mek inhibitor
5049187|NCT01428427|GSK1120212|gsk1120212
5049188|NCT01428414|HER2|her2
5049189|NCT01428414|Breast cancer|breast cancer
5049190|NCT01428414|neoadjuvant chemotherapy|neoadjuvant chemotherapy
5049191|NCT01428414|efficacy|efficacy
5049192|NCT01428414|safety|safety
5049193|NCT01428401|Complementary therapies|complementary therapies
5049194|NCT01428401|Acute hemorrhagic stroke|acute hemorrhagic stroke
5049195|NCT01428388|macular edema|macular edema
5049196|NCT01428388|vein occlusion|vein occlusion
5049197|NCT01428388|bevacizumab|bevacizumab
5049198|NCT01428388|ranibizumab|ranibizumab
5049199|NCT01428388|vascular endothelial growth factor|vascular endothelial growth factor
5049200|NCT01428375|intravenous paracetamol|intravenous paracetamol
5049201|NCT01428375|intrapartum analgesia|intrapartum analgesia
5049202|NCT01428375|labor pain|labor pain
5049203|NCT01428375|intrapartum pains|intrapartum pains
5049204|NCT01428362|donepezil|donepezil
5049205|NCT01428362|VI-1121|vi-1121
5049206|NCT01428349|Incarcerated offenders|incarcerated offenders
5049207|NCT01428349|emotionally reactive|emotionally reactive
5049208|NCT01428349|emotionally stable|emotionally stable
5049209|NCT01428349|psychopathy|psychopathy
5049210|NCT01428310|dietary supplement|dietary supplement
5049211|NCT01428310|nutraceutical|nutraceutical
5049212|NCT01428297|Atopic dermatitis|atopic dermatitis
5049213|NCT01428297|Eczema|eczema
5049214|NCT01428297|Skin Diseases, Eczematous|skin diseases, eczematous
5049215|NCT01428297|Netherton syndrome|netherton syndrome
5049216|NCT01428297|Skin Diseases, Genetic|skin diseases, genetic
5049217|NCT01428297|BPR277|bpr277
5049218|NCT01428284|Healthy Volunteers|healthy volunteers
5049219|NCT01428284|Canagliflozin (JNJ-28431754)|canagliflozin (jnj-28431754)
5049220|NCT01428284|Pharmacokinetic|pharmacokinetic
5049221|NCT01428284|Probenecid|probenecid
5049222|NCT01428258|Diet therapy|diet therapy
5049223|NCT01428258|Low phenylalanine diet|low phenylalanine diet
5049224|NCT01428258|Attention|attention
5049225|NCT01428258|Executive function|executive function
5049226|NCT01428232|Breastfeeding|breastfeeding
5049227|NCT01428232|Baby Friendly Hospital Initiative|baby friendly hospital initiative
5049228|NCT01428232|Well-child clinics|well-child clinics
5049229|NCT01428219|Prostate|prostate
5049230|NCT01428219|Cancer|cancer
5049231|NCT01428219|Metastatic|metastatic
5049232|NCT01428206|palliative care|palliative care
5049233|NCT01428206|nursing homes|nursing homes
5049234|NCT01428206|Liverpool care pathway|liverpool care pathway
5049235|NCT01428193|PCOS|pcos
5049236|NCT01428193|hyperandrogenemia|hyperandrogenemia
5049237|NCT01428180|preterm neonates|preterm neonates
5049238|NCT01428180|hemodynamically relevant patent ductus arteriosus|hemodynamically relevant patent ductus arteriosus
5049239|NCT01428167|Thyroid cancer|thyroid cancer
5049240|NCT01428167|Hashimotos thyroiditis|hashimotos thyroiditis
5049241|NCT01428167|Thyroidectomy|thyroidectomy
5049242|NCT01428167|Anti-inflammatory factors|anti-inflammatory factors
5049243|NCT01428154|paediatric|paediatric
5049244|NCT01428154|dialysis|dialysis
5049245|NCT01428154|CKD|ckd
5049246|NCT01428154|pediatric|pediatric
5049247|NCT01428141|Cancer|cancer
5049248|NCT01428141|Gastrointestinal Cancer|gastrointestinal cancer
5049249|NCT01428115|monoclonal|monoclonal
5049250|NCT01428115|anxiety|anxiety
5049251|NCT01428115|antibodies|antibodies
5049252|NCT01428115|adalimumab|adalimumab
5049253|NCT01428115|severe crohn's disease|severe crohn's disease
5049254|NCT01428115|quality of life|quality of life
5049255|NCT01428115|biological products|biological products
5049256|NCT01428102|Thromboelastography|thromboelastography
5049257|NCT01428102|TEG|teg
5049258|NCT01428102|Coagulation|coagulation
5049259|NCT01428102|RapidTEG|rapidteg
5049260|NCT01428102|Kaolin|kaolin
5049261|NCT01428089|hyperandrogenemia|hyperandrogenemia
5049262|NCT01428076|Varicose Veins|varicose veins
5049263|NCT01428076|SFJ Reflux|sfj reflux
5049264|NCT01428050|whipple|whipple
5049265|NCT01428050|hypertonic saline|hypertonic saline
5049266|NCT01428050|pancreaticoduodenectomy|pancreaticoduodenectomy
5049267|NCT01428050|fluid restriction|fluid restriction
5049268|NCT01428050|resuscitation strategy|resuscitation strategy
5049269|NCT01428037|Vaginal Misoprostol|vaginal misoprostol
5049270|NCT01428037|Cervical Ripening|cervical ripening
5049271|NCT01428037|Labor Induced|labor induced
5049272|NCT01428024|efficacy|efficacy
5049273|NCT01428024|safety|safety
5049274|NCT01428024|Restylane|restylane
5049275|NCT01428024|Lip products|lip products
5049276|NCT01428024|injection techniques|injection techniques
5049277|NCT01428011|Hypertension|hypertension
5049278|NCT01428011|Patient-Provider Communication|patient-provider communication
5049279|NCT01428011|Medication Adherence|medication adherence
5049280|NCT01428011|Race Concordance|race concordance
5049281|NCT01427998|diabetes|diabetes
5049282|NCT01427998|blood glucose|blood glucose
5049283|NCT01427998|olive leaf extract|olive leaf extract
5049284|NCT01427946|KRAS mutant|kras mutant
5049285|NCT01427946|Non-Small Cell Lung Cancer|non-small cell lung cancer
5049286|NCT01427946|NSCLC|nsclc
5049287|NCT01427933|Breast Cancer|breast cancer
5049288|NCT01427907|Serum phosphorus levels|serum phosphorus levels
5049289|NCT01427894|Prematurity|prematurity
5049290|NCT01427894|Music|music
5049291|NCT01427894|Kangaroo Care|kangaroo care
5049292|NCT01427894|Bonding Mother infant|bonding mother infant
5049293|NCT01427868|LB80380|lb80380
5049294|NCT01427868|bioequivalence|bioequivalence
5049295|NCT01427855|Dietary Protein|dietary protein
5049296|NCT01427855|Red Meat|red meat
5049297|NCT01427855|White Meat|white meat
5049298|NCT01427855|Vegetable Protein|vegetable protein
5049299|NCT01427855|Saturated Fat|saturated fat
5049300|NCT01427855|LDL Subclasses|ldl subclasses
5049301|NCT01427855|Cholesterol|cholesterol
5049302|NCT01427855|Atherogenic Dyslipidemia|atherogenic dyslipidemia
5049303|NCT01427842|Trough concentration|trough concentration
5049304|NCT01427842|Vancomycin|vancomycin
5049305|NCT01427842|Pharmacokinetics|pharmacokinetics
5049306|NCT01427829|pilot|pilot
5049307|NCT01427829|randomized controlled trial|randomized controlled trial
5049308|NCT01427829|RCT|rct
5049309|NCT01427829|computer|computer
5049310|NCT01427829|screening|screening
5049311|NCT01427829|community heath center|community heath center
5049312|NCT01427829|psychosocial|psychosocial
5049313|NCT01427829|immigrant|immigrant
5049314|NCT01427816|Dry eye syndromes|dry eye syndromes
5049315|NCT01427816|Corneal diseases|corneal diseases
5049316|NCT01427816|Conjunctival diseases|conjunctival diseases
5049317|NCT01427803|Actual Use Trial|actual use trial
5049318|NCT01427764|Dentin sensitivity|dentin sensitivity
5049319|NCT01427764|Dental scaling|dental scaling
5049320|NCT01427764|Ultrasonic|ultrasonic
5049321|NCT01427764|manual and ultrasonic instrumentation|manual and ultrasonic instrumentation
5049322|NCT01427725|Digestive System Diseases|digestive system diseases
5049323|NCT01427725|Therapeutic Uses|therapeutic uses
5049324|NCT01427725|Pancreatectomy|pancreatectomy
5049325|NCT01427725|Gastrointestinal Agents|gastrointestinal agents
5049326|NCT01427725|Pancreatic Diseases|pancreatic diseases
5049327|NCT01427725|Pancrelipase|pancrelipase
5049328|NCT01427725|Exocrine Pancreatic Insufficiency|exocrine pancreatic insufficiency
5049329|NCT01427712|Digestive System Diseases|digestive system diseases
5049330|NCT01427712|Cystic Fibrosis|cystic fibrosis
5049331|NCT01427712|Therapeutic Uses|therapeutic uses
5049332|NCT01427712|Gastrointestinal Agents|gastrointestinal agents
5049333|NCT01427712|Pancreatic Diseases|pancreatic diseases
5049334|NCT01427712|Pancrelipase|pancrelipase
5049335|NCT01427712|Exocrine Pancreatic Insufficiency|exocrine pancreatic insufficiency
5049336|NCT01427673|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5049440|NCT01427270|Opioid|opioid
5049337|NCT01427673|Obstructive Sleep Apnea|obstructive sleep apnea
5049338|NCT01427673|Overlap Syndrome|overlap syndrome
5049339|NCT01427673|COPD|copd
5049340|NCT01427673|OSA|osa
5049341|NCT01427660|Diabetes|diabetes
5049342|NCT01427660|Decision Aid|decision aid
5049343|NCT01427660|AntiHyperglycemic Medication|antihyperglycemic medication
5049344|NCT01427660|Tailored health information|tailored health information
5049345|NCT01427660|Medication information|medication information
5049346|NCT01427647|Laparoscopy|laparoscopy
5049347|NCT01427647|Anesthesia, Epidural|anesthesia, epidural
5049348|NCT01427634|Heart Failure|heart failure
5049349|NCT01427634|Ventricular Assist Device|ventricular assist device
5049350|NCT01427634|Palliative Care|palliative care
5049351|NCT01427595|hyperandrogenemia|hyperandrogenemia
5049352|NCT01427569|Diabetes|diabetes
5049353|NCT01427569|Chronic wound|chronic wound
5049354|NCT01427556|Food intake|food intake
5049355|NCT01427556|Breakfast eating|breakfast eating
5049356|NCT01427543|behavioral intervention|behavioral intervention
5049357|NCT01427543|HIV risk reduction|hiv risk reduction
5049358|NCT01427543|African Americans|african americans
5049359|NCT01427543|incarceration|incarceration
5049360|NCT01427543|bisexual|bisexual
5049361|NCT01427543|reduce risk behaviors|reduce risk behaviors
5049362|NCT01427530|brain activity|brain activity
5049363|NCT01427530|implanted with DBS electrodes|implanted with dbs electrodes
5049364|NCT01427517|Parkinson's disease|parkinson's disease
5049365|NCT01427517|Gaucher's disease|gaucher's disease
5049366|NCT01427517|Control|control
5049367|NCT01427504|HCV|hcv
5049368|NCT01427504|HIV|hiv
5049369|NCT01427478|Head and neck squamous cell carcinoma|head and neck squamous cell carcinoma
5049370|NCT01427478|Post operative radio-chemotherapy|post operative radio-chemotherapy
5049371|NCT01427478|Randomisation|randomisation
5049372|NCT01427478|Maintenance treatment|maintenance treatment
5049373|NCT01427478|Afatinib|afatinib
5049374|NCT01427465|Brief|brief
5049375|NCT01427465|Image|image
5049376|NCT01427465|Intervention|intervention
5049377|NCT01427465|Adolescents|adolescents
5049378|NCT01427465|School|school
5049379|NCT01427452|Live Donor|live donor
5049380|NCT01427452|Kidney Donation|kidney donation
5049381|NCT01427452|Living Donation|living donation
5049382|NCT01427452|Live Donor Kidney Transplantation|live donor kidney transplantation
5049383|NCT01427452|Donor Nephrectomy|donor nephrectomy
5049384|NCT01427439|MDD|mdd
5049385|NCT01427439|Non-interventional study|non-interventional study
5049386|NCT01427439|Observational study|observational study
5049387|NCT01427426|Health|health
5049388|NCT01427426|Vitality|vitality
5049389|NCT01427426|Well-being|well-being
5049390|NCT01427426|Nutritional Supplement|nutritional supplement
5049391|NCT01427426|Phytonutrient|phytonutrient
5049392|NCT01427426|Greens|greens
5049393|NCT01427413|blastocoele fluid|blastocoele fluid
5049394|NCT01427413|mass spectrometry|mass spectrometry
5049395|NCT01427413|metabolomics|metabolomics
5049396|NCT01427400|Breast expander|breast expander
5049397|NCT01427400|Breast reconstruction|breast reconstruction
5049398|NCT01427400|Implants|implants
5049399|NCT01427400|Botox|botox
5049400|NCT01427387|ASP0456|asp0456
5049401|NCT01427387|Pharmacokinetics|pharmacokinetics
5049402|NCT01427387|safety|safety
5049403|NCT01427387|tolerability|tolerability
5049404|NCT01427387|food effect|food effect
5049405|NCT01427374|hemodialysis|hemodialysis
5049406|NCT01427374|peritoneal dialysis|peritoneal dialysis
5049407|NCT01427374|chronic kidney disease|chronic kidney disease
5049408|NCT01427374|cardiovascular risk factors|cardiovascular risk factors
5049409|NCT01427374|cardiac imaging|cardiac imaging
5049410|NCT01427374|dialysis|dialysis
5049411|NCT01427374|parathyroid hormone|parathyroid hormone
5049412|NCT01427374|vitamin D|vitamin d
5049413|NCT01427374|coronary artery calcification|coronary artery calcification
5049414|NCT01427374|left ventricular hypertrophy|left ventricular hypertrophy
5049415|NCT01427374|genetic predisposition|genetic predisposition
5049416|NCT01427374|biochemical markers|biochemical markers
5049417|NCT01427374|infection|infection
5049418|NCT01427374|pharmacogenomics|pharmacogenomics
5049419|NCT01427335|OHSS|ohss
5049420|NCT01427335|ICSI|icsi
5049421|NCT01427335|calcium injection|calcium injection
5049422|NCT01427322|lapatinib|lapatinib
5049423|NCT01427322|radiation therapy|radiation therapy
5049424|NCT01427322|metastases|metastases
5049425|NCT01427309|Influenza|influenza
5049426|NCT01427309|Trivalent Inactivated Influenza Vaccine|trivalent inactivated influenza vaccine
5049427|NCT01427309|High-Dose Trivalent Inactivated Influenza Vaccine|high-dose trivalent inactivated influenza vaccine
5049428|NCT01427309|Fluzone® High-Dose|fluzone® high-dose
5049429|NCT01427309|Influenza vaccines|influenza vaccines
5049430|NCT01427296|Colon Cleansing|colon cleansing
5049431|NCT01427296|Bowel Prep|bowel prep
5049432|NCT01427296|Colonoscopy|colonoscopy
5049433|NCT01427283|Low back pain|low back pain
5049434|NCT01427283|Chronic pain|chronic pain
5049435|NCT01427283|Opioid|opioid
5049436|NCT01427283|Constipation|constipation
5049437|NCT01427283|Moderate to severe|moderate to severe
5049438|NCT01427270|Low back pain|low back pain
5049439|NCT01427270|Chronic pain|chronic pain
5049441|NCT01427270|Constipation|constipation
5049442|NCT01427270|Moderate to severe chronic low back pain|moderate to severe chronic low back pain
5049443|NCT01427244|HER2+|her2+
5049444|NCT01427244|Histologic confirmation|histologic confirmation
5049445|NCT01427244|measurable disease|measurable disease
5049446|NCT01427244|HER2 positive|her2 positive
5049447|NCT01427244|HER2 overexpression|her2 overexpression
5049448|NCT01427244|persistent vulvar Paget's disease|persistent vulvar paget's disease
5049449|NCT01427244|recurrent vulvar Paget's disease|recurrent vulvar paget's disease
5049450|NCT01427231|Cognitive performance|cognitive performance
5049451|NCT01427231|Attention|attention
5049452|NCT01427231|Memory|memory
5049453|NCT01427231|Glucose|glucose
5049454|NCT01427231|Sacharose|sacharose
5049455|NCT01427231|Elderly|elderly
5049456|NCT01427231|Memory complaints|memory complaints
5049457|NCT01427218|pharmacist|pharmacist
5049458|NCT01427218|medication therapy management|medication therapy management
5049459|NCT01427218|evidence based medicine|evidence based medicine
5049460|NCT01427205|Head and Neck Squamous Cell Carcinoma|head and neck squamous cell carcinoma
5049461|NCT01427205|HNSCC|hnscc
5049462|NCT01427205|recurrent|recurrent
5049463|NCT01427205|metastatic|metastatic
5049464|NCT01427205|oral cavity|oral cavity
5049465|NCT01427205|Cetuximab|cetuximab
5049466|NCT01427205|C225|c225
5049467|NCT01427205|Erbitux|erbitux
5049468|NCT01427205|IMC-C225|imc-c225
5049469|NCT01427205|OSI-906|osi-906
5049470|NCT01427205|Placebo|placebo
5049471|NCT01427205|sugar pill|sugar pill
5049472|NCT01427205|oropharynx|oropharynx
5049473|NCT01427205|larynx|larynx
5049474|NCT01427205|hypopharynx|hypopharynx
5049475|NCT01427192|Breathing-Related Sleep Disorder|breathing-related sleep disorder
5049476|NCT01427192|Pulmonary Hypertension|pulmonary hypertension
5049477|NCT01427179|Spontaneous coronary artery dissection|spontaneous coronary artery dissection
5049478|NCT01427179|SCAD|scad
5049479|NCT01427166|Breast Cancer|breast cancer
5049480|NCT01427166|Cording|cording
5049481|NCT01427166|Lymphedema|lymphedema
5049482|NCT01427166|upper extremity cording|upper extremity cording
5049483|NCT01427166|following treatment|following treatment
5049484|NCT01427153|knee osteoarthritis|knee osteoarthritis
5049485|NCT01427153|physical therapy|physical therapy
5049486|NCT01427153|corticosteroid|corticosteroid
5049487|NCT01427153|treatment|treatment
5049488|NCT01427140|Liver fat|liver fat
5049489|NCT01427140|Polyunsaturated fatty acids (PUFA)|polyunsaturated fatty acids (pufa)
5049490|NCT01427140|Saturated fatty acids (SFA)|saturated fatty acids (sfa)
5049491|NCT01427140|Weight gain|weight gain
5049492|NCT01427140|Overfeed|overfeed
5049493|NCT01427140|Dietary fatty acids|dietary fatty acids
5049494|NCT01427140|Palm oil|palm oil
5049495|NCT01427140|Sunflower oil|sunflower oil
5049496|NCT01427114|extranodal marginal zone lymphoma|extranodal marginal zone lymphoma
5049497|NCT01427114|ocular adnexal lymphoma|ocular adnexal lymphoma
5049498|NCT01427114|mucosa associated lymphoid tissue|mucosa associated lymphoid tissue
5049499|NCT01427114|cyclophosphamide|cyclophosphamide
5049500|NCT01427114|vincristine|vincristine
5049501|NCT01427114|prednisolone|prednisolone
5049502|NCT01427101|Pseudomyxoma Peritonei|pseudomyxoma peritonei
5049503|NCT01427101|Cytoreductive surgery|cytoreductive surgery
5049504|NCT01427101|Debulking surgery|debulking surgery
5049505|NCT01427101|Intraperitoneal chemotherapy|intraperitoneal chemotherapy
5049506|NCT01427088|rTMS-induced cumulative pattern of sBDNF|rtms-induced cumulative pattern of sbdnf
5049507|NCT01427075|Magnetic Resonance Imaging|magnetic resonance imaging
5049508|NCT01427075|Sleep Apnea, Obstructive|sleep apnea, obstructive
5049509|NCT01427075|Pharyngeal Muscles|pharyngeal muscles
5049510|NCT01427062|parkinson's disease|parkinson's disease
5049511|NCT01427062|balance|balance
5049512|NCT01427062|anticipatory postural adjustment|anticipatory postural adjustment
5049513|NCT01427062|componsatory postural adjustment|componsatory postural adjustment
5049514|NCT01427062|falls|falls
5049515|NCT01427049|renal denervation|renal denervation
5049516|NCT01427049|renal sympathetic denervation|renal sympathetic denervation
5049517|NCT01427049|renal ablation|renal ablation
5049518|NCT01427049|resistant hypertension|resistant hypertension
5049519|NCT01427049|hypertension|hypertension
5049520|NCT01427049|renal oxygenation|renal oxygenation
5049521|NCT01427049|renal perfusion|renal perfusion
5049522|NCT01427023|APTIMA Trichomonas vaginalis Assay|aptima trichomonas vaginalis assay
5049523|NCT01427023|APTIMA|aptima
5049524|NCT01427023|trichomonas|trichomonas
5049525|NCT01427023|trichomonas vaginalis|trichomonas vaginalis
5049526|NCT01426997|Major Depressive Disorder|major depressive disorder
5049527|NCT01426997|Depression|depression
5049528|NCT01426971|Migraine|migraine
5049529|NCT01426945|alveolar childhood rhabdomyosarcoma|alveolar childhood rhabdomyosarcoma
5049530|NCT01426945|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
5049531|NCT01426945|previously untreated childhood rhabdomyosarcoma|previously untreated childhood rhabdomyosarcoma
5049532|NCT01426945|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
5049533|NCT01426945|embryonal childhood rhabdomyosarcoma|embryonal childhood rhabdomyosarcoma
5049534|NCT01426932|Vestibular Function Tests|vestibular function tests
5049535|NCT01426932|Caloric Test|caloric test
5049536|NCT01426932|Electronystagmography|electronystagmography
5049537|NCT01426932|Prediction|prediction
5049538|NCT01426919|Traumatic Brain Injury|traumatic brain injury
5049539|NCT01426919|Head Injury|head injury
5049540|NCT01426893|Respiratory disease|respiratory disease
5049541|NCT01426893|COPD|copd
5049543|NCT01426880|German Breast Group|german breast group
5049544|NCT01426880|neo-adjuvant|neo-adjuvant
5049545|NCT01426880|GBG Forschungs GmbH|gbg forschungs gmbh
5049546|NCT01426880|Tubular breast cancer stage II|tubular breast cancer stage ii
5049547|NCT01426880|Mucinous breast cancer stage II|mucinous breast cancer stage ii
5049548|NCT01426880|Invasive ductal breast cancer|invasive ductal breast cancer
5049549|NCT01426880|Tubular breast cancer stage III|tubular breast cancer stage iii
5049550|NCT01426880|HER-2 positive breast cancer|her-2 positive breast cancer
5049551|NCT01426880|Inflammatory breast cancer stage IV|inflammatory breast cancer stage iv
5049552|NCT01426880|Inflammatory breast cancer|inflammatory breast cancer
5049553|NCT01426867|Open-Angle Glaucoma|open-angle glaucoma
5049554|NCT01426867|Ocular Hypertension|ocular hypertension
5049555|NCT01426867|Intraocular Pressure|intraocular pressure
5049556|NCT01426867|Brinzolamide|brinzolamide
5049557|NCT01426867|Brimonidine|brimonidine
5049558|NCT01426854|Cataract Surgery|cataract surgery
5049559|NCT01426854|Anti-ocular Inflammation|anti-ocular inflammation
5049560|NCT01426854|Anti-ocular Pain|anti-ocular pain
5049561|NCT01426841|Small cell lung cancer|small cell lung cancer
5049562|NCT01426841|Adaptive radiotherapy|adaptive radiotherapy
5049563|NCT01426841|Thoracic radiotherapy|thoracic radiotherapy
5049564|NCT01426828|adult|adult
5049565|NCT01426828|symptomatic multiple myeloma|symptomatic multiple myeloma
5049566|NCT01426828|myeloma|myeloma
5049567|NCT01426828|diagnosis within 12 months of initiation of systemic therapy|diagnosis within 12 months of initiation of systemic therapy
5049568|NCT01426815|Peripheral spondylarthritis according to ASAS- criteria|peripheral spondylarthritis according to asas- criteria
5049569|NCT01426802|metformin|metformin
5049570|NCT01426802|vildagliptin|vildagliptin
5049571|NCT01426802|T2DM|t2dm
5049572|NCT01426789|Rheumatoid Arthritis|rheumatoid arthritis
5049573|NCT01426789|IgG1K monoclonal antibody|igg1k monoclonal antibody
5049574|NCT01426789|Interleukin-17A neutralizing|interleukin-17a neutralizing
5049575|NCT01426776|Cheyne-Stokes respiration|cheyne-stokes respiration
5049576|NCT01426776|Heart valve disease|heart valve disease
5049577|NCT01426776|Central Sleep Apnea|central sleep apnea
5049578|NCT01426763|HAE|hae
5049579|NCT01426763|C1 esterase inhibitor|c1 esterase inhibitor
5049580|NCT01426763|C1 INH|c1 inh
5049581|NCT01426763|Subcutaneous|subcutaneous
5049582|NCT01426763|hyaluronidase|hyaluronidase
5049583|NCT01426763|rHuPH20|rhuph20
5049584|NCT01426750|Nutritional support.|nutritional support.
5049585|NCT01426750|Cancer.|cancer.
5049586|NCT01426750|Malnutrition.|malnutrition.
5049587|NCT01426750|Child.|child.
5049588|NCT01426750|Adolescent|adolescent
5049589|NCT01426724|Vitamin D|vitamin d
5049590|NCT01426724|Chronic Kidney Disease|chronic kidney disease
5049591|NCT01426724|Hyperparathyroidism|hyperparathyroidism
5049592|NCT01426724|Renal Blood Flow|renal blood flow
5049593|NCT01426724|Proteinuria|proteinuria
5049594|NCT01426724|Inflammation|inflammation
5049595|NCT01426724|Renin Angiotensin System|renin angiotensin system
5049596|NCT01426698|delayed cord clamping|delayed cord clamping
5049597|NCT01426698|developmental delay|developmental delay
5049598|NCT01426685|sudden death|sudden death
5049599|NCT01426685|coronary artery disease|coronary artery disease
5049600|NCT01426685|diabetes|diabetes
5049601|NCT01426672|Strabismic deviation less than 12 prism diopeters|strabismic deviation less than 12 prism diopeters
5049602|NCT01426659|language|language
5049603|NCT01426659|constraints|constraints
5049604|NCT01426659|premature|premature
5049605|NCT01426659|phonology|phonology
5049606|NCT01426659|implied|implied
5049607|NCT01426659|early development (< 5 years)|early development (< 5 years)
5049608|NCT01426646|gastric cancer|gastric cancer
5049609|NCT01426646|S-1|s-1
5049610|NCT01426646|cisplatin|cisplatin
5049611|NCT01426646|adjuvant chemotherapy|adjuvant chemotherapy
5049612|NCT01426633|L-sarcomas|l-sarcomas
5049613|NCT01426620|NSCLC|nsclc
5049614|NCT01426620|blueberry|blueberry
5049615|NCT01426620|salvage therapy|salvage therapy
5049616|NCT01426620|docetaxel|docetaxel
5049617|NCT01426620|non-small cell lung cancer|non-small cell lung cancer
5049618|NCT01426620|second-line|second-line
5049619|NCT01426620|polyphenol|polyphenol
5049620|NCT01426594|Observational|observational
5049621|NCT01426594|Colombia|colombia
5049622|NCT01426594|Metpure XL|metpure xl
5049624|NCT01426581|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
5049625|NCT01426581|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
5049626|NCT01426581|Lung Disease, Obstructive|lung disease, obstructive
5049627|NCT01426581|Self-management|self-management
5049628|NCT01426581|Health Literacy|health literacy
5049629|NCT01426568|Multi-Convergent Therapy|multi-convergent therapy
5049630|NCT01426568|Mindfulness Meditation|mindfulness meditation
5049631|NCT01426568|Functional Abdominal Symptoms|functional abdominal symptoms
5049632|NCT01426568|Irritable Bowel Syndrome|irritable bowel syndrome
5049831|NCT01425632|TAU-284|tau-284
5049633|NCT01426568|Inflammatory Bowel Disease|inflammatory bowel disease
5049634|NCT01426568|Psychological Stress|psychological stress
5049635|NCT01426555|Disorder of Bone Density and Structure, Unspecified|disorder of bone density and structure, unspecified
5049636|NCT01426555|Weakening of the bone structure|weakening of the bone structure
5049637|NCT01426542|brain injury|brain injury
5049638|NCT01426542|stroke|stroke
5049639|NCT01426542|cerebral palsy|cerebral palsy
5049640|NCT01426542|seizures|seizures
5049641|NCT01426516|Treatment Resistant|treatment resistant
5049642|NCT01426516|Depression|depression
5049643|NCT01426477|Ventral hernia|ventral hernia
5049644|NCT01426477|Abdominal wall hernia|abdominal wall hernia
5049645|NCT01426477|Incisional hernia|incisional hernia
5049646|NCT01426477|Biologic mesh|biologic mesh
5049647|NCT01426477|Veritas Collagen Matrix|veritas collagen matrix
5049648|NCT01426477|Veritas|veritas
5049649|NCT01426464|Glaucoma|glaucoma
5049650|NCT01426464|Xalatan|xalatan
5049651|NCT01426464|Transdermal|transdermal
5049652|NCT01426451|Dramatherapy|dramatherapy
5049653|NCT01426451|Group tutoring activities|group tutoring activities
5049654|NCT01426451|Impairment|impairment
5049655|NCT01426451|Emotional and behavioural problems|emotional and behavioural problems
5049656|NCT01426451|Learning difficulties|learning difficulties
5049657|NCT01426425|Cardiac cryoablation|cardiac cryoablation
5049658|NCT01426425|AVNRT|avnrt
5049659|NCT01426425|heart disease|heart disease
5049660|NCT01426425|tachycardia|tachycardia
5049661|NCT01426425|AtrioVentricular Nodal Reentrant Tachycardia|atrioventricular nodal reentrant tachycardia
5049662|NCT01426425|Supraventricular tachycardia|supraventricular tachycardia
5049663|NCT01426425|SVT|svt
5049664|NCT01426360|dentifrice|dentifrice
5049665|NCT01426360|potassium nitrate|potassium nitrate
5049666|NCT01426360|strontium chloride|strontium chloride
5049667|NCT01426347|Rheumatoid Arthritis|rheumatoid arthritis
5049668|NCT01426347|Vitamin D deficiency|vitamin d deficiency
5049669|NCT01426347|Disability|disability
5049670|NCT01426321|Cardiac resynchronization therapy|cardiac resynchronization therapy
5049671|NCT01426321|Echocardiography|echocardiography
5049672|NCT01426321|Cardiac computed tomography|cardiac computed tomography
5049673|NCT01426295|hematologic disease candidates for autologous or allogeneic bone marrow|hematologic disease candidates for autologous or allogeneic bone marrow
5049674|NCT01426282|Out-patient Compliance|out-patient compliance
5049675|NCT01426282|Nurse, Heath Education|nurse, heath education
5049676|NCT01426282|Cardiovascular Diseases|cardiovascular diseases
5049677|NCT01426282|Treatment and Prevention|treatment and prevention
5049678|NCT01426256|vitamin D|vitamin d
5049679|NCT01426256|cholecalciferol|cholecalciferol
5049680|NCT01426256|cystic fibrosis|cystic fibrosis
5049681|NCT01426256|respiratory tract infection|respiratory tract infection
5049682|NCT01426256|immunity|immunity
5049683|NCT01426256|intervention studies|intervention studies
5049684|NCT01426256|inflammation|inflammation
5049685|NCT01426256|dietary supplements|dietary supplements
5049686|NCT01426256|alpha-Defensins|alpha-defensins
5049687|NCT01426256|Cytokines|cytokines
5049688|NCT01426256|mortality|mortality
5049689|NCT01426256|biological markers|biological markers
5049690|NCT01426256|Biomedical Research|biomedical research
5049691|NCT01426230|PHN|phn
5049692|NCT01426230|Post Herpetic Neuralgia|post herpetic neuralgia
5049693|NCT01426230|Shingles|shingles
5049694|NCT01426230|HZ roster|hz roster
5049695|NCT01426204|Hepatitis C|hepatitis c
5049696|NCT01426204|Retreatment|retreatment
5049697|NCT01426204|Failures|failures
5049698|NCT01426204|Infergen|infergen
5049699|NCT01426204|Interferon Alfacon-1|interferon alfacon-1
5049700|NCT01426191|Cefotaxime sulbactam sodium|cefotaxime sulbactam sodium
5049701|NCT01426191|Phase IV clinical studies|phase iv clinical studies
5049702|NCT01426191|Respiratory and urinary tract infections|respiratory and urinary tract infections
5049703|NCT01426178|Respiratory Insufficiency|respiratory insufficiency
5049704|NCT01426178|Respiration, Artificial|respiration, artificial
5049705|NCT01426178|Intermittent Positive-Pressure Ventilation|intermittent positive-pressure ventilation
5049706|NCT01426178|Neurally Adjusted Ventilatory Assist|neurally adjusted ventilatory assist
5049707|NCT01426178|Non Invasive Ventilation|non invasive ventilation
5049708|NCT01426165|hypomagnesemia|hypomagnesemia
5049709|NCT01426165|magnesium|magnesium
5049710|NCT01426165|magnesium sulfate|magnesium sulfate
5049711|NCT01426152|IVF|ivf
5049712|NCT01426152|progesterone|progesterone
5049713|NCT01426152|ovulation induction|ovulation induction
5049714|NCT01426152|pregnancy rates|pregnancy rates
5049715|NCT01426152|Female Infertility Due to Nonimplantation|female infertility due to nonimplantation
5049716|NCT01426126|urothelial carcinoma|urothelial carcinoma
5049717|NCT01426126|gemcitabine|gemcitabine
5049718|NCT01426126|platinum|platinum
5049719|NCT01426126|refractory|refractory
5049720|NCT01426126|salvage chemotherapy|salvage chemotherapy
5049721|NCT01426100|CKD-828|ckd-828
5049722|NCT01426100|Hypertension|hypertension
5049723|NCT01426100|Primary Hypertension|primary hypertension
5049724|NCT01426100|S-Amlodipine|s-amlodipine
5049725|NCT01426100|Telmisartan|telmisartan
5049726|NCT01426100|Amlodipine|amlodipine
5049727|NCT01426100|Non-Responder|non-responder
5049832|NCT01425632|Bepotastine besilate|bepotastine besilate
5049728|NCT01426061|Complementary and alternative medicine|complementary and alternative medicine
5049729|NCT01426061|Reflexology|reflexology
5049730|NCT01426061|Homeopathy|homeopathy
5049731|NCT01426061|Asthma|asthma
5049732|NCT01426061|Randomized controlled trial|randomized controlled trial
5049733|NCT01426035|SUPERFICIAL VARICOSE VEINS|superficial varicose veins
5049734|NCT01426022|alcohol|alcohol
5049735|NCT01426022|mood|mood
5049736|NCT01426022|postprandial|postprandial
5049737|NCT01426009|COPD|copd
5049738|NCT01425996|HCC|hcc
5049739|NCT01425996|PVTT|pvtt
5049740|NCT01425983|stress|stress
5049741|NCT01425983|lability and irritative disturbances|lability and irritative disturbances
5049742|NCT01425983|dietary supplement|dietary supplement
5049743|NCT01425983|amino acid composition|amino acid composition
5049744|NCT01425983|psychological neurological questionnaire (PNF)|psychological neurological questionnaire (pnf)
5049745|NCT01425970|Inhibitex|inhibitex
5049746|NCT01425970|Chronic Hepatitis|chronic hepatitis
5049747|NCT01425970|Hepatitis C Virus|hepatitis c virus
5049748|NCT01425957|MEMORY and COGNITIVE IMPAIRMENT|memory and cognitive impairment
5049749|NCT01425957|ALZHEIMER DISEASE CONVERSION|alzheimer disease conversion
5049750|NCT01425957|Amyloid beta-Peptides|amyloid beta-peptides
5049751|NCT01425944|Sturge Weber Syndrome|sturge weber syndrome
5049752|NCT01425944|Biomarkers|biomarkers
5049753|NCT01425944|DNA arrays|dna arrays
5049754|NCT01425944|brain vessel malformations|brain vessel malformations
5049755|NCT01425918|Autism Spectrum Disorder|autism spectrum disorder
5049756|NCT01425918|language|language
5049757|NCT01425918|social|social
5049758|NCT01425918|toddlers|toddlers
5049759|NCT01425905|Female|female
5049760|NCT01425905|Depression|depression
5049761|NCT01425905|Obesity|obesity
5049762|NCT01425905|Insulin Resistance|insulin resistance
5049763|NCT01425905|Adolescents|adolescents
5049764|NCT01425905|Overweight|overweight
5049765|NCT01425905|Type 2 Diabetes Risk|type 2 diabetes risk
5049766|NCT01425905|Mood|mood
5049767|NCT01425892|Salivary Gland|salivary gland
5049768|NCT01425892|Pathogenesis|pathogenesis
5049769|NCT01425892|Sj(SqrRoot)(Delta)gren s Syndrome|sj(sqrroot)(delta)gren s syndrome
5049770|NCT01425892|Sjogren Syndrome|sjogren syndrome
5049771|NCT01425866|Diabetes Mellitus|diabetes mellitus
5049772|NCT01425866|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
5049773|NCT01425866|Structured self-management education|structured self-management education
5049774|NCT01425866|Therapeutic patient education|therapeutic patient education
5049775|NCT01425866|Lifestyle changes|lifestyle changes
5049776|NCT01425866|Self-management Blood glucose|self-management blood glucose
5049777|NCT01425866|Empowerment|empowerment
5049778|NCT01425866|Adult learning|adult learning
5049779|NCT01425866|Socio-constructivism|socio-constructivism
5049780|NCT01425866|Health management network|health management network
5049781|NCT01425866|Reunion island|reunion island
5049782|NCT01425840|Lidocaine,|lidocaine,
5049783|NCT01425840|liposome encapsulation,|liposome encapsulation,
5049784|NCT01425840|topical anesthesia,|topical anesthesia,
5049785|NCT01425840|palatal mucosa|palatal mucosa
5049786|NCT01425827|duloxetine|duloxetine
5049787|NCT01425827|osteoarthritis|osteoarthritis
5049788|NCT01425827|pain|pain
5049789|NCT01425827|function|function
5049790|NCT01425814|COPD|copd
5049791|NCT01425801|COPD|copd
5049792|NCT01425788|Grass pollen induced allergic rhinoconjunctivitis|grass pollen induced allergic rhinoconjunctivitis
5049793|NCT01425775|SLE|sle
5049794|NCT01425775|disease activity markers|disease activity markers
5049795|NCT01425775|vitamin D|vitamin d
5049796|NCT01425749|melanoma|melanoma
5049797|NCT01425749|MAGE-A3|mage-a3
5049798|NCT01425749|immunotherapy|immunotherapy
5049799|NCT01425749|adjuvant|adjuvant
5049800|NCT01425749|skin cancer|skin cancer
5049801|NCT01425749|skin diseases|skin diseases
5049802|NCT01425749|immunology|immunology
5049803|NCT01425736|Nimotuzumab|nimotuzumab
5049804|NCT01425736|Chemotherapy|chemotherapy
5049805|NCT01425736|Head and Neck Squamous Cell Carcinoma|head and neck squamous cell carcinoma
5049806|NCT01425723|B-LONG|b-long
5049807|NCT01425723|B-YOND|b-yond
5049808|NCT01425723|B-LONG Extension|b-long extension
5049809|NCT01425723|rFIXFc|rfixfc
5049810|NCT01425723|Severe Hemophilia B|severe hemophilia b
5049811|NCT01425710|Pheochromocytoma|pheochromocytoma
5049812|NCT01425710|Adrenalectomy|adrenalectomy
5049813|NCT01425710|Cardiac output|cardiac output
5049814|NCT01425710|Fluid managment|fluid managment
5049815|NCT01425710|Esopagheal doppler sonography|esopagheal doppler sonography
5049816|NCT01425697|Adult Cardiac surgery|adult cardiac surgery
5049817|NCT01425697|Surgery site infections|surgery site infections
5049818|NCT01425684|MRI|mri
5049819|NCT01425684|Smoking|smoking
5049820|NCT01425684|Schizophrenia|schizophrenia
5049821|NCT01425671|Schizophrenia|schizophrenia
5049822|NCT01425671|Family|family
5049823|NCT01425671|Psychosis|psychosis
5049824|NCT01425658|Fentanyl|fentanyl
5049825|NCT01425658|clonidine|clonidine
5049826|NCT01425658|intrathcal|intrathcal
5049827|NCT01425658|bupivacaine|bupivacaine
5049828|NCT01425645|gestational diabetes|gestational diabetes
5049829|NCT01425645|GDM|gdm
5049830|NCT01425645|prevention|prevention
5049833|NCT01425632|Histamine H1 receptor antagonists|histamine h1 receptor antagonists
5049834|NCT01425619|Anxiety Disorder due to Allergy Skin Testing|anxiety disorder due to allergy skin testing
5049835|NCT01425580|Congestive Heart Failure|congestive heart failure
5049836|NCT01425580|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
5049837|NCT01425580|GLP-1|glp-1
5049838|NCT01425580|Liraglutide|liraglutide
5049839|NCT01425567|cholestasis|cholestasis
5049840|NCT01425567|parenteral nutrition|parenteral nutrition
5049841|NCT01425554|Vascular malformations in the internal jugular veins|vascular malformations in the internal jugular veins
5049842|NCT01425515|hypertension|hypertension
5049843|NCT01425515|genomics|genomics
5049844|NCT01425502|High risk prescribing|high risk prescribing
5049845|NCT01425502|Primary care|primary care
5049846|NCT01425502|Non-steroidal anti-inflammatory drugs|non-steroidal anti-inflammatory drugs
5049847|NCT01425502|Anti-platelet agents|anti-platelet agents
5049848|NCT01425502|Stepped wedge design|stepped wedge design
5049849|NCT01425502|Cluster randomised controlled trial|cluster randomised controlled trial
5049850|NCT01425502|United Kingdom|united kingdom
5049851|NCT01425489|Krabbe Disease|krabbe disease
5049852|NCT01425489|Biomarker|biomarker
5049853|NCT01425476|breast|breast
5049854|NCT01425476|high risk women|high risk women
5049855|NCT01425476|biomarkers|biomarkers
5049856|NCT01425476|vitamin D|vitamin d
5049857|NCT01425463|Ferrous (II) Glycine Sulphate Complex|ferrous (ii) glycine sulphate complex
5049858|NCT01425463|Polyferose|polyferose
5049859|NCT01425463|Ferro Sanol duodenal|ferro sanol duodenal
5049860|NCT01425463|Niferex|niferex
5049861|NCT01425463|Iron Deficiency Anemia|iron deficiency anemia
5049862|NCT01425437|Keloid|keloid
5049863|NCT01425424|Vitamin D|vitamin d
5049864|NCT01425424|Prediabetes|prediabetes
5049865|NCT01425424|Prehypertension|prehypertension
5049866|NCT01425411|hypertension|hypertension
5049867|NCT01425411|left ventricular hypertrophy|left ventricular hypertrophy
5049868|NCT01425411|angiotensin receptor blocker|angiotensin receptor blocker
5049869|NCT01425411|midwall mechanics|midwall mechanics
5049870|NCT01425411|tissue Doppler imaging|tissue doppler imaging
5049871|NCT01425411|Hypertension with left ventricular hypertrophy|hypertension with left ventricular hypertrophy
5049872|NCT01425385|liver failure|liver failure
5049873|NCT01425385|liver transplantation|liver transplantation
5049874|NCT01425372|vaccine|vaccine
5049875|NCT01425372|pneumococcal conjugate vaccine|pneumococcal conjugate vaccine
5049876|NCT01425372|immune responses|immune responses
5049877|NCT01425372|primary immunisation|primary immunisation
5049878|NCT01425372|Vaccine responses to primary immunisation in the UK|vaccine responses to primary immunisation in the uk
5049879|NCT01425359|Chronic angina|chronic angina
5049880|NCT01425359|Angina pectoris|angina pectoris
5049881|NCT01425359|Coronary artery disease|coronary artery disease
5049882|NCT01425359|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
5049883|NCT01425346|Ophthalmic, healthy eye, fluorescence, lens|ophthalmic, healthy eye, fluorescence, lens
5049884|NCT01425333|Ovarian endometriomas|ovarian endometriomas
5049885|NCT01425333|Laparoscopy|laparoscopy
5049886|NCT01425333|Cystectomy|cystectomy
5049887|NCT01425333|Ablation|ablation
5049888|NCT01425307|Phase III|phase iii
5049889|NCT01425307|Sickle cell anemia|sickle cell anemia
5049890|NCT01425307|Abnormally high Transcranial Doppler velocities.|abnormally high transcranial doppler velocities.
5049891|NCT01425307|Reduce risk of primary stroke|reduce risk of primary stroke
5049892|NCT01425307|Pediatric patients|pediatric patients
5049893|NCT01425307|Chelation therapy|chelation therapy
5049894|NCT01425294|Chinese post-menopausal women|chinese post-menopausal women
5049895|NCT01425294|oestrogen receptor-positive locally advanced|oestrogen receptor-positive locally advanced
5049896|NCT01425294|metastatic breast cancer|metastatic breast cancer
5049897|NCT01425294|fulvestrant 250 mg|fulvestrant 250 mg
5049898|NCT01425294|failure to adjuvant anti-oestrogen therapy|failure to adjuvant anti-oestrogen therapy
5049899|NCT01425281|Bioabsorbable|bioabsorbable
5049900|NCT01425281|Coronary scaffold|coronary scaffold
5049901|NCT01425281|Coronary Stent|coronary stent
5049902|NCT01425281|Everolimus|everolimus
5049903|NCT01425281|Drug eluting stents|drug eluting stents
5049904|NCT01425281|Angioplasty|angioplasty
5049905|NCT01425281|Coronary artery disease|coronary artery disease
5049906|NCT01425281|Total coronary occlusion|total coronary occlusion
5049907|NCT01425281|Coronary artery restenosis|coronary artery restenosis
5049908|NCT01425281|Stent thrombosis|stent thrombosis
5049909|NCT01425281|Myocardial ischemia|myocardial ischemia
5049910|NCT01425281|Coronary artery stenosis|coronary artery stenosis
5049911|NCT01425268|Tissue Expansion|tissue expansion
5049912|NCT01425268|Tissue Expander|tissue expander
5049913|NCT01425268|Breast Tissue Expansion|breast tissue expansion
5049914|NCT01425268|Breast Tissue Expander|breast tissue expander
5049915|NCT01425268|Breast Reconstruction|breast reconstruction
5049916|NCT01425268|Two Stage Breast Reconstruction|two stage breast reconstruction
5049917|NCT01425268|2 Stage Breast Reconstruction|2 stage breast reconstruction
5049918|NCT01425255|Type 1 diabetes|type 1 diabetes
5049919|NCT01425255|Sleep quality|sleep quality
5049920|NCT01425255|Parents|parents
5049921|NCT01425242|inflammation|inflammation
5049922|NCT01425242|aneurysm|aneurysm
5049923|NCT01425242|hypertension|hypertension
5049924|NCT01425242|aliskiren|aliskiren
5049925|NCT01425229|steady state|steady state
5049926|NCT01425229|bosentan|bosentan
5049927|NCT01425229|clarithromycin|clarithromycin
5049928|NCT01425216|Keloid|keloid
5049929|NCT01425216|Patient who have extensive or massive keloids|patient who have extensive or massive keloids
5049930|NCT01425177|Retained CBD Stones|retained cbd stones
5049931|NCT01425177|Recurrent CBD Stones|recurrent cbd stones
5049932|NCT01425164|hemodialysis|hemodialysis
5049933|NCT01425164|coronary heart disease|coronary heart disease
5049934|NCT01425164|angina|angina
5049935|NCT01425164|betablocker|betablocker
5049936|NCT01425164|carvedilol|carvedilol
5049937|NCT01425164|ivabradine|ivabradine
5049938|NCT01425138|psoriasis|psoriasis
5049939|NCT01425138|systematic review|systematic review
5049940|NCT01425138|meta-analyses|meta-analyses
5049941|NCT01425125|nonedematous hyponatremia|nonedematous hyponatremia
5049942|NCT01425125|fractional urate excretion|fractional urate excretion
5049943|NCT01425112|trabeculectomy|trabeculectomy
5049944|NCT01425112|bevacizumab|bevacizumab
5049945|NCT01425112|anti-VEGF|anti-vegf
5049946|NCT01425112|Efficacy|efficacy
5049947|NCT01425086|Incubator,|incubator,
5049948|NCT01425086|hypothermia,|hypothermia,
5049949|NCT01425086|preterm,|preterm,
5049950|NCT01425086|low-birthweight infants,|low-birthweight infants,
5049951|NCT01425086|embrace device,|embrace device,
5049952|NCT01425086|phase change materials|phase change materials
5049953|NCT01425086|PCM|pcm
5049954|NCT01425073|HIV|hiv
5049955|NCT01425073|Co-Infections|co-infections
5049956|NCT01425073|Malaria|malaria
5049957|NCT01425073|Pneumonia|pneumonia
5049958|NCT01425073|Diarrhea|diarrhea
5049959|NCT01425060|Contraception|contraception
5049960|NCT01425060|Unintended pregnancy|unintended pregnancy
5049961|NCT01425060|HIV|hiv
5049962|NCT01425060|HIV Risk|hiv risk
5049963|NCT01425060|Sexually Transmitted Infections|sexually transmitted infections
5049964|NCT01425060|Women|women
5049965|NCT01425060|Pregnancy|pregnancy
5049966|NCT01425060|Neonatal Health|neonatal health
5049967|NCT01425060|Drug Use|drug use
5049968|NCT01425060|Drug Treatment|drug treatment
5049969|NCT01425060|Opioids|opioids
5049970|NCT01425047|mangosteen|mangosteen
5049971|NCT01425047|xanthones|xanthones
5049972|NCT01425047|dietary supplement|dietary supplement
5049973|NCT01425047|botanical supplement|botanical supplement
5049974|NCT01425047|bioavailability|bioavailability
5049975|NCT01425047|Determine bioavailability of mangosteen xanthones in adults|determine bioavailability of mangosteen xanthones in adults
5049976|NCT01425034|Cast|cast
5049977|NCT01425034|motion|motion
5049978|NCT01425034|thumb CMC arthritis|thumb cmc arthritis
5049979|NCT01425034|Collateral Ligament of Metacarpophalangeal Joint|collateral ligament of metacarpophalangeal joint
5049980|NCT01424995|trigger thumb|trigger thumb
5049981|NCT01424995|flexor pollicis longus tendon of the thumb|flexor pollicis longus tendon of the thumb
5049982|NCT01424995|stenosis tenosynovitis|stenosis tenosynovitis
5049983|NCT01424982|Leukemia|leukemia
5049984|NCT01424982|Ph-positive acute lymphoblastic leukemia|ph-positive acute lymphoblastic leukemia
5049985|NCT01424982|ALL|all
5049986|NCT01424982|Philadelphia (Ph) chromosome|philadelphia (ph) chromosome
5049987|NCT01424982|BCR-ABL|bcr-abl
5049988|NCT01424982|Depo-Medrol|depo-medrol
5049989|NCT01424982|Medrol|medrol
5049990|NCT01424982|Solu-Medrol|solu-medrol
5049991|NCT01424982|Methylprednisolone|methylprednisolone
5049992|NCT01424982|Vincristine|vincristine
5049993|NCT01424982|Dexamethasone|dexamethasone
5049994|NCT01424982|Decadron|decadron
5049995|NCT01424982|Ponatinib|ponatinib
5049996|NCT01424982|G-CSF|g-csf
5049997|NCT01424982|Filgrastim|filgrastim
5049998|NCT01424982|NeupogenTM|neupogentm
5049999|NCT01424982|Cyclophosphamide|cyclophosphamide
5050000|NCT01424982|Cytoxan|cytoxan
5050001|NCT01424982|Neosar|neosar
5050002|NCT01424982|Doxorubicin|doxorubicin
5050003|NCT01424982|Doxorubicin Hydrochloride|doxorubicin hydrochloride
5050004|NCT01424982|Adriamycin PFS|adriamycin pfs
5050005|NCT01424982|Adriamycin RDF|adriamycin rdf
5050006|NCT01424982|Adriamycin|adriamycin
5050007|NCT01424982|Rubex|rubex
5050008|NCT01424982|Rituximab|rituximab
5050009|NCT01424982|Rituxan|rituxan
5050010|NCT01424982|Mesna|mesna
5050011|NCT01424982|Mesnex|mesnex
5050012|NCT01424982|Cytarabine|cytarabine
5050013|NCT01424982|Ara-C|ara-c
5050014|NCT01424982|Cytosar|cytosar
5050015|NCT01424982|DepoCyt|depocyt
5050016|NCT01424982|Cytosine Arabinosine Hydrochloride|cytosine arabinosine hydrochloride
5050017|NCT01424982|Methotrexate|methotrexate
5050018|NCT01424982|Leucovorin|leucovorin
5050019|NCT01424982|Wellcovorin|wellcovorin
5050020|NCT01424982|Citrovorum|citrovorum
5050021|NCT01424982|Prednisone|prednisone
5050022|NCT01424982|NeulastaTM|neulastatm
5050023|NCT01424982|PEG-G-CSF|peg-g-csf
5050024|NCT01424969|rotator cuff repair|rotator cuff repair
5050025|NCT01424969|arthroscopic|arthroscopic
5050026|NCT01424969|platelet-rich plasma|platelet-rich plasma
5050027|NCT01424969|platelet-rich fibrin matrix|platelet-rich fibrin matrix
5050028|NCT01424969|outcomes|outcomes
5050029|NCT01424969|tendon healing|tendon healing
5050227|NCT01424059|induction|induction
5050030|NCT01424969|magnetic resonance imaging|magnetic resonance imaging
5050031|NCT01424956|breast|breast
5050032|NCT01424956|breast cancer|breast cancer
5050033|NCT01424956|breast screening|breast screening
5050034|NCT01424956|breast cancer screening|breast cancer screening
5050035|NCT01424956|ultrasound|ultrasound
5050036|NCT01424956|ultrasonography|ultrasonography
5050037|NCT01424956|mammogram|mammogram
5050038|NCT01424956|mammography|mammography
5050039|NCT01424956|breast density|breast density
5050040|NCT01424956|dense breasts|dense breasts
5050041|NCT01424956|early detection|early detection
5050042|NCT01424956|somo v|somo v
5050043|NCT01424956|somo•v|somo•v
5050044|NCT01424956|U-Systems|u-systems
5050045|NCT01424956|Automated Breast Ultrasound|automated breast ultrasound
5050046|NCT01424956|Ultrasonography, Mammary|ultrasonography, mammary
5050047|NCT01424956|Breast Neoplasms|breast neoplasms
5050048|NCT01424956|Breast Density > 50% (BI-RADS III & IV)|breast density > 50% (bi-rads iii & iv)
5050049|NCT01424943|prevention|prevention
5050050|NCT01424943|evidence-based parenting intervention|evidence-based parenting intervention
5050051|NCT01424943|children|children
5050052|NCT01424943|disabilities|disabilities
5050053|NCT01424943|IDEA Part C|idea part c
5050054|NCT01424943|Stepping Stones Triple P|stepping stones triple p
5050055|NCT01424930|Metastatic castration-resistant prostate cancer|metastatic castration-resistant prostate cancer
5050056|NCT01424930|CRPC|crpc
5050057|NCT01424930|Abiraterone Acetate|abiraterone acetate
5050058|NCT01424930|Prednisone|prednisone
5050059|NCT01424930|Food Safety|food safety
5050060|NCT01424917|Cardiac Allograft Vasculopathy|cardiac allograft vasculopathy
5050061|NCT01424904|Ergogenic aid|ergogenic aid
5050062|NCT01424904|Exercise endurance|exercise endurance
5050063|NCT01424904|High performance|high performance
5050064|NCT01424904|Time trial performance|time trial performance
5050065|NCT01424904|Glutathione|glutathione
5050066|NCT01424878|Molecular Analysis of Medullary Thyroid Carcinoma Tissues|molecular analysis of medullary thyroid carcinoma tissues
5050067|NCT01424865|HER2-positive breast cancer|her2-positive breast cancer
5050068|NCT01424865|stage II breast cancer|stage ii breast cancer
5050069|NCT01424865|stage IIIA breast cancer|stage iiia breast cancer
5050070|NCT01424852|Probiotics|probiotics
5050071|NCT01424852|Caries|caries
5050072|NCT01424852|Oral flora|oral flora
5050073|NCT01424839|SIOP CNS GCT II|siop cns gct ii
5050074|NCT01424839|Patients with the primary disease of an Intracranial Germ Cell Tumors|patients with the primary disease of an intracranial germ cell tumors
5050075|NCT01424826|Healthy volunteers|healthy volunteers
5050076|NCT01424813|Asthma|asthma
5050077|NCT01424813|dry powder inhaler|dry powder inhaler
5050078|NCT01424813|short-acting beta2-agonist|short-acting beta2-agonist
5050079|NCT01424813|SABA|saba
5050080|NCT01424813|bronchoconstriction|bronchoconstriction
5050081|NCT01424813|bronchodilation|bronchodilation
5050082|NCT01424813|bronchodilator|bronchodilator
5050083|NCT01424813|metered dose inhaler|metered dose inhaler
5050084|NCT01424774|Radiation Exposure|radiation exposure
5050085|NCT01424774|Rubidium 82|rubidium 82
5050086|NCT01424774|Strontium 82|strontium 82
5050087|NCT01424774|Strontium 85|strontium 85
5050088|NCT01424748|Noni juice|noni juice
5050089|NCT01424748|Safety|safety
5050090|NCT01424735|Best corrected Visual Acuity|best corrected visual acuity
5050091|NCT01424735|Pupillary Reaction|pupillary reaction
5050092|NCT01424735|Colour vision|colour vision
5050093|NCT01424735|Disc edema|disc edema
5050094|NCT01424722|ICD Indicated patients|icd indicated patients
5050095|NCT01424722|documented CAD|documented cad
5050096|NCT01424709|Chemotherapy|chemotherapy
5050097|NCT01424709|Individual therapy|individual therapy
5050098|NCT01424709|RRM1|rrm1
5050099|NCT01424709|BRCA1|brca1
5050100|NCT01424696|growth measures|growth measures
5050101|NCT01424696|nutritional status|nutritional status
5050102|NCT01424696|pulmonary infection|pulmonary infection
5050103|NCT01424696|inflammatory markers|inflammatory markers
5050104|NCT01424696|pancreatic enzyme replacement therapy|pancreatic enzyme replacement therapy
5050105|NCT01424683|Qol|qol
5050106|NCT01424683|Quality of life|quality of life
5050107|NCT01424683|VAS|vas
5050108|NCT01424683|Visual Analogue Scale|visual analogue scale
5050109|NCT01424683|CABG|cabg
5050110|NCT01424683|Coronary Artery Bypass Graft|coronary artery bypass graft
5050111|NCT01424683|Qol conversion|qol conversion
5050112|NCT01424683|post hoc HTA|post hoc hta
5050113|NCT01424670|Multidrug resistant tuberculosis|multidrug resistant tuberculosis
5050114|NCT01424657|MRCP|mrcp
5050115|NCT01424657|ERCP|ercp
5050116|NCT01424657|BILIARY OBSTRUCTION|biliary obstruction
5050117|NCT01424657|EFFECTIVENESS|effectiveness
5050118|NCT01424644|meningitis|meningitis
5050119|NCT01424644|human papillomavirus|human papillomavirus
5050120|NCT01424644|tetanus|tetanus
5050121|NCT01424644|diptheria|diptheria
5050122|NCT01424644|pertussis|pertussis
5050123|NCT01424618|Donor eggs|donor eggs
5050124|NCT01424618|Donor oocytes|donor oocytes
5050125|NCT01424618|Pregnancy|pregnancy
5050126|NCT01424618|Embryo Implantation|embryo implantation
5050127|NCT01424618|Infertility|infertility
5050128|NCT01424618|IVF|ivf
5050129|NCT01424605|left-sided double lumen bronchial tube|left-sided double lumen bronchial tube
5050130|NCT01424605|GlideScope videolaryngoscope|glidescope videolaryngoscope
5050131|NCT01424605|direct laryngoscope|direct laryngoscope
5050132|NCT01424592|Portable sleep apnea testing|portable sleep apnea testing
5050133|NCT01424592|Positive airway pressure therapy|positive airway pressure therapy
5050134|NCT01424592|Polysomnography|polysomnography
5050135|NCT01424566|Cancer pain|cancer pain
5050136|NCT01424566|Opioid therapy|opioid therapy
5050137|NCT01424566|Inadequate analgesia|inadequate analgesia
5050138|NCT01424566|Optimized chronic opioid therapy|optimized chronic opioid therapy
5050139|NCT01424553|Low birthweight|low birthweight
5050140|NCT01424553|Bronchopulmonary dysplasia|bronchopulmonary dysplasia
5050141|NCT01424553|Lung development|lung development
5050142|NCT01424553|Airway obstruction|airway obstruction
5050143|NCT01424553|Asthma|asthma
5050144|NCT01424527|Chronic Obstructive Pulmonary Disease(COPD)|chronic obstructive pulmonary disease(copd)
5050145|NCT01424527|COPD Assessment Test(CAT)|copd assessment test(cat)
5050146|NCT01424501|Tuberculosis vaccine|tuberculosis vaccine
5050147|NCT01424501|HIV-negative|hiv-negative
5050148|NCT01424501|tuberculosis treatment|tuberculosis treatment
5050149|NCT01424488|sugammadex|sugammadex
5050150|NCT01424488|reversal|reversal
5050151|NCT01424488|pipecuronium-induced neuromuscular blockade|pipecuronium-induced neuromuscular blockade
5050152|NCT01424462|healthy volunteers|healthy volunteers
5050153|NCT01424462|firategrast|firategrast
5050154|NCT01424462|Pharmacokinetics|pharmacokinetics
5050155|NCT01424462|modified release|modified release
5050156|NCT01424436|CSF sampling|csf sampling
5050157|NCT01424436|Alzheimer's disease|alzheimer's disease
5050158|NCT01424436|Amyloid beta levels|amyloid beta levels
5050159|NCT01424423|Safety|safety
5050160|NCT01424423|GSK1223249|gsk1223249
5050161|NCT01424423|Pharmacokinetics|pharmacokinetics
5050162|NCT01424423|Single dose escalation|single dose escalation
5050163|NCT01424423|anti-GSK1223249 antibodies|anti-gsk1223249 antibodies
5050164|NCT01424423|Multiple Sclerosis|multiple sclerosis
5050165|NCT01424410|paediatric schistosomiasis morbidity immunology|paediatric schistosomiasis morbidity immunology
5050166|NCT01424384|healthy volunteers|healthy volunteers
5050167|NCT01424384|Anxiety Disorder|anxiety disorder
5050168|NCT01424384|neuropsychological tests|neuropsychological tests
5050169|NCT01424345|Kidney Transplantation|kidney transplantation
5050170|NCT01424345|Immunosuppression|immunosuppression
5050171|NCT01424345|Immune monitoring|immune monitoring
5050172|NCT01424332|Pharmacodynamics|pharmacodynamics
5050173|NCT01424332|pharmacokinetics|pharmacokinetics
5050174|NCT01424332|darexaban|darexaban
5050175|NCT01424332|Acetyl Salicylic Acid|acetyl salicylic acid
5050176|NCT01424332|darexaban glucuronide|darexaban glucuronide
5050177|NCT01424332|YM150|ym150
5050178|NCT01424332|YM-222714|ym-222714
5050179|NCT01424332|Phase 1|phase 1
5050180|NCT01424319|Endothelin Receptor Antagonists|endothelin receptor antagonists
5050181|NCT01424319|Proteinuria|proteinuria
5050182|NCT01424306|Inflammation|inflammation
5050183|NCT01424306|Intestinal permeability|intestinal permeability
5050184|NCT01424306|Type 2 diabetes mellitus|type 2 diabetes mellitus
5050185|NCT01424306|Cardiovascular disease|cardiovascular disease
5050186|NCT01424306|Obesity|obesity
5050187|NCT01424306|Sweetened beverages|sweetened beverages
5050188|NCT01424306|Sugar|sugar
5050189|NCT01424306|Fructose|fructose
5050190|NCT01424306|Glucose|glucose
5050191|NCT01424306|High-fructose corn syrup|high-fructose corn syrup
5050192|NCT01424293|Rectal Cancer|rectal cancer
5050193|NCT01424293|Colon Cancer|colon cancer
5050194|NCT01424293|Diverticulitis|diverticulitis
5050195|NCT01424293|Anastamosis|anastamosis
5050196|NCT01424293|colectomy|colectomy
5050197|NCT01424293|low anterior resection|low anterior resection
5050198|NCT01424267|low profile|low profile
5050199|NCT01424267|endovascular graft|endovascular graft
5050200|NCT01424267|endovascular procedure|endovascular procedure
5050201|NCT01424267|aortic aneurysm, abdominal aortic aneurysm|aortic aneurysm, abdominal aortic aneurysm
5050202|NCT01424254|Gastrointestinal Bleeding of Obscure Origin|gastrointestinal bleeding of obscure origin
5050203|NCT01424241|Sandostatin LAR|sandostatin lar
5050204|NCT01424228|Long term|long term
5050205|NCT01424228|Constipation|constipation
5050206|NCT01424228|Digestive signs and symptoms|digestive signs and symptoms
5050207|NCT01424202|Post extubation failure|post extubation failure
5050208|NCT01424202|Mechanical Insufflation-Exsufflation|mechanical insufflation-exsufflation
5050209|NCT01424202|Noninvasive Ventilation|noninvasive ventilation
5050210|NCT01424202|Weaning|weaning
5050211|NCT01424189|Cataract surgery|cataract surgery
5050212|NCT01424189|Intraocular lens|intraocular lens
5050213|NCT01424150|Postoperative fluid|postoperative fluid
5050214|NCT01424150|surgery|surgery
5050215|NCT01424150|anaesthesia|anaesthesia
5050216|NCT01424150|fluid|fluid
5050217|NCT01424150|mortality|mortality
5050218|NCT01424150|morbidity|morbidity
5050219|NCT01424111|Biomarkers|biomarkers
5050220|NCT01424111|Depression|depression
5050221|NCT01424111|Major Depressive Disorder|major depressive disorder
5050222|NCT01424111|Escitalopram|escitalopram
5050223|NCT01424072|stress psychological|stress psychological
5050224|NCT01424072|coping behavior|coping behavior
5050225|NCT01424059|fear|fear
5050226|NCT01424059|labor|labor
5050228|NCT01424059|amniotomy|amniotomy
5050229|NCT01424059|WEDQ-B|wedq-b
5050230|NCT01424059|parous|parous
5050231|NCT01424059|cesarean section|cesarean section
5050232|NCT01424046|type 1 diabetes|type 1 diabetes
5050233|NCT01424046|basal insulin|basal insulin
5050234|NCT01424046|developing world|developing world
5050235|NCT01424046|comparative effectiveness|comparative effectiveness
5050236|NCT01424033|Interstitial lung disease|interstitial lung disease
5050237|NCT01424033|Connective tissue disease|connective tissue disease
5050238|NCT01424033|Scleroderma|scleroderma
5050239|NCT01424033|Rheumatoid arthritis|rheumatoid arthritis
5050240|NCT01424033|Sjogren's syndrome|sjogren's syndrome
5050241|NCT01424033|Mixed connective tissue disease|mixed connective tissue disease
5050242|NCT01424033|Dermatomyositis|dermatomyositis
5050243|NCT01424033|Polymyositis|polymyositis
5050244|NCT01424033|Systemic lupus erythematosis|systemic lupus erythematosis
5050245|NCT01424020|Questionnaire|questionnaire
5050246|NCT01424020|peripheral artery disease|peripheral artery disease
5050247|NCT01424020|execise|execise
5050248|NCT01424007|Obese|obese
5050249|NCT01424007|Women|women
5050250|NCT01424007|Weight loss|weight loss
5050251|NCT01424007|Exercise|exercise
5050252|NCT01424007|Physical activity|physical activity
5050253|NCT01424007|Diet|diet
5050254|NCT01424007|Female|female
5050255|NCT01423994|syncope|syncope
5050256|NCT01423994|fainting|fainting
5050257|NCT01423994|implantable loop recorder|implantable loop recorder
5050258|NCT01423994|pacemaker|pacemaker
5050259|NCT01423994|heart block|heart block
5050260|NCT01423994|bifascicular heart block|bifascicular heart block
5050261|NCT01423981|Keloid|keloid
5050262|NCT01423981|Scar|scar
5050263|NCT01423981|hypertrophic scar|hypertrophic scar
5050264|NCT01423981|familial keloid|familial keloid
5050265|NCT01423968|Sepsis|sepsis
5050266|NCT01423968|Inflammation|inflammation
5050267|NCT01423968|Lipopolysaccharide|lipopolysaccharide
5050268|NCT01423968|Muscle protein turnover|muscle protein turnover
5050269|NCT01423968|Insulin resistance|insulin resistance
5050270|NCT01423955|Erythropoietin|erythropoietin
5050271|NCT01423955|Erythropoetin|erythropoetin
5050272|NCT01423955|Cardiac surgery|cardiac surgery
5050273|NCT01423955|Ischemia|ischemia
5050274|NCT01423955|Reperfusion|reperfusion
5050275|NCT01423955|Renal function|renal function
5050276|NCT01423955|Cystatin C|cystatin c
5050277|NCT01423955|Creatinine|creatinine
5050278|NCT01423955|Safety|safety
5050279|NCT01423929|Oxygen|oxygen
5050280|NCT01423929|Myocardial infarction|myocardial infarction
5050281|NCT01423929|Ambulance|ambulance
5050282|NCT01423929|Percutaneous coronary intervention|percutaneous coronary intervention
5050283|NCT01423929|Cardiac magnetic resonance imaging|cardiac magnetic resonance imaging
5050284|NCT01423916|Schizophrenia|schizophrenia
5050285|NCT01423916|QTc Interval|qtc interval
5050286|NCT01423903|Phase I|phase i
5050287|NCT01423903|STAT-3 inhibitor|stat-3 inhibitor
5050288|NCT01423903|solid tumors|solid tumors
5050289|NCT01423890|Breast Cancer|breast cancer
5050290|NCT01423890|Oncotype DX|oncotype dx
5050291|NCT01423890|Adjuvant! Online|adjuvant! online
5050292|NCT01423890|Decisional Conflict Scale|decisional conflict scale
5050293|NCT01423877|bariatric surgery|bariatric surgery
5050294|NCT01423877|diabetes|diabetes
5050295|NCT01423877|sleeve gastrectomy|sleeve gastrectomy
5050296|NCT01423877|gastric bypass|gastric bypass
5050297|NCT01423877|gastric banding|gastric banding
5050298|NCT01423864|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
5050299|NCT01423864|Multi-organ Dysfunction Syndrome|multi-organ dysfunction syndrome
5050300|NCT01423864|Extracorporeal Membrane Oxygenation|extracorporeal membrane oxygenation
5050301|NCT01423851|Keywords provided by NS Pharma, Inc.:|keywords provided by ns pharma, inc.:
5050302|NCT01423851|JAK2 kinase inhibitor|jak2 kinase inhibitor
5050303|NCT01423851|NS-018|ns-018
5050304|NCT01423851|Myeloproliferative Neoplasms|myeloproliferative neoplasms
5050305|NCT01423851|Primary Myelofibrosis|primary myelofibrosis
5050306|NCT01423851|post-Polycythemia Vera Myelofibrosis|post-polycythemia vera myelofibrosis
5050307|NCT01423851|post-Essential Thrombocythemia Myelofibrosis|post-essential thrombocythemia myelofibrosis
5050308|NCT01423851|Additional relevant MeSH terms:|additional relevant mesh terms:
5050309|NCT01423851|Bone Marrow Diseases|bone marrow diseases
5050310|NCT01423851|Hematologic Diseases|hematologic diseases
5050311|NCT01423851|Polycythemia Vera|polycythemia vera
5050312|NCT01423851|Thrombocythemia, Essential|thrombocythemia, essential
5050313|NCT01423851|PMF|pmf
5050314|NCT01423851|post-PV MF|post-pv mf
5050315|NCT01423851|post-ET MF|post-et mf
5050316|NCT01423838|Overactive bladder|overactive bladder
5050317|NCT01423838|Solifenacin|solifenacin
5050318|NCT01423838|Oxybutynin|oxybutynin
5050319|NCT01423812|HIV|hiv
5050320|NCT01423812|treatment-experienced|treatment-experienced
5050321|NCT01423812|protease inhibitor|protease inhibitor
5050322|NCT01423812|adherence|adherence
5050323|NCT01423812|lipids|lipids
5050324|NCT01423799|Quality of life|quality of life
5050325|NCT01423799|Cancer|cancer
5050326|NCT01423799|Immunonutrition|immunonutrition
5050327|NCT01423760|Vaccine|vaccine
5050328|NCT01423760|Stimuvax|stimuvax
5050329|NCT01423760|Tecemotide|tecemotide
5050330|NCT01423760|L-BLP25|l-blp25
5050331|NCT01423760|Non-Small Cell Lung Carcinoma|non-small cell lung carcinoma
5050332|NCT01423760|Multiple Myeloma|multiple myeloma
5050333|NCT01423747|ALL|all
5050334|NCT01423747|HSCT|hsct
5050335|NCT01423747|children|children
5050336|NCT01423747|adolescents|adolescents
5050337|NCT01423734|ADRENAL GLAND|adrenal gland
5050338|NCT01423734|MRI|mri
5050339|NCT01423734|11-122|11-122
5050340|NCT01423708|Liver Transplantation|liver transplantation
5050341|NCT01423708|Graft Rejection|graft rejection
5050342|NCT01423708|Graft Survival|graft survival
5050343|NCT01423708|Transplantation Immunology|transplantation immunology
5050344|NCT01423708|Anti-Rejection Therapy|anti-rejection therapy
5050345|NCT01423708|Immunosuppression|immunosuppression
5050346|NCT01423708|Organ Transplantation|organ transplantation
5050347|NCT01423708|Host vs Graft Reaction|host vs graft reaction
5050348|NCT01423708|Gastroenterology|gastroenterology
5050349|NCT01423708|Hepatology|hepatology
5050350|NCT01423669|Psychotic Disorders|psychotic disorders
5050351|NCT01423643|HIV|hiv
5050352|NCT01423643|Human immunodeficiency virus|human immunodeficiency virus
5050353|NCT01423643|Acquired Immune Deficiency Syndrome Virus|acquired immune deficiency syndrome virus
5050354|NCT01423643|AIDS Virus|aids virus
5050355|NCT01423643|Immunodeficiency Virus, Human|immunodeficiency virus, human
5050356|NCT01423643|Virus, Human Immunodeficiency|virus, human immunodeficiency
5050357|NCT01423643|Hepatitis C|hepatitis c
5050358|NCT01423643|Hepatitis C, chronic|hepatitis c, chronic
5050359|NCT01423643|Hepatitis C virus|hepatitis c virus
5050360|NCT01423643|Hepatitis C antibodies|hepatitis c antibodies
5050361|NCT01423643|Hepatitis C antigens|hepatitis c antigens
5050362|NCT01423630|fatty liver|fatty liver
5050363|NCT01423630|probiotics|probiotics
5050364|NCT01423630|Lactobacillus|lactobacillus
5050365|NCT01423630|fruit|fruit
5050366|NCT01423630|fibre|fibre
5050367|NCT01423630|dietary intervention|dietary intervention
5050368|NCT01423630|obesity|obesity
5050369|NCT01423617|overweight|overweight
5050370|NCT01423617|weight loss|weight loss
5050371|NCT01423617|body fat|body fat
5050372|NCT01423617|waist circumference|waist circumference
5050373|NCT01423617|satiety|satiety
5050374|NCT01423617|appetite|appetite
5050375|NCT01423604|Metastatic pancreatic cancer|metastatic pancreatic cancer
5050376|NCT01423591|Infliximab|infliximab
5050377|NCT01423591|polymyalgia rheumatica|polymyalgia rheumatica
5050378|NCT01423591|refractory|refractory
5050379|NCT01423591|double blind|double blind
5050380|NCT01423591|placebo controlled|placebo controlled
5050381|NCT01423591|trial|trial
5050382|NCT01423578|craving|craving
5050383|NCT01423578|mood|mood
5050384|NCT01423578|cue reactivity|cue reactivity
5050385|NCT01423578|smoking behavior|smoking behavior
5050386|NCT01423578|quit smoking|quit smoking
5050387|NCT01423578|prevention|prevention
5050388|NCT01423578|Hatha yoga|hatha yoga
5050389|NCT01423578|cardiovascular exercise|cardiovascular exercise
5050390|NCT01423565|Deep Brain Stimulation|deep brain stimulation
5050391|NCT01423565|Parkinson's Disease|parkinson's disease
5050392|NCT01423565|Subthalamic Nucleus|subthalamic nucleus
5050393|NCT01423565|Constant Current|constant current
5050394|NCT01423552|Heart transplantation|heart transplantation
5050395|NCT01423552|Immunosuppression|immunosuppression
5050396|NCT01423552|Pharmacokinetics|pharmacokinetics
5050397|NCT01423552|Pharmacogenetics|pharmacogenetics
5050398|NCT01423513|ankle tape|ankle tape
5050399|NCT01423513|Hoffmann reflex|hoffmann reflex
5050400|NCT01423513|Balance|balance
5050401|NCT01423500|ALL|all
5050402|NCT01423500|HSCT|hsct
5050403|NCT01423500|children|children
5050404|NCT01423500|adolescents|adolescents
5050405|NCT01423487|Metformin|metformin
5050406|NCT01423487|Risperidone|risperidone
5050407|NCT01423487|Prevention|prevention
5050408|NCT01423487|weight gain|weight gain
5050409|NCT01423487|Amenorrhea|amenorrhea
5050410|NCT01423474|Radiotherapy|radiotherapy
5050411|NCT01423474|Hypofractionation|hypofractionation
5050412|NCT01423448|Depression|depression
5050413|NCT01423448|mental health|mental health
5050414|NCT01423448|wellbeing|wellbeing
5050415|NCT01423448|online bulletin board|online bulletin board
5050416|NCT01423448|online support group|online support group
5050417|NCT01423435|TRK-100STP|trk-100stp
5050418|NCT01423435|PK|pk
5050419|NCT01423435|beraprost sodium|beraprost sodium
5050420|NCT01423422|Exercise stress test|exercise stress test
5050421|NCT01423422|Effort Angina|effort angina
5050422|NCT01423422|Exercise induced angina|exercise induced angina
5050423|NCT01423409|visual analog pain scale|visual analog pain scale
5050424|NCT01423409|Deaf persons|deaf persons
5050425|NCT01423409|clinical trial|clinical trial
5050426|NCT01423409|multicentric|multicentric
5050427|NCT01423396|Alzheimer's disease|alzheimer's disease
5050428|NCT01423396|cardiovascular risk factors|cardiovascular risk factors
5050429|NCT01423383|Keloid|keloid
5050430|NCT01423370|Erectile Dysfunction|erectile dysfunction
5050431|NCT01423370|YHD1023|yhd1023
5050432|NCT01423370|YCD190|ycd190
5050433|NCT01423370|Cialis|cialis
5050434|NCT01423370|Yuhan|yuhan
5050435|NCT01423357|HIV prevention|hiv prevention
5050436|NCT01423357|condom distribution|condom distribution
5050437|NCT01423357|youth peer education|youth peer education
5050438|NCT01423357|high risk places|high risk places
5050439|NCT01423357|condom use|condom use
5050440|NCT01423357|prevention through increased condom use|prevention through increased condom use
5050441|NCT01423344|multiple myeloma|multiple myeloma
5050442|NCT01423344|Free light chains|free light chains
5050443|NCT01423331|Postpartum depression|postpartum depression
5050444|NCT01423331|maternal mental health|maternal mental health
5050445|NCT01423305|Asthma|asthma
5050446|NCT01423266|High Protein Diet in heart failure|high protein diet in heart failure
5050447|NCT01423266|obesity and heart failure|obesity and heart failure
5050448|NCT01423266|Weight management in Heart failure|weight management in heart failure
5050449|NCT01423266|heart failure, diabetes and obesity|heart failure, diabetes and obesity
5050450|NCT01423253|Depression|depression
5050451|NCT01423253|Lurasidone|lurasidone
5050452|NCT01423253|Latuda|latuda
5050453|NCT01423240|Depression|depression
5050454|NCT01423240|Lurasidone|lurasidone
5050455|NCT01423240|Latuda|latuda
5050456|NCT01423227|COPD|copd
5050457|NCT01423227|exercise|exercise
5050458|NCT01423227|rehabilitation|rehabilitation
5050459|NCT01423227|dyspnea|dyspnea
5050460|NCT01423227|quality of life|quality of life
5050461|NCT01423227|economic evaluation|economic evaluation
5050462|NCT01423214|rectal cancer|rectal cancer
5050463|NCT01423214|robot|robot
5050464|NCT01423214|laparoscopy|laparoscopy
5050465|NCT01423214|total mesorectal excision|total mesorectal excision
5050466|NCT01423214|robotic surgery|robotic surgery
5050467|NCT01423201|TIA|tia
5050468|NCT01423201|triage|triage
5050469|NCT01423201|Lp-PLA2|lp-pla2
5050470|NCT01423201|Proteomic|proteomic
5050471|NCT01423201|Genomic|genomic
5050472|NCT01423188|ApolipoproteinA1|apolipoproteina1
5050473|NCT01423188|HDL-C|hdl-c
5050474|NCT01423188|Atherosclerosis|atherosclerosis
5050475|NCT01423175|high risk acute myeloid leukemia|high risk acute myeloid leukemia
5050476|NCT01423175|advanced myelodysplastic syndrome|advanced myelodysplastic syndrome
5050477|NCT01423175|allogenic stem cell transplantation|allogenic stem cell transplantation
5050478|NCT01423175|clofarabine|clofarabine
5050479|NCT01423162|Iron absorption|iron absorption
5050480|NCT01423162|Oats|oats
5050481|NCT01423162|fortified oat beverages|fortified oat beverages
5050482|NCT01423149|subfoveal choroidal neovascularization|subfoveal choroidal neovascularization
5050483|NCT01423149|pathologic myopia|pathologic myopia
5050484|NCT01423136|Patients undergoing non-cardiac Surgery|patients undergoing non-cardiac surgery
5050485|NCT01423123|Paclitaxel|paclitaxel
5050486|NCT01423123|Trastuzumab|trastuzumab
5050487|NCT01423123|Neratinib|neratinib
5050488|NCT01423123|Breast Cancer|breast cancer
5050489|NCT01423123|HER2-positive|her2-positive
5050490|NCT01423110|sporadic Inclusion Body Myositis|sporadic inclusion body myositis
5050491|NCT01423097|osteoarthritis symptoms|osteoarthritis symptoms
5050492|NCT01423084|Meningococcal Meningitis|meningococcal meningitis
5050493|NCT01423084|prevention, vaccination|prevention, vaccination
5050494|NCT01423084|adolescents|adolescents
5050495|NCT01423071|Pulmonary Hypertension|pulmonary hypertension
5050496|NCT01423071|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
5050497|NCT01423071|Prevalence|prevalence
5050498|NCT01423071|Quality of life|quality of life
5050499|NCT01423045|Chronic kidney disease|chronic kidney disease
5050500|NCT01423045|Urine osmolarity|urine osmolarity
5050501|NCT01423045|Glomerular filtration rate|glomerular filtration rate
5050502|NCT01423032|relapsed|relapsed
5050503|NCT01423019|Weight Loss|weight loss
5050504|NCT01423019|Body Composition|body composition
5050505|NCT01423019|Fat Free Mass|fat free mass
5050506|NCT01423019|Bone Mineral Density|bone mineral density
5050507|NCT01423019|Adipose Tissue|adipose tissue
5050508|NCT01423019|Dual-Energy X-Ray Absorptiometry|dual-energy x-ray absorptiometry
5050509|NCT01423019|Body Fat|body fat
5050510|NCT01423019|Eating and appetite control|eating and appetite control
5050511|NCT01423019|Basal Metabolic Rate|basal metabolic rate
5050512|NCT01423006|Pilot|pilot
5050513|NCT01423006|Ablation|ablation
5050514|NCT01423006|Low Risk|low risk
5050515|NCT01423006|Radio Frequency|radio frequency
5050517|NCT01423006|minimally invasive|minimally invasive
5050518|NCT01423006|prostate gland|prostate gland
5050519|NCT01422993|Oxaliplatin Induced|oxaliplatin induced
5050520|NCT01422993|Peripheral Neuropathy|peripheral neuropathy
5050521|NCT01422993|Strength|strength
5050522|NCT01422993|Balance|balance
5050523|NCT01422993|Training Program|training program
5050524|NCT01422993|Colon|colon
5050525|NCT01422993|Rectal|rectal
5050526|NCT01422980|dairy product|dairy product
5050527|NCT01422980|upper gastric discomfort|upper gastric discomfort
5050528|NCT01422980|adult|adult
5050529|NCT01422967|Osteoarthritis|osteoarthritis
5050530|NCT01422967|Sleep|sleep
5050531|NCT01422967|muscle strength|muscle strength
5050532|NCT01422967|balance|balance
5050533|NCT01422928|Radiotherapy|radiotherapy
5050534|NCT01422928|Acupuncture|acupuncture
5050535|NCT01422928|Immune System|immune system
5050536|NCT01422915|Sorbent|sorbent
5050537|NCT01422915|Resin|resin
5050538|NCT01422915|EPP|epp
5050539|NCT01422915|Cutaneous porphyria|cutaneous porphyria
5050540|NCT01422915|Adult|adult
5050541|NCT01422915|over age 21|over age 21
5050542|NCT01422915|without intercurrent illness|without intercurrent illness
5050543|NCT01422915|not pregnant|not pregnant
5050544|NCT01422915|willing to participate|willing to participate
5050545|NCT01422902|Schizophrenia|schizophrenia
5050546|NCT01422902|Cognitive deficits|cognitive deficits
5050547|NCT01422902|Cognitive remediation|cognitive remediation
5050548|NCT01422902|Software|software
5050549|NCT01422902|Brain Plasticity|brain plasticity
5050550|NCT01422889|Atherosclerosis|atherosclerosis
5050551|NCT01422889|Coronary Artery Disease|coronary artery disease
5050552|NCT01422863|weight loss|weight loss
5050553|NCT01422863|exercise|exercise
5050554|NCT01422863|diet|diet
5050555|NCT01422863|sleep apnea|sleep apnea
5050556|NCT01422863|aging|aging
5050557|NCT01422850|hormone-refractory prostate cancer|hormone-refractory prostate cancer
5050558|NCT01422850|Immunotherapy|immunotherapy
5050559|NCT01422837|opioid|opioid
5050560|NCT01422837|dependence|dependence
5050561|NCT01422837|VIVITROL|vivitrol
5050562|NCT01422811|Public health|public health
5050563|NCT01422811|Policy|policy
5050564|NCT01422811|Training|training
5050565|NCT01422785|Acne Vulgaris|acne vulgaris
5050566|NCT01422720|Epilepsy|epilepsy
5050567|NCT01422720|ESL|esl
5050568|NCT01422720|Eslicarbazepine Acetate|eslicarbazepine acetate
5050569|NCT01422720|BIAL|bial
5050570|NCT01422720|BIA|bia
5050571|NCT01422720|Partial-onset Seizures|partial-onset seizures
5050572|NCT01422694|Sacroiliitis|sacroiliitis
5050573|NCT01422694|Ankylosing Spondylitis|ankylosing spondylitis
5050574|NCT01422694|Spondyloarthritis|spondyloarthritis
5050575|NCT01422694|HLA-B27|hla-b27
5050576|NCT01422694|Enthesitis-Related Arthritis|enthesitis-related arthritis
5050577|NCT01422681|COPD|copd
5050578|NCT01422668|Glycemic index|glycemic index
5050579|NCT01422668|Dates|dates
5050580|NCT01422668|Diabetes|diabetes
5050581|NCT01422668|Coffee|coffee
5050582|NCT01422629|Breast Fibroadenoma|breast fibroadenoma
5050583|NCT01422629|High Intensity Focused Ultrasound|high intensity focused ultrasound
5050584|NCT01422616|Ischemic stroke|ischemic stroke
5050585|NCT01422616|High blood pressure|high blood pressure
5050586|NCT01422616|Thrombolysis|thrombolysis
5050587|NCT01422616|Antihypertensive drugs|antihypertensive drugs
5050588|NCT01422616|Disability|disability
5050589|NCT01422616|Clinical trial|clinical trial
5050590|NCT01422603|High risk|high risk
5050591|NCT01422603|AML|aml
5050592|NCT01422603|MDS|mds
5050593|NCT01422590|sitagliptin|sitagliptin
5050594|NCT01422590|mitiglinide|mitiglinide
5050595|NCT01422590|type 2 diabetes mellitus|type 2 diabetes mellitus
5050596|NCT01422590|Pharmacodynamics|pharmacodynamics
5050597|NCT01422590|Safety|safety
5050598|NCT01422551|stress management intervention|stress management intervention
5050599|NCT01422551|breast cancer|breast cancer
5050600|NCT01422551|quality of life|quality of life
5050601|NCT01422551|psychosocial adaptation|psychosocial adaptation
5050602|NCT01422538|Ulthera® System|ulthera® system
5050603|NCT01422538|Ultherapy™ treatment|ultherapy™ treatment
5050604|NCT01422538|Ulthera, Inc.|ulthera, inc.
5050605|NCT01422538|Ultrasound treatment for skin tightening|ultrasound treatment for skin tightening
5050606|NCT01422538|Skin laxity on the face and neck.|skin laxity on the face and neck.
5050607|NCT01422512|seasonal influenza|seasonal influenza
5050608|NCT01422512|vaccine|vaccine
5050609|NCT01422499|pediatric oncology|pediatric oncology
5050610|NCT01422499|relapsed solid tumor|relapsed solid tumor
5050611|NCT01422499|lymphoma|lymphoma
5050612|NCT01422499|leukemia|leukemia
5050613|NCT01422499|vorinostat|vorinostat
5050614|NCT01422486|Hematology|hematology
5050615|NCT01422486|MDS|mds
5050616|NCT01422486|Myelodysplastic Syndrome|myelodysplastic syndrome
5050617|NCT01422486|Low risk MDS|low risk mds
5050618|NCT01422486|Intermediate-1 risk MDS|intermediate-1 risk mds
5050619|NCT01422486|Int-1 risk MDS|int-1 risk mds
5050620|NCT01422486|Transfusion dependence|transfusion dependence
5050621|NCT01422486|Lenalidomide refractory|lenalidomide refractory
5050622|NCT01422486|Revlimid refractory|revlimid refractory
5050623|NCT01422486|Lenalidomide resistant|lenalidomide resistant
5050624|NCT01422486|Revlimid resistant|revlimid resistant
5050625|NCT01422486|Telintra|telintra
5050626|NCT01422486|ezatiostat|ezatiostat
5050627|NCT01422486|ezatiostat hydrochloride|ezatiostat hydrochloride
5050628|NCT01422486|TLK199|tlk199
5050629|NCT01422486|Glutathione|glutathione
5050630|NCT01422486|Glutathione analog|glutathione analog
5050631|NCT01422486|Glutathione Transferase|glutathione transferase
5050632|NCT01422486|Glutathione Transferase P1-1 inhibitor|glutathione transferase p1-1 inhibitor
5050633|NCT01422486|GST P1-1 inhibitor|gst p1-1 inhibitor
5050634|NCT01422486|Apoptosis|apoptosis
5050635|NCT01422486|Differentiation|differentiation
5050636|NCT01422486|Enzyme inhibitor|enzyme inhibitor
5050637|NCT01422473|Hemorrhoids|hemorrhoids
5050638|NCT01422473|Rectal Diseases|rectal diseases
5050639|NCT01422473|Intestinal Diseases|intestinal diseases
5050640|NCT01422473|Gastrointestinal Diseases|gastrointestinal diseases
5050641|NCT01422473|Digestive System Diseases|digestive system diseases
5050642|NCT01422460|Osteoarthritis|osteoarthritis
5050643|NCT01422460|PRP|prp
5050644|NCT01422460|PRGF|prgf
5050645|NCT01422447|mental health education|mental health education
5050646|NCT01422447|community-based|community-based
5050647|NCT01422434|A national|a national
5050648|NCT01422434|multi-centre|multi-centre
5050649|NCT01422434|prospective|prospective
5050650|NCT01422434|randomised|randomised
5050651|NCT01422434|double-blind|double-blind
5050652|NCT01422434|active-controlled|active-controlled
5050653|NCT01422434|3-arm|3-arm
5050654|NCT01422434|parallel group|parallel group
5050655|NCT01422434|4 week study|4 week study
5050656|NCT01422421|type 2 diabetes|type 2 diabetes
5050657|NCT01422421|coronary artery disease|coronary artery disease
5050658|NCT01422421|hypertension|hypertension
5050659|NCT01422421|dyslipidemia|dyslipidemia
5050660|NCT01422395|Vitrification|vitrification
5050661|NCT01422395|Egg Freezing|egg freezing
5050662|NCT01422395|Oocyte Cryopreservation|oocyte cryopreservation
5050663|NCT01422382|Healthy Volunteers|healthy volunteers
5050664|NCT01422369|Healthy Volunteers|healthy volunteers
5050665|NCT01422356|cohort study|cohort study
5050666|NCT01422356|men who have sex with men|men who have sex with men
5050667|NCT01422343|peripheral arterial disease|peripheral arterial disease
5050668|NCT01422343|cell-derived microparticles|cell-derived microparticles
5050669|NCT01422343|immunity, innate|immunity, innate
5050670|NCT01422343|blood coagulation|blood coagulation
5050671|NCT01422330|Human Immunodeficiency Virus (HIV) infection|human immunodeficiency virus (hiv) infection
5050672|NCT01422330|TMC125IFD3002|tmc125ifd3002
5050673|NCT01422330|TMC125|tmc125
5050674|NCT01422330|Intelence|intelence
5050675|NCT01422330|HIV|hiv
5050676|NCT01422317|n-3 fatty acids|n-3 fatty acids
5050677|NCT01422317|randomized double-blind study|randomized double-blind study
5050678|NCT01422317|coronary events|coronary events
5050679|NCT01422317|serum lipids|serum lipids
5050680|NCT01422317|antithrombotic effects of omega-3 fatty acids|antithrombotic effects of omega-3 fatty acids
5050681|NCT01422317|anti-inflammatory effects of omega-3 fatty acids|anti-inflammatory effects of omega-3 fatty acids
5050682|NCT01422317|prognostic biomarkers in myocardial infarction (MI)-patients|prognostic biomarkers in myocardial infarction (mi)-patients
5050683|NCT01422291|Low back pain|low back pain
5050684|NCT01422291|paracetamol|paracetamol
5050685|NCT01422291|dexketoprofen|dexketoprofen
5050686|NCT01422291|morphine|morphine
5050687|NCT01422252|Falls Elderly persons|falls elderly persons
5050688|NCT01422252|Isolated At risk for falls|isolated at risk for falls
5050689|NCT01422252|Fall detection device|fall detection device
5050690|NCT01422252|Precocious detection Vigi'Fall®|precocious detection vigi'fall®
5050691|NCT01422239|smoking|smoking
5050692|NCT01422239|treatment|treatment
5050693|NCT01422239|perceived risks|perceived risks
5050694|NCT01422226|IUD|iud
5050695|NCT01422226|contraception|contraception
5050696|NCT01422226|nulliparous|nulliparous
5050697|NCT01422226|women|women
5050698|NCT01422213|MDD|mdd
5050699|NCT01422213|Cognitive dysfunction|cognitive dysfunction
5050700|NCT01422200|DMD|dmd
5050701|NCT01422200|SMA|sma
5050702|NCT01422200|CMD|cmd
5050703|NCT01422200|flu vaccine|flu vaccine
5050704|NCT01422187|enzyme replacement therapy|enzyme replacement therapy
5050705|NCT01422174|Primary prevention|primary prevention
5050706|NCT01422174|Latin America|latin america
5050707|NCT01422174|Sudden death|sudden death
5050708|NCT01422174|Myocardial infarction|myocardial infarction
5050709|NCT01422174|Ejection Fraction|ejection fraction
5050710|NCT01422174|ICD|icd
5050711|NCT01422161|Rehabilitation|rehabilitation
5050712|NCT01422161|Fingers|fingers
5050713|NCT01422161|Grasp|grasp
5050714|NCT01422161|Hand|hand
5050715|NCT01422161|Strength|strength
5050716|NCT01422161|Brain Infraction|brain infraction
5050717|NCT01422161|Pathology|pathology
5050718|NCT01422161|Physiopathology|physiopathology
5050719|NCT01422161|Functional Laterality|functional laterality
5050720|NCT01422161|Neuronal Plasticity|neuronal plasticity
5050721|NCT01422161|Psychomotor Performance|psychomotor performance
5050722|NCT01422161|Biomechanics|biomechanics
5050723|NCT01422161|Touch|touch
5050724|NCT01422161|Weight-Bearing|weight-bearing
5050725|NCT01422148|cardiac surgery|cardiac surgery
5050726|NCT01422148|atrial fibrillation|atrial fibrillation
5050727|NCT01422148|minocycline|minocycline
5050728|NCT01422148|amiodarone|amiodarone
5050729|NCT01422135|PK and safety|pk and safety
5050730|NCT01422135|Pharmacokinetic profile (PK) and safety|pharmacokinetic profile (pk) and safety
5050731|NCT01422122|vitamin D|vitamin d
5050732|NCT01422122|pregnancy|pregnancy
5050733|NCT01422122|periodontal health|periodontal health
5050734|NCT01422122|biomarkers|biomarkers
5050735|NCT01422109|YH14659|yh14659
5050736|NCT01422109|Aspirin|aspirin
5050737|NCT01422109|Clopidogrel|clopidogrel
5050738|NCT01422109|Yuhan|yuhan
5050739|NCT01422070|mortality|mortality
5050740|NCT01422070|intensive care|intensive care
5050741|NCT01422070|critical care|critical care
5050742|NCT01422070|intermediate care|intermediate care
5050743|NCT01422057|diabetes|diabetes
5050744|NCT01422057|coronary artery disease|coronary artery disease
5051020|NCT01421173|Vorinostat|vorinostat
5050745|NCT01422057|ischemic heart disease|ischemic heart disease
5050746|NCT01422057|autonomic function|autonomic function
5050747|NCT01422057|heart rate turbulence|heart rate turbulence
5050748|NCT01422057|deceleration capacity|deceleration capacity
5050749|NCT01422057|severe autonomic failure|severe autonomic failure
5050750|NCT01422044|aortic stenosis|aortic stenosis
5050751|NCT01422044|autonomic function|autonomic function
5050752|NCT01422031|Primary care|primary care
5050753|NCT01422031|Family doctor|family doctor
5050754|NCT01422031|Consultation|consultation
5050755|NCT01422031|utilization|utilization
5050756|NCT01422031|Non-drug managements|non-drug managements
5050757|NCT01422031|Patient enablement index|patient enablement index
5050869|NCT01421667|Drug Therapy|drug therapy
5050758|NCT01422018|clinically significant macular edema|clinically significant macular edema
5050759|NCT01422018|diabetic macular edema|diabetic macular edema
5050760|NCT01422018|focal edema|focal edema
5050761|NCT01422018|focal laser photocoagulation|focal laser photocoagulation
5050762|NCT01422018|hard exudates|hard exudates
5050763|NCT01422018|intravitreal bevacizumab|intravitreal bevacizumab
5050764|NCT01422005|Rehabilitation|rehabilitation
5050765|NCT01422005|Fingers|fingers
5050766|NCT01422005|Grasp|grasp
5050767|NCT01422005|Hand|hand
5050768|NCT01422005|Strength|strength
5050769|NCT01422005|Brain Infraction|brain infraction
5050770|NCT01422005|Hand Function|hand function
5050771|NCT01422005|Post Stroke|post stroke
5050772|NCT01422005|Neural mechanisms|neural mechanisms
5050773|NCT01422005|Motor Control|motor control
5050774|NCT01422005|Motor Function|motor function
5050775|NCT01421992|randomized|randomized
5050776|NCT01421992|double-blind|double-blind
5050777|NCT01421992|crossover|crossover
5050778|NCT01421992|methylphenidate|methylphenidate
5050779|NCT01421992|excessive daytime sleepiness|excessive daytime sleepiness
5050780|NCT01421966|chronic ulcers|chronic ulcers
5050781|NCT01421966|diabetic foot ulcers|diabetic foot ulcers
5050782|NCT01421953|Positron Emission Tomography|positron emission tomography
5050783|NCT01421953|Computed Tomography|computed tomography
5050784|NCT01421953|Lung cancer|lung cancer
5050785|NCT01421940|Udenafil|udenafil
5050786|NCT01421940|rectal cancer|rectal cancer
5050787|NCT01421940|penile rehabilitation|penile rehabilitation
5050788|NCT01421940|total mesorectal excision|total mesorectal excision
5050789|NCT01421927|lenalidomide|lenalidomide
5050790|NCT01421914|Ultrasound|ultrasound
5050791|NCT01421914|Axillary block|axillary block
5050792|NCT01421914|Bupivacaine|bupivacaine
5050793|NCT01421914|Minimum|minimum
5050794|NCT01421914|Volume|volume
5050795|NCT01421914|Minimum volume of bupivacaine 0,5%|minimum volume of bupivacaine 0,5%
5050796|NCT01421901|Acute appendicitis|acute appendicitis
5050797|NCT01421901|Surgery|surgery
5050798|NCT01421901|Antibiotics|antibiotics
5050799|NCT01421901|comparison surgery and antibiotics|comparison surgery and antibiotics
5050800|NCT01421901|resolutions of symptoms|resolutions of symptoms
5050801|NCT01421888|Immunity|immunity
5050802|NCT01421888|Urea Cycle Disorder|urea cycle disorder
5050803|NCT01421888|Nutrition|nutrition
5050804|NCT01421888|Vaccination|vaccination
5050805|NCT01421888|Influenza|influenza
5050806|NCT01421875|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5050807|NCT01421875|adult acute myeloid leukemia with del(5q)|adult acute myeloid leukemia with del(5q)
5050808|NCT01421875|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5050809|NCT01421875|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5050810|NCT01421875|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5050811|NCT01421875|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
5050812|NCT01421875|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
5050813|NCT01421875|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
5050814|NCT01421875|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
5050815|NCT01421875|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
5050816|NCT01421875|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
5050817|NCT01421875|adult erythroleukemia (M6a)|adult erythroleukemia (m6a)
5050818|NCT01421875|adult pure erythroid leukemia (M6b)|adult pure erythroid leukemia (m6b)
5050819|NCT01421875|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
5050820|NCT01421875|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
5050821|NCT01421862|adult acute basophilic leukemia|adult acute basophilic leukemia
5050822|NCT01421862|adult acute eosinophilic leukemia|adult acute eosinophilic leukemia
5050823|NCT01421862|adult erythroleukemia (M6a)|adult erythroleukemia (m6a)
5050824|NCT01421862|adult pure erythroid leukemia (M6b)|adult pure erythroid leukemia (m6b)
5050825|NCT01421862|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
5050826|NCT01421862|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
5050827|NCT01421862|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
5050828|NCT01421862|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
5051021|NCT01421173|SAHA|saha
5050829|NCT01421862|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
5050830|NCT01421862|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5050831|NCT01421862|adult acute myeloid leukemia with del(5q)|adult acute myeloid leukemia with del(5q)
5050832|NCT01421862|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5050833|NCT01421862|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5050834|NCT01421862|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5050835|NCT01421862|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
5050836|NCT01421862|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
5050837|NCT01421862|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
5050838|NCT01421849|single implant denture|single implant denture
5050839|NCT01421849|Elderly with an unstable mandibular denture|elderly with an unstable mandibular denture
5050840|NCT01421836|stent patency|stent patency
5050841|NCT01421836|EUS guided insertion|eus guided insertion
5050842|NCT01421836|ERCP guided insertion|ercp guided insertion
5050843|NCT01421823|Fecal Incontinence|fecal incontinence
5050844|NCT01421823|Alpha agonist|alpha agonist
5050845|NCT01421732|Dengue fever|dengue fever
5050846|NCT01421732|severe dengue fever|severe dengue fever
5050847|NCT01421732|NS1 detection assay|ns1 detection assay
5050848|NCT01421732|Prognosis|prognosis
5050849|NCT01421732|Diagnosis|diagnosis
5050850|NCT01421719|Parkinson's Disease|parkinson's disease
5050851|NCT01421719|Neurogenic Bladder|neurogenic bladder
5050852|NCT01421719|Urinary Incontinence|urinary incontinence
5050853|NCT01421719|botulinum toxin|botulinum toxin
5050854|NCT01421719|cystoscopy|cystoscopy
5050855|NCT01421719|Effect of Other Parasympatholytics [Anticholinergics and Antimuscarinics] and Spasmolytics|effect of other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics
5050856|NCT01421706|clarithromycin|clarithromycin
5050857|NCT01421706|sibutramine|sibutramine
5050858|NCT01421706|clopidogrel|clopidogrel
5050859|NCT01421693|Gatifloxacin|gatifloxacin
5050860|NCT01421693|Ceftriaxone|ceftriaxone
5050861|NCT01421693|Enteric fever|enteric fever
5050862|NCT01421693|Typhoid fever|typhoid fever
5050863|NCT01421667|Lymphoma, Large B-Cell, Diffuse|lymphoma, large b-cell, diffuse
5050864|NCT01421667|Antigens, CD30|antigens, cd30
5050865|NCT01421667|Antibody-Drug Conjugate|antibody-drug conjugate
5050866|NCT01421667|Antibodies, Monoclonal|antibodies, monoclonal
5050867|NCT01421667|Lymphoma, Non-Hodgkin|lymphoma, non-hodgkin
5050868|NCT01421667|Monomethyl auristatin E|monomethyl auristatin e
5050870|NCT01421667|Immunotherapy|immunotherapy
5050871|NCT01421667|Hematologic Diseases|hematologic diseases
5050872|NCT01421667|Lymphoma|lymphoma
5050873|NCT01421667|Lymphoma, B-Cell|lymphoma, b-cell
5050874|NCT01421667|Lymphoma, T-Cell|lymphoma, t-cell
5050875|NCT01421654|OSA|osa
5050876|NCT01421654|Sleep Apnea|sleep apnea
5050877|NCT01421654|PAP|pap
5050878|NCT01421654|positive airway pressure|positive airway pressure
5050879|NCT01421641|Tenaculum|tenaculum
5050880|NCT01421641|Pain|pain
5050881|NCT01421641|Lidocaine|lidocaine
5050882|NCT01421628|older adults|older adults
5050883|NCT01421628|exercise|exercise
5050884|NCT01421628|stretching|stretching
5050885|NCT01421628|mobility|mobility
5050886|NCT01421615|Bacterial vaginosis|bacterial vaginosis
5050887|NCT01421615|Probiotics|probiotics
5050888|NCT01421615|Lactobacilli|lactobacilli
5050889|NCT01421615|Pregnancy outcome|pregnancy outcome
5050890|NCT01421615|Randomized controlled trial|randomized controlled trial
5050891|NCT01421602|Inguinal Hernia|inguinal hernia
5050892|NCT01421602|Self-fixating mesh|self-fixating mesh
5050893|NCT01421602|Progrip|progrip
5050894|NCT01421602|Hernia Recurrence|hernia recurrence
5050895|NCT01421602|Mesh, Surgical|mesh, surgical
5050896|NCT01421602|Recurrence|recurrence
5050897|NCT01421589|Growth hormone|growth hormone
5050898|NCT01421589|GH|gh
5050899|NCT01421589|Obesity|obesity
5050900|NCT01421589|Mitochondrial function|mitochondrial function
5050901|NCT01421589|reduced growth hormone secretion|reduced growth hormone secretion
5050902|NCT01421550|umbilical|umbilical
5050903|NCT01421550|hernia|hernia
5050904|NCT01421550|cirrhosis|cirrhosis
5050905|NCT01421550|ascites|ascites
5050906|NCT01421550|conservative|conservative
5050907|NCT01421550|surgery|surgery
5050908|NCT01421550|optimal management|optimal management
5050909|NCT01421537|Thromboprophylaxis|thromboprophylaxis
5050910|NCT01421537|enoxaparin|enoxaparin
5050911|NCT01421524|Neoplasm|neoplasm
5050912|NCT01421524|Malignancy|malignancy
5050913|NCT01421524|Carcinoma|carcinoma
5050914|NCT01421524|Lymphoma|lymphoma
5050915|NCT01421524|Multiple Myeloma|multiple myeloma
5050916|NCT01421524|DNA-PK inhibitor|dna-pk inhibitor
5050917|NCT01421524|Advanced Solid Tumors|advanced solid tumors
5050918|NCT01421524|Glioblastoma multiforme|glioblastoma multiforme
5050919|NCT01421524|Hepatocellular Carcinoma|hepatocellular carcinoma
5050920|NCT01421524|Diffuse large B-cell lymphoma|diffuse large b-cell lymphoma
5050921|NCT01421524|Mantel Cell Lymphoma|mantel cell lymphoma
5050922|NCT01421524|Advanced unresectable Solid Tumors|advanced unresectable solid tumors
5051124|NCT01420705|DTP|dtp
5050923|NCT01421524|Primary CNS Lymphoma|primary cns lymphoma
5050924|NCT01421511|ABSSSI|absssi
5050925|NCT01421511|Tedizolid Phosphate|tedizolid phosphate
5050926|NCT01421511|TR-701|tr-701
5050927|NCT01421511|Acute Bacterial Skin and Skin Structure Infections|acute bacterial skin and skin structure infections
5050928|NCT01421498|Dry Eye|dry eye
5050929|NCT01421498|ophthalmic delivery|ophthalmic delivery
5050930|NCT01421472|Breast Cancer|breast cancer
5050931|NCT01421472|Neoadjuvant|neoadjuvant
5050932|NCT01421472|Her2 negative|her2 negative
5050933|NCT01421472|Her2 non-overexpressing|her2 non-overexpressing
5050934|NCT01421472|Estrogen Receptor Positive|estrogen receptor positive
5050935|NCT01421472|Triple Negative|triple negative
5050936|NCT01421472|MM-121|mm-121
5050937|NCT01421472|Paclitaxel|paclitaxel
5050938|NCT01421459|Diabetes|diabetes
5050939|NCT01421459|Type 2 Diabetes|type 2 diabetes
5050940|NCT01421446|Neuropsychology|neuropsychology
5050941|NCT01421433|Clonixin|clonixin
5050942|NCT01421433|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal
5050943|NCT01421433|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors
5050944|NCT01421433|Lysine|lysine
5050945|NCT01421433|L-Lysine|l-lysine
5050946|NCT01421433|Lysine Acetate|lysine acetate
5050947|NCT01421433|Lysine Hydrochloride|lysine hydrochloride
5050948|NCT01421433|Amitriptyline|amitriptyline
5050949|NCT01421420|Alzheimer's|alzheimer's
5050950|NCT01421420|Dementia|dementia
5050951|NCT01421420|Mild Cognitive Impairment|mild cognitive impairment
5050952|NCT01421407|Secondary hyperparathyroidism|secondary hyperparathyroidism
5050953|NCT01421407|End stage renal disease|end stage renal disease
5050954|NCT01421407|Parathyroid hyperplasia|parathyroid hyperplasia
5050955|NCT01421407|High Intensity Focused Ultrasound|high intensity focused ultrasound
5050956|NCT01421394|spinal cord injury(SCI)|spinal cord injury(sci)
5050957|NCT01421394|diffusion tensor imaging(DTI)|diffusion tensor imaging(dti)
5050958|NCT01421394|tractography|tractography
5050959|NCT01421381|leber's hereditary optic neuropathy|leber's hereditary optic neuropathy
5050960|NCT01421381|idebenone|idebenone
5050961|NCT01421342|Mood Disorder|mood disorder
5050962|NCT01421342|Depression|depression
5050963|NCT01421342|Depressive Disorder|depressive disorder
5050964|NCT01421342|Depressive Disorder, Major|depressive disorder, major
5050965|NCT01421342|Bupropion|bupropion
5050966|NCT01421342|Aripiprazole|aripiprazole
5050967|NCT01421342|Remission|remission
5050968|NCT01421342|Relapse|relapse
5050969|NCT01421342|Cost-Effectiveness|cost-effectiveness
5050970|NCT01421342|Atypical Antipsychotic|atypical antipsychotic
5050971|NCT01421342|Antidepressant|antidepressant
5050972|NCT01421342|Augmentation|augmentation
5050973|NCT01421342|Veterans|veterans
5050974|NCT01421342|Mental Health|mental health
5050975|NCT01421316|Patients treated with whole brain radiotherapy in the setting of brain metastases|patients treated with whole brain radiotherapy in the setting of brain metastases
5050976|NCT01421316|Patients treated with whole brain radiotherapy in the prophylactic treatment for small cell lung cancer (extended disease).|patients treated with whole brain radiotherapy in the prophylactic treatment for small cell lung cancer (extended disease).
5050977|NCT01421290|Cartilage lesions in the knee joint|cartilage lesions in the knee joint
5050978|NCT01421264|concussion|concussion
5050979|NCT01421264|gabapentin|gabapentin
5050980|NCT01421264|neurontin|neurontin
5050981|NCT01421264|insomnia|insomnia
5050982|NCT01421251|H1N1|h1n1
5050983|NCT01421251|Flu|flu
5050984|NCT01421251|Influenza|influenza
5050985|NCT01421251|Vaccine|vaccine
5050986|NCT01421251|Manitoba|manitoba
5050987|NCT01421251|Canada|canada
5050988|NCT01421251|Safety|safety
5050989|NCT01421238|Decision Making|decision making
5050990|NCT01421238|Premature infant|premature infant
5050991|NCT01421238|Informed consent|informed consent
5050992|NCT01421238|Prematurity|prematurity
5050993|NCT01421238|Framing|framing
5050994|NCT01421238|Negotiation Model|negotiation model
5050995|NCT01421225|Closed Loop Insulin Delivery|closed loop insulin delivery
5050996|NCT01421225|Diabetes|diabetes
5050997|NCT01421225|Type 1 Diabetes|type 1 diabetes
5050998|NCT01421225|Artificial pancreas|artificial pancreas
5050999|NCT01421212|Liver Transplantation|liver transplantation
5051000|NCT01421212|Liver Disease|liver disease
5051001|NCT01421212|Hepatitis B|hepatitis b
5051002|NCT01421212|Hepatitis B Infection|hepatitis b infection
5051003|NCT01421212|Hepatitis B Associated Liver Disease|hepatitis b associated liver disease
5051004|NCT01421212|HBV|hbv
5051005|NCT01421199|Otitis Media with Effusion|otitis media with effusion
5051006|NCT01421199|Middle Ear Effusion|middle ear effusion
5051007|NCT01421186|Multiple Myeloma|multiple myeloma
5051008|NCT01421186|MOR03087 (MOR202)|mor03087 (mor202)
5051009|NCT01421186|Lenalidomide|lenalidomide
5051010|NCT01421186|Pomalidomide|pomalidomide
5051011|NCT01421186|CD38|cd38
5051012|NCT01421173|Lymphoma|lymphoma
5051013|NCT01421173|Lymphoid malignancies|lymphoid malignancies
5051014|NCT01421173|Relapsed|relapsed
5051015|NCT01421173|Refractory|refractory
5051016|NCT01421173|Autologous hematopoietic cell support|autologous hematopoietic cell support
5051017|NCT01421173|Stem cell infusion|stem cell infusion
5051018|NCT01421173|Hodgkin's lymphoma|hodgkin's lymphoma
5051019|NCT01421173|non-Hodgkin's lymphoma|non-hodgkin's lymphoma
5051022|NCT01421173|Suberoylanilide Hydroxamic Acid|suberoylanilide hydroxamic acid
5051023|NCT01421173|MSK-390|msk-390
5051024|NCT01421173|Zolinza|zolinza
5051025|NCT01421173|Busulfan|busulfan
5051026|NCT01421173|Busulfex|busulfex
5051027|NCT01421173|Myleran|myleran
5051028|NCT01421173|Gemcitabine|gemcitabine
5051029|NCT01421173|Gemcitabine Hydrochloride|gemcitabine hydrochloride
5051030|NCT01421173|Gemzar|gemzar
5051031|NCT01421173|Melphalan|melphalan
5051032|NCT01421173|Alkeran|alkeran
5051033|NCT01421173|Rituximab|rituximab
5051034|NCT01421173|Rituxan|rituxan
5051035|NCT01421173|Dexamethasone|dexamethasone
5051036|NCT01421173|Decadron|decadron
5051037|NCT01421173|G-CSF|g-csf
5051038|NCT01421173|Filgrastim|filgrastim
5051039|NCT01421173|NeupogenTM|neupogentm
5051040|NCT01421173|Palifermin|palifermin
5051041|NCT01421173|Kepivance|kepivance
5051042|NCT01421160|Chronic|chronic
5051043|NCT01421160|Inflammatory|inflammatory
5051044|NCT01421160|Joint|joint
5051045|NCT01421160|Pain|pain
5051046|NCT01421147|Diabetes|diabetes
5051047|NCT01421147|Type 1 Diabetes|type 1 diabetes
5051048|NCT01421147|Diabetes Mellitus|diabetes mellitus
5051049|NCT01421134|depression|depression
5051050|NCT01421134|Lurasidone|lurasidone
5051051|NCT01421134|Latuda|latuda
5051052|NCT01421108|oral health|oral health
5051053|NCT01421108|dental brushing|dental brushing
5051054|NCT01421108|dental flossing|dental flossing
5051055|NCT01421095|Fertility|fertility
5051056|NCT01421095|adolescent|adolescent
5051057|NCT01421095|young adult|young adult
5051058|NCT01421095|cancer survivors|cancer survivors
5051059|NCT01421082|LVRS (Lung Volume Reduction Surgery)|lvrs (lung volume reduction surgery)
5051060|NCT01421082|LVRC (Lung Volume Reduction Coil)|lvrc (lung volume reduction coil)
5051061|NCT01421082|Emphysema|emphysema
5051062|NCT01421082|coil|coil
5051063|NCT01421082|RePneu|repneu
5051064|NCT01421069|Use of etanercept to treat pediatric subjects with extended oligoarticular JIA|use of etanercept to treat pediatric subjects with extended oligoarticular jia
5051065|NCT01421069|enthestitis related arthritis (ERA)|enthestitis related arthritis (era)
5051066|NCT01421069|or psoriatic arthritis (PsA).|or psoriatic arthritis (psa).
5051067|NCT01421043|bioequivalence study|bioequivalence study
5051068|NCT01421043|triazolam|triazolam
5051069|NCT01421043|liquid oral drops|liquid oral drops
5051070|NCT01421043|tablet|tablet
5051071|NCT01421030|quality of life|quality of life
5051072|NCT01421030|congenital heart disease|congenital heart disease
5051073|NCT01421030|open heart surgery|open heart surgery
5051074|NCT01421030|percutaneous pulmonary valve implantation|percutaneous pulmonary valve implantation
5051075|NCT01421030|costs|costs
5051076|NCT01421017|radiation therapy|radiation therapy
5051077|NCT01421017|combination therapy|combination therapy
5051078|NCT01421017|immunotherapy|immunotherapy
5051079|NCT01421017|immune response modifier|immune response modifier
5051080|NCT01421017|immunostimulatory|immunostimulatory
5051081|NCT01421017|immunomodulator|immunomodulator
5051082|NCT01421004|cancer|cancer
5051083|NCT01421004|tumors|tumors
5051084|NCT01421004|phase I|phase i
5051085|NCT01421004|crossover|crossover
5051086|NCT01421004|bioequivalence|bioequivalence
5051087|NCT01420965|Anti PD-1 Monoclonal Antibody|anti pd-1 monoclonal antibody
5051088|NCT01420965|Vaccine|vaccine
5051089|NCT01420965|Autologous Cellular Immunotherapy|autologous cellular immunotherapy
5051090|NCT01420965|Prostate Cancer|prostate cancer
5051091|NCT01420952|Positron Emission Tomograhy (PET)|positron emission tomograhy (pet)
5051092|NCT01420952|Metabolic Glutamate Receptors|metabolic glutamate receptors
5051093|NCT01420952|Brain|brain
5051094|NCT01420939|TBI|tbi
5051095|NCT01420939|Brain|brain
5051096|NCT01420939|Traumatic Brain Injury|traumatic brain injury
5051097|NCT01420939|Biomarkers|biomarkers
5051098|NCT01420939|Healthy Volunteer|healthy volunteer
5051099|NCT01420939|HV|hv
5051100|NCT01420913|To evaluate the pharmacokinetic characteristics of Lyrica, YHD1119 A,B,C|to evaluate the pharmacokinetic characteristics of lyrica, yhd1119 a,b,c
5051101|NCT01420887|CPM|cpm
5051102|NCT01420887|elbow joint surgery|elbow joint surgery
5051103|NCT01420887|continuous passive motion|continuous passive motion
5051104|NCT01420887|Recovery after surgery to restore elbow motion|recovery after surgery to restore elbow motion
5051105|NCT01420861|castrate resistant|castrate resistant
5051106|NCT01420848|stress disorders|stress disorders
5051107|NCT01420848|anxiety disorders|anxiety disorders
5051108|NCT01420835|Stress|stress
5051109|NCT01420835|Quality of life|quality of life
5051110|NCT01420796|Parkinson's disease|parkinson's disease
5051111|NCT01420796|dysphagia|dysphagia
5051112|NCT01420796|swallowing treatment|swallowing treatment
5051113|NCT01420757|operation time|operation time
5051114|NCT01420757|length of hospital stay|length of hospital stay
5051115|NCT01420744|Endotracheal ventilation|endotracheal ventilation
5051116|NCT01420744|Bacterial pneumonia|bacterial pneumonia
5051117|NCT01420731|sexual life, back pain|sexual life, back pain
5051118|NCT01420718|partial pulpotomy|partial pulpotomy
5051119|NCT01420718|Cvek pulpotomy|cvek pulpotomy
5051120|NCT01420718|MTA|mta
5051121|NCT01420718|iRootBP|irootbp
5051122|NCT01420718|dentin bridge|dentin bridge
5051123|NCT01420705|Bacille Calmette-Guérin|bacille calmette-guérin
5051125|NCT01420705|Vaccination|vaccination
5051126|NCT01420705|Allergy|allergy
5051127|NCT01420705|Atopy|atopy
5051128|NCT01420705|Guinea-Bissau|guinea-bissau
5051129|NCT01420692|Tip 2 DM|tip 2 dm
5051130|NCT01420692|Endothelium|endothelium
5051131|NCT01420692|Gliclazide|gliclazide
5051132|NCT01420692|Insulin detemir|insulin detemir
5051133|NCT01420679|Lymphoproliferative Disorders|lymphoproliferative disorders
5051134|NCT01420679|Lymphoma|lymphoma
5051135|NCT01420679|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
5051136|NCT01420679|T-cell Lymphoma|t-cell lymphoma
5051137|NCT01420640|Fibromyalgia|fibromyalgia
5051138|NCT01420640|Tai Chi|tai chi
5051139|NCT01420640|mind-body exercise|mind-body exercise
5051140|NCT01420640|aerobic exercise|aerobic exercise
5051141|NCT01420640|exercise|exercise
5051142|NCT01420640|pain|pain
5051143|NCT01420614|radial access|radial access
5051144|NCT01420614|primary angioplasty|primary angioplasty
5051145|NCT01420614|trial|trial
5051146|NCT01420614|randomization|randomization
5051147|NCT01420614|outcome|outcome
5051148|NCT01420601|Torisel|torisel
5051149|NCT01420601|Long-term use|long-term use
5051150|NCT01420601|Regulatory Post Marketing Commitment Plan|regulatory post marketing commitment plan
5051151|NCT01420588|Oncologic Investigations|oncologic investigations
5051152|NCT01420588|Gastric Diseases|gastric diseases
5051153|NCT01420588|Gastric Cancer|gastric cancer
5051154|NCT01420588|Gastric Ulcer|gastric ulcer
5051155|NCT01420588|Breath Analysis|breath analysis
5051156|NCT01420588|Volatile Biomarkers|volatile biomarkers
5051157|NCT01420588|Nanosensors Array|nanosensors array
5051158|NCT01420588|Discriminant Factor Analysis|discriminant factor analysis
5051159|NCT01420588|GC-MS|gc-ms
5051160|NCT01420588|Breath Tests|breath tests
5051161|NCT01420575|Schizophrenia|schizophrenia
5051162|NCT01420575|Schizoaffective Disorder|schizoaffective disorder
5051163|NCT01420575|Shared Decision|shared decision
5051164|NCT01420575|Decision Aid|decision aid
5051165|NCT01420575|Antipsychotic|antipsychotic
5051166|NCT01420575|Weight Gain|weight gain
5051167|NCT01420575|Olanzapine|olanzapine
5051168|NCT01420575|Lexapro|lexapro
5051169|NCT01420575|Perphenazine|perphenazine
5051170|NCT01420562|allogeneic HSCT|allogeneic hsct
5051171|NCT01420562|posaconazole|posaconazole
5051172|NCT01420562|prophylaxis|prophylaxis
5051173|NCT01420562|mucositis|mucositis
5051174|NCT01420562|pharmacokinetics|pharmacokinetics
5051175|NCT01420549|Hypercholesterolemia|hypercholesterolemia
5051176|NCT01420549|Dyslipidemia|dyslipidemia
5051177|NCT01420536|Bilateral Balanced Occlusion|bilateral balanced occlusion
5051178|NCT01420536|Canine Guidance|canine guidance
5051179|NCT01420536|Complete Denture|complete denture
5051180|NCT01420536|Denture Retention|denture retention
5051181|NCT01420536|Dental Occlusion|dental occlusion
5051182|NCT01420536|Edentulous|edentulous
5051183|NCT01420536|Edentulism|edentulism
5051184|NCT01420536|Mandibular movement|mandibular movement
5051185|NCT01420536|Mastication|mastication
5051186|NCT01420536|Patient Acceptance of Health Care|patient acceptance of health care
5051187|NCT01420536|Patient Satisfaction|patient satisfaction
5051188|NCT01420523|HIV|hiv
5051189|NCT01420523|Lipohypertrophy|lipohypertrophy
5051190|NCT01420510|Patients satisfaction|patients satisfaction
5051191|NCT01420510|Side effects|side effects
5051192|NCT01420497|methylprednisolone|methylprednisolone
5051193|NCT01420497|intra articular infiltration|intra articular infiltration
5051194|NCT01420497|glycemia|glycemia
5051195|NCT01420497|epidural infiltration|epidural infiltration
5051196|NCT01420497|diabetes|diabetes
5051197|NCT01420484|CNAP|cnap
5051198|NCT01420484|continuous non-invasive arterial pressure|continuous non-invasive arterial pressure
5051199|NCT01420484|IAP|iap
5051200|NCT01420484|blood pressure|blood pressure
5051201|NCT01420484|analgosedation|analgosedation
5051202|NCT01420484|high-risk patients|high-risk patients
5051203|NCT01420484|rapid-pacing|rapid-pacing
5051204|NCT01420471|Endoscopic Sinus Surgery|endoscopic sinus surgery
5051205|NCT01420471|Triamcinolone|triamcinolone
5051206|NCT01420471|Merocel Middle Meatus Spacers|merocel middle meatus spacers
5051207|NCT01420458|bioequivalence|bioequivalence
5051208|NCT01420432|Ankylosing Spondylitis|ankylosing spondylitis
5051209|NCT01420432|Umbilical Cord/placenta-Derived MSC|umbilical cord/placenta-derived msc
5051210|NCT01420432|Transplantation|transplantation
5051211|NCT01420419|nipple pain|nipple pain
5051212|NCT01420419|breastfeeding|breastfeeding
5051213|NCT01420419|nipple damage|nipple damage
5051214|NCT01420419|lanolin|lanolin
5051215|NCT01420419|clinical trial|clinical trial
5051216|NCT01420406|lactation|lactation
5051217|NCT01420406|cryptoxanthin|cryptoxanthin
5051218|NCT01420406|beta-carotene|beta-carotene
5051219|NCT01420406|vitamin A|vitamin a
5051220|NCT01420393|Heart Failure|heart failure
5051221|NCT01420393|Atrial Fibrillation|atrial fibrillation
5051222|NCT01420393|Catheter Ablation|catheter ablation
5051223|NCT01420393|Anti-arrhythmic Medications|anti-arrhythmic medications
5051224|NCT01420393|Cardiovascular Mortality|cardiovascular mortality
5051225|NCT01420367|Paediatric|paediatric
5051226|NCT01420367|Simple|simple
5051227|NCT01420367|Non-perforated|non-perforated
5051228|NCT01420354|Metabolic stones|metabolic stones
5051229|NCT01420354|kidney stones|kidney stones
5051230|NCT01420354|renal calculi|renal calculi
5051231|NCT01420354|metabolic evaluation|metabolic evaluation
5051232|NCT01420341|Meliodosis|meliodosis
5051233|NCT01420341|Co-trimoxazole|co-trimoxazole
5051234|NCT01420341|Relapse|relapse
5051235|NCT01420315|vitamin D|vitamin d
5051236|NCT01420315|deficiency|deficiency
5051237|NCT01420315|alzheimer's disease|alzheimer's disease
5051238|NCT01420302|critical illness|critical illness
5051239|NCT01420302|intensive care|intensive care
5051240|NCT01420302|insulin|insulin
5051241|NCT01420302|glucose|glucose
5051242|NCT01420302|algorithm|algorithm
5051243|NCT01420302|blood glucose control|blood glucose control
5051244|NCT01420289|Ischemic ulcers|ischemic ulcers
5051245|NCT01420289|PAD|pad
5051246|NCT01420289|Intermittent Claudication Pain|intermittent claudication pain
5051247|NCT01420276|Female sexual function|female sexual function
5051248|NCT01420263|premature infant|premature infant
5051249|NCT01420263|feeding|feeding
5051250|NCT01420263|residuals|residuals
5051251|NCT01420263|fresh feeds|fresh feeds
5051252|NCT01420263|full feeds|full feeds
5051253|NCT01420263|digestive system|digestive system
5051254|NCT01420250|Prostate cancer|prostate cancer
5051255|NCT01420250|Adenocarcinoma of the prostate|adenocarcinoma of the prostate
5051256|NCT01420237|Noninflammatory joint disease of the hip.|noninflammatory joint disease of the hip.
5051257|NCT01420224|Air travel|air travel
5051258|NCT01420224|Aircraft cabin hypoxia|aircraft cabin hypoxia
5051259|NCT01420224|Pulmonary artery pressure|pulmonary artery pressure
5051260|NCT01420224|Hypoxic pulmonary vasoconstriction|hypoxic pulmonary vasoconstriction
5051261|NCT01420224|Pulmonary hypertension|pulmonary hypertension
5051262|NCT01420211|pharmacokinetics|pharmacokinetics
5051263|NCT01420211|MRI|mri
5051264|NCT01420211|liver|liver
5051265|NCT01420211|drug transporter|drug transporter
5051266|NCT01420211|Gd-EOB-DTPA|gd-eob-dtpa
5051267|NCT01420198|Diabetes type 2|diabetes type 2
5051268|NCT01420198|Lifestyle intervention|lifestyle intervention
5051269|NCT01420198|QALY|qaly
5051270|NCT01420198|Ethnic group|ethnic group
5051271|NCT01420198|Impaired glucose tolerance|impaired glucose tolerance
5051272|NCT01420198|Impaired fasting glucose|impaired fasting glucose
5051273|NCT01420185|estrogen receptor-positive breast cancer|estrogen receptor-positive breast cancer
5051274|NCT01420185|stage II breast cancer|stage ii breast cancer
5051275|NCT01420185|stage IIIA breast cancer|stage iiia breast cancer
5051276|NCT01420159|Pain|pain
5051277|NCT01420159|Trauma|trauma
5051278|NCT01420159|Analgesia|analgesia
5051279|NCT01420133|Corticosteroids|corticosteroids
5051280|NCT01420133|Diet low in sugar and salt|diet low in sugar and salt
5051281|NCT01420133|Dermatological disease|dermatological disease
5051282|NCT01420133|Corticosteroids Allergy|corticosteroids allergy
5051283|NCT01420133|3 Months|3 months
5051284|NCT01420120|Biodegradable stent, PAD|biodegradable stent, pad
5051285|NCT01420107|Infant, Premature|infant, premature
5051286|NCT01420107|Delivery Rooms|delivery rooms
5051287|NCT01420107|Video Recording|video recording
5051288|NCT01420107|Outcome Assessment (Health Care)|outcome assessment (health care)
5051289|NCT01420094|Drugs, Investigational|drugs, investigational
5051290|NCT01420094|Acetylsalicylic Acid|acetylsalicylic acid
5051291|NCT01420094|Aspirin|aspirin
5051292|NCT01420094|dental pain|dental pain
5051293|NCT01420081|uterine neoplasms|uterine neoplasms
5051294|NCT01420081|endometrial|endometrial
5051295|NCT01420081|uterine|uterine
5051296|NCT01420081|cancer|cancer
5051297|NCT01420081|PI3K|pi3k
5051298|NCT01420081|mTOR|mtor
5051299|NCT01420081|PI3K/mTOR|pi3k/mtor
5051300|NCT01420081|recurrent|recurrent
5051301|NCT01420081|metastatic|metastatic
5051302|NCT01420068|Pediatric|pediatric
5051303|NCT01420068|hypertension|hypertension
5051304|NCT01420068|aliskiren|aliskiren
5051305|NCT01420055|Multiple sclerosis|multiple sclerosis
5051306|NCT01420055|Fingolimod|fingolimod
5051307|NCT01420055|Coping|coping
5051308|NCT01420055|Anxiety|anxiety
5051309|NCT01420055|France|france
5051310|NCT01420055|Treatment Satisfaction Questionnaire for Medication-9 items (TSQM 9)|treatment satisfaction questionnaire for medication-9 items (tsqm 9)
5051311|NCT01420055|Active|active
5051312|NCT01420029|Low birth weight neonates|low birth weight neonates
5051313|NCT01420029|Neurodevelopmental outcome|neurodevelopmental outcome
5051314|NCT01420029|Thyroid dysfunction|thyroid dysfunction
5051315|NCT01420029|Extrauterine growth|extrauterine growth
5051316|NCT01420029|Plasticizers|plasticizers
5051317|NCT01420016|Cardiovascular risk|cardiovascular risk
5051318|NCT01420003|Allergen Challenge|allergen challenge
5051319|NCT01420003|B cell activation|b cell activation
5051320|NCT01420003|M1 prime related biomarkers|m1 prime related biomarkers
5051321|NCT01419977|sickle cell disease|sickle cell disease
5051322|NCT01419977|vaso-occlusive crisis|vaso-occlusive crisis
5051323|NCT01419977|anticoagulation|anticoagulation
5051324|NCT01419964|Vitiligo|vitiligo
5051325|NCT01419964|Macular depigmentation|macular depigmentation
5051326|NCT01419964|Stachytarpheta cayensensis|stachytarpheta cayensensis
5051327|NCT01419951|Behavioral treatment|behavioral treatment
5051821|NCT01417806|topotecan|topotecan
5051328|NCT01419951|Preschool aged children|preschool aged children
5051329|NCT01419951|Obesity|obesity
5051330|NCT01419938|Light therapy|light therapy
5051331|NCT01419938|circadian rhythm|circadian rhythm
5051332|NCT01419938|CBT|cbt
5051333|NCT01419925|influenza vaccine|influenza vaccine
5051334|NCT01419925|peptide|peptide
5051335|NCT01419925|universal|universal
5051336|NCT01419925|prime|prime
5051337|NCT01419925|boost|boost
5051338|NCT01419925|TIV|tiv
5051339|NCT01419925|HAI|hai
5051340|NCT01419925|Hemagglutination Inhibition|hemagglutination inhibition
5051341|NCT01419925|elderly|elderly
5051342|NCT01419899|Brief intervention|brief intervention
5051343|NCT01419899|Rapid testing|rapid testing
5051344|NCT01419873|Hyperglycaemia|hyperglycaemia
5051345|NCT01419873|Very low birthweight infants|very low birthweight infants
5051346|NCT01419873|Insulin|insulin
5051347|NCT01419860|Microcirculation|microcirculation
5051348|NCT01419860|Colon|colon
5051349|NCT01419860|Anastomosis|anastomosis
5051350|NCT01419860|ICG|icg
5051351|NCT01419860|Gastro surgery|gastro surgery
5051352|NCT01419860|benign colon diseases requiring resection|benign colon diseases requiring resection
5051353|NCT01419834|CNS|cns
5051354|NCT01419834|Brain|brain
5051355|NCT01419834|MAB 3F8|mab 3f8
5051356|NCT01419834|Hu3F8|hu3f8
5051357|NCT01419834|11-009|11-009
5051358|NCT01419821|Vitamin D|vitamin d
5051359|NCT01419821|Bone densitometry|bone densitometry
5051360|NCT01419821|Vitamin D supplementation|vitamin d supplementation
5051361|NCT01419821|Growth|growth
5051362|NCT01419808|Scaphoid|scaphoid
5051363|NCT01419808|Non-Union|non-union
5051364|NCT01419808|Proximal pole|proximal pole
5051365|NCT01419808|Bone Graft|bone graft
5051366|NCT01419808|Vascularized|vascularized
5051367|NCT01419808|Non-Vascularized|non-vascularized
5051368|NCT01419808|PREE|pree
5051369|NCT01419782|bone|bone
5051370|NCT01419782|osteocyte|osteocyte
5051371|NCT01419782|rest muscle electrical activity|rest muscle electrical activity
5051372|NCT01419782|whole-body vibration|whole-body vibration
5051373|NCT01419782|sclerostin|sclerostin
5051374|NCT01419769|symptomatic pancreatic pseudocyst|symptomatic pancreatic pseudocyst
5051375|NCT01419769|pancreatic pseudocyst|pancreatic pseudocyst
5051376|NCT01419769|transluminal drainage|transluminal drainage
5051377|NCT01419769|minimally invasive|minimally invasive
5051378|NCT01419769|Nitinol stent|nitinol stent
5051379|NCT01419769|transmural endoscopic drainage|transmural endoscopic drainage
5051380|NCT01419769|catheter based|catheter based
5051381|NCT01419743|Vitamin D deficiency|vitamin d deficiency
5051382|NCT01419743|Supplementation|supplementation
5051383|NCT01419743|Infertility|infertility
5051384|NCT01419743|Clinical pregnancy rates|clinical pregnancy rates
5051385|NCT01419717|cancer|cancer
5051386|NCT01419717|bone metastases|bone metastases
5051387|NCT01419717|breast cancer|breast cancer
5051388|NCT01419717|prostate cancer|prostate cancer
5051389|NCT01419704|other hemoglobinopathies|other hemoglobinopathies
5051390|NCT01419704|chimerism|chimerism
5051391|NCT01419704|sickle cell|sickle cell
5051392|NCT01419704|thalassemia|thalassemia
5051393|NCT01419704|Marrow/Enriched Hematopoetic Stem Cell Transplant|marrow/enriched hematopoetic stem cell transplant
5051394|NCT01419691|auranofin|auranofin
5051395|NCT01419691|chronic lymphocytic leukemia|chronic lymphocytic leukemia
5051396|NCT01419691|relapsed|relapsed
5051397|NCT01419691|refractory|refractory
5051398|NCT01419691|CLL|cll
5051399|NCT01419691|SLL|sll
5051400|NCT01419691|PLL|pll
5051401|NCT01419678|posaconazole|posaconazole
5051402|NCT01419678|PK blood sampling|pk blood sampling
5051403|NCT01419665|Follicular Lymphoma|follicular lymphoma
5051404|NCT01419665|Biosimilar|biosimilar
5051405|NCT01419665|GP13-301|gp13-301
5051406|NCT01419665|rituximab|rituximab
5051407|NCT01419665|Antibodies|antibodies
5051408|NCT01419665|CD20|cd20
5051409|NCT01419652|percutaneous coronary intervention|percutaneous coronary intervention
5051410|NCT01419639|Neurofibromatosis Type II|neurofibromatosis type ii
5051411|NCT01419639|cranial nerve schwannomas|cranial nerve schwannomas
5051412|NCT01419639|meningiomas|meningiomas
5051413|NCT01419639|ependymomas|ependymomas
5051414|NCT01419613|healthy lifestyle|healthy lifestyle
5051415|NCT01419613|physical activity|physical activity
5051416|NCT01419613|behavior|behavior
5051417|NCT01419613|motivational|motivational
5051418|NCT01419613|interview|interview
5051419|NCT01419613|breast cancer survivor|breast cancer survivor
5051420|NCT01419600|Phase 1|phase 1
5051421|NCT01419600|healthy volunteers|healthy volunteers
5051422|NCT01419600|safety|safety
5051423|NCT01419600|tolerability|tolerability
5051424|NCT01419600|pharmacokinetics|pharmacokinetics
5051425|NCT01419600|single ascending dose study|single ascending dose study
5051426|NCT01419587|Carcinoma, Non-Small-Cell Lung|carcinoma, non-small-cell lung
5051427|NCT01419587|Non small cell lung cancer|non small cell lung cancer
5051428|NCT01419587|NSCLC|nsclc
5051429|NCT01419587|Ketogenic Diet|ketogenic diet
5051430|NCT01419587|radiotherapy|radiotherapy
5051431|NCT01419587|paclitaxel|paclitaxel
5051432|NCT01419587|carboplatin|carboplatin
5051433|NCT01419574|Carotid Artery Plaque|carotid artery plaque
5051434|NCT01419574|Contrast Agents|contrast agents
5051435|NCT01419574|Vasa Vasorum|vasa vasorum
5051436|NCT01419574|MRI|mri
5051437|NCT01419574|Intraplaque Hemorrhage|intraplaque hemorrhage
5051438|NCT01419574|Solid Tumor|solid tumor
5051439|NCT01419574|Metastatic Solid Tumor|metastatic solid tumor
5051440|NCT01419561|KSHV|kshv
5051441|NCT01419561|KICS|kics
5051442|NCT01419561|HIV|hiv
5051443|NCT01419561|Cytokines|cytokines
5051444|NCT01419561|HHV-8|hhv-8
5051445|NCT01419561|KSHV Inflammatory Cytokine Syndrome|kshv inflammatory cytokine syndrome
5051446|NCT01419561|Kaposi Sarcoma Heres Virus|kaposi sarcoma heres virus
5051447|NCT01419548|ABT-888|abt-888
5051448|NCT01419548|Liver Dysfunction|liver dysfunction
5051449|NCT01419548|Kidney Dysfunction|kidney dysfunction
5051450|NCT01419548|PARP Inhibitor|parp inhibitor
5051451|NCT01419548|Pharmacokinetics|pharmacokinetics
5051452|NCT01419548|Cancer|cancer
5051453|NCT01419535|Metabolism|metabolism
5051454|NCT01419535|Cortisol|cortisol
5051455|NCT01419535|Hypercortisolism|hypercortisolism
5051456|NCT01419535|Glucose Intolerance|glucose intolerance
5051457|NCT01419522|Traumatic Brain Injury|traumatic brain injury
5051458|NCT01419522|Walking Impairment|walking impairment
5051459|NCT01419522|Gait Training|gait training
5051460|NCT01419522|TBI|tbi
5051461|NCT01419509|alveolar childhood rhabdomyosarcoma|alveolar childhood rhabdomyosarcoma
5051462|NCT01419509|embryonal childhood rhabdomyosarcoma|embryonal childhood rhabdomyosarcoma
5051463|NCT01419509|embryonal-botryoid childhood rhabdomyosarcoma|embryonal-botryoid childhood rhabdomyosarcoma
5051464|NCT01419509|mixed childhood rhabdomyosarcoma|mixed childhood rhabdomyosarcoma
5051465|NCT01419509|pleomorphic childhood rhabdomyosarcoma|pleomorphic childhood rhabdomyosarcoma
5051466|NCT01419509|previously untreated childhood rhabdomyosarcoma|previously untreated childhood rhabdomyosarcoma
5051467|NCT01419509|nonmetastatic childhood soft tissue sarcoma|nonmetastatic childhood soft tissue sarcoma
5051468|NCT01419496|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5051469|NCT01419496|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5051470|NCT01419496|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5051471|NCT01419496|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5051472|NCT01419496|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5051473|NCT01419496|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5051474|NCT01419496|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5051475|NCT01419496|adult acute myeloid leukemia with del(5q)|adult acute myeloid leukemia with del(5q)
5051476|NCT01419483|Pancreatic neoplasms|pancreatic neoplasms
5051477|NCT01419483|Pancreatic cancer|pancreatic cancer
5051478|NCT01419483|Ketogenic Diet|ketogenic diet
5051479|NCT01419483|radiotherapy|radiotherapy
5051480|NCT01419483|gemcitabine|gemcitabine
5051481|NCT01419457|Healthy|healthy
5051482|NCT01419457|hepatic impairment|hepatic impairment
5051483|NCT01419457|T-705a|t-705a
5051484|NCT01419457|Favipiravir|favipiravir
5051485|NCT01419444|Voice|voice
5051486|NCT01419444|Muscle Tension Dysphonia|muscle tension dysphonia
5051487|NCT01419444|Hyperfunction|hyperfunction
5051488|NCT01419444|Treatment|treatment
5051489|NCT01419431|Colon cancer|colon cancer
5051490|NCT01419418|Peripheral Arterial Disease (PAD)|peripheral arterial disease (pad)
5051491|NCT01419418|Qualitative analysis|qualitative analysis
5051492|NCT01419418|Patients' perspective|patients' perspective
5051493|NCT01419405|analgesia|analgesia
5051494|NCT01419405|acute experimental pain|acute experimental pain
5051495|NCT01419405|cold pressor test|cold pressor test
5051496|NCT01419405|pregabalin|pregabalin
5051497|NCT01419405|remifentanil|remifentanil
5051498|NCT01419392|sildenafil citrate|sildenafil citrate
5051499|NCT01419392|Doppler Ultrasonography|doppler ultrasonography
5051500|NCT01419392|nitric oxide|nitric oxide
5051501|NCT01419392|total antioxidant capacity|total antioxidant capacity
5051502|NCT01419379|COPD exacerbation rate|copd exacerbation rate
5051503|NCT01419353|Infertility, IVF, Estrogen|infertility, ivf, estrogen
5051504|NCT01419327|Fosrenol|fosrenol
5051505|NCT01419327|Hyperphosphatemia|hyperphosphatemia
5051506|NCT01419327|Hemodialysis|hemodialysis
5051507|NCT01419314|Physical Therapy|physical therapy
5051508|NCT01419314|Splint|splint
5051509|NCT01419314|Sleep|sleep
5051510|NCT01419314|Pain|pain
5051511|NCT01419314|6 min walk|6 min walk
5051512|NCT01419314|forward reach|forward reach
5051513|NCT01419314|Function|function
5051514|NCT01419301|multiple sclerosis|multiple sclerosis
5051515|NCT01419301|glatiramer acetate|glatiramer acetate
5051516|NCT01419301|stress reduction|stress reduction
5051517|NCT01419301|medication adherence|medication adherence
5051518|NCT01419288|Amputees|amputees
5051519|NCT01419262|Vitamin D|vitamin d
5051520|NCT01419262|Randomized Controlled Trial|randomized controlled trial
5051521|NCT01419262|Child, Preschool|child, preschool
5051522|NCT01419262|Dietary Supplements|dietary supplements
5051523|NCT01419262|Respiratory Tract Infections|respiratory tract infections
5051524|NCT01419262|Asthma|asthma
5051525|NCT01419249|Growth Hormone Deficiency|growth hormone deficiency
5051526|NCT01419249|Turner syndrome|turner syndrome
5051527|NCT01419249|Pharmacogenetics|pharmacogenetics
5051528|NCT01419249|Recombinant Human Growth Hormone therapy|recombinant human growth hormone therapy
5051529|NCT01419236|Ejaculatory Dysfunction|ejaculatory dysfunction
5051530|NCT01419236|Orgasmic Dysfunction|orgasmic dysfunction
5051531|NCT01419236|Sexual Dysfunction|sexual dysfunction
5051532|NCT01419236|Climax Dysfunction|climax dysfunction
5051533|NCT01419236|Erectile Dysfunction|erectile dysfunction
5051534|NCT01419236|Impotence|impotence
5051535|NCT01419236|Hypogonadism|hypogonadism
5051536|NCT01419236|Low testosterone|low testosterone
5051537|NCT01419236|Low t|low t
5051538|NCT01419223|Qualitative research|qualitative research
5051539|NCT01419223|Health Knowledge, Attitudes, Practice|health knowledge, attitudes, practice
5051540|NCT01419223|Refusal to Participate|refusal to participate
5051541|NCT01419210|Complementary Medicine|complementary medicine
5051542|NCT01419210|Traditional Medicine|traditional medicine
5051543|NCT01419184|Complicated Skin and Skin Structure Infections (cSSSI)|complicated skin and skin structure infections (csssi)
5051544|NCT01419184|Methicillin-resistant Staphylococcus aureus (MRSA)|methicillin-resistant staphylococcus aureus (mrsa)
5051545|NCT01419184|Daptomycin|daptomycin
5051546|NCT01419184|Vancomycin|vancomycin
5051547|NCT01419184|Antibiotics|antibiotics
5051548|NCT01419158|Alpha-1 antitrypsin|alpha-1 antitrypsin
5051549|NCT01419158|Alpha-1 antitrypsin deficiency|alpha-1 antitrypsin deficiency
5051550|NCT01419158|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
5051551|NCT01419145|cachexia|cachexia
5051552|NCT01419145|neoplasms|neoplasms
5051553|NCT01419145|complications|complications
5051554|NCT01419145|combined modality therapy|combined modality therapy
5051555|NCT01419145|exercise therapy|exercise therapy
5051556|NCT01419145|diet therapy|diet therapy
5051557|NCT01419145|anti-inflammatory agents|anti-inflammatory agents
5051558|NCT01419132|furosemide|furosemide
5051559|NCT01419132|hypertonic saline solution|hypertonic saline solution
5051560|NCT01419132|troponin I|troponin i
5051561|NCT01419119|vitamin D insufficiency|vitamin d insufficiency
5051562|NCT01419119|Cholecalciferol|cholecalciferol
5051564|NCT01419119|Parathyroid Hormone|parathyroid hormone
5051565|NCT01419119|25-hydroxyvitamin D3|25-hydroxyvitamin d3
5051566|NCT01419119|RDA, recommended daily intake (nutrition policy)|rda, recommended daily intake (nutrition policy)
5051567|NCT01419119|Vitamin D|vitamin d
5051568|NCT01419119|Hypovitaminosis-D|hypovitaminosis-d
5051569|NCT01419119|Pharmacologic treatment|pharmacologic treatment
5051570|NCT01419106|Hypotension|hypotension
5051571|NCT01419106|Emergency care|emergency care
5051572|NCT01419106|Point of care Ultrasound|point of care ultrasound
5051573|NCT01419106|Shock|shock
5051574|NCT01419093|Physical Activity|physical activity
5051575|NCT01419093|Exercise|exercise
5051576|NCT01419080|Peripheral Arterial Disease|peripheral arterial disease
5051577|NCT01419080|Quality of Life|quality of life
5051578|NCT01419080|Quality of Care|quality of care
5051579|NCT01419067|Proton Therapy|proton therapy
5051580|NCT01419067|Radical resection|radical resection
5051581|NCT01419041|renal impairment|renal impairment
5051582|NCT01419041|crizotinib|crizotinib
5051583|NCT01419041|pharmacokinetics|pharmacokinetics
5051584|NCT01419028|Hypophosphatasia|hypophosphatasia
5051585|NCT01419028|HPP|hpp
5051586|NCT01419028|Bone disease|bone disease
5051587|NCT01419028|Soft bones|soft bones
5051588|NCT01419028|Low alkaline phosphatase|low alkaline phosphatase
5051589|NCT01419028|Genetic metabolic disorder|genetic metabolic disorder
5051590|NCT01419028|Alkaline phosphatase|alkaline phosphatase
5051591|NCT01419028|Tissue non-specific alkaline phosphatase|tissue non-specific alkaline phosphatase
5051592|NCT01419028|Rickets|rickets
5051593|NCT01419028|Osteomalacia|osteomalacia
5051594|NCT01419015|SAPIEN XT Valve (20mm)|sapien xt valve (20mm)
5051595|NCT01419015|Cardiovascular Disease|cardiovascular disease
5051596|NCT01419015|Valvular Heart Disease|valvular heart disease
5051597|NCT01419015|Aortic Stenosis|aortic stenosis
5051598|NCT01419015|Heart Valve Therapy|heart valve therapy
5051599|NCT01419015|Transcatheter|transcatheter
5051600|NCT01419015|Transfemoral|transfemoral
5051601|NCT01419015|Efficacy endpoints|efficacy endpoints
5051602|NCT01419015|Indexed Aortic Valve Area|indexed aortic valve area
5051603|NCT01419015|NYHA|nyha
5051604|NCT01419002|Pancreatic Cancer|pancreatic cancer
5051605|NCT01419002|Adenocarcinoma|adenocarcinoma
5051606|NCT01419002|Neoadjuvant Radiotherapy|neoadjuvant radiotherapy
5051607|NCT01418976|physical therapy techniques|physical therapy techniques
5051608|NCT01418976|brain injuries, traumatic|brain injuries, traumatic
5051609|NCT01418976|walking|walking
5051610|NCT01418976|gait|gait
5051611|NCT01418976|postural balance|postural balance
5051612|NCT01418950|Prematurity Counseling for pregnant women and their family|prematurity counseling for pregnant women and their family
5051613|NCT01418937|HPV vaccine|hpv vaccine
5051614|NCT01418937|serious adverse events (SAEs)|serious adverse events (saes)
5051615|NCT01418937|medically significant conditions|medically significant conditions
5051616|NCT01418937|cervical neoplasia|cervical neoplasia
5051617|NCT01418924|sclerostin|sclerostin
5051618|NCT01418924|estradiol|estradiol
5051619|NCT01418924|progesterone|progesterone
5051620|NCT01418924|testosteron|testosteron
5051621|NCT01418924|sex hormones|sex hormones
5051622|NCT01418898|Iron deficiency anemia|iron deficiency anemia
5051623|NCT01418898|iron|iron
5051624|NCT01418898|zinc|zinc
5051625|NCT01418898|vitamin A|vitamin a
5051626|NCT01418898|vitamin C|vitamin c
5051627|NCT01418898|oats|oats
5051628|NCT01418885|subcortical ischemic vascular disease|subcortical ischemic vascular disease
5051629|NCT01418872|Obesity|obesity
5051630|NCT01418872|Cardiovascular Diseases Prevention|cardiovascular diseases prevention
5051631|NCT01418872|Paediatrics|paediatrics
5051632|NCT01418859|cervical cancer|cervical cancer
5051633|NCT01418859|postoperation|postoperation
5051634|NCT01418859|chemotherapy|chemotherapy
5051635|NCT01418859|radiotherapy|radiotherapy
5051636|NCT01418846|voriconazole|voriconazole
5051637|NCT01418846|saliva|saliva
5051638|NCT01418846|pharmacokinetics|pharmacokinetics
5051639|NCT01418833|voriconazole|voriconazole
5051640|NCT01418833|therapeutic drug monitoring|therapeutic drug monitoring
5051641|NCT01418833|plasma levels|plasma levels
5051642|NCT01418833|dose adjustment|dose adjustment
5051643|NCT01418820|hemianopia|hemianopia
5051644|NCT01418820|visual field defect|visual field defect
5051645|NCT01418820|stroke|stroke
5051646|NCT01418820|non-invasive brain stimulation|non-invasive brain stimulation
5051647|NCT01418820|alternating current stimulation|alternating current stimulation
5051648|NCT01418794|Acute Coronary Syndromes|acute coronary syndromes
5051649|NCT01418794|Drug eluting stent|drug eluting stent
5051650|NCT01418794|Diffused lesion|diffused lesion
5051651|NCT01418781|gout|gout
5051652|NCT01418781|cost|cost
5051653|NCT01418781|utilization|utilization
5051654|NCT01418768|COPD|copd
5051655|NCT01418768|CAT|cat
5051656|NCT01418768|Rehabilitation|rehabilitation
5051657|NCT01418768|chronic obstructive pulmonary disease GOLD III/IV|chronic obstructive pulmonary disease gold iii/iv
5051658|NCT01418755|Platelet-Rich Plasma|platelet-rich plasma
5051659|NCT01418755|Knee|knee
5051660|NCT01418755|Tibiofemoral Chondromalacia|tibiofemoral chondromalacia
5051661|NCT01418755|Injection|injection
5051662|NCT01418742|skin toxicity|skin toxicity
5051663|NCT01418716|Disease Management|disease management
5051664|NCT01418716|Quality Improvement|quality improvement
5051665|NCT01418716|Cooperative Behavior (collaboration)|cooperative behavior (collaboration)
5051666|NCT01418677|Unspecified Advance Solid Tumor, Protocol Specific|unspecified advance solid tumor, protocol specific
5051667|NCT01418664|vitamin D|vitamin d
5051668|NCT01418664|adverse pregnancy outcome|adverse pregnancy outcome
5051669|NCT01418664|Pakistan|pakistan
5051670|NCT01418638|Major Depressive Disorder|major depressive disorder
5051671|NCT01418638|Antidepressants|antidepressants
5051672|NCT01418573|glucose, insulin, post prandial|glucose, insulin, post prandial
5051673|NCT01418560|renal artery|renal artery
5051674|NCT01418560|sympathetic nerves|sympathetic nerves
5051675|NCT01418560|modification|modification
5051676|NCT01418560|chronic renal failure|chronic renal failure
5051677|NCT01418521|Cardiac surgery|cardiac surgery
5051678|NCT01418521|Balanced 3rd generation Hydroxyethyl starch|balanced 3rd generation hydroxyethyl starch
5051679|NCT01418521|Tetraspan|tetraspan
5051680|NCT01418521|Ringer-albumin|ringer-albumin
5051681|NCT01418469|COPD|copd
5051682|NCT01418469|protein metabolism|protein metabolism
5051683|NCT01418469|branched-chain amino acid metabolism|branched-chain amino acid metabolism
5051684|NCT01418469|exercise|exercise
5051685|NCT01418469|protein feeding|protein feeding
5051686|NCT01418456|diabetes|diabetes
5051687|NCT01418456|antibiotics|antibiotics
5051688|NCT01418456|clean foot ulcers|clean foot ulcers
5051689|NCT01418404|Stroke|stroke
5051690|NCT01418404|Effects of TS in U/E motor recovery|effects of ts in u/e motor recovery
5051691|NCT01418404|Brain mapping|brain mapping
5051692|NCT01418404|Kinematics analysis|kinematics analysis
5051693|NCT01418391|minimal laparotomy|minimal laparotomy
5051694|NCT01418391|TAP block|tap block
5051695|NCT01418391|morphine consumption|morphine consumption
5051696|NCT01418391|post-operative analgesia|post-operative analgesia
5051697|NCT01418378|Sigma|sigma
5051698|NCT01418378|cruciate|cruciate
5051699|NCT01418378|retaining|retaining
5051700|NCT01418378|fixed|fixed
5051701|NCT01418378|primary|primary
5051702|NCT01418378|total|total
5051703|NCT01418378|knee|knee
5051704|NCT01418378|arthroplasty|arthroplasty
5051705|NCT01418378|cemented|cemented
5051706|NCT01418378|osteoarthritis|osteoarthritis
5051707|NCT01418352|Tourette's Disorder|tourette's disorder
5051708|NCT01418352|tic disorders|tic disorders
5051709|NCT01418339|Tourette's Disorder|tourette's disorder
5051710|NCT01418339|tic disorders|tic disorders
5051711|NCT01418326|Cancer - breast|cancer - breast
5051712|NCT01418326|colo-rectal|colo-rectal
5051713|NCT01418326|skin|skin
5051714|NCT01418313|Atherosclerosis|atherosclerosis
5051715|NCT01418313|Non-invasive imaging|non-invasive imaging
5051716|NCT01418313|Magnetic Resonance Imaging|magnetic resonance imaging
5051717|NCT01418313|MRI|mri
5051718|NCT01418313|Positron Emission Tomography|positron emission tomography
5051719|NCT01418313|PET/CT|pet/ct
5051720|NCT01418313|PET/MRI|pet/mri
5051721|NCT01418313|Inflammation|inflammation
5051722|NCT01418313|Neovascularization|neovascularization
5052019|NCT01416883|Japanese|japanese
5051723|NCT01418261|uncontrolled hypertension|uncontrolled hypertension
5051724|NCT01418261|renal denervation|renal denervation
5051725|NCT01418248|cardiac catheterization|cardiac catheterization
5051726|NCT01418248|echocardiography|echocardiography
5051727|NCT01418235|HIV Infections|hiv infections
5051728|NCT01418235|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5051729|NCT01418235|Lentivirus Infections|lentivirus infections
5051730|NCT01418235|Retroviridae Infections|retroviridae infections
5051731|NCT01418235|RNA Virus Infections|rna virus infections
5051732|NCT01418235|Virus Diseases|virus diseases
5051733|NCT01418235|Sexually Transmitted Diseases, Viral|sexually transmitted diseases, viral
5051734|NCT01418235|Sexually Transmitted Diseases|sexually transmitted diseases
5051735|NCT01418235|Immunologic Deficiency Syndromes|immunologic deficiency syndromes
5051736|NCT01418235|Immune System Diseases|immune system diseases
5051737|NCT01418235|Slow Virus Diseases|slow virus diseases
5051738|NCT01418209|Menopause|menopause
5051739|NCT01418209|Vasomotor|vasomotor
5051740|NCT01418209|Symptoms|symptoms
5051741|NCT01418209|Estradiol|estradiol
5051742|NCT01418209|Venlafaxine|venlafaxine
5051743|NCT01418196|TMAO|tmao
5051744|NCT01418196|Children|children
5051745|NCT01418196|Dietary choline|dietary choline
5051746|NCT01418196|Cardiovascular disease risk|cardiovascular disease risk
5051747|NCT01418196|Atherogenic dyslipidemia|atherogenic dyslipidemia
5051748|NCT01418183|Orthognathic surgery|orthognathic surgery
5051749|NCT01418183|Pain control|pain control
5051750|NCT01418183|Trigeminal nerve|trigeminal nerve
5051751|NCT01418183|Levobupivacaine|levobupivacaine
5051752|NCT01418170|myofascial pain syndrome|myofascial pain syndrome
5051753|NCT01418170|myofascial trigger points|myofascial trigger points
5051754|NCT01418170|spinal manipulative therapy|spinal manipulative therapy
5051755|NCT01418170|algometer|algometer
5051756|NCT01418170|pressure pain thresholds|pressure pain thresholds
5051757|NCT01418157|Acute mountain sickness|acute mountain sickness
5051758|NCT01418157|Rapid ascent|rapid ascent
5051759|NCT01418157|High altitude headache|high altitude headache
5051760|NCT01418157|Mountain Medicine Society Nepal|mountain medicine society nepal
5051761|NCT01418131|Proctitis|proctitis
5051762|NCT01418131|resistant|resistant
5051763|NCT01418131|ulcerative colitis|ulcerative colitis
5051764|NCT01418131|inflammatory bowel disease|inflammatory bowel disease
5051765|NCT01418118|noradrenaline|noradrenaline
5051766|NCT01418118|norepinephrine|norepinephrine
5051767|NCT01418118|epinephrine|epinephrine
5051768|NCT01418118|adrenaline|adrenaline
5051769|NCT01418118|dobutamine|dobutamine
5051770|NCT01418118|dopexamine|dopexamine
5051771|NCT01418118|inotrope|inotrope
5051772|NCT01418118|pressor|pressor
5051773|NCT01418118|sympathomimetic|sympathomimetic
5051774|NCT01418118|free flap|free flap
5051775|NCT01418118|transplantation|transplantation
5051776|NCT01418118|free tissue transfer|free tissue transfer
5051777|NCT01418118|microsurgery|microsurgery
5051778|NCT01418118|survival|survival
5051779|NCT01418105|spine injuries|spine injuries
5051780|NCT01418105|brain lesions|brain lesions
5051781|NCT01418105|dysphagia|dysphagia
5051782|NCT01418079|Spectroscopy, near infrared|spectroscopy, near infrared
5051783|NCT01418079|cerebral oxygenation|cerebral oxygenation
5051784|NCT01418027|NAFLD|nafld
5051785|NCT01418027|exercise|exercise
5051786|NCT01418027|hepatic triglycerides|hepatic triglycerides
5051787|NCT01418001|GEMCITABINE|gemcitabine
5051788|NCT01418001|GW786034 (PAZOPANIB)|gw786034 (pazopanib)
5051789|NCT01418001|TAXOTERE (DOCETAXEL)|taxotere (docetaxel)
5051790|NCT01418001|11-104|11-104
5051791|NCT01417988|TB|tb
5051792|NCT01417975|exercise|exercise
5051793|NCT01417975|smoking satisfaction|smoking satisfaction
5051794|NCT01417975|topography|topography
5051795|NCT01417975|cravings|cravings
5051796|NCT01417962|Autopsy|autopsy
5051797|NCT01417962|MRI|mri
5051798|NCT01417962|Stillbirths|stillbirths
5051799|NCT01417962|Neonatal death|neonatal death
5051800|NCT01417962|Sudden Infant death|sudden infant death
5051801|NCT01417923|chronic musculo-skeletal pain|chronic musculo-skeletal pain
5051802|NCT01417923|therapeutic&serology effects of vitamin D|therapeutic&serology effects of vitamin d
5051803|NCT01417923|CRP, IL-6, IL-8, TNF and prostaglandin E2|crp, il-6, il-8, tnf and prostaglandin e2
5051804|NCT01417923|patients suffering from chronic musculo-skeletal pain|patients suffering from chronic musculo-skeletal pain
5051805|NCT01417884|molecular cardiology|molecular cardiology
5051806|NCT01417884|molecular epidemiology|molecular epidemiology
5051807|NCT01417884|platelets|platelets
5051808|NCT01417884|cardiovascular disease|cardiovascular disease
5051809|NCT01417858|intra-ocular pressure|intra-ocular pressure
5051810|NCT01417858|iridectomy|iridectomy
5051811|NCT01417858|gonioscopy|gonioscopy
5051812|NCT01417858|ocular tonometry|ocular tonometry
5051813|NCT01417832|Dental caries|dental caries
5051814|NCT01417832|Proximal surfaces|proximal surfaces
5051815|NCT01417832|Preventive therapy|preventive therapy
5051816|NCT01417832|Dental radiography|dental radiography
5051817|NCT01417832|Treatment efficacy|treatment efficacy
5051818|NCT01417832|Young adults|young adults
5051819|NCT01417806|small cell lung cancer|small cell lung cancer
5051820|NCT01417806|somatostatin|somatostatin
5051822|NCT01417793|Smoking cessation rate|smoking cessation rate
5051823|NCT01417767|myelodysplastic syndromes|myelodysplastic syndromes
5051824|NCT01417767|Decitabine|decitabine
5051825|NCT01417767|homoharringtonine|homoharringtonine
5051826|NCT01417767|cytarabine|cytarabine
5051827|NCT01417767|G-CSF|g-csf
5051828|NCT01417754|toremifene|toremifene
5051829|NCT01417728|endomicroscopy|endomicroscopy
5051830|NCT01417728|inflammatory bowel disease|inflammatory bowel disease
5051831|NCT01417728|mucosal healing|mucosal healing
5051832|NCT01417728|infliximab|infliximab
5051833|NCT01417689|glaucoma|glaucoma
5051834|NCT01417689|randomized controlled trial|randomized controlled trial
5051835|NCT01417689|eye drops|eye drops
5051836|NCT01417689|instillation|instillation
5051837|NCT01417689|compliance|compliance
5051838|NCT01417676|prostate cancer|prostate cancer
5051839|NCT01417676|locally advanced|locally advanced
5051840|NCT01417676|lymph node positive|lymph node positive
5051841|NCT01417676|radiation therapy|radiation therapy
5051842|NCT01417676|morbidity|morbidity
5051843|NCT01417676|early morbidity|early morbidity
5051844|NCT01417676|late morbidity|late morbidity
5051845|NCT01417663|Aging|aging
5051846|NCT01417663|Cardiovascular disease|cardiovascular disease
5051847|NCT01417663|Endothelial function|endothelial function
5051848|NCT01417663|Physical activity|physical activity
5051849|NCT01417663|Advanced Glycation Endproducts|advanced glycation endproducts
5051850|NCT01417663|AGE crosslink breakers|age crosslink breakers
5051851|NCT01417650|temporomandibular disorder|temporomandibular disorder
5051852|NCT01417650|laser therapy|laser therapy
5051853|NCT01417650|osteoarthritis|osteoarthritis
5051854|NCT01417637|TMD|tmd
5051855|NCT01417637|myofacial pain syndrome|myofacial pain syndrome
5051856|NCT01417637|low level laser therapy|low level laser therapy
5051857|NCT01417637|LLLT|lllt
5051858|NCT01417624|Heart Failure|heart failure
5051859|NCT01417624|Cardiac Resynchronisation Therapy|cardiac resynchronisation therapy
5051860|NCT01417611|screening colonoscopy|screening colonoscopy
5051861|NCT01417598|Balance|balance
5051862|NCT01417598|Gait|gait
5051863|NCT01417598|Physical activity|physical activity
5051864|NCT01417585|Activities of daily living|activities of daily living
5051865|NCT01417585|Caregiver burden|caregiver burden
5051866|NCT01417585|Client centered|client centered
5051867|NCT01417585|Life satisfaction|life satisfaction
5051868|NCT01417585|Participation|participation
5051869|NCT01417585|Patient satisfaction|patient satisfaction
5051870|NCT01417585|Rehabilitation|rehabilitation
5051871|NCT01417585|Self rated impact of stroke|self rated impact of stroke
5051872|NCT01417585|Stroke|stroke
5051873|NCT01417546|Dose-Limiting Toxicity|dose-limiting toxicity
5051874|NCT01417546|Maximum Tolerated Dose|maximum tolerated dose
5051875|NCT01417546|Immune Response|immune response
5051876|NCT01417546|Pharmacokinetics|pharmacokinetics
5051877|NCT01417546|Dose Escalation|dose escalation
5051878|NCT01417546|Cancer|cancer
5051879|NCT01417546|Metastatic Solid Tumor|metastatic solid tumor
5051880|NCT01417546|Solid Tumor|solid tumor
5051881|NCT01417533|Hereditary Inclusion Body Myopathy|hereditary inclusion body myopathy
5051882|NCT01417533|N-Acetyl-D-mannosamine (ManNAc)|n-acetyl-d-mannosamine (mannac)
5051883|NCT01417533|UDP-N-acetyglucosamine 2-epimerase (GNE)|udp-n-acetyglucosamine 2-epimerase (gne)
5051884|NCT01417533|Sialic Acid|sialic acid
5051885|NCT01417533|Muscular Dystrophy|muscular dystrophy
5051886|NCT01417533|HIBM|hibm
5051887|NCT01417520|Histiocytosis|histiocytosis
5051888|NCT01417520|Xanthomatosis|xanthomatosis
5051889|NCT01417520|Fibrosis|fibrosis
5051890|NCT01417520|Osteosclerosis|osteosclerosis
5051891|NCT01417520|Erdheim-Chester Disease|erdheim-chester disease
5051892|NCT01417520|ECD|ecd
5051893|NCT01417494|adenocarcinoma of the colon|adenocarcinoma of the colon
5051894|NCT01417494|stage IVA colon cancer|stage iva colon cancer
5051895|NCT01417494|stage IVB colon cancer|stage ivb colon cancer
5051896|NCT01417494|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5051897|NCT01417494|stage IVA rectal cancer|stage iva rectal cancer
5051898|NCT01417494|stage IVB rectal cancer|stage ivb rectal cancer
5051899|NCT01417481|cystic fibrosis|cystic fibrosis
5051900|NCT01417481|glycine|glycine
5051901|NCT01417481|airway inflammation|airway inflammation
5051902|NCT01417468|Cognitive Rehabilitation|cognitive rehabilitation
5051903|NCT01417468|Learning Styles|learning styles
5051904|NCT01417468|Learning Modes|learning modes
5051905|NCT01417468|Learning Modalities|learning modalities
5051906|NCT01417468|Multiple Intelligences|multiple intelligences
5051907|NCT01417468|Educational Intervention|educational intervention
5051908|NCT01417468|Instructional Design|instructional design
5051909|NCT01417455|Rheumatoid arthritis|rheumatoid arthritis
5051910|NCT01417455|Ankylosing spondylitis|ankylosing spondylitis
5051911|NCT01417455|Osteoclasts|osteoclasts
5051912|NCT01417455|TNF antagonists|tnf antagonists
5051913|NCT01417442|papillary thyroid carcinoma|papillary thyroid carcinoma
5051914|NCT01417442|BRAF V600E|braf v600e
5051915|NCT01417442|poor prognosis|poor prognosis
5051916|NCT01417442|aggressive|aggressive
5051917|NCT01417429|galantamine|galantamine
5051918|NCT01417429|subjective nicotine|subjective nicotine
5051919|NCT01417429|tobacco withdrawal symptoms|tobacco withdrawal symptoms
5051920|NCT01417429|nicotine|nicotine
5051921|NCT01417390|Nasopharyngeal Carcinoma|nasopharyngeal carcinoma
5051922|NCT01417364|Sarcopenia|sarcopenia
5051923|NCT01417364|Aging muscle|aging muscle
5051924|NCT01417364|Testosterone administration|testosterone administration
5051925|NCT01417364|Bone metabolism|bone metabolism
5051926|NCT01417351|pregnancy|pregnancy
5051927|NCT01417351|immune function|immune function
5051928|NCT01417338|Hypertension,pulmonary|hypertension,pulmonary
5051929|NCT01417338|Mortality|mortality
5051930|NCT01417338|Risk factors|risk factors
5051931|NCT01417312|Multiple sclerosis|multiple sclerosis
5051932|NCT01417312|Green tea extract|green tea extract
5051933|NCT01417312|Metabolism|metabolism
5051934|NCT01417299|chronic vegetative state|chronic vegetative state
5051935|NCT01417299|RPh201|rph201
5051936|NCT01417299|functional MRI|functional mri
5051937|NCT01417273|Multiple sclerosis|multiple sclerosis
5051938|NCT01417273|immune system|immune system
5051939|NCT01417273|vitamin A|vitamin a
5051940|NCT01417273|(MSFC)Multiple Sclerosis Functional Composite|(msfc)multiple sclerosis functional composite
5051941|NCT01417273|(EDSS)Expanded Disability Status Scale|(edss)expanded disability status scale
5051942|NCT01417273|(MRI)Magnetic resonance imaging|(mri)magnetic resonance imaging
5051943|NCT01417247|renal artery|renal artery
5051944|NCT01417247|sympathetic nerves|sympathetic nerves
5051945|NCT01417247|modification|modification
5051946|NCT01417247|metabolic syndrome|metabolic syndrome
5051947|NCT01417221|renal artery|renal artery
5051948|NCT01417221|sympathetic nerves|sympathetic nerves
5051949|NCT01417221|modification|modification
5051950|NCT01417221|essential hypertension|essential hypertension
5051951|NCT01417221|primary hypertension|primary hypertension
5051952|NCT01417195|Assisted Reproductive Technology|assisted reproductive technology
5051953|NCT01417182|Patients with Advanced Prostate Cancer|patients with advanced prostate cancer
5051954|NCT01417143|dovitinib|dovitinib
5051955|NCT01417130|Naproxen|naproxen
5051956|NCT01417130|Celecoxib|celecoxib
5051957|NCT01417130|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal
5051958|NCT01417117|Intracerebral Hemorrhage|intracerebral hemorrhage
5051959|NCT01417117|Ischemic Stroke|ischemic stroke
5051960|NCT01417117|Diffusion Weight Imaging Abnormalities|diffusion weight imaging abnormalities
5051961|NCT01417117|Neurologic Outcome|neurologic outcome
5051962|NCT01417104|plaque|plaque
5051963|NCT01417104|magnetic resonance imaging (MRI)|magnetic resonance imaging (mri)
5051964|NCT01417104|high blood pressure|high blood pressure
5051965|NCT01417104|MI|mi
5051966|NCT01417104|heart attack|heart attack
5051967|NCT01417104|CVA|cva
5051968|NCT01417104|stroke|stroke
5051969|NCT01417104|PAD|pad
5051970|NCT01417091|Brittle bone disease|brittle bone disease
5051971|NCT01417091|inherited|inherited
5051972|NCT01417091|connective tissue disorder|connective tissue disorder
5051973|NCT01417091|fracture|fracture
5051974|NCT01417065|Cancer|cancer
5051975|NCT01417065|mTOR inhibitor Temsirolimus|mtor inhibitor temsirolimus
5051976|NCT01417065|Torisel|torisel
5051977|NCT01417065|CCI-779|cci-779
5051978|NCT01417065|pharmacodynamic targets|pharmacodynamic targets
5051979|NCT01417026|Autism Spectrum Disorders|autism spectrum disorders
5051980|NCT01417026|Oxytocin|oxytocin
5051981|NCT01417026|Clinical Trial|clinical trial
5051982|NCT01417026|Computer-based Intervention|computer-based intervention
5051983|NCT01417026|Social Perception|social perception
5051984|NCT01417026|Social Motivation|social motivation
5051985|NCT01417026|Social Cognition|social cognition
5051986|NCT01417013|Dry eye or lubricant eye drops|dry eye or lubricant eye drops
5051987|NCT01417000|Cancer|cancer
5051988|NCT01417000|Cancer vaccine|cancer vaccine
5051989|NCT01417000|Listeria monocytogenes|listeria monocytogenes
5051990|NCT01417000|Listeria-based vaccines|listeria-based vaccines
5051991|NCT01417000|GVAX|gvax
5051992|NCT01417000|Cyclophosphamide|cyclophosphamide
5051993|NCT01417000|Cytoxan|cytoxan
5051994|NCT01417000|T regulatory cells|t regulatory cells
5051995|NCT01417000|Heterologous Prime-Boost|heterologous prime-boost
5051996|NCT01417000|Immunotherapy|immunotherapy
5051997|NCT01417000|Mesothelin|mesothelin
5051998|NCT01417000|Pancreatic cancer|pancreatic cancer
5051999|NCT01416974|19-28Z RETROVIRUS|19-28z retrovirus
5052000|NCT01416974|CYCLOPHOSPHAMIDE (CYTOXAN)|cyclophosphamide (cytoxan)
5052001|NCT01416974|autologous T cells|autologous t cells
5052002|NCT01416974|Leukapheresis|leukapheresis
5052003|NCT01416974|11-048|11-048
5052004|NCT01416961|Squamous Cell|squamous cell
5052005|NCT01416961|Non-squamous cell|non-squamous cell
5052006|NCT01416948|Cognitive Complaints, TBI, PTSD|cognitive complaints, tbi, ptsd
5052007|NCT01416935|Atrial Fibrillation|atrial fibrillation
5052008|NCT01416935|Anti-Arrhythmic Medication|anti-arrhythmic medication
5052009|NCT01416909|Medication-induced|medication-induced
5052010|NCT01416909|Constipation in Cancer|constipation in cancer
5052011|NCT01416896|End stage Renal Disease|end stage renal disease
5052012|NCT01416896|Hemodialysis|hemodialysis
5052013|NCT01416896|Oxidative Stress|oxidative stress
5052014|NCT01416896|Inflammation|inflammation
5052015|NCT01416883|oral mucosal absorption|oral mucosal absorption
5052016|NCT01416883|pharmacokinetics|pharmacokinetics
5052017|NCT01416883|safety|safety
5052018|NCT01416883|bicalutamide|bicalutamide
5052020|NCT01416883|healthy subject|healthy subject
5052021|NCT01416870|Bioequivalence|bioequivalence
5052022|NCT01416870|pharmacokinetics|pharmacokinetics
5052023|NCT01416870|safety|safety
5052024|NCT01416870|bicalutamide|bicalutamide
5052025|NCT01416870|Casodex|casodex
5052026|NCT01416870|Japanese|japanese
5052027|NCT01416870|healthy subject|healthy subject
5052028|NCT01416857|Medicare|medicare
5052029|NCT01416844|Metastatic melanoma|metastatic melanoma
5052030|NCT01416844|anti-OX40|anti-ox40
5052031|NCT01416844|Immunostimulatory|immunostimulatory
5052032|NCT01416831|metastatic melanoma|metastatic melanoma
5052033|NCT01416831|IL-2|il-2
5052034|NCT01416831|Interleukin 2|interleukin 2
5052035|NCT01416831|Radiation|radiation
5052036|NCT01416831|Stereotactic Body Radiation Treatment|stereotactic body radiation treatment
5052037|NCT01416831|SBRT|sbrt
5052038|NCT01416831|Immunotherapy|immunotherapy
5052039|NCT01416818|Depression;|depression;
5052040|NCT01416818|Parkinson's disease;|parkinson's disease;
5052041|NCT01416818|antidepressant|antidepressant
5052042|NCT01416805|childhood anxiety disorders|childhood anxiety disorders
5052043|NCT01416805|cognitive behavioral therapy|cognitive behavioral therapy
5052044|NCT01416805|CBT|cbt
5052045|NCT01416805|Generalized Anxiety Disorder|generalized anxiety disorder
5052046|NCT01416805|Social Phobia|social phobia
5052047|NCT01416805|Separation Anxiety Disorder|separation anxiety disorder
5052048|NCT01416805|Psychotherapy|psychotherapy
5052049|NCT01416805|Counseling|counseling
5052050|NCT01416805|Social Anxiety Disorder|social anxiety disorder
5052051|NCT01416779|Writing Intervention|writing intervention
5052052|NCT01416779|Bereaved Caregivers|bereaved caregivers
5052053|NCT01416779|Older Adults|older adults
5052054|NCT01416779|hope|hope
5052055|NCT01416779|inventory of daily widowed life|inventory of daily widowed life
5052056|NCT01416766|Blood Pressure Monitors|blood pressure monitors
5052057|NCT01416766|Medical Informatics|medical informatics
5052058|NCT01416766|Disease Management|disease management
5052059|NCT01416766|Comparative Effectiveness Research|comparative effectiveness research
5052060|NCT01416753|hemodialysis|hemodialysis
5052061|NCT01416753|blood volume monitoring|blood volume monitoring
5052062|NCT01416740|Indirect magnetic resonance arthrogram|indirect magnetic resonance arthrogram
5052063|NCT01416740|Direct magnetic resonance arthrogram|direct magnetic resonance arthrogram
5052064|NCT01416740|Diagnostic tests for shoulder pain|diagnostic tests for shoulder pain
5052065|NCT01416727|Patient Simulation|patient simulation
5052066|NCT01416727|Education, Medical, Graduate|education, medical, graduate
5052067|NCT01416727|Internship and Residency|internship and residency
5052068|NCT01416727|Psychiatry|psychiatry
5052069|NCT01416701|COPD|copd
5052070|NCT01416701|Vitamin D|vitamin d
5052071|NCT01416701|Pulmonary rehabilitation|pulmonary rehabilitation
5052072|NCT01416688|therapy-related toxicity|therapy-related toxicity
5052073|NCT01416688|dermatologic complications|dermatologic complications
5052074|NCT01416688|stage I colon cancer|stage i colon cancer
5052075|NCT01416688|stage IIA colon cancer|stage iia colon cancer
5052076|NCT01416688|stage IIB colon cancer|stage iib colon cancer
5052077|NCT01416688|stage IIC colon cancer|stage iic colon cancer
5052078|NCT01416688|stage IIIA colon cancer|stage iiia colon cancer
5052079|NCT01416688|stage IIIB colon cancer|stage iiib colon cancer
5052080|NCT01416688|stage IIIC colon cancer|stage iiic colon cancer
5052081|NCT01416688|stage IVA colon cancer|stage iva colon cancer
5052082|NCT01416688|stage IVB colon cancer|stage ivb colon cancer
5052083|NCT01416688|stage I rectal cancer|stage i rectal cancer
5052084|NCT01416688|stage IIA rectal cancer|stage iia rectal cancer
5052085|NCT01416688|stage IIB rectal cancer|stage iib rectal cancer
5052086|NCT01416688|stage IIC rectal cancer|stage iic rectal cancer
5052087|NCT01416688|stage IIIA rectal cancer|stage iiia rectal cancer
5052088|NCT01416688|stage IIIB rectal cancer|stage iiib rectal cancer
5052089|NCT01416688|stage IIIC rectal cancer|stage iiic rectal cancer
5052090|NCT01416688|stage IVA rectal cancer|stage iva rectal cancer
5052091|NCT01416688|stage IVB rectal cancer|stage ivb rectal cancer
5052092|NCT01416688|stage IA non-small cell lung cancer|stage ia non-small cell lung cancer
5052093|NCT01416688|stage IB non-small cell lung cancer|stage ib non-small cell lung cancer
5052094|NCT01416688|stage IIA non-small cell lung cancer|stage iia non-small cell lung cancer
5052095|NCT01416688|stage IIB non-small cell lung cancer|stage iib non-small cell lung cancer
5052096|NCT01416688|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5052097|NCT01416688|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5052098|NCT01416688|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5052099|NCT01416688|extensive stage small cell lung cancer|extensive stage small cell lung cancer
5052100|NCT01416688|limited stage small cell lung cancer|limited stage small cell lung cancer
5052101|NCT01416688|recurrent small cell lung cancer|recurrent small cell lung cancer
5052102|NCT01416688|recurrent colon cancer|recurrent colon cancer
5052103|NCT01416688|recurrent rectal cancer|recurrent rectal cancer
5052104|NCT01416688|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5052105|NCT01416662|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
5052106|NCT01416662|stage IA pancreatic cancer|stage ia pancreatic cancer
5052107|NCT01416662|stage IB pancreatic cancer|stage ib pancreatic cancer
5052108|NCT01416662|stage IIA pancreatic cancer|stage iia pancreatic cancer
5052109|NCT01416623|Advanced solid cancer|advanced solid cancer
5052110|NCT01416623|Henatinib|henatinib
5052111|NCT01416623|phase I|phase i
5052112|NCT01416597|Influenza|influenza
5052113|NCT01416597|Systematic review|systematic review
5052114|NCT01416597|Meta-analysis|meta-analysis
5052115|NCT01416597|Mismatched strains|mismatched strains
5052116|NCT01416597|Cross-protection|cross-protection
5052117|NCT01416571|H5N1|h5n1
5052118|NCT01416571|Influenza vaccine|influenza vaccine
5052119|NCT01416571|influenza infection|influenza infection
5052120|NCT01416571|GSK1557484A|gsk1557484a
5052121|NCT01416558|German Breast Group|german breast group
5052122|NCT01416558|GBG Forschungs GmbH|gbg forschungs gmbh
5052124|NCT01416558|GBG 65|gbg 65
5052125|NCT01416558|Tiffany|tiffany
5052126|NCT01416558|Breast Cancer|breast cancer
5052127|NCT01416558|Metastatic Breast Cancer|metastatic breast cancer
5052128|NCT01416558|Nab-Paclitaxel|nab-paclitaxel
5052129|NCT01416558|Abraxane|abraxane
5052130|NCT01416558|Taxane Failure|taxane failure
5052131|NCT01416545|Primary Prevention|primary prevention
5052132|NCT01416545|Cardiovascular disease|cardiovascular disease
5052133|NCT01416545|Child|child
5052134|NCT01416545|Behavior modification|behavior modification
5052135|NCT01416545|Activities, Educational|activities, educational
5052136|NCT01416532|coronary Atheroslcerosis|coronary atheroslcerosis
5052137|NCT01416532|Computed Tomography|computed tomography
5052138|NCT01416519|Continuous Positive Airway Pressure|continuous positive airway pressure
5052139|NCT01416519|Cough|cough
5052140|NCT01416519|Oxygen Inhalation Therapy|oxygen inhalation therapy
5052141|NCT01416506|Pneumonia, surveillance|pneumonia, surveillance
5052142|NCT01416493|acute rheumatoid arthritis|acute rheumatoid arthritis
5052143|NCT01416480|Theobromine|theobromine
5052144|NCT01416480|cough|cough
5052145|NCT01416480|acute bronchitis|acute bronchitis
5052146|NCT01416467|lysosomal storage disease|lysosomal storage disease
5052147|NCT01416467|AAV vector|aav vector
5052148|NCT01416467|gene transfer|gene transfer
5052149|NCT01416467|disease characterization|disease characterization
5052150|NCT01416441|Tourette's Disorder|tourette's disorder
5052151|NCT01416441|tic disorders|tic disorders
5052152|NCT01416428|multiple myeloma|multiple myeloma
5052153|NCT01416428|waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
5052154|NCT01416415|Glaucoma, Open-Angle|glaucoma, open-angle
5052155|NCT01416415|Ophthalmic Solutions, Eye drops|ophthalmic solutions, eye drops
5052156|NCT01416415|Instructional Films and Videos|instructional films and videos
5052157|NCT01416402|Hyperuricemia|hyperuricemia
5052158|NCT01416402|gout|gout
5052159|NCT01416402|serum uric acid|serum uric acid
5052160|NCT01416389|Locally|locally
5052161|NCT01416389|Recurrent|recurrent
5052162|NCT01416389|Breast|breast
5052163|NCT01416389|Cancer|cancer
5052164|NCT01416363|firategrast|firategrast
5052165|NCT01416363|pharmacokinetics, modified release, firategrast,|pharmacokinetics, modified release, firategrast,
5052166|NCT01416363|simulated gastro-retentive|simulated gastro-retentive
5052167|NCT01416363|pharmacokinetics|pharmacokinetics
5052168|NCT01416363|healthy volunteers, simulated gastro-retentive|healthy volunteers, simulated gastro-retentive
5052169|NCT01416363|healthy volunteers|healthy volunteers
5052170|NCT01416363|modified release|modified release
5052171|NCT01416324|pharmacodynamics|pharmacodynamics
5052172|NCT01416324|first time in human|first time in human
5052173|NCT01416324|pharmacokinetics|pharmacokinetics
5052174|NCT01416298|Acute Kidney Injury|acute kidney injury
5052175|NCT01416298|Critically ill children|critically ill children
5052176|NCT01416298|Biomarkers|biomarkers
5052177|NCT01416298|NGAL|ngal
5052178|NCT01416298|Fluid Overload|fluid overload
5052179|NCT01416298|Continuous Renal Replacement Therapy (CRRT)|continuous renal replacement therapy (crrt)
5052180|NCT01416285|Congestive heart failure (CHF)|congestive heart failure (chf)
5052181|NCT01416285|CHF education|chf education
5052182|NCT01416285|self-care training|self-care training
5052183|NCT01416285|CHF center|chf center
5052184|NCT01416259|QTc Prolongation|qtc prolongation
5052185|NCT01416246|Stem cell Infusions|stem cell infusions
5052186|NCT01416246|Autologous Stem Cell Transplant|autologous stem cell transplant
5052187|NCT01416246|11-105|11-105
5052188|NCT01416233|autologous|autologous
5052189|NCT01416233|fat|fat
5052190|NCT01416233|orbit|orbit
5052191|NCT01416233|atrophy|atrophy
5052192|NCT01416233|cannula|cannula
5052193|NCT01416220|depression|depression
5052194|NCT01416220|bipolar disorder|bipolar disorder
5052195|NCT01416220|manic depressive illness|manic depressive illness
5052196|NCT01416194|Osteoporosis|osteoporosis
5052197|NCT01416181|Natalizumab|natalizumab
5052198|NCT01416181|secondary|secondary
5052199|NCT01416181|multiple sclerosis|multiple sclerosis
5052200|NCT01416181|MS|ms
5052201|NCT01416181|SPMS|spms
5052202|NCT01416181|Tysabri|tysabri
5052203|NCT01416168|Colon|colon
5052204|NCT01416168|Geriatric|geriatric
5052205|NCT01416168|McCorkle Model|mccorkle model
5052206|NCT01416168|Questionnaire|questionnaire
5052207|NCT01416116|Tramadol|tramadol
5052208|NCT01416116|QUTENZA|qutenza
5052209|NCT01416116|Pre-treatment|pre-treatment
5052210|NCT01416116|Tolerability|tolerability
5052211|NCT01416090|syndactyly|syndactyly
5052212|NCT01416077|fluid|fluid
5052213|NCT01416077|goal-directed|goal-directed
5052214|NCT01416077|FloTrac|flotrac
5052215|NCT01416077|pulse contour analysis|pulse contour analysis
5052216|NCT01416077|postoperative complications|postoperative complications
5052217|NCT01416077|anesthesia|anesthesia
5052218|NCT01416077|esophagus|esophagus
5052219|NCT01416038|vaccine|vaccine
5052220|NCT01416038|immunotherapy|immunotherapy
5052221|NCT01416038|ovarian|ovarian
5052222|NCT01416038|fallopian tube|fallopian tube
5052223|NCT01416038|peritoneal|peritoneal
5052224|NCT01416038|cancer|cancer
5052225|NCT01416038|tumor|tumor
5052226|NCT01416038|Phase 1|phase 1
5052227|NCT01416038|Phase I|phase i
5052228|NCT01416038|combination therapy|combination therapy
5052229|NCT01416025|Voriconazole|voriconazole
5052230|NCT01416025|Therapeutic drug monitoring|therapeutic drug monitoring
5052231|NCT01416025|Hematopoietic stem cell transplant|hematopoietic stem cell transplant
5052232|NCT01416025|Hematologic malignancy|hematologic malignancy
5052233|NCT01416025|Invasive mould infection|invasive mould infection
5052234|NCT01415999|anthracycline|anthracycline
5052235|NCT01415999|cardiac function|cardiac function
5052236|NCT01415999|echocardiography|echocardiography
5052237|NCT01415999|biomarkers|biomarkers
5052238|NCT01415986|Advanced head and neck cancer|advanced head and neck cancer
5052239|NCT01415986|Squamous cell carcinoma|squamous cell carcinoma
5052240|NCT01415986|SCC|scc
5052241|NCT01415986|HNSCC|hnscc
5052242|NCT01415973|beef|beef
5052243|NCT01415973|protein|protein
5052244|NCT01415973|synergy|synergy
5052245|NCT01415973|intact beef constituents|intact beef constituents
5052246|NCT01415973|protein constituent|protein constituent
5052247|NCT01415973|Nutrient Synergy|nutrient synergy
5052248|NCT01415960|Prostate Cancer|prostate cancer
5052249|NCT01415960|androgen deprivation therapy.|androgen deprivation therapy.
5052250|NCT01415960|Leuprolide Acetate Depot Formulation|leuprolide acetate depot formulation
5052251|NCT01415960|Pharmacokinetics|pharmacokinetics
5052252|NCT01415960|testosterone|testosterone
5052253|NCT01415960|serum luteinizing hormone|serum luteinizing hormone
5052254|NCT01415960|follicle-stimulating hormone|follicle-stimulating hormone
5052255|NCT01415960|prostate-specific antigen|prostate-specific antigen
5052256|NCT01415947|Heart disease|heart disease
5052257|NCT01415947|Device|device
5052258|NCT01415947|Mitral valve|mitral valve
5052259|NCT01415947|leaflet prolapse|leaflet prolapse
5052260|NCT01415947|Heart valve disease|heart valve disease
5052261|NCT01415947|Cardiovascular disease|cardiovascular disease
5052262|NCT01415947|Neochordae|neochordae
5052263|NCT01415921|heart failure|heart failure
5052264|NCT01415921|autonomic function|autonomic function
5052265|NCT01415921|sympathovagal balance|sympathovagal balance
5052266|NCT01415921|cholinesterase inhibitors|cholinesterase inhibitors
5052267|NCT01415921|pharmacology|pharmacology
5052268|NCT01415908|advanced degenerative disease of the lumbosacral spine|advanced degenerative disease of the lumbosacral spine
5052269|NCT01415908|lumbosacral spine|lumbosacral spine
5052270|NCT01415908|radiculopathy|radiculopathy
5052271|NCT01415908|degenerative instability|degenerative instability
5052272|NCT01415908|spondylolisthesis|spondylolisthesis
5052273|NCT01415908|retrolisthesis|retrolisthesis
5052274|NCT01415908|lateral listhesis|lateral listhesis
5052275|NCT01415908|spinal stenosis|spinal stenosis
5052276|NCT01415908|disc herniation|disc herniation
5052277|NCT01415908|INFUSE Bone Graft|infuse bone graft
5052278|NCT01415908|CD HORIZON Spinal System|cd horizon spinal system
5052279|NCT01415908|CAPSTONE Spinal System|capstone spinal system
5052280|NCT01415895|back pain|back pain
5052281|NCT01415895|cervical pain|cervical pain
5052282|NCT01415895|neuropathic pain|neuropathic pain
5052283|NCT01415895|radicular pain|radicular pain
5052284|NCT01415869|Ventricular Assist Device|ventricular assist device
5052285|NCT01415869|Gastrointestinal Bleeding|gastrointestinal bleeding
5052286|NCT01415869|VAD|vad
5052287|NCT01415856|pulsed electromagnetic fields device|pulsed electromagnetic fields device
5052288|NCT01415856|Torino II|torino ii
5052289|NCT01415856|postoperative knee pain|postoperative knee pain
5052290|NCT01415856|knee replacement|knee replacement
5052291|NCT01415830|Anti-Scorpion venom serum|anti-scorpion venom serum
5052292|NCT01415830|venom|venom
5052293|NCT01415830|efficacy|efficacy
5052294|NCT01415830|safety|safety
5052295|NCT01415830|children|children
5052296|NCT01415817|Quality Improvement|quality improvement
5052297|NCT01415817|Adenoma Detection Rate|adenoma detection rate
5052298|NCT01415817|Polyp detection rate|polyp detection rate
5052299|NCT01415817|Colonoscopy|colonoscopy
5052300|NCT01415817|Training|training
5052301|NCT01415817|Colorectal cancer screening|colorectal cancer screening
5052302|NCT01415804|Dissection|dissection
5052303|NCT01415804|Aorta|aorta
5052304|NCT01415804|Surgery|surgery
5052305|NCT01415791|oral mucosal absorption|oral mucosal absorption
5052306|NCT01415791|pharmacokinetics|pharmacokinetics
5052307|NCT01415791|safety|safety
5052308|NCT01415791|bicalutamide|bicalutamide
5052309|NCT01415791|Japanese|japanese
5052310|NCT01415791|healthy subject|healthy subject
5052311|NCT01415778|Bioequivalence|bioequivalence
5052312|NCT01415778|pharmacokinetics|pharmacokinetics
5052313|NCT01415778|safety|safety
5052314|NCT01415778|bicalutamide|bicalutamide
5052315|NCT01415778|Casodex|casodex
5052316|NCT01415778|Japanese|japanese
5052317|NCT01415778|healthy subject|healthy subject
5052318|NCT01415765|Germinal Center Like B-Cell (GCB) DLBCL|germinal center like b-cell (gcb) dlbcl
5052319|NCT01415765|Activated B-Cell Like (ABC) DLBCL|activated b-cell like (abc) dlbcl
5052320|NCT01415765|NF-KappaB Pathway|nf-kappab pathway
5052321|NCT01415765|Drug Resistance|drug resistance
5052322|NCT01415765|Nedd-8 Activating Enzyme Inhibitor|nedd-8 activating enzyme inhibitor
5052323|NCT01415765|Diffuse Large B-Cell Lymphoma|diffuse large b-cell lymphoma
5052324|NCT01415765|Lymphoma|lymphoma
5052325|NCT01415752|neurotoxicity|neurotoxicity
5052326|NCT01415752|therapy-related toxicity|therapy-related toxicity
5052327|NCT01415752|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
5052328|NCT01415752|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5052329|NCT01415752|stage I mantle cell lymphoma|stage i mantle cell lymphoma
5052330|NCT01415752|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5052331|NCT01415752|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5052332|NCT01415739|stage IA non-small cell lung cancer|stage ia non-small cell lung cancer
5052333|NCT01415739|stage IB non-small cell lung cancer|stage ib non-small cell lung cancer
5052334|NCT01415739|adenocarcinoma of the lung|adenocarcinoma of the lung
5052335|NCT01415739|squamous cell lung cancer|squamous cell lung cancer
5052336|NCT01415726|Cord blood stem cells|cord blood stem cells
5052337|NCT01415726|inflammation|inflammation
5052338|NCT01415726|type 2 diabetes|type 2 diabetes
5052339|NCT01415726|stem cell educator|stem cell educator
5052340|NCT01415726|autoimmunity|autoimmunity
5052341|NCT01415726|immune modulation|immune modulation
5052342|NCT01415713|enroll the 80 patients in this trial|enroll the 80 patients in this trial
5052343|NCT01415700|feet STEPPAGE of central neurological origin|feet steppage of central neurological origin
5052344|NCT01415700|implanted functional electrical stimulation|implanted functional electrical stimulation
5052345|NCT01415700|feet orthosis|feet orthosis
5052346|NCT01415687|preoperative care|preoperative care
5052347|NCT01415687|colonoscopy|colonoscopy
5052348|NCT01415687|cathartics|cathartics
5052349|NCT01415674|Squamous cell carcinoma of the head and neck|squamous cell carcinoma of the head and neck
5052350|NCT01415674|pre operative treatment|pre operative treatment
5052351|NCT01415674|Afatinib|afatinib
5052352|NCT01415674|BIBW2992|bibw2992
5052353|NCT01415674|Biological markers|biological markers
5052354|NCT01415648|with surgical indication|with surgical indication
5052355|NCT01415648|Cerebral oximetry|cerebral oximetry
5052356|NCT01415648|carotid endarterectomy|carotid endarterectomy
5052357|NCT01415648|MRI|mri
5052358|NCT01415648|ischemic lesion|ischemic lesion
5052359|NCT01415648|cost/effectiveness analysis|cost/effectiveness analysis
5052360|NCT01415648|Neurocognitive Outcome|neurocognitive outcome
5052361|NCT01415648|protein S-100B|protein s-100b
5052362|NCT01415635|Nutritional risk, Hospital food, Nutritional Intervention|nutritional risk, hospital food, nutritional intervention
5052363|NCT01415622|plasma therapy|plasma therapy
5052364|NCT01415622|ulcus cruris|ulcus cruris
5052365|NCT01415609|Gastrointestinal neoplasia|gastrointestinal neoplasia
5052366|NCT01415609|Submucosal resection|submucosal resection
5052367|NCT01415570|Protein-energy wasting (PEW)|protein-energy wasting (pew)
5052368|NCT01415570|racial disparities|racial disparities
5052369|NCT01415570|hemodialysis|hemodialysis
5052370|NCT01415570|survival paradoxes|survival paradoxes
5052371|NCT01415570|Stage 5|stage 5
5052372|NCT01415557|micronutrient|micronutrient
5052373|NCT01415557|healthy children|healthy children
5052374|NCT01415557|vitamins|vitamins
5052375|NCT01415557|minerals|minerals
5052376|NCT01415557|cognition|cognition
5052377|NCT01415557|physical performance|physical performance
5052378|NCT01415557|iron|iron
5052379|NCT01415557|Micronutrient status|micronutrient status
5052380|NCT01415557|Cognitive Performance|cognitive performance
5052381|NCT01415544|Diabetes|diabetes
5052382|NCT01415531|Stage 1|stage 1
5052383|NCT01415531|Stage 2|stage 2
5052384|NCT01415531|Hypertension|hypertension
5052385|NCT01415518|Severe chronic obstructive pulmonary disease (COPD) patients|severe chronic obstructive pulmonary disease (copd) patients
5052386|NCT01415505|Stage 1|stage 1
5052387|NCT01415505|Stage 2|stage 2
5052388|NCT01415505|Hypertension|hypertension
5052389|NCT01415505|1 year open label safety study|1 year open label safety study
5052390|NCT01415492|Exercise|exercise
5052391|NCT01415492|Physical activity|physical activity
5052392|NCT01415492|Cigarette Smoking|cigarette smoking
5052393|NCT01415492|Smoking cessation|smoking cessation
5052394|NCT01415492|Multi Vitamin intake|multi vitamin intake
5052395|NCT01415492|Vegetable consumption|vegetable consumption
5052396|NCT01415492|Fruit consumption|fruit consumption
5052397|NCT01415492|Meat consumption|meat consumption
5052398|NCT01415479|Colon cancer|colon cancer
5052399|NCT01415479|Screening|screening
5052400|NCT01415479|Decision-making|decision-making
5052401|NCT01415453|retinitis pigmentosa|retinitis pigmentosa
5052402|NCT01415453|acoustic radiation force ultrasound|acoustic radiation force ultrasound
5052403|NCT01415453|RP|rp
5052404|NCT01415453|visual field loss|visual field loss
5052405|NCT01415453|Photoreceptor|photoreceptor
5052406|NCT01415453|Vision loss|vision loss
5052407|NCT01415453|retina|retina
5052408|NCT01415453|progressive vision loss|progressive vision loss
5052409|NCT01415453|ultrasound|ultrasound
5052410|NCT01415440|ADHD|adhd
5052411|NCT01415440|Vyvanse|vyvanse
5052412|NCT01415440|stimulant medication|stimulant medication
5052413|NCT01415440|ADD|add
5052414|NCT01415427|Mucopolysaccharidosis IV type A|mucopolysaccharidosis iv type a
5052415|NCT01415427|MPS IV Type A|mps iv type a
5052416|NCT01415427|Mucopolysaccharidosis IVA|mucopolysaccharidosis iva
5052417|NCT01415427|MPS IVA|mps iva
5052418|NCT01415427|Morquio A Syndrome|morquio a syndrome
5052419|NCT01415427|Lysosomal Storage Disorder|lysosomal storage disorder
5052420|NCT01415427|LSD|lsd
5052421|NCT01415427|N-acetylgalactosamine-6-sulfatase|n-acetylgalactosamine-6-sulfatase
5052422|NCT01415427|N-acetylgalactosamine-6-sulfate sulfatase|n-acetylgalactosamine-6-sulfate sulfatase
5052423|NCT01415427|galactose-6-sulfatase|galactose-6-sulfatase
5052424|NCT01415427|GALNS|galns
5052425|NCT01415427|enzyme replacement therapy|enzyme replacement therapy
5052426|NCT01415427|ERT|ert
5052427|NCT01415414|Image quality|image quality
5052428|NCT01415414|CNR|cnr
5052429|NCT01415414|SNR|snr
5052430|NCT01415414|Abdominal|abdominal
5052431|NCT01415414|Pelvic|pelvic
5052432|NCT01415401|Glaucoma|glaucoma
5052433|NCT01415401|Ocular hypertension|ocular hypertension
5052434|NCT01415401|Intraocular pressure (IOP)|intraocular pressure (iop)
5052435|NCT01415401|Open angle glaucoma|open angle glaucoma
5052436|NCT01415401|Pigment dispersion glaucoma|pigment dispersion glaucoma
5052437|NCT01415401|Pigmentary|pigmentary
5052438|NCT01415388|Maintenance of normal blood triglyceride levels|maintenance of normal blood triglyceride levels
5052439|NCT01415375|prostate-specific antigen (146-154)|prostate-specific antigen (146-154)
5052440|NCT01415375|prostate-specific antigen (154-163)|prostate-specific antigen (154-163)
5052441|NCT01415362|transcranial direct current stimulation|transcranial direct current stimulation
5052442|NCT01415362|electroencephalography|electroencephalography
5052443|NCT01415323|Emergency services, psychiatric|emergency services, psychiatric
5052444|NCT01415323|Psychomotor agitation|psychomotor agitation
5052445|NCT01415323|Suicide|suicide
5052446|NCT01415323|Violence|violence
5052447|NCT01415310|Geriatric Psychiatry|geriatric psychiatry
5052448|NCT01415310|Quality register|quality register
5052449|NCT01415310|Quality improvement|quality improvement
5052450|NCT01415310|Quality control|quality control
5052451|NCT01415310|Research elderly patients with psychiatric disorders|research elderly patients with psychiatric disorders
5052452|NCT01415297|Phase 1|phase 1
5052453|NCT01415297|advanced solid tumors|advanced solid tumors
5052454|NCT01415284|Obstetric anesthesia|obstetric anesthesia
5052455|NCT01415284|Spinal anesthesia|spinal anesthesia
5052456|NCT01415284|Hypotension|hypotension
5052457|NCT01415284|Fluid therapy|fluid therapy
5052458|NCT01415284|Cesarean section|cesarean section
5052459|NCT01415284|phenylephrine|phenylephrine
5052460|NCT01415284|cardiac output|cardiac output
5052461|NCT01415271|diabetes|diabetes
5052462|NCT01415271|A1c|a1c
5052463|NCT01415271|internet|internet
5052464|NCT01415271|long term care|long term care
5052465|NCT01415258|cancer|cancer
5052466|NCT01415258|vulnerability|vulnerability
5052467|NCT01415258|frail|frail
5052468|NCT01415232|Obesity|obesity
5052469|NCT01415232|Ultrasound|ultrasound
5052470|NCT01415219|rehabilitation|rehabilitation
5052471|NCT01415219|exercise|exercise
5052472|NCT01415219|efficacy|efficacy
5052473|NCT01415219|functional status|functional status
5052474|NCT01415206|Behavioral changes|behavioral changes
5052475|NCT01415206|Multiple risks|multiple risks
5052476|NCT01415180|sepsis|sepsis
5052477|NCT01415180|health related quality of life|health related quality of life
5052478|NCT01415180|functional status|functional status
5052479|NCT01415180|chronic comorbid conditions|chronic comorbid conditions
5052480|NCT01415180|organ dysfunction|organ dysfunction
5052481|NCT01415154|TMS|tms
5052482|NCT01415154|Major Depressive Disorder|major depressive disorder
5052483|NCT01415154|NeuroStar TMS|neurostar tms
5052484|NCT01415141|genotype 1|genotype 1
5052485|NCT01415141|IL28B CC polymorphism|il28b cc polymorphism
5052486|NCT01415141|telaprevir|telaprevir
5052487|NCT01415141|peginterferon|peginterferon
5052488|NCT01415141|ribavirin|ribavirin
5052489|NCT01415115|diabetes|diabetes
5052490|NCT01415115|hypertension|hypertension
5052491|NCT01415089|Cancer|cancer
5052492|NCT01415089|Quality of life|quality of life
5052493|NCT01415089|Family caregiver|family caregiver
5052494|NCT01415089|Stress and coping|stress and coping
5052495|NCT01415089|Web-based intervention|web-based intervention
5052496|NCT01415089|Communication|communication
5052497|NCT01415063|Hepatocellular Carcinoma|hepatocellular carcinoma
5052498|NCT01415063|RFA|rfa
5052499|NCT01415063|TACE|tace
5052500|NCT01415050|Osteoporosis|osteoporosis
5052501|NCT01415050|Menopause|menopause
5052502|NCT01415050|Raloxifane|raloxifane
5052503|NCT01415050|Alendronate|alendronate
5052504|NCT01415037|Annular Array Ultrasound|annular array ultrasound
5052505|NCT01415037|Ultrasound Exam|ultrasound exam
5052506|NCT01415037|Posterior Vitreous Detachment|posterior vitreous detachment
5052507|NCT01415037|PVD|pvd
5052508|NCT01415037|Diabetic Retinopathy|diabetic retinopathy
5052509|NCT01415024|CRT|crt
5052510|NCT01415024|Dual LV|dual lv
5052511|NCT01415024|Triple Ventricle stimulation|triple ventricle stimulation
5052512|NCT01415024|two leftventricular leads|two leftventricular leads
5052513|NCT01415024|Av VV optimization|av vv optimization
5052514|NCT01415024|Lv dp/dt measurement|lv dp/dt measurement
5052515|NCT01415011|Afatinib (BIBW2992)|afatinib (bibw2992)
5052516|NCT01415011|EGFR Mutation|egfr mutation
5052517|NCT01415011|Non Small Cell Lung Cancer|non small cell lung cancer
5052518|NCT01415011|Poor performance status|poor performance status
5052519|NCT01415011|Elderly|elderly
5052520|NCT01414985|Batten Disease|batten disease
5052521|NCT01414972|Atherosclerosis|atherosclerosis
5052522|NCT01414972|Coronary Artery Disease|coronary artery disease
5052523|NCT01414972|Vitamin A|vitamin a
5052524|NCT01414972|CD4-Positive T-Lymphocytes|cd4-positive t-lymphocytes
5052525|NCT01414972|gene expression|gene expression
5052526|NCT01414959|intensive care patient|intensive care patient
5052527|NCT01414959|intubation|intubation
5052528|NCT01414959|(please change wording as you like!)|(please change wording as you like!)
5052529|NCT01414920|Drug Therapy|drug therapy
5052530|NCT01414907|Drinking Behavior|drinking behavior
5052531|NCT01414907|Harm Reduction|harm reduction
5052532|NCT01414907|Tobacco Use Cessation|tobacco use cessation
5052533|NCT01414907|Smoking Cessation|smoking cessation
5052534|NCT01414907|Rehabilitation|rehabilitation
5052535|NCT01414907|Health Promotion|health promotion
5052536|NCT01414907|Nutrition Therapy|nutrition therapy
5052537|NCT01414907|Feeding Behavior|feeding behavior
5052538|NCT01414907|Exercise|exercise
5052539|NCT01414881|ApoB (Apolipoprotein B)|apob (apolipoprotein b)
5052540|NCT01414881|LDL (low density lipoprotein)|ldl (low density lipoprotein)
5052541|NCT01414881|mipomersen|mipomersen
5052542|NCT01414868|Leukotriene|leukotriene
5052543|NCT01414868|leukotriene receptor antagonist|leukotriene receptor antagonist
5052544|NCT01414868|bronchial provocation test|bronchial provocation test
5052545|NCT01414868|therapeutic outcome|therapeutic outcome
5052546|NCT01414829|Peptic disease|peptic disease
5052547|NCT01414829|Helicobacter pylori|helicobacter pylori
5052548|NCT01414829|Different methods|different methods
5052549|NCT01414816|Multiple Sclerosis|multiple sclerosis
5052550|NCT01414816|Clinical Isolated Syndrome (CIS)|clinical isolated syndrome (cis)
5052551|NCT01414803|rosuvastatin, fenofibrate, creatine kinase, alanine aminotransferase|rosuvastatin, fenofibrate, creatine kinase, alanine aminotransferase
5052552|NCT01414790|human acellular dermal matrix|human acellular dermal matrix
5052553|NCT01414790|parotid tumor|parotid tumor
5052554|NCT01414790|total parotidectomy|total parotidectomy
5052555|NCT01414777|c-section|c-section
5052556|NCT01414777|Hypotension after spinal anesthesia for C-section|hypotension after spinal anesthesia for c-section
5052557|NCT01414764|rotator cuff tendon repair surgery|rotator cuff tendon repair surgery
5052558|NCT01414764|supraspinatus tendon repair|supraspinatus tendon repair
5052559|NCT01414751|Risk communication|risk communication
5052560|NCT01414751|Shared decision making|shared decision making
5052561|NCT01414751|Cardiovascular diseases|cardiovascular diseases
5052562|NCT01414751|Hypercholesterolemia|hypercholesterolemia
5052563|NCT01414751|Prevention|prevention
5052564|NCT01414725|Multiple Sclerosis|multiple sclerosis
5052565|NCT01414725|Mobility|mobility
5052566|NCT01414725|Balance|balance
5052567|NCT01414725|Core Stability|core stability
5052568|NCT01414725|Physiotherapy|physiotherapy
5052569|NCT01414712|Low- and Intermediate-Risk Prostate Cancer|low- and intermediate-risk prostate cancer
5052570|NCT01414699|dietary variety|dietary variety
5052571|NCT01414699|course sequence|course sequence
5052572|NCT01414699|preschool|preschool
5052573|NCT01414699|child feeding|child feeding
5052574|NCT01414673|IUI|iui
5052575|NCT01414673|HCG|hcg
5052576|NCT01414673|Spontaneous LH|spontaneous lh
5052577|NCT01414673|pregnancy|pregnancy
5052578|NCT01414660|interleukin 7|interleukin 7
5052579|NCT01414660|transplantation|transplantation
5052580|NCT01414660|liver|liver
5052581|NCT01414660|kidney|kidney
5052582|NCT01414660|islet|islet
5052583|NCT01414660|diabetes|diabetes
5052584|NCT01414647|Bilberry|bilberry
5052585|NCT01414647|Vaccinium myrtillus|vaccinium myrtillus
5052586|NCT01414647|Metabolic syndrome|metabolic syndrome
5052587|NCT01414647|Glucose metabolism|glucose metabolism
5052588|NCT01414647|Lipid metabolism|lipid metabolism
5052589|NCT01414647|Inflammation|inflammation
5052590|NCT01414647|Gene expression|gene expression
5052591|NCT01414621|CABG|cabg
5052592|NCT01414595|adenocarcinoma of the lung|adenocarcinoma of the lung
5052593|NCT01414595|adenosquamous cell lung cancer|adenosquamous cell lung cancer
5052594|NCT01414595|non-small cell lung cancer|non-small cell lung cancer
5052595|NCT01414595|squamous cell lung cancer|squamous cell lung cancer
5052596|NCT01414582|tDCS|tdcs
5052597|NCT01414582|Stroke|stroke
5052598|NCT01414582|Functional MRI|functional mri
5052599|NCT01414582|Motor Learning|motor learning
5052600|NCT01414543|violence|violence
5052601|NCT01414517|Prebiotics|prebiotics
5052602|NCT01414517|Acute Intestinal Injury|acute intestinal injury
5052603|NCT01414517|Chronic radiation enteritis|chronic radiation enteritis
5052604|NCT01414504|pneumococcal,|pneumococcal,
5052605|NCT01414504|pneumococcal polysaccharide vaccine,|pneumococcal polysaccharide vaccine,
5052606|NCT01414504|challenge dose,|challenge dose,
5052607|NCT01414504|hyporesponsiveness,|hyporesponsiveness,
5052608|NCT01414504|Papua New Guinea|papua new guinea
5052609|NCT01414478|emesis|emesis
5052610|NCT01414478|nausea|nausea
5052611|NCT01414465|Fatty acids|fatty acids
5052612|NCT01414465|orlistat|orlistat
5052613|NCT01414465|lipase|lipase
5052614|NCT01414465|BMC (Body Mass Index) between 30 to 40 kg/m2|bmc (body mass index) between 30 to 40 kg/m2
5052615|NCT01414465|Women|women
5052616|NCT01414465|18 to 45 years|18 to 45 years
5052617|NCT01414465|Premenopausal stage|premenopausal stage
5052618|NCT01414452|Myocardial Infarction|myocardial infarction
5052619|NCT01414452|Reperfusion injury|reperfusion injury
5052620|NCT01414452|Adiponectin|adiponectin
5052621|NCT01414452|endothelial progenitor cells|endothelial progenitor cells
5052622|NCT01414413|HIV|hiv
5052623|NCT01414413|AIDS|aids
5052624|NCT01414413|Antiretroviral therapy|antiretroviral therapy
5052625|NCT01414413|Community-based study|community-based study
5052626|NCT01414413|Cluster-randomised trial|cluster-randomised trial
5052627|NCT01414413|HIV testing|hiv testing
5052628|NCT01414413|Africa|africa
5052629|NCT01414400|Bacteremia|bacteremia
5052630|NCT01414400|Spyglass|spyglass
5052631|NCT01414400|Cholangioscopy|cholangioscopy
5052632|NCT01414387|carotid stenosis|carotid stenosis
5052633|NCT01414387|cerebral embolization|cerebral embolization
5052634|NCT01414387|stents|stents
5052635|NCT01414387|stroke|stroke
5052636|NCT01414374|iron|iron
5052637|NCT01414374|anemia|anemia
5052638|NCT01414374|herbal medicine|herbal medicine
5052639|NCT01414374|phytotherapy|phytotherapy
5052640|NCT01414374|Centella asiatica|centella asiatica
5052641|NCT01414374|Hibiscus sabdariffa|hibiscus sabdariffa
5052642|NCT01414361|Coronary artery stenosis|coronary artery stenosis
5052643|NCT01414361|Fractional flow reserve|fractional flow reserve
5052644|NCT01414361|Intravascular ultrasonography|intravascular ultrasonography
5052645|NCT01414348|participation|participation
5052646|NCT01414348|activities of daily living|activities of daily living
5052647|NCT01414348|brain injuries|brain injuries
5052648|NCT01414348|executive function|executive function
5052649|NCT01414335|amino acids|amino acids
5052650|NCT01414335|immune system|immune system
5052651|NCT01414335|vitamins|vitamins
5052652|NCT01414335|chronic infection|chronic infection
5052653|NCT01414335|common cold|common cold
5052654|NCT01414335|ear|ear
5052655|NCT01414335|nose|nose
5052656|NCT01414335|throat|throat
5052657|NCT01414309|Heart Failure|heart failure
5052658|NCT01414309|Central Sleep Apnea|central sleep apnea
5052659|NCT01414309|Sleep Disordered Breathing|sleep disordered breathing
5052660|NCT01414309|Cardiac Dysfunction|cardiac dysfunction
5052661|NCT01414257|Rheumatrex|rheumatrex
5052662|NCT01414257|High Dose|high dose
5052663|NCT01414244|Irritable Bowel Syndrome|irritable bowel syndrome
5052664|NCT01414244|Glutamine|glutamine
5052665|NCT01414244|Intestinal Permeability|intestinal permeability
5052666|NCT01414231|AML|aml
5052667|NCT01414231|acute myeloid leukaemia|acute myeloid leukaemia
5052668|NCT01414231|low vs intermediate dose AraC|low vs intermediate dose arac
5052669|NCT01414231|CR rate|cr rate
5052670|NCT01414231|patients <60 years|patients <60 years
5052671|NCT01414218|elderly|elderly
5052672|NCT01414218|humor|humor
5052673|NCT01414218|general well being|general well being
5052674|NCT01414218|psychological distress|psychological distress
5052675|NCT01414218|health quality of life|health quality of life
5052676|NCT01414179|nutrition|nutrition
5052677|NCT01414179|environnement|environnement
5052678|NCT01414179|cardiovascular pathology|cardiovascular pathology
5052679|NCT01414153|choroidal neovascularization|choroidal neovascularization
5052680|NCT01414153|age-related macular degeneration|age-related macular degeneration
5052681|NCT01414153|iSONEP|isonep
5052682|NCT01414153|sonepcizumab|sonepcizumab
5052683|NCT01414153|Lucentis|lucentis
5052684|NCT01414153|ranibizumab|ranibizumab
5052685|NCT01414153|Avastin|avastin
5052686|NCT01414153|bevacizumab|bevacizumab
5052687|NCT01414153|Eylea|eylea
5052688|NCT01414153|aflibercept|aflibercept
5052689|NCT01414140|Mirena, contraception|mirena, contraception
5052690|NCT01414114|Clinical Trial, Phase 2|clinical trial, phase 2
5052691|NCT01414114|Renal Dialysis|renal dialysis
5052692|NCT01414114|Secondary Hyperparathyroidism|secondary hyperparathyroidism
5052693|NCT01414114|Chronic kidney disease-mineral and bone disorder|chronic kidney disease-mineral and bone disorder
5052694|NCT01414114|Parathyroid hormone|parathyroid hormone
5052695|NCT01414101|Rheumatoid Arthritis|rheumatoid arthritis
5052696|NCT01414088|Nephrology|nephrology
5052697|NCT01414088|ENaC|enac
5052698|NCT01414088|NCC|ncc
5052699|NCT01414088|NKCC|nkcc
5052700|NCT01414088|Sodium channels|sodium channels
5052701|NCT01414088|renal biomarkers|renal biomarkers
5052702|NCT01414075|Kidney|kidney
5052703|NCT01414075|ESRD|esrd
5052704|NCT01414075|Renal|renal
5052705|NCT01414075|End-Stage Renal Disease|end-stage renal disease
5052706|NCT01414075|Anemia|anemia
5052707|NCT01414075|Oral anemia treatment|oral anemia treatment
5052708|NCT01414075|Hemoglobin levels|hemoglobin levels
5052709|NCT01414075|Hemodialysis|hemodialysis
5052710|NCT01414075|Peritoneal|peritoneal
5052711|NCT01414075|HD|hd
5052712|NCT01414075|PD|pd
5052713|NCT01414075|Hb|hb
5052714|NCT01414075|Erythropoietin|erythropoietin
5052715|NCT01414075|Blood count|blood count
5052716|NCT01414062|Breast Cancer|breast cancer
5052717|NCT01414062|Healthy meals|healthy meals
5052718|NCT01414062|Cocinar|cocinar
5052719|NCT01414062|Dietary|dietary
5052720|NCT01414062|Dietary Intervention|dietary intervention
5052721|NCT01414062|fruits and vegetables|fruits and vegetables
5052722|NCT01414062|Cancer survivor|cancer survivor
5052723|NCT01414062|Nutrition|nutrition
5052724|NCT01414049|CABG|cabg
5052725|NCT01414049|Off-pump CABG|off-pump cabg
5052726|NCT01414049|Beating heart|beating heart
5052727|NCT01414049|Graft patency|graft patency
5052728|NCT01414049|Computed tomography angiography|computed tomography angiography
5052729|NCT01414049|Angiographic evaluation of coronary graft patency|angiographic evaluation of coronary graft patency
5052730|NCT01414036|cigarette smoking|cigarette smoking
5052731|NCT01414036|patient navigation|patient navigation
5052732|NCT01414036|primary care|primary care
5052733|NCT01414023|High OCI-R scores|high oci-r scores
5052734|NCT01414010|healthy volunteers|healthy volunteers
5052735|NCT01414010|gut microbiota|gut microbiota
5052736|NCT01414010|gut microbiome|gut microbiome
5052737|NCT01414010|prebiotic|prebiotic
5052738|NCT01414010|probiotic|probiotic
5052739|NCT01414010|antibiotic|antibiotic
5052740|NCT01414010|antibiotic-associated diarrhea|antibiotic-associated diarrhea
5052741|NCT01414010|intestinal bacterial overgrowth|intestinal bacterial overgrowth
5052742|NCT01413984|Trauma|trauma
5052743|NCT01413984|incarceration|incarceration
5052744|NCT01413984|treatment|treatment
5052745|NCT01413984|substance abuse|substance abuse
5052746|NCT01413958|Nasal Decongestants|nasal decongestants
5052747|NCT01413958|Rhinitis, Allergic, Seasonal|rhinitis, allergic, seasonal
5052748|NCT01413958|Rhinitis|rhinitis
5052749|NCT01413958|Nose Conditions|nose conditions
5052750|NCT01413958|Respiratory Tract Diseases|respiratory tract diseases
5052751|NCT01413958|Phenylephrine|phenylephrine
5052752|NCT01413945|Ileocecal valve|ileocecal valve
5052753|NCT01413945|Irritable bowel syndrome|irritable bowel syndrome
5052754|NCT01413945|small bowel bacteria|small bowel bacteria
5052755|NCT01413867|hemorrhoids|hemorrhoids
5052756|NCT01413867|circular staplers|circular staplers
5052757|NCT01413867|mucosal resection|mucosal resection
5052758|NCT01413867|hemostatic suture|hemostatic suture
5052760|NCT01413841|oxygen|oxygen
5052761|NCT01413828|breast cancer|breast cancer
5052762|NCT01413828|adjuvant chemotherapy|adjuvant chemotherapy
5052763|NCT01413828|trastuzumab|trastuzumab
5052764|NCT01413828|anthracycline|anthracycline
5052765|NCT01413815|peri-operative|peri-operative
5052766|NCT01413815|cardiovascular risk|cardiovascular risk
5052767|NCT01413815|oral supplementation|oral supplementation
5052768|NCT01413815|amino acid L-arginine|amino acid l-arginine
5052769|NCT01413802|Thyroid surgery|thyroid surgery
5052770|NCT01413763|Actinic keratosis|actinic keratosis
5052771|NCT01413763|Atrial ectopy|atrial ectopy
5052772|NCT01413724|Administered analgesic therapy|administered analgesic therapy
5052773|NCT01413711|IS|is
5052774|NCT01413711|Pharmacokinetics|pharmacokinetics
5052775|NCT01413711|Area under the curve|area under the curve
5052776|NCT01413711|Maximum plasma concentration|maximum plasma concentration
5052777|NCT01413711|Time to maximum concentration|time to maximum concentration
5052778|NCT01413685|tacrolimus|tacrolimus
5052779|NCT01413685|calcineurin|calcineurin
5052780|NCT01413685|pharmacodynamic|pharmacodynamic
5052781|NCT01413685|TDM|tdm
5052782|NCT01413685|pharmacokinetics|pharmacokinetics
5052783|NCT01413672|ostomy|ostomy
5052784|NCT01413672|colostomy|colostomy
5052785|NCT01413672|ileostomy|ileostomy
5052786|NCT01413672|barrier|barrier
5052787|NCT01413672|irritation|irritation
5052788|NCT01413659|Colorectal surgery|colorectal surgery
5052789|NCT01413659|Surgical site infection|surgical site infection
5052790|NCT01413659|Symbiotic|symbiotic
5052791|NCT01413646|obesity|obesity
5052792|NCT01413646|walnuts|walnuts
5052793|NCT01413646|endothelial function|endothelial function
5052794|NCT01413620|Vitamin E|vitamin e
5052795|NCT01413620|Burn|burn
5052796|NCT01413620|Oxidation|oxidation
5052797|NCT01413620|Lung Dysfunction|lung dysfunction
5052798|NCT01413620|Fatty Liver|fatty liver
5052799|NCT01413620|Lipid Peroxidation|lipid peroxidation
5052800|NCT01413607|nephrectomy|nephrectomy
5052801|NCT01413607|self retaining sutures|self retaining sutures
5052802|NCT01413607|laparoscopy|laparoscopy
5052803|NCT01413594|cerebral palsy|cerebral palsy
5052804|NCT01413594|constraint-induced therapy|constraint-induced therapy
5052805|NCT01413594|constraint-induced movement therapy|constraint-induced movement therapy
5052806|NCT01413594|CP|cp
5052807|NCT01413594|hemiplegia|hemiplegia
5052808|NCT01413594|hand|hand
5052809|NCT01413594|forced use|forced use
5052810|NCT01413594|motor control|motor control
5052811|NCT01413594|children|children
5052812|NCT01413594|HABIT|habit
5052813|NCT01413594|Hand-arm bimanual intensive therapy|hand-arm bimanual intensive therapy
5052814|NCT01413594|bilateral training|bilateral training
5052815|NCT01413594|bimanual training|bimanual training
5052816|NCT01413594|functional therapy|functional therapy
5052817|NCT01413594|physical therapy|physical therapy
5052818|NCT01413594|occupational therapy|occupational therapy
5052819|NCT01413594|intensive|intensive
5052820|NCT01413594|pediatric|pediatric
5052821|NCT01413594|development|development
5052822|NCT01413594|upper extremity|upper extremity
5052823|NCT01413594|hemiplegic|hemiplegic
5052824|NCT01413594|childhood stroke|childhood stroke
5052825|NCT01413581|rhBSSL|rhbssl
5052826|NCT01413581|preterm infants|preterm infants
5052827|NCT01413581|Swedish Orphan Biovitrum|swedish orphan biovitrum
5052828|NCT01413581|growth velocity|growth velocity
5052829|NCT01413581|Prevention of growth restriction|prevention of growth restriction
5052830|NCT01413555|blood culture|blood culture
5052831|NCT01413555|emergency department|emergency department
5052832|NCT01413555|quality improvement|quality improvement
5052833|NCT01413542|DPPIV inhibitors|dppiv inhibitors
5052834|NCT01413542|ACE inhibitors|ace inhibitors
5052835|NCT01413542|Bradykinin|bradykinin
5052836|NCT01413542|glucagon-like peptide (GLP-1)|glucagon-like peptide (glp-1)
5052837|NCT01413542|BNP|bnp
5052838|NCT01413542|diabetes|diabetes
5052839|NCT01413542|hypertension|hypertension
5052840|NCT01413529|HIV infected persons with co-occurring drug use|hiv infected persons with co-occurring drug use
5052841|NCT01413516|Varenicline|varenicline
5052842|NCT01413516|Placebo|placebo
5052843|NCT01413516|Inpatient|inpatient
5052844|NCT01413503|Pheochromocytoma|pheochromocytoma
5052845|NCT01413503|Paraganglioma|paraganglioma
5052846|NCT01413503|MIBG|mibg
5052847|NCT01413503|131I-MIBG|131i-mibg
5052848|NCT01413503|Resistant|resistant
5052849|NCT01413503|Relapsed|relapsed
5052850|NCT01413503|Treatment|treatment
5052851|NCT01413503|UCSF|ucsf
5052852|NCT01413503|Pediatric|pediatric
5052853|NCT01413503|Adult|adult
5052854|NCT01413503|Oncology|oncology
5052855|NCT01413490|hepatitis C virus|hepatitis c virus
5052856|NCT01413490|Interferon|interferon
5052857|NCT01413490|rimantadine|rimantadine
5052858|NCT01413490|liver|liver
5052859|NCT01413477|Allergic contact dermatitis|allergic contact dermatitis
5052860|NCT01413477|Nickel allergy|nickel allergy
5052861|NCT01413477|Desensitization therapy|desensitization therapy
5052862|NCT01413464|Renal Transplant|renal transplant
5052863|NCT01413464|Venous Thrombosis|venous thrombosis
5052864|NCT01413464|Deep Vein Thrombosis|deep vein thrombosis
5052865|NCT01413464|Prophylaxis|prophylaxis
5052866|NCT01413464|Bleeding|bleeding
5052867|NCT01413451|Monoclonal IgG Antibody|monoclonal igg antibody
5052868|NCT01413451|Biodistribution|biodistribution
5052869|NCT01413451|Pharmacokinetics|pharmacokinetics
5052870|NCT01413451|HACA|haca
5052871|NCT01413451|Safety|safety
5052872|NCT01413451|Mesothelioma|mesothelioma
5052873|NCT01413451|Ovarian Cancer|ovarian cancer
5052874|NCT01413451|Pancreatic Duct Cancer|pancreatic duct cancer
5052875|NCT01413451|Non-Small Cell Lung Cancer|non-small cell lung cancer
5052876|NCT01413438|Bevacizumab|bevacizumab
5052877|NCT01413438|Quality of Life|quality of life
5052878|NCT01413438|Glioblastoma Multiforme|glioblastoma multiforme
5052879|NCT01413438|Neurosurgery|neurosurgery
5052880|NCT01413438|Glioblastoma|glioblastoma
5052881|NCT01413438|GBM|gbm
5052882|NCT01413438|Brain Tumor|brain tumor
5052883|NCT01413425|Smith-Lemli-Opitz Syndrome|smith-lemli-opitz syndrome
5052884|NCT01413425|Cholesterol|cholesterol
5052885|NCT01413425|SLOS|slos
5052886|NCT01413412|Ventral Hernia|ventral hernia
5052887|NCT01413412|Postoperative Pain|postoperative pain
5052888|NCT01413412|Ventral Hernia Pain Questionnaire|ventral hernia pain questionnaire
5052889|NCT01413412|Postoperative Abdominal wall and muscle function|postoperative abdominal wall and muscle function
5052890|NCT01413412|Biodex|biodex
5052891|NCT01413386|paclitaxel|paclitaxel
5052892|NCT01413386|drug eluting stent|drug eluting stent
5052893|NCT01413373|cephalometry|cephalometry
5052894|NCT01413373|three-dimensional|three-dimensional
5052895|NCT01413373|CT scan|ct scan
5052896|NCT01413373|lateral radiography|lateral radiography
5052897|NCT01413373|facial symmetry|facial symmetry
5052898|NCT01413373|maxillomandibular dysmorphoses|maxillomandibular dysmorphoses
5052899|NCT01413334|Coronary artery disease|coronary artery disease
5052900|NCT01413334|CT|ct
5052901|NCT01413321|Brain Injuries|brain injuries
5052902|NCT01413321|Post Traumatic Encephalopathy|post traumatic encephalopathy
5052903|NCT01413321|TBI (Traumatic Brain Injury)|tbi (traumatic brain injury)
5052904|NCT01413321|Cerebral Stroke|cerebral stroke
5052905|NCT01413321|Vascular Accidents, Brain|vascular accidents, brain
5052906|NCT01413321|Cerebrovascular Apoplexy|cerebrovascular apoplexy
5052907|NCT01413321|Cerebrovascular Accident|cerebrovascular accident
5052908|NCT01413321|hemiparesis|hemiparesis
5052909|NCT01413308|Fontan|fontan
5052910|NCT01413308|lung function test|lung function test
5052911|NCT01413308|nitric oxide production|nitric oxide production
5052912|NCT01413308|NYHA class 1-2 without acute or chronic specified lung disease|nyha class 1-2 without acute or chronic specified lung disease
5052913|NCT01413295|Colorectal Neoplasms|colorectal neoplasms
5052914|NCT01413295|Dendritic Cells|dendritic cells
5052915|NCT01413282|Acute coronary syndrome|acute coronary syndrome
5052916|NCT01413269|breast cancer patients|breast cancer patients
5052917|NCT01413269|breast conservation surgery|breast conservation surgery
5052918|NCT01413269|hypofractionated radiotherapy|hypofractionated radiotherapy
5052919|NCT01413243|Multipe sclerosis, Trichuris suis ova|multipe sclerosis, trichuris suis ova
5052920|NCT01413230|Systemic lupus erythematosus|systemic lupus erythematosus
5052921|NCT01413230|vitamin D supplementation|vitamin d supplementation
5052922|NCT01413230|regulatory T cells|regulatory t cells
5052923|NCT01413230|Th17 cells|th17 cells
5052924|NCT01413204|TA-7284|ta-7284
5052925|NCT01413204|JNJ-28431754|jnj-28431754
5052926|NCT01413204|Canagliflozin|canagliflozin
5052927|NCT01413204|Sodium Glucose Co-transporter (SGLT2 inhibitor)|sodium glucose co-transporter (sglt2 inhibitor)
5052928|NCT01413178|Myeloma|myeloma
5052929|NCT01413178|Multiple Myeloma|multiple myeloma
5052930|NCT01413178|Light chain Multiple Myeloma|light chain multiple myeloma
5052931|NCT01413178|MM|mm
5052932|NCT01413178|Autologous Hematopoietic Stem Cell Transplantation|autologous hematopoietic stem cell transplantation
5052933|NCT01413178|Busulfan|busulfan
5052934|NCT01413178|Busulfex|busulfex
5052935|NCT01413178|Myleran|myleran
5052936|NCT01413178|Melphalan|melphalan
5052937|NCT01413178|Alkeran|alkeran
5052938|NCT01413178|G-CSF|g-csf
5052939|NCT01413178|Filgrastim|filgrastim
5052940|NCT01413178|NeupogenTM|neupogentm
5052941|NCT01413178|Questionnaire|questionnaire
5052942|NCT01413178|Survey|survey
5052943|NCT01413178|Quality of Life|quality of life
5052944|NCT01413178|QOL|qol
5052945|NCT01413152|men having sex with men|men having sex with men
5052946|NCT01413139|peripheral Vascular Disease|peripheral vascular disease
5052947|NCT01413139|claudication|claudication
5052948|NCT01413139|rest pain|rest pain
5052949|NCT01413126|Peanut|peanut
5052950|NCT01413126|Blood glucose|blood glucose
5052951|NCT01413126|Insulin|insulin
5052952|NCT01413126|Non-esterified free fatty acids|non-esterified free fatty acids
5052953|NCT01413126|Glucagon-like peptide-1|glucagon-like peptide-1
5052954|NCT01413126|Peptide YY|peptide yy
5052955|NCT01413126|Cholecystokinin|cholecystokinin
5052956|NCT01413126|Appetitive|appetitive
5052957|NCT01413126|Food intake|food intake
5052958|NCT01413087|Pancreatic cancer|pancreatic cancer
5052959|NCT01413087|Gemcitabine|gemcitabine
5052960|NCT01413087|BC-819|bc-819
5052961|NCT01413087|Adenocarcinoma|adenocarcinoma
5052962|NCT01413087|Resectable|resectable
5052963|NCT01413087|H19 gene|h19 gene
5052964|NCT01413087|DTA-H19|dta-h19
5052965|NCT01413087|BioCancell|biocancell
5052966|NCT01413074|End Stage Renal Disease|end stage renal disease
5052967|NCT01413074|ESRD|esrd
5052968|NCT01413074|Peritoneal Dialysis|peritoneal dialysis
5052969|NCT01413074|PD|pd
5052970|NCT01413074|Hemodialysis|hemodialysis
5052971|NCT01413074|HD|hd
5052972|NCT01413061|Other Hindfoot Conditions requiring Subtalar Arthrodesis|other hindfoot conditions requiring subtalar arthrodesis
5052973|NCT01413061|Post-traumatic Arthritis|post-traumatic arthritis
5052974|NCT01413048|Essential Hypertension|essential hypertension
5052975|NCT01413048|Hypertension|hypertension
5052976|NCT01413035|Diabetes|diabetes
5052977|NCT01413035|Diabetes Medicines: Oral Hypoglycemic Drugs and Insulins.|diabetes medicines: oral hypoglycemic drugs and insulins.
5052978|NCT01413035|Umbilical Cord/placenta-Derived MSC|umbilical cord/placenta-derived msc
5052979|NCT01413035|Transplantation|transplantation
5052980|NCT01413009|delirium|delirium
5052981|NCT01413009|ICU|icu
5052982|NCT01413009|spontaneous awakening trials|spontaneous awakening trials
5052983|NCT01413009|spontaneous breathing trials|spontaneous breathing trials
5052984|NCT01413009|early mobility|early mobility
5052985|NCT01412970|hemodynamic monitoring|hemodynamic monitoring
5052986|NCT01412970|volume responsiveness|volume responsiveness
5052987|NCT01412970|electrical impedance tomography|electrical impedance tomography
5052988|NCT01412957|Best Supportive Care|best supportive care
5052989|NCT01412957|Panitumumab|panitumumab
5052990|NCT01412957|Chemorefractory|chemorefractory
5052991|NCT01412957|Wild-type KRAS|wild-type kras
5052992|NCT01412957|Overall Survival|overall survival
5052993|NCT01412957|Phase 3|phase 3
5052994|NCT01412944|Psoriasis|psoriasis
5052995|NCT01412944|plaque|plaque
5052996|NCT01412944|inflammatory skin disease|inflammatory skin disease
5052997|NCT01412944|scaly patches|scaly patches
5052998|NCT01412944|AIN457|ain457
5052999|NCT01412944|secukinumab|secukinumab
5053000|NCT01412944|Moderate to severe|moderate to severe
5053001|NCT01412918|Tinnitus|tinnitus
5053002|NCT01412918|Inhibitor Device|inhibitor device
5053003|NCT01412918|SCN9 gene|scn9 gene
5053004|NCT01412918|Ringing in the ears|ringing in the ears
5053005|NCT01412918|Milwaukee|milwaukee
5053006|NCT01412918|Medical College of Wisconsin|medical college of wisconsin
5053007|NCT01412905|screening|screening
5053008|NCT01412905|diabetic retinopathy|diabetic retinopathy
5053009|NCT01412892|Neurofibromatosis type 1|neurofibromatosis type 1
5053010|NCT01412892|Everolimus|everolimus
5053011|NCT01412892|Plexiform neurofibromas|plexiform neurofibromas
5053012|NCT01412892|Rapamycin|rapamycin
5053013|NCT01412879|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
5053412|NCT01411397|Infection|infection
5053014|NCT01412879|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5053015|NCT01412879|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5053016|NCT01412879|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5053017|NCT01412866|schizophrenia|schizophrenia
5053018|NCT01412866|severe mental illness|severe mental illness
5053019|NCT01412866|nicotine|nicotine
5053020|NCT01412866|smoking|smoking
5053021|NCT01412866|motivation|motivation
5053022|NCT01412866|electronic decision support system|electronic decision support system
5053023|NCT01412866|motivational interviewing|motivational interviewing
5053024|NCT01412853|localized|localized
5053025|NCT01412840|Ureterolithiasis|ureterolithiasis
5053026|NCT01412840|Pain|pain
5053027|NCT01412840|Complementary|complementary
5053028|NCT01412840|RCT|rct
5053029|NCT01412827|Single-photon emission computed tomography|single-photon emission computed tomography
5053030|NCT01412827|myocardial perfusion imaging|myocardial perfusion imaging
5053031|NCT01412827|rest/stress|rest/stress
5053032|NCT01412827|treadmill|treadmill
5053033|NCT01412827|persantine|persantine
5053034|NCT01412827|half-dose|half-dose
5053035|NCT01412827|radiotracer|radiotracer
5053036|NCT01412827|tetrofosmin|tetrofosmin
5053037|NCT01412827|Thallium|thallium
5053038|NCT01412827|cadmium zinc telluride|cadmium zinc telluride
5053039|NCT01412827|diagnostic|diagnostic
5053040|NCT01412827|prognostic|prognostic
5053041|NCT01412814|Total knee arthroplasty|total knee arthroplasty
5053042|NCT01412814|Total knee replacement|total knee replacement
5053043|NCT01412814|End-stage knee osteoarthritis|end-stage knee osteoarthritis
5053044|NCT01412814|Gait patterns|gait patterns
5053045|NCT01412814|Neuromuscular education|neuromuscular education
5053046|NCT01412801|Group B streptococcus|group b streptococcus
5053047|NCT01412801|GBS|gbs
5053048|NCT01412801|Vaccine|vaccine
5053049|NCT01412801|Prevention of group B streptococcus infection|prevention of group b streptococcus infection
5053050|NCT01412788|breast cancer|breast cancer
5053051|NCT01412788|Breast Conserving Surgery|breast conserving surgery
5053052|NCT01412788|Peri-areolar Incision|peri-areolar incision
5053053|NCT01412775|stress|stress
5053054|NCT01412775|burnout|burnout
5053055|NCT01412775|exhaustion|exhaustion
5053056|NCT01412762|Surgery|surgery
5053057|NCT01412762|interview|interview
5053058|NCT01412762|11-087|11-087
5053059|NCT01412749|registry|registry
5053060|NCT01412749|database|database
5053061|NCT01412749|eHNS|ehns
5053062|NCT01412749|Endoscopic Head and Neck Surgery|endoscopic head and neck surgery
5053063|NCT01412749|Transoral Endoscopic Surgery Trial|transoral endoscopic surgery trial
5053064|NCT01412749|TEST|test
5053065|NCT01412749|melanoma|melanoma
5053066|NCT01412749|head and neck surgery|head and neck surgery
5053067|NCT01412723|Iron Deficiency|iron deficiency
5053068|NCT01412723|Child, Preschool|child, preschool
5053069|NCT01412723|Dietary Iron|dietary iron
5053070|NCT01412723|Ferrous sulfate|ferrous sulfate
5053071|NCT01412723|Bis-glycino iron II|bis-glycino iron ii
5053072|NCT01412710|Type 2 Diabetes|type 2 diabetes
5053073|NCT01412710|Cholecalciferol|cholecalciferol
5053074|NCT01412710|Vitamin D|vitamin d
5053075|NCT01412710|Insulin resistance|insulin resistance
5053076|NCT01412710|Cardiovascular disease risk|cardiovascular disease risk
5053077|NCT01412710|Minorities|minorities
5053078|NCT01412697|Rural youth|rural youth
5053079|NCT01412697|Theory-based intervention|theory-based intervention
5053080|NCT01412697|Randomized by schools|randomized by schools
5053081|NCT01412697|Fruit and vegetable intake|fruit and vegetable intake
5053082|NCT01412697|Health classes|health classes
5053083|NCT01412671|Nexavar|nexavar
5053084|NCT01412671|unresectable or advanced renal cell carcinoma|unresectable or advanced renal cell carcinoma
5053085|NCT01412645|Obesity|obesity
5053086|NCT01412645|Inflammation|inflammation
5053087|NCT01412645|Metabolic Syndrome|metabolic syndrome
5053088|NCT01412645|Insulin sensitivity|insulin sensitivity
5053089|NCT01412645|Osteoporosis|osteoporosis
5053090|NCT01412645|Bone turnover|bone turnover
5053091|NCT01412645|Ectopic fat accumulation|ectopic fat accumulation
5053092|NCT01412645|Resveratrol|resveratrol
5053093|NCT01412619|Neurological Outcome|neurological outcome
5053094|NCT01412619|Intraoperative intracerebral Oxygen level|intraoperative intracerebral oxygen level
5053095|NCT01412619|Mean arterial blood pressure|mean arterial blood pressure
5053096|NCT01412619|Central venous blood pressure|central venous blood pressure
5053097|NCT01412619|Cardiac output|cardiac output
5053098|NCT01412619|Serum Lactate|serum lactate
5053099|NCT01412619|Venous oxygen saturation|venous oxygen saturation
5053100|NCT01412619|Fluid balance|fluid balance
5053101|NCT01412606|Unexplained infertility-endometrial scratching|unexplained infertility-endometrial scratching
5053102|NCT01412606|effect of endometrial biopsy (scratching) on clinical pregnancy rates in women with unexplained infertility|effect of endometrial biopsy (scratching) on clinical pregnancy rates in women with unexplained infertility
5053103|NCT01412567|Hepatitis B|hepatitis b
5053104|NCT01412567|HBsAg|hbsag
5053105|NCT01412567|Antenatal|antenatal
5053106|NCT01412567|Pregnancy|pregnancy
5053107|NCT01412567|Vertical transmission|vertical transmission
5053108|NCT01412567|Placenta|placenta
5053109|NCT01412567|HBV DNA|hbv dna
5053413|NCT01411397|Prosthesis|prosthesis
5053110|NCT01412554|Insulin resistance|insulin resistance
5053111|NCT01412554|Diabetes mellitus|diabetes mellitus
5053112|NCT01412554|Adipositas|adipositas
5053113|NCT01412541|Arms|arms
5053114|NCT01412541|Experimental|experimental
5053115|NCT01412541|Drug Coated Angioplasty Balloon|drug coated angioplasty balloon
5053116|NCT01412541|Active Comparator|active comparator
5053117|NCT01412541|Standard Angioplasty Balloon|standard angioplasty balloon
5053118|NCT01412515|mTOR inhibitors|mtor inhibitors
5053119|NCT01412502|Tissue Donors|tissue donors
5053120|NCT01412502|Tissue and Organ Procurement|tissue and organ procurement
5053121|NCT01412502|Brain death|brain death
5053122|NCT01412502|Withdrawal of life support|withdrawal of life support
5053123|NCT01412489|Uterine synechiae|uterine synechiae
5053124|NCT01412489|HyalobarrierR Gel Endo|hyalobarrierr gel endo
5053125|NCT01412489|Operative hysteroscopy|operative hysteroscopy
5053126|NCT01412489|submucous myoma|submucous myoma
5053254|NCT01412034|ApoA-1|apoa-1
5053127|NCT01412450|symptomatic popliteal artery stenosis or occlusion|symptomatic popliteal artery stenosis or occlusion
5053128|NCT01412437|PKU|pku
5053129|NCT01412437|MRI|mri
5053130|NCT01412437|neurocognition|neurocognition
5053131|NCT01412437|sapropterin dihydrochloride|sapropterin dihydrochloride
5053132|NCT01412424|acromegaly|acromegaly
5053133|NCT01412424|IGF-1|igf-1
5053134|NCT01412424|growth hormone|growth hormone
5053135|NCT01412424|Octreolin|octreolin
5053136|NCT01412424|octreotide|octreotide
5053137|NCT01412424|somatostatin analog|somatostatin analog
5053138|NCT01412411|Anemia|anemia
5053139|NCT01412411|Growth|growth
5053140|NCT01412411|Infants|infants
5053141|NCT01412411|Focus of the study is to assess the level of anemia and growth indicators among the infants|focus of the study is to assess the level of anemia and growth indicators among the infants
5053142|NCT01412398|Fosrenol|fosrenol
5053143|NCT01412398|Hyperphosphatemia|hyperphosphatemia
5053144|NCT01412398|Continuous Cyclic Peritoneal Dialysis|continuous cyclic peritoneal dialysis
5053145|NCT01412372|Irritable Bowel Syndrome|irritable bowel syndrome
5053146|NCT01412372|Diarrhea|diarrhea
5053147|NCT01412372|Mesalamine|mesalamine
5053148|NCT01412372|Gastroenteritis|gastroenteritis
5053149|NCT01412372|abdominal pain|abdominal pain
5053150|NCT01412372|hypersensitivity|hypersensitivity
5053151|NCT01412359|TPN Cholestasis|tpn cholestasis
5053152|NCT01412346|human|human
5053153|NCT01412346|clinical trial|clinical trial
5053154|NCT01412346|dietary intervention study|dietary intervention study
5053155|NCT01412346|blood pressure|blood pressure
5053156|NCT01412346|cardiovascular biomarkers|cardiovascular biomarkers
5053157|NCT01412346|nutritional biomarkers|nutritional biomarkers
5053158|NCT01412346|gene expression|gene expression
5053159|NCT01412307|Hodgkin Lymphoma|hodgkin lymphoma
5053160|NCT01412307|Lenalidomide|lenalidomide
5053161|NCT01412307|Bendamustine|bendamustine
5053162|NCT01412307|Salvage therapy|salvage therapy
5053163|NCT01412307|Palliation|palliation
5053164|NCT01412294|gastric cancer|gastric cancer
5053165|NCT01412294|recurrent gastric cancer|recurrent gastric cancer
5053166|NCT01412294|adenocarcinoma of the stomach|adenocarcinoma of the stomach
5053167|NCT01412294|capecitabine|capecitabine
5053168|NCT01412294|xp|xp
5053169|NCT01412281|Influenza|influenza
5053170|NCT01412281|Virus|virus
5053171|NCT01412281|Vaccination|vaccination
5053172|NCT01412281|Immunisation|immunisation
5053173|NCT01412268|Obesity|obesity
5053174|NCT01412268|Bariatric surgery|bariatric surgery
5053175|NCT01412268|Behavioral changes|behavioral changes
5053176|NCT01412268|Eating habits|eating habits
5053177|NCT01412268|Eating addiction|eating addiction
5053178|NCT01412242|Deep vein thrombosis|deep vein thrombosis
5053179|NCT01412242|Ultrasonography|ultrasonography
5053180|NCT01412242|Pulmonary embolism|pulmonary embolism
5053181|NCT01412242|D-dimer|d-dimer
5053182|NCT01412242|Pre-test probability|pre-test probability
5053183|NCT01412229|Head and neck cancer|head and neck cancer
5053184|NCT01412229|Phase II|phase ii
5053185|NCT01412229|Locally advanced|locally advanced
5053186|NCT01412229|Squamous Cell|squamous cell
5053187|NCT01412229|Carboplatin|carboplatin
5053188|NCT01412229|Nab-paclitaxel|nab-paclitaxel
5053189|NCT01412229|Abraxane|abraxane
5053190|NCT01412229|Cetuximab|cetuximab
5053191|NCT01412229|Induction|induction
5053192|NCT01412229|Chemotherapy|chemotherapy
5053193|NCT01412216|Sedentarism|sedentarism
5053194|NCT01412216|Physical inactivity|physical inactivity
5053195|NCT01412216|Fish oil|fish oil
5053196|NCT01412216|Omega-3 fatty acids|omega-3 fatty acids
5053197|NCT01412216|Endothelial dysfunction|endothelial dysfunction
5053198|NCT01412216|Insulin resistance|insulin resistance
5053199|NCT01412216|Metabolic syndrome|metabolic syndrome
5053200|NCT01412216|peripheral arterial disease|peripheral arterial disease
5053201|NCT01412203|Physical activity|physical activity
5053202|NCT01412203|Healthy weight|healthy weight
5053203|NCT01412203|Healthy eating|healthy eating
5053204|NCT01412203|Physical fitness|physical fitness
5053205|NCT01412203|Children|children
5053206|NCT01412203|School based|school based
5053207|NCT01412203|Community based|community based
5053208|NCT01412203|Obesity|obesity
5053209|NCT01412203|Health promotion|health promotion
5053210|NCT01412203|Socio-ecological|socio-ecological
5053211|NCT01412203|Environment based|environment based
5053212|NCT01412190|Skin rejuvenation|skin rejuvenation
5053213|NCT01412177|Meniere's Disease|meniere's disease
5053214|NCT01412177|Vertigo|vertigo
5053215|NCT01412177|Definitive vertigo|definitive vertigo
5053216|NCT01412177|Vertigo episodes|vertigo episodes
5053217|NCT01412177|Vertigo frequency|vertigo frequency
5053218|NCT01412177|Tinnitus|tinnitus
5053219|NCT01412177|Hearing loss|hearing loss
5053220|NCT01412177|Aural fullness|aural fullness
5053221|NCT01412164|DES|des
5053222|NCT01412164|CAD|cad
5053223|NCT01412164|FIREHAWK|firehawk
5053224|NCT01412164|MicroPort|microport
5053225|NCT01412164|PCI|pci
5053226|NCT01412151|Symptomatic|symptomatic
5053227|NCT01412151|Huntington's Disease|huntington's disease
5053228|NCT01412151|HD|hd
5053229|NCT01412125|Biomarkers|biomarkers
5053230|NCT01412125|Genetic polymorphism|genetic polymorphism
5053231|NCT01412125|Neuroimaging markers|neuroimaging markers
5053232|NCT01412125|Neuropsychology|neuropsychology
5053233|NCT01412099|Exercise|exercise
5053234|NCT01412099|Fast Foods|fast foods
5053235|NCT01412099|Fruits|fruits
5053236|NCT01412099|Vegetables|vegetables
5053237|NCT01412099|Beverages|beverages
5053238|NCT01412099|Non-traditional college students|non-traditional college students
5053239|NCT01412099|Motivational Interviewing|motivational interviewing
5053240|NCT01412099|Peer Counselors|peer counselors
5053241|NCT01412099|Cancer Prevention|cancer prevention
5053242|NCT01412073|caesarean section, intrapartum haemorrhage|caesarean section, intrapartum haemorrhage
5053243|NCT01412060|Schizophrenia|schizophrenia
5053244|NCT01412060|Schizophrenic disorder|schizophrenic disorder
5053245|NCT01412047|Paroxysmal Nocturnal Hemoglobinuria|paroxysmal nocturnal hemoglobinuria
5053246|NCT01412047|PNH|pnh
5053247|NCT01412047|Human Anti-Human Antibody|human anti-human antibody
5053248|NCT01412047|HAHA|haha
5053249|NCT01412047|Soliris|soliris
5053250|NCT01412047|eculizumab|eculizumab
5053251|NCT01412034|Homozygous Familial Hypercholesterolemia|homozygous familial hypercholesterolemia
5053252|NCT01412034|Familial Hypercholesterolemia|familial hypercholesterolemia
5053253|NCT01412034|HDL mimetic|hdl mimetic
5053255|NCT01412021|Arthritis, Juvenile Rheumatoid|arthritis, juvenile rheumatoid
5053256|NCT01412008|MRI|mri
5053257|NCT01412008|Magnetic Resonance Imaging|magnetic resonance imaging
5053258|NCT01412008|Botox|botox
5053259|NCT01412008|botulinum toxin|botulinum toxin
5053260|NCT01412008|neurological|neurological
5053261|NCT01412008|stroke|stroke
5053262|NCT01412008|spasticity|spasticity
5053263|NCT01412008|muscle stiffness|muscle stiffness
5053264|NCT01412008|diffusion|diffusion
5053265|NCT01412008|Weill Cornell|weill cornell
5053266|NCT01412008|New York Presbyterian Hospital|new york presbyterian hospital
5053267|NCT01412008|O'Dell|o'dell
5053268|NCT01411995|intrauterine device|intrauterine device
5053269|NCT01411995|pain|pain
5053270|NCT01411995|lidocaine gel|lidocaine gel
5053271|NCT01411982|PACAP (pituitary adenylate cyclase-activating polypeptide)|pacap (pituitary adenylate cyclase-activating polypeptide)
5053272|NCT01411982|Nephrotic syndrome|nephrotic syndrome
5053273|NCT01411982|Thrombosis|thrombosis
5053274|NCT01411982|Platelets|platelets
5053275|NCT01411969|external nasal dilator strip|external nasal dilator strip
5053276|NCT01411969|nasal valve|nasal valve
5053277|NCT01411969|acoustic rhinometry|acoustic rhinometry
5053278|NCT01411956|Health Behavior Theory|health behavior theory
5053279|NCT01411956|Patient Education|patient education
5053280|NCT01411956|Hypertension|hypertension
5053281|NCT01411956|Health beliefs related to hypertension and hypertension treatment|health beliefs related to hypertension and hypertension treatment
5053282|NCT01411943|Epigenetics|epigenetics
5053283|NCT01411943|Inflammatory|inflammatory
5053284|NCT01411943|Psychoneurologic Symptoms|psychoneurologic symptoms
5053285|NCT01411943|Cognitive Dysfunction|cognitive dysfunction
5053286|NCT01411943|Pain|pain
5053287|NCT01411943|Fatigue|fatigue
5053288|NCT01411943|Sleep Disturbance|sleep disturbance
5053289|NCT01411943|Depression|depression
5053290|NCT01411943|Depressive Symptoms|depressive symptoms
5053291|NCT01411943|Anxiety|anxiety
5053292|NCT01411943|Breast Cancer|breast cancer
5053293|NCT01411930|Insulin resistance|insulin resistance
5053294|NCT01411930|Antipsychotics|antipsychotics
5053295|NCT01411930|Olanzapine|olanzapine
5053296|NCT01411930|Aripiprazole|aripiprazole
5053297|NCT01411917|surgical stomas|surgical stomas
5053298|NCT01411917|Nerve block|nerve block
5053299|NCT01411904|Leukemia|leukemia
5053300|NCT01411904|magnetic needle|magnetic needle
5053301|NCT01411904|magnetic nanoparticles|magnetic nanoparticles
5053302|NCT01411904|CD34|cd34
5053303|NCT01411891|Arthroplasty|arthroplasty
5053304|NCT01411891|Infection Control|infection control
5053305|NCT01411878|Teen Pregnancy Prevention|teen pregnancy prevention
5053306|NCT01411865|Pragmatic randomized controlled trial|pragmatic randomized controlled trial
5053307|NCT01411865|Cardiovascular risk reduction|cardiovascular risk reduction
5053308|NCT01411865|Knowledge translation|knowledge translation
5053309|NCT01411865|Clinical practice guidelines|clinical practice guidelines
5053310|NCT01411865|Administrative databases|administrative databases
5053311|NCT01411852|fluid volume resuscitation|fluid volume resuscitation
5053312|NCT01411852|trauma|trauma
5053313|NCT01411852|hemorrhagic shock|hemorrhagic shock
5053314|NCT01411839|Depression|depression
5053315|NCT01411839|Latinos|latinos
5053316|NCT01411839|Adherence|adherence
5053317|NCT01411839|Cognitive-Behavioral Therapy|cognitive-behavioral therapy
5053318|NCT01411839|HIV/AIDS|hiv/aids
5053319|NCT01411826|Colon cancer screening|colon cancer screening
5053320|NCT01411787|Breast cancer|breast cancer
5053321|NCT01411787|neoadjuvant chemotherapy|neoadjuvant chemotherapy
5053322|NCT01411787|exercise|exercise
5053323|NCT01411787|Ki-67|ki-67
5053324|NCT01411774|Obsessive-compulsive disorder|obsessive-compulsive disorder
5053325|NCT01411774|OCD|ocd
5053326|NCT01411761|indirect hyperbilirubinemia|indirect hyperbilirubinemia
5053327|NCT01411761|very low birth weight infants|very low birth weight infants
5053328|NCT01411722|Electrical Activity of Diaphragm|electrical activity of diaphragm
5053329|NCT01411722|Weaning outcome|weaning outcome
5053330|NCT01411722|NAVA|nava
5053331|NCT01411683|Cost estimates|cost estimates
5053332|NCT01411683|Complete Denture|complete denture
5053333|NCT01411683|Dental Economics|dental economics
5053334|NCT01411683|Dental Implants|dental implants
5053335|NCT01411683|Dental Prosthesis, Implant-Supported|dental prosthesis, implant-supported
5053336|NCT01411683|Denture Retention|denture retention
5053337|NCT01411683|Edentulous|edentulous
5053338|NCT01411683|Edentulism|edentulism
5053339|NCT01411683|Mini dental implant|mini dental implant
5053340|NCT01411683|Oral Health-Related Quality of Life|oral health-related quality of life
5053341|NCT01411683|Overdenture|overdenture
5053342|NCT01411683|Patient Acceptance of Health Care|patient acceptance of health care
5053343|NCT01411683|Quality of Health Care|quality of health care
5053344|NCT01411683|Quality of Life|quality of life
5053345|NCT01411683|Patient Satisfaction|patient satisfaction
5053346|NCT01411670|Human Protein C|human protein c
5053347|NCT01411670|Activated protein C|activated protein c
5053348|NCT01411670|Microcirculation|microcirculation
5053349|NCT01411670|Septic Shock|septic shock
5053350|NCT01411670|Sepsis|sepsis
5053351|NCT01411644|POF|pof
5053352|NCT01411644|IOF|iof
5053353|NCT01411644|Poor response|poor response
5053354|NCT01411644|early menopause|early menopause
5053355|NCT01411644|Primary amenorrhea|primary amenorrhea
5053356|NCT01411631|Polyphenols|polyphenols
5053357|NCT01411631|Cognition|cognition
5053358|NCT01411631|Cognitive function|cognitive function
5053359|NCT01411631|Driving performance|driving performance
5053360|NCT01411631|Stress|stress
5053361|NCT01411618|Antiplaque agents|antiplaque agents
5053362|NCT01411618|chemical plaque control|chemical plaque control
5053363|NCT01411618|oral hygiene|oral hygiene
5053364|NCT01411618|essential oils|essential oils
5053365|NCT01411618|alcohol|alcohol
5053366|NCT01411618|mouthwash|mouthwash
5053367|NCT01411605|Obesity|obesity
5053368|NCT01411605|Adolescent|adolescent
5053369|NCT01411605|Exercise training|exercise training
5053370|NCT01411605|Exercise tolerance|exercise tolerance
5053371|NCT01411592|All-Ceramic|all-ceramic
5053372|NCT01411592|Resin-bonded Fixed Dental Protheses|resin-bonded fixed dental protheses
5053373|NCT01411592|Single Retainer|single retainer
5053374|NCT01411592|Randomized Clinical Trial|randomized clinical trial
5053375|NCT01411592|Resin Bond|resin bond
5053376|NCT01411592|Bonding System|bonding system
5053377|NCT01411579|liver|liver
5053378|NCT01411579|metastases|metastases
5053379|NCT01411579|hepatocarcinoma|hepatocarcinoma
5053380|NCT01411579|MR|mr
5053381|NCT01411579|DWI|dwi
5053382|NCT01411579|chemotherapy|chemotherapy
5053383|NCT01411566|KLIPS|klips
5053384|NCT01411553|ICU|icu
5053385|NCT01411553|Telemetry|telemetry
5053386|NCT01411553|ECG lead wire monitoring|ecg lead wire monitoring
5053387|NCT01411553|Infection|infection
5053388|NCT01411553|Nuisance alarms|nuisance alarms
5053389|NCT01411540|Body composition|body composition
5053390|NCT01411540|Health markers|health markers
5053391|NCT01411540|Diet|diet
5053392|NCT01411527|Hormones|hormones
5053393|NCT01411527|Endocrine Disrupters|endocrine disrupters
5053394|NCT01411527|Polymorphism, Genetic|polymorphism, genetic
5053395|NCT01411514|Relapsing remittent multipse sclerosis|relapsing remittent multipse sclerosis
5053396|NCT01411514|Secondary progressive multiple sclerosis|secondary progressive multiple sclerosis
5053397|NCT01411514|Clinically isolated syndrome|clinically isolated syndrome
5053398|NCT01411514|Primary progressive multiple sclerosis|primary progressive multiple sclerosis
5053399|NCT01411501|Acupuncture|acupuncture
5053400|NCT01411501|Functional constipation|functional constipation
5053401|NCT01411488|Focus: anal erosion|focus: anal erosion
5053402|NCT01411449|Primovist|primovist
5053403|NCT01411449|MRI agent|mri agent
5053404|NCT01411436|Nexavar|nexavar
5053405|NCT01411436|unresectable hepatocellular carcinoma|unresectable hepatocellular carcinoma
5053406|NCT01411423|Nexavar|nexavar
5053407|NCT01411423|Unresectable or advanced renal cell carcinoma|unresectable or advanced renal cell carcinoma
5053408|NCT01411410|phase I|phase i
5053409|NCT01411410|phosphatidylinositol 3΄-kinase (PI3K)|phosphatidylinositol 3΄-kinase (pi3k)
5053410|NCT01411410|paclitaxel|paclitaxel
5053411|NCT01411410|Maximum tolerated Dose|maximum tolerated dose
5053414|NCT01411397|Recurrence|recurrence
5053415|NCT01411397|Strangulation|strangulation
5053416|NCT01411384|Keratoconus (KC)|keratoconus (kc)
5053417|NCT01411384|Corneal collagen cross-linking (CXL)|corneal collagen cross-linking (cxl)
5053418|NCT01411384|Corneal hysteresis (CH)|corneal hysteresis (ch)
5053419|NCT01411384|Corneal resistance factor (CRF)|corneal resistance factor (crf)
5053420|NCT01411384|Ocular Response Analyzer (ORA)|ocular response analyzer (ora)
5053421|NCT01411371|Atrial fibrillation|atrial fibrillation
5053422|NCT01411371|Heart failure|heart failure
5053423|NCT01411371|Catheter ablation|catheter ablation
5053424|NCT01411358|influenza|influenza
5053425|NCT01411358|vaccine|vaccine
5053426|NCT01411358|immunogenicity|immunogenicity
5053427|NCT01411345|Prostate Cancer|prostate cancer
5053428|NCT01411345|Prostate Adenocarcinoma|prostate adenocarcinoma
5053429|NCT01411332|Prostate Cancer|prostate cancer
5053430|NCT01411332|Prostate Adenocarcinoma|prostate adenocarcinoma
5053431|NCT01411319|Prostate Cancer|prostate cancer
5053432|NCT01411319|Prostate Adenocarcinoma|prostate adenocarcinoma
5053433|NCT01411293|cardiovascular disease|cardiovascular disease
5053434|NCT01411293|oxidative stress|oxidative stress
5053435|NCT01411293|dairy consumption|dairy consumption
5053436|NCT01411293|metabolic syndrome|metabolic syndrome
5053437|NCT01411293|obesity|obesity
5053438|NCT01411293|endothelial function|endothelial function
5053439|NCT01411267|Relapse|relapse
5053440|NCT01411267|Lymphoblastic|lymphoblastic
5053441|NCT01411267|Leukemia|leukemia
5053442|NCT01411267|AC220|ac220
5053443|NCT01411267|Refractory|refractory
5053444|NCT01411267|Myelogenous|myelogenous
5053445|NCT01411267|Acute|acute
5053446|NCT01411267|Childhood|childhood
5053447|NCT01411267|Pediatric|pediatric
5053448|NCT01411267|ALL|all
5053449|NCT01411267|AML|aml
5053450|NCT01411254|DME|dme
5053451|NCT01411241|Dengue|dengue
5053452|NCT01411241|Dengue Hemorrhagic Fever|dengue hemorrhagic fever
5053453|NCT01411241|CYD Dengue Vaccines|cyd dengue vaccines
5053454|NCT01411241|Pentaxim™|pentaxim™
5053455|NCT01411228|Gaucher disease|gaucher disease
5053456|NCT01411228|pediatrics|pediatrics
5053457|NCT01411215|Rheumatoid arthritis|rheumatoid arthritis
5053458|NCT01411215|ankylosing spondylitis|ankylosing spondylitis
5053459|NCT01411215|observational study|observational study
5053460|NCT01411202|Malignant Pleural Effusion|malignant pleural effusion
5053461|NCT01411202|Doxycycline|doxycycline
5053462|NCT01411202|Pleurodesis|pleurodesis
5053463|NCT01411202|Pleurx catheter|pleurx catheter
5053464|NCT01411189|therapeutic upper gastrointestinal endoscopy|therapeutic upper gastrointestinal endoscopy
5053465|NCT01411189|percutaneous endoscopic gastrostomy|percutaneous endoscopic gastrostomy
5053466|NCT01411189|endoscopic mucosal resection|endoscopic mucosal resection
5053467|NCT01411189|endoscopic submucosal dissection|endoscopic submucosal dissection
5053468|NCT01411189|PEG|peg
5053469|NCT01411189|EMR|emr
5053470|NCT01411189|ESD|esd
5053471|NCT01411189|endoscopic hemostasis|endoscopic hemostasis
5053472|NCT01411176|upper gastrointestinal endoscopy|upper gastrointestinal endoscopy
5053473|NCT01411176|suspected gastric cancer|suspected gastric cancer
5053474|NCT01411163|Premanifest|premanifest
5053475|NCT01411163|At-Risk|at-risk
5053476|NCT01411163|Huntington's Disease|huntington's disease
5053477|NCT01411163|HD|hd
5053478|NCT01411150|Premanifest|premanifest
5053479|NCT01411150|At-Risk|at-risk
5053480|NCT01411150|Huntington's Disease|huntington's disease
5053481|NCT01411150|HD|hd
5053482|NCT01411124|gabapentin|gabapentin
5053483|NCT01411124|restless leg syndrome|restless leg syndrome
5053484|NCT01411111|Drug-drug interaction|drug-drug interaction
5053485|NCT01411111|rosuvastatin|rosuvastatin
5053486|NCT01411111|asthma|asthma
5053487|NCT01411111|FLAP inhibitor|flap inhibitor
5053488|NCT01411085|Schizophrenia|schizophrenia
5053489|NCT01411085|Alcoholism|alcoholism
5053490|NCT01411085|Dual Diagnosis|dual diagnosis
5053491|NCT01411085|Desipramine|desipramine
5053492|NCT01411085|Risperidone|risperidone
5053493|NCT01411072|Biomarker directed adjuvant chemotherapy|biomarker directed adjuvant chemotherapy
5053494|NCT01411072|resected pancreas cancer|resected pancreas cancer
5053495|NCT01411059|yoga biomechanics seniors|yoga biomechanics seniors
5053496|NCT01411046|Glucocorticoid|glucocorticoid
5053497|NCT01411046|polymorphism|polymorphism
5053498|NCT01411046|Glucocorticoid receptor gene|glucocorticoid receptor gene
5053499|NCT01411046|rheumatoid arthritis|rheumatoid arthritis
5053500|NCT01411046|adrenal insufficiency|adrenal insufficiency
5053501|NCT01411046|prednisolone treatment|prednisolone treatment
5053502|NCT01411007|Nicotine|nicotine
5053503|NCT01411007|Cigarettes|cigarettes
5053504|NCT01411007|Smoker|smoker
5053505|NCT01411007|realtime fMRI|realtime fmri
5053506|NCT01411007|brain imaging|brain imaging
5053507|NCT01411007|imaging|imaging
5053508|NCT01410994|glomerular filtration rate|glomerular filtration rate
5053509|NCT01410955|probiotics|probiotics
5053510|NCT01410955|diarrhoea|diarrhoea
5053511|NCT01410955|prevention|prevention
5053512|NCT01410955|colon cancer|colon cancer
5053513|NCT01410955|irinotecan|irinotecan
5053514|NCT01410942|Prostate Cancer|prostate cancer
5053515|NCT01410942|Multimodal Therapy|multimodal therapy
5053517|NCT01410942|Fatigue|fatigue
5053518|NCT01410942|Cognitive Behavioral Therapy|cognitive behavioral therapy
5053519|NCT01410942|CBT|cbt
5053520|NCT01410942|Radiation therapy|radiation therapy
5053521|NCT01410942|Radiotherapy|radiotherapy
5053522|NCT01410942|RT|rt
5053523|NCT01410942|Functional Assessment of Chronic Illness Therapy - Fatigue|functional assessment of chronic illness therapy - fatigue
5053524|NCT01410942|FACIT-F|facit-f
5053525|NCT01410942|Androgen deprivation therapy|androgen deprivation therapy
5053526|NCT01410942|Methylphenidate|methylphenidate
5053527|NCT01410942|Methylphenidate Hydrochloride|methylphenidate hydrochloride
5053528|NCT01410942|Ritalin|ritalin
5053529|NCT01410942|Concerta|concerta
5053530|NCT01410942|Placebo|placebo
5053531|NCT01410942|Sugar Pill|sugar pill
5053532|NCT01410929|multiple myeloma|multiple myeloma
5053533|NCT01410929|VCF|vcf
5053534|NCT01410929|Vertebral Compression Fracture|vertebral compression fracture
5053535|NCT01410929|Spine|spine
5053536|NCT01410929|Kyphoplasty|kyphoplasty
5053537|NCT01410929|Back pain|back pain
5053538|NCT01410929|Cancer|cancer
5053539|NCT01410916|STEC-HUS|stec-hus
5053540|NCT01410916|Shiga-like toxin-producing Escherichia Coli Hemolytic-Uremic Syndrome|shiga-like toxin-producing escherichia coli hemolytic-uremic syndrome
5053541|NCT01410916|uncontrolled complement activation|uncontrolled complement activation
5053542|NCT01410864|cerebrospinal fluid leaks|cerebrospinal fluid leaks
5053543|NCT01410864|dural opening|dural opening
5053544|NCT01410864|dural sealing|dural sealing
5053545|NCT01410838|Obesity|obesity
5053546|NCT01410838|Food preferences|food preferences
5053547|NCT01410838|Eating Behavior|eating behavior
5053548|NCT01410825|WAS|was
5053549|NCT01410825|Wiskott|wiskott
5053550|NCT01410825|Gene Transfer|gene transfer
5053551|NCT01410825|Gene Therapy|gene therapy
5053552|NCT01410812|Interest in exercising more|interest in exercising more
5053553|NCT01410799|Growth Hormone Releasing Hormone|growth hormone releasing hormone
5053554|NCT01410799|Growth Hormone Insufficiency|growth hormone insufficiency
5053555|NCT01410799|Aging|aging
5053556|NCT01410799|Growth Hormone|growth hormone
5053557|NCT01410799|Physiologic Effects of Drugs|physiologic effects of drugs
5053558|NCT01410799|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists
5053559|NCT01410799|Hormones|hormones
5053560|NCT01410760|Imaging study|imaging study
5053561|NCT01410760|Perfusion Computerised Tomography|perfusion computerised tomography
5053562|NCT01410747|long-term treatment|long-term treatment
5053563|NCT01410747|tacrolimus|tacrolimus
5053564|NCT01410747|renal failure|renal failure
5053565|NCT01410734|cholecystectomy|cholecystectomy
5053566|NCT01410734|chronic right upper quadrant pain|chronic right upper quadrant pain
5053567|NCT01410721|TBI|tbi
5053568|NCT01410721|PTSD|ptsd
5053569|NCT01410721|Veterans|veterans
5053570|NCT01410708|Human Breast Cancer Tissue|human breast cancer tissue
5053571|NCT01410708|Dasatinin|dasatinin
5053572|NCT01410695|Rheumatoid Arthritis|rheumatoid arthritis
5053573|NCT01410695|RA|ra
5053574|NCT01410695|masitinib|masitinib
5053575|NCT01410695|DMARD|dmard
5053576|NCT01410695|methotrexate|methotrexate
5053577|NCT01410682|oral hygiene|oral hygiene
5053578|NCT01410682|ventilator-associated pneumonia|ventilator-associated pneumonia
5053579|NCT01410682|infection control|infection control
5053580|NCT01410682|intensive care|intensive care
5053581|NCT01410682|pediatric nursing|pediatric nursing
5053582|NCT01410682|pediatrics|pediatrics
5053583|NCT01410669|Self-efficacy|self-efficacy
5053584|NCT01410669|Intimate partner violence|intimate partner violence
5053585|NCT01410669|Randomized clinical trial|randomized clinical trial
5053586|NCT01410669|Depression|depression
5053587|NCT01410656|Survivors|survivors
5053588|NCT01410643|puberty|puberty
5053589|NCT01410643|body composition|body composition
5053590|NCT01410643|metabolism|metabolism
5053591|NCT01410643|obesity|obesity
5053592|NCT01410643|optimization of body composition|optimization of body composition
5053593|NCT01410643|pubertal transition|pubertal transition
5053594|NCT01410604|Metformin|metformin
5053595|NCT01410604|Obesity|obesity
5053596|NCT01410604|Insulin resistance|insulin resistance
5053597|NCT01410604|Interleukin six|interleukin six
5053598|NCT01410604|Adiponectin|adiponectin
5053599|NCT01410604|High sensitivity C reactive protein.|high sensitivity c reactive protein.
5053600|NCT01410604|Tumour Necrosis Factor alpha|tumour necrosis factor alpha
5053601|NCT01410591|transjugular intrahepatic portosystemic shunt|transjugular intrahepatic portosystemic shunt
5053602|NCT01410591|TIPS|tips
5053603|NCT01410591|liver cirrhosis|liver cirrhosis
5053604|NCT01410591|variceal bleeding|variceal bleeding
5053605|NCT01410591|8- or 10-mm covered stent|8- or 10-mm covered stent
5053606|NCT01410578|sTRE-1|stre-1
5053607|NCT01410578|PCT|pct
5053608|NCT01410578|CRP|crp
5053609|NCT01410578|sepsis|sepsis
5053610|NCT01410578|bacteremia|bacteremia
5053611|NCT01410578|FUO|fuo
5053612|NCT01410578|diagnosis|diagnosis
5053613|NCT01410578|prognosis|prognosis
5053614|NCT01410565|Bladder Cancer|bladder cancer
5053615|NCT01410565|Non-Muscle Invasive Bladder Cancer|non-muscle invasive bladder cancer
5053616|NCT01410565|NMIBC|nmibc
5053617|NCT01410565|Apaziquone|apaziquone
5053618|NCT01410565|EOquin|eoquin
5053619|NCT01410565|GU Cancer|gu cancer
5053620|NCT01410565|TURBT|turbt
5053621|NCT01410552|Primary prevention|primary prevention
5053622|NCT01410552|Secondary prevention|secondary prevention
5053623|NCT01410539|Stent Thrombosis|stent thrombosis
5053624|NCT01410539|Percutaneous Coronary Intervention|percutaneous coronary intervention
5053625|NCT01410539|Bare Metal Stent|bare metal stent
5053626|NCT01410539|Drug Eluting Stent|drug eluting stent
5053627|NCT01410539|Residual Platelet Reactivity|residual platelet reactivity
5053628|NCT01410539|Optical Coherence Tomography|optical coherence tomography
5053629|NCT01410539|OCT|oct
5053630|NCT01410526|VAC|vac
5053631|NCT01410526|Severe abdominal sepsis|severe abdominal sepsis
5053632|NCT01410526|Peritoneal immune reaction|peritoneal immune reaction
5053633|NCT01410526|Peritonitis|peritonitis
5053634|NCT01410526|Immune peritoneal reaction when abdominal sepsis is treated with VAC|immune peritoneal reaction when abdominal sepsis is treated with vac
5053635|NCT01410500|multiple myeloma|multiple myeloma
5053636|NCT01410487|pulmonary circulation|pulmonary circulation
5053637|NCT01410474|Meningococcal|meningococcal
5053638|NCT01410474|ACWY|acwy
5053639|NCT01410474|bacterial meningitis|bacterial meningitis
5053640|NCT01410474|conjugate vaccine|conjugate vaccine
5053641|NCT01410474|healthy|healthy
5053642|NCT01410474|children|children
5053643|NCT01410474|adolescents|adolescents
5053644|NCT01410474|Taiwan|taiwan
5053645|NCT01410461|painful bladder|painful bladder
5053646|NCT01410461|physical therapy|physical therapy
5053647|NCT01410461|levator ani|levator ani
5053648|NCT01410448|Immunosuppression|immunosuppression
5053649|NCT01410448|Kidney transplantation|kidney transplantation
5053650|NCT01410448|everolimus|everolimus
5053651|NCT01410448|safety|safety
5053652|NCT01410422|COPD|copd
5053653|NCT01410422|Bronchiectasis|bronchiectasis
5053654|NCT01410422|Metabolomics|metabolomics
5053655|NCT01410409|Osteoarthritis, Knee|osteoarthritis, knee
5053656|NCT01410409|Treatment Outcome|treatment outcome
5053657|NCT01410409|Time Factors|time factors
5053658|NCT01410409|Arthroplasty, Replacement|arthroplasty, replacement
5053659|NCT01410409|Rehabilitation|rehabilitation
5053660|NCT01410409|Combined Modality Therapy|combined modality therapy
5053661|NCT01410409|Middle Aged|middle aged
5053662|NCT01410409|Aged|aged
5053663|NCT01410409|Aged, 80 and over|aged, 80 and over
5053664|NCT01410409|Male|male
5053665|NCT01410409|Female|female
5053666|NCT01410409|Humans|humans
5053667|NCT01410409|Analysis of Variance|analysis of variance
5053668|NCT01410396|Atrial Fibrillation|atrial fibrillation
5053669|NCT01410396|Stroke|stroke
5053670|NCT01410383|hypercholesterolemia,|hypercholesterolemia,
5053671|NCT01410383|dyslipidemia,|dyslipidemia,
5053672|NCT01410383|thyroid,|thyroid,
5053673|NCT01410383|safety,|safety,
5053674|NCT01410383|Heterozygous Familial Hypercholesterolaemia|heterozygous familial hypercholesterolaemia
5053675|NCT01410383|coronary artery disease|coronary artery disease
5053676|NCT01410370|Endostar|endostar
5053677|NCT01410370|Radiotherapy|radiotherapy
5053678|NCT01410370|Brain Metastases|brain metastases
5053679|NCT01410357|serious mental illness|serious mental illness
5053680|NCT01410357|diabetes|diabetes
5053681|NCT01410344|HIV|hiv
5053682|NCT01410344|ALL|all
5053683|NCT01410344|AML|aml
5053684|NCT01410344|MDS|mds
5053685|NCT01410344|Non-Hodgkin Lymphoma|non-hodgkin lymphoma
5053686|NCT01410331|CLI|cli
5053687|NCT01410331|peripheral vascular disease|peripheral vascular disease
5053688|NCT01410331|PVD|pvd
5053689|NCT01410331|PAD|pad
5053690|NCT01410331|SDF-1|sdf-1
5053691|NCT01410318|Atherosclerosis|atherosclerosis
5053692|NCT01410318|PESA|pesa
5053693|NCT01410318|Subclinical|subclinical
5053694|NCT01410318|Cardiovascular diseases|cardiovascular diseases
5053695|NCT01410318|Coronary disease|coronary disease
5053696|NCT01410318|Heart diseases|heart diseases
5053697|NCT01410318|Heart Failure|heart failure
5053698|NCT01410318|Myocardial Infarction|myocardial infarction
5053699|NCT01410318|Stroke|stroke
5053700|NCT01410318|Arteriosclerosis|arteriosclerosis
5053701|NCT01410305|Vitamin D Deficiency|vitamin d deficiency
5053702|NCT01410305|HIV+ Children|hiv+ children
5053703|NCT01410305|HIV+ Young Adults|hiv+ young adults
5053704|NCT01410292|fiber|fiber
5053705|NCT01410292|glycemic index|glycemic index
5053706|NCT01410292|glycemic response|glycemic response
5053707|NCT01410292|diabetes|diabetes
5053708|NCT01410292|ghrelin|ghrelin
5053709|NCT01410279|pulmonary hypertension|pulmonary hypertension
5053710|NCT01410279|inspiratory muscle training|inspiratory muscle training
5053711|NCT01410279|inspiratory muscle weakness|inspiratory muscle weakness
5053712|NCT01410279|pulmonary functional|pulmonary functional
5053713|NCT01410279|functional capacity|functional capacity
5053714|NCT01410279|quality of life|quality of life
5053715|NCT01410266|medical abortion|medical abortion
5053716|NCT01410266|first trimester|first trimester
5053717|NCT01410266|follow-up|follow-up
5053718|NCT01410266|pregnancy test|pregnancy test
5053719|NCT01410214|NSCLC|nsclc
5053720|NCT01410214|EGFR Mutation Positive|egfr mutation positive
5053721|NCT01410214|complete resection|complete resection
5053819|NCT01409798|Hypercalcemia|hypercalcemia
5053722|NCT01410214|Erlotinib Versus NVB/Cisplatin as Adjuvant treatment|erlotinib versus nvb/cisplatin as adjuvant treatment
5053723|NCT01410201|Epiretinal Membrane|epiretinal membrane
5053724|NCT01410201|Macular Edema|macular edema
5053725|NCT01410201|Dexamethasone Intravitreal Implant (Ozurdex)|dexamethasone intravitreal implant (ozurdex)
5053726|NCT01410201|Pars Plana Vitrectomy|pars plana vitrectomy
5053727|NCT01410188|open-angle glaucoma|open-angle glaucoma
5053728|NCT01410188|glaucoma|glaucoma
5053729|NCT01410188|ocular hypertension|ocular hypertension
5053730|NCT01410188|intraocular pressure|intraocular pressure
5053731|NCT01410162|Renal|renal
5053732|NCT01410162|Kidney/Pancreas|kidney/pancreas
5053733|NCT01410162|Transplant|transplant
5053734|NCT01410162|conversion|conversion
5053735|NCT01410162|bioequivalence|bioequivalence
5053736|NCT01410162|Mycophenolate Acid|mycophenolate acid
5053737|NCT01410149|PAV (proportional assist ventilation); sleep; polysomnography; mechanical ventilation|pav (proportional assist ventilation); sleep; polysomnography; mechanical ventilation
5053738|NCT01410136|Knee|knee
5053739|NCT01410136|Femur|femur
5053740|NCT01410136|Articular cartilage|articular cartilage
5053741|NCT01410136|Lesions|lesions
5053742|NCT01410136|Defects|defects
5053743|NCT01410136|Osteochondral graft|osteochondral graft
5053744|NCT01410136|Cartilage treatments|cartilage treatments
5053745|NCT01410136|Osteochondritis Dissecans|osteochondritis dissecans
5053746|NCT01410136|OCD|ocd
5053747|NCT01410110|Substance Abuse|substance abuse
5053748|NCT01410110|Substance Dependence|substance dependence
5053749|NCT01410110|Cognitive Impairment|cognitive impairment
5053750|NCT01410084|vitamin D|vitamin d
5053751|NCT01410084|falls|falls
5053752|NCT01410084|deficiency|deficiency
5053753|NCT01410084|insufficiency|insufficiency
5053754|NCT01410071|Sphincter of Oddi Dysfunction|sphincter of oddi dysfunction
5053755|NCT01410058|HIV|hiv
5053756|NCT01410058|antiretroviral drug interaction|antiretroviral drug interaction
5053757|NCT01410058|herbal medicine|herbal medicine
5053758|NCT01410058|pharmacokinetics|pharmacokinetics
5053759|NCT01410058|herbal pharmacology|herbal pharmacology
5053760|NCT01410045|Turner syndrome|turner syndrome
5053761|NCT01410045|infertility|infertility
5053762|NCT01410045|ovarian insufficiency|ovarian insufficiency
5053763|NCT01410045|ovarian cryopreservation|ovarian cryopreservation
5053764|NCT01410032|clavicle|clavicle
5053765|NCT01410032|clavicular|clavicular
5053766|NCT01410032|fracture|fracture
5053767|NCT01410032|midshaft|midshaft
5053768|NCT01410032|plate|plate
5053769|NCT01410032|ESIN|esin
5053770|NCT01410032|intramedullary|intramedullary
5053771|NCT01410032|flexible|flexible
5053772|NCT01410032|nailing|nailing
5053773|NCT01410019|X-linked Severe Combined Immunodeficiency (SCID-X1)|x-linked severe combined immunodeficiency (scid-x1)
5053774|NCT01410019|severe infection|severe infection
5053775|NCT01410019|gene therapy|gene therapy
5053776|NCT01410019|HLA identical family donor|hla identical family donor
5053777|NCT01410019|without HLA identical unrelated donor|without hla identical unrelated donor
5053778|NCT01410006|NF1|nf1
5053779|NCT01410006|neurofibromatosis|neurofibromatosis
5053780|NCT01410006|NF|nf
5053781|NCT01409993|BMI greater than 25|bmi greater than 25
5053782|NCT01409993|Elevated fasting blood sugar (100-125mg/dL)|elevated fasting blood sugar (100-125mg/dl)
5053783|NCT01409980|delta phalanx|delta phalanx
5053784|NCT01409980|thumb reconstructed|thumb reconstructed
5053785|NCT01409980|triphalangeal thumbs|triphalangeal thumbs
5053786|NCT01409967|Anemia|anemia
5053787|NCT01409967|Transfusion|transfusion
5053788|NCT01409967|Biological markers|biological markers
5053789|NCT01409954|Fusion|fusion
5053790|NCT01409954|Spine|spine
5053791|NCT01409954|Decompression|decompression
5053792|NCT01409954|Pseudarthrosis|pseudarthrosis
5053793|NCT01409954|bone harvest|bone harvest
5053794|NCT01409954|Instrumented posterolateral fusion|instrumented posterolateral fusion
5053795|NCT01409941|cerebral oxygen saturation,|cerebral oxygen saturation,
5053796|NCT01409941|NTproBNP|ntprobnp
5053797|NCT01409941|hsTNT|hstnt
5053798|NCT01409941|GDF-15|gdf-15
5053799|NCT01409928|obesity|obesity
5053800|NCT01409928|adolescent|adolescent
5053801|NCT01409928|pediatric|pediatric
5053802|NCT01409928|weight loss|weight loss
5053803|NCT01409928|bariatric surgery|bariatric surgery
5053804|NCT01409928|gastric banding|gastric banding
5053805|NCT01409915|Alzheimer's disease|alzheimer's disease
5053806|NCT01409915|neuropsychological assessment|neuropsychological assessment
5053807|NCT01409915|Granulocyte-Macrophage Colony-Stimulating Factor|granulocyte-macrophage colony-stimulating factor
5053808|NCT01409915|Leukine|leukine
5053809|NCT01409876|histoscanning|histoscanning
5053810|NCT01409876|brachytherapy|brachytherapy
5053811|NCT01409863|post surgical or post traumatic scar on face or scalp|post surgical or post traumatic scar on face or scalp
5053812|NCT01409837|Oligospermia|oligospermia
5053813|NCT01409837|Male infertility|male infertility
5053814|NCT01409837|Lisinopril|lisinopril
5053815|NCT01409824|clinical decision support system|clinical decision support system
5053816|NCT01409824|performance based incentives|performance based incentives
5053817|NCT01409824|quality of maternal health care services|quality of maternal health care services
5053818|NCT01409798|Hyperparathyroidism|hyperparathyroidism
5053820|NCT01409785|supraglottic airway devices in children|supraglottic airway devices in children
5053821|NCT01409759|Perforators|perforators
5053822|NCT01409759|Interposition plasty|interposition plasty
5053823|NCT01409759|Contracture release|contracture release
5053824|NCT01409746|twin|twin
5053825|NCT01409746|brain development|brain development
5053826|NCT01409746|MRI|mri
5053827|NCT01409720|bony metastases|bony metastases
5053828|NCT01409720|physical exercise|physical exercise
5053829|NCT01409694|Alzheimer Disease|alzheimer disease
5053830|NCT01409694|Vitamin D|vitamin d
5053831|NCT01409694|Cholecalciferol|cholecalciferol
5053832|NCT01409694|Memantine|memantine
5053833|NCT01409694|Cognition Disorders|cognition disorders
5053834|NCT01409655|AIDS, HIV, Adherence, Compliance, Contingency management|aids, hiv, adherence, compliance, contingency management
5053835|NCT01409616|Pharmacodynamics|pharmacodynamics
5053836|NCT01409616|darexaban|darexaban
5053837|NCT01409616|Acetyl Salicylic Acid|acetyl salicylic acid
5053838|NCT01409616|clopidogrel|clopidogrel
5053839|NCT01409616|YM150|ym150
5053840|NCT01409616|Phase 1|phase 1
5053841|NCT01409603|Pharmacodynamics|pharmacodynamics
5053842|NCT01409603|darexaban|darexaban
5053843|NCT01409603|naproxen|naproxen
5053844|NCT01409603|YM150|ym150
5053845|NCT01409603|Phase 1|phase 1
5053846|NCT01409590|Schizophrenia|schizophrenia
5053847|NCT01409590|weight gain|weight gain
5053848|NCT01409590|atypical neuroleptics|atypical neuroleptics
5053849|NCT01409577|Coronary stenosis|coronary stenosis
5053850|NCT01409577|stent|stent
5053851|NCT01409577|fractional flow reserve|fractional flow reserve
5053852|NCT01409564|Alzheimer's dementia|alzheimer's dementia
5053853|NCT01409564|Cilostazol|cilostazol
5053854|NCT01409551|Pleural effusion|pleural effusion
5053855|NCT01409551|VATS|vats
5053856|NCT01409551|hyperthermia|hyperthermia
5053857|NCT01409551|thoracostomy|thoracostomy
5053858|NCT01409551|pleurodesis|pleurodesis
5053859|NCT01409512|Heart rate variability, anti cholinergic medication|heart rate variability, anti cholinergic medication
5053860|NCT01409499|hepatocellular carcinoma, treatments, survival|hepatocellular carcinoma, treatments, survival
5053861|NCT01409486|Pompe disease|pompe disease
5053862|NCT01409486|Alpha glucosidase|alpha glucosidase
5053863|NCT01409486|Newborn screening|newborn screening
5053864|NCT01409486|Tandem Mass Spectrometry (LC-MS-MS)|tandem mass spectrometry (lc-ms-ms)
5053865|NCT01409486|The study aims:|the study aims:
5053866|NCT01409486|To establish the control mean values of alpha glucosidase activity in Dry blood spots of Newborn babies from Israel.|to establish the control mean values of alpha glucosidase activity in dry blood spots of newborn babies from israel.
5053867|NCT01409486|To include the alpha glucosidase assay in the newborn screening program in Israel|to include the alpha glucosidase assay in the newborn screening program in israel
5053868|NCT01409473|Prostate cancer|prostate cancer
5053869|NCT01409473|Stereotactic body radiotherapy|stereotactic body radiotherapy
5053870|NCT01409473|Radiosurgery|radiosurgery
5053871|NCT01409473|Intensity-modulated radiotherapy|intensity-modulated radiotherapy
5053872|NCT01409473|SBRT|sbrt
5053873|NCT01409473|IMRT|imrt
5053874|NCT01409473|Early-stage prostate cancer|early-stage prostate cancer
5053875|NCT01409473|Low-risk prostate cancer|low-risk prostate cancer
5053876|NCT01409473|Intermediate-risk prostate cancer|intermediate-risk prostate cancer
5053877|NCT01409473|Intraprostatic lesions|intraprostatic lesions
5053878|NCT01409473|IPL|ipl
5053879|NCT01409421|adherence|adherence
5053880|NCT01409421|glaucoma|glaucoma
5053881|NCT01409421|motivational interviewing|motivational interviewing
5053882|NCT01409408|Hypertension|hypertension
5053883|NCT01409408|Diabetes Mellitus|diabetes mellitus
5053884|NCT01409408|Vascular stiffness|vascular stiffness
5053885|NCT01409408|Endothelial function|endothelial function
5053886|NCT01409395|Drug drug interaction|drug drug interaction
5053887|NCT01409382|neonatal hypoglycemia|neonatal hypoglycemia
5053888|NCT01409382|pregnancy|pregnancy
5053889|NCT01409382|physical activity|physical activity
5053890|NCT01409382|sedentary lifestyle|sedentary lifestyle
5053891|NCT01409382|high-glycemic index diet|high-glycemic index diet
5053892|NCT01409382|take-home baby|take-home baby
5053893|NCT01409382|recurrent miscarriages|recurrent miscarriages
5053894|NCT01409382|preterm delivery|preterm delivery
5053895|NCT01409356|Obesity|obesity
5053896|NCT01409356|Portal hypertension|portal hypertension
5053897|NCT01409356|Cirrhosis|cirrhosis
5053898|NCT01409356|Diet|diet
5053899|NCT01409356|Exercise|exercise
5053900|NCT01409343|advanced solid cancers|advanced solid cancers
5053901|NCT01409343|metastatic solid cancers|metastatic solid cancers
5053902|NCT01409330|insulin sensitivity|insulin sensitivity
5053903|NCT01409330|type 2 diabetes|type 2 diabetes
5053904|NCT01409330|diet intervention|diet intervention
5053905|NCT01409317|Major Depression|major depression
5053906|NCT01409317|Functional Magnetic Resonance Imaging|functional magnetic resonance imaging
5053907|NCT01409317|Deep Transcranial Magnetic Stimulation|deep transcranial magnetic stimulation
5053908|NCT01409317|Repetitive Transcranial Magnetic Stimulation|repetitive transcranial magnetic stimulation
5053909|NCT01409317|rTMS|rtms
5053910|NCT01409317|DTMS|dtms
5053911|NCT01409317|fMRI|fmri
5053912|NCT01409317|Randomized, Sham-Controlled Trial|randomized, sham-controlled trial
5054020|NCT01409135|ASG-22ME|asg-22me
5053913|NCT01409304|Major depression|major depression
5053914|NCT01409304|Deep Transcranial Magnetic Stimulation|deep transcranial magnetic stimulation
5053915|NCT01409304|Naturalistic Trial|naturalistic trial
5053916|NCT01409304|DTMS|dtms
5053917|NCT01409291|low socioeconomic status|low socioeconomic status
5053918|NCT01409291|stress|stress
5053919|NCT01409291|women|women
5053920|NCT01409291|children|children
5053921|NCT01409291|cortisol|cortisol
5053922|NCT01409265|stroke rehabilitation|stroke rehabilitation
5053923|NCT01409265|perceptual deficits|perceptual deficits
5053924|NCT01409252|Stroke|stroke
5053925|NCT01409252|intracerebral hemorrhage|intracerebral hemorrhage
5053926|NCT01409252|surgery|surgery
5053927|NCT01409239|hospital|hospital
5053928|NCT01409239|diabetes|diabetes
5053929|NCT01409239|glycemic variability|glycemic variability
5053930|NCT01409239|autonomic tone|autonomic tone
5053931|NCT01409226|high-risk of breast cancer|high-risk of breast cancer
5053932|NCT01409226|BRCA1 mutation carrier|brca1 mutation carrier
5053933|NCT01409226|BRCA2 mutation carrier|brca2 mutation carrier
5053934|NCT01409226|diagnostic|diagnostic
5053935|NCT01409226|MRI|mri
5053936|NCT01409226|BI-RADS 4|bi-rads 4
5053937|NCT01409226|mammographically occult|mammographically occult
5053938|NCT01409200|Prostate cancer|prostate cancer
5053939|NCT01409200|Adenocarcinoma of the prostate|adenocarcinoma of the prostate
5053940|NCT01409200|Ductal adenocarcinoma|ductal adenocarcinoma
5053941|NCT01409200|Androgen deprivation therapy|androgen deprivation therapy
5053942|NCT01409200|ADT|adt
5053943|NCT01409200|Hormonal therapy|hormonal therapy
5053944|NCT01409200|Suspected lymph node metastasis|suspected lymph node metastasis
5053945|NCT01409200|TxN1M0 or TxNxM1a|txn1m0 or txnxm1a
5053946|NCT01409200|Progression-free|progression-free
5053947|NCT01409200|Pathologic complete response|pathologic complete response
5053948|NCT01409200|pCR|pcr
5053949|NCT01409200|Systemic therapy|systemic therapy
5053950|NCT01409200|Radical prostatectomy|radical prostatectomy
5053951|NCT01409200|Pelvic lymph node dissection|pelvic lymph node dissection
5053952|NCT01409200|Axitinib|axitinib
5053953|NCT01409200|AG-013736|ag-013736
5053954|NCT01409187|Melanoma|melanoma
5053955|NCT01409187|Metastatic Melanoma|metastatic melanoma
5053956|NCT01409187|Cytotoxic Drugs|cytotoxic drugs
5053957|NCT01409187|IPI-Biotherapy|ipi-biotherapy
5053958|NCT01409187|Ipilimumab|ipilimumab
5053959|NCT01409187|Yervoy|yervoy
5053960|NCT01409187|BMS-734016|bms-734016
5053961|NCT01409187|MDX010|mdx010
5053962|NCT01409187|Interferon|interferon
5053963|NCT01409187|IFN Alpha-2b|ifn alpha-2b
5053964|NCT01409187|Intron A|intron a
5053965|NCT01409187|Interferon Apha-2b|interferon apha-2b
5053966|NCT01409187|Interleukin-2|interleukin-2
5053967|NCT01409187|IL-2|il-2
5053968|NCT01409187|Aldesleukin|aldesleukin
5053969|NCT01409187|Proleukin|proleukin
5053970|NCT01409174|Melanoma|melanoma
5053971|NCT01409174|Metastatic|metastatic
5053972|NCT01409174|IPI-Biochemotherapy|ipi-biochemotherapy
5053973|NCT01409174|Chemonaive|chemonaive
5053974|NCT01409174|Advanced stage IV|advanced stage iv
5053975|NCT01409174|Unresectable stage III melanoma|unresectable stage iii melanoma
5053976|NCT01409174|1.0 cm or larger|1.0 cm or larger
5053977|NCT01409174|Ipilimumab|ipilimumab
5053978|NCT01409174|Yervoy|yervoy
5053979|NCT01409174|BMS-734016|bms-734016
5053980|NCT01409174|MDX010|mdx010
5053981|NCT01409174|Interferon Alpha-2b|interferon alpha-2b
5053982|NCT01409174|Intron A|intron a
5053983|NCT01409174|Temozolomide|temozolomide
5053984|NCT01409174|Temodar|temodar
5053985|NCT01409174|Cisplatin|cisplatin
5053986|NCT01409174|Platinol-AQ|platinol-aq
5053987|NCT01409174|Platinol|platinol
5053988|NCT01409174|CDDP|cddp
5053989|NCT01409174|Interleukin-2|interleukin-2
5053990|NCT01409174|IL-2|il-2
5053991|NCT01409174|Aldesleukin|aldesleukin
5053992|NCT01409174|Proleukin|proleukin
5053993|NCT01409161|Leukemia|leukemia
5053994|NCT01409161|Acute Promyelocytic Leukemia|acute promyelocytic leukemia
5053995|NCT01409161|APL|apl
5053996|NCT01409161|ATRA|atra
5053997|NCT01409161|Tretinoin|tretinoin
5053998|NCT01409161|All-trans retinoic acid|all-trans retinoic acid
5053999|NCT01409161|Vesanoid|vesanoid
5054000|NCT01409161|ATO|ato
5054001|NCT01409161|Arsenic trioxide|arsenic trioxide
5054002|NCT01409161|Trisenox|trisenox
5054003|NCT01409161|GO|go
5054004|NCT01409161|Gemtuzumab|gemtuzumab
5054005|NCT01409161|Mylotarg|mylotarg
5054006|NCT01409161|Gemtuzumab ozogamicin|gemtuzumab ozogamicin
5054007|NCT01409161|Methylprednisolone|methylprednisolone
5054008|NCT01409161|Depo-Medrol|depo-medrol
5054009|NCT01409161|Medrol|medrol
5054010|NCT01409161|Solu-Medrol|solu-medrol
5054011|NCT01409148|Radioimmunoimaging|radioimmunoimaging
5054012|NCT01409148|AL Amyloidosis|al amyloidosis
5054013|NCT01409148|PET/CT|pet/ct
5054014|NCT01409135|Nectin 4 protein, humans|nectin 4 protein, humans
5054015|NCT01409135|Cancer|cancer
5054016|NCT01409135|Pharmacokinetics of AGS-22M6E|pharmacokinetics of ags-22m6e
5054017|NCT01409135|Pharmacokinetics of ASG-22CE|pharmacokinetics of asg-22ce
5054018|NCT01409135|Safety|safety
5054019|NCT01409135|Clinical Trial, Phase 1|clinical trial, phase 1
5054021|NCT01409135|AGS-22M6E|ags-22m6e
5054022|NCT01409135|ASG-22CE|asg-22ce
5054023|NCT01409135|ASG-22C3|asg-22c3
5054024|NCT01409122|vasodilator|vasodilator
5054025|NCT01409122|nitric oxide|nitric oxide
5054026|NCT01409122|sodium nitrite|sodium nitrite
5054027|NCT01409122|sildenafil|sildenafil
5054028|NCT01409122|PDE-5|pde-5
5054029|NCT01409122|pulmonary hypertension|pulmonary hypertension
5054030|NCT01409122|pulmonary arterial hypertension|pulmonary arterial hypertension
5054031|NCT01409109|Schizophrenia|schizophrenia
5054032|NCT01409109|Schizoaffective|schizoaffective
5054033|NCT01409109|Neuroimaging|neuroimaging
5054034|NCT01409109|Magnetic Resonance Imaging (MRI)|magnetic resonance imaging (mri)
5054035|NCT01409109|Functional Magnetic Resonance Imaging (fMRI)|functional magnetic resonance imaging (fmri)
5054036|NCT01409109|Spectroscopy|spectroscopy
5054037|NCT01409083|infiltration|infiltration
5054038|NCT01409083|extravasation|extravasation
5054039|NCT01409083|end-tidal carbon dioxide|end-tidal carbon dioxide
5054040|NCT01409083|sodium bicarbonate|sodium bicarbonate
5054041|NCT01409070|MDS|mds
5054042|NCT01409057|Inflammation parameters|inflammation parameters
5054043|NCT01409057|Various blood values|various blood values
5054044|NCT01409057|Clinical Outcome|clinical outcome
5054045|NCT01409057|Residence in ICU/ Hospital|residence in icu/ hospital
5054046|NCT01409057|SAPS-Score|saps-score
5054047|NCT01409057|SOFA-Score|sofa-score
5054048|NCT01409057|Duration of artificial respiration|duration of artificial respiration
5054049|NCT01409044|Patient-Controlled Analgesia (PCA)|patient-controlled analgesia (pca)
5054050|NCT01409044|Music Listening|music listening
5054051|NCT01409044|Opioids|opioids
5054052|NCT01409044|Post Surgical Intensive Care Patient|post surgical intensive care patient
5054053|NCT01409044|Patient-Controlled Analgesia|patient-controlled analgesia
5054054|NCT01409031|newborns|newborns
5054055|NCT01409031|respiratory failure|respiratory failure
5054056|NCT01409031|pulmonary hypertension|pulmonary hypertension
5054057|NCT01409031|treatment|treatment
5054058|NCT01409018|pediatric|pediatric
5054059|NCT01409018|cancer|cancer
5054060|NCT01409018|invasive fungal disease|invasive fungal disease
5054061|NCT01409018|antifungal agent|antifungal agent
5054062|NCT01408992|Hearing screening|hearing screening
5054063|NCT01408992|Questionnaire|questionnaire
5054064|NCT01408992|Hearing disability|hearing disability
5054065|NCT01408979|Severe preeclampsia|severe preeclampsia
5054066|NCT01408979|magnesium sulfate|magnesium sulfate
5054067|NCT01408979|anticonvulsivant|anticonvulsivant
5054068|NCT01408966|Dark chocolate|dark chocolate
5054069|NCT01408966|Catechins|catechins
5054070|NCT01408966|Intrahepatic endothelial dysfunction|intrahepatic endothelial dysfunction
5054071|NCT01408966|Cirrhosis|cirrhosis
5054072|NCT01408966|Portal Hypertension|portal hypertension
5054073|NCT01408953|Keloid|keloid
5054074|NCT01408927|Thienopyridine resistance|thienopyridine resistance
5054075|NCT01408927|Aspirin resistance|aspirin resistance
5054076|NCT01408927|Platelet reactivity|platelet reactivity
5054077|NCT01408901|peripheral arterial disease|peripheral arterial disease
5054078|NCT01408901|granulocyte macrophage colony stimulating factor|granulocyte macrophage colony stimulating factor
5054079|NCT01408901|PAD|pad
5054080|NCT01408901|GM-CSF|gm-csf
5054081|NCT01408901|sargramostim|sargramostim
5054082|NCT01408901|leukine|leukine
5054083|NCT01408901|treadmill exercise|treadmill exercise
5054084|NCT01408875|Chronic Heart Failure|chronic heart failure
5054085|NCT01408875|Cardiac rehabilitation|cardiac rehabilitation
5054086|NCT01408875|Exercise training|exercise training
5054087|NCT01408875|Peak VO2|peak vo2
5054088|NCT01408875|Electrical myostimulation|electrical myostimulation
5054089|NCT01408862|GLP1|glp1
5054090|NCT01408862|GIP|gip
5054091|NCT01408862|platelets|platelets
5054092|NCT01408862|human|human
5054093|NCT01408862|aggregation|aggregation
5054094|NCT01408849|Endoscopy|endoscopy
5054095|NCT01408849|Herbal medicine|herbal medicine
5054096|NCT01408849|Phytotherapy|phytotherapy
5054097|NCT01408836|Vasculitis|vasculitis
5054098|NCT01408836|ANCA|anca
5054099|NCT01408836|Therapy|therapy
5054100|NCT01408836|Plasma exchange|plasma exchange
5054101|NCT01408836|Immunosuppression|immunosuppression
5054102|NCT01408823|Pediatrics|pediatrics
5054103|NCT01408823|Scoliosis|scoliosis
5054104|NCT01408823|Pharmacokinetics|pharmacokinetics
5054105|NCT01408823|Hemorrhage|hemorrhage
5054106|NCT01408823|Orthopedic Surgery|orthopedic surgery
5054107|NCT01408810|infliximab|infliximab
5054108|NCT01408810|ulcerative colitis|ulcerative colitis
5054109|NCT01408810|histologic remission|histologic remission
5054110|NCT01408797|clonal deletion|clonal deletion
5054111|NCT01408797|kidney transplantation|kidney transplantation
5054112|NCT01408784|calories|calories
5054113|NCT01408784|counting|counting
5054114|NCT01408784|obesity|obesity
5054115|NCT01408784|overweight|overweight
5054116|NCT01408784|categories|categories
5054117|NCT01408784|calorie|calorie
5054118|NCT01408784|method|method
5054119|NCT01408784|counting calories|counting calories
5054120|NCT01408784|lose weight|lose weight
5054121|NCT01408784|diet|diet
5054122|NCT01408784|energy balance|energy balance
5054123|NCT01408784|energy intake|energy intake
5054124|NCT01408784|24 hours recall|24 hours recall
5054125|NCT01408784|food intake|food intake
5054126|NCT01408771|Urodynamics|urodynamics
5054127|NCT01408771|Overactive Bladder|overactive bladder
5054128|NCT01408745|medical device|medical device
5054129|NCT01408745|sternal closure|sternal closure
5054130|NCT01408745|sternotomy|sternotomy
5054131|NCT01408745|dehiscence|dehiscence
5054132|NCT01408745|sternal wound healing|sternal wound healing
5054133|NCT01408745|randomized trial|randomized trial
5054134|NCT01408745|steel wire|steel wire
5054135|NCT01408732|Epistaxis|epistaxis
5054136|NCT01408732|Hereditary Hemorrhagic Telangiectasia|hereditary hemorrhagic telangiectasia
5054137|NCT01408732|HHT|hht
5054138|NCT01408732|Sclerotherapy|sclerotherapy
5054139|NCT01408732|Epistaxis (nosebleeds) due to Hereditary Hemorrhagic Telangiectasia|epistaxis (nosebleeds) due to hereditary hemorrhagic telangiectasia
5054140|NCT01408719|Beta-Glucan|beta-glucan
5054141|NCT01408719|Barley|barley
5054142|NCT01408719|Molecular Weight|molecular weight
5054143|NCT01408719|Viscosity|viscosity
5054144|NCT01408719|Cholesterol|cholesterol
5054145|NCT01408719|Stable isotope|stable isotope
5054146|NCT01408719|Gene-nutrient interaction|gene-nutrient interaction
5054147|NCT01408719|Gut microbiota|gut microbiota
5054148|NCT01408693|hip fracture|hip fracture
5054149|NCT01408693|hemiarthroplasty|hemiarthroplasty
5054150|NCT01408693|endoprosthesis|endoprosthesis
5054151|NCT01408693|elderly|elderly
5054152|NCT01408693|minimally invasive surgery|minimally invasive surgery
5054153|NCT01408693|anterior approach|anterior approach
5054154|NCT01408693|geriatric patients|geriatric patients
5054155|NCT01408680|End-stage Renal Disease|end-stage renal disease
5054156|NCT01408680|Hemodialysis|hemodialysis
5054157|NCT01408680|Cardiovascular Disease|cardiovascular disease
5054158|NCT01408680|Antioxidants|antioxidants
5054159|NCT01408680|Atherosclerosis|atherosclerosis
5054160|NCT01408680|Coenzyme Q10|coenzyme q10
5054161|NCT01408667|insulin sensitivity|insulin sensitivity
5054162|NCT01408667|cardiometabolic risk|cardiometabolic risk
5054163|NCT01408667|hyperinsulinemic euglycemic clamp|hyperinsulinemic euglycemic clamp
5054164|NCT01408654|Suicidal Ideation|suicidal ideation
5054165|NCT01408654|Loneliness|loneliness
5054166|NCT01408654|Social Support|social support
5054167|NCT01408654|Voluntary Workers|voluntary workers
5054168|NCT01408654|Friends/Companions|friends/companions
5054169|NCT01408654|Prevention|prevention
5054170|NCT01408654|Aged|aged
5054171|NCT01408641|topiramate|topiramate
5054172|NCT01408641|PTSD|ptsd
5054173|NCT01408641|drinking|drinking
5054174|NCT01408641|alcohol|alcohol
5054175|NCT01408602|Rheumatoid Arthritis|rheumatoid arthritis
5054176|NCT01408589|alcohol|alcohol
5054177|NCT01408589|craving|craving
5054178|NCT01408589|mood|mood
5054179|NCT01408589|optimum dose of atomoxetine|optimum dose of atomoxetine
5054180|NCT01408576|Lupus|lupus
5054181|NCT01408576|Monoclonal antibody|monoclonal antibody
5054182|NCT01408576|B-Cell immunotherapy|b-cell immunotherapy
5054183|NCT01408576|Epratuzumab|epratuzumab
5054184|NCT01408563|NHL|nhl
5054185|NCT01408563|lymphoma|lymphoma
5054186|NCT01408563|leukemia|leukemia
5054187|NCT01408563|myelodysplastic disorder|myelodysplastic disorder
5054188|NCT01408563|aplastic anemia|aplastic anemia
5054189|NCT01408550|IVIG in pemphigoid|ivig in pemphigoid
5054190|NCT01408550|Patients with bullous pemphigoid unresponsive to corticosteroids|patients with bullous pemphigoid unresponsive to corticosteroids
5054191|NCT01408537|inactivated Japanese encephalitis vaccine|inactivated japanese encephalitis vaccine
5054192|NCT01408537|vero cell|vero cell
5054193|NCT01408537|children|children
5054194|NCT01408537|immunogenicity|immunogenicity
5054195|NCT01408537|safety|safety
5054196|NCT01408524|Hypertension|hypertension
5054197|NCT01408524|emergence|emergence
5054198|NCT01408524|craniotomy|craniotomy
5054199|NCT01408524|Hypertension during the emergence after craniotomy|hypertension during the emergence after craniotomy
5054200|NCT01408498|Testosterone|testosterone
5054201|NCT01408498|Social psychology|social psychology
5054202|NCT01408498|Human behavior|human behavior
5054203|NCT01408459|Prostate cancer prevention|prostate cancer prevention
5054204|NCT01408446|Hypertension|hypertension
5054205|NCT01408446|Menthol|menthol
5054206|NCT01408446|Metabolism|metabolism
5054207|NCT01408433|embryo transfer|embryo transfer
5054208|NCT01408433|in-vitro fertilization (IVF)|in-vitro fertilization (ivf)
5054209|NCT01408433|pre-implantation diagnosis (PGD)|pre-implantation diagnosis (pgd)
5054210|NCT01408433|infertility|infertility
5054211|NCT01408433|single embryo transfer|single embryo transfer
5054212|NCT01408433|two embryo transfer|two embryo transfer
5054213|NCT01408433|double embryo transfer|double embryo transfer
5054214|NCT01408420|Renal insufficiency|renal insufficiency
5054215|NCT01408420|Acute Kidney Injury|acute kidney injury
5054216|NCT01408420|Postoperative|postoperative
5054217|NCT01408420|Extracorporeal Circulation|extracorporeal circulation
5054218|NCT01408420|Heart surgery|heart surgery
5054219|NCT01408407|Patients with anal canal, low rectal or gynecological cancer|patients with anal canal, low rectal or gynecological cancer
5054220|NCT01408394|safety|safety
5054221|NCT01408394|pharmacokinetics|pharmacokinetics
5054222|NCT01408394|controlled release|controlled release
5054223|NCT01408394|formulation|formulation
5054224|NCT01408381|Critical Limb Ischemia (CLI)|critical limb ischemia (cli)
5054225|NCT01408381|Cell Therapy|cell therapy
5054226|NCT01408381|Bone marrow mononuclear cells|bone marrow mononuclear cells
5054227|NCT01408368|Graves' disease|graves' disease
5054228|NCT01408368|total thyroidectomy|total thyroidectomy
5054229|NCT01408368|bilateral subtotal thyroidectomy|bilateral subtotal thyroidectomy
5054230|NCT01408368|Graves' ophthalmopathy|graves' ophthalmopathy
5054231|NCT01408368|morbidity rate|morbidity rate
5054232|NCT01408342|Alemtuzumab|alemtuzumab
5054233|NCT01408342|Rituximab|rituximab
5054234|NCT01408342|Aplastic anemia|aplastic anemia
5054235|NCT01408342|cyclosporine|cyclosporine
5054236|NCT01408316|Healthy Volunteer|healthy volunteer
5054237|NCT01408316|PX-866|px-866
5054238|NCT01408316|PI3K Inhibitor|pi3k inhibitor
5054239|NCT01408303|dyslipidemia|dyslipidemia
5054240|NCT01408303|hyperlipidemia|hyperlipidemia
5054241|NCT01408303|cardiovascular risk|cardiovascular risk
5054242|NCT01408290|seasonal|seasonal
5054243|NCT01408290|prevention|prevention
5054244|NCT01408290|influenza|influenza
5054245|NCT01408290|infection|infection
5054246|NCT01408290|influenza vaccine|influenza vaccine
5054247|NCT01408290|vaccine|vaccine
5054248|NCT01408290|influenza in humans|influenza in humans
5054249|NCT01408277|Diabetic Foot Ulcers|diabetic foot ulcers
5054250|NCT01408277|Diabetic Foot Wounds|diabetic foot wounds
5054251|NCT01408238|Immunotherapy|immunotherapy
5054252|NCT01408238|Skin prick test|skin prick test
5054253|NCT01408238|Standardization|standardization
5054254|NCT01408238|Secale cereale|secale cereale
5054255|NCT01408225|MGUS|mgus
5054256|NCT01408225|Multiple Myeloma|multiple myeloma
5054257|NCT01408225|Tissue Bank|tissue bank
5054258|NCT01408199|Lenalidomide|lenalidomide
5054259|NCT01408199|Refractory Cutaneous Lupus|refractory cutaneous lupus
5054260|NCT01408186|aspirin|aspirin
5054261|NCT01408186|PPI|ppi
5054262|NCT01408186|H2RA|h2ra
5054263|NCT01408173|caffeine|caffeine
5054264|NCT01408173|apnea|apnea
5054265|NCT01408173|prematurity|prematurity
5054266|NCT01408147|Postpartum weight retention|postpartum weight retention
5054267|NCT01408147|Low income women|low income women
5054268|NCT01408147|WIC|wic
5054269|NCT01408147|Online|online
5054270|NCT01408134|Inter-reader variability of myocardial viability imaging|inter-reader variability of myocardial viability imaging
5054271|NCT01408121|Platelet reactivity|platelet reactivity
5054272|NCT01408121|Genotyping|genotyping
5054273|NCT01408108|Hiatal hernia|hiatal hernia
5054274|NCT01408108|Gastro-oesophageal reflux disease|gastro-oesophageal reflux disease
5054275|NCT01408108|Laparoscopic hiatal repair|laparoscopic hiatal repair
5054276|NCT01408108|Laparoscopic anti-reflux surgery|laparoscopic anti-reflux surgery
5054277|NCT01408108|Partially absorbable lightweight mesh|partially absorbable lightweight mesh
5054278|NCT01408095|diabetes|diabetes
5054279|NCT01408095|glimepiride|glimepiride
5054280|NCT01408095|diabetes type II|diabetes type ii
5054281|NCT01408095|diabetes type 2|diabetes type 2
5054282|NCT01408095|Type 2 diabetes|type 2 diabetes
5054283|NCT01408095|diabetes mellitus|diabetes mellitus
5054284|NCT01408069|headache|headache
5054285|NCT01408069|migraine|migraine
5054286|NCT01408056|Hemangioma|hemangioma
5054287|NCT01408056|Infantile Hemangioma|infantile hemangioma
5054288|NCT01408056|Ulcerated Hemangioma|ulcerated hemangioma
5054289|NCT01408056|Timolol|timolol
5054290|NCT01408056|Beta blocker|beta blocker
5054291|NCT01408056|Vascular anomaly|vascular anomaly
5054292|NCT01408030|epistaxis|epistaxis
5054293|NCT01408030|HHT|hht
5054294|NCT01408030|bevacizumab|bevacizumab
5054295|NCT01408030|tranexamic acid|tranexamic acid
5054296|NCT01408030|nosebleed|nosebleed
5054297|NCT01408030|estrogen|estrogen
5054298|NCT01408004|Renal carcinoma|renal carcinoma
5054299|NCT01408004|Resistance|resistance
5054300|NCT01408004|Reversible|reversible
5054301|NCT01408004|Translational|translational
5054302|NCT01407991|Enteral tube placement|enteral tube placement
5054303|NCT01407978|Influenza|influenza
5054304|NCT01407978|Pandemic vaccine|pandemic vaccine
5054305|NCT01407978|Seasonal vaccine|seasonal vaccine
5054306|NCT01407978|Prevention|prevention
5054307|NCT01407978|Influenza vaccine|influenza vaccine
5054308|NCT01407978|Influenza in humans|influenza in humans
5054309|NCT01407978|Pandemic influenza in humans|pandemic influenza in humans
5054310|NCT01407978|Influenza vaccine for children|influenza vaccine for children
5054311|NCT01407978|Influenza vaccine for adolescents|influenza vaccine for adolescents
5054312|NCT01407978|Seasonal vaccine for children|seasonal vaccine for children
5054313|NCT01407978|Seasonal vaccine for adolescents|seasonal vaccine for adolescents
5054314|NCT01407965|obesity|obesity
5054315|NCT01407965|pharmacokinetic|pharmacokinetic
5054316|NCT01407965|ertapenem|ertapenem
5054317|NCT01407965|meropenem|meropenem
5054318|NCT01407952|treatment trial|treatment trial
5054319|NCT01407952|cerebral aneurysm|cerebral aneurysm
5054320|NCT01407952|randomized|randomized
5054321|NCT01407952|coils|coils
5054322|NCT01407952|endovascular|endovascular
5054323|NCT01407952|HEAT|heat
5054324|NCT01407952|bare platinum|bare platinum
5054325|NCT01407952|Hydrogel|hydrogel
5054326|NCT01407952|Hydrocoil|hydrocoil
5054327|NCT01407939|Bitter Taste|bitter taste
5054328|NCT01407939|Bitter Blockers|bitter blockers
5054329|NCT01407939|Pediatric Medications|pediatric medications
5054330|NCT01407939|Sensory methodology|sensory methodology
5054331|NCT01407939|Children|children
5054332|NCT01407926|Depression|depression
5054333|NCT01407926|Aging|aging
5054334|NCT01407926|Clinical Effectiveness|clinical effectiveness
5054335|NCT01407926|Home Care|home care
5054336|NCT01407926|Nurse-Led|nurse-led
5054337|NCT01407900|CD NP|cd np
5054338|NCT01407900|dual receptor|dual receptor
5054339|NCT01407900|NPR A|npr a
5054340|NCT01407900|NPR B|npr b
5054341|NCT01407900|Adult, aged over 45|adult, aged over 45
5054342|NCT01407887|children|children
5054343|NCT01407874|Gout|gout
5054344|NCT01407874|Hyperuricemia|hyperuricemia
5054345|NCT01407874|Arthritis|arthritis
5054346|NCT01407874|Joint Disease|joint disease
5054347|NCT01407874|Allopurinol|allopurinol
5054348|NCT01407874|Renal Insufficiency|renal insufficiency
5054349|NCT01407835|Immunotherapy|immunotherapy
5054350|NCT01407835|Skin prick test|skin prick test
5054351|NCT01407835|Standardization|standardization
5054352|NCT01407835|Dactylis glomerata|dactylis glomerata
5054353|NCT01407822|Lung cancer|lung cancer
5054354|NCT01407822|IIIA-N2|iiia-n2
5054355|NCT01407822|Neo-adjuvant treatment|neo-adjuvant treatment
5054356|NCT01407822|EGFR mutations|egfr mutations
5054357|NCT01407822|Tyrosine kinase inhibitor|tyrosine kinase inhibitor
5054358|NCT01407796|lung inflammation|lung inflammation
5054359|NCT01407796|positron emission tomography (PET)|positron emission tomography (pet)
5054360|NCT01407796|fluorodeoxyglucose (FDG)|fluorodeoxyglucose (fdg)
5054361|NCT01407796|inducible nitric oxide synthase (iNOS)|inducible nitric oxide synthase (inos)
5054362|NCT01407796|lung anti-inflammatory therapy|lung anti-inflammatory therapy
5054363|NCT01407783|Post-partum depression|post-partum depression
5054364|NCT01407783|Low-income mothers|low-income mothers
5054365|NCT01407783|home nurse visitation|home nurse visitation
5054366|NCT01407770|radiation toxicity|radiation toxicity
5054367|NCT01407770|skin reactions secondary to radiation therapy|skin reactions secondary to radiation therapy
5054368|NCT01407770|pain|pain
5054369|NCT01407770|fatigue|fatigue
5054370|NCT01407770|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
5054371|NCT01407770|depression|depression
5054372|NCT01407770|cognitive/functional effects|cognitive/functional effects
5054373|NCT01407770|stage IA breast cancer|stage ia breast cancer
5054374|NCT01407770|stage IB breast cancer|stage ib breast cancer
5054375|NCT01407770|stage II breast cancer|stage ii breast cancer
5054376|NCT01407770|stage IIIA breast cancer|stage iiia breast cancer
5054377|NCT01407770|ductal breast carcinoma in situ|ductal breast carcinoma in situ
5054378|NCT01407757|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5054379|NCT01407757|adult acute myeloid leukemia with del(5q)|adult acute myeloid leukemia with del(5q)
5054380|NCT01407757|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5054381|NCT01407757|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5054382|NCT01407757|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5054383|NCT01407757|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
5054384|NCT01407757|untreated childhood acute myeloid leukemia and other myeloid malignancies|untreated childhood acute myeloid leukemia and other myeloid malignancies
5054385|NCT01407757|adult acute basophilic leukemia|adult acute basophilic leukemia
5054386|NCT01407757|childhood acute basophilic leukemia|childhood acute basophilic leukemia
5054387|NCT01407757|adult acute eosinophilic leukemia|adult acute eosinophilic leukemia
5054388|NCT01407757|childhood acute eosinophilic leukemia|childhood acute eosinophilic leukemia
5054389|NCT01407757|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
5054390|NCT01407757|childhood acute myeloblastic leukemia without maturation (M1)|childhood acute myeloblastic leukemia without maturation (m1)
5054391|NCT01407757|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
5054392|NCT01407757|childhood acute minimally differentiated myeloid leukemia (M0)|childhood acute minimally differentiated myeloid leukemia (m0)
5054393|NCT01407757|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
5054394|NCT01407757|childhood acute myeloblastic leukemia with maturation (M2)|childhood acute myeloblastic leukemia with maturation (m2)
5054395|NCT01407757|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
5054396|NCT01407757|childhood acute myelomonocytic leukemia (M4)|childhood acute myelomonocytic leukemia (m4)
5054397|NCT01407757|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
5054398|NCT01407757|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
5054399|NCT01407757|childhood acute monoblastic leukemia (M5a)|childhood acute monoblastic leukemia (m5a)
5054400|NCT01407757|childhood acute monocytic leukemia (M5b)|childhood acute monocytic leukemia (m5b)
5054401|NCT01407757|adult erythroleukemia (M6a)|adult erythroleukemia (m6a)
5054402|NCT01407757|adult pure erythroid leukemia (M6b)|adult pure erythroid leukemia (m6b)
5054403|NCT01407757|childhood acute erythroleukemia (M6)|childhood acute erythroleukemia (m6)
5054404|NCT01407757|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
5054598|NCT01406977|HPP|hpp
5054405|NCT01407757|childhood acute megakaryocytic leukemia (M7)|childhood acute megakaryocytic leukemia (m7)
5054406|NCT01407757|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5054407|NCT01407757|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5054408|NCT01407731|disseminated neuroblastoma|disseminated neuroblastoma
5054409|NCT01407731|localized resectable neuroblastoma|localized resectable neuroblastoma
5054410|NCT01407731|localized unresectable neuroblastoma|localized unresectable neuroblastoma
5054411|NCT01407731|stage 4S neuroblastoma|stage 4s neuroblastoma
5054412|NCT01407718|Knee pain|knee pain
5054413|NCT01407718|tibial nailing|tibial nailing
5054414|NCT01407705|spinal cord injury with traumatic event|spinal cord injury with traumatic event
5054415|NCT01407692|menstrual cycle|menstrual cycle
5054416|NCT01407692|estrogen|estrogen
5054417|NCT01407679|cutaneous lupus erythematosus|cutaneous lupus erythematosus
5054418|NCT01407679|discoid lupus erythematosus|discoid lupus erythematosus
5054419|NCT01407679|subacute cutaneous lupus erythematosus|subacute cutaneous lupus erythematosus
5054420|NCT01407679|lupus erythematosus tumidus|lupus erythematosus tumidus
5054421|NCT01407666|paravertebral block|paravertebral block
5054422|NCT01407666|epidural block|epidural block
5054423|NCT01407666|pain management|pain management
5054424|NCT01407666|liver resection|liver resection
5054425|NCT01407666|comparison|comparison
5054426|NCT01407653|Low back pain|low back pain
5054427|NCT01407653|virtual reality|virtual reality
5054428|NCT01407640|Insulin allergy|insulin allergy
5054429|NCT01407640|adverse drug reaction|adverse drug reaction
5054430|NCT01407640|diabetes|diabetes
5054431|NCT01407640|type 1 hypersensitivity|type 1 hypersensitivity
5054432|NCT01407640|immediate hypersensitivity|immediate hypersensitivity
5054433|NCT01407640|type 4 hypersensitivity|type 4 hypersensitivity
5054434|NCT01407640|insulin analogs|insulin analogs
5054435|NCT01407640|intradermal testing|intradermal testing
5054436|NCT01407640|insulin antibody|insulin antibody
5054437|NCT01407640|mast cell|mast cell
5054438|NCT01407640|CD+ TCELL|cd+ tcell
5054439|NCT01407627|human|human
5054440|NCT01407627|fructose|fructose
5054441|NCT01407627|dextrose|dextrose
5054442|NCT01407627|renin angiotensin system|renin angiotensin system
5054443|NCT01407627|kidney|kidney
5054444|NCT01407627|renal hemodynamics|renal hemodynamics
5054445|NCT01407614|Subarachnoid hemorrhage|subarachnoid hemorrhage
5054446|NCT01407614|delayed cerebral ischemia|delayed cerebral ischemia
5054447|NCT01407614|external lumbar drainage|external lumbar drainage
5054448|NCT01407614|vasospasm|vasospasm
5054449|NCT01407601|vitamin K|vitamin k
5054450|NCT01407601|MK-7|mk-7
5054451|NCT01407601|Hemodialysis|hemodialysis
5054452|NCT01407601|vascular calcification|vascular calcification
5054453|NCT01407601|Matrix Gla protein|matrix gla protein
5054454|NCT01407601|Osteocalcin|osteocalcin
5054455|NCT01407588|Atrial fibrillation|atrial fibrillation
5054456|NCT01407588|Ablation|ablation
5054457|NCT01407575|Buprenorphine|buprenorphine
5054458|NCT01407575|Receptors, opioid|receptors, opioid
5054459|NCT01407575|Receptors, opioid, kappa|receptors, opioid, kappa
5054460|NCT01407536|Stroke|stroke
5054461|NCT01407536|Thermal Stimulation|thermal stimulation
5054462|NCT01407536|Upper Extremity|upper extremity
5054463|NCT01407536|Motor Recovery|motor recovery
5054464|NCT01407536|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
5054465|NCT01407523|Levetiracetam|levetiracetam
5054466|NCT01407523|Infusion|infusion
5054467|NCT01407523|Epilepsy|epilepsy
5054468|NCT01407523|Partial Onset Seizures|partial onset seizures
5054469|NCT01407497|HIV|hiv
5054470|NCT01407497|Vaccine|vaccine
5054471|NCT01407497|DNA|dna
5054472|NCT01407497|Prevention|prevention
5054473|NCT01407484|Infertility|infertility
5054474|NCT01407484|Assisted reproductive technology|assisted reproductive technology
5054475|NCT01407484|Double blind therapeutical trial|double blind therapeutical trial
5054476|NCT01407484|Multicentric study|multicentric study
5054477|NCT01407484|Prospective randomized study|prospective randomized study
5054478|NCT01407471|aldosterone|aldosterone
5054479|NCT01407471|clobetasol|clobetasol
5054480|NCT01407471|atrophy|atrophy
5054481|NCT01407471|skin|skin
5054482|NCT01407471|epidermis|epidermis
5054483|NCT01407471|wound healing|wound healing
5054484|NCT01407471|mineral corticoid receptor|mineral corticoid receptor
5054485|NCT01407471|spironolactone|spironolactone
5054486|NCT01407445|Menopause|menopause
5054487|NCT01407445|Sexual dysfunction|sexual dysfunction
5054488|NCT01407445|Tribulus|tribulus
5054489|NCT01407445|Sexuality|sexuality
5054490|NCT01407445|Phytotherapeutic Drugs|phytotherapeutic drugs
5054491|NCT01407432|Male infertility|male infertility
5054492|NCT01407432|folic acid|folic acid
5054493|NCT01407432|in VITRO fertilization|in vitro fertilization
5054494|NCT01407432|sperm parameters|sperm parameters
5054495|NCT01407432|MTHFR genotype|mthfr genotype
5054496|NCT01407419|Rheumatoid Arthritis|rheumatoid arthritis
5054497|NCT01407393|overweight|overweight
5054498|NCT01407393|obesity|obesity
5054499|NCT01407393|weight loss|weight loss
5054500|NCT01407393|body fat|body fat
5054501|NCT01407393|waste cirumference|waste cirumference
5054502|NCT01407393|satiety|satiety
5054503|NCT01407393|appetite|appetite
5054504|NCT01407380|Advanced malignancies|advanced malignancies
5054505|NCT01407380|solid tumors|solid tumors
5054506|NCT01407380|cancer|cancer
5054507|NCT01407367|patient safety|patient safety
5054508|NCT01407367|chronic kidney disease|chronic kidney disease
5054509|NCT01407367|medical errors|medical errors
5054510|NCT01407354|robotic weight support|robotic weight support
5054511|NCT01407354|aquatic exercise|aquatic exercise
5054512|NCT01407354|incomplete motor spinal cord injury|incomplete motor spinal cord injury
5054513|NCT01407354|ASIA C and D|asia c and d
5054514|NCT01407328|shoulder arthroscopic surgery|shoulder arthroscopic surgery
5054515|NCT01407328|respiratory discomfort|respiratory discomfort
5054516|NCT01407328|airway obstruction|airway obstruction
5054517|NCT01407328|restrictive pathology|restrictive pathology
5054518|NCT01407328|diaphragm palsy|diaphragm palsy
5054519|NCT01407315|Continuous subcutaneous glucose monitoring|continuous subcutaneous glucose monitoring
5054520|NCT01407315|Type 1 Diabetes|type 1 diabetes
5054521|NCT01407302|Laryngeal mask airway|laryngeal mask airway
5054522|NCT01407302|internal jugular vein cannulation|internal jugular vein cannulation
5054523|NCT01407263|radical prostatectomy|radical prostatectomy
5054524|NCT01407263|anastomotic suturing|anastomotic suturing
5054525|NCT01407263|lymph node dissection|lymph node dissection
5054526|NCT01407263|11-096|11-096
5054527|NCT01407237|HIV-infection|hiv-infection
5054528|NCT01407237|renin|renin
5054529|NCT01407237|aldosterone|aldosterone
5054530|NCT01407237|visceral fat|visceral fat
5054531|NCT01407224|Exclusive Breastfeeding|exclusive breastfeeding
5054532|NCT01407224|Skin to skin contact|skin to skin contact
5054533|NCT01407224|Cord Clumping|cord clumping
5054534|NCT01407224|Prelactial feeding|prelactial feeding
5054535|NCT01407211|multiple sclerosis|multiple sclerosis
5054536|NCT01407211|Myelin Oligodendrocyte Glycoprotein(MOG)|myelin oligodendrocyte glycoprotein(mog)
5054537|NCT01407211|Vitamin A|vitamin a
5054538|NCT01407211|CD4-Positive T-Lymphocytes|cd4-positive t-lymphocytes
5054539|NCT01407211|gene expression|gene expression
5054540|NCT01407211|Th1 Cells|th1 cells
5054541|NCT01407211|Th2 Cells|th2 cells
5054542|NCT01407198|High Risk Chordoma|high risk chordoma
5054543|NCT01407185|heart failure|heart failure
5054544|NCT01407185|quality of life|quality of life
5054545|NCT01407185|fall prevention|fall prevention
5054546|NCT01407185|endurance|endurance
5054547|NCT01407185|resistive training|resistive training
5054548|NCT01407172|PAD|pad
5054549|NCT01407172|Peripheral arterial disease|peripheral arterial disease
5054550|NCT01407172|Hydrogen Sulfide|hydrogen sulfide
5054551|NCT01407172|Gasotransmitter|gasotransmitter
5054552|NCT01407159|type b dissection|type b dissection
5054553|NCT01407159|thoracic stentgraft|thoracic stentgraft
5054554|NCT01407159|aortic stent|aortic stent
5054555|NCT01407159|clinical and technical success|clinical and technical success
5054556|NCT01407159|safety and feasibility of E-XL aortic stent|safety and feasibility of e-xl aortic stent
5054557|NCT01407146|acute myocardial infarction|acute myocardial infarction
5054558|NCT01407146|care-seeking behavior|care-seeking behavior
5054559|NCT01407146|acute coronary syndrome|acute coronary syndrome
5054560|NCT01407146|care-seeking delay|care-seeking delay
5054561|NCT01407146|cardiac delay|cardiac delay
5054562|NCT01407146|prehospital delay|prehospital delay
5054563|NCT01407146|acute myocardial infarction & PTSD|acute myocardial infarction & ptsd
5054564|NCT01407146|help seeking behaviors|help seeking behaviors
5054565|NCT01407146|seeking treatment|seeking treatment
5054566|NCT01407146|cardiac patients|cardiac patients
5054567|NCT01407146|decision time|decision time
5054568|NCT01407133|Neuro-otology|neuro-otology
5054569|NCT01407133|Chronic tinnitus|chronic tinnitus
5054570|NCT01407133|Sensory disability|sensory disability
5054571|NCT01407133|Repetitive transcranial magnetic stimulation|repetitive transcranial magnetic stimulation
5054572|NCT01407133|Dose escalation|dose escalation
5054573|NCT01407120|Prevention|prevention
5054574|NCT01407120|Divorce|divorce
5054575|NCT01407107|nitroglycerin|nitroglycerin
5054576|NCT01407107|5-flourouracil|5-flourouracil
5054577|NCT01407107|radiation therapy|radiation therapy
5054578|NCT01407107|neo-adjuvant treatment|neo-adjuvant treatment
5054579|NCT01407094|Depression, Major Depressive Disorder, Mood Disorder|depression, major depressive disorder, mood disorder
5054580|NCT01407081|cognitive rehabilitation|cognitive rehabilitation
5054581|NCT01407081|SMART goals|smart goals
5054582|NCT01407081|telehealth|telehealth
5054583|NCT01407055|Coronary Artery Bypass Graft Surgery (CABG)|coronary artery bypass graft surgery (cabg)
5054584|NCT01407055|Patients' Expectations|patients' expectations
5054585|NCT01407055|Coronary Heart Disease|coronary heart disease
5054586|NCT01407055|Illness Perception Intervention|illness perception intervention
5054587|NCT01407055|Randomized Controlled Trial|randomized controlled trial
5054588|NCT01407042|unicondylar knee arthroplasty|unicondylar knee arthroplasty
5054589|NCT01407042|mobile-bearing|mobile-bearing
5054590|NCT01407042|patellofemoral pain|patellofemoral pain
5054591|NCT01407016|metronidazole infusion|metronidazole infusion
5054592|NCT01407003|T2DM, blood glucose, OGTT, LIK066|t2dm, blood glucose, ogtt, lik066
5054593|NCT01406990|aspirin resistance|aspirin resistance
5054594|NCT01406990|hyporesponsive|hyporesponsive
5054595|NCT01406990|CAD|cad
5054596|NCT01406990|women|women
5054597|NCT01406977|Hypophosphatasia|hypophosphatasia
5054599|NCT01406977|Rathbun's disease|rathbun's disease
5054600|NCT01406964|Chlamidia Antibody test, Hysterosalpyngography, Tubal disease|chlamidia antibody test, hysterosalpyngography, tubal disease
5054601|NCT01406951|sTREM-1|strem-1
5054602|NCT01406951|PCT|pct
5054603|NCT01406951|CPIS|cpis
5054604|NCT01406951|VAP|vap
5054605|NCT01406951|EVC|evc
5054606|NCT01406951|diagnosis|diagnosis
5054607|NCT01406951|prognosis|prognosis
5054608|NCT01406938|Psoriasis|psoriasis
5054609|NCT01406938|plaque|plaque
5054610|NCT01406938|inflammatory skin disease|inflammatory skin disease
5054611|NCT01406938|scaly patches|scaly patches
5054612|NCT01406938|AIN457|ain457
5054613|NCT01406938|secukinumab|secukinumab
5054614|NCT01406938|Moderate to Severe Plaque-type Psoriasis|moderate to severe plaque-type psoriasis
5054615|NCT01406912|Stroke Rehabilitation|stroke rehabilitation
5054616|NCT01406912|Ischemic Stroke|ischemic stroke
5054617|NCT01406912|Virtual Reality|virtual reality
5054618|NCT01406912|Nintendo Wii|nintendo wii
5054619|NCT01406912|Recreational Activity|recreational activity
5054620|NCT01406912|Motor Function|motor function
5054621|NCT01406886|Modifiable environmental|modifiable environmental
5054622|NCT01406886|behavioral factors|behavioral factors
5054623|NCT01406873|Myotonic Dystrophy|myotonic dystrophy
5054624|NCT01406873|Myotonic Dystrophy Type 1 (DM1)|myotonic dystrophy type 1 (dm1)
5054625|NCT01406873|Muscular Dystrophy|muscular dystrophy
5054626|NCT01406873|Mexiletine|mexiletine
5054627|NCT01406860|Headaches|headaches
5054628|NCT01406860|Migraines|migraines
5054629|NCT01406860|Tension headaches|tension headaches
5054630|NCT01406860|Cluster headaches|cluster headaches
5054631|NCT01406847|Spinal Manipulation|spinal manipulation
5054632|NCT01406847|Body-based intervention|body-based intervention
5054633|NCT01406847|Experimental pain|experimental pain
5054634|NCT01406834|PTSD|ptsd
5054635|NCT01406834|Veterans|veterans
5054636|NCT01406834|Killing|killing
5054637|NCT01406834|Military|military
5054638|NCT01406821|PRP|prp
5054639|NCT01406821|platelet-rich-plasma|platelet-rich-plasma
5054640|NCT01406821|platelet|platelet
5054641|NCT01406821|tendinosis|tendinosis
5054642|NCT01406821|tendinitis|tendinitis
5054643|NCT01406821|tendonitis|tendonitis
5054644|NCT01406821|tendinopathy|tendinopathy
5054645|NCT01406821|enthesopathy|enthesopathy
5054646|NCT01406821|muscle|muscle
5054647|NCT01406821|sport|sport
5054648|NCT01406821|tendon|tendon
5054649|NCT01406821|patella|patella
5054650|NCT01406821|patellar tendon|patellar tendon
5054651|NCT01406808|genetic|genetic
5054652|NCT01406808|atherosclerosis|atherosclerosis
5054653|NCT01406808|myocardial infarction|myocardial infarction
5054654|NCT01406808|risk|risk
5054655|NCT01406808|preventive cardiology|preventive cardiology
5054656|NCT01406795|Post Thrombotic Syndrome|post thrombotic syndrome
5054657|NCT01406795|Venous Stasis|venous stasis
5054658|NCT01406795|Venous Occlusions|venous occlusions
5054659|NCT01406795|Venous Stenosis|venous stenosis
5054660|NCT01406782|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5054661|NCT01406782|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5054662|NCT01406782|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5054663|NCT01406782|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5054664|NCT01406743|Spine and pelvis parameters|spine and pelvis parameters
5054665|NCT01406743|Sagittal balance|sagittal balance
5054666|NCT01406743|Database|database
5054667|NCT01406730|running exercise|running exercise
5054668|NCT01406730|cardiac hypertrophy|cardiac hypertrophy
5054669|NCT01406730|blood|blood
5054670|NCT01406730|maximum oxygen uptake|maximum oxygen uptake
5054671|NCT01406730|intervention|intervention
5054672|NCT01406730|untrained|untrained
5054673|NCT01406730|males|males
5054674|NCT01406717|SPIL1033|spil1033
5054675|NCT01406717|type 2 diabetes mellitus|type 2 diabetes mellitus
5054676|NCT01406691|sleep|sleep
5054677|NCT01406691|delayed sleep phase disorder|delayed sleep phase disorder
5054678|NCT01406691|circadian|circadian
5054679|NCT01406691|teen|teen
5054680|NCT01406691|adolescent|adolescent
5054681|NCT01406678|remote ischemic preconditioning|remote ischemic preconditioning
5054682|NCT01406678|coronary artery bypass grafting|coronary artery bypass grafting
5054683|NCT01406678|myocardial injury|myocardial injury
5054684|NCT01406665|diabetes|diabetes
5054685|NCT01406665|impaired glucose tolerance|impaired glucose tolerance
5054686|NCT01406652|septic bursitis|septic bursitis
5054687|NCT01406652|bursectomy|bursectomy
5054688|NCT01406652|primary closure|primary closure
5054689|NCT01406639|Hereditary Hemorrhagic Telangiectasia (HHT)|hereditary hemorrhagic telangiectasia (hht)
5054690|NCT01406639|Nosebleeds|nosebleeds
5054691|NCT01406639|Ranibizumab|ranibizumab
5054692|NCT01406639|Lucentis|lucentis
5054693|NCT01406626|HIV|hiv
5054694|NCT01406626|AIDS|aids
5054695|NCT01406626|Health navigation|health navigation
5054696|NCT01406626|Viral load|viral load
5054697|NCT01406626|Corrections|corrections
5054698|NCT01406613|Observational|observational
5054699|NCT01406613|Bone Density|bone density
5054700|NCT01406613|alendronate|alendronate
5054701|NCT01406613|ibandronate|ibandronate
5054702|NCT01406613|risedronate|risedronate
5054703|NCT01406613|postmenopausal|postmenopausal
5054704|NCT01406613|osteoporosis|osteoporosis
5054705|NCT01406600|recombinant hCG|recombinant hcg
5054706|NCT01406600|poor responder|poor responder
5054707|NCT01406600|oocyte maturity|oocyte maturity
5054708|NCT01406587|Burning|burning
5054709|NCT01406587|Dysuria|dysuria
5054710|NCT01406587|Frequency|frequency
5054711|NCT01406587|Pain|pain
5054712|NCT01406587|Uncomplicated Urinary Tract Infection|uncomplicated urinary tract infection
5054713|NCT01406587|Uncomplicated UTI|uncomplicated uti
5054714|NCT01406587|Urinary Tract Infection|urinary tract infection
5054715|NCT01406587|UTI|uti
5054716|NCT01406587|Burning during urination associated with uncomplicated urinary tract infection|burning during urination associated with uncomplicated urinary tract infection
5054717|NCT01406587|Urination frequency associated with uncomplicated urinary tract infection|urination frequency associated with uncomplicated urinary tract infection
5054718|NCT01406587|Pain associated with uncomplicated urinary tract infection|pain associated with uncomplicated urinary tract infection
5054719|NCT01406574|Hepatocellular carcinoma|hepatocellular carcinoma
5054720|NCT01406561|Meniscectomy|meniscectomy
5054721|NCT01406561|Knee Pain|knee pain
5054722|NCT01406561|Postoperative Pain|postoperative pain
5054723|NCT01406548|Osteopenia|osteopenia
5054724|NCT01406548|osteoporosis|osteoporosis
5054725|NCT01406548|low bone mineral density|low bone mineral density
5054726|NCT01406535|Phosphodiesterase 5 inhibition|phosphodiesterase 5 inhibition
5054727|NCT01406535|myocardial perfusion|myocardial perfusion
5054728|NCT01406535|angiogenesis|angiogenesis
5054729|NCT01406535|coronary artery disease|coronary artery disease
5054730|NCT01406535|therapy refractory|therapy refractory
5054731|NCT01406522|Acetylcholine|acetylcholine
5054732|NCT01406522|Cholinesterases|cholinesterases
5054733|NCT01406522|Cocaine|cocaine
5054734|NCT01406522|Self-Administration|self-administration
5054735|NCT01406509|Safety|safety
5054736|NCT01406509|Conjugate vaccine|conjugate vaccine
5054737|NCT01406496|Insulin bolus|insulin bolus
5054738|NCT01406496|glucose excursions|glucose excursions
5054739|NCT01406496|post-prandial|post-prandial
5054740|NCT01406496|timing|timing
5054741|NCT01406496|meal content|meal content
5054742|NCT01406483|Platelet reactivity|platelet reactivity
5054743|NCT01406483|CABG|cabg
5054744|NCT01406483|Perioperative and in hospital bleeding|perioperative and in hospital bleeding
5054745|NCT01406470|IGIV|igiv
5054746|NCT01406470|Primary Immune Deficiency|primary immune deficiency
5054747|NCT01406470|Immunoglobulin G|immunoglobulin g
5054748|NCT01406457|Subarachnoid Hemorrhage|subarachnoid hemorrhage
5054749|NCT01406444|Anorexia Nervosa|anorexia nervosa
5054750|NCT01406444|Osteopenia|osteopenia
5054751|NCT01406444|Osteoporosis|osteoporosis
5054752|NCT01406444|Bone density|bone density
5054753|NCT01406431|pitavastatin|pitavastatin
5054754|NCT01406431|Livalo|livalo
5054755|NCT01406418|Influenza|influenza
5054756|NCT01406418|Virus|virus
5054757|NCT01406418|Monoclonal|monoclonal
5054758|NCT01406418|Antibody|antibody
5054759|NCT01406418|Immunization|immunization
5054760|NCT01406418|Treatment|treatment
5054761|NCT01406405|Degenerative disc disease|degenerative disc disease
5054762|NCT01406405|spinal stenosis|spinal stenosis
5054763|NCT01406405|herniated disc|herniated disc
5054764|NCT01406392|Misoprostol|misoprostol
5054765|NCT01406392|Sublingual|sublingual
5054766|NCT01406392|Induced|induced
5054767|NCT01406392|Labor|labor
5054768|NCT01406366|Pediatric oral health|pediatric oral health
5054769|NCT01406366|Bright Futures|bright futures
5054770|NCT01406366|Health promotion|health promotion
5054771|NCT01406353|Mitral Stenosis|mitral stenosis
5054772|NCT01406353|Mitral Valvuloplasty|mitral valvuloplasty
5054773|NCT01406314|Phase 1|phase 1
5054774|NCT01406314|Patient|patient
5054775|NCT01406314|Systemic Amyloidosis|systemic amyloidosis
5054776|NCT01406314|Amyloidosis|amyloidosis
5054777|NCT01406301|prescribing information|prescribing information
5054778|NCT01406288|hemolytic-uremic syndrome|hemolytic-uremic syndrome
5054779|NCT01406288|shiga-toxin-producing E. Coli|shiga-toxin-producing e. coli
5054780|NCT01406262|albiglutide|albiglutide
5054781|NCT01406262|QT interval|qt interval
5054782|NCT01406262|cardiac repolarization|cardiac repolarization
5054783|NCT01406262|ECG study|ecg study
5054784|NCT01406249|unresectable gastric cancer|unresectable gastric cancer
5054785|NCT01406249|recurrent gastric cancer|recurrent gastric cancer
5054786|NCT01406249|StageIV gastric cancer|stageiv gastric cancer
5054787|NCT01406249|adenocarcinoma of the stomach|adenocarcinoma of the stomach
5054788|NCT01406249|XP|xp
5054789|NCT01406249|SP|sp
5054790|NCT01406236|Female|female
5054791|NCT01406236|urgent or elective percutaneous coronary intervention|urgent or elective percutaneous coronary intervention
5054792|NCT01406236|PCI|pci
5054793|NCT01406236|diagnostic angiography|diagnostic angiography
5054794|NCT01406223|Nicotine addiction|nicotine addiction
5054795|NCT01406223|Cigarette smoking|cigarette smoking
5054796|NCT01406223|Smoking cessation|smoking cessation
5054797|NCT01406223|Zyban|zyban
5054798|NCT01406223|Chantix|chantix
5054799|NCT01406223|Nicotine patches|nicotine patches
5054800|NCT01406223|varenicline|varenicline
5054801|NCT01406223|bupropion|bupropion
5054802|NCT01406223|fMRI|fmri
5054803|NCT01406210|Lung Transplant|lung transplant
5054804|NCT01406210|REflux Surgery|reflux surgery
5054805|NCT01406210|Gastroesophageal Reflux Disease (GERD)|gastroesophageal reflux disease (gerd)
5054806|NCT01406210|Fundoplication|fundoplication
5054807|NCT01406197|Progesterone|progesterone
5054808|NCT01406197|Progestins|progestins
5054809|NCT01406197|Preterm labor|preterm labor
5054810|NCT01406197|Premature birth|premature birth
5054811|NCT01406197|Uterine electromyography|uterine electromyography
5054812|NCT01406197|Uterine contractility|uterine contractility
5054813|NCT01406184|Child Abuse|child abuse
5054814|NCT01406184|Child Neglect|child neglect
5054815|NCT01406184|Child Hospital Emergency Room Presentations|child hospital emergency room presentations
5054816|NCT01406184|Child Well-Care Compliance|child well-care compliance
5054817|NCT01406184|Child Immunization Compliance|child immunization compliance
5054818|NCT01406171|Isavuconazole|isavuconazole
5054819|NCT01406171|ASP9766|asp9766
5054820|NCT01406171|BAL8557|bal8557
5054821|NCT01406171|Midazolam|midazolam
5054822|NCT01406171|Healthy volunteers|healthy volunteers
5054823|NCT01406158|Solifenacin succinate|solifenacin succinate
5054824|NCT01406158|VESIcare|vesicare
5054825|NCT01406158|Healthy Volunteers|healthy volunteers
5054826|NCT01406158|YM905|ym905
5054827|NCT01406145|Alzheimer's Disease|alzheimer's disease
5054828|NCT01406145|ASP0777|asp0777
5054829|NCT01406132|ASP015K|asp015k
5054830|NCT01406132|Healthy volunteers|healthy volunteers
5054831|NCT01406106|Hypercholesterolemia|hypercholesterolemia
5054832|NCT01406106|Lipids|lipids
5054833|NCT01406106|Cardiovascular disease|cardiovascular disease
5054834|NCT01406106|Risks factors|risks factors
5054835|NCT01406106|Primary Care|primary care
5054836|NCT01406093|Candidemia|candidemia
5054837|NCT01406093|Early-onset|early-onset
5054838|NCT01406093|Late-onset|late-onset
5054839|NCT01406093|Health-care associated|health-care associated
5054840|NCT01406093|Nosocomial|nosocomial
5054841|NCT01406080|Photoaging|photoaging
5054842|NCT01406080|Photodamage|photodamage
5054843|NCT01406080|Adapalene|adapalene
5054844|NCT01406080|Differin|differin
5054845|NCT01406067|social skills training,|social skills training,
5054846|NCT01406067|social competence training,|social competence training,
5054847|NCT01406067|Oppositional Defiant Disorder|oppositional defiant disorder
5054848|NCT01406067|peer related aggressive behavior|peer related aggressive behavior
5054849|NCT01406067|randomized controlled trial|randomized controlled trial
5054850|NCT01406054|athletes|athletes
5054851|NCT01406054|injury prevention|injury prevention
5054852|NCT01406054|neuromuscular training|neuromuscular training
5054853|NCT01406054|public school|public school
5054854|NCT01406054|physical education|physical education
5054855|NCT01406054|knee|knee
5054856|NCT01406054|sports|sports
5054857|NCT01406054|ACL|acl
5054858|NCT01406054|KIPP|kipp
5054859|NCT01406041|Fluid and electrolyte imbalance|fluid and electrolyte imbalance
5054860|NCT01406041|Hyponatremia|hyponatremia
5054861|NCT01406041|Hypernatremia|hypernatremia
5054862|NCT01406041|Electrolytes disorder|electrolytes disorder
5054863|NCT01406028|IVF|ivf
5054864|NCT01406028|Stress|stress
5054865|NCT01406028|Infertility|infertility
5054866|NCT01406015|Obesity|obesity
5054867|NCT01406015|Insulin resistance|insulin resistance
5054868|NCT01406015|Mineralocorticoid receptor|mineralocorticoid receptor
5054869|NCT01406002|Pharmacokinetics|pharmacokinetics
5054870|NCT01406002|darexaban|darexaban
5054871|NCT01406002|YM150|ym150
5054872|NCT01406002|rifampicin|rifampicin
5054873|NCT01406002|Phase 1|phase 1
5054874|NCT01405989|Pharmacokinetics|pharmacokinetics
5054875|NCT01405989|darexaban|darexaban
5054876|NCT01405989|ketoconazole|ketoconazole
5054877|NCT01405989|Phase 1|phase 1
5054878|NCT01405976|sleep apneas|sleep apneas
5054879|NCT01405976|noninvasive ventilation|noninvasive ventilation
5054880|NCT01405976|CPAP|cpap
5054881|NCT01405963|Amgen|amgen
5054882|NCT01405963|AMG 157|amg 157
5054883|NCT01405963|Asthma|asthma
5054884|NCT01405898|hypertension|hypertension
5054885|NCT01405898|nitrite|nitrite
5054886|NCT01405898|blood pressure|blood pressure
5054887|NCT01405898|endothelial function|endothelial function
5054888|NCT01405885|Universal Influenza|universal influenza
5054889|NCT01405885|Intradermal DNA vaccine|intradermal dna vaccine
5054890|NCT01405885|Electroporation|electroporation
5054891|NCT01405885|H1 and H5|h1 and h5
5054892|NCT01405885|DNA Vaccination|dna vaccination
5054893|NCT01405885|Influenza|influenza
5054894|NCT01405885|INO-3510|ino-3510
5054895|NCT01405859|Tourette|tourette
5054896|NCT01405859|tic|tic
5054897|NCT01405859|Tourette's|tourette's
5054898|NCT01405859|Tourette syndrome|tourette syndrome
5054899|NCT01405859|Tourette's syndrome|tourette's syndrome
5054900|NCT01405807|Vasculitis|vasculitis
5054901|NCT01405807|ANCA|anca
5054902|NCT01405807|Refractory|refractory
5054903|NCT01405742|Hemophilia|hemophilia
5054904|NCT01405742|Prophylaxis|prophylaxis
5054905|NCT01405742|Recombinant factor VIII|recombinant factor viii
5054906|NCT01405716|Mindfulness|mindfulness
5054907|NCT01405716|Back Pain|back pain
5054908|NCT01405716|Older adults|older adults
5054909|NCT01405703|Clavicle Fractures|clavicle fractures
5054910|NCT01405703|Numbness|numbness
5054911|NCT01405703|Percutaneous plate fixation|percutaneous plate fixation
5054912|NCT01405703|open plate fixation|open plate fixation
5054913|NCT01405703|incision related numbness|incision related numbness
5054914|NCT01405703|union rates|union rates
5054915|NCT01405703|subjective|subjective
5054916|NCT01405703|questionnaire based outcomes|questionnaire based outcomes
5054917|NCT01405703|Diaphyseal|diaphyseal
5054918|NCT01405690|CAD|cad
5054919|NCT01405690|CTCA|ctca
5054920|NCT01405690|multidetector computer tomography (MDCT)|multidetector computer tomography (mdct)
5054921|NCT01405677|Hepatitis A|hepatitis a
5054922|NCT01405677|Vaccination|vaccination
5054923|NCT01405677|Immunisation|immunisation
5054924|NCT01405651|ONO-6950|ono-6950
5054925|NCT01405651|Healthy adult subjects|healthy adult subjects
5054926|NCT01405625|Asthma|asthma
5054927|NCT01405625|Health literacy|health literacy
5054928|NCT01405625|Parent knowledge of appropriate action plan steps|parent knowledge of appropriate action plan steps
5054929|NCT01405599|Ulimorelin|ulimorelin
5054930|NCT01405599|Hepatic Impairment|hepatic impairment
5054931|NCT01405586|elderly|elderly
5054932|NCT01405586|chemotherapy|chemotherapy
5054933|NCT01405573|Child Pugh B|child pugh b
5054934|NCT01405573|first line|first line
5054935|NCT01405547|Gestational Diabetes|gestational diabetes
5054936|NCT01405547|Gestational Hyperglycemia|gestational hyperglycemia
5054937|NCT01405547|Gestational Insulinemia|gestational insulinemia
5054938|NCT01405547|Maternal Obesity|maternal obesity
5054939|NCT01405547|Human Milk|human milk
5054940|NCT01405547|Lactogenesis|lactogenesis
5054941|NCT01405547|Obstetrics|obstetrics
5054942|NCT01405547|Nutrition|nutrition
5054943|NCT01405547|Infant Growth|infant growth
5054944|NCT01405534|Catheterization, Central Venous|catheterization, central venous
5054945|NCT01405521|typhoid vaccine M01ZH09|typhoid vaccine m01zh09
5054946|NCT01405521|Ty21a typhoid vaccine|ty21a typhoid vaccine
5054947|NCT01405508|N01258|n01258
5054948|NCT01405508|Brivaracetam|brivaracetam
5054949|NCT01405508|Epilepsy|epilepsy
5054950|NCT01405508|IV|iv
5054951|NCT01405508|intravenous|intravenous
5054952|NCT01405495|Posttraumatic Stress Disorder|posttraumatic stress disorder
5054953|NCT01405495|Working Memory|working memory
5054954|NCT01405495|Attentional Bias|attentional bias
5054955|NCT01405495|Connectivity|connectivity
5054956|NCT01405495|Structural Neuroimaging|structural neuroimaging
5054957|NCT01405495|Functional Neuroimaging|functional neuroimaging
5054958|NCT01405495|Diffusion Tensor Imaging|diffusion tensor imaging
5054959|NCT01405495|Arterial Spin Labelling|arterial spin labelling
5054960|NCT01405495|Cortisol|cortisol
5054961|NCT01405495|Psychophysiology|psychophysiology
5054962|NCT01405495|Early development of|early development of
5054963|NCT01405482|Botulinum Toxin Type A|botulinum toxin type a
5054964|NCT01405482|Thoracic Outlet Syndrome|thoracic outlet syndrome
5054965|NCT01405469|Achalasia|achalasia
5054966|NCT01405469|Heller myotomy|heller myotomy
5054967|NCT01405469|Dysphagia|dysphagia
5054968|NCT01405469|Peroral Endoscopic Myotomy|peroral endoscopic myotomy
5054969|NCT01405456|HIV-infection|hiv-infection
5054970|NCT01405456|eplerenone|eplerenone
5054971|NCT01405456|aldosterone|aldosterone
5054972|NCT01405456|visceral fat|visceral fat
5054973|NCT01405456|lipodystrophy|lipodystrophy
5054974|NCT01405443|Simulator training|simulator training
5054975|NCT01405443|Flexible endoscopy|flexible endoscopy
5054976|NCT01405443|Gastrointestinal endoscopy|gastrointestinal endoscopy
5054977|NCT01405443|Colonoscopy|colonoscopy
5054978|NCT01405443|Training|training
5054979|NCT01405443|Performance|performance
5054980|NCT01405417|Achalasia|achalasia
5054981|NCT01405417|Heller myotomy|heller myotomy
5054982|NCT01405417|Dysphagia|dysphagia
5054983|NCT01405417|Peroral Endoscopic Myotomy|peroral endoscopic myotomy
5054984|NCT01405404|parenting childcare discounts child behavior|parenting childcare discounts child behavior
5054985|NCT01405404|No Intervention Control|no intervention control
5054986|NCT01405404|Intervention no childcare discount|intervention no childcare discount
5054987|NCT01405404|Intervention with childcare discount|intervention with childcare discount
5054988|NCT01405391|Pharma Mar|pharma mar
5054989|NCT01405391|PM01183|pm01183
5054990|NCT01405391|Non-Colorectal Cancer (non-CRC)|non-colorectal cancer (non-crc)
5054991|NCT01405391|Dose finding phase I|dose finding phase i
5054992|NCT01405365|Periodontitis|periodontitis
5054993|NCT01405365|Periodontal diseases|periodontal diseases
5054994|NCT01405365|Obesity|obesity
5054995|NCT01405365|Metronidazole|metronidazole
5054996|NCT01405365|Prognosis|prognosis
5054997|NCT01405365|Probing depth|probing depth
5054998|NCT01405365|Periodontal attachment loss|periodontal attachment loss
5054999|NCT01405352|obesity|obesity
5055000|NCT01405352|vitamin A|vitamin a
5055001|NCT01405352|immune system|immune system
5055002|NCT01405326|rheumatoid arthritis|rheumatoid arthritis
5055003|NCT01405326|biological therapy|biological therapy
5055004|NCT01405326|adalimumab|adalimumab
5055005|NCT01405326|ability to work|ability to work
5055006|NCT01405326|sick leaves|sick leaves
5055007|NCT01405287|stent|stent
5055008|NCT01405287|drug eluting stent|drug eluting stent
5055009|NCT01405287|healing|healing
5055010|NCT01405287|endothelium|endothelium
5055011|NCT01405287|DES|des
5055012|NCT01405287|OCT|oct
5055013|NCT01405287|MI|mi
5055014|NCT01405287|ACS|acs
5055015|NCT01405248|Butylphthalide|butylphthalide
5055016|NCT01405235|Paclitaxel/Topotecan|paclitaxel/topotecan
5055017|NCT01405235|Cisplatin/Topotecan|cisplatin/topotecan
5055018|NCT01405222|exacerbation|exacerbation
5055019|NCT01405222|COPD|copd
5055020|NCT01405222|Cough|cough
5055021|NCT01405209|EKG|ekg
5055022|NCT01405209|AF|af
5055023|NCT01405209|biosignals|biosignals
5055024|NCT01405196|double-blind|double-blind
5055025|NCT01405196|placebo-controlled|placebo-controlled
5055026|NCT01405196|multicenter|multicenter
5055027|NCT01405196|dose-ranging|dose-ranging
5055028|NCT01405196|efficacy|efficacy
5055029|NCT01405196|safety|safety
5055030|NCT01405196|lupus.|lupus.
5055031|NCT01405183|Hepatitis C|hepatitis c
5055032|NCT01405183|Renal Cell Carcinoma|renal cell carcinoma
5055033|NCT01405183|Colorectal Cancer|colorectal cancer
5055034|NCT01405170|bioequivalence study|bioequivalence study
5055035|NCT01405170|methylprednisolone|methylprednisolone
5055036|NCT01405170|suspension|suspension
5055037|NCT01405170|tablets|tablets
5055038|NCT01405170|fed|fed
5055039|NCT01405157|bioequivalence study|bioequivalence study
5055040|NCT01405157|methylprednisolone|methylprednisolone
5055041|NCT01405157|suspension|suspension
5055042|NCT01405157|tablets|tablets
5055043|NCT01405157|fasting|fasting
5055044|NCT01405144|Photoaging|photoaging
5055045|NCT01405144|Actinic keratosis|actinic keratosis
5055046|NCT01405144|5-fluoruracil|5-fluoruracil
5055047|NCT01405144|Carcinogenesis|carcinogenesis
5055048|NCT01405131|bioequivalence study|bioequivalence study
5055049|NCT01405131|methylprednisolone|methylprednisolone
5055050|NCT01405131|suspension|suspension
5055051|NCT01405131|tablets|tablets
5055052|NCT01405118|Drug-Drug Interaction Healthy Volunteers CP-690|drug-drug interaction healthy volunteers cp-690
5055053|NCT01405118|550 Metformin|550 metformin
5055054|NCT01405092|volume|volume
5055055|NCT01405092|acute kidney injury|acute kidney injury
5055056|NCT01405092|continuous renal replacement|continuous renal replacement
5055057|NCT01405079|Lung cancer|lung cancer
5055058|NCT01405079|II-IIIA(N1-N2)|ii-iiia(n1-n2)
5055059|NCT01405079|Adjuvant treatment|adjuvant treatment
5055060|NCT01405079|EGFR mutations|egfr mutations
5055061|NCT01405079|Tyrosine kinase inhibitor|tyrosine kinase inhibitor
5055062|NCT01405066|Computed Tomography (CT)|computed tomography (ct)
5055063|NCT01405066|Ionizing radiation|ionizing radiation
5055064|NCT01405066|Advanced medical imaging|advanced medical imaging
5055065|NCT01405066|Radiation Dose Audit Reports|radiation dose audit reports
5055066|NCT01405053|Central Nervous System|central nervous system
5055067|NCT01405040|Cardiac|cardiac
5055068|NCT01405040|Output|output
5055069|NCT01405040|Preload|preload
5055070|NCT01405040|Lung|lung
5055071|NCT01405040|Water|water
5055072|NCT01405027|HCV|hcv
5055073|NCT01405027|Genotype1|genotype1
5055074|NCT01405027|Naive|naive
5055075|NCT01405027|Partial responder|partial responder
5055076|NCT01405027|Relapser|relapser
5055077|NCT01405014|Hold Me Tight|hold me tight
5055078|NCT01405014|Emotionally Focused Therapy|emotionally focused therapy
5055079|NCT01405014|Relationship enhancement|relationship enhancement
5055080|NCT01405014|Couples counseling|couples counseling
5055081|NCT01405014|Marital therapy|marital therapy
5055082|NCT01405014|Acquired brain injury|acquired brain injury
5055083|NCT01405014|Traumatic brain injury|traumatic brain injury
5055084|NCT01405014|Stroke|stroke
5055085|NCT01405001|Emergencies|emergencies
5055086|NCT01405001|War|war
5055087|NCT01405001|Intubation, Intratracheal|intubation, intratracheal
5055088|NCT01404988|Heart Failure|heart failure
5055089|NCT01404988|Telemedicine|telemedicine
5055090|NCT01404988|Medication Adherence|medication adherence
5055091|NCT01404975|Delirium|delirium
5055092|NCT01404975|PVB|pvb
5055093|NCT01404975|PCA|pca
5055094|NCT01404975|Opioid|opioid
5055095|NCT01404975|Aortic Valve replacement|aortic valve replacement
5055096|NCT01404962|Haemophilus influenza type b|haemophilus influenza type b
5055097|NCT01404962|children|children
5055098|NCT01404962|Korea|korea
5055099|NCT01404962|vaccine|vaccine
5055100|NCT01404962|Prevention of haemophilus influenza type b|prevention of haemophilus influenza type b
5055101|NCT01404949|Tretinoin|tretinoin
5055102|NCT01404949|all-trans retinoic acid|all-trans retinoic acid
5055103|NCT01404949|ATRA|atra
5055104|NCT01404949|Vesanoid|vesanoid
5055105|NCT01404949|Arsenic Trioxide|arsenic trioxide
5055106|NCT01404949|ATO|ato
5055107|NCT01404949|Trisenox|trisenox
5055108|NCT01404949|11-040|11-040
5055109|NCT01404936|Lymphoma|lymphoma
5055110|NCT01404936|Hodgkin's Disease|hodgkin's disease
5055111|NCT01404936|Stage III and IV|stage iii and iv
5055112|NCT01404936|Adriamycin|adriamycin
5055113|NCT01404936|Doxorubicin|doxorubicin
5055114|NCT01404936|Rubex|rubex
5055115|NCT01404936|Bleomycin|bleomycin
5055116|NCT01404936|Bleomycin Sulfate|bleomycin sulfate
5055117|NCT01404936|BLM|blm
5055118|NCT01404936|Dacarbazine|dacarbazine
5055119|NCT01404936|DTIC-DOME|dtic-dome
5055120|NCT01404936|Interferon-2A|interferon-2a
5055121|NCT01404936|Interferon-Alfa-2a|interferon-alfa-2a
5055122|NCT01404936|Roferon-A|roferon-a
5055123|NCT01404936|Velban|velban
5055124|NCT01404936|Vinblastine|vinblastine
5055125|NCT01404910|Pregnancy|pregnancy
5055126|NCT01404910|Preeclampsia|preeclampsia
5055127|NCT01404910|Pre-term|pre-term
5055128|NCT01404910|sFlt-1|sflt-1
5055129|NCT01404910|Apheresis|apheresis
5055130|NCT01404910|Hypertension|hypertension
5055131|NCT01404910|Proteinuria|proteinuria
5055132|NCT01404910|VEGF|vegf
5055133|NCT01404897|carbohydrate|carbohydrate
5055134|NCT01404897|DASH diet|dash diet
5055135|NCT01404897|blood pressure|blood pressure
5055136|NCT01404897|cholesterol|cholesterol
5055137|NCT01404884|myopia|myopia
5055138|NCT01404884|astigmatism|astigmatism
5055139|NCT01404884|presbyopia|presbyopia
5055140|NCT01404884|SUPRACOR|supracor
5055141|NCT01404884|multifocal|multifocal
5055142|NCT01404871|OCD|ocd
5055143|NCT01404871|pharmacogenetics|pharmacogenetics
5055144|NCT01404871|cortical inhibition|cortical inhibition
5055145|NCT01404871|genetics|genetics
5055146|NCT01404858|IVF|ivf
5055147|NCT01404858|Lifestyle habits|lifestyle habits
5055148|NCT01404845|exudative AMD|exudative amd
5055149|NCT01404845|dietary supplements|dietary supplements
5055150|NCT01404845|macular pigment|macular pigment
5055151|NCT01404845|lutein|lutein
5055152|NCT01404845|zeaxanthin|zeaxanthin
5055153|NCT01404845|Nutrof total|nutrof total
5055154|NCT01404845|in one eye|in one eye
5055155|NCT01404832|Gastroesophageal reflux|gastroesophageal reflux
5055156|NCT01404832|Proton pump inhibitor|proton pump inhibitor
5055157|NCT01404832|Eosinophilic esophagitis|eosinophilic esophagitis
5055158|NCT01404793|Liver Transplantation|liver transplantation
5055159|NCT01404793|Solid Phase Micro Extraction|solid phase micro extraction
5055160|NCT01404793|Rocuronium|rocuronium
5055161|NCT01404793|Metabolomics|metabolomics
5055162|NCT01404793|Pharmacokinetics|pharmacokinetics
5055163|NCT01404793|Clinical Marker|clinical marker
5055164|NCT01404780|Double lumen ET intubation|double lumen et intubation
5055165|NCT01404780|Laryngoscope|laryngoscope
5055166|NCT01404780|Lung Surgery|lung surgery
5055167|NCT01404767|Vascular surgery|vascular surgery
5055168|NCT01404767|esmolol|esmolol
5055169|NCT01404767|hemodynamic control|hemodynamic control
5055170|NCT01404754|MDMA|mdma
5055171|NCT01404754|mood|mood
5055172|NCT01404754|subjective effects|subjective effects
5055173|NCT01404754|interpersonal closeness|interpersonal closeness
5055174|NCT01404741|MDS|mds
5055175|NCT01404741|CMML|cmml
5055176|NCT01404741|allogeneic stem cell transplantation|allogeneic stem cell transplantation
5055177|NCT01404741|5-azacytidine|5-azacytidine
5055178|NCT01404728|Vaginal length|vaginal length
5055179|NCT01404728|Sexual dysfunction|sexual dysfunction
5055180|NCT01404715|Drug drug interaction|drug drug interaction
5055181|NCT01404702|Neuroblastoma|neuroblastoma
5055182|NCT01404702|Pediatrics|pediatrics
5055183|NCT01404702|Refractory|refractory
5055184|NCT01404702|Immunotherapy|immunotherapy
5055185|NCT01404702|Biological therapy|biological therapy
5055186|NCT01404702|Lymphocytes|lymphocytes
5055187|NCT01404702|Cancer|cancer
5055188|NCT01404702|Bisphosphonate|bisphosphonate
5055189|NCT01404689|dexmedetomidine|dexmedetomidine
5055190|NCT01404689|midazolam|midazolam
5055191|NCT01404689|ERCP|ercp
5055192|NCT01404689|cholangiopancreatography|cholangiopancreatography
5055193|NCT01404689|sedation|sedation
5055194|NCT01404689|propofol|propofol
5055195|NCT01404676|Glucose variability|glucose variability
5055196|NCT01404676|Oxidative stress|oxidative stress
5055197|NCT01404676|Endothelial cell function|endothelial cell function
5055198|NCT01404663|bone marrow CD133 transplantation side effects|bone marrow cd133 transplantation side effects
5055199|NCT01404663|side effects|side effects
5055200|NCT01404650|GIST|gist
5055201|NCT01404650|Refractory|refractory
5055202|NCT01404650|Gastrointestinal|gastrointestinal
5055203|NCT01404650|Stromal|stromal
5055204|NCT01404650|Tumor|tumor
5055205|NCT01404611|with tubes|with tubes
5055206|NCT01404559|Amputee|amputee
5055207|NCT01404559|Transtibial|transtibial
5055208|NCT01404559|Military|military
5055209|NCT01404559|Gait|gait
5055210|NCT01404559|Rehabilitation|rehabilitation
5055211|NCT01404546|stroke smoking cessation cost-free pharmacotherapy|stroke smoking cessation cost-free pharmacotherapy
5055212|NCT01404533|NTBI|ntbi
5055213|NCT01404533|Iron|iron
5055214|NCT01404533|Absorption|absorption
5055215|NCT01404520|#14 Cancer Related fatigue|#14 cancer related fatigue
5055216|NCT01404520|#13 Quality of Life|#13 quality of life
5055217|NCT01404520|"#12 Psychosocial Intervention[ti/ab]"|"#12 psychosocial intervention[ti/ab]"
5055218|NCT01404520|#11 Rehabilitation[tw]|#11 rehabilitation[tw]
5055219|NCT01404520|"#10 Physical Fitness[tw]"|"#10 physical fitness[tw]"
5055220|NCT01404520|"#9 Physical Activity[tw]"|"#9 physical activity[tw]"
5055221|NCT01404520|"#8 Exercise Therapy[tw]"|"#8 exercise therapy[tw]"
5055222|NCT01404520|#7 Exercise[tw]|#7 exercise[tw]
5055223|NCT01404520|#6 Hematologic[tw]|#6 hematologic[tw]
5055224|NCT01404520|#5 Hematological[tw]|#5 hematological[tw]
5055225|NCT01404520|#4 Leukemia, Myeloid, Acute[mh]|#4 leukemia, myeloid, acute[mh]
5055226|NCT01404520|"#3 Acute Myeloid Leukemia[tw]"|"#3 acute myeloid leukemia[tw]"
5055227|NCT01404520|"#2 Acute Lymphoblastic Leukemia[tw]"|"#2 acute lymphoblastic leukemia[tw]"
5055228|NCT01404520|"#1 Acute Leukemia[tw]"|"#1 acute leukemia[tw]"
5055229|NCT01404507|Acute Myocardial Infarction|acute myocardial infarction
5055230|NCT01404494|Haptic Skills|haptic skills
5055231|NCT01404494|Computer Assisted Interface|computer assisted interface
5055232|NCT01404494|TBI|tbi
5055233|NCT01404494|Traumatic Brain Injury|traumatic brain injury
5055234|NCT01404481|Urinary retention|urinary retention
5055235|NCT01404481|CISC|cisc
5055236|NCT01404481|Single use|single use
5055237|NCT01404481|Re use|re use
5055238|NCT01404442|midazolam|midazolam
5055239|NCT01404442|ketamine|ketamine
5055240|NCT01404442|intrathecal|intrathecal
5055241|NCT01404442|pain|pain
5055242|NCT01404429|Rheumatoid arthritis|rheumatoid arthritis
5055243|NCT01404429|Active|active
5055244|NCT01404390|Phase I|phase i
5055245|NCT01404390|Japanese|japanese
5055246|NCT01404377|breast surgery : postoperative pain; ropivacaine|breast surgery : postoperative pain; ropivacaine
5055247|NCT01404364|Triamcinolone|triamcinolone
5055248|NCT01404364|Chlorpromazine|chlorpromazine
5055249|NCT01404364|Refractory glaucoma|refractory glaucoma
5055250|NCT01404364|Blind painful eye|blind painful eye
5055251|NCT01404351|Reduction mammaplasty|reduction mammaplasty
5055252|NCT01404351|Breast reduction|breast reduction
5055253|NCT01404351|PlasmaBlade|plasmablade
5055254|NCT01404351|PEAK|peak
5055255|NCT01404325|Lung transplantation|lung transplantation
5055256|NCT01404325|everolimus|everolimus
5055257|NCT01404325|kidney function|kidney function
5055258|NCT01404299|Frailty,|frailty,
5055259|NCT01404299|nutritional supplementation,|nutritional supplementation,
5055260|NCT01404299|functional status|functional status
5055261|NCT01404260|chemotherapy|chemotherapy
5055262|NCT01404260|maintenance therapy|maintenance therapy
5055263|NCT01404260|gefitinib|gefitinib
5055264|NCT01404247|retina|retina
5055265|NCT01404247|optic nerve|optic nerve
5055266|NCT01404247|fovea|fovea
5055267|NCT01404247|Eyes|eyes
5055268|NCT01404247|Neonates|neonates
5055269|NCT01404234|Cystic fibrosis|cystic fibrosis
5055270|NCT01404234|CF|cf
5055271|NCT01404234|PA|pa
5055272|NCT01404234|Pseudomonas aeruginosa|pseudomonas aeruginosa
5055273|NCT01404234|AZLI|azli
5055274|NCT01404234|aztreonam|aztreonam
5055275|NCT01404234|Chronic Pseudomonas aeruginosa|chronic pseudomonas aeruginosa
5055276|NCT01404195|Nutritional supplement|nutritional supplement
5055277|NCT01404195|CaHMB|cahmb
5055278|NCT01404195|Barthel index|barthel index
5055279|NCT01404195|Frailty|frailty
5055280|NCT01404182|seasonal|seasonal
5055281|NCT01404182|prevention|prevention
5055282|NCT01404182|influenza|influenza
5055283|NCT01404182|infection|infection
5055284|NCT01404182|influenza vaccine|influenza vaccine
5055285|NCT01404182|vaccine|vaccine
5055286|NCT01404182|influenza in humans|influenza in humans
5055287|NCT01404169|Alzheimer Disease|alzheimer disease
5055288|NCT01404169|Dementia|dementia
5055289|NCT01404169|Delirium|delirium
5055290|NCT01404169|Amnestic|amnestic
5055291|NCT01404169|Cognitive Disorders|cognitive disorders
5055292|NCT01404169|Donepezil|donepezil
5055293|NCT01404169|Brain Diseases|brain diseases
5055294|NCT01404169|Central Nervous System Diseases|central nervous system diseases
5055295|NCT01404169|Nervous System Diseases|nervous system diseases
5055296|NCT01404169|Tauopathies|tauopathies
5055297|NCT01404169|Neurodegenerative Diseases|neurodegenerative diseases
5055298|NCT01404169|Mental Disorders|mental disorders
5055299|NCT01404169|Cholinesterase Inhibitors|cholinesterase inhibitors
5055300|NCT01404169|Enzy|enzy
5055301|NCT01404156|Esophageal cancer|esophageal cancer
5055302|NCT01404156|Neoadjuvant|neoadjuvant
5055303|NCT01404156|Chemotherapy|chemotherapy
5055304|NCT01404156|Chemoradiation|chemoradiation
5055305|NCT01404156|Surgery|surgery
5055306|NCT01404156|Esophagectomy|esophagectomy
5055307|NCT01404156|Adenocarcinoma|adenocarcinoma
5055308|NCT01404156|Gastroesophageal|gastroesophageal
5055309|NCT01404130|isotretinoin|isotretinoin
5055310|NCT01404130|hippocampus|hippocampus
5055311|NCT01404130|memory|memory
5055312|NCT01404130|learning|learning
5055313|NCT01404130|CANTAB|cantab
5055314|NCT01404065|transcranial direct current stimulation|transcranial direct current stimulation
5055315|NCT01404052|transcranial direct current stimulation|transcranial direct current stimulation
5055316|NCT01404052|transcranial ultrasound|transcranial ultrasound
5055317|NCT01404039|learning|learning
5055318|NCT01404039|pain perception|pain perception
5055319|NCT01404026|Transcranial Direct Current Stimulation|transcranial direct current stimulation
5055320|NCT01404013|Montelukast|montelukast
5055321|NCT01404013|Cough variant asthma|cough variant asthma
5055322|NCT01404013|Inhaled Corticosteroid|inhaled corticosteroid
5055323|NCT01403987|Education|education
5055324|NCT01403987|Ascites|ascites
5055325|NCT01403987|Liver|liver
5055326|NCT01403987|Guidelines|guidelines
5055416|NCT01403506|kidney transplantation|kidney transplantation
5055417|NCT01403506|N-Acetyl Cysteine|n-acetyl cysteine
5055327|NCT01403922|Phase I, Randomised, Placebo-Controlled, Double-Blind,Hypertensive Patients, Blood Pressure, Calcium Channel Blockers, Beta Blockers, ACE Inhibitors|phase i, randomised, placebo-controlled, double-blind,hypertensive patients, blood pressure, calcium channel blockers, beta blockers, ace inhibitors
5055328|NCT01403922|Scientific terminology: To determine if treatment with TC5214 alone or in combination with Anti-Hypertensive Medications has an effect on sitting blood pressure|scientific terminology: to determine if treatment with tc5214 alone or in combination with anti-hypertensive medications has an effect on sitting blood pressure
5055329|NCT01403922|Laymen terminology: Hypertension|laymen terminology: hypertension
5055330|NCT01403896|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
5055331|NCT01403896|Plerixafor|plerixafor
5055332|NCT01403896|Healthy Donors|healthy donors
5055333|NCT01403896|Stem Cell Graft|stem cell graft
5055334|NCT01403883|Rectal cancer|rectal cancer
5055335|NCT01403883|Temporary stoma|temporary stoma
5055336|NCT01403883|Psychological disorders|psychological disorders
5055337|NCT01403870|Low Back Pain|low back pain
5055338|NCT01403857|Acceptability|acceptability
5055339|NCT01403857|liking|liking
5055340|NCT01403844|resonance Raman spectroscopy|resonance raman spectroscopy
5055341|NCT01403844|Dietary Guidelines|dietary guidelines
5055342|NCT01403844|fruits|fruits
5055343|NCT01403844|biomarkers|biomarkers
5055344|NCT01403844|carotenoids|carotenoids
5055345|NCT01403844|MyPlate|myplate
5055346|NCT01403844|vegetables|vegetables
5055347|NCT01403818|ASP1941|asp1941
5055348|NCT01403818|ipragliflozin|ipragliflozin
5055349|NCT01403818|Mitiglinide calcium hydrate|mitiglinide calcium hydrate
5055350|NCT01403818|Drug-Drug interaction|drug-drug interaction
5055351|NCT01403818|Pharmacokinetics|pharmacokinetics
5055352|NCT01403805|Oral care|oral care
5055353|NCT01403805|Vaccine|vaccine
5055354|NCT01403805|Pneumonia|pneumonia
5055355|NCT01403805|Elderly|elderly
5055356|NCT01403805|Prevention|prevention
5055357|NCT01403805|Primary care|primary care
5055358|NCT01403792|Human Immunodeficiency Virus|human immunodeficiency virus
5055359|NCT01403792|Neutralising monoclonal antibody|neutralising monoclonal antibody
5055360|NCT01403779|Intensity-Modulated Radiation Therapy (IMRT)|intensity-modulated radiation therapy (imrt)
5055361|NCT01403779|Breast cancer|breast cancer
5055362|NCT01403779|Hypofractionation|hypofractionation
5055363|NCT01403766|pediatric|pediatric
5055364|NCT01403766|kidney|kidney
5055365|NCT01403766|transplant|transplant
5055366|NCT01403766|GFR|gfr
5055367|NCT01403766|creatinine|creatinine
5055368|NCT01403766|cystatin C|cystatin c
5055369|NCT01403766|iohexol|iohexol
5055370|NCT01403753|Obesity|obesity
5055371|NCT01403753|Child|child
5055372|NCT01403753|Dietary Habits|dietary habits
5055373|NCT01403740|acquired haemophilia|acquired haemophilia
5055374|NCT01403740|factor VIII|factor viii
5055375|NCT01403727|Biopsy of liver tumors|biopsy of liver tumors
5055376|NCT01403714|acute heart failure|acute heart failure
5055377|NCT01403701|physical therapy|physical therapy
5055378|NCT01403701|pelvic prolapse|pelvic prolapse
5055379|NCT01403701|incontinence|incontinence
5055380|NCT01403701|quality of life|quality of life
5055381|NCT01403688|fertility high risk, controlled ovarian stimulation, breast cancer|fertility high risk, controlled ovarian stimulation, breast cancer
5055382|NCT01403675|women with cancer whose ovarian tissue has been collected and stored in liquid nitrogen before cancer therapy (surgery, chemotherapy, radiotherapy),|women with cancer whose ovarian tissue has been collected and stored in liquid nitrogen before cancer therapy (surgery, chemotherapy, radiotherapy),
5055383|NCT01403675|who are in remission (no recurrence of disease for 5 years),|who are in remission (no recurrence of disease for 5 years),
5055384|NCT01403675|who are in normal organ function and have no contraindication for surgery or pregnancy, and|who are in normal organ function and have no contraindication for surgery or pregnancy, and
5055385|NCT01403675|who wish to restore ovarian function using stored ovarian tissue.|who wish to restore ovarian function using stored ovarian tissue.
5055386|NCT01403662|bipolar disorder|bipolar disorder
5055387|NCT01403662|depression|depression
5055388|NCT01403662|major depression|major depression
5055389|NCT01403662|bipolar I depression|bipolar i depression
5055390|NCT01403662|bipolar II depression|bipolar ii depression
5055391|NCT01403662|bipolar I disorder|bipolar i disorder
5055392|NCT01403662|bipolar II disorder|bipolar ii disorder
5055393|NCT01403662|minocycline|minocycline
5055394|NCT01403662|minocin|minocin
5055395|NCT01403623|Hypothermia|hypothermia
5055396|NCT01403623|Newborn|newborn
5055397|NCT01403623|Resuscitation|resuscitation
5055398|NCT01403623|Plastic bag|plastic bag
5055399|NCT01403610|TH-302|th-302
5055400|NCT01403610|Bevacizumab|bevacizumab
5055401|NCT01403610|Phase 2|phase 2
5055402|NCT01403610|Glioma|glioma
5055403|NCT01403610|High Grade Glioma|high grade glioma
5055404|NCT01403610|CNS|cns
5055405|NCT01403597|Skin wrinkling|skin wrinkling
5055406|NCT01403597|Skin aging|skin aging
5055407|NCT01403597|Skin pigmentation|skin pigmentation
5055408|NCT01403545|Safety|safety
5055409|NCT01403545|Tolerability|tolerability
5055410|NCT01403545|Pharmacokinetics|pharmacokinetics
5055411|NCT01403545|Liposomal Curcumin|liposomal curcumin
5055412|NCT01403532|Hypogonadotropic Hypogonadism|hypogonadotropic hypogonadism
5055413|NCT01403532|Kallmann Syndrome|kallmann syndrome
5055414|NCT01403532|LH|lh
5055415|NCT01403532|FSH|fsh
5055617|NCT01402687|Mucositis|mucositis
5055418|NCT01403506|living donor|living donor
5055419|NCT01403506|delayed graft function|delayed graft function
5055420|NCT01403493|Irritable bowel syndrome|irritable bowel syndrome
5055421|NCT01403493|Patient education|patient education
5055422|NCT01403480|Basal Cell Carcinoma|basal cell carcinoma
5055423|NCT01403467|Bronchial disease|bronchial disease
5055424|NCT01403467|asthma|asthma
5055425|NCT01403467|continuous positive airway pressure (CPAP)|continuous positive airway pressure (cpap)
5055426|NCT01403467|Bronchoconstriction|bronchoconstriction
5055427|NCT01403454|chronic kidney disease|chronic kidney disease
5055428|NCT01403454|web-based application|web-based application
5055429|NCT01403454|dialysis education|dialysis education
5055430|NCT01403441|Refractory Bipolar Depression|refractory bipolar depression
5055431|NCT01403428|Asthma|asthma
5055432|NCT01403428|non invasive ventilation|non invasive ventilation
5055433|NCT01403428|pediatrics|pediatrics
5055434|NCT01403428|noninvasive positive pressure ventilation (NPPV)|noninvasive positive pressure ventilation (nppv)
5055435|NCT01403402|Congenital Muscular Dystrophy|congenital muscular dystrophy
5055436|NCT01403402|Congenital Myopathy|congenital myopathy
5055437|NCT01403402|Neuromuscular Diseases|neuromuscular diseases
5055438|NCT01403402|Musculoskeletal Diseases|musculoskeletal diseases
5055439|NCT01403389|Kidney Transplant|kidney transplant
5055440|NCT01403389|Delayed Graft Function|delayed graft function
5055441|NCT01403350|Malaria|malaria
5055442|NCT01403350|Fever|fever
5055443|NCT01403350|Acute febrile illness|acute febrile illness
5055444|NCT01403350|Pneumonia|pneumonia
5055445|NCT01403350|Community health worker|community health worker
5055446|NCT01403350|Rapid diagnostic test|rapid diagnostic test
5055447|NCT01403337|peripheral arterial disease|peripheral arterial disease
5055448|NCT01403337|myocardial infarction|myocardial infarction
5055449|NCT01403324|metastatic or locally advanced differentiated thyroid cancer|metastatic or locally advanced differentiated thyroid cancer
5055450|NCT01403324|planned for a therapeutic activity of 131I after thyroid hormone withdrawal|planned for a therapeutic activity of 131i after thyroid hormone withdrawal
5055451|NCT01403311|Anaplastic astrocytoma|anaplastic astrocytoma
5055452|NCT01403311|Astrocytoma|astrocytoma
5055453|NCT01403311|Brain stem glioma|brain stem glioma
5055454|NCT01403311|Ependymoma|ependymoma
5055455|NCT01403311|Glioblastoma|glioblastoma
5055456|NCT01403311|Glioblastoma multiforme|glioblastoma multiforme
5055457|NCT01403311|Gliosarcoma|gliosarcoma
5055458|NCT01403311|oligodendroglioma|oligodendroglioma
5055459|NCT01403311|Medulloblastoma|medulloblastoma
5055460|NCT01403311|Mixed astrocytoma-ependymoma|mixed astrocytoma-ependymoma
5055461|NCT01403311|ALA|ala
5055462|NCT01403298|Adolescent|adolescent
5055463|NCT01403298|HIV|hiv
5055464|NCT01403298|AIDS|aids
5055465|NCT01403298|Sexual risk|sexual risk
5055466|NCT01403298|Family|family
5055467|NCT01403298|Prevention|prevention
5055468|NCT01403298|Juvenile Drug Court|juvenile drug court
5055469|NCT01403298|Juvenile Justice|juvenile justice
5055470|NCT01403298|Drug Use|drug use
5055471|NCT01403298|Marijuana|marijuana
5055472|NCT01403285|Glioblastoma|glioblastoma
5055473|NCT01403285|stable disease|stable disease
5055474|NCT01403272|pressure ulcers|pressure ulcers
5055475|NCT01403272|stage 1|stage 1
5055476|NCT01403272|stage 2|stage 2
5055477|NCT01403272|stage 3|stage 3
5055478|NCT01403272|stage 4|stage 4
5055479|NCT01403272|wounds|wounds
5055480|NCT01403272|sores|sores
5055481|NCT01403272|infection|infection
5055482|NCT01403272|bioburden|bioburden
5055483|NCT01403272|bacterial contamination|bacterial contamination
5055484|NCT01403272|bed linen|bed linen
5055485|NCT01403272|sheets|sheets
5055486|NCT01403272|underpad|underpad
5055487|NCT01403272|skin assessment|skin assessment
5055488|NCT01403272|microclimate|microclimate
5055489|NCT01403272|shear|shear
5055490|NCT01403272|friction|friction
5055491|NCT01403272|moisture|moisture
5055492|NCT01403272|fabrics|fabrics
5055493|NCT01403272|long term care|long term care
5055494|NCT01403272|nursing home|nursing home
5055495|NCT01403272|decubitus ulcer|decubitus ulcer
5055496|NCT01403272|bed ridden|bed ridden
5055497|NCT01403272|anti-microbial|anti-microbial
5055498|NCT01403259|Nasopharyngeal carcinoma|nasopharyngeal carcinoma
5055499|NCT01403259|S-1|s-1
5055500|NCT01403259|Oxaliplatin|oxaliplatin
5055501|NCT01403246|CLL|cll
5055502|NCT01403246|Lenalidomide|lenalidomide
5055503|NCT01403246|Chlorambucil|chlorambucil
5055504|NCT01403246|No previous treatment|no previous treatment
5055505|NCT01403233|Pharmacokinetics|pharmacokinetics
5055506|NCT01403233|Safety|safety
5055507|NCT01403207|Sex differences|sex differences
5055508|NCT01403207|knee joint|knee joint
5055509|NCT01403207|inflammatory mediators|inflammatory mediators
5055510|NCT01403207|Vitamin D|vitamin d
5055511|NCT01403207|osteoarthritis|osteoarthritis
5055512|NCT01403194|Sleep Disordered Breathing|sleep disordered breathing
5055513|NCT01403194|CPAP|cpap
5055514|NCT01403194|BiPAP|bipap
5055515|NCT01403194|Cardiovascular risk markers|cardiovascular risk markers
5055516|NCT01403181|HCV|hcv
5055517|NCT01403181|T cells|t cells
5055518|NCT01403181|cytokines|cytokines
5055519|NCT01403181|cytotoxicity|cytotoxicity
5055720|NCT01402362|Ethiopians|ethiopians
5055520|NCT01403181|proliferation|proliferation
5055521|NCT01403168|Osteopathy|osteopathy
5055522|NCT01403168|Breast cancer|breast cancer
5055523|NCT01403168|Pain|pain
5055524|NCT01403155|H5N1|h5n1
5055525|NCT01403155|Avian Influenza|avian influenza
5055526|NCT01403155|DNA Vaccine|dna vaccine
5055527|NCT01403155|Intradermal (ID) Injection|intradermal (id) injection
5055528|NCT01403155|Electroporation|electroporation
5055529|NCT01403155|Healthy Adults|healthy adults
5055530|NCT01403142|heart transplant|heart transplant
5055531|NCT01403142|vasculopathy|vasculopathy
5055532|NCT01403129|keratoconus|keratoconus
5055533|NCT01403129|keratoconus-suspect|keratoconus-suspect
5055534|NCT01403129|ultrasound exam|ultrasound exam
5055535|NCT01403129|acoustic radiation force ultrasound exam|acoustic radiation force ultrasound exam
5055536|NCT01403116|testosterone|testosterone
5055537|NCT01403116|male hypogonadism|male hypogonadism
5055538|NCT01403116|low testosterone|low testosterone
5055539|NCT01403090|Pulmonary Embolism|pulmonary embolism
5055540|NCT01403090|Deep Vein Thrombosis|deep vein thrombosis
5055541|NCT01403090|Venous Thromboembolism|venous thromboembolism
5055542|NCT01403090|Central Line Catheter|central line catheter
5055543|NCT01403090|Vena Cava Filters|vena cava filters
5055544|NCT01403077|Superficial femoral artery|superficial femoral artery
5055545|NCT01403077|Peripheral arterial disease|peripheral arterial disease
5055546|NCT01403077|Atherosclerosis|atherosclerosis
5055547|NCT01403077|Intermittent Claudication|intermittent claudication
5055548|NCT01403077|Vascular Diseases|vascular diseases
5055549|NCT01403077|Cardiovascular Diseases|cardiovascular diseases
5055550|NCT01403064|Oral mucositis; head and neck cancer; chemotherapy; radiotherapy|oral mucositis; head and neck cancer; chemotherapy; radiotherapy
5055551|NCT01403038|healthy volunteers|healthy volunteers
5055552|NCT01403038|elagolix|elagolix
5055553|NCT01403038|endometriosis|endometriosis
5055554|NCT01403038|ovarian reserve|ovarian reserve
5055555|NCT01403038|gonadotropin-releasing hormone antagonist|gonadotropin-releasing hormone antagonist
5055556|NCT01403038|ovulation|ovulation
5055557|NCT01403038|ovarian activity|ovarian activity
5055558|NCT01403012|To identify clinical and metabolomic markers that underlie variability in response to systemic therapy in psoriasis|to identify clinical and metabolomic markers that underlie variability in response to systemic therapy in psoriasis
5055559|NCT01403012|To identify metabolomic signatures associated with psoriasis|to identify metabolomic signatures associated with psoriasis
5055560|NCT01403012|To identify possible treatment-specific metabolomic signatures|to identify possible treatment-specific metabolomic signatures
5055561|NCT01402999|Growth disorders|growth disorders
5055562|NCT01402999|Saizen|saizen
5055563|NCT01402999|Easypod|easypod
5055564|NCT01402999|Growth hormone|growth hormone
5055565|NCT01402999|Pediatric subject|pediatric subject
5055566|NCT01402986|Asthma|asthma
5055567|NCT01402986|Tralokinumab|tralokinumab
5055568|NCT01402986|CAT-354|cat-354
5055569|NCT01402960|High-Definition Transcranial Direct Current Stimulation|high-definition transcranial direct current stimulation
5055570|NCT01402908|Hepatocellular Carcinoma|hepatocellular carcinoma
5055571|NCT01402908|PI-88|pi-88
5055572|NCT01402908|Phase III|phase iii
5055573|NCT01402908|Adjuvant Therapy|adjuvant therapy
5055574|NCT01402908|Hepatoma|hepatoma
5055575|NCT01402908|Liver Cancer|liver cancer
5055576|NCT01402895|Nerve conduction|nerve conduction
5055577|NCT01402895|H-reflex, mobilizations|h-reflex, mobilizations
5055578|NCT01402895|with neurodynamic component|with neurodynamic component
5055579|NCT01402882|traumatic brain injury|traumatic brain injury
5055580|NCT01402882|tranexamic acid|tranexamic acid
5055581|NCT01402882|antifibrinolytic|antifibrinolytic
5055582|NCT01402882|randomised|randomised
5055583|NCT01402882|clinical trial|clinical trial
5055584|NCT01402869|Methemoglobin|methemoglobin
5055585|NCT01402869|Methemoglobinemia|methemoglobinemia
5055586|NCT01402869|Prilocaine|prilocaine
5055587|NCT01402869|Lidocaine|lidocaine
5055588|NCT01402856|Prevention|prevention
5055589|NCT01402856|Adolescent|adolescent
5055590|NCT01402856|Trauma|trauma
5055591|NCT01402856|Driving|driving
5055592|NCT01402843|phase III combination study|phase iii combination study
5055593|NCT01402830|cancer|cancer
5055594|NCT01402830|depression|depression
5055595|NCT01402830|pain|pain
5055596|NCT01402817|NF1|nf1
5055597|NCT01402817|plexiform neurofibromas|plexiform neurofibromas
5055598|NCT01402817|Sunitinib|sunitinib
5055599|NCT01402817|Sutent®|sutent®
5055600|NCT01402739|PoC|poc
5055601|NCT01402739|ROTEM|rotem
5055602|NCT01402739|Multiplate|multiplate
5055603|NCT01402739|transfusion|transfusion
5055604|NCT01402739|cardiac surgery|cardiac surgery
5055605|NCT01402739|drainage blood loss|drainage blood loss
5055606|NCT01402739|chest tube output|chest tube output
5055607|NCT01402726|renal artery|renal artery
5055608|NCT01402726|sympathetic nerves|sympathetic nerves
5055609|NCT01402726|modification|modification
5055610|NCT01402726|heart failure|heart failure
5055611|NCT01402700|Peripheral arterial disease|peripheral arterial disease
5055612|NCT01402700|claudication|claudication
5055613|NCT01402700|stent|stent
5055614|NCT01402700|VISI-Pro|visi-pro
5055615|NCT01402700|Iliac artery|iliac artery
5055616|NCT01402687|Stem Cell Transplant|stem cell transplant
5055618|NCT01402674|Obesity treatment|obesity treatment
5055619|NCT01402674|Phentermine|phentermine
5055620|NCT01402674|Withholding treatment|withholding treatment
5055621|NCT01402674|Phentermine dependence|phentermine dependence
5055622|NCT01402661|rheumatoid arthritis|rheumatoid arthritis
5055623|NCT01402661|psoriatic arthritis|psoriatic arthritis
5055624|NCT01402661|disease registry|disease registry
5055625|NCT01402648|Non adenomatous mucosa|non adenomatous mucosa
5055626|NCT01402648|Estrogen Receptor beta and apoptosis|estrogen receptor beta and apoptosis
5055627|NCT01402648|Adenoma recurrence|adenoma recurrence
5055628|NCT01402648|Screening colonoscopy every 3-5 years|screening colonoscopy every 3-5 years
5055629|NCT01402648|patients at intermediate risk for CRC|patients at intermediate risk for crc
5055630|NCT01402635|crowding|crowding
5055631|NCT01402635|Point-of-Care Systems|point-of-care systems
5055632|NCT01402635|emergency medicine|emergency medicine
5055633|NCT01402609|Continuity of care|continuity of care
5055634|NCT01402609|Patient safety|patient safety
5055635|NCT01402609|Communication between acute and community care providers|communication between acute and community care providers
5055636|NCT01402596|Deep Sedation|deep sedation
5055637|NCT01402596|Pediatrics|pediatrics
5055638|NCT01402596|Emergency Hospital Services|emergency hospital services
5055639|NCT01402596|Midazolam|midazolam
5055640|NCT01402596|Chloral hydrate|chloral hydrate
5055641|NCT01402596|Randomized controlled trial|randomized controlled trial
5055642|NCT01402583|Hepatitis C|hepatitis c
5055643|NCT01402583|Gender|gender
5055644|NCT01402583|Menopause|menopause
5055645|NCT01402583|Sustained viral response|sustained viral response
5055646|NCT01402583|Cytokines|cytokines
5055647|NCT01402570|disability|disability
5055648|NCT01402570|polio|polio
5055649|NCT01402570|rehabilitation|rehabilitation
5055650|NCT01402570|wellness|wellness
5055651|NCT01402557|Obesity|obesity
5055652|NCT01402557|Body Weight Changes|body weight changes
5055653|NCT01402557|Internet|internet
5055654|NCT01402544|AMD|amd
5055655|NCT01402544|Choroidal neovascularization|choroidal neovascularization
5055656|NCT01402544|Ranibizumab|ranibizumab
5055657|NCT01402544|Age-related Macular Degeneration|age-related macular degeneration
5055658|NCT01402544|Genome|genome
5055659|NCT01402531|Hereditary hemorrhagic telangiectasia (HHT)|hereditary hemorrhagic telangiectasia (hht)
5055660|NCT01402531|nosebleed|nosebleed
5055661|NCT01402531|Bevacizumab|bevacizumab
5055662|NCT01402531|Avastin|avastin
5055663|NCT01402518|achalasia|achalasia
5055664|NCT01402518|myotomy|myotomy
5055665|NCT01402518|endoscopic myotomy|endoscopic myotomy
5055666|NCT01402518|difficulty swallowing|difficulty swallowing
5055667|NCT01402505|obesity|obesity
5055668|NCT01402505|sleeve gastrectomy|sleeve gastrectomy
5055669|NCT01402505|transvaginal NOTES|transvaginal notes
5055670|NCT01402492|Cocaine-Related disorders|cocaine-related disorders
5055671|NCT01402492|Cocaine|cocaine
5055672|NCT01402492|Substance-Related disorders|substance-related disorders
5055673|NCT01402492|Opioid abuse|opioid abuse
5055674|NCT01402492|Opioid dependence|opioid dependence
5055675|NCT01402492|abuse|abuse
5055676|NCT01402492|addiction|addiction
5055677|NCT01402492|treatment|treatment
5055678|NCT01402492|buprenorphine|buprenorphine
5055679|NCT01402492|naltrexone|naltrexone
5055680|NCT01402492|Suboxone|suboxone
5055681|NCT01402492|Vivitrol|vivitrol
5055682|NCT01402479|migraine,|migraine,
5055683|NCT01402479|ramipril,|ramipril,
5055684|NCT01402479|hypertension|hypertension
5055685|NCT01402466|Drug users|drug users
5055686|NCT01402466|criminal justice|criminal justice
5055687|NCT01402466|HIV care|hiv care
5055688|NCT01402466|HAART|haart
5055689|NCT01402466|incarceration|incarceration
5055690|NCT01402453|Incentives|incentives
5055691|NCT01402453|Social psychology|social psychology
5055692|NCT01402453|Randomized trial|randomized trial
5055693|NCT01402453|Hypertension|hypertension
5055694|NCT01402453|Intervention|intervention
5055695|NCT01402453|Pilot Study|pilot study
5055696|NCT01402440|Diffuse Large B-Cell Lymphoma,|diffuse large b-cell lymphoma,
5055697|NCT01402440|Phase 1,|phase 1,
5055698|NCT01402440|CD79 Mutation|cd79 mutation
5055699|NCT01402427|Coronary Artery Disease|coronary artery disease
5055700|NCT01402427|Coronary Angiography|coronary angiography
5055701|NCT01402427|Percutaneous Coronary Intervention|percutaneous coronary intervention
5055702|NCT01402427|Transradial|transradial
5055703|NCT01402427|Radial Artery Spasm|radial artery spasm
5055704|NCT01402427|Verapamil|verapamil
5055705|NCT01402427|Adverse Effects|adverse effects
5055706|NCT01402414|atopic dermatitis|atopic dermatitis
5055707|NCT01402414|NB-UVB|nb-uvb
5055708|NCT01402414|phototherapy|phototherapy
5055709|NCT01402414|balneophototherapy|balneophototherapy
5055710|NCT01402414|Bath-PUVA|bath-puva
5055711|NCT01402414|SCORAD index|scorad index
5055712|NCT01402401|HER2+,|her2+,
5055713|NCT01402401|Gastric Cancer,|gastric cancer,
5055714|NCT01402401|HSP90,|hsp90,
5055715|NCT01402401|2nd-line,|2nd-line,
5055716|NCT01402401|Trastuzumab|trastuzumab
5055717|NCT01402375|Pain Management|pain management
5055718|NCT01402375|Emergency Medicine|emergency medicine
5055719|NCT01402375|Extremity Injuries|extremity injuries
5055721|NCT01402362|Diabetes Mellitus|diabetes mellitus
5055722|NCT01402362|Glucose tolerance|glucose tolerance
5055723|NCT01402362|Israel|israel
5055724|NCT01402362|Included in the year 2000 study|included in the year 2000 study
5055725|NCT01402349|Chronic rhinosinusitis, SNOT 22, Quality of life|chronic rhinosinusitis, snot 22, quality of life
5055726|NCT01402336|Polycystic ovary syndrome|polycystic ovary syndrome
5055727|NCT01402336|ovulation induction|ovulation induction
5055728|NCT01402336|In vitro fertilization-embryo transfer|in vitro fertilization-embryo transfer
5055729|NCT01402310|Onset of labor|onset of labor
5055730|NCT01402310|Bishop score|bishop score
5055731|NCT01402310|Cervical length|cervical length
5055732|NCT01402310|Multiple proteins|multiple proteins
5055733|NCT01402310|Cervicovaginal fluid|cervicovaginal fluid
5055734|NCT01402297|apocynin|apocynin
5055735|NCT01402297|COPD|copd
5055736|NCT01402284|Novel Drug Combinations|novel drug combinations
5055737|NCT01402284|Protease Inhibitors|protease inhibitors
5055738|NCT01402284|Decreased Peripheral Neuropathy|decreased peripheral neuropathy
5055739|NCT01402284|Auto Stem Cell Transplant|auto stem cell transplant
5055740|NCT01402284|Multiple Myeloma|multiple myeloma
5055741|NCT01402271|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5055742|NCT01402271|recurrent fallopian tube cancer|recurrent fallopian tube cancer
5055743|NCT01402271|recurrent primary peritoneal cavity cancer|recurrent primary peritoneal cavity cancer
5055744|NCT01402245|pneumonia|pneumonia
5055745|NCT01402245|pneumococcal polysaccharide vaccine|pneumococcal polysaccharide vaccine
5055746|NCT01402245|pneumococcal conjugate vaccine|pneumococcal conjugate vaccine
5055747|NCT01402232|contrast-induced nephropathy|contrast-induced nephropathy
5055748|NCT01402232|contrast medium|contrast medium
5055749|NCT01402232|creatinine clearance|creatinine clearance
5055750|NCT01402232|coronary angiography|coronary angiography
5055751|NCT01402232|diabetes|diabetes
5055752|NCT01402232|chronic kidney disease|chronic kidney disease
5055753|NCT01402232|predictive|predictive
5055754|NCT01402219|contrast-induced nephropathy|contrast-induced nephropathy
5055755|NCT01402219|contrast medium|contrast medium
5055756|NCT01402219|creatinine clearance|creatinine clearance
5055757|NCT01402219|coronary angiography|coronary angiography
5055758|NCT01402219|chronic kidney disease|chronic kidney disease
5055759|NCT01402206|Depression|depression
5055760|NCT01402206|Intervention|intervention
5055761|NCT01402206|Primary health care|primary health care
5055762|NCT01402193|Breast Cancer|breast cancer
5055763|NCT01402193|Timing of Radiotherapy|timing of radiotherapy
5055764|NCT01402193|TGF-beta1|tgf-beta1
5055765|NCT01402180|Esophageal squamous cell carcinoma|esophageal squamous cell carcinoma
5055766|NCT01402180|lymph nodes recurrence|lymph nodes recurrence
5055767|NCT01402180|chemoradiation|chemoradiation
5055768|NCT01402180|Nimotuzumab|nimotuzumab
5055769|NCT01402141|Chungkookjang|chungkookjang
5055770|NCT01402141|histamine|histamine
5055771|NCT01402141|skin reaction|skin reaction
5055772|NCT01402141|wheal|wheal
5055773|NCT01402128|Soluble fiber|soluble fiber
5055774|NCT01402128|Polycan|polycan
5055775|NCT01402128|Overweight|overweight
5055776|NCT01402128|LDL-C(Low Density Lipoprotein-cholesterol)|ldl-c(low density lipoprotein-cholesterol)
5055777|NCT01402115|Polycan|polycan
5055778|NCT01402115|Bone metabolism|bone metabolism
5055779|NCT01402115|Osteocalcin|osteocalcin
5055780|NCT01402115|Deoxypyridinoline|deoxypyridinoline
5055781|NCT01402102|Aged garlic|aged garlic
5055782|NCT01402102|Hyperlipidemic|hyperlipidemic
5055783|NCT01402102|LDL|ldl
5055784|NCT01402102|HDL|hdl
5055785|NCT01402102|Triglyceride|triglyceride
5055786|NCT01402089|phenotyping|phenotyping
5055787|NCT01402089|cytochrome p450|cytochrome p450
5055788|NCT01402089|erlotinib|erlotinib
5055789|NCT01402089|sunitinib|sunitinib
5055790|NCT01402089|lung cancer|lung cancer
5055791|NCT01402089|renal-cell cancer|renal-cell cancer
5055792|NCT01402089|gastrointestinal stromal tumor|gastrointestinal stromal tumor
5055793|NCT01402076|Pharmacokinetics|pharmacokinetics
5055794|NCT01402076|Drug Interaction|drug interaction
5055795|NCT01402063|Brain Tumors|brain tumors
5055796|NCT01402063|Glioblastoma Multiforme|glioblastoma multiforme
5055797|NCT01402063|GBM|gbm
5055798|NCT01402050|Time from the start of the induction to delivery|time from the start of the induction to delivery
5055799|NCT01402037|type 1 diabetes|type 1 diabetes
5055800|NCT01402037|Prevention|prevention
5055801|NCT01402037|First degree relatives|first degree relatives
5055802|NCT01402037|High risk for type 1 diabetes|high risk for type 1 diabetes
5055803|NCT01402011|Prolotherapy|prolotherapy
5055804|NCT01402011|regenerative injection therapy|regenerative injection therapy
5055805|NCT01402011|dextrose injections|dextrose injections
5055806|NCT01401998|cystic kidney disease|cystic kidney disease
5055807|NCT01401998|polycystic kidney disease|polycystic kidney disease
5055808|NCT01401998|congenital hepatic fibrosis|congenital hepatic fibrosis
5055809|NCT01401998|genetic disease|genetic disease
5055810|NCT01401985|Opioid induced constipation|opioid induced constipation
5055811|NCT01401985|OIC|oic
5055812|NCT01401985|Constipation|constipation
5055813|NCT01401985|Opioid side effects|opioid side effects
5055814|NCT01401985|morphine induced constipation|morphine induced constipation
5055815|NCT01401972|prostate|prostate
5055816|NCT01401972|cancer|cancer
5055817|NCT01401972|ultrasound|ultrasound
5055818|NCT01401972|spectroscopy|spectroscopy
5055819|NCT01401959|Metastatic Breast Cancer|metastatic breast cancer
5055820|NCT01401959|Adjuvant|adjuvant
5055821|NCT01401959|Residual Disease|residual disease
5055822|NCT01401959|eribulin|eribulin
5055823|NCT01401959|Trastuzumab|trastuzumab
5055824|NCT01401920|internal jugular vein cannulation|internal jugular vein cannulation
5055825|NCT01401920|cross-sectional area|cross-sectional area
5055826|NCT01401920|passive leg elevation|passive leg elevation
5055827|NCT01401920|trendelenburg position|trendelenburg position
5055828|NCT01401920|open heart surgery|open heart surgery
5055829|NCT01401907|Palliative care|palliative care
5055830|NCT01401907|Lung|lung
5055831|NCT01401907|Gastric|gastric
5055832|NCT01401907|Liver|liver
5055833|NCT01401907|Pancreatic|pancreatic
5055834|NCT01401907|Esophageal|esophageal
5055835|NCT01401907|Caregiver|caregiver
5055836|NCT01401894|advanced cancer|advanced cancer
5055837|NCT01401868|solid tumor|solid tumor
5055838|NCT01401868|recurrent|recurrent
5055839|NCT01401868|advanced|advanced
5055840|NCT01401868|metastatic|metastatic
5055841|NCT01401855|Diagnosis|diagnosis
5055842|NCT01401855|Fine Needle Aspiration Biopsy|fine needle aspiration biopsy
5055843|NCT01401842|low back muscular strength and endurance|low back muscular strength and endurance
5055844|NCT01401829|endometrial cancer|endometrial cancer
5055845|NCT01401829|aerobic walking|aerobic walking
5055846|NCT01401829|stretching/flexibility exercises|stretching/flexibility exercises
5055847|NCT01401829|quality of life|quality of life
5055848|NCT01401816|Adolescents|adolescents
5055849|NCT01401816|Sexually Active|sexually active
5055850|NCT01401816|Unprotected Sex|unprotected sex
5055851|NCT01401816|Emergency Contraception|emergency contraception
5055852|NCT01401803|periorbital|periorbital
5055853|NCT01401803|glabella|glabella
5055854|NCT01401803|ptosis|ptosis
5055855|NCT01401803|eyelid|eyelid
5055856|NCT01401803|brow|brow
5055857|NCT01401790|Children|children
5055858|NCT01401790|Adolescents|adolescents
5055859|NCT01401790|Telehomecare|telehomecare
5055860|NCT01401777|Kidney Tumors, Cryoablation, Biopsy|kidney tumors, cryoablation, biopsy
5055861|NCT01401751|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
5055862|NCT01401751|Artificial Pancreas|artificial pancreas
5055863|NCT01401738|Shoulder Arthroscopic Surgery|shoulder arthroscopic surgery
5055864|NCT01401725|venous thromboembolism|venous thromboembolism
5055865|NCT01401725|thromboprophylaxis|thromboprophylaxis
5055866|NCT01401725|anticoagulants|anticoagulants
5055867|NCT01401725|hospitalized medical patients|hospitalized medical patients
5055868|NCT01401725|electronic order sets|electronic order sets
5055869|NCT01401725|decision support|decision support
5055870|NCT01401725|knowledge translation|knowledge translation
5055871|NCT01401725|patient safety|patient safety
5055872|NCT01401712|ON-Q|on-q
5055873|NCT01401712|epidural|epidural
5055874|NCT01401712|analgesia|analgesia
5055875|NCT01401699|Barrett's|barrett's
5055876|NCT01401699|esophagus|esophagus
5055877|NCT01401699|OCT|oct
5055878|NCT01401699|imaging|imaging
5055879|NCT01401673|Chronic Cough|chronic cough
5055880|NCT01401673|Indantadol|indantadol
5055881|NCT01401660|low back pain|low back pain
5055882|NCT01401647|cardiac arrest|cardiac arrest
5055883|NCT01401647|cardiopulmonary resuscitation|cardiopulmonary resuscitation
5055884|NCT01401647|ventricular fibrillation|ventricular fibrillation
5055885|NCT01401647|pulseless ventricular tachycardia|pulseless ventricular tachycardia
5055886|NCT01401647|Non-traumatic Out of Hospital Cardiac Arrest (OOHCA)|non-traumatic out of hospital cardiac arrest (oohca)
5055887|NCT01401634|Hyperglycemia Hydration|hyperglycemia hydration
5055888|NCT01401621|behavioral economics|behavioral economics
5055889|NCT01401621|nudge|nudge
5055890|NCT01401621|scratch off|scratch off
5055891|NCT01401621|blood pressure check|blood pressure check
5055892|NCT01401621|cholesterol test|cholesterol test
5055893|NCT01401608|VT|vt
5055894|NCT01401608|ventricular tachycardia|ventricular tachycardia
5055895|NCT01401608|ablation|ablation
5055896|NCT01401608|magnetic navigation|magnetic navigation
5055897|NCT01401608|robotic|robotic
5055898|NCT01401582|health care|health care
5055899|NCT01401582|dementia care|dementia care
5055900|NCT01401582|caregiver support|caregiver support
5055901|NCT01401582|epidemiological study|epidemiological study
5055902|NCT01401569|Exercise,|exercise,
5055903|NCT01401569|counseling,|counseling,
5055904|NCT01401569|smoking cessation,|smoking cessation,
5055905|NCT01401569|depressive disorders|depressive disorders
5055906|NCT01401556|osteoporosis|osteoporosis
5055907|NCT01401556|fracture|fracture
5055908|NCT01401556|treatment|treatment
5055909|NCT01401556|guidelines|guidelines
5055910|NCT01401556|quality|quality
5055911|NCT01401543|testosterone|testosterone
5055912|NCT01401543|energy|energy
5055913|NCT01401543|libido|libido
5055914|NCT01401543|erectile function|erectile function
5055915|NCT01401543|weak muscles|weak muscles
5055916|NCT01401530|Neoplasms|neoplasms
5055917|NCT01401530|Neoplasms by Histologic Type|neoplasms by histologic type
5055918|NCT01401530|Lymphoma|lymphoma
5055919|NCT01401530|Non-Hodgkin|non-hodgkin
5055920|NCT01401530|T- Cell|t- cell
5055921|NCT01401530|Lymphatic Diseases|lymphatic diseases
5055922|NCT01401530|Lymphoproliferative Disorders|lymphoproliferative disorders
5055923|NCT01401530|lmmune System Diseases|lmmune system diseases
5055924|NCT01401530|lmmunoproliferative Disorders|lmmunoproliferative disorders
5055925|NCT01401504|Anti-cancer|anti-cancer
5055926|NCT01401504|ASP3026|asp3026
5055927|NCT01401504|Anaplastic Lymphoma Kinase (ALK)|anaplastic lymphoma kinase (alk)
5055928|NCT01401491|schizophrenia|schizophrenia
5055929|NCT01401491|clozapine|clozapine
5055930|NCT01401491|fluvoxamine|fluvoxamine
5055931|NCT01401491|metabolic syndrome|metabolic syndrome
5055932|NCT01401478|Secondary Hyperparathyroidism|secondary hyperparathyroidism
5055933|NCT01401478|Chronic Renal Insufficiency|chronic renal insufficiency
5055934|NCT01401465|perennial allergic rhinitis|perennial allergic rhinitis
5055935|NCT01401465|PAR|par
5055936|NCT01401452|Monoclonals|monoclonals
5055937|NCT01401452|Moderate to severe plaque psoriasis|moderate to severe plaque psoriasis
5055938|NCT01401452|Psoriasis Area & Severity Index (PASI)|psoriasis area & severity index (pasi)
5055939|NCT01401452|Adalimumab|adalimumab
5055940|NCT01401452|Biological disease modifying anti-rheumatic drugs (BDMARD)|biological disease modifying anti-rheumatic drugs (bdmard)
5055941|NCT01401452|Co-morbidities|co-morbidities
5055942|NCT01401452|Antibodies|antibodies
5055943|NCT01401452|Disease Life Quality Index (DLQI)|disease life quality index (dlqi)
5055944|NCT01401439|cystic fibrosis|cystic fibrosis
5055945|NCT01401439|body mass index|body mass index
5055946|NCT01401439|fat free mass|fat free mass
5055947|NCT01401439|Children with cystic fibrosis|children with cystic fibrosis
5055948|NCT01401426|overweight|overweight
5055949|NCT01401426|Obesity, Morbid|obesity, morbid
5055950|NCT01401374|Vitiligo Vulgaris|vitiligo vulgaris
5055951|NCT01401374|Autoimmunity|autoimmunity
5055952|NCT01401374|Thyroid Disease|thyroid disease
5055953|NCT01401296|Depression|depression
5055954|NCT01401296|Online-Therapy|online-therapy
5055955|NCT01401296|Deprexis|deprexis
5055956|NCT01401296|Self-help|self-help
5055957|NCT01401257|PXT3003|pxt3003
5055958|NCT01401257|Charcot-Marie-Tooth Disease|charcot-marie-tooth disease
5055959|NCT01401257|Hereditary Motor and Sensory Neuropathies|hereditary motor and sensory neuropathies
5055960|NCT01401231|depression|depression
5055961|NCT01401231|pregnancy|pregnancy
5055962|NCT01401218|thoracic aortic surgery|thoracic aortic surgery
5055963|NCT01401218|acute kidney injury|acute kidney injury
5055964|NCT01401205|shoulder arthroscopic surgery|shoulder arthroscopic surgery
5055965|NCT01401205|dyspnea|dyspnea
5055966|NCT01401205|airway diameter|airway diameter
5055967|NCT01401192|thymidylate synthase|thymidylate synthase
5055968|NCT01401179|Preterm Premature Rupture of Fetal Membranes|preterm premature rupture of fetal membranes
5055969|NCT01401179|antibiotic therapy|antibiotic therapy
5055970|NCT01401140|Coronary Artery Bypass|coronary artery bypass
5055971|NCT01401140|Coronary Artery Surgery|coronary artery surgery
5055972|NCT01401140|Coronary Artery Bypass Graft|coronary artery bypass graft
5055973|NCT01401140|Coronary Revascularization|coronary revascularization
5055974|NCT01401140|Cardiac microdialysis|cardiac microdialysis
5055975|NCT01401140|Custodiol|custodiol
5055976|NCT01401140|St Thomas|st thomas
5055977|NCT01401140|Cardioplegic solutions|cardioplegic solutions
5055978|NCT01401127|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
5055979|NCT01401127|Exercise|exercise
5055980|NCT01401127|Continuous Subcutaneous Insulin Infusion|continuous subcutaneous insulin infusion
5055981|NCT01401127|CSII|csii
5055982|NCT01401127|Insulin Pump Therapy|insulin pump therapy
5055983|NCT01401114|Wellnara|wellnara
5055984|NCT01401114|Postmenopausal osteoporosis|postmenopausal osteoporosis
5055985|NCT01401101|mental health|mental health
5055986|NCT01401101|PTSD|ptsd
5055987|NCT01401101|primary care|primary care
5055988|NCT01401101|quality improvement|quality improvement
5055989|NCT01401101|collaborative care|collaborative care
5055990|NCT01401088|patient with refractory glaucoma|patient with refractory glaucoma
5055991|NCT01401075|Quality of Life|quality of life
5055992|NCT01401075|QoL|qol
5055993|NCT01401075|EORTC QLQ-C30|eortc qlq-c30
5055994|NCT01401075|EORTC QLQ-STO22|eortc qlq-sto22
5055995|NCT01401075|5-FU|5-fu
5055996|NCT01401075|Viscum album|viscum album
5055997|NCT01401062|metastatic breast cancer|metastatic breast cancer
5055998|NCT01401062|TGF-beta|tgf-beta
5055999|NCT01401062|fresolimumab|fresolimumab
5056000|NCT01401062|monoclonal antibody|monoclonal antibody
5056001|NCT01401062|radiation therapy|radiation therapy
5056002|NCT01401062|abscopal response|abscopal response
5056003|NCT01401049|Fospropofol|fospropofol
5056004|NCT01401049|Propofol|propofol
5056005|NCT01401049|Colonoscopy|colonoscopy
5056006|NCT01401049|Lusedra|lusedra
5056007|NCT01401036|acute myocardial infarction|acute myocardial infarction
5056008|NCT01401036|stents|stents
5056009|NCT01401036|angioplasty|angioplasty
5056010|NCT01401036|thrombosis|thrombosis
5056011|NCT01401010|neutropenia|neutropenia
5056012|NCT01401010|doripenem|doripenem
5056013|NCT01400997|Growth disorders|growth disorders
5056014|NCT01400997|Saizen|saizen
5056015|NCT01400997|Easypod|easypod
5056016|NCT01400997|Growth hormone|growth hormone
5056017|NCT01400997|Pediatric subject|pediatric subject
5056018|NCT01400984|Growth disorders|growth disorders
5056019|NCT01400984|Saizen|saizen
5056020|NCT01400984|Easypod|easypod
5056021|NCT01400984|Growth hormone|growth hormone
5056022|NCT01400984|Pediatric subject|pediatric subject
5056023|NCT01400971|Diabetes|diabetes
5056024|NCT01400971|Insulin|insulin
5056025|NCT01400971|Progression|progression
5056026|NCT01400971|Patient Reported Measures|patient reported measures
5056027|NCT01400971|Adherence|adherence
5056028|NCT01400971|Heterogeneity|heterogeneity
5056029|NCT01400971|Hypoglycemia|hypoglycemia
5056030|NCT01400958|fatigue|fatigue
5056031|NCT01400958|external beam radiation|external beam radiation
5056032|NCT01400958|EBRT|ebrt
5056033|NCT01400958|radiation therapy|radiation therapy
5056034|NCT01400958|placebo|placebo
5056035|NCT01400958|cognitive function|cognitive function
5056036|NCT01400958|TMZ|tmz
5056037|NCT01400958|Temozolomide|temozolomide
5056038|NCT01400945|GERD|gerd
5056039|NCT01400945|endoscopy|endoscopy
5056040|NCT01400945|LA grade|la grade
5056041|NCT01400945|heartburn|heartburn
5056042|NCT01400932|inflammatory lesion|inflammatory lesion
5056043|NCT01400932|Benzoyl peroxide (BPO)|benzoyl peroxide (bpo)
5056044|NCT01400932|once daily|once daily
5056045|NCT01400932|acne vulgaris|acne vulgaris
5056046|NCT01400932|vehicle gel|vehicle gel
5056047|NCT01400932|clindamycin (CLDM) 1%-BPO 3% gel|clindamycin (cldm) 1%-bpo 3% gel
5056048|NCT01400932|non-inflammatory lesion|non-inflammatory lesion
5056049|NCT01400919|Peripheral arterial disease|peripheral arterial disease
5056050|NCT01400919|claudication|claudication
5056051|NCT01400919|stent|stent
5056052|NCT01400919|EverFlex|everflex
5056053|NCT01400919|GPS|gps
5056054|NCT01400919|Iliac Artery|iliac artery
5056055|NCT01400893|Acute Renal Failure|acute renal failure
5056056|NCT01400893|Acute kidney injury|acute kidney injury
5056057|NCT01400893|Acute tubular necrosis|acute tubular necrosis
5056058|NCT01400893|Continuous Renal Replacement Therapy|continuous renal replacement therapy
5056059|NCT01400893|Severe sepsis|severe sepsis
5056060|NCT01400893|Selective cytopheretic device|selective cytopheretic device
5056061|NCT01400880|Maternal Fetal Monitoring|maternal fetal monitoring
5056062|NCT01400867|Infections|infections
5056063|NCT01400867|Pediatrics|pediatrics
5056064|NCT01400867|Teflaro|teflaro
5056065|NCT01400867|cephalosporin|cephalosporin
5056066|NCT01400854|breakthrough cancer pain|breakthrough cancer pain
5056067|NCT01400841|Aortic Insufficiency, Aortic Regurgitation, Aortic Valve Repair|aortic insufficiency, aortic regurgitation, aortic valve repair
5056068|NCT01400815|smoking|smoking
5056069|NCT01400815|smoking cessation|smoking cessation
5056070|NCT01400815|quitting smoking|quitting smoking
5056071|NCT01400776|Postmenopausal Women, Vaginal Dryness|postmenopausal women, vaginal dryness
5056072|NCT01400763|focus of study|focus of study
5056073|NCT01400750|cystic fibrosis- P aeruginosa- eradication-child|cystic fibrosis- p aeruginosa- eradication-child
5056074|NCT01400737|ibuprofen|ibuprofen
5056075|NCT01400737|prophylaxis|prophylaxis
5056076|NCT01400737|VELBW|velbw
5056077|NCT01400724|menopause|menopause
5056078|NCT01400724|metabolic syndrome|metabolic syndrome
5056079|NCT01400724|myo-inositol|myo-inositol
5056080|NCT01400724|insulin resistance|insulin resistance
5056081|NCT01400724|cocoa polyphenols|cocoa polyphenols
5056082|NCT01400724|isoflavones|isoflavones
5056083|NCT01400711|Fast-tract surgery, Enhanced recovery after surgery, multimodal surgery.|fast-tract surgery, enhanced recovery after surgery, multimodal surgery.
5056084|NCT01400698|Intra-uterine growth retardation (IUGR)|intra-uterine growth retardation (iugr)
5056085|NCT01400698|Saizen|saizen
5056086|NCT01400698|Recombinant human growth hormone (r-hGH)|recombinant human growth hormone (r-hgh)
5056087|NCT01400698|Final height|final height
5056088|NCT01400698|Bone age|bone age
5056089|NCT01400698|SGA (Small for Gestational Age)|sga (small for gestational age)
5056090|NCT01400685|CLL|cll
5056091|NCT01400685|Leukemia|leukemia
5056092|NCT01400685|Untreated|untreated
5056093|NCT01400685|B-CLL|b-cll
5056094|NCT01400685|SLL|sll
5056095|NCT01400672|Diffuse intrinsic pontine glioma|diffuse intrinsic pontine glioma
5056096|NCT01400659|CSII|csii
5056097|NCT01400659|prandial insulin requirements|prandial insulin requirements
5056098|NCT01400659|bolus calculation|bolus calculation
5056099|NCT01400659|dual-wave bolus|dual-wave bolus
5056100|NCT01400646|Rivaroxaban|rivaroxaban
5056101|NCT01400646|JNJ-39039039|jnj-39039039
5056102|NCT01400646|BAY59-7939|bay59-7939
5056103|NCT01400646|Warfarin|warfarin
5056104|NCT01400646|Transition|transition
5056105|NCT01400633|Myelodysplastic Syndrome|myelodysplastic syndrome
5056106|NCT01400633|Dacogen|dacogen
5056107|NCT01400633|decitabine|decitabine
5056108|NCT01400633|epigenetic therapy|epigenetic therapy
5056109|NCT01400633|hypomethylating agent|hypomethylating agent
5056110|NCT01400620|oral mucositis|oral mucositis
5056111|NCT01400620|chemoradiation|chemoradiation
5056112|NCT01400620|head and neck cancer|head and neck cancer
5056113|NCT01400607|cartilage|cartilage
5056114|NCT01400607|knee surgery|knee surgery
5056115|NCT01400607|cartilage injury|cartilage injury
5056116|NCT01400607|knee pain|knee pain
5056117|NCT01400607|cartilage repair|cartilage repair
5056118|NCT01400607|cartilage damage|cartilage damage
5056119|NCT01400607|cartilage lesion|cartilage lesion
5056120|NCT01400607|cartilage defect|cartilage defect
5056121|NCT01400607|articular cartilage lesion|articular cartilage lesion
5056122|NCT01400607|articular cartilage defect|articular cartilage defect
5056123|NCT01400607|juvenile|juvenile
5056124|NCT01400607|cells|cells
5056125|NCT01400607|ISTO Technologies|isto technologies
5056126|NCT01400607|Neocartilage|neocartilage
5056127|NCT01400607|RevaFlex|revaflex
5056128|NCT01400594|Onychomycosis|onychomycosis
5056129|NCT01400555|Prostate Cancer|prostate cancer
5056130|NCT01400555|Metastatic Castration-Resistant Prostate Cancer|metastatic castration-resistant prostate cancer
5056131|NCT01400555|Abiraterone Acetate|abiraterone acetate
5056132|NCT01400555|Docetaxel|docetaxel
5056133|NCT01400555|Prednisone|prednisone
5056134|NCT01400555|Dexamethasone|dexamethasone
5056135|NCT01400542|Early Onset Alzheimer Disease|early onset alzheimer disease
5056136|NCT01400542|Alzheimer Disease|alzheimer disease
5056137|NCT01400542|Sleep Apnea Syndromes|sleep apnea syndromes
5056138|NCT01400542|Obstructive Sleep Apnea Syndromes|obstructive sleep apnea syndromes
5056139|NCT01400542|Cognitive functions|cognitive functions
5056140|NCT01400542|Continuous Positive Airway Pressure (CPAP) treatment|continuous positive airway pressure (cpap) treatment
5056141|NCT01400529|Osteoarthritis|osteoarthritis
5056142|NCT01400529|knee|knee
5056143|NCT01400529|hip|hip
5056144|NCT01400529|population based|population based
5056145|NCT01400516|Rheumatoid Arthritis|rheumatoid arthritis
5056146|NCT01400516|Bone erosion|bone erosion
5056147|NCT01400516|Osteopenia|osteopenia
5056148|NCT01400503|Multicentric Castleman's Disease|multicentric castleman's disease
5056149|NCT01400503|Multicentric|multicentric
5056150|NCT01400503|Castleman|castleman
5056151|NCT01400503|Siltuximab|siltuximab
5056152|NCT01400503|Long term safety|long term safety
5056153|NCT01400477|Drug Trial|drug trial
5056154|NCT01400477|Smoking|smoking
5056155|NCT01400477|Smoking Cessation|smoking cessation
5056156|NCT01400477|Cognition|cognition
5056157|NCT01400477|Mental Focus|mental focus
5056158|NCT01400464|Giant Cell Arteritis|giant cell arteritis
5056159|NCT01400464|prednisone|prednisone
5056160|NCT01400464|pharmacokinetics|pharmacokinetics
5056161|NCT01400438|Herceptin|herceptin
5056162|NCT01400438|Breast cancer|breast cancer
5056163|NCT01400438|Quality of life|quality of life
5056164|NCT01400438|fatigue|fatigue
5056165|NCT01400399|AJCC DCIS or T1- T2, N0|ajcc dcis or t1- t2, n0
5056166|NCT01400373|Hypothermia, induced|hypothermia, induced
5056167|NCT01400373|Intra-arrest cooling|intra-arrest cooling
5056168|NCT01400373|Cardiac arrest|cardiac arrest
5056169|NCT01400373|Prehospital emergency care|prehospital emergency care
5056170|NCT01400373|Emergency Medical Services|emergency medical services
5056171|NCT01400360|cerebral vasospasm|cerebral vasospasm
5056172|NCT01400360|subarachnoid hemorrhage|subarachnoid hemorrhage
5056173|NCT01400360|transluminal balloon angioplasty|transluminal balloon angioplasty
5056174|NCT01400360|intraarterial treatment|intraarterial treatment
5056175|NCT01400347|Motor activity, lower extremity, physical exercise|motor activity, lower extremity, physical exercise
5056176|NCT01400334|Ischemic Cardiomyopathy|ischemic cardiomyopathy
5056177|NCT01400334|Sudden Cardiac Death|sudden cardiac death
5056178|NCT01400334|Positron Emission Tomography|positron emission tomography
5056179|NCT01400334|Hibernating Myocardium|hibernating myocardium
5056180|NCT01400334|Denervated Myocardium|denervated myocardium
5056181|NCT01400321|dental implant|dental implant
5056182|NCT01400321|soft tissue maintenance|soft tissue maintenance
5056183|NCT01400321|bone remodelling|bone remodelling
5056184|NCT01400321|inclined atrophy|inclined atrophy
5056185|NCT01400308|Methicillin Resistant Staphylococcus Aureus colonization.|methicillin resistant staphylococcus aureus colonization.
5056186|NCT01400308|Methicillin Resistant Staphylococcus Aureus infection.|methicillin resistant staphylococcus aureus infection.
5056187|NCT01400295|contrast-induced nephropathy|contrast-induced nephropathy
5056188|NCT01400295|contrast medium|contrast medium
5056189|NCT01400295|creatinine clearance|creatinine clearance
5056190|NCT01400295|coronary angiography|coronary angiography
5056191|NCT01400295|diabetes|diabetes
5056192|NCT01400295|chronic kidney disease|chronic kidney disease
5056193|NCT01400269|PACE|pace
5056194|NCT01400256|diagnostic|diagnostic
5056195|NCT01400243|Marijuana|marijuana
5056196|NCT01400243|Drug withdrawal symptoms|drug withdrawal symptoms
5056197|NCT01400243|Nicotine|nicotine
5056198|NCT01400230|computed tomography|computed tomography
5056199|NCT01400230|intravascular ultrasound|intravascular ultrasound
5056200|NCT01400230|coronary stenosis|coronary stenosis
5056201|NCT01400230|fractional flow reserve|fractional flow reserve
5056202|NCT01400217|Primary Care|primary care
5056203|NCT01400217|Particle size|particle size
5056204|NCT01400217|beclomethasone dipropionate|beclomethasone dipropionate
5056205|NCT01400217|Asthma Management|asthma management
5056206|NCT01400217|Maintenance Therapy|maintenance therapy
5056207|NCT01400217|Metered-Dose Inhaler|metered-dose inhaler
5056208|NCT01400204|hangover|hangover
5056209|NCT01400204|next day effects|next day effects
5056210|NCT01400204|MDMA|mdma
5056211|NCT01400204|Alcohol|alcohol
5056212|NCT01400191|Metformin|metformin
5056213|NCT01400191|Hypoglycemic Agents|hypoglycemic agents
5056214|NCT01400191|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
5056215|NCT01400191|Gluconeogenesis|gluconeogenesis
5056216|NCT01400191|Pharmacodynamics|pharmacodynamics
5056217|NCT01400191|Pharmacogenetics|pharmacogenetics
5056218|NCT01400178|cochlear implant|cochlear implant
5056219|NCT01400178|children|children
5056220|NCT01400178|follow up|follow up
5056221|NCT01400178|results|results
5056222|NCT01400165|Therapeutic Equivalency|therapeutic equivalency
5056223|NCT01400165|Human Experimentation|human experimentation
5056224|NCT01400165|Bioequivalence|bioequivalence
5056225|NCT01400165|Brand name|brand name
5056226|NCT01400165|Generic|generic
5056227|NCT01400165|Healthy volunteers|healthy volunteers
5056228|NCT01400152|Hypothermia, body temperature regulation,thermal comfort, active warming, passive warming, prehospital trauma care|hypothermia, body temperature regulation,thermal comfort, active warming, passive warming, prehospital trauma care
5056229|NCT01400139|Pain|pain
5056230|NCT01400139|Nonmalignant pain|nonmalignant pain
5056231|NCT01400139|Nonneuropathic Pain|nonneuropathic pain
5056232|NCT01400139|Opioid|opioid
5056233|NCT01400126|Ultrapure water,hemodialysis, CRP, blood pressure|ultrapure water,hemodialysis, crp, blood pressure
5056234|NCT01400113|Acute Agitation|acute agitation
5056235|NCT01400113|schizophrenia|schizophrenia
5056236|NCT01400113|bipolar|bipolar
5056237|NCT01400113|psychosis|psychosis
5056238|NCT01400113|panss-ec|panss-ec
5056239|NCT01400100|octreotide|octreotide
5056240|NCT01400100|intraarterial|intraarterial
5056241|NCT01400100|pancreatic hardness|pancreatic hardness
5056242|NCT01400100|pancreatoduodenectomy|pancreatoduodenectomy
5056243|NCT01400100|durometer|durometer
5056244|NCT01400100|dynamometer|dynamometer
5056245|NCT01400087|colonoscopy|colonoscopy
5056246|NCT01400087|Lower Gastrointestinal Tract|lower gastrointestinal tract
5056247|NCT01400087|Cecal intubation|cecal intubation
5056248|NCT01400087|Cap-attached colonoscopy|cap-attached colonoscopy
5056249|NCT01400087|Trainee|trainee
5056250|NCT01400061|obesity, etiology, pathogenesis, treatment|obesity, etiology, pathogenesis, treatment
5056251|NCT01400035|acute cerebral infarction, Vinpocetine|acute cerebral infarction, vinpocetine
5056252|NCT01400022|lichen|lichen
5056253|NCT01400022|sclerosus|sclerosus
5056254|NCT01400022|genital|genital
5056255|NCT01400022|vulvar|vulvar
5056256|NCT01400022|UVA1|uva1
5056257|NCT01400009|Statin|statin
5056258|NCT01400009|HMG COA Reductase Inhibitor|hmg coa reductase inhibitor
5056259|NCT01400009|myalgia|myalgia
5056260|NCT01400009|vitamin D|vitamin d
5056261|NCT01399996|probiotic|probiotic
5056262|NCT01399996|microbiota|microbiota
5056263|NCT01399996|transit time|transit time
5056264|NCT01399996|immunity|immunity
5056265|NCT01399996|immune function|immune function
5056266|NCT01399996|constipation|constipation
5056267|NCT01399996|bowel function|bowel function
5056268|NCT01399983|six minute walk|six minute walk
5056269|NCT01399970|Mobile Teledermatology|mobile teledermatology
5056270|NCT01399970|Telemedicine|telemedicine
5056271|NCT01399970|Acne|acne
5056272|NCT01399957|Multiple Sclerosis|multiple sclerosis
5056273|NCT01399957|Dalfampridine-ER|dalfampridine-er
5056274|NCT01399957|Walking speed|walking speed
5056275|NCT01399944|bitter taste|bitter taste
5056276|NCT01399944|psychophysics|psychophysics
5056277|NCT01399944|genetics|genetics
5056278|NCT01399944|epigenetics|epigenetics
5056279|NCT01399944|bitterness sensitivity|bitterness sensitivity
5056280|NCT01399931|Early stage|early stage
5056281|NCT01399918|Kidney|kidney
5056282|NCT01399918|Everolimus|everolimus
5056283|NCT01399918|Bevacizumab|bevacizumab
5056284|NCT01399918|10-226|10-226
5056285|NCT01399918|non-clear cell histology|non-clear cell histology
5056286|NCT01399918|Advanced|advanced
5056287|NCT01399905|Parkinson's disease|parkinson's disease
5056288|NCT01399905|Levodopa|levodopa
5056289|NCT01399905|Carbidopa|carbidopa
5056290|NCT01399905|Blood brain barrier|blood brain barrier
5056291|NCT01399879|Surface potential|surface potential
5056292|NCT01399879|Electrical|electrical
5056293|NCT01399879|Motion stabilization|motion stabilization
5056294|NCT01399866|D-cycloserine|d-cycloserine
5056295|NCT01399866|Smoking cues|smoking cues
5056296|NCT01399866|Cognitive remediation|cognitive remediation
5056297|NCT01399866|physiologic reactivity|physiologic reactivity
5056298|NCT01399866|craving|craving
5056299|NCT01399853|immunogenicity|immunogenicity
5056300|NCT01399853|safety|safety
5056301|NCT01399853|inactivated EV71 vaccine|inactivated ev71 vaccine
5056302|NCT01399801|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
5056303|NCT01399801|medically refractory heart failure patients|medically refractory heart failure patients
5056304|NCT01399788|Bioequivalence|bioequivalence
5056305|NCT01399788|Healthy Volunteers|healthy volunteers
5056306|NCT01399775|Atrophy of Edentulous Alveolar Ridge|atrophy of edentulous alveolar ridge
5056307|NCT01399775|Dental Prosthesis, Implant-Supported|dental prosthesis, implant-supported
5056308|NCT01399775|Dental Implants, Single-Tooth|dental implants, single-tooth
5056309|NCT01399762|stroke, acute|stroke, acute
5056310|NCT01399762|mechanical recanalization|mechanical recanalization
5056311|NCT01399762|interventional neuroradiology|interventional neuroradiology
5056312|NCT01399762|clinical registry|clinical registry
5056313|NCT01399749|Cartilage|cartilage
5056314|NCT01399749|Articular|articular
5056315|NCT01399749|Femoral|femoral
5056316|NCT01399749|Knee|knee
5056317|NCT01399749|Chondrocytes|chondrocytes
5056318|NCT01399749|Adipose tissue-derived mesenchymal stem cells|adipose tissue-derived mesenchymal stem cells
5056319|NCT01399736|PCI FFR STEMI MVD|pci ffr stemi mvd
5056320|NCT01399736|FFR guided PCI in acute STEMI patients with MVD|ffr guided pci in acute stemi patients with mvd
5056321|NCT01399723|Severe pneumonia|severe pneumonia
5056322|NCT01399710|colorectal cancer|colorectal cancer
5056323|NCT01399710|CT colonography|ct colonography
5056324|NCT01399710|CAD|cad
5056325|NCT01399671|depression|depression
5056326|NCT01399671|vestibular|vestibular
5056327|NCT01399658|Brachytherapy|brachytherapy
5056328|NCT01399658|Gynecological cancer|gynecological cancer
5056329|NCT01399645|Randomized trial|randomized trial
5056330|NCT01399645|Open label|open label
5056331|NCT01399645|Pilot study|pilot study
5056332|NCT01399645|Single center|single center
5056333|NCT01399606|Excessive Daytime Sleepiness (EDS)|excessive daytime sleepiness (eds)
5056334|NCT01399606|Narcolepsy|narcolepsy
5056335|NCT01399593|Antibody Mediated Rejection|antibody mediated rejection
5056336|NCT01399593|AMR|amr
5056337|NCT01399593|Acute Humoral Rejection|acute humoral rejection
5056338|NCT01399593|AHR|ahr
5056339|NCT01399593|Living Donor|living donor
5056340|NCT01399593|Kidney Transplant|kidney transplant
5056341|NCT01399580|endothelin receptor antagonists|endothelin receptor antagonists
5056342|NCT01399567|pain|pain
5056343|NCT01399567|depression|depression
5056344|NCT01399567|nursing homes|nursing homes
5056345|NCT01399567|diffusion of innovations|diffusion of innovations
5056346|NCT01399567|clinical trial|clinical trial
5056347|NCT01399541|Symptoms|symptoms
5056348|NCT01399541|Symptoms cluster|symptoms cluster
5056349|NCT01399541|Fatigue|fatigue
5056350|NCT01399541|Depression|depression
5056351|NCT01399541|Sleeplessness|sleeplessness
5056352|NCT01399541|Social support|social support
5056353|NCT01399541|Stigma|stigma
5056354|NCT01399515|Retinitis pigmentosa|retinitis pigmentosa
5056355|NCT01399515|Valproic acid|valproic acid
5056356|NCT01399502|Depression|depression
5056357|NCT01399502|Self Care|self care
5056358|NCT01399489|Aerobic exercise|aerobic exercise
5056359|NCT01399489|Moderate intensity|moderate intensity
5056360|NCT01399489|Ambulatory blood pressure|ambulatory blood pressure
5056361|NCT01399489|Post exercise hypotension|post exercise hypotension
5056362|NCT01399476|Achalasia|achalasia
5056363|NCT01399463|Drug Eluting Stent, Drug Eluting Balloon, Fractional Flow Reserve, DES, DEB, FFR|drug eluting stent, drug eluting balloon, fractional flow reserve, des, deb, ffr
5056364|NCT01399450|Schizophrenia, depressive symptom, paliperidone|schizophrenia, depressive symptom, paliperidone
5056365|NCT01399437|Default Network|default network
5056366|NCT01399437|Schizophrenia|schizophrenia
5056367|NCT01399437|fMRI|fmri
5056368|NCT01399437|Spatial Attention|spatial attention
5056369|NCT01399437|Sentinel Function|sentinel function
5056370|NCT01399424|Shigellosis|shigellosis
5056371|NCT01399424|Safety and Immunogenicity|safety and immunogenicity
5056372|NCT01399424|Conjugate Vaccine|conjugate vaccine
5056373|NCT01399424|Shigella|shigella
5056374|NCT01399424|Vaccine|vaccine
5056375|NCT01399411|Self-Reported|self-reported
5056376|NCT01399411|Farming|farming
5056377|NCT01399411|Agriculture|agriculture
5056378|NCT01399411|Disease Validation|disease validation
5056379|NCT01399411|Autoimmune Disorders|autoimmune disorders
5056380|NCT01399398|Brain Scan|brain scan
5056381|NCT01399398|Kinetic Analysis|kinetic analysis
5056382|NCT01399398|Healthy Subjects|healthy subjects
5056383|NCT01399398|Healthy Volunteer|healthy volunteer
5056384|NCT01399398|HV|hv
5056385|NCT01399385|Arteriosclerosis|arteriosclerosis
5056386|NCT01399385|Arteriosclerosis, Narrowing of Vessels|arteriosclerosis, narrowing of vessels
5056387|NCT01399385|Endothelial Dysfunction|endothelial dysfunction
5056388|NCT01399385|Hardening of the arteries|hardening of the arteries
5056389|NCT01399385|Noninvasive Plaque Imaging|noninvasive plaque imaging
5056390|NCT01399385|Cardiovascular Disease|cardiovascular disease
5056391|NCT01399385|Heart Disease|heart disease
5056392|NCT01399385|Healthy Volunteer|healthy volunteer
5056393|NCT01399385|HV|hv
5056394|NCT01399372|neurotoxicity|neurotoxicity
5056395|NCT01399372|chemotherapeutic agent toxicity|chemotherapeutic agent toxicity
5056396|NCT01399372|radiation toxicity|radiation toxicity
5056397|NCT01399372|cognitive/functional effects|cognitive/functional effects
5056398|NCT01399372|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
5056399|NCT01399359|breast cancer|breast cancer
5056400|NCT01399346|Insulin aspart|insulin aspart
5056401|NCT01399346|Type 1 diabetes|type 1 diabetes
5056402|NCT01399346|Glucose clamp|glucose clamp
5056403|NCT01399346|Pharmacodynamics|pharmacodynamics
5056404|NCT01399346|Pharmacokinetics|pharmacokinetics
5056405|NCT01399346|Rapid Acting Insulin Analog|rapid acting insulin analog
5056406|NCT01399333|PDCAAS|pdcaas
5056407|NCT01399333|Bariatric patient|bariatric patient
5056408|NCT01399320|Pilonidal disease|pilonidal disease
5056409|NCT01399320|Excision|excision
5056410|NCT01399320|cyanoacrylate|cyanoacrylate
5056411|NCT01399307|Stem|stem
5056412|NCT01399307|Cell|cell
5056413|NCT01399307|Antria|antria
5056414|NCT01399307|Adipose|adipose
5056415|NCT01399307|Stromal|stromal
5056416|NCT01399307|Vascular|vascular
5056417|NCT01399307|Fraction|fraction
5056418|NCT01399307|Shahram|shahram
5056419|NCT01399307|Shah|shah
5056420|NCT01399307|Rahimian|rahimian
5056421|NCT01399294|Palliative Care|palliative care
5056422|NCT01399294|Advanced Cancer|advanced cancer
5056423|NCT01399294|Constipation|constipation
5056424|NCT01399294|Traditional Chinese Medicine|traditional chinese medicine
5056425|NCT01399294|Syndrome Distribution|syndrome distribution
5056426|NCT01399281|juvenile idiopathic arthritis, biologics, methotrexate|juvenile idiopathic arthritis, biologics, methotrexate
5056427|NCT01399268|Bilateral total knee replacement|bilateral total knee replacement
5056428|NCT01399268|cytokine|cytokine
5056429|NCT01399268|desmosine|desmosine
5056430|NCT01399242|Disorder Related to Renal Transplantation|disorder related to renal transplantation
5056431|NCT01399203|contrast-induced nephropathy|contrast-induced nephropathy
5056432|NCT01399203|contrast medium|contrast medium
5056433|NCT01399203|creatinine clearance|creatinine clearance
5056434|NCT01399203|percutaneous coronary intervention|percutaneous coronary intervention
5056435|NCT01399164|Vitamin B-12|vitamin b-12
5056436|NCT01399151|Vitamin D|vitamin d
5056437|NCT01399151|Immune function|immune function
5056438|NCT01399138|Pre-diabetes|pre-diabetes
5056439|NCT01399138|Metabolic syndrome|metabolic syndrome
5056440|NCT01399138|Diabetes|diabetes
5056441|NCT01399138|Hypertension|hypertension
5056442|NCT01399138|Blueberries|blueberries
5056443|NCT01399138|Anthocyanins|anthocyanins
5056444|NCT01399138|Insulin sensitivity|insulin sensitivity
5056445|NCT01399138|Insulin resistance|insulin resistance
5056446|NCT01399125|Alzheimer's|alzheimer's
5056447|NCT01399125|Rivastigmine|rivastigmine
5056448|NCT01399125|Patch|patch
5056449|NCT01399125|Dementia|dementia
5056450|NCT01399112|Smoking Cessation|smoking cessation
5056451|NCT01399112|First episode psychosis|first episode psychosis
5056452|NCT01399112|Electronic Decision Support System|electronic decision support system
5056453|NCT01399099|scar|scar
5056454|NCT01399099|incision|incision
5056455|NCT01399099|wound healing|wound healing
5056456|NCT01399099|scarring|scarring
5056457|NCT01399099|post-surgical|post-surgical
5056458|NCT01399086|Cancer|cancer
5056459|NCT01399086|Breast|breast
5056460|NCT01399086|Metastatic|metastatic
5056461|NCT01399086|Hormonotherapy|hormonotherapy
5056462|NCT01399073|stroke|stroke
5056463|NCT01399073|neglect|neglect
5056464|NCT01399073|hemianopsia|hemianopsia
5056465|NCT01399073|virtual reality|virtual reality
5056466|NCT01399060|Cough|cough
5056467|NCT01399060|tobacco smoke exposure|tobacco smoke exposure
5056468|NCT01399047|Batten Disease|batten disease
5056469|NCT01399034|Epigenomics|epigenomics
5056470|NCT01399034|DNA methylation|dna methylation
5056471|NCT01399034|MicroRNA|microrna
5056472|NCT01399034|Periodontitis|periodontitis
5056473|NCT01399034|Inflammation|inflammation
5056474|NCT01399034|Obesity|obesity
5056475|NCT01399021|Parotidectomy|parotidectomy
5056476|NCT01399021|Drain removal|drain removal
5056477|NCT01399021|Timing|timing
5056478|NCT01399021|Hematoma|hematoma
5056479|NCT01399021|Surgical wound infection|surgical wound infection
5056480|NCT01399008|Hyperuricemia|hyperuricemia
5056481|NCT01398995|Type 1 Diabetes|type 1 diabetes
5056482|NCT01398995|Exercise|exercise
5056483|NCT01398995|continuous subcutaneous insulin infusion|continuous subcutaneous insulin infusion
5056484|NCT01398969|Randomized|randomized
5056485|NCT01398969|Double Blind|double blind
5056486|NCT01398969|Fecal Transplant|fecal transplant
5056487|NCT01398969|Recurrent|recurrent
5056488|NCT01398969|Clostridium difficile infection|clostridium difficile infection
5056490|NCT01398969|HBT|hbt
5056491|NCT01398969|Diarrhea|diarrhea
5056492|NCT01398969|Frozen HBT|frozen hbt
5056493|NCT01398969|Thawed HBT|thawed hbt
5056494|NCT01398969|Fecal Enema|fecal enema
5056495|NCT01398956|Levetiracetam|levetiracetam
5056496|NCT01398956|Epilepsy|epilepsy
5056497|NCT01398956|Generalized tonic-clonic seizures|generalized tonic-clonic seizures
5056498|NCT01398943|flow-mediated dilation|flow-mediated dilation
5056499|NCT01398943|arterial stiffness|arterial stiffness
5056500|NCT01398943|intima-media thickness|intima-media thickness
5056501|NCT01398943|pulse wave velocity|pulse wave velocity
5056502|NCT01398943|dual energy x-ray absorptiometry|dual energy x-ray absorptiometry
5056503|NCT01398943|inflammatory markers|inflammatory markers
5056504|NCT01398943|blood lipids|blood lipids
5056505|NCT01398943|tetrahydrobiopterin|tetrahydrobiopterin
5056506|NCT01398943|body mass index|body mass index
5056507|NCT01398943|hemoglobin A1c|hemoglobin a1c
5056508|NCT01398943|complete blood count|complete blood count
5056509|NCT01398943|oxidative stress biomarkers|oxidative stress biomarkers
5056510|NCT01398943|pulmonary function test|pulmonary function test
5056511|NCT01398943|lung|lung
5056512|NCT01398943|COPD|copd
5056513|NCT01398930|acupuncture; knee osteoarthritis; adjunctive therapy; chronic pain; algometer; etoricoxib.|acupuncture; knee osteoarthritis; adjunctive therapy; chronic pain; algometer; etoricoxib.
5056514|NCT01398917|psc|psc
5056515|NCT01398917|dominant stricture|dominant stricture
5056516|NCT01398904|BDD|bdd
5056517|NCT01398878|Medical education, graduate|medical education, graduate
5056518|NCT01398878|Patient care|patient care
5056519|NCT01398878|Outcome assessment (Health care)|outcome assessment (health care)
5056520|NCT01398878|Work schedule tolerance|work schedule tolerance
5056521|NCT01398865|BDD|bdd
5056522|NCT01398826|Type 1 Diabetes|type 1 diabetes
5056523|NCT01398826|Exercise|exercise
5056524|NCT01398826|Continuous glucose monitoring|continuous glucose monitoring
5056526|NCT01398813|XLHED|xlhed
5056527|NCT01398774|Pseudohypoparathyroidism|pseudohypoparathyroidism
5056528|NCT01398774|Albright Hereditary Osteodystrophy|albright hereditary osteodystrophy
5056529|NCT01398761|Continuity of patient care|continuity of patient care
5056530|NCT01398761|Workflow|workflow
5056531|NCT01398761|Quality of signout|quality of signout
5056532|NCT01398761|Web based|web based
5056533|NCT01398761|Handoffs|handoffs
5056534|NCT01398761|Multi disciplinary|multi disciplinary
5056535|NCT01398761|Written signout|written signout
5056536|NCT01398761|Information science|information science
5056537|NCT01398748|Parkinson's disease|parkinson's disease
5056538|NCT01398748|Neuroprotection|neuroprotection
5056539|NCT01398748|Glutathione|glutathione
5056540|NCT01398748|Intranasal|intranasal
5056541|NCT01398722|cardiac surgery|cardiac surgery
5056542|NCT01398722|prognosis|prognosis
5056543|NCT01398722|intensive insulin therapy|intensive insulin therapy
5056544|NCT01398709|Cardiopulmonary Bypass|cardiopulmonary bypass
5056545|NCT01398709|Prognosis|prognosis
5056546|NCT01398709|Cardiac Surgery|cardiac surgery
5056547|NCT01398709|Rewarming Rate|rewarming rate
5056548|NCT01398696|Patient Information Leaflets|patient information leaflets
5056549|NCT01398696|primary care|primary care
5056550|NCT01398696|patient behaviour|patient behaviour
5056551|NCT01398696|pharyngitis|pharyngitis
5056552|NCT01398696|gastroenteritis|gastroenteritis
5056553|NCT01398670|Type I Diabetes|type i diabetes
5056554|NCT01398670|Wockhardt's Insulin analogue Lispro|wockhardt's insulin analogue lispro
5056555|NCT01398670|Humalog®|humalog®
5056556|NCT01398670|Humalog Mix|humalog mix
5056557|NCT01398670|Wockhardt|wockhardt
5056558|NCT01398670|Biosimilar|biosimilar
5056559|NCT01398670|Phase 3|phase 3
5056560|NCT01398657|localized|localized
5056561|NCT01398657|High risk|high risk
5056562|NCT01398657|Prostate Cancer|prostate cancer
5056563|NCT01398657|Randomized|randomized
5056564|NCT01398657|Cryotherapy|cryotherapy
5056565|NCT01398657|Cryoablation|cryoablation
5056566|NCT01398657|Adjuvant|adjuvant
5056567|NCT01398657|Androgen Deprivation Therapy|androgen deprivation therapy
5056568|NCT01398657|Hormone therapy|hormone therapy
5056569|NCT01398657|ADT|adt
5056570|NCT01398644|Phlebotomy|phlebotomy
5056571|NCT01398644|Therapeutic erythrocytapheresis|therapeutic erythrocytapheresis
5056572|NCT01398644|Hereditary Hemochromatosis|hereditary hemochromatosis
5056573|NCT01398644|maintenance therapy|maintenance therapy
5056574|NCT01398631|Risk scores|risk scores
5056575|NCT01398631|ACS|acs
5056576|NCT01398631|HEART-score|heart-score
5056577|NCT01398618|latent tuberculosis infection|latent tuberculosis infection
5056578|NCT01398618|tuberculosis|tuberculosis
5056579|NCT01398618|interferon-gamma release assay|interferon-gamma release assay
5056580|NCT01398618|preventive therapy|preventive therapy
5056581|NCT01398618|9-month isoniazid|9-month isoniazid
5056582|NCT01398618|4-month rifampin|4-month rifampin
5056583|NCT01398605|Postmenopausal women|postmenopausal women
5056584|NCT01398605|Physical activity|physical activity
5056585|NCT01398605|Cardiovascular risks|cardiovascular risks
5056586|NCT01398605|Cardiac function|cardiac function
5056587|NCT01398605|Dose-response|dose-response
5056588|NCT01398592|Diabetes mellitus Type two|diabetes mellitus type two
5056589|NCT01398592|T2DM|t2dm
5056590|NCT01398592|vildagliptin|vildagliptin
5056591|NCT01398592|sitagliptin|sitagliptin
5056592|NCT01398592|FPG|fpg
5056593|NCT01398592|DPP-4|dpp-4
5056594|NCT01398579|intestinal metaplasia|intestinal metaplasia
5056595|NCT01398579|dysplasia|dysplasia
5056596|NCT01398579|probe-based confocal endomicroscopy|probe-based confocal endomicroscopy
5056597|NCT01398566|TBI|tbi
5056598|NCT01398566|concussion|concussion
5056599|NCT01398566|brain injury|brain injury
5056600|NCT01398553|stroke|stroke
5056601|NCT01398553|tbi|tbi
5056602|NCT01398553|rehabilitation|rehabilitation
5056603|NCT01398553|upper limb|upper limb
5056604|NCT01398527|Long-Term Care|long-term care
5056605|NCT01398527|Vitamin D|vitamin d
5056606|NCT01398501|AML|aml
5056607|NCT01398501|FLT3-ITD|flt3-itd
5056608|NCT01398501|Stem cell transplant|stem cell transplant
5056609|NCT01398488|Trough levels|trough levels
5056610|NCT01398488|Education|education
5056611|NCT01398488|Adherence|adherence
5056612|NCT01398449|thoracic esophageal squamous cell carcinoma|thoracic esophageal squamous cell carcinoma
5056613|NCT01398449|esophagectomy|esophagectomy
5056614|NCT01398449|elective nodal irradiation|elective nodal irradiation
5056615|NCT01398449|adjuvant chemotherapy|adjuvant chemotherapy
5056616|NCT01398436|Central venous saturation|central venous saturation
5056617|NCT01398436|Mixed venous saturation|mixed venous saturation
5056618|NCT01398436|Right atrium|right atrium
5056619|NCT01398436|Central Venous Catheter position|central venous catheter position
5056620|NCT01398423|Hypertension|hypertension
5056621|NCT01398423|Diabetes mellitis|diabetes mellitis
5056622|NCT01398423|Nephropathy|nephropathy
5056623|NCT01398423|Albuminuria|albuminuria
5056624|NCT01398410|Rabeprazole|rabeprazole
5056625|NCT01398410|proton pump inhibitor|proton pump inhibitor
5056626|NCT01398410|Acetylsalicylic Acid|acetylsalicylic acid
5056627|NCT01398410|Aspirin|aspirin
5056628|NCT01398410|Gastric Ulcer|gastric ulcer
5056629|NCT01398410|Duodenal Ulcer|duodenal ulcer
5056630|NCT01398397|HED|hed
5056631|NCT01398397|XLHED|xlhed
5056632|NCT01398397|X-linked Hypohidrotic Ectodermal Dysplasia (XLHED)|x-linked hypohidrotic ectodermal dysplasia (xlhed)
5056633|NCT01398384|ST Elevation MI|st elevation mi
5056634|NCT01398384|STEMI|stemi
5056635|NCT01398371|Heart failure|heart failure
5056636|NCT01398371|Digoxin withdrawal|digoxin withdrawal
5056637|NCT01398358|obesity|obesity
5056638|NCT01398358|prevention|prevention
5056639|NCT01398358|children|children
5056640|NCT01398319|prevention|prevention
5056641|NCT01398319|alcohol abuse|alcohol abuse
5056642|NCT01398306|Angiogenesis Inhibitors|angiogenesis inhibitors
5056643|NCT01398306|Neoplasms, Glandular and Epithelial|neoplasms, glandular and epithelial
5056644|NCT01398306|Neoplasms by Histologic Type|neoplasms by histologic type
5056645|NCT01398306|Neoplasms|neoplasms
5056646|NCT01398306|Adenocarcinoma|adenocarcinoma
5056647|NCT01398306|Kidney Neoplasms|kidney neoplasms
5056648|NCT01398306|Urologic Neoplasms|urologic neoplasms
5056649|NCT01398306|Urogenital Neoplasms|urogenital neoplasms
5056650|NCT01398306|Neoplasms by Site|neoplasms by site
5056651|NCT01398306|Kidney Diseases|kidney diseases
5056652|NCT01398306|Angiogenesis Inducing Agents|angiogenesis inducing agents
5056653|NCT01398306|Biological Markers|biological markers
5056654|NCT01398280|Rosacea|rosacea
5056655|NCT01398280|Dermatology|dermatology
5056656|NCT01398280|UCSD|ucsd
5056657|NCT01398280|Skin disease|skin disease
5056658|NCT01398254|ST-Elevation Myocardial Infarction|st-elevation myocardial infarction
5056659|NCT01398254|Mortality|mortality
5056660|NCT01398228|Quality of care|quality of care
5056661|NCT01398228|Acute Coronary Syndromes (ACS)|acute coronary syndromes (acs)
5056662|NCT01398215|umbilical hernia|umbilical hernia
5056663|NCT01398215|ventral hernia|ventral hernia
5056664|NCT01398202|Vitamin D status|vitamin d status
5056665|NCT01398202|25-hydroxyvitamin D|25-hydroxyvitamin d
5056666|NCT01398202|Vitamin D3|vitamin d3
5056667|NCT01398202|RCT|rct
5056668|NCT01398202|Bio-efficacy|bio-efficacy
5056669|NCT01398189|clozapine|clozapine
5056670|NCT01398189|PET|pet
5056671|NCT01398189|schizophrenia|schizophrenia
5056672|NCT01398189|schizoaffective disorder|schizoaffective disorder
5056673|NCT01398176|gamma delta T cell|gamma delta t cell
5056674|NCT01398176|proliferation|proliferation
5056675|NCT01398163|probiotics|probiotics
5056676|NCT01398163|digestive well-being|digestive well-being
5056677|NCT01398163|fMRI|fmri
5056678|NCT01398163|brain-gut axis|brain-gut axis
5056679|NCT01398150|gamma delta T cell|gamma delta t cell
5056680|NCT01398150|proliferation|proliferation
5056681|NCT01398150|cytokine secretion|cytokine secretion
5056682|NCT01398150|immune function|immune function
5056683|NCT01398150|antioxidant status|antioxidant status
5056684|NCT01398137|Ragweed allergy|ragweed allergy
5056685|NCT01398124|early stage non-small cell lung cancer|early stage non-small cell lung cancer
5056686|NCT01398124|non-small cell lung cancer|non-small cell lung cancer
5056687|NCT01398085|Papillary thyroid carcinoma|papillary thyroid carcinoma
5056688|NCT01398085|Follicular thyroid carcinoma|follicular thyroid carcinoma
5056689|NCT01398085|Hurthle cell carcinoma of the thyroid|hurthle cell carcinoma of the thyroid
5056690|NCT01398085|Iodine Radioisotopes|iodine radioisotopes
5056691|NCT01398059|Sedentary Behavior|sedentary behavior
5056692|NCT01398059|Cardiometabolic Risk|cardiometabolic risk
5056693|NCT01398059|Pediatrics|pediatrics
5056694|NCT01398046|dasatinib|dasatinib
5056695|NCT01398046|betaine|betaine
5056696|NCT01398046|betaine hydrochloride|betaine hydrochloride
5056697|NCT01398046|pharmacokinetics|pharmacokinetics
5056698|NCT01398046|healthy volunteer|healthy volunteer
5056699|NCT01398033|infrapopliteal arteries|infrapopliteal arteries
5056700|NCT01398033|In-stent stenosis|in-stent stenosis
5056701|NCT01398033|long lesions|long lesions
5056702|NCT01398033|drug-coated balloon|drug-coated balloon
5056703|NCT01398020|Bowel Preparation|bowel preparation
5056704|NCT01398020|Patient comfort|patient comfort
5056705|NCT01398020|Bi-Peglyte|bi-peglyte
5056706|NCT01397994|Nicorandil therapy in patients of chronic stable angina|nicorandil therapy in patients of chronic stable angina
5056707|NCT01397968|partial onset seizures|partial onset seizures
5056708|NCT01397968|treatment resistant|treatment resistant
5056709|NCT01397968|partial epilepsy|partial epilepsy
5056710|NCT01397955|Julina|julina
5056711|NCT01397955|Postmenopausal osteoporosis|postmenopausal osteoporosis
5056712|NCT01397942|Diet intervention|diet intervention
5056713|NCT01397942|Type 2 diabetes|type 2 diabetes
5056714|NCT01397942|Vegetables|vegetables
5056715|NCT01397942|Phytochemicals|phytochemicals
5056716|NCT01397916|CLL|cll
5056717|NCT01397916|IDO|ido
5056810|NCT01397448|Acetylsalicylic Acid|acetylsalicylic acid
5056718|NCT01397903|antidepressant therapy, inadequate control, add-on therapy|antidepressant therapy, inadequate control, add-on therapy
5056719|NCT01397890|Severe chronic obstructive pulmonary disease (COPD) patients|severe chronic obstructive pulmonary disease (copd) patients
5056720|NCT01397877|endometrial cancer|endometrial cancer
5056721|NCT01397877|BKM|bkm
5056722|NCT01397877|monotherapy|monotherapy
5056723|NCT01397877|metastatic|metastatic
5056724|NCT01397877|initial treatment|initial treatment
5056725|NCT01397864|Hereditary Angioedema|hereditary angioedema
5056726|NCT01397864|HAE|hae
5056727|NCT01397864|Angioedema|angioedema
5056728|NCT01397864|Recombinant C1 Inhibitor|recombinant c1 inhibitor
5056729|NCT01397864|rhC1INH|rhc1inh
5056730|NCT01397864|registry|registry
5056731|NCT01397838|Osteopenia|osteopenia
5056732|NCT01397812|Rejection of the Heart Transplant|rejection of the heart transplant
5056733|NCT01397812|Heart Transplant Rejection, an immune-mediated allograft injury|heart transplant rejection, an immune-mediated allograft injury
5056734|NCT01397812|Non-cellular or humoral rejection in cardiac transplant recipients|non-cellular or humoral rejection in cardiac transplant recipients
5056735|NCT01397812|Right ventricular endomyocardial biopsy to detect Heart transplant rejection|right ventricular endomyocardial biopsy to detect heart transplant rejection
5056736|NCT01397799|Acute Myelogenous Leukemia|acute myelogenous leukemia
5056737|NCT01397799|AML|aml
5056738|NCT01397799|Refractory|refractory
5056739|NCT01397799|Elderly|elderly
5056740|NCT01397773|Hemodialysis|hemodialysis
5056741|NCT01397773|peritoneal dialysis|peritoneal dialysis
5056742|NCT01397773|chronic kidney disease|chronic kidney disease
5056743|NCT01397773|inflammation|inflammation
5056744|NCT01397773|carotis intima media thickness|carotis intima media thickness
5056745|NCT01397760|DIFFICULT TO CONTROL ASTHMA|difficult to control asthma
5056746|NCT01397760|OMALIZUMABE|omalizumabe
5056747|NCT01397747|Cancer|cancer
5056748|NCT01397747|Colorectal Cancer|colorectal cancer
5056749|NCT01397747|Neoplasm|neoplasm
5056750|NCT01397747|Colorectal Neoplasm|colorectal neoplasm
5056751|NCT01397747|Intestinal Neoplasms|intestinal neoplasms
5056752|NCT01397747|Gastrointestinal Neoplasms|gastrointestinal neoplasms
5056753|NCT01397747|Digestive System Neoplasms|digestive system neoplasms
5056754|NCT01397747|Neoplasms by Site|neoplasms by site
5056755|NCT01397747|Neoplasms|neoplasms
5056756|NCT01397747|Digestive System Diseases|digestive system diseases
5056757|NCT01397747|Gastrointestinal Diseases|gastrointestinal diseases
5056758|NCT01397747|Colonic Diseases|colonic diseases
5056759|NCT01397747|Intestinal Diseases|intestinal diseases
5056760|NCT01397747|Rectal Diseases|rectal diseases
5056761|NCT01397734|CML|cml
5056762|NCT01397734|Chronic myelogenous leukemia|chronic myelogenous leukemia
5056763|NCT01397734|Chronic Myeloid leukemia|chronic myeloid leukemia
5056764|NCT01397734|Arsenic|arsenic
5056765|NCT01397734|Arsenic trioxide|arsenic trioxide
5056766|NCT01397734|Imatinib|imatinib
5056767|NCT01397734|Dasatinib|dasatinib
5056768|NCT01397734|Nilotinib|nilotinib
5056769|NCT01397734|TKI|tki
5056770|NCT01397734|Tyrosine kinase inhibitor|tyrosine kinase inhibitor
5056894|NCT01397123|vegetables|vegetables
5056771|NCT01397721|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
5056772|NCT01397721|pulmonary vasculature|pulmonary vasculature
5056773|NCT01397721|pulmonary hypertension|pulmonary hypertension
5056774|NCT01397721|atherosclerosis|atherosclerosis
5056775|NCT01397721|smokers|smokers
5056776|NCT01397721|emphysema|emphysema
5056777|NCT01397708|Melanoma|melanoma
5056778|NCT01397708|Unresectable|unresectable
5056779|NCT01397682|Comprehensive Geriatric Assessment|comprehensive geriatric assessment
5056780|NCT01397682|Frail elderly|frail elderly
5056781|NCT01397682|Italy/epidemiology|italy/epidemiology
5056782|NCT01397682|Geriatric Health Service|geriatric health service
5056783|NCT01397682|Polypharmacy|polypharmacy
5056784|NCT01397682|Biological Markers|biological markers
5056785|NCT01397682|Epidemiologic Research Design|epidemiologic research design
5056786|NCT01397656|cardiac arrest|cardiac arrest
5056787|NCT01397656|CPR|cpr
5056788|NCT01397656|resuscitation|resuscitation
5056789|NCT01397656|fatigue|fatigue
5056790|NCT01397656|quality|quality
5056791|NCT01397565|Cholecystectomy|cholecystectomy
5056792|NCT01397565|Laparoscopy|laparoscopy
5056793|NCT01397565|Minilaparoscopic surgery|minilaparoscopic surgery
5056794|NCT01397565|Post-operative pain|post-operative pain
5056795|NCT01397565|Recovery time|recovery time
5056796|NCT01397526|Congenital heart disease|congenital heart disease
5056797|NCT01397526|Cardiopulmonary bypass|cardiopulmonary bypass
5056798|NCT01397526|Capillary leak|capillary leak
5056799|NCT01397526|Colloid osmotic pressure|colloid osmotic pressure
5056800|NCT01397526|Children|children
5056801|NCT01397513|Fibrin network structure|fibrin network structure
5056802|NCT01397513|Aspirin treatment|aspirin treatment
5056803|NCT01397513|Platelet microparticles|platelet microparticles
5056804|NCT01397487|morphometric parameters, embryo biopsy|morphometric parameters, embryo biopsy
5056805|NCT01397474|peripheral perfusion|peripheral perfusion
5056806|NCT01397474|critically ill patients|critically ill patients
5056807|NCT01397474|fluid administration|fluid administration
5056808|NCT01397448|Rabeprazole|rabeprazole
5056809|NCT01397448|proton pump inhibitor|proton pump inhibitor
5056811|NCT01397448|Aspirin|aspirin
5056812|NCT01397448|Gastric Ulcer|gastric ulcer
5056813|NCT01397448|Duodenal Ulcer|duodenal ulcer
5056814|NCT01397435|Lysosomal diseases|lysosomal diseases
5056815|NCT01397435|Magnetic resonance Spectroscopy|magnetic resonance spectroscopy
5056816|NCT01397435|MRI|mri
5056817|NCT01397422|Levodopa-induced dyskinesia|levodopa-induced dyskinesia
5056818|NCT01397422|Parkinsonism|parkinsonism
5056819|NCT01397370|Safety|safety
5056820|NCT01397370|Tolerability|tolerability
5056821|NCT01397370|Pharmacokinetics|pharmacokinetics
5056822|NCT01397370|Pharmacodynamics|pharmacodynamics
5056823|NCT01397357|Cardiac magnetic resonance|cardiac magnetic resonance
5056824|NCT01397357|Myocardial Ischemia|myocardial ischemia
5056825|NCT01397357|Coronary Artery Disease|coronary artery disease
5056826|NCT01397357|suspected Myocardial Ischemia|suspected myocardial ischemia
5056827|NCT01397344|People in the outpatient waiting room|people in the outpatient waiting room
5056828|NCT01397331|inhalational anesthesia|inhalational anesthesia
5056829|NCT01397331|intravenous anesthesia|intravenous anesthesia
5056830|NCT01397331|cardiac surgery|cardiac surgery
5056831|NCT01397318|TaiChi Exercise|taichi exercise
5056832|NCT01397318|pregnant women|pregnant women
5056833|NCT01397305|5,10-methylenetetrahydrofolate|5,10-methylenetetrahydrofolate
5056834|NCT01397305|neoadjuvant therapy|neoadjuvant therapy
5056835|NCT01397305|pemetrexed|pemetrexed
5056836|NCT01397305|Neoplasms|neoplasms
5056837|NCT01397305|Rectal Neoplasms|rectal neoplasms
5056838|NCT01397305|Colorectal Neoplasms|colorectal neoplasms
5056839|NCT01397305|Intestinal Neoplasms|intestinal neoplasms
5056840|NCT01397305|Gastrointestinal Neoplasms|gastrointestinal neoplasms
5056841|NCT01397305|Digestive System Neoplasms|digestive system neoplasms
5056842|NCT01397305|Neoplasms by Site|neoplasms by site
5056843|NCT01397305|Rectal Diseases|rectal diseases
5056844|NCT01397305|Digestive System Diseases|digestive system diseases
5056845|NCT01397305|Gastrointestinal Diseases|gastrointestinal diseases
5056846|NCT01397305|Intestinal Diseases|intestinal diseases
5056847|NCT01397305|Pharmacologic Actions|pharmacologic actions
5056848|NCT01397305|Therapeutic Uses|therapeutic uses
5056849|NCT01397305|Antineoplastic Agents|antineoplastic agents
5056850|NCT01397305|Enzyme Inhibitors|enzyme inhibitors
5056851|NCT01397305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
5056852|NCT01397305|Folic Acid Antagonists|folic acid antagonists
5056853|NCT01397305|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic
5056854|NCT01397305|Antimetabolites|antimetabolites
5056855|NCT01397292|Bronchoscopy|bronchoscopy
5056856|NCT01397292|Interventional Pulmonary|interventional pulmonary
5056857|NCT01397292|Pleuroscopy|pleuroscopy
5056858|NCT01397292|Tracheostomy|tracheostomy
5056859|NCT01397279|type 2 diabetes|type 2 diabetes
5056860|NCT01397279|insulin sensitivity|insulin sensitivity
5056861|NCT01397279|hyperinsulinemic euglycemic clamp|hyperinsulinemic euglycemic clamp
5056862|NCT01397266|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
5056863|NCT01397266|Cocaine|cocaine
5056864|NCT01397266|impulsivity|impulsivity
5056865|NCT01397266|rating scale|rating scale
5056866|NCT01397253|Automated Communication Tools|automated communication tools
5056867|NCT01397253|Medication errors|medication errors
5056868|NCT01397253|PCP communication|pcp communication
5056869|NCT01397227|Malaria|malaria
5056870|NCT01397227|Plasmodium falciparum|plasmodium falciparum
5056871|NCT01397227|Vaccination|vaccination
5056872|NCT01397227|Prophylaxis|prophylaxis
5056873|NCT01397227|Adenovirus|adenovirus
5056874|NCT01397188|PiCCO|picco
5056875|NCT01397175|Coronary artery disease|coronary artery disease
5056876|NCT01397175|Percutaneous coronary intervention|percutaneous coronary intervention
5056877|NCT01397175|Drug-eluting stent|drug-eluting stent
5056878|NCT01397149|Chronic lymphocytic leukemia|chronic lymphocytic leukemia
5056879|NCT01397149|Thrombocytopenia|thrombocytopenia
5056880|NCT01397149|Alkylating agents|alkylating agents
5056881|NCT01397149|Purine derivatives|purine derivatives
5056882|NCT01397149|TPO receptor agonist|tpo receptor agonist
5056883|NCT01397136|Human embryo|human embryo
5056884|NCT01397136|Culture media|culture media
5056885|NCT01397136|Cell-free DNA|cell-free dna
5056886|NCT01397136|In vitro fertilization|in vitro fertilization
5056887|NCT01397136|Infertility|infertility
5056888|NCT01397123|BMI z-score|bmi z-score
5056889|NCT01397123|children|children
5056890|NCT01397123|overweight|overweight
5056891|NCT01397123|school-based intervention|school-based intervention
5056892|NCT01397123|trained teachers|trained teachers
5056893|NCT01397123|fruit|fruit
5056895|NCT01397123|Low nutrition energy dense foods|low nutrition energy dense foods
5056896|NCT01397084|esomeprazole 20mg|esomeprazole 20mg
5056897|NCT01397084|heartburn|heartburn
5056898|NCT01397084|rabeprazole 10mg|rabeprazole 10mg
5056899|NCT01397084|reflux esophagitis|reflux esophagitis
5056900|NCT01397084|Phase IV|phase iv
5056901|NCT01397071|Avocado, antioxidant|avocado, antioxidant
5056902|NCT01397045|Lung|lung
5056903|NCT01397045|Nodule|nodule
5056904|NCT01397045|Rehabilitation|rehabilitation
5056905|NCT01397045|VATS|vats
5056906|NCT01397045|Thoracotomy|thoracotomy
5056907|NCT01397032|attention bias modification treatment|attention bias modification treatment
5056908|NCT01397032|cognitive bias modification|cognitive bias modification
5056909|NCT01397032|attention training|attention training
5056910|NCT01397032|social anxiety|social anxiety
5056911|NCT01397019|Pancreatic cancer|pancreatic cancer
5056912|NCT01397019|Chemotherapy|chemotherapy
5056913|NCT01397019|Chemoradiotherapy|chemoradiotherapy
5056914|NCT01397006|Fibromyalgia|fibromyalgia
5056915|NCT01397006|pregabalin|pregabalin
5056916|NCT01397006|Lyrica|lyrica
5056917|NCT01396980|hemodialysis|hemodialysis
5056918|NCT01396980|intensive care|intensive care
5056919|NCT01396980|microcirculation|microcirculation
5056920|NCT01396967|capsulorhexis|capsulorhexis
5056921|NCT01396954|Liver cirrhosis|liver cirrhosis
5056922|NCT01396954|Diabetes mellitus|diabetes mellitus
5056923|NCT01396954|Hepatogenous diabetes|hepatogenous diabetes
5056924|NCT01396954|Oral glucose tolerance test|oral glucose tolerance test
5056925|NCT01396954|Insulin resistance.|insulin resistance.
5056926|NCT01396941|Diabetes|diabetes
5056927|NCT01396928|Low rectal adenocarcinoma|low rectal adenocarcinoma
5056928|NCT01396915|Skeletal muscle lipid content|skeletal muscle lipid content
5056929|NCT01396915|whole muscle volume|whole muscle volume
5056930|NCT01396915|fasting glucose|fasting glucose
5056931|NCT01396915|insulin|insulin
5056932|NCT01396915|blood urea nitrogen|blood urea nitrogen
5056933|NCT01396889|Upper Respiratory Tract Infections|upper respiratory tract infections
5056934|NCT01396889|Echinacea|echinacea
5056935|NCT01396889|viral infections|viral infections
5056936|NCT01396876|Medical clown|medical clown
5056937|NCT01396876|Pediatric emergency medicine|pediatric emergency medicine
5056938|NCT01396876|Emergency procedures|emergency procedures
5056939|NCT01396863|Renal dialysis|renal dialysis
5056940|NCT01396863|Hemodiafiltration|hemodiafiltration
5056941|NCT01396863|Hemodialysis|hemodialysis
5056942|NCT01396863|MRI|mri
5056943|NCT01396850|Psychotic Patients|psychotic patients
5056944|NCT01396837|Diabetic Foot Ulcer|diabetic foot ulcer
5056945|NCT01396837|Diabetic Ulcer|diabetic ulcer
5056946|NCT01396837|Diabetic Wound|diabetic wound
5056947|NCT01396837|Chronic Ulcer|chronic ulcer
5056948|NCT01396837|Chronic Wound|chronic wound
5056949|NCT01396837|Neuropathic Diabetic Foot Ulcer|neuropathic diabetic foot ulcer
5056950|NCT01396837|Neuropathic DFU|neuropathic dfu
5056951|NCT01396837|DFU|dfu
5056952|NCT01396824|Malnutrition|malnutrition
5056953|NCT01396824|Undernutrition|undernutrition
5056954|NCT01396824|Nutrition Assessment|nutrition assessment
5056955|NCT01396824|Nutritional Assessment|nutritional assessment
5056956|NCT01396824|Nutritional Index|nutritional index
5056957|NCT01396824|Prognostic Nutritional Index|prognostic nutritional index
5056958|NCT01396824|Prognostic Nutritional Index (PNI)|prognostic nutritional index (pni)
5056959|NCT01396824|Nutritional Status|nutritional status
5056960|NCT01396824|Prognosis|prognosis
5056961|NCT01396824|Heart Failure|heart failure
5056962|NCT01396824|Cardiovascular Diseases|cardiovascular diseases
5056963|NCT01396824|Body Composition|body composition
5056964|NCT01396824|Body Weights and Measures|body weights and measures
5056965|NCT01396811|Tinea Pedis|tinea pedis
5056966|NCT01396811|Antifungal|antifungal
5056967|NCT01396798|serious infections|serious infections
5056968|NCT01396798|meningitis|meningitis
5056969|NCT01396785|Tinea Pedis|tinea pedis
5056970|NCT01396785|Antifungal|antifungal
5056971|NCT01396772|prediabetes|prediabetes
5056972|NCT01396772|diabetes prevention|diabetes prevention
5056973|NCT01396772|adults|adults
5056974|NCT01396772|lifestyle intervention|lifestyle intervention
5056975|NCT01396772|Social Cognitive Theory|social cognitive theory
5056976|NCT01396772|dietary intake|dietary intake
5056977|NCT01396772|physical activity|physical activity
5056978|NCT01396759|Bubble CPAP|bubble cpap
5056979|NCT01396759|Humidified high flow|humidified high flow
5056980|NCT01396759|Hypoxaemia|hypoxaemia
5056981|NCT01396759|Nasal prong|nasal prong
5056982|NCT01396759|Severe pneumonia|severe pneumonia
5056983|NCT01396733|thyroid|thyroid
5056984|NCT01396733|cancer|cancer
5056985|NCT01396733|redifferentiation|redifferentiation
5056986|NCT01396733|lipoic acid|lipoic acid
5056987|NCT01396707|HER2|her2
5056988|NCT01396707|Trastuzumab|trastuzumab
5056989|NCT01396707|XELOX|xelox
5056990|NCT01396707|PHASE 2|phase 2
5056991|NCT01396681|resected pancreatic cancer|resected pancreatic cancer
5056992|NCT01396668|locally advanced|locally advanced
5056993|NCT01396655|breast cancer|breast cancer
5056994|NCT01396655|neoadjuvant chemotherapy|neoadjuvant chemotherapy
5056995|NCT01396655|molecular marker|molecular marker
5056996|NCT01396655|FDG PET|fdg pet
5056997|NCT01396655|locally advanced breast cancer|locally advanced breast cancer
5056998|NCT01396642|Topical Emollient Therapy|topical emollient therapy
5056999|NCT01396642|Emollient|emollient
5057000|NCT01396642|Preterm|preterm
5057001|NCT01396642|Hospital Acquired Infection|hospital acquired infection
5057002|NCT01396629|cartridge IOL|cartridge iol
5057003|NCT01396603|Optical Frequency Domain Imaging|optical frequency domain imaging
5057004|NCT01396603|Optical Coherence Tomography|optical coherence tomography
5057005|NCT01396603|Optical biopsy|optical biopsy
5057006|NCT01396603|Comprehensive Microscopy|comprehensive microscopy
5057007|NCT01396590|Central Nervous System|central nervous system
5057008|NCT01396577|Central Nervous System|central nervous system
5057009|NCT01396564|Type 2 diabetes|type 2 diabetes
5057010|NCT01396564|Resistin|resistin
5057011|NCT01396564|Inflammation|inflammation
5057012|NCT01396564|Insulin Resistance|insulin resistance
5057013|NCT01396551|Anchored Beacon Transponder|anchored beacon transponder
5057014|NCT01396551|Anchored Transponder|anchored transponder
5057015|NCT01396551|Lung cancer|lung cancer
5057016|NCT01396551|Calypso system|calypso system
5057017|NCT01396551|Realtime tracking|realtime tracking
5057018|NCT01396538|anti-HBc alone ；occult HBV infection|anti-hbc alone ；occult hbv infection
5057019|NCT01396525|Atherosclerosis|atherosclerosis
5057020|NCT01396525|Peripheral artery disease|peripheral artery disease
5057021|NCT01396525|Peripheral vascular disease|peripheral vascular disease
5057022|NCT01396525|PAD|pad
5057023|NCT01396525|Claudication|claudication
5057024|NCT01396525|Peripheral Arterial Occlusive Disease|peripheral arterial occlusive disease
5057025|NCT01396525|Stent|stent
5057026|NCT01396525|PAOD|paod
5057027|NCT01396525|PVD|pvd
5057028|NCT01396512|Japanese Encephalitis|japanese encephalitis
5057029|NCT01396512|Japanese Encephalitis Virus Disease|japanese encephalitis virus disease
5057030|NCT01396512|IMOJEV™|imojev™
5057031|NCT01396512|CD.JEVAX™|cd.jevax™
5057032|NCT01396499|Leukemia|leukemia
5057033|NCT01396499|Acute leukemias|acute leukemias
5057034|NCT01396499|Relapsed/refractory leukemias|relapsed/refractory leukemias
5057035|NCT01396499|Acute myelogenous leukemia|acute myelogenous leukemia
5057036|NCT01396499|AML|aml
5057037|NCT01396499|Acute lymphoblastic leukemia|acute lymphoblastic leukemia
5057038|NCT01396499|ALL|all
5057039|NCT01396499|BKM120|bkm120
5057040|NCT01396486|Omega-3 Fatty Acids|omega-3 fatty acids
5057041|NCT01396486|Fish Oil|fish oil
5057042|NCT01396486|Inositol|inositol
5057043|NCT01396486|Natural supplements|natural supplements
5057044|NCT01396486|Bipolar Spectrum Disorders|bipolar spectrum disorders
5057045|NCT01396486|Mania|mania
5057046|NCT01396486|Depression|depression
5057047|NCT01396486|Children|children
5057048|NCT01396473|afterschool|afterschool
5057049|NCT01396473|accelerometers|accelerometers
5057050|NCT01396473|plate waste|plate waste
5057051|NCT01396473|policy|policy
5057052|NCT01396473|environment|environment
5057053|NCT01396460|respiratory quotient|respiratory quotient
5057054|NCT01396460|fat oxidation|fat oxidation
5057055|NCT01396460|morbid obesity|morbid obesity
5057056|NCT01396460|bariatric|bariatric
5057057|NCT01396460|Bariatric Surgery|bariatric surgery
5057058|NCT01396447|Bipolar I disorder|bipolar i disorder
5057059|NCT01396447|Bipolar depression|bipolar depression
5057060|NCT01396447|Depression|depression
5057061|NCT01396447|Bipolar disorder|bipolar disorder
5057062|NCT01396395|Nicorandil|nicorandil
5057063|NCT01396395|Stable angina|stable angina
5057064|NCT01396382|neuroendocrine|neuroendocrine
5057065|NCT01396382|neuroendocrine carcinoma|neuroendocrine carcinoma
5057066|NCT01396382|neuroendocrine tumor|neuroendocrine tumor
5057067|NCT01396382|carcinoid|carcinoid
5057068|NCT01396382|carcinoid tumor|carcinoid tumor
5057069|NCT01396382|islet cell tumor|islet cell tumor
5057070|NCT01396382|APUDoma|apudoma
5057071|NCT01396382|Gallium|gallium
5057072|NCT01396382|PET Scan|pet scan
5057073|NCT01396343|Pediatric Multiple Sclerosis|pediatric multiple sclerosis
5057074|NCT01396343|Relapsing Remitting Multiple Sclerosis|relapsing remitting multiple sclerosis
5057075|NCT01396343|Clinically Isolated Syndrome|clinically isolated syndrome
5057076|NCT01396343|Demyelinating Disease|demyelinating disease
5057077|NCT01396317|PMR|pmr
5057078|NCT01396317|POLYMYALGIA RHEUMATICA|polymyalgia rheumatica
5057079|NCT01396317|Tocilizumab|tocilizumab
5057080|NCT01396317|Hospital for Special Surgery|hospital for special surgery
5057081|NCT01396317|HSS|hss
5057082|NCT01396317|Robert Spiera|robert spiera
5057083|NCT01396304|leg ulcer|leg ulcer
5057084|NCT01396304|infection|infection
5057085|NCT01396304|closure|closure
5057086|NCT01396304|wound dressings|wound dressings
5057087|NCT01396239|DMD|dmd
5057088|NCT01396226|Atrial refractoriness|atrial refractoriness
5057089|NCT01396226|cardiac electrophysiology|cardiac electrophysiology
5057090|NCT01396226|IKACh|ikach
5057091|NCT01396213|larazotide acetate|larazotide acetate
5057092|NCT01396187|Type 2 diabetes|type 2 diabetes
5057093|NCT01396187|safety|safety
5057094|NCT01396187|multiple dose|multiple dose
5057095|NCT01396187|intravenous|intravenous
5057096|NCT01396174|breast cancer|breast cancer
5057097|NCT01396174|breast tumor|breast tumor
5057098|NCT01396161|Phase 1|phase 1
5057099|NCT01396161|Multiple Doses|multiple doses
5057100|NCT01396161|Safety|safety
5057101|NCT01396161|Pharmacokinetics|pharmacokinetics
5057102|NCT01396161|Pharmacodynamics|pharmacodynamics
5057103|NCT01396161|Healthy Volunteers|healthy volunteers
5057104|NCT01396161|Type 2 Diabetic Patients|type 2 diabetic patients
5057105|NCT01396148|Children and young adults with GIST|children and young adults with gist
5057106|NCT01396148|sunitinib malate|sunitinib malate
5057107|NCT01396148|pharmacokinetics|pharmacokinetics
5057108|NCT01396148|tumor response|tumor response
5057109|NCT01396148|overall survival|overall survival
5057110|NCT01396148|tumor KIT mutation status|tumor kit mutation status
5057111|NCT01396135|Phase 1|phase 1
5057112|NCT01396135|Pharmacokinetics|pharmacokinetics
5057113|NCT01396135|Healthy|healthy
5057114|NCT01396135|Japanese|japanese
5057115|NCT01396135|Non-smokers|non-smokers
5057116|NCT01396135|Major Depressive Disorder|major depressive disorder
5057117|NCT01396135|CP-601|cp-601
5057118|NCT01396135|927|927
5057119|NCT01396096|Bariatric Surgery|bariatric surgery
5057120|NCT01396083|Visual impairment|visual impairment
5057121|NCT01396083|macular edema|macular edema
5057122|NCT01396083|Central retinal vein occlusion|central retinal vein occlusion
5057123|NCT01396083|Dexamethasone implant|dexamethasone implant
5057124|NCT01396083|Ranibizumab|ranibizumab
5057125|NCT01396057|Visual impairment|visual impairment
5057126|NCT01396057|macular edema|macular edema
5057127|NCT01396057|branch retinal vein occlusion|branch retinal vein occlusion
5057128|NCT01396057|Dexamethasone implant|dexamethasone implant
5057129|NCT01396057|Ranibizumab|ranibizumab
5057130|NCT01396044|Quality improvement|quality improvement
5057131|NCT01396044|Checklist|checklist
5057132|NCT01396044|Critical care|critical care
5057133|NCT01396044|Anti-bacterial agents|anti-bacterial agents
5057134|NCT01396044|Mechanical ventilation|mechanical ventilation
5057135|NCT01395966|with tubes|with tubes
5057136|NCT01395953|Buspirone|buspirone
5057137|NCT01395953|Buspar|buspar
5057138|NCT01395953|Autism Spectrum Disorders|autism spectrum disorders
5057139|NCT01395953|Pervasive Developmental Disorders|pervasive developmental disorders
5057140|NCT01395953|Children|children
5057141|NCT01395953|Adolescents|adolescents
5057142|NCT01395953|Anxiety|anxiety
5057143|NCT01395940|Gonadotropin-Releasing Hormone (GnRH) antagonist|gonadotropin-releasing hormone (gnrh) antagonist
5057144|NCT01395927|Canagliflozin|canagliflozin
5057145|NCT01395927|Rifampin|rifampin
5057146|NCT01395927|Pharmacokinetics|pharmacokinetics
5057147|NCT01395901|Prevention of Postoperative Nausea and Vomiting|prevention of postoperative nausea and vomiting
5057148|NCT01395901|Palonosetron|palonosetron
5057149|NCT01395901|Ondansetron|ondansetron
5057150|NCT01395901|Pediatric|pediatric
5057151|NCT01395836|Coronary Artery Bypass Grafting|coronary artery bypass grafting
5057152|NCT01395836|Cardiology|cardiology
5057153|NCT01395836|Cardiac Electrophysiology|cardiac electrophysiology
5057154|NCT01395836|Cardiac Surgery|cardiac surgery
5057155|NCT01395784|Oxycodone|oxycodone
5057156|NCT01395784|Opioid abuse|opioid abuse
5057157|NCT01395771|Effect|effect
5057158|NCT01395771|Phone call|phone call
5057159|NCT01395771|Intervention|intervention
5057160|NCT01395771|Promote|promote
5057161|NCT01395771|HAART adherence|haart adherence
5057162|NCT01395758|KRAS mutation|kras mutation
5057163|NCT01395758|metastatic NSCLC|metastatic nsclc
5057164|NCT01395745|SLE|sle
5057165|NCT01395745|Lupus|lupus
5057166|NCT01395745|Lupus Erythematosus, Systemic|lupus erythematosus, systemic
5057167|NCT01395745|Autoimmune Diseases|autoimmune diseases
5057168|NCT01395745|A-623|a-623
5057169|NCT01395745|Blisibimod|blisibimod
5057170|NCT01395719|renal transplantation|renal transplantation
5057171|NCT01395719|glomerular filtration rate|glomerular filtration rate
5057172|NCT01395719|remote ischemic preconditioning|remote ischemic preconditioning
5057173|NCT01395719|remote ischemic conditioning|remote ischemic conditioning
5057174|NCT01395706|Malignant Neoplasm of Breast|malignant neoplasm of breast
5057175|NCT01395706|Sentinel lymph node detection|sentinel lymph node detection
5057176|NCT01395706|ICG fluorescence technique|icg fluorescence technique
5057177|NCT01395706|Population of male and female patients with mamma carcinoma|population of male and female patients with mamma carcinoma
5057178|NCT01395680|cancer adolescent|cancer adolescent
5057179|NCT01395680|resilience|resilience
5057180|NCT01395641|Aromatic Amino Acid Decarboxylase|aromatic amino acid decarboxylase
5057181|NCT01395641|AADC|aadc
5057182|NCT01395641|DDC|ddc
5057183|NCT01395641|Gene Therapy|gene therapy
5057184|NCT01395641|AAV2-AADC|aav2-aadc
5057185|NCT01395641|Viral Vector|viral vector
5057186|NCT01395641|Gene Transfer|gene transfer
5057187|NCT01395641|Aromatic L-Amino Acid Decarboxylase Deficiency|aromatic l-amino acid decarboxylase deficiency
5057188|NCT01395628|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5057189|NCT01395628|childhood acute promyelocytic leukemia (M3)|childhood acute promyelocytic leukemia (m3)
5057190|NCT01395628|childhood acute myeloid leukemia/other myeloid malignancies|childhood acute myeloid leukemia/other myeloid malignancies
5057191|NCT01395628|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5057192|NCT01395628|adult acute myeloid leukemia with del(5q)|adult acute myeloid leukemia with del(5q)
5057193|NCT01395628|adult acute promyelocytic leukemia (M3)|adult acute promyelocytic leukemia (m3)
5057194|NCT01395589|allergy|allergy
5057195|NCT01395589|clinical trial|clinical trial
5057196|NCT01395589|exacerbation|exacerbation
5057197|NCT01395589|pediatrics|pediatrics
5057198|NCT01395576|Genu recurvatum|genu recurvatum
5057199|NCT01395576|Knee hyper extension|knee hyper extension
5057200|NCT01395576|Orthosis|orthosis
5057201|NCT01395576|Gait analysis|gait analysis
5057202|NCT01395576|Post stroke|post stroke
5057203|NCT01395524|Non-Cancer-Related Pain|non-cancer-related pain
5057204|NCT01395524|Opioid-Induced Constipation.|opioid-induced constipation.
5057205|NCT01395511|whiplash associated disorder,|whiplash associated disorder,
5057206|NCT01395511|Intractable Traumatic Cervical Syndrome,|intractable traumatic cervical syndrome,
5057207|NCT01395511|Acupuncture,|acupuncture,
5057208|NCT01395511|Randomized controlled trial|randomized controlled trial
5057209|NCT01395498|CMV|cmv
5057210|NCT01395498|PCP|pcp
5057211|NCT01395498|bronchoalveolar lavage|bronchoalveolar lavage
5057212|NCT01395485|Amgen|amgen
5057213|NCT01395485|Adolescent|adolescent
5057214|NCT01395485|Single Dose|single dose
5057215|NCT01395485|Safety|safety
5057216|NCT01395485|Pharmacokinetics|pharmacokinetics
5057217|NCT01395472|TBI|tbi
5057218|NCT01395472|Acute physical exercise|acute physical exercise
5057219|NCT01395472|Cognitive functions|cognitive functions
5057220|NCT01395472|Mood|mood
5057221|NCT01395459|screening|screening
5057222|NCT01395459|cancer prevention|cancer prevention
5057223|NCT01395459|IVR|ivr
5057224|NCT01395433|Assessing the bioequivalence of escitalopram dosage forms|assessing the bioequivalence of escitalopram dosage forms
5057225|NCT01395420|Phase 1|phase 1
5057226|NCT01395420|open label|open label
5057227|NCT01395420|healthy male and female (post menopausal) volunteers|healthy male and female (post menopausal) volunteers
5057228|NCT01395420|Pharmacokinetics|pharmacokinetics
5057229|NCT01395420|CAZ104|caz104
5057230|NCT01395420|Avibactam|avibactam
5057231|NCT01395420|Ceftazidime|ceftazidime
5057232|NCT01395420|open label, at least 2 different regimens, concentration of investigational product (IP), CAZ104, Avibactam, Ceftazidime, Cmax, tmax|open label, at least 2 different regimens, concentration of investigational product (ip), caz104, avibactam, ceftazidime, cmax, tmax
5057233|NCT01395407|Brain|brain
5057234|NCT01395407|Neoplasm|neoplasm
5057235|NCT01395407|Neoplasm Metastasis|neoplasm metastasis
5057236|NCT01395407|Radiosurgery|radiosurgery
5057237|NCT01395394|Phenylketonuria|phenylketonuria
5057238|NCT01395394|PKU|pku
5057239|NCT01395394|tetrahydrobiopterin|tetrahydrobiopterin
5057240|NCT01395394|sapropterin dihydrochloride|sapropterin dihydrochloride
5057241|NCT01395394|BH4|bh4
5057242|NCT01395394|Kuvan|kuvan
5057243|NCT01395394|Oxidative stress|oxidative stress
5057244|NCT01395368|subjective|subjective
5057245|NCT01395368|unilateral|unilateral
5057246|NCT01395368|bilateral|bilateral
5057247|NCT01395368|non-pulsatile|non-pulsatile
5057248|NCT01395368|6 month's duration or longer|6 month's duration or longer
5057249|NCT01395355|binge eating|binge eating
5057250|NCT01395355|loss of control eating|loss of control eating
5057251|NCT01395355|eating in the absence of hunger|eating in the absence of hunger
5057252|NCT01395355|emotional eating|emotional eating
5057253|NCT01395342|Pregnant women|pregnant women
5057254|NCT01395342|Pre-eclampsia|pre-eclampsia
5057255|NCT01395342|Exercise|exercise
5057256|NCT01395342|Hypertension, Pregnancy-Induced|hypertension, pregnancy-induced
5057257|NCT01395342|Parturition|parturition
5057258|NCT01395303|infarction|infarction
5057259|NCT01395303|stroke|stroke
5057260|NCT01395303|diabetes|diabetes
5057261|NCT01395303|fracture|fracture
5057262|NCT01395303|aortic stenosis|aortic stenosis
5057263|NCT01395303|cancer|cancer
5057264|NCT01395303|death|death
5057265|NCT01395303|vitamin D|vitamin d
5057266|NCT01395303|androgens|androgens
5057267|NCT01395303|thyroid hormones|thyroid hormones
5057268|NCT01395290|staphylococcus aureus|staphylococcus aureus
5057269|NCT01395290|vitamin D|vitamin d
5057270|NCT01395277|Nitric Oxide|nitric oxide
5057271|NCT01395277|Vascular Function|vascular function
5057272|NCT01395277|Aging|aging
5057273|NCT01395277|Blood Pressure|blood pressure
5057274|NCT01395277|Arterial Stiffness|arterial stiffness
5057275|NCT01395277|Cardiovascular Disease|cardiovascular disease
5057276|NCT01395277|Cerebral Blood Flow|cerebral blood flow
5057277|NCT01395251|rheumatoid arthritis|rheumatoid arthritis
5057278|NCT01395251|diagnosis|diagnosis
5057279|NCT01395251|sensitivity|sensitivity
5057280|NCT01395251|glucocorticoids|glucocorticoids
5057281|NCT01395238|fathers|fathers
5057282|NCT01395238|parenting|parenting
5057283|NCT01395238|high-risk|high-risk
5057284|NCT01395238|child maltreatment|child maltreatment
5057285|NCT01395238|prevention|prevention
5057286|NCT01395225|Fat Emulsifying|fat emulsifying
5057287|NCT01395225|Radical Cystectomy|radical cystectomy
5057288|NCT01395225|Pelvic Lymph Node Dissection|pelvic lymph node dissection
5057289|NCT01395225|Pathological Lymph Node Processing|pathological lymph node processing
5057290|NCT01395225|Bladder Cancer|bladder cancer
5057291|NCT01395225|Transitional Cell Carcinoma|transitional cell carcinoma
5057292|NCT01395225|Urothelial Cell Carcinoma|urothelial cell carcinoma
5057293|NCT01395212|Cell-based cardiac regenerative therapy|cell-based cardiac regenerative therapy
5057294|NCT01395212|Intramyocardial injections|intramyocardial injections
5057295|NCT01395212|NOGA procedure|noga procedure
5057296|NCT01395212|Acute myocardial infarction|acute myocardial infarction
5057297|NCT01395199|Magnetic resonance imaging|magnetic resonance imaging
5057298|NCT01395199|Thalassemia|thalassemia
5057299|NCT01395199|Iron overload|iron overload
5057300|NCT01395186|varicocele|varicocele
5057301|NCT01395186|pain|pain
5057302|NCT01395173|detection|detection
5057303|NCT01395160|Attention deficit hyperactivity disorder|attention deficit hyperactivity disorder
5057304|NCT01395160|ADHD|adhd
5057305|NCT01395160|Bipolar Disorder|bipolar disorder
5057306|NCT01395160|Electrophysiological|electrophysiological
5057307|NCT01395160|EEG|eeg
5057308|NCT01395160|ERP|erp
5057309|NCT01395160|Attention|attention
5057310|NCT01395160|Motivation|motivation
5057311|NCT01395160|Mood instability|mood instability
5057312|NCT01395147|Drug Therapy|drug therapy
5057313|NCT01395134|External branch of the superior laryngeal nerve,|external branch of the superior laryngeal nerve,
5057314|NCT01395134|Recurrent laryngeal nerve,|recurrent laryngeal nerve,
5057315|NCT01395134|Intraoperative neuromonitoring,|intraoperative neuromonitoring,
5057316|NCT01395134|Thyroid surgery|thyroid surgery
5057317|NCT01395121|c-KIT mutation|c-kit mutation
5057318|NCT01395121|advanced disease|advanced disease
5057319|NCT01395121|tyrosine kinase inhibitors|tyrosine kinase inhibitors
5057320|NCT01395095|cardiac rehabilitation|cardiac rehabilitation
5057321|NCT01395095|risk factor|risk factor
5057322|NCT01395095|lifestyle|lifestyle
5057323|NCT01395082|Myocarditis|myocarditis
5057324|NCT01395082|Pericarditis|pericarditis
5057325|NCT01395082|Vaccinia virus|vaccinia virus
5057326|NCT01395082|ACAM2000®|acam2000®
5057327|NCT01395082|Smallpox vaccine|smallpox vaccine
5057328|NCT01395069|Post-cataract surgery|post-cataract surgery
5057329|NCT01395069|macular edema|macular edema
5057330|NCT01395056|breast neoplasm|breast neoplasm
5057331|NCT01395056|Neoplasm Metastasis|neoplasm metastasis
5057332|NCT01395056|Drug Therapy|drug therapy
5057333|NCT01395043|Transversus Abdominis Plane catheter|transversus abdominis plane catheter
5057334|NCT01395043|TAP catheter|tap catheter
5057335|NCT01395017|Pancreatic cancer|pancreatic cancer
5057336|NCT01395017|Dasatinib|dasatinib
5057337|NCT01395017|chemotherapy|chemotherapy
5057338|NCT01395017|Locally advanced|locally advanced
5057339|NCT01394991|Epoetin alfa (EPREX, ERYPO)|epoetin alfa (eprex, erypo)
5057340|NCT01394978|Pleural air leak|pleural air leak
5057341|NCT01394978|Pulmonary resection|pulmonary resection
5057342|NCT01394978|Open thoracotomy|open thoracotomy
5057343|NCT01394965|ECG|ecg
5057344|NCT01394965|Mapping|mapping
5057345|NCT01394965|ecg mapping|ecg mapping
5057346|NCT01394965|arrythmias|arrythmias
5057347|NCT01394952|Cardiovascular disease|cardiovascular disease
5057348|NCT01394952|Diabetes Mellitus|diabetes mellitus
5057349|NCT01394952|Dulaglutide|dulaglutide
5057350|NCT01394939|Vaccinia|vaccinia
5057351|NCT01394939|Vaccinia Virus|vaccinia virus
5057352|NCT01394939|JX-594|jx-594
5057353|NCT01394939|Jennerex|jennerex
5057354|NCT01394939|Colorectal Carcinoma|colorectal carcinoma
5057355|NCT01394939|Colorectal cancer|colorectal cancer
5057356|NCT01394939|Colon Cancer|colon cancer
5057357|NCT01394939|Rectal Cancer|rectal cancer
5057358|NCT01394939|oncolytic virus|oncolytic virus
5057359|NCT01394939|viral therapy|viral therapy
5057360|NCT01394939|RAS mutant|ras mutant
5057361|NCT01394939|Erbitux failure|erbitux failure
5057362|NCT01394939|Oxaliplatin failure|oxaliplatin failure
5057363|NCT01394939|FOLFOX failure|folfox failure
5057364|NCT01394939|FOLFIRI failure|folfiri failure
5057365|NCT01394939|Irinotecan failure|irinotecan failure
5057366|NCT01394939|Pexa-Vec|pexa-vec
5057367|NCT01394926|CE-U/S - Contrast-Enhanced U/S|ce-u/s - contrast-enhanced u/s
5057368|NCT01394926|U/S - Ultrasound|u/s - ultrasound
5057369|NCT01394926|Assess effectiveness|assess effectiveness
5057370|NCT01394900|HIV|hiv
5057371|NCT01394900|sexually transmitted infection|sexually transmitted infection
5057372|NCT01394900|STI|sti
5057373|NCT01394900|men who have sex with men|men who have sex with men
5057374|NCT01394900|MSM|msm
5057375|NCT01394900|couples|couples
5057376|NCT01394900|African American|african american
5057377|NCT01394900|Black|black
5057378|NCT01394887|Metformin, inflammation|metformin, inflammation
5057379|NCT01394887|resistin|resistin
5057380|NCT01394887|impaired glucose tolerance|impaired glucose tolerance
5057381|NCT01394887|children|children
5057382|NCT01394874|osteoarthritis|osteoarthritis
5057383|NCT01394874|exercise|exercise
5057384|NCT01394861|Endoscopic Submucosal Dissection|endoscopic submucosal dissection
5057385|NCT01394861|ESD|esd
5057386|NCT01394861|EMR|emr
5057387|NCT01394861|Early Gastric Cancer|early gastric cancer
5057388|NCT01394861|Flexible Endoscopic Robotic System|flexible endoscopic robotic system
5057389|NCT01394861|Master Slave Robot|master slave robot
5057390|NCT01394861|Ease & Safety of ESD by Flexible Master Slave Robotic System|ease & safety of esd by flexible master slave robotic system
5057391|NCT01394835|Patient after lung transplantation|patient after lung transplantation
5057392|NCT01394809|osteoporosis|osteoporosis
5057393|NCT01394809|wrist fracture|wrist fracture
5057394|NCT01394809|mental practice|mental practice
5057395|NCT01394809|mirror therapy|mirror therapy
5057396|NCT01394809|immobilization|immobilization
5057397|NCT01394809|elderly|elderly
5057398|NCT01394783|Endotracheal intubation, Teaching, Videolaryngoscope|endotracheal intubation, teaching, videolaryngoscope
5057399|NCT01394770|hypertension|hypertension
5057400|NCT01394770|dialysis|dialysis
5057401|NCT01394770|aliskiren|aliskiren
5057402|NCT01394770|amlodipine|amlodipine
5057403|NCT01394770|outcome|outcome
5057404|NCT01394744|metal|metal
5057405|NCT01394744|ion|ion
5057406|NCT01394744|cytokine|cytokine
5057407|NCT01394744|hip arthroplasty|hip arthroplasty
5057408|NCT01394744|blood|blood
5057409|NCT01394744|Assessment|assessment
5057410|NCT01394744|cytokine profile|cytokine profile
5057411|NCT01394718|analgesic adjunct|analgesic adjunct
5057412|NCT01394718|acetaminophen|acetaminophen
5057413|NCT01394718|spine fusion surgery|spine fusion surgery
5057414|NCT01394718|opiate reduction|opiate reduction
5057415|NCT01394718|pain management after elective surgical operation|pain management after elective surgical operation
5057416|NCT01394705|patients at increased risk for atherosclerosis|patients at increased risk for atherosclerosis
5057417|NCT01394692|intraoperative MRI|intraoperative mri
5057418|NCT01394692|glioma surgery|glioma surgery
5057419|NCT01394692|extent of resection|extent of resection
5057420|NCT01394679|Lung Cancer|lung cancer
5057421|NCT01394679|Recurrent Lung Cancer no treatment within 3 months|recurrent lung cancer no treatment within 3 months
5057422|NCT01394653|YM060|ym060
5057423|NCT01394653|ramosetron|ramosetron
5057424|NCT01394653|orally-disintegrating tablet|orally-disintegrating tablet
5057425|NCT01394653|OD tablet|od tablet
5057426|NCT01394653|bioequivalence|bioequivalence
5057427|NCT01394614|Cataplexy|cataplexy
5057428|NCT01394614|MSLT|mslt
5057429|NCT01394614|Hypocretin|hypocretin
5057430|NCT01394614|HLA typing|hla typing
5057431|NCT01394614|Polysomnography|polysomnography
5057432|NCT01394614|A/H1N1 vaccine|a/h1n1 vaccine
5057433|NCT01394601|Antipsychotics|antipsychotics
5057434|NCT01394601|schizophrenia|schizophrenia
5057435|NCT01394601|acute inpatient|acute inpatient
5057436|NCT01394588|Cardiac Surgery|cardiac surgery
5057437|NCT01394588|Perioperative Glucose Control|perioperative glucose control
5057438|NCT01394575|breast cancer|breast cancer
5057439|NCT01394575|radiotherapy|radiotherapy
5057440|NCT01394575|simultaneous integrated boost|simultaneous integrated boost
5057441|NCT01394575|tumor bed|tumor bed
5057442|NCT01394575|IMRT|imrt
5057443|NCT01394536|Post-operative|post-operative
5057444|NCT01394536|post-op|post-op
5057445|NCT01394536|nausea|nausea
5057446|NCT01394536|vomiting|vomiting
5057447|NCT01394510|insulin secretion|insulin secretion
5057448|NCT01394510|beta-cell function|beta-cell function
5057449|NCT01394510|oxidative stress|oxidative stress
5057450|NCT01394510|type 2 diabetes|type 2 diabetes
5057451|NCT01394497|Liver Transplantation|liver transplantation
5057452|NCT01394497|Graft Survival|graft survival
5057453|NCT01394497|Graft Rejection|graft rejection
5057454|NCT01394497|Primary Graft Dysfunction|primary graft dysfunction
5057455|NCT01394497|Tissue and Organ Harvesting|tissue and organ harvesting
5057456|NCT01394497|Tissue and Organ Procurement|tissue and organ procurement
5057457|NCT01394497|Tissue Donors|tissue donors
5057458|NCT01394497|Cold Ischemia|cold ischemia
5057459|NCT01394471|schizophrenia|schizophrenia
5057460|NCT01394471|schizoaffective disorder|schizoaffective disorder
5057461|NCT01394471|oxytocin|oxytocin
5057462|NCT01394471|OT|ot
5057463|NCT01394471|social cognition|social cognition
5057464|NCT01394471|social functioning|social functioning
5057465|NCT01394471|paranoia|paranoia
5057466|NCT01394471|psychosis|psychosis
5057467|NCT01394471|psychotic symptoms|psychotic symptoms
5057468|NCT01394471|social deficits|social deficits
5057469|NCT01394471|intranasal administration|intranasal administration
5057470|NCT01394458|catheter related infection|catheter related infection
5057471|NCT01394458|bacteremia|bacteremia
5057472|NCT01394458|hemodialysis|hemodialysis
5057473|NCT01394432|Endocardial Stem Cells Injection|endocardial stem cells injection
5057474|NCT01394432|Percutaneous Coronary Intervention|percutaneous coronary intervention
5057475|NCT01394393|obesity treatment|obesity treatment
5057476|NCT01394393|evidence based intervention|evidence based intervention
5057477|NCT01394393|cognitive behavioral treatment|cognitive behavioral treatment
5057478|NCT01394393|virtual reality environments|virtual reality environments
5057479|NCT01394380|sugar|sugar
5057480|NCT01394380|sweetened beverages|sweetened beverages
5057481|NCT01394380|hepatic steatosis|hepatic steatosis
5057482|NCT01394380|visceral obesity|visceral obesity
5057483|NCT01394380|metabolic syndrome|metabolic syndrome
5057484|NCT01394367|respiratory therapy|respiratory therapy
5057485|NCT01394367|exercise therapy|exercise therapy
5057486|NCT01394367|oxygen uptake|oxygen uptake
5057487|NCT01394367|quality of life|quality of life
5057488|NCT01394367|right ventricular function|right ventricular function
5057489|NCT01394367|severe pulmonary hypertension|severe pulmonary hypertension
5057490|NCT01394354|Multiple Myeloma relapsed refractory|multiple myeloma relapsed refractory
5057491|NCT01394341|Liraglutide|liraglutide
5057492|NCT01394341|Uremia|uremia
5057493|NCT01394341|Dialysis|dialysis
5057494|NCT01394341|Type 2 diabetes mellitus|type 2 diabetes mellitus
5057495|NCT01394341|Safety|safety
5057496|NCT01394341|Efficacy|efficacy
5057497|NCT01394328|Delirium|delirium
5057498|NCT01394328|Dementia|dementia
5057499|NCT01394328|Confusion Assessment Method|confusion assessment method
5057500|NCT01394328|Elderly|elderly
5057501|NCT01394315|diffuse optical tomography|diffuse optical tomography
5057502|NCT01394315|response|response
5057503|NCT01394315|neoadjuvant chemotherapy|neoadjuvant chemotherapy
5057504|NCT01394315|breast cancer|breast cancer
5057505|NCT01394302|Trigger Finger|trigger finger
5057506|NCT01394289|Standardization|standardization
5057507|NCT01394289|Immunotherapy|immunotherapy
5057508|NCT01394289|Skin prick test|skin prick test
5057509|NCT01394263|prostate cancer|prostate cancer
5057510|NCT01394263|PSA|psa
5057511|NCT01394263|testosterone suppression|testosterone suppression
5057512|NCT01394250|Pain|pain
5057513|NCT01394250|Anxiety|anxiety
5057514|NCT01394250|IV Cannulation|iv cannulation
5057515|NCT01394250|Topical Lidocaine|topical lidocaine
5057516|NCT01394250|Buzzy|buzzy
5057517|NCT01394250|Face, Legs, Activity, Crying, Consolability (FLACC) scale|face, legs, activity, crying, consolability (flacc) scale
5057518|NCT01394250|Faces Pain Scale Revised (FPS-R)|faces pain scale revised (fps-r)
5057519|NCT01394250|Child Rating of Anxiety Scale|child rating of anxiety scale
5057520|NCT01394224|Healthy volunteers|healthy volunteers
5057521|NCT01394224|Japanese|japanese
5057647|NCT01393561|Common cold|common cold
5057522|NCT01394198|Osteopathic Manipulative Medicine (OMM)|osteopathic manipulative medicine (omm)
5057523|NCT01394198|Neuromuscular Medicine (NMM)|neuromuscular medicine (nmm)
5057524|NCT01394198|Somatic Dysfunction|somatic dysfunction
5057525|NCT01394198|Correlational Study|correlational study
5057526|NCT01394198|Endoscopy|endoscopy
5057527|NCT01394185|marijuana|marijuana
5057528|NCT01394185|dronabinol|dronabinol
5057529|NCT01394185|pharmacotherapy|pharmacotherapy
5057530|NCT01394172|Tidal Volume|tidal volume
5057531|NCT01394172|Pediatric|pediatric
5057532|NCT01394172|Difficult airway|difficult airway
5057533|NCT01394172|Ventilation|ventilation
5057534|NCT01394172|Airway management|airway management
5057535|NCT01394159|passes required to establish diagnosis|passes required to establish diagnosis
5057536|NCT01394146|phosphorus-based food additives|phosphorus-based food additives
5057537|NCT01394146|phosphorus metabolism|phosphorus metabolism
5057538|NCT01394133|HIV Infected Women|hiv infected women
5057539|NCT01394120|Pancreas cancer|pancreas cancer
5057540|NCT01394120|Targeted Therapy|targeted therapy
5057541|NCT01394107|Thromboprophylaxis|thromboprophylaxis
5057542|NCT01394107|Effect of LMWH on coagulation|effect of lmwh on coagulation
5057543|NCT01394107|Pregnancy|pregnancy
5057544|NCT01394107|Neuraxial anesthesia|neuraxial anesthesia
5057545|NCT01394107|Spinal haematoma|spinal haematoma
5057546|NCT01394094|Gum chewing|gum chewing
5057547|NCT01394094|Bowel function|bowel function
5057548|NCT01394094|benign gynecologic surgery|benign gynecologic surgery
5057549|NCT01394081|Veterans|veterans
5057550|NCT01394081|Health Care Utilization|health care utilization
5057551|NCT01394081|Rural Health|rural health
5057552|NCT01394081|Patient Navigation|patient navigation
5057553|NCT01394081|Motivational Interviewing|motivational interviewing
5057554|NCT01394068|Selenium level|selenium level
5057555|NCT01394068|Various blood values|various blood values
5057556|NCT01394068|Duration of artificial respiration|duration of artificial respiration
5057557|NCT01394068|Residence in ICU/ Hospital|residence in icu/ hospital
5057558|NCT01394068|SOFA-Score|sofa-score
5057559|NCT01394068|SAPS-Score|saps-score
5057560|NCT01394055|Diabetes Mellitus Type 1 and 2|diabetes mellitus type 1 and 2
5057561|NCT01394055|Delayed Gastric Emptying|delayed gastric emptying
5057562|NCT01394055|Gastroparesis|gastroparesis
5057563|NCT01394055|Gastrointestinal Motility Disorder|gastrointestinal motility disorder
5057564|NCT01394042|Biopsy proven primary prostate cancer|biopsy proven primary prostate cancer
5057565|NCT01394029|iron overload|iron overload
5057566|NCT01394029|iron chelation|iron chelation
5057567|NCT01394029|deferasirox|deferasirox
5057568|NCT01394029|observational|observational
5057569|NCT01394003|Advanced cancer|advanced cancer
5057570|NCT01393977|Spinal Cord Injuries|spinal cord injuries
5057571|NCT01393977|Stem Cell Transplantation|stem cell transplantation
5057572|NCT01393977|Rehabilitation|rehabilitation
5057573|NCT01393951|Recombinant Influenza hemagglutinin vaccine|recombinant influenza hemagglutinin vaccine
5057574|NCT01393938|Mullerian Duct Anomaly|mullerian duct anomaly
5057575|NCT01393938|3-dimensional Ultrasound|3-dimensional ultrasound
5057576|NCT01393938|Magnetic Resonance Imaging|magnetic resonance imaging
5057577|NCT01393912|crenolanib|crenolanib
5057578|NCT01393912|radiation therapy|radiation therapy
5057579|NCT01393912|malignant brain tumors|malignant brain tumors
5057580|NCT01393912|pediatric|pediatric
5057581|NCT01393899|tofacitinib|tofacitinib
5057582|NCT01393899|Xeljanz|xeljanz
5057583|NCT01393899|CP-690,550|cp-690,550
5057584|NCT01393899|maintenance therapy|maintenance therapy
5057585|NCT01393886|Obesity Surgery|obesity surgery
5057586|NCT01393873|Obesity|obesity
5057587|NCT01393873|Type 2 DM|type 2 dm
5057588|NCT01393860|Diabetes|diabetes
5057589|NCT01393860|aliskiren|aliskiren
5057590|NCT01393860|hypertension|hypertension
5057591|NCT01393860|renal impairment|renal impairment
5057592|NCT01393847|Sickle Cell|sickle cell
5057593|NCT01393847|Pain|pain
5057594|NCT01393847|Genetics|genetics
5057595|NCT01393847|Sickle Cell Disease|sickle cell disease
5057596|NCT01393847|Healthy Volunteer|healthy volunteer
5057597|NCT01393847|HV|hv
5057598|NCT01393834|Delayed cord clamping|delayed cord clamping
5057599|NCT01393834|Umbilical cord|umbilical cord
5057600|NCT01393834|Preterm|preterm
5057601|NCT01393834|Cord milking|cord milking
5057602|NCT01393808|Type 2 diabetes|type 2 diabetes
5057603|NCT01393808|Paricalcitol|paricalcitol
5057604|NCT01393808|Proteinuria|proteinuria
5057605|NCT01393808|Sodium intake|sodium intake
5057606|NCT01393795|Pulmonary Hypertension|pulmonary hypertension
5057607|NCT01393795|Pain|pain
5057608|NCT01393782|high output shock|high output shock
5057609|NCT01393782|distributive shock|distributive shock
5057610|NCT01393782|warm shock|warm shock
5057611|NCT01393782|septic shock|septic shock
5057612|NCT01393782|pressor|pressor
5057613|NCT01393782|angiotensin|angiotensin
5057614|NCT01393782|ATII|atii
5057615|NCT01393782|vasopressor|vasopressor
5057616|NCT01393769|Retinoblastoma|retinoblastoma
5057617|NCT01393769|RTB|rtb
5057618|NCT01393769|Ocular tumour|ocular tumour
5057619|NCT01393769|Melfalan|melfalan
5057620|NCT01393769|Enucleation|enucleation
5057621|NCT01393769|Tumor of the eye|tumor of the eye
5057622|NCT01393769|Eye|eye
5057623|NCT01393769|Ocular cancer|ocular cancer
5057624|NCT01393769|Ocular chemotherapy|ocular chemotherapy
5057625|NCT01393769|Ophthalmic artery|ophthalmic artery
5057626|NCT01393769|Intra-arterial chemotherapy|intra-arterial chemotherapy
5057627|NCT01393743|Central Nervous System|central nervous system
5057628|NCT01393730|prostate|prostate
5057629|NCT01393730|metastatic|metastatic
5057630|NCT01393730|castrate resistant|castrate resistant
5057631|NCT01393704|myomectomy|myomectomy
5057632|NCT01393704|vasopressin|vasopressin
5057633|NCT01393704|blood loss|blood loss
5057634|NCT01393691|nighttime fears|nighttime fears
5057635|NCT01393691|anxiety|anxiety
5057636|NCT01393691|sleep|sleep
5057637|NCT01393691|actigraphy|actigraphy
5057638|NCT01393691|intervention|intervention
5057639|NCT01393652|Pharmacokinetics Safety Tolerability Pharmacodynamics|pharmacokinetics safety tolerability pharmacodynamics
5057640|NCT01393639|treatment of rheumatoid arthritis|treatment of rheumatoid arthritis
5057641|NCT01393639|treatment of RA|treatment of ra
5057642|NCT01393639|patients on methotrexate for rheumatoid arthritis|patients on methotrexate for rheumatoid arthritis
5057643|NCT01393639|prednisone for rheumatoid arthritis|prednisone for rheumatoid arthritis
5057644|NCT01393587|Oxidative Stress|oxidative stress
5057645|NCT01393587|Laproscopy|laproscopy
5057646|NCT01393561|Rhinitis|rhinitis
5057648|NCT01393561|Nasal symptoms|nasal symptoms
5057649|NCT01393561|Children|children
5057650|NCT01393548|Rhinitis|rhinitis
5057651|NCT01393548|common cold|common cold
5057652|NCT01393548|nasal symptoms|nasal symptoms
5057653|NCT01393548|children|children
5057654|NCT01393535|Adiponectin|adiponectin
5057655|NCT01393535|Prognosis|prognosis
5057656|NCT01393535|Cardiac Surgery|cardiac surgery
5057657|NCT01393522|headache|headache
5057658|NCT01393522|migraine|migraine
5057659|NCT01393509|PU-H71|pu-h71
5057660|NCT01393509|Solid Tumor|solid tumor
5057661|NCT01393509|Lymphoma|lymphoma
5057662|NCT01393509|11-041|11-041
5057663|NCT01393509|incurable, locally advanced or metastatic solid tumor malignancy or lymphoma|incurable, locally advanced or metastatic solid tumor malignancy or lymphoma
5057664|NCT01393496|prematurity|prematurity
5057665|NCT01393496|anemia|anemia
5057666|NCT01393496|transfusion|transfusion
5057667|NCT01393483|esophagectomy|esophagectomy
5057668|NCT01393483|endoscopy|endoscopy
5057669|NCT01393483|biopsy|biopsy
5057670|NCT01393483|Tissue mesothelin|tissue mesothelin
5057671|NCT01393483|Serum mesothelin|serum mesothelin
5057672|NCT01393483|11-037|11-037
5057673|NCT01393470|HPV|hpv
5057674|NCT01393470|Vaccine|vaccine
5057675|NCT01393470|long-term efficacy|long-term efficacy
5057676|NCT01393470|registry-based study|registry-based study
5057677|NCT01393470|Evaluation of long-term HPV vaccine efficacy: a population-based, registry-based cohort study in Finland.|evaluation of long-term hpv vaccine efficacy: a population-based, registry-based cohort study in finland.
5057678|NCT01393457|cocaine|cocaine
5057679|NCT01393457|cognition|cognition
5057680|NCT01393457|medication|medication
5057681|NCT01393457|treatment|treatment
5057682|NCT01393444|Electrocorticography|electrocorticography
5057683|NCT01393444|Tetraplegia|tetraplegia
5057684|NCT01393444|Spinal cord injury|spinal cord injury
5057685|NCT01393444|Brainstem stroke|brainstem stroke
5057686|NCT01393444|Neuroprosthetic|neuroprosthetic
5057687|NCT01393444|Brain-computer interface|brain-computer interface
5057688|NCT01393444|Direct brain interface|direct brain interface
5057689|NCT01393444|Neural activity|neural activity
5057690|NCT01393444|Motor cortex|motor cortex
5057691|NCT01393431|Exhaled breath condensate pH|exhaled breath condensate ph
5057692|NCT01393431|Predictive value of pH|predictive value of ph
5057693|NCT01393418|Erythropoietin|erythropoietin
5057694|NCT01393418|Cardiac Surgery|cardiac surgery
5057695|NCT01393418|Renal Biomarker|renal biomarker
5057696|NCT01393418|Acute Kidney Injury|acute kidney injury
5057697|NCT01393418|Hypothermic Circulatory Arrest|hypothermic circulatory arrest
5057698|NCT01393392|smoking cessation|smoking cessation
5057699|NCT01393392|methadone treatment|methadone treatment
5057700|NCT01393392|nicotine addiction|nicotine addiction
5057701|NCT01393392|drug treatment|drug treatment
5057702|NCT01393392|drug addiction|drug addiction
5057703|NCT01393392|tobacco dependence|tobacco dependence
5057704|NCT01393327|physical training|physical training
5057807|NCT01392898|insulin|insulin
5057705|NCT01393327|remaining post-operative pulmonary vascular changes|remaining post-operative pulmonary vascular changes
5057706|NCT01393327|right ventricular pump function|right ventricular pump function
5057707|NCT01393327|PEA|pea
5057708|NCT01393301|Nicotine dependence|nicotine dependence
5057709|NCT01393301|Smoking, cessation|smoking, cessation
5057710|NCT01393301|Quitting|quitting
5057711|NCT01393301|Anxiety symptoms|anxiety symptoms
5057712|NCT01393301|Cognitive-behavioral therapy|cognitive-behavioral therapy
5057713|NCT01393275|diabetes|diabetes
5057714|NCT01393275|exercise|exercise
5057715|NCT01393275|intervention|intervention
5057716|NCT01393275|rehabilitation|rehabilitation
5057717|NCT01393275|metabolic rate|metabolic rate
5057718|NCT01393275|sport|sport
5057719|NCT01393249|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
5057720|NCT01393249|Pediatric|pediatric
5057721|NCT01393249|Asparaginase|asparaginase
5057722|NCT01393249|Pancreatitis|pancreatitis
5057723|NCT01393223|Interstitial Cystitis|interstitial cystitis
5057724|NCT01393223|Painful Bladder Syndrome|painful bladder syndrome
5057725|NCT01393223|Bladder Pain Syndrome|bladder pain syndrome
5057726|NCT01393223|Liposome|liposome
5057727|NCT01393223|LP-08|lp-08
5057728|NCT01393210|insulin sensitivity|insulin sensitivity
5057729|NCT01393210|adipose tissue|adipose tissue
5057730|NCT01393210|inflammation|inflammation
5057731|NCT01393197|HCC|hcc
5057732|NCT01393197|TACE|tace
5057733|NCT01393184|Target therapy|target therapy
5057734|NCT01393171|Anterior Vaginal Prolapse|anterior vaginal prolapse
5057735|NCT01393171|Cystocele|cystocele
5057736|NCT01393171|Pelvic Organ Prolapse|pelvic organ prolapse
5057737|NCT01393145|Chronic obstructive pulmonary disease (COPD)|chronic obstructive pulmonary disease (copd)
5057738|NCT01393145|salmeterol|salmeterol
5057739|NCT01393145|fluticasone|fluticasone
5057740|NCT01393145|formoterol|formoterol
5057741|NCT01393145|FEV1|fev1
5057742|NCT01393145|Moderate-to-severe|moderate-to-severe
5057743|NCT01393132|Dry Eye|dry eye
5057744|NCT01393132|Sjogren's Syndrome|sjogren's syndrome
5057745|NCT01393132|Graft vs. Host Disease|graft vs. host disease
5057746|NCT01393132|Rheumatoid arthritis|rheumatoid arthritis
5057747|NCT01393132|Systemic lupus erythematosus|systemic lupus erythematosus
5057748|NCT01393132|Scleroderma|scleroderma
5057749|NCT01393106|HL|hl
5057750|NCT01393106|idelalisib|idelalisib
5057751|NCT01393106|CAL-101|cal-101
5057752|NCT01393106|GS-1101|gs-1101
5057753|NCT01393106|PI3K|pi3k
5057754|NCT01393093|HCC|hcc
5057755|NCT01393093|TACE|tace
5057756|NCT01393080|nimotuzumab|nimotuzumab
5057757|NCT01393080|non-small cell lung cancer|non-small cell lung cancer
5057758|NCT01393080|chemotherapy|chemotherapy
5057759|NCT01393067|cSEMS|csems
5057760|NCT01393067|NEPS|neps
5057761|NCT01393067|ERCP|ercp
5057762|NCT01393067|biliary stricture|biliary stricture
5057763|NCT01393067|biliary stenosis|biliary stenosis
5057764|NCT01393067|liver transplantation|liver transplantation
5057765|NCT01393054|Nigella sativa seed extract|nigella sativa seed extract
5057766|NCT01393054|hypertension|hypertension
5057767|NCT01393054|elderly|elderly
5057768|NCT01393028|coronary artery disease|coronary artery disease
5057769|NCT01393028|angina pectoris|angina pectoris
5057770|NCT01393028|Stable chest pain complaints|stable chest pain complaints
5057771|NCT01393015|automatic|automatic
5057772|NCT01393015|automation|automation
5057773|NCT01393015|oxygen|oxygen
5057774|NCT01393015|weaning|weaning
5057775|NCT01393015|COPD|copd
5057776|NCT01393015|exacerbation|exacerbation
5057777|NCT01393002|intensive care|intensive care
5057778|NCT01393002|candidemia|candidemia
5057779|NCT01393002|fungal infection|fungal infection
5057780|NCT01392976|cancer|cancer
5057781|NCT01392976|advanced|advanced
5057782|NCT01392976|solid|solid
5057783|NCT01392976|tumor|tumor
5057784|NCT01392976|gemcitabine|gemcitabine
5057785|NCT01392976|human equilibrative nucleoside transporter-1 (hENT1)|human equilibrative nucleoside transporter-1 (hent1)
5057786|NCT01392976|CO-1.01|co-1.01
5057787|NCT01392976|CO-101|co-101
5057788|NCT01392976|CO101|co101
5057789|NCT01392963|botox|botox
5057790|NCT01392963|depression|depression
5057791|NCT01392950|silicone hydrogel contact lenses for daily wear|silicone hydrogel contact lenses for daily wear
5057792|NCT01392937|AIOL|aiol
5057793|NCT01392937|multipurpose solution|multipurpose solution
5057794|NCT01392937|silicone hydrogel lenses|silicone hydrogel lenses
5057795|NCT01392937|The safety and efficacy of the All-in-One Light multipurpose care regimen by comparison with the Aquify care regimen|the safety and efficacy of the all-in-one light multipurpose care regimen by comparison with the aquify care regimen
5057796|NCT01392911|Dose Ranging|dose ranging
5057797|NCT01392911|Extended Early Bactericidal Activity|extended early bactericidal activity
5057798|NCT01392911|Maximum tolerable dose|maximum tolerable dose
5057799|NCT01392911|Pharmacokinetics|pharmacokinetics
5057800|NCT01392911|Pulmonary Tuberculosis|pulmonary tuberculosis
5057801|NCT01392911|Rifampicin|rifampicin
5057802|NCT01392911|Rifafour|rifafour
5057803|NCT01392911|Safety|safety
5057804|NCT01392911|Tolerability|tolerability
5057805|NCT01392911|Max Tolerable Dose|max tolerable dose
5057806|NCT01392898|liraglutide|liraglutide
5057808|NCT01392898|type 2 diabetes mellitus|type 2 diabetes mellitus
5057809|NCT01392885|Schizophrenia|schizophrenia
5057810|NCT01392885|Schizoaffective Disorder|schizoaffective disorder
5057811|NCT01392885|Brain Health|brain health
5057812|NCT01392885|Exercise|exercise
5057813|NCT01392885|Mental Health|mental health
5057814|NCT01392885|Poor memory|poor memory
5057815|NCT01392872|Immunosuppressant|immunosuppressant
5057816|NCT01392872|Quality of life|quality of life
5057817|NCT01392872|Cognitive function|cognitive function
5057818|NCT01392872|Relapsing Multiple Sclerosis|relapsing multiple sclerosis
5057819|NCT01392846|Coronary artery disease requiring drug eluting stents|coronary artery disease requiring drug eluting stents
5057820|NCT01392833|iga nephropathy|iga nephropathy
5057821|NCT01392833|chronic kidney disease|chronic kidney disease
5057822|NCT01392833|proteinuria|proteinuria
5057823|NCT01392833|steroids|steroids
5057824|NCT01392833|azathioprine|azathioprine
5057825|NCT01392820|Phase I|phase i
5057826|NCT01392820|Japan|japan
5057827|NCT01392820|Elderly|elderly
5057828|NCT01392820|PK|pk
5057829|NCT01392820|SAD|sad
5057830|NCT01392820|MAD|mad
5057831|NCT01392807|Phase 1|phase 1
5057832|NCT01392807|volunteers with hepatic impairment|volunteers with hepatic impairment
5057833|NCT01392807|pharmacokinetics|pharmacokinetics
5057834|NCT01392807|NKTR-118|nktr-118
5057835|NCT01392807|Child-Pugh scale|child-pugh scale
5057836|NCT01392807|AUC|auc
5057837|NCT01392807|Cmax|cmax
5057838|NCT01392807|tmax|tmax
5057839|NCT01392807|t1/2|t1/2
5057840|NCT01392794|YM060|ym060
5057841|NCT01392794|ramosetron|ramosetron
5057842|NCT01392794|orally-disintegrating tablet|orally-disintegrating tablet
5057843|NCT01392794|OD tablet|od tablet
5057844|NCT01392794|bioequivalence|bioequivalence
5057845|NCT01392781|PCOS|pcos
5057846|NCT01392781|hsC-RP|hsc-rp
5057847|NCT01392781|Lp-PLA2|lp-pla2
5057848|NCT01392781|cardiovascular risk|cardiovascular risk
5057849|NCT01392768|Epilepsy|epilepsy
5057850|NCT01392768|Partial|partial
5057851|NCT01392768|Seizures|seizures
5057852|NCT01392768|Adjunctive|adjunctive
5057853|NCT01392690|No condition|no condition
5057854|NCT01392690|Primary prevention|primary prevention
5057855|NCT01392690|Anxiety|anxiety
5057856|NCT01392677|dapagliflozin|dapagliflozin
5057857|NCT01392677|diabetes|diabetes
5057858|NCT01392677|hyperglycaemia|hyperglycaemia
5057859|NCT01392651|Urinary stress incontinence|urinary stress incontinence
5057860|NCT01392651|TVT|tvt
5057861|NCT01392638|Sildenafil|sildenafil
5057862|NCT01392638|Nitric oxide synthase|nitric oxide synthase
5057863|NCT01392638|Polymorphism|polymorphism
5057864|NCT01392638|Hemodynamics|hemodynamics
5057865|NCT01392625|Non ischemic dilated cardiomyopathy|non ischemic dilated cardiomyopathy
5057866|NCT01392625|Dilated cardiomyopathy|dilated cardiomyopathy
5057867|NCT01392625|Heart failure|heart failure
5057868|NCT01392625|Cardiac Stem Cell Transplantation|cardiac stem cell transplantation
5057869|NCT01392625|Stem Cells|stem cells
5057870|NCT01392612|thrombosis|thrombosis
5057871|NCT01392612|hypertension|hypertension
5057872|NCT01392612|gender|gender
5057873|NCT01392612|endothelium|endothelium
5057874|NCT01392599|CRPS Type II|crps type ii
5057875|NCT01392599|Pain|pain
5057876|NCT01392599|Surgery|surgery
5057877|NCT01392599|Regional Subcutaneous Venous Sympathectomy(RSVS)|regional subcutaneous venous sympathectomy(rsvs)
5057878|NCT01392599|Sudeck|sudeck
5057879|NCT01392599|Reflex sympathetic dystrophy (RSD)|reflex sympathetic dystrophy (rsd)
5057880|NCT01392599|Causalgia|causalgia
5057881|NCT01392599|Algodystrophy|algodystrophy
5057882|NCT01392586|survival|survival
5057883|NCT01392586|systemic therapy|systemic therapy
5057884|NCT01392586|upfront surgery|upfront surgery
5057885|NCT01392534|Hypertension|hypertension
5057886|NCT01392534|Telmisartan|telmisartan
5057887|NCT01392534|Hydrochlorothiazide|hydrochlorothiazide
5057888|NCT01392534|Potassium|potassium
5057889|NCT01392534|Glucose metabolism|glucose metabolism
5057890|NCT01392534|Lipid metabolism|lipid metabolism
5057891|NCT01392521|Safety|safety
5057892|NCT01392521|Tolerability|tolerability
5057893|NCT01392521|Pharmacokinetics|pharmacokinetics
5057894|NCT01392495|Pulmonary arterial hypertension|pulmonary arterial hypertension
5057895|NCT01392495|imatinib|imatinib
5057896|NCT01392495|6MWD|6mwd
5057897|NCT01392482|Schizophrenia|schizophrenia
5057898|NCT01392482|Bipolar Disorder|bipolar disorder
5057899|NCT01392469|Pulmonary arterial hypertension|pulmonary arterial hypertension
5057900|NCT01392469|pulmonary vascular resistance|pulmonary vascular resistance
5057901|NCT01392469|imatinib|imatinib
5057902|NCT01392469|bosentan|bosentan
5057903|NCT01392469|sildenafil|sildenafil
5058032|NCT01392066|spouses/partners|spouses/partners
5057904|NCT01392456|OHIP-EDENT, VALIDATION, OVERDENTURE, ROMANIAN|ohip-edent, validation, overdenture, romanian
5057905|NCT01392443|INC424|inc424
5057906|NCT01392443|Ruxolitinib|ruxolitinib
5057907|NCT01392443|Myelofibrosis|myelofibrosis
5057908|NCT01392443|MF|mf
5057909|NCT01392430|Primary prophylaxis|primary prophylaxis
5057910|NCT01392430|Secondary prophylaxis|secondary prophylaxis
5057911|NCT01392430|Discontinuation|discontinuation
5057912|NCT01392391|Stroke|stroke
5057913|NCT01392391|Exercise|exercise
5057914|NCT01392391|Protein synthesis|protein synthesis
5057915|NCT01392391|Protein breakdown|protein breakdown
5057916|NCT01392391|Muscle atrophy|muscle atrophy
5057917|NCT01392391|Muscle phenotype|muscle phenotype
5057918|NCT01392391|Inflammation|inflammation
5057919|NCT01392391|Insulin resistance|insulin resistance
5057920|NCT01392391|Fitness|fitness
5057921|NCT01392378|Prevenar 13|prevenar 13
5057922|NCT01392378|13vPnC|13vpnc
5057923|NCT01392378|Antipyretic medication|antipyretic medication
5057924|NCT01392378|Healthy subjects|healthy subjects
5057925|NCT01392365|Crohn's disease|crohn's disease
5057926|NCT01392365|Intestinal tuberculosis|intestinal tuberculosis
5057927|NCT01392365|Diagnosis, Differential|diagnosis, differential
5057928|NCT01392352|pazopanib|pazopanib
5057929|NCT01392352|hypertension|hypertension
5057930|NCT01392352|forearm blood flow|forearm blood flow
5057931|NCT01392339|Obstructive Sleep Apnea|obstructive sleep apnea
5057932|NCT01392339|CPAP|cpap
5057933|NCT01392339|hypoxia|hypoxia
5057934|NCT01392339|sleep|sleep
5057935|NCT01392339|translational science|translational science
5057936|NCT01392339|gene expression|gene expression
5057937|NCT01392326|Psoriatic arthritis|psoriatic arthritis
5057938|NCT01392326|PsA|psa
5057939|NCT01392326|ACR|acr
5057940|NCT01392326|CASPAR|caspar
5057941|NCT01392313|carnitine, kidney|carnitine, kidney
5057942|NCT01392287|Geriatric|geriatric
5057943|NCT01392287|Older adults|older adults
5057944|NCT01392287|Major Depressive Disorder|major depressive disorder
5057945|NCT01392287|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
5057946|NCT01392287|memantine hydrochloride|memantine hydrochloride
5057947|NCT01392287|N-Acetylaspartylglutamate|n-acetylaspartylglutamate
5057948|NCT01392287|NAAG|naag
5057949|NCT01392287|Cognitive impairment|cognitive impairment
5057950|NCT01392248|EEG|eeg
5057951|NCT01392248|breast cancer surgery|breast cancer surgery
5057952|NCT01392248|prediction|prediction
5057953|NCT01392248|acute postoperative pain|acute postoperative pain
5057954|NCT01392248|chronic pain|chronic pain
5057955|NCT01392235|Recurrent and/or Metastatic Nasopharyngeal Carcinoma (NPC)|recurrent and/or metastatic nasopharyngeal carcinoma (npc)
5057956|NCT01392222|focus group|focus group
5057957|NCT01392222|11-108|11-108
5057958|NCT01392209|BEVACIZUMAB|bevacizumab
5057959|NCT01392209|HYPOFRACTIONATED STEREOTACTIC RADIOTHERAPY|hypofractionated stereotactic radiotherapy
5057960|NCT01392209|Brain|brain
5057961|NCT01392209|CNS|cns
5057962|NCT01392209|anti-VEGF antibody|anti-vegf antibody
5057963|NCT01392209|11-057|11-057
5057964|NCT01392196|Renal Impairment|renal impairment
5057965|NCT01392183|Kidney cancer|kidney cancer
5057966|NCT01392183|Renal Cell Carcinoma|renal cell carcinoma
5057967|NCT01392183|Poor-Risk Clear-Cell Renal Cell Carcinoma|poor-risk clear-cell renal cell carcinoma
5057968|NCT01392183|RCC|rcc
5057969|NCT01392183|Metastatic|metastatic
5057970|NCT01392183|Locally advanced|locally advanced
5057971|NCT01392183|Complete response|complete response
5057972|NCT01392183|CR|cr
5057973|NCT01392183|Partial Response|partial response
5057974|NCT01392183|PR|pr
5057975|NCT01392183|Overall survival|overall survival
5057976|NCT01392183|OS|os
5057977|NCT01392183|Time to progression|time to progression
5057978|NCT01392183|TTP|ttp
5057979|NCT01392183|Pazopanib|pazopanib
5057980|NCT01392183|GW786034|gw786034
5057981|NCT01392183|Temsirolimus|temsirolimus
5057982|NCT01392183|CCI-779|cci-779
5057983|NCT01392183|Torisel|torisel
5057984|NCT01392183|Benadryl|benadryl
5057985|NCT01392183|Diphenhydramine|diphenhydramine
5057986|NCT01392183|TemPa|tempa
5057987|NCT01392170|Leukemia|leukemia
5057988|NCT01392170|Chronic Myeloid Leukemia|chronic myeloid leukemia
5057989|NCT01392170|CML|cml
5057990|NCT01392170|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors
5057991|NCT01392170|TKI|tki
5057992|NCT01392170|Complete cytogenetic remission|complete cytogenetic remission
5057993|NCT01392170|CCyR|ccyr
5057994|NCT01392170|Minimal residual disease|minimal residual disease
5057995|NCT01392170|MRD|mrd
5057996|NCT01392170|PEG-IFNa-2a|peg-ifna-2a
5057997|NCT01392170|Pegasys|pegasys
5057998|NCT01392170|Peginterferon Alpha-2a|peginterferon alpha-2a
5057999|NCT01392170|Philadelphia chromosome (Ph)-positive|philadelphia chromosome (ph)-positive
5058000|NCT01392170|BCR-ABL1-positive|bcr-abl1-positive
5058001|NCT01392144|Radiation pneumonitis|radiation pneumonitis
5058002|NCT01392144|RP|rp
5058003|NCT01392144|Nitric oxide|nitric oxide
5058004|NCT01392144|NO|no
5058005|NCT01392144|Thoracic|thoracic
5058006|NCT01392144|Esophagus cancer|esophagus cancer
5058007|NCT01392144|Lung cancer|lung cancer
5058008|NCT01392144|Radiation therapy|radiation therapy
5058009|NCT01392144|radiotherapy|radiotherapy
5058010|NCT01392144|RT|rt
5058011|NCT01392144|XRT|xrt
5058012|NCT01392144|Airway|airway
5058013|NCT01392144|Alveolar|alveolar
5058014|NCT01392144|Nitric oxide breath analyzer|nitric oxide breath analyzer
5058015|NCT01392144|Questionnaires|questionnaires
5058016|NCT01392131|Oncoxin|oncoxin
5058017|NCT01392131|Safety of Oncoxin|safety of oncoxin
5058018|NCT01392131|Therapeutic efficacy of Oncoxin|therapeutic efficacy of oncoxin
5058019|NCT01392131|Improvement of quality of life with Oncoxin|improvement of quality of life with oncoxin
5058020|NCT01392131|Survival benefit with Oncoxin|survival benefit with oncoxin
5058021|NCT01392105|Mesenchymal stem cells|mesenchymal stem cells
5058022|NCT01392105|Myocardial infarction|myocardial infarction
5058023|NCT01392105|Left ventricular dysfunction|left ventricular dysfunction
5058024|NCT01392092|Contingency Management|contingency management
5058025|NCT01392092|Drug Self-Administration|drug self-administration
5058026|NCT01392079|CLL|cll
5058027|NCT01392079|17p deletion|17p deletion
5058028|NCT01392079|refractory to fludarabine|refractory to fludarabine
5058029|NCT01392079|subcutaneous alemtuzumab|subcutaneous alemtuzumab
5058030|NCT01392079|CLL with 17p- or refractory to fludarabine|cll with 17p- or refractory to fludarabine
5058031|NCT01392066|breast neoplasms|breast neoplasms
5058033|NCT01392066|couples|couples
5058034|NCT01392066|interpersonal relations|interpersonal relations
5058035|NCT01392066|psychosocial adjustment|psychosocial adjustment
5058036|NCT01392066|psychological adaptation|psychological adaptation
5058037|NCT01392066|depression|depression
5058038|NCT01392066|quality of life|quality of life
5058039|NCT01392066|dyadic coping|dyadic coping
5058040|NCT01392066|coping behavior|coping behavior
5058041|NCT01392066|cohort|cohort
5058042|NCT01392066|questionnaire|questionnaire
5058043|NCT01392053|labor|labor
5058044|NCT01392053|pain|pain
5058045|NCT01392053|massage|massage
5058046|NCT01392027|Pancreatic Cancer|pancreatic cancer
5058047|NCT01392027|Chronic Pancreatitis|chronic pancreatitis
5058048|NCT01392027|Diseases of the pancreas|diseases of the pancreas
5058049|NCT01392014|malaria|malaria
5058051|NCT01392014|PQ|pq
5058052|NCT01392014|gametocytes|gametocytes
5058053|NCT01391975|arteriovenous fistula|arteriovenous fistula
5058054|NCT01391975|surveillance|surveillance
5058055|NCT01391975|arterial stenosis|arterial stenosis
5058056|NCT01391975|venous stenosis|venous stenosis
5058057|NCT01391962|Pharmacodynamics|pharmacodynamics
5058058|NCT01391962|VEGF Inhibitor|vegf inhibitor
5058059|NCT01391962|Alveolar Soft Part Sarcoma|alveolar soft part sarcoma
5058060|NCT01391962|Anti-Angiogenesis|anti-angiogenesis
5058061|NCT01391962|Gene Expression Profiling|gene expression profiling
5058062|NCT01391949|disability|disability
5058063|NCT01391949|walking|walking
5058064|NCT01391949|feedback|feedback
5058065|NCT01391949|exercise|exercise
5058066|NCT01391923|Lipolysis|lipolysis
5058067|NCT01391923|Cryolipolysis|cryolipolysis
5058068|NCT01391923|Fat Reduction|fat reduction
5058069|NCT01391910|rhinosinusitis|rhinosinusitis
5058070|NCT01391897|somatoform disorders|somatoform disorders
5058071|NCT01391897|PTSD|ptsd
5058072|NCT01391897|epigenetics|epigenetics
5058073|NCT01391897|psychotherapy|psychotherapy
5058074|NCT01391897|psychosomatics|psychosomatics
5058075|NCT01391884|Incretin hormones|incretin hormones
5058076|NCT01391884|GLP-1|glp-1
5058077|NCT01391884|GIP|gip
5058078|NCT01391884|Uremia|uremia
5058079|NCT01391884|Dialysis|dialysis
5058080|NCT01391858|Pregabalin|pregabalin
5058081|NCT01391858|Postoperative pain|postoperative pain
5058082|NCT01391858|Mastectomy|mastectomy
5058083|NCT01391845|progesterone|progesterone
5058084|NCT01391845|glycodelin-A|glycodelin-a
5058085|NCT01391845|ulipristal acetate|ulipristal acetate
5058086|NCT01391832|rTMS|rtms
5058087|NCT01391832|PTSD|ptsd
5058088|NCT01391832|Post Traumatic Stress Disorder|post traumatic stress disorder
5058089|NCT01391832|repetitive transcranial magnetic stimulation|repetitive transcranial magnetic stimulation
5058090|NCT01391832|combat related PTSD|combat related ptsd
5058091|NCT01391832|OEF|oef
5058092|NCT01391832|OIF|oif
5058093|NCT01391832|Veterans|veterans
5058094|NCT01391832|operation enduring freedom|operation enduring freedom
5058095|NCT01391832|operation iraqi freedom|operation iraqi freedom
5058096|NCT01391832|CPT|cpt
5058097|NCT01391832|cognitive processing therapy|cognitive processing therapy
5058098|NCT01391819|Brazil|brazil
5058099|NCT01391819|Incidence|incidence
5058100|NCT01391819|Dengue virus|dengue virus
5058101|NCT01391819|Dengue|dengue
5058102|NCT01391819|Dengue infection|dengue infection
5058103|NCT01391806|Breast cancer|breast cancer
5058104|NCT01391806|Preoperative breast MRI|preoperative breast mri
5058105|NCT01391806|Breast-conserving surgery|breast-conserving surgery
5058106|NCT01391806|Mastectomy|mastectomy
5058107|NCT01391806|Prospective study|prospective study
5058108|NCT01391793|Renal scarring|renal scarring
5058109|NCT01391793|Dexamethasone|dexamethasone
5058110|NCT01391793|Child|child
5058111|NCT01391793|Corticosteroids|corticosteroids
5058112|NCT01391793|Pediatric|pediatric
5058113|NCT01391793|Urinary tract infection|urinary tract infection
5058114|NCT01391793|Escherichia Coli Urinary Tract Infection|escherichia coli urinary tract infection
5058115|NCT01391780|pelvic floor evaluation,|pelvic floor evaluation,
5058116|NCT01391780|women,|women,
5058117|NCT01391780|stress urinary incontinence;|stress urinary incontinence;
5058118|NCT01391780|urgency urinary incontinence.|urgency urinary incontinence.
5058119|NCT01391767|Ridge Preservation|ridge preservation
5058120|NCT01391767|Dental Implant|dental implant
5058121|NCT01391767|Histology|histology
5058122|NCT01391754|child abuse|child abuse
5058123|NCT01391741|Parkinson´s Disease|parkinson´s disease
5058124|NCT01391741|Walking|walking
5058125|NCT01391741|Exercise|exercise
5058126|NCT01391741|Automaticity|automaticity
5058127|NCT01391741|Dual Task|dual task
5058128|NCT01391741|Visual Cues|visual cues
5058129|NCT01391741|Cueing|cueing
5058130|NCT01391741|Neuroplasticity|neuroplasticity
5058131|NCT01391741|Gait analysis|gait analysis
5058132|NCT01391715|Gastroesophageal reflux disease|gastroesophageal reflux disease
5058133|NCT01391715|Proton pump inhibitor|proton pump inhibitor
5058134|NCT01391715|standard dose|standard dose
5058135|NCT01391715|Double dose|double dose
5058136|NCT01391676|glaucoma|glaucoma
5058137|NCT01391676|trabeculectomy|trabeculectomy
5058138|NCT01391676|filtering bleb|filtering bleb
5058139|NCT01391676|spectral domain optical coherence tomography|spectral domain optical coherence tomography
5058140|NCT01391663|Drug Therapy|drug therapy
5058141|NCT01391650|ACL|acl
5058142|NCT01391650|double-bundle|double-bundle
5058143|NCT01391650|navigation system|navigation system
5058144|NCT01391637|Long term follow-up|long term follow-up
5058145|NCT01391637|HuCNS-SC cells|hucns-sc cells
5058146|NCT01391637|human central nervous system stem cells|human central nervous system stem cells
5058147|NCT01391624|chocolate|chocolate
5058148|NCT01391624|craving|craving
5058149|NCT01391624|addiction|addiction
5058150|NCT01391624|compulsion|compulsion
5058151|NCT01391598|fibromyalgia|fibromyalgia
5058152|NCT01391598|intravenous lidocaine|intravenous lidocaine
5058153|NCT01391598|substance P|substance p
5058154|NCT01391598|interleukins|interleukins
5058155|NCT01391585|Text|text
5058156|NCT01391585|SMS|sms
5058157|NCT01391585|diabetes|diabetes
5058158|NCT01391585|self-monitoring|self-monitoring
5058159|NCT01391585|self-management|self-management
5058160|NCT01391585|adherence|adherence
5058161|NCT01391572|thoracic esophageal squamous cell carcinoma|thoracic esophageal squamous cell carcinoma
5058162|NCT01391572|esophagectomy|esophagectomy
5058163|NCT01391572|radiation|radiation
5058164|NCT01391572|tumor bed|tumor bed
5058165|NCT01391572|elective nodal irradiation|elective nodal irradiation
5058166|NCT01391559|breathing difficulty|breathing difficulty
5058167|NCT01391520|Acute Kidney Injury|acute kidney injury
5058168|NCT01391520|Contrast-Induced Nephropathy|contrast-induced nephropathy
5058169|NCT01391520|Labile Iron|labile iron
5058170|NCT01391520|Iron Chelation|iron chelation
5058171|NCT01391520|Deferiprone|deferiprone
5058172|NCT01391507|Anti-beta1-receptor autoantibodies|anti-beta1-receptor autoantibodies
5058174|NCT01391507|Heart failure|heart failure
5058175|NCT01391494|Human Enterovirus 71 (EV71)|human enterovirus 71 (ev71)
5058176|NCT01391494|Hand, Foot and Mouth Disease|hand, foot and mouth disease
5058177|NCT01391494|Inactivated Vaccine|inactivated vaccine
5058178|NCT01391494|Human Diploid cell|human diploid cell
5058179|NCT01391494|Safety|safety
5058180|NCT01391494|Immunogenicity|immunogenicity
5058181|NCT01391494|Adverse reactions associated with vaccine|adverse reactions associated with vaccine
5058182|NCT01391481|Perfluorocarbon|perfluorocarbon
5058183|NCT01391481|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
5058184|NCT01391481|Acute lung injury|acute lung injury
5058185|NCT01391455|Inguinal hernia repair|inguinal hernia repair
5058186|NCT01391455|Mesh|mesh
5058187|NCT01391455|Groin pain|groin pain
5058188|NCT01391455|Testicular pain|testicular pain
5058189|NCT01391442|follow up of troop,|follow up of troop,
5058190|NCT01391442|MRI, Echocardiography, Functional indices|mri, echocardiography, functional indices
5058191|NCT01391416|Hyperhomocysteinemia|hyperhomocysteinemia
5058192|NCT01391416|Chronic kidney disease|chronic kidney disease
5058193|NCT01391403|Schizophrenia|schizophrenia
5058194|NCT01391403|Risperidone|risperidone
5058195|NCT01391403|Artemisinin|artemisinin
5058196|NCT01391403|Toxoplasma|toxoplasma
5058197|NCT01391403|Immune|immune
5058198|NCT01391390|Tardive Dyskinesia|tardive dyskinesia
5058199|NCT01391390|Schizophrenia|schizophrenia
5058200|NCT01391390|Melatonin|melatonin
5058201|NCT01391390|Oxidative Stress|oxidative stress
5058202|NCT01391390|Antioxidant|antioxidant
5058203|NCT01391377|HDL|hdl
5058204|NCT01391377|High density Lipoprotein|high density lipoprotein
5058205|NCT01391377|Peripheral arterial disease|peripheral arterial disease
5058206|NCT01391377|Tredaptive|tredaptive
5058207|NCT01391377|Niacin|niacin
5058208|NCT01391377|Laropiprant|laropiprant
5058209|NCT01391377|Plaque|plaque
5058210|NCT01391377|Atherosclerosis|atherosclerosis
5058211|NCT01391377|Lipid content|lipid content
5058212|NCT01391351|carcinoma of the ovary, the fallopian tube or peritoneal serous-type advanced stage|carcinoma of the ovary, the fallopian tube or peritoneal serous-type advanced stage
5058213|NCT01391351|chemotherapy with Taxol and Carboplatin|chemotherapy with taxol and carboplatin
5058214|NCT01391351|predictors of therapeutic response|predictors of therapeutic response
5058215|NCT01391351|serum miRNA|serum mirna
5058216|NCT01391351|identification of polymorphisms or SNPs (Single Nucleotide Polymorphism)|identification of polymorphisms or snps (single nucleotide polymorphism)
5058217|NCT01391338|Prostatitis|prostatitis
5058218|NCT01391338|Chronic|chronic
5058219|NCT01391338|Pelvic Pain|pelvic pain
5058220|NCT01391338|NIH-CPSI|nih-cpsi
5058221|NCT01391338|Pain domain score in NIH-CPSI|pain domain score in nih-cpsi
5058222|NCT01391260|Locally Advanced NSCLC|locally advanced nsclc
5058223|NCT01391260|EGFR Mutation Positive|egfr mutation positive
5058224|NCT01391260|Radiotherapy combined Gefitinib|radiotherapy combined gefitinib
5058225|NCT01391247|open angle glaucoma|open angle glaucoma
5058226|NCT01391247|low tension glaucoma|low tension glaucoma
5058227|NCT01391247|oximetry|oximetry
5058228|NCT01391234|Metastatic bone disease|metastatic bone disease
5058229|NCT01391234|Bone metastases|bone metastases
5058230|NCT01391234|Radiation therapy|radiation therapy
5058231|NCT01391234|TomoTherapy|tomotherapy
5058232|NCT01391221|Depression|depression
5058233|NCT01391221|Inflammation|inflammation
5058234|NCT01391221|Cognition|cognition
5058235|NCT01391221|Pain|pain
5058236|NCT01391221|Allostatic load|allostatic load
5058237|NCT01391208|Barrett's Esophagus with High Grade Dysplasia|barrett's esophagus with high grade dysplasia
5058238|NCT01391208|Esophageal adenocarcinoma|esophageal adenocarcinoma
5058239|NCT01391195|low level laser therapy|low level laser therapy
5058240|NCT01391195|muscle performance|muscle performance
5058241|NCT01391195|fatigue index|fatigue index
5058242|NCT01391195|endurance training|endurance training
5058243|NCT01391195|ventilatory threshold|ventilatory threshold
5058244|NCT01391195|VO2Max|vo2max
5058245|NCT01391195|VO2Peak|vo2peak
5058246|NCT01391182|Epsilon Aminocaproic Acid|epsilon aminocaproic acid
5058247|NCT01391182|blood loss|blood loss
5058248|NCT01391182|total hip arthroplasty|total hip arthroplasty
5058249|NCT01391182|reduction in blood transfusions|reduction in blood transfusions
5058250|NCT01391182|Amicar|amicar
5058251|NCT01391156|minoxidil|minoxidil
5058252|NCT01391156|finasteride|finasteride
5058253|NCT01391156|topical|topical
5058254|NCT01391156|lotion|lotion
5058255|NCT01391156|male pattern hair loss|male pattern hair loss
5058256|NCT01391156|androgenetic alopecia|androgenetic alopecia
5058257|NCT01391143|Prostate cancer|prostate cancer
5058258|NCT01391143|Melanoma|melanoma
5058259|NCT01391143|Renal cell carcinoma|renal cell carcinoma
5058260|NCT01391143|Triple-negative breast cancer|triple-negative breast cancer
5058261|NCT01391143|Head and neck cancer|head and neck cancer
5058262|NCT01391143|Bladder cancer|bladder cancer
5058263|NCT01391143|Non-small cell lung cancer|non-small cell lung cancer
5058264|NCT01391143|Squamous cell carcinoma|squamous cell carcinoma
5058265|NCT01391130|Cancer|cancer
5058266|NCT01391130|Tumor|tumor
5058267|NCT01391130|Metastasis|metastasis
5058268|NCT01391117|TMC649128|tmc649128
5058269|NCT01391117|HCV|hcv
5058270|NCT01391117|TMC649128HPC1002|tmc649128hpc1002
5058271|NCT01391117|Hepatitis C|hepatitis c
5058272|NCT01391117|Hep C|hep c
5058273|NCT01391104|Pulmonary Hypertension|pulmonary hypertension
5058274|NCT01391104|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
5058275|NCT01391104|Exercise|exercise
5058276|NCT01391104|Six-minute walk test|six-minute walk test
5058277|NCT01391104|sildenafil|sildenafil
5058278|NCT01391078|glaucoma|glaucoma
5058279|NCT01391078|IOP|iop
5058280|NCT01391078|Sensimed Triggerfish|sensimed triggerfish
5058281|NCT01391078|Goldmann Applanation Tonometry|goldmann applanation tonometry
5058282|NCT01391078|fluctuation|fluctuation
5058283|NCT01391078|comparison|comparison
5058284|NCT01391065|Diffusion Weighted MRI|diffusion weighted mri
5058285|NCT01391065|FLT PET|flt pet
5058286|NCT01391065|F-Miso PET|f-miso pet
5058287|NCT01391065|Image Guided Brachytherapy|image guided brachytherapy
5058288|NCT01391065|Cervix|cervix
5058289|NCT01391065|Postoperative Residual Disease/Postoperative recurrences|postoperative residual disease/postoperative recurrences
5058290|NCT01391052|Intrauterine system|intrauterine system
5058291|NCT01391052|reproductive age|reproductive age
5058292|NCT01391052|menstrual bleeding|menstrual bleeding
5058293|NCT01391039|Ductal Carcinoma In-situ|ductal carcinoma in-situ
5058294|NCT01391039|Contrast Ultrasound|contrast ultrasound
5058295|NCT01391039|Microinvasion|microinvasion
5058296|NCT01391039|Elastography|elastography
5058297|NCT01391026|Medical informatics|medical informatics
5058298|NCT01391026|Health services accessibility|health services accessibility
5058299|NCT01391013|Human immunodeficiency virus 1|human immunodeficiency virus 1
5058300|NCT01391013|Acquired immunodeficiency syndrome|acquired immunodeficiency syndrome
5058301|NCT01391013|Immunologic deficiency syndrome|immunologic deficiency syndrome
5058302|NCT01391013|Darunavir/ritonavir|darunavir/ritonavir
5058303|NCT01391013|Darunavir|darunavir
5058304|NCT01391013|Ritonavir|ritonavir
5058305|NCT01391013|Nucleoside reverse transcriptase inhibitors (NRTIs)|nucleoside reverse transcriptase inhibitors (nrtis)
5058306|NCT01391013|Prezista|prezista
5058307|NCT01391000|rotator cuff surgery|rotator cuff surgery
5058308|NCT01391000|pain|pain
5058309|NCT01391000|exercise therapy|exercise therapy
5058310|NCT01390974|ACS|acs
5058311|NCT01390974|PCI|pci
5058312|NCT01390974|thienopyridines|thienopyridines
5058313|NCT01390974|prasugrel therapy|prasugrel therapy
5058314|NCT01390974|clopidogrel therapy|clopidogrel therapy
5058315|NCT01390961|Allergic conjunctivitis|allergic conjunctivitis
5058316|NCT01390935|guideline adherence|guideline adherence
5058317|NCT01390935|systolic heart failure|systolic heart failure
5058318|NCT01390909|epilepsy|epilepsy
5058319|NCT01390909|anti-epileptic drug|anti-epileptic drug
5058320|NCT01390909|polytherapy|polytherapy
5058321|NCT01390909|adherence|adherence
5058322|NCT01390909|Medicaid|medicaid
5058323|NCT01390870|Enlarged prostate, 5-alpha-reductase inhibitor, alpha-blocker, adherence|enlarged prostate, 5-alpha-reductase inhibitor, alpha-blocker, adherence
5058324|NCT01390818|MEK inhibitor (Pimasertib)|mek inhibitor (pimasertib)
5058325|NCT01390818|PI3K/mTOR Inhibitor|pi3k/mtor inhibitor
5058326|NCT01390818|Solid Tumor|solid tumor
5058327|NCT01390818|Phase I|phase i
5058328|NCT01390766|Antirejection|antirejection
5058329|NCT01390740|Transthoracic echocardiography|transthoracic echocardiography
5058330|NCT01390727|hypertension|hypertension
5058331|NCT01390727|device-guided breathing|device-guided breathing
5058332|NCT01390727|autonomic function|autonomic function
5058333|NCT01390727|Resperate|resperate
5058334|NCT01390714|Proton Pump Inhibitors|proton pump inhibitors
5058335|NCT01390714|Gastroesophageal Reflux Disease|gastroesophageal reflux disease
5058336|NCT01390714|pharmacokinetics|pharmacokinetics
5058337|NCT01390714|pharmacodynamics|pharmacodynamics
5058338|NCT01390701|randomized|randomized
5058339|NCT01390701|cross-over|cross-over
5058340|NCT01390701|transcutaneous electrical nerve stimulation|transcutaneous electrical nerve stimulation
5058341|NCT01390701|felodipin|felodipin
5058342|NCT01390701|hypertension|hypertension
5058343|NCT01390701|blood pressure|blood pressure
5058344|NCT01390701|treatment|treatment
5058345|NCT01390688|Brain-derived Neurotrophic factor|brain-derived neurotrophic factor
5058346|NCT01390688|Low-grade inflammation|low-grade inflammation
5058347|NCT01390688|Cognitive dysfunction|cognitive dysfunction
5058348|NCT01390662|serum 25-hydroxyvitamin d,vitamin D supplement, depression,|serum 25-hydroxyvitamin d,vitamin d supplement, depression,
5058349|NCT01390662|parathyroid hormone|parathyroid hormone
5058350|NCT01390649|ITP|itp
5058351|NCT01390636|Continuous Glucose Monitoring|continuous glucose monitoring
5058352|NCT01390636|Type 1 Diabetes and an Eating Disorder|type 1 diabetes and an eating disorder
5058353|NCT01390636|Eating Disorder Only|eating disorder only
5058354|NCT01390623|Acute Uncomplicated Pyelonephritis|acute uncomplicated pyelonephritis
5058355|NCT01390623|Short-term antibiotic|short-term antibiotic
5058356|NCT01390623|Ceftriaxone|ceftriaxone
5058357|NCT01390623|Cefixime|cefixime
5058358|NCT01390623|Women|women
5058359|NCT01390623|Efficacy|efficacy
5058360|NCT01390610|Continuous Glucose Monitoring|continuous glucose monitoring
5058361|NCT01390610|Self Monitored Blood Glucose|self monitored blood glucose
5058362|NCT01390610|Type 2 Diabetes|type 2 diabetes
5058363|NCT01390597|peripheral T-cell lymphoma|peripheral t-cell lymphoma
5058364|NCT01390597|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
5058365|NCT01390597|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
5058366|NCT01390597|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
5058367|NCT01390597|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
5058368|NCT01390597|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5058369|NCT01390584|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
5058370|NCT01390584|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
5058371|NCT01390584|adult favorable prognosis Hodgkin lymphoma|adult favorable prognosis hodgkin lymphoma
5058372|NCT01390584|adult mixed cellularity Hodgkin lymphoma|adult mixed cellularity hodgkin lymphoma
5058373|NCT01390584|adult nodular sclerosis Hodgkin lymphoma|adult nodular sclerosis hodgkin lymphoma
5058374|NCT01390584|adult lymphocyte depletion Hodgkin lymphoma|adult lymphocyte depletion hodgkin lymphoma
5058375|NCT01390584|adult unfavorable prognosis Hodgkin lymphoma|adult unfavorable prognosis hodgkin lymphoma
5058376|NCT01390571|adult glioblastoma|adult glioblastoma
5058377|NCT01390571|adult giant cell glioblastoma|adult giant cell glioblastoma
5058378|NCT01390571|adult gliosarcoma|adult gliosarcoma
5058379|NCT01390571|recurrent adult brain tumor|recurrent adult brain tumor
5058380|NCT01390558|Down Syndrome|down syndrome
5058381|NCT01390558|Orthotics|orthotics
5058382|NCT01390558|Gait Analysis|gait analysis
5058383|NCT01390545|Rheumatoid arthritis|rheumatoid arthritis
5058384|NCT01390545|anti-CD20 antibody|anti-cd20 antibody
5058385|NCT01390545|subcutaneous|subcutaneous
5058386|NCT01390532|Left Ventricular Dyssynchrony|left ventricular dyssynchrony
5058387|NCT01390532|Gated blood-pool|gated blood-pool
5058388|NCT01390532|D-SPECT|d-spect
5058389|NCT01390532|Pharmacological stress|pharmacological stress
5058390|NCT01390532|NYHA III/IV|nyha iii/iv
5058391|NCT01390532|LVEF < 35 %|lvef < 35 %
5058392|NCT01390532|QRS > 120 ms|qrs > 120 ms
5058393|NCT01390532|optimal medical treatment|optimal medical treatment
5058394|NCT01390532|cardiac resynchronization therapy|cardiac resynchronization therapy
5058395|NCT01390519|mRCC,|mrcc,
5058396|NCT01390519|observational,|observational,
5058397|NCT01390519|Afinitor,|afinitor,
5058398|NCT01390519|everolimus,|everolimus,
5058399|NCT01390519|2.line|2.line
5058400|NCT01390506|cardiac arrest|cardiac arrest
5058401|NCT01390506|resuscitation|resuscitation
5058402|NCT01390506|neurological outcome|neurological outcome
5058403|NCT01390493|neurofeedback, alpha, anorexia nervosa|neurofeedback, alpha, anorexia nervosa
5058404|NCT01390480|vitamin D|vitamin d
5058405|NCT01390480|Autoimmune disease|autoimmune disease
5058406|NCT01390480|diabetes|diabetes
5058407|NCT01390467|Paracetamol|paracetamol
5058408|NCT01390467|Cognitive impact|cognitive impact
5058409|NCT01390441|Rheumatoid arthritis|rheumatoid arthritis
5058410|NCT01390441|RA|ra
5058411|NCT01390441|Rituximab|rituximab
5058412|NCT01390441|Rituxan|rituxan
5058413|NCT01390441|MabThera|mabthera
5058414|NCT01390441|Methotrexate|methotrexate
5058415|NCT01390441|Rheumatrex|rheumatrex
5058416|NCT01390441|Trexall|trexall
5058417|NCT01390441|MK-8808|mk-8808
5058418|NCT01390402|Alloreactive haploidentical NK cells|alloreactive haploidentical nk cells
5058419|NCT01390402|Natural killer cells|natural killer cells
5058420|NCT01390402|Stem Cell Transplantation|stem cell transplantation
5058421|NCT01390402|Immune cells|immune cells
5058422|NCT01390402|Chronic myelogenous leukemia|chronic myelogenous leukemia
5058423|NCT01390402|CML|cml
5058424|NCT01390402|Human leukocyte antigen|human leukocyte antigen
5058425|NCT01390402|HLA|hla
5058426|NCT01390402|Graft-vs-host disease|graft-vs-host disease
5058427|NCT01390402|GVHD|gvhd
5058428|NCT01390402|Antithymocyte globulin|antithymocyte globulin
5058429|NCT01390402|ATG|atg
5058430|NCT01390402|Thymoglobulin|thymoglobulin
5058431|NCT01390402|Interleukin-2|interleukin-2
5058432|NCT01390402|IL-2|il-2
5058433|NCT01390402|Aldesleukin|aldesleukin
5058434|NCT01390402|Proleukin|proleukin
5058435|NCT01390402|Fludarabine|fludarabine
5058436|NCT01390402|Fludarabine phosphate|fludarabine phosphate
5058437|NCT01390402|Fludara|fludara
5058438|NCT01390402|Tacrolimus|tacrolimus
5058439|NCT01390402|Prograf|prograf
5058440|NCT01390402|Busulfan|busulfan
5058441|NCT01390402|Busulfex|busulfex
5058442|NCT01390402|Myleran|myleran
5058443|NCT01390402|Methotrexate|methotrexate
5058444|NCT01390389|Geriatric bipolar depression|geriatric bipolar depression
5058445|NCT01390389|MR Spectroscopy|mr spectroscopy
5058446|NCT01390389|Coenzyme Q10|coenzyme q10
5058447|NCT01390389|Mitochondrial Dysfunction|mitochondrial dysfunction
5058448|NCT01390376|Schizophrenia|schizophrenia
5058449|NCT01390376|NMDA|nmda
5058450|NCT01390376|DAAOI|daaoi
5058451|NCT01390376|Clozapine resistant schizophrenia|clozapine resistant schizophrenia
5058452|NCT01390363|immunization|immunization
5058453|NCT01390363|reminder systems|reminder systems
5058454|NCT01390350|Schnitzler syndrome|schnitzler syndrome
5058455|NCT01390350|autoinflammatory syndrome|autoinflammatory syndrome
5058456|NCT01390337|AC220|ac220
5058457|NCT01390337|Acute Myeloid Leukemia (AML)|acute myeloid leukemia (aml)
5058458|NCT01390337|De Novo Acute Myeloid Leukemia (AML)|de novo acute myeloid leukemia (aml)
5058459|NCT01390337|Newly diagnosed Acute Myeloid Leukemia (AML)|newly diagnosed acute myeloid leukemia (aml)
5058460|NCT01390337|FMS-like tyrosine kinase (FLT3)|fms-like tyrosine kinase (flt3)
5058461|NCT01390337|FMS-like tyrosine kinase (FLT3) Inhibitor|fms-like tyrosine kinase (flt3) inhibitor
5058462|NCT01390337|Kinase|kinase
5058463|NCT01390337|Kinase Inhibitor|kinase inhibitor
5058464|NCT01390337|Pharmacokinetics|pharmacokinetics
5058465|NCT01390337|ASP2689|asp2689
5058466|NCT01390337|quizartinib|quizartinib
5058467|NCT01390324|Migraine|migraine
5058468|NCT01390324|Naratriptan|naratriptan
5058469|NCT01390324|Naproxen|naproxen
5058470|NCT01390298|chronic pain after knee replacement surgery|chronic pain after knee replacement surgery
5058471|NCT01390272|Hypertension|hypertension
5058472|NCT01390272|Telephone|telephone
5058473|NCT01390272|Disease Management|disease management
5058474|NCT01390272|Veterans|veterans
5058475|NCT01390272|Pharmacists|pharmacists
5058476|NCT01390272|Nurses|nurses
5058477|NCT01390246|Pregnancy|pregnancy
5058478|NCT01390246|Tobacco use disorder|tobacco use disorder
5058479|NCT01390246|Smoking cessation|smoking cessation
5058480|NCT01390246|Bupropion SR|bupropion sr
5058481|NCT01390246|Zyban|zyban
5058482|NCT01390233|Labor, obstetric|labor, obstetric
5058483|NCT01390233|Labor, induced|labor, induced
5058484|NCT01390220|Epilepsy|epilepsy
5058485|NCT01390220|seizure clusters|seizure clusters
5058486|NCT01390220|acute repetitive seizures|acute repetitive seizures
5058487|NCT01390220|rescue treatment|rescue treatment
5058488|NCT01390220|ARTEMIS|artemis
5058489|NCT01390207|hCG triggering|hcg triggering
5058490|NCT01390207|pregnancy|pregnancy
5058491|NCT01390207|GnRH antagonist|gnrh antagonist
5058492|NCT01390194|liver disease|liver disease
5058493|NCT01390194|hepatocellular carcinoma|hepatocellular carcinoma
5058494|NCT01390155|Electrocardiography|electrocardiography
5058495|NCT01390155|Coronary Artery Disease|coronary artery disease
5058496|NCT01390155|Atrial Fibrillation|atrial fibrillation
5058497|NCT01390155|Heart Atria|heart atria
5058498|NCT01390155|Coronary Circulation|coronary circulation
5058499|NCT01390155|Ischemia|ischemia
5058500|NCT01390116|gamma delta T cell|gamma delta t cell
5058501|NCT01390116|natural killer cell|natural killer cell
5058502|NCT01390116|proliferation|proliferation
5058503|NCT01390116|cytokine secretion|cytokine secretion
5058504|NCT01390116|Improvement in immune cell function in healthy humans|improvement in immune cell function in healthy humans
5058505|NCT01390103|hip pain|hip pain
5058506|NCT01390090|piriformis muscle|piriformis muscle
5058507|NCT01390077|homogentisic acid|homogentisic acid
5058508|NCT01390051|birth weight|birth weight
5058509|NCT01390051|thrombosis|thrombosis
5058510|NCT01390051|anticoagulant therapy|anticoagulant therapy
5058511|NCT01390025|Influenza|influenza
5058512|NCT01390025|Monoclonal antibody|monoclonal antibody
5058513|NCT01389973|Diseases [C] - Digestive System Diseases [C06]|diseases [c] - digestive system diseases [c06]
5058514|NCT01389973|primary biliary cirrhosis|primary biliary cirrhosis
5058515|NCT01389973|ursodeoxycholic acid (UDCA)|ursodeoxycholic acid (udca)
5058516|NCT01389973|STELARA|stelara
5058517|NCT01389973|ustekinumab|ustekinumab
5058518|NCT01389947|mesenteric ischemia|mesenteric ischemia
5058519|NCT01389947|extracorporeal circulation|extracorporeal circulation
5058520|NCT01389947|microcirculation|microcirculation
5058521|NCT01389947|cardiac surgery|cardiac surgery
5058522|NCT01389947|IFABP|ifabp
5058523|NCT01389947|citrullinemia|citrullinemia
5058524|NCT01389947|glycocalyx|glycocalyx
5058525|NCT01389947|vascular occlusion test|vascular occlusion test
5058526|NCT01389947|NIRS probe on thenar eminence|nirs probe on thenar eminence
5058527|NCT01389934|levo-bupicaine|levo-bupicaine
5058528|NCT01389934|Radical|radical
5058529|NCT01389934|Mastectomy|mastectomy
5058530|NCT01389921|lower urinary tract|lower urinary tract
5058531|NCT01389921|sensory evoked potential|sensory evoked potential
5058532|NCT01389921|contact heat evoked potential stimulation|contact heat evoked potential stimulation
5058533|NCT01389921|electroencephalogram|electroencephalogram
5058534|NCT01389921|cortical processing|cortical processing
5058535|NCT01389921|bladder sensations|bladder sensations
5058536|NCT01389921|lower urinary tract dysfunction|lower urinary tract dysfunction
5058537|NCT01389921|overactive bladder|overactive bladder
5058538|NCT01389895|Lupus|lupus
5058539|NCT01389895|Cutaneous lupus|cutaneous lupus
5058540|NCT01389882|mechanical ventilation|mechanical ventilation
5058541|NCT01389882|diaphragm electrical activity|diaphragm electrical activity
5058542|NCT01389882|pressure support|pressure support
5058543|NCT01389869|Emotional tears|emotional tears
5058544|NCT01389869|Postprandial plasma|postprandial plasma
5058545|NCT01389869|Chemosignal|chemosignal
5058546|NCT01389869|Obesity|obesity
5058547|NCT01389869|Appetite|appetite
5058548|NCT01389869|Food intake|food intake
5058549|NCT01389856|Persistent pulmonary hypertension, newborn|persistent pulmonary hypertension, newborn
5058550|NCT01389856|PPHN|pphn
5058551|NCT01389843|Heart failure|heart failure
5058552|NCT01389843|Registry|registry
5058553|NCT01389843|Cohort|cohort
5058554|NCT01389843|Heart Disease|heart disease
5058555|NCT01389843|Cardiovascular Diseases|cardiovascular diseases
5058556|NCT01389830|End of Life|end of life
5058557|NCT01389830|EOL|eol
5058558|NCT01389830|Latinos|latinos
5058559|NCT01389830|Hispanic American|hispanic american
5058560|NCT01389830|Medicare beneficiaries|medicare beneficiaries
5058561|NCT01389830|stage III diagnosis|stage iii diagnosis
5058562|NCT01389830|Breast cancer|breast cancer
5058563|NCT01389830|Colorectal cancer|colorectal cancer
5058564|NCT01389830|Prostate cancer|prostate cancer
5058565|NCT01389830|Lung cancer|lung cancer
5058566|NCT01389830|Cancer Prevention and Treatment Demonstration|cancer prevention and treatment demonstration
5058567|NCT01389830|CPTD|cptd
5058568|NCT01389804|transplant, pediatric|transplant, pediatric
5058569|NCT01389791|muscle relaxation|muscle relaxation
5058570|NCT01389791|magnesium sulfate|magnesium sulfate
5058571|NCT01389791|rocuronium|rocuronium
5058572|NCT01389739|continuity of care|continuity of care
5058573|NCT01389739|interprofessional collaboration|interprofessional collaboration
5058574|NCT01389726|custodial grandparents|custodial grandparents
5058575|NCT01389726|kinship caregivers|kinship caregivers
5058576|NCT01389726|grandparents raising grandchildren|grandparents raising grandchildren
5058577|NCT01389726|grandmothers|grandmothers
5058578|NCT01389726|grandchildren|grandchildren
5058579|NCT01389726|psychological well-being|psychological well-being
5058580|NCT01389713|ovarian reserve|ovarian reserve
5058581|NCT01389713|ovarian stimulation|ovarian stimulation
5058582|NCT01389713|clomifene citrate|clomifene citrate
5058583|NCT01389713|high doses Follicle Stimulating Hormone (FSH)|high doses follicle stimulating hormone (fsh)
5058584|NCT01389687|Poliomyelitis|poliomyelitis
5058585|NCT01389687|Inactivated polio vaccine|inactivated polio vaccine
5058586|NCT01389687|Polio|polio
5058587|NCT01389687|Poliovirus|poliovirus
5058588|NCT01389674|coronary stenosis|coronary stenosis
5058589|NCT01389674|Angina pectoris|angina pectoris
5058590|NCT01389674|left ventricular wall motion abnormalities|left ventricular wall motion abnormalities
5058591|NCT01389661|Maxillary bone cysts|maxillary bone cysts
5058592|NCT01389661|Cell therapy|cell therapy
5058593|NCT01389661|Mesenchymal stem cells|mesenchymal stem cells
5058594|NCT01389661|Autologous serum scaffold|autologous serum scaffold
5058595|NCT01389648|adult|adult
5058596|NCT01389635|Abdominoplasty|abdominoplasty
5058597|NCT01389635|Epidural|epidural
5058598|NCT01389622|Acupuncture|acupuncture
5058599|NCT01389622|smoking cessation|smoking cessation
5058600|NCT01389609|Bioequivalence|bioequivalence
5058601|NCT01389609|Orally-disintegrating Tablet|orally-disintegrating tablet
5058602|NCT01389596|safety|safety
5058603|NCT01389596|efficacy|efficacy
5058604|NCT01389596|partial onset seizures|partial onset seizures
5058605|NCT01389596|pediatric|pediatric
5058606|NCT01389596|pregabalin|pregabalin
5058607|NCT01389596|placebo-controlled|placebo-controlled
5058608|NCT01389596|double-blind|double-blind
5059316|NCT01386658|Children|children
5058609|NCT01389583|GIST(Gastrointestinal stromal tumor)|gist(gastrointestinal stromal tumor)
5058610|NCT01389583|HSP(Heat Shock Protein)|hsp(heat shock protein)
5058611|NCT01389583|Biomarker|biomarker
5058612|NCT01389557|malaria|malaria
5058613|NCT01389557|DHP|dhp
5058614|NCT01389557|PQ|pq
5058615|NCT01389557|MST|mst
5058616|NCT01389518|Symptomatic treatment|symptomatic treatment
5058617|NCT01389518|Common Cold|common cold
5058618|NCT01389518|flu syndrome|flu syndrome
5058619|NCT01389505|Proliferative Diabetic Retinopathy|proliferative diabetic retinopathy
5058620|NCT01389505|Bevacizumab|bevacizumab
5058621|NCT01389505|Panretinal Photocoagulation|panretinal photocoagulation
5058622|NCT01389492|meat|meat
5058623|NCT01389492|LDL|ldl
5058624|NCT01389492|MDA|mda
5058625|NCT01389466|Avian influenza|avian influenza
5058626|NCT01389453|umbilical cord mesenchyma stem cell transplantation|umbilical cord mesenchyma stem cell transplantation
5058627|NCT01389440|Resectable pancreatic adenocarcinoma|resectable pancreatic adenocarcinoma
5058628|NCT01389440|Gemcitabine|gemcitabine
5058629|NCT01389440|Erlotinib|erlotinib
5058630|NCT01389440|Radiotherapy|radiotherapy
5058631|NCT01389440|Neoadjuvant treatment|neoadjuvant treatment
5058632|NCT01389414|cholangiocarcinoma|cholangiocarcinoma
5058633|NCT01389414|biliary|biliary
5058634|NCT01389414|gallbladder|gallbladder
5058635|NCT01389414|intrahepatic|intrahepatic
5058636|NCT01389414|extrahepatic|extrahepatic
5058637|NCT01389401|Larynx|larynx
5058638|NCT01389401|GERD|gerd
5058639|NCT01389401|saliva|saliva
5058640|NCT01389401|epidermal growth factor|epidermal growth factor
5058641|NCT01389388|Carotid plaques|carotid plaques
5058642|NCT01389388|inflammatory joint disease|inflammatory joint disease
5058643|NCT01389388|statins|statins
5058644|NCT01389388|inflammation|inflammation
5058645|NCT01389388|lipoprotein components|lipoprotein components
5058646|NCT01389375|Closure Device|closure device
5058647|NCT01389375|Coronary Angiography|coronary angiography
5058648|NCT01389362|Diabetes|diabetes
5058649|NCT01389362|foot ulcer|foot ulcer
5058650|NCT01389362|Chinese herbal medicine|chinese herbal medicine
5058651|NCT01389349|tonsillectomy|tonsillectomy
5058652|NCT01389349|adenotonsillectomy|adenotonsillectomy
5058653|NCT01389349|acupuncture|acupuncture
5058654|NCT01389349|children|children
5058655|NCT01389349|postoperative pain|postoperative pain
5058656|NCT01389349|postoperative nausea|postoperative nausea
5058657|NCT01389336|Fibromyalgia Syndrome|fibromyalgia syndrome
5058658|NCT01389336|Fibromyalgia|fibromyalgia
5058659|NCT01389336|Ayurveda|ayurveda
5058660|NCT01389336|Traditional Indian Medicine|traditional indian medicine
5058661|NCT01389336|CAM|cam
5058662|NCT01389336|Pain|pain
5058663|NCT01389336|Chronic Widespread Pain|chronic widespread pain
5058664|NCT01389297|alcohol dependence intervention|alcohol dependence intervention
5058665|NCT01389297|Internet delivered intervention|internet delivered intervention
5058666|NCT01389297|alcohol dependence treatment|alcohol dependence treatment
5058667|NCT01389297|Internet delivered treatment|internet delivered treatment
5058668|NCT01389284|Naproxen Sodium,|naproxen sodium,
5058669|NCT01389284|dental pain|dental pain
5058670|NCT01389271|Pulmonary hypertension|pulmonary hypertension
5058671|NCT01389271|Inhaled iloprost|inhaled iloprost
5058672|NCT01389271|Efficacy|efficacy
5058673|NCT01389271|Safety|safety
5058674|NCT01389271|Tolerability|tolerability
5058675|NCT01389271|Survival|survival
5058676|NCT01389271|NYHA class III and IV|nyha class iii and iv
5058677|NCT01389219|Post partum|post partum
5058678|NCT01389219|Neonate|neonate
5058679|NCT01389219|community health care workers|community health care workers
5058680|NCT01389193|ibudilast|ibudilast
5058681|NCT01389193|migraine|migraine
5058682|NCT01389193|glial cell|glial cell
5058683|NCT01389154|diagnostic yield|diagnostic yield
5058684|NCT01389154|Electromagnetic Tip Tracked|electromagnetic tip tracked
5058685|NCT01389154|peripheral lung lesion|peripheral lung lesion
5058686|NCT01389141|ovary|ovary
5058687|NCT01389141|follicle|follicle
5058688|NCT01389141|hormones|hormones
5058689|NCT01389141|bone|bone
5058690|NCT01389141|muscle|muscle
5058691|NCT01389128|labor|labor
5058692|NCT01389128|pain|pain
5058693|NCT01389128|massage|massage
5058694|NCT01389128|natural birth|natural birth
5058695|NCT01389115|liver cirrhosis|liver cirrhosis
5058696|NCT01389115|oxidative stress|oxidative stress
5058697|NCT01389115|liver transplant|liver transplant
5058698|NCT01389102|Postmenopause|postmenopause
5058699|NCT01389102|Hot Flashes|hot flashes
5058700|NCT01389102|Estradiol|estradiol
5058701|NCT01389102|Polyestradiol phosphate|polyestradiol phosphate
5058702|NCT01389102|Estradiol valerate|estradiol valerate
5058703|NCT01389102|Estradiol 3-benzoate|estradiol 3-benzoate
5058704|NCT01389102|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate
5058705|NCT01389102|Estrogens|estrogens
5058706|NCT01389102|Hormones|hormones
5058707|NCT01389102|Hormones, Hormone Substitutes|hormones, hormone substitutes
5058708|NCT01389102|Hormone Antagonists|hormone antagonists
5058709|NCT01389089|edema reduction|edema reduction
5058710|NCT01389089|ice|ice
5058711|NCT01389089|multi-layer compression bandage|multi-layer compression bandage
5059603|NCT01385241|Stigma|stigma
5058712|NCT01389089|A-V Impulse compression|a-v impulse compression
5058713|NCT01389089|ankle|ankle
5058714|NCT01389076|Previously Untreated, Advanced-Stage, Follicular Lymphoma|previously untreated, advanced-stage, follicular lymphoma
5058715|NCT01389063|endothelial function|endothelial function
5058716|NCT01389063|CCR5 receptor|ccr5 receptor
5058717|NCT01389063|Maraviroc|maraviroc
5058718|NCT01389063|Abacavir|abacavir
5058719|NCT01389063|Flow Mediated Dilatation|flow mediated dilatation
5058720|NCT01389063|EndoPAT|endopat
5058721|NCT01389037|African American|african american
5058722|NCT01389037|High blood pressure|high blood pressure
5058723|NCT01389024|sickle cell disease|sickle cell disease
5058724|NCT01389024|stroke|stroke
5058725|NCT01389024|silent cerebral infarct|silent cerebral infarct
5058726|NCT01389024|children|children
5058727|NCT01389011|PI|pi
5058728|NCT01389011|PVI|pvi
5058729|NCT01389011|Interscalene block|interscalene block
5058730|NCT01388998|fluid management|fluid management
5058731|NCT01388998|fluid therapy|fluid therapy
5058732|NCT01388998|dPP|dpp
5058733|NCT01388998|difference in pulse pressure|difference in pulse pressure
5058734|NCT01388998|PVI|pvi
5058735|NCT01388998|pleth variability index|pleth variability index
5058736|NCT01388998|external pressure applied on the caval vein|external pressure applied on the caval vein
5058737|NCT01388985|Rabies|rabies
5058738|NCT01388985|Vaccination|vaccination
5058739|NCT01388985|Boostability|boostability
5058740|NCT01388972|Community nutritional environment|community nutritional environment
5058741|NCT01388972|Physical activity|physical activity
5058742|NCT01388946|acute postoperative pain|acute postoperative pain
5058743|NCT01388946|late pain|late pain
5058744|NCT01388946|chronic pain|chronic pain
5058745|NCT01388946|wound irrigation with local anesthetic|wound irrigation with local anesthetic
5058746|NCT01388933|Crohn's Disease|crohn's disease
5058747|NCT01388933|natural|natural
5058748|NCT01388933|herbal|herbal
5058749|NCT01388933|Kampo|kampo
5058750|NCT01388933|inflammatory bowel disease|inflammatory bowel disease
5058751|NCT01388933|Adult ages 18 to 75|adult ages 18 to 75
5058752|NCT01388933|Male and female subjects|male and female subjects
5058753|NCT01388920|COPD|copd
5058754|NCT01388920|Muscle wasting|muscle wasting
5058755|NCT01388907|myomectomy|myomectomy
5058756|NCT01388907|adhesion prevention|adhesion prevention
5058757|NCT01388907|pregnancy rate|pregnancy rate
5058758|NCT01388881|reading difficulties|reading difficulties
5058759|NCT01388868|infusion dose|infusion dose
5058760|NCT01388868|vecuronium|vecuronium
5058761|NCT01388868|motor evoked potential|motor evoked potential
5058762|NCT01388868|neuromuscular blocking agent|neuromuscular blocking agent
5058763|NCT01388855|Heart Failure|heart failure
5058764|NCT01388855|Vitamin D|vitamin d
5058765|NCT01388855|Pain|pain
5058766|NCT01388855|Pilot Study|pilot study
5058767|NCT01388855|RCT|rct
5058768|NCT01388842|severe malaria|severe malaria
5058769|NCT01388842|children|children
5058770|NCT01388842|adjunctive treatment|adjunctive treatment
5058771|NCT01388829|formulation comparison|formulation comparison
5058772|NCT01388816|Randomized|randomized
5058773|NCT01388816|Double-Blind|double-blind
5058774|NCT01388816|Placebo Controlled|placebo controlled
5058775|NCT01388816|Parallel Arm|parallel arm
5058776|NCT01388816|Type II Hyperlipidemia|type ii hyperlipidemia
5058777|NCT01388816|Cholesteryl Ester Transferase Protein Inhibitor|cholesteryl ester transferase protein inhibitor
5058778|NCT01388816|CETP Inhibitor|cetp inhibitor
5058779|NCT01388803|bronchial blocker|bronchial blocker
5058780|NCT01388803|VATS|vats
5058781|NCT01388790|Gastric Cancer|gastric cancer
5058782|NCT01388790|Cetuximab|cetuximab
5058783|NCT01388790|EMD271786|emd271786
5058784|NCT01388790|TS-1|ts-1
5058785|NCT01388790|Cisplatin|cisplatin
5058786|NCT01388777|Breast Cancer|breast cancer
5058787|NCT01388777|Breast Carcinoma|breast carcinoma
5058788|NCT01388777|Cryoablation|cryoablation
5058789|NCT01388777|The Visica 2™ Treatment System|the visica 2™ treatment system
5058790|NCT01388777|Unifocal primary invasive ductal breast carcinoma|unifocal primary invasive ductal breast carcinoma
5058791|NCT01388777|Cryoprobe|cryoprobe
5058792|NCT01388764|L-arginine supplement study|l-arginine supplement study
5058793|NCT01388751|Mallet Finger splinting|mallet finger splinting
5058794|NCT01388738|Navigation Brain Stimulation (NEXSTIM)|navigation brain stimulation (nexstim)
5058795|NCT01388738|cerebroprotective drug effectiveness|cerebroprotective drug effectiveness
5058796|NCT01388738|acute ischemic stroke|acute ischemic stroke
5058797|NCT01388725|sTREM-1|strem-1
5058798|NCT01388725|sCD163|scd163
5058799|NCT01388725|PCT|pct
5058800|NCT01388725|CRP|crp
5058801|NCT01388725|WBC count|wbc count
5058802|NCT01388725|SOFA score|sofa score
5058803|NCT01388725|SIRS|sirs
5058804|NCT01388725|sepsis|sepsis
5058805|NCT01388725|severity|severity
5058806|NCT01388725|prognosis|prognosis
5058807|NCT01388712|Probiotics|probiotics
5058808|NCT01388712|constipation|constipation
5058809|NCT01388712|children|children
5058810|NCT01388699|Migraine with aura|migraine with aura
5058811|NCT01388686|sepsis|sepsis
5058812|NCT01388686|catheter|catheter
5058813|NCT01388686|blood stream infection|blood stream infection
5058814|NCT01388686|blood culture|blood culture
5058815|NCT01388673|prior RYGB procedure|prior rygb procedure
5058816|NCT01388673|regained weight over time|regained weight over time
5058817|NCT01388673|dilated pouch and/or stoma|dilated pouch and/or stoma
5058818|NCT01388660|Healthy|healthy
5058819|NCT01388660|Platelet Aggregation Inhibitors|platelet aggregation inhibitors
5058820|NCT01388660|Pharmacokinetics|pharmacokinetics
5058821|NCT01388647|Neoadjuvant Treatment|neoadjuvant treatment
5058822|NCT01388647|HER-2 Positive Breast Cancer|her-2 positive breast cancer
5058823|NCT01388634|Length of hospital stay|length of hospital stay
5058824|NCT01388634|readmission|readmission
5058825|NCT01388634|ventral hernia|ventral hernia
5058826|NCT01388621|ovarian cancer|ovarian cancer
5058827|NCT01388621|fallopian cancer|fallopian cancer
5058828|NCT01388621|recurrent|recurrent
5058829|NCT01388621|platinum-sensitive|platinum-sensitive
5058830|NCT01388621|KRAS-Wildtype|kras-wildtype
5058831|NCT01388608|rheumatoid arthritis|rheumatoid arthritis
5058832|NCT01388608|etanercept|etanercept
5058833|NCT01388608|step activity measure|step activity measure
5058834|NCT01388582|contraceptives|contraceptives
5058835|NCT01388582|hormonal|hormonal
5058836|NCT01388582|breastfeeding|breastfeeding
5058837|NCT01388582|infant weight|infant weight
5058838|NCT01388569|stage IV melanoma|stage iv melanoma
5058839|NCT01388556|exercise|exercise
5058840|NCT01388556|Parkinson disease|parkinson disease
5058841|NCT01388556|motor symptoms|motor symptoms
5058842|NCT01388556|gait|gait
5058843|NCT01388556|balance|balance
5058844|NCT01388543|Pharmacokinetics|pharmacokinetics
5058845|NCT01388543|Clinical Pharmacology|clinical pharmacology
5058846|NCT01388543|Pharmacogenomics|pharmacogenomics
5058847|NCT01388543|HIV|hiv
5058848|NCT01388517|Pityriasis alba|pityriasis alba
5058849|NCT01388517|Tacrolimus|tacrolimus
5058850|NCT01388517|Calcitriol|calcitriol
5058851|NCT01388517|Petrolatum|petrolatum
5058852|NCT01388491|Contraception|contraception
5058853|NCT01388491|Hemostasis|hemostasis
5058854|NCT01388491|Blood Coagulation|blood coagulation
5058855|NCT01388478|Safety|safety
5058856|NCT01388478|Tolerability|tolerability
5058857|NCT01388478|R(+)Pramipexole|r(+)pramipexole
5058858|NCT01388478|Alzheimer's|alzheimer's
5058859|NCT01388465|Adherence|adherence
5058860|NCT01388465|Intervention|intervention
5058861|NCT01388452|HIV|hiv
5058862|NCT01388452|routine HIV testing|routine hiv testing
5058863|NCT01388452|provider-initiated HIV testing and counseling|provider-initiated hiv testing and counseling
5058864|NCT01388452|early infant diagnosis|early infant diagnosis
5058865|NCT01388452|Africa South of the Sahara|africa south of the sahara
5058866|NCT01388439|oseltamivir|oseltamivir
5058867|NCT01388439|influenza|influenza
5058868|NCT01388439|neonate|neonate
5058869|NCT01388439|premature|premature
5058870|NCT01388439|pharmacokinetics|pharmacokinetics
5058871|NCT01388413|neurogenic bladder|neurogenic bladder
5058872|NCT01388413|urinary tract infection|urinary tract infection
5058873|NCT01388400|stroke|stroke
5058874|NCT01388400|rehabilitation|rehabilitation
5058875|NCT01388400|virtual reality|virtual reality
5058876|NCT01388400|upper limb|upper limb
5058877|NCT01388387|pharmacogenetics|pharmacogenetics
5058878|NCT01388387|pharmacokinetics|pharmacokinetics
5058879|NCT01388387|tacrolimus|tacrolimus
5058880|NCT01388387|genetic polymorphism|genetic polymorphism
5058881|NCT01388387|CYP3A5|cyp3a5
5058882|NCT01388387|liver transplantation|liver transplantation
5058883|NCT01388374|Delivery of Health Care|delivery of health care
5058884|NCT01388374|Nurse Practitioners|nurse practitioners
5058885|NCT01388374|Out of Hours Medical Care|out of hours medical care
5058886|NCT01388374|Primary Health Care|primary health care
5058887|NCT01388374|Emergency Medical Services|emergency medical services
5058888|NCT01388348|benign prostatic hyperplasia (BPH)|benign prostatic hyperplasia (bph)
5058889|NCT01388348|acoustic vibration|acoustic vibration
5058890|NCT01388322|Pregnancy|pregnancy
5058891|NCT01388322|Preeclampsia|preeclampsia
5058892|NCT01388322|Placental insufficiency|placental insufficiency
5058893|NCT01388283|prognostic marker|prognostic marker
5058894|NCT01388270|Hemodialysis|hemodialysis
5058895|NCT01388270|Anticoagulation|anticoagulation
5058896|NCT01388270|Clotting|clotting
5058897|NCT01388270|Coagulation|coagulation
5058898|NCT01388270|dalteparin|dalteparin
5058899|NCT01388270|Clotting in the extracorporeal system during HD|clotting in the extracorporeal system during hd
5058900|NCT01388270|Antithrombogenic property of Evodial HD filter|antithrombogenic property of evodial hd filter
5058901|NCT01388270|Anticoagulation during HD|anticoagulation during hd
5058902|NCT01388257|Crohn Disease|crohn disease
5058903|NCT01388257|Anoperineal fistula|anoperineal fistula
5058904|NCT01388257|Anal fistula|anal fistula
5058905|NCT01388257|Proctology|proctology
5058906|NCT01388257|Drainage|drainage
5058907|NCT01388257|Colorectal Surgery|colorectal surgery
5058908|NCT01388257|Fistulotomy|fistulotomy
5058909|NCT01388257|Plug|plug
5058910|NCT01388257|Advancement flap|advancement flap
5058911|NCT01388257|Glue|glue
5058912|NCT01388257|Anti Tumor Necrosis Factor-alpha|anti tumor necrosis factor-alpha
5058913|NCT01388257|Adalimumab|adalimumab
5058914|NCT01388244|Screening|screening
5058915|NCT01388244|Risk Assessment|risk assessment
5058916|NCT01388244|Fractures|fractures
5058917|NCT01388244|Absorptiometry, Photon|absorptiometry, photon
5058918|NCT01388244|Fracture prevention|fracture prevention
5058920|NCT01388244|Patient prespective|patient prespective
5058921|NCT01388231|social phobia, cognitive-behavioral therapy, treatment|social phobia, cognitive-behavioral therapy, treatment
5058922|NCT01388218|Physical Activity|physical activity
5058923|NCT01388218|Patient Reported Outcome (PRO)|patient reported outcome (pro)
5058924|NCT01388218|Chronic obstructive pulmonary disease (COPD)|chronic obstructive pulmonary disease (copd)
5058925|NCT01388218|Innovative Medicines Initiative - Joint Undertaking (IMI-JU)|innovative medicines initiative - joint undertaking (imi-ju)
5058926|NCT01388205|Myopia|myopia
5058927|NCT01388205|Outdoor activity|outdoor activity
5058928|NCT01388205|Physical activity|physical activity
5058929|NCT01388205|Randomized Controlled Trial|randomized controlled trial
5058930|NCT01388205|Pedometer|pedometer
5058931|NCT01388205|Behavior modification|behavior modification
5058932|NCT01388205|Obesity|obesity
5058933|NCT01388192|Pancreaticoduodenectomy|pancreaticoduodenectomy
5058934|NCT01388192|diabetes|diabetes
5058935|NCT01388192|sugar metabolism|sugar metabolism
5058936|NCT01388179|Autism|autism
5058937|NCT01388179|TMS|tms
5058938|NCT01388153|Bioequivalence, acarbose, ODT|bioequivalence, acarbose, odt
5058939|NCT01388140|dissociation|dissociation
5058940|NCT01388140|psychosis|psychosis
5058941|NCT01388140|trauma|trauma
5058942|NCT01388140|parenting|parenting
5058943|NCT01388140|executive functions|executive functions
5058944|NCT01388114|Procalcitonin Measurement|procalcitonin measurement
5058945|NCT01388101|LECT2|lect2
5058946|NCT01388088|Hypertension|hypertension
5058947|NCT01388088|Potassium|potassium
5058948|NCT01388088|Blood-pressure|blood-pressure
5058949|NCT01388075|induction|induction
5058950|NCT01388075|CYP2C9|cyp2c9
5058951|NCT01388075|Genetic variability|genetic variability
5058952|NCT01388075|Expression|expression
5058953|NCT01388062|influenza virus|influenza virus
5058954|NCT01388049|EV71|ev71
5058955|NCT01388036|heart rate|heart rate
5058956|NCT01388023|SmellX|smellx
5058957|NCT01388023|malodor|malodor
5058958|NCT01388023|halitosis|halitosis
5058959|NCT01388023|herbal formulation|herbal formulation
5058960|NCT01388023|natural medicinals|natural medicinals
5058961|NCT01388023|slow release delivery system|slow release delivery system
5058962|NCT01388023|gingivitis|gingivitis
5058963|NCT01388023|Bad Breath|bad breath
5058964|NCT01388010|probiotics|probiotics
5058965|NCT01388010|gastrointestinal well being|gastrointestinal well being
5058966|NCT01388010|digestive symptoms|digestive symptoms
5058967|NCT01388010|healthy population|healthy population
5058968|NCT01387997|HPV|hpv
5058969|NCT01387984|Type 2 diabetes mellitus|type 2 diabetes mellitus
5058970|NCT01387984|Diabetic complications|diabetic complications
5058971|NCT01387984|YKL-40|ykl-40
5058972|NCT01387971|impression cytology|impression cytology
5058973|NCT01387971|ocular surface disorders|ocular surface disorders
5058974|NCT01387971|ocular surface cells' variation|ocular surface cells' variation
5058975|NCT01387971|Limbal insufficiency|limbal insufficiency
5058976|NCT01387958|Hepatitis C virus|hepatitis c virus
5058977|NCT01387958|Chronically infected|chronically infected
5058978|NCT01387958|treatment naive|treatment naive
5058979|NCT01387958|non responders to prior therapy|non responders to prior therapy
5058980|NCT01387945|Home blood pressure monitoring|home blood pressure monitoring
5058981|NCT01387945|Patient activation|patient activation
5058982|NCT01387945|Patient-centered care|patient-centered care
5058983|NCT01387945|Community Health Aides|community health aides
5058984|NCT01387945|Primary Health Care|primary health care
5058985|NCT01387932|Hepatocellular carcinoma|hepatocellular carcinoma
5058986|NCT01387932|TACE|tace
5058987|NCT01387932|HepaSphere Microspheres|hepasphere microspheres
5058988|NCT01387932|QuadraSphere Microspheres|quadrasphere microspheres
5058989|NCT01387932|Doxorubicin|doxorubicin
5058990|NCT01387919|Set time points during 48 hours of fasting|set time points during 48 hours of fasting
5058991|NCT01387906|mild|mild
5058992|NCT01387906|moderate|moderate
5058993|NCT01387893|Benign Prostatic Hyperplasia|benign prostatic hyperplasia
5058994|NCT01387893|BPH|bph
5058995|NCT01387893|Lower Urinary Tract Symptoms|lower urinary tract symptoms
5058996|NCT01387893|LUTS|luts
5058997|NCT01387893|Self-Administered Maneuver|self-administered maneuver
5058998|NCT01387893|Symptomatic Relief|symptomatic relief
5058999|NCT01387893|Digital Repetitive Infrapubic Pressure maneuver|digital repetitive infrapubic pressure maneuver
5059000|NCT01387880|Metastatic colorectal cancer|metastatic colorectal cancer
5059001|NCT01387880|Third line therapy|third line therapy
5059002|NCT01387880|Fourth line therapy|fourth line therapy
5059003|NCT01387880|KRAS mutation status|kras mutation status
5059004|NCT01387880|Cetuximab|cetuximab
5059005|NCT01387880|Everolimus|everolimus
5059006|NCT01387880|Irinotecan|irinotecan
5059007|NCT01387867|Exercise|exercise
5059008|NCT01387867|Hip osteoarthritis|hip osteoarthritis
5059009|NCT01387867|Randomized controlled trial|randomized controlled trial
5059010|NCT01387841|yoga|yoga
5059011|NCT01387841|chemotherapy|chemotherapy
5059012|NCT01387841|nausea|nausea
5059013|NCT01387841|vomiting|vomiting
5059014|NCT01387828|Splenic artery|splenic artery
5059015|NCT01387828|Aneurysm|aneurysm
5059016|NCT01387828|laparoscopic|laparoscopic
5059017|NCT01387828|Vascular reconstruction|vascular reconstruction
5059018|NCT01387828|Splenectomy|splenectomy
5059019|NCT01387815|Effectiveness|effectiveness
5059020|NCT01387815|Psoriasis|psoriasis
5059021|NCT01387815|Observational|observational
5059022|NCT01387815|Prospective|prospective
5059023|NCT01387815|Adalimumab|adalimumab
5059024|NCT01387815|Traditional Systemic Agents|traditional systemic agents
5059025|NCT01387815|Topical Agents|topical agents
5059026|NCT01387815|Comparative|comparative
5059027|NCT01387802|Assessing Effectiveness in Ankylosing Spondylitis|assessing effectiveness in ankylosing spondylitis
5059028|NCT01387789|Product Surveillance|product surveillance
5059029|NCT01387789|Postmarketing|postmarketing
5059030|NCT01387750|Acute Pain|acute pain
5059031|NCT01387750|Musculoskeletal Pain|musculoskeletal pain
5059032|NCT01387750|Topical Analgesic|topical analgesic
5059033|NCT01387737|TA-7284|ta-7284
5059034|NCT01387737|JNJ-28431754|jnj-28431754
5059035|NCT01387737|Canagliflozin|canagliflozin
5059036|NCT01387737|Sodium Glucose Co-Transporter (SGLT2 inhibitor)|sodium glucose co-transporter (sglt2 inhibitor)
5059037|NCT01387724|disseminated neuroblastoma|disseminated neuroblastoma
5059038|NCT01387724|localized resectable neuroblastoma|localized resectable neuroblastoma
5059039|NCT01387724|localized unresectable neuroblastoma|localized unresectable neuroblastoma
5059040|NCT01387724|regional neuroblastoma|regional neuroblastoma
5059041|NCT01387724|stage 4S neuroblastoma|stage 4s neuroblastoma
5059042|NCT01387672|postmenopausal|postmenopausal
5059043|NCT01387672|osteoporosis|osteoporosis
5059044|NCT01387672|bone turnover|bone turnover
5059045|NCT01387672|nitrate|nitrate
5059046|NCT01387672|headache|headache
5059047|NCT01387659|Myfortic|myfortic
5059048|NCT01387659|Simulect|simulect
5059049|NCT01387659|Steroids|steroids
5059050|NCT01387659|Diabetes|diabetes
5059051|NCT01387659|Transplant|transplant
5059052|NCT01387659|Gastric emptying|gastric emptying
5059053|NCT01387659|Gastric motility|gastric motility
5059054|NCT01387646|STI, abuse, substance use, unintended pregnancy|sti, abuse, substance use, unintended pregnancy
5059055|NCT01387633|Nursing care|nursing care
5059056|NCT01387633|Diabetes mellitus|diabetes mellitus
5059057|NCT01387633|Health Education|health education
5059058|NCT01387633|Patient compliance|patient compliance
5059059|NCT01387633|Social support|social support
5059060|NCT01387633|Self-efficacy|self-efficacy
5059061|NCT01387633|Adaptation strategy|adaptation strategy
5059062|NCT01387620|Phacoemulsification|phacoemulsification
5059063|NCT01387620|Corneal Edema|corneal edema
5059064|NCT01387620|Corneal Endothelium|corneal endothelium
5059065|NCT01387620|Viscoelastic Substances|viscoelastic substances
5059066|NCT01387607|Pregabalin|pregabalin
5059067|NCT01387607|fibromyalgia|fibromyalgia
5059068|NCT01387594|Crohn's disease lumbar puncture anti-MAdCAM monoclonal antibody PF-00547659 Ulcerative Colitis|crohn's disease lumbar puncture anti-madcam monoclonal antibody pf-00547659 ulcerative colitis
5059069|NCT01387555|liver cancer|liver cancer
5059070|NCT01387555|liver tumor|liver tumor
5059071|NCT01387555|advanced hcc|advanced hcc
5059072|NCT01387555|hepatocellular cancer|hepatocellular cancer
5059073|NCT01387555|Jennerex|jennerex
5059074|NCT01387555|HCC|hcc
5059075|NCT01387555|sorafenib|sorafenib
5059076|NCT01387555|sorafenib failure|sorafenib failure
5059077|NCT01387555|sorafenib intolerant|sorafenib intolerant
5059078|NCT01387555|Nexavar|nexavar
5059079|NCT01387555|Nexavar failure|nexavar failure
5059080|NCT01387555|JX594|jx594
5059081|NCT01387555|oncolytic virus|oncolytic virus
5059082|NCT01387555|vaccinia|vaccinia
5059083|NCT01387555|viral therapy|viral therapy
5059084|NCT01387555|JX|jx
5059085|NCT01387555|Biotherapeutics|biotherapeutics
5059086|NCT01387555|HEP018|hep018
5059087|NCT01387555|traverse|traverse
5059088|NCT01387555|biologic|biologic
5059089|NCT01387555|Pexa-Vec|pexa-vec
5059090|NCT01387542|Schizophrenia|schizophrenia
5059091|NCT01387542|Paliperidone Extended Release (ER)|paliperidone extended release (er)
5059092|NCT01387542|INVEGA|invega
5059093|NCT01387529|Reference Values|reference values
5059094|NCT01387516|nicotine|nicotine
5059095|NCT01387516|juveniles|juveniles
5059096|NCT01387516|detention|detention
5059097|NCT01387503|Hepatocellular Carcinoma|hepatocellular carcinoma
5059098|NCT01387503|Liver Transplantation|liver transplantation
5059099|NCT01387503|Downstaging|downstaging
5059100|NCT01387503|Trans-arterial chemoembolization (TACE)|trans-arterial chemoembolization (tace)
5059101|NCT01387503|Radiofrequency ablation (RFA)|radiofrequency ablation (rfa)
5059102|NCT01387503|Liver resection|liver resection
5059103|NCT01387503|Sorafenib|sorafenib
5059104|NCT01387490|Mild Traumatic Brain Injury|mild traumatic brain injury
5059105|NCT01387490|Telephone counseling|telephone counseling
5059106|NCT01387477|hypoglycemia|hypoglycemia
5059107|NCT01387477|lactate|lactate
5059108|NCT01387477|glucose|glucose
5059109|NCT01387477|ICU|icu
5059110|NCT01387464|bromfenac concentrations|bromfenac concentrations
5059111|NCT01387464|ISV-303|isv-303
5059112|NCT01387464|Bromday|bromday
5059113|NCT01387451|Brown adipose tissue|brown adipose tissue
5059114|NCT01387451|Different regions|different regions
5059115|NCT01387451|Chinese adults|chinese adults
5059116|NCT01387438|Brown Adipose Tissue|brown adipose tissue
5059117|NCT01387438|Cross sectional study|cross sectional study
5059118|NCT01387438|Chinese Adults|chinese adults
5059119|NCT01387438|Factor|factor
5059120|NCT01387425|Smoking cessation of diabetic smoker|smoking cessation of diabetic smoker
5059121|NCT01387412|genital warts|genital warts
5059122|NCT01387412|HIV|hiv
5059123|NCT01387412|MSM|msm
5059124|NCT01387412|Peru|peru
5059125|NCT01387412|HPV|hpv
5059126|NCT01387399|ovarian cancer|ovarian cancer
5059127|NCT01387399|recurrence|recurrence
5059128|NCT01387399|platinum-sensitive recurrent ovarian cancer|platinum-sensitive recurrent ovarian cancer
5059129|NCT01387399|HIPEC|hipec
5059130|NCT01387399|intraperitoneal chemotherapy|intraperitoneal chemotherapy
5059131|NCT01387399|hyperthermic intraperitoneal chemoperfusion|hyperthermic intraperitoneal chemoperfusion
5059132|NCT01387399|cisplatin|cisplatin
5059133|NCT01387373|breast cancer|breast cancer
5059134|NCT01387373|metastatic|metastatic
5059135|NCT01387373|liver metastases|liver metastases
5059136|NCT01387373|intrahepatic|intrahepatic
5059137|NCT01387373|chemotherapy|chemotherapy
5059138|NCT01387360|Myopia|myopia
5059139|NCT01387360|Hyperopia|hyperopia
5059140|NCT01387360|Presbyopia|presbyopia
5059141|NCT01387360|Pseudophakia|pseudophakia
5059142|NCT01387360|LASIK|lasik
5059143|NCT01387347|Thymosin beta 4|thymosin beta 4
5059144|NCT01387347|Dry eye syndrome|dry eye syndrome
5059145|NCT01387347|Dry eye|dry eye
5059146|NCT01387334|resistive exercise|resistive exercise
5059147|NCT01387334|Resistance Exercise Training Program|resistance exercise training program
5059148|NCT01387334|Rubber Bands|rubber bands
5059149|NCT01387334|Glycemic Control|glycemic control
5059150|NCT01387334|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
5059151|NCT01387321|Pi3K|pi3k
5059152|NCT01387321|Advanced solid tumor|advanced solid tumor
5059153|NCT01387308|Phase 1|phase 1
5059154|NCT01387308|Healthy male volunteers|healthy male volunteers
5059155|NCT01387308|pharmacokinetics|pharmacokinetics
5059156|NCT01387308|fostamatinib|fostamatinib
5059157|NCT01387308|Scientific Terminology: Bioavailability, R406 plasma AUC and C_maxR406 plasma AUC0-t, t1/2λz and t_max|scientific terminology: bioavailability, r406 plasma auc and c_maxr406 plasma auc0-t, t1/2λz and t_max
5059158|NCT01387308|Laymen Terminology: Amount of R406 in blood|laymen terminology: amount of r406 in blood
5059159|NCT01387295|breast cancer|breast cancer
5059160|NCT01387295|liver metastases|liver metastases
5059161|NCT01387295|intrahepatic chemotherapy|intrahepatic chemotherapy
5059162|NCT01387256|abortion|abortion
5059163|NCT01387256|mifepristone|mifepristone
5059164|NCT01387256|misoprostol|misoprostol
5059165|NCT01387256|with gestations > 63 days LMP|with gestations > 63 days lmp
5059166|NCT01387243|behavior modification|behavior modification
5059167|NCT01387243|overweight|overweight
5059168|NCT01387243|orlistat|orlistat
5059169|NCT01387230|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
5059170|NCT01387230|long acting muscarinic antagonist|long acting muscarinic antagonist
5059171|NCT01387217|GSK2018682|gsk2018682
5059172|NCT01387217|First Time in Human|first time in human
5059173|NCT01387217|Healthy Volunteer|healthy volunteer
5059174|NCT01387204|MEK inhibitor|mek inhibitor
5059175|NCT01387204|elimination|elimination
5059176|NCT01387204|Phase 1|phase 1
5059177|NCT01387204|GSK1120212|gsk1120212
5059178|NCT01387204|cancer|cancer
5059179|NCT01387204|Pharmacokinetics|pharmacokinetics
5059180|NCT01387204|oncology|oncology
5059181|NCT01387204|radiolabeled ADME|radiolabeled adme
5059182|NCT01387178|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
5059183|NCT01387178|cost and cost analysis|cost and cost analysis
5059184|NCT01387178|bronchodilators|bronchodilators
5059185|NCT01387178|healthcare utilization|healthcare utilization
5059186|NCT01387178|fluticasone propionate/salmeterol|fluticasone propionate/salmeterol
5059187|NCT01387178|tiotropium|tiotropium
5059188|NCT01387165|Latin America|latin america
5059189|NCT01387165|diabetes complications|diabetes complications
5059190|NCT01387165|patient compliance|patient compliance
5059191|NCT01387165|Diabetes mellitus, type 2|diabetes mellitus, type 2
5059192|NCT01387165|health services accessibility|health services accessibility
5059193|NCT01387152|chest pain|chest pain
5059194|NCT01387152|myocardial perfusion scintigraphy|myocardial perfusion scintigraphy
5059195|NCT01387152|nuclear stress testing|nuclear stress testing
5059196|NCT01387152|low radiation dose|low radiation dose
5059197|NCT01387139|Ketamine|ketamine
5059198|NCT01387139|Propofol|propofol
5059199|NCT01387139|Procedural Sedation and Analgesia|procedural sedation and analgesia
5059200|NCT01387113|stroke|stroke
5059201|NCT01387113|tPA|tpa
5059202|NCT01387113|Thrombolysis|thrombolysis
5059203|NCT01387113|rt-PA|rt-pa
5059204|NCT01387113|Ischemic|ischemic
5059205|NCT01387113|CTP|ctp
5059206|NCT01387113|Imaging|imaging
5059207|NCT01387113|CT Perfusion Imaging|ct perfusion imaging
5059208|NCT01387113|Perfusion|perfusion
5059209|NCT01387113|CTA|cta
5059210|NCT01387113|CT Angiography|ct angiography
5059211|NCT01387113|Acute ischemic stroke|acute ischemic stroke
5059989|NCT01383538|Leucovorin|leucovorin
5059212|NCT01387113|Acute stroke therapy|acute stroke therapy
5059213|NCT01387113|(AIS)|(ais)
5059214|NCT01387100|supportive employment|supportive employment
5059215|NCT01387100|vocational rehabilitation|vocational rehabilitation
5059216|NCT01387087|ASP015K|asp015k
5059217|NCT01387087|Healthy subjects|healthy subjects
5059218|NCT01387087|Pharmacodynamics|pharmacodynamics
5059219|NCT01387087|Maximum tolerated dose|maximum tolerated dose
5059220|NCT01387061|liver resection|liver resection
5059221|NCT01387061|hepatic resection|hepatic resection
5059222|NCT01387061|intraoperative ultrasound|intraoperative ultrasound
5059223|NCT01387048|acne vulgaris|acne vulgaris
5059224|NCT01387048|late-type acne|late-type acne
5059225|NCT01387048|Skinoren|skinoren
5059226|NCT01387048|maintenance|maintenance
5059227|NCT01387022|Antiretroviral treatment|antiretroviral treatment
5059228|NCT01387022|Tenofovir|tenofovir
5059229|NCT01387022|Drug resistance|drug resistance
5059230|NCT01387022|Treatment outcome|treatment outcome
5059231|NCT01386983|Enlarged prostate, 5-alpha-reductase inhibitor, alpha-blocker, acute urinary retention, surgery, early, costs|enlarged prostate, 5-alpha-reductase inhibitor, alpha-blocker, acute urinary retention, surgery, early, costs
5059232|NCT01386983|benign prostatic hyperplasia|benign prostatic hyperplasia
5059233|NCT01386970|Pharmacokinetics|pharmacokinetics
5059234|NCT01386970|antiretroviral therapy|antiretroviral therapy
5059235|NCT01386970|nucleoside analogs|nucleoside analogs
5059236|NCT01386970|mitochondrial toxicity|mitochondrial toxicity
5059237|NCT01386970|clinical pharmacology|clinical pharmacology
5059238|NCT01386970|cellular pharmacology|cellular pharmacology
5059239|NCT01386970|pharmacogenetics|pharmacogenetics
5059240|NCT01386957|Nephrotic Syndrome|nephrotic syndrome
5059241|NCT01386957|Steroid treatment|steroid treatment
5059242|NCT01386957|Proteinuria|proteinuria
5059243|NCT01386957|Child|child
5059244|NCT01386944|Rotigotine|rotigotine
5059245|NCT01386944|Neupro®|neupro®
5059246|NCT01386944|Augmentation|augmentation
5059247|NCT01386944|Restless Legs Syndrome|restless legs syndrome
5059248|NCT01386944|Moderate to severe|moderate to severe
5059249|NCT01386944|idiopathic|idiopathic
5059250|NCT01386944|adults|adults
5059251|NCT01386931|Biopsy, Fine-Needle|biopsy, fine-needle
5059252|NCT01386931|Endoscopic Ultrasonography|endoscopic ultrasonography
5059253|NCT01386931|cytopathology|cytopathology
5059254|NCT01386918|Hallucinations|hallucinations
5059255|NCT01386918|Schizophrenia|schizophrenia
5059256|NCT01386905|Obesity|obesity
5059257|NCT01386879|suction|suction
5059258|NCT01386879|aspiration|aspiration
5059259|NCT01386879|general anesthesia|general anesthesia
5059260|NCT01386879|intubation|intubation
5059261|NCT01386879|endotracheal tube|endotracheal tube
5059262|NCT01386879|respiratory complications|respiratory complications
5059263|NCT01386866|AMG 706|amg 706
5059264|NCT01386866|Motesanib|motesanib
5059265|NCT01386866|Amgen|amgen
5059266|NCT01386866|Phase 1|phase 1
5059267|NCT01386853|Hyperlipidemia|hyperlipidemia
5059268|NCT01386853|Pitavastatin|pitavastatin
5059269|NCT01386853|Atorvastatin|atorvastatin
5059270|NCT01386840|Efficacy of Treatment|efficacy of treatment
5059271|NCT01386840|Severe|severe
5059272|NCT01386840|home treatment|home treatment
5059273|NCT01386840|treatment at hospital|treatment at hospital
5059274|NCT01386827|Ixiaro|ixiaro
5059275|NCT01386827|japanese encephalitis vaccine|japanese encephalitis vaccine
5059276|NCT01386827|booster|booster
5059277|NCT01386801|Diabetes|diabetes
5059278|NCT01386801|Controls|controls
5059279|NCT01386801|Biospecimen|biospecimen
5059280|NCT01386788|Smoke, cyanide, closed space fires|smoke, cyanide, closed space fires
5059281|NCT01386775|X-Linked Hypohidrotic Ectodermal Dysplasia|x-linked hypohidrotic ectodermal dysplasia
5059282|NCT01386775|XLHED|xlhed
5059283|NCT01386775|Hypohidrotic Ectodermal Dysplasia|hypohidrotic ectodermal dysplasia
5059284|NCT01386775|HED|hed
5059285|NCT01386762|paralysis|paralysis
5059286|NCT01386762|paraplegia|paraplegia
5059288|NCT01386749|Vibration treatment|vibration treatment
5059289|NCT01386749|Fracture healing|fracture healing
5059290|NCT01386749|Muscular function|muscular function
5059291|NCT01386736|insulin resistance|insulin resistance
5059292|NCT01386736|obesity|obesity
5059293|NCT01386736|adolescence|adolescence
5059294|NCT01386736|vitamin D supplementation|vitamin d supplementation
5059295|NCT01386723|eltrombopag|eltrombopag
5059296|NCT01386723|promacta|promacta
5059297|NCT01386723|immune thrombocytopenia (ITP)|immune thrombocytopenia (itp)
5059298|NCT01386710|GBM|gbm
5059299|NCT01386710|AA|aa
5059300|NCT01386710|AO|ao
5059301|NCT01386710|Brain|brain
5059302|NCT01386710|Tumors|tumors
5059303|NCT01386710|Malignant|malignant
5059304|NCT01386710|Glioblastoma|glioblastoma
5059305|NCT01386710|Multiforme|multiforme
5059306|NCT01386710|Anaplastic|anaplastic
5059307|NCT01386710|Astrocytoma|astrocytoma
5059308|NCT01386684|Prostate Cancer|prostate cancer
5059309|NCT01386671|Type 2 Diabetes|type 2 diabetes
5059310|NCT01386671|metformin glycinate|metformin glycinate
5059311|NCT01386671|metabolic control|metabolic control
5059312|NCT01386658|Efficacy|efficacy
5059313|NCT01386658|Hereditary angioedema|hereditary angioedema
5059314|NCT01386658|HAE|hae
5059315|NCT01386658|Pediatric|pediatric
5059317|NCT01386658|Pharmacokinetics|pharmacokinetics
5059318|NCT01386658|Safety|safety
5059319|NCT01386658|Firazyr|firazyr
5059320|NCT01386658|icatibant|icatibant
5059321|NCT01386645|impaired glucose tolerance|impaired glucose tolerance
5059322|NCT01386645|prediabetes|prediabetes
5059323|NCT01386645|dietary glycemic index|dietary glycemic index
5059324|NCT01386645|beta-cell function|beta-cell function
5059325|NCT01386645|insulin secretion|insulin secretion
5059326|NCT01386645|oxidative stress|oxidative stress
5059327|NCT01386645|glycemic variability|glycemic variability
5059328|NCT01386632|Stage III-IV Squamous Cell Carcinoma|stage iii-iv squamous cell carcinoma
5059329|NCT01386593|Cytochrome|cytochrome
5059330|NCT01386593|Phenotyping|phenotyping
5059331|NCT01386593|Pharmacokinetics|pharmacokinetics
5059332|NCT01386580|Brain Neoplasms|brain neoplasms
5059333|NCT01386580|Neoplasm Metastasis|neoplasm metastasis
5059334|NCT01386580|Neoplasms|neoplasms
5059335|NCT01386580|Central Nervous System Neoplasms|central nervous system neoplasms
5059336|NCT01386580|Nervous System Neoplasms|nervous system neoplasms
5059337|NCT01386580|Neoplasms by Site|neoplasms by site
5059338|NCT01386580|Brain Diseases|brain diseases
5059339|NCT01386580|Central Nervous System Diseases|central nervous system diseases
5059340|NCT01386580|Nervous System Diseases|nervous system diseases
5059341|NCT01386580|Neoplastic Processes|neoplastic processes
5059342|NCT01386580|Pathologic Processes|pathologic processes
5059343|NCT01386567|hypogonadism|hypogonadism
5059344|NCT01386567|low testosterone|low testosterone
5059345|NCT01386567|low T|low t
5059346|NCT01386554|H.P. Acthar Gel|h.p. acthar gel
5059347|NCT01386554|Acthar|acthar
5059348|NCT01386554|nephrotic syndrome|nephrotic syndrome
5059349|NCT01386554|idiopathic membranous nephropathy|idiopathic membranous nephropathy
5059350|NCT01386554|proteinuria|proteinuria
5059351|NCT01386515|Adaptation|adaptation
5059352|NCT01386515|Duchenne Muscular Dystrophy|duchenne muscular dystrophy
5059353|NCT01386515|Communication about Duchenne Muscular Dystrophy|communication about duchenne muscular dystrophy
5059354|NCT01386515|Sibling|sibling
5059355|NCT01386502|Solid Tumors|solid tumors
5059356|NCT01386502|Monoclonal Antibody|monoclonal antibody
5059357|NCT01386502|Peptide Vaccine|peptide vaccine
5059358|NCT01386502|Toxicity|toxicity
5059359|NCT01386502|PD-1 ligand|pd-1 ligand
5059360|NCT01386502|Solid Tumor|solid tumor
5059361|NCT01386502|Breast Cancer|breast cancer
5059362|NCT01386502|Ovarian Cancer|ovarian cancer
5059363|NCT01386502|Pancreatic Cancer|pancreatic cancer
5059364|NCT01386502|Colon Cancer|colon cancer
5059365|NCT01386502|Sarcoma|sarcoma
5059366|NCT01386489|HIV-uninfected|hiv-uninfected
5059367|NCT01386489|Mucosal Immunity|mucosal immunity
5059368|NCT01386489|Kinetics|kinetics
5059369|NCT01386489|Cytokines|cytokines
5059370|NCT01386489|Chemokines|chemokines
5059371|NCT01386489|Healthy Volunteer|healthy volunteer
5059372|NCT01386489|HV|hv
5059373|NCT01386476|5-HT1A Receptors|5-ht1a receptors
5059374|NCT01386476|Blood Brain Barrier|blood brain barrier
5059375|NCT01386476|Drug Resistance|drug resistance
5059376|NCT01386476|Healthy Volunteer|healthy volunteer
5059377|NCT01386476|HV|hv
5059378|NCT01386437|Fungal Infection|fungal infection
5059379|NCT01386437|Immunopathogenesis|immunopathogenesis
5059380|NCT01386437|Genetics|genetics
5059381|NCT01386437|Fungal Infections|fungal infections
5059382|NCT01386437|Mucocutaneous Fungal Infection|mucocutaneous fungal infection
5059383|NCT01386437|Invasive Fungal Infection|invasive fungal infection
5059384|NCT01386424|Influenza|influenza
5059385|NCT01386424|Human|human
5059386|NCT01386424|Challenge Study|challenge study
5059387|NCT01386424|Healthy Volunteer|healthy volunteer
5059388|NCT01386424|HV|hv
5059389|NCT01386411|Genetic testing|genetic testing
5059390|NCT01386411|BRCA testing|brca testing
5059391|NCT01386411|Ashkenazi descent|ashkenazi descent
5059392|NCT01386411|11-086|11-086
5059393|NCT01386398|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
5059394|NCT01386398|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
5059395|NCT01386398|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
5059396|NCT01386398|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
5059397|NCT01386398|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
5059398|NCT01386398|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
5059399|NCT01386398|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5059400|NCT01386398|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5059401|NCT01386372|Hyponatremia|hyponatremia
5059402|NCT01386372|Vasopressin|vasopressin
5059403|NCT01386372|Tolvaptan|tolvaptan
5059404|NCT01386372|SIADH|siadh
5059405|NCT01386346|gastroesophageal junction|gastroesophageal junction
5059406|NCT01386346|GEJ|gej
5059407|NCT01386346|esophageal|esophageal
5059408|NCT01386346|esophagus|esophagus
5059409|NCT01386333|Frontotemporal Dementia|frontotemporal dementia
5059410|NCT01386333|oxytocin|oxytocin
5059411|NCT01386333|Pick's disease|pick's disease
5059412|NCT01386320|anaesthetic techniques, regional; surgery orthopaedic|anaesthetic techniques, regional; surgery orthopaedic
5059413|NCT01386307|Pain|pain
5059414|NCT01386307|Hospitalization|hospitalization
5059415|NCT01386281|Julina|julina
5059416|NCT01386281|Postmenopausal osteoporosis|postmenopausal osteoporosis
5059417|NCT01386268|Kogenate FS|kogenate fs
5059418|NCT01386268|Hemophilia A|hemophilia a
5059419|NCT01386255|GERD|gerd
5059420|NCT01386242|Colorectal Cancer|colorectal cancer
5059421|NCT01386242|Novaferon|novaferon
5059422|NCT01386229|hemodynamic stability|hemodynamic stability
5059423|NCT01386229|etomidate|etomidate
5059424|NCT01386229|ketamine|ketamine
5059425|NCT01386229|coronary artery bypass surgery after induction of anesthesia, hemodynamic stability|coronary artery bypass surgery after induction of anesthesia, hemodynamic stability
5059426|NCT01386216|Critical limb ischemia|critical limb ischemia
5059427|NCT01386216|Peripheral vascular disease|peripheral vascular disease
5059428|NCT01386216|platelet-rich plasma|platelet-rich plasma
5059429|NCT01386203|lung cancer|lung cancer
5059430|NCT01386203|biomarkers|biomarkers
5059431|NCT01386203|breath|breath
5059432|NCT01386203|early detection|early detection
5059433|NCT01386190|preterm infant, body composition, exercise|preterm infant, body composition, exercise
5059434|NCT01386177|MDMA|mdma
5059435|NCT01386177|doxazosin|doxazosin
5059436|NCT01386177|norepinephrine|norepinephrine
5059437|NCT01386177|alpha1- receptor|alpha1- receptor
5059438|NCT01386177|ecstasy|ecstasy
5059439|NCT01386177|stimulants|stimulants
5059440|NCT01386151|Moderate asthmatic, uncontrolled|moderate asthmatic, uncontrolled
5059441|NCT01386138|HIV|hiv
5059442|NCT01386138|HIV Risk|hiv risk
5059443|NCT01386138|Sexually Transmitted Infections|sexually transmitted infections
5059444|NCT01386138|Women|women
5059445|NCT01386138|Pregnancy|pregnancy
5059446|NCT01386138|Neonatal Health|neonatal health
5059447|NCT01386138|Drug Use|drug use
5059448|NCT01386138|Drug Treatment|drug treatment
5059449|NCT01386138|Gender-specific Treatment|gender-specific treatment
5059450|NCT01386138|Methamphetamine|methamphetamine
5059451|NCT01386138|Opioids|opioids
5059452|NCT01386138|Cocaine|cocaine
5059453|NCT01386138|Injection Drugs|injection drugs
5059454|NCT01386138|Stimulants|stimulants
5059455|NCT01386138|Alcohol|alcohol
5059456|NCT01386138|Mandrax|mandrax
5059457|NCT01386138|Marijuana|marijuana
5059458|NCT01386138|Nicotine|nicotine
5059459|NCT01386086|Aripiprazole|aripiprazole
5059460|NCT01386086|adjunctive therapy|adjunctive therapy
5059461|NCT01386086|mood stabilizers|mood stabilizers
5059462|NCT01386086|major depressive disorder|major depressive disorder
5059463|NCT01386086|postpartum|postpartum
5059464|NCT01386086|Augmentation therapy|augmentation therapy
5059465|NCT01386086|resistant|resistant
5059466|NCT01386060|Stress|stress
5059467|NCT01386060|Mindfulness|mindfulness
5059468|NCT01386060|Meditation|meditation
5059469|NCT01386047|Clinical Prediction Rules|clinical prediction rules
5059470|NCT01386047|Electronic Health Records|electronic health records
5059471|NCT01386047|Walsh Clinical Prediction Rule|walsh clinical prediction rule
5059472|NCT01386047|Heckerling Clinical Prediction Rule|heckerling clinical prediction rule
5059473|NCT01386034|Nutrition, protein metabolism, stable isotopes, mass spectrometry, intestinal failure|nutrition, protein metabolism, stable isotopes, mass spectrometry, intestinal failure
5059474|NCT01386021|allograft|allograft
5059475|NCT01386021|coronary|coronary
5059476|NCT01386021|patency|patency
5059477|NCT01386021|morbidity|morbidity
5059478|NCT01385969|overinflation of LMAs|overinflation of lmas
5059479|NCT01385956|metastatic|metastatic
5059480|NCT01385956|locally advanced|locally advanced
5059481|NCT01385956|combination therapy|combination therapy
5059482|NCT01385956|dose escalation|dose escalation
5059483|NCT01385956|epithelial cancer|epithelial cancer
5059484|NCT01385956|adenocarcinoma|adenocarcinoma
5059485|NCT01385956|exocrine pancreas|exocrine pancreas
5059486|NCT01385943|Reflectance Confocal Microscopy|reflectance confocal microscopy
5059487|NCT01385943|Dermoscopy|dermoscopy
5059488|NCT01385943|Clinical Photos|clinical photos
5059489|NCT01385943|Telemedicine|telemedicine
5059490|NCT01385930|Overweight|overweight
5059491|NCT01385930|Obesity|obesity
5059492|NCT01385930|lifestyle counseling|lifestyle counseling
5059493|NCT01385917|Duchenne Muscular Dystrophy|duchenne muscular dystrophy
5059494|NCT01385917|strength and function tests|strength and function tests
5059495|NCT01385917|MRI|mri
5059496|NCT01385878|Microcoaxial phacoemulsification, 1.8mm, 2.2mm|microcoaxial phacoemulsification, 1.8mm, 2.2mm
5059497|NCT01385852|CME|cme
5059498|NCT01385852|OCT|oct
5059499|NCT01385852|Optical coherence tomography|optical coherence tomography
5059500|NCT01385852|macular thickness|macular thickness
5059501|NCT01385839|Alopecia|alopecia
5059502|NCT01385839|Hair transplantation|hair transplantation
5059503|NCT01385839|Needle irritation|needle irritation
5059504|NCT01385839|Medical needling|medical needling
5059505|NCT01385826|Uveitis|uveitis
5059506|NCT01385826|Juvenile arthritis|juvenile arthritis
5059507|NCT01385826|Anti-tumor necrosis factor alpha monoclonal antibody|anti-tumor necrosis factor alpha monoclonal antibody
5059508|NCT01385826|treatment|treatment
5059509|NCT01385813|pre-eclampsia|pre-eclampsia
5059510|NCT01385813|inflammatory markers|inflammatory markers
5059511|NCT01385813|serological biobank|serological biobank
5059602|NCT01385241|Human Immunodeficiency Virus (HIV)|human immunodeficiency virus (hiv)
5059512|NCT01385813|To assess whether the inflammatory markers could be useful|to assess whether the inflammatory markers could be useful
5059513|NCT01385813|in order to identify pregnant women at risk to|in order to identify pregnant women at risk to
5059514|NCT01385813|develop preeclampsia|develop preeclampsia
5059515|NCT01385800|Grass allergy|grass allergy
5059516|NCT01385800|Rhinoconjunctivitis|rhinoconjunctivitis
5059517|NCT01385800|Environmental Exposure Unit|environmental exposure unit
5059518|NCT01385800|Immunotherapy|immunotherapy
5059519|NCT01385800|ToleroMune Grass|toleromune grass
5059520|NCT01385787|Pediatric (ages 0-21 years)|pediatric (ages 0-21 years)
5059521|NCT01385787|myeloablative HCT|myeloablative hct
5059522|NCT01385787|PBMTC sites|pbmtc sites
5059523|NCT01385774|Intermittent Claudication|intermittent claudication
5059524|NCT01385774|Percutaneous Transluminal Angioplasty|percutaneous transluminal angioplasty
5059525|NCT01385774|Supervised Exercise Therapy|supervised exercise therapy
5059526|NCT01385774|Peripheral Arterial Disease|peripheral arterial disease
5059527|NCT01385761|Supraglottic airway devices|supraglottic airway devices
5059528|NCT01385735|Parkinson Disease|parkinson disease
5059529|NCT01385735|Emotion|emotion
5059530|NCT01385735|mood|mood
5059531|NCT01385735|executive function|executive function
5059532|NCT01385709|Lithium|lithium
5059533|NCT01385709|Sertraline|sertraline
5059534|NCT01385683|Healthy volunteer|healthy volunteer
5059535|NCT01385683|Pharmacokinetic|pharmacokinetic
5059536|NCT01385683|pharmacodynamic|pharmacodynamic
5059537|NCT01385683|Polymorphism, Genetic|polymorphism, genetic
5059538|NCT01385670|Patent Foramen Ovale|patent foramen ovale
5059539|NCT01385670|PFO|pfo
5059540|NCT01385644|Mesenchymal stem cells|mesenchymal stem cells
5059541|NCT01385644|Idiopathic pulmonary fibrosis|idiopathic pulmonary fibrosis
5059542|NCT01385631|ST-Segment Elevation Myocardial Infarction|st-segment elevation myocardial infarction
5059543|NCT01385631|Intravascular ultrasound|intravascular ultrasound
5059544|NCT01385631|IVUS|ivus
5059545|NCT01385631|Optical coherence tomography|optical coherence tomography
5059546|NCT01385631|OCT|oct
5059547|NCT01385631|Ezetimibe|ezetimibe
5059548|NCT01385631|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors
5059549|NCT01385631|Atorvastatin|atorvastatin
5059550|NCT01385631|Randomized trial|randomized trial
5059551|NCT01385631|Hypolipidemic Agents|hypolipidemic agents
5059552|NCT01385631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
5059553|NCT01385631|Pharmacologic Actions|pharmacologic actions
5059554|NCT01385631|Enzyme Inhibitors|enzyme inhibitors
5059555|NCT01385631|Lipid Regulating Agents|lipid regulating agents
5059556|NCT01385631|Therapeutic Uses|therapeutic uses
5059557|NCT01385592|Parkinson Disease|parkinson disease
5059558|NCT01385592|L-dopa|l-dopa
5059559|NCT01385592|Levodopa|levodopa
5059560|NCT01385592|Dyskinesia|dyskinesia
5059561|NCT01385592|Anti-Dyskinesia Agents|anti-dyskinesia agents
5059562|NCT01385579|colorectal cancer screening|colorectal cancer screening
5059563|NCT01385579|fecal occult blood testing (FOBT)|fecal occult blood testing (fobt)
5059564|NCT01385579|vulnerable populations|vulnerable populations
5059565|NCT01385579|community health center|community health center
5059566|NCT01385540|Tinnitus, fMRI, task-based fMRI, attention network|tinnitus, fmri, task-based fmri, attention network
5059567|NCT01385488|lymphedema|lymphedema
5059568|NCT01385488|breast cancer|breast cancer
5059569|NCT01385488|self care|self care
5059570|NCT01385488|bioelectrical impedance|bioelectrical impedance
5059571|NCT01385488|monitoring|monitoring
5059572|NCT01385475|Resistance Training|resistance training
5059573|NCT01385475|Physical Function|physical function
5059574|NCT01385475|Older Adults|older adults
5059575|NCT01385449|nerve block|nerve block
5059576|NCT01385449|shoulder surgery|shoulder surgery
5059577|NCT01385449|physical therapy|physical therapy
5059578|NCT01385436|human papillomavirus (HPV)|human papillomavirus (hpv)
5059579|NCT01385436|cervical cancer|cervical cancer
5059580|NCT01385436|high grade cervical squamous intraepithelial lesion (HSIL)|high grade cervical squamous intraepithelial lesion (hsil)
5059581|NCT01385423|acute myelogenous leukemia|acute myelogenous leukemia
5059582|NCT01385423|natural killer cells|natural killer cells
5059583|NCT01385423|haploidentical donor|haploidentical donor
5059584|NCT01385410|breastfeeding exclusively|breastfeeding exclusively
5059585|NCT01385397|Health system organization|health system organization
5059586|NCT01385345|Vitamin D deficiency|vitamin d deficiency
5059587|NCT01385345|Insulin resistance|insulin resistance
5059588|NCT01385332|Metaphase II|metaphase ii
5059589|NCT01385332|Ovarian stimulation|ovarian stimulation
5059590|NCT01385332|Egg donors|egg donors
5059591|NCT01385319|Bare metal stent|bare metal stent
5059592|NCT01385319|zotarolimus eluting stent|zotarolimus eluting stent
5059593|NCT01385319|triple anti-thrombotic therapy|triple anti-thrombotic therapy
5059594|NCT01385319|high bleeding riskduration of dual anti-platelet therapy|high bleeding riskduration of dual anti-platelet therapy
5059595|NCT01385293|BKM120|bkm120
5059596|NCT01385293|prostate cancer|prostate cancer
5059597|NCT01385293|metastatic castrate-resistant prostate cancer (mCRPC)|metastatic castrate-resistant prostate cancer (mcrpc)
5059598|NCT01385254|very low birthweight|very low birthweight
5059599|NCT01385254|premature|premature
5059600|NCT01385254|sibling adjustment|sibling adjustment
5059601|NCT01385254|preterm|preterm
5059604|NCT01385241|Safe disclosure of seropositive status|safe disclosure of seropositive status
5059605|NCT01385241|HIV positive women|hiv positive women
5059606|NCT01385241|Self-efficacy|self-efficacy
5059607|NCT01385228|prostate cancer|prostate cancer
5059608|NCT01385228|metastatic|metastatic
5059609|NCT01385228|pazopanib|pazopanib
5059610|NCT01385228|docetaxel|docetaxel
5059611|NCT01385228|metastatic prostate cancer|metastatic prostate cancer
5059612|NCT01385215|Vaccination|vaccination
5059613|NCT01385215|Mucosal Immunity|mucosal immunity
5059614|NCT01385215|Nasal Immunization|nasal immunization
5059615|NCT01385202|Atrial Fibrillation|atrial fibrillation
5059616|NCT01385202|Paroxysmal Atrial Fibrillation|paroxysmal atrial fibrillation
5059617|NCT01385189|Human Hookworm Vaccine Initiative|human hookworm vaccine initiative
5059618|NCT01385189|HHVI|hhvi
5059619|NCT01385189|Human Hookworm|human hookworm
5059620|NCT01385189|Hookworm|hookworm
5059621|NCT01385189|Hookworm Disease|hookworm disease
5059622|NCT01385189|N. americanus|n. americanus
5059623|NCT01385189|Soil-transmitted helminth infection|soil-transmitted helminth infection
5059624|NCT01385189|Intestinal blood loss|intestinal blood loss
5059625|NCT01385189|Iron deficiency anemia|iron deficiency anemia
5059626|NCT01385176|Heart failure|heart failure
5059627|NCT01385176|Congestive heart failure|congestive heart failure
5059628|NCT01385176|New York Heart Association Class II-III|new york heart association class ii-iii
5059629|NCT01385176|Vagal therapy|vagal therapy
5059630|NCT01385176|Vagal nerve stimulation|vagal nerve stimulation
5059631|NCT01385163|mental health|mental health
5059632|NCT01385163|gender-based violence|gender-based violence
5059633|NCT01385163|Africa|africa
5059634|NCT01385150|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5059635|NCT01385150|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5059636|NCT01385150|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5059637|NCT01385150|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5059638|NCT01385150|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
5059639|NCT01385150|adult acute basophilic leukemia|adult acute basophilic leukemia
5059640|NCT01385150|adult acute eosinophilic leukemia|adult acute eosinophilic leukemia
5059641|NCT01385150|adult erythroleukemia (M6a)|adult erythroleukemia (m6a)
5059642|NCT01385150|adult pure erythroid leukemia (M6b)|adult pure erythroid leukemia (m6b)
5059643|NCT01385150|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
5059644|NCT01385150|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
5059645|NCT01385150|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
5059646|NCT01385150|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
5059647|NCT01385150|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
5059648|NCT01385150|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
5059649|NCT01385137|estrogen receptor-positive breast cancer|estrogen receptor-positive breast cancer
5059650|NCT01385137|progesterone receptor-positive breast cancer|progesterone receptor-positive breast cancer
5059651|NCT01385137|stage I breast cancer|stage i breast cancer
5059652|NCT01385137|stage II breast cancer|stage ii breast cancer
5059653|NCT01385137|stage IIIA breast cancer|stage iiia breast cancer
5059654|NCT01385137|pain|pain
5059655|NCT01385137|arthralgia|arthralgia
5059656|NCT01385124|Cannabidiol|cannabidiol
5059657|NCT01385124|GVHD|gvhd
5059658|NCT01385124|Allogeneic transplantation|allogeneic transplantation
5059659|NCT01385124|Prophylaxis|prophylaxis
5059660|NCT01385111|endobronchial ultrasound|endobronchial ultrasound
5059661|NCT01385111|endoscopic ultrasound|endoscopic ultrasound
5059662|NCT01385111|EBUS-TBNA|ebus-tbna
5059663|NCT01385111|EUS-FNA|eus-fna
5059664|NCT01385111|EUS-B-FNA|eus-b-fna
5059665|NCT01385111|lung cancer|lung cancer
5059666|NCT01385111|staging|staging
5059667|NCT01385098|Vitamin D|vitamin d
5059668|NCT01385098|Bariatric surgery|bariatric surgery
5059669|NCT01385098|Roux-en Y surgery|roux-en y surgery
5059670|NCT01385098|Gastric sleeve surgery|gastric sleeve surgery
5059671|NCT01385098|Parathyroid Hormone|parathyroid hormone
5059672|NCT01385085|Vitamin D|vitamin d
5059673|NCT01385085|Sunlight|sunlight
5059674|NCT01385085|Deficiency|deficiency
5059675|NCT01385072|acute leukemia|acute leukemia
5059676|NCT01385072|relapse|relapse
5059677|NCT01385072|induction failure|induction failure
5059678|NCT01385072|allogeneic transplantation|allogeneic transplantation
5059679|NCT01385072|graft versus leukemia effect|graft versus leukemia effect
5059680|NCT01385046|physical inactivity|physical inactivity
5059681|NCT01385046|poor diet|poor diet
5059682|NCT01385020|Red yeast rice|red yeast rice
5059683|NCT01385020|Gemfibrozil|gemfibrozil
5059684|NCT01385020|Drug-drug interaction|drug-drug interaction
5059685|NCT01385020|Pharmacokinetics|pharmacokinetics
5059686|NCT01385007|Rural|rural
5059687|NCT01385007|Veterans|veterans
5059688|NCT01385007|Dementia|dementia
5059689|NCT01385007|Pain|pain
5059690|NCT01385007|Aggression|aggression
5059691|NCT01385007|residence in a VA designated rural area|residence in a va designated rural area
5059692|NCT01385007|presence of a caregiver|presence of a caregiver
5059693|NCT01384994|Colorectal Cancer|colorectal cancer
5059694|NCT01384994|PARLIM|parlim
5059695|NCT01384994|KRAS Wildtype|kras wildtype
5059696|NCT01384994|Liver metastases|liver metastases
5059697|NCT01384981|chronic obstructive pulmonary rehabilitation|chronic obstructive pulmonary rehabilitation
5059698|NCT01384981|COPD|copd
5059699|NCT01384981|non invasive ventilation|non invasive ventilation
5059700|NCT01384981|NIV|niv
5059701|NCT01384981|exercise capacity|exercise capacity
5059702|NCT01384981|pulmonary rehabilitation|pulmonary rehabilitation
5059703|NCT01384968|nitrite|nitrite
5059704|NCT01384968|exercise|exercise
5059705|NCT01384968|cycling|cycling
5059706|NCT01384955|scoliosis|scoliosis
5059707|NCT01384955|physical therapy|physical therapy
5059708|NCT01384955|long term outcome|long term outcome
5059709|NCT01384955|pulmonary function|pulmonary function
5059710|NCT01384955|physical fitness|physical fitness
5059711|NCT01384955|health related quality of life|health related quality of life
5059712|NCT01384955|psychopathology|psychopathology
5059713|NCT01384942|Bereavement|bereavement
5059714|NCT01384942|Grief|grief
5059715|NCT01384942|Mourning|mourning
5059716|NCT01384942|Loss|loss
5059717|NCT01384942|Death|death
5059718|NCT01384942|Meaning|meaning
5059719|NCT01384942|Group|group
5059720|NCT01384942|Counseling|counseling
5059721|NCT01384942|Psychotherapy|psychotherapy
5059722|NCT01384942|Uncomplicated|uncomplicated
5059723|NCT01384942|Support|support
5059724|NCT01384916|depression|depression
5059725|NCT01384916|yoga|yoga
5059726|NCT01384916|health education|health education
5059727|NCT01384916|antidepressant|antidepressant
5059728|NCT01384877|Pain|pain
5059729|NCT01384877|Cancer|cancer
5059730|NCT01384877|Lidocaine|lidocaine
5059731|NCT01384877|Sodium Channel Blockers|sodium channel blockers
5059732|NCT01384864|barrett's esophagus|barrett's esophagus
5059733|NCT01384864|intraepithelial neoplasia|intraepithelial neoplasia
5059734|NCT01384864|cross polarized reflectance examination|cross polarized reflectance examination
5059735|NCT01384864|vital-dye enhanced fluorescence examination|vital-dye enhanced fluorescence examination
5059736|NCT01384838|breast cancer|breast cancer
5059737|NCT01384838|physical activity|physical activity
5059738|NCT01384838|sports|sports
5059739|NCT01384838|exercise|exercise
5059740|NCT01384825|Multiple Sclerosis|multiple sclerosis
5059741|NCT01384825|Other Neurodegenerative Diseases|other neurodegenerative diseases
5059742|NCT01384825|Chronic CerebroSpinal Venous Insufficiency|chronic cerebrospinal venous insufficiency
5059743|NCT01384825|Prevalence|prevalence
5059744|NCT01384825|Case-control|case-control
5059745|NCT01384773|Keratoconus|keratoconus
5059746|NCT01384773|Ectasia|ectasia
5059747|NCT01384773|UVA light|uva light
5059748|NCT01384773|riboflavin|riboflavin
5059749|NCT01384773|post-LASIK (laser in situ keratomileusis)|post-lasik (laser in situ keratomileusis)
5059750|NCT01384773|pellucid marginal degeneration|pellucid marginal degeneration
5059751|NCT01384773|irregular astigmatism|irregular astigmatism
5059752|NCT01384721|Computed Tomography Coronary Angiography|computed tomography coronary angiography
5059753|NCT01384721|Coronary Artery Disease|coronary artery disease
5059754|NCT01384721|Prevalence Of Disease|prevalence of disease
5059755|NCT01384721|Prognosis|prognosis
5059756|NCT01384721|Risk Stratification|risk stratification
5059757|NCT01384708|squamous cell cancer|squamous cell cancer
5059758|NCT01384708|squamous cell neoplasia|squamous cell neoplasia
5059759|NCT01384695|Barrett's esophagus|barrett's esophagus
5059760|NCT01384695|confocal microendoscopy|confocal microendoscopy
5059761|NCT01384617|distal pancreatectomy|distal pancreatectomy
5059762|NCT01384617|pancreatic fistula|pancreatic fistula
5059763|NCT01384617|pancreaticojejunostomy|pancreaticojejunostomy
5059764|NCT01384617|Roux-en-Y anastomosis|roux-en-y anastomosis
5059765|NCT01384617|stapling closure|stapling closure
5059766|NCT01384604|Schizophrenia|schizophrenia
5059767|NCT01384604|Schizoaffective disorder|schizoaffective disorder
5059768|NCT01384604|Bipolar disorder|bipolar disorder
5059769|NCT01384604|Psychosis|psychosis
5059770|NCT01384604|Genetics|genetics
5059771|NCT01384604|Phenotype|phenotype
5059772|NCT01384591|oxidative stress|oxidative stress
5059773|NCT01384591|blood flow|blood flow
5059774|NCT01384591|antioxidant|antioxidant
5059775|NCT01384591|muscle|muscle
5059776|NCT01384591|elderly|elderly
5059777|NCT01384552|normal weight|normal weight
5059778|NCT01384552|overweight|overweight
5059779|NCT01384552|dietary restraint|dietary restraint
5059780|NCT01384552|package unit size|package unit size
5059781|NCT01384552|food intake|food intake
5059782|NCT01384539|chronic kidney disease|chronic kidney disease
5059783|NCT01384539|vitamin D deficiency|vitamin d deficiency
5059784|NCT01384526|hormone therapy|hormone therapy
5059785|NCT01384526|ovarian aging|ovarian aging
5059786|NCT01384526|ovarian reserve|ovarian reserve
5059787|NCT01384526|fertility|fertility
5059788|NCT01384526|breast cancer|breast cancer
5059789|NCT01384513|Allogeneic HSCT|allogeneic hsct
5059790|NCT01384513|Hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
5059791|NCT01384487|Viewing and axial cross sectional imaging of ocular|viewing and axial cross sectional imaging of ocular
5059990|NCT01383538|Irinotecan|irinotecan
5059792|NCT01384487|structures, including the anterior chamber|structures, including the anterior chamber
5059793|NCT01384474|Crew Resource Management|crew resource management
5059794|NCT01384474|Surgical safety checklist|surgical safety checklist
5059795|NCT01384474|Postoperative complications|postoperative complications
5059796|NCT01384448|stress echocardiography|stress echocardiography
5059797|NCT01384448|coronary ct angiography|coronary ct angiography
5059798|NCT01384435|Spinocerebellar degeneration (SCD)|spinocerebellar degeneration (scd)
5059799|NCT01384435|Thyrotropin-Releasing Hormone (TRH)|thyrotropin-releasing hormone (trh)
5059800|NCT01384422|methotrexate-refractory|methotrexate-refractory
5059801|NCT01384383|Chronic Hepatitis C|chronic hepatitis c
5059802|NCT01384383|IL28B CC Genotype|il28b cc genotype
5059803|NCT01384383|Treatment naive|treatment naive
5059804|NCT01384383|Peginterferon α-2a (PEG)|peginterferon α-2a (peg)
5059805|NCT01384383|Genotype 1a/b|genotype 1a/b
5059806|NCT01384383|GS 9451|gs 9451
5059807|NCT01384383|GS 5885|gs 5885
5059808|NCT01384383|Ribavirin (RBV)|ribavirin (rbv)
5059809|NCT01384383|HCV NS5A inhibitor|hcv ns5a inhibitor
5059810|NCT01384383|HCV NS3 protease inhibitor|hcv ns3 protease inhibitor
5059811|NCT01384357|lymphadenopathy|lymphadenopathy
5059812|NCT01384357|needle biopsy|needle biopsy
5059813|NCT01384357|sonography|sonography
5059814|NCT01384331|Implanon users|implanon users
5059815|NCT01384331|Frequent bleeding|frequent bleeding
5059816|NCT01384331|Prolonged bleeding|prolonged bleeding
5059817|NCT01384331|Comparison of treatments|comparison of treatments
5059818|NCT01384331|Placebo controlled|placebo controlled
5059819|NCT01384331|Randomly allocated tretment|randomly allocated tretment
5059820|NCT01384292|Cancer-Related Pain|cancer-related pain
5059821|NCT01384292|Opioid-Induced Constipation|opioid-induced constipation
5059822|NCT01384292|OIC|oic
5059823|NCT01384279|metformin|metformin
5059824|NCT01384279|topiramate|topiramate
5059825|NCT01384279|obesity|obesity
5059826|NCT01384279|metabolic syndrome|metabolic syndrome
5059827|NCT01384266|Intraocular Inflammation following routine Cataract Surgery|intraocular inflammation following routine cataract surgery
5059828|NCT01384253|HER2+|her2+
5059829|NCT01384253|HER-2 positive|her-2 positive
5059830|NCT01384253|intraperitoneal|intraperitoneal
5059831|NCT01384253|intra-abdominal|intra-abdominal
5059832|NCT01384253|Lead 212|lead 212
5059833|NCT01384253|Radio Immunotherapy|radio immunotherapy
5059834|NCT01384253|Alpha particle|alpha particle
5059835|NCT01384253|Antibodies|antibodies
5059836|NCT01384253|Immunoglobulins|immunoglobulins
5059837|NCT01384253|Antibodies, Monoclonal|antibodies, monoclonal
5059838|NCT01384253|Immunologic Factors|immunologic factors
5059839|NCT01384253|Physiological Effects of Drugs|physiological effects of drugs
5059840|NCT01384253|Pharmacologic Actions|pharmacologic actions
5059841|NCT01384253|RIT|rit
5059842|NCT01384240|colon polyps|colon polyps
5059843|NCT01384240|colonic dysplasia|colonic dysplasia
5059844|NCT01384240|anal dysplasia|anal dysplasia
5059845|NCT01384240|microendoscopy|microendoscopy
5059846|NCT01384227|Barrett's esophagus|barrett's esophagus
5059847|NCT01384227|in vivo imaging|in vivo imaging
5059848|NCT01384227|image guide microscope|image guide microscope
5059849|NCT01384201|intestinal metaplasia, gastric cancer|intestinal metaplasia, gastric cancer
5059850|NCT01384175|Epidural Analgesia|epidural analgesia
5059851|NCT01384175|OPCAB|opcab
5059852|NCT01384175|PCEA|pcea
5059853|NCT01384162|ALS|als
5059854|NCT01384162|VEGF165|vegf165
5059855|NCT01384162|Safety|safety
5059856|NCT01384162|Intracerebroventricular|intracerebroventricular
5059857|NCT01384162|Infusion|infusion
5059858|NCT01384162|Implantable|implantable
5059859|NCT01384149|intra ocular pressure|intra ocular pressure
5059860|NCT01384149|open angle glaucoma|open angle glaucoma
5059861|NCT01384149|selective laser trabeculoplasty|selective laser trabeculoplasty
5059862|NCT01384149|external laser treatment|external laser treatment
5059863|NCT01384123|stable pulmonary sarcoidosis with no change in medication during the last 3 months/|stable pulmonary sarcoidosis with no change in medication during the last 3 months/
5059864|NCT01384110|Amylase|amylase
5059865|NCT01384110|Glucosidase|glucosidase
5059866|NCT01384110|Glycemic response|glycemic response
5059867|NCT01384110|Sucrose|sucrose
5059868|NCT01384110|Seaweed|seaweed
5059869|NCT01384097|haemodynamic|haemodynamic
5059870|NCT01384097|goal-directed therapy|goal-directed therapy
5059871|NCT01384097|surgery|surgery
5059872|NCT01384097|anaesthesia|anaesthesia
5059873|NCT01384084|pelvic organ prolapse|pelvic organ prolapse
5059874|NCT01384084|urinary incontinence|urinary incontinence
5059875|NCT01384084|sacropexy|sacropexy
5059876|NCT01384084|sling|sling
5059877|NCT01384071|Low back pain|low back pain
5059878|NCT01384071|Unstable shoes|unstable shoes
5059879|NCT01384071|Gait|gait
5059880|NCT01384071|Balance|balance
5059881|NCT01384058|atherogenic lipoprotein|atherogenic lipoprotein
5059882|NCT01384058|cardiovascular disease|cardiovascular disease
5059883|NCT01384058|coronary artery disease|coronary artery disease
5059884|NCT01384058|type 2 diabetes|type 2 diabetes
5059885|NCT01384058|small, dense LDL|small, dense ldl
5059886|NCT01384045|Type II Diabetes|type ii diabetes
5059887|NCT01384045|Diabetes|diabetes
5059888|NCT01384032|CVD, LDL-C, apoE, SFA, DHA|cvd, ldl-c, apoe, sfa, dha
5059889|NCT01384019|ST-elevation myocardial infarction|st-elevation myocardial infarction
5059890|NCT01384019|percutaneous coronary intervention|percutaneous coronary intervention
5059891|NCT01384019|cardiac magnetic resonance imaging|cardiac magnetic resonance imaging
5059892|NCT01384019|microvascular occlusion|microvascular occlusion
5059893|NCT01384019|myocardial salvage|myocardial salvage
5059894|NCT01384006|Pancreas transplantation|pancreas transplantation
5059895|NCT01384006|extended donor criteria|extended donor criteria
5059896|NCT01384006|organ survival|organ survival
5059897|NCT01383993|Open-Label|open-label
5059898|NCT01383993|Pharmacokinetics|pharmacokinetics
5059899|NCT01383993|Intravenous to oral switch|intravenous to oral switch
5059900|NCT01383993|Safety|safety
5059901|NCT01383993|Voriconazole|voriconazole
5059902|NCT01383993|Immunocompromise|immunocompromise
5059903|NCT01383993|Children|children
5059904|NCT01383993|High Risk For Systemic Fungal Infection|high risk for systemic fungal infection
5059905|NCT01383980|Enteral Nutrition|enteral nutrition
5059906|NCT01383980|Enteral Feeding|enteral feeding
5059907|NCT01383980|nasogastric tubes|nasogastric tubes
5059908|NCT01383980|gastrostomy tubes|gastrostomy tubes
5059909|NCT01383980|jejunostomy tubes|jejunostomy tubes
5059910|NCT01383954|Knee osteoarthritis|knee osteoarthritis
5059911|NCT01383941|asthma|asthma
5059912|NCT01383941|rhinitis|rhinitis
5059913|NCT01383941|difficult-to-treat asthmatic|difficult-to-treat asthmatic
5059914|NCT01383941|phenotypes|phenotypes
5059915|NCT01383889|Physical exercise|physical exercise
5059916|NCT01383889|Pregnancy|pregnancy
5059917|NCT01383889|Fetal well being|fetal well being
5059918|NCT01383876|cervical|cervical
5059919|NCT01383876|laminectomy|laminectomy
5059920|NCT01383876|fusion|fusion
5059921|NCT01383876|neurological compression|neurological compression
5059922|NCT01383876|spondylosis|spondylosis
5059923|NCT01383850|preterm infants|preterm infants
5059924|NCT01383850|nasal continuous positive airway pressure|nasal continuous positive airway pressure
5059925|NCT01383850|heliox|heliox
5059926|NCT01383850|bronchopulmonary dysplasia.|bronchopulmonary dysplasia.
5059927|NCT01383837|HIV/STI|hiv/sti
5059928|NCT01383837|Prevention|prevention
5059929|NCT01383837|Adolescents|adolescents
5059930|NCT01383837|Substance Use Disorders|substance use disorders
5059931|NCT01383837|Family-based intervention|family-based intervention
5059932|NCT01383824|Hip Replacement|hip replacement
5059933|NCT01383824|Femoral Component|femoral component
5059934|NCT01383811|Treatment Resistant Depression|treatment resistant depression
5059935|NCT01383811|Exercise|exercise
5059936|NCT01383798|iron deficiency, physical performance, female athletes|iron deficiency, physical performance, female athletes
5059937|NCT01383785|Primary PTCA|primary ptca
5059938|NCT01383785|Thrombus Aspiration Catheter|thrombus aspiration catheter
5059939|NCT01383785|Intracoronary Abciximab|intracoronary abciximab
5059940|NCT01383772|Proliferative diabetic retinopathy|proliferative diabetic retinopathy
5059941|NCT01383772|Pan retinal photocoagulation|pan retinal photocoagulation
5059942|NCT01383772|Multi-spot Photocoagulator|multi-spot photocoagulator
5059943|NCT01383772|Visual field tests|visual field tests
5059944|NCT01383759|BORTEZOMIB (VELCADE)|bortezomib (velcade)
5059945|NCT01383759|CYCLOPHOSPHAMIDE (CYTOXAN)|cyclophosphamide (cytoxan)
5059946|NCT01383759|DEXAMETHASONE|dexamethasone
5059947|NCT01383759|MELPHALAN|melphalan
5059948|NCT01383759|11-061|11-061
5059949|NCT01383746|Cholangiocarcinoma|cholangiocarcinoma
5059950|NCT01383746|RADIOEMBOLIZATION|radioembolization
5059951|NCT01383746|tumor response|tumor response
5059952|NCT01383746|progression-free survival|progression-free survival
5059953|NCT01383746|safety|safety
5059954|NCT01383746|second-line therapy|second-line therapy
5059955|NCT01383720|Aortic Valve Stenosis|aortic valve stenosis
5059956|NCT01383720|Transcatheter Aortic Valve Replacement|transcatheter aortic valve replacement
5059957|NCT01383655|wheezy bronchitis|wheezy bronchitis
5059958|NCT01383655|asthma|asthma
5059959|NCT01383655|rhinovirus|rhinovirus
5059960|NCT01383655|magnesium|magnesium
5059961|NCT01383629|Vitrectomy|vitrectomy
5059962|NCT01383629|Local anaesthesia|local anaesthesia
5059963|NCT01383629|Counselling|counselling
5059964|NCT01383629|Fear|fear
5059965|NCT01383629|Visual perception|visual perception
5059966|NCT01383616|osteoporosis|osteoporosis
5059967|NCT01383616|vertebral compression fractures|vertebral compression fractures
5059968|NCT01383603|Cat Allergy|cat allergy
5059969|NCT01383603|Rhinoconjunctivitis|rhinoconjunctivitis
5059970|NCT01383603|Immunotherapy|immunotherapy
5059971|NCT01383603|Cat-PAD|cat-pad
5059972|NCT01383590|Cat allergy|cat allergy
5059973|NCT01383590|Rhinoconjunctivitis|rhinoconjunctivitis
5059974|NCT01383590|Immunotherapy|immunotherapy
5059975|NCT01383590|Cat-PAD|cat-pad
5059976|NCT01383577|Hemorrhoids|hemorrhoids
5059977|NCT01383577|Ligation|ligation
5059978|NCT01383577|Pain|pain
5059979|NCT01383577|Morbidity|morbidity
5059980|NCT01383577|Patient Satisfaction|patient satisfaction
5059981|NCT01383577|Cost-Benefit Analysis|cost-benefit analysis
5059982|NCT01383551|Depression|depression
5059983|NCT01383551|Marital relationship|marital relationship
5059984|NCT01383551|Parental competence|parental competence
5059985|NCT01383538|pancreas|pancreas
5059986|NCT01383538|cancer|cancer
5059987|NCT01383538|adenocarcinoma|adenocarcinoma
5059988|NCT01383538|Oxaliplatin|oxaliplatin
5059991|NCT01383538|5-FU|5-fu
5059992|NCT01383538|IPI-926|ipi-926
5059993|NCT01383525|SLT, LTP|slt, ltp
5059994|NCT01383525|non contact|non contact
5059995|NCT01383525|Trabeculoplasty|trabeculoplasty
5059996|NCT01383525|Laser|laser
5059997|NCT01383525|intraocular pressure|intraocular pressure
5059998|NCT01383512|stroke|stroke
5059999|NCT01383512|rehabilitation|rehabilitation
5060000|NCT01383512|robotics|robotics
5060001|NCT01383512|motor control|motor control
5060002|NCT01383512|upper limb|upper limb
5060003|NCT01383486|Self Selection Tria|self selection tria
5060004|NCT01383473|cancer therapy|cancer therapy
5060005|NCT01383473|school attendance|school attendance
5060006|NCT01383473|cancer diagnosis|cancer diagnosis
5060007|NCT01383473|perception|perception
5060008|NCT01383460|Acute-on-chronic liver failure|acute-on-chronic liver failure
5060009|NCT01383460|ACLF|aclf
5060010|NCT01383460|cirrhosis|cirrhosis
5060011|NCT01383460|acute hepatitis|acute hepatitis
5060012|NCT01383421|Rheumatoid Arthritis|rheumatoid arthritis
5060013|NCT01383421|Patient Support Program|patient support program
5060014|NCT01383421|adalimumab|adalimumab
5060015|NCT01383408|breath sample analysis|breath sample analysis
5060016|NCT01383408|exhalation analysis|exhalation analysis
5060017|NCT01383408|volatile organic compounds|volatile organic compounds
5060018|NCT01383408|screening|screening
5060019|NCT01383408|lung cancer|lung cancer
5060020|NCT01383408|breast cancer|breast cancer
5060021|NCT01383408|ovarian cancer|ovarian cancer
5060022|NCT01383408|canine scent detection|canine scent detection
5060023|NCT01383382|Heart Diseases|heart diseases
5060024|NCT01383382|Cardiovascular Diseases|cardiovascular diseases
5060025|NCT01383382|Acute Myocardial Infarction|acute myocardial infarction
5060026|NCT01383382|Decision Making|decision making
5060027|NCT01383382|Percutaneous Coronary Intervention|percutaneous coronary intervention
5060028|NCT01383382|Informed Consent|informed consent
5060029|NCT01383382|Quality of Care|quality of care
5060030|NCT01383330|megesterol|megesterol
5060031|NCT01383317|Remote Ischemic Preconditioning|remote ischemic preconditioning
5060032|NCT01383317|Acute Pain|acute pain
5060033|NCT01383304|Platelet aggregation|platelet aggregation
5060034|NCT01383304|Aspirin|aspirin
5060035|NCT01383304|Drug resistance|drug resistance
5060036|NCT01383304|Thromboxane B2|thromboxane b2
5060037|NCT01383304|Pharmacologic Actions|pharmacologic actions
5060038|NCT01383304|Platelet Aggregation Inhibitors|platelet aggregation inhibitors
5060039|NCT01383291|pelvic floor prolapse|pelvic floor prolapse
5060040|NCT01383291|prolift|prolift
5060041|NCT01383291|IVS|ivs
5060042|NCT01383291|Surgery|surgery
5060043|NCT01383278|tobacco|tobacco
5060044|NCT01383278|smoking|smoking
5060045|NCT01383278|smoking cessation|smoking cessation
5060046|NCT01383265|screening colonoscopy|screening colonoscopy
5060047|NCT01383265|adenoma|adenoma
5060048|NCT01383265|water method|water method
5060049|NCT01383252|water method|water method
5060050|NCT01383252|air method|air method
5060051|NCT01383252|unsedated colonoscopy|unsedated colonoscopy
5060052|NCT01383252|adenoma detection|adenoma detection
5060053|NCT01383239|Rotator Cuff Tear Repair|rotator cuff tear repair
5060054|NCT01383239|Rotator Cuff Tear Repair and postoperative treatment|rotator cuff tear repair and postoperative treatment
5060055|NCT01383226|endosonography|endosonography
5060056|NCT01383226|enlarged thoracic lymph adenopathies|enlarged thoracic lymph adenopathies
5060057|NCT01383226|non-cancer patient|non-cancer patient
5060058|NCT01383213|Acute Respiratory Failure|acute respiratory failure
5060059|NCT01383213|Pneumonia|pneumonia
5060060|NCT01383213|Continuous Positive Airway Pressure|continuous positive airway pressure
5060061|NCT01383200|efficacy|efficacy
5060062|NCT01383200|comfort|comfort
5060063|NCT01383187|Deep Burn Trauma|deep burn trauma
5060064|NCT01383187|Dermo-Epidermal Graft|dermo-epidermal graft
5060065|NCT01383187|Platelet Rich Plasma Concentrate (PRP)|platelet rich plasma concentrate (prp)
5060066|NCT01383187|Vancouver Scar Score|vancouver scar score
5060067|NCT01383187|Scarring|scarring
5060068|NCT01383187|Hypertrophic Scarring|hypertrophic scarring
5060069|NCT01383174|Breast cancer|breast cancer
5060070|NCT01383174|Latinas|latinas
5060071|NCT01383174|Peer support counselor|peer support counselor
5060072|NCT01383174|Spanish speaking|spanish speaking
5060073|NCT01383174|Community based|community based
5060074|NCT01383161|Curcumin|curcumin
5060075|NCT01383161|Turmeric|turmeric
5060076|NCT01383161|Memory|memory
5060077|NCT01383161|Cognitive Impairment|cognitive impairment
5060078|NCT01383161|Brain Imaging|brain imaging
5060079|NCT01383161|Supplement|supplement
5060080|NCT01383148|NSCLC|nsclc
5060081|NCT01383135|Healthy volunteers|healthy volunteers
5060082|NCT01383122|Pulsed electromagnetic field device|pulsed electromagnetic field device
5060083|NCT01383122|Cesarean section|cesarean section
5060084|NCT01383109|Mass Balance|mass balance
5060085|NCT01383109|Accelerated Mass Spectrometry (AMS)|accelerated mass spectrometry (ams)
5060086|NCT01383109|microdose|microdose
5060087|NCT01383109|Focus of the study: ADME|focus of the study: adme
5060088|NCT01383096|OZ439|oz439
5060089|NCT01383096|Bioavailability|bioavailability
5060090|NCT01383096|Food Effect|food effect
5060181|NCT01382576|chitotriosidase activity|chitotriosidase activity
5060091|NCT01383083|Pulmonary arterial hypertension|pulmonary arterial hypertension
5060092|NCT01383083|Congenital heart disease|congenital heart disease
5060093|NCT01383083|Eisenmenger physiology|eisenmenger physiology
5060094|NCT01383070|Timely initiation of breast feeding|timely initiation of breast feeding
5060095|NCT01383070|Exclusive breast feeding|exclusive breast feeding
5060096|NCT01383070|Timely introduction of complimentary feeding|timely introduction of complimentary feeding
5060097|NCT01383070|Breast Feeding, Exclusive|breast feeding, exclusive
5060098|NCT01383070|Childbirth and the Puerperium|childbirth and the puerperium
5060099|NCT01383044|Carvedilol|carvedilol
5060100|NCT01383044|Banding ligation with Carvedilol|banding ligation with carvedilol
5060101|NCT01383044|the efficacy & safety of combining EVL and carvedilol in prevention of first variceal bleeding|the efficacy & safety of combining evl and carvedilol in prevention of first variceal bleeding
5060102|NCT01383031|laparoscopic cholecystectomy|laparoscopic cholecystectomy
5060103|NCT01383031|single site|single site
5060104|NCT01383031|randomized controlled trail|randomized controlled trail
5060105|NCT01383018|Erectile Dysfunction (ED)|erectile dysfunction (ed)
5060106|NCT01383018|Penile Implant|penile implant
5060107|NCT01383018|Impotence|impotence
5060108|NCT01383018|Penile Prosthesis|penile prosthesis
5060109|NCT01383018|Registry|registry
5060110|NCT01383005|Treatment satisfaction|treatment satisfaction
5060111|NCT01383005|Adherence to treatment|adherence to treatment
5060112|NCT01382992|Carcinoma, Non-Small-Cell Lung|carcinoma, non-small-cell lung
5060113|NCT01382992|erbB-1|erbb-1
5060114|NCT01382979|Alcohol misuse prevention|alcohol misuse prevention
5060115|NCT01382979|College students|college students
5060116|NCT01382979|Intervention and control|intervention and control
5060117|NCT01382966|sclerostin|sclerostin
5060118|NCT01382966|arteriovenous fistula thrombosis|arteriovenous fistula thrombosis
5060119|NCT01382966|carpal tunnel syndrome|carpal tunnel syndrome
5060120|NCT01382966|echocardiography|echocardiography
5060121|NCT01382953|Holter Monitor, Ambulatory Electrocardiography Monitoring|holter monitor, ambulatory electrocardiography monitoring
5060122|NCT01382888|Haemodialysis|haemodialysis
5060123|NCT01382888|Arteriovenous fistula|arteriovenous fistula
5060124|NCT01382888|Severe chronic kidney disease|severe chronic kidney disease
5060125|NCT01382888|Newly constructed primary arteriovenous fistulas in patients planned for haemodialysis|newly constructed primary arteriovenous fistulas in patients planned for haemodialysis
5060126|NCT01382875|Multi-disciplinary management program|multi-disciplinary management program
5060127|NCT01382875|Conventional care program|conventional care program
5060128|NCT01382875|Balance Ability|balance ability
5060129|NCT01382875|Quality of Life|quality of life
5060130|NCT01382862|acute ischemic stroke|acute ischemic stroke
5060131|NCT01382862|thrombolysis|thrombolysis
5060132|NCT01382862|prehospital|prehospital
5060133|NCT01382862|emergency medicine|emergency medicine
5060134|NCT01382862|suspected acute stroke|suspected acute stroke
5060135|NCT01382862|telemedicine|telemedicine
5060136|NCT01382849|amyloid|amyloid
5060137|NCT01382849|cerebral amyloid angiopathy|cerebral amyloid angiopathy
5060138|NCT01382849|hemorrhages|hemorrhages
5060139|NCT01382849|cerebral spot sign|cerebral spot sign
5060140|NCT01382810|dry eye signs and symptoms|dry eye signs and symptoms
5060141|NCT01382771|low back pain|low back pain
5060142|NCT01382771|zygapophysial joint pain|zygapophysial joint pain
5060143|NCT01382771|medial branch block|medial branch block
5060144|NCT01382771|> 6 months duration|> 6 months duration
5060145|NCT01382771|non-radicular|non-radicular
5060146|NCT01382758|Near Infrared Spectroscopy (NIRS)|near infrared spectroscopy (nirs)
5060147|NCT01382758|Acute kidney injury (AKI)|acute kidney injury (aki)
5060148|NCT01382732|Pre-eclampsia|pre-eclampsia
5060149|NCT01382732|Postpartum hemorrhage|postpartum hemorrhage
5060150|NCT01382732|Carbetocin|carbetocin
5060151|NCT01382732|Oxytocin|oxytocin
5060152|NCT01382719|FSAD|fsad
5060153|NCT01382719|HSDD|hsdd
5060154|NCT01382719|female sexual dysfunction|female sexual dysfunction
5060155|NCT01382719|FSD|fsd
5060156|NCT01382719|Female Sexual Arousal Disorder|female sexual arousal disorder
5060157|NCT01382719|Hypoactive Sexual Desire Disorder|hypoactive sexual desire disorder
5060158|NCT01382693|Behavioral symptoms|behavioral symptoms
5060159|NCT01382693|Long-term care|long-term care
5060160|NCT01382667|mucositis|mucositis
5060161|NCT01382667|dyspepsia|dyspepsia
5060162|NCT01382667|chemotherapy|chemotherapy
5060163|NCT01382667|GLP-2|glp-2
5060164|NCT01382667|questionnaire|questionnaire
5060165|NCT01382641|Cataract surgery|cataract surgery
5060166|NCT01382628|Diabetes|diabetes
5060167|NCT01382628|Ulcers|ulcers
5060168|NCT01382628|Equinus Deformity|equinus deformity
5060169|NCT01382628|Amputation|amputation
5060170|NCT01382628|Achilles Tendon|achilles tendon
5060171|NCT01382628|Limb Loss|limb loss
5060172|NCT01382615|Multiple Myeloma|multiple myeloma
5060173|NCT01382602|Urinary Incontinence, Stress|urinary incontinence, stress
5060174|NCT01382602|Tissue Therapy (Cell Therapy)|tissue therapy (cell therapy)
5060175|NCT01382602|Transplantation, Autologous|transplantation, autologous
5060176|NCT01382589|vitiligo|vitiligo
5060177|NCT01382589|depigmentation|depigmentation
5060178|NCT01382589|phototherapy|phototherapy
5060179|NCT01382589|non-segmental vitiligo|non-segmental vitiligo
5060180|NCT01382576|polycystic ovary syndrome|polycystic ovary syndrome
5060182|NCT01382563|Eosinophilic Gastrointestinal Disorders|eosinophilic gastrointestinal disorders
5060183|NCT01382563|EGID|egid
5060184|NCT01382563|Eosinophilic Esophagitis|eosinophilic esophagitis
5060185|NCT01382563|Registry|registry
5060186|NCT01382563|Eosinophils|eosinophils
5060187|NCT01382563|Eosinophilia|eosinophilia
5060188|NCT01382563|Eosinophilic enteropathy|eosinophilic enteropathy
5060189|NCT01382563|Eosinophilic enteritis|eosinophilic enteritis
5060190|NCT01382563|Eosinophilic gastritis|eosinophilic gastritis
5060191|NCT01382563|Eosinophilic gastroenteritis|eosinophilic gastroenteritis
5060192|NCT01382563|Eosinophilic gastroenteropathy|eosinophilic gastroenteropathy
5060193|NCT01382550|antithrombin|antithrombin
5060194|NCT01382550|venous thrombosis|venous thrombosis
5060195|NCT01382550|thrombosis risk factors|thrombosis risk factors
5060196|NCT01382550|thrombophilia|thrombophilia
5060197|NCT01382537|Neck|neck
5060198|NCT01382537|Chronic|chronic
5060199|NCT01382537|Musculoskeletal|musculoskeletal
5060200|NCT01382537|Shoulder|shoulder
5060201|NCT01382524|PIV therapy|piv therapy
5060202|NCT01382498|Endothelin-1 high sensitivity CRP|endothelin-1 high sensitivity crp
5060203|NCT01382485|non union|non union
5060204|NCT01382485|bone defect|bone defect
5060205|NCT01382485|tibia non union|tibia non union
5060206|NCT01382485|femur non union|femur non union
5060207|NCT01382485|bone graft|bone graft
5060208|NCT01382472|STEMI|stemi
5060209|NCT01382472|PPCI|ppci
5060210|NCT01382472|Statins|statins
5060211|NCT01382472|Infarct size|infarct size
5060212|NCT01382459|children|children
5060213|NCT01382446|Trauma|trauma
5060214|NCT01382446|Mechanical Ventilation|mechanical ventilation
5060215|NCT01382446|Ventilator Associated Pneumonia|ventilator associated pneumonia
5060216|NCT01382446|Oral Care|oral care
5060217|NCT01382433|Chronic Cannabis Users|chronic cannabis users
5060218|NCT01382433|negative symptoms|negative symptoms
5060219|NCT01382433|cognitive electrophysiology functions|cognitive electrophysiology functions
5060220|NCT01382420|subclinical cushing syndrome|subclinical cushing syndrome
5060221|NCT01382420|hypercortisolism|hypercortisolism
5060222|NCT01382420|adrenal incidentaloma|adrenal incidentaloma
5060223|NCT01382420|adrenalectomy|adrenalectomy
5060224|NCT01382407|skin rash reaction|skin rash reaction
5060225|NCT01382407|ERBITUX® (cetuximab)|erbitux® (cetuximab)
5060226|NCT01382407|acne|acne
5060227|NCT01382394|Sepsis|sepsis
5060228|NCT01382394|heart failure|heart failure
5060229|NCT01382394|BNP|bnp
5060230|NCT01382394|IL-6|il-6
5060231|NCT01382394|Procalcitonin|procalcitonin
5060232|NCT01382394|Prognosis|prognosis
5060233|NCT01382368|Post Pneumonectomy Patients|post pneumonectomy patients
5060234|NCT01382368|IPF|ipf
5060235|NCT01382368|COPD|copd
5060236|NCT01382355|Kidney transplant|kidney transplant
5060237|NCT01382355|Kidney/Pancreas transplant|kidney/pancreas transplant
5060238|NCT01382355|Antibody|antibody
5060239|NCT01382355|Monitoring|monitoring
5060240|NCT01382342|Parkinson's disease|parkinson's disease
5060241|NCT01382342|cognition|cognition
5060242|NCT01382342|executive function|executive function
5060243|NCT01382342|rasagiline|rasagiline
5060244|NCT01382329|Prophylaxis of influenza infection caused by a pandemic influenza virus (H5N1)|prophylaxis of influenza infection caused by a pandemic influenza virus (h5n1)
5060245|NCT01382316|12-step facilitation|12-step facilitation
5060246|NCT01382316|Alcoholics Anonymous|alcoholics anonymous
5060247|NCT01382316|Narcotics Anonymous|narcotics anonymous
5060248|NCT01382316|AA|aa
5060249|NCT01382316|Self-help|self-help
5060250|NCT01382303|Type 2 Diabetes|type 2 diabetes
5060251|NCT01382303|pentoxifylline|pentoxifylline
5060252|NCT01382303|proteinuria|proteinuria
5060253|NCT01382290|MRI|mri
5060254|NCT01382290|Spine|spine
5060255|NCT01382290|Diffusion|diffusion
5060256|NCT01382264|Poorly controlled diabetes Type 2|poorly controlled diabetes type 2
5060257|NCT01382264|Computer Assisted Decision Support|computer assisted decision support
5060258|NCT01382264|Primary Care Providers|primary care providers
5060259|NCT01382251|Activities of Daily Living|activities of daily living
5060260|NCT01382251|Caregivers|caregivers
5060261|NCT01382251|Ambulatory Surgical Procedures|ambulatory surgical procedures
5060262|NCT01382238|dolutegravir|dolutegravir
5060263|NCT01382238|pediatric|pediatric
5060264|NCT01382238|granule formulation|granule formulation
5060265|NCT01382238|GSK1349572|gsk1349572
5060266|NCT01382238|HIV|hiv
5060267|NCT01382225|Dry eyes|dry eyes
5060268|NCT01382225|Ocular discomfort|ocular discomfort
5060269|NCT01382212|Evaluate safety through the evaluation of the incidence of hypercalcemia in pediatric subjects|evaluate safety through the evaluation of the incidence of hypercalcemia in pediatric subjects
5060270|NCT01382199|Antibiotic Associated Diarrhea in Adult Patients|antibiotic associated diarrhea in adult patients
5060271|NCT01382186|Qualitative|qualitative
5060272|NCT01382186|User, Computer Interface|user, computer interface
5060273|NCT01382186|quantitative|quantitative
5060274|NCT01382186|survey|survey
5060275|NCT01382186|telemedicine|telemedicine
5060276|NCT01382173|Knee injury|knee injury
5060277|NCT01382173|Osteoarthritis|osteoarthritis
5060278|NCT01382173|Anterior Cruciate Ligament injury|anterior cruciate ligament injury
5060279|NCT01382173|Patellar dislocation|patellar dislocation
5060280|NCT01382160|Rheumatoid arthritis|rheumatoid arthritis
5060281|NCT01382160|adalimumab|adalimumab
5060282|NCT01382160|pharmacokinetic-pharmacodynamic relationship|pharmacokinetic-pharmacodynamic relationship
5060283|NCT01382160|immunogenicity|immunogenicity
5060284|NCT01382160|Fc gamma receptors polymorphisms|fc gamma receptors polymorphisms
5060285|NCT01382134|Platelet dysfunction|platelet dysfunction
5060286|NCT01382134|Hemodilution|hemodilution
5060287|NCT01382134|Mild hypothermia|mild hypothermia
5060288|NCT01382134|NSAID|nsaid
5060289|NCT01382134|Desmopressin|desmopressin
5060290|NCT01382121|Peer modeling|peer modeling
5060291|NCT01382121|Observational learning|observational learning
5060292|NCT01382121|Obesity|obesity
5060293|NCT01382121|Adolescents|adolescents
5060294|NCT01382121|Maximum ventilatory oxygen|maximum ventilatory oxygen
5060295|NCT01382121|Aerobic fitness|aerobic fitness
5060296|NCT01382121|Health behaviour|health behaviour
5060297|NCT01382095|ETEC|etec
5060298|NCT01382095|Diarrhea|diarrhea
5060299|NCT01382095|Vaccine|vaccine
5060300|NCT01382082|cognitive function|cognitive function
5060301|NCT01382082|memory|memory
5060302|NCT01382082|attention|attention
5060303|NCT01382082|breast cancer|breast cancer
5060304|NCT01382082|lymphoma|lymphoma
5060305|NCT01382069|androgen|androgen
5060306|NCT01382069|male contraception|male contraception
5060307|NCT01382069|dimethandrolone|dimethandrolone
5060308|NCT01382069|healthy men|healthy men
5060309|NCT01382056|Peripheral Artery Disease|peripheral artery disease
5060310|NCT01382056|Pulses|pulses
5060311|NCT01382056|Beans|beans
5060312|NCT01382056|PAD|pad
5060313|NCT01382043|percutaneous coronary angioplasty|percutaneous coronary angioplasty
5060314|NCT01382043|zotarolimus-eluting stent|zotarolimus-eluting stent
5060315|NCT01382043|sirolimus-eluting stent|sirolimus-eluting stent
5060316|NCT01382043|biodegradable polymer|biodegradable polymer
5060317|NCT01382043|biocompatible polymer|biocompatible polymer
5060318|NCT01382030|Soft tissue sarcoma|soft tissue sarcoma
5060319|NCT01382030|High-risk|high-risk
5060320|NCT01382030|Neoadjuvant|neoadjuvant
5060321|NCT01382030|Adjuvant|adjuvant
5060322|NCT01382030|Chemotherapy|chemotherapy
5060323|NCT01382030|Radiotherapy|radiotherapy
5060324|NCT01382017|lacosamide|lacosamide
5060325|NCT01382017|carbamazepine|carbamazepine
5060326|NCT01382017|placebo|placebo
5060327|NCT01382017|transcranial magnetic stimulation|transcranial magnetic stimulation
5060328|NCT01382017|TMS|tms
5060329|NCT01382017|motor cortex|motor cortex
5060330|NCT01382017|sodium channel|sodium channel
5060331|NCT01382017|inhibition|inhibition
5060332|NCT01382017|threshold|threshold
5060333|NCT01382004|Neglected diseases|neglected diseases
5060334|NCT01382004|Children|children
5060335|NCT01381991|Gastroesophageal Reflux Disease|gastroesophageal reflux disease
5060336|NCT01381991|Reflux esophagitis|reflux esophagitis
5060337|NCT01381991|i-scan|i-scan
5060338|NCT01381978|Nutritional status of scholars|nutritional status of scholars
5060339|NCT01381978|Risk factors of obesity|risk factors of obesity
5060340|NCT01381978|Socioeconomical status|socioeconomical status
5060341|NCT01381978|Physical activity habits|physical activity habits
5060342|NCT01381965|spectral-domain optical coherence tomography|spectral-domain optical coherence tomography
5060343|NCT01381965|idiopathic macular hole|idiopathic macular hole
5060344|NCT01381965|cone outer segment tips line|cone outer segment tips line
5060345|NCT01381965|vitrectomy|vitrectomy
5060346|NCT01381952|X-ray|x-ray
5060347|NCT01381952|Image processing|image processing
5060348|NCT01381952|Neuro angiography|neuro angiography
5060349|NCT01381952|Radiation exposure|radiation exposure
5060350|NCT01381939|Intrahepatic Cholestasis of Pregnancy|intrahepatic cholestasis of pregnancy
5060351|NCT01381939|Induction of labor|induction of labor
5060352|NCT01381939|Pregnancy|pregnancy
5060353|NCT01381939|Caesarian section|caesarian section
5060354|NCT01381939|Pruritus|pruritus
5060355|NCT01381939|IUFD|iufd
5060356|NCT01381926|Type 2 diabetes|type 2 diabetes
5060357|NCT01381926|exenatide|exenatide
5060358|NCT01381926|Byetta|byetta
5060359|NCT01381913|Gastric cancer|gastric cancer
5060360|NCT01381913|Chemoradiotherapy|chemoradiotherapy
5060361|NCT01381913|Adjacent tissue invasion|adjacent tissue invasion
5060362|NCT01381913|Feasibility trial|feasibility trial
5060363|NCT01381900|Canagliflozin|canagliflozin
5060364|NCT01381900|Placebo|placebo
5060365|NCT01381900|Type 2 diabetes mellitus|type 2 diabetes mellitus
5060366|NCT01381887|Canagliflozin|canagliflozin
5060367|NCT01381887|Placebo|placebo
5060368|NCT01381887|Type 2 diabetes mellitus|type 2 diabetes mellitus
5060369|NCT01381874|Breast cancer|breast cancer
5060370|NCT01381874|Abiraterone|abiraterone
5060371|NCT01381874|Postmenopausal|postmenopausal
5060372|NCT01381874|Metastatic|metastatic
5060373|NCT01381848|Doripenem|doripenem
5060374|NCT01381848|DORIPED1003|doriped1003
5060375|NCT01381848|Intravenous|intravenous
5060376|NCT01381848|Infection|infection
5060377|NCT01381848|Colonization|colonization
5060378|NCT01381848|Prophylaxis|prophylaxis
5060379|NCT01381848|Pediatric|pediatric
5060380|NCT01381848|Antibiotic|antibiotic
5060381|NCT01381848|Pharmacokinetics|pharmacokinetics
5060673|NCT01380678|bevacizumab|bevacizumab
5060382|NCT01381835|TMC435-TiDP16-C126|tmc435-tidp16-c126
5060383|NCT01381835|TMC435-C126|tmc435-c126
5060384|NCT01381835|TMC435|tmc435
5060385|NCT01381835|HCV|hcv
5060386|NCT01381835|Hepatitis C|hepatitis c
5060387|NCT01381835|Hep C|hep c
5060388|NCT01381835|severe renal impairement|severe renal impairement
5060389|NCT01381822|TH-302|th-302
5060390|NCT01381822|Advanced Renal Cell Carcinoma|advanced renal cell carcinoma
5060391|NCT01381822|RCC|rcc
5060392|NCT01381822|Gastrointestinal Stromal Tumors|gastrointestinal stromal tumors
5060393|NCT01381822|GIST|gist
5060394|NCT01381822|Phase 1|phase 1
5060395|NCT01381822|Sunitinib|sunitinib
5060396|NCT01381822|Pancreatic Neuroendocrine Tumors|pancreatic neuroendocrine tumors
5060397|NCT01381822|PNET|pnet
5060398|NCT01381809|Myelodysplastic Syndromes|myelodysplastic syndromes
5060399|NCT01381809|Myeloproliferative Disorders|myeloproliferative disorders
5060400|NCT01381809|Bone Marrow disease|bone marrow disease
5060401|NCT01381809|Anemia|anemia
5060402|NCT01381809|Epoetin Alfa|epoetin alfa
5060403|NCT01381809|Eprex|eprex
5060404|NCT01381809|Erypo|erypo
5060405|NCT01381809|Erythropoiesis-stimulating agent|erythropoiesis-stimulating agent
5060406|NCT01381783|topical anaesthesia|topical anaesthesia
5060407|NCT01381783|Phacoemulsification|phacoemulsification
5060408|NCT01381770|muscular lesions grade 2|muscular lesions grade 2
5060409|NCT01381770|muscular lesions grade 3|muscular lesions grade 3
5060410|NCT01381757|Extensively Drug-Resistant Tuberculosis|extensively drug-resistant tuberculosis
5060411|NCT01381757|First-Line Antituberculous Drugs|first-line antituberculous drugs
5060412|NCT01381757|Second-Line Antituberculous Drugs|second-line antituberculous drugs
5060413|NCT01381757|Middlebrook Culture|middlebrook culture
5060414|NCT01381757|Agar Proportion Method|agar proportion method
5060415|NCT01381744|Yersinia pestis, vaccine, plague, Flagellin/F1/V, Parent Protocol of 15-0104|yersinia pestis, vaccine, plague, flagellin/f1/v, parent protocol of 15-0104
5060416|NCT01381731|post PRK wound healing|post prk wound healing
5060417|NCT01381718|childhood brain tumor|childhood brain tumor
5060418|NCT01381718|neurotoxicity|neurotoxicity
5060419|NCT01381718|fatigue|fatigue
5060420|NCT01381718|cognitive/functional effects|cognitive/functional effects
5060421|NCT01381718|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
5060422|NCT01381705|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5060423|NCT01381705|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5060424|NCT01381653|sexual risk|sexual risk
5060425|NCT01381653|substance use|substance use
5060426|NCT01381653|HIV prevention|hiv prevention
5060427|NCT01381653|intervention acceptability and feasibility|intervention acceptability and feasibility
5060428|NCT01381653|young men who have sex with men|young men who have sex with men
5060429|NCT01381640|paracetamol|paracetamol
5060430|NCT01381640|healthy volunteer|healthy volunteer
5060431|NCT01381640|pharmacoscintography|pharmacoscintography
5060432|NCT01381627|EBUS-TBNA|ebus-tbna
5060433|NCT01381627|Dexmedetomidine|dexmedetomidine
5060434|NCT01381627|Precedex|precedex
5060435|NCT01381627|Remifentanil|remifentanil
5060436|NCT01381627|Ultiva|ultiva
5060437|NCT01381627|Monitored Anesthesia Care|monitored anesthesia care
5060438|NCT01381627|Sedation|sedation
5060439|NCT01381627|Bronchoscopy|bronchoscopy
5060440|NCT01381627|Lung cancer|lung cancer
5060441|NCT01381627|Mediastinal node|mediastinal node
5060442|NCT01381627|Cancer staging|cancer staging
5060443|NCT01381627|Anesthesia|anesthesia
5060444|NCT01381627|Remote location|remote location
5060445|NCT01381614|retrospective database analysis|retrospective database analysis
5060446|NCT01381614|economic burden|economic burden
5060447|NCT01381601|retrospective database analysis|retrospective database analysis
5060448|NCT01381601|economic burden|economic burden
5060449|NCT01381575|HPV infection|hpv infection
5060450|NCT01381575|Human Papillomavirus|human papillomavirus
5060451|NCT01381575|Cervical cancer|cervical cancer
5060452|NCT01381575|HPV-16|hpv-16
5060453|NCT01381575|HPV-18|hpv-18
5060454|NCT01381575|vaccine|vaccine
5060455|NCT01381562|intra-abdominal infection|intra-abdominal infection
5060456|NCT01381562|belly|belly
5060457|NCT01381562|Gram-negative pathogen|gram-negative pathogen
5060458|NCT01381562|abscess|abscess
5060459|NCT01381562|peritonitis|peritonitis
5060460|NCT01381549|Gram-negative|gram-negative
5060461|NCT01381549|uropathogens|uropathogens
5060462|NCT01381549|complicated lower urinary tract infection|complicated lower urinary tract infection
5060463|NCT01381549|pyelonephritis|pyelonephritis
5060464|NCT01381536|Anti Blys Antibody|anti blys antibody
5060465|NCT01381523|resource utilization|resource utilization
5060466|NCT01381523|naproxen sodium|naproxen sodium
5060467|NCT01381523|cost and cost analysis|cost and cost analysis
5060468|NCT01381523|triptan|triptan
5060469|NCT01381523|migraine|migraine
5060470|NCT01381510|Benign prostatic hyperplasia|benign prostatic hyperplasia
5060471|NCT01381510|Adherence|adherence
5060472|NCT01381510|Acute urinary retention|acute urinary retention
5060473|NCT01381510|Enlarged prostate|enlarged prostate
5060474|NCT01381510|5-alpha reductase inhibitor|5-alpha reductase inhibitor
5060475|NCT01381510|Surgery|surgery
5060476|NCT01381510|Cost and cost analysis|cost and cost analysis
5060477|NCT01381497|presenteeism|presenteeism
5060478|NCT01381497|migraine disorders|migraine disorders
5060479|NCT01381497|work productivity|work productivity
5060480|NCT01381497|triptan|triptan
5060481|NCT01381497|sumatriptan and naproxen sodium|sumatriptan and naproxen sodium
5060482|NCT01381497|absenteeism|absenteeism
5060483|NCT01381484|Periorbital wrinkles|periorbital wrinkles
5060484|NCT01381484|Efficacy and safety|efficacy and safety
5060485|NCT01381432|Antirejection|antirejection
5060486|NCT01381419|pharmacokinetics|pharmacokinetics
5060487|NCT01381419|safety|safety
5060488|NCT01381419|positron emission tomography (PET)|positron emission tomography (pet)
5060489|NCT01381419|single ascending dose|single ascending dose
5060490|NCT01381393|osteoporosis|osteoporosis
5060491|NCT01381393|ibandronate|ibandronate
5060492|NCT01381380|myofascial pain|myofascial pain
5060493|NCT01381380|trigger point injection|trigger point injection
5060494|NCT01381380|manual therapy|manual therapy
5060495|NCT01381367|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
5060496|NCT01381367|Inhaled corticosteroid|inhaled corticosteroid
5060497|NCT01381367|Pneumococcal vaccine|pneumococcal vaccine
5060498|NCT01381367|Acute exacerbation|acute exacerbation
5060499|NCT01381367|High-dose daily inhaled corticosteroid usage|high-dose daily inhaled corticosteroid usage
5060500|NCT01381367|Efficacy of the PPSV23 pneumococcal vaccine|efficacy of the ppsv23 pneumococcal vaccine
5060501|NCT01381354|Secondary Progressive Multiple Sclerosis, primary progressive multiple sclerosis|secondary progressive multiple sclerosis, primary progressive multiple sclerosis
5060502|NCT01381328|HIV-1 infected patients|hiv-1 infected patients
5060503|NCT01381328|RALTEGRAVIR regimen|raltegravir regimen
5060504|NCT01381328|genotypic evaluations|genotypic evaluations
5060505|NCT01381328|phenotypic evaluations|phenotypic evaluations
5060506|NCT01381315|Sentinel lymph node biopsy|sentinel lymph node biopsy
5060507|NCT01381315|Axillary lymph node dissection|axillary lymph node dissection
5060508|NCT01381315|Prevention of lymphedema|prevention of lymphedema
5060509|NCT01381302|Severity of disease|severity of disease
5060510|NCT01381276|Vitamin A|vitamin a
5060511|NCT01381250|Pathological gambling according to DSM and having gambled at least once the past month.|pathological gambling according to dsm and having gambled at least once the past month.
5060512|NCT01381250|Being atleast 18 years old|being atleast 18 years old
5060513|NCT01381237|Balance|balance
5060514|NCT01381237|Postural|postural
5060515|NCT01381237|Rehabilitation|rehabilitation
5060516|NCT01381237|Therapy|therapy
5060517|NCT01381237|computer-assisted|computer-assisted
5060518|NCT01381237|Video Games|video games
5060519|NCT01381237|Center of Pressure|center of pressure
5060520|NCT01381224|low back pain|low back pain
5060521|NCT01381224|lumbar|lumbar
5060522|NCT01381224|injection|injection
5060523|NCT01381224|lumbar pain|lumbar pain
5060524|NCT01381211|Intermediate stage hepatocellular carcinoma|intermediate stage hepatocellular carcinoma
5060525|NCT01381198|cerebral palsy|cerebral palsy
5060526|NCT01381198|distal rectus femoris transfer|distal rectus femoris transfer
5060527|NCT01381198|stiff knee gait pattern|stiff knee gait pattern
5060528|NCT01381198|gait analysis|gait analysis
5060529|NCT01381198|single event multilevel surgery|single event multilevel surgery
5060530|NCT01381198|randomized trial|randomized trial
5060531|NCT01381198|crouch gait|crouch gait
5060532|NCT01381185|myocardial infarction|myocardial infarction
5060533|NCT01381185|percutaneous coronary intervention (PCI)|percutaneous coronary intervention (pci)
5060534|NCT01381185|high platelet reactivity (HPR)|high platelet reactivity (hpr)
5060535|NCT01381172|Heart Failure|heart failure
5060536|NCT01381172|Congestive Heart Failure|congestive heart failure
5060537|NCT01381172|Chronic heart disease|chronic heart disease
5060538|NCT01381172|Cardiac contractility modulation|cardiac contractility modulation
5060539|NCT01381172|CCM|ccm
5060540|NCT01381172|CHF|chf
5060541|NCT01381159|Adherence|adherence
5060542|NCT01381159|Asthma Control|asthma control
5060543|NCT01381159|Asthma Quality Of Life|asthma quality of life
5060544|NCT01381159|Motivational Communication|motivational communication
5060545|NCT01381159|Motivational Interviewing|motivational interviewing
5060546|NCT01381146|criminal behavior|criminal behavior
5060547|NCT01381146|substance abuse|substance abuse
5060548|NCT01381146|HIV risk behavior|hiv risk behavior
5060549|NCT01381146|criminogenic thinking|criminogenic thinking
5060550|NCT01381146|shame|shame
5060551|NCT01381146|guilt|guilt
5060552|NCT01381146|empathy|empathy
5060553|NCT01381146|jail inmates|jail inmates
5060554|NCT01381146|restorative justice|restorative justice
5060555|NCT01381146|Crime|crime
5060556|NCT01381133|Substance abuse|substance abuse
5060557|NCT01381133|Adolescent outpatient treatment|adolescent outpatient treatment
5060558|NCT01381133|Continuing care|continuing care
5060559|NCT01381133|Outcomes|outcomes
5060560|NCT01381120|Flank Pain|flank pain
5060561|NCT01381120|Lower Urinary Tract Symptoms|lower urinary tract symptoms
5060562|NCT01381120|LUTS|luts
5060563|NCT01381120|Urgency|urgency
5060564|NCT01381120|Nocturia|nocturia
5060565|NCT01381120|Frequency|frequency
5060566|NCT01381120|Ureteroscopy|ureteroscopy
5060567|NCT01381120|Kidney Stones|kidney stones
5060568|NCT01381120|Stent|stent
5060569|NCT01381120|Incontinence|incontinence
5060570|NCT01381120|VESIcare|vesicare
5060571|NCT01381120|Ureter|ureter
5060674|NCT01380678|pterygium|pterygium
5060572|NCT01381120|Urinary Bladder, Overactive|urinary bladder, overactive
5060573|NCT01381120|OAB|oab
5060574|NCT01381120|Overactive Bladder Syndrome|overactive bladder syndrome
5060575|NCT01381094|anemia|anemia
5060576|NCT01381094|chronic kidney disease|chronic kidney disease
5060577|NCT01381094|CKD|ckd
5060578|NCT01381094|chronic renal insufficiency|chronic renal insufficiency
5060579|NCT01381094|renal impairment|renal impairment
5060580|NCT01381094|erythropoietin|erythropoietin
5060581|NCT01381094|safety|safety
5060582|NCT01381094|efficacy|efficacy
5060583|NCT01381094|tolerability|tolerability
5060584|NCT01381094|pharmacokinetics|pharmacokinetics
5060585|NCT01381081|knee osteoarthritis|knee osteoarthritis
5060586|NCT01381081|comparing platelet-rich plasma|comparing platelet-rich plasma
5060587|NCT01381081|intra-articular knee injections|intra-articular knee injections
5060588|NCT01381068|ventilation|ventilation
5060589|NCT01381068|end tidal carbon dioxide|end tidal carbon dioxide
5060590|NCT01381068|hypercapnia|hypercapnia
5060591|NCT01381068|hypocapnia|hypocapnia
5060592|NCT01381068|positive pressure ventilation|positive pressure ventilation
5060593|NCT01381068|neonates|neonates
5060594|NCT01381068|delivery room resuscitation|delivery room resuscitation
5060595|NCT01381055|Cutaneous leishmaniasis|cutaneous leishmaniasis
5060596|NCT01381055|Pentoxifylline|pentoxifylline
5060597|NCT01381055|Meglumine antimoniate|meglumine antimoniate
5060598|NCT01381055|L. braziliensis|l. braziliensis
5060599|NCT01381042|Brown Adipose Tissue|brown adipose tissue
5060600|NCT01381042|Incidence|incidence
5060601|NCT01381042|Factor|factor
5060602|NCT01381042|Human|human
5060603|NCT01381016|LH pulsatility|lh pulsatility
5060604|NCT01381016|Obesity|obesity
5060605|NCT01381016|Reproduction|reproduction
5060606|NCT01381003|Chronic Granulomatous Disease|chronic granulomatous disease
5060607|NCT01381003|Gene therapy|gene therapy
5060608|NCT01381003|X-CGD|x-cgd
5060609|NCT01381003|NADPH-oxidase|nadph-oxidase
5060610|NCT01381003|gp91-phox|gp91-phox
5060611|NCT01380977|crime|crime
5060612|NCT01380977|substance abuse|substance abuse
5060613|NCT01380977|HIV risk|hiv risk
5060614|NCT01380977|criminogenic thinking|criminogenic thinking
5060615|NCT01380977|shame|shame
5060616|NCT01380977|guilt|guilt
5060617|NCT01380977|restorative justice|restorative justice
5060618|NCT01380977|victim impact group|victim impact group
5060619|NCT01380964|Duchenne Muscular Dystrophy|duchenne muscular dystrophy
5060620|NCT01380964|biomarkers|biomarkers
5060621|NCT01380964|transcriptomics|transcriptomics
5060622|NCT01380964|mironics|mironics
5060623|NCT01380964|proteomics|proteomics
5060624|NCT01380951|liver cirrhosis|liver cirrhosis
5060625|NCT01380951|chronic hepatitis B|chronic hepatitis b
5060626|NCT01380951|antiviral therapy|antiviral therapy
5060627|NCT01380951|telbivudine|telbivudine
5060628|NCT01380938|genotypes 2 and 3|genotypes 2 and 3
5060629|NCT01380938|combination treatment|combination treatment
5060630|NCT01380938|individualized treatment|individualized treatment
5060631|NCT01380912|breast cancer|breast cancer
5060632|NCT01380912|mastectomy|mastectomy
5060633|NCT01380912|methylprednisoloneacetate|methylprednisoloneacetate
5060634|NCT01380912|seroma|seroma
5060635|NCT01380912|numbers of punctures|numbers of punctures
5060636|NCT01380899|Parkinson Disease|parkinson disease
5060637|NCT01380899|Parkinsonian Disorders|parkinsonian disorders
5060638|NCT01380899|Lewy Bodies|lewy bodies
5060639|NCT01380899|alpha-Synuclein|alpha-synuclein
5060640|NCT01380860|mesh|mesh
5060641|NCT01380860|hernia|hernia
5060642|NCT01380847|Kidney Transplantation|kidney transplantation
5060643|NCT01380847|Allograft|allograft
5060644|NCT01380847|Kidney failure|kidney failure
5060645|NCT01380847|Chronic allograft nephropathy|chronic allograft nephropathy
5060646|NCT01380847|Monitoring|monitoring
5060647|NCT01380847|Urine|urine
5060648|NCT01380834|paravertebral nerve blocks|paravertebral nerve blocks
5060649|NCT01380834|laparoscopic cholecystectomy|laparoscopic cholecystectomy
5060650|NCT01380821|clinical indication for myocardial SPECT|clinical indication for myocardial spect
5060651|NCT01380821|suspected or known coronary artery disease|suspected or known coronary artery disease
5060652|NCT01380795|non-small cell lung cancer carcinoma|non-small cell lung cancer carcinoma
5060653|NCT01380795|circulating tumor cells|circulating tumor cells
5060654|NCT01380795|EGFR|egfr
5060655|NCT01380795|K-ras|k-ras
5060656|NCT01380782|brain tumor|brain tumor
5060657|NCT01380782|recurrent disease|recurrent disease
5060658|NCT01380756|Amgen|amgen
5060659|NCT01380756|Phase 1|phase 1
5060660|NCT01380756|Clinical Trial|clinical trial
5060661|NCT01380756|Aurora kinase inhibitor|aurora kinase inhibitor
5060662|NCT01380756|Open label|open label
5060663|NCT01380756|Oncology|oncology
5060664|NCT01380756|Hematology|hematology
5060665|NCT01380743|Amicus Therapeutics|amicus therapeutics
5060666|NCT01380743|duvoglustat|duvoglustat
5060667|NCT01380743|AT2220|at2220
5060668|NCT01380743|alpha-glucosidase|alpha-glucosidase
5060669|NCT01380743|alglucosidase alfa|alglucosidase alfa
5060670|NCT01380730|Hypercholesterolemia|hypercholesterolemia
5060671|NCT01380730|Proprotein convertase subtilisin/kexin type 9 (PCSK9)|proprotein convertase subtilisin/kexin type 9 (pcsk9)
5060672|NCT01380704|Depression|depression
5060675|NCT01380678|treatment|treatment
5060676|NCT01380678|elevation|elevation
5060677|NCT01380665|Prevena|prevena
5060678|NCT01380665|Incision|incision
5060679|NCT01380665|Management|management
5060680|NCT01380665|System|system
5060681|NCT01380665|total|total
5060682|NCT01380665|knee|knee
5060684|NCT01380665|replacement|replacement
5060685|NCT01380665|Surgery|surgery
5060686|NCT01380665|Negative|negative
5060687|NCT01380665|Pressure|pressure
5060688|NCT01380665|dressing|dressing
5060689|NCT01380665|KCI|kci
5060690|NCT01380652|COPD III/IV|copd iii/iv
5060691|NCT01380652|Activity Monitoring|activity monitoring
5060692|NCT01380652|SenseWear|sensewear
5060693|NCT01380652|Vibration training|vibration training
5060694|NCT01380652|Galileo|galileo
5060695|NCT01380652|Pulmonary rehabilitation|pulmonary rehabilitation
5060696|NCT01380639|COPD III/IV|copd iii/iv
5060697|NCT01380639|6-Minutes-Walking-Distance|6-minutes-walking-distance
5060698|NCT01380639|Vibration training|vibration training
5060699|NCT01380639|Galileo|galileo
5060700|NCT01380639|Pulmonary rehabilitation|pulmonary rehabilitation
5060701|NCT01380626|alpha-1-antitrypsin-deficiency|alpha-1-antitrypsin-deficiency
5060702|NCT01380626|COPD|copd
5060703|NCT01380626|exercise training|exercise training
5060704|NCT01380626|muscle biopsy|muscle biopsy
5060705|NCT01380613|HIV|hiv
5060706|NCT01380613|depression|depression
5060707|NCT01380613|drug use,|drug use,
5060708|NCT01380613|risk reduction|risk reduction
5060709|NCT01380600|Vaccinia|vaccinia
5060710|NCT01380600|Vaccinia Virus|vaccinia virus
5060711|NCT01380600|JX-594|jx-594
5060712|NCT01380600|Jennerex|jennerex
5060713|NCT01380600|Colorectal Carcinoma|colorectal carcinoma
5060714|NCT01380600|Colorectal cancer|colorectal cancer
5060715|NCT01380600|Colon Cancer|colon cancer
5060716|NCT01380600|Rectal Cancer|rectal cancer
5060717|NCT01380600|Pexa-Vec|pexa-vec
5060718|NCT01380587|ALL|all
5060719|NCT01380587|XCL1|xcl1
5060720|NCT01380587|Cytokines|cytokines
5060721|NCT01380587|Prognosis|prognosis
5060722|NCT01380574|atrial fibrillation|atrial fibrillation
5060723|NCT01380574|cardioversion|cardioversion
5060724|NCT01380574|stroke|stroke
5060725|NCT01380574|thromboembolism|thromboembolism
5060726|NCT01380561|asimadoline|asimadoline
5060727|NCT01380561|pharmacokinetic|pharmacokinetic
5060728|NCT01380561|excretion of 14C-derived radioactivity|excretion of 14c-derived radioactivity
5060729|NCT01380561|metabolite profile|metabolite profile
5060730|NCT01380561|14C-asimadoline|14c-asimadoline
5060731|NCT01380561|metabolites|metabolites
5060732|NCT01380561|single and multiple oral doses|single and multiple oral doses
5060733|NCT01380535|Extracorporeal photopheresis therapy|extracorporeal photopheresis therapy
5060734|NCT01380535|Methoxsalen|methoxsalen
5060735|NCT01380535|UVADEX|uvadex
5060736|NCT01380535|Chronic graft versus host disease (cGvHD): National Institute Health Consensus Criteria|chronic graft versus host disease (cgvhd): national institute health consensus criteria
5060737|NCT01380522|Bioequivalence, single-dose, fed|bioequivalence, single-dose, fed
5060738|NCT01380509|Bioequivalence, single-dose, fasting|bioequivalence, single-dose, fasting
5060739|NCT01380496|bioequivalence|bioequivalence
5060740|NCT01380496|doxycycline monohydrate|doxycycline monohydrate
5060741|NCT01380496|fed|fed
5060742|NCT01380483|bioequivalence|bioequivalence
5060743|NCT01380483|doxycycline monohydrate|doxycycline monohydrate
5060744|NCT01380483|fasting|fasting
5060745|NCT01380470|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5060746|NCT01380470|Diagnosis differential|diagnosis differential
5060747|NCT01380470|Dyspnea/classification|dyspnea/classification
5060748|NCT01380470|Dyspnea/etiology|dyspnea/etiology
5060749|NCT01380457|bioequivalence|bioequivalence
5060750|NCT01380457|dronabinol|dronabinol
5060751|NCT01380457|fasting|fasting
5060752|NCT01380444|Intertrochanteric fracture|intertrochanteric fracture
5060753|NCT01380444|Gamma3 intramedullary nail|gamma3 intramedullary nail
5060754|NCT01380444|Sliding hip screw|sliding hip screw
5060755|NCT01380431|bioequivalence, lisinopril, fed|bioequivalence, lisinopril, fed
5060756|NCT01380418|Obesity|obesity
5060757|NCT01380405|Inhalators|inhalators
5060758|NCT01380405|Education|education
5060759|NCT01380405|Primary care|primary care
5060760|NCT01380392|Liver cancer|liver cancer
5060761|NCT01380392|Uncertainty|uncertainty
5060762|NCT01380392|Personality|personality
5060763|NCT01380392|coping strategies|coping strategies
5060764|NCT01380379|physical violence|physical violence
5060765|NCT01380379|sexual violence|sexual violence
5060766|NCT01380366|Malabsorption|malabsorption
5060767|NCT01380353|Women undergoing total mastectomy|women undergoing total mastectomy
5060768|NCT01380353|Breast cancer prevention|breast cancer prevention
5060769|NCT01380340|Seniors|seniors
5060770|NCT01380340|Driving|driving
5060771|NCT01380340|Group work|group work
5060772|NCT01380327|cockroach|cockroach
5060773|NCT01380327|immunotherapy|immunotherapy
5060774|NCT01380327|sublingual immunotherapy (SLIT)|sublingual immunotherapy (slit)
5060775|NCT01380327|inner city asthma|inner city asthma
5060776|NCT01380314|leishmaniasis|leishmaniasis
5060777|NCT01380314|cutaneois leishmaniasis|cutaneois leishmaniasis
5060778|NCT01380314|miltefosine|miltefosine
5060779|NCT01380314|oral therapy|oral therapy
5060780|NCT01380314|treatment|treatment
5060781|NCT01380314|imiquimod|imiquimod
5060782|NCT01380301|Leishmaniasis|leishmaniasis
5060783|NCT01380301|Miltefosine|miltefosine
5060784|NCT01380301|Antimony|antimony
5060786|NCT01380288|Alzheimer's disease|alzheimer's disease
5060787|NCT01380288|rivastigmine patch|rivastigmine patch
5060788|NCT01380288|white matter change|white matter change
5060789|NCT01380275|recurrent, refractory, bone, soft tissue, sarcomas|recurrent, refractory, bone, soft tissue, sarcomas
5060790|NCT01380262|Colorectal Cancer|colorectal cancer
5060791|NCT01380262|Skin Rash|skin rash
5060792|NCT01380262|Pre-emptive treatment|pre-emptive treatment
5060793|NCT01380262|Doxycycline|doxycycline
5060794|NCT01380262|Anti-EGFR antibody|anti-egfr antibody
5060795|NCT01380262|Cetuximab|cetuximab
5060796|NCT01380262|Panitumumab|panitumumab
5060797|NCT01380249|Phase I|phase i
5060798|NCT01380249|Phase I multiple doses|phase i multiple doses
5060799|NCT01380249|PDM08|pdm08
5060800|NCT01380249|Cancer Treatment|cancer treatment
5060801|NCT01380249|Pharmacokinetics and Pharmacodynamics|pharmacokinetics and pharmacodynamics
5060802|NCT01380249|Advanced Solid Tumors|advanced solid tumors
5060803|NCT01380249|Prodimed|prodimed
5060804|NCT01380210|Carbon dioxide intoxication|carbon dioxide intoxication
5060805|NCT01380210|Diffusion weighted images(DWI)|diffusion weighted images(dwi)
5060806|NCT01380197|pain|pain
5060807|NCT01380197|sickle cell|sickle cell
5060808|NCT01380197|nubain|nubain
5060809|NCT01380197|morphine|morphine
5060810|NCT01380197|acute chest|acute chest
5060811|NCT01380197|side effects|side effects
5060812|NCT01380184|Relapsed cancer|relapsed cancer
5060813|NCT01380158|pessary|pessary
5060814|NCT01380158|preterm birth|preterm birth
5060815|NCT01380158|short cervix|short cervix
5060816|NCT01380158|cervical incompetence|cervical incompetence
5060817|NCT01380145|multiple myeloma|multiple myeloma
5060818|NCT01380145|MAGE-A3|mage-a3
5060819|NCT01380145|autologous stem cell transplant|autologous stem cell transplant
5060820|NCT01380132|Fecal incontinence|fecal incontinence
5060821|NCT01380132|Treatment|treatment
5060822|NCT01380132|Surgery|surgery
5060823|NCT01380119|sputum conversion|sputum conversion
5060824|NCT01380119|liver biochemistry|liver biochemistry
5060825|NCT01380119|weight loss|weight loss
5060826|NCT01380119|quality of life|quality of life
5060827|NCT01380106|Multiple myeloma|multiple myeloma
5060828|NCT01380106|Relapsed|relapsed
5060829|NCT01380106|Revlimid|revlimid
5060830|NCT01380093|abuse potential|abuse potential
5060831|NCT01380093|abuse liability|abuse liability
5060832|NCT01380093|recreational opioid use|recreational opioid use
5060833|NCT01380093|morphine|morphine
5060834|NCT01380067|Inguinal hernia|inguinal hernia
5060835|NCT01380067|Lateral umbilicus ligament|lateral umbilicus ligament
5060836|NCT01380067|Recurrence|recurrence
5060837|NCT01380054|Pulmonary Hypertension|pulmonary hypertension
5060838|NCT01380054|Quality of life|quality of life
5060839|NCT01380054|Coping|coping
5060840|NCT01380054|Depression|depression
5060841|NCT01380054|Anxiety|anxiety
5060842|NCT01380054|Social support|social support
5060843|NCT01380054|Control beliefs|control beliefs
5060844|NCT01380041|Multiple sclerosisCerebrospinal fluidBiomarkerCytokineArray|multiple sclerosiscerebrospinal fluidbiomarkercytokinearray
5060845|NCT01380028|chronic subdural hematomas|chronic subdural hematomas
5060846|NCT01380028|corticosteroid|corticosteroid
5060847|NCT01380028|treatment|treatment
5060848|NCT01380028|neurosurgery|neurosurgery
5060849|NCT01380028|recurrence, adjuvant|recurrence, adjuvant
5060850|NCT01380015|osteoarthritis|osteoarthritis
5060851|NCT01380015|spearmint|spearmint
5060852|NCT01380015|rosmarinic acid|rosmarinic acid
5060853|NCT01380002|care needs|care needs
5060854|NCT01379976|lung|lung
5060855|NCT01379976|cancer|cancer
5060856|NCT01379976|non small cell lung cancer|non small cell lung cancer
5060857|NCT01379976|Advanced or metastatic non small cell lung cancer|advanced or metastatic non small cell lung cancer
5060858|NCT01379937|influenza|influenza
5060859|NCT01379937|H5N1|h5n1
5060860|NCT01379937|vaccine|vaccine
5060861|NCT01379937|children|children
5060862|NCT01379911|Satiety|satiety
5060863|NCT01379911|Food intake|food intake
5060864|NCT01379911|Yogurt|yogurt
5060865|NCT01379898|Pheochromocytoma|pheochromocytoma
5060866|NCT01379898|Doxazosin|doxazosin
5060867|NCT01379898|Phenoxybenzamine|phenoxybenzamine
5060868|NCT01379885|Pain|pain
5060869|NCT01379885|immunization|immunization
5060870|NCT01379885|distraction|distraction
5060871|NCT01379885|hypnosis|hypnosis
5060872|NCT01379885|injections|injections
5060873|NCT01379885|anxiety|anxiety
5060874|NCT01379872|Prostate|prostate
5060875|NCT01379872|Head and Neck|head and neck
5060876|NCT01379872|Anal|anal
5060877|NCT01379846|Immunostimulation|immunostimulation
5060878|NCT01379846|Haemophilus b conjugate vaccine|haemophilus b conjugate vaccine
5060879|NCT01379846|HIB|hib
5060880|NCT01379833|Chronic Inflammatory Demyelinating Polyneuropathy|chronic inflammatory demyelinating polyneuropathy
5060881|NCT01379833|Neurotrophic corneal ulcer|neurotrophic corneal ulcer
5060882|NCT01379820|NEONATAL RESPIRATORY FAILURE|neonatal respiratory failure
5061186|NCT01378650|Tinnitus|tinnitus
5060883|NCT01379820|OROTRACHEAL cpap|orotracheal cpap
5060884|NCT01379820|NASAL cpap|nasal cpap
5060885|NCT01379820|MECHANICAL VENTILATION|mechanical ventilation
5060886|NCT01379820|PNEUMOTHORAX|pneumothorax
5060887|NCT01379820|COMPENSATION BAG|compensation bag
5060888|NCT01379781|prevention|prevention
5060889|NCT01379781|postpartum depression|postpartum depression
5060890|NCT01379755|stability|stability
5060891|NCT01379755|single-radius|single-radius
5060892|NCT01379755|multi-radius|multi-radius
5060893|NCT01379755|total knee arthroplasty|total knee arthroplasty
5060894|NCT01379742|prostate cancer|prostate cancer
5060895|NCT01379742|prostate brachytherapy|prostate brachytherapy
5060896|NCT01379729|Type 1 Diabetes|type 1 diabetes
5060897|NCT01379729|Transplantation|transplantation
5060898|NCT01379729|Beta Cells|beta cells
5060899|NCT01379729|Encapsulation|encapsulation
5060900|NCT01379703|HIV-1 infected patients|hiv-1 infected patients
5060901|NCT01379703|Protease inhibitor|protease inhibitor
5060902|NCT01379703|Kaletra®|kaletra®
5060903|NCT01379690|HbA1c|hba1c
5060904|NCT01379677|Coronary Artery Disease|coronary artery disease
5060905|NCT01379677|Myocardial perfusion imaging|myocardial perfusion imaging
5060906|NCT01379677|Rubidium|rubidium
5060907|NCT01379677|Technetium|technetium
5060908|NCT01379664|Sevoflurane|sevoflurane
5060909|NCT01379664|Isoflurane|isoflurane
5060910|NCT01379664|volatile anesthetic|volatile anesthetic
5060911|NCT01379664|duration of hospitalization|duration of hospitalization
5060912|NCT01379651|Egg allergy,specific oral tolerance induction|egg allergy,specific oral tolerance induction
5060913|NCT01379638|cardiopulmonary bypass|cardiopulmonary bypass
5060914|NCT01379638|cardiac output|cardiac output
5060915|NCT01379638|flow rate|flow rate
5060916|NCT01379638|lactate|lactate
5060917|NCT01379625|fatty acid oxidation|fatty acid oxidation
5060918|NCT01379625|triheptanoin|triheptanoin
5060919|NCT01379625|long-chain fatty acid oxidation disorders|long-chain fatty acid oxidation disorders
5060920|NCT01379625|LCHADD|lchadd
5060921|NCT01379625|VLCADD|vlcadd
5060922|NCT01379625|CPT2|cpt2
5060923|NCT01379625|TFP|tfp
5060924|NCT01379612|Ultrasound elastography|ultrasound elastography
5060925|NCT01379612|Rectal cancer|rectal cancer
5060926|NCT01379612|Preoperative chemoradiation|preoperative chemoradiation
5060927|NCT01379599|cocaine|cocaine
5060928|NCT01379599|heroin|heroin
5060929|NCT01379599|STIs|stis
5060930|NCT01379599|HIV|hiv
5060931|NCT01379599|brief motivational intervention|brief motivational intervention
5060932|NCT01379599|voluntary testing and counseling|voluntary testing and counseling
5060933|NCT01379586|ONO-4053|ono-4053
5060934|NCT01379586|Healthy adult subjects|healthy adult subjects
5060935|NCT01379586|First time in humans|first time in humans
5060936|NCT01379573|hydroxychloroquine|hydroxychloroquine
5060937|NCT01379573|Plaquenil|plaquenil
5060938|NCT01379573|congenital heart block|congenital heart block
5060939|NCT01379573|neonatal lupus|neonatal lupus
5060940|NCT01379573|systemic lupus erythematosus|systemic lupus erythematosus
5060941|NCT01379573|Sjogren's syndrome|sjogren's syndrome
5060942|NCT01379573|autoantibodies|autoantibodies
5060943|NCT01379573|SSA/Ro|ssa/ro
5060944|NCT01379573|SSB/La|ssb/la
5060945|NCT01379573|autoimmunity|autoimmunity
5060946|NCT01379573|pregnancy|pregnancy
5060947|NCT01379573|immunoglobulin|immunoglobulin
5060948|NCT01379547|Procalcitonin|procalcitonin
5060949|NCT01379547|sepsis|sepsis
5060950|NCT01379547|ICU|icu
5060951|NCT01379547|antibiotic|antibiotic
5060952|NCT01379547|antibiotic duration|antibiotic duration
5060953|NCT01379547|Antibiotic treatment duration|antibiotic treatment duration
5060954|NCT01379534|Solid tumors,|solid tumors,
5060955|NCT01379534|advanced endometrial cancer,|advanced endometrial cancer,
5060956|NCT01379534|Endometrial Cancer,|endometrial cancer,
5060957|NCT01379534|Second-line treatment,|second-line treatment,
5060958|NCT01379534|VEGF,|vegf,
5060959|NCT01379534|Neoplasms,|neoplasms,
5060960|NCT01379534|Endometrial Neoplasms,|endometrial neoplasms,
5060961|NCT01379534|Uterine Neoplasms,|uterine neoplasms,
5060962|NCT01379534|Female Genital Neoplasms,|female genital neoplasms,
5060963|NCT01379534|Cancer,|cancer,
5060964|NCT01379534|Carcinoma,|carcinoma,
5060965|NCT01379534|Uterine Diseases,|uterine diseases,
5060966|NCT01379534|Female Genital Diseases,|female genital diseases,
5060967|NCT01379534|Tumors,|tumors,
5060968|NCT01379534|Oral Administration,|oral administration,
5060969|NCT01379534|Capsules,|capsules,
5060970|NCT01379534|Tablets,|tablets,
5060971|NCT01379534|CHIR258,|chir258,
5060972|NCT01379534|CHIR-258,|chir-258,
5060973|NCT01379534|CHIR 258,|chir 258,
5060974|NCT01379534|TKI258,|tki258,
5060975|NCT01379534|TKI-258,|tki-258,
5060976|NCT01379534|TKI 258|tki 258
5060977|NCT01379521|Localised|localised
5060978|NCT01379521|unresectable|unresectable
5060979|NCT01379521|chemoembolization|chemoembolization
5060980|NCT01379495|burns|burns
5060981|NCT01379495|rehabilitation|rehabilitation
5060982|NCT01379482|Peritoneal carcinomatosis from gastric cancer|peritoneal carcinomatosis from gastric cancer
5060983|NCT01379469|Carbamazepine (Tegretol) use|carbamazepine (tegretol) use
5060984|NCT01379469|severe liver disease|severe liver disease
5061589|NCT01377181|Laparoscope|laparoscope
5060985|NCT01379469|alpha-1-antitrypsin deficiency|alpha-1-antitrypsin deficiency
5060986|NCT01379443|Children|children
5060987|NCT01379443|Rehabilitation|rehabilitation
5060988|NCT01379443|Family Functioning|family functioning
5060989|NCT01379443|Mental Health|mental health
5060990|NCT01379443|Costs|costs
5060991|NCT01379443|Integration|integration
5060992|NCT01379430|Vaccine|vaccine
5060993|NCT01379430|Immune response|immune response
5060994|NCT01379417|Prematurity|prematurity
5060995|NCT01379417|Nutrition|nutrition
5060996|NCT01379417|Growth|growth
5060997|NCT01379404|sepsis, fluid status, BIA, CVP|sepsis, fluid status, bia, cvp
5060998|NCT01379391|Allogeneic Hematopoietic Stem Cell Transplantation|allogeneic hematopoietic stem cell transplantation
5060999|NCT01379391|Platelet Engraftment|platelet engraftment
5061000|NCT01379391|TPO|tpo
5061001|NCT01379365|wrinkle rhytid aging|wrinkle rhytid aging
5061002|NCT01379352|liver transplantation|liver transplantation
5061003|NCT01379352|vecuronium|vecuronium
5061004|NCT01379339|Cabazitaxel|cabazitaxel
5061005|NCT01379339|Cabazitaxel and Cisplatin|cabazitaxel and cisplatin
5061006|NCT01379339|Phase I|phase i
5061007|NCT01379339|PF Induction Chemotherapy|pf induction chemotherapy
5061008|NCT01379339|Squamous Cell Carcinoma|squamous cell carcinoma
5061009|NCT01379339|Head and Neck|head and neck
5061010|NCT01379339|Sanofi-Aventis Oncology|sanofi-aventis oncology
5061011|NCT01379339|Locally Advanced|locally advanced
5061012|NCT01379313|laparoscopic gynecologic surgery|laparoscopic gynecologic surgery
5061013|NCT01379313|gas exchange|gas exchange
5061014|NCT01379313|inspiratory time|inspiratory time
5061015|NCT01379313|expiratory time|expiratory time
5061016|NCT01379313|I:E ratio|i:e ratio
5061017|NCT01379300|Hemophilia B|hemophilia b
5061018|NCT01379287|Iso-Fludelone|iso-fludelone
5061019|NCT01379287|KOS-1803|kos-1803
5061020|NCT01379287|Dose-Escalation|dose-escalation
5061021|NCT01379287|10-202|10-202
5061022|NCT01379274|MDS|mds
5061023|NCT01379274|Low risk disease|low risk disease
5061024|NCT01379274|IPSS|ipss
5061025|NCT01379261|STEMI|stemi
5061026|NCT01379261|primary PCI|primary pci
5061027|NCT01379261|Hypothermia|hypothermia
5061028|NCT01379261|Endovascular cooling|endovascular cooling
5061029|NCT01379261|Cardiac MRI|cardiac mri
5061030|NCT01379235|independent 65 years old and above|independent 65 years old and above
5061031|NCT01379222|AAA|aaa
5061032|NCT01379222|Abdominal Aortic Aneurysm|abdominal aortic aneurysm
5061033|NCT01379222|EVAR|evar
5061034|NCT01379222|Endovascular aneurysm repair|endovascular aneurysm repair
5061035|NCT01379209|AHSCT|ahsct
5061036|NCT01379209|Bone Marrow Transplant|bone marrow transplant
5061037|NCT01379209|Leukemia|leukemia
5061038|NCT01379209|myelodysplastic syndrome|myelodysplastic syndrome
5061039|NCT01379209|hematological malignancies|hematological malignancies
5061040|NCT01379209|Graft-versus-host-disease|graft-versus-host-disease
5061041|NCT01379209|GvHD|gvhd
5061042|NCT01379209|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
5061043|NCT01379209|Stem Cell|stem cell
5061044|NCT01379209|Transplantation|transplantation
5061045|NCT01379196|Graves Orbitopathy|graves orbitopathy
5061046|NCT01379196|Macrolide antibiotics|macrolide antibiotics
5061047|NCT01379196|Inflammation|inflammation
5061048|NCT01379196|Clinical Activity Score|clinical activity score
5061049|NCT01379183|Healthy|healthy
5061050|NCT01379183|Men|men
5061051|NCT01379183|Women|women
5061052|NCT01379183|No known gastrointestinal disease|no known gastrointestinal disease
5061053|NCT01379183|Aged between 18-70 years|aged between 18-70 years
5061054|NCT01379170|brown adipose tissue|brown adipose tissue
5061055|NCT01379170|mitochondrial dysfunction|mitochondrial dysfunction
5061056|NCT01379170|insulin resistance|insulin resistance
5061057|NCT01379157|Patients with ventilator-associated pneumonia|patients with ventilator-associated pneumonia
5061058|NCT01379131|Manifestation|manifestation
5061059|NCT01379131|Coronary Heart Disease|coronary heart disease
5061060|NCT01379131|Myocardial infarction|myocardial infarction
5061061|NCT01379131|Angina pectoris|angina pectoris
5061062|NCT01379131|Unheralded|unheralded
5061063|NCT01379131|General Practice Research Database|general practice research database
5061064|NCT01379131|Myocardial Ischaemia National Audit Project|myocardial ischaemia national audit project
5061065|NCT01379131|CALIBER|caliber
5061066|NCT01379118|Total knee replacement|total knee replacement
5061067|NCT01379105|Electromyography|electromyography
5061068|NCT01379105|Muscle Stretching Exercises|muscle stretching exercises
5061069|NCT01379105|Neuromuscular agents|neuromuscular agents
5061070|NCT01379105|Sedentary Lifestyle|sedentary lifestyle
5061071|NCT01379092|Radiography|radiography
5061072|NCT01379092|Breast Specimen Imaging|breast specimen imaging
5061073|NCT01379066|Mycobacterium tuberculosis|mycobacterium tuberculosis
5061074|NCT01379066|Pulmonary tuberculosis|pulmonary tuberculosis
5061075|NCT01379066|Electronic nose|electronic nose
5061076|NCT01379066|Gas chromatography|gas chromatography
5061077|NCT01379053|Staphylococcus aureus|staphylococcus aureus
5061078|NCT01379053|Methicillin-resistant staphylococcus aureus|methicillin-resistant staphylococcus aureus
5061079|NCT01379053|Nosocomial disease|nosocomial disease
5061080|NCT01379053|Electronic nose|electronic nose
5061081|NCT01379053|Gas chromatography|gas chromatography
5062195|NCT01374568|sitagliptin|sitagliptin
5061082|NCT01379040|Cystic Fibrosis|cystic fibrosis
5061083|NCT01379040|Pseudomonas aeruginosa|pseudomonas aeruginosa
5061084|NCT01379040|Volatile Organic Compounds|volatile organic compounds
5061085|NCT01379040|Electronic nose|electronic nose
5061086|NCT01379040|Gas Chromatography|gas chromatography
5061087|NCT01379027|Depression|depression
5061088|NCT01379027|Website intervention|website intervention
5061089|NCT01379027|CBT|cbt
5061090|NCT01379014|Decisional conflict|decisional conflict
5061091|NCT01379014|Disclosure|disclosure
5061092|NCT01379014|Mental Health history|mental health history
5061093|NCT01379014|Mental health service users|mental health service users
5061094|NCT01379014|Decision Aid Tool|decision aid tool
5061095|NCT01379014|Vocational Specialists|vocational specialists
5061096|NCT01379001|cholinergic function|cholinergic function
5061097|NCT01379001|aging|aging
5061098|NCT01379001|pharmacologic MRI|pharmacologic mri
5061099|NCT01378949|pain score|pain score
5061100|NCT01378936|criminal behavior|criminal behavior
5061101|NCT01378936|substance abuse|substance abuse
5061102|NCT01378936|HIV risk behavior|hiv risk behavior
5061103|NCT01378936|criminogenic thinking|criminogenic thinking
5061104|NCT01378936|shame|shame
5061105|NCT01378936|guilt|guilt
5061106|NCT01378936|empathy|empathy
5061107|NCT01378936|jail inmates|jail inmates
5061108|NCT01378936|restorative justice|restorative justice
5061109|NCT01378936|crime|crime
5061110|NCT01378923|Mindfulness|mindfulness
5061111|NCT01378923|Values|values
5061112|NCT01378923|Jail Inmates|jail inmates
5061113|NCT01378923|Impulsivity|impulsivity
5061114|NCT01378923|Substance Abuse|substance abuse
5061115|NCT01378923|HIV risk behavior|hiv risk behavior
5061116|NCT01378923|Anxiety|anxiety
5061117|NCT01378923|Depression|depression
5061118|NCT01378923|Criminogenic Thinking|criminogenic thinking
5061119|NCT01378910|HIV|hiv
5061120|NCT01378910|TROPISM|tropism
5061121|NCT01378910|PBMC|pbmc
5061122|NCT01378910|GENOTYPE|genotype
5061123|NCT01378910|454 SEQUENCING|454 sequencing
5061124|NCT01378897|bariatric surgery|bariatric surgery
5061125|NCT01378897|gastric bypass surgery|gastric bypass surgery
5061126|NCT01378884|Gastroparesis|gastroparesis
5061127|NCT01378884|Domperidone|domperidone
5061128|NCT01378884|Motilium|motilium
5061129|NCT01378871|T Cell|t cell
5061130|NCT01378871|T-Cell|t-cell
5061131|NCT01378871|Leukemia|leukemia
5061132|NCT01378871|Lymphoma|lymphoma
5061133|NCT01378871|Leukemia/Lymphoma|leukemia/lymphoma
5061134|NCT01378871|ATL|atl
5061135|NCT01378858|Smoking|smoking
5061136|NCT01378858|Substance-Related Disorders|substance-related disorders
5061137|NCT01378858|medication adherence|medication adherence
5061138|NCT01378858|Methadone|methadone
5061139|NCT01378845|Morbus Raynaud|morbus raynaud
5061140|NCT01378845|Ulcera Hands, Toes|ulcera hands, toes
5061141|NCT01378845|Vasospastic disorder|vasospastic disorder
5061142|NCT01378845|Raynaud's phenomenon|raynaud's phenomenon
5061143|NCT01378832|Intra-abdominal abscess|intra-abdominal abscess
5061144|NCT01378832|wound infection|wound infection
5061145|NCT01378832|colorectal surgery|colorectal surgery
5061146|NCT01378819|laparoscopic cholecystectomy|laparoscopic cholecystectomy
5061147|NCT01378819|Postoperative pain|postoperative pain
5061148|NCT01378806|overweight|overweight
5061149|NCT01378806|obesity|obesity
5061150|NCT01378806|adults|adults
5061151|NCT01378806|children|children
5061152|NCT01378793|Acupressure|acupressure
5061153|NCT01378793|Insomnia|insomnia
5061154|NCT01378793|Sleep Disorders|sleep disorders
5061155|NCT01378780|Stroke|stroke
5061156|NCT01378780|hypertension|hypertension
5061157|NCT01378780|diet|diet
5061158|NCT01378780|sodium|sodium
5061159|NCT01378780|physical activity|physical activity
5061160|NCT01378767|Dietary restriction|dietary restriction
5061161|NCT01378767|oxidative stress|oxidative stress
5061162|NCT01378767|fasting|fasting
5061163|NCT01378754|hydrodilation|hydrodilation
5061164|NCT01378754|general anesthetic|general anesthetic
5061165|NCT01378741|delirium|delirium
5061166|NCT01378741|cardiac surgery|cardiac surgery
5061167|NCT01378741|postoperative sedation|postoperative sedation
5061168|NCT01378728|Optical imaging|optical imaging
5061169|NCT01378728|Fluorescence imaging|fluorescence imaging
5061170|NCT01378728|Chronic and acute wounds|chronic and acute wounds
5061171|NCT01378728|Wound bacteria|wound bacteria
5061172|NCT01378728|Bacterial biofilms|bacterial biofilms
5061173|NCT01378728|Pathogenic bacteria|pathogenic bacteria
5061174|NCT01378728|Microorganisms|microorganisms
5061175|NCT01378728|Wound infection|wound infection
5061176|NCT01378728|Wound healing|wound healing
5061177|NCT01378728|Treatment response assessment|treatment response assessment
5061178|NCT01378715|coronary artery disease|coronary artery disease
5061179|NCT01378715|percutaneous coronary intervention|percutaneous coronary intervention
5061180|NCT01378715|statins|statins
5061181|NCT01378715|periprocedural myocardial infarction|periprocedural myocardial infarction
5061182|NCT01378702|Mistletoe|mistletoe
5061183|NCT01378702|Anthroposophical medicine|anthroposophical medicine
5061184|NCT01378663|Congenital cardiac surgery|congenital cardiac surgery
5061185|NCT01378663|Postoperative pain management|postoperative pain management
5061187|NCT01378650|Medication therapy management|medication therapy management
5061188|NCT01378650|Cilostazol|cilostazol
5061189|NCT01378650|Antiplatelet agents|antiplatelet agents
5061191|NCT01378637|Robotic device|robotic device
5061192|NCT01378637|AMES|ames
5061193|NCT01378637|Stroke|stroke
5061194|NCT01378637|Cerebrovascular Accident|cerebrovascular accident
5061195|NCT01378637|Rehabilitation|rehabilitation
5061196|NCT01378611|intractable childhood epilepsy|intractable childhood epilepsy
5061197|NCT01378611|VNS|vns
5061198|NCT01378611|immune system|immune system
5061199|NCT01378598|erlotinib|erlotinib
5061200|NCT01378598|educational intervention|educational intervention
5061201|NCT01378598|direct care nurse|direct care nurse
5061202|NCT01378585|DLBS1033|dlbs1033
5061203|NCT01378585|safety|safety
5061204|NCT01378585|fibrinolytic|fibrinolytic
5061205|NCT01378585|fibrinogenolytic|fibrinogenolytic
5061206|NCT01378585|antiplatelet|antiplatelet
5061207|NCT01378572|ICD|icd
5061208|NCT01378572|sudden cardiac death|sudden cardiac death
5061209|NCT01378572|mapping|mapping
5061210|NCT01378559|Penis prosthesis|penis prosthesis
5061211|NCT01378559|Titan|titan
5061212|NCT01378559|Satisfaction|satisfaction
5061213|NCT01378559|Complications|complications
5061214|NCT01378533|triple-negative breast cancer|triple-negative breast cancer
5061215|NCT01378533|dose-dense|dose-dense
5061216|NCT01378533|epirubicin and cyclophosphamide followed by paclitaxel（AC-T）|epirubicin and cyclophosphamide followed by paclitaxel（ac-t）
5061217|NCT01378533|paclitaxel plus carboplatin（PC）|paclitaxel plus carboplatin（pc）
5061218|NCT01378533|3 years DFS|3 years dfs
5061219|NCT01378533|the tolerance|the tolerance
5061220|NCT01378520|breathlessness|breathlessness
5061221|NCT01378520|resistive load breathing|resistive load breathing
5061222|NCT01378520|beta-endorphins|beta-endorphins
5061223|NCT01378507|endoscopic submucosal dissection|endoscopic submucosal dissection
5061224|NCT01378507|gastrointestinal neoplasm|gastrointestinal neoplasm
5061225|NCT01378494|osteoporosis|osteoporosis
5061226|NCT01378494|bone|bone
5061227|NCT01378494|HIV|hiv
5061228|NCT01378494|antiretrovirals|antiretrovirals
5061229|NCT01378494|inflammation|inflammation
5061230|NCT01378455|handwriting|handwriting
5061231|NCT01378455|cerebral palsy|cerebral palsy
5061232|NCT01378455|visual perception|visual perception
5061233|NCT01378455|sensory function|sensory function
5061234|NCT01378455|motor function|motor function
5061235|NCT01378455|computerized handwriting programs|computerized handwriting programs
5061236|NCT01378442|Cerebral palsy|cerebral palsy
5061237|NCT01378442|bone density|bone density
5061238|NCT01378442|bone strength|bone strength
5061239|NCT01378429|Perennial Allergic Rhinitis|perennial allergic rhinitis
5061240|NCT01378429|PAR|par
5061241|NCT01378416|Acute myelogenous leukemia|acute myelogenous leukemia
5061242|NCT01378416|myelodysplastic Syndrome|myelodysplastic syndrome
5061243|NCT01378416|cancer|cancer
5061244|NCT01378403|Schizophrenia|schizophrenia
5061245|NCT01378403|Cognitive deficites|cognitive deficites
5061246|NCT01378403|Degraded objects|degraded objects
5061247|NCT01378403|Magnocellular pathway|magnocellular pathway
5061248|NCT01378390|Complex perianal fistula|complex perianal fistula
5061249|NCT01378390|Crohn disease|crohn disease
5061250|NCT01378390|Adipose-derived stem cells|adipose-derived stem cells
5061251|NCT01378390|Liposuction|liposuction
5061252|NCT01378377|MEK inhibitor|mek inhibitor
5061253|NCT01378377|Temsirolimus|temsirolimus
5061254|NCT01378377|Neoplasms|neoplasms
5061255|NCT01378377|Phase I|phase i
5061256|NCT01378377|Pimasertib|pimasertib
5061257|NCT01378338|GERD|gerd
5061258|NCT01378338|Comparison between ERD and NERD|comparison between erd and nerd
5061259|NCT01378338|Rate of complete resolution|rate of complete resolution
5061260|NCT01378338|rate of recurrence|rate of recurrence
5061261|NCT01378338|QOL|qol
5061262|NCT01378338|To investigate the frequency and related risk factors of recurrence, and quality of life in patients with GERD after treatment with PPI|to investigate the frequency and related risk factors of recurrence, and quality of life in patients with gerd after treatment with ppi
5061263|NCT01378338|The aim of this study is to investigate the frequency and related risk factors of recurrence, and quality of life in patients with GERD after treatment with PPI|the aim of this study is to investigate the frequency and related risk factors of recurrence, and quality of life in patients with gerd after treatment with ppi
5061264|NCT01378325|spinal|spinal
5061265|NCT01378325|cesarean delivery|cesarean delivery
5061266|NCT01378325|phenylephrine|phenylephrine
5061267|NCT01378325|hypotension|hypotension
5061268|NCT01378312|vaccine|vaccine
5061269|NCT01378312|TB|tb
5061270|NCT01378312|tuberculosis|tuberculosis
5061271|NCT01378299|testosterone|testosterone
5061272|NCT01378273|neuroprotection|neuroprotection
5061273|NCT01378273|erythropoietin|erythropoietin
5061274|NCT01378273|Epo|epo
5061275|NCT01378273|ELGANs|elgans
5061276|NCT01378273|preterm|preterm
5061277|NCT01378273|neonate|neonate
5061278|NCT01378260|Peripheral Arterial Disease|peripheral arterial disease
5061279|NCT01378260|Claudication|claudication
5061280|NCT01378260|Comparative Effectiveness Research|comparative effectiveness research
5061281|NCT01378260|PAD Study|pad study
5061282|NCT01378260|PAD|pad
5061283|NCT01378260|atherosclerosis|atherosclerosis
5061284|NCT01378260|Intermittent claudication|intermittent claudication
5061285|NCT01378260|leg pain|leg pain
5061286|NCT01378247|Heart Failure|heart failure
5061287|NCT01378247|Family Nursing|family nursing
5061288|NCT01378247|Health-Related Quality of Life|health-related quality of life
5061289|NCT01378247|Heart Failure Clinic|heart failure clinic
5061290|NCT01378221|vitamin D|vitamin d
5061291|NCT01378221|cardiac surgery|cardiac surgery
5061292|NCT01378221|inflammation|inflammation
5061293|NCT01378221|immune system|immune system
5061294|NCT01378221|age|age
5061295|NCT01378208|Intermittent fasting|intermittent fasting
5061296|NCT01378208|Meal frequency|meal frequency
5061297|NCT01378208|body composition|body composition
5061298|NCT01378208|cognitive function|cognitive function
5061299|NCT01378208|glucose metabolism|glucose metabolism
5061300|NCT01378195|Alzheimer's Disease|alzheimer's disease
5061301|NCT01378195|Dementia|dementia
5061302|NCT01378195|caregiving|caregiving
5061303|NCT01378195|caregiver|caregiver
5061304|NCT01378195|coping|coping
5061305|NCT01378195|coping with caregiving|coping with caregiving
5061306|NCT01378195|stress|stress
5061307|NCT01378182|Transplantation,Stem Cell|transplantation,stem cell
5061308|NCT01378182|Wilson's Disease|wilson's disease
5061309|NCT01378169|SIRS|sirs
5061310|NCT01378169|Sepsis|sepsis
5061311|NCT01378169|Severe Sepsis|severe sepsis
5061312|NCT01378169|Septic Shock|septic shock
5061313|NCT01378169|Inflammatory processes|inflammatory processes
5061314|NCT01378169|Cytokines|cytokines
5061315|NCT01378169|HLA-DR|hla-dr
5061316|NCT01378169|HLA type II|hla type ii
5061317|NCT01378169|Chemokines|chemokines
5061318|NCT01378169|TLR expression|tlr expression
5061319|NCT01378169|mRNA expression in whole blood|mrna expression in whole blood
5061320|NCT01378169|Bacterial DNA detection|bacterial dna detection
5061321|NCT01378169|Prognosis factors|prognosis factors
5061322|NCT01378169|Infection|infection
5061323|NCT01378169|Diagnosis|diagnosis
5061324|NCT01378156|Therapy for HIV Infection|therapy for hiv infection
5061325|NCT01378156|Suppressive ART with no failures|suppressive art with no failures
5061326|NCT01378156|Treatment interruption|treatment interruption
5061327|NCT01378143|Colorectal Cancer|colorectal cancer
5061328|NCT01378143|Pentamidine bis(2-hydroxyethanesulfonate)|pentamidine bis(2-hydroxyethanesulfonate)
5061329|NCT01378143|OCZ103-OS|ocz103-os
5061330|NCT01378143|Standard of Care|standard of care
5061331|NCT01378130|CCS|ccs
5061332|NCT01378130|CSC|csc
5061333|NCT01378130|Subretinal Fluid|subretinal fluid
5061334|NCT01378130|multimodal imaging|multimodal imaging
5061335|NCT01378117|diabetes|diabetes
5061336|NCT01378117|non critical care setting|non critical care setting
5061337|NCT01378117|hyperglycemia|hyperglycemia
5061338|NCT01378117|treatment|treatment
5061339|NCT01378117|oral antidiabetic agents|oral antidiabetic agents
5061340|NCT01378117|subcutaneous insulin|subcutaneous insulin
5061341|NCT01378104|reducing dose of peginterferon|reducing dose of peginterferon
5061342|NCT01378104|chronic hepatitis c|chronic hepatitis c
5061343|NCT01378104|Koreans|koreans
5061344|NCT01378104|IL28B polymorphism|il28b polymorphism
5061345|NCT01378091|Androgen Independent Prostate Cancer|androgen independent prostate cancer
5061346|NCT01378078|schizophrenia|schizophrenia
5061347|NCT01378078|negative syndrome|negative syndrome
5061348|NCT01378078|PANSS|panss
5061349|NCT01378065|POP|pop
5061350|NCT01378065|pelvic organ prolapse|pelvic organ prolapse
5061351|NCT01378065|anterior prolapse|anterior prolapse
5061352|NCT01378065|posterior prolapse|posterior prolapse
5061353|NCT01378065|vaginal prolapse|vaginal prolapse
5061354|NCT01378065|vaginal floor reconstruction|vaginal floor reconstruction
5061355|NCT01378039|COPD|copd
5061356|NCT01378039|Asthma|asthma
5061357|NCT01378039|Pathophysiology|pathophysiology
5061358|NCT01378039|Genetics|genetics
5061359|NCT01378039|Phenotype|phenotype
5061360|NCT01378039|Treatment response|treatment response
5061361|NCT01378026|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
5061362|NCT01378026|G72|g72
5061363|NCT01378026|SNP|snp
5061364|NCT01378013|Metabonomics|metabonomics
5061365|NCT01378013|Systems biology|systems biology
5061366|NCT01378013|Intelligent knife|intelligent knife
5061367|NCT01378013|Colorectal cancer|colorectal cancer
5061368|NCT01378013|NMR|nmr
5061369|NCT01378013|Mass spectrometry|mass spectrometry
5061370|NCT01377974|Leishmaniasis|leishmaniasis
5061371|NCT01377974|Mucocutaneous Leishmaniasis|mucocutaneous leishmaniasis
5061372|NCT01377974|Therapeutics|therapeutics
5061373|NCT01377974|meglumine antimoniate|meglumine antimoniate
5061374|NCT01377974|miltefosine|miltefosine
5061375|NCT01377948|Anger|anger
5061376|NCT01377948|Aggression|aggression
5061377|NCT01377948|CBT|cbt
5061378|NCT01377948|Videogame|videogame
5061379|NCT01377948|biofeedback|biofeedback
5061380|NCT01377909|chronic hepatitis C, interferon|chronic hepatitis c, interferon
5061381|NCT01377883|Needle, Anxiety, Pain, Clowns|needle, anxiety, pain, clowns
5061382|NCT01377870|multiple sclerosis mesenchymal stem cell intravenous injection|multiple sclerosis mesenchymal stem cell intravenous injection
5061383|NCT01377844|Diabetes mellitus|diabetes mellitus
5061384|NCT01377818|COPD|copd
5061385|NCT01377818|Exercise trainig|exercise trainig
5061386|NCT01377805|Multiple Sclerosis hydrocephalus|multiple sclerosis hydrocephalus
5061387|NCT01377792|hypertonic saline|hypertonic saline
5061388|NCT01377792|cystic fibrosis|cystic fibrosis
5061389|NCT01377792|pulmonary inflammation|pulmonary inflammation
5061390|NCT01377792|pulmonary exacerbation|pulmonary exacerbation
5061391|NCT01377779|Oxiplex/AP gel|oxiplex/ap gel
5061392|NCT01377779|Prevention of Asherman's syndrome|prevention of asherman's syndrome
5061393|NCT01377779|Intra uterine adhesions|intra uterine adhesions
5061394|NCT01377766|Bell's palsy|bell's palsy
5061395|NCT01377766|psychological stress|psychological stress
5061396|NCT01377766|personality factors|personality factors
5061397|NCT01377766|psychological factors|psychological factors
5061398|NCT01377753|Toxicity|toxicity
5061399|NCT01377753|Thermal Ablation/Damage|thermal ablation/damage
5061400|NCT01377753|Localized Prostate Cancer|localized prostate cancer
5061401|NCT01377753|Laser Ablation|laser ablation
5061402|NCT01377753|PSA Levels|psa levels
5061403|NCT01377753|Prostate Cancer|prostate cancer
5061404|NCT01377740|Lipolysis|lipolysis
5061405|NCT01377740|Cryolipolysis|cryolipolysis
5061406|NCT01377740|Fat Reduction|fat reduction
5061407|NCT01377701|pituitary adenomas|pituitary adenomas
5061408|NCT01377701|recovery of vision|recovery of vision
5061409|NCT01377701|trans-sphenoidal surgery|trans-sphenoidal surgery
5061410|NCT01377688|DKD|dkd
5061411|NCT01377636|Isoproterenol|isoproterenol
5061412|NCT01377636|Bispectral index (BIS)|bispectral index (bis)
5061413|NCT01377636|electrophysiology studies (EPS)|electrophysiology studies (eps)
5061414|NCT01377623|Spinal fusion|spinal fusion
5061415|NCT01377623|Inflammatory response|inflammatory response
5061416|NCT01377623|Inflammatory markers|inflammatory markers
5061417|NCT01377623|Dexmedetomidine|dexmedetomidine
5061418|NCT01377610|Outpatient detoxification|outpatient detoxification
5061419|NCT01377610|Opioid dependence|opioid dependence
5061420|NCT01377610|Naltrexone|naltrexone
5061421|NCT01377610|Vivitrol|vivitrol
5061422|NCT01377610|Buprenorphine|buprenorphine
5061423|NCT01377597|retinal vein occlusion|retinal vein occlusion
5061424|NCT01377597|branch retinal vein occlusion|branch retinal vein occlusion
5061425|NCT01377597|central retinal vein occlusion|central retinal vein occlusion
5061426|NCT01377597|visual impairment|visual impairment
5061427|NCT01377597|macular edema|macular edema
5061428|NCT01377597|ranibizumab|ranibizumab
5061429|NCT01377584|Continuous Positive Airway Pressure|continuous positive airway pressure
5061430|NCT01377584|Patient Compliance|patient compliance
5061431|NCT01377584|Intervention Studies|intervention studies
5061432|NCT01377584|Spouses|spouses
5061433|NCT01377571|diarrhea|diarrhea
5061434|NCT01377571|fever|fever
5061435|NCT01377571|nausea|nausea
5061436|NCT01377571|vomit|vomit
5061437|NCT01377571|irritability|irritability
5061438|NCT01377558|aerobic training|aerobic training
5061439|NCT01377558|resistance training|resistance training
5061440|NCT01377558|combination of aerobic and resistance training|combination of aerobic and resistance training
5061441|NCT01377558|diabetes|diabetes
5061442|NCT01377558|type 2 diabetes|type 2 diabetes
5061443|NCT01377558|HbA1c|hba1c
5061444|NCT01377558|endothelial dysfunction|endothelial dysfunction
5061445|NCT01377558|inflammation markers|inflammation markers
5061446|NCT01377558|Parodontitis|parodontitis
5061447|NCT01377558|Exercise intervention|exercise intervention
5061448|NCT01377558|training|training
5061449|NCT01377545|Infraclavicular|infraclavicular
5061450|NCT01377545|Nerve Block|nerve block
5061451|NCT01377545|Needle|needle
5061452|NCT01377545|Perineural Catheter|perineural catheter
5061453|NCT01377545|Volunteer|volunteer
5061454|NCT01377545|Upper Extremity Nerve Block|upper extremity nerve block
5061455|NCT01377545|Sensation|sensation
5061456|NCT01377545|Strength|strength
5061457|NCT01377532|Pheochromocytoma|pheochromocytoma
5061458|NCT01377532|Paraganglioma|paraganglioma
5061459|NCT01377532|MIBG|mibg
5061460|NCT01377532|131I-MIBG|131i-mibg
5061461|NCT01377532|Resistant|resistant
5061462|NCT01377532|Relapsed|relapsed
5061463|NCT01377532|Treatment|treatment
5061464|NCT01377532|UCSF|ucsf
5061465|NCT01377532|Pediatric|pediatric
5061466|NCT01377532|Adult|adult
5061467|NCT01377532|Oncology|oncology
5061468|NCT01377519|Fibroids|fibroids
5061469|NCT01377519|Uterine|uterine
5061470|NCT01377519|Focused Ultrasound|focused ultrasound
5061471|NCT01377519|Magnetic Resonance focused ultrasound|magnetic resonance focused ultrasound
5061472|NCT01377519|HIFU|hifu
5061473|NCT01377519|NOninvasive|noninvasive
5061474|NCT01377519|Treatment|treatment
5061475|NCT01377506|behavioral weight control|behavioral weight control
5061476|NCT01377506|lifestyle intervention|lifestyle intervention
5061477|NCT01377506|memory training|memory training
5061478|NCT01377506|cognitive training|cognitive training
5061479|NCT01377506|community-based|community-based
5061480|NCT01377493|chewing-gum|chewing-gum
5061481|NCT01377493|enamel subsurface lesion|enamel subsurface lesion
5061482|NCT01377493|calcium additives|calcium additives
5061483|NCT01377493|fluoride|fluoride
5061484|NCT01377493|in situ|in situ
5061485|NCT01377467|Osteoporosis|osteoporosis
5061486|NCT01377467|Osteopenia|osteopenia
5061487|NCT01377467|Denosumab|denosumab
5061488|NCT01377467|Transplantation|transplantation
5061489|NCT01377467|Kidney|kidney
5061490|NCT01377454|mTBI|mtbi
5061491|NCT01377454|concussion|concussion
5061492|NCT01377454|mild Traumatic Brain Injury|mild traumatic brain injury
5061493|NCT01377454|balance|balance
5061494|NCT01377454|sensors|sensors
5061495|NCT01377441|Ibuprofen|ibuprofen
5061496|NCT01377441|Cytokines|cytokines
5061497|NCT01377441|Recovery|recovery
5061498|NCT01377441|IV ibuprofen|iv ibuprofen
5061499|NCT01377441|major surgery|major surgery
5061500|NCT01377428|COPD|copd
5061501|NCT01377428|Indacaterol|indacaterol
5061502|NCT01377428|Formoterol|formoterol
5061503|NCT01377415|arthroscopy|arthroscopy
5061504|NCT01377415|shoulder surgery|shoulder surgery
5061505|NCT01377415|subacromial|subacromial
5061506|NCT01377415|continuous bupivacaine|continuous bupivacaine
5061507|NCT01377389|Prostate cancer|prostate cancer
5061508|NCT01377389|Castrate sensitive prostate carcinoma|castrate sensitive prostate carcinoma
5061509|NCT01377389|Metastatic prostate carcinoma|metastatic prostate carcinoma
5061510|NCT01377389|Androgen deprivation therapy|androgen deprivation therapy
5061511|NCT01377389|ADT|adt
5061512|NCT01377389|Prostate-specific antigen|prostate-specific antigen
5061513|NCT01377389|PSA|psa
5061514|NCT01377389|Ipilimumab|ipilimumab
5061515|NCT01377389|Yervoy|yervoy
5061516|NCT01377389|BMS-734016|bms-734016
5061517|NCT01377389|MDX010|mdx010
5061518|NCT01377389|Leuprolide|leuprolide
5061519|NCT01377389|Lupron Depot|lupron depot
5061520|NCT01377389|Leuprolide Acetate|leuprolide acetate
5061521|NCT01377389|Goserelin|goserelin
5061522|NCT01377389|Zoladex|zoladex
5061523|NCT01377389|Degarelix|degarelix
5061524|NCT01377389|Firmagon|firmagon
5061525|NCT01377363|metastatic breast cancer|metastatic breast cancer
5061526|NCT01377363|primary breast cancer|primary breast cancer
5061527|NCT01377350|Heart failure|heart failure
5061528|NCT01377350|monitoring|monitoring
5061529|NCT01377337|cardiac arrest|cardiac arrest
5061530|NCT01377337|cardiopulmonary resuscitation|cardiopulmonary resuscitation
5061531|NCT01377337|(sodium) bicarbonate|(sodium) bicarbonate
5061532|NCT01377337|return of spontaneous circulation|return of spontaneous circulation
5061533|NCT01377337|outcome|outcome
5061534|NCT01377324|Breast cancer|breast cancer
5061535|NCT01377324|Fulvestrant|fulvestrant
5061536|NCT01377324|FES|fes
5061537|NCT01377324|PET|pet
5061538|NCT01377324|Positron|positron
5061539|NCT01377324|Emission|emission
5061540|NCT01377324|Tomography|tomography
5061541|NCT01377324|Fluoroestradiol|fluoroestradiol
5061542|NCT01377324|FES-PET|fes-pet
5061543|NCT01377324|Molecular Imaging|molecular imaging
5061544|NCT01377324|Estrogen Receptor|estrogen receptor
5061545|NCT01377311|limbal stem cell|limbal stem cell
5061546|NCT01377311|amniotic membrane|amniotic membrane
5061547|NCT01377311|ex vivo expansion of autologous limbal stem cell|ex vivo expansion of autologous limbal stem cell
5061548|NCT01377311|unilateral limbal stem cell insufficiency|unilateral limbal stem cell insufficiency
5061549|NCT01377285|chronic kidney disease|chronic kidney disease
5061550|NCT01377285|pentoxifylline|pentoxifylline
5061551|NCT01377285|angiotensin receptor blockers(ARB)|angiotensin receptor blockers(arb)
5061552|NCT01377272|HIV/AIDS|hiv/aids
5061553|NCT01377272|spatial epidemiology|spatial epidemiology
5061554|NCT01377272|geographic information system|geographic information system
5061555|NCT01377272|HIV-infection/Aids|hiv-infection/aids
5061556|NCT01377259|changes|changes
5061557|NCT01377259|tissue|tissue
5061558|NCT01377259|oxygenation|oxygenation
5061559|NCT01377259|saturation|saturation
5061560|NCT01377259|between|between
5061561|NCT01377259|upper|upper
5061562|NCT01377259|lower|lower
5061563|NCT01377259|extremities|extremities
5061564|NCT01377259|patients|patients
5061565|NCT01377259|Adverse Effect|adverse effect
5061566|NCT01377259|Spinal and Epidural|spinal and epidural
5061567|NCT01377246|Somatostatin.|somatostatin.
5061568|NCT01377246|Polycystic kidney disease.|polycystic kidney disease.
5061569|NCT01377246|Renal insufficiency.|renal insufficiency.
5061570|NCT01377233|Schizophrenia|schizophrenia
5061571|NCT01377233|Antipsychotic|antipsychotic
5061572|NCT01377233|Zicronapine|zicronapine
5061573|NCT01377233|Lu 31-310|lu 31-310
5061574|NCT01377220|Hepatocellular carcinoma|hepatocellular carcinoma
5061575|NCT01377220|Positron Emission Tomography/computed tomography (PET-CT)|positron emission tomography/computed tomography (pet-ct)
5061576|NCT01377220|11C-Choline|11c-choline
5061577|NCT01377220|alpha fetoprotein|alpha fetoprotein
5061578|NCT01377220|Dynamic magnetic resonance imaging|dynamic magnetic resonance imaging
5061579|NCT01377220|Abdomen computed tomography|abdomen computed tomography
5061580|NCT01377220|Tumoral liver biopsy|tumoral liver biopsy
5061581|NCT01377207|ST segment Elevation Myocardial Infarction|st segment elevation myocardial infarction
5061582|NCT01377207|Optical Coherence Tomography|optical coherence tomography
5061583|NCT01377207|Percutaneous Coronary Intervention|percutaneous coronary intervention
5061584|NCT01377207|Thrombus hystopathology|thrombus hystopathology
5061585|NCT01377207|Gender differences|gender differences
5061586|NCT01377194|Depression|depression
5061587|NCT01377194|Major Depressive Disorder|major depressive disorder
5061588|NCT01377181|Inguinal hernia|inguinal hernia
5061590|NCT01377181|Lateral us ligament|lateral us ligament
5061591|NCT01377181|Recurrence|recurrence
5061592|NCT01377181|Pediatric|pediatric
5061593|NCT01377181|unilateral inguinal hernia|unilateral inguinal hernia
5061594|NCT01377155|basal insulin|basal insulin
5061595|NCT01377155|hypoglycemia|hypoglycemia
5061596|NCT01377155|diabetes mellitus type two|diabetes mellitus type two
5061597|NCT01377142|Uterovaginal prolapse|uterovaginal prolapse
5061598|NCT01377142|hysteropexy|hysteropexy
5061599|NCT01377142|mesh|mesh
5061600|NCT01377129|Residual Rotational Laxity|residual rotational laxity
5061601|NCT01377103|heart failure|heart failure
5061602|NCT01377103|hypogonadism|hypogonadism
5061603|NCT01377103|testosterone|testosterone
5061604|NCT01377077|vitiligo|vitiligo
5061605|NCT01377077|piebaldism|piebaldism
5061606|NCT01377077|punchgrafting|punchgrafting
5061607|NCT01377077|minigrafting|minigrafting
5061608|NCT01377077|stable for at least 12 months|stable for at least 12 months
5061609|NCT01377064|HIV|hiv
5061610|NCT01377064|physical activity|physical activity
5061611|NCT01377064|cardiovascular disease risk|cardiovascular disease risk
5061612|NCT01377051|COPD|copd
5061613|NCT01377051|Inspiratory capacity|inspiratory capacity
5061614|NCT01377051|Residual volume|residual volume
5061615|NCT01377051|Total lung resistance|total lung resistance
5061616|NCT01377051|Arterial Oxygen|arterial oxygen
5061617|NCT01377038|Osteoarthritis|osteoarthritis
5061618|NCT01377038|Chronic pain|chronic pain
5061619|NCT01377038|Central pain|central pain
5061620|NCT01377012|Rheumatoid Arthritis|rheumatoid arthritis
5061621|NCT01377012|RA|ra
5061622|NCT01377012|ACR|acr
5061623|NCT01377012|inflammatory joints|inflammatory joints
5061624|NCT01376999|Sterility|sterility
5061625|NCT01376999|FSH-r|fsh-r
5061626|NCT01376999|intrauterine insemination|intrauterine insemination
5061627|NCT01376999|unexplained sterility|unexplained sterility
5061628|NCT01376973|stress, temporomandibular disorders.|stress, temporomandibular disorders.
5061629|NCT01376960|forefoot surgery|forefoot surgery
5061630|NCT01376960|Ankle Block|ankle block
5061631|NCT01376960|Popliteal Fossa Block|popliteal fossa block
5061632|NCT01376947|IUD device insertion|iud device insertion
5061633|NCT01376947|Nulliparous|nulliparous
5061634|NCT01376947|Multiparous|multiparous
5061635|NCT01376947|Pain|pain
5061636|NCT01376934|hysteroscopy|hysteroscopy
5061637|NCT01376934|saline solution|saline solution
5061638|NCT01376934|carbon dioxide|carbon dioxide
5061639|NCT01376934|compare two techniques in office hysteroscopy co2 and saline solution|compare two techniques in office hysteroscopy co2 and saline solution
5061640|NCT01376921|Growth disorders|growth disorders
5061641|NCT01376921|Saizen|saizen
5061642|NCT01376921|Easypod|easypod
5061643|NCT01376921|Growth hormone|growth hormone
5061644|NCT01376921|Pediatric subject|pediatric subject
5061645|NCT01376908|Phenylketonuria (PKU)|phenylketonuria (pku)
5061646|NCT01376908|Kuvan® (Sapropterin)|kuvan® (sapropterin)
5061647|NCT01376908|Phe-restricted diet|phe-restricted diet
5061648|NCT01376908|Paediatric <4 years old|paediatric <4 years old
5061649|NCT01376908|responders to BH4|responders to bh4
5061650|NCT01376908|Phe tolerance|phe tolerance
5061651|NCT01376895|Black MSM/W|black msm/w
5061652|NCT01376895|HIV|hiv
5061653|NCT01376882|Caffeine|caffeine
5061654|NCT01376882|Withdrawal|withdrawal
5061655|NCT01376882|Cognitive function|cognitive function
5061656|NCT01376882|Mood|mood
5061657|NCT01376882|Cerebral haemodynamics|cerebral haemodynamics
5061658|NCT01376869|Hops|hops
5061659|NCT01376869|Mood|mood
5061660|NCT01376869|Cognitive Function|cognitive function
5061661|NCT01376869|Bioavailability|bioavailability
5061662|NCT01376869|Satiety|satiety
5061663|NCT01376869|Blood Pressure|blood pressure
5061664|NCT01376869|Heart rate|heart rate
5061665|NCT01376856|mediastinal lymph node with false positive FDG PET/CT results in lung cancer staging|mediastinal lymph node with false positive fdg pet/ct results in lung cancer staging
5061666|NCT01376843|latent tuberculosis in health care workers|latent tuberculosis in health care workers
5061667|NCT01376830|COPD|copd
5061668|NCT01376830|Exacerbations|exacerbations
5061669|NCT01376830|Viruses|viruses
5061670|NCT01376817|Severe acute pancreatitis|severe acute pancreatitis
5061671|NCT01376817|total parenteral nutrition|total parenteral nutrition
5061672|NCT01376817|fat emulsions|fat emulsions
5061673|NCT01376817|omega 3 fatty acids|omega 3 fatty acids
5061674|NCT01376791|Periodontal disease|periodontal disease
5061675|NCT01376791|Atherosclerosis|atherosclerosis
5061676|NCT01376791|Oral Pathogens|oral pathogens
5061677|NCT01376791|Native Americans|native americans
5061678|NCT01376791|Inflammatory cytokines|inflammatory cytokines
5061679|NCT01376791|Microbial metagenomics|microbial metagenomics
5061680|NCT01376778|Perinatology|perinatology
5061681|NCT01376778|Cytomegalovirus immune globulin|cytomegalovirus immune globulin
5061682|NCT01376778|Cytogam|cytogam
5061683|NCT01376778|CMVIG infusions|cmvig infusions
5061684|NCT01376765|SARS, coronavirus, vaccine, adjuvant, Alhydrogel®, severe acute respiratory syndrome|sars, coronavirus, vaccine, adjuvant, alhydrogel®, severe acute respiratory syndrome
5061685|NCT01376739|Magnevist|magnevist
5061686|NCT01376739|MR angiography|mr angiography
5061687|NCT01376713|Melanoma|melanoma
5061688|NCT01376687|Osteopathic Medicine|osteopathic medicine
5061689|NCT01376687|Cervical Spine|cervical spine
5061690|NCT01376687|Kinetics|kinetics
5061691|NCT01376674|localised|localised
5061692|NCT01376674|prostate cancer|prostate cancer
5061693|NCT01376674|radiotherapy|radiotherapy
5061694|NCT01376674|immunology|immunology
5061695|NCT01376661|Prostate Cancer|prostate cancer
5061696|NCT01376661|Active Surveillance|active surveillance
5061697|NCT01376661|Low risk prostate cancer|low risk prostate cancer
5061698|NCT01376635|Chronic Kidney Disease|chronic kidney disease
5061699|NCT01376635|Autonomic Dysfunction|autonomic dysfunction
5061700|NCT01376609|Stroke|stroke
5061701|NCT01376609|Ischaemic Stroke|ischaemic stroke
5061702|NCT01376609|Cerebral Infarction|cerebral infarction
5061703|NCT01376609|Cerebrovascular Disorders|cerebrovascular disorders
5061704|NCT01376609|Brain Diseases|brain diseases
5061705|NCT01376609|Nervous System Diseases|nervous system diseases
5061706|NCT01376609|Vascular Diseases|vascular diseases
5061707|NCT01376609|Brain Infarction|brain infarction
5061708|NCT01376609|Brain Ischemia|brain ischemia
5061709|NCT01376609|mismatch|mismatch
5061710|NCT01376609|PWI/DWI mismatch|pwi/dwi mismatch
5061711|NCT01376609|ischaemic penumbra|ischaemic penumbra
5061712|NCT01376609|image analysis|image analysis
5061713|NCT01376596|Remission|remission
5061714|NCT01376596|Psychosocial Functioning|psychosocial functioning
5061715|NCT01376596|Symptoms reduction|symptoms reduction
5061716|NCT01376583|Breast cancer|breast cancer
5061717|NCT01376583|Exercise|exercise
5061718|NCT01376583|Myokines|myokines
5061719|NCT01376583|AMPK|ampk
5061720|NCT01376570|HIV|hiv
5061721|NCT01376570|Opiate dependence|opiate dependence
5061722|NCT01376570|Opiate replacement therapy|opiate replacement therapy
5061723|NCT01376570|Cocaine-related disorders|cocaine-related disorders
5061724|NCT01376570|Risk Reduction Behavior|risk reduction behavior
5061725|NCT01376570|Medication Adherence|medication adherence
5061726|NCT01376570|Motivation|motivation
5061727|NCT01376557|diabetes mellitus|diabetes mellitus
5061728|NCT01376544|Neonate|neonate
5061729|NCT01376544|Weaning|weaning
5061730|NCT01376544|Assist control ventilation|assist control ventilation
5061731|NCT01376544|Pressure support ventilation|pressure support ventilation
5061732|NCT01376531|acute renal failure|acute renal failure
5061733|NCT01376531|cerebrovascular autoregulation|cerebrovascular autoregulation
5061734|NCT01376531|transcranial Doppler|transcranial doppler
5061735|NCT01376531|continuous veno-venous hemodialysis|continuous veno-venous hemodialysis
5061736|NCT01376518|acute respiratory distress syndrome|acute respiratory distress syndrome
5061737|NCT01376518|acute lung injury|acute lung injury
5061738|NCT01376518|cerebrovascular autoregulation|cerebrovascular autoregulation
5061739|NCT01376518|transcranial Doppler|transcranial doppler
5061740|NCT01376518|ventilation|ventilation
5061741|NCT01376505|Vaccine Therapy|vaccine therapy
5061742|NCT01376492|Schizophrenia|schizophrenia
5061743|NCT01376492|Sleep disturbances|sleep disturbances
5061744|NCT01376492|Quality of sleep|quality of sleep
5061745|NCT01376492|Functioning level|functioning level
5061746|NCT01376492|Antipsychotic therapy.|antipsychotic therapy.
5061747|NCT01376479|HFMD|hfmd
5061748|NCT01376479|EV71|ev71
5061749|NCT01376479|Enterovirus|enterovirus
5061750|NCT01376479|INV21|inv21
5061751|NCT01376479|Encephalitis|encephalitis
5061752|NCT01376466|acute appendicitis|acute appendicitis
5061753|NCT01376466|diagnosis|diagnosis
5061754|NCT01376466|computed tomography|computed tomography
5061755|NCT01376453|External Radiation Therapy|external radiation therapy
5061756|NCT01376453|Locally Advanced Rectal|locally advanced rectal
5061757|NCT01376453|Adenocarcinoma|adenocarcinoma
5061758|NCT01376440|three or more loss stools in 24 hours|three or more loss stools in 24 hours
5061759|NCT01376414|dyspepsia|dyspepsia
5061760|NCT01376414|abdominal|abdominal
5061761|NCT01376414|pain|pain
5061762|NCT01376414|helicobacter|helicobacter
5061763|NCT01376414|pylori|pylori
5061764|NCT01376414|[C06.405.748.398]|[c06.405.748.398]
5061765|NCT01376414|[C06.405.748.586]|[c06.405.748.586]
5061766|NCT01376414|[C06.405.748.586.698]|[c06.405.748.586.698]
5061767|NCT01376414|[C06.405.748.586.849]|[c06.405.748.586.849]
5061768|NCT01376388|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
5061769|NCT01376388|Pharmacogenetics|pharmacogenetics
5061770|NCT01376388|GSK573719/GW642444|gsk573719/gw642444
5061771|NCT01376375|Acupuncture|acupuncture
5061772|NCT01376375|Low Back Pain|low back pain
5061773|NCT01376362|Cystoid Macular Edema|cystoid macular edema
5061774|NCT01376362|Intermediate Uveitis|intermediate uveitis
5061775|NCT01376362|Uveitis|uveitis
5061776|NCT01376362|OCT|oct
5061777|NCT01376362|Interferon-Gamma (IFN-Gamma)|interferon-gamma (ifn-gamma)
5061778|NCT01376349|depression|depression
5061779|NCT01376349|anxiety disorder|anxiety disorder
5061780|NCT01376349|cognitive/functional effects|cognitive/functional effects
5061781|NCT01376349|sexual dysfunction|sexual dysfunction
5061782|NCT01376349|cancer survivor|cancer survivor
5061783|NCT01376349|breast cancer|breast cancer
5061784|NCT01376349|cervical cancer|cervical cancer
5061785|NCT01376349|fallopian tube cancer|fallopian tube cancer
5061786|NCT01376349|uterine sarcoma|uterine sarcoma
5061787|NCT01376349|vaginal cancer|vaginal cancer
5061788|NCT01376349|vulvar cancer|vulvar cancer
5061789|NCT01376349|ovarian epithelial cancer|ovarian epithelial cancer
5061790|NCT01376349|ovarian germ cell tumor|ovarian germ cell tumor
5061791|NCT01376349|ovarian sarcoma|ovarian sarcoma
5061792|NCT01376349|ovarian stromal cancer|ovarian stromal cancer
5061793|NCT01376349|primary peritoneal cavity cancer|primary peritoneal cavity cancer
5061794|NCT01376349|endometrial cancer|endometrial cancer
5061795|NCT01376336|environmental health|environmental health
5061796|NCT01376336|diarrhea|diarrhea
5061798|NCT01376336|HIV|hiv
5061799|NCT01376323|Safety|safety
5061800|NCT01376323|Dose Ranging|dose ranging
5061801|NCT01376323|Efficacy|efficacy
5061802|NCT01376258|benign prostatic hyperplasia|benign prostatic hyperplasia
5061803|NCT01376258|acute urinary retention|acute urinary retention
5061804|NCT01376258|adherence|adherence
5061805|NCT01376258|5-alpha reductase inhibitor|5-alpha reductase inhibitor
5061806|NCT01376258|enlarged prostate|enlarged prostate
5061807|NCT01376258|surgery|surgery
5061808|NCT01376232|Anaemia|anaemia
5061809|NCT01376232|Drug- Drug Interaction|drug- drug interaction
5061810|NCT01376219|GINA|gina
5061811|NCT01376219|direct / indirect costs|direct / indirect costs
5061812|NCT01376219|exacerbations|exacerbations
5061813|NCT01376219|European|european
5061814|NCT01376219|asthma control|asthma control
5061815|NCT01376219|Asthma Control Test (TM - QualityMetric Incorporated)|asthma control test (tm - qualitymetric incorporated)
5061816|NCT01376102|osteoporosis|osteoporosis
5061817|NCT01376102|ibandronate|ibandronate
5061818|NCT01376089|Safety|safety
5061819|NCT01376076|schizophrenia|schizophrenia
5061820|NCT01376076|QTc|qtc
5061821|NCT01376076|cardiac repolarization|cardiac repolarization
5061822|NCT01376050|venous stasis ulcer|venous stasis ulcer
5061823|NCT01376050|leg ulcer|leg ulcer
5061824|NCT01376037|upper arm|upper arm
5061825|NCT01376037|body contouring|body contouring
5061826|NCT01376037|body shaping|body shaping
5061827|NCT01376024|Carpometacarpal arthritis|carpometacarpal arthritis
5061828|NCT01376024|Basal joint arthritis|basal joint arthritis
5061829|NCT01376024|CMC arthritis|cmc arthritis
5061830|NCT01376024|Osteoarthritis|osteoarthritis
5061831|NCT01376011|quercetin|quercetin
5061832|NCT01376011|brain blood flow|brain blood flow
5061833|NCT01376011|aging|aging
5061834|NCT01376011|memory|memory
5061835|NCT01375998|YAZ|yaz
5061836|NCT01375998|Dysmenorrhea|dysmenorrhea
5061837|NCT01375972|biliary cancer|biliary cancer
5061838|NCT01375972|systemic chemotherapy|systemic chemotherapy
5061839|NCT01375972|S-1|s-1
5061840|NCT01375972|gemcitabine|gemcitabine
5061841|NCT01375972|cisplatin|cisplatin
5061842|NCT01375959|resveratrol|resveratrol
5061843|NCT01375959|glucose intolerance|glucose intolerance
5061844|NCT01375959|insulin resistance|insulin resistance
5061845|NCT01375959|endothelial function|endothelial function
5061846|NCT01375946|Pharmacokinetic Profile (PK) and Safety|pharmacokinetic profile (pk) and safety
5061847|NCT01375946|PK analysis of EE and LNG|pk analysis of ee and lng
5061848|NCT01375933|Smoking|smoking
5061849|NCT01375933|NicVAX|nicvax
5061850|NCT01375933|Smoking vaccine|smoking vaccine
5061851|NCT01375920|Depression|depression
5061852|NCT01375920|Antiglucocorticoid|antiglucocorticoid
5061853|NCT01375920|Anti-depressants|anti-depressants
5061854|NCT01375907|blood cell counts|blood cell counts
5061855|NCT01375907|BUN|bun
5061856|NCT01375907|ALT|alt
5061857|NCT01375907|AST|ast
5061858|NCT01375907|diarrhea|diarrhea
5061859|NCT01375907|fever|fever
5061860|NCT01375907|vomit|vomit
5061861|NCT01375907|nausea|nausea
5061862|NCT01375907|loss of appetite|loss of appetite
5061863|NCT01375907|irritability|irritability
5061864|NCT01375881|HIV|hiv
5061865|NCT01375881|darunavir|darunavir
5061866|NCT01375881|ritonavir|ritonavir
5061867|NCT01375881|Prezista|prezista
5061868|NCT01375881|naive|naive
5061869|NCT01375881|experienced|experienced
5061870|NCT01375868|HPV|hpv
5061871|NCT01375868|recurrent respiratory papillomatosis|recurrent respiratory papillomatosis
5061872|NCT01375868|antibodies|antibodies
5061873|NCT01375855|Late stent malapposition|late stent malapposition
5061874|NCT01375855|stent thrombosis|stent thrombosis
5061875|NCT01375855|IVUS|ivus
5061876|NCT01375855|non-polimeric stent|non-polimeric stent
5061877|NCT01375816|adenocarcinoma of the colon|adenocarcinoma of the colon
5061878|NCT01375816|recurrent colon cancer|recurrent colon cancer
5061879|NCT01375816|stage IV colon cancer|stage iv colon cancer
5061880|NCT01375816|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5061881|NCT01375816|recurrent rectal cancer|recurrent rectal cancer
5061882|NCT01375816|stage IV rectal cancer|stage iv rectal cancer
5061883|NCT01375803|dietary fiber|dietary fiber
5061884|NCT01375803|fiber|fiber
5061885|NCT01375803|insulin sensitivity|insulin sensitivity
5061886|NCT01375803|insulin resistance|insulin resistance
5061887|NCT01375803|glucose metabolism|glucose metabolism
5061888|NCT01375790|whole-body vibration|whole-body vibration
5061889|NCT01375790|older people|older people
5061890|NCT01375790|exercise|exercise
5061891|NCT01375790|body balance|body balance
5061892|NCT01375790|muscle performance|muscle performance
5061893|NCT01375790|falls|falls
5061894|NCT01375790|physiotherapy|physiotherapy
5061895|NCT01375777|High cholesterol|high cholesterol
5061896|NCT01375777|Proprotein convertase subtilisin/kexin type 9 (PCSK9)|proprotein convertase subtilisin/kexin type 9 (pcsk9)
5061897|NCT01375777|Treatment for high cholesterol|treatment for high cholesterol
5061898|NCT01375777|Lowering cholesterol|lowering cholesterol
5061899|NCT01375777|Lowering high cholesterol|lowering high cholesterol
5061900|NCT01375777|Hypercholesterolemia|hypercholesterolemia
5061901|NCT01375764|Proprotein convertase subtilisin/kexin type 9 (PCSK9)|proprotein convertase subtilisin/kexin type 9 (pcsk9)
5061902|NCT01375764|Cholesterol|cholesterol
5061903|NCT01375764|High Cholesterol|high cholesterol
5061904|NCT01375764|Raised Cholesterol|raised cholesterol
5061905|NCT01375764|Elevated Cholesterol|elevated cholesterol
5061906|NCT01375764|Statin intolerant|statin intolerant
5061907|NCT01375764|Hypercholesterolemia|hypercholesterolemia
5061908|NCT01375751|Heterozygous Familial Hypercholesterolemia|heterozygous familial hypercholesterolemia
5061909|NCT01375751|Proprotein convertase subtilisin/kexin type 9 (PCSK9)|proprotein convertase subtilisin/kexin type 9 (pcsk9)
5061910|NCT01375738|Early gastric cancer|early gastric cancer
5061911|NCT01375712|Hard or lumpy stools|hard or lumpy stools
5061912|NCT01375712|Stool consistency|stool consistency
5061913|NCT01375712|Stool frequency|stool frequency
5061914|NCT01375712|Constipation related symptoms|constipation related symptoms
5061915|NCT01375712|Constipation related quality of life|constipation related quality of life
5061916|NCT01375699|Breast cancer|breast cancer
5061917|NCT01375699|Gastrointestinal cancer|gastrointestinal cancer
5061918|NCT01375699|Genitourinary cancer|genitourinary cancer
5061919|NCT01375699|Sarcoma|sarcoma
5061920|NCT01375699|Gynecologic cancer|gynecologic cancer
5061921|NCT01375686|Diabetes|diabetes
5061922|NCT01375673|Exercise|exercise
5061923|NCT01375673|Heart Failure|heart failure
5061924|NCT01375673|Mixed Effects Modeling|mixed effects modeling
5061925|NCT01375660|Vitamin D|vitamin d
5061926|NCT01375660|Glucose intolerance|glucose intolerance
5061927|NCT01375660|African American men|african american men
5061928|NCT01375647|Oral Vaccines|oral vaccines
5061929|NCT01375647|Vaccine Responsiveness|vaccine responsiveness
5061930|NCT01375647|Tropical Enteropathy|tropical enteropathy
5061931|NCT01375634|Intubation|intubation
5061932|NCT01375634|Gastrointestinal|gastrointestinal
5061933|NCT01375621|Farming|farming
5061934|NCT01375621|Antibiotic Resistant|antibiotic resistant
5061935|NCT01375621|Bacteria|bacteria
5061936|NCT01375608|Neutropenia|neutropenia
5061937|NCT01375608|Hemaglobin|hemaglobin
5061938|NCT01375608|Coagulation Disorders|coagulation disorders
5061939|NCT01375608|Thrombocytosis|thrombocytosis
5061940|NCT01375608|Red Blood Cells|red blood cells
5061941|NCT01375608|Sickle Cell Disease|sickle cell disease
5061942|NCT01375595|Working Memory|working memory
5061943|NCT01375595|Repetitive TMS (rTMS)|repetitive tms (rtms)
5061944|NCT01375595|Language|language
5061945|NCT01375595|Healthy Volunteer|healthy volunteer
5061946|NCT01375595|HV|hv
5061947|NCT01375582|Dry Eye|dry eye
5061948|NCT01375582|tear film|tear film
5061949|NCT01375582|lipid|lipid
5061950|NCT01375582|tear volume|tear volume
5061951|NCT01375582|environmental chamber|environmental chamber
5061952|NCT01375582|thermal imaging|thermal imaging
5061953|NCT01375569|CD105|cd105
5061954|NCT01375569|Monoclonal Antibody|monoclonal antibody
5061955|NCT01375569|Anti-Angiogenic|anti-angiogenic
5061956|NCT01375569|Chimeric|chimeric
5061957|NCT01375569|Apoptosis|apoptosis
5061958|NCT01375569|Liver Cancer|liver cancer
5061959|NCT01375556|Alcohol Clamp|alcohol clamp
5061960|NCT01375556|Pharmacogenetics|pharmacogenetics
5061961|NCT01375556|Family History of Alcoholism|family history of alcoholism
5061962|NCT01375556|Pharmacodynamics|pharmacodynamics
5061963|NCT01375556|Healthy Volunteer|healthy volunteer
5061964|NCT01375556|HV|hv
5061965|NCT01375543|Gene Identification|gene identification
5061966|NCT01375543|Genetics|genetics
5061967|NCT01375543|Genetic Disorders|genetic disorders
5061968|NCT01375530|Prevention|prevention
5061969|NCT01375530|Vaccine|vaccine
5061970|NCT01375530|Immunity|immunity
5061971|NCT01375530|Evaluate|evaluate
5061972|NCT01375530|Screen|screen
5061973|NCT01375530|Healthy Volunteer|healthy volunteer
5061974|NCT01375530|HV|hv
5061975|NCT01375504|Obesity|obesity
5061976|NCT01375504|Body Mass Index|body mass index
5061977|NCT01375504|Mindfulness Training|mindfulness training
5061978|NCT01375504|Attention and Interpretation Therapy|attention and interpretation therapy
5061979|NCT01375491|doxycycline|doxycycline
5061980|NCT01375491|insulin resistance|insulin resistance
5061981|NCT01375491|obesity|obesity
5061982|NCT01375491|inflammation|inflammation
5061983|NCT01375439|Pregnancy|pregnancy
5061984|NCT01375439|vulvovaginitis|vulvovaginitis
5061985|NCT01375439|uterine cervicitis|uterine cervicitis
5061986|NCT01375439|pregnancy outcome|pregnancy outcome
5061987|NCT01375426|Non-severe pneumonia|non-severe pneumonia
5061988|NCT01375426|Treatment failure|treatment failure
5061989|NCT01375426|Double dose amoxicillin|double dose amoxicillin
5061990|NCT01375426|Children|children
5061991|NCT01375413|Parkinson's disease|parkinson's disease
5061992|NCT01375413|Gait|gait
5061993|NCT01375413|Rehabilitation|rehabilitation
5061994|NCT01375413|Cognition|cognition
5061995|NCT01375413|Freezing of gait|freezing of gait
5061996|NCT01375400|aspirin|aspirin
5061997|NCT01375400|platelet|platelet
5061998|NCT01375387|Vimpat|vimpat
5061999|NCT01375387|Pharmacokinetics|pharmacokinetics
5062000|NCT01375387|Healthy Japanese male|healthy japanese male
5062001|NCT01375387|Healthy Chinese male|healthy chinese male
5062002|NCT01375374|Vimpat|vimpat
5062003|NCT01375374|Partial seizures|partial seizures
5062004|NCT01375374|Carbamazepine|carbamazepine
5062005|NCT01375374|Hormone levels|hormone levels
5062006|NCT01375374|Lipid levels|lipid levels
5062007|NCT01375374|Lacosamide|lacosamide
5062008|NCT01375361|albuterol|albuterol
5062009|NCT01375348|Cognitive function|cognitive function
5062010|NCT01375348|Experimental pain|experimental pain
5062011|NCT01375335|Postoperative|postoperative
5062012|NCT01375335|Dobutamine|dobutamine
5062013|NCT01375335|Inotropes|inotropes
5062014|NCT01375335|Stunning|stunning
5062015|NCT01375335|Heart failure|heart failure
5062016|NCT01375309|probiotics|probiotics
5062017|NCT01375309|preterm infants|preterm infants
5062018|NCT01375309|enteral feeding|enteral feeding
5062019|NCT01375309|Bifidobacterium on enteral feeding|bifidobacterium on enteral feeding
5062020|NCT01375270|diabetes|diabetes
5062021|NCT01375270|incretin|incretin
5062022|NCT01375270|beta-cell function|beta-cell function
5062023|NCT01375270|glucolipotoxicity|glucolipotoxicity
5062024|NCT01375270|glucagon-like peptide 1|glucagon-like peptide 1
5062025|NCT01375270|glucose-dependent insulinotropic polypeptide|glucose-dependent insulinotropic polypeptide
5062026|NCT01375244|bioequivalence|bioequivalence
5062027|NCT01375244|lisinopril|lisinopril
5062028|NCT01375244|fasting|fasting
5062029|NCT01375205|atopic dermatitis|atopic dermatitis
5062030|NCT01375205|skin care|skin care
5062031|NCT01375179|Inflammatory Bowel disease|inflammatory bowel disease
5062032|NCT01375179|Ulcerative colitis|ulcerative colitis
5062033|NCT01375153|BNP administration|bnp administration
5062034|NCT01375153|appetite|appetite
5062035|NCT01375153|ghrelin|ghrelin
5062036|NCT01375153|PYY|pyy
5062037|NCT01375140|Myeloproliferative Diseases|myeloproliferative diseases
5062038|NCT01375140|Myelofibrosis|myelofibrosis
5062039|NCT01375140|Post essential thrombocythemia/polycythemia vera|post essential thrombocythemia/polycythemia vera
5062040|NCT01375140|Ruxolitinib|ruxolitinib
5062041|NCT01375140|INCB018424|incb018424
5062042|NCT01375140|Lenalidomide|lenalidomide
5062043|NCT01375140|CC-5013|cc-5013
5062044|NCT01375140|Revlimid|revlimid
5062045|NCT01375140|Prednisone|prednisone
5062046|NCT01375140|Interactive Voice Response System|interactive voice response system
5062047|NCT01375140|IVR|ivr
5062048|NCT01375127|Observational|observational
5062049|NCT01375127|clinical follow-up data|clinical follow-up data
5062050|NCT01375114|Advanced Cancers|advanced cancers
5062051|NCT01375114|Solid Tumors|solid tumors
5062052|NCT01375114|Cancer related fatigue|cancer related fatigue
5062053|NCT01375114|CRF|crf
5062054|NCT01375114|Panax ginseng|panax ginseng
5062055|NCT01375114|Placebo|placebo
5062056|NCT01375114|Sugar pill|sugar pill
5062057|NCT01375114|Functional Assessment of Chronic Illness Therapy-Fatigue|functional assessment of chronic illness therapy-fatigue
5062058|NCT01375114|FACIT-F|facit-f
5062059|NCT01375114|Quality of life|quality of life
5062060|NCT01375114|QOL|qol
5062061|NCT01375114|FACT-G|fact-g
5062062|NCT01375114|Hospital Anxiety and Depression Inventory|hospital anxiety and depression inventory
5062063|NCT01375114|Neurocognitive function|neurocognitive function
5062064|NCT01375114|SDMT|sdmt
5062065|NCT01375114|Global Symptom Evaluation|global symptom evaluation
5062066|NCT01375114|GSE|gse
5062067|NCT01375101|lichen planus|lichen planus
5062068|NCT01375101|quercetin|quercetin
5062069|NCT01375088|propolis|propolis
5062070|NCT01375088|mucositis|mucositis
5062071|NCT01375088|radiotherapy|radiotherapy
5062072|NCT01375088|cancer|cancer
5062073|NCT01375049|Cystic fibrosis|cystic fibrosis
5062074|NCT01375049|CF|cf
5062075|NCT01375049|PA|pa
5062076|NCT01375049|Pseudomonas aeruginosa|pseudomonas aeruginosa
5062077|NCT01375049|AZLI|azli
5062078|NCT01375049|aztreonam|aztreonam
5062079|NCT01375036|Cystic fibrosis|cystic fibrosis
5062080|NCT01375036|PA|pa
5062081|NCT01375036|Pseudomonas aeruginosa|pseudomonas aeruginosa
5062082|NCT01375036|CF|cf
5062083|NCT01375036|aztreonam|aztreonam
5062084|NCT01375023|Allogenic Haematopoietic Cell Transplantation|allogenic haematopoietic cell transplantation
5062085|NCT01375023|Total Lymphoid Irradiation|total lymphoid irradiation
5062086|NCT01375023|Anti-Thymocyte Globulin|anti-thymocyte globulin
5062087|NCT01375023|Triple Negative Breast Cancer|triple negative breast cancer
5062088|NCT01375010|HIV|hiv
5062089|NCT01375010|Postmenopausal women|postmenopausal women
5062090|NCT01375010|Vitamin D|vitamin d
5062091|NCT01374984|smallpox|smallpox
5062092|NCT01374984|vaccination|vaccination
5062093|NCT01374984|complications|complications
5062094|NCT01374971|Rheumatoid Arthritis|rheumatoid arthritis
5062095|NCT01374971|Cimzia|cimzia
5062096|NCT01374971|Certolizumab Pegol|certolizumab pegol
5062196|NCT01374568|Januvia|januvia
5062097|NCT01374971|Arthroscopic Synovial biopsy|arthroscopic synovial biopsy
5062098|NCT01374971|Office Based Procedure|office based procedure
5062099|NCT01374971|Biologic|biologic
5062100|NCT01374971|Tumor Necrosis Factor (TNF)|tumor necrosis factor (tnf)
5062101|NCT01374971|Anti-TNF|anti-tnf
5062102|NCT01374932|Asthma|asthma
5062103|NCT01374932|Obstructive Sleep Apnea Syndrome|obstructive sleep apnea syndrome
5062104|NCT01374919|Intravenous iron|intravenous iron
5062105|NCT01374919|ferumoxytol|ferumoxytol
5062106|NCT01374919|iron deficiency anemia|iron deficiency anemia
5062107|NCT01374919|Treatment of iron deficiency|treatment of iron deficiency
5062108|NCT01374919|Intolerance of or ineffectiveness of oral iron|intolerance of or ineffectiveness of oral iron
5062109|NCT01374906|SOM230|som230
5062110|NCT01374906|Cushing's Disease|cushing's disease
5062111|NCT01374906|Mean Urinary Free Cortisol|mean urinary free cortisol
5062112|NCT01374906|Pasireotide|pasireotide
5062113|NCT01374906|Pasireotide LAR|pasireotide lar
5062114|NCT01374906|Pasireotide long-acting release|pasireotide long-acting release
5062115|NCT01374906|secondary hypercortisolism|secondary hypercortisolism
5062116|NCT01374906|secondary hypercorticism|secondary hypercorticism
5062117|NCT01374906|Itsenko-Cushing disease|itsenko-cushing disease
5062118|NCT01374906|increased secretion of adrenocorticotropic hormone (ACTH)|increased secretion of adrenocorticotropic hormone (acth)
5062119|NCT01374906|hyperpituitarism|hyperpituitarism
5062120|NCT01374893|Function, hospitalization, elderly|function, hospitalization, elderly
5062121|NCT01374880|Heart failure|heart failure
5062122|NCT01374880|Dyspnea|dyspnea
5062123|NCT01374880|Heart disease|heart disease
5062124|NCT01374880|Pulmonary disease|pulmonary disease
5062125|NCT01374880|Natriuretic peptide|natriuretic peptide
5062126|NCT01374880|Rehabilitation|rehabilitation
5062127|NCT01374867|Cardiogenic shock|cardiogenic shock
5062128|NCT01374867|Myocardial infarction|myocardial infarction
5062129|NCT01374867|Low-output syndrome|low-output syndrome
5062130|NCT01374867|Prognosis|prognosis
5062131|NCT01374867|Biomarkers|biomarkers
5062132|NCT01374867|Pathophysiology|pathophysiology
5062133|NCT01374854|type 1 diabetes mellitus|type 1 diabetes mellitus
5062134|NCT01374854|umbilical mesenchymal stem cell|umbilical mesenchymal stem cell
5062135|NCT01374854|mononuclear cell|mononuclear cell
5062136|NCT01374841|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
5062137|NCT01374841|High-Risk Hematologic Neoplasms|high-risk hematologic neoplasms
5062138|NCT01374841|Haploidentical Donors|haploidentical donors
5062139|NCT01374841|Cyclophosphamide|cyclophosphamide
5062140|NCT01374828|Toradol|toradol
5062141|NCT01374828|Ketorolac|ketorolac
5062142|NCT01374828|Normal saline|normal saline
5062143|NCT01374828|Laparoscopic|laparoscopic
5062144|NCT01374828|Postoperative pain control|postoperative pain control
5062145|NCT01374828|Incisional analgesia|incisional analgesia
5062146|NCT01374815|Children's diet quality|children's diet quality
5062147|NCT01374815|Health-related social problems|health-related social problems
5062148|NCT01374763|Naloxone|naloxone
5062149|NCT01374763|Oxycodone|oxycodone
5062150|NCT01374763|Constipation|constipation
5062151|NCT01374763|Pain, postoperative|pain, postoperative
5062152|NCT01374763|Physiological effects of drugs|physiological effects of drugs
5062153|NCT01374763|Analgesics, Opioid|analgesics, opioid
5062154|NCT01374724|Tobacco Use|tobacco use
5062155|NCT01374724|Relapse Prevention|relapse prevention
5062156|NCT01374724|Military|military
5062157|NCT01374724|Smokeless Tobacco Use|smokeless tobacco use
5062158|NCT01374724|Dual Use|dual use
5062159|NCT01374711|Endotoxin|endotoxin
5062160|NCT01374711|Inflammation|inflammation
5062161|NCT01374711|Sepsis|sepsis
5062162|NCT01374711|GM-CSF|gm-csf
5062163|NCT01374711|IFN-y|ifn-y
5062164|NCT01374698|PCI|pci
5062165|NCT01374698|Aspirin|aspirin
5062166|NCT01374698|Reload|reload
5062167|NCT01374685|BRCA1|brca1
5062168|NCT01374685|BRCA2|brca2
5062169|NCT01374685|Breast Cancer|breast cancer
5062170|NCT01374685|African American|african american
5062171|NCT01374685|Women|women
5062172|NCT01374659|124-I PET|124-i pet
5062173|NCT01374659|FDG-PET|fdg-pet
5062174|NCT01374659|PET/CT|pet/ct
5062175|NCT01374659|recurrence|recurrence
5062176|NCT01374659|differentiated thyroid carcinoma|differentiated thyroid carcinoma
5062177|NCT01374659|diagnostic value|diagnostic value
5062178|NCT01374646|Childhood Obesity|childhood obesity
5062179|NCT01374646|Group Treatment|group treatment
5062180|NCT01374646|Community-based Programs|community-based programs
5062181|NCT01374633|Sevoflurane|sevoflurane
5062182|NCT01374633|Brain injury|brain injury
5062183|NCT01374633|Intra cranial pressure|intra cranial pressure
5062184|NCT01374633|Sedation|sedation
5062185|NCT01374633|Brain injury with initial Glasgow score less than 9|brain injury with initial glasgow score less than 9
5062186|NCT01374620|Cancer|cancer
5062187|NCT01374607|acute coronary syndrome|acute coronary syndrome
5062188|NCT01374607|myocardial ischemia|myocardial ischemia
5062189|NCT01374607|high-sensitivity cardiac troponin T|high-sensitivity cardiac troponin t
5062190|NCT01374581|retreatment|retreatment
5062191|NCT01374581|artemisinin-based combination|artemisinin-based combination
5062192|NCT01374581|malaria|malaria
5062193|NCT01374581|resistant|resistant
5062194|NCT01374568|Type 2 diabetes|type 2 diabetes
5062197|NCT01374555|Coronary artery disease|coronary artery disease
5062198|NCT01374542|Bronchoscopy|bronchoscopy
5062199|NCT01374542|Thoracoscopy|thoracoscopy
5062200|NCT01374516|Dengue Virus|dengue virus
5062201|NCT01374516|Dengue fever|dengue fever
5062202|NCT01374516|Dengue Hemorrhagic Fever|dengue hemorrhagic fever
5062203|NCT01374516|CYD dengue vaccine|cyd dengue vaccine
5062204|NCT01374516|Flavivirus|flavivirus
5062205|NCT01374516|Dengue Disease|dengue disease
5062206|NCT01374490|HIV +|hiv +
5062207|NCT01374490|HIV positive|hiv positive
5062208|NCT01374490|HIV associated diarrhea|hiv associated diarrhea
5062209|NCT01374490|AIDS|aids
5062210|NCT01374490|Diarrhea|diarrhea
5062211|NCT01374477|Preeclampsia in Adolescence|preeclampsia in adolescence
5062212|NCT01374477|Adolescent|adolescent
5062213|NCT01374477|Primipaternity|primipaternity
5062214|NCT01374464|Interscalene brachial plexus nerve block|interscalene brachial plexus nerve block
5062215|NCT01374464|Nerve block|nerve block
5062216|NCT01374451|Pancreatic|pancreatic
5062217|NCT01374451|Neuroendocrine tumors|neuroendocrine tumors
5062218|NCT01374451|PNET|pnet
5062219|NCT01374451|Pasireotide|pasireotide
5062220|NCT01374451|Everolimus|everolimus
5062221|NCT01374451|Advanced progressive pancreatic neuroendocrine tumor|advanced progressive pancreatic neuroendocrine tumor
5062222|NCT01374438|Alzheimer's disease|alzheimer's disease
5062223|NCT01374438|cognitive function|cognitive function
5062224|NCT01374438|brain glucose utilization|brain glucose utilization
5062225|NCT01374438|FDG-PET|fdg-pet
5062226|NCT01374399|allogeneic stem cell transplantation|allogeneic stem cell transplantation
5062227|NCT01374399|exercise|exercise
5062228|NCT01374399|survival|survival
5062229|NCT01374399|fatigue|fatigue
5062230|NCT01374399|quality of life|quality of life
5062231|NCT01374399|cancer|cancer
5062232|NCT01374399|physical performance|physical performance
5062233|NCT01374386|adolescent obesity|adolescent obesity
5062234|NCT01374373|Chemotherapy|chemotherapy
5062235|NCT01374373|Anemia|anemia
5062236|NCT01374373|Epoetin alfa|epoetin alfa
5062237|NCT01374373|Erythropoiesis stimulating agent (ESA)|erythropoiesis stimulating agent (esa)
5062238|NCT01374360|PNH|pnh
5062239|NCT01374360|Paroxysmal Nocturnal hemoglobinuria|paroxysmal nocturnal hemoglobinuria
5062240|NCT01374360|Soliris|soliris
5062241|NCT01374360|Eculizumab|eculizumab
5062242|NCT01374308|NASVAC|nasvac
5062243|NCT01374308|Pegylated Interferon-2b|pegylated interferon-2b
5062244|NCT01374308|CHB|chb
5062245|NCT01374269|NSAIDS (Nonsteroidal anti-inflammatory drugs)|nsaids (nonsteroidal anti-inflammatory drugs)
5062246|NCT01374269|Exercise|exercise
5062247|NCT01374269|Physiotherapy|physiotherapy
5062248|NCT01374269|Subacute Low Back Pain|subacute low back pain
5062249|NCT01374269|Pain|pain
5062250|NCT01374269|Visual Analogue Scale|visual analogue scale
5062251|NCT01374269|oswesrty|oswesrty
5062252|NCT01374269|Roland Morris|roland morris
5062253|NCT01374269|SF-36|sf-36
5062254|NCT01374269|Quality of life|quality of life
5062255|NCT01374256|carbapenem|carbapenem
5062256|NCT01374256|sulbactam|sulbactam
5062257|NCT01374256|Acinetobacter baumannii|acinetobacter baumannii
5062258|NCT01374230|clinical outcomes|clinical outcomes
5062259|NCT01374230|radiographic outcomes|radiographic outcomes
5062260|NCT01374230|total knee arthroplasty|total knee arthroplasty
5062261|NCT01374230|survivorship|survivorship
5062262|NCT01374204|Epilepsy|epilepsy
5062263|NCT01374204|Stigma|stigma
5062264|NCT01374191|botox|botox
5062265|NCT01374191|neuroma pain|neuroma pain
5062266|NCT01374191|pain|pain
5062267|NCT01374191|chronic pain|chronic pain
5062268|NCT01374191|botulinum toxin|botulinum toxin
5062269|NCT01374191|botulinum toxin A|botulinum toxin a
5062270|NCT01374191|botox and pain|botox and pain
5062271|NCT01374191|botox and neuroma|botox and neuroma
5062272|NCT01374191|botox treatment|botox treatment
5062273|NCT01374191|onabotulinum|onabotulinum
5062274|NCT01374191|onabotulinum toxin|onabotulinum toxin
5062275|NCT01374191|onabotulinum toxin type A|onabotulinum toxin type a
5062276|NCT01374165|SCD|scd
5062277|NCT01374152|stroke|stroke
5062278|NCT01374152|upper extremity|upper extremity
5062279|NCT01374152|rehabilitation|rehabilitation
5062280|NCT01374152|perfetti|perfetti
5062281|NCT01374139|Bosutinib|bosutinib
5062282|NCT01374139|Bioequivalence and Food Effect Studies|bioequivalence and food effect studies
5062283|NCT01374113|safinamide|safinamide
5062284|NCT01374113|pharmacokinetics|pharmacokinetics
5062285|NCT01374113|renal impairment|renal impairment
5062286|NCT01374113|Moderate and Severe Renal Impairment|moderate and severe renal impairment
5062287|NCT01374100|Qigong|qigong
5062288|NCT01374100|Complementary Medicine|complementary medicine
5062289|NCT01374100|Exercise|exercise
5062290|NCT01374100|Traditional Chinese Medicine|traditional chinese medicine
5062291|NCT01374100|Meditation|meditation
5062292|NCT01374100|Standard Exercise|standard exercise
5062293|NCT01374100|Chemotherapy|chemotherapy
5062294|NCT01374100|Advanced cancer|advanced cancer
5062295|NCT01374100|Quality of Life|quality of life
5062296|NCT01374100|Functional Assessment of Cancer Therapy|functional assessment of cancer therapy
5062297|NCT01374100|Hospital Anxiety and Depression Scale|hospital anxiety and depression scale
5062298|NCT01374100|Anxiety|anxiety
5062299|NCT01374100|Depression|depression
5062300|NCT01374100|Cancer Nutrition-Rehabilitation Program|cancer nutrition-rehabilitation program
5062301|NCT01374100|Edmonton Symptom Assessment Scale|edmonton symptom assessment scale
5062302|NCT01374100|Simmonds Functional Assessment|simmonds functional assessment
5062303|NCT01374087|Recurrent Prostate Carcinoma|recurrent prostate carcinoma
5062304|NCT01374087|Brachytherapy|brachytherapy
5062305|NCT01374087|Triptorelin|triptorelin
5062306|NCT01374087|Hormone Therapy|hormone therapy
5062307|NCT01374074|Barrett's Esophagus (BE)|barrett's esophagus (be)
5062308|NCT01374074|Intestinal metaplasia|intestinal metaplasia
5062309|NCT01374074|Gastroesophageal reflux disease (GERD)|gastroesophageal reflux disease (gerd)
5062310|NCT01374074|Racial Disparity|racial disparity
5062311|NCT01374061|Emergency intubation|emergency intubation
5062312|NCT01374061|Glide scope Ranger|glide scope ranger
5062313|NCT01374061|Pre hospital|pre hospital
5062314|NCT01374035|Health Service|health service
5062315|NCT01374035|Coordination|coordination
5062316|NCT01374035|Referral letters|referral letters
5062317|NCT01374035|Mental Health|mental health
5062318|NCT01374035|Adults|adults
5062319|NCT01374022|Respiratory Distress Syndrome, Adult|respiratory distress syndrome, adult
5062320|NCT01374022|Randomized Controlled Trial|randomized controlled trial
5062321|NCT01374022|Respiration, Artificial|respiration, artificial
5062322|NCT01373996|Invasive blood pressure monitoring|invasive blood pressure monitoring
5062323|NCT01373996|Intensive care unit|intensive care unit
5062324|NCT01373996|Wireless Technology|wireless technology
5062325|NCT01373983|Neuropathic pain|neuropathic pain
5062326|NCT01373983|Intrathecal analgesia|intrathecal analgesia
5062327|NCT01373983|Ziconotide|ziconotide
5062328|NCT01373983|Bolus|bolus
5062329|NCT01373983|trauma|trauma
5062330|NCT01373983|central|central
5062331|NCT01373983|severe|severe
5062332|NCT01373983|chronic|chronic
5062333|NCT01373970|Functional Dyspepsia|functional dyspepsia
5062334|NCT01373970|Protonpump inhibitor|protonpump inhibitor
5062335|NCT01373970|Rebound Acid HyperSecretion|rebound acid hypersecretion
5062336|NCT01373957|Acute Coronary Syndrome|acute coronary syndrome
5062337|NCT01373957|antithrombotic management|antithrombotic management
5062338|NCT01373957|STEMI|stemi
5062339|NCT01373957|NSTE-ACS|nste-acs
5062340|NCT01373944|MPI|mpi
5062341|NCT01373944|SPECT|spect
5062342|NCT01373944|Stress-Only|stress-only
5062343|NCT01373944|Spectrum Dynamics Camera|spectrum dynamics camera
5062344|NCT01373944|Anger|anger
5062345|NCT01373918|cholestasis|cholestasis
5062346|NCT01373918|neonates|neonates
5062347|NCT01373918|parenteral nutrition|parenteral nutrition
5062348|NCT01373918|gastrointestinal disorders|gastrointestinal disorders
5062349|NCT01373905|ARDS|ards
5062350|NCT01373905|PEEP|peep
5062351|NCT01373905|Recruitment maneuver|recruitment maneuver
5062352|NCT01373879|Vaccine|vaccine
5062353|NCT01373879|Immune response|immune response
5062354|NCT01373866|Repetitive Transcranial Magnetic Stimulation|repetitive transcranial magnetic stimulation
5062355|NCT01373866|Neuronavigation|neuronavigation
5062356|NCT01373866|Functional Magnetic Resonance Imaging|functional magnetic resonance imaging
5062357|NCT01373866|Diffusion Tensor Imaging|diffusion tensor imaging
5062358|NCT01373853|Lens Fragmentation|lens fragmentation
5062359|NCT01373853|Cataract|cataract
5062360|NCT01373853|Phacoemulsification|phacoemulsification
5062361|NCT01373853|Femtosecond Laser|femtosecond laser
5062362|NCT01373840|focal|focal
5062363|NCT01373840|dystonia|dystonia
5062364|NCT01373840|dopamine|dopamine
5062365|NCT01373840|receptor|receptor
5062366|NCT01373827|VASER|vaser
5062367|NCT01373827|VASERShape|vasershape
5062368|NCT01373827|MC1|mc1
5062369|NCT01373827|ultrasound|ultrasound
5062370|NCT01373801|Postpartum women, after surgical repair of vaginal and cervical lacerations|postpartum women, after surgical repair of vaginal and cervical lacerations
5062371|NCT01373775|Heart failure|heart failure
5062372|NCT01373775|Revisit|revisit
5062373|NCT01373775|Emergency room|emergency room
5062374|NCT01373762|Adherence|adherence
5062375|NCT01373762|Motivation|motivation
5062376|NCT01373762|Health-related fitness|health-related fitness
5062377|NCT01373762|Exercise videogames|exercise videogames
5062378|NCT01373762|Physical Activity|physical activity
5062379|NCT01373749|PPHN|pphn
5062380|NCT01373749|NO inhalation|no inhalation
5062381|NCT01373749|Sildenafil|sildenafil
5062382|NCT01373749|Treatment|treatment
5062383|NCT01373749|Safety|safety
5062384|NCT01373723|Uterine Cervical Neoplasms|uterine cervical neoplasms
5062385|NCT01373723|cancer screening|cancer screening
5062386|NCT01373723|Costs and Cost Analysis|costs and cost analysis
5062387|NCT01373723|cost-effectiveness analysis|cost-effectiveness analysis
5062388|NCT01373723|Clinical Trial|clinical trial
5062389|NCT01373723|Primary Health Care|primary health care
5062390|NCT01373710|Adverse Reaction to Trastuzumab Administered by intrathecal|adverse reaction to trastuzumab administered by intrathecal
5062391|NCT01373697|Ibuprofen|ibuprofen
5062392|NCT01373697|muscle pain|muscle pain
5062393|NCT01373697|sprains|sprains
5062394|NCT01373697|contusions|contusions
5062395|NCT01373697|tendonitis|tendonitis
5062396|NCT01373684|Chronic hepatitis B|chronic hepatitis b
5062397|NCT01373684|HBeAg-negative|hbeag-negative
5062398|NCT01373671|Mammography|mammography
5062399|NCT01373671|Screening|screening
5062400|NCT01373671|Diagnostic|diagnostic
5062401|NCT01373632|significant stenosis (>70% of lumen stenosis)|significant stenosis (>70% of lumen stenosis)
5062402|NCT01373632|epicardial coronary arteries|epicardial coronary arteries
5062403|NCT01373632|clinical ischemic|clinical ischemic
5062404|NCT01373619|Heart failure with normal ejection fraction|heart failure with normal ejection fraction
5062405|NCT01373619|hemodialysis patients|hemodialysis patients
5062406|NCT01373619|ivabradine|ivabradine
5062407|NCT01373619|Echocardiography|echocardiography
5062408|NCT01373619|NYHA class|nyha class
5062409|NCT01373619|6-minutes walking test|6-minutes walking test
5062410|NCT01373593|persistent postherniorrhaphy pain|persistent postherniorrhaphy pain
5062411|NCT01373580|presbyopia|presbyopia
5062412|NCT01373580|LASIK|lasik
5062413|NCT01373580|loss of accommodation|loss of accommodation
5062414|NCT01373580|Emmetrope|emmetrope
5062415|NCT01373567|Plaque Psoriasis|plaque psoriasis
5062416|NCT01373528|Sinonasal Budesonide|sinonasal budesonide
5062417|NCT01373528|Endoscopic sinus surgery|endoscopic sinus surgery
5062542|NCT01372943|infection|infection
5062418|NCT01373528|Hypothalamic-Pituitary-Adrenal Axis Function|hypothalamic-pituitary-adrenal axis function
5062419|NCT01373515|DCOne|dcone
5062420|NCT01373515|DCP-001|dcp-001
5062421|NCT01373515|Second complete remission of AML|second complete remission of aml
5062422|NCT01373515|Relapse AML|relapse aml
5062423|NCT01373489|type 2 diabetes|type 2 diabetes
5062424|NCT01373489|nurse case management|nurse case management
5062425|NCT01373489|telemedicine|telemedicine
5062426|NCT01373476|Diabetic Retinopathy|diabetic retinopathy
5062427|NCT01373476|Traditional Chinese medicine|traditional chinese medicine
5062428|NCT01373476|Diabetic Eye Problems|diabetic eye problems
5062429|NCT01373476|Retinal Disorders|retinal disorders
5062430|NCT01373463|resectable|resectable
5062431|NCT01373437|Ultrasonography|ultrasonography
5062432|NCT01373437|US|us
5062433|NCT01373437|Confirming|confirming
5062434|NCT01373437|Confirmation|confirmation
5062435|NCT01373437|Proper|proper
5062436|NCT01373437|Position|position
5062437|NCT01373437|Endotracheal tube|endotracheal tube
5062438|NCT01373437|ETT|ett
5062439|NCT01373437|Emergency department|emergency department
5062440|NCT01373437|ED|ed
5062441|NCT01373437|Applicability|applicability
5062442|NCT01373437|Accuracy|accuracy
5062443|NCT01373424|Observational study|observational study
5062444|NCT01373424|Cross-sectional and Prospective study|cross-sectional and prospective study
5062445|NCT01373424|Cohort and case-control study|cohort and case-control study
5062446|NCT01373411|CABG|cabg
5062447|NCT01373411|Ticagrelor|ticagrelor
5062448|NCT01373411|Coronary Artery Bypass Surgery|coronary artery bypass surgery
5062449|NCT01373398|bladder cancer|bladder cancer
5062450|NCT01373398|EO9|eo9
5062451|NCT01373398|Apaziquone|apaziquone
5062452|NCT01373385|pediatric urology|pediatric urology
5062453|NCT01373385|vesicoureteral reflux|vesicoureteral reflux
5062454|NCT01373385|ureteral reimplant|ureteral reimplant
5062455|NCT01373385|Deflux|deflux
5062456|NCT01373372|functional dyspepsia|functional dyspepsia
5062457|NCT01373372|GI|gi
5062458|NCT01373359|Misoprostol, oxytocin, postpartum blood loss, hemoglobin|misoprostol, oxytocin, postpartum blood loss, hemoglobin
5062459|NCT01373346|type II diabetes|type ii diabetes
5062460|NCT01373346|Gastric cancer|gastric cancer
5062461|NCT01373346|Long limb Roux-en Y|long limb roux-en y
5062462|NCT01373320|Smoking cessation|smoking cessation
5062463|NCT01373320|Cancer screening|cancer screening
5062464|NCT01373320|Appalachia|appalachia
5062465|NCT01373320|Group-randomized trial|group-randomized trial
5062466|NCT01373320|Faith-placed|faith-placed
5062467|NCT01373307|Overweight|overweight
5062468|NCT01373307|obesity|obesity
5062469|NCT01373307|Appalachian|appalachian
5062470|NCT01373307|intergenerational|intergenerational
5062471|NCT01373307|families|families
5062472|NCT01373307|energy balance|energy balance
5062473|NCT01373307|group-randomized trial|group-randomized trial
5062474|NCT01373294|non-muscle-invasive|non-muscle-invasive
5062475|NCT01373294|transitional cell|transitional cell
5062476|NCT01373294|oral lenalidomide|oral lenalidomide
5062477|NCT01373294|intravesical|intravesical
5062478|NCT01373281|Dengue|dengue
5062479|NCT01373281|Dengue fever|dengue fever
5062480|NCT01373281|Dengue Hemorrhagic Fever|dengue hemorrhagic fever
5062481|NCT01373281|CYD dengue vaccine|cyd dengue vaccine
5062482|NCT01373281|Flavivirus|flavivirus
5062483|NCT01373255|Placenta accreta|placenta accreta
5062484|NCT01373255|Internal iliac artery catheterization|internal iliac artery catheterization
5062485|NCT01373255|Post partum bleeding|post partum bleeding
5062486|NCT01373229|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
5062487|NCT01373229|CLL|cll
5062488|NCT01373203|Acute Lung Injury(ALI)|acute lung injury(ali)
5062489|NCT01373190|epilepsy|epilepsy
5062490|NCT01373190|thermography|thermography
5062491|NCT01373164|Neoplasms|neoplasms
5062492|NCT01373164|Neoplasm Metastasis|neoplasm metastasis
5062493|NCT01373164|Pancreatic Cancer|pancreatic cancer
5062494|NCT01373138|Bioequivalence|bioequivalence
5062495|NCT01373138|Desloratadine and pseudoephedrine|desloratadine and pseudoephedrine
5062496|NCT01373138|crossover|crossover
5062497|NCT01373125|Barrett's Esophagus|barrett's esophagus
5062498|NCT01373125|Intestinal metaplasia|intestinal metaplasia
5062499|NCT01373125|Gastroesophageal reflux disease (GERD)|gastroesophageal reflux disease (gerd)
5062500|NCT01373125|Neosquamous epithelium|neosquamous epithelium
5062501|NCT01373125|Radiofrequency ablation (RFA)|radiofrequency ablation (rfa)
5062502|NCT01373112|arthroplasty|arthroplasty
5062503|NCT01373112|knee replacement|knee replacement
5062504|NCT01373112|Osteoarthritis|osteoarthritis
5062505|NCT01373112|knee Infection|knee infection
5062506|NCT01373112|Prosthetic Joint Infection|prosthetic joint infection
5062507|NCT01373112|Complications; Arthroplasty, Infection or Inflammation|complications; arthroplasty, infection or inflammation
5062508|NCT01373112|Complications; Arthroplasty|complications; arthroplasty
5062509|NCT01373099|arthroplasty|arthroplasty
5062510|NCT01373099|hip replacement|hip replacement
5062511|NCT01373099|Osteoarthritis|osteoarthritis
5062512|NCT01373099|knee Infection|knee infection
5062513|NCT01373099|Prosthetic Joint Infection|prosthetic joint infection
5062514|NCT01373099|Complications; Arthroplasty, Infection or Inflammation|complications; arthroplasty, infection or inflammation
5062515|NCT01373099|Complications; Arthroplasty|complications; arthroplasty
5062516|NCT01373086|Hypertension,|hypertension,
5062517|NCT01373086|mild hypertension,|mild hypertension,
5062518|NCT01373086|moderate hypertension,|moderate hypertension,
5062519|NCT01373086|high blood pressure,|high blood pressure,
5062520|NCT01373086|uncomplicated hypertension.|uncomplicated hypertension.
5062521|NCT01373060|ASP1941|asp1941
5062522|NCT01373060|ipragliflozin|ipragliflozin
5062523|NCT01373060|plasma glucose|plasma glucose
5062524|NCT01373060|urine glucose|urine glucose
5062525|NCT01373047|liver metastases|liver metastases
5062526|NCT01373047|immunotherapy|immunotherapy
5062527|NCT01373047|regional therapy|regional therapy
5062528|NCT01373047|T cells|t cells
5062529|NCT01373008|Inhaled steroids|inhaled steroids
5062530|NCT01373008|bronchopulmonary dysplasia|bronchopulmonary dysplasia
5062531|NCT01373008|Infants with moderate to severe BPD|infants with moderate to severe bpd
5062532|NCT01372995|critical care|critical care
5062533|NCT01372995|nosocomial infection|nosocomial infection
5062534|NCT01372995|antiAntimicrobial peptide expression|antiantimicrobial peptide expression
5062535|NCT01372995|LL-37|ll-37
5062536|NCT01372995|hBD-2|hbd-2
5062537|NCT01372995|cathelicidin|cathelicidin
5062538|NCT01372995|microbial peptide|microbial peptide
5062539|NCT01372956|LDL-C, cholesterol, risk factor|ldl-c, cholesterol, risk factor
5062540|NCT01372943|Clostridium difficile|clostridium difficile
5062541|NCT01372943|recurrent|recurrent
5062543|NCT01372930|Etanercept|etanercept
5062544|NCT01372930|acute ST segment elevated myocardial infarction|acute st segment elevated myocardial infarction
5062545|NCT01372930|percutaneous coronary intervention|percutaneous coronary intervention
5062546|NCT01372930|myocardial reperfusion injury|myocardial reperfusion injury
5062547|NCT01372904|Cisplatin|cisplatin
5062548|NCT01372904|Hearing loss|hearing loss
5062549|NCT01372904|Ototoxicity|ototoxicity
5062550|NCT01372904|Intratympanic injection|intratympanic injection
5062551|NCT01372904|Dexamethasone|dexamethasone
5062552|NCT01372904|Steroids|steroids
5062553|NCT01372904|Prevention|prevention
5062554|NCT01372891|Contrast Induced Nephropathy|contrast induced nephropathy
5062555|NCT01372891|percutaneous coronary interventions|percutaneous coronary interventions
5062556|NCT01372878|Polyps|polyps
5062557|NCT01372878|Capsule endoscopy|capsule endoscopy
5062558|NCT01372878|Colonoscopy|colonoscopy
5062559|NCT01372852|Diabetes mellitus|diabetes mellitus
5062560|NCT01372839|Myocardial Infarction|myocardial infarction
5062561|NCT01372839|Unstable Angina|unstable angina
5062562|NCT01372826|Phase 1|phase 1
5062563|NCT01372826|Pharmacokinetics|pharmacokinetics
5062564|NCT01372826|NKTR-118|nktr-118
5062565|NCT01372826|renal impairment|renal impairment
5062566|NCT01372826|parallel study|parallel study
5062567|NCT01372826|QTcF Interval|qtcf interval
5062568|NCT01372826|AUC(0-t)|auc(0-t)
5062569|NCT01372826|Cmax|cmax
5062570|NCT01372826|tmax|tmax
5062571|NCT01372813|Advanced Clear Cell Renal Cell Carcinoma|advanced clear cell renal cell carcinoma
5062572|NCT01372813|Cancer|cancer
5062573|NCT01372813|Renal|renal
5062574|NCT01372813|Renal Cell Carcinoma|renal cell carcinoma
5062575|NCT01372813|Kidney Cancer|kidney cancer
5062576|NCT01372800|adiponectin|adiponectin
5062577|NCT01372800|cardiovascular diseases|cardiovascular diseases
5062578|NCT01372800|cerebrovascular diseases|cerebrovascular diseases
5062579|NCT01372774|neurotoxicity|neurotoxicity
5062580|NCT01372774|radiation toxicity|radiation toxicity
5062581|NCT01372774|cognitive/functional effects|cognitive/functional effects
5062582|NCT01372774|tumors metastatic to brain|tumors metastatic to brain
5062583|NCT01372774|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5062584|NCT01372761|Obese|obese
5062585|NCT01372761|Obesity|obesity
5062586|NCT01372761|Overweight|overweight
5062587|NCT01372748|cardiac arrest|cardiac arrest
5062588|NCT01372748|cardiopulmonary resuscitation|cardiopulmonary resuscitation
5062589|NCT01372735|pancreatic cancer|pancreatic cancer
5062590|NCT01372735|intensity-modulated radiation therapy|intensity-modulated radiation therapy
5062591|NCT01372735|intraoperative radiation therapy|intraoperative radiation therapy
5062592|NCT01372722|treatment resistant|treatment resistant
5062593|NCT01372709|abdominal|abdominal
5062594|NCT01372709|aortic|aortic
5062595|NCT01372709|aneurysm|aneurysm
5062596|NCT01372683|Appetite|appetite
5062597|NCT01372683|Satiety|satiety
5062598|NCT01372683|Subjective energy|subjective energy
5062599|NCT01372683|Oats|oats
5062600|NCT01372670|Treating meal related anxiety|treating meal related anxiety
5062601|NCT01372657|cataract|cataract
5062602|NCT01372657|refraction|refraction
5062603|NCT01372657|iol|iol
5062604|NCT01372657|calculation|calculation
5062605|NCT01372657|formula|formula
5062606|NCT01372631|Reduction mammoplasty|reduction mammoplasty
5062607|NCT01372631|mastectomy|mastectomy
5062608|NCT01372631|partial mastectomy|partial mastectomy
5062609|NCT01372631|lumpectomy|lumpectomy
5062610|NCT01372631|breast conserving surgery|breast conserving surgery
5062611|NCT01372631|breast cancer|breast cancer
5062612|NCT01372605|Depression|depression
5062613|NCT01372605|HIV|hiv
5062614|NCT01372605|Adherence|adherence
5062615|NCT01372605|Collaborative care|collaborative care
5062616|NCT01372605|Measurement-Based Care|measurement-based care
5062617|NCT01372553|Primary care|primary care
5062618|NCT01372553|Family History|family history
5062619|NCT01372553|Risk Stratification|risk stratification
5062620|NCT01372553|Cancer|cancer
5062621|NCT01372553|Thrombosis|thrombosis
5062622|NCT01372540|Relapsed/Refractory Multiple Myeloma|relapsed/refractory multiple myeloma
5062623|NCT01372540|MM|mm
5062624|NCT01372540|Plasma Cell Leukemia|plasma cell leukemia
5062625|NCT01372540|PCL|pcl
5062626|NCT01372540|Arry-520|arry-520
5062627|NCT01372540|Carfilzomib|carfilzomib
5062628|NCT01372540|Dexamethasone|dexamethasone
5062629|NCT01372540|Decadron|decadron
5062630|NCT01372540|Filgrastim|filgrastim
5062631|NCT01372540|G-CSF|g-csf
5062632|NCT01372540|Neupogen|neupogen
5062633|NCT01372527|medical informatics|medical informatics
5062634|NCT01372527|health IT|health it
5062635|NCT01372527|primary care|primary care
5062636|NCT01372527|screening|screening
5062637|NCT01372527|cervical cancer|cervical cancer
5062638|NCT01372527|colorectal cancer|colorectal cancer
5062639|NCT01372527|breast cancer|breast cancer
5062640|NCT01372527|mammography|mammography
5062641|NCT01372527|colonoscopy|colonoscopy
5062642|NCT01372527|pap smear|pap smear
5062643|NCT01372514|Thromboembolism|thromboembolism
5062644|NCT01372514|Venous Thromboembolism|venous thromboembolism
5062645|NCT01372514|Pulmonary Embolism|pulmonary embolism
5062646|NCT01372501|Obesity|obesity
5062647|NCT01372488|Suture self removal|suture self removal
5062648|NCT01372488|non-absorbable sutures|non-absorbable sutures
5062649|NCT01372475|Osteoarthritis|osteoarthritis
5062650|NCT01372475|Knee|knee
5062651|NCT01372475|Hyaluronan|hyaluronan
5062652|NCT01372475|Hyaluronic Acid|hyaluronic acid
5062653|NCT01372475|Viscoelastic|viscoelastic
5062654|NCT01372475|Hydrogel|hydrogel
5062655|NCT01372462|COPD|copd
5062656|NCT01372462|Ventilator|ventilator
5062657|NCT01372462|Constant work rate|constant work rate
5062658|NCT01372449|Autism|autism
5062659|NCT01372449|Psychopharmacology|psychopharmacology
5062660|NCT01372449|Clinical Trial|clinical trial
5062661|NCT01372449|Children|children
5062662|NCT01372436|dental decay|dental decay
5062663|NCT01372436|DMFT|dmft
5062664|NCT01372436|Individual Caries Risk|individual caries risk
5062665|NCT01372436|Risk factors|risk factors
5062666|NCT01372410|Long acting muscarinic antagonist|long acting muscarinic antagonist
5062667|NCT01372410|Tiotropium|tiotropium
5062668|NCT01372410|Chronic Bronchitis|chronic bronchitis
5062669|NCT01372410|Emphysema|emphysema
5062670|NCT01372410|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5062671|NCT01372371|Vancomycin, Gentamycin|vancomycin, gentamycin
5062672|NCT01372371|Local Powder Antibiotic's Efficacy in Controlling Post Surgical Infection|local powder antibiotic's efficacy in controlling post surgical infection
5062673|NCT01372332|homonymous hemianopia|homonymous hemianopia
5062674|NCT01372332|quality of life (QoL)|quality of life (qol)
5062675|NCT01372332|visual exploration|visual exploration
5062676|NCT01372332|on-road car driving|on-road car driving
5062677|NCT01372332|driving simulator|driving simulator
5062678|NCT01372332|useful field of view (UFOV)|useful field of view (ufov)
5062679|NCT01372332|modified field of view (MAFOV)|modified field of view (mafov)
5062680|NCT01372319|glaucoma|glaucoma
5062681|NCT01372319|binocular visual field loss|binocular visual field loss
5062682|NCT01372319|semi-automated kinetic perimetry (SKP)|semi-automated kinetic perimetry (skp)
5062683|NCT01372319|quality of life (QoL)|quality of life (qol)
5062684|NCT01372319|visual exploration|visual exploration
5062685|NCT01372319|on-road car driving|on-road car driving
5062686|NCT01372319|driving simulator|driving simulator
5062687|NCT01372293|PCOS|pcos
5062688|NCT01372293|oral contraceptive pill|oral contraceptive pill
5062689|NCT01372293|polymorphisms|polymorphisms
5062690|NCT01372267|Cognitive Behavioral Therapy|cognitive behavioral therapy
5062691|NCT01372267|Chronic Pain|chronic pain
5062692|NCT01372267|Substance Use Disorders|substance use disorders
5062991|NCT01371253|elderly|elderly
5062693|NCT01372267|Psychoeducational control group|psychoeducational control group
5062694|NCT01372254|Cigarette Smoking|cigarette smoking
5062695|NCT01372254|Drug Use|drug use
5062696|NCT01372254|Depressed Mood|depressed mood
5062697|NCT01372241|Papanicolaou test|papanicolaou test
5062698|NCT01372241|Cervical cancer screening|cervical cancer screening
5062699|NCT01372241|Randomized controlled trial|randomized controlled trial
5062700|NCT01372241|Faith-placed|faith-placed
5062701|NCT01372241|Appalachia|appalachia
5062702|NCT01372228|hematopoietic stem cell Tx, chimerism, leukodystrophy|hematopoietic stem cell tx, chimerism, leukodystrophy
5062703|NCT01372215|Breast mass|breast mass
5062704|NCT01372215|Breast lesion|breast lesion
5062705|NCT01372202|Operable|operable
5062706|NCT01372202|Based on CHFR Methylation Status|based on chfr methylation status
5062707|NCT01372202|Diagnostic Biopsies|diagnostic biopsies
5062708|NCT01372189|molecular imaging|molecular imaging
5062709|NCT01372189|epidermal growth factor receptor|epidermal growth factor receptor
5062710|NCT01372189|colorectal neoplasia|colorectal neoplasia
5062711|NCT01372189|confocal laser endomicroscopy|confocal laser endomicroscopy
5062712|NCT01372176|Intensive care unit|intensive care unit
5062713|NCT01372176|Critical illness|critical illness
5062714|NCT01372176|Mortality|mortality
5062715|NCT01372176|Reduced quality of life|reduced quality of life
5062716|NCT01372176|Loss of lean body mass|loss of lean body mass
5062717|NCT01372176|Loss of physical function|loss of physical function
5062718|NCT01372176|Optimised nutritional support|optimised nutritional support
5062719|NCT01372176|Early initiation of nutrition|early initiation of nutrition
5062720|NCT01372176|Indirect calorimetry|indirect calorimetry
5062721|NCT01372163|Phase 1|phase 1
5062722|NCT01372163|Multiple Ascending Doses|multiple ascending doses
5062723|NCT01372163|Safety|safety
5062724|NCT01372163|Pharmacokinetics|pharmacokinetics
5062725|NCT01372163|Healthy Volunteers|healthy volunteers
5062726|NCT01372163|Type 2 Diabetic Patients|type 2 diabetic patients
5062727|NCT01372150|major depressive disorder|major depressive disorder
5062728|NCT01372150|MDD|mdd
5062729|NCT01372150|depression|depression
5062730|NCT01372137|NOX-H94|nox-h94
5062731|NCT01372137|Hepcidin|hepcidin
5062732|NCT01372137|Anemia|anemia
5062733|NCT01372137|Inflammation|inflammation
5062734|NCT01372124|Renal impairment|renal impairment
5062735|NCT01372124|NOX-E36|nox-e36
5062736|NCT01372111|Stg III or IVa Squamous Cell Carcinoma.|stg iii or iva squamous cell carcinoma.
5062737|NCT01372111|Advanced|advanced
5062738|NCT01372098|Domestic Violence|domestic violence
5062739|NCT01372098|Spouse Abuse|spouse abuse
5062740|NCT01372072|chronic respiratory hypercapnic failure|chronic respiratory hypercapnic failure
5062741|NCT01372046|technology transfer|technology transfer
5062742|NCT01372046|skill development|skill development
5062743|NCT01372046|organizational change|organizational change
5062744|NCT01372033|drug treatment|drug treatment
5062745|NCT01372033|substance abuse|substance abuse
5062746|NCT01372033|offenders|offenders
5062747|NCT01372033|high risk|high risk
5062748|NCT01372020|Varicose ulcer|varicose ulcer
5062749|NCT01372020|wound healing|wound healing
5062750|NCT01372020|electrical stimulation|electrical stimulation
5062751|NCT01372007|Rectal carcinoma|rectal carcinoma
5062752|NCT01371994|Radical Robotic Arm|radical robotic arm
5062753|NCT01371994|Vesicare|vesicare
5062754|NCT01371994|Post Prostatectomy Incontinence|post prostatectomy incontinence
5062755|NCT01371994|YM905|ym905
5062756|NCT01371968|Alfentanil|alfentanil
5062757|NCT01371968|optimal dose|optimal dose
5062758|NCT01371968|laryngeal mask airway|laryngeal mask airway
5062759|NCT01371955|diabetic nephropathy|diabetic nephropathy
5062760|NCT01371955|CYBA|cyba
5062761|NCT01371955|p22phox|p22phox
5062762|NCT01371955|RAGE|rage
5062763|NCT01371955|12LOX|12lox
5062764|NCT01371955|genetic|genetic
5062765|NCT01371955|Type 1 Diabetes Mellitus with Diabetic Dermatitis|type 1 diabetes mellitus with diabetic dermatitis
5062766|NCT01371955|caucasian|caucasian
5062767|NCT01371955|more than twenty years of diabetes duration|more than twenty years of diabetes duration
5062768|NCT01371955|older than 18 years|older than 18 years
5062769|NCT01371955|no nephropathy other than diabetic nephropathy|no nephropathy other than diabetic nephropathy
5062770|NCT01371942|Colorectal cancer(CRC)|colorectal cancer(crc)
5062771|NCT01371916|tuberculous meningitis|tuberculous meningitis
5062772|NCT01371916|early secretory antigenic target 6|early secretory antigenic target 6
5062773|NCT01371916|diagnosis|diagnosis
5062774|NCT01371903|morphine|morphine
5062775|NCT01371903|fentanyl|fentanyl
5062776|NCT01371903|dilaudid|dilaudid
5062777|NCT01371903|opioid|opioid
5062778|NCT01371903|capnography|capnography
5062779|NCT01371890|hemodialysis|hemodialysis
5062780|NCT01371890|end-stage renal disease|end-stage renal disease
5062781|NCT01371890|hypertension|hypertension
5062782|NCT01371877|urticaria|urticaria
5062783|NCT01371877|angioedema|angioedema
5062784|NCT01371877|hive|hive
5062785|NCT01371877|swelling|swelling
5062786|NCT01371864|Congenital cardiac disease|congenital cardiac disease
5062787|NCT01371864|Teamwork|teamwork
5062788|NCT01371864|Communication|communication
5062789|NCT01371864|Peri-operative|peri-operative
5063197|NCT01370291|Risperidone|risperidone
5062790|NCT01371838|Community-Acquired Bacterial Pneumonia|community-acquired bacterial pneumonia
5062791|NCT01371825|LIPA|lipa
5062792|NCT01371825|Wolman Disease|wolman disease
5062793|NCT01371825|Wolman Phenotype|wolman phenotype
5062794|NCT01371825|Acid Lipase Deficiency|acid lipase deficiency
5062795|NCT01371825|Acid Cholesteryl Hydrolase|acid cholesteryl hydrolase
5062796|NCT01371825|Acid Lipase Disease Deficiency, type 2|acid lipase disease deficiency, type 2
5062797|NCT01371825|Cholesteryl Ester Storage Disease (CESD)|cholesteryl ester storage disease (cesd)
5062798|NCT01371825|Cholesteryl Ester Hydrolase Deficiency|cholesteryl ester hydrolase deficiency
5062799|NCT01371825|Early Onset Lysosomal Acid Lipase Deficiency (Wolman Disease)|early onset lysosomal acid lipase deficiency (wolman disease)
5062800|NCT01371825|LAL Deficiency|lal deficiency
5062801|NCT01371825|Late Onset Lysosomal Acid Lipase Deficiency (CESD)|late onset lysosomal acid lipase deficiency (cesd)
5062802|NCT01371825|Wolman Disease (early onset LAL Deficiency)|wolman disease (early onset lal deficiency)
5062803|NCT01371825|Related Disorders:|related disorders:
5062804|NCT01371825|Non-alcoholic Fatty Liver Disease (NAFLD)|non-alcoholic fatty liver disease (nafld)
5062805|NCT01371825|Non-alcoholic Steatohepatitis (NASH)|non-alcoholic steatohepatitis (nash)
5062806|NCT01371825|Alcoholic Liver Disease|alcoholic liver disease
5062807|NCT01371825|Cryptogenic Cirrhosis|cryptogenic cirrhosis
5062808|NCT01371825|Niemann-Pick Disease (NPD) Type C|niemann-pick disease (npd) type c
5062809|NCT01371825|Chanarin Dorfman Syndrome|chanarin dorfman syndrome
5062810|NCT01371799|Schizophrenia|schizophrenia
5062811|NCT01371786|Ciclesonide|ciclesonide
5062812|NCT01371786|Allergic Rhinitis|allergic rhinitis
5062813|NCT01371760|Multiple sclerosis|multiple sclerosis
5062814|NCT01371760|Chronic cerebrospinal venous insufficiency|chronic cerebrospinal venous insufficiency
5062815|NCT01371760|Percutaneous Transluminal Angioplasty (PTA)|percutaneous transluminal angioplasty (pta)
5062816|NCT01371760|Internal jugular vein|internal jugular vein
5062817|NCT01371760|Azygous vein|azygous vein
5062818|NCT01371747|Hyperkalemia|hyperkalemia
5062819|NCT01371747|Chronic Kidney Disease|chronic kidney disease
5062820|NCT01371747|Treatment of Hyperkalemia|treatment of hyperkalemia
5062821|NCT01371747|Hypertension|hypertension
5062822|NCT01371747|Diabetic Nephropathy|diabetic nephropathy
5062823|NCT01371734|Major Depressive Disorder|major depressive disorder
5062824|NCT01371734|MDD|mdd
5062825|NCT01371734|Depression|depression
5062826|NCT01371721|Major Depressive Disorder|major depressive disorder
5062827|NCT01371721|MDD|mdd
5062828|NCT01371721|Depression|depression
5062829|NCT01371708|Major Depressive Disorder|major depressive disorder
5062830|NCT01371708|MDD|mdd
5062831|NCT01371708|Depression|depression
5062832|NCT01371695|IGF-II levels|igf-ii levels
5062833|NCT01371669|Pulmonary arterial hypertension|pulmonary arterial hypertension
5062834|NCT01371669|Chronic post embolic disease|chronic post embolic disease
5062835|NCT01371669|Sleep hypoxemia|sleep hypoxemia
5062836|NCT01371669|polysomnography|polysomnography
5062837|NCT01371669|sleep apnea|sleep apnea
5062838|NCT01371669|periodic respiration|periodic respiration
5062839|NCT01371630|Leukemia|leukemia
5062840|NCT01371630|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
5062841|NCT01371630|ALL|all
5062842|NCT01371630|pre-B, Philadelphia chromosome (Ph-) negative|pre-b, philadelphia chromosome (ph-) negative
5062843|NCT01371630|Maximum tolerated dose|maximum tolerated dose
5062844|NCT01371630|Inotuzumab Ozogamycin|inotuzumab ozogamycin
5062845|NCT01371630|CMC-544|cmc-544
5062846|NCT01371630|Vincristine|vincristine
5062847|NCT01371630|Rituximab|rituximab
5062848|NCT01371630|Rituxan|rituxan
5062849|NCT01371630|Cyclophosphamide|cyclophosphamide
5062850|NCT01371630|Cytoxan|cytoxan
5062851|NCT01371630|Neosar|neosar
5062852|NCT01371630|Dexamethasone|dexamethasone
5062853|NCT01371630|Decadron|decadron
5062854|NCT01371630|Mesna|mesna
5062855|NCT01371630|Mesnex|mesnex
5062856|NCT01371630|Pegfilgrastim|pegfilgrastim
5062857|NCT01371630|Neulasta|neulasta
5062858|NCT01371630|PEG-G-CSF|peg-g-csf
5062859|NCT01371630|Ara-C|ara-c
5062860|NCT01371630|Cytarabine|cytarabine
5062861|NCT01371630|Cytosar|cytosar
5062862|NCT01371630|DepoCyt|depocyt
5062863|NCT01371630|Cytosine Arabinosine Hydrochloride|cytosine arabinosine hydrochloride
5062864|NCT01371630|6-Mercaptopurine|6-mercaptopurine
5062865|NCT01371630|Mercaptopurine|mercaptopurine
5062866|NCT01371630|Purinethol|purinethol
5062867|NCT01371630|6-MP|6-mp
5062868|NCT01371630|Methotrexate|methotrexate
5062869|NCT01371630|Otrexup|otrexup
5062870|NCT01371630|Rasuvo|rasuvo
5062871|NCT01371630|Rheumatrex|rheumatrex
5062872|NCT01371630|Trexall|trexall
5062873|NCT01371630|Amethopterin|amethopterin
5062874|NCT01371630|Methotrexate Sodium|methotrexate sodium
5062875|NCT01371630|MTX|mtx
5062876|NCT01371630|Oncovin|oncovin
5062877|NCT01371630|Vincristine Sulfate|vincristine sulfate
5062878|NCT01371630|Vincasar Pfs|vincasar pfs
5062879|NCT01371630|Prednisone|prednisone
5062880|NCT01371630|Deltasone|deltasone
5062881|NCT01371630|Sterapred|sterapred
5062882|NCT01371630|Rayos|rayos
5062883|NCT01371630|Meticorten|meticorten
5062884|NCT01371630|Citrovorum|citrovorum
5062885|NCT01371630|Leucovorin|leucovorin
5062886|NCT01371630|Wellcovorin|wellcovorin
5062887|NCT01371630|Calcium Leucovorin|calcium leucovorin
5062888|NCT01371630|Folinic Acid|folinic acid
5062889|NCT01371630|Citrovorum Factor|citrovorum factor
5062890|NCT01371617|IPI-926|ipi-926
5062891|NCT01371617|926|926
5062892|NCT01371617|Myelofibrosis|myelofibrosis
5062893|NCT01371617|Hedgehog|hedgehog
5062894|NCT01371617|Infinity Pharmaceuticals|infinity pharmaceuticals
5062895|NCT01371617|Post Essential thrombocythemia|post essential thrombocythemia
5062896|NCT01371617|Post Polycythemia vera|post polycythemia vera
5062897|NCT01371604|Hepatitis C|hepatitis c
5062898|NCT01371604|HCV|hcv
5062899|NCT01371604|treatment-naive|treatment-naive
5062900|NCT01371591|Bleeding|bleeding
5062901|NCT01371591|gastrointestinal|gastrointestinal
5062902|NCT01371591|hemorrhage|hemorrhage
5062903|NCT01371591|ulcer|ulcer
5062904|NCT01371591|varix|varix
5062905|NCT01371591|varices|varices
5062906|NCT01371591|ulcers|ulcers
5062907|NCT01371591|GI|gi
5062908|NCT01371591|stomach|stomach
5062909|NCT01371591|esophagus|esophagus
5062910|NCT01371591|duodenum|duodenum
5062911|NCT01371591|melena|melena
5062912|NCT01371591|hematemesis|hematemesis
5062913|NCT01371591|coffee-ground|coffee-ground
5062914|NCT01371578|Hepatitis C|hepatitis c
5062915|NCT01371578|HCV|hcv
5062916|NCT01371578|Rapid Virologic Response|rapid virologic response
5062917|NCT01371578|Sustained Virologic Response|sustained virologic response
5062918|NCT01371578|Direct Acting Antiviral|direct acting antiviral
5063046|NCT01370967|infant formula|infant formula
5062919|NCT01371578|Combination Therapy HCV RNA|combination therapy hcv rna
5062920|NCT01371578|Polymerase inhibitor|polymerase inhibitor
5062921|NCT01371578|Protease inhibitor|protease inhibitor
5062922|NCT01371578|Treatment naïve|treatment naïve
5062923|NCT01371578|GS-5885|gs-5885
5062924|NCT01371578|GS-9190|gs-9190
5062925|NCT01371578|Tegobuvir|tegobuvir
5062926|NCT01371578|GS-9451|gs-9451
5062927|NCT01371565|Cushing's Disease|cushing's disease
5062928|NCT01371565|Cushing's Syndrome|cushing's syndrome
5062929|NCT01371565|Cushings|cushings
5062930|NCT01371565|Pituitary|pituitary
5062931|NCT01371565|Ectopic ACTH secretion|ectopic acth secretion
5062932|NCT01371539|Myopia|myopia
5062933|NCT01371539|Presbyopia|presbyopia
5062934|NCT01371513|Serum prostate specific antigen|serum prostate specific antigen
5062935|NCT01371422|Paravertebral nerve blockade|paravertebral nerve blockade
5062936|NCT01371422|Percutaneous nephrolithotomy/nephrolithotripsy|percutaneous nephrolithotomy/nephrolithotripsy
5062937|NCT01371422|opioids|opioids
5062938|NCT01371422|pain|pain
5062939|NCT01371409|Stroke|stroke
5062940|NCT01371409|TMS|tms
5062941|NCT01371409|Paired Pulse|paired pulse
5062942|NCT01371409|EEG|eeg
5062943|NCT01371409|Motor Learning|motor learning
5062944|NCT01371396|Metabolic syndrome|metabolic syndrome
5062945|NCT01371396|Non-alcoholic fatty liver disease|non-alcoholic fatty liver disease
5062946|NCT01371396|Obesity Metabolism|obesity metabolism
5062947|NCT01371396|Stable isotopes|stable isotopes
5062948|NCT01371396|Dietary weight loss|dietary weight loss
5062949|NCT01371370|low intensity resistance exercise training|low intensity resistance exercise training
5062950|NCT01371370|hypocaloric diet|hypocaloric diet
5062951|NCT01371370|prehypertension|prehypertension
5062952|NCT01371370|hypertension|hypertension
5062953|NCT01371370|obesity|obesity
5062954|NCT01371370|arterial function|arterial function
5062955|NCT01371370|arterial stiffness|arterial stiffness
5062956|NCT01371370|pulse wave velocity|pulse wave velocity
5062957|NCT01371370|autonomic function|autonomic function
5062958|NCT01371370|endothelial function|endothelial function
5062959|NCT01371370|adipocytokines|adipocytokines
5062960|NCT01371357|Remethylation|remethylation
5062961|NCT01371357|Human Subjects|human subjects
5062962|NCT01371357|Clinical Trial|clinical trial
5062963|NCT01371357|B-vitamin|b-vitamin
5062964|NCT01371357|Creatine|creatine
5062965|NCT01371344|Liver Transplantation|liver transplantation
5062966|NCT01371344|Kidney Transplantation|kidney transplantation
5062967|NCT01371344|Heart Transplantation|heart transplantation
5062968|NCT01371344|Pharmacokinetics|pharmacokinetics
5062969|NCT01371331|Kidney Transplantation|kidney transplantation
5062970|NCT01371331|Pharmacokinetics|pharmacokinetics
5062971|NCT01371331|Heart Transplantation|heart transplantation
5062972|NCT01371331|Liver Transplantation|liver transplantation
5062973|NCT01371318|diabetic foot ulcer|diabetic foot ulcer
5062974|NCT01371318|amputation|amputation
5062975|NCT01371318|wounds|wounds
5062976|NCT01371318|diabetic foot|diabetic foot
5062977|NCT01371318|diabetes complications|diabetes complications
5062978|NCT01371292|Physical activity|physical activity
5062979|NCT01371292|Transformational leadership|transformational leadership
5062980|NCT01371292|Physical education|physical education
5062981|NCT01371266|Glucose intolerance|glucose intolerance
5062982|NCT01371266|Insulin resistance|insulin resistance
5062983|NCT01371266|Insulin|insulin
5062984|NCT01371266|metabolic syndrome|metabolic syndrome
5062985|NCT01371266|honey|honey
5062986|NCT01371266|Inflammation|inflammation
5062987|NCT01371266|oxidative stress|oxidative stress
5062988|NCT01371253|Nintendo wii|nintendo wii
5062989|NCT01371253|postural balance|postural balance
5062990|NCT01371253|muscle strength|muscle strength
5062992|NCT01371240|pancreas cancer|pancreas cancer
5062993|NCT01371240|MRI|mri
5062994|NCT01371240|CT scan|ct scan
5062995|NCT01371227|Multiple myeloma|multiple myeloma
5062996|NCT01371227|Relapsed or refractory multiple myeloma|relapsed or refractory multiple myeloma
5062997|NCT01371227|JNS002|jns002
5062998|NCT01371227|Bortezomib|bortezomib
5062999|NCT01371214|exercise|exercise
5063000|NCT01371214|exercise movement techniques|exercise movement techniques
5063001|NCT01371214|activities of daily living|activities of daily living
5063002|NCT01371175|HIV|hiv
5063003|NCT01371123|serum aluminum|serum aluminum
5063004|NCT01371123|parenteral nutrition|parenteral nutrition
5063005|NCT01371123|children|children
5063006|NCT01371110|OCD|ocd
5063007|NCT01371110|Obsessive-Compulsive Disorder|obsessive-compulsive disorder
5063008|NCT01371110|ketamine|ketamine
5063009|NCT01371110|treatment|treatment
5063010|NCT01371097|Barthel Index|barthel index
5063011|NCT01371097|elderly hospitalised patients|elderly hospitalised patients
5063012|NCT01371097|progressive resistance training|progressive resistance training
5063013|NCT01371071|Clinically isolated syndrome (CIS)|clinically isolated syndrome (cis)
5063014|NCT01371071|Multiple sclerosis (MS)|multiple sclerosis (ms)
5063015|NCT01371071|Immunomodulatory therapy|immunomodulatory therapy
5063016|NCT01371071|Prognostic markers|prognostic markers
5063017|NCT01371071|MRI|mri
5063018|NCT01371071|OCT|oct
5063019|NCT01371058|high on-treatment platelet reactivity|high on-treatment platelet reactivity
5063020|NCT01371058|percutaneous coronary intervention|percutaneous coronary intervention
5063021|NCT01371058|stent thrombosis|stent thrombosis
5063022|NCT01371045|Acromegaly|acromegaly
5063023|NCT01371045|Growth Hormone|growth hormone
5063024|NCT01371045|Carcinoid Syndrome|carcinoid syndrome
5063025|NCT01371045|Somatostatin|somatostatin
5063026|NCT01371019|Preterm Birth, Proteomics|preterm birth, proteomics
5063027|NCT01370993|Hypoxemia|hypoxemia
5063028|NCT01370993|Model|model
5063029|NCT01370993|Bronchoscopes|bronchoscopes
5063030|NCT01370993|Monitored anesthesia care|monitored anesthesia care
5063031|NCT01370980|Medication Adherence|medication adherence
5063032|NCT01370980|Patient Compliance|patient compliance
5063033|NCT01370980|Patient Acceptance of Health Care|patient acceptance of health care
5063034|NCT01370980|Administration, Oral|administration, oral
5063035|NCT01370980|Cancer|cancer
5063036|NCT01370980|Letrozol|letrozol
5063037|NCT01370980|Exemestan|exemestan
5063038|NCT01370980|Imatinib|imatinib
5063039|NCT01370980|Sunitinib|sunitinib
5063040|NCT01370980|Nilotinib|nilotinib
5063041|NCT01370980|Everolimus|everolimus
5063042|NCT01370980|Deferasirox|deferasirox
5063043|NCT01370967|infant|infant
5063044|NCT01370967|term birth|term birth
5063045|NCT01370967|human milk|human milk
5063047|NCT01370967|breast feeding|breast feeding
5063048|NCT01370967|bottle feeding|bottle feeding
5063049|NCT01370967|gastrointestinal tract|gastrointestinal tract
5063050|NCT01370967|quality of life|quality of life
5063051|NCT01370967|infant development|infant development
5063052|NCT01370954|CerefolinNAC|cerefolinnac
5063053|NCT01370954|early memory loss|early memory loss
5063054|NCT01370954|pre-alzheimer's disease|pre-alzheimer's disease
5063055|NCT01370954|cognitive function|cognitive function
5063056|NCT01370954|folic acid|folic acid
5063057|NCT01370954|folate|folate
5063058|NCT01370954|L-methylfolate|l-methylfolate
5063059|NCT01370954|vitamin B12|vitamin b12
5063060|NCT01370954|methylcobalamin|methylcobalamin
5063061|NCT01370954|N-acetylcysteine|n-acetylcysteine
5063063|NCT01370954|oxidative stress|oxidative stress
5063064|NCT01370954|memory deficit|memory deficit
5063065|NCT01370954|antioxidant|antioxidant
5063066|NCT01370941|Chymosin|chymosin
5063067|NCT01370941|24H urine calcium excretion|24h urine calcium excretion
5063068|NCT01370941|Calcium absorption|calcium absorption
5063069|NCT01370941|Intestinal Absorption of Calcium|intestinal absorption of calcium
5063070|NCT01370928|Colonoscopy performance|colonoscopy performance
5063071|NCT01370928|Pain|pain
5063072|NCT01370928|Discomfort|discomfort
5063073|NCT01370928|Screening|screening
5063074|NCT01370928|Colorectal cancer|colorectal cancer
5063075|NCT01370928|Colorectal cancer screening, diagnostics of adenomas|colorectal cancer screening, diagnostics of adenomas
5063076|NCT01370915|postoperative pain, nasal septum surgery, pregabalin|postoperative pain, nasal septum surgery, pregabalin
5063077|NCT01370876|Oxaliplatin|oxaliplatin
5063078|NCT01370876|Head and Neck cancer|head and neck cancer
5063079|NCT01370863|GERD|gerd
5063080|NCT01370863|Gastroesophageal reflux disease|gastroesophageal reflux disease
5063081|NCT01370863|SPD557|spd557
5063082|NCT01370863|Proton pump inhibitors|proton pump inhibitors
5063083|NCT01370850|Retina pathology|retina pathology
5063084|NCT01370824|Diagnosis|diagnosis
5063085|NCT01370824|Clinical|clinical
5063086|NCT01370824|Punch biopsy|punch biopsy
5063087|NCT01370824|Surgical excision|surgical excision
5063088|NCT01370824|Histology|histology
5063089|NCT01370824|Histopathology|histopathology
5063090|NCT01370824|Observed agreement|observed agreement
5063091|NCT01370824|Diagnostic value|diagnostic value
5063092|NCT01370824|Accuracy|accuracy
5063093|NCT01370824|Interobserver variability|interobserver variability
5063094|NCT01370824|Intraobserver variability|intraobserver variability
5063095|NCT01370811|oxybutynin|oxybutynin
5063096|NCT01370811|clonidine|clonidine
5063097|NCT01370811|OC Oral Solution|oc oral solution
5063098|NCT01370811|sialorrhoea|sialorrhoea
5063099|NCT01370811|Parkinson's disease|parkinson's disease
5063100|NCT01370798|Severe hypospadias|severe hypospadias
5063101|NCT01370798|local oestrogen|local oestrogen
5063102|NCT01370798|promestriene|promestriene
5063103|NCT01370798|Onlay-tube-onlay urethroplasty|onlay-tube-onlay urethroplasty
5063104|NCT01370798|post-operative complications|post-operative complications
5063105|NCT01370798|fistula dehiscence|fistula dehiscence
5063106|NCT01370772|B CLL|b cll
5063107|NCT01370772|Fist line treatment|fist line treatment
5063108|NCT01370759|bowel prep|bowel prep
5063109|NCT01370759|PillCam|pillcam
5063110|NCT01370733|TMS,|tms,
5063111|NCT01370733|MDD,|mdd,
5063112|NCT01370733|Depression,|depression,
5063113|NCT01370733|sTMS,|stms,
5063114|NCT01370733|NEST,|nest,
5063115|NCT01370733|NeoSync,|neosync,
5063116|NCT01370733|EEG,|eeg,
5063117|NCT01370733|synchronous,|synchronous,
5063118|NCT01370733|non-invasive neuromodulation,|non-invasive neuromodulation,
5063119|NCT01370733|transcranial magnetic stimulation,|transcranial magnetic stimulation,
5063120|NCT01370733|antidepressant,|antidepressant,
5063121|NCT01370720|IBS|ibs
5063122|NCT01370720|mast cell activation|mast cell activation
5063123|NCT01370720|low grade inflammation|low grade inflammation
5063124|NCT01370720|visceral hyperalgesia|visceral hyperalgesia
5063125|NCT01370668|functional remediation|functional remediation
5063126|NCT01370668|psychoeducation|psychoeducation
5063127|NCT01370668|neurocognition|neurocognition
5063128|NCT01370629|atrial fibrillation|atrial fibrillation
5063129|NCT01370629|cardioversion|cardioversion
5063130|NCT01370616|Infection|infection
5063131|NCT01370616|Diabetes complications|diabetes complications
5063132|NCT01370616|Diabetes wound infection|diabetes wound infection
5063133|NCT01370616|Soft tissue infection|soft tissue infection
5063134|NCT01370616|Osteomyelitis|osteomyelitis
5063135|NCT01370616|Diabetes mellitus|diabetes mellitus
5063136|NCT01370577|Predictors for asthma control|predictors for asthma control
5063137|NCT01370577|Asthma Exacerbation rate|asthma exacerbation rate
5063138|NCT01370577|Mean frequency of PFT|mean frequency of pft
5063139|NCT01370577|sputum assessments|sputum assessments
5063140|NCT01370577|refill adherence(%)|refill adherence(%)
5063141|NCT01370577|prescription persistence|prescription persistence
5063142|NCT01370564|Heart failure|heart failure
5063143|NCT01370564|Cardiac filling pressure|cardiac filling pressure
5063144|NCT01370538|Heartburn|heartburn
5063145|NCT01370525|Heartburn|heartburn
5063146|NCT01370486|Lennox-Gastaut syndrome|lennox-gastaut syndrome
5063147|NCT01370486|Epileptic encephalopathy|epileptic encephalopathy
5063148|NCT01370486|Melatonin|melatonin
5063149|NCT01370486|Tonic seizures|tonic seizures
5063150|NCT01370486|Interictal discharges|interictal discharges
5063151|NCT01370486|Quality of sleep|quality of sleep
5063152|NCT01370473|Hyponatremia|hyponatremia
5063153|NCT01370460|Tranexamic Acid|tranexamic acid
5063154|NCT01370460|Blood transfusion|blood transfusion
5063155|NCT01370460|Total knee arthroplasty|total knee arthroplasty
5063156|NCT01370447|Leigh syndrome|leigh syndrome
5063157|NCT01370447|MELAS|melas
5063158|NCT01370447|Kearns-Sayre|kearns-sayre
5063159|NCT01370447|Alper's|alper's
5063160|NCT01370447|Inherited mitochondrial disease|inherited mitochondrial disease
5063161|NCT01370447|Friedreich's ataxia|friedreich's ataxia
5063162|NCT01370447|POLG1 deficiency|polg1 deficiency
5063163|NCT01370434|MM|mm
5063164|NCT01370408|Autologous stem cell transplant|autologous stem cell transplant
5063165|NCT01370408|BEAM|beam
5063166|NCT01370408|Oral busulfan|oral busulfan
5063167|NCT01370408|Cyclophosphamide|cyclophosphamide
5063168|NCT01370408|Etoposide|etoposide
5063169|NCT01370408|Carboplatin|carboplatin
5063170|NCT01370408|melphalan|melphalan
5063171|NCT01370395|geriatrics|geriatrics
5063172|NCT01370395|troponin|troponin
5063173|NCT01370395|electrocardiography|electrocardiography
5063174|NCT01370395|diagnosis|diagnosis
5063175|NCT01370395|myocardial infarction|myocardial infarction
5063176|NCT01370382|geriatrics|geriatrics
5063177|NCT01370382|troponin|troponin
5063178|NCT01370382|electrocardiography|electrocardiography
5063179|NCT01370382|diagnosis|diagnosis
5063180|NCT01370382|myocardial infarction|myocardial infarction
5063181|NCT01370356|smoking reduction|smoking reduction
5063182|NCT01370356|smoking cessation|smoking cessation
5063183|NCT01370330|Neuroblastoma|neuroblastoma
5063184|NCT01370330|MIBG|mibg
5063185|NCT01370330|131I-MIBG|131i-mibg
5063186|NCT01370330|Resistant|resistant
5063187|NCT01370330|Relapsed|relapsed
5063188|NCT01370330|Treatment|treatment
5063189|NCT01370330|UCSF|ucsf
5063190|NCT01370330|Pediatric|pediatric
5063191|NCT01370330|Oncology|oncology
5063192|NCT01370304|repetitive Transcranial Magnetic Stimulation (rTMS)|repetitive transcranial magnetic stimulation (rtms)
5063193|NCT01370304|Depression|depression
5063194|NCT01370304|Venlafaxine|venlafaxine
5063195|NCT01370304|fMRI|fmri
5063196|NCT01370291|rTMS|rtms
5063198|NCT01370278|Central airway obstruction|central airway obstruction
5063199|NCT01370278|lumen obstruction|lumen obstruction
5063200|NCT01370278|Sodium bicarbonate|sodium bicarbonate
5063201|NCT01370278|Baking soda|baking soda
5063202|NCT01370278|Normal saline|normal saline
5063203|NCT01370278|Salt water|salt water
5063204|NCT01370278|Airway stents|airway stents
5063205|NCT01370278|Bronchoscopy|bronchoscopy
5063206|NCT01370278|mucus obstruction|mucus obstruction
5063207|NCT01370265|Regadenoson (Lexiscan)|regadenoson (lexiscan)
5063208|NCT01370265|PET N-13 ammonia imaging|pet n-13 ammonia imaging
5063209|NCT01370265|Myocardial Blood Flow (MBF)|myocardial blood flow (mbf)
5063210|NCT01370265|Regadenoson Stress|regadenoson stress
5063211|NCT01370252|ankle arthrodesis|ankle arthrodesis
5063212|NCT01370252|pain|pain
5063213|NCT01370252|arthroscopic technique|arthroscopic technique
5063214|NCT01370252|ankle osteoarthritis|ankle osteoarthritis
5063215|NCT01370239|monoclonal antibody|monoclonal antibody
5063216|NCT01370239|Lewis|lewis
5063217|NCT01370239|breast cancer|breast cancer
5063218|NCT01370213|non-myeloablative haploidentical transplant|non-myeloablative haploidentical transplant
5063219|NCT01370213|hematopoietic cell transplant|hematopoietic cell transplant
5063220|NCT01370213|natural killer cells|natural killer cells
5063221|NCT01370213|adoptive cellular therapy|adoptive cellular therapy
5063222|NCT01370200|citrate|citrate
5063223|NCT01370200|anticoagulation|anticoagulation
5063224|NCT01370200|plasma exchange|plasma exchange
5063225|NCT01370200|efficacy|efficacy
5063226|NCT01370187|Bronchiolitis|bronchiolitis
5063227|NCT01370187|Postbronchiolitis wheezing|postbronchiolitis wheezing
5063228|NCT01370187|Montelukast|montelukast
5063229|NCT01370174|Falls|falls
5063230|NCT01370174|Balance|balance
5063231|NCT01370174|Protective Stepping|protective stepping
5063232|NCT01370174|Lateral Balance|lateral balance
5063233|NCT01370174|Elderly|elderly
5063234|NCT01370161|transjugular intrahepatic portosystemic shunt|transjugular intrahepatic portosystemic shunt
5063235|NCT01370161|TIPS|tips
5063236|NCT01370161|variceal bleeding|variceal bleeding
5063237|NCT01370161|liver cirrhosis|liver cirrhosis
5063238|NCT01370161|hepatitis B|hepatitis b
5063239|NCT01370148|Pharmacokinetics|pharmacokinetics
5063240|NCT01370148|Protein Binding|protein binding
5063241|NCT01370148|Conivaptan|conivaptan
5063242|NCT01370148|Vaprisol|vaprisol
5063243|NCT01370148|Liver Disease|liver disease
5063244|NCT01370148|YM087|ym087
5063245|NCT01370135|neovascular glaucoma|neovascular glaucoma
5063246|NCT01370135|rubeosis|rubeosis
5063247|NCT01370135|anterior chamber|anterior chamber
5063248|NCT01370135|intraocular|intraocular
5063249|NCT01370135|intravitreal injections|intravitreal injections
5063250|NCT01370135|Lucentis|lucentis
5063251|NCT01370135|Ranibizumab|ranibizumab
5063252|NCT01370135|short ans longterm effects|short ans longterm effects
5063253|NCT01370135|best corrected visual acuity|best corrected visual acuity
5063254|NCT01370135|gonioscopy|gonioscopy
5063255|NCT01370135|BCVA|bcva
5063256|NCT01370135|quality of life|quality of life
5063257|NCT01370122|Women over the age of 20|women over the age of 20
5063258|NCT01370083|Dysphagia|dysphagia
5063259|NCT01370083|Viscosity|viscosity
5063260|NCT01370083|Tongue|tongue
5063261|NCT01370083|Pressure|pressure
5063262|NCT01370057|Adolescent Idiopathic Scoliosis|adolescent idiopathic scoliosis
5063263|NCT01370057|Scoliosis|scoliosis
5063264|NCT01370057|AIS|ais
5063265|NCT01370057|Brace|brace
5063266|NCT01370057|TLSO|tlso
5063267|NCT01370044|Febrile Seizure|febrile seizure
5063268|NCT01370044|Carbon Dioxide|carbon dioxide
5063269|NCT01370044|Carbogen|carbogen
5063270|NCT01370044|Respiratory Alkalosis|respiratory alkalosis
5063271|NCT01370031|Asthma|asthma
5063272|NCT01370031|PK|pk
5063273|NCT01370031|Adults|adults
5063274|NCT01370018|CD4 counts|cd4 counts
5063275|NCT01369992|Metastatic Cancer|metastatic cancer
5063276|NCT01369979|Lumped constant|lumped constant
5063277|NCT01369979|FDG|fdg
5063278|NCT01369979|PET|pet
5063279|NCT01369966|Smoking Cessation|smoking cessation
5063280|NCT01369966|Schizophrenic Smokers|schizophrenic smokers
5063281|NCT01369966|fMRI|fmri
5063282|NCT01369966|Neural Circuits|neural circuits
5063283|NCT01369953|Civic Ideals/Social Norms|civic ideals/social norms
5063284|NCT01369953|Genetic Counseling|genetic counseling
5063285|NCT01369953|Genetic Disorders|genetic disorders
5063286|NCT01369953|Genetic Testing|genetic testing
5063287|NCT01369953|Whole Genome Sequencing|whole genome sequencing
5063288|NCT01369940|Growth Discordancy|growth discordancy
5063289|NCT01369940|Fetal Growth|fetal growth
5063290|NCT01369940|Twin Growth|twin growth
5063291|NCT01369927|Shigellosis|shigellosis
5063292|NCT01369927|Safety and Immunogenicity|safety and immunogenicity
5063293|NCT01369927|Conjugate Vaccine|conjugate vaccine
5063294|NCT01369914|Graft-Versus-Host Disease|graft-versus-host disease
5063295|NCT01369914|Natural History Study|natural history study
5063296|NCT01369914|Hematopoietic Stem Cell Transplant|hematopoietic stem cell transplant
5063297|NCT01369914|GVHD|gvhd
5063298|NCT01369901|Exercise|exercise
5063299|NCT01369901|Spinal Bulbar Muscular Atrophy|spinal bulbar muscular atrophy
5063300|NCT01369901|Spinal and Bulbar Muscular Atrophy|spinal and bulbar muscular atrophy
5063301|NCT01369901|SBMA|sbma
5063302|NCT01369901|Motor Neuron Disease|motor neuron disease
5063303|NCT01369888|Immunotherapy|immunotherapy
5063304|NCT01369888|Cell Therapy|cell therapy
5063305|NCT01369888|IL-15 Cytokine|il-15 cytokine
5063306|NCT01369888|Melanoma|melanoma
5063307|NCT01369888|Metastatic Melanoma|metastatic melanoma
5063308|NCT01369888|Skin Cancer|skin cancer
5063309|NCT01369875|Immunotherapy|immunotherapy
5063310|NCT01369875|Cell Therapy|cell therapy
5063311|NCT01369875|Metastatic Cancer|metastatic cancer
5063312|NCT01369875|Melanoma|melanoma
5063313|NCT01369875|Metastatic Melanoma|metastatic melanoma
5063314|NCT01369875|Skin Cancer|skin cancer
5063315|NCT01369862|live attenuated flu vaccines|live attenuated flu vaccines
5063316|NCT01369862|influenza A (H1N1)|influenza a (h1n1)
5063317|NCT01369862|intranasal application|intranasal application
5063318|NCT01369862|replication-deficient influenza virus|replication-deficient influenza virus
5063319|NCT01369836|Tafamidis|tafamidis
5063320|NCT01369836|Pharmacokinetics|pharmacokinetics
5063321|NCT01369836|TTR stabilization|ttr stabilization
5063322|NCT01369823|HbA1c|hba1c
5063323|NCT01369823|Paradigm 522/722 Infusion Pump|paradigm 522/722 infusion pump
5063324|NCT01369823|Transmitter (MMT-7703WW)|transmitter (mmt-7703ww)
5063325|NCT01369823|Sensor MMT-7002 (i.e. Glucose Sensor)|sensor mmt-7002 (i.e. glucose sensor)
5063326|NCT01369823|Levels of HbA1c at enrollment higher than 7|levels of hba1c at enrollment higher than 7
5063327|NCT01369810|Epidemiological|epidemiological
5063328|NCT01369810|asthma|asthma
5063329|NCT01369810|COPD|copd
5063330|NCT01369810|reimbursement|reimbursement
5063331|NCT01369810|switch|switch
5063332|NCT01369810|outcomes associated with the change in reimbursement|outcomes associated with the change in reimbursement
5063333|NCT01369797|UPSAV|upsav
5063334|NCT01369797|autonomy|autonomy
5063335|NCT01369797|the elderly of 75 years and older|the elderly of 75 years and older
5063336|NCT01369784|Diffuse large B-cell Lymphoma|diffuse large b-cell lymphoma
5063337|NCT01369784|R-IPI|r-ipi
5063338|NCT01369771|Confocal microscopic findings|confocal microscopic findings
5063339|NCT01369771|Ocular Hypertension|ocular hypertension
5063340|NCT01369771|Open-Angle Glaucoma|open-angle glaucoma
5063341|NCT01369771|Preservative-free eye drops|preservative-free eye drops
5063342|NCT01369758|morcellator|morcellator
5063343|NCT01369758|hysteroscope|hysteroscope
5063344|NCT01369758|myomectomy|myomectomy
5063345|NCT01369758|polypectomy|polypectomy
5063346|NCT01369758|uterine fibroids|uterine fibroids
5063347|NCT01369758|uterine polyps|uterine polyps
5063348|NCT01369745|Rheumatoid Arthritis|rheumatoid arthritis
5063349|NCT01369745|Moderate to severe|moderate to severe
5063350|NCT01369719|Thalassemia|thalassemia
5063351|NCT01369719|Iron overload|iron overload
5063352|NCT01369719|transfusion|transfusion
5063353|NCT01369719|osveral|osveral
5063354|NCT01369719|desferal|desferal
5063355|NCT01369706|electromagnetic interference|electromagnetic interference
5063356|NCT01369706|hand-held metal detector|hand-held metal detector
5063357|NCT01369706|pacemaker|pacemaker
5063358|NCT01369706|cardioverter-defibrillator|cardioverter-defibrillator
5063359|NCT01369693|smokeless tobacco|smokeless tobacco
5063360|NCT01369693|Nicotine|nicotine
5063361|NCT01369693|Cadmium|cadmium
5063362|NCT01369693|lead|lead
5063363|NCT01369693|Tobacco Specific Nitrosamines|tobacco specific nitrosamines
5063364|NCT01369680|Ketamine|ketamine
5063365|NCT01369680|Chronic pain|chronic pain
5063366|NCT01369680|Children|children
5063367|NCT01369680|Oral pain medication|oral pain medication
5063368|NCT01369654|hysterectomy with Bilateral Salpingo Oophorectomy|hysterectomy with bilateral salpingo oophorectomy
5063369|NCT01369654|Oophorectomy|oophorectomy
5063370|NCT01369654|Gynecologic condition|gynecologic condition
5063371|NCT01369641|cisplatin|cisplatin
5063372|NCT01369641|STS|sts
5063373|NCT01369641|sodium thiosulfate|sodium thiosulfate
5063374|NCT01369641|Adults|adults
5063375|NCT01369641|dose range of 80-120mg/m2|dose range of 80-120mg/m2
5063376|NCT01369628|Open label|open label
5063377|NCT01369628|Dose Escalating|dose escalating
5063378|NCT01369628|Phase Ib|phase ib
5063379|NCT01369615|Malignant pain|malignant pain
5063380|NCT01369615|Nonmalignant pain|nonmalignant pain
5063381|NCT01369615|Pain|pain
5063382|NCT01369615|Pediatric|pediatric
5063383|NCT01369615|Opioid|opioid
5063384|NCT01369615|Moderate to severe|moderate to severe
5063385|NCT01369589|Xerostomia|xerostomia
5063386|NCT01369589|dry mouth|dry mouth
5063387|NCT01369589|Sjogren's Syndrome|sjogren's syndrome
5063388|NCT01369563|rhinitis|rhinitis
5063389|NCT01369563|ciclesonide|ciclesonide
5063390|NCT01369563|intermittent rhinitis|intermittent rhinitis
5063391|NCT01369563|persistent rhinitis|persistent rhinitis
5063392|NCT01369524|fluid responsiveness|fluid responsiveness
5063393|NCT01369524|microcirculation|microcirculation
5063394|NCT01369524|Intensive Care|intensive care
5063395|NCT01369511|Disuse Atrophy|disuse atrophy
5063396|NCT01369511|Muscle|muscle
5063397|NCT01369511|Strength|strength
5063398|NCT01369511|Arthroplasty|arthroplasty
5063399|NCT01369511|Hip|hip
5063400|NCT01369511|Joint Replacement|joint replacement
5063401|NCT01369498|Hematology|hematology
5063402|NCT01369498|Myelofibrosis|myelofibrosis
5063403|NCT01369498|Thrombocythemia Myelofibrosis|thrombocythemia myelofibrosis
5063404|NCT01369498|Bone Marrow Diseases|bone marrow diseases
5063405|NCT01369498|Hematologic Diseases|hematologic diseases
5063406|NCT01369498|Blood Diseases|blood diseases
5063407|NCT01369498|Leukemia|leukemia
5063408|NCT01369498|Blood Disorders|blood disorders
5063409|NCT01369485|Urinary Incontinence|urinary incontinence
5063410|NCT01369485|Overactive Bladder|overactive bladder
5063411|NCT01369485|Frequency|frequency
5063412|NCT01369485|Urgency|urgency
5063413|NCT01369459|Comorbid|comorbid
5063414|NCT01369459|ADHD|adhd
5063415|NCT01369459|SUD|sud
5063416|NCT01369459|ASU|asu
5063417|NCT01369446|In vitro fertilization|in vitro fertilization
5063418|NCT01369446|Assisted reproduction|assisted reproduction
5063419|NCT01369446|Noninvasive imaging of embryos|noninvasive imaging of embryos
5063420|NCT01369446|Time lapse imaging of embryos|time lapse imaging of embryos
5063421|NCT01369446|Traditional morphological grading of embryos|traditional morphological grading of embryos
5063422|NCT01369446|Prediction of blastocysts|prediction of blastocysts
5063423|NCT01369433|tivozanib|tivozanib
5063424|NCT01369420|locoregional cancer therapy|locoregional cancer therapy
5063425|NCT01369420|pancreatic cancer|pancreatic cancer
5063426|NCT01369420|unresectable pancreatic cancer|unresectable pancreatic cancer
5063427|NCT01369420|pancreatic adenocarcinoma|pancreatic adenocarcinoma
5063428|NCT01369420|locally advanced, unresectable pancreatic cancer|locally advanced, unresectable pancreatic cancer
5063429|NCT01369420|pancreatic cancer tumor ablation|pancreatic cancer tumor ablation
5063430|NCT01369420|NanoKnife tumor ablation for pancreatic cancer|nanoknife tumor ablation for pancreatic cancer
5063431|NCT01369420|NanoKnife LEDC system tumor ablation|nanoknife ledc system tumor ablation
5063432|NCT01369420|Non thermal ablation|non thermal ablation
5063433|NCT01369420|Irreversible electroporation for pancreatic cancer treatment|irreversible electroporation for pancreatic cancer treatment
5063434|NCT01369420|IRE for unresectable pancreatic cancer|ire for unresectable pancreatic cancer
5063435|NCT01369407|Heart failure|heart failure
5063436|NCT01369407|HF|hf
5063437|NCT01369407|Heart Diseases|heart diseases
5063438|NCT01369407|Cardiovascular Diseases|cardiovascular diseases
5063439|NCT01369407|Heart Failure NYHA class III|heart failure nyha class iii
5063440|NCT01369407|Advanced heart failure|advanced heart failure
5063441|NCT01369407|Systolic Heart Failure|systolic heart failure
5063442|NCT01369394|Measles|measles
5063443|NCT01369394|Mumps|mumps
5063444|NCT01369394|Rubella|rubella
5063445|NCT01369394|MMR|mmr
5063446|NCT01369394|Prevention|prevention
5063447|NCT01369394|Tailoring|tailoring
5063448|NCT01369394|Persuasive communication|persuasive communication
5063449|NCT01369394|Children|children
5063450|NCT01369381|Cervical spine|cervical spine
5063451|NCT01369381|Endotracheal intubation|endotracheal intubation
5063452|NCT01369381|Laryngoscope|laryngoscope
5063453|NCT01369381|Biomechanics|biomechanics
5063454|NCT01369368|Acute myeloid leukemia|acute myeloid leukemia
5063455|NCT01369368|Allogeneic stem cell transplantation|allogeneic stem cell transplantation
5063456|NCT01369368|Relapse|relapse
5063457|NCT01369368|Disease stabilization, survival|disease stabilization, survival
5063458|NCT01369355|Ustekinumab|ustekinumab
5063459|NCT01369355|Stelara, Moderately to severely active Crohn's Disease|stelara, moderately to severely active crohn's disease
5063460|NCT01369355|IBD, Crohn's|ibd, crohn's
5063461|NCT01369355|UNITI|uniti
5063462|NCT01369355|colitis|colitis
5063463|NCT01369355|IL-12|il-12
5063464|NCT01369355|IL-23|il-23
5063465|NCT01369342|ustekinumab|ustekinumab
5063466|NCT01369342|moderately to severely active Crohn's Disease|moderately to severely active crohn's disease
5063467|NCT01369342|Stelara|stelara
5063468|NCT01369342|IBD|ibd
5063469|NCT01369342|colitis|colitis
5063470|NCT01369342|crohn|crohn
5063471|NCT01369342|UNITI|uniti
5063472|NCT01369342|Crohn's|crohn's
5063473|NCT01369329|ustekinumab|ustekinumab
5063474|NCT01369329|moderately to severely active Crohn's Disease|moderately to severely active crohn's disease
5063475|NCT01369329|tumor necrosis factor, Stelara|tumor necrosis factor, stelara
5063476|NCT01369329|Crohn|crohn
5063477|NCT01369329|Crohn's|crohn's
5063478|NCT01369329|IBD|ibd
5063479|NCT01369329|UNITI|uniti
5063480|NCT01369303|HIV|hiv
5063481|NCT01369290|Depression|depression
5063482|NCT01369290|Antidepressant Medication|antidepressant medication
5063483|NCT01369290|CBT|cbt
5063484|NCT01369277|PF-04991532|pf-04991532
5063485|NCT01369277|safety and tolerability|safety and tolerability
5063486|NCT01369277|PK|pk
5063487|NCT01369277|Japanese and Western population|japanese and western population
5063488|NCT01369264|Repetitive Transcranial Magnetic Stimulation (rTMS)|repetitive transcranial magnetic stimulation (rtms)
5063489|NCT01369264|Electroencephalography (EEG)|electroencephalography (eeg)
5063490|NCT01369264|Magnetic Resonance Imaging|magnetic resonance imaging
5063491|NCT01369264|Quantitative EEG (QEEG)|quantitative eeg (qeeg)
5063492|NCT01369238|bee venom acupuncture|bee venom acupuncture
5063493|NCT01369238|east west collaborative medicine|east west collaborative medicine
5063494|NCT01369238|whiplash associated disorder|whiplash associated disorder
5063495|NCT01369225|Randomized|randomized
5063496|NCT01369225|Safety Study|safety study
5063497|NCT01369225|Open Label|open label
5063498|NCT01369199|Hepatitis B|hepatitis b
5063499|NCT01369199|Immune-tolerant hepatitis B|immune-tolerant hepatitis b
5063500|NCT01369199|HBV|hbv
5063501|NCT01369173|Healthy|healthy
5063502|NCT01369147|SICU|sicu
5063503|NCT01369147|calories|calories
5063504|NCT01369147|TPN|tpn
5063505|NCT01369147|tube feeding|tube feeding
5063506|NCT01369147|Optimum Energy Dose in SICU|optimum energy dose in sicu
5063507|NCT01369134|self-etch adhesive|self-etch adhesive
5063508|NCT01369134|selective enamel etching|selective enamel etching
5063509|NCT01369134|Adper Easy Bond|adper easy bond
5063510|NCT01369134|Supreme Ultra|supreme ultra
5063511|NCT01369134|Molar and premolar teeth|molar and premolar teeth
5063512|NCT01369134|Adult|adult
5063513|NCT01369134|Class I and II cavities|class i and ii cavities
5063514|NCT01369121|peritumoral brain edema|peritumoral brain edema
5063515|NCT01369121|edema|edema
5063516|NCT01369121|malignant brain tumor|malignant brain tumor
5063517|NCT01369121|brain tumor|brain tumor
5063518|NCT01369121|dexamethasone|dexamethasone
5063519|NCT01369121|Decadron|decadron
5063520|NCT01369108|small Class I|small class i
5063521|NCT01369108|molar and premolar|molar and premolar
5063522|NCT01369108|low stress flowable composite|low stress flowable composite
5063523|NCT01369108|adult|adult
5063524|NCT01369108|Restoration|restoration
5063525|NCT01369108|small caries lesions|small caries lesions
5063526|NCT01369082|islet allograft function|islet allograft function
5063527|NCT01369082|c-peptide production|c-peptide production
5063528|NCT01369082|maintenance immunosuppressive medications|maintenance immunosuppressive medications
5063529|NCT01369069|stroke|stroke
5063530|NCT01369069|diabetes|diabetes
5063531|NCT01369069|hyperglycemia|hyperglycemia
5063532|NCT01369056|antiretroviral therapy, highly active|antiretroviral therapy, highly active
5063533|NCT01369056|treatment adherence|treatment adherence
5063534|NCT01369043|Vitamin E|vitamin e
5063535|NCT01369043|Vitamin C|vitamin c
5063536|NCT01369043|Exercise|exercise
5063537|NCT01369043|Antioxidant|antioxidant
5063538|NCT01369030|L-methylfolate|l-methylfolate
5063539|NCT01369030|Deplin|deplin
5063540|NCT01369030|depression|depression
5063541|NCT01369030|antidepressant|antidepressant
5063542|NCT01369030|combination therapy|combination therapy
5063543|NCT01369030|augmentation|augmentation
5063544|NCT01369030|folate|folate
5063545|NCT01369030|folic acid|folic acid
5063546|NCT01369030|homocysteine|homocysteine
5063547|NCT01369030|methionine|methionine
5063548|NCT01369030|MTHFR genotype|mthfr genotype
5063549|NCT01369030|C677T mutation|c677t mutation
5063550|NCT01369030|vitamin B6|vitamin b6
5063551|NCT01369030|vitamin B12|vitamin b12
5063552|NCT01369017|healthy volunteer|healthy volunteer
5063553|NCT01369017|endotoxin|endotoxin
5063554|NCT01369004|self-weighing|self-weighing
5063555|NCT01369004|self-monitoring|self-monitoring
5063556|NCT01369004|weight loss|weight loss
5063557|NCT01369004|obesity|obesity
5063558|NCT01368991|Coronary Artery Bypass Grafts|coronary artery bypass grafts
5063559|NCT01368991|Sternal Closure|sternal closure
5063560|NCT01368991|Biologic Bone cement|biologic bone cement
5063561|NCT01368978|TIDM|tidm
5063562|NCT01368952|Obstructive Sleep Apnea|obstructive sleep apnea
5063563|NCT01368952|Prone positioning|prone positioning
5063564|NCT01368952|Positional Treatment|positional treatment
5063565|NCT01368952|Hypoxemia|hypoxemia
5063566|NCT01368939|breast imaging|breast imaging
5063567|NCT01368939|MBI|mbi
5063568|NCT01368939|dose reduction|dose reduction
5063569|NCT01368939|Tc-99m|tc-99m
5063570|NCT01368939|imaging|imaging
5063571|NCT01368939|cardiac|cardiac
5063572|NCT01368900|Ultherapy™ Treatment|ultherapy™ treatment
5063573|NCT01368900|Ulthera, Inc.|ulthera, inc.
5063574|NCT01368900|Ultrasound treatment for skin tightening|ultrasound treatment for skin tightening
5063575|NCT01368887|psoriasis|psoriasis
5063576|NCT01368887|scalp psoriasis|scalp psoriasis
5063577|NCT01368861|infant|infant
5063578|NCT01368861|immunizations|immunizations
5063579|NCT01368861|pain|pain
5063580|NCT01368861|pain management|pain management
5063581|NCT01368861|vaccines|vaccines
5063582|NCT01368861|analgesia|analgesia
5063583|NCT01368848|AGMT|agmt
5063584|NCT01368848|NSCLC|nsclc
5063585|NCT01368848|non-small cell lung cancer|non-small cell lung cancer
5063586|NCT01368848|bevacizumab|bevacizumab
5063587|NCT01368848|Avastin|avastin
5063588|NCT01368848|Cisplatin|cisplatin
5063589|NCT01368848|Docetaxel|docetaxel
5063590|NCT01368848|Taxotere|taxotere
5063591|NCT01368848|Inoperable|inoperable
5063592|NCT01368848|stages IIIB and IV|stages iiib and iv
5063593|NCT01368809|Ambulatory surgery|ambulatory surgery
5063594|NCT01368809|Pain management|pain management
5063595|NCT01368809|Perioperative outcomes|perioperative outcomes
5063596|NCT01368809|Fentanyl|fentanyl
5063597|NCT01368809|Coughing during insertion of an LMA|coughing during insertion of an lma
5063598|NCT01368809|Ambulatory surgery procedures|ambulatory surgery procedures
5063599|NCT01368796|Vaccine|vaccine
5063600|NCT01368796|Influenza vaccine|influenza vaccine
5063601|NCT01368796|Adjuvanted Influenza vaccine|adjuvanted influenza vaccine
5063706|NCT01368341|Borrelia|borrelia
5063602|NCT01368796|Intradermal Influenza vaccine|intradermal influenza vaccine
5063603|NCT01368796|Seniors|seniors
5063604|NCT01368796|Acceptability of vaccines|acceptability of vaccines
5063605|NCT01368796|Influenza|influenza
5063606|NCT01368757|Chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5063607|NCT01368757|CMML|cmml
5063608|NCT01368757|Lenalidomide|lenalidomide
5063609|NCT01368757|Revlimid|revlimid
5063610|NCT01368744|Breast Neoplasms|breast neoplasms
5063611|NCT01368744|Breast Diseases|breast diseases
5063612|NCT01368705|Infants|infants
5063613|NCT01368705|Nitrogen Balance|nitrogen balance
5063614|NCT01368705|Cardiothoracic surgery|cardiothoracic surgery
5063615|NCT01368705|Congenital heart disease|congenital heart disease
5063616|NCT01368705|Malnutrition|malnutrition
5063617|NCT01368692|subclavian vein catheterization success rate|subclavian vein catheterization success rate
5063618|NCT01368679|Aortic Aneurysm, Abdominal|aortic aneurysm, abdominal
5063619|NCT01368679|Abdominal Aortic|abdominal aortic
5063620|NCT01368666|Aortic valve replacement|aortic valve replacement
5063621|NCT01368666|Aortic stenosis|aortic stenosis
5063622|NCT01368666|Biological valve|biological valve
5063623|NCT01368666|Sutureless valve|sutureless valve
5063624|NCT01368666|Stented valve|stented valve
5063625|NCT01368666|Aortic Valve Disease|aortic valve disease
5063626|NCT01368653|Tobacco|tobacco
5063627|NCT01368653|Smoking|smoking
5063628|NCT01368653|Smoking Cessation|smoking cessation
5063629|NCT01368653|Tobacco Dependence|tobacco dependence
5063630|NCT01368653|Tobacco Use|tobacco use
5063631|NCT01368653|Nicotine Dependence|nicotine dependence
5063632|NCT01368627|Coronary Artery Disease|coronary artery disease
5063633|NCT01368627|Restenosis|restenosis
5063634|NCT01368627|Stent thrombosis|stent thrombosis
5063635|NCT01368627|Coronary stents|coronary stents
5063636|NCT01368627|Angioplasty|angioplasty
5063637|NCT01368627|Drug Eluting Stents(DES)|drug eluting stents(des)
5063638|NCT01368614|OHS|ohs
5063639|NCT01368601|Lung Cancer|lung cancer
5063640|NCT01368601|CPAP|cpap
5063641|NCT01368601|PPC|ppc
5063642|NCT01368601|lobectomy|lobectomy
5063643|NCT01368601|One-lung ventilation|one-lung ventilation
5063644|NCT01368588|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5063645|NCT01368588|stage I prostate cancer|stage i prostate cancer
5063646|NCT01368588|stage IIA prostate cancer|stage iia prostate cancer
5063647|NCT01368588|stage IIB prostate cancer|stage iib prostate cancer
5063648|NCT01368588|stage III prostate cancer|stage iii prostate cancer
5063649|NCT01368575|Ischemic|ischemic
5063650|NCT01368575|Mitral|mitral
5063651|NCT01368575|Valve|valve
5063652|NCT01368575|Insufficiency|insufficiency
5063653|NCT01368575|SVR|svr
5063654|NCT01368549|Metanx|metanx
5063655|NCT01368549|diabetes|diabetes
5063656|NCT01368549|neuropathy|neuropathy
5063657|NCT01368549|folic acid|folic acid
5063658|NCT01368549|folate|folate
5063659|NCT01368549|L-methylfolate|l-methylfolate
5063660|NCT01368549|vitamin B6|vitamin b6
5063661|NCT01368549|Pyridoxal 5'-phosphate|pyridoxal 5'-phosphate
5063662|NCT01368549|vitamin B12|vitamin b12
5063663|NCT01368549|methylcobalamin|methylcobalamin
5063664|NCT01368549|DPN|dpn
5063665|NCT01368536|High blood pressure|high blood pressure
5063666|NCT01368536|diabetes|diabetes
5063667|NCT01368523|Chronic Myelogenous Leukemia|chronic myelogenous leukemia
5063668|NCT01368523|chronic phase|chronic phase
5063669|NCT01368523|accelerated phase|accelerated phase
5063670|NCT01368523|blastic phase|blastic phase
5063671|NCT01368523|nilotinib|nilotinib
5063672|NCT01368510|obsessive-compulsive disorder (OCD)|obsessive-compulsive disorder (ocd)
5063673|NCT01368510|cognitive-behavioral therapy (CBT)|cognitive-behavioral therapy (cbt)
5063674|NCT01368510|magnetic resonance spectroscopy (MRS)|magnetic resonance spectroscopy (mrs)
5063675|NCT01368510|glutamate|glutamate
5063676|NCT01368510|cingulate gyrus|cingulate gyrus
5063677|NCT01368497|Hepatitis B|hepatitis b
5063678|NCT01368497|HBV|hbv
5063679|NCT01368471|STEMI|stemi
5063680|NCT01368471|myocardial infarction|myocardial infarction
5063681|NCT01368471|stent|stent
5063682|NCT01368432|TBI|tbi
5063683|NCT01368432|Depression|depression
5063684|NCT01368432|Mood|mood
5063685|NCT01368432|Behavior|behavior
5063686|NCT01368419|Endostar|endostar
5063687|NCT01368419|Radiotherapy|radiotherapy
5063688|NCT01368419|Esophageal Cancer|esophageal cancer
5063689|NCT01368406|schizophrenia|schizophrenia
5063690|NCT01368406|weight gain|weight gain
5063691|NCT01368406|intervention|intervention
5063692|NCT01368380|Breast cancer|breast cancer
5063693|NCT01368380|Partners|partners
5063694|NCT01368380|Couples|couples
5063695|NCT01368380|Attachment|attachment
5063696|NCT01368380|Intervention|intervention
5063697|NCT01368367|Burns|burns
5063698|NCT01368354|Community Led Total Sanitation|community led total sanitation
5063699|NCT01368354|Open Defecation|open defecation
5063700|NCT01368354|Cysticercosis|cysticercosis
5063701|NCT01368354|Soil transmitted helminths|soil transmitted helminths
5063702|NCT01368354|Zambia|zambia
5063703|NCT01368341|Antibiotics|antibiotics
5063704|NCT01368341|General Practice|general practice
5063705|NCT01368341|Erythema migrans|erythema migrans
5063707|NCT01368341|Ticks|ticks
5063708|NCT01368328|Type 2 Diabetes|type 2 diabetes
5063709|NCT01368328|Chromium|chromium
5063710|NCT01368328|Insulin resistance|insulin resistance
5063711|NCT01368302|attention bias modification treatment|attention bias modification treatment
5063712|NCT01368302|cognitive bias modification|cognitive bias modification
5063713|NCT01368302|attention training|attention training
5063714|NCT01368302|anxiety|anxiety
5063715|NCT01368276|Melanoma|melanoma
5063716|NCT01368276|Stage IIIb, IIIc and IV Disease|stage iiib, iiic and iv disease
5063717|NCT01368276|oncolytic|oncolytic
5063718|NCT01368276|OncoVex|oncovex
5063719|NCT01368276|OncoVEX^GM-CSF|oncovex^gm-csf
5063720|NCT01368250|Aortic|aortic
5063721|NCT01368250|Stenosis|stenosis
5063722|NCT01368250|Valve|valve
5063723|NCT01368250|VARC|varc
5063724|NCT01368250|Transcatheter|transcatheter
5063725|NCT01368250|Minimal-invasive|minimal-invasive
5063726|NCT01368237|Computed tomography|computed tomography
5063727|NCT01368237|Myocardial perfusion|myocardial perfusion
5063728|NCT01368237|Coronary heart disease|coronary heart disease
5063729|NCT01368224|Skin sensitivity|skin sensitivity
5063730|NCT01368224|Trans-epidermal water loss|trans-epidermal water loss
5063731|NCT01368224|Clinical score|clinical score
5063732|NCT01368224|skin moisturization factors|skin moisturization factors
5063733|NCT01368224|serum immune-regulatory cytokine|serum immune-regulatory cytokine
5063734|NCT01368224|Evaluation of intestinal flora composition|evaluation of intestinal flora composition
5063735|NCT01368211|Mirasol|mirasol
5063736|NCT01368211|Thrombocytopenic|thrombocytopenic
5063737|NCT01368211|Pathogen reduction|pathogen reduction
5063738|NCT01368211|Platelets|platelets
5063739|NCT01368211|Thromboelastography|thromboelastography
5063740|NCT01368211|CCI|cci
5063741|NCT01368211|Corrected Count Increment|corrected count increment
5063742|NCT01368198|Ocular Emulsion|ocular emulsion
5063743|NCT01368198|OPTIVE™ Lubricant|optive™ lubricant
5063744|NCT01368198|Tear Film Break Up Time|tear film break up time
5063745|NCT01368185|Essential hypertension Uric acid Retrospective Hyzaar|essential hypertension uric acid retrospective hyzaar
5063746|NCT01368172|spinal cord injury|spinal cord injury
5063747|NCT01368172|physical activity|physical activity
5063748|NCT01368172|physical fitness|physical fitness
5063749|NCT01368133|acromegaly|acromegaly
5063750|NCT01368133|pituitary tumor|pituitary tumor
5063751|NCT01368107|IL-7|il-7
5063752|NCT01368107|metastatic breast cancer patients|metastatic breast cancer patients
5063753|NCT01368107|lymphopenia|lymphopenia
5063754|NCT01368094|Pancreaticoduodenectomy|pancreaticoduodenectomy
5063755|NCT01368094|Drainage|drainage
5063756|NCT01368094|Surgical site infection|surgical site infection
5063757|NCT01368068|Perimenopause|perimenopause
5063758|NCT01368068|Depression|depression
5063759|NCT01368055|Proton Radiation, Prostate Cancer|proton radiation, prostate cancer
5063760|NCT01368042|Quality of Life changes|quality of life changes
5063761|NCT01368042|Secondary Hyperparathyroidism|secondary hyperparathyroidism
5063762|NCT01368042|Chronic Kidney Disease|chronic kidney disease
5063763|NCT01368042|Hemodialysis|hemodialysis
5063764|NCT01368042|Paricalcitol intravenous treatment|paricalcitol intravenous treatment
5063765|NCT01368029|LGG|lgg
5063766|NCT01368029|Immune response|immune response
5063767|NCT01368029|Influenza vaccine|influenza vaccine
5063768|NCT01368029|Elderly|elderly
5063769|NCT01368029|Healthy|healthy
5063770|NCT01368029|Microbiome|microbiome
5063771|NCT01368016|Smoking Cessation|smoking cessation
5063772|NCT01368016|Nicotine Pharmacodynamics|nicotine pharmacodynamics
5063773|NCT01368003|Castration resistant prostate cancer|castration resistant prostate cancer
5063774|NCT01367990|alopecia|alopecia
5063775|NCT01367990|hair loss|hair loss
5063776|NCT01367990|prevention|prevention
5063777|NCT01367990|radiotherapy|radiotherapy
5063778|NCT01367990|head & neck cancer|head & neck cancer
5063779|NCT01367990|radiodermatitis|radiodermatitis
5063780|NCT01367990|radiation dermatitis|radiation dermatitis
5063781|NCT01367990|radiation-induced alopecia|radiation-induced alopecia
5063782|NCT01367977|Ehlers Danlos Syndrome|ehlers danlos syndrome
5063783|NCT01367977|External Communicating Hydrocephalus|external communicating hydrocephalus
5063784|NCT01367977|Dysautonomia|dysautonomia
5063785|NCT01367977|Postural orthostatic tachycardia syndrome|postural orthostatic tachycardia syndrome
5063786|NCT01367977|Chronic cerebrospinal venous insufficiency|chronic cerebrospinal venous insufficiency
5063787|NCT01367964|Hypsarrhythmia|hypsarrhythmia
5063788|NCT01367964|Spasms, Infantile|spasms, infantile
5063789|NCT01367964|West Syndrome|west syndrome
5063790|NCT01367951|unstable chest injury|unstable chest injury
5063791|NCT01367951|flail chest|flail chest
5063792|NCT01367951|chest wall injury|chest wall injury
5063793|NCT01367951|rib fracture|rib fracture
5063794|NCT01367938|Osteoarthritis|osteoarthritis
5063795|NCT01367938|Total Knee Replacement|total knee replacement
5063796|NCT01367938|Total Knee Arthroplasty|total knee arthroplasty
5063797|NCT01367938|TKA|tka
5063798|NCT01367938|Knee|knee
5063799|NCT01367925|Osteoarthritis|osteoarthritis
5063800|NCT01367925|Total Knee Replacement|total knee replacement
5063801|NCT01367925|TKA|tka
5063802|NCT01367925|Knee|knee
5063803|NCT01367925|PS|ps
5063804|NCT01367925|CS|cs
5063805|NCT01367912|Luteal phase support|luteal phase support
5063806|NCT01367912|estradiol supplementation|estradiol supplementation
5063807|NCT01367912|IVF/ICSI|ivf/icsi
5063808|NCT01367912|clinical pregnancy rate|clinical pregnancy rate
5063809|NCT01367899|Safety|safety
5063810|NCT01367899|Efficacy|efficacy
5063811|NCT01367886|Urine proteomics|urine proteomics
5063812|NCT01367886|overactive bladder|overactive bladder
5063813|NCT01367860|spine surgery|spine surgery
5063814|NCT01367860|low back pain|low back pain
5063815|NCT01367860|herniated disk|herniated disk
5063816|NCT01367847|Parenting|parenting
5063817|NCT01367847|Parent-Child Relations|parent-child relations
5063818|NCT01367847|Child Behavior|child behavior
5063819|NCT01367834|Turner Syndrome|turner syndrome
5063820|NCT01367834|growth hormone|growth hormone
5063821|NCT01367834|brain development|brain development
5063822|NCT01367821|Obstructive jaundice|obstructive jaundice
5063823|NCT01367821|ERCP|ercp
5063824|NCT01367821|Immune dysfunction|immune dysfunction
5063825|NCT01367821|Endotoxin tolerance|endotoxin tolerance
5063826|NCT01367821|Quorum sensing|quorum sensing
5063827|NCT01367808|Buprenorphine|buprenorphine
5063828|NCT01367808|Vorikonazole|vorikonazole
5063829|NCT01367808|Posakonazole|posakonazole
5063830|NCT01367808|Interactions|interactions
5063831|NCT01367795|palliation|palliation
5063832|NCT01367795|quality of life|quality of life
5063833|NCT01367795|surgery|surgery
5063834|NCT01367795|surgery; palliative|surgery; palliative
5063835|NCT01367795|lifestyle|lifestyle
5063836|NCT01367782|UPDRS|updrs
5063837|NCT01367769|Deep vein thrombosis|deep vein thrombosis
5063838|NCT01367769|superficial thrombophlebitis|superficial thrombophlebitis
5063839|NCT01367769|contrast ultrasound|contrast ultrasound
5063840|NCT01367743|myocardial infarction|myocardial infarction
5063841|NCT01367743|epinephrine|epinephrine
5063842|NCT01367743|norepinephrine|norepinephrine
5063843|NCT01367743|cardiac output|cardiac output
5063844|NCT01367730|osteopenia and osteoporosis|osteopenia and osteoporosis
5063845|NCT01367717|Creatine|creatine
5063846|NCT01367717|Creatinine|creatinine
5063847|NCT01367717|Serum Creatinine|serum creatinine
5063848|NCT01367717|Urine Creatinine|urine creatinine
5063849|NCT01367717|Creatine Monohydrate|creatine monohydrate
5063850|NCT01367717|Creatine Ethyl Ester|creatine ethyl ester
5063851|NCT01367717|Acute Kidney Injury|acute kidney injury
5063852|NCT01367717|Renal|renal
5063853|NCT01367717|Kidney|kidney
5063854|NCT01367704|gender-based violence|gender-based violence
5063855|NCT01367704|intimate partner violence|intimate partner violence
5063856|NCT01367704|relationship abuse|relationship abuse
5063857|NCT01367704|sexual harassment|sexual harassment
5063858|NCT01367704|sexual violence|sexual violence
5063859|NCT01367691|CRT|crt
5063860|NCT01367691|heart failure|heart failure
5063861|NCT01367691|CMR|cmr
5063862|NCT01367691|safety|safety
5063863|NCT01367639|BRCA 1/2 Carriers|brca 1/2 carriers
5063864|NCT01367639|IBSR|ibsr
5063865|NCT01367639|The Work|the work
5063866|NCT01367639|Randomized clinical trial|randomized clinical trial
5063867|NCT01367613|Advanced medical illness|advanced medical illness
5063868|NCT01367600|Advanced medical illness|advanced medical illness
5063869|NCT01367574|Opioid-induced bowel dysfunction|opioid-induced bowel dysfunction
5063870|NCT01367444|Stargardt's Disease|stargardt's disease
5063871|NCT01367431|Xanthohumol|xanthohumol
5063872|NCT01367431|Metabolic syndrome|metabolic syndrome
5063873|NCT01367418|Analgesia: Thoracic epidural, patient controlled|analgesia: thoracic epidural, patient controlled
5063874|NCT01367418|Surgery: Radical retropubic prostatectomy|surgery: radical retropubic prostatectomy
5063875|NCT01367418|Immune system|immune system
5063876|NCT01367418|Inflammation|inflammation
5063877|NCT01367405|Surgical decompression|surgical decompression
5063878|NCT01367405|conservative treatment|conservative treatment
5063879|NCT01367405|incomplete spinal cord lesion|incomplete spinal cord lesion
5063880|NCT01367405|recovery|recovery
5063881|NCT01367379|Physician|physician
5063882|NCT01367379|duty loading|duty loading
5063883|NCT01367379|stress response|stress response
5063884|NCT01367379|Physician with different amount of duty area|physician with different amount of duty area
5063885|NCT01367366|malignant mediastinal lymphadenopathy|malignant mediastinal lymphadenopathy
5063886|NCT01367366|positron emission tomography|positron emission tomography
5063887|NCT01367366|endobronchial ultrasound|endobronchial ultrasound
5063888|NCT01367366|transbronchial needle aspiration|transbronchial needle aspiration
5063889|NCT01367327|Exercise|exercise
5063890|NCT01367288|locally advanced breast cancer|locally advanced breast cancer
5063891|NCT01367288|neoadjuvant chemotherapy|neoadjuvant chemotherapy
5063892|NCT01367288|HER2-negative breast cancer|her2-negative breast cancer
5063893|NCT01367288|stage IIb breast cancer|stage iib breast cancer
5063894|NCT01367288|stage IIIa breast cancer|stage iiia breast cancer
5063895|NCT01367288|Zoledronic acid|zoledronic acid
5063896|NCT01367288|bisphosphonate|bisphosphonate
5063897|NCT01367288|zometa|zometa
5063898|NCT01367288|therapeutic response|therapeutic response
5063899|NCT01367288|VEGF serum|vegf serum
5063900|NCT01367288|tumors markers|tumors markers
5063901|NCT01367288|neoangiogenesis|neoangiogenesis
5063902|NCT01367288|apoptosis|apoptosis
5063903|NCT01367288|proliferation|proliferation
5063904|NCT01367288|disseminated tumors cells|disseminated tumors cells
5063905|NCT01367288|gamma-delta T cells activation|gamma-delta t cells activation
5063906|NCT01367275|colon|colon
5063907|NCT01367275|Colorectum|colorectum
5063908|NCT01367275|Colorectal Cancer|colorectal cancer
5063909|NCT01367275|Plasma FGF|plasma fgf
5063910|NCT01367275|Colorectal adenocarcinoma|colorectal adenocarcinoma
5063911|NCT01367275|Bevacizumab|bevacizumab
5063912|NCT01367275|Brivanib|brivanib
5063913|NCT01367275|BMS-582664|bms-582664
5063914|NCT01367275|Irinotecan|irinotecan
5063915|NCT01367275|CPT-11|cpt-11
5063916|NCT01367275|Camptosar|camptosar
5063917|NCT01367275|Fibroblast Growth Factor|fibroblast growth factor
5063918|NCT01367275|bFGF|bfgf
5063919|NCT01367275|tyrosine kinase receptors|tyrosine kinase receptors
5063920|NCT01367275|vascular endothelial growth factor receptors|vascular endothelial growth factor receptors
5063921|NCT01367275|VEGFR|vegfr
5063922|NCT01367275|fibroblast growth factor receptors|fibroblast growth factor receptors
5063923|NCT01367275|FGFR|fgfr
5063924|NCT01367262|Absorption|absorption
5063925|NCT01367262|Distribution|distribution
5063926|NCT01367262|Metabolism|metabolism
5063927|NCT01367262|Excretion|excretion
5063928|NCT01367249|cataract surgery|cataract surgery
5063929|NCT01367223|inflammatory response|inflammatory response
5063930|NCT01367223|parenteral nutrition|parenteral nutrition
5063931|NCT01367223|glutamine|glutamine
5063932|NCT01367223|amino acid|amino acid
5063933|NCT01367223|pediatric|pediatric
5063934|NCT01367223|intensive care|intensive care
5063935|NCT01367223|systemic infection|systemic infection
5063936|NCT01367223|abdominal surgery|abdominal surgery
5063937|NCT01367223|polytraumatised|polytraumatised
5063938|NCT01367223|mortality|mortality
5063939|NCT01367223|mean stay in the intensive care unit|mean stay in the intensive care unit
5063940|NCT01367223|occurrence of infections|occurrence of infections
5063941|NCT01367210|HIV|hiv
5063942|NCT01367210|AIDS|aids
5063943|NCT01367210|Highly Active AntiRetroviral Therapy|highly active antiretroviral therapy
5063944|NCT01367210|Simplification|simplification
5063945|NCT01367210|Maraviroc|maraviroc
5063946|NCT01367210|Darunavir|darunavir
5063947|NCT01367210|Treatment experienced|treatment experienced
5063948|NCT01367210|Tropism|tropism
5063949|NCT01367197|exercise training|exercise training
5063950|NCT01367197|atrial fibrillation|atrial fibrillation
5063951|NCT01367184|VTE|vte
5063952|NCT01367184|Inferior vena cava|inferior vena cava
5063953|NCT01367184|Venous thrombo-embolism|venous thrombo-embolism
5063954|NCT01367184|Outcome data|outcome data
5063955|NCT01367184|IVC Filters|ivc filters
5063956|NCT01367158|Meningococcal disease|meningococcal disease
5063957|NCT01367158|vaccines|vaccines
5063958|NCT01367158|adolescents|adolescents
5063959|NCT01367158|prevention|prevention
5063960|NCT01367158|Meningitis|meningitis
5063961|NCT01367145|OMEGA-3 polyunsaturated fatty-acids|omega-3 polyunsaturated fatty-acids
5063962|NCT01367145|Peripheral Arterial Disease|peripheral arterial disease
5063963|NCT01367145|Endothelial Function|endothelial function
5063964|NCT01367145|Inflammation|inflammation
5063965|NCT01367145|Platelet Function|platelet function
5063966|NCT01367132|ultrasound|ultrasound
5063967|NCT01367132|first trimester|first trimester
5063968|NCT01367132|umbilical cord|umbilical cord
5063969|NCT01367119|Depression|depression
5063970|NCT01367119|Electroconvulsive therapy|electroconvulsive therapy
5063971|NCT01367119|Ketamine|ketamine
5063972|NCT01367119|Methohexital|methohexital
5063973|NCT01367106|offspring of 21-hydroxylase enzyme block|offspring of 21-hydroxylase enzyme block
5063974|NCT01367093|BIOLOGICAL MARKERS|biological markers
5063975|NCT01367093|INTENSIVE CARE UNIT|intensive care unit
5063976|NCT01367093|MORTALITY|mortality
5063977|NCT01367093|QUALITY OF LIFE|quality of life
5063978|NCT01367093|CARDIOVASCULAR|cardiovascular
5063979|NCT01367080|depression|depression
5063980|NCT01367067|claustrophobia|claustrophobia
5063981|NCT01367067|magnetic resonance imaging|magnetic resonance imaging
5063982|NCT01367067|MRI|mri
5063983|NCT01367067|anxiety|anxiety
5063984|NCT01367067|anxious patients|anxious patients
5063985|NCT01367067|phobic disorders|phobic disorders
5063986|NCT01367067|anxiety disorders|anxiety disorders
5063987|NCT01367067|mental disorders|mental disorders
5063988|NCT01367054|Metformine|metformine
5063989|NCT01367054|adverse events|adverse events
5063990|NCT01367054|bioequivalence|bioequivalence
5063991|NCT01367041|bone|bone
5063992|NCT01367041|muscle electrical activity|muscle electrical activity
5063993|NCT01367041|whole-body vibration|whole-body vibration
5063994|NCT01367028|HER2-positive early breast cancer|her2-positive early breast cancer
5063995|NCT01367015|Preterm|preterm
5063996|NCT01367015|SGA|sga
5063997|NCT01367015|AREDF|aredf
5063998|NCT01367015|Early feeding|early feeding
5063999|NCT01367015|Late feeding|late feeding
5064000|NCT01367015|Feed intolerance|feed intolerance
5064001|NCT01367015|Necrotizing enterocolitis|necrotizing enterocolitis
5064002|NCT01367015|Days to achieve Full Feeds defined as 150 mL/kg|days to achieve full feeds defined as 150 ml/kg
5064003|NCT01367002|Uterine serous papillary carcinoma|uterine serous papillary carcinoma
5064004|NCT01367002|Type II endometrial cancer|type ii endometrial cancer
5064005|NCT01367002|HER2/neu|her2/neu
5064006|NCT01367002|Paclitaxel, Carboplatin, Trastuzumab|paclitaxel, carboplatin, trastuzumab
5064007|NCT01366989|Total Ankle Arthroplasty|total ankle arthroplasty
5064008|NCT01366976|oxidative stress|oxidative stress
5064009|NCT01366976|cardiopulmonary bypass|cardiopulmonary bypass
5064010|NCT01366976|acetaminophen|acetaminophen
5064011|NCT01366976|hemolysis|hemolysis
5064012|NCT01366963|postural tachycardia syndrome|postural tachycardia syndrome
5064013|NCT01366963|brain fog|brain fog
5064014|NCT01366963|cognitive dysfunction|cognitive dysfunction
5064015|NCT01366937|vitamin B12|vitamin b12
5064016|NCT01366937|egg|egg
5064017|NCT01366937|14C|14c
5064018|NCT01366937|fecal excretion|fecal excretion
5064019|NCT01366924|protein turnover|protein turnover
5064020|NCT01366924|whole body protein turnover|whole body protein turnover
5064021|NCT01366924|essential amino acids|essential amino acids
5064022|NCT01366924|leucine|leucine
5064023|NCT01366911|stem cells|stem cells
5064024|NCT01366911|QCT testing|qct testing
5064025|NCT01366911|Bone density findings|bone density findings
5064026|NCT01366911|mesenchymal stem cells|mesenchymal stem cells
5064027|NCT01366885|Autism|autism
5064028|NCT01366885|Pregnancy|pregnancy
5064029|NCT01366885|Newborn siblings|newborn siblings
5064030|NCT01366872|ankle|ankle
5064031|NCT01366872|arthritis|arthritis
5064032|NCT01366872|total ankle arthroplasty|total ankle arthroplasty
5064033|NCT01366872|Agility LP,|agility lp,
5064034|NCT01366859|Autism|autism
5064035|NCT01366859|Children|children
5064036|NCT01366859|Behavior|behavior
5064037|NCT01366859|Glutathione|glutathione
5064038|NCT01366859|Whey Protein|whey protein
5064039|NCT01366859|Immunocal|immunocal
5064040|NCT01366859|Antioxidant|antioxidant
5064041|NCT01366846|Peanut|peanut
5064042|NCT01366833|Dysphagia|dysphagia
5064043|NCT01366833|Esophagus|esophagus
5064044|NCT01366833|Cancer|cancer
5064045|NCT01366833|Esophageal Cancer|esophageal cancer
5064046|NCT01366794|Gut hormones|gut hormones
5064047|NCT01366794|Insulin secretion|insulin secretion
5064048|NCT01366781|Gut hormones|gut hormones
5064049|NCT01366781|Insulin secretion|insulin secretion
5064050|NCT01366768|Gut hormones|gut hormones
5064051|NCT01366768|Insulin secretion|insulin secretion
5064052|NCT01366768|Normal physiology|normal physiology
5064053|NCT01366729|hemiplegia|hemiplegia
5064054|NCT01366729|walking|walking
5064055|NCT01366729|canes|canes
5064056|NCT01366729|TheraTogs|theratogs
5064057|NCT01366729|EMG|emg
5064058|NCT01366729|balance|balance
5064059|NCT01366729|Timed up and go|timed up and go
5064060|NCT01366716|Contingency Management|contingency management
5064061|NCT01366716|Cash|cash
5064062|NCT01366716|Substance Abuse|substance abuse
5064063|NCT01366716|Ethics|ethics
5064064|NCT01366703|heart failure|heart failure
5064065|NCT01366703|implantable loop recorder|implantable loop recorder
5064066|NCT01366690|HIV|hiv
5064067|NCT01366690|community health workers|community health workers
5064068|NCT01366690|randomized trial|randomized trial
5064069|NCT01366690|task shifting|task shifting
5064070|NCT01366690|Uganda|uganda
5064071|NCT01366690|retention|retention
5064072|NCT01366690|operations research|operations research
5064073|NCT01366690|implementation research|implementation research
5064074|NCT01366664|Premature Ejaculation|premature ejaculation
5064075|NCT01366664|Selective Serotonin Reuptake Inhibitor|selective serotonin reuptake inhibitor
5064076|NCT01366664|Dapoxetine|dapoxetine
5064077|NCT01366664|PRILIGY|priligy
5064078|NCT01366664|Terazosin|terazosin
5064079|NCT01366664|Pharmacodynamic|pharmacodynamic
5064080|NCT01366664|Pharmacokinetic|pharmacokinetic
5064081|NCT01366651|Doripenem|doripenem
5064082|NCT01366651|DORIPED1002|doriped1002
5064083|NCT01366651|Intravenous|intravenous
5064084|NCT01366651|Pediatric|pediatric
5064085|NCT01366651|Antibiotic|antibiotic
5064086|NCT01366651|Meningitis|meningitis
5064087|NCT01366638|Hepatitis C, Chronic|hepatitis c, chronic
5064088|NCT01366638|TMC435|tmc435
5064089|NCT01366638|Hepatitis C|hepatitis c
5064090|NCT01366638|Hepatitis C virus|hepatitis c virus
5064091|NCT01366638|Interferon Alfa-2b|interferon alfa-2b
5064092|NCT01366638|Ribavirin|ribavirin
5064093|NCT01366638|Viral ribonucleic acid|viral ribonucleic acid
5064094|NCT01366625|hypertension, resistant|hypertension, resistant
5064095|NCT01366625|obstructive sleep apnea|obstructive sleep apnea
5064096|NCT01366625|renal denervation|renal denervation
5064097|NCT01366625|continuous positive airway pressure therapy|continuous positive airway pressure therapy
5064098|NCT01366612|Allogeneic Stem Cell Transplant|allogeneic stem cell transplant
5064099|NCT01366612|AML|aml
5064100|NCT01366612|CML|cml
5064101|NCT01366612|MDS|mds
5064102|NCT01366599|highly emetogenic chemotherapy|highly emetogenic chemotherapy
5064103|NCT01366599|HEC|hec
5064104|NCT01366599|moderately emetogenic chemotherapy|moderately emetogenic chemotherapy
5064105|NCT01366599|MEC|mec
5064106|NCT01366573|Pharmacokinetics|pharmacokinetics
5064107|NCT01366573|mu-opioid receptors|mu-opioid receptors
5064108|NCT01366573|Addiction|addiction
5064109|NCT01366573|Pharmacodynamics|pharmacodynamics
5064110|NCT01366573|Alcohol|alcohol
5064111|NCT01366547|Bioavailability|bioavailability
5064112|NCT01366547|Lamivudine|lamivudine
5064113|NCT01366547|Dolutegravir|dolutegravir
5064114|NCT01366547|integrase|integrase
5064115|NCT01366547|Abacavir|abacavir
5064116|NCT01366534|safety|safety
5064117|NCT01366534|Vaccine|vaccine
5064118|NCT01366534|Phase 1/2|phase 1/2
5064119|NCT01366534|immunogenicity|immunogenicity
5064120|NCT01366534|Malaria|malaria
5064121|NCT01366534|efficacy|efficacy
5064122|NCT01366534|sporozoite challenge|sporozoite challenge
5064123|NCT01366495|Seek|seek
5064124|NCT01366495|Test|test
5064125|NCT01366495|Treat|treat
5064126|NCT01366482|Peripheral arterial disease,|peripheral arterial disease,
5064127|NCT01366482|claudication,|claudication,
5064128|NCT01366482|atherectomy,|atherectomy,
5064129|NCT01366482|plaque excision,|plaque excision,
5064130|NCT01366482|drug-coated balloon|drug-coated balloon
5064131|NCT01366482|drug-eluting balloon|drug-eluting balloon
5064132|NCT01366469|coronary artery bypass grafting|coronary artery bypass grafting
5064133|NCT01366469|coronary artery disease|coronary artery disease
5064134|NCT01366469|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
5064135|NCT01366456|Temperature Change|temperature change
5064136|NCT01366456|Moxibustion|moxibustion
5064137|NCT01366456|Warming effect|warming effect
5064138|NCT01366443|ROM PLUS|rom plus
5064139|NCT01366443|conventional clinical tests of rupture of membranes (ROM)|conventional clinical tests of rupture of membranes (rom)
5064140|NCT01366443|speculum exam|speculum exam
5064141|NCT01366443|visualization of leakage|visualization of leakage
5064142|NCT01366443|pooling of amniotic fluid in the posterior fornix|pooling of amniotic fluid in the posterior fornix
5064143|NCT01366443|nitrazine testing|nitrazine testing
5064144|NCT01366443|ferning|ferning
5064145|NCT01366430|BPPV(benign paroxysmal positional vertigo)|bppv(benign paroxysmal positional vertigo)
5064146|NCT01366430|HC-BPPV(BPPV involving the horizontal semicircular canal)|hc-bppv(bppv involving the horizontal semicircular canal)
5064147|NCT01366430|Nystagmus|nystagmus
5064148|NCT01366430|Treatment outcome|treatment outcome
5064149|NCT01366430|Horizontal Canal Benign Paroxysmal Positional Vertigo|horizontal canal benign paroxysmal positional vertigo
5064150|NCT01366404|FFR|ffr
5064151|NCT01366391|polycystic ovary syndrome|polycystic ovary syndrome
5064152|NCT01366391|metformin|metformin
5064153|NCT01366391|pharmacokinetic|pharmacokinetic
5064154|NCT01366313|paracetamol|paracetamol
5064155|NCT01366313|morphine|morphine
5064156|NCT01366313|median effective dose|median effective dose
5064157|NCT01366313|pain|pain
5064158|NCT01366287|Relative bioavailability|relative bioavailability
5064159|NCT01366287|food effect|food effect
5064160|NCT01366287|tablet|tablet
5064161|NCT01366287|suspension|suspension
5064162|NCT01366287|single dose|single dose
5064163|NCT01366287|crossover|crossover
5064164|NCT01366287|healthy subjects|healthy subjects
5064165|NCT01366274|Trauma|trauma
5064166|NCT01366261|Flex-rigid pleuroscopy|flex-rigid pleuroscopy
5064167|NCT01366261|pleural biopsy|pleural biopsy
5064168|NCT01366261|pleural effusion|pleural effusion
5064169|NCT01366261|safety|safety
5064170|NCT01366261|thoracoscopy|thoracoscopy
5064171|NCT01366222|asthma|asthma
5064172|NCT01366209|Pirfenidone|pirfenidone
5064173|NCT01366209|ASCEND|ascend
5064174|NCT01366209|IPF|ipf
5064175|NCT01366209|FVC|fvc
5064176|NCT01366196|Orthopedic Procedures|orthopedic procedures
5064177|NCT01366196|Spinal Fusions|spinal fusions
5064178|NCT01366196|Pregabalin|pregabalin
5064179|NCT01366196|Gamma-Aminobutyric Acid|gamma-aminobutyric acid
5064180|NCT01366196|Analgesics|analgesics
5064181|NCT01366196|Sensory System Agents|sensory system agents
5064182|NCT01366196|Peripheral Nervous System Agents|peripheral nervous system agents
5064183|NCT01366196|Physiological Effects of Drugs|physiological effects of drugs
5064184|NCT01366196|Pharmacologic Actions|pharmacologic actions
5064185|NCT01366196|Central Nervous System Agents|central nervous system agents
5064186|NCT01366196|Therapeutic Uses|therapeutic uses
5064187|NCT01366196|Anticonvulsants|anticonvulsants
5064188|NCT01366196|GABA Agents|gaba agents
5064189|NCT01366196|Neurotransmitter Agents|neurotransmitter agents
5064190|NCT01366196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
5064191|NCT01366170|childhood anaplastic large cell lymphoma|childhood anaplastic large cell lymphoma
5064192|NCT01366157|childhood favorable prognosis Hodgkin lymphoma|childhood favorable prognosis hodgkin lymphoma
5064193|NCT01366157|stage I childhood Hodgkin lymphoma|stage i childhood hodgkin lymphoma
5064194|NCT01366157|stage II childhood Hodgkin lymphoma|stage ii childhood hodgkin lymphoma
5064195|NCT01366157|stage III childhood Hodgkin lymphoma|stage iii childhood hodgkin lymphoma
5064196|NCT01366157|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
5064197|NCT01366157|childhood lymphocyte depletion Hodgkin lymphoma|childhood lymphocyte depletion hodgkin lymphoma
5064198|NCT01366157|childhood lymphocyte predominant Hodgkin lymphoma|childhood lymphocyte predominant hodgkin lymphoma
5064199|NCT01366157|childhood mixed cellularity Hodgkin lymphoma|childhood mixed cellularity hodgkin lymphoma
5064200|NCT01366157|childhood nodular lymphocyte predominant Hodgkin lymphoma|childhood nodular lymphocyte predominant hodgkin lymphoma
5064201|NCT01366157|childhood nodular sclerosis Hodgkin lymphoma|childhood nodular sclerosis hodgkin lymphoma
5064202|NCT01366118|Rectal cancer, Chemoradiotherapy, target therapy|rectal cancer, chemoradiotherapy, target therapy
5064203|NCT01366105|Wound healing|wound healing
5064204|NCT01366105|Negative Pressure Wound Therapy|negative pressure wound therapy
5064205|NCT01366105|V.A.C.|v.a.c.
5064206|NCT01366105|Incision|incision
5064207|NCT01366092|stem cell transplant|stem cell transplant
5064208|NCT01366092|GVHD|gvhd
5064209|NCT01366092|bone marrow transplant|bone marrow transplant
5064210|NCT01366092|cord blood transplant|cord blood transplant
5064211|NCT01366092|regulatory T cell|regulatory t cell
5064212|NCT01366092|interleukin|interleukin
5064213|NCT01366066|Stress incontinence|stress incontinence
5064214|NCT01366066|urge incontinence|urge incontinence
5064215|NCT01366066|overactive bladder syndrome|overactive bladder syndrome
5064216|NCT01366066|vibration|vibration
5064217|NCT01366066|nerve stimulation|nerve stimulation
5064218|NCT01366053|Prostate Cancer|prostate cancer
5064219|NCT01366053|Androgen Deprivation Therapy|androgen deprivation therapy
5064220|NCT01366053|Agonist|agonist
5064221|NCT01366053|Antagonist|antagonist
5064222|NCT01366053|PSA Failure|psa failure
5064223|NCT01366053|PSA Rise|psa rise
5064224|NCT01366040|Patient Satisfaction|patient satisfaction
5064225|NCT01366040|Multiple Sclerosis|multiple sclerosis
5064226|NCT01366040|Autoinjector|autoinjector
5064227|NCT01366040|Avonex|avonex
5064228|NCT01366027|pseudobulbar affect|pseudobulbar affect
5064229|NCT01366014|osteoarthritis|osteoarthritis
5064230|NCT01366014|knee|knee
5064231|NCT01366014|pain|pain
5064232|NCT01366014|NSAID|nsaid
5064233|NCT01366001|Opioid|opioid
5064234|NCT01366001|Cocaine|cocaine
5064235|NCT01366001|Dependence|dependence
5064236|NCT01366001|Abuse|abuse
5064237|NCT01366001|Intravenous|intravenous
5064238|NCT01366001|Buprenorphine|buprenorphine
5064239|NCT01365988|fMRI|fmri
5064240|NCT01365988|Risk-Taking|risk-taking
5064241|NCT01365988|Decision-Making|decision-making
5064242|NCT01365988|Memory|memory
5064243|NCT01365988|Resting-State Functional Connectivity|resting-state functional connectivity
5064244|NCT01365975|Cohort Study|cohort study
5064245|NCT01365975|Folinic Acid, peri-conception|folinic acid, peri-conception
5064246|NCT01365975|Pediatric Leukemia|pediatric leukemia
5064247|NCT01365975|Pediatric Cancer|pediatric cancer
5064248|NCT01365962|alveolar childhood rhabdomyosarcoma|alveolar childhood rhabdomyosarcoma
5064249|NCT01365962|embryonal childhood rhabdomyosarcoma|embryonal childhood rhabdomyosarcoma
5064250|NCT01365962|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
5064251|NCT01365962|previously untreated childhood rhabdomyosarcoma|previously untreated childhood rhabdomyosarcoma
5064252|NCT01365962|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
5064253|NCT01365949|Ewing sarcoma/peripheral primitive neuroectodermal tumor (PNET)|ewing sarcoma/peripheral primitive neuroectodermal tumor (pnet)
5064254|NCT01365936|IVF|ivf
5064255|NCT01365936|ICSI|icsi
5064256|NCT01365936|OHSS|ohss
5064257|NCT01365936|PCOS|pcos
5064258|NCT01365936|recFSH|recfsh
5064259|NCT01365936|HMG|hmg
5064260|NCT01365897|Modafinil|modafinil
5064261|NCT01365897|Memory|memory
5064262|NCT01365897|Executive Functions|executive functions
5064263|NCT01365897|Memory, Short-Term|memory, short-term
5064264|NCT01365897|Attention|attention
5064265|NCT01365897|University Students|university students
5064266|NCT01365897|Stroop Effect|stroop effect
5064267|NCT01365897|Digit Span|digit span
5064268|NCT01365897|Backwards Digit Span|backwards digit span
5064269|NCT01365897|Biber Cognitive Estimation Test|biber cognitive estimation test
5064270|NCT01365871|prostate biopsy|prostate biopsy
5064271|NCT01365871|pain|pain
5064272|NCT01365845|Proton Radiation|proton radiation
5064273|NCT01365845|Breast Cancer|breast cancer
5064274|NCT01365819|Crystal meth dependence|crystal meth dependence
5064275|NCT01365819|crystal meth|crystal meth
5064276|NCT01365819|methamphetamine dependence|methamphetamine dependence
5064277|NCT01365819|substance abuse|substance abuse
5064278|NCT01365806|heart transplantation|heart transplantation
5064279|NCT01365806|allograft rejection|allograft rejection
5064280|NCT01365806|QT interval|qt interval
5064281|NCT01365806|electrocardiogram (ECG)|electrocardiogram (ecg)
5064282|NCT01365793|cerebral edema|cerebral edema
5064283|NCT01365793|diabetic ketoacidosis|diabetic ketoacidosis
5064284|NCT01365793|pediatric diabetes|pediatric diabetes
5064285|NCT01365793|fluid therapy|fluid therapy
5064286|NCT01365780|microcirculation, O2c|microcirculation, o2c
5064287|NCT01365767|Crohn disease|crohn disease
5064288|NCT01365767|Ultrasonography, contrast enhanced|ultrasonography, contrast enhanced
5064289|NCT01365767|Elasticity Imaging Techniques|elasticity imaging techniques
5064290|NCT01365767|Small intestine|small intestine
5064291|NCT01365767|Magnetic Resonance Imaging|magnetic resonance imaging
5064292|NCT01365767|CDAI|cdai
5064293|NCT01365767|Calprotectin|calprotectin
5064294|NCT01365767|IBD|ibd
5064295|NCT01365767|Sonography|sonography
5064296|NCT01365754|Lumbar degenerative disease|lumbar degenerative disease
5064297|NCT01365741|PCI|pci
5064298|NCT01365741|STEMI|stemi
5064299|NCT01365741|Interventions|interventions
5064300|NCT01365741|Heart disease|heart disease
5064301|NCT01365741|Thrombocytic inhibition|thrombocytic inhibition
5064302|NCT01365741|Cross-over study|cross-over study
5064303|NCT01365741|Percutaneous coronary intervention|percutaneous coronary intervention
5064304|NCT01365728|Femtosecond Laser|femtosecond laser
5064305|NCT01365728|FS60|fs60
5064306|NCT01365728|iFS|ifs
5064307|NCT01365728|Intralase|intralase
5064308|NCT01365728|Wavefront-guided LASIK|wavefront-guided lasik
5064309|NCT01365728|IntraLASIK|intralasik
5064310|NCT01365728|LASIK|lasik
5064311|NCT01365728|Myopia|myopia
5064312|NCT01365728|Nearsightedness|nearsightedness
5064313|NCT01365715|Preoperative embolization|preoperative embolization
5064314|NCT01365715|Transcatheter arterial embolization|transcatheter arterial embolization
5064315|NCT01365715|Therapeutic angiography|therapeutic angiography
5064316|NCT01365715|Embolization|embolization
5064317|NCT01365715|Surgical blood loss|surgical blood loss
5064318|NCT01365715|Spinal metastases|spinal metastases
5064319|NCT01365715|Spinal neoplasms|spinal neoplasms
5064320|NCT01365715|Vertebral metastases|vertebral metastases
5064321|NCT01365715|metastatic spine surgery|metastatic spine surgery
5064322|NCT01365715|Spinal surgery|spinal surgery
5064323|NCT01365702|COPD|copd
5064324|NCT01365702|tiotropium|tiotropium
5064325|NCT01365702|tuberculous destroyed lung|tuberculous destroyed lung
5064326|NCT01365676|Edema|edema
5064327|NCT01365676|Depression|depression
5064328|NCT01365676|Hot Flashes|hot flashes
5064329|NCT01365676|Anxiety|anxiety
5064330|NCT01365676|Irritability|irritability
5064332|NCT01365663|Hypercholesterolemia|hypercholesterolemia
5064333|NCT01365663|LDL|ldl
5064334|NCT01365663|HDL|hdl
5064335|NCT01365663|apoB|apob
5064336|NCT01365663|hyperlipidemia|hyperlipidemia
5064337|NCT01365663|LNA-oligonucleotide|lna-oligonucleotide
5064338|NCT01365637|safety|safety
5064339|NCT01365637|tolerability|tolerability
5064340|NCT01365637|pharmacokinetics|pharmacokinetics
5064341|NCT01365637|PF-05089771|pf-05089771
5064342|NCT01365598|malaria|malaria
5064343|NCT01365598|uncomplicated malaria|uncomplicated malaria
5064344|NCT01365598|gametocytocidal drug|gametocytocidal drug
5064345|NCT01365598|gametocytocidal|gametocytocidal
5064346|NCT01365598|gametocyte|gametocyte
5064347|NCT01365598|primaquine|primaquine
5064348|NCT01365598|transmission blocking|transmission blocking
5064349|NCT01365598|malaria transmission|malaria transmission
5064350|NCT01365598|sexual parasite|sexual parasite
5064351|NCT01365598|sexual stage|sexual stage
5064352|NCT01365598|Uganda|uganda
5064353|NCT01365598|Africa|africa
5064354|NCT01365585|Pulmonary arterial hypertension|pulmonary arterial hypertension
5064355|NCT01365585|sildenafil citrate|sildenafil citrate
5064356|NCT01365585|Revatio|revatio
5064357|NCT01365572|Drug-eluting stent|drug-eluting stent
5064358|NCT01365559|multiple myeloma|multiple myeloma
5064359|NCT01365559|carfilzomib|carfilzomib
5064360|NCT01365559|relapsed|relapsed
5064361|NCT01365559|refractory|refractory
5064362|NCT01365559|bortezomib|bortezomib
5064363|NCT01365559|Oncotherapeutics|oncotherapeutics
5064364|NCT01365533|Airway Inflammation|airway inflammation
5064365|NCT01365533|Roflumilast|roflumilast
5064366|NCT01365494|Rabies|rabies
5064367|NCT01365494|rabies vaccines|rabies vaccines
5064368|NCT01365494|post-exposure prophylaxis|post-exposure prophylaxis
5064369|NCT01365481|Hypertension, pediatric|hypertension, pediatric
5064370|NCT01365481|Hypertension with or without chronic kidney disease|hypertension with or without chronic kidney disease
5064371|NCT01365468|RAD001,|rad001,
5064372|NCT01365468|Everolimus,|everolimus,
5064373|NCT01365468|Plexiform Neurofibroma,|plexiform neurofibroma,
5064374|NCT01365468|Neurofibromatosis Type 1|neurofibromatosis type 1
5064375|NCT01365455|Psoriasis|psoriasis
5064376|NCT01365455|plaque|plaque
5064377|NCT01365455|plaque-type psoriasis|plaque-type psoriasis
5064378|NCT01365455|IL-17 blocker|il-17 blocker
5064379|NCT01365455|subcutaneous|subcutaneous
5064380|NCT01365455|psoriatic arthritis|psoriatic arthritis
5064381|NCT01365455|injection|injection
5064382|NCT01365455|AIN457|ain457
5064383|NCT01365455|AIN457A|ain457a
5064384|NCT01365455|secukinumab|secukinumab
5064385|NCT01365442|Cholera|cholera
5064386|NCT01365442|Vaccination|vaccination
5064387|NCT01365442|Oral cholera vaccine|oral cholera vaccine
5064388|NCT01365442|Mass vaccination|mass vaccination
5064389|NCT01365442|Oral whole cell cholera vaccine|oral whole cell cholera vaccine
5064390|NCT01365429|Lung Transplant, Transplantation Lung|lung transplant, transplantation lung
5064391|NCT01365416|diabetes|diabetes
5064392|NCT01365416|diabetes remission|diabetes remission
5064393|NCT01365416|obesity|obesity
5064394|NCT01365416|bariatric surgery|bariatric surgery
5064395|NCT01365416|gene expression|gene expression
5064396|NCT01365416|genetic variation|genetic variation
5064397|NCT01365416|metabolomics|metabolomics
5064398|NCT01365416|metabonomics|metabonomics
5064399|NCT01365416|epigenetic variation|epigenetic variation
5064400|NCT01365416|mutations|mutations
5064401|NCT01365390|prospective|prospective
5064402|NCT01365390|Incidence|incidence
5064403|NCT01365390|otitis|otitis
5064404|NCT01365390|observational|observational
5064405|NCT01365390|Epidemiological|epidemiological
5064406|NCT01365390|retrospective|retrospective
5064407|NCT01365377|Anxiety|anxiety
5064408|NCT01365377|Depression|depression
5064409|NCT01365377|Post-traumatic stress disorders|post-traumatic stress disorders
5064410|NCT01365377|Quality of life|quality of life
5064411|NCT01365377|Family|family
5064412|NCT01365377|ICU|icu
5064413|NCT01365364|PLM|plm
5064414|NCT01365364|dopamine|dopamine
5064415|NCT01365364|physical exercise|physical exercise
5064416|NCT01365338|schizophrenia fMRI cognition working memory ASL|schizophrenia fmri cognition working memory asl
5064417|NCT01365312|Central line associated infection|central line associated infection
5064418|NCT01365312|PICC associated infection|picc associated infection
5064419|NCT01365312|Neonatal central line associated sepsis|neonatal central line associated sepsis
5064420|NCT01365312|Central line colonization|central line colonization
5064421|NCT01365312|Ethanol Lock|ethanol lock
5064422|NCT01365286|asthma, chronic obstructive pulmonary disease, COPD, ivabradine, heart rate|asthma, chronic obstructive pulmonary disease, copd, ivabradine, heart rate
5064423|NCT01365273|Split thickness skin grafts|split thickness skin grafts
5064424|NCT01365273|Mepitel One|mepitel one
5064425|NCT01365273|Bridal Veil and staples|bridal veil and staples
5064426|NCT01365273|Pain|pain
5064427|NCT01365247|Co-morbid substance disorders and PTSD|co-morbid substance disorders and ptsd
5064428|NCT01365247|Trauma|trauma
5064429|NCT01365247|Alcohol and other drug use disorders|alcohol and other drug use disorders
5064430|NCT01365247|Treatment outcome|treatment outcome
5064431|NCT01365247|Post-Traumatic Stress Disorder (PTSD)|post-traumatic stress disorder (ptsd)
5064432|NCT01365247|Co-morbid Alcohol and other drug use disorders (AOD)|co-morbid alcohol and other drug use disorders (aod)
5064433|NCT01365247|Behavioral Treatment|behavioral treatment
5064434|NCT01365221|Acute Coronary Syndrome|acute coronary syndrome
5064435|NCT01365221|Clopidogrel|clopidogrel
5064436|NCT01365221|Prasugrel|prasugrel
5064437|NCT01365195|opioid|opioid
5064438|NCT01365195|Fentanyl|fentanyl
5064439|NCT01365195|Anesthetic adjuvant|anesthetic adjuvant
5064440|NCT01365195|Pain management|pain management
5064441|NCT01365195|Perioperative outcomes|perioperative outcomes
5064442|NCT01365195|Constipation|constipation
5064443|NCT01365195|Ileus|ileus
5064444|NCT01365195|Colorectal|colorectal
5064445|NCT01365182|prostate cancer|prostate cancer
5064446|NCT01365182|urinary incontinence|urinary incontinence
5064447|NCT01365182|pelvic floor muscle exercise|pelvic floor muscle exercise
5064448|NCT01365182|self-management|self-management
5064449|NCT01365182|behavioral intervention|behavioral intervention
5064450|NCT01365182|quality of life|quality of life
5064451|NCT01365169|Cyberinfrastructure|cyberinfrastructure
5064452|NCT01365169|CI|ci
5064453|NCT01365169|CYCORE|cycore
5064454|NCT01365169|Quality of Life|quality of life
5064455|NCT01365169|QOL|qol
5064456|NCT01365169|Head and Neck|head and neck
5064457|NCT01365169|H&N|h&n
5064458|NCT01365169|Carbon Monoxide|carbon monoxide
5064459|NCT01365169|CO|co
5064460|NCT01365169|Colorectal Cancer|colorectal cancer
5064461|NCT01365169|Oropharyngeal Cancer|oropharyngeal cancer
5064462|NCT01365169|Laryngeal Cancer|laryngeal cancer
5064463|NCT01365169|Hypopharyngeal Cancer|hypopharyngeal cancer
5064464|NCT01365169|Nasopharyngeal Cancer|nasopharyngeal cancer
5064465|NCT01365169|Smoker|smoker
5064466|NCT01365169|Recent Smoking Cessation|recent smoking cessation
5064467|NCT01365156|locally advanced cervical cancer|locally advanced cervical cancer
5064468|NCT01365156|pretherapeutic para-aortic surgical staging|pretherapeutic para-aortic surgical staging
5064469|NCT01365156|radiologic staging|radiologic staging
5064470|NCT01365156|pretherapeutic surgical staging|pretherapeutic surgical staging
5064471|NCT01365156|para-aortic metastatic disease|para-aortic metastatic disease
5064472|NCT01365130|esophageal cancer|esophageal cancer
5064473|NCT01365130|gastroesophageal cancer|gastroesophageal cancer
5064474|NCT01365130|gastric cancer|gastric cancer
5064475|NCT01365104|brain blood flow|brain blood flow
5064476|NCT01365104|stroke|stroke
5064477|NCT01365104|cerebrovascular|cerebrovascular
5064478|NCT01365104|aging|aging
5064479|NCT01365104|cerebrovascular hemodynamics|cerebrovascular hemodynamics
5064480|NCT01365078|n-3 polyunsaturated fatty acids|n-3 polyunsaturated fatty acids
5064481|NCT01365078|Stearidonic acid|stearidonic acid
5064482|NCT01365078|Lipid metabolism|lipid metabolism
5064483|NCT01365078|Serum triacylglycerol|serum triacylglycerol
5064484|NCT01365052|Maximum Use Safety Trial|maximum use safety trial
5064485|NCT01365039|contact lens|contact lens
5064486|NCT01365026|Healthy Lifestyle|healthy lifestyle
5064487|NCT01365026|Health promotion|health promotion
5064488|NCT01365026|Counselling|counselling
5064489|NCT01365026|Action Plan|action plan
5064490|NCT01365026|Primary Health Care|primary health care
5064491|NCT01365013|Lifestyle|lifestyle
5064492|NCT01365013|Prediabetic State|prediabetic state
5064493|NCT01365013|Patient Education|patient education
5064494|NCT01365013|Primary Health Care|primary health care
5064495|NCT01365000|Phase 1|phase 1
5064496|NCT01365000|Pharmacokinetics|pharmacokinetics
5064497|NCT01365000|NKTR-118|nktr-118
5064498|NCT01365000|fasting or fed state|fasting or fed state
5064499|NCT01365000|cross-over study|cross-over study
5064500|NCT01365000|AUC(0-t)|auc(0-t)
5064501|NCT01365000|Cmax|cmax
5064502|NCT01365000|tmax|tmax
5064503|NCT01365000|QTcF Interval|qtcf interval
5064504|NCT01364987|transplant|transplant
5064505|NCT01364987|ASP015K|asp015k
5064506|NCT01364987|healthy subjects|healthy subjects
5064507|NCT01364974|ASP015K|asp015k
5064508|NCT01364974|Healthy subjects|healthy subjects
5064509|NCT01364961|Resveratrol|resveratrol
5064510|NCT01364961|FMD|fmd
5064511|NCT01364961|PWV|pwv
5064512|NCT01364961|HDL-cholesterol|hdl-cholesterol
5064513|NCT01364961|Macrovasculature|macrovasculature
5064514|NCT01364961|Microvasculature|microvasculature
5064515|NCT01364948|Preterm|preterm
5064516|NCT01364948|VLBW|vlbw
5064517|NCT01364948|Coconut Oil application|coconut oil application
5064518|NCT01364948|Trans epidermal water loss|trans epidermal water loss
5064519|NCT01364948|Weight gain|weight gain
5064520|NCT01364909|Sepsis|sepsis
5064521|NCT01364909|Severe sepsis|severe sepsis
5064522|NCT01364909|Septic shock|septic shock
5064523|NCT01364909|Septicaemia|septicaemia
5064524|NCT01364909|Bacteremia|bacteremia
5064525|NCT01364896|Non-corticosteroid immunosuppressive agent|non-corticosteroid immunosuppressive agent
5064526|NCT01364883|Vaccine|vaccine
5064527|NCT01364883|Immune response|immune response
5064528|NCT01364870|Knee OA|knee oa
5064529|NCT01364870|TENS|tens
5064530|NCT01364870|Total knee replacement|total knee replacement
5064531|NCT01364870|Knee arthroplasty|knee arthroplasty
5064532|NCT01364870|total unilateral knee replacement|total unilateral knee replacement
5064533|NCT01364857|port wine stain of a limb|port wine stain of a limb
5064534|NCT01364831|sleep time|sleep time
5064535|NCT01364831|athletic performance|athletic performance
5064536|NCT01364792|schizophrenia|schizophrenia
5064537|NCT01364792|treatment|treatment
5064538|NCT01364792|inflammation|inflammation
5064539|NCT01364792|neuroinflammation|neuroinflammation
5064540|NCT01364792|hippocampal|hippocampal
5064541|NCT01364779|aspirin|aspirin
5064542|NCT01364779|Chronic kidney disease|chronic kidney disease
5064543|NCT01364753|Memory|memory
5064544|NCT01364753|Aviation|aviation
5064545|NCT01364714|ICU acquired weakness|icu acquired weakness
5064546|NCT01364701|Erectile dysfunction|erectile dysfunction
5064547|NCT01364701|combination therapy|combination therapy
5064548|NCT01364701|Sildenafil|sildenafil
5064549|NCT01364701|tadalafil|tadalafil
5064550|NCT01364701|PDE5i|pde5i
5064551|NCT01364701|No Conditions|no conditions
5064552|NCT01364688|coronary calcification|coronary calcification
5064553|NCT01364688|vascular calcification|vascular calcification
5064554|NCT01364688|active vitamin D|active vitamin d
5064555|NCT01364688|alfacalcidol|alfacalcidol
5064556|NCT01364675|Impaired fasting glucose|impaired fasting glucose
5064557|NCT01364675|Impaired glucose tolerance|impaired glucose tolerance
5064558|NCT01364675|Pre-diabetes|pre-diabetes
5064559|NCT01364675|Pre-hypertensives|pre-hypertensives
5064560|NCT01364675|Cardiovascular events|cardiovascular events
5064561|NCT01364662|Impulsive Aggression|impulsive aggression
5064562|NCT01364662|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
5064563|NCT01364662|ADHD|adhd
5064564|NCT01364649|Sexual Dysfunction, Physiological|sexual dysfunction, physiological
5064565|NCT01364649|Depressive Disorder, Major|depressive disorder, major
5064566|NCT01364649|Depression|depression
5064567|NCT01364649|Antidepressive Agents|antidepressive agents
5064568|NCT01364649|Drug Therapy|drug therapy
5064569|NCT01364636|1-Heart Failure|1-heart failure
5064570|NCT01364636|2-Acute Heart Failure|2-acute heart failure
5064571|NCT01364636|3-Acute Decompensated Heart Failure|3-acute decompensated heart failure
5064572|NCT01364636|4-Worsening Renal Function|4-worsening renal function
5064573|NCT01364636|5-Acute Kidney Injury|5-acute kidney injury
5064574|NCT01364636|6-Cardiorenal Syndrome|6-cardiorenal syndrome
5064575|NCT01364623|testosterone|testosterone
5064576|NCT01364623|pharmacokinetics|pharmacokinetics
5064577|NCT01364610|diagnosis|diagnosis
5064578|NCT01364610|pH measurement|ph measurement
5064579|NCT01364610|catheter|catheter
5064580|NCT01364610|wireless|wireless
5064581|NCT01364597|Brivaracetam|brivaracetam
5064582|NCT01364597|Epilepsy|epilepsy
5064583|NCT01364597|Child|child
5064584|NCT01364597|Infant|infant
5064585|NCT01364597|Adolescents|adolescents
5064586|NCT01364571|Staphylococcus aureus|staphylococcus aureus
5064587|NCT01364571|vaccine|vaccine
5064588|NCT01364571|staphylococcal infection|staphylococcal infection
5064589|NCT01364532|transulnar arterial access|transulnar arterial access
5064590|NCT01364532|transradial arterial access|transradial arterial access
5064591|NCT01364532|percutaneous coronary intervention|percutaneous coronary intervention
5064592|NCT01364519|COPD|copd
5064593|NCT01364506|Cardiovascular capacity|cardiovascular capacity
5064594|NCT01364506|Water exercise|water exercise
5064595|NCT01364506|Hydrokinetic Therapy|hydrokinetic therapy
5064596|NCT01364506|Pregnancy|pregnancy
5064597|NCT01364506|Perinatal outcomes|perinatal outcomes
5064598|NCT01364493|HER2-positive|her2-positive
5064599|NCT01364493|adenocarcinoma of the stomach or gastro-esophageal junction|adenocarcinoma of the stomach or gastro-esophageal junction
5064600|NCT01364493|Inoperable|inoperable
5064601|NCT01364493|locally advanced|locally advanced
5064602|NCT01364493|recurrent|recurrent
5064603|NCT01364493|metastatic|metastatic
5064604|NCT01364480|Tetraplegia|tetraplegia
5064605|NCT01364480|Spinal cord injury|spinal cord injury
5064606|NCT01364480|Brainstem or spinal stroke|brainstem or spinal stroke
5064607|NCT01364480|Neuroprosthetic|neuroprosthetic
5064608|NCT01364480|Brain-machine interface|brain-machine interface
5064609|NCT01364480|Brain-computer interface|brain-computer interface
5064610|NCT01364480|Neural activity|neural activity
5064611|NCT01364454|Colorectal Cancer Screening|colorectal cancer screening
5064612|NCT01364454|Faecal Occult Blood test|faecal occult blood test
5064613|NCT01364454|General Practitioners Involvement|general practitioners involvement
5064614|NCT01364454|Patient's Participation|patient's participation
5064615|NCT01364454|Reminder|reminder
5064616|NCT01364441|ONO-2950|ono-2950
5064617|NCT01364441|healthy adult subjects|healthy adult subjects
5064618|NCT01364441|first in human|first in human
5064619|NCT01364441|safety|safety
5064620|NCT01364441|tolerability|tolerability
5064621|NCT01364441|pharmacokinetics|pharmacokinetics
5064622|NCT01364415|MTD|mtd
5064623|NCT01364415|pasireotide|pasireotide
5064624|NCT01364415|LAR|lar
5064625|NCT01364415|NETs|nets
5064626|NCT01364415|advanced neuroendocrine tumors|advanced neuroendocrine tumors
5064627|NCT01364402|scheduled for PCI|scheduled for pci
5064628|NCT01364389|Polymyalgia Rheumatica|polymyalgia rheumatica
5064629|NCT01364389|Inflammatory Disease|inflammatory disease
5064630|NCT01364389|Rheumatic Disease|rheumatic disease
5064631|NCT01364376|Gastric Cancer|gastric cancer
5064632|NCT01364363|Transplant|transplant
5064633|NCT01364363|Allogeneic|allogeneic
5064634|NCT01364363|Allogeneic transplant|allogeneic transplant
5064635|NCT01364363|Unrelated donor transplant|unrelated donor transplant
5064636|NCT01364363|MUD|mud
5064637|NCT01364363|HSCT|hsct
5064638|NCT01364363|Stem cell transplant|stem cell transplant
5064639|NCT01364350|type 2 diabetes mellitus|type 2 diabetes mellitus
5064640|NCT01364350|pediatrics|pediatrics
5064641|NCT01364350|post-intervention study|post-intervention study
5064642|NCT01364350|metformin|metformin
5064643|NCT01364350|complications|complications
5064644|NCT01364337|Hypertension|hypertension
5064645|NCT01364324|tuberculosis|tuberculosis
5064646|NCT01364324|pharmacokinetics|pharmacokinetics
5064647|NCT01364324|first-line drugs|first-line drugs
5064648|NCT01364324|gastrectomy|gastrectomy
5064649|NCT01364311|Dry Eye Syndromes|dry eye syndromes
5064650|NCT01364311|Dietary Supplements|dietary supplements
5064651|NCT01364311|Vitamac® Tag and Nacht capsules|vitamac® tag and nacht capsules
5064652|NCT01364311|Lutein|lutein
5064653|NCT01364311|Vitamin C|vitamin c
5064654|NCT01364311|Zinc|zinc
5064655|NCT01364311|ginkgo biloba|ginkgo biloba
5064656|NCT01364311|Flavinoids|flavinoids
5064657|NCT01364311|Fishoil|fishoil
5064658|NCT01364311|Zeaxanthin|zeaxanthin
5064659|NCT01364311|Vitamin E|vitamin e
5064660|NCT01364311|Copper|copper
5064661|NCT01364311|Selen|selen
5064662|NCT01364311|Alpha Lipon acid|alpha lipon acid
5064663|NCT01364311|Break up time (BUT)|break up time (but)
5064664|NCT01364311|Improvement of subjective symptoms of dry eye syndrome|improvement of subjective symptoms of dry eye syndrome
5064665|NCT01364311|Visual Acuity|visual acuity
5064666|NCT01364311|Tear film osmolarity|tear film osmolarity
5064667|NCT01364311|OSI (Objective Scattering Index)|osi (objective scattering index)
5064668|NCT01364311|Schirmer I test|schirmer i test
5064669|NCT01364311|Staining of the cornea with fluorescein|staining of the cornea with fluorescein
5064670|NCT01364311|Impression cytology|impression cytology
5064671|NCT01364311|Tear cytokines/chemokines|tear cytokines/chemokines
5064672|NCT01364311|Data from patient diary how often Hylo-Comod® eye drops were used|data from patient diary how often hylo-comod® eye drops were used
5064673|NCT01364298|Gabapentin/B complex|gabapentin/b complex
5064674|NCT01364298|Pregabalin|pregabalin
5064675|NCT01364298|Pain|pain
5064676|NCT01364298|Neuropathic|neuropathic
5064677|NCT01364298|Gavindo|gavindo
5064678|NCT01364298|Lyrica|lyrica
5064679|NCT01364259|tic douloureux|tic douloureux
5064680|NCT01364246|Progressive Multiple Sclerosis|progressive multiple sclerosis
5064681|NCT01364246|neuromyelitis optica|neuromyelitis optica
5064682|NCT01364246|Umbilical Cord Mesenchymal Stem Cell|umbilical cord mesenchymal stem cell
5064683|NCT01364220|Additional relevant MeSH terms|additional relevant mesh terms
5064684|NCT01364220|Stroke|stroke
5064685|NCT01364220|Cerebral Infarction|cerebral infarction
5064686|NCT01364220|Cerebrovascular Disorders|cerebrovascular disorders
5064812|NCT01363726|southern Israel|southern israel
5064687|NCT01364220|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors
5064688|NCT01364220|Magnetic Resonance Imaging|magnetic resonance imaging
5064689|NCT01364220|Recurrence|recurrence
5064690|NCT01364194|Post operative pain|post operative pain
5064691|NCT01364194|Total knee replacement|total knee replacement
5064692|NCT01364194|Total knee arthroplasty|total knee arthroplasty
5064693|NCT01364194|Bupivacaine|bupivacaine
5064694|NCT01364194|Periarticular injection|periarticular injection
5064695|NCT01364194|Placebo|placebo
5064696|NCT01364194|Morphine consumption|morphine consumption
5064697|NCT01364181|Udenafil|udenafil
5064698|NCT01364181|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
5064699|NCT01364181|pulmonary hypertension|pulmonary hypertension
5064800|NCT01363765|cost-effectiveness|cost-effectiveness
5064700|NCT01364181|Phosphodiesterase 5 inhibitors|phosphodiesterase 5 inhibitors
5064701|NCT01364181|Exercise|exercise
5064702|NCT01364181|Dyspnea|dyspnea
5064703|NCT01364129|Diabetes|diabetes
5064704|NCT01364129|Diabetic Retinopathy Screening|diabetic retinopathy screening
5064705|NCT01364129|Ophthalmic Telemedicine|ophthalmic telemedicine
5064706|NCT01364129|Comparative Effectiveness Research|comparative effectiveness research
5064707|NCT01364116|Pulse CO-Oximetry™|pulse co-oximetry™
5064708|NCT01364116|children|children
5064709|NCT01364116|noninvasive|noninvasive
5064710|NCT01364103|pulse pressure variation|pulse pressure variation
5064711|NCT01364103|systolic pressure variation|systolic pressure variation
5064712|NCT01364103|central venous pressure|central venous pressure
5064713|NCT01364103|aortic blood flow velocity variation|aortic blood flow velocity variation
5064714|NCT01364103|pleth variability index|pleth variability index
5064715|NCT01364090|hepatitis C|hepatitis c
5064716|NCT01364090|treatment|treatment
5064717|NCT01364090|injection drug users or receiving opiate substitution therapy|injection drug users or receiving opiate substitution therapy
5064718|NCT01364077|Heart rate|heart rate
5064719|NCT01364077|Dialysis|dialysis
5064720|NCT01364077|ESRD|esrd
5064721|NCT01364077|ivabradine|ivabradine
5064722|NCT01363973|oropharyngeal dysphagia|oropharyngeal dysphagia
5064723|NCT01363973|post-stroke|post-stroke
5064724|NCT01363960|Incidence|incidence
5064725|NCT01363960|neonatal care|neonatal care
5064726|NCT01363960|retinopathy of prematurity|retinopathy of prematurity
5064727|NCT01363960|risk factors|risk factors
5064728|NCT01363934|Erythropoietin|erythropoietin
5064729|NCT01363934|EPO-hFC|epo-hfc
5064730|NCT01363921|CKD5|ckd5
5064731|NCT01363921|dialysis|dialysis
5064732|NCT01363921|high porous membranes|high porous membranes
5064733|NCT01363921|micro-inflammation|micro-inflammation
5064734|NCT01363908|Beta-Thalassemia|beta-thalassemia
5064735|NCT01363908|Sickle Cell Anemia|sickle cell anemia
5064736|NCT01363908|Transfusional iron overload|transfusional iron overload
5064737|NCT01363908|Iron Overload|iron overload
5064738|NCT01363908|Iron Chelation|iron chelation
5064739|NCT01363895|atrial fibrillation|atrial fibrillation
5064740|NCT01363895|catheter ablation|catheter ablation
5064741|NCT01363895|percutaneous closure of LAA|percutaneous closure of laa
5064742|NCT01363895|intervention|intervention
5064743|NCT01363882|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
5064744|NCT01363882|Noninvasive Ventilation|noninvasive ventilation
5064745|NCT01363882|Respiratory Dysfunction|respiratory dysfunction
5064746|NCT01363882|Positive Pressure Ventilation|positive pressure ventilation
5064747|NCT01363869|hyperuricemia|hyperuricemia
5064748|NCT01363869|gout|gout
5064749|NCT01363869|uric acid|uric acid
5064750|NCT01363869|xanthine oxidase inhibitor|xanthine oxidase inhibitor
5064751|NCT01363869|green tea|green tea
5064752|NCT01363869|catechins|catechins
5064753|NCT01363869|antioxidant|antioxidant
5064754|NCT01363856|first ever stroke|first ever stroke
5064755|NCT01363843|neoadjuvant|neoadjuvant
5064756|NCT01363843|chemo/radiation|chemo/radiation
5064757|NCT01363843|rectal cancer|rectal cancer
5064758|NCT01363843|rectum cancer|rectum cancer
5064759|NCT01363843|colon cancer|colon cancer
5064760|NCT01363843|colorectal cancer|colorectal cancer
5064761|NCT01363830|Disc|disc
5064762|NCT01363830|lumbar|lumbar
5064763|NCT01363830|herniation|herniation
5064764|NCT01363804|AV-951|av-951
5064765|NCT01363804|Tivozanib|tivozanib
5064766|NCT01363804|Healthy Subjects|healthy subjects
5064767|NCT01363804|rifampin|rifampin
5064768|NCT01363804|Pharmacokinetics|pharmacokinetics
5064769|NCT01363791|Systematic review and meta-analysis|systematic review and meta-analysis
5064770|NCT01363791|Evidence-based medicine (EBM)|evidence-based medicine (ebm)
5064771|NCT01363791|Evidence-based nutrition (EBN)|evidence-based nutrition (ebn)
5064772|NCT01363791|Clinical practice guidelines|clinical practice guidelines
5064773|NCT01363791|Clinical trials|clinical trials
5064774|NCT01363791|Dietary sugars|dietary sugars
5064775|NCT01363791|Fructose|fructose
5064776|NCT01363791|High fructose corn syrup|high fructose corn syrup
5064777|NCT01363791|Fruit|fruit
5064778|NCT01363791|Isocaloric|isocaloric
5064779|NCT01363791|Hypercaloric|hypercaloric
5064780|NCT01363791|Cardiometabolic risk factors|cardiometabolic risk factors
5064781|NCT01363791|Triglycerides|triglycerides
5064782|NCT01363791|Cholesterol|cholesterol
5064783|NCT01363791|Glycemic control|glycemic control
5064784|NCT01363791|Insulin resistance|insulin resistance
5064785|NCT01363791|Body weight|body weight
5064786|NCT01363791|Uric acid|uric acid
5064787|NCT01363791|Blood pressure|blood pressure
5064788|NCT01363791|Fatty liver|fatty liver
5064789|NCT01363791|Fasting|fasting
5064790|NCT01363791|Postprandial|postprandial
5064791|NCT01363778|AV-951|av-951
5064792|NCT01363778|Tivozanib|tivozanib
5064793|NCT01363778|Healthy Subjects|healthy subjects
5064794|NCT01363778|ketoconazole|ketoconazole
5064795|NCT01363778|Pharmacokinetics|pharmacokinetics
5064796|NCT01363765|diagnosis|diagnosis
5064797|NCT01363765|polymerase chain reaction|polymerase chain reaction
5064798|NCT01363765|sputum smear|sputum smear
5064799|NCT01363765|stepped-wedge design|stepped-wedge design
5064801|NCT01363765|Xpert MTB/Rif|xpert mtb/rif
5064802|NCT01363752|Kidney|kidney
5064803|NCT01363752|Kidney Failure, Acute|kidney failure, acute
5064804|NCT01363752|Astagraf XL|astagraf xl
5064805|NCT01363752|Immunosuppression|immunosuppression
5064806|NCT01363752|Advagraf|advagraf
5064807|NCT01363752|Tacrolimus|tacrolimus
5064808|NCT01363752|Transplant|transplant
5064809|NCT01363739|VEGF polymorphism Bevacizumab|vegf polymorphism bevacizumab
5064810|NCT01363726|surveillance Rotavirus Gastroenteritis Children|surveillance rotavirus gastroenteritis children
5064811|NCT01363726|< 5 years of age|< 5 years of age
5064813|NCT01363726|Signed informed concent|signed informed concent
5064814|NCT01363674|Growth disorders|growth disorders
5064815|NCT01363674|Saizen|saizen
5064816|NCT01363674|Easypod|easypod
5064817|NCT01363674|Growth hormone|growth hormone
5064818|NCT01363674|Pediatric subject|pediatric subject
5064819|NCT01363661|angina pectoris|angina pectoris
5064820|NCT01363661|atherosclerosis|atherosclerosis
5064821|NCT01363661|endothelial dysfunction|endothelial dysfunction
5064822|NCT01363648|VCI-HS|vci-hs
5064823|NCT01363648|stroke|stroke
5064824|NCT01363648|choline alphoscerate|choline alphoscerate
5064825|NCT01363635|severe sepsis/septic shock|severe sepsis/septic shock
5064826|NCT01363635|organ failure|organ failure
5064827|NCT01363635|AKI|aki
5064828|NCT01363635|PMI|pmi
5064829|NCT01363635|ALI|ali
5064830|NCT01363635|Stroke|stroke
5064831|NCT01363635|ICU death|icu death
5064832|NCT01363622|Vaspin|vaspin
5064833|NCT01363622|LGA|lga
5064834|NCT01363622|SGA|sga
5064835|NCT01363622|Insulin|insulin
5064836|NCT01363622|Blood glucose|blood glucose
5064837|NCT01363596|Infertility|infertility
5064838|NCT01363596|Fertility|fertility
5064839|NCT01363596|Reproductive Medicine|reproductive medicine
5064840|NCT01363596|Pregnancy|pregnancy
5064841|NCT01363596|Conception|conception
5064842|NCT01363596|Miscarriage|miscarriage
5064843|NCT01363596|Ovulation Detection|ovulation detection
5064844|NCT01363596|Cervical Mucus|cervical mucus
5064845|NCT01363596|IVF Alternative|ivf alternative
5064846|NCT01363583|traumatic brain injury|traumatic brain injury
5064847|NCT01363570|Macular Degeneration|macular degeneration
5064848|NCT01363570|Age related macular degeneration|age related macular degeneration
5064849|NCT01363570|Macula Risk|macula risk
5064850|NCT01363570|Genetic test|genetic test
5064851|NCT01363570|Anti-inflammatory|anti-inflammatory
5064852|NCT01363570|Anti-vascular endothelial growth factor (Anti-VEGF)|anti-vascular endothelial growth factor (anti-vegf)
5064853|NCT01363570|Lucentis|lucentis
5064854|NCT01363570|Ranibizumab|ranibizumab
5064855|NCT01363570|Vision loss|vision loss
5064856|NCT01363557|Randomized|randomized
5064857|NCT01363557|Brain Radiation Therapy|brain radiation therapy
5064858|NCT01363557|Lung Cancer|lung cancer
5064859|NCT01363557|Brain Metastasis|brain metastasis
5064860|NCT01363557|Gefitinib|gefitinib
5064861|NCT01363544|ADHD|adhd
5064862|NCT01363544|neurofeedback|neurofeedback
5064863|NCT01363544|exercise|exercise
5064864|NCT01363544|neurophysiology|neurophysiology
5064865|NCT01363531|Prescription|prescription
5064866|NCT01363531|Antibiotic|antibiotic
5064867|NCT01363531|Acute respiratory infections|acute respiratory infections
5064868|NCT01363531|Satisfaction|satisfaction
5064869|NCT01363531|Perception|perception
5064870|NCT01363531|Pharyngitis and/or acute tonsillitis|pharyngitis and/or acute tonsillitis
5064871|NCT01363531|Rhinosinusitis|rhinosinusitis
5064872|NCT01363531|Acute bronchitis|acute bronchitis
5064873|NCT01363531|Acute exacerbation of chronic obstructive pulmonary disease (mild to moderate)|acute exacerbation of chronic obstructive pulmonary disease (mild to moderate)
5064874|NCT01363518|humerus|humerus
5064875|NCT01363518|fracture|fracture
5064876|NCT01363518|operative treatment|operative treatment
5064877|NCT01363518|non-operative treatment|non-operative treatment
5064878|NCT01363492|agalsidase alfa|agalsidase alfa
5064879|NCT01363492|Replagal|replagal
5064880|NCT01363492|Enzyme Replacement Therapy|enzyme replacement therapy
5064881|NCT01363440|Diabetic Macular Edema|diabetic macular edema
5064882|NCT01363440|Diabetic Retinopathy|diabetic retinopathy
5064883|NCT01363414|Dry eye|dry eye
5064884|NCT01363414|Ocular aberration|ocular aberration
5064885|NCT01363401|Amyotrophic lateral sclerosis|amyotrophic lateral sclerosis
5064886|NCT01363401|ALS|als
5064887|NCT01363401|Motor neuron disease|motor neuron disease
5064888|NCT01363401|MND|mnd
5064889|NCT01363401|HYNR-CS inj|hynr-cs inj
5064890|NCT01363401|Autologous bone marrow derived stem cell|autologous bone marrow derived stem cell
5064891|NCT01363401|Intrathecal injection|intrathecal injection
5064892|NCT01363375|Plantar fascia|plantar fascia
5064893|NCT01363375|Plantar fasciitis|plantar fasciitis
5064894|NCT01363375|Foot orthosis|foot orthosis
5064895|NCT01363375|Finite element analysis|finite element analysis
5064896|NCT01363375|Gait analysis|gait analysis
5064897|NCT01363375|Plantar pressure measurement|plantar pressure measurement
5064898|NCT01363362|Selective Laser Trabeculoplasty|selective laser trabeculoplasty
5064899|NCT01363362|pulsatile ocular blood flow|pulsatile ocular blood flow
5064900|NCT01363336|Adalat|adalat
5064901|NCT01363336|Hypertension|hypertension
5064902|NCT01363336|Diabetes|diabetes
5064903|NCT01363336|Chronic kidney disease|chronic kidney disease
5064904|NCT01363297|Relapsed/Refractory Acute Lymphocytic Leukemia (ALL)|relapsed/refractory acute lymphocytic leukemia (all)
5064905|NCT01363258|Elderly|elderly
5064906|NCT01363258|Dementia|dementia
5064907|NCT01363258|Care-resistant behavior|care-resistant behavior
5064908|NCT01363258|Oral health|oral health
5064909|NCT01363258|Long-term care|long-term care
5064910|NCT01363245|cost effectiveness|cost effectiveness
5064911|NCT01363245|behavioral health counseling|behavioral health counseling
5064912|NCT01363232|BKM120|bkm120
5064913|NCT01363232|MEK162|mek162
5064914|NCT01363232|RAS RAF mutations|ras raf mutations
5064915|NCT01363232|triple negative breast cancer|triple negative breast cancer
5064916|NCT01363232|pancreatic cancer, ovarian cancer|pancreatic cancer, ovarian cancer
5064917|NCT01363232|NSCLC progressed on EGFR TKI|nsclc progressed on egfr tki
5064918|NCT01363232|PI3K inhibitor|pi3k inhibitor
5064919|NCT01363232|MEK inhibitor|mek inhibitor
5064920|NCT01363206|Melanoma|melanoma
5064921|NCT01363206|GM-CSF|gm-csf
5064922|NCT01363206|Ipilimumab|ipilimumab
5064923|NCT01363206|Immunologic Response|immunologic response
5064924|NCT01363193|Weight-based heparin dosing|weight-based heparin dosing
5064925|NCT01363193|Obesity|obesity
5064926|NCT01363193|Body Mass Index|body mass index
5064927|NCT01363193|Venous thromboembolism|venous thromboembolism
5064928|NCT01363193|Atrial fibrillation|atrial fibrillation
5064929|NCT01363193|Lean body weight|lean body weight
5064930|NCT01363193|Unfractionated heparin|unfractionated heparin
5064931|NCT01363193|heparin|heparin
5064932|NCT01363167|vitamin D|vitamin d
5064933|NCT01363167|preterm infants|preterm infants
5064934|NCT01363167|calcium|calcium
5064935|NCT01363167|bone|bone
5064936|NCT01363167|parathyroid hormone|parathyroid hormone
5064937|NCT01363154|Children's Health|children's health
5064938|NCT01363154|Pediatrics|pediatrics
5064939|NCT01363154|Epilepsy|epilepsy
5064940|NCT01363154|Photoparoxysmal|photoparoxysmal
5064941|NCT01363154|Photosensitive|photosensitive
5064942|NCT01363154|Music|music
5064943|NCT01363154|Mozart|mozart
5064944|NCT01363154|K-448|k-448
5064945|NCT01363141|Cardiovascular Diseases|cardiovascular diseases
5064946|NCT01363141|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
5064947|NCT01363141|Abdominal Fat|abdominal fat
5064948|NCT01363141|Atherogenic Dyslipidemia|atherogenic dyslipidemia
5064949|NCT01363141|Hypertension|hypertension
5064950|NCT01363141|Hyperglycemia|hyperglycemia
5064951|NCT01363141|Insulin Resistance|insulin resistance
5064952|NCT01363141|Thrombosis state|thrombosis state
5064953|NCT01363128|Leukemia|leukemia
5064954|NCT01363128|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
5064955|NCT01363128|CD-20 Positive Acute Lymphoblastic Leukemia|cd-20 positive acute lymphoblastic leukemia
5064956|NCT01363128|Any level of CD20 expression|any level of cd20 expression
5064957|NCT01363128|Lymphoblastic lymphoma|lymphoblastic lymphoma
5064958|NCT01363128|Central Venous Catheter|central venous catheter
5064959|NCT01363128|CVC|cvc
5064960|NCT01363128|HCVAD|hcvad
5064961|NCT01363128|Cyclophosphamide|cyclophosphamide
5064962|NCT01363128|Cytoxan|cytoxan
5064963|NCT01363128|Neosar|neosar
5064964|NCT01363128|Mesna|mesna
5064965|NCT01363128|Mesnex|mesnex
5064966|NCT01363128|Doxorubicin|doxorubicin
5064967|NCT01363128|Adriamycin|adriamycin
5064968|NCT01363128|Rubex|rubex
5064969|NCT01363128|Vincristine|vincristine
5064970|NCT01363128|Dexamethasone|dexamethasone
5064971|NCT01363128|Decadron|decadron
5064972|NCT01363128|Ofatumumab|ofatumumab
5064973|NCT01363128|Arzerra|arzerra
5064974|NCT01363128|Methotrexate|methotrexate
5064975|NCT01363128|Cytarabine|cytarabine
5064976|NCT01363128|Ara-C|ara-c
5064977|NCT01363128|Cytosar|cytosar
5064978|NCT01363128|DepoCyt|depocyt
5064979|NCT01363128|Cytosine Arabinosine Hydrochloride|cytosine arabinosine hydrochloride
5064980|NCT01363115|Body Weight|body weight
5064981|NCT01363115|Dietary Supplement|dietary supplement
5064982|NCT01363115|Calcium|calcium
5064983|NCT01363115|Vitamin D|vitamin d
5064984|NCT01363102|Muscle strength|muscle strength
5064985|NCT01363102|functional mobility|functional mobility
5064986|NCT01363102|outcome|outcome
5064987|NCT01363102|intensive care unit|intensive care unit
5064988|NCT01363102|quality of life|quality of life
5064989|NCT01363037|HIV infections|hiv infections
5064990|NCT01363037|Anti-HIV agents|anti-hiv agents
5064991|NCT01363037|HIV-1|hiv-1
5064992|NCT01363024|Solid Cancers|solid cancers
5064993|NCT01363011|HIV-1|hiv-1
5064994|NCT01363011|Treatment Naive|treatment naive
5064995|NCT01363011|Treatment Experienced|treatment experienced
5064996|NCT01362998|fentanyl, morphine, duramorph, Cesarean section, epidural|fentanyl, morphine, duramorph, cesarean section, epidural
5064997|NCT01362959|Delirium|delirium
5064998|NCT01362959|Psychomotor Agitation|psychomotor agitation
5064999|NCT01362959|Substance Withdrawal Syndrome|substance withdrawal syndrome
5065000|NCT01362959|Nicotine replacement therapy|nicotine replacement therapy
5065001|NCT01362946|Conduct problems|conduct problems
5065002|NCT01362946|callous-unemotional traits|callous-unemotional traits
5065003|NCT01362946|disruptive behavior disorders|disruptive behavior disorders
5065004|NCT01362933|PE|pe
5065005|NCT01362933|DVT|dvt
5065006|NCT01362933|SVT|svt
5065007|NCT01362933|LMWH|lmwh
5065008|NCT01362933|VKA|vka
5065009|NCT01362933|international Venous Thromboembolism Recommendations|international venous thromboembolism recommendations
5065010|NCT01362920|Sepsis|sepsis
5065011|NCT01362920|Septic shock|septic shock
5065012|NCT01362920|Procalcitonin|procalcitonin
5065013|NCT01362920|PCT|pct
5065014|NCT01362881|Early|early
5065015|NCT01362881|Onset|onset
5065016|NCT01362881|Scoliosis|scoliosis
5065017|NCT01362868|Glaucoma|glaucoma
5065018|NCT01362868|Triggerfish|triggerfish
5065019|NCT01362868|Water drinking test|water drinking test
5065020|NCT01362855|Advance Care Planning|advance care planning
5065021|NCT01362855|End of life|end of life
5065022|NCT01362855|Knowledge translation|knowledge translation
5065023|NCT01362855|Goals of care|goals of care
5065024|NCT01362855|Advance directive|advance directive
5065025|NCT01362855|Lining will|lining will
5065026|NCT01362842|Lung Cancer|lung cancer
5065027|NCT01362842|Symptom distress|symptom distress
5065028|NCT01362842|Post-operation|post-operation
5065029|NCT01362842|Anxiety|anxiety
5065030|NCT01362842|Depression|depression
5065031|NCT01362842|Uncertainty|uncertainty
5065032|NCT01362842|Fear of recurrence|fear of recurrence
5065033|NCT01362842|Self-efficacy|self-efficacy
5065034|NCT01362842|Needs|needs
5065035|NCT01362803|Maximum Tolerated Dose|maximum tolerated dose
5065036|NCT01362803|Pharmacokinetics|pharmacokinetics
5065037|NCT01362803|Pharmacodynamics|pharmacodynamics
5065038|NCT01362803|Response Rate|response rate
5065039|NCT01362803|pain, quality of life and physical functioning|pain, quality of life and physical functioning
5065040|NCT01362803|Neurofibromatosis Type 1|neurofibromatosis type 1
5065041|NCT01362803|NF1|nf1
5065042|NCT01362803|Plexiform Neurofibroma|plexiform neurofibroma
5065043|NCT01362790|Immune Therapy|immune therapy
5065044|NCT01362790|Immunotoxin|immunotoxin
5065045|NCT01362790|T-Cell Depletion|t-cell depletion
5065046|NCT01362790|Mesothelioma|mesothelioma
5065047|NCT01362777|Obstructive Sleep Apnea/Hypopnea Syndrome|obstructive sleep apnea/hypopnea syndrome
5065048|NCT01362777|Exercise training program|exercise training program
5065049|NCT01362777|Inflammation|inflammation
5065050|NCT01362777|Oxidative Stress|oxidative stress
5065051|NCT01362777|Resistance to insulin|resistance to insulin
5065052|NCT01362764|Abiraterone Acetate|abiraterone acetate
5065053|NCT01362764|ZYTIGA|zytiga
5065054|NCT01362738|Long-standing persistent atrial fibrillation|long-standing persistent atrial fibrillation
5065055|NCT01362725|spinal cord stimulation|spinal cord stimulation
5065056|NCT01362725|systolic heart failure|systolic heart failure
5065057|NCT01362712|breast cancer|breast cancer
5065058|NCT01362712|radiotherapy|radiotherapy
5065059|NCT01362712|chemoradiotherapy|chemoradiotherapy
5065060|NCT01362712|radiation|radiation
5065061|NCT01362712|chemoradiation|chemoradiation
5065062|NCT01362712|[F-18]|[f-18]
5065063|NCT01362699|Alcoholism|alcoholism
5065064|NCT01362699|Alcohol-Related Disorders|alcohol-related disorders
5065065|NCT01362699|Substance-Related Disorders|substance-related disorders
5065066|NCT01362699|Mental Disorders|mental disorders
5065067|NCT01362699|Alcohol Dependence|alcohol dependence
5065068|NCT01362699|JNJ-31001074|jnj-31001074
5065069|NCT01362699|Bavisant|bavisant
5065070|NCT01362686|diagnosis of Alzheimer's disease|diagnosis of alzheimer's disease
5065071|NCT01362686|medication adherence|medication adherence
5065072|NCT01362673|Phase 1|phase 1
5065073|NCT01362673|Pharmacokinetics|pharmacokinetics
5065074|NCT01362673|food effect|food effect
5065075|NCT01362673|Healthy Japanese|healthy japanese
5065076|NCT01362673|rheumatoid arthritis|rheumatoid arthritis
5065077|NCT01362660|post-natal monitoring|post-natal monitoring
5065078|NCT01362660|exposure in utero|exposure in utero
5065079|NCT01362647|Muscle Relaxation|muscle relaxation
5065080|NCT01362634|HIV/AIDS|hiv/aids
5065081|NCT01362634|substance use|substance use
5065082|NCT01362634|club drugs|club drugs
5065083|NCT01362634|sexual risk|sexual risk
5065084|NCT01362621|Allergic asthma|allergic asthma
5065085|NCT01362621|Pediatrics|pediatrics
5065086|NCT01362621|Exacerbations|exacerbations
5065087|NCT01362621|Perennial aeroallergens|perennial aeroallergens
5065088|NCT01362621|Inhaled corticosteroids|inhaled corticosteroids
5065089|NCT01362608|Gout|gout
5065090|NCT01362608|Inflammatory gout|inflammatory gout
5065091|NCT01362608|acute gout|acute gout
5065092|NCT01362595|leucine administration|leucine administration
5065093|NCT01362595|red blood cell transfusion|red blood cell transfusion
5065094|NCT01362595|Diamond Blackfan anemia|diamond blackfan anemia
5065095|NCT01362582|Pancreatic cancer|pancreatic cancer
5065096|NCT01362582|progression under chemotherapy|progression under chemotherapy
5065097|NCT01362582|parenteral nutrition|parenteral nutrition
5065098|NCT01362582|pancreatic adenocarcinoma|pancreatic adenocarcinoma
5065099|NCT01362582|chemotherapy|chemotherapy
5065100|NCT01362569|endotoxin|endotoxin
5065101|NCT01362569|neutrophil function|neutrophil function
5065102|NCT01362569|albumin function|albumin function
5065103|NCT01362543|PTSD|ptsd
5065104|NCT01362543|Depression|depression
5065105|NCT01362543|Refugees|refugees
5065106|NCT01362543|Trauma|trauma
5065107|NCT01362517|Vaccination|vaccination
5065108|NCT01362517|Immunisation|immunisation
5065109|NCT01362517|Virus|virus
5065110|NCT01362517|Diphtheria|diphtheria
5065111|NCT01362517|Pertussis|pertussis
5065112|NCT01362517|Tetanus|tetanus
5065113|NCT01362517|Hepatitis B|hepatitis b
5065114|NCT01362517|Haemophilus Influenzae|haemophilus influenzae
5065115|NCT01362517|Immunity|immunity
5065116|NCT01362504|Pro-adrenomedullin|pro-adrenomedullin
5065117|NCT01362504|Neonatal sepsis|neonatal sepsis
5065118|NCT01362504|Prognosis|prognosis
5065119|NCT01362504|Sepsis marker|sepsis marker
5065120|NCT01362504|Clinical sepsis|clinical sepsis
5065121|NCT01362504|Proven sepsis|proven sepsis
5065122|NCT01362491|Headache|headache
5065123|NCT01362478|schizophrenia|schizophrenia
5065124|NCT01362478|gene promoter|gene promoter
5065125|NCT01362478|methylation|methylation
5065126|NCT01362478|endophenotype|endophenotype
5065127|NCT01362478|epigenetic|epigenetic
5065128|NCT01362452|Leukemia|leukemia
5065129|NCT01362452|Lymphoma|lymphoma
5065130|NCT01362452|CD19-specific T cells|cd19-specific t cells
5065131|NCT01362452|Umbilical cord blood transplantation|umbilical cord blood transplantation
5065132|NCT01362452|B-Lineage Lymphoid Malignancies|b-lineage lymphoid malignancies
5065133|NCT01362452|B-cell leukemia|b-cell leukemia
5065134|NCT01362452|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
5065135|NCT01362452|ALL|all
5065136|NCT01362452|Biphenotypic Leukemia|biphenotypic leukemia
5065137|NCT01362452|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
5065138|NCT01362452|NHL|nhl
5065139|NCT01362452|Small Lymphocytic Lymphoma|small lymphocytic lymphoma
5065140|NCT01362452|SLL|sll
5065141|NCT01362452|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
5065142|NCT01362452|CLL|cll
5065143|NCT01362452|White blood cells|white blood cells
5065144|NCT01362452|T cells|t cells
5065145|NCT01362452|Melphalan|melphalan
5065146|NCT01362452|Alkeran|alkeran
5065147|NCT01362452|Thiotepa|thiotepa
5065148|NCT01362452|Fludarabine|fludarabine
5065149|NCT01362452|Fludarabine Phosphate|fludarabine phosphate
5065150|NCT01362452|Fludara|fludara
5065151|NCT01362452|ATG|atg
5065152|NCT01362452|Antithymocyte Globulin|antithymocyte globulin
5065153|NCT01362452|Thymoglobulin|thymoglobulin
5065154|NCT01362452|Rituxan|rituxan
5065155|NCT01362452|Rituximab|rituximab
5065156|NCT01362452|Cyclophosphamide|cyclophosphamide
5065157|NCT01362452|Cytoxan|cytoxan
5065158|NCT01362452|Neosar|neosar
5065159|NCT01362439|Schizophrenia|schizophrenia
5065160|NCT01362439|Paliperidone|paliperidone
5065161|NCT01362426|schizophrenia|schizophrenia
5065162|NCT01362426|paliperidone palmitate|paliperidone palmitate
5065163|NCT01362426|INVEGA SUSTENNA|invega sustenna
5065164|NCT01362426|registries|registries
5065165|NCT01362426|quality of healthcare|quality of healthcare
5065166|NCT01362413|pseudarthrosis|pseudarthrosis
5065167|NCT01362413|mineralization|mineralization
5065168|NCT01362413|platelet-rich-plasma|platelet-rich-plasma
5065169|NCT01362413|serum|serum
5065170|NCT01362400|LUNG NEOPLASMS|lung neoplasms
5065171|NCT01362400|LARGE CELL CARCINOMA|large cell carcinoma
5065172|NCT01362400|SQUAMOUS CELL CARCINOMA|squamous cell carcinoma
5065173|NCT01362387|Medical abortion|medical abortion
5065174|NCT01362387|abortion follow-up|abortion follow-up
5065175|NCT01362361|Second line colorectal cancer|second line colorectal cancer
5065176|NCT01362348|Age-related Macular Degeneration|age-related macular degeneration
5065177|NCT01362322|dTpa|dtpa
5065178|NCT01362322|Boostrix|boostrix
5065179|NCT01362309|Alcohol|alcohol
5065180|NCT01362309|Cues|cues
5065181|NCT01362309|Extinction|extinction
5065182|NCT01362309|D-Cycloserine|d-cycloserine
5065183|NCT01362296|NRAS|nras
5065184|NCT01362296|docetaxel|docetaxel
5065185|NCT01362296|NSCLC|nsclc
5065186|NCT01362296|GSK1120212|gsk1120212
5065187|NCT01362296|MEK inhibitor|mek inhibitor
5065188|NCT01362296|targeted therapy|targeted therapy
5065189|NCT01362296|KRAS|kras
5065190|NCT01362296|BRAF|braf
5065191|NCT01362270|Anxiolytics|anxiolytics
5065192|NCT01362270|Sedatives|sedatives
5065193|NCT01362270|Acupuncture Therapy|acupuncture therapy
5065194|NCT01362244|Quality of Life|quality of life
5065195|NCT01362244|Intranasal Steroids|intranasal steroids
5065196|NCT01362244|Severe Nasal Polyposis|severe nasal polyposis
5065197|NCT01362244|Polyp Relapse|polyp relapse
5065198|NCT01362244|Endoscopic Polyp Score|endoscopic polyp score
5065199|NCT01362244|Surgery|surgery
5065200|NCT01362231|Fibrosis|fibrosis
5065201|NCT01362231|Pulmonary Fibrosis|pulmonary fibrosis
5065202|NCT01362231|Lung Diseases|lung diseases
5065203|NCT01362231|Interstitial|interstitial
5065204|NCT01362205|Severe Alcohol Withdrawal Delirium Tremens|severe alcohol withdrawal delirium tremens
5065205|NCT01362192|Telangiectasis|telangiectasis
5065206|NCT01362192|Spider Veins|spider veins
5065207|NCT01362192|Excel V|excel v
5065208|NCT01362192|Cutera|cutera
5065209|NCT01362192|Laser|laser
5065210|NCT01362192|Leg Veins|leg veins
5065211|NCT01362192|Venulectasia|venulectasia
5065212|NCT01362192|Lower Extremity veins|lower extremity veins
5065213|NCT01362192|Laser light|laser light
5065214|NCT01362192|KTP|ktp
5065215|NCT01362192|532nm|532nm
5065313|NCT01361828|Bevacizumab|bevacizumab
5065216|NCT01362179|malignant myeloid hematologic disorders|malignant myeloid hematologic disorders
5065217|NCT01362179|filgrastim|filgrastim
5065218|NCT01362179|long term incidence|long term incidence
5065219|NCT01362179|donors who received and in those who did not receive filgrastim.|donors who received and in those who did not receive filgrastim.
5065220|NCT01362166|Chinese medicine|chinese medicine
5065221|NCT01362166|channel|channel
5065222|NCT01362166|acupuncture|acupuncture
5065223|NCT01362166|ZuSanLi|zusanli
5065224|NCT01362166|XianGu|xiangu
5065225|NCT01362166|frequency response|frequency response
5065226|NCT01362166|resonance|resonance
5065227|NCT01362166|male volunteer|male volunteer
5065228|NCT01362166|aged within 20-35 years old|aged within 20-35 years old
5065229|NCT01362153|Golimumab|golimumab
5065230|NCT01362153|Simponi|simponi
5065231|NCT01362153|Rheumatoid Arthritis|rheumatoid arthritis
5065232|NCT01362153|PK|pk
5065233|NCT01362153|PD|pd
5065234|NCT01362140|Randomized|randomized
5065235|NCT01362140|Darbepoetin alfa|darbepoetin alfa
5065236|NCT01362140|Myelodysplastic Syndromes|myelodysplastic syndromes
5065237|NCT01362140|Placebo-controlled|placebo-controlled
5065238|NCT01362140|low risk MDS|low risk mds
5065239|NCT01362140|intermediate-1 risk MDS|intermediate-1 risk mds
5065240|NCT01362140|International Prognostic Scoring System|international prognostic scoring system
5065241|NCT01362127|Histologically confirmed squamos cell carcinoma or adenocarcinoma of the esophagus and gastric cardia.Suitable for surgery.|histologically confirmed squamos cell carcinoma or adenocarcinoma of the esophagus and gastric cardia.suitable for surgery.
5065242|NCT01362114|Hwa-byung|hwa-byung
5065243|NCT01362114|Sihogayonggolmoryeo-tang|sihogayonggolmoryeo-tang
5065244|NCT01362114|Anxiety|anxiety
5065245|NCT01362101|cue reactivity|cue reactivity
5065246|NCT01362101|physiologic activation|physiologic activation
5065247|NCT01362101|craving|craving
5065248|NCT01362101|smoking cues|smoking cues
5065249|NCT01362101|Behavioral therapy|behavioral therapy
5065250|NCT01362088|microcirculation|microcirculation
5065251|NCT01362088|intensive care|intensive care
5065252|NCT01362088|ultrafiltration|ultrafiltration
5065253|NCT01362088|CVVH|cvvh
5065254|NCT01362075|Shoulder Arthroplasty|shoulder arthroplasty
5065255|NCT01362075|Local infiltration analgesia|local infiltration analgesia
5065256|NCT01362049|Stabilization exercise|stabilization exercise
5065257|NCT01362049|Physical therapy|physical therapy
5065258|NCT01362049|Rehabilitation|rehabilitation
5065259|NCT01362049|Movement System Impairment exercise|movement system impairment exercise
5065260|NCT01362010|Acne|acne
5065261|NCT01362010|Acne Vulgaris|acne vulgaris
5065262|NCT01362010|Topical|topical
5065263|NCT01362010|Minocycline|minocycline
5065264|NCT01362010|Foam|foam
5065265|NCT01362010|Phase II|phase ii
5065266|NCT01361997|Antiseptics|antiseptics
5065267|NCT01361997|Hemoculture contamination|hemoculture contamination
5065268|NCT01361997|Anti-infecting agents, local|anti-infecting agents, local
5065269|NCT01361984|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5065270|NCT01361984|COPD|copd
5065271|NCT01361984|Emphysema|emphysema
5065272|NCT01361984|Chronic Bronchitis|chronic bronchitis
5065273|NCT01361984|Brovana|brovana
5065274|NCT01361984|Serevent|serevent
5065275|NCT01361971|Insulin resistance|insulin resistance
5065276|NCT01361971|Inflammation|inflammation
5065277|NCT01361971|Hypoxia|hypoxia
5065278|NCT01361945|ER+|er+
5065279|NCT01361945|HER2+|her2+
5065280|NCT01361945|Breast|breast
5065281|NCT01361919|compressions|compressions
5065282|NCT01361919|quality|quality
5065283|NCT01361919|teaching method|teaching method
5065284|NCT01361919|feedback|feedback
5065285|NCT01361919|CPR performance - how well do students perform CPR when taught with feedback?|cpr performance - how well do students perform cpr when taught with feedback?
5065286|NCT01361919|Cardiopulmonary resuscitation (CPR)|cardiopulmonary resuscitation (cpr)
5065287|NCT01361906|Musculoskeletal and Neural Physiological Phenomena|musculoskeletal and neural physiological phenomena
5065288|NCT01361906|Postural Balance|postural balance
5065289|NCT01361906|Eye/hand coordination|eye/hand coordination
5065290|NCT01361893|SIDS|sids
5065291|NCT01361893|African American|african american
5065292|NCT01361893|Infants|infants
5065293|NCT01361893|Disparity|disparity
5065294|NCT01361880|African American|african american
5065295|NCT01361880|Anticipatory Guidance|anticipatory guidance
5065296|NCT01361880|Health Promotion|health promotion
5065297|NCT01361880|Infant Mortality|infant mortality
5065298|NCT01361880|Injury Prevention|injury prevention
5065299|NCT01361880|Nurses|nurses
5065300|NCT01361880|Parent Education|parent education
5065301|NCT01361880|sudden Infant Death Syndrome|sudden infant death syndrome
5065302|NCT01361867|motor adaptation|motor adaptation
5065303|NCT01361867|lower extremity motor learning|lower extremity motor learning
5065304|NCT01361854|polysomnography|polysomnography
5065305|NCT01361854|portable monitoring|portable monitoring
5065306|NCT01361854|sleep|sleep
5065307|NCT01361854|sleep disordered breathing|sleep disordered breathing
5065308|NCT01361854|home based polysomnography|home based polysomnography
5065309|NCT01361841|Latanoprost|latanoprost
5065310|NCT01361841|bimatoprost|bimatoprost
5065311|NCT01361841|travoprost|travoprost
5065312|NCT01361841|non responders|non responders
5065314|NCT01361828|VEP|vep
5065315|NCT01361828|ERG|erg
5065316|NCT01361828|Optic nerve and retinal functions following intravitreal bevacizumab|optic nerve and retinal functions following intravitreal bevacizumab
5065317|NCT01361815|Depression|depression
5065318|NCT01361815|MDD|mdd
5065319|NCT01361815|SSRIs|ssris
5065320|NCT01361815|TMS|tms
5065321|NCT01361789|Arthroscopic reconstruction|arthroscopic reconstruction
5065322|NCT01361789|Anterior crucial ligament|anterior crucial ligament
5065323|NCT01361789|Coxib|coxib
5065324|NCT01361789|Dexamethasone|dexamethasone
5065325|NCT01361776|immune response|immune response
5065326|NCT01361776|TBE-vaccine|tbe-vaccine
5065327|NCT01361776|elderly|elderly
5065328|NCT01361776|additional doses|additional doses
5065329|NCT01361763|Dabigatran|dabigatran
5065330|NCT01361763|Microbleeds|microbleeds
5065331|NCT01361763|Microthrombi|microthrombi
5065332|NCT01361763|CADASIL|cadasil
5065333|NCT01361763|Small Vessel Disease|small vessel disease
5065334|NCT01361737|Preeclampsia|preeclampsia
5065335|NCT01361737|serological bio-bank|serological bio-bank
5065336|NCT01361737|adiponectin|adiponectin
5065337|NCT01361737|suPAR|supar
5065338|NCT01361724|Parkinson's disease|parkinson's disease
5065340|NCT01361724|Exercise|exercise
5065341|NCT01361724|Balance|balance
5065342|NCT01361724|Mobility|mobility
5065343|NCT01361698|recovery|recovery
5065344|NCT01361698|illness management|illness management
5065345|NCT01361698|rehabilitation|rehabilitation
5065346|NCT01361698|mental illness|mental illness
5065347|NCT01361698|psychosocial intervention|psychosocial intervention
5065348|NCT01361698|Clinical recovery (increase in functioning, decrease in symptoms)|clinical recovery (increase in functioning, decrease in symptoms)
5065349|NCT01361698|Personal recovery (Hope, optimism, living a fulfilling life)|personal recovery (hope, optimism, living a fulfilling life)
5065350|NCT01361659|anginal complaints|anginal complaints
5065351|NCT01361659|Lithotripsy|lithotripsy
5065352|NCT01361659|no option patients|no option patients
5065353|NCT01361633|d-cycloserine|d-cycloserine
5065354|NCT01361633|geriatric|geriatric
5065355|NCT01361633|neuropsychology|neuropsychology
5065356|NCT01361633|cognition|cognition
5065357|NCT01361633|cognitive-enhancer|cognitive-enhancer
5065358|NCT01361633|aging|aging
5065359|NCT01361633|neuropsychological functioning|neuropsychological functioning
5065360|NCT01361620|genomic markers|genomic markers
5065361|NCT01361620|aspirin resistance|aspirin resistance
5065362|NCT01361607|Cancer pain|cancer pain
5065363|NCT01361607|Opioid therapy|opioid therapy
5065364|NCT01361607|Inadequate analgesia|inadequate analgesia
5065365|NCT01361607|Optimized chronic opioid therapy|optimized chronic opioid therapy
5065366|NCT01361594|Diabetes|diabetes
5065367|NCT01361594|Coronary Artery Bypass Surgery|coronary artery bypass surgery
5065368|NCT01361594|Glycemic control|glycemic control
5065369|NCT01361594|Insulin infusion|insulin infusion
5065370|NCT01361581|Acute renal failure|acute renal failure
5065371|NCT01361581|Anticoagulation|anticoagulation
5065372|NCT01361581|Citrate|citrate
5065373|NCT01361581|Haemodiafiltration|haemodiafiltration
5065374|NCT01361581|Haemofiltration|haemofiltration
5065375|NCT01361581|Renal replacement therapy|renal replacement therapy
5065376|NCT01361568|pain|pain
5065377|NCT01361568|acute pain|acute pain
5065378|NCT01361568|visceral pain|visceral pain
5065379|NCT01361568|kappa agonist|kappa agonist
5065380|NCT01361568|opioid analgesics|opioid analgesics
5065381|NCT01361568|peripheral nervous system agents|peripheral nervous system agents
5065382|NCT01361568|physiological effects of drugs|physiological effects of drugs
5065383|NCT01361568|surgery|surgery
5065384|NCT01361568|hysterectomy|hysterectomy
5065385|NCT01361568|post-operative|post-operative
5065386|NCT01361568|post-operative complications|post-operative complications
5065387|NCT01361542|TNF|tnf
5065388|NCT01361542|BMD|bmd
5065389|NCT01361542|Ankylosing spondylitis|ankylosing spondylitis
5065390|NCT01361542|bone health|bone health
5065391|NCT01361542|Anti TNF therapy|anti tnf therapy
5065392|NCT01361542|Disease activity|disease activity
5065393|NCT01361529|dose escalation|dose escalation
5065394|NCT01361516|Urolithiasis|urolithiasis
5065395|NCT01361516|ESWL|eswl
5065396|NCT01361516|Stone Fragmentation efficacy|stone fragmentation efficacy
5065397|NCT01361516|Sedation|sedation
5065398|NCT01361516|General Anaesthesia|general anaesthesia
5065399|NCT01361503|Autism Spectrum Disorders|autism spectrum disorders
5065400|NCT01361503|Pervasive Developmental Disorders|pervasive developmental disorders
5065401|NCT01361503|Asperger's Syndrome|asperger's syndrome
5065402|NCT01361503|Adolescents|adolescents
5065403|NCT01361503|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
5065404|NCT01361503|Diffusion Tensor Imaging|diffusion tensor imaging
5065405|NCT01361477|General surgical ICU|general surgical icu
5065406|NCT01361477|ICU Siamitra|icu siamitra
5065407|NCT01361477|ICU Salad-Samung|icu salad-samung
5065408|NCT01361477|Data registry|data registry
5065409|NCT01361477|ICU refusal|icu refusal
5065410|NCT01361477|ICU complications|icu complications
5065411|NCT01361477|ICU resource utilization|icu resource utilization
5065412|NCT01361477|Adverse events|adverse events
5065413|NCT01361477|ICU readmission|icu readmission
5065984|NCT01359137|Probation|probation
5065414|NCT01361451|parasternal electromyogram|parasternal electromyogram
5065415|NCT01361451|neural respiratory drive|neural respiratory drive
5065416|NCT01361451|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
5065417|NCT01361451|respiratory physiology|respiratory physiology
5065418|NCT01361451|Acute exacerbation|acute exacerbation
5065419|NCT01361425|hypertension|hypertension
5065420|NCT01361425|ultrasonography|ultrasonography
5065421|NCT01361425|preeclampsia|preeclampsia
5065422|NCT01361425|clinical trials|clinical trials
5065423|NCT01361425|treatment|treatment
5065424|NCT01361425|methyldopa|methyldopa
5065425|NCT01361412|ragweed allergy|ragweed allergy
5065426|NCT01361412|immunotherapy|immunotherapy
5065427|NCT01361399|Sore Throat|sore throat
5065428|NCT01361386|Long-term follow up|long-term follow up
5065429|NCT01361386|Antithrombotic management patterns|antithrombotic management patterns
5065430|NCT01361386|Acute Coronary Syndrome|acute coronary syndrome
5065431|NCT01361386|Asia|asia
5065432|NCT01361386|quality of life|quality of life
5065433|NCT01361347|milk allergy|milk allergy
5065434|NCT01361347|desensitization|desensitization
5065435|NCT01361347|anaphylaxis|anaphylaxis
5065436|NCT01361347|school-age|school-age
5065437|NCT01361334|(other than AML M3)|(other than aml m3)
5065438|NCT01361321|follow up|follow up
5065439|NCT01361321|Guided bone regeneration|guided bone regeneration
5065440|NCT01361321|Micro computerized tomography|micro computerized tomography
5065441|NCT01361321|histological examination|histological examination
5065442|NCT01361308|Menopause|menopause
5065443|NCT01361308|Vasomotor Symptoms|vasomotor symptoms
5065444|NCT01361308|Hot Flashes Perimenopause|hot flashes perimenopause
5065445|NCT01361308|Climacteric Symptoms|climacteric symptoms
5065446|NCT01361308|Mesafem|mesafem
5065447|NCT01361308|Low-Dose Mesylate salt of Paroxetine (LDMP)|low-dose mesylate salt of paroxetine (ldmp)
5065448|NCT01361295|Atrial fibrillation|atrial fibrillation
5065449|NCT01361295|cerebral embolism|cerebral embolism
5065450|NCT01361295|catheter ablation|catheter ablation
5065451|NCT01361282|Total Corneal Power|total corneal power
5065452|NCT01361282|Optical Coherence Tomography|optical coherence tomography
5065453|NCT01361282|Descemet Stripping Endothelial Keratoplasty|descemet stripping endothelial keratoplasty
5065454|NCT01361256|Macular Degeneration|macular degeneration
5065455|NCT01361256|Visual Impairment|visual impairment
5065456|NCT01361256|Implantable Telescope|implantable telescope
5065457|NCT01361243|Pediatric Overweight|pediatric overweight
5065458|NCT01361243|Pediatric Obesity|pediatric obesity
5065459|NCT01361217|Fluoxetine|fluoxetine
5065460|NCT01361217|CYP3A4|cyp3a4
5065461|NCT01361217|CYP2D6|cyp2d6
5065462|NCT01361217|CYP2C19|cyp2c19
5065463|NCT01361217|Drug-Drug Interaction|drug-drug interaction
5065464|NCT01361217|Multi-CYP Inhibition|multi-cyp inhibition
5065465|NCT01361204|stress|stress
5065466|NCT01361204|students|students
5065467|NCT01361204|pharmacy practice|pharmacy practice
5065468|NCT01361204|theanine|theanine
5065469|NCT01361204|pharmacy training|pharmacy training
5065470|NCT01361191|DLBCL|dlbcl
5065471|NCT01361191|PET|pet
5065472|NCT01361191|IPI|ipi
5065473|NCT01361191|R-MegaCHOP|r-megachop
5065474|NCT01361191|Autologous stem cell transplantation|autologous stem cell transplantation
5065475|NCT01361165|Pediatric|pediatric
5065476|NCT01361165|Data Analysis|data analysis
5065477|NCT01361152|total knee arthroplasty|total knee arthroplasty
5065478|NCT01361152|fixed-bearing|fixed-bearing
5065479|NCT01361152|mobile-bearing|mobile-bearing
5065480|NCT01361152|long-term|long-term
5065481|NCT01361139|Chronic obstructive lung disease|chronic obstructive lung disease
5065482|NCT01361139|Interstitial lung disease|interstitial lung disease
5065483|NCT01361139|Asthma|asthma
5065484|NCT01361139|Sarcoidosis|sarcoidosis
5065485|NCT01361139|Pulmonary hypertension|pulmonary hypertension
5065486|NCT01361139|Ultrasound|ultrasound
5065487|NCT01361139|Doppler|doppler
5065488|NCT01361139|Lung disease diagnosis|lung disease diagnosis
5065489|NCT01361113|Renal Cell Carcinoma|renal cell carcinoma
5065490|NCT01361113|RCC|rcc
5065491|NCT01361113|Votrient|votrient
5065492|NCT01361113|Pazopanib|pazopanib
5065493|NCT01361113|Nephrectomy|nephrectomy
5065494|NCT01361113|Neoadjuvant|neoadjuvant
5065495|NCT01361113|Phase II|phase ii
5065496|NCT01361113|LCCC 1028|lccc 1028
5065497|NCT01361113|Lineberger Comprehensive Cancer Center|lineberger comprehensive cancer center
5065498|NCT01361100|Otolaryngology|otolaryngology
5065499|NCT01361087|TGF-B blood levels Atenolol vs, Losartan Study, NIH, NIHLB and NMF|tgf-b blood levels atenolol vs, losartan study, nih, nihlb and nmf
5065500|NCT01361074|Virtual reality|virtual reality
5065501|NCT01361074|Augmented reality|augmented reality
5065502|NCT01361074|In vivo exposure|in vivo exposure
5065503|NCT01361074|One session treatment|one session treatment
5065504|NCT01361074|ICT|ict
5065505|NCT01361074|Efficacy|efficacy
5065506|NCT01361074|Specific phobia|specific phobia
5065507|NCT01361074|Anxiety disorders|anxiety disorders
5065508|NCT01361061|liver cirrhosis|liver cirrhosis
5065509|NCT01361061|screening|screening
5065510|NCT01361061|hepatocellular carcinoma|hepatocellular carcinoma
5065511|NCT01361061|liver cancer markers: AFP, AFP-L3% and DCP|liver cancer markers: afp, afp-l3% and dcp
5065512|NCT01361048|trichomonas|trichomonas
5065513|NCT01361035|health literacy|health literacy
5065514|NCT01361035|cancer screening|cancer screening
5065515|NCT01361035|doctor-patient communication|doctor-patient communication
5065516|NCT01361035|standardized patient|standardized patient
5065517|NCT01361035|continuing medical education|continuing medical education
5065518|NCT01360996|PCOS|pcos
5065519|NCT01360970|hepatitis A vaccine|hepatitis a vaccine
5065520|NCT01360970|TNF-alfa inhibitory drugs|tnf-alfa inhibitory drugs
5065521|NCT01360970|Rheumatoid arthritis|rheumatoid arthritis
5065522|NCT01360970|methotrexate|methotrexate
5065523|NCT01360957|Obesity|obesity
5065524|NCT01360944|PPT, topical, psoriasis|ppt, topical, psoriasis
5065525|NCT01360931|Lung cancer|lung cancer
5065526|NCT01360931|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
5065527|NCT01360905|PTL|ptl
5065528|NCT01360905|Multiples|multiples
5065529|NCT01360892|Hepatitis B virus|hepatitis b virus
5065530|NCT01360892|Hepatitis C virus|hepatitis c virus
5065531|NCT01360892|Chronic hepatitis|chronic hepatitis
5065532|NCT01360892|Liver chlorosis|liver chlorosis
5065533|NCT01360892|Liver stiffness|liver stiffness
5065534|NCT01360892|Liver fibrosis|liver fibrosis
5065535|NCT01360879|Hepatitis B virus|hepatitis b virus
5065536|NCT01360879|Hepatitis C virus|hepatitis c virus
5065537|NCT01360879|Chronic hepatitis|chronic hepatitis
5065538|NCT01360879|Liver cirrhosis|liver cirrhosis
5065539|NCT01360879|Liver stiffness|liver stiffness
5065540|NCT01360879|Liver fibrosis|liver fibrosis
5065541|NCT01360866|OPC-34712|opc-34712
5065542|NCT01360866|brexpiprazole|brexpiprazole
5065543|NCT01360866|Major Depressive Disorder|major depressive disorder
5065544|NCT01360866|Adjunctive Treatment|adjunctive treatment
5065545|NCT01360853|pancreatic cancer|pancreatic cancer
5065546|NCT01360853|gemcitabine|gemcitabine
5065547|NCT01360853|ON 01910.Na|on 01910.na
5065548|NCT01360853|rigosertib sodium|rigosertib sodium
5065549|NCT01360840|Asymptomatic|asymptomatic
5065550|NCT01360840|mildly symptomatic|mildly symptomatic
5065551|NCT01360840|metastatic castrate-resistant prostate cancer|metastatic castrate-resistant prostate cancer
5065552|NCT01360840|mCRPC|mcrpc
5065553|NCT01360827|Safety|safety
5065554|NCT01360827|tolerability|tolerability
5065555|NCT01360827|maximum tolerated dose of EMD 1201081|maximum tolerated dose of emd 1201081
5065556|NCT01360827|TLR9 agonists|tlr9 agonists
5065557|NCT01360827|squamous cell carcinoma of the head and neck|squamous cell carcinoma of the head and neck
5065558|NCT01360827|First line subjects|first line subjects
5065559|NCT01360827|recurrent/metastatic|recurrent/metastatic
5065560|NCT01360788|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
5065561|NCT01360788|lung function|lung function
5065562|NCT01360788|symptoms|symptoms
5065563|NCT01360788|activity-related dyspnea|activity-related dyspnea
5065564|NCT01360788|quadriceps muscle function|quadriceps muscle function
5065565|NCT01360788|exercise capacity|exercise capacity
5065566|NCT01360788|physical activity in daily life|physical activity in daily life
5065567|NCT01360788|muscle biopsy|muscle biopsy
5065568|NCT01360788|systemic inflammation|systemic inflammation
5065569|NCT01360788|GOLD stage I|gold stage i
5065570|NCT01360788|pulmonary function|pulmonary function
5065571|NCT01360775|Nutritional status|nutritional status
5065572|NCT01360775|Dependent patients|dependent patients
5065573|NCT01360775|Nutritional educational intervention|nutritional educational intervention
5065574|NCT01360775|Caregivers|caregivers
5065575|NCT01360775|Clinical assay|clinical assay
5065576|NCT01360762|Secondary prophylaxis|secondary prophylaxis
5065577|NCT01360762|Visceral leishmaniasis|visceral leishmaniasis
5065578|NCT01360762|Relapses|relapses
5065579|NCT01360762|HIV co-infection|hiv co-infection
5065580|NCT01360762|Pentamidine|pentamidine
5065581|NCT01360762|Ethiopia|ethiopia
5065582|NCT01360749|Pain management|pain management
5065583|NCT01360749|Lidocaine|lidocaine
5065584|NCT01360736|Suicide Prevention|suicide prevention
5065585|NCT01360736|Suicide Attempt|suicide attempt
5065586|NCT01360736|Suicide Ideation|suicide ideation
5065587|NCT01360736|Randomized Controlled Trial|randomized controlled trial
5065588|NCT01360736|Safety Planning|safety planning
5065589|NCT01360710|male age 18-30 years old|male age 18-30 years old
5065590|NCT01360710|presence of central obesity|presence of central obesity
5065591|NCT01360710|no history of cardiovascular disease, depression|no history of cardiovascular disease, depression
5065592|NCT01360710|not on any medication|not on any medication
5065593|NCT01360697|Diabetes|diabetes
5065594|NCT01360697|Structured care|structured care
5065595|NCT01360671|PPHN|pphn
5065596|NCT01360671|persistent pulmonary hypertension of the newborn|persistent pulmonary hypertension of the newborn
5065597|NCT01360671|sildenafil|sildenafil
5065598|NCT01360671|iv|iv
5065599|NCT01360658|Intravenous immunoglobulins|intravenous immunoglobulins
5065600|NCT01360658|Solar urticaria|solar urticaria
5065601|NCT01360658|Minimal urticaria dose|minimal urticaria dose
5065602|NCT01360658|Quality of life|quality of life
5065603|NCT01360658|Safety|safety
5065604|NCT01360645|OPC-34712|opc-34712
5065605|NCT01360645|brexpiprazole|brexpiprazole
5065606|NCT01360645|Major Depressive Disorder|major depressive disorder
5065607|NCT01360645|Adjunctive Treatment|adjunctive treatment
5065608|NCT01360632|OPC-34712|opc-34712
5065609|NCT01360632|brexpiprazole|brexpiprazole
5065610|NCT01360632|Major Depressive Disorder|major depressive disorder
5065611|NCT01360632|Adjunctive Treatment|adjunctive treatment
5065612|NCT01360619|To demonstrate that multifunction Keito is as effective, as safe and accurate as the predicate K014009 on its body fat measurement.|to demonstrate that multifunction keito is as effective, as safe and accurate as the predicate k014009 on its body fat measurement.
5065613|NCT01360606|Liver|liver
5065614|NCT01360606|Mets|mets
5065615|NCT01360593|Pancreas|pancreas
5065616|NCT01360567|green tea|green tea
5065617|NCT01360567|EGCG|egcg
5065618|NCT01360567|type 2 diabetes|type 2 diabetes
5065619|NCT01360567|hyperlipidemia|hyperlipidemia
5065620|NCT01360554|comparative study of PF-00299804 and Erlotinib|comparative study of pf-00299804 and erlotinib
5065621|NCT01360554|Double-Blind Phase 3 trial of TKI|double-blind phase 3 trial of tki
5065622|NCT01360541|Barrett oesophagus|barrett oesophagus
5065623|NCT01360541|Low grade dysplasia|low grade dysplasia
5065624|NCT01360541|Radiofrequency ablation|radiofrequency ablation
5065625|NCT01360528|Folic acid replacement|folic acid replacement
5065626|NCT01360528|Folic acid|folic acid
5065627|NCT01360528|Preterm neonate|preterm neonate
5065628|NCT01360515|esophagoscope|esophagoscope
5065629|NCT01360515|esophageal disease|esophageal disease
5065630|NCT01360515|gastroesophageal reflux|gastroesophageal reflux
5065631|NCT01360515|esophageal varices|esophageal varices
5065632|NCT01360502|capsule endoscopy|capsule endoscopy
5065633|NCT01360502|cardiac pacemaker|cardiac pacemaker
5065634|NCT01360502|implantable cardiac defibrillator|implantable cardiac defibrillator
5065635|NCT01360476|hypertension|hypertension
5065636|NCT01360476|left ventricular hypertrophy|left ventricular hypertrophy
5065637|NCT01360476|Vitamin D|vitamin d
5065638|NCT01360476|African-Americans|african-americans
5065639|NCT01360463|drug abuse counseling|drug abuse counseling
5065640|NCT01360463|HIV risk reduction counseling|hiv risk reduction counseling
5065641|NCT01360463|HIV infection|hiv infection
5065642|NCT01360463|injection drug users|injection drug users
5065643|NCT01360463|AIDS|aids
5065644|NCT01360450|opioid withdrawal|opioid withdrawal
5065645|NCT01360450|Neonatal Pain, Agitation, and Sedation Scale (NPASS)|neonatal pain, agitation, and sedation scale (npass)
5065646|NCT01360450|duraclon|duraclon
5065647|NCT01360437|coronary angioplasty|coronary angioplasty
5065648|NCT01360437|clopidogrel hyporesponsiveness|clopidogrel hyporesponsiveness
5065649|NCT01360437|prasugrel|prasugrel
5065650|NCT01360437|ticagrelor|ticagrelor
5065651|NCT01360437|CAD|cad
5065652|NCT01360437|ACS|acs
5065653|NCT01360424|osteoporosis|osteoporosis
5065654|NCT01360424|teriparatide|teriparatide
5065655|NCT01360424|bone turnover|bone turnover
5065656|NCT01360424|New forms of inherited low-turnover osteoporosis|new forms of inherited low-turnover osteoporosis
5065657|NCT01360411|elastography|elastography
5065658|NCT01360411|strain ratio|strain ratio
5065659|NCT01360411|pancreas|pancreas
5065660|NCT01360411|GI wall lesions|gi wall lesions
5065661|NCT01360411|lymph nodes|lymph nodes
5065662|NCT01360398|pathogen|pathogen
5065663|NCT01360398|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5065664|NCT01360398|Acute Exacerbations of Chronic Obstructive Pulmonary Disease|acute exacerbations of chronic obstructive pulmonary disease
5065665|NCT01360398|COPD|copd
5065666|NCT01360398|respiratory|respiratory
5065667|NCT01360398|AECOPD|aecopd
5065668|NCT01360398|exacerbation|exacerbation
5065669|NCT01360385|Central retinal rein occlusion|central retinal rein occlusion
5065670|NCT01360385|Retinal oximetry|retinal oximetry
5065671|NCT01360385|Oxymap Retinal Oximeter|oxymap retinal oximeter
5065672|NCT01360385|Visual acuity|visual acuity
5065673|NCT01360385|Central retinal thickness|central retinal thickness
5065674|NCT01360372|Hydrogen breath test value and gastric residual volume measurements|hydrogen breath test value and gastric residual volume measurements
5065675|NCT01360372|Tube feeding tolerance while taking a stable dose of opiate|tube feeding tolerance while taking a stable dose of opiate
5065676|NCT01360359|low back pain|low back pain
5065677|NCT01360359|core stabilization|core stabilization
5065678|NCT01360359|trunk muscle exercises|trunk muscle exercises
5065679|NCT01360359|physical therapy|physical therapy
5065680|NCT01360359|RCT|rct
5065681|NCT01360346|Enteral Sedation|enteral sedation
5065682|NCT01360346|Intravenous Sedation|intravenous sedation
5065683|NCT01360346|Critically ill ICU patient|critically ill icu patient
5065684|NCT01360346|Conscious Sedation|conscious sedation
5065685|NCT01360346|Deep Sedation|deep sedation
5065686|NCT01360346|RASS|rass
5065687|NCT01360346|CAM-ICU|cam-icu
5065688|NCT01360346|VNR|vnr
5065689|NCT01360346|BPS|bps
5065690|NCT01360346|Propofol|propofol
5065691|NCT01360346|Midazolam|midazolam
5065692|NCT01360346|Hydroxyzine|hydroxyzine
5065693|NCT01360346|Lorazepam|lorazepam
5065694|NCT01360346|Melatonin|melatonin
5065695|NCT01360333|Dehydration|dehydration
5065696|NCT01360333|Hydration|hydration
5065697|NCT01360320|Green tea|green tea
5065698|NCT01360320|polyphenol|polyphenol
5065699|NCT01360320|catechin|catechin
5065701|NCT01360320|Epigallocatechin gallate|epigallocatechin gallate
5065702|NCT01360320|colorectal adenoma|colorectal adenoma
5065703|NCT01360320|adenoma prevention|adenoma prevention
5065704|NCT01360320|colon cancer prevention|colon cancer prevention
5065705|NCT01360307|psychometric validation|psychometric validation
5065706|NCT01360307|major depressive disorder|major depressive disorder
5065707|NCT01360307|patient-reported outcome|patient-reported outcome
5065708|NCT01360294|Asthma|asthma
5065709|NCT01360294|Small airways disease|small airways disease
5065710|NCT01360294|Questionnaire|questionnaire
5065711|NCT01360281|Quadriceps strength|quadriceps strength
5065712|NCT01360281|osteoarthritis rehabilitation|osteoarthritis rehabilitation
5065713|NCT01360281|NMES|nmes
5065714|NCT01360255|Hepatocellular Carcinoma|hepatocellular carcinoma
5065715|NCT01360255|transarterial chemoembolisation|transarterial chemoembolisation
5065716|NCT01360255|liver cancer markers: AFP, AFP-L3% and DCP|liver cancer markers: afp, afp-l3% and dcp
5065717|NCT01360242|Acute STEMI|acute stemi
5065718|NCT01360242|Thrombus aspiration|thrombus aspiration
5065719|NCT01360242|Angioplasty|angioplasty
5065720|NCT01360242|Primary Percutaneous Coronary Intervention|primary percutaneous coronary intervention
5065721|NCT01360229|Parkinsons Disease|parkinsons disease
5065722|NCT01360229|Fatigue|fatigue
5065723|NCT01360216|Long-acting reversible contraception|long-acting reversible contraception
5065724|NCT01360216|Intrauterine contraception|intrauterine contraception
5065725|NCT01360216|Intrauterine devices|intrauterine devices
5065726|NCT01360216|Single-rod implant|single-rod implant
5065727|NCT01360216|Hormonal contraception|hormonal contraception
5065728|NCT01360190|MDD|mdd
5065729|NCT01360190|major depressive disorder|major depressive disorder
5065730|NCT01360190|QEEG|qeeg
5065731|NCT01360190|electroencephalograph|electroencephalograph
5065732|NCT01360190|fluoxtine|fluoxtine
5065733|NCT01360190|placebo|placebo
5065734|NCT01360164|Human Umbilical Cord Mesenchymal Stem Cells|human umbilical cord mesenchymal stem cells
5065735|NCT01360151|VEGF (Vascular endothelial growth factor)|vegf (vascular endothelial growth factor)
5065736|NCT01360125|adult acute basophilic leukemia|adult acute basophilic leukemia
5065737|NCT01360125|adult acute eosinophilic leukemia|adult acute eosinophilic leukemia
5065738|NCT01360125|adult acute erythroid leukemia (M6)|adult acute erythroid leukemia (m6)
5065739|NCT01360125|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
5065740|NCT01360125|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
5065741|NCT01360125|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
5065742|NCT01360125|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
5065743|NCT01360125|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
5065744|NCT01360125|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
5065745|NCT01360125|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5065746|NCT01360125|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5065747|NCT01360125|adult acute myeloid leukemia with del(5q)|adult acute myeloid leukemia with del(5q)
5065748|NCT01360125|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5065749|NCT01360125|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5065750|NCT01360125|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5065751|NCT01360125|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
5065752|NCT01360112|Mosquito|mosquito
5065753|NCT01360112|Membrane|membrane
5065754|NCT01360112|Feeding|feeding
5065755|NCT01360112|Parasites|parasites
5065756|NCT01360112|Infection|infection
5065757|NCT01360112|Malaria|malaria
5065758|NCT01360099|Atypical Hip Fracture|atypical hip fracture
5065759|NCT01360099|Biosphosphonates|biosphosphonates
5065760|NCT01360099|Subtrochanteric Hip Fracture|subtrochanteric hip fracture
5065761|NCT01360099|Osteoporosis|osteoporosis
5065762|NCT01360086|adenocarcinoma of the gastroesophageal junction|adenocarcinoma of the gastroesophageal junction
5065763|NCT01360086|adenocarcinoma of the stomach|adenocarcinoma of the stomach
5065764|NCT01360086|stage IB gastric cancer|stage ib gastric cancer
5065765|NCT01360086|stage IIA gastric cancer|stage iia gastric cancer
5065766|NCT01360086|stage IIB gastric cancer|stage iib gastric cancer
5065767|NCT01360086|stage IIIA gastric cancer|stage iiia gastric cancer
5065768|NCT01360086|stage IIIB gastric cancer|stage iiib gastric cancer
5065769|NCT01360086|stage IIIC gastric cancer|stage iiic gastric cancer
5065770|NCT01360073|MI|mi
5065771|NCT01360073|low dose aspirin|low dose aspirin
5065772|NCT01360073|PPI|ppi
5065773|NCT01360073|epidemiology|epidemiology
5065774|NCT01360073|Nonfatal MI and coronary death|nonfatal mi and coronary death
5065775|NCT01360047|MI|mi
5065776|NCT01360047|low dose aspirin|low dose aspirin
5065777|NCT01360047|PPI|ppi
5065778|NCT01360047|epidemiology|epidemiology
5065779|NCT01360034|Obstetric labor, premature|obstetric labor, premature
5065780|NCT01360034|Short cervix|short cervix
5065781|NCT01360034|Nifedipine|nifedipine
5065782|NCT01360034|Indomethacin|indomethacin
5065783|NCT01360008|Cardiac arrhythmia|cardiac arrhythmia
5065784|NCT01360008|Catheter ablation|catheter ablation
5065785|NCT01360008|Cohort Study|cohort study
5065786|NCT01360008|cryoballoon|cryoballoon
5065787|NCT01360008|radiofrequency|radiofrequency
5065788|NCT01359995|cytomegalovirus endotheliitis|cytomegalovirus endotheliitis
5065789|NCT01359982|Advanced Solid Tumors|advanced solid tumors
5065790|NCT01359982|Lymphomas|lymphomas
5065791|NCT01359982|Safety|safety
5065792|NCT01359982|Blood flow|blood flow
5065793|NCT01359982|Nitric oxide|nitric oxide
5065794|NCT01359982|Cancer|cancer
5065795|NCT01359982|Dynamic contrast enhanced MRI (DCE-MRI)|dynamic contrast enhanced mri (dce-mri)
5065796|NCT01359982|Contrast Enhanced Ultrasound (CEUS)|contrast enhanced ultrasound (ceus)
5065797|NCT01359969|Hereditary Angioedema|hereditary angioedema
5065798|NCT01359969|HAE|hae
5065799|NCT01359969|Angioedema|angioedema
5065800|NCT01359969|Recombinant C1 Inhibitor|recombinant c1 inhibitor
5065801|NCT01359969|rhC1INH|rhc1inh
5065802|NCT01359969|Pediatrics|pediatrics
5065803|NCT01359943|Rheumatoid Arthritis|rheumatoid arthritis
5065804|NCT01359943|RA|ra
5065805|NCT01359943|secukinumab|secukinumab
5065806|NCT01359943|AIN457|ain457
5065807|NCT01359943|inflammatory joints|inflammatory joints
5065808|NCT01359943|American College of Rheumatology|american college of rheumatology
5065809|NCT01359943|ACR|acr
5065810|NCT01359904|dialysate glucose|dialysate glucose
5065811|NCT01359904|glycemic control|glycemic control
5065812|NCT01359904|hypoglycemic episodes|hypoglycemic episodes
5065813|NCT01359878|Postpartum haemorrhage|postpartum haemorrhage
5065814|NCT01359878|Postpartum bleeding|postpartum bleeding
5065815|NCT01359878|Postnatal bleeding|postnatal bleeding
5065816|NCT01359878|Fibrinogen concentrate|fibrinogen concentrate
5065817|NCT01359878|Transfusion|transfusion
5065818|NCT01359878|Haemostatis|haemostatis
5065819|NCT01359878|Thrombelastography|thrombelastography
5065820|NCT01359865|Total hip arthroplasty|total hip arthroplasty
5065821|NCT01359865|lumbar plexus block|lumbar plexus block
5065822|NCT01359865|spinal anesthesia|spinal anesthesia
5065823|NCT01359865|range of motion|range of motion
5065824|NCT01359865|Anesthetic Technique|anesthetic technique
5065825|NCT01359865|Post-operative Pain Scores|post-operative pain scores
5065826|NCT01359852|JNJ-42491293|jnj-42491293
5065827|NCT01359852|JNJ-40411813|jnj-40411813
5065828|NCT01359852|Metabotropic glutamate subtype 2 receptor (mGlu2R)|metabotropic glutamate subtype 2 receptor (mglu2r)
5065829|NCT01359852|Positive allosteric modulator (PAM)|positive allosteric modulator (pam)
5065830|NCT01359852|positron emission tomography (PET)|positron emission tomography (pet)
5065831|NCT01359826|Systemic Lupus Erythematosus|systemic lupus erythematosus
5065832|NCT01359826|Widespread Pain|widespread pain
5065833|NCT01359826|Fibromyalgia|fibromyalgia
5065834|NCT01359826|Fatigue|fatigue
5065835|NCT01359826|Pain|pain
5065836|NCT01359826|Quality of Life|quality of life
5065837|NCT01359800|HIV|hiv
5065838|NCT01359800|HAART|haart
5065839|NCT01359774|Energy|energy
5065840|NCT01359774|Metabolism|metabolism
5065841|NCT01359774|Spectroscopy|spectroscopy
5065842|NCT01359761|Suicide|suicide
5065843|NCT01359761|Cognitive Therapy|cognitive therapy
5065844|NCT01359761|Inpatient|inpatient
5065845|NCT01359761|Military|military
5065846|NCT01359748|Non Invasive Blood Pressure measurement study.|non invasive blood pressure measurement study.
5065847|NCT01359735|Wound|wound
5065848|NCT01359735|non-melanoma skin cancer|non-melanoma skin cancer
5065849|NCT01359735|Mohs micrographic surgery|mohs micrographic surgery
5065850|NCT01359735|Head or neck|head or neck
5065851|NCT01359722|N-acetylcysteine|n-acetylcysteine
5065852|NCT01359722|Myocardial Revascularization|myocardial revascularization
5065853|NCT01359722|Acute Renal Failure|acute renal failure
5065854|NCT01359722|Oxidative Stress|oxidative stress
5065855|NCT01359696|solid cancers|solid cancers
5065856|NCT01359670|Duchenne|duchenne
5065857|NCT01359670|muscular dystrophy|muscular dystrophy
5065858|NCT01359670|tadalafil|tadalafil
5065859|NCT01359670|sildenafil|sildenafil
5065860|NCT01359670|muscle ischemia|muscle ischemia
5065861|NCT01359670|exercise|exercise
5065862|NCT01359657|Relapsed|relapsed
5065863|NCT01359657|Refractory|refractory
5065864|NCT01359631|Chronic Cluster Headache|chronic cluster headache
5065865|NCT01359618|Phase I|phase i
5065866|NCT01359618|Safety|safety
5065867|NCT01359618|tolerability|tolerability
5065868|NCT01359618|healthy|healthy
5065869|NCT01359618|major depressive disorder|major depressive disorder
5065870|NCT01359618|thorough QT|thorough qt
5065871|NCT01359618|maximum tolerated dose|maximum tolerated dose
5065872|NCT01359618|elimination|elimination
5065873|NCT01359618|heart electrical signal|heart electrical signal
5065874|NCT01359605|ADME|adme
5065875|NCT01359605|Healthy volunteers|healthy volunteers
5065876|NCT01359592|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
5065877|NCT01359592|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
5065878|NCT01359592|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5065879|NCT01359592|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5065880|NCT01359592|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5065881|NCT01359579|renal impairment|renal impairment
5065882|NCT01359579|phase 1|phase 1
5065883|NCT01359579|healthy volunteers|healthy volunteers
5065884|NCT01359540|Total Hip Arthroplasty|total hip arthroplasty
5065885|NCT01359540|Bone Loss|bone loss
5065886|NCT01359540|Femoral Remodeling|femoral remodeling
5065887|NCT01359540|Bone mineral density|bone mineral density
5065888|NCT01359540|THA|tha
5065889|NCT01359540|DXA|dxa
5065890|NCT01359540|DEXA|dexa
5065891|NCT01359540|Dual Energy X-Ray Absorptiometry|dual energy x-ray absorptiometry
5065892|NCT01359527|Total Hip Replacement|total hip replacement
5065893|NCT01359527|Hip Resurfacing|hip resurfacing
5065894|NCT01359527|Femoral Remodeling|femoral remodeling
5065895|NCT01359527|Bone Loss|bone loss
5065896|NCT01359527|Bone Mineral Density|bone mineral density
5065897|NCT01359527|BMD|bmd
5065898|NCT01359527|DXA|dxa
5065899|NCT01359527|DEXA|dexa
5065900|NCT01359527|THA|tha
5065901|NCT01359501|patients receiving chemotherapy|patients receiving chemotherapy
5065902|NCT01359488|Growth Hormone Deficiency|growth hormone deficiency
5065903|NCT01359488|rhGH|rhgh
5065904|NCT01359488|hGH|hgh
5065905|NCT01359488|Versartis|versartis
5065906|NCT01359488|AGHD|aghd
5065907|NCT01359488|Hormones|hormones
5065908|NCT01359488|Hormone substitute|hormone substitute
5065909|NCT01359488|Endocrin System disease|endocrin system disease
5065910|NCT01359488|Bone disease|bone disease
5065911|NCT01359488|Bone disease, developmental|bone disease, developmental
5065912|NCT01359488|Bone diseases|bone diseases
5065913|NCT01359488|Musculoskeletal diseases|musculoskeletal diseases
5065914|NCT01359488|Bone diseases, endocrine|bone diseases, endocrine
5065915|NCT01359488|Metabolism diseases|metabolism diseases
5065916|NCT01359488|Hypopituitarism|hypopituitarism
5065917|NCT01359488|Pituitary disease|pituitary disease
5065918|NCT01359488|Hypothalmic disease|hypothalmic disease
5065919|NCT01359488|Brain disease|brain disease
5065920|NCT01359488|Growth Hormone Releasing Hormone|growth hormone releasing hormone
5065921|NCT01359488|Hormone replacement therapy|hormone replacement therapy
5065922|NCT01359488|IGF-I|igf-i
5065923|NCT01359488|IGFBP-3|igfbp-3
5065924|NCT01359475|Acetal crowns|acetal crowns
5065925|NCT01359475|Primary molars|primary molars
5065926|NCT01359475|The retention of acetal crowns in primary dentition|the retention of acetal crowns in primary dentition
5065927|NCT01359475|Color changes of acetal crowns|color changes of acetal crowns
5065928|NCT01359462|hepatic cirrhosis patients with ascites|hepatic cirrhosis patients with ascites
5065929|NCT01359449|Meningitis|meningitis
5065930|NCT01359449|Meningococcal Infection|meningococcal infection
5065931|NCT01359449|Menactra®|menactra®
5065932|NCT01359449|MenC|menc
5065933|NCT01359410|Pancreas adenocarcinoma|pancreas adenocarcinoma
5065934|NCT01359410|Precancerous lesions of the pancreas (mucinous cystic neoplasms, IPMN)|precancerous lesions of the pancreas (mucinous cystic neoplasms, ipmn)
5065935|NCT01359410|Pancreas neuroendocrine cancer|pancreas neuroendocrine cancer
5065936|NCT01359397|Adenoca. stomach/gastr. Junct.|adenoca. stomach/gastr. junct.
5065937|NCT01359384|severe primary immune deficieny|severe primary immune deficieny
5065938|NCT01359371|Smoking Cessation|smoking cessation
5065939|NCT01359371|Telephone|telephone
5065940|NCT01359371|Hospital Volunteers|hospital volunteers
5065941|NCT01359358|MRSA|mrsa
5065942|NCT01359358|MLST|mlst
5065943|NCT01359358|PFGE|pfge
5065944|NCT01359358|Resistance|resistance
5065945|NCT01359358|isolated from colonization|isolated from colonization
5065946|NCT01359345|NSF|nsf
5065947|NCT01359345|ESRD|esrd
5065948|NCT01359345|MRA|mra
5065949|NCT01359345|MRI|mri
5065950|NCT01359345|occurrence of NSF|occurrence of nsf
5065951|NCT01359345|Use of Gadollinum|use of gadollinum
5065952|NCT01359332|Convulsive status EPILEPTICUS|convulsive status epilepticus
5065953|NCT01359332|hypothermia therapy|hypothermia therapy
5065954|NCT01359332|(defined as continuous SEIZURING for longer than 5 min or three seizures|(defined as continuous seizuring for longer than 5 min or three seizures
5065955|NCT01359332|not separated by recovery of normal consciousness|not separated by recovery of normal consciousness
5065956|NCT01359332|or of the level of consciousness present before the|or of the level of consciousness present before the
5065957|NCT01359332|seizures)|seizures)
5065958|NCT01359319|Phase 1 Safety and Pharmacokinetic Study|phase 1 safety and pharmacokinetic study
5065959|NCT01359306|Acute myocardial infarction|acute myocardial infarction
5065960|NCT01359306|Right ventricular infarction|right ventricular infarction
5065961|NCT01359306|Cardiovascular Magnetic Resonance|cardiovascular magnetic resonance
5065962|NCT01359306|Prognosis|prognosis
5065963|NCT01359280|HIV|hiv
5065964|NCT01359280|AIDS|aids
5065965|NCT01359280|Medication|medication
5065966|NCT01359280|Adherence|adherence
5065967|NCT01359241|dysglycemia|dysglycemia
5065968|NCT01359241|diabetes|diabetes
5065969|NCT01359241|closed loop insulin delivery|closed loop insulin delivery
5065970|NCT01359228|Rosacea|rosacea
5065971|NCT01359202|Stroke|stroke
5065972|NCT01359202|ICH|ich
5065973|NCT01359202|Intracerebral hemorrhage|intracerebral hemorrhage
5065974|NCT01359202|acute stroke|acute stroke
5065975|NCT01359202|rfVIIa|rfviia
5065976|NCT01359202|Niastase|niastase
5065977|NCT01359189|Suspected Primary Prostate Cancer|suspected primary prostate cancer
5065978|NCT01359163|bioequivalence study|bioequivalence study
5065979|NCT01359163|marketed vs reformulation tablets|marketed vs reformulation tablets
5065980|NCT01359163|Femulen|femulen
5065981|NCT01359137|Behavior|behavior
5065982|NCT01359137|Drug users|drug users
5065983|NCT01359137|Criminal Justice|criminal justice
5065985|NCT01359124|Osteoarthritis, Knee|osteoarthritis, knee
5065986|NCT01359124|Exercise Therapies|exercise therapies
5065987|NCT01359111|Intradermal injections|intradermal injections
5065988|NCT01359111|Vaccination|vaccination
5065989|NCT01359098|swimmer's ear|swimmer's ear
5065990|NCT01359098|ear drops|ear drops
5065991|NCT01359098|ear foam|ear foam
5065992|NCT01359098|otic foam|otic foam
5065993|NCT01359098|ear infection|ear infection
5065994|NCT01359098|ear pain|ear pain
5065995|NCT01359098|ear inflammation|ear inflammation
5065996|NCT01359085|To compare postoperative pain relief by pregabalin versus ISBPB following arthroscopic rotator cuff repair|to compare postoperative pain relief by pregabalin versus isbpb following arthroscopic rotator cuff repair
5065997|NCT01359085|To compare postoperative opioid consumption and opioid related AEs|to compare postoperative opioid consumption and opioid related aes
5065998|NCT01359085|To compare patients recovery profile and patients satisfaction|to compare patients recovery profile and patients satisfaction
5065999|NCT01359072|coping|coping
5066000|NCT01359072|psychological distress|psychological distress
5066001|NCT01359072|self-administered intervention|self-administered intervention
5066002|NCT01359059|assess the beneficial effects of PGL administered either pre or post surgery|assess the beneficial effects of pgl administered either pre or post surgery
5066003|NCT01359059|assess the satisfaction rate in the orthopedic oncologic patients|assess the satisfaction rate in the orthopedic oncologic patients
5066004|NCT01359046|CAUTI|cauti
5066005|NCT01359046|UTI|uti
5066006|NCT01359033|Myocardial Infarction|myocardial infarction
5066007|NCT01359033|UK|uk
5066008|NCT01359033|Sweden|sweden
5066009|NCT01359033|National audit registry|national audit registry
5066010|NCT01359033|MINAP|minap
5066011|NCT01359033|RIKS-HIA|riks-hia
5066012|NCT01359020|Fever|fever
5066013|NCT01359020|Ibuprofen|ibuprofen
5066014|NCT01359020|Acetaminophen|acetaminophen
5066015|NCT01359020|Dipyrone|dipyrone
5066016|NCT01359007|Locally advanced unresectable adenocarcinoma of pancreas|locally advanced unresectable adenocarcinoma of pancreas
5066017|NCT01359007|Borderline resectable adenocarcinoma of pancreas|borderline resectable adenocarcinoma of pancreas
5066018|NCT01358994|metformin|metformin
5066019|NCT01358994|type 2 diabetes|type 2 diabetes
5066020|NCT01358994|e-GFR|e-gfr
5066021|NCT01358994|creatinine|creatinine
5066022|NCT01358994|lactic acidosis|lactic acidosis
5066023|NCT01358955|mild cognitive impairment|mild cognitive impairment
5066024|NCT01358955|cognitive therapy|cognitive therapy
5066025|NCT01358955|prevention|prevention
5066026|NCT01358916|antimicrobial resistance|antimicrobial resistance
5066027|NCT01358916|antibiotic prescription|antibiotic prescription
5066028|NCT01358916|primary health care|primary health care
5066029|NCT01358916|cluster-randomized trial|cluster-randomized trial
5066030|NCT01358890|over weight|over weight
5066031|NCT01358890|obesity|obesity
5066032|NCT01358838|Patients with either hypertrophic or atrophic scars|patients with either hypertrophic or atrophic scars
5066033|NCT01358838|Efficacy of ablative 10600nm fractional laser therapy|efficacy of ablative 10600nm fractional laser therapy
5066034|NCT01358838|Laser therapy compared to no treatment of (part of) the scar|laser therapy compared to no treatment of (part of) the scar
5066035|NCT01358825|Infanrix-IPV/Hib|infanrix-ipv/hib
5066036|NCT01358825|Long-term follow up|long-term follow up
5066037|NCT01358825|Persistence|persistence
5066038|NCT01358825|Infanrix hexa|infanrix hexa
5066039|NCT01358812|RAS Wild-Type|ras wild-type
5066040|NCT01358812|BRAF Wild-Type|braf wild-type
5066041|NCT01358799|Chlamydia trachomatis|chlamydia trachomatis
5066042|NCT01358799|APTIMA Assay for Chlamydia trachomatis|aptima assay for chlamydia trachomatis
5066043|NCT01358786|Quilting suture|quilting suture
5066044|NCT01358786|seroma|seroma
5066045|NCT01358786|Procedure|procedure
5066046|NCT01358786|Surgery|surgery
5066047|NCT01358773|Obesity|obesity
5066048|NCT01358773|Therapy|therapy
5066049|NCT01358773|Interdisciplinary|interdisciplinary
5066050|NCT01358760|Vulvar/vaginal atrophy|vulvar/vaginal atrophy
5066051|NCT01358760|Atrophic Vaginitis|atrophic vaginitis
5066052|NCT01358760|Dehydroepiandrosterone|dehydroepiandrosterone
5066053|NCT01358760|DHEA|dhea
5066054|NCT01358760|Prasterone|prasterone
5066055|NCT01358760|Vaginorm|vaginorm
5066056|NCT01358760|Menopause|menopause
5066057|NCT01358760|Intrarosa|intrarosa
5066058|NCT01358734|AML|aml
5066059|NCT01358734|elderly|elderly
5066060|NCT01358734|acute myelogenous leukemia|acute myelogenous leukemia
5066061|NCT01358734|vidaza|vidaza
5066062|NCT01358734|azacitidine|azacitidine
5066063|NCT01358734|elderly AML|elderly aml
5066064|NCT01358734|revlimid|revlimid
5066065|NCT01358734|lenalidomide|lenalidomide
5066066|NCT01358695|Lateral Canthal Lines|lateral canthal lines
5066067|NCT01358695|Crow's Feet|crow's feet
5066068|NCT01358669|Denosumab|denosumab
5066069|NCT01358669|Total Hip Arthroplasty|total hip arthroplasty
5066070|NCT01358643|OEF/OIF|oef/oif
5066071|NCT01358643|Physical Activity|physical activity
5066072|NCT01358643|Preferences|preferences
5066073|NCT01358630|Periodontitis|periodontitis
5066074|NCT01358630|Vascular disease|vascular disease
5066075|NCT01358630|Proinflammatory cytokines|proinflammatory cytokines
5066076|NCT01358604|localized resectable neuroblastoma|localized resectable neuroblastoma
5066077|NCT01358604|recurrent neuroblastoma|recurrent neuroblastoma
5066584|NCT01356277|allograft|allograft
5066078|NCT01358604|regional neuroblastoma|regional neuroblastoma
5066079|NCT01358604|stage 4S neuroblastoma|stage 4s neuroblastoma
5066080|NCT01358604|localized unresectable neuroblastoma|localized unresectable neuroblastoma
5066081|NCT01358578|Psoriasis,|psoriasis,
5066082|NCT01358578|inflammatory skin disease,|inflammatory skin disease,
5066083|NCT01358578|scaly patches|scaly patches
5066084|NCT01358578|Psoriasis|psoriasis
5066085|NCT01358578|inflammatory skin disease|inflammatory skin disease
5066086|NCT01358552|Neevo|neevo
5066087|NCT01358552|Neevo DHA|neevo dha
5066088|NCT01358552|L-methylfolate|l-methylfolate
5066089|NCT01358552|anemia during pregnancy|anemia during pregnancy
5066090|NCT01358552|folic acid|folic acid
5066091|NCT01358552|vitamin B12|vitamin b12
5066092|NCT01358552|prenatal vitamins|prenatal vitamins
5066093|NCT01358552|hemoglobin|hemoglobin
5066094|NCT01358552|iron deficiency|iron deficiency
5066095|NCT01358552|Pregnancy|pregnancy
5066096|NCT01358539|palliation|palliation
5066097|NCT01358539|pain education|pain education
5066098|NCT01358526|Low back pain|low back pain
5066099|NCT01358526|Chronic pain|chronic pain
5066100|NCT01358526|Opioid|opioid
5066101|NCT01358526|Moderate to severe chronic low back pain|moderate to severe chronic low back pain
5066102|NCT01358513|Positron Emission Tomography|positron emission tomography
5066103|NCT01358513|Inflammation|inflammation
5066104|NCT01358513|Calcification|calcification
5066105|NCT01358500|opioid dependence|opioid dependence
5066106|NCT01358500|tolerant|tolerant
5066107|NCT01358500|dependent|dependent
5066108|NCT01358487|Major depression|major depression
5066109|NCT01358487|Cognitive Behavioral preventive intervention|cognitive behavioral preventive intervention
5066110|NCT01358487|Mood Management|mood management
5066111|NCT01358487|Self-help|self-help
5066112|NCT01358487|Internet|internet
5066113|NCT01358474|Parkinson disease|parkinson disease
5066114|NCT01358474|idiopathic rapid eye movement sleep disorder|idiopathic rapid eye movement sleep disorder
5066115|NCT01358474|Gaucher disease|gaucher disease
5066116|NCT01358474|healthy volunteer|healthy volunteer
5066117|NCT01358448|Treatment of childhood obesity|treatment of childhood obesity
5066118|NCT01358422|Prospective observational study|prospective observational study
5066119|NCT01358422|major adverse cardiac events (MACE)|major adverse cardiac events (mace)
5066120|NCT01358422|clinically significant bleeding events|clinically significant bleeding events
5066121|NCT01358422|Dual anti-platelet therapy|dual anti-platelet therapy
5066122|NCT01358422|aspirin alone therapy|aspirin alone therapy
5066123|NCT01358422|non-cardiac surgery|non-cardiac surgery
5066124|NCT01358422|percutaneous coronary intervention (PCI)|percutaneous coronary intervention (pci)
5066125|NCT01358422|placement of a bare metal or drug eluting stent|placement of a bare metal or drug eluting stent
5066126|NCT01358422|OBTAIN|obtain
5066127|NCT01358422|Simon Howell|simon howell
5066128|NCT01358422|ESA|esa
5066129|NCT01358422|European Society of Anaesthesiology|european society of anaesthesiology
5066130|NCT01358409|steatosis|steatosis
5066131|NCT01358409|MR spectroscopy|mr spectroscopy
5066132|NCT01358409|Nebivolol|nebivolol
5066133|NCT01358409|cardiac MRI|cardiac mri
5066134|NCT01358396|Diabetic Macular Edema, Glycemic Control|diabetic macular edema, glycemic control
5066135|NCT01358383|Juvenile Idiopathic Arthritis|juvenile idiopathic arthritis
5066136|NCT01358383|Pharmacokinetics|pharmacokinetics
5066137|NCT01358383|VIMOVO|vimovo
5066138|NCT01358383|fasting state|fasting state
5066139|NCT01358383|Amount of VIMOVO in the blood|amount of vimovo in the blood
5066140|NCT01358383|taken on empty stomach|taken on empty stomach
5066141|NCT01358370|LAL Deficiency|lal deficiency
5066142|NCT01358370|LIPA|lipa
5066143|NCT01358370|Wolman disease|wolman disease
5066144|NCT01358370|Wolman Phenotype|wolman phenotype
5066145|NCT01358370|Early Onset LAL Deficiency|early onset lal deficiency
5066146|NCT01358370|Acid Lipase Deficiency|acid lipase deficiency
5066147|NCT01358357|Lurasidone|lurasidone
5066148|NCT01358357|Latuda|latuda
5066149|NCT01358357|Bipolar I|bipolar i
5066150|NCT01358318|obesity|obesity
5066151|NCT01358318|satiety|satiety
5066152|NCT01358318|soy protein|soy protein
5066153|NCT01358318|soy fiber|soy fiber
5066154|NCT01358318|control appetite|control appetite
5066155|NCT01358318|reduce food intake|reduce food intake
5066156|NCT01358305|muscle|muscle
5066157|NCT01358305|synthesis|synthesis
5066158|NCT01358305|mTOR|mtor
5066159|NCT01358305|antioxidant|antioxidant
5066160|NCT01358305|inflammatory markers|inflammatory markers
5066161|NCT01358305|soy protein|soy protein
5066162|NCT01358305|whey|whey
5066163|NCT01358305|casein|casein
5066164|NCT01358292|Intramedullary tibia nailing|intramedullary tibia nailing
5066165|NCT01358292|Anterior Knee Pain|anterior knee pain
5066166|NCT01358292|Nail positioning|nail positioning
5066167|NCT01358253|Rituximab|rituximab
5066168|NCT01358253|HyperCVAD|hypercvad
5066169|NCT01358240|Econazole Nitrate|econazole nitrate
5066170|NCT01358240|Foam|foam
5066171|NCT01358240|Quinnova|quinnova
5066172|NCT01358240|Tinea Pedis|tinea pedis
5066173|NCT01358214|Sub-urethral Sling|sub-urethral sling
5066174|NCT01358214|Treatment Outcome|treatment outcome
5066175|NCT01358214|Quality of Life|quality of life
5066275|NCT01357863|Metastatic Breast Cancer|metastatic breast cancer
5066176|NCT01358201|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
5066177|NCT01358188|Gaucher disease|gaucher disease
5066178|NCT01358188|immunity|immunity
5066179|NCT01358188|inflammation|inflammation
5066180|NCT01358188|macrophage activation|macrophage activation
5066181|NCT01358175|Ankylosing spondylitis|ankylosing spondylitis
5066182|NCT01358175|AS|as
5066183|NCT01358175|ASAS|asas
5066184|NCT01358175|inflammatory back pain|inflammatory back pain
5066185|NCT01358162|Tuberculosis|tuberculosis
5066186|NCT01358136|Thyroidectomy|thyroidectomy
5066187|NCT01358136|Mitochondria|mitochondria
5066188|NCT01358123|liver cirrhosis|liver cirrhosis
5066189|NCT01358123|portal hypertension|portal hypertension
5066190|NCT01358123|survival|survival
5066191|NCT01358123|von willebrand factor|von willebrand factor
5066192|NCT01358123|hepatic venous pressure gradient|hepatic venous pressure gradient
5066193|NCT01358110|palliative care|palliative care
5066194|NCT01358110|cancer|cancer
5066195|NCT01358110|emergency medicine|emergency medicine
5066196|NCT01358110|end- of- life care|end- of- life care
5066197|NCT01358097|Head and neck cancer|head and neck cancer
5066198|NCT01358097|Oropharyngeal cancer|oropharyngeal cancer
5066199|NCT01358097|Human papillomavirus|human papillomavirus
5066200|NCT01358097|Squamous cell carcinoma|squamous cell carcinoma
5066201|NCT01358097|Radiation treatment|radiation treatment
5066202|NCT01358097|Chemotherapy|chemotherapy
5066203|NCT01358097|Induction chemotherapy|induction chemotherapy
5066204|NCT01358097|Immune status|immune status
5066205|NCT01358097|Immune monitoring|immune monitoring
5066206|NCT01358097|head and neck robotic surgery|head and neck robotic surgery
5066207|NCT01358084|Malignant Pleural Mesothelioma|malignant pleural mesothelioma
5066208|NCT01358084|MPM|mpm
5066209|NCT01358084|Maintenance treatment|maintenance treatment
5066210|NCT01358084|NGR-hTNF|ngr-htnf
5066211|NCT01358071|NGR-hTNF|ngr-htnf
5066212|NCT01358071|Pegylated liposomal doxorubicin|pegylated liposomal doxorubicin
5066213|NCT01358071|Doxorubicin|doxorubicin
5066214|NCT01358071|Platinum-resistant|platinum-resistant
5066215|NCT01358071|Progression or recurrence Ovarian Cancer|progression or recurrence ovarian cancer
5066216|NCT01358071|Ovarian Cancer|ovarian cancer
5066217|NCT01358071|Advanced or metastatic|advanced or metastatic
5066218|NCT01358058|Brain tumors|brain tumors
5066219|NCT01358058|Radiation|radiation
5066220|NCT01358058|Proton|proton
5066221|NCT01358058|Gliomas|gliomas
5066222|NCT01358045|Topical|topical
5066223|NCT01358045|Diclofenac|diclofenac
5066224|NCT01358045|Vitamin D3|vitamin d3
5066225|NCT01358032|Fear of falling|fear of falling
5066226|NCT01358032|Cognitive behavioral therapy|cognitive behavioral therapy
5066227|NCT01358032|Randomized controlled trial|randomized controlled trial
5066228|NCT01358032|Frailty|frailty
5066229|NCT01358032|Accidental Falls|accidental falls
5066230|NCT01358006|JNJ-40411813|jnj-40411813
5066231|NCT01358006|Positron Emission Tomography (PET)|positron emission tomography (pet)
5066232|NCT01358006|Serotonin-2A (5-HT2A) receptor antagonist|serotonin-2a (5-ht2a) receptor antagonist
5066233|NCT01358006|Male Volunteers|male volunteers
5066234|NCT01357993|Methylphenidate hydrochloride|methylphenidate hydrochloride
5066235|NCT01357993|Concerta|concerta
5066236|NCT01357993|Adults|adults
5066237|NCT01357993|Attention-Deficit / Hyperactivity Disorder|attention-deficit / hyperactivity disorder
5066238|NCT01357993|ADHD|adhd
5066239|NCT01357993|Long term safety|long term safety
5066240|NCT01357980|Detrusor Muscle Overactivity|detrusor muscle overactivity
5066241|NCT01357954|Postural control|postural control
5066242|NCT01357954|Targeted Training|targeted training
5066243|NCT01357954|Gross motor function|gross motor function
5066244|NCT01357954|Cerebral palsy|cerebral palsy
5066245|NCT01357941|venous thromboembolism|venous thromboembolism
5066246|NCT01357941|thromboembolism|thromboembolism
5066247|NCT01357941|deep vein thrombosis|deep vein thrombosis
5066248|NCT01357941|pulmonary embolism|pulmonary embolism
5066249|NCT01357941|thromboprophylaxis|thromboprophylaxis
5066250|NCT01357941|thrombosis|thrombosis
5066251|NCT01357941|embolism and thrombosis|embolism and thrombosis
5066252|NCT01357941|cardiovascular diseases|cardiovascular diseases
5066253|NCT01357941|venous thrombosis|venous thrombosis
5066254|NCT01357941|vascular diseases|vascular diseases
5066255|NCT01357941|anticoagulants|anticoagulants
5066256|NCT01357941|hematologic agents|hematologic agents
5066257|NCT01357941|cardiovascular agents|cardiovascular agents
5066258|NCT01357941|enoxaparin|enoxaparin
5066259|NCT01357941|dalteparin|dalteparin
5066260|NCT01357941|tinzaparin|tinzaparin
5066261|NCT01357941|pregnancy complications|pregnancy complications
5066262|NCT01357928|TEG|teg
5066263|NCT01357928|Thromboelastography|thromboelastography
5066264|NCT01357928|Coagulation|coagulation
5066265|NCT01357915|Cytomegalovirus|cytomegalovirus
5066266|NCT01357915|Vaccine|vaccine
5066267|NCT01357889|pharmacokinetics|pharmacokinetics
5066268|NCT01357889|pharmacodynamics|pharmacodynamics
5066269|NCT01357889|GSK716155|gsk716155
5066270|NCT01357889|albiglutide|albiglutide
5066271|NCT01357863|Lapatinib|lapatinib
5066272|NCT01357863|Observational Study|observational study
5066273|NCT01357863|Trastuzumab|trastuzumab
5066274|NCT01357863|Brazil|brazil
5066581|NCT01356290|metronomic|metronomic
5066276|NCT01357837|Osteoarthritis, knee|osteoarthritis, knee
5066277|NCT01357837|Analgesia|analgesia
5066278|NCT01357837|Pain|pain
5066279|NCT01357837|Painful|painful
5066280|NCT01357824|Intubation|intubation
5066281|NCT01357824|Sellick´s maneuver|sellick´s maneuver
5066282|NCT01357824|aspiration|aspiration
5066283|NCT01357824|[E05.497.578]|[e05.497.578]
5066284|NCT01357811|Genz-112638|genz-112638
5066285|NCT01357811|digoxin|digoxin
5066286|NCT01357798|Headache|headache
5066287|NCT01357798|Allodynia|allodynia
5066288|NCT01357798|Botulinum Toxin Type A|botulinum toxin type a
5066289|NCT01357785|Periodontal ligament stem cells|periodontal ligament stem cells
5066290|NCT01357785|Periodontal regeneration|periodontal regeneration
5066291|NCT01357785|Clinical trial|clinical trial
5066292|NCT01357785|Deep intraosseous defects|deep intraosseous defects
5066293|NCT01357746|Pulmonary arterial blood pressure doppler|pulmonary arterial blood pressure doppler
5066294|NCT01357733|Diffuse, Large B-Cell, Lymphoma|diffuse, large b-cell, lymphoma
5066295|NCT01357733|18F Fluorodeoxyglucose|18f fluorodeoxyglucose
5066296|NCT01357733|Radionuclide-Emission Computed Tomography|radionuclide-emission computed tomography
5066297|NCT01357720|Vaccination|vaccination
5066298|NCT01357720|Immunisation|immunisation
5066299|NCT01357720|Virus|virus
5066300|NCT01357720|Diphtheria|diphtheria
5066301|NCT01357720|Pertussis|pertussis
5066302|NCT01357720|Tetanus|tetanus
5066303|NCT01357720|Hepatitis B|hepatitis b
5066304|NCT01357720|Haemophilus Influenzae|haemophilus influenzae
5066305|NCT01357720|Immunity|immunity
5066306|NCT01357694|psychotherapy|psychotherapy
5066307|NCT01357694|depression|depression
5066308|NCT01357694|anxiety|anxiety
5066309|NCT01357694|surgical patients|surgical patients
5066310|NCT01357681|Huntington Disease|huntington disease
5066311|NCT01357681|Cognition|cognition
5066312|NCT01357681|Motor|motor
5066313|NCT01357681|Behaviour|behaviour
5066314|NCT01357681|Functional Capacity|functional capacity
5066315|NCT01357681|Quality of Life|quality of life
5066316|NCT01357681|Biomarker|biomarker
5066317|NCT01357681|MRI|mri
5066318|NCT01357681|Huntingtin|huntingtin
5066319|NCT01357681|EGCG|egcg
5066320|NCT01357655|Myelogenous|myelogenous
5066321|NCT01357655|Chronic|chronic
5066322|NCT01357655|BCR-ABL Positive|bcr-abl positive
5066323|NCT01357642|asthma|asthma
5066324|NCT01357642|bronchial asthma|bronchial asthma
5066325|NCT01357642|shortness of breath|shortness of breath
5066326|NCT01357629|Vaccination follow-up|vaccination follow-up
5066327|NCT01357616|Glaucoma|glaucoma
5066328|NCT01357616|Open-angle glaucoma|open-angle glaucoma
5066329|NCT01357616|Ocular hypertension|ocular hypertension
5066330|NCT01357616|OAG|oag
5066331|NCT01357616|OH|oh
5066332|NCT01357590|aneurysm, penetrating ulcer, descending thoracic aorta|aneurysm, penetrating ulcer, descending thoracic aorta
5066333|NCT01357577|PTSD|ptsd
5066334|NCT01357577|Substance Use Disorders|substance use disorders
5066335|NCT01357564|dementia|dementia
5066336|NCT01357564|caregivers|caregivers
5066337|NCT01357564|tailored activity|tailored activity
5066338|NCT01357551|obesity|obesity
5066339|NCT01357551|intervention studies|intervention studies
5066340|NCT01357551|patient adherence|patient adherence
5066341|NCT01357538|Bibrocathol|bibrocathol
5066342|NCT01357538|eye ointment|eye ointment
5066343|NCT01357538|blepharitis|blepharitis
5066344|NCT01357538|eye lid|eye lid
5066345|NCT01357525|Pancreas|pancreas
5066346|NCT01357525|Resected|resected
5066347|NCT01357512|prostate cancer diagnosis|prostate cancer diagnosis
5066348|NCT01357512|magnetic resonance imaging|magnetic resonance imaging
5066349|NCT01357512|prostate biopsy|prostate biopsy
5066350|NCT01357486|Hepatocellular Carcinoma|hepatocellular carcinoma
5066351|NCT01357486|CHILD B|child b
5066352|NCT01357486|palliative management|palliative management
5066353|NCT01357486|Sorafenib|sorafenib
5066354|NCT01357486|Pravastatin|pravastatin
5066355|NCT01357473|hormonal values|hormonal values
5066356|NCT01357473|menstruations|menstruations
5066357|NCT01357473|pregnancy|pregnancy
5066358|NCT01357473|antagonist|antagonist
5066359|NCT01357460|Emphysema|emphysema
5066360|NCT01357460|alpha1 antitrypsin deficiency|alpha1 antitrypsin deficiency
5066361|NCT01357460|endoscopic lung volume reduction|endoscopic lung volume reduction
5066362|NCT01357447|Sjogren's syndrome|sjogren's syndrome
5066363|NCT01357447|Cough|cough
5066364|NCT01357408|without an indication for ICD or CRT|without an indication for icd or crt
5066365|NCT01357408|left ventricular function greater than or equal to 40%|left ventricular function greater than or equal to 40%
5066366|NCT01357395|Small Cell Lung Carcinoma|small cell lung carcinoma
5066367|NCT01357382|low fat diet|low fat diet
5066368|NCT01357382|low carbohydrate diet|low carbohydrate diet
5066369|NCT01357369|bacteria infections|bacteria infections
5066370|NCT01357343|Low back pain|low back pain
5066371|NCT01357343|Chiropractic|chiropractic
5066372|NCT01357343|Acupuncture|acupuncture
5066373|NCT01357343|Integrated care|integrated care
5066374|NCT01357330|locally advanced or metastatic|locally advanced or metastatic
5066375|NCT01357317|Kidney disease|kidney disease
5066376|NCT01357317|Hyperphosphatemia|hyperphosphatemia
5066377|NCT01357317|Parathyroid hormone|parathyroid hormone
5066582|NCT01356290|intrathecal|intrathecal
5066378|NCT01357304|Group treatment|group treatment
5066379|NCT01357304|Physical activity referral|physical activity referral
5066380|NCT01357304|Type 2 diabetes|type 2 diabetes
5066381|NCT01357304|Hypertension|hypertension
5066382|NCT01357291|Behavior|behavior
5066383|NCT01357291|Drug users|drug users
5066384|NCT01357291|Inmates|inmates
5066385|NCT01357278|osteoporosis|osteoporosis
5066386|NCT01357278|exercise|exercise
5066387|NCT01357278|intervention|intervention
5066388|NCT01357278|rehabilitation|rehabilitation
5066389|NCT01357278|bone mineral density|bone mineral density
5066390|NCT01357278|muscle strength|muscle strength
5066391|NCT01357265|Seasonal Influenza|seasonal influenza
5066392|NCT01357265|vaccine|vaccine
5066393|NCT01357252|Diabetes mellitus|diabetes mellitus
5066394|NCT01357252|vildagliptin|vildagliptin
5066395|NCT01357239|Fragile X Syndrome|fragile x syndrome
5066396|NCT01357239|Martin-Bell Syndrome|martin-bell syndrome
5066397|NCT01357239|Genetic Diseases|genetic diseases
5066398|NCT01357239|X-Linked|x-linked
5066399|NCT01357239|Escalante's syndrome|escalante's syndrome
5066400|NCT01357226|measurement in two environments|measurement in two environments
5066401|NCT01357213|Botulism, Clostridium|botulism, clostridium
5066402|NCT01357187|Lumbar pathology|lumbar pathology
5066403|NCT01357187|requiring elective lumbar interbody fusion|requiring elective lumbar interbody fusion
5066404|NCT01357096|intervention|intervention
5066405|NCT01357096|CABG or PTCA|cabg or ptca
5066406|NCT01357083|Melatonin|melatonin
5066407|NCT01357083|Periodicity|periodicity
5066408|NCT01357083|Depressive disorder, major|depressive disorder, major
5066409|NCT01357083|Serum|serum
5066410|NCT01357083|Depression|depression
5066411|NCT01357057|Medical records|medical records
5066412|NCT01357057|Outcome scale|outcome scale
5066413|NCT01357057|Biological biomarkers|biological biomarkers
5066414|NCT01357044|Semen quality|semen quality
5066415|NCT01357044|Plant extracts|plant extracts
5066416|NCT01357031|Amitriptyline|amitriptyline
5066417|NCT01357031|Placebo|placebo
5066418|NCT01357031|Melatonin|melatonin
5066419|NCT01357031|Migraine|migraine
5066420|NCT01357031|Headache|headache
5066421|NCT01357031|Drug therapy|drug therapy
5066422|NCT01357031|Preventive treatment of migraine|preventive treatment of migraine
5066423|NCT01357018|Ankylosing spondylitis|ankylosing spondylitis
5066424|NCT01357018|Disease activity|disease activity
5066425|NCT01357018|EQ-5D|eq-5d
5066426|NCT01357018|Quality of life|quality of life
5066427|NCT01357018|Rheumatoid arthritis|rheumatoid arthritis
5066428|NCT01356992|non-inferiority phase III study|non-inferiority phase iii study
5066429|NCT01356992|Low-Molecular Weight Heparin|low-molecular weight heparin
5066430|NCT01356992|Versa® (enoxaparin - Eurofarma)|versa® (enoxaparin - eurofarma)
5066431|NCT01356992|Clexane® (enoxaparin - Sanofi-Aventis)|clexane® (enoxaparin - sanofi-aventis)
5066559|NCT01356394|Obesity|obesity
5066432|NCT01356992|Acute coronary syndrome without ST-segment elevation|acute coronary syndrome without st-segment elevation
5066433|NCT01356979|Medical thoracoscopy|medical thoracoscopy
5066434|NCT01356979|Pleural effusion|pleural effusion
5066435|NCT01356979|Malignant pleural diseases|malignant pleural diseases
5066436|NCT01356979|Tuberculous pleuritis|tuberculous pleuritis
5066437|NCT01356979|Fibrinous pleuritis|fibrinous pleuritis
5066438|NCT01356953|Aerobic Exercise|aerobic exercise
5066439|NCT01356953|Blood Pressure|blood pressure
5066440|NCT01356940|Ambulation|ambulation
5066441|NCT01356927|long acting reversible contraception|long acting reversible contraception
5066442|NCT01356927|medical abortion|medical abortion
5066443|NCT01356927|DMPA|dmpa
5066444|NCT01356927|etonogestrel implant|etonogestrel implant
5066445|NCT01356927|Implanon|implanon
5066446|NCT01356927|contraceptive continuation|contraceptive continuation
5066447|NCT01356875|myelodysplastic syndrome|myelodysplastic syndrome
5066448|NCT01356875|Transfusion|transfusion
5066449|NCT01356875|Hydralazine|hydralazine
5066450|NCT01356875|valproic acid|valproic acid
5066451|NCT01356862|mastectomy|mastectomy
5066452|NCT01356862|axillary node dissection|axillary node dissection
5066453|NCT01356862|adjuvant or neoadjuvant|adjuvant or neoadjuvant
5066454|NCT01356849|Endothelin Receptor Antagonists|endothelin receptor antagonists
5066455|NCT01356849|Proteinuria|proteinuria
5066456|NCT01356836|Coronary collateral development|coronary collateral development
5066457|NCT01356836|monocyte subsets|monocyte subsets
5066458|NCT01356836|collateralization|collateralization
5066459|NCT01356823|Human Papilloma Virus 16|human papilloma virus 16
5066460|NCT01356823|Human Papilloma Virus 18|human papilloma virus 18
5066461|NCT01356823|vaccine|vaccine
5066462|NCT01356823|Cervical Intraepithelial Neoplasia|cervical intraepithelial neoplasia
5066463|NCT01356823|cervical Cancer|cervical cancer
5066464|NCT01356810|Delirium|delirium
5066465|NCT01356810|Primary Prevention|primary prevention
5066466|NCT01356810|Elderly|elderly
5066467|NCT01356797|knee arthroscopy|knee arthroscopy
5066468|NCT01356797|hyperbaric bupivacaine|hyperbaric bupivacaine
5066469|NCT01356797|hypobaric levobupivacaine plus fentanyl|hypobaric levobupivacaine plus fentanyl
5066470|NCT01356784|Sick-listed|sick-listed
5066471|NCT01356784|Tailored physical activity|tailored physical activity
5066472|NCT01356784|Patient education|patient education
5066583|NCT01356277|renal|renal
5066473|NCT01356784|Returning to work|returning to work
5066474|NCT01356784|DK-Sønderborg Municipality|dk-sønderborg municipality
5066475|NCT01356784|columna|columna
5066476|NCT01356784|upper body|upper body
5066477|NCT01356771|Risk Assessment|risk assessment
5066478|NCT01356771|Intervention|intervention
5066479|NCT01356745|premixed nitrous oxide and oxygen|premixed nitrous oxide and oxygen
5066480|NCT01356745|acute pain|acute pain
5066481|NCT01356745|prehospital setting|prehospital setting
5066482|NCT01356732|mechanical ventilation|mechanical ventilation
5066483|NCT01356732|Midazolam|midazolam
5066484|NCT01356732|Ramsay|ramsay
5066485|NCT01356732|Sufentanil|sufentanil
5066486|NCT01356719|Tracheostomy|tracheostomy
5066487|NCT01356719|adverse effects|adverse effects
5066488|NCT01356719|Critical Care|critical care
5066489|NCT01356719|standards|standards
5066490|NCT01356719|safety|safety
5066491|NCT01356706|liver metastases|liver metastases
5066492|NCT01356706|colorectal cancer|colorectal cancer
5066493|NCT01356706|surgery|surgery
5066494|NCT01356706|prognosis|prognosis
5066495|NCT01356693|Cough|cough
5066496|NCT01356693|Common cold|common cold
5066497|NCT01356693|Child|child
5066498|NCT01356693|Adolescent|adolescent
5066499|NCT01356680|Hodgkin Lymphoma|hodgkin lymphoma
5066500|NCT01356680|intermediate stage|intermediate stage
5066501|NCT01356680|PET|pet
5066502|NCT01356667|American Indians|american indians
5066503|NCT01356667|Native Americans|native americans
5066504|NCT01356667|substance abuse|substance abuse
5066505|NCT01356667|culture|culture
5066506|NCT01356654|Stroke|stroke
5066507|NCT01356654|TDCS|tdcs
5066508|NCT01356654|Gait|gait
5066509|NCT01356654|Balance|balance
5066510|NCT01356654|loss of postural balance|loss of postural balance
5066511|NCT01356641|Antibiotic treatment|antibiotic treatment
5066512|NCT01356641|Non perforated appendicitis|non perforated appendicitis
5066513|NCT01356641|Children|children
5066514|NCT01356628|Advanced Hepatocellular Carcinoma|advanced hepatocellular carcinoma
5066515|NCT01356628|HCC|hcc
5066516|NCT01356628|Liver Cancer|liver cancer
5066517|NCT01356628|PD-0332991|pd-0332991
5066518|NCT01356615|anticoagulation|anticoagulation
5066519|NCT01356615|hemodialysis|hemodialysis
5066520|NCT01356615|heparin|heparin
5066521|NCT01356615|lipids|lipids
5066522|NCT01356615|low molecular weight heparins|low molecular weight heparins
5066523|NCT01356602|Gout|gout
5066524|NCT01356602|arthritis|arthritis
5066525|NCT01356602|gout flare|gout flare
5066526|NCT01356602|acute gout|acute gout
5066527|NCT01356602|gouty|gouty
5066528|NCT01356602|rheumatic disease|rheumatic disease
5066529|NCT01356602|uric acid|uric acid
5066530|NCT01356563|hemodialysis|hemodialysis
5066531|NCT01356563|pharmacist|pharmacist
5066532|NCT01356563|medication-related problems|medication-related problems
5066533|NCT01356563|compliance|compliance
5066534|NCT01356511|Purpura, Thrombocytopenic, Idiopathic|purpura, thrombocytopenic, idiopathic
5066535|NCT01356498|gout|gout
5066536|NCT01356498|chronic gout|chronic gout
5066537|NCT01356485|Sickle cell anemia|sickle cell anemia
5066538|NCT01356485|Sickle cell disease|sickle cell disease
5066539|NCT01356485|Sickling crisis|sickling crisis
5066540|NCT01356485|Vaso-occlusive crisis|vaso-occlusive crisis
5066541|NCT01356485|Carboxyhemoglobin|carboxyhemoglobin
5066542|NCT01356485|Oxygen therapeutic|oxygen therapeutic
5066543|NCT01356485|Hemoglobin solutions|hemoglobin solutions
5066544|NCT01356485|Pegylated hemoglobin|pegylated hemoglobin
5066545|NCT01356472|Methicillin-resistant Staphylococcus aureus|methicillin-resistant staphylococcus aureus
5066546|NCT01356472|Pneumonia, Ventilator-Associated|pneumonia, ventilator-associated
5066547|NCT01356472|linezolid|linezolid
5066548|NCT01356472|imipenem/cilastatin|imipenem/cilastatin
5066549|NCT01356459|Pressure ulcers|pressure ulcers
5066550|NCT01356459|ICU|icu
5066551|NCT01356459|Prevention|prevention
5066552|NCT01356446|safety|safety
5066553|NCT01356446|team|team
5066554|NCT01356446|team performance|team performance
5066555|NCT01356446|surgery|surgery
5066556|NCT01356446|outcome|outcome
5066557|NCT01356433|dialysis,inflammation,vitamin C|dialysis,inflammation,vitamin c
5066558|NCT01356420|SLOS|slos
5066560|NCT01356394|Metabolic Syndrome|metabolic syndrome
5066561|NCT01356394|Microalbuminuria|microalbuminuria
5066562|NCT01356394|Chronic Kidney Disease|chronic kidney disease
5066563|NCT01356381|Diabetes mellitus|diabetes mellitus
5066564|NCT01356381|vildagliptin|vildagliptin
5066565|NCT01356368|Lung cancer|lung cancer
5066566|NCT01356355|Stent discomfort|stent discomfort
5066567|NCT01356355|Herbmed plus|herbmed plus
5066568|NCT01356355|Tolterodine|tolterodine
5066569|NCT01356342|Influenza|influenza
5066570|NCT01356342|Vaccine|vaccine
5066571|NCT01356342|Immunogenicity|immunogenicity
5066572|NCT01356329|Gynecologic malignancy ,major surgery|gynecologic malignancy ,major surgery
5066573|NCT01356316|Influenza|influenza
5066574|NCT01356316|Vaccine|vaccine
5066575|NCT01356316|Immunogenicity|immunogenicity
5066576|NCT01356303|Lung cancer|lung cancer
5066577|NCT01356290|Medulloblastoma|medulloblastoma
5066578|NCT01356290|Relapse|relapse
5066579|NCT01356290|Children|children
5066580|NCT01356290|antiangiogenic|antiangiogenic
5066585|NCT01356277|immunosuppressive|immunosuppressive
5066586|NCT01356277|immunosuppression|immunosuppression
5066587|NCT01356277|adherence|adherence
5066588|NCT01356277|medication|medication
5066589|NCT01356277|compliance|compliance
5066590|NCT01356264|colorectal cancer|colorectal cancer
5066591|NCT01356264|colorectal surgery|colorectal surgery
5066592|NCT01356264|prehabilitation|prehabilitation
5066593|NCT01356264|surgical recovery|surgical recovery
5066594|NCT01356264|exercise|exercise
5066595|NCT01356264|referred for scheduled resection|referred for scheduled resection
5066596|NCT01356251|Quality of life|quality of life
5066597|NCT01356251|support group|support group
5066598|NCT01356251|questionnaires|questionnaires
5066599|NCT01356251|Internet-based support group|internet-based support group
5066600|NCT01356251|11-066|11-066
5066601|NCT01356225|pain following dental impaction surgery|pain following dental impaction surgery
5066602|NCT01356199|Gonalgia|gonalgia
5066603|NCT01356199|Quality of Life|quality of life
5066604|NCT01356199|Dietary supplement|dietary supplement
5066605|NCT01356199|Nutrition|nutrition
5066606|NCT01356186|Suicide|suicide
5066607|NCT01356186|Cognitive Therapy|cognitive therapy
5066608|NCT01356186|Inpatient|inpatient
5066609|NCT01356186|Military|military
5066610|NCT01356173|solid cancers|solid cancers
5066611|NCT01356160|Hepatitis C|hepatitis c
5066613|NCT01356160|Rapid Virologic Response|rapid virologic response
5066614|NCT01356160|Sustained Virologic Response|sustained virologic response
5066615|NCT01356160|Direct Acting Antiviral|direct acting antiviral
5066616|NCT01356160|Combination Therapy HCV RNA|combination therapy hcv rna
5066617|NCT01356160|Protease inhibitor|protease inhibitor
5066618|NCT01356160|Treatment naïve|treatment naïve
5066619|NCT01356160|GS-5885|gs-5885
5066620|NCT01356160|GS-9451|gs-9451
5066621|NCT01356147|ventilator associated pulmonary infections|ventilator associated pulmonary infections
5066622|NCT01356134|multiple sclerosis|multiple sclerosis
5066623|NCT01356134|ehlers danlos syndrome|ehlers danlos syndrome
5066624|NCT01356134|CCSVI|ccsvi
5066625|NCT01356134|chronic cerebrospinal venous insufficiency|chronic cerebrospinal venous insufficiency
5066626|NCT01356134|fundus|fundus
5066627|NCT01356134|retina|retina
5066628|NCT01356108|Conduit|conduit
5066629|NCT01356108|Pulmonic|pulmonic
5066630|NCT01356108|Stenosis|stenosis
5066631|NCT01356108|Regurgitation|regurgitation
5066632|NCT01356108|Dysfunctional|dysfunctional
5066633|NCT01356095|Tuberculosis|tuberculosis
5066634|NCT01356095|Treatment Adherence|treatment adherence
5066635|NCT01356095|knowledge translation|knowledge translation
5066636|NCT01356095|Educational outreach|educational outreach
5066637|NCT01356069|BPD|bpd
5066638|NCT01356069|MHS|mhs
5066639|NCT01356069|heavy users|heavy users
5066640|NCT01356069|sequential psychotherapy|sequential psychotherapy
5066641|NCT01356004|severe resistant|severe resistant
5066642|NCT01355991|Spinal Cord Injury|spinal cord injury
5066643|NCT01355991|Tetraplegia|tetraplegia
5066644|NCT01355991|Pulmonary Function|pulmonary function
5066645|NCT01355991|Bronchodilator|bronchodilator
5066646|NCT01355965|completed standard first line therapy|completed standard first line therapy
5066647|NCT01355965|platinum based double regimen|platinum based double regimen
5066648|NCT01355965|Progressive Disease|progressive disease
5066649|NCT01355965|chosen not to pursue primary standard of care therapy|chosen not to pursue primary standard of care therapy
5066650|NCT01355952|Obesity|obesity
5066651|NCT01355952|Weight Loss|weight loss
5066652|NCT01355952|Schizophrenia|schizophrenia
5066653|NCT01355952|Alpha Lipoic Acid|alpha lipoic acid
5066654|NCT01355939|Hernia|hernia
5066655|NCT01355939|Adhesiolysis|adhesiolysis
5066656|NCT01355939|Adhesions|adhesions
5066657|NCT01355939|Intraperitoneal Mesh|intraperitoneal mesh
5066658|NCT01355939|Abdominal Re-exploration|abdominal re-exploration
5066659|NCT01355939|Mesh|mesh
5066660|NCT01355939|Barrier-Coated Mesh|barrier-coated mesh
5066661|NCT01355939|Non-Barrier-Coated Mesh|non-barrier-coated mesh
5066662|NCT01355939|Laparoscopic Approach|laparoscopic approach
5066663|NCT01355939|Open Approach|open approach
5066664|NCT01355939|Abdominal Re-Exploration Surgery|abdominal re-exploration surgery
5066665|NCT01355926|Flexible Fiber-based CO2 Laser|flexible fiber-based co2 laser
5066666|NCT01355926|Monopolar Cautery|monopolar cautery
5066667|NCT01355926|Oral Cavity Lesions|oral cavity lesions
5066668|NCT01355926|Quality of life|quality of life
5066669|NCT01355926|Assessing Pain|assessing pain
5066670|NCT01355926|11-034|11-034
5066671|NCT01355913|Myelodysplastic syndromes (MDS)|myelodysplastic syndromes (mds)
5066672|NCT01355913|chromosmal aberrations|chromosmal aberrations
5066673|NCT01355913|cytogenetics|cytogenetics
5066674|NCT01355913|Fluorescence in situ hybridization (FISH)|fluorescence in situ hybridization (fish)
5066675|NCT01355913|CD34+ cells|cd34+ cells
5066676|NCT01355913|peripheral blood|peripheral blood
5066677|NCT01355900|Total knee arthroplasty|total knee arthroplasty
5066678|NCT01355900|Tourniquet|tourniquet
5066679|NCT01355900|Blood loss|blood loss
5066680|NCT01355900|Volume loading test|volume loading test
5066681|NCT01355887|blood loss|blood loss
5066682|NCT01355887|hepatectomy|hepatectomy
5066683|NCT01355887|prospective study|prospective study
5066684|NCT01355887|PTC|ptc
5067201|NCT01353625|Carcinoma|carcinoma
5066685|NCT01355874|Internal Symptomatic Hemorrhoids|internal symptomatic hemorrhoids
5066686|NCT01355861|sarcopenia|sarcopenia
5066688|NCT01355861|rehabilitation|rehabilitation
5066689|NCT01355861|exercise|exercise
5066690|NCT01355848|Suicide|suicide
5066691|NCT01355848|Brief Intervention|brief intervention
5066692|NCT01355848|Youth|youth
5066693|NCT01355848|Acute Medical Setting|acute medical setting
5066694|NCT01355848|Readiness to Change|readiness to change
5066695|NCT01355848|Suicidality|suicidality
5066696|NCT01355835|Parkinson's disease|parkinson's disease
5066697|NCT01355835|gait|gait
5066698|NCT01355835|deep brain stimulation|deep brain stimulation
5066699|NCT01355835|substantia nigra pars reticulata|substantia nigra pars reticulata
5066700|NCT01355835|subthalamic nucleus|subthalamic nucleus
5066701|NCT01355822|abortion|abortion
5066702|NCT01355822|perinatal death|perinatal death
5066703|NCT01355822|IUGR|iugr
5066704|NCT01355822|preterm birth|preterm birth
5066705|NCT01355822|placental abruption|placental abruption
5066706|NCT01355822|preeclampsia|preeclampsia
5066707|NCT01355809|Six-Minute Walk Test|six-minute walk test
5066708|NCT01355757|shoulder arthroscopy|shoulder arthroscopy
5066709|NCT01355757|24-week follow-up|24-week follow-up
5066710|NCT01355757|quality of life|quality of life
5066711|NCT01355757|rehabilitation achievement|rehabilitation achievement
5066712|NCT01355757|rotator cuff repair|rotator cuff repair
5066713|NCT01355744|humans|humans
5066714|NCT01355744|insect bites|insect bites
5066715|NCT01355731|Registered Nurse|registered nurse
5066716|NCT01355731|Behaviors|behaviors
5066717|NCT01355731|Attitudes|attitudes
5066718|NCT01355692|DME|dme
5066719|NCT01355692|Laser|laser
5066720|NCT01355692|Selective laser therapy|selective laser therapy
5066721|NCT01355692|photocoagulation|photocoagulation
5066722|NCT01355666|pressure ulcers|pressure ulcers
5066723|NCT01355666|stage 1|stage 1
5066724|NCT01355666|stage 2|stage 2
5066725|NCT01355666|stage 3|stage 3
5066726|NCT01355666|stage 4|stage 4
5066727|NCT01355666|wounds|wounds
5066728|NCT01355666|sores|sores
5066729|NCT01355666|infection|infection
5066730|NCT01355666|bioburden|bioburden
5066731|NCT01355666|bacterial contamination|bacterial contamination
5066732|NCT01355666|bed linen|bed linen
5066733|NCT01355666|sheets|sheets
5066734|NCT01355666|underpad|underpad
5066735|NCT01355666|skin assessment|skin assessment
5066736|NCT01355666|microclimate|microclimate
5066737|NCT01355666|shear|shear
5066738|NCT01355666|friction|friction
5066739|NCT01355666|moisture|moisture
5066740|NCT01355666|fabrics|fabrics
5066741|NCT01355666|long term care|long term care
5066742|NCT01355666|nursing home|nursing home
5066743|NCT01355666|decubitus ulcer|decubitus ulcer
5066744|NCT01355666|bed ridden|bed ridden
5066745|NCT01355666|anti-microbial|anti-microbial
5066746|NCT01355653|heat|heat
5066747|NCT01355653|device|device
5066748|NCT01355653|safety|safety
5066749|NCT01355653|performance|performance
5066750|NCT01355653|heatwrap|heatwrap
5066751|NCT01355653|elderly|elderly
5066752|NCT01355653|overweight|overweight
5066753|NCT01355640|heel lance|heel lance
5066754|NCT01355640|pain|pain
5066755|NCT01355640|newborn|newborn
5066756|NCT01355627|CSF leaks|csf leaks
5066757|NCT01355627|Skull base surgery|skull base surgery
5066758|NCT01355627|pseudomeningocele|pseudomeningocele
5066759|NCT01355627|TachoSil®|tachosil®
5066760|NCT01355627|Prevention|prevention
5066761|NCT01355627|post-operative|post-operative
5066762|NCT01355614|Crohn's Disease|crohn's disease
5066763|NCT01355614|Fistula|fistula
5066764|NCT01355575|Microbiota|microbiota
5066765|NCT01355575|Insulin resistance|insulin resistance
5066766|NCT01355575|Bacterial endotoxin|bacterial endotoxin
5066767|NCT01355575|Hepatic triglyceride|hepatic triglyceride
5066768|NCT01355575|Inflammation|inflammation
5066769|NCT01355549|Shoulder pain|shoulder pain
5066770|NCT01355549|Rotator cuff disease|rotator cuff disease
5066771|NCT01355549|Spinal cord injuries|spinal cord injuries
5066772|NCT01355549|Platelet-rich plasma therapy|platelet-rich plasma therapy
5066773|NCT01355549|Rehabilitation|rehabilitation
5066774|NCT01355536|Preterm birth|preterm birth
5066775|NCT01355536|Preterm labour|preterm labour
5066776|NCT01355536|Polycystic Ovary Syndrome|polycystic ovary syndrome
5066777|NCT01355536|PCOS|pcos
5066778|NCT01355536|Diabetes Mellitus|diabetes mellitus
5066779|NCT01355536|Hyperandrogenism|hyperandrogenism
5066780|NCT01355536|Hirsutism|hirsutism
5066781|NCT01355536|Ovarian cysts|ovarian cysts
5066782|NCT01355536|Anti Muller Hormone|anti muller hormone
5066783|NCT01355536|Hypertension|hypertension
5066784|NCT01355523|Breast cancer surgery|breast cancer surgery
5066785|NCT01355523|Melatonin|melatonin
5066786|NCT01355523|Depression|depression
5066787|NCT01355523|Anxiety|anxiety
5066788|NCT01355523|Sleep disturbances|sleep disturbances
5066789|NCT01355523|Cognitive function|cognitive function
5066790|NCT01355471|rosacea|rosacea
5066791|NCT01355458|rosacea|rosacea
5066792|NCT01355419|Obstructive sleep apnea|obstructive sleep apnea
5066793|NCT01355419|CPAP|cpap
5066794|NCT01355419|actigraphy|actigraphy
5066795|NCT01355419|sleep|sleep
5066796|NCT01355419|physical activity|physical activity
5066797|NCT01355406|FlexStent|flexstent
5066798|NCT01355406|Superficial Femoral Artery or SFA|superficial femoral artery or sfa
5066799|NCT01355406|Self Expanding Stent|self expanding stent
5066800|NCT01355406|Stent|stent
5066801|NCT01355406|Bare Metal Stent|bare metal stent
5066802|NCT01355393|Breast Cancer|breast cancer
5066803|NCT01355393|HER2+|her2+
5066804|NCT01355393|Vaccine|vaccine
5066805|NCT01355393|Stage II|stage ii
5066806|NCT01355393|Stage III|stage iii
5066807|NCT01355393|Stage IV|stage iv
5066808|NCT01355380|Pulmonary arterial hypertension|pulmonary arterial hypertension
5066809|NCT01355380|Inhaled iloprost|inhaled iloprost
5066810|NCT01355380|Quality of life|quality of life
5066811|NCT01355367|BAYA1040 CR|baya1040 cr
5066812|NCT01355367|Nifedipine|nifedipine
5066813|NCT01355367|Essential hypertension|essential hypertension
5066814|NCT01355367|Japanese Patients|japanese patients
5066815|NCT01355367|Phase III|phase iii
5066816|NCT01355367|Extension study|extension study
5066817|NCT01355354|Phase 1|phase 1
5066818|NCT01355354|healthy volunteers|healthy volunteers
5066819|NCT01355354|pharmacokinetics|pharmacokinetics
5066820|NCT01355354|Rheumatoid arthritis|rheumatoid arthritis
5066821|NCT01355354|RA, Fostamatinib|ra, fostamatinib
5066822|NCT01355354|Digoxin, drug-drug interaction|digoxin, drug-drug interaction
5066823|NCT01355354|Scientific terminology: Rheumatoid arthritis|scientific terminology: rheumatoid arthritis
5066824|NCT01355354|Fostamatinib|fostamatinib
5066825|NCT01355354|Digoxin|digoxin
5066826|NCT01355354|drug-drug interaction|drug-drug interaction
5066827|NCT01355354|Laymen terminology: Rheumatoid arthritis|laymen terminology: rheumatoid arthritis
5066828|NCT01355354|Amount of Digoxin in blood|amount of digoxin in blood
5066829|NCT01355341|RENAL CALCULI HERBMED PLUS|renal calculi herbmed plus
5066830|NCT01355328|light|light
5066831|NCT01355315|EECP|eecp
5066832|NCT01355315|ischemic cardiomyopathy|ischemic cardiomyopathy
5066833|NCT01355315|endothelin-1|endothelin-1
5066834|NCT01355315|ischemia coronary artery diseases|ischemia coronary artery diseases
5066835|NCT01355315|congestive heart failure not amenable to standard procedures|congestive heart failure not amenable to standard procedures
5066836|NCT01355302|Cancer|cancer
5066837|NCT01355302|Solid Tumors|solid tumors
5066838|NCT01355302|Gastric|gastric
5066839|NCT01355302|Phase I|phase i
5066840|NCT01355302|Phase II|phase ii
5066841|NCT01355289|Chronic Hepatitis C related|chronic hepatitis c related
5066842|NCT01355276|Cinitapride|cinitapride
5066843|NCT01355276|efficacy|efficacy
5066844|NCT01355276|safety|safety
5066845|NCT01355276|mild to moderate functional dyspepsia|mild to moderate functional dyspepsia
5066846|NCT01355263|vitamin a|vitamin a
5066847|NCT01355263|preschool children|preschool children
5066848|NCT01355263|iron metabolic homeostasis|iron metabolic homeostasis
5066849|NCT01355263|supplementation effect|supplementation effect
5066850|NCT01355237|Complementary and alternative medicine (CAM)|complementary and alternative medicine (cam)
5066851|NCT01355224|obesity|obesity
5066852|NCT01355224|genetics|genetics
5066853|NCT01355224|risk assessment|risk assessment
5066854|NCT01355224|health behaviors|health behaviors
5066855|NCT01355224|randomized controlled trial|randomized controlled trial
5066856|NCT01355211|Altered Mental Status|altered mental status
5066857|NCT01355211|non-convulsive seizure|non-convulsive seizure
5066858|NCT01355211|status epilepticus|status epilepticus
5066859|NCT01355211|electroencephalography|electroencephalography
5066860|NCT01355185|Seed movement|seed movement
5066861|NCT01355185|implants|implants
5066862|NCT01355185|prostate brachytherapy|prostate brachytherapy
5066863|NCT01355185|localized|localized
5066864|NCT01355172|Influenza|influenza
5066865|NCT01355172|Vaccine|vaccine
5066866|NCT01355172|Immunogenicity|immunogenicity
5066867|NCT01355159|Pregnancy|pregnancy
5066868|NCT01355159|Folic Acid supplementation|folic acid supplementation
5066869|NCT01355159|Preeclampsia|preeclampsia
5066870|NCT01355146|Patients with proven Fabry's Disease|patients with proven fabry's disease
5066871|NCT01355133|Urinary incontinence|urinary incontinence
5066872|NCT01355133|Myoblasts|myoblasts
5066873|NCT01355133|Muscle derived cells|muscle derived cells
5066874|NCT01355133|Stem cells|stem cells
5066875|NCT01355120|advanced ocular melanoma|advanced ocular melanoma
5066876|NCT01355107|selenium level measurement|selenium level measurement
5066877|NCT01355094|temporary abdomen closure|temporary abdomen closure
5066878|NCT01355094|peritoneal vacuum therapy|peritoneal vacuum therapy
5066879|NCT01355094|open abdomen|open abdomen
5066880|NCT01355094|abdominal compartment syndrome|abdominal compartment syndrome
5066881|NCT01355094|intra-abdominal sepsis|intra-abdominal sepsis
5066882|NCT01355094|intra-abdominal hypertension|intra-abdominal hypertension
5066883|NCT01355094|critical care|critical care
5066884|NCT01355081|Drug Therapy|drug therapy
5066885|NCT01355068|phenytoin|phenytoin
5066886|NCT01355068|chewable tablets|chewable tablets
5066887|NCT01355068|dilantin|dilantin
5066888|NCT01355068|epanutin|epanutin
5066889|NCT01355068|infatabs|infatabs
5066890|NCT01355068|bioequivalence|bioequivalence
5066891|NCT01355068|Partial seizure|partial seizure
5066892|NCT01355068|Tonic-clonic seizure|tonic-clonic seizure
5066893|NCT01355029|Stroke caregivers|stroke caregivers
5066894|NCT01355029|Family Caregivers|family caregivers
5066895|NCT01355029|Stroke|stroke
5066896|NCT01355016|RSV|rsv
5066897|NCT01354977|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
5066898|NCT01354977|Glucose Metabolism Disorders|glucose metabolism disorders
5066899|NCT01354977|Metabolic Diseases|metabolic diseases
5066900|NCT01354977|Diabetes Mellitus|diabetes mellitus
5066901|NCT01354977|Endocrin System Diseases|endocrin system diseases
5066902|NCT01354977|Resveratrol|resveratrol
5066903|NCT01354977|Therapeutic Uses|therapeutic uses
5066904|NCT01354964|Glucose Metabolism Disorders|glucose metabolism disorders
5066905|NCT01354964|Insulin Resistance|insulin resistance
5066906|NCT01354964|Endocrine System|endocrine system
5066907|NCT01354964|Vitamin D|vitamin d
5066908|NCT01354951|Focal Brachytherapy|focal brachytherapy
5066909|NCT01354951|Endorectal coil MRI|endorectal coil mri
5066910|NCT01354951|Quality of Life|quality of life
5066911|NCT01354951|11-056|11-056
5066912|NCT01354938|Bronchitis|bronchitis
5066913|NCT01354925|Diabetes type 2|diabetes type 2
5066914|NCT01354925|Fasting|fasting
5066915|NCT01354925|Ramadan|ramadan
5066916|NCT01354925|Insulin analogues|insulin analogues
5066917|NCT01354912|mycobacterial infection|mycobacterial infection
5066918|NCT01354912|culture|culture
5066919|NCT01354912|ct scan|ct scan
5066920|NCT01354886|in-vitro fertilization|in-vitro fertilization
5066921|NCT01354886|reproductive disorder|reproductive disorder
5066922|NCT01354873|Colonoscopy|colonoscopy
5066923|NCT01354873|Colon Polyps|colon polyps
5066924|NCT01354860|knee osteoarthritis|knee osteoarthritis
5066925|NCT01354847|extracorporeal circulation|extracorporeal circulation
5066926|NCT01354847|platelet dysfunction|platelet dysfunction
5066927|NCT01354847|Multiplate electrode aggregometry analyses|multiplate electrode aggregometry analyses
5066928|NCT01354847|Multiplate|multiplate
5066929|NCT01354821|Aorta|aorta
5066930|NCT01354821|Aneurysm|aneurysm
5066931|NCT01354821|endovascular|endovascular
5066932|NCT01354821|stent-graft|stent-graft
5066933|NCT01354808|Cilostazol|cilostazol
5066934|NCT01354808|Platelet|platelet
5066935|NCT01354808|Inflammation|inflammation
5066936|NCT01354808|Myonecrosis|myonecrosis
5066937|NCT01354795|EUS FNA|eus fna
5066938|NCT01354795|stylet|stylet
5066939|NCT01354795|suction|suction
5066940|NCT01354782|Pharmacokinetic|pharmacokinetic
5066941|NCT01354782|Roflumilast|roflumilast
5066942|NCT01354756|sleep apnea|sleep apnea
5066943|NCT01354756|polysomnography|polysomnography
5066944|NCT01354756|obesity|obesity
5066945|NCT01354756|bariatric surgery|bariatric surgery
5066946|NCT01354743|atrophy|atrophy
5066947|NCT01354743|rhytids|rhytids
5066948|NCT01354743|glabellar|glabellar
5066949|NCT01354743|periorbital|periorbital
5066950|NCT01354730|incidence|incidence
5066951|NCT01354730|nature|nature
5066952|NCT01354730|seriousness|seriousness
5066953|NCT01354730|ADRs|adrs
5066954|NCT01354730|vaccination|vaccination
5066955|NCT01354704|deep veinous thrombosis|deep veinous thrombosis
5066956|NCT01354704|enoxaparin|enoxaparin
5066957|NCT01354691|Alzheimer's Disease|alzheimer's disease
5066958|NCT01354691|Dementia|dementia
5066959|NCT01354691|Memory Loss|memory loss
5066960|NCT01354691|Cognitive Impairment|cognitive impairment
5066961|NCT01354691|Brain Diseases|brain diseases
5066962|NCT01354691|Central Nervous System Diseases|central nervous system diseases
5066963|NCT01354691|Nervous System Diseases|nervous system diseases
5066964|NCT01354691|Neurodegenerative Diseases|neurodegenerative diseases
5066965|NCT01354691|Delirium, Dementia, Amnestic, Cognitive Disorders|delirium, dementia, amnestic, cognitive disorders
5066966|NCT01354691|Mental Disorders|mental disorders
5066967|NCT01354691|Depression|depression
5066968|NCT01354691|Anxiety|anxiety
5066969|NCT01354678|heart failure|heart failure
5066970|NCT01354678|bone marrow mononuclear cells|bone marrow mononuclear cells
5066971|NCT01354665|Multiple sclerosis|multiple sclerosis
5066972|NCT01354665|Interferon beta-1b|interferon beta-1b
5066973|NCT01354665|Fatigue|fatigue
5066974|NCT01354665|Depression|depression
5066975|NCT01354652|lactic acidosis|lactic acidosis
5066976|NCT01354652|entecavir|entecavir
5066977|NCT01354652|lamivudine|lamivudine
5066978|NCT01354626|Hepatic fat accumulation|hepatic fat accumulation
5066979|NCT01354626|Dietary protein|dietary protein
5066980|NCT01354626|NAFLD|nafld
5066981|NCT01354600|Obesity|obesity
5066982|NCT01354600|Appetite|appetite
5066983|NCT01354600|Hormones|hormones
5066984|NCT01354600|Exercise|exercise
5066985|NCT01354600|Body Weight|body weight
5066986|NCT01354587|immunodeficiency|immunodeficiency
5066987|NCT01354574|energy metabolism|energy metabolism
5066988|NCT01354574|lipids|lipids
5066989|NCT01354574|lipoproteins|lipoproteins
5066990|NCT01354574|satiety|satiety
5066991|NCT01354574|glycemic load|glycemic load
5066992|NCT01354574|insulin|insulin
5066993|NCT01354561|respiratory physiotherapy|respiratory physiotherapy
5066994|NCT01354561|cardiac autonomic modulation|cardiac autonomic modulation
5066995|NCT01354561|paediatric patients|paediatric patients
5066996|NCT01354548|Trismus|trismus
5066997|NCT01354548|Cancer|cancer
5066998|NCT01354548|Radiotherapy|radiotherapy
5066999|NCT01354548|Quality of life|quality of life
5067000|NCT01354535|periprosthetic|periprosthetic
5067001|NCT01354535|femur fractures|femur fractures
5067002|NCT01354535|Vancouver B1|vancouver b1
5067003|NCT01354509|Normothermia|normothermia
5067004|NCT01354509|fever control|fever control
5067005|NCT01354509|Outcome study|outcome study
5067006|NCT01354496|Healthy Volunteers|healthy volunteers
5067007|NCT01354496|Bioavailability|bioavailability
5067008|NCT01354483|spinal cord injury|spinal cord injury
5067009|NCT01354483|umbilical cord blood mononuclear cell|umbilical cord blood mononuclear cell
5067010|NCT01354483|lithium carbonate|lithium carbonate
5067011|NCT01354470|Meth|meth
5067012|NCT01354470|Methamphetamine Addiction|methamphetamine addiction
5067013|NCT01354470|Methamphetamine Treatment|methamphetamine treatment
5067014|NCT01354470|Modafinil|modafinil
5067015|NCT01354457|Patient with relapsing or refractory CD22+B-acute lymphoblastic leukemia (ALL)|patient with relapsing or refractory cd22+b-acute lymphoblastic leukemia (all)
5067016|NCT01354444|Memory problems|memory problems
5067017|NCT01354444|Alzheimer's Disease|alzheimer's disease
5067018|NCT01354431|Advanced/Metastatic|advanced/metastatic
5067019|NCT01354431|clear cell component|clear cell component
5067020|NCT01354392|Relapsed or refractory|relapsed or refractory
5067021|NCT01354392|Large B-Cell|large b-cell
5067022|NCT01354392|Diffuse|diffuse
5067023|NCT01354340|Cholesterol|cholesterol
5067024|NCT01354340|LDL-cholesterol|ldl-cholesterol
5067025|NCT01354340|Coronary artery disease|coronary artery disease
5067026|NCT01354340|Red yeast rice|red yeast rice
5067027|NCT01354340|Plants extract|plants extract
5067028|NCT01354340|Cholesterol excess|cholesterol excess
5067029|NCT01354340|Delivery of Health Care|delivery of health care
5067030|NCT01354327|Delivery of Health Care|delivery of health care
5067031|NCT01354327|Cholesterol|cholesterol
5067032|NCT01354327|LDL-cholesterol|ldl-cholesterol
5067033|NCT01354327|Coronary artery disease|coronary artery disease
5067034|NCT01354327|Red yeast rice|red yeast rice
5067035|NCT01354327|Plants extract|plants extract
5067036|NCT01354327|Cholesterol excess|cholesterol excess
5067037|NCT01354314|HIV|hiv
5067038|NCT01354314|Neurocognitive impairment|neurocognitive impairment
5067039|NCT01354314|Memory|memory
5067040|NCT01354314|Dementia|dementia
5067041|NCT01354314|CSF marker|csf marker
5067042|NCT01354314|Functional assessment|functional assessment
5067043|NCT01354314|MRS|mrs
5067044|NCT01354314|Magnetic resonance spectroscopy|magnetic resonance spectroscopy
5067045|NCT01354314|Arterial spin labeling|arterial spin labeling
5067046|NCT01354314|SSRI|ssri
5067047|NCT01354301|kidney transplantation|kidney transplantation
5067048|NCT01354301|thymoglobulin|thymoglobulin
5067049|NCT01354301|everolimus|everolimus
5067050|NCT01354288|Diabetes|diabetes
5067051|NCT01354288|Children|children
5067052|NCT01354288|Disease management|disease management
5067053|NCT01354288|Ketosis|ketosis
5067054|NCT01354288|Hypoglycemia|hypoglycemia
5067055|NCT01354288|Parents|parents
5067056|NCT01354288|Education|education
5067057|NCT01354275|PCOS|pcos
5067058|NCT01354275|IVF/ICSI|ivf/icsi
5067059|NCT01354275|Clinical Pregnancy rates|clinical pregnancy rates
5067060|NCT01354275|GnRH Antagonist|gnrh antagonist
5067061|NCT01354275|GnRH Agonist|gnrh agonist
5067062|NCT01354262|Diabetes|diabetes
5067063|NCT01354262|Vitamin D deficiency|vitamin d deficiency
5067064|NCT01354262|Hemoglobin A1c|hemoglobin a1c
5067065|NCT01354249|preoperative fasting|preoperative fasting
5067066|NCT01354249|insulin resistance|insulin resistance
5067067|NCT01354249|carbohydrates|carbohydrates
5067068|NCT01354249|whey protein|whey protein
5067069|NCT01354249|inflammatory response|inflammatory response
5067070|NCT01354223|silicone hydrogel contact lens|silicone hydrogel contact lens
5067071|NCT01354223|SHCL|shcl
5067072|NCT01354223|stenfilcon A|stenfilcon a
5067073|NCT01354223|ocufilcon B|ocufilcon b
5067074|NCT01354223|daily disposable|daily disposable
5067075|NCT01354223|substantial equivalence|substantial equivalence
5067076|NCT01354223|CooperVision ClearSight™ 1 Day SCL|coopervision clearsight™ 1 day scl
5067077|NCT01354210|Patient Adherence|patient adherence
5067078|NCT01354210|HIV|hiv
5067079|NCT01354197|Adverse events|adverse events
5067080|NCT01354197|Mortality|mortality
5067081|NCT01354197|Readmission|readmission
5067082|NCT01354197|Surgical intensive care unit|surgical intensive care unit
5067083|NCT01354171|active surveillance|active surveillance
5067084|NCT01354171|low risk prostate cancer|low risk prostate cancer
5067085|NCT01354132|schizophrenia|schizophrenia
5067086|NCT01354132|schizoaffective|schizoaffective
5067087|NCT01354132|schizophreniform|schizophreniform
5067088|NCT01354132|early schizophrenia spectrum psychosis|early schizophrenia spectrum psychosis
5067089|NCT01354106|Skin condition after wear|skin condition after wear
5067090|NCT01354093|MacTel|mactel
5067091|NCT01354093|Macular telangiectasia type 2|macular telangiectasia type 2
5067092|NCT01354080|constipation|constipation
5067093|NCT01354080|massage|massage
5067094|NCT01354080|tensegrity|tensegrity
5067095|NCT01354067|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
5067096|NCT01354067|Lung Diseases, Obstructive|lung diseases, obstructive
5067097|NCT01354067|Single Limb|single limb
5067202|NCT01353625|Lymphoma|lymphoma
5067098|NCT01354067|Elastic Resistance|elastic resistance
5067099|NCT01354067|Resistance Training|resistance training
5067100|NCT01354067|Minor Muscle Mass|minor muscle mass
5067101|NCT01354067|Local muscle training|local muscle training
5067102|NCT01354054|Knee OA|knee oa
5067103|NCT01354054|TENS|tens
5067104|NCT01354041|fear and health worries about cancer recurrence|fear and health worries about cancer recurrence
5067105|NCT01354028|premature infant|premature infant
5067106|NCT01354028|massage therapy|massage therapy
5067107|NCT01354028|sleep induction|sleep induction
5067108|NCT01354028|relaxation|relaxation
5067109|NCT01354015|Diabetes|diabetes
5067110|NCT01354015|Technology|technology
5067111|NCT01354002|human biological samples|human biological samples
5067112|NCT01354002|tissue banking|tissue banking
5067113|NCT01353989|hepatitis A|hepatitis a
5067114|NCT01353989|vaccination|vaccination
5067115|NCT01353989|elderly|elderly
5067116|NCT01353989|protection to hepatitis A after vaccination|protection to hepatitis a after vaccination
5067117|NCT01353976|Econazole Nitrate|econazole nitrate
5067118|NCT01353976|Foam|foam
5067119|NCT01353976|Quinnova|quinnova
5067120|NCT01353976|Tinea Pedis|tinea pedis
5067121|NCT01353950|Costimulatory molecules|costimulatory molecules
5067122|NCT01353950|Cystic Fibrosis|cystic fibrosis
5067123|NCT01353950|Biomarkers|biomarkers
5067124|NCT01353937|wound healing|wound healing
5067125|NCT01353924|Allergy|allergy
5067126|NCT01353924|Vaccine|vaccine
5067127|NCT01353924|rBet v 1|rbet v 1
5067128|NCT01353924|Prevention|prevention
5067129|NCT01353885|Primary Osteoarthritis, Hip|primary osteoarthritis, hip
5067130|NCT01353885|Total Hip Arthroplasty|total hip arthroplasty
5067131|NCT01353885|Anterior Approach|anterior approach
5067132|NCT01353885|Posterior Approach|posterior approach
5067133|NCT01353885|Anterolateral Approach|anterolateral approach
5067134|NCT01353885|Cohort Study|cohort study
5067135|NCT01353885|Outcomes, Complication Rate|outcomes, complication rate
5067136|NCT01353885|Outcomes, Quality of Life|outcomes, quality of life
5067137|NCT01353872|Fatigue|fatigue
5067138|NCT01353872|Tennis|tennis
5067139|NCT01353872|Nutrition|nutrition
5067140|NCT01353872|Tournament simulation|tournament simulation
5067141|NCT01353872|Delivery of Health Care|delivery of health care
5067142|NCT01353846|oocyte donation program|oocyte donation program
5067143|NCT01353846|natural cycle|natural cycle
5067144|NCT01353846|hormone replacement therapy|hormone replacement therapy
5067145|NCT01353820|Midly hypercholesterolemic subjects|midly hypercholesterolemic subjects
5067146|NCT01353820|Probiotic|probiotic
5067147|NCT01353820|Cholesterol lowering|cholesterol lowering
5067148|NCT01353820|Dairy|dairy
5067149|NCT01353807|Fish oil|fish oil
5067150|NCT01353807|Pregnancy|pregnancy
5067151|NCT01353807|RCT|rct
5067152|NCT01353807|Birth weight|birth weight
5067153|NCT01353807|Gestational age|gestational age
5067154|NCT01353807|Asthma and allergies|asthma and allergies
5067155|NCT01353807|Metabolic syndrome|metabolic syndrome
5067156|NCT01353807|Obesity|obesity
5067157|NCT01353794|SORAFENIB|sorafenib
5067158|NCT01353794|RENAL CELL CARCINOMA|renal cell carcinoma
5067159|NCT01353794|TYROSINE KINASE INHIBITOR|tyrosine kinase inhibitor
5067160|NCT01353794|OBSERVATIONAL STUDY|observational study
5067161|NCT01353781|Phase 1|phase 1
5067162|NCT01353781|advanced solid tumor|advanced solid tumor
5067163|NCT01353781|AKT|akt
5067164|NCT01353781|Ascending|ascending
5067165|NCT01353781|Japanese|japanese
5067166|NCT01353768|Influenza|influenza
5067167|NCT01353755|specific immunotherapy|specific immunotherapy
5067168|NCT01353755|SIT|sit
5067169|NCT01353729|12-lead ECG|12-lead ecg
5067170|NCT01353729|cardiac repolarization|cardiac repolarization
5067171|NCT01353729|QTc|qtc
5067172|NCT01353729|influenza|influenza
5067173|NCT01353729|GR121167|gr121167
5067174|NCT01353729|zanamivir|zanamivir
5067175|NCT01353703|Infanrix hexa™|infanrix hexa™
5067176|NCT01353703|Primary vaccination|primary vaccination
5067177|NCT01353703|India|india
5067178|NCT01353703|combination vaccine|combination vaccine
5067179|NCT01353703|infants|infants
5067180|NCT01353690|Cell Therapy|cell therapy
5067181|NCT01353690|Heart Failure|heart failure
5067182|NCT01353690|Heart Disease|heart disease
5067183|NCT01353690|Myocardial Infarction|myocardial infarction
5067184|NCT01353690|Myocardial Ischemia|myocardial ischemia
5067185|NCT01353690|Autologous|autologous
5067186|NCT01353690|Muscle-derived Cell|muscle-derived cell
5067187|NCT01353677|Hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
5067188|NCT01353677|QOL|qol
5067189|NCT01353664|rollover protocol|rollover protocol
5067190|NCT01353664|romidepsin|romidepsin
5067191|NCT01353664|Gloucester Pharmaceuticals|gloucester pharmaceuticals
5067192|NCT01353664|Celgene Corporation|celgene corporation
5067193|NCT01353664|continuing treatment|continuing treatment
5067194|NCT01353638|Peritoneal dialysis|peritoneal dialysis
5067195|NCT01353638|Alanyl-Glutamine-Dipeptide|alanyl-glutamine-dipeptide
5067196|NCT01353638|Heat shock protein|heat shock protein
5067197|NCT01353638|Peritoneal cells|peritoneal cells
5067198|NCT01353638|functional maintenance of the peritoneal membrane|functional maintenance of the peritoneal membrane
5067199|NCT01353625|Neoplasm|neoplasm
5067200|NCT01353625|Malignancy|malignancy
5067203|NCT01353625|Leukemia|leukemia
5067204|NCT01353625|Multiple myeloma|multiple myeloma
5067205|NCT01353625|mTOR kinase inhibitor|mtor kinase inhibitor
5067206|NCT01353625|Castration-resistant prostate cancer|castration-resistant prostate cancer
5067207|NCT01353625|Hormone-resistant prostate cancer|hormone-resistant prostate cancer
5067208|NCT01353625|Diffuse Large B-cell lymphoma|diffuse large b-cell lymphoma
5067209|NCT01353599|Spinal Cord Injury|spinal cord injury
5067210|NCT01353599|Tetraplegia|tetraplegia
5067211|NCT01353599|Pulmonary Function|pulmonary function
5067212|NCT01353573|Brain Neoplasms|brain neoplasms
5067213|NCT01353573|Neoplasm Metastasis|neoplasm metastasis
5067214|NCT01353573|Neoplasms|neoplasms
5067215|NCT01353560|integrative medicine|integrative medicine
5067216|NCT01353560|barriers to utilization|barriers to utilization
5067217|NCT01353560|communication|communication
5067218|NCT01353534|Immunogenicity and Safety|immunogenicity and safety
5067219|NCT01353521|complex renal cysts|complex renal cysts
5067220|NCT01353521|Contrast enhanced ultrasound|contrast enhanced ultrasound
5067221|NCT01353508|Sodium excretion,|sodium excretion,
5067222|NCT01353508|LCZ696|lcz696
5067223|NCT01353495|Diabetic Foot Ulcers|diabetic foot ulcers
5067224|NCT01353482|mesothelioma|mesothelioma
5067225|NCT01353482|vorinostat|vorinostat
5067226|NCT01353456|Ambulation|ambulation
5067227|NCT01353456|Side effects|side effects
5067228|NCT01353456|Serum sCD40L|serum scd40l
5067229|NCT01353456|Bowel function|bowel function
5067230|NCT01353456|Postoperative pain|postoperative pain
5067231|NCT01353443|Abdominal Aortic Aneurysm|abdominal aortic aneurysm
5067232|NCT01353443|AAA|aaa
5067233|NCT01353430|IBMPFD - Inclusion Body Myopathy associated with|ibmpfd - inclusion body myopathy associated with
5067234|NCT01353430|Paget's disease of bone and Frontotemporal Dementia|paget's disease of bone and frontotemporal dementia
5067235|NCT01353430|VCP gene - Valosin-containing protein gene|vcp gene - valosin-containing protein gene
5067236|NCT01353417|Grafting, kidney|grafting, kidney
5067237|NCT01353417|Transplantation, kidney|transplantation, kidney
5067238|NCT01353391|Diabetes|diabetes
5067239|NCT01353391|MiTy|mity
5067240|NCT01353391|Metformin in Women|metformin in women
5067241|NCT01353391|Type 2 Diabetes Pregnancy|type 2 diabetes pregnancy
5067242|NCT01353378|dexmedetomidine|dexmedetomidine
5067243|NCT01353378|emergence delirium|emergence delirium
5067244|NCT01353378|sevoflurane anesthesia|sevoflurane anesthesia
5067245|NCT01353378|preschool children|preschool children
5067246|NCT01353378|oral maxillofacial surgery|oral maxillofacial surgery
5067247|NCT01353352|Evaluation|evaluation
5067248|NCT01353352|C-Spine|c-spine
5067249|NCT01353352|Nursing|nursing
5067250|NCT01353352|Clinical Decision Rule|clinical decision rule
5067251|NCT01353339|Kidney Transplant|kidney transplant
5067252|NCT01353339|BK Polyomavirus Infection|bk polyomavirus infection
5067253|NCT01353326|non-inflammatory degenerative joint disease|non-inflammatory degenerative joint disease
5067254|NCT01353326|hip resurfacing|hip resurfacing
5067255|NCT01353326|bone mineral density|bone mineral density
5067256|NCT01353326|cemented|cemented
5067257|NCT01353326|cementless|cementless
5067258|NCT01353313|NICHD Neonatal Research Network|nichd neonatal research network
5067259|NCT01353313|Extremely Low Birth Weight (ELBW)|extremely low birth weight (elbw)
5067260|NCT01353313|Very Low Birth Weight (VLBW)|very low birth weight (vlbw)
5067261|NCT01353313|Prematurity|prematurity
5067262|NCT01353313|Mechanical ventilation|mechanical ventilation
5067263|NCT01353313|Intubation|intubation
5067264|NCT01353313|Neurodevelopmental impairment|neurodevelopmental impairment
5067265|NCT01353300|embryonal childhood rhabdomyosarcoma|embryonal childhood rhabdomyosarcoma
5067266|NCT01353300|cystic nephroma|cystic nephroma
5067267|NCT01353300|neuroblastoma|neuroblastoma
5067268|NCT01353300|childhood medulloblastoma|childhood medulloblastoma
5067269|NCT01353300|childhood hepatoblastoma|childhood hepatoblastoma
5067270|NCT01353300|stromal predominant Wilms tumor|stromal predominant wilms tumor
5067271|NCT01353300|hereditary Wilms tumor|hereditary wilms tumor
5067272|NCT01353300|pleuropulmonary blastoma|pleuropulmonary blastoma
5067273|NCT01353287|Transcatheter Aortic Valve Intervention (TAVI)|transcatheter aortic valve intervention (tavi)
5067274|NCT01353287|Live case transmission|live case transmission
5067275|NCT01353261|Platelet reactivity|platelet reactivity
5067276|NCT01353248|Hepatitis C|hepatitis c
5067277|NCT01353248|HCV|hcv
5067278|NCT01353248|Rapid Virologic Response|rapid virologic response
5067279|NCT01353248|Sustained Virologic Response|sustained virologic response
5067280|NCT01353248|Direct Acting Antiviral|direct acting antiviral
5067281|NCT01353248|Combination Therapy|combination therapy
5067282|NCT01353248|HCV RNA|hcv rna
5067283|NCT01353248|Polymerase inhibitor|polymerase inhibitor
5067284|NCT01353248|Protease inhibitor|protease inhibitor
5067285|NCT01353248|Treatment naïve|treatment naïve
5067286|NCT01353248|GS-5885|gs-5885
5067287|NCT01353248|GS-9451|gs-9451
5067288|NCT01353248|Tegobuvir|tegobuvir
5067289|NCT01353235|COPD|copd
5067290|NCT01353235|acute respiratory failure|acute respiratory failure
5067291|NCT01353235|mechanical ventilation|mechanical ventilation
5067292|NCT01353235|non invasive ventilation|non invasive ventilation
5067293|NCT01353235|steroids|steroids
5067294|NCT01353222|Bladder cancer|bladder cancer
5067295|NCT01353222|Renal pelvis cancer|renal pelvis cancer
5067296|NCT01353222|Ureteral cancer|ureteral cancer
5067297|NCT01353222|Urethral cancer|urethral cancer
5067298|NCT01353222|Bladder|bladder
5067299|NCT01353222|Renal pelvis|renal pelvis
5067300|NCT01353222|Ureter|ureter
5067301|NCT01353222|Urethra|urethra
5067302|NCT01353222|Immune therapy|immune therapy
5067303|NCT01353222|Immunotherapy|immunotherapy
5067304|NCT01353222|Vaccine|vaccine
5067305|NCT01353222|Dendritic cells|dendritic cells
5067306|NCT01353222|Antigen-presenting cells|antigen-presenting cells
5067307|NCT01353222|Antigen presenting cells|antigen presenting cells
5067308|NCT01353222|Cancer vaccine|cancer vaccine
5067309|NCT01353222|Urothelial carcinoma|urothelial carcinoma
5067310|NCT01353222|Urothelial neoplasms|urothelial neoplasms
5067311|NCT01353222|Neoplasms by site|neoplasms by site
5067312|NCT01353222|Neoplasms|neoplasms
5067313|NCT01353196|carotid|carotid
5067314|NCT01353196|atherosclerosis|atherosclerosis
5067315|NCT01353196|cognitive function|cognitive function
5067316|NCT01353183|biopsies, enteric nervous system, biomarker|biopsies, enteric nervous system, biomarker
5067317|NCT01353170|Serum calcium|serum calcium
5067318|NCT01353170|Dialysate|dialysate
5067319|NCT01353170|Mass balance|mass balance
5067320|NCT01353170|Blood pressure|blood pressure
5067321|NCT01353157|cytokine|cytokine
5067322|NCT01353157|cardiac surgery|cardiac surgery
5067323|NCT01353157|clinical scoring system|clinical scoring system
5067324|NCT01353144|aspirin|aspirin
5067325|NCT01353144|peptic ulcer|peptic ulcer
5067326|NCT01353131|electrocardiogram,|electrocardiogram,
5067327|NCT01353131|cardiac magnetic resonance|cardiac magnetic resonance
5067328|NCT01353131|heart failure|heart failure
5067329|NCT01353131|sudden cardiac death|sudden cardiac death
5067330|NCT01353131|ECG scoring|ecg scoring
5067331|NCT01353131|Delayed enhancement|delayed enhancement
5067332|NCT01353118|diabetes|diabetes
5067333|NCT01353118|bariatric surgery|bariatric surgery
5067334|NCT01353118|Roux-en-y gastric bypass|roux-en-y gastric bypass
5067335|NCT01353118|retinopathy|retinopathy
5067336|NCT01353118|neuropathy|neuropathy
5067337|NCT01353118|nephropathy|nephropathy
5067338|NCT01353105|cystic fibrosis|cystic fibrosis
5067339|NCT01353105|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
5067340|NCT01353105|pulmonary fibrosis|pulmonary fibrosis
5067341|NCT01353092|Randomized Controlled Trial|randomized controlled trial
5067342|NCT01353092|Major depression|major depression
5067343|NCT01353092|Hamilton|hamilton
5067344|NCT01353092|PEMF|pemf
5067345|NCT01353066|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
5067346|NCT01353066|BMI 30.0-34.9 kg/m2|bmi 30.0-34.9 kg/m2
5067347|NCT01353053|Immunosuppression|immunosuppression
5067348|NCT01353053|Cytomegalovirus|cytomegalovirus
5067349|NCT01353053|Renal Transplant|renal transplant
5067350|NCT01353053|Atrophy/interstitial|atrophy/interstitial
5067351|NCT01353053|Conversion of tacrolimus everolimus|conversion of tacrolimus everolimus
5067352|NCT01353014|Nutrigenomics|nutrigenomics
5067353|NCT01353014|Diet|diet
5067354|NCT01353014|Nutrition|nutrition
5067355|NCT01353001|Intervention Studies|intervention studies
5067356|NCT01353001|Magnetic Resonance Imaging|magnetic resonance imaging
5067357|NCT01353001|C-Reactive Protein|c-reactive protein
5067358|NCT01352988|C17.300.475|c17.300.475
5067359|NCT01352988|C17.800.480|c17.800.480
5067360|NCT01352975|Age Related Macular Degeneration (AMD)|age related macular degeneration (amd)
5067361|NCT01352975|Dark Adaptation|dark adaptation
5067362|NCT01352975|Age Related Macular Degeneration|age related macular degeneration
5067363|NCT01352975|AMD|amd
5067364|NCT01352962|Dose Limiting Toxicity|dose limiting toxicity
5067365|NCT01352962|Urethra Cancer|urethra cancer
5067366|NCT01352962|Carcinoma of the Bladder|carcinoma of the bladder
5067367|NCT01352962|Cancer of the Renal Pelvis|cancer of the renal pelvis
5067368|NCT01352962|Ureter Cancer|ureter cancer
5067369|NCT01352962|Urethral Cancer|urethral cancer
5067370|NCT01352962|Solid Tumor|solid tumor
5067371|NCT01352962|Pancreatic Cancer|pancreatic cancer
5067372|NCT01352962|Ovarian Cancer|ovarian cancer
5067373|NCT01352962|Non-Small Cell Lung Cancer|non-small cell lung cancer
5067374|NCT01352949|Anthropometry|anthropometry
5067375|NCT01352949|Stereophotogrammetry|stereophotogrammetry
5067376|NCT01352949|Torso|torso
5067377|NCT01352949|Spinal Deformity|spinal deformity
5067378|NCT01352949|Chest Wall Deformity|chest wall deformity
5067379|NCT01352949|Overweight|overweight
5067380|NCT01352949|Obese|obese
5067381|NCT01352949|Healthy Volunteer|healthy volunteer
5067382|NCT01352949|HV|hv
5067383|NCT01352936|nephrotoxicity|nephrotoxicity
5067384|NCT01352936|hospital cost|hospital cost
5067385|NCT01352936|Staphylococcus aureus|staphylococcus aureus
5067386|NCT01352936|bacteremia|bacteremia
5067387|NCT01352936|vancomycin|vancomycin
5067388|NCT01352936|teicoplanin|teicoplanin
5067389|NCT01352923|PEAR1 gene|pear1 gene
5067390|NCT01352923|whether and how PEAR 1 modulate intracellular signaling pathways relevant for platelet function|whether and how pear 1 modulate intracellular signaling pathways relevant for platelet function
5067391|NCT01352897|Cholesterol|cholesterol
5067392|NCT01352897|rosuvastatin|rosuvastatin
5067393|NCT01352897|retrospective|retrospective
5067394|NCT01352884|Cancer|cancer
5067395|NCT01352884|Carcinoma|carcinoma
5067396|NCT01352884|Tumor|tumor
5067397|NCT01352884|Solid tumor|solid tumor
5067398|NCT01352884|Metastatic|metastatic
5067399|NCT01352884|Melanoma|melanoma
5067400|NCT01352871|Immunity, Innate|immunity, innate
5067401|NCT01352871|Attention|attention
5067402|NCT01352871|Concentration|concentration
5067403|NCT01352858|Arthritis|arthritis
5067404|NCT01352858|RA|ra
5067405|NCT01352858|Auto-immune disorders|auto-immune disorders
5067406|NCT01352832|Chronic NSAID use|chronic nsaid use
5067407|NCT01352806|accuracy of identifying intralaminar space|accuracy of identifying intralaminar space
5067408|NCT01352793|phase 3 safety study|phase 3 safety study
5067409|NCT01352793|5700 healthy subjects|5700 healthy subjects
5067410|NCT01352793|3 vaccine doses at month 0|3 vaccine doses at month 0
5067411|NCT01352793|2|2
5067412|NCT01352793|and 6|and 6
5067413|NCT01352793|control HAV/saline/HAV|control hav/saline/hav
5067414|NCT01352780|motivational interviewing|motivational interviewing
5067415|NCT01352780|psoriasis|psoriasis
5067416|NCT01352780|self management|self management
5067417|NCT01352767|insulin injection|insulin injection
5067418|NCT01352754|Hip fracture|hip fracture
5067419|NCT01352754|Troponin T|troponin t
5067420|NCT01352754|myocardial infarction|myocardial infarction
5067421|NCT01352741|low back pain|low back pain
5067422|NCT01352741|neuropathic|neuropathic
5067423|NCT01352741|pain assessment|pain assessment
5067424|NCT01352741|centrally acting tapentadol pregabalin|centrally acting tapentadol pregabalin
5067425|NCT01352741|severe chronic|severe chronic
5067426|NCT01352728|Unresectable|unresectable
5067427|NCT01352689|CKD-828|ckd-828
5067428|NCT01352689|Hypertension|hypertension
5067429|NCT01352689|Primary Hypertension|primary hypertension
5067430|NCT01352689|Healthy Volunteer|healthy volunteer
5067431|NCT01352689|S-Amlodipine|s-amlodipine
5067432|NCT01352689|Telmisartan|telmisartan
5067433|NCT01352689|Amlodipine|amlodipine
5067434|NCT01352689|Pharmacokinetic|pharmacokinetic
5067435|NCT01352689|Phase 1|phase 1
5067436|NCT01352676|renal colic|renal colic
5067437|NCT01352676|flank pain|flank pain
5067438|NCT01352676|back pain|back pain
5067439|NCT01352663|Type I Diabetes|type i diabetes
5067440|NCT01352663|Wockhardt|wockhardt
5067441|NCT01352663|Insulin Analogue|insulin analogue
5067442|NCT01352650|leukemia|leukemia
5067443|NCT01352637|Traumatic Event|traumatic event
5067444|NCT01352637|Trauma Survivor|trauma survivor
5067445|NCT01352637|Exposure Therapy|exposure therapy
5067446|NCT01352637|PTSD DCS|ptsd dcs
5067447|NCT01352637|Virtual Reality Exposure|virtual reality exposure
5067448|NCT01352637|Veteran|veteran
5067449|NCT01352637|Combat-related PTSD|combat-related ptsd
5067450|NCT01352611|Tactile Defensiveness|tactile defensiveness
5067451|NCT01352611|Autistic Disorder|autistic disorder
5067452|NCT01352598|prostate cancer|prostate cancer
5067453|NCT01352598|stereotactic radiotherapy|stereotactic radiotherapy
5067454|NCT01352572|Antidepressant Response|antidepressant response
5067455|NCT01352572|Signal Transduction|signal transduction
5067456|NCT01352572|Lymphocyte|lymphocyte
5067457|NCT01352572|Biomarkers|biomarkers
5067458|NCT01352572|Depressed Patients|depressed patients
5067459|NCT01352572|Antidepressant Drug Adverse Reaction|antidepressant drug adverse reaction
5067460|NCT01352559|Pharmacogenomics|pharmacogenomics
5067461|NCT01352559|Prediction of Antidepressant Response|prediction of antidepressant response
5067462|NCT01352559|Depressed Patients|depressed patients
5067463|NCT01352559|biomarkers|biomarkers
5067464|NCT01352559|phenotype|phenotype
5067465|NCT01352559|Antidepressant Response|antidepressant response
5067466|NCT01352559|Adverse Reaction to Drug|adverse reaction to drug
5067467|NCT01352546|vaginismus|vaginismus
5067468|NCT01352546|painful sex|painful sex
5067469|NCT01352546|painful intercourse|painful intercourse
5067470|NCT01352546|dyspareunia|dyspareunia
5067471|NCT01352546|inability to have intercourse|inability to have intercourse
5067472|NCT01352546|inability to consummate marriage|inability to consummate marriage
5067473|NCT01352546|vaginal spasm|vaginal spasm
5067474|NCT01352546|"hitting a wall"|"hitting a wall"
5067475|NCT01352546|pain during sex|pain during sex
5067476|NCT01352546|pain during intercourse|pain during intercourse
5067477|NCT01352546|burning with intercourse|burning with intercourse
5067478|NCT01352520|systemic therapy|systemic therapy
5067479|NCT01352520|cutaneous anaplastic large T cell lymphoma|cutaneous anaplastic large t cell lymphoma
5067480|NCT01352520|ALCL|alcl
5067481|NCT01352520|lymphomatoid papulosis|lymphomatoid papulosis
5067482|NCT01352520|LyP|lyp
5067483|NCT01352520|mycosis fungoides|mycosis fungoides
5067484|NCT01352520|MF|mf
5067485|NCT01352520|SGN-35 (brentuximab vedotin)|sgn-35 (brentuximab vedotin)
5067486|NCT01352520|skin lymphomas|skin lymphomas
5067487|NCT01352520|CD30-positive lymphoproliferative disorders|cd30-positive lymphoproliferative disorders
5067488|NCT01352520|tumor lymphocytes|tumor lymphocytes
5067489|NCT01352520|cutaneous lymphomas|cutaneous lymphomas
5067490|NCT01352520|CD30+ expression|cd30+ expression
5067491|NCT01352520|Hematologic Disorder|hematologic disorder
5067492|NCT01352520|Lymphoma|lymphoma
5067493|NCT01352494|locally advanced breast cancer|locally advanced breast cancer
5067494|NCT01352494|docetaxel|docetaxel
5067495|NCT01352494|gemcitabine|gemcitabine
5067496|NCT01352481|Speech sound development|speech sound development
5067497|NCT01352468|ADHD|adhd
5067498|NCT01352468|cognitive training|cognitive training
5067499|NCT01352455|Hemodialysis|hemodialysis
5067500|NCT01352455|Pediatric|pediatric
5067501|NCT01352455|Outcomes|outcomes
5067502|NCT01352455|Comparative Effectiveness|comparative effectiveness
5067503|NCT01352455|End Stage Renal Disease|end stage renal disease
5067504|NCT01352442|Presbyopia|presbyopia
5067505|NCT01352442|Accommodation|accommodation
5067506|NCT01352442|Near visual acuity|near visual acuity
5067507|NCT01352442|LASIK|lasik
5067508|NCT01352429|adult|adult
5067509|NCT01352429|histologically confirmed|histologically confirmed
5067510|NCT01352416|Suppress Atrial Fibrillation|suppress atrial fibrillation
5067511|NCT01352416|heart bypass surgery|heart bypass surgery
5067512|NCT01352416|heart valve surgery|heart valve surgery
5067513|NCT01352403|obesity|obesity
5067514|NCT01352403|bariatric surgery|bariatric surgery
5067515|NCT01352403|gastric bypass|gastric bypass
5067516|NCT01352403|life style intervention|life style intervention
5067517|NCT01352403|cardiac function|cardiac function
5067518|NCT01352390|behavioral economics|behavioral economics
5067519|NCT01352390|nudge|nudge
5067520|NCT01352390|artwork|artwork
5067521|NCT01352390|Pap smear|pap smear
5067522|NCT01352390|Blood pressure check|blood pressure check
5067523|NCT01352390|Cholesterol test|cholesterol test
5067524|NCT01352390|Fasting plasma glucose test|fasting plasma glucose test
5067525|NCT01352364|Physiotherapy.|physiotherapy.
5067526|NCT01352364|Deafness.|deafness.
5067527|NCT01352364|Postural balance.|postural balance.
5067528|NCT01352364|Motor skills.|motor skills.
5067529|NCT01352351|Breast feeding Exclusive|breast feeding exclusive
5067530|NCT01352351|Initiation of breastfeeding|initiation of breastfeeding
5067531|NCT01352338|REPEAT|repeat
5067532|NCT01352338|multiple myeloma|multiple myeloma
5067533|NCT01352338|revlimid|revlimid
5067534|NCT01352338|lenalidomide|lenalidomide
5067535|NCT01352338|cyclophosphamide|cyclophosphamide
5067536|NCT01352338|endoxan|endoxan
5067537|NCT01352338|prednisone|prednisone
5067538|NCT01352338|lenalidomide refractory|lenalidomide refractory
5067539|NCT01352312|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
5067540|NCT01352312|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
5067541|NCT01352312|B-cell|b-cell
5067542|NCT01352312|leukemia|leukemia
5067543|NCT01352312|lymphoma|lymphoma
5067544|NCT01352312|bendamustine|bendamustine
5067545|NCT01352312|pentostatin|pentostatin
5067546|NCT01352312|ofatumumab|ofatumumab
5067547|NCT01352312|NHL|nhl
5067548|NCT01352312|CLL|cll
5067549|NCT01352299|Macintosh laryngoscope blade|macintosh laryngoscope blade
5067550|NCT01352299|MacCoy laryngoscope blade|maccoy laryngoscope blade
5067551|NCT01352299|Miller laryngoscope blade|miller laryngoscope blade
5067552|NCT01352299|TrueView laryngoscope|trueview laryngoscope
5067553|NCT01352286|Multiple myeloma|multiple myeloma
5067554|NCT01352286|Autologous stem cell transplantation|autologous stem cell transplantation
5067555|NCT01352286|Received initial treatment previously|received initial treatment previously
5067556|NCT01352273|advanced Solid tumors|advanced solid tumors
5067557|NCT01352273|harboring RAS|harboring ras
5067558|NCT01352273|harboring BRAFV600E|harboring brafv600e
5067559|NCT01352260|Near Infrared Spectroscopy|near infrared spectroscopy
5067560|NCT01352260|Neuromonitoring|neuromonitoring
5067561|NCT01352260|Aortic Arch Replacement|aortic arch replacement
5067562|NCT01352221|iron deficiency|iron deficiency
5067563|NCT01352221|anaemia|anaemia
5067564|NCT01352221|inflammatory bowel disease|inflammatory bowel disease
5067565|NCT01352221|Crohn's Disease|crohn's disease
5067566|NCT01352208|ASP9521|asp9521
5067567|NCT01352208|Castrate Resistant Prostate Cancer|castrate resistant prostate cancer
5067568|NCT01352208|Phase 1/2|phase 1/2
5067569|NCT01352195|Forever Free|forever free
5067570|NCT01352143|Neonates|neonates
5067571|NCT01352130|Postoperative nausea and vomiting|postoperative nausea and vomiting
5067572|NCT01352130|Ondansetron|ondansetron
5067573|NCT01352130|Granisetron|granisetron
5067574|NCT01352130|QTc interval|qtc interval
5067575|NCT01352104|Externalizing Problem Behaviour in Preschoolers|externalizing problem behaviour in preschoolers
5067576|NCT01352091|breast cancer|breast cancer
5067577|NCT01352091|adjuvant endocrine therapy|adjuvant endocrine therapy
5067579|NCT01352091|Zoladex|zoladex
5067580|NCT01352078|Non healing ulcer|non healing ulcer
5067581|NCT01352078|Wound|wound
5067582|NCT01352078|Hidradenitis suppurativa|hidradenitis suppurativa
5067583|NCT01352078|Acne Inversa|acne inversa
5067584|NCT01352078|Hidradenitis|hidradenitis
5067585|NCT01352065|Pharmacokinetics|pharmacokinetics
5067586|NCT01352065|Exercise performance|exercise performance
5067587|NCT01352065|Athletes|athletes
5067588|NCT01352052|chronic widespread pain|chronic widespread pain
5067589|NCT01352052|fibromyalgia|fibromyalgia
5067590|NCT01352052|outcome assessment|outcome assessment
5067591|NCT01352052|functional ability|functional ability
5067592|NCT01352052|AMPS|amps
5067593|NCT01352052|rehabilitation|rehabilitation
5067594|NCT01352039|Heparin Sodium|heparin sodium
5067595|NCT01352039|Thromboprophylaxis|thromboprophylaxis
5067596|NCT01352039|Hip Fracture Surgery.|hip fracture surgery.
5067597|NCT01352013|Fibromyalgia|fibromyalgia
5067598|NCT01352013|Omega-3|omega-3
5067599|NCT01352013|Chronic Pain|chronic pain
5067600|NCT01352013|Fatigue|fatigue
5067601|NCT01352013|Mood|mood
5067602|NCT01352013|docosahexaenoic acid (DHA)|docosahexaenoic acid (dha)
5067603|NCT01352013|eicosapentaenoic acid (EPA)|eicosapentaenoic acid (epa)
5067604|NCT01352000|self help|self help
5067605|NCT01352000|smoking cessation|smoking cessation
5067606|NCT01352000|cancer prevention|cancer prevention
5067607|NCT01351987|Benign Prostatic Hyperplasia|benign prostatic hyperplasia
5067608|NCT01351974|breast cancer|breast cancer
5067609|NCT01351974|sentinel lymph node biopsy|sentinel lymph node biopsy
5067610|NCT01351974|axillary recurrence|axillary recurrence
5067611|NCT01351961|Hypertension|hypertension
5067612|NCT01351961|Cognitive function|cognitive function
5067613|NCT01351948|Immune response|immune response
5067614|NCT01351935|non-hodgkin's lymphoma|non-hodgkin's lymphoma
5067615|NCT01351935|lymphoma|lymphoma
5067616|NCT01351935|leukemia|leukemia
5067617|NCT01351935|chronic lymphocytic leukemia|chronic lymphocytic leukemia
5067618|NCT01351935|b-cell malignancies|b-cell malignancies
5067619|NCT01351935|Btk inhibitor|btk inhibitor
5067620|NCT01351935|Phase 1b|phase 1b
5067621|NCT01351935|Avila Therapeutics|avila therapeutics
5067622|NCT01351935|Waldenstrom Macroglobulinemia|waldenstrom macroglobulinemia
5067623|NCT01351883|immunomodulating diet|immunomodulating diet
5067624|NCT01351883|postoperative infection|postoperative infection
5067625|NCT01351857|Type 1 Diabetes|type 1 diabetes
5067626|NCT01351857|17 to 20 years of age|17 to 20 years of age
5067627|NCT01351844|Aromatase inhibitor|aromatase inhibitor
5067628|NCT01351844|Arthralgia Syndrome|arthralgia syndrome
5067629|NCT01351844|Exercise|exercise
5067630|NCT01351831|Arthroplasty, Replacement, Knee|arthroplasty, replacement, knee
5067631|NCT01351831|Resistance training|resistance training
5067632|NCT01351831|Physical Therapy Modalities|physical therapy modalities
5067633|NCT01351831|Randomized Controlled Trial|randomized controlled trial
5067634|NCT01351805|vitamin D|vitamin d
5067635|NCT01351805|omega-3 fatty acid|omega-3 fatty acid
5067636|NCT01351805|fish oil|fish oil
5067637|NCT01351805|prevention|prevention
5067638|NCT01351805|trial|trial
5067639|NCT01351805|autoimmune disease|autoimmune disease
5067640|NCT01351805|rheumatoid arthritis|rheumatoid arthritis
5067641|NCT01351805|psoriasis|psoriasis
5067642|NCT01351805|systemic inflammation|systemic inflammation
5067643|NCT01351805|Interleukin-6|interleukin-6
5067644|NCT01351805|C-reactive peptide|c-reactive peptide
5067645|NCT01351805|tumor necrosis factor|tumor necrosis factor
5067646|NCT01351805|osteoarthritis|osteoarthritis
5067647|NCT01351779|Intraocular pressure|intraocular pressure
5067648|NCT01351779|Contact lens sensor|contact lens sensor
5067649|NCT01351779|Optic disc hemorrhage|optic disc hemorrhage
5067650|NCT01351766|Behavioral Activation|behavioral activation
5067651|NCT01351753|Obesity|obesity
5067652|NCT01351753|Metabolic Syndrome X|metabolic syndrome x
5067653|NCT01351753|Hypertension|hypertension
5067654|NCT01351753|Dyslipidemia|dyslipidemia
5067655|NCT01351753|Impaired glucose tolerance|impaired glucose tolerance
5067656|NCT01351740|HIV|hiv
5067657|NCT01351740|Anti-HIV Agents|anti-hiv agents
5067658|NCT01351740|HIV Protease Inhibitors|hiv protease inhibitors
5067659|NCT01351727|seniors|seniors
5067660|NCT01351727|seizures|seizures
5067661|NCT01351727|epilepsy|epilepsy
5067662|NCT01351727|quality of life|quality of life
5067663|NCT01351714|D3 resection|d3 resection
5067664|NCT01351714|right colectomy|right colectomy
5067665|NCT01351714|MDCT angiography|mdct angiography
5067666|NCT01351714|lymphadenectomy|lymphadenectomy
5067667|NCT01351714|safe|safe
5067668|NCT01351714|right colon|right colon
5067669|NCT01351714|preoperative|preoperative
5067670|NCT01351701|Diabetic foot|diabetic foot
5067671|NCT01351701|Bacteriological epidemiology|bacteriological epidemiology
5067672|NCT01351701|Wagner's Grading|wagner's grading
5067673|NCT01351701|eastern India|eastern india
5067674|NCT01351688|Phase 1|phase 1
5067675|NCT01351688|Metastatic|metastatic
5067676|NCT01351688|Castration resistant|castration resistant
5067677|NCT01351688|Prostate cancer|prostate cancer
5067678|NCT01351688|Androgen receptor|androgen receptor
5067679|NCT01351688|Down regulation|down regulation
5067680|NCT01351688|Japanese|japanese
5067681|NCT01351675|Chronic kidney disease|chronic kidney disease
5067682|NCT01351675|Type 2 diabetes|type 2 diabetes
5067683|NCT01351675|Diabetic nephropathy|diabetic nephropathy
5067684|NCT01351662|Lupus|lupus
5067685|NCT01351662|stress|stress
5067686|NCT01351649|exercise|exercise
5067687|NCT01351649|adolescent|adolescent
5067688|NCT01351649|intervention|intervention
5067689|NCT01351649|female|female
5067690|NCT01351649|counseling|counseling
5067691|NCT01351636|chronic kidney disease|chronic kidney disease
5067692|NCT01351636|hypertension|hypertension
5067693|NCT01351623|PR-171 (CARFILZOMIB)|pr-171 (carfilzomib)
5067694|NCT01351623|Chemotherapy|chemotherapy
5067695|NCT01351623|10-228|10-228
5067696|NCT01351610|Critical Limb Ischemia|critical limb ischemia
5067697|NCT01351610|Peripheral Arterial Occlusive Disease|peripheral arterial occlusive disease
5067902|NCT01350570|acupuncture|acupuncture
5067698|NCT01351610|Peripheral Artery Disease|peripheral artery disease
5067699|NCT01351610|Peripheral Vascular Disease|peripheral vascular disease
5067700|NCT01351610|Stem Cell Therapy|stem cell therapy
5067701|NCT01351610|Mesenchymal Stem Cells|mesenchymal stem cells
5067702|NCT01351597|recurrent breast cancer|recurrent breast cancer
5067703|NCT01351597|metastatic breast cancer|metastatic breast cancer
5067704|NCT01351597|docetaxel|docetaxel
5067705|NCT01351597|oxaliplatin|oxaliplatin
5067706|NCT01351584|Breast Cancer|breast cancer
5067707|NCT01351584|Advanced Breast Cancer|advanced breast cancer
5067708|NCT01351584|Epidemiology|epidemiology
5067709|NCT01351584|Registry|registry
5067710|NCT01351584|Health Services Research|health services research
5067711|NCT01351584|Germany|germany
5067712|NCT01351584|Palliative Treatment|palliative treatment
5067713|NCT01351584|Adjuvant Drug Therapy|adjuvant drug therapy
5067714|NCT01351584|Nutrition Assessment|nutrition assessment
5067715|NCT01351584|Physical Activity|physical activity
5067716|NCT01351519|Glioma|glioma
5067717|NCT01351519|Glioblastoma|glioblastoma
5067718|NCT01351519|Glioblastoma Multiforme|glioblastoma multiforme
5067719|NCT01351519|Astrocytoma|astrocytoma
5067720|NCT01351519|Brain Tumor|brain tumor
5067721|NCT01351506|Body weight|body weight
5067722|NCT01351506|Body mass index|body mass index
5067723|NCT01351506|Weight change|weight change
5067724|NCT01351506|ICU outcomes|icu outcomes
5067725|NCT01351493|pressure sore|pressure sore
5067726|NCT01351493|nitric oxide|nitric oxide
5067727|NCT01351480|Auto-immune Disease|auto-immune disease
5067728|NCT01351480|Arthritis|arthritis
5067729|NCT01351480|Rheumatoid Arthritis|rheumatoid arthritis
5067730|NCT01351467|Parkinson's|parkinson's
5067731|NCT01351467|genetic|genetic
5067732|NCT01351467|online|online
5067733|NCT01351467|GWAS|gwas
5067734|NCT01351467|genome wide association|genome wide association
5067735|NCT01351454|Depression|depression
5067736|NCT01351454|Substance Use|substance use
5067737|NCT01351454|HIV Medication Adherence|hiv medication adherence
5067738|NCT01351454|Behavioral Activation|behavioral activation
5067739|NCT01351441|Geriatric|geriatric
5067740|NCT01351441|Pharmacoeconomics|pharmacoeconomics
5067741|NCT01351441|Health Literacy|health literacy
5067742|NCT01351441|Adherence|adherence
5067743|NCT01351428|Non invasive cardiac output monitor|non invasive cardiac output monitor
5067744|NCT01351428|NICOM|nicom
5067745|NCT01351428|Hypertension|hypertension
5067746|NCT01351428|Pregnancy|pregnancy
5067747|NCT01351428|Pre-Eclampsia|pre-eclampsia
5067748|NCT01351402|Massage|massage
5067749|NCT01351402|Rest|rest
5067750|NCT01351389|Brief|brief
5067751|NCT01351389|Alcohol|alcohol
5067752|NCT01351389|Intervention|intervention
5067753|NCT01351389|Sex|sex
5067754|NCT01351389|Risk|risk
5067755|NCT01351376|Lymphedema, Low Level Laser, Breast Cancer|lymphedema, low level laser, breast cancer
5067756|NCT01351363|Arthroscopic shoulder surgery|arthroscopic shoulder surgery
5067757|NCT01351363|Pain threshold|pain threshold
5067758|NCT01351350|Solid tumor, mTORC1/2 inhibitors, HER2|solid tumor, mtorc1/2 inhibitors, her2
5067759|NCT01351337|Diffusion tensor imaging, Glioma, Intraoperative monitoring, Pyramidal tract, Subcortical|diffusion tensor imaging, glioma, intraoperative monitoring, pyramidal tract, subcortical
5067760|NCT01351337|stimulation, Tractography|stimulation, tractography
5067761|NCT01351324|Endothelial function|endothelial function
5067762|NCT01351324|Non-esterified fatty acids|non-esterified fatty acids
5067763|NCT01351324|Insulin sensitivity|insulin sensitivity
5067764|NCT01351311|treatment|treatment
5067765|NCT01351311|exercise|exercise
5067766|NCT01351311|resistance training|resistance training
5067767|NCT01351311|swiss ball|swiss ball
5067768|NCT01351311|functional capacity|functional capacity
5067769|NCT01351259|Mechanical ventilation|mechanical ventilation
5067770|NCT01351259|Intubation|intubation
5067771|NCT01351259|Cuff pressure|cuff pressure
5067772|NCT01351259|Microaspiration|microaspiration
5067773|NCT01351246|Program Evaluation|program evaluation
5067774|NCT01351246|ADHD|adhd
5067775|NCT01351233|Cataract|cataract
5067776|NCT01351220|CRC screening|crc screening
5067777|NCT01351220|Prevention and early detection of CRC|prevention and early detection of crc
5067778|NCT01351220|Filipino|filipino
5067779|NCT01351220|Dissemination|dissemination
5067780|NCT01351194|Hepatocellular Carcinoma|hepatocellular carcinoma
5067781|NCT01351194|RFA|rfa
5067782|NCT01351194|HR|hr
5067783|NCT01351181|Diabetes|diabetes
5067784|NCT01351168|Parkinson's disease|parkinson's disease
5067785|NCT01351168|zolpidem|zolpidem
5067786|NCT01351155|acute respiratory failure|acute respiratory failure
5067787|NCT01351155|noninvasive ventilation|noninvasive ventilation
5067788|NCT01351129|formulation comparison|formulation comparison
5067789|NCT01351116|brachytherapy|brachytherapy
5067790|NCT01351116|external beam radiation|external beam radiation
5067791|NCT01351116|high dose rate intraluminal brachytherapy|high dose rate intraluminal brachytherapy
5067792|NCT01351116|lung cancer|lung cancer
5067793|NCT01351116|quality of life|quality of life
5067794|NCT01351116|radiation treatment|radiation treatment
5067795|NCT01351116|bronchus|bronchus
5067796|NCT01351103|LGK974|lgk974
5067797|NCT01351103|pancreatic adenocarcinoma|pancreatic adenocarcinoma
5067798|NCT01351103|BRAF mutant colorectal cancer|braf mutant colorectal cancer
5067799|NCT01351103|RNF43 mutation|rnf43 mutation
5067800|NCT01351103|RSPO fusion|rspo fusion
5067801|NCT01351103|melanoma|melanoma
5067802|NCT01351103|triple negative breast cancer|triple negative breast cancer
5067803|NCT01351103|PDR001|pdr001
5067804|NCT01351103|immunotherapy|immunotherapy
5067805|NCT01351103|head and neck scc|head and neck scc
5067806|NCT01351103|cervical scc|cervical scc
5067807|NCT01351103|esophageal scc|esophageal scc
5067808|NCT01351103|lung scc|lung scc
5067809|NCT01351077|Developmental Delay|developmental delay
5067810|NCT01351064|ADHD|adhd
5067811|NCT01351012|Canola oil|canola oil
5067812|NCT01351012|High oleic canola oil|high oleic canola oil
5067813|NCT01351012|Flax oil|flax oil
5067814|NCT01351012|ALA|ala
5067815|NCT01351012|DHA|dha
5067816|NCT01351012|Metabolic syndrome|metabolic syndrome
5067817|NCT01351012|Cardiovascular disease|cardiovascular disease
5067818|NCT01351012|Endothelial function|endothelial function
5067819|NCT01351012|FADS1|fads1
5067820|NCT01351012|Gut microbiome|gut microbiome
5067821|NCT01351012|Body composition|body composition
5067822|NCT01351012|Psychosocial status|psychosocial status
5067823|NCT01351012|Cholesterol|cholesterol
5067824|NCT01351012|Lipids|lipids
5067825|NCT01351012|Lipoproteins|lipoproteins
5067826|NCT01351012|Inflammation|inflammation
5067827|NCT01351012|Lipid peroxidation|lipid peroxidation
5067828|NCT01350999|Drug Therapy|drug therapy
5067829|NCT01350986|Controlled Clinical Trials, Randomized|controlled clinical trials, randomized
5067830|NCT01350973|Drug Therapy|drug therapy
5067831|NCT01350960|hypercholesterolemia|hypercholesterolemia
5067832|NCT01350960|hyperlipidemia|hyperlipidemia
5067834|NCT01350960|HDL|hdl
5067835|NCT01350960|PCSK9|pcsk9
5067836|NCT01350960|LNA-oligonucleotide|lna-oligonucleotide
5067837|NCT01350947|Chronic Myelomonocytic Leukemia|chronic myelomonocytic leukemia
5067838|NCT01350947|CMML|cmml
5067839|NCT01350921|phase 1|phase 1
5067840|NCT01350921|ticagrelor|ticagrelor
5067841|NCT01350921|venlafaxine|venlafaxine
5067842|NCT01350895|Polycystic ovarian syndrome (PCOS)|polycystic ovarian syndrome (pcos)
5067843|NCT01350882|kidney transplantation|kidney transplantation
5067844|NCT01350882|acute humoral rejection|acute humoral rejection
5067845|NCT01350882|rituximab|rituximab
5067846|NCT01350856|Uncomplicated P. falciparum malaria|uncomplicated p. falciparum malaria
5067847|NCT01350843|Men|men
5067848|NCT01350843|Orange Juice|orange juice
5067849|NCT01350843|Cholesterol|cholesterol
5067850|NCT01350843|Obesity|obesity
5067851|NCT01350830|inguinal hernia|inguinal hernia
5067852|NCT01350830|groin hernia|groin hernia
5067853|NCT01350830|chronic pain|chronic pain
5067854|NCT01350830|mesh repair|mesh repair
5067855|NCT01350804|Rheumatoid Arthritis|rheumatoid arthritis
5067856|NCT01350804|RA|ra
5067857|NCT01350804|ACR|acr
5067858|NCT01350804|inflammatory joints|inflammatory joints
5067859|NCT01350778|Coronary artery disease requiring drug eluting stents|coronary artery disease requiring drug eluting stents
5067860|NCT01350765|Birth asphyxia|birth asphyxia
5067861|NCT01350765|Low birth weight|low birth weight
5067862|NCT01350765|neonatal sepsis|neonatal sepsis
5067863|NCT01350765|mortality|mortality
5067864|NCT01350765|community based interventions|community based interventions
5067865|NCT01350752|cost effectiveness|cost effectiveness
5067866|NCT01350752|provider knowledge|provider knowledge
5067867|NCT01350752|schools|schools
5067868|NCT01350726|Cirrhosis|cirrhosis
5067869|NCT01350726|Hepatic Carcinoma|hepatic carcinoma
5067870|NCT01350713|skin|skin
5067871|NCT01350713|burn|burn
5067872|NCT01350713|povidone iodine|povidone iodine
5067873|NCT01350713|cold water|cold water
5067874|NCT01350700|QOL|qol
5067875|NCT01350687|Calcium Phosphore|calcium phosphore
5067876|NCT01350687|Renagel|renagel
5067877|NCT01350674|mediastinal tuberculosis|mediastinal tuberculosis
5067878|NCT01350674|endoscopy|endoscopy
5067879|NCT01350674|EBUS|ebus
5067880|NCT01350674|tuberculous lymphadenopathy|tuberculous lymphadenopathy
5067881|NCT01350674|endobronchial ultrasound|endobronchial ultrasound
5067882|NCT01350661|Asthma|asthma
5067883|NCT01350661|Questionnaires|questionnaires
5067884|NCT01350648|Viral Hepatitis|viral hepatitis
5067885|NCT01350648|Prospective Cohort|prospective cohort
5067886|NCT01350648|Hepatocellular Carcinoma|hepatocellular carcinoma
5067887|NCT01350648|HIV-HCV Co-Infection|hiv-hcv co-infection
5067888|NCT01350648|HIV-HBV Co-Infection|hiv-hbv co-infection
5067889|NCT01350648|Hepatitis B|hepatitis b
5067890|NCT01350648|Hepatitis C|hepatitis c
5067891|NCT01350648|Hepatitis|hepatitis
5067892|NCT01350635|Specific Immunotherapy|specific immunotherapy
5067893|NCT01350635|Grass pollen vaccine|grass pollen vaccine
5067894|NCT01350635|Allergy|allergy
5067895|NCT01350635|Grass Pollen Allergy|grass pollen allergy
5067896|NCT01350622|pain management|pain management
5067897|NCT01350609|essential hypertension, blood pressure, nifedipine, candesartan, FDC|essential hypertension, blood pressure, nifedipine, candesartan, fdc
5067898|NCT01350596|Bioequivalence Study|bioequivalence study
5067899|NCT01350596|Ibuprofen|ibuprofen
5067900|NCT01350596|Alivium|alivium
5067901|NCT01350583|tumor related pain|tumor related pain
5067903|NCT01350570|loperamide|loperamide
5067904|NCT01350570|functional diarrhea|functional diarrhea
5067905|NCT01350570|IBS|ibs
5067906|NCT01350557|Elderly|elderly
5067907|NCT01350557|Hip fracture|hip fracture
5067908|NCT01350557|Intervention program|intervention program
5067909|NCT01350544|HIV|hiv
5067910|NCT01350544|Adherence|adherence
5067911|NCT01350544|African American/Black|african american/black
5067912|NCT01350544|Disparities|disparities
5067913|NCT01350531|Obesity|obesity
5067914|NCT01350531|African American adolescents|african american adolescents
5067915|NCT01350531|Motivation|motivation
5067916|NCT01350518|Intra-Abdominal Fat|intra-abdominal fat
5067917|NCT01350518|Metabolic Syndrome|metabolic syndrome
5067918|NCT01350518|Hepatic steatosis|hepatic steatosis
5067919|NCT01350505|Postural Balance|postural balance
5067920|NCT01350505|Sleep Initiation and Maintenance Disorders|sleep initiation and maintenance disorders
5067921|NCT01350492|pain|pain
5067922|NCT01350492|brain imaging|brain imaging
5067923|NCT01350492|exercise|exercise
5067924|NCT01350479|Cross infection|cross infection
5067925|NCT01350479|Long term care|long term care
5067926|NCT01350466|Chronic rhinosinusitis|chronic rhinosinusitis
5067927|NCT01350453|CIT|cit
5067928|NCT01350453|Stroke|stroke
5067929|NCT01350427|leucine supplementation|leucine supplementation
5067930|NCT01350427|BCCA supplementation|bcca supplementation
5067931|NCT01350427|resistance exercise-induced muscle remodeling|resistance exercise-induced muscle remodeling
5067932|NCT01350401|Melanoma|melanoma
5067933|NCT01350401|Cell Therapy|cell therapy
5067934|NCT01350401|T Cell Therapy|t cell therapy
5067935|NCT01350401|NY-ESO-1|ny-eso-1
5067936|NCT01350401|Immuno-oncology|immuno-oncology
5067937|NCT01350401|Metastatic|metastatic
5067938|NCT01350401|Previously treated|previously treated
5067939|NCT01350401|T Cell Receptor|t cell receptor
5067940|NCT01350388|Chronic Kidney Disease|chronic kidney disease
5067941|NCT01350388|Diabetes|diabetes
5067942|NCT01350388|Febuxostat|febuxostat
5067943|NCT01350388|Inflammation|inflammation
5067944|NCT01350388|Hyperuricemia|hyperuricemia
5067945|NCT01350362|tideglusib|tideglusib
5067946|NCT01350362|Alzheimer|alzheimer
5067947|NCT01350362|NP-12|np-12
5067948|NCT01350362|NP031112|np031112
5067949|NCT01350362|ARGO|argo
5067950|NCT01350362|Noscira|noscira
5067951|NCT01350349|Depression|depression
5067952|NCT01350349|Dementia|dementia
5067953|NCT01350349|Geriatrics|geriatrics
5067954|NCT01350310|Heart failure|heart failure
5067955|NCT01350310|Dilated cardiomyopathy|dilated cardiomyopathy
5067956|NCT01350310|Stem cells|stem cells
5067957|NCT01350297|tetraplegia|tetraplegia
5067958|NCT01350297|reinnervation|reinnervation
5067959|NCT01350297|phrenic nerve|phrenic nerve
5067960|NCT01350284|Antioxidants|antioxidants
5067961|NCT01350284|Glucose Intolerance prevention and control|glucose intolerance prevention and control
5067962|NCT01350284|Diabetes Mellitus prevention and control|diabetes mellitus prevention and control
5067963|NCT01350271|Hookworm|hookworm
5067964|NCT01350271|Necator americanus|necator americanus
5067965|NCT01350271|Mebendazole|mebendazole
5067966|NCT01350258|allogeneic HSCT|allogeneic hsct
5067967|NCT01350258|Hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
5067968|NCT01350245|Acute Myeloid Leukemia|acute myeloid leukemia
5067969|NCT01350245|Myelodysplastic Syndromes|myelodysplastic syndromes
5067970|NCT01350245|Biphenotypic Leukemia|biphenotypic leukemia
5067971|NCT01350245|Acute Lymphocytic Leukemia|acute lymphocytic leukemia
5067972|NCT01350245|Chronic Myeloid Leukemia|chronic myeloid leukemia
5067973|NCT01350245|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
5067974|NCT01350245|Plasma Cell Neoplasms|plasma cell neoplasms
5067975|NCT01350245|Lymphoma|lymphoma
5067976|NCT01350245|Hodgkin's Disease|hodgkin's disease
5067977|NCT01350245|Aplastic Anemia|aplastic anemia
5067978|NCT01350245|Hematopoietic stem cell transplant (HSCT)|hematopoietic stem cell transplant (hsct)
5067979|NCT01350245|myeloablative haploidentical HSCT|myeloablative haploidentical hsct
5067980|NCT01350245|graft versus host disease (GVHD)|graft versus host disease (gvhd)
5067981|NCT01350232|sickle cell|sickle cell
5067982|NCT01350232|SS disease|ss disease
5067983|NCT01350232|SC disease|sc disease
5067984|NCT01350232|S-thalassemia|s-thalassemia
5067985|NCT01350232|transplant|transplant
5067986|NCT01350232|bone marrow transplant|bone marrow transplant
5067987|NCT01350232|stem cell transplant|stem cell transplant
5067988|NCT01350232|matched sibling|matched sibling
5067989|NCT01350232|haploidentical|haploidentical
5067990|NCT01350232|hemoglobinopathy|hemoglobinopathy
5067991|NCT01350232|anemia|anemia
5067992|NCT01350232|desensitization|desensitization
5067993|NCT01350219|Cord blood stem cells|cord blood stem cells
5067994|NCT01350219|Immune modulation|immune modulation
5067995|NCT01350219|Stem cell educator|stem cell educator
5067996|NCT01350219|Autoimmunity|autoimmunity
5067997|NCT01350219|Islet beta cell regeneration|islet beta cell regeneration
5067998|NCT01350219|Type 1 diabetes|type 1 diabetes
5067999|NCT01350206|Carcinoma,Hepatocellular|carcinoma,hepatocellular
5068000|NCT01350206|Liver Neoplasms|liver neoplasms
5068001|NCT01350206|Therapeutic|therapeutic
5068002|NCT01350206|Chemoembolization,|chemoembolization,
5068003|NCT01350206|TACE|tace
5068004|NCT01350206|hepatic resection|hepatic resection
5068005|NCT01350193|Manuka Honey|manuka honey
5068006|NCT01350193|Irrigation|irrigation
5068007|NCT01350193|Endoscopic Sinus Surgery|endoscopic sinus surgery
5068008|NCT01350180|biochemical failure|biochemical failure
5068009|NCT01350180|hormonal therapy|hormonal therapy
5068010|NCT01350167|Hepatocellular Carcinoma|hepatocellular carcinoma
5068011|NCT01350167|Liver Cancer|liver cancer
5068012|NCT01350167|Ultrasound|ultrasound
5068013|NCT01350167|Computed Tomography|computed tomography
5068014|NCT01350167|Alpha fetoprotein|alpha fetoprotein
5068015|NCT01350167|Cirrhosis|cirrhosis
5068016|NCT01350167|Screening|screening
5068017|NCT01350167|Advanced Liver Disease|advanced liver disease
5068018|NCT01350154|clinical trial|clinical trial
5068019|NCT01350154|sildenafil|sildenafil
5068020|NCT01350154|revatio|revatio
5068021|NCT01350154|muscular dystrophy|muscular dystrophy
5068022|NCT01350154|adult|adult
5068023|NCT01350154|nNOS|nnos
5068024|NCT01350141|Hypercholesterolemia|hypercholesterolemia
5068025|NCT01350141|dyslipidemia|dyslipidemia
5068026|NCT01350141|high cholesterol|high cholesterol
5068027|NCT01350141|LDL|ldl
5068028|NCT01350141|antibody|antibody
5068029|NCT01350141|PCSK9|pcsk9
5068030|NCT01350141|PF-04950615|pf-04950615
5068031|NCT01350141|RN316|rn316
5068032|NCT01350128|COPD|copd
5068033|NCT01350115|Basal Cell Carcinoma|basal cell carcinoma
5068034|NCT01350115|Gorlin Syndrome,|gorlin syndrome,
5068035|NCT01350115|Gorlin-Goltz Syndrome,|gorlin-goltz syndrome,
5068036|NCT01350115|Basal Cell Nevus Syndrome,|basal cell nevus syndrome,
5068037|NCT01350115|Nevoid Basal Cell Carcinoma Syndrome,|nevoid basal cell carcinoma syndrome,
5068038|NCT01350115|Basal Cell Carcinoma Nevus Syndrome|basal cell carcinoma nevus syndrome
5068039|NCT01350115|Smo inhibitor,|smo inhibitor,
5068040|NCT01350115|Hedgehog pathway inhibitor|hedgehog pathway inhibitor
5068041|NCT01350115|BCCs|bccs
5068042|NCT01350102|Adult|adult
5068043|NCT01350089|energy drinks|energy drinks
5068044|NCT01350089|alcohol intoxication|alcohol intoxication
5068045|NCT01350076|intraoperative fluid|intraoperative fluid
5068046|NCT01350076|pediatric|pediatric
5068047|NCT01350076|goal directed therapy|goal directed therapy
5068048|NCT01350076|pediatric with major abdominal surgery|pediatric with major abdominal surgery
5068049|NCT01350076|ASA less than or equal to 3|asa less than or equal to 3
5068050|NCT01350076|Duration of surgery less than 2 hours|duration of surgery less than 2 hours
5068051|NCT01350076|Body weight more than or equal to 15 kg|body weight more than or equal to 15 kg
5068052|NCT01350063|water|water
5068053|NCT01350063|tubewell|tubewell
5068054|NCT01350063|diarrhea|diarrhea
5068055|NCT01350063|chlorination|chlorination
5068056|NCT01350063|safe storage|safe storage
5068057|NCT01350050|topical pharyngeal anesthesia|topical pharyngeal anesthesia
5068058|NCT01350050|articaine|articaine
5068059|NCT01350037|patient-controlled sedation|patient-controlled sedation
5068060|NCT01350037|propofol|propofol
5068061|NCT01350037|alfentanil|alfentanil
5068062|NCT01350037|remifentanil|remifentanil
5068063|NCT01350037|endoscopic retrograde cholangiopancreatography|endoscopic retrograde cholangiopancreatography
5068064|NCT01350024|Conjunctival Mullerectomy|conjunctival mullerectomy
5068065|NCT01350024|Blepharoptosis|blepharoptosis
5068066|NCT01350024|Ptosis surgery|ptosis surgery
5068067|NCT01350024|Pain Control|pain control
5068068|NCT01350011|Nicotine Replacement Therapy|nicotine replacement therapy
5068069|NCT01350011|Buprenorphine|buprenorphine
5068070|NCT01350011|Varenicline|varenicline
5068071|NCT01350011|Smoking Cessation|smoking cessation
5068072|NCT01350011|Addiction|addiction
5068073|NCT01350011|The Innovative System (IS) Treatment|the innovative system (is) treatment
5068074|NCT01350011|The Standard Treatment Control (STC)|the standard treatment control (stc)
5068075|NCT01349985|Naltrexone|naltrexone
5068076|NCT01349985|problem drinking|problem drinking
5068077|NCT01349985|medication adherence|medication adherence
5068078|NCT01349985|adherence|adherence
5068079|NCT01349985|smartphone|smartphone
5068080|NCT01349920|biological markers|biological markers
5068081|NCT01349920|endoscopy|endoscopy
5068082|NCT01349920|gastrointestinal|gastrointestinal
5068083|NCT01349881|Eflornithine/sulindac prevention trial|eflornithine/sulindac prevention trial
5068084|NCT01349868|COPD|copd
5068085|NCT01349829|Hepatitis A|hepatitis a
5068086|NCT01349829|Vaccination|vaccination
5068087|NCT01349829|Immunity|immunity
5068088|NCT01349816|COPD|copd
5068089|NCT01349803|COPD|copd
5068090|NCT01349790|ITP|itp
5068091|NCT01349790|Primary immune thrombocytopenia|primary immune thrombocytopenia
5068092|NCT01349777|antiplatelet therapy post drug eluting stents|antiplatelet therapy post drug eluting stents
5068093|NCT01349764|vitamin D replacement|vitamin d replacement
5068094|NCT01349764|Urolithiasis|urolithiasis
5068095|NCT01349764|deficiency|deficiency
5068096|NCT01349764|insufficiency|insufficiency
5068097|NCT01349751|abdominal incision|abdominal incision
5068098|NCT01349751|hyperbaric|hyperbaric
5068099|NCT01349751|isobaric|isobaric
5068100|NCT01349751|levobupivacaine|levobupivacaine
5068101|NCT01349751|spinal anaesthesia|spinal anaesthesia
5068102|NCT01349725|Safety|safety
5068103|NCT01349699|endotoxemia|endotoxemia
5068104|NCT01349699|inflammation|inflammation
5068105|NCT01349699|iron|iron
5068106|NCT01349699|iron chelation|iron chelation
5068107|NCT01349699|cytokines|cytokines
5068108|NCT01349686|Food|food
5068109|NCT01349686|Fluids|fluids
5068110|NCT01349686|Labor|labor
5068111|NCT01349673|Open-label|open-label
5068112|NCT01349673|Proctitis|proctitis
5068113|NCT01349673|Proctosigmoiditis|proctosigmoiditis
5068114|NCT01349673|Ulcerative|ulcerative
5068115|NCT01349673|Salix|salix
5068116|NCT01349673|Budesonide foam|budesonide foam
5068117|NCT01349673|Budesonide|budesonide
5068118|NCT01349673|Rectal|rectal
5068119|NCT01349673|Gastrointestinal|gastrointestinal
5068120|NCT01349673|Colitis|colitis
5068121|NCT01349673|UC|uc
5068122|NCT01349673|UP|up
5068123|NCT01349673|UPS|ups
5068124|NCT01349673|Additional relevant MeSH terms:|additional relevant mesh terms:
5068125|NCT01349673|Proctocolitis|proctocolitis
5068126|NCT01349673|Ulcer|ulcer
5068127|NCT01349673|Colitis, Ulcerative|colitis, ulcerative
5068128|NCT01349673|Gastroenteritis|gastroenteritis
5068129|NCT01349673|Gastrointestinal Diseases|gastrointestinal diseases
5068130|NCT01349673|Digestive System Diseases|digestive system diseases
5068131|NCT01349673|Rectal Diseases|rectal diseases
5068132|NCT01349673|Intestinal Diseases|intestinal diseases
5068133|NCT01349673|Colonic Diseases|colonic diseases
5068134|NCT01349673|Sigmoid Diseases|sigmoid diseases
5068135|NCT01349673|Pathologic Processes|pathologic processes
5068136|NCT01349673|Inflammatory Bowel Diseases|inflammatory bowel diseases
5068137|NCT01349673|Bronchodilator Agents|bronchodilator agents
5068138|NCT01349673|Autonomic Agents|autonomic agents
5068139|NCT01349673|Peripheral Nervous System Agents|peripheral nervous system agents
5068140|NCT01349673|Physiological Effects of Drugs|physiological effects of drugs
5068141|NCT01349673|Pharmacologic Actions|pharmacologic actions
5068142|NCT01349673|Anti-Asthmatic Agents|anti-asthmatic agents
5068143|NCT01349673|Respiratory System Agents|respiratory system agents
5068144|NCT01349673|Therapeutic Uses|therapeutic uses
5068145|NCT01349673|Glucocorticoids|glucocorticoids
5068146|NCT01349673|Hormones|hormones
5068147|NCT01349673|Hormones, Hormone Substitutes and Hormone Antagonists|hormones, hormone substitutes and hormone antagonists
5068148|NCT01349673|Anti-inflammatory Agents|anti-inflammatory agents
5068149|NCT01349660|Glioblastoma multiforme|glioblastoma multiforme
5068150|NCT01349660|GBM|gbm
5068151|NCT01349660|Bevacizumab|bevacizumab
5068152|NCT01349660|PI3K Pathway|pi3k pathway
5068153|NCT01349660|BKM120|bkm120
5068154|NCT01349647|FUCOSYL-GM1-KLH|fucosyl-gm1-klh
5068155|NCT01349647|GLOBO H-KLH CONJUGATE|globo h-klh conjugate
5068156|NCT01349647|OPT-821|opt-821
5068157|NCT01349647|POLYSIALIC ACID - KLH|polysialic acid - klh
5068158|NCT01349647|Vaccine|vaccine
5068159|NCT01349647|08-095|08-095
5068160|NCT01349634|iodine|iodine
5068161|NCT01349634|goiter|goiter
5068162|NCT01349634|cretinism|cretinism
5068163|NCT01349634|child nutrition|child nutrition
5068164|NCT01349634|cognition|cognition
5068165|NCT01349621|Abnormal Pap results|abnormal pap results
5068166|NCT01349621|Colposcopy|colposcopy
5068167|NCT01349608|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5068168|NCT01349608|Motivational Interviewing|motivational interviewing
5068169|NCT01349608|Health Coaching|health coaching
5068170|NCT01349608|Physical Activity|physical activity
5068171|NCT01349582|flow diversion|flow diversion
5068172|NCT01349582|endovascular treatment|endovascular treatment
5068173|NCT01349582|symptomatic aneurysm|symptomatic aneurysm
5068174|NCT01349582|cavernous carotid aneurysm|cavernous carotid aneurysm
5068175|NCT01349582|ophthalmic aneurysm|ophthalmic aneurysm
5068176|NCT01349582|vertebral aneurysm|vertebral aneurysm
5068177|NCT01349556|cancer|cancer
5068178|NCT01349556|chemotherapy|chemotherapy
5068179|NCT01349556|EGFR inhibitors|egfr inhibitors
5068180|NCT01349556|tretinoin|tretinoin
5068181|NCT01349556|EGFRi drug rash|egfri drug rash
5068182|NCT01349543|Respiratory syncytial virus|respiratory syncytial virus
5068183|NCT01349543|RSV|rsv
5068184|NCT01349543|Immunology|immunology
5068185|NCT01349543|Viral infection|viral infection
5068186|NCT01349543|Bronchiolitis|bronchiolitis
5068187|NCT01349543|Viral challenge|viral challenge
5068188|NCT01349543|Viral lung disease|viral lung disease
5068189|NCT01349530|Usual medical care|usual medical care
5068190|NCT01349530|Anticoagulation by VKAs: COUMADINE® & PREVISCAN®|anticoagulation by vkas: coumadine® & previscan®
5068191|NCT01349530|Anticoagulation clinic care, CREATIF|anticoagulation clinic care, creatif
5068192|NCT01349517|health-related quality of life(HRQL)|health-related quality of life(hrql)
5068193|NCT01349517|Esophageal Cancer|esophageal cancer
5068194|NCT01349491|Atrial Fibrillation|atrial fibrillation
5068195|NCT01349491|Ranolazine|ranolazine
5068196|NCT01349478|paraplegia|paraplegia
5068197|NCT01349478|tetraplegia|tetraplegia
5068198|NCT01349478|passive gait training|passive gait training
5068199|NCT01349478|O2 consumption|o2 consumption
5068200|NCT01349478|exercise capacity|exercise capacity
5068201|NCT01349478|CVD risk factors|cvd risk factors
5068202|NCT01349478|spasticity|spasticity
5068203|NCT01349478|pain|pain
5068204|NCT01349478|bladder, bowel|bladder, bowel
5068205|NCT01349478|well being|well being
5068206|NCT01349465|Hepatitis C|hepatitis c
5068207|NCT01349465|Hepatitis|hepatitis
5068209|NCT01349465|Liver disease|liver disease
5068210|NCT01349465|Virus Infection|virus infection
5068211|NCT01349452|Conjunctivitis, Viral|conjunctivitis, viral
5068212|NCT01349452|Adenoviridae Infections|adenoviridae infections
5068213|NCT01349452|Ganciclovir|ganciclovir
5068214|NCT01349452|Adenovirus Keratoconjunctivitis|adenovirus keratoconjunctivitis
5068215|NCT01349452|Treatment of viral conjunctivitis|treatment of viral conjunctivitis
5068216|NCT01349426|Lung resection|lung resection
5068217|NCT01349426|Parenchymal pneumostasis, haemostasis|parenchymal pneumostasis, haemostasis
5068218|NCT01349426|Fissure closure|fissure closure
5068219|NCT01349426|Automatic staplers,LigaSure, Force Triad Generator|automatic staplers,ligasure, force triad generator
5068220|NCT01349426|Bipolar fusion|bipolar fusion
5068221|NCT01349426|Procedure cost|procedure cost
5068222|NCT01349413|Functional dyspepsia|functional dyspepsia
5068223|NCT01349413|symptom response|symptom response
5068224|NCT01349413|postprandial fullness|postprandial fullness
5068225|NCT01349413|gastroesophageal reflux disease|gastroesophageal reflux disease
5068226|NCT01349413|acid suppression|acid suppression
5068227|NCT01349400|asymptomatic|asymptomatic
5068228|NCT01349400|minimally symptomatic|minimally symptomatic
5068229|NCT01349348|Tolvaptan treatment to ascites and hepatic cirrhosis|tolvaptan treatment to ascites and hepatic cirrhosis
5068230|NCT01349322|stage IA breast cancer|stage ia breast cancer
5068231|NCT01349322|stage IB breast cancer|stage ib breast cancer
5068232|NCT01349322|stage II breast cancer|stage ii breast cancer
5068233|NCT01349322|estrogen receptor-negative breast cancer|estrogen receptor-negative breast cancer
5068234|NCT01349322|estrogen receptor-positive breast cancer|estrogen receptor-positive breast cancer
5068235|NCT01349322|progesterone receptor-negative breast cancer|progesterone receptor-negative breast cancer
5068236|NCT01349322|progesterone receptor-positive breast cancer|progesterone receptor-positive breast cancer
5068237|NCT01349322|ductal breast carcinoma in situ|ductal breast carcinoma in situ
5068238|NCT01349309|Prophylactic Swallowing Exercises|prophylactic swallowing exercises
5068239|NCT01349309|Head and Neck Cancer|head and neck cancer
5068240|NCT01349309|Dysphagia|dysphagia
5068241|NCT01349296|Solid Tumors|solid tumors
5068242|NCT01349283|Hepatitis B Vaccine|hepatitis b vaccine
5068243|NCT01349283|Hepatitis B Virus|hepatitis b virus
5068244|NCT01349283|Antigen|antigen
5068245|NCT01349283|Antibody|antibody
5068246|NCT01349283|Vaccination|vaccination
5068247|NCT01349270|chronic inflammatory demyelinating polyneuropathy|chronic inflammatory demyelinating polyneuropathy
5068248|NCT01349270|immunoglobulin|immunoglobulin
5068249|NCT01349270|prednisone|prednisone
5068250|NCT01349257|Asthmatic patients|asthmatic patients
5068251|NCT01349244|hydronephrosis|hydronephrosis
5068252|NCT01349244|CT|ct
5068253|NCT01349244|POC US|poc us
5068254|NCT01349231|obsessive-compulsive disorder|obsessive-compulsive disorder
5068255|NCT01349231|ketamine|ketamine
5068256|NCT01349231|glutamate|glutamate
5068257|NCT01349218|Potassium|potassium
5068258|NCT01349218|Infants|infants
5068259|NCT01349218|Heel Stick|heel stick
5068260|NCT01349218|Less than or equal to 6 months of age|less than or equal to 6 months of age
5068261|NCT01349218|IV catheter blood samples|iv catheter blood samples
5068262|NCT01349218|perioperatively|perioperatively
5068263|NCT01349218|elective surgical procedures|elective surgical procedures
5068264|NCT01349205|OSA|osa
5068265|NCT01349205|Caffeine|caffeine
5068266|NCT01349205|Tonsillectomy|tonsillectomy
5068267|NCT01349205|Adenoidectomy|adenoidectomy
5068268|NCT01349205|Sleep Study|sleep study
5068269|NCT01349192|MRSA|mrsa
5068270|NCT01349192|Cystic Fibrosis|cystic fibrosis
5068271|NCT01349192|Early Infection|early infection
5068272|NCT01349192|Treatment|treatment
5068273|NCT01349179|Hip|hip
5068274|NCT01349179|Arthroplasty|arthroplasty
5068275|NCT01349179|Metal on metal|metal on metal
5068276|NCT01349179|operated on 2002|operated on 2002
5068277|NCT01349166|Obesity|obesity
5068278|NCT01349166|Type 2 diabetes|type 2 diabetes
5068279|NCT01349166|glucose intolerance|glucose intolerance
5068280|NCT01349166|Physical Activity|physical activity
5068281|NCT01349166|Inflammation|inflammation
5068282|NCT01349166|HPA axis|hpa axis
5068283|NCT01349166|Cytokines|cytokines
5068284|NCT01349153|Physical Activity|physical activity
5068285|NCT01349153|Young Adults|young adults
5068286|NCT01349153|Cancer Survivors|cancer survivors
5068287|NCT01349127|Vitamin D|vitamin d
5068288|NCT01349127|Cholecalciferol|cholecalciferol
5068289|NCT01349127|Nutrient requirements|nutrient requirements
5068290|NCT01349127|Randomised Controlled Trial|randomised controlled trial
5068291|NCT01349127|Lactation|lactation
5068292|NCT01349127|pregnancy|pregnancy
5068293|NCT01349127|Cord blood|cord blood
5068294|NCT01349127|Human milk|human milk
5068295|NCT01349127|serum 25-hydroxyvitamin D|serum 25-hydroxyvitamin d
5068296|NCT01349127|deficiency|deficiency
5068297|NCT01349127|insufficiency|insufficiency
5068298|NCT01349127|nutrition|nutrition
5068299|NCT01349114|aliskiren|aliskiren
5068300|NCT01349114|endothelial function|endothelial function
5068301|NCT01349114|hypertension|hypertension
5068302|NCT01349101|hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
5068303|NCT01349101|HSCT|hsct
5068304|NCT01349101|allogeneic marrow transplantation|allogeneic marrow transplantation
5068305|NCT01349101|cyclophosphamide|cyclophosphamide
5068306|NCT01349101|graft-versus-host disease|graft-versus-host disease
5068307|NCT01349101|GVHD|gvhd
5068308|NCT01349088|breast cancer|breast cancer
5068309|NCT01349088|metastatic breast cancer|metastatic breast cancer
5068310|NCT01349088|stage IV breast cancer|stage iv breast cancer
5068311|NCT01349088|motesanib|motesanib
5068312|NCT01349088|ixabepilone|ixabepilone
5068313|NCT01349088|capecitabine|capecitabine
5068314|NCT01349075|Unresectable|unresectable
5068315|NCT01349075|Hepatocellular Carcinoma|hepatocellular carcinoma
5068316|NCT01349075|TheraSphere|therasphere
5068317|NCT01349075|Yttrium-90|yttrium-90
5068318|NCT01349062|Prolonged Viral Suppression|prolonged viral suppression
5068319|NCT01349062|HIV Infections|hiv infections
5068320|NCT01349049|AML|aml
5068321|NCT01349049|relapsed|relapsed
5068322|NCT01349049|refractory|refractory
5068323|NCT01349036|GBM|gbm
5068324|NCT01349036|Glioblastoma|glioblastoma
5068325|NCT01349036|brain cancer|brain cancer
5068326|NCT01349023|energy content|energy content
5068327|NCT01349023|energy density|energy density
5068328|NCT01349023|energy intake|energy intake
5068329|NCT01349023|pre-portioned entrees|pre-portioned entrees
5068330|NCT01349010|hyperlipidemia|hyperlipidemia
5068331|NCT01348997|cancer|cancer
5068332|NCT01348997|cancer survivors|cancer survivors
5068333|NCT01348997|internet|internet
5068334|NCT01348997|depression|depression
5068335|NCT01348997|anxiety|anxiety
5068336|NCT01348984|postoperative|postoperative
5068337|NCT01348984|pain score|pain score
5068338|NCT01348984|morphine consumption|morphine consumption
5068339|NCT01348971|sodium nitrate|sodium nitrate
5068340|NCT01348971|coronary artery bypass surgery|coronary artery bypass surgery
5068341|NCT01348971|ischemia-reperfusion|ischemia-reperfusion
5068342|NCT01348971|myocardial injury|myocardial injury
5068343|NCT01348958|Patello femoral|patello femoral
5068344|NCT01348958|osteoarthritis|osteoarthritis
5068345|NCT01348958|arthroplasty|arthroplasty
5068346|NCT01348945|Partial tear ACL|partial tear acl
5068347|NCT01348945|Stump preserved ACL surgery|stump preserved acl surgery
5068348|NCT01348932|asthma|asthma
5068349|NCT01348932|Chitinase 3-like 1 (CHI3L1)|chitinase 3-like 1 (chi3l1)
5068350|NCT01348932|YKL-40|ykl-40
5068351|NCT01348932|single nucleotide polymorphism(SNP)|single nucleotide polymorphism(snp)
5068352|NCT01348932|Real time PCR|real time pcr
5068353|NCT01348932|gene|gene
5068354|NCT01348919|Cancer|cancer
5068355|NCT01348919|Multiple myeloma|multiple myeloma
5068356|NCT01348919|CEP-18770|cep-18770
5068357|NCT01348919|Lenalidomide|lenalidomide
5068358|NCT01348919|Dexamethasone|dexamethasone
5068359|NCT01348906|cardiopulmonary bypass|cardiopulmonary bypass
5068360|NCT01348893|Mental health|mental health
5068361|NCT01348893|Education|education
5068362|NCT01348893|Mind Body Therapies|mind body therapies
5068363|NCT01348880|drug-drug interaction|drug-drug interaction
5068364|NCT01348867|Diabetes|diabetes
5068365|NCT01348867|Structured Care|structured care
5068366|NCT01348854|astigmatism|astigmatism
5068367|NCT01348841|community wound care|community wound care
5068368|NCT01348841|systematic wound team referral|systematic wound team referral
5068369|NCT01348841|Advanced in-home nurse wound training|advanced in-home nurse wound training
5068370|NCT01348828|Abdominal Aortic Aneurysm|abdominal aortic aneurysm
5068371|NCT01348828|Fenestrated|fenestrated
5068372|NCT01348828|Renal Stent|renal stent
5068373|NCT01348828|Juxtarenal|juxtarenal
5068374|NCT01348828|Pararenal|pararenal
5068375|NCT01348828|Endologix|endologix
5068376|NCT01348828|Renal|renal
5068377|NCT01348802|Knowledge Translation|knowledge translation
5068378|NCT01348802|Push-out Evidence|push-out evidence
5068379|NCT01348802|Technology-Based Knowledge Translation|technology-based knowledge translation
5068380|NCT01348802|Pain|pain
5068381|NCT01348802|Interdisciplinary|interdisciplinary
5068382|NCT01348802|Physician|physician
5068383|NCT01348802|Rehabilitation|rehabilitation
5068384|NCT01348802|Nursing|nursing
5068385|NCT01348802|Knowledge Uptake|knowledge uptake
5068386|NCT01348789|Hair removal|hair removal
5068387|NCT01348789|Hair Clearance|hair clearance
5068388|NCT01348789|Epilation|epilation
5068389|NCT01348776|hair reduction|hair reduction
5068390|NCT01348776|hair removal|hair removal
5068391|NCT01348776|hair clearance|hair clearance
5068392|NCT01348750|PTSD|ptsd
5068393|NCT01348750|Healing Touch|healing touch
5068394|NCT01348750|Guided Imagery|guided imagery
5068395|NCT01348750|Military|military
5068396|NCT01348750|Complementary Medicine|complementary medicine
5068397|NCT01348737|Phase 1|phase 1
5068398|NCT01348737|healthy volunteers|healthy volunteers
5068399|NCT01348737|double-blind|double-blind
5068400|NCT01348737|placebo-controlled|placebo-controlled
5068401|NCT01348737|AZD3839|azd3839
5068402|NCT01348737|pharmacokinetics|pharmacokinetics
5068403|NCT01348737|Alzheimer's Disease|alzheimer's disease
5068404|NCT01348724|Radioactive carbon|radioactive carbon
5068405|NCT01348724|Absorption|absorption
5068406|NCT01348724|Distribution|distribution
5068407|NCT01348724|Metabolism|metabolism
5068408|NCT01348724|Excretion|excretion
5068409|NCT01348724|Healthy Volunteers|healthy volunteers
5068410|NCT01348711|Pre-eclampsia|pre-eclampsia
5068411|NCT01348698|Adrenal Cancer|adrenal cancer
5068412|NCT01348698|Pheochromocytoma|pheochromocytoma
5068413|NCT01348698|Functioning Tumor|functioning tumor
5068414|NCT01348698|Nonfunctioning Tumor|nonfunctioning tumor
5068415|NCT01348698|Gene Expression|gene expression
5068416|NCT01348698|Adrenal Tumor|adrenal tumor
5068417|NCT01348672|Age related macular degeneration|age related macular degeneration
5068418|NCT01348672|Glaucoma|glaucoma
5068419|NCT01348672|Diabetic retinopathy|diabetic retinopathy
5068420|NCT01348672|Retinal oxygen saturation|retinal oxygen saturation
5068421|NCT01348672|Blood flow|blood flow
5068422|NCT01348672|Vascular function|vascular function
5068423|NCT01348672|High resolution imaging|high resolution imaging
5068424|NCT01348659|Hypertonic saline|hypertonic saline
5068425|NCT01348659|Extracellular fluid|extracellular fluid
5068426|NCT01348659|cardiopulmonary bypass|cardiopulmonary bypass
5068427|NCT01348646|Smoking|smoking
5068428|NCT01348646|Adolescence|adolescence
5068429|NCT01348646|Brief intervention|brief intervention
5068430|NCT01348633|Doppler SD-OCT Blood Flow Technology|doppler sd-oct blood flow technology
5068431|NCT01348633|Retinal and choroidal blood flow|retinal and choroidal blood flow
5068432|NCT01348633|Canon Laser Blood Flowmeter|canon laser blood flowmeter
5068433|NCT01348620|single port cholecystectomy|single port cholecystectomy
5068434|NCT01348607|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
5068435|NCT01348607|sleep disorders|sleep disorders
5068436|NCT01348607|fatigue|fatigue
5068437|NCT01348607|childhood craniopharyngioma|childhood craniopharyngioma
5068438|NCT01348594|Vitamin D|vitamin d
5068439|NCT01348594|In vitro Fertilization|in vitro fertilization
5068440|NCT01348581|Adult|adult
5068441|NCT01348581|Aged|aged
5068442|NCT01348581|Aged, 80 and over|aged, 80 and over
5068443|NCT01348581|Bandages|bandages
5068444|NCT01348581|Biological Dressings|biological dressings
5068445|NCT01348581|Chronic Disease|chronic disease
5068446|NCT01348581|Collagen|collagen
5068447|NCT01348581|Epithelium|epithelium
5068448|NCT01348581|Extracellular Matrix|extracellular matrix
5068449|NCT01348581|Fibroblasts|fibroblasts
5068450|NCT01348581|Granulation Tissue|granulation tissue
5068451|NCT01348581|Humans|humans
5068452|NCT01348581|Leg Ulcer|leg ulcer
5068453|NCT01348581|Middle Aged|middle aged
5068454|NCT01348581|Prospective Studies|prospective studies
5068455|NCT01348581|Soft Tissue Injuries|soft tissue injuries
5068456|NCT01348581|Treatment Outcome|treatment outcome
5068457|NCT01348581|Varicose Ulcer|varicose ulcer
5068458|NCT01348581|Wound Healing|wound healing
5068459|NCT01348581|Wounds and Injuries|wounds and injuries
5068460|NCT01348555|COPD|copd
5068461|NCT01348542|Chronic Insomnia|chronic insomnia
5068462|NCT01348542|Short Sleep Duration|short sleep duration
5068463|NCT01348542|Trazodone|trazodone
5068464|NCT01348542|Cognitive Behavioral Therapy|cognitive behavioral therapy
5068465|NCT01348542|Efficacy|efficacy
5068466|NCT01348529|OCD|ocd
5068467|NCT01348529|CBT|cbt
5068468|NCT01348529|Reducing OCD symptoms|reducing ocd symptoms
5068469|NCT01348516|HIV|hiv
5068470|NCT01348490|PMF|pmf
5068471|NCT01348490|PPV-MF|ppv-mf
5068472|NCT01348490|PET-MF|pet-mf
5068473|NCT01348477|inguinal|inguinal
5068474|NCT01348477|hernia|hernia
5068475|NCT01348477|pain|pain
5068476|NCT01348477|inguinodynia|inguinodynia
5068477|NCT01348477|mesh|mesh
5068478|NCT01348464|appendectomy|appendectomy
5068479|NCT01348464|appendicitis|appendicitis
5068480|NCT01348464|laparoscopic surgery|laparoscopic surgery
5068481|NCT01348451|Human spinal cord derived neural stem cell transplantation|human spinal cord derived neural stem cell transplantation
5068482|NCT01348451|ALS|als
5068483|NCT01348438|high risk|high risk
5068484|NCT01348438|surgical valve replacement|surgical valve replacement
5068485|NCT01348425|PAD|pad
5068486|NCT01348412|non resectable metastases|non resectable metastases
5068487|NCT01348412|liver of colic or rectal origin|liver of colic or rectal origin
5068488|NCT01348412|after failure of the conventional treatments|after failure of the conventional treatments
5068489|NCT01348399|Coronary artery disease requiring drug eluting stents|coronary artery disease requiring drug eluting stents
5068490|NCT01348386|Potassium hydroxide.|potassium hydroxide.
5068491|NCT01348386|Molluscum Contagiosum|molluscum contagiosum
5068492|NCT01348373|drug eluting stents|drug eluting stents
5068493|NCT01348334|Sling surgery|sling surgery
5068494|NCT01348334|synthetic meshes|synthetic meshes
5068495|NCT01348334|ultrapromesh®|ultrapromesh®
5068496|NCT01348334|mix mesh|mix mesh
5068497|NCT01348334|incontinence|incontinence
5068498|NCT01348334|The Ultrapromesh® synthetic sling procedures have lower complications incidence and higher success rates than the other synthetic slings in 3-year follow-up.|the ultrapromesh® synthetic sling procedures have lower complications incidence and higher success rates than the other synthetic slings in 3-year follow-up.
5068499|NCT01348308|Late diagnosed HIV-1 infected patients|late diagnosed hiv-1 infected patients
5068500|NCT01348308|AIDS-defining events|aids-defining events
5068501|NCT01348308|Immune restoration|immune restoration
5068906|NCT01346813|Premature|premature
5068502|NCT01348295|Mechanical ventilation|mechanical ventilation
5068503|NCT01348295|Children|children
5068504|NCT01348295|Neonates|neonates
5068505|NCT01348295|Pediatric intensive care|pediatric intensive care
5068506|NCT01348282|Neurocognitive Impairment|neurocognitive impairment
5068507|NCT01348282|Controlled Randomized Trial|controlled randomized trial
5068508|NCT01348282|Coadjunctive Treatments|coadjunctive treatments
5068509|NCT01348282|Lithium; Rivastigmine|lithium; rivastigmine
5068510|NCT01348282|Antiretroviral Therapy|antiretroviral therapy
5068511|NCT01348282|HIV Infection|hiv infection
5068512|NCT01348269|bone marrow edema|bone marrow edema
5068513|NCT01348269|Aclasta|aclasta
5068514|NCT01348256|colorectal carcinoma|colorectal carcinoma
5068515|NCT01348256|resectable hepatic metastasis|resectable hepatic metastasis
5068516|NCT01348256|adjuvant treatment|adjuvant treatment
5068517|NCT01348256|dendritic cells|dendritic cells
5068518|NCT01348230|Premature prolonged rupture of membranes|premature prolonged rupture of membranes
5068519|NCT01348230|Premature labor|premature labor
5068520|NCT01348230|Uromodulin|uromodulin
5068521|NCT01348230|Glycosylation|glycosylation
5068522|NCT01348217|unoperated cancers|unoperated cancers
5068523|NCT01348217|oesophagus|oesophagus
5068524|NCT01348217|radiochemotherapy|radiochemotherapy
5068525|NCT01348217|with and without increased doses|with and without increased doses
5068526|NCT01348204|Cystic Fibrosis|cystic fibrosis
5068527|NCT01348191|Thyrotrophin|thyrotrophin
5068528|NCT01348191|Pregnancy|pregnancy
5068529|NCT01348191|Human myometrium|human myometrium
5068530|NCT01348191|Relaxation|relaxation
5068531|NCT01348191|Contractility|contractility
5068532|NCT01348152|Gastric Emptying|gastric emptying
5068533|NCT01348139|Asthma|asthma
5068534|NCT01348139|patients|patients
5068535|NCT01348139|lung function|lung function
5068536|NCT01348126|Advanced non-small cell lung cancer|advanced non-small cell lung cancer
5068537|NCT01348126|NSCLC|nsclc
5068538|NCT01348126|Lung cancer|lung cancer
5068539|NCT01348113|Alcohol Use Disorders Identification Test|alcohol use disorders identification test
5068540|NCT01348113|alcohol dependence|alcohol dependence
5068541|NCT01348113|Alcohol problem|alcohol problem
5068542|NCT01348100|Schizophrenia|schizophrenia
5068543|NCT01348100|Iloperidone|iloperidone
5068544|NCT01348100|Depot|depot
5068545|NCT01348100|Injection|injection
5068546|NCT01348087|Fragile X Syndrome|fragile x syndrome
5068547|NCT01348087|Martin-Bell Syndrome|martin-bell syndrome
5068548|NCT01348087|Genetic Diseases|genetic diseases
5068549|NCT01348087|X-Linked|x-linked
5068550|NCT01348087|Escalante's syndrome|escalante's syndrome
5068551|NCT01348074|warfarin|warfarin
5068552|NCT01348074|surgery|surgery
5068553|NCT01348074|management|management
5068554|NCT01348074|thromboembolism|thromboembolism
5068555|NCT01348074|bleeding|bleeding
5068556|NCT01348061|Alzheimers Disease|alzheimers disease
5068557|NCT01348061|Progressive Supranuclear Palsy|progressive supranuclear palsy
5068558|NCT01348061|CSF|csf
5068559|NCT01348061|Cerebrospinal Fluid|cerebrospinal fluid
5068560|NCT01348061|Biomarker|biomarker
5068561|NCT01348061|Heavy Water|heavy water
5068562|NCT01348061|Cargo proteins|cargo proteins
5068563|NCT01348048|palliative care|palliative care
5068564|NCT01348048|end-of-life care|end-of-life care
5068565|NCT01348048|randomized clinical trial|randomized clinical trial
5068566|NCT01348048|quality of life|quality of life
5068567|NCT01348048|needs assessment|needs assessment
5068568|NCT01348048|patient satisfaction|patient satisfaction
5068569|NCT01348048|cost-effectiveness|cost-effectiveness
5068570|NCT01348048|Screening|screening
5068571|NCT01348035|Autosomal Dominant Polycystic Kidney Disease.|autosomal dominant polycystic kidney disease.
5068572|NCT01348035|Arginine vasopressin|arginine vasopressin
5068573|NCT01348035|Total Kidney Volume|total kidney volume
5068574|NCT01348035|Glomerular Filtration Rate|glomerular filtration rate
5068575|NCT01348009|Gastric cancer|gastric cancer
5068576|NCT01348009|First-line therapy|first-line therapy
5068577|NCT01348009|Tesetaxel|tesetaxel
5068578|NCT01348009|Taxane|taxane
5068579|NCT01348009|Capecitabine|capecitabine
5068580|NCT01348009|Oral fluoropyrimidine|oral fluoropyrimidine
5068581|NCT01348009|Cisplatin|cisplatin
5068582|NCT01348009|Platinum|platinum
5068583|NCT01347996|AML|aml
5068584|NCT01347996|Leukemia|leukemia
5068585|NCT01347996|Acute Myeloid Leukemia|acute myeloid leukemia
5068586|NCT01347996|Minimal Residual Disease|minimal residual disease
5068587|NCT01347996|Ceplene|ceplene
5068588|NCT01347996|Histamine|histamine
5068589|NCT01347996|interleukin 2|interleukin 2
5068590|NCT01347983|RA|ra
5068591|NCT01347970|childhood cancer survivor|childhood cancer survivor
5068592|NCT01347970|CHF|chf
5068593|NCT01347970|risk of congestive heart failure|risk of congestive heart failure
5068594|NCT01347944|MORE|more
5068595|NCT01347944|Monitoring Revlimid|monitoring revlimid
5068596|NCT01347944|Myelodysplastic Syndrome|myelodysplastic syndrome
5068597|NCT01347944|Transfusion-dependent anemia|transfusion-dependent anemia
5068598|NCT01347944|5q deletion|5q deletion
5068599|NCT01347944|lenalidomide|lenalidomide
5068600|NCT01347918|Fluorine MRI, small intestinal transit and motor activity|fluorine mri, small intestinal transit and motor activity
5068907|NCT01346813|Pain|pain
5068601|NCT01347892|Talar injury|talar injury
5068602|NCT01347892|ankle|ankle
5068603|NCT01347892|lesion|lesion
5068604|NCT01347892|defect|defect
5068605|NCT01347892|cartilage repair|cartilage repair
5068606|NCT01347879|Acne vulgaris|acne vulgaris
5068607|NCT01347879|PDT|pdt
5068608|NCT01347866|Advanced metastatic cancer (solid tumors)|advanced metastatic cancer (solid tumors)
5068609|NCT01347866|PI3K|pi3k
5068610|NCT01347866|mTOR|mtor
5068611|NCT01347866|MEK|mek
5068612|NCT01347840|Obesity Gastric Bypass Roux en Y|obesity gastric bypass roux en y
5068613|NCT01347827|Coronary artery bypass surgery|coronary artery bypass surgery
5068614|NCT01347827|Oximetry|oximetry
5068615|NCT01347827|Brain metabolism|brain metabolism
5068616|NCT01347814|Domperidone|domperidone
5068617|NCT01347814|gastric emptying|gastric emptying
5068618|NCT01347814|obesity|obesity
5068619|NCT01347814|diabetes mellitus|diabetes mellitus
5068620|NCT01347814|Domperidone/pharmacology|domperidone/pharmacology
5068621|NCT01347814|Pharmacologic Actions|pharmacologic actions
5068622|NCT01347814|Physiological Effects of Drugs|physiological effects of drugs
5068623|NCT01347814|Gastrointestinal Agents|gastrointestinal agents
5068624|NCT01347814|Humans|humans
5068625|NCT01347801|GLP-1|glp-1
5068626|NCT01347801|Inflammation|inflammation
5068627|NCT01347801|Glucose|glucose
5068628|NCT01347788|Prostate cancer|prostate cancer
5068629|NCT01347788|Castration Resistant|castration resistant
5068630|NCT01347788|Bone Metastases|bone metastases
5068631|NCT01347775|Renal failure|renal failure
5068632|NCT01347775|Respiratory muscles|respiratory muscles
5068633|NCT01347775|Resistance training|resistance training
5068634|NCT01347762|cannabis dependence|cannabis dependence
5068635|NCT01347762|marijuana dependence|marijuana dependence
5068636|NCT01347762|cannabis use disorders|cannabis use disorders
5068637|NCT01347762|cannabis withdrawal|cannabis withdrawal
5068638|NCT01347762|nabilone|nabilone
5068639|NCT01347749|Meditation|meditation
5068640|NCT01347749|Mindfulness|mindfulness
5068641|NCT01347749|Compassion|compassion
5068642|NCT01347749|Group Psychotherapy|group psychotherapy
5068643|NCT01347749|Emotional Regulation|emotional regulation
5068644|NCT01347749|fMRI|fmri
5068645|NCT01347710|Coronary Artery Disease.|coronary artery disease.
5068646|NCT01347710|Positron Emission Tomography Myocardial Perfusion Imaging.|positron emission tomography myocardial perfusion imaging.
5068647|NCT01347710|Single Positron Emission Computed Tomography.|single positron emission computed tomography.
5068648|NCT01347710|Flurpiridaz F18 Injection.|flurpiridaz f18 injection.
5068649|NCT01347697|rectal neoplasms|rectal neoplasms
5068650|NCT01347697|reconstructive surgical procedure|reconstructive surgical procedure
5068651|NCT01347697|bioprosthesis|bioprosthesis
5068652|NCT01347697|surgical flaps|surgical flaps
5068653|NCT01347697|locomotion|locomotion
5068654|NCT01347697|lesser pelvis|lesser pelvis
5068655|NCT01347684|headache|headache
5068656|NCT01347684|elavil|elavil
5068657|NCT01347684|splints|splints
5068658|NCT01347684|physical therapy|physical therapy
5068659|NCT01347684|behavioral therapy|behavioral therapy
5068660|NCT01347671|analgesia|analgesia
5068661|NCT01347671|analgesics|analgesics
5068662|NCT01347671|pain|pain
5068663|NCT01347671|chronic pain|chronic pain
5068664|NCT01347671|neuropathic pain|neuropathic pain
5068665|NCT01347658|etravirine|etravirine
5068666|NCT01347658|Echinacea purpurea|echinacea purpurea
5068667|NCT01347658|interaction|interaction
5068668|NCT01347645|locally advanced|locally advanced
5068669|NCT01347645|metastatic colon|metastatic colon
5068670|NCT01347645|rectal cancer|rectal cancer
5068671|NCT01347632|Bacterial Vaginosis|bacterial vaginosis
5068672|NCT01347632|Vaginal discharge|vaginal discharge
5068673|NCT01347632|Vaginal infections|vaginal infections
5068674|NCT01347619|Comparative Effectiveness Research Summary Guide (CERSG)|comparative effectiveness research summary guide (cersg)
5068675|NCT01347619|anti-psychotic use|anti-psychotic use
5068676|NCT01347619|Nursing Home|nursing home
5068677|NCT01347619|Long-term care|long-term care
5068678|NCT01347619|Qualitative assessment of influences on CERSG adoption in NH|qualitative assessment of influences on cersg adoption in nh
5068679|NCT01347619|Development of toolkit of CERSG-based products for NHs|development of toolkit of cersg-based products for nhs
5068680|NCT01347619|Evaluation of 3 implementation strategies of the toolkit|evaluation of 3 implementation strategies of the toolkit
5068681|NCT01347606|thyroid|thyroid
5068682|NCT01347606|secure|secure
5068683|NCT01347606|surgery|surgery
5068684|NCT01347606|methylene|methylene
5068685|NCT01347606|blue|blue
5068686|NCT01347593|ceftizoxime|ceftizoxime
5068687|NCT01347593|Cesarean|cesarean
5068688|NCT01347593|post caesarean febrile morbidity|post caesarean febrile morbidity
5068689|NCT01347580|Heart attack|heart attack
5068690|NCT01347580|heart disease|heart disease
5068691|NCT01347580|cardiovascular disease|cardiovascular disease
5068692|NCT01347580|stroke|stroke
5068693|NCT01347580|reperfusion|reperfusion
5068694|NCT01347580|pre hospital settings|pre hospital settings
5068695|NCT01347580|ticagrelor|ticagrelor
5068696|NCT01347580|Percutaneous Coronary Intervention|percutaneous coronary intervention
5068697|NCT01347567|Fingerstick BNP test|fingerstick bnp test
5068698|NCT01347567|Home Health Management System|home health management system
5068699|NCT01347567|Acute Decompensated Heart Failure|acute decompensated heart failure
5068700|NCT01347567|Hospital Readmission|hospital readmission
5068701|NCT01347567|Prevention|prevention
5068702|NCT01347554|drug-eluting stent|drug-eluting stent
5068703|NCT01347554|everolimus|everolimus
5068704|NCT01347554|zotarolimus|zotarolimus
5068705|NCT01347554|myocardial ischemia|myocardial ischemia
5068706|NCT01347554|cardiovascular diseases|cardiovascular diseases
5068707|NCT01347554|MACE|mace
5068708|NCT01347554|safety|safety
5068709|NCT01347541|PTSD|ptsd
5068710|NCT01347528|Medication adherence|medication adherence
5068711|NCT01347528|Heart failure|heart failure
5068712|NCT01347528|Telemonitoring|telemonitoring
5068713|NCT01347528|Determinants of adherence|determinants of adherence
5068714|NCT01347515|Phenol-enriched olive oil|phenol-enriched olive oil
5068715|NCT01347515|bioavailability|bioavailability
5068716|NCT01347515|bioactivity|bioactivity
5068717|NCT01347489|gender|gender
5068718|NCT01347476|prostate-specific antigen|prostate-specific antigen
5068719|NCT01347476|radical prostatectomy|radical prostatectomy
5068720|NCT01347450|Flavonoids|flavonoids
5068721|NCT01347450|cacao|cacao
5068722|NCT01347450|lipid peroxidation|lipid peroxidation
5068723|NCT01347450|plasma|plasma
5068724|NCT01347437|HIV|hiv
5068725|NCT01347437|antiretroviral medication|antiretroviral medication
5068726|NCT01347437|adherence|adherence
5068727|NCT01347437|adolescent|adolescent
5068728|NCT01347424|NSCLC|nsclc
5068729|NCT01347424|NPC|npc
5068730|NCT01347398|Sleep apnoea|sleep apnoea
5068731|NCT01347398|Diagnosis|diagnosis
5068732|NCT01347398|Blood pressure|blood pressure
5068733|NCT01347398|Body mass index|body mass index
5068734|NCT01347398|Breath analysis|breath analysis
5068735|NCT01347385|Fibroids|fibroids
5068736|NCT01347385|Laparoscopic myomectomy|laparoscopic myomectomy
5068737|NCT01347385|Barbed suture|barbed suture
5068738|NCT01347372|peer support|peer support
5068739|NCT01347372|peer mentoring|peer mentoring
5068740|NCT01347372|peer counselling|peer counselling
5068741|NCT01347372|arthritis|arthritis
5068742|NCT01347372|chronic disease|chronic disease
5068743|NCT01347372|inflammatory arthritis|inflammatory arthritis
5068744|NCT01347372|early inflammatory arthritis|early inflammatory arthritis
5068745|NCT01347372|rheumatoid arthritis|rheumatoid arthritis
5068746|NCT01347359|Peer support|peer support
5068747|NCT01347359|Peer mentoring|peer mentoring
5068748|NCT01347359|Peer counselling|peer counselling
5068749|NCT01347359|Arthritis|arthritis
5068750|NCT01347359|Inflammatory arthritis|inflammatory arthritis
5068751|NCT01347359|Early inflammatory arthritis|early inflammatory arthritis
5068752|NCT01347359|Rheumatoid arthritis|rheumatoid arthritis
5068753|NCT01347359|Chronic disease|chronic disease
5068754|NCT01347346|Wiskott-Aldrich Syndrome|wiskott-aldrich syndrome
5068755|NCT01347346|Primary immune deficiency|primary immune deficiency
5068756|NCT01347346|ex vivo gene therapy|ex vivo gene therapy
5068757|NCT01347346|hematopoietic stem cells|hematopoietic stem cells
5068758|NCT01347333|liver metastases|liver metastases
5068759|NCT01347333|stereotactic radiotherapy|stereotactic radiotherapy
5068760|NCT01347320|Prostate cancer|prostate cancer
5068761|NCT01347320|preoperative staging|preoperative staging
5068762|NCT01347320|MRI|mri
5068763|NCT01347320|Free surgical margins|free surgical margins
5068764|NCT01347307|stereotactic radiotherapy|stereotactic radiotherapy
5068765|NCT01347307|spinal metastases|spinal metastases
5068766|NCT01347307|vertebral metastases|vertebral metastases
5068767|NCT01347307|benign spinal tumors|benign spinal tumors
5068768|NCT01347281|Cancer of the Head and Neck|cancer of the head and neck
5068769|NCT01347281|[18F]HX4|[18f]hx4
5068770|NCT01347281|hypoxia|hypoxia
5068771|NCT01347281|PET|pet
5068772|NCT01347281|phase II trial|phase ii trial
5068773|NCT01347268|coasting|coasting
5068774|NCT01347268|withdrawing GnRH agonist|withdrawing gnrh agonist
5068775|NCT01347268|GnRH antagonist|gnrh antagonist
5068776|NCT01347268|IVF|ivf
5068777|NCT01347242|Wiskott-Aldrich Syndrome|wiskott-aldrich syndrome
5068778|NCT01347242|Primary immune deficiency|primary immune deficiency
5068779|NCT01347242|ex vivo gene therapy|ex vivo gene therapy
5068780|NCT01347242|hematopoietic stem cells|hematopoietic stem cells
5068781|NCT01347229|Glaucoma|glaucoma
5068782|NCT01347229|Triggerfish|triggerfish
5068783|NCT01347229|body position|body position
5068784|NCT01347216|Drug treatment|drug treatment
5068785|NCT01347216|Treatment pathways|treatment pathways
5068786|NCT01347216|Clinical routine|clinical routine
5068787|NCT01347216|Registry|registry
5068788|NCT01347216|Treatment outcomes|treatment outcomes
5068789|NCT01347216|Endothelin receptor antagonist|endothelin receptor antagonist
5068790|NCT01347216|Phosphodiesterase-V inhibitor|phosphodiesterase-v inhibitor
5068791|NCT01347216|Prostanoid|prostanoid
5068792|NCT01347216|Sildenafil|sildenafil
5068793|NCT01347216|Bosentan|bosentan
5068794|NCT01347216|Macitentan|macitentan
5068795|NCT01347216|Sitaxentan|sitaxentan
5068796|NCT01347216|Ambrisentan|ambrisentan
5068797|NCT01347216|Imatinib|imatinib
5068798|NCT01347216|Epoprostenol|epoprostenol
5068799|NCT01347216|Treprostinil|treprostinil
5068800|NCT01347216|Iloprost|iloprost
5068801|NCT01347216|Infusion pump|infusion pump
5068802|NCT01347216|Riociguat|riociguat
5068803|NCT01347216|soluble guanylate cyclase stimulator|soluble guanylate cyclase stimulator
5068804|NCT01347216|Quality of life|quality of life
5068805|NCT01347216|Patient-related outcomes|patient-related outcomes
5068806|NCT01347216|Economic model|economic model
5068807|NCT01347216|Adverse event|adverse event
5068808|NCT01347216|Safety|safety
5068809|NCT01347216|Combination therapy|combination therapy
5068810|NCT01347216|Internet|internet
5068811|NCT01347216|Europe|europe
5068812|NCT01347216|Australia|australia
5068813|NCT01347216|Japan|japan
5068814|NCT01347216|Eisenmenger|eisenmenger
5068815|NCT01347216|Adults|adults
5068816|NCT01347216|Children|children
5068817|NCT01347216|Selexipag|selexipag
5068818|NCT01347216|Baltic states|baltic states
5068819|NCT01347203|phase I|phase i
5068820|NCT01347203|healthy volunteers|healthy volunteers
5068821|NCT01347203|crossover study|crossover study
5068822|NCT01347203|pharmacokinetics|pharmacokinetics
5068823|NCT01347203|pharmacodynamics|pharmacodynamics
5068824|NCT01347190|Cystic Fibrosis|cystic fibrosis
5068825|NCT01347164|bisexual|bisexual
5068826|NCT01347164|HIV prevention|hiv prevention
5068827|NCT01347151|Glide scope|glide scope
5068828|NCT01347151|Pentax|pentax
5068829|NCT01347151|C spine movement|c spine movement
5068830|NCT01347138|Screening|screening
5068831|NCT01347138|depression|depression
5068832|NCT01347138|case management|case management
5068833|NCT01347125|DHF (diastolic heart failure)|dhf (diastolic heart failure)
5069073|NCT01346254|after|after
5068834|NCT01347125|HFNEF (heart failure with normal ejection fraction|hfnef (heart failure with normal ejection fraction
5068836|NCT01347112|tobacco dependence|tobacco dependence
5068837|NCT01347112|alcohol dependence|alcohol dependence
5068838|NCT01347099|CBT|cbt
5068839|NCT01347099|OCD|ocd
5068840|NCT01347099|Internet|internet
5068841|NCT01347099|Reduce symptom burden|reduce symptom burden
5068842|NCT01347073|Urea Cycle Disorder|urea cycle disorder
5068843|NCT01347073|UCD|ucd
5068844|NCT01347073|GT4P|gt4p
5068845|NCT01347073|Buphenyl|buphenyl
5068846|NCT01347073|hyperammonemia|hyperammonemia
5068847|NCT01347073|sodium phenylbutyrate|sodium phenylbutyrate
5068848|NCT01347060|Asthma|asthma
5068849|NCT01347060|treatment|treatment
5068850|NCT01347060|Advair and inhaled corticosteroids|advair and inhaled corticosteroids
5068851|NCT01347060|Medicare|medicare
5068852|NCT01347060|Outcomes|outcomes
5068853|NCT01347060|costs|costs
5068854|NCT01347047|Amyloidosis|amyloidosis
5068855|NCT01347047|Known or Suspected|known or suspected
5068856|NCT01347034|radiation|radiation
5068857|NCT01347034|neoadjuvant|neoadjuvant
5068858|NCT01347034|intratumoral|intratumoral
5068859|NCT01347034|autologous|autologous
5068860|NCT01347034|dendritic cells|dendritic cells
5068861|NCT01347021|vaginal colpopexy sacrospinous|vaginal colpopexy sacrospinous
5068862|NCT01347021|vaginal colpopexy uterosacral|vaginal colpopexy uterosacral
5068863|NCT01347008|Sildenafil|sildenafil
5068864|NCT01347008|Endothelial Progenitor Cells|endothelial progenitor cells
5068865|NCT01347008|Laser Doppler Imaging|laser doppler imaging
5068866|NCT01346982|Darunavir|darunavir
5068867|NCT01346982|Silimarine|silimarine
5068868|NCT01346982|interaction|interaction
5068869|NCT01346969|Skin scarring|skin scarring
5068870|NCT01346969|cicatrix|cicatrix
5068871|NCT01346969|breast scar|breast scar
5068872|NCT01346956|Cigarette|cigarette
5068873|NCT01346956|Smoking|smoking
5068874|NCT01346956|Cardiovascular Effects|cardiovascular effects
5068875|NCT01346956|2D Echocardiography|2d echocardiography
5068876|NCT01346956|Doppler|doppler
5068877|NCT01346943|Abdominal Aortic Aneurysms, AAA|abdominal aortic aneurysms, aaa
5068878|NCT01346930|Idiopathic pulmonary fibrosis|idiopathic pulmonary fibrosis
5068879|NCT01346930|IPF|ipf
5068880|NCT01346930|pulmonary fibrosis|pulmonary fibrosis
5068881|NCT01346917|Colorectal cancer|colorectal cancer
5068882|NCT01346917|Laparoscopic surgery|laparoscopic surgery
5068883|NCT01346917|Postoperative ileus|postoperative ileus
5068884|NCT01346917|Lidocaine|lidocaine
5068885|NCT01346917|Early oral feeding|early oral feeding
5068886|NCT01346878|Ultra deep sequencing|ultra deep sequencing
5068887|NCT01346878|Virological failure|virological failure
5068888|NCT01346878|Salvage antiretroviral therapy|salvage antiretroviral therapy
5068889|NCT01346865|triple anti-platelet therapy|triple anti-platelet therapy
5068890|NCT01346865|dual antiplatelet therapy|dual antiplatelet therapy
5068891|NCT01346865|DES|des
5068892|NCT01346865|Coronary Artery Disease|coronary artery disease
5068893|NCT01346852|pediatrics|pediatrics
5068894|NCT01346852|Medicaid|medicaid
5068895|NCT01346852|asthma|asthma
5068896|NCT01346852|outcomes|outcomes
5068897|NCT01346852|asthma medication ratio|asthma medication ratio
5068898|NCT01346839|Diagnostic delay|diagnostic delay
5068899|NCT01346839|Prevention|prevention
5068900|NCT01346839|Diagnostic errors|diagnostic errors
5068901|NCT01346826|Crohn's disease|crohn's disease
5068902|NCT01346826|Ulcerative colitis|ulcerative colitis
5068903|NCT01346826|Infliximab|infliximab
5068904|NCT01346826|Infusion reaction|infusion reaction
5068905|NCT01346813|Newborns|newborns
5068908|NCT01346813|Pain assessment|pain assessment
5068909|NCT01346813|Painful Procedures|painful procedures
5068910|NCT01346813|Stressful Procedures|stressful procedures
5068911|NCT01346813|Endotracheal Intubation|endotracheal intubation
5068912|NCT01346813|Analgesia|analgesia
5068913|NCT01346813|Sedation|sedation
5068914|NCT01346813|Longterm effects of pain|longterm effects of pain
5068915|NCT01346813|Epidemiology|epidemiology
5068916|NCT01346787|carfilzomib|carfilzomib
5068917|NCT01346787|dexamethasone|dexamethasone
5068918|NCT01346787|cyclophosphamide|cyclophosphamide
5068919|NCT01346787|multiple myeloma|multiple myeloma
5068920|NCT01346787|newly diagnosed|newly diagnosed
5068921|NCT01346774|cystitis|cystitis
5068922|NCT01346774|pyelonephritis|pyelonephritis
5068923|NCT01346774|bladder infection|bladder infection
5068924|NCT01346774|kidney infection|kidney infection
5068925|NCT01346761|Genetic Counseling|genetic counseling
5068926|NCT01346761|Genetic Counseling Interventions|genetic counseling interventions
5068927|NCT01346761|Genetic Testing|genetic testing
5068928|NCT01346761|BRCA1 gene|brca1 gene
5068929|NCT01346761|BRCA2 gene|brca2 gene
5068930|NCT01346761|Risk Communication|risk communication
5068931|NCT01346748|vasospasm prevention|vasospasm prevention
5068932|NCT01346735|Ventilator associated pneumonia|ventilator associated pneumonia
5068933|NCT01346735|Catheter related blood stream infection|catheter related blood stream infection
5068934|NCT01346735|Catheter associated urinary tract infection|catheter associated urinary tract infection
5068935|NCT01346735|ICU-related infections (VAP, CAUTI and CRBSI)|icu-related infections (vap, cauti and crbsi)
5068936|NCT01346735|India|india
5068937|NCT01346709|Operative surgical procedures|operative surgical procedures
5068938|NCT01346709|Postoperative pulmonary complications (PPC)|postoperative pulmonary complications (ppc)
5068939|NCT01346709|Epidemiological Study|epidemiological study
5068940|NCT01346709|ARISCAT score|ariscat score
5068941|NCT01346709|Risk Score|risk score
5068942|NCT01346709|Europe|europe
5068943|NCT01346709|PERISCOPE|periscope
5068944|NCT01346709|observational study|observational study
5068945|NCT01346709|Mild respiratory failure|mild respiratory failure
5068946|NCT01346709|Severe respiratory failure|severe respiratory failure
5068947|NCT01346709|acute lung injury (ALI)|acute lung injury (ali)
5068948|NCT01346709|Acute respiratory distress syndrome (ARDS)|acute respiratory distress syndrome (ards)
5068949|NCT01346709|Suspected pulmonary infection|suspected pulmonary infection
5068950|NCT01346709|Pulmonary infiltrate|pulmonary infiltrate
5068951|NCT01346709|Pleural effusion|pleural effusion
5068952|NCT01346709|Atelectasis|atelectasis
5068953|NCT01346709|Pneumothorax|pneumothorax
5068954|NCT01346709|Bronchospasm|bronchospasm
5068955|NCT01346709|Aspiration Pneumonitis|aspiration pneumonitis
5068956|NCT01346709|Cardiopulmonary edema|cardiopulmonary edema
5068957|NCT01346709|Prospective Evaluation|prospective evaluation
5068958|NCT01346709|nonobstetric in-hospital surgical procedure|nonobstetric in-hospital surgical procedure
5068959|NCT01346709|general or regional anaesthesia|general or regional anaesthesia
5068960|NCT01346709|continued 7-day period recruitment|continued 7-day period recruitment
5068961|NCT01346670|Red yeast rice|red yeast rice
5068962|NCT01346670|Lovastatin|lovastatin
5068963|NCT01346670|Bioavailability|bioavailability
5068964|NCT01346657|Nifidipine|nifidipine
5068965|NCT01346657|red yeast rice|red yeast rice
5068966|NCT01346657|drug-drug interaction|drug-drug interaction
5068967|NCT01346644|Probiotic|probiotic
5068968|NCT01346644|infant nutrition|infant nutrition
5068969|NCT01346644|safety|safety
5068970|NCT01346644|infections|infections
5068971|NCT01346618|bone age|bone age
5068972|NCT01346618|children|children
5068973|NCT01346618|x-ray|x-ray
5068974|NCT01346618|ultrasound|ultrasound
5068975|NCT01346618|ultrasound based method|ultrasound based method
5068976|NCT01346618|safe|safe
5068977|NCT01346618|valid|valid
5068978|NCT01346618|reproducable|reproducable
5068979|NCT01346605|Cardiac CT, heart disease|cardiac ct, heart disease
5068980|NCT01346592|Adjuvanted Trivalent Subunit Influenza Vaccine|adjuvanted trivalent subunit influenza vaccine
5068981|NCT01346592|vaccine|vaccine
5068982|NCT01346592|influenza|influenza
5068983|NCT01346592|adjuvant|adjuvant
5068984|NCT01346592|MF-59|mf-59
5068985|NCT01346592|pediatric|pediatric
5068986|NCT01346579|stage IA breast cancer|stage ia breast cancer
5068987|NCT01346579|stage IB breast cancer|stage ib breast cancer
5068988|NCT01346579|estrogen receptor-positive breast cancer|estrogen receptor-positive breast cancer
5068989|NCT01346566|Cionni Ring|cionni ring
5068990|NCT01346566|In-the-bag IOL|in-the-bag iol
5068991|NCT01346566|Subluxated lenses|subluxated lenses
5068992|NCT01346566|Intraoperative Performance|intraoperative performance
5068993|NCT01346566|Postoperative Outcome|postoperative outcome
5068994|NCT01346553|Chronic Venous Insufficiency (CVI)|chronic venous insufficiency (cvi)
5068995|NCT01346527|diabetes|diabetes
5068996|NCT01346527|pregnancy|pregnancy
5068997|NCT01346527|left ventricular dysfunction|left ventricular dysfunction
5068998|NCT01346527|neonatal|neonatal
5068999|NCT01346527|lipid|lipid
5069000|NCT01346527|lipotoxicity|lipotoxicity
5069001|NCT01346527|neurodevelopment|neurodevelopment
5069002|NCT01346514|Homeless Persons|homeless persons
5069003|NCT01346514|Housing|housing
5069004|NCT01346514|Case Management|case management
5069005|NCT01346514|Veterans|veterans
5069006|NCT01346514|Substance Related Disorders|substance related disorders
5069007|NCT01346514|Mental Disorders|mental disorders
5069008|NCT01346514|Social Adjustment|social adjustment
5069009|NCT01346501|Rheumatoid arthritis|rheumatoid arthritis
5069010|NCT01346488|Rheumatoid arthritis|rheumatoid arthritis
5069011|NCT01346449|Obesity|obesity
5069012|NCT01346423|Sick leave|sick leave
5069013|NCT01346423|musculoskeletal pain|musculoskeletal pain
5069014|NCT01346423|return to work|return to work
5069015|NCT01346423|multidisciplinary intervention|multidisciplinary intervention
5069016|NCT01346423|randomised controlled trial|randomised controlled trial
5069017|NCT01346410|pancreatic cancer|pancreatic cancer
5069018|NCT01346397|rejection|rejection
5069019|NCT01346397|survival|survival
5069020|NCT01346397|alemtuzumab|alemtuzumab
5069021|NCT01346397|cyclosporine|cyclosporine
5069022|NCT01346397|tacrolimus|tacrolimus
5069023|NCT01346384|intracuff pressure|intracuff pressure
5069024|NCT01346384|laryngeal tube|laryngeal tube
5069025|NCT01346384|nitrous oxide|nitrous oxide
5069026|NCT01346371|Allergic|allergic
5069027|NCT01346371|conjunctivitis|conjunctivitis
5069028|NCT01346371|Allergic conjunctivitis|allergic conjunctivitis
5069029|NCT01346358|Advanced Solid Tumors|advanced solid tumors
5069030|NCT01346345|Recession|recession
5069031|NCT01346319|dose escalating|dose escalating
5069032|NCT01346293|Tetanus|tetanus
5069033|NCT01346293|Diphtheria|diphtheria
5069034|NCT01346293|Pertussis|pertussis
5069035|NCT01346293|DTap-IPV|dtap-ipv
5069036|NCT01346293|DAPTACEL®|daptacel®
5069037|NCT01346293|VARIVAX®|varivax®
5069038|NCT01346280|Adherence to Evidence-Based Guidelines|adherence to evidence-based guidelines
5069039|NCT01346280|Multidisciplinary Care|multidisciplinary care
5069040|NCT01346280|Patient Experiences|patient experiences
5069041|NCT01346280|Quality of Care Outcomes|quality of care outcomes
5069042|NCT01346267|nausea and vomiting|nausea and vomiting
5069043|NCT01346267|unspecified childhood solid tumor|unspecified childhood solid tumor
5069044|NCT01346267|childhood central nervous system embryonal tumor|childhood central nervous system embryonal tumor
5069045|NCT01346267|childhood central nervous system germ cell tumor|childhood central nervous system germ cell tumor
5069046|NCT01346267|childhood central nervous system germinoma|childhood central nervous system germinoma
5069047|NCT01346267|childhood central nervous system mixed germ cell tumor|childhood central nervous system mixed germ cell tumor
5069048|NCT01346267|childhood central nervous system teratoma|childhood central nervous system teratoma
5069049|NCT01346267|childhood central nervous system yolk sac tumor|childhood central nervous system yolk sac tumor
5069050|NCT01346267|childhood mixed glioma|childhood mixed glioma
5069051|NCT01346267|childhood oligodendroglioma|childhood oligodendroglioma
5069052|NCT01346267|untreated childhood brain stem glioma|untreated childhood brain stem glioma
5069053|NCT01346267|untreated childhood visual pathway and hypothalamic glioma|untreated childhood visual pathway and hypothalamic glioma
5069054|NCT01346267|untreated childhood visual pathway glioma|untreated childhood visual pathway glioma
5069055|NCT01346267|childhood high-grade cerebellar astrocytoma|childhood high-grade cerebellar astrocytoma
5069056|NCT01346267|childhood high-grade cerebral astrocytoma|childhood high-grade cerebral astrocytoma
5069057|NCT01346267|childhood low-grade cerebellar astrocytoma|childhood low-grade cerebellar astrocytoma
5069058|NCT01346267|childhood low-grade cerebral astrocytoma|childhood low-grade cerebral astrocytoma
5069059|NCT01346267|untreated childhood cerebellar astrocytoma|untreated childhood cerebellar astrocytoma
5069060|NCT01346267|untreated childhood cerebral astrocytoma|untreated childhood cerebral astrocytoma
5069061|NCT01346267|untreated childhood subependymal giant cell astrocytoma|untreated childhood subependymal giant cell astrocytoma
5069062|NCT01346267|childhood ependymoblastoma|childhood ependymoblastoma
5069063|NCT01346267|untreated childhood medulloblastoma|untreated childhood medulloblastoma
5069064|NCT01346267|untreated childhood pineoblastoma|untreated childhood pineoblastoma
5069065|NCT01346267|childhood choroid plexus tumor|childhood choroid plexus tumor
5069066|NCT01346267|childhood craniopharyngioma|childhood craniopharyngioma
5069067|NCT01346267|childhood supratentorial ependymoma|childhood supratentorial ependymoma
5069068|NCT01346267|childhood supratentorial primitive neuroectodermal tumor|childhood supratentorial primitive neuroectodermal tumor
5069069|NCT01346267|childhood medulloepithelioma|childhood medulloepithelioma
5069070|NCT01346267|childhood infratentorial ependymoma|childhood infratentorial ependymoma
5069071|NCT01346267|newly diagnosed childhood ependymoma|newly diagnosed childhood ependymoma
5069072|NCT01346267|childhood meningioma|childhood meningioma
5069074|NCT01346241|Panic|panic
5069075|NCT01346241|Anxiety|anxiety
5069076|NCT01346228|Panic|panic
5069077|NCT01346228|Panic Disorder|panic disorder
5069078|NCT01346228|Anxiety|anxiety
5069079|NCT01346215|heparin|heparin
5069080|NCT01346215|renal insufficiency, chronic|renal insufficiency, chronic
5069081|NCT01346215|extracorporeal dialysis|extracorporeal dialysis
5069082|NCT01346215|fibrinolytic agents|fibrinolytic agents
5069083|NCT01346215|anticoagulants|anticoagulants
5069084|NCT01346215|aPTT|aptt
5069085|NCT01346202|multi-modal pain therapy, chronic pain|multi-modal pain therapy, chronic pain
5069086|NCT01346189|Cardiovascular Disease|cardiovascular disease
5069087|NCT01346163|Schizophrenia|schizophrenia
5069088|NCT01346163|Cognitive Impairment|cognitive impairment
5069193|NCT01345630|Ccr5 tropic|ccr5 tropic
5069089|NCT01346163|Electrophysiology|electrophysiology
5069090|NCT01346163|H3 receptor antagonist|h3 receptor antagonist
5069091|NCT01346137|ovulation|ovulation
5069092|NCT01346137|unruptured luteinized follicle|unruptured luteinized follicle
5069093|NCT01346137|meloxicam|meloxicam
5069094|NCT01346124|radiation|radiation
5069095|NCT01346124|IMRT|imrt
5069096|NCT01346124|IMPT|impt
5069097|NCT01346098|diabetes|diabetes
5069098|NCT01346098|islet transplantation|islet transplantation
5069099|NCT01346098|pancreas|pancreas
5069100|NCT01346098|pancreatectomy|pancreatectomy
5069101|NCT01346085|islet transplantation|islet transplantation
5069102|NCT01346085|brittle diabetes|brittle diabetes
5069103|NCT01346085|type 1 diabetes|type 1 diabetes
5069104|NCT01346072|tolvaptan|tolvaptan
5069105|NCT01346072|copeptin|copeptin
5069106|NCT01346072|heart failure|heart failure
5069107|NCT01346072|vasopressin antagonist|vasopressin antagonist
5069108|NCT01346059|Clostridium|clostridium
5069109|NCT01346059|Colitis|colitis
5069110|NCT01346059|Intracolonic vancomycin|intracolonic vancomycin
5069111|NCT01346059|psuedomembranous colitis|psuedomembranous colitis
5069112|NCT01346046|Type 2 Diabetes|type 2 diabetes
5069113|NCT01346046|Adults 18 years and older|adults 18 years and older
5069114|NCT01346046|Taking Control of Your Diabetes Health Fair|taking control of your diabetes health fair
5069115|NCT01346033|Type 2 Diabetes|type 2 diabetes
5069116|NCT01346033|Adults 18 years and older|adults 18 years and older
5069117|NCT01346033|Taking Control of Your Diabetes Health Fair|taking control of your diabetes health fair
5069118|NCT01345968|anemia|anemia
5069119|NCT01345968|transfusion|transfusion
5069120|NCT01345968|intravenous ferric carboxymaltose|intravenous ferric carboxymaltose
5069121|NCT01345929|cUTI|cuti
5069122|NCT01345890|swallowing|swallowing
5069123|NCT01345890|stroke|stroke
5069124|NCT01345890|aspiration|aspiration
5069125|NCT01345890|human|human
5069126|NCT01345890|electrical stimulation|electrical stimulation
5069127|NCT01345890|post stroke dysphagia|post stroke dysphagia
5069128|NCT01345877|burn injury|burn injury
5069129|NCT01345877|cold pressor test|cold pressor test
5069130|NCT01345877|gender|gender
5069131|NCT01345877|pain|pain
5069132|NCT01345877|pain sensitivity|pain sensitivity
5069133|NCT01345877|pain prediction|pain prediction
5069134|NCT01345877|psychometrics|psychometrics
5069135|NCT01345877|quantitative sensory testing|quantitative sensory testing
5069136|NCT01345864|attention cognition memory problem solving scopolamine challenge|attention cognition memory problem solving scopolamine challenge
5069137|NCT01345825|osteoarthrosis|osteoarthrosis
5069138|NCT01345825|unicompartmental knee replacement|unicompartmental knee replacement
5069139|NCT01345825|knee|knee
5069140|NCT01345825|resistance training|resistance training
5069141|NCT01345825|Muscle power|muscle power
5069142|NCT01345825|gait analysis|gait analysis
5069143|NCT01345825|gait|gait
5069144|NCT01345825|physiotherapy|physiotherapy
5069145|NCT01345825|Gyro sensor|gyro sensor
5069146|NCT01345812|ART|art
5069147|NCT01345812|IVF|ivf
5069148|NCT01345812|Timelapse|timelapse
5069149|NCT01345799|Crohn's Disease Activity Index|crohn's disease activity index
5069150|NCT01345799|Crohn's Disease|crohn's disease
5069151|NCT01345799|Inflammatory Bowel Disease|inflammatory bowel disease
5069152|NCT01345760|Basal Cell Carcinoma|basal cell carcinoma
5069153|NCT01345760|Squamous Cell Carcinoma|squamous cell carcinoma
5069154|NCT01345760|Actinic Keratosis|actinic keratosis
5069155|NCT01345760|microRNA|microrna
5069156|NCT01345760|Dicer|dicer
5069157|NCT01345760|Drosha|drosha
5069158|NCT01345760|RISC|risc
5069159|NCT01345760|microprocessor complex|microprocessor complex
5069160|NCT01345760|Argonaute|argonaute
5069161|NCT01345760|DGCR8|dgcr8
5069162|NCT01345760|TARBP|tarbp
5069163|NCT01345747|laryngeal tube suction|laryngeal tube suction
5069164|NCT01345747|gynecology|gynecology
5069165|NCT01345747|laparoscopic surgery|laparoscopic surgery
5069166|NCT01345721|Meningococcal|meningococcal
5069167|NCT01345721|ACWY|acwy
5069168|NCT01345721|Conjugate Vaccine|conjugate vaccine
5069169|NCT01345721|Meningitis|meningitis
5069170|NCT01345721|Toddlers|toddlers
5069171|NCT01345721|Children|children
5069172|NCT01345721|Persistence|persistence
5069173|NCT01345721|Boost|boost
5069174|NCT01345708|Low dose rituximab|low dose rituximab
5069175|NCT01345708|WAIHA|waiha
5069176|NCT01345708|CHD|chd
5069177|NCT01345695|Childhood diarrhea|childhood diarrhea
5069178|NCT01345695|childhood pneumonia|childhood pneumonia
5069179|NCT01345695|telemedicine|telemedicine
5069180|NCT01345695|cluster|cluster
5069181|NCT01345695|treatment-control trial|treatment-control trial
5069182|NCT01345656|Chronic Heart Failure|chronic heart failure
5069183|NCT01345643|Transfusion|transfusion
5069184|NCT01345643|Hemoglobin level|hemoglobin level
5069185|NCT01345630|Double-blind|double-blind
5069186|NCT01345630|comparative|comparative
5069187|NCT01345630|trial|trial
5069188|NCT01345630|maraviroc|maraviroc
5069189|NCT01345630|versus|versus
5069190|NCT01345630|emtricitabine/tenofovir|emtricitabine/tenofovir
5069191|NCT01345630|both with darunavir/ritonavir|both with darunavir/ritonavir
5069192|NCT01345630|antiretroviral-naive|antiretroviral-naive
5069194|NCT01345630|Hiv 1|hiv 1
5069195|NCT01345630|patients.|patients.
5069196|NCT01345591|BTI|bti
5069197|NCT01345591|Craniomaxillofacial (CMF) Battle-injured (BI)|craniomaxillofacial (cmf) battle-injured (bi)
5069198|NCT01345591|Facial Trauma|facial trauma
5069199|NCT01345591|Fat Grafts|fat grafts
5069200|NCT01345591|Autogenous Fat Transfers (AFT)|autogenous fat transfers (aft)
5069201|NCT01345591|Wounded warriors|wounded warriors
5069202|NCT01345578|Urea Cycle Disorders|urea cycle disorders
5069203|NCT01345578|Carbamoyl-Phosphate Synthase I Deficiency Disease|carbamoyl-phosphate synthase i deficiency disease
5069204|NCT01345578|Citrullinemia|citrullinemia
5069205|NCT01345578|Ornithine Carbamoyltransferase Deficiency Disease|ornithine carbamoyltransferase deficiency disease
5069206|NCT01345578|Crigler-Najjar Syndrome|crigler-najjar syndrome
5069207|NCT01345565|fulminant hepatic failure|fulminant hepatic failure
5069208|NCT01345552|Oligo mets|oligo mets
5069209|NCT01345552|Oligometastatic disease|oligometastatic disease
5069210|NCT01345539|Oligo mets|oligo mets
5069211|NCT01345539|Oligometastatic disease|oligometastatic disease
5069212|NCT01345513|Genomic Analysis|genomic analysis
5069213|NCT01345513|Sequencing|sequencing
5069214|NCT01345513|Genetic|genetic
5069215|NCT01345513|Biopsy|biopsy
5069216|NCT01345513|Solid tumors|solid tumors
5069217|NCT01345500|Overweight|overweight
5069218|NCT01345500|Obese|obese
5069219|NCT01345500|Type 2 Diabetic|type 2 diabetic
5069220|NCT01345500|Diabetes|diabetes
5069221|NCT01345500|Weight loss|weight loss
5069222|NCT01345500|Physical activity|physical activity
5069223|NCT01345500|Diet|diet
5069224|NCT01345500|Prepackaged meals|prepackaged meals
5069225|NCT01345487|appetite|appetite
5069226|NCT01345487|protein|protein
5069227|NCT01345487|legumes|legumes
5069228|NCT01345487|meat|meat
5069229|NCT01345448|Glaucoma|glaucoma
5069230|NCT01345448|Brimonidine|brimonidine
5069231|NCT01345448|Transdermal|transdermal
5069232|NCT01345435|telemonitoring|telemonitoring
5069233|NCT01345435|usual care|usual care
5069234|NCT01345435|telemedicine|telemedicine
5069235|NCT01345435|telehealth|telehealth
5069236|NCT01345435|home care|home care
5069237|NCT01345435|Health Care Quality|health care quality
5069238|NCT01345435|Access|access
5069239|NCT01345435|Evaluation|evaluation
5069240|NCT01345409|Musculoskeletal pain|musculoskeletal pain
5069241|NCT01345409|Chronic pain|chronic pain
5069242|NCT01345409|Acupuncture|acupuncture
5069243|NCT01345409|Chiropractic|chiropractic
5069244|NCT01345396|Asthma|asthma
5069245|NCT01345396|Health education|health education
5069246|NCT01345396|Pregnancy|pregnancy
5069247|NCT01345383|smoking|smoking
5069248|NCT01345383|bronchoscopy|bronchoscopy
5069249|NCT01345383|cough|cough
5069250|NCT01345370|Glioblastoma|glioblastoma
5069251|NCT01345357|Solid tumors|solid tumors
5069252|NCT01345357|mantle cell lymphoma|mantle cell lymphoma
5069253|NCT01345357|Gemcitabine|gemcitabine
5069254|NCT01345357|Cisplatin|cisplatin
5069255|NCT01345357|Cancer|cancer
5069256|NCT01345357|Neoplasms|neoplasms
5069257|NCT01345357|Antineoplastic agents|antineoplastic agents
5069258|NCT01345318|Crohn's Disease|crohn's disease
5069259|NCT01345318|safety|safety
5069260|NCT01345318|efficacy|efficacy
5069261|NCT01345318|pharmacokinetics|pharmacokinetics
5069262|NCT01345318|pharmacodynamics|pharmacodynamics
5069263|NCT01345318|Crohn's Disease Activity Index (CDAI)|crohn's disease activity index (cdai)
5069264|NCT01345305|Sturge-Weber Syndrome|sturge-weber syndrome
5069265|NCT01345305|Biomarkers|biomarkers
5069266|NCT01345305|Quantitative EEG|quantitative eeg
5069267|NCT01345305|Transcranial Doppler Ultrasound|transcranial doppler ultrasound
5069268|NCT01345305|Medical Rehabilitation Scales|medical rehabilitation scales
5069269|NCT01345305|Optical Coherence Tomography|optical coherence tomography
5069270|NCT01345266|Pharyngometry|pharyngometry
5069271|NCT01345266|Novel Dry Powder Inhaler|novel dry powder inhaler
5069272|NCT01345266|HRCT|hrct
5069273|NCT01345266|Inhalation Profiles|inhalation profiles
5069274|NCT01345253|SLEDAI|sledai
5069275|NCT01345253|Asia|asia
5069276|NCT01345253|placebo|placebo
5069277|NCT01345253|BLys|blys
5069278|NCT01345253|PGA|pga
5069279|NCT01345253|BILAG|bilag
5069280|NCT01345253|systemic lupus erythematosus|systemic lupus erythematosus
5069281|NCT01345253|SELENA|selena
5069282|NCT01345253|Lupus|lupus
5069283|NCT01345253|SRI|sri
5069284|NCT01345253|efficacy|efficacy
5069285|NCT01345253|B cell|b cell
5069286|NCT01345253|SLE Flare Index|sle flare index
5069287|NCT01345253|belimumab|belimumab
5069288|NCT01345253|safety|safety
5069289|NCT01345253|phase III|phase iii
5069290|NCT01345253|B lymphocyte|b lymphocyte
5069291|NCT01345240|Africa|africa
5069292|NCT01345240|Plasmodium falciparum|plasmodium falciparum
5069293|NCT01345240|Malaria vaccine|malaria vaccine
5069294|NCT01345240|hepatitis B|hepatitis b
5069295|NCT01345240|EPI|epi
5069296|NCT01345227|Type 1 diabetes|type 1 diabetes
5069297|NCT01345227|islet transplantation|islet transplantation
5069298|NCT01345227|autotransplantation|autotransplantation
5069299|NCT01345214|ONO-7746|ono-7746
5069397|NCT01344824|adenocarcinoma of the lung|adenocarcinoma of the lung
5069300|NCT01345214|Chemotherapy Induced Thrombocytopenia|chemotherapy induced thrombocytopenia
5069301|NCT01345214|Thrombocytopenia|thrombocytopenia
5069302|NCT01345201|Phase 1|phase 1
5069303|NCT01345201|dose escalation|dose escalation
5069304|NCT01345201|histologically confirmed|histologically confirmed
5069305|NCT01345201|malignancy metastatic|malignancy metastatic
5069306|NCT01345175|rectal|rectal
5069307|NCT01345175|colon|colon
5069308|NCT01345175|PLACEBO|placebo
5069309|NCT01345175|RIFAXIMIN|rifaximin
5069310|NCT01345175|metronidazole|metronidazole
5069311|NCT01345175|11-045|11-045
5069312|NCT01345162|Herniotomy|herniotomy
5069313|NCT01345149|Obesity|obesity
5069314|NCT01345149|Pregnancy|pregnancy
5069315|NCT01345149|Intervention|intervention
5069316|NCT01345149|Diet|diet
5069317|NCT01345149|Physical activity|physical activity
5069318|NCT01345136|Neurofibromatosis Type 2|neurofibromatosis type 2
5069319|NCT01345136|Vestibular schwannoma|vestibular schwannoma
5069320|NCT01345136|Hearing|hearing
5069321|NCT01345110|dementia|dementia
5069322|NCT01345110|mild cognitive impairment|mild cognitive impairment
5069323|NCT01345110|prevalence|prevalence
5069324|NCT01345110|incidence|incidence
5069325|NCT01345110|elderly|elderly
5069326|NCT01345110|longitudinal study|longitudinal study
5069327|NCT01345110|population study|population study
5069328|NCT01345097|short, metaphyseal-fitting femoral stem|short, metaphyseal-fitting femoral stem
5069329|NCT01345097|cementless anatomical femoral stem|cementless anatomical femoral stem
5069330|NCT01345097|young patient|young patient
5069331|NCT01345097|elderly patient|elderly patient
5069332|NCT01345071|Rheumatoid Arthritis|rheumatoid arthritis
5069333|NCT01345071|Pregnancy|pregnancy
5069334|NCT01345071|Anti-TNF|anti-tnf
5069335|NCT01345071|Preconceptional counselling|preconceptional counselling
5069336|NCT01345071|Disease activity|disease activity
5069337|NCT01345058|Epilepsy|epilepsy
5069338|NCT01345058|antiepileptic drug|antiepileptic drug
5069339|NCT01345058|polytherapy|polytherapy
5069340|NCT01345045|Diabetic Asymmetric Polyneuropathy|diabetic asymmetric polyneuropathy
5069341|NCT01345045|Symmetric Diabetic Proximal Motor Neuropathy|symmetric diabetic proximal motor neuropathy
5069342|NCT01345045|Diabetic Mononeuropathy Simplex,|diabetic mononeuropathy simplex,
5069343|NCT01345045|Diabetic Autonomic Neuropathy,|diabetic autonomic neuropathy,
5069344|NCT01345045|Diabetic Amyotrophy|diabetic amyotrophy
5069345|NCT01345045|Mononeuropathy|mononeuropathy
5069346|NCT01345045|Diabetic Neuropathy|diabetic neuropathy
5069347|NCT01345045|Asymmetric Diabetic Proximal Motor Neuropathy|asymmetric diabetic proximal motor neuropathy
5069348|NCT01345045|Diabetic Polyneuropathy|diabetic polyneuropathy
5069349|NCT01345045|Painful|painful
5069350|NCT01345045|Diabetic Mononeuropathy|diabetic mononeuropathy
5069351|NCT01345045|Neuralgia|neuralgia
5069352|NCT01345019|zoledronic acid|zoledronic acid
5069353|NCT01345019|hematologic malignancies|hematologic malignancies
5069354|NCT01345019|SRE|sre
5069355|NCT01345019|skeletal-related event|skeletal-related event
5069356|NCT01345019|blood cancer|blood cancer
5069357|NCT01345019|lytic bone lesions|lytic bone lesions
5069358|NCT01345019|bone metastases|bone metastases
5069359|NCT01345019|myeloma|myeloma
5069360|NCT01345019|fractures|fractures
5069361|NCT01345019|spinal cord compression|spinal cord compression
5069362|NCT01345019|radiation to bone|radiation to bone
5069363|NCT01345019|surgery to bone|surgery to bone
5069364|NCT01345019|bisphosphonates|bisphosphonates
5069365|NCT01345019|Neoplasms, Plasma Cell|neoplasms, plasma cell
5069366|NCT01345019|Paraproteinemias|paraproteinemias
5069367|NCT01345019|Neoplasms|neoplasms
5069368|NCT01345019|Neoplasm Metastasis|neoplasm metastasis
5069369|NCT01345019|Bone Neoplasms|bone neoplasms
5069370|NCT01345019|Bone Marrow Diseases|bone marrow diseases
5069371|NCT01345019|Blood Protein Disorders|blood protein disorders
5069372|NCT01345019|Hematologic Diseases|hematologic diseases
5069373|NCT01345019|multiple myeloma|multiple myeloma
5069374|NCT01345019|denosumab|denosumab
5069375|NCT01345019|Neoplastic Processes|neoplastic processes
5069376|NCT01345019|Bone Diseases|bone diseases
5069377|NCT01345019|Diphosphonates|diphosphonates
5069378|NCT01345019|Bone Density Conservation Agents|bone density conservation agents
5069379|NCT01345006|juvenile macular dystrophy|juvenile macular dystrophy
5069380|NCT01345006|SMD|smd
5069381|NCT01345006|fundus flavimaculatus|fundus flavimaculatus
5069382|NCT01344993|Dry AMD|dry amd
5069383|NCT01344993|Geographic atrophy|geographic atrophy
5069384|NCT01344941|Vaccine response|vaccine response
5069385|NCT01344941|Human Lymphocytes|human lymphocytes
5069386|NCT01344915|Patella|patella
5069387|NCT01344915|Knee|knee
5069388|NCT01344915|Brace|brace
5069389|NCT01344876|multiple myeloma [MM]|multiple myeloma [mm]
5069390|NCT01344876|non-Hodgkin lymphoma [NHL]|non-hodgkin lymphoma [nhl]
5069391|NCT01344876|acute myeloid leukemia [AML]|acute myeloid leukemia [aml]
5069392|NCT01344876|acute lymphoid leukemia [ALL]|acute lymphoid leukemia [all]
5069393|NCT01344876|chronic myeloid leukemia [CML]|chronic myeloid leukemia [cml]
5069394|NCT01344824|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5069395|NCT01344824|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5069396|NCT01344824|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5069398|NCT01344824|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
5069399|NCT01344824|large cell lung cancer|large cell lung cancer
5069400|NCT01344811|telemonitoring|telemonitoring
5069401|NCT01344811|usual care|usual care
5069402|NCT01344811|telehealth|telehealth
5069403|NCT01344811|home care|home care
5069404|NCT01344811|Health Care Quality|health care quality
5069405|NCT01344811|Access|access
5069406|NCT01344811|Evaluation|evaluation
5069407|NCT01344798|limb girdle muscular dystrophy type 2C|limb girdle muscular dystrophy type 2c
5069408|NCT01344798|gamma-sarcoglycanopathy|gamma-sarcoglycanopathy
5069409|NCT01344798|gene therapy|gene therapy
5069410|NCT01344798|AAV vector|aav vector
5069411|NCT01344798|neuromuscular disease|neuromuscular disease
5069412|NCT01344798|orphan disease|orphan disease
5069413|NCT01344785|Intertrochanteric Fractures|intertrochanteric fractures
5069414|NCT01344785|Intramedullary nailing|intramedullary nailing
5069415|NCT01344785|Hip function|hip function
5069416|NCT01344785|Pain|pain
5069417|NCT01344772|femoral neck fracture|femoral neck fracture
5069418|NCT01344772|total hip arthroplasty|total hip arthroplasty
5069419|NCT01344772|internal fixation|internal fixation
5069420|NCT01344759|Obstructive Sleep Apnea|obstructive sleep apnea
5069421|NCT01344759|MRI|mri
5069422|NCT01344759|Pediatrics|pediatrics
5069423|NCT01344759|Dexmedetomidine|dexmedetomidine
5069424|NCT01344759|Propofol|propofol
5069425|NCT01344759|Anesthesia|anesthesia
5069426|NCT01344746|sleep-disordered breathing|sleep-disordered breathing
5069427|NCT01344733|Major Depressive Disorder|major depressive disorder
5069428|NCT01344733|MDD|mdd
5069429|NCT01344720|Low Back Pain|low back pain
5069430|NCT01344720|Etoricoxib|etoricoxib
5069431|NCT01344720|Oxycodone|oxycodone
5069432|NCT01344707|Hematologic Malignancies|hematologic malignancies
5069433|NCT01344707|Acute Myeloid Leukemia (AML)|acute myeloid leukemia (aml)
5069434|NCT01344707|Acute Lymphocytic Leukemia (ALL)|acute lymphocytic leukemia (all)
5069435|NCT01344707|Chronic Lymphocytic Leukemia (CLL)|chronic lymphocytic leukemia (cll)
5069436|NCT01344707|Multiple Myeloma (MM)|multiple myeloma (mm)
5069437|NCT01344707|Myelodysplastic Syndrome (MDS)|myelodysplastic syndrome (mds)
5069438|NCT01344707|Malignant Lymphomas|malignant lymphomas
5069439|NCT01344707|Histone Deacetylase (HDAC)|histone deacetylase (hdac)
5069440|NCT01344707|4SC-202|4sc-202
5069441|NCT01344707|Phase I|phase i
5069442|NCT01344694|Epicardial fat|epicardial fat
5069443|NCT01344694|Visceral fat|visceral fat
5069444|NCT01344694|atherosclerosis|atherosclerosis
5069445|NCT01344694|coronary computed tomography angiography|coronary computed tomography angiography
5069446|NCT01344694|Carotid Doppler ultrasound|carotid doppler ultrasound
5069447|NCT01344668|Diabetes|diabetes
5069448|NCT01344642|HIV|hiv
5069449|NCT01344642|RNA|rna
5069450|NCT01344616|computer-based behavioral support|computer-based behavioral support
5069451|NCT01344603|cardiac surgery|cardiac surgery
5069452|NCT01344603|cardiac anesthesia|cardiac anesthesia
5069453|NCT01344603|epidural|epidural
5069454|NCT01344590|central line associated blood stream infections|central line associated blood stream infections
5069455|NCT01344577|Buccal Plate Augmentation technique|buccal plate augmentation technique
5069456|NCT01344577|socket preservation|socket preservation
5069457|NCT01344577|porcine biomaterial|porcine biomaterial
5069458|NCT01344564|Prostate cancer|prostate cancer
5069459|NCT01344564|Hormone therapy|hormone therapy
5069460|NCT01344564|Testosterone measures|testosterone measures
5069461|NCT01344538|ginger|ginger
5069462|NCT01344538|Zingiber officinale|zingiber officinale
5069463|NCT01344538|Cancer Risk Reductive|cancer risk reductive
5069464|NCT01344538|Eicosanoids|eicosanoids
5069465|NCT01344538|Colorectal Cancer|colorectal cancer
5069466|NCT01344538|Inflammation|inflammation
5069467|NCT01344525|obesity therapy|obesity therapy
5069468|NCT01344525|metabolic syndrome|metabolic syndrome
5069469|NCT01344525|gastrointestinal tract|gastrointestinal tract
5069470|NCT01344525|microbiota|microbiota
5069471|NCT01344525|metabolomics|metabolomics
5069472|NCT01344525|micronutrients|micronutrients
5069473|NCT01344525|outcome|outcome
5069474|NCT01344525|sustainability|sustainability
5069475|NCT01344512|Pharmacokinetic|pharmacokinetic
5069476|NCT01344512|Population|population
5069477|NCT01344512|Children|children
5069478|NCT01344512|Ceftazidime|ceftazidime
5069479|NCT01344512|Ciprofloxacin|ciprofloxacin
5069480|NCT01344512|Voriconazole|voriconazole
5069481|NCT01344512|Pediatric|pediatric
5069482|NCT01344499|women|women
5069483|NCT01344499|laparoscopic subtotal hysterectomy|laparoscopic subtotal hysterectomy
5069484|NCT01344486|women undergoing laparoscopic surgery|women undergoing laparoscopic surgery
5069485|NCT01344473|Remineralisation|remineralisation
5069486|NCT01344473|White Spot Lesions|white spot lesions
5069487|NCT01344473|Orthodontic treatment|orthodontic treatment
5069488|NCT01344473|Tooth Mousse creme|tooth mousse creme
5069489|NCT01344473|Casein Phosphopeptide|casein phosphopeptide
5069490|NCT01344460|magnetic resonance angiography (MRA) of the renal arteries|magnetic resonance angiography (mra) of the renal arteries
5069491|NCT01344447|Supra-aortic vascular disease|supra-aortic vascular disease
5069493|NCT01344447|CTA|cta
5069494|NCT01344447|Males and females aged 18 years or older|males and females aged 18 years or older
5069495|NCT01344447|Stroke|stroke
5069496|NCT01344447|Transient Ischemic Attack (TIA)|transient ischemic attack (tia)
5069497|NCT01344421|Movement capture system|movement capture system
5069498|NCT01344421|Movement analysis|movement analysis
5069499|NCT01344421|Hip dysplasia|hip dysplasia
5069500|NCT01344421|Hip pain|hip pain
5069501|NCT01344421|Quality of life|quality of life
5069502|NCT01344421|Physical function|physical function
5069503|NCT01344408|Dizziness|dizziness
5069504|NCT01344408|rehabilitation|rehabilitation
5069505|NCT01344408|geriatric|geriatric
5069506|NCT01344408|IT-technology|it-technology
5069507|NCT01344382|Adolescent|adolescent
5069508|NCT01344382|Parent|parent
5069509|NCT01344382|Substance Abuse|substance abuse
5069510|NCT01344382|Parent Training|parent training
5069511|NCT01344382|Community Reinforcement and Family Training|community reinforcement and family training
5069512|NCT01344382|CRAFT|craft
5069513|NCT01344382|Community Reinforcement Approach|community reinforcement approach
5069514|NCT01344382|Addiction|addiction
5069515|NCT01344382|Family Intervention|family intervention
5069516|NCT01344369|Healthy Subjects|healthy subjects
5069517|NCT01344369|Bioequivalence|bioequivalence
5069518|NCT01344356|stereotactic radiosurgery|stereotactic radiosurgery
5069519|NCT01344356|head and neck tumors|head and neck tumors
5069520|NCT01344356|squamous cell carcinoma of head and neck|squamous cell carcinoma of head and neck
5069521|NCT01344330|Colon cancer|colon cancer
5069522|NCT01344330|Prevention|prevention
5069523|NCT01344330|Cruciferous vegetables|cruciferous vegetables
5069524|NCT01344330|Histone status|histone status
5069525|NCT01344304|aprepitant therapy|aprepitant therapy
5069526|NCT01344304|fosaprepitant therapy|fosaprepitant therapy
5069527|NCT01344304|5HT3-receptor antagonist|5ht3-receptor antagonist
5069528|NCT01344304|dexamethasone|dexamethasone
5069529|NCT01344304|colorectal cancer|colorectal cancer
5069530|NCT01344304|FOLFOX|folfox
5069531|NCT01344304|XELOX|xelox
5069532|NCT01344304|SOX|sox
5069533|NCT01344291|hyperprolactinoma|hyperprolactinoma
5069534|NCT01344291|turmeric|turmeric
5069535|NCT01344291|amenorrhea|amenorrhea
5069536|NCT01344265|B-type natriuretic peptide|b-type natriuretic peptide
5069537|NCT01344265|global end diastolic volume|global end diastolic volume
5069538|NCT01344239|aortic aneurysm|aortic aneurysm
5069539|NCT01344239|ischemia/reperfusion|ischemia/reperfusion
5069540|NCT01344239|preconditioning|preconditioning
5069541|NCT01344239|pulmonary injury|pulmonary injury
5069542|NCT01344239|intestinal injury|intestinal injury
5069543|NCT01344226|steroid responder|steroid responder
5069544|NCT01344213|Pregabalin|pregabalin
5069545|NCT01344213|Celecoxib|celecoxib
5069546|NCT01344213|Intrathecal morphine|intrathecal morphine
5069547|NCT01344213|Total knee arthroplasty|total knee arthroplasty
5069548|NCT01344200|Pharmacokinetics|pharmacokinetics
5069549|NCT01344200|Celecoxib|celecoxib
5069550|NCT01344200|Pediatric|pediatric
5069551|NCT01344200|Peds QL|peds ql
5069552|NCT01344200|CYP2C9|cyp2c9
5069553|NCT01344174|Acute-on-chronic liver failure|acute-on-chronic liver failure
5069554|NCT01344174|HBV|hbv
5069555|NCT01344174|Dexamethasone|dexamethasone
5069556|NCT01344174|Prognosis|prognosis
5069557|NCT01344161|Vitamin D|vitamin d
5069558|NCT01344161|Metabolic profile|metabolic profile
5069559|NCT01344161|Overweight|overweight
5069560|NCT01344161|Obesity|obesity
5069561|NCT01344148|Anti- TB|anti- tb
5069562|NCT01344148|HAART|haart
5069563|NCT01344148|choice of the right moment|choice of the right moment
5069564|NCT01344135|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
5069565|NCT01344135|Muscular Atrophy|muscular atrophy
5069566|NCT01344135|Nutritional rehabilitation|nutritional rehabilitation
5069567|NCT01344135|Counselling|counselling
5069568|NCT01344096|Gaucher disease|gaucher disease
5069569|NCT01344096|Thrombocytopathy|thrombocytopathy
5069570|NCT01344096|Imiglucerase|imiglucerase
5069571|NCT01344070|innovator formulations|innovator formulations
5069572|NCT01344070|generic formulations|generic formulations
5069573|NCT01344070|bioequivalence|bioequivalence
5069574|NCT01344070|interchangeability|interchangeability
5069575|NCT01344070|inter-patch variation|inter-patch variation
5069576|NCT01344070|quality of generic drug formulations on the market|quality of generic drug formulations on the market
5069577|NCT01344070|Interchangeability between marketed generic formulations|interchangeability between marketed generic formulations
5069578|NCT01344070|prevalence of large intrasubject variability despite average bioequivalence|prevalence of large intrasubject variability despite average bioequivalence
5069579|NCT01344070|Causes of large intrasubject variability|causes of large intrasubject variability
5069580|NCT01344057|Seasonal Influenza, vaccine|seasonal influenza, vaccine
5069581|NCT01344044|Brain-Computer Interface|brain-computer interface
5069582|NCT01344018|adult angiosarcoma|adult angiosarcoma
5069583|NCT01344018|adult fibrosarcoma|adult fibrosarcoma
5069584|NCT01344018|adult leiomyosarcoma|adult leiomyosarcoma
5069585|NCT01344018|adult liposarcoma|adult liposarcoma
5069586|NCT01344018|adult malignant fibrous histiocytoma|adult malignant fibrous histiocytoma
5069587|NCT01344018|adult malignant mesenchymoma|adult malignant mesenchymoma
5069588|NCT01344018|stage I adult soft tissue sarcoma|stage i adult soft tissue sarcoma
5069589|NCT01344018|stage II adult soft tissue sarcoma|stage ii adult soft tissue sarcoma
5069590|NCT01344018|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
5069591|NCT01344005|non-small cell lung cancer|non-small cell lung cancer
5069592|NCT01344005|small cell lung cancer|small cell lung cancer
5069593|NCT01344005|tobacco use disorder|tobacco use disorder
5069594|NCT01343992|Embryo transfer|embryo transfer
5069595|NCT01343992|Implantation rate|implantation rate
5069596|NCT01343992|Pregnancy rate|pregnancy rate
5069597|NCT01343992|bedrest|bedrest
5069598|NCT01343992|neutral|neutral
5069599|NCT01343992|benevolent|benevolent
5069600|NCT01343992|deterious|deterious
5069601|NCT01343992|implantation|implantation
5069602|NCT01343992|gestation rates|gestation rates
5069603|NCT01343953|severe aplastic anemia|severe aplastic anemia
5069604|NCT01343953|cord blood transplantation|cord blood transplantation
5069605|NCT01343940|RCT|rct
5069606|NCT01343940|randomized block repeated measures design|randomized block repeated measures design
5069607|NCT01343940|efficacy trial|efficacy trial
5069608|NCT01343940|high risk population|high risk population
5069609|NCT01343927|Chronic low back pain|chronic low back pain
5069610|NCT01343927|Community health center|community health center
5069611|NCT01343927|Yoga|yoga
5069612|NCT01343927|Physical therapy|physical therapy
5069613|NCT01343927|Minority populations|minority populations
5069614|NCT01343927|Health education|health education
5069615|NCT01343862|moderate traumatic brain injury|moderate traumatic brain injury
5069616|NCT01343862|brain contusion|brain contusion
5069617|NCT01343849|breast cancer|breast cancer
5069618|NCT01343849|auto antibodies|auto antibodies
5069619|NCT01343836|autologous tenocytes|autologous tenocytes
5069620|NCT01343836|cell therapy|cell therapy
5069621|NCT01343836|eccentric exercises|eccentric exercises
5069622|NCT01343810|Mindfulness-Based Stress Reduction|mindfulness-based stress reduction
5069623|NCT01343810|Meditation|meditation
5069624|NCT01343810|Psychological stress|psychological stress
5069625|NCT01343810|Sleep quality|sleep quality
5069626|NCT01343810|Cardiovascular disease|cardiovascular disease
5069627|NCT01343810|Inflammation|inflammation
5069628|NCT01343797|Glycemic index|glycemic index
5069629|NCT01343797|Insulinemic index|insulinemic index
5069630|NCT01343797|Fructo-oligosaccharide syrup|fructo-oligosaccharide syrup
5069631|NCT01343797|Fructose syrup|fructose syrup
5069632|NCT01343797|Aged between eighteen and fifty years old|aged between eighteen and fifty years old
5069633|NCT01343797|BMI between nineteen and twenty five kg/m²|bmi between nineteen and twenty five kg/m²
5069634|NCT01343797|Non diabetic or pre-diabetic|non diabetic or pre-diabetic
5069635|NCT01343797|Without liver, renal or gastro-intestinal disorder|without liver, renal or gastro-intestinal disorder
5069636|NCT01343797|Non-smoker|non-smoker
5069637|NCT01343784|Voiding trial|voiding trial
5069638|NCT01343784|sling|sling
5069639|NCT01343784|post-operative assessment|post-operative assessment
5069640|NCT01343784|urinary retention|urinary retention
5069641|NCT01343771|Anorexia Nervosa (AN)|anorexia nervosa (an)
5069642|NCT01343771|bone density|bone density
5069643|NCT01343771|DHEA|dhea
5069644|NCT01343771|estrogen therapy|estrogen therapy
5069645|NCT01343771|eating disorder|eating disorder
5069646|NCT01343693|DDD|ddd
5069647|NCT01343693|Deformity|deformity
5069648|NCT01343693|Tumor|tumor
5069649|NCT01343693|Fracture|fracture
5069650|NCT01343693|Cervical|cervical
5069651|NCT01343667|GORE Neuro Protection System|gore neuro protection system
5069652|NCT01343667|GORE Flow Reversal System|gore flow reversal system
5069653|NCT01343667|carotid artery stenosis|carotid artery stenosis
5069654|NCT01343667|embolic protection device|embolic protection device
5069655|NCT01343667|reverse flow|reverse flow
5069656|NCT01343667|proximal occlusion device|proximal occlusion device
5069657|NCT01343667|GNPS|gnps
5069658|NCT01343667|Parodi|parodi
5069659|NCT01343667|EMPiRE|empire
5069660|NCT01343667|distal embolization|distal embolization
5069661|NCT01343667|minimizing risks of CAS|minimizing risks of cas
5069662|NCT01343667|PAES|paes
5069663|NCT01343667|embolic filter|embolic filter
5069664|NCT01343654|HIV medication adherence|hiv medication adherence
5069665|NCT01343654|drug use|drug use
5069666|NCT01343654|rural|rural
5069667|NCT01343654|nonadherence to HIV medications|nonadherence to hiv medications
5069668|NCT01343641|Kidney Disease|kidney disease
5069669|NCT01343641|Chronic Kidney Disease|chronic kidney disease
5069670|NCT01343641|Growth Hormone|growth hormone
5069671|NCT01343628|Alcohol, atomoxetine, Strattera, alcohol dependence, alcoholism|alcohol, atomoxetine, strattera, alcohol dependence, alcoholism
5069672|NCT01343602|stroke|stroke
5069673|NCT01343602|Constraint Induced Movement Therapy|constraint induced movement therapy
5069674|NCT01343602|participation|participation
5069675|NCT01343602|Physical Therapy|physical therapy
5069676|NCT01343602|Occupational Therapy|occupational therapy
5069677|NCT01343563|Depression|depression
5069678|NCT01343563|Major Depressive Disorder (MDD)|major depressive disorder (mdd)
5069679|NCT01343563|EEG|eeg
5069680|NCT01343563|Trigeminal Nerve Stimulation|trigeminal nerve stimulation
5069681|NCT01343550|Borderline Personality Disorder|borderline personality disorder
5069682|NCT01343550|Borderline Personality|borderline personality
5069683|NCT01343550|Borderline|borderline
5069684|NCT01343537|Brain Bleed|brain bleed
5069685|NCT01343537|SAH|sah
5069686|NCT01343537|Vasospasm|vasospasm
5069687|NCT01343524|cystic fibrosis|cystic fibrosis
5069688|NCT01343524|spirometry|spirometry
5069689|NCT01343524|PFT's|pft's
5069690|NCT01343524|pulmonary function test|pulmonary function test
5069691|NCT01343511|Autism|autism
5069692|NCT01343511|human cord blood mononuclear cells|human cord blood mononuclear cells
5069693|NCT01343511|human umbilical cord mesenchymal stem cells|human umbilical cord mesenchymal stem cells
5069694|NCT01343498|Solid Tumor Malignancy|solid tumor malignancy
5069695|NCT01343498|Advanced Solid Tumors|advanced solid tumors
5069696|NCT01343498|BEZ235|bez235
5069697|NCT01343498|mTOR Inhibitor|mtor inhibitor
5069698|NCT01343485|Human papillomavirus (HPV) vaccine|human papillomavirus (hpv) vaccine
5069699|NCT01343485|Gardasil vaccine|gardasil vaccine
5069700|NCT01343472|Behavior|behavior
5069701|NCT01343472|Drug users|drug users
5069702|NCT01343459|Hypofractionated Whole breast irradiation|hypofractionated whole breast irradiation
5069703|NCT01343459|Hypofractionated Whole breast irradiation long term results|hypofractionated whole breast irradiation long term results
5069704|NCT01343459|Breast conserving therapy|breast conserving therapy
5069705|NCT01343459|IORT with electrons in breast cancer|iort with electrons in breast cancer
5069706|NCT01343459|IOERT as anticipated Boost|ioert as anticipated boost
5069707|NCT01343459|IOERT and hypofractionated whole breast irradiation|ioert and hypofractionated whole breast irradiation
5069708|NCT01343446|Sleep impairment, Coping Style, Diabetes Mellitus|sleep impairment, coping style, diabetes mellitus
5069709|NCT01343433|Delirium|delirium
5069710|NCT01343433|Intensive Care Unit Syndrome|intensive care unit syndrome
5069711|NCT01343433|Bright light therapy|bright light therapy
5069712|NCT01343433|Intensive Care Unit|intensive care unit
5069713|NCT01343420|Skin tests|skin tests
5069714|NCT01343420|Dog Hair|dog hair
5069715|NCT01343420|Allergy Extract|allergy extract
5069716|NCT01343394|Autologous|autologous
5069717|NCT01343394|Stem Cells|stem cells
5069718|NCT01343394|Hearing Loss|hearing loss
5069719|NCT01343394|Children|children
5069720|NCT01343381|Heparin|heparin
5069721|NCT01343381|Coronary artery bypass graft surgery|coronary artery bypass graft surgery
5069722|NCT01343381|Anti-coagulation efficacy|anti-coagulation efficacy
5069723|NCT01343368|Post-menarchal|post-menarchal
5069724|NCT01343355|Tropical Spastic Paraparesis|tropical spastic paraparesis
5069725|NCT01343355|HAM|ham
5069726|NCT01343355|TSP|tsp
5069727|NCT01343342|omega-3|omega-3
5069728|NCT01343342|PUFA|pufa
5069729|NCT01343342|fatty acids|fatty acids
5069730|NCT01343342|cardiovascular disease|cardiovascular disease
5069731|NCT01343342|gene expression|gene expression
5069732|NCT01343329|Traumatic Brain Injury|traumatic brain injury
5069733|NCT01343329|Dysautonomia|dysautonomia
5069734|NCT01343329|Brain Injury|brain injury
5069735|NCT01343329|Sympathetic hyperactivity|sympathetic hyperactivity
5069736|NCT01343316|Enteral Feeds|enteral feeds
5069737|NCT01343316|Supplemental Feeds|supplemental feeds
5069738|NCT01343316|Transpyloric Tube|transpyloric tube
5069739|NCT01343316|Nasogastric Tube|nasogastric tube
5069740|NCT01343303|Osteoarthritis, knee|osteoarthritis, knee
5069741|NCT01343303|knee pain|knee pain
5069742|NCT01343303|pain measurement|pain measurement
5069743|NCT01343290|Canagliflozin (JNJ-28431754)|canagliflozin (jnj-28431754)
5069744|NCT01343290|Pharmacokinetic|pharmacokinetic
5069745|NCT01343290|Oral Bioavailability|oral bioavailability
5069746|NCT01343290|Food effect|food effect
5069747|NCT01343277|Advanced Liposarcoma or Leiomyosarcoma|advanced liposarcoma or leiomyosarcoma
5069748|NCT01343277|Trabectedin|trabectedin
5069749|NCT01343277|Yondelis|yondelis
5069750|NCT01343277|Dacarbazine|dacarbazine
5069751|NCT01343277|Anthracycline|anthracycline
5069752|NCT01343277|L-sarcoma|l-sarcoma
5069753|NCT01343264|Radical Pleurectomy|radical pleurectomy
5069754|NCT01343264|Pleurectomy/decortication|pleurectomy/decortication
5069755|NCT01343264|Cisplatin|cisplatin
5069756|NCT01343264|Pemetrexed|pemetrexed
5069757|NCT01343264|Radiation|radiation
5069758|NCT01343251|dialysis|dialysis
5069759|NCT01343251|HeRO graft|hero graft
5069760|NCT01343251|catheter|catheter
5069761|NCT01343251|chronic renal failure|chronic renal failure
5069762|NCT01343251|end stage renal disease|end stage renal disease
5069763|NCT01343251|renal insufficiency|renal insufficiency
5069764|NCT01343238|obesity|obesity
5069765|NCT01343238|diet|diet
5069766|NCT01343238|exercise|exercise
5069767|NCT01343225|African american vitamin d bone density|african american vitamin d bone density
5069768|NCT01343225|African American male or female treatment naive|african american male or female treatment naive
5069769|NCT01343212|hepatocellular carcinoma|hepatocellular carcinoma
5069770|NCT01343212|stiffness|stiffness
5069771|NCT01343186|Peginterferon|peginterferon
5069772|NCT01343186|Healthy subject|healthy subject
5069773|NCT01343186|Pharmacokinetics|pharmacokinetics
5069774|NCT01343186|Pharmacodynamics|pharmacodynamics
5069775|NCT01343186|Safety|safety
5069776|NCT01343173|Leukemia|leukemia
5069777|NCT01343173|Adult Chronic|adult chronic
5069778|NCT01343173|Myeloid|myeloid
5069779|NCT01343147|Hyperthermia|hyperthermia
5069780|NCT01343147|Microwave diathermy|microwave diathermy
5069781|NCT01343147|Hot packs|hot packs
5069782|NCT01343147|Pain|pain
5069985|NCT01342224|pancreatic|pancreatic
5069783|NCT01343147|Physical function|physical function
5069784|NCT01343134|Retina|retina
5069785|NCT01343134|Rhegmatogenous retinal detachment|rhegmatogenous retinal detachment
5069786|NCT01343134|Macular detachment|macular detachment
5069787|NCT01343134|Spectral domain OCT|spectral domain oct
5069788|NCT01343134|Microperimetry|microperimetry
5069789|NCT01343121|Radiotherapy|radiotherapy
5069790|NCT01343121|GemX Chemoradiotherapy|gemx chemoradiotherapy
5069791|NCT01343121|Bladder Cancer|bladder cancer
5069792|NCT01343108|Emotional Labor|emotional labor
5069793|NCT01343108|Burnout|burnout
5069794|NCT01343108|Job Satisfaction|job satisfaction
5069795|NCT01343108|Emotional Intelligence|emotional intelligence
5069796|NCT01343108|Job stress|job stress
5069797|NCT01343108|Job involvement|job involvement
5069798|NCT01343095|ICU Delirium|icu delirium
5069799|NCT01343095|Delirium|delirium
5069800|NCT01343095|Sleep Quality|sleep quality
5069801|NCT01343095|Sleep Efficiency|sleep efficiency
5069802|NCT01343095|ICU Noise|icu noise
5069803|NCT01343095|Noise Reduction|noise reduction
5069804|NCT01343095|Earplugs|earplugs
5069805|NCT01343095|Noise Canceling Headphones|noise canceling headphones
5069806|NCT01343069|safety|safety
5069807|NCT01343069|team|team
5069808|NCT01343069|team performance|team performance
5069809|NCT01343069|surgery|surgery
5069810|NCT01343069|outcome|outcome
5069811|NCT01343056|Diabetes Self Management Education (DSME)|diabetes self management education (dsme)
5069812|NCT01343056|Diabetes|diabetes
5069813|NCT01343056|Self Management Support (SMS)|self management support (sms)
5069814|NCT01343043|Sarcoma|sarcoma
5069815|NCT01343043|Cell Therapy|cell therapy
5069816|NCT01343043|T Cell Therapy|t cell therapy
5069817|NCT01343043|NY-ESO-1|ny-eso-1
5069818|NCT01343043|Immuno-oncology|immuno-oncology
5069819|NCT01343043|Metastatic|metastatic
5069820|NCT01343043|Previously treated|previously treated
5069821|NCT01343043|T Cell Receptor|t cell receptor
5069822|NCT01343017|Anaesthesia|anaesthesia
5069823|NCT01343017|Pulmonary gas exchange|pulmonary gas exchange
5069824|NCT01343017|Functional residual capacity|functional residual capacity
5069825|NCT01343017|Cardiac output|cardiac output
5069826|NCT01343017|Sevoflurane|sevoflurane
5069827|NCT01343004|BA058|ba058
5069828|NCT01343004|abaloparatide|abaloparatide
5069829|NCT01343004|Abaloparatide-SC|abaloparatide-sc
5069830|NCT01343004|osteoporosis|osteoporosis
5069831|NCT01343004|postmenopausal|postmenopausal
5069832|NCT01343004|bone loss|bone loss
5069833|NCT01343004|ACTIVE|active
5069834|NCT01343004|fracture|fracture
5069835|NCT01342991|Haemorrhoids|haemorrhoids
5069836|NCT01342991|Haemorrhoidectomy|haemorrhoidectomy
5069837|NCT01342991|Laser Haemorrhoidectomy|laser haemorrhoidectomy
5069838|NCT01342991|Milligan-Morgan Haemorrhoidectomy|milligan-morgan haemorrhoidectomy
5069839|NCT01342991|Open Haemorrhoidectomy|open haemorrhoidectomy
5069840|NCT01342978|HPV|hpv
5069841|NCT01342978|HNSCC|hnscc
5069842|NCT01342952|pulmonary arterial hypertension|pulmonary arterial hypertension
5069843|NCT01342952|pediatrics|pediatrics
5069844|NCT01342939|Monogenetic diabetes|monogenetic diabetes
5069845|NCT01342939|Diabetes mellitus|diabetes mellitus
5069846|NCT01342926|age-related macular degeneration|age-related macular degeneration
5069847|NCT01342926|geographic atrophy|geographic atrophy
5069848|NCT01342926|dry AMD|dry amd
5069849|NCT01342900|tissue oxygenation|tissue oxygenation
5069850|NCT01342900|higk risk surgery|higk risk surgery
5069851|NCT01342900|high risk patient|high risk patient
5069852|NCT01342900|postoperative complications|postoperative complications
5069853|NCT01342874|inositol|inositol
5069854|NCT01342874|gestational diabetes mellitus|gestational diabetes mellitus
5069855|NCT01342874|obstetric adverse outcomes|obstetric adverse outcomes
5069856|NCT01342861|protein supplementation|protein supplementation
5069857|NCT01342861|caloric intake|caloric intake
5069858|NCT01342861|breakfast|breakfast
5069859|NCT01342861|transthyretin (prealbumin)|transthyretin (prealbumin)
5069860|NCT01342861|albumin|albumin
5069861|NCT01342861|Length of stay|length of stay
5069862|NCT01342848|NSTE-ACS|nste-acs
5069863|NCT01342848|PCI|pci
5069864|NCT01342848|Thrombus Aspiration|thrombus aspiration
5069865|NCT01342848|IVUS|ivus
5069866|NCT01342848|Periprocedural Myocardial Infarction|periprocedural myocardial infarction
5069867|NCT01342835|propofol|propofol
5069868|NCT01342835|sevoflurane|sevoflurane
5069869|NCT01342835|postoperative pain|postoperative pain
5069870|NCT01342835|children|children
5069871|NCT01342822|Heart disease|heart disease
5069872|NCT01342822|Coronary Revascularization|coronary revascularization
5069873|NCT01342809|Depression|depression
5069874|NCT01342809|Hopelessness|hopelessness
5069875|NCT01342809|Suicidal ideation|suicidal ideation
5069876|NCT01342796|Cell mediated immunity|cell mediated immunity
5069877|NCT01342796|cell mediated immune response|cell mediated immune response
5069878|NCT01342796|Children|children
5069879|NCT01342796|adjuvanted|adjuvanted
5069880|NCT01342783|metastatic childhood soft tissue sarcoma|metastatic childhood soft tissue sarcoma
5069881|NCT01342783|nonmetastatic childhood soft tissue sarcoma|nonmetastatic childhood soft tissue sarcoma
5069882|NCT01342783|recurrent childhood soft tissue sarcoma|recurrent childhood soft tissue sarcoma
5069883|NCT01342783|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
5069884|NCT01342783|previously untreated childhood rhabdomyosarcoma|previously untreated childhood rhabdomyosarcoma
5069885|NCT01342783|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
5069886|NCT01342744|Cardiovascular risk factors|cardiovascular risk factors
5069887|NCT01342731|Tigecycline|tigecycline
5069888|NCT01342731|A.baumannii|a.baumannii
5069889|NCT01342731|Drug safety|drug safety
5069890|NCT01342718|Irritable bowel syndrome|irritable bowel syndrome
5069891|NCT01342718|Herbal medicine|herbal medicine
5069892|NCT01342718|Probiotics|probiotics
5069893|NCT01342679|chronic myeloid leukemia|chronic myeloid leukemia
5069894|NCT01342679|dasatinib|dasatinib
5069895|NCT01342679|complete molecular response|complete molecular response
5069896|NCT01342666|High density lipoprotein cholesterol|high density lipoprotein cholesterol
5069897|NCT01342666|Tomato|tomato
5069898|NCT01342666|Lycopene|lycopene
5069899|NCT01342666|Hypoalphalipoproteinemia|hypoalphalipoproteinemia
5069900|NCT01342666|Dyslipidemia|dyslipidemia
5069901|NCT01342653|Peritoneal|peritoneal
5069902|NCT01342653|Carcinomatosis|carcinomatosis
5069903|NCT01342653|Gastric|gastric
5069904|NCT01342653|Cancer|cancer
5069905|NCT01342653|NIPS|nips
5069906|NCT01342653|HIPEC|hipec
5069907|NCT01342627|Renal Carcinoma|renal carcinoma
5069908|NCT01342627|Metastatic|metastatic
5069909|NCT01342627|Sorafenib|sorafenib
5069910|NCT01342627|Elderly|elderly
5069911|NCT01342614|Hypertension|hypertension
5069912|NCT01342614|Insulin Resistance|insulin resistance
5069913|NCT01342614|Hyperinsulinemia|hyperinsulinemia
5069914|NCT01342614|Metformin|metformin
5069915|NCT01342614|Fosinopril|fosinopril
5069916|NCT01342588|Pedicle screws|pedicle screws
5069917|NCT01342588|safety|safety
5069918|NCT01342575|ACDF|acdf
5069919|NCT01342549|Alcohol Use Disorders|alcohol use disorders
5069920|NCT01342549|Traumatic Brain Injury|traumatic brain injury
5069921|NCT01342549|Mood and Anxiety Disorders|mood and anxiety disorders
5069922|NCT01342536|Depression|depression
5069923|NCT01342523|Smoking Cessation|smoking cessation
5069924|NCT01342523|Smoking|smoking
5069925|NCT01342523|Nicotine|nicotine
5069926|NCT01342510|Intravenous Anesthesia|intravenous anesthesia
5069927|NCT01342510|General Anesthesia|general anesthesia
5069928|NCT01342497|diabetic foot ulcer|diabetic foot ulcer
5069929|NCT01342471|Physical activity intervention|physical activity intervention
5069930|NCT01342471|walking|walking
5069931|NCT01342471|TV|tv
5069932|NCT01342471|sedentary|sedentary
5069933|NCT01342458|Knee osteoarthritis|knee osteoarthritis
5069934|NCT01342458|Shoes|shoes
5069935|NCT01342458|Gait|gait
5069936|NCT01342458|Biomechanics|biomechanics
5069937|NCT01342432|low back pain|low back pain
5069938|NCT01342432|balance reeducation|balance reeducation
5069939|NCT01342432|pain|pain
5069940|NCT01342432|function|function
5069941|NCT01342367|Prostate cancer|prostate cancer
5069942|NCT01342367|Quality of Life|quality of life
5069943|NCT01342354|Pancreatic Cancer|pancreatic cancer
5069944|NCT01342354|Stereotactic Radiation|stereotactic radiation
5069945|NCT01342328|Sleep disruption|sleep disruption
5069946|NCT01342328|Sleep hygiene|sleep hygiene
5069947|NCT01342328|Sedative agents and sleep|sedative agents and sleep
5069948|NCT01342328|Electroencephalography|electroencephalography
5069949|NCT01342328|REM sleep|rem sleep
5069950|NCT01342328|Magnetoencephalography|magnetoencephalography
5069951|NCT01342315|Tinea Cruris, antifungal|tinea cruris, antifungal
5069952|NCT01342302|Breast Cancer|breast cancer
5069953|NCT01342302|Couples|couples
5069954|NCT01342302|Distress|distress
5069955|NCT01342302|Online Support|online support
5069956|NCT01342302|e-health|e-health
5069957|NCT01342302|Intervention|intervention
5069958|NCT01342302|Relationships|relationships
5069959|NCT01342289|Nonmyeloablative|nonmyeloablative
5069960|NCT01342289|Allogeneic|allogeneic
5069961|NCT01342289|Bone Marrow Transplant (BMT)|bone marrow transplant (bmt)
5069962|NCT01342289|Tacrolimus|tacrolimus
5069963|NCT01342289|Cyclophosphamide|cyclophosphamide
5069964|NCT01342276|Heart failure|heart failure
5069965|NCT01342276|Self-management|self-management
5069966|NCT01342276|Telehealth|telehealth
5069967|NCT01342276|Internet|internet
5069968|NCT01342263|Chronic disease management|chronic disease management
5069969|NCT01342263|Ischemic heart disease|ischemic heart disease
5069970|NCT01342263|Heart failure|heart failure
5069971|NCT01342263|Chronic kidney disease|chronic kidney disease
5069972|NCT01342263|Diabetes|diabetes
5069973|NCT01342263|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
5069974|NCT01342263|Telehealth|telehealth
5069975|NCT01342263|Internet|internet
5069976|NCT01342250|Decompensated Liver Cirrhosis|decompensated liver cirrhosis
5069977|NCT01342250|Umbilical Cord Mesenchymal Stem Cells|umbilical cord mesenchymal stem cells
5069978|NCT01342237|Brain tumors|brain tumors
5069979|NCT01342237|Stem cell transplantation|stem cell transplantation
5069980|NCT01342237|topotecan|topotecan
5069981|NCT01342237|thiotepa|thiotepa
5069982|NCT01342237|carboplatin|carboplatin
5069983|NCT01342237|melphalan|melphalan
5069984|NCT01342237|etoposide|etoposide
5069986|NCT01342224|cancer|cancer
5069987|NCT01342224|adenocarcinoma|adenocarcinoma
5069988|NCT01342224|vaccine|vaccine
5069989|NCT01342211|PF-04950615|pf-04950615
5069990|NCT01342211|RN316|rn316
5069991|NCT01342198|pregabalin|pregabalin
5069992|NCT01342198|pharmacokinetics|pharmacokinetics
5069993|NCT01342198|bioavailability|bioavailability
5069994|NCT01342198|bioequivalence|bioequivalence
5069995|NCT01342185|Medical ozone therapy|medical ozone therapy
5069996|NCT01342185|chronic hepatitis B|chronic hepatitis b
5069997|NCT01342172|Bladder Cancer|bladder cancer
5069998|NCT01342172|Urothelial Cancer|urothelial cancer
5069999|NCT01342172|Chemotherapy|chemotherapy
5070000|NCT01342172|First-line|first-line
5070001|NCT01342172|Metastatic|metastatic
5070002|NCT01342159|bevacizumab, diabetic macular edema, triamcinolone|bevacizumab, diabetic macular edema, triamcinolone
5070003|NCT01342146|pegylated Somatropin|pegylated somatropin
5070004|NCT01342146|PEG-GH|peg-gh
5070005|NCT01342146|Growth hormone|growth hormone
5070006|NCT01342146|PEG-rhGH|peg-rhgh
5070007|NCT01342146|Growth hormone deficiency (GHD)|growth hormone deficiency (ghd)
5070008|NCT01342146|Phase 2 study|phase 2 study
5070009|NCT01342120|atypical antipsychotics|atypical antipsychotics
5070010|NCT01342120|quetiapine|quetiapine
5070011|NCT01342107|Contact Lenses|contact lenses
5070012|NCT01342107|Contact Lens Care|contact lens care
5070013|NCT01342107|Multi-Purpose Solution Wettability|multi-purpose solution wettability
5070014|NCT01342107|Myopia|myopia
5070015|NCT01342094|Primary open angle glaucoma or ocular hypertension|primary open angle glaucoma or ocular hypertension
5070016|NCT01342081|Primary open angle glaucoma or ocular hypertension|primary open angle glaucoma or ocular hypertension
5070017|NCT01342068|Thoracic outlet syndrome|thoracic outlet syndrome
5070018|NCT01342068|Osteopathic medicine|osteopathic medicine
5070019|NCT01342068|Osteopathic Manual Manipulations|osteopathic manual manipulations
5070020|NCT01342068|OMT|omt
5070021|NCT01342068|Wright's Test|wright's test
5070022|NCT01342068|Adson's Test|adson's test
5070023|NCT01342068|Halstead's Maneuver|halstead's maneuver
5070024|NCT01342068|TOS|tos
5070025|NCT01342068|Vascular Sonography|vascular sonography
5070026|NCT01342042|diabetes|diabetes
5070027|NCT01342042|rRE-4|rre-4
5070028|NCT01342042|exenatide|exenatide
5070029|NCT01342042|metformin|metformin
5070030|NCT01342042|CSPC ZhongQi|cspc zhongqi
5070031|NCT01342029|Microvascular Coronary Dysfunction (MCD)|microvascular coronary dysfunction (mcd)
5070032|NCT01342016|prograf|prograf
5070033|NCT01342016|nephritis|nephritis
5070034|NCT01342016|leflunomide|leflunomide
5070035|NCT01342016|immunosuppressant|immunosuppressant
5070036|NCT01342003|HCV infection|hcv infection
5070037|NCT01342003|genotype 1a|genotype 1a
5070038|NCT01342003|genotype 1 b|genotype 1 b
5070039|NCT01341990|Contact Lenses|contact lenses
5070040|NCT01341990|Contact Lens Care|contact lens care
5070041|NCT01341990|Multi-Purpose Solution|multi-purpose solution
5070042|NCT01341977|Contact Lenses|contact lenses
5070043|NCT01341977|Contact Lens Care|contact lens care
5070044|NCT01341977|Multi-Purpose Solution|multi-purpose solution
5070045|NCT01341964|Clopidogrel|clopidogrel
5070046|NCT01341964|Aspirin|aspirin
5070047|NCT01341964|Interaction|interaction
5070048|NCT01341951|liver failure, Acute|liver failure, acute
5070049|NCT01341938|Smokeless Tobacco Use|smokeless tobacco use
5070050|NCT01341925|childhood depression|childhood depression
5070051|NCT01341899|Type 1 diabetes|type 1 diabetes
5070052|NCT01341899|stem cell|stem cell
5070053|NCT01341899|C-peptide|c-peptide
5070054|NCT01341899|Immune function|immune function
5070055|NCT01341886|differentiated thyroid cancer|differentiated thyroid cancer
5070056|NCT01341886|THS suppression|ths suppression
5070057|NCT01341886|metformin|metformin
5070058|NCT01341834|Nasopharyngeal carcinoma, antiangiogenesis, HDACi, mTOR, Phase Ib|nasopharyngeal carcinoma, antiangiogenesis, hdaci, mtor, phase ib
5070059|NCT01341821|Leadership Style|leadership style
5070060|NCT01341821|Team Climate|team climate
5070061|NCT01341808|Crohn's disease|crohn's disease
5070062|NCT01341808|Ulcerative colitis|ulcerative colitis
5070063|NCT01341808|Hepatitis A|hepatitis a
5070064|NCT01341808|vaccine|vaccine
5070065|NCT01341795|Newly diagnosed type 2 diabetes patients|newly diagnosed type 2 diabetes patients
5070066|NCT01341782|Secondary hyperparathyroidism|secondary hyperparathyroidism
5070067|NCT01341782|Paricalcitol|paricalcitol
5070068|NCT01341782|Hemodialysis|hemodialysis
5070069|NCT01341782|Maxacalcitol|maxacalcitol
5070070|NCT01341756|Gastric Cancer|gastric cancer
5070071|NCT01341756|Radiotherapy|radiotherapy
5070072|NCT01341756|palliation|palliation
5070073|NCT01341756|bleeding|bleeding
5070074|NCT01341756|pain|pain
5070075|NCT01341756|obstruction|obstruction
5070076|NCT01341743|chronic hepatitis B|chronic hepatitis b
5070077|NCT01341743|inadequate response|inadequate response
5070078|NCT01341743|NUC therapy|nuc therapy
5070079|NCT01341730|Atherosclerosis|atherosclerosis
5070080|NCT01341730|Pioglitazone|pioglitazone
5070081|NCT01341730|Atorvastatin|atorvastatin
5070083|NCT01341717|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
5070084|NCT01341717|Sitagliptin|sitagliptin
5070085|NCT01341717|Insulin|insulin
5070086|NCT01341704|malaria|malaria
5070087|NCT01341704|vaccine|vaccine
5070088|NCT01341704|clinical trials|clinical trials
5070089|NCT01341704|proof of concept|proof of concept
5070090|NCT01341704|efficacy|efficacy
5070091|NCT01341691|chronic kidney disease|chronic kidney disease
5070092|NCT01341691|K2CG chewing gum|k2cg chewing gum
5070093|NCT01341691|phosphorus|phosphorus
5070094|NCT01341691|saliva|saliva
5070095|NCT01341678|chronic kidney disease|chronic kidney disease
5070096|NCT01341678|phosphorus|phosphorus
5070097|NCT01341678|circadian rhythm|circadian rhythm
5070098|NCT01341678|saliva|saliva
5070099|NCT01341665|hyponatremia|hyponatremia
5070100|NCT01341665|SIADH|siadh
5070101|NCT01341665|copeptin|copeptin
5070102|NCT01341639|combination vaccine|combination vaccine
5070103|NCT01341639|diphtheria|diphtheria
5070104|NCT01341639|pertussis|pertussis
5070105|NCT01341639|tetanus|tetanus
5070106|NCT01341639|hepatitis B|hepatitis b
5070107|NCT01341639|Hep B|hep b
5070108|NCT01341639|Haemophilus influenzae b|haemophilus influenzae b
5070109|NCT01341639|Hib|hib
5070110|NCT01341639|polio|polio
5070111|NCT01341639|poliovirus|poliovirus
5070112|NCT01341626|delinquency|delinquency
5070113|NCT01341626|drug use|drug use
5070114|NCT01341626|HIV risk behavior|hiv risk behavior
5070115|NCT01341626|economic costs|economic costs
5070116|NCT01341600|Clopidogrel|clopidogrel
5070117|NCT01341600|Pharmacogenetics|pharmacogenetics
5070118|NCT01341600|Platelets|platelets
5070119|NCT01341600|Healthy Subjects|healthy subjects
5070120|NCT01341587|SMBG (self monitoring of blood glucose)|smbg (self monitoring of blood glucose)
5070121|NCT01341587|diabetes|diabetes
5070122|NCT01341587|mobile technology|mobile technology
5070123|NCT01341574|spatial neglect|spatial neglect
5070124|NCT01341574|stroke|stroke
5070125|NCT01341548|Nasal|nasal
5070126|NCT01341548|Cluster Headache|cluster headache
5070127|NCT01341548|Episodic Cluster|episodic cluster
5070128|NCT01341548|Headache|headache
5070129|NCT01341548|Phase 3|phase 3
5070130|NCT01341548|Civamide|civamide
5070131|NCT01341548|TRPV-1 Receptor|trpv-1 receptor
5070132|NCT01341509|Surgical Treatment of Insertional Achilles Tendinopathy|surgical treatment of insertional achilles tendinopathy
5070133|NCT01341496|Metastatic Cancer|metastatic cancer
5070134|NCT01341496|Cancer Vaccine|cancer vaccine
5070135|NCT01341496|Immunotherapy|immunotherapy
5070136|NCT01341496|Chest Metastases|chest metastases
5070137|NCT01341496|Sarcoma|sarcoma
5070138|NCT01341496|Melanoma|melanoma
5070139|NCT01341483|erectile dysfunction|erectile dysfunction
5070140|NCT01341483|internal pudendal artery|internal pudendal artery
5070141|NCT01341483|erection|erection
5070142|NCT01341483|coronary artery disease|coronary artery disease
5070143|NCT01341483|peripheral atherosclerotic disease|peripheral atherosclerotic disease
5070144|NCT01341431|Parkinson disease|parkinson disease
5070145|NCT01341431|Bee venom|bee venom
5070146|NCT01341431|Motor fluctuations|motor fluctuations
5070147|NCT01341431|Disease progression|disease progression
5070148|NCT01341418|tibia|tibia
5070149|NCT01341418|suprapatellar|suprapatellar
5070150|NCT01341392|Drug-Drug interaction between the CKD-501 and Amlodipine|drug-drug interaction between the ckd-501 and amlodipine
5070151|NCT01341379|Ureagenesis|ureagenesis
5070152|NCT01341379|Urea cycle|urea cycle
5070153|NCT01341379|Inborn errors of metabolism|inborn errors of metabolism
5070154|NCT01341366|Laparoscopic surgery|laparoscopic surgery
5070155|NCT01341340|Stent|stent
5070156|NCT01341340|Infrapopliteal|infrapopliteal
5070157|NCT01341340|Tibial|tibial
5070158|NCT01341340|Limb Salvage|limb salvage
5070159|NCT01341327|Left Main|left main
5070160|NCT01341314|joint pain|joint pain
5070161|NCT01341314|stiffness|stiffness
5070162|NCT01341301|allogeneic stem cell transplant|allogeneic stem cell transplant
5070163|NCT01341301|TJU 2 Step|tju 2 step
5070164|NCT01341301|HSCT|hsct
5070165|NCT01341301|Hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
5070166|NCT01341288|prostate cancer|prostate cancer
5070167|NCT01341288|EUCLIDIAN|euclidian
5070168|NCT01341288|Endo-Uro Computed Lattice for Intratumoral Delivery, Implantation, Ablation with Nanosensing|endo-uro computed lattice for intratumoral delivery, implantation, ablation with nanosensing
5070169|NCT01341288|robot|robot
5070170|NCT01341288|brachytherapy|brachytherapy
5070171|NCT01341288|seed implantation|seed implantation
5070172|NCT01341275|hepatitis B vaccine|hepatitis b vaccine
5070173|NCT01341275|duration of protection|duration of protection
5070174|NCT01341275|adolescent immunization|adolescent immunization
5070175|NCT01341275|anamnestic response|anamnestic response
5070176|NCT01341275|booster dose|booster dose
5070177|NCT01341275|Immunity to hepatitis B as measured by anti-HBSAg titers|immunity to hepatitis b as measured by anti-hbsag titers
5070178|NCT01341262|autologous stem cell transplantation|autologous stem cell transplantation
5070179|NCT01341262|thalidomide|thalidomide
5070180|NCT01341262|induction therapy|induction therapy
5070181|NCT01341236|VLBW|vlbw
5070182|NCT01341236|IUGR|iugr
5070183|NCT01341236|NIRS|nirs
5070184|NCT01341236|enteral nutrition|enteral nutrition
5070185|NCT01341236|superior mesenteric artery doppler|superior mesenteric artery doppler
5070186|NCT01341210|Patients Satisfaction|patients satisfaction
5070187|NCT01341210|Decision Making|decision making
5070188|NCT01341210|Informed Consent|informed consent
5070189|NCT01341197|Fecal immunochemical test|fecal immunochemical test
5070190|NCT01341197|Guaiac fecal occult blood test|guaiac fecal occult blood test
5070191|NCT01341197|Helicobacter pylori stool antigen test|helicobacter pylori stool antigen test
5070192|NCT01341197|Mass screening|mass screening
5070193|NCT01341197|Bidirectional endoscopy|bidirectional endoscopy
5070194|NCT01341184|rifabutin|rifabutin
5070195|NCT01341184|rifampin|rifampin
5070196|NCT01341184|TMC207|tmc207
5070197|NCT01341184|tuberculosis|tuberculosis
5070198|NCT01341171|tamoxifen|tamoxifen
5070199|NCT01341171|aromatase inhibitors|aromatase inhibitors
5070200|NCT01341171|breast cancer|breast cancer
5070201|NCT01341171|platelets|platelets
5070202|NCT01341158|Malignatn Melanoma|malignatn melanoma
5070203|NCT01341145|hypertension|hypertension
5070204|NCT01341145|aerobic exercise|aerobic exercise
5070205|NCT01341145|relaxation|relaxation
5070206|NCT01341145|functional magnetic resonance imaging (fMRI)|functional magnetic resonance imaging (fmri)
5070207|NCT01341145|magnetic resonance spectroscopy (MRS)|magnetic resonance spectroscopy (mrs)
5070208|NCT01341145|brain health|brain health
5070210|NCT01341132|Hepatocellular Carcinoma|hepatocellular carcinoma
5070211|NCT01341132|MRI|mri
5070212|NCT01341132|Liver|liver
5070213|NCT01341106|chronic hepatitis B|chronic hepatitis b
5070214|NCT01341106|liver fibrosis|liver fibrosis
5070215|NCT01341106|treatment with Entecavir|treatment with entecavir
5070216|NCT01341080|Balance|balance
5070217|NCT01341080|Postural impairment|postural impairment
5070218|NCT01341080|Falls|falls
5070219|NCT01341080|Parkinson Disease|parkinson disease
5070220|NCT01341054|mucositis|mucositis
5070221|NCT01341054|chamomilla|chamomilla
5070222|NCT01341054|therapeutics|therapeutics
5070223|NCT01341028|weight loss|weight loss
5070224|NCT01341028|appetite|appetite
5070225|NCT01341028|ghrelin|ghrelin
5070226|NCT01341028|PYY|pyy
5070227|NCT01341028|GLP-1|glp-1
5070228|NCT01341028|insulin|insulin
5070229|NCT01341028|laparoscopic|laparoscopic
5070230|NCT01341028|Roux-en-Y gastric bypass|roux-en-y gastric bypass
5070231|NCT01341028|gastric fundus resection|gastric fundus resection
5070232|NCT01341002|Postoperative Care|postoperative care
5070233|NCT01341002|red blood cell transfusion|red blood cell transfusion
5070234|NCT01341002|venous oxygen saturation|venous oxygen saturation
5070235|NCT01340989|women undergoing laparoscopic surgery for: hysterectomy, colpopexy, endometriosis, adhesions or myomas|women undergoing laparoscopic surgery for: hysterectomy, colpopexy, endometriosis, adhesions or myomas
5070236|NCT01340976|Cancer Related Anemia|cancer related anemia
5070237|NCT01340963|Chagas heart disease|chagas heart disease
5070238|NCT01340963|ventricular tachycardia|ventricular tachycardia
5070239|NCT01340963|atrial fibrillation|atrial fibrillation
5070240|NCT01340963|stroke|stroke
5070241|NCT01340963|cardiac death|cardiac death
5070242|NCT01340963|signal averaged electrocardiogram|signal averaged electrocardiogram
5070243|NCT01340950|Prevention|prevention
5070244|NCT01340950|Anti-Retroviral Agents|anti-retroviral agents
5070245|NCT01340950|Neuropsychological Tests|neuropsychological tests
5070246|NCT01340937|Diphtheria|diphtheria
5070247|NCT01340937|Tetanus|tetanus
5070248|NCT01340937|Whooping Cough (pertussis)|whooping cough (pertussis)
5070249|NCT01340937|Poliomyelitis|poliomyelitis
5070250|NCT01340937|Hepatitis B infection|hepatitis b infection
5070251|NCT01340937|Haemophilus influenzae type b infection|haemophilus influenzae type b infection
5070252|NCT01340924|Gestational diabetes|gestational diabetes
5070253|NCT01340924|Type 2 diabetes|type 2 diabetes
5070254|NCT01340898|meningococcal conjugate vaccine|meningococcal conjugate vaccine
5070255|NCT01340898|serogroups A,C, W-135 or Y|serogroups a,c, w-135 or y
5070256|NCT01340898|meningococcal diseases|meningococcal diseases
5070257|NCT01340898|Immunogenicity|immunogenicity
5070258|NCT01340898|Neisseria meningitidis|neisseria meningitidis
5070259|NCT01340898|co-administration|co-administration
5070260|NCT01340898|routine vaccines|routine vaccines
5070261|NCT01340885|attention|attention
5070262|NCT01340885|mild cognitive impairment|mild cognitive impairment
5070263|NCT01340885|dementia|dementia
5070264|NCT01340872|iron deficiency|iron deficiency
5070265|NCT01340872|anaemia|anaemia
5070266|NCT01340872|inflammatory bowel disease|inflammatory bowel disease
5070267|NCT01340872|ulcerative colitis|ulcerative colitis
5070268|NCT01340859|Suicide|suicide
5070269|NCT01340859|Cognitive Therapy|cognitive therapy
5070270|NCT01340859|Inpatient|inpatient
5070271|NCT01340859|Military|military
5070272|NCT01340846|gemfibrozil|gemfibrozil
5070273|NCT01340846|BRAF|braf
5070274|NCT01340846|Drug Interactions|drug interactions
5070275|NCT01340846|GSK2118436|gsk2118436
5070276|NCT01340846|warfarin|warfarin
5070277|NCT01340846|ketoconazole|ketoconazole
5070278|NCT01340846|BRAF inhibitor|braf inhibitor
5070279|NCT01340846|oncology|oncology
5070280|NCT01340846|BRAF positive tumor|braf positive tumor
5070281|NCT01340833|GSK2118436|gsk2118436
5070282|NCT01340833|BRAF inhibitor|braf inhibitor
5070283|NCT01340833|BRAF-mutation positive tumor|braf-mutation positive tumor
5070284|NCT01340833|Oncology|oncology
5070285|NCT01340833|absolute bioavailability|absolute bioavailability
5070286|NCT01340833|microtracer|microtracer
5070287|NCT01340781|inpatients|inpatients
5070288|NCT01340781|medical|medical
5070289|NCT01340781|polysomnogram|polysomnogram
5070290|NCT01340781|questionnaires|questionnaires
5070291|NCT01340768|Glucose metabolism disorders Metabolic diseases Peptidase inhibitors|glucose metabolism disorders metabolic diseases peptidase inhibitors
5070292|NCT01340755|Rectal cancer|rectal cancer
5070293|NCT01340742|Remote ischemic preconditioning|remote ischemic preconditioning
5070294|NCT01340742|Abdominal surgery|abdominal surgery
5070295|NCT01340742|Perioperative complications|perioperative complications
5070296|NCT01340729|melanoma|melanoma
5070297|NCT01340729|TPI 287|tpi 287
5070298|NCT01340729|tumor recurrence|tumor recurrence
5070299|NCT01340729|tumor progression|tumor progression
5070300|NCT01340729|novel taxane analog|novel taxane analog
5070301|NCT01340703|optic disc pit|optic disc pit
5070302|NCT01340703|retinal detachment|retinal detachment
5070303|NCT01340703|retinoschisis|retinoschisis
5070304|NCT01340703|vitrectomy|vitrectomy
5070305|NCT01340703|posterior vitreous detachment|posterior vitreous detachment
5070306|NCT01340690|ADHD|adhd
5070307|NCT01340690|children|children
5070308|NCT01340690|adolescents|adolescents
5070309|NCT01340690|Polyunsaturated Fatty Acids|polyunsaturated fatty acids
5070310|NCT01340690|ADHDRS - IV|adhdrs - iv
5070311|NCT01340677|Canagliflozin (JNJ-28431754)|canagliflozin (jnj-28431754)
5070312|NCT01340677|Pharmacokinetic|pharmacokinetic
5070313|NCT01340677|Dose proportionality|dose proportionality
5070314|NCT01340664|Canagliflozin|canagliflozin
5070315|NCT01340664|Placebo|placebo
5070316|NCT01340664|Metformin|metformin
5070317|NCT01340664|Hemoglobin A1c|hemoglobin a1c
5070318|NCT01340664|Type 2 diabetes mellitus|type 2 diabetes mellitus
5070319|NCT01340651|myelofibrosis|myelofibrosis
5070320|NCT01340651|myeloproliferative neoplasms|myeloproliferative neoplasms
5070321|NCT01340651|PMF|pmf
5070322|NCT01340651|PET-MF|pet-mf
5070323|NCT01340651|PPV-MF|ppv-mf
5070324|NCT01340638|Seal pressure|seal pressure
5070325|NCT01340638|Cookgas|cookgas
5070326|NCT01340638|AirQ|airq
5070327|NCT01340638|LMA|lma
5070328|NCT01340638|supraglottic device|supraglottic device
5070329|NCT01340625|Healthy Subjects|healthy subjects
5070330|NCT01340612|large aneurysm|large aneurysm
5070331|NCT01340612|wide-necked aneurysm|wide-necked aneurysm
5070332|NCT01340612|recurring aneurysm|recurring aneurysm
5070333|NCT01340586|PHARMACOKINETIC|pharmacokinetic
5070334|NCT01340586|NOS|nos
5070335|NCT01340573|Chronic Hepatitis C|chronic hepatitis c
5070336|NCT01340573|pegylated interferon|pegylated interferon
5070337|NCT01340573|PegIntron Pen|pegintron pen
5070338|NCT01340573|Ribavirin|ribavirin
5070339|NCT01340560|Endometrium, local injury, implantation, pregnancy, in vitro fertilization|endometrium, local injury, implantation, pregnancy, in vitro fertilization
5070340|NCT01340547|Phase I|phase i
5070341|NCT01340547|Safety|safety
5070342|NCT01340547|PK|pk
5070343|NCT01340547|ECG QTc|ecg qtc
5070344|NCT01340547|Efficacy|efficacy
5070345|NCT01340547|Palifosfamide-tris|palifosfamide-tris
5070346|NCT01340547|non-randomized|non-randomized
5070347|NCT01340534|Surgical wound infection|surgical wound infection
5070348|NCT01340534|Oxygen|oxygen
5070349|NCT01340534|Cesarean|cesarean
5070350|NCT01340521|Pituitary Hormone Response|pituitary hormone response
5070351|NCT01340521|Clomiphene Citrate|clomiphene citrate
5070352|NCT01340521|Follicle Stimulating Hormone|follicle stimulating hormone
5070353|NCT01340521|Luteinizing Hormone|luteinizing hormone
5070354|NCT01340508|Pathological complete response|pathological complete response
5070355|NCT01340508|Intensity modulated radiotherapy|intensity modulated radiotherapy
5070356|NCT01340508|Rectal cancer|rectal cancer
5070357|NCT01340495|Breast Cancer|breast cancer
5070358|NCT01340495|Mastectomy|mastectomy
5070359|NCT01340482|XLH|xlh
5070360|NCT01340469|nosocomial infections|nosocomial infections
5070361|NCT01340469|necrotizing enterocolitis|necrotizing enterocolitis
5070362|NCT01340469|preterm infants|preterm infants
5070363|NCT01340469|ver low birth weight|ver low birth weight
5070364|NCT01340469|probiotics|probiotics
5070365|NCT01340456|4beta-OHcholesterol|4beta-ohcholesterol
5070366|NCT01340456|Midazolam|midazolam
5070367|NCT01340456|CYP3A4|cyp3a4
5070368|NCT01340456|Enzyme induction|enzyme induction
5070369|NCT01340456|Drug metabolism|drug metabolism
5070370|NCT01340430|her2 positive breast cancer|her2 positive breast cancer
5070371|NCT01340430|her2 positive non operable breast cancer|her2 positive non operable breast cancer
5070372|NCT01340430|her2 positive locally advanced breast cancer|her2 positive locally advanced breast cancer
5070373|NCT01340430|neoadjuvant trastuzumab|neoadjuvant trastuzumab
5070374|NCT01340430|pathologic complete response|pathologic complete response
5070375|NCT01340417|melatonin|melatonin
5070376|NCT01340417|preterm|preterm
5070377|NCT01340417|deficiency|deficiency
5070378|NCT01340417|neuroprotection|neuroprotection
5070379|NCT01340391|cast, radius fracture|cast, radius fracture
5070380|NCT01340378|neonatal surgery|neonatal surgery
5070381|NCT01340378|Blalock-Taussig shunt|blalock-taussig shunt
5070382|NCT01340339|Jaundice|jaundice
5070383|NCT01340339|Hyperbilirubinemia|hyperbilirubinemia
5070384|NCT01340339|Phototherapy and Super-LED Fluorescent lamps|phototherapy and super-led fluorescent lamps
5070774|NCT01338896|Rotigotine|rotigotine
5070385|NCT01340326|Post myocardial infarction ventricular remodeling|post myocardial infarction ventricular remodeling
5070386|NCT01340326|valsartan|valsartan
5070387|NCT01340313|caudal block, children, ultrasound, urological surgery|caudal block, children, ultrasound, urological surgery
5070388|NCT01340300|Colorectal|colorectal
5070389|NCT01340300|Breast|breast
5070390|NCT01340300|Insulin|insulin
5070391|NCT01340300|Exercise|exercise
5070392|NCT01340287|Plant sterol|plant sterol
5070393|NCT01340287|Hypercholesterolemia|hypercholesterolemia
5070394|NCT01340287|diet|diet
5070395|NCT01340287|dairy|dairy
5070396|NCT01340287|isoprostanes|isoprostanes
5070397|NCT01340287|Midly hypercholesterolemic subjects|midly hypercholesterolemic subjects
5070398|NCT01340274|Community Reinforcement and Family Training|community reinforcement and family training
5070399|NCT01340274|Concerned Significant Others|concerned significant others
5070400|NCT01340274|Identified Problem Gambler|identified problem gambler
5070401|NCT01340274|Therapeutics|therapeutics
5070402|NCT01340261|Pediatric|pediatric
5070403|NCT01340261|Chronic Pain|chronic pain
5070404|NCT01340248|food effect|food effect
5070405|NCT01340248|pharmacokinetics|pharmacokinetics
5070406|NCT01340248|healthy male volunteers|healthy male volunteers
5070407|NCT01340222|Preterm labour|preterm labour
5070408|NCT01340222|monocyte|monocyte
5070409|NCT01340222|lymphocyte|lymphocyte
5070410|NCT01340222|MCP-1|mcp-1
5070411|NCT01340222|Treg Lymphocytes|treg lymphocytes
5070412|NCT01340222|biologic markers|biologic markers
5070413|NCT01340222|immunology|immunology
5070414|NCT01340222|HLA-DR|hla-dr
5070415|NCT01340222|Th17|th17
5070416|NCT01340183|Phase I|phase i
5070417|NCT01340183|safety|safety
5070418|NCT01340183|tolerability|tolerability
5070419|NCT01340183|pharmacokinetics|pharmacokinetics
5070420|NCT01340183|AZD5099|azd5099
5070421|NCT01340183|volunteers|volunteers
5070422|NCT01340183|safety of the drug AZD5099|safety of the drug azd5099
5070423|NCT01340183|blood and urine levels of AZD5099|blood and urine levels of azd5099
5070424|NCT01340183|single intravenous doses|single intravenous doses
5070425|NCT01340183|healthy volunteers|healthy volunteers
5070426|NCT01340157|Fexinidazole|fexinidazole
5070427|NCT01340157|Phase I|phase i
5070428|NCT01340157|Bioavailability study|bioavailability study
5070429|NCT01340157|Food effect|food effect
5070430|NCT01340157|Human African Trypanosomiasis|human african trypanosomiasis
5070431|NCT01340144|total knee replacement|total knee replacement
5070432|NCT01340144|patellar crepitus|patellar crepitus
5070433|NCT01340144|Replacement of knee joint|replacement of knee joint
5070434|NCT01340131|CKD-828|ckd-828
5070435|NCT01340131|Hypertension|hypertension
5070436|NCT01340131|Primary Hypertension|primary hypertension
5070437|NCT01340131|Healthy Volunteer|healthy volunteer
5070438|NCT01340131|S-Amlodipine|s-amlodipine
5070439|NCT01340131|Telmisartan|telmisartan
5070440|NCT01340131|Amlodipine|amlodipine
5070441|NCT01340131|Pharmacokinetic|pharmacokinetic
5070442|NCT01340131|Phase 1|phase 1
5070443|NCT01340118|Asthma|asthma
5070444|NCT01340118|FEF25-75|fef25-75
5070445|NCT01340118|exhaled nitric oxide|exhaled nitric oxide
5070446|NCT01340118|inhaled corticosteroid|inhaled corticosteroid
5070447|NCT01340118|children|children
5070448|NCT01340105|Microwave ablation|microwave ablation
5070449|NCT01340105|Radiofrequency ablation|radiofrequency ablation
5070450|NCT01340105|Randomised controlled trial|randomised controlled trial
5070451|NCT01340092|Family Navigator|family navigator
5070452|NCT01340092|Autistic Disorder|autistic disorder
5070453|NCT01340092|Early Intervention|early intervention
5070454|NCT01340092|Developmental Disabilities|developmental disabilities
5070455|NCT01340092|Child Development Disorders|child development disorders
5070456|NCT01340079|diabetes mellitus, non-insulin dependent|diabetes mellitus, non-insulin dependent
5070457|NCT01340066|urinary incontinence|urinary incontinence
5070458|NCT01340066|stress incontinence|stress incontinence
5070459|NCT01340066|urge incontinence|urge incontinence
5070460|NCT01340066|mixed incontinence|mixed incontinence
5070461|NCT01340040|Phase I|phase i
5070462|NCT01340040|cancer|cancer
5070463|NCT01340040|solid tumours|solid tumours
5070464|NCT01340040|advanced solid malignancies|advanced solid malignancies
5070465|NCT01340040|dose escalation|dose escalation
5070466|NCT01340040|Insulin like growth factor|insulin like growth factor
5070467|NCT01340040|Japanese|japanese
5070468|NCT01340027|Overactive bladder (OAB)|overactive bladder (oab)
5070469|NCT01340027|Frequency|frequency
5070470|NCT01340027|Micturition|micturition
5070471|NCT01340027|Urgency|urgency
5070472|NCT01340027|Urinary incontinence|urinary incontinence
5070473|NCT01340027|Urgency incontinence|urgency incontinence
5070474|NCT01340027|YM178|ym178
5070475|NCT01340014|Glaucoma|glaucoma
5070476|NCT01340014|Intraocular pressure|intraocular pressure
5070477|NCT01340014|Tonometry, ocular|tonometry, ocular
5070478|NCT01340001|Dementia with Lewy bodies|dementia with lewy bodies
5070479|NCT01340001|Nucleus basalis of Meynert|nucleus basalis of meynert
5070480|NCT01340001|Deep brain stimulation|deep brain stimulation
5070481|NCT01339988|Stem-cells|stem-cells
5070482|NCT01339988|Transplantation|transplantation
5070483|NCT01339988|Busulfex|busulfex
5070775|NCT01338896|Neupro|neupro
5070484|NCT01339988|Cyclophosphamide|cyclophosphamide
5070485|NCT01339988|Total-Body-Ittadiation|total-body-ittadiation
5070486|NCT01339975|Renal Cell Carcinoma|renal cell carcinoma
5070487|NCT01339975|Nephrectomy|nephrectomy
5070488|NCT01339975|Antiangiogenics|antiangiogenics
5070489|NCT01339975|Chemokines|chemokines
5070490|NCT01339975|Prognostic value|prognostic value
5070491|NCT01339975|Carcinoma|carcinoma
5070492|NCT01339975|Carcinoma, Renal Cell|carcinoma, renal cell
5070493|NCT01339975|Kidney Neoplasms|kidney neoplasms
5070494|NCT01339975|Kidney Diseases|kidney diseases
5070495|NCT01339975|Neoplasms, Glandular and Epithelial|neoplasms, glandular and epithelial
5070496|NCT01339975|Neoplasms by Histologic Type|neoplasms by histologic type
5070497|NCT01339975|Neoplasms|neoplasms
5070498|NCT01339975|Adenocarcinoma|adenocarcinoma
5070499|NCT01339975|Urologic Neoplasms|urologic neoplasms
5070500|NCT01339975|Urogenital Neoplasms|urogenital neoplasms
5070501|NCT01339975|Neoplasms by Site|neoplasms by site
5070502|NCT01339975|Urologic Diseases|urologic diseases
5070503|NCT01339975|Adjuvants, Immunologic|adjuvants, immunologic
5070504|NCT01339975|Physiological Effects of Drugs|physiological effects of drugs
5070505|NCT01339975|Pharmacologic Actions|pharmacologic actions
5070506|NCT01339975|Biomarkers|biomarkers
5070507|NCT01339975|Targeted therapies|targeted therapies
5070508|NCT01339975|Surgery|surgery
5070509|NCT01339962|Metastatic renal cell carcinoma|metastatic renal cell carcinoma
5070510|NCT01339949|AMD|amd
5070511|NCT01339949|wet AMD|wet amd
5070512|NCT01339949|Macular Degeneration|macular degeneration
5070513|NCT01339949|wet Age-related Macular Degeneration|wet age-related macular degeneration
5070514|NCT01339949|Age-Related Macular Degeneration|age-related macular degeneration
5070515|NCT01339949|IRay|iray
5070516|NCT01339949|radiation|radiation
5070517|NCT01339949|Oraya|oraya
5070518|NCT01339949|Oraya Therapeutics, Inc|oraya therapeutics, inc
5070519|NCT01339949|Low-voltage stereotactic radiosurgery|low-voltage stereotactic radiosurgery
5070520|NCT01339949|radiosurgery|radiosurgery
5070521|NCT01339949|x-ray|x-ray
5070522|NCT01339949|Lucentis|lucentis
5070523|NCT01339949|external beam radiation|external beam radiation
5070524|NCT01339923|Meningococcal disease|meningococcal disease
5070525|NCT01339923|Vaccines|vaccines
5070526|NCT01339923|intercalated administration|intercalated administration
5070527|NCT01339910|Acute Myelogenous Leukemia|acute myelogenous leukemia
5070528|NCT01339910|Myelodysplastic Syndrome|myelodysplastic syndrome
5070529|NCT01339897|N6022, GSNORi|n6022, gsnori
5070530|NCT01339884|Friedreich ataxia|friedreich ataxia
5070531|NCT01339884|Resveratrol|resveratrol
5070532|NCT01339884|Frataxin|frataxin
5070533|NCT01339884|Cardiomyopathy|cardiomyopathy
5070534|NCT01339884|Oxidative stress|oxidative stress
5070535|NCT01339871|Pazopanib|pazopanib
5070536|NCT01339871|Vorinostat|vorinostat
5070537|NCT01339871|Advanced Malignancies|advanced malignancies
5070538|NCT01339845|Cholera vaccine|cholera vaccine
5070539|NCT01339845|Behaviour change intervention|behaviour change intervention
5070540|NCT01339845|Cost effectiveness and cost-benefit|cost effectiveness and cost-benefit
5070541|NCT01339845|Prevention of cholera|prevention of cholera
5070542|NCT01339845|Control of Cholera|control of cholera
5070543|NCT01339845|Vaccination|vaccination
5070544|NCT01339806|mTBI|mtbi
5070545|NCT01339806|Concussion|concussion
5070546|NCT01339793|corporate social responsibility|corporate social responsibility
5070547|NCT01339793|social identity theory|social identity theory
5070548|NCT01339793|stakeholder theory|stakeholder theory
5070549|NCT01339793|organizational commitment|organizational commitment
5070550|NCT01339793|organizational performance|organizational performance
5070551|NCT01339767|Autism|autism
5070552|NCT01339767|Language Acquisition|language acquisition
5070553|NCT01339767|Language Development|language development
5070554|NCT01339767|Toddlers|toddlers
5070555|NCT01339754|recurrent pancreatic cancer|recurrent pancreatic cancer
5070556|NCT01339754|stage IV pancreatic cancer|stage iv pancreatic cancer
5070557|NCT01339754|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
5070558|NCT01339741|Psoriasis Vulgaris|psoriasis vulgaris
5070559|NCT01339741|Vitamin D Deficiency|vitamin d deficiency
5070560|NCT01339741|Vitamin D Insufficiency|vitamin d insufficiency
5070561|NCT01339741|Vitamin D Supplement|vitamin d supplement
5070562|NCT01339741|Psoriasis Area and Severity Index (PASI Score)|psoriasis area and severity index (pasi score)
5070563|NCT01339741|Dermatologic Life Qualify Index (DLQI)|dermatologic life qualify index (dlqi)
5070564|NCT01339715|Ryodoraku|ryodoraku
5070565|NCT01339715|Heart Rate Variability|heart rate variability
5070566|NCT01339715|Traditional medicine|traditional medicine
5070567|NCT01339715|Autonomic Nervous System|autonomic nervous system
5070568|NCT01339715|Acupuncture|acupuncture
5070569|NCT01339715|Far Infrared Ray|far infrared ray
5070570|NCT01339715|CV12 Acupoint|cv12 acupoint
5070571|NCT01339702|Traumatic Brain Injury|traumatic brain injury
5070572|NCT01339702|TBI|tbi
5070573|NCT01339702|Head Trauma|head trauma
5070574|NCT01339702|Acute Traumatic Brain Injury|acute traumatic brain injury
5070575|NCT01339702|Trauma, Brain|trauma, brain
5070576|NCT01339689|PTSD|ptsd
5070705|NCT01339117|chronic abdominal pain|chronic abdominal pain
5070577|NCT01339689|Posttraumatic Stress Disorder|posttraumatic stress disorder
5070578|NCT01339689|pharmacotherapy|pharmacotherapy
5070579|NCT01339689|ganaxolone|ganaxolone
5070580|NCT01339676|Vitamin D|vitamin d
5070581|NCT01339676|Multiple Sclerosis|multiple sclerosis
5070583|NCT01339676|Randomised Trial|randomised trial
5070584|NCT01339676|Finland|finland
5070585|NCT01339650|Solid Tumor|solid tumor
5070586|NCT01339650|BRCA 1 and BRCA 2 Mutations|brca 1 and brca 2 mutations
5070587|NCT01339650|Breast Cancer 1|breast cancer 1
5070588|NCT01339650|Breast Cancer 2|breast cancer 2
5070589|NCT01339650|High Grade Serous Ovarian, Fallopian Tube, or Primary Peritoneal Cancers|high grade serous ovarian, fallopian tube, or primary peritoneal cancers
5070590|NCT01339650|Solid Tumors|solid tumors
5070591|NCT01339637|Impaired Glucose Tolerance|impaired glucose tolerance
5070592|NCT01339637|Diabetes Risk Factors|diabetes risk factors
5070593|NCT01339637|Dark Skin|dark skin
5070594|NCT01339624|analgesia|analgesia
5070595|NCT01339624|renal colic|renal colic
5070596|NCT01339624|ketorolac|ketorolac
5070597|NCT01339624|nasal fentanyl|nasal fentanyl
5070598|NCT01339624|morphine.|morphine.
5070599|NCT01339624|treatment of acute renal colic|treatment of acute renal colic
5070600|NCT01339611|quality of life|quality of life
5070601|NCT01339611|medical adherence|medical adherence
5070602|NCT01339611|warfarin|warfarin
5070603|NCT01339611|Health education|health education
5070604|NCT01339572|autologous transplantation|autologous transplantation
5070605|NCT01339572|peripheral stem cell mobilization|peripheral stem cell mobilization
5070606|NCT01339559|Epilepsy|epilepsy
5070607|NCT01339559|Brivaracetam|brivaracetam
5070608|NCT01339559|Partial Onset Seizures|partial onset seizures
5070609|NCT01339559|Adjunctive treatment|adjunctive treatment
5070610|NCT01339546|ecologic|ecologic
5070611|NCT01339546|cross sectional|cross sectional
5070612|NCT01339546|trend analysis|trend analysis
5070613|NCT01339533|ALI|ali
5070614|NCT01339533|ARDS|ards
5070615|NCT01339481|Orencia|orencia
5070616|NCT01339481|Abatacept|abatacept
5070617|NCT01339481|Rheumatoid Arthritis|rheumatoid arthritis
5070618|NCT01339481|Infusion|infusion
5070619|NCT01339468|advagraf|advagraf
5070620|NCT01339468|prograf|prograf
5070621|NCT01339468|living donor liver transplantation|living donor liver transplantation
5070622|NCT01339468|FK506|fk506
5070623|NCT01339468|Immunosuppressant|immunosuppressant
5070624|NCT01339455|Neuromyelitis Optica|neuromyelitis optica
5070625|NCT01339455|NMO|nmo
5070626|NCT01339455|Devic's Disease|devic's disease
5070627|NCT01339455|Stem Cell Transplant|stem cell transplant
5070628|NCT01339429|wound|wound
5070629|NCT01339429|negative pressure wound therapy|negative pressure wound therapy
5070630|NCT01339429|non-powered negative pressure wound therapy|non-powered negative pressure wound therapy
5070631|NCT01339390|Obesity|obesity
5070632|NCT01339390|Veteran|veteran
5070633|NCT01339390|Self Care|self care
5070634|NCT01339390|Patient Education|patient education
5070635|NCT01339390|Peer Group|peer group
5070636|NCT01339377|Ozone|ozone
5070637|NCT01339377|Oxygen|oxygen
5070638|NCT01339377|Oxygen-Ozone|oxygen-ozone
5070639|NCT01339377|AO-1000|ao-1000
5070640|NCT01339377|ActiveO|activeo
5070641|NCT01339377|Herniated Disc|herniated disc
5070642|NCT01339377|Disc|disc
5070643|NCT01339377|Lumbar|lumbar
5070644|NCT01339351|breast cancer|breast cancer
5070645|NCT01339351|social connection|social connection
5070646|NCT01339325|Laparo-endoscopic single site cholecystectomy|laparo-endoscopic single site cholecystectomy
5070647|NCT01339325|Quality of Life|quality of life
5070648|NCT01339325|Postoperative Pain|postoperative pain
5070649|NCT01339325|Cosmetics|cosmetics
5070650|NCT01339325|Complication|complication
5070651|NCT01339312|Rabies|rabies
5070652|NCT01339312|Rabies virus|rabies virus
5070653|NCT01339312|Purified Vero Rabies Vaccine - Serum Free|purified vero rabies vaccine - serum free
5070654|NCT01339299|COS|cos
5070655|NCT01339299|ART|art
5070656|NCT01339299|Infertility|infertility
5070657|NCT01339273|TAP block|tap block
5070658|NCT01339273|Laparoscopic hemicolectomy|laparoscopic hemicolectomy
5070659|NCT01339273|Laparoscopic anterior resection|laparoscopic anterior resection
5070660|NCT01339273|laparoscopic colonic resection|laparoscopic colonic resection
5070661|NCT01339247|Bioequivalence|bioequivalence
5070662|NCT01339247|Paroxetine reference/test|paroxetine reference/test
5070663|NCT01339247|healthy volunteers|healthy volunteers
5070664|NCT01339247|Fed condition|fed condition
5070665|NCT01339234|treadmill exercise|treadmill exercise
5070666|NCT01339234|rehabilitation|rehabilitation
5070667|NCT01339234|progressive multiple sclerosis|progressive multiple sclerosis
5070668|NCT01339234|functional ability|functional ability
5070669|NCT01339234|quality of life|quality of life
5070670|NCT01339234|fatigue|fatigue
5070671|NCT01339221|Observational|observational
5070672|NCT01339221|Rotarix™|rotarix™
5070673|NCT01339221|post-marketing|post-marketing
5070674|NCT01339208|Type 2 Diabetes|type 2 diabetes
5070675|NCT01339195|Dementia|dementia
5070676|NCT01339195|Alzheimer disease|alzheimer disease
5070677|NCT01339195|stroke|stroke
5070678|NCT01339195|cognitive impairment|cognitive impairment
5070679|NCT01339182|somatropin|somatropin
5070680|NCT01339182|PK|pk
5070681|NCT01339182|PD|pd
5070682|NCT01339182|male|male
5070683|NCT01339182|pharmacokinetics|pharmacokinetics
5070684|NCT01339182|pharmacodynamics|pharmacodynamics
5070685|NCT01339182|safety|safety
5070686|NCT01339169|YF476|yf476
5070687|NCT01339169|Hypergastrinaemia|hypergastrinaemia
5070688|NCT01339169|netazepide|netazepide
5070689|NCT01339169|gastric carcinoids|gastric carcinoids
5070690|NCT01339156|Safety|safety
5070691|NCT01339156|Tolerability|tolerability
5070692|NCT01339156|Food Effect|food effect
5070693|NCT01339156|Pharmacokinetics|pharmacokinetics
5070694|NCT01339143|Vildagliptin|vildagliptin
5070695|NCT01339130|Alzheimer disease|alzheimer disease
5070696|NCT01339130|Stroke|stroke
5070697|NCT01339130|Frontotemporal Lobar Degeneration|frontotemporal lobar degeneration
5070698|NCT01339130|Lewy Body Dementia|lewy body dementia
5070699|NCT01339130|Huntington Disease|huntington disease
5070700|NCT01339130|mild cognitive impairment|mild cognitive impairment
5070701|NCT01339130|vascular injury|vascular injury
5070702|NCT01339130|Parkinson's disease|parkinson's disease
5070703|NCT01339117|irritable bowel syndrome|irritable bowel syndrome
5070704|NCT01339117|children|children
5070706|NCT01339117|recurrent abdominal pain|recurrent abdominal pain
5070707|NCT01339104|Cardiovascular safety|cardiovascular safety
5070708|NCT01339078|Biliary strictures|biliary strictures
5070709|NCT01339078|liver transplantation|liver transplantation
5070710|NCT01339065|ketamine|ketamine
5070711|NCT01339065|inflammatory|inflammatory
5070712|NCT01339065|pro inflammatory|pro inflammatory
5070713|NCT01339065|pro inflammatory markers IL-6 and IL-1beta|pro inflammatory markers il-6 and il-1beta
5070714|NCT01339052|BKM120|bkm120
5070715|NCT01339052|Brain tumor|brain tumor
5070716|NCT01339039|AMD3100|amd3100
5070717|NCT01339039|plerixafor|plerixafor
5070718|NCT01339039|Mozobil|mozobil
5070719|NCT01339039|bevacizumab|bevacizumab
5070720|NCT01339026|Acute coronary syndrome|acute coronary syndrome
5070721|NCT01339026|Platelet reactivity|platelet reactivity
5070722|NCT01339026|Clopidogrel|clopidogrel
5070723|NCT01339026|Percutaneous coronary intervention|percutaneous coronary intervention
5070724|NCT01339013|Quantification|quantification
5070725|NCT01339013|ventilatory requirements|ventilatory requirements
5070726|NCT01339013|charcoal filter|charcoal filter
5070727|NCT01339000|Colorectal Cancer|colorectal cancer
5070728|NCT01339000|Breast Cancer|breast cancer
5070729|NCT01339000|Immunization|immunization
5070730|NCT01339000|Immunocompromised Host|immunocompromised host
5070731|NCT01339000|Bladder Cancer|bladder cancer
5070732|NCT01339000|Colon Cancer|colon cancer
5070733|NCT01338987|FLT|flt
5070734|NCT01338987|Lupron|lupron
5070735|NCT01338987|Thymic Renewal|thymic renewal
5070736|NCT01338987|Stem Cell Transplant|stem cell transplant
5070737|NCT01338987|Acute Lymphocytic Leukemia|acute lymphocytic leukemia
5070738|NCT01338987|Acute Myelogenous Leukemia|acute myelogenous leukemia
5070739|NCT01338987|Myelodyplastic Syndrome|myelodyplastic syndrome
5070740|NCT01338974|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5070741|NCT01338974|adult acute myeloid leukemia with del(5q)|adult acute myeloid leukemia with del(5q)
5070742|NCT01338974|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5070743|NCT01338974|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5070744|NCT01338974|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5070745|NCT01338974|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5070746|NCT01338974|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
5070747|NCT01338974|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
5070748|NCT01338974|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
5070749|NCT01338974|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
5070750|NCT01338974|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
5070751|NCT01338974|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
5070752|NCT01338974|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
5070753|NCT01338974|adult erythroleukemia (M6a)|adult erythroleukemia (m6a)
5070754|NCT01338974|adult pure erythroid leukemia (M6b)|adult pure erythroid leukemia (m6b)
5070755|NCT01338974|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
5070756|NCT01338961|Cardiopulmonary Bypass|cardiopulmonary bypass
5070757|NCT01338961|Hypothermia|hypothermia
5070758|NCT01338961|Normothermia|normothermia
5070759|NCT01338961|Troponin I|troponin i
5070760|NCT01338961|Bleeding|bleeding
5070761|NCT01338935|CW 002|cw 002
5070762|NCT01338935|Phase I trial|phase i trial
5070763|NCT01338935|safety|safety
5070764|NCT01338935|efficacy|efficacy
5070765|NCT01338935|pharmacokinetics|pharmacokinetics
5070766|NCT01338935|estimated dose|estimated dose
5070767|NCT01338935|Neuromuscular Blocking Agents|neuromuscular blocking agents
5070768|NCT01338935|Treatment Effectiveness|treatment effectiveness
5070769|NCT01338935|Drug Antagonism|drug antagonism
5070770|NCT01338909|prasugrel|prasugrel
5070771|NCT01338909|clopidogrel|clopidogrel
5070772|NCT01338909|primary percutaneous coronary intervention|primary percutaneous coronary intervention
5070773|NCT01338909|high platelet reactivity|high platelet reactivity
5070776|NCT01338883|HIV-1 Infection|hiv-1 infection
5070777|NCT01338883|CCR5-tropic|ccr5-tropic
5070778|NCT01338883|Anti-retroviral naive|anti-retroviral naive
5070779|NCT01338870|Phase 2|phase 2
5070780|NCT01338870|safety and efficacy study with PF-04991532|safety and efficacy study with pf-04991532
5070781|NCT01338870|Type 2 diabetes|type 2 diabetes
5070782|NCT01338857|neurofibromatosis1 (NF1)|neurofibromatosis1 (nf1)
5070783|NCT01338857|Recurrent or progressive optic pathway gliomas (OPG)|recurrent or progressive optic pathway gliomas (opg)
5070784|NCT01338857|Recurrent or progressive low-grade glioma|recurrent or progressive low-grade glioma
5070785|NCT01338857|sorafenib|sorafenib
5070786|NCT01338857|low-grade astrocytoma|low-grade astrocytoma
5070787|NCT01338844|Poor oocyte quality|poor oocyte quality
5070788|NCT01338844|IVF failure|ivf failure
5070789|NCT01338831|prostate cancer,|prostate cancer,
5070790|NCT01338831|breast cancer,|breast cancer,
5070791|NCT01338831|prolactin,|prolactin,
5070792|NCT01338831|prolactin receptor|prolactin receptor
5070793|NCT01338831|uterine leiomyoma|uterine leiomyoma
5070794|NCT01338818|Attention Deficit /Hyperactivity Disorder,|attention deficit /hyperactivity disorder,
5070795|NCT01338818|hyperactivity|hyperactivity
5070796|NCT01338805|Partial onset seizure|partial onset seizure
5070797|NCT01338805|seizure frequency|seizure frequency
5070798|NCT01338805|nervous system diseases|nervous system diseases
5070799|NCT01338805|central nervous system diseases|central nervous system diseases
5070800|NCT01338805|CNS|cns
5070801|NCT01338805|brain diseases|brain diseases
5070802|NCT01338805|neurologic manifestations|neurologic manifestations
5070803|NCT01338805|adjunctive treatment|adjunctive treatment
5070804|NCT01338805|AEDs|aeds
5070805|NCT01338805|antiepileptic drug|antiepileptic drug
5070806|NCT01338779|Tolerance|tolerance
5070807|NCT01338779|Renal|renal
5070808|NCT01338779|Allograft|allograft
5070809|NCT01338779|B Cell Signature|b cell signature
5070810|NCT01338766|spondylolisthesis|spondylolisthesis
5070811|NCT01338766|lumbar spinal stenosis|lumbar spinal stenosis
5070812|NCT01338753|breast|breast
5070813|NCT01338753|cancer|cancer
5070814|NCT01338753|Pharmacogenomics|pharmacogenomics
5070815|NCT01338753|bevacizumab|bevacizumab
5070816|NCT01338740|Chrohn's disease|chrohn's disease
5070817|NCT01338740|Moderate to severely active Crohn's disease patients|moderate to severely active crohn's disease patients
5070818|NCT01338714|HBV carrier|hbv carrier
5070819|NCT01338714|HBV DNA title|hbv dna title
5070820|NCT01338714|Chinese Medicine|chinese medicine
5070821|NCT01338714|Liver function|liver function
5070822|NCT01338714|RHD-1|rhd-1
5070823|NCT01338701|TBI|tbi
5070824|NCT01338701|Headaches|headaches
5070825|NCT01338701|Military|military
5070826|NCT01338701|Acupuncture|acupuncture
5070827|NCT01338701|Walter Reed Army Medical Center|walter reed army medical center
5070828|NCT01338701|Fort Belvoir Community Hospital|fort belvoir community hospital
5070829|NCT01338675|Chronic granulomatous disease|chronic granulomatous disease
5070830|NCT01338675|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
5070831|NCT01338662|Parkinson`s disease|parkinson`s disease
5070832|NCT01338649|Parkinson's disease|parkinson's disease
5070833|NCT01338649|Daytime somnolence|daytime somnolence
5070834|NCT01338649|Sleepiness|sleepiness
5070835|NCT01338649|Light therapy|light therapy
5070836|NCT01338636|Exercise-induced pulmonary arterial hypertension (EIPAH)|exercise-induced pulmonary arterial hypertension (eipah)
5070837|NCT01338636|Pulmonary arterial hypertension (PAH)|pulmonary arterial hypertension (pah)
5070838|NCT01338636|ambrisentan|ambrisentan
5070839|NCT01338636|Advanced cardiopulmonary exercise test (CPET)|advanced cardiopulmonary exercise test (cpet)
5070840|NCT01338623|bioequivalence|bioequivalence
5070841|NCT01338623|tansulosine|tansulosine
5070842|NCT01338610|Ocular discomfort|ocular discomfort
5070843|NCT01338597|thyroidectomy|thyroidectomy
5070844|NCT01338597|invasiveness|invasiveness
5070845|NCT01338584|Pelvic floor muscle training|pelvic floor muscle training
5070846|NCT01338584|Post prostatectomy|post prostatectomy
5070847|NCT01338584|Early regaining of urinary continence|early regaining of urinary continence
5070848|NCT01338584|Positive improvement in quality of life|positive improvement in quality of life
5070849|NCT01338571|stool fatty acid|stool fatty acid
5070850|NCT01338532|Hip osteoarthritis|hip osteoarthritis
5070851|NCT01338532|Exercise|exercise
5070852|NCT01338532|Patient Education|patient education
5070853|NCT01338532|Total Hip Replacement|total hip replacement
5070854|NCT01338506|Military|military
5070855|NCT01338506|Posttraumatic Stress Disorder|posttraumatic stress disorder
5070856|NCT01338506|PTSD|ptsd
5070857|NCT01338506|PostTraumatic Stress Disorders|posttraumatic stress disorders
5070858|NCT01338506|Combat|combat
5070859|NCT01338506|Psychological Treatment|psychological treatment
5070860|NCT01338506|Psychotherapy|psychotherapy
5070861|NCT01338506|Trauma|trauma
5070862|NCT01338506|Posttraumatic Stress|posttraumatic stress
5070863|NCT01338506|Prolonged Exposure|prolonged exposure
5070864|NCT01338506|Exposure therapy|exposure therapy
5070865|NCT01338506|Behavior Therapy|behavior therapy
5070866|NCT01338506|Cognitive Behavior Therapy|cognitive behavior therapy
5070867|NCT01338506|Stress Disorders|stress disorders
5070868|NCT01338506|Drug Abuse|drug abuse
5070869|NCT01338506|Drug Dependence|drug dependence
5070870|NCT01338506|Alcohol Abuse|alcohol abuse
5070871|NCT01338506|Alcohol Dependence|alcohol dependence
5070872|NCT01338506|Substance Use Disorders|substance use disorders
5070873|NCT01338506|Alcoholism|alcoholism
5070874|NCT01338480|trauma|trauma
5070875|NCT01338480|surgery|surgery
5070876|NCT01338480|informed consent|informed consent
5070877|NCT01338467|Glaucoma|glaucoma
5070878|NCT01338467|Refractory glaucoma|refractory glaucoma
5070879|NCT01338467|Cyclocoagulation|cyclocoagulation
5070880|NCT01338467|High Intensity Focused Ultrasound|high intensity focused ultrasound
5070881|NCT01338441|Drug induced QT prolongation|drug induced qt prolongation
5070882|NCT01338428|rape|rape
5070883|NCT01338428|sexual assault|sexual assault
5070884|NCT01338428|intervention|intervention
5070885|NCT01338428|female university students|female university students
5070886|NCT01338415|pediatric|pediatric
5070887|NCT01338415|pulmonary arterial hypertension|pulmonary arterial hypertension
5070888|NCT01338415|bosentan|bosentan
5070889|NCT01338415|Tracleer|tracleer
5070890|NCT01338363|acid suppressing drugs|acid suppressing drugs
5070891|NCT01338363|pharmacoepidemiology|pharmacoepidemiology
5070892|NCT01338363|children|children
5070893|NCT01338350|safety|safety
5070894|NCT01338350|tolerability|tolerability
5070895|NCT01338350|pharmacokinetics|pharmacokinetics
5070896|NCT01338350|pharmacodynamics|pharmacodynamics
5070897|NCT01338350|AZD5423|azd5423
5070898|NCT01338350|Japanese|japanese
5070899|NCT01338337|Low risk International Prognostic Scoring System (IPSS) (0 or Int-1)|low risk international prognostic scoring system (ipss) (0 or int-1)
5070900|NCT01338337|Patients who have not responded to previous treatment with erythropoietin (EPO)|patients who have not responded to previous treatment with erythropoietin (epo)
5070901|NCT01338337|Eastern Cooperative Oncology Group (ECOG) score ≤ 3|eastern cooperative oncology group (ecog) score ≤ 3
5070902|NCT01338324|Biomarker|biomarker
5070903|NCT01338324|Pharmacokinetics|pharmacokinetics
5070904|NCT01338324|Villous|villous
5070905|NCT01338324|Simvastatin|simvastatin
5070906|NCT01338324|Celiac disease|celiac disease
5070907|NCT01338298|Schizophrenia|schizophrenia
5070908|NCT01338298|Symptomatic Hyperprolactinemia|symptomatic hyperprolactinemia
5070909|NCT01338298|Hormone|hormone
5070910|NCT01338298|Menstrual|menstrual
5070911|NCT01338285|Industry Hygiene|industry hygiene
5070912|NCT01338285|Molecular Epidemiology|molecular epidemiology
5070913|NCT01338285|Cancer Susceptability|cancer susceptability
5070914|NCT01338285|Genotoxocity|genotoxocity
5070915|NCT01338285|FISH|fish
5070916|NCT01338142|postmenopausal|postmenopausal
5070917|NCT01338142|women|women
5070918|NCT01338142|absorption|absorption
5070919|NCT01338142|calcium|calcium
5070920|NCT01338142|amorphous calcium|amorphous calcium
5070921|NCT01338129|vitamin c|vitamin c
5070922|NCT01338129|ascorbic acid|ascorbic acid
5070923|NCT01338129|ankle fracture|ankle fracture
5070924|NCT01338129|crps|crps
5070926|NCT01338129|crps prevention|crps prevention
5070927|NCT01338116|computerized decision support system|computerized decision support system
5070928|NCT01338116|PCR|pcr
5070929|NCT01338116|antibiotic treatment|antibiotic treatment
5070930|NCT01338103|Pemphigus|pemphigus
5070931|NCT01338103|Rituximab|rituximab
5070932|NCT01338103|Cylex|cylex
5070933|NCT01338090|VEGF imaging|vegf imaging
5070934|NCT01338090|neuroendocrine tumors|neuroendocrine tumors
5070935|NCT01338090|biomarker|biomarker
5070936|NCT01338090|mTOR inhibition|mtor inhibition
5070937|NCT01338077|Alginate|alginate
5070938|NCT01338077|Gastroesophageal reflux disease|gastroesophageal reflux disease
5070939|NCT01338064|Silicosis|silicosis
5070940|NCT01338051|Community based participatory research|community based participatory research
5070941|NCT01338025|HIV|hiv
5070942|NCT01338025|Bridging|bridging
5070943|NCT01338025|Strategy|strategy
5070944|NCT01338012|metastatic castrate resistant prostate cancer|metastatic castrate resistant prostate cancer
5070945|NCT01338012|prostate cancer|prostate cancer
5070946|NCT01338012|prostate|prostate
5070947|NCT01338012|immune therapy|immune therapy
5070948|NCT01338012|immunotherapy|immunotherapy
5070949|NCT01338012|vaccine|vaccine
5070950|NCT01338012|dendritic cells|dendritic cells
5070951|NCT01338012|antigen-presenting cells|antigen-presenting cells
5070952|NCT01338012|antigen presenting cells|antigen presenting cells
5070953|NCT01338012|cancer vaccine|cancer vaccine
5070954|NCT01338012|prostatic adenocarcinoma|prostatic adenocarcinoma
5070955|NCT01338012|Sipuleucel-T|sipuleucel-t
5070956|NCT01338012|castration resistant prostate cancer (CRPC)|castration resistant prostate cancer (crpc)
5070957|NCT01338012|booster|booster
5070958|NCT01338012|retreatment|retreatment
5070959|NCT01338012|immune memory|immune memory
5070960|NCT01338012|immune response|immune response
5070961|NCT01337986|Multiple Sclerosis|multiple sclerosis
5070962|NCT01337986|Optic Neuritis|optic neuritis
5070963|NCT01337986|Ampyra|ampyra
5070964|NCT01337986|Dalfampridine|dalfampridine
5070965|NCT01337986|Fampridine|fampridine
5070966|NCT01337986|Remote Optic Neuritis|remote optic neuritis
5070967|NCT01337986|Contrast Sensitivity|contrast sensitivity
5070968|NCT01337986|Treatment|treatment
5070969|NCT01337973|violence|violence
5070970|NCT01337973|aggression|aggression
5070971|NCT01337973|Substance-Related Disorders|substance-related disorders
5070972|NCT01337973|Alcohol-Related Disorders|alcohol-related disorders
5070973|NCT01337973|Drug-Related Disorders|drug-related disorders
5070974|NCT01337960|Stroke|stroke
5070975|NCT01337960|Robotics|robotics
5070976|NCT01337960|Neurorehabilitation|neurorehabilitation
5070977|NCT01337947|Type 1 diabetes|type 1 diabetes
5070978|NCT01337947|adolescents|adolescents
5070979|NCT01337947|exercise|exercise
5070980|NCT01337947|vascular function|vascular function
5070981|NCT01337934|Septic shock|septic shock
5070982|NCT01337934|Sepsis|sepsis
5070983|NCT01337934|Albumin|albumin
5070984|NCT01337934|Lactated Ringer|lactated ringer
5070985|NCT01337908|depression|depression
5070986|NCT01337908|quality of life|quality of life
5070987|NCT01337908|disability|disability
5070988|NCT01337895|Dairy|dairy
5070989|NCT01337895|obesity|obesity
5070990|NCT01337895|overweight|overweight
5070991|NCT01337895|weight loss|weight loss
5070992|NCT01337895|adults|adults
5070993|NCT01337882|Air Pollution|air pollution
5070994|NCT01337882|Diesel exhaust|diesel exhaust
5070995|NCT01337882|Biodiesel exhaust|biodiesel exhaust
5070996|NCT01337882|Vascular function|vascular function
5070997|NCT01337882|Fibrinolysis|fibrinolysis
5070998|NCT01337882|Acute vascular and endothelial responses|acute vascular and endothelial responses
5070999|NCT01337869|Bascom Procedure, Limberg, Pilonidal Disease|bascom procedure, limberg, pilonidal disease
5071000|NCT01337856|time-effectiveness|time-effectiveness
5071001|NCT01337856|hand hygiene protocols|hand hygiene protocols
5071002|NCT01337843|Chronic low back pain|chronic low back pain
5071003|NCT01337843|cognitive behavioral pain management|cognitive behavioral pain management
5071004|NCT01337843|coping|coping
5071005|NCT01337843|mindfulness|mindfulness
5071006|NCT01337843|physical activity|physical activity
5071007|NCT01337843|Back Pain Lower Back Chronic|back pain lower back chronic
5071008|NCT01337830|smoking|smoking
5071009|NCT01337830|smokeless|smokeless
5071010|NCT01337830|aversion|aversion
5071011|NCT01337830|nicotine|nicotine
5071012|NCT01337830|nicotine replacement|nicotine replacement
5071013|NCT01337817|smoking|smoking
5071014|NCT01337817|smokeless|smokeless
5071015|NCT01337817|aversion|aversion
5071016|NCT01337817|nicotine|nicotine
5071017|NCT01337817|nicotine replacement|nicotine replacement
5071018|NCT01337791|chronic hepatitis B|chronic hepatitis b
5071019|NCT01337791|hepatitis B virus|hepatitis b virus
5071020|NCT01337791|perinatal transmission|perinatal transmission
5071021|NCT01337791|Telbivudine|telbivudine
5071022|NCT01337778|gender based violence|gender based violence
5071023|NCT01337778|maternal and child health|maternal and child health
5071024|NCT01337778|women|women
5071025|NCT01337778|India|india
5071026|NCT01337765|BEZ235,|bez235,
5071027|NCT01337765|MEK162|mek162
5071028|NCT01337765|RAS RAF mutations,|ras raf mutations,
5071029|NCT01337765|triple negative breast cancer|triple negative breast cancer
5071030|NCT01337765|pancreatic cancer,|pancreatic cancer,
5071031|NCT01337765|NSCLC progressed on EGFR TKI|nsclc progressed on egfr tki
5071032|NCT01337765|PI3K/mTOR inhibitor,|pi3k/mtor inhibitor,
5071033|NCT01337765|MEK inhibitor|mek inhibitor
5071034|NCT01337765|Advanced and selected solid tumors|advanced and selected solid tumors
5071035|NCT01337752|multiple myeloma|multiple myeloma
5071036|NCT01337752|renal insufficiency|renal insufficiency
5071037|NCT01337752|untreated multiple myeloma|untreated multiple myeloma
5071038|NCT01337739|Hysteroscopic Surgery|hysteroscopic surgery
5071039|NCT01337739|Dexmedetomidine|dexmedetomidine
5071040|NCT01337739|Sedation|sedation
5071041|NCT01337739|Opioids|opioids
5071042|NCT01337726|Depression|depression
5071043|NCT01337726|Heart Failure|heart failure
5071044|NCT01337726|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5071045|NCT01337726|Quality of Life|quality of life
5071046|NCT01337726|Functional Impairment|functional impairment
5071047|NCT01337713|Anxiety, GAD, Massage|anxiety, gad, massage
5071048|NCT01337700|ASD|asd
5071049|NCT01337700|Autism|autism
5071050|NCT01337700|Autism Spectrum Disorder|autism spectrum disorder
5071051|NCT01337700|Asperger Syndrome|asperger syndrome
5071052|NCT01337700|Asperger|asperger
5071053|NCT01337700|PDD|pdd
5071054|NCT01337700|PDD-NOS|pdd-nos
5071055|NCT01337687|Autism|autism
5071056|NCT01337687|Autism Spectrum Disorders|autism spectrum disorders
5071057|NCT01337687|Oxytocin|oxytocin
5071058|NCT01337687|Hollander|hollander
5071059|NCT01337687|ASD|asd
5071060|NCT01337687|Asperger Syndrome|asperger syndrome
5071061|NCT01337687|Asperger|asperger
5071062|NCT01337661|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5071063|NCT01337661|COPD|copd
5071064|NCT01337661|Acute Exacerbation of COPD|acute exacerbation of copd
5071065|NCT01337661|AECOPD|aecopd
5071066|NCT01337648|Fecal biomarkers|fecal biomarkers
5071067|NCT01337648|Radiation biodosimetry|radiation biodosimetry
5071068|NCT01337648|Total-body irradiation (TBI)|total-body irradiation (tbi)
5071069|NCT01337648|Hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
5071070|NCT01337648|Gene expression profiles|gene expression profiles
5071071|NCT01337648|Fecal metabolites|fecal metabolites
5071072|NCT01337609|Depression|depression
5071073|NCT01337609|Irritable Bowel Syndrome|irritable bowel syndrome
5071074|NCT01337609|Probiotic|probiotic
5071075|NCT01337609|Bacillus Coagulans|bacillus coagulans
5071076|NCT01337596|pain|pain
5071077|NCT01337596|neuropathic pain|neuropathic pain
5071078|NCT01337596|headaches|headaches
5071079|NCT01337583|HIV Infections|hiv infections
5071080|NCT01337583|Anti-HIV agents|anti-hiv agents
5071081|NCT01337583|HIV-1|hiv-1
5071082|NCT01337570|HIV Infections|hiv infections
5071083|NCT01337570|Anti-HIV agents|anti-hiv agents
5071084|NCT01337570|HIV-1|hiv-1
5071085|NCT01337557|Allergic conjunctivitis|allergic conjunctivitis
5071086|NCT01337544|HAPLOIDENTICAL STEM CELL TRANSPLANTATION|haploidentical stem cell transplantation
5071087|NCT01337544|NK CELL|nk cell
5071088|NCT01337544|IL-15|il-15
5071089|NCT01337531|Ovarian Response in PCOS|ovarian response in pcos
5071090|NCT01337531|pregnancy rate in PCOS|pregnancy rate in pcos
5071091|NCT01337531|miscarriage rate in PCOS|miscarriage rate in pcos
5071092|NCT01337518|Prostate Specific Antigen|prostate specific antigen
5071093|NCT01337518|Castration Resistant Prostate Cancer|castration resistant prostate cancer
5071094|NCT01337518|Adenocarcinoma|adenocarcinoma
5071095|NCT01337518|Androgen Receptor|androgen receptor
5071096|NCT01337518|Metastases|metastases
5071097|NCT01337505|INNO-206|inno-206
5071098|NCT01337505|Phase 1|phase 1
5071099|NCT01337505|DOXO-EMCH|doxo-emch
5071100|NCT01337505|Advanced solid tumors|advanced solid tumors
5071101|NCT01337492|Hepatocellular Carcinoma|hepatocellular carcinoma
5071102|NCT01337492|Orthotopic Liver Transplant|orthotopic liver transplant
5071103|NCT01337466|Phase I|phase i
5071104|NCT01337466|FIAU|fiau
5071105|NCT01337466|Fialuridine|fialuridine
5071106|NCT01337466|Biodistribution|biodistribution
5071107|NCT01337466|Dosimetry|dosimetry
5071108|NCT01337466|Prosthetic|prosthetic
5071109|NCT01337466|Joint|joint
5071110|NCT01337466|Infection|infection
5071111|NCT01337466|PET-CT|pet-ct
5071112|NCT01337453|botulinum toxin|botulinum toxin
5071113|NCT01337453|flu like symptoms|flu like symptoms
5071114|NCT01337453|frequency of FLS|frequency of fls
5071115|NCT01337453|Botox|botox
5071116|NCT01337440|Ursodeoxycholic Acid|ursodeoxycholic acid
5071117|NCT01337440|sitagliptin|sitagliptin
5071118|NCT01337440|bile acids|bile acids
5071119|NCT01337440|GLP-1|glp-1
5071120|NCT01337427|multiple sclerosis|multiple sclerosis
5071121|NCT01337427|relapsing|relapsing
5071122|NCT01337427|MS|ms
5071123|NCT01337427|injectable|injectable
5071124|NCT01337427|subcutaneous|subcutaneous
5071125|NCT01337427|SC|sc
5071126|NCT01337427|PEGylated|pegylated
5071127|NCT01337427|interferon|interferon
5071128|NCT01337427|PEG|peg
5071129|NCT01337427|OCT|oct
5071130|NCT01337427|Optical Coherence Tomography|optical coherence tomography
5071131|NCT01337414|age-related macular degeneration|age-related macular degeneration
5071132|NCT01337414|screening|screening
5071133|NCT01337414|monitoring|monitoring
5071134|NCT01337414|diagnosis|diagnosis
5071135|NCT01337414|dry or non-neovascular age-related macular degeneration (high risk, intermediate, geographic atrophy or AREDS grade 3/4 AMD)|dry or non-neovascular age-related macular degeneration (high risk, intermediate, geographic atrophy or areds grade 3/4 amd)
5071136|NCT01337401|Cediranib|cediranib
5071137|NCT01337401|ASPS|asps
5071138|NCT01337401|Sarcoma|sarcoma
5071139|NCT01337362|Diabetes|diabetes
5071140|NCT01337362|Hypoglycaemia|hypoglycaemia
5071141|NCT01337362|EEG|eeg
5071142|NCT01337362|Thermography|thermography
5071143|NCT01337362|Hypoglycaemia-associated autonomic failure|hypoglycaemia-associated autonomic failure
5071144|NCT01337362|QTc interval|qtc interval
5071145|NCT01337362|Hypoglycemic alarm device|hypoglycemic alarm device
5071146|NCT01337362|Hormone response|hormone response
5071147|NCT01337349|Pentoxifylline|pentoxifylline
5071148|NCT01337349|Chronic Congestive Heart Failure|chronic congestive heart failure
5071149|NCT01337349|Left Systolic Function|left systolic function
5071150|NCT01337349|Biomarkers|biomarkers
5071151|NCT01337323|allergic rhinitis, allergies, concomitant medications, allergy symptoms|allergic rhinitis, allergies, concomitant medications, allergy symptoms
5071152|NCT01337310|Advanced solid tumors|advanced solid tumors
5071153|NCT01337297|crack cocaine|crack cocaine
5071154|NCT01337297|addiction|addiction
5071155|NCT01337297|tDCS|tdcs
5071156|NCT01337297|ERP|erp
5071157|NCT01337297|P300|p300
5071158|NCT01337297|attention|attention
5071159|NCT01337297|inhibitory control|inhibitory control
5071160|NCT01337297|working memory|working memory
5071161|NCT01337271|artificial, ventilation|artificial, ventilation
5071162|NCT01337271|mechanical ventilation|mechanical ventilation
5071163|NCT01337271|weaning|weaning
5071164|NCT01337258|cost effectiveness|cost effectiveness
5071165|NCT01337258|dutasteride|dutasteride
5071166|NCT01337258|elevated risk population|elevated risk population
5071167|NCT01337258|Prostate cancer|prostate cancer
5071168|NCT01337258|prevention|prevention
5071169|NCT01337245|Envenomation|envenomation
5071170|NCT01337245|Coral Snake|coral snake
5071171|NCT01337245|Antivenom|antivenom
5071172|NCT01337245|Micrurus fulvius|micrurus fulvius
5071173|NCT01337232|language development disorders|language development disorders
5071174|NCT01337232|learning disorders|learning disorders
5071175|NCT01337232|sentences|sentences
5071176|NCT01337232|syntax|syntax
5071177|NCT01337232|school-age|school-age
5071178|NCT01337232|language|language
5071179|NCT01337219|cystic fibrosis|cystic fibrosis
5071180|NCT01337219|bioequivalence|bioequivalence
5071181|NCT01337219|pharmacokinetic|pharmacokinetic
5071182|NCT01337219|sputum|sputum
5071183|NCT01337219|plasma|plasma
5071184|NCT01337206|Esophageal Stenosis|esophageal stenosis
5071185|NCT01337206|Esopageal Strictures|esopageal strictures
5071186|NCT01337206|Esophageal Dysphagia|esophageal dysphagia
5071187|NCT01337193|stress urinary incontinence|stress urinary incontinence
5071188|NCT01337193|exercise|exercise
5071189|NCT01337193|pelvic floor muscles|pelvic floor muscles
5071190|NCT01337193|biofeedback|biofeedback
5071191|NCT01337193|rehabilitative ultrasound imaging|rehabilitative ultrasound imaging
5071192|NCT01337180|lung function|lung function
5071193|NCT01337180|respiratory symptoms|respiratory symptoms
5071194|NCT01337180|dust|dust
5071195|NCT01337180|inflammation|inflammation
5071196|NCT01337180|prospective|prospective
5071197|NCT01337167|Diphtheria|diphtheria
5071198|NCT01337167|Tetanus|tetanus
5071199|NCT01337167|Whooping Cough (pertussis)|whooping cough (pertussis)
5071200|NCT01337167|Poliomyelitis|poliomyelitis
5071201|NCT01337167|Hepatitis B infection|hepatitis b infection
5071202|NCT01337167|Haemophilus influenzae type b infection|haemophilus influenzae type b infection
5071203|NCT01337154|NSCLC|nsclc
5071204|NCT01337154|non-small cell lung cancer|non-small cell lung cancer
5071205|NCT01337154|tamibarotene|tamibarotene
5071206|NCT01337141|Telemedicine|telemedicine
5071207|NCT01337141|Type 1 diabetes|type 1 diabetes
5071208|NCT01337141|Metabolic control optimisation|metabolic control optimisation
5071209|NCT01337141|Health care costs|health care costs
5071210|NCT01337141|Intervention study|intervention study
5071211|NCT01337141|Access to internet|access to internet
5071212|NCT01337115|Postoperative pain|postoperative pain
5071213|NCT01337115|Knee arthroplasty|knee arthroplasty
5071214|NCT01337115|Peripheral nerve blocks|peripheral nerve blocks
5071215|NCT01337115|Sciatic nerve block|sciatic nerve block
5071216|NCT01337115|Femoral nerve block|femoral nerve block
5071217|NCT01337102|Lung Cancer|lung cancer
5071218|NCT01337102|Stage 3b|stage 3b
5071219|NCT01337102|Stage 4|stage 4
5071220|NCT01337102|First Line Chemotherapy Treatment|first line chemotherapy treatment
5071221|NCT01337102|Quality Of Life|quality of life
5071222|NCT01337102|Palliative Care|palliative care
5071223|NCT01337102|Randomized|randomized
5071224|NCT01337102|Lung Cancer Scale|lung cancer scale
5071225|NCT01337089|Cancer pain|cancer pain
5071226|NCT01337089|Opioid therapy|opioid therapy
5071227|NCT01337089|Inadequate analgesia|inadequate analgesia
5071228|NCT01337089|Optimized chronic opioid therapy|optimized chronic opioid therapy
5071229|NCT01337063|Adverse drug events|adverse drug events
5071230|NCT01337050|Hepatocellular Carcinoma|hepatocellular carcinoma
5071231|NCT01337050|Advanced/Metastatic solid tumors|advanced/metastatic solid tumors
5071232|NCT01337037|video-assisted thoracic surgery|video-assisted thoracic surgery
5071233|NCT01337037|Lung cancer|lung cancer
5071234|NCT01337037|lobectomy|lobectomy
5071235|NCT01337024|HRV|hrv
5071236|NCT01337024|NDO|ndo
5071237|NCT01337024|BoNT/A,|bont/a,
5071238|NCT01337024|adverse effects|adverse effects
5071239|NCT01337011|Chronic Ischemic Cardiomyopathy|chronic ischemic cardiomyopathy
5071240|NCT01336998|necrotizing enterocolitis|necrotizing enterocolitis
5071241|NCT01336998|arginine supplementation|arginine supplementation
5071242|NCT01336998|calprotectin|calprotectin
5071243|NCT01336985|Chemoembolization|chemoembolization
5071244|NCT01336985|Hepatic Metastases|hepatic metastases
5071245|NCT01336985|Irinotecan|irinotecan
5071246|NCT01336985|Drug Eluding Beads|drug eluding beads
5071247|NCT01336985|Colorectal Cancer|colorectal cancer
5071248|NCT01336985|Liver Cancer|liver cancer
5071249|NCT01336985|Hepatic Cancer|hepatic cancer
5071250|NCT01336985|Melanoma|melanoma
5071251|NCT01336959|Acute Kidney Injury|acute kidney injury
5071252|NCT01336959|Cardiopulmonary Bypass|cardiopulmonary bypass
5071253|NCT01336959|CABG|cabg
5071254|NCT01336959|Cardiac Surgery|cardiac surgery
5071255|NCT01336946|lifestyle|lifestyle
5071256|NCT01336946|mental disorder|mental disorder
5071257|NCT01336907|CNV|cnv
5071258|NCT01336907|AMD|amd
5071259|NCT01336907|Wet-treated CNV|wet-treated cnv
5071260|NCT01336894|stage IA non-small cell lung cancer|stage ia non-small cell lung cancer
5071261|NCT01336894|stage IB non-small cell lung cancer|stage ib non-small cell lung cancer
5071262|NCT01336855|HIV|hiv
5071263|NCT01336855|Observational|observational
5071264|NCT01336855|Pathogenesis|pathogenesis
5071265|NCT01336855|Immunology|immunology
5071266|NCT01336855|Virology|virology
5071267|NCT01336855|Control|control
5071268|NCT01336855|Healthy control|healthy control
5071269|NCT01336855|Men who have sex with men|men who have sex with men
5071270|NCT01336842|panobinostat|panobinostat
5071271|NCT01336842|cisplatin|cisplatin
5071272|NCT01336842|pemetrexed|pemetrexed
5071273|NCT01336842|dose escalation|dose escalation
5071274|NCT01336829|Hepatitis C|hepatitis c
5071275|NCT01336829|HIV|hiv
5071276|NCT01336829|TMC125IFD1001|tmc125ifd1001
5071277|NCT01336829|TMC125|tmc125
5071278|NCT01336829|Intelence|intelence
5071279|NCT01336829|etravirine|etravirine
5071280|NCT01336829|ETR|etr
5071281|NCT01336829|TMC278|tmc278
5071282|NCT01336829|telaprevir|telaprevir
5071283|NCT01336829|TVR|tvr
5071284|NCT01336829|VX-950|vx-950
5071285|NCT01336829|healthy volunteers|healthy volunteers
5071286|NCT01336829|crossover|crossover
5071287|NCT01336816|smoking|smoking
5071288|NCT01336816|smokeless|smokeless
5071289|NCT01336816|aversion|aversion
5071290|NCT01336816|nicotine|nicotine
5071291|NCT01336816|nicotine replacement|nicotine replacement
5071292|NCT01336790|Lymphatic disease|lymphatic disease
5071293|NCT01336790|Lymphedema|lymphedema
5071294|NCT01336790|Lymphangiomatosis|lymphangiomatosis
5071295|NCT01336790|Lymphangiectasia|lymphangiectasia
5071296|NCT01336790|Protein-losing enteropathy|protein-losing enteropathy
5071297|NCT01336790|Vascular Anomalies|vascular anomalies
5071298|NCT01336777|obesity|obesity
5071299|NCT01336777|adipocyte differentiation|adipocyte differentiation
5071300|NCT01336777|inflammation|inflammation
5071301|NCT01336777|insulin resistance|insulin resistance
5071302|NCT01336777|visceral fat|visceral fat
5071303|NCT01336777|regional fat depots|regional fat depots
5071304|NCT01336764|driving distress|driving distress
5071305|NCT01336764|veterans|veterans
5071306|NCT01336764|OEF/OIF|oef/oif
5071307|NCT01336738|Phase 2|phase 2
5071308|NCT01336738|safety and efficacy study with PF-04991532|safety and efficacy study with pf-04991532
5071309|NCT01336738|Type 2 diabetes|type 2 diabetes
5071310|NCT01336725|Morbid obesity|morbid obesity
5071311|NCT01336725|Patient education|patient education
5071312|NCT01336712|CML|cml
5071313|NCT01336712|CLL|cll
5071314|NCT01336712|AML|aml
5071315|NCT01336712|ALL|all
5071316|NCT01336712|MDS|mds
5071317|NCT01336712|HD|hd
5071318|NCT01336712|NHL|nhl
5071319|NCT01336712|MFB|mfb
5071320|NCT01336712|P.vera|p.vera
5071321|NCT01336712|Essential Thrombocytosis|essential thrombocytosis
5071322|NCT01336699|shigellosis, vaccine, Shigella sonnei, WRSs2, WRSs3|shigellosis, vaccine, shigella sonnei, wrss2, wrss3
5071323|NCT01336673|Glucophage XR|glucophage xr
5071324|NCT01336673|Tolerability|tolerability
5071325|NCT01336660|Effectiveness|effectiveness
5071326|NCT01336660|New Antivenom|new antivenom
5071327|NCT01336660|North Africa and Middle East Scorpio Envenomation|north africa and middle east scorpio envenomation
5071328|NCT01336634|BRAF V600E|braf v600e
5071329|NCT01336634|trametinib|trametinib
5071330|NCT01336634|dabrafenib|dabrafenib
5071331|NCT01336634|GSK2118436|gsk2118436
5071332|NCT01336634|GSK1120212|gsk1120212
5071333|NCT01336634|Oncology|oncology
5071334|NCT01336634|Non-Small Cell Lung Cancer|non-small cell lung cancer
5071335|NCT01336621|Partial-onset seizures|partial-onset seizures
5071336|NCT01336621|retigabine IR|retigabine ir
5071337|NCT01336621|Open Label Extension|open label extension
5071338|NCT01336621|GW582892|gw582892
5071339|NCT01336621|Epilepsy|epilepsy
5071340|NCT01336595|total knee arthroplasty|total knee arthroplasty
5071341|NCT01336595|oxidized zirconium|oxidized zirconium
5071342|NCT01336595|genesis II|genesis ii
5071343|NCT01336595|femoral component|femoral component
5071344|NCT01336595|cobalt chrome|cobalt chrome
5071345|NCT01336582|suitable candidate|suitable candidate
5071346|NCT01336582|single agent docetaxel therapy|single agent docetaxel therapy
5071347|NCT01336582|Advanced Solid Tumor|advanced solid tumor
5071348|NCT01336569|Primary Open-Angle Glaucoma|primary open-angle glaucoma
5071349|NCT01336569|Ocular Hypertension|ocular hypertension
5071350|NCT01336569|Pigment Dispersion Glaucoma|pigment dispersion glaucoma
5071351|NCT01336569|IOP|iop
5071352|NCT01336556|Oral appliance|oral appliance
5071353|NCT01336556|Continuous positive airway pressure|continuous positive airway pressure
5071354|NCT01336556|Obstructive Sleep Apnea Syndrome|obstructive sleep apnea syndrome
5071355|NCT01336556|Snore|snore
5071356|NCT01336543|Non small cell lung cancer|non small cell lung cancer
5071357|NCT01336543|Inoperable Stage III|inoperable stage iii
5071358|NCT01336543|Inoperable|inoperable
5071359|NCT01336543|Stage III|stage iii
5071360|NCT01336530|Oesophageal pain|oesophageal pain
5071361|NCT01336530|Radiotherapy|radiotherapy
5071362|NCT01336530|Combined radio-chemotherapy|combined radio-chemotherapy
5071363|NCT01336530|Oesophageal symptoms|oesophageal symptoms
5071364|NCT01336517|Stroke|stroke
5071365|NCT01336517|Hemiplegia|hemiplegia
5071366|NCT01336517|AFO|afo
5071367|NCT01336517|Gait|gait
5071368|NCT01336478|NK|nk
5071369|NCT01336478|natural killer|natural killer
5071370|NCT01336478|immunotherapy|immunotherapy
5071371|NCT01336478|leukemia|leukemia
5071372|NCT01336478|hematological malignancies|hematological malignancies
5071373|NCT01336478|stem cell transplantation|stem cell transplantation
5071374|NCT01336478|adoptive therapy|adoptive therapy
5071375|NCT01336439|Bruxism|bruxism
5071376|NCT01336439|Polysomnography|polysomnography
5071377|NCT01336439|Botulinum toxin type A|botulinum toxin type a
5071378|NCT01336439|Masseter muscle|masseter muscle
5071379|NCT01336439|Temporal muscle|temporal muscle
5071380|NCT01336426|Peripheral Artery Disease|peripheral artery disease
5071381|NCT01336426|PAD|pad
5071480|NCT01335997|LDL|ldl
5071382|NCT01336413|brain injuries, traumatic|brain injuries, traumatic
5071383|NCT01336413|pregnenolone|pregnenolone
5071384|NCT01336413|Veteran|veteran
5071385|NCT01336413|OEF/OIF|oef/oif
5071386|NCT01336413|neurosteroid|neurosteroid
5071387|NCT01336413|allopregnanolone|allopregnanolone
5071388|NCT01336400|Single cell haplotyping|single cell haplotyping
5071389|NCT01336400|Preimplantation genetic diagnosis|preimplantation genetic diagnosis
5071390|NCT01336361|Palliative Care|palliative care
5071391|NCT01336361|Physical Therapy|physical therapy
5071392|NCT01336361|Functionally Dependent Elderly|functionally dependent elderly
5071393|NCT01336348|Prasugrel|prasugrel
5071394|NCT01336348|Tirofiban|tirofiban
5071395|NCT01336348|Clopidogrel|clopidogrel
5071396|NCT01336348|glycoprotein IIa/IIIa inhibitors|glycoprotein iia/iiia inhibitors
5071397|NCT01336348|P2Y12 blockers|p2y12 blockers
5071398|NCT01336335|sleep apnea, obstructive|sleep apnea, obstructive
5071399|NCT01336335|sympathetic nerve activity|sympathetic nerve activity
5071400|NCT01336335|treatment|treatment
5071401|NCT01336322|beta-cell function|beta-cell function
5071402|NCT01336322|insulin resistance|insulin resistance
5071403|NCT01336309|Yoga|yoga
5071404|NCT01336283|COPD|copd
5071405|NCT01336283|Exercise Training|exercise training
5071406|NCT01336270|Melanoma|melanoma
5071407|NCT01336270|NK cells|nk cells
5071408|NCT01336270|T lymphocytes|t lymphocytes
5071409|NCT01336270|macrophages|macrophages
5071410|NCT01336257|Decision Support Techniques|decision support techniques
5071411|NCT01336257|Electronic Health Records|electronic health records
5071412|NCT01336257|Reminder Systems|reminder systems
5071413|NCT01336257|Early Detection of Cancer|early detection of cancer
5071414|NCT01336257|Mammography|mammography
5071415|NCT01336257|Women|women
5071416|NCT01336244|Safety|safety
5071417|NCT01336244|Tolerability|tolerability
5071418|NCT01336244|Pharmacokinetics|pharmacokinetics
5071419|NCT01336231|quality of life|quality of life
5071420|NCT01336231|cognitive functions|cognitive functions
5071421|NCT01336231|antiangiogenic agents|antiangiogenic agents
5071422|NCT01336231|kidney cancer|kidney cancer
5071423|NCT01336231|metastatic|metastatic
5071424|NCT01336218|Phase 1|phase 1
5071425|NCT01336218|healthy volunteers|healthy volunteers
5071426|NCT01336218|Rheumatoid arthritis|rheumatoid arthritis
5071427|NCT01336218|RA|ra
5071428|NCT01336218|Fostamatinib|fostamatinib
5071429|NCT01336218|Rifampicin|rifampicin
5071430|NCT01336218|drug-drug interaction|drug-drug interaction
5071431|NCT01336218|Pharmacokinetics|pharmacokinetics
5071432|NCT01336218|Amount of Rifampicin in blood|amount of rifampicin in blood
5071433|NCT01336205|Non-Cancer-Related Pain|non-cancer-related pain
5071434|NCT01336205|Opioid-Induced Constipation|opioid-induced constipation
5071435|NCT01336192|Advanced NSCLC|advanced nsclc
5071436|NCT01336192|Maintenance therapy|maintenance therapy
5071437|NCT01336192|Gemcitabine|gemcitabine
5071438|NCT01336179|gingivitis|gingivitis
5071439|NCT01336179|dental plaque|dental plaque
5071440|NCT01336179|oral hygiene|oral hygiene
5071441|NCT01336179|toothbrush|toothbrush
5071442|NCT01336179|chewing sticks|chewing sticks
5071443|NCT01336166|H1N1|h1n1
5071444|NCT01336166|Vaccine|vaccine
5071445|NCT01336166|Immunogenicity|immunogenicity
5071446|NCT01336166|Safety|safety
5071447|NCT01336153|Safety|safety
5071448|NCT01336153|Efficacy|efficacy
5071449|NCT01336153|MLC601|mlc601
5071450|NCT01336153|motor recovery|motor recovery
5071451|NCT01336140|regadenoson|regadenoson
5071452|NCT01336140|chronic kidney disease|chronic kidney disease
5071453|NCT01336140|renal failure|renal failure
5071454|NCT01336140|lexiscan|lexiscan
5071455|NCT01336140|aminophylline|aminophylline
5071456|NCT01336140|SPECT|spect
5071457|NCT01336140|Myocardial Perfusion Imaging|myocardial perfusion imaging
5071458|NCT01336140|pharmacologic stress test|pharmacologic stress test
5071459|NCT01336140|Patients with stage IV or V chronic kidney disease being assessed with nuclear stress testing of the heart using the stress agent regadenoson (Lexiscan ®)|patients with stage iv or v chronic kidney disease being assessed with nuclear stress testing of the heart using the stress agent regadenoson (lexiscan ®)
5071460|NCT01336127|Occupational Therapy|occupational therapy
5071461|NCT01336127|Parkinson's Disease|parkinson's disease
5071462|NCT01336127|Effectiveness|effectiveness
5071463|NCT01336127|RCT|rct
5071464|NCT01336127|Activities of daily living|activities of daily living
5071465|NCT01336127|Participation|participation
5071466|NCT01336127|Caregiver's Burden|caregiver's burden
5071467|NCT01336127|Economic evaluation|economic evaluation
5071468|NCT01336101|PAD|pad
5071469|NCT01336101|SFA|sfa
5071470|NCT01336088|dyskinesia|dyskinesia
5071471|NCT01336088|Parkinson's disease|parkinson's disease
5071472|NCT01336075|Percutaneous radiofrequency catheter ablation|percutaneous radiofrequency catheter ablation
5071473|NCT01336075|Mini invasive thoracoscopic radiofrequency ablation|mini invasive thoracoscopic radiofrequency ablation
5071474|NCT01336062|advanced|advanced
5071475|NCT01336062|resistant to prior chemotherapy|resistant to prior chemotherapy
5071476|NCT01336010|Hepatitis C|hepatitis c
5071477|NCT01336010|Acute Hepatitis C|acute hepatitis c
5071478|NCT01336010|Early chronic Hepatitis C|early chronic hepatitis c
5071479|NCT01335997|Low-density lipoprotein|low-density lipoprotein
5071481|NCT01335997|High-density lipoprotein|high-density lipoprotein
5071482|NCT01335997|HDL|hdl
5071483|NCT01335997|Niacin|niacin
5071484|NCT01335997|Lipid modifying therapy|lipid modifying therapy
5071485|NCT01335997|Cholesterol|cholesterol
5071486|NCT01335997|High cholesterol|high cholesterol
5071487|NCT01335997|Triglycerides|triglycerides
5071488|NCT01335984|telemonitoring|telemonitoring
5071489|NCT01335984|usual care|usual care
5071490|NCT01335984|telemedicine|telemedicine
5071491|NCT01335984|telehealth|telehealth
5071492|NCT01335984|home care|home care
5071493|NCT01335984|Health Care Quality|health care quality
5071494|NCT01335984|Access|access
5071495|NCT01335984|Evaluation|evaluation
5071496|NCT01335971|COPD|copd
5071497|NCT01335971|Nrf2|nrf2
5071498|NCT01335971|Sulforaphane|sulforaphane
5071499|NCT01335945|Cryoablation|cryoablation
5071500|NCT01335945|Cryotherapy|cryotherapy
5071501|NCT01335945|Cryosurgery|cryosurgery
5071502|NCT01335945|Pancreas|pancreas
5071503|NCT01335945|Pancreatic Cancer|pancreatic cancer
5071504|NCT01335945|Celiac Plexus|celiac plexus
5071505|NCT01335945|Pain|pain
5071506|NCT01335945|Abdominal pain|abdominal pain
5071507|NCT01335932|Acute Lung Injury|acute lung injury
5071508|NCT01335932|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
5071509|NCT01335932|Respiratory Failure|respiratory failure
5071510|NCT01335932|Cytomegalovirus seropositive|cytomegalovirus seropositive
5071511|NCT01335932|Infection|infection
5071512|NCT01335932|Intravenous Ganciclovir|intravenous ganciclovir
5071513|NCT01335932|Non-immunocompromised|non-immunocompromised
5071514|NCT01335932|Valganciclovir|valganciclovir
5071515|NCT01335919|Hemoglobin|hemoglobin
5071516|NCT01335919|Monitoring, Physiologic|monitoring, physiologic
5071517|NCT01335919|Blood Gas Monitoring, Transcutaneous|blood gas monitoring, transcutaneous
5071518|NCT01335906|Cancer Screening Tests|cancer screening tests
5071519|NCT01335906|Early Diagnosis of Cancer|early diagnosis of cancer
5071520|NCT01335906|Mammography|mammography
5071521|NCT01335906|Informed Consent|informed consent
5071522|NCT01335906|Consent Forms|consent forms
5071523|NCT01335893|Imaging|imaging
5071524|NCT01335893|Indocyanine Green|indocyanine green
5071525|NCT01335893|Lung Cancer|lung cancer
5071526|NCT01335893|Lung Neoplasms|lung neoplasms
5071527|NCT01335893|Preliminary Study|preliminary study
5071528|NCT01335880|Obesity|obesity
5071529|NCT01335880|Heart Disease|heart disease
5071530|NCT01335880|Seniors|seniors
5071531|NCT01335880|Elderly|elderly
5071532|NCT01335880|Chronic Disease|chronic disease
5071533|NCT01335880|Prevention|prevention
5071534|NCT01335854|Apnea-hypopnea index|apnea-hypopnea index
5071535|NCT01335854|Continuous positive airway pressure|continuous positive airway pressure
5071536|NCT01335854|CPAP adherence|cpap adherence
5071537|NCT01335828|Echography|echography
5071538|NCT01335828|Elastography|elastography
5071539|NCT01335828|Thyroid nodules|thyroid nodules
5071540|NCT01335828|Needles punction|needles punction
5071541|NCT01335828|Thyroid surgery|thyroid surgery
5071542|NCT01335828|Patients with thyroids nodules|patients with thyroids nodules
5071543|NCT01335802|Abortion, Spontaneous|abortion, spontaneous
5071544|NCT01335802|Pre-eclampsia|pre-eclampsia
5071545|NCT01335802|Gestational hypertension|gestational hypertension
5071546|NCT01335802|Pregnancy Complications|pregnancy complications
5071547|NCT01335802|Subclinical hypothyroidism|subclinical hypothyroidism
5071548|NCT01335802|Thyroperoxidase antibodies (TPOab)|thyroperoxidase antibodies (tpoab)
5071549|NCT01335802|Mitochondrial dysfunction|mitochondrial dysfunction
5071550|NCT01335789|marijuana|marijuana
5071551|NCT01335789|substance abuse|substance abuse
5071552|NCT01335789|drug abuse|drug abuse
5071553|NCT01335789|marijuana dependence|marijuana dependence
5071554|NCT01335789|drug addiction|drug addiction
5071555|NCT01335776|Mindfulness-Based Stress Reduction|mindfulness-based stress reduction
5071556|NCT01335776|Cognitive Behavior Therapy|cognitive behavior therapy
5071557|NCT01335776|Actigraphy|actigraphy
5071558|NCT01335776|Noninferiority|noninferiority
5071559|NCT01335776|MBSR|mbsr
5071560|NCT01335776|CBT-I|cbt-i
5071561|NCT01335763|HbA1c|hba1c
5071562|NCT01335763|Multicentre before-after design|multicentre before-after design
5071563|NCT01335763|Glycemic control|glycemic control
5071564|NCT01335763|Community pharmacists|community pharmacists
5071565|NCT01335750|corneal staining|corneal staining
5071566|NCT01335698|Pediatric|pediatric
5071567|NCT01335685|Drug Therapy|drug therapy
5071568|NCT01335672|Myocardial infarction|myocardial infarction
5071569|NCT01335672|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
5071570|NCT01335672|General Practice Research Database|general practice research database
5071571|NCT01335672|Myocardial Ischaemia National Audit Project|myocardial ischaemia national audit project
5071572|NCT01335672|CALIBER|caliber
5071573|NCT01335659|FFR|ffr
5071574|NCT01335659|IVUS|ivus
5071575|NCT01335659|QCA|qca
5071576|NCT01335633|MS|ms
5071577|NCT01335633|Neuropsychological tests|neuropsychological tests
5071578|NCT01335607|HCV|hcv
5071579|NCT01335607|Hepatitis C Virus|hepatitis c virus
5071580|NCT01335594|Sleep apnea, obstructive|sleep apnea, obstructive
5071581|NCT01335594|Deglutition Disorders|deglutition disorders
5071582|NCT01335594|Manometry|manometry
5071583|NCT01335594|Endoscopy|endoscopy
5071584|NCT01335568|Hepatocyte|hepatocyte
5071585|NCT01335568|Scaffold|scaffold
5071586|NCT01335568|Matrix|matrix
5071587|NCT01335568|Liver cirrhosis|liver cirrhosis
5071588|NCT01335568|Liver insufficiency|liver insufficiency
5071589|NCT01335529|HCV infection|hcv infection
5071590|NCT01335529|HIV-1 infection|hiv-1 infection
5071591|NCT01335503|gluten|gluten
5071592|NCT01335451|AZD5213|azd5213
5071593|NCT01335451|safety|safety
5071594|NCT01335451|pharmacokinetics|pharmacokinetics
5071595|NCT01335451|single dose|single dose
5071596|NCT01335451|repeated dose|repeated dose
5071597|NCT01335451|young|young
5071598|NCT01335451|elderly|elderly
5071599|NCT01335451|Japanese|japanese
5071600|NCT01335451|healthy subject|healthy subject
5071601|NCT01335438|total knee arthroplasty|total knee arthroplasty
5071602|NCT01335438|cemented|cemented
5071603|NCT01335438|cementless|cementless
5071604|NCT01335438|fixation|fixation
5071605|NCT01335438|posterior stabilized|posterior stabilized
5071606|NCT01335438|cruciate retaining|cruciate retaining
5071607|NCT01335425|Language problems|language problems
5071608|NCT01335425|childhood epilepsy|childhood epilepsy
5071609|NCT01335425|bening (rolandic) epilepsy (of childhood) with centro temporal spikes|bening (rolandic) epilepsy (of childhood) with centro temporal spikes
5071610|NCT01335425|brain maturation|brain maturation
5071611|NCT01335425|structral connectivity|structral connectivity
5071612|NCT01335425|functional connectivity|functional connectivity
5071613|NCT01335399|Newly Diagnosed|newly diagnosed
5071614|NCT01335399|Previously Untreated|previously untreated
5071615|NCT01335373|Vaginal candidiasis|vaginal candidiasis
5071616|NCT01335373|Bacterial vaginosis (also known as non-specific, or Gardnerellosis, or anaerobic vaginosis)|bacterial vaginosis (also known as non-specific, or gardnerellosis, or anaerobic vaginosis)
5071617|NCT01335373|Trichomonal vaginitis|trichomonal vaginitis
5071618|NCT01335373|Vaginitis due to mixed infection|vaginitis due to mixed infection
5071619|NCT01335360|nevirapine|nevirapine
5071620|NCT01335360|pharmacokinetics|pharmacokinetics
5071621|NCT01335347|Influenza|influenza
5071622|NCT01335347|pandemic|pandemic
5071623|NCT01335347|avian influenza|avian influenza
5071624|NCT01335347|H5N1|h5n1
5071625|NCT01335347|flu|flu
5071626|NCT01335334|Effectiveness|effectiveness
5071627|NCT01335334|eradication|eradication
5071628|NCT01335334|Asymptomatic|asymptomatic
5071629|NCT01335321|viscosupplementation|viscosupplementation
5071630|NCT01335321|intra-articular injection|intra-articular injection
5071631|NCT01335321|hyaluronic acid|hyaluronic acid
5071632|NCT01335321|osteoarthritis|osteoarthritis
5071633|NCT01335321|knee|knee
5071634|NCT01335308|Pediatric Obesity|pediatric obesity
5071635|NCT01335308|Motivational Interviewing|motivational interviewing
5071636|NCT01335308|Overweight|overweight
5071637|NCT01335308|Behavior Change|behavior change
5071638|NCT01335295|Flavocoxid|flavocoxid
5071639|NCT01335295|Duchenne muscular dystrophy|duchenne muscular dystrophy
5071640|NCT01335295|pilot study|pilot study
5071641|NCT01335256|Phase I, dose escalation, kinase inhibitor, cyclin-dependent kinase inhibitor, target therapy, small molecule|phase i, dose escalation, kinase inhibitor, cyclin-dependent kinase inhibitor, target therapy, small molecule
5071642|NCT01335243|Orthopedic Procedures|orthopedic procedures
5071643|NCT01335243|Spine|spine
5071644|NCT01335243|Interbody fusion|interbody fusion
5071645|NCT01335243|Arthrodesis|arthrodesis
5071646|NCT01335243|Lumbar Vertebrae|lumbar vertebrae
5071647|NCT01335243|CT Scan|ct scan
5071648|NCT01335243|Spine balance|spine balance
5071649|NCT01335243|Instrumented fusion|instrumented fusion
5071650|NCT01335243|Posterior fusion|posterior fusion
5071651|NCT01335243|Degenerative spine|degenerative spine
5071652|NCT01335243|painful|painful
5071653|NCT01335230|HIV|hiv
5071654|NCT01335230|HCV|hcv
5071655|NCT01335230|Hepatitis C|hepatitis c
5071656|NCT01335230|HIV and Hepatitis C coinfection|hiv and hepatitis c coinfection
5071657|NCT01335230|HIV/HCV|hiv/hcv
5071658|NCT01335217|Depression|depression
5071659|NCT01335217|Major Depressive Disorder (MDD)|major depressive disorder (mdd)
5071660|NCT01335217|Trigeminal Nerve Stimulation|trigeminal nerve stimulation
5071661|NCT01335217|Post Traumatic Stress Disorder|post traumatic stress disorder
5071662|NCT01335204|Castration-resistant prostate cancer|castration-resistant prostate cancer
5071663|NCT01335204|Prostate Cancer|prostate cancer
5071664|NCT01335204|JEVTANA|jevtana
5071665|NCT01335204|Cabazitaxel|cabazitaxel
5071666|NCT01335204|Bavituximab|bavituximab
5071667|NCT01335191|HIV|hiv
5071668|NCT01335191|vaccine|vaccine
5071669|NCT01335191|lipopeptide|lipopeptide
5071670|NCT01335191|Tat|tat
5071671|NCT01335191|TUTI-16|tuti-16
5071672|NCT01335191|THYMON|thymon
5071673|NCT01335178|Tobacco smoke exposure|tobacco smoke exposure
5071674|NCT01335178|Secondhand smoke exposure|secondhand smoke exposure
5071675|NCT01335178|Passive smoking|passive smoking
5071676|NCT01335178|Child health|child health
5071677|NCT01335178|Prevention|prevention
5071678|NCT01335178|Tobacco control|tobacco control
5071679|NCT01335178|Motivational Interviewing|motivational interviewing
5071680|NCT01335178|Air quality|air quality
5071681|NCT01335178|Pilot Study|pilot study
5071682|NCT01335165|PNH|pnh
5071683|NCT01335152|stress|stress
5071684|NCT01335152|depression|depression
5071685|NCT01335152|anxiety|anxiety
5071686|NCT01335152|web|web
5071687|NCT01335152|internet|internet
5071688|NCT01335152|coping|coping
5071689|NCT01335139|sublingual immunotherapy|sublingual immunotherapy
5071690|NCT01335139|subcutaneous immunotherapy|subcutaneous immunotherapy
5071691|NCT01335126|Artificial tears|artificial tears
5071692|NCT01335100|Functional outcome|functional outcome
5071693|NCT01335100|Quality of life|quality of life
5071694|NCT01335100|Global Positioning System (GPS)|global positioning system (gps)
5071695|NCT01335100|Advanced tracking technologies|advanced tracking technologies
5071696|NCT01335100|Time-space activity.|time-space activity.
5071697|NCT01335100|walking speed|walking speed
5071698|NCT01335100|distances|distances
5071699|NCT01335100|number of walking events and destinations|number of walking events and destinations
5071700|NCT01335087|sleep apnea|sleep apnea
5071701|NCT01335087|secondary prevention|secondary prevention
5071702|NCT01335087|cardiovascular endpoint|cardiovascular endpoint
5071703|NCT01335061|Hemophilia B|hemophilia b
5071704|NCT01335061|on-demand|on-demand
5071705|NCT01335061|prophylaxis|prophylaxis
5071706|NCT01335061|nonacog alfa|nonacog alfa
5071707|NCT01335061|BeneFIX|benefix
5071708|NCT01335061|FIX|fix
5071709|NCT01335048|Clopidogrel|clopidogrel
5071710|NCT01335048|Statins|statins
5071711|NCT01335048|Platelet reactivity|platelet reactivity
5071712|NCT01335048|Point-of-care platelet function test|point-of-care platelet function test
5071713|NCT01335035|Iron metabolism,|iron metabolism,
5071714|NCT01335035|Allogenetic Hematopoietic Stem Cell Transplant,|allogenetic hematopoietic stem cell transplant,
5071715|NCT01335035|haematological diseases|haematological diseases
5071716|NCT01335009|melanoma|melanoma
5071717|NCT01335009|malignant|malignant
5071718|NCT01335009|metastatic|metastatic
5071719|NCT01334983|cancer|cancer
5071720|NCT01334983|function|function
5071721|NCT01334983|fatigue|fatigue
5071722|NCT01334983|late stage|late stage
5071723|NCT01334983|metastases|metastases
5071724|NCT01334983|quality of life|quality of life
5071725|NCT01334983|functional decline in cancer|functional decline in cancer
5071726|NCT01334944|Pain|pain
5071727|NCT01334944|Fever|fever
5071728|NCT01334931|Exposure to Ionizing Radiation|exposure to ionizing radiation
5071729|NCT01334931|Occupational Exposure to Radiation|occupational exposure to radiation
5071730|NCT01334918|pharmacologic stress|pharmacologic stress
5071731|NCT01334918|Coronary Artery Disease (CAD)|coronary artery disease (cad)
5071732|NCT01334918|regadenoson|regadenoson
5071733|NCT01334918|ischemia|ischemia
5071734|NCT01334905|Overactive Bladder|overactive bladder
5071735|NCT01334905|Urinary incontinence|urinary incontinence
5071736|NCT01334905|YM178|ym178
5071737|NCT01334905|mirabegron|mirabegron
5071738|NCT01334905|Food effect|food effect
5071739|NCT01334879|radiation|radiation
5071740|NCT01334879|retinopathy|retinopathy
5071741|NCT01334879|anti-VEGF|anti-vegf
5071742|NCT01334879|eye|eye
5071743|NCT01334866|Minimally invasive coronary surgery|minimally invasive coronary surgery
5071744|NCT01334866|Coronary artery bypass grafting|coronary artery bypass grafting
5071745|NCT01334866|MICS CABG|mics cabg
5071746|NCT01334840|Cardiovascular risk|cardiovascular risk
5071747|NCT01334840|Cholecystokinin|cholecystokinin
5071748|NCT01334840|Gallbladder emptying|gallbladder emptying
5071749|NCT01334840|Lipid absorption|lipid absorption
5071750|NCT01334840|Postprandial triacylglycerols|postprandial triacylglycerols
5071751|NCT01334840|Sodium-bicarbonated mineral water|sodium-bicarbonated mineral water
5071752|NCT01334827|topical microbicide|topical microbicide
5071753|NCT01334827|primary prevention|primary prevention
5071754|NCT01334827|HIV|hiv
5071755|NCT01334827|AIDS|aids
5071756|NCT01334827|drug delivery systems|drug delivery systems
5071757|NCT01334801|aortic stenosis|aortic stenosis
5071758|NCT01334801|von Willebrand factor|von willebrand factor
5071759|NCT01334801|mitral valve replacement|mitral valve replacement
5071760|NCT01334801|aortic valve replacement|aortic valve replacement
5071761|NCT01334801|prosthetic valve dysfunction|prosthetic valve dysfunction
5071762|NCT01334801|brain natriuretic peptide|brain natriuretic peptide
5071763|NCT01334801|mitral valve regurgitation|mitral valve regurgitation
5071764|NCT01334801|aortic valve regurgitation|aortic valve regurgitation
5071765|NCT01334801|hypertrophic cardiomyopathy|hypertrophic cardiomyopathy
5071766|NCT01334801|tricuspid insufficiency|tricuspid insufficiency
5071767|NCT01334788|sleep deprivation|sleep deprivation
5071768|NCT01334788|sleep restriction|sleep restriction
5071769|NCT01334775|Inguinal hernia|inguinal hernia
5071770|NCT01334775|Postoperative pain|postoperative pain
5071771|NCT01334775|Surgical mesh|surgical mesh
5071772|NCT01334762|minimal to mild endometriosis|minimal to mild endometriosis
5071773|NCT01334762|letrozole|letrozole
5071774|NCT01334762|clomiphene citrate|clomiphene citrate
5071775|NCT01334762|IUI|iui
5071776|NCT01334749|Stroke|stroke
5071777|NCT01334749|Dementia|dementia
5071778|NCT01334749|Dementia, Vascular|dementia, vascular
5071779|NCT01334749|Alzheimer's Disease|alzheimer's disease
5071780|NCT01334749|Intracranial Hemorrhage|intracranial hemorrhage
5071781|NCT01334749|Brain Ischemia|brain ischemia
5072065|NCT01333605|IGEV|igev
5071782|NCT01334736|smoking cessation|smoking cessation
5071783|NCT01334736|contingency management|contingency management
5071784|NCT01334736|spirometry|spirometry
5071785|NCT01334736|lung age|lung age
5071786|NCT01334723|Benign prostatic hyperplasia, enlarged prostate, 5-alpha-reductase inhibitor, adherence, surgery, acute urinary retention|benign prostatic hyperplasia, enlarged prostate, 5-alpha-reductase inhibitor, adherence, surgery, acute urinary retention
5071787|NCT01334710|Liver cancer|liver cancer
5071788|NCT01334697|Cardiotrophin-1|cardiotrophin-1
5071789|NCT01334697|CT-1|ct-1
5071790|NCT01334684|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
5071791|NCT01334684|Metformin Efficacy|metformin efficacy
5071792|NCT01334684|Gene Expression Profiles|gene expression profiles
5071793|NCT01334684|Personalized Medicine|personalized medicine
5071794|NCT01334671|ST-elevation myocardial infarction(STEMI)|st-elevation myocardial infarction(stemi)
5071795|NCT01334671|emergency percutaneous coronary intervention(PCI)|emergency percutaneous coronary intervention(pci)
5071796|NCT01334671|lipitor or Atorvastatin|lipitor or atorvastatin
5071797|NCT01334658|Corneal endothelium|corneal endothelium
5071798|NCT01334658|Cataract surgery|cataract surgery
5071799|NCT01334658|Irrigation solutions intraocular|irrigation solutions intraocular
5071800|NCT01334658|Phacoemulsification|phacoemulsification
5071801|NCT01334645|Copeptin|copeptin
5071802|NCT01334645|Troponin|troponin
5071803|NCT01334645|Diagnosis|diagnosis
5071804|NCT01334645|Chest pain|chest pain
5071805|NCT01334645|Acute Coronary Syndrome|acute coronary syndrome
5071806|NCT01334645|Acute Myocardial Infarction|acute myocardial infarction
5071807|NCT01334645|Unstable Angina|unstable angina
5071808|NCT01334632|Electrophysiological study|electrophysiological study
5071809|NCT01334632|Nerve block|nerve block
5071810|NCT01334632|Analgesia, patient-controlled|analgesia, patient-controlled
5071811|NCT01334632|Shoulder surgery|shoulder surgery
5071812|NCT01334619|Anesthetic techniques,regional|anesthetic techniques,regional
5071813|NCT01334619|Drug delivery,volume|drug delivery,volume
5071814|NCT01334619|Anesthetic, local: ropivacaine|anesthetic, local: ropivacaine
5071815|NCT01334606|diabetes|diabetes
5071816|NCT01334606|pen needle|pen needle
5071817|NCT01334606|basal insulin|basal insulin
5071818|NCT01334606|long-acting insulin|long-acting insulin
5071819|NCT01334554|African American|african american
5071820|NCT01334554|Women|women
5071821|NCT01334554|Metabolic Syndrome|metabolic syndrome
5071822|NCT01334554|Endothelial function|endothelial function
5071823|NCT01334554|Sildenafil citrate|sildenafil citrate
5071824|NCT01334528|Deployment Acquired Mild Traumatic Brain Injury|deployment acquired mild traumatic brain injury
5071825|NCT01334528|Persistent Post-Concussive Symptoms|persistent post-concussive symptoms
5071826|NCT01334528|Repeated measures|repeated measures
5071827|NCT01334502|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
5071828|NCT01334502|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5071829|NCT01334502|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5071830|NCT01334502|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5071831|NCT01334489|Monochorionic pregnancy|monochorionic pregnancy
5071832|NCT01334489|Twin to twin transfusion syndrome|twin to twin transfusion syndrome
5071833|NCT01334489|Cervical pessary|cervical pessary
5071834|NCT01334489|Cervical lenght|cervical lenght
5071835|NCT01334476|Data Repository|data repository
5071836|NCT01334476|Facilitate Recruitment of Participants for Ongoing and Future Research|facilitate recruitment of participants for ongoing and future research
5071837|NCT01334450|Improvement of ADAS-COG|improvement of adas-cog
5071838|NCT01334437|blood test|blood test
5071839|NCT01334437|ovarian cancer|ovarian cancer
5071840|NCT01334437|Associated Auto Antibodies|associated auto antibodies
5071841|NCT01334424|Robot assisted laparoscopic radical prostatectomy|robot assisted laparoscopic radical prostatectomy
5071842|NCT01334424|Hypoperfusion reperfusion injury,|hypoperfusion reperfusion injury,
5071843|NCT01334424|Propofol|propofol
5071844|NCT01334424|oxidative stress|oxidative stress
5071845|NCT01334398|Traumatic Brain Injury|traumatic brain injury
5071846|NCT01334372|suicide|suicide
5071847|NCT01334372|veterans|veterans
5071848|NCT01334372|assessment|assessment
5071849|NCT01334372|CAMS|cams
5071850|NCT01334359|physical activity|physical activity
5071851|NCT01334359|fitness|fitness
5071852|NCT01334359|brain health|brain health
5071853|NCT01334359|cognition|cognition
5071854|NCT01334359|scholastic achievement|scholastic achievement
5071855|NCT01334359|preadolescent children|preadolescent children
5071856|NCT01334346|Running|running
5071857|NCT01334346|Footwear|footwear
5071858|NCT01334346|Injury incidence|injury incidence
5071859|NCT01334346|injury risk|injury risk
5071860|NCT01334346|pain|pain
5071861|NCT01334333|kidney transplant|kidney transplant
5071862|NCT01334333|tacrolimus|tacrolimus
5071863|NCT01334333|medication adherence|medication adherence
5071864|NCT01334333|depression|depression
5071865|NCT01334333|neuropsychological|neuropsychological
5071866|NCT01334333|cognition|cognition
5071867|NCT01334333|Self-efficacy|self-efficacy
5071868|NCT01334333|everyday problem solving|everyday problem solving
5071869|NCT01334320|oral squamous cell carcinoma|oral squamous cell carcinoma
5071870|NCT01334320|elective neck dissection|elective neck dissection
5071871|NCT01334320|"watchful waiting"|"watchful waiting"
5071872|NCT01334320|survival benefit|survival benefit
5071873|NCT01334320|recurrence rate|recurrence rate
5071874|NCT01334307|Emphysema|emphysema
5071875|NCT01334307|RePneu|repneu
5071876|NCT01334294|CNV|cnv
5071877|NCT01334294|AMD|amd
5071878|NCT01334281|Panel Reactive Antibody (PRA)|panel reactive antibody (pra)
5071879|NCT01334281|Sensitization|sensitization
5071880|NCT01334281|Organ Transplant|organ transplant
5071881|NCT01334268|In-stent Late Lumen Loss (LLL)|in-stent late lumen loss (lll)
5071882|NCT01334268|TARGET VESSEL FAILURE (TVF)|target vessel failure (tvf)
5071883|NCT01334268|MYOCARDIAL INFARCTION (MI)|myocardial infarction (mi)
5071884|NCT01334268|TARGET VESSEL REVASCULARIZATION (TVR)|target vessel revascularization (tvr)
5071885|NCT01334268|TARGET LESION REVASCULARIZATION (TLR)|target lesion revascularization (tlr)
5071886|NCT01334268|TARGET LESION FAILURE (TLF)|target lesion failure (tlf)
5071887|NCT01334268|STENT THROMBOSIS|stent thrombosis
5071888|NCT01334268|RESTENOTIC LESION|restenotic lesion
5071889|NCT01334268|PERCUTANEOUS CORONARY INTERVENTION (PCI)|percutaneous coronary intervention (pci)
5071890|NCT01334268|REAL-WORLD|real-world
5071891|NCT01334268|THE RANDOMIZED CONTROLLED TRIAL|the randomized controlled trial
5071892|NCT01334255|Pigment epithelial detachment|pigment epithelial detachment
5071893|NCT01334255|Exudative age-related macular degeneration|exudative age-related macular degeneration
5071894|NCT01334255|Polypoidal choroidal vasculopathy|polypoidal choroidal vasculopathy
5071895|NCT01334242|Pharmacodynamics|pharmacodynamics
5071896|NCT01334229|sitagliptin|sitagliptin
5071897|NCT01334229|diabetes|diabetes
5071898|NCT01334229|apolipoprotein B48 and B100|apolipoprotein b48 and b100
5071899|NCT01334216|smoking|smoking
5071900|NCT01334216|quitting|quitting
5071901|NCT01334216|tobacco|tobacco
5071902|NCT01334216|Parental|parental
5071903|NCT01334203|Chronic angina|chronic angina
5071904|NCT01334203|Angina pectoris|angina pectoris
5071905|NCT01334203|Coronary artery disease|coronary artery disease
5071906|NCT01334203|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
5071907|NCT01334203|ETT|ett
5071908|NCT01334190|AE adverse event|ae adverse event
5071909|NCT01334190|AIDS acquired immunodeficiency syndrome|aids acquired immunodeficiency syndrome
5071910|NCT01334190|ALT (SGPT) alanine aminotransferase|alt (sgpt) alanine aminotransferase
5071911|NCT01334190|ART antiretroviral therapy|art antiretroviral therapy
5071912|NCT01334190|AST (SGOT) aspartate aminotransferase|ast (sgot) aspartate aminotransferase
5071913|NCT01334190|DCF data collection forms|dcf data collection forms
5071914|NCT01334190|DMC Data Monitoring Committee|dmc data monitoring committee
5071915|NCT01334190|FDA (U.S.) Food and Drug Administration|fda (u.s.) food and drug administration
5071916|NCT01334190|GCP Good Clinical Practice guidelines|gcp good clinical practice guidelines
5071917|NCT01334190|HB sAg Hepatitis B surface antigen|hb sag hepatitis b surface antigen
5071918|NCT01334190|ICH International Conference of Harmonisation|ich international conference of harmonisation
5071919|NCT01334190|IND Investigational New Drug Application|ind investigational new drug application
5071920|NCT01334190|IRB Institutional Review Board|irb institutional review board
5071921|NCT01334190|IU international units|iu international units
5071922|NCT01334190|mg milligram(s)|mg milligram(s)
5071923|NCT01334190|mm3 cubic millimeter(s)|mm3 cubic millimeter(s)
5071924|NCT01334190|PCR polymerase chain reaction|pcr polymerase chain reaction
5071925|NCT01334190|SAE serious adverse event|sae serious adverse event
5071926|NCT01334190|µg microgram|µg microgram
5071927|NCT01334190|ULN upper limit of the normal range|uln upper limit of the normal range
5071928|NCT01334190|WB Western Blot|wb western blot
5071929|NCT01334190|post-marketing monitoring|post-marketing monitoring
5071930|NCT01334190|safety|safety
5071931|NCT01334190|efficacy|efficacy
5071932|NCT01334190|acceptability|acceptability
5071933|NCT01334164|substance use disorder|substance use disorder
5071934|NCT01334164|offenders|offenders
5071935|NCT01334164|reentry|reentry
5071936|NCT01334164|HIV risk behavior|hiv risk behavior
5071937|NCT01334164|recidivism|recidivism
5071938|NCT01334138|hypertension|hypertension
5071939|NCT01334138|sodium|sodium
5071940|NCT01334138|diet|diet
5071941|NCT01334125|Double Diabetes|double diabetes
5071942|NCT01334125|Type 1 diabetes|type 1 diabetes
5071943|NCT01334125|Type 2 diabetes|type 2 diabetes
5071944|NCT01334125|Obesity|obesity
5071945|NCT01334125|Acanthosis nigricans|acanthosis nigricans
5071946|NCT01334125|Diabetes associated autoantibodies|diabetes associated autoantibodies
5071947|NCT01334112|Hepatocellular Carcinoma|hepatocellular carcinoma
5071948|NCT01334112|Advanced Hepatocellular Carcinoma|advanced hepatocellular carcinoma
5071949|NCT01334112|Liver Cancer|liver cancer
5071950|NCT01334112|Axitinib|axitinib
5071951|NCT01334112|AG-013736|ag-013736
5071952|NCT01334086|AML|aml
5071953|NCT01334073|Phase I|phase i
5071954|NCT01334073|Axitinib|axitinib
5071955|NCT01334073|Everolimus|everolimus
5071956|NCT01334073|Maximum tolerated dose (MTD)|maximum tolerated dose (mtd)
5071957|NCT01334073|solid tumor|solid tumor
5071958|NCT01334073|Renal cell cancer (RCC)|renal cell cancer (rcc)
5071959|NCT01334073|Pharmacokinetics (PK/PD)|pharmacokinetics (pk/pd)
5071960|NCT01334021|Genomic Testing|genomic testing
5071961|NCT01334021|Genetic Testing|genetic testing
5071962|NCT01334021|HER2 Negative|her2 negative
5072367|NCT01332201|Pancreas|pancreas
5071963|NCT01334021|Primary Invasive Breast Cancer|primary invasive breast cancer
5071964|NCT01334021|Stage I|stage i
5071965|NCT01334021|Stage II|stage ii
5071966|NCT01334021|Stage III|stage iii
5071967|NCT01334021|Registry|registry
5071968|NCT01334021|Biopsy|biopsy
5071969|NCT01334021|Tumor sampling|tumor sampling
5071970|NCT01334008|Circulating tumor DNA|circulating tumor dna
5071971|NCT01334008|Choroidal Melanoma|choroidal melanoma
5071972|NCT01333995|Peer counselling|peer counselling
5071973|NCT01333995|Infant|infant
5071974|NCT01333995|Intervention|intervention
5071975|NCT01333995|breastfeeding|breastfeeding
5071976|NCT01333995|complementary feeding|complementary feeding
5071977|NCT01333995|stunting|stunting
5071978|NCT01333982|Neonatal Sepsis|neonatal sepsis
5071979|NCT01333982|Evaluation|evaluation
5071980|NCT01333982|Bangladesh|bangladesh
5071981|NCT01333982|Drying|drying
5071982|NCT01333982|Wrapping|wrapping
5071983|NCT01333982|Bathing|bathing
5071984|NCT01333943|Total Knee Replacement|total knee replacement
5071985|NCT01333943|Regional Anesthesia|regional anesthesia
5071986|NCT01333943|Quadriceps|quadriceps
5071987|NCT01333943|Muscle Strength|muscle strength
5071988|NCT01333943|Muscle Strength Dynamometer|muscle strength dynamometer
5071989|NCT01333943|Quadriceps muscle strength after regional anesthesia for TKA|quadriceps muscle strength after regional anesthesia for tka
5071990|NCT01333930|immunological effects|immunological effects
5071991|NCT01333930|Active O2|active o2
5071992|NCT01333930|strenuous exercise|strenuous exercise
5071993|NCT01333930|procedures|procedures
5071994|NCT01333930|pharmacodynamic parameters|pharmacodynamic parameters
5071995|NCT01333930|blood sampling scheme|blood sampling scheme
5071996|NCT01333917|Curcumin|curcumin
5071997|NCT01333917|Colorectal Cancer|colorectal cancer
5071998|NCT01333917|GWAS|gwas
5071999|NCT01333865|Memantine|memantine
5072000|NCT01333865|Namenda|namenda
5072001|NCT01333865|Autism Spectrum Disorders|autism spectrum disorders
5072002|NCT01333865|Pervasive Developmental Disorders|pervasive developmental disorders
5072003|NCT01333865|Adults|adults
5072004|NCT01333852|head and neck cancer|head and neck cancer
5072005|NCT01333852|paclitaxel|paclitaxel
5072006|NCT01333852|metformin|metformin
5072007|NCT01333852|squamous cell carcinoma|squamous cell carcinoma
5072008|NCT01333839|CABG surgery|cabg surgery
5072009|NCT01333839|exercise intervention|exercise intervention
5072010|NCT01333839|insulin sensitivity|insulin sensitivity
5072011|NCT01333839|muscle mass|muscle mass
5072012|NCT01333813|immune response|immune response
5072013|NCT01333813|Engerix-B™Kinder|engerix-b™kinder
5072014|NCT01333813|Persistence|persistence
5072015|NCT01333813|challenge dose|challenge dose
5072016|NCT01333787|dietary fiber|dietary fiber
5072017|NCT01333787|clinical trial|clinical trial
5072018|NCT01333787|constipation|constipation
5072019|NCT01333787|children|children
5072020|NCT01333774|Diabetes|diabetes
5072021|NCT01333774|Acarbose|acarbose
5072022|NCT01333774|Diet|diet
5072023|NCT01333774|Compliance|compliance
5072024|NCT01333774|Advising|advising
5072025|NCT01333761|right to left cardiac shunt finding|right to left cardiac shunt finding
5072026|NCT01333748|breast cancer|breast cancer
5072027|NCT01333748|ovarian cancer|ovarian cancer
5072028|NCT01333748|BRCA 1 and BRCA 2|brca 1 and brca 2
5072029|NCT01333735|cognitive functions|cognitive functions
5072030|NCT01333735|quality of life|quality of life
5072031|NCT01333735|breast cancer|breast cancer
5072032|NCT01333735|chemotherapy|chemotherapy
5072033|NCT01333735|ages patients|ages patients
5072034|NCT01333709|locally advanced rectal carcinoma|locally advanced rectal carcinoma
5072035|NCT01333709|Tailored treatment strategy|tailored treatment strategy
5072036|NCT01333709|MRI volumetry|mri volumetry
5072037|NCT01333709|Early tumor response|early tumor response
5072038|NCT01333696|Squamous cell carcinoma of head and neck|squamous cell carcinoma of head and neck
5072039|NCT01333696|Pemetrexed|pemetrexed
5072040|NCT01333683|tinnitus|tinnitus
5072041|NCT01333683|hearing loss|hearing loss
5072042|NCT01333683|arterial hypertension|arterial hypertension
5072043|NCT01333683|ototoxicity|ototoxicity
5072044|NCT01333657|sTREM-1|strem-1
5072045|NCT01333657|sepsis|sepsis
5072046|NCT01333657|SIRS|sirs
5072047|NCT01333657|blood|blood
5072048|NCT01333657|urine|urine
5072049|NCT01333657|diagnosis|diagnosis
5072050|NCT01333657|prognosis|prognosis
5072051|NCT01333644|HIV Infection|hiv infection
5072052|NCT01333644|Endothelial function|endothelial function
5072053|NCT01333644|Cardiovascular Disease|cardiovascular disease
5072054|NCT01333644|Inflammation|inflammation
5072055|NCT01333644|Antiretroviral medication|antiretroviral medication
5072056|NCT01333644|Treatment naive|treatment naive
5072057|NCT01333644|Treatment experienced|treatment experienced
5072058|NCT01333631|Locally advanced unresectable pancreatic cancer|locally advanced unresectable pancreatic cancer
5072059|NCT01333618|Filter Tilt|filter tilt
5072060|NCT01333618|Preventional efficiency|preventional efficiency
5072061|NCT01333618|Günther Tulip filter|günther tulip filter
5072062|NCT01333618|Transfemoral Approach|transfemoral approach
5072063|NCT01333605|Hodgkin lymphoma|hodgkin lymphoma
5072064|NCT01333605|Chemotherapy|chemotherapy
5072066|NCT01333605|Autologous stem cell transplantation|autologous stem cell transplantation
5072067|NCT01333592|Type 2 diabetes|type 2 diabetes
5072068|NCT01333592|HbA1c|hba1c
5072069|NCT01333592|Long-term study|long-term study
5072070|NCT01333553|birthmark|birthmark
5072071|NCT01333540|constipation|constipation
5072072|NCT01333540|opioid induced|opioid induced
5072073|NCT01333514|diabetes|diabetes
5072074|NCT01333514|prandial|prandial
5072075|NCT01333514|insulin|insulin
5072076|NCT01333514|aspart|aspart
5072077|NCT01333514|carbohydrate|carbohydrate
5072078|NCT01333514|inpatient|inpatient
5072079|NCT01333514|novolog|novolog
5072080|NCT01333501|Multiple sclerosis|multiple sclerosis
5072081|NCT01333501|cognitive symptoms|cognitive symptoms
5072082|NCT01333501|relapsing-remitting multiple sclerosis (RRMS)|relapsing-remitting multiple sclerosis (rrms)
5072083|NCT01333501|fingolimod|fingolimod
5072084|NCT01333501|Magnetic resonance imaging (MRI)|magnetic resonance imaging (mri)
5072085|NCT01333488|Traumatic|traumatic
5072086|NCT01333488|Brain|brain
5072087|NCT01333488|Injury|injury
5072088|NCT01333475|Targeted Therapy|targeted therapy
5072089|NCT01333475|KRAS Mutation|kras mutation
5072090|NCT01333475|Metastatic Colorectal Cancer|metastatic colorectal cancer
5072091|NCT01333475|Colorectal Cancer|colorectal cancer
5072092|NCT01333449|Decitabine|decitabine
5072093|NCT01333449|MDS, myelodysplastic syndrome|mds, myelodysplastic syndrome
5072094|NCT01333449|prospective open label, phaseII|prospective open label, phaseii
5072095|NCT01333449|Allogeneic Hematopoietic cell transplant|allogeneic hematopoietic cell transplant
5072096|NCT01333423|Breast Cancer|breast cancer
5072097|NCT01333423|Metastatic Triple Negative|metastatic triple negative
5072098|NCT01333423|ER/PR/HER2 negative|er/pr/her2 negative
5072099|NCT01333423|Locally advanced|locally advanced
5072100|NCT01333423|Stage IV|stage iv
5072101|NCT01333423|Metastatic|metastatic
5072102|NCT01333423|Seliciclib|seliciclib
5072103|NCT01333423|Liposomal Doxorubicin|liposomal doxorubicin
5072104|NCT01333423|Doxil|doxil
5072105|NCT01333423|Doxorubicin Hydrochloride (Liposomal)|doxorubicin hydrochloride (liposomal)
5072106|NCT01333410|vitiligo|vitiligo
5072107|NCT01333410|tacrolimus|tacrolimus
5072108|NCT01333410|mometasone furoate|mometasone furoate
5072109|NCT01333371|Distal Radius|distal radius
5072110|NCT01333371|Volar locked plating|volar locked plating
5072111|NCT01333371|Cost Effectiveness|cost effectiveness
5072112|NCT01333371|Randomization|randomization
5072113|NCT01333371|Outcomes|outcomes
5072114|NCT01333358|Relapsing|relapsing
5072115|NCT01333358|remitting|remitting
5072116|NCT01333345|Cataract replacement surgery|cataract replacement surgery
5072117|NCT01333345|implantation|implantation
5072118|NCT01333345|EC-3 IOL|ec-3 iol
5072119|NCT01333332|Pancreas|pancreas
5072120|NCT01333332|Radiation|radiation
5072121|NCT01333319|liver transplantation|liver transplantation
5072122|NCT01333319|acute kidney injury|acute kidney injury
5072123|NCT01333306|tDCS|tdcs
5072124|NCT01333306|cognitive training|cognitive training
5072125|NCT01333293|mastocytosis|mastocytosis
5072126|NCT01333293|omalizumab|omalizumab
5072127|NCT01333267|Endocrine System Diseases|endocrine system diseases
5072128|NCT01333267|MusculoSkeletal System Disease|musculoskeletal system disease
5072129|NCT01333267|Hormones|hormones
5072130|NCT01333267|Postmenopausal Women|postmenopausal women
5072131|NCT01333267|Bone metabolism|bone metabolism
5072132|NCT01333267|Physiologic Properties|physiologic properties
5072133|NCT01333267|African-Americans|african-americans
5072134|NCT01333254|urinary tract infections|urinary tract infections
5072135|NCT01333254|urinary catheterisation|urinary catheterisation
5072136|NCT01333241|Hispanic Americans|hispanic americans
5072137|NCT01333241|Cardiovascular disease|cardiovascular disease
5072138|NCT01333241|Obesity|obesity
5072139|NCT01333241|Intervention|intervention
5072140|NCT01333215|Suicide, Attempted|suicide, attempted
5072141|NCT01333215|Cognitive Symptoms|cognitive symptoms
5072142|NCT01333202|Fresh lime|fresh lime
5072143|NCT01333202|nicotine gum|nicotine gum
5072144|NCT01333202|smoking cessation|smoking cessation
5072145|NCT01333202|craving|craving
5072146|NCT01333189|total knee arthroplasty|total knee arthroplasty
5072147|NCT01333189|osteoarthritis|osteoarthritis
5072148|NCT01333189|biomechanics|biomechanics
5072149|NCT01333189|gait|gait
5072150|NCT01333176|Type 2 Diabetes|type 2 diabetes
5072151|NCT01333176|Hb A1c screening for diabetes in aboriginals|hb a1c screening for diabetes in aboriginals
5072152|NCT01333150|Temporomandibular disorders|temporomandibular disorders
5072153|NCT01333150|Orofacial pain|orofacial pain
5072154|NCT01333137|Triple negative breast cancer|triple negative breast cancer
5072155|NCT01333124|Preoperative chemoradiotherapy with Gemcitabine|preoperative chemoradiotherapy with gemcitabine
5072156|NCT01333098|anxiety|anxiety
5072157|NCT01333098|older adult|older adult
5072158|NCT01333098|memory|memory
5072159|NCT01333098|cognitive|cognitive
5072160|NCT01333098|Saint Louis|saint louis
5072161|NCT01333098|treatment|treatment
5072162|NCT01333098|Non-dementia cognitive impairment in older adults with anxiety disorders.|non-dementia cognitive impairment in older adults with anxiety disorders.
5072163|NCT01333085|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5072164|NCT01333085|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5072165|NCT01333085|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
5072166|NCT01333085|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5072167|NCT01333085|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
5072168|NCT01333085|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5072169|NCT01333085|tongue cancer|tongue cancer
5072170|NCT01333072|Autistic Disorder|autistic disorder
5072171|NCT01333059|Sedation|sedation
5072172|NCT01333059|Cycling|cycling
5072173|NCT01333059|Pediatric|pediatric
5072174|NCT01333046|Hodgkin Lymphoma|hodgkin lymphoma
5072175|NCT01333046|Non-Hodgkin Lymphoma|non-hodgkin lymphoma
5072176|NCT01333046|CTL|ctl
5072177|NCT01333033|adenocarcinoma of the gastroesophageal junction|adenocarcinoma of the gastroesophageal junction
5072178|NCT01333033|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
5072179|NCT01333033|stage IB esophageal cancer|stage ib esophageal cancer
5072180|NCT01333033|stage IIA esophageal cancer|stage iia esophageal cancer
5072181|NCT01333033|stage IIB esophageal cancer|stage iib esophageal cancer
5072182|NCT01333033|stage IIIA esophageal cancer|stage iiia esophageal cancer
5072183|NCT01333033|stage IIIB esophageal cancer|stage iiib esophageal cancer
5072184|NCT01333033|stage IIIC esophageal cancer|stage iiic esophageal cancer
5072185|NCT01333020|emulsion|emulsion
5072186|NCT01333020|protein|protein
5072187|NCT01333020|cross-linking|cross-linking
5072188|NCT01333020|gastric emptying|gastric emptying
5072189|NCT01332955|Hepatitis C, Chronic|hepatitis c, chronic
5072190|NCT01332955|HIV Infection|hiv infection
5072191|NCT01332955|Telaprevir|telaprevir
5072192|NCT01332955|Peginterferon alfa-2a|peginterferon alfa-2a
5072193|NCT01332955|Ribavirin|ribavirin
5072194|NCT01332955|Pharmacokinetic|pharmacokinetic
5072195|NCT01332955|Pharmacogenetic|pharmacogenetic
5072196|NCT01332955|Previous peginterferon-ribavirin regimen failure|previous peginterferon-ribavirin regimen failure
5072197|NCT01332942|Anemia|anemia
5072198|NCT01332929|brain radiation therapy|brain radiation therapy
5072199|NCT01332929|Bevacizumab|bevacizumab
5072200|NCT01332929|brain metastasis|brain metastasis
5072201|NCT01332929|solid tumor|solid tumor
5072202|NCT01332916|No metastatic breast cancer|no metastatic breast cancer
5072203|NCT01332916|cognitive troubles|cognitive troubles
5072204|NCT01332916|adjuvant chemotherapy|adjuvant chemotherapy
5072205|NCT01332890|Drug interaction|drug interaction
5072206|NCT01332890|revaprazan|revaprazan
5072207|NCT01332890|Itopride HCI|itopride hci
5072208|NCT01332877|Obesity|obesity
5072209|NCT01332877|Weight loss|weight loss
5072210|NCT01332877|Ghrelin|ghrelin
5072211|NCT01332877|Satiety|satiety
5072212|NCT01332877|Hunger|hunger
5072213|NCT01332864|headache|headache
5072214|NCT01332864|migraine|migraine
5072215|NCT01332864|cephalgia|cephalgia
5072216|NCT01332864|osteopathic manipulative treatment|osteopathic manipulative treatment
5072217|NCT01332851|child welfare|child welfare
5072218|NCT01332851|child protective services|child protective services
5072219|NCT01332851|child abuse|child abuse
5072220|NCT01332851|child neglect|child neglect
5072221|NCT01332851|infant|infant
5072222|NCT01332851|parenting|parenting
5072223|NCT01332825|olfaction|olfaction
5072224|NCT01332825|smell dysfunction|smell dysfunction
5072225|NCT01332812|Dexamethasone|dexamethasone
5072226|NCT01332812|Postoperative cognitive dysfunction|postoperative cognitive dysfunction
5072227|NCT01332812|General Anesthesia|general anesthesia
5072228|NCT01332812|neuropsychological tests|neuropsychological tests
5072229|NCT01332799|cardiovascular disease|cardiovascular disease
5072230|NCT01332799|kidney transplantation|kidney transplantation
5072231|NCT01332786|AML|aml
5072232|NCT01332760|ergonomics|ergonomics
5072233|NCT01332760|workplace|workplace
5072234|NCT01332760|occupational|occupational
5072235|NCT01332760|tool|tool
5072236|NCT01332760|dental|dental
5072237|NCT01332760|dentist|dentist
5072238|NCT01332747|TC|tc
5072239|NCT01332747|TG|tg
5072240|NCT01332747|HDL|hdl
5072241|NCT01332747|LDL|ldl
5072242|NCT01332747|VLDL|vldl
5072243|NCT01332734|microcirculation|microcirculation
5072244|NCT01332734|SDF|sdf
5072245|NCT01332734|magnesium sulfate|magnesium sulfate
5072246|NCT01332721|TRC105|trc105
5072247|NCT01332721|CD105|cd105
5072248|NCT01332721|Endoglin|endoglin
5072249|NCT01332721|Solid Tumors|solid tumors
5072250|NCT01332721|Avastin|avastin
5072251|NCT01332721|Bevacizumab|bevacizumab
5072252|NCT01332708|high complex carbohydrates|high complex carbohydrates
5072253|NCT01332708|hypocaloric diet|hypocaloric diet
5072254|NCT01332708|cholinergic status|cholinergic status
5072255|NCT01332708|overweight|overweight
5072256|NCT01332708|obese|obese
5072257|NCT01332695|tremor|tremor
5072258|NCT01332695|WHIGET|whiget
5072259|NCT01332695|Fahn Tolosa Marin Scale|fahn tolosa marin scale
5072260|NCT01332682|head and neck cancer|head and neck cancer
5072261|NCT01332682|resistance training|resistance training
5072262|NCT01332682|nutrition counseling|nutrition counseling
5072263|NCT01332682|pharyngeal or laryngeal cancer|pharyngeal or laryngeal cancer
5072264|NCT01332669|hepatocellular carcinoma|hepatocellular carcinoma
5072265|NCT01332669|chemoembolization|chemoembolization
5072266|NCT01332669|drug eluting beads|drug eluting beads
5072267|NCT01332669|HCC|hcc
5072268|NCT01332669|Liver cancer|liver cancer
5072269|NCT01332669|Korea|korea
5072270|NCT01332643|Preimplantation Genetic Diagnosis|preimplantation genetic diagnosis
5072271|NCT01332643|recurrent pregnancy loss|recurrent pregnancy loss
5072272|NCT01332643|infertility|infertility
5072273|NCT01332643|genetic screening|genetic screening
5072274|NCT01332643|trisomy 21|trisomy 21
5072275|NCT01332643|Down syndrome|down syndrome
5072276|NCT01332630|Breast cancer|breast cancer
5072277|NCT01332630|Brain metastases|brain metastases
5072278|NCT01332630|TPI 287|tpi 287
5072279|NCT01332630|Computed Tomography|computed tomography
5072280|NCT01332630|CT|ct
5072281|NCT01332630|Magnetic Resonance Imaging|magnetic resonance imaging
5072282|NCT01332630|MRI|mri
5072283|NCT01332617|Multiple Myeloma|multiple myeloma
5072284|NCT01332617|Simvastatin|simvastatin
5072285|NCT01332617|Zoledronic|zoledronic
5072286|NCT01332617|Bortezomib|bortezomib
5072287|NCT01332617|Bendamustine|bendamustine
5072288|NCT01332617|Methylprednisolone|methylprednisolone
5072289|NCT01332591|STEMI, primary PCI, non-infarct, non-culprit lesion, CABG|stemi, primary pci, non-infarct, non-culprit lesion, cabg
5072290|NCT01332565|GSK1349572|gsk1349572
5072291|NCT01332565|pharmacokinetics|pharmacokinetics
5072292|NCT01332565|Japanese|japanese
5072293|NCT01332565|HIV|hiv
5072294|NCT01332552|pharmacokinetics|pharmacokinetics
5072295|NCT01332552|First administration to human|first administration to human
5072296|NCT01332552|antiviral activity|antiviral activity
5072297|NCT01332552|safety|safety
5072298|NCT01332552|hepatitis C|hepatitis c
5072299|NCT01332526|FFT|fft
5072300|NCT01332526|inflammation|inflammation
5072301|NCT01332526|lipid metabolism|lipid metabolism
5072302|NCT01332526|hyperuricemia|hyperuricemia
5072303|NCT01332526|Agents Affecting Uric Acid Metabolism|agents affecting uric acid metabolism
5072304|NCT01332513|Healthy Volunteers|healthy volunteers
5072305|NCT01332500|Triptans|triptans
5072306|NCT01332500|Migraine|migraine
5072307|NCT01332487|5-alpha-reductase inhibitor|5-alpha-reductase inhibitor
5072308|NCT01332487|prostate surgery|prostate surgery
5072309|NCT01332487|alpha-blocker|alpha-blocker
5072310|NCT01332487|enlarged prostate|enlarged prostate
5072311|NCT01332487|acute urinary retention|acute urinary retention
5072312|NCT01332487|Benign prostatic hyperplasia|benign prostatic hyperplasia
5072313|NCT01332474|Botox|botox
5072314|NCT01332474|JCP|jcp
5072315|NCT01332448|Xenical|xenical
5072316|NCT01332448|Alli|alli
5072317|NCT01332448|safety|safety
5072318|NCT01332448|meta-analysis|meta-analysis
5072319|NCT01332448|liver-function test|liver-function test
5072320|NCT01332448|Roche|roche
5072321|NCT01332448|orlistat|orlistat
5072322|NCT01332435|Enlarged prostate, 5-alpha-reductase inhibitor, alpha-blocker, early, costs|enlarged prostate, 5-alpha-reductase inhibitor, alpha-blocker, early, costs
5072323|NCT01332370|Retrospective|retrospective
5072324|NCT01332370|Type 2 Diabetes|type 2 diabetes
5072325|NCT01332370|Cost Analysis|cost analysis
5072326|NCT01332370|Rosiglitazone|rosiglitazone
5072327|NCT01332370|Sitagliptin|sitagliptin
5072328|NCT01332357|fluticasone/propionate salmeterol combination|fluticasone/propionate salmeterol combination
5072329|NCT01332357|hospitalization|hospitalization
5072330|NCT01332357|emergency department|emergency department
5072331|NCT01332357|asthma|asthma
5072332|NCT01332344|fluticasone propionate/salmeterol combination|fluticasone propionate/salmeterol combination
5072333|NCT01332344|Asthma|asthma
5072334|NCT01332344|inhaled corticosteroids|inhaled corticosteroids
5072335|NCT01332344|outcomes|outcomes
5072336|NCT01332331|pulmonary arterial hypertension|pulmonary arterial hypertension
5072337|NCT01332331|pediatric|pediatric
5072338|NCT01332292|inhalation profiles|inhalation profiles
5072339|NCT01332292|pharmacokinetics|pharmacokinetics
5072340|NCT01332292|pharyngometry|pharyngometry
5072341|NCT01332292|asthma|asthma
5072342|NCT01332292|pediatric subjects|pediatric subjects
5072343|NCT01332292|GW685698|gw685698
5072344|NCT01332292|Fluticasone furoate|fluticasone furoate
5072345|NCT01332292|safety|safety
5072346|NCT01332266|Cancer|cancer
5072347|NCT01332266|head and neck|head and neck
5072348|NCT01332266|squamous cell carcinoma of the head and neck|squamous cell carcinoma of the head and neck
5072349|NCT01332266|phase I|phase i
5072350|NCT01332266|phase II|phase ii
5072351|NCT01332253|Tonsillectomy, Pediatric|tonsillectomy, pediatric
5072352|NCT01332240|staging|staging
5072353|NCT01332240|endosonography|endosonography
5072354|NCT01332240|lung cancer|lung cancer
5072355|NCT01332240|stage III|stage iii
5072356|NCT01332214|Phase 1|phase 1
5072357|NCT01332214|healthy male volunteers|healthy male volunteers
5072358|NCT01332214|dose escalation|dose escalation
5072359|NCT01332214|pharmacokinetics|pharmacokinetics
5072360|NCT01332214|Single Ascending Dose|single ascending dose
5072361|NCT01332214|AZD2820 Cmax|azd2820 cmax
5072362|NCT01332214|tmax|tmax
5072363|NCT01332214|t1/2λz|t1/2λz
5072364|NCT01332201|Advagraf|advagraf
5072365|NCT01332201|Heart|heart
5072366|NCT01332201|Lung|lung
5072368|NCT01332201|Transplant|transplant
5072369|NCT01332201|Immunosuppression|immunosuppression
5072370|NCT01332201|Pharmacokinetics|pharmacokinetics
5072371|NCT01332162|Hypertrophic Obstructive Cardiomyopathy (HOCM)|hypertrophic obstructive cardiomyopathy (hocm)
5072372|NCT01332162|Pacing|pacing
5072373|NCT01332149|Diabetic Neuropathies|diabetic neuropathies
5072374|NCT01332149|Pain|pain
5072375|NCT01332149|Efficacy of pregabalin|efficacy of pregabalin
5072376|NCT01332149|Placebo controlled|placebo controlled
5072377|NCT01332110|Footwear|footwear
5072378|NCT01332110|Motion Analysis|motion analysis
5072379|NCT01332110|Running Injury|running injury
5072380|NCT01332097|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5072381|NCT01332097|Exacerbation|exacerbation
5072382|NCT01332097|Pulmonary Inflammation|pulmonary inflammation
5072383|NCT01332084|SOTI|soti
5072384|NCT01332084|tolerance|tolerance
5072385|NCT01332084|desensitization|desensitization
5072386|NCT01332084|challenge test|challenge test
5072387|NCT01332084|HA wheat cereals|ha wheat cereals
5072388|NCT01332071|Metformin|metformin
5072389|NCT01332071|Rosiglitazone|rosiglitazone
5072390|NCT01332071|Healthy volunteers|healthy volunteers
5072391|NCT01332071|Avandamet|avandamet
5072392|NCT01332071|Fed conditions|fed conditions
5072393|NCT01332071|Bioequivalence|bioequivalence
5072394|NCT01332058|Peripheral arterial disease|peripheral arterial disease
5072395|NCT01332058|Walking|walking
5072396|NCT01332058|Motivational Interviewing|motivational interviewing
5072397|NCT01332032|cost effectiveness|cost effectiveness
5072398|NCT01332032|screening mammography|screening mammography
5072399|NCT01332032|repeat mammography|repeat mammography
5072400|NCT01332032|telephone counseling|telephone counseling
5072401|NCT01332032|computerized reminders|computerized reminders
5072402|NCT01332032|compliance|compliance
5072403|NCT01332019|Subcutaneous|subcutaneous
5072404|NCT01332019|Extension|extension
5072405|NCT01332019|Interferon|interferon
5072406|NCT01332019|MS|ms
5072407|NCT01332019|PEGylated|pegylated
5072408|NCT01332019|Injectable|injectable
5072409|NCT01332019|SC|sc
5072410|NCT01332019|PEG|peg
5072411|NCT01332019|peginterferon beta-1a|peginterferon beta-1a
5072412|NCT01332019|Relapsing|relapsing
5072413|NCT01331993|Phase 1|phase 1
5072414|NCT01331993|crossover|crossover
5072415|NCT01331993|bioequivalence|bioequivalence
5072416|NCT01331993|naproxen|naproxen
5072417|NCT01331993|esomeprazole|esomeprazole
5072418|NCT01331993|vimovo|vimovo
5072419|NCT01331993|healthy volunteers|healthy volunteers
5072420|NCT01331980|cystic fibrosis|cystic fibrosis
5072421|NCT01331980|bone|bone
5072422|NCT01331967|pioglitazone|pioglitazone
5072423|NCT01331967|optical coherence tomography|optical coherence tomography
5072424|NCT01331967|microRNA|microrna
5072425|NCT01331967|neointima|neointima
5072426|NCT01331967|major adverse cardiovascular event|major adverse cardiovascular event
5072427|NCT01331941|AMG 386|amg 386
5072428|NCT01331941|Pharmacokinetic|pharmacokinetic
5072429|NCT01331941|Renal Impairment|renal impairment
5072430|NCT01331928|Sequential chemotherapy, gastric cancer|sequential chemotherapy, gastric cancer
5072431|NCT01331915|Metastatic Melanoma|metastatic melanoma
5072432|NCT01331915|Safety|safety
5072433|NCT01331915|Theravac vaccine|theravac vaccine
5072434|NCT01331915|HLA-A2 typing|hla-a2 typing
5072435|NCT01331915|Tyrosinase.A2 gene expression|tyrosinase.a2 gene expression
5072436|NCT01331902|Adenosine|adenosine
5072437|NCT01331902|Nicorandil|nicorandil
5072438|NCT01331902|Fractional Flow Reserve|fractional flow reserve
5072439|NCT01331902|Maximal Hyperemia|maximal hyperemia
5072440|NCT01331889|transfusion|transfusion
5072441|NCT01331889|liver transplantation|liver transplantation
5072442|NCT01331889|potassium|potassium
5072443|NCT01331876|Cognitive and Behavioral Therapy|cognitive and behavioral therapy
5072444|NCT01331863|Bronchial disease|bronchial disease
5072445|NCT01331863|Lung cancer surgery|lung cancer surgery
5072446|NCT01331863|Aorta/aortic Allograft|aorta/aortic allograft
5072447|NCT01331863|homograft|homograft
5072448|NCT01331863|Tracheal disease|tracheal disease
5072449|NCT01331863|Benign|benign
5072450|NCT01331863|Malignant|malignant
5072451|NCT01331824|Bladder Cancer|bladder cancer
5072452|NCT01331824|Urothelial Cancer|urothelial cancer
5072453|NCT01331824|Chemotherapy|chemotherapy
5072454|NCT01331824|Second-line|second-line
5072455|NCT01331824|Metastatic|metastatic
5072456|NCT01331811|HIV|hiv
5072457|NCT01331811|Tuberculosis|tuberculosis
5072458|NCT01331811|Diagnosis|diagnosis
5072459|NCT01331811|Pediatrics|pediatrics
5072460|NCT01331811|Asia|asia
5072461|NCT01331811|Africa|africa
5072462|NCT01331798|Abdominoplasty|abdominoplasty
5072463|NCT01331785|paracentesis|paracentesis
5072464|NCT01331785|ascites|ascites
5072465|NCT01331785|hypotension|hypotension
5072466|NCT01331772|Breast cancer|breast cancer
5072467|NCT01331772|Adapted Physical activity|adapted physical activity
5072468|NCT01331772|Nutrition|nutrition
5072469|NCT01331772|Assessment|assessment
5072470|NCT01331772|Patient education|patient education
5072471|NCT01331759|Burnout|burnout
5072472|NCT01331759|Subthreshold Disorder|subthreshold disorder
5072473|NCT01331707|drug-eluting stent|drug-eluting stent
5072474|NCT01331707|Zotarolimus|zotarolimus
5072475|NCT01331707|Everolimus|everolimus
5072476|NCT01331707|all comers population|all comers population
5072477|NCT01331707|target vessel failure|target vessel failure
5072478|NCT01331707|coronary artery disease|coronary artery disease
5072479|NCT01331681|Diabetic Macular Edema (DME)|diabetic macular edema (dme)
5072480|NCT01331681|VEGF Trap-Eye|vegf trap-eye
5072481|NCT01331681|Best-corrected visual acuity (BCVA)|best-corrected visual acuity (bcva)
5072482|NCT01331642|Lymphatic Diseases|lymphatic diseases
5072483|NCT01331642|Metabolism, Inborn Errors|metabolism, inborn errors
5072484|NCT01331642|Genetic Diseases, Inborn|genetic diseases, inborn
5072485|NCT01331642|Lipidoses|lipidoses
5072486|NCT01331642|Lipid Metabolism, Inborn Errors|lipid metabolism, inborn errors
5072487|NCT01331642|Metabolic Diseases|metabolic diseases
5072488|NCT01331642|Lipid Metabolism Disorders|lipid metabolism disorders
5072489|NCT01331629|breast cancer|breast cancer
5072490|NCT01331629|fatigue|fatigue
5072491|NCT01331629|quality of life|quality of life
5072492|NCT01331629|art-therapie|art-therapie
5072493|NCT01331629|adjuvant radiotherapy|adjuvant radiotherapy
5072494|NCT01331616|Prospective study|prospective study
5072495|NCT01331616|Glioblastoma|glioblastoma
5072496|NCT01331616|Avastin|avastin
5072497|NCT01331616|Visual Evoked Potential|visual evoked potential
5072498|NCT01331616|Optic neuropathy|optic neuropathy
5072499|NCT01331616|Chemo-radiotherapy|chemo-radiotherapy
5072500|NCT01331603|MDS|mds
5072501|NCT01331603|primary myelofibrosis|primary myelofibrosis
5072502|NCT01331603|low+high risk MDS patients|low+high risk mds patients
5072503|NCT01331603|patients|patients
5072504|NCT01331577|Healthy|healthy
5072505|NCT01331577|Primary Prevention|primary prevention
5072506|NCT01331577|Stress|stress
5072507|NCT01331577|Kinesiology|kinesiology
5072508|NCT01331577|cognitive behavioural therapy|cognitive behavioural therapy
5072509|NCT01331577|Prevention|prevention
5072510|NCT01331564|Pregnancy|pregnancy
5072511|NCT01331564|Postpartum|postpartum
5072512|NCT01331564|Weight gain|weight gain
5072513|NCT01331564|Weight retention|weight retention
5072514|NCT01331564|Behavior|behavior
5072515|NCT01331564|Electronic Media|electronic media
5072516|NCT01331564|Randomized Clinical Trial|randomized clinical trial
5072517|NCT01331551|Inflammatory Bowel disease|inflammatory bowel disease
5072518|NCT01331538|temporomandibular dysfunction|temporomandibular dysfunction
5072519|NCT01331538|posture|posture
5072520|NCT01331525|Small cell lung cancer|small cell lung cancer
5072521|NCT01331525|Chemotherapy|chemotherapy
5072522|NCT01331525|Immunotherapy|immunotherapy
5072523|NCT01331525|CTLA-4|ctla-4
5072524|NCT01331525|Ipilimumab|ipilimumab
5072525|NCT01331512|Clinical Geriatrics|clinical geriatrics
5072526|NCT01331512|Biomechanics|biomechanics
5072527|NCT01331512|Epidemiology|epidemiology
5072528|NCT01331512|Decline in Ambulation|decline in ambulation
5072529|NCT01331499|Blood loss|blood loss
5072530|NCT01331499|transfusions|transfusions
5072531|NCT01331499|instrumented spinal fusion|instrumented spinal fusion
5072532|NCT01331486|Prehypertension|prehypertension
5072533|NCT01331486|Mild hypertension|mild hypertension
5072534|NCT01331486|Flow mediated dilation|flow mediated dilation
5072535|NCT01331486|Hawthorn|hawthorn
5072536|NCT01331473|Carotid Artery|carotid artery
5072537|NCT01331473|Stenting|stenting
5072538|NCT01331473|CAS|cas
5072539|NCT01331473|proximal protection|proximal protection
5072540|NCT01331460|HIV|hiv
5072541|NCT01331460|HIV risk|hiv risk
5072542|NCT01331460|Sexually Transmitted Diseases|sexually transmitted diseases
5072543|NCT01331460|Drug Use|drug use
5072544|NCT01331460|Women|women
5072545|NCT01331460|Drug Treatment|drug treatment
5072546|NCT01331460|opioids|opioids
5072547|NCT01331460|injection drug use|injection drug use
5072548|NCT01331460|stimulants|stimulants
5072549|NCT01331460|gender-specific treatment|gender-specific treatment
5072550|NCT01331395|Infertility|infertility
5072551|NCT01331395|IVF|ivf
5072552|NCT01331395|Acupuncture|acupuncture
5072553|NCT01331382|Resveratrol|resveratrol
5072554|NCT01331382|Piperine|piperine
5072555|NCT01331382|Cerebral blood flow|cerebral blood flow
5072556|NCT01331382|Near- infrared spectroscopy|near- infrared spectroscopy
5072557|NCT01331382|Bioavailability|bioavailability
5072558|NCT01331369|adherence|adherence
5072559|NCT01331369|compliance|compliance
5072560|NCT01331369|persistence|persistence
5072561|NCT01331369|drop out|drop out
5072562|NCT01331369|abandon|abandon
5072563|NCT01331356|Chronic proctalgia|chronic proctalgia
5072564|NCT01331356|Botulinum toxin type A|botulinum toxin type a
5072565|NCT01331356|Ganglion Impar|ganglion impar
5072566|NCT01331356|Perineal pain|perineal pain
5072567|NCT01331356|Pudendal neuralgia|pudendal neuralgia
5072568|NCT01331356|Refractory chronic proctalgia|refractory chronic proctalgia
5072569|NCT01331343|Diabetes|diabetes
5072570|NCT01331343|Glycemic Control|glycemic control
5072571|NCT01331343|Continuous Glucose Monitoring|continuous glucose monitoring
5072572|NCT01331330|Depressive Disorder|depressive disorder
5072573|NCT01331330|Unipolar|unipolar
5072574|NCT01331330|Implantable Stimulation Electrodes|implantable stimulation electrodes
5072575|NCT01331317|Cardiovascular disease and mortality|cardiovascular disease and mortality
5072576|NCT01331317|Plasma NTproBNP|plasma ntprobnp
5072577|NCT01331317|UAER|uaer
5072578|NCT01331304|Bipolar disorder|bipolar disorder
5072579|NCT01331304|Comparative effectiveness trial|comparative effectiveness trial
5072580|NCT01331304|Lithium|lithium
5072581|NCT01331304|Quetiapine|quetiapine
5072582|NCT01331291|bosutinib|bosutinib
5072583|NCT01331291|SKI-606|ski-606
5072584|NCT01331278|total joint replacement|total joint replacement
5072585|NCT01331278|knee|knee
5072586|NCT01331265|perceived lactose intolerance|perceived lactose intolerance
5072587|NCT01331265|calcium/dairy consumption|calcium/dairy consumption
5072588|NCT01331265|specific health outcomes|specific health outcomes
5072589|NCT01331239|Cushing Disease|cushing disease
5072590|NCT01331239|LCI699|lci699
5072591|NCT01331239|Pituitary Gland|pituitary gland
5072592|NCT01331239|Adrenocorticotropic Hormone|adrenocorticotropic hormone
5072593|NCT01331213|Pregabalin|pregabalin
5072594|NCT01331213|Irritable Bowel Syndrome|irritable bowel syndrome
5072595|NCT01331213|motor|motor
5072596|NCT01331213|sensation|sensation
5072597|NCT01331213|colon|colon
5072598|NCT01331213|human|human
5072599|NCT01331200|ischemic stroke|ischemic stroke
5072600|NCT01331200|tissue plasminogen activator|tissue plasminogen activator
5072601|NCT01331200|early mobilization|early mobilization
5072602|NCT01331200|patient safety|patient safety
5072603|NCT01331200|length of stay|length of stay
5072604|NCT01331187|Echocardiography|echocardiography
5072605|NCT01331187|Heart failure|heart failure
5072606|NCT01331187|Ultrasonography|ultrasonography
5072607|NCT01331187|pocket-size device|pocket-size device
5072608|NCT01331187|Aorta|aorta
5072609|NCT01331187|Education|education
5072610|NCT01331174|knee|knee
5072611|NCT01331174|osteoarthritis|osteoarthritis
5072612|NCT01331174|physical therapy|physical therapy
5072613|NCT01331174|pulsed short wave|pulsed short wave
5072614|NCT01331161|shingles vaccine|shingles vaccine
5072615|NCT01331161|immune responses|immune responses
5072616|NCT01331148|sickle cell disease|sickle cell disease
5072617|NCT01331148|vitamin D|vitamin d
5072618|NCT01331148|pediatrics|pediatrics
5072619|NCT01331148|pain|pain
5072620|NCT01331135|pediatrics|pediatrics
5072621|NCT01331135|sirolimus|sirolimus
5072622|NCT01331135|relapse|relapse
5072623|NCT01331109|Fibromyalgia|fibromyalgia
5072624|NCT01331109|Pediatric Fibromyalgia|pediatric fibromyalgia
5072625|NCT01331109|Adolescent Fibromyalgia|adolescent fibromyalgia
5072626|NCT01331109|milnacipran|milnacipran
5072627|NCT01331109|Savella|savella
5072628|NCT01331109|loss of therapeutic response|loss of therapeutic response
5072629|NCT01331109|Forest Research Institute|forest research institute
5072630|NCT01331109|Pain|pain
5072631|NCT01331109|Fatigue|fatigue
5072632|NCT01331109|Serotonin Norepinephrine Reuptake Inhibitors|serotonin norepinephrine reuptake inhibitors
5072633|NCT01331096|thyroid gland resection surgery|thyroid gland resection surgery
5072634|NCT01331096|total intravenous anesthesia|total intravenous anesthesia
5072635|NCT01331070|Chronic obstructive pulmonary disease (COPD)|chronic obstructive pulmonary disease (copd)
5072636|NCT01331057|Bilingualism|bilingualism
5072637|NCT01331057|Language|language
5072638|NCT01331057|Evaluation transcultural|evaluation transcultural
5072639|NCT01331057|Intra Familial Relationship|intra familial relationship
5072640|NCT01331057|Transmissions mother|transmissions mother
5072641|NCT01331057|Tongue french|tongue french
5072642|NCT01331057|Language tamil|language tamil
5072643|NCT01331057|Language arabic|language arabic
5072644|NCT01331057|Language soninke|language soninke
5072645|NCT01331057|Language cultural|language cultural
5072646|NCT01331057|Affiliations crossbreeding|affiliations crossbreeding
5072647|NCT01331044|RUTF|rutf
5072648|NCT01331044|Severe Acute Malnutrition|severe acute malnutrition
5072649|NCT01331044|Children|children
5072650|NCT01331044|Body composition|body composition
5072651|NCT01331044|Microbiota|microbiota
5072652|NCT01331044|Short Chain Fatty Acid|short chain fatty acid
5072653|NCT01331044|Acceptability of RUTF|acceptability of rutf
5072654|NCT01331044|Edema free 15 percent weight gain|edema free 15 percent weight gain
5072655|NCT01331044|Changes in body composition|changes in body composition
5072656|NCT01331044|Gut microbiota|gut microbiota
5072657|NCT01331044|Genome wide association|genome wide association
5072658|NCT01331031|temporomandibular disorder|temporomandibular disorder
5072659|NCT01331031|adolescents|adolescents
5072660|NCT01331005|Macular Edema|macular edema
5072661|NCT01331005|Non steroidal anti-inflammatories|non steroidal anti-inflammatories
5072662|NCT01330992|Circadian rhythms|circadian rhythms
5072663|NCT01330992|Melatonin|melatonin
5072664|NCT01330992|Ocular light exposure|ocular light exposure
5072665|NCT01330992|Darkness Exposure|darkness exposure
5072666|NCT01330992|Performance|performance
5072667|NCT01330992|Alertness|alertness
5072668|NCT01330979|Intraocular pressure|intraocular pressure
5072669|NCT01330966|surgically unresectable chondrosarcoma|surgically unresectable chondrosarcoma
5072670|NCT01330953|Anemia|anemia
5072671|NCT01330940|Kidney stones|kidney stones
5072672|NCT01330940|Calcium|calcium
5072673|NCT01330940|citrate|citrate
5072674|NCT01330927|VA106483|va106483
5072675|NCT01330927|Nocturia|nocturia
5072676|NCT01330927|Benign Prostatic Hypertrophy|benign prostatic hypertrophy
5072677|NCT01330927|BPH|bph
5072678|NCT01330927|Elderly|elderly
5072679|NCT01330927|Males|males
5072680|NCT01330927|Nocturnal voids|nocturnal voids
5072681|NCT01330927|Anti-diuretic|anti-diuretic
5072682|NCT01330914|Obesity, Morbid|obesity, morbid
5072683|NCT01330914|Bariatric Surgery|bariatric surgery
5072684|NCT01330914|Gastric Bypass|gastric bypass
5072685|NCT01330914|Calcium Metabolism Disorders|calcium metabolism disorders
5072686|NCT01330914|Vitamin D|vitamin d
5072687|NCT01330914|Bone Density|bone density
5072688|NCT01330914|Body Composition|body composition
5072689|NCT01330914|Weight Loss|weight loss
5072690|NCT01330888|war|war
5072691|NCT01330888|religion|religion
5072692|NCT01330888|caregiver|caregiver
5072693|NCT01330888|combat stress disorder|combat stress disorder
5072694|NCT01330862|patient outcomes|patient outcomes
5072695|NCT01330849|Attention-deficit/hyperactivity disorder|attention-deficit/hyperactivity disorder
5072696|NCT01330849|School|school
5072697|NCT01330849|Behavioral Intervention|behavioral intervention
5072698|NCT01330849|RCT|rct
5072699|NCT01330823|pancreatic carcinoma|pancreatic carcinoma
5072700|NCT01330823|L-Carnitine|l-carnitine
5072701|NCT01330823|quality of life|quality of life
5072702|NCT01330823|survival|survival
5072703|NCT01330823|malnutrition|malnutrition
5072704|NCT01330823|cancer cachexia|cancer cachexia
5072705|NCT01330823|fatigue|fatigue
5072706|NCT01330810|Pharmacokinetics|pharmacokinetics
5072707|NCT01330810|Dietary Supplements|dietary supplements
5072708|NCT01330810|Curcumin|curcumin
5072709|NCT01330797|Cataract|cataract
5072710|NCT01330797|Intravitreal|intravitreal
5072711|NCT01330797|Ranibizumab|ranibizumab
5072712|NCT01330797|LOCS III|locs iii
5072714|NCT01330758|Healthy male and non-fertile female volunteers|healthy male and non-fertile female volunteers
5072715|NCT01330758|Bioavailability|bioavailability
5072716|NCT01330758|AZD8931|azd8931
5072717|NCT01330745|cardiopulmonary bypass|cardiopulmonary bypass
5072718|NCT01330745|mesenteric|mesenteric
5072719|NCT01330745|microcirculatory function|microcirculatory function
5072720|NCT01330732|SPINESCAN®|spinescan®
5072721|NCT01330732|kyphosis|kyphosis
5072722|NCT01330719|Periodontitis|periodontitis
5072723|NCT01330706|Skin Diseases [C17.800]|skin diseases [c17.800]
5072724|NCT01330706|Nail Diseases [C17.800.529]|nail diseases [c17.800.529]
5072725|NCT01330706|Nails, Ingrown [C17.800.529.406]|nails, ingrown [c17.800.529.406]
5072726|NCT01330693|ADHD|adhd
5072727|NCT01330693|Atomoxetine|atomoxetine
5072728|NCT01330693|Biomarker|biomarker
5072729|NCT01330680|coffee|coffee
5072730|NCT01330680|caffeine|caffeine
5072731|NCT01330680|blood pressure|blood pressure
5072732|NCT01330680|nutrigenetics|nutrigenetics
5072733|NCT01330680|gene polymorphisms|gene polymorphisms
5072734|NCT01330680|Acute Cardiovascular and Neuropsychologic Effects|acute cardiovascular and neuropsychologic effects
5072735|NCT01330667|Hyperbilirubinemia|hyperbilirubinemia
5072736|NCT01330667|Breastfeeding|breastfeeding
5072737|NCT01330667|Limited Formula|limited formula
5072738|NCT01330654|Intermediate risk of adverse cardiac event|intermediate risk of adverse cardiac event
5072739|NCT01330654|Undergoing laparoscopic surgical procedure|undergoing laparoscopic surgical procedure
5072740|NCT01330654|Age forty to seventy five|age forty to seventy five
5072741|NCT01330641|Tendonitis|tendonitis
5072742|NCT01330641|Rotator Cuff|rotator cuff
5072743|NCT01330641|Shoulder|shoulder
5072744|NCT01330641|Injection|injection
5072745|NCT01330628|peripheral arterial disease|peripheral arterial disease
5072746|NCT01330628|in stent restenosis|in stent restenosis
5072747|NCT01330628|peripheral vascular disease|peripheral vascular disease
5072748|NCT01330615|EMLA|emla
5072749|NCT01330615|plantar warts|plantar warts
5072750|NCT01330615|cryotherapy|cryotherapy
5072751|NCT01330589|Percutaneous coronary intervention|percutaneous coronary intervention
5072752|NCT01330589|Clopidogrel|clopidogrel
5072753|NCT01330589|St. John's Wort|st. john's wort
5072754|NCT01330589|CYP 2C19 loss-of-function allele|cyp 2c19 loss-of-function allele
5072755|NCT01330576|Hypothermia|hypothermia
5072756|NCT01330576|cooling|cooling
5072757|NCT01330576|necrotizing enterocolitis|necrotizing enterocolitis
5072758|NCT01330576|NEC|nec
5072759|NCT01330576|neonates|neonates
5072760|NCT01330576|preterm|preterm
5072761|NCT01330563|Drug-Drug interaction between the CKD-501 and ketoconazole|drug-drug interaction between the ckd-501 and ketoconazole
5072762|NCT01330550|High fiber sugar free biscuit|high fiber sugar free biscuit
5072763|NCT01330550|pre-diabetics|pre-diabetics
5072764|NCT01330537|perceptual development|perceptual development
5072765|NCT01330537|topological perception theory|topological perception theory
5072766|NCT01330537|familiarization/novelty preference method|familiarization/novelty preference method
5072767|NCT01330537|Discriminate a disk and a ring (topologically different),|discriminate a disk and a ring (topologically different),
5072768|NCT01330537|Discriminate a disk and a triangle (geometrically different)|discriminate a disk and a triangle (geometrically different)
5072769|NCT01330537|Detect a change in the number of holes|detect a change in the number of holes
5072770|NCT01330537|Detect the size of the hole|detect the size of the hole
5072771|NCT01330511|Newborn infant|newborn infant
5072772|NCT01330511|Congenital hydronephrosis|congenital hydronephrosis
5072773|NCT01330511|Postnatal imaging evaluation|postnatal imaging evaluation
5072774|NCT01330511|Diagnostic algorithm|diagnostic algorithm
5072775|NCT01330498|Longitudinal assessment of biomarkers|longitudinal assessment of biomarkers
5072776|NCT01330498|duration of natalizumab|duration of natalizumab
5072777|NCT01330498|stratification of risk for PML|stratification of risk for pml
5072778|NCT01330472|Alprazolam|alprazolam
5072779|NCT01330472|Xanax|xanax
5072780|NCT01330472|Bioequivalence|bioequivalence
5072781|NCT01330472|Panic disorder with or without agoraphobia.|panic disorder with or without agoraphobia.
5072782|NCT01330459|Pain during first trimester surgical abortion|pain during first trimester surgical abortion
5072783|NCT01330446|Head and Neck Cancer|head and neck cancer
5072784|NCT01330446|HNC|hnc
5072785|NCT01330446|Fatigue|fatigue
5072786|NCT01330446|Patient-Reported Fatigue|patient-reported fatigue
5072787|NCT01330446|Fatigue-Symptom Intervention|fatigue-symptom intervention
5072788|NCT01330446|Postoperative Radiation Therapy|postoperative radiation therapy
5072789|NCT01330446|Postoperative Chemoradiation Therapy|postoperative chemoradiation therapy
5072790|NCT01330446|Armodafinil|armodafinil
5072791|NCT01330446|Nuvigil|nuvigil
5072792|NCT01330446|Placebo|placebo
5072793|NCT01330446|Sugar Pill|sugar pill
5072794|NCT01330446|Questionnaires|questionnaires
5072795|NCT01330446|Surveys|surveys
5072796|NCT01330394|Alcoholism|alcoholism
5072797|NCT01330394|Lesch's typology|lesch's typology
5072798|NCT01330394|tDCS|tdcs
5072799|NCT01330394|ERP|erp
5072800|NCT01330394|P300|p300
5072801|NCT01330394|FAB|fab
5072802|NCT01330394|MMSE|mmse
5072803|NCT01330394|Cognitive tasks|cognitive tasks
5072804|NCT01330368|Systemic Lupus Erythematosus|systemic lupus erythematosus
5072805|NCT01330368|SLE|sle
5072806|NCT01330368|Lupus|lupus
5072807|NCT01330368|children with SLE|children with sle
5072808|NCT01330355|Ocular infections, bacterial|ocular infections, bacterial
5072809|NCT01330329|Obesity|obesity
5072810|NCT01330329|Weight loss|weight loss
5072811|NCT01330329|Exercise|exercise
5072812|NCT01330329|Intervention studies|intervention studies
5072813|NCT01330303|Bioequivalence|bioequivalence
5072814|NCT01330303|Healthy volunteers|healthy volunteers
5072815|NCT01330303|tamsulosin hydrochloride|tamsulosin hydrochloride
5072816|NCT01330303|Fed administration|fed administration
5072817|NCT01330290|Rotigotine|rotigotine
5072818|NCT01330290|Neupro®|neupro®
5072819|NCT01330290|Parkinson|parkinson
5072820|NCT01330290|Treatment preference|treatment preference
5072821|NCT01330290|Care-giving|care-giving
5072822|NCT01330277|Metabolic Diseases|metabolic diseases
5072823|NCT01330277|Biomarker|biomarker
5072824|NCT01330277|Mucopolysaccharidosis II|mucopolysaccharidosis ii
5072825|NCT01330277|Lysosomal Storage Diseases|lysosomal storage diseases
5072826|NCT01330277|Morbus Hunter|morbus hunter
5072827|NCT01330277|Mucopolysaccharidoses|mucopolysaccharidoses
5072828|NCT01330264|Intracranial Pressure (ICP) Monitoring|intracranial pressure (icp) monitoring
5072829|NCT01330264|Admission to Intensive Care Unit (ICU)|admission to intensive care unit (icu)
5072830|NCT01330238|Low back pain|low back pain
5072831|NCT01330238|Modic changes|modic changes
5072832|NCT01330238|Vertebral endplate signal changes|vertebral endplate signal changes
5072833|NCT01330238|Efficacy|efficacy
5072834|NCT01330238|Zoledronic acid|zoledronic acid
5072835|NCT01330238|Bisphosphonates|bisphosphonates
5072837|NCT01330199|Healthy|healthy
5072838|NCT01330199|Female|female
5072839|NCT01330199|Volunteer|volunteer
5072840|NCT01330160|stroke|stroke
5072841|NCT01330160|Brain ischemia|brain ischemia
5072842|NCT01330160|Intracranial hemorrhage|intracranial hemorrhage
5072843|NCT01330160|Dementia, Vascular|dementia, vascular
5072844|NCT01330160|Alzheimer's disease|alzheimer's disease
5072845|NCT01330147|HPV|hpv
5072846|NCT01330147|oral cancer|oral cancer
5072847|NCT01330147|oropharyngeal cancer|oropharyngeal cancer
5072848|NCT01330147|tonsillectomy|tonsillectomy
5072849|NCT01330134|procedural|procedural
5072850|NCT01330121|Adherence with discharge diabetes medications|adherence with discharge diabetes medications
5072851|NCT01330121|Diabeted mellitus type 2 greater than one year|diabeted mellitus type 2 greater than one year
5072852|NCT01330121|Patient with provider and prescriptions filled within CCHS|patient with provider and prescriptions filled within cchs
5072853|NCT01330108|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
5072854|NCT01330108|PAH|pah
5072855|NCT01330108|WHO Group 1|who group 1
5072856|NCT01330095|Bifidobacterium bifidum|bifidobacterium bifidum
5072857|NCT01330095|Very low birth weight infant|very low birth weight infant
5072858|NCT01330095|Enteral feeding|enteral feeding
5072859|NCT01330095|Growth|growth
5072860|NCT01330095|amount of enteral feeding|amount of enteral feeding
5072861|NCT01330082|Photodynamic therapy|photodynamic therapy
5072862|NCT01330082|Light-emitting diode|light-emitting diode
5072863|NCT01330082|toluidine blue|toluidine blue
5072864|NCT01330082|scaling and root planing|scaling and root planing
5072865|NCT01330056|Laryngeal and pharyngeal preservation, survivals|laryngeal and pharyngeal preservation, survivals
5072866|NCT01330043|smoking cessation intervention|smoking cessation intervention
5072867|NCT01330017|Seasonal allergies|seasonal allergies
5072868|NCT01329991|RA|ra
5072869|NCT01329991|Methotrexate|methotrexate
5072870|NCT01329978|Hepatitis C|hepatitis c
5072871|NCT01329978|HCV|hcv
5072872|NCT01329978|Chronic Hepatitis C|chronic hepatitis c
5072873|NCT01329965|Cardiovascular disease|cardiovascular disease
5072874|NCT01329965|Inflammation|inflammation
5072875|NCT01329965|LPS|lps
5072876|NCT01329965|Endotoxin|endotoxin
5072877|NCT01329939|Asthma|asthma
5072878|NCT01329939|Obesity|obesity
5072879|NCT01329939|Pediatric|pediatric
5072880|NCT01329939|Inflammation|inflammation
5072881|NCT01329939|Leukotriene|leukotriene
5072882|NCT01329939|Montelukast|montelukast
5072883|NCT01329926|Parkinson's disease|parkinson's disease
5072884|NCT01329926|Neural stem cells|neural stem cells
5072885|NCT01329900|Chemotherapy|chemotherapy
5072886|NCT01329900|Stem Cell Collection|stem cell collection
5072887|NCT01329900|Ofatumumab|ofatumumab
5072888|NCT01329900|Arzerra|arzerra
5072889|NCT01329900|Ifosfamide|ifosfamide
5072890|NCT01329900|Ifex|ifex
5072891|NCT01329900|Etoposide|etoposide
5072892|NCT01329900|VePesid|vepesid
5072893|NCT01329900|Mesna|mesna
5072894|NCT01329900|Mesnex|mesnex
5072895|NCT01329900|G-CSF|g-csf
5072896|NCT01329900|Filgrastim|filgrastim
5072897|NCT01329900|Neupogen|neupogen
5072898|NCT01329900|Apheresis|apheresis
5072899|NCT01329887|microcirculation|microcirculation
5072900|NCT01329887|SDF|sdf
5072901|NCT01329887|ketanserin|ketanserin
5072902|NCT01329887|severe sepsis|severe sepsis
5072903|NCT01329861|chronic back pain|chronic back pain
5072904|NCT01329861|internet based treatment|internet based treatment
5072905|NCT01329861|pain management programme|pain management programme
5072906|NCT01329861|cognitive behavioural therapy|cognitive behavioural therapy
5072907|NCT01329861|minimal therapist contact|minimal therapist contact
5072908|NCT01329848|Accommodation|accommodation
5072909|NCT01329848|Reading|reading
5072910|NCT01329848|Autorefraction|autorefraction
5072911|NCT01329822|type 2 diabetes|type 2 diabetes
5072912|NCT01329822|overweight|overweight
5072913|NCT01329809|metastatic colorectal cancer|metastatic colorectal cancer
5072914|NCT01329809|colon cancer|colon cancer
5072915|NCT01329809|liver metastasis|liver metastasis
5072916|NCT01329809|Pexa-vec|pexa-vec
5072917|NCT01329809|JX-594|jx-594
5072918|NCT01329796|dysmenorrhea,|dysmenorrhea,
5072919|NCT01329796|pelvic pain|pelvic pain
5072920|NCT01329796|dyspareunia|dyspareunia
5072921|NCT01329796|endometriosis|endometriosis
5072922|NCT01329770|Neurodevelopmental disability|neurodevelopmental disability
5072923|NCT01329770|Hyperactivity|hyperactivity
5072924|NCT01329770|Anxiety|anxiety
5072925|NCT01329770|Cognitive problems|cognitive problems
5072926|NCT01329770|Behavioural symptoms|behavioural symptoms
5072927|NCT01329770|Fragile X syndrome|fragile x syndrome
5072928|NCT01329770|Autism|autism
5072929|NCT01329770|inherited Genetic condition|inherited genetic condition
5072930|NCT01329757|Spinal Cord Injury|spinal cord injury
5072931|NCT01329757|Growth Hormone|growth hormone
5072932|NCT01329757|Trauma|trauma
5072933|NCT01329757|Incomplete|incomplete
5072934|NCT01329757|ASIA|asia
5072935|NCT01329744|HIV lipodystrophy|hiv lipodystrophy
5072936|NCT01329731|white spot lesion|white spot lesion
5072937|NCT01329731|initial caries|initial caries
5072938|NCT01329731|fluoride|fluoride
5072939|NCT01329731|amine fluoride|amine fluoride
5072940|NCT01329731|orthodontics|orthodontics
5072941|NCT01329731|remineralization|remineralization
5072942|NCT01329731|brackets|brackets
5072943|NCT01329718|Stability of the Septin 9 biomarker|stability of the septin 9 biomarker
5072944|NCT01329718|Epi Pro Colon Test|epi pro colon test
5072945|NCT01329718|CRC|crc
5072946|NCT01329692|RYGB|rygb
5072947|NCT01329692|Intervention|intervention
5072948|NCT01329692|follow-up|follow-up
5072949|NCT01329692|standard-of-care|standard-of-care
5072950|NCT01329692|Back on Track program|back on track program
5072951|NCT01329692|poor weight loss|poor weight loss
5072952|NCT01329692|morbidly obese|morbidly obese
5072953|NCT01329666|Primary Hyperparathyroidism|primary hyperparathyroidism
5072954|NCT01329666|Endocrinology|endocrinology
5072955|NCT01329666|Hypercalcemia|hypercalcemia
5072956|NCT01329666|Vitamin D deficiency|vitamin d deficiency
5072957|NCT01329666|Parathyroid Hormone|parathyroid hormone
5072958|NCT01329666|Osteoporosis|osteoporosis
5072959|NCT01329666|Bone Density|bone density
5072960|NCT01329666|Vitamin D repletion|vitamin d repletion
5072961|NCT01329666|Vitamin D Supplements|vitamin d supplements
5072962|NCT01329653|cerebral blood volume|cerebral blood volume
5072963|NCT01329653|aging|aging
5072964|NCT01329653|exercise|exercise
5072965|NCT01329640|Metronimic chemotherapy|metronimic chemotherapy
5072966|NCT01329640|Locally Advanced HER2-positive Breast Cancer|locally advanced her2-positive breast cancer
5072967|NCT01329601|cognitive training|cognitive training
5072968|NCT01329601|Alzheimer disease|alzheimer disease
5072969|NCT01329601|tertiary prevention|tertiary prevention
5072970|NCT01329588|Female sex workers|female sex workers
5072971|NCT01329588|West Africa|west africa
5072972|NCT01329588|Presumptive treatment|presumptive treatment
5072973|NCT01329588|Sexually transmitted infections|sexually transmitted infections
5072974|NCT01329575|endoluminal ultrasound|endoluminal ultrasound
5072975|NCT01329575|Mediastinal LN invasion|mediastinal ln invasion
5072976|NCT01329562|Menstrual migraine|menstrual migraine
5072977|NCT01329562|Menstrually-related migraine|menstrually-related migraine
5072978|NCT01329562|Treximet|treximet
5072979|NCT01329562|CGRP|cgrp
5072980|NCT01329562|calcitonin gene-related peptide|calcitonin gene-related peptide
5072981|NCT01329536|Alzheimer's Disease|alzheimer's disease
5072982|NCT01329536|Agitation|agitation
5072983|NCT01329536|Genetics|genetics
5072984|NCT01329536|Apolipoprotein|apolipoprotein
5072985|NCT01329536|ApoE4|apoe4
5072986|NCT01329523|Dementia|dementia
5072987|NCT01329523|Insulin-like growth factor|insulin-like growth factor
5072988|NCT01329523|IGF|igf
5072989|NCT01329523|APO E4|apo e4
5072990|NCT01329523|Genetics|genetics
5072991|NCT01329510|ADHD|adhd
5072992|NCT01329510|Adult|adult
5072993|NCT01329484|Alzheimer|alzheimer
5072994|NCT01329484|Dementia|dementia
5072995|NCT01329484|Computer|computer
5072996|NCT01329484|Cognitive training|cognitive training
5072997|NCT01329484|Reminiscence therapy|reminiscence therapy
5072998|NCT01329458|FLL|fll
5072999|NCT01329458|CEUS|ceus
5073000|NCT01329458|SonoVue|sonovue
5073001|NCT01329458|HCC|hcc
5073002|NCT01329458|Liver metastases|liver metastases
5073003|NCT01329458|Hemangiomas|hemangiomas
5073004|NCT01329458|FNH|fnh
5073005|NCT01329445|Cartilage repair|cartilage repair
5073006|NCT01329445|Articular cartilage defects|articular cartilage defects
5073007|NCT01329432|surfactant|surfactant
5073008|NCT01329432|intubation|intubation
5073009|NCT01329432|spontaneous breathing|spontaneous breathing
5073010|NCT01329432|bronchopulmonary dysplasia|bronchopulmonary dysplasia
5073011|NCT01329406|Osteoarthritis (OA)|osteoarthritis (oa)
5073012|NCT01329406|Milnacipran|milnacipran
5073013|NCT01329406|Serotonin-norepinephrine reuptake inhibitor (SNRI)|serotonin-norepinephrine reuptake inhibitor (snri)
5073014|NCT01329406|Knee pain|knee pain
5073015|NCT01329393|Disability|disability
5073016|NCT01329393|Social Security|social security
5073017|NCT01329393|Representative Payee|representative payee
5073018|NCT01329380|Ankylosing Spondylitis|ankylosing spondylitis
5073019|NCT01329367|EVASYON|evasyon
5073020|NCT01329367|GENOI|genoi
5073021|NCT01329367|antioxidants|antioxidants
5073022|NCT01329367|legume|legume
5073023|NCT01329367|fish|fish
5073024|NCT01329354|Follicular lymphoma|follicular lymphoma
5073025|NCT01329354|Follicular non-Hodgkin´s lymphoma|follicular non-hodgkin´s lymphoma
5073026|NCT01329354|Autologous effector lymphocytes|autologous effector lymphocytes
5073027|NCT01329354|Cell Therapy|cell therapy
5073028|NCT01329354|Maintenance therapy|maintenance therapy
5073029|NCT01329354|Rituximab|rituximab
5073030|NCT01329341|PTSD|ptsd
5073031|NCT01329341|Service Dogs|service dogs
5073032|NCT01329328|whole-body vibration|whole-body vibration
5073033|NCT01329328|radiofrequency|radiofrequency
5073034|NCT01329328|hormonal status|hormonal status
5073035|NCT01329328|muscular strength|muscular strength
5073036|NCT01329328|balance|balance
5073037|NCT01329276|COPD|copd
5073038|NCT01329276|Symbicort|symbicort
5073039|NCT01329276|Turbohaler|turbohaler
5073040|NCT01329276|Computational Fluid Dynamics|computational fluid dynamics
5073041|NCT01329276|Functional Imaging|functional imaging
5073042|NCT01329276|Budesonide|budesonide
5073043|NCT01329276|Formoterol|formoterol
5073044|NCT01329263|menthol cigarettes|menthol cigarettes
5073045|NCT01329250|Tuberculosis|tuberculosis
5073046|NCT01329250|Moxifloxacin|moxifloxacin
5073047|NCT01329250|Pharmacokinetics|pharmacokinetics
5073048|NCT01329250|Safety|safety
5073049|NCT01329237|drug-eluting stent|drug-eluting stent
5073050|NCT01329237|coronary endothelial function|coronary endothelial function
5073051|NCT01329237|coronary imaging|coronary imaging
5073052|NCT01329224|acetylsalicylic acid resistance|acetylsalicylic acid resistance
5073053|NCT01329211|Gastroparesis|gastroparesis
5073054|NCT01329211|Quality of Life|quality of life
5073055|NCT01329198|tourette|tourette
5073056|NCT01329198|tourette's|tourette's
5073057|NCT01329198|TS|ts
5073058|NCT01329198|tourette syndrome|tourette syndrome
5073059|NCT01329198|tourette's syndrome|tourette's syndrome
5073060|NCT01329185|EBV Viremia in posttransplant kidney recipients|ebv viremia in posttransplant kidney recipients
5073061|NCT01329185|CMV viremia in posttransplant kidney recipients|cmv viremia in posttransplant kidney recipients
5073062|NCT01329172|PUFA|pufa
5073063|NCT01329172|Cystic Fibrosis|cystic fibrosis
5073064|NCT01329172|Nasal brushing|nasal brushing
5073065|NCT01329172|Mucins|mucins
5073066|NCT01329172|Mucin production|mucin production
5073067|NCT01329159|High altitude|high altitude
5073068|NCT01329159|respiratory function|respiratory function
5073069|NCT01329159|cardiorespiratory health|cardiorespiratory health
5073070|NCT01329159|indoor pollution|indoor pollution
5073071|NCT01329146|pulse pressure variation|pulse pressure variation
5073072|NCT01329146|preload dependency|preload dependency
5073073|NCT01329146|one-lung ventilation|one-lung ventilation
5073074|NCT01329146|thoracic surgery|thoracic surgery
5073075|NCT01329133|Deep brain stimulation (DBS)|deep brain stimulation (dbs)
5073181|NCT01328652|LTH|lth
5073076|NCT01329133|Obsessive compulsive disorder|obsessive compulsive disorder
5073077|NCT01329133|ventral striatum|ventral striatum
5073078|NCT01329133|subthalamic nucleus|subthalamic nucleus
5073079|NCT01329107|Rehabilitation|rehabilitation
5073080|NCT01329107|Enhanced Recovery|enhanced recovery
5073081|NCT01329107|Health related Qouality of Life|health related qouality of life
5073082|NCT01329107|Patient outcomes|patient outcomes
5073083|NCT01329094|Severe mental illness|severe mental illness
5073084|NCT01329094|physical activity|physical activity
5073085|NCT01329094|evaluation|evaluation
5073086|NCT01329081|Rehabilitation|rehabilitation
5073087|NCT01329081|Strength training|strength training
5073088|NCT01329081|Long-term effect|long-term effect
5073089|NCT01329081|Activity and participation after fast-track knee arthroplasty|activity and participation after fast-track knee arthroplasty
5073090|NCT01329068|breast cancer|breast cancer
5073091|NCT01329042|Potassium sodium citrate|potassium sodium citrate
5073092|NCT01329042|stone recurrence|stone recurrence
5073093|NCT01329042|ESWL|eswl
5073094|NCT01329042|PCNL|pcnl
5073095|NCT01329042|Hypocitraturia|hypocitraturia
5073096|NCT01329042|intervention|intervention
5073097|NCT01329029|COPD|copd
5073098|NCT01329029|Roflumilast|roflumilast
5073099|NCT01329029|Daxas|daxas
5073100|NCT01329016|Pregnancy|pregnancy
5073101|NCT01329016|Glyburide|glyburide
5073102|NCT01329016|Metformin|metformin
5073103|NCT01329016|Pharmacokinetics|pharmacokinetics
5073104|NCT01329016|Pharmacodynamics|pharmacodynamics
5073105|NCT01329003|Silicosis|silicosis
5073106|NCT01328990|IPTc|iptc
5073107|NCT01328990|malaria|malaria
5073108|NCT01328990|children|children
5073109|NCT01328990|pharmacokinetics|pharmacokinetics
5073110|NCT01328990|amodiaquiane|amodiaquiane
5073111|NCT01328990|sulfadoxine-pyrimethamine|sulfadoxine-pyrimethamine
5073112|NCT01328964|pediatric|pediatric
5073113|NCT01328964|asthma|asthma
5073114|NCT01328964|outcomes|outcomes
5073115|NCT01328964|inhaled cortcosteroids|inhaled cortcosteroids
5073116|NCT01328938|Pegfilgrastim|pegfilgrastim
5073117|NCT01328938|neutropenia|neutropenia
5073118|NCT01328925|Rotavirus|rotavirus
5073119|NCT01328925|Viral gastroenteritis|viral gastroenteritis
5073120|NCT01328925|Gastroenteritis|gastroenteritis
5073121|NCT01328912|ischemic preconditioning|ischemic preconditioning
5073122|NCT01328912|cardiac surgery|cardiac surgery
5073123|NCT01328912|vascular surgery|vascular surgery
5073124|NCT01328899|Emphysema|emphysema
5073125|NCT01328899|COPD|copd
5073126|NCT01328899|RePneu|repneu
5073127|NCT01328886|omalizumab|omalizumab
5073128|NCT01328886|allergic asthma|allergic asthma
5073129|NCT01328886|pediatric patients|pediatric patients
5073130|NCT01328873|Pulmonary infiltrates|pulmonary infiltrates
5073131|NCT01328873|stem cell transplant|stem cell transplant
5073132|NCT01328873|leukemia|leukemia
5073133|NCT01328860|Autologous|autologous
5073134|NCT01328860|Stem Cells|stem cells
5073135|NCT01328860|Spinal Cord Injury|spinal cord injury
5073136|NCT01328860|Children|children
5073137|NCT01328834|Nephritis, Lupus|nephritis, lupus
5073138|NCT01328834|Tacrolimus|tacrolimus
5073139|NCT01328821|Safety|safety
5073140|NCT01328821|Tolerability|tolerability
5073141|NCT01328821|Pharmacokinetics|pharmacokinetics
5073142|NCT01328821|Healthy volunteers|healthy volunteers
5073143|NCT01328808|Acetaminophen|acetaminophen
5073144|NCT01328808|Preterm Infants|preterm infants
5073145|NCT01328795|Cardiogoniometry|cardiogoniometry
5073146|NCT01328795|Chest Pain Unit|chest pain unit
5073147|NCT01328795|ST-elevation|st-elevation
5073148|NCT01328795|Troponin|troponin
5073149|NCT01328795|Catheter intervention|catheter intervention
5073150|NCT01328795|Fast Track|fast track
5073151|NCT01328782|elbow fracture|elbow fracture
5073152|NCT01328782|supracondylar elbow fracture|supracondylar elbow fracture
5073153|NCT01328782|elbow|elbow
5073154|NCT01328782|fracture|fracture
5073155|NCT01328782|pain management|pain management
5073156|NCT01328782|pediatric|pediatric
5073157|NCT01328769|uric acid|uric acid
5073158|NCT01328769|febuxostat|febuxostat
5073159|NCT01328769|hypertension|hypertension
5073160|NCT01328769|intra-renal renin-angiotensin system|intra-renal renin-angiotensin system
5073161|NCT01328769|renal plasma flow|renal plasma flow
5073162|NCT01328769|angiotensin II|angiotensin ii
5073163|NCT01328756|ADHD|adhd
5073164|NCT01328730|significant stenosis (>70% of lumen stenosis)|significant stenosis (>70% of lumen stenosis)
5073165|NCT01328730|epicardial coronary arteries.|epicardial coronary arteries.
5073166|NCT01328704|Iron deficiency|iron deficiency
5073167|NCT01328704|Vitamin D deficiency|vitamin d deficiency
5073168|NCT01328704|Anemia|anemia
5073169|NCT01328704|Athletes|athletes
5073170|NCT01328704|Triathletes|triathletes
5073171|NCT01328704|Triathlon|triathlon
5073172|NCT01328691|Carcinoma, Renal Cell|carcinoma, renal cell
5073173|NCT01328691|thrombus|thrombus
5073174|NCT01328691|body mass index|body mass index
5073175|NCT01328691|grade|grade
5073176|NCT01328678|Alopecia Areata|alopecia areata
5073177|NCT01328678|Vitamin D|vitamin d
5073178|NCT01328678|Parathyroid|parathyroid
5073179|NCT01328678|Calcium|calcium
5073180|NCT01328652|LPR|lpr
5073182|NCT01328639|Collaborative care|collaborative care
5073183|NCT01328639|Diabetes management|diabetes management
5073184|NCT01328639|Depression management|depression management
5073185|NCT01328639|Primary care|primary care
5073186|NCT01328626|Safety|safety
5073187|NCT01328626|Maximum Tolerated Dose|maximum tolerated dose
5073188|NCT01328626|Pharmacokinetics|pharmacokinetics
5073189|NCT01328626|ABT-199|abt-199
5073190|NCT01328626|Preliminary Efficacy|preliminary efficacy
5073191|NCT01328626|Cancer|cancer
5073192|NCT01328626|Non-Hodgkin Lymphoma|non-hodgkin lymphoma
5073193|NCT01328626|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
5073194|NCT01328613|BDNF|bdnf
5073195|NCT01328613|Homeosis|homeosis
5073196|NCT01328613|Women|women
5073197|NCT01328613|Childbirth|childbirth
5073198|NCT01328613|Major Depressive Disorder|major depressive disorder
5073199|NCT01328600|Placenta|placenta
5073200|NCT01328600|Pregnancy|pregnancy
5073201|NCT01328600|Hypertension|hypertension
5073202|NCT01328600|Supplementation|supplementation
5073203|NCT01328600|Antibody|antibody
5073204|NCT01328587|Autoimmunity|autoimmunity
5073205|NCT01328587|Neutropenia|neutropenia
5073206|NCT01328587|Cytokine|cytokine
5073207|NCT01328587|Hematopoiesis|hematopoiesis
5073208|NCT01328587|Thrombocytopenia|thrombocytopenia
5073209|NCT01328587|Aplastic Anemia|aplastic anemia
5073210|NCT01328574|Progression-Free Survival|progression-free survival
5073211|NCT01328574|Carcinoma of the Bladder|carcinoma of the bladder
5073212|NCT01328574|Cancer of the Renal Pelvis|cancer of the renal pelvis
5073213|NCT01328574|Ureter Cancer|ureter cancer
5073214|NCT01328574|Survival|survival
5073215|NCT01328574|Bladder Cancer|bladder cancer
5073216|NCT01328574|Renal Pelvis Cancer|renal pelvis cancer
5073217|NCT01328574|Urothelial Cancer|urothelial cancer
5073218|NCT01328561|Arginine|arginine
5073219|NCT01328561|Oxytocin|oxytocin
5073220|NCT01328561|Vasopressin|vasopressin
5073222|NCT01328561|Analgesia|analgesia
5073223|NCT01328561|Healthy Volunteer|healthy volunteer
5073224|NCT01328561|HV|hv
5073225|NCT01328548|varicella-zoster virus|varicella-zoster virus
5073226|NCT01328548|vaccine|vaccine
5073227|NCT01328548|T-cell|t-cell
5073228|NCT01328548|genes|genes
5073229|NCT01328548|frail elderly|frail elderly
5073230|NCT01328548|immunosenescence|immunosenescence
5073231|NCT01328548|immune and genetic correlates of response to zoster vaccine in the elderly|immune and genetic correlates of response to zoster vaccine in the elderly
5073232|NCT01328509|Zinc|zinc
5073233|NCT01328496|Hematologic Malignancies|hematologic malignancies
5073234|NCT01328496|Umbilical Cord Blood transplantation|umbilical cord blood transplantation
5073235|NCT01328496|Hematopoietic Cell Transplantation|hematopoietic cell transplantation
5073236|NCT01328483|Neonates|neonates
5073237|NCT01328483|Intrapartum Oropharyngeal Suctioning|intrapartum oropharyngeal suctioning
5073238|NCT01328483|Meconium Aspiration Syndrome|meconium aspiration syndrome
5073239|NCT01328470|platelet|platelet
5073240|NCT01328470|cilostazol|cilostazol
5073241|NCT01328470|clopidogrel|clopidogrel
5073242|NCT01328470|chronic kidney disease|chronic kidney disease
5073243|NCT01328457|Leishmaniasis, Visceral|leishmaniasis, visceral
5073244|NCT01328457|kala-azar|kala-azar
5073245|NCT01328457|Paromomycin|paromomycin
5073246|NCT01328457|Bangladesh|bangladesh
5073247|NCT01328457|Injections, Intramuscular|injections, intramuscular
5073248|NCT01328457|Treatment Outcome|treatment outcome
5073249|NCT01328457|Patient compliance|patient compliance
5073250|NCT01328457|Medication adherence|medication adherence
5073251|NCT01328457|Drug toxicity|drug toxicity
5073252|NCT01328431|Tobacco Use Cessation|tobacco use cessation
5073253|NCT01328431|Smoking Cessation|smoking cessation
5073254|NCT01328431|Nicotine Replacement Therapy|nicotine replacement therapy
5073255|NCT01328431|Brief Intervention|brief intervention
5073256|NCT01328418|Lengthening|lengthening
5073257|NCT01328392|LPR|lpr
5073258|NCT01328392|GERD|gerd
5073259|NCT01328366|Quality of Life|quality of life
5073260|NCT01328366|Psychosocial factors|psychosocial factors
5073261|NCT01328353|triage|triage
5073262|NCT01328353|aprn|aprn
5073263|NCT01328353|telehealth|telehealth
5073264|NCT01328353|CCHCN|cchcn
5073265|NCT01328353|advanced practice nurse|advanced practice nurse
5073266|NCT01328353|improve family quality of life|improve family quality of life
5073267|NCT01328353|reduce unplanned use of health care services|reduce unplanned use of health care services
5073268|NCT01328353|telehealth triage intervention|telehealth triage intervention
5073269|NCT01328340|muscle power, exercise, aging|muscle power, exercise, aging
5073270|NCT01328301|gait|gait
5073271|NCT01328301|hemiplegia|hemiplegia
5073272|NCT01328301|treadmill|treadmill
5073273|NCT01328301|physiotherapy|physiotherapy
5073274|NCT01328301|rehabilitation|rehabilitation
5073275|NCT01328288|HIV related adverse events|hiv related adverse events
5073276|NCT01328288|Immunological failure|immunological failure
5073277|NCT01328288|virological failure|virological failure
5073278|NCT01328288|quality of life|quality of life
5073279|NCT01328288|depression|depression
5073280|NCT01328288|genotypic resistance|genotypic resistance
5073281|NCT01328275|HIV related adverse events|hiv related adverse events
5073282|NCT01328275|immunological failure|immunological failure
5073283|NCT01328275|virological failure|virological failure
5073284|NCT01328275|quality of life|quality of life
5073285|NCT01328275|depression|depression
5073286|NCT01328275|genotypic resistance|genotypic resistance
5073287|NCT01328262|Hemoglobins|hemoglobins
5073288|NCT01328249|Breast Cancer|breast cancer
5073289|NCT01328249|HER2-normal Stage I to III invasive breast cancer|her2-normal stage i to iii invasive breast cancer
5073290|NCT01328236|Bortezomib|bortezomib
5073291|NCT01328236|PCL|pcl
5073292|NCT01328223|Hepatocellular carcinoma|hepatocellular carcinoma
5073293|NCT01328223|radiotherapy|radiotherapy
5073294|NCT01328223|sorafenib|sorafenib
5073295|NCT01328210|metabolic syndrome|metabolic syndrome
5073296|NCT01328210|Phlebotomy|phlebotomy
5073297|NCT01328210|blood letting|blood letting
5073298|NCT01328210|hypertension|hypertension
5073299|NCT01328210|insulin sensitivity|insulin sensitivity
5073300|NCT01328197|Treovance|treovance
5073301|NCT01328197|aneurysm|aneurysm
5073302|NCT01328197|AAA|aaa
5073303|NCT01328158|Kaletra, Lopinavir (LPV)/Ritonavir (RTV), Human Immunodeficiency Virus (HIV) infection|kaletra, lopinavir (lpv)/ritonavir (rtv), human immunodeficiency virus (hiv) infection
5073304|NCT01328132|Liver|liver
5073305|NCT01328132|transplant|transplant
5073306|NCT01328132|albumin|albumin
5073307|NCT01328067|MRgFus|mrgfus
5073308|NCT01328067|Uterine Fibroids|uterine fibroids
5073309|NCT01328067|Pelvic Pain|pelvic pain
5073310|NCT01328067|Quality of Life|quality of life
5073311|NCT01328067|Symptomatic Uterine Fibroids|symptomatic uterine fibroids
5073312|NCT01328054|cancer|cancer
5073313|NCT01328054|cardiac repolarization|cardiac repolarization
5073314|NCT01328054|Holter monitor|holter monitor
5073315|NCT01328054|pharmacokinetics|pharmacokinetics
5073316|NCT01328054|GW572016|gw572016
5073317|NCT01328054|lapatinib|lapatinib
5073318|NCT01328054|QTc interval|qtc interval
5073319|NCT01328054|safety|safety
5073320|NCT01328054|ECG|ecg
5073321|NCT01328041|GSK1349572|gsk1349572
5073322|NCT01328041|resistance to raltegravir or elvitegravir|resistance to raltegravir or elvitegravir
5073323|NCT01328041|Integrase inhibitor|integrase inhibitor
5073324|NCT01328041|ART-experienced|art-experienced
5073325|NCT01328041|dolutegravir|dolutegravir
5073326|NCT01328028|Invasive cervical cancer|invasive cervical cancer
5073327|NCT01328028|Human papillomavirus|human papillomavirus
5073328|NCT01328015|hyperhidrosis|hyperhidrosis
5073329|NCT01328015|oxybutynin|oxybutynin
5073330|NCT01328015|plantar sweating|plantar sweating
5073331|NCT01328015|compensatory sweating|compensatory sweating
5073332|NCT01328002|Fibromyalgia|fibromyalgia
5073333|NCT01328002|Pediatric Fibromyalgia|pediatric fibromyalgia
5073334|NCT01328002|Adolescent Fibromyalgia|adolescent fibromyalgia
5073335|NCT01328002|milnacipran|milnacipran
5073336|NCT01328002|Savella|savella
5073337|NCT01328002|loss of therapeutic response|loss of therapeutic response
5073338|NCT01328002|Forest Research Institute|forest research institute
5073339|NCT01328002|Pain|pain
5073340|NCT01328002|Fatigue|fatigue
5073341|NCT01328002|Serotonin Norepinephrine Reuptake Inhibitors|serotonin norepinephrine reuptake inhibitors
5073342|NCT01328002|Randomized Withdrawal|randomized withdrawal
5073343|NCT01327989|Solitaire FR Device|solitaire fr device
5073344|NCT01327989|Mechanical Thrombectomy|mechanical thrombectomy
5073345|NCT01327989|Recanalization|recanalization
5073346|NCT01327989|Brain artery recanalization|brain artery recanalization
5073347|NCT01327989|Neurovascular intervention|neurovascular intervention
5073348|NCT01327989|Interventional Neuroradiology|interventional neuroradiology
5073349|NCT01327989|STAR|star
5073350|NCT01327989|Acute Ischemic Stroke|acute ischemic stroke
5073351|NCT01327976|Obesity|obesity
5073352|NCT01327976|Bariatric surgery|bariatric surgery
5073353|NCT01327976|Excess weight loss|excess weight loss
5073354|NCT01327976|Vagus nerve|vagus nerve
5073355|NCT01327976|Vagal blocking|vagal blocking
5073356|NCT01327976|vBloc Therapy|vbloc therapy
5073357|NCT01327963|Gastroesophageal reflux disease|gastroesophageal reflux disease
5073358|NCT01327963|GERD|gerd
5073359|NCT01327963|Heartburn|heartburn
5073360|NCT01327963|Reflux|reflux
5073361|NCT01327963|Regurgitation|regurgitation
5073362|NCT01327963|Hoarseness|hoarseness
5073363|NCT01327963|Cough|cough
5073364|NCT01327950|Percutaneous treatment|percutaneous treatment
5073365|NCT01327950|Superficial Femoral Artery lesions|superficial femoral artery lesions
5073366|NCT01327950|EPIC Nitinol Vascular Stent System|epic nitinol vascular stent system
5073367|NCT01327911|Mactel|mactel
5073368|NCT01327911|Macular Telangiectasia Type 2|macular telangiectasia type 2
5073369|NCT01327898|MSM|msm
5073370|NCT01327898|HIV/AIDS|hiv/aids
5073371|NCT01327898|sexual risk|sexual risk
5073372|NCT01327898|substance use|substance use
5073373|NCT01327872|Idiopathic Thrombocytopenia Purpura(ITP)|idiopathic thrombocytopenia purpura(itp)
5073374|NCT01327872|Acute and Chronic Thrombocytopenia Associated with Chronic Liver Disease|acute and chronic thrombocytopenia associated with chronic liver disease
5073375|NCT01327872|TLD|tld
5073376|NCT01327846|Cardiovascular Death|cardiovascular death
5073377|NCT01327846|Myocardial Infarction|myocardial infarction
5073378|NCT01327846|Stroke|stroke
5073379|NCT01327846|Canakinumab|canakinumab
5073380|NCT01327846|IL-1B|il-1b
5073381|NCT01327846|hsCRP|hscrp
5073382|NCT01327820|Oxygen consumption|oxygen consumption
5073383|NCT01327820|Aortic Aneurysm|aortic aneurysm
5073384|NCT01327820|Peripheral Arterial Disease|peripheral arterial disease
5073385|NCT01327807|Registries|registries
5073386|NCT01327807|Cystinosis|cystinosis
5073387|NCT01327807|Nephropathic Cystinosis|nephropathic cystinosis
5073388|NCT01327807|Renal Fanconi Syndrome|renal fanconi syndrome
5073389|NCT01327807|Cystine|cystine
5073390|NCT01327807|Kidney|kidney
5073391|NCT01327807|Rare Diseases|rare diseases
5073392|NCT01327794|recurrent pancreatic cancer|recurrent pancreatic cancer
5073393|NCT01327794|stage III pancreatic cancer|stage iii pancreatic cancer
5073394|NCT01327794|stage IV pancreatic cancer|stage iv pancreatic cancer
5073395|NCT01327768|Stroke,|stroke,
5073396|NCT01327768|Stem Cell,|stem cell,
5073397|NCT01327768|Olfactory Ensheathing Cells,|olfactory ensheathing cells,
5073398|NCT01327768|Intracerebral Implantation of Olfactory Ensheathing Cells.|intracerebral implantation of olfactory ensheathing cells.
5073399|NCT01327755|Selenium|selenium
5073400|NCT01327755|HIV/ AIDS|hiv/ aids
5073401|NCT01327755|CD4 counts|cd4 counts
5073402|NCT01327755|Antiretroviral therapy|antiretroviral therapy
5073403|NCT01327742|Relay|relay
5073404|NCT01327742|Thoracic|thoracic
5073405|NCT01327742|Aneurysm|aneurysm
5073406|NCT01327729|pegylated interferon|pegylated interferon
5073407|NCT01327729|interferon|interferon
5073408|NCT01327729|HCV|hcv
5073409|NCT01327729|genotype 4|genotype 4
5073410|NCT01327703|Exocrine Pancreatic Insufficiency|exocrine pancreatic insufficiency
5073411|NCT01327703|Cystic Fibrosis|cystic fibrosis
5073412|NCT01327703|Steatorrhea|steatorrhea
5073413|NCT01327703|Malabsorption|malabsorption
5073414|NCT01327703|Malnutrition|malnutrition
5073415|NCT01327677|pain management|pain management
5073416|NCT01327677|opioid analgesic therapy|opioid analgesic therapy
5073417|NCT01327677|safety|safety
5073418|NCT01327677|craniotomy|craniotomy
5073419|NCT01327664|Quiescent uveitis|quiescent uveitis
5073420|NCT01327664|intermediate uveitis|intermediate uveitis
5073421|NCT01327664|panuveitis|panuveitis
5073422|NCT01327664|posterior uveitis|posterior uveitis
5073423|NCT01327664|uveitis|uveitis
5073424|NCT01327651|Drug Administration Schedule|drug administration schedule
5073425|NCT01327651|Nucleoside Reverse Transcriptase Inhibitors|nucleoside reverse transcriptase inhibitors
5073426|NCT01327651|Pharmacokinetics|pharmacokinetics
5073427|NCT01327625|Allogeneic hematopoietic cell transplantation|allogeneic hematopoietic cell transplantation
5073428|NCT01327625|Graft versus host disease|graft versus host disease
5073429|NCT01327625|Bronchiolitis obliterans|bronchiolitis obliterans
5073430|NCT01327625|Azithromycin|azithromycin
5073431|NCT01327625|N-acetylcystein|n-acetylcystein
5073432|NCT01327625|Fluticasone|fluticasone
5073433|NCT01327625|Inhaled steroid|inhaled steroid
5073434|NCT01327612|AMG 655|amg 655
5073435|NCT01327612|AMG 479|amg 479
5073436|NCT01327612|Apoptosis|apoptosis
5073437|NCT01327612|Monoclonal Antibody|monoclonal antibody
5073438|NCT01327612|Tumor Necrosis Factor|tumor necrosis factor
5073439|NCT01327612|Insulin-like Growth Factor|insulin-like growth factor
5073440|NCT01327612|Bevacizumab|bevacizumab
5073441|NCT01327612|Modified FOLFOX6|modified folfox6
5073442|NCT01327612|mFOLFOX6|mfolfox6
5073443|NCT01327612|FOLFOX|folfox
5073444|NCT01327612|Lymphoma|lymphoma
5073445|NCT01327612|Trail Receptor|trail receptor
5073446|NCT01327612|ganitumab|ganitumab
5073447|NCT01327612|conatumumab|conatumumab
5073448|NCT01327599|Open-angle glaucoma|open-angle glaucoma
5073449|NCT01327599|Ocular hypertension|ocular hypertension
5073450|NCT01327599|Pigment dispersion glaucoma|pigment dispersion glaucoma
5073451|NCT01327599|Intraocular pressure|intraocular pressure
5073452|NCT01327586|disability|disability
5073453|NCT01327586|substance abuse|substance abuse
5073454|NCT01327586|cocaine abuse|cocaine abuse
5073455|NCT01327586|dual diagnosis|dual diagnosis
5073456|NCT01327586|representative payee|representative payee
5073457|NCT01327586|HIV risk reduction|hiv risk reduction
5073458|NCT01327573|chronic kidney allograft injury|chronic kidney allograft injury
5073459|NCT01327573|complement protein|complement protein
5073460|NCT01327573|eculizumab|eculizumab
5073461|NCT01327573|Kidney transplantation|kidney transplantation
5073462|NCT01327560|hemodialysis patients|hemodialysis patients
5073463|NCT01327560|sleep quality|sleep quality
5073464|NCT01327560|restless legs syndrome|restless legs syndrome
5073591|NCT01326988|ultrasound|ultrasound
5073465|NCT01327560|excessive daytime sleepiness|excessive daytime sleepiness
5073466|NCT01327560|sleep apnea syndrome|sleep apnea syndrome
5073467|NCT01327547|HIV coinfection|hiv coinfection
5073468|NCT01327547|maraviroc|maraviroc
5073469|NCT01327547|CCR5 blocker|ccr5 blocker
5073470|NCT01327547|entry inhibitor|entry inhibitor
5073471|NCT01327547|liver disease|liver disease
5073472|NCT01327547|viral hepatitis|viral hepatitis
5073473|NCT01327534|STEMI|stemi
5073474|NCT01327534|clopidogrel|clopidogrel
5073475|NCT01327534|prasugrel|prasugrel
5073476|NCT01327534|platelet reactivity index|platelet reactivity index
5073477|NCT01327534|ST resolution|st resolution
5073478|NCT01327495|Androgen replacement in men|androgen replacement in men
5073479|NCT01327482|Raltegravir|raltegravir
5073480|NCT01327482|Pharmacokinetics|pharmacokinetics
5073481|NCT01327456|health literacy|health literacy
5073482|NCT01327456|self-management|self-management
5073483|NCT01327456|inhaler technique|inhaler technique
5073484|NCT01327443|NAFLD|nafld
5073485|NCT01327443|NASH|nash
5073486|NCT01327443|Weight loss|weight loss
5073487|NCT01327443|Exercise|exercise
5073488|NCT01327443|NAS scores|nas scores
5073489|NCT01327443|Mitochondrial dysfunction|mitochondrial dysfunction
5073490|NCT01327430|glycerophosphates|glycerophosphates
5073491|NCT01327430|sphingomyelins|sphingomyelins
5073492|NCT01327417|Depression|depression
5073493|NCT01327404|Depression|depression
5073494|NCT01327404|Diabetes Mellitus|diabetes mellitus
5073495|NCT01327391|on line hemodiafiltration|on line hemodiafiltration
5073496|NCT01327391|tolerance|tolerance
5073497|NCT01327391|quality of life|quality of life
5073498|NCT01327391|cardiovascular risk|cardiovascular risk
5073499|NCT01327391|Hemodialysis patients|hemodialysis patients
5073500|NCT01327365|significant coronary artery disease|significant coronary artery disease
5073501|NCT01327365|PCI|pci
5073502|NCT01327365|radial approach|radial approach
5073503|NCT01327365|women|women
5073504|NCT01327365|bifurcation lesion|bifurcation lesion
5073505|NCT01327365|ostial lesion|ostial lesion
5073506|NCT01327365|7 Fr guiding catheter|7 fr guiding catheter
5073507|NCT01327365|percutaneous coronary intervention|percutaneous coronary intervention
5073508|NCT01327352|lupus|lupus
5073509|NCT01327326|Pain modulation|pain modulation
5073510|NCT01327326|Experimental pain|experimental pain
5073511|NCT01327313|alpha v integrin|alpha v integrin
5073512|NCT01327313|antibody|antibody
5073513|NCT01327313|solid tumor|solid tumor
5073514|NCT01327313|Japanese|japanese
5073515|NCT01327313|EMD525797|emd525797
5073516|NCT01327300|Irritable Bowel Syndrome|irritable bowel syndrome
5073517|NCT01327300|Irritable Bowel Syndrome Treatment|irritable bowel syndrome treatment
5073518|NCT01327300|Mesalamine|mesalamine
5073519|NCT01327300|Anti-inflammatory drugs|anti-inflammatory drugs
5073520|NCT01327300|5-ASA drugs|5-asa drugs
5073521|NCT01327300|Apriso ™|apriso ™
5073522|NCT01327287|thoracic epidural|thoracic epidural
5073523|NCT01327287|blunt|blunt
5073524|NCT01327287|blunt thoracic injury|blunt thoracic injury
5073525|NCT01327274|Pectus excavatum|pectus excavatum
5073526|NCT01327274|Chest wall deformity|chest wall deformity
5073527|NCT01327274|Magnetic Mini-Mover Procedure|magnetic mini-mover procedure
5073528|NCT01327274|Pectus Severity Index|pectus severity index
5073529|NCT01327274|pediatric medical device|pediatric medical device
5073530|NCT01327274|magnetic alteration|magnetic alteration
5073531|NCT01327274|sunken chest|sunken chest
5073532|NCT01327261|levodopa|levodopa
5073533|NCT01327261|benserazide|benserazide
5073534|NCT01327261|bioequivalence|bioequivalence
5073535|NCT01327261|pharmacokinetics|pharmacokinetics
5073536|NCT01327261|A Single - Dose|a single - dose
5073537|NCT01327261|Randomized- Sequence|randomized- sequence
5073538|NCT01327261|Open -Label Crossover Study|open -label crossover study
5073539|NCT01327248|Bronchiolitis obliterans|bronchiolitis obliterans
5073540|NCT01327248|HRCT|hrct
5073541|NCT01327248|Sputum|sputum
5073542|NCT01327248|Blood|blood
5073543|NCT01327248|Inflammation|inflammation
5073544|NCT01327248|adaptive immune system|adaptive immune system
5073545|NCT01327248|innate immune system|innate immune system
5073546|NCT01327222|age-related macular degeneration|age-related macular degeneration
5073547|NCT01327222|bevacizumab|bevacizumab
5073548|NCT01327196|dementia|dementia
5073549|NCT01327196|cardiovascular risk|cardiovascular risk
5073550|NCT01327196|elderly|elderly
5073551|NCT01327196|aging|aging
5073552|NCT01327196|older 65-100 years|older 65-100 years
5073553|NCT01327157|Facial Paralysis / rehabilitation.|facial paralysis / rehabilitation.
5073554|NCT01327157|Dental Occlusion.|dental occlusion.
5073555|NCT01327157|Occlusal Adjustment.|occlusal adjustment.
5073556|NCT01327157|Malocclusion / therapy.|malocclusion / therapy.
5073557|NCT01327092|Injury|injury
5073558|NCT01327092|Injury Prevention|injury prevention
5073559|NCT01327092|Cincinnati Home Injury Prevention|cincinnati home injury prevention
5073560|NCT01327092|Injury Hazards|injury hazards
5073561|NCT01327092|Modifiable Injury Hazards|modifiable injury hazards
5073562|NCT01327092|CHIP|chip
5073563|NCT01327092|Literacy Promotion|literacy promotion
5073564|NCT01327092|Reduce exposure to injury hazards|reduce exposure to injury hazards
5073565|NCT01327092|preventable and medically attended injury|preventable and medically attended injury
5073566|NCT01327092|young children|young children
5073567|NCT01327079|NICU|nicu
5073568|NCT01327079|Methadone|methadone
5073569|NCT01327079|neonates|neonates
5073570|NCT01327066|QTc|qtc
5073571|NCT01327066|ECG Effects|ecg effects
5073572|NCT01327053|locally advanced basal cell carcinoma,|locally advanced basal cell carcinoma,
5073573|NCT01327053|metastatic basal cell carcinoma|metastatic basal cell carcinoma
5073574|NCT01327040|light|light
5073575|NCT01327040|melatonin|melatonin
5073576|NCT01327040|circadian|circadian
5073577|NCT01327040|delayed sleep phase disorder|delayed sleep phase disorder
5073578|NCT01327040|circadian light sensitivity|circadian light sensitivity
5073579|NCT01327040|circadian timing system|circadian timing system
5073580|NCT01327027|vasopressin|vasopressin
5073581|NCT01327027|antisocial|antisocial
5073582|NCT01327027|affiliation|affiliation
5073583|NCT01327014|Hyperlipidemia|hyperlipidemia
5073584|NCT01327014|Cholesterol|cholesterol
5073585|NCT01327014|Lipids|lipids
5073586|NCT01327014|Lipoproteins|lipoproteins
5073587|NCT01327014|XueZhiKang|xuezhikang
5073588|NCT01327014|Botanical|botanical
5073589|NCT01327001|Asthma bronchiale, fixed combination|asthma bronchiale, fixed combination
5073590|NCT01326988|Spinal anesthesia|spinal anesthesia
5073592|NCT01326988|real-time|real-time
5073593|NCT01326975|infant, premature|infant, premature
5073594|NCT01326975|infant, very low birth weight|infant, very low birth weight
5073595|NCT01326975|diaphragm|diaphragm
5073596|NCT01326975|apnea|apnea
5073597|NCT01326975|continuous positive airway pressure|continuous positive airway pressure
5073598|NCT01326936|Online education|online education
5073599|NCT01326936|Medical education|medical education
5073600|NCT01326936|Substance abuse training|substance abuse training
5073601|NCT01326936|Drug abuse training|drug abuse training
5073602|NCT01326923|Head|head
5073603|NCT01326923|Neck|neck
5073604|NCT01326923|Locally advanced|locally advanced
5073605|NCT01326923|Squamous Cell|squamous cell
5073606|NCT01326923|Hypopharynx|hypopharynx
5073607|NCT01326923|Larynx|larynx
5073608|NCT01326923|Oral Cavity|oral cavity
5073609|NCT01326923|Base of Tongue|base of tongue
5073610|NCT01326923|Tonsil|tonsil
5073611|NCT01326923|Neck lymph node|neck lymph node
5073612|NCT01326923|Resection|resection
5073613|NCT01326910|Eczema|eczema
5073614|NCT01326884|aortic aneurysm|aortic aneurysm
5073615|NCT01326884|iliac aneurysm|iliac aneurysm
5073616|NCT01326884|endovascular procedures|endovascular procedures
5073617|NCT01326871|cancer|cancer
5073618|NCT01326871|immunotherapy|immunotherapy
5073619|NCT01326871|immunochemotherapy|immunochemotherapy
5073620|NCT01326871|combinational therapy|combinational therapy
5073621|NCT01326871|targeted|targeted
5073622|NCT01326871|metastatic|metastatic
5073623|NCT01326871|muscle invasive|muscle invasive
5073624|NCT01326871|interleukin-2|interleukin-2
5073625|NCT01326871|cisplatin|cisplatin
5073626|NCT01326871|gemcitabine|gemcitabine
5073627|NCT01326871|antitumor|antitumor
5073628|NCT01326871|TCR|tcr
5073629|NCT01326871|T-cell receptor|t-cell receptor
5073630|NCT01326871|p53|p53
5073631|NCT01326871|p53 gene|p53 gene
5073632|NCT01326871|p53 tumor supressor protein|p53 tumor supressor protein
5073633|NCT01326871|urothelial cancer|urothelial cancer
5073634|NCT01326871|bladder cancer|bladder cancer
5073635|NCT01326871|renal pelvis cancer|renal pelvis cancer
5073636|NCT01326871|ureters cancer|ureters cancer
5073637|NCT01326871|urethra cancer|urethra cancer
5073638|NCT01326871|HLA-A2 positive|hla-a2 positive
5073639|NCT01326871|HLA-A*0201/p53 aa264-272|hla-a*0201/p53 aa264-272
5073640|NCT01326871|HLA complex|hla complex
5073641|NCT01326871|Muscle Invasive or Metastatic|muscle invasive or metastatic
5073642|NCT01326858|Ocular discomfort|ocular discomfort
5073643|NCT01326858|AL-4943A Ophthalmic Solution|al-4943a ophthalmic solution
5073644|NCT01326845|Gastrointestinal adverse events,|gastrointestinal adverse events,
5073645|NCT01326845|myelodysplastic syndrome,|myelodysplastic syndrome,
5073646|NCT01326845|transfusional iron overload diarrhea,|transfusional iron overload diarrhea,
5073647|NCT01326845|constipation abdominal pain,|constipation abdominal pain,
5073648|NCT01326845|vomiting|vomiting
5073649|NCT01326832|THA|tha
5073650|NCT01326819|Near infrared spectroscopy|near infrared spectroscopy
5073651|NCT01326819|Skin pigmentation|skin pigmentation
5073652|NCT01326819|Regional oxygen saturation|regional oxygen saturation
5073653|NCT01326806|Parent-based intervention|parent-based intervention
5073654|NCT01326806|Sexual risk behavior|sexual risk behavior
5073655|NCT01326806|Adolescents|adolescents
5073656|NCT01326793|telepsychiatry|telepsychiatry
5073657|NCT01326793|MDD|mdd
5073658|NCT01326793|Depression|depression
5073659|NCT01326793|Major Depressive Disorder|major depressive disorder
5073660|NCT01326793|Skype|skype
5073661|NCT01326793|college|college
5073662|NCT01326793|university|university
5073663|NCT01326780|Acne|acne
5073664|NCT01326780|Irritation|irritation
5073665|NCT01326780|Safety|safety
5073666|NCT01326780|Sebum|sebum
5073667|NCT01326741|clonal mast cell disorder|clonal mast cell disorder
5073668|NCT01326741|exercise-induced anaphylaxis|exercise-induced anaphylaxis
5073669|NCT01326741|hypotension|hypotension
5073670|NCT01326728|Relapse|relapse
5073671|NCT01326728|Hematologic Malignancy|hematologic malignancy
5073672|NCT01326728|Allogeneic|allogeneic
5073673|NCT01326728|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
5073674|NCT01326728|Leukemia|leukemia
5073675|NCT01326728|Lymphoma|lymphoma
5073676|NCT01326728|Hodgkin Lymphoma|hodgkin lymphoma
5073677|NCT01326715|Multiple Sclerosis|multiple sclerosis
5073678|NCT01326715|MRI|mri
5073679|NCT01326715|Manganese Enhanced MRI|manganese enhanced mri
5073680|NCT01326715|Optic Neuritis|optic neuritis
5073681|NCT01326715|Healthy Volunteer|healthy volunteer
5073682|NCT01326676|Polypill|polypill
5073683|NCT01326676|Red Heart Pill|red heart pill
5073684|NCT01326676|Cardiovascular disease|cardiovascular disease
5073685|NCT01326676|Secondary prevention|secondary prevention
5073686|NCT01326676|carotid intima media thickness|carotid intima media thickness
5073687|NCT01326663|Veterans|veterans
5073688|NCT01326663|TBI|tbi
5073689|NCT01326663|Alcoholism|alcoholism
5073690|NCT01326663|Mood|mood
5073691|NCT01326650|vitamin D, mortality, event-free survival, heart failure|vitamin d, mortality, event-free survival, heart failure
5073692|NCT01326637|primary health care|primary health care
5073693|NCT01326637|aged|aged
5073694|NCT01326624|heart failure|heart failure
5073695|NCT01326624|ventricular dysfunction|ventricular dysfunction
5073696|NCT01326624|sudden death|sudden death
5073697|NCT01326624|sudden cardiac arrest|sudden cardiac arrest
5073698|NCT01326624|ventricular tachycardia|ventricular tachycardia
5073699|NCT01326624|ventricular fibrillation|ventricular fibrillation
5073700|NCT01326624|wearable defibrillator|wearable defibrillator
5073701|NCT01326611|Chronic lung disease|chronic lung disease
5073702|NCT01326611|Clarithromycin|clarithromycin
5073703|NCT01326611|Ureaplasma urealyticum|ureaplasma urealyticum
5073704|NCT01326598|V Go™|v go™
5073705|NCT01326598|Type 2 Diabetes|type 2 diabetes
5073706|NCT01326598|Insulin|insulin
5073707|NCT01326598|Oral Anti Hypoglycemic Drugs|oral anti hypoglycemic drugs
5073708|NCT01326585|Scleral Buckling|scleral buckling
5073709|NCT01326585|Dexamethasone|dexamethasone
5073710|NCT01326585|Post-operative Nausea and Vomiting|post-operative nausea and vomiting
5073711|NCT01326572|HIV|hiv
5073712|NCT01326572|Pulmonary disease|pulmonary disease
5073713|NCT01326572|emphysema|emphysema
5073714|NCT01326572|COPD|copd
5073715|NCT01326559|induction chemotherapy|induction chemotherapy
5073716|NCT01326559|docetaxel|docetaxel
5073717|NCT01326559|cisplatin|cisplatin
5073718|NCT01326559|fluorouracil|fluorouracil
5073719|NCT01326559|cetuximab|cetuximab
5073720|NCT01326559|intensity-modulated radiotherapy|intensity-modulated radiotherapy
5073721|NCT01326546|Therapeutic HBV Vaccine|therapeutic hbv vaccine
5073722|NCT01326546|Chronic Hepatitis B|chronic hepatitis b
5073723|NCT01326546|HBeAg positive|hbeag positive
5073724|NCT01326533|pre-diabetes|pre-diabetes
5073725|NCT01326533|hydroxychloroquine|hydroxychloroquine
5073726|NCT01326533|frequently sampled intravenous glucose tolerance testing|frequently sampled intravenous glucose tolerance testing
5073727|NCT01326533|insulin resistance|insulin resistance
5073728|NCT01326533|insulin secretion|insulin secretion
5073729|NCT01326533|glucose tolerance|glucose tolerance
5073730|NCT01326507|pulmonary embolism|pulmonary embolism
5073731|NCT01326507|Heart-type fatty acid-binding protein|heart-type fatty acid-binding protein
5073732|NCT01326507|cardiac biomarkers|cardiac biomarkers
5073733|NCT01326507|risk stratification|risk stratification
5073734|NCT01326494|Upper Respiratory Tract Infection|upper respiratory tract infection
5073735|NCT01326494|Asthma|asthma
5073736|NCT01326494|URTI induced exacerbation of Asthma|urti induced exacerbation of asthma
5073737|NCT01326481|TRC105|trc105
5073738|NCT01326481|Breast Cancer|breast cancer
5073739|NCT01326481|CD105|cd105
5073740|NCT01326481|Endoglin|endoglin
5073741|NCT01326481|TRACON Pharma|tracon pharma
5073742|NCT01326481|Roswell Park Cancer Institute|roswell park cancer institute
5073743|NCT01326481|Department of Defense|department of defense
5073744|NCT01326468|head and neck cancer|head and neck cancer
5073745|NCT01326468|temsirolimus|temsirolimus
5073746|NCT01326468|cetuximab|cetuximab
5073747|NCT01326468|cisplatin|cisplatin
5073748|NCT01326468|radiation therapy|radiation therapy
5073749|NCT01326455|transradial|transradial
5073750|NCT01326455|angiogram|angiogram
5073751|NCT01326455|device|device
5073752|NCT01326455|Care of the radial artery post transradial angiogram|care of the radial artery post transradial angiogram
5073753|NCT01326442|weight loss|weight loss
5073754|NCT01326442|overweight|overweight
5073755|NCT01326442|body composition|body composition
5073756|NCT01326442|visceral obesity|visceral obesity
5073757|NCT01326442|insulin|insulin
5073758|NCT01326442|glucose tolerance|glucose tolerance
5073759|NCT01326442|cholesterol|cholesterol
5073760|NCT01326442|hypertriglyceridemia|hypertriglyceridemia
5073761|NCT01326429|Sodium|sodium
5073762|NCT01326429|Hyponatremia|hyponatremia
5073763|NCT01326429|Hypernatremia|hypernatremia
5073764|NCT01326429|Emergency department|emergency department
5073765|NCT01326416|obesity|obesity
5073766|NCT01326416|metabolic syndrome|metabolic syndrome
5073767|NCT01326416|leucine|leucine
5073768|NCT01326416|arginine|arginine
5073769|NCT01326416|physical activity|physical activity
5073770|NCT01326403|proximal|proximal
5073771|NCT01326403|hip|hip
5073772|NCT01326403|fractures|fractures
5073773|NCT01326338|Diarrhea|diarrhea
5073774|NCT01326325|Cancer|cancer
5073775|NCT01326325|Refractory pain|refractory pain
5073776|NCT01326325|Uncontrolled pain|uncontrolled pain
5073777|NCT01326325|Ketamine|ketamine
5073778|NCT01326286|Comparative Effectiveness Research|comparative effectiveness research
5073779|NCT01326286|Prostatectomy|prostatectomy
5073780|NCT01326286|radiotherapy|radiotherapy
5073781|NCT01326286|quality of life|quality of life
5073782|NCT01326273|CMV|cmv
5073783|NCT01326273|cytomegalovirus|cytomegalovirus
5073784|NCT01326273|autologous|autologous
5073785|NCT01326273|leukemia|leukemia
5073983|NCT01325415|Phase 1|phase 1
5073786|NCT01326273|hematological malignancies|hematological malignancies
5073787|NCT01326273|stem cell transplantation|stem cell transplantation
5073788|NCT01326273|CMV reactivation|cmv reactivation
5073789|NCT01326273|adoptive therapy|adoptive therapy
5073790|NCT01326260|resuscitation|resuscitation
5073791|NCT01326260|trauma|trauma
5073792|NCT01326260|THAM|tham
5073793|NCT01326260|colloids|colloids
5073794|NCT01326260|crystalloids|crystalloids
5073795|NCT01326234|Smoking|smoking
5073796|NCT01326234|Motivation|motivation
5073797|NCT01326234|Cessation|cessation
5073798|NCT01326221|Truvada|truvada
5073799|NCT01326221|tenofovir|tenofovir
5073800|NCT01326221|emtricitabine|emtricitabine
5073801|NCT01326221|Pharmacokinetics|pharmacokinetics
5073802|NCT01326221|Healthy Volunteers|healthy volunteers
5073803|NCT01326208|electrical impedance tomography|electrical impedance tomography
5073804|NCT01326208|positive end-expiratory pressure|positive end-expiratory pressure
5073805|NCT01326208|regional ventilation delay index|regional ventilation delay index
5073806|NCT01326195|HIV Prevention|hiv prevention
5073807|NCT01326195|Dating Violence|dating violence
5073808|NCT01326195|Females|females
5073809|NCT01326195|Romantic relationships|romantic relationships
5073810|NCT01326195|Adolescents|adolescents
5073811|NCT01326195|Sexuality|sexuality
5073812|NCT01326195|Underserved youth|underserved youth
5073813|NCT01326182|asthma|asthma
5073814|NCT01326182|depression|depression
5073815|NCT01326182|Latino|latino
5073816|NCT01326169|Alcohol|alcohol
5073817|NCT01326169|brief intervention|brief intervention
5073818|NCT01326169|injuries|injuries
5073819|NCT01326156|Osteoarthritis|osteoarthritis
5073820|NCT01326156|Knee|knee
5073821|NCT01326156|Knee cap|knee cap
5073822|NCT01326156|Patella|patella
5073823|NCT01326156|Patellofemoral|patellofemoral
5073824|NCT01326143|MRD|mrd
5073825|NCT01326143|Narval|narval
5073826|NCT01326143|Oral appliance|oral appliance
5073827|NCT01326143|Obstructive Sleep apnea|obstructive sleep apnea
5073828|NCT01326143|OSAH|osah
5073829|NCT01326143|OSA treatment|osa treatment
5073830|NCT01326130|Integrated care network|integrated care network
5073831|NCT01326130|Chronic care model|chronic care model
5073832|NCT01326130|Health services research|health services research
5073833|NCT01326117|gastroparesis|gastroparesis
5073834|NCT01326117|gastric emptying|gastric emptying
5073835|NCT01326117|diabetes|diabetes
5073836|NCT01326117|Stomach Diseases|stomach diseases
5073837|NCT01326117|Gastrointestinal Diseases|gastrointestinal diseases
5073838|NCT01326117|Digestive System Diseases|digestive system diseases
5073839|NCT01326117|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors
5073840|NCT01326117|Neurologic Manifestations|neurologic manifestations
5073841|NCT01326117|Paralysis|paralysis
5073842|NCT01326117|Signs and Symptoms|signs and symptoms
5073843|NCT01326117|Pharmacologic Actions|pharmacologic actions
5073844|NCT01326104|Medulloblastoma|medulloblastoma
5073845|NCT01326104|Primitive Neuroectodermal Tumor|primitive neuroectodermal tumor
5073846|NCT01326091|Lumbar fusion surgery|lumbar fusion surgery
5073847|NCT01326078|sedation|sedation
5073848|NCT01326078|children|children
5073849|NCT01326078|leukemia|leukemia
5073850|NCT01326078|bone marrow biopsy|bone marrow biopsy
5073851|NCT01326013|Stool|stool
5073852|NCT01326013|Feces|feces
5073853|NCT01326013|Gastrointestinal|gastrointestinal
5073854|NCT01326013|Pathogen|pathogen
5073855|NCT01326013|Panel|panel
5073856|NCT01326013|xTAG GPP|xtag gpp
5073857|NCT01326013|Infectious colitis|infectious colitis
5073858|NCT01326013|Gastroenteritis|gastroenteritis
5073859|NCT01326013|Detection|detection
5073860|NCT01325987|Type 2 diabetes|type 2 diabetes
5073861|NCT01325987|Vitamin D deficiency|vitamin d deficiency
5073862|NCT01325987|Glycemic control|glycemic control
5073863|NCT01325974|Malaria|malaria
5073864|NCT01325974|Plasmodium falciparum|plasmodium falciparum
5073865|NCT01325974|Diagnosis|diagnosis
5073866|NCT01325974|Rapid diagnostic test|rapid diagnostic test
5073867|NCT01325974|malaria transmission|malaria transmission
5073868|NCT01325961|prostate, cervical and anal canal cancers with pelvic lymph node irradiation|prostate, cervical and anal canal cancers with pelvic lymph node irradiation
5073869|NCT01325948|COPD|copd
5073870|NCT01325935|Coronary Artery Disease|coronary artery disease
5073871|NCT01325935|Coronary Disease|coronary disease
5073872|NCT01325935|Myocardial Ischemia|myocardial ischemia
5073873|NCT01325935|Heart Disease|heart disease
5073874|NCT01325935|Cardiovascular Disease|cardiovascular disease
5073875|NCT01325935|Arteriosclerosis|arteriosclerosis
5073876|NCT01325935|Arterial Occlusive Disease|arterial occlusive disease
5073877|NCT01325935|Vascular Disease|vascular disease
5073878|NCT01325935|Clopidogrel|clopidogrel
5073879|NCT01325935|Platelet Aggregation Inhibitors|platelet aggregation inhibitors
5073880|NCT01325896|Multiple Mieloma, PEG-Intron|multiple mieloma, peg-intron
5073881|NCT01325870|cardiopulmonary resuscitation|cardiopulmonary resuscitation
5073882|NCT01325818|Coronary Artery Disease|coronary artery disease
5073883|NCT01325818|Coronary Disease|coronary disease
5073884|NCT01325818|Dyslipidemia|dyslipidemia
5073885|NCT01325818|Stable Angina Pectoris|stable angina pectoris
5073886|NCT01325818|Heart Diseases|heart diseases
5073887|NCT01325818|Cardiovascular Diseases|cardiovascular diseases
5073888|NCT01325818|Arteriosclerosis|arteriosclerosis
5073889|NCT01325818|Arterial Occlusive Diseases|arterial occlusive diseases
5073890|NCT01325818|Vascular Diseases Pravastatin|vascular diseases pravastatin
5073891|NCT01325818|Rosuvastatin|rosuvastatin
5073892|NCT01325818|Anticholesteremic Agents|anticholesteremic agents
5073893|NCT01325818|Antilipemic Agents|antilipemic agents
5073894|NCT01325818|Antimetabolites|antimetabolites
5073895|NCT01325818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
5073896|NCT01325818|Pharmacologic Actions|pharmacologic actions
5073897|NCT01325818|Therapeutic Uses|therapeutic uses
5073898|NCT01325818|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors
5073899|NCT01325805|Miscarriage|miscarriage
5073900|NCT01325805|Recurrent Pregnancy Loss|recurrent pregnancy loss
5073901|NCT01325805|Obesity|obesity
5073902|NCT01325805|Overweight|overweight
5073903|NCT01325805|Diet|diet
5073904|NCT01325792|Complex ventral incisional hernia repair|complex ventral incisional hernia repair
5073905|NCT01325792|reapproximation of the rectus abdominis muscle|reapproximation of the rectus abdominis muscle
5073906|NCT01325792|retrorectus or intraperitoneal placement technique|retrorectus or intraperitoneal placement technique
5073907|NCT01325792|mobility for midline fascial closure|mobility for midline fascial closure
5073908|NCT01325779|deep venous thrombosis|deep venous thrombosis
5073909|NCT01325779|DVT|dvt
5073910|NCT01325779|enoxaparin|enoxaparin
5073911|NCT01325779|heparin|heparin
5073912|NCT01325779|surgical intensive care|surgical intensive care
5073913|NCT01325766|Cystic Fibrosis|cystic fibrosis
5073914|NCT01325766|Yoga|yoga
5073915|NCT01325701|PCI-32765|pci-32765
5073916|NCT01325701|Lymphoma, B-Cell|lymphoma, b-cell
5073917|NCT01325701|Bruton's Tyrosine Kinase|bruton's tyrosine kinase
5073918|NCT01325701|Non Hodgkin's Lymphoma|non hodgkin's lymphoma
5073919|NCT01325701|Germinal Center B-Cell|germinal center b-cell
5073920|NCT01325701|Activated B-Cell|activated b-cell
5073921|NCT01325688|PEP005|pep005
5073922|NCT01325688|Peplin|peplin
5073923|NCT01325688|sBCC|sbcc
5073924|NCT01325675|Atrial fibrillation|atrial fibrillation
5073925|NCT01325675|Motor activity|motor activity
5073926|NCT01325649|rectal cancer|rectal cancer
5073927|NCT01325649|MRI|mri
5073928|NCT01325649|selective preoperative radiochemotherapy|selective preoperative radiochemotherapy
5073929|NCT01325649|involvement of circumferential resection margin|involvement of circumferential resection margin
5073930|NCT01325649|locoregional recurrence rate|locoregional recurrence rate
5073931|NCT01325636|Allogenic haematopoietic stem cell transplant|allogenic haematopoietic stem cell transplant
5073932|NCT01325636|Cytomegalovirus or Adenovirus infection|cytomegalovirus or adenovirus infection
5073933|NCT01325636|Graft versus Host|graft versus host
5073934|NCT01325623|Automatic Magnet Mode (AMM)|automatic magnet mode (amm)
5073935|NCT01325623|Vagal Nerve Stimulation|vagal nerve stimulation
5073936|NCT01325610|vitamin D|vitamin d
5073937|NCT01325610|kidney|kidney
5073938|NCT01325610|renal|renal
5073939|NCT01325597|Heart failure|heart failure
5073940|NCT01325597|Electric stimulation|electric stimulation
5073941|NCT01325597|Breathing exercises|breathing exercises
5073942|NCT01325571|prograf|prograf
5073943|NCT01325571|immunosuppressant|immunosuppressant
5073944|NCT01325558|cancer|cancer
5073945|NCT01325558|tissue factor|tissue factor
5073946|NCT01325558|solid tumor|solid tumor
5073947|NCT01325558|ovarian cancer|ovarian cancer
5073948|NCT01325558|breast cancer|breast cancer
5073949|NCT01325558|non-small cell lung cancer|non-small cell lung cancer
5073950|NCT01325558|colon cancer|colon cancer
5073951|NCT01325558|pancreatic cancer|pancreatic cancer
5073952|NCT01325558|head and neck cancer|head and neck cancer
5073953|NCT01325558|prostate cancer|prostate cancer
5073954|NCT01325558|soft-tissue sarcoma|soft-tissue sarcoma
5073955|NCT01325558|metastatic|metastatic
5073956|NCT01325558|gemcitabine|gemcitabine
5073957|NCT01325558|anti-tumor|anti-tumor
5073958|NCT01325558|venous thromboembolism|venous thromboembolism
5073959|NCT01325545|Stroke|stroke
5073960|NCT01325545|Atrial Fibrillation|atrial fibrillation
5073961|NCT01325532|depression|depression
5073962|NCT01325532|Major Depressive Disorder|major depressive disorder
5073963|NCT01325532|MDD|mdd
5073964|NCT01325532|Cranial Electrical Stimulation|cranial electrical stimulation
5073965|NCT01325532|CES|ces
5073966|NCT01325506|Prostatectomy|prostatectomy
5073967|NCT01325493|opioid tolerance|opioid tolerance
5073968|NCT01325493|hyperalgesia|hyperalgesia
5073969|NCT01325493|scoliosis|scoliosis
5073970|NCT01325493|pupillometry|pupillometry
5073971|NCT01325480|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
5073972|NCT01325480|Pacing|pacing
5073973|NCT01325480|His Bundle|his bundle
5073974|NCT01325467|coronary artery disease|coronary artery disease
5073975|NCT01325467|high frequency QRS analysis|high frequency qrs analysis
5073976|NCT01325467|ischemia|ischemia
5073977|NCT01325467|exercise testing|exercise testing
5073978|NCT01325467|diagnosis of coronary artery disease|diagnosis of coronary artery disease
5073979|NCT01325454|Pleural effusion|pleural effusion
5073980|NCT01325454|angiogenic cytokine|angiogenic cytokine
5073981|NCT01325454|fibrinolytic activity|fibrinolytic activity
5073982|NCT01325441|BBI608|bbi608
5073984|NCT01325415|healthy male volunteers|healthy male volunteers
5073985|NCT01325415|cross-over study|cross-over study
5073986|NCT01325415|NKTR-118|nktr-118
5073987|NCT01325402|Radioligand|radioligand
5073988|NCT01325402|Alzheimers disease|alzheimers disease
5073989|NCT01325402|Maximum Diagnostic Mass|maximum diagnostic mass
5073990|NCT01325402|Beta amyloid|beta amyloid
5073991|NCT01325376|overweight|overweight
5073992|NCT01325376|obesity|obesity
5073993|NCT01325363|Schizophrenia|schizophrenia
5073994|NCT01325363|Novel metaphor|novel metaphor
5073995|NCT01325298|Keratoconus|keratoconus
5073996|NCT01325298|Ectasia|ectasia
5073997|NCT01325298|cross linking|cross linking
5073998|NCT01325298|collagen cross linking|collagen cross linking
5073999|NCT01325298|corneal crosslinking|corneal crosslinking
5074000|NCT01325298|corneal diseases|corneal diseases
5074001|NCT01325298|eye diseases|eye diseases
5074002|NCT01325285|Intraocular pressure|intraocular pressure
5074003|NCT01325285|Hypercapnia|hypercapnia
5074004|NCT01325285|Hyperoxia|hyperoxia
5074005|NCT01325285|Rebreathing circuit|rebreathing circuit
5074006|NCT01325272|otoacoustic emissions in newborns|otoacoustic emissions in newborns
5074007|NCT01325246|ventral hernia|ventral hernia
5074008|NCT01325246|repair|repair
5074009|NCT01325246|clinical|clinical
5074010|NCT01325246|reoperation|reoperation
5074011|NCT01325233|Astragulus polysaccharides|astragulus polysaccharides
5074012|NCT01325233|Hemorrhagic stroke|hemorrhagic stroke
5074013|NCT01325207|Breast Cancer|breast cancer
5074014|NCT01325194|DLBCL|dlbcl
5074015|NCT01325194|FL grade 3B|fl grade 3b
5074016|NCT01325194|high risk|high risk
5074017|NCT01325194|CNS prophylaxis|cns prophylaxis
5074018|NCT01325194|chemoimmunotherapy|chemoimmunotherapy
5074019|NCT01325181|Chronic central serous chorioretinopathy|chronic central serous chorioretinopathy
5074020|NCT01325181|Ranibizumab|ranibizumab
5074021|NCT01325181|Photodynamic therapy|photodynamic therapy
5074022|NCT01325168|PTSD|ptsd
5074023|NCT01325168|empathy|empathy
5074024|NCT01325168|oxytocin|oxytocin
5074025|NCT01325155|Air Pollution|air pollution
5074026|NCT01325155|particulate matter|particulate matter
5074027|NCT01325155|cardiovascular Disease|cardiovascular disease
5074028|NCT01325142|Osteonecrosis of the Jaw (ONJ)|osteonecrosis of the jaw (onj)
5074029|NCT01325129|ESIN|esin
5074030|NCT01325129|Clavicular Fracture|clavicular fracture
5074031|NCT01325129|Dislocation|dislocation
5074032|NCT01325129|Children|children
5074033|NCT01325129|Adolescents|adolescents
5074034|NCT01325116|STEMI|stemi
5074035|NCT01325116|Medication Adherence|medication adherence
5074036|NCT01325116|Quality Improvement|quality improvement
5074037|NCT01325103|Spinal cord injury|spinal cord injury
5074038|NCT01325103|Mesenchymal stem cells|mesenchymal stem cells
5074039|NCT01325103|Bone marrow|bone marrow
5074040|NCT01325090|neuropathic pain due to thoracotomy|neuropathic pain due to thoracotomy
5074041|NCT01325090|Neuropathic Pain Due to Thoracoscopy|neuropathic pain due to thoracoscopy
5074042|NCT01325077|Nurse-based, acute pain service, pediatric, postoperative,|nurse-based, acute pain service, pediatric, postoperative,
5074043|NCT01325077|pain|pain
5074044|NCT01325064|Carotid Artery Diseases|carotid artery diseases
5074045|NCT01325064|Blood Pressure|blood pressure
5074046|NCT01325064|Blood Pressure Monitoring, Ambulatory|blood pressure monitoring, ambulatory
5074047|NCT01325064|Peripheral Vascular Diseases|peripheral vascular diseases
5074048|NCT01325064|Retinal Vessels|retinal vessels
5074049|NCT01325051|raltegravir|raltegravir
5074050|NCT01325051|pharmacokinetics|pharmacokinetics
5074051|NCT01325051|healthy|healthy
5074052|NCT01325051|male|male
5074053|NCT01325051|volunteers|volunteers
5074054|NCT01325051|gastrointestinal|gastrointestinal
5074055|NCT01325051|tract|tract
5074056|NCT01325038|resting metabolic rate|resting metabolic rate
5074057|NCT01325025|Metachromatic Leukodystrophy|metachromatic leukodystrophy
5074058|NCT01325025|Demyelinating Diseases|demyelinating diseases
5074059|NCT01325025|Magnetic Resonance Imaging|magnetic resonance imaging
5074060|NCT01325025|Diffusion Tensor Imaging|diffusion tensor imaging
5074061|NCT01325025|Relaxometry|relaxometry
5074062|NCT01325025|Spectroscopy|spectroscopy
5074063|NCT01325025|Longitudinal Studies|longitudinal studies
5074064|NCT01325012|Pain|pain
5074065|NCT01325012|Surgery|surgery
5074066|NCT01325012|Catheter|catheter
5074067|NCT01325012|Nerve Block|nerve block
5074068|NCT01325012|Popliteal|popliteal
5074069|NCT01325012|Subgluteal|subgluteal
5074070|NCT01325012|Sciatic|sciatic
5074071|NCT01325012|UCSD|ucsd
5074072|NCT01325012|Moderate-to-severe pain|moderate-to-severe pain
5074073|NCT01325012|Perineural Catheter|perineural catheter
5074074|NCT01325012|Orthopedic Surgery|orthopedic surgery
5074075|NCT01325012|foot surgery surgery|foot surgery surgery
5074076|NCT01325012|sciatic perineural catheter|sciatic perineural catheter
5074077|NCT01325012|age =>18|age =>18
5074078|NCT01324999|Sarcoidosis Associated Pulmonary Hypertension|sarcoidosis associated pulmonary hypertension
5074079|NCT01324986|extraesophageal symptoms of gastroesophageal reflux disease|extraesophageal symptoms of gastroesophageal reflux disease
5074080|NCT01324973|Medical Informatics|medical informatics
5074081|NCT01324973|Therapy, Computer-Assisted|therapy, computer-assisted
5074082|NCT01324973|Health Education|health education
5074083|NCT01324973|Diet|diet
5074084|NCT01324973|Exercise|exercise
5074085|NCT01324960|IPSS|ipss
5074086|NCT01324960|High risk|high risk
5074087|NCT01324960|Azacitidine|azacitidine
5074088|NCT01324960|Ceplene|ceplene
5074089|NCT01324947|Myeloma|myeloma
5074090|NCT01324947|Multiple Myeloma|multiple myeloma
5074091|NCT01324947|Relapsed Multiple Myeloma|relapsed multiple myeloma
5074092|NCT01324947|Relapsed and Refractory Multiple Myeloma|relapsed and refractory multiple myeloma
5074093|NCT01324947|Refractory Myeloma|refractory myeloma
5074094|NCT01324947|Resistant Multiple Myeloma|resistant multiple myeloma
5074095|NCT01324947|Treatment-resistant Multiple Myeloma|treatment-resistant multiple myeloma
5074096|NCT01324947|Pomalidomide|pomalidomide
5074097|NCT01324947|Lenalidomide-resistant|lenalidomide-resistant
5074098|NCT01324947|Bortezomib-resistant|bortezomib-resistant
5074099|NCT01324947|Companion|companion
5074100|NCT01324934|acute rejection|acute rejection
5074101|NCT01324934|chronic rejection|chronic rejection
5074102|NCT01324934|subclinical rejection|subclinical rejection
5074103|NCT01324934|renal transplantation|renal transplantation
5074104|NCT01324934|steroid-free|steroid-free
5074105|NCT01324934|kidney transplantation|kidney transplantation
5074106|NCT01324895|Small intestinal bacterial overgrowth syndrome (SIBO)|small intestinal bacterial overgrowth syndrome (sibo)
5074107|NCT01324895|bacterial overgrowth syndrome|bacterial overgrowth syndrome
5074108|NCT01324895|Small Bowel Bacterial Overgrowth Syndrome (SBBOS)|small bowel bacterial overgrowth syndrome (sbbos)
5074109|NCT01324895|14-Co2 D-Xylose Breath Testing|14-co2 d-xylose breath testing
5074110|NCT01324895|Antibiotics|antibiotics
5074111|NCT01324895|Prokinteics|prokinteics
5074112|NCT01324895|Prokinetic Agents|prokinetic agents
5074113|NCT01324882|colonoscopy|colonoscopy
5074114|NCT01324869|KH902|kh902
5074115|NCT01324869|Diabetic macular Edema|diabetic macular edema
5074116|NCT01324869|Intravitreal injection|intravitreal injection
5074117|NCT01324869|Multiple injections|multiple injections
5074118|NCT01324869|20 patients|20 patients
5074119|NCT01324869|0.5mg/eye/time|0.5mg/eye/time
5074120|NCT01324856|pancreatic cancer|pancreatic cancer
5074121|NCT01324856|periampulary cancer|periampulary cancer
5074122|NCT01324856|pancreaticogastro vs pancreaticojejuno anastomosis|pancreaticogastro vs pancreaticojejuno anastomosis
5074123|NCT01324843|Safety and Tolerability|safety and tolerability
5074124|NCT01324843|Intradermal Electroporation|intradermal electroporation
5074125|NCT01324817|Non-Contact|non-contact
5074126|NCT01324817|Radar|radar
5074127|NCT01324817|Doppler|doppler
5074128|NCT01324817|Respiratory|respiratory
5074129|NCT01324817|Respiration|respiration
5074130|NCT01324817|Breathing|breathing
5074131|NCT01324817|Rate|rate
5074132|NCT01324817|Frequency|frequency
5074133|NCT01324817|Respiratory Mechanics|respiratory mechanics
5074134|NCT01324817|Respiratory Rate Measurement|respiratory rate measurement
5074135|NCT01324817|Apnea|apnea
5074136|NCT01324817|Sleep Apnea|sleep apnea
5074137|NCT01324804|postoperative wound healing|postoperative wound healing
5074138|NCT01324778|Edentulism in the Upper Jaw|edentulism in the upper jaw
5074139|NCT01324765|Women|women
5074140|NCT01324765|PTSD|ptsd
5074141|NCT01324765|Group Therapy|group therapy
5074142|NCT01324765|Incarceration|incarceration
5074143|NCT01324752|Drug-drug interaction|drug-drug interaction
5074144|NCT01324752|Pharmacokinetics|pharmacokinetics
5074145|NCT01324752|PA21|pa21
5074146|NCT01324726|Bacterial colonization|bacterial colonization
5074147|NCT01324726|Extended spectrum beta lactamase producing organisms|extended spectrum beta lactamase producing organisms
5074148|NCT01324687|Telemedicine|telemedicine
5074149|NCT01324687|Geriatrics|geriatrics
5074150|NCT01324674|Common Mental Disorder|common mental disorder
5074151|NCT01324674|Efficacy of Bach´s flower remedy|efficacy of bach´s flower remedy
5074152|NCT01324674|Spiritual well-being|spiritual well-being
5074153|NCT01324648|Guided self-help|guided self-help
5074154|NCT01324648|Telephone delivery|telephone delivery
5074155|NCT01324648|Cognitive behavior therapy|cognitive behavior therapy
5074156|NCT01324648|Bibliotherapy|bibliotherapy
5074157|NCT01324635|glioma|glioma
5074158|NCT01324635|meningioma|meningioma
5074159|NCT01324635|brain metastasis|brain metastasis
5074160|NCT01324635|stereotactic|stereotactic
5074161|NCT01324635|radiotherapy|radiotherapy
5074162|NCT01324635|radiosurgery|radiosurgery
5074163|NCT01324622|Spinal Cord Diseases|spinal cord diseases
5074164|NCT01324622|Myelopathy|myelopathy
5074165|NCT01324622|Myeloradiculopathy|myeloradiculopathy
5074166|NCT01324622|Laminectomy|laminectomy
5074167|NCT01324622|Laminoplasty|laminoplasty
5074168|NCT01324609|choroidal nevus|choroidal nevus
5074169|NCT01324609|vitrectomy|vitrectomy
5074170|NCT01324596|Lymphoma, Large B-Cell, Diffuse|lymphoma, large b-cell, diffuse
5074171|NCT01324596|Bortezomib|bortezomib
5074172|NCT01324596|R-CHOP|r-chop
5074173|NCT01324596|Molecular profiling|molecular profiling
5074174|NCT01324596|Chemotherapy|chemotherapy
5074175|NCT01324570|Pain|pain
5074176|NCT01324570|Opioid|opioid
5074177|NCT01324570|Analgesia|analgesia
5074178|NCT01324570|Moderate to severe pain|moderate to severe pain
5074179|NCT01324557|Continuous glucose monitoring|continuous glucose monitoring
5074180|NCT01324557|CAPD patients|capd patients
5074181|NCT01324557|Insulin pump|insulin pump
5074182|NCT01324544|Acute Pain|acute pain
5074183|NCT01324544|Opioid|opioid
5074184|NCT01324544|Analgesia|analgesia
5074185|NCT01324531|Bankart repair|bankart repair
5074186|NCT01324531|remplissage|remplissage
5074187|NCT01324531|Hill-Sachs defect|hill-sachs defect
5074188|NCT01324531|shoulder instability|shoulder instability
5074189|NCT01324531|anterior shoulder instability|anterior shoulder instability
5074190|NCT01324492|phase Ib,|phase ib,
5074191|NCT01324492|RAD001,|rad001,
5074192|NCT01324492|advanced pulmonary neuroendocrine tumor|advanced pulmonary neuroendocrine tumor
5074193|NCT01324479|Non-small cell lung cancer,|non-small cell lung cancer,
5074194|NCT01324479|hepatocellular,|hepatocellular,
5074195|NCT01324479|gastric,|gastric,
5074196|NCT01324479|renal cell,|renal cell,
5074197|NCT01324479|c-MET,|c-met,
5074198|NCT01324479|refractory,|refractory,
5074199|NCT01324479|glioblastoma,|glioblastoma,
5074200|NCT01324479|breast,|breast,
5074201|NCT01324479|nasopharyngeal,|nasopharyngeal,
5074202|NCT01324479|confirmed evidence of c-MET dysregulation|confirmed evidence of c-met dysregulation
5074203|NCT01324453|Acute Myocardial Infarction|acute myocardial infarction
5074204|NCT01324453|STEMI|stemi
5074205|NCT01324453|Post Conditioning|post conditioning
5074206|NCT01324453|Primary Percutaneous Coronary Intervention|primary percutaneous coronary intervention
5074207|NCT01324440|Bacterial Vaccines|bacterial vaccines
5074208|NCT01324440|Staphylococcus Aureus|staphylococcus aureus
5074209|NCT01324440|Adjuvanted Vaccine|adjuvanted vaccine
5074210|NCT01324427|Telemedicine|telemedicine
5074211|NCT01324427|Virtual Medical Visit|virtual medical visit
5074212|NCT01324427|Quality of Life|quality of life
5074213|NCT01324427|11-022|11-022
5074214|NCT01324401|Peanut Allergy|peanut allergy
5074215|NCT01324401|Peanut Hypersensitivity|peanut hypersensitivity
5074216|NCT01324362|FP|fp
5074217|NCT01324362|Asthma|asthma
5074218|NCT01324362|Sont|sont
5074219|NCT01324362|FSC|fsc
5074220|NCT01324362|BHR|bhr
5074221|NCT01324349|Hepatic|hepatic
5074222|NCT01324349|Topical Hemostat|topical hemostat
5074223|NCT01324336|ALL|all
5074224|NCT01324336|acute lymphoblastic leukemia|acute lymphoblastic leukemia
5074225|NCT01324336|6-Mercaptopurine|6-mercaptopurine
5074226|NCT01324336|Pediatric|pediatric
5074227|NCT01324323|ROMI-001|romi-001
5074228|NCT01324323|romi|romi
5074229|NCT01324323|Romidepsin|romidepsin
5074230|NCT01324323|Istodax|istodax
5074231|NCT01324323|advanced malignancy|advanced malignancy
5074232|NCT01324323|PK|pk
5074233|NCT01324323|pharmacokinetics|pharmacokinetics
5074234|NCT01324310|ROMI-001|romi-001
5074235|NCT01324310|romi|romi
5074236|NCT01324310|Romidepsin|romidepsin
5074237|NCT01324310|Istodax|istodax
5074238|NCT01324310|advanced malignancy|advanced malignancy
5074239|NCT01324310|PK|pk
5074240|NCT01324310|pharmacokinetics|pharmacokinetics
5074241|NCT01324297|Diagnostic Techniques and Procedures|diagnostic techniques and procedures
5074242|NCT01324297|Sensitivity and Specificity|sensitivity and specificity
5074243|NCT01324297|Skin Tests|skin tests
5074244|NCT01324297|Biological Markers|biological markers
5074245|NCT01324284|Lubiprostone|lubiprostone
5074246|NCT01324284|Bowel preparation regime|bowel preparation regime
5074247|NCT01324271|Tympanostomy tube placement|tympanostomy tube placement
5074248|NCT01324258|pancreatic cancer (combination with gemcitabine)|pancreatic cancer (combination with gemcitabine)
5074249|NCT01324258|Non-small cell lung cancer (combination with gemcitabine)|non-small cell lung cancer (combination with gemcitabine)
5074250|NCT01324258|solid tumors (single agent)|solid tumors (single agent)
5074251|NCT01324258|MEK inhibitor|mek inhibitor
5074252|NCT01324258|GSK1120212|gsk1120212
5074253|NCT01324258|biliary cancer (combination with gemcitabine)|biliary cancer (combination with gemcitabine)
5074254|NCT01324258|urothelial cancer (combination with gemcitabine)|urothelial cancer (combination with gemcitabine)
5074255|NCT01324245|Salt|salt
5074256|NCT01324245|Balance|balance
5074257|NCT01324245|Renin Angiotensin System|renin angiotensin system
5074258|NCT01324245|Fenoldopam\blood Pressure|fenoldopam\blood pressure
5074259|NCT01324245|Sodium|sodium
5074260|NCT01324219|nursing staff|nursing staff
5074261|NCT01324219|residents|residents
5074262|NCT01324206|Whole-Body|whole-body
5074263|NCT01324206|Development|development
5074264|NCT01324206|Exposure|exposure
5074265|NCT01324206|Magnetic|magnetic
5074266|NCT01324206|Resonance|resonance
5074267|NCT01324180|ALL|all
5074268|NCT01324180|Relapsed|relapsed
5074269|NCT01324180|Refractory|refractory
5074270|NCT01324167|schizophrenia|schizophrenia
5074271|NCT01324167|schizoaffective disorder|schizoaffective disorder
5074272|NCT01324141|Anal Cancer|anal cancer
5074273|NCT01324141|Radioprotector|radioprotector
5074274|NCT01324141|Topical|topical
5074275|NCT01324141|Radiation|radiation
5074276|NCT01324141|Dermatitis|dermatitis
5074277|NCT01324128|PA21|pa21
5074278|NCT01324128|Phosphate Binder|phosphate binder
5074279|NCT01324115|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5074280|NCT01324102|Neoplasms|neoplasms
5074281|NCT01324089|Resveratrol|resveratrol
5074282|NCT01324089|Piperine|piperine
5074481|NCT01323309|11-021|11-021
5074283|NCT01324076|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
5074284|NCT01324076|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
5074285|NCT01324076|advanced adult primary liver cancer|advanced adult primary liver cancer
5074286|NCT01324063|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
5074287|NCT01324037|suspected upper extremity deep vein thrombosis|suspected upper extremity deep vein thrombosis
5074288|NCT01324037|diagnostic algorithm|diagnostic algorithm
5074289|NCT01324024|Menopause|menopause
5074290|NCT01324024|Aging|aging
5074291|NCT01324024|Memory|memory
5074292|NCT01324024|Women|women
5074293|NCT01323998|enlarged prostate|enlarged prostate
5074294|NCT01323998|Benign prostatic hyperplasia|benign prostatic hyperplasia
5074295|NCT01323998|alpha-blocker|alpha-blocker
5074296|NCT01323998|5-alpha-reductase inhibitor|5-alpha-reductase inhibitor
5074297|NCT01323972|Malaria|malaria
5074298|NCT01323972|Plasmodium falciparum|plasmodium falciparum
5074299|NCT01323959|BoostrixTM Polio|boostrixtm polio
5074300|NCT01323959|dTpa-IPV|dtpa-ipv
5074301|NCT01323959|booster|booster
5074302|NCT01323946|H5N1|h5n1
5074303|NCT01323946|influenza infection|influenza infection
5074304|NCT01323946|Influenza vaccine GSK1562902A|influenza vaccine gsk1562902a
5074305|NCT01323933|Solid tumors|solid tumors
5074306|NCT01323933|Oncology|oncology
5074307|NCT01323933|Cancer|cancer
5074308|NCT01323920|Stem Cell Transplant|stem cell transplant
5074309|NCT01323920|Allogeneic Transplant|allogeneic transplant
5074310|NCT01323920|Donors|donors
5074311|NCT01323907|Total Parenteral Nutrition-induced Cholestasis|total parenteral nutrition-induced cholestasis
5074312|NCT01323907|Omegaven|omegaven
5074313|NCT01323907|liver disease|liver disease
5074314|NCT01323907|Cholestasis|cholestasis
5074315|NCT01323907|Fat emulsions|fat emulsions
5074316|NCT01323881|theta burst stimulation, stroke, motor, plasticity|theta burst stimulation, stroke, motor, plasticity
5074317|NCT01323842|renal colic|renal colic
5074318|NCT01323842|hydronephrosis|hydronephrosis
5074319|NCT01323842|abdominal aortic aneurysm|abdominal aortic aneurysm
5074320|NCT01323842|ultrasound|ultrasound
5074321|NCT01323842|emergency medicine|emergency medicine
5074322|NCT01323842|urolithiasis|urolithiasis
5074323|NCT01323829|High Tone Pelvic Floor Dysfunction|high tone pelvic floor dysfunction
5074324|NCT01323829|Botulinum toxin type A|botulinum toxin type a
5074325|NCT01323829|EMG|emg
5074326|NCT01323803|Eosinophilic Esophagitis|eosinophilic esophagitis
5074327|NCT01323790|Non-Cancer-Related Pain|non-cancer-related pain
5074328|NCT01323790|Opioid-Induced Constipation|opioid-induced constipation
5074329|NCT01323777|Cataracts|cataracts
5074330|NCT01323777|Intraocular lens|intraocular lens
5074331|NCT01323777|Multifocal|multifocal
5074332|NCT01323777|Toric|toric
5074333|NCT01323777|Astigmatism|astigmatism
5074334|NCT01323777|Presbyopia|presbyopia
5074335|NCT01323764|Hydrocephalus|hydrocephalus
5074336|NCT01323764|CSF shunts|csf shunts
5074337|NCT01323764|Normal Pressure Hydrocephalus|normal pressure hydrocephalus
5074338|NCT01323764|NPH|nph
5074339|NCT01323764|ShuntCheck|shuntcheck
5074340|NCT01323764|Shunt Malfunction|shunt malfunction
5074341|NCT01323764|Suspected shunt malfunction in adult hydrocephalus patients|suspected shunt malfunction in adult hydrocephalus patients
5074342|NCT01323738|Psychoeducation|psychoeducation
5074343|NCT01323738|Group Control|group control
5074344|NCT01323725|Team-based financial incentives|team-based financial incentives
5074345|NCT01323725|Smoking cessation|smoking cessation
5074346|NCT01323712|CKD|ckd
5074347|NCT01323712|LV mass|lv mass
5074348|NCT01323712|Vitamin D|vitamin d
5074349|NCT01323712|LV function|lv function
5074350|NCT01323699|Parkinson Disease|parkinson disease
5074351|NCT01323699|Anxiety|anxiety
5074352|NCT01323699|Depression|depression
5074353|NCT01323647|IPV|ipv
5074354|NCT01323647|PoliorixTM|poliorixtm
5074355|NCT01323647|China|china
5074356|NCT01323608|Thalassemia|thalassemia
5074357|NCT01323608|hypercalciuria|hypercalciuria
5074358|NCT01323608|vitamin D|vitamin d
5074359|NCT01323608|To conduct a pilot study to determine the effect of various doses of|to conduct a pilot study to determine the effect of various doses of
5074360|NCT01323608|vitamin D supplementation on vitamin D stores and their association with calcium excretion|vitamin d supplementation on vitamin d stores and their association with calcium excretion
5074361|NCT01323595|Pain control|pain control
5074362|NCT01323595|testicular sperm extraction|testicular sperm extraction
5074363|NCT01323595|sperm|sperm
5074364|NCT01323582|Gastroparesis|gastroparesis
5074365|NCT01323582|Gastroparesis Treatment|gastroparesis treatment
5074366|NCT01323582|Gastric Emptying|gastric emptying
5074367|NCT01323582|Prokinetic Agents|prokinetic agents
5074368|NCT01323582|Macrolides|macrolides
5074369|NCT01323582|Erythromycin|erythromycin
5074370|NCT01323582|Azithromycin|azithromycin
5074371|NCT01323582|Erythromycin Cardiac Side-effects|erythromycin cardiac side-effects
5074372|NCT01323582|Erythromycin drug interactions|erythromycin drug interactions
5074373|NCT01323582|AZI|azi
5074374|NCT01323569|Sativex|sativex
5074375|NCT01323569|Cannabinoids|cannabinoids
5074376|NCT01323569|Abuse potential|abuse potential
5074377|NCT01323569|Addiction|addiction
5074378|NCT01323556|Panic disorder|panic disorder
5074379|NCT01323556|agoraphobia|agoraphobia
5074380|NCT01323556|panic attacks|panic attacks
5074381|NCT01323556|exposure based learning|exposure based learning
5074382|NCT01323556|interoceptive exposure exercises|interoceptive exposure exercises
5074383|NCT01323556|fear augmentation|fear augmentation
5074384|NCT01323556|in vivo exposure|in vivo exposure
5074385|NCT01323543|Back Pain,|back pain,
5074386|NCT01323543|Back Pains, Low|back pains, low
5074387|NCT01323543|Low Back Pains|low back pains
5074388|NCT01323543|Pain, Low Back|pain, low back
5074389|NCT01323543|Pains, Low Back|pains, low back
5074390|NCT01323543|Lumbago|lumbago
5074391|NCT01323543|Lower Back Pain|lower back pain
5074392|NCT01323543|Back Pain, Lower|back pain, lower
5074393|NCT01323543|Back Pains, Lower|back pains, lower
5074394|NCT01323543|Lower Back Pains|lower back pains
5074395|NCT01323543|Pain, Lower Back|pain, lower back
5074396|NCT01323543|Pains, Lower Back|pains, lower back
5074397|NCT01323543|Low Back Ache|low back ache
5074398|NCT01323543|Ache, Low Back|ache, low back
5074399|NCT01323543|Aches, Low Back|aches, low back
5074400|NCT01323543|Back Ache, Low|back ache, low
5074401|NCT01323543|Back Aches, Low|back aches, low
5074402|NCT01323543|Low Back Aches|low back aches
5074403|NCT01323543|Low Backache|low backache
5074404|NCT01323543|Backache, Low|backache, low
5074405|NCT01323543|Backaches, Low|backaches, low
5074406|NCT01323543|Low Backaches|low backaches
5074407|NCT01323543|Low Back Pain, Recurrent|low back pain, recurrent
5074408|NCT01323543|Recurrent Low Back Pain|recurrent low back pain
5074409|NCT01323543|Low Back Pain, Postural|low back pain, postural
5074410|NCT01323543|Postural Low Back Pain|postural low back pain
5074411|NCT01323543|Low Back Pain, Mechanical|low back pain, mechanical
5074412|NCT01323543|Mechanical Low Back Pain|mechanical low back pain
5074413|NCT01323543|Low Back Pain, Posterior Compartment|low back pain, posterior compartment
5074414|NCT01323530|metastatic breast cancer|metastatic breast cancer
5074415|NCT01323517|skin|skin
5074416|NCT01323517|DACTINOMYCIN|dactinomycin
5074417|NCT01323517|MDX-010 (Ipilimumab)|mdx-010 (ipilimumab)
5074418|NCT01323517|MELPHALAN|melphalan
5074419|NCT01323517|Isolated Limb Infusion|isolated limb infusion
5074420|NCT01323517|10-101|10-101
5074421|NCT01323504|Stage 5 arteritis|stage 5 arteritis
5074422|NCT01323504|Stage 6 arteritis|stage 6 arteritis
5074423|NCT01323504|rutherford classification|rutherford classification
5074424|NCT01323491|smoking cessation|smoking cessation
5074425|NCT01323491|nicotine replacement therapy|nicotine replacement therapy
5074426|NCT01323491|routine smokers|routine smokers
5074427|NCT01323478|Depressive Disorder|depressive disorder
5074428|NCT01323478|Depression|depression
5074429|NCT01323478|Depressive Disorder, Major|depressive disorder, major
5074430|NCT01323478|Mood Disorders|mood disorders
5074431|NCT01323478|Mental Disorders|mental disorders
5074432|NCT01323478|Behavioural Symptoms|behavioural symptoms
5074433|NCT01323465|Sativex|sativex
5074434|NCT01323465|Cytochrome P450|cytochrome p450
5074435|NCT01323465|Pharmacokinetics|pharmacokinetics
5074436|NCT01323465|Cannabinoids|cannabinoids
5074437|NCT01323465|ketoconazole|ketoconazole
5074438|NCT01323465|omeprazole|omeprazole
5074439|NCT01323465|rifampicin|rifampicin
5074440|NCT01323452|entecavir|entecavir
5074441|NCT01323452|hepatitis B|hepatitis b
5074442|NCT01323439|Patients presenting with an intracranial aneurysm|patients presenting with an intracranial aneurysm
5074443|NCT01323426|urinary incontinence, stress|urinary incontinence, stress
5074444|NCT01323426|autologous|autologous
5074445|NCT01323413|stroke|stroke
5074446|NCT01323413|penumbra|penumbra
5074447|NCT01323413|determinants|determinants
5074448|NCT01323413|CT perfusion|ct perfusion
5074449|NCT01323400|GIST|gist
5074450|NCT01323400|Resistant|resistant
5074451|NCT01323400|Pazopanib|pazopanib
5074452|NCT01323400|Tyrosine kinase inhibitor|tyrosine kinase inhibitor
5074453|NCT01323400|Best supportive care|best supportive care
5074454|NCT01323400|Progression-free survival|progression-free survival
5074455|NCT01323400|Overall survival|overall survival
5074456|NCT01323400|Objective response rate|objective response rate
5074457|NCT01323400|Best response|best response
5074458|NCT01323400|Tolerance profile|tolerance profile
5074459|NCT01323374|Fibromyalgia|fibromyalgia
5074460|NCT01323374|FMS|fms
5074461|NCT01323374|droxidopa|droxidopa
5074462|NCT01323374|pain|pain
5074463|NCT01323361|inflammation|inflammation
5074464|NCT01323361|laparoscopy|laparoscopy
5074465|NCT01323361|hernia|hernia
5074466|NCT01323361|incisional|incisional
5074467|NCT01323361|trauma|trauma
5074468|NCT01323348|Diabetes|diabetes
5074469|NCT01323348|Diabetes Education|diabetes education
5074470|NCT01323348|Diabetic Retinopathy|diabetic retinopathy
5074471|NCT01323348|HbA1c|hba1c
5074472|NCT01323335|Uric Acid|uric acid
5074473|NCT01323335|Rasburicase|rasburicase
5074474|NCT01323335|Inflammatory Markers|inflammatory markers
5074475|NCT01323322|Socioeconomic Status|socioeconomic status
5074476|NCT01323322|Longitudinal Study|longitudinal study
5074477|NCT01323322|Health Disparities|health disparities
5074478|NCT01323322|Epidemiology|epidemiology
5074479|NCT01323309|Supportive Psychotherapy|supportive psychotherapy
5074480|NCT01323309|Therapy|therapy
5074482|NCT01323296|Myocardial infarction|myocardial infarction
5074483|NCT01323296|Magnetic resonance|magnetic resonance
5074484|NCT01323296|Nanoparticle|nanoparticle
5074485|NCT01323296|Iron|iron
5074486|NCT01323296|Inflammation|inflammation
5074487|NCT01323283|Omega-3|omega-3
5074488|NCT01323283|physical activity|physical activity
5074489|NCT01323283|children|children
5074490|NCT01323283|obesity|obesity
5074491|NCT01323283|sedentary|sedentary
5074492|NCT01323283|accelerometry|accelerometry
5074493|NCT01323283|BMI|bmi
5074494|NCT01323283|fatty acids|fatty acids
5074495|NCT01323283|inflammatory markers|inflammatory markers
5074496|NCT01323283|intervention|intervention
5074497|NCT01323283|randomized|randomized
5074498|NCT01323283|double blind|double blind
5074499|NCT01323270|Healthy adolescents|healthy adolescents
5074500|NCT01323257|TMC435-TiDP16-C115|tmc435-tidp16-c115
5074501|NCT01323257|TMC435-C115|tmc435-c115
5074502|NCT01323257|TMC435|tmc435
5074503|NCT01323257|HCV|hcv
5074504|NCT01323257|Hepatitis C|hepatitis c
5074505|NCT01323257|Hep C|hep c
5074506|NCT01323257|healthy volunteers|healthy volunteers
5074507|NCT01323244|TMC435-TiDP16-C213|tmc435-tidp16-c213
5074508|NCT01323244|TMC435-C213|tmc435-c213
5074509|NCT01323244|TMC435|tmc435
5074510|NCT01323244|HCV|hcv
5074511|NCT01323244|Hepatitis C|hepatitis c
5074512|NCT01323231|XY-Zone|xy-zone
5074513|NCT01323231|school drop-out risk|school drop-out risk
5074514|NCT01323231|protective factors|protective factors
5074515|NCT01323231|truancy|truancy
5074516|NCT01323218|Obstructive sleep apnea-hypopnea syndrome|obstructive sleep apnea-hypopnea syndrome
5074517|NCT01323218|OSAHS|osahs
5074518|NCT01323218|Vitamin D|vitamin d
5074519|NCT01323205|JNJ-40411813|jnj-40411813
5074520|NCT01323192|Concerta|concerta
5074521|NCT01323192|Adults|adults
5074522|NCT01323192|Attention-Deficit/Hyperactivity Disorder|attention-deficit/hyperactivity disorder
5074523|NCT01323192|ADHD|adhd
5074524|NCT01323192|Methylphenidate hydrochloride|methylphenidate hydrochloride
5074525|NCT01323179|Postoperative pain|postoperative pain
5074526|NCT01323179|Postoperative opioid requirements|postoperative opioid requirements
5074527|NCT01323166|rectal cancer|rectal cancer
5074528|NCT01323140|hypogonadism, testosterone, transdermal system|hypogonadism, testosterone, transdermal system
5074529|NCT01323114|type 2 diabetes mellitus|type 2 diabetes mellitus
5074530|NCT01323114|non-morbidly obese|non-morbidly obese
5074531|NCT01323114|laparoscopic duodenal exclusion|laparoscopic duodenal exclusion
5074532|NCT01323088|Childhood obesity|childhood obesity
5074533|NCT01323088|Visceral fat|visceral fat
5074534|NCT01323088|Insulin resistance|insulin resistance
5074535|NCT01323088|Liver fat|liver fat
5074536|NCT01323088|Skeletal muscle lipid|skeletal muscle lipid
5074537|NCT01323088|Regular exercise|regular exercise
5074538|NCT01323062|chemotherapy naive|chemotherapy naive
5074539|NCT01323062|stage IV non squamous non small cell lung cancer|stage iv non squamous non small cell lung cancer
5074540|NCT01323062|Phase 1b|phase 1b
5074541|NCT01323062|Bavituximab|bavituximab
5074542|NCT01323062|Chimeric 3G4|chimeric 3g4
5074543|NCT01323062|U of North Carolina at Chapel Hill|u of north carolina at chapel hill
5074544|NCT01323049|extubation strategy|extubation strategy
5074545|NCT01323010|asthma|asthma
5074546|NCT01323010|albuterol|albuterol
5074547|NCT01323010|metered dose inhalers|metered dose inhalers
5074548|NCT01322984|ASD|asd
5074549|NCT01322984|Startle|startle
5074550|NCT01322971|Bacterial Vaginosis|bacterial vaginosis
5074551|NCT01322971|Infertility|infertility
5074552|NCT01322971|Miscarriage|miscarriage
5074553|NCT01322971|Metronidazole|metronidazole
5074554|NCT01322958|bedside ultrasound|bedside ultrasound
5074555|NCT01322932|Medication Adherence|medication adherence
5074556|NCT01322932|HIV Infection|hiv infection
5074557|NCT01322932|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination [Substance Name]|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination [substance name]
5074558|NCT01322932|efavirenz|efavirenz
5074559|NCT01322932|emtricitabine|emtricitabine
5074560|NCT01322932|Patient Satisfaction|patient satisfaction
5074561|NCT01322932|tenofovir disoproxil fumarate|tenofovir disoproxil fumarate
5074562|NCT01322919|PresbyLASIK|presbylasik
5074563|NCT01322919|Presbyopia|presbyopia
5074564|NCT01322919|LASIK|lasik
5074565|NCT01322919|Supracor|supracor
5074566|NCT01322919|refractive|refractive
5074567|NCT01322919|Myopia|myopia
5074568|NCT01322919|Hyperopia|hyperopia
5074569|NCT01322906|ABMLF|abmlf
5074570|NCT01322906|Allogenic Bone marrow Mesenchymal Stem Cells|allogenic bone marrow mesenchymal stem cells
5074571|NCT01322906|Liver Failure|liver failure
5074572|NCT01322906|Transplantation|transplantation
5074573|NCT01322893|Metastatic breast cancer|metastatic breast cancer
5074574|NCT01322893|Circulating tumour cells|circulating tumour cells
5074575|NCT01322893|CTC|ctc
5074576|NCT01322893|Prognostic factors|prognostic factors
5074577|NCT01322893|Treatment response|treatment response
5074578|NCT01322880|domestic violence|domestic violence
5074579|NCT01322867|bioequivalence study|bioequivalence study
5074580|NCT01322867|alprazolam|alprazolam
5074581|NCT01322867|frontal|frontal
5074582|NCT01322854|IMRT|imrt
5074583|NCT01322854|Integrated boost|integrated boost
5074584|NCT01322854|adjuvant radiotherapy|adjuvant radiotherapy
5074585|NCT01322854|breast cancer|breast cancer
5074586|NCT01322854|breast conserving surgery|breast conserving surgery
5074587|NCT01322841|CHICA|chica
5074588|NCT01322841|clinical decision support|clinical decision support
5074589|NCT01322828|Bicep|bicep
5074590|NCT01322828|Tendon|tendon
5074591|NCT01322828|Distal|distal
5074592|NCT01322828|Ruptures|ruptures
5074593|NCT01322828|Randomized|randomized
5074594|NCT01322828|Surgery|surgery
5074595|NCT01322815|colon cancer|colon cancer
5074596|NCT01322815|metastatic|metastatic
5074597|NCT01322815|vaccine|vaccine
5074598|NCT01322802|Ovarian Cancer|ovarian cancer
5074599|NCT01322802|Vaccine|vaccine
5074600|NCT01322802|Stage III|stage iii
5074601|NCT01322802|Stage IV|stage iv
5074602|NCT01322802|Remission|remission
5074603|NCT01322789|Diabetes mellitus|diabetes mellitus
5074604|NCT01322789|Stem cells|stem cells
5074605|NCT01322789|Autologous stem cell transplantation|autologous stem cell transplantation
5074606|NCT01322789|Autoimmune diseases|autoimmune diseases
5074607|NCT01322776|Mantle Cell Lymphoma|mantle cell lymphoma
5074608|NCT01322776|Recurrent|recurrent
5074609|NCT01322776|Bortezomib|bortezomib
5074610|NCT01322776|Combination Treatment|combination treatment
5074611|NCT01322737|resection|resection
5074612|NCT01322737|open|open
5074613|NCT01322737|laparoscopic|laparoscopic
5074614|NCT01322737|benign|benign
5074615|NCT01322737|malignant|malignant
5074616|NCT01322737|disease|disease
5074617|NCT01322737|colon|colon
5074618|NCT01322737|gastric|gastric
5074619|NCT01322724|colonoscopy|colonoscopy
5074620|NCT01322724|colon cancer screening|colon cancer screening
5074621|NCT01322724|patient discomfort scores|patient discomfort scores
5074622|NCT01322724|sedation medication requirements|sedation medication requirements
5074623|NCT01322724|water insertion method|water insertion method
5074624|NCT01322711|Thromboxane|thromboxane
5074625|NCT01322711|Aspirin|aspirin
5074626|NCT01322711|Atorvastatin|atorvastatin
5074627|NCT01322711|Platelet activation|platelet activation
5074628|NCT01322711|Thrombin Activation|thrombin activation
5074629|NCT01322711|Oxidative stress|oxidative stress
5074630|NCT01322698|ICU|icu
5074631|NCT01322685|Tuberculosis|tuberculosis
5074632|NCT01322685|Lung cancer|lung cancer
5074633|NCT01322672|Anesthetic Agents|anesthetic agents
5074634|NCT01322672|POCD|pocd
5074635|NCT01322672|Delirium|delirium
5074636|NCT01322672|Cognitive Testing|cognitive testing
5074637|NCT01322672|Aging|aging
5074638|NCT01322672|Surgery|surgery
5074639|NCT01322672|fMRI|fmri
5074640|NCT01322672|Diffusion Tensor Imaging|diffusion tensor imaging
5074641|NCT01322672|White Matter|white matter
5074642|NCT01322659|Mechanical ventilation|mechanical ventilation
5074643|NCT01322659|Weaning|weaning
5074644|NCT01322659|Noninvasive ventilation|noninvasive ventilation
5074645|NCT01322659|Acute respiratory failure|acute respiratory failure
5074646|NCT01322659|Helmet|helmet
5074647|NCT01322646|ADHD|adhd
5074648|NCT01322646|Driving|driving
5074649|NCT01322646|Behavior modification|behavior modification
5074650|NCT01322633|Pantoprazole|pantoprazole
5074651|NCT01322633|proton pump inhibitor|proton pump inhibitor
5074652|NCT01322633|gastric cancer|gastric cancer
5074653|NCT01322633|digestive system cancer|digestive system cancer
5074654|NCT01322633|cancer|cancer
5074655|NCT01322607|Exercise|exercise
5074656|NCT01322607|Rehabilitation|rehabilitation
5074657|NCT01322607|Stroke|stroke
5074658|NCT01322594|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5074659|NCT01322594|COPD|copd
5074660|NCT01322581|Plasmodium Falciparum|plasmodium falciparum
5074661|NCT01322581|Genome-Wide Expression|genome-wide expression
5074662|NCT01322581|Antibody Profiling by Protein Microarray|antibody profiling by protein microarray
5074663|NCT01322581|Multiplex Cytokine Analysis|multiplex cytokine analysis
5074664|NCT01322581|Children and Adults|children and adults
5074665|NCT01322581|Malaria|malaria
5074666|NCT01322568|Aging|aging
5074667|NCT01322568|Gene|gene
5074668|NCT01322568|Environment|environment
5074669|NCT01322568|Inflammation|inflammation
5074670|NCT01322568|Iceland|iceland
5074671|NCT01322555|PBR28|pbr28
5074672|NCT01322555|Positron Emission Tomography (PET)|positron emission tomography (pet)
5074673|NCT01322555|Propofol|propofol
5074674|NCT01322555|Autism|autism
5074675|NCT01322555|Immune Response|immune response
5074676|NCT01322555|Autism Spectrum Disorders|autism spectrum disorders
5074677|NCT01322555|ASD|asd
5074678|NCT01322555|Healthy Volunteer|healthy volunteer
5074679|NCT01322555|HV|hv
5074680|NCT01322529|nulliparity|nulliparity
5074681|NCT01322529|pregnant women|pregnant women
5074682|NCT01322529|pregnancy outcomes|pregnancy outcomes
5074683|NCT01322529|pregnancy complications|pregnancy complications
5074684|NCT01322490|PROSTVAC|prostvac
5074685|NCT01322490|metastatic|metastatic
5074686|NCT01322490|prostate cancer|prostate cancer
5074687|NCT01322490|castrate-resistant|castrate-resistant
5074688|NCT01322490|vaccine|vaccine
5074689|NCT01322490|immunotherapy|immunotherapy
5074690|NCT01322490|Phase 3|phase 3
5074794|NCT01321996|NSIP|nsip
5074691|NCT01322477|Identification of treatment efficacy in patients with advanced HCC by PET/CT F18-FDG|identification of treatment efficacy in patients with advanced hcc by pet/ct f18-fdg
5074692|NCT01322464|Sativex|sativex
5074693|NCT01322464|bio-availability|bio-availability
5074694|NCT01322464|cannabinoid|cannabinoid
5074695|NCT01322464|pharmacokinetics|pharmacokinetics
5074696|NCT01322451|Safety|safety
5074697|NCT01322451|Tolerability|tolerability
5074698|NCT01322451|Pharmacokinetics|pharmacokinetics
5074699|NCT01322438|healthy volunteers|healthy volunteers
5074700|NCT01322438|rifampin|rifampin
5074701|NCT01322438|pharmacokinetics|pharmacokinetics
5074702|NCT01322438|single dose|single dose
5074703|NCT01322412|Adapted physical activity|adapted physical activity
5074704|NCT01322412|breast cancer|breast cancer
5074705|NCT01322399|low back pain|low back pain
5074706|NCT01322399|chronic pain|chronic pain
5074707|NCT01322399|manual therapy|manual therapy
5074708|NCT01322399|Structural Integration|structural integration
5074709|NCT01322386|PSC|psc
5074710|NCT01322386|BA|ba
5074711|NCT01322373|Alzheimer's disease|alzheimer's disease
5074712|NCT01322373|magnetoencephalography|magnetoencephalography
5074713|NCT01322373|MEG|meg
5074714|NCT01322373|SNI|sni
5074715|NCT01322347|End Stage Renal Disease|end stage renal disease
5074716|NCT01322347|Hemodialysis|hemodialysis
5074717|NCT01322347|SFP|sfp
5074718|NCT01322347|Hemodialysis-dependent chronic renal failure|hemodialysis-dependent chronic renal failure
5074719|NCT01322334|Snoring|snoring
5074720|NCT01322334|Sleep apnea|sleep apnea
5074721|NCT01322334|Pharyngeal muscle tone|pharyngeal muscle tone
5074722|NCT01322321|ACZ885|acz885
5074723|NCT01322321|diabetes|diabetes
5074724|NCT01322321|type 1|type 1
5074725|NCT01322321|C-peptide|c-peptide
5074726|NCT01322308|lupus|lupus
5074727|NCT01322308|HDL particles|hdl particles
5074728|NCT01322308|endothelial function|endothelial function
5074729|NCT01322308|pioglitazone|pioglitazone
5074730|NCT01322243|Anxiety|anxiety
5074731|NCT01322243|Metabolic state|metabolic state
5074732|NCT01322243|Stress|stress
5074733|NCT01322230|Instructional Design|instructional design
5074734|NCT01322230|Online learning module|online learning module
5074735|NCT01322230|Surgical education|surgical education
5074736|NCT01322217|Medication adherence|medication adherence
5074737|NCT01322217|Substance use|substance use
5074738|NCT01322217|Sexual risk behaviors|sexual risk behaviors
5074739|NCT01322204|codeine, neonates, pediatric pharmacology|codeine, neonates, pediatric pharmacology
5074740|NCT01322191|pain, pain management, pediatrics, morphine pharmacokinetics|pain, pain management, pediatrics, morphine pharmacokinetics
5074741|NCT01322178|cetuximab|cetuximab
5074742|NCT01322178|colorectal carcinoma|colorectal carcinoma
5074743|NCT01322165|Marfan syndrome|marfan syndrome
5074744|NCT01322165|Turner syndrome|turner syndrome
5074745|NCT01322165|Bicuspid aortic valve|bicuspid aortic valve
5074746|NCT01322165|Ehlers-Danlos Syndrome|ehlers-danlos syndrome
5074747|NCT01322165|Loeys-Dietz syndrome|loeys-dietz syndrome
5074748|NCT01322165|Aneurysm|aneurysm
5074749|NCT01322165|Genetic|genetic
5074750|NCT01322165|aortic|aortic
5074751|NCT01322165|thoracic|thoracic
5074752|NCT01322165|mutation|mutation
5074753|NCT01322165|dissection|dissection
5074754|NCT01322152|metastases|metastases
5074755|NCT01322152|neoplasm|neoplasm
5074756|NCT01322139|Sativex|sativex
5074757|NCT01322139|Cannabinoid|cannabinoid
5074758|NCT01322139|Electrocardiogram|electrocardiogram
5074759|NCT01322139|QT interval|qt interval
5074760|NCT01322113|BIPOLAR|bipolar
5074761|NCT01322113|MANIA|mania
5074762|NCT01322113|DEPRESSION|depression
5074763|NCT01322100|Brain Metastases, CNS Metastases|brain metastases, cns metastases
5074764|NCT01322087|Nutrition|nutrition
5074765|NCT01322087|new energy dense food concept|new energy dense food concept
5074766|NCT01322074|Acute postoperative pain|acute postoperative pain
5074767|NCT01322074|systemic inflammation|systemic inflammation
5074768|NCT01322074|CRP|crp
5074769|NCT01322074|IL6|il6
5074770|NCT01322061|Gallbladder removal|gallbladder removal
5074771|NCT01322061|acute cholecystitis|acute cholecystitis
5074772|NCT01322061|Laparoscopic cholecestectomy|laparoscopic cholecestectomy
5074773|NCT01322048|Sympathetic Hyperactivity|sympathetic hyperactivity
5074774|NCT01322048|Traumatic Brain Injury|traumatic brain injury
5074775|NCT01322048|Agitation|agitation
5074776|NCT01322048|Severe TBI|severe tbi
5074777|NCT01322048|TBI|tbi
5074778|NCT01322048|Catecholamines|catecholamines
5074779|NCT01322048|Heart rate variability|heart rate variability
5074780|NCT01322048|Adrenergic alpha-Agonists|adrenergic alpha-agonists
5074781|NCT01322048|Adrenergic beta-Antagonists|adrenergic beta-antagonists
5074782|NCT01322048|Cognitive Impairment|cognitive impairment
5074783|NCT01322022|Autism|autism
5074784|NCT01322022|Autism Spectrum Disorders|autism spectrum disorders
5074785|NCT01322022|Sleep Problems|sleep problems
5074786|NCT01322022|Sleep Disturbances|sleep disturbances
5074787|NCT01322022|Interventions|interventions
5074788|NCT01322009|Children|children
5074789|NCT01322009|Brain injury|brain injury
5074790|NCT01322009|Trauma|trauma
5074791|NCT01321996|PET/CT|pet/ct
5074792|NCT01321996|68Ga-DOTANOC|68ga-dotanoc
5074793|NCT01321996|IPF|ipf
5074795|NCT01321996|Idiopathic pulmonary fibrosis|idiopathic pulmonary fibrosis
5074796|NCT01321931|Smoking Cessation|smoking cessation
5074797|NCT01321931|Nicotine pharmacokinetics|nicotine pharmacokinetics
5074798|NCT01321892|HRME|hrme
5074799|NCT01321892|High-resolution microendoscope|high-resolution microendoscope
5074800|NCT01321892|Optical imaging technology|optical imaging technology
5074801|NCT01321892|Non-invasive fluorescence and reflectance imaging|non-invasive fluorescence and reflectance imaging
5074802|NCT01321892|Upper aerodigestive tract|upper aerodigestive tract
5074803|NCT01321892|Cancer surgery|cancer surgery
5074804|NCT01321892|Squamous cell carcinoma|squamous cell carcinoma
5074805|NCT01321892|Oral cavity|oral cavity
5074806|NCT01321892|Oropharynx|oropharynx
5074807|NCT01321892|Larynx|larynx
5074808|NCT01321892|Hypopharynx|hypopharynx
5074809|NCT01321892|Squamous cell carcinoma of the oral cavity, oropharynx, larynx, and/or hypopharynx|squamous cell carcinoma of the oral cavity, oropharynx, larynx, and/or hypopharynx
5074810|NCT01321879|Gram Positive Bloodstream Infections|gram positive bloodstream infections
5074811|NCT01321879|Sepsis|sepsis
5074812|NCT01321879|Staphylococcus aureus|staphylococcus aureus
5074813|NCT01321879|Enterococci|enterococci
5074814|NCT01321879|Streptococci|streptococci
5074815|NCT01321879|Pneumococci|pneumococci
5074816|NCT01321879|Corynebacterium|corynebacterium
5074817|NCT01321879|Propionibacterium or Bacillus species|propionibacterium or bacillus species
5074818|NCT01321879|Telavancin|telavancin
5074819|NCT01321879|Vibativ|vibativ
5074820|NCT01321866|Angioplasty|angioplasty
5074821|NCT01321866|cutting balloon|cutting balloon
5074822|NCT01321853|Home health care|home health care
5074823|NCT01321853|Medication Management|medication management
5074824|NCT01321853|Cognitive impairment|cognitive impairment
5074825|NCT01321853|Medication adherence|medication adherence
5074826|NCT01321853|Older adults|older adults
5074827|NCT01321853|Care Coordination management|care coordination management
5074828|NCT01321840|Endometriosis|endometriosis
5074829|NCT01321840|pain|pain
5074830|NCT01321840|sart|sart
5074831|NCT01321840|autonomic nervous system|autonomic nervous system
5074832|NCT01321840|fMRI|fmri
5074833|NCT01321840|perfusion|perfusion
5074834|NCT01321840|connectivity|connectivity
5074835|NCT01321840|hypnotherapy|hypnotherapy
5074836|NCT01321840|traditional Chinese medicine|traditional chinese medicine
5074837|NCT01321827|ABPA|abpa
5074838|NCT01321814|Hyperacusis|hyperacusis
5074839|NCT01321814|Personality|personality
5074840|NCT01321814|Comorbidity|comorbidity
5074841|NCT01321814|Treatment|treatment
5074842|NCT01321814|Cognitive behavioral therapy|cognitive behavioral therapy
5074843|NCT01321801|Pregabalin|pregabalin
5074844|NCT01321801|Laparoscopic cholecystectomy|laparoscopic cholecystectomy
5074845|NCT01321801|Postoperative pain|postoperative pain
5074846|NCT01321801|Opioid consumption|opioid consumption
5074847|NCT01321788|thromboprophylaxis|thromboprophylaxis
5074848|NCT01321788|pregnancy|pregnancy
5074849|NCT01321788|post-cesarian section|post-cesarian section
5074850|NCT01321762|Prolapse|prolapse
5074851|NCT01321762|Childbirth|childbirth
5074852|NCT01321762|Pregnancy|pregnancy
5074853|NCT01321749|ischemic cerebral vascular disease|ischemic cerebral vascular disease
5074854|NCT01321749|stroke secondary prevention|stroke secondary prevention
5074855|NCT01321749|remote ischemic preconditioning|remote ischemic preconditioning
5074856|NCT01321736|dietary fiber|dietary fiber
5074857|NCT01321736|enteral nutrition|enteral nutrition
5074858|NCT01321736|laxation|laxation
5074859|NCT01321723|Osteoporosis|osteoporosis
5074860|NCT01321723|Bone Diseases, Metabolic|bone diseases, metabolic
5074861|NCT01321723|Bone Diseases|bone diseases
5074862|NCT01321723|Bone Density Conservation Agents|bone density conservation agents
5074863|NCT01321710|sleep hygiene|sleep hygiene
5074864|NCT01321710|actigraphy|actigraphy
5074865|NCT01321710|maternal|maternal
5074867|NCT01321710|postpartum period|postpartum period
5074868|NCT01321710|immunization|immunization
5074869|NCT01321710|acetaminophen|acetaminophen
5074870|NCT01321697|Being seen in the Winthrop P. Rockefeller Cancer Institute for vulvar|being seen in the winthrop p. rockefeller cancer institute for vulvar
5074871|NCT01321697|cancer requiring lymph node evaluation for the ipsilateral or contralateral|cancer requiring lymph node evaluation for the ipsilateral or contralateral
5074872|NCT01321697|groin|groin
5074873|NCT01321671|pregabalin|pregabalin
5074874|NCT01321671|pharmacokinetics|pharmacokinetics
5074875|NCT01321671|bioavailability|bioavailability
5074876|NCT01321671|bioequivalence|bioequivalence
5074877|NCT01321658|Geriatric Assessment|geriatric assessment
5074878|NCT01321658|Perioperative Care|perioperative care
5074879|NCT01321658|Colorectal Neoplasms|colorectal neoplasms
5074880|NCT01321658|Frail Elderly|frail elderly
5074881|NCT01321645|Acne Vulgaris|acne vulgaris
5074882|NCT01321645|Homoeopathy|homoeopathy
5074883|NCT01321645|Homeopathy|homeopathy
5074884|NCT01321645|Azadirachta Indica|azadirachta indica
5074885|NCT01321632|Acne Vulgaris|acne vulgaris
5074886|NCT01321632|Homoeopathy|homoeopathy
5074887|NCT01321632|Zingiber officinalis|zingiber officinalis
5074888|NCT01321619|Chronic venous insufficiency|chronic venous insufficiency
5074889|NCT01321619|Hemorrhoidal syndrome|hemorrhoidal syndrome
5074890|NCT01321619|Varicell|varicell
5074891|NCT01321606|infection|infection
5074892|NCT01321606|probiotics|probiotics
5074893|NCT01321567|rabeprazole sodium|rabeprazole sodium
5074894|NCT01321567|refractory reflux esophagitis|refractory reflux esophagitis
5074895|NCT01321541|non-hodgkin lymphoma|non-hodgkin lymphoma
5074896|NCT01321541|DLBCL|dlbcl
5074897|NCT01321541|relapsed|relapsed
5074898|NCT01321541|aggressive NHL|aggressive nhl
5074899|NCT01321541|Diffuse large B-cell lymphoma|diffuse large b-cell lymphoma
5074900|NCT01321541|Rituximab|rituximab
5074901|NCT01321541|Rituxan|rituxan
5074902|NCT01321541|Pixantrone|pixantrone
5074903|NCT01321541|NHL|nhl
5074904|NCT01321541|non hodgkin's lymphoma|non hodgkin's lymphoma
5074905|NCT01321541|de novo DLBCL|de novo dlbcl
5074906|NCT01321541|DLBCL transformed from Indolent Lymphoma|dlbcl transformed from indolent lymphoma
5074907|NCT01321541|Follicular Grade 3 Lymphoma|follicular grade 3 lymphoma
5074908|NCT01321502|treatment of herpes|treatment of herpes
5074909|NCT01321489|Phase III|phase iii
5074910|NCT01321489|Sildenafil Citrate Tablet Sublingual|sildenafil citrate tablet sublingual
5074911|NCT01321489|Erectile dysfunction|erectile dysfunction
5074912|NCT01321437|Melanoma|melanoma
5074913|NCT01321437|Axitinib|axitinib
5074914|NCT01321437|Anti-angiogenesis|anti-angiogenesis
5074915|NCT01321437|Neoadjuvant Melanoma|neoadjuvant melanoma
5074916|NCT01321424|Dry Eye|dry eye
5074917|NCT01321424|Tear Osmolarity|tear osmolarity
5074918|NCT01321424|Meibomain Gland Disease|meibomain gland disease
5074919|NCT01321424|Aqueous Dificiency|aqueous dificiency
5074920|NCT01321424|Tear film abnormality|tear film abnormality
5074921|NCT01321411|Respiratory Muscle Blood Flow|respiratory muscle blood flow
5074922|NCT01321411|Work of Breathing|work of breathing
5074923|NCT01321411|Near Infrared Spectroscopy|near infrared spectroscopy
5074924|NCT01321398|High Frequency Oscillation|high frequency oscillation
5074925|NCT01321398|Oscillation|oscillation
5074926|NCT01321398|HFO|hfo
5074927|NCT01321398|Transpulmonary pressure|transpulmonary pressure
5074928|NCT01321385|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
5074929|NCT01321385|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5074930|NCT01321385|untreated childhood acute myeloid leukemia and other myeloid malignancies|untreated childhood acute myeloid leukemia and other myeloid malignancies
5074931|NCT01321385|childhood acute erythroleukemia (M6)|childhood acute erythroleukemia (m6)
5074932|NCT01321385|childhood acute megakaryocytic leukemia (M7)|childhood acute megakaryocytic leukemia (m7)
5074933|NCT01321385|childhood acute monoblastic leukemia (M5a)|childhood acute monoblastic leukemia (m5a)
5074934|NCT01321385|childhood acute monocytic leukemia (M5b)|childhood acute monocytic leukemia (m5b)
5074935|NCT01321385|childhood acute myeloblastic leukemia with maturation (M2)|childhood acute myeloblastic leukemia with maturation (m2)
5074936|NCT01321385|childhood acute myeloblastic leukemia without maturation (M1)|childhood acute myeloblastic leukemia without maturation (m1)
5074937|NCT01321385|childhood acute myelomonocytic leukemia (M4)|childhood acute myelomonocytic leukemia (m4)
5074938|NCT01321385|childhood acute minimally differentiated myeloid leukemia (M0)|childhood acute minimally differentiated myeloid leukemia (m0)
5074939|NCT01321346|Relapse|relapse
5074940|NCT01321346|Lymphoblastic|lymphoblastic
5074941|NCT01321346|Leukemia|leukemia
5074942|NCT01321346|Panobinostat|panobinostat
5074943|NCT01321346|LBH589|lbh589
5074944|NCT01321346|Refractory|refractory
5074945|NCT01321346|Hodgkin's|hodgkin's
5074946|NCT01321346|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
5074947|NCT01321346|Lymphoma|lymphoma
5074948|NCT01321346|Myelogenous|myelogenous
5074949|NCT01321346|Acute|acute
5074950|NCT01321346|Childhood|childhood
5074951|NCT01321346|Pediatric|pediatric
5074952|NCT01321346|ALL|all
5074953|NCT01321346|AML|aml
5074954|NCT01321346|NHL|nhl
5074955|NCT01321346|HD|hd
5074956|NCT01321333|thoracic spinal cord injury|thoracic spinal cord injury
5074957|NCT01321333|spinal cord injury thoracic|spinal cord injury thoracic
5074958|NCT01321333|sub-acute spinal cord injury|sub-acute spinal cord injury
5074959|NCT01321333|human neural stem cells|human neural stem cells
5074960|NCT01321333|stem cells|stem cells
5074961|NCT01321333|stem cells transplant|stem cells transplant
5074962|NCT01321333|stem cells transplant spinal cord injury|stem cells transplant spinal cord injury
5074963|NCT01321320|ICUAP|icuap
5074964|NCT01321320|Critical illness|critical illness
5074965|NCT01321320|Muscle wasting|muscle wasting
5074966|NCT01321320|ICU|icu
5074967|NCT01321307|Aphtostomatitis|aphtostomatitis
5074968|NCT01321307|Mucositis|mucositis
5074969|NCT01321307|Mouth sores|mouth sores
5074970|NCT01321307|Natural|natural
5074971|NCT01321307|Herbal|herbal
5074972|NCT01321281|Osteoarthritis|osteoarthritis
5074973|NCT01321268|orange peel skin|orange peel skin
5074974|NCT01321268|cellulite|cellulite
5074975|NCT01321255|Myocardial Infarction|myocardial infarction
5074976|NCT01321255|Treatment Adherence|treatment adherence
5074977|NCT01321242|Resting heart rate|resting heart rate
5074978|NCT01321242|Stable Angina|stable angina
5074979|NCT01321242|Hypertension|hypertension
5074980|NCT01321242|beta-blockers|beta-blockers
5074981|NCT01321229|Sleep apnea|sleep apnea
5074982|NCT01321229|NIHSS scale|nihss scale
5074983|NCT01321229|FIM scale|fim scale
5074984|NCT01321229|FUGL-MEYER scale|fugl-meyer scale
5074985|NCT01321216|rotavirus|rotavirus
5074986|NCT01321216|gastroenteritis|gastroenteritis
5074987|NCT01321216|children|children
5074988|NCT01321216|Pediatric|pediatric
5074989|NCT01321216|dehydration|dehydration
5074990|NCT01321216|vaccine|vaccine
5074991|NCT01321203|carbon dioxide insufflation|carbon dioxide insufflation
5074992|NCT01321177|Schizophrenia|schizophrenia
5074993|NCT01321177|Schizoaffective Disorder|schizoaffective disorder
5074994|NCT01321177|Schizophreniform Disorder|schizophreniform disorder
5074995|NCT01321177|Brief Psychotic Disorder|brief psychotic disorder
5074996|NCT01321177|Psychotic Disorder NOS|psychotic disorder nos
5074997|NCT01321177|First Episode|first episode
5074998|NCT01321151|Mild Brain Injury|mild brain injury
5074999|NCT01321151|Concussions|concussions
5075000|NCT01321151|Resveratrol|resveratrol
5075001|NCT01321151|Boxers|boxers
5075002|NCT01321151|ImPACT|impact
5075003|NCT01321151|MRI|mri
5075004|NCT01321138|Electrophysiological study|electrophysiological study
5075005|NCT01321138|Nerve block|nerve block
5075006|NCT01321138|Analgesia, Patient-Controlled|analgesia, patient-controlled
5075007|NCT01321138|Anterior cruciate ligament|anterior cruciate ligament
5075008|NCT01321125|Antiseptics|antiseptics
5075009|NCT01321125|Administration cutaneously|administration cutaneously
5075010|NCT01321125|Chlorine compounds|chlorine compounds
5075011|NCT01321125|Anti-infecting agents, local|anti-infecting agents, local
5075012|NCT01321112|Conversion|conversion
5075013|NCT01321112|Mycophenolate mofetil|mycophenolate mofetil
5075014|NCT01321112|Calcineurin inhibitors|calcineurin inhibitors
5075015|NCT01321112|Liver transplantation|liver transplantation
5075016|NCT01321112|Gene expression|gene expression
5075017|NCT01321099|Iron absorption|iron absorption
5075018|NCT01321099|Complementary food fortificant|complementary food fortificant
5075019|NCT01321099|Young children|young children
5075020|NCT01321086|PAD|pad
5075021|NCT01321060|severe acute pancreatitis|severe acute pancreatitis
5075022|NCT01321060|acute fluid collection|acute fluid collection
5075023|NCT01321060|catheter drainage|catheter drainage
5075024|NCT01321060|repeated aspiration|repeated aspiration
5075025|NCT01321047|sedation|sedation
5075026|NCT01321047|benzodiazepine|benzodiazepine
5075027|NCT01321047|opioid|opioid
5075028|NCT01321047|propofol|propofol
5075029|NCT01321034|Lipoprotein (a)|lipoprotein (a)
5075030|NCT01321034|LPA|lpa
5075031|NCT01321034|Niacin|niacin
5075032|NCT01321034|Kringle IV-2 repeats|kringle iv-2 repeats
5075033|NCT01321008|NK cell lymphoma-nasal type|nk cell lymphoma-nasal type
5075034|NCT01321008|Stage I/II|stage i/ii
5075035|NCT01321008|Radiation therapy|radiation therapy
5075036|NCT01321008|XRT|xrt
5075037|NCT01321008|chemotherapy|chemotherapy
5075038|NCT01321008|CHOP|chop
5075039|NCT01321008|Cyclophosphamide|cyclophosphamide
5075040|NCT01321008|Cytoxan|cytoxan
5075041|NCT01321008|Neosar|neosar
5075042|NCT01321008|Adriamycin|adriamycin
5075043|NCT01321008|Doxorubicin|doxorubicin
5075044|NCT01321008|Rubex|rubex
5075045|NCT01321008|Vincristine|vincristine
5075046|NCT01321008|Oncovin|oncovin
5075047|NCT01321008|Prednisone|prednisone
5075048|NCT01320995|Second degree vaginal tear|second degree vaginal tear
5075049|NCT01320995|Perineal ultrasound|perineal ultrasound
5075050|NCT01320995|Anal incontinence|anal incontinence
5075051|NCT01320982|Schizophrenia|schizophrenia
5075052|NCT01320982|schizoaffective disorder|schizoaffective disorder
5075053|NCT01320969|mindfulness, fear conditioning|mindfulness, fear conditioning
5075054|NCT01320956|hypnosis|hypnosis
5075055|NCT01320956|HYPNOANALGESIA|hypnoanalgesia
5075056|NCT01320956|surgery|surgery
5075057|NCT01320956|children|children
5075058|NCT01320956|anxiety|anxiety
5075059|NCT01320956|morphine|morphine
5075060|NCT01320956|pain|pain
5075061|NCT01320956|A-VAS|a-vas
5075062|NCT01320956|orthopaedics|orthopaedics
5075063|NCT01320956|osteotomy|osteotomy
5075064|NCT01320956|tenotomy|tenotomy
5075065|NCT01320956|arthrodesis|arthrodesis
5075066|NCT01320956|spinal column surgery|spinal column surgery
5075067|NCT01320943|stopping oral antiviral therapy|stopping oral antiviral therapy
5075068|NCT01320943|HBsAg loss|hbsag loss
5075069|NCT01320943|seroconversion|seroconversion
5075070|NCT01320943|restarting oral antiviral therapy|restarting oral antiviral therapy
5075071|NCT01320930|Effect of Pulmonary rehabilitation.|effect of pulmonary rehabilitation.
5075072|NCT01320930|Exercise capacity|exercise capacity
5075073|NCT01320930|Quality of life|quality of life
5075074|NCT01320917|obesity|obesity
5075075|NCT01320917|contraceptives hormonal|contraceptives hormonal
5075076|NCT01320917|levonorgestrel-releasing intrauterine device|levonorgestrel-releasing intrauterine device
5075077|NCT01320917|cardiovascular risk|cardiovascular risk
5075078|NCT01320904|Closed Kinetic Chain|closed kinetic chain
5075079|NCT01320904|NMES|nmes
5075080|NCT01320904|Knee Osteoarthritis|knee osteoarthritis
5075081|NCT01320891|general anaesthesia for major abdominal surgery|general anaesthesia for major abdominal surgery
5075082|NCT01320878|pulmonary hypertension|pulmonary hypertension
5075083|NCT01320852|Transplant|transplant
5075084|NCT01320826|colonoscopy|colonoscopy
5075085|NCT01320826|primary care physicians|primary care physicians
5075086|NCT01320826|quality assurance|quality assurance
5075087|NCT01320813|da vinci robot|da vinci robot
5075088|NCT01320813|Thyroidectomy|thyroidectomy
5075089|NCT01320787|Brain|brain
5075090|NCT01320787|Adenocarcinoma of the prostate|adenocarcinoma of the prostate
5075091|NCT01320787|Locally advanced breast cancer|locally advanced breast cancer
5075092|NCT01320787|Estrogen receptor|estrogen receptor
5075093|NCT01320787|ER|er
5075094|NCT01320787|Progesterone receptor|progesterone receptor
5075095|NCT01320787|PR|pr
5075096|NCT01320787|Negative for ErbB2|negative for erbb2
5075097|NCT01320787|Malignant tumor of the central nervous system|malignant tumor of the central nervous system
5075098|NCT01320787|CNS|cns
5075099|NCT01320761|Formulation Comparison|formulation comparison
5075100|NCT01320748|Abstinence from alcohol|abstinence from alcohol
5075101|NCT01320748|Substance Abuse and Mental Health Services|substance abuse and mental health services
5075102|NCT01320748|Social Support|social support
5075103|NCT01320748|Psychosocial Support Systems|psychosocial support systems
5075104|NCT01320748|Psychological support|psychological support
5075105|NCT01320748|Cognitive Support|cognitive support
5075106|NCT01320748|Emotional Support|emotional support
5075107|NCT01320748|Mental Support|mental support
5075108|NCT01320748|Psychosocial Support|psychosocial support
5075109|NCT01320748|Intervention Studies|intervention studies
5075110|NCT01320748|Prevention & control|prevention & control
5075111|NCT01320748|Preventive therapy|preventive therapy
5075112|NCT01320748|Treatment|treatment
5075113|NCT01320748|Therapy|therapy
5075114|NCT01320748|Magnetic Resonance Imaging|magnetic resonance imaging
5075115|NCT01320748|fMRI|fmri
5075116|NCT01320748|Imaging|imaging
5075117|NCT01320748|Magnetic Resonance Imaging, Functional|magnetic resonance imaging, functional
5075118|NCT01320748|MRI Scans|mri scans
5075119|NCT01320748|MRI, Functional|mri, functional
5075120|NCT01320748|Clinical Protocols|clinical protocols
5075121|NCT01320748|Protocols, Treatment|protocols, treatment
5075122|NCT01320748|Drug Abuse Treatment Center|drug abuse treatment center
5075123|NCT01320748|Substance Abuse Treatment Center|substance abuse treatment center
5075124|NCT01320735|Lucrin Depot|lucrin depot
5075125|NCT01320735|intermittent adjuvant regimen|intermittent adjuvant regimen
5075126|NCT01320735|advanced prostate cancer|advanced prostate cancer
5075127|NCT01320735|Leuprorelin|leuprorelin
5075128|NCT01320722|renin angiotensin system|renin angiotensin system
5075129|NCT01320722|vitamin D|vitamin d
5075130|NCT01320722|uric acid|uric acid
5075131|NCT01320722|allopurinol|allopurinol
5075132|NCT01320722|probenecid|probenecid
5075133|NCT01320722|endothelial function|endothelial function
5075134|NCT01320709|Emergency contraception|emergency contraception
5075135|NCT01320709|Contraception|contraception
5075136|NCT01320670|pharmacoresistance|pharmacoresistance
5075137|NCT01320657|Self-ligating|self-ligating
5075138|NCT01320657|orthodontic|orthodontic
5075139|NCT01320657|appliance|appliance
5075140|NCT01320657|expansion|expansion
5075141|NCT01320657|dental inclination|dental inclination
5075142|NCT01320657|Expansion and inclination changes arising with orthodontic treatment|expansion and inclination changes arising with orthodontic treatment
5075143|NCT01320644|Uterine prolapse|uterine prolapse
5075144|NCT01320644|vaginal prolapse|vaginal prolapse
5075145|NCT01320644|mesh erosion|mesh erosion
5075146|NCT01320644|urinary incontinence|urinary incontinence
5075147|NCT01320644|bowel symptoms|bowel symptoms
5075148|NCT01320631|uterine prolapse|uterine prolapse
5075149|NCT01320631|vaginal prolapse|vaginal prolapse
5075150|NCT01320618|uterine prolapse|uterine prolapse
5075151|NCT01320618|vaginal prolapse|vaginal prolapse
5075152|NCT01320618|mesh erosion|mesh erosion
5075153|NCT01320618|urinary incontinence|urinary incontinence
5075154|NCT01320618|bowel symptoms|bowel symptoms
5075155|NCT01320592|Patient must have histologically or cytologically-confirmed metastatic|patient must have histologically or cytologically-confirmed metastatic
5075156|NCT01320592|breast cancer|breast cancer
5075157|NCT01320592|Any ER, PR or Her2 status is allowed.|any er, pr or her2 status is allowed.
5075158|NCT01320592|Tumor must express Retinoblastoma (Rb) protein, defined as|tumor must express retinoblastoma (rb) protein, defined as
5075159|NCT01320592|any measurable staining by immunohistochemistry on the invasive tumor component|any measurable staining by immunohistochemistry on the invasive tumor component
5075160|NCT01320592|<3 prior cyttoxic chemotherapy regimens for metastatic disease.|<3 prior cyttoxic chemotherapy regimens for metastatic disease.
5075161|NCT01320592|Performance status of 0-1 on the ECOG Performance Scale and life expectancy > 3 months.|performance status of 0-1 on the ecog performance scale and life expectancy > 3 months.
5075162|NCT01320592|Patient must have evaluable disease. Measureable disease is not required.|patient must have evaluable disease. measureable disease is not required.
5075163|NCT01320592|The subject has adequate organ function|the subject has adequate organ function
5075164|NCT01320579|atopic dermatitis|atopic dermatitis
5075165|NCT01320579|cis-urocanic acid|cis-urocanic acid
5075166|NCT01320566|Polymeric Lung Volume Reduction (PLVR)|polymeric lung volume reduction (plvr)
5075167|NCT01320566|Bolilogic Lung Volume Reduction (BLVR)|bolilogic lung volume reduction (blvr)
5075168|NCT01320566|AeriSeal|aeriseal
5075169|NCT01320566|treatment|treatment
5075170|NCT01320566|device|device
5075171|NCT01320566|breathing|breathing
5075172|NCT01320566|COPD|copd
5075173|NCT01320566|emphysema|emphysema
5075174|NCT01320566|heterogeneous|heterogeneous
5075175|NCT01320566|homogeneous|homogeneous
5075176|NCT01320566|Pathologic Processes|pathologic processes
5075177|NCT01320566|Respiratory Tract Diseases|respiratory tract diseases
5075178|NCT01320566|Lung Diseases|lung diseases
5075179|NCT01320566|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
5075180|NCT01320527|dietary supplement|dietary supplement
5075181|NCT01320527|cognition|cognition
5075182|NCT01320527|mood|mood
5075183|NCT01320527|Alzheimer's disease|alzheimer's disease
5075184|NCT01320527|memory loss|memory loss
5075185|NCT01320501|Lung Cancer|lung cancer
5075186|NCT01320488|Breast Cancer|breast cancer
5075187|NCT01320475|thoracic epidural analgesia|thoracic epidural analgesia
5075188|NCT01320475|epidural opioid|epidural opioid
5075189|NCT01320475|ketamine|ketamine
5075190|NCT01320475|adverse effect|adverse effect
5075191|NCT01320462|Smoking|smoking
5075192|NCT01320462|quit|quit
5075193|NCT01320462|surgery|surgery
5075194|NCT01320462|anesthesia|anesthesia
5075195|NCT01320462|champix|champix
5075196|NCT01320449|EPO|epo
5075197|NCT01320449|Proteomics|proteomics
5075198|NCT01320449|Carbohydrate metabolism|carbohydrate metabolism
5075199|NCT01320449|Fat metabolism|fat metabolism
5075200|NCT01320449|Protein metabolism|protein metabolism
5075201|NCT01320436|Ulcerative colitis|ulcerative colitis
5075202|NCT01320436|Curcumin|curcumin
5075203|NCT01320423|Intracerebral Haemorrhage|intracerebral haemorrhage
5075204|NCT01320384|ALI|ali
5075205|NCT01320371|barbed sutures|barbed sutures
5075206|NCT01320371|knotted sutures|knotted sutures
5075207|NCT01320371|total knee arthroplasty|total knee arthroplasty
5075208|NCT01320371|knee surgery|knee surgery
5075209|NCT01320358|Patient compliance|patient compliance
5075210|NCT01320358|ECMPS-IEM|ecmps-iem
5075211|NCT01320358|transplantation|transplantation
5075212|NCT01320358|renal maintenance|renal maintenance
5075213|NCT01320358|Proteus|proteus
5075214|NCT01320345|Diabetes Mellitus|diabetes mellitus
5075215|NCT01320345|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
5075216|NCT01320345|Retinopathy|retinopathy
5075217|NCT01320345|Diabetic Nephropathy|diabetic nephropathy
5075218|NCT01320345|Fenofibrate|fenofibrate
5075219|NCT01320332|Ulcerative colitis|ulcerative colitis
5075220|NCT01320332|ASP3291|asp3291
5075221|NCT01320293|Moderate to Severe Chronic plaque type psoriasis|moderate to severe chronic plaque type psoriasis
5075349|NCT01319851|severe aplastic anemia|severe aplastic anemia
5075222|NCT01320280|Prostate cancer, BIBW 2992 (Afatinib) , HER inhibitor|prostate cancer, bibw 2992 (afatinib) , her inhibitor
5075223|NCT01320267|Resectable right colon cancer|resectable right colon cancer
5075224|NCT01320254|Palliative treatment|palliative treatment
5075225|NCT01320254|Panitumumab|panitumumab
5075226|NCT01320254|Cisplatin|cisplatin
5075227|NCT01320254|Cisplatinum|cisplatinum
5075228|NCT01320254|Gemcitabine|gemcitabine
5075229|NCT01320254|Vectibix|vectibix
5075230|NCT01320228|Obesity|obesity
5075231|NCT01320228|orlistat|orlistat
5075232|NCT01320228|fat excretion|fat excretion
5075233|NCT01320228|fiber|fiber
5075234|NCT01320228|dairy calcium|dairy calcium
5075235|NCT01320215|da Vinci Robot|da vinci robot
5075236|NCT01320215|uterine prolapse|uterine prolapse
5075237|NCT01320215|vaginal prolapse|vaginal prolapse
5075238|NCT01320215|sacrohysteropexy|sacrohysteropexy
5075239|NCT01320202|End Stage Renal Disease|end stage renal disease
5075240|NCT01320202|Hemodialysis|hemodialysis
5075241|NCT01320202|SFP|sfp
5075242|NCT01320202|Hemodialysis-dependent chronic renal failure|hemodialysis-dependent chronic renal failure
5075243|NCT01320189|Energy intake|energy intake
5075244|NCT01320189|Protein requirement|protein requirement
5075245|NCT01320189|Satiety|satiety
5075246|NCT01320189|Protein leverage hypothesis|protein leverage hypothesis
5075247|NCT01320150|persistent postsurgical pain (PPP)|persistent postsurgical pain (ppp)
5075248|NCT01320137|Immunological assay|immunological assay
5075249|NCT01320137|Birch allergy|birch allergy
5075250|NCT01320124|Contractures|contractures
5075251|NCT01320124|Total knee arthroplasty|total knee arthroplasty
5075252|NCT01320124|Tissue bank|tissue bank
5075253|NCT01320124|Osteoarthritis|osteoarthritis
5075254|NCT01320124|Gene expressions|gene expressions
5075255|NCT01320111|progression free survival|progression free survival
5075256|NCT01320111|paclitaxel|paclitaxel
5075257|NCT01320111|sorafenib|sorafenib
5075258|NCT01320111|metastatic breast cancer|metastatic breast cancer
5075259|NCT01320098|Attention|attention
5075260|NCT01320098|Behavior Problems|behavior problems
5075261|NCT01320098|Compliance|compliance
5075262|NCT01320098|Evaluation|evaluation
5075263|NCT01320098|Preschool|preschool
5075264|NCT01320098|ADHD|adhd
5075265|NCT01320098|Overactive|overactive
5075266|NCT01320098|Inattentive|inattentive
5075267|NCT01320098|Attention Deficit Hyperactivity Disorder in Preschoolers|attention deficit hyperactivity disorder in preschoolers
5075268|NCT01320085|Metastatic melanoma,|metastatic melanoma,
5075269|NCT01320085|BRAF-mutant,|braf-mutant,
5075270|NCT01320085|NRAS-mutant|nras-mutant
5075271|NCT01320072|aspirin|aspirin
5075272|NCT01320072|asthma|asthma
5075273|NCT01320072|diagnosis|diagnosis
5075274|NCT01320072|prostaglandins|prostaglandins
5075275|NCT01320072|leukotrienes|leukotrienes
5075276|NCT01320059|18F-Fluoro-PEG6-IPQA|18f-fluoro-peg6-ipqa
5075277|NCT01320059|Radioactive Imaging Solution|radioactive imaging solution
5075278|NCT01320059|Non-Small Cell Lung Cancer|non-small cell lung cancer
5075279|NCT01320059|Positron Emission Tomography|positron emission tomography
5075280|NCT01320059|PET Scan|pet scan
5075281|NCT01320059|CT|ct
5075282|NCT01320059|Computed Tomography|computed tomography
5075283|NCT01320046|Urinary Incontinence|urinary incontinence
5075284|NCT01320046|Vulvar pruritus|vulvar pruritus
5075285|NCT01320046|Vulvar contact dermatitis|vulvar contact dermatitis
5075286|NCT01320033|acne vulgaris|acne vulgaris
5075287|NCT01320033|inflammatory lesions|inflammatory lesions
5075288|NCT01320020|Cancer|cancer
5075289|NCT01320020|Neoplasm|neoplasm
5075290|NCT01320020|Carcinoma|carcinoma
5075291|NCT01320020|intravenous|intravenous
5075292|NCT01320020|Monoclonal Antibody|monoclonal antibody
5075293|NCT01320020|Removab|removab
5075294|NCT01319994|glucocorticoid|glucocorticoid
5075295|NCT01319981|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
5075296|NCT01319981|ALL|all
5075297|NCT01319981|Lymphoblastic lymphoma|lymphoblastic lymphoma
5075298|NCT01319981|Cytoxan|cytoxan
5075299|NCT01319981|Neosar|neosar
5075300|NCT01319981|Mesnex|mesnex
5075301|NCT01319981|Liposomal Vincristine|liposomal vincristine
5075302|NCT01319981|Vincristine Sulfate Liposomes Injection|vincristine sulfate liposomes injection
5075303|NCT01319981|Marqibo|marqibo
5075304|NCT01319981|Dexamethasone|dexamethasone
5075305|NCT01319981|Adriamycin|adriamycin
5075306|NCT01319981|Rubex|rubex
5075307|NCT01319981|Cytarabine|cytarabine
5075308|NCT01319981|Cytosar|cytosar
5075309|NCT01319981|DepoCyt|depocyt
5075310|NCT01319981|Cytosine Arabinosine Hydrochloride|cytosine arabinosine hydrochloride
5075311|NCT01319981|Imatinib Mesylate|imatinib mesylate
5075312|NCT01319981|Gleevec|gleevec
5075313|NCT01319981|ST1571|st1571
5075314|NCT01319981|NSC-716051|nsc-716051
5075315|NCT01319981|Filgrastim|filgrastim
5075316|NCT01319981|Neupogen|neupogen
5075317|NCT01319968|Postpartum dyspareunia|postpartum dyspareunia
5075318|NCT01319968|Vaginal atrophy|vaginal atrophy
5075319|NCT01319955|Pneumonia|pneumonia
5075320|NCT01319955|Influenza|influenza
5075321|NCT01319955|Child|child
5075322|NCT01319955|Respiratory|respiratory
5075323|NCT01319955|Pathogen|pathogen
5075324|NCT01319942|Radiotherapy|radiotherapy
5075325|NCT01319942|Sorafenib|sorafenib
5075326|NCT01319942|Treatment outcome|treatment outcome
5075327|NCT01319929|Osteoarthritis, knee pain, osteoarthritic knee pain|osteoarthritis, knee pain, osteoarthritic knee pain
5075328|NCT01319903|sepsis|sepsis
5075329|NCT01319903|inflammation|inflammation
5075330|NCT01319903|complement|complement
5075331|NCT01319903|immune system|immune system
5075332|NCT01319890|all histologic subtypes|all histologic subtypes
5075333|NCT01319890|benign|benign
5075334|NCT01319890|malignant|malignant
5075335|NCT01319864|leukemia|leukemia
5075336|NCT01319851|bone marrow transplant|bone marrow transplant
5075337|NCT01319851|sickle cell disease|sickle cell disease
5075338|NCT01319851|thalassemia|thalassemia
5075339|NCT01319851|Glanzmann thrombasthenia|glanzmann thrombasthenia
5075340|NCT01319851|Wiskott-Aldrich syndrome|wiskott-aldrich syndrome
5075341|NCT01319851|chronic-granulomatous disease|chronic-granulomatous disease
5075342|NCT01319851|severe congenital neutropenia|severe congenital neutropenia
5075343|NCT01319851|leukocyte adhesion deficiency|leukocyte adhesion deficiency
5075344|NCT01319851|Schwachman-Diamond syndrome|schwachman-diamond syndrome
5075345|NCT01319851|Diamond-Blackfan anemia|diamond-blackfan anemia
5075346|NCT01319851|Fanconi anemia|fanconi anemia
5075347|NCT01319851|dyskeratosis-congenita|dyskeratosis-congenita
5075348|NCT01319851|Chediak-Higashi syndrome|chediak-higashi syndrome
5075350|NCT01319838|neuroblastoma|neuroblastoma
5075351|NCT01319838|isotretinoin|isotretinoin
5075352|NCT01319812|Vascular intervention|vascular intervention
5075353|NCT01319812|Endovascular|endovascular
5075354|NCT01319812|Peripheral stent|peripheral stent
5075355|NCT01319799|Embolism|embolism
5075356|NCT01319799|Nervous system|nervous system
5075358|NCT01319799|Valves|valves
5075359|NCT01319799|Ultrasonics|ultrasonics
5075360|NCT01319786|Hypertension|hypertension
5075361|NCT01319786|Microvascular function|microvascular function
5075362|NCT01319760|STEMI|stemi
5075363|NCT01319747|atrial|atrial
5075364|NCT01319747|fibrillation|fibrillation
5075365|NCT01319747|pvi|pvi
5075366|NCT01319747|vats|vats
5075367|NCT01319747|ablation|ablation
5075368|NCT01319734|Vitamin C|vitamin c
5075369|NCT01319734|Oxidative stress|oxidative stress
5075370|NCT01319734|Type 2DM|type 2dm
5075371|NCT01319721|Amniotic membrane|amniotic membrane
5075372|NCT01319721|Limbal conjunctival autograft|limbal conjunctival autograft
5075373|NCT01319721|Limbal|limbal
5075374|NCT01319721|Conjunctival|conjunctival
5075375|NCT01319721|Mitomycin C|mitomycin c
5075376|NCT01319721|Recurrent pterygium|recurrent pterygium
5075377|NCT01319721|Pterygium|pterygium
5075378|NCT01319708|ovarian stimulation|ovarian stimulation
5075379|NCT01319708|climiphene citrate|climiphene citrate
5075380|NCT01319708|Gonadotropin-Releasing Hormone agonists/antagonists|gonadotropin-releasing hormone agonists/antagonists
5075381|NCT01319708|Follicle Stimulating Hormone|follicle stimulating hormone
5075382|NCT01319695|corifollitropin alfa|corifollitropin alfa
5075383|NCT01319695|FSH ovarian stimulation|fsh ovarian stimulation
5075384|NCT01319695|IVF|ivf
5075385|NCT01319682|Pain|pain
5075386|NCT01319682|Preemptive|preemptive
5075387|NCT01319682|Lidocaine|lidocaine
5075388|NCT01319682|Intravenous|intravenous
5075389|NCT01319682|Lumbar fusion|lumbar fusion
5075390|NCT01319656|Chronic diseases|chronic diseases
5075391|NCT01319656|Primary care|primary care
5075392|NCT01319656|Rehabilitation|rehabilitation
5075393|NCT01319656|Chronic Care Model|chronic care model
5075394|NCT01319656|Patient centered medical home|patient centered medical home
5075395|NCT01319643|Oxygen|oxygen
5075396|NCT01319643|Hyperoxia|hyperoxia
5075397|NCT01319643|Intensive care unit|intensive care unit
5075398|NCT01319643|Mortality|mortality
5075399|NCT01319643|Organ dysfunction|organ dysfunction
5075400|NCT01319643|Postoperative care|postoperative care
5075401|NCT01319630|sepsis|sepsis
5075402|NCT01319630|microcirculation|microcirculation
5075403|NCT01319630|saline|saline
5075404|NCT01319630|crystalloid|crystalloid
5075405|NCT01319630|colloid|colloid
5075406|NCT01319630|albumin|albumin
5075407|NCT01319630|hydroxyethyl starch|hydroxyethyl starch
5075408|NCT01319578|chronic kidney disease|chronic kidney disease
5075409|NCT01319578|phosphorus|phosphorus
5075410|NCT01319578|phosphate|phosphate
5075411|NCT01319578|saliva|saliva
5075412|NCT01319578|K2CG|k2cg
5075413|NCT01319578|medical food|medical food
5075414|NCT01319578|chitosan|chitosan
5075415|NCT01319565|Young TIL|young til
5075416|NCT01319565|Metastatic Melanoma|metastatic melanoma
5075417|NCT01319565|Immunotherapy|immunotherapy
5075418|NCT01319565|Adoptive Cell Therapy|adoptive cell therapy
5075419|NCT01319565|Skin Cancer|skin cancer
5075420|NCT01319552|red blood cells|red blood cells
5075421|NCT01319552|transfusion|transfusion
5075422|NCT01319552|storage|storage
5075423|NCT01319552|sickle cell disease|sickle cell disease
5075424|NCT01319552|β-thalassemia|β-thalassemia
5075425|NCT01319552|hemoglobin-associated iron|hemoglobin-associated iron
5075426|NCT01319526|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5075427|NCT01319526|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5075428|NCT01319526|HIV infection|hiv infection
5075429|NCT01319500|Drug Utilization|drug utilization
5075430|NCT01319500|Oral Contraceptives|oral contraceptives
5075431|NCT01319474|Deep vein thrombosis|deep vein thrombosis
5075432|NCT01319474|Pulmonary embolism|pulmonary embolism
5075433|NCT01319474|Ultrasound|ultrasound
5075434|NCT01319474|Pregnancy|pregnancy
5075435|NCT01319461|Osteoarthritis|osteoarthritis
5075436|NCT01319461|Hyalgan|hyalgan
5075437|NCT01319448|Sickle cell disease|sickle cell disease
5075438|NCT01319448|Malaria|malaria
5075439|NCT01319448|Intermittent Preventive Treatment (IPT)|intermittent preventive treatment (ipt)
5075440|NCT01319448|prophylaxis|prophylaxis
5075441|NCT01319435|Ciprofloxacin|ciprofloxacin
5075442|NCT01319435|Neonates|neonates
5075443|NCT01319435|Gram negative infection|gram negative infection
5075444|NCT01319422|myeloma|myeloma
5075445|NCT01319422|multiple myeloma|multiple myeloma
5075446|NCT01319422|pomalidomide|pomalidomide
5075447|NCT01319422|immunomodulatory|immunomodulatory
5075448|NCT01319409|Anterior cruciate ligament surgery|anterior cruciate ligament surgery
5075449|NCT01319409|Anterior cruciate ligament reconstruction|anterior cruciate ligament reconstruction
5075450|NCT01319409|Single bundle anterior cruciate ligament reconstruction|single bundle anterior cruciate ligament reconstruction
5075451|NCT01319409|Double bundle anterior cruciate ligament reconstruction|double bundle anterior cruciate ligament reconstruction
5075452|NCT01319409|Randomized clinical trial|randomized clinical trial
5075453|NCT01319396|breathing rate|breathing rate
5075454|NCT01319383|HIV-1 Infection|hiv-1 infection
5075455|NCT01319383|HIV RNA <50 copies/mL|hiv rna <50 copies/ml
5075456|NCT01319383|Stable ART|stable art
5075457|NCT01319383|Resting CD4+ T cells|resting cd4+ t cells
5075458|NCT01319383|Leukapheresis|leukapheresis
5075459|NCT01319383|Vorinostat|vorinostat
5075460|NCT01319383|HIV RNA expression|hiv rna expression
5075461|NCT01319383|PK visits|pk visits
5075462|NCT01319331|diabetes|diabetes
5075463|NCT01319331|type 1 diabetes|type 1 diabetes
5075464|NCT01319331|AAT|aat
5075465|NCT01319331|Alpha-1 Antitrypsin|alpha-1 antitrypsin
5075466|NCT01319279|Pharmacokinetics|pharmacokinetics
5075467|NCT01319279|Hydrocodone|hydrocodone
5075468|NCT01319279|Extended Release|extended release
5075469|NCT01319279|Hepatic impairment|hepatic impairment
5075470|NCT01319266|hydrocodone|hydrocodone
5075471|NCT01319266|extended release|extended release
5075472|NCT01319266|pharmacokinetics|pharmacokinetics
5075473|NCT01319266|renal impairment|renal impairment
5075474|NCT01319253|Cystic Fibrosis|cystic fibrosis
5075475|NCT01319253|Pseudomonas aeruginosa|pseudomonas aeruginosa
5075476|NCT01319227|Periprosthetic bone remodeling|periprosthetic bone remodeling
5075477|NCT01319227|Stress shielding|stress shielding
5075478|NCT01319227|Short femoral stem|short femoral stem
5075479|NCT01319227|Porous Titanium Construct|porous titanium construct
5075480|NCT01319227|Polyethylene wear|polyethylene wear
5075672|NCT01318200|Accuray|accuray
5075481|NCT01319214|cocaine addiction treatment craving|cocaine addiction treatment craving
5075482|NCT01319188|Age-related macular degeneration|age-related macular degeneration
5075483|NCT01319188|ranibizumab|ranibizumab
5075484|NCT01319188|acute thromboembolic events|acute thromboembolic events
5075485|NCT01319188|coronary artery disease|coronary artery disease
5075486|NCT01319188|cerebrovascular disease|cerebrovascular disease
5075487|NCT01319175|hip flexion strength training|hip flexion strength training
5075488|NCT01319175|elastic bands|elastic bands
5075489|NCT01319175|external resistance|external resistance
5075490|NCT01319162|PCOS|pcos
5075491|NCT01319149|molecular methods|molecular methods
5075492|NCT01319136|new infusion test method|new infusion test method
5075493|NCT01319136|reference method|reference method
5075494|NCT01319136|cerebrospinal fluid dynamics|cerebrospinal fluid dynamics
5075495|NCT01319123|dressing for venous leg ulcers|dressing for venous leg ulcers
5075496|NCT01319110|Cardiac Arrest|cardiac arrest
5075497|NCT01319110|Post Cardiac Arrest|post cardiac arrest
5075498|NCT01319110|CoQ10|coq10
5075499|NCT01319110|Ubiquinone|ubiquinone
5075500|NCT01319110|Post Arrest|post arrest
5075501|NCT01319097|Reduction on local soft tissue edema|reduction on local soft tissue edema
5075502|NCT01319058|obstructive sleep apnea|obstructive sleep apnea
5075503|NCT01319058|Tonsillectomy|tonsillectomy
5075504|NCT01319058|Tonsillotomy|tonsillotomy
5075505|NCT01319058|Inflammation|inflammation
5075506|NCT01319058|Pain|pain
5075507|NCT01319058|Post tonsillectomy bleeding|post tonsillectomy bleeding
5075508|NCT01319045|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
5075509|NCT01319045|Congenital Heart Disease|congenital heart disease
5075510|NCT01319045|Eisenmenger's Syndrome|eisenmenger's syndrome
5075511|NCT01319045|Prostacyclin|prostacyclin
5075512|NCT01319045|Iloprost|iloprost
5075513|NCT01319019|lung function|lung function
5075514|NCT01319019|bronchodilator|bronchodilator
5075515|NCT01319019|COPD, dose response, dosing interval, efficacy, safety, PD, PK|copd, dose response, dosing interval, efficacy, safety, pd, pk
5075516|NCT01319006|relative bioavailability|relative bioavailability
5075517|NCT01318993|GSK1605786A; Inflammatory Bowel Disease; Crohn's disease; long-term treatment; quality of life; CCR9 antagonist|gsk1605786a; inflammatory bowel disease; crohn's disease; long-term treatment; quality of life; ccr9 antagonist
5075518|NCT01318980|ADME|adme
5075519|NCT01318980|IV radiolabelled|iv radiolabelled
5075520|NCT01318980|pharmacokinetics|pharmacokinetics
5075521|NCT01318967|Renal blood flow|renal blood flow
5075522|NCT01318967|Regional renal blood flow|regional renal blood flow
5075523|NCT01318967|MRI|mri
5075524|NCT01318941|Ophthalmology, age-related macular degeneration, Diabetic Macular Edema, Retinal Vein Occlusion, ranibizumab|ophthalmology, age-related macular degeneration, diabetic macular edema, retinal vein occlusion, ranibizumab
5075525|NCT01318941|Ophthalmology|ophthalmology
5075526|NCT01318941|Age-related macular degeneration|age-related macular degeneration
5075527|NCT01318941|Diabetic Macular Edema|diabetic macular edema
5075528|NCT01318941|Retinal Vein Occlusion|retinal vein occlusion
5075529|NCT01318941|LUMINOUS|luminous
5075530|NCT01318941|Ranibizumab|ranibizumab
5075531|NCT01318928|Periodontitis|periodontitis
5075532|NCT01318928|antibiotics|antibiotics
5075533|NCT01318928|treatment period|treatment period
5075534|NCT01318928|microbiology|microbiology
5075535|NCT01318915|Kidney transplantation|kidney transplantation
5075536|NCT01318915|Living donor transplant|living donor transplant
5075537|NCT01318915|Graft rejection|graft rejection
5075538|NCT01318915|Graft loss|graft loss
5075539|NCT01318915|Induction with rituximab and ATG|induction with rituximab and atg
5075540|NCT01318915|Immunosuppression (IS)|immunosuppression (is)
5075541|NCT01318889|Dexpanthenol|dexpanthenol
5075542|NCT01318889|Radiotherapy|radiotherapy
5075543|NCT01318889|chemotherapy|chemotherapy
5075544|NCT01318889|Mucositis|mucositis
5075545|NCT01318876|influenza|influenza
5075546|NCT01318876|vaccine safety|vaccine safety
5075547|NCT01318876|adverse events|adverse events
5075548|NCT01318876|health care workers|health care workers
5075549|NCT01318863|aged matched normal control samples|aged matched normal control samples
5075550|NCT01318850|schizophrenia|schizophrenia
5075551|NCT01318850|cognitive remediation|cognitive remediation
5075552|NCT01318850|fMRI|fmri
5075553|NCT01318837|OABSS|oabss
5075554|NCT01318837|IPSS|ipss
5075555|NCT01318837|PPBC|ppbc
5075556|NCT01318837|Solifenacin|solifenacin
5075557|NCT01318824|Neonatal Respiratory Failure|neonatal respiratory failure
5075558|NCT01318824|Newborn Infant|newborn infant
5075559|NCT01318824|BiPAP|bipap
5075560|NCT01318824|NIPPV|nippv
5075561|NCT01318811|Heparin|heparin
5075562|NCT01318811|CRRT|crrt
5075563|NCT01318811|Continuous renal replacement therapy|continuous renal replacement therapy
5075564|NCT01318811|CVVHD|cvvhd
5075565|NCT01318811|Anticoagulation|anticoagulation
5075566|NCT01318798|Development|development
5075567|NCT01318798|Pre- and intra-operative predictors|pre- and intra-operative predictors
5075568|NCT01318798|Acute renal failure|acute renal failure
5075569|NCT01318798|Liver Surgery|liver surgery
5075570|NCT01318798|Prediction score|prediction score
5075571|NCT01318798|Validation|validation
5075572|NCT01318798|Clinical consequences|clinical consequences
5075573|NCT01318798|Decision curve analysis|decision curve analysis
5075574|NCT01318798|predictors of acute renal failure after liver resection|predictors of acute renal failure after liver resection
5075575|NCT01318785|secondary arm-lymphedema|secondary arm-lymphedema
5075576|NCT01318785|breast cancer related arm-lymphedema|breast cancer related arm-lymphedema
5075577|NCT01318746|change of potassium amount, circadian and day-to-day variability|change of potassium amount, circadian and day-to-day variability
5075578|NCT01318733|Rosacea|rosacea
5075579|NCT01318720|Neck Pain|neck pain
5075580|NCT01318720|Thrust Manipulation|thrust manipulation
5075581|NCT01318720|Non-Thrust Manipulation|non-thrust manipulation
5075582|NCT01318707|Severe Hemophilia A|severe hemophilia a
5075583|NCT01318707|Hemophilia A Patients|hemophilia a patients
5075584|NCT01318707|Serum collection vs a method of added FVIII to blood samples|serum collection vs a method of added fviii to blood samples
5075585|NCT01318694|Chronic hepatitis C|chronic hepatitis c
5075586|NCT01318694|Cyclophilin inhibitor|cyclophilin inhibitor
5075587|NCT01318681|driving, memory, cognition|driving, memory, cognition
5075588|NCT01318668|fmri smoking vaccination mood|fmri smoking vaccination mood
5075589|NCT01318655|Phase I|phase i
5075590|NCT01318655|Japan|japan
5075591|NCT01318655|SAD|sad
5075592|NCT01318655|MAD|mad
5075593|NCT01318642|Adenocarcinoma|adenocarcinoma
5075594|NCT01318642|pancreas|pancreas
5075595|NCT01318642|pancreatic cancer|pancreatic cancer
5075596|NCT01318642|local|local
5075597|NCT01318642|unresectable|unresectable
5075598|NCT01318642|stage II|stage ii
5075599|NCT01318642|stage III|stage iii
5075600|NCT01318616|hip adduction strength training|hip adduction strength training
5075601|NCT01318616|Improvement in adductor strength|improvement in adductor strength
5075602|NCT01318590|Pancreatitis, Chronic|pancreatitis, chronic
5075603|NCT01318590|Abdominal Pain|abdominal pain
5075604|NCT01318590|Celiac bloc|celiac bloc
5075605|NCT01318590|Endosonography|endosonography
5075606|NCT01318564|Type II Diabetes|type ii diabetes
5075607|NCT01318564|Unit dose packaging devices|unit dose packaging devices
5075608|NCT01318564|Metformin|metformin
5075609|NCT01318564|Lisinopril|lisinopril
5075610|NCT01318564|Enalapril|enalapril
5075611|NCT01318564|Atorvastatin|atorvastatin
5075612|NCT01318564|Lipitor|lipitor
5075613|NCT01318564|Simvastatin|simvastatin
5075614|NCT01318564|Aspirin|aspirin
5075615|NCT01318564|Questionnaires|questionnaires
5075616|NCT01318551|Anemia|anemia
5075617|NCT01318538|Substance use disorders, Gender differences, women, treatment outcomes, group therapy|substance use disorders, gender differences, women, treatment outcomes, group therapy
5075618|NCT01318499|cataract|cataract
5075619|NCT01318499|inflammation|inflammation
5075620|NCT01318499|pain|pain
5075621|NCT01318499|inflammatory cells|inflammatory cells
5075622|NCT01318499|aqueous flare|aqueous flare
5075623|NCT01318473|cancer|cancer
5075624|NCT01318460|coronary artery disease|coronary artery disease
5075625|NCT01318460|levosimendan|levosimendan
5075626|NCT01318460|coronary artery bypass grafting|coronary artery bypass grafting
5075627|NCT01318460|cardiac surgery|cardiac surgery
5075628|NCT01318447|Hepatic metastases|hepatic metastases
5075629|NCT01318447|Liver metastases|liver metastases
5075630|NCT01318447|Colorectal cancer|colorectal cancer
5075631|NCT01318447|Colorectal adenocarcinoma|colorectal adenocarcinoma
5075632|NCT01318447|Accuray|accuray
5075633|NCT01318447|CyberKnife|cyberknife
5075634|NCT01318434|Outpatient|outpatient
5075635|NCT01318421|Relapsing forms of secondary progressive multiple sclerosis (SPMS)or relapsing-remitting multiple sclerosis (RRMS)|relapsing forms of secondary progressive multiple sclerosis (spms)or relapsing-remitting multiple sclerosis (rrms)
5075636|NCT01318356|Q fever|q fever
5075637|NCT01318356|Cognitive behavioral therapy|cognitive behavioral therapy
5075638|NCT01318356|Doxycycline|doxycycline
5075639|NCT01318356|Fatigue|fatigue
5075640|NCT01318356|Coxiella|coxiella
5075641|NCT01318343|Cryolipolysis|cryolipolysis
5075642|NCT01318343|Abdominal Fat|abdominal fat
5075643|NCT01318343|Adipose Tissue|adipose tissue
5075644|NCT01318343|Fat Reduction|fat reduction
5075645|NCT01318343|Non Invasive|non invasive
5075646|NCT01318304|innate immunity|innate immunity
5075647|NCT01318304|HIV|hiv
5075648|NCT01318304|pregnancy|pregnancy
5075649|NCT01318304|vaginal immunity|vaginal immunity
5075650|NCT01318291|IVF|ivf
5075651|NCT01318291|Drop out|drop out
5075652|NCT01318278|Hypotension|hypotension
5075653|NCT01318278|Low blood pressure|low blood pressure
5075654|NCT01318278|Neonate|neonate
5075655|NCT01318278|Dopamine|dopamine
5075656|NCT01318278|Vasopressin|vasopressin
5075657|NCT01318278|Extremely Low Birth Weight Infant|extremely low birth weight infant
5075658|NCT01318265|drug interactions|drug interactions
5075659|NCT01318265|ketoconazole|ketoconazole
5075660|NCT01318265|pharmacokinetics|pharmacokinetics
5075661|NCT01318265|human volunteers|human volunteers
5075662|NCT01318252|Elevated IOP|elevated iop
5075663|NCT01318226|postherpetic neuralgia|postherpetic neuralgia
5075664|NCT01318226|shingles|shingles
5075665|NCT01318226|analgesia|analgesia
5075666|NCT01318226|neuropathic pain|neuropathic pain
5075667|NCT01318213|VRE|vre
5075668|NCT01318213|MRSA|mrsa
5075669|NCT01318200|Primary liver cancer|primary liver cancer
5075670|NCT01318200|Hepatocellular carcinoma|hepatocellular carcinoma
5075671|NCT01318200|CyberKnife|cyberknife
5075673|NCT01318200|TACE|tace
5075674|NCT01318200|Transarterial chemoembolization|transarterial chemoembolization
5075675|NCT01318187|renal colic|renal colic
5075676|NCT01318187|paracetamol|paracetamol
5075677|NCT01318187|morphine|morphine
5075678|NCT01318187|emergency department|emergency department
5075679|NCT01318174|Pulmonary embolism|pulmonary embolism
5075680|NCT01318174|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
5075681|NCT01318161|Epidural analgesia|epidural analgesia
5075682|NCT01318161|Patient controlled analgesia|patient controlled analgesia
5075683|NCT01318161|Colorectal cancer|colorectal cancer
5075684|NCT01318161|Morbidity|morbidity
5075685|NCT01318161|Mortality|mortality
5075686|NCT01318148|Echinocandins|echinocandins
5075687|NCT01318148|Caspofungin|caspofungin
5075688|NCT01318148|Pharmacokinetics|pharmacokinetics
5075689|NCT01318148|Prophylaxis|prophylaxis
5075690|NCT01318148|Antifungal|antifungal
5075691|NCT01318148|Aspergillosis|aspergillosis
5075692|NCT01318148|Acute Leucemia|acute leucemia
5075693|NCT01318135|Diabetes Mellitus - Type 2|diabetes mellitus - type 2
5075694|NCT01318135|Diabetes Mellitus|diabetes mellitus
5075695|NCT01318135|Drug Therapy|drug therapy
5075696|NCT01318122|Diabetes Mellitus - Type 2|diabetes mellitus - type 2
5075697|NCT01318122|Diabetes Mellitus|diabetes mellitus
5075698|NCT01318122|Drug Therapy|drug therapy
5075699|NCT01318109|Diabetes Mellitus - Type 2|diabetes mellitus - type 2
5075700|NCT01318109|Diabetes Mellitus|diabetes mellitus
5075701|NCT01318109|Drug Therapy|drug therapy
5075702|NCT01318096|safety|safety
5075703|NCT01318096|efficacy|efficacy
5075704|NCT01318096|raltegravir|raltegravir
5075705|NCT01318096|HBV/HIV co-infection|hbv/hiv co-infection
5075706|NCT01318083|Diabetes Mellitus - Type 2|diabetes mellitus - type 2
5075707|NCT01318083|Diabetes Mellitus|diabetes mellitus
5075708|NCT01318083|Drug Therapy|drug therapy
5075709|NCT01318070|Diabetes Mellitus - Type2|diabetes mellitus - type2
5075710|NCT01318070|Diabetes Mellitus|diabetes mellitus
5075711|NCT01318070|Drug Therapy|drug therapy
5075712|NCT01318057|Pharmacogenetics|pharmacogenetics
5075713|NCT01318057|Warfarin|warfarin
5075714|NCT01318057|Personalized Medicine|personalized medicine
5075715|NCT01318057|Puerto Ricans|puerto ricans
5075716|NCT01318057|Physiogenomics|physiogenomics
5075717|NCT01318057|Hispanics|hispanics
5075718|NCT01318057|Anticoagulants|anticoagulants
5075719|NCT01318057|Cardiovascular|cardiovascular
5075720|NCT01318057|Deep Vein Thrombosis with or without Pulmonary Embolism|deep vein thrombosis with or without pulmonary embolism
5075721|NCT01318057|Cardiac Valvular Replacement|cardiac valvular replacement
5075722|NCT01318044|thiopental|thiopental
5075723|NCT01318044|propofol|propofol
5075724|NCT01318044|sedation|sedation
5075725|NCT01318044|MRI|mri
5075726|NCT01318031|DDI|ddi
5075727|NCT01318031|Healthy Volunteers|healthy volunteers
5075728|NCT01318018|depression|depression
5075729|NCT01318018|bispectral index|bispectral index
5075730|NCT01318018|electroconvulsive therapy|electroconvulsive therapy
5075731|NCT01318018|magnetic seizure therapy|magnetic seizure therapy
5075732|NCT01317992|Medication overuse headache|medication overuse headache
5075733|NCT01317992|ibudilast|ibudilast
5075734|NCT01317992|glia|glia
5075735|NCT01317940|Leukemia|leukemia
5075736|NCT01317940|ALL|all
5075737|NCT01317940|Vitamin D|vitamin d
5075738|NCT01317940|Bone Density|bone density
5075739|NCT01317940|Body Fat|body fat
5075740|NCT01317940|Obesity|obesity
5075741|NCT01317940|Adipose|adipose
5075742|NCT01317927|belionstat|belionstat
5075743|NCT01317927|warfarin|warfarin
5075744|NCT01317927|hematological malignancy|hematological malignancy
5075745|NCT01317927|solid tumors|solid tumors
5075746|NCT01317927|PK/PD study|pk/pd study
5075747|NCT01317901|follicular lymphoma|follicular lymphoma
5075748|NCT01317901|small lymphocytic lymphoma|small lymphocytic lymphoma
5075749|NCT01317901|marginal zone lymphoma|marginal zone lymphoma
5075750|NCT01317901|non-Hodgkin's lymphoma|non-hodgkin's lymphoma
5075751|NCT01317901|indolent lymphoma|indolent lymphoma
5075752|NCT01317888|high grade gliomas of the brain|high grade gliomas of the brain
5075753|NCT01317888|anti-body treatment|anti-body treatment
5075754|NCT01317888|survival|survival
5075755|NCT01317862|labor induction, transcervical foley catheter, prostaglandin|labor induction, transcervical foley catheter, prostaglandin
5075756|NCT01317849|folic acid|folic acid
5075757|NCT01317849|B vitamins|b vitamins
5075758|NCT01317849|secondary prevention|secondary prevention
5075759|NCT01317849|stroke|stroke
5075760|NCT01317849|randomized controlled trial|randomized controlled trial
5075761|NCT01317849|homocysteine|homocysteine
5075762|NCT01317836|pancreatic cystic lesion|pancreatic cystic lesion
5075763|NCT01317836|PET|pet
5075764|NCT01317836|PET-CT|pet-ct
5075765|NCT01317836|diagnosis|diagnosis
5075766|NCT01317823|Multiparas, Bishop score, Cervical length, Cervical ripening|multiparas, bishop score, cervical length, cervical ripening
5075767|NCT01317810|Overactive Bladder (OAB)|overactive bladder (oab)
5075768|NCT01317810|Observational|observational
5075769|NCT01317810|Registry|registry
5075770|NCT01317797|Rheumatoid Arthritis|rheumatoid arthritis
5075771|NCT01317797|MT203|mt203
5076273|NCT01316406|Hand-foot syndrome|hand-foot syndrome
5075772|NCT01317797|Human IgG1 monoclonal antibody|human igg1 monoclonal antibody
5075773|NCT01317797|GM-CSF monoclonal antibody|gm-csf monoclonal antibody
5075774|NCT01317784|diagnosis screening|diagnosis screening
5075775|NCT01317784|HIV serodiagnosis|hiv serodiagnosis
5075776|NCT01317784|HCV antibodies|hcv antibodies
5075777|NCT01317784|serologic tests|serologic tests
5075778|NCT01317784|Bedside testing|bedside testing
5075779|NCT01317784|diagnostic test kits|diagnostic test kits
5075780|NCT01317784|syphilis serodiagnosis|syphilis serodiagnosis
5075781|NCT01317771|Proximal Biceps Pathology|proximal biceps pathology
5075782|NCT01317758|influenza, vaccine, H5N1|influenza, vaccine, h5n1
5075783|NCT01317745|H5N1, vaccine, influenza|h5n1, vaccine, influenza
5075784|NCT01317732|Energy expenditure, physical activity, accelerometer, magnetometer, monitoring|energy expenditure, physical activity, accelerometer, magnetometer, monitoring
5075785|NCT01317719|Rupture of Distal Bicep Tendon|rupture of distal bicep tendon
5075786|NCT01317706|Bishop score, Cervical length, Cervical ripening, Labor induction|bishop score, cervical length, cervical ripening, labor induction
5075787|NCT01317693|LI-ESWT|li-eswt
5075788|NCT01317693|Erectile Dysfunction|erectile dysfunction
5075789|NCT01317693|ED|ed
5075790|NCT01317693|Shock waves|shock waves
5075791|NCT01317693|Therapy|therapy
5075792|NCT01317680|Erectile Dysfunction|erectile dysfunction
5075793|NCT01317680|ED|ed
5075794|NCT01317680|PDE5 inhibitors|pde5 inhibitors
5075795|NCT01317680|LI-ESWT|li-eswt
5075796|NCT01317667|Ricin|ricin
5075797|NCT01317667|RVEc|rvec
5075798|NCT01317654|Tuberculosis meningitis|tuberculosis meningitis
5075799|NCT01317628|tobacco smoke, intervention program|tobacco smoke, intervention program
5075800|NCT01317615|Large cell carcinoma,|large cell carcinoma,
5075801|NCT01317615|Lung cancer,|lung cancer,
5075802|NCT01317615|Neuroendocrine Tumors,|neuroendocrine tumors,
5075803|NCT01317615|RAD001|rad001
5075804|NCT01317602|Atrial Fibrillation|atrial fibrillation
5075805|NCT01317602|AF|af
5075806|NCT01317589|Pain|pain
5075807|NCT01317589|Cancer of Head and Neck|cancer of head and neck
5075808|NCT01317589|methadone|methadone
5075809|NCT01317589|Fentanyl|fentanyl
5075810|NCT01317576|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
5075811|NCT01317576|Exercise|exercise
5075812|NCT01317563|asthma|asthma
5075813|NCT01317563|obesity|obesity
5075814|NCT01317563|nutrition|nutrition
5075815|NCT01317563|antioxidant|antioxidant
5075816|NCT01317550|Non-Small Cell Lung Cancer|non-small cell lung cancer
5075817|NCT01317550|NSCLC|nsclc
5075818|NCT01317550|Symptoms|symptoms
5075819|NCT01317550|Concurrent Chemoradiation|concurrent chemoradiation
5075820|NCT01317550|CXRT|cxrt
5075821|NCT01317550|Fatigue|fatigue
5075822|NCT01317550|Pain|pain
5075823|NCT01317550|Disturbed Sleep|disturbed sleep
5075824|NCT01317550|Lack of Appetite|lack of appetite
5075825|NCT01317550|Drowsiness|drowsiness
5075826|NCT01317550|Armodafinil|armodafinil
5075827|NCT01317550|Nuvigil|nuvigil
5075828|NCT01317550|Minocycline|minocycline
5075829|NCT01317550|Dynacin|dynacin
5075830|NCT01317550|Minocin|minocin
5075831|NCT01317550|Minocin PAC|minocin pac
5075832|NCT01317550|Myrac|myrac
5075833|NCT01317550|Solodyn|solodyn
5075834|NCT01317550|Placebo|placebo
5075835|NCT01317537|personal health records|personal health records
5075836|NCT01317524|Milk|milk
5075837|NCT01317524|Homogenization|homogenization
5075838|NCT01317524|Postprandial hyperlipidemia|postprandial hyperlipidemia
5075839|NCT01317524|Postprandial inflammation|postprandial inflammation
5075840|NCT01317524|Overweight|overweight
5075841|NCT01317498|ART|art
5075842|NCT01317498|antiretroviral|antiretroviral
5075843|NCT01317498|treatment|treatment
5075844|NCT01317498|Vietnam|vietnam
5075845|NCT01317498|Asia|asia
5075846|NCT01317498|viral load|viral load
5075847|NCT01317485|diverticulitis|diverticulitis
5075848|NCT01317485|perforation|perforation
5075849|NCT01317485|sigmoidectomy|sigmoidectomy
5075850|NCT01317485|sigmoid resection|sigmoid resection
5075851|NCT01317485|lavage|lavage
5075852|NCT01317485|laparoscopic|laparoscopic
5075853|NCT01317485|wash-out|wash-out
5075854|NCT01317485|rinsing|rinsing
5075855|NCT01317485|hartmann|hartmann
5075856|NCT01317485|end-colostomy|end-colostomy
5075857|NCT01317485|primary anastomosis|primary anastomosis
5075858|NCT01317472|laryngopharyngeal reflux, acid reflux, throat reflux|laryngopharyngeal reflux, acid reflux, throat reflux
5075859|NCT01317459|Self management|self management
5075860|NCT01317459|Diabetes type one|diabetes type one
5075861|NCT01317459|Empowerment|empowerment
5075862|NCT01317459|Intrinsic motivation|intrinsic motivation
5075863|NCT01317446|gingivitis index|gingivitis index
5075864|NCT01317446|plaque index|plaque index
5075865|NCT01317446|discoloration index|discoloration index
5075866|NCT01317446|mouth rinse|mouth rinse
5075867|NCT01317446|amine fluoride/stannous fluoride|amine fluoride/stannous fluoride
5075868|NCT01317446|clinical trial|clinical trial
5075869|NCT01317433|Metastatic Colorectal Cancer|metastatic colorectal cancer
5075870|NCT01317433|K-RAS wild-type|k-ras wild-type
5075871|NCT01317433|FOLFIRI|folfiri
5075872|NCT01317433|Cetuximab|cetuximab
5075873|NCT01317407|postoperative delirium|postoperative delirium
5075874|NCT01317394|non-albicans candidemia|non-albicans candidemia
5075875|NCT01317368|Postoperative analgesic treatment|postoperative analgesic treatment
5075876|NCT01317368|TAP block|tap block
5075877|NCT01317368|Prostatectomy|prostatectomy
5075878|NCT01317368|Double blinded randomized clinical trial|double blinded randomized clinical trial
5075879|NCT01317355|Cancer|cancer
5075880|NCT01317355|Symptom burden|symptom burden
5075881|NCT01317355|Symptom cluster|symptom cluster
5075882|NCT01317355|Distress|distress
5075883|NCT01317355|Pain|pain
5075884|NCT01317355|Fatigue|fatigue
5075885|NCT01317355|Sleep disorder|sleep disorder
5075886|NCT01317355|HRQoL|hrqol
5075887|NCT01317342|liver transplantation|liver transplantation
5075888|NCT01317342|machine liver perfusion|machine liver perfusion
5075889|NCT01317342|extended criteria liver grafts|extended criteria liver grafts
5075890|NCT01317342|donation after cardiac death|donation after cardiac death
5075891|NCT01317342|hypothermic machine liver perfusion|hypothermic machine liver perfusion
5075892|NCT01317342|liver reperfusion injury|liver reperfusion injury
5075893|NCT01317303|paired associative stimulation|paired associative stimulation
5075894|NCT01317303|theta burst stimulation|theta burst stimulation
5075895|NCT01317303|transcranial magnetic stimulation|transcranial magnetic stimulation
5075896|NCT01317303|neuroplasticity|neuroplasticity
5075897|NCT01317303|healthy controls|healthy controls
5075898|NCT01317290|Conversion of ALA|conversion of ala
5075899|NCT01317277|interventions|interventions
5075900|NCT01317277|technology|technology
5075901|NCT01317277|drug abuse|drug abuse
5075902|NCT01317277|methamphetamine|methamphetamine
5075903|NCT01317264|β-glucan|β-glucan
5075904|NCT01317264|cholesterol|cholesterol
5075905|NCT01317264|bile acids|bile acids
5075906|NCT01317264|blood glucose|blood glucose
5075907|NCT01317264|appetite|appetite
5075908|NCT01317251|Obesity prevention|obesity prevention
5075909|NCT01317251|appetite regulation|appetite regulation
5075910|NCT01317251|hyperlipidemia|hyperlipidemia
5075911|NCT01317238|Smallpox vaccine efficacy|smallpox vaccine efficacy
5075912|NCT01317225|Progesterone|progesterone
5075913|NCT01317225|Obstetric labor, premature|obstetric labor, premature
5075914|NCT01317225|Short cervix|short cervix
5075915|NCT01317212|Glioblastoma multiforme|glioblastoma multiforme
5075916|NCT01317212|Carboplatin|carboplatin
5075917|NCT01317212|Convection-enhanced delivery|convection-enhanced delivery
5075918|NCT01317199|Rising psa|rising psa
5075919|NCT01317186|FGF 23|fgf 23
5075920|NCT01317186|ADMA|adma
5075921|NCT01317186|chronic kidney disease|chronic kidney disease
5075922|NCT01317186|Ca-P metabolism disorder|ca-p metabolism disorder
5075923|NCT01317173|Chronic kidney disease progression|chronic kidney disease progression
5075924|NCT01317173|FGF 23|fgf 23
5075925|NCT01317173|Klotho|klotho
5075926|NCT01317160|Achilles Tendon|achilles tendon
5075927|NCT01317160|Immobilization|immobilization
5075928|NCT01317160|Wound Healing|wound healing
5075929|NCT01317160|Intermittent Pneumatic Compression|intermittent pneumatic compression
5075930|NCT01317160|Ultrasonography|ultrasonography
5075931|NCT01317160|Microdialysis|microdialysis
5075932|NCT01317147|pharmacokinetics|pharmacokinetics
5075933|NCT01317147|serotonin reuptake inhibitors|serotonin reuptake inhibitors
5075934|NCT01317147|gastric bypass|gastric bypass
5075935|NCT01317147|depression|depression
5075936|NCT01317147|bioavailability|bioavailability
5075937|NCT01317147|drug absorption|drug absorption
5075938|NCT01317147|area under curve|area under curve
5075939|NCT01317134|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
5075940|NCT01317134|Prognostic factors|prognostic factors
5075941|NCT01317134|Signal transduction|signal transduction
5075942|NCT01317134|Genetics|genetics
5075943|NCT01317121|Patients with a first episode of schizophrenia|patients with a first episode of schizophrenia
5075944|NCT01317121|Subjects at risk for psychosis|subjects at risk for psychosis
5075945|NCT01317108|node-negative|node-negative
5075946|NCT01317095|Rigid fixation|rigid fixation
5075947|NCT01317095|Sternal closure|sternal closure
5075948|NCT01317095|Open heart surgery|open heart surgery
5075949|NCT01317082|Postoperative Nausea & Vomiting.|postoperative nausea & vomiting.
5075950|NCT01317017|Psoriasis|psoriasis
5075951|NCT01317004|Multiple sclerosis|multiple sclerosis
5075952|NCT01317004|Fingolimod|fingolimod
5075953|NCT01317004|Disease Modifying Therapy|disease modifying therapy
5075954|NCT01317004|TSQM-9|tsqm-9
5075955|NCT01316991|chewing gum|chewing gum
5075956|NCT01316991|appetite|appetite
5075957|NCT01316991|hunger|hunger
5075958|NCT01316991|satiety|satiety
5075959|NCT01316991|metabolic|metabolic
5075960|NCT01316991|nutrition|nutrition
5075961|NCT01316991|gut peptide hormones|gut peptide hormones
5075962|NCT01316991|psychological phenomena and processes|psychological phenomena and processes
5075963|NCT01316965|Postoperative delirium|postoperative delirium
5075964|NCT01316965|elderly|elderly
5075965|NCT01316965|prevention|prevention
5075966|NCT01316965|stepped wedge design|stepped wedge design
5075967|NCT01316965|healthcare workers|healthcare workers
5075968|NCT01316952|carvedilol|carvedilol
5075969|NCT01316952|propranolol|propranolol
5075970|NCT01316952|hypersensitivity reactions|hypersensitivity reactions
5075971|NCT01316952|beta- blockers|beta- blockers
5075972|NCT01316952|Coreg|coreg
5076274|NCT01316406|capecitabine|capecitabine
5075973|NCT01316939|Crohn's disease, oral CCR9 antagonist, placebo-controlled, maintenance of remission, 52-week treatment, quality of life|crohn's disease, oral ccr9 antagonist, placebo-controlled, maintenance of remission, 52-week treatment, quality of life
5075974|NCT01316926|fast condition|fast condition
5075975|NCT01316926|Paroxetine reference/test|paroxetine reference/test
5075976|NCT01316926|healthy volunteers|healthy volunteers
5075977|NCT01316926|Bioequivalence|bioequivalence
5075978|NCT01316913|tiotropium|tiotropium
5075979|NCT01316913|long-acting muscarinic antagonist|long-acting muscarinic antagonist
5075980|NCT01316913|COPD|copd
5075981|NCT01316913|long-acting beta agonist|long-acting beta agonist
5075982|NCT01316900|long-acting muscarinic antagonist|long-acting muscarinic antagonist
5075983|NCT01316900|tiotropium|tiotropium
5075984|NCT01316900|COPD|copd
5075985|NCT01316900|long-acting beta agonist|long-acting beta agonist
5075986|NCT01316887|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5075987|NCT01316887|COPD|copd
5075988|NCT01316887|nDPI|ndpi
5075989|NCT01316887|long-acting beta agonist|long-acting beta agonist
5075990|NCT01316887|long-acting muscarinic antagonist|long-acting muscarinic antagonist
5075991|NCT01316887|tolerability|tolerability
5075992|NCT01316887|safety|safety
5075993|NCT01316874|Valrubicin|valrubicin
5075994|NCT01316874|CIS|cis
5075995|NCT01316874|AD 32, BCG-refractory CIS|ad 32, bcg-refractory cis
5075996|NCT01316874|Carcinoma in situ (CIS) previously treated with BCG|carcinoma in situ (cis) previously treated with bcg
5075997|NCT01316848|AV-951|av-951
5075998|NCT01316848|tivozanib|tivozanib
5075999|NCT01316848|healthy Subjects|healthy subjects
5076000|NCT01316848|food Effect|food effect
5076001|NCT01316848|pharmacokinetics|pharmacokinetics
5076002|NCT01316835|retrospective,sitagliptin, glycemia control,real world|retrospective,sitagliptin, glycemia control,real world
5076003|NCT01316822|CSF1R|csf1r
5076004|NCT01316822|M-CSF|m-csf
5076005|NCT01316822|CSF-1|csf-1
5076006|NCT01316822|c-FMS|c-fms
5076007|NCT01316822|Tumor-associated macrophage|tumor-associated macrophage
5076008|NCT01316822|Macrophage-Colony Stimulating Factor-1|macrophage-colony stimulating factor-1
5076009|NCT01316822|Receptor tyrosine kinase inhibitor|receptor tyrosine kinase inhibitor
5076010|NCT01316822|Tumor cell-induced osteolysis|tumor cell-induced osteolysis
5076011|NCT01316809|Brain|brain
5076012|NCT01316809|Tumor|tumor
5076013|NCT01316809|Recurrent|recurrent
5076014|NCT01316809|Surgery|surgery
5076015|NCT01316809|Radiation|radiation
5076016|NCT01316809|Glioma|glioma
5076017|NCT01316809|Brain Tumor|brain tumor
5076018|NCT01316809|Glioblastoma Multiforme|glioblastoma multiforme
5076019|NCT01316809|Astrocytoma|astrocytoma
5076020|NCT01316809|Brainstem Glioma|brainstem glioma
5076021|NCT01316796|Sickle Cell Disease|sickle cell disease
5076022|NCT01316796|Hemolysis|hemolysis
5076023|NCT01316796|Anemia|anemia
5076024|NCT01316796|Nitric Oxide|nitric oxide
5076025|NCT01316796|Blood Flow|blood flow
5076026|NCT01316796|Leg Ulcer|leg ulcer
5076027|NCT01316796|Sickle Cell Anemia|sickle cell anemia
5076028|NCT01316796|Thalassemia|thalassemia
5076029|NCT01316796|Hemolytic Blood Disorder|hemolytic blood disorder
5076030|NCT01316783|Cardiometabolic Diseases|cardiometabolic diseases
5076031|NCT01316783|African Descent|african descent
5076032|NCT01316783|Cardiovascular Disease|cardiovascular disease
5076033|NCT01316783|Diabetes|diabetes
5076034|NCT01316770|Xerostomia|xerostomia
5076035|NCT01316770|Sj(SqrRoot)(Delta)gren s Syndrome|sj(sqrroot)(delta)gren s syndrome
5076036|NCT01316770|Interventional Study|interventional study
5076037|NCT01316770|Sjogren Syndrome|sjogren syndrome
5076038|NCT01316770|Dry Mouth|dry mouth
5076039|NCT01316744|long-term effects secondary to cancer therapy in adults|long-term effects secondary to cancer therapy in adults
5076040|NCT01316744|anxiety disorder|anxiety disorder
5076041|NCT01316744|depression|depression
5076042|NCT01316744|pain|pain
5076043|NCT01316744|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5076044|NCT01316744|neuropathy|neuropathy
5076045|NCT01316744|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5076046|NCT01316744|acute undifferentiated leukemia|acute undifferentiated leukemia
5076047|NCT01316744|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5076048|NCT01316744|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5076049|NCT01316744|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5076050|NCT01316744|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5076051|NCT01316744|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5076052|NCT01316744|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5076053|NCT01316744|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5076054|NCT01316744|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
5076055|NCT01316744|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5076056|NCT01316744|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5076057|NCT01316744|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5076058|NCT01316744|mast cell leukemia|mast cell leukemia
5076864|NCT01313936|131I-MIBG|131i-mibg
5076059|NCT01316744|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
5076060|NCT01316744|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
5076061|NCT01316744|prolymphocytic leukemia|prolymphocytic leukemia
5076062|NCT01316744|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5076063|NCT01316744|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5076064|NCT01316744|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
5076065|NCT01316744|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5076066|NCT01316744|refractory hairy cell leukemia|refractory hairy cell leukemia
5076067|NCT01316744|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5076068|NCT01316744|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5076069|NCT01316744|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
5076070|NCT01316744|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
5076071|NCT01316744|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
5076072|NCT01316744|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
5076073|NCT01316744|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
5076074|NCT01316744|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5076075|NCT01316744|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
5076076|NCT01316744|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5076077|NCT01316744|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
5076078|NCT01316744|AIDS-related diffuse large cell lymphoma|aids-related diffuse large cell lymphoma
5076079|NCT01316744|AIDS-related diffuse mixed cell lymphoma|aids-related diffuse mixed cell lymphoma
5076080|NCT01316744|AIDS-related diffuse small cleaved cell lymphoma|aids-related diffuse small cleaved cell lymphoma
5076081|NCT01316744|AIDS-related immunoblastic large cell lymphoma|aids-related immunoblastic large cell lymphoma
5076082|NCT01316744|AIDS-related lymphoblastic lymphoma|aids-related lymphoblastic lymphoma
5076083|NCT01316744|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
5076084|NCT01316744|AIDS-related primary CNS lymphoma|aids-related primary cns lymphoma
5076085|NCT01316744|AIDS-related small noncleaved cell lymphoma|aids-related small noncleaved cell lymphoma
5076086|NCT01316744|HIV-associated Hodgkin lymphoma|hiv-associated hodgkin lymphoma
5076087|NCT01316744|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5076088|NCT01316744|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
5076089|NCT01316744|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
5076090|NCT01316744|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5076091|NCT01316744|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5076092|NCT01316744|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5076093|NCT01316744|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
5076094|NCT01316744|cutaneous B-cell non-Hodgkin lymphoma|cutaneous b-cell non-hodgkin lymphoma
5076095|NCT01316744|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5076096|NCT01316744|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
5076097|NCT01316744|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
5076098|NCT01316744|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
5076099|NCT01316744|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
5076100|NCT01316744|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5076101|NCT01316744|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
5076102|NCT01316744|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
5076103|NCT01316744|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
5076104|NCT01316744|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
5076105|NCT01316744|adult grade III lymphomatoid granulomatosis|adult grade iii lymphomatoid granulomatosis
5076106|NCT01316744|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
5076107|NCT01316744|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
5076108|NCT01316744|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5076109|NCT01316744|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5076110|NCT01316744|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5076111|NCT01316744|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
5076112|NCT01316744|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
5076113|NCT01316744|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
5076114|NCT01316744|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
5076115|NCT01316744|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
5076116|NCT01316744|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
5076117|NCT01316744|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
5076118|NCT01316744|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
5076119|NCT01316744|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
5076120|NCT01316744|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
5076865|NCT01313936|Irinotecan|irinotecan
5076121|NCT01316744|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
5076122|NCT01316744|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
5076123|NCT01316744|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
5076124|NCT01316744|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
5076125|NCT01316744|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
5076126|NCT01316744|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
5076127|NCT01316744|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
5076128|NCT01316744|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
5076129|NCT01316744|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
5076130|NCT01316744|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
5076131|NCT01316744|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
5076132|NCT01316744|stage I mantle cell lymphoma|stage i mantle cell lymphoma
5076133|NCT01316744|stage I marginal zone lymphoma|stage i marginal zone lymphoma
5076134|NCT01316744|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
5076135|NCT01316744|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
5076136|NCT01316744|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5076137|NCT01316744|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
5076138|NCT01316744|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
5076139|NCT01316744|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
5076140|NCT01316744|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
5076141|NCT01316744|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5076142|NCT01316744|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5076143|NCT01316744|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5076144|NCT01316744|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5076145|NCT01316744|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
5076146|NCT01316744|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
5076147|NCT01316744|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5076148|NCT01316744|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5076149|NCT01316744|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5076150|NCT01316744|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5076151|NCT01316744|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5076152|NCT01316744|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5076153|NCT01316744|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5076154|NCT01316744|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5076155|NCT01316744|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5076156|NCT01316744|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5076157|NCT01316744|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5076158|NCT01316744|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5076159|NCT01316744|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5076160|NCT01316744|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5076161|NCT01316744|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5076162|NCT01316744|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5076163|NCT01316744|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5076164|NCT01316744|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5076165|NCT01316744|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5076166|NCT01316744|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5076167|NCT01316744|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5076168|NCT01316744|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5076169|NCT01316744|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5076170|NCT01316744|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5076171|NCT01316744|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5076172|NCT01316744|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5076173|NCT01316744|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5076174|NCT01316744|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5076175|NCT01316744|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
5076176|NCT01316744|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5076177|NCT01316744|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5076178|NCT01316744|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5076179|NCT01316744|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5076180|NCT01316744|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5076181|NCT01316744|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5076182|NCT01316744|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5076183|NCT01316744|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5076184|NCT01316744|intraocular lymphoma|intraocular lymphoma
5076185|NCT01316744|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
5076186|NCT01316744|primary central nervous system Hodgkin lymphoma|primary central nervous system hodgkin lymphoma
5076187|NCT01316744|post-transplant lymphoproliferative disorder|post-transplant lymphoproliferative disorder
5076188|NCT01316744|chronic eosinophilic leukemia|chronic eosinophilic leukemia
5076189|NCT01316744|chronic neutrophilic leukemia|chronic neutrophilic leukemia
5076190|NCT01316744|primary myelofibrosis|primary myelofibrosis
5076191|NCT01316744|essential thrombocythemia|essential thrombocythemia
5076192|NCT01316744|polycythemia vera|polycythemia vera
5076193|NCT01316744|extramedullary plasmacytoma|extramedullary plasmacytoma
5076194|NCT01316744|isolated plasmacytoma of bone|isolated plasmacytoma of bone
5076195|NCT01316744|stage I multiple myeloma|stage i multiple myeloma
5076196|NCT01316744|stage II multiple myeloma|stage ii multiple myeloma
5076197|NCT01316744|stage III multiple myeloma|stage iii multiple myeloma
5076198|NCT01316744|primary systemic amyloidosis|primary systemic amyloidosis
5076199|NCT01316744|refractory multiple myeloma|refractory multiple myeloma
5076200|NCT01316744|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5076201|NCT01316744|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5076202|NCT01316744|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5076203|NCT01316744|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
5076204|NCT01316718|IBS|ibs
5076205|NCT01316718|diarrhoea|diarrhoea
5076206|NCT01316679|HCC|hcc
5076207|NCT01316679|Liver Disease without HCC|liver disease without hcc
5076208|NCT01316666|orthostatic hypotension|orthostatic hypotension
5076209|NCT01316666|Multiple System Atrophy|multiple system atrophy
5076210|NCT01316666|Pure Autonomic Failure|pure autonomic failure
5076211|NCT01316666|Parkinson's Disease|parkinson's disease
5076212|NCT01316627|Body Dysmorphic Disorder (BDD)|body dysmorphic disorder (bdd)
5076213|NCT01316627|Cognitive Behavior Therapy (CBT)|cognitive behavior therapy (cbt)
5076214|NCT01316627|Obsessive Compulsive Disorder (OCD)|obsessive compulsive disorder (ocd)
5076215|NCT01316627|Mirror Retraining|mirror retraining
5076216|NCT01316627|Crooked Mirror Externalization Therapy|crooked mirror externalization therapy
5076217|NCT01316614|Fine-Needle Aspiration|fine-needle aspiration
5076218|NCT01316614|Stylet|stylet
5076219|NCT01316614|Solid Mass|solid mass
5076220|NCT01316614|Endoscopic Ultrasound (EUS)|endoscopic ultrasound (eus)
5076221|NCT01316588|recolonization|recolonization
5076222|NCT01316588|Plastic adhesive drape|plastic adhesive drape
5076223|NCT01316588|microbial sealant|microbial sealant
5076224|NCT01316588|SSI|ssi
5076225|NCT01316588|bacterial growth|bacterial growth
5076226|NCT01316575|Continuous Positive Airway Pressure|continuous positive airway pressure
5076227|NCT01316575|Postoperative Complications|postoperative complications
5076228|NCT01316575|Respiratory Insufficiency|respiratory insufficiency
5076229|NCT01316575|Colorectal Surgery|colorectal surgery
5076230|NCT01316549|fludarabine|fludarabine
5076231|NCT01316549|pharmacokinetics|pharmacokinetics
5076232|NCT01316549|pediatric|pediatric
5076233|NCT01316549|allogeneic|allogeneic
5076234|NCT01316549|hematopoietic cell transplantation|hematopoietic cell transplantation
5076235|NCT01316536|pain, agitation, music|pain, agitation, music
5076236|NCT01316523|Lenalidomide|lenalidomide
5076237|NCT01316523|Rituximab|rituximab
5076238|NCT01316523|untreated indolent Non-Hodgkin's Lymphoma|untreated indolent non-hodgkin's lymphoma
5076239|NCT01316510|Probiotic|probiotic
5076240|NCT01316510|bifidobacteria|bifidobacteria
5076241|NCT01316510|intestinal motility|intestinal motility
5076242|NCT01316497|Acute kidney injury|acute kidney injury
5076243|NCT01316497|Ischemic preconditioning|ischemic preconditioning
5076244|NCT01316497|Congenital heart defects|congenital heart defects
5076245|NCT01316497|Cardiac surgical procedures|cardiac surgical procedures
5076246|NCT01316497|Infant|infant
5076247|NCT01316497|Child|child
5076248|NCT01316484|Cognitive Debriefing|cognitive debriefing
5076249|NCT01316471|Chronic Pain|chronic pain
5076250|NCT01316471|Abdominal Pain|abdominal pain
5076251|NCT01316471|Headache|headache
5076252|NCT01316471|Adolescents|adolescents
5076253|NCT01316471|Internet Interventions|internet interventions
5076254|NCT01316471|Behavioral Interventions|behavioral interventions
5076255|NCT01316458|Prostate cancer,|prostate cancer,
5076256|NCT01316458|radical prostatectomy,|radical prostatectomy,
5076257|NCT01316458|PSA rise|psa rise
5076258|NCT01316445|Electroencephalography|electroencephalography
5076259|NCT01316445|Benzodiazepines|benzodiazepines
5076260|NCT01316445|Midazolam|midazolam
5076261|NCT01316432|Cenderitide|cenderitide
5076262|NCT01316432|CD-NP|cd-np
5076263|NCT01316432|Natriuretic peptide|natriuretic peptide
5076264|NCT01316432|Heart failure|heart failure
5076265|NCT01316432|Chronic heart failure|chronic heart failure
5076266|NCT01316432|HF|hf
5076267|NCT01316432|CHF|chf
5076268|NCT01316406|safety|safety
5076269|NCT01316406|efficacy|efficacy
5076270|NCT01316406|treatment|treatment
5076271|NCT01316406|PPES|ppes
5076272|NCT01316406|Palmar-Plantar Erythrodysesthesia Syndrome|palmar-plantar erythrodysesthesia syndrome
5076275|NCT01316393|xerostomia, saliva, mucoprotection, oral health|xerostomia, saliva, mucoprotection, oral health
5076276|NCT01316367|Health Promotion Education|health promotion education
5076277|NCT01316367|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
5076278|NCT01316367|Cardiovascular Risk Factors|cardiovascular risk factors
5076279|NCT01316367|Spain|spain
5076280|NCT01316354|Arabinoxylan|arabinoxylan
5076281|NCT01316354|Beta glucan|beta glucan
5076282|NCT01316354|Whole grain|whole grain
5076283|NCT01316354|Dietary fibre|dietary fibre
5076284|NCT01316354|Metabolic syndrome|metabolic syndrome
5076285|NCT01316354|Glycemic index|glycemic index
5076286|NCT01316354|Satiety|satiety
5076287|NCT01316328|toxicity after single shot partial breast irradiation (SSPBI)|toxicity after single shot partial breast irradiation (sspbi)
5076288|NCT01316302|Social Anxiety Disorder|social anxiety disorder
5076289|NCT01316302|Social Phobia|social phobia
5076290|NCT01316302|SAD|sad
5076291|NCT01316289|tibial fractures|tibial fractures
5076292|NCT01316289|pilon|pilon
5076293|NCT01316289|pilon fractures|pilon fractures
5076294|NCT01316289|tibial plafond|tibial plafond
5076295|NCT01316289|reduction quality|reduction quality
5076296|NCT01316289|anatomical reduction|anatomical reduction
5076297|NCT01316289|functional outcome|functional outcome
5076298|NCT01316289|ankle joint|ankle joint
5076299|NCT01316276|Cystic Fibrosis|cystic fibrosis
5076300|NCT01316276|Respiratory Infections|respiratory infections
5076301|NCT01316276|Pulmonary Cystic Fibrosis|pulmonary cystic fibrosis
5076302|NCT01316276|CFTR|cftr
5076303|NCT01316276|Anti-bacterial Agent|anti-bacterial agent
5076304|NCT01316250|chronic myelogenous leukemia|chronic myelogenous leukemia
5076305|NCT01316250|nilotinib|nilotinib
5076306|NCT01316250|complete cytogenetic response|complete cytogenetic response
5076307|NCT01316250|imatinib mesylate|imatinib mesylate
5076308|NCT01316237|Hepatitis C|hepatitis c
5076309|NCT01316237|HCV|hcv
5076310|NCT01316237|HCV RNA|hcv rna
5076311|NCT01316237|Polymerase inhibitor|polymerase inhibitor
5076312|NCT01316237|Treatment naïve|treatment naïve
5076313|NCT01316237|GS-6620|gs-6620
5076314|NCT01316224|Psoriasis|psoriasis
5076315|NCT01316224|Incidence|incidence
5076316|NCT01316224|Quality of Life|quality of life
5076317|NCT01316224|Psoriatic Arthritis|psoriatic arthritis
5076318|NCT01316224|Prevalence|prevalence
5076319|NCT01316211|Back Pains|back pains
5076320|NCT01316211|Pain, Back|pain, back
5076321|NCT01316211|Pains, Back|pains, back
5076322|NCT01316211|Backache|backache
5076323|NCT01316211|Backaches|backaches
5076324|NCT01316211|Back Ache|back ache
5076325|NCT01316211|Ache, Back|ache, back
5076326|NCT01316211|Aches, Back|aches, back
5076327|NCT01316211|Back Aches|back aches
5076328|NCT01316211|Back Pain without Radiation|back pain without radiation
5076329|NCT01316211|Vertebrogenic Pain Syndrome|vertebrogenic pain syndrome
5076330|NCT01316211|Pain Syndrome, Vertebrogenic|pain syndrome, vertebrogenic
5076331|NCT01316211|Pain Syndromes, Vertebrogenic|pain syndromes, vertebrogenic
5076332|NCT01316211|Syndrome, Vertebrogenic Pain|syndrome, vertebrogenic pain
5076333|NCT01316211|Syndromes, Vertebrogenic Pain|syndromes, vertebrogenic pain
5076334|NCT01316211|Vertebrogenic Pain Syndromes|vertebrogenic pain syndromes
5076335|NCT01316211|Back Pain with Radiation|back pain with radiation
5076336|NCT01316211|Stenosis, spinal|stenosis, spinal
5076337|NCT01316211|Caudal stenosis|caudal stenosis
5076338|NCT01316211|Spondylopathy|spondylopathy
5076339|NCT01316211|Spondylopathies|spondylopathies
5076340|NCT01316211|Low back pain|low back pain
5076341|NCT01316211|Lower back pain|lower back pain
5076342|NCT01316198|human study|human study
5076343|NCT01316198|AMD|amd
5076344|NCT01316198|lutein|lutein
5076345|NCT01316198|zeaxanthin|zeaxanthin
5076346|NCT01316198|optical density|optical density
5076347|NCT01316185|Hepatitis D|hepatitis d
5076348|NCT01316185|HDV|hdv
5076349|NCT01316185|Hepatitis|hepatitis
5076350|NCT01316172|consultation|consultation
5076351|NCT01316146|Hodgkin's Lymphoma|hodgkin's lymphoma
5076352|NCT01316146|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
5076353|NCT01316146|Lymphoma|lymphoma
5076354|NCT01316146|T lymphocytes|t lymphocytes
5076355|NCT01316133|Tacrolimus|tacrolimus
5076356|NCT01316133|Prograf|prograf
5076357|NCT01316133|FK506|fk506
5076358|NCT01316133|Proteinuria|proteinuria
5076359|NCT01316133|Calcineurin inhibitor|calcineurin inhibitor
5076360|NCT01316120|Self-collected vaginal samples|self-collected vaginal samples
5076361|NCT01316120|HPV|hpv
5076362|NCT01316120|HPV self-obtained sample|hpv self-obtained sample
5076363|NCT01316120|HPV specimen transport medium|hpv specimen transport medium
5076364|NCT01316107|ASP1941|asp1941
5076365|NCT01316107|Diabetes mellitus|diabetes mellitus
5076366|NCT01316107|nateglinide|nateglinide
5076367|NCT01316107|long-term safety|long-term safety
5076368|NCT01316094|Renal impairment|renal impairment
5076369|NCT01316094|ASP1941|asp1941
5076370|NCT01316094|Pharmacokinetics|pharmacokinetics
5076371|NCT01316081|antioxidant supplementation|antioxidant supplementation
5076372|NCT01316081|childhood obesity|childhood obesity
5076373|NCT01316081|hepcidin|hepcidin
5076374|NCT01316081|iron status|iron status
5076375|NCT01316081|oxidative stress|oxidative stress
5076376|NCT01316081|inflammation|inflammation
5076377|NCT01316068|diabetic nephropathy|diabetic nephropathy
5076378|NCT01316068|albuminuria|albuminuria
5076379|NCT01316068|type 2 diabetes|type 2 diabetes
5076380|NCT01316068|sulodexide|sulodexide
5076381|NCT01316042|Puberty|puberty
5076382|NCT01316042|Hormones|hormones
5076383|NCT01316029|Laying-on-of-hands|laying-on-of-hands
5076384|NCT01316029|Therapeutic touch|therapeutic touch
5076385|NCT01316029|cross-sectional study|cross-sectional study
5076386|NCT01316029|healing environment|healing environment
5076387|NCT01316029|safety and effectiveness|safety and effectiveness
5076388|NCT01316029|optimal condition for the intervention|optimal condition for the intervention
5076389|NCT01316016|obesity|obesity
5076390|NCT01316016|glucose intolerance|glucose intolerance
5076391|NCT01316016|cholesterol|cholesterol
5076392|NCT01316016|blood pressure|blood pressure
5076393|NCT01316003|cone outer segment tips line|cone outer segment tips line
5076394|NCT01316003|Optical coherence tomography|optical coherence tomography
5076395|NCT01315990|Phase IV Study|phase iv study
5076396|NCT01315990|Metastatic Colorectal Cancer (mCRC|metastatic colorectal cancer (mcrc
5076397|NCT01315990|Cetuximab (Erbitux)|cetuximab (erbitux)
5076398|NCT01315990|first-line treatment|first-line treatment
5076399|NCT01315990|acneiform follicular exanthema|acneiform follicular exanthema
5076400|NCT01315990|rash|rash
5076401|NCT01315990|vitamin K1|vitamin k1
5076402|NCT01315977|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
5076403|NCT01315977|Antioxidant oxidant balance|antioxidant oxidant balance
5076404|NCT01315977|Activation of Antioxidant Response Element|activation of antioxidant response element
5076405|NCT01315964|cholesterol|cholesterol
5076406|NCT01315964|plant sterols|plant sterols
5076407|NCT01315964|atherosclerosis|atherosclerosis
5076408|NCT01315964|arterial stiffness|arterial stiffness
5076409|NCT01315951|Non scalp Seborrheic Dermatitis|non scalp seborrheic dermatitis
5076410|NCT01315925|Acute myeloid leukemia|acute myeloid leukemia
5076411|NCT01315925|invasive fungal infection|invasive fungal infection
5076412|NCT01315925|Aspergillosis|aspergillosis
5076413|NCT01315925|candidiasis|candidiasis
5076414|NCT01315912|clomiphene citrate|clomiphene citrate
5076415|NCT01315912|infertility|infertility
5076416|NCT01315912|letrozole|letrozole
5076417|NCT01315899|Raynaud's phenomenon|raynaud's phenomenon
5076418|NCT01315899|Systemic sclerosis|systemic sclerosis
5076419|NCT01315886|sublingual|sublingual
5076420|NCT01315886|fentanyl|fentanyl
5076421|NCT01315886|titration|titration
5076422|NCT01315886|conversion|conversion
5076423|NCT01315886|breakthrough cancer pain|breakthrough cancer pain
5076424|NCT01315886|pain intensity difference|pain intensity difference
5076425|NCT01315886|PID|pid
5076426|NCT01315886|Edmonton Symptom Assessment System|edmonton symptom assessment system
5076427|NCT01315886|ESAS|esas
5076428|NCT01315873|myeloma|myeloma
5076429|NCT01315873|multiple myeloma|multiple myeloma
5076430|NCT01315873|relapsed myeloma|relapsed myeloma
5076431|NCT01315873|refractory myeloma|refractory myeloma
5076432|NCT01315860|Low Back Pain|low back pain
5076433|NCT01315860|Pregnancy|pregnancy
5076434|NCT01315860|Biomechanics|biomechanics
5076435|NCT01315821|Saccharomyces boulardii|saccharomyces boulardii
5076436|NCT01315821|necrotizing enterocolitis|necrotizing enterocolitis
5076437|NCT01315795|polycystic liver disease|polycystic liver disease
5076438|NCT01315782|Sepsis|sepsis
5076439|NCT01315782|Severe sepsis|severe sepsis
5076440|NCT01315782|Septic shock|septic shock
5076441|NCT01315782|Alveolar dead space|alveolar dead space
5076442|NCT01315782|Multi-organ failure|multi-organ failure
5076443|NCT01315730|stuttering|stuttering
5076444|NCT01315730|haptic|haptic
5076445|NCT01315730|feedback|feedback
5076446|NCT01315730|fluency|fluency
5076447|NCT01315691|Cystic Fibrosis|cystic fibrosis
5076448|NCT01315691|Respiratory Infections|respiratory infections
5076449|NCT01315691|Pulmonary Cystic Fibrosis|pulmonary cystic fibrosis
5076450|NCT01315691|Amikacin|amikacin
5076451|NCT01315691|Anti-bacterial agents|anti-bacterial agents
5076452|NCT01315678|Cystic Fibrosis|cystic fibrosis
5076453|NCT01315678|Respiratory Infections|respiratory infections
5076454|NCT01315678|Pulmonary Cystic Fibrosis|pulmonary cystic fibrosis
5076455|NCT01315678|CFTR|cftr
5076456|NCT01315678|Amikacin|amikacin
5076457|NCT01315678|Anti-bacterial Agents|anti-bacterial agents
5076458|NCT01315665|broccoli sprouts|broccoli sprouts
5076459|NCT01315665|sulforaphane|sulforaphane
5076460|NCT01315665|triterpenoid|triterpenoid
5076461|NCT01315665|Nrf2 activation|nrf2 activation
5076462|NCT01315665|cystic fibrosis|cystic fibrosis
5076463|NCT01315665|healthy volunteers|healthy volunteers
5076464|NCT01315665|anti-inflammatory|anti-inflammatory
5076465|NCT01315652|1 Rheumatoid arthritis|1 rheumatoid arthritis
5076466|NCT01315652|2 Education|2 education
5076467|NCT01315652|3 Co-morbidities|3 co-morbidities
5076468|NCT01315652|4 Nurse|4 nurse
5076469|NCT01315639|Dementia|dementia
5076470|NCT01315639|Cognitive impairment|cognitive impairment
5076471|NCT01315639|Memory impairment|memory impairment
5076472|NCT01315639|Mild Cognitive Impairment|mild cognitive impairment
5076473|NCT01315639|Cerebrospinal fluid|cerebrospinal fluid
5076474|NCT01315639|Plasma|plasma
5076475|NCT01315639|Biomarker|biomarker
5076476|NCT01315639|Longitudinal|longitudinal
5076477|NCT01315639|Abeta peptide amyloid, saPP alpha|abeta peptide amyloid, sapp alpha
5076478|NCT01315639|Oculomotor impairment|oculomotor impairment
5076479|NCT01315626|Bronchiectasis|bronchiectasis
5076480|NCT01315626|pulmonary exacerbations|pulmonary exacerbations
5076481|NCT01315626|pulmonary infections|pulmonary infections
5076482|NCT01315574|Glaucoma|glaucoma
5076483|NCT01315574|Xalatan|xalatan
5076484|NCT01315574|Travatan Z|travatan z
5076485|NCT01315574|Latanoprost|latanoprost
5076486|NCT01315574|Travoprost|travoprost
5076487|NCT01315574|Dry Eye|dry eye
5076488|NCT01315561|acute low back pain|acute low back pain
5076489|NCT01315561|motion stlye acupuncture treatment|motion stlye acupuncture treatment
5076490|NCT01315561|disability|disability
5076491|NCT01315561|MSAT|msat
5076492|NCT01315548|Contrast enhanced harmonic endoscopic ultrasound|contrast enhanced harmonic endoscopic ultrasound
5076493|NCT01315548|Pancreatic adenocarcinoma|pancreatic adenocarcinoma
5076494|NCT01315548|Chronic pancreatitis|chronic pancreatitis
5076495|NCT01315535|Mandibular Advancement|mandibular advancement
5076496|NCT01315535|Oral Appliance|oral appliance
5076497|NCT01315535|TMD|tmd
5076498|NCT01315522|Stents|stents
5076499|NCT01315522|Endoscopy|endoscopy
5076500|NCT01315522|Cholangiopancreatography|cholangiopancreatography
5076501|NCT01315522|Endoscopic Retrograde|endoscopic retrograde
5076502|NCT01315509|Severe mental illness|severe mental illness
5076503|NCT01315509|Dental measures|dental measures
5076504|NCT01315509|Resistant depression|resistant depression
5076505|NCT01315496|Human Immunoglobulin G|human immunoglobulin g
5076506|NCT01315496|Sepsis|sepsis
5076507|NCT01315496|Septic shock|septic shock
5076508|NCT01315483|Breast cancer|breast cancer
5076509|NCT01315483|survivors|survivors
5076510|NCT01315483|weight lose|weight lose
5076511|NCT01315483|dietary pattern|dietary pattern
5076512|NCT01315470|improving pregnancy rate and endometrial thickness|improving pregnancy rate and endometrial thickness
5076513|NCT01315457|alemtuzumab, infection, prophylaxis, treatment|alemtuzumab, infection, prophylaxis, treatment
5076514|NCT01315431|Solid tumor malignancy, excluding lymphoma|solid tumor malignancy, excluding lymphoma
5076515|NCT01315418|Probiotic - Lactobacillus casei DN-114 001 - dairy product -|probiotic - lactobacillus casei dn-114 001 - dairy product -
5076516|NCT01315418|infections - firemen|infections - firemen
5076517|NCT01315418|Common infectious diseases, occuring in healthy subjects,|common infectious diseases, occuring in healthy subjects,
5076518|NCT01315418|including upper respiratory tract infections (defined as|including upper respiratory tract infections (defined as
5076519|NCT01315418|rhinopharyngitis, sore throat, sinusitis and otitis)|rhinopharyngitis, sore throat, sinusitis and otitis)
5076520|NCT01315418|lower respiratory tract infections (defined as bronchitis|lower respiratory tract infections (defined as bronchitis
5076521|NCT01315418|pneumopathy and flu and flu-like syndromes)|pneumopathy and flu and flu-like syndromes)
5076522|NCT01315418|gastrointestinal tract infection defined as gastroenteritis|gastrointestinal tract infection defined as gastroenteritis
5076523|NCT01315405|Emotional facial expression|emotional facial expression
5076524|NCT01315405|Apathy|apathy
5076525|NCT01315405|Mirror neurons|mirror neurons
5076526|NCT01315379|Prolonged Exposure|prolonged exposure
5076527|NCT01315379|CBT|cbt
5076528|NCT01315379|PTSD|ptsd
5076529|NCT01315379|Mild Traumatic Brain Injury|mild traumatic brain injury
5076530|NCT01315379|Post Concussive Syndrome|post concussive syndrome
5076531|NCT01315366|Vitamin D|vitamin d
5076532|NCT01315366|Elderly|elderly
5076533|NCT01315366|Cardiovascular profile|cardiovascular profile
5076534|NCT01315366|Insulin resistance|insulin resistance
5076535|NCT01315366|Gene polymorphisms|gene polymorphisms
5076536|NCT01315327|Tourette's Disorder, Obsessive-Compulsive Disorder, tics|tourette's disorder, obsessive-compulsive disorder, tics
5076665|NCT01314755|Post-operative|post-operative
5076537|NCT01315314|Glucose degradation products|glucose degradation products
5076538|NCT01315314|Inflammation|inflammation
5076539|NCT01315314|Endothelial dysfunction|endothelial dysfunction
5076540|NCT01315314|Soluble adhesion molecules|soluble adhesion molecules
5076541|NCT01315314|Peritoneal dialysis|peritoneal dialysis
5076542|NCT01315301|Efavirenz|efavirenz
5076543|NCT01315301|Rifampicin|rifampicin
5076544|NCT01315301|HAART|haart
5076545|NCT01315301|Anti Tuberculosis|anti tuberculosis
5076546|NCT01315288|Medical decision making|medical decision making
5076547|NCT01315288|Asymptomatic Carotid Stenosis|asymptomatic carotid stenosis
5076548|NCT01315275|visual impairment|visual impairment
5076549|NCT01315275|macular edema|macular edema
5076550|NCT01315275|ranibizumab|ranibizumab
5076551|NCT01315275|visual impairment due to macular edema|visual impairment due to macular edema
5076552|NCT01315262|Sildenafil 100|sildenafil 100
5076553|NCT01315262|restoring erectile function after radical prostatectomy|restoring erectile function after radical prostatectomy
5076554|NCT01315249|QVA149|qva149
5076555|NCT01315249|indacaterol|indacaterol
5076556|NCT01315249|NVA237|nva237
5076557|NCT01315249|COPD|copd
5076558|NCT01315249|fluticasone/salmeterol|fluticasone/salmeterol
5076559|NCT01315210|Fibromyalgia|fibromyalgia
5076560|NCT01315210|Fatigue|fatigue
5076561|NCT01315210|D-Ribose|d-ribose
5076562|NCT01315197|Low back Pain|low back pain
5076563|NCT01315184|Interactive Voice Response|interactive voice response
5076564|NCT01315184|Computer-based Treatment|computer-based treatment
5076565|NCT01315184|Opioid Agonist|opioid agonist
5076566|NCT01315184|Buprenorphine|buprenorphine
5076567|NCT01315184|Methadone|methadone
5076568|NCT01315171|medium chain triglycerides|medium chain triglycerides
5076569|NCT01315171|hypoglycemia|hypoglycemia
5076570|NCT01315171|cognitive function|cognitive function
5076571|NCT01315171|functional MRI|functional mri
5076572|NCT01315158|Obstructive Sleep Apnea|obstructive sleep apnea
5076573|NCT01315158|Body Mass Index|body mass index
5076574|NCT01315132|Myeloablative Hematopoietic Stem Cell Transplant|myeloablative hematopoietic stem cell transplant
5076575|NCT01315132|Cyclophosphamide tolerization|cyclophosphamide tolerization
5076576|NCT01315132|2 Step Approach|2 step approach
5076577|NCT01315132|Hematological malignancies|hematological malignancies
5076578|NCT01315132|leukemia|leukemia
5076579|NCT01315132|lymphoma|lymphoma
5076580|NCT01315132|multiple myeloma|multiple myeloma
5076581|NCT01315132|Hodgkin's Disease|hodgkin's disease
5076582|NCT01315093|In Vitro Fertilisation|in vitro fertilisation
5076583|NCT01315093|poor responders|poor responders
5076584|NCT01315080|mammillary fistula|mammillary fistula
5076585|NCT01315080|triamcinolone|triamcinolone
5076586|NCT01315080|ultrasound management|ultrasound management
5076587|NCT01315080|percutaneous treatment|percutaneous treatment
5076588|NCT01315067|kidney transplantation|kidney transplantation
5076589|NCT01315067|acute rejection|acute rejection
5076590|NCT01315067|diagnosis|diagnosis
5076591|NCT01315067|urine analysis|urine analysis
5076592|NCT01315067|urinary peptides|urinary peptides
5076593|NCT01315067|mass spectrometry|mass spectrometry
5076594|NCT01315067|allograft biopsy|allograft biopsy
5076595|NCT01315067|pathology|pathology
5076596|NCT01315067|diagnostic study|diagnostic study
5076597|NCT01315054|IDUs|idus
5076598|NCT01315054|high risk behaviors|high risk behaviors
5076599|NCT01315054|HIV|hiv
5076600|NCT01315054|MMT dosage and retention|mmt dosage and retention
5076601|NCT01315054|psychosocial services|psychosocial services
5076602|NCT01315028|mania|mania
5076603|NCT01315028|hypomania|hypomania
5076604|NCT01315028|bipolar affective disorder|bipolar affective disorder
5076605|NCT01315028|psychological intervention|psychological intervention
5076606|NCT01315028|cognitive therapy|cognitive therapy
5076607|NCT01315015|Breast cancer|breast cancer
5076608|NCT01315015|Breast neoplasm|breast neoplasm
5076609|NCT01315015|Magnetic Resonance Imaging|magnetic resonance imaging
5076610|NCT01315015|Breast density|breast density
5076611|NCT01315015|Early detection of cancer|early detection of cancer
5076612|NCT01315015|Cancer screening test|cancer screening test
5076613|NCT01315015|Secondary prevention|secondary prevention
5076614|NCT01315002|nicotine|nicotine
5076615|NCT01315002|schizophrenia|schizophrenia
5076616|NCT01315002|endophenotype|endophenotype
5076617|NCT01314976|Children|children
5076618|NCT01314976|parasite|parasite
5076619|NCT01314976|intestinal|intestinal
5076620|NCT01314976|treatment|treatment
5076621|NCT01314976|RCT|rct
5076622|NCT01314937|preschool-age children|preschool-age children
5076623|NCT01314937|soil-transmitted helminths|soil-transmitted helminths
5076624|NCT01314937|growth|growth
5076625|NCT01314937|development|development
5076626|NCT01314937|deworming|deworming
5076627|NCT01314924|Hypertension|hypertension
5076628|NCT01314924|Endothelial dysfunction|endothelial dysfunction
5076629|NCT01314924|Vascular stiffness|vascular stiffness
5076630|NCT01314924|Use of one or two antihypertensive drugs|use of one or two antihypertensive drugs
5076631|NCT01314911|H1N1|h1n1
5076632|NCT01314911|Complications|complications
5076633|NCT01314911|PCR|pcr
5076634|NCT01314911|Seasonal Influenza|seasonal influenza
5076635|NCT01314911|Viral Shedding|viral shedding
5076636|NCT01314898|Single dose|single dose
5076637|NCT01314898|cross-over|cross-over
5076638|NCT01314898|active-control|active-control
5076639|NCT01314898|placebo control|placebo control
5076640|NCT01314898|antimineralocorticoid activity|antimineralocorticoid activity
5076641|NCT01314885|Healthy|healthy
5076642|NCT01314872|Overactive bladder|overactive bladder
5076643|NCT01314872|MK-4618|mk-4618
5076644|NCT01314872|tolterodine|tolterodine
5076645|NCT01314859|Nifedipine|nifedipine
5076646|NCT01314859|Obstetric Labor|obstetric labor
5076647|NCT01314859|Premature|premature
5076648|NCT01314859|Tocolysis|tocolysis
5076649|NCT01314833|Luminal A|luminal a
5076650|NCT01314833|Luminal B|luminal b
5076651|NCT01314833|Her-2 overexpression|her-2 overexpression
5076652|NCT01314833|DFS|dfs
5076653|NCT01314833|DDFS|ddfs
5076654|NCT01314833|OS|os
5076655|NCT01314820|Knee|knee
5076656|NCT01314820|Osteoarthritis|osteoarthritis
5076657|NCT01314820|Effusion.|effusion.
5076658|NCT01314807|COPD|copd
5076659|NCT01314781|Overactive Bladder|overactive bladder
5076660|NCT01314781|urinary frequency|urinary frequency
5076661|NCT01314755|Head and Neck neoplasm|head and neck neoplasm
5076662|NCT01314755|Nutrition|nutrition
5076663|NCT01314755|Carcinoma|carcinoma
5076664|NCT01314755|Infection|infection
5076666|NCT01314755|Surgery|surgery
5076667|NCT01314755|Immune-enhancing|immune-enhancing
5076668|NCT01314742|neonates|neonates
5076669|NCT01314742|mechanical ventilation|mechanical ventilation
5076670|NCT01314742|oral care|oral care
5076671|NCT01314742|duration of mechanical ventilation|duration of mechanical ventilation
5076672|NCT01314742|feasibility|feasibility
5076673|NCT01314742|ventilator-associated pneumonia|ventilator-associated pneumonia
5076674|NCT01314729|Orthodontic fixed retainer|orthodontic fixed retainer
5076675|NCT01314729|fiber-reinforced-composite retainer|fiber-reinforced-composite retainer
5076676|NCT01314729|composite-wire retainer|composite-wire retainer
5076677|NCT01314690|obesity|obesity
5076678|NCT01314690|low calorie diet|low calorie diet
5076679|NCT01314690|intestinal microbiota|intestinal microbiota
5076680|NCT01314690|inflammation (systemic and in adipose tissue)|inflammation (systemic and in adipose tissue)
5076681|NCT01314690|fat mass|fat mass
5076682|NCT01314690|Impact of nutritional transition on intestinal microbiota|impact of nutritional transition on intestinal microbiota
5076683|NCT01314690|relation between food intake, clinical parameters and intestinal microbiota|relation between food intake, clinical parameters and intestinal microbiota
5076684|NCT01314664|Non-Muscle Invasive Bladder Cancer|non-muscle invasive bladder cancer
5076686|NCT01314664|BCG Refractory|bcg refractory
5076687|NCT01314651|Migraine Disorders|migraine disorders
5076688|NCT01314651|Chronic migraine|chronic migraine
5076689|NCT01314651|Insomnia|insomnia
5076690|NCT01314651|Behavioral sleep management|behavioral sleep management
5076691|NCT01314612|Insomnia|insomnia
5076692|NCT01314612|group psychotherapy|group psychotherapy
5076693|NCT01314612|nightmares|nightmares
5076694|NCT01314612|PTSD|ptsd
5076695|NCT01314612|posttraumatic stress disorder|posttraumatic stress disorder
5076696|NCT01314612|Veterans|veterans
5076697|NCT01314612|cognitive-behavioral intervention|cognitive-behavioral intervention
5076698|NCT01314599|Leukemia|leukemia
5076699|NCT01314599|lurbinectedin|lurbinectedin
5076700|NCT01314599|PM01183|pm01183
5076701|NCT01314599|Pharma Mar|pharma mar
5076702|NCT01314599|Acute Leukemia in Relapse and Primary Refractory|acute leukemia in relapse and primary refractory
5076703|NCT01314586|hypercholesterolemia|hypercholesterolemia
5076704|NCT01314586|postmenopause|postmenopause
5076705|NCT01314586|secoisolariciresinol diglucoside|secoisolariciresinol diglucoside
5076706|NCT01314586|flaxseed|flaxseed
5076707|NCT01314586|lignans|lignans
5076708|NCT01314586|enterolactone|enterolactone
5076709|NCT01314586|enterodiol|enterodiol
5076710|NCT01314586|serum cholesterol|serum cholesterol
5076711|NCT01314586|LDL cholesterol|ldl cholesterol
5076712|NCT01314573|High intensity exercise training|high intensity exercise training
5076713|NCT01314573|Vascular health|vascular health
5076714|NCT01314573|Endothelial function|endothelial function
5076715|NCT01314573|Circulating angiogenic cells|circulating angiogenic cells
5076716|NCT01314573|endothelial progenitor cells|endothelial progenitor cells
5076717|NCT01314573|Aerobic capacity|aerobic capacity
5076718|NCT01314573|Arterial stiffness|arterial stiffness
5076719|NCT01314573|Traditional and emerging cardiovascular disease risk factors|traditional and emerging cardiovascular disease risk factors
5076720|NCT01314560|Lowe syndrome|lowe syndrome
5076721|NCT01314560|OCRL|ocrl
5076722|NCT01314560|Haemostasis|haemostasis
5076723|NCT01314560|Bleeding Disorders|bleeding disorders
5076724|NCT01314560|Platelet Function Tests|platelet function tests
5076725|NCT01314547|Environment|environment
5076726|NCT01314547|spondylarthritis|spondylarthritis
5076727|NCT01314547|vasculitis|vasculitis
5076728|NCT01314547|stress|stress
5076729|NCT01314547|life event|life event
5076730|NCT01314547|vaccine|vaccine
5076731|NCT01314534|Kabuki syndrome|kabuki syndrome
5076732|NCT01314534|Genetic|genetic
5076733|NCT01314534|CGH-array|cgh-array
5076734|NCT01314521|Suicide|suicide
5076735|NCT01314521|Depression|depression
5076736|NCT01314521|Adolescents|adolescents
5076737|NCT01314508|pre-pubertal children|pre-pubertal children
5076738|NCT01314508|pre-transplant|pre-transplant
5076739|NCT01314508|not treated with growth hormone for at least 3 months|not treated with growth hormone for at least 3 months
5076740|NCT01314495|Alopecia Areata|alopecia areata
5076741|NCT01314482|Neuropathic pain|neuropathic pain
5076742|NCT01314482|Minocycline|minocycline
5076743|NCT01314469|Quality of life in patients with macular edema compared to patients without macular edema.|quality of life in patients with macular edema compared to patients without macular edema.
5076744|NCT01314456|Prostate biopsy|prostate biopsy
5076745|NCT01314456|Trans-rectal ultrasound|trans-rectal ultrasound
5076746|NCT01314456|Prostate cancer|prostate cancer
5076747|NCT01314443|smoking cessation|smoking cessation
5076748|NCT01314443|gamma-tocopherol|gamma-tocopherol
5076749|NCT01314443|nicotine-replacement therapy|nicotine-replacement therapy
5076750|NCT01314443|oxidative stress|oxidative stress
5076751|NCT01314417|Uveitis|uveitis
5076752|NCT01314417|Macular Edema|macular edema
5076753|NCT01314417|Methotrexate|methotrexate
5076754|NCT01314404|Human papillomavirus|human papillomavirus
5076755|NCT01314404|Prevalence|prevalence
5076756|NCT01314404|Knowledge Attitude and Practice|knowledge attitude and practice
5076757|NCT01314404|Willingness to Participate|willingness to participate
5076758|NCT01314404|Vaccine|vaccine
5076759|NCT01314404|HPV|hpv
5076760|NCT01314391|stage I Wilms tumor|stage i wilms tumor
5076761|NCT01314391|stage II Wilms tumor|stage ii wilms tumor
5076762|NCT01314391|stage III Wilms tumor|stage iii wilms tumor
5076763|NCT01314391|stage IV Wilms tumor|stage iv wilms tumor
5076764|NCT01314391|stage V Wilms tumor|stage v wilms tumor
5076765|NCT01314391|renal failure|renal failure
5076766|NCT01314378|Mindfulness|mindfulness
5076767|NCT01314378|Cognitive behavioral therapy|cognitive behavioral therapy
5076768|NCT01314378|Smoking|smoking
5076769|NCT01314378|Impulsivity|impulsivity
5076770|NCT01314378|Inhibitory Control|inhibitory control
5076771|NCT01314326|Optical Coherence Tomography|optical coherence tomography
5076772|NCT01314326|Glaucoma|glaucoma
5076773|NCT01314326|Advanced Imaging|advanced imaging
5076774|NCT01314313|SAPIEN XT|sapien xt
5076775|NCT01314313|Transfemoral|transfemoral
5076776|NCT01314313|Transapical|transapical
5076777|NCT01314313|Transaortic|transaortic
5076778|NCT01314313|NovaFlex|novaflex
5076779|NCT01314313|TAVI|tavi
5076780|NCT01314313|Aortic Stenosis|aortic stenosis
5076781|NCT01314313|THV|thv
5076782|NCT01314313|Aortic Valve|aortic valve
5076783|NCT01314313|Transcatheter Heart Valve|transcatheter heart valve
5076784|NCT01314313|TAVR|tavr
5076785|NCT01314300|Child, adolescent, young adult|child, adolescent, young adult
5076786|NCT01314300|Plaster|plaster
5076787|NCT01314300|Lidocaine|lidocaine
5076788|NCT01314287|Anaesthesia|anaesthesia
5076789|NCT01314287|pulmonary complications|pulmonary complications
5076790|NCT01314287|Atelectasis|atelectasis
5076791|NCT01314274|Epistaxis|epistaxis
5076792|NCT01314274|Osler|osler
5076793|NCT01314274|Weber|weber
5076794|NCT01314274|Rendu|rendu
5076795|NCT01314274|HHT|hht
5076796|NCT01314274|Hereditary haemorrhagic telangiectasia|hereditary haemorrhagic telangiectasia
5076797|NCT01314248|airway sealing pressure|airway sealing pressure
5076798|NCT01314248|fiberoptic assessment|fiberoptic assessment
5076799|NCT01314248|ease and time for successful insertion|ease and time for successful insertion
5076800|NCT01314248|incidence of gastric insufflation|incidence of gastric insufflation
5076801|NCT01314248|complications were also evaluated|complications were also evaluated
5076802|NCT01314235|anticoagulation with ASS|anticoagulation with ass
5076803|NCT01314235|anticoagulation with clopidogrel|anticoagulation with clopidogrel
5076804|NCT01314209|dexmedetomidine|dexmedetomidine
5076805|NCT01314209|pharmacokinetics|pharmacokinetics
5076806|NCT01314209|critical illness|critical illness
5076807|NCT01314209|continuous renal replacement therapy|continuous renal replacement therapy
5076808|NCT01314196|biceps|biceps
5076809|NCT01314196|resistance training|resistance training
5076810|NCT01314196|rehabilitation|rehabilitation
5076811|NCT01314196|impact syndrome|impact syndrome
5076812|NCT01314183|Knee|knee
5076813|NCT01314183|Physical Therapy|physical therapy
5076814|NCT01314183|Exercise|exercise
5076815|NCT01314170|Implant, glaucoma, refractory glaucoma.|implant, glaucoma, refractory glaucoma.
5076816|NCT01314157|low back pain|low back pain
5076817|NCT01314157|pain|pain
5076818|NCT01314157|incapacity|incapacity
5076819|NCT01314157|life quality|life quality
5076820|NCT01314157|rehabilitation|rehabilitation
5076821|NCT01314144|axillary clearance|axillary clearance
5076822|NCT01314144|wound infiltration|wound infiltration
5076823|NCT01314144|wound infusion|wound infusion
5076824|NCT01314144|local anaesthetic wound infusion|local anaesthetic wound infusion
5076825|NCT01314118|abiraterone acetate|abiraterone acetate
5076826|NCT01314118|prednisone|prednisone
5076827|NCT01314118|zytiga|zytiga
5076828|NCT01314092|crohn's disease|crohn's disease
5076829|NCT01314092|fistula|fistula
5076830|NCT01314092|complex|complex
5076831|NCT01314079|Crohn's fistula|crohn's fistula
5076832|NCT01314079|Autologous adipose derived stem cell|autologous adipose derived stem cell
5076833|NCT01314053|Daptomycin|daptomycin
5076834|NCT01314053|Serious Gram-positive Infections|serious gram-positive infections
5076835|NCT01314040|Dietary protein|dietary protein
5076836|NCT01314040|Biomarkers|biomarkers
5076837|NCT01314040|filtration rate|filtration rate
5076838|NCT01314040|urinary acid excretion|urinary acid excretion
5076839|NCT01314014|Non Hodgkin's Lymphoma|non hodgkin's lymphoma
5076840|NCT01314014|Lymphoma, Low Grade|lymphoma, low grade
5076841|NCT01314014|Lymphoma, Intermediate Grade|lymphoma, intermediate grade
5076842|NCT01314014|Lymphoma, High Grade|lymphoma, high grade
5076843|NCT01314014|Lymphoma, B Cell|lymphoma, b cell
5076844|NCT01314001|Tobacco, Smoking, Varenicline, Nicotine Patch|tobacco, smoking, varenicline, nicotine patch
5076845|NCT01313988|dose-response study|dose-response study
5076846|NCT01313988|blood lipid profile|blood lipid profile
5076847|NCT01313988|plant sterols|plant sterols
5076848|NCT01313988|fish oil|fish oil
5076849|NCT01313975|Electrolyte disturbances|electrolyte disturbances
5076850|NCT01313975|Fluid balance|fluid balance
5076851|NCT01313975|subarachnoid hemorrhage|subarachnoid hemorrhage
5076852|NCT01313975|traumatic brain injury|traumatic brain injury
5076853|NCT01313975|Cerebral salt wasting|cerebral salt wasting
5076854|NCT01313975|SIADH|siadh
5076855|NCT01313975|Diabetes insipidus|diabetes insipidus
5076856|NCT01313962|antiviral|antiviral
5076857|NCT01313962|intranasal|intranasal
5076858|NCT01313962|influenza|influenza
5076859|NCT01313949|Diabetes|diabetes
5076860|NCT01313949|Peer Support|peer support
5076861|NCT01313949|Structured Care|structured care
5076862|NCT01313936|Neuroblastoma|neuroblastoma
5076863|NCT01313936|MIBG|mibg
5076866|NCT01313936|Vincristine|vincristine
5076867|NCT01313936|Resistant|resistant
5076868|NCT01313936|Relapsed|relapsed
5076869|NCT01313936|Treatment|treatment
5076870|NCT01313936|UCSF|ucsf
5076871|NCT01313936|Pediatric|pediatric
5076872|NCT01313936|Oncology|oncology
5076873|NCT01313923|Pemphigus|pemphigus
5076874|NCT01313910|HIV|hiv
5076875|NCT01313910|diarrhea|diarrhea
5076876|NCT01313897|Multiple Myeloma|multiple myeloma
5076877|NCT01313832|ventricular septal defect|ventricular septal defect
5076878|NCT01313832|remote ischemic preconditioning|remote ischemic preconditioning
5076879|NCT01313832|pulmonary hypertension|pulmonary hypertension
5076880|NCT01313832|infant with ventricular septal defect and pulmonary hypertension|infant with ventricular septal defect and pulmonary hypertension
5076881|NCT01313819|Freezing|freezing
5076882|NCT01313806|dementia|dementia
5076883|NCT01313806|memory loss|memory loss
5076884|NCT01313806|cognitive decline|cognitive decline
5076885|NCT01313793|Bioequivalence (BE) Study|bioequivalence (be) study
5076886|NCT01313793|Healthy Volunteers|healthy volunteers
5076887|NCT01313780|cancer related pain|cancer related pain
5076888|NCT01313767|spasticity|spasticity
5076889|NCT01313767|upperlimb|upperlimb
5076890|NCT01313767|Botulinum toxin|botulinum toxin
5076891|NCT01313754|Skin closure|skin closure
5076892|NCT01313754|dermabond|dermabond
5076893|NCT01313754|vicryl|vicryl
5076894|NCT01313754|monocryl|monocryl
5076895|NCT01313754|Suburethral sling|suburethral sling
5076896|NCT01313754|Transobturator Sling|transobturator sling
5076897|NCT01313754|Pain|pain
5076898|NCT01313754|Discomfort|discomfort
5076899|NCT01313754|Skin irritation|skin irritation
5076900|NCT01313728|Acne|acne
5076901|NCT01313728|Irritation|irritation
5076902|NCT01313715|Safety|safety
5076903|NCT01313715|Immunogenicity|immunogenicity
5076904|NCT01313715|inactivated EV71 vaccine|inactivated ev71 vaccine
5076905|NCT01313702|polypill, compliance, cardiovascular disease|polypill, compliance, cardiovascular disease
5076906|NCT01313689|OMB157|omb157
5076907|NCT01313689|Lymphocytic|lymphocytic
5076908|NCT01313689|Chronic|chronic
5076909|NCT01313689|Safety|safety
5076910|NCT01313689|Refractory|refractory
5076911|NCT01313689|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
5076912|NCT01313689|Oncology|oncology
5076913|NCT01313689|Ofatumumab|ofatumumab
5076914|NCT01313689|Efficacy|efficacy
5076915|NCT01313689|Physicians' Choice|physicians' choice
5076916|NCT01313689|Bulky Fludarabine Refractory Chronic Lymphocytic Leukemia|bulky fludarabine refractory chronic lymphocytic leukemia
5076917|NCT01313689|CLL|cll
5076918|NCT01313676|COPD|copd
5076919|NCT01313676|Cardiovascular disease|cardiovascular disease
5076920|NCT01313676|Novel Dry Powder Inhaler|novel dry powder inhaler
5076921|NCT01313676|Survival|survival
5076922|NCT01313663|GW786034|gw786034
5076923|NCT01313663|non-small cell lung cancer|non-small cell lung cancer
5076924|NCT01313663|NSCLC|nsclc
5076925|NCT01313663|pemetrexed|pemetrexed
5076926|NCT01313663|pazopanib|pazopanib
5076927|NCT01313650|long-acting beta agonist|long-acting beta agonist
5076928|NCT01313650|anticholinergic|anticholinergic
5076929|NCT01313637|anticholinergic|anticholinergic
5076930|NCT01313637|long-acting beta agonist|long-acting beta agonist
5076931|NCT01313598|Patients with solid tumors|patients with solid tumors
5076932|NCT01313598|Treatment-refractory|treatment-refractory
5076933|NCT01313585|Primary care|primary care
5076934|NCT01313585|asthma management|asthma management
5076935|NCT01313585|inhaler device|inhaler device
5076936|NCT01313585|maintenance therapy|maintenance therapy
5076937|NCT01313585|reliever therapy|reliever therapy
5076938|NCT01313585|Easibreathe salbutamol|easibreathe salbutamol
5076939|NCT01313572|Coronary Artery Disease|coronary artery disease
5076940|NCT01313572|Myocardial Perfusion Imaging|myocardial perfusion imaging
5076941|NCT01313559|Castrate Resistant|castrate resistant
5076942|NCT01313559|Chemotherapy Naive|chemotherapy naive
5076943|NCT01313559|Prostate Cancer|prostate cancer
5076944|NCT01313559|SOM230|som230
5076945|NCT01313559|Everolimus|everolimus
5076946|NCT01313546|Femoral nerve block|femoral nerve block
5076947|NCT01313546|total knee arthroplasty|total knee arthroplasty
5076948|NCT01313533|Atherosclerosis of Autologous Vein Bypass Graft|atherosclerosis of autologous vein bypass graft
5076949|NCT01313507|Primary Immunodeficiency Disease|primary immunodeficiency disease
5076950|NCT01313507|PID|pid
5076951|NCT01313494|COPD|copd
5076952|NCT01313494|Roflumilast|roflumilast
5076953|NCT01313494|FEV1|fev1
5076954|NCT01313494|China|china
5076955|NCT01313481|Older persons|older persons
5076956|NCT01313481|Exercise|exercise
5076957|NCT01313481|Balance|balance
5076958|NCT01313468|NEAT|neat
5076959|NCT01313468|maximal oxygen uptake|maximal oxygen uptake
5076960|NCT01313468|stroke volume|stroke volume
5076961|NCT01313455|Oligomenorrhea|oligomenorrhea
5076962|NCT01313455|Adrenal Hyperplasia|adrenal hyperplasia
5076963|NCT01313455|Obesity|obesity
5076964|NCT01313455|Hyperandrogenism|hyperandrogenism
5076965|NCT01313455|Polycystic Ovarian Syndrome|polycystic ovarian syndrome
5076966|NCT01313455|PCOS|pcos
5076967|NCT01313455|Polycystic Ovary|polycystic ovary
5076968|NCT01313455|Healthy Volunteer|healthy volunteer
5076969|NCT01313455|HV|hv
5076970|NCT01313442|Gut Microbiota|gut microbiota
5076971|NCT01313442|Analysis of immune subsets with regard to their function|analysis of immune subsets with regard to their function
5076972|NCT01313442|Samples|samples
5076973|NCT01313442|Gastrointestinal Cancer|gastrointestinal cancer
5076974|NCT01313442|Gastrointestinal Tract Cancer|gastrointestinal tract cancer
5076975|NCT01313429|Metastatic Cancer|metastatic cancer
5076976|NCT01313429|Cancer Vaccine|cancer vaccine
5076977|NCT01313429|Immunotherapy|immunotherapy
5076978|NCT01313429|Adjuvant Therapy|adjuvant therapy
5076979|NCT01313429|Chest Metastases|chest metastases
5076980|NCT01313429|Cancer|cancer
5076981|NCT01313429|Melanoma|melanoma
5076982|NCT01313429|Lung Cancer|lung cancer
5076983|NCT01313429|Sarcoma|sarcoma
5076984|NCT01313416|Adjuvant Therapy|adjuvant therapy
5076985|NCT01313416|Recombinant Monoclonal Antibody|recombinant monoclonal antibody
5076986|NCT01313416|Adenocarcinoma of the Pancreas|adenocarcinoma of the pancreas
5076987|NCT01313416|Vaccination|vaccination
5076988|NCT01313416|PD-1 Receptor|pd-1 receptor
5076989|NCT01313416|Pancreas Cancer|pancreas cancer
5076990|NCT01313416|Pancreatic Cancer|pancreatic cancer
5076991|NCT01313403|5-HT1A Receptors|5-ht1a receptors
5076992|NCT01313403|Major Depression|major depression
5076993|NCT01313403|PET Imaging|pet imaging
5076994|NCT01313403|Depression|depression
5076995|NCT01313403|Healthy Volunteer|healthy volunteer
5076996|NCT01313403|HV|hv
5076997|NCT01313390|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
5076998|NCT01313390|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
5076999|NCT01313390|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5077000|NCT01313390|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
5077001|NCT01313390|stage III verrucous carcinoma of the larynx|stage iii verrucous carcinoma of the larynx
5077002|NCT01313390|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5077003|NCT01313390|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
5077004|NCT01313390|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
5077005|NCT01313390|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
5077006|NCT01313390|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
5077007|NCT01313390|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
5077008|NCT01313390|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5077009|NCT01313390|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
5077010|NCT01313390|stage III verrucous carcinoma of the oral cavity|stage iii verrucous carcinoma of the oral cavity
5077011|NCT01313390|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
5077012|NCT01313390|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
5077013|NCT01313390|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
5077014|NCT01313390|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
5077015|NCT01313390|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
5077016|NCT01313390|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
5077017|NCT01313390|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
5077018|NCT01313390|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
5077019|NCT01313390|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5077020|NCT01313390|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
5077021|NCT01313390|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
5077022|NCT01313390|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
5077023|NCT01313390|recurrent salivary gland cancer|recurrent salivary gland cancer
5077024|NCT01313390|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
5077025|NCT01313390|stage III salivary gland cancer|stage iii salivary gland cancer
5077026|NCT01313390|stage IV salivary gland cancer|stage iv salivary gland cancer
5077027|NCT01313390|tongue cancer|tongue cancer
5077028|NCT01313377|adenocarcinoma of the extrahepatic bile duct|adenocarcinoma of the extrahepatic bile duct
5077029|NCT01313377|cholangiocarcinoma of the extrahepatic bile duct|cholangiocarcinoma of the extrahepatic bile duct
5077030|NCT01313377|liver and intrahepatic biliary tract cancer|liver and intrahepatic biliary tract cancer
5077031|NCT01313377|localized extrahepatic bile duct cancer|localized extrahepatic bile duct cancer
5077032|NCT01313377|adenocarcinoma of the gallbladder|adenocarcinoma of the gallbladder
5077033|NCT01313377|cholangiocarcinoma of the gallbladder|cholangiocarcinoma of the gallbladder
5077034|NCT01313377|localized gallbladder cancer|localized gallbladder cancer
5077035|NCT01313325|hippotherapy|hippotherapy
5077036|NCT01313325|neuromuscular disorders|neuromuscular disorders
5077037|NCT01313325|balance deficits|balance deficits
5077038|NCT01313325|participation|participation
5077141|NCT01312740|adipocytes|adipocytes
5077039|NCT01313286|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
5077040|NCT01313260|Refractory partial epilepsies|refractory partial epilepsies
5077041|NCT01313247|Paracetamol|paracetamol
5077042|NCT01313247|opioids|opioids
5077043|NCT01313247|cancer pain|cancer pain
5077044|NCT01313221|plaque psoriasis|plaque psoriasis
5077045|NCT01313221|moderate|moderate
5077046|NCT01313221|severe|severe
5077047|NCT01313221|etanercept|etanercept
5077048|NCT01313221|Enbrel|enbrel
5077049|NCT01313221|topical|topical
5077050|NCT01313208|RA|ra
5077051|NCT01313208|Enbrel|enbrel
5077052|NCT01313208|DMARD|dmard
5077053|NCT01313208|Joint Count|joint count
5077054|NCT01313208|Rheumatoid Arthritis|rheumatoid arthritis
5077055|NCT01313208|Etanercept|etanercept
5077056|NCT01313208|disease modifying anti-rheumatic drug|disease modifying anti-rheumatic drug
5077057|NCT01313169|Electronic medical record reminders, Panel management|electronic medical record reminders, panel management
5077058|NCT01313156|Metabolic Syndrome, Syndrome X, MetS,|metabolic syndrome, syndrome x, mets,
5077059|NCT01313156|Type 2 Diabetes|type 2 diabetes
5077060|NCT01313143|AOP200704, Esmolol, Pharmacokinetics, Pharmacodynamics|aop200704, esmolol, pharmacokinetics, pharmacodynamics
5077061|NCT01313130|traumatic brain injury|traumatic brain injury
5077062|NCT01313130|post traumatic stress disorder|post traumatic stress disorder
5077063|NCT01313130|Diffusion tensor imaging|diffusion tensor imaging
5077064|NCT01313130|resting state functional connectivity|resting state functional connectivity
5077065|NCT01313130|genetic factors|genetic factors
5077066|NCT01313117|chemotherapy|chemotherapy
5077067|NCT01313117|peripheral neuropathy|peripheral neuropathy
5077068|NCT01313117|paclitaxel|paclitaxel
5077069|NCT01313117|breast cancer|breast cancer
5077070|NCT01313078|Ovarian Cancer|ovarian cancer
5077071|NCT01313078|Fallopian Tube Cancer|fallopian tube cancer
5077072|NCT01313078|Primary Peritoneal Cancer|primary peritoneal cancer
5077073|NCT01313078|Relapsed or Refractory|relapsed or refractory
5077074|NCT01313078|Pegaspargase|pegaspargase
5077075|NCT01313078|Pegylated L-Asparaginase|pegylated l-asparaginase
5077076|NCT01313065|VX15/2503|vx15/2503
5077077|NCT01313065|Semaphorin 4D|semaphorin 4d
5077078|NCT01313065|SEMA4D|sema4d
5077079|NCT01313065|CD100|cd100
5077080|NCT01313065|safety|safety
5077081|NCT01313065|tolerability|tolerability
5077082|NCT01313065|pharmacokinetics|pharmacokinetics
5077083|NCT01313065|pharmacodynamics|pharmacodynamics
5077084|NCT01313065|advanced solid tumors|advanced solid tumors
5077085|NCT01313052|Psychotic|psychotic
5077086|NCT01313052|Criminal|criminal
5077087|NCT01313039|Breast Cancer|breast cancer
5077088|NCT01313039|ER-negative|er-negative
5077089|NCT01313039|Allred Score|allred score
5077090|NCT01313026|Percutaneous nerve evaluation|percutaneous nerve evaluation
5077091|NCT01313026|Transanal irrigation|transanal irrigation
5077092|NCT01313026|Low anterior resection syndrome|low anterior resection syndrome
5077093|NCT01313000|fat, transfer, autologous fat transfer, bicep|fat, transfer, autologous fat transfer, bicep
5077094|NCT01312948|Obstructive sleep apnea|obstructive sleep apnea
5077095|NCT01312948|OSA|osa
5077096|NCT01312948|CPAP|cpap
5077097|NCT01312948|CPAP mask|cpap mask
5077098|NCT01312948|Non-invasive ventilation|non-invasive ventilation
5077099|NCT01312948|NIV|niv
5077100|NCT01312935|Percutaneous Coronary Intervention|percutaneous coronary intervention
5077101|NCT01312935|Heparin|heparin
5077102|NCT01312935|Angioplasty|angioplasty
5077103|NCT01312935|LMWH|lmwh
5077104|NCT01312909|smoking cessation in adolescents|smoking cessation in adolescents
5077105|NCT01312857|colon|colon
5077106|NCT01312857|rectal|rectal
5077107|NCT01312857|liver|liver
5077108|NCT01312857|AMG 954 (Panitumumab)|amg 954 (panitumumab)
5077109|NCT01312857|DEXAMETHASONE|dexamethasone
5077110|NCT01312857|FLOXURIDINE|floxuridine
5077111|NCT01312857|FLUOROURACIL|fluorouracil
5077112|NCT01312857|IRINOTECAN (CPT-11) CAMPTOSAR|irinotecan (cpt-11) camptosar
5077113|NCT01312857|LEUCOVORIN|leucovorin
5077114|NCT01312857|10-137|10-137
5077115|NCT01312831|cobalamin|cobalamin
5077116|NCT01312831|B12|b12
5077117|NCT01312831|homocysteine|homocysteine
5077118|NCT01312831|MMA|mma
5077119|NCT01312831|holotranscobalamin|holotranscobalamin
5077120|NCT01312831|Eligen|eligen
5077121|NCT01312805|asthma|asthma
5077122|NCT01312805|clinical decision support|clinical decision support
5077123|NCT01312805|CHICA|chica
5077124|NCT01312792|Severe Pneumonia|severe pneumonia
5077125|NCT01312792|Pneumonia|pneumonia
5077126|NCT01312792|ARI|ari
5077127|NCT01312792|IMCI|imci
5077128|NCT01312792|Modified IMCI|modified imci
5077129|NCT01312792|1st level Health facilities|1st level health facilities
5077130|NCT01312792|Children|children
5077131|NCT01312792|Operational Research|operational research
5077132|NCT01312792|Bangladesh|bangladesh
5077133|NCT01312792|Treatment of Severe Pneumonia|treatment of severe pneumonia
5077134|NCT01312779|Mitral Valve Replacement|mitral valve replacement
5077135|NCT01312779|23mm CEP|23mm cep
5077136|NCT01312779|Magna|magna
5077137|NCT01312740|obesity|obesity
5077138|NCT01312740|dietary treatment|dietary treatment
5077139|NCT01312740|high protein diet|high protein diet
5077140|NCT01312740|Low glycaemic index|low glycaemic index
5077142|NCT01312740|fat mass|fat mass
5077143|NCT01312740|systemic inflammatory markers|systemic inflammatory markers
5077144|NCT01312740|improvement of complications|improvement of complications
5077145|NCT01312740|effect on weight loss|effect on weight loss
5077146|NCT01312727|Tubulointerstitial renal diseases|tubulointerstitial renal diseases
5077147|NCT01312727|Hereditary renal diseases|hereditary renal diseases
5077148|NCT01312727|Uromodulin|uromodulin
5077149|NCT01312727|Renin gene|renin gene
5077150|NCT01312714|Hemodialysis|hemodialysis
5077151|NCT01312714|Peritoneal dialysis|peritoneal dialysis
5077152|NCT01312714|Vitamin D Deficiency|vitamin d deficiency
5077153|NCT01312714|blood pressure|blood pressure
5077154|NCT01312714|arterial stiffness|arterial stiffness
5077155|NCT01312714|Heart function|heart function
5077156|NCT01312714|Renin-angiotensin system|renin-angiotensin system
5077157|NCT01312714|Calcium|calcium
5077158|NCT01312714|FGF-23|fgf-23
5077159|NCT01312714|Brain natriuretic peptide|brain natriuretic peptide
5077160|NCT01312701|cancer|cancer
5077161|NCT01312701|immunomonitoring|immunomonitoring
5077162|NCT01312701|CD247 -zeta chain|cd247 -zeta chain
5077163|NCT01312701|chronic inflamation|chronic inflamation
5077164|NCT01312701|anticancertherapy|anticancertherapy
5077165|NCT01312688|Early Goal Directed Hemodunamic Therapy in Sepsis|early goal directed hemodunamic therapy in sepsis
5077166|NCT01312675|severe sepsis|severe sepsis
5077167|NCT01312675|mechanical ventilation|mechanical ventilation
5077168|NCT01312610|orange juice|orange juice
5077169|NCT01312610|cognitive function|cognitive function
5077170|NCT01312610|flavonoids|flavonoids
5077171|NCT01312610|flavanones|flavanones
5077172|NCT01312597|Flavonoid|flavonoid
5077173|NCT01312597|Cognitive performance|cognitive performance
5077174|NCT01312597|Cognitive function|cognitive function
5077175|NCT01312597|Executive function|executive function
5077176|NCT01312597|fMRI|fmri
5077177|NCT01312597|Cerebral blood flow|cerebral blood flow
5077178|NCT01312597|Acute|acute
5077179|NCT01312584|Flavanol|flavanol
5077180|NCT01312584|Cocoa|cocoa
5077181|NCT01312584|Vascular function|vascular function
5077182|NCT01312584|Absorption|absorption
5077183|NCT01312584|Metabolism|metabolism
5077184|NCT01312584|Alkalisation|alkalisation
5077185|NCT01312558|obstructive sleep apnoea/hypopnoea syndrome|obstructive sleep apnoea/hypopnoea syndrome
5077186|NCT01312558|Mediterranean diet|mediterranean diet
5077187|NCT01312558|exercise|exercise
5077188|NCT01312558|weight loss|weight loss
5077189|NCT01312558|continuous positive airway pressure|continuous positive airway pressure
5077190|NCT01312558|lipid peroxidation|lipid peroxidation
5077191|NCT01312545|orbital implant|orbital implant
5077192|NCT01312545|evisceration|evisceration
5077193|NCT01312545|economic|economic
5077194|NCT01312545|polyethylene|polyethylene
5077195|NCT01312545|porous|porous
5077196|NCT01312532|Total knee arthroplasty|total knee arthroplasty
5077197|NCT01312532|Fixed-bearing|fixed-bearing
5077198|NCT01312532|Mobile-bearing|mobile-bearing
5077199|NCT01312519|Bone marrow biopsy of iliac crest|bone marrow biopsy of iliac crest
5077200|NCT01312506|metastatic|metastatic
5077201|NCT01312506|melanoma|melanoma
5077202|NCT01312506|CNS|cns
5077203|NCT01312493|Head and neck cancer|head and neck cancer
5077204|NCT01312493|Phase II|phase ii
5077205|NCT01312493|Locally advanced|locally advanced
5077206|NCT01312493|Panitumumab|panitumumab
5077207|NCT01312493|Vectibix|vectibix
5077208|NCT01312493|Lineberger|lineberger
5077209|NCT01312493|Radiation Therapy|radiation therapy
5077210|NCT01312493|Intensity modulated radiation therapy (IMRT)|intensity modulated radiation therapy (imrt)
5077211|NCT01312493|Stage III to IVB|stage iii to ivb
5077212|NCT01312480|Tobacco|tobacco
5077213|NCT01312480|Tobacco Prevention|tobacco prevention
5077214|NCT01312480|Tobacco Cessation|tobacco cessation
5077215|NCT01312480|5A's Model|5a's model
5077216|NCT01312480|Adolescence|adolescence
5077217|NCT01312480|Media Use|media use
5077218|NCT01312454|intravitreal injection|intravitreal injection
5077219|NCT01312454|intraocular pressure|intraocular pressure
5077220|NCT01312454|open-angle glaucoma|open-angle glaucoma
5077221|NCT01312454|ocular hypertension|ocular hypertension
5077222|NCT01312441|Vitamin D|vitamin d
5077223|NCT01312441|Ergocalciferol|ergocalciferol
5077224|NCT01312415|total knee arthroplasty|total knee arthroplasty
5077225|NCT01312415|total knee replacement|total knee replacement
5077226|NCT01312415|local infiltration analgesia|local infiltration analgesia
5077227|NCT01312415|intra-articular local anaesthesia|intra-articular local anaesthesia
5077228|NCT01312415|patients undergoing total knee arthroplasty (total knee replacement)|patients undergoing total knee arthroplasty (total knee replacement)
5077229|NCT01312363|Alzheimer's disease|alzheimer's disease
5077230|NCT01312363|Rivastigmine|rivastigmine
5077231|NCT01312363|Patch|patch
5077232|NCT01312363|Tolerability|tolerability
5077233|NCT01312350|neoadjuvant chemotherapy|neoadjuvant chemotherapy
5077234|NCT01312350|definitive chemoradiation therapy|definitive chemoradiation therapy
5077235|NCT01312350|head and neck cancer|head and neck cancer
5077236|NCT01312350|base of tongue|base of tongue
5077237|NCT01312350|Locally advanced|locally advanced
5077238|NCT01312337|gefitinib|gefitinib
5077239|NCT01312337|EGFR mutation negative|egfr mutation negative
5077240|NCT01312337|NSCLC|nsclc
5077241|NCT01312324|neoadjuvant chemotherapy|neoadjuvant chemotherapy
5077242|NCT01312324|thymic cancer|thymic cancer
5077243|NCT01312311|nasopharyngeal cancer|nasopharyngeal cancer
5077244|NCT01312311|weekly docetaxel|weekly docetaxel
5077245|NCT01312311|cisplatin|cisplatin
5077246|NCT01312298|Arthritis|arthritis
5077247|NCT01312298|General anaesthesia|general anaesthesia
5077248|NCT01312298|Spinal anaesthesia|spinal anaesthesia
5077249|NCT01312285|osteoarthritis|osteoarthritis
5077250|NCT01312285|painful hips|painful hips
5077251|NCT01312272|Schizophrenia|schizophrenia
5077252|NCT01312272|Social Intelligence|social intelligence
5077253|NCT01312272|Perception, Social|perception, social
5077254|NCT01312272|Oxytocin|oxytocin
5077255|NCT01312259|Painful Bladder Syndrome|painful bladder syndrome
5077256|NCT01312259|Interstitial Cystitis|interstitial cystitis
5077257|NCT01312259|Pelvic Floor dysfunction|pelvic floor dysfunction
5077258|NCT01312259|Fecal incontinence|fecal incontinence
5077259|NCT01312259|Constipation|constipation
5077260|NCT01312259|Sexual dysfunction|sexual dysfunction
5077261|NCT01312259|Dyspareunia|dyspareunia
5077262|NCT01312259|Vulvodynia|vulvodynia
5077263|NCT01312246|vessel ligation|vessel ligation
5077264|NCT01312246|colon resection|colon resection
5077265|NCT01312207|tractional retinoschisis|tractional retinoschisis
5077266|NCT01312207|traction retinal detachment|traction retinal detachment
5077267|NCT01312194|Periapical Periodontitis|periapical periodontitis
5077268|NCT01312194|Dental Pulp Necrosis|dental pulp necrosis
5077269|NCT01312194|Root canal Therapy|root canal therapy
5077270|NCT01312194|Adolescent|adolescent
5077271|NCT01312181|Technology based intervention|technology based intervention
5077272|NCT01312181|HIV primary care clinic|hiv primary care clinic
5077273|NCT01312181|Brief behavioral intervention|brief behavioral intervention
5077274|NCT01312181|Drug abuse|drug abuse
5077275|NCT01312168|Cardiovascular disease|cardiovascular disease
5077276|NCT01312168|Continuous positive airway pressure|continuous positive airway pressure
5077277|NCT01312168|Endothelium|endothelium
5077278|NCT01312168|Vascular function|vascular function
5077279|NCT01312168|Inflammation|inflammation
5077280|NCT01312168|Sleep Apnea|sleep apnea
5077281|NCT01312168|Obstructive|obstructive
5077282|NCT01312155|endotracheal|endotracheal
5077283|NCT01312155|intubation|intubation
5077284|NCT01312155|video|video
5077285|NCT01312155|time|time
5077286|NCT01312129|Alcohol|alcohol
5077287|NCT01312129|Sulfasalazine|sulfasalazine
5077288|NCT01312116|Internet treatment|internet treatment
5077289|NCT01312116|GAD|gad
5077290|NCT01312116|guided self-help|guided self-help
5077291|NCT01312103|Safety Planning|safety planning
5077292|NCT01312090|Weight loss|weight loss
5077293|NCT01312090|brown adipose tissue|brown adipose tissue
5077294|NCT01312090|white adipose tissue|white adipose tissue
5077295|NCT01312090|muscle, metabolism|muscle, metabolism
5077296|NCT01312090|cold exposure|cold exposure
5077297|NCT01312077|total hip arthroplasty|total hip arthroplasty
5077298|NCT01312077|total hip replacement|total hip replacement
5077299|NCT01312077|local infiltration analgesia|local infiltration analgesia
5077300|NCT01312077|wound infusion|wound infusion
5077301|NCT01312077|patients undergoing total hip replacement (total hip arthroplasty)|patients undergoing total hip replacement (total hip arthroplasty)
5077302|NCT01312064|rituximab|rituximab
5077303|NCT01312064|everolimus|everolimus
5077304|NCT01312038|Eustachian tube|eustachian tube
5077305|NCT01312038|otitis|otitis
5077306|NCT01312038|middle-ear pressure|middle-ear pressure
5077307|NCT01312038|simethicone|simethicone
5077308|NCT01312012|hepatitis B virus,mother-infant transmission, nucleoside analog,pregnant women|hepatitis b virus,mother-infant transmission, nucleoside analog,pregnant women
5077309|NCT01311999|latent tuberculosis, renal failure, dialysis, interferon-gamma release assay|latent tuberculosis, renal failure, dialysis, interferon-gamma release assay
5077310|NCT01311986|atopic dermatitis|atopic dermatitis
5077311|NCT01311986|nummular eczema|nummular eczema
5077312|NCT01311986|chemokines|chemokines
5077313|NCT01311973|Chronic kidney disease, phosphorus, salivary phosphorus|chronic kidney disease, phosphorus, salivary phosphorus
5077314|NCT01311960|pterygium|pterygium
5077315|NCT01311960|recurrent pterygium|recurrent pterygium
5077316|NCT01311960|bevacizumab|bevacizumab
5077317|NCT01311960|VEGF|vegf
5077318|NCT01311960|anti-VEGF|anti-vegf
5077319|NCT01311947|Chronic hepatitis B|chronic hepatitis b
5077320|NCT01311947|Peginterferon alfa-2a|peginterferon alfa-2a
5077321|NCT01311921|enterovirus 71, host genetics, social, behavior, environmental factors|enterovirus 71, host genetics, social, behavior, environmental factors
5077322|NCT01311908|Pancreaticoduodenectomy|pancreaticoduodenectomy
5077323|NCT01311908|Roux-en-Y reconstruction|roux-en-y reconstruction
5077324|NCT01311908|Reflux esophagitis|reflux esophagitis
5077325|NCT01311895|acute|acute
5077326|NCT01311895|pain|pain
5077327|NCT01311895|emergency department|emergency department
5077328|NCT01311895|hydromorphone|hydromorphone
5077329|NCT01311856|Behavioral intervention|behavioral intervention
5077330|NCT01311856|Exercise|exercise
5077331|NCT01311856|Physical Assessment|physical assessment
5077332|NCT01311856|Questionnaire|questionnaire
5077333|NCT01311856|Survey|survey
5077334|NCT01311856|Telephone counseling|telephone counseling
5077335|NCT01311856|Internet interventions|internet interventions
5077336|NCT01311856|Overweight cancer survivors|overweight cancer survivors
5077337|NCT01311856|Exercise and weight management program|exercise and weight management program
5077338|NCT01311791|Left ventricular augmentation|left ventricular augmentation
5077339|NCT01311791|Left ventricular restoration|left ventricular restoration
5077340|NCT01311765|Postoperative peritonitis|postoperative peritonitis
5077341|NCT01311765|Intra-abdominal infection|intra-abdominal infection
5077342|NCT01311765|Surgery|surgery
5077343|NCT01311765|Laparotomy|laparotomy
5077344|NCT01311765|Nosocomial infection|nosocomial infection
5077345|NCT01311765|Antibiotic therapy|antibiotic therapy
5077346|NCT01311765|Duration of treatment|duration of treatment
5077347|NCT01311765|Multidrug resistant bacteria|multidrug resistant bacteria
5077348|NCT01311752|human papillomavirus|human papillomavirus
5077349|NCT01311752|follow up|follow up
5077350|NCT01311739|Pharmacokinetics|pharmacokinetics
5077351|NCT01311713|cancer|cancer
5077352|NCT01311713|tumors|tumors
5077353|NCT01311713|PARP|parp
5077354|NCT01311700|Ischemia|ischemia
5077355|NCT01311700|Reperfusion|reperfusion
5077356|NCT01311700|Myocardial infarction|myocardial infarction
5077357|NCT01311700|Beta blockers|beta blockers
5077358|NCT01311700|Metoprolol|metoprolol
5077359|NCT01311700|Acute myocardial infarction|acute myocardial infarction
5077360|NCT01311700|Necrosis|necrosis
5077361|NCT01311700|Salvaged Myocardium|salvaged myocardium
5077362|NCT01311687|Myeloma|myeloma
5077363|NCT01311687|Multiple Myeloma|multiple myeloma
5077364|NCT01311687|Relapsed Multiple Myeloma|relapsed multiple myeloma
5077365|NCT01311687|Relapsed and Refractory Multiple Myeloma|relapsed and refractory multiple myeloma
5077366|NCT01311687|Refractory Myeloma|refractory myeloma
5077367|NCT01311687|Resistant Multiple Myeloma|resistant multiple myeloma
5077368|NCT01311687|Treatment-resistant Multiple Myeloma|treatment-resistant multiple myeloma
5077369|NCT01311687|Pomalidomide|pomalidomide
5077370|NCT01311687|Lenalidomide-resistant|lenalidomide-resistant
5077371|NCT01311687|Bortezomib-resistant|bortezomib-resistant
5077372|NCT01311648|recombinant factor VIII|recombinant factor viii
5077373|NCT01311648|pediatric use|pediatric use
5077374|NCT01311635|Phase 1|phase 1
5077375|NCT01311635|bioavailability study|bioavailability study
5077376|NCT01311635|AZD1981|azd1981
5077377|NCT01311635|tablets|tablets
5077378|NCT01311635|To study the relative bioavailability of single dose AZD1981 via three different tablets|to study the relative bioavailability of single dose azd1981 via three different tablets
5077379|NCT01311635|To compare the bioavailability between three different AZD1981 tablets|to compare the bioavailability between three different azd1981 tablets
5077380|NCT01311622|drug-drug interaction|drug-drug interaction
5077381|NCT01311622|Phase 1|phase 1
5077382|NCT01311622|healthy subjects|healthy subjects
5077383|NCT01311622|warfarin|warfarin
5077384|NCT01311622|Rheumatoid arthritis|rheumatoid arthritis
5077385|NCT01311622|RA|ra
5077386|NCT01311622|fostamatinib open-label|fostamatinib open-label
5077387|NCT01311622|pharmacokinetics|pharmacokinetics
5077388|NCT01311622|pharmacodynamics|pharmacodynamics
5077389|NCT01311622|level of Warfarin in the blood|level of warfarin in the blood
5077390|NCT01311609|Systane, Dry Eye|systane, dry eye
5077391|NCT01311596|icons in clinic or office for patients with Autism|icons in clinic or office for patients with autism
5077392|NCT01311583|Self-care|self-care
5077393|NCT01311583|Teach Back|teach back
5077394|NCT01311557|Tetanus|tetanus
5077395|NCT01311557|Diphtheria|diphtheria
5077396|NCT01311557|Pertussis|pertussis
5077397|NCT01311557|Tdap vaccine|tdap vaccine
5077398|NCT01311557|Adacel®|adacel®
5077399|NCT01311531|Fracture|fracture
5077400|NCT01311531|Radius|radius
5077401|NCT01311531|Surgery|surgery
5077402|NCT01311531|Osteosynthesis|osteosynthesis
5077403|NCT01311518|Thymosin Beta 4|thymosin beta 4
5077404|NCT01311518|Thymosin β4 (Tβ4) Injectable Solution|thymosin β4 (tβ4) injectable solution
5077405|NCT01311518|RGN-352|rgn-352
5077406|NCT01311505|bioequivalence; rifampicin|bioequivalence; rifampicin
5077407|NCT01311492|Alzheimer's Disease|alzheimer's disease
5077408|NCT01311492|exercise|exercise
5077409|NCT01311492|physical activity|physical activity
5077410|NCT01311492|intervention|intervention
5077411|NCT01311479|Osteopathic Manipulation|osteopathic manipulation
5077412|NCT01311479|Interstitial Cystitis|interstitial cystitis
5077413|NCT01311479|Sacroiliac Joint Dysfunction|sacroiliac joint dysfunction
5077414|NCT01311466|Liver transplantation|liver transplantation
5077415|NCT01311466|Overall survival|overall survival
5077416|NCT01311440|RCT|rct
5077417|NCT01311440|modified Atkins diet|modified atkins diet
5077418|NCT01311440|epilepsy|epilepsy
5077419|NCT01311440|adults|adults
5077420|NCT01311440|ketogenic diet|ketogenic diet
5077421|NCT01311401|2 diabetes mellitus,Circassians, High fasting glucose|2 diabetes mellitus,circassians, high fasting glucose
5077422|NCT01311388|cancer|cancer
5077423|NCT01311375|spinal,, bone, cord injury, lipid,antioxidant|spinal,, bone, cord injury, lipid,antioxidant
5077424|NCT01311362|Steady-state|steady-state
5077425|NCT01311362|Ambrisentan|ambrisentan
5077426|NCT01311362|St. Johns Wort|st. johns wort
5077427|NCT01311349|Susceptibility of tigecycline|susceptibility of tigecycline
5077428|NCT01311349|Drug Resistance, Bacterial|drug resistance, bacterial
5077429|NCT01311336|Pegfilgrastim|pegfilgrastim
5077430|NCT01311336|Loratadine|loratadine
5077431|NCT01311336|Myalgia/arthralgia|myalgia/arthralgia
5077432|NCT01311323|Multivessel Coronary Artery Disease|multivessel coronary artery disease
5077433|NCT01311323|Left Main Narrowing|left main narrowing
5077434|NCT01311323|Percutaneous Coronary Intervention|percutaneous coronary intervention
5077435|NCT01311323|Coronary Artery Bypass Grafting|coronary artery bypass grafting
5077436|NCT01311323|Drug-Eluting Stent|drug-eluting stent
5077437|NCT01311310|troponin, open heart surgery, children|troponin, open heart surgery, children
5077438|NCT01311284|Nasotracheal intubation|nasotracheal intubation
5077439|NCT01311284|Macintosh laryngoscope|macintosh laryngoscope
5077440|NCT01311284|Airtraq|airtraq
5077441|NCT01311284|McGrath|mcgrath
5077442|NCT01311284|Manikin|manikin
5077443|NCT01311284|airway management|airway management
5077444|NCT01311271|Stroke|stroke
5077445|NCT01311271|Cerebrovascular disease|cerebrovascular disease
5077446|NCT01311271|hemiplegia|hemiplegia
5077447|NCT01311271|Transcranial magnetic stimulation|transcranial magnetic stimulation
5077448|NCT01311271|repetitive transcranial magnetic stimulation|repetitive transcranial magnetic stimulation
5077449|NCT01311271|rTMS|rtms
5077450|NCT01311271|rehabilitation|rehabilitation
5077451|NCT01311271|Upper Extremity|upper extremity
5077452|NCT01311258|AML|aml
5077453|NCT01311258|MDS|mds
5077454|NCT01311245|Risky drinking|risky drinking
5077455|NCT01311245|Brief intervention|brief intervention
5077456|NCT01311245|Computer-generated feedback|computer-generated feedback
5077457|NCT01311245|Stage-tailored|stage-tailored
5077458|NCT01311245|Non-stage-tailored|non-stage-tailored
5077459|NCT01311232|rituximab, lymphoma, hepatitis B virus|rituximab, lymphoma, hepatitis b virus
5077460|NCT01311206|knee osteoarthritis|knee osteoarthritis
5077461|NCT01311206|isokinetic knee extensor strength|isokinetic knee extensor strength
5077462|NCT01311206|quadriceps volume|quadriceps volume
5077463|NCT01311206|symptomatic knee osteoarthritis|symptomatic knee osteoarthritis
5077464|NCT01311193|Circadian rhythms|circadian rhythms
5077465|NCT01311193|Sleep-wake cycles|sleep-wake cycles
5077466|NCT01311193|Melatonin|melatonin
5077467|NCT01311193|Borderline Personality Disorder|borderline personality disorder
5077468|NCT01311193|Light therapy|light therapy
5077469|NCT01311167|Dexamethasone|dexamethasone
5077470|NCT01311167|Sodium|sodium
5077471|NCT01311154|carriers|carriers
5077472|NCT01311154|resistant Enterobacteriaceae|resistant enterobacteriaceae
5077473|NCT01311154|AMR|amr
5077474|NCT01311154|antibiotic|antibiotic
5077475|NCT01311128|Blood pressure|blood pressure
5077476|NCT01311128|Heart rate|heart rate
5077477|NCT01311128|Cardiac output|cardiac output
5077478|NCT01311128|Critical care|critical care
5077479|NCT01311128|Perioperative care|perioperative care
5077480|NCT01311102|Pain score|pain score
5077481|NCT01311102|IUD placement|iud placement
5077482|NCT01311076|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
5077483|NCT01311076|Insulin|insulin
5077484|NCT01311076|Glucose|glucose
5077485|NCT01311076|Drug Therapy|drug therapy
5077486|NCT01311050|Metastatic Colorectal Cancer|metastatic colorectal cancer
5077487|NCT01311037|Premenopausal Women with Advanced Breast Cancer|premenopausal women with advanced breast cancer
5077488|NCT01311024|Children|children
5077489|NCT01311024|Pneumococcal Vaccines|pneumococcal vaccines
5077490|NCT01311011|Critical Limb Ischemia|critical limb ischemia
5077491|NCT01310998|Schizophrenia|schizophrenia
5077492|NCT01310998|high intensity exercise|high intensity exercise
5077493|NCT01310998|interval training exercise|interval training exercise
5077494|NCT01310985|Rectal Cancer|rectal cancer
5077495|NCT01310972|Adjuvant Colon Cancer|adjuvant colon cancer
5077496|NCT01310959|Aplastic Anemia Marrow Failure Syndrome|aplastic anemia marrow failure syndrome
5077497|NCT01310946|Acute Lymphocytic Leukemia|acute lymphocytic leukemia
5077498|NCT01310894|Prostatic Disease|prostatic disease
5077499|NCT01310894|Genital Neoplasm,male|genital neoplasm,male
5077500|NCT01310894|Urogenital neoplasm|urogenital neoplasm
5077501|NCT01310894|Genital disease,male|genital disease,male
5077502|NCT01310894|Male urogenital disease|male urogenital disease
5077503|NCT01310894|Neoplasms|neoplasms
5077504|NCT01310894|Neoplasms by site|neoplasms by site
5077505|NCT01310894|Prostatic neoplasm|prostatic neoplasm
5077506|NCT01310894|Carcinoma|carcinoma
5077507|NCT01310881|Neurogenesis|neurogenesis
5077508|NCT01310881|hippocampal stem cells|hippocampal stem cells
5077509|NCT01310881|depression|depression
5077510|NCT01310881|stroke|stroke
5077511|NCT01310868|adult giant cell glioblastoma|adult giant cell glioblastoma
5077512|NCT01310868|adult gliosarcoma|adult gliosarcoma
5077513|NCT01310868|adult glioblastoma|adult glioblastoma
5077514|NCT01310855|adult giant cell glioblastoma|adult giant cell glioblastoma
5077515|NCT01310855|adult glioblastoma|adult glioblastoma
5077516|NCT01310855|adult gliosarcoma|adult gliosarcoma
5077517|NCT01310855|recurrent adult brain tumor|recurrent adult brain tumor
5077518|NCT01310842|Smoker|smoker
5077519|NCT01310842|Smoking Cessation|smoking cessation
5077520|NCT01310842|Social Determinants|social determinants
5077521|NCT01310842|Environmental Effects|environmental effects
5077522|NCT01310842|Individual-level effects|individual-level effects
5077523|NCT01310842|Nicotine patch|nicotine patch
5077524|NCT01310842|Smart Phone|smart phone
5077525|NCT01310842|SP|sp
5077526|NCT01310842|Global Positioning System|global positioning system
5077527|NCT01310842|GPS|gps
5077528|NCT01310842|Questionnaires|questionnaires
5077529|NCT01310842|Saliva samples|saliva samples
5077530|NCT01310829|Genetic counselor|genetic counselor
5077531|NCT01310829|Genetic counseling degree program|genetic counseling degree program
5077532|NCT01310829|Genetic counseling students|genetic counseling students
5077533|NCT01310829|Virtual reality-based intervention|virtual reality-based intervention
5077534|NCT01310829|VR|vr
5077535|NCT01310829|Genetic counseling|genetic counseling
5077536|NCT01310829|hereditary cancers|hereditary cancers
5077537|NCT01310829|Questionnaires|questionnaires
5077538|NCT01310829|Physiological measurements|physiological measurements
5077539|NCT01310829|Skin sensors|skin sensors
5077540|NCT01310816|malignant neoplasms of the bone|malignant neoplasms of the bone
5077541|NCT01310816|bone sarcoma|bone sarcoma
5077542|NCT01310803|Urinary Bladder Neoplasms|urinary bladder neoplasms
5077543|NCT01310803|Neoplasms|neoplasms
5077544|NCT01310803|Urologic Neoplasms|urologic neoplasms
5077545|NCT01310803|Urogenital Neoplasms|urogenital neoplasms
5077546|NCT01310803|Neoplasms by Site|neoplasms by site
5077547|NCT01310803|Urinary Bladder Diseases|urinary bladder diseases
5077548|NCT01310803|Urologic Diseases|urologic diseases
5077549|NCT01310803|TURBT|turbt
5077550|NCT01310803|Valstar|valstar
5077551|NCT01310790|septic shock|septic shock
5077552|NCT01310790|lactic acid clearance|lactic acid clearance
5077553|NCT01310790|ScVO2|scvo2
5077554|NCT01310777|Open-Angle glaucoma|open-angle glaucoma
5077555|NCT01310777|Ocular Hypertension|ocular hypertension
5077556|NCT01310777|OAG|oag
5077557|NCT01310777|OHT|oht
5077558|NCT01310764|Intraocular pressure|intraocular pressure
5077559|NCT01310764|Trabeculectomy|trabeculectomy
5077560|NCT01310764|Mitomycin C|mitomycin c
5077561|NCT01310764|Bevacizumab|bevacizumab
5077562|NCT01310738|Visceral leishmaniasis|visceral leishmaniasis
5077563|NCT01310738|Leishmania infantum|leishmania infantum
5077564|NCT01310738|Leishmania chagasi|leishmania chagasi
5077565|NCT01310725|CABG|cabg
5077566|NCT01310725|LIMA|lima
5077567|NCT01310725|saphenous vein|saphenous vein
5077568|NCT01310725|radial artery|radial artery
5077569|NCT01310712|hyperhidrosis|hyperhidrosis
5077570|NCT01310712|oxybutynin|oxybutynin
5077571|NCT01310699|Colonoscopy|colonoscopy
5077572|NCT01310699|Diagnostic imaging|diagnostic imaging
5077573|NCT01310699|Colorectal Neoplasm|colorectal neoplasm
5077574|NCT01310699|Tandem Colonoscopy|tandem colonoscopy
5077575|NCT01310699|Flat Polyp|flat polyp
5077576|NCT01310699|Nonpolypoid|nonpolypoid
5077577|NCT01310699|Flat and Depressed Lesions|flat and depressed lesions
5077578|NCT01310699|Primary Prevention|primary prevention
5077579|NCT01310699|Endoscopy|endoscopy
5077580|NCT01310686|wet AMD anti-VEGF|wet amd anti-vegf
5077581|NCT01310686|Genetic analysis of patients with Wet AMD who have not responded fully to anti-VEGF treatments|genetic analysis of patients with wet amd who have not responded fully to anti-vegf treatments
5077582|NCT01310673|Gout|gout
5077583|NCT01310673|Allopurinol|allopurinol
5077584|NCT01310673|Acute gout|acute gout
5077585|NCT01310647|estradiol|estradiol
5077586|NCT01310647|testosterone|testosterone
5077587|NCT01310647|combined oral contraceptive|combined oral contraceptive
5077588|NCT01310647|low responders|low responders
5077589|NCT01310647|ICSI|icsi
5077590|NCT01310634|Neonates|neonates
5077591|NCT01310634|Parenting|parenting
5077592|NCT01310634|Anxiety|anxiety
5077593|NCT01310634|Depression|depression
5077594|NCT01310621|Neonate|neonate
5077595|NCT01310621|Meconium aspiration syndrome|meconium aspiration syndrome
5077596|NCT01310621|surfactant lung lavage|surfactant lung lavage
5077597|NCT01310608|Atherosclerosis aorta|atherosclerosis aorta
5077598|NCT01310608|A-View|a-view
5077599|NCT01310608|Distal ascending aorta|distal ascending aorta
5077600|NCT01310608|Transoesophageal echocardiography|transoesophageal echocardiography
5077601|NCT01310608|CABG|cabg
5077602|NCT01310608|Cerebral embolisation|cerebral embolisation
5077603|NCT01310595|Musculoskeletal manipulations|musculoskeletal manipulations
5077604|NCT01310595|Proprioception|proprioception
5077605|NCT01310595|Postural balance|postural balance
5077606|NCT01310582|Sevoflurane|sevoflurane
5077607|NCT01310582|Desflurane|desflurane
5077608|NCT01310569|PCOS, Skinfold thickness, HOMA-IR|pcos, skinfold thickness, homa-ir
5077609|NCT01310556|OGTT|ogtt
5077610|NCT01310556|coronary artery disease|coronary artery disease
5077611|NCT01310543|Teenage pregnancy|teenage pregnancy
5077612|NCT01310543|Adolescent|adolescent
5077613|NCT01310543|Sexual health|sexual health
5077614|NCT01310543|Youth development|youth development
5077615|NCT01310530|Breast Cancer|breast cancer
5077616|NCT01310530|Partial Breast|partial breast
5077617|NCT01310530|Proton Beam|proton beam
5077618|NCT01310517|Angiogram|angiogram
5077619|NCT01310517|Injected Contrast|injected contrast
5077620|NCT01310517|Heart Function|heart function
5077621|NCT01310517|contrast dye|contrast dye
5077622|NCT01310478|Recombinant human endostatin|recombinant human endostatin
5077623|NCT01310478|Metastatic colorectal cancer|metastatic colorectal cancer
5077624|NCT01310478|DLT|dlt
5077625|NCT01310478|MTD|mtd
5077626|NCT01310478|Pharmacokinetics|pharmacokinetics
5077627|NCT01310452|diabetes, basal insulin, metformin, liver fat, visceral fat|diabetes, basal insulin, metformin, liver fat, visceral fat
5077628|NCT01310426|Anal Sphincter injury|anal sphincter injury
5077629|NCT01310426|Fecal Incontinence|fecal incontinence
5077630|NCT01310413|Influenza|influenza
5077631|NCT01310413|H5N1|h5n1
5077632|NCT01310413|Pandemic|pandemic
5077633|NCT01310400|Influenza|influenza
5077634|NCT01310400|Virus|virus
5077635|NCT01310400|Vaccination|vaccination
5077636|NCT01310400|Immunisation|immunisation
5077637|NCT01310387|Lung cancer|lung cancer
5077638|NCT01310387|Cancer pain|cancer pain
5077639|NCT01310387|Opioid|opioid
5077640|NCT01310374|influenza vaccine|influenza vaccine
5077641|NCT01310374|immune response|immune response
5077642|NCT01310374|dynamic changes|dynamic changes
5077643|NCT01310361|Pharyngitis|pharyngitis
5077644|NCT01310361|Group A β-hemolytic Streptococci|group a β-hemolytic streptococci
5077645|NCT01310361|Exudate|exudate
5077646|NCT01310361|Erythema Penicillin|erythema penicillin
5077647|NCT01310361|Amoxicillin|amoxicillin
5077648|NCT01310348|Bone|bone
5077649|NCT01310348|Muscle strength|muscle strength
5077650|NCT01310348|whole-body vibration|whole-body vibration
5077651|NCT01310335|sclerostin|sclerostin
5077652|NCT01310335|whole-body vibration|whole-body vibration
5077653|NCT01310322|Phase I|phase i
5077654|NCT01310322|Healthy male volunteers|healthy male volunteers
5077655|NCT01310322|mild asthmatics|mild asthmatics
5077656|NCT01310322|pharmacokinetics|pharmacokinetics
5077657|NCT01310322|Bioavailability and AUC|bioavailability and auc
5077658|NCT01310322|Level of AZD5423 in your blood|level of azd5423 in your blood
5077659|NCT01310309|Stents|stents
5077660|NCT01310309|Drug-eluting Stent|drug-eluting stent
5077661|NCT01310309|Angioplasty|angioplasty
5077662|NCT01310309|Coronary Artery stenosis|coronary artery stenosis
5077663|NCT01310309|Coronary Artery Stent Restenosis|coronary artery stent restenosis
5077664|NCT01310309|Stent Thrombosis|stent thrombosis
5077665|NCT01310296|Phase 1|phase 1
5077666|NCT01310296|Normal Healthy Volunteers|normal healthy volunteers
5077667|NCT01310296|Mass Balance|mass balance
5077668|NCT01310296|ADME|adme
5077669|NCT01310296|Absolute Bioavailability|absolute bioavailability
5077670|NCT01310283|dental caries|dental caries
5077671|NCT01310283|children|children
5077672|NCT01310283|mutans streptococci|mutans streptococci
5077673|NCT01310283|lactobacilli|lactobacilli
5077674|NCT01310283|cariogenic bacteria|cariogenic bacteria
5077675|NCT01310244|Phase 1/2|phase 1/2
5077676|NCT01310244|MTD|mtd
5077677|NCT01310244|stage IV|stage iv
5077678|NCT01310244|NSCLC|nsclc
5077679|NCT01310244|chemo-naive|chemo-naive
5077680|NCT01310244|Mixed-cell dose escalation|mixed-cell dose escalation
5077681|NCT01310244|lung cancer|lung cancer
5077682|NCT01310244|non-small-cell|non-small-cell
5077683|NCT01310244|phase I|phase i
5077684|NCT01310244|Belinostat|belinostat
5077685|NCT01310244|Carboplatin|carboplatin
5077686|NCT01310244|Paclitaxel|paclitaxel
5077687|NCT01310244|adenocarcinoma|adenocarcinoma
5077688|NCT01310244|PXD-101|pxd-101
5077689|NCT01310231|Metastatic Breast Cancer|metastatic breast cancer
5077690|NCT01310231|Metformin|metformin
5077691|NCT01310218|orthopedics, carpal tunnel syndrome, postoperative care|orthopedics, carpal tunnel syndrome, postoperative care
5077692|NCT01310205|HCV|hcv
5077693|NCT01310205|Genotype 1|genotype 1
5077694|NCT01310205|relapsers|relapsers
5077695|NCT01310205|non cirrhotic|non cirrhotic
5077696|NCT01310205|Chronic Hepatitis C|chronic hepatitis c
5077697|NCT01310179|gene therapy|gene therapy
5077698|NCT01310179|advanced solid tumors|advanced solid tumors
5077699|NCT01310179|Head and Neck cancer|head and neck cancer
5077700|NCT01310179|intratumoral therapy|intratumoral therapy
5077701|NCT01310166|Multiple sclerosis|multiple sclerosis
5077702|NCT01310166|RRMS|rrms
5077703|NCT01310166|relapsing-remitting|relapsing-remitting
5077704|NCT01310166|fingolimod|fingolimod
5077705|NCT01310166|biomarkers|biomarkers
5077706|NCT01310140|Metabolic Syndrome|metabolic syndrome
5077707|NCT01310140|Insulin Resistance|insulin resistance
5077708|NCT01310140|Massachusetts General Hospital|massachusetts general hospital
5077709|NCT01310140|Major Depressive Disorder|major depressive disorder
5077710|NCT01310140|Major Depressive Disorder with Psychotic Features|major depressive disorder with psychotic features
5077711|NCT01310140|Cortisol|cortisol
5077712|NCT01310140|Dexamethasone Suppression Test|dexamethasone suppression test
5077713|NCT01310127|NSAID|nsaid
5077714|NCT01310127|Ocular Inflammation|ocular inflammation
5077715|NCT01310127|bromfenac|bromfenac
5077716|NCT01310114|Human Placenta-Derived Cells|human placenta-derived cells
5077717|NCT01310114|Stem cells|stem cells
5077718|NCT01310114|Stroke|stroke
5077719|NCT01310114|PDA001|pda001
5077720|NCT01310114|Celgene|celgene
5077721|NCT01310114|cenplacel-L|cenplacel-l
5077722|NCT01310101|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
5077723|NCT01310101|Refractory|refractory
5077724|NCT01310101|Relapse|relapse
5077725|NCT01310101|Ofatumumab|ofatumumab
5077726|NCT01310101|Dexamethasone|dexamethasone
5077727|NCT01310088|Childhood|childhood
5077728|NCT01310088|Child|child
5077729|NCT01310088|adolescent|adolescent
5077730|NCT01310088|central blood pressure|central blood pressure
5077731|NCT01310088|ambulatory blood pressure monitoring|ambulatory blood pressure monitoring
5077732|NCT01310088|ABPM|abpm
5077733|NCT01310088|clinic blood pressure|clinic blood pressure
5077734|NCT01310088|pulse wave velocity|pulse wave velocity
5077735|NCT01310088|PWV|pwv
5077736|NCT01310088|Pulse cave analysis|pulse cave analysis
5077737|NCT01310088|PWA|pwa
5077738|NCT01310088|heart rate variability|heart rate variability
5077739|NCT01310088|HRV|hrv
5077740|NCT01310088|Echocardiography|echocardiography
5077741|NCT01310088|Urine microalbuminuria|urine microalbuminuria
5077742|NCT01310088|blood samples|blood samples
5077743|NCT01310075|Mastectomy|mastectomy
5077744|NCT01310075|Bioprosthetic Mesh|bioprosthetic mesh
5077745|NCT01310075|Breast Reconstruction|breast reconstruction
5077746|NCT01310075|Tissue Expander|tissue expander
5077747|NCT01310075|Alloderm|alloderm
5077748|NCT01310075|Surgimend|surgimend
5077749|NCT01310062|hepatocellular carcinoma|hepatocellular carcinoma
5077750|NCT01310062|microarray|microarray
5077751|NCT01310062|gene expression profiling|gene expression profiling
5077752|NCT01310062|biomarkers|biomarkers
5077753|NCT01310049|Exploratory study in healthy subjects|exploratory study in healthy subjects
5077754|NCT01310023|Conditions and diagnoses potentially related to perinatal exposure to antiretroviral medications|conditions and diagnoses potentially related to perinatal exposure to antiretroviral medications
5077755|NCT01309997|Imatinib|imatinib
5077756|NCT01309997|Rituximab|rituximab
5077757|NCT01309997|Chronic Graft-vs-Host Disease|chronic graft-vs-host disease
5077758|NCT01309984|Monitored anesthesia care|monitored anesthesia care
5077759|NCT01309971|Assessment|assessment
5077760|NCT01309971|Questionable Caries|questionable caries
5077761|NCT01309958|Dental Caries|dental caries
5077762|NCT01309958|Intervention|intervention
5077763|NCT01309958|Non-invasive treatment for early caries|non-invasive treatment for early caries
5077764|NCT01309919|intrauterine device|intrauterine device
5077765|NCT01309919|Mirena|mirena
5077766|NCT01309919|levonorgestrel intrauterine system|levonorgestrel intrauterine system
5077767|NCT01309919|postpartum contraception|postpartum contraception
5077768|NCT01309893|Contact lens|contact lens
5077769|NCT01309880|Contact lens|contact lens
5077770|NCT01309854|Phase 1|phase 1
5077771|NCT01309854|healthy volunteers|healthy volunteers
5077772|NCT01309854|pharmacokinetics|pharmacokinetics
5077773|NCT01309854|Rheumatoid arthritis|rheumatoid arthritis
5077774|NCT01309854|RA|ra
5077775|NCT01309854|fostamatinib|fostamatinib
5077776|NCT01309854|pioglitazone|pioglitazone
5077777|NCT01309854|drug-drug interaction|drug-drug interaction
5077778|NCT01309841|Non-Cancer-Related Pain, Opioid-Induced Constipation|non-cancer-related pain, opioid-induced constipation
5077779|NCT01309828|Renal Insufficiency|renal insufficiency
5077780|NCT01309828|Kidney Diseases|kidney diseases
5077781|NCT01309828|Hypertension|hypertension
5077782|NCT01309828|Drug Therapy|drug therapy
5077783|NCT01309815|neoplasms|neoplasms
5077784|NCT01309815|existentialism|existentialism
5077785|NCT01309815|existential concerns|existential concerns
5077786|NCT01309815|Meaning making|meaning making
5077787|NCT01309815|early palliative phase|early palliative phase
5077788|NCT01309815|elderly|elderly
5077789|NCT01309802|botox|botox
5077790|NCT01309802|raynaud's|raynaud's
5077791|NCT01309802|botulinum toxin|botulinum toxin
5077792|NCT01309802|botulinum toxin A|botulinum toxin a
5077793|NCT01309802|raynaud's disease|raynaud's disease
5077794|NCT01309802|raynaud's syndrome|raynaud's syndrome
5077795|NCT01309802|raynaud's phenomenon|raynaud's phenomenon
5077796|NCT01309802|ischemic digits|ischemic digits
5077797|NCT01309802|ischemia|ischemia
5077798|NCT01309802|botox treatment|botox treatment
5077799|NCT01309802|onabotulinum|onabotulinum
5077800|NCT01309802|onabotulinum toxin|onabotulinum toxin
5077801|NCT01309802|onabotulinum toxin type A|onabotulinum toxin type a
5077802|NCT01309789|Antibodies, Monoclonal|antibodies, monoclonal
5077803|NCT01309789|Antibody-Drug Conjugate|antibody-drug conjugate
5077804|NCT01309789|Antigens, CD30|antigens, cd30
5077805|NCT01309789|Drug Therapy|drug therapy
5077806|NCT01309789|Hematologic Diseases|hematologic diseases
5077807|NCT01309789|Lymphoma|lymphoma
5077808|NCT01309789|monomethyl auristatin E|monomethyl auristatin e
5077809|NCT01309789|Lymphoma, Large-Cell, Anaplastic|lymphoma, large-cell, anaplastic
5077810|NCT01309789|Lymphoma, T-cell|lymphoma, t-cell
5077811|NCT01309789|Lymphoma, NK-cell|lymphoma, nk-cell
5077812|NCT01309737|Xeljanz|xeljanz
5077813|NCT01309737|tofacitinib|tofacitinib
5077814|NCT01309737|Jak-inhibitor|jak-inhibitor
5077815|NCT01309737|oral treatment|oral treatment
5077816|NCT01309737|chronic|chronic
5077817|NCT01309737|severe|severe
5077818|NCT01309737|moderate|moderate
5077819|NCT01309737|Pruritus|pruritus
5077820|NCT01309737|Itch|itch
5077821|NCT01309737|DLQI|dlqi
5077822|NCT01309737|treatment|treatment
5077823|NCT01309737|safety|safety
5077824|NCT01309737|efficacy|efficacy
5077825|NCT01309737|CP-690,550|cp-690,550
5077826|NCT01309737|Plaque Psoriasis|plaque psoriasis
5077827|NCT01309737|Psoriasis Vulgaris|psoriasis vulgaris
5077828|NCT01309724|Hypotension|hypotension
5077829|NCT01309724|Fluid|fluid
5077830|NCT01309711|MRI|mri
5077831|NCT01309711|Biomarkers|biomarkers
5077832|NCT01309711|Neonatal encephalopathy|neonatal encephalopathy
5077833|NCT01309711|Therapeutic hypothermia|therapeutic hypothermia
5077834|NCT01309698|Drug interaction|drug interaction
5077835|NCT01309685|Cognition|cognition
5077836|NCT01309685|Smoking|smoking
5077837|NCT01309685|Nicotine|nicotine
5077838|NCT01309685|Varenicline|varenicline
5077839|NCT01309685|Withdrawal|withdrawal
5077840|NCT01309672|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5077841|NCT01309672|hormone-resistant prostate cancer|hormone-resistant prostate cancer
5077842|NCT01309672|stage IV prostate cancer|stage iv prostate cancer
5077843|NCT01309672|recurrent prostate cancer|recurrent prostate cancer
5077844|NCT01309659|Anemia|anemia
5077845|NCT01309659|Unexplained anemia|unexplained anemia
5077846|NCT01309659|elderly|elderly
5077847|NCT01309659|geriatric|geriatric
5077848|NCT01309659|older adults|older adults
5077849|NCT01309659|UAE|uae
5077850|NCT01309659|over 65|over 65
5077851|NCT01309659|iron|iron
5077852|NCT01309659|pactte|pactte
5077853|NCT01309659|pactee|pactee
5077854|NCT01309659|aging|aging
5077855|NCT01309659|aged|aged
5077856|NCT01309659|old|old
5077857|NCT01309659|older|older
5077858|NCT01309646|Primary vaccination|primary vaccination
5077859|NCT01309646|combination vaccine|combination vaccine
5077860|NCT01309646|South Korea|south korea
5077861|NCT01309633|locally advanced|locally advanced
5077862|NCT01309633|metastatic|metastatic
5077863|NCT01309620|zinc, oxidative stress, vascular indices, type 2 diabetes|zinc, oxidative stress, vascular indices, type 2 diabetes
5077864|NCT01309581|depression|depression
5077865|NCT01309581|electroconvulsive therapy|electroconvulsive therapy
5077866|NCT01309581|ketamine|ketamine
5077867|NCT01309581|antidepressant|antidepressant
5077868|NCT01309555|Growth disorders|growth disorders
5077869|NCT01309555|Saizen|saizen
5077870|NCT01309555|easypod™|easypod™
5077871|NCT01309555|Growth hormone|growth hormone
5077872|NCT01309555|Pediatric subject|pediatric subject
5077873|NCT01309542|major depressive disorder|major depressive disorder
5077874|NCT01309542|desvenlafaxine|desvenlafaxine
5077875|NCT01309542|antidepressant|antidepressant
5077876|NCT01309529|general thoracic surgery|general thoracic surgery
5077877|NCT01309529|epidural analgesia|epidural analgesia
5077878|NCT01309529|postoperative retention of urine|postoperative retention of urine
5077879|NCT01309529|postoperative urinary tract infection|postoperative urinary tract infection
5077880|NCT01309529|catheter associated urinary tract infection|catheter associated urinary tract infection
5077881|NCT01309516|Postnatal depression|postnatal depression
5077882|NCT01309516|Maternal depression|maternal depression
5077883|NCT01309516|Psychosocial intervention|psychosocial intervention
5077884|NCT01309490|high eIF4E expression|high eif4e expression
5077885|NCT01309490|solid tumor cancer|solid tumor cancer
5077886|NCT01309477|Refractory Nephrotic Syndrome|refractory nephrotic syndrome
5077887|NCT01309477|Tacrolimus|tacrolimus
5077888|NCT01309451|diabetic macular edema|diabetic macular edema
5077889|NCT01309451|DME|dme
5077890|NCT01309438|Healthy|healthy
5077891|NCT01309438|Renal Insufficiency|renal insufficiency
5077892|NCT01309438|Rivaroxaban (BAY 59-7939, JNJ-39039039)|rivaroxaban (bay 59-7939, jnj-39039039)
5077893|NCT01309438|Erythromycin|erythromycin
5077894|NCT01309438|Pharmacokinetic|pharmacokinetic
5077895|NCT01309438|Pharmacodynamic|pharmacodynamic
5077896|NCT01309425|tapentadol|tapentadol
5077897|NCT01309425|NUCYNTA|nucynta
5077898|NCT01309425|CG5503|cg5503
5077899|NCT01309425|R331333|r331333
5077900|NCT01309425|pharmacokinetics|pharmacokinetics
5077901|NCT01309425|healthy volunteer|healthy volunteer
5077902|NCT01309412|Relapsed or refractory multiple myeloma|relapsed or refractory multiple myeloma
5077903|NCT01309412|CNTO 328|cnto 328
5077904|NCT01309412|siltuximab|siltuximab
5077905|NCT01309412|bortezomib|bortezomib
5077906|NCT01309412|dexamethasone|dexamethasone
5077907|NCT01309399|bone formation rate|bone formation rate
5077908|NCT01309399|total hip arthroplasty|total hip arthroplasty
5077909|NCT01309386|Tapentadol|tapentadol
5077910|NCT01309386|Tumor related pain|tumor related pain
5077911|NCT01309386|Opioid|opioid
5077912|NCT01309386|Cancer related pain|cancer related pain
5077913|NCT01309386|Morphine|morphine
5077914|NCT01309373|Schizophrenia|schizophrenia
5077915|NCT01309373|Schizoaffective Disorder|schizoaffective disorder
5077916|NCT01309373|Remission|remission
5077917|NCT01309373|Psychosocial|psychosocial
5077918|NCT01309373|Symtomatic|symtomatic
5077919|NCT01309373|Integration|integration
5077920|NCT01309373|Schizoaffective|schizoaffective
5077921|NCT01309373|Adherence|adherence
5077922|NCT01309360|ultrasound|ultrasound
5077923|NCT01309360|methaemoglobin|methaemoglobin
5077924|NCT01309360|prilocaine|prilocaine
5077925|NCT01309360|regional anesthesia|regional anesthesia
5077926|NCT01309360|ASA risk groups I-II|asa risk groups i-ii
5077927|NCT01309360|adult outpatients|adult outpatients
5077928|NCT01309360|surgical spectrum covered procedures|surgical spectrum covered procedures
5077929|NCT01309360|distal forearm|distal forearm
5077930|NCT01309360|hand|hand
5078324|NCT01307514|DIABETES|diabetes
5077931|NCT01309347|prosthetic socket, residual limb volume fluctuation|prosthetic socket, residual limb volume fluctuation
5077933|NCT01309334|PET-scan|pet-scan
5077934|NCT01309334|multiple myeloma|multiple myeloma
5077935|NCT01309334|prognosis|prognosis
5077936|NCT01309334|pharmacoeconomic analysis|pharmacoeconomic analysis
5077937|NCT01309321|Perinatal|perinatal
5077938|NCT01309321|Handwashing|handwashing
5077939|NCT01309321|Neonatal|neonatal
5077940|NCT01309321|Morbidity|morbidity
5077941|NCT01309321|Mortality|mortality
5077942|NCT01309321|Primiparous|primiparous
5077943|NCT01309321|Health behavior|health behavior
5077944|NCT01309321|Developing countries|developing countries
5077945|NCT01309321|Sepsis|sepsis
5077946|NCT01309321|Omphalitis|omphalitis
5077947|NCT01309321|Infectious disease|infectious disease
5077948|NCT01309321|Bangladesh|bangladesh
5077949|NCT01309308|cervical length|cervical length
5077950|NCT01309308|sweeping the membranes|sweeping the membranes
5077951|NCT01309256|distal gastrectomy|distal gastrectomy
5077952|NCT01309256|Robotic gastrectomy|robotic gastrectomy
5077953|NCT01309256|registry|registry
5077954|NCT01309256|learning curve|learning curve
5077955|NCT01309256|cost-effectiveness|cost-effectiveness
5077956|NCT01309256|quality of life|quality of life
5077957|NCT01309256|acute inflammatory reaction|acute inflammatory reaction
5077958|NCT01309256|Robotic and laparoscopic surgery|robotic and laparoscopic surgery
5077959|NCT01309243|HIV|hiv
5077960|NCT01309243|HIV-1|hiv-1
5077961|NCT01309243|Antiretroviral Treatment-Naïve|antiretroviral treatment-naïve
5077962|NCT01309230|Stage III|stage iii
5077963|NCT01309230|Stage IV|stage iv
5077964|NCT01309230|epithelial ovarian cancer|epithelial ovarian cancer
5077965|NCT01309230|ovarian cancer|ovarian cancer
5077966|NCT01309230|Adjuvant|adjuvant
5077967|NCT01309230|immunotherapy|immunotherapy
5077968|NCT01309204|open-angle glaucoma|open-angle glaucoma
5077969|NCT01309204|ocular hypertension|ocular hypertension
5077970|NCT01309204|OAG|oag
5077971|NCT01309204|OHT|oht
5077972|NCT01309191|Androgenetic Alopecia|androgenetic alopecia
5077973|NCT01309191|Minoxidil|minoxidil
5077974|NCT01309191|Microarray|microarray
5077975|NCT01309165|stroke|stroke
5077976|NCT01309165|cognition|cognition
5077977|NCT01309165|cognitive strategies|cognitive strategies
5077978|NCT01309165|motor skill acquisition|motor skill acquisition
5077979|NCT01309165|participation|participation
5077980|NCT01309152|cefazolin|cefazolin
5077981|NCT01309152|microdialysis|microdialysis
5077982|NCT01309152|morbid obesity|morbid obesity
5077983|NCT01309152|pharmacokinetics|pharmacokinetics
5077984|NCT01309126|Colorectal Cancer|colorectal cancer
5077985|NCT01309126|KRAS Wild Type|kras wild type
5077986|NCT01309126|Imprime PGG|imprime pgg
5077987|NCT01309126|Cetuximab|cetuximab
5077988|NCT01309126|Phase 3|phase 3
5077989|NCT01309126|Efficacy|efficacy
5077990|NCT01309126|Safety|safety
5077991|NCT01309126|Recurrent or Progressive KRAS Wild Type Colorectal Cancer|recurrent or progressive kras wild type colorectal cancer
5077992|NCT01309087|Gene Expression|gene expression
5077993|NCT01309087|Lung Cancer|lung cancer
5077994|NCT01309087|Smoking|smoking
5077995|NCT01309074|Anxiety|anxiety
5077996|NCT01309074|Epilepsy|epilepsy
5077997|NCT01309048|bone metastasis|bone metastasis
5077998|NCT01309048|Patients with bone metastasis|patients with bone metastasis
5077999|NCT01309035|Prothesis fixation|prothesis fixation
5078000|NCT01309035|Bloodlessness|bloodlessness
5078001|NCT01309022|Diabetes Mellitus, Type 1|diabetes mellitus, type 1
5078002|NCT01309022|T1D|t1d
5078003|NCT01309022|T1DM|t1dm
5078004|NCT01309022|Islets of Langerhans Transplantation|islets of langerhans transplantation
5078005|NCT01309022|Pancreatic Islets Transplantation|pancreatic islets transplantation
5078006|NCT01309022|Islet Transplant|islet transplant
5078007|NCT01309022|Tacrolimus|tacrolimus
5078008|NCT01309022|Sirolimus|sirolimus
5078009|NCT01309022|Mycophenolate mofetil|mycophenolate mofetil
5078010|NCT01309022|Mycophenolic acid|mycophenolic acid
5078011|NCT01309009|Infantile Colic|infantile colic
5078012|NCT01309009|Tachykinin antagonist|tachykinin antagonist
5078013|NCT01309009|Nepadutant|nepadutant
5078014|NCT01308996|alveolar ridge augmentation|alveolar ridge augmentation
5078015|NCT01308996|edentulous ridge|edentulous ridge
5078016|NCT01308996|alveolar ridge defect|alveolar ridge defect
5078017|NCT01308996|posterior mandible defect|posterior mandible defect
5078018|NCT01308996|bone morphogenic protein|bone morphogenic protein
5078019|NCT01308996|osseointegration|osseointegration
5078020|NCT01308983|Prehypertension|prehypertension
5078021|NCT01308983|Flow mediated dilation|flow mediated dilation
5078022|NCT01308983|Pulse wave velocity|pulse wave velocity
5078023|NCT01308983|carotid compliance|carotid compliance
5078024|NCT01308983|Prehypertension and amiloride|prehypertension and amiloride
5078025|NCT01308944|invasive epithelial ovarian cancer,|invasive epithelial ovarian cancer,
5078026|NCT01308944|primary peritoneal carcinoma,|primary peritoneal carcinoma,
5078027|NCT01308944|fallopian tube cancer|fallopian tube cancer
5078028|NCT01308931|Contraception|contraception
5078029|NCT01308931|IUD|iud
5078030|NCT01308931|Essure|essure
5078031|NCT01308931|Tubal ligation|tubal ligation
5078032|NCT01308931|Anti-Mullerian hormone|anti-mullerian hormone
5078033|NCT01308918|Thoracic surgery|thoracic surgery
5078034|NCT01308918|Double lumen tube intubation|double lumen tube intubation
5078035|NCT01308918|GlideScope|glidescope
5078036|NCT01308918|Stylet|stylet
5078037|NCT01308905|Neuroblastoma|neuroblastoma
5078038|NCT01308879|Contextualized Feedback System (CFS)|contextualized feedback system (cfs)
5078039|NCT01308879|Mental health outcomes|mental health outcomes
5078040|NCT01308879|Quality improvement|quality improvement
5078041|NCT01308879|Feedback|feedback
5078042|NCT01308879|Clinical trial|clinical trial
5078043|NCT01308866|cardiovascular diseases|cardiovascular diseases
5078044|NCT01308866|patient education|patient education
5078045|NCT01308866|primary health care|primary health care
5078046|NCT01308866|consumer participation|consumer participation
5078047|NCT01308866|decision aids|decision aids
5078048|NCT01308840|Unresectable|unresectable
5078049|NCT01308840|metastatic|metastatic
5078050|NCT01308840|biliary tract|biliary tract
5078051|NCT01308840|gallbladder cancer|gallbladder cancer
5078052|NCT01308827|Children 28 days to 36 months of age with suspected pneumococcal disease|children 28 days to 36 months of age with suspected pneumococcal disease
5078053|NCT01308814|Perimenopause|perimenopause
5078054|NCT01308814|Menopause|menopause
5078055|NCT01308814|Depression|depression
5078056|NCT01308814|Cardiovascular health|cardiovascular health
5078057|NCT01308801|fibromyalgia|fibromyalgia
5078058|NCT01308801|pain|pain
5078059|NCT01308801|repetitive transcranial magnetic stimulation|repetitive transcranial magnetic stimulation
5078060|NCT01308801|rehabilitation exercise|rehabilitation exercise
5078061|NCT01308801|quality of life|quality of life
5078062|NCT01308788|glaucoma blood flow|glaucoma blood flow
5078063|NCT01308775|SIS.NET|sis.net
5078064|NCT01308736|tobacco|tobacco
5078065|NCT01308736|nicotine|nicotine
5078066|NCT01308736|cigarette smoking|cigarette smoking
5078067|NCT01308710|endothelial function|endothelial function
5078068|NCT01308710|lipids|lipids
5078069|NCT01308710|pediatrics|pediatrics
5078070|NCT01308697|Flail|flail
5078071|NCT01308697|Chest|chest
5078072|NCT01308671|coronary artery disease|coronary artery disease
5078073|NCT01308671|varenicline|varenicline
5078074|NCT01308671|clopidogrel|clopidogrel
5078075|NCT01308658|TMC114-C176|tmc114-c176
5078076|NCT01308658|TMC114|tmc114
5078077|NCT01308658|DRV|drv
5078078|NCT01308658|HIV|hiv
5078079|NCT01308658|Healthy volunteers|healthy volunteers
5078080|NCT01308645|SBP Injection|sbp injection
5078081|NCT01308645|HCC|hcc
5078082|NCT01308632|glioblastoma|glioblastoma
5078083|NCT01308632|temozolamide|temozolamide
5078084|NCT01308632|radiotherapy|radiotherapy
5078085|NCT01308632|TMZ|tmz
5078086|NCT01308632|irinotecan|irinotecan
5078087|NCT01308606|TMC435-TiDP16-C116|tmc435-tidp16-c116
5078088|NCT01308606|TMC435-C116|tmc435-c116
5078089|NCT01308606|TMC435|tmc435
5078090|NCT01308606|HCV|hcv
5078091|NCT01308606|Hepatitis C|hepatitis c
5078092|NCT01308606|Hep C|hep c
5078093|NCT01308606|healthy volunteers|healthy volunteers
5078094|NCT01308554|TAP block|tap block
5078095|NCT01308554|Pain|pain
5078096|NCT01308554|Obesity|obesity
5078097|NCT01308554|Surgery|surgery
5078098|NCT01308554|Laparoscopic gastric bypass|laparoscopic gastric bypass
5078099|NCT01308528|Venous Thromboembolism|venous thromboembolism
5078100|NCT01308515|knee|knee
5078101|NCT01308515|osteoarthritis|osteoarthritis
5078102|NCT01308515|joint|joint
5078103|NCT01308515|replacement|replacement
5078104|NCT01308515|knee surgery|knee surgery
5078105|NCT01308502|laryngopharyngeal reflux|laryngopharyngeal reflux
5078106|NCT01308502|LPR|lpr
5078107|NCT01308502|GERD|gerd
5078108|NCT01308502|gastroesophageal reflux|gastroesophageal reflux
5078109|NCT01308502|nasopharyngeal probe|nasopharyngeal probe
5078110|NCT01308463|elbow long-term Survivorship|elbow long-term survivorship
5078111|NCT01308463|Study participant Discovery Elbow Multi-center Study who|study participant discovery elbow multi-center study who
5078112|NCT01308463|consent for the Discovery Elbow Long-term SurvivorshipStudy|consent for the discovery elbow long-term survivorshipstudy
5078113|NCT01308450|ADHD Normative Control Group|adhd normative control group
5078114|NCT01308424|Herpes Labialis|herpes labialis
5078115|NCT01308424|Herpes Simplex|herpes simplex
5078116|NCT01308424|Herpes|herpes
5078117|NCT01308411|Asthma|asthma
5078118|NCT01308411|Inhaled Corticosteroids|inhaled corticosteroids
5078119|NCT01308411|Exhaled Nitric oxide|exhaled nitric oxide
5078120|NCT01308411|Airways inflammation|airways inflammation
5078121|NCT01308411|Step down|step down
5078122|NCT01308411|Predicting response|predicting response
5078123|NCT01308372|cardiovascular risk|cardiovascular risk
5078124|NCT01308372|France|france
5078125|NCT01308372|General practice|general practice
5078126|NCT01308372|Primary prevention|primary prevention
5078127|NCT01308372|Non treated patients|non treated patients
5078128|NCT01308359|fetal movement|fetal movement
5078129|NCT01308346|Bioabsorbable|bioabsorbable
5078130|NCT01308346|Coronary Stent|coronary stent
5078131|NCT01308346|Everolimus|everolimus
5078132|NCT01308346|drug eluting stents|drug eluting stents
5078133|NCT01308346|stents|stents
5078134|NCT01308346|angioplasty|angioplasty
5078135|NCT01308346|coronary artery disease|coronary artery disease
5078136|NCT01308346|total coronary occlusion|total coronary occlusion
5078137|NCT01308346|coronary artery restenosis|coronary artery restenosis
5078138|NCT01308346|stent thrombosis|stent thrombosis
5078139|NCT01308346|myocardial ischemia|myocardial ischemia
5078140|NCT01308346|coronary artery stenosis|coronary artery stenosis
5078141|NCT01308307|Non-cycloplegic photorefraction|non-cycloplegic photorefraction
5078142|NCT01308307|cycloplegic refraction,|cycloplegic refraction,
5078143|NCT01308307|Amblyopia|amblyopia
5078144|NCT01308294|Melanoma|melanoma
5078145|NCT01308294|Stage II-IV|stage ii-iv
5078146|NCT01308294|Immunotherapy|immunotherapy
5078147|NCT01308294|Vaccination|vaccination
5078148|NCT01308294|HLA class I and II tumor-specific peptides|hla class i and ii tumor-specific peptides
5078149|NCT01308294|IMP321|imp321
5078150|NCT01308294|Montanide ISA-51 VG|montanide isa-51 vg
5078151|NCT01308268|STH|sth
5078152|NCT01308268|Soil-transmitted Helminthiasis|soil-transmitted helminthiasis
5078153|NCT01308268|mass drug administration|mass drug administration
5078154|NCT01308229|Bifurcation|bifurcation
5078155|NCT01308229|Dedicated|dedicated
5078156|NCT01308229|Drug-eluting stent|drug-eluting stent
5078157|NCT01308229|Angioplasty|angioplasty
5078158|NCT01308229|Coronary artery disease|coronary artery disease
5078159|NCT01308229|Coronary artery stenosis|coronary artery stenosis
5078160|NCT01308216|Transcranial Laser Therapy|transcranial laser therapy
5078161|NCT01308216|Hemiplegia|hemiplegia
5078162|NCT01308216|Rehabilitation|rehabilitation
5078163|NCT01308216|Physiotherapy|physiotherapy
5078164|NCT01308216|Ischemic stroke|ischemic stroke
5078165|NCT01308190|Preoperative chemoradiotherapy|preoperative chemoradiotherapy
5078166|NCT01308190|Transanal endoscopic microsurgery|transanal endoscopic microsurgery
5078167|NCT01308190|Rectal Cancer|rectal cancer
5078168|NCT01308190|T2-T3s-N0|t2-t3s-n0
5078169|NCT01308164|Type 1 diabetes|type 1 diabetes
5078170|NCT01308164|Insulin Pump Therapy|insulin pump therapy
5078171|NCT01308151|CBT, self harm, depression, cultural adaptation, Pakistan|cbt, self harm, depression, cultural adaptation, pakistan
5078172|NCT01308138|Physical Activity|physical activity
5078173|NCT01308138|pathology|pathology
5078174|NCT01308138|Physical Deconditioning|physical deconditioning
5078175|NCT01308125|Stable Angina|stable angina
5078176|NCT01308125|Coronary artery disease|coronary artery disease
5078177|NCT01308125|PCI|pci
5078178|NCT01308125|Reperfusion|reperfusion
5078179|NCT01308125|Myocardial Infarction|myocardial infarction
5078180|NCT01308125|collateral flow pressure index|collateral flow pressure index
5078181|NCT01308125|CFpI|cfpi
5078182|NCT01308125|pressure controlled intermittent coronary sinus occlusion|pressure controlled intermittent coronary sinus occlusion
5078183|NCT01308125|PICSO|picso
5078184|NCT01308112|Iron|iron
5078185|NCT01308112|Plasmodium|plasmodium
5078186|NCT01308112|Malaria|malaria
5078187|NCT01308112|Pregnancy|pregnancy
5078188|NCT01308112|Kenya|kenya
5078189|NCT01308099|POTS|pots
5078190|NCT01308099|Vascular Endothelial Function|vascular endothelial function
5078191|NCT01308086|Cancer|cancer
5078192|NCT01308086|colorectal cancer|colorectal cancer
5078193|NCT01308086|adjuvant chemotherapy|adjuvant chemotherapy
5078194|NCT01308086|capecitabine|capecitabine
5078195|NCT01308086|oxaliplatin|oxaliplatin
5078196|NCT01308086|5 fluorouracil|5 fluorouracil
5078197|NCT01308060|Canthal lines|canthal lines
5078198|NCT01308034|non GIST sarcomas|non gist sarcomas
5078199|NCT01308034|sunitinib|sunitinib
5078200|NCT01308034|radiotherapy|radiotherapy
5078201|NCT01308034|dose escalation|dose escalation
5078202|NCT01308021|Rhinoconjunctivitis|rhinoconjunctivitis
5078203|NCT01308021|Allergy|allergy
5078204|NCT01308021|Grass pollen|grass pollen
5078205|NCT01308021|Hypersensitivity|hypersensitivity
5078206|NCT01308021|Immune system disorder|immune system disorder
5078207|NCT01308008|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
5078208|NCT01308008|Mobility Limitation|mobility limitation
5078209|NCT01307995|GDM|gdm
5078210|NCT01307995|incretin effect|incretin effect
5078211|NCT01307995|gestation|gestation
5078212|NCT01307995|reversibility|reversibility
5078213|NCT01307982|Gastroesophageal Reflux|gastroesophageal reflux
5078214|NCT01307982|Nervous System Diseases|nervous system diseases
5078215|NCT01307982|Fundoplication|fundoplication
5078216|NCT01307982|Enteral Nutrition|enteral nutrition
5078217|NCT01307969|liposomes|liposomes
5078218|NCT01307969|ropivacaine|ropivacaine
5078219|NCT01307969|dental anesthesia|dental anesthesia
5078220|NCT01307969|dentistry|dentistry
5078221|NCT01307943|MBSR|mbsr
5078222|NCT01307943|adolescent|adolescent
5078223|NCT01307943|mental health|mental health
5078224|NCT01307930|Echinocandin|echinocandin
5078225|NCT01307930|Obesity|obesity
5078226|NCT01307930|Pharmacokinetics|pharmacokinetics
5078227|NCT01307930|Pharmacodynamics|pharmacodynamics
5078228|NCT01307930|Fungal infection|fungal infection
5078229|NCT01307917|diabetes mellitus|diabetes mellitus
5078230|NCT01307917|diabetic nephropathy|diabetic nephropathy
5078231|NCT01307917|vascular endothelial dysfunction|vascular endothelial dysfunction
5078232|NCT01307917|flavonoids|flavonoids
5078233|NCT01307917|flow-mediated dilation|flow-mediated dilation
5078234|NCT01307904|Glycemic index|glycemic index
5078235|NCT01307904|Dates|dates
5078236|NCT01307904|Blood glucose|blood glucose
5078237|NCT01307891|Triple negative breast cancer (TNBC)|triple negative breast cancer (tnbc)
5078238|NCT01307891|Metastatic breast cancer|metastatic breast cancer
5078239|NCT01307891|Tigatuzumab (CS-1008)|tigatuzumab (cs-1008)
5078240|NCT01307891|Abraxane (ABI-007)|abraxane (abi-007)
5078241|NCT01307891|HER-2-neu negative|her-2-neu negative
5078242|NCT01307891|ER negative, PR negative|er negative, pr negative
5078243|NCT01307865|midface volume loss|midface volume loss
5078244|NCT01307865|aging of midface|aging of midface
5078245|NCT01307865|sculptra|sculptra
5078246|NCT01307865|sculptra aesthetic|sculptra aesthetic
5078247|NCT01307865|poly-L-lactic acid|poly-l-lactic acid
5078248|NCT01307852|Fiber optic radiation detectors|fiber optic radiation detectors
5078249|NCT01307852|Enhanced endorectal balloon|enhanced endorectal balloon
5078250|NCT01307852|Radiation treatment|radiation treatment
5078251|NCT01307852|Radiotherapy|radiotherapy
5078252|NCT01307852|External beam radiation|external beam radiation
5078253|NCT01307852|Dosimetry|dosimetry
5078254|NCT01307839|labor|labor
5078255|NCT01307839|epidural|epidural
5078256|NCT01307826|massage|massage
5078257|NCT01307826|shoulder|shoulder
5078258|NCT01307826|pain|pain
5078259|NCT01307826|range of motion|range of motion
5078260|NCT01307826|restricted range of motion|restricted range of motion
5078261|NCT01307813|colon distal|colon distal
5078262|NCT01307813|surgical resection|surgical resection
5078263|NCT01307787|exercise|exercise
5078264|NCT01307787|education|education
5078265|NCT01307787|self-management|self-management
5078266|NCT01307787|rehabilitation|rehabilitation
5078267|NCT01307774|parental acceptability of HPV vaccine|parental acceptability of hpv vaccine
5078268|NCT01307761|fine needle aspiration; predictor; ultrasonography; thyroid cancer|fine needle aspiration; predictor; ultrasonography; thyroid cancer
5078269|NCT01307748|aromatherapy|aromatherapy
5078270|NCT01307748|stress|stress
5078271|NCT01307748|older adults|older adults
5078272|NCT01307748|stress-related change|stress-related change
5078273|NCT01307735|myocarditis|myocarditis
5078274|NCT01307735|edema|edema
5078275|NCT01307735|hyperemia|hyperemia
5078276|NCT01307735|fibrosis|fibrosis
5078277|NCT01307735|necrosis|necrosis
5078278|NCT01307735|cardiovascular magnetic resonance imaging|cardiovascular magnetic resonance imaging
5078279|NCT01307722|left atrial distensibility|left atrial distensibility
5078280|NCT01307722|advanced chronic heart failure|advanced chronic heart failure
5078281|NCT01307722|decompensation|decompensation
5078282|NCT01307722|rehospitalization|rehospitalization
5078283|NCT01307722|prognosis|prognosis
5078284|NCT01307722|all-cause mortality|all-cause mortality
5078285|NCT01307722|heart failure with hospitalization|heart failure with hospitalization
5078286|NCT01307722|the duration of hospitalization|the duration of hospitalization
5078287|NCT01307696|Umbilical Hernia Repair|umbilical hernia repair
5078288|NCT01307696|PVP Mesh|pvp mesh
5078289|NCT01307683|Pregnancy|pregnancy
5078290|NCT01307683|Overweight|overweight
5078291|NCT01307683|Obese|obese
5078292|NCT01307683|Stress|stress
5078293|NCT01307683|Mindfulness|mindfulness
5078294|NCT01307657|clopidogrel|clopidogrel
5078295|NCT01307657|platelet|platelet
5078296|NCT01307657|platelet function test|platelet function test
5078297|NCT01307657|healthy|healthy
5078298|NCT01307657|Platelet function tests|platelet function tests
5078299|NCT01307644|Overweight|overweight
5078300|NCT01307644|Obesity|obesity
5078301|NCT01307644|Rural Health|rural health
5078302|NCT01307644|Weight Loss|weight loss
5078303|NCT01307644|Weight Maintenance|weight maintenance
5078304|NCT01307644|Rural Middle Aged and Older Women|rural middle aged and older women
5078305|NCT01307644|Web Intervention Weight Loss|web intervention weight loss
5078306|NCT01307644|Class I, II, & III obese (BMI 28 to 45)|class i, ii, & iii obese (bmi 28 to 45)
5078307|NCT01307605|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
5078308|NCT01307605|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
5078309|NCT01307605|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
5078310|NCT01307605|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5078311|NCT01307605|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5078312|NCT01307605|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5078313|NCT01307605|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5078314|NCT01307605|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5078315|NCT01307605|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5078316|NCT01307605|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5078317|NCT01307605|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5078318|NCT01307605|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5078319|NCT01307592|peripheral T-cell lymphoma|peripheral t-cell lymphoma
5078320|NCT01307592|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5078321|NCT01307592|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5078322|NCT01307592|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5078323|NCT01307592|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5078325|NCT01307514|PHARMACOKINETICS|pharmacokinetics
5078326|NCT01307514|PHARMACODYNAMICS|pharmacodynamics
5078327|NCT01307514|INSULIN|insulin
5078328|NCT01307501|Cryoablation|cryoablation
5078329|NCT01307501|Cryotherapy|cryotherapy
5078330|NCT01307501|Cryosurgery|cryosurgery
5078331|NCT01307501|Metastatic|metastatic
5078332|NCT01307501|Lung|lung
5078333|NCT01307501|Pleura|pleura
5078334|NCT01307501|Tumors|tumors
5078336|NCT01307488|AIDS|aids
5078337|NCT01307488|Atazanavir|atazanavir
5078338|NCT01307488|Simplification|simplification
5078339|NCT01307475|Chronic Post-Traumatic Stress Disorder|chronic post-traumatic stress disorder
5078340|NCT01307475|Delayed Onset Post-Traumatic Stress Disorder|delayed onset post-traumatic stress disorder
5078341|NCT01307475|Post-Traumatic Neuroses|post-traumatic neuroses
5078342|NCT01307475|Posttraumatic Neuroses|posttraumatic neuroses
5078343|NCT01307475|Post-Traumatic Stress Disorders|post-traumatic stress disorders
5078344|NCT01307475|Posttraumatic Stress Disorders|posttraumatic stress disorders
5078345|NCT01307475|PTSD|ptsd
5078346|NCT01307475|Post TraumaticStress Disorder|post traumaticstress disorder
5078347|NCT01307475|Endogenous Depression|endogenous depression
5078348|NCT01307475|Neurotic Depression|neurotic depression
5078349|NCT01307475|Depressive Syndrome|depressive syndrome
5078350|NCT01307475|Melancholia|melancholia
5078351|NCT01307475|Depressive Neurosis|depressive neurosis
5078352|NCT01307475|Unipolar Depression|unipolar depression
5078353|NCT01307475|Depressive Symptoms|depressive symptoms
5078354|NCT01307475|Emotional Depression|emotional depression
5078355|NCT01307475|Quality of Life|quality of life
5078356|NCT01307449|pneumococcal vaccine|pneumococcal vaccine
5078357|NCT01307449|immune responses|immune responses
5078358|NCT01307436|Hepatitis A Vaccine|hepatitis a vaccine
5078359|NCT01307436|Combined Vaccines|combined vaccines
5078360|NCT01307436|DTP Vaccine|dtp vaccine
5078361|NCT01307436|MMR Vaccine|mmr vaccine
5078362|NCT01307423|psoriasis|psoriasis
5078363|NCT01307423|Arthritis|arthritis
5078364|NCT01307423|Psoriatic Arthritis|psoriatic arthritis
5078365|NCT01307423|inflammation|inflammation
5078366|NCT01307423|skin condition|skin condition
5078367|NCT01307423|inflammatory cells|inflammatory cells
5078368|NCT01307423|apremilast|apremilast
5078369|NCT01307423|CC-10004|cc-10004
5078370|NCT01307423|phosphodiesterase type 4|phosphodiesterase type 4
5078371|NCT01307410|Patients with type 2 diabetes and participated in 3B Study|patients with type 2 diabetes and participated in 3b study
5078372|NCT01307384|Total Hip Arthroplasty|total hip arthroplasty
5078373|NCT01307384|Total Hip Replacement (THR)|total hip replacement (thr)
5078374|NCT01307384|Primary Hip Arthroplasty|primary hip arthroplasty
5078375|NCT01307384|THA|tha
5078376|NCT01307384|THR|thr
5078377|NCT01307371|Bone Marrow Mononuclear cells;|bone marrow mononuclear cells;
5078378|NCT01307371|Diabetes;|diabetes;
5078379|NCT01307371|ST-segment Elevation Myocardial Infarction;|st-segment elevation myocardial infarction;
5078380|NCT01307371|Percutaneous Coronary Intervention;|percutaneous coronary intervention;
5078381|NCT01307371|Left Ventricular Function|left ventricular function
5078382|NCT01307332|Multiple Sclerosis|multiple sclerosis
5078383|NCT01307332|MS|ms
5078384|NCT01307332|Relapsing Remitting Multiple Sclerosis|relapsing remitting multiple sclerosis
5078385|NCT01307332|RRMS|rrms
5078386|NCT01307332|Alemtuzumab|alemtuzumab
5078387|NCT01307332|Demyelination|demyelination
5078388|NCT01307332|Remyelination|remyelination
5078389|NCT01307332|Tolerogenic|tolerogenic
5078390|NCT01307332|T cells|t cells
5078391|NCT01307332|Demyelinating Autoimmune Diseases, CNS|demyelinating autoimmune diseases, cns
5078392|NCT01307332|Autoimmune Diseases of the Nervous System|autoimmune diseases of the nervous system
5078393|NCT01307332|Nervous System Diseases|nervous system diseases
5078394|NCT01307332|Demyelinating Diseases|demyelinating diseases
5078395|NCT01307332|Autoimmune Diseases|autoimmune diseases
5078396|NCT01307332|Immune System Diseases|immune system diseases
5078397|NCT01307319|Allergies|allergies
5078398|NCT01307319|Hayfever|hayfever
5078399|NCT01307306|Thermal injury|thermal injury
5078400|NCT01307306|Chemical Burn|chemical burn
5078401|NCT01307306|Flame Burn|flame burn
5078402|NCT01307280|Behavioral Weight Management Intervention|behavioral weight management intervention
5078403|NCT01307280|weight loss|weight loss
5078404|NCT01307280|cost-effective analysis|cost-effective analysis
5078405|NCT01307280|high blood pressure|high blood pressure
5078406|NCT01307280|randomized clinical trial|randomized clinical trial
5078407|NCT01307280|behavioral interventions|behavioral interventions
5078408|NCT01307280|physical activity|physical activity
5078409|NCT01307280|dietary change|dietary change
5078410|NCT01307280|obesity|obesity
5078411|NCT01307267|Phase 1|phase 1
5078412|NCT01307267|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
5078413|NCT01307267|Advanced malignancies|advanced malignancies
5078414|NCT01307241|Acute lymphoblastic leukemia|acute lymphoblastic leukemia
5078415|NCT01307241|prognostic factor|prognostic factor
5078416|NCT01307241|pharmacogenetics.|pharmacogenetics.
5078417|NCT01307228|Knowledge translation|knowledge translation
5078418|NCT01307228|Policymakers|policymakers
5078419|NCT01307228|Health systems|health systems
5078420|NCT01307215|TAP block|tap block
5078421|NCT01307215|incision pain|incision pain
5078422|NCT01307215|total hysterectomy|total hysterectomy
5078423|NCT01307202|knee|knee
5078424|NCT01307202|arthroplasty|arthroplasty
5078425|NCT01307202|postoperative pain|postoperative pain
5078426|NCT01307202|gabapentin|gabapentin
5078427|NCT01307189|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
5078428|NCT01307189|Exercise|exercise
5078429|NCT01307189|Endurance shuttle walking test|endurance shuttle walking test
5078430|NCT01307189|Bronchodilation|bronchodilation
5078431|NCT01307189|Tiotropium|tiotropium
5078432|NCT01307176|ataxia|ataxia
5078433|NCT01307176|exercise|exercise
5078434|NCT01307176|training|training
5078435|NCT01307176|cerebellar|cerebellar
5078436|NCT01307176|rehabilitation|rehabilitation
5078437|NCT01307163|saliva|saliva
5078438|NCT01307163|liver transplantation|liver transplantation
5078439|NCT01307163|children|children
5078440|NCT01307163|In this prospective study 60 subjects will be examined|in this prospective study 60 subjects will be examined
5078441|NCT01307163|children and adolescents|children and adolescents
5078442|NCT01307163|after a successful liver transplantation|after a successful liver transplantation
5078443|NCT01307163|informed consent forms signed be the examinees parents|informed consent forms signed be the examinees parents
5078444|NCT01307150|Atopic Dermatitis|atopic dermatitis
5078445|NCT01307150|Dead Sea|dead sea
5078446|NCT01307150|Climatotherapy|climatotherapy
5078447|NCT01307150|SCORAD|scorad
5078448|NCT01307124|safety and efficacy|safety and efficacy
5078449|NCT01307124|low dose LPV/r|low dose lpv/r
5078450|NCT01307124|standard dose LPV/r|standard dose lpv/r
5078451|NCT01307124|HIV infected children|hiv infected children
5078452|NCT01307111|Misoprostol|misoprostol
5078453|NCT01307111|IUD insertion|iud insertion
5078454|NCT01307111|Nulliparous Women|nulliparous women
5078455|NCT01307111|Contraception|contraception
5078456|NCT01307111|Family Planning|family planning
5078457|NCT01307111|IUD insertion in nulliparous women|iud insertion in nulliparous women
5078458|NCT01307098|Enzyme Replacement Therapy (ERT)|enzyme replacement therapy (ert)
5078459|NCT01307098|Lysosomal Storage Disease|lysosomal storage disease
5078460|NCT01307098|Late Onset Lysosomal Acid Lipase (LAL) Deficiency|late onset lysosomal acid lipase (lal) deficiency
5078461|NCT01307098|Acid cholesteryl ester hydrolase deficiency, type 2|acid cholesteryl ester hydrolase deficiency, type 2
5078462|NCT01307098|Acid lipase disease|acid lipase disease
5078463|NCT01307098|Cholesterol ester hydrolase deficiency|cholesterol ester hydrolase deficiency
5078464|NCT01307098|LAL Deficiency|lal deficiency
5078465|NCT01307098|LIPA Deficiency|lipa deficiency
5078466|NCT01307098|Wolman disease|wolman disease
5078467|NCT01307085|remote ischemic preconditioning|remote ischemic preconditioning
5078468|NCT01307085|lung injury|lung injury
5078469|NCT01307085|pulmonary resection|pulmonary resection
5078470|NCT01307072|periodic examinations, compliance|periodic examinations, compliance
5078471|NCT01307059|Growth disorders|growth disorders
5078472|NCT01307059|Saizen|saizen
5078473|NCT01307059|Easypod|easypod
5078474|NCT01307059|Growth hormone|growth hormone
5078475|NCT01307059|Pediatric subject|pediatric subject
5078476|NCT01307046|Essential hypertension|essential hypertension
5078477|NCT01307046|Uncontrolled hypertension|uncontrolled hypertension
5078478|NCT01307046|Antihypertensive agents|antihypertensive agents
5078479|NCT01307046|Blood pressure|blood pressure
5078480|NCT01307033|Essential hypertension|essential hypertension
5078481|NCT01307033|Uncontrolled hypertension|uncontrolled hypertension
5078482|NCT01307033|Antihypertensive agents|antihypertensive agents
5078483|NCT01307033|Blood pressure|blood pressure
5078484|NCT01307020|Moderate to severe pain|moderate to severe pain
5078485|NCT01307020|Postoperative pain|postoperative pain
5078486|NCT01307020|Analgesics|analgesics
5078487|NCT01307020|Dexketoprofen|dexketoprofen
5078488|NCT01307020|Tramadol|tramadol
5078489|NCT01306994|Exercise Test|exercise test
5078490|NCT01306994|Bicycle Ergometry Test|bicycle ergometry test
5078491|NCT01306994|Stress Test|stress test
5078492|NCT01306981|Diabetes Mellitus|diabetes mellitus
5078493|NCT01306981|Diabetes Complications|diabetes complications
5078494|NCT01306981|Retinal Diseases|retinal diseases
5078495|NCT01306981|Endothelial Growth Factors|endothelial growth factors
5078496|NCT01306981|Monoclonal Antibodies|monoclonal antibodies
5078497|NCT01306981|Ranibizumab|ranibizumab
5078498|NCT01306981|Vitrectomy|vitrectomy
5078499|NCT01306981|Vitreoretinal Surgery|vitreoretinal surgery
5078500|NCT01306968|mild tramatic brain injury|mild tramatic brain injury
5078501|NCT01306968|mTBI|mtbi
5078502|NCT01306968|hyperbaric oxygen|hyperbaric oxygen
5078503|NCT01306968|post concussive symptoms|post concussive symptoms
5078504|NCT01306968|active duty military|active duty military
5078505|NCT01306968|veterans|veterans
5078506|NCT01306955|retinal vasculitis|retinal vasculitis
5078507|NCT01306955|posterior uveitis|posterior uveitis
5078508|NCT01306955|methylprednisolone|methylprednisolone
5078509|NCT01306942|HER2 positive breast cancer|her2 positive breast cancer
5078510|NCT01306942|first line treatment|first line treatment
5078511|NCT01306942|Dasatinib|dasatinib
5078512|NCT01306942|SRC kinase|src kinase
5078513|NCT01306942|Trastuzumab resistance|trastuzumab resistance
5078514|NCT01306929|Huntington Disease.|huntington disease.
5078639|NCT01306448|vibrating capsule|vibrating capsule
5078515|NCT01306916|thyroid disease, hyperthyroidism|thyroid disease, hyperthyroidism
5078516|NCT01306903|Minimizing Cardiopulmonary Bypass MECC damage organ failure|minimizing cardiopulmonary bypass mecc damage organ failure
5078517|NCT01306877|hemorrhoid|hemorrhoid
5078518|NCT01306877|hemorrhoid stapler|hemorrhoid stapler
5078519|NCT01306864|Endoscopic Hemostasis|endoscopic hemostasis
5078520|NCT01306864|Peptic Ulcer|peptic ulcer
5078521|NCT01306864|Recurrent Bleeding|recurrent bleeding
5078522|NCT01306864|Injection Therapy|injection therapy
5078523|NCT01306864|Thermal Probe|thermal probe
5078524|NCT01306851|fibrin glue|fibrin glue
5078525|NCT01306851|anastomotic leak|anastomotic leak
5078526|NCT01306851|gastrointestinal high risk anastomosis|gastrointestinal high risk anastomosis
5078527|NCT01306838|Short bowel syndrome|short bowel syndrome
5078528|NCT01306838|Necrotizing enterocolitis|necrotizing enterocolitis
5078529|NCT01306838|Small intestine perforation|small intestine perforation
5078530|NCT01306838|Enterostomy|enterostomy
5078531|NCT01306838|Intralipid|intralipid
5078532|NCT01306838|Microlipid|microlipid
5078533|NCT01306838|Fish oil|fish oil
5078534|NCT01306825|Daptomycin|daptomycin
5078535|NCT01306825|Bone disease,infectious|bone disease,infectious
5078536|NCT01306825|Osteomyelitis|osteomyelitis
5078537|NCT01306825|Diabetic foot|diabetic foot
5078538|NCT01306825|Staphylococcus aureus|staphylococcus aureus
5078539|NCT01306812|Adolescent|adolescent
5078540|NCT01306812|Alcohol|alcohol
5078541|NCT01306812|Criminology|criminology
5078542|NCT01306812|Genes|genes
5078543|NCT01306812|Environment|environment
5078544|NCT01306812|Mono amine Oxidase|mono amine oxidase
5078545|NCT01306812|Serotonin|serotonin
5078546|NCT01306812|Social Support|social support
5078547|NCT01306799|Barrett's Esophagus|barrett's esophagus
5078548|NCT01306799|Erosive Esophagitis|erosive esophagitis
5078549|NCT01306799|Proton Pump Inhibitor (PPI)|proton pump inhibitor (ppi)
5078550|NCT01306799|Bone|bone
5078551|NCT01306799|Bone Density|bone density
5078552|NCT01306799|GERD|gerd
5078553|NCT01306799|ulcer prophylaxis|ulcer prophylaxis
5078554|NCT01306773|Influenza A|influenza a
5078555|NCT01306773|convalescent plasma|convalescent plasma
5078556|NCT01306773|death|death
5078557|NCT01306760|depression|depression
5078558|NCT01306760|electroconvulsive therapy|electroconvulsive therapy
5078559|NCT01306760|ketamine|ketamine
5078560|NCT01306747|Chronic pain|chronic pain
5078561|NCT01306747|Stanford chronic pain self-management programme|stanford chronic pain self-management programme
5078562|NCT01306747|Patient education|patient education
5078563|NCT01306734|Extracorporeal circulation|extracorporeal circulation
5078564|NCT01306734|Deep Hypothermic Circulatory Arrest|deep hypothermic circulatory arrest
5078565|NCT01306734|aortic aneurism|aortic aneurism
5078566|NCT01306734|neurological injury|neurological injury
5078567|NCT01306734|inflammation|inflammation
5078568|NCT01306734|coagulation|coagulation
5078569|NCT01306708|Adhesive Capsulitis|adhesive capsulitis
5078570|NCT01306708|Shoulder|shoulder
5078571|NCT01306708|SPADI|spadi
5078572|NCT01306695|Dementia|dementia
5078573|NCT01306695|Depressive symptoms|depressive symptoms
5078574|NCT01306695|Caregiver Burden|caregiver burden
5078575|NCT01306695|Hispanic|hispanic
5078576|NCT01306695|Latino|latino
5078577|NCT01306695|Intervention|intervention
5078578|NCT01306695|Geriatric Depression Scale|geriatric depression scale
5078579|NCT01306695|Zarit Caregiver Burden Scale|zarit caregiver burden scale
5078580|NCT01306656|Endocrinology|endocrinology
5078581|NCT01306656|Metabolic Bone Disease|metabolic bone disease
5078582|NCT01306656|Primary Hyperparathyroidism|primary hyperparathyroidism
5078583|NCT01306656|PHPT|phpt
5078584|NCT01306656|Vitamin D Deficiency|vitamin d deficiency
5078585|NCT01306656|Bone Mineral Density|bone mineral density
5078586|NCT01306656|Hyper-calcemia|hyper-calcemia
5078587|NCT01306643|Indolent Non-Hodgkin's Lymphoma|indolent non-hodgkin's lymphoma
5078588|NCT01306643|Non-Hodgkin Lymphoma|non-hodgkin lymphoma
5078589|NCT01306643|iNHL|inhl
5078590|NCT01306643|NHL|nhl
5078591|NCT01306643|CAL-101|cal-101
5078592|NCT01306643|PI3K|pi3k
5078593|NCT01306643|Phosphatidylinositol 3-kinase|phosphatidylinositol 3-kinase
5078594|NCT01306643|Follicular Lymphoma (FL)|follicular lymphoma (fl)
5078595|NCT01306643|Small Lymphocytic Lymphoma (SLL)|small lymphocytic lymphoma (sll)
5078596|NCT01306643|Marginal Zone Lymphoma (MZL)|marginal zone lymphoma (mzl)
5078597|NCT01306630|AV-951|av-951
5078598|NCT01306630|tivozanib|tivozanib
5078599|NCT01306630|capecitabine (Xeloda®)|capecitabine (xeloda®)
5078600|NCT01306604|Genetic Diseases|genetic diseases
5078601|NCT01306604|Lipidoses|lipidoses
5078602|NCT01306604|Lipid Metabolism|lipid metabolism
5078603|NCT01306604|Lysosomal Storage Diseases|lysosomal storage diseases
5078604|NCT01306604|Metabolic Diseases|metabolic diseases
5078605|NCT01306604|Lipid Metabolism Disorders|lipid metabolism disorders
5078606|NCT01306591|neovascular age-related macular degeneration|neovascular age-related macular degeneration
5078607|NCT01306591|Bevacizumab|bevacizumab
5078608|NCT01306591|Multicenter Randomized Study|multicenter randomized study
5078609|NCT01306578|Guillain Barre syndrome|guillain barre syndrome
5078610|NCT01306578|IVIG|ivig
5078611|NCT01306578|Plasma exchange|plasma exchange
5078612|NCT01306565|Unstable angina|unstable angina
5078613|NCT01306565|NSTMI|nstmi
5078614|NCT01306565|Statin|statin
5078615|NCT01306565|Atorvastatin|atorvastatin
5078616|NCT01306552|Tobacco use|tobacco use
5078617|NCT01306552|Adolescents|adolescents
5078618|NCT01306552|Primary prevention|primary prevention
5078619|NCT01306552|Program effectiveness|program effectiveness
5078620|NCT01306552|Parental component|parental component
5078621|NCT01306539|deep brain stimulation|deep brain stimulation
5078622|NCT01306539|subthalamic nucleus|subthalamic nucleus
5078623|NCT01306526|Thin-cap fibroatheroma|thin-cap fibroatheroma
5078624|NCT01306526|Vulnerable plaque|vulnerable plaque
5078625|NCT01306526|Coronary artery disease|coronary artery disease
5078626|NCT01306526|Obstructive sleep apnea|obstructive sleep apnea
5078627|NCT01306526|Intravascular Ultrasound|intravascular ultrasound
5078628|NCT01306513|emphysema|emphysema
5078629|NCT01306513|lung volume reduction surgery|lung volume reduction surgery
5078630|NCT01306513|mesenchymal stromal cells|mesenchymal stromal cells
5078631|NCT01306500|Gastric lavage|gastric lavage
5078632|NCT01306500|Neonate|neonate
5078633|NCT01306500|Meconium stained amniotic fluid|meconium stained amniotic fluid
5078634|NCT01306500|Feeding problems|feeding problems
5078635|NCT01306487|macular hole|macular hole
5078636|NCT01306474|CD4/CD25 Tr cell,TNF,IFN-γ,IL-2|cd4/cd25 tr cell,tnf,ifn-γ,il-2
5078637|NCT01306448|constipation|constipation
5078638|NCT01306448|gastro|gastro
5078640|NCT01306448|safety|safety
5078641|NCT01306435|Osteoarthritis|osteoarthritis
5078642|NCT01306435|Low Power Laser Therapy|low power laser therapy
5078643|NCT01306435|Exercise|exercise
5078644|NCT01306435|Knee|knee
5078645|NCT01306422|hoodia gordonii|hoodia gordonii
5078646|NCT01306422|energy intake|energy intake
5078647|NCT01306422|food intake|food intake
5078648|NCT01306422|efficacy|efficacy
5078649|NCT01306422|body weight|body weight
5078650|NCT01306422|functional food|functional food
5078651|NCT01306422|plant extract|plant extract
5078652|NCT01306422|safety|safety
5078653|NCT01306422|steroid glycosides|steroid glycosides
5078654|NCT01306422|tolerability|tolerability
5078655|NCT01306409|anemia|anemia
5078656|NCT01306409|kidney disease|kidney disease
5078657|NCT01306396|NAFLD|nafld
5078658|NCT01306396|metabolic syndrome|metabolic syndrome
5078659|NCT01306396|children|children
5078660|NCT01306396|fructose|fructose
5078661|NCT01306383|SODIS|sodis
5078662|NCT01306383|waterborne|waterborne
5078663|NCT01306383|Disease|disease
5078664|NCT01306383|Diarrhoea|diarrhoea
5078665|NCT01306383|dysentery|dysentery
5078666|NCT01306370|primary knee arthroplasty|primary knee arthroplasty
5078667|NCT01306370|fibrin glue|fibrin glue
5078668|NCT01306370|tranexamic acid|tranexamic acid
5078669|NCT01306370|topic|topic
5078670|NCT01306357|Turner's syndrome|turner's syndrome
5078671|NCT01306357|somatropin|somatropin
5078672|NCT01306357|human growth hormone deficiency|human growth hormone deficiency
5078673|NCT01306344|Qualitative Research|qualitative research
5078674|NCT01306344|Interview, Psychological|interview, psychological
5078675|NCT01306344|Patients|patients
5078676|NCT01306344|Nurses|nurses
5078677|NCT01306344|Physicians|physicians
5078678|NCT01306305|Influenza|influenza
5078679|NCT01306305|Virus|virus
5078680|NCT01306305|Vaccination|vaccination
5078681|NCT01306305|Immunisation|immunisation
5078682|NCT01306292|Pulmonary hypertension|pulmonary hypertension
5078683|NCT01306292|Right heart Catheterization|right heart catheterization
5078684|NCT01306279|Cystic Fibrosis|cystic fibrosis
5078685|NCT01306279|Infection|infection
5078686|NCT01306279|Pulmonary exacerbation|pulmonary exacerbation
5078687|NCT01306279|Hypermutators|hypermutators
5078688|NCT01306279|Bacterial diversity|bacterial diversity
5078689|NCT01306279|Quorum sensing|quorum sensing
5078690|NCT01306266|active duty|active duty
5078691|NCT01306266|blast induced|blast induced
5078692|NCT01306266|headache|headache
5078693|NCT01306253|Influenza|influenza
5078694|NCT01306253|Virus|virus
5078695|NCT01306253|Vaccination|vaccination
5078696|NCT01306253|Immunisation|immunisation
5078697|NCT01306240|Infant newborn|infant newborn
5078698|NCT01306240|Infant preterm|infant preterm
5078699|NCT01306240|Acute respiratory distress syndrome|acute respiratory distress syndrome
5078700|NCT01306240|surfactant|surfactant
5078701|NCT01306240|Hyaline Membrane disease|hyaline membrane disease
5078702|NCT01306240|Newborn acute respiratory distress syndrome (ARDS)|newborn acute respiratory distress syndrome (ards)
5078703|NCT01306227|Infant, newborn|infant, newborn
5078704|NCT01306227|Infant, preterm|infant, preterm
5078705|NCT01306227|Thyroid|thyroid
5078706|NCT01306227|Outcome|outcome
5078707|NCT01306227|Newborns less than 32 weeks of gestation|newborns less than 32 weeks of gestation
5078708|NCT01306227|TSH < 20 mIU/L and a FT4 < 0.80 ng/dL|tsh < 20 miu/l and a ft4 < 0.80 ng/dl
5078709|NCT01306201|Hospital Setting|hospital setting
5078710|NCT01306188|metastatic cancer|metastatic cancer
5078711|NCT01306188|lymphopenia|lymphopenia
5078712|NCT01306188|T cell receptor diversity|t cell receptor diversity
5078713|NCT01306149|biochemical parameters|biochemical parameters
5078714|NCT01306149|mineral metabolism|mineral metabolism
5078715|NCT01306149|protein-bound uremic retention solutes|protein-bound uremic retention solutes
5078716|NCT01306149|incident PD patients|incident pd patients
5079023|NCT01304979|acupuncture|acupuncture
5078717|NCT01306136|Posttraumatic stress disorder|posttraumatic stress disorder
5078718|NCT01306136|Prolonged exposure|prolonged exposure
5078719|NCT01306136|Cognitive behavior therapy|cognitive behavior therapy
5078720|NCT01306123|bioavailability|bioavailability
5078721|NCT01306123|pharmacokinetics|pharmacokinetics
5078722|NCT01306123|cyanocobalamin|cyanocobalamin
5078723|NCT01306123|intranasal|intranasal
5078724|NCT01306123|intramuscular|intramuscular
5078725|NCT01306110|Liver fibrosis|liver fibrosis
5078726|NCT01306110|diabetes|diabetes
5078727|NCT01306110|Fibroscan|fibroscan
5078728|NCT01306110|Fibrotest|fibrotest
5078729|NCT01306110|noninvasive fibrosis biomarkers|noninvasive fibrosis biomarkers
5078730|NCT01306097|Zinc Supplement|zinc supplement
5078731|NCT01306097|Diarrhea|diarrhea
5078732|NCT01306097|Sever Diarrhea|sever diarrhea
5078733|NCT01306084|Respiratory Infections|respiratory infections
5078734|NCT01306084|Norovirus|norovirus
5078735|NCT01306084|Adenovirus|adenovirus
5078736|NCT01306084|Viral Infection|viral infection
5078737|NCT01306084|Respiratory Viruses|respiratory viruses
5078738|NCT01306058|Hepatocellular Carcinoma|hepatocellular carcinoma
5078739|NCT01306058|TRC105|trc105
5078740|NCT01306058|Sorafenib|sorafenib
5078741|NCT01306058|Liver Cancer|liver cancer
5078742|NCT01306058|Monoclonal Antibody|monoclonal antibody
5078743|NCT01306045|AZD6244|azd6244
5078744|NCT01306045|MK-2206|mk-2206
5078745|NCT01306045|Lapatinib|lapatinib
5078746|NCT01306045|Erlotinib|erlotinib
5078747|NCT01306045|Sunitinib|sunitinib
5078748|NCT01306045|Lung Cancer|lung cancer
5078749|NCT01306045|Thymic Cancer|thymic cancer
5078750|NCT01306045|Small Cell Lung Cancer|small cell lung cancer
5078751|NCT01306045|Non-Small Cell Lung Cancer|non-small cell lung cancer
5078752|NCT01306032|PARP Inhibitor|parp inhibitor
5078753|NCT01306032|BRCA Mutations|brca mutations
5078754|NCT01306032|DNA Damage Repair|dna damage repair
5078755|NCT01306032|Pharmacodynamics|pharmacodynamics
5078756|NCT01306032|Metronomic Cyclophosphamide|metronomic cyclophosphamide
5078757|NCT01306032|Ovarian Cancer|ovarian cancer
5078758|NCT01306032|Breast Cancer|breast cancer
5078759|NCT01306032|Fallopian Tube Cancer|fallopian tube cancer
5078760|NCT01306032|Peritoneal Cancer|peritoneal cancer
5078761|NCT01306019|X-Linked Severe Combined Immunodeficiency (XSCID)|x-linked severe combined immunodeficiency (xscid)
5078762|NCT01306019|Gene Transfer|gene transfer
5078763|NCT01306019|Peripheral Blood Stem Cells|peripheral blood stem cells
5078764|NCT01306019|Common Gamma Chain (GC), Immune Reconstitution|common gamma chain (gc), immune reconstitution
5078765|NCT01306019|Immune Reconstitution|immune reconstitution
5078766|NCT01306019|X-Linked Severe Combined Immunodeficiency|x-linked severe combined immunodeficiency
5078767|NCT01306019|SCID|scid
5078768|NCT01306006|Mortality|mortality
5078769|NCT01306006|Vaccines|vaccines
5078770|NCT01305954|Breast|breast
5078771|NCT01305954|Cancer|cancer
5078772|NCT01305954|Breast Cancer|breast cancer
5078773|NCT01305954|New Diagnosis|new diagnosis
5078774|NCT01305954|Treatment|treatment
5078775|NCT01305954|Chemotherapy|chemotherapy
5078776|NCT01305954|Blood|blood
5078777|NCT01305954|Blood Draw|blood draw
5078778|NCT01305954|Lab Draw|lab draw
5078779|NCT01305954|Gene|gene
5078780|NCT01305954|Gene Therapy|gene therapy
5078781|NCT01305954|Geriatric|geriatric
5078782|NCT01305954|Oncology|oncology
5078783|NCT01305954|Muss|muss
5078784|NCT01305954|UNC|unc
5078785|NCT01305954|North Carolina Cancer Hospital|north carolina cancer hospital
5078786|NCT01305954|Initial Treatment|initial treatment
5078787|NCT01305954|CBC|cbc
5078788|NCT01305941|everolimus|everolimus
5078789|NCT01305941|trastuzumab|trastuzumab
5078790|NCT01305941|vinorelbine|vinorelbine
5078791|NCT01305941|RAD001|rad001
5078792|NCT01305941|Breast Cancer|breast cancer
5078793|NCT01305941|Herceptin|herceptin
5078794|NCT01305941|Navelbine|navelbine
5078795|NCT01305941|Lineberger Comprehensive Cancer Center|lineberger comprehensive cancer center
5078796|NCT01305941|Brain Metastases|brain metastases
5078797|NCT01305915|single-session group|single-session group
5078798|NCT01305915|psychoeducational intervention|psychoeducational intervention
5078799|NCT01305889|Depression|depression
5078800|NCT01305889|Cerebral perfusion|cerebral perfusion
5078801|NCT01305889|Brain derived neurotropic factor|brain derived neurotropic factor
5078802|NCT01305889|Problem Solving Therapy|problem solving therapy
5078803|NCT01305889|Sertraline|sertraline
5078804|NCT01305876|yoga|yoga
5078805|NCT01305876|emotional behavioral disorder|emotional behavioral disorder
5078806|NCT01305876|intervention|intervention
5078807|NCT01305876|school|school
5078808|NCT01305876|meditation|meditation
5078809|NCT01305876|focus: yoga intervention in students with emotional behavioral disorders in an urban school|focus: yoga intervention in students with emotional behavioral disorders in an urban school
5078810|NCT01305863|Peripheral Vascular Disease (PVD)|peripheral vascular disease (pvd)
5078811|NCT01305850|Aliskiren|aliskiren
5078812|NCT01305850|Losartan|losartan
5078813|NCT01305850|Peritoneal membrane dysfunction|peritoneal membrane dysfunction
5078814|NCT01305837|multiple sclerosis|multiple sclerosis
5078815|NCT01305837|methylprednisolone|methylprednisolone
5078816|NCT01305837|osteopontin|osteopontin
5079131|NCT01304550|hemoglobin|hemoglobin
5078817|NCT01305837|inflammation|inflammation
5078818|NCT01305837|demyelinating|demyelinating
5078819|NCT01305824|arteriovenous fistula|arteriovenous fistula
5078820|NCT01305824|AVF|avf
5078821|NCT01305824|hemodialysis|hemodialysis
5078822|NCT01305824|vascular access|vascular access
5078823|NCT01305824|dialysis|dialysis
5078824|NCT01305824|fistula|fistula
5078825|NCT01305824|PRT-201|prt-201
5078826|NCT01305824|vonapanitase|vonapanitase
5078827|NCT01305824|kidney|kidney
5078828|NCT01305824|renal|renal
5078829|NCT01305811|Complex Medical Illness|complex medical illness
5078830|NCT01305811|Gulf War Illness|gulf war illness
5078831|NCT01305811|Veteran|veteran
5078832|NCT01305798|Biometric Screenings|biometric screenings
5078833|NCT01305798|Active Choice|active choice
5078834|NCT01305798|Behavioral Economics|behavioral economics
5078835|NCT01305798|Default|default
5078836|NCT01305772|SCCHN|scchn
5078837|NCT01305772|untreated|untreated
5078838|NCT01305772|Stage III or IVa-b (M0)|stage iii or iva-b (m0)
5078839|NCT01305759|Total knee arthroplasty|total knee arthroplasty
5078840|NCT01305759|Total hip arthroplasty|total hip arthroplasty
5078841|NCT01305759|Peri acetabular osteotomy|peri acetabular osteotomy
5078842|NCT01305759|Social class|social class
5078843|NCT01305759|Health related quality of life|health related quality of life
5078844|NCT01305746|SLE|sle
5078845|NCT01305746|Lupus|lupus
5078846|NCT01305746|Lupus Erythematosus, Systemic|lupus erythematosus, systemic
5078847|NCT01305746|A-623|a-623
5078848|NCT01305746|Autoimmune Diseases|autoimmune diseases
5078849|NCT01305746|Blisibimod|blisibimod
5078850|NCT01305733|Pain relief|pain relief
5078851|NCT01305720|mydriatic|mydriatic
5078852|NCT01305720|NIRS|nirs
5078853|NCT01305720|preterm|preterm
5078854|NCT01305720|eye drops|eye drops
5078855|NCT01305720|cerebral|cerebral
5078856|NCT01305720|mesenteric oxygenation|mesenteric oxygenation
5078857|NCT01305707|Consolidation ECT|consolidation ect
5078858|NCT01305707|Pharmacotherapy|pharmacotherapy
5078859|NCT01305707|Efficacy|efficacy
5078860|NCT01305707|Depression|depression
5078861|NCT01305707|Prevention|prevention
5078862|NCT01305707|Electroconvulsive therapy|electroconvulsive therapy
5078863|NCT01305707|Drug therapy|drug therapy
5078864|NCT01305668|COPD|copd
5078865|NCT01305668|Emphysema phenotype|emphysema phenotype
5078866|NCT01305655|Drug: Glucarpidase|drug: glucarpidase
5078867|NCT01305642|Postnatal development|postnatal development
5078868|NCT01305642|Breast milk fortification|breast milk fortification
5078869|NCT01305642|Composition of breast milk|composition of breast milk
5078870|NCT01305629|HIV|hiv
5078871|NCT01305629|Medication Adherence|medication adherence
5078872|NCT01305629|Substance Use|substance use
5078873|NCT01305629|Older adults|older adults
5078874|NCT01305629|Treatment|treatment
5078875|NCT01305616|Open angle Glaucoma|open angle glaucoma
5078876|NCT01305616|Yellow-tinted intraocular lens|yellow-tinted intraocular lens
5078877|NCT01305616|Short-wavelength Automated Perimetry (SWAP)|short-wavelength automated perimetry (swap)
5078878|NCT01305616|Standard Automated Perimetry (SAP)|standard automated perimetry (sap)
5078879|NCT01305616|cataract|cataract
5078880|NCT01305590|HIV|hiv
5078881|NCT01305590|AIDS|aids
5078882|NCT01305590|Medication Adherence|medication adherence
5078883|NCT01305590|Commitment Devices|commitment devices
5078884|NCT01305590|Behavioral Economics|behavioral economics
5078885|NCT01305564|Pulmonary embolism (PE)|pulmonary embolism (pe)
5078886|NCT01305564|Deep vein thrombosis (DVT)|deep vein thrombosis (dvt)
5078887|NCT01305564|Vena cava|vena cava
5078888|NCT01305564|Vena cava filter|vena cava filter
5078889|NCT01305564|Inferior vena cava|inferior vena cava
5078890|NCT01305564|Venous thromboembolic disease (VTED)|venous thromboembolic disease (vted)
5078891|NCT01305525|SCS|scs
5078892|NCT01305525|St. Jude Medical|st. jude medical
5078893|NCT01305525|Neuromodulation|neuromodulation
5078894|NCT01305512|Solid|solid
5078895|NCT01305512|Tumor|tumor
5078896|NCT01305512|Taxane|taxane
5078897|NCT01305499|AML|aml
5078898|NCT01305447|smoking cessation|smoking cessation
5078899|NCT01305447|exercise maintenance|exercise maintenance
5078900|NCT01305447|preventing relapse|preventing relapse
5078901|NCT01305447|weight gain|weight gain
5078902|NCT01305447|group-mediated cognitive behavioural therapy|group-mediated cognitive behavioural therapy
5078903|NCT01305434|diabetes mellitus type 2|diabetes mellitus type 2
5078904|NCT01305434|mulberry leaf extract|mulberry leaf extract
5078905|NCT01305434|post prandial blood glucose|post prandial blood glucose
5078906|NCT01305421|ICU|icu
5078907|NCT01305421|muscle strength|muscle strength
5078908|NCT01305421|mechanical ventilation|mechanical ventilation
5078909|NCT01305421|weaning|weaning
5078910|NCT01305408|Bipolar I Disorder|bipolar i disorder
5078911|NCT01305395|Cardiac Allograft Vasculopathy in Heart Transplant|cardiac allograft vasculopathy in heart transplant
5078912|NCT01305382|Cardiac Allograft Vasculopathy|cardiac allograft vasculopathy
5078913|NCT01305369|ASTHMA|asthma
5078914|NCT01305369|PLATELET RECEPTOR P2Y12|platelet receptor p2y12
5078915|NCT01305369|PRASUGREL|prasugrel
5078916|NCT01305369|INFLAMMATION|inflammation
5078917|NCT01305356|degenerative joint disease|degenerative joint disease
5078918|NCT01305356|DJD|djd
5078919|NCT01305356|joint fusion|joint fusion
5078920|NCT01305356|hindfoot|hindfoot
5078921|NCT01305356|congenital deformity|congenital deformity
5078922|NCT01305356|osteoarthritis|osteoarthritis
5078923|NCT01305356|rheumatoid arthritis|rheumatoid arthritis
5078924|NCT01305356|post-traumatic arthritis|post-traumatic arthritis
5078925|NCT01305356|ankylosing spondylitis|ankylosing spondylitis
5078926|NCT01305356|Augment(tm) Injectable Bone Graft|augment(tm) injectable bone graft
5078927|NCT01305356|autologous bone graft|autologous bone graft
5078928|NCT01305356|autogenous bone graft|autogenous bone graft
5078929|NCT01305356|beta-TCP|beta-tcp
5078930|NCT01305356|bovine collagen|bovine collagen
5078931|NCT01305356|rhPDGF(bb)|rhpdgf(bb)
5078932|NCT01305343|Spinal Deformity|spinal deformity
5078933|NCT01305343|Scoliosis|scoliosis
5078934|NCT01305343|Neurologic complications|neurologic complications
5078935|NCT01305330|small renal mass|small renal mass
5078936|NCT01305330|active surveillance|active surveillance
5078937|NCT01305330|kidney mass|kidney mass
5078938|NCT01305330|kidney tumour|kidney tumour
5078939|NCT01305317|Statin|statin
5078940|NCT01305291|dietary fiber|dietary fiber
5078941|NCT01305291|satiety response|satiety response
5078942|NCT01305291|hunger|hunger
5078943|NCT01305291|CCK|cck
5078944|NCT01305291|PYY|pyy
5078945|NCT01305291|ghrelin|ghrelin
5078946|NCT01305291|GIP|gip
5078947|NCT01305291|GLP-1|glp-1
5078948|NCT01305278|Balance|balance
5078949|NCT01305278|Rehabilitation|rehabilitation
5078950|NCT01305278|Vestibular|vestibular
5078951|NCT01305265|sore throat|sore throat
5078952|NCT01305265|dysphagia|dysphagia
5078953|NCT01305265|hoarseness|hoarseness
5078954|NCT01305265|post operative|post operative
5078955|NCT01305265|endotracheal intubation|endotracheal intubation
5078956|NCT01305239|Observational|observational
5078957|NCT01305239|epidemiological|epidemiological
5078958|NCT01305239|cohort|cohort
5078959|NCT01305239|cross-sectional|cross-sectional
5078960|NCT01305239|prospective|prospective
5078961|NCT01305239|multicenter|multicenter
5078962|NCT01305239|survey|survey
5078963|NCT01305239|France.|france.
5078964|NCT01305226|THR 100|thr 100
5078965|NCT01305174|Common Iliac Artery and External Iliac Artery|common iliac artery and external iliac artery
5078966|NCT01305161|1Allergy|1allergy
5078967|NCT01305161|2 Neuromuscular blockers|2 neuromuscular blockers
5078968|NCT01305148|warfarin|warfarin
5078969|NCT01305148|genetic testing|genetic testing
5078970|NCT01305148|personalized medicine|personalized medicine
5078971|NCT01305148|anti-coagulants|anti-coagulants
5078972|NCT01305148|coumadin|coumadin
5078973|NCT01305135|myelodysplastic syndrome, azacitidine, idarubicin|myelodysplastic syndrome, azacitidine, idarubicin
5078974|NCT01305122|Glioma|glioma
5078975|NCT01305122|Neurocognitive functions|neurocognitive functions
5078976|NCT01305096|heart rate variability|heart rate variability
5078977|NCT01305096|oxygen uptake|oxygen uptake
5078978|NCT01305096|heart rate recovery|heart rate recovery
5078979|NCT01305096|perceived stress|perceived stress
5078980|NCT01305096|sleep|sleep
5078981|NCT01305096|blood pressure|blood pressure
5078982|NCT01305096|body mass index|body mass index
5078983|NCT01305096|body weight|body weight
5078984|NCT01305096|hand grip strength|hand grip strength
5078985|NCT01305096|sleep quality|sleep quality
5078986|NCT01305096|subjective health complaints|subjective health complaints
5078987|NCT01305096|blood lipids|blood lipids
5078988|NCT01305096|salivary cortisol|salivary cortisol
5078989|NCT01305096|blood sugar|blood sugar
5078990|NCT01305096|HbA1C|hba1c
5078991|NCT01305096|Adiponectin|adiponectin
5078992|NCT01305096|Leptin|leptin
5078993|NCT01305096|Adipolipoproteins|adipolipoproteins
5078994|NCT01305096|blood proteins|blood proteins
5078995|NCT01305096|cytokines|cytokines
5078996|NCT01305096|insomnia|insomnia
5078997|NCT01305096|sleeplessness|sleeplessness
5078998|NCT01305096|yoga|yoga
5078999|NCT01305070|Standard balloon angioplasty|standard balloon angioplasty
5079000|NCT01305070|POBA|poba
5079001|NCT01305070|Angioplasty with paclitaxel-eluting balloon|angioplasty with paclitaxel-eluting balloon
5079002|NCT01305070|Superficial femoral artery|superficial femoral artery
5079003|NCT01305057|dry skin condition|dry skin condition
5079004|NCT01305044|tai chi|tai chi
5079005|NCT01305044|elderly cancer survivor|elderly cancer survivor
5079006|NCT01305044|mind body intervention|mind body intervention
5079007|NCT01305031|Asphyxia|asphyxia
5079008|NCT01305031|Resuscitation|resuscitation
5079009|NCT01305031|Room Air|room air
5079010|NCT01305018|Branched-chain amino acids|branched-chain amino acids
5079011|NCT01305018|Leucine|leucine
5079012|NCT01305018|Muscle damage|muscle damage
5079013|NCT01305018|Inflammation|inflammation
5079014|NCT01305018|supplementation|supplementation
5079015|NCT01305018|resistance exercise-induced|resistance exercise-induced
5079016|NCT01305005|blood flow|blood flow
5079017|NCT01304992|Dietary protein|dietary protein
5079018|NCT01304992|Lupin protein|lupin protein
5079019|NCT01304992|Cholesterol metabolism|cholesterol metabolism
5079020|NCT01304992|Protein metabolism|protein metabolism
5079021|NCT01304992|Hypercholesterolemia|hypercholesterolemia
5079022|NCT01304992|Protein-enriched drinks|protein-enriched drinks
5079024|NCT01304979|auricular acu-therapy|auricular acu-therapy
5079025|NCT01304979|gua sha therapy|gua sha therapy
5079026|NCT01304979|low back 'spine fusion'|low back 'spine fusion'
5079027|NCT01304979|post surgical pain|post surgical pain
5079028|NCT01304979|post surgical recovery|post surgical recovery
5079029|NCT01304979|Pain and recovery from 'spine fusion' surgery|pain and recovery from 'spine fusion' surgery
5079030|NCT01304966|RRP|rrp
5079031|NCT01304966|HPV|hpv
5079032|NCT01304953|General anaesthetics|general anaesthetics
5079033|NCT01304953|gynaecological laparoscopy|gynaecological laparoscopy
5079034|NCT01304953|anaesthetic i.v.|anaesthetic i.v.
5079035|NCT01304953|propofol|propofol
5079036|NCT01304953|anaesthetic volatile|anaesthetic volatile
5079037|NCT01304953|evoflurane|evoflurane
5079038|NCT01304953|antiemetics|antiemetics
5079039|NCT01304953|reopisetron|reopisetron
5079040|NCT01304953|postoperative pain|postoperative pain
5079041|NCT01304940|Stress|stress
5079042|NCT01304940|Stress Disorders, Post-Traumatic|stress disorders, post-traumatic
5079043|NCT01304940|Stress Disorders, Traumatic|stress disorders, traumatic
5079044|NCT01304927|Reproduction|reproduction
5079045|NCT01304927|Sex hormones|sex hormones
5079046|NCT01304927|Glucose metabolism|glucose metabolism
5079047|NCT01304927|Bone metabolism|bone metabolism
5079048|NCT01304927|Calcium|calcium
5079049|NCT01304927|Sperm|sperm
5079050|NCT01304927|testis|testis
5079051|NCT01304927|bone|bone
5079052|NCT01304927|endocrinology|endocrinology
5079053|NCT01304914|Respiratory tract infections|respiratory tract infections
5079054|NCT01304914|Gastrointestinal tract infections|gastrointestinal tract infections
5079055|NCT01304914|Pediatrics|pediatrics
5079056|NCT01304914|Specimen collection|specimen collection
5079057|NCT01304901|Acute asthma|acute asthma
5079058|NCT01304901|Children|children
5079059|NCT01304901|Montelukast|montelukast
5079060|NCT01304901|Emergency room|emergency room
5079061|NCT01304888|Food consumption|food consumption
5079062|NCT01304875|Fabry disease|fabry disease
5079063|NCT01304875|alpha-galactosidase deficiency|alpha-galactosidase deficiency
5079064|NCT01304875|exercise|exercise
5079065|NCT01304875|pulmonary|pulmonary
5079066|NCT01304849|Hodgkin's Lymphoma|hodgkin's lymphoma
5079067|NCT01304849|PET CT scan|pet ct scan
5079068|NCT01304849|Escalated BEACOPP|escalated beacopp
5079069|NCT01304849|ABVD|abvd
5079070|NCT01304849|Response adapted therapy|response adapted therapy
5079071|NCT01304836|Kidney|kidney
5079072|NCT01304836|Diabetes Mellitus|diabetes mellitus
5079073|NCT01304836|Transplant|transplant
5079074|NCT01304836|Immunosuppression|immunosuppression
5079075|NCT01304823|T1R2/T1R3|t1r2/t1r3
5079076|NCT01304823|gastric emptying|gastric emptying
5079077|NCT01304823|gut|gut
5079078|NCT01304823|lactisole|lactisole
5079079|NCT01304823|nutrient sensing|nutrient sensing
5079080|NCT01304810|NicVAX|nicvax
5079081|NCT01304810|Smoking cessation|smoking cessation
5079082|NCT01304797|MM302|mm302
5079083|NCT01304797|Breast Cancer|breast cancer
5079084|NCT01304797|Locally advanced/unresectable|locally advanced/unresectable
5079085|NCT01304797|metastatic|metastatic
5079086|NCT01304784|Solid tumors|solid tumors
5079087|NCT01304784|Failed at least one line of standard therapy|failed at least one line of standard therapy
5079088|NCT01304771|Safety|safety
5079089|NCT01304771|AKSB|aksb
5079090|NCT01304771|probiotic|probiotic
5079091|NCT01304771|synbiotic|synbiotic
5079092|NCT01304771|enterococcus|enterococcus
5079093|NCT01304771|Saccharomyces|saccharomyces
5079094|NCT01304771|elderly|elderly
5079095|NCT01304771|influenza|influenza
5079096|NCT01304771|vaccine|vaccine
5079097|NCT01304771|immune|immune
5079098|NCT01304771|response|response
5079099|NCT01304693|AMD|amd
5079100|NCT01304693|Wet AMD|wet amd
5079101|NCT01304693|Exudative|exudative
5079102|NCT01304693|CNV|cnv
5079103|NCT01304667|Vulvar cancer|vulvar cancer
5079104|NCT01304667|Radiotherapy|radiotherapy
5079105|NCT01304667|Chemotherapy|chemotherapy
5079106|NCT01304654|acute lung injury|acute lung injury
5079107|NCT01304654|respiratory distress syndrome|respiratory distress syndrome
5079108|NCT01304654|neoplasms|neoplasms
5079109|NCT01304654|child|child
5079110|NCT01304641|Dyslipidemia|dyslipidemia
5079111|NCT01304641|Cardiovascular|cardiovascular
5079112|NCT01304641|Statin|statin
5079113|NCT01304628|asthma|asthma
5079114|NCT01304615|Overweight|overweight
5079115|NCT01304615|Obesity|obesity
5079116|NCT01304615|Young Adults|young adults
5079117|NCT01304615|Energy Density|energy density
5079118|NCT01304615|Culinary Skills|culinary skills
5079119|NCT01304615|Physical Activity|physical activity
5079120|NCT01304615|Consumption of Self-made Meals|consumption of self-made meals
5079121|NCT01304615|Family History of diabetes|family history of diabetes
5079122|NCT01304602|colorectal cancer|colorectal cancer
5079123|NCT01304602|BKM120|bkm120
5079124|NCT01304602|irinotecan|irinotecan
5079125|NCT01304589|provoked vestibulodynia|provoked vestibulodynia
5079126|NCT01304589|vulvodynia|vulvodynia
5079127|NCT01304589|PVD|pvd
5079128|NCT01304576|stroke|stroke
5079129|NCT01304576|parietal lesions|parietal lesions
5079130|NCT01304550|non-invasive|non-invasive
5079132|NCT01304524|CIN 2/3 or CIN 3|cin 2/3 or cin 3
5079133|NCT01304524|Cervical cancer|cervical cancer
5079134|NCT01304524|Papillomavirus|papillomavirus
5079135|NCT01304485|Recurrent Prostate Carcinoma|recurrent prostate carcinoma
5079136|NCT01304485|sodium acetate c11|sodium acetate c11
5079137|NCT01304485|PET|pet
5079138|NCT01304485|prostate cancer|prostate cancer
5079139|NCT01304485|rising PSA|rising psa
5079140|NCT01304485|PSA recurrence|psa recurrence
5079141|NCT01304485|biochemical recurrence|biochemical recurrence
5079142|NCT01304472|coronary angioplasty|coronary angioplasty
5079143|NCT01304472|clopidogrel resistance|clopidogrel resistance
5079144|NCT01304472|prasugrel|prasugrel
5079145|NCT01304446|Nutritional support|nutritional support
5079146|NCT01304446|Cancer|cancer
5079147|NCT01304446|Malnutrition|malnutrition
5079148|NCT01304446|Child|child
5079149|NCT01304446|Adolescent|adolescent
5079150|NCT01304446|pediatric|pediatric
5079151|NCT01304420|Juvenile idiopathic arthritis|juvenile idiopathic arthritis
5079152|NCT01304420|Ultrasonography|ultrasonography
5079153|NCT01304420|Cartilage|cartilage
5079154|NCT01304420|Cartilage biomarkers|cartilage biomarkers
5079155|NCT01304420|Bone biomarkers|bone biomarkers
5079156|NCT01304407|Rothmund-Thomson Syndrome|rothmund-thomson syndrome
5079157|NCT01304407|Calcium absorption|calcium absorption
5079158|NCT01304407|Bone density|bone density
5079159|NCT01304394|Parenteral Nutrition|parenteral nutrition
5079160|NCT01304394|Multi Chamber Bag|multi chamber bag
5079161|NCT01304381|Heart failure|heart failure
5079162|NCT01304381|Palliative care|palliative care
5079163|NCT01304381|Integrated care|integrated care
5079164|NCT01304368|Hyperthermia, Induced|hyperthermia, induced
5079165|NCT01304368|Randomized Controlled Trial|randomized controlled trial
5079166|NCT01304368|Neck Pain|neck pain
5079167|NCT01304368|Sensory Thresholds|sensory thresholds
5079168|NCT01304368|Pain Measurements|pain measurements
5079169|NCT01304355|IBS|ibs
5079170|NCT01304355|Cognition|cognition
5079171|NCT01304355|Kynurenine Pathway|kynurenine pathway
5079172|NCT01304355|Gastrointestinal|gastrointestinal
5079173|NCT01304342|Propofol|propofol
5079174|NCT01304342|remifentanil|remifentanil
5079175|NCT01304342|fentanyl|fentanyl
5079176|NCT01304342|ERCP|ercp
5079177|NCT01304342|Quality of sedation|quality of sedation
5079178|NCT01304342|recovery|recovery
5079179|NCT01304342|satisfaction|satisfaction
5079180|NCT01304342|respiratory depression|respiratory depression
5079181|NCT01304303|solid|solid
5079182|NCT01304303|tumor|tumor
5079183|NCT01304303|taxane|taxane
5079184|NCT01304303|platinum|platinum
5079185|NCT01304290|inflammatory process|inflammatory process
5079186|NCT01304290|hyperglycaemia|hyperglycaemia
5079187|NCT01304290|inflammatory cytokine response|inflammatory cytokine response
5079188|NCT01304290|organ survival|organ survival
5079189|NCT01304290|hyperinsulinemic clamp|hyperinsulinemic clamp
5079190|NCT01304277|Replagal|replagal
5079191|NCT01304264|glaucoma, ocular, blood flow, fluctuations|glaucoma, ocular, blood flow, fluctuations
5079192|NCT01304251|short-term fasting|short-term fasting
5079193|NCT01304251|adjuvant chemotherapy|adjuvant chemotherapy
5079194|NCT01304251|toxicity|toxicity
5079195|NCT01304251|side-effects|side-effects
5079196|NCT01304238|Retrospective evaluation of patients with acute Heparin-induced Thrombocytopenia type II treated with Fondaparinux|retrospective evaluation of patients with acute heparin-induced thrombocytopenia type ii treated with fondaparinux
5079197|NCT01304225|diabetic retinopathy|diabetic retinopathy
5079198|NCT01304225|photocoagulation|photocoagulation
5079199|NCT01304225|PASCAL laser|pascal laser
5079200|NCT01304212|total knee arthroplasty|total knee arthroplasty
5079201|NCT01304212|intraarticular infiltration|intraarticular infiltration
5079202|NCT01304212|femoral block|femoral block
5079203|NCT01304199|Cancer survivor|cancer survivor
5079204|NCT01304199|Neoplasms|neoplasms
5079205|NCT01304199|Treatments|treatments
5079206|NCT01304199|Physical status|physical status
5079207|NCT01304199|Psychosocial status|psychosocial status
5079208|NCT01304199|Survivorship survey|survivorship survey
5079209|NCT01304199|Survivorship care|survivorship care
5079210|NCT01304199|Research|research
5079211|NCT01304199|Cancer patient|cancer patient
5079212|NCT01304186|Health literacy|health literacy
5079213|NCT01304186|HIV|hiv
5079214|NCT01304186|Medication Adherence|medication adherence
5079215|NCT01304186|IMB Model|imb model
5079216|NCT01304173|BCG|bcg
5079217|NCT01304173|refractory|refractory
5079218|NCT01304173|NMIBC|nmibc
5079219|NCT01304173|CIS|cis
5079220|NCT01304173|non-muscle invasive|non-muscle invasive
5079221|NCT01304160|pancreatic cancer|pancreatic cancer
5079222|NCT01304160|stereotactic body radiotherapy|stereotactic body radiotherapy
5079223|NCT01304160|radiation|radiation
5079224|NCT01304160|gemcitabine|gemcitabine
5079225|NCT01304160|locally advanced|locally advanced
5079226|NCT01304147|ketamine|ketamine
5079227|NCT01304147|depression|depression
5079228|NCT01304147|treatment resistance|treatment resistance
5079229|NCT01304147|intranasal, antidepressant|intranasal, antidepressant
5079230|NCT01304147|glutamate|glutamate
5079231|NCT01304147|NMDA receptor|nmda receptor
5079232|NCT01304121|Bone tumors|bone tumors
5079436|NCT01303406|ICARS|icars
5079233|NCT01304121|Bioactive glass|bioactive glass
5079234|NCT01304121|Autogenous bone grafting|autogenous bone grafting
5079235|NCT01304121|Allogeneic bone grafting|allogeneic bone grafting
5079236|NCT01304121|PET imaging|pet imaging
5079237|NCT01304108|Venous Thromboembolism|venous thromboembolism
5079238|NCT01304108|Delivery of Health Care|delivery of health care
5079239|NCT01304108|Quality Improvement|quality improvement
5079240|NCT01304108|Evidence-Based Practice|evidence-based practice
5079241|NCT01304095|Coronary Artery Disease, Angina, Metabolic Syndrome|coronary artery disease, angina, metabolic syndrome
5079242|NCT01304082|pain pH local anesthetics|pain ph local anesthetics
5079243|NCT01304069|Pharmacokinetics|pharmacokinetics
5079244|NCT01304069|Pharmacodynamics|pharmacodynamics
5079245|NCT01304056|Ventilatory physiology|ventilatory physiology
5079246|NCT01304043|ovarian tumors|ovarian tumors
5079247|NCT01304043|rare ovarian tumors|rare ovarian tumors
5079248|NCT01304043|germinal tumors|germinal tumors
5079249|NCT01304043|sexual cords tumors|sexual cords tumors
5079250|NCT01304043|observatory|observatory
5079251|NCT01304043|forum|forum
5079252|NCT01304030|Empathy|empathy
5079253|NCT01304017|rehabilitation|rehabilitation
5079254|NCT01304017|stroke|stroke
5079255|NCT01304017|intervention|intervention
5079256|NCT01304017|physical activity|physical activity
5079257|NCT01304017|participation|participation
5079258|NCT01304004|Obesity|obesity
5079259|NCT01304004|Yogurt|yogurt
5079260|NCT01304004|Proteins|proteins
5079261|NCT01304004|Fibres|fibres
5079262|NCT01304004|Women|women
5079263|NCT01304004|Satiety|satiety
5079264|NCT01303952|cold agglutinin disease|cold agglutinin disease
5079265|NCT01303952|hemolysis|hemolysis
5079266|NCT01303952|eculizumab|eculizumab
5079267|NCT01303952|terminal complement inhibition|terminal complement inhibition
5079268|NCT01303939|Glaucoma|glaucoma
5079269|NCT01303939|MRI Brain Scan|mri brain scan
5079270|NCT01303939|Voxel-Based Morphometry|voxel-based morphometry
5079271|NCT01303926|QoL|qol
5079272|NCT01303926|EQ5D score|eq5d score
5079273|NCT01303926|cisplatin pemetrexed|cisplatin pemetrexed
5079274|NCT01303926|carboplatin paclitaxel bevacizumab|carboplatin paclitaxel bevacizumab
5079275|NCT01303926|maintenance|maintenance
5079276|NCT01303913|COPD|copd
5079277|NCT01303913|Oxygen desaturation|oxygen desaturation
5079278|NCT01303913|Walking test|walking test
5079279|NCT01303900|Haemophilia|haemophilia
5079280|NCT01303900|Cardiovascular disease|cardiovascular disease
5079407|NCT01303523|thromboembolism|thromboembolism
5079281|NCT01303900|Cardiovascular disease risk factors|cardiovascular disease risk factors
5079282|NCT01303900|Prospective|prospective
5079283|NCT01303900|QRISK2|qrisk2
5079284|NCT01303900|Hypertension|hypertension
5079285|NCT01303900|Hypercholesterolaemia|hypercholesterolaemia
5079286|NCT01303900|Diabetes|diabetes
5079287|NCT01303900|Obesity|obesity
5079288|NCT01303887|PACIFICO|pacifico
5079289|NCT01303887|Follicular Lymphoma|follicular lymphoma
5079290|NCT01303887|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
5079291|NCT01303887|Rituximab|rituximab
5079292|NCT01303887|R-CVP|r-cvp
5079293|NCT01303887|R-FC|r-fc
5079294|NCT01303887|Older|older
5079295|NCT01303874|Rheumatoid arthritis|rheumatoid arthritis
5079296|NCT01303874|Inflammatory arthritis|inflammatory arthritis
5079297|NCT01303874|Undifferentiated arthritis|undifferentiated arthritis
5079298|NCT01303874|Etanercept|etanercept
5079299|NCT01303874|Combination Therapy|combination therapy
5079300|NCT01303861|Nicotine addiction|nicotine addiction
5079301|NCT01303861|Cigarette smoking|cigarette smoking
5079302|NCT01303861|Smoking cessation|smoking cessation
5079303|NCT01303861|Zyban|zyban
5079304|NCT01303861|Chantix|chantix
5079305|NCT01303861|Nicotine patches|nicotine patches
5079306|NCT01303861|Nicotrol Inhaler|nicotrol inhaler
5079307|NCT01303861|varenicline|varenicline
5079308|NCT01303861|bupropion|bupropion
5079309|NCT01303848|Blood lactate|blood lactate
5079310|NCT01303848|Lipid transfer proteins|lipid transfer proteins
5079311|NCT01303848|Lactate|lactate
5079312|NCT01303848|PLTP|pltp
5079313|NCT01303848|CETP|cetp
5079314|NCT01303848|PPARs|ppars
5079315|NCT01303848|CLOCk|clock
5079316|NCT01303848|Bal1|bal1
5079317|NCT01303835|malignant glioma|malignant glioma
5079318|NCT01303835|glioblastoma multiforme|glioblastoma multiforme
5079319|NCT01303835|quality of life|quality of life
5079320|NCT01303835|naltrexone|naltrexone
5079321|NCT01303809|Perioperative care|perioperative care
5079322|NCT01303809|Fast-track|fast-track
5079323|NCT01303809|Enhanced Recovery After Surgery|enhanced recovery after surgery
5079324|NCT01303809|ERAS|eras
5079325|NCT01303809|Obesity|obesity
5079326|NCT01303809|Bariatric surgery|bariatric surgery
5079327|NCT01303809|Laparoscopic Sleeve Gastrectomy|laparoscopic sleeve gastrectomy
5079328|NCT01303796|AML|aml
5079329|NCT01303783|Nifedipine GITS|nifedipine gits
5079330|NCT01303783|Candesartan|candesartan
5079331|NCT01303783|mild to moderate Hypertension|mild to moderate hypertension
5079332|NCT01303783|Combination therapy|combination therapy
5079333|NCT01303770|Multiple Sclerosis|multiple sclerosis
5079334|NCT01303770|Cognitive impairment|cognitive impairment
5079335|NCT01303770|Self-management programs|self-management programs
5079336|NCT01303770|Occupational Therapy|occupational therapy
5079337|NCT01303770|Rehabilitation|rehabilitation
5079338|NCT01303757|obesity|obesity
5079339|NCT01303731|Spinal anesthesia|spinal anesthesia
5079340|NCT01303731|Cesarean section|cesarean section
5079341|NCT01303731|Marcaine Spinal 0.5% Heavy minidose|marcaine spinal 0.5% heavy minidose
5079342|NCT01303731|Fentanyl|fentanyl
5079343|NCT01303731|Local Anesthetics|local anesthetics
5079344|NCT01303718|LV Dysfunction|lv dysfunction
5079345|NCT01303718|Heart Failure|heart failure
5079346|NCT01303705|progressive metastatic prostate cancer|progressive metastatic prostate cancer
5079347|NCT01303705|cancer of the prostate|cancer of the prostate
5079348|NCT01303705|prostate cancer|prostate cancer
5079349|NCT01303692|bone mineral loss|bone mineral loss
5079350|NCT01303692|prostate cancer|prostate cancer
5079351|NCT01303692|GnRH agonist alone vs. GnRH agonist plus anti-androgen combination|gnrh agonist alone vs. gnrh agonist plus anti-androgen combination
5079352|NCT01303679|First line metastatic breast cancer|first line metastatic breast cancer
5079353|NCT01303679|Positive estrogen receptors|positive estrogen receptors
5079354|NCT01303679|Negative HER2 receptors|negative her2 receptors
5079355|NCT01303679|At least stable disease after 4 months of paclitaxel-bevcizumab induction chemotheray|at least stable disease after 4 months of paclitaxel-bevcizumab induction chemotheray
5079356|NCT01303653|endoscopic tissue closure,|endoscopic tissue closure,
5079357|NCT01303653|gastro-gastric fistulas,|gastro-gastric fistulas,
5079358|NCT01303653|gastrointestinal perforations|gastrointestinal perforations
5079359|NCT01303640|Coronary stent|coronary stent
5079360|NCT01303627|Remifentanil|remifentanil
5079361|NCT01303627|Laryngeal mask airway removal|laryngeal mask airway removal
5079362|NCT01303627|Hemodynamic changing|hemodynamic changing
5079363|NCT01303627|Infusion|infusion
5079364|NCT01303627|Ureterorenoscopy|ureterorenoscopy
5079365|NCT01303614|hysterosalpingography|hysterosalpingography
5079366|NCT01303614|prilocaine|prilocaine
5079367|NCT01303614|local anaesthetic|local anaesthetic
5079368|NCT01303614|pain relief|pain relief
5079369|NCT01303614|gynecological pathology|gynecological pathology
5079370|NCT01303601|Olanzapine|olanzapine
5079371|NCT01303601|Monotherapy|monotherapy
5079372|NCT01303601|bipolar Ⅰ depression|bipolar ⅰ depression
5079373|NCT01303588|elderly patients|elderly patients
5079374|NCT01303575|Adolescents|adolescents
5079375|NCT01303575|Youth|youth
5079376|NCT01303575|Sexual Health|sexual health
5079377|NCT01303575|Sex Education|sex education
5079378|NCT01303575|Pregnancy Prevention|pregnancy prevention
5079379|NCT01303575|Abstinence Education|abstinence education
5079380|NCT01303575|HIV|hiv
5079381|NCT01303575|Human Immunodeficiency Virus|human immunodeficiency virus
5079382|NCT01303575|STI|sti
5079383|NCT01303575|Chlamydia|chlamydia
5079384|NCT01303575|Gonorrhea|gonorrhea
5079385|NCT01303575|Sexually Transmitted Infections|sexually transmitted infections
5079386|NCT01303575|American Indian|american indian
5079387|NCT01303575|Alaska Native|alaska native
5079388|NCT01303575|Native American|native american
5079389|NCT01303575|Internet-Based|internet-based
5079390|NCT01303575|Computer-based Education|computer-based education
5079391|NCT01303575|Computer-based learning|computer-based learning
5079392|NCT01303562|oat|oat
5079393|NCT01303562|barley|barley
5079394|NCT01303562|whole grain|whole grain
5079395|NCT01303562|bioavailability|bioavailability
5079396|NCT01303562|phytochemical|phytochemical
5079397|NCT01303549|Liver transplantation|liver transplantation
5079398|NCT01303549|Hepatic transplant|hepatic transplant
5079399|NCT01303549|Antifungal prophylaxis|antifungal prophylaxis
5079400|NCT01303549|Anidulafungin|anidulafungin
5079401|NCT01303549|Liposomal Amphotericin B|liposomal amphotericin b
5079402|NCT01303523|LMWH|lmwh
5079403|NCT01303523|heparin|heparin
5079404|NCT01303523|immobilization|immobilization
5079405|NCT01303523|anticoagulant prophylaxis|anticoagulant prophylaxis
5079406|NCT01303523|leg injuries|leg injuries
5079408|NCT01303510|Influenza|influenza
5079409|NCT01303510|Virus|virus
5079410|NCT01303510|Vaccination|vaccination
5079411|NCT01303510|Immunisation|immunisation
5079412|NCT01303497|Angiosarcoma|angiosarcoma
5079413|NCT01303497|Paclitaxel|paclitaxel
5079414|NCT01303497|bevacizumab|bevacizumab
5079415|NCT01303471|pain assessment|pain assessment
5079416|NCT01303471|anesthesia|anesthesia
5079417|NCT01303471|analgesia|analgesia
5079418|NCT01303471|opioid|opioid
5079419|NCT01303471|HRV|hrv
5079420|NCT01303471|APV|apv
5079421|NCT01303471|autonomic nervous system (ANS)|autonomic nervous system (ans)
5079422|NCT01303471|pupil size|pupil size
5079423|NCT01303458|community resource|community resource
5079424|NCT01303458|well-child care visit|well-child care visit
5079425|NCT01303458|low-income|low-income
5079426|NCT01303432|Joint discomfort|joint discomfort
5079427|NCT01303432|Functional Food|functional food
5079428|NCT01303432|Joint function|joint function
5079429|NCT01303432|Mobilee|mobilee
5079430|NCT01303419|mammography|mammography
5079431|NCT01303406|randomized withdrawal|randomized withdrawal
5079432|NCT01303406|idebenone|idebenone
5079433|NCT01303406|friedreich's ataxia|friedreich's ataxia
5079434|NCT01303406|Miconos|miconos
5079435|NCT01303406|Patient reported outcome|patient reported outcome
5079437|NCT01303393|Patient education. Patient discharge. Needs assessment.|patient education. patient discharge. needs assessment.
5079438|NCT01303380|Hyper IgD syndrome|hyper igd syndrome
5079439|NCT01303380|canakinumab|canakinumab
5079440|NCT01303380|HIDS|hids
5079441|NCT01303380|mevalonate kinase deficiency|mevalonate kinase deficiency
5079442|NCT01303380|MKD|mkd
5079443|NCT01303367|Dementia|dementia
5079444|NCT01303367|behavioral and psychological symptoms of dementia|behavioral and psychological symptoms of dementia
5079445|NCT01303354|Epidural, Transforaminal, Steroid Injection, Dexamethasone|epidural, transforaminal, steroid injection, dexamethasone
5079446|NCT01303315|C19 246 300|c19 246 300
5079447|NCT01303302|C19 246 300|c19 246 300
5079448|NCT01303289|Total Enteral Nutrition|total enteral nutrition
5079449|NCT01303289|Severe insufficient nutrition|severe insufficient nutrition
5079450|NCT01303289|T-Diet plus Standard|t-diet plus standard
5079451|NCT01303289|Lipidic profile|lipidic profile
5079452|NCT01303289|Quality of life|quality of life
5079453|NCT01303276|retinal vein occlusion|retinal vein occlusion
5079454|NCT01303276|anti-VEGF|anti-vegf
5079455|NCT01303276|blood flow|blood flow
5079456|NCT01303263|efficiency|efficiency
5079457|NCT01303263|cost-awareness|cost-awareness
5079458|NCT01303263|hospitals|hospitals
5079459|NCT01303263|graduate medical education|graduate medical education
5079460|NCT01303250|goal-directed fluid optimization|goal-directed fluid optimization
5079461|NCT01303250|hemodynamic optimization|hemodynamic optimization
5079462|NCT01303250|crystalloid|crystalloid
5079463|NCT01303250|colloid|colloid
5079464|NCT01303237|LA SCCHN|la scchn
5079465|NCT01303237|Cetuximab|cetuximab
5079466|NCT01303237|RT|rt
5079467|NCT01303237|PMS|pms
5079468|NCT01303224|Irritable Bowel Syndrome|irritable bowel syndrome
5079469|NCT01303224|Colon, irritable|colon, irritable
5079470|NCT01303224|Bowel disease|bowel disease
5079471|NCT01303211|Meningococcal serogroup A conjugate vaccine|meningococcal serogroup a conjugate vaccine
5079472|NCT01303211|Vaccine efficacy|vaccine efficacy
5079473|NCT01303211|Serogroup A meningococcal diseases|serogroup a meningococcal diseases
5079474|NCT01303198|CPAP|cpap
5079475|NCT01303198|APAP|apap
5079476|NCT01303198|sleep apnea|sleep apnea
5079477|NCT01303185|Psoriatic Nail|psoriatic nail
5079478|NCT01303185|Pulsed dye laser|pulsed dye laser
5079479|NCT01303159|Cholangiocarcinoma|cholangiocarcinoma
5079480|NCT01303159|Pancreatic Cancer|pancreatic cancer
5079481|NCT01303159|Radiofrequency|radiofrequency
5079482|NCT01303159|Ablation|ablation
5079483|NCT01303146|Metachromatic Leukodystrophy|metachromatic leukodystrophy
5079484|NCT01303146|Enzyme replacement therapy|enzyme replacement therapy
5079485|NCT01303146|Allogeneic hematopoietic stem cell transplantation|allogeneic hematopoietic stem cell transplantation
5079486|NCT01303133|beta amyloid, Down Syndrome, Alzheimer's Disease|beta amyloid, down syndrome, alzheimer's disease
5079487|NCT01303081|Smoking Cessation|smoking cessation
5079488|NCT01303081|Work-site|work-site
5079489|NCT01303081|Incentives|incentives
5079490|NCT01303081|Health Behavior|health behavior
5079491|NCT01303081|Smoking|smoking
5079492|NCT01303068|CF|cf
5079493|NCT01303055|Pancreatic beta Cell|pancreatic beta cell
5079494|NCT01303055|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
5079495|NCT01303055|Glucose Metabolism Disorders|glucose metabolism disorders
5079496|NCT01303055|Metabolic Diseases|metabolic diseases
5079497|NCT01303055|Endocrine System Diseases|endocrine system diseases
5079498|NCT01303055|Metformin|metformin
5079499|NCT01303055|Hypoglycemic Agents|hypoglycemic agents
5079500|NCT01303055|Physiological Effects of Drugs|physiological effects of drugs
5079501|NCT01303055|Pharmacologic Actions|pharmacologic actions
5079502|NCT01303055|hemoglobin A1c protein, human|hemoglobin a1c protein, human
5079503|NCT01303055|Oral Glucose Tolerance Test|oral glucose tolerance test
5079504|NCT01303042|insulin LISPRO|insulin lispro
5079505|NCT01303042|Insulin therapy|insulin therapy
5079506|NCT01303042|hemoglobin A1c protein, human|hemoglobin a1c protein, human
5079507|NCT01303042|Blood Glucose Self-Monitoring|blood glucose self-monitoring
5079508|NCT01303042|Quality of Life|quality of life
5079509|NCT01303042|Hypoglycemia|hypoglycemia
5079510|NCT01303042|Diabetes Mellitus|diabetes mellitus
5079511|NCT01303042|1,5-Anhydroglucitol|1,5-anhydroglucitol
5079512|NCT01303029|Pancreatic cancer|pancreatic cancer
5079513|NCT01303029|gemcitabine|gemcitabine
5079514|NCT01303029|erlotinib|erlotinib
5079515|NCT01303029|capecitabine|capecitabine
5079516|NCT01302990|Influenza|influenza
5079517|NCT01302990|Respiratory disease|respiratory disease
5079518|NCT01302990|Prevention|prevention
5079519|NCT01302977|Congenital diaphragmatic hernia|congenital diaphragmatic hernia
5079520|NCT01302977|Fetal anomalies|fetal anomalies
5079521|NCT01302964|Autistic Disorder|autistic disorder
5079522|NCT01302964|Asperger's Disorder|asperger's disorder
5079523|NCT01302964|Pervasive Developmental Disorder|pervasive developmental disorder
5079524|NCT01302951|pharmacokinetics|pharmacokinetics
5079525|NCT01302951|liver resection|liver resection
5079526|NCT01302938|Double-blind|double-blind
5079527|NCT01302938|Placebo-controlled|placebo-controlled
5079528|NCT01302938|frequency|frequency
5079529|NCT01302938|urgency|urgency
5079530|NCT01302938|web-based|web-based
5079531|NCT01302938|incontinence|incontinence
5079532|NCT01302938|methodology|methodology
5079533|NCT01302938|ediary|ediary
5079534|NCT01302938|safety|safety
5079535|NCT01302938|efficacy|efficacy
5079536|NCT01302938|tolerability ER|tolerability er
5079537|NCT01302938|overactive bladder|overactive bladder
5079538|NCT01302912|ocular adnexal lymphomas|ocular adnexal lymphomas
5079539|NCT01302886|High risk Smoldering multiple myeloma,|high risk smoldering multiple myeloma,
5079540|NCT01302886|BHQ880,|bhq880,
5079541|NCT01302886|MM|mm
5079542|NCT01302873|Tinnitus|tinnitus
5079543|NCT01302873|AMPA Receptor antagonist|ampa receptor antagonist
5079544|NCT01302860|Cryopyrin-associated periodic syndromes (CAPS)|cryopyrin-associated periodic syndromes (caps)
5079545|NCT01302860|Familial Cold Autoinflammatory Syndrome (FCAS)|familial cold autoinflammatory syndrome (fcas)
5079546|NCT01302860|Muckle-Wells Syndrome (MWS) or Neonatal Onset Multisystem Inflammatory Disease (NOMID)|muckle-wells syndrome (mws) or neonatal onset multisystem inflammatory disease (nomid)
5079547|NCT01302860|children|children
5079548|NCT01302860|systemic autoinflammatory disease|systemic autoinflammatory disease
5079549|NCT01302860|CIAS-1 gene|cias-1 gene
5079550|NCT01302860|NALP-3|nalp-3
5079551|NCT01302860|NLRP3|nlrp3
5079552|NCT01302860|ACZ885|acz885
5079553|NCT01302860|Ilaris|ilaris
5079554|NCT01302860|human monoclonal anti-human interleukin-1 beta (IL-beta)|human monoclonal anti-human interleukin-1 beta (il-beta)
5079555|NCT01302860|antibody|antibody
5079556|NCT01302860|autosomal dominant|autosomal dominant
5079557|NCT01302860|familial autoinflammatory syndrome|familial autoinflammatory syndrome
5079558|NCT01302847|Integrase Inhibitors|integrase inhibitors
5079559|NCT01302847|Infant|infant
5079560|NCT01302847|Child|child
5079561|NCT01302847|Adolescent|adolescent
5079562|NCT01302834|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
5079563|NCT01302834|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5079564|NCT01302834|human papilloma virus infection|human papilloma virus infection
5079565|NCT01302821|breast - male|breast - male
5079566|NCT01302821|breast - female|breast - female
5079567|NCT01302821|metastatic|metastatic
5079568|NCT01302821|invasive|invasive
5079569|NCT01302808|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5079570|NCT01302808|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5079571|NCT01302808|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5079572|NCT01302808|malignant pleural effusion|malignant pleural effusion
5079573|NCT01302808|adenocarcinoma of the lung|adenocarcinoma of the lung
5079574|NCT01302808|adenosquamous cell lung cancer|adenosquamous cell lung cancer
5079575|NCT01302808|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
5079576|NCT01302808|large cell lung cancer|large cell lung cancer
5079577|NCT01302808|squamous cell lung cancer|squamous cell lung cancer
5079578|NCT01302795|Interleukin 1 beta|interleukin 1 beta
5079579|NCT01302795|Canakinumab|canakinumab
5079580|NCT01302795|autoinflammatory syndrome|autoinflammatory syndrome
5079581|NCT01302782|Altitude|altitude
5079582|NCT01302782|Glucose|glucose
5079583|NCT01302769|Acute Sore Throat|acute sore throat
5079584|NCT01302769|Ear Acupuncture|ear acupuncture
5079585|NCT01302756|gestational diabetes|gestational diabetes
5079586|NCT01302756|gestational hypertension|gestational hypertension
5079587|NCT01302756|folic acid|folic acid
5079588|NCT01302743|Diabetes|diabetes
5079589|NCT01302743|Metformin|metformin
5079590|NCT01302743|Cinnamon|cinnamon
5079591|NCT01302730|ankylosing spondylitis|ankylosing spondylitis
5079592|NCT01302730|spondylarthritis|spondylarthritis
5079593|NCT01302730|inflammatory back pain|inflammatory back pain
5079594|NCT01302730|seronegative|seronegative
5079595|NCT01302717|Left ventricular pacing|left ventricular pacing
5079596|NCT01302704|Vitamin D|vitamin d
5079597|NCT01302704|Proton Pump Inhibitors|proton pump inhibitors
5079598|NCT01302691|Essential hypertension|essential hypertension
5079599|NCT01302691|Uncontrolled hypertension|uncontrolled hypertension
5079600|NCT01302691|Antihypertensive agents|antihypertensive agents
5079601|NCT01302691|Blood pressure|blood pressure
5079602|NCT01302652|acromegaly|acromegaly
5079603|NCT01302652|growth hormone|growth hormone
5079604|NCT01302652|growth hormone deficiency|growth hormone deficiency
5079605|NCT01302626|NSCLC|nsclc
5079606|NCT01302626|SCLC|sclc
5079607|NCT01302626|lung cancer|lung cancer
5079608|NCT01302626|RNA|rna
5079609|NCT01302626|DNA|dna
5079610|NCT01302626|imaging|imaging
5079611|NCT01302626|genomics|genomics
5079612|NCT01302626|proteomics|proteomics
5079613|NCT01302626|predictive model|predictive model
5079614|NCT01302626|prospective study|prospective study
5079615|NCT01302613|rectal cancer|rectal cancer
5079616|NCT01302574|T1R2/T1R3|t1r2/t1r3
5079617|NCT01302574|gastric emptying|gastric emptying
5079618|NCT01302574|gut|gut
5079619|NCT01302574|lactisole|lactisole
5079620|NCT01302574|nutrient sensing|nutrient sensing
5079621|NCT01302561|adults|adults
5079622|NCT01302561|fiber|fiber
5079623|NCT01302561|cold|cold
5079624|NCT01302561|flu|flu
5079625|NCT01302561|immune function|immune function
5079626|NCT01302561|microbiota|microbiota
5079627|NCT01302548|Abscess|abscess
5079628|NCT01302548|Wound Irrigation|wound irrigation
5079629|NCT01302548|Wound Debridement|wound debridement
5079630|NCT01302548|Wound Healing|wound healing
5079631|NCT01302548|Incision and drainage|incision and drainage
5079632|NCT01302548|Chlorhexidine|chlorhexidine
5079633|NCT01302535|Yoga|yoga
5079634|NCT01302535|Hypertension|hypertension
5079635|NCT01302535|Quality of Life|quality of life
5079636|NCT01302535|Primary Health Care|primary health care
5079637|NCT01302509|Nutritional support.|nutritional support.
5079638|NCT01302509|Cancer.|cancer.
5079639|NCT01302509|Malnutrition.|malnutrition.
5079640|NCT01302509|Child.|child.
5079641|NCT01302509|Adolescent|adolescent
5079642|NCT01302496|Previously Treated|previously treated
5079643|NCT01302496|Unresectable|unresectable
5079644|NCT01302496|Stage III or IV Melanoma|stage iii or iv melanoma
5079645|NCT01302470|biventricular pacing|biventricular pacing
5079646|NCT01302457|Thermal Burn Trauma|thermal burn trauma
5079647|NCT01302444|treprostinil|treprostinil
5079648|NCT01302444|pulmonary hypertension, tadalafil|pulmonary hypertension, tadalafil
5079649|NCT01302431|experimental|experimental
5079650|NCT01302431|intervention|intervention
5079651|NCT01302431|nurse-led|nurse-led
5079652|NCT01302431|nurse specialist|nurse specialist
5079653|NCT01302431|multiple sclerosis|multiple sclerosis
5079654|NCT01302431|support of caregivers|support of caregivers
5079655|NCT01302418|Respiratory Virus|respiratory virus
5079656|NCT01302418|Influenza|influenza
5079658|NCT01302418|Parainfluenza|parainfluenza
5079659|NCT01302418|Metapneumovirus|metapneumovirus
5079660|NCT01302418|Rhinovirus|rhinovirus
5079661|NCT01302418|Coxsackie virus|coxsackie virus
5079662|NCT01302418|Echo virus|echo virus
5079663|NCT01302418|Adenovirus|adenovirus
5079664|NCT01302418|Coronavirus|coronavirus
5079665|NCT01302418|Bocavirus|bocavirus
5079666|NCT01302405|Advanced solid tumor|advanced solid tumor
5079667|NCT01302405|cancer|cancer
5079668|NCT01302405|phase 1|phase 1
5079669|NCT01302405|pancreatic cancer|pancreatic cancer
5079670|NCT01302405|colon cancer|colon cancer
5079671|NCT01302405|unresectable neoplastic disease|unresectable neoplastic disease
5079672|NCT01302405|Progressive cancer|progressive cancer
5079673|NCT01302405|metastatic solid tumor|metastatic solid tumor
5079674|NCT01302379|Obesity|obesity
5079675|NCT01302379|Survival|survival
5079676|NCT01302379|Weight loss|weight loss
5079677|NCT01302379|Metformin|metformin
5079678|NCT01302379|Biological markers|biological markers
5079679|NCT01302366|multiple myeloma|multiple myeloma
5079680|NCT01302366|myeloma|myeloma
5079681|NCT01302366|asymptomatic myeloma|asymptomatic myeloma
5079682|NCT01302366|smoldering myeloma|smoldering myeloma
5079683|NCT01302366|Asymptomatic (smoldering) myeloma|asymptomatic (smoldering) myeloma
5079684|NCT01302353|Phase I trial|phase i trial
5079685|NCT01302353|Emulsified Isoflurane|emulsified isoflurane
5079686|NCT01302353|Health volunteer|health volunteer
5079687|NCT01302340|Dementia|dementia
5079688|NCT01302340|Alzheimer|alzheimer
5079689|NCT01302340|Cannabis|cannabis
5079690|NCT01302340|THC|thc
5079691|NCT01302340|Behavioral Disturbances|behavioral disturbances
5079692|NCT01302340|Neuropsychiatric Inventory|neuropsychiatric inventory
5079693|NCT01302327|Wolfram syndrome|wolfram syndrome
5079694|NCT01302327|Diabetes mellitus|diabetes mellitus
5079695|NCT01302327|Exenatide|exenatide
5079696|NCT01302327|GLP-1 analog|glp-1 analog
5079697|NCT01302327|beta cell function|beta cell function
5079698|NCT01302301|endolumenal myotomy, per oral endoscopic myotomy|endolumenal myotomy, per oral endoscopic myotomy
5079699|NCT01302288|endolumenal myotomy, per oral endoscopic myotomy|endolumenal myotomy, per oral endoscopic myotomy
5079700|NCT01302275|neuropathic pain|neuropathic pain
5079701|NCT01302275|oxcarbazepine|oxcarbazepine
5079702|NCT01302275|pain mechanism|pain mechanism
5079703|NCT01302262|Smoking-induced dopamine release|smoking-induced dopamine release
5079704|NCT01302262|[11C]-(+)-PHNO PET Study|[11c]-(+)-phno pet study
5079705|NCT01302249|Glaucoma|glaucoma
5079706|NCT01302249|Intraocular pressure|intraocular pressure
5079707|NCT01302249|Ocular hypertension|ocular hypertension
5079708|NCT01302236|Elderly|elderly
5079709|NCT01302236|Early stage chronic kidney disease|early stage chronic kidney disease
5079710|NCT01302236|Hypertension|hypertension
5079711|NCT01302236|Eplerenone|eplerenone
5079712|NCT01302223|burns|burns
5079713|NCT01302223|Growth Factors, Combined Defect of|growth factors, combined defect of
5079714|NCT01302223|inflammation|inflammation
5079715|NCT01302223|Cytokine Storm|cytokine storm
5079716|NCT01302210|MRSA|mrsa
5079717|NCT01302210|Cluster Randomized Trial|cluster randomized trial
5079718|NCT01302210|Infection Control Intervention|infection control intervention
5079719|NCT01302197|Stroke|stroke
5079720|NCT01302197|Body Composition|body composition
5079721|NCT01302197|Glucose Tolerance|glucose tolerance
5079722|NCT01302171|dilated cardiomyopathy|dilated cardiomyopathy
5079723|NCT01302171|adult stem cells|adult stem cells
5079724|NCT01302171|bone marrow progenitor cells|bone marrow progenitor cells
5079725|NCT01302171|bone marrow stem cells|bone marrow stem cells
5079726|NCT01302171|autologous|autologous
5079727|NCT01302171|granulocyte-colony stimulating factor|granulocyte-colony stimulating factor
5079728|NCT01302171|intracoronary injection|intracoronary injection
5079729|NCT01302171|left ventricular function|left ventricular function
5079730|NCT01302171|To determine if patient's own bone marrow derived stem cells can be used to improve cardiac function|to determine if patient's own bone marrow derived stem cells can be used to improve cardiac function
5079731|NCT01302158|Drug-Drug interaction|drug-drug interaction
5079732|NCT01302158|ASP1941|asp1941
5079733|NCT01302158|Glimepiride|glimepiride
5079734|NCT01302158|Healthy subjects|healthy subjects
5079735|NCT01302145|pharmacokinetics|pharmacokinetics
5079736|NCT01302145|metformin|metformin
5079737|NCT01302145|Drug to drug interaction|drug to drug interaction
5079738|NCT01302145|ASP1941|asp1941
5079739|NCT01302132|Mass Balance|mass balance
5079740|NCT01302132|ASP1941|asp1941
5079741|NCT01302132|Pharmacokinetics|pharmacokinetics
5079742|NCT01302119|Onychomycosis|onychomycosis
5079743|NCT01302119|nail fungus|nail fungus
5079744|NCT01302119|toenail fungus|toenail fungus
5079745|NCT01302119|fungal nail|fungal nail
5079746|NCT01302119|hyperkeratosis|hyperkeratosis
5079747|NCT01302119|nail infection|nail infection
5079748|NCT01302119|nail treatment|nail treatment
5079749|NCT01302119|toenail infection|toenail infection
5079750|NCT01302119|toenail treatment|toenail treatment
5079751|NCT01302119|foot dermatoses|foot dermatoses
5079752|NCT01302119|fungal culture|fungal culture
5079753|NCT01302119|onycholysis|onycholysis
5079754|NCT01302119|podiatrist|podiatrist
5079755|NCT01302119|podiatry|podiatry
5079756|NCT01302119|subungual|subungual
5079757|NCT01302119|tinea unguium|tinea unguium
5079758|NCT01302119|antifungal|antifungal
5079759|NCT01302119|anti-fungal|anti-fungal
5079760|NCT01302119|dermatologist|dermatologist
5079761|NCT01302119|dermatology|dermatology
5079762|NCT01302119|dermatophyte|dermatophyte
5079763|NCT01302119|distal subungual onychomycosis|distal subungual onychomycosis
5079764|NCT01302119|yellow nail|yellow nail
5079765|NCT01302119|thick nail|thick nail
5079766|NCT01302119|brittle nail|brittle nail
5079767|NCT01302119|crumbling nail|crumbling nail
5079768|NCT01302119|discolored nail|discolored nail
5079769|NCT01302119|weak nail|weak nail
5079770|NCT01302106|Myelodysplastic Syndromes|myelodysplastic syndromes
5079771|NCT01302106|Clofarabine|clofarabine
5079772|NCT01302106|Low Dose Cytarabine|low dose cytarabine
5079773|NCT01302106|Poor risk MDS|poor risk mds
5079774|NCT01302080|prospective|prospective
5079775|NCT01302080|cohort|cohort
5079776|NCT01302080|sertraline|sertraline
5079777|NCT01302080|long-term impact|long-term impact
5079778|NCT01302080|cognition|cognition
5079779|NCT01302080|emotional and physical development|emotional and physical development
5079780|NCT01302080|pubertal maturation|pubertal maturation
5079781|NCT01302054|Bladder Overactive|bladder overactive
5079782|NCT01302054|Overactive urinary bladder|overactive urinary bladder
5079783|NCT01302054|Overactive Bladder|overactive bladder
5079784|NCT01302041|bone turnover|bone turnover
5079785|NCT01302041|hormone-naïve|hormone-naïve
5079786|NCT01302041|prostate specific antigen|prostate specific antigen
5079787|NCT01302041|Prostate Cancer|prostate cancer
5079788|NCT01302028|Renal Impairment|renal impairment
5079790|NCT01302028|Pharmacokinetics|pharmacokinetics
5079791|NCT01302002|Breast Cancer|breast cancer
5079792|NCT01302002|Metformin|metformin
5079793|NCT01302002|Pre-Surgery|pre-surgery
5079794|NCT01301989|Sleep|sleep
5079795|NCT01301989|Children|children
5079796|NCT01301989|Disparities|disparities
5079797|NCT01301989|Minority|minority
5079798|NCT01301989|Urban|urban
5079799|NCT01301976|nutritional state|nutritional state
5079800|NCT01301976|nutrients intake|nutrients intake
5079801|NCT01301976|ulcerative colitis|ulcerative colitis
5079802|NCT01301950|Arthroplasties, Knee Replacement|arthroplasties, knee replacement
5079803|NCT01301950|Arthroplasties, Replacement, Knee|arthroplasties, replacement, knee
5079804|NCT01301950|Arthroplasty, Knee Replacement|arthroplasty, knee replacement
5079805|NCT01301950|Knee Replacement Arthroplasties|knee replacement arthroplasties
5079806|NCT01301950|Knee Replacement Arthroplasty|knee replacement arthroplasty
5079807|NCT01301950|Knee Replacement, Total|knee replacement, total
5079808|NCT01301950|Replacement Arthroplasties, Knee|replacement arthroplasties, knee
5079809|NCT01301950|Replacement Arthroplasty, Knee|replacement arthroplasty, knee
5079810|NCT01301950|Replacement, Total Knee|replacement, total knee
5079811|NCT01301950|Total Knee Replacement|total knee replacement
5079812|NCT01301937|Mucosal Leishmaniasis|mucosal leishmaniasis
5079813|NCT01301937|Leishmania braziliensis|leishmania braziliensis
5079814|NCT01301937|Meglumine Antimoniate|meglumine antimoniate
5079815|NCT01301937|Treatment Effectiveness|treatment effectiveness
5079816|NCT01301937|Controlled Clinical Trials, Randomized|controlled clinical trials, randomized
5079817|NCT01301924|Leishmaniasis Cutaneous|leishmaniasis cutaneous
5079818|NCT01301924|Leishmania braziliensis|leishmania braziliensis
5079819|NCT01301924|Meglumine Antimoniate|meglumine antimoniate
5079820|NCT01301924|Treatment Effectiveness|treatment effectiveness
5079821|NCT01301924|Controlled Clinical Trials, Randomized|controlled clinical trials, randomized
5079822|NCT01301911|Breast cancer, Advanced|breast cancer, advanced
5079823|NCT01301911|Cipatinib|cipatinib
5079824|NCT01301911|phase I|phase i
5079825|NCT01301911|HER2 positive or uncertain advanced breast cancer|her2 positive or uncertain advanced breast cancer
5079826|NCT01301898|Hunter syndrome|hunter syndrome
5079827|NCT01301898|MPS II|mps ii
5079828|NCT01301898|Idursulfase|idursulfase
5079829|NCT01301885|endometriosis|endometriosis
5079830|NCT01301885|dysmenorrhea|dysmenorrhea
5079831|NCT01301885|infertility|infertility
5079832|NCT01301885|biomarker|biomarker
5079833|NCT01301885|drug target|drug target
5079834|NCT01301859|older adults|older adults
5079835|NCT01301859|adherence|adherence
5079836|NCT01301859|antidepressant|antidepressant
5079837|NCT01301859|depression|depression
5079838|NCT01301833|insulin resistance|insulin resistance
5079839|NCT01301820|maintenance treatment|maintenance treatment
5079840|NCT01301820|Disease free survival|disease free survival
5079841|NCT01301807|Relapsed/refractory multiple myeloma|relapsed/refractory multiple myeloma
5079842|NCT01301807|RRMM|rrmm
5079843|NCT01301807|Carfilzomib|carfilzomib
5079844|NCT01301807|Panobinostat|panobinostat
5079845|NCT01301807|LBH589B|lbh589b
5079846|NCT01301794|Hypertriglyceridemia|hypertriglyceridemia
5079847|NCT01301794|Fish oil|fish oil
5079848|NCT01301794|Omega 3 fatty acids|omega 3 fatty acids
5079849|NCT01301768|Dietary Intervention|dietary intervention
5079850|NCT01301768|Pregnancy Jail|pregnancy jail
5079851|NCT01301768|Iodine Deficiency|iodine deficiency
5079852|NCT01301768|Iodine Nutrition|iodine nutrition
5079853|NCT01301768|Dietary Habits|dietary habits
5079854|NCT01301768|Urinary Iodine|urinary iodine
5079855|NCT01301768|Pregnancy|pregnancy
5079856|NCT01301768|Group Education|group education
5079857|NCT01301768|Cluster Randomized Trial|cluster randomized trial
5079858|NCT01301768|Primary Health Care|primary health care
5079859|NCT01301703|rheumatoid pertussis tetanus|rheumatoid pertussis tetanus
5079860|NCT01301690|neck mass|neck mass
5079861|NCT01301690|ultrasound|ultrasound
5079862|NCT01301690|FNA|fna
5079863|NCT01301690|BMVC|bmvc
5079864|NCT01301664|The bone marrow-derived mesenchymal stem cells (BMMSCs) were obtained from redundant bone marrow from drilling during the joint replacement surgery.|the bone marrow-derived mesenchymal stem cells (bmmscs) were obtained from redundant bone marrow from drilling during the joint replacement surgery.
5079865|NCT01301664|The synovial-derived mesenchymal stem cells (SMSCs) were isolated from synovial membranes in the joint replacement surgery.|the synovial-derived mesenchymal stem cells (smscs) were isolated from synovial membranes in the joint replacement surgery.
5079866|NCT01301664|Cartilage slices were obtained from discard cartilage in the joint replacement surgery.|cartilage slices were obtained from discard cartilage in the joint replacement surgery.
5079867|NCT01301651|Virtual Reality|virtual reality
5079868|NCT01301651|Balance|balance
5079869|NCT01301651|Parkinson's disease|parkinson's disease
5079870|NCT01301651|Dual Task|dual task
5079871|NCT01301625|MitraClip|mitraclip
5079872|NCT01301625|mitral regurgitation (MR)|mitral regurgitation (mr)
5079873|NCT01301625|mitral valve insufficiency|mitral valve insufficiency
5079874|NCT01301625|percutaneous mitral valve repair|percutaneous mitral valve repair
5079875|NCT01301625|congestive heart failure|congestive heart failure
5079876|NCT01301612|carcinoma or adenocarcinoma or uterine cervix adenosquamous carcinoma|carcinoma or adenocarcinoma or uterine cervix adenosquamous carcinoma
5079877|NCT01301599|Benign Prostatic Hyperplasia|benign prostatic hyperplasia
5079878|NCT01301599|alpha blocker|alpha blocker
5079879|NCT01301599|5-alpha reductase inhibitor|5-alpha reductase inhibitor
5079880|NCT01301599|combination therapy|combination therapy
5079881|NCT01301560|Asymptomatic brain metastasis|asymptomatic brain metastasis
5079882|NCT01301560|NSCLC|nsclc
5079883|NCT01301560|GKS|gks
5079884|NCT01301534|abdominal aortic aneurysm|abdominal aortic aneurysm
5079885|NCT01301521|Pre-Diabetes|pre-diabetes
5079886|NCT01301521|cinnamon|cinnamon
5079887|NCT01301508|atopic dermatitis|atopic dermatitis
5079888|NCT01301495|Esophageal Cancer, Malignant, Dysphagia, Esophagus, Cancer|esophageal cancer, malignant, dysphagia, esophagus, cancer
5079889|NCT01301482|Acute Sore Throat|acute sore throat
5079890|NCT01301482|Ear Acupuncture|ear acupuncture
5079891|NCT01301456|Phase 1|phase 1
5079892|NCT01301456|Type 2 Diabetes|type 2 diabetes
5079893|NCT01301456|CVX-096|cvx-096
5079894|NCT01301443|Age Related Macular Degeneration|age related macular degeneration
5079895|NCT01301430|Progressive glioblastoma multiforme|progressive glioblastoma multiforme
5079896|NCT01301430|Recurrent glioblastoma multiforme|recurrent glioblastoma multiforme
5079897|NCT01301430|Oncolytic virus|oncolytic virus
5079898|NCT01301417|Compression Anastomosis|compression anastomosis
5079899|NCT01301404|Postoperative nausea and vomiting (PONV)|postoperative nausea and vomiting (ponv)
5079900|NCT01301404|Spinal morphine|spinal morphine
5079901|NCT01301404|Total knee replacement (TKR)|total knee replacement (tkr)
5079902|NCT01301404|blood sugar|blood sugar
5079903|NCT01301404|carbohydrate drink|carbohydrate drink
5079904|NCT01301391|B3 and C malignant thymoma|b3 and c malignant thymoma
5079905|NCT01301365|autonomic response|autonomic response
5079906|NCT01301352|Critical Care|critical care
5079907|NCT01301352|Intubation, gastrointestinal|intubation, gastrointestinal
5079908|NCT01301352|Child|child
5079909|NCT01301352|Infant|infant
5079910|NCT01301352|Adolescent|adolescent
5079911|NCT01301352|Continuous positive airway pressure|continuous positive airway pressure
5079912|NCT01301352|Enteral Nutrition|enteral nutrition
5079913|NCT01301339|Pre-Diabetes|pre-diabetes
5079914|NCT01301339|Diabetes|diabetes
5079915|NCT01301339|cardiovascular risks|cardiovascular risks
5079916|NCT01301326|retinal arterial macroaneurysm|retinal arterial macroaneurysm
5079917|NCT01301326|laser treatment|laser treatment
5079918|NCT01301313|Acute heart failure|acute heart failure
5079919|NCT01301313|Children|children
5079920|NCT01301313|Levosimendan|levosimendan
5079921|NCT01301313|Inotropic treatment|inotropic treatment
5079922|NCT01301274|hyponatremia|hyponatremia
5079923|NCT01301274|maintenance solutions|maintenance solutions
5079924|NCT01301274|pediatrics|pediatrics
5079925|NCT01301261|Sugammadex|sugammadex
5079926|NCT01301261|entropy|entropy
5079927|NCT01301261|bispectral index|bispectral index
5079928|NCT01301261|blood pressure|blood pressure
5079929|NCT01301261|heart rate|heart rate
5079930|NCT01301261|oxygenation|oxygenation
5079931|NCT01301261|end-tidal CO2|end-tidal co2
5079932|NCT01301261|hemodynamics|hemodynamics
5079933|NCT01301261|general anesthesia|general anesthesia
5079934|NCT01301248|locally advanced,|locally advanced,
5079935|NCT01301248|unresectable,|unresectable,
5079936|NCT01301248|head and neck squamous cell carcinoma,|head and neck squamous cell carcinoma,
5079937|NCT01301248|stage III/IV|stage iii/iv
5079938|NCT01301235|Mitochondria|mitochondria
5079939|NCT01301222|octreotide|octreotide
5079940|NCT01301222|pancreatic fistula|pancreatic fistula
5079941|NCT01301222|soft pancreas|soft pancreas
5079942|NCT01301222|pancreatoduodenectomy|pancreatoduodenectomy
5079943|NCT01301196|sedentary behaviour|sedentary behaviour
5079944|NCT01301196|diabetes|diabetes
5079945|NCT01301196|structured education|structured education
5079946|NCT01301196|18-30 years olds|18-30 years olds
5079947|NCT01301196|family history of T2DM or CVD|family history of t2dm or cvd
5079948|NCT01301196|BMI ≥ 25 (≥23 for south Asians)|bmi ≥ 25 (≥23 for south asians)
5079949|NCT01301183|Anorexia Nervosa|anorexia nervosa
5079950|NCT01301183|Estrogen|estrogen
5079951|NCT01301183|Teenagers|teenagers
5079952|NCT01301183|IGF-1|igf-1
5079953|NCT01301170|Neck pain|neck pain
5079954|NCT01301170|Dry Needling|dry needling
5079955|NCT01301170|Manual Therapy|manual therapy
5079956|NCT01301170|Manipulation|manipulation
5079957|NCT01301144|Tuberculosis|tuberculosis
5079958|NCT01301144|Urea Breath Test|urea breath test
5079959|NCT01301118|Transplantation Infection|transplantation infection
5079960|NCT01301118|Wound of skin|wound of skin
5079961|NCT01301118|Burns|burns
5079962|NCT01301118|Graft Loss|graft loss
5079963|NCT01301118|Infection|infection
5079964|NCT01301105|pain regulation|pain regulation
5079965|NCT01301105|social stress|social stress
5079966|NCT01301105|affect|affect
5079967|NCT01301105|attention|attention
5079968|NCT01301105|brain|brain
5079969|NCT01301105|immune|immune
5079970|NCT01301105|endocrine|endocrine
5079971|NCT01301079|Remifentanil|remifentanil
5079972|NCT01301079|Hyperalgesia|hyperalgesia
5079973|NCT01301079|Ketamine|ketamine
5079974|NCT01301079|Von Frey's filament|von frey's filament
5079975|NCT01301079|Algometer|algometer
5079976|NCT01301079|Interleukines|interleukines
5079977|NCT01301079|Opioid-induced hyperalgesia|opioid-induced hyperalgesia
5079978|NCT01301053|hyperglycemia and increased mortality in the ICU|hyperglycemia and increased mortality in the icu
5079979|NCT01301053|hypoglycemia and increased mortality in the ICU|hypoglycemia and increased mortality in the icu
5079980|NCT01301053|glucose variability and increased mortality in the ICU|glucose variability and increased mortality in the icu
5079981|NCT01301053|Continuous Glucose Monitoring (CGM) and hypoglycemia|continuous glucose monitoring (cgm) and hypoglycemia
5079982|NCT01301053|hypoglycemia|hypoglycemia
5079983|NCT01301053|reducing ICU mortality|reducing icu mortality
5079984|NCT01301040|breast cancer, elderly, early cardiac toxicity|breast cancer, elderly, early cardiac toxicity
5079985|NCT01301027|End stage renal disease|end stage renal disease
5079986|NCT01301027|Hemodialysis|hemodialysis
5079987|NCT01301027|Pioglitazone|pioglitazone
5079988|NCT01301027|Adipokines|adipokines
5079989|NCT01301014|accuracy, anterior cruciate ligament, diagnostic value, examination, knee, Lachman test, sensitivity, specificity|accuracy, anterior cruciate ligament, diagnostic value, examination, knee, lachman test, sensitivity, specificity
5079990|NCT01301001|Vulvodynia|vulvodynia
5079991|NCT01300988|HIV infection|hiv infection
5079992|NCT01300988|Neurokinin-1 receptor antagonist|neurokinin-1 receptor antagonist
5079993|NCT01300988|CCR5 expression|ccr5 expression
5079994|NCT01300988|Treatment Naive|treatment naive
5079995|NCT01300975|Leishmaniasis|leishmaniasis
5079996|NCT01300975|intralesional antimony|intralesional antimony
5079997|NCT01300975|cryotherapy|cryotherapy
5079998|NCT01300962|Xeloda|xeloda
5079999|NCT01300962|Capecitabine|capecitabine
5080000|NCT01300962|BKM120|bkm120
5080001|NCT01300962|Lineberger Comprehensive Cancer Center|lineberger comprehensive cancer center
5080002|NCT01300962|Metastatic|metastatic
5080003|NCT01300962|BYL719 Breast Cancer|byl719 breast cancer
5080004|NCT01300949|Contrast Sensitivity|contrast sensitivity
5080005|NCT01300949|Pelli-Robson Test|pelli-robson test
5080006|NCT01300923|Fragile X Syndrome|fragile x syndrome
5080007|NCT01300923|Acamprosate|acamprosate
5080008|NCT01300910|Adult Males|adult males
5080009|NCT01300910|Circumcision|circumcision
5080010|NCT01300910|HIV prevention|hiv prevention
5080011|NCT01300910|Device|device
5080012|NCT01300910|Shang Ring|shang ring
5080117|NCT01300429|core biopsy|core biopsy
5080219|NCT01300013|IV|iv
5080013|NCT01300897|cortical evoked potentials, motor evoked potential responses|cortical evoked potentials, motor evoked potential responses
5080014|NCT01300845|Oxygen mask|oxygen mask
5080015|NCT01300845|Oxygen cannula|oxygen cannula
5080016|NCT01300845|Humidification|humidification
5080017|NCT01300845|Oxygen therapy|oxygen therapy
5080018|NCT01300845|Intensive Care Unit|intensive care unit
5080019|NCT01300832|Surgery|surgery
5080020|NCT01300832|Deep Vein Thrombosis|deep vein thrombosis
5080021|NCT01300832|Preoperative|preoperative
5080022|NCT01300819|Rotigotine|rotigotine
5080023|NCT01300819|Neupro®|neupro®
5080024|NCT01300819|Non-motor symptoms|non-motor symptoms
5080025|NCT01300806|HIV|hiv
5080026|NCT01300806|harmful substance use|harmful substance use
5080027|NCT01300793|V-RICE|v-rice
5080028|NCT01300793|Relapsed NHL|relapsed nhl
5080029|NCT01300793|Primary Refractory NHL|primary refractory nhl
5080030|NCT01300780|bleaching agent|bleaching agent
5080031|NCT01300780|tooth bleaching|tooth bleaching
5080032|NCT01300780|sensibility|sensibility
5080033|NCT01300754|Osgood-Schlatter|osgood-schlatter
5080034|NCT01300754|Tendinosis|tendinosis
5080035|NCT01300754|Apophysitis|apophysitis
5080036|NCT01300754|Enthesopathy|enthesopathy
5080037|NCT01300754|Dextrose.|dextrose.
5080038|NCT01300728|Intravenous immunotherapy|intravenous immunotherapy
5080039|NCT01300728|Conversion to Alzheimer Disease|conversion to alzheimer disease
5080040|NCT01300715|zygapophysial joint|zygapophysial joint
5080041|NCT01300715|facet joint|facet joint
5080042|NCT01300715|low back pain|low back pain
5080043|NCT01300715|radiofrequency|radiofrequency
5080044|NCT01300715|neurotomy|neurotomy
5080045|NCT01300689|HPV|hpv
5080046|NCT01300689|MSM|msm
5080047|NCT01300689|Vaccine|vaccine
5080048|NCT01300689|China|china
5080049|NCT01300676|Tualang honey|tualang honey
5080050|NCT01300676|HRT|hrt
5080051|NCT01300676|safety profiles|safety profiles
5080052|NCT01300676|cardiovascular parameters|cardiovascular parameters
5080053|NCT01300676|hormonal levels|hormonal levels
5080054|NCT01300676|bone changes|bone changes
5080055|NCT01300676|postmenopausal women|postmenopausal women
5080056|NCT01300650|Heart failure|heart failure
5080057|NCT01300650|Inflammation|inflammation
5080058|NCT01300650|Interleukin-1|interleukin-1
5080059|NCT01300650|Cardiopulmonary exercise|cardiopulmonary exercise
5080060|NCT01300637|schizophrenia|schizophrenia
5080061|NCT01300637|clozapine|clozapine
5080062|NCT01300637|metabolic dysregulation|metabolic dysregulation
5080063|NCT01300637|metformin|metformin
5080064|NCT01300624|Aphasia|aphasia
5080065|NCT01300624|therapy|therapy
5080066|NCT01300624|treatment|treatment
5080067|NCT01300624|verbs|verbs
5080068|NCT01300624|sentences|sentences
5080069|NCT01300611|Double Cord Blood Transplantation|double cord blood transplantation
5080070|NCT01300611|Neutrophil Engraftment|neutrophil engraftment
5080071|NCT01300611|Platelet Engraftment|platelet engraftment
5080072|NCT01300611|Immune Reconstitution|immune reconstitution
5080073|NCT01300611|Mucositis|mucositis
5080074|NCT01300585|Breast|breast
5080075|NCT01300585|Cancer|cancer
5080076|NCT01300559|efficacy|efficacy
5080077|NCT01300559|hemoglobin|hemoglobin
5080078|NCT01300559|spine|spine
5080079|NCT01300546|Frequent migraine|frequent migraine
5080080|NCT01300546|Migraine transformation|migraine transformation
5080081|NCT01300546|Migraine|migraine
5080082|NCT01300546|Treximet|treximet
5080083|NCT01300546|Naproxen|naproxen
5080084|NCT01300546|Sumatriptan|sumatriptan
5080085|NCT01300533|Cancer|cancer
5080086|NCT01300533|Neoplasms|neoplasms
5080087|NCT01300533|Solid Tumor|solid tumor
5080088|NCT01300533|Ovarian Cancer|ovarian cancer
5080089|NCT01300533|Lung Cancer|lung cancer
5080090|NCT01300533|Non-Small Cell Lung Cancer|non-small cell lung cancer
5080091|NCT01300533|Pancreatic Cancer|pancreatic cancer
5080092|NCT01300533|Breast Cancer|breast cancer
5080093|NCT01300533|Endometrial Cancer|endometrial cancer
5080094|NCT01300533|Melanoma|melanoma
5080095|NCT01300533|Prostate Cancer|prostate cancer
5080096|NCT01300533|Skin Cancer|skin cancer
5080097|NCT01300533|Head and Neck Cancer|head and neck cancer
5080098|NCT01300533|Solid Malignancies|solid malignancies
5080099|NCT01300520|Fluoroscopy|fluoroscopy
5080100|NCT01300520|Femoral fracture|femoral fracture
5080101|NCT01300520|Tibial fracture|tibial fracture
5080102|NCT01300520|Spinal Fusion|spinal fusion
5080103|NCT01300507|stent thrombosis|stent thrombosis
5080104|NCT01300507|intra coronary imaging|intra coronary imaging
5080105|NCT01300507|blood platelet function testing|blood platelet function testing
5080106|NCT01300494|bifurcation lesion|bifurcation lesion
5080107|NCT01300494|optimal viewing angle|optimal viewing angle
5080108|NCT01300494|automated software|automated software
5080109|NCT01300468|advanced/metastatic solid tumors|advanced/metastatic solid tumors
5080110|NCT01300455|Insomnia|insomnia
5080111|NCT01300455|obstructive sleep apnea|obstructive sleep apnea
5080112|NCT01300455|orexin receptor antagonist|orexin receptor antagonist
5080113|NCT01300442|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
5080114|NCT01300442|diaphragm|diaphragm
5080115|NCT01300442|electrical stimulation|electrical stimulation
5080116|NCT01300442|pulmonary rehabilitation|pulmonary rehabilitation
5080118|NCT01300429|Resistance to Crizotinib|resistance to crizotinib
5080119|NCT01300429|Non-small Cell Lung Cancer|non-small cell lung cancer
5080120|NCT01300429|11-014|11-014
5080121|NCT01300416|Kidney transplantation|kidney transplantation
5080122|NCT01300416|mycophenolate sodium|mycophenolate sodium
5080123|NCT01300416|EC-MPS|ec-mps
5080124|NCT01300416|Health Related Quality of Life|health related quality of life
5080125|NCT01300416|GI symptoms|gi symptoms
5080126|NCT01300416|Immunosuppressants|immunosuppressants
5080127|NCT01300416|HRQL|hrql
5080128|NCT01300416|PGWB|pgwb
5080129|NCT01300416|GIQLI|giqli
5080130|NCT01300390|liver transplant|liver transplant
5080131|NCT01300390|end-stage liver disease|end-stage liver disease
5080132|NCT01300390|cirrhosis|cirrhosis
5080133|NCT01300377|Post-operative pain|post-operative pain
5080134|NCT01300377|pain|pain
5080135|NCT01300377|pacemaker|pacemaker
5080136|NCT01300377|defibrillator|defibrillator
5080137|NCT01300377|post-operative narcotic use|post-operative narcotic use
5080138|NCT01300377|local anesthesia|local anesthesia
5080139|NCT01300351|Advanced breast cancer|advanced breast cancer
5080140|NCT01300351|metastatic breast cancer|metastatic breast cancer
5080141|NCT01300338|Diabetes|diabetes
5080142|NCT01300325|Bronchiolitis, 3% Hypertonic Saline Solution|bronchiolitis, 3% hypertonic saline solution
5080143|NCT01300312|eperisone|eperisone
5080144|NCT01300312|diclofenac|diclofenac
5080145|NCT01300312|low back pain|low back pain
5080146|NCT01300299|lung cancer|lung cancer
5080147|NCT01300299|radiation|radiation
5080148|NCT01300299|stereotactic|stereotactic
5080149|NCT01300273|Diabetic nephropathy|diabetic nephropathy
5080150|NCT01300273|Podocyte|podocyte
5080151|NCT01300273|Low Protein Diet|low protein diet
5080152|NCT01300273|Ketoanalogs|ketoanalogs
5080153|NCT01300234|tenofovir disoproxil fumarate|tenofovir disoproxil fumarate
5080154|NCT01300234|chronic hepatitis B|chronic hepatitis b
5080155|NCT01300234|adefovir dipivoxil|adefovir dipivoxil
5080156|NCT01300221|Three dimension echocardiography|three dimension echocardiography
5080157|NCT01300221|Congenital heart disease|congenital heart disease
5080158|NCT01300221|Z-score|z-score
5080159|NCT01300208|cutaneous lupus erythematosus|cutaneous lupus erythematosus
5080160|NCT01300208|subacute lupus erythematosus|subacute lupus erythematosus
5080161|NCT01300208|discoid lupus erythematosus|discoid lupus erythematosus
5080162|NCT01300208|lupus|lupus
5080163|NCT01300195|VATS|vats
5080164|NCT01300195|standardized surgery|standardized surgery
5080165|NCT01300195|persistent pain|persistent pain
5080166|NCT01300182|ACLR|aclr
5080167|NCT01300169|Suicide|suicide
5080168|NCT01300169|Assessment|assessment
5080169|NCT01300169|Intervention|intervention
5080170|NCT01300169|CAMS|cams
5080171|NCT01300156|Hodgkin's disease|hodgkin's disease
5080172|NCT01300156|lymphoma|lymphoma
5080173|NCT01300156|Relapsed|relapsed
5080174|NCT01300156|refractory|refractory
5080175|NCT01300130|neurological development|neurological development
5080176|NCT01300130|preterm infants|preterm infants
5080177|NCT01300130|fatty acid status|fatty acid status
5080178|NCT01300117|cardiac surgery|cardiac surgery
5080179|NCT01300117|adamts13|adamts13
5080180|NCT01300117|TTP|ttp
5080181|NCT01300117|extracorporeal circulation|extracorporeal circulation
5080182|NCT01300117|Heart-Lung Machine|heart-lung machine
5080183|NCT01300104|prostate cancer progression|prostate cancer progression
5080184|NCT01300104|active surveillance|active surveillance
5080185|NCT01300104|whole grain rye|whole grain rye
5080186|NCT01300104|exercise|exercise
5080187|NCT01300104|insulin sensitivity|insulin sensitivity
5080188|NCT01300104|quality of life|quality of life
5080189|NCT01300091|Shoulder|shoulder
5080190|NCT01300091|Pain|pain
5080191|NCT01300091|Range of Motion|range of motion
5080192|NCT01300091|Disability Evaluation|disability evaluation
5080193|NCT01300091|Function|function
5080194|NCT01300091|Sick Leave|sick leave
5080195|NCT01300091|Primary Health Care|primary health care
5080196|NCT01300091|Visual Analog Scale|visual analog scale
5080197|NCT01300091|Visual Analog Pain Scale|visual analog pain scale
5080198|NCT01300091|The American Shoulder and Elbow Surgeons Standardized Shoulder Assessment Form|the american shoulder and elbow surgeons standardized shoulder assessment form
5080199|NCT01300078|Hot Flashes|hot flashes
5080200|NCT01300078|Hot Flushes|hot flushes
5080201|NCT01300078|Vasomotor Symptoms|vasomotor symptoms
5080202|NCT01300078|Menopausal Symptoms|menopausal symptoms
5080203|NCT01300052|psoriasis|psoriasis
5080204|NCT01300039|nephrolithiasis|nephrolithiasis
5080205|NCT01300039|urolithiasis|urolithiasis
5080206|NCT01300039|hyperoxaluria|hyperoxaluria
5080207|NCT01300039|Helicobacter pylori|helicobacter pylori
5080208|NCT01300026|Low intermediate grade B cell Lymphoma|low intermediate grade b cell lymphoma
5080209|NCT01300026|Non-cutaneous T-cell NHL|non-cutaneous t-cell nhl
5080210|NCT01300026|Mantle Cell Lymphoma|mantle cell lymphoma
5080211|NCT01300026|PI3K delta|pi3k delta
5080212|NCT01300026|Lymphoid|lymphoid
5080213|NCT01300026|NHL|nhl
5080214|NCT01300026|MCL|mcl
5080215|NCT01300026|Hematologic|hematologic
5080216|NCT01300026|CLL|cll
5080217|NCT01300026|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
5080218|NCT01300013|Intravenous|intravenous
5080220|NCT01300013|Left Ventricular Systolic Dysfunction|left ventricular systolic dysfunction
5080221|NCT01300013|Hospitalized|hospitalized
5080222|NCT01300013|Acute heart failure|acute heart failure
5080223|NCT01300013|Heart failure|heart failure
5080224|NCT01300013|Left ventricular ejection fraction|left ventricular ejection fraction
5080225|NCT01300013|pharmacokinetics|pharmacokinetics
5080226|NCT01300013|Pharmacodynamics|pharmacodynamics
5080227|NCT01300013|Dyspnea|dyspnea
5080228|NCT01300013|hospitalization|hospitalization
5080229|NCT01300013|In-patient|in-patient
5080230|NCT01300013|Omecamtiv mecarbil|omecamtiv mecarbil
5080231|NCT01300013|Double-blind|double-blind
5080232|NCT01300013|Randomized|randomized
5080233|NCT01300013|Placebo-controlled|placebo-controlled
5080234|NCT01299987|Keywords provided by University Hospital Mannheim:|keywords provided by university hospital mannheim:
5080235|NCT01299987|Intraoperative Radiotherapy|intraoperative radiotherapy
5080236|NCT01299987|Early Breast Cancer|early breast cancer
5080237|NCT01299987|Elderly Patients|elderly patients
5080238|NCT01299974|Family-centered|family-centered
5080239|NCT01299974|teaching|teaching
5080240|NCT01299974|residents|residents
5080241|NCT01299974|family faculty|family faculty
5080242|NCT01299961|Rheumatoid Arthritis|rheumatoid arthritis
5080243|NCT01299961|Subcutaneous Abatacept|subcutaneous abatacept
5080244|NCT01299961|Ultrasound|ultrasound
5080245|NCT01299948|HIV|hiv
5080246|NCT01299948|AIDS|aids
5080247|NCT01299948|CD4|cd4
5080248|NCT01299948|progression|progression
5080249|NCT01299948|immune activation|immune activation
5080250|NCT01299935|stress reduction|stress reduction
5080251|NCT01299935|Transcendental Meditation technique|transcendental meditation technique
5080252|NCT01299935|secondary prevention of coronary heart disease|secondary prevention of coronary heart disease
5080253|NCT01299922|Lupus nephritis|lupus nephritis
5080254|NCT01299922|Therapy|therapy
5080255|NCT01299922|Cyclosporin|cyclosporin
5080256|NCT01299922|Mycophenolic acid|mycophenolic acid
5080257|NCT01299909|Mindfulness Training for Smokers|mindfulness training for smokers
5080258|NCT01299909|Smoking|smoking
5080259|NCT01299909|Smoking cessation|smoking cessation
5080260|NCT01299909|Addiction|addiction
5080261|NCT01299909|behavioral intervention|behavioral intervention
5080262|NCT01299909|Nicotine|nicotine
5080263|NCT01299909|Tobacco|tobacco
5080264|NCT01299909|Mindfulness|mindfulness
5080265|NCT01299909|Meditation|meditation
5080266|NCT01299909|MBSR|mbsr
5080267|NCT01299909|Mindfulness Based Stress Reduction|mindfulness based stress reduction
5080268|NCT01299909|Mindfulness Based Cognitive Therapy|mindfulness based cognitive therapy
5080269|NCT01299909|MBCT|mbct
5080270|NCT01299909|Mindfulness Based Relapse Prevention|mindfulness based relapse prevention
5080271|NCT01299909|MBRP|mbrp
5080272|NCT01299909|Mindfulness Training|mindfulness training
5080273|NCT01299909|Nicotine Patch|nicotine patch
5080274|NCT01299909|Quit Line|quit line
5080275|NCT01299909|Phone counseling|phone counseling
5080276|NCT01299909|Freedom from Smoking|freedom from smoking
5080277|NCT01299896|Cigarette Smoking|cigarette smoking
5080278|NCT01299896|Smoking, Tobacco|smoking, tobacco
5080279|NCT01299896|Tobacco Smoking|tobacco smoking
5080280|NCT01299896|Smoking Cessation|smoking cessation
5080281|NCT01299896|Tobacco Dependence|tobacco dependence
5080282|NCT01299883|Cancer|cancer
5080283|NCT01299883|CVD|cvd
5080284|NCT01299883|African American|african american
5080285|NCT01299883|Health Education Intervention|health education intervention
5080286|NCT01299883|Intervention RCT|intervention rct
5080287|NCT01299883|Study focus is to examine the influence of health education regarding either CVD or CVD and cancer on health behaviors.|study focus is to examine the influence of health education regarding either cvd or cvd and cancer on health behaviors.
5080288|NCT01299857|pemphigus|pemphigus
5080289|NCT01299857|Mabthéra (R)|mabthéra (r)
5080290|NCT01299857|B lymphocytes|b lymphocytes
5080291|NCT01299857|desmogleines|desmogleines
5080292|NCT01299844|Type 2 Diabetes|type 2 diabetes
5080293|NCT01299818|central pain|central pain
5080294|NCT01299818|spine surgey|spine surgey
5080295|NCT01299818|outcome|outcome
5080296|NCT01299818|patients undergo spinal surgery|patients undergo spinal surgery
5080297|NCT01299805|Drug Therapy|drug therapy
5080298|NCT01299805|pharmacodynamic|pharmacodynamic
5080299|NCT01299792|spinal cord injury|spinal cord injury
5080300|NCT01299792|urodynamics|urodynamics
5080301|NCT01299792|ultrasound|ultrasound
5080302|NCT01299792|neurogenic bladder dysfunction|neurogenic bladder dysfunction
5080303|NCT01299779|hyponatremia|hyponatremia
5080304|NCT01299779|PEG-SD|peg-sd
5080305|NCT01299779|PEG-ELS|peg-els
5080306|NCT01299766|Mild Cognitive Impairment|mild cognitive impairment
5080307|NCT01299766|Memory|memory
5080308|NCT01299727|Recombinant Human Heparan N-Sulfatase (rhHNS)|recombinant human heparan n-sulfatase (rhhns)
5080309|NCT01299727|Sanfilippo Syndrome Type A (MPS IIIA)|sanfilippo syndrome type a (mps iiia)
5080310|NCT01299727|Lysosomal storage disease (LSD)|lysosomal storage disease (lsd)
5080311|NCT01299727|Mucopolysaccharidosis (MPS) III|mucopolysaccharidosis (mps) iii
5080312|NCT01299714|Human Papilloma Virus|human papilloma virus
5080313|NCT01299714|vaccine|vaccine
5080314|NCT01299714|stress|stress
5080315|NCT01299714|cervical cancer|cervical cancer
5080316|NCT01299714|GARDASIL|gardasil
5080317|NCT01299701|Advanced or metastatic cancer|advanced or metastatic cancer
5080318|NCT01299701|refractory|refractory
5080319|NCT01299701|core phase|core phase
5080320|NCT01299701|extension phase|extension phase
5080321|NCT01299701|dose escalation|dose escalation
5080322|NCT01299701|standard chemotherapy|standard chemotherapy
5080323|NCT01299701|docetaxel|docetaxel
5080324|NCT01299701|paclitaxel|paclitaxel
5080325|NCT01299701|carboplatin|carboplatin
5080326|NCT01299701|safety|safety
5080327|NCT01299701|tolerability|tolerability
5080328|NCT01299675|MR conditional|mr conditional
5080329|NCT01299649|CAD|cad
5080330|NCT01299636|PM060184|pm060184
5080331|NCT01299636|Phase I|phase i
5080332|NCT01299636|Pharma Mar|pharma mar
5080333|NCT01299623|breast cancer|breast cancer
5080334|NCT01299623|breast cancer prevention|breast cancer prevention
5080335|NCT01299623|African American women|african american women
5080336|NCT01299610|Atopic Dermatitis|atopic dermatitis
5080337|NCT01299610|GW870086X|gw870086x
5080338|NCT01299610|TIS|tis
5080339|NCT01299610|IGA|iga
5080340|NCT01299597|repeat dose|repeat dose
5080341|NCT01299597|statins|statins
5080342|NCT01299597|safety and tolerability|safety and tolerability
5080343|NCT01299597|drug interaction|drug interaction
5080344|NCT01299597|sb649868|sb649868
5080345|NCT01299597|healthy male subjects|healthy male subjects
5080346|NCT01299597|pharmacokinetics|pharmacokinetics
5080347|NCT01299558|pharmacokinetics|pharmacokinetics
5080348|NCT01299558|GW642444|gw642444
5080349|NCT01299558|absolute bioavailability|absolute bioavailability
5080350|NCT01299558|healthy subjects|healthy subjects
5080351|NCT01299558|fluticasone furoate|fluticasone furoate
5080352|NCT01299558|GW685698|gw685698
5080353|NCT01299545|Rheumatoid Arthritis|rheumatoid arthritis
5080354|NCT01299545|Anti TNF|anti tnf
5080355|NCT01299545|Infliximab|infliximab
5080356|NCT01299545|Methotrexate|methotrexate
5080357|NCT01299545|DMARDs|dmards
5080358|NCT01299545|Gene expression biomarkers|gene expression biomarkers
5080359|NCT01299519|obesity|obesity
5080360|NCT01299519|weight loss|weight loss
5080361|NCT01299519|insulin resistance|insulin resistance
5080362|NCT01299506|soft tissue sarcoma|soft tissue sarcoma
5080363|NCT01299506|trabectedin|trabectedin
5080364|NCT01299506|Netherlands|netherlands
5080365|NCT01299493|carcinoma|carcinoma
5080366|NCT01299493|colorectal cancer|colorectal cancer
5080367|NCT01299493|community health centers|community health centers
5080368|NCT01299493|cluster-randomized|cluster-randomized
5080369|NCT01299493|health behavior|health behavior
5080370|NCT01299480|Healthy adolescents|healthy adolescents
5080371|NCT01299467|Asthma|asthma
5080372|NCT01299467|duration of action|duration of action
5080373|NCT01299467|allergen challenge|allergen challenge
5080374|NCT01299428|CEREBRAL OXYGENATION|cerebral oxygenation
5080375|NCT01299428|HYPERNATREMİA|hypernatremia
5080376|NCT01299428|NEWBORN|newborn
5080377|NCT01299428|NA VALUES|na values
5080378|NCT01299415|ASA404,|asa404,
5080379|NCT01299415|Phase I,|phase i,
5080380|NCT01299415|Oncology,|oncology,
5080381|NCT01299415|CYP1A2,|cyp1a2,
5080382|NCT01299415|fluvoxamine,|fluvoxamine,
5080383|NCT01299415|drug drug interaction,|drug drug interaction,
5080384|NCT01299415|Novartis,|novartis,
5080385|NCT01299415|Antisoma|antisoma
5080386|NCT01299389|Paliperidone palmitate|paliperidone palmitate
5080387|NCT01299389|Schizophrenia|schizophrenia
5080388|NCT01299376|Essential hypertension|essential hypertension
5080389|NCT01299376|Antihypertensive agents|antihypertensive agents
5080390|NCT01299376|Blood pressure|blood pressure
5080391|NCT01299376|Uncontrolled hypertension|uncontrolled hypertension
5080392|NCT01299363|Prolapse|prolapse
5080393|NCT01299363|Pain with intercourse|pain with intercourse
5080394|NCT01299363|Dyspareunia|dyspareunia
5080395|NCT01299363|Post operative pain|post operative pain
5080396|NCT01299350|Heart failure|heart failure
5080397|NCT01299350|Nt-proBNP|nt-probnp
5080398|NCT01299324|CHF|chf
5080399|NCT01299311|insulin sensitivity|insulin sensitivity
5080400|NCT01299285|Absorption|absorption
5080401|NCT01299285|Distribution|distribution
5080402|NCT01299285|Metabolism|metabolism
5080403|NCT01299285|Excretion|excretion
5080404|NCT01299285|Mass balance|mass balance
5080405|NCT01299285|Metabolic profile|metabolic profile
5080406|NCT01299285|Radiolabeled study|radiolabeled study
5080407|NCT01299285|14C|14c
5080408|NCT01299259|Text message reminders|text message reminders
5080409|NCT01299259|Pelvic inflammatory disease|pelvic inflammatory disease
5080410|NCT01299259|PID|pid
5080411|NCT01299259|Primary care follow-up|primary care follow-up
5080412|NCT01299259|Emergency department care|emergency department care
5080413|NCT01299259|Discharge instructions|discharge instructions
5080414|NCT01299246|Diabetic Foot|diabetic foot
5080415|NCT01299246|non-invasive DFP assessment tools|non-invasive dfp assessment tools
5080416|NCT01299246|early detection of DFP|early detection of dfp
5080417|NCT01299220|Erlotinib|erlotinib
5080418|NCT01299220|Acitretin|acitretin
5080419|NCT01299220|Rash|rash
5080420|NCT01299220|Dermatology|dermatology
5080421|NCT01299220|Oncology|oncology
5080422|NCT01299207|Stents|stents
5080799|NCT01297504|palivizumab|palivizumab
5080423|NCT01299207|Drug-Eluting Stents|drug-eluting stents
5080424|NCT01299207|Stent Thrombosis|stent thrombosis
5080425|NCT01299207|Bleeding|bleeding
5080426|NCT01299207|Dual-Antiplatelet Therapy|dual-antiplatelet therapy
5080427|NCT01299194|BRONCHIECTASIS|bronchiectasis
5080428|NCT01299194|PSEUDOMONAS AERUGINOSA|pseudomonas aeruginosa
5080429|NCT01299194|STATIN|statin
5080430|NCT01299194|OUTCOME|outcome
5080431|NCT01299181|Bronchiectasis|bronchiectasis
5080432|NCT01299181|Outcome|outcome
5080433|NCT01299181|Statin therapy|statin therapy
5080434|NCT01299168|global gene expression|global gene expression
5080435|NCT01299168|molecular diagnostic classifiers|molecular diagnostic classifiers
5080436|NCT01299155|Intraocular Lens|intraocular lens
5080437|NCT01299155|Presbyopia Correcting IOL|presbyopia correcting iol
5080438|NCT01299142|Influenza|influenza
5080439|NCT01299142|antibodies|antibodies
5080440|NCT01299142|monoclonal|monoclonal
5080441|NCT01299142|virus|virus
5080442|NCT01299129|Uveitis|uveitis
5080443|NCT01299129|Cystoid macular edema|cystoid macular edema
5080444|NCT01299129|microperimetry|microperimetry
5080445|NCT01299129|functional visual acuity|functional visual acuity
5080446|NCT01299129|intravitreal triamcinolone|intravitreal triamcinolone
5080447|NCT01299116|AE-adverse event|ae-adverse event
5080448|NCT01299116|FDA-(U.S.) Food and Drug Administration|fda-(u.s.) food and drug administration
5080449|NCT01299116|GCP-Good Clinical Practice guidelines|gcp-good clinical practice guidelines
5080450|NCT01299116|ICH-International Committee on Harmonisation|ich-international committee on harmonisation
5080451|NCT01299116|IRB-Institutional Review Board|irb-institutional review board
5080452|NCT01299116|IU-International units|iu-international units
5080453|NCT01299116|mg-milligram(s)|mg-milligram(s)
5080454|NCT01299116|mm3-cubic millimeter(s)|mm3-cubic millimeter(s)
5080455|NCT01299116|LARC-Long-Acting reversible contraception|larc-long-acting reversible contraception
5080456|NCT01299116|PPCNC-Planned Parenthood of North Carolina|ppcnc-planned parenthood of north carolina
5080457|NCT01299116|SAE-serious adverse event|sae-serious adverse event
5080458|NCT01299116|SARC-Short-Acting reversible contraception|sarc-short-acting reversible contraception
5080459|NCT01299116|µg-microgram|µg-microgram
5080460|NCT01299116|ULN-upper limit of the normal range|uln-upper limit of the normal range
5080461|NCT01299116|SubQ-subcutaneous|subq-subcutaneous
5080462|NCT01299103|wrinkle|wrinkle
5080463|NCT01299103|rhytide|rhytide
5080464|NCT01299090|wrinkles|wrinkles
5080465|NCT01299090|rhytides|rhytides
5080466|NCT01299077|Lumbar disc degenerative disease|lumbar disc degenerative disease
5080467|NCT01299077|Methycobal|methycobal
5080468|NCT01299064|mindfulness-based intervention|mindfulness-based intervention
5080469|NCT01299064|symptoms reduction|symptoms reduction
5080470|NCT01299064|mental health|mental health
5080471|NCT01299051|Weight Management|weight management
5080472|NCT01299051|Employee Health|employee health
5080473|NCT01299038|Crestor|crestor
5080474|NCT01299038|TFBP|tfbp
5080475|NCT01299038|rosuvastatin|rosuvastatin
5080476|NCT01299025|balance|balance
5080477|NCT01299025|walking|walking
5080478|NCT01298999|Barrett's Esophagus|barrett's esophagus
5080479|NCT01298999|Esophageal Adenocarcinoma|esophageal adenocarcinoma
5080480|NCT01298999|GERD|gerd
5080481|NCT01298999|Acid Reflux|acid reflux
5080482|NCT01298986|atrial fibrillation ablation procedures|atrial fibrillation ablation procedures
5080483|NCT01298960|Poor Ovarian response in IVF|poor ovarian response in ivf
5080484|NCT01298960|Metaphase II oocytes|metaphase ii oocytes
5080485|NCT01298960|Pregnancy Rate|pregnancy rate
5080486|NCT01298960|Growth Hormone|growth hormone
5080487|NCT01298947|Photoablative Atherectomy|photoablative atherectomy
5080488|NCT01298947|Paclitaxel-Coated Balloon|paclitaxel-coated balloon
5080489|NCT01298947|Instent Femoro-popliteal Obstructions|instent femoro-popliteal obstructions
5080490|NCT01298921|Headache|headache
5080491|NCT01298921|Cluster Headache|cluster headache
5080492|NCT01298921|Oxygen Therapy|oxygen therapy
5080493|NCT01298908|varicose veins, oedema|varicose veins, oedema
5080494|NCT01298895|optical components|optical components
5080495|NCT01298895|pseudoexfoliation|pseudoexfoliation
5080496|NCT01298895|cataract|cataract
5080497|NCT01298895|LENSTAR® LS 900®|lenstar® ls 900®
5080498|NCT01298882|Type 2 diabetes mellitus|type 2 diabetes mellitus
5080499|NCT01298882|Overweight|overweight
5080500|NCT01298882|Obesity|obesity
5080501|NCT01298869|CKD|ckd
5080502|NCT01298869|HPV infection|hpv infection
5080503|NCT01298869|HPV vaccine|hpv vaccine
5080504|NCT01298869|antibodies titer|antibodies titer
5080505|NCT01298856|hydrotherapy|hydrotherapy
5080506|NCT01298856|chronic ankle instability|chronic ankle instability
5080507|NCT01298856|ankle taping|ankle taping
5080508|NCT01298843|Confirmed or Suspected Infections|confirmed or suspected infections
5080509|NCT01298817|Obesity|obesity
5080510|NCT01298817|Aging|aging
5080511|NCT01298817|Soy|soy
5080512|NCT01298817|Weight Loss|weight loss
5080513|NCT01298817|Ectopic Fat|ectopic fat
5080514|NCT01298778|chronic pain post delivery|chronic pain post delivery
5080515|NCT01298778|postpartum depression|postpartum depression
5080516|NCT01298778|tailored pain management|tailored pain management
5080517|NCT01298765|buccal soluble film|buccal soluble film
5080518|NCT01298739|asthma control level , ACQ|asthma control level , acq
5080519|NCT01298726|PHARMACEUTICAL SERVICES|pharmaceutical services
5080520|NCT01298726|DIABETES MELLITUS|diabetes mellitus
5080521|NCT01298713|Hormonoresistance|hormonoresistance
5080522|NCT01298713|tamoxifen|tamoxifen
5080523|NCT01298713|Previously received anti-aromatase treatment|previously received anti-aromatase treatment
5080524|NCT01298713|mTor inhibitor|mtor inhibitor
5080525|NCT01298687|open-angle glaucoma|open-angle glaucoma
5080526|NCT01298687|ocular hypertension|ocular hypertension
5080527|NCT01298687|divided dose|divided dose
5080528|NCT01298661|Exercise Test|exercise test
5080529|NCT01298661|Reproducibility of Results|reproducibility of results
5080530|NCT01298661|Mortality|mortality
5080531|NCT01298648|Crohn's Disease|crohn's disease
5080532|NCT01298635|Primary angle-closure glaucoma|primary angle-closure glaucoma
5080533|NCT01298635|cataract|cataract
5080534|NCT01298635|trabeculectomy|trabeculectomy
5080535|NCT01298635|phacotrabeculectomy|phacotrabeculectomy
5080536|NCT01298609|Fibromyalgia|fibromyalgia
5080537|NCT01298609|Occipital Nerve Stimulation|occipital nerve stimulation
5080538|NCT01298570|Metastatic Colorectal Cancer|metastatic colorectal cancer
5080539|NCT01298570|K-RAS mutation|k-ras mutation
5080540|NCT01298570|BRAF mutation|braf mutation
5080541|NCT01298570|Regorafenib|regorafenib
5080542|NCT01298570|BAY 73-4506|bay 73-4506
5080543|NCT01298570|FOLFIRI|folfiri
5080544|NCT01298570|Irinotecan|irinotecan
5080545|NCT01298570|5-FU|5-fu
5080546|NCT01298570|Leucovorin|leucovorin
5080547|NCT01298570|Placebo|placebo
5080548|NCT01298570|Phase II|phase ii
5080549|NCT01298570|Multi-Center|multi-center
5080550|NCT01298570|Randomized|randomized
5080551|NCT01298570|Lineberger|lineberger
5080552|NCT01298570|North Carolina Cancer Hospital|north carolina cancer hospital
5080553|NCT01298570|UNC|unc
5080554|NCT01298557|Traumatic brain injury|traumatic brain injury
5080555|NCT01298557|Post-concussive symptoms|post-concussive symptoms
5080556|NCT01298557|Brain imaging|brain imaging
5080557|NCT01298557|Neurocognitive testing|neurocognitive testing
5080558|NCT01298544|Vaccine|vaccine
5080559|NCT01298544|Prevenar|prevenar
5080560|NCT01298544|Pneumococcal disease|pneumococcal disease
5080561|NCT01298531|Etanercept|etanercept
5080562|NCT01298531|Axial Spondyloarthritis|axial spondyloarthritis
5080563|NCT01298531|NSAIDs sparing effect|nsaids sparing effect
5080564|NCT01298518|multiple dose study in type 2 diabetes patients|multiple dose study in type 2 diabetes patients
5080565|NCT01298505|Phase 1 multiple dose safety toleration fexofenadine|phase 1 multiple dose safety toleration fexofenadine
5080566|NCT01298492|Active Crohn's disease|active crohn's disease
5080567|NCT01298492|Anti-TNF Refractory|anti-tnf refractory
5080568|NCT01298492|Immunosuppressant Refractory|immunosuppressant refractory
5080569|NCT01298479|volume delivery|volume delivery
5080570|NCT01298466|identification|identification
5080571|NCT01298466|chronic|chronic
5080572|NCT01298466|neuropathic|neuropathic
5080573|NCT01298466|low back pain|low back pain
5080574|NCT01298466|primary care|primary care
5080575|NCT01298466|pregabalin|pregabalin
5080576|NCT01298414|childhood acute myeloid leukemia/other myeloid malignancies|childhood acute myeloid leukemia/other myeloid malignancies
5080577|NCT01298401|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
5080578|NCT01298401|stage IIB pancreatic cancer|stage iib pancreatic cancer
5080579|NCT01298401|stage III pancreatic cancer|stage iii pancreatic cancer
5080580|NCT01298388|long-term effects secondary to cancer therapy in children|long-term effects secondary to cancer therapy in children
5080581|NCT01298388|cancer survivor|cancer survivor
5080582|NCT01298388|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5080583|NCT01298388|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
5080584|NCT01298388|T-cell childhood acute lymphoblastic leukemia|t-cell childhood acute lymphoblastic leukemia
5080585|NCT01298388|non-T, non-B childhood acute lymphoblastic leukemia|non-t, non-b childhood acute lymphoblastic leukemia
5080586|NCT01298388|non-T, non-B, cALLa positive childhood acute lymphoblastic leukemia|non-t, non-b, calla positive childhood acute lymphoblastic leukemia
5080587|NCT01298388|non-T, non-B, cALLa negative childhood acute lymphoblastic leukemia|non-t, non-b, calla negative childhood acute lymphoblastic leukemia
5080588|NCT01298388|non-T, non-B, cALLa positive, pre-B childhood acute lymphoblastic leukemia|non-t, non-b, calla positive, pre-b childhood acute lymphoblastic leukemia
5080589|NCT01298388|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
5080590|NCT01298375|Metabolic flexibility|metabolic flexibility
5080591|NCT01298375|Mitochondrial function|mitochondrial function
5080592|NCT01298375|Human primary myoblasts|human primary myoblasts
5080593|NCT01298375|Lipid metabolism|lipid metabolism
5080594|NCT01298336|Mycobacterium Xenopi Pulmonary Infection|mycobacterium xenopi pulmonary infection
5080595|NCT01298336|Clarithromycin|clarithromycin
5080596|NCT01298336|Moxifloxacin|moxifloxacin
5080597|NCT01298323|Medullary Thyroid Cancer|medullary thyroid cancer
5080598|NCT01298323|Locally advanced|locally advanced
5080599|NCT01298323|Metastatic|metastatic
5080600|NCT01298323|Vandetanib|vandetanib
5080601|NCT01298323|Patient Outreach|patient outreach
5080602|NCT01298310|Morton's neuroma, QST measurements|morton's neuroma, qst measurements
5080603|NCT01298297|Buprenorphine, acute pain, analgesia|buprenorphine, acute pain, analgesia
5080604|NCT01298284|Variceal bleeding|variceal bleeding
5080605|NCT01298284|portal hypertension|portal hypertension
5080606|NCT01298284|hepatocelluar carcinoma|hepatocelluar carcinoma
5080607|NCT01298284|endoscopic variceal ligation|endoscopic variceal ligation
5080608|NCT01298284|non-selective beta-blocker|non-selective beta-blocker
5080609|NCT01298284|rebleeding|rebleeding
5080610|NCT01298271|gastric variceal bleeding|gastric variceal bleeding
5080611|NCT01298271|primaryprevention|primaryprevention
5080612|NCT01298271|cyanoacrylate injection|cyanoacrylate injection
5080613|NCT01298271|non-selective beta-blocker|non-selective beta-blocker
5080614|NCT01298245|diabetes|diabetes
5080615|NCT01298245|diabetic retinopathy|diabetic retinopathy
5080616|NCT01298245|Chinese|chinese
5080617|NCT01298245|gene|gene
5080618|NCT01298245|associations|associations
5080619|NCT01298206|A/H1N1 Influenza|a/h1n1 influenza
5080620|NCT01298206|swine flu|swine flu
5080621|NCT01298206|virus disease|virus disease
5080622|NCT01298206|Avian flu|avian flu
5080623|NCT01298193|Early-stage breast cancer patients|early-stage breast cancer patients
5080624|NCT01298180|Prader-Willi Syndrome|prader-willi syndrome
5080625|NCT01298180|Growth Hormone Deficiency|growth hormone deficiency
5080626|NCT01298167|Cyanoacrylate|cyanoacrylate
5080627|NCT01298167|Fast Absorbing Gut|fast absorbing gut
5080628|NCT01298167|Mohs Surgery|mohs surgery
5080629|NCT01298167|Epidermal closure method|epidermal closure method
5080630|NCT01298154|Food intake|food intake
5080631|NCT01298154|Blood glucose|blood glucose
5080632|NCT01298154|Pulses|pulses
5080633|NCT01298154|Protein|protein
5080634|NCT01298141|Replagal|replagal
5080635|NCT01298141|Enzyme Replacement Therapy|enzyme replacement therapy
5080636|NCT01298141|agalsidase alfa|agalsidase alfa
5080637|NCT01298115|chronic kidney disease|chronic kidney disease
5080638|NCT01298115|dialysis|dialysis
5080639|NCT01298115|pre dialysis education|pre dialysis education
5080640|NCT01298115|transplantation|transplantation
5080641|NCT01298115|conservative care|conservative care
5080642|NCT01298102|kidney|kidney
5080643|NCT01298102|transplantation|transplantation
5080644|NCT01298102|haemodialysis|haemodialysis
5080645|NCT01298102|vaccination|vaccination
5080646|NCT01298102|influenza H1N1 2009|influenza h1n1 2009
5080647|NCT01298089|Flap|flap
5080648|NCT01298089|LASIK|lasik
5080649|NCT01298089|Corneal|corneal
5080650|NCT01298076|Diabetes|diabetes
5080651|NCT01298076|Retinopathy|retinopathy
5080652|NCT01298076|Macular oedema|macular oedema
5080653|NCT01298076|Laser|laser
5080654|NCT01298076|Photocoagulation|photocoagulation
5080655|NCT01298076|Fovea|fovea
5080656|NCT01298076|Steroid|steroid
5080657|NCT01298076|Bevacizumab|bevacizumab
5080658|NCT01298076|Intravitreal|intravitreal
5080659|NCT01298037|Immunology, Hepatitis B, HBV|immunology, hepatitis b, hbv
5080660|NCT01298024|Achilles tendon rupture|achilles tendon rupture
5080661|NCT01298024|Non-surgical treatment|non-surgical treatment
5080662|NCT01298024|Exercise|exercise
5080663|NCT01298024|Neuromuscular training|neuromuscular training
5080664|NCT01298011|operable|operable
5080665|NCT01298011|pancreas|pancreas
5080666|NCT01298011|Abraxane|abraxane
5080667|NCT01298011|Gemcitabine|gemcitabine
5080668|NCT01298011|Preoperative|preoperative
5080669|NCT01298011|potentially|potentially
5080670|NCT01298011|Pancreatic Cancer|pancreatic cancer
5080671|NCT01297985|Serious mental illness|serious mental illness
5080672|NCT01297985|Psychiatric disability|psychiatric disability
5080673|NCT01297985|Mental health peer-led|mental health peer-led
5080674|NCT01297985|Mental illness education|mental illness education
5080675|NCT01297985|Illness self-management|illness self-management
5080676|NCT01297972|Aplastic Anemia|aplastic anemia
5080677|NCT01297972|Mesenchymal Stem Cells|mesenchymal stem cells
5080678|NCT01297959|Surgical Wound Infection|surgical wound infection
5080679|NCT01297959|Therapeutic Enzyme System|therapeutic enzyme system
5080680|NCT01297959|Singlet Oxygen|singlet oxygen
5080681|NCT01297959|Peroxidase|peroxidase
5080682|NCT01297959|Glucose Oxidase|glucose oxidase
5080683|NCT01297959|Colorectal surgery|colorectal surgery
5080684|NCT01297959|Incisional Surgical Site Infections (SSI)|incisional surgical site infections (ssi)
5080685|NCT01297959|Anti-infective Agents, Local|anti-infective agents, local
5080686|NCT01297959|Clinical Trial, Phase III|clinical trial, phase iii
5080687|NCT01297933|parenteral nutrition associated liver disease|parenteral nutrition associated liver disease
5080688|NCT01297933|cholestasis|cholestasis
5080689|NCT01297933|short bowel syndrome|short bowel syndrome
5080690|NCT01297933|Omegaven|omegaven
5080691|NCT01297920|Open-Angle Glaucoma|open-angle glaucoma
5080692|NCT01297920|Ocular Hypertension|ocular hypertension
5080693|NCT01297920|Brinzolamide|brinzolamide
5080694|NCT01297920|Brimonidine|brimonidine
5080695|NCT01297920|Intraocular pressure|intraocular pressure
5080696|NCT01297907|Crohn's Disease|crohn's disease
5080697|NCT01297907|Bronchial hyper reactivity|bronchial hyper reactivity
5080698|NCT01297907|Fractional exhaled NO|fractional exhaled no
5080699|NCT01297907|Methacholine Challenge Test|methacholine challenge test
5080700|NCT01297907|Pediatric Crohn's Disease Activity Index|pediatric crohn's disease activity index
5080701|NCT01297907|To determine the frequency of bronchial hyperreactivity in pediatric patients followed and treated for Crohn disease|to determine the frequency of bronchial hyperreactivity in pediatric patients followed and treated for crohn disease
5080702|NCT01297894|A. baumannii|a. baumannii
5080703|NCT01297894|colistin|colistin
5080704|NCT01297894|fosfomycin|fosfomycin
5080705|NCT01297881|Caucasian outpatients|caucasian outpatients
5080706|NCT01297881|undiagnosed respiratory symptoms|undiagnosed respiratory symptoms
5080707|NCT01297881|dyspnea|dyspnea
5080708|NCT01297881|cough|cough
5080709|NCT01297881|sputum|sputum
5080710|NCT01297829|ibuprofen|ibuprofen
5080711|NCT01297829|postoperative narcotics|postoperative narcotics
5080712|NCT01297829|visual analog pain scale|visual analog pain scale
5080713|NCT01297829|inguinal hernia repair|inguinal hernia repair
5080714|NCT01297829|umbilical hernia repair|umbilical hernia repair
5080715|NCT01297790|Cough|cough
5080716|NCT01297790|Inhalational cough challenges|inhalational cough challenges
5080717|NCT01297790|Cough reflex sensitivity|cough reflex sensitivity
5080718|NCT01297790|Chronic cough.|chronic cough.
5080719|NCT01297777|Mast cell|mast cell
5080720|NCT01297777|Mastocytosis|mastocytosis
5080721|NCT01297777|Mast cell disease|mast cell disease
5080722|NCT01297738|diet manipulation|diet manipulation
5080723|NCT01297738|serotonin|serotonin
5080724|NCT01297738|dopamine|dopamine
5080725|NCT01297738|insulin sensitivity|insulin sensitivity
5080726|NCT01297725|Cesarean section|cesarean section
5080727|NCT01297725|Cesarean section[*methods]|cesarean section[*methods]
5080728|NCT01297725|Fascia [*surgery]|fascia [*surgery]
5080729|NCT01297725|Randomized Controlled Trial|randomized controlled trial
5080730|NCT01297725|Abdominal Wall [*surgery]|abdominal wall [*surgery]
5080731|NCT01297725|Pain, postoperative|pain, postoperative
5080732|NCT01297725|Surgical wound infection|surgical wound infection
5080733|NCT01297712|screening colonoscopy|screening colonoscopy
5080734|NCT01297712|adenoma|adenoma
5080735|NCT01297712|hyperplastic polyp|hyperplastic polyp
5080736|NCT01297712|differential diagnosis|differential diagnosis
5080737|NCT01297699|Graves´ orbitopathy|graves´ orbitopathy
5080738|NCT01297699|Graves´ ophthalmopathy|graves´ ophthalmopathy
5080739|NCT01297699|Thyroid eye disease|thyroid eye disease
5080740|NCT01297699|Thyroid-associated ophthalmopathy|thyroid-associated ophthalmopathy
5080741|NCT01297699|Tocilizumab|tocilizumab
5080742|NCT01297699|EUGOGO|eugogo
5080743|NCT01297699|CAS|cas
5080744|NCT01297686|Chronic plantar fasciitis|chronic plantar fasciitis
5080745|NCT01297686|Workplace injury|workplace injury
5080746|NCT01297686|Foot and Ankle Disability Index|foot and ankle disability index
5080747|NCT01297686|Ultrasound measure of disease severity|ultrasound measure of disease severity
5080748|NCT01297673|vesico-ureteral reflux|vesico-ureteral reflux
5080749|NCT01297673|neurogenic bladder dysfunction|neurogenic bladder dysfunction
5080750|NCT01297673|spinal cord injury|spinal cord injury
5080751|NCT01297660|neurogenic detrusor overactivity|neurogenic detrusor overactivity
5080752|NCT01297660|detrusor sphincter dyssynergia|detrusor sphincter dyssynergia
5080753|NCT01297660|compliance|compliance
5080754|NCT01297660|video urodynamic|video urodynamic
5080755|NCT01297660|spinal cord injury|spinal cord injury
5080756|NCT01297647|urinary tract infection|urinary tract infection
5080757|NCT01297647|urodynamics|urodynamics
5080758|NCT01297647|spinal cord injury|spinal cord injury
5080759|NCT01297634|Botulinum toxin type A|botulinum toxin type a
5080760|NCT01297634|Hyperfunctional forehead lines|hyperfunctional forehead lines
5080761|NCT01297634|Randomized controlled trial|randomized controlled trial
5080762|NCT01297634|Double-blinded trial|double-blinded trial
5080763|NCT01297634|Electromyogram (EMG)|electromyogram (emg)
5080764|NCT01297634|Electromyographic activity|electromyographic activity
5080765|NCT01297634|Frontal Area|frontal area
5080766|NCT01297621|breast hypertrophy|breast hypertrophy
5080767|NCT01297621|physical activity|physical activity
5080768|NCT01297621|sexuality|sexuality
5080769|NCT01297621|patient satisfaction|patient satisfaction
5080770|NCT01297595|relative bioavailability|relative bioavailability
5080771|NCT01297595|pharmacokinetics|pharmacokinetics
5080772|NCT01297595|crizotinib|crizotinib
5080773|NCT01297595|oral liquid formulation|oral liquid formulation
5080774|NCT01297595|formulated capsule|formulated capsule
5080775|NCT01297582|ONO-6950|ono-6950
5080776|NCT01297582|Healthy Adult Subjects|healthy adult subjects
5080777|NCT01297569|Diabetic macular edema|diabetic macular edema
5080778|NCT01297569|Macular edema|macular edema
5080780|NCT01297569|Diabetic retinopathy|diabetic retinopathy
5080781|NCT01297569|Diabetic eye disease|diabetic eye disease
5080782|NCT01297569|anti-VEGF|anti-vegf
5080783|NCT01297569|ranibizumab|ranibizumab
5080784|NCT01297569|Lucentis|lucentis
5080785|NCT01297556|Irritable Bowel Syndrome|irritable bowel syndrome
5080786|NCT01297543|Induction chemotherapy|induction chemotherapy
5080787|NCT01297543|Re-induction chemotherapy|re-induction chemotherapy
5080788|NCT01297543|Consolidation chemotherapy|consolidation chemotherapy
5080789|NCT01297543|Leukemia|leukemia
5080790|NCT01297543|Myelodysplasia|myelodysplasia
5080791|NCT01297530|Phase I|phase i
5080792|NCT01297530|Dose Escalation|dose escalation
5080793|NCT01297530|Hypoxia inducible factor 1 alpha|hypoxia inducible factor 1 alpha
5080794|NCT01297530|Neoplasms|neoplasms
5080795|NCT01297517|AOG|aog
5080796|NCT01297517|OHT|oht
5080797|NCT01297517|Open-Angle Glaucoma|open-angle glaucoma
5080798|NCT01297517|Ocular Hypertension|ocular hypertension
5080800|NCT01297504|lower respiratory tract infection|lower respiratory tract infection
5080801|NCT01297504|Respiratory syncytial virus|respiratory syncytial virus
5080802|NCT01297504|usage patterns|usage patterns
5080803|NCT01297491|NSCLC|nsclc
5080804|NCT01297491|PI3K|pi3k
5080805|NCT01297465|Ovulation Induction|ovulation induction
5080806|NCT01297465|Ovarian Stimulation|ovarian stimulation
5080807|NCT01297465|Reproductive Technique, Assisted|reproductive technique, assisted
5080808|NCT01297465|Assisted Reproductive Technics|assisted reproductive technics
5080809|NCT01297465|Assisted Reproductive Technique|assisted reproductive technique
5080810|NCT01297465|Reproductive Technology, Assisted|reproductive technology, assisted
5080811|NCT01297452|BKM120|bkm120
5080812|NCT01297452|CARBOPLATIN|carboplatin
5080813|NCT01297452|TAXOL (PACLITAXEL)|taxol (paclitaxel)
5080814|NCT01297452|Chemotherapy|chemotherapy
5080815|NCT01297452|10-192|10-192
5080816|NCT01297439|shoulder dystocia,|shoulder dystocia,
5080817|NCT01297439|Mac Roberts' maneuver,|mac roberts' maneuver,
5080818|NCT01297439|pushing maneuver|pushing maneuver
5080819|NCT01297413|allogeneic|allogeneic
5080820|NCT01297413|adult|adult
5080821|NCT01297413|stem|stem
5080822|NCT01297413|cells|cells
5080823|NCT01297413|stroke|stroke
5080824|NCT01297413|ischemic|ischemic
5080825|NCT01297400|Burns, Partial Thickness Burns|burns, partial thickness burns
5080826|NCT01297387|Diabetic Patients|diabetic patients
5080827|NCT01297387|Critical Limb Ischemia|critical limb ischemia
5080828|NCT01297387|Revascularization|revascularization
5080829|NCT01297374|Obesity|obesity
5080830|NCT01297348|Lybrel|lybrel
5080831|NCT01297348|levonorgestrel|levonorgestrel
5080832|NCT01297348|ethinyl estradiol|ethinyl estradiol
5080833|NCT01297348|venus thromboembolism (VTE)|venus thromboembolism (vte)
5080834|NCT01297348|oral contraceptives (OC)|oral contraceptives (oc)
5080835|NCT01297348|safety|safety
5080836|NCT01297348|database study|database study
5080837|NCT01297348|case-control study|case-control study
5080838|NCT01297335|intrathecal|intrathecal
5080839|NCT01297335|clonidine|clonidine
5080840|NCT01297335|poorly|poorly
5080841|NCT01297335|controlled|controlled
5080842|NCT01297335|hypertension|hypertension
5080843|NCT01297322|vascular closure system|vascular closure system
5080844|NCT01297322|manual compression|manual compression
5080845|NCT01297322|femoral arteriotomy|femoral arteriotomy
5080846|NCT01297322|percutaneous endovascular procedures|percutaneous endovascular procedures
5080847|NCT01297309|PTH 1-84|pth 1-84
5080848|NCT01297309|Hypoparathyroidism|hypoparathyroidism
5080849|NCT01297309|Parathyroid Hormone 1-84|parathyroid hormone 1-84
5080850|NCT01297309|NPSP558|npsp558
5080851|NCT01297296|heart failure|heart failure
5080852|NCT01297296|percutaneous|percutaneous
5080853|NCT01297296|interventional cardiology|interventional cardiology
5080854|NCT01297296|apical remodeling|apical remodeling
5080855|NCT01297296|LV dilatation|lv dilatation
5080856|NCT01297296|akinesis|akinesis
5080857|NCT01297296|dyskinesis|dyskinesis
5080858|NCT01297296|myocardial infarction|myocardial infarction
5080859|NCT01297283|Heart failure|heart failure
5080860|NCT01297283|Cardiac resynchronization|cardiac resynchronization
5080861|NCT01297283|Leadless ECG|leadless ecg
5080862|NCT01297283|Follow-up|follow-up
5080863|NCT01297244|AV-951|av-951
5080864|NCT01297244|Tivozanib|tivozanib
5080865|NCT01297244|Advanced Renal Cell Carcinoma|advanced renal cell carcinoma
5080866|NCT01297244|RCC|rcc
5080867|NCT01297244|Biomarkers|biomarkers
5080868|NCT01297231|fibroglandular tissue|fibroglandular tissue
5080869|NCT01297231|tamoxifen|tamoxifen
5080870|NCT01297231|MRI|mri
5080871|NCT01297231|Background Parenchymal Enhancement|background parenchymal enhancement
5080872|NCT01297231|10-217|10-217
5080873|NCT01297218|Alzheimer, Mesenchymal Stem Cells, Umbilical Cord Blood|alzheimer, mesenchymal stem cells, umbilical cord blood
5080874|NCT01297205|Human Umbilical Cord Blood Derived Mesenchymal Stem Cells|human umbilical cord blood derived mesenchymal stem cells
5080875|NCT01297205|Bronchopulmonary dysplasia|bronchopulmonary dysplasia
5080876|NCT01297205|Premature infants|premature infants
5080877|NCT01297192|YM178|ym178
5080878|NCT01297192|Mirabegron|mirabegron
5080879|NCT01297192|DDI|ddi
5080880|NCT01297192|Phase I|phase i
5080881|NCT01297192|Solifenacin|solifenacin
5080882|NCT01297192|Pharmacokinetics|pharmacokinetics
5080883|NCT01297192|Pharmacokinetics of mirabegron|pharmacokinetics of mirabegron
5080884|NCT01297179|Pharmacokinetics|pharmacokinetics
5080885|NCT01297179|Oral contraceptives|oral contraceptives
5080886|NCT01297179|Drug interactions|drug interactions
5080887|NCT01297179|Pharmacokinetics of mirabegron|pharmacokinetics of mirabegron
5080888|NCT01297153|Congenital Cataract|congenital cataract
5080889|NCT01297153|Children younger than 2 years|children younger than 2 years
5080890|NCT01297153|Aphakia|aphakia
5080891|NCT01297153|Primary IOL Implantation|primary iol implantation
5080892|NCT01297140|Psychiatry|psychiatry
5080893|NCT01297140|Behaviour|behaviour
5080894|NCT01297140|Alzheimer's|alzheimer's
5080895|NCT01297140|Personality|personality
5080896|NCT01297088|Proof of Mechanism|proof of mechanism
5080897|NCT01297088|Phase I|phase i
5080898|NCT01297088|Neoplasm|neoplasm
5080899|NCT01297088|Inflammation|inflammation
5081209|NCT01295723|IORT|iort
5080900|NCT01297075|Health Services Research|health services research
5080901|NCT01297075|Chronic Care|chronic care
5080902|NCT01297075|Outreach Visits|outreach visits
5080903|NCT01297075|Primary care|primary care
5080904|NCT01297075|chronic disease management|chronic disease management
5080905|NCT01297062|Diabetes|diabetes
5080906|NCT01297062|exenatide|exenatide
5080907|NCT01297062|Amylin|amylin
5080908|NCT01297062|Lilly|lilly
5080909|NCT01297062|QT interval|qt interval
5080910|NCT01297049|Diabetes|diabetes
5080911|NCT01297049|obesity|obesity
5080912|NCT01297049|behavior therapy|behavior therapy
5080913|NCT01297049|self management|self management
5080914|NCT01297036|Pharmacokinetics|pharmacokinetics
5080915|NCT01297036|Bioequivalence|bioequivalence
5080916|NCT01297036|Donepezil|donepezil
5080917|NCT01297023|calcium phosphate|calcium phosphate
5080918|NCT01297023|vitamin d3|vitamin d3
5080919|NCT01297023|bone metabolism|bone metabolism
5080920|NCT01297023|human study|human study
5080921|NCT01297010|Nausea and Vomiting|nausea and vomiting
5080922|NCT01297010|Vomiting|vomiting
5080923|NCT01297010|Postoperative|postoperative
5080924|NCT01297010|Anesthesia|anesthesia
5080925|NCT01296997|calcium phosphate|calcium phosphate
5080926|NCT01296997|incretins|incretins
5080927|NCT01296997|human study|human study
5080928|NCT01296984|Rectal cancer|rectal cancer
5080929|NCT01296984|APR|apr
5080930|NCT01296958|Taenia solium|taenia solium
5080931|NCT01296958|cysticercosis|cysticercosis
5080932|NCT01296958|neurocysticercosis|neurocysticercosis
5080933|NCT01296919|Chronic rhinosinusitis|chronic rhinosinusitis
5080934|NCT01296919|Histopathology|histopathology
5080935|NCT01296919|Infundibulum|infundibulum
5080936|NCT01296919|Lamina propria|lamina propria
5080937|NCT01296919|Uncinate process|uncinate process
5080938|NCT01296906|Reminder/recall messages|reminder/recall messages
5080939|NCT01296906|reminders|reminders
5080940|NCT01296906|recall|recall
5080941|NCT01296906|immunizations|immunizations
5080942|NCT01296906|immunization information systems|immunization information systems
5080943|NCT01296906|effectiveness of reminder/recall|effectiveness of reminder/recall
5080944|NCT01296906|population-based reminder/recall|population-based reminder/recall
5080945|NCT01296867|Laser ablation algorithms|laser ablation algorithms
5080946|NCT01296867|Excimer laser|excimer laser
5080947|NCT01296867|Refractive correction|refractive correction
5080948|NCT01296867|Corneal Asphericity Adjustment|corneal asphericity adjustment
5080949|NCT01296854|spa therapy|spa therapy
5080950|NCT01296841|telemedicine|telemedicine
5080951|NCT01296841|remote consultation|remote consultation
5080952|NCT01296841|telehealth|telehealth
5080953|NCT01296841|ehealth|ehealth
5080954|NCT01296841|image archiving|image archiving
5080955|NCT01296841|inflammatory bowel disease|inflammatory bowel disease
5080956|NCT01296815|Kaposi sarcoma|kaposi sarcoma
5080957|NCT01296815|HIV|hiv
5080958|NCT01296815|Bevacizumab|bevacizumab
5080959|NCT01296802|Ecstasy|ecstasy
5080960|NCT01296802|MDMA|mdma
5080961|NCT01296802|Serotonin|serotonin
5080962|NCT01296802|Neurotoxicity|neurotoxicity
5080963|NCT01296802|dexfenfluramine|dexfenfluramine
5080964|NCT01296802|Positron emission tomography|positron emission tomography
5080965|NCT01296802|altanserin|altanserin
5080966|NCT01296802|5-HT2A receptor|5-ht2a receptor
5080967|NCT01296776|exercise|exercise
5080968|NCT01296776|whole-body electromyostimulation|whole-body electromyostimulation
5080969|NCT01296776|bone mineral density|bone mineral density
5080970|NCT01296776|falls|falls
5080971|NCT01296776|physical fitness|physical fitness
5080972|NCT01296776|pain|pain
5080973|NCT01296763|Irinotecan|irinotecan
5080974|NCT01296763|Cisplatin|cisplatin
5080975|NCT01296763|Carboplatin|carboplatin
5080976|NCT01296763|Mitomycin-C|mitomycin-c
5080977|NCT01296763|Olaparib|olaparib
5080978|NCT01296763|AZD2281|azd2281
5080979|NCT01296711|Rheumatoid arthritis|rheumatoid arthritis
5080980|NCT01296711|CDP6038|cdp6038
5080981|NCT01296711|Interleukin-6|interleukin-6
5080982|NCT01296698|Smoking Cessation|smoking cessation
5080983|NCT01296698|Tobacco Use Disorder|tobacco use disorder
5080984|NCT01296685|cardiovascular surgical procedure|cardiovascular surgical procedure
5080985|NCT01296672|Finasteride|finasteride
5080986|NCT01296672|Placebo|placebo
5080987|NCT01296672|Prostate cancer|prostate cancer
5080988|NCT01296672|Prostate Specific Antigen (PSA)|prostate specific antigen (psa)
5080989|NCT01296672|Men at intermediate risk of prostate cancer|men at intermediate risk of prostate cancer
5080990|NCT01296672|Men scheduled for prostate biopsy|men scheduled for prostate biopsy
5080991|NCT01296659|sarcoma|sarcoma
5080992|NCT01296659|Ridaforolimus|ridaforolimus
5080993|NCT01296659|soft tissue sarcoma|soft tissue sarcoma
5080994|NCT01296659|unresectable sarcoma|unresectable sarcoma
5080995|NCT01296646|Alcohol|alcohol
5080996|NCT01296646|Alcoholics|alcoholics
5080997|NCT01296646|Substance Abuse|substance abuse
5080998|NCT01296646|Alcohol Abuse|alcohol abuse
5080999|NCT01296646|Alcohol Addiction|alcohol addiction
5081000|NCT01296633|health literacy|health literacy
5081001|NCT01296633|patient education|patient education
5081002|NCT01296633|medication adherence|medication adherence
5081489|NCT01294787|exercise|exercise
5081003|NCT01296633|patient/provider communication|patient/provider communication
5081004|NCT01296633|Diabetes Mellitus|diabetes mellitus
5081005|NCT01296607|Pharmacodynamics|pharmacodynamics
5081006|NCT01296607|Pharmacokinetics|pharmacokinetics
5081007|NCT01296607|Urocortin 2|urocortin 2
5081008|NCT01296607|Urocortin 3|urocortin 3
5081009|NCT01296607|Reproducibility|reproducibility
5081010|NCT01296607|Onset/ Offset|onset/ offset
5081011|NCT01296607|Forearm blood flow|forearm blood flow
5081012|NCT01296607|Plethysmography|plethysmography
5081013|NCT01296607|Heart Failure|heart failure
5081014|NCT01296581|Cancer|cancer
5081015|NCT01296581|Tumors|tumors
5081016|NCT01296581|VEGFR|vegfr
5081017|NCT01296581|PDGFR|pdgfr
5081018|NCT01296568|metastatic solid tumors|metastatic solid tumors
5081019|NCT01296568|Malignant/M-Neoplasm|malignant/m-neoplasm
5081020|NCT01296568|Pancreas NOS|pancreas nos
5081021|NCT01296568|Absorption|absorption
5081022|NCT01296568|Distribution|distribution
5081023|NCT01296568|Metabolism|metabolism
5081024|NCT01296568|Excretion|excretion
5081025|NCT01296568|Mass balance|mass balance
5081026|NCT01296568|Metabolic profile|metabolic profile
5081027|NCT01296568|Radiolabeled study|radiolabeled study
5081028|NCT01296516|Women|women
5081029|NCT01296516|Postpartum|postpartum
5081030|NCT01296516|GDM|gdm
5081031|NCT01296503|Multiple Myeloma|multiple myeloma
5081032|NCT01296503|Treatment|treatment
5081033|NCT01296503|Maintenance|maintenance
5081034|NCT01296503|Thalidomide|thalidomide
5081035|NCT01296490|oxidative stress, physical exercise, fitness level|oxidative stress, physical exercise, fitness level
5081036|NCT01296477|Asthma|asthma
5081037|NCT01296477|ASTHMA IQ tool|asthma iq tool
5081038|NCT01296477|Asthma Control Test (ACT)|asthma control test (act)
5081039|NCT01296477|EPR-3 Guidelines, Exacerbations|epr-3 guidelines, exacerbations
5081040|NCT01296464|Parkinson's Disease|parkinson's disease
5081041|NCT01296464|Motor response|motor response
5081042|NCT01296464|Wearing-off|wearing-off
5081043|NCT01296451|Hepatitis C|hepatitis c
5081044|NCT01296451|vaccine|vaccine
5081045|NCT01296451|Adenovirus|adenovirus
5081046|NCT01296451|MVA|mva
5081047|NCT01296451|chronic infection|chronic infection
5081048|NCT01296451|interferon|interferon
5081049|NCT01296451|ribavirin|ribavirin
5081050|NCT01296425|Growth disorders|growth disorders
5081051|NCT01296425|Saizen|saizen
5081052|NCT01296425|Easypod|easypod
5081053|NCT01296425|Growth hormone|growth hormone
5081054|NCT01296425|Pediatric subject|pediatric subject
5081055|NCT01296399|in stent restenosis|in stent restenosis
5081056|NCT01296399|bare metal stent|bare metal stent
5081057|NCT01296399|drug eluting stent|drug eluting stent
5081058|NCT01296399|de novo lesion|de novo lesion
5081059|NCT01296373|HIV-1|hiv-1
5081060|NCT01296373|immune|immune
5081061|NCT01296373|restoration|restoration
5081062|NCT01296373|observational|observational
5081063|NCT01296360|immune response|immune response
5081064|NCT01296360|IC51-325|ic51-325
5081065|NCT01296360|Japanese Encephalitis|japanese encephalitis
5081066|NCT01296360|Intercell AG|intercell ag
5081067|NCT01296347|Ketamine|ketamine
5081068|NCT01296347|Thoracotomy|thoracotomy
5081069|NCT01296347|VATS|vats
5081070|NCT01296347|Pain|pain
5081071|NCT01296334|opioids|opioids
5081072|NCT01296334|analgesia|analgesia
5081073|NCT01296334|secondary hyperalgesia|secondary hyperalgesia
5081074|NCT01296334|quantitative sensory testing|quantitative sensory testing
5081075|NCT01296334|inflammatory injury|inflammatory injury
5081076|NCT01296308|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
5081077|NCT01296308|Diabetic Neuropathy|diabetic neuropathy
5081078|NCT01296308|Complementary Medicine|complementary medicine
5081079|NCT01296308|Alternative Medicine|alternative medicine
5081080|NCT01296308|Integrative Medicine|integrative medicine
5081081|NCT01296308|Quality of Life|quality of life
5081082|NCT01296308|Quantitative Sensory Testing|quantitative sensory testing
5081083|NCT01296295|smoking cessation advice|smoking cessation advice
5081084|NCT01296295|spirometry|spirometry
5081085|NCT01296295|primary health care|primary health care
5081086|NCT01296269|social cognition|social cognition
5081087|NCT01296269|oxytocin|oxytocin
5081088|NCT01296269|vasopressin|vasopressin
5081089|NCT01296269|decision making|decision making
5081090|NCT01296269|social decision making|social decision making
5081091|NCT01296256|Bendamustine|bendamustine
5081092|NCT01296256|Conditioning Therapy|conditioning therapy
5081093|NCT01296256|Autologous Stem Cell Transplant|autologous stem cell transplant
5081094|NCT01296256|Aggressive Non Hodgkin's Lymphoma|aggressive non hodgkin's lymphoma
5081095|NCT01296243|Castration-resistant prostate cancer|castration-resistant prostate cancer
5081096|NCT01296243|Tesetaxel|tesetaxel
5081097|NCT01296243|Taxanes|taxanes
5081098|NCT01296243|Chemotherapy-naive|chemotherapy-naive
5081099|NCT01296243|Chemotherapy-exposed|chemotherapy-exposed
5081100|NCT01296243|Progressive, metastatic castration-resistant prostate cancer|progressive, metastatic castration-resistant prostate cancer
5081101|NCT01296217|Patients with infiltrant prostatic carcinoma|patients with infiltrant prostatic carcinoma
5081102|NCT01296165|Travel|travel
5081103|NCT01296165|Spread|spread
5081104|NCT01296165|Antibiotic resistance|antibiotic resistance
5081105|NCT01296139|Non-Cutaneous Malignancy|non-cutaneous malignancy
5081106|NCT01296139|Prostatectomy|prostatectomy
5081107|NCT01296139|Metastatic Prostate Cancer|metastatic prostate cancer
5081108|NCT01296139|Imaging Study|imaging study
5081109|NCT01296139|Magnetic Resonance Imaging|magnetic resonance imaging
5081110|NCT01296139|Prostate Cancer|prostate cancer
5081111|NCT01296126|Post Traumatic Stress Disorder (PTSD)|post traumatic stress disorder (ptsd)
5081112|NCT01296126|MRI|mri
5081113|NCT01296126|TBI|tbi
5081114|NCT01296126|Traumatic Brain Injury|traumatic brain injury
5081115|NCT01296126|Post Traumatic Stress Disorder|post traumatic stress disorder
5081116|NCT01296126|PTSD|ptsd
5081117|NCT01296100|impaired glucose tolerance|impaired glucose tolerance
5081118|NCT01296100|nutrition|nutrition
5081119|NCT01296100|physical activity|physical activity
5081120|NCT01296087|Asthma|asthma
5081121|NCT01296087|Mild to Moderate Asthma|mild to moderate asthma
5081122|NCT01296074|monocyte|monocyte
5081123|NCT01296074|cardiopulmonary bypass|cardiopulmonary bypass
5081124|NCT01296074|cardiac surgery|cardiac surgery
5081125|NCT01296061|Dialysis|dialysis
5081126|NCT01296061|Renal Transplantation|renal transplantation
5081127|NCT01296061|Failure of allograft|failure of allograft
5081128|NCT01296048|weight|weight
5081129|NCT01296048|body fat|body fat
5081130|NCT01296048|total body water|total body water
5081131|NCT01296048|bone mass|bone mass
5081132|NCT01296048|muscle mass|muscle mass
5081133|NCT01296035|recurrent ovarian cancer|recurrent ovarian cancer
5081134|NCT01296035|platinum-refractory ovarian cancer|platinum-refractory ovarian cancer
5081135|NCT01296022|Heart rhythm disturbances|heart rhythm disturbances
5081136|NCT01296022|Implantable cardiac defibrillator|implantable cardiac defibrillator
5081137|NCT01296009|embryonic implantation|embryonic implantation
5081138|NCT01296009|endometrial receptivity|endometrial receptivity
5081139|NCT01296009|traditional Chinese medicines|traditional chinese medicines
5081140|NCT01296009|in vitro fertilization-embryo transfer|in vitro fertilization-embryo transfer
5081141|NCT01296009|pregnant rate|pregnant rate
5081142|NCT01295970|Surgery of the brain|surgery of the brain
5081143|NCT01295970|Radiosurgery|radiosurgery
5081144|NCT01295970|Brain Metastasis|brain metastasis
5081145|NCT01295944|Chemotherapy|chemotherapy
5081146|NCT01295944|Brain Tumor|brain tumor
5081147|NCT01295944|Spinal Cord Tumor|spinal cord tumor
5081148|NCT01295944|Malignancy|malignancy
5081149|NCT01295944|Neurologic|neurologic
5081150|NCT01295931|Near-infrared|near-infrared
5081151|NCT01295931|NIR|nir
5081152|NCT01295931|Indocyanine green|indocyanine green
5081153|NCT01295931|ICG|icg
5081154|NCT01295931|Melanoma|melanoma
5081155|NCT01295931|Fluorescent dyes|fluorescent dyes
5081156|NCT01295931|Lymph nodes|lymph nodes
5081157|NCT01295931|Experimental camera|experimental camera
5081158|NCT01295918|probiotic|probiotic
5081159|NCT01295918|AAD|aad
5081160|NCT01295918|Lactobacillus reuteri|lactobacillus reuteri
5081161|NCT01295918|diarrhea|diarrhea
5081162|NCT01295892|menopause|menopause
5081163|NCT01295892|obesity|obesity
5081164|NCT01295892|capillary|capillary
5081165|NCT01295892|microcirculation|microcirculation
5081166|NCT01295892|estrogen|estrogen
5081167|NCT01295892|Microvascular Function|microvascular function
5081168|NCT01295879|Vitamin D insufficiency|vitamin d insufficiency
5081169|NCT01295866|chronic nasal inflammation|chronic nasal inflammation
5081170|NCT01295866|nasal nitric oxide|nasal nitric oxide
5081171|NCT01295866|atopy|atopy
5081172|NCT01295827|Melanoma|melanoma
5081173|NCT01295827|Carcinoma|carcinoma
5081174|NCT01295827|Cancer|cancer
5081175|NCT01295827|Advanced cancer|advanced cancer
5081176|NCT01295827|Metastatic cancer|metastatic cancer
5081177|NCT01295827|Metastatic melanoma|metastatic melanoma
5081178|NCT01295827|PD-1|pd-1
5081179|NCT01295827|PD1|pd1
5081180|NCT01295814|Interstitial cystitis|interstitial cystitis
5081181|NCT01295814|Humira|humira
5081182|NCT01295814|Adalimumab|adalimumab
5081183|NCT01295801|Linezolid|linezolid
5081184|NCT01295801|Vitamin B6|vitamin b6
5081185|NCT01295801|Linezolid-associated cytopenias|linezolid-associated cytopenias
5081186|NCT01295775|diabetic retinopathy|diabetic retinopathy
5081187|NCT01295775|sulodexide|sulodexide
5081188|NCT01295775|hard exudates|hard exudates
5081189|NCT01295775|microaneurysms|microaneurysms
5081190|NCT01295775|hemorrhages|hemorrhages
5081191|NCT01295775|intraretinal microvascular abnormalities|intraretinal microvascular abnormalities
5081192|NCT01295762|Children|children
5081193|NCT01295762|Cancer|cancer
5081194|NCT01295762|Immunomonitoring|immunomonitoring
5081195|NCT01295762|Prognostic/Predictive Factors|prognostic/predictive factors
5081196|NCT01295762|Immunotherapy|immunotherapy
5081197|NCT01295749|cardiac arrest|cardiac arrest
5081198|NCT01295749|No Flow|no flow
5081199|NCT01295749|Emergency|emergency
5081200|NCT01295749|Nurse|nurse
5081201|NCT01295749|laryngeal Tube|laryngeal tube
5081202|NCT01295736|scleroderma|scleroderma
5081203|NCT01295736|digital|digital
5081204|NCT01295736|ulcer|ulcer
5081205|NCT01295723|Breast cancer|breast cancer
5081206|NCT01295723|Radiation therapy|radiation therapy
5081207|NCT01295723|Mobetron|mobetron
5081208|NCT01295723|IOERT|ioert
5081210|NCT01295723|Hypofractionated radiation therapy|hypofractionated radiation therapy
5081211|NCT01295723|Partial breast radiation|partial breast radiation
5081212|NCT01295710|adult acute myeloid leukemia|adult acute myeloid leukemia
5081213|NCT01295710|adult acute lymphoid leukemia|adult acute lymphoid leukemia
5081214|NCT01295710|adult myelodysplastic syndrome|adult myelodysplastic syndrome
5081215|NCT01295710|allogenic stem cell transplantation|allogenic stem cell transplantation
5081216|NCT01295710|unrelated donor|unrelated donor
5081217|NCT01295710|GVHD|gvhd
5081218|NCT01295710|US-ATG-F (Anti-human-T-lymphocyte Immune Globulin, Rabbit)|us-atg-f (anti-human-t-lymphocyte immune globulin, rabbit)
5081219|NCT01295697|Patients with non-CNS or CNS tumors|patients with non-cns or cns tumors
5081220|NCT01295697|Pediatric patients with Relapsed/Refractory Solid Tumors|pediatric patients with relapsed/refractory solid tumors
5081221|NCT01295684|cranberry|cranberry
5081222|NCT01295684|cardiovascular|cardiovascular
5081223|NCT01295684|adhesion|adhesion
5081224|NCT01295684|polyphenol|polyphenol
5081225|NCT01295658|cancer|cancer
5081226|NCT01295658|cancer survivorship|cancer survivorship
5081227|NCT01295658|psychosocial needs|psychosocial needs
5081228|NCT01295658|cancer experience|cancer experience
5081229|NCT01295658|metastatic breast cancer|metastatic breast cancer
5081230|NCT01295658|breast cancer|breast cancer
5081231|NCT01295658|caregiver|caregiver
5081232|NCT01295645|Stem Cell Transplant|stem cell transplant
5081233|NCT01295645|Hemorrhagic Cystitis|hemorrhagic cystitis
5081234|NCT01295645|Bladder inflammation|bladder inflammation
5081235|NCT01295645|Frequent urination|frequent urination
5081236|NCT01295645|Pain|pain
5081237|NCT01295645|Polyomavirus hominis type I|polyomavirus hominis type i
5081238|NCT01295645|BK virus|bk virus
5081239|NCT01295645|BKV|bkv
5081240|NCT01295645|Cidofovir|cidofovir
5081241|NCT01295645|Vistide|vistide
5081242|NCT01295632|Recurrent glioblastoma multiforme|recurrent glioblastoma multiforme
5081243|NCT01295632|Hormone resistant prostate cancer|hormone resistant prostate cancer
5081244|NCT01295632|Relapsed ovarian carcinoma|relapsed ovarian carcinoma
5081245|NCT01295632|Refractory ovarian carcinoma|refractory ovarian carcinoma
5081246|NCT01295632|Refractory breast cancer|refractory breast cancer
5081247|NCT01295632|Relapsed breast cancer|relapsed breast cancer
5081248|NCT01295619|Dura|dura
5081249|NCT01295619|Sealant|sealant
5081250|NCT01295619|Cranial|cranial
5081251|NCT01295619|Craniotomy|craniotomy
5081252|NCT01295619|CSF leakage|csf leakage
5081253|NCT01295619|CSF leakage following cranial surgery|csf leakage following cranial surgery
5081254|NCT01295606|cefazolin|cefazolin
5081255|NCT01295606|prophylaxis|prophylaxis
5081256|NCT01295606|pharmacokinetics|pharmacokinetics
5081257|NCT01295606|newborn|newborn
5081258|NCT01295593|CLL previously treated|cll previously treated
5081259|NCT01295567|ischemia reperfusion injury|ischemia reperfusion injury
5081260|NCT01295567|CABG|cabg
5081261|NCT01295567|dipyridamole|dipyridamole
5081262|NCT01295567|HS-troponin-I|hs-troponin-i
5081263|NCT01295554|Peripheral arterial disease, MRA|peripheral arterial disease, mra
5081264|NCT01295541|ICU LOS|icu los
5081265|NCT01295541|Progressive Mobility|progressive mobility
5081266|NCT01295541|Deconditioning|deconditioning
5081267|NCT01295528|blood pressure|blood pressure
5081268|NCT01295528|heart rate|heart rate
5081269|NCT01295515|HIV|hiv
5081270|NCT01295515|Replication|replication
5081271|NCT01295515|Antiretroviral|antiretroviral
5081272|NCT01295515|Interferon|interferon
5081273|NCT01295515|Reservoirs|reservoirs
5081274|NCT01295476|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5081275|NCT01295476|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
5081276|NCT01295476|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5081277|NCT01295476|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5081278|NCT01295476|T-cell adult acute lymphoblastic leukemia|t-cell adult acute lymphoblastic leukemia
5081279|NCT01295476|T-cell childhood acute lymphoblastic leukemia|t-cell childhood acute lymphoblastic leukemia
5081280|NCT01295463|sexual dysfunction|sexual dysfunction
5081281|NCT01295463|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
5081282|NCT01295463|infertility|infertility
5081283|NCT01295463|colon cancer|colon cancer
5081284|NCT01295463|male breast cancer|male breast cancer
5081285|NCT01295463|breast cancer|breast cancer
5081286|NCT01295463|germ cell tumor|germ cell tumor
5081287|NCT01295463|ovarian sarcoma|ovarian sarcoma
5081288|NCT01295463|uterine sarcoma|uterine sarcoma
5081289|NCT01295463|chronic lymphocytic leukemia|chronic lymphocytic leukemia
5081290|NCT01295463|osteosarcoma|osteosarcoma
5081291|NCT01295463|chronic myelogenous leukemia|chronic myelogenous leukemia
5081292|NCT01295463|non-Hodgkin lymphoma|non-hodgkin lymphoma
5081293|NCT01295463|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5081294|NCT01295463|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5081295|NCT01295463|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5081296|NCT01295463|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5081297|NCT01295463|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5081298|NCT01295463|mast cell leukemia|mast cell leukemia
5081299|NCT01295463|hairy cell leukemia|hairy cell leukemia
5081300|NCT01295463|prolymphocytic leukemia|prolymphocytic leukemia
5081301|NCT01295463|adult acute lymphoblastic leukemia|adult acute lymphoblastic leukemia
5081302|NCT01295463|adult acute myeloid leukemia|adult acute myeloid leukemia
5081303|NCT01295463|adult Hodgkin lymphoma|adult hodgkin lymphoma
5081304|NCT01295463|adult T-cell leukemia/lymphoma|adult t-cell leukemia/lymphoma
5081305|NCT01295463|small intestine lymphoma|small intestine lymphoma
5081306|NCT01295463|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5081307|NCT01295463|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
5081308|NCT01295463|mycosis fungoides/Sezary syndrome|mycosis fungoides/sezary syndrome
5081309|NCT01295463|intraocular lymphoma|intraocular lymphoma
5081310|NCT01295463|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
5081311|NCT01295463|primary central nervous system Hodgkin lymphoma|primary central nervous system hodgkin lymphoma
5081312|NCT01295463|noncutaneous extranodal lymphoma|noncutaneous extranodal lymphoma
5081313|NCT01295463|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5081314|NCT01295463|acute undifferentiated leukemia|acute undifferentiated leukemia
5081315|NCT01295463|central nervous system leukemia|central nervous system leukemia
5081316|NCT01295463|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
5081317|NCT01295463|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
5081318|NCT01295463|clear cell sarcoma of the kidney|clear cell sarcoma of the kidney
5081319|NCT01295463|Kaposi sarcoma|kaposi sarcoma
5081320|NCT01295463|adult soft tissue sarcoma|adult soft tissue sarcoma
5081321|NCT01295463|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5081322|NCT01295463|secondary central nervous system Hodgkin lymphoma|secondary central nervous system hodgkin lymphoma
5081323|NCT01295463|cutaneous lymphoma|cutaneous lymphoma
5081324|NCT01295463|adult non-Hodgkin lymphoma|adult non-hodgkin lymphoma
5081325|NCT01295450|Phase III|phase iii
5081326|NCT01295450|Apevinat BC|apevinat bc
5081327|NCT01295450|Lack of appetite|lack of appetite
5081328|NCT01295437|inguinal hernia, Lichtenstein hernioplasty, chronic pain|inguinal hernia, lichtenstein hernioplasty, chronic pain
5081329|NCT01295424|Cardiac Arrest|cardiac arrest
5081330|NCT01295424|Intensive Care Unit|intensive care unit
5081331|NCT01295424|Emergency Medical Service|emergency medical service
5081332|NCT01295385|type 2 diabetes|type 2 diabetes
5081333|NCT01295385|Cardiovascular diseases|cardiovascular diseases
5081334|NCT01295385|coronary syndrome have abnormalities of glucidic metabolism|coronary syndrome have abnormalities of glucidic metabolism
5081335|NCT01295372|Schizophrenia|schizophrenia
5081336|NCT01295372|Antipsychotic|antipsychotic
5081337|NCT01295372|Risperidone|risperidone
5081338|NCT01295372|Lu 31-130|lu 31-130
5081339|NCT01295359|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5081340|NCT01295359|Walking|walking
5081341|NCT01295359|Hospital|hospital
5081342|NCT01295359|Exercise Tolerance|exercise tolerance
5081343|NCT01295359|Physical Therapy|physical therapy
5081344|NCT01295320|Herpes Zoster|herpes zoster
5081345|NCT01295320|vaccine|vaccine
5081346|NCT01295320|safety|safety
5081347|NCT01295320|immunogenicity|immunogenicity
5081348|NCT01295307|acute myeloid leukemia|acute myeloid leukemia
5081349|NCT01295307|relapsed|relapsed
5081350|NCT01295307|refractory|refractory
5081351|NCT01295307|Relapsed or refractory AML|relapsed or refractory aml
5081352|NCT01295294|Uterine Hemorrhage|uterine hemorrhage
5081353|NCT01295294|Contraception|contraception
5081354|NCT01295294|Contraceptive Methods|contraceptive methods
5081355|NCT01295294|Intrauterine devices|intrauterine devices
5081356|NCT01295294|Mirena|mirena
5081357|NCT01295268|Vulvar pain|vulvar pain
5081358|NCT01295268|Vulvodynia|vulvodynia
5081359|NCT01295268|Vestibulodynia|vestibulodynia
5081360|NCT01295268|Vulvar vestibulitis|vulvar vestibulitis
5081361|NCT01295255|Allergic rhinitis|allergic rhinitis
5081362|NCT01295255|Psychological status|psychological status
5081363|NCT01295255|Asthma|asthma
5081364|NCT01295255|Aeroallergen|aeroallergen
5081365|NCT01295242|HPV|hpv
5081366|NCT01295242|Cervical Cancer|cervical cancer
5081367|NCT01295216|prehypertension|prehypertension
5081368|NCT01295216|blood pressure|blood pressure
5081369|NCT01295216|mobile technology|mobile technology
5081370|NCT01295216|Latin America|latin america
5081371|NCT01295216|behavioral change|behavioral change
5081372|NCT01295216|healthy lifestyles|healthy lifestyles
5081373|NCT01295216|mHealth|mhealth
5081374|NCT01295177|wound healing|wound healing
5081375|NCT01295177|diabetes mellitus|diabetes mellitus
5081376|NCT01295164|keratoconus, wave-front sensing technology, aberrometer|keratoconus, wave-front sensing technology, aberrometer
5081377|NCT01295138|Constipation|constipation
5081378|NCT01295138|Caesarean section|caesarean section
5081379|NCT01295138|Abdominal Pain|abdominal pain
5081380|NCT01295138|Nausea|nausea
5081381|NCT01295138|Vomiting|vomiting
5081382|NCT01295125|Infected ventral hernia|infected ventral hernia
5081383|NCT01295125|Contaminated incisional hernia|contaminated incisional hernia
5081384|NCT01295099|scar formation|scar formation
5081385|NCT01295099|5-FU|5-fu
5081386|NCT01295099|genetic link|genetic link
5081387|NCT01295099|psychological impact|psychological impact
5081388|NCT01295099|social impact|social impact
5081389|NCT01295086|Adenocarcinoma of the gastro-esophageal|adenocarcinoma of the gastro-esophageal
5081390|NCT01295086|Her2|her2
5081391|NCT01295086|Dose finding|dose finding
5081392|NCT01295086|Taxotere (Docetaxel)|taxotere (docetaxel)
5081393|NCT01295086|Eloxatin (Oxaliplatin)|eloxatin (oxaliplatin)
5081394|NCT01295086|Xeloda (Capecitabine)|xeloda (capecitabine)
5081395|NCT01295086|Herceptin (Trastuzumab)|herceptin (trastuzumab)
5081396|NCT01295073|Trientine|trientine
5081397|NCT01295073|Cataract surgery|cataract surgery
5081398|NCT01295073|Macular Edema|macular edema
5081399|NCT01295060|Acromegaly|acromegaly
5081400|NCT01295060|Octreotide|octreotide
5081401|NCT01295060|IGF-1|igf-1
5081402|NCT01295060|Growth Hormone|growth hormone
5081403|NCT01295060|Implant|implant
5081404|NCT01295060|Hydrogel|hydrogel
5081405|NCT01295047|Marfan Syndrome|marfan syndrome
5081406|NCT01295047|Large arterial function|large arterial function
5081407|NCT01295047|LV function|lv function
5081408|NCT01295047|atenolol|atenolol
5081409|NCT01295047|perindopril|perindopril
5081410|NCT01295047|verapamil|verapamil
5081411|NCT01295047|central arterial pressure|central arterial pressure
5081412|NCT01295034|HIV|hiv
5081413|NCT01295034|combination antiretroviral therapy|combination antiretroviral therapy
5081414|NCT01295034|vitamin D|vitamin d
5081415|NCT01295034|low bone density|low bone density
5081416|NCT01295021|The prevalence of sympathetic overactivity in hypertensive patients.|the prevalence of sympathetic overactivity in hypertensive patients.
5081417|NCT01295008|Fabry disease|fabry disease
5081418|NCT01295008|Male pattern baldness|male pattern baldness
5081419|NCT01295008|Alopecia|alopecia
5081420|NCT01295008|GLA gene mutation|gla gene mutation
5081421|NCT01295008|Alpha-galactosidase A|alpha-galactosidase a
5081422|NCT01294995|short term consumption|short term consumption
5081423|NCT01294995|Chinese liquor|chinese liquor
5081424|NCT01294995|serum lipids|serum lipids
5081425|NCT01294995|uric acid|uric acid
5081426|NCT01294995|inflammation biomarkers|inflammation biomarkers
5081427|NCT01294982|OAB|oab
5081428|NCT01294982|Over Active Bladder|over active bladder
5081429|NCT01294982|overactive bladder|overactive bladder
5081430|NCT01294982|Urinary Urge Incontinence|urinary urge incontinence
5081431|NCT01294982|Urinary Incontinence|urinary incontinence
5081432|NCT01294969|Allergic conjunctivitis|allergic conjunctivitis
5081433|NCT01294956|Dry eye|dry eye
5081434|NCT01294956|artificial tears|artificial tears
5081435|NCT01294956|corneal staining|corneal staining
5081436|NCT01294943|Intensive Care Units|intensive care units
5081437|NCT01294943|Biofilms|biofilms
5081438|NCT01294943|Tongue|tongue
5081439|NCT01294943|Infection|infection
5081440|NCT01294943|Pneumonia/Aspiration|pneumonia/aspiration
5081441|NCT01294930|hip fracture|hip fracture
5081442|NCT01294930|mortality|mortality
5081443|NCT01294930|complications|complications
5081444|NCT01294904|Hormone|hormone
5081445|NCT01294904|Sperm|sperm
5081446|NCT01294904|Chronic kidney disease|chronic kidney disease
5081447|NCT01294891|Rheology|rheology
5081448|NCT01294891|Sickle cell|sickle cell
5081449|NCT01294891|Paroxysmal nocturnal hemoglobinuria|paroxysmal nocturnal hemoglobinuria
5081450|NCT01294891|contrast ultrasound|contrast ultrasound
5081451|NCT01294878|anti-IgE treatment|anti-ige treatment
5081452|NCT01294878|interstitial cystitis/bladder pain syndrome|interstitial cystitis/bladder pain syndrome
5081453|NCT01294878|omalizumab|omalizumab
5081454|NCT01294865|Sepsis|sepsis
5081455|NCT01294865|late-onset|late-onset
5081456|NCT01294865|suPAR|supar
5081457|NCT01294852|prophylactic|prophylactic
5081458|NCT01294852|surfactant|surfactant
5081459|NCT01294852|premature|premature
5081460|NCT01294852|mechanical ventilation|mechanical ventilation
5081461|NCT01294852|mortality|mortality
5081462|NCT01294852|morbidities|morbidities
5081463|NCT01294839|sinus-node dysfunction|sinus-node dysfunction
5081464|NCT01294839|RVOTs pacing|rvots pacing
5081465|NCT01294839|RVA pacing|rva pacing
5081466|NCT01294826|Colorectal Neoplasms|colorectal neoplasms
5081467|NCT01294826|Intestinal Neoplasms|intestinal neoplasms
5081468|NCT01294826|Gastrointestinal Neoplasms|gastrointestinal neoplasms
5081469|NCT01294826|Digestive System Neoplasms|digestive system neoplasms
5081470|NCT01294826|Neoplasms by Site|neoplasms by site
5081471|NCT01294826|Neoplasms|neoplasms
5081472|NCT01294826|Digestive System Diseases|digestive system diseases
5081473|NCT01294826|Gastrointestinal Diseases|gastrointestinal diseases
5081474|NCT01294826|Colonic Diseases|colonic diseases
5081475|NCT01294826|Intestinal Diseases|intestinal diseases
5081476|NCT01294826|Rectal Diseases|rectal diseases
5081477|NCT01294826|Cetuximab|cetuximab
5081478|NCT01294826|HSP90 Heat-Shock Proteins|hsp90 heat-shock proteins
5081479|NCT01294826|EGFR protein, human|egfr protein, human
5081480|NCT01294813|Electric Impedance Tomography (EIT)|electric impedance tomography (eit)
5081481|NCT01294813|Ventilation|ventilation
5081482|NCT01294813|Bronchoscopy|bronchoscopy
5081483|NCT01294813|Lung Impedance|lung impedance
5081484|NCT01294813|Recruitment|recruitment
5081485|NCT01294800|Parkinson's disease|parkinson's disease
5081486|NCT01294787|COPD|copd
5081487|NCT01294787|QVA149|qva149
5081488|NCT01294787|tiotropium|tiotropium
5081490|NCT01294787|exercise tolerance|exercise tolerance
5081491|NCT01294787|combination bronchodilator|combination bronchodilator
5081492|NCT01294787|moderate to severe COPD|moderate to severe copd
5081493|NCT01294774|Lupus erythematosus|lupus erythematosus
5081494|NCT01294774|skin lupus|skin lupus
5081495|NCT01294761|HIV-1|hiv-1
5081496|NCT01294761|AIDS|aids
5081497|NCT01294761|Clinical Trials, Randomized|clinical trials, randomized
5081498|NCT01294748|Coronary Artery Disease|coronary artery disease
5081499|NCT01294748|Drug-eluting Stent|drug-eluting stent
5081500|NCT01294748|Sirolimus|sirolimus
5081501|NCT01294735|Temozolomide|temozolomide
5081502|NCT01294735|glioblastoma multiforme|glioblastoma multiforme
5081503|NCT01294735|melanoma|melanoma
5081504|NCT01294735|advanced neoplasm|advanced neoplasm
5081505|NCT01294722|Rheumatoid Arthritis|rheumatoid arthritis
5081506|NCT01294722|anti-TNF α|anti-tnf α
5081507|NCT01294709|angina pectoris|angina pectoris
5081508|NCT01294709|coronary artery disease|coronary artery disease
5081509|NCT01294709|calcitonin gene-related peptide|calcitonin gene-related peptide
5081510|NCT01294709|exercise tolerance,|exercise tolerance,
5081511|NCT01294696|Osteoarthritis|osteoarthritis
5081512|NCT01294696|Standard of care|standard of care
5081513|NCT01294683|Low-density lipoprotein|low-density lipoprotein
5081514|NCT01294683|LDL|ldl
5081515|NCT01294683|High-density lipoprotein|high-density lipoprotein
5081516|NCT01294683|HDL|hdl
5081517|NCT01294683|Niacin|niacin
5081518|NCT01294683|Lipid modifying therapy|lipid modifying therapy
5081519|NCT01294683|Cholesterol|cholesterol
5081520|NCT01294683|High cholesterol|high cholesterol
5081521|NCT01294683|Triglycerides|triglycerides
5081522|NCT01294683|Mixed Dyslipidemia|mixed dyslipidemia
5081523|NCT01294670|ETOPOSIDE (VP-16)|etoposide (vp-16)
5081524|NCT01294670|SAHA (SUBEROYLANILIDE HYDROXAMIC ACID) (Vorinostat)|saha (suberoylanilide hydroxamic acid) (vorinostat)
5081525|NCT01294670|Pediatric|pediatric
5081526|NCT01294670|10-096|10-096
5081527|NCT01294670|POETIC|poetic
5081528|NCT01294670|phase II component: the population will be restricted to relapsed/refractory sarcomas.|phase ii component: the population will be restricted to relapsed/refractory sarcomas.
5081529|NCT01294657|Obesity|obesity
5081530|NCT01294657|Cancer Risk|cancer risk
5081531|NCT01294657|African Americans|african americans
5081532|NCT01294657|Diet|diet
5081533|NCT01294657|Physical Activity|physical activity
5081534|NCT01294631|Canagliflozin|canagliflozin
5081535|NCT01294631|JNJ-28431754|jnj-28431754
5081536|NCT01294631|Hydrochlorothiazide|hydrochlorothiazide
5081537|NCT01294631|Pharmacokinetic|pharmacokinetic
5081538|NCT01294631|Pharmacodynamic|pharmacodynamic
5081539|NCT01294618|Chronic Myelogenous Leukemia|chronic myelogenous leukemia
5081540|NCT01294618|nilotinib|nilotinib
5081541|NCT01294618|pegylated interferon|pegylated interferon
5081542|NCT01294618|BCR-ABL Philadelphia chromosome|bcr-abl philadelphia chromosome
5081543|NCT01294618|Hematologic, cytogenetic and molecular response rates and kinetics will be studied in addition to the safety of the combination|hematologic, cytogenetic and molecular response rates and kinetics will be studied in addition to the safety of the combination
5081544|NCT01294605|DTPa|dtpa
5081545|NCT01294605|Td|td
5081546|NCT01294605|IPV|ipv
5081547|NCT01294579|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
5081548|NCT01294579|Ofatumumab|ofatumumab
5081549|NCT01294579|Relapsed|relapsed
5081550|NCT01294579|Rituximab|rituximab
5081551|NCT01294579|Bendamustine|bendamustine
5081552|NCT01294566|safety|safety
5081553|NCT01294566|motilin agonist|motilin agonist
5081554|NCT01294566|single dose|single dose
5081555|NCT01294566|ascending dose|ascending dose
5081556|NCT01294566|GSK1322888|gsk1322888
5081557|NCT01294566|migrating motor complex|migrating motor complex
5081558|NCT01294566|tolerability|tolerability
5081559|NCT01294566|FTIH|ftih
5081560|NCT01294566|gastric emptying|gastric emptying
5081561|NCT01294527|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
5081562|NCT01294527|cardiac pacing|cardiac pacing
5081563|NCT01294527|electrical stimulation|electrical stimulation
5081564|NCT01294527|bi-ventricular pacing|bi-ventricular pacing
5081565|NCT01294514|Respiratory Rate|respiratory rate
5081566|NCT01294501|Medication administration|medication administration
5081567|NCT01294501|Medication errors|medication errors
5081568|NCT01294501|Health Literacy|health literacy
5081569|NCT01294501|Pediatric Emergency Department|pediatric emergency department
5081570|NCT01294501|Web-based education|web-based education
5081571|NCT01294488|PCIT|pcit
5081572|NCT01294488|Child Maltreatment Prevention|child maltreatment prevention
5081573|NCT01294488|Practitioner Fidelity|practitioner fidelity
5081574|NCT01294462|acute coronary syndrome|acute coronary syndrome
5081575|NCT01294462|coronary disease|coronary disease
5081576|NCT01294462|coronary artery disease|coronary artery disease
5081577|NCT01294436|Phase3|phase3
5081578|NCT01294436|Clinical trial|clinical trial
5081579|NCT01294436|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
5081580|NCT01294423|Phase3|phase3
5081581|NCT01294423|Clinical trial|clinical trial
5081582|NCT01294423|Type2 Diabetes Mellitus|type2 diabetes mellitus
5081583|NCT01294397|Amgen|amgen
5081584|NCT01294397|Phase 1|phase 1
5081585|NCT01294397|Postmenopausal|postmenopausal
5081586|NCT01294397|Osteopenia|osteopenia
5081587|NCT01294397|Rheumatoid|rheumatoid
5081588|NCT01294397|Bone Mineral Density|bone mineral density
5081589|NCT01294397|Arthritis|arthritis
5081590|NCT01294397|Pharmacokinetics|pharmacokinetics
5081591|NCT01294397|Osteoporosis|osteoporosis
5081592|NCT01294371|Lucrin Depot|lucrin depot
5081593|NCT01294371|genital endometriosis|genital endometriosis
5081594|NCT01294371|6 months therapy|6 months therapy
5081595|NCT01294358|Pancreatic Cancer|pancreatic cancer
5081596|NCT01294358|Regional Therapy|regional therapy
5081597|NCT01294358|Selective Arterial Infusion|selective arterial infusion
5081598|NCT01294358|Locally Advanced Disease|locally advanced disease
5081599|NCT01294345|Genomics|genomics
5081600|NCT01294345|Personalized|personalized
5081601|NCT01294345|Congenital Malformations|congenital malformations
5081602|NCT01294345|Birth Defects|birth defects
5081603|NCT01294332|Cognition|cognition
5081604|NCT01294332|TBI|tbi
5081605|NCT01294332|Mood|mood
5081606|NCT01294332|Aerobic Exercise Training|aerobic exercise training
5081607|NCT01294332|Cardiorespiratory Fitness|cardiorespiratory fitness
5081608|NCT01294332|Traumatic Brain Injury|traumatic brain injury
5081609|NCT01294319|Cortical Resistance|cortical resistance
5081610|NCT01294319|ACTH|acth
5081611|NCT01294319|Glucocorticoid|glucocorticoid
5081612|NCT01294319|Mifepristone|mifepristone
5081613|NCT01294319|SPIRONOLACTONE|spironolactone
5081614|NCT01294319|Exercise|exercise
5081615|NCT01294319|Hypothalamic-Pituitary-Adrenal Axis|hypothalamic-pituitary-adrenal axis
5081616|NCT01294319|Healthy Volunteer|healthy volunteer
5081617|NCT01294319|HV|hv
5081618|NCT01294280|Stage I Non-Small Cell Lung Cancer|stage i non-small cell lung cancer
5081619|NCT01294280|Stage II Non-Small Cell Lung Cancer|stage ii non-small cell lung cancer
5081620|NCT01294267|Ventricular Tachycardia|ventricular tachycardia
5081621|NCT01294267|Radio Frequency Ablation|radio frequency ablation
5081622|NCT01294267|Percutaneous Left Ventricular Assist Device|percutaneous left ventricular assist device
5081623|NCT01294267|Hemodynamic Management|hemodynamic management
5081624|NCT01294267|Interventional Cardiac Procedure|interventional cardiac procedure
5081625|NCT01294267|Mechanical Cardiac Assistance|mechanical cardiac assistance
5081626|NCT01294267|Intra-Aortic Balloon Pump|intra-aortic balloon pump
5081627|NCT01294267|Coronary Intervention|coronary intervention
5081628|NCT01294267|Impella 2.5|impella 2.5
5081629|NCT01294267|Circulation Support system|circulation support system
5081630|NCT01294254|wound reepithelialization|wound reepithelialization
5081631|NCT01294241|Epidermolysis bullosa|epidermolysis bullosa
5081632|NCT01294241|Wound healing|wound healing
5081633|NCT01294241|Epithelialization|epithelialization
5081634|NCT01294215|BAYA1040|baya1040
5081635|NCT01294215|Nifedipine|nifedipine
5081636|NCT01294215|Essential hypertension|essential hypertension
5081637|NCT01294215|Japanese Patients|japanese patients
5081638|NCT01294215|Phase III|phase iii
5081639|NCT01294215|combination study|combination study
5081641|NCT01294202|GIST|gist
5081642|NCT01294202|Gastrointestinal Stromal Tumor|gastrointestinal stromal tumor
5081643|NCT01294202|unresectable|unresectable
5081644|NCT01294202|metastatic|metastatic
5081645|NCT01294202|AT13387|at13387
5081646|NCT01294202|Astex|astex
5081647|NCT01294202|Gleevec|gleevec
5081648|NCT01294202|Imatinib|imatinib
5081649|NCT01294189|end-of-life decisions, critical care, advance directive|end-of-life decisions, critical care, advance directive
5081650|NCT01294176|Optic Neuritis|optic neuritis
5081651|NCT01294176|Lipoic Acid|lipoic acid
5081652|NCT01294176|Multiple Sclerosis|multiple sclerosis
5081653|NCT01294176|Antioxidant|antioxidant
5081654|NCT01294176|OCT|oct
5081655|NCT01294176|Acute|acute
5081656|NCT01294163|Xenon|xenon
5081657|NCT01294163|Sevoflurane|sevoflurane
5081658|NCT01294163|Propofol|propofol
5081659|NCT01294163|Total intravenous anaesthesia|total intravenous anaesthesia
5081660|NCT01294163|Anaesthesia|anaesthesia
5081661|NCT01294163|Coronary artery disease|coronary artery disease
5081662|NCT01294163|Coronary artery bypass graft|coronary artery bypass graft
5081663|NCT01294137|frail|frail
5081664|NCT01294137|elderly|elderly
5081665|NCT01294137|hospitalized|hospitalized
5081666|NCT01294137|sleep apnea|sleep apnea
5081667|NCT01294137|oximetry|oximetry
5081668|NCT01294111|Fatigue|fatigue
5081669|NCT01294111|Quality of life|quality of life
5081670|NCT01294111|Elderly|elderly
5081671|NCT01294098|Femoral Fractures|femoral fractures
5081672|NCT01294098|Pediatrics|pediatrics
5081673|NCT01294098|Pain, Postoperative|pain, postoperative
5081674|NCT01294072|curcumin|curcumin
5081675|NCT01294072|plant exosomes|plant exosomes
5081676|NCT01294072|malignant colon tissue|malignant colon tissue
5081677|NCT01294059|Fibromyalgia|fibromyalgia
5081678|NCT01294059|Hyperalgesia|hyperalgesia
5081679|NCT01294059|Pain|pain
5081680|NCT01294059|Central Sensitization|central sensitization
5081681|NCT01294046|Episodic migraine headache|episodic migraine headache
5081682|NCT01294020|Transplant|transplant
5081683|NCT01294020|Liver|liver
5081684|NCT01294020|Tacrolimus|tacrolimus
5081685|NCT01294020|Kidney|kidney
5081686|NCT01294020|Heart|heart
5081687|NCT01294020|Lung|lung
5081688|NCT01294020|Immunosuppression|immunosuppression
5081689|NCT01294020|Advagraf|advagraf
5082185|NCT01291953|prevention|prevention
5081690|NCT01294020|Pharmacokinetics|pharmacokinetics
5081691|NCT01293994|Chronic Pain, Genetic Variation, Opioid Medications, Pain|chronic pain, genetic variation, opioid medications, pain
5081692|NCT01293968|Aphthous Stomatitis|aphthous stomatitis
5081693|NCT01293968|Ibuprofen|ibuprofen
5081694|NCT01293968|treatment efficacy|treatment efficacy
5081695|NCT01293955|cartilage|cartilage
5081696|NCT01293955|knee osteoarthritis|knee osteoarthritis
5081697|NCT01293955|protective effect|protective effect
5081698|NCT01293942|unresectable liver-only metastases in colorectal cancer|unresectable liver-only metastases in colorectal cancer
5081699|NCT01293916|pediatric|pediatric
5081700|NCT01293916|femur|femur
5081701|NCT01293916|femoral|femoral
5081702|NCT01293916|fracture|fracture
5081703|NCT01293916|spica|spica
5081704|NCT01293916|cast|cast
5081705|NCT01293916|diaphyseal|diaphyseal
5081706|NCT01293916|single|single
5081707|NCT01293916|double|double
5081708|NCT01293916|patient age 2 to 6 years old|patient age 2 to 6 years old
5081709|NCT01293903|Immunomodulation|immunomodulation
5081710|NCT01293890|adherence|adherence
5081711|NCT01293890|medication|medication
5081712|NCT01293890|exacerbations|exacerbations
5081713|NCT01293890|hospital admission|hospital admission
5081714|NCT01293877|Laparoscopy|laparoscopy
5081715|NCT01293877|obesity|obesity
5081716|NCT01293877|gastric|gastric
5081717|NCT01293877|restrictive|restrictive
5081718|NCT01293864|structural analysis, diffusible proteins, glycosaminoglycans|structural analysis, diffusible proteins, glycosaminoglycans
5081719|NCT01293851|Biomarkers|biomarkers
5081720|NCT01293851|Gene Expression|gene expression
5081721|NCT01293851|Neuropathic Pain|neuropathic pain
5081722|NCT01293851|Neurotoxicity|neurotoxicity
5081723|NCT01293851|Chemotherapy|chemotherapy
5081724|NCT01293851|Peripheral Neuropathic Pain|peripheral neuropathic pain
5081725|NCT01293851|Cancer|cancer
5081726|NCT01293838|Adolescents|adolescents
5081727|NCT01293838|Anxiety Disorder|anxiety disorder
5081728|NCT01293838|Cipralex|cipralex
5081729|NCT01293838|Social Phobia|social phobia
5081730|NCT01293838|Separation Anxiety Disorder|separation anxiety disorder
5081731|NCT01293838|Panic Disorder|panic disorder
5081732|NCT01293838|Generalized Anxiety Disorder|generalized anxiety disorder
5081733|NCT01293838|physiological arousal|physiological arousal
5081734|NCT01293838|stress response|stress response
5081735|NCT01293838|salivary cortisol|salivary cortisol
5081736|NCT01293838|salivary alpha-amylase|salivary alpha-amylase
5081737|NCT01293838|heart rate variability|heart rate variability
5081738|NCT01293799|Randomized|randomized
5081739|NCT01293799|Peritoneal dialysis|peritoneal dialysis
5081740|NCT01293799|Peritonitis|peritonitis
5081741|NCT01293799|Primary prevention|primary prevention
5081742|NCT01293799|Quality control|quality control
5081743|NCT01293799|Self care|self care
5081744|NCT01293799|Kidney failure, chronic|kidney failure, chronic
5081745|NCT01293786|magnesium|magnesium
5081746|NCT01293786|kidney transplantation|kidney transplantation
5081747|NCT01293786|hypomagnesemia|hypomagnesemia
5081748|NCT01293773|Randomized controlled trial|randomized controlled trial
5081749|NCT01293773|Drug-eluting Stent|drug-eluting stent
5081750|NCT01293773|Multicenter study|multicenter study
5081751|NCT01293760|intrauterine device|intrauterine device
5081752|NCT01293760|contraception|contraception
5081753|NCT01293747|Estrogen|estrogen
5081754|NCT01293747|Progesterone|progesterone
5081755|NCT01293747|Microspheres|microspheres
5081756|NCT01293747|Menopause|menopause
5081757|NCT01293747|Pharmacokinetics|pharmacokinetics
5081758|NCT01293734|bronchial asthma|bronchial asthma
5081759|NCT01293734|cold type|cold type
5081760|NCT01293734|heat type|heat type
5081761|NCT01293734|Asthenia type|asthenia type
5081762|NCT01293734|TCM syndrome|tcm syndrome
5081763|NCT01293734|symptoms|symptoms
5081764|NCT01293734|physical signs|physical signs
5081765|NCT01293721|Bone Mineral Density|bone mineral density
5081766|NCT01293721|Vibration|vibration
5081767|NCT01293721|Rehabilitation|rehabilitation
5081768|NCT01293721|Fracture healing rate|fracture healing rate
5081769|NCT01293708|Octogenarians|octogenarians
5081770|NCT01293708|HRQOL|hrqol
5081771|NCT01293708|mortality|mortality
5081772|NCT01293708|prospective observational|prospective observational
5081773|NCT01293708|Elderly|elderly
5081774|NCT01293695|hot flashes|hot flashes
5081775|NCT01293695|post menopausal women|post menopausal women
5081776|NCT01293695|skin conductance monitors|skin conductance monitors
5081777|NCT01293695|hypnosis|hypnosis
5081778|NCT01293695|hypnotizability|hypnotizability
5081779|NCT01293669|Type 2 Diabetes|type 2 diabetes
5081780|NCT01293669|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
5081781|NCT01293604|Barley|barley
5081782|NCT01293604|Oats|oats
5081783|NCT01293604|Whole grains|whole grains
5081784|NCT01293604|Cardiovascular disease|cardiovascular disease
5081785|NCT01293604|adults not taking lipid-lowering or glucoregulatory medications.|adults not taking lipid-lowering or glucoregulatory medications.
5081786|NCT01293591|Garlic|garlic
5081787|NCT01293591|Cancer biomarkers|cancer biomarkers
5081788|NCT01293591|Gene expression|gene expression
5081789|NCT01293591|Oxidative stress|oxidative stress
5081790|NCT01293591|DNA damage|dna damage
5081791|NCT01293578|Decision Aids|decision aids
5081792|NCT01293578|Shared Medical Decision Making|shared medical decision making
5081793|NCT01293578|Patient Education|patient education
5081794|NCT01293578|Endocrine System Diseases|endocrine system diseases
5081795|NCT01293578|Glucose Metabolism Disorders|glucose metabolism disorders
5081796|NCT01293578|Metabolic Diseases|metabolic diseases
5081797|NCT01293565|X-Linked Hypohidrotic Ectodermal Dysplasia|x-linked hypohidrotic ectodermal dysplasia
5081798|NCT01293565|Hypohidrotic Ectodermal Dysplasia|hypohidrotic ectodermal dysplasia
5081799|NCT01293565|XLHED|xlhed
5081801|NCT01293539|Retinoblastoma|retinoblastoma
5081802|NCT01293539|intra-arterial chemotherapy|intra-arterial chemotherapy
5081803|NCT01293539|angiography|angiography
5081804|NCT01293526|Heart failure|heart failure
5081805|NCT01293526|echocardiography|echocardiography
5081806|NCT01293513|Only patients with Acute or Primary HIV infection will be studied|only patients with acute or primary hiv infection will be studied
5081807|NCT01293500|SIRS|sirs
5081808|NCT01293500|shock|shock
5081809|NCT01293500|sepsis|sepsis
5081810|NCT01293500|pediatric|pediatric
5081811|NCT01293500|inter-facility transport|inter-facility transport
5081812|NCT01293500|specialized transport|specialized transport
5081813|NCT01293500|NIRS monitoring|nirs monitoring
5081814|NCT01293487|Phase 1|phase 1
5081815|NCT01293487|Osteopenia|osteopenia
5081816|NCT01293487|RN564|rn564
5081817|NCT01293448|Esophagectomy|esophagectomy
5081818|NCT01293448|Barrett's Esophagus|barrett's esophagus
5081819|NCT01293435|Community Acquired Pneumonia (CAP)|community acquired pneumonia (cap)
5081820|NCT01293435|Complicated Skin and Skin Structures Infections (cSSSI)|complicated skin and skin structures infections (csssi)
5081821|NCT01293435|Complicated Skin and Soft Tissues Infections (cSSTI)|complicated skin and soft tissues infections (cssti)
5081822|NCT01293435|Antibiotics|antibiotics
5081823|NCT01293435|Infection management|infection management
5081824|NCT01293435|Use of Resources|use of resources
5081825|NCT01293435|MRSA|mrsa
5081826|NCT01293435|PRSP|prsp
5081827|NCT01293422|PXR, glucose, cholesterol|pxr, glucose, cholesterol
5081828|NCT01293396|insulin aspart 30|insulin aspart 30
5081829|NCT01293396|insulin aspart 70|insulin aspart 70
5081830|NCT01293396|insulin aspart|insulin aspart
5081831|NCT01293396|postprandial glucose and lipid metabolism|postprandial glucose and lipid metabolism
5081832|NCT01293396|consecutive mixed meals|consecutive mixed meals
5081833|NCT01293344|Cardiovascular diseases|cardiovascular diseases
5081834|NCT01293344|Controlled nutritional intervention|controlled nutritional intervention
5081835|NCT01293344|Sex differences|sex differences
5081836|NCT01293344|Women|women
5081837|NCT01293344|Men|men
5081838|NCT01293344|Cardiovascular risk|cardiovascular risk
5081839|NCT01293344|Lipid profile|lipid profile
5081840|NCT01293344|Blood pressure|blood pressure
5081841|NCT01293344|Insulin sensitivity|insulin sensitivity
5081842|NCT01293344|Inflammatory markers|inflammatory markers
5081843|NCT01293344|Endothelial function|endothelial function
5081844|NCT01293344|Oxidative stress|oxidative stress
5081845|NCT01293331|Dengue Fever Fever Seroprevalence|dengue fever fever seroprevalence
5081846|NCT01293318|Copeptin|copeptin
5081847|NCT01293318|Vasopressin|vasopressin
5081848|NCT01293318|antidiuretic hormone (ADH)|antidiuretic hormone (adh)
5081849|NCT01293305|osteoarthritis|osteoarthritis
5081850|NCT01293292|Osteoporosis|osteoporosis
5081851|NCT01293292|Forsteo|forsteo
5081852|NCT01293292|Teriparatide|teriparatide
5081853|NCT01293279|HCV viral genotypes|hcv viral genotypes
5081854|NCT01293279|host genotypes|host genotypes
5081855|NCT01293279|IL28B|il28b
5081856|NCT01293279|ITPA|itpa
5081857|NCT01293279|RNA|rna
5081858|NCT01293279|China|china
5081859|NCT01293266|Propofol|propofol
5081860|NCT01293266|Metabolic Acidosis|metabolic acidosis
5081861|NCT01293266|Pediatric Cardiology|pediatric cardiology
5081862|NCT01293266|Anesthesia|anesthesia
5081863|NCT01293227|Wrist Fracture|wrist fracture
5081864|NCT01293214|limb transplantation|limb transplantation
5081865|NCT01293214|limb allotransplantation|limb allotransplantation
5081866|NCT01293214|hand transplantation|hand transplantation
5081867|NCT01293214|hand allotransplantation|hand allotransplantation
5081868|NCT01293214|hand amputation|hand amputation
5081869|NCT01293214|leg transplantation|leg transplantation
5081870|NCT01293201|SAR|sar
5081871|NCT01293201|Seasonal Allergic Rhinitis|seasonal allergic rhinitis
5081872|NCT01293188|Aortic Valve Replacement|aortic valve replacement
5081873|NCT01293188|Bioprosthetic|bioprosthetic
5081874|NCT01293175|whole grains|whole grains
5081875|NCT01293175|polyphenols|polyphenols
5081876|NCT01293175|overweight|overweight
5081877|NCT01293175|bioavailability|bioavailability
5081878|NCT01293175|antioxidant status|antioxidant status
5081879|NCT01293175|inflammation|inflammation
5081880|NCT01293162|Metabolic syndrome|metabolic syndrome
5081881|NCT01293162|Cardiovascular risk|cardiovascular risk
5081882|NCT01293149|knee, reconstructive surgery|knee, reconstructive surgery
5081883|NCT01293149|femoral nerve block|femoral nerve block
5081884|NCT01293136|knee|knee
5081885|NCT01293136|reconstructive surgery|reconstructive surgery
5081886|NCT01293136|femoral nerve block|femoral nerve block
5081887|NCT01293123|HIV|hiv
5081888|NCT01293123|raltegravir|raltegravir
5081889|NCT01293123|cerebrospinal fluid|cerebrospinal fluid
5081890|NCT01293110|urodynamics|urodynamics
5081891|NCT01293110|neurogenic lower urinary tract dysfunction|neurogenic lower urinary tract dysfunction
5081892|NCT01293110|neurological disease/injury|neurological disease/injury
5081893|NCT01293084|mucociliary clearance|mucociliary clearance
5081894|NCT01293084|children|children
5081895|NCT01293084|cystic fibrosis|cystic fibrosis
5081896|NCT01293084|hypertonic saline|hypertonic saline
5081897|NCT01293071|Antibiotic rotation|antibiotic rotation
5081898|NCT01293071|Cycling|cycling
5081899|NCT01293071|Mixing|mixing
5081900|NCT01293071|Gram-negative|gram-negative
5081901|NCT01293071|EU|eu
5081902|NCT01293071|Multi center|multi center
5081903|NCT01293071|Multi Centre|multi centre
5081904|NCT01293071|Cluster randomized trial|cluster randomized trial
5081905|NCT01293071|Cross over|cross over
5081906|NCT01293058|opioid|opioid
5081907|NCT01293058|overdose|overdose
5081908|NCT01293058|naloxone|naloxone
5081909|NCT01293058|intranasal|intranasal
5081910|NCT01293045|Osteoporosis|osteoporosis
5081911|NCT01293045|Postmenopausal women|postmenopausal women
5081912|NCT01293045|Functional food|functional food
5081913|NCT01293045|Hydrolysed collagen|hydrolysed collagen
5081914|NCT01293045|Bone metabolism|bone metabolism
5081915|NCT01293045|Bone marker of resorption|bone marker of resorption
5081916|NCT01293045|Bone marker of formation|bone marker of formation
5081917|NCT01293032|Estrogen Receptor Positive|estrogen receptor positive
5081918|NCT01293032|Progesterone Receptor Positive|progesterone receptor positive
5081919|NCT01293032|HER2/Neu Negative|her2/neu negative
5081920|NCT01293032|Breast Cancer|breast cancer
5081921|NCT01293019|Complementary and alternative medicine|complementary and alternative medicine
5081922|NCT01293019|Osteopathic treatment|osteopathic treatment
5081923|NCT01293006|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
5081924|NCT01292980|sDTI|sdti
5081925|NCT01292980|Pressure ulcers|pressure ulcers
5081926|NCT01292980|Therapy surfaces|therapy surfaces
5081927|NCT01292980|Mattresses|mattresses
5081928|NCT01292980|Deep Tissue Injury|deep tissue injury
5081929|NCT01292980|pressure ulcer treatment|pressure ulcer treatment
5081930|NCT01292967|Flavanol|flavanol
5081931|NCT01292967|cocoa|cocoa
5081932|NCT01292967|maltitol|maltitol
5081933|NCT01292967|absorption|absorption
5081934|NCT01292967|metabolism|metabolism
5081935|NCT01292967|chocolate|chocolate
5081936|NCT01292967|food matrix|food matrix
5081937|NCT01292967|bioavailability|bioavailability
5081938|NCT01292954|blueberries|blueberries
5081939|NCT01292954|vascular function|vascular function
5081940|NCT01292954|FMD|fmd
5081941|NCT01292954|Blood pressure|blood pressure
5081942|NCT01292954|Laser Doppler|laser doppler
5081943|NCT01292954|pharmacokinetics|pharmacokinetics
5081944|NCT01292954|absorption|absorption
5081945|NCT01292954|metabolism|metabolism
5081946|NCT01292954|polyphenols|polyphenols
5081947|NCT01292954|flavonoids|flavonoids
5081948|NCT01292928|Atherosclerosis, Superficial Femoral Artery (SFA), Proximal Popliteal Artery (PPA), lower extremities, Stenting|atherosclerosis, superficial femoral artery (sfa), proximal popliteal artery (ppa), lower extremities, stenting
5081949|NCT01292915|Re-bleeding, NVUGIB|re-bleeding, nvugib
5081950|NCT01292889|Seasonal Affective Disorder|seasonal affective disorder
5081951|NCT01292889|Major Depressive Disorder|major depressive disorder
5081952|NCT01292889|Depression|depression
5081953|NCT01292889|Winter Blues|winter blues
5081954|NCT01292876|MTURR|mturr
5081955|NCT01292876|ECM|ecm
5081956|NCT01292876|Muscle Loss|muscle loss
5081957|NCT01292876|Tendon|tendon
5081958|NCT01292876|Tendon Repair|tendon repair
5081959|NCT01292876|Muscle Repair|muscle repair
5081960|NCT01292876|Soft Tissue Repair|soft tissue repair
5081961|NCT01292876|Scaffold|scaffold
5081962|NCT01292876|Extracellular Matrix|extracellular matrix
5081963|NCT01292863|Peritoneal dialysis|peritoneal dialysis
5081964|NCT01292863|Biocompatible dialysis fluid|biocompatible dialysis fluid
5081965|NCT01292850|Topical|topical
5081966|NCT01292850|Skin|skin
5081967|NCT01292850|sterility|sterility
5081968|NCT01292850|ethylchloride|ethylchloride
5081969|NCT01292850|ethyl|ethyl
5081970|NCT01292850|chloride|chloride
5081971|NCT01292850|spray|spray
5081972|NCT01292837|Levetiracetam|levetiracetam
5081973|NCT01292837|Epilepsy|epilepsy
5081974|NCT01292837|Generalized tonic-clonic seizures|generalized tonic-clonic seizures
5081975|NCT01292824|Hepatitis C virus|hepatitis c virus
5081976|NCT01292824|Entry|entry
5081977|NCT01292824|Scavenger receptor-BI|scavenger receptor-bi
5081978|NCT01292824|High density lipoprotein|high density lipoprotein
5081979|NCT01292824|Liver transplantation|liver transplantation
5081980|NCT01292811|Spinal Cord Injury|spinal cord injury
5081981|NCT01292811|Functional Electrical Stimulation|functional electrical stimulation
5081982|NCT01292811|Hand function|hand function
5081983|NCT01292811|Tetraplegia|tetraplegia
5081984|NCT01292798|Diabetes|diabetes
5081985|NCT01292798|Macula|macula
5081986|NCT01292798|Edema|edema
5081987|NCT01292798|Retina|retina
5081988|NCT01292772|breast cancer|breast cancer
5081989|NCT01292772|bilateral mastectomy|bilateral mastectomy
5082387|NCT01291238|adolescents|adolescents
5081990|NCT01292772|immediate breast reconstruction|immediate breast reconstruction
5081991|NCT01292772|locally advanced unilateral breast cancer|locally advanced unilateral breast cancer
5081992|NCT01292772|bilateral mastectomy for prophylaxis|bilateral mastectomy for prophylaxis
5081993|NCT01292759|stroke volume|stroke volume
5081994|NCT01292759|cardiac output|cardiac output
5081995|NCT01292759|validation|validation
5081996|NCT01292733|Women with increased risk for developing ovarian cancer|women with increased risk for developing ovarian cancer
5081997|NCT01292733|Women diagnosed with reproductive cancer|women diagnosed with reproductive cancer
5081998|NCT01292733|Women with relatives who have had ovarian or breast cancer|women with relatives who have had ovarian or breast cancer
5081999|NCT01292720|vitamin D deficiency, vitamin D insufficiency, heart failure|vitamin d deficiency, vitamin d insufficiency, heart failure
5082000|NCT01292707|malaria|malaria
5082001|NCT01292707|rdt|rdt
5082002|NCT01292707|fever|fever
5082003|NCT01292707|treatment|treatment
5082004|NCT01292694|supine hypertension|supine hypertension
5082005|NCT01292694|autonomic failure|autonomic failure
5082006|NCT01292694|angiotensin|angiotensin
5082007|NCT01292694|losartan|losartan
5082008|NCT01292694|captopril|captopril
5082009|NCT01292681|colorectal cancer|colorectal cancer
5082010|NCT01292681|FDG-PET-CT|fdg-pet-ct
5082011|NCT01292681|MRS,|mrs,
5082012|NCT01292681|DCE-MRI|dce-mri
5082013|NCT01292681|DWI|dwi
5082014|NCT01292681|colorectal cancer with histologically proven distant metastases|colorectal cancer with histologically proven distant metastases
5082015|NCT01292642|cognitive behavioral therapy|cognitive behavioral therapy
5082016|NCT01292642|nicotine dependence|nicotine dependence
5082017|NCT01292642|cannabis dependence|cannabis dependence
5082018|NCT01292642|smoking cessation|smoking cessation
5082019|NCT01292642|nicotine replacement therapy|nicotine replacement therapy
5082020|NCT01292629|intraocular lens|intraocular lens
5082021|NCT01292629|IOL|iol
5082022|NCT01292629|cataract|cataract
5082023|NCT01292629|Hoya|hoya
5082024|NCT01292629|surgical|surgical
5082025|NCT01292629|optics|optics
5082026|NCT01292629|ocular|ocular
5082027|NCT01292629|visual acuity|visual acuity
5082028|NCT01292577|Schizophrenia|schizophrenia
5082029|NCT01292577|Schizoaffective Disorder|schizoaffective disorder
5082030|NCT01292577|Cannabis|cannabis
5082031|NCT01292577|Alcohol|alcohol
5082032|NCT01292577|Substance Misuse|substance misuse
5082033|NCT01292577|Cognition|cognition
5082034|NCT01292577|Psychosocial Treatment|psychosocial treatment
5082035|NCT01292577|Cognitive Enhancement Therapy|cognitive enhancement therapy
5082036|NCT01292577|Personal Therapy|personal therapy
5082037|NCT01292577|Treatment as Usual|treatment as usual
5082038|NCT01292551|single ventricle physiology|single ventricle physiology
5082039|NCT01292551|Fontan procedure|fontan procedure
5082040|NCT01292525|Withdrawal of Tacrolimus and renal graft|withdrawal of tacrolimus and renal graft
5082041|NCT01292525|renal allograft|renal allograft
5082042|NCT01292525|stable renal function|stable renal function
5082043|NCT01292512|Bereavement management|bereavement management
5082044|NCT01292512|Complicated grief|complicated grief
5082045|NCT01292499|psychotherapy|psychotherapy
5082046|NCT01292499|psychoeducation|psychoeducation
5082047|NCT01292499|depression|depression
5082048|NCT01292447|Pain measurement|pain measurement
5082049|NCT01292447|Intrauterine devices|intrauterine devices
5082050|NCT01292447|Lidocaine|lidocaine
5082051|NCT01292434|Diet|diet
5082052|NCT01292434|Obesity|obesity
5082053|NCT01292434|Child Preschool|child preschool
5082054|NCT01292434|Treatment Outcome|treatment outcome
5082055|NCT01292434|Body Mass Index|body mass index
5082056|NCT01292434|Intervention Studies|intervention studies
5082057|NCT01292434|Randomized Controlled Trial|randomized controlled trial
5082058|NCT01292434|Child Day Care Centers|child day care centers
5082059|NCT01292434|Schools Nursery|schools nursery
5082060|NCT01292434|Child Care|child care
5082061|NCT01292408|autophagy|autophagy
5082062|NCT01292408|hydroxychloroquine|hydroxychloroquine
5082063|NCT01292408|hypoxia|hypoxia
5082064|NCT01292408|proven invasive adenocarcinoma of the breast: tumors are found to be ER negative (<10% ER pos cells)|proven invasive adenocarcinoma of the breast: tumors are found to be er negative (<10% er pos cells)
5082065|NCT01292395|dietary supplement|dietary supplement
5082066|NCT01292395|protein metabolism|protein metabolism
5082067|NCT01292395|bone turnover|bone turnover
5082068|NCT01292382|Elderly|elderly
5082069|NCT01292382|Memory|memory
5082070|NCT01292382|Cognition|cognition
5082071|NCT01292382|Repetitive transcranial magnetic stimulation|repetitive transcranial magnetic stimulation
5082072|NCT01292369|breath test|breath test
5082073|NCT01292369|colon cancer|colon cancer
5082074|NCT01292369|breast cancer|breast cancer
5082075|NCT01292343|third molars|third molars
5082076|NCT01292343|triclosan|triclosan
5082077|NCT01292343|toothpaste|toothpaste
5082078|NCT01292343|dry socket|dry socket
5082079|NCT01292343|wound infection|wound infection
5082080|NCT01292330|liver Tumor|liver tumor
5082081|NCT01292317|NGAL|ngal
5082082|NCT01292317|neutrophil gelatinase-associated Lipocalin|neutrophil gelatinase-associated lipocalin
5082083|NCT01292317|contrast media nephropathy|contrast media nephropathy
5082084|NCT01292317|CIN|cin
5082085|NCT01292317|volume expansion|volume expansion
5082086|NCT01292317|acute kidney injury|acute kidney injury
5082087|NCT01292317|contrast media|contrast media
5082088|NCT01292304|Cirrhotic|cirrhotic
5082089|NCT01292304|Tolvaptan|tolvaptan
5082090|NCT01292304|v2 receptor antagonist|v2 receptor antagonist
5082091|NCT01292291|stage I prostate cancer|stage i prostate cancer
5082092|NCT01292291|stage IIA prostate cancer|stage iia prostate cancer
5082093|NCT01292291|stage IIB prostate cancer|stage iib prostate cancer
5082094|NCT01292278|subarachnoid hemorrhage|subarachnoid hemorrhage
5082095|NCT01292278|cerebral vasospasm|cerebral vasospasm
5082096|NCT01292278|neuropeptide Y|neuropeptide y
5082097|NCT01292278|spontaneous|spontaneous
5082098|NCT01292278|aneurysmal|aneurysmal
5082099|NCT01292265|Arthritis|arthritis
5082100|NCT01292265|Joint pain|joint pain
5082101|NCT01292265|Inflammation|inflammation
5082102|NCT01292265|Rheumatoid Arthritis|rheumatoid arthritis
5082103|NCT01292239|Hepatitis C, Chronic|hepatitis c, chronic
5082104|NCT01292239|Hepatitis C|hepatitis c
5082105|NCT01292239|Hepatitis C virus|hepatitis c virus
5082106|NCT01292239|Interferon Alfa-2a|interferon alfa-2a
5082107|NCT01292239|Ribavirin|ribavirin
5082108|NCT01292239|Viral RNA|viral rna
5082109|NCT01292213|Chronic cough|chronic cough
5082110|NCT01292213|Haemophilus influenzae|haemophilus influenzae
5082111|NCT01292200|Chinese women|chinese women
5082112|NCT01292200|Mammography|mammography
5082113|NCT01292200|Breast Cancer|breast cancer
5082114|NCT01292187|Osteoporosis|osteoporosis
5082115|NCT01292187|Osteopenia|osteopenia
5082116|NCT01292187|Osteoporosis, Postmenopausal|osteoporosis, postmenopausal
5082117|NCT01292187|Bone Diseases, Metabolic|bone diseases, metabolic
5082118|NCT01292187|Bone Diseases|bone diseases
5082119|NCT01292187|Musculoskeletal Diseases|musculoskeletal diseases
5082120|NCT01292187|Salmon calcitonin|salmon calcitonin
5082121|NCT01292187|Calcitonin|calcitonin
5082122|NCT01292174|HIV prevention|hiv prevention
5082123|NCT01292161|Hepatitis C|hepatitis c
5082124|NCT01292161|Silymarin|silymarin
5082125|NCT01292161|Quality of life|quality of life
5082126|NCT01292148|resuscitation, hypothermia|resuscitation, hypothermia
5082127|NCT01292135|Lymphoma, B-Cell|lymphoma, b-cell
5082128|NCT01292135|Leukemia, Lymphoid|leukemia, lymphoid
5082129|NCT01292135|Leukemia, B-Cell|leukemia, b-cell
5082130|NCT01292135|Bruton's Tyrosine Kinase|bruton's tyrosine kinase
5082131|NCT01292122|Wounds|wounds
5082132|NCT01292122|Grafts|grafts
5082133|NCT01292122|Wound Healing|wound healing
5082134|NCT01292122|Cell Therapy|cell therapy
5082135|NCT01292122|Split-thickness skin graft donor site wound|split-thickness skin graft donor site wound
5082136|NCT01292109|endoscopy|endoscopy
5082137|NCT01292109|colonoscopy|colonoscopy
5082138|NCT01292109|preparation for surgery|preparation for surgery
5082139|NCT01292096|homelessness|homelessness
5082140|NCT01292096|substance use|substance use
5082141|NCT01292096|frequent hospitalization|frequent hospitalization
5082142|NCT01292096|frequent users of health services|frequent users of health services
5082143|NCT01292096|enhanced care management|enhanced care management
5082144|NCT01292096|coordination services p|coordination services p
5082145|NCT01292096|high risk for frequent hospitalization|high risk for frequent hospitalization
5082146|NCT01292070|Fel d 1 protein, Felis domesticus|fel d 1 protein, felis domesticus
5082147|NCT01292070|Injections, Intradermal|injections, intradermal
5082148|NCT01292057|Alcohol|alcohol
5082149|NCT01292057|Aripiprazole|aripiprazole
5082150|NCT01292057|Impulsivity|impulsivity
5082151|NCT01292057|Alcoholism|alcoholism
5082152|NCT01292057|drinking|drinking
5082153|NCT01292057|treatment|treatment
5082154|NCT01292057|craving|craving
5082155|NCT01292057|brain imaging|brain imaging
5082156|NCT01292057|genetics|genetics
5082157|NCT01292044|elastography|elastography
5082158|NCT01292044|cytology|cytology
5082159|NCT01292031|VAP|vap
5082160|NCT01292031|MDR-GNB|mdr-gnb
5082161|NCT01292031|colistin|colistin
5082162|NCT01292031|meropenem|meropenem
5082163|NCT01292018|Management of dyslipidemia in Type 2 Diabetes Mellitus adult patients in India|management of dyslipidemia in type 2 diabetes mellitus adult patients in india
5082164|NCT01292018|Dyslipidemia control rates in Type 2 diabetic Mellitus patients|dyslipidemia control rates in type 2 diabetic mellitus patients
5082165|NCT01292005|pancreatitis|pancreatitis
5082166|NCT01292005|pancreatic necrosis|pancreatic necrosis
5082167|NCT01292005|severe acute pancreatitis (SAP)|severe acute pancreatitis (sap)
5082168|NCT01292005|Alcoholic pancreatitis|alcoholic pancreatitis
5082169|NCT01292005|gallstone pancreatitis|gallstone pancreatitis
5082170|NCT01291992|Non-convulsive seizures|non-convulsive seizures
5082171|NCT01291992|Cardiac Surgery|cardiac surgery
5082172|NCT01291992|Postop|postop
5082173|NCT01291992|24 hour EEG Monitoring|24 hour eeg monitoring
5082174|NCT01291979|Pain|pain
5082175|NCT01291979|Preemptive|preemptive
5082176|NCT01291979|Lidocaine|lidocaine
5082177|NCT01291979|Intravenous|intravenous
5082178|NCT01291979|Tonsillectomy|tonsillectomy
5082179|NCT01291966|medication errors|medication errors
5082180|NCT01291966|Patient Compliance|patient compliance
5082181|NCT01291966|patient safety|patient safety
5082182|NCT01291966|polypharmacy|polypharmacy
5082183|NCT01291953|atrial fibrillation|atrial fibrillation
5082184|NCT01291953|screening|screening
5082186|NCT01291953|case finding|case finding
5082187|NCT01291953|primary care|primary care
5082188|NCT01291927|Periampullary carcinoma|periampullary carcinoma
5082189|NCT01291927|Pancreas-sparing Duodenectomy|pancreas-sparing duodenectomy
5082190|NCT01291927|pancreaticoduodenectomy|pancreaticoduodenectomy
5082191|NCT01291927|lymphadenectomy|lymphadenectomy
5082192|NCT01291914|Osteoarthritis|osteoarthritis
5082193|NCT01291914|knee|knee
5082194|NCT01291914|intra-articular|intra-articular
5082195|NCT01291914|safety|safety
5082196|NCT01291914|efficacy|efficacy
5082197|NCT01291914|pharmacokinetics|pharmacokinetics
5082198|NCT01291914|pain|pain
5082199|NCT01291901|pain|pain
5082200|NCT01291901|cancer|cancer
5082201|NCT01291901|malignancy|malignancy
5082202|NCT01291901|intractable|intractable
5082203|NCT01291901|gene therapy|gene therapy
5082204|NCT01291901|enkephalin|enkephalin
5082205|NCT01291901|opioid|opioid
5082206|NCT01291875|Type 2 Diabetes mellitus|type 2 diabetes mellitus
5082207|NCT01291875|Periodontal Disease|periodontal disease
5082208|NCT01291875|metabolic control|metabolic control
5082209|NCT01291875|periodontal treatment|periodontal treatment
5082210|NCT01291875|inflammatory markers|inflammatory markers
5082211|NCT01291849|nasal surgery|nasal surgery
5082212|NCT01291849|endoscopic sinus surgery|endoscopic sinus surgery
5082213|NCT01291849|septoplasty|septoplasty
5082214|NCT01291849|Cough|cough
5082215|NCT01291836|Acute Kidney Injury (AKI)|acute kidney injury (aki)
5082216|NCT01291836|Acute Decompensated Heart Failure (ADHF)|acute decompensated heart failure (adhf)
5082217|NCT01291836|Neutrophil Gelatinase Associated Lipocalin (NGAL)|neutrophil gelatinase associated lipocalin (ngal)
5082218|NCT01291836|biomarker|biomarker
5082219|NCT01291823|gefitinib|gefitinib
5082220|NCT01291823|radiation|radiation
5082221|NCT01291823|esophageal cancer|esophageal cancer
5082222|NCT01291797|congenital heart disease|congenital heart disease
5082223|NCT01291797|neurodevelopmental outcome|neurodevelopmental outcome
5082224|NCT01291797|AEEG|aeeg
5082225|NCT01291797|sleep wake cycles|sleep wake cycles
5082226|NCT01291784|monoclonal antibody|monoclonal antibody
5082227|NCT01291771|End stage renal disease|end stage renal disease
5082228|NCT01291771|myocardial microvascular disease|myocardial microvascular disease
5082229|NCT01291771|cardiorenal syndrome|cardiorenal syndrome
5082230|NCT01291771|coronary flow reserve|coronary flow reserve
5082231|NCT01291771|index of microvascular resistance|index of microvascular resistance
5082232|NCT01291771|Patients with end stage renal disease scheduled or not for kidney or kidney + pancreatic transplantation|patients with end stage renal disease scheduled or not for kidney or kidney + pancreatic transplantation
5082233|NCT01291758|Persian Gulf War|persian gulf war
5082234|NCT01291758|Gulf War Syndrome|gulf war syndrome
5082235|NCT01291758|GWI|gwi
5082236|NCT01291758|Gulf War Illness|gulf war illness
5082237|NCT01291758|Exercise|exercise
5082238|NCT01291758|Chronic Fatigue|chronic fatigue
5082239|NCT01291758|Fibromyalgia|fibromyalgia
5082240|NCT01291758|Veterans|veterans
5082241|NCT01291758|Irritable Bowel Syndrome|irritable bowel syndrome
5082242|NCT01291758|Migraine headaches|migraine headaches
5082243|NCT01291758|Neuropathy|neuropathy
5082244|NCT01291719|closed loop glucose control|closed loop glucose control
5082245|NCT01291719|intensive care glucose control|intensive care glucose control
5082246|NCT01291706|Transcranial Doppler|transcranial doppler
5082247|NCT01291706|Mild and moderate Traumatic Brain Injury|mild and moderate traumatic brain injury
5082248|NCT01291706|Neurological deterioration|neurological deterioration
5082249|NCT01291706|Brain CT scan|brain ct scan
5082250|NCT01291693|Hazardous drinking|hazardous drinking
5082251|NCT01291693|general hospital|general hospital
5082252|NCT01291693|brief intervention|brief intervention
5082253|NCT01291693|Motivational Interviewing|motivational interviewing
5082254|NCT01291693|computer-generated feedback|computer-generated feedback
5082255|NCT01291693|stage-tailored|stage-tailored
5082256|NCT01291693|delivery channel|delivery channel
5082257|NCT01291680|Pregnancy|pregnancy
5082258|NCT01291680|Chronic pain|chronic pain
5082259|NCT01291680|Fibromyalgia|fibromyalgia
5082260|NCT01291654|PDA|pda
5082261|NCT01291654|Paracetamol|paracetamol
5082262|NCT01291654|Indomethacin|indomethacin
5082263|NCT01291654|Ibuprofen|ibuprofen
5082264|NCT01291641|Hyperlipidemias|hyperlipidemias
5082265|NCT01291641|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors
5082266|NCT01291641|Probucol|probucol
5082267|NCT01291641|Cilostazol|cilostazol
5082268|NCT01291628|Capecitabine|capecitabine
5082269|NCT01291628|Hand and foot syndrome|hand and foot syndrome
5082271|NCT01291628|Copper|copper
5082272|NCT01291628|Toxicity|toxicity
5082273|NCT01291602|NXL104|nxl104
5082274|NCT01291602|ceftazidime|ceftazidime
5082275|NCT01291602|CAZ104|caz104
5082276|NCT01291602|Healthy Japanese volunteers|healthy japanese volunteers
5082277|NCT01291602|Phase 1|phase 1
5082278|NCT01291602|Single and Multiple Dose Study|single and multiple dose study
5082279|NCT01291589|HIV-infected|hiv-infected
5082280|NCT01291589|MSM|msm
5082281|NCT01291589|HIV prevention|hiv prevention
5082282|NCT01291576|Deep infiltrating endometriosis|deep infiltrating endometriosis
5082283|NCT01291576|Rectal endometriosis|rectal endometriosis
5082284|NCT01291576|Colorectal resection|colorectal resection
5082285|NCT01291576|Nodule excision|nodule excision
5082286|NCT01291576|Rectal shaving|rectal shaving
5082287|NCT01291576|Functional outcomes|functional outcomes
5082288|NCT01291576|Constipation|constipation
5082289|NCT01291563|TMC207TBC1003|tmc207tbc1003
5082290|NCT01291563|TMC207|tmc207
5082291|NCT01291563|M.Tuberculosis|m.tuberculosis
5082292|NCT01291563|TBC|tbc
5082293|NCT01291563|Moxifloxacin|moxifloxacin
5082294|NCT01291563|ECG|ecg
5082295|NCT01291563|QT/QTc|qt/qtc
5082296|NCT01291563|Healthy volunteers|healthy volunteers
5082297|NCT01291550|Detecting volatile biomarkers using breath sample|detecting volatile biomarkers using breath sample
5082298|NCT01291537|Advanced|advanced
5082299|NCT01291537|Severe form|severe form
5082300|NCT01291524|pregabalin|pregabalin
5082301|NCT01291524|pharmacokinetics|pharmacokinetics
5082302|NCT01291524|bioavailability|bioavailability
5082303|NCT01291524|bioequivalence|bioequivalence
5082304|NCT01291511|Schizophrenia|schizophrenia
5082305|NCT01291511|Mental Disorders|mental disorders
5082306|NCT01291511|Antipsychotic Agents|antipsychotic agents
5082307|NCT01291511|Iloperdione|iloperdione
5082308|NCT01291511|Relapse Prevention|relapse prevention
5082309|NCT01291498|Primary Parathyroid Adenomas|primary parathyroid adenomas
5082310|NCT01291485|HIV|hiv
5082311|NCT01291485|Medication adherence|medication adherence
5082312|NCT01291485|computer-based intervention|computer-based intervention
5082313|NCT01291472|ketorolac|ketorolac
5082314|NCT01291472|pain|pain
5082315|NCT01291472|pregnancy|pregnancy
5082316|NCT01291472|non-pregnant state|non-pregnant state
5082317|NCT01291459|HIV|hiv
5082318|NCT01291459|naive patients|naive patients
5082319|NCT01291459|maraviroc|maraviroc
5082320|NCT01291459|raltegravir|raltegravir
5082321|NCT01291446|Intestinal gas production|intestinal gas production
5082322|NCT01291446|Intestinal microbiota|intestinal microbiota
5082323|NCT01291407|Combined Modality|combined modality
5082324|NCT01291407|Gastric Cancer|gastric cancer
5082325|NCT01291407|Radiation Therapy|radiation therapy
5082326|NCT01291407|S-1|s-1
5082327|NCT01291394|Growth disorders|growth disorders
5082328|NCT01291394|Saizen|saizen
5082329|NCT01291394|Easypod|easypod
5082330|NCT01291394|Growth hormone|growth hormone
5082331|NCT01291394|Pediatric subject|pediatric subject
5082332|NCT01291381|allergic rhinitis|allergic rhinitis
5082333|NCT01291381|peripheral tolerance|peripheral tolerance
5082334|NCT01291381|regulatory T cells|regulatory t cells
5082335|NCT01291381|specific immunotherapy|specific immunotherapy
5082336|NCT01291381|Tr1 cells|tr1 cells
5082337|NCT01291368|Sedation|sedation
5082338|NCT01291368|Delirium|delirium
5082339|NCT01291368|PTSD|ptsd
5082340|NCT01291368|Depression|depression
5082341|NCT01291368|Anxiety|anxiety
5082342|NCT01291368|HRQoL|hrqol
5082343|NCT01291368|CAM-ICU|cam-icu
5082344|NCT01291368|RASS|rass
5082345|NCT01291368|SF-36|sf-36
5082346|NCT01291368|ICU-memory tool|icu-memory tool
5082347|NCT01291368|Antipsychotic Agents|antipsychotic agents
5082348|NCT01291368|Mobilization|mobilization
5082349|NCT01291368|ICU-nursing|icu-nursing
5082350|NCT01291368|ICU|icu
5082351|NCT01291368|intensive care|intensive care
5082352|NCT01291368|critical care|critical care
5082353|NCT01291368|critical care nursing|critical care nursing
5082354|NCT01291355|Maternal position|maternal position
5082355|NCT01291355|Occipitoposterior position|occipitoposterior position
5082356|NCT01291355|Labor|labor
5082357|NCT01291355|Dystocia|dystocia
5082358|NCT01291355|Fetal presentation Abnormalities|fetal presentation abnormalities
5082359|NCT01291342|Pregnancy|pregnancy
5082360|NCT01291342|Preeclampsia|preeclampsia
5082361|NCT01291342|Volatile biomarkers|volatile biomarkers
5082362|NCT01291342|Chemical sensors|chemical sensors
5082363|NCT01291342|Nanomaterials|nanomaterials
5082364|NCT01291342|Nanosensors|nanosensors
5082365|NCT01291342|NA-NOSE|na-nose
5082366|NCT01291329|stem cell|stem cell
5082367|NCT01291329|acute ST-Elevation Myocardial Infarction|acute st-elevation myocardial infarction
5082368|NCT01291303|Non invasive ventilation|non invasive ventilation
5082369|NCT01291303|acute exacerbation of COPD|acute exacerbation of copd
5082370|NCT01291303|optimized ventilation|optimized ventilation
5082371|NCT01291290|rAAA|raaa
5082372|NCT01291290|Platelets|platelets
5082373|NCT01291290|TEG|teg
5082374|NCT01291290|Massive bleeding|massive bleeding
5082375|NCT01291290|Coagulopathy|coagulopathy
5082376|NCT01291277|gastrointestinal hemorrhage|gastrointestinal hemorrhage
5082377|NCT01291277|esophageal varices|esophageal varices
5082378|NCT01291277|gastrointestinal endoscopy|gastrointestinal endoscopy
5082379|NCT01291277|ligation|ligation
5082380|NCT01291264|Chlamydia trachomatis|chlamydia trachomatis
5082381|NCT01291264|Neisseria gonorrhoeae|neisseria gonorrhoeae
5082382|NCT01291264|Sexually Transmitted Diseases|sexually transmitted diseases
5082383|NCT01291238|learning disability|learning disability
5082384|NCT01291238|blood lipids|blood lipids
5082385|NCT01291238|cardio metabolic risk factors|cardio metabolic risk factors
5082386|NCT01291238|upper secondary school for learning disability students|upper secondary school for learning disability students
5082388|NCT01291238|cardio respiratory fitness|cardio respiratory fitness
5082389|NCT01291238|absorptiometry photos|absorptiometry photos
5082390|NCT01291225|playgrounds|playgrounds
5082391|NCT01291225|farms|farms
5082392|NCT01291225|injury prevention|injury prevention
5082393|NCT01291225|safety knowledge, attitudes and practices|safety knowledge, attitudes and practices
5082394|NCT01291225|safe play|safe play
5082395|NCT01291225|rural|rural
5082396|NCT01291212|In Vitro Fertilization|in vitro fertilization
5082397|NCT01291212|Testosterone|testosterone
5082398|NCT01291212|Ovarian Stimulation|ovarian stimulation
5082399|NCT01291212|Luteinizing Hormone|luteinizing hormone
5082400|NCT01291199|double-blind placebo controlled cross-over study|double-blind placebo controlled cross-over study
5082401|NCT01291186|spinal anesthesia|spinal anesthesia
5082402|NCT01291186|intrathecal bupivacaine|intrathecal bupivacaine
5082403|NCT01291186|median effective dose|median effective dose
5082404|NCT01291186|height|height
5082405|NCT01291147|pain|pain
5082406|NCT01291147|anaesthetic|anaesthetic
5082407|NCT01291121|Age related macular degeneration|age related macular degeneration
5082408|NCT01291121|Intravitreal ranibizumab|intravitreal ranibizumab
5082409|NCT01291121|Intravitreal expansile gas injection|intravitreal expansile gas injection
5082410|NCT01291082|Breast cancer|breast cancer
5082411|NCT01291082|metastasis|metastasis
5082412|NCT01291082|bone|bone
5082413|NCT01291082|diffusion MRI|diffusion mri
5082414|NCT01291069|Fontan|fontan
5082415|NCT01291069|Tadalafil|tadalafil
5082416|NCT01291069|Exercise performance|exercise performance
5082417|NCT01291056|Clomiphene citrate|clomiphene citrate
5082418|NCT01291056|Mood symptoms|mood symptoms
5082419|NCT01291056|Infertility|infertility
5082420|NCT01291056|Superovulation|superovulation
5082421|NCT01291056|Effects of clomiphene on mood|effects of clomiphene on mood
5082422|NCT01291043|Shiatsu|shiatsu
5082423|NCT01291043|Fibromyalgia|fibromyalgia
5082424|NCT01291043|Pain|pain
5082425|NCT01291043|Quality of sleep|quality of sleep
5082426|NCT01291043|Balance|balance
5082427|NCT01291043|Quality of life|quality of life
5082428|NCT01291017|Advanced stage|advanced stage
5082429|NCT01290952|off-pump|off-pump
5082430|NCT01290952|bypass|bypass
5082431|NCT01290952|coronary artery surgery|coronary artery surgery
5082432|NCT01290939|adult glioblastoma|adult glioblastoma
5082433|NCT01290939|recurrent adult brain tumor|recurrent adult brain tumor
5082434|NCT01290939|Cognition Disorders|cognition disorders
5082435|NCT01290939|functional defects|functional defects
5082436|NCT01290926|advanced chemorefractory colorectal cancer|advanced chemorefractory colorectal cancer
5082437|NCT01290926|sorafenib|sorafenib
5082438|NCT01290926|capecitabine|capecitabine
5082439|NCT01290926|FDG-PET|fdg-pet
5082440|NCT01290926|early metabolic response|early metabolic response
5082441|NCT01290913|peanut allergy|peanut allergy
5082442|NCT01290913|Xolair|xolair
5082443|NCT01290900|NXL104|nxl104
5082444|NCT01290900|CAZ104|caz104
5082445|NCT01290900|Ceftazidime|ceftazidime
5082446|NCT01290900|CXL104|cxl104
5082447|NCT01290900|Ceftaroline|ceftaroline
5082448|NCT01290900|Healthy Male Volunteers|healthy male volunteers
5082449|NCT01290900|Phase 1|phase 1
5082450|NCT01290900|OT|ot
5082451|NCT01290900|Single Dose Study|single dose study
5082452|NCT01290874|Asthma|asthma
5082453|NCT01290874|Blacks|blacks
5082454|NCT01290874|LABA|laba
5082455|NCT01290874|Tiotropium|tiotropium
5082456|NCT01290874|Spiriva|spiriva
5082457|NCT01290874|African American|african american
5082458|NCT01290874|Serevent|serevent
5082459|NCT01290874|salmeterol|salmeterol
5082460|NCT01290874|Foradil|foradil
5082461|NCT01290874|formoterol|formoterol
5082462|NCT01290874|Advair|advair
5082463|NCT01290874|Symbicort|symbicort
5082464|NCT01290874|Dulera|dulera
5082465|NCT01290861|Huntington's Disease|huntington's disease
5082466|NCT01290861|Cognitive Battery|cognitive battery
5082467|NCT01290861|Cognitive Testing|cognitive testing
5082468|NCT01290861|Cognition|cognition
5082469|NCT01290861|pre-manifest Huntington's Disease|pre-manifest huntington's disease
5082470|NCT01290848|pediatrics|pediatrics
5082471|NCT01290848|Health Promotion Campaign|health promotion campaign
5082472|NCT01290848|Community events|community events
5082473|NCT01290835|Stereotactic radiotherapy|stereotactic radiotherapy
5082474|NCT01290835|CyberKnife following lumpectomy|cyberknife following lumpectomy
5082475|NCT01290835|Breast cancer|breast cancer
5082476|NCT01290822|Biventricular pacing|biventricular pacing
5082477|NCT01290822|Dilated Cardiomyopathy|dilated cardiomyopathy
5082478|NCT01290822|Ischemic Cardiomyopathy|ischemic cardiomyopathy
5082479|NCT01290822|Congestive heart failure|congestive heart failure
5082480|NCT01290822|Cardiac allograft|cardiac allograft
5082481|NCT01290822|Cardiac surgery|cardiac surgery
5082482|NCT01290822|AVD|avd
5082483|NCT01290822|VVD|vvd
5082484|NCT01290822|LV pacing site|lv pacing site
5082485|NCT01290822|pacing optimization|pacing optimization
5082486|NCT01290809|Prophylactic Cranial Irradiation|prophylactic cranial irradiation
5082487|NCT01290809|lung cancer|lung cancer
5082488|NCT01290783|mCRC|mcrc
5082489|NCT01290783|CRC|crc
5082490|NCT01290783|colorectal|colorectal
5082491|NCT01290783|irinotecan|irinotecan
5082492|NCT01290783|Hyaluronic acid|hyaluronic acid
5082493|NCT01290783|Hyaluronan|hyaluronan
5082494|NCT01290770|obesity|obesity
5082495|NCT01290770|men|men
5082496|NCT01290770|TFPI|tfpi
5082497|NCT01290770|Lipoprotein(a)|lipoprotein(a)
5082498|NCT01290770|Lp(a)|lp(a)
5082499|NCT01290770|Tissue Factor pathway inhibitor|tissue factor pathway inhibitor
5082500|NCT01290770|aspirin|aspirin
5082501|NCT01290744|leprosy|leprosy
5082502|NCT01290744|ENL|enl
5082503|NCT01290744|clofazimine|clofazimine
5082504|NCT01290731|Hepatitis C, Chronic|hepatitis c, chronic
5082505|NCT01290731|Hepatitis C virus|hepatitis c virus
5082506|NCT01290731|Interferon Alfa-2a|interferon alfa-2a
5082507|NCT01290731|Ribavirin|ribavirin
5082508|NCT01290731|Viral RNA|viral rna
5082509|NCT01290705|Knee|knee
5082510|NCT01290705|Anterior Cruciate Ligament|anterior cruciate ligament
5082511|NCT01290705|Pain|pain
5082512|NCT01290705|Patella|patella
5082513|NCT01290705|Exercise Therapy|exercise therapy
5082514|NCT01290692|Brain Neoplasms|brain neoplasms
5082515|NCT01290692|Central Nervous System Neoplasms|central nervous system neoplasms
5082516|NCT01290692|Brain Diseases|brain diseases
5082517|NCT01290692|Neoplasms|neoplasms
5082518|NCT01290692|Nervous System Neoplasms|nervous system neoplasms
5082519|NCT01290692|Glioblastoma|glioblastoma
5082520|NCT01290692|Astrocytoma|astrocytoma
5082521|NCT01290692|Nervous System Diseases|nervous system diseases
5082522|NCT01290692|Central Nervous System Diseases|central nervous system diseases
5082523|NCT01290692|Glioma|glioma
5082524|NCT01290692|Recurrent astrocytoma|recurrent astrocytoma
5082525|NCT01290692|Recurrent glioma|recurrent glioma
5082526|NCT01290692|Cancer vaccine|cancer vaccine
5082527|NCT01290692|Immunotherapy|immunotherapy
5082528|NCT01290692|Killer T cells|killer t cells
5082529|NCT01290692|Activated T cells|activated t cells
5082530|NCT01290692|GM-CSF|gm-csf
5082531|NCT01290692|Activated lymphocytes|activated lymphocytes
5082532|NCT01290679|Hepatitis C|hepatitis c
5082533|NCT01290679|TMC435|tmc435
5082534|NCT01290679|HCV|hcv
5082535|NCT01290679|Hep C|hep c
5082536|NCT01290679|genotype 1|genotype 1
5082537|NCT01290601|malaria|malaria
5082538|NCT01290601|Plasmodium vivax|plasmodium vivax
5082539|NCT01290601|adults|adults
5082540|NCT01290601|treatment|treatment
5082541|NCT01290601|tafenoquine|tafenoquine
5082542|NCT01290562|SBRT|sbrt
5082543|NCT01290562|spinal Metastases|spinal metastases
5082544|NCT01290562|Paraspinal Metastases|paraspinal metastases
5082545|NCT01290562|spinal Metastases and SBRT|spinal metastases and sbrt
5082546|NCT01290562|Paraspinal Metastases and SBRT|paraspinal metastases and sbrt
5082547|NCT01290536|Liver metastases|liver metastases
5082548|NCT01290510|tendinopathy|tendinopathy
5082549|NCT01290510|hyaluronan|hyaluronan
5082550|NCT01290510|tendon|tendon
5082551|NCT01290510|hyaluronic acid|hyaluronic acid
5082552|NCT01290484|Lymphatic malformation, vascular malformation|lymphatic malformation, vascular malformation
5082553|NCT01290458|Eccentric training|eccentric training
5082554|NCT01290458|Free radicals|free radicals
5082555|NCT01290458|Antioxidant supplements|antioxidant supplements
5082556|NCT01290458|Training adaptations|training adaptations
5082557|NCT01290458|Lipid profile|lipid profile
5082558|NCT01290445|varenicline|varenicline
5082559|NCT01290445|smoking|smoking
5082560|NCT01290445|smoking cessation|smoking cessation
5082561|NCT01290445|cohort study|cohort study
5082562|NCT01290445|drug safety|drug safety
5082563|NCT01290445|prospective study|prospective study
5082564|NCT01290432|female fertility|female fertility
5082565|NCT01290432|ovarian reserve|ovarian reserve
5082566|NCT01290432|oocyte quality|oocyte quality
5082567|NCT01290432|oocyte quantity|oocyte quantity
5082568|NCT01290432|antimullerian hormone|antimullerian hormone
5082569|NCT01290432|AMH|amh
5082570|NCT01290432|dietary supplements|dietary supplements
5082571|NCT01290432|inofolic plus|inofolic plus
5082572|NCT01290432|myoinositol|myoinositol
5082573|NCT01290432|folic acid|folic acid
5082574|NCT01290419|RSV|rsv
5082575|NCT01290406|Endometrial cancer,|endometrial cancer,
5082576|NCT01290406|uterine cancer,|uterine cancer,
5082577|NCT01290406|PI3K,|pi3k,
5082578|NCT01290406|mTOR,|mtor,
5082579|NCT01290406|targeted therapy|targeted therapy
5082580|NCT01290393|vaccine|vaccine
5082581|NCT01290393|Spontaneous abortions|spontaneous abortions
5082582|NCT01290393|Human papillomavirus|human papillomavirus
5082583|NCT01290393|HPV|hpv
5082584|NCT01290393|Cervarix|cervarix
5082585|NCT01290393|pregnancy|pregnancy
5082586|NCT01290380|Solid tumor malignancies,|solid tumor malignancies,
5082587|NCT01290380|simvastatin,|simvastatin,
5082588|NCT01290380|caffeine,|caffeine,
5082589|NCT01290380|omeprazole and diclofenac,|omeprazole and diclofenac,
5082590|NCT01290380|ASA404,|asa404,
5082591|NCT01290380|PK data|pk data
5082592|NCT01290367|Chronic Lumbar Back Pain|chronic lumbar back pain
5082593|NCT01290367|Low back pain|low back pain
5082594|NCT01290367|Back pain|back pain
5082595|NCT01290367|Degenerative Disc Disease|degenerative disc disease
5082596|NCT01290367|Injection of Degenerated Lumbar Disc|injection of degenerated lumbar disc
5082597|NCT01290367|Stem Cells|stem cells
5083096|NCT01288417|boceprevir|boceprevir
5082598|NCT01290367|Adult Stem Cells|adult stem cells
5082599|NCT01290367|Allogeneic Mesenchymal Precursor cells (MPCs)|allogeneic mesenchymal precursor cells (mpcs)
5082600|NCT01290367|Mesoblast|mesoblast
5082601|NCT01290354|Brain penetration|brain penetration
5082602|NCT01290354|positron emission tomography|positron emission tomography
5082603|NCT01290354|Lapatinib|lapatinib
5082604|NCT01290341|fungal infection|fungal infection
5082605|NCT01290341|athlete foot|athlete foot
5082606|NCT01290328|anemia|anemia
5082607|NCT01290328|kidney transplant|kidney transplant
5082608|NCT01290328|alloimmunity|alloimmunity
5082609|NCT01290289|Labor|labor
5082610|NCT01290289|Epidural|epidural
5082611|NCT01290289|Combined spinal epidural|combined spinal epidural
5082612|NCT01290289|pethidine|pethidine
5082613|NCT01290276|Ondansetron|ondansetron
5082614|NCT01290276|Methylphenidate|methylphenidate
5082615|NCT01290263|Glioblastoma|glioblastoma
5082616|NCT01290263|GBM|gbm
5082617|NCT01290263|Brain Tumor|brain tumor
5082618|NCT01290263|Glioma|glioma
5082619|NCT01290237|vancomycin|vancomycin
5082620|NCT01290237|loading dose|loading dose
5082621|NCT01290237|pharmacokinetic|pharmacokinetic
5082622|NCT01290237|pediatric|pediatric
5082623|NCT01290237|Methicillin-Resistant Staphylococcus aureus (MRSA)|methicillin-resistant staphylococcus aureus (mrsa)
5082624|NCT01290237|Serious infection with Gram positive bacteria|serious infection with gram positive bacteria
5082625|NCT01290211|maraviroc|maraviroc
5082626|NCT01290211|fosamprenavir|fosamprenavir
5082627|NCT01290211|drug interaction|drug interaction
5082628|NCT01290211|pharmacokinetics|pharmacokinetics
5082629|NCT01290211|HIV|hiv
5082630|NCT01290211|AIDS|aids
5082631|NCT01290211|CCR5|ccr5
5082632|NCT01290211|protease inhibitor|protease inhibitor
5082633|NCT01290198|epoxy-eicosatrienoic acid|epoxy-eicosatrienoic acid
5082634|NCT01290198|Laser Doppler|laser doppler
5082635|NCT01290198|Endothelium derived hyperpolarizing factor|endothelium derived hyperpolarizing factor
5082636|NCT01290198|cutaneous microcirculation|cutaneous microcirculation
5082637|NCT01290198|post-occlusive hyperaemia|post-occlusive hyperaemia
5082638|NCT01290198|thermal hyperemia|thermal hyperemia
5082639|NCT01290198|intradermal microdialysis|intradermal microdialysis
5082640|NCT01290198|fluconazole|fluconazole
5082641|NCT01290185|Arthroplasty|arthroplasty
5082642|NCT01290185|Pharmacol Nerve Block|pharmacol nerve block
5082643|NCT01290172|Liver transplant|liver transplant
5082644|NCT01290172|portal hypertension|portal hypertension
5082645|NCT01290159|tolerance to heat|tolerance to heat
5082646|NCT01290146|Heart Failure|heart failure
5082647|NCT01290146|Levosimendan|levosimendan
5082648|NCT01290146|Inotropic agents|inotropic agents
5082649|NCT01290146|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors
5082650|NCT01290146|Vasodilators|vasodilators
5082651|NCT01290146|Diuretics|diuretics
5082652|NCT01290120|Burkitt Lymphoma|burkitt lymphoma
5082653|NCT01290120|B-ALL|b-all
5082654|NCT01290120|Adult patients|adult patients
5082655|NCT01290107|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5082656|NCT01290107|childhood acute myeloid leukemia/other myeloid malignancies|childhood acute myeloid leukemia/other myeloid malignancies
5082657|NCT01290081|Tuberculosis|tuberculosis
5082658|NCT01290081|Injecting drug users|injecting drug users
5082659|NCT01290081|Case management|case management
5082660|NCT01290068|Intraocular Lens|intraocular lens
5082661|NCT01290055|yellow fever|yellow fever
5082662|NCT01290055|vaccine|vaccine
5082663|NCT01290055|memory T cells|memory t cells
5082664|NCT01290029|pediatric|pediatric
5082666|NCT01290029|dialysis|dialysis
5082667|NCT01290029|paediatric|paediatric
5082668|NCT01290016|randomized controlled trial|randomized controlled trial
5082669|NCT01290016|children|children
5082670|NCT01290016|obesity|obesity
5082671|NCT01290016|nutrition|nutrition
5082672|NCT01290016|exercise|exercise
5082673|NCT01290003|Antibacterial agents|antibacterial agents
5082674|NCT01290003|Neonate|neonate
5082675|NCT01290003|Meconium stained amniotic fluid|meconium stained amniotic fluid
5082676|NCT01290003|Neonatal sepsis|neonatal sepsis
5082677|NCT01289977|Sandfly|sandfly
5082678|NCT01289977|leishmaniasis|leishmaniasis
5082679|NCT01289977|immune response|immune response
5082680|NCT01289977|individuals age 18-50|individuals age 18-50
5082681|NCT01289951|HIV|hiv
5082682|NCT01289951|VHC|vhc
5082683|NCT01289951|Advanced hepatic cirrhosis|advanced hepatic cirrhosis
5082684|NCT01289951|Pharmacokinetic|pharmacokinetic
5082685|NCT01289951|Raltegravir|raltegravir
5082686|NCT01289938|pharmacokinetic|pharmacokinetic
5082687|NCT01289938|pharmacogenetic|pharmacogenetic
5082688|NCT01289938|Metoclopramide|metoclopramide
5082689|NCT01289938|Diphenhydramine|diphenhydramine
5082690|NCT01289938|CYP2D6 polymorphisms|cyp2d6 polymorphisms
5082691|NCT01289925|dietary supplement|dietary supplement
5082692|NCT01289925|selenium|selenium
5082693|NCT01289925|healthy volunteer|healthy volunteer
5082694|NCT01289925|Johns Hopkins|johns hopkins
5082695|NCT01289925|older|older
5082696|NCT01289925|aging|aging
5082697|NCT01289925|geriatrics|geriatrics
5082698|NCT01289925|baltimore|baltimore
5082699|NCT01289925|mineral|mineral
5082700|NCT01289925|over 70|over 70
5082701|NCT01289912|Tuberous Sclerosis Complex|tuberous sclerosis complex
5082702|NCT01289912|Autism|autism
5082703|NCT01289912|Neurocognition|neurocognition
5082704|NCT01289912|RAD001|rad001
5082705|NCT01289912|Everolimus|everolimus
5082706|NCT01289912|Afinitor|afinitor
5082707|NCT01289912|TSC|tsc
5082708|NCT01289899|BR-A-657|br-a-657
5082709|NCT01289899|Fimasartan|fimasartan
5082710|NCT01289899|multiple-dose|multiple-dose
5082711|NCT01289899|pharmacokinetic|pharmacokinetic
5082712|NCT01289899|pharmacodynamic|pharmacodynamic
5082713|NCT01289899|safety|safety
5082714|NCT01289886|single-dose|single-dose
5082715|NCT01289886|pharmacokinetic|pharmacokinetic
5082716|NCT01289886|pharmacodynamic|pharmacodynamic
5082717|NCT01289886|safety|safety
5082718|NCT01289847|Primary Immune Deficiency Disorders|primary immune deficiency disorders
5082719|NCT01289847|Common Variable Immunodeficiency|common variable immunodeficiency
5082720|NCT01289847|X-linked agammaglobulinemia|x-linked agammaglobulinemia
5082721|NCT01289847|Hyper-IgM syndrome|hyper-igm syndrome
5082722|NCT01289847|Wiskott-Aldrich Syndrome|wiskott-aldrich syndrome
5082723|NCT01289847|Immunoglobulins|immunoglobulins
5082724|NCT01289847|Bacterial Infections|bacterial infections
5082725|NCT01289834|RSA|rsa
5082726|NCT01289834|Bone Cement|bone cement
5082727|NCT01289808|Glucose|glucose
5082728|NCT01289808|analgesic|analgesic
5082729|NCT01289808|newborns|newborns
5082730|NCT01289795|Stroke|stroke
5082731|NCT01289795|Cerebral Infarction|cerebral infarction
5082732|NCT01289795|Cerebrovascular Disorders|cerebrovascular disorders
5082733|NCT01289795|Brain Diseases|brain diseases
5082734|NCT01289795|Central Nervous System Diseases|central nervous system diseases
5082735|NCT01289782|Hepatitis C|hepatitis c
5082736|NCT01289782|TMC435|tmc435
5082737|NCT01289782|HCV|hcv
5082738|NCT01289782|Hep C|hep c
5082739|NCT01289782|Genotype 1|genotype 1
5082740|NCT01289756|pharmacokinetic|pharmacokinetic
5082741|NCT01289756|clomiphene|clomiphene
5082742|NCT01289756|CYP2D6 polymorphisms|cyp2d6 polymorphisms
5082743|NCT01289756|inhibition of CYP2D6 and CYP3A4|inhibition of cyp2d6 and cyp3a4
5082744|NCT01289743|ankylosing spondylitis|ankylosing spondylitis
5082745|NCT01289743|atanercept|atanercept
5082746|NCT01289743|therapy|therapy
5082747|NCT01289743|magnetic resonance imaging|magnetic resonance imaging
5082748|NCT01289730|undifferentiated spondyloarthritis|undifferentiated spondyloarthritis
5082749|NCT01289730|etanercept|etanercept
5082750|NCT01289730|therapy|therapy
5082751|NCT01289730|magnetic resonance imaging|magnetic resonance imaging
5082752|NCT01289717|biomarkers|biomarkers
5082753|NCT01289717|proteogenomic profiling|proteogenomic profiling
5082754|NCT01289717|acute rejection|acute rejection
5082755|NCT01289717|chronic allograft nephropathy/interstitial fibrosis and tubular atrophy|chronic allograft nephropathy/interstitial fibrosis and tubular atrophy
5082756|NCT01289704|Charcot−Marie−Tooth disease,|charcot−marie−tooth disease,
5082757|NCT01289704|CMT1A,|cmt1a,
5082758|NCT01289704|rehabilitation,|rehabilitation,
5082759|NCT01289704|treadmill,|treadmill,
5082760|NCT01289704|stretching,|stretching,
5082761|NCT01289704|proprioception,|proprioception,
5082762|NCT01289704|Randomised Controlled Trial.|randomised controlled trial.
5082763|NCT01289691|One Lung Ventilation|one lung ventilation
5082764|NCT01289691|Atelectasis|atelectasis
5082765|NCT01289691|Oxygenation|oxygenation
5082766|NCT01289678|acute myelogenous leukemia|acute myelogenous leukemia
5082767|NCT01289678|interleukin-2|interleukin-2
5082768|NCT01289665|lubricating|lubricating
5082769|NCT01289665|gel|gel
5082770|NCT01289665|speculum|speculum
5082771|NCT01289665|Pain, Pelvic|pain, pelvic
5082772|NCT01289665|Examination, Gynecological|examination, gynecological
5082773|NCT01289652|Acute hepatitis C (HCV)|acute hepatitis c (hcv)
5082774|NCT01289652|Human immunodeficiency virus (HIV)|human immunodeficiency virus (hiv)
5082775|NCT01289639|non-alcoholic fatty liver disease|non-alcoholic fatty liver disease
5082776|NCT01289639|non-alcoholic steatohepatitis|non-alcoholic steatohepatitis
5082777|NCT01289639|insulin resistance|insulin resistance
5082778|NCT01289639|pioglitazone|pioglitazone
5082779|NCT01289639|fenofibrate|fenofibrate
5082780|NCT01289626|Calciphylaxis, dialysis|calciphylaxis, dialysis
5082781|NCT01289613|Bispectral Index|bispectral index
5082782|NCT01289613|Anesthesia|anesthesia
5082783|NCT01289613|Asymmetry|asymmetry
5082784|NCT01289587|Diabetes|diabetes
5082785|NCT01289587|Physical activity|physical activity
5082786|NCT01289587|Body composition|body composition
5082787|NCT01289587|Aerobic fitness|aerobic fitness
5082788|NCT01289587|Metabolic control|metabolic control
5082789|NCT01289574|androgen receptor degradation enhancer|androgen receptor degradation enhancer
5082790|NCT01289548|remote ischaemic preconditioning|remote ischaemic preconditioning
5082791|NCT01289548|kidney transplantation|kidney transplantation
5082792|NCT01289535|Influenza vaccine|influenza vaccine
5082793|NCT01289535|immune response|immune response
5082794|NCT01289535|elderly|elderly
5082795|NCT01289522|Squamous cell carcinoma of the head and neck|squamous cell carcinoma of the head and neck
5082796|NCT01289522|recurrent or metastatic|recurrent or metastatic
5082797|NCT01289522|first line chemotherapy|first line chemotherapy
5082798|NCT01289522|cetuximab|cetuximab
5082799|NCT01289522|docetaxel|docetaxel
5082800|NCT01289522|cisplatin|cisplatin
5082801|NCT01289522|antineoplastic agents|antineoplastic agents
5082802|NCT01289522|First Line Palliative Treatment|first line palliative treatment
5082803|NCT01289496|Ribavirin|ribavirin
5082804|NCT01289496|Pegasys|pegasys
5082805|NCT01289496|Hepatitis|hepatitis
5082806|NCT01289483|awake fiberoptic intubation (AFI)|awake fiberoptic intubation (afi)
5082807|NCT01289483|difficult airway|difficult airway
5082808|NCT01289483|fospropofol|fospropofol
5082809|NCT01289470|NIRS Technology|nirs technology
5082810|NCT01289470|Cardiovascular surgery|cardiovascular surgery
5082811|NCT01289470|valvular surgery with cardiopulmonary bypass|valvular surgery with cardiopulmonary bypass
5082812|NCT01289457|Acute Myelogenous Leukemia|acute myelogenous leukemia
5082813|NCT01289457|AML|aml
5082814|NCT01289457|High-Risk Myelodysplastic Syndrome|high-risk myelodysplastic syndrome
5082815|NCT01289457|MDS|mds
5082816|NCT01289457|Relapsed|relapsed
5082817|NCT01289457|Refractory|refractory
5082818|NCT01289457|Clofarabine|clofarabine
5082819|NCT01289457|Clofarex|clofarex
5082820|NCT01289457|Clolar|clolar
5082821|NCT01289457|Idarubicin|idarubicin
5082822|NCT01289457|Idamycin|idamycin
5082823|NCT01289457|Cytarabine|cytarabine
5082824|NCT01289457|Ara-C|ara-c
5082825|NCT01289457|Cytosar|cytosar
5082826|NCT01289457|DepoCyt|depocyt
5082827|NCT01289457|Cytosine Arabinosine Hydrochloride|cytosine arabinosine hydrochloride
5082828|NCT01289444|palliative care|palliative care
5082829|NCT01289444|AIDS|aids
5082830|NCT01289444|adolescents|adolescents
5082831|NCT01289444|quality of life|quality of life
5082832|NCT01289444|adherence|adherence
5082833|NCT01289444|spiritual|spiritual
5082834|NCT01289444|threat appraisal|threat appraisal
5082835|NCT01289444|treatment congruence|treatment congruence
5082836|NCT01289444|treatment preferences|treatment preferences
5082837|NCT01289444|dialysis|dialysis
5082838|NCT01289444|hospitalization|hospitalization
5082839|NCT01289444|communication|communication
5082840|NCT01289444|family intervention|family intervention
5082841|NCT01289444|Family Centered Advance Care Planning|family centered advance care planning
5082842|NCT01289444|decision making|decision making
5082843|NCT01289444|advance care planning|advance care planning
5082844|NCT01289444|end of life|end of life
5082845|NCT01289418|H1N1|h1n1
5082846|NCT01289418|vaccine safety|vaccine safety
5082847|NCT01289418|adverse events|adverse events
5082848|NCT01289418|health care workers|health care workers
5082849|NCT01289405|obstructive sleep apnea|obstructive sleep apnea
5082850|NCT01289405|oropharyngeal exercises|oropharyngeal exercises
5082851|NCT01289405|speech therapy|speech therapy
5082852|NCT01289392|Obstructive Sleep Apnea|obstructive sleep apnea
5082853|NCT01289392|CPAP|cpap
5082854|NCT01289392|Oral appliance|oral appliance
5082855|NCT01289392|Aerobic exercise|aerobic exercise
5082856|NCT01289392|Resistance training|resistance training
5082857|NCT01289379|pneumoperitoneum|pneumoperitoneum
5082858|NCT01289379|laparoscopy|laparoscopy
5082859|NCT01289379|HFJV|hfjv
5082860|NCT01289379|cardiovascular|cardiovascular
5082861|NCT01289379|Symptomatic|symptomatic
5082862|NCT01289353|triple negative|triple negative
5082863|NCT01289353|breast cancer|breast cancer
5082864|NCT01289353|adjuvant therapy|adjuvant therapy
5082865|NCT01289353|Carboplatin|carboplatin
5082866|NCT01289353|chemotherapy|chemotherapy
5082867|NCT01289353|radiation therapy|radiation therapy
5082868|NCT01289353|chemo-radiotherapy|chemo-radiotherapy
5082869|NCT01289353|accelerated radiotherapy|accelerated radiotherapy
5082870|NCT01289340|wound healing|wound healing
5082871|NCT01289340|pain|pain
5082872|NCT01289340|burn|burn
5082873|NCT01289314|total laparoscopic hysterectomy|total laparoscopic hysterectomy
5082874|NCT01289314|laparoscopic supracervical hysterectomy|laparoscopic supracervical hysterectomy
5082875|NCT01289301|renal transplantation|renal transplantation
5082876|NCT01289301|polyoma BK virus infection|polyoma bk virus infection
5082877|NCT01289301|everolimus|everolimus
5082878|NCT01289301|calcineurin inhibitor|calcineurin inhibitor
5082879|NCT01289301|mTOR inhibitor|mtor inhibitor
5082880|NCT01289288|colorectal cancer screening|colorectal cancer screening
5082881|NCT01289288|Chinese Americans|chinese americans
5082882|NCT01289288|patients nonadherent with CRC Screening|patients nonadherent with crc screening
5082883|NCT01289275|tobacco cessation|tobacco cessation
5082884|NCT01289275|smoking cessation|smoking cessation
5082885|NCT01289275|telephone|telephone
5082886|NCT01289275|self-help|self-help
5082887|NCT01289275|smoking abstinence|smoking abstinence
5082888|NCT01289275|tobacco use disorder|tobacco use disorder
5082889|NCT01289275|hospital|hospital
5082890|NCT01289275|cardiopulmonary diseases|cardiopulmonary diseases
5082891|NCT01289275|disparity|disparity
5082892|NCT01289262|Cesarean section|cesarean section
5082893|NCT01289262|Kerr incision|kerr incision
5082894|NCT01289262|Purse string suturing in CS|purse string suturing in cs
5082895|NCT01289262|Continuous locked suturing in CS|continuous locked suturing in cs
5082896|NCT01289249|meropenem|meropenem
5082897|NCT01289249|child|child
5082898|NCT01289249|bacterial infection|bacterial infection
5082899|NCT01289249|treatment evaluation|treatment evaluation
5082900|NCT01289236|Shoulder Pain|shoulder pain
5082998|NCT01288833|Diagnostic Imaging|diagnostic imaging
5082901|NCT01289223|Indolent B-cell NHL, bendamustine, rituximab, progression-free survival|indolent b-cell nhl, bendamustine, rituximab, progression-free survival
5082902|NCT01289210|B cell|b cell
5082903|NCT01289210|lymphoma|lymphoma
5082904|NCT01289184|Occupational Health Hazards|occupational health hazards
5082905|NCT01289184|Air Pollution|air pollution
5082906|NCT01289184|Photocopiers|photocopiers
5082907|NCT01289184|Other Specified Personal Exposures|other specified personal exposures
5082908|NCT01289184|History Presenting Hazards to Health|history presenting hazards to health
5082909|NCT01289171|The efficacy, tolerability and safety of 15% glycolic acid lotion for treatment of diffuse flat warts among HIV+ children were investigated|the efficacy, tolerability and safety of 15% glycolic acid lotion for treatment of diffuse flat warts among hiv+ children were investigated
5082910|NCT01289158|malonic and methylmalonic aciduria|malonic and methylmalonic aciduria
5082911|NCT01289158|malonyl-coenzyme A decarboxylase|malonyl-coenzyme a decarboxylase
5082912|NCT01289158|MLYCD|mlycd
5082913|NCT01289145|Action Planning|action planning
5082914|NCT01289145|Positive Outcome Expectancies|positive outcome expectancies
5082915|NCT01289145|Randomized Controlled Trial|randomized controlled trial
5082916|NCT01289145|Stages of change|stages of change
5082917|NCT01289145|Health behavior|health behavior
5082918|NCT01289145|Motivation|motivation
5082919|NCT01289132|Drug Therapy|drug therapy
5082920|NCT01289119|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
5082921|NCT01289119|Drug Therapy|drug therapy
5082922|NCT01289106|Hepatitis B vaccine|hepatitis b vaccine
5082923|NCT01289106|HIV infection|hiv infection
5082924|NCT01289106|Modified HBV vaccine dose|modified hbv vaccine dose
5082925|NCT01289106|Modified HBV vaccine schedule|modified hbv vaccine schedule
5082926|NCT01289093|inguinal hernia|inguinal hernia
5082927|NCT01289093|incisional hernia|incisional hernia
5082928|NCT01289093|quality of life|quality of life
5082929|NCT01289093|disease-specific|disease-specific
5082930|NCT01289080|Schizophrenia|schizophrenia
5082931|NCT01289080|psychiatric disorders|psychiatric disorders
5082932|NCT01289080|renal failure|renal failure
5082933|NCT01289067|Metastatic|metastatic
5082934|NCT01289067|Castration Resistant|castration resistant
5082935|NCT01289067|Prostate Cancer|prostate cancer
5082936|NCT01289054|Female|female
5082937|NCT01289054|Pregnancy|pregnancy
5082938|NCT01289054|Hematologic Pregnancy|hematologic pregnancy
5082939|NCT01289054|Complications|complications
5082940|NCT01289054|Registry|registry
5082941|NCT01289054|Pregnant Registry|pregnant registry
5082942|NCT01289054|CML|cml
5082943|NCT01289054|GIST|gist
5082944|NCT01289054|Gleevec|gleevec
5082945|NCT01289054|Tasigna|tasigna
5082946|NCT01289054|Glivec|glivec
5082947|NCT01289054|Pregnancy Exposure|pregnancy exposure
5082948|NCT01289041|Advanced endometrial cancer|advanced endometrial cancer
5082949|NCT01289041|PI3K pathway|pi3k pathway
5082950|NCT01289041|second-line treatment|second-line treatment
5082951|NCT01289028|GIST|gist
5082952|NCT01289028|Imatinib|imatinib
5082953|NCT01289028|Sunitinib|sunitinib
5082954|NCT01289028|Gastrointestinal|gastrointestinal
5082955|NCT01289028|Stromal|stromal
5082956|NCT01289028|Tumors|tumors
5082957|NCT01289015|fungal infection|fungal infection
5082958|NCT01289015|athlete foot|athlete foot
5082959|NCT01288989|Advanced Solid Tumors|advanced solid tumors
5082960|NCT01288976|Mitral Valve|mitral valve
5082961|NCT01288976|Mitral Regurgitation|mitral regurgitation
5082962|NCT01288976|MitraClip|mitraclip
5082963|NCT01288976|Mitral Valve Surgery|mitral valve surgery
5082964|NCT01288976|Mitral Valve Insufficiency or Mitral Regurgitation|mitral valve insufficiency or mitral regurgitation
5082965|NCT01288963|melanoma|melanoma
5082966|NCT01288963|IL-2|il-2
5082967|NCT01288963|Aldesleukin|aldesleukin
5082968|NCT01288950|BCG vaccine|bcg vaccine
5082969|NCT01288950|Vitamin D|vitamin d
5082970|NCT01288950|Cholecalciferol|cholecalciferol
5082971|NCT01288950|Tuberculosis|tuberculosis
5082972|NCT01288937|Milnacipran|milnacipran
5082973|NCT01288937|Idiopathic Peripheral Neuropathy|idiopathic peripheral neuropathy
5082974|NCT01288937|Diabetic neuropathy|diabetic neuropathy
5082975|NCT01288937|Neuropathic pain|neuropathic pain
5082976|NCT01288911|Metastatic|metastatic
5082977|NCT01288911|MDV3100|mdv3100
5082978|NCT01288911|Prostate|prostate
5082979|NCT01288911|progressive|progressive
5082980|NCT01288911|Cancer|cancer
5082981|NCT01288911|enzalutamide|enzalutamide
5082982|NCT01288898|ASP1941|asp1941
5082983|NCT01288898|Diabetes Mellitus|diabetes mellitus
5082984|NCT01288898|Multiple ascending doses|multiple ascending doses
5082985|NCT01288898|Healthy subjects|healthy subjects
5082986|NCT01288885|ASP1941|asp1941
5082987|NCT01288885|Diabetes Mellitus|diabetes mellitus
5082988|NCT01288885|First in Men|first in men
5082989|NCT01288872|Praziquantal, Schistosomiasis, pregnant women, Philippines|praziquantal, schistosomiasis, pregnant women, philippines
5082990|NCT01288859|polyphenols|polyphenols
5082991|NCT01288859|curcumin|curcumin
5082992|NCT01288859|bioavailability|bioavailability
5082993|NCT01288859|cocoa|cocoa
5082994|NCT01288846|medication list|medication list
5082995|NCT01288846|changes in medication|changes in medication
5082996|NCT01288846|prescription medication|prescription medication
5082997|NCT01288833|Colonoscopy|colonoscopy
5082999|NCT01288833|Colorectal Neoplasm|colorectal neoplasm
5083000|NCT01288833|Primary Prevention|primary prevention
5083001|NCT01288833|Cost and Cost Analysis|cost and cost analysis
5083002|NCT01288833|Endoscopy|endoscopy
5083003|NCT01288807|Fibromyalgia|fibromyalgia
5083004|NCT01288807|pain|pain
5083005|NCT01288794|Cirrhosis|cirrhosis
5083006|NCT01288794|Uncomplicated ascites|uncomplicated ascites
5083007|NCT01288794|Refractory ascites|refractory ascites
5083008|NCT01288794|Chronic albumin treatment|chronic albumin treatment
5083009|NCT01288781|High Altitude Headache; intra-cranial pressure; hypoxia|high altitude headache; intra-cranial pressure; hypoxia
5083010|NCT01288768|Meniscal injury|meniscal injury
5083011|NCT01288768|Knee arthroscopy|knee arthroscopy
5083012|NCT01288768|Middleaged|middleaged
5083013|NCT01288768|Functional outcome|functional outcome
5083014|NCT01288755|TMC278-TiDP6-C153|tmc278-tidp6-c153
5083015|NCT01288755|TMC278-C153|tmc278-c153
5083016|NCT01288755|TMC278|tmc278
5083017|NCT01288755|HIV|hiv
5083018|NCT01288742|TMC435-TiDP16-C108|tmc435-tidp16-c108
5083019|NCT01288742|TMC435-C108|tmc435-c108
5083020|NCT01288742|TMC435|tmc435
5083021|NCT01288742|HPC|hpc
5083022|NCT01288742|HCV|hcv
5083023|NCT01288742|Hepatitis C|hepatitis c
5083024|NCT01288716|ASD|asd
5083025|NCT01288716|Autism|autism
5083026|NCT01288716|Asperger Syndrome|asperger syndrome
5083027|NCT01288703|urinary incontinence|urinary incontinence
5083028|NCT01288690|Refugees|refugees
5083029|NCT01288690|Trauma|trauma
5083030|NCT01288690|Narrative|narrative
5083031|NCT01288690|Exposure|exposure
5083032|NCT01288690|Middle East|middle east
5083033|NCT01288690|Therapy|therapy
5083034|NCT01288677|Healthy volunteer|healthy volunteer
5083035|NCT01288677|TMC649128HPC1001|tmc649128hpc1001
5083036|NCT01288677|TMC649128|tmc649128
5083037|NCT01288677|HCV|hcv
5083038|NCT01288677|Hepatitis C|hepatitis c
5083039|NCT01288677|healthy volunteers|healthy volunteers
5083040|NCT01288677|Phase I trial|phase i trial
5083041|NCT01288664|Lupus Nephritis|lupus nephritis
5083042|NCT01288664|Tacrolimus|tacrolimus
5083043|NCT01288664|Induction Phase|induction phase
5083044|NCT01288651|Pulmonary arterial hypertension|pulmonary arterial hypertension
5083045|NCT01288651|Iron deficiency|iron deficiency
5083046|NCT01288651|Exercise|exercise
5083047|NCT01288638|Polycystic Ovary Syndrome|polycystic ovary syndrome
5083048|NCT01288638|Metabolic Syndrome|metabolic syndrome
5083049|NCT01288638|Pulse|pulse
5083050|NCT01288638|Lifestyle Intervention|lifestyle intervention
5083051|NCT01288638|Aerobic Exercise|aerobic exercise
5083052|NCT01288638|Diet|diet
5083053|NCT01288625|Identify whether Cytofos can reduce the incidence and duration of HNC patients' oral mucositis caused by radiotherapy.|identify whether cytofos can reduce the incidence and duration of hnc patients' oral mucositis caused by radiotherapy.
5083054|NCT01288612|Barrett's Esophagus|barrett's esophagus
5083055|NCT01288599|Laparoscopy|laparoscopy
5083056|NCT01288599|Randomized|randomized
5083057|NCT01288599|Single port access|single port access
5083058|NCT01288599|Adnexal disease|adnexal disease
5083059|NCT01288599|LESS|less
5083060|NCT01288586|Post Traumatic Arthritis|post traumatic arthritis
5083061|NCT01288586|Rheumatoid Arthritis|rheumatoid arthritis
5083062|NCT01288586|Osteoarthritis|osteoarthritis
5083063|NCT01288560|medical imaging|medical imaging
5083064|NCT01288560|heart failure|heart failure
5083065|NCT01288560|morbidity and mortality|morbidity and mortality
5083066|NCT01288560|PET/CT,CMR,SPECT, echo, coronary angiography|pet/ct,cmr,spect, echo, coronary angiography
5083067|NCT01288560|knowledge translation|knowledge translation
5083068|NCT01288560|cost effectiveness|cost effectiveness
5083069|NCT01288560|quality of life|quality of life
5083070|NCT01288560|prospective comparative effectiveness randomized clinical trial|prospective comparative effectiveness randomized clinical trial
5083071|NCT01288547|cognition|cognition
5083072|NCT01288547|attention|attention
5083073|NCT01288547|methylxanthine|methylxanthine
5083074|NCT01288521|kidney transplantation|kidney transplantation
5083075|NCT01288521|tacrolimus|tacrolimus
5083076|NCT01288521|P-glycoprotein|p-glycoprotein
5083077|NCT01288521|ABCB1|abcb1
5083078|NCT01288521|genotyping|genotyping
5083079|NCT01288482|Methacholine challenge|methacholine challenge
5083080|NCT01288482|nebulizer|nebulizer
5083081|NCT01288482|English-Wright|english-wright
5083082|NCT01288482|AeroEclipse II|aeroeclipse ii
5083083|NCT01288469|10020603|10020603
5083084|NCT01288456|medical device, space-occupying device|medical device, space-occupying device
5083085|NCT01288430|Heat shock protein 90|heat shock protein 90
5083086|NCT01288430|Advanced solid tumors|advanced solid tumors
5083087|NCT01288430|Non-small cell lung carcinoma|non-small cell lung carcinoma
5083088|NCT01288430|Epidermal growth factor receptor|epidermal growth factor receptor
5083089|NCT01288430|Tyrosine kinase inhibitor acquired resistance|tyrosine kinase inhibitor acquired resistance
5083090|NCT01288430|Non-small cell lung carcinoma with acquired resistance to erlotinib, gefitinib, afatinib or others.|non-small cell lung carcinoma with acquired resistance to erlotinib, gefitinib, afatinib or others.
5083091|NCT01288417|HIV infections|hiv infections
5083092|NCT01288417|HCV infections|hcv infections
5083093|NCT01288417|interaction|interaction
5083094|NCT01288417|pharmacokinetics|pharmacokinetics
5083095|NCT01288417|raltegravir|raltegravir
5083097|NCT01288404|Bevacizumab, impending recurrent pterygium|bevacizumab, impending recurrent pterygium
5083098|NCT01288378|fungal infection|fungal infection
5083099|NCT01288378|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5083100|NCT01288378|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5083101|NCT01288378|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5083102|NCT01288378|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5083103|NCT01288378|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
5083104|NCT01288378|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5083105|NCT01288378|adult acute myeloid leukemia with del(5q)|adult acute myeloid leukemia with del(5q)
5083106|NCT01288378|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5083107|NCT01288378|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5083108|NCT01288378|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5083109|NCT01288378|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5083110|NCT01288378|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5083111|NCT01288365|heart failure|heart failure
5083112|NCT01288365|preserved ejection fraction|preserved ejection fraction
5083113|NCT01288352|early treatment|early treatment
5083114|NCT01288352|rhythm control|rhythm control
5083115|NCT01288352|atrial fibrillation|atrial fibrillation
5083116|NCT01288352|cardiovascular complications|cardiovascular complications
5083117|NCT01288313|human milk|human milk
5083118|NCT01288313|polyunsaturated fatty acids|polyunsaturated fatty acids
5083119|NCT01288313|linolenic acid|linolenic acid
5083120|NCT01288313|rapeseed oil|rapeseed oil
5083121|NCT01288287|Certolizumab pegol|certolizumab pegol
5083122|NCT01288287|Cimzia®|cimzia®
5083123|NCT01288274|Contraception|contraception
5083124|NCT01288274|Family planning|family planning
5083125|NCT01288274|Task Shifting|task shifting
5083126|NCT01288274|Community based distribution|community based distribution
5083127|NCT01288274|Ethiopia|ethiopia
5083128|NCT01288274|DMPA|dmpa
5083129|NCT01288248|Airway|airway
5083130|NCT01288248|Airway laryngeal mask|airway laryngeal mask
5083131|NCT01288248|Endotracheal tube|endotracheal tube
5083132|NCT01288248|Respiration artificial|respiration artificial
5083133|NCT01288248|Laryngospasm|laryngospasm
5083134|NCT01288248|Safety of airway laryngeal mask|safety of airway laryngeal mask
5083135|NCT01288235|proton radiotherapy|proton radiotherapy
5083136|NCT01288222|acute myelogenous leukemia|acute myelogenous leukemia
5083137|NCT01288222|hematopoietic cell transplantation|hematopoietic cell transplantation
5083138|NCT01288222|unrelated donor|unrelated donor
5083139|NCT01288209|Hepatitis C, Chronic|hepatitis c, chronic
5083140|NCT01288209|Hepatitis C|hepatitis c
5083141|NCT01288209|Hepatitis C virus|hepatitis c virus
5083142|NCT01288209|Interferon Alfa-2a|interferon alfa-2a
5083143|NCT01288209|Ribavirin|ribavirin
5083144|NCT01288209|Viral RNA|viral rna
5083145|NCT01288196|CNTO 6785|cnto 6785
5083146|NCT01288196|Intravenous|intravenous
5083147|NCT01288196|Subcutaneous|subcutaneous
5083148|NCT01288196|Pharmacokinetics|pharmacokinetics
5083149|NCT01288196|Immunogenicity|immunogenicity
5083150|NCT01288196|Safety|safety
5083151|NCT01288196|Tolerability|tolerability
5083152|NCT01288183|tobacco|tobacco
5083153|NCT01288183|smoking|smoking
5083154|NCT01288183|tDCS|tdcs
5083155|NCT01288183|DLPFC|dlpfc
5083156|NCT01288170|cystic fibrosis, bioequivalence, pharmacokinetic, sputum, plasma|cystic fibrosis, bioequivalence, pharmacokinetic, sputum, plasma
5083157|NCT01288157|healthy|healthy
5083158|NCT01288157|adult|adult
5083159|NCT01288157|Chinese|chinese
5083160|NCT01288157|male|male
5083161|NCT01288157|Simponi|simponi
5083162|NCT01288157|CNTO 148|cnto 148
5083163|NCT01288144|Screening|screening
5083164|NCT01288144|Gestational diabetes mellitus|gestational diabetes mellitus
5083165|NCT01288131|Anti-r-HuEpo antibody|anti-r-huepo antibody
5083166|NCT01288131|Anti-r-HuEpo associated PRCA|anti-r-huepo associated prca
5083167|NCT01288131|Treatment|treatment
5083168|NCT01288131|Absolute reticulocyte count|absolute reticulocyte count
5083169|NCT01288105|drug-eluting stents|drug-eluting stents
5083170|NCT01288105|noncardiac surgery|noncardiac surgery
5083171|NCT01288092|Metastatic breast cancer|metastatic breast cancer
5083172|NCT01288092|HER2 negative|her2 negative
5083173|NCT01288092|HR positive|hr positive
5083174|NCT01288092|PI3K pathway|pi3k pathway
5083175|NCT01288092|no more than 2 prior lines of chemotherapy|no more than 2 prior lines of chemotherapy
5083176|NCT01288092|Metastatic Breast Cancer(MBC)|metastatic breast cancer(mbc)
5083177|NCT01288079|Major Depressive Disorder|major depressive disorder
5083178|NCT01288079|MDD|mdd
5083179|NCT01288079|Monotherapy|monotherapy
5083180|NCT01288079|Inadequate Response to Antidepressant Therapy|inadequate response to antidepressant therapy
5083181|NCT01288066|Shoulder|shoulder
5083182|NCT01288066|Total arthroplasty|total arthroplasty
5083183|NCT01288066|Hemiarthroplasty|hemiarthroplasty
5083184|NCT01288066|Resurfacing|resurfacing
5083185|NCT01288066|Glenoid|glenoid
5083186|NCT01288066|Constant score|constant score
5083187|NCT01288040|stroke|stroke
5083188|NCT01288040|treadmill|treadmill
5083189|NCT01288040|walking|walking
5083190|NCT01288040|hemiparesis|hemiparesis
5083191|NCT01288040|training|training
5083192|NCT01288014|immune response|immune response
5083193|NCT01288014|varicella zoster virus (VZV)|varicella zoster virus (vzv)
5083194|NCT01288014|cytokine levels|cytokine levels
5083195|NCT01288014|immunization|immunization
5083196|NCT01287975|Stroke Rehabilitation|stroke rehabilitation
5083197|NCT01287975|Brain Computer Interface|brain computer interface
5083198|NCT01287975|Upper Limb Rehabilitation|upper limb rehabilitation
5083199|NCT01287975|EEG-based Motor Imagery|eeg-based motor imagery
5083200|NCT01287975|Robotic Rehabilitation|robotic rehabilitation
5083201|NCT01287975|Haptic Knob|haptic knob
5083202|NCT01287962|Apatinib|apatinib
5083203|NCT01287962|Non-small Cell Lung Cancer|non-small cell lung cancer
5083204|NCT01287962|VEGFR TKIs|vegfr tkis
5083205|NCT01287949|Diphtheria|diphtheria
5083206|NCT01287949|Tetanus|tetanus
5083207|NCT01287949|Poliomyelitis|poliomyelitis
5083208|NCT01287949|Pertussis (acellular)|pertussis (acellular)
5083209|NCT01287949|Biological/vaccine|biological/vaccine
5083210|NCT01287936|Chronic Stroke|chronic stroke
5083211|NCT01287936|Stable Stroke|stable stroke
5083212|NCT01287923|Hematology|hematology
5083213|NCT01287923|Secondary lymphoid organs|secondary lymphoid organs
5083214|NCT01287910|Cardiac|cardiac
5083215|NCT01287910|Angina|angina
5083216|NCT01287910|Chest pain|chest pain
5083217|NCT01287897|Crohn's Disease|crohn's disease
5083218|NCT01287897|safety|safety
5083219|NCT01287897|efficacy|efficacy
5083220|NCT01287897|pharmacokinetics|pharmacokinetics
5083221|NCT01287897|pharmacodynamics|pharmacodynamics
5083222|NCT01287897|Crohn's Disease Activity Index (CDAI)|crohn's disease activity index (cdai)
5083223|NCT01287884|ABG|abg
5083224|NCT01287884|VBG|vbg
5083225|NCT01287884|pH|ph
5083226|NCT01287884|pCO2|pco2
5083227|NCT01287871|Cervical Cancer Screening|cervical cancer screening
5083228|NCT01287845|Prostate cancer|prostate cancer
5083229|NCT01287845|Neoplasm|neoplasm
5083230|NCT01287845|Diagnostic Imaging|diagnostic imaging
5083231|NCT01287845|PET (Positron Emission Tomography) -tracer|pet (positron emission tomography) -tracer
5083232|NCT01287845|PET-diagnosis|pet-diagnosis
5083233|NCT01287832|Methicillin-resistant|methicillin-resistant
5083234|NCT01287832|Staphylococcus aureus|staphylococcus aureus
5083235|NCT01287806|ulinastatin|ulinastatin
5083236|NCT01287806|inhalation injury|inhalation injury
5083237|NCT01287780|Humans|humans
5083238|NCT01287780|Prostheses and Implants|prostheses and implants
5083239|NCT01287780|Gentamicin administration and dosage|gentamicin administration and dosage
5083240|NCT01287780|Surgical sponges|surgical sponges
5083241|NCT01287780|Treatment outcomes|treatment outcomes
5083242|NCT01287767|Dementia|dementia
5083243|NCT01287767|Depression|depression
5083244|NCT01287767|Burden of care|burden of care
5083245|NCT01287767|Psychosocial intervention|psychosocial intervention
5083246|NCT01287767|Family home care|family home care
5083247|NCT01287702|early feeding|early feeding
5083248|NCT01287702|varices bleeding|varices bleeding
5083249|NCT01287702|to evaluate impact of early feeding on early rebleeding after ligation of varices|to evaluate impact of early feeding on early rebleeding after ligation of varices
5083250|NCT01287689|Non-interventional trial|non-interventional trial
5083251|NCT01287689|immunodeficiency|immunodeficiency
5083252|NCT01287689|outcome study, registry|outcome study, registry
5083253|NCT01287689|long-term outcomes, drug utilization|long-term outcomes, drug utilization
5083254|NCT01287689|effectiveness, treatment patterns|effectiveness, treatment patterns
5083255|NCT01287689|patient characteristics under real life conditions|patient characteristics under real life conditions
5083256|NCT01287689|factors for treatment success|factors for treatment success
5083257|NCT01287689|long-term tolerability|long-term tolerability
5083258|NCT01287689|quality of life|quality of life
5083259|NCT01287637|Rectal cancer|rectal cancer
5083260|NCT01287637|Temporary ileostomy|temporary ileostomy
5083261|NCT01287637|Ealy reversal|ealy reversal
5083262|NCT01287637|Morbidity|morbidity
5083263|NCT01287637|Mortality|mortality
5083264|NCT01287637|Quality of life|quality of life
5083265|NCT01287637|Economic effect|economic effect
5083266|NCT01287624|triple negative breast cancer|triple negative breast cancer
5083267|NCT01287624|fine line chemotherapy|fine line chemotherapy
5083268|NCT01287611|Cesarean section|cesarean section
5083269|NCT01287611|Kerr incision|kerr incision
5083270|NCT01287611|Purse string suturing in C/S|purse string suturing in c/s
5083271|NCT01287611|Continuous locked suturing in C/S|continuous locked suturing in c/s
5083272|NCT01287598|Phase I|phase i
5083273|NCT01287598|Probe substrate|probe substrate
5083274|NCT01287598|target therapy|target therapy
5083275|NCT01287598|small molecule|small molecule
5083276|NCT01287598|pharmacokinetics|pharmacokinetics
5083277|NCT01287585|Hepatocellular carcinoma|hepatocellular carcinoma
5083278|NCT01287585|Arginine|arginine
5083279|NCT01287585|Arginine deiminase|arginine deiminase
5083280|NCT01287585|ADI-PEG 20|adi-peg 20
5083281|NCT01287572|TcCO2|tcco2
5083282|NCT01287572|sedation|sedation
5083283|NCT01287572|procedure|procedure
5083284|NCT01287572|PICU|picu
5083285|NCT01287559|NEC|nec
5083286|NCT01287559|Premature Infant|premature infant
5083287|NCT01287533|Rheumatoid arthritis|rheumatoid arthritis
5083288|NCT01287533|Glucocorticoid induced osteoporosis|glucocorticoid induced osteoporosis
5083289|NCT01287533|Vertebral fracture|vertebral fracture
5083290|NCT01287507|VLBW, NEC, Late onset sepsis|vlbw, nec, late onset sepsis
5083291|NCT01287494|elderly|elderly
5083292|NCT01287494|care management|care management
5083293|NCT01287494|primary care|primary care
5083294|NCT01287481|Fibromyalgia|fibromyalgia
5083295|NCT01287481|Behavioral interventions|behavioral interventions
5083296|NCT01287481|Psychological interventions|psychological interventions
5083297|NCT01287468|phytomedicines|phytomedicines
5083298|NCT01287468|breast cancer|breast cancer
5083299|NCT01287468|stromal fibroblasts|stromal fibroblasts
5083300|NCT01287468|MDSCs|mdscs
5083301|NCT01287468|functional mechanism|functional mechanism
5083302|NCT01287455|Asthma|asthma
5083303|NCT01287455|Vitamin D|vitamin d
5083304|NCT01287455|airway reactivity|airway reactivity
5083305|NCT01287455|metacholine challenge test|metacholine challenge test
5083306|NCT01287429|Ultrasonography|ultrasonography
5083307|NCT01287416|Suicide Intervention|suicide intervention
5083308|NCT01287416|Applied Suicide Intervention Skills Training (ASIST)|applied suicide intervention skills training (asist)
5083309|NCT01287416|Resilience Retreat|resilience retreat
5083310|NCT01287416|First Nations|first nations
5083311|NCT01287416|Suicide Intervention and Response Inventory (SIRI)|suicide intervention and response inventory (siri)
5083312|NCT01287403|Cereals|cereals
5083313|NCT01287403|Alkylresorcinols|alkylresorcinols
5083314|NCT01287403|Betaine|betaine
5083315|NCT01287403|Phenolics|phenolics
5083316|NCT01287403|Plasma and urine cereal phytochemicals|plasma and urine cereal phytochemicals
5083317|NCT01287390|squamous cell carcinoma|squamous cell carcinoma
5083318|NCT01287390|oral cavity|oral cavity
5083319|NCT01287390|oropharynx|oropharynx
5083320|NCT01287390|hypopharynx|hypopharynx
5083321|NCT01287390|larynx|larynx
5083322|NCT01287377|tobacco cessation|tobacco cessation
5083323|NCT01287377|smoking cessation|smoking cessation
5083324|NCT01287377|nicotine|nicotine
5083325|NCT01287377|counseling|counseling
5083326|NCT01287377|telephone|telephone
5083327|NCT01287377|self-help|self-help
5083328|NCT01287377|smoking abstinence|smoking abstinence
5083329|NCT01287377|tobacco use disorder|tobacco use disorder
5083330|NCT01287377|nicotine replacement therapy|nicotine replacement therapy
5083331|NCT01287364|perennial allergic rhinitis|perennial allergic rhinitis
5083332|NCT01287364|PAR|par
5083333|NCT01287351|Real-world|real-world
5083334|NCT01287351|observational|observational
5083335|NCT01287351|Fluticasone propionate|fluticasone propionate
5083336|NCT01287351|Metred dose inhaler|metred dose inhaler
5083337|NCT01287351|Extra-fine hydrofluoroalkane|extra-fine hydrofluoroalkane
5083338|NCT01287351|Asthma management|asthma management
5083339|NCT01287351|Inhaled corticosteroids|inhaled corticosteroids
5083340|NCT01287351|Beclomethasone dipropionate|beclomethasone dipropionate
5083341|NCT01287351|USA|usa
5083342|NCT01287325|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
5083343|NCT01287325|Cough|cough
5083344|NCT01287325|DNK333|dnk333
5083345|NCT01287312|We will treat children age 1 month to 20 years with recurrent TEF after surgical failure|we will treat children age 1 month to 20 years with recurrent tef after surgical failure
5083346|NCT01287299|pregnancy|pregnancy
5083347|NCT01287299|obesity|obesity
5083348|NCT01287299|diet glycemic load|diet glycemic load
5083349|NCT01287299|body composition|body composition
5083350|NCT01287299|body fat|body fat
5083351|NCT01287299|gestational weight gain|gestational weight gain
5083352|NCT01287299|insulin resistance|insulin resistance
5083353|NCT01287286|Cancers|cancers
5083354|NCT01287286|Antrodia cinnamomea|antrodia cinnamomea
5083355|NCT01287286|Chemotherapy|chemotherapy
5083356|NCT01287286|Gastrointestinal Disorder|gastrointestinal disorder
5083357|NCT01287273|frozen-thawed|frozen-thawed
5083358|NCT01287273|IVF|ivf
5083359|NCT01287273|incubation|incubation
5083360|NCT01287273|pregnancy rate|pregnancy rate
5083361|NCT01287273|Pregnancy rate of frozen-thawed embryos of IVF treatments|pregnancy rate of frozen-thawed embryos of ivf treatments
5083362|NCT01287260|BAYA1040_Nifedipine|baya1040_nifedipine
5083363|NCT01287260|Nifedipine|nifedipine
5083364|NCT01287260|Essential hypertension|essential hypertension
5083365|NCT01287260|Japanese Patients|japanese patients
5083366|NCT01287260|Phase III|phase iii
5083367|NCT01287260|13176|13176
5083368|NCT01287247|Cervical dystonia|cervical dystonia
5083369|NCT01287247|Blepharospasm|blepharospasm
5083370|NCT01287208|Physical activity|physical activity
5083371|NCT01287208|Accelerometer|accelerometer
5083372|NCT01287208|Steps|steps
5083373|NCT01287208|Medical residents|medical residents
5083374|NCT01287195|Ulcerative Colitis|ulcerative colitis
5083375|NCT01287195|Inflammatory Bowel Disease|inflammatory bowel disease
5083376|NCT01287182|Asymptomatic Myocardial Ischemic patients|asymptomatic myocardial ischemic patients
5083377|NCT01287169|Bisphenol A|bisphenol a
5083378|NCT01287156|Recruitment|recruitment
5083379|NCT01287156|TBI|tbi
5083380|NCT01287156|Screening|screening
5083381|NCT01287156|Traumatic Brain Injury|traumatic brain injury
5083382|NCT01287143|Fever|fever
5083383|NCT01287143|Signs and Symptoms|signs and symptoms
5083685|NCT01285856|patients|patients
5083384|NCT01287143|Febrile Assessment Tool (FAST)|febrile assessment tool (fast)
5083385|NCT01287130|Antibodies|antibodies
5083386|NCT01287130|Pharmacokinetics|pharmacokinetics
5083387|NCT01287130|Kinase Inhibitors|kinase inhibitors
5083388|NCT01287130|Colon Cancer|colon cancer
5083389|NCT01287130|K-Ras|k-ras
5083390|NCT01287130|Colorectal Cancer|colorectal cancer
5083391|NCT01287130|Solid Tumor|solid tumor
5083392|NCT01287104|Leukemia/Lymphoma|leukemia/lymphoma
5083393|NCT01287104|Hematologic Malignacies|hematologic malignacies
5083394|NCT01287104|Leukemia|leukemia
5083395|NCT01287104|Lymphoma|lymphoma
5083396|NCT01287104|Ewing Sarcoma|ewing sarcoma
5083397|NCT01287104|Rhabdomyosarcoma|rhabdomyosarcoma
5083398|NCT01287104|Neuroblastoma|neuroblastoma
5083399|NCT01287104|Healthy Donor|healthy donor
5083400|NCT01287078|Chronic GVHD of the Lung|chronic gvhd of the lung
5083401|NCT01287078|Peripheral Blood Stem Cell Transplant|peripheral blood stem cell transplant
5083402|NCT01287078|Inhaled Cyclosporine|inhaled cyclosporine
5083403|NCT01287078|Graft-Versus-Host Disease|graft-versus-host disease
5083404|NCT01287078|GVHD|gvhd
5083405|NCT01287078|Bronchiolitis Obliterans|bronchiolitis obliterans
5083406|NCT01287078|Lung|lung
5083407|NCT01287065|Fluticasone furoate|fluticasone furoate
5083408|NCT01287065|Vilanterol|vilanterol
5083409|NCT01287065|Efficacy|efficacy
5083410|NCT01287065|FEV1|fev1
5083411|NCT01287065|FF/VI Inhalation powder|ff/vi inhalation powder
5083412|NCT01287052|Migraine|migraine
5083413|NCT01287052|Pediatric|pediatric
5083414|NCT01287052|Adolescent|adolescent
5083415|NCT01287052|Nitrous Oxide|nitrous oxide
5083416|NCT01287026|MRI Catheterization|mri catheterization
5083417|NCT01287026|Right Heart Catheterization|right heart catheterization
5083418|NCT01287026|Pulmonary Artery Catheterization|pulmonary artery catheterization
5083419|NCT01287026|MRI Safety|mri safety
5083420|NCT01287026|Jugular Vein Catheterization|jugular vein catheterization
5083421|NCT01287026|Heart Catheterization|heart catheterization
5083422|NCT01287026|Heart Disease|heart disease
5083423|NCT01287026|Cardiovascular Disease|cardiovascular disease
5083424|NCT01287013|Image Guided Procedures|image guided procedures
5083425|NCT01287013|Xperguide CT|xperguide ct
5083426|NCT01287013|Electromagnetic Tracking|electromagnetic tracking
5083427|NCT01287013|Navigation|navigation
5083428|NCT01287013|Image Guided Procedure|image guided procedure
5083429|NCT01287013|Cancer|cancer
5083430|NCT01287013|Granuloma|granuloma
5083431|NCT01287000|Respiratory Health Outcomes|respiratory health outcomes
5083432|NCT01287000|Petroleum|petroleum
5083433|NCT01287000|Dispersant(s)|dispersant(s)
5083434|NCT01287000|Oil Spill|oil spill
5083435|NCT01287000|Longitudinal Study|longitudinal study
5083436|NCT01286987|BRCA1 Protein|brca1 protein
5083437|NCT01286987|BRCA2 Protein|brca2 protein
5083438|NCT01286961|Bowel preparation|bowel preparation
5083439|NCT01286961|Polyethylene glycols|polyethylene glycols
5083440|NCT01286961|Colonoscopy|colonoscopy
5083441|NCT01286961|Outpatient|outpatient
5083442|NCT01286948|LNG gel|lng gel
5083443|NCT01286948|oral LNG|oral lng
5083444|NCT01286948|follicle rupture|follicle rupture
5083445|NCT01286948|intra-vaginal administration|intra-vaginal administration
5083446|NCT01286948|growth of the leading follicle|growth of the leading follicle
5083447|NCT01286948|preovulatory peak of serum luteinizing hormone|preovulatory peak of serum luteinizing hormone
5083448|NCT01286948|characteristics of the cervical mucus|characteristics of the cervical mucus
5083449|NCT01286948|serum levels of estradiol (E2) and progesterone (P)|serum levels of estradiol (e2) and progesterone (p)
5083450|NCT01286935|Parkinson's Disease|parkinson's disease
5083451|NCT01286935|PD|pd
5083452|NCT01286935|Levodopa|levodopa
5083453|NCT01286935|Patients with idiopathic Parkinson's Disease with motor fluctuations,|patients with idiopathic parkinson's disease with motor fluctuations,
5083454|NCT01286922|diabetes|diabetes
5083455|NCT01286922|exercise|exercise
5083456|NCT01286922|insulin resistance|insulin resistance
5083457|NCT01286922|interval training|interval training
5083458|NCT01286922|physical activity|physical activity
5083459|NCT01286909|Metabolic|metabolic
5083460|NCT01286896|advanced solid tumors|advanced solid tumors
5083461|NCT01286883|stem cell markers|stem cell markers
5083462|NCT01286883|prognostic markers|prognostic markers
5083463|NCT01286883|metastatic colorectal cancer|metastatic colorectal cancer
5083464|NCT01286883|circulating tumor cells|circulating tumor cells
5083465|NCT01286883|tumor microenvironment|tumor microenvironment
5083466|NCT01286883|colorectal cancer|colorectal cancer
5083467|NCT01286883|advanced colorectal cancer|advanced colorectal cancer
5083468|NCT01286870|Primary Breast Reconstruction|primary breast reconstruction
5083469|NCT01286831|Accelerator Mass Spectrometry (AMS)|accelerator mass spectrometry (ams)
5083470|NCT01286831|Beta-2 agonist|beta-2 agonist
5083471|NCT01286831|Absorption, Distribution, Metabolism and Excretion (ADME)|absorption, distribution, metabolism and excretion (adme)
5083472|NCT01286831|Radiolabel|radiolabel
5083473|NCT01286818|Colon Cancer|colon cancer
5083474|NCT01286818|Rectal Cancer|rectal cancer
5083475|NCT01286766|unresectable|unresectable
5083476|NCT01286766|locally advanced|locally advanced
5083477|NCT01286740|HIV-1|hiv-1
5083478|NCT01286740|HIV|hiv
5083479|NCT01286740|Treatment Experienced|treatment experienced
5083480|NCT01286701|Bioequivalence|bioequivalence
5083481|NCT01286701|crossover|crossover
5083482|NCT01286701|Terbinafine hydrochloride|terbinafine hydrochloride
5083483|NCT01286701|fed|fed
5083484|NCT01286688|Bioequivalence|bioequivalence
5083485|NCT01286688|crossover|crossover
5083486|NCT01286688|Terbinafine hydrochloride|terbinafine hydrochloride
5083487|NCT01286688|Fasting|fasting
5083488|NCT01286675|ASCT|asct
5083489|NCT01286675|G-CSF|g-csf
5083490|NCT01286662|gardner syndrome|gardner syndrome
5083491|NCT01286662|colorectal carcinoma|colorectal carcinoma
5083492|NCT01286662|desmoid tumor|desmoid tumor
5083493|NCT01286662|resection|resection
5083494|NCT01286662|colon|colon
5083495|NCT01286649|Alopecia|alopecia
5083496|NCT01286649|Alopecia, Androgenetic|alopecia, androgenetic
5083497|NCT01286649|Androgenetic Alopecia|androgenetic alopecia
5083498|NCT01286636|artificial neural network|artificial neural network
5083499|NCT01286610|vibration|vibration
5083500|NCT01286610|ICU|icu
5083501|NCT01286610|blood pressure|blood pressure
5083502|NCT01286610|intracranial pressure|intracranial pressure
5083503|NCT01286610|infection|infection
5083504|NCT01286610|indirect calorimetry|indirect calorimetry
5083505|NCT01286597|lactose intolerance|lactose intolerance
5083506|NCT01286597|DNA sequencing|dna sequencing
5083507|NCT01286597|psychosocial factors|psychosocial factors
5083508|NCT01286597|irritable bowel syndrome|irritable bowel syndrome
5083509|NCT01286597|visceral hypersensitivity|visceral hypersensitivity
5083510|NCT01286584|varenicline|varenicline
5083511|NCT01286584|alcohol|alcohol
5083512|NCT01286584|placebo|placebo
5083513|NCT01286584|smoking cessation|smoking cessation
5083514|NCT01286545|Ankylosing spondylitis|ankylosing spondylitis
5083515|NCT01286545|Infliximab|infliximab
5083516|NCT01286545|Radiographic progression|radiographic progression
5083517|NCT01286532|Asthma, Asthma in Children|asthma, asthma in children
5083518|NCT01286519|pharmacokinetics|pharmacokinetics
5083519|NCT01286506|Pulse pressure variation|pulse pressure variation
5083520|NCT01286506|Continuous venovenous hemodialysis|continuous venovenous hemodialysis
5083521|NCT01286506|Volume status|volume status
5083522|NCT01286506|Critical care|critical care
5083523|NCT01286493|HIV|hiv
5083524|NCT01286493|booster|booster
5083525|NCT01286493|rabies|rabies
5083526|NCT01286493|immune response|immune response
5083527|NCT01286480|Health Care Transition|health care transition
5083528|NCT01286480|Adolescent|adolescent
5083529|NCT01286467|PF-04449913|pf-04449913
5083530|NCT01286467|Hedgehog Inhibitor|hedgehog inhibitor
5083531|NCT01286467|Solid tumor|solid tumor
5083532|NCT01286467|Pharmacokinetics|pharmacokinetics
5083533|NCT01286467|Safety|safety
5083534|NCT01286467|Pharmacodynamics|pharmacodynamics
5083535|NCT01286454|BIOAVAILABILITY|bioavailability
5083536|NCT01286454|FOOD EFFECT|food effect
5083537|NCT01286441|Verruca vulgaris|verruca vulgaris
5083538|NCT01286428|liver|liver
5083539|NCT01286428|cancer|cancer
5083540|NCT01286428|tumor|tumor
5083541|NCT01286428|ablation|ablation
5083542|NCT01286428|Pathfinder|pathfinder
5083543|NCT01286415|Posttraumatic Stress Disorder|posttraumatic stress disorder
5083544|NCT01286415|Cognitive Processing Therapy|cognitive processing therapy
5083545|NCT01286415|combat|combat
5083546|NCT01286415|military|military
5083547|NCT01286415|CPT|cpt
5083548|NCT01286415|group therapy|group therapy
5083549|NCT01286402|Smoking cessation during pregnancy|smoking cessation during pregnancy
5083550|NCT01286402|bupropion|bupropion
5083551|NCT01286389|Mild cognitive impairment|mild cognitive impairment
5083552|NCT01286389|Dementia|dementia
5083553|NCT01286389|Obesity|obesity
5083554|NCT01286389|Overweight|overweight
5083555|NCT01286389|diet|diet
5083556|NCT01286389|caloric restriction|caloric restriction
5083557|NCT01286389|body composition|body composition
5083558|NCT01286389|weight loss|weight loss
5083559|NCT01286376|Symbiotics|symbiotics
5083560|NCT01286376|Fiber|fiber
5083561|NCT01286376|Constipation|constipation
5083562|NCT01286363|Bite force|bite force
5083563|NCT01286363|Dental occlusion|dental occlusion
5083564|NCT01286363|Face|face
5083565|NCT01286363|Mastication|mastication
5083566|NCT01286363|Morphology|morphology
5083567|NCT01286350|motivational interviewing|motivational interviewing
5083568|NCT01286350|problem solving skills training|problem solving skills training
5083569|NCT01286350|family communication|family communication
5083570|NCT01286350|social support|social support
5083571|NCT01286350|adolescents|adolescents
5083572|NCT01286337|axilla|axilla
5083573|NCT01286337|surgery|surgery
5083574|NCT01286337|technique|technique
5083575|NCT01286337|bipolar vessel sealing|bipolar vessel sealing
5083576|NCT01286324|Matricaria|matricaria
5083577|NCT01286324|Chamomile|chamomile
5083578|NCT01286324|Herb|herb
5083579|NCT01286324|Insomnia|insomnia
5083580|NCT01286311|Health Education|health education
5083581|NCT01286311|Health Knowledge, Attitudes, Practice|health knowledge, attitudes, practice
5083582|NCT01286311|Hypolipidemic Agents/therapeutic use|hypolipidemic agents/therapeutic use
5083583|NCT01286311|Patient Education as Topic|patient education as topic
5083584|NCT01286298|diode laser|diode laser
5083585|NCT01286298|gingival enlargement|gingival enlargement
5083586|NCT01286298|gingival overgrowth|gingival overgrowth
5083587|NCT01286298|gingival hyperplasia|gingival hyperplasia
5083588|NCT01286298|orthodontics|orthodontics
5083589|NCT01286285|influenza|influenza
5083590|NCT01286285|acute respiratory infections|acute respiratory infections
5083591|NCT01286285|paediatric|paediatric
5083592|NCT01286285|intensive care units|intensive care units
5083593|NCT01286285|epidemiology|epidemiology
5083594|NCT01286259|HIV|hiv
5083595|NCT01286259|HAART suppressed|haart suppressed
5083596|NCT01286259|Disulfiram|disulfiram
5083597|NCT01286259|Antabuse|antabuse
5083598|NCT01286259|Latent reservoir|latent reservoir
5083599|NCT01286259|Eradication|eradication
5083600|NCT01286259|Cure|cure
5083601|NCT01286246|Progesterone|progesterone
5083602|NCT01286246|Randomized controlled trial|randomized controlled trial
5083603|NCT01286233|fatigue|fatigue
5083604|NCT01286233|sleep disorders|sleep disorders
5083605|NCT01286233|depression|depression
5083606|NCT01286233|stage IA breast cancer|stage ia breast cancer
5083607|NCT01286233|stage IB breast cancer|stage ib breast cancer
5083608|NCT01286233|stage II breast cancer|stage ii breast cancer
5083609|NCT01286233|stage IIIA breast cancer|stage iiia breast cancer
5083610|NCT01286207|Migraine headache|migraine headache
5083611|NCT01286181|COPD|copd
5083612|NCT01286181|Biofeedback|biofeedback
5083613|NCT01286181|Dyspnea|dyspnea
5083614|NCT01286181|Quality of life|quality of life
5083615|NCT01286181|Stress|stress
5083616|NCT01286168|Bilateral breast mastectomy|bilateral breast mastectomy
5083617|NCT01286168|Immediate tissue expanders reconstruction|immediate tissue expanders reconstruction
5083618|NCT01286155|Barrett's esophagus|barrett's esophagus
5083619|NCT01286155|gastroesophageal reflux disease|gastroesophageal reflux disease
5083620|NCT01286155|GERD|gerd
5083621|NCT01286142|Prospective, Observational Safety Study|prospective, observational safety study
5083622|NCT01286116|heart failure|heart failure
5083623|NCT01286116|percutaneous|percutaneous
5083624|NCT01286116|interventional cardiology|interventional cardiology
5083625|NCT01286116|apical remodeling|apical remodeling
5083626|NCT01286116|LV dilatation|lv dilatation
5083627|NCT01286116|akinesis|akinesis
5083628|NCT01286116|dyskinesis|dyskinesis
5083629|NCT01286116|myocardial infarction|myocardial infarction
5083630|NCT01286103|Canagliflozin|canagliflozin
5083631|NCT01286103|Pharmacokinetics|pharmacokinetics
5083632|NCT01286103|Pharmacodynamics|pharmacodynamics
5083633|NCT01286090|Cisapride (PREPULSID)|cisapride (prepulsid)
5083634|NCT01286090|Placebo|placebo
5083635|NCT01286090|Diabetes mellitus|diabetes mellitus
5083636|NCT01286090|Diabetic gastroparesis|diabetic gastroparesis
5083637|NCT01286077|Multiple Myeloma|multiple myeloma
5083638|NCT01286077|bortezomib|bortezomib
5083639|NCT01286077|hematology|hematology
5083640|NCT01286077|bone marrow cancer|bone marrow cancer
5083641|NCT01286077|Myeloma-related bone disease|myeloma-related bone disease
5083642|NCT01286077|bone mineral density|bone mineral density
5083643|NCT01286077|bone markers|bone markers
5083644|NCT01286064|adenocarcinoma,|adenocarcinoma,
5083645|NCT01286064|colorectal tumors,|colorectal tumors,
5083646|NCT01286064|endogenous porphyrins,|endogenous porphyrins,
5083647|NCT01286064|fluorescence,|fluorescence,
5083648|NCT01286064|tumor markers.|tumor markers.
5083649|NCT01286051|ovulation induction, GnRH|ovulation induction, gnrh
5083650|NCT01286038|platelets|platelets
5083651|NCT01286025|medical education|medical education
5083652|NCT01286025|problem-based learning|problem-based learning
5083653|NCT01286025|interactive tutorial|interactive tutorial
5083654|NCT01286012|End Stage Renal Disease, Hemodialysis, SFP|end stage renal disease, hemodialysis, sfp
5083655|NCT01285986|Graft patency|graft patency
5083656|NCT01285986|Limb salvage|limb salvage
5083657|NCT01285960|Uterine fibroids|uterine fibroids
5083658|NCT01285960|MRgFUS|mrgfus
5083659|NCT01285960|ExAblate|exablate
5083660|NCT01285960|Focused Ultrasound|focused ultrasound
5083661|NCT01285960|Symptomatic uterine fibroids|symptomatic uterine fibroids
5083662|NCT01285947|pain experience|pain experience
5083663|NCT01285947|energy devices|energy devices
5083664|NCT01285947|Ulthera|ulthera
5083665|NCT01285947|Thermage|thermage
5083666|NCT01285947|VBeam|vbeam
5083667|NCT01285921|hippocampal|hippocampal
5083668|NCT01285921|vestibular test|vestibular test
5083669|NCT01285908|Baroreceptor|baroreceptor
5083670|NCT01285908|Norepinephrine|norepinephrine
5083671|NCT01285908|Orthostatic Hypotension|orthostatic hypotension
5083672|NCT01285908|Sympathetic Nervous System|sympathetic nervous system
5083673|NCT01285908|Blood Pressure|blood pressure
5083674|NCT01285895|Lung and heart transplantations|lung and heart transplantations
5083675|NCT01285895|Mucoviscidosis|mucoviscidosis
5083676|NCT01285895|Educational needs|educational needs
5083677|NCT01285882|Lung transplantations|lung transplantations
5083678|NCT01285882|Representations|representations
5083679|NCT01285882|Mucoviscidosis|mucoviscidosis
5083680|NCT01285869|Pneumonia|pneumonia
5083681|NCT01285869|Intervention Studies|intervention studies
5083682|NCT01285869|Aged|aged
5083683|NCT01285869|Aged, 80 and over|aged, 80 and over
5083684|NCT01285869|Geriatric Assessment|geriatric assessment
5083686|NCT01285856|illicit consumption of psychotropic agents and alcohol|illicit consumption of psychotropic agents and alcohol
5083687|NCT01285856|buprenorphine|buprenorphine
5083688|NCT01285856|methadone|methadone
5083689|NCT01285830|Infants|infants
5083690|NCT01285830|Probiotics|probiotics
5083691|NCT01285830|Prevention|prevention
5083692|NCT01285830|Lactobacillus reuteri|lactobacillus reuteri
5083693|NCT01285830|Eczema|eczema
5083694|NCT01285830|IgE|ige
5083695|NCT01285830|Sensitization|sensitization
5083696|NCT01285830|Microbiota|microbiota
5083697|NCT01285830|Chemokines|chemokines
5083698|NCT01285791|morbid obesity|morbid obesity
5083699|NCT01285791|intra-abdominal visceral fat|intra-abdominal visceral fat
5083700|NCT01285791|gastric bypass|gastric bypass
5083701|NCT01285791|sleeve gastrectomy|sleeve gastrectomy
5083702|NCT01285791|gastric banding|gastric banding
5083703|NCT01285791|visceral fat|visceral fat
5083704|NCT01285778|Anal squamous cell carcinoma|anal squamous cell carcinoma
5083705|NCT01285778|panitumumab|panitumumab
5083706|NCT01285778|chemoradiation|chemoradiation
5083707|NCT01285778|anal cancer|anal cancer
5083708|NCT01285778|GEMCAD-09-02|gemcad-09-02
5083709|NCT01285739|Pulmonary Disease, Chronic Obstructive.|pulmonary disease, chronic obstructive.
5083710|NCT01285739|Tracheostomy.|tracheostomy.
5083711|NCT01285739|Invasive Mechanical Ventilation.|invasive mechanical ventilation.
5083712|NCT01285739|Non-Invasive Mechanical Ventilation.|non-invasive mechanical ventilation.
5083713|NCT01285726|Peritoneal dialysis|peritoneal dialysis
5083714|NCT01285726|Hydration status|hydration status
5083715|NCT01285726|Residual renal function|residual renal function
5083716|NCT01285726|Bioimpedance spectroscopy|bioimpedance spectroscopy
5083717|NCT01285726|Body composition monitor|body composition monitor
5083718|NCT01285713|Dehydration|dehydration
5083719|NCT01285713|Gastroenteritis|gastroenteritis
5083720|NCT01285713|Dehydration in Gastroenteritis|dehydration in gastroenteritis
5083721|NCT01285687|Tonsillectomy|tonsillectomy
5083722|NCT01285687|Post-Operative Pain|post-operative pain
5083723|NCT01285687|Acupuncture|acupuncture
5083724|NCT01285674|cisplatin|cisplatin
5083725|NCT01285674|ototoxicity|ototoxicity
5083726|NCT01285674|intratympanic steroids|intratympanic steroids
5083727|NCT01285661|Deep venous thrombosis|deep venous thrombosis
5083728|NCT01285661|Pulmonary embolism|pulmonary embolism
5083729|NCT01285661|Ultrasonography|ultrasonography
5083730|NCT01285661|D-dimer|d-dimer
5083731|NCT01285661|Venous thromboembolism|venous thromboembolism
5083732|NCT01285661|Bleeding|bleeding
5083733|NCT01285648|chest tubes,|chest tubes,
5083734|NCT01285648|Continuous Positive Airway Pressure,|continuous positive airway pressure,
5083735|NCT01285648|lung resection, thoracic surgery,|lung resection, thoracic surgery,
5083736|NCT01285648|noninvasive ventilation,|noninvasive ventilation,
5083737|NCT01285648|postoperative|postoperative
5083738|NCT01285622|Surgery; gynecological|surgery; gynecological
5083739|NCT01285622|Stroke volume|stroke volume
5083740|NCT01285596|Pharmacokinetics|pharmacokinetics
5083741|NCT01285596|Cardiography|cardiography
5083742|NCT01285596|Impedance|impedance
5083743|NCT01285596|Age groups|age groups
5083744|NCT01285596|Gender Identity|gender identity
5083745|NCT01285583|Amyotrophoc Lateral Sclerosis|amyotrophoc lateral sclerosis
5083746|NCT01285583|TRO19622|tro19622
5083747|NCT01285583|Olesoxime|olesoxime
5083748|NCT01285583|Trophos|trophos
5083749|NCT01285557|Gastric Cancer , S-1, Phase 3|gastric cancer , s-1, phase 3
5083750|NCT01285544|statins|statins
5083751|NCT01285544|cholesterol|cholesterol
5083752|NCT01285544|hypercholesterolemia|hypercholesterolemia
5083753|NCT01285544|atorvastatin|atorvastatin
5083754|NCT01285544|Dyslipidemia in cardiovascular disease (KoLipinon)|dyslipidemia in cardiovascular disease (kolipinon)
5083755|NCT01285531|lumbar puncture|lumbar puncture
5083756|NCT01285531|Compass|compass
5083757|NCT01285531|pressure transducer|pressure transducer
5083758|NCT01285531|manometry|manometry
5083759|NCT01285531|The focus of the study is to improve lumbar puncture(LP)success, reduce the number of LP attempts, reduce the number of traumatic attempts.|the focus of the study is to improve lumbar puncture(lp)success, reduce the number of lp attempts, reduce the number of traumatic attempts.
5083760|NCT01285518|Type 2 diabetes|type 2 diabetes
5083761|NCT01285518|intravenous|intravenous
5083762|NCT01285518|single dose|single dose
5083763|NCT01285505|alprazolam|alprazolam
5083764|NCT01285505|sublingual|sublingual
5083765|NCT01285505|bioequivalence|bioequivalence
5083766|NCT01285492|COPD|copd
5083767|NCT01285492|QVA149|qva149
5083768|NCT01285492|NVA237|nva237
5083769|NCT01285492|indacaterol|indacaterol
5083770|NCT01285492|combination bronchodilator|combination bronchodilator
5083771|NCT01285479|Fingolimod|fingolimod
5083772|NCT01285479|FTY720|fty720
5083773|NCT01285479|Gilenya|gilenya
5083774|NCT01285479|Multiple sclerosis|multiple sclerosis
5083775|NCT01285479|MS|ms
5083776|NCT01285479|Safety|safety
5083777|NCT01285479|Pregnancy|pregnancy
5083778|NCT01285479|Pregnancy outcomes|pregnancy outcomes
5083779|NCT01285466|Cancer|cancer
5083780|NCT01285466|BEZ235|bez235
5083781|NCT01285466|BKM120|bkm120
5083782|NCT01285466|paclitaxel|paclitaxel
5083783|NCT01285466|trastuzumab|trastuzumab
5083784|NCT01285453|ASA404,|asa404,
5083785|NCT01285453|vadimezan,|vadimezan,
5083786|NCT01285453|docetaxel|docetaxel
5083787|NCT01285440|breast|breast
5083788|NCT01285440|biopsy|biopsy
5083789|NCT01285440|suspicious lesion|suspicious lesion
5083790|NCT01285440|molecular breast imaging|molecular breast imaging
5083791|NCT01285427|DNA, sequencing|dna, sequencing
5083792|NCT01285427|Identification and definition of Class I and II Human Leukocyte Antigens (HLA)|identification and definition of class i and ii human leukocyte antigens (hla)
5083793|NCT01285414|Glioblastoma|glioblastoma
5083794|NCT01285414|Brain Neoplasms|brain neoplasms
5083795|NCT01285414|Brain Cancer|brain cancer
5083796|NCT01285414|Verubulin|verubulin
5083797|NCT01285401|Multiple Sclerosis|multiple sclerosis
5083798|NCT01285401|Rebif|rebif
5083799|NCT01285401|VigantOL® oil|vigantol® oil
5083800|NCT01285401|Vitamin D|vitamin d
5083801|NCT01285401|Add-on treatment|add-on treatment
5083802|NCT01285388|Safety|safety
5083803|NCT01285388|Tolerability|tolerability
5083804|NCT01285388|Pharmacokinetic|pharmacokinetic
5083805|NCT01285362|Fatty Liver Disease|fatty liver disease
5083806|NCT01285362|Hepatic Steatosis|hepatic steatosis
5083807|NCT01285362|Docosahexaenoic Acid|docosahexaenoic acid
5083808|NCT01285362|Eicosapentanoic Acid|eicosapentanoic acid
5083809|NCT01285362|Omega-3 Fatty Acids|omega-3 fatty acids
5083810|NCT01285362|Elevated Transaminases|elevated transaminases
5083811|NCT01285362|Fish oil supplements|fish oil supplements
5083812|NCT01285349|HIV, STI, condom use, drug use,|hiv, sti, condom use, drug use,
5083813|NCT01285336|Rheumatoid arthritis (RA)|rheumatoid arthritis (ra)
5083814|NCT01285336|DNA repair system|dna repair system
5083815|NCT01285336|polymorphism|polymorphism
5083816|NCT01285336|susceptibility|susceptibility
5083817|NCT01285336|copy number variation (CNV)|copy number variation (cnv)
5083818|NCT01285310|Rheumatoid, Arthritis|rheumatoid, arthritis
5083819|NCT01285297|Transmyocardial revascularization (TMR)|transmyocardial revascularization (tmr)
5083820|NCT01285297|Bone marrow aspirate concentrate (BMAC)|bone marrow aspirate concentrate (bmac)
5083821|NCT01285297|Angina|angina
5083822|NCT01285284|Colonoscopy|colonoscopy
5083823|NCT01285284|Music|music
5083824|NCT01285284|Tolerance|tolerance
5083825|NCT01285284|Pain|pain
5083826|NCT01285284|Anxiety|anxiety
5083827|NCT01285284|Dose of sedative drugs administered during the procedure|dose of sedative drugs administered during the procedure
5083828|NCT01285271|xenon|xenon
5083829|NCT01285271|sevoflurane|sevoflurane
5083830|NCT01285271|cardiac anesthesia|cardiac anesthesia
5083831|NCT01285271|CABG|cabg
5083832|NCT01285271|Bypass surgery|bypass surgery
5083833|NCT01285258|Peripartum|peripartum
5083834|NCT01285258|hysterectomy|hysterectomy
5083835|NCT01285258|placenta accreta|placenta accreta
5083836|NCT01285258|mortality|mortality
5083837|NCT01285245|insulin sensitivity|insulin sensitivity
5083838|NCT01285245|interleukin-1 receptor antagonist|interleukin-1 receptor antagonist
5083839|NCT01285245|inflammation|inflammation
5083840|NCT01285245|hyperglycemia-induced insulin resistance|hyperglycemia-induced insulin resistance
5083841|NCT01285219|Granulocyte colony-stimulating factor , recombinant|granulocyte colony-stimulating factor , recombinant
5083842|NCT01285219|Polyethylene glycols|polyethylene glycols
5083843|NCT01285219|Neutropenia|neutropenia
5083844|NCT01285219|Drug therapy, combination|drug therapy, combination
5083845|NCT01285193|hypertension|hypertension
5083846|NCT01285193|high blood pressure|high blood pressure
5083847|NCT01285193|treatment|treatment
5083848|NCT01285193|breath control|breath control
5083849|NCT01285193|breathing exercise|breathing exercise
5083850|NCT01285193|audio CD|audio cd
5083851|NCT01285180|COPD|copd
5083852|NCT01285180|Quality of life|quality of life
5083853|NCT01285180|sociodemographic data|sociodemographic data
5083854|NCT01285180|cost-of-illness data|cost-of-illness data
5083855|NCT01285180|roflumilast|roflumilast
5083856|NCT01285180|Daxas|daxas
5083857|NCT01285167|COPD|copd
5083858|NCT01285167|Quality of life|quality of life
5083859|NCT01285167|lung function|lung function
5083860|NCT01285167|spirometry|spirometry
5083861|NCT01285167|roflumilast|roflumilast
5083862|NCT01285167|Daxas|daxas
5083863|NCT01285167|severe COPD|severe copd
5083864|NCT01285154|Hip dysplasia|hip dysplasia
5083865|NCT01285154|Triple Osteotomy|triple osteotomy
5083866|NCT01285154|Femoral Head Coverage|femoral head coverage
5083867|NCT01285154|Femoral Head Medialization|femoral head medialization
5083868|NCT01285141|HIV Infections|hiv infections
5083869|NCT01285141|Acquired Immune Deficiency Syndrome|acquired immune deficiency syndrome
5083870|NCT01285115|Generalized anxiety disorder|generalized anxiety disorder
5083871|NCT01285115|Jingji-zhengchong|jingji-zhengchong
5083872|NCT01285115|Gamisoyosan|gamisoyosan
5083873|NCT01285115|anxiety|anxiety
5083874|NCT01285063|overweight|overweight
5083875|NCT01285063|obesity|obesity
5083876|NCT01285063|physical fitness|physical fitness
5083877|NCT01285063|kinder garden|kinder garden
5083878|NCT01285063|preschool|preschool
5083879|NCT01285050|HIV|hiv
5083880|NCT01285050|Human immunodeficiency virus|human immunodeficiency virus
5083881|NCT01285050|Acquired Immune Deficiency Syndrome Virus|acquired immune deficiency syndrome virus
5083882|NCT01285050|AIDS Virus|aids virus
5083883|NCT01285050|Immunodeficiency Virus, Human|immunodeficiency virus, human
5083884|NCT01285050|Virus, Human Immunodeficiency|virus, human immunodeficiency
5083885|NCT01285050|Hepatitis C|hepatitis c
5083886|NCT01285050|Hepatitis C, chronic|hepatitis c, chronic
5083887|NCT01285050|Hepatitis C virus|hepatitis c virus
5083888|NCT01285050|Hepatitis C antibodies|hepatitis c antibodies
5083889|NCT01285050|Hepatitis C antigens|hepatitis c antigens
5083890|NCT01285024|total hip arthroplasty|total hip arthroplasty
5083891|NCT01285024|transfusion|transfusion
5083892|NCT01285024|hemostat|hemostat
5083893|NCT01285011|arthrodesis|arthrodesis
5083894|NCT01285011|PIP joint|pip joint
5083895|NCT01284998|forefoot deformities|forefoot deformities
5083896|NCT01284998|basal osteotomy|basal osteotomy
5083897|NCT01284959|cognitive function|cognitive function
5083898|NCT01284959|subjective experiences|subjective experiences
5083899|NCT01284959|neuroleptic-induced deficit syndrome|neuroleptic-induced deficit syndrome
5083900|NCT01284959|paliperidone extended-release|paliperidone extended-release
5083901|NCT01284959|risperidone|risperidone
5083902|NCT01284946|PCT sporadic or familial|pct sporadic or familial
5083903|NCT01284946|Skin fragility and bullae lesions|skin fragility and bullae lesions
5083904|NCT01284946|non-transfusion iron overload|non-transfusion iron overload
5083905|NCT01284933|Stroke|stroke
5083906|NCT01284933|Ischemic Attack, Transient|ischemic attack, transient
5083907|NCT01284933|Magnetic Resonance Imaging|magnetic resonance imaging
5083908|NCT01284933|Carotid Arteries|carotid arteries
5083909|NCT01284933|Carotid Artery Plaque|carotid artery plaque
5083910|NCT01284933|Atherosclerosis|atherosclerosis
5083911|NCT01284920|MDV3100|mdv3100
5083912|NCT01284920|Response Evaluation Criteria in Solid Tumor (RECIST)|response evaluation criteria in solid tumor (recist)
5083913|NCT01284920|docetaxel|docetaxel
5083914|NCT01284920|PSA level|psa level
5083915|NCT01284907|Asthma|asthma
5083916|NCT01284907|Asthma therapy|asthma therapy
5083917|NCT01284907|Randomized controlled trial|randomized controlled trial
5083918|NCT01284907|children|children
5083919|NCT01284894|Dysphagia|dysphagia
5083920|NCT01284894|Conventional manometry|conventional manometry
5083921|NCT01284894|High resolution manometry|high resolution manometry
5083922|NCT01284881|MRA|mra
5083923|NCT01284881|compliance|compliance
5083924|NCT01284881|OSAHS|osahs
5083925|NCT01284868|Mechanisms of Pharmacological Action|mechanisms of pharmacological action
5083926|NCT01284868|Pharmacodynamics|pharmacodynamics
5083927|NCT01284868|Pharmacokinetics|pharmacokinetics
5083928|NCT01284855|neurotoxic envenoming (WHO ICD-10 T63.0)|neurotoxic envenoming (who icd-10 t63.0)
5083929|NCT01284842|sleep-deprivation|sleep-deprivation
5083930|NCT01284842|virtual reality|virtual reality
5083931|NCT01284842|residency|residency
5083932|NCT01284842|performance|performance
5083933|NCT01284816|severely obese patients|severely obese patients
5083934|NCT01284803|patients|patients
5083935|NCT01284803|moderate depression|moderate depression
5083936|NCT01284777|cancerology|cancerology
5083937|NCT01284777|genetic|genetic
5083938|NCT01284764|Endoscopy|endoscopy
5083939|NCT01284764|Gastrectomy|gastrectomy
5083940|NCT01284764|Stomach neoplasms|stomach neoplasms
5083941|NCT01284738|TM|tm
5083942|NCT01284738|TI|ti
5083943|NCT01284738|MP|mp
5083944|NCT01284712|treatment by bleedings|treatment by bleedings
5083945|NCT01284699|Parkinson|parkinson
5083946|NCT01284699|contraindication to Intracerebral electrode implantation|contraindication to intracerebral electrode implantation
5083947|NCT01284699|Gamma Knife radiosurgery|gamma knife radiosurgery
5083948|NCT01284686|Pathophysiology|pathophysiology
5083949|NCT01284686|Parkinson|parkinson
5083950|NCT01284686|neuronal oscillations|neuronal oscillations
5083951|NCT01284673|Cord blood stem|cord blood stem
5083952|NCT01284673|neonatal asphyxia|neonatal asphyxia
5083953|NCT01284647|Chronic Erosive Gastritis|chronic erosive gastritis
5083954|NCT01284647|Teprenone|teprenone
5083955|NCT01284647|Sucralfate|sucralfate
5083956|NCT01284634|Cannabidiol|cannabidiol
5083957|NCT01284634|Fatty liver|fatty liver
5083958|NCT01284634|Diabetes|diabetes
5083959|NCT01284634|Body fat|body fat
5083960|NCT01284608|Observational|observational
5083961|NCT01284608|prospective|prospective
5083962|NCT01284608|metabolic changes|metabolic changes
5083963|NCT01284608|metabolic syndrome|metabolic syndrome
5083964|NCT01284608|diabetes|diabetes
5083965|NCT01284608|prostatic cancer|prostatic cancer
5083966|NCT01284608|risk fracture|risk fracture
5083967|NCT01284595|Radioactive carbon|radioactive carbon
5083968|NCT01284595|Absorption|absorption
5083969|NCT01284595|Distribution|distribution
5083970|NCT01284595|Metabolism|metabolism
5083971|NCT01284595|Excretion|excretion
5083972|NCT01284595|Healthy Volunteers|healthy volunteers
5083973|NCT01284582|CETP|cetp
5083974|NCT01284582|Vaccine|vaccine
5083975|NCT01284582|Cholesterol|cholesterol
5083976|NCT01284582|Inhibition|inhibition
5083977|NCT01284556|partial onset seizures|partial onset seizures
5083978|NCT01284530|Epilepsy|epilepsy
5083979|NCT01284530|Pediatrics|pediatrics
5083980|NCT01284530|Young Adults|young adults
5083981|NCT01284517|Bipolar I Depression|bipolar i depression
5083982|NCT01284517|Lurasidone|lurasidone
5083983|NCT01284517|Latuda|latuda
5083984|NCT01284491|Breast reduction|breast reduction
5083985|NCT01284491|PlasmaBlade|plasmablade
5083986|NCT01284491|Electrosurgery|electrosurgery
5083987|NCT01284491|PEAK Surgical|peak surgical
5083988|NCT01284491|Medtronic Advanced Energy|medtronic advanced energy
5083989|NCT01284491|Medtronic|medtronic
5083990|NCT01284478|pseudophakic cystoid macular edema, diabetic macular edema, Irvine Gass Syndrome, cataract surgery, ozurdex, dexamethasone|pseudophakic cystoid macular edema, diabetic macular edema, irvine gass syndrome, cataract surgery, ozurdex, dexamethasone
5083991|NCT01284465|Type 2 diabetes self-management|type 2 diabetes self-management
5083992|NCT01284465|Minority women|minority women
5083993|NCT01284465|Barriers to diabetes self-management|barriers to diabetes self-management
5083994|NCT01284452|Septic shock|septic shock
5083995|NCT01284452|Severe sepsis|severe sepsis
5083996|NCT01284452|Acute lung injury|acute lung injury
5083997|NCT01284452|Acute respiratory distress syndrome|acute respiratory distress syndrome
5083998|NCT01284452|ARDS|ards
5083999|NCT01284426|Chronic urticaria|chronic urticaria
5084000|NCT01284426|Natural course|natural course
5084001|NCT01284426|Remission|remission
5084002|NCT01284400|heart failure|heart failure
5084003|NCT01284400|disease management|disease management
5084004|NCT01284387|Mild to moderate Alzheimer's disease|mild to moderate alzheimer's disease
5084005|NCT01284387|immunization|immunization
5084006|NCT01284387|amyloid imaging|amyloid imaging
5084007|NCT01284387|injection|injection
5084008|NCT01284387|vaccine|vaccine
5084009|NCT01284374|HPV Vaccines|hpv vaccines
5084010|NCT01284374|Attitude to Health|attitude to health
5084011|NCT01284374|Decision Making|decision making
5084012|NCT01284374|Qualitative Research|qualitative research
5084013|NCT01284361|intermittent catheter|intermittent catheter
5084014|NCT01284361|preference|preference
5084015|NCT01284348|Chemotherapy induced anemia|chemotherapy induced anemia
5084016|NCT01284348|Non-small cell lung cancer|non-small cell lung cancer
5084017|NCT01284335|Advanced solid tumors|advanced solid tumors
5084018|NCT01284335|Unresectable|unresectable
5084019|NCT01284335|Metastatic|metastatic
5084020|NCT01284335|Limited treatment options|limited treatment options
5084021|NCT01284335|Measurable or nonmeasurable disease|measurable or nonmeasurable disease
5084022|NCT01284309|Intraocular Pressure (IOP)|intraocular pressure (iop)
5084023|NCT01284309|YM178|ym178
5084024|NCT01284283|Arthrosis|arthrosis
5084025|NCT01284283|Rheumatoid Arthrosis|rheumatoid arthrosis
5084026|NCT01284283|Arthritic Joint|arthritic joint
5084027|NCT01284283|Rheumatoid Arthritis|rheumatoid arthritis
5084028|NCT01284283|Osteoarthritis|osteoarthritis
5084029|NCT01284283|Total Ankle Replacement|total ankle replacement
5084030|NCT01284270|Cardiac MRI|cardiac mri
5084031|NCT01284270|Plaque|plaque
5084032|NCT01284257|EC-MPS|ec-mps
5084033|NCT01284257|MMF|mmf
5084034|NCT01284257|kidney transplant|kidney transplant
5084035|NCT01284257|outcomes|outcomes
5084036|NCT01284257|mycophenolate sodium|mycophenolate sodium
5084037|NCT01284257|mycophenolic acid (MPA)|mycophenolic acid (mpa)
5084038|NCT01284244|Urinary Incontinence, Stress|urinary incontinence, stress
5084039|NCT01284244|pessary|pessary
5084040|NCT01284244|conservative management|conservative management
5084041|NCT01284231|MEDI-565, gastrointestinal adenocarcinomas, carcinoembryonic antigen, bispecific T-cell engager|medi-565, gastrointestinal adenocarcinomas, carcinoembryonic antigen, bispecific t-cell engager
5084042|NCT01284205|non-muscle invasive bladder cancer|non-muscle invasive bladder cancer
5084043|NCT01284205|superficial bladder cancer|superficial bladder cancer
5084044|NCT01284192|B-cell Lymphoma|b-cell lymphoma
5084045|NCT01284192|Advanced Malignancies|advanced malignancies
5084046|NCT01284192|Anaplastic Lymphoma Kinase (ALK)|anaplastic lymphoma kinase (alk)
5084047|NCT01284192|ASP3026|asp3026
5084048|NCT01284192|Solid Tumor|solid tumor
5084049|NCT01284179|Functional Chest Pain|functional chest pain
5084050|NCT01284179|Functional GI Disorders|functional gi disorders
5084051|NCT01284179|Home Hypnotherapy|home hypnotherapy
5084052|NCT01284153|respiratory gating|respiratory gating
5084053|NCT01284153|prone radiotherapy|prone radiotherapy
5084054|NCT01284153|breast cancer|breast cancer
5084055|NCT01284140|Critical illness|critical illness
5084056|NCT01284140|Sleep|sleep
5084057|NCT01284140|Polysomnography|polysomnography
5084058|NCT01284140|Respiratory failure|respiratory failure
5084059|NCT01284140|Circadian rhythm|circadian rhythm
5084060|NCT01284140|Sedation|sedation
5084061|NCT01284127|superficial siderosis|superficial siderosis
5084062|NCT01284114|Elderly chronic kidney disease|elderly chronic kidney disease
5084063|NCT01284114|Hypertension|hypertension
5084064|NCT01284114|Aliskiren|aliskiren
5084065|NCT01284088|Male Circumcision|male circumcision
5084066|NCT01284088|HIV Prevention|hiv prevention
5084067|NCT01284088|Medical Device|medical device
5084068|NCT01284062|Active Ulcerative Colitis|active ulcerative colitis
5084069|NCT01284062|Phase 2A|phase 2a
5084070|NCT01284062|Double-blind|double-blind
5084071|NCT01284062|Randomized|randomized
5084072|NCT01284062|PK/PD Biomarker Study|pk/pd biomarker study
5084073|NCT01284049|Home Parenteral Nutrition|home parenteral nutrition
5084074|NCT01284049|Intralipid 20%®|intralipid 20%®
5084075|NCT01284049|OMEGAVEN 10%®|omegaven 10%®
5084076|NCT01284049|Liver diseases|liver diseases
5084077|NCT01284036|Healthy subject|healthy subject
5084078|NCT01284036|safety|safety
5084079|NCT01284036|PK study|pk study
5084080|NCT01284036|healthy volunteers|healthy volunteers
5084081|NCT01284023|near infrared spectroscopy|near infrared spectroscopy
5084082|NCT01284023|acute compartment syndrome|acute compartment syndrome
5084083|NCT01284010|adult acute lymphoblastic leukemia|adult acute lymphoblastic leukemia
5084084|NCT01283997|Multiple Myeloma|multiple myeloma
5084085|NCT01283997|Neuropathy|neuropathy
5084086|NCT01283997|Peripheral Nerve Function|peripheral nerve function
5084087|NCT01283997|Touch Detection Threshold|touch detection threshold
5084088|NCT01283997|Nerve Damage|nerve damage
5084089|NCT01283997|Thalidomide|thalidomide
5084090|NCT01283997|Bortezomib|bortezomib
5084091|NCT01283997|Velcade|velcade
5084092|NCT01283997|Minocycline|minocycline
5084093|NCT01283997|Dynacin|dynacin
5084094|NCT01283997|Minocin|minocin
5084095|NCT01283997|Minocin PAC|minocin pac
5084096|NCT01283997|Myrac|myrac
5084097|NCT01283997|Solodyn|solodyn
5084098|NCT01283984|Safety|safety
5084099|NCT01283984|tolerability|tolerability
5084100|NCT01283984|healthy|healthy
5084101|NCT01283984|inhaled|inhaled
5084102|NCT01283984|respiratory disease|respiratory disease
5084103|NCT01283958|Iloprost, Eisenmenger's syndrome|iloprost, eisenmenger's syndrome
5084104|NCT01283945|VEGFRs|vegfrs
5084105|NCT01283945|FGFR1|fgfr1
5084106|NCT01283945|angiogenesis|angiogenesis
5084107|NCT01283906|Mucositis|mucositis
5084108|NCT01283906|Head and Neck Cancer|head and neck cancer
5084109|NCT01283906|Squamous Cell Cancer|squamous cell cancer
5084110|NCT01283906|Chemotherapy|chemotherapy
5084111|NCT01283906|Radiation Therapy|radiation therapy
5084112|NCT01283906|Oral Rinse|oral rinse
5084113|NCT01283880|kidney|kidney
5084114|NCT01283880|transplantation|transplantation
5084115|NCT01283880|metabolic acidosis|metabolic acidosis
5084116|NCT01283880|renal tubular acidosis|renal tubular acidosis
5084117|NCT01283880|nephrocalcinosis|nephrocalcinosis
5084118|NCT01283815|Laparoscopy|laparoscopy
5084119|NCT01283815|Drainage|drainage
5084120|NCT01283815|Appendectomy|appendectomy
5084121|NCT01283789|breast|breast
5084122|NCT01283789|cancer|cancer
5084123|NCT01283789|metastatic|metastatic
5084124|NCT01283789|metastasis|metastasis
5084125|NCT01283763|Cervical Intraepithelial Neoplasia, Imiquimod, conization|cervical intraepithelial neoplasia, imiquimod, conization
5084126|NCT01283750|care coordination|care coordination
5084127|NCT01283750|dementia care|dementia care
5084128|NCT01283750|intervention|intervention
5084129|NCT01283750|unmet needs|unmet needs
5084130|NCT01283750|community|community
5084131|NCT01283750|older adults|older adults
5084132|NCT01283750|caregiver|caregiver
5084133|NCT01283737|Osteochondritis Dissecans|osteochondritis dissecans
5084134|NCT01283737|OCD|ocd
5084135|NCT01283737|Mosaicplasty|mosaicplasty
5084136|NCT01283737|Demineralised Bone Matrix|demineralised bone matrix
5084137|NCT01283737|DBX|dbx
5084138|NCT01283737|DBX Putty|dbx putty
5084139|NCT01283724|Endometriosis|endometriosis
5084140|NCT01283724|DEXA|dexa
5084141|NCT01283724|Adolescent|adolescent
5084142|NCT01283724|Safety|safety
5084143|NCT01283724|Efficacy|efficacy
5084144|NCT01283724|Post-menarche|post-menarche
5084145|NCT01283711|wrinkles reduction|wrinkles reduction
5084146|NCT01283711|rhytides reduction|rhytides reduction
5084147|NCT01283711|RF treatment|rf treatment
5084148|NCT01283698|psoriasis|psoriasis
5084149|NCT01283698|topical|topical
5084150|NCT01283698|PPT|ppt
5084151|NCT01283685|Exercise, Physical|exercise, physical
5084152|NCT01283672|Whole grains|whole grains
5084153|NCT01283672|Barley|barley
5084154|NCT01283672|Oats|oats
5084155|NCT01283672|Cardiovascular disease|cardiovascular disease
5084156|NCT01283672|Postprandial lipid metabolism|postprandial lipid metabolism
5084157|NCT01283672|Endothelial function|endothelial function
5084158|NCT01283672|Risk of cardiovascular disease in healthy men and women|risk of cardiovascular disease in healthy men and women
5084159|NCT01283659|computed tomographic angiography|computed tomographic angiography
5084160|NCT01283659|coronary angiogram|coronary angiogram
5084161|NCT01283659|cost effectiveness|cost effectiveness
5084162|NCT01283659|QoL|qol
5084163|NCT01283659|Heart failure|heart failure
5084164|NCT01283659|diagnostic accuracy|diagnostic accuracy
5084165|NCT01283659|prospective comparative effectiveness randomized clinical trial|prospective comparative effectiveness randomized clinical trial
5084166|NCT01283633|neuromodulation|neuromodulation
5084167|NCT01283633|remote presence robotics|remote presence robotics
5084168|NCT01283620|stroke|stroke
5084169|NCT01283620|extremity, upper|extremity, upper
5084170|NCT01283607|in vitro fertilization|in vitro fertilization
5084171|NCT01283607|e-health|e-health
5084172|NCT01283607|cognitive behavioral therapy|cognitive behavioral therapy
5084173|NCT01283607|psychosocial risk profile|psychosocial risk profile
5084174|NCT01283607|emotional maladjustment|emotional maladjustment
5084175|NCT01283568|PMS, climacteric, depression|pms, climacteric, depression
5084176|NCT01283555|Microbicide, Applicator, Safety|microbicide, applicator, safety
5084177|NCT01283542|Non-functioning pituitary adenoma,|non-functioning pituitary adenoma,
5084178|NCT01283542|pasireotide LAR,|pasireotide lar,
5084179|NCT01283542|tumor volume|tumor volume
5084663|NCT01281202|Catalyst|catalyst
5084180|NCT01283529|Intrathoracal blood volume|intrathoracal blood volume
5084181|NCT01283529|Cardiac output|cardiac output
5084182|NCT01283529|Children|children
5084183|NCT01283516|ALK inhibitor,|alk inhibitor,
5084184|NCT01283516|NSCLC,|nsclc,
5084185|NCT01283516|LDK378,|ldk378,
5084186|NCT01283516|ceritinib,|ceritinib,
5084187|NCT01283516|genetic abnormalities|genetic abnormalities
5084188|NCT01283503|PI3K,|pi3k,
5084189|NCT01283503|Advanced solid tumor|advanced solid tumor
5084190|NCT01283490|topical anesthetic, sonophoresis|topical anesthetic, sonophoresis
5084191|NCT01283477|Caesarean Delivery|caesarean delivery
5084192|NCT01283477|Pruritis|pruritis
5084193|NCT01283477|Intrathecal Morphine|intrathecal morphine
5084194|NCT01283477|Acupuncture At LI11|acupuncture at li11
5084195|NCT01283464|Retinol|retinol
5084196|NCT01283464|Tretinoin|tretinoin
5084197|NCT01283451|near-infrared spectroscopy|near-infrared spectroscopy
5084198|NCT01283425|MiniMed Paradigm insulin pump|minimed paradigm insulin pump
5084199|NCT01283425|insulin Lispro|insulin lispro
5084200|NCT01283425|Insulin Aspart|insulin aspart
5084201|NCT01283425|Quick-set infusion set|quick-set infusion set
5084202|NCT01283412|Delirium|delirium
5084203|NCT01283412|Dexmedetomidine|dexmedetomidine
5084204|NCT01283412|Adult Patients|adult patients
5084205|NCT01283412|Elective Major Surgery|elective major surgery
5084206|NCT01283412|General Anesthesia|general anesthesia
5084207|NCT01283360|MSM|msm
5084208|NCT01283360|HIV negative|hiv negative
5084209|NCT01283360|microbicide|microbicide
5084210|NCT01283360|prevention|prevention
5084211|NCT01283347|Parkinson's disease|parkinson's disease
5084212|NCT01283334|Head and Neck Cancer|head and neck cancer
5084213|NCT01283334|Recurrent Metastatic Squamous Cell Carcinoma of the Head and Neck (SCCHN)|recurrent metastatic squamous cell carcinoma of the head and neck (scchn)
5084214|NCT01283321|Hemostasis|hemostasis
5084215|NCT01283321|Cardiopulmonary bypass (heart-lung machine)|cardiopulmonary bypass (heart-lung machine)
5084216|NCT01283321|Fibrinogen|fibrinogen
5084217|NCT01283321|platelet|platelet
5084218|NCT01283308|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
5084219|NCT01283308|India|india
5084220|NCT01283308|Prevention & Control|prevention & control
5084221|NCT01283308|Lifestyle Intervention|lifestyle intervention
5084222|NCT01283308|Translational Research|translational research
5084223|NCT01283269|Rehabilitation|rehabilitation
5084224|NCT01283269|Cognitive Intervention|cognitive intervention
5084225|NCT01283269|Prevention|prevention
5084226|NCT01283243|ARFI Imaging|arfi imaging
5084227|NCT01283243|Normal values|normal values
5084228|NCT01283243|HIV infection|hiv infection
5084229|NCT01283230|ARFI imaging|arfi imaging
5084230|NCT01283230|normal values|normal values
5084231|NCT01283230|chronic liver disease|chronic liver disease
5084232|NCT01283230|liver donors|liver donors
5084233|NCT01283230|kidney donors|kidney donors
5084234|NCT01283191|substance use|substance use
5084235|NCT01283191|drug use|drug use
5084236|NCT01283191|drug abuse|drug abuse
5084237|NCT01283191|exercise|exercise
5084238|NCT01283191|physical activity|physical activity
5084239|NCT01283178|squamous cell carcinoma of the paranasal sinus and nasal cavity|squamous cell carcinoma of the paranasal sinus and nasal cavity
5084240|NCT01283165|health education|health education
5084241|NCT01283165|Polyparasitism|polyparasitism
5084242|NCT01283165|school based deworming program|school based deworming program
5084243|NCT01283165|integrated control of parasites|integrated control of parasites
5084244|NCT01283152|Hepatic Encephalopathy|hepatic encephalopathy
5084245|NCT01283152|HE|he
5084246|NCT01283152|Cirrhosis|cirrhosis
5084247|NCT01283152|PSE|pse
5084248|NCT01283152|Portosystemic Encephalopathy|portosystemic encephalopathy
5084249|NCT01283152|Hepatic coma|hepatic coma
5084250|NCT01283152|AMS|ams
5084251|NCT01283152|Altered mental status|altered mental status
5084252|NCT01283152|Complications of cirrhosis|complications of cirrhosis
5084253|NCT01283152|Chronic liver disease|chronic liver disease
5084254|NCT01283139|SLE|sle
5084255|NCT01283139|Systemic Lupus Erythematosus|systemic lupus erythematosus
5084256|NCT01283139|Sifalimumab|sifalimumab
5084257|NCT01283139|MEDI-545|medi-545
5084258|NCT01283126|Hypoglycemia, cognitive function|hypoglycemia, cognitive function
5084259|NCT01283113|Visceral Fat|visceral fat
5084260|NCT01283113|Waist Circumference|waist circumference
5084261|NCT01283113|Bioelectrical Impedance|bioelectrical impedance
5084262|NCT01283113|Metabolic Syndrome|metabolic syndrome
5084263|NCT01283113|Obesity|obesity
5084264|NCT01283113|Type 2 Diabetes|type 2 diabetes
5084265|NCT01283100|HIV, GSK2248761, GSK1349572, drug interaction, pharmacokinetics|hiv, gsk2248761, gsk1349572, drug interaction, pharmacokinetics
5084266|NCT01283087|TNS|tns
5084267|NCT01283087|Spinal anesthesia|spinal anesthesia
5084268|NCT01283087|Lidocaine|lidocaine
5084269|NCT01283048|Kidney Cancer|kidney cancer
5084270|NCT01283048|Avastin|avastin
5084271|NCT01283022|Pharmacokinetics|pharmacokinetics
5084272|NCT01283022|Misoprostol Vaginal Insert|misoprostol vaginal insert
5084273|NCT01283022|Induction of labor|induction of labor
5084274|NCT01283022|Cervical Ripening|cervical ripening
5084275|NCT01283022|Rate of Cesarean section|rate of cesarean section
5084276|NCT01283009|pneumoniae|pneumoniae
5084277|NCT01282996|Mechanical ventilation|mechanical ventilation
5084278|NCT01282996|Postoperative pulmonary complications|postoperative pulmonary complications
5084279|NCT01282996|Positive end-expiratory pressure|positive end-expiratory pressure
5084280|NCT01282996|Protective lung ventilation|protective lung ventilation
5084281|NCT01282996|Alveolar recruitment maneuver|alveolar recruitment maneuver
5084282|NCT01282996|General anesthesia|general anesthesia
5084283|NCT01282996|Abdominal surgery|abdominal surgery
5084284|NCT01282983|fiber|fiber
5084285|NCT01282983|orange juice|orange juice
5084286|NCT01282983|digestive symptom|digestive symptom
5084287|NCT01282944|physical activity in adults 65 or older|physical activity in adults 65 or older
5084288|NCT01282931|Women|women
5084289|NCT01282931|Stage IV|stage iv
5084290|NCT01282931|Metastatic|metastatic
5084291|NCT01282931|Breast Cancer|breast cancer
5084292|NCT01282931|Progressed|progressed
5084293|NCT01282931|Progression|progression
5084294|NCT01282918|ICD|icd
5084295|NCT01282918|DF Test|df test
5084296|NCT01282918|intra-operative DF testing|intra-operative df testing
5084297|NCT01282918|VT|vt
5084298|NCT01282892|Visceral fat|visceral fat
5084299|NCT01282892|fatty liver|fatty liver
5084300|NCT01282892|atherosclerosis|atherosclerosis
5084301|NCT01282892|coronary computed tomography angiography|coronary computed tomography angiography
5084302|NCT01282879|Itraconazole oral solution|itraconazole oral solution
5084303|NCT01282879|invasive fungal infections|invasive fungal infections
5084304|NCT01282879|prophylaxis|prophylaxis
5084305|NCT01282879|Graft vs Host Disease|graft vs host disease
5084306|NCT01282879|transplantation|transplantation
5084307|NCT01282853|peptic ulcer|peptic ulcer
5084308|NCT01282853|hemorrhage|hemorrhage
5084309|NCT01282853|rapid urease test|rapid urease test
5084310|NCT01282853|urea breath test|urea breath test
5084311|NCT01282840|LUTS|luts
5084312|NCT01282814|Bioequivalence|bioequivalence
5084313|NCT01282814|Healthy Subjects|healthy subjects
5084314|NCT01282801|Bioequivalence|bioequivalence
5084315|NCT01282801|Healthy Subjects|healthy subjects
5084316|NCT01282788|infant nutrition|infant nutrition
5084317|NCT01282788|complementary feeding|complementary feeding
5084318|NCT01282788|malnutrition|malnutrition
5084319|NCT01282788|stunting of growth|stunting of growth
5084320|NCT01282775|overweight|overweight
5084321|NCT01282775|obesity|obesity
5084322|NCT01282775|worksite|worksite
5084323|NCT01282762|Prevention of Hepatitis B infection.|prevention of hepatitis b infection.
5084324|NCT01282762|End Stage Renal Disease|end stage renal disease
5084325|NCT01282762|Hepatitis B vaccination|hepatitis b vaccination
5084326|NCT01282762|Hepatitis B virus (HBV)|hepatitis b virus (hbv)
5084327|NCT01282749|Overweight|overweight
5084328|NCT01282749|Obesity|obesity
5084329|NCT01282749|African American|african american
5084330|NCT01282749|Women|women
5084331|NCT01282749|Translational|translational
5084332|NCT01282749|Faith based|faith based
5084333|NCT01282749|Community based participatory research|community based participatory research
5084334|NCT01282736|eating disorder|eating disorder
5084335|NCT01282736|binge eating|binge eating
5084336|NCT01282684|Safety|safety
5084337|NCT01282684|Tolerability|tolerability
5084338|NCT01282684|Pharmacokinetics|pharmacokinetics
5084339|NCT01282684|PLX5622|plx5622
5084340|NCT01282671|breathing exercises|breathing exercises
5084341|NCT01282671|cardiac surgery|cardiac surgery
5084342|NCT01282671|lung function|lung function
5084343|NCT01282671|postoperative complication|postoperative complication
5084344|NCT01282671|positive expiratory pressure|positive expiratory pressure
5084345|NCT01282658|CPT-11,pharmacogenomics,colorectal cancer|cpt-11,pharmacogenomics,colorectal cancer
5084346|NCT01282645|Cranial defect|cranial defect
5084347|NCT01282645|PSI|psi
5084348|NCT01282645|patient specific implant|patient specific implant
5084349|NCT01282645|PEEK|peek
5084350|NCT01282645|polyether ether ketone|polyether ether ketone
5084351|NCT01282645|craniectomy|craniectomy
5084352|NCT01282645|craniotomy|craniotomy
5084353|NCT01282632|depression|depression
5084354|NCT01282632|treatment resistant depression|treatment resistant depression
5084355|NCT01282632|unipolar|unipolar
5084356|NCT01282632|non- psychotic major depression|non- psychotic major depression
5084357|NCT01282632|add-on to a serotonin type antidepressants|add-on to a serotonin type antidepressants
5084358|NCT01282632|risperidone|risperidone
5084359|NCT01282632|olanzapine|olanzapine
5084360|NCT01282632|double blind comparison|double blind comparison
5084361|NCT01282632|randomized|randomized
5084362|NCT01282606|Chemonucleolysis|chemonucleolysis
5084363|NCT01282606|Lumbar Vertebrae|lumbar vertebrae
5084364|NCT01282606|Hernia|hernia
5084365|NCT01282593|TEL/ALM1_positive ALL relapses|tel/alm1_positive all relapses
5084366|NCT01282580|Women at high risk of developing breast cancer|women at high risk of developing breast cancer
5084367|NCT01282541|Tearing, Epiphora, Botulinum Toxin A|tearing, epiphora, botulinum toxin a
5084368|NCT01282502|rectal cancer|rectal cancer
5084369|NCT01282502|chemotherapy|chemotherapy
5084370|NCT01282502|chemoradiation|chemoradiation
5084371|NCT01282476|DLBCL (Diffuse Large B Cell Lymphoma)|dlbcl (diffuse large b cell lymphoma)
5084372|NCT01282476|Panobinostat|panobinostat
5084373|NCT01282476|LBH589 (Panobinostat)|lbh589 (panobinostat)
5084374|NCT01282476|LBH-589 (Panobinostat)|lbh-589 (panobinostat)
5085245|NCT01278433|Poliovirus|poliovirus
5084375|NCT01282476|HDAC inhibitor (Histone deacetylase inhibitor)|hdac inhibitor (histone deacetylase inhibitor)
5084376|NCT01282476|DAC inhibitor (deacetylase inhibitor)|dac inhibitor (deacetylase inhibitor)
5084377|NCT01282476|deacetylase inhibitor|deacetylase inhibitor
5084378|NCT01282476|lymphoma|lymphoma
5084379|NCT01282463|Carcinoma, Renal Cell|carcinoma, renal cell
5084380|NCT01282450|Radiotherapy|radiotherapy
5084381|NCT01282450|NSCLC|nsclc
5084382|NCT01282424|indolent Non-Hodgkin Lymphoma|indolent non-hodgkin lymphoma
5084383|NCT01282424|Non-Hodgkin Lymphoma|non-hodgkin lymphoma
5084384|NCT01282424|iNHL|inhl
5084385|NCT01282424|NHL|nhl
5084386|NCT01282424|GS-1101|gs-1101
5084387|NCT01282424|CAL-101|cal-101
5084388|NCT01282424|PI3K|pi3k
5084389|NCT01282424|Phosphatidylinositol 3-kinase|phosphatidylinositol 3-kinase
5084390|NCT01282424|Follicular Lymphoma (FL)|follicular lymphoma (fl)
5084391|NCT01282424|Small lymphocytic lymphoma (SLL)|small lymphocytic lymphoma (sll)
5084392|NCT01282424|Lymphoplasmacytoid lymphoma (LPL)|lymphoplasmacytoid lymphoma (lpl)
5084393|NCT01282424|Marginal zone lymphoma (MZL)|marginal zone lymphoma (mzl)
5084394|NCT01282372|Ankylosing spondylitis|ankylosing spondylitis
5084395|NCT01282372|Sleep|sleep
5084396|NCT01282372|Psoriatic arthritis|psoriatic arthritis
5084397|NCT01282372|Work Productivity|work productivity
5084398|NCT01282372|Rheumatoid Arthritis|rheumatoid arthritis
5084399|NCT01282359|Educational asthma program|educational asthma program
5084400|NCT01282359|Clusters analysis study|clusters analysis study
5084401|NCT01282359|Asthma Control Test|asthma control test
5084402|NCT01282346|Glaucoma shunt|glaucoma shunt
5084403|NCT01282346|Ocular implant|ocular implant
5084404|NCT01282346|Gold|gold
5084405|NCT01282346|Trabeculectomy|trabeculectomy
5084406|NCT01282320|Randomized Controlled Trial|randomized controlled trial
5084407|NCT01282320|Clinical Tria|clinical tria
5084408|NCT01282320|Postmenopause|postmenopause
5084409|NCT01282320|Hot-flashes|hot-flashes
5084410|NCT01282320|Quality of life|quality of life
5084411|NCT01282320|Physical Fitness|physical fitness
5084412|NCT01282307|Guided Self-Determination|guided self-determination
5084413|NCT01282307|Improving insight|improving insight
5084414|NCT01282307|Autonomy-supportive problem solving intervention|autonomy-supportive problem solving intervention
5084415|NCT01282307|Evaluate the effects of the method Guided Self-Determination|evaluate the effects of the method guided self-determination
5084416|NCT01282307|Improving insight in patients diagnosed with schizophrenia|improving insight in patients diagnosed with schizophrenia
5084417|NCT01282281|Bipolar Disorder|bipolar disorder
5084418|NCT01282281|Youth|youth
5084419|NCT01282281|Adults|adults
5084420|NCT01282281|Endocrine-metabolic changes|endocrine-metabolic changes
5084421|NCT01282268|fragile X syndrome|fragile x syndrome
5084422|NCT01282268|autism spectrum disorder|autism spectrum disorder
5084423|NCT01282242|acute stroke, IV rt-PA, Activase, Alteplase|acute stroke, iv rt-pa, activase, alteplase
5084424|NCT01282229|LANAP, Laser dentistry|lanap, laser dentistry
5084425|NCT01282203|General surgery|general surgery
5084426|NCT01282203|General anesthesia|general anesthesia
5084427|NCT01282203|Inhalation anesthesia|inhalation anesthesia
5084428|NCT01282203|Sevorane|sevorane
5084429|NCT01282203|Sevoflurane|sevoflurane
5084430|NCT01282190|dyslipidemia, motivational interview, prevention|dyslipidemia, motivational interview, prevention
5084431|NCT01282177|surveillance, safety , tolerability , vaccine|surveillance, safety , tolerability , vaccine
5084432|NCT01282164|glucagon stimulation test|glucagon stimulation test
5084433|NCT01282164|insulin tolerance test|insulin tolerance test
5084434|NCT01282164|growth hormone deficiency|growth hormone deficiency
5084435|NCT01282164|hypothalamic-pituitary disorders|hypothalamic-pituitary disorders
5084436|NCT01282151|NSCLC|nsclc
5084437|NCT01282151|Non Squamous cell|non squamous cell
5084438|NCT01282151|Docetaxel|docetaxel
5084439|NCT01282151|Pemetrexed|pemetrexed
5084440|NCT01282138|Allergic conjunctivitis|allergic conjunctivitis
5084441|NCT01282125|general population|general population
5084442|NCT01282125|prevalence|prevalence
5084443|NCT01282125|Norway|norway
5084444|NCT01282099|all children entering the PICU eligible for enrollment|all children entering the picu eligible for enrollment
5084445|NCT01282099|age range: neonate to 16 years|age range: neonate to 16 years
5084446|NCT01282086|Sevorane|sevorane
5084447|NCT01282086|Sevoflurane|sevoflurane
5084448|NCT01282086|General anesthesia|general anesthesia
5084449|NCT01282086|Inhalation anesthesia|inhalation anesthesia
5084450|NCT01282086|General surgery|general surgery
5084451|NCT01282073|Idiopathic membranous nephropathy|idiopathic membranous nephropathy
5084452|NCT01282073|Mycophenolate mofetil|mycophenolate mofetil
5084453|NCT01282073|Proteinuria|proteinuria
5084454|NCT01282073|Renal function|renal function
5084455|NCT01282060|HBA1C|hba1c
5084456|NCT01282060|DIABETES-RELATED COMPLICATIONS|diabetes-related complications
5084457|NCT01282060|GLYCAEMIC BALANCE|glycaemic balance
5084458|NCT01282047|Lenalidomide|lenalidomide
5084459|NCT01282047|Kaposi|kaposi
5084460|NCT01282047|HIV|hiv
5084461|NCT01282047|efficacy|efficacy
5084462|NCT01282047|safety|safety
5084463|NCT01282034|CHONDRAL|chondral
5084464|NCT01282034|OSTEOCHONDRAL|osteochondral
5084465|NCT01282021|RBC Antigens|rbc antigens
5084466|NCT01282021|Molecular Typing|molecular typing
5085344|NCT01278173|GABA Agents|gaba agents
5084467|NCT01282021|Ethiopian Sub-Populations|ethiopian sub-populations
5084468|NCT01282021|Immunohematology|immunohematology
5084469|NCT01282021|Immune Response|immune response
5084470|NCT01282008|Online Surveys|online surveys
5084471|NCT01282008|Tobacco Corrective Statements|tobacco corrective statements
5084472|NCT01282008|Message Testing|message testing
5084473|NCT01282008|Focus Groups|focus groups
5084474|NCT01281995|Biologic Samples|biologic samples
5084475|NCT01281995|Hydrocortisone|hydrocortisone
5084476|NCT01281995|Laboratory Research Specimens|laboratory research specimens
5084477|NCT01281995|Glucocorticoids|glucocorticoids
5084478|NCT01281995|Immune Modulation|immune modulation
5084479|NCT01281995|Healthy Volunteer|healthy volunteer
5084480|NCT01281995|HV|hv
5084481|NCT01281982|Imaging|imaging
5084482|NCT01281982|Gliomas|gliomas
5084483|NCT01281982|Pet Scan|pet scan
5084484|NCT01281982|Blood Brain Barrier|blood brain barrier
5084485|NCT01281982|P-Glycoprotein|p-glycoprotein
5084486|NCT01281982|Brain Tumor|brain tumor
5084487|NCT01281982|Glioma|glioma
5084488|NCT01281982|Glioblastoma Multiforme|glioblastoma multiforme
5084489|NCT01281982|Astrocytoma|astrocytoma
5084490|NCT01281969|Placebo Controlled|placebo controlled
5084491|NCT01281969|Obsessive-Compulsive Disorder|obsessive-compulsive disorder
5084492|NCT01281969|Children and Adolescents|children and adolescents
5084493|NCT01281969|Intravenous Immunoglobulin|intravenous immunoglobulin
5084494|NCT01281969|PANDAS|pandas
5084495|NCT01281956|Epilepsy|epilepsy
5084496|NCT01281956|Drug Trial|drug trial
5084497|NCT01281956|Serotonin|serotonin
5084498|NCT01281956|Serotonin 1A Receptor|serotonin 1a receptor
5084499|NCT01281956|Temporal Lobe Epilepsy|temporal lobe epilepsy
5084500|NCT01281956|Partial Epilepsy|partial epilepsy
5084501|NCT01281930|Superficial abscess|superficial abscess
5084502|NCT01281930|packing material|packing material
5084503|NCT01281930|wick|wick
5084504|NCT01281930|incision and drainage|incision and drainage
5084505|NCT01281917|velcade|velcade
5084506|NCT01281917|temsirolimus|temsirolimus
5084507|NCT01281917|non-hodgkins lymphoma|non-hodgkins lymphoma
5084508|NCT01281891|Drug: Morphine intrathecal|drug: morphine intrathecal
5084509|NCT01281891|Pain: Postoperative|pain: postoperative
5084510|NCT01281891|Surgery: Total hip arthroplasty|surgery: total hip arthroplasty
5084511|NCT01281878|primary hyperoxaluria|primary hyperoxaluria
5084512|NCT01281878|Pyridoxal-phosphate|pyridoxal-phosphate
5084513|NCT01281839|Hepatitis C|hepatitis c
5084514|NCT01281839|TMC435|tmc435
5084515|NCT01281839|HCV|hcv
5084516|NCT01281839|Hep C|hep c
5084517|NCT01281839|Genotype 1|genotype 1
5084518|NCT01281813|TMC114IFD3001|tmc114ifd3001
5084519|NCT01281813|TMC114|tmc114
5084520|NCT01281813|HIV|hiv
5084521|NCT01281813|Darunavir|darunavir
5084522|NCT01281813|PREZISTA|prezista
5084523|NCT01281787|FAP= post-surgery atrial fibrillation|fap= post-surgery atrial fibrillation
5084524|NCT01281787|ACEI= angiotensin converting enzyme-inhibitors|acei= angiotensin converting enzyme-inhibitors
5084525|NCT01281787|ARBs= angiotensin II receptor blockers|arbs= angiotensin ii receptor blockers
5084526|NCT01281787|NT-proBNP= brain natriuretic peptide|nt-probnp= brain natriuretic peptide
5084527|NCT01281748|acute exacerbation of COPD|acute exacerbation of copd
5084528|NCT01281735|treatment outcome|treatment outcome
5084529|NCT01281735|side effects|side effects
5084530|NCT01281735|Protein Kinase Inhibitors|protein kinase inhibitors
5084531|NCT01281735|pediatrics|pediatrics
5084532|NCT01281722|healthy adults|healthy adults
5084533|NCT01281722|melanoma|melanoma
5084534|NCT01281696|Breast cancer|breast cancer
5084535|NCT01281696|CNS metastasis|cns metastasis
5084536|NCT01281696|Brain metastasis|brain metastasis
5084537|NCT01281696|Leptomeningeal metastasis|leptomeningeal metastasis
5084538|NCT01281696|Bevacizumab|bevacizumab
5084539|NCT01281696|Etoposide|etoposide
5084540|NCT01281696|Cisplatin|cisplatin
5084541|NCT01281670|H reflex; muscle activation; rate of force development; whole body vibration|h reflex; muscle activation; rate of force development; whole body vibration
5084542|NCT01281657|Fingolimod|fingolimod
5084543|NCT01281657|FTY720|fty720
5084544|NCT01281657|Relapsing forms of multiple sclerosis|relapsing forms of multiple sclerosis
5084545|NCT01281657|Multiple sclerosis|multiple sclerosis
5084546|NCT01281657|MS|ms
5084547|NCT01281657|Safety|safety
5084548|NCT01281657|Efficacy|efficacy
5084549|NCT01281644|Keratosis pilaris (KP)|keratosis pilaris (kp)
5084550|NCT01281631|ALS|als
5084551|NCT01281618|Barrett's esophagus|barrett's esophagus
5084552|NCT01281605|Type 2 diabetes|type 2 diabetes
5084553|NCT01281605|Basal insulin|basal insulin
5084554|NCT01281605|Insulin detemir|insulin detemir
5084555|NCT01281605|Insulin titration algorithm|insulin titration algorithm
5084556|NCT01281579|Pharmacokinetics|pharmacokinetics
5084557|NCT01281579|Pharmacodynamics|pharmacodynamics
5084558|NCT01281579|Canagliflozin|canagliflozin
5084559|NCT01281566|Cisapride (Prepulsid)|cisapride (prepulsid)
5084560|NCT01281566|Feeding intolerance|feeding intolerance
5084561|NCT01281566|Enteral feeding|enteral feeding
5084562|NCT01281566|Nasogastric tube|nasogastric tube
5084563|NCT01281566|Neonate|neonate
5084564|NCT01281553|Cisapride (PREPULSID)|cisapride (prepulsid)
5084565|NCT01281553|Placebo|placebo
5084762|NCT01280682|C-peptide levels|c-peptide levels
5084566|NCT01281553|Gastroesophageal Reflux Disease (GERD)|gastroesophageal reflux disease (gerd)
5084567|NCT01281553|Gastro-oesophageal Reflux Disease (GORD)|gastro-oesophageal reflux disease (gord)
5084568|NCT01281540|Cisapride ( PREPULSID )|cisapride ( prepulsid )
5084569|NCT01281540|Placebo|placebo
5084570|NCT01281540|Idiopathic|idiopathic
5084571|NCT01281540|Stomach Diseases|stomach diseases
5084572|NCT01281540|Stomach|stomach
5084573|NCT01281527|Paliperidone palmitate|paliperidone palmitate
5084574|NCT01281527|Schizophrenia|schizophrenia
5084575|NCT01281527|Intramuscular injection|intramuscular injection
5084576|NCT01281501|Dyspepsia|dyspepsia
5084577|NCT01281501|Emergency treatment|emergency treatment
5084578|NCT01281501|Pantoprazole|pantoprazole
5084579|NCT01281501|Antacid|antacid
5084580|NCT01281501|Pain measurement|pain measurement
5084581|NCT01281475|Angelman syndrome|angelman syndrome
5084582|NCT01281475|Levodopa|levodopa
5084583|NCT01281475|Carbidopa|carbidopa
5084584|NCT01281475|L-dopa|l-dopa
5084585|NCT01281462|complicated Urinary Tract Infection|complicated urinary tract infection
5084586|NCT01281462|Acute Pyelonephritis|acute pyelonephritis
5084587|NCT01281436|childhood|childhood
5084588|NCT01281436|overweight|overweight
5084589|NCT01281436|obesity|obesity
5084590|NCT01281436|Health information technology|health information technology
5084591|NCT01281436|HeartSmartKids|heartsmartkids
5084592|NCT01281436|Motivational Interviewing|motivational interviewing
5084593|NCT01281410|respiratory muscles|respiratory muscles
5084594|NCT01281410|hematopoetic stem cell transplantation|hematopoetic stem cell transplantation
5084595|NCT01281410|inspiratory muscle training|inspiratory muscle training
5084596|NCT01281397|cardiac surgery|cardiac surgery
5084597|NCT01281397|aggregometry|aggregometry
5084598|NCT01281397|thromboelastometry|thromboelastometry
5084599|NCT01281397|platelet function|platelet function
5084600|NCT01281397|bleeding|bleeding
5084601|NCT01281397|antiplatelet therapy|antiplatelet therapy
5084602|NCT01281384|cardiac magnetic resonance imaging|cardiac magnetic resonance imaging
5084603|NCT01281384|echocardiography|echocardiography
5084604|NCT01281384|heart failure|heart failure
5084605|NCT01281384|imaging|imaging
5084606|NCT01281384|cost effectiveness|cost effectiveness
5084607|NCT01281384|quality of life|quality of life
5084608|NCT01281384|definitive diagnosis|definitive diagnosis
5084609|NCT01281384|prospective comparative effectiveness randomized clinical trial|prospective comparative effectiveness randomized clinical trial
5084610|NCT01281358|Premature infants|premature infants
5084611|NCT01281358|Motor Development|motor development
5084612|NCT01281345|icu|icu
5084613|NCT01281345|candida|candida
5084614|NCT01281345|epidemiology|epidemiology
5084615|NCT01281345|blood stream infection|blood stream infection
5084616|NCT01281345|candidemia|candidemia
5084617|NCT01281332|menopause|menopause
5084618|NCT01281332|hot flash|hot flash
5084619|NCT01281332|quality of life|quality of life
5084620|NCT01281319|preterm labor|preterm labor
5084621|NCT01281319|PROM|prom
5084622|NCT01281319|mycoplasma|mycoplasma
5084623|NCT01281319|ureaplasma|ureaplasma
5084624|NCT01281319|high risk pregnancy|high risk pregnancy
5084625|NCT01281306|hypertension|hypertension
5084626|NCT01281306|blood pressure|blood pressure
5084627|NCT01281306|LCZ696|lcz696
5084628|NCT01281306|dual-acting|dual-acting
5084629|NCT01281306|neprilysin|neprilysin
5084630|NCT01281306|nep inhibitor|nep inhibitor
5084631|NCT01281306|vasopeptidase|vasopeptidase
5084632|NCT01281306|angiotensin receptor|angiotensin receptor
5084633|NCT01281306|angiotensin receptor neprilysin inhibitor (ARNi)|angiotensin receptor neprilysin inhibitor (arni)
5084634|NCT01281293|V-COMPAS; Vagus Nerve Stimulation Clinical Outcomes;|v-compas; vagus nerve stimulation clinical outcomes;
5084635|NCT01281280|PuLsE 2, Drug-resistant Epilepsy Partial-onset Seizures|pulse 2, drug-resistant epilepsy partial-onset seizures
5084636|NCT01281267|facial transplantation|facial transplantation
5084637|NCT01281267|face transplantation|face transplantation
5084638|NCT01281267|composite tissue allotransplantation|composite tissue allotransplantation
5084639|NCT01281267|VCA|vca
5084640|NCT01281267|composite tissue allograft|composite tissue allograft
5084641|NCT01281267|facial allograft|facial allograft
5084642|NCT01281254|Fallopian tube cancer|fallopian tube cancer
5084643|NCT01281254|Primary peritoneal cancer|primary peritoneal cancer
5084644|NCT01281254|AMG386|amg386
5084645|NCT01281254|Pegylated Liposomal Doxorubicin|pegylated liposomal doxorubicin
5084646|NCT01281254|Recurrent epithelial ovarian cancer|recurrent epithelial ovarian cancer
5084647|NCT01281241|MTWA|mtwa
5084648|NCT01281241|mechanical alternans|mechanical alternans
5084649|NCT01281228|Exenatide|exenatide
5084650|NCT01281228|Type 2 diabetes mellitus|type 2 diabetes mellitus
5084651|NCT01281228|Incretin hormones|incretin hormones
5084652|NCT01281228|GLP-1 agonist|glp-1 agonist
5084653|NCT01281228|Satiety|satiety
5084654|NCT01281228|Reward|reward
5084655|NCT01281215|Pharmaceutical Education|pharmaceutical education
5084656|NCT01281215|Rational Drug Use|rational drug use
5084657|NCT01281215|Asthma|asthma
5084658|NCT01281202|Cocaine|cocaine
5084659|NCT01281202|Cocaine Addiction Treatment|cocaine addiction treatment
5084660|NCT01281202|Cocaine Treatment|cocaine treatment
5084661|NCT01281202|Vigabatrin|vigabatrin
5084662|NCT01281202|CPP-109|cpp-109
5084664|NCT01281202|National Institute on Drug Abuse|national institute on drug abuse
5084665|NCT01281189|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
5084666|NCT01281189|ALS|als
5084667|NCT01281189|Motor Neurone Disease|motor neurone disease
5084668|NCT01281137|stage IA breast cancer|stage ia breast cancer
5084669|NCT01281137|stage IB breast cancer|stage ib breast cancer
5084670|NCT01281137|stage II breast cancer|stage ii breast cancer
5084671|NCT01281137|stage IIIA breast cancer|stage iiia breast cancer
5084672|NCT01281098|High Risk Proliferative Diabetic Retinopathy|high risk proliferative diabetic retinopathy
5084673|NCT01281098|Diabetes Mellitus Type I, Type II|diabetes mellitus type i, type ii
5084674|NCT01281098|Pegaptanib|pegaptanib
5084675|NCT01281098|Panretinal Photocoagulation|panretinal photocoagulation
5084676|NCT01281085|Shoulder|shoulder
5084677|NCT01281085|Outcome treatment|outcome treatment
5084678|NCT01281085|Validation Studies|validation studies
5084679|NCT01281085|Biomechanics|biomechanics
5084680|NCT01281033|primary PCI|primary pci
5084681|NCT01281033|ST-segment elevation myocardial infarction|st-segment elevation myocardial infarction
5084682|NCT01281033|thrombus aspiration|thrombus aspiration
5084683|NCT01281020|Glaucoma|glaucoma
5084684|NCT01281020|Adherence|adherence
5084685|NCT01281020|Fixed combination therapy|fixed combination therapy
5084686|NCT01281007|Herpes Simplex Virus|herpes simplex virus
5084687|NCT01280994|Lung Disease|lung disease
5084688|NCT01280994|Pulmonary Disease|pulmonary disease
5084689|NCT01280994|Diagnostic Imaging|diagnostic imaging
5084690|NCT01280994|MRI|mri
5084691|NCT01280981|Menorrhagia|menorrhagia
5084692|NCT01280981|Heavy Menstrual Bleeding|heavy menstrual bleeding
5084693|NCT01280981|Lysteda|lysteda
5084694|NCT01280955|Plerixafor and Allogeneic Myeloablative Stem Cell Transplant|plerixafor and allogeneic myeloablative stem cell transplant
5084695|NCT01280942|clinical deterioration|clinical deterioration
5084696|NCT01280942|detection algorithms|detection algorithms
5084697|NCT01280942|automated warning systems|automated warning systems
5084698|NCT01280929|High Risk Proliferative Diabetic Retinopathy|high risk proliferative diabetic retinopathy
5084699|NCT01280929|Ranibizumab|ranibizumab
5084700|NCT01280929|Panretinal Photocoagulation|panretinal photocoagulation
5084701|NCT01280903|Osteoarthritis, Knee|osteoarthritis, knee
5084702|NCT01280903|Hypertension|hypertension
5084703|NCT01280903|Exercise|exercise
5084704|NCT01280903|Physical activity|physical activity
5084705|NCT01280903|Self Efficacy|self efficacy
5084706|NCT01280903|Patient Compliance|patient compliance
5084707|NCT01280903|Aged|aged
5084708|NCT01280890|Dementia|dementia
5084709|NCT01280890|Nursing home|nursing home
5084710|NCT01280890|Person-centred Care|person-centred care
5084711|NCT01280890|Staff training|staff training
5084712|NCT01280877|optic neuropathy|optic neuropathy
5084713|NCT01280877|visual field|visual field
5084714|NCT01280877|electric stimulation|electric stimulation
5084715|NCT01280877|alternating current|alternating current
5084716|NCT01280877|perimetry|perimetry
5084717|NCT01280851|Living renal donor|living renal donor
5084718|NCT01280851|Magnetic Resonance Imaging|magnetic resonance imaging
5084719|NCT01280851|Renal vascular anatomy|renal vascular anatomy
5084720|NCT01280851|Renal function|renal function
5084721|NCT01280812|mobile phone|mobile phone
5084722|NCT01280812|physical activity|physical activity
5084723|NCT01280812|women|women
5084724|NCT01280812|maintenance|maintenance
5084725|NCT01280812|health promotion|health promotion
5084726|NCT01280812|prevention|prevention
5084727|NCT01280799|Anorexia Nervosa|anorexia nervosa
5084728|NCT01280799|Adolescents|adolescents
5084729|NCT01280799|Family Treatment|family treatment
5084730|NCT01280799|Eating Disorder|eating disorder
5084731|NCT01280799|Acceptance and Commitment Therapy|acceptance and commitment therapy
5084732|NCT01280786|AML|aml
5084733|NCT01280786|leukemia|leukemia
5084734|NCT01280786|relapsed or refractory AML|relapsed or refractory aml
5084735|NCT01280773|weaning, mechanical ventilation|weaning, mechanical ventilation
5084736|NCT01280747|Prior authorization|prior authorization
5084737|NCT01280747|Fibromyalgia|fibromyalgia
5084738|NCT01280747|Painful Diabetic Peripheral Neuropathy|painful diabetic peripheral neuropathy
5084739|NCT01280747|Policy|policy
5084740|NCT01280747|Real World Data|real world data
5084741|NCT01280734|melatonin|melatonin
5084742|NCT01280734|circadin|circadin
5084743|NCT01280734|zolpidem|zolpidem
5084744|NCT01280734|body sway|body sway
5084745|NCT01280734|postural instability|postural instability
5084746|NCT01280708|Urology|urology
5084747|NCT01280708|Nephrology|nephrology
5084748|NCT01280708|Renal and pancreas transplantation|renal and pancreas transplantation
5084749|NCT01280708|Data base|data base
5084750|NCT01280708|Epidemiology|epidemiology
5084751|NCT01280695|Type 2|type 2
5084752|NCT01280695|Diabetes Mellitus|diabetes mellitus
5084753|NCT01280695|Diabetes|diabetes
5084754|NCT01280695|High blood sugar|high blood sugar
5084755|NCT01280695|Blood sugar|blood sugar
5084756|NCT01280695|Blood glucose|blood glucose
5084757|NCT01280695|Glucose|glucose
5084758|NCT01280682|type 1 diabetes|type 1 diabetes
5084759|NCT01280682|age|age
5084760|NCT01280682|course of disease|course of disease
5084761|NCT01280682|autoantibodies|autoantibodies
5084763|NCT01280669|Non-infectious|non-infectious
5084764|NCT01280669|Uveitis|uveitis
5084765|NCT01280669|Panuveitis|panuveitis
5084766|NCT01280643|stage IVA colon cancer|stage iva colon cancer
5084767|NCT01280643|stage IVA rectal cancer|stage iva rectal cancer
5084768|NCT01280643|stage IVB colon cancer|stage ivb colon cancer
5084769|NCT01280643|stage IVB rectal cancer|stage ivb rectal cancer
5084770|NCT01280630|ACS: Acute coronary syndrome Retrospective Registry|acs: acute coronary syndrome retrospective registry
5084771|NCT01280617|Renal Transplant|renal transplant
5084772|NCT01280617|Thymoglubulin|thymoglubulin
5084773|NCT01280591|Naproxen sodium|naproxen sodium
5084774|NCT01280591|Diphenhydramine|diphenhydramine
5084775|NCT01280578|Migraine|migraine
5084776|NCT01280565|non-resectable or metastatic stage 3 or stage 4 melanoma carrying a mutation in the juxta membrane domain of c-kit|non-resectable or metastatic stage 3 or stage 4 melanoma carrying a mutation in the juxta membrane domain of c-kit
5084777|NCT01280552|Glioblastoma Multiforme|glioblastoma multiforme
5084778|NCT01280539|Multiple Sclerosis|multiple sclerosis
5084779|NCT01280539|Transcutaneous electrical nerve stimulation|transcutaneous electrical nerve stimulation
5084780|NCT01280539|Cortical Excitability|cortical excitability
5084781|NCT01280487|ZSTK474|zstk474
5084782|NCT01280487|PI3K inhibitor|pi3k inhibitor
5084783|NCT01280474|depression during pregnancy|depression during pregnancy
5084784|NCT01280474|postpartum depression|postpartum depression
5084785|NCT01280474|pregnancy outcomes|pregnancy outcomes
5084786|NCT01280474|newborn development|newborn development
5084787|NCT01280474|paternal psychopathology|paternal psychopathology
5084788|NCT01280461|Pneumonia|pneumonia
5084789|NCT01280448|Lung Cancer|lung cancer
5084790|NCT01280448|Tobacco Smoking|tobacco smoking
5084791|NCT01280448|gene polymorphism|gene polymorphism
5084792|NCT01280435|Online Discourse|online discourse
5084793|NCT01280435|e-Learning|e-learning
5084794|NCT01280435|Biopsy|biopsy
5084795|NCT01280435|Virtual Pathologic Section|virtual pathologic section
5084796|NCT01280422|ROCDR|rocdr
5084797|NCT01280396|metabolic|metabolic
5084798|NCT01280396|SGAs|sgas
5084799|NCT01280396|clozapine|clozapine
5084800|NCT01280383|non-invasive ventilation|non-invasive ventilation
5084801|NCT01280383|diaphragm|diaphragm
5084802|NCT01280383|electrical activity|electrical activity
5084803|NCT01280383|neurally adjusted ventilatory assist|neurally adjusted ventilatory assist
5084804|NCT01280383|critically ill patients|critically ill patients
5084805|NCT01280370|Incisional hernia repair|incisional hernia repair
5084806|NCT01280357|Fetal Heart Rate (FHR)|fetal heart rate (fhr)
5084807|NCT01280357|Uterine Activity (UA)|uterine activity (ua)
5084808|NCT01280357|Labor & Delivery|labor & delivery
5084809|NCT01280331|Bunionectomy|bunionectomy
5084810|NCT01280305|schizophrenia|schizophrenia
5084811|NCT01280305|schizoaffective disorder|schizoaffective disorder
5084812|NCT01280292|central hypothyroidism, hypopituitarism, eltroxin|central hypothyroidism, hypopituitarism, eltroxin
5084813|NCT01280279|Behavior modification, Behavior therapy, Nocturia, Polyuria, Quality of life|behavior modification, behavior therapy, nocturia, polyuria, quality of life
5084814|NCT01280266|Pathological Conditions|pathological conditions
5084815|NCT01280266|Signs and Symptoms|signs and symptoms
5084816|NCT01280266|Blood circulation|blood circulation
5084817|NCT01280253|Predictor|predictor
5084818|NCT01280253|outcome|outcome
5084819|NCT01280253|biochemical|biochemical
5084820|NCT01280240|anemia|anemia
5084821|NCT01280240|cancer|cancer
5084822|NCT01280240|CIA|cia
5084823|NCT01280227|Symptom management|symptom management
5084824|NCT01280227|Symptom assessment|symptom assessment
5084825|NCT01280227|Patient satisfaction|patient satisfaction
5084826|NCT01280227|Patient-provider communication|patient-provider communication
5084827|NCT01280201|Neuroendocrine Tumors|neuroendocrine tumors
5084828|NCT01280201|Pazopanib|pazopanib
5084829|NCT01280201|GETNE|getne
5084830|NCT01280201|Biomarkers|biomarkers
5084831|NCT01280188|Diabetes|diabetes
5084832|NCT01280175|BDP|bdp
5084833|NCT01280175|Formoterol|formoterol
5084834|NCT01280175|pMDI|pmdi
5084835|NCT01280175|Aerochamber Plus|aerochamber plus
5084836|NCT01280175|Charcoal|charcoal
5084837|NCT01280162|Plasmodium falciparum, Plasmodium vivax|plasmodium falciparum, plasmodium vivax
5084838|NCT01280149|substance P|substance p
5084839|NCT01280149|allergic rhinitis|allergic rhinitis
5084840|NCT01280149|allergen immunotherapy|allergen immunotherapy
5084841|NCT01280136|HIV|hiv
5084842|NCT01280136|Sexually Transmitted Diseases|sexually transmitted diseases
5084843|NCT01280136|Pregnancy Prevention|pregnancy prevention
5084844|NCT01280136|Abstinence Education|abstinence education
5084845|NCT01280136|Adolescents|adolescents
5084846|NCT01280136|Sexual Health|sexual health
5084847|NCT01280123|Parkinson's Disease|parkinson's disease
5084848|NCT01280123|Biomarkers|biomarkers
5084849|NCT01280110|dry eye|dry eye
5084850|NCT01280110|pseudophakia|pseudophakia
5084851|NCT01280110|cornea|cornea
5084852|NCT01280110|lubricating drop|lubricating drop
5084853|NCT01280110|BAK|bak
5084854|NCT01280110|blood aqueous barrier|blood aqueous barrier
5084855|NCT01280110|blood-retina barrier|blood-retina barrier
5084856|NCT01280097|Intensive care unit delirium|intensive care unit delirium
5084857|NCT01280097|Sleep disruption|sleep disruption
5084858|NCT01280097|Sleep hygiene|sleep hygiene
5084859|NCT01280097|Early mobilization in the Intensive care unit|early mobilization in the intensive care unit
5084860|NCT01280097|Sedative agents and sleep|sedative agents and sleep
5084861|NCT01280097|Circadian rhythm|circadian rhythm
5084862|NCT01280097|Cognitive disorder|cognitive disorder
5084863|NCT01280097|Electroencephalography (EEG) to measure sleep|electroencephalography (eeg) to measure sleep
5084864|NCT01280097|Confusion Assessment Method in the Intensive Care Unit|confusion assessment method in the intensive care unit
5084865|NCT01280097|Immune function|immune function
5084866|NCT01280097|REM sleep|rem sleep
5084867|NCT01280084|neonate activity|neonate activity
5084868|NCT01280084|labour analgesia|labour analgesia
5084869|NCT01280032|intraoperative radiotherapy|intraoperative radiotherapy
5084870|NCT01280032|kyphoplasty|kyphoplasty
5084871|NCT01280032|spinal metastases|spinal metastases
5084872|NCT01280019|functional residual capacity|functional residual capacity
5084873|NCT01280019|electrical impedance tomography|electrical impedance tomography
5084874|NCT01280019|inflammatory parameters|inflammatory parameters
5084875|NCT01280006|Obstructive Sleep Apnea|obstructive sleep apnea
5084876|NCT01280006|Hypoxia|hypoxia
5084877|NCT01280006|Sleep|sleep
5084878|NCT01280006|Blood Pressure|blood pressure
5084879|NCT01280006|Hypertension|hypertension
5084880|NCT01280006|Myocardial Infarction|myocardial infarction
5084881|NCT01280006|Stroke|stroke
5084882|NCT01280006|Ventilation|ventilation
5084883|NCT01280006|Brain|brain
5084884|NCT01280006|Cerebral Blood Flow|cerebral blood flow
5084885|NCT01280006|Renal Blood Flow|renal blood flow
5084886|NCT01279980|ERAS|eras
5084887|NCT01279980|Local anaesthetic wound catheter|local anaesthetic wound catheter
5084888|NCT01279980|Painbuster|painbuster
5084889|NCT01279980|Epidural|epidural
5084890|NCT01279980|colorectal surgery|colorectal surgery
5084891|NCT01279980|enhanced recovery program|enhanced recovery program
5084892|NCT01279967|Pleural Mesothelioma|pleural mesothelioma
5084893|NCT01279967|ADI-PEG 20|adi-peg 20
5084894|NCT01279928|paediatric and adolescent population|paediatric and adolescent population
5084895|NCT01279928|nailfold capillaroscopy|nailfold capillaroscopy
5084896|NCT01279928|laser Doppler flowmetry|laser doppler flowmetry
5084897|NCT01279928|retinal vessel calibre|retinal vessel calibre
5084898|NCT01279928|retinal vessel fractal analysis|retinal vessel fractal analysis
5084899|NCT01279928|24 hour Ambulatory Blood Pressure Monitoring|24 hour ambulatory blood pressure monitoring
5084900|NCT01279915|ASP0456|asp0456
5084901|NCT01279915|Pharmacokinetics|pharmacokinetics
5084902|NCT01279915|safety|safety
5084903|NCT01279915|tolerability|tolerability
5084904|NCT01279902|diffuse large B-cell lymphoma|diffuse large b-cell lymphoma
5084905|NCT01279902|rituximab|rituximab
5084906|NCT01279902|CHOP|chop
5084907|NCT01279902|abbreviated therapy|abbreviated therapy
5084908|NCT01279889|hypotension|hypotension
5084909|NCT01279889|cesarean delivery|cesarean delivery
5084910|NCT01279889|cardiac output|cardiac output
5084911|NCT01279889|blood pressure|blood pressure
5084912|NCT01279889|plethysmography variability index|plethysmography variability index
5084913|NCT01279863|Pneumonia|pneumonia
5084914|NCT01279863|Cough|cough
5084915|NCT01279863|Shortness of breath|shortness of breath
5084916|NCT01279863|VRI|vri
5084917|NCT01279850|Lyrica|lyrica
5084918|NCT01279850|Regulatory Post Marketing Commitment Plan|regulatory post marketing commitment plan
5084919|NCT01279850|Safety|safety
5084920|NCT01279850|Neuropathic Pain|neuropathic pain
5084921|NCT01279850|Post Marketing Surveillance|post marketing surveillance
5084922|NCT01279837|swallowing disorders|swallowing disorders
5084923|NCT01279837|swallowing therapy|swallowing therapy
5084924|NCT01279837|head neck cancer|head neck cancer
5084925|NCT01279837|oropharyngeal dysphagia|oropharyngeal dysphagia
5084926|NCT01279824|swallowing, treatment, stroke,rehabilitation|swallowing, treatment, stroke,rehabilitation
5084927|NCT01279811|spinal cord injury, CSF, biomarkers, CSF pressure|spinal cord injury, csf, biomarkers, csf pressure
5084928|NCT01279798|Lung Cancer|lung cancer
5084929|NCT01279798|NSCLC|nsclc
5084930|NCT01279798|stage III or IV NSCLC|stage iii or iv nsclc
5084931|NCT01279785|Molecular Imaging|molecular imaging
5084932|NCT01279785|PSMA|psma
5084933|NCT01279785|adenocarcinoma|adenocarcinoma
5084934|NCT01279785|prostatectomy|prostatectomy
5084935|NCT01279759|Anterior Cruciate Ligament Reconstruction Predictive Factors|anterior cruciate ligament reconstruction predictive factors
5084936|NCT01279759|Function Downstairs walking Step time Symmetry|function downstairs walking step time symmetry
5084937|NCT01279746|DVT Ultrasound compression Hypoxia Pulmonary Emboli|dvt ultrasound compression hypoxia pulmonary emboli
5084938|NCT01279746|Occult DVT in hypoxic patients|occult dvt in hypoxic patients
5084939|NCT01279733|microarray|microarray
5084940|NCT01279720|Adenosine deaminase deficiency|adenosine deaminase deficiency
5084941|NCT01279720|Gene therapy|gene therapy
5084942|NCT01279694|newly-diagnosed multiple myeloma.|newly-diagnosed multiple myeloma.
5084943|NCT01279681|neurotoxicity|neurotoxicity
5084944|NCT01279681|cognitive/functional effects|cognitive/functional effects
5084945|NCT01279681|stage IVA colon cancer|stage iva colon cancer
5084946|NCT01279681|stage IVA rectal cancer|stage iva rectal cancer
5084947|NCT01279681|stage IVB colon cancer|stage ivb colon cancer
5084948|NCT01279681|stage IVB rectal cancer|stage ivb rectal cancer
5084949|NCT01279681|recurrent colon cancer|recurrent colon cancer
5084950|NCT01279681|recurrent rectal cancer|recurrent rectal cancer
5084951|NCT01279668|Montelukast|montelukast
5084952|NCT01279668|Persistent cough|persistent cough
5084953|NCT01279668|Adults|adults
5084954|NCT01279668|Double-blind randomised placebo controlled trial|double-blind randomised placebo controlled trial
5084955|NCT01279642|Catheterization, Peripheral|catheterization, peripheral
5084956|NCT01279642|Ultrasonography, Interventional|ultrasonography, interventional
5084957|NCT01279642|Nursing|nursing
5084958|NCT01279642|Pediatric|pediatric
5084959|NCT01279629|chronic plaque psoriasis|chronic plaque psoriasis
5084960|NCT01279629|To evaluate the efficacy of the drugs under study for treating chronic plaque psoriasis|to evaluate the efficacy of the drugs under study for treating chronic plaque psoriasis
5084961|NCT01279616|sickle cell|sickle cell
5084962|NCT01279616|stem cell transplant|stem cell transplant
5084963|NCT01279603|Cancer|cancer
5084964|NCT01279590|Hyperlipidemia|hyperlipidemia
5084965|NCT01279590|Dyslipidemia|dyslipidemia
5084966|NCT01279590|Metabolic diseases|metabolic diseases
5084967|NCT01279590|Lipid metabolism disorders|lipid metabolism disorders
5084968|NCT01279590|Hyperlipoproteinemia Type IIa|hyperlipoproteinemia type iia
5084969|NCT01279590|Hyperlipoproteinemia Type IIb|hyperlipoproteinemia type iib
5084970|NCT01279590|Hypercholesterolemia, Autosomal Dominant|hypercholesterolemia, autosomal dominant
5084971|NCT01279590|Hypercholesterolemia, Autosomal Dominant, Type B|hypercholesterolemia, autosomal dominant, type b
5084972|NCT01279590|Frederickson Type IIa|frederickson type iia
5084973|NCT01279590|Frederickson Type IIb Hyperlipidemia|frederickson type iib hyperlipidemia
5084974|NCT01279577|Crohn´s disease|crohn´s disease
5084975|NCT01279577|Trichuris suis|trichuris suis
5084976|NCT01279577|randomized|randomized
5084977|NCT01279577|placebo|placebo
5084978|NCT01279577|induction of remission|induction of remission
5084979|NCT01279577|porcine whipworm|porcine whipworm
5084980|NCT01279564|Endotracheal intubation and its outcomes|endotracheal intubation and its outcomes
5084981|NCT01279538|Kidney Transplantation|kidney transplantation
5084982|NCT01279538|Pharmacokinetics|pharmacokinetics
5084983|NCT01279538|Pharmacology|pharmacology
5084984|NCT01279538|ASKP1240|askp1240
5084985|NCT01279525|Falls|falls
5084986|NCT01279525|Prevention|prevention
5084987|NCT01279525|Elderly|elderly
5084988|NCT01279512|Metformin Acarbose pco infertility overweight|metformin acarbose pco infertility overweight
5084989|NCT01279499|Morbid obesity|morbid obesity
5084990|NCT01279499|Sevoflurane|sevoflurane
5084991|NCT01279499|Propofol|propofol
5084992|NCT01279499|Remifentanyl|remifentanyl
5084993|NCT01279499|BIS|bis
5084994|NCT01279499|Cardiovascular stability|cardiovascular stability
5084995|NCT01279499|Recovery scores|recovery scores
5084996|NCT01279499|Drug consumption|drug consumption
5084997|NCT01279486|Pregnancy,|pregnancy,
5084998|NCT01279473|Chronic Myelogenous Leukemia|chronic myelogenous leukemia
5084999|NCT01279473|CML|cml
5085000|NCT01279473|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
5085001|NCT01279473|Philadelphia Chromosome Positive, ph+ ALL|philadelphia chromosome positive, ph+ all
5085002|NCT01279473|Acute Lymphoblastic Leukemia (Philadelphia Chromosome Positive)|acute lymphoblastic leukemia (philadelphia chromosome positive)
5085003|NCT01279460|chronic kidney disease|chronic kidney disease
5085004|NCT01279460|CKD|ckd
5085005|NCT01279460|pulse wave velocity|pulse wave velocity
5085006|NCT01279460|PWV|pwv
5085007|NCT01279447|infrapatellar nerve|infrapatellar nerve
5085008|NCT01279447|saphenous nerve|saphenous nerve
5085009|NCT01279447|knee arthroscopy|knee arthroscopy
5085010|NCT01279447|nerve block|nerve block
5085011|NCT01279408|Palliative treatment|palliative treatment
5085012|NCT01279408|advanced non-small cell lung cancer|advanced non-small cell lung cancer
5085013|NCT01279408|Patients with Asymptomatic Centrally Located Advance NSCLC who are palliative|patients with asymptomatic centrally located advance nsclc who are palliative
5085014|NCT01279395|atherosclerosis|atherosclerosis
5085015|NCT01279395|cholesterol|cholesterol
5085016|NCT01279395|cyclooxygenase|cyclooxygenase
5085017|NCT01279395|gene expression|gene expression
5085018|NCT01279395|lipid metabolism|lipid metabolism
5085019|NCT01279382|Symptoms|symptoms
5085020|NCT01279382|Psychological status|psychological status
5085021|NCT01279382|Hypnotherapy|hypnotherapy
5085022|NCT01279382|Relaxation training|relaxation training
5085023|NCT01279369|Pregnancy|pregnancy
5085024|NCT01279369|Trauma|trauma
5085025|NCT01279369|Placental Abruption|placental abruption
5085026|NCT01279369|Fetal fibronectin|fetal fibronectin
5085027|NCT01279356|Liver diseases|liver diseases
5085028|NCT01279356|Volatile organic compounds|volatile organic compounds
5085029|NCT01279356|Inflammation|inflammation
5085030|NCT01279356|Oxidative stress|oxidative stress
5085031|NCT01279356|non-invasive tests|non-invasive tests
5085032|NCT01279343|labor induction|labor induction
5085033|NCT01279343|foley bulb|foley bulb
5085034|NCT01279343|misoprostol|misoprostol
5085035|NCT01279330|Colorectal Cancer|colorectal cancer
5085036|NCT01279330|Screening|screening
5085037|NCT01279330|General Practitioner|general practitioner
5085038|NCT01279330|Fecal Occult Blood Tests|fecal occult blood tests
5085039|NCT01279304|breast cancer|breast cancer
5085040|NCT01279304|locoregional recurrence rate|locoregional recurrence rate
5085041|NCT01279304|neoadjuvant chemotherapy and surgery|neoadjuvant chemotherapy and surgery
5085042|NCT01279304|radiotherapy|radiotherapy
5085043|NCT01279304|risk model|risk model
5085044|NCT01279304|overall survival|overall survival
5085045|NCT01279304|relapse free survival|relapse free survival
5085046|NCT01279304|cT1-2cN0-1 breast cancer|ct1-2cn0-1 breast cancer
5085047|NCT01279291|advanced solid tumor|advanced solid tumor
5085048|NCT01279291|Ovarian cancer|ovarian cancer
5085049|NCT01279291|Primary peritoneal cancer|primary peritoneal cancer
5085050|NCT01279291|Fallopian tube cancer|fallopian tube cancer
5085051|NCT01279278|Colorectal Cancer|colorectal cancer
5085052|NCT01279278|Screening|screening
5085053|NCT01279278|General Practitioner|general practitioner
5085054|NCT01279278|Fecal Occult Blood Tests|fecal occult blood tests
5085055|NCT01279265|Lactobacillus|lactobacillus
5085056|NCT01279265|Probiotic|probiotic
5085057|NCT01279265|Crying time|crying time
5085058|NCT01279265|Fecal microbiota|fecal microbiota
5085059|NCT01279265|Calprotectin|calprotectin
5085060|NCT01279265|Colic|colic
5085061|NCT01279265|Infant Crying|infant crying
5085062|NCT01279265|Barr Diary|barr diary
5085063|NCT01279265|Breath Hydrogen|breath hydrogen
5085064|NCT01279265|Clinical Design|clinical design
5085065|NCT01279239|Poly Trauma|poly trauma
5085066|NCT01279239|Metabonomics|metabonomics
5085067|NCT01279239|NMR|nmr
5085068|NCT01279239|MOF|mof
5085069|NCT01279200|letrozole|letrozole
5085070|NCT01279200|ovulation monitoring|ovulation monitoring
5085071|NCT01279200|pregnancy rate|pregnancy rate
5085072|NCT01279187|dental|dental
5085073|NCT01279187|implant|implant
5085074|NCT01279174|Hip, arthrosis|hip, arthrosis
5085075|NCT01279161|overweight, obesity, children, insulin, pump therapy, FTO|overweight, obesity, children, insulin, pump therapy, fto
5085076|NCT01279148|biopsy guidance|biopsy guidance
5085077|NCT01279148|tracking device|tracking device
5085078|NCT01279135|IGRT,Postoperative, Cervix, Late toxicity, Bowel|igrt,postoperative, cervix, late toxicity, bowel
5085079|NCT01279109|gestational weight gain|gestational weight gain
5085080|NCT01279096|Acute lymphoblastic leukemia|acute lymphoblastic leukemia
5085081|NCT01279096|relapse|relapse
5085082|NCT01279096|childhood|childhood
5085083|NCT01279096|clofarabine|clofarabine
5085084|NCT01279070|Schizophrenia|schizophrenia
5085085|NCT01279070|Cognitive remediation|cognitive remediation
5085086|NCT01279070|Group training|group training
5085087|NCT01279070|Executive function|executive function
5085088|NCT01279070|Social functioning|social functioning
5085089|NCT01279057|Rhinitis, allergic, seasonal, fluticasone furoate, equivalence|rhinitis, allergic, seasonal, fluticasone furoate, equivalence
5085090|NCT01279044|HIV|hiv
5085091|NCT01279044|MSM|msm
5085092|NCT01279044|SUMSM|sumsm
5085093|NCT01279018|Persistent postsurgical pain|persistent postsurgical pain
5085094|NCT01279018|breast cancer|breast cancer
5085095|NCT01279018|postmastectomy pain syndrome|postmastectomy pain syndrome
5085096|NCT01279018|neuropathic pain|neuropathic pain
5085097|NCT01279005|MSM|msm
5085098|NCT01279005|focus group|focus group
5085099|NCT01279005|HIV|hiv
5085100|NCT01279005|risk-taking|risk-taking
5085101|NCT01279005|risk-denial|risk-denial
5085102|NCT01279005|signature on inform consent, willing to participate, MSM either HIV positive or negative, age 20-50 years old|signature on inform consent, willing to participate, msm either hiv positive or negative, age 20-50 years old
5085103|NCT01278992|fatigue|fatigue
5085104|NCT01278992|adaptogen|adaptogen
5085105|NCT01278992|Rhodiola rosea|rhodiola rosea
5085106|NCT01278979|obstetric|obstetric
5085107|NCT01278979|perineal tear|perineal tear
5085108|NCT01278979|perineal injury|perineal injury
5085109|NCT01278979|diagnosis|diagnosis
5085110|NCT01278966|Epilepsy|epilepsy
5085111|NCT01278966|Diet|diet
5085112|NCT01278966|the Modified Atkins Diet|the modified atkins diet
5085113|NCT01278966|Ketogenic diet|ketogenic diet
5085114|NCT01278953|paroxysmal atrial fibrillation|paroxysmal atrial fibrillation
5085115|NCT01278953|atrial fibrillation|atrial fibrillation
5085116|NCT01278953|radiofrequency ablation|radiofrequency ablation
5085117|NCT01278953|pulmonary vein isolation|pulmonary vein isolation
5085118|NCT01278953|ablation catheter|ablation catheter
5085119|NCT01278953|RF|rf
5085120|NCT01278953|contact force sensing|contact force sensing
5085121|NCT01278953|contact force|contact force
5085122|NCT01278953|contact force assisted ablation|contact force assisted ablation
5085123|NCT01278927|exercise|exercise
5085124|NCT01278927|stress management|stress management
5085125|NCT01278927|post transplant|post transplant
5085126|NCT01278927|physical and emotional relaxation|physical and emotional relaxation
5085127|NCT01278901|helicobacter pylori|helicobacter pylori
5085128|NCT01278901|urease test|urease test
5085129|NCT01278901|13C-UBT|13c-ubt
5085130|NCT01278901|the focus of the study is to evaluate a possible effect of PPI therapy on Helicobacter pylori diagnostic tests|the focus of the study is to evaluate a possible effect of ppi therapy on helicobacter pylori diagnostic tests
5085131|NCT01278888|Lung cancer|lung cancer
5085132|NCT01278888|Pain|pain
5085133|NCT01278888|Quality of life|quality of life
5085134|NCT01278888|Economy|economy
5085135|NCT01278875|High density lipoproteins|high density lipoproteins
5085136|NCT01278875|Acute coronary syndromes|acute coronary syndromes
5085137|NCT01278875|Cellular cholesterol efflux|cellular cholesterol efflux
5085138|NCT01278875|HDL: proteomics|hdl: proteomics
5085139|NCT01278875|Nitric Acid production|nitric acid production
5085140|NCT01278862|Crowns|crowns
5085141|NCT01278862|posterior teeth|posterior teeth
5085142|NCT01278862|CAD CAM crowns|cad cam crowns
5085143|NCT01278862|digital veneer system|digital veneer system
5085144|NCT01278862|Lava|lava
5085145|NCT01278862|clinical|clinical
5085146|NCT01278849|Advanced or metastatic cancer,|advanced or metastatic cancer,
5085147|NCT01278849|refractory,|refractory,
5085148|NCT01278849|core phase,|core phase,
5085149|NCT01278849|extension phase,|extension phase,
5085150|NCT01278849|dose escalation,|dose escalation,
5085151|NCT01278849|standard chemotherapy,|standard chemotherapy,
5085152|NCT01278849|pharmacokinetics,|pharmacokinetics,
5085153|NCT01278849|doctaxel,|doctaxel,
5085154|NCT01278849|paclitaxel,|paclitaxel,
5085155|NCT01278849|carboplatin,|carboplatin,
5085156|NCT01278849|safety,|safety,
5085157|NCT01278849|tolerability,|tolerability,
5085158|NCT01278849|hepatic impairment|hepatic impairment
5085159|NCT01278836|Flap|flap
5085160|NCT01278836|leg defect|leg defect
5085161|NCT01278836|reconstruction|reconstruction
5085162|NCT01278836|tissue|tissue
5085163|NCT01278823|obesity|obesity
5085164|NCT01278823|type 2 diabetes|type 2 diabetes
5085165|NCT01278810|Icaritin,|icaritin,
5085166|NCT01278810|ERa36|era36
5085167|NCT01278784|Dry eye syndromes|dry eye syndromes
5085168|NCT01278784|Chitosan-N-Acetylcysteine|chitosan-n-acetylcysteine
5085170|NCT01278758|Advanced or metastatic cancer,|advanced or metastatic cancer,
5085171|NCT01278758|refractory,|refractory,
5085172|NCT01278758|core phase,|core phase,
5085173|NCT01278758|extension phase,|extension phase,
5085174|NCT01278758|dose escalation,|dose escalation,
5085175|NCT01278758|standard chemotherapy,|standard chemotherapy,
5085176|NCT01278758|doctaxel,|doctaxel,
5085177|NCT01278758|paclitaxel,|paclitaxel,
5085178|NCT01278758|carboplatin,|carboplatin,
5085179|NCT01278758|safety,|safety,
5085180|NCT01278758|tolerability|tolerability
5085181|NCT01278745|cardiac allograft vasculopathy (CAV)|cardiac allograft vasculopathy (cav)
5085182|NCT01278745|prevention|prevention
5085183|NCT01278745|cardiac transplantation|cardiac transplantation
5085184|NCT01278745|rituximab|rituximab
5085185|NCT01278732|arterial hypertension|arterial hypertension
5085186|NCT01278719|Antrochoanal polyp|antrochoanal polyp
5085187|NCT01278719|Ethmoidal polyp|ethmoidal polyp
5085188|NCT01278719|Recurrence|recurrence
5085189|NCT01278719|Risk factors|risk factors
5085190|NCT01278719|Environmental factors|environmental factors
5085191|NCT01278719|Gene expression|gene expression
5085192|NCT01278719|Micro array|micro array
5085193|NCT01278719|Mutation|mutation
5085194|NCT01278693|Renal failure, hemodialysis, dyslipidemia, L-carnitine.|renal failure, hemodialysis, dyslipidemia, l-carnitine.
5085195|NCT01278680|Behavioral economics|behavioral economics
5085196|NCT01278680|Incentives|incentives
5085197|NCT01278680|Health|health
5085198|NCT01278667|ADHD|adhd
5085199|NCT01278667|Memory|memory
5085200|NCT01278667|Social|social
5085201|NCT01278667|Emotion|emotion
5085202|NCT01278667|Methylphenidate|methylphenidate
5085203|NCT01278641|Fibromyalgia|fibromyalgia
5085204|NCT01278641|Widespread pain|widespread pain
5085205|NCT01278641|Fatigue|fatigue
5085206|NCT01278641|Physical exercise|physical exercise
5085207|NCT01278602|Diffuse large B-cell lymphoma|diffuse large b-cell lymphoma
5085208|NCT01278602|Chemotherapy|chemotherapy
5085209|NCT01278602|R-ESHAP|r-eshap
5085210|NCT01278602|Autologous stem cell transplantation|autologous stem cell transplantation
5085211|NCT01278576|Muscle spasticity|muscle spasticity
5085212|NCT01278576|Stroke|stroke
5085213|NCT01278576|Botulinum Toxins|botulinum toxins
5085214|NCT01278576|Lower extremity|lower extremity
5085215|NCT01278576|Ankle|ankle
5085216|NCT01278563|Low Glycemic Index Diet|low glycemic index diet
5085217|NCT01278537|elderly|elderly
5085218|NCT01278537|cancer surgery|cancer surgery
5085219|NCT01278537|quality of life|quality of life
5085220|NCT01278537|empowerment|empowerment
5085221|NCT01278537|shared-decision|shared-decision
5085222|NCT01278524|Delirium|delirium
5085223|NCT01278524|Analgosedation|analgosedation
5085224|NCT01278524|ICU|icu
5085225|NCT01278524|Pain|pain
5085226|NCT01278524|Implementation|implementation
5085227|NCT01278511|Canadian C-Spine Rule|canadian c-spine rule
5085228|NCT01278511|Prehospital Emergency Care|prehospital emergency care
5085229|NCT01278511|Cervical Spine Injuries|cervical spine injuries
5085230|NCT01278511|Cervical Spine Fractures|cervical spine fractures
5085231|NCT01278511|Emergency Medicine Undergraduates|emergency medicine undergraduates
5085232|NCT01278498|Escitalopram|escitalopram
5085233|NCT01278498|Depression|depression
5085234|NCT01278498|Stroke|stroke
5085235|NCT01278485|Diabetes complications|diabetes complications
5085236|NCT01278472|cholecystectomy|cholecystectomy
5085237|NCT01278472|laparoscopic|laparoscopic
5085238|NCT01278472|single-port|single-port
5085239|NCT01278472|gallstones|gallstones
5085240|NCT01278459|endothelial function|endothelial function
5085241|NCT01278459|cardiovascular|cardiovascular
5085242|NCT01278446|Cow's Milk Allergy|cow's milk allergy
5085243|NCT01278446|CMA|cma
5085244|NCT01278433|Polio|polio
5085246|NCT01278433|IMOVAX Polio™|imovax polio™
5085247|NCT01278420|Visual outcomes with bilateral implantation of Tecnis MF and ReSTOR IOLs Six months post cataract surgery|visual outcomes with bilateral implantation of tecnis mf and restor iols six months post cataract surgery
5085248|NCT01278407|DLB|dlb
5085249|NCT01278407|Dementia with Lewy bodies|dementia with lewy bodies
5085250|NCT01278407|Lewy Body Disease|lewy body disease
5085251|NCT01278407|Dementia|dementia
5085252|NCT01278407|E2020|e2020
5085253|NCT01278407|Donepezil|donepezil
5085254|NCT01278407|Aricept|aricept
5085255|NCT01278394|Onychomycosis|onychomycosis
5085256|NCT01278394|Fungal Nail|fungal nail
5085257|NCT01278381|pancreas, pancreaticoduodenectomy, major complications|pancreas, pancreaticoduodenectomy, major complications
5085258|NCT01278368|pancreatic cancer, neoadjuvant chemotherapy|pancreatic cancer, neoadjuvant chemotherapy
5085259|NCT01278355|pain|pain
5085260|NCT01278355|acupuncture|acupuncture
5085261|NCT01278342|Sandostatin LAR|sandostatin lar
5085262|NCT01278342|High Dose|high dose
5085263|NCT01278342|GH-receptor antagonist|gh-receptor antagonist
5085264|NCT01278342|combination with dopamine-agonist|combination with dopamine-agonist
5085265|NCT01278342|acromegalic patients|acromegalic patients
5085266|NCT01278342|octreotide acetate|octreotide acetate
5085267|NCT01278342|Somavert|somavert
5085268|NCT01278342|Dostinex|dostinex
5085269|NCT01278342|pegvisomant|pegvisomant
5085270|NCT01278342|cabergoline|cabergoline
5085271|NCT01278342|not adequately controlled|not adequately controlled
5085272|NCT01278342|active acromegaly|active acromegaly
5085273|NCT01278329|Music|music
5085274|NCT01278329|Foetal learning|foetal learning
5085275|NCT01278329|Brazelton Neonatal Behavioral Assessment Scale|brazelton neonatal behavioral assessment scale
5085276|NCT01278316|PTSD|ptsd
5085277|NCT01278316|TBI|tbi
5085278|NCT01278316|Cognition|cognition
5085279|NCT01278316|Cognitive Training|cognitive training
5085280|NCT01278303|Coarctation|coarctation
5085281|NCT01278303|Aorta|aorta
5085282|NCT01278290|Triptorelin acetate|triptorelin acetate
5085283|NCT01278290|precocious puberty|precocious puberty
5085284|NCT01278290|premature thelarche|premature thelarche
5085285|NCT01278290|GnRH analog|gnrh analog
5085286|NCT01278290|Diagnostic validation study|diagnostic validation study
5085287|NCT01278277|Stargardt disease|stargardt disease
5085288|NCT01278277|macula|macula
5085289|NCT01278277|electroretinogram|electroretinogram
5085290|NCT01278277|saffron|saffron
5085291|NCT01278264|Transversus abdominis plane block|transversus abdominis plane block
5085292|NCT01278264|Ultrasound guided|ultrasound guided
5085293|NCT01278264|Abdominoplasty|abdominoplasty
5085294|NCT01278238|Hypotension|hypotension
5085295|NCT01278238|Caesarean section|caesarean section
5085296|NCT01278238|Spinal anaesthesia|spinal anaesthesia
5085297|NCT01278238|Lower limb compression / wrapping|lower limb compression / wrapping
5085298|NCT01278238|Phenylephrine|phenylephrine
5085299|NCT01278225|Neurofeedback|neurofeedback
5085300|NCT01278225|Neural Function|neural function
5085301|NCT01278225|Neuromodulation|neuromodulation
5085302|NCT01278225|Chemotherapy-Induced Neuropathic Pain|chemotherapy-induced neuropathic pain
5085303|NCT01278225|Electroencephalogram|electroencephalogram
5085304|NCT01278225|EEG|eeg
5085305|NCT01278225|Biofeedback|biofeedback
5085306|NCT01278225|BF|bf
5085307|NCT01278225|Quality of Life|quality of life
5085308|NCT01278225|QOL|qol
5085309|NCT01278225|Pain Quality Assessment Scale|pain quality assessment scale
5085310|NCT01278225|PQAS|pqas
5085311|NCT01278225|Brief Symptom Inventory|brief symptom inventory
5085312|NCT01278225|BSI|bsi
5085313|NCT01278225|Sleep Disturbances|sleep disturbances
5085314|NCT01278225|Fatigue|fatigue
5085315|NCT01278225|Questionnaires|questionnaires
5085316|NCT01278212|breast cancer|breast cancer
5085317|NCT01278212|breast neoplasm|breast neoplasm
5085318|NCT01278212|breast tumor|breast tumor
5085319|NCT01278212|radiotherapy|radiotherapy
5085320|NCT01278212|radiation|radiation
5085321|NCT01278212|accelerated|accelerated
5085322|NCT01278212|lumpectomy|lumpectomy
5085323|NCT01278199|Bronchial Artery Embolization|bronchial artery embolization
5085324|NCT01278199|Non-severe Hemoptysis|non-severe hemoptysis
5085325|NCT01278199|Bleeding mild-to-moderate abundance|bleeding mild-to-moderate abundance
5085326|NCT01278199|Volume ranging from 100 ml to 200 ml|volume ranging from 100 ml to 200 ml
5085327|NCT01278186|Coronary stenosis|coronary stenosis
5085328|NCT01278186|Bifurcation|bifurcation
5085329|NCT01278186|Drug-eluting balloon|drug-eluting balloon
5085330|NCT01278186|Drug-eluting stent|drug-eluting stent
5085331|NCT01278186|Angiographic follow-up|angiographic follow-up
5085332|NCT01278186|Late Lumen Loss|late lumen loss
5085333|NCT01278186|Restenosis|restenosis
5085334|NCT01278173|Vigabatrin-associated vision change|vigabatrin-associated vision change
5085335|NCT01278173|Adult refractory complex partial seizures|adult refractory complex partial seizures
5085336|NCT01278173|CPS|cps
5085337|NCT01278173|Epilepsy|epilepsy
5085338|NCT01278173|Seizures|seizures
5085339|NCT01278173|Brain diseases|brain diseases
5085340|NCT01278173|Central Nervous System Diseases|central nervous system diseases
5085341|NCT01278173|Nervous System Diseases|nervous system diseases
5085342|NCT01278173|Neurologic Manifestations|neurologic manifestations
5085343|NCT01278173|Enzyme Inhibitors|enzyme inhibitors
5085345|NCT01278147|cancer|cancer
5085346|NCT01278147|fatigue program education|fatigue program education
5085347|NCT01278121|Obesity|obesity
5085348|NCT01278121|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
5085349|NCT01278121|Cardiovascular diseases|cardiovascular diseases
5085350|NCT01278108|Safety|safety
5085351|NCT01278108|Tolerability|tolerability
5085352|NCT01278108|Pharmacokinetics|pharmacokinetics
5085353|NCT01278095|Safety|safety
5085354|NCT01278095|Tolerability|tolerability
5085355|NCT01278095|Pharmacokinetics|pharmacokinetics
5085356|NCT01278082|Randomized|randomized
5085357|NCT01278082|double-blind|double-blind
5085358|NCT01278082|Placebo-controlled|placebo-controlled
5085359|NCT01278082|budesonide|budesonide
5085360|NCT01278082|collagenous colitis|collagenous colitis
5085361|NCT01278082|acute treatment|acute treatment
5085362|NCT01278082|maintaining remission|maintaining remission
5085363|NCT01278069|Acute myeloid Leukemia|acute myeloid leukemia
5085364|NCT01278069|Myeloid Sarcoma|myeloid sarcoma
5085365|NCT01278069|Extramedullary Acute myeloid Leukemia|extramedullary acute myeloid leukemia
5085366|NCT01278069|18FDG-PET-CT|18fdg-pet-ct
5085367|NCT01278056|Non-alcoholic steatohepatitis (NASH) and increased iron storage / disturbed distribution|non-alcoholic steatohepatitis (nash) and increased iron storage / disturbed distribution
5085368|NCT01278043|Antiplatelet|antiplatelet
5085369|NCT01278043|Percutaneous Coronary Intervention|percutaneous coronary intervention
5085370|NCT01278043|Coronary artery disease|coronary artery disease
5085371|NCT01278043|Antiplatelet Response, Interval Variability & Events in Percutaneous Coronary Intervention|antiplatelet response, interval variability & events in percutaneous coronary intervention
5085372|NCT01278017|nontyphoidal salmonellae|nontyphoidal salmonellae
5085373|NCT01278017|enterocolitis|enterocolitis
5085374|NCT01278017|ceftriaxone|ceftriaxone
5085375|NCT01278004|Adult cancer patients with chemotherapy-induced painful peripheral neuropathy|adult cancer patients with chemotherapy-induced painful peripheral neuropathy
5085376|NCT01277991|Bioequivalence|bioequivalence
5085377|NCT01277991|healthy volunteer study|healthy volunteer study
5085378|NCT01277991|Rheumatoid Arthritis|rheumatoid arthritis
5085379|NCT01277978|Caesarean section|caesarean section
5085380|NCT01277978|Cardiovascular effects|cardiovascular effects
5085381|NCT01277978|Postpartum hemorrhage|postpartum hemorrhage
5085382|NCT01277978|Carbetocin|carbetocin
5085383|NCT01277978|Oxytocin|oxytocin
5085384|NCT01277965|Algorithm basal insulin|algorithm basal insulin
5085385|NCT01277965|physical activity|physical activity
5085386|NCT01277965|Type 1 diabetes|type 1 diabetes
5085387|NCT01277965|Insulin pump treatment|insulin pump treatment
5085388|NCT01277952|Traumatic Brain Injury|traumatic brain injury
5085389|NCT01277952|DBS|dbs
5085390|NCT01277926|Breast Cancer|breast cancer
5085391|NCT01277926|Hormone Receptor Positive, Advanced Breast Cancer|hormone receptor positive, advanced breast cancer
5085392|NCT01277913|diabetes|diabetes
5085393|NCT01277913|vitamin D|vitamin d
5085394|NCT01277913|bone density|bone density
5085395|NCT01277913|children|children
5085396|NCT01277887|Smoking|smoking
5085397|NCT01277887|Nicotine|nicotine
5085398|NCT01277887|Nicotine polacrilex|nicotine polacrilex
5085399|NCT01277887|Nicotine replacement|nicotine replacement
5085400|NCT01277861|Desflurane, Fentanyl, Airway responses|desflurane, fentanyl, airway responses
5085401|NCT01277848|PLAC1|plac1
5085402|NCT01277848|pregnant|pregnant
5085403|NCT01277848|first prenatal visit|first prenatal visit
5085404|NCT01277848|pre-eclampsia|pre-eclampsia
5085405|NCT01277835|video-assisted|video-assisted
5085406|NCT01277835|thoracic surgery|thoracic surgery
5085407|NCT01277835|VATS|vats
5085408|NCT01277835|lidocaine infusion|lidocaine infusion
5085409|NCT01277835|VATS procedures|vats procedures
5085410|NCT01277822|Hypertension|hypertension
5085411|NCT01277822|Uncontrolled hypertension|uncontrolled hypertension
5085412|NCT01277822|High blood pressure|high blood pressure
5085413|NCT01277822|Uncontrolled high blood pressure|uncontrolled high blood pressure
5085414|NCT01277822|Untreated high blood pressure|untreated high blood pressure
5085415|NCT01277822|Untreated hypertension|untreated hypertension
5085416|NCT01277822|Essential hypertension|essential hypertension
5085417|NCT01277809|Long term care|long term care
5085418|NCT01277809|Aging|aging
5085419|NCT01277809|Accidental Falls|accidental falls
5085420|NCT01277809|Muscle Weakness|muscle weakness
5085421|NCT01277809|Gait|gait
5085422|NCT01277809|Physical Fitness|physical fitness
5085423|NCT01277809|Muscle Strength|muscle strength
5085424|NCT01277809|Postural Balance|postural balance
5085425|NCT01277809|Activities of Daily Living|activities of daily living
5085426|NCT01277809|Body Weight|body weight
5085427|NCT01277809|Blood Pressure|blood pressure
5085428|NCT01277809|Depression|depression
5085429|NCT01277809|Behavior|behavior
5085430|NCT01277809|Dementia|dementia
5085431|NCT01277770|Thymoglobulin|thymoglobulin
5085432|NCT01277770|Kidney Transplant Recipients|kidney transplant recipients
5085433|NCT01277770|Steroid-Free|steroid-free
5085434|NCT01277770|Immunosuppression|immunosuppression
5085435|NCT01277744|Desmoplastic small round cell tumor|desmoplastic small round cell tumor
5085436|NCT01277744|DSRCT|dsrct
5085437|NCT01277744|Hyperthermic peritoneal perfusion|hyperthermic peritoneal perfusion
5085438|NCT01277744|HIPEC|hipec
5085439|NCT01277744|Complete abdominal tumor excision|complete abdominal tumor excision
5085440|NCT01277744|Extensive abdominal disease|extensive abdominal disease
5085441|NCT01277744|Non-carcinoma tumors|non-carcinoma tumors
5085442|NCT01277744|Abdominal cavity|abdominal cavity
5085443|NCT01277744|Cisplatin|cisplatin
5085444|NCT01277744|Platinol-AQ|platinol-aq
5085445|NCT01277744|Platinol|platinol
5085446|NCT01277744|CDDP|cddp
5085447|NCT01277744|Diffuse peritoneal tumor|diffuse peritoneal tumor
5085448|NCT01277744|Retroperitoneal tumor|retroperitoneal tumor
5085449|NCT01277744|Ovarian germ cell|ovarian germ cell
5085450|NCT01277744|Wilms' tumor|wilms' tumor
5085451|NCT01277705|Booster vaccination|booster vaccination
5085452|NCT01277692|First administration to human, safety, pharmacokinetics, healthy subjects, antiviral activity, hepatitis C patients|first administration to human, safety, pharmacokinetics, healthy subjects, antiviral activity, hepatitis c patients
5085453|NCT01277679|lung water measures|lung water measures
5085454|NCT01277679|pulmonary edema|pulmonary edema
5085455|NCT01277679|MRI|mri
5085456|NCT01277679|heart failure|heart failure
5085457|NCT01277666|Crohn's disease|crohn's disease
5085458|NCT01277666|capsule|capsule
5085459|NCT01277666|GSK1605786A|gsk1605786a
5085460|NCT01277666|quality of life|quality of life
5085461|NCT01277666|inflammatory bowel disease|inflammatory bowel disease
5085462|NCT01277666|oral therapy|oral therapy
5085463|NCT01277653|Hepatocellular carcinoma|hepatocellular carcinoma
5085464|NCT01277640|male tolerance|male tolerance
5085465|NCT01277640|HIV-1|hiv-1
5085466|NCT01277640|microbicide|microbicide
5085467|NCT01277640|dapivirine|dapivirine
5085468|NCT01277627|HCV|hcv
5085469|NCT01277627|HIV|hiv
5085470|NCT01277627|Nevirapine|nevirapine
5085471|NCT01277627|HCV viral load|hcv viral load
5085472|NCT01277627|Efavirenz|efavirenz
5085473|NCT01277627|Protease inhibitors|protease inhibitors
5085474|NCT01277614|lifestyle|lifestyle
5085475|NCT01277614|diet|diet
5085476|NCT01277614|exercise|exercise
5085477|NCT01277601|Chronic Hepatitis B|chronic hepatitis b
5085478|NCT01277601|Hep B|hep b
5085479|NCT01277601|Non cirrhotic|non cirrhotic
5085480|NCT01277601|Tenofovir disoproxil fumarate (TDF)|tenofovir disoproxil fumarate (tdf)
5085481|NCT01277601|Peginterferon α-2a (Peg-IFN)|peginterferon α-2a (peg-ifn)
5085482|NCT01277588|fetal scalp sampling|fetal scalp sampling
5085483|NCT01277588|experience questionnaire|experience questionnaire
5085484|NCT01277575|stroke|stroke
5085485|NCT01277575|aphasia|aphasia
5085486|NCT01277575|language|language
5085487|NCT01277562|Breast Cancer|breast cancer
5085488|NCT01277562|Prostate Cancer|prostate cancer
5085489|NCT01277562|Osteopenia|osteopenia
5085490|NCT01277562|Osteoporosis|osteoporosis
5085491|NCT01277562|Secondary causes of bone loss|secondary causes of bone loss
5085492|NCT01277549|Leukapheresis|leukapheresis
5085493|NCT01277549|Hematopoetic Stem Cell Mobilization|hematopoetic stem cell mobilization
5085494|NCT01277510|dialysis|dialysis
5085495|NCT01277510|sensipar|sensipar
5085496|NCT01277510|mimpara|mimpara
5085497|NCT01277510|hemodialysis|hemodialysis
5085498|NCT01277510|peritoneal dialysis|peritoneal dialysis
5085499|NCT01277510|renal|renal
5085500|NCT01277510|parathyroid hormone|parathyroid hormone
5085501|NCT01277510|pediatric|pediatric
5085502|NCT01277497|Chronic kidney disease|chronic kidney disease
5085503|NCT01277497|Phosphate binder|phosphate binder
5085504|NCT01277497|Sevelamer carbonate|sevelamer carbonate
5085505|NCT01277497|Calcium acetate|calcium acetate
5085506|NCT01277497|Vascular calcification|vascular calcification
5085507|NCT01277497|Endothelial Dysfunction|endothelial dysfunction
5085508|NCT01277484|decitabine|decitabine
5085509|NCT01277484|dose|dose
5085510|NCT01277484|schedule|schedule
5085511|NCT01277484|safety|safety
5085512|NCT01277484|allogeneic stem cell transplantation|allogeneic stem cell transplantation
5085513|NCT01277471|meal frequency|meal frequency
5085514|NCT01277471|type two diabetes|type two diabetes
5085515|NCT01277458|HIV|hiv
5085516|NCT01277458|MSM|msm
5085517|NCT01277458|Ethnicity|ethnicity
5085518|NCT01277445|gut microbiome|gut microbiome
5085519|NCT01277445|prebiotics|prebiotics
5085520|NCT01277445|immunological status|immunological status
5085521|NCT01277445|fructans|fructans
5085522|NCT01277432|Diabetes|diabetes
5085523|NCT01277432|Depression|depression
5085524|NCT01277406|Colorectal Carcinoma|colorectal carcinoma
5085525|NCT01277406|Resminostat|resminostat
5085526|NCT01277406|HDAC|hdac
5085527|NCT01277406|4SC-201|4sc-201
5085528|NCT01277406|Phase I|phase i
5085529|NCT01277406|Phase II|phase ii
5085530|NCT01277393|Enteral nutrition feeding|enteral nutrition feeding
5085531|NCT01277380|H1N1 Influenza virus|h1n1 influenza virus
5085532|NCT01277380|swine flu|swine flu
5085533|NCT01277380|Real Time RT-PCR|real time rt-pcr
5085534|NCT01277367|Obesity|obesity
5085535|NCT01277367|Sedentary|sedentary
5085536|NCT01277367|Physical activity|physical activity
5085537|NCT01277367|exercise|exercise
5085538|NCT01277367|incentives|incentives
5085539|NCT01277354|Cognitive Processing Therapy (CPT)|cognitive processing therapy (cpt)
5085540|NCT01277315|ALS|als
5085541|NCT01277315|Anakinra|anakinra
5085542|NCT01277315|Kineret|kineret
5085543|NCT01277315|Progressive Muscular Atrophy|progressive muscular atrophy
5085544|NCT01277315|PMA|pma
5085545|NCT01277315|Safety Trial|safety trial
5085546|NCT01277315|Tolerability Trial|tolerability trial
5085547|NCT01277289|dexamethasone|dexamethasone
5085548|NCT01277289|ery-dex|ery-dex
5085549|NCT01277289|Chron's disease|chron's disease
5085550|NCT01277289|CD|cd
5085551|NCT01277276|Medical tool|medical tool
5085552|NCT01277263|Breast Cancer|breast cancer
5085553|NCT01277250|Hospitalized adults|hospitalized adults
5085554|NCT01277250|Tobacco users|tobacco users
5085555|NCT01277250|Smokers|smokers
5085556|NCT01277250|Smoking cessation|smoking cessation
5085557|NCT01277250|Web-based|web-based
5085558|NCT01277250|Transition coach|transition coach
5085559|NCT01277237|Non alcoholic fatty liver disease|non alcoholic fatty liver disease
5085560|NCT01277224|physical activity|physical activity
5085561|NCT01277224|obesity|obesity
5085562|NCT01277224|adiposity|adiposity
5085563|NCT01277224|children|children
5085564|NCT01277224|blood lipids|blood lipids
5085565|NCT01277224|blood pressure|blood pressure
5085566|NCT01277224|randomized controlled trials|randomized controlled trials
5085567|NCT01277211|Contraception|contraception
5085568|NCT01277211|NuvaRing|nuvaring
5085569|NCT01277198|kidney calculi|kidney calculi
5085570|NCT01277198|ureteral calculi|ureteral calculi
5085571|NCT01277198|cystoscopes|cystoscopes
5085572|NCT01277198|laparoscopes|laparoscopes
5085573|NCT01277185|calcium|calcium
5085574|NCT01277185|healthy|healthy
5085575|NCT01277185|Mexican-American adolescents|mexican-american adolescents
5085576|NCT01277185|camp|camp
5085577|NCT01277185|girls|girls
5085578|NCT01277185|boys|boys
5085579|NCT01277185|bone|bone
5085580|NCT01277172|DLBCL|dlbcl
5085581|NCT01277172|pharmacokinetics|pharmacokinetics
5085582|NCT01277172|pharmacodynamics|pharmacodynamics
5085583|NCT01277172|Rituximab|rituximab
5085584|NCT01277172|LymphomaLymphoma|lymphomalymphoma
5085585|NCT01277172|Non-HodgkinLymphoma|non-hodgkinlymphoma
5085586|NCT01277172|B-CellLymphoma|b-celllymphoma
5085587|NCT01277172|Large B-Cell|large b-cell
5085588|NCT01277172|Disorders Lymphatic Diseases|disorders lymphatic diseases
5085589|NCT01277172|Immunoproliferative Disorders|immunoproliferative disorders
5085590|NCT01277172|Antineoplastic Agents|antineoplastic agents
5085591|NCT01277172|Adverse Effects|adverse effects
5085592|NCT01277159|Analgesia|analgesia
5085593|NCT01277159|Duration|duration
5085594|NCT01277159|Popliteal Fossa Nerve Block|popliteal fossa nerve block
5085595|NCT01277159|Dexamethasone|dexamethasone
5085596|NCT01277159|Buprenorphine|buprenorphine
5085597|NCT01277159|Additives|additives
5085598|NCT01277159|Ankle surgery|ankle surgery
5085599|NCT01277146|Phase 1|phase 1
5085600|NCT01277146|dose escalation|dose escalation
5085601|NCT01277146|histologically confirmed|histologically confirmed
5085602|NCT01277146|malignancy metastatic|malignancy metastatic
5085603|NCT01277107|PSG|psg
5085604|NCT01277107|LPS|lps
5085605|NCT01277107|TST|tst
5085606|NCT01277107|WASO|waso
5085607|NCT01277107|Subjects With Insomnia characterized by both Difficulty in Falling Asleep and Staying Asleep|subjects with insomnia characterized by both difficulty in falling asleep and staying asleep
5085608|NCT01277081|Paracetamol|paracetamol
5085609|NCT01277081|Common cold|common cold
5085610|NCT01277068|obese patients|obese patients
5085611|NCT01277068|TRL|trl
5085612|NCT01277068|the bariatric surgery|the bariatric surgery
5085613|NCT01277042|Safety|safety
5085614|NCT01277042|HPV vaccine|hpv vaccine
5085615|NCT01277042|Immune response|immune response
5085616|NCT01277042|Human papillomavirus|human papillomavirus
5085617|NCT01277042|China|china
5085618|NCT01277016|Amyloidosis|amyloidosis
5085619|NCT01277016|Bortezomib|bortezomib
5085620|NCT01276977|Migraine|migraine
5085621|NCT01276977|Acute Migraine|acute migraine
5085622|NCT01276977|Headache|headache
5085623|NCT01276964|menses|menses
5085624|NCT01276964|quantitative determination of menstrual losses|quantitative determination of menstrual losses
5085625|NCT01276964|kinetic definition of menses|kinetic definition of menses
5085626|NCT01276951|Cocoa|cocoa
5085627|NCT01276951|Chocolate|chocolate
5085628|NCT01276951|Endothelial disfunction|endothelial disfunction
5085629|NCT01276951|Cardiovascular disease|cardiovascular disease
5085630|NCT01276951|Blood Pressure|blood pressure
5085631|NCT01276951|Hypertension|hypertension
5085632|NCT01276938|Breast cancer|breast cancer
5085633|NCT01276938|Intra Operative Radiation Therapy|intra operative radiation therapy
5085634|NCT01276938|Toxicity|toxicity
5085635|NCT01276925|Hip arthroplasty|hip arthroplasty
5085636|NCT01276925|Peripheral nervous blockade|peripheral nervous blockade
5085637|NCT01276925|Postoperative|postoperative
5085638|NCT01276925|Pain|pain
5085639|NCT01276925|Ropivacaine|ropivacaine
5085640|NCT01276899|Breast Cancer|breast cancer
5085641|NCT01276899|Triple negative breast cancer|triple negative breast cancer
5085642|NCT01276899|ERnegative, PRnegative and Her2negative|ernegative, prnegative and her2negative
5085643|NCT01276899|Taxanes|taxanes
5085644|NCT01276899|Metastases|metastases
5085645|NCT01276899|Biomarkers|biomarkers
5085646|NCT01276899|Resistance|resistance
5085647|NCT01276899|Biobanking|biobanking
5085648|NCT01276899|Breast cancer with unresectable metastases to the liver|breast cancer with unresectable metastases to the liver
5085649|NCT01276899|Breast cancer with unresectable metastases to the skin|breast cancer with unresectable metastases to the skin
5085650|NCT01276899|Breast cancer with unresectable metastases to the lymph node|breast cancer with unresectable metastases to the lymph node
5085651|NCT01276899|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
5085652|NCT01276886|Left sided acute diverticulitis diagnosed clinically by the presence of abdominal pain, leukocytosis (>11x109) and/or fever >38°C, confirmed by imaging.|left sided acute diverticulitis diagnosed clinically by the presence of abdominal pain, leukocytosis (>11x109) and/or fever >38°c, confirmed by imaging.
5085653|NCT01276886|CT criteria: localized thickening (≥4 mm) of the colonic wall and signs of inflammation of the pericolic fat, abscess and/or extraluminal air and/or contrast.|ct criteria: localized thickening (≥4 mm) of the colonic wall and signs of inflammation of the pericolic fat, abscess and/or extraluminal air and/or contrast.
5085654|NCT01276886|US criteria: bowel wall thickening (>4 mm), diverticular inflammation, pericolic fat edema, intramural or pericolic inflammatory mass, intramural fistula.|us criteria: bowel wall thickening (>4 mm), diverticular inflammation, pericolic fat edema, intramural or pericolic inflammatory mass, intramural fistula.
5085655|NCT01276886|WSCE criteria: segmental luminal narrowing and a tethered mucosa with or without a mass effect or extravasation of contrast and/or extraluminal air.|wsce criteria: segmental luminal narrowing and a tethered mucosa with or without a mass effect or extravasation of contrast and/or extraluminal air.
5085656|NCT01276873|Artificial Respiration|artificial respiration
5085657|NCT01276873|Suction|suction
5085658|NCT01276873|Pain|pain
5085659|NCT01276873|Nursing|nursing
5085660|NCT01276873|Neonatology|neonatology
5085661|NCT01276860|Obstructive Sleep Apnea|obstructive sleep apnea
5085662|NCT01276860|Pediatric Obstructive Sleep Apnea|pediatric obstructive sleep apnea
5085663|NCT01276860|OSA|osa
5085664|NCT01276860|PVT|pvt
5085665|NCT01276860|Psychomotor Vigilance Testing|psychomotor vigilance testing
5085666|NCT01276860|Psychomotor Vigilance Task|psychomotor vigilance task
5085667|NCT01276847|psoriasis|psoriasis
5085668|NCT01276847|Ustekinumab|ustekinumab
5085669|NCT01276847|Stelara|stelara
5085670|NCT01276847|Etanercept|etanercept
5085671|NCT01276847|Enbrel|enbrel
5085672|NCT01276821|Bronchiolitis|bronchiolitis
5085673|NCT01276821|L-Epinephrine|l-epinephrine
5085674|NCT01276821|3% Hypertonic Saline|3% hypertonic saline
5085675|NCT01276821|Clinical Severity Score|clinical severity score
5085676|NCT01276808|Magnetic navigation, percutaneous coronary intervention|magnetic navigation, percutaneous coronary intervention
5085677|NCT01276769|Triple Negative Breast Cancer|triple negative breast cancer
5085678|NCT01276769|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
5085679|NCT01276769|Platinum|platinum
5085680|NCT01276730|Advanced cervical cancer|advanced cervical cancer
5085681|NCT01276730|India|india
5085682|NCT01276691|Vascular function|vascular function
5085683|NCT01276691|Inflammation|inflammation
5085684|NCT01276691|Oxidative stress|oxidative stress
5085685|NCT01276691|Hemostatic balance|hemostatic balance
5085686|NCT01276691|Aspirin|aspirin
5085687|NCT01276691|Firefighting|firefighting
5085688|NCT01276678|CAD|cad
5085689|NCT01276665|Bladder cancer|bladder cancer
5085690|NCT01276665|urinary diversion|urinary diversion
5085691|NCT01276665|Postoperative Complications|postoperative complications
5085692|NCT01276665|Fluid Therapy|fluid therapy
5085693|NCT01276665|Norepinephrine|norepinephrine
5085694|NCT01276652|Polysomnography|polysomnography
5085695|NCT01276652|Circadian rhythmicity|circadian rhythmicity
5085696|NCT01276639|Xeljanz|xeljanz
5085697|NCT01276639|tofacitinib|tofacitinib
5085698|NCT01276639|chronic|chronic
5085699|NCT01276639|Pruritus|pruritus
5085700|NCT01276639|Itch|itch
5085701|NCT01276639|DLQI|dlqi
5085702|NCT01276639|severe|severe
5085703|NCT01276639|moderate|moderate
5085704|NCT01276639|treatment|treatment
5085705|NCT01276639|safety|safety
5085706|NCT01276639|efficacy|efficacy
5085707|NCT01276639|CP-690,550|cp-690,550
5085708|NCT01276639|Plaque Psoriasis|plaque psoriasis
5085709|NCT01276639|Psoriasis Vulgaris|psoriasis vulgaris
5085710|NCT01276639|Jax-inhibitor|jax-inhibitor
5085711|NCT01276639|Oral Treatment|oral treatment
5085712|NCT01276613|Resectable Adenocarcinoma of the Pancreas|resectable adenocarcinoma of the pancreas
5085713|NCT01276613|Gemcitabine|gemcitabine
5085714|NCT01276613|Gemcitabine Hydrochloride|gemcitabine hydrochloride
5085715|NCT01276613|Gemzar|gemzar
5085716|NCT01276587|sickle cell disease|sickle cell disease
5085717|NCT01276587|children|children
5085718|NCT01276587|vitamin D|vitamin d
5085719|NCT01276587|safety|safety
5085720|NCT01276574|PET/CT|pet/ct
5085721|NCT01276574|Ovarian cancer|ovarian cancer
5085722|NCT01276574|HE4|he4
5085723|NCT01276561|laparoscopy|laparoscopy
5085724|NCT01276561|splenectomy|splenectomy
5085725|NCT01276561|single site|single site
5085726|NCT01276561|trial|trial
5085727|NCT01276522|Schnitzler syndrome|schnitzler syndrome
5085728|NCT01276522|IL-1 beta|il-1 beta
5085729|NCT01276522|Canakinumab|canakinumab
5085730|NCT01276522|Ilaris|ilaris
5085731|NCT01276522|Treatment|treatment
5085732|NCT01276522|Efficacy|efficacy
5085733|NCT01276522|Safety|safety
5085828|NCT01276119|single-dose|single-dose
5085829|NCT01276119|pharmacokinetics|pharmacokinetics
5085734|NCT01276509|Crohn's disease Safety Efficacy Pharmacokinetics Pharmacodynamics Crohn's Disease Activity Index (CDAI)|crohn's disease safety efficacy pharmacokinetics pharmacodynamics crohn's disease activity index (cdai)
5085735|NCT01276483|GIST|gist
5085736|NCT01276483|Response Monitoring|response monitoring
5085737|NCT01276483|Functional Magnetic Imaging|functional magnetic imaging
5085738|NCT01276483|Positron Emission Tomography|positron emission tomography
5085739|NCT01276483|Computer Tomography|computer tomography
5085740|NCT01276470|Adult and Pediatric Autoimmune Disease|adult and pediatric autoimmune disease
5085741|NCT01276470|Antibody|antibody
5085742|NCT01276470|Autoimmune Diseases|autoimmune diseases
5085743|NCT01276470|Autoimmunity Pathogenesis|autoimmunity pathogenesis
5085744|NCT01276470|Environmental Risk Factors|environmental risk factors
5085745|NCT01276470|Dermatomyositis|dermatomyositis
5085746|NCT01276470|Polymyositis|polymyositis
5085747|NCT01276470|Juvenile Dermatomyositis|juvenile dermatomyositis
5085748|NCT01276470|Juvenile Polymyositis|juvenile polymyositis
5085749|NCT01276470|Myositis|myositis
5085750|NCT01276457|immunosuppression|immunosuppression
5085751|NCT01276457|kidney transplantation|kidney transplantation
5085752|NCT01276457|everolimus|everolimus
5085753|NCT01276457|safety|safety
5085754|NCT01276444|valve repair|valve repair
5085755|NCT01276444|postoperative period|postoperative period
5085756|NCT01276444|goal-directed therapy|goal-directed therapy
5085757|NCT01276444|pulmonary artery catheter|pulmonary artery catheter
5085758|NCT01276444|transpulmonary thermodilution|transpulmonary thermodilution
5085759|NCT01276444|central venous oxygen saturation|central venous oxygen saturation
5085760|NCT01276392|regional and systemical anticoagulation|regional and systemical anticoagulation
5085761|NCT01276392|continuous renal replacement therapy|continuous renal replacement therapy
5085762|NCT01276392|multiplate|multiplate
5085763|NCT01276392|rotational thrombelastometry|rotational thrombelastometry
5085764|NCT01276379|colorectal cancer|colorectal cancer
5085765|NCT01276379|advanced|advanced
5085766|NCT01276379|metastatic|metastatic
5085767|NCT01276379|KRAS|kras
5085768|NCT01276379|biomarkers (BRAF, IGF1P/MMp7,PI3K-PTEN)|biomarkers (braf, igf1p/mmp7,pi3k-pten)
5085769|NCT01276379|cetuximab|cetuximab
5085770|NCT01276366|Heel lance|heel lance
5085771|NCT01276366|Premature|premature
5085772|NCT01276366|Breast milk|breast milk
5085773|NCT01276353|Alzheimer Disease|alzheimer disease
5085774|NCT01276353|Dementia|dementia
5085775|NCT01276353|Delirium|delirium
5085776|NCT01276353|Amnestic|amnestic
5085777|NCT01276353|Cognitive Disorders|cognitive disorders
5085778|NCT01276353|Donepezil|donepezil
5085779|NCT01276353|Brain Diseases|brain diseases
5085780|NCT01276353|Central Nervous System Diseases|central nervous system diseases
5085781|NCT01276353|Nervous System Diseases|nervous system diseases
5085782|NCT01276353|Tauopathies|tauopathies
5085783|NCT01276353|Neurodegenerative Diseases|neurodegenerative diseases
5085784|NCT01276353|Mental Disorders|mental disorders
5085785|NCT01276353|Cholinesterase Inhibitors|cholinesterase inhibitors
5085786|NCT01276353|Enzy|enzy
5085787|NCT01276340|Urinary Incontinence|urinary incontinence
5085788|NCT01276340|Urinary stress incontinence|urinary stress incontinence
5085789|NCT01276340|Urinary urge incontinence|urinary urge incontinence
5085790|NCT01276340|Women|women
5085791|NCT01276340|electrical stimulation|electrical stimulation
5085792|NCT01276340|KEAT stimulator|keat stimulator
5085793|NCT01276340|quality of life|quality of life
5085794|NCT01276314|SCAR|scar
5085795|NCT01276314|anti-TNF-a|anti-tnf-a
5085796|NCT01276275|Acute coronary syndrome, thienopyridine, epidemiology|acute coronary syndrome, thienopyridine, epidemiology
5085797|NCT01276262|Phase 1, healthy female volunteers, oral contraceptive, pharmacokinetics, Rheumatoid arthritis, RA, fostamatinib|phase 1, healthy female volunteers, oral contraceptive, pharmacokinetics, rheumatoid arthritis, ra, fostamatinib
5085798|NCT01276249|Aptus Endosystem|aptus endosystem
5085799|NCT01276249|EndoStaple|endostaple
5085800|NCT01276249|Endograft|endograft
5085801|NCT01276249|Stent Graft|stent graft
5085802|NCT01276249|Abdominal Aortic Aneurysm|abdominal aortic aneurysm
5085803|NCT01276249|Heli-FX|heli-fx
5085804|NCT01276249|EndoAnchor|endoanchor
5085805|NCT01276236|Kaposi's Sarcoma|kaposi's sarcoma
5085806|NCT01276236|Maraviroc|maraviroc
5085807|NCT01276236|CCR5|ccr5
5085808|NCT01276236|HIV|hiv
5085809|NCT01276223|Dry eye|dry eye
5085810|NCT01276223|ocular discomfort|ocular discomfort
5085811|NCT01276197|hypertension|hypertension
5085812|NCT01276197|healthcare disparities|healthcare disparities
5085813|NCT01276197|minority health|minority health
5085814|NCT01276197|health behavior|health behavior
5085815|NCT01276184|HPV Vaccine|hpv vaccine
5085816|NCT01276184|HPV vaccination|hpv vaccination
5085817|NCT01276184|SMS|sms
5085818|NCT01276184|Text Message|text message
5085819|NCT01276184|Gardasil|gardasil
5085820|NCT01276145|pudendal artery disease|pudendal artery disease
5085821|NCT01276145|erectile dysfunction|erectile dysfunction
5085822|NCT01276145|coronary angiography|coronary angiography
5085823|NCT01276145|coronary disease|coronary disease
5085824|NCT01276145|cardiac|cardiac
5085825|NCT01276132|percutaneous coronary artery intervention|percutaneous coronary artery intervention
5085826|NCT01276132|coronary disease|coronary disease
5085827|NCT01276119|CDP6038|cdp6038
5085830|NCT01276119|healthy subjects|healthy subjects
5085831|NCT01276106|AC-201|ac-201
5085832|NCT01276106|Interleukin 1 inhibitor|interleukin 1 inhibitor
5085833|NCT01276093|Atrial fibrillation|atrial fibrillation
5085834|NCT01276093|PVI ablation|pvi ablation
5085835|NCT01276093|Elderly patients|elderly patients
5085836|NCT01276093|Efficacy|efficacy
5085837|NCT01276041|MAB 2C4 (PERTUZUMAB)|mab 2c4 (pertuzumab)
5085838|NCT01276041|MAB HER 2 (HERCEPTIN) (TRASTUZUMAB)|mab her 2 (herceptin) (trastuzumab)
5085839|NCT01276041|TAXOL (PACLITAXEL)|taxol (paclitaxel)
5085840|NCT01276041|10-142|10-142
5085841|NCT01276041|Stage IV HER2 (+) breast cancer|stage iv her2 (+) breast cancer
5085842|NCT01276028|Acupuncture|acupuncture
5085843|NCT01276028|Hot Flashes|hot flashes
5085844|NCT01276028|Menopause|menopause
5085845|NCT01276028|Vasomotor Symptoms|vasomotor symptoms
5085846|NCT01276015|BoNT-A-botulinum neurotoxin type A|bont-a-botulinum neurotoxin type a
5085847|NCT01276015|CMAP-compound muscle action potential|cmap-compound muscle action potential
5085848|NCT01276015|CP-cerebral palsy|cp-cerebral palsy
5085849|NCT01276015|LG-lateral gastrocnemius|lg-lateral gastrocnemius
5085850|NCT01276015|MG-medial gastrocnemius|mg-medial gastrocnemius
5085851|NCT01276015|TA-tibialis anterior|ta-tibialis anterior
5085852|NCT01276015|PROMS-passive range of movement|proms-passive range of movement
5085853|NCT01276015|MAS-modified Ashworth scale|mas-modified ashworth scale
5085854|NCT01276015|EVGS-Edinburgh visual gait scale|evgs-edinburgh visual gait scale
5085855|NCT01276015|GMF-CS-gross motor function classification system|gmf-cs-gross motor function classification system
5085856|NCT01276002|disrupted duct|disrupted duct
5085857|NCT01276002|pancreatic pseudocysts|pancreatic pseudocysts
5085858|NCT01275976|C1-esterase inhibitor|c1-esterase inhibitor
5085859|NCT01275976|Systemic inflammation|systemic inflammation
5085860|NCT01275976|Sepsis|sepsis
5085861|NCT01275976|Trauma|trauma
5085862|NCT01275976|Multiple Organ Dysfunction Syndrome|multiple organ dysfunction syndrome
5085863|NCT01275976|Cytokines|cytokines
5085864|NCT01275963|Echocardiography|echocardiography
5085865|NCT01275963|Strain imaging|strain imaging
5085866|NCT01275963|Ventricular Dysfunction|ventricular dysfunction
5085867|NCT01275963|Cardiomyopathy|cardiomyopathy
5085868|NCT01275963|Longitudinal left ventricular function|longitudinal left ventricular function
5085869|NCT01275950|Tobacco vendor|tobacco vendor
5085870|NCT01275950|students|students
5085871|NCT01275950|knowledge|knowledge
5085872|NCT01275950|attitude|attitude
5085873|NCT01275950|practice|practice
5085874|NCT01275950|direct advertisements|direct advertisements
5085875|NCT01275950|surrogate advertisements|surrogate advertisements
5085876|NCT01275924|Syndesmosis|syndesmosis
5085877|NCT01275924|Injury|injury
5085878|NCT01275924|Ankle|ankle
5085879|NCT01275924|Fracture|fracture
5085880|NCT01275898|NIRS|nirs
5085881|NCT01275898|cerebral oxygenation|cerebral oxygenation
5085882|NCT01275885|cholecalciferol|cholecalciferol
5085883|NCT01275885|infant|infant
5085884|NCT01275885|bone mineral density|bone mineral density
5085885|NCT01275872|guided imagery|guided imagery
5085886|NCT01275872|progressive muscle relaxation|progressive muscle relaxation
5085887|NCT01275872|complimentary and alternative medicine|complimentary and alternative medicine
5085888|NCT01275872|quality of life|quality of life
5085889|NCT01275872|stress|stress
5085890|NCT01275872|pain|pain
5085891|NCT01275872|anxiety|anxiety
5085892|NCT01275859|Neoadjuvant|neoadjuvant
5085893|NCT01275859|Letrozole|letrozole
5085894|NCT01275859|Lapatinib|lapatinib
5085895|NCT01275859|Postmenopausal|postmenopausal
5085896|NCT01275846|heart failure|heart failure
5085897|NCT01275846|congestive heart failure|congestive heart failure
5085898|NCT01275846|telemedicine|telemedicine
5085899|NCT01275833|Implantable ICD|implantable icd
5085900|NCT01275833|First Degree AV block|first degree av block
5085901|NCT01275820|diabetes, insulin, blood sugar|diabetes, insulin, blood sugar
5085902|NCT01275807|climacteric, climacteric syndrome|climacteric, climacteric syndrome
5085903|NCT01275794|Type 2 Diabetes|type 2 diabetes
5085904|NCT01275781|Phase 1|phase 1
5085905|NCT01275781|healthy male volunteers|healthy male volunteers
5085906|NCT01275781|radioactivity|radioactivity
5085907|NCT01275781|excretion|excretion
5085908|NCT01275781|metabolism|metabolism
5085909|NCT01275781|AZD9742|azd9742
5085910|NCT01275781|amount of radioactive AZD9742 in urine, feces, and vomitus (if appropriate)|amount of radioactive azd9742 in urine, feces, and vomitus (if appropriate)
5085911|NCT01275768|radio-frequency ablation|radio-frequency ablation
5085912|NCT01275768|Malignant jaundice|malignant jaundice
5085913|NCT01275755|opioid therapy|opioid therapy
5085914|NCT01275755|constipation|constipation
5085915|NCT01275755|chronic noncancer pain|chronic noncancer pain
5085916|NCT01275755|mu opioid receptor antagonist|mu opioid receptor antagonist
5085917|NCT01275755|ADL5945|adl5945
5085918|NCT01275755|Opioid Induced Constipation|opioid induced constipation
5085919|NCT01275742|Heart failure|heart failure
5085920|NCT01275742|Depression|depression
5085921|NCT01275742|Depressive symptoms|depressive symptoms
5085922|NCT01275742|Cognitive therapy|cognitive therapy
5085923|NCT01275742|Hospitalization|hospitalization
5085924|NCT01275742|Quality of life|quality of life
5085925|NCT01275729|Renal Replacement Therapy|renal replacement therapy
5085926|NCT01275729|Diuretics|diuretics
5085927|NCT01275729|Biomarkers|biomarkers
5085928|NCT01275729|Renal Insufficiency|renal insufficiency
5085929|NCT01275729|Furosemide|furosemide
5085930|NCT01275729|Therapeutic Uses|therapeutic uses
5085931|NCT01275729|Physiological Effects of Drugs|physiological effects of drugs
5085932|NCT01275729|Biological Markers|biological markers
5085933|NCT01275716|Patient Education|patient education
5085934|NCT01275716|coronary artery disease|coronary artery disease
5085935|NCT01275716|Impact of Coronary Images Used During Patient Education on Coronary Artery Disease and Subsequent Lifestyle Modifications.|impact of coronary images used during patient education on coronary artery disease and subsequent lifestyle modifications.
5085936|NCT01275703|To determine the utility of a noninvasive method of measuring cardiac output during exercise testing in patients with PH|to determine the utility of a noninvasive method of measuring cardiac output during exercise testing in patients with ph
5085937|NCT01275690|cardiac|cardiac
5085938|NCT01275690|pulmonary hypertension|pulmonary hypertension
5085939|NCT01275690|To determine the accuracy of a noninvasive method of measuring cardiac output as compared to the standard invasive approach in patients with PH|to determine the accuracy of a noninvasive method of measuring cardiac output as compared to the standard invasive approach in patients with ph
5085940|NCT01275651|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5085941|NCT01275651|recurrent prostate cancer|recurrent prostate cancer
5085942|NCT01275638|cortisol, prednisolone, adrenal insufficiency, sepsis|cortisol, prednisolone, adrenal insufficiency, sepsis
5085943|NCT01275625|maraviroc|maraviroc
5085944|NCT01275625|naive|naive
5085945|NCT01275625|hiv|hiv
5085946|NCT01275625|zidovudine|zidovudine
5085947|NCT01275625|lamivudine|lamivudine
5085948|NCT01275625|combivir|combivir
5085949|NCT01275625|Clade A|clade a
5085950|NCT01275612|Mesenchymal Stromal Cells|mesenchymal stromal cells
5085951|NCT01275612|Solid tumors|solid tumors
5085952|NCT01275612|Cisplatin therapy|cisplatin therapy
5085953|NCT01275612|Acute kidney injury|acute kidney injury
5085954|NCT01275586|NF1|nf1
5085955|NCT01275586|plexiform neurofibromas|plexiform neurofibromas
5085956|NCT01275586|nilotinib|nilotinib
5085957|NCT01275586|Tasigna|tasigna
5085958|NCT01275573|Repetitive Transcranial Magnetic Stimulation|repetitive transcranial magnetic stimulation
5085959|NCT01275573|pain threshold|pain threshold
5085960|NCT01275573|Parkinson's disease|parkinson's disease
5085961|NCT01275573|Pain threshold in Parkinson's disease|pain threshold in parkinson's disease
5085962|NCT01275547|Patient controlled analgesia|patient controlled analgesia
5085963|NCT01275547|Morphine|morphine
5085964|NCT01275547|S-Ketamine intranasal|s-ketamine intranasal
5085965|NCT01275547|Midazolam intranasal|midazolam intranasal
5085966|NCT01275534|Stem cell transplantation|stem cell transplantation
5085967|NCT01275534|Symptom experience|symptom experience
5085968|NCT01275534|Late effects|late effects
5085969|NCT01275534|Self-management|self-management
5085970|NCT01275508|Subjects with active Crohn's disease|subjects with active crohn's disease
5085971|NCT01275508|Safety and tolerability of FITC-Adalimumab|safety and tolerability of fitc-adalimumab
5085972|NCT01275508|Intestinal topical application|intestinal topical application
5085973|NCT01275495|Stroke|stroke
5085974|NCT01275495|Family Caregivers|family caregivers
5085975|NCT01275495|Cerebrovascular Accident|cerebrovascular accident
5085976|NCT01275495|Carers|carers
5085977|NCT01275495|Care Givers|care givers
5085978|NCT01275495|Depression|depression
5085979|NCT01275495|Life change events|life change events
5085980|NCT01275495|Family health|family health
5085981|NCT01275495|Quality of life|quality of life
5085982|NCT01275495|Cost|cost
5085983|NCT01275495|Intervention studies|intervention studies
5085984|NCT01275495|Clinical trial|clinical trial
5085985|NCT01275482|Latent Myofascial trigger point.|latent myofascial trigger point.
5085986|NCT01275482|Transverse friction massage|transverse friction massage
5085987|NCT01275482|Local twitch response|local twitch response
5085988|NCT01275482|Effectiveness|effectiveness
5085989|NCT01275469|Impaired Glucose tolerance|impaired glucose tolerance
5085990|NCT01275469|OGTT|ogtt
5085991|NCT01275469|PPARs|ppars
5085992|NCT01275456|allergen provocation|allergen provocation
5085993|NCT01275456|environmental challenge|environmental challenge
5085994|NCT01275456|allergen chamber|allergen chamber
5085995|NCT01275456|house dust mite|house dust mite
5085996|NCT01275456|immunotherapy|immunotherapy
5085997|NCT01275443|HIV|hiv
5085998|NCT01275430|central venous catheters|central venous catheters
5085999|NCT01275430|peripherally inserted central catheters (PICC_|peripherally inserted central catheters (picc_
5086000|NCT01275430|Electrocardiography (ECG)|electrocardiography (ecg)
5086001|NCT01275430|intravascular ECG|intravascular ecg
5086002|NCT01275430|Tip Positioning System|tip positioning system
5086003|NCT01275417|Acupuncture|acupuncture
5086004|NCT01275404|Erectile Dysfunction|erectile dysfunction
5086005|NCT01275404|focus group|focus group
5086006|NCT01275404|Quality of Life|quality of life
5086007|NCT01275404|10-204|10-204
5086008|NCT01275391|Tobacco use|tobacco use
5086009|NCT01275391|Alcohol abuse|alcohol abuse
5086010|NCT01275391|Drug abuse|drug abuse
5086011|NCT01275391|Substance use|substance use
5086012|NCT01275391|Prevention|prevention
5086013|NCT01275391|Brief intervention|brief intervention
5086014|NCT01275391|Screening|screening
5086015|NCT01275391|Adolescents|adolescents
5086016|NCT01275365|Mobility Limitation|mobility limitation
5086017|NCT01275365|Low Protein Intake|low protein intake
5086018|NCT01275365|Older Men|older men
5086019|NCT01275365|Testosterone|testosterone
5086020|NCT01275352|left ventricular hypertrophy|left ventricular hypertrophy
5086021|NCT01275352|heart failure|heart failure
5086022|NCT01275339|Aortic valve stenosis|aortic valve stenosis
5086023|NCT01275339|Tadalafil|tadalafil
5086024|NCT01275339|Phosphodiesterase inhibitors|phosphodiesterase inhibitors
5086025|NCT01275339|Hypertension, pulmonary|hypertension, pulmonary
5086026|NCT01275339|Hypertrophy, left ventricular|hypertrophy, left ventricular
5086027|NCT01275326|Indoor Air Quality|indoor air quality
5086028|NCT01275326|Infectious Aerosols|infectious aerosols
5086029|NCT01275313|Pressure ulcers|pressure ulcers
5086030|NCT01275313|wheelchairs|wheelchairs
5086031|NCT01275313|wheelchair functional capacity|wheelchair functional capacity
5086032|NCT01275313|custom-fitted wheelchair|custom-fitted wheelchair
5086033|NCT01275287|Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis|anti-neutrophil cytoplasmic antibody-associated vasculitis
5086034|NCT01275287|Complement Activation|complement activation
5086035|NCT01275274|ANCA|anca
5086036|NCT01275274|Vasculitis|vasculitis
5086037|NCT01275274|Pauci-immune vasculitis|pauci-immune vasculitis
5086038|NCT01275261|Stroke|stroke
5086039|NCT01275261|Urinary Tract Infection|urinary tract infection
5086040|NCT01275248|OCD|ocd
5086041|NCT01275248|Obsessive Compulsive Disorder|obsessive compulsive disorder
5086042|NCT01275222|GIST|gist
5086043|NCT01275222|everolimus|everolimus
5086044|NCT01275222|mTOR|mtor
5086045|NCT01275222|Imatinib resistant|imatinib resistant
5086046|NCT01275222|Imatinib-refractory/resistant gastrointestinal stromal tumors|imatinib-refractory/resistant gastrointestinal stromal tumors
5086047|NCT01275209|HCD122|hcd122
5086048|NCT01275209|Lucatumumab|lucatumumab
5086049|NCT01275209|CD40|cd40
5086050|NCT01275209|Follicular Lymphoma|follicular lymphoma
5086051|NCT01275209|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
5086052|NCT01275209|Antibody|antibody
5086053|NCT01275196|Newly diagnosed,|newly diagnosed,
5086054|NCT01275196|Ph+ chronic myeloid leukemia,|ph+ chronic myeloid leukemia,
5086055|NCT01275196|CML-CP|cml-cp
5086056|NCT01275183|HNSCC|hnscc
5086057|NCT01275183|SCC|scc
5086058|NCT01275183|head and neck|head and neck
5086059|NCT01275183|squamous cell|squamous cell
5086060|NCT01275183|nasopharyngeal|nasopharyngeal
5086061|NCT01275157|Absorption|absorption
5086062|NCT01275157|Distribution|distribution
5086063|NCT01275157|Metabolism|metabolism
5086064|NCT01275157|Excretion|excretion
5086065|NCT01275157|Mass balance|mass balance
5086066|NCT01275157|Metabolic profile|metabolic profile
5086067|NCT01275157|Radiolabeled study|radiolabeled study
5086068|NCT01275157|14C|14c
5086069|NCT01275131|Insulin analog|insulin analog
5086070|NCT01275131|Type 1 diabetes mellitus|type 1 diabetes mellitus
5086071|NCT01275131|Pharmacokinetic|pharmacokinetic
5086072|NCT01275131|Glucodynamic|glucodynamic
5086073|NCT01275131|Phase 1|phase 1
5086074|NCT01275092|robotic-assisted PCI|robotic-assisted pci
5086075|NCT01275092|coronary intervention|coronary intervention
5086076|NCT01275092|CorPath PRECISE|corpath precise
5086077|NCT01275092|PCI|pci
5086078|NCT01275079|tonsillectomy|tonsillectomy
5086079|NCT01275079|nasalance|nasalance
5086080|NCT01275079|tonsil volume|tonsil volume
5086081|NCT01275079|Thai|thai
5086082|NCT01275079|adult|adult
5086083|NCT01275066|Mucopolysaccharidosis IV type A|mucopolysaccharidosis iv type a
5086084|NCT01275066|MPS IV Type A|mps iv type a
5086085|NCT01275066|Mucopolysaccharidosis IVA|mucopolysaccharidosis iva
5086086|NCT01275066|MPS IVA|mps iva
5086087|NCT01275066|Morquio A Syndrome|morquio a syndrome
5086088|NCT01275066|Lysosomal Storage Disorder|lysosomal storage disorder
5086089|NCT01275066|LSD|lsd
5086090|NCT01275066|N-acetylgalactosamine-6-sulfatase|n-acetylgalactosamine-6-sulfatase
5086091|NCT01275066|N-acetylgalactosamine-6-sulfate sulfatase|n-acetylgalactosamine-6-sulfate sulfatase
5086092|NCT01275066|galactose-6-sulfatase|galactose-6-sulfatase
5086093|NCT01275066|GALNS|galns
5086094|NCT01275066|enzyme replacement therapy|enzyme replacement therapy
5086095|NCT01275066|ERT|ert
5086096|NCT01275053|Leptin|leptin
5086097|NCT01275053|In Vivo|in vivo
5086098|NCT01275053|Diabetic|diabetic
5086099|NCT01275053|Obese|obese
5086100|NCT01275053|Lean|lean
5086101|NCT01275040|diabetes|diabetes
5086102|NCT01275040|mobile screening|mobile screening
5086103|NCT01275040|complications|complications
5086104|NCT01275040|primary care|primary care
5086105|NCT01275040|specialised care|specialised care
5086106|NCT01275040|quality of care|quality of care
5086107|NCT01275027|diabetes|diabetes
5086108|NCT01275027|blood sugar|blood sugar
5086109|NCT01275027|insulin|insulin
5086110|NCT01275027|nutritional supplement|nutritional supplement
5086111|NCT01275027|nutraceutical|nutraceutical
5086112|NCT01275014|TMJ|tmj
5086113|NCT01275014|corticosteroids|corticosteroids
5086114|NCT01275014|osteoarthritis|osteoarthritis
5086115|NCT01275014|arthrocentesis|arthrocentesis
5086116|NCT01275014|pain|pain
5086117|NCT01275001|brain|brain
5086118|NCT01275001|brain development|brain development
5086119|NCT01275001|MRI|mri
5086120|NCT01275001|preschool children|preschool children
5086121|NCT01275001|cortical mantle thickness|cortical mantle thickness
5086122|NCT01275001|hippocampal volume|hippocampal volume
5086123|NCT01274988|Opiate dependence|opiate dependence
5086124|NCT01274988|Deep brain stimulation|deep brain stimulation
5086125|NCT01274988|Nucleus accumbens|nucleus accumbens
5086126|NCT01274949|LI-ESWT|li-eswt
5086127|NCT01274949|Erectile Dysfunction|erectile dysfunction
5086128|NCT01274949|Radical Prostatectomy|radical prostatectomy
5086129|NCT01274949|Non PDE5 inhibitor responders|non pde5 inhibitor responders
5086130|NCT01274949|Shock wave|shock wave
5086131|NCT01274923|Erectile dysfunction|erectile dysfunction
5086132|NCT01274923|Low Intensity Shock Wave|low intensity shock wave
5086133|NCT01274910|Fish Oil|fish oil
5086134|NCT01274910|Knee|knee
5086135|NCT01274910|Analgetics|analgetics
5086136|NCT01274897|Meningococcal|meningococcal
5086137|NCT01274897|ACWY-CRM|acwy-crm
5086138|NCT01274897|Conjugate Vaccine|conjugate vaccine
5086139|NCT01274897|Meningitis|meningitis
5086140|NCT01274897|Adolescents|adolescents
5086141|NCT01274897|Persistence|persistence
5086142|NCT01274897|Adults|adults
5086143|NCT01274884|Acromioclavicular|acromioclavicular
5086144|NCT01274884|Injury|injury
5086145|NCT01274884|Dislocation|dislocation
5086146|NCT01274884|Surgery|surgery
5086147|NCT01274871|Thoracotomy|thoracotomy
5086148|NCT01274871|Chronic Pain|chronic pain
5086149|NCT01274871|persistent post-surgical pain|persistent post-surgical pain
5086150|NCT01274858|persistent pain|persistent pain
5086151|NCT01274858|neuropathic pain|neuropathic pain
5086152|NCT01274858|Thoracotomy|thoracotomy
5086153|NCT01274858|Chronic Pain|chronic pain
5086154|NCT01274845|Meconium aspiration syndrome|meconium aspiration syndrome
5086155|NCT01274845|Heliox|heliox
5086156|NCT01274845|Mechanical ventilation|mechanical ventilation
5086157|NCT01274845|Newborn|newborn
5086158|NCT01274832|Parkinson|parkinson
5086159|NCT01274832|DBS of STN|dbs of stn
5086160|NCT01274832|PD|pd
5086161|NCT01274832|Deep Brain stimulation of STN|deep brain stimulation of stn
5086162|NCT01274832|Early treatment|early treatment
5086163|NCT01274819|delirium|delirium
5086164|NCT01274819|confusion|confusion
5086165|NCT01274806|breast cancer|breast cancer
5086166|NCT01274806|physical therapy|physical therapy
5086167|NCT01274806|massage|massage
5086168|NCT01274806|core stability|core stability
5086169|NCT01274793|functional constipation|functional constipation
5086170|NCT01274793|functional diarrhea|functional diarrhea
5086171|NCT01274793|acupuncture|acupuncture
5086172|NCT01274754|neuroprotection|neuroprotection
5086173|NCT01274754|erythromycin|erythromycin
5086174|NCT01274754|neurocognitive assessment|neurocognitive assessment
5086175|NCT01274741|Posttraumatic stress disorder|posttraumatic stress disorder
5086176|NCT01274741|Substance use disorder|substance use disorder
5086177|NCT01274741|Treatment efficacy|treatment efficacy
5086178|NCT01274741|Randomized trial|randomized trial
5086179|NCT01274728|Acute myocardial infarction|acute myocardial infarction
5086180|NCT01274728|Primary percutaneous coronary intervention|primary percutaneous coronary intervention
5086181|NCT01274728|Drug-eluting balloon|drug-eluting balloon
5086182|NCT01274728|Bivalirudin|bivalirudin
5086183|NCT01274715|Behavioral health coaching|behavioral health coaching
5086184|NCT01274715|Diabetes|diabetes
5086185|NCT01274715|Emotional health|emotional health
5086186|NCT01274702|History of|history of
5086187|NCT01274702|Patients|patients
5086188|NCT01274702|acute|acute
5086189|NCT01274689|lagophthalmos|lagophthalmos
5086190|NCT01274689|parotis tumor|parotis tumor
5086191|NCT01274689|m. orbicularis oculi paresis|m. orbicularis oculi paresis
5086192|NCT01274676|stenting|stenting
5086193|NCT01274676|carotid plaque|carotid plaque
5086194|NCT01274676|stenosis|stenosis
5086195|NCT01274676|angioplasty|angioplasty
5086196|NCT01274663|Single Ascending Dose|single ascending dose
5086197|NCT01274663|Phase 1|phase 1
5086198|NCT01274663|Safety and Tolerability|safety and tolerability
5086199|NCT01274663|PK|pk
5086200|NCT01274663|Healthy Subjects|healthy subjects
5086201|NCT01274637|postpartum|postpartum
5086202|NCT01274637|low molecular weight heparin|low molecular weight heparin
5086203|NCT01274637|venous thromboembolism|venous thromboembolism
5086204|NCT01274637|prophylaxis|prophylaxis
5086205|NCT01274637|Dalteparin Sodium|dalteparin sodium
5086206|NCT01274624|Colorectal|colorectal
5086207|NCT01274624|Cancer|cancer
5086208|NCT01274624|REOLYSIN®|reolysin®
5086209|NCT01274624|Chemotherapy|chemotherapy
5086210|NCT01274624|FOLFIRI|folfiri
5086211|NCT01274624|Reovirus|reovirus
5086212|NCT01274624|Oncolytic virus|oncolytic virus
5086213|NCT01274624|Fluorouracil|fluorouracil
5086214|NCT01274624|Irinotecan|irinotecan
5086215|NCT01274624|Leucovorin|leucovorin
5086216|NCT01274624|Bevacizumab|bevacizumab
5086217|NCT01274611|sweating|sweating
5086218|NCT01274611|sweat|sweat
5086219|NCT01274611|underarm|underarm
5086220|NCT01274611|axillary|axillary
5086221|NCT01274611|hyperhidrosis|hyperhidrosis
5086222|NCT01274611|botox|botox
5086223|NCT01274611|liposuction|liposuction
5086224|NCT01274611|suction-curettage|suction-curettage
5086225|NCT01274611|suction|suction
5086226|NCT01274611|curettage|curettage
5086227|NCT01274598|Probiotics|probiotics
5086228|NCT01274598|Safety|safety
5086229|NCT01274598|Elderly|elderly
5086230|NCT01274598|Lactobacillus|lactobacillus
5086231|NCT01274598|LGG|lgg
5086232|NCT01274559|MK-0524A/ER|mk-0524a/er
5086233|NCT01274559|Hypercholesterolemia|hypercholesterolemia
5086234|NCT01274559|Dyslipidemia|dyslipidemia
5086235|NCT01274559|Niacin|niacin
5086236|NCT01274559|Laropiprant|laropiprant
5086237|NCT01274533|ATLL|atll
5086238|NCT01274520|ECD liver transplant allografts|ecd liver transplant allografts
5086239|NCT01274520|Hypothermic machine perfusion|hypothermic machine perfusion
5086240|NCT01274520|Cold storage preservation|cold storage preservation
5086241|NCT01274520|liver transplant|liver transplant
5086242|NCT01274520|portable bypass system|portable bypass system
5086243|NCT01274520|machine perfusion preservation|machine perfusion preservation
5086244|NCT01274520|extended criteria liver|extended criteria liver
5086245|NCT01274507|Asthma|asthma
5086246|NCT01274507|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
5086247|NCT01274507|Healthy|healthy
5086248|NCT01274507|Longitudinal Study|longitudinal study
5086249|NCT01274507|Bronchoscopy|bronchoscopy
5086250|NCT01274494|Hypertension|hypertension
5086251|NCT01274481|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
5086252|NCT01274481|Acute Lung Injury|acute lung injury
5086253|NCT01274481|pulmonary hypertension|pulmonary hypertension
5086254|NCT01274481|oxygenation|oxygenation
5086255|NCT01274481|lung mechanics|lung mechanics
5086256|NCT01274481|gas exchange|gas exchange
5086257|NCT01274455|Gene therapy|gene therapy
5086258|NCT01274455|pancreatic carcinoma|pancreatic carcinoma
5086259|NCT01274455|gemcitabine|gemcitabine
5086260|NCT01274455|endoscopic ultrasound|endoscopic ultrasound
5086261|NCT01274442|dental implant|dental implant
5086262|NCT01274429|Peanut allergy|peanut allergy
5086263|NCT01274429|Immunotherapy|immunotherapy
5086264|NCT01274429|OIT|oit
5086265|NCT01274416|Anorexia Nervosa|anorexia nervosa
5086266|NCT01274416|Eating Disorder|eating disorder
5086267|NCT01274416|Treatment|treatment
5086268|NCT01274416|Acceptance and Commitment Therapy|acceptance and commitment therapy
5086269|NCT01274416|Separated Family Treatment|separated family treatment
5086270|NCT01274403|Multiple Myeloma|multiple myeloma
5086271|NCT01274403|Elderly patients|elderly patients
5086272|NCT01274390|Cardiac Surgery|cardiac surgery
5086273|NCT01274390|Red Blood Cell|red blood cell
5086274|NCT01274390|Transfusion|transfusion
5086275|NCT01274390|Oxygen Saturation|oxygen saturation
5086276|NCT01274390|Microvascular Flow|microvascular flow
5086277|NCT01274377|nonmyeloablative allogeneic stem cell transplantation|nonmyeloablative allogeneic stem cell transplantation
5086278|NCT01274377|cytomegalovirus|cytomegalovirus
5086279|NCT01274377|donor lymphocyte infusions|donor lymphocyte infusions
5086280|NCT01274377|cytotoxic T lymphocyte|cytotoxic t lymphocyte
5086281|NCT01274364|Diabetes|diabetes
5086282|NCT01274364|Structured Care|structured care
5086283|NCT01274351|First line treatment|first line treatment
5086284|NCT01274351|newly diagnosed|newly diagnosed
5086285|NCT01274351|Philadelphia chromosome positive|philadelphia chromosome positive
5086286|NCT01274351|Chronic Myelogenous Leukemia|chronic myelogenous leukemia
5086287|NCT01274351|Ph+|ph+
5086288|NCT01274351|CML-CP|cml-cp
5086289|NCT01274351|major molecular response|major molecular response
5086290|NCT01274351|Social risk|social risk
5086291|NCT01274325|asthma|asthma
5086292|NCT01274312|Somato-sensory reflex arch|somato-sensory reflex arch
5086293|NCT01274312|Spinal cord injury|spinal cord injury
5086294|NCT01274312|Xiao Procedure|xiao procedure
5086295|NCT01274299|Infants|infants
5086296|NCT01274299|morphometry|morphometry
5086297|NCT01274299|face|face
5086298|NCT01274299|3D|3d
5086299|NCT01274286|hospital accreditation|hospital accreditation
5086300|NCT01274286|patient-centered|patient-centered
5086301|NCT01274286|healthcare quality index|healthcare quality index
5086302|NCT01274286|documentary analysis|documentary analysis
5086303|NCT01274286|meta analysis|meta analysis
5086304|NCT01274273|Bevacizumab|bevacizumab
5086305|NCT01274273|interleukin-2|interleukin-2
5086306|NCT01274273|interferon-alpha|interferon-alpha
5086307|NCT01274260|child|child
5086308|NCT01274260|infant|infant
5086309|NCT01274260|lung injury|lung injury
5086310|NCT01274260|inflammation|inflammation
5086311|NCT01274260|pneumonia|pneumonia
5086312|NCT01274260|ventilator|ventilator
5086313|NCT01274247|Tongue-tie|tongue-tie
5086314|NCT01274247|Ankyloglossia|ankyloglossia
5086315|NCT01274234|EPC capturing sirolimus eluting COMBO stent|epc capturing sirolimus eluting combo stent
5086316|NCT01274234|Optical coherence tomography (OCT)|optical coherence tomography (oct)
5086317|NCT01274234|Early neointimal healing and stent coverage|early neointimal healing and stent coverage
5086318|NCT01274234|Late neointimal thickness, neointimal area, and lumen loss|late neointimal thickness, neointimal area, and lumen loss
5086319|NCT01274208|Gaucher disease, Hepatitis C , Glucocerebroside immunity|gaucher disease, hepatitis c , glucocerebroside immunity
5086320|NCT01274195|Hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
5086321|NCT01274156|Erectile dysfunction|erectile dysfunction
5086422|NCT01273740|PTFE bypass|ptfe bypass
5086322|NCT01274156|Low Intensity Shock Wave|low intensity shock wave
5086323|NCT01274143|Colorectal|colorectal
5086324|NCT01274143|Cancer|cancer
5086325|NCT01274143|Colon|colon
5086326|NCT01274143|Rectal|rectal
5086327|NCT01274143|Behavioral Intervention|behavioral intervention
5086328|NCT01274143|Screening|screening
5086329|NCT01274143|Motivational Interviewing|motivational interviewing
5086330|NCT01274143|Extended Parallel Process Model|extended parallel process model
5086331|NCT01274143|Implementation Intentions|implementation intentions
5086332|NCT01274143|Family CARE|family care
5086333|NCT01274117|Chronic renal failure|chronic renal failure
5086334|NCT01274117|Basilic vein transposition fistula|basilic vein transposition fistula
5086335|NCT01274104|statin-related myalgia|statin-related myalgia
5086336|NCT01274104|high cholesterol|high cholesterol
5086337|NCT01274091|Gene-diet interaction|gene-diet interaction
5086338|NCT01274091|PPARgamma gene|ppargamma gene
5086339|NCT01274091|Pro12Ala|pro12ala
5086340|NCT01274091|Fatty acids|fatty acids
5086341|NCT01274091|Dietary modification|dietary modification
5086342|NCT01274091|Insulin sensitivity|insulin sensitivity
5086343|NCT01274091|Glucose metabolism|glucose metabolism
5086344|NCT01274078|inflammation|inflammation
5086345|NCT01274078|lipids|lipids
5086346|NCT01274078|CRP|crp
5086347|NCT01274065|psychiatry|psychiatry
5086348|NCT01274065|psychiatric illness|psychiatric illness
5086349|NCT01274065|developmental disability|developmental disability
5086350|NCT01274065|mental health|mental health
5086351|NCT01274065|medication burden|medication burden
5086352|NCT01274052|Gestational diabetes mellitus|gestational diabetes mellitus
5086353|NCT01274052|Meal test|meal test
5086354|NCT01274052|Incretin hormones|incretin hormones
5086355|NCT01274052|Glucagon-like peptide-1 (GLP-1)|glucagon-like peptide-1 (glp-1)
5086356|NCT01274052|Glucose-dependent insulinotropic polypeptide|glucose-dependent insulinotropic polypeptide
5086357|NCT01274052|Insulin|insulin
5086358|NCT01274052|C-peptide|c-peptide
5086359|NCT01274052|Glucagon|glucagon
5086360|NCT01274026|phenylketonuria|phenylketonuria
5086361|NCT01274026|PKU|pku
5086362|NCT01274026|phenylalanine|phenylalanine
5086363|NCT01274026|neurotransmitters|neurotransmitters
5086364|NCT01274026|gene|gene
5086365|NCT01274026|Kuvan|kuvan
5086366|NCT01274026|sapropterin|sapropterin
5086367|NCT01274013|Hepatitis C|hepatitis c
5086368|NCT01274013|Chronic Hepatitis C|chronic hepatitis c
5086369|NCT01274013|Vitamin D|vitamin d
5086370|NCT01274013|Vitamin D deficiency|vitamin d deficiency
5086371|NCT01274000|diarrhea|diarrhea
5086372|NCT01274000|IBS|ibs
5086373|NCT01274000|Colonic disease|colonic disease
5086374|NCT01274000|YM060|ym060
5086375|NCT01274000|Ramosetron|ramosetron
5086376|NCT01273974|intradermal influenza vaccine|intradermal influenza vaccine
5086377|NCT01273974|hemodialysis patients|hemodialysis patients
5086378|NCT01273935|Aspirin, Acute Cerebrovascular Ischemia, Platelet Function|aspirin, acute cerebrovascular ischemia, platelet function
5086379|NCT01273922|NDV-3|ndv-3
5086380|NCT01273922|vaccine|vaccine
5086381|NCT01273922|Staphylococcus aureus|staphylococcus aureus
5086382|NCT01273922|MRSA|mrsa
5086383|NCT01273922|Candida|candida
5086384|NCT01273909|Breast Cancer|breast cancer
5086385|NCT01273909|BRACA1/2 Genotype|braca1/2 genotype
5086386|NCT01273909|Acquired Lymphedema|acquired lymphedema
5086387|NCT01273909|Congenital Lymphedema|congenital lymphedema
5086388|NCT01273896|STA-9090|sta-9090
5086389|NCT01273896|advanced breast cancer|advanced breast cancer
5086390|NCT01273896|10-145|10-145
5086391|NCT01273883|hearing|hearing
5086392|NCT01273883|magnesium|magnesium
5086393|NCT01273870|hemodialysis|hemodialysis
5086394|NCT01273870|high-flux-dialyzer|high-flux-dialyzer
5086395|NCT01273870|performance|performance
5086396|NCT01273870|blood compatibility|blood compatibility
5086397|NCT01273857|Cardiac progenitor cells|cardiac progenitor cells
5086398|NCT01273857|Cell therapy|cell therapy
5086399|NCT01273857|Hypoplastic Left Heart Syndrome|hypoplastic left heart syndrome
5086400|NCT01273857|Single Ventricle|single ventricle
5086401|NCT01273857|Norwood|norwood
5086402|NCT01273857|Sano modification|sano modification
5086403|NCT01273857|Glenn|glenn
5086404|NCT01273857|Fontan|fontan
5086405|NCT01273844|hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
5086406|NCT01273844|amyloidosis|amyloidosis
5086407|NCT01273844|Bortezomib|bortezomib
5086408|NCT01273831|intraocular pressure, anesthesia,cisatracurium,atracurium.|intraocular pressure, anesthesia,cisatracurium,atracurium.
5086409|NCT01273818|inguinal hernia|inguinal hernia
5086410|NCT01273818|infection prophylaxis|infection prophylaxis
5086411|NCT01273818|topical gentamicin|topical gentamicin
5086412|NCT01273805|metastatic pancreatic cancer|metastatic pancreatic cancer
5086413|NCT01273805|hydroxychloroquine|hydroxychloroquine
5086414|NCT01273779|sepsis|sepsis
5086415|NCT01273779|talactoferrin|talactoferrin
5086416|NCT01273779|lactoferrin|lactoferrin
5086417|NCT01273779|recombinant human lactoferrin|recombinant human lactoferrin
5086418|NCT01273753|End-stage renal disease|end-stage renal disease
5086419|NCT01273753|Hemodialysis|hemodialysis
5086420|NCT01273753|Bioimpedance analysis|bioimpedance analysis
5086421|NCT01273753|Blood volume monitoring|blood volume monitoring
5086423|NCT01273740|femoro-popliteal|femoro-popliteal
5086424|NCT01273740|femoro-crural|femoro-crural
5086425|NCT01273740|popliteal arteries|popliteal arteries
5086426|NCT01273740|crural arteries|crural arteries
5086427|NCT01273740|external support|external support
5086428|NCT01273740|crtical limb ischemia|crtical limb ischemia
5086429|NCT01273727|epiretinal membrane|epiretinal membrane
5086430|NCT01273727|macular pucker|macular pucker
5086431|NCT01273727|cellophane maculopathy|cellophane maculopathy
5086432|NCT01273727|macular edema|macular edema
5086433|NCT01273727|retinal edema|retinal edema
5086434|NCT01273727|ozurdex|ozurdex
5086435|NCT01273727|dexamethasone|dexamethasone
5086436|NCT01273727|intravitreal implant|intravitreal implant
5086437|NCT01273714|benign thyroid disease|benign thyroid disease
5086438|NCT01273714|incidental thyroid cancer|incidental thyroid cancer
5086439|NCT01273714|recurrent goiter|recurrent goiter
5086440|NCT01273714|revision thyroid surgery|revision thyroid surgery
5086441|NCT01273701|amphetamine|amphetamine
5086442|NCT01273701|methamphetamine|methamphetamine
5086443|NCT01273701|psychosocial intervention|psychosocial intervention
5086444|NCT01273701|contingency management|contingency management
5086445|NCT01273701|slow prosecution|slow prosecution
5086446|NCT01273701|substance use disorder|substance use disorder
5086447|NCT01273688|pain|pain
5086448|NCT01273688|elbow|elbow
5086449|NCT01273688|tendinopathy|tendinopathy
5086450|NCT01273675|Hypertension|hypertension
5086451|NCT01273675|Primary disease|primary disease
5086453|NCT01273649|muscle activation|muscle activation
5086454|NCT01273649|ACL reconstruction|acl reconstruction
5086455|NCT01273649|cryotherapy|cryotherapy
5086456|NCT01273649|TENS|tens
5086457|NCT01273636|Endometrial hyperplasia|endometrial hyperplasia
5086458|NCT01273636|Hysterectomy|hysterectomy
5086459|NCT01273636|Endometrial carcinoma|endometrial carcinoma
5086460|NCT01273623|PAD, Peripheral Arterial Disease, Calcium, Atherectomy, Jetstream|pad, peripheral arterial disease, calcium, atherectomy, jetstream
5086461|NCT01273610|Breast Neoplasms|breast neoplasms
5086462|NCT01273610|HER2 protein, human|her2 protein, human
5086463|NCT01273610|Geriatric Health Services|geriatric health services
5086464|NCT01273610|Antineoplastic Agents, Combined|antineoplastic agents, combined
5086465|NCT01273610|Geriatric Assessment|geriatric assessment
5086466|NCT01273610|Pharmacokinetics|pharmacokinetics
5086467|NCT01273610|Toxicity|toxicity
5086468|NCT01273610|Patient Adherence|patient adherence
5086469|NCT01273597|Parathyroid hormone,Kidney failure, chronic,Hyperparathyroidism, secondary|parathyroid hormone,kidney failure, chronic,hyperparathyroidism, secondary
5086470|NCT01273584|Metformin, obese, pregnancy, gestational diabetes|metformin, obese, pregnancy, gestational diabetes
5086471|NCT01273571|Canagliflozin|canagliflozin
5086472|NCT01273571|Metformin (GLUCOPHAGE IR)|metformin (glucophage ir)
5086473|NCT01273571|Pharmacokinetics|pharmacokinetics
5086474|NCT01273571|Pharmacodynamics|pharmacodynamics
5086475|NCT01273558|Canagliflozin|canagliflozin
5086476|NCT01273558|Renal threshold for glucose|renal threshold for glucose
5086477|NCT01273558|Pharmacodynamics|pharmacodynamics
5086478|NCT01273545|Dapoxetine hydrochloride (PRILIGY)|dapoxetine hydrochloride (priligy)
5086479|NCT01273545|Premature ejaculation|premature ejaculation
5086480|NCT01273532|tapentadol|tapentadol
5086481|NCT01273532|NUCYNTA|nucynta
5086482|NCT01273532|CG5503|cg5503
5086483|NCT01273532|R331333|r331333
5086484|NCT01273532|pharmacokinetics|pharmacokinetics
5086485|NCT01273532|healthy volunteer|healthy volunteer
5086486|NCT01273519|Ankylosing|ankylosing
5086487|NCT01273519|Rheumatoid|rheumatoid
5086488|NCT01273519|Antibodies|antibodies
5086489|NCT01273519|Arthritis|arthritis
5086490|NCT01273519|Pain|pain
5086491|NCT01273519|Antirheumatic Agents|antirheumatic agents
5086492|NCT01273519|Psoriatic|psoriatic
5086493|NCT01273519|Spondylitis|spondylitis
5086494|NCT01273519|Monoclonals|monoclonals
5086495|NCT01273506|tapentadol|tapentadol
5086496|NCT01273506|NUCYNTA|nucynta
5086497|NCT01273506|CG5503|cg5503
5086498|NCT01273506|R331333|r331333
5086499|NCT01273506|pharmacokinetics|pharmacokinetics
5086500|NCT01273506|healthy volunteer|healthy volunteer
5086501|NCT01273493|Trabectedin, YONDELIS|trabectedin, yondelis
5086502|NCT01273493|Antineoplastic Agents|antineoplastic agents
5086503|NCT01273493|Solid tumors|solid tumors
5086504|NCT01273493|Locally advanced or metastatic disease|locally advanced or metastatic disease
5086505|NCT01273493|Chemotherapy|chemotherapy
5086506|NCT01273493|Pharmacokinetics|pharmacokinetics
5086507|NCT01273493|Hepatic Dysfunction|hepatic dysfunction
5086508|NCT01273480|Trabectedin, YONDELIS|trabectedin, yondelis
5086509|NCT01273480|Rifampin (RIFADIN)|rifampin (rifadin)
5086510|NCT01273480|Antineoplastic Agents|antineoplastic agents
5086511|NCT01273480|Solid tumors|solid tumors
5086512|NCT01273480|Locally advanced or metastatic disease|locally advanced or metastatic disease
5086513|NCT01273480|Chemotherapy|chemotherapy
5086514|NCT01273480|Pharmacokinetics|pharmacokinetics
5086515|NCT01273467|Ischemic Cerebral Infarction|ischemic cerebral infarction
5086516|NCT01273467|Stroke|stroke
5086517|NCT01273467|CNTO0007|cnto0007
5086518|NCT01273467|42037788|42037788
5086519|NCT01273454|Open-label|open-label
5086520|NCT01273454|Non-interventional|non-interventional
5086521|NCT01273454|OROS hydromorphone|oros hydromorphone
5086522|NCT01273454|Korean cancer patients|korean cancer patients
5086523|NCT01273415|hormone receptor-positive breast cancer|hormone receptor-positive breast cancer
5086524|NCT01273415|nomogram|nomogram
5086525|NCT01273415|Ki67|ki67
5086526|NCT01273415|Effects of Chemotherapy|effects of chemotherapy
5086527|NCT01273402|colorectal cancer|colorectal cancer
5086528|NCT01273402|TF2 (Recombinant, humanized Tri-Fab bsMAb composed of 2 humanized MN-14 anti-CEA Fab x and one 679 anti-HSG Fab)|tf2 (recombinant, humanized tri-fab bsmab composed of 2 humanized mn-14 anti-cea fab x and one 679 anti-hsg fab)
5086529|NCT01273402|IMP288 (DOTA-di-HSG hapten-peptide for 111In/90Y labeling)|imp288 (dota-di-hsg hapten-peptide for 111in/90y labeling)
5086530|NCT01273389|Lupus nephritis|lupus nephritis
5086531|NCT01273389|CNTO 136|cnto 136
5086532|NCT01273389|Sirukumab|sirukumab
5086533|NCT01273389|Kidney diseases|kidney diseases
5086534|NCT01273389|Proteinuria|proteinuria
5086535|NCT01273389|Glomerulonephritis|glomerulonephritis
5086536|NCT01273376|MDD|mdd
5086537|NCT01273376|Depression|depression
5086538|NCT01273376|Major Depression|major depression
5086539|NCT01273363|Asthma|asthma
5086540|NCT01273363|Asthma in Children|asthma in children
5086541|NCT01273350|internal carotid artery|internal carotid artery
5086542|NCT01273350|common carotid artery|common carotid artery
5086543|NCT01273350|bruit|bruit
5086544|NCT01273350|tia|tia
5086545|NCT01273337|Stroke|stroke
5086546|NCT01273337|Ischemia|ischemia
5086547|NCT01273337|Ischemic Stroke|ischemic stroke
5086548|NCT01273337|Middle Cerebral Artery|middle cerebral artery
5086549|NCT01273337|MCA|mca
5086550|NCT01273337|Stem Cells|stem cells
5086551|NCT01273337|Stem Cell|stem cell
5086552|NCT01273337|Autologous Bone Marrow|autologous bone marrow
5086553|NCT01273337|Ipsilateral MCA|ipsilateral mca
5086554|NCT01273324|Osteoarthritis|osteoarthritis
5086555|NCT01273311|Brain Aging|brain aging
5086556|NCT01273311|Diabetes|diabetes
5086557|NCT01273311|Aging|aging
5086558|NCT01273311|Obesity|obesity
5086559|NCT01273311|CARDIA|cardia
5086560|NCT01273298|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
5086561|NCT01273298|exercise|exercise
5086562|NCT01273298|dynamic hyperinflation|dynamic hyperinflation
5086563|NCT01273298|cardioselective beta blockers|cardioselective beta blockers
5086564|NCT01273272|Cognitive Behavior Therapy|cognitive behavior therapy
5086565|NCT01273272|Early dementia, Alzheimer type|early dementia, alzheimer type
5086566|NCT01273259|Hypertension, pulmonary|hypertension, pulmonary
5086567|NCT01273259|DHEA|dhea
5086568|NCT01273259|six-minute walk test|six-minute walk test
5086569|NCT01273259|pulmonary arterial pressure|pulmonary arterial pressure
5086570|NCT01273220|Epidemiology|epidemiology
5086571|NCT01273220|Epidemiologic Survey|epidemiologic survey
5086572|NCT01273220|Alcohol|alcohol
5086573|NCT01273207|Peripheral Blood Stem Cell Transplant|peripheral blood stem cell transplant
5086574|NCT01273207|Inhaled Cyclosporine|inhaled cyclosporine
5086575|NCT01273207|Graft-Versus-Host Disease|graft-versus-host disease
5086576|NCT01273207|Bronchiolitis Obliterans|bronchiolitis obliterans
5086577|NCT01273207|Graft Versus Host Disease|graft versus host disease
5086578|NCT01273194|Palliative Care|palliative care
5086579|NCT01273194|Survey|survey
5086580|NCT01273194|Quality of Life|quality of life
5086581|NCT01273194|Attitudes|attitudes
5086582|NCT01273194|Pediatric Cancer|pediatric cancer
5086583|NCT01273181|Immunotherapy|immunotherapy
5086584|NCT01273181|Gene Therapy|gene therapy
5086585|NCT01273181|Metastatic Cancer|metastatic cancer
5086586|NCT01273181|Clinical Response|clinical response
5086587|NCT01273181|Metastatic Melanoma|metastatic melanoma
5086588|NCT01273181|Metastatic Renal Cell Cancer|metastatic renal cell cancer
5086589|NCT01273168|Pharmacokinetics|pharmacokinetics
5086590|NCT01273168|Advanced Cancer|advanced cancer
5086591|NCT01273168|Cytochrome P 450|cytochrome p 450
5086592|NCT01273168|Selective Estrogen Receptor Modulator|selective estrogen receptor modulator
5086593|NCT01273168|Tamoxifen Metabolite|tamoxifen metabolite
5086594|NCT01273168|Gynecologic Cancer|gynecologic cancer
5086595|NCT01273168|Breast Cancer|breast cancer
5086596|NCT01273168|Desmoid Tumor|desmoid tumor
5086597|NCT01273168|Endometrial Cancer|endometrial cancer
5086598|NCT01273168|Ovarian Cancer|ovarian cancer
5086599|NCT01273168|Uterine Cancer|uterine cancer
5086600|NCT01273168|Fallopian Tube Cancer|fallopian tube cancer
5086601|NCT01273168|Peritoneal Cancer|peritoneal cancer
5086602|NCT01273155|Histone Deacetylase Inhibitor|histone deacetylase inhibitor
5086603|NCT01273155|Liver Dysfunction|liver dysfunction
5086604|NCT01273155|Pharmacokinetics|pharmacokinetics
5086605|NCT01273155|UGT1A1 Polymorphisms|ugt1a1 polymorphisms
5086606|NCT01273155|Solid Tumor|solid tumor
5086607|NCT01273155|Cancer|cancer
5086608|NCT01273155|Lymphoma|lymphoma
5086609|NCT01273142|Human Immunodeficiency Virus, liver toxicity, hapatitis co-infection|human immunodeficiency virus, liver toxicity, hapatitis co-infection
5086610|NCT01273129|Neurosurgery|neurosurgery
5086611|NCT01273129|Childhood Epilepsy|childhood epilepsy
5086612|NCT01273129|Epilepsy|epilepsy
5086613|NCT01273129|Frontal Lobe Epilepsy|frontal lobe epilepsy
5086614|NCT01273129|Temporal Lobe Epilepsy|temporal lobe epilepsy
5086615|NCT01273116|frailty|frailty
5086616|NCT01273116|integrated care|integrated care
5086617|NCT01273116|hospital|hospital
5086618|NCT01273116|geriatrics|geriatrics
5086619|NCT01273116|hospital-wide intervention|hospital-wide intervention
5086620|NCT01273090|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
5086621|NCT01273090|recurrent childhood anaplastic large cell lymphoma|recurrent childhood anaplastic large cell lymphoma
5086723|NCT01272752|weight management|weight management
5086622|NCT01273090|recurrent childhood grade III lymphomatoid granulomatosis|recurrent childhood grade iii lymphomatoid granulomatosis
5086623|NCT01273090|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
5086624|NCT01273090|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
5086625|NCT01273090|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
5086626|NCT01273090|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
5086627|NCT01273090|recurrent childhood brain stem glioma|recurrent childhood brain stem glioma
5086628|NCT01273090|recurrent childhood anaplastic astrocytoma|recurrent childhood anaplastic astrocytoma
5086629|NCT01273090|recurrent childhood anaplastic oligoastrocytoma|recurrent childhood anaplastic oligoastrocytoma
5086630|NCT01273090|recurrent childhood anaplastic oligodendroglioma|recurrent childhood anaplastic oligodendroglioma
5086631|NCT01273090|recurrent childhood cerebellar astrocytoma|recurrent childhood cerebellar astrocytoma
5086632|NCT01273090|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
5086633|NCT01273090|recurrent childhood diffuse astrocytoma|recurrent childhood diffuse astrocytoma
5086634|NCT01273090|recurrent childhood fibrillary astrocytoma|recurrent childhood fibrillary astrocytoma
5086635|NCT01273090|recurrent childhood gemistocytic astrocytoma|recurrent childhood gemistocytic astrocytoma
5086636|NCT01273090|recurrent childhood giant cell glioblastoma|recurrent childhood giant cell glioblastoma
5086637|NCT01273090|recurrent childhood glioblastoma|recurrent childhood glioblastoma
5086638|NCT01273090|recurrent childhood gliomatosis cerebri|recurrent childhood gliomatosis cerebri
5086639|NCT01273090|recurrent childhood gliosarcoma|recurrent childhood gliosarcoma
5086640|NCT01273090|recurrent childhood oligoastrocytoma|recurrent childhood oligoastrocytoma
5086641|NCT01273090|recurrent childhood oligodendroglioma|recurrent childhood oligodendroglioma
5086642|NCT01273090|recurrent childhood pilocytic astrocytoma|recurrent childhood pilocytic astrocytoma
5086643|NCT01273090|recurrent childhood pilomyxoid astrocytoma|recurrent childhood pilomyxoid astrocytoma
5086644|NCT01273090|recurrent childhood pleomorphic xanthoastrocytoma|recurrent childhood pleomorphic xanthoastrocytoma
5086645|NCT01273090|recurrent childhood protoplasmic astrocytoma|recurrent childhood protoplasmic astrocytoma
5086646|NCT01273090|recurrent childhood subependymal giant cell astrocytoma|recurrent childhood subependymal giant cell astrocytoma
5086647|NCT01273090|recurrent childhood visual pathway and hypothalamic glioma|recurrent childhood visual pathway and hypothalamic glioma
5086648|NCT01273090|recurrent childhood visual pathway glioma|recurrent childhood visual pathway glioma
5086649|NCT01273090|childhood pineal parenchymal tumor|childhood pineal parenchymal tumor
5086650|NCT01273090|recurrent childhood central nervous system embryonal tumor|recurrent childhood central nervous system embryonal tumor
5086651|NCT01273090|childhood central nervous system choriocarcinoma|childhood central nervous system choriocarcinoma
5086652|NCT01273090|childhood central nervous system germ cell tumor|childhood central nervous system germ cell tumor
5086653|NCT01273090|childhood central nervous system germinoma|childhood central nervous system germinoma
5086654|NCT01273090|childhood central nervous system mixed germ cell tumor|childhood central nervous system mixed germ cell tumor
5086655|NCT01273090|childhood central nervous system teratoma|childhood central nervous system teratoma
5086656|NCT01273090|childhood central nervous system yolk sac tumor|childhood central nervous system yolk sac tumor
5086657|NCT01273090|recurrent childhood pineoblastoma|recurrent childhood pineoblastoma
5086658|NCT01273090|childhood diffuse large cell lymphoma|childhood diffuse large cell lymphoma
5086659|NCT01273090|childhood nasal type extranodal NK/T-cell lymphoma|childhood nasal type extranodal nk/t-cell lymphoma
5086660|NCT01273090|childhood nodular lymphocyte predominant Hodgkin lymphoma|childhood nodular lymphocyte predominant hodgkin lymphoma
5086661|NCT01273090|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
5086662|NCT01273090|childhood Burkitt lymphoma|childhood burkitt lymphoma
5086663|NCT01273090|childhood grade III lymphomatoid granulomatosis|childhood grade iii lymphomatoid granulomatosis
5086664|NCT01273090|childhood immunoblastic large cell lymphoma|childhood immunoblastic large cell lymphoma
5086665|NCT01273090|cutaneous B-cell non-Hodgkin lymphoma|cutaneous b-cell non-hodgkin lymphoma
5086666|NCT01273090|hepatosplenic T-cell lymphoma|hepatosplenic t-cell lymphoma
5086667|NCT01273090|intraocular lymphoma|intraocular lymphoma
5086668|NCT01273090|noncutaneous extranodal lymphoma|noncutaneous extranodal lymphoma
5086669|NCT01273090|peripheral T-cell lymphoma|peripheral t-cell lymphoma
5086670|NCT01273090|post-transplant lymphoproliferative disorder|post-transplant lymphoproliferative disorder
5086671|NCT01273090|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5086672|NCT01273090|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5086673|NCT01273090|small intestine lymphoma|small intestine lymphoma
5086674|NCT01273077|Rotavirus|rotavirus
5086675|NCT01273077|Rotarix|rotarix
5086677|NCT01273064|Null Responders|null responders
5086678|NCT01273051|Rectal Cancer|rectal cancer
5086679|NCT01273051|Radiochemotherapy|radiochemotherapy
5086680|NCT01273051|TEM|tem
5086681|NCT01273051|Organ preservation|organ preservation
5086682|NCT01273025|pharmacokinetic|pharmacokinetic
5086683|NCT01273025|lime powder regimen|lime powder regimen
5086684|NCT01273025|kidney stone|kidney stone
5086685|NCT01273025|Oxidative stress|oxidative stress
5086686|NCT01273012|probiotic|probiotic
5086687|NCT01273012|cost-effectiveness|cost-effectiveness
5086688|NCT01273012|diarrhea|diarrhea
5086689|NCT01273012|children|children
5086690|NCT01273012|Sum of the monetary cost of the hospitalization|sum of the monetary cost of the hospitalization
5086691|NCT01272999|Acute otitis media|acute otitis media
5086692|NCT01272999|Prevnar 13|prevnar 13
5086693|NCT01272999|Streptococcus pneumoniae|streptococcus pneumoniae
5086694|NCT01272986|Determination of the level of oxidised LDL by measuring the level of IgG in Blood|determination of the level of oxidised ldl by measuring the level of igg in blood
5086695|NCT01272960|Contraception|contraception
5086696|NCT01272960|Postnatal care|postnatal care
5086697|NCT01272947|Blunt soft tissue injury/contusion|blunt soft tissue injury/contusion
5086698|NCT01272934|Ankle Sprain, soft tissue injury|ankle sprain, soft tissue injury
5086699|NCT01272895|OCT images|oct images
5086700|NCT01272895|Stent strut coverage|stent strut coverage
5086701|NCT01272895|Endothelialization|endothelialization
5086702|NCT01272895|Neointimal thickness, area and hyperplasia|neointimal thickness, area and hyperplasia
5086703|NCT01272895|Stent malapposition|stent malapposition
5086704|NCT01272830|total joint arthroplasty|total joint arthroplasty
5086705|NCT01272830|synovitis|synovitis
5086706|NCT01272830|ALVAL (Aseptic Lymphocyte-Dominant Vasculitis-Associated Lesion)|alval (aseptic lymphocyte-dominant vasculitis-associated lesion)
5086707|NCT01272830|osteolysis|osteolysis
5086708|NCT01272830|periprosthetic metallosis|periprosthetic metallosis
5086709|NCT01272817|Nonmyeloablative transplant|nonmyeloablative transplant
5086710|NCT01272817|Allogeneic transplant|allogeneic transplant
5086711|NCT01272817|Transplant|transplant
5086712|NCT01272804|Pharmacokinetics PK Pharmacodynamics PD T2DM Phase 1 Type 2 diabetes mellitus safety and tolerability|pharmacokinetics pk pharmacodynamics pd t2dm phase 1 type 2 diabetes mellitus safety and tolerability
5086713|NCT01272791|metastatic stage IV pancreatic cancer|metastatic stage iv pancreatic cancer
5086714|NCT01272765|obesity|obesity
5086715|NCT01272765|weight loss|weight loss
5086716|NCT01272765|weight management|weight management
5086717|NCT01272765|anti-psychotic medication|anti-psychotic medication
5086718|NCT01272765|Zyprexa|zyprexa
5086719|NCT01272765|Seroquel|seroquel
5086720|NCT01272765|Risperdal|risperdal
5086721|NCT01272752|obesity|obesity
5086722|NCT01272752|weight loss|weight loss
5086724|NCT01272752|anti-psychotic medication|anti-psychotic medication
5086725|NCT01272752|nutriceutical|nutriceutical
5086726|NCT01272739|obesity|obesity
5086727|NCT01272739|weight loss|weight loss
5086728|NCT01272739|weight management|weight management
5086729|NCT01272739|overweight|overweight
5086730|NCT01272739|nutriceutical|nutriceutical
5086731|NCT01272687|Parkinson Disease|parkinson disease
5086732|NCT01272687|Parkinsonian Disorders|parkinsonian disorders
5086733|NCT01272687|Brain Diseases|brain diseases
5086734|NCT01272687|Central Nervous System Diseases|central nervous system diseases
5086735|NCT01272687|Nervous System Diseases|nervous system diseases
5086736|NCT01272687|Neurodegenerative Diseases|neurodegenerative diseases
5086737|NCT01272661|breastfeeding|breastfeeding
5086738|NCT01272661|low-income|low-income
5086739|NCT01272661|high-risk|high-risk
5086740|NCT01272661|African-American|african-american
5086741|NCT01272661|health disparity|health disparity
5086742|NCT01272648|Rehabilitation|rehabilitation
5086743|NCT01272648|Coping|coping
5086744|NCT01272648|Prostate cancer|prostate cancer
5086745|NCT01272648|Nursing|nursing
5086746|NCT01272648|Physiotherapy|physiotherapy
5086747|NCT01272648|Pelvic floor exercises|pelvic floor exercises
5086748|NCT01272648|Motivational Interviewing|motivational interviewing
5086749|NCT01272635|Asthma|asthma
5086750|NCT01272635|Wheezing|wheezing
5086751|NCT01272635|Respiratory Tract Illness|respiratory tract illness
5086752|NCT01272635|Azythromycin|azythromycin
5086753|NCT01272635|Prednisolone|prednisolone
5086754|NCT01272635|Preschool-age|preschool-age
5086755|NCT01272622|Quality of life|quality of life
5086756|NCT01272622|Endocrinology|endocrinology
5086757|NCT01272622|Oncology|oncology
5086758|NCT01272622|Hypothalamus|hypothalamus
5086759|NCT01272622|Irradiation|irradiation
5086760|NCT01272622|Neurosurgery|neurosurgery
5086761|NCT01272622|Pediatric Brain tumors|pediatric brain tumors
5086762|NCT01272622|Randomized trial|randomized trial
5086763|NCT01272596|Multiple Sclerosis|multiple sclerosis
5086764|NCT01272596|Visual Contrast Acuity|visual contrast acuity
5086765|NCT01272596|Visual Contrast Sensitivity|visual contrast sensitivity
5086766|NCT01272596|Sloan Charts|sloan charts
5086767|NCT01272583|Type 1 diabetes|type 1 diabetes
5086768|NCT01272583|DPP-4 inhibitor|dpp-4 inhibitor
5086769|NCT01272583|Glucagon|glucagon
5086770|NCT01272570|breast|breast
5086771|NCT01272570|oral|oral
5086772|NCT01272570|cancer|cancer
5086773|NCT01272557|HCC|hcc
5086774|NCT01272544|Dental caries|dental caries
5086775|NCT01272544|Epidemiology|epidemiology
5086776|NCT01272544|Gingivitis|gingivitis
5086777|NCT01272544|Oral health|oral health
5086778|NCT01272531|pharmacogenetics|pharmacogenetics
5086779|NCT01272531|bipolar disorders|bipolar disorders
5086780|NCT01272531|affective disorders|affective disorders
5086781|NCT01272531|mood disorders|mood disorders
5086782|NCT01272531|pharmacologic actions|pharmacologic actions
5086783|NCT01272531|psychotropic drugs|psychotropic drugs
5086784|NCT01272531|antimanic agents|antimanic agents
5086785|NCT01272531|antidepressant agents|antidepressant agents
5086786|NCT01272531|lithium|lithium
5086787|NCT01272531|lithium carbonate|lithium carbonate
5086788|NCT01272531|Lithobid|lithobid
5086789|NCT01272531|Eskalith|eskalith
5086790|NCT01272531|divalproex|divalproex
5086791|NCT01272531|divalproex sodium|divalproex sodium
5086792|NCT01272531|Depakote|depakote
5086793|NCT01272531|valproate|valproate
5086794|NCT01272518|chaos theory heart rate variability mania bipolar disorder|chaos theory heart rate variability mania bipolar disorder
5086795|NCT01272479|hemodialysis|hemodialysis
5086796|NCT01272479|hepatitis C|hepatitis c
5086797|NCT01272479|inflammation|inflammation
5086798|NCT01272479|iron stores|iron stores
5086799|NCT01272479|prohepcidin|prohepcidin
5086800|NCT01272466|multiple myeloma|multiple myeloma
5086801|NCT01272466|vaccination|vaccination
5086802|NCT01272466|antiapoptotic proteins|antiapoptotic proteins
5086803|NCT01272466|proteasome inhibition|proteasome inhibition
5086804|NCT01272453|coronary artery disease|coronary artery disease
5086805|NCT01272453|CT scan|ct scan
5086806|NCT01272453|coronary angiography|coronary angiography
5086807|NCT01272453|chest pain|chest pain
5086808|NCT01272453|aortic aneurysm|aortic aneurysm
5086809|NCT01272453|pulmonary embolism|pulmonary embolism
5086810|NCT01272440|PEG-asparaginase|peg-asparaginase
5086811|NCT01272440|children|children
5086812|NCT01272440|pharmacokinetics|pharmacokinetics
5086813|NCT01272440|antibodies|antibodies
5086814|NCT01272440|acute lymphoblastic leukaemia|acute lymphoblastic leukaemia
5086815|NCT01272440|adverse effects|adverse effects
5086816|NCT01272414|Eyelid retraction|eyelid retraction
5086817|NCT01272414|Botulinum Toxins|botulinum toxins
5086818|NCT01272388|Aortic valve stenosis|aortic valve stenosis
5086819|NCT01272388|Tadalafil|tadalafil
5086820|NCT01272388|Phosphodiesterase inhibitors|phosphodiesterase inhibitors
5086821|NCT01272388|Hypertension, pulmonary|hypertension, pulmonary
5086822|NCT01272388|Hypertrophy, left ventricular|hypertrophy, left ventricular
5086823|NCT01272362|Indacaterol|indacaterol
5086824|NCT01272362|COPD|copd
5086825|NCT01272362|LABA|laba
5086826|NCT01272362|Reversibility|reversibility
5086827|NCT01272349|spinal cord injury|spinal cord injury
5086828|NCT01272349|walking|walking
5086829|NCT01272349|low oxygen|low oxygen
5086830|NCT01272349|air|air
5086831|NCT01272349|strength|strength
5086832|NCT01272336|spinal cord injury, low oxygen, strength, motor control|spinal cord injury, low oxygen, strength, motor control
5086833|NCT01272323|Cat allergy|cat allergy
5086834|NCT01272323|Rhinoconjunctivitis|rhinoconjunctivitis
5086835|NCT01272310|Chronic Hepatitis C|chronic hepatitis c
5086836|NCT01272310|Combination Therapy|combination therapy
5086837|NCT01272310|Hydroxychloroquine|hydroxychloroquine
5086838|NCT01272310|Pegylated Interferon Alpha-2a|pegylated interferon alpha-2a
5086839|NCT01272310|Ribavirin|ribavirin
5086840|NCT01272310|Chronic Hepatitis C Genotype 1 infected adult subjects|chronic hepatitis c genotype 1 infected adult subjects
5086841|NCT01272297|LI-ESWT|li-eswt
5086842|NCT01272297|Erectile Dysfunction|erectile dysfunction
5086843|NCT01272297|Non PDE5 inhibitor responders|non pde5 inhibitor responders
5086844|NCT01272297|Shock wave|shock wave
5086845|NCT01272284|Female|female
5086846|NCT01272284|Stress urinary incontinence|stress urinary incontinence
5086847|NCT01272284|Mini sling|mini sling
5086848|NCT01272284|Single incision sling|single incision sling
5086849|NCT01272284|Urinary incontinence|urinary incontinence
5086850|NCT01272284|Mixed urinary incontinence|mixed urinary incontinence
5086851|NCT01272284|Additional relevant MeSH terms:|additional relevant mesh terms:
5086852|NCT01272284|Stress|stress
5086853|NCT01272284|Urinary Incontinence, Stress|urinary incontinence, stress
5086854|NCT01272284|Pathological Processes|pathological processes
5086855|NCT01272284|Urination Disorders|urination disorders
5086856|NCT01272284|Urological Disorders|urological disorders
5086857|NCT01272284|Urological Manifestations|urological manifestations
5086858|NCT01272284|Signs and Symptoms|signs and symptoms
5086859|NCT01272271|Contact lens|contact lens
5086860|NCT01272271|Infection|infection
5086861|NCT01272271|Cornea|cornea
5086862|NCT01272245|Acute Myelogenous Leukemia|acute myelogenous leukemia
5086863|NCT01272245|AML|aml
5086864|NCT01272245|High-Risk Myelodysplastic Syndrome|high-risk myelodysplastic syndrome
5086865|NCT01272245|MDS|mds
5086866|NCT01272245|Omacetaxine|omacetaxine
5086867|NCT01272245|Cytarabine|cytarabine
5086868|NCT01272245|ARA-C|ara-c
5086869|NCT01272245|Cytosar|cytosar
5086870|NCT01272245|DepoCyt|depocyt
5086871|NCT01272245|Cytosine Arabinosine Hydrochloride|cytosine arabinosine hydrochloride
5086872|NCT01272180|Safety|safety
5086873|NCT01272180|Immunogenicity|immunogenicity
5086874|NCT01272180|Vaccine|vaccine
5086875|NCT01272180|Meningococcal|meningococcal
5086876|NCT01272180|Seroresponse|seroresponse
5086877|NCT01272167|Post-menopausal women|post-menopausal women
5086878|NCT01272167|Grapefruit juice|grapefruit juice
5086879|NCT01272167|Naringin|naringin
5086880|NCT01272167|Vascular protection|vascular protection
5086881|NCT01272167|Bone metabolism|bone metabolism
5086882|NCT01272154|Cerebellum|cerebellum
5086883|NCT01272154|Cortical plasticity|cortical plasticity
5086884|NCT01272154|Sensorimotor adaptation|sensorimotor adaptation
5086885|NCT01272154|Dystonia|dystonia
5086886|NCT01272154|Cerebral Palsy|cerebral palsy
5086887|NCT01272154|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
5086888|NCT01272154|and|and
5086889|NCT01272141|Metastatic breast cancer|metastatic breast cancer
5086890|NCT01272141|Triple negative breast cancer|triple negative breast cancer
5086891|NCT01272141|Estrogen receptor (ER)/progesterone receptor (PR)/human epidermal growth factor receptor 2 (HER2)-negative breast cancer|estrogen receptor (er)/progesterone receptor (pr)/human epidermal growth factor receptor 2 (her2)-negative breast cancer
5086892|NCT01272115|Climacteric stage|climacteric stage
5086893|NCT01272115|Integrative health care model|integrative health care model
5086894|NCT01272115|Empowerment approach|empowerment approach
5086895|NCT01272115|Primary care services|primary care services
5086896|NCT01272076|Age Related Macular Degeneration|age related macular degeneration
5086897|NCT01272076|Geographic Atrophy|geographic atrophy
5086898|NCT01272076|Imaging|imaging
5086899|NCT01272076|OCT|oct
5086900|NCT01272063|Drusen|drusen
5086901|NCT01272063|Dry AMD|dry amd
5086902|NCT01272063|OCT|oct
5086903|NCT01272063|Imaging|imaging
5086904|NCT01272050|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5086905|NCT01272050|recurrent prostate cancer|recurrent prostate cancer
5086906|NCT01272050|stage IIA prostate cancer|stage iia prostate cancer
5086907|NCT01272050|stage IIB prostate cancer|stage iib prostate cancer
5086908|NCT01272050|stage III prostate cancer|stage iii prostate cancer
5086909|NCT01272024|clinical trial|clinical trial
5086910|NCT01272024|symptom education|symptom education
5086911|NCT01272024|advanced cancer|advanced cancer
5086912|NCT01272011|Respiration|respiration
5086913|NCT01272011|Spinal cord injuries|spinal cord injuries
5086914|NCT01272011|Walking recovery|walking recovery
5086915|NCT01271998|antibiotic|antibiotic
5086916|NCT01271998|healthy subjects|healthy subjects
5086917|NCT01271998|pharmacokinetics|pharmacokinetics
5086918|NCT01271985|Cardiovascular Diseases|cardiovascular diseases
5086919|NCT01271985|Drug Combinations|drug combinations
5086920|NCT01271985|prevention and control|prevention and control
5086921|NCT01271985|Aspirin|aspirin
5086922|NCT01271985|Antihypertensive Agents|antihypertensive agents
5086923|NCT01271985|Antilipemic Agents|antilipemic agents
5086924|NCT01271959|Ovarian|ovarian
5086925|NCT01271959|Fallopian Tube|fallopian tube
5086926|NCT01271959|Peritoneal|peritoneal
5086927|NCT01271959|Uterine Neoplasms|uterine neoplasms
5086928|NCT01271959|Vulva|vulva
5086929|NCT01271959|Endometrial|endometrial
5086930|NCT01271959|Cervical|cervical
5086931|NCT01271959|Lung|lung
5086932|NCT01271959|Carcinoid|carcinoid
5086933|NCT01271959|Sarcoma|sarcoma
5086934|NCT01271959|Mesothelioma|mesothelioma
5086935|NCT01271959|Adenocarcinoma|adenocarcinoma
5086936|NCT01271959|Colorectal|colorectal
5086937|NCT01271959|Breast|breast
5086938|NCT01271959|Assay|assay
5086939|NCT01271959|Chemotherapy|chemotherapy
5086940|NCT01271959|Recurrent|recurrent
5086941|NCT01271959|Refractory|refractory
5086942|NCT01271959|Persistent|persistent
5086943|NCT01271959|Chemoresponse|chemoresponse
5086944|NCT01271933|fibromyalgia|fibromyalgia
5086945|NCT01271933|pain|pain
5086946|NCT01271933|pregabalin|pregabalin
5086947|NCT01271933|Lyrica|lyrica
5086948|NCT01271920|Trastuzumab-refractory|trastuzumab-refractory
5086949|NCT01271920|advanced HER2-positive breast cancer,|advanced her2-positive breast cancer,
5086950|NCT01271920|Hsp90,|hsp90,
5086951|NCT01271920|2nd or 3rd line treatment|2nd or 3rd line treatment
5086952|NCT01271907|Skin Cancer|skin cancer
5086953|NCT01271907|Malignancy|malignancy
5086954|NCT01271907|Immunotherapy|immunotherapy
5086955|NCT01271907|Melanoma Peptides|melanoma peptides
5086956|NCT01271907|Melanoma|melanoma
5086957|NCT01271907|Metastatic Melanoma|metastatic melanoma
5086958|NCT01271894|HIV|hiv
5086959|NCT01271894|efavirenz|efavirenz
5086960|NCT01271894|pharmacokinetic|pharmacokinetic
5086961|NCT01271881|Hemodialysis|hemodialysis
5086962|NCT01271881|Fistula|fistula
5086963|NCT01271881|Angiograph|angiograph
5086964|NCT01271881|Angiogram|angiogram
5086965|NCT01271881|Adult patients who are currently receiving hemodialysis treatment via an AV vascular graft or fistula located in the upper extremity|adult patients who are currently receiving hemodialysis treatment via an av vascular graft or fistula located in the upper extremity
5086966|NCT01271868|Recombinant Factor IX|recombinant factor ix
5086967|NCT01271855|Belladonna|belladonna
5086968|NCT01271855|Opium|opium
5086969|NCT01271855|Suppository|suppository
5086970|NCT01271829|Avocados|avocados
5086971|NCT01271829|Satiety|satiety
5086972|NCT01271829|Feeding study|feeding study
5086973|NCT01271816|genetics|genetics
5086974|NCT01271816|sudden death|sudden death
5086975|NCT01271816|monitoring|monitoring
5086976|NCT01271816|loop recorder|loop recorder
5086977|NCT01271816|cardiomyopathy|cardiomyopathy
5086978|NCT01271790|Hepatitis C|hepatitis c
5086980|NCT01271790|Rapid Virologic Response|rapid virologic response
5086981|NCT01271790|Sustained Virologic Response|sustained virologic response
5086982|NCT01271790|Direct Acting Antiviral|direct acting antiviral
5086983|NCT01271790|Combination Therapy|combination therapy
5086984|NCT01271790|HCV RNA|hcv rna
5086985|NCT01271790|Polymerase inhibitor|polymerase inhibitor
5086986|NCT01271790|Protease inhibitor|protease inhibitor
5086987|NCT01271790|Treatment naïve|treatment naïve
5086988|NCT01271790|GS-9190|gs-9190
5086989|NCT01271790|GS-9451|gs-9451
5086990|NCT01271777|Pre-diabetes|pre-diabetes
5086991|NCT01271777|Clamp technique|clamp technique
5086992|NCT01271777|PPARs|ppars
5086993|NCT01271777|Insulin resistance|insulin resistance
5086994|NCT01271751|Atherogenic-dyslipidaemia|atherogenic-dyslipidaemia
5086995|NCT01271751|PPARs|ppars
5086996|NCT01271738|Breast Cancer|breast cancer
5086997|NCT01271738|Tumors or cancer of the human breast|tumors or cancer of the human breast
5086998|NCT01271738|Breast Tumors|breast tumors
5086999|NCT01271738|Cancer of Breast|cancer of breast
5087000|NCT01271738|Cancer of the Breast|cancer of the breast
5087001|NCT01271738|Human Mammary Carcinoma|human mammary carcinoma
5087002|NCT01271738|Neoplasms, Breast|neoplasms, breast
5087003|NCT01271712|Gastrointestinal stromal cancer|gastrointestinal stromal cancer
5087004|NCT01271712|GIST|gist
5087005|NCT01271712|multikinase inhibitor|multikinase inhibitor
5087006|NCT01271699|Fabry Disease|fabry disease
5087007|NCT01271699|Fabry´s Disease|fabry´s disease
5087008|NCT01271699|Anderson-Fabry Disease|anderson-fabry disease
5087009|NCT01271699|Multiple Sclerosis|multiple sclerosis
5087010|NCT01271660|muscle cramp|muscle cramp
5087011|NCT01271660|liver cirrhosis|liver cirrhosis
5087012|NCT01271660|pregabalin|pregabalin
5087013|NCT01271647|osteopenia,chinese herb|osteopenia,chinese herb
5087014|NCT01271634|cross-transmission|cross-transmission
5087015|NCT01271634|offending vessel|offending vessel
5087016|NCT01271621|Airtraq, Intraocular pressure|airtraq, intraocular pressure
5087017|NCT01271608|Accident prevention|accident prevention
5087018|NCT01271608|Blood-borne pathogens|blood-borne pathogens
5087019|NCT01271608|Protective devices.|protective devices.
5087020|NCT01271608|Needlestick injuries|needlestick injuries
5087021|NCT01271608|Injections subcutaneous|injections subcutaneous
5087022|NCT01271608|Injections intradermal|injections intradermal
5087023|NCT01271595|acupuncture|acupuncture
5087024|NCT01271595|autonomic nervous system|autonomic nervous system
5087025|NCT01271595|seasonal allergic rhinitis|seasonal allergic rhinitis
5087026|NCT01271582|Colorecatal cancer|colorecatal cancer
5087027|NCT01271582|Gastric cancer|gastric cancer
5087028|NCT01271582|Irinotecan|irinotecan
5087029|NCT01271582|UGT1A1|ugt1a1
5087030|NCT01271582|Neutropenia|neutropenia
5087031|NCT01271556|COPD|copd
5087032|NCT01271556|LABA|laba
5087033|NCT01271556|salmeterol|salmeterol
5087034|NCT01271543|Comparison of hemodynamic|comparison of hemodynamic
5087035|NCT01271543|endotracheal intubation|endotracheal intubation
5087036|NCT01271543|changes induced by|changes induced by
5087037|NCT01271543|performed|performed
5087038|NCT01271543|the aid of the SOS|the aid of the sos
5087039|NCT01271543|as compared to the Macintosh Laryngoscope|as compared to the macintosh laryngoscope
5087040|NCT01271530|Late Effects of Polio|late effects of polio
5087041|NCT01271530|Cardiovascular Fitness|cardiovascular fitness
5087042|NCT01271530|Fatigue|fatigue
5087043|NCT01271530|Energy cost of Walking|energy cost of walking
5087044|NCT01271530|Pain|pain
5087045|NCT01271517|Basal insulin|basal insulin
5087046|NCT01271517|long acting insulin analogs|long acting insulin analogs
5087047|NCT01271517|metabolic control|metabolic control
5087048|NCT01271517|HbA1c|hba1c
5087049|NCT01271517|C-peptide|c-peptide
5087050|NCT01271517|IGF-I|igf-i
5087051|NCT01271517|GH|gh
5087052|NCT01271517|IGFBP|igfbp
5087053|NCT01271504|Cancer|cancer
5087054|NCT01271504|liver|liver
5087055|NCT01271504|hepatocellular carcinoma|hepatocellular carcinoma
5087056|NCT01271504|phase I|phase i
5087057|NCT01271504|phase II|phase ii
5087058|NCT01271491|Pediatric|pediatric
5087059|NCT01271478|inflammation|inflammation
5087060|NCT01271478|telmisartan|telmisartan
5087061|NCT01271478|captopril|captopril
5087062|NCT01271478|hemodialysis|hemodialysis
5087063|NCT01271426|Polypoidal Choroidal Vasculopathy|polypoidal choroidal vasculopathy
5087064|NCT01271426|Ranibizumab|ranibizumab
5087065|NCT01271400|Infertility treatments|infertility treatments
5087066|NCT01271400|Frozen embryo transfers (FET).|frozen embryo transfers (fet).
5087067|NCT01271400|IVF.|ivf.
5087068|NCT01271400|ART.|art.
5087069|NCT01271400|Cryopreservation|cryopreservation
5087070|NCT01271400|Slow-Freeze|slow-freeze
5087071|NCT01271400|Freeze / thaw survival rates|freeze / thaw survival rates
5087072|NCT01271400|Blastocyst formation|blastocyst formation
5087073|NCT01271400|Pregnancy|pregnancy
5087074|NCT01271387|Liver disease|liver disease
5087075|NCT01271387|pharmacokinetics|pharmacokinetics
5087076|NCT01271374|African American|african american
5087077|NCT01271374|Hypertension|hypertension
5087078|NCT01271374|Cardiometabolic Syndrome|cardiometabolic syndrome
5087079|NCT01271361|thrombus aspiration|thrombus aspiration
5087080|NCT01271361|Drug-Eluting Stent|drug-eluting stent
5087081|NCT01271361|optical frequency domain imaging (OFDI)|optical frequency domain imaging (ofdi)
5087082|NCT01271335|CTO|cto
5087083|NCT01271335|Angioplasty|angioplasty
5087084|NCT01271335|PCI|pci
5087085|NCT01271322|PET|pet
5087086|NCT01271322|response evaluation|response evaluation
5087087|NCT01271322|neoadjuvant|neoadjuvant
5087088|NCT01271322|radiochemotherapy|radiochemotherapy
5087089|NCT01271322|adenocarcinoma of the esophagogastric junction|adenocarcinoma of the esophagogastric junction
5087090|NCT01271322|esophageal carcinoma|esophageal carcinoma
5087091|NCT01271322|evaluation of preoperative (radio)-chemotherapy in patients with adenocarcinomas of the oesophagogastric junction|evaluation of preoperative (radio)-chemotherapy in patients with adenocarcinomas of the oesophagogastric junction
5087092|NCT01271296|Addison Disease|addison disease
5087093|NCT01271296|Pharmacokinetics|pharmacokinetics
5087094|NCT01271296|Hormone Replacement Therapy|hormone replacement therapy
5087095|NCT01271296|cortisone acetate|cortisone acetate
5087096|NCT01271296|Quality of Life|quality of life
5087097|NCT01271270|Age-Related Macular Degeneration (AMD)|age-related macular degeneration (amd)
5087098|NCT01271270|Palomid 529|palomid 529
5087099|NCT01271270|Age Related Macular Degeneration|age related macular degeneration
5087100|NCT01271270|AMD|amd
5087101|NCT01271257|misoprostol, pharmacokinetics|misoprostol, pharmacokinetics
5087102|NCT01271231|periodontal treatment, diabetes, glycemia, glycated hemoglobin|periodontal treatment, diabetes, glycemia, glycated hemoglobin
5087103|NCT01271205|pneumonia|pneumonia
5087104|NCT01271205|RDW|rdw
5087105|NCT01271205|mortality|mortality
5087106|NCT01271205|prognostic factor|prognostic factor
5087107|NCT01271192|local recurrent rectal cancer|local recurrent rectal cancer
5087108|NCT01271192|surgical resection|surgical resection
5087109|NCT01271192|adjuvant therapy|adjuvant therapy
5087110|NCT01271179|orthotopic liver transplantation|orthotopic liver transplantation
5087111|NCT01271179|preservation solution|preservation solution
5087112|NCT01271179|peribiliary plexus|peribiliary plexus
5087113|NCT01271179|nonanastomotic biliary strictures|nonanastomotic biliary strictures
5087114|NCT01271179|primary non-function|primary non-function
5087115|NCT01271166|Colorectal,|colorectal,
5087116|NCT01271166|Cancer|cancer
5087117|NCT01271153|Septic shock|septic shock
5087118|NCT01271127|radiation therapy|radiation therapy
5087119|NCT01271127|coronary artery disease|coronary artery disease
5087120|NCT01271127|Hodgkin Lymphoma|hodgkin lymphoma
5087121|NCT01271101|Non-ST-elevated acute coronary syndromes (NSTE-ACS)|non-st-elevated acute coronary syndromes (nste-acs)
5087122|NCT01271101|anticoagulation|anticoagulation
5087123|NCT01271088|ototoxicity|ototoxicity
5087124|NCT01271088|aminoglycoside|aminoglycoside
5087125|NCT01271088|vancomycine|vancomycine
5087126|NCT01271088|peritoneal dialysis|peritoneal dialysis
5087127|NCT01271088|peritonitis|peritonitis
5087128|NCT01271075|urticaria|urticaria
5087129|NCT01271075|bilastine|bilastine
5087130|NCT01271062|Resolvment of Diabetes Mellitus, Type 2|resolvment of diabetes mellitus, type 2
5087131|NCT01271062|gastric bypass|gastric bypass
5087132|NCT01271036|Lubricating Agents|lubricating agents
5087133|NCT01271036|Personal Lubricant|personal lubricant
5087134|NCT01270984|Imatinib mesylate|imatinib mesylate
5087135|NCT01270984|Pharmacokinetics|pharmacokinetics
5087136|NCT01270984|Healthy volunteers|healthy volunteers
5087137|NCT01270971|Onychomycosis|onychomycosis
5087138|NCT01270971|nail fungus|nail fungus
5087139|NCT01270971|toenail fungus|toenail fungus
5087140|NCT01270971|fungal nail|fungal nail
5087141|NCT01270971|hyperkeratosis|hyperkeratosis
5087142|NCT01270971|nail infection|nail infection
5087143|NCT01270971|nail treatment|nail treatment
5087144|NCT01270971|toenail infection|toenail infection
5087145|NCT01270971|toenail treatment|toenail treatment
5087146|NCT01270971|foot dermatoses|foot dermatoses
5087147|NCT01270971|fungal culture|fungal culture
5087148|NCT01270971|onycholysis|onycholysis
5087149|NCT01270971|podiatrist|podiatrist
5087150|NCT01270971|podiatry|podiatry
5087151|NCT01270971|subungual|subungual
5087152|NCT01270971|tinea unguium|tinea unguium
5087153|NCT01270971|antifungal|antifungal
5087154|NCT01270971|anti-fungal|anti-fungal
5087155|NCT01270971|dermatologist|dermatologist
5087156|NCT01270971|dermatology|dermatology
5087157|NCT01270971|dermatophyte|dermatophyte
5087158|NCT01270971|distal subungual onychomycosis|distal subungual onychomycosis
5087159|NCT01270971|yellow nail|yellow nail
5087160|NCT01270971|thick nail|thick nail
5087161|NCT01270971|brittle nail|brittle nail
5087162|NCT01270971|crumbling nail|crumbling nail
5087163|NCT01270971|discolored nail|discolored nail
5087164|NCT01270971|weak nail|weak nail
5087165|NCT01270958|AVY-REG00108VN|avy-reg00108vn
5087166|NCT01270906|Neoplasms|neoplasms
5087167|NCT01270906|Cancer|cancer
5087168|NCT01270906|Tumors|tumors
5087169|NCT01270906|Administration|administration
5087170|NCT01270906|oral|oral
5087171|NCT01270906|CHIR258|chir258
5087172|NCT01270906|CHIR-258|chir-258
5087173|NCT01270906|CHIR 258|chir 258
5087174|NCT01270906|TKI258|tki258
5087175|NCT01270906|TKI-258|tki-258
5087176|NCT01270906|TKI 258|tki 258
5087177|NCT01270906|dose finding|dose finding
5087178|NCT01270893|Gastrointestinal stromal tumor|gastrointestinal stromal tumor
5087179|NCT01270893|GIST|gist
5087180|NCT01270893|Nilotinib|nilotinib
5087181|NCT01270893|AMN107|amn107
5087182|NCT01270893|Tasigna|tasigna
5087183|NCT01270867|Ischemia|ischemia
5087184|NCT01270867|Stroke|stroke
5087185|NCT01270867|Ischemic Stroke|ischemic stroke
5087186|NCT01270867|Mechanical Thrombectomy|mechanical thrombectomy
5087187|NCT01270867|Brain|brain
5087188|NCT01270867|Brain clot|brain clot
5087189|NCT01270867|Cerebrovascular disease|cerebrovascular disease
5087190|NCT01270867|Recanalization|recanalization
5087191|NCT01270867|Revascularization|revascularization
5087192|NCT01270854|Normal saline|normal saline
5087193|NCT01270854|Plasmalyte|plasmalyte
5087194|NCT01270854|Intravenous fluid|intravenous fluid
5087195|NCT01270854|Traumatic injury|traumatic injury
5087196|NCT01270854|Fluid resuscitation|fluid resuscitation
5087197|NCT01270828|Control Release Pregabalin in Post Herpetic Neuralgia|control release pregabalin in post herpetic neuralgia
5087198|NCT01270815|pregabalin|pregabalin
5087199|NCT01270815|pharmacokinetics|pharmacokinetics
5087200|NCT01270815|bioavailability|bioavailability
5087201|NCT01270815|bioequivalence|bioequivalence
5087202|NCT01270802|Endothelial function|endothelial function
5087203|NCT01270802|Vitamin D|vitamin d
5087204|NCT01270802|Efavirenz|efavirenz
5087205|NCT01270802|Raltegravir|raltegravir
5087206|NCT01270789|beta-cell function|beta-cell function
5087207|NCT01270789|GLP-1 analogue|glp-1 analogue
5087208|NCT01270789|diabetes|diabetes
5087209|NCT01270776|Randomized Controlled Trial|randomized controlled trial
5087210|NCT01270776|Chlorhexidine|chlorhexidine
5087211|NCT01270776|Infant, Premature|infant, premature
5087212|NCT01270763|Obesity|obesity
5087213|NCT01270763|physical fitness|physical fitness
5087214|NCT01270763|cholesterol levels|cholesterol levels
5087215|NCT01270763|genetics|genetics
5087216|NCT01270763|weight loss|weight loss
5087217|NCT01270750|ENDOTHELIN RECEPTOR ANTAGONIST|endothelin receptor antagonist
5087218|NCT01270750|BOSENTAN|bosentan
5087219|NCT01270750|SECONDARY PULMONARY HYPERTENSION|secondary pulmonary hypertension
5087220|NCT01270750|RHEUMATOID FEVER|rheumatoid fever
5087221|NCT01270750|CONGESTIVE HEART FAILURE|congestive heart failure
5087222|NCT01270750|SECONDARY PULMONARY HYPERTENSION DUE TO MITRAL STENOSIS|secondary pulmonary hypertension due to mitral stenosis
5087223|NCT01270711|compliance study|compliance study
5087224|NCT01270711|effectiveness study|effectiveness study
5087225|NCT01270711|hyperprolactinemia|hyperprolactinemia
5087226|NCT01270711|Parkinson's disease|parkinson's disease
5087227|NCT01270711|retrospective cohort study|retrospective cohort study
5087228|NCT01270698|colorectal cancer|colorectal cancer
5087229|NCT01270672|MDMA|mdma
5087230|NCT01270672|carvedilol|carvedilol
5087231|NCT01270672|norepinephrine|norepinephrine
5087232|NCT01270672|alpha - beta receptor|alpha - beta receptor
5087233|NCT01270672|Ecstasy|ecstasy
5087234|NCT01270672|stimulant|stimulant
5087235|NCT01270659|Fentanyl buccal tablet|fentanyl buccal tablet
5087236|NCT01270646|Cardiac insufficiency|cardiac insufficiency
5087237|NCT01270646|Invasive procedure|invasive procedure
5087238|NCT01270646|Heart Failure|heart failure
5087239|NCT01270646|Noninvasive procedure|noninvasive procedure
5087240|NCT01270646|Congestive Heart Failure|congestive heart failure
5087241|NCT01270646|Mapping|mapping
5087242|NCT01270646|Cardiac resynchronisation therapy|cardiac resynchronisation therapy
5087243|NCT01270646|Open study|open study
5087244|NCT01270646|Cardiac Pacings, Artificial|cardiac pacings, artificial
5087245|NCT01270646|Hemodynamics|hemodynamics
5087246|NCT01270620|elderly obese|elderly obese
5087247|NCT01270581|transient tachypnea of the newborn|transient tachypnea of the newborn
5087248|NCT01270581|high flow nasal cannula|high flow nasal cannula
5087249|NCT01270581|bubble nasal|bubble nasal
5087250|NCT01270581|continuous positive airway pressure|continuous positive airway pressure
5087251|NCT01270568|positive psychology|positive psychology
5087252|NCT01270568|cardiovascular disease|cardiovascular disease
5087253|NCT01270542|Traction Retinal Detachment (PDR)|traction retinal detachment (pdr)
5087254|NCT01270542|Proliferative Diabetic Retinopathy (PDR)|proliferative diabetic retinopathy (pdr)
5087255|NCT01270529|Physical Activity|physical activity
5087256|NCT01270529|Physical Performance|physical performance
5087257|NCT01270529|Physical Functioning|physical functioning
5087258|NCT01270529|CKD|ckd
5087259|NCT01270529|ESRD|esrd
5087260|NCT01270529|Transplant Recipients|transplant recipients
5087261|NCT01270516|diaphragm|diaphragm
5087262|NCT01270516|limb muscle|limb muscle
5087263|NCT01270516|EPA|epa
5087264|NCT01270516|HMB|hmb
5087265|NCT01270516|ICU patients|icu patients
5087266|NCT01270503|Meningitis|meningitis
5087267|NCT01270503|Meningococcal disease|meningococcal disease
5087268|NCT01270503|Menactra®|menactra®
5087269|NCT01270490|candidemia|candidemia
5087270|NCT01270490|candida sepsis|candida sepsis
5087271|NCT01270490|invasive fungal disease|invasive fungal disease
5087272|NCT01270477|Frost injury|frost injury
5087273|NCT01270451|Weight maintenance|weight maintenance
5087274|NCT01270451|Group counseling|group counseling
5087275|NCT01270451|Prevention of diseases|prevention of diseases
5087276|NCT01270425|systemic sclerosis|systemic sclerosis
5087277|NCT01270425|hashimoto thyroiditis|hashimoto thyroiditis
5087278|NCT01270425|thyroid nodules|thyroid nodules
5087279|NCT01270412|Osteoarthritis|osteoarthritis
5087280|NCT01270412|PRP|prp
5087281|NCT01270412|PRGF|prgf
5087282|NCT01270412|Hyaluronic acid|hyaluronic acid
5087283|NCT01270386|NSCLC|nsclc
5087284|NCT01270386|apatinib|apatinib
5087285|NCT01270386|phase II|phase ii
5087286|NCT01270386|lung|lung
5087287|NCT01270386|cancer|cancer
5087288|NCT01270373|neoadjuvant therapy|neoadjuvant therapy
5087289|NCT01270373|drug therapy|drug therapy
5087290|NCT01270321|Thyroid Cancer|thyroid cancer
5087291|NCT01270308|Bioequivalence|bioequivalence
5087292|NCT01270308|two way crossover|two way crossover
5087293|NCT01270295|Receptor for advanced glycation end products (RAGE)|receptor for advanced glycation end products (rage)
5087294|NCT01270295|Soluble RAGE (sRAGE)|soluble rage (srage)
5087295|NCT01270295|Endogenous secretory RAGE (esRAGE)|endogenous secretory rage (esrage)
5087296|NCT01270295|High-mobility group box-1 protein (HMGB-1)|high-mobility group box-1 protein (hmgb-1)
5087297|NCT01270295|Extracellular newly-identified RAGE-binding protein (EN-RAGE or S100A12)|extracellular newly-identified rage-binding protein (en-rage or s100a12)
5087298|NCT01270295|Advanced glycation endproducts (AGEs)|advanced glycation endproducts (ages)
5087299|NCT01270295|Pentosidine|pentosidine
5087300|NCT01270295|N--carboxymethyllysine|n--carboxymethyllysine
5087301|NCT01270295|Acute lung injury (ALI)|acute lung injury (ali)
5087302|NCT01270295|Acute respiratory distress syndrome (ARDS)|acute respiratory distress syndrome (ards)
5087303|NCT01270295|Alveolar epithelium|alveolar epithelium
5087304|NCT01270295|Mechanical ventilation|mechanical ventilation
5087305|NCT01270295|Intensive Care Unit (ICU)|intensive care unit (icu)
5087306|NCT01270269|Asthenia|asthenia
5087307|NCT01270269|Muscle Weakness|muscle weakness
5087308|NCT01270269|Brain Injuries|brain injuries
5087309|NCT01270269|Critical Illness|critical illness
5087310|NCT01270269|Critical Illness Myoneuropathy|critical illness myoneuropathy
5087311|NCT01270269|Rehabilitation|rehabilitation
5087312|NCT01270269|Sepsis|sepsis
5087313|NCT01270269|Respiratory Failure|respiratory failure
5087314|NCT01270269|Delirium|delirium
5087315|NCT01270269|Over-sedation|over-sedation
5087316|NCT01270269|Immobility|immobility
5087317|NCT01270269|Aging|aging
5087318|NCT01270269|Signs and Symptoms|signs and symptoms
5087319|NCT01270269|Muscular Diseases|muscular diseases
5087320|NCT01270269|Musculoskeletal Diseases|musculoskeletal diseases
5087321|NCT01270269|Neuromuscular Manifestations|neuromuscular manifestations
5087322|NCT01270269|Neurologic Manifestations|neurologic manifestations
5087323|NCT01270269|Pathologic Processes|pathologic processes
5087324|NCT01270269|Brain Diseases|brain diseases
5087325|NCT01270269|Central Nervous System Diseases|central nervous system diseases
5087326|NCT01270269|Craniocerebral Trauma|craniocerebral trauma
5087327|NCT01270269|Trauma, Nervous System|trauma, nervous system
5087328|NCT01270269|Wounds and Injuries|wounds and injuries
5087329|NCT01270269|Disorders of Environmental Origin|disorders of environmental origin
5087330|NCT01270256|allergy|allergy
5087331|NCT01270230|HIV Prevention Intervention|hiv prevention intervention
5087332|NCT01270230|African American Men who have Sex with Men|african american men who have sex with men
5087333|NCT01270217|Automobile driving|automobile driving
5087334|NCT01270217|Driving under the influence|driving under the influence
5087335|NCT01270217|Interview, psychological|interview, psychological
5087336|NCT01270217|Brief intervention|brief intervention
5087337|NCT01270217|Brief motivational interview|brief motivational interview
5087338|NCT01270204|Dysphagia|dysphagia
5087339|NCT01270204|Swallowing Problems|swallowing problems
5087340|NCT01270204|Dynamic Fluoroscopic Swallow Study|dynamic fluoroscopic swallow study
5087341|NCT01270204|Aspiration|aspiration
5087342|NCT01270204|Regurgitation|regurgitation
5087343|NCT01270204|Acid Reflux|acid reflux
5087344|NCT01270191|Exenatide, Beta-Cell Function, Glycemic Control|exenatide, beta-cell function, glycemic control
5087345|NCT01270191|in Newly Diagnosed Type 2 Diabetic Patients|in newly diagnosed type 2 diabetic patients
5087346|NCT01270165|lamivudine|lamivudine
5087347|NCT01270165|telbivudine|telbivudine
5087348|NCT01270165|adefovir|adefovir
5087349|NCT01270165|lamivudine resistance|lamivudine resistance
5087350|NCT01270152|ascorbic acid|ascorbic acid
5087351|NCT01270152|catheterization central venous|catheterization central venous
5087352|NCT01270152|nursing care|nursing care
5087353|NCT01270139|nanoparticles|nanoparticles
5087354|NCT01270139|mesenchymal stem cell|mesenchymal stem cell
5087355|NCT01270139|plasmonics|plasmonics
5087356|NCT01270139|atherosclerosis|atherosclerosis
5087357|NCT01270139|IVUS|ivus
5087358|NCT01270139|stenting|stenting
5087359|NCT01270126|optic neuropathy|optic neuropathy
5087360|NCT01270126|alternating current stimulation|alternating current stimulation
5087361|NCT01270126|vision recovery|vision recovery
5087362|NCT01270126|restoration|restoration
5087363|NCT01270126|plasticity|plasticity
5087364|NCT01270087|Rheumatoid arthritis, cardiovascular disease, adalimumab|rheumatoid arthritis, cardiovascular disease, adalimumab
5087365|NCT01270074|double blind placebo controlled randomised clinical trial|double blind placebo controlled randomised clinical trial
5087366|NCT01270074|azithromycin|azithromycin
5087367|NCT01270074|infant|infant
5087368|NCT01270074|pediatric|pediatric
5087369|NCT01270074|cystic fibrosis|cystic fibrosis
5087370|NCT01270074|bronchiectasis|bronchiectasis
5087371|NCT01270061|HIV testing|hiv testing
5087372|NCT01270061|black Africans|black africans
5087373|NCT01270061|immigrants|immigrants
5087374|NCT01270061|health screening|health screening
5087375|NCT01270048|Hwa-byung, Bunsimgi-eum(Fenxinqiyin)|hwa-byung, bunsimgi-eum(fenxinqiyin)
5087376|NCT01269996|type 2 diabetes mellitus|type 2 diabetes mellitus
5087377|NCT01269996|JUBILEE Study|jubilee study
5087378|NCT01269996|Janumet|janumet
5087379|NCT01269996|Lantus|lantus
5087380|NCT01269983|low back pain|low back pain
5087381|NCT01269983|fascial manipulation|fascial manipulation
5087382|NCT01269983|physioterapy|physioterapy
5087383|NCT01269983|physical activity|physical activity
5087384|NCT01269957|halitosis|halitosis
5087385|NCT01269957|pediatric dentistry|pediatric dentistry
5087386|NCT01269957|mouth breathing|mouth breathing
5087387|NCT01269944|osteoarthritis|osteoarthritis
5087388|NCT01269944|knee|knee
5087389|NCT01269944|high wedge tibial osteotomy|high wedge tibial osteotomy
5087390|NCT01269944|dGEMRIC|dgemric
5087391|NCT01269931|endobronchial ultrasound|endobronchial ultrasound
5087392|NCT01269931|bronchoscopy|bronchoscopy
5087393|NCT01269931|education|education
5087394|NCT01269931|interventional bronchoscopy|interventional bronchoscopy
5087395|NCT01269931|simulation|simulation
5087396|NCT01269918|Craniotomy, pain relief|craniotomy, pain relief
5087397|NCT01269918|Adult solid neoplasm|adult solid neoplasm
5087398|NCT01269892|diarrhea, lactose, milk, weight, acute.|diarrhea, lactose, milk, weight, acute.
5087399|NCT01269879|epicondylitis|epicondylitis
5087400|NCT01269879|pain|pain
5087401|NCT01269879|tendon|tendon
5087402|NCT01269866|Lupus Pain|lupus pain
5087403|NCT01269866|Lupus|lupus
5087404|NCT01269866|Pain|pain
5087405|NCT01269866|Systemic Lupus Erythematosus|systemic lupus erythematosus
5087406|NCT01269866|Duloxetine|duloxetine
5087407|NCT01269866|Cymbalta|cymbalta
5087408|NCT01269853|GBM|gbm
5087409|NCT01269853|AA|aa
5087410|NCT01269853|AO|ao
5087411|NCT01269853|Brain|brain
5087412|NCT01269853|Tumors|tumors
5087413|NCT01269853|Malignant|malignant
5087414|NCT01269853|Glioblastoma|glioblastoma
5087415|NCT01269853|Multiforme|multiforme
5087416|NCT01269853|Anaplastic|anaplastic
5087417|NCT01269853|Astrocytoma|astrocytoma
5087418|NCT01269827|inflammation|inflammation
5087419|NCT01269827|pentoxifylline|pentoxifylline
5087420|NCT01269827|hemodialysis|hemodialysis
5087421|NCT01269814|Gastrointestinal bleeding|gastrointestinal bleeding
5087422|NCT01269814|Emergency endoscopy|emergency endoscopy
5087423|NCT01269814|Rockall Risk Scoring System|rockall risk scoring system
5087424|NCT01269801|BOTOX|botox
5087425|NCT01269801|JUVEDERM|juvederm
5087426|NCT01269801|Prospective|prospective
5087427|NCT01269801|Open Label|open label
5087428|NCT01269801|Randomized|randomized
5087429|NCT01269801|Crossover Study|crossover study
5087430|NCT01269788|non-erosive reflux disease|non-erosive reflux disease
5087431|NCT01269788|heartburn|heartburn
5087432|NCT01269788|functional|functional
5087433|NCT01269788|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation
5087434|NCT01269788|Proton Pump Inhibitors|proton pump inhibitors
5087435|NCT01269762|Red yeast rice|red yeast rice
5087436|NCT01269762|Lovastatin|lovastatin
5087437|NCT01269762|Drug-drug interaction|drug-drug interaction
5087438|NCT01269762|Pharmacokinetics|pharmacokinetics
5087439|NCT01269749|Hyperthyroidism|hyperthyroidism
5087440|NCT01269749|Antithyroid drugs|antithyroid drugs
5087441|NCT01269749|Cancer|cancer
5087442|NCT01269749|Dosimetry|dosimetry
5087443|NCT01269749|Children|children
5087444|NCT01269736|electrocardiographic monitoring|electrocardiographic monitoring
5087445|NCT01269736|arrhythmia|arrhythmia
5087446|NCT01269736|myocardial ischemia|myocardial ischemia
5087447|NCT01269723|Smoking|smoking
5087448|NCT01269723|influenza|influenza
5087449|NCT01269723|influenza vaccine|influenza vaccine
5087450|NCT01269710|Second Generation Antipsychotics|second generation antipsychotics
5087451|NCT01269710|Schizophrenia|schizophrenia
5087452|NCT01269710|Schizoaffective|schizoaffective
5087453|NCT01269710|Schizophreniform|schizophreniform
5087454|NCT01269710|Psychosis NOS|psychosis nos
5087455|NCT01269710|Mood Disorders|mood disorders
5087456|NCT01269710|Weight|weight
5087457|NCT01269710|Autism|autism
5087458|NCT01269697|AMD|amd
5087459|NCT01269697|food supplementation|food supplementation
5087460|NCT01269697|macular pigments|macular pigments
5087461|NCT01269697|luthéine|luthéine
5087462|NCT01269697|zéaxanthine|zéaxanthine
5087463|NCT01269697|visual acuity|visual acuity
5087464|NCT01269697|prevention|prevention
5087465|NCT01269697|genetique risk|genetique risk
5087466|NCT01269684|Kidney|kidney
5087467|NCT01269684|renal|renal
5087468|NCT01269684|transplantation|transplantation
5087469|NCT01269684|tacrolimus|tacrolimus
5087470|NCT01269684|everolimus|everolimus
5087471|NCT01269684|stable allograft recipients|stable allograft recipients
5087472|NCT01269671|Functional Abdominal Pain|functional abdominal pain
5087473|NCT01269671|Irritable Bowel Syndrome|irritable bowel syndrome
5087474|NCT01269671|IBS|ibs
5087475|NCT01269671|Functional Dyspepsia|functional dyspepsia
5087476|NCT01269671|Melatonin|melatonin
5087477|NCT01269671|Simethicone|simethicone
5087478|NCT01269671|Peppermint Oil|peppermint oil
5087479|NCT01269671|mentharil|mentharil
5087480|NCT01269671|functional bowel disorders|functional bowel disorders
5087481|NCT01269671|quality of life|quality of life
5087482|NCT01269645|Cancer|cancer
5087483|NCT01269645|Clinical trials|clinical trials
5087484|NCT01269632|teenagers to adult transition|teenagers to adult transition
5087485|NCT01269632|comparison|comparison
5087486|NCT01269619|back pain|back pain
5087487|NCT01269619|posture|posture
5087488|NCT01269619|lumbar support|lumbar support
5087489|NCT01269619|dynamic support|dynamic support
5087490|NCT01269593|PET Scan|pet scan
5087491|NCT01269593|124I-PUH71|124i-puh71
5087492|NCT01269593|10-139|10-139
5087493|NCT01269567|RectalNeoplasms|rectalneoplasms
5087494|NCT01269567|Colorectal Neoplasms|colorectal neoplasms
5087495|NCT01269567|Intestinal Neoplasms|intestinal neoplasms
5087496|NCT01269567|Gastrointestinal Neoplasms|gastrointestinal neoplasms
5087497|NCT01269567|Digestive System Neoplasms|digestive system neoplasms
5087498|NCT01269567|Neoplasms by Site|neoplasms by site
5087499|NCT01269567|Digestive System Diseases|digestive system diseases
5087500|NCT01269567|Gastrointestinal Diseases|gastrointestinal diseases
5087501|NCT01269567|Intestinal Diseases|intestinal diseases
5087502|NCT01269567|Rectal Diseases|rectal diseases
5087503|NCT01269554|diarrhea|diarrhea
5087504|NCT01269554|Guinea-Bissau|guinea-bissau
5087505|NCT01269554|Finland|finland
5087506|NCT01269554|Children|children
5087507|NCT01269554|Adults|adults
5087508|NCT01269554|Intestinal pathogens|intestinal pathogens
5087509|NCT01269554|Bacteria|bacteria
5087510|NCT01269554|Virus|virus
5087511|NCT01269554|Parasites|parasites
5087512|NCT01269528|Palivizumab|palivizumab
5087513|NCT01269528|Airway Hyperreactivity|airway hyperreactivity
5087514|NCT01269528|EBC|ebc
5087515|NCT01269528|MCT|mct
5087516|NCT01269515|Cox-2 inhibitor|cox-2 inhibitor
5087517|NCT01269515|HIV|hiv
5087518|NCT01269515|immune activation|immune activation
5087519|NCT01269515|immune modulating|immune modulating
5087520|NCT01269515|progression markers|progression markers
5087521|NCT01269515|vaccine|vaccine
5087522|NCT01269489|quality of life|quality of life
5087523|NCT01269489|general Slovenian population|general slovenian population
5087524|NCT01269489|EORTC QLQ C30|eortc qlq c30
5087525|NCT01269463|Attention deficit|attention deficit
5087526|NCT01269463|Hyperactivity|hyperactivity
5087527|NCT01269463|Impulsivity|impulsivity
5087528|NCT01269463|Inattention|inattention
5087529|NCT01269450|second trimester vaginal bleeding|second trimester vaginal bleeding
5087530|NCT01269450|late abortion|late abortion
5087531|NCT01269450|preterm birth|preterm birth
5087532|NCT01269450|progesterone|progesterone
5087533|NCT01269437|mild to moderate asthma|mild to moderate asthma
5087534|NCT01269424|adult giant cell glioblastoma|adult giant cell glioblastoma
5087535|NCT01269424|adult glioblastoma|adult glioblastoma
5087536|NCT01269424|adult gliosarcoma|adult gliosarcoma
5087537|NCT01269385|Imprime PGG|imprime pgg
5087538|NCT01269372|polyps|polyps
5087539|NCT01269372|capsule endoscopy|capsule endoscopy
5087540|NCT01269372|colonoscopy|colonoscopy
5087541|NCT01269346|Locally recurrent|locally recurrent
5087542|NCT01269346|metastatic HER2Positive breast cancer|metastatic her2positive breast cancer
5087543|NCT01269307|Anesthesia|anesthesia
5087544|NCT01269307|Pain|pain
5087545|NCT01269307|Procedural sedation|procedural sedation
5087546|NCT01269307|Airway/Anesthesia/Analgesia|airway/anesthesia/analgesia
5087547|NCT01269294|Hepatitis C|hepatitis c
5087548|NCT01269294|TMC435-TiDP16-C117|tmc435-tidp16-c117
5087549|NCT01269294|TMC435-C117|tmc435-c117
5087550|NCT01269294|TMC435|tmc435
5087551|NCT01269294|HCV|hcv
5087552|NCT01269294|Moxifloxacin|moxifloxacin
5087553|NCT01269294|ECG|ecg
5087554|NCT01269294|QT|qt
5087555|NCT01269294|QTc|qtc
5087556|NCT01269281|Bioequivalence|bioequivalence
5087557|NCT01269281|two way crossover|two way crossover
5087558|NCT01269242|coronary restenosis|coronary restenosis
5087559|NCT01269242|angioplasty|angioplasty
5087560|NCT01269242|stent|stent
5087561|NCT01269242|MCP-1/CCL2|mcp-1/ccl2
5087562|NCT01269242|MCP-3/CCL7|mcp-3/ccl7
5087563|NCT01269203|multiple myeloma|multiple myeloma
5087564|NCT01269203|MM|mm
5087565|NCT01269203|maintenance therapy|maintenance therapy
5087566|NCT01269203|lenalidomide|lenalidomide
5087567|NCT01269203|bone marrow transplantation|bone marrow transplantation
5087568|NCT01269203|auto-HSCT|auto-hsct
5087569|NCT01269203|Autologous Hematopoietic Stem Cell Transplantation|autologous hematopoietic stem cell transplantation
5087570|NCT01269203|NF-kB inhibition|nf-kb inhibition
5087571|NCT01269203|reducing symptoms|reducing symptoms
5087572|NCT01269203|maintenance chemotherapy|maintenance chemotherapy
5087573|NCT01269203|inflammatory cytokines|inflammatory cytokines
5087574|NCT01269203|nuclear factor kappa B|nuclear factor kappa b
5087575|NCT01269203|NF-kB|nf-kb
5087576|NCT01269203|interleukin|interleukin
5087577|NCT01269203|IL-6|il-6
5087578|NCT01269203|tumor necrosis factor|tumor necrosis factor
5087579|NCT01269203|TNF-a|tnf-a
5087580|NCT01269203|NF-kB activation levels|nf-kb activation levels
5087581|NCT01269190|oral mucosa in vivo|oral mucosa in vivo
5087582|NCT01269190|Wide-Field In Vivo Imaging|wide-field in vivo imaging
5087583|NCT01269190|High Resolution In Vivo Imaging|high resolution in vivo imaging
5087584|NCT01269190|Oral Neoplasia|oral neoplasia
5087585|NCT01269190|Topical Fluorescent Dyes|topical fluorescent dyes
5087586|NCT01269190|contrast dye|contrast dye
5087587|NCT01269190|oral dysplasia|oral dysplasia
5087588|NCT01269190|Proflavine|proflavine
5087589|NCT01269190|oral lesions|oral lesions
5087590|NCT01269190|surgical resection|surgical resection
5087591|NCT01269190|High Resolution Microendoscope|high resolution microendoscope
5087592|NCT01269190|HRME|hrme
5087593|NCT01269190|Identafi 3000|identafi 3000
5087594|NCT01269190|Multispectral Digital Microscope|multispectral digital microscope
5087595|NCT01269190|MDM|mdm
5087596|NCT01269190|Portable Screening System|portable screening system
5087597|NCT01269190|PS2|ps2
5087598|NCT01269177|ACPE|acpe
5087599|NCT01269177|Acute respiratory failure|acute respiratory failure
5087600|NCT01269177|Non invasive ventilation|non invasive ventilation
5087601|NCT01269177|acute cardiogenic pulmonary edema|acute cardiogenic pulmonary edema
5087602|NCT01269164|Face Transplant|face transplant
5087603|NCT01269164|Facial Transplantation|facial transplantation
5087604|NCT01269164|Composite Facial Allograft Transplantation|composite facial allograft transplantation
5087605|NCT01269151|Age-Related Macular Degeneration|age-related macular degeneration
5087606|NCT01269151|Retinal Function|retinal function
5087607|NCT01269151|multifocal-ERG|multifocal-erg
5087608|NCT01269151|Electroretinography|electroretinography
5087609|NCT01269151|microperimetry|microperimetry
5087610|NCT01269151|Lucentis|lucentis
5087611|NCT01269151|Ranibizumab|ranibizumab
5087612|NCT01269151|longterm effects|longterm effects
5087613|NCT01269151|best corrected visual acuity|best corrected visual acuity
5087614|NCT01269151|BCVA|bcva
5087615|NCT01269138|Inherited Factor VII deficiency|inherited factor vii deficiency
5087616|NCT01269138|Inhibitor development in Factor VII deficiency|inhibitor development in factor vii deficiency
5087617|NCT01269138|Bleeding in Factor VII Deficiency|bleeding in factor vii deficiency
5087618|NCT01269138|Surgery in Factor VII deficiency|surgery in factor vii deficiency
5087619|NCT01269138|Prophylaxis in Factor VII Deficiency|prophylaxis in factor vii deficiency
5087620|NCT01269125|cytokines|cytokines
5087621|NCT01269125|endometriosis|endometriosis
5087622|NCT01269125|fertilization rate|fertilization rate
5087623|NCT01269125|follicular fluid|follicular fluid
5087624|NCT01269125|pregnancy rate|pregnancy rate
5087625|NCT01269099|hypokalemia|hypokalemia
5087626|NCT01269099|intravenous patient controlled analgesia|intravenous patient controlled analgesia
5087627|NCT01269086|Primary Heath Care|primary heath care
5087628|NCT01269086|Preventive Medicine|preventive medicine
5087629|NCT01269086|Adolescent Health Services|adolescent health services
5087630|NCT01269086|Spouses|spouses
5087631|NCT01269086|Family|family
5087632|NCT01269086|Family Practice|family practice
5087633|NCT01269073|Obstructive Sleep Apnea|obstructive sleep apnea
5087634|NCT01269060|Colorectal Cancer, laparoscopic surgery|colorectal cancer, laparoscopic surgery
5087635|NCT01269047|type 1 diabetes|type 1 diabetes
5087636|NCT01269047|Symlin|symlin
5087637|NCT01269047|Byetta|byetta
5087638|NCT01269047|CGMS iPro|cgms ipro
5087639|NCT01269034|Type 1 diabetes Milletus|type 1 diabetes milletus
5087640|NCT01269034|diabetes|diabetes
5087641|NCT01269034|healthy controls|healthy controls
5087642|NCT01269034|exenatide|exenatide
5087643|NCT01269034|byetta|byetta
5087644|NCT01269021|MMF treatment IgA Nephropathy (IgAN)|mmf treatment iga nephropathy (igan)
5087645|NCT01269008|Closed loop|closed loop
5087646|NCT01269008|type 1 diabetes|type 1 diabetes
5087647|NCT01269008|Symlin|symlin
5087648|NCT01269008|Byetta|byetta
5087649|NCT01269008|diabetes|diabetes
5087650|NCT01269008|insulin|insulin
5087651|NCT01269008|insulin pump|insulin pump
5087652|NCT01268995|NODAT|nodat
5087653|NCT01268995|kidney transplantation|kidney transplantation
5087654|NCT01268995|beta cell function|beta cell function
5087655|NCT01268995|insulin|insulin
5087656|NCT01268995|Tacrolimus|tacrolimus
5087657|NCT01268995|Cyclosporine A|cyclosporine a
5087658|NCT01268982|socket preservation|socket preservation
5087659|NCT01268982|alveolar ridge augmentation|alveolar ridge augmentation
5087660|NCT01268969|pilonidal disease PND|pilonidal disease pnd
5087661|NCT01268943|rectal neoplasms|rectal neoplasms
5087662|NCT01268943|aged|aged
5087663|NCT01268943|radiotherapy|radiotherapy
5087664|NCT01268943|drug therapy|drug therapy
5087665|NCT01268943|dose-escalation|dose-escalation
5087666|NCT01268943|capecitabine|capecitabine
5087667|NCT01268930|ovarian reserve|ovarian reserve
5087668|NCT01268930|endometrioma excision|endometrioma excision
5087669|NCT01268930|hemostatic matrix|hemostatic matrix
5087670|NCT01268930|bipolar electrocoagulation|bipolar electrocoagulation
5087671|NCT01268930|thermal injury|thermal injury
5087672|NCT01268917|coronary artery disease|coronary artery disease
5087673|NCT01268917|off-pump coronary artery bypass|off-pump coronary artery bypass
5087674|NCT01268917|aspirin|aspirin
5087675|NCT01268891|Azilect|azilect
5087676|NCT01268891|Motor fluctuations|motor fluctuations
5087677|NCT01268891|Parkinson´s Disease|parkinson´s disease
5087678|NCT01268891|Rasagiline|rasagiline
5087679|NCT01268878|effect of febrile neutropenia resulting chemotherapy by TPF|effect of febrile neutropenia resulting chemotherapy by tpf
5087780|NCT01268371|Coronary artery disease|coronary artery disease
5087680|NCT01268865|Acoustic Radiation Force Impulse (ARFI)|acoustic radiation force impulse (arfi)
5087681|NCT01268865|Virtual Touch Quantification (VTQ)|virtual touch quantification (vtq)
5087682|NCT01268865|liver stiffness measurement (LSM)|liver stiffness measurement (lsm)
5087683|NCT01268865|liver fibrosis|liver fibrosis
5087684|NCT01268865|cirrhosis|cirrhosis
5087685|NCT01268865|hepatitis B|hepatitis b
5087686|NCT01268865|hepatitis C|hepatitis c
5087687|NCT01268839|TMC278, rilpivirine, efavirenz, healthy volunteer|tmc278, rilpivirine, efavirenz, healthy volunteer
5087688|NCT01268800|AML|aml
5087689|NCT01268800|Induction|induction
5087690|NCT01268761|Ovarian hyperstimulation syndrome (OHSS)|ovarian hyperstimulation syndrome (ohss)
5087691|NCT01268761|GnRH antagonist|gnrh antagonist
5087692|NCT01268761|Ascitis.|ascitis.
5087693|NCT01268748|single site surgery|single site surgery
5087694|NCT01268748|laparoscopic surgery|laparoscopic surgery
5087695|NCT01268748|pain|pain
5087696|NCT01268748|nausea|nausea
5087697|NCT01268735|Dysfunctional Tear Syndrome|dysfunctional tear syndrome
5087698|NCT01268735|Dry Eye|dry eye
5087699|NCT01268735|LIPCOF|lipcof
5087700|NCT01268735|Hydroxypropyl-guar|hydroxypropyl-guar
5087701|NCT01268722|Nitinol Stent|nitinol stent
5087702|NCT01268722|Balloon angioplasty|balloon angioplasty
5087703|NCT01268722|Chronic total occlusions|chronic total occlusions
5087704|NCT01268722|Femoropopliteal|femoropopliteal
5087705|NCT01268696|diabetes|diabetes
5087706|NCT01268696|obesity|obesity
5087707|NCT01268696|hypertension|hypertension
5087708|NCT01268696|dyslipidemia|dyslipidemia
5087709|NCT01268683|Ischemic stroke|ischemic stroke
5087710|NCT01268657|PTSD|ptsd
5087711|NCT01268657|Fear of Falling|fear of falling
5087712|NCT01268657|Older Adults|older adults
5087713|NCT01268657|Injurious Falls|injurious falls
5087714|NCT01268657|Exposure Therapy|exposure therapy
5087715|NCT01268644|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
5087716|NCT01268631|Fibromyalgia|fibromyalgia
5087717|NCT01268631|Pain modulation|pain modulation
5087718|NCT01268618|IBS|ibs
5087719|NCT01268618|Diarrhea|diarrhea
5087720|NCT01268618|Dyspepsia|dyspepsia
5087721|NCT01268605|Dental caries|dental caries
5087722|NCT01268605|Resin based composite|resin based composite
5087723|NCT01268605|Hypersensitivity|hypersensitivity
5087724|NCT01268605|Teeth|teeth
5087725|NCT01268605|Dentistry|dentistry
5087726|NCT01268605|Practice-based research network|practice-based research network
5087727|NCT01268592|fertility preservation|fertility preservation
5087728|NCT01268592|oocyte cryopreservation|oocyte cryopreservation
5087729|NCT01268592|vitrification|vitrification
5087730|NCT01268592|egg freezing|egg freezing
5087856|NCT01267981|video-capsule endoscopy|video-capsule endoscopy
5087731|NCT01268592|fertility preservation in female cancer patients|fertility preservation in female cancer patients
5087732|NCT01268579|ribavirin|ribavirin
5087733|NCT01268579|VIRAZOLE|virazole
5087734|NCT01268579|tonsil|tonsil
5087735|NCT01268579|base of tongue|base of tongue
5087736|NCT01268579|squamous cell carcinoma|squamous cell carcinoma
5087737|NCT01268579|10-218|10-218
5087738|NCT01268566|Glioblastoma|glioblastoma
5087739|NCT01268553|pulmonary arterial hypertension|pulmonary arterial hypertension
5087740|NCT01268553|inhaled prostacyclin|inhaled prostacyclin
5087741|NCT01268540|intraocular lens|intraocular lens
5087742|NCT01268540|IOL|iol
5087743|NCT01268540|cataract|cataract
5087744|NCT01268540|refractive astigmatism|refractive astigmatism
5087745|NCT01268540|Aspheric|aspheric
5087746|NCT01268540|Toric|toric
5087747|NCT01268540|Hoya|hoya
5087748|NCT01268540|Surgical|surgical
5087749|NCT01268540|Optics|optics
5087750|NCT01268540|visual acuity|visual acuity
5087751|NCT01268527|Psoriasis vulgaris|psoriasis vulgaris
5087752|NCT01268514|Complex|complex
5087753|NCT01268514|Abdominal Wall Reconstruction|abdominal wall reconstruction
5087754|NCT01268514|AWR|awr
5087755|NCT01268514|Hernia|hernia
5087756|NCT01268475|Bronchiectasis|bronchiectasis
5087757|NCT01268475|Quality of Life|quality of life
5087758|NCT01268475|Respiratory Function Tests|respiratory function tests
5087759|NCT01268475|Exercise Test|exercise test
5087760|NCT01268449|Tinnitus|tinnitus
5087761|NCT01268449|Low power laser|low power laser
5087762|NCT01268423|Percutaneous tracheostomy|percutaneous tracheostomy
5087763|NCT01268423|Swallowing dysfunction|swallowing dysfunction
5087764|NCT01268423|Mechanical ventilation|mechanical ventilation
5087765|NCT01268423|Intensive Care|intensive care
5087766|NCT01268410|Acute respiratory failure|acute respiratory failure
5087767|NCT01268410|Acute lung injury|acute lung injury
5087768|NCT01268410|Acute respiratory distress syndrome|acute respiratory distress syndrome
5087769|NCT01268410|Mechanical Ventilation|mechanical ventilation
5087770|NCT01268410|Non-Invasive Ventilation|non-invasive ventilation
5087771|NCT01268397|elderly|elderly
5087772|NCT01268397|wrist fracture|wrist fracture
5087773|NCT01268397|fracture of the distal radius|fracture of the distal radius
5087774|NCT01268397|volar plate|volar plate
5087775|NCT01268397|plaster cast|plaster cast
5087776|NCT01268384|pancreatic cancer|pancreatic cancer
5087777|NCT01268384|neoadjuvant chemotherapy|neoadjuvant chemotherapy
5087778|NCT01268384|gemcitabine|gemcitabine
5087779|NCT01268384|capecitabine|capecitabine
5087781|NCT01268371|Stent|stent
5087782|NCT01268345|blood glucose|blood glucose
5087783|NCT01268332|Placebo IVR as a delivery method|placebo ivr as a delivery method
5087784|NCT01268319|Myocardial Infarction|myocardial infarction
5087785|NCT01268319|percutaneous coronary intervention|percutaneous coronary intervention
5087786|NCT01268319|embolization|embolization
5087787|NCT01268319|necrotic core|necrotic core
5087788|NCT01268319|vulnerable plaque|vulnerable plaque
5087789|NCT01268319|coronary plaque rupture|coronary plaque rupture
5087790|NCT01268306|contact lens|contact lens
5087791|NCT01268306|corneal staining|corneal staining
5087792|NCT01268306|fluorescein staining|fluorescein staining
5087793|NCT01268306|preservatives|preservatives
5087794|NCT01268306|keratitis|keratitis
5087795|NCT01268306|punctate keratopathy|punctate keratopathy
5087796|NCT01268306|superficial punctate keratopathy|superficial punctate keratopathy
5087797|NCT01268306|SPK|spk
5087798|NCT01268293|Cancer|cancer
5087799|NCT01268254|wine|wine
5087800|NCT01268254|aging|aging
5087801|NCT01268254|atherosclerosis|atherosclerosis
5087802|NCT01268254|telomere|telomere
5087803|NCT01268254|tomography|tomography
5087804|NCT01268254|coronary vessels|coronary vessels
5087805|NCT01268241|Fabry Disease|fabry disease
5087806|NCT01268241|Fabry´s Disease|fabry´s disease
5087807|NCT01268241|Anderson-Fabry Disease|anderson-fabry disease
5087808|NCT01268228|intracoronary ECG|intracoronary ecg
5087809|NCT01268228|coronary bifurcation stenosis|coronary bifurcation stenosis
5087810|NCT01268228|side branch compromise|side branch compromise
5087811|NCT01268228|Periprocedural myonecrosis during coronary bifurcation lesion stenting assessed with ic ECG|periprocedural myonecrosis during coronary bifurcation lesion stenting assessed with ic ecg
5087812|NCT01268215|Bronchopulmonary Dysplasia|bronchopulmonary dysplasia
5087813|NCT01268215|Budesonide|budesonide
5087814|NCT01268215|Infasurf|infasurf
5087815|NCT01268202|cutaneous radioinduced fibrosis|cutaneous radioinduced fibrosis
5087816|NCT01268189|burn wound|burn wound
5087817|NCT01268189|management with oxygen|management with oxygen
5087818|NCT01268176|Vitamin D|vitamin d
5087819|NCT01268176|vitamin D deficiency|vitamin d deficiency
5087820|NCT01268176|vitamin D absorption|vitamin d absorption
5087821|NCT01268163|Docetaxel|docetaxel
5087822|NCT01268163|Phase I|phase i
5087823|NCT01268163|Pharmacokinetic|pharmacokinetic
5087824|NCT01268163|Bioequivalence|bioequivalence
5087825|NCT01268137|MDD|mdd
5087826|NCT01268137|DBS|dbs
5087827|NCT01268124|Japanese|japanese
5087828|NCT01268111|vitamin D deficiency, insulin sensitivity|vitamin d deficiency, insulin sensitivity
5087829|NCT01268098|Hypoparathyroidism, rhPTH[1-84], NPSP558|hypoparathyroidism, rhpth[1-84], npsp558
5087830|NCT01268085|Radiation Safety|radiation safety
5087831|NCT01268085|Computerized Physician Order Entry|computerized physician order entry
5087832|NCT01268085|Decision Support|decision support
5087833|NCT01268085|Cat Scans|cat scans
5087834|NCT01268072|COPD|copd
5087835|NCT01268059|Non-small cell lung cancer|non-small cell lung cancer
5087836|NCT01268059|NSCLC|nsclc
5087837|NCT01268046|aging|aging
5087838|NCT01268046|postmenopausal women|postmenopausal women
5087839|NCT01268046|estrogen|estrogen
5087840|NCT01268046|memory|memory
5087841|NCT01268033|rituximab|rituximab
5087842|NCT01268033|idiopathic nephrotic syndrome|idiopathic nephrotic syndrome
5087843|NCT01268033|minimal change disease|minimal change disease
5087844|NCT01268033|focal and segmental glomerulosclerosis|focal and segmental glomerulosclerosis
5087845|NCT01268020|Alzheimer|alzheimer
5087846|NCT01268020|AD|ad
5087847|NCT01267994|Steroid|steroid
5087848|NCT01267994|Steroid-Resistant|steroid-resistant
5087849|NCT01267994|Autoimmune Inner Ear Disease|autoimmune inner ear disease
5087850|NCT01267994|Immune Mediated Hearing Loss|immune mediated hearing loss
5087851|NCT01267994|Sudden Sensorineural Hearing Loss|sudden sensorineural hearing loss
5087852|NCT01267994|Meniere's Disease|meniere's disease
5087853|NCT01267994|Autoimmune|autoimmune
5087854|NCT01267994|Hearing|hearing
5087855|NCT01267981|Small bowel|small bowel
5087857|NCT01267981|gastrointestinal bleeding|gastrointestinal bleeding
5087858|NCT01267981|polyethylene glycol|polyethylene glycol
5087859|NCT01267968|pharmacokinetics|pharmacokinetics
5087860|NCT01267968|bronchoalveolar lavage|bronchoalveolar lavage
5087861|NCT01267968|GSK2251052|gsk2251052
5087862|NCT01267968|pulmonary|pulmonary
5087863|NCT01267968|healthy volunteer|healthy volunteer
5087864|NCT01267968|antimicrobial|antimicrobial
5087865|NCT01267942|Adenotonsillectomy.|adenotonsillectomy.
5087866|NCT01267929|Children with cerebral palsy|children with cerebral palsy
5087867|NCT01267929|Gross Motor Function Measure|gross motor function measure
5087868|NCT01267929|Imitative learning|imitative learning
5087869|NCT01267929|Mirror neuron|mirror neuron
5087870|NCT01267929|Action observation|action observation
5087871|NCT01267929|Conventional physical therapy|conventional physical therapy
5087872|NCT01267916|intrinsic positive end-expiratory pressure|intrinsic positive end-expiratory pressure
5087873|NCT01267916|obesity|obesity
5087874|NCT01267916|ventilator setting|ventilator setting
5087875|NCT01267916|respiratory rate|respiratory rate
5087876|NCT01267903|Vaccines Adverse Reaction|vaccines adverse reaction
5087877|NCT01267890|ethics|ethics
5087878|NCT01267890|law|law
5087879|NCT01267890|surrogate|surrogate
5087880|NCT01267890|conflict|conflict
5087881|NCT01267877|U.S. Preventive Services Task Force|u.s. preventive services task force
5087882|NCT01267877|Patient attitude|patient attitude
5087883|NCT01267877|Mammogram|mammogram
5087884|NCT01267877|Guideline|guideline
5087885|NCT01267864|migraine|migraine
5087886|NCT01267864|emergency|emergency
5087887|NCT01267864|metoclopramide|metoclopramide
5087888|NCT01267864|ketorolac|ketorolac
5087889|NCT01267864|valproate|valproate
5087890|NCT01267851|gynecologic disease|gynecologic disease
5087891|NCT01267838|Coronary artery disease|coronary artery disease
5087892|NCT01267838|Restenosis|restenosis
5087893|NCT01267838|Stent thrombosis|stent thrombosis
5087894|NCT01267825|Disc herniation|disc herniation
5087895|NCT01267825|Lumbosacral radiculopathy|lumbosacral radiculopathy
5087896|NCT01267825|Corticosteroids|corticosteroids
5087897|NCT01267786|Oxidotic stress|oxidotic stress
5087898|NCT01267773|depression|depression
5087899|NCT01267773|conduct problems|conduct problems
5087900|NCT01267760|dialysis|dialysis
5087901|NCT01267760|hemodialysis|hemodialysis
5087902|NCT01267760|Effect of recycled low-volume dialysate on dialysis efficacy|effect of recycled low-volume dialysate on dialysis efficacy
5087903|NCT01267747|Atrial fibrillation|atrial fibrillation
5087904|NCT01267747|Atrial Flutter|atrial flutter
5087905|NCT01267747|Primary Aldosteronism|primary aldosteronism
5087906|NCT01267747|Aldosterone Producing Adenoma|aldosterone producing adenoma
5087907|NCT01267734|Everolimus|everolimus
5087908|NCT01267734|Zotarolimus|zotarolimus
5087909|NCT01267734|Cilostazol|cilostazol
5087910|NCT01267734|Clopidogrel|clopidogrel
5087911|NCT01267721|heart surgery|heart surgery
5087912|NCT01267695|Gastrointestinal Stromal Tumor|gastrointestinal stromal tumor
5087913|NCT01267695|Imatinib mesylate|imatinib mesylate
5087914|NCT01267695|Perioperative therapy|perioperative therapy
5087915|NCT01267682|Delirium|delirium
5087916|NCT01267682|Dementia|dementia
5087917|NCT01267682|Non-pharmacological Intervention|non-pharmacological intervention
5087918|NCT01267682|Post-acute care|post-acute care
5087919|NCT01267669|Variceal bleeding|variceal bleeding
5087920|NCT01267669|Endoscopic therapy|endoscopic therapy
5087921|NCT01267669|Band ligation|band ligation
5087922|NCT01267669|Somatostatin|somatostatin
5087923|NCT01267669|Vasoactive drugs|vasoactive drugs
5087924|NCT01267669|Octreotide|octreotide
5087925|NCT01267643|Alefacept|alefacept
5087926|NCT01267643|Amevive|amevive
5087927|NCT01267643|Aplastic Anemia|aplastic anemia
5087928|NCT01267643|Moderate to Severe Aplastic Anemia|moderate to severe aplastic anemia
5087929|NCT01267630|Delirium of Mixed Origin|delirium of mixed origin
5087930|NCT01267630|Subacute Delirium|subacute delirium
5087931|NCT01267630|Mental Disorders, Organic|mental disorders, organic
5087932|NCT01267630|Organic Brain Syndrome, Nonpsychotic|organic brain syndrome, nonpsychotic
5087933|NCT01267630|Organic Mental Disorders|organic mental disorders
5087934|NCT01267630|Organic Mental Disorders, Psychotic|organic mental disorders, psychotic
5087935|NCT01267630|Psychoses, Traumatic|psychoses, traumatic
5087936|NCT01267630|Cognition Disorder|cognition disorder
5087937|NCT01267630|Confusion state|confusion state
5087938|NCT01267630|Disorientation|disorientation
5087939|NCT01267617|hemodialysis|hemodialysis
5087940|NCT01267617|hypotension|hypotension
5087941|NCT01267617|circulatory stress|circulatory stress
5087942|NCT01267617|photo-plethysmography|photo-plethysmography
5087943|NCT01267578|Epitope peptide, CTL, Esophageal cancer, Vaccination|epitope peptide, ctl, esophageal cancer, vaccination
5087944|NCT01267565|ventilator-acquired pneumonia|ventilator-acquired pneumonia
5087945|NCT01267565|prevention|prevention
5087946|NCT01267565|amylase|amylase
5087947|NCT01267565|tracheal aspiration|tracheal aspiration
5087948|NCT01267565|microaspiration|microaspiration
5087949|NCT01267552|Breast cancer|breast cancer
5087950|NCT01267552|Surgery|surgery
5087951|NCT01267552|Complications|complications
5087952|NCT01267552|Drainage|drainage
5087953|NCT01267552|Seroma|seroma
5087954|NCT01267539|Suan Zao Ren Tang, climacteric, PSQI, WHOQOL-BREF|suan zao ren tang, climacteric, psqi, whoqol-bref
5087955|NCT01267526|Growth disorders|growth disorders
5087956|NCT01267526|Saizen|saizen
5087957|NCT01267526|Easypod|easypod
5087958|NCT01267526|Growth hormone|growth hormone
5087959|NCT01267526|Pediatric subject|pediatric subject
5087960|NCT01267513|oxygen saturation|oxygen saturation
5087961|NCT01267513|pulse rate|pulse rate
5087962|NCT01267513|tachycardia|tachycardia
5087963|NCT01267513|bradycardia|bradycardia
5087964|NCT01267513|hypoxia|hypoxia
5087965|NCT01267487|Heparin|heparin
5087966|NCT01267487|Protamine|protamine
5087967|NCT01267487|Cardiopulmonary Bypass|cardiopulmonary bypass
5087968|NCT01267487|Titration|titration
5087969|NCT01267474|School children|school children
5087970|NCT01267474|Sugar intake|sugar intake
5087971|NCT01267474|Nutritional education program|nutritional education program
5087972|NCT01267461|To asses the biological actions of insulin analogs in primary tumor cells|to asses the biological actions of insulin analogs in primary tumor cells
5087973|NCT01267448|Diabetes Mellitus Type2.|diabetes mellitus type2.
5087974|NCT01267448|Severe Hyperglycemia - blood glucose levels >300mg/dl.|severe hyperglycemia - blood glucose levels >300mg/dl.
5088067|NCT01266993|Persistence|persistence
5087975|NCT01267435|Arthroscopy, Anterior Cruciate Ligament, Tibial Tunnel.|arthroscopy, anterior cruciate ligament, tibial tunnel.
5087976|NCT01267422|Leber's Hereditary Optic Neuropathy,11778 LHON mutation,|leber's hereditary optic neuropathy,11778 lhon mutation,
5087977|NCT01267422|rAAV2-ND4,triamcinolone acetonide|raav2-nd4,triamcinolone acetonide
5087978|NCT01267409|Mapping the emotional territories of the STN|mapping the emotional territories of the stn
5087979|NCT01267409|Identifying the emotional spectral signature of the STN single unit activity|identifying the emotional spectral signature of the stn single unit activity
5087980|NCT01267409|Manipulating emotional processing of PD patients by high and low frequency stimulation|manipulating emotional processing of pd patients by high and low frequency stimulation
5087981|NCT01267409|Affecting long-term emotional states of the PD patients|affecting long-term emotional states of the pd patients
5087982|NCT01267396|Bioequivalence|bioequivalence
5087983|NCT01267396|Sertraline|sertraline
5087984|NCT01267396|crossover|crossover
5087985|NCT01267383|Bioequivalence|bioequivalence
5087986|NCT01267383|Sertraline|sertraline
5087987|NCT01267383|crossover|crossover
5087988|NCT01267370|clinical trial|clinical trial
5087989|NCT01267370|dietary fiber|dietary fiber
5087990|NCT01267370|constipation|constipation
5087991|NCT01267370|children|children
5087992|NCT01267357|Serous Papillary Endometrial Cancer|serous papillary endometrial cancer
5087993|NCT01267357|Endometrioid endometrial cancer|endometrioid endometrial cancer
5087994|NCT01267357|biomarkers|biomarkers
5087995|NCT01267357|P16|p16
5087996|NCT01267357|P53|p53
5087997|NCT01267357|Prognosis|prognosis
5087998|NCT01267344|biliary tract cancer|biliary tract cancer
5087999|NCT01267344|BTC|btc
5088000|NCT01267344|cetuximaba|cetuximaba
5088001|NCT01267331|Old Myocardial Infarction|old myocardial infarction
5088002|NCT01267331|Stem Cell Therapy|stem cell therapy
5088003|NCT01267331|Coronary Artery Bypass Grafting|coronary artery bypass grafting
5088004|NCT01267331|Coronary Artery Disease|coronary artery disease
5088005|NCT01267318|Gastric juice|gastric juice
5088006|NCT01267318|Stomach|stomach
5088007|NCT01267318|GI|gi
5088008|NCT01267318|Gastric juice samples with presence of blood.|gastric juice samples with presence of blood.
5088009|NCT01267305|esophagectomy|esophagectomy
5088010|NCT01267305|lung resection|lung resection
5088011|NCT01267305|venous thromboembolism|venous thromboembolism
5088012|NCT01267305|low molecular weight heparin|low molecular weight heparin
5088013|NCT01267305|chest drainage|chest drainage
5088014|NCT01267305|TEG|teg
5088015|NCT01267292|cocaine dependence|cocaine dependence
5088016|NCT01267292|psychopharmacology|psychopharmacology
5088017|NCT01267292|attentional bias|attentional bias
5088018|NCT01267292|risky decision making|risky decision making
5088019|NCT01267292|buspirone|buspirone
5088020|NCT01267292|methylphenidate|methylphenidate
5088021|NCT01267227|Hyperlipidemia|hyperlipidemia
5088022|NCT01267227|Cholesterol|cholesterol
5088023|NCT01267227|Blood Pressure|blood pressure
5088024|NCT01267227|Oxidative Stress|oxidative stress
5088025|NCT01267227|Pterostilbene|pterostilbene
5088026|NCT01267227|Blueberry|blueberry
5088027|NCT01267227|Grape Extract|grape extract
5088028|NCT01267201|Single dose bioavailability study of methylprednisolone powder for oral suspension (4mg/mL) versus methylprednisolone tablet (32 mg)|single dose bioavailability study of methylprednisolone powder for oral suspension (4mg/ml) versus methylprednisolone tablet (32 mg)
5088029|NCT01267162|CHB|chb
5088030|NCT01267149|superficial vertical perioral lines|superficial vertical perioral lines
5088031|NCT01267149|superficial horizontal and lateral canthal lines|superficial horizontal and lateral canthal lines
5088032|NCT01267149|correct moderate to severe facial wrinkles and folds|correct moderate to severe facial wrinkles and folds
5088033|NCT01267136|Tonsillectomy|tonsillectomy
5088034|NCT01267136|Pain|pain
5088035|NCT01267136|Pediatric|pediatric
5088036|NCT01267136|Opioids|opioids
5088037|NCT01267136|Tramadol|tramadol
5088038|NCT01267136|Codeine|codeine
5088039|NCT01267097|Pediatric Obesity|pediatric obesity
5088040|NCT01267097|Treatment|treatment
5088041|NCT01267097|Cognitive Behavioural Therapy|cognitive behavioural therapy
5088042|NCT01267097|Psychoeducation|psychoeducation
5088043|NCT01267097|Canada|canada
5088044|NCT01267084|Trabectedin (YONDELIS)|trabectedin (yondelis)
5088045|NCT01267084|Ketoconazole|ketoconazole
5088046|NCT01267084|Antineoplastic Agents|antineoplastic agents
5088047|NCT01267084|Solid tumors|solid tumors
5088048|NCT01267084|Locally advanced or metastatic disease|locally advanced or metastatic disease
5088049|NCT01267084|Chemotherapy|chemotherapy
5088050|NCT01267084|Pharmacokinetics|pharmacokinetics
5088051|NCT01267071|Entero-test|entero-test
5088052|NCT01267071|Phase I|phase i
5088053|NCT01267071|GSK962040|gsk962040
5088054|NCT01267071|i.v. microtracer|i.v. microtracer
5088055|NCT01267071|radioactivity|radioactivity
5088056|NCT01267071|pharmacokinetics|pharmacokinetics
5088057|NCT01267071|healthy volunteer|healthy volunteer
5088058|NCT01267058|Booster vaccination|booster vaccination
5088059|NCT01267045|Persian Gulf Syndrome|persian gulf syndrome
5088060|NCT01267045|Pain|pain
5088061|NCT01267045|Fatigue|fatigue
5088062|NCT01267045|Attention|attention
5088063|NCT01267045|Meditation|meditation
5088064|NCT01267019|social cognition|social cognition
5088065|NCT01267019|training intervention|training intervention
5088066|NCT01266993|Immunogenicity|immunogenicity
5088068|NCT01266993|Safety|safety
5088069|NCT01266993|Conjugate vaccine|conjugate vaccine
5088070|NCT01266993|Meningococcal vaccine|meningococcal vaccine
5088071|NCT01266980|cortisol|cortisol
5088072|NCT01266980|renal impairment|renal impairment
5088073|NCT01266980|serum potassium|serum potassium
5088074|NCT01266980|pharmacokinetics|pharmacokinetics
5088075|NCT01266980|Fluticasone furoate|fluticasone furoate
5088076|NCT01266980|heart rate|heart rate
5088077|NCT01266967|GSK2118436|gsk2118436
5088078|NCT01266967|Metastatic melanoma to the brain|metastatic melanoma to the brain
5088079|NCT01266967|Brain metastases|brain metastases
5088080|NCT01266967|Braf mutation|braf mutation
5088081|NCT01266967|Brain neoplasm|brain neoplasm
5088082|NCT01266967|BRAF inhibitor|braf inhibitor
5088083|NCT01266954|Cancer|cancer
5088084|NCT01266954|18F FDG|18f fdg
5088085|NCT01266954|PK|pk
5088086|NCT01266954|PET|pet
5088087|NCT01266954|Positron Emission Tomography|positron emission tomography
5088088|NCT01266954|PD|pd
5088089|NCT01266954|AKT Inhibitor|akt inhibitor
5088090|NCT01266954|GSK2141795|gsk2141795
5088091|NCT01266941|pharmacokinetics|pharmacokinetics
5088092|NCT01266941|hepatic impairment|hepatic impairment
5088093|NCT01266941|heart rate|heart rate
5088094|NCT01266941|serum potassium|serum potassium
5088095|NCT01266941|serum cortisol|serum cortisol
5088096|NCT01266941|GW642444M|gw642444m
5088097|NCT01266941|Fluticasone furoate (GW685698)|fluticasone furoate (gw685698)
5088098|NCT01266915|SCLE|scle
5088099|NCT01266915|CLE|cle
5088100|NCT01266915|DLE|dle
5088101|NCT01266902|HIV-1 Infection|hiv-1 infection
5088102|NCT01266902|HIV-1|hiv-1
5088103|NCT01266902|HIV|hiv
5088104|NCT01266902|TMC278-TiDP6-C222|tmc278-tidp6-c222
5088105|NCT01266902|TMC278-C222|tmc278-c222
5088106|NCT01266902|TMC278|tmc278
5088107|NCT01266902|Rilpivirine|rilpivirine
5088108|NCT01266889|preterm infant,cerebral oxygenation, intracranial haemorrhagia|preterm infant,cerebral oxygenation, intracranial haemorrhagia
5088109|NCT01266863|Hospital-acquired pneumonia|hospital-acquired pneumonia
5088110|NCT01266863|E test|e test
5088111|NCT01266863|Antibiogram|antibiogram
5088112|NCT01266863|Bronchoalveolar lavage|bronchoalveolar lavage
5088113|NCT01266850|vaccine, rotavirus, gastroenteritis, infants|vaccine, rotavirus, gastroenteritis, infants
5088114|NCT01266837|metastatic renal cell carcinoma|metastatic renal cell carcinoma
5088115|NCT01266837|biomarker|biomarker
5088116|NCT01266837|Everolimus|everolimus
5088117|NCT01266824|Pain|pain
5088118|NCT01266824|Retinopathy of Prematurity|retinopathy of prematurity
5088119|NCT01266824|Neonates|neonates
5088120|NCT01266811|dexamethasone|dexamethasone
5088121|NCT01266811|Siltuximab|siltuximab
5088122|NCT01266811|CNTO 328|cnto 328
5088123|NCT01266811|IL-6|il-6
5088124|NCT01266811|Monoclonal Antibody|monoclonal antibody
5088125|NCT01266811|Multiple Myeloma|multiple myeloma
5088126|NCT01266811|Relapsed or Refractory|relapsed or refractory
5088127|NCT01266811|Velcade|velcade
5088128|NCT01266811|bortezomib|bortezomib
5088129|NCT01266798|Health literacy, participation|health literacy, participation
5088130|NCT01266785|crohn's|crohn's
5088131|NCT01266785|Infliximab|infliximab
5088132|NCT01266785|Inflammatory bowel disease|inflammatory bowel disease
5088133|NCT01266785|digestive tract|digestive tract
5088134|NCT01266785|Interleukin|interleukin
5088135|NCT01266772|asthma; children; montelukast; treatment; exacerbation|asthma; children; montelukast; treatment; exacerbation
5088136|NCT01266759|Menorrhagia|menorrhagia
5088137|NCT01266759|Vaginal ring|vaginal ring
5088138|NCT01266759|Norethisterone Acetate|norethisterone acetate
5088139|NCT01266746|gas tamponade,|gas tamponade,
5088140|NCT01266746|macular hole,|macular hole,
5088141|NCT01266746|macular hole retinal detachment,|macular hole retinal detachment,
5088142|NCT01266746|optical coherence tomography|optical coherence tomography
5088143|NCT01266733|fibromyalgia, non pharmacological intervention|fibromyalgia, non pharmacological intervention
5088144|NCT01266720|pancreatic cancer|pancreatic cancer
5088145|NCT01266720|peptide vaccine|peptide vaccine
5088146|NCT01266720|VEGFR|vegfr
5088147|NCT01266720|gemcitabine|gemcitabine
5088148|NCT01266707|Hepatocellular carcinoma|hepatocellular carcinoma
5088149|NCT01266707|peptide vaccine|peptide vaccine
5088150|NCT01266707|VEGFR|vegfr
5088151|NCT01266694|Pericardial effusion|pericardial effusion
5088152|NCT01266694|Cardiac surgery|cardiac surgery
5088153|NCT01266694|Tamponade|tamponade
5088154|NCT01266694|colchicine|colchicine
5088155|NCT01266668|Diffuse large B cell lymphoma|diffuse large b cell lymphoma
5088156|NCT01266668|Breast|breast
5088157|NCT01266668|Rituximab|rituximab
5088158|NCT01266642|Breast cancer|breast cancer
5088159|NCT01266642|Early invasive breast cancer|early invasive breast cancer
5088160|NCT01266642|Ductal carcinoma in situ of the breast|ductal carcinoma in situ of the breast
5088161|NCT01266642|Tis|tis
5088162|NCT01266642|T1|t1
5088163|NCT01266642|T2|t2
5088164|NCT01266642|N0|n0
5088165|NCT01266642|N1mic|n1mic
5088166|NCT01266642|N1a|n1a
5088167|NCT01266642|Lumpectomy|lumpectomy
5088168|NCT01266642|Hypofractionated whole breast irradiation|hypofractionated whole breast irradiation
5088169|NCT01266642|HF-WBI|hf-wbi
5088273|NCT01266213|goserelin|goserelin
5088274|NCT01266213|tamoxifen|tamoxifen
5088170|NCT01266642|Conventionally fractionated whole breast irradiation|conventionally fractionated whole breast irradiation
5088171|NCT01266642|CF-WBI|cf-wbi
5088172|NCT01266642|Radiation therapy|radiation therapy
5088173|NCT01266642|Radiotherapy|radiotherapy
5088174|NCT01266629|small bowel|small bowel
5088175|NCT01266616|Interleukin-12|interleukin-12
5088176|NCT01266616|Electroporation|electroporation
5088177|NCT01266616|HIV Therapeutic Vaccine|hiv therapeutic vaccine
5088178|NCT01266603|Metastatic Melanoma|metastatic melanoma
5088179|NCT01266603|Unresectable Melanoma|unresectable melanoma
5088180|NCT01266603|HDIL-2|hdil-2
5088181|NCT01266603|Interleukin-2|interleukin-2
5088182|NCT01266603|IL-2|il-2
5088183|NCT01266603|Aldesleukin|aldesleukin
5088184|NCT01266603|Proleukin|proleukin
5088185|NCT01266603|recMAGE-A3 + AS15|recmage-a3 + as15
5088186|NCT01266603|ASCI|asci
5088187|NCT01266603|recMAGE-A3|recmage-a3
5088188|NCT01266603|Recombinant MAGE-A3 protein|recombinant mage-a3 protein
5088189|NCT01266603|recMAGE-A3 + AS15 ASCI|recmage-a3 + as15 asci
5088190|NCT01266603|MAGE-A3|mage-a3
5088191|NCT01266603|MAGE-A3 ASCI|mage-a3 asci
5088192|NCT01266577|Brain Metabolism|brain metabolism
5088193|NCT01266577|Neurochemistry|neurochemistry
5088194|NCT01266577|Magnetic Resonance Imaging|magnetic resonance imaging
5088195|NCT01266577|Mental Illness|mental illness
5088196|NCT01266577|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
5088197|NCT01266577|Healthy Volunteer|healthy volunteer
5088198|NCT01266577|HV|hv
5088199|NCT01266551|Antireflux procedure|antireflux procedure
5088200|NCT01266551|Gastroesophageal reflux|gastroesophageal reflux
5088201|NCT01266551|Infant sleep position|infant sleep position
5088202|NCT01266551|pH monitoring|ph monitoring
5088203|NCT01266499|Klebsiella , pneumonia, carbapenem-hydrolyzing lactamase, carbapenem-resistant Klebsiella (KPC), eradication,|klebsiella , pneumonia, carbapenem-hydrolyzing lactamase, carbapenem-resistant klebsiella (kpc), eradication,
5088204|NCT01266486|Breast cancer|breast cancer
5088205|NCT01266486|Pharmacodynamics|pharmacodynamics
5088206|NCT01266486|AMPK|ampk
5088207|NCT01266486|PET Scan|pet scan
5088208|NCT01266473|Adults|adults
5088209|NCT01266434|moderate persistent asthma|moderate persistent asthma
5088210|NCT01266434|Inhaled corticosteroids|inhaled corticosteroids
5088211|NCT01266421|DNG|dng
5088212|NCT01266421|Anemia|anemia
5088213|NCT01266421|Depression|depression
5088214|NCT01266408|Drospirenone|drospirenone
5088215|NCT01266408|Dienogest|dienogest
5088216|NCT01266408|Metafolin|metafolin
5088217|NCT01266408|Folic acid|folic acid
5088218|NCT01266408|Safety|safety
5088219|NCT01266395|morning symptoms COPD|morning symptoms copd
5088220|NCT01266369|mastocytosis|mastocytosis
5088221|NCT01266369|D816V|d816v
5088222|NCT01266369|handicaps|handicaps
5088223|NCT01266356|Minor Traumatic Brain Injury|minor traumatic brain injury
5088224|NCT01266356|Translation|translation
5088225|NCT01266343|Glaucoma|glaucoma
5088226|NCT01266343|anterior chamber paracentesis|anterior chamber paracentesis
5088227|NCT01266343|conventional Mannitol infusion|conventional mannitol infusion
5088228|NCT01266330|dairy|dairy
5088229|NCT01266330|inflammation|inflammation
5088230|NCT01266330|reactive oxygen species|reactive oxygen species
5088231|NCT01266330|oxidative stress|oxidative stress
5088232|NCT01266330|body composition|body composition
5088233|NCT01266291|Tuberous sclerosis|tuberous sclerosis
5088234|NCT01266291|TS|ts
5088235|NCT01266291|Seizures|seizures
5088236|NCT01266278|shoulder injuries|shoulder injuries
5088237|NCT01266265|pulmonary arterial hypertension|pulmonary arterial hypertension
5088238|NCT01266265|PAH|pah
5088239|NCT01266265|treprostinil sodium|treprostinil sodium
5088240|NCT01266265|Tyvaso|tyvaso
5088241|NCT01266265|inhalation|inhalation
5088242|NCT01266265|Ventavis|ventavis
5088243|NCT01266265|iloprost|iloprost
5088244|NCT01266265|prostacyclin|prostacyclin
5088245|NCT01266265|epoprostenol sodium|epoprostenol sodium
5088246|NCT01266265|Flolan|flolan
5088247|NCT01266265|Veletri|veletri
5088248|NCT01266265|subcutaneous and intravenous prostacyclin analogue|subcutaneous and intravenous prostacyclin analogue
5088249|NCT01266265|Remodulin|remodulin
5088250|NCT01266265|oral ERA|oral era
5088251|NCT01266265|bosentan|bosentan
5088252|NCT01266265|Tracleer|tracleer
5088253|NCT01266265|ambrisentan|ambrisentan
5088254|NCT01266265|Letairis|letairis
5088255|NCT01266265|oral PDE5 inhibitors|oral pde5 inhibitors
5088256|NCT01266265|sildenafil|sildenafil
5088257|NCT01266265|Revatio|revatio
5088258|NCT01266265|tadalafil|tadalafil
5088259|NCT01266265|Adcirca|adcirca
5088260|NCT01266265|Opsumit|opsumit
5088261|NCT01266265|macitentan|macitentan
5088262|NCT01266265|Adempas|adempas
5088263|NCT01266265|riociguat|riociguat
5088264|NCT01266265|Orenitram|orenitram
5088265|NCT01266265|oral treprostinil|oral treprostinil
5088266|NCT01266252|neonates|neonates
5088267|NCT01266252|single organ respiratory failure|single organ respiratory failure
5088268|NCT01266239|Bifurcation lesion, drug-eluting stent, symmetric expansion|bifurcation lesion, drug-eluting stent, symmetric expansion
5088269|NCT01266226|Rotator cuff tears|rotator cuff tears
5088270|NCT01266226|ACP|acp
5088271|NCT01266213|fulvestrant|fulvestrant
5088272|NCT01266213|anastrozole|anastrozole
5088275|NCT01266213|premenopausal|premenopausal
5088276|NCT01266213|hormone receptor positive|hormone receptor positive
5088277|NCT01266200|microcirculation|microcirculation
5088278|NCT01266200|vertebral fracture|vertebral fracture
5088279|NCT01266200|inflammation|inflammation
5088280|NCT01266200|minimal-invasive surgery|minimal-invasive surgery
5088281|NCT01266187|FOLFOX|folfox
5088282|NCT01266187|liver metastasis|liver metastasis
5088283|NCT01266187|cetuximab|cetuximab
5088284|NCT01266174|CIAS|cias
5088285|NCT01266174|Cognition|cognition
5088286|NCT01266174|Schizophrenia|schizophrenia
5088287|NCT01266174|Eltoprazine|eltoprazine
5088288|NCT01266161|dental pain|dental pain
5088289|NCT01266161|multiple dose|multiple dose
5088290|NCT01266161|ibuprofen|ibuprofen
5088291|NCT01266161|third molar extraction|third molar extraction
5088292|NCT01266135|Interstitial Lung Disease|interstitial lung disease
5088293|NCT01266135|Usual Interstitial Pneumonia|usual interstitial pneumonia
5088294|NCT01266135|Fibrosis,|fibrosis,
5088295|NCT01266135|Pulmonary Fibrosis,|pulmonary fibrosis,
5088296|NCT01266135|Respiratory Disease,|respiratory disease,
5088297|NCT01266135|Interstitial Lung Disease,|interstitial lung disease,
5088298|NCT01266135|Biological Therapy,|biological therapy,
5088299|NCT01266135|Therapeutic Uses,|therapeutic uses,
5088300|NCT01266122|HIV|hiv
5088301|NCT01266122|Psychosocial problems|psychosocial problems
5088302|NCT01266122|MSM|msm
5088303|NCT01266122|India|india
5088304|NCT01266109|Substance Use|substance use
5088305|NCT01266109|Delinquency|delinquency
5088306|NCT01266109|Juvenile Drug Court|juvenile drug court
5088307|NCT01266109|Contingency Management|contingency management
5088308|NCT01266109|Family Engagement|family engagement
5088309|NCT01266096|124I-cRGDY-PEG-dots|124i-crgdy-peg-dots
5088310|NCT01266096|Pet scan|pet scan
5088311|NCT01266096|10-155|10-155
5088312|NCT01266096|melanoma|melanoma
5088313|NCT01266096|brain|brain
5088314|NCT01266083|MONTANIDE ISA 51|montanide isa 51
5088315|NCT01266083|WT1 PEPTIDE SPECIFIC T CELLS|wt1 peptide specific t cells
5088316|NCT01266083|vaccine|vaccine
5088317|NCT01266083|10-143|10-143
5088318|NCT01266070|VHL|vhl
5088319|NCT01266070|Hemangioblastoma|hemangioblastoma
5088320|NCT01266070|Tumor of the central nervous system|tumor of the central nervous system
5088321|NCT01266070|TKI258|tki258
5088322|NCT01266057|Advanced Malignancies|advanced malignancies
5088323|NCT01266057|Metastatic cancers|metastatic cancers
5088324|NCT01266057|Sirolimus|sirolimus
5088325|NCT01266057|Hydroxychloroquine|hydroxychloroquine
5088326|NCT01266057|Vorinostat|vorinostat
5088327|NCT01266057|Plaquenil|plaquenil
5088328|NCT01266057|Rapamune|rapamune
5088329|NCT01266057|Saha|saha
5088330|NCT01266057|Suberoylanilide Hydroxamic Acid|suberoylanilide hydroxamic acid
5088331|NCT01266057|MSK-390|msk-390
5088332|NCT01266057|Zolinza|zolinza
5088333|NCT01266044|Radiation-induced xerostomia|radiation-induced xerostomia
5088334|NCT01266044|Acupuncture|acupuncture
5088335|NCT01266044|Oropharyngeal cancer|oropharyngeal cancer
5088336|NCT01266044|Radiation Therapy|radiation therapy
5088337|NCT01266044|IMRT|imrt
5088338|NCT01266044|Dry mouth|dry mouth
5088339|NCT01266031|Glioblastoma Multiforme|glioblastoma multiforme
5088340|NCT01266018|small cell lung cancer|small cell lung cancer
5088341|NCT01266018|SCLC|sclc
5088342|NCT01266018|ADI-PEG 20|adi-peg 20
5088343|NCT01266018|arginine deiminase pegylated|arginine deiminase pegylated
5088344|NCT01266005|HBe Ag(-) Chronic Hepatitis B|hbe ag(-) chronic hepatitis b
5088345|NCT01265992|Secondary hyperparathyroidism|secondary hyperparathyroidism
5088346|NCT01265992|Mineral and Bone Disorder (CKD-MBD)|mineral and bone disorder (ckd-mbd)
5088347|NCT01265992|Chronic Kidney Disease|chronic kidney disease
5088348|NCT01265979|advanced|advanced
5088349|NCT01265979|metastatic|metastatic
5088350|NCT01265979|gastro-intestinal|gastro-intestinal
5088351|NCT01265979|stromal|stromal
5088352|NCT01265979|GIST|gist
5088353|NCT01265979|regorafenib|regorafenib
5088354|NCT01265966|Moderate Sedation|moderate sedation
5088355|NCT01265966|Sedation, Deep|sedation, deep
5088356|NCT01265953|cancer prevention|cancer prevention
5088357|NCT01265953|isothiocyanate|isothiocyanate
5088358|NCT01265953|sulforaphane|sulforaphane
5088359|NCT01265940|bladder cancer|bladder cancer
5088360|NCT01265940|urothelial cancer|urothelial cancer
5088361|NCT01265940|metastatic urothelial cancer|metastatic urothelial cancer
5088362|NCT01265940|advanced urothelial cancer|advanced urothelial cancer
5088363|NCT01265927|Breast Cancer|breast cancer
5088364|NCT01265927|Breast Tumors|breast tumors
5088365|NCT01265927|Cancer of Breast|cancer of breast
5088366|NCT01265927|Cancer of the Breast|cancer of the breast
5088367|NCT01265927|Genes, HER-2|genes, her-2
5088368|NCT01265927|Genes, HER2|genes, her2
5088369|NCT01265901|Metastatic Renal Cell Carcinoma|metastatic renal cell carcinoma
5088370|NCT01265901|First line|first line
5088371|NCT01265901|Eligible for sunitinib|eligible for sunitinib
5088372|NCT01265888|PAH|pah
5088373|NCT01265888|PH IPF|ph ipf
5088374|NCT01265875|Chronic Pancreatitis|chronic pancreatitis
5088375|NCT01265862|Tracheal intubation|tracheal intubation
5088376|NCT01265862|Supraglottic airway devices|supraglottic airway devices
5089163|NCT01262261|implant|implant
5088377|NCT01265862|Patients undergoing general anesthesia|patients undergoing general anesthesia
5088378|NCT01265836|Dyslipidemia Treatment and Cardiovascular Outcomes|dyslipidemia treatment and cardiovascular outcomes
5088379|NCT01265823|Humira|humira
5088380|NCT01265823|Adalimumab|adalimumab
5088381|NCT01265823|Plaque Psoriasis|plaque psoriasis
5088382|NCT01265810|stomatitis|stomatitis
5088383|NCT01265810|targeted therapy|targeted therapy
5088384|NCT01265810|Caphosol|caphosol
5088385|NCT01265810|mouthrinses|mouthrinses
5088386|NCT01265771|Arrhythmia|arrhythmia
5088387|NCT01265771|Children|children
5088388|NCT01265758|Atrial fibrillation|atrial fibrillation
5088389|NCT01265758|Cardiac arrhythmia|cardiac arrhythmia
5088390|NCT01265758|ECG|ecg
5088391|NCT01265758|Telemonitoring|telemonitoring
5088392|NCT01265758|Telemetry|telemetry
5088393|NCT01265758|Holter|holter
5088394|NCT01265745|Phase I|phase i
5088395|NCT01265732|Phase 1|phase 1
5088396|NCT01265732|relative bioavailability|relative bioavailability
5088397|NCT01265732|healthy volunteers|healthy volunteers
5088398|NCT01265732|pharmacokinetics|pharmacokinetics
5088399|NCT01265732|suspension|suspension
5088400|NCT01265732|dispersion|dispersion
5088401|NCT01265719|Prospective|prospective
5088402|NCT01265719|non-interventional|non-interventional
5088403|NCT01265719|longitudinal|longitudinal
5088404|NCT01265719|cohort study|cohort study
5088405|NCT01265706|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors
5088406|NCT01265680|Blood Transfusion|blood transfusion
5088407|NCT01265680|Heart surgery|heart surgery
5088408|NCT01265680|Erythropoietin|erythropoietin
5088409|NCT01265680|HRE|hre
5088410|NCT01265667|Psoriasis|psoriasis
5088411|NCT01265667|Plaque psoriasis|plaque psoriasis
5088412|NCT01265654|Advanced Breast Cancer|advanced breast cancer
5088413|NCT01265654|Hormonal Treatment|hormonal treatment
5088414|NCT01265615|chronic allograft nephropathy|chronic allograft nephropathy
5088415|NCT01265615|stem-progenitor cells|stem-progenitor cells
5088416|NCT01265615|cardiorenal syndrome|cardiorenal syndrome
5088417|NCT01265615|calcitriol|calcitriol
5088418|NCT01265615|paricalcitol|paricalcitol
5088419|NCT01265615|cholecalciferol|cholecalciferol
5088420|NCT01265615|cardiac repair|cardiac repair
5088421|NCT01265615|renal repair|renal repair
5088422|NCT01265602|Actinic Keratosis|actinic keratosis
5088423|NCT01265602|AK|ak
5088424|NCT01265602|NMSC|nmsc
5088425|NCT01265589|RDS|rds
5088426|NCT01265589|Infant, newborn|infant, newborn
5088427|NCT01265589|Vitamin A|vitamin a
5088428|NCT01265589|Surfactant|surfactant
5088429|NCT01265563|silymarin|silymarin
5088430|NCT01265563|glutathione|glutathione
5088431|NCT01265563|diabetic nephropathies|diabetic nephropathies
5088432|NCT01265563|oxidative stress|oxidative stress
5088433|NCT01265563|N-acetylcysteine|n-acetylcysteine
5088434|NCT01265563|protein tholation|protein tholation
5088435|NCT01265537|Transplant|transplant
5088436|NCT01265537|Tacrolimus|tacrolimus
5088437|NCT01265537|Diabetes after transplant|diabetes after transplant
5088438|NCT01265537|Acute rejection prevention|acute rejection prevention
5088439|NCT01265537|New onset diabetes after transplant|new onset diabetes after transplant
5088440|NCT01265511|Hepatitis C|hepatitis c
5088441|NCT01265511|SCY-635|scy-635
5088442|NCT01265511|Ribavirin|ribavirin
5088443|NCT01265511|Interferon|interferon
5088444|NCT01265498|Farnesoid X Receptor|farnesoid x receptor
5088445|NCT01265498|FXR|fxr
5088446|NCT01265498|Nonalcoholic fatty liver disease|nonalcoholic fatty liver disease
5088447|NCT01265498|Nonalcoholic steatohepatitis|nonalcoholic steatohepatitis
5088448|NCT01265498|NAFLD|nafld
5088449|NCT01265498|NASH|nash
5088450|NCT01265498|obeticholic acid|obeticholic acid
5088451|NCT01265472|Translocator Protein|translocator protein
5088452|NCT01265472|Basal Cell Carcinoma|basal cell carcinoma
5088453|NCT01265472|Squamous Cell Carcinoma|squamous cell carcinoma
5088454|NCT01265472|Malignancy|malignancy
5088455|NCT01265446|Sore throat, upper respiratory tract infection, lozenge with lidocaine and cetylpyridinium chloride.|sore throat, upper respiratory tract infection, lozenge with lidocaine and cetylpyridinium chloride.
5088456|NCT01265433|GM-CSF|gm-csf
5088457|NCT01265433|MONTANIDE ISA 51|montanide isa 51
5088458|NCT01265433|WT1 PEPTIDE SPECIFIC T CELLS|wt1 peptide specific t cells
5088459|NCT01265433|Vaccine|vaccine
5088460|NCT01265433|10-134|10-134
5088461|NCT01265420|Dupuytren|dupuytren
5088462|NCT01265420|Dupuytren's Disease|dupuytren's disease
5088463|NCT01265407|Children|children
5088464|NCT01265407|Hemoglobinopathies|hemoglobinopathies
5088465|NCT01265407|Epidemiology|epidemiology
5088466|NCT01265407|Malaria|malaria
5088467|NCT01265394|Amyloid|amyloid
5088468|NCT01265394|Magnetic resonance imaging|magnetic resonance imaging
5088469|NCT01265394|Positron Emission Tomography|positron emission tomography
5088470|NCT01265394|Standard uptake value ratios|standard uptake value ratios
5088471|NCT01265394|Healthy Subjects|healthy subjects
5088472|NCT01265381|Cohort|cohort
5088473|NCT01265381|Radiation|radiation
5088474|NCT01265381|Thyroid Cancer|thyroid cancer
5088475|NCT01265368|Advanced Renal Cell Carcinoma|advanced renal cell carcinoma
5088476|NCT01265368|Tumor Vaccine|tumor vaccine
5088477|NCT01265368|Cell-based Therapy|cell-based therapy
5088478|NCT01265342|Bronchial Spasm|bronchial spasm
5088479|NCT01265342|Respiratory Tract Infections|respiratory tract infections
5088480|NCT01265342|Viral wheezing|viral wheezing
5088481|NCT01265342|Child, Preschool|child, preschool
5088482|NCT01265342|Beclomethasone|beclomethasone
5088483|NCT01265342|Italy|italy
5088484|NCT01265342|Physicians, Primary Care|physicians, primary care
5088485|NCT01265342|Pediatrics|pediatrics
5088486|NCT01265316|Cardiac arrest, CPR, pediatric|cardiac arrest, cpr, pediatric
5088487|NCT01265303|ablation, cardiac arrhythmia, atrial fibrillation, telemonitoring, telemetry|ablation, cardiac arrhythmia, atrial fibrillation, telemonitoring, telemetry
5088488|NCT01265290|Cardiac arrhythmia|cardiac arrhythmia
5088489|NCT01265290|Cardiogenic syncope|cardiogenic syncope
5088490|NCT01265290|Pediatrics|pediatrics
5088491|NCT01265290|Children|children
5088492|NCT01265277|sudden infant death syndrome|sudden infant death syndrome
5088493|NCT01265277|SIDS|sids
5088494|NCT01265277|infant|infant
5088495|NCT01265277|licensed day care|licensed day care
5088496|NCT01265277|sleep patterns|sleep patterns
5088497|NCT01265277|stress levels|stress levels
5088498|NCT01265264|Gout|gout
5088499|NCT01265264|hyperuricemia|hyperuricemia
5088500|NCT01265264|arthritis|arthritis
5088501|NCT01265264|joint diseases|joint diseases
5088502|NCT01265264|allopurinol|allopurinol
5088503|NCT01265251|Normal Pressure Hydrocephalus|normal pressure hydrocephalus
5088504|NCT01265251|Neuropsychological Test|neuropsychological test
5088505|NCT01265251|Assessment of cognitive disorders/dementia|assessment of cognitive disorders/dementia
5088506|NCT01265251|Neuropsychological assessment|neuropsychological assessment
5088507|NCT01265238|Spastic equinovarus foot|spastic equinovarus foot
5088508|NCT01265238|Stroke|stroke
5088509|NCT01265238|Neurotomy|neurotomy
5088510|NCT01265238|Tendon surgery|tendon surgery
5088511|NCT01265225|breast cancer stages 0-II|breast cancer stages 0-ii
5088512|NCT01265199|AML|aml
5088513|NCT01265186|Sedation|sedation
5088514|NCT01265186|BIS|bis
5088515|NCT01265186|aEEG|aeeg
5088516|NCT01265186|Neonatal Pain and Sedation Scale|neonatal pain and sedation scale
5088517|NCT01265186|neonate|neonate
5088518|NCT01265186|newborn|newborn
5088519|NCT01265173|SBP|sbp
5088520|NCT01265173|liver cirrhosis|liver cirrhosis
5088521|NCT01265173|antibiotics|antibiotics
5088522|NCT01265134|the elders|the elders
5088523|NCT01265134|falling|falling
5088524|NCT01265134|loss balance|loss balance
5088525|NCT01265121|Acromegaly|acromegaly
5088526|NCT01265121|Insulin resistance|insulin resistance
5088527|NCT01265121|Euglycemic Clamp|euglycemic clamp
5088528|NCT01265121|Somatostatin analogues|somatostatin analogues
5088529|NCT01265095|VRE|vre
5088530|NCT01265069|Helicobacter pylori|helicobacter pylori
5088531|NCT01265069|concomitant therapy|concomitant therapy
5088532|NCT01265069|high dose dual therapy|high dose dual therapy
5088533|NCT01265069|antibiotic resistance|antibiotic resistance
5088534|NCT01265043|oral health|oral health
5088535|NCT01265043|oral hygiene|oral hygiene
5088536|NCT01265043|bacteria|bacteria
5088537|NCT01265043|quality of life|quality of life
5088538|NCT01265043|Clinical oral health in patients following acute stroke|clinical oral health in patients following acute stroke
5088539|NCT01265043|Oral opportunistic pathogens in patients following acute stroke|oral opportunistic pathogens in patients following acute stroke
5088540|NCT01265043|Oral health-related quality of life in patients following acute stroke|oral health-related quality of life in patients following acute stroke
5088541|NCT01265030|Desmoid Tumor|desmoid tumor
5088542|NCT01265030|Sirolimus|sirolimus
5088543|NCT01265030|Surgically-Resectable Desmoid Tumor|surgically-resectable desmoid tumor
5088544|NCT01265017|type 1 diabetes|type 1 diabetes
5088545|NCT01265017|pregnancy|pregnancy
5088546|NCT01265017|insulin requirement|insulin requirement
5088547|NCT01265004|Functional outcome|functional outcome
5088548|NCT01264991|Sham|sham
5088549|NCT01264991|Meniscus tear|meniscus tear
5088550|NCT01264991|Meniscectomy|meniscectomy
5088551|NCT01264978|COPD|copd
5088552|NCT01264978|Rehabilitation|rehabilitation
5088553|NCT01264978|Neuromuscular stimulation|neuromuscular stimulation
5088554|NCT01264978|Quadriceps muscle|quadriceps muscle
5088555|NCT01264978|Magnetic stimulation|magnetic stimulation
5088556|NCT01264965|Pain|pain
5088557|NCT01264965|Analgesia|analgesia
5088558|NCT01264965|Cognitive impairment|cognitive impairment
5088559|NCT01264965|Randomized controlled trial|randomized controlled trial
5088560|NCT01264965|Physical function|physical function
5088561|NCT01264952|Liver metastases of colorectal cancer|liver metastases of colorectal cancer
5088562|NCT01264952|Bleomycin|bleomycin
5088563|NCT01264952|Electrochemotherapy|electrochemotherapy
5088564|NCT01264900|Psychotherapy|psychotherapy
5088565|NCT01264900|Cognitive Behavioral Therapy|cognitive behavioral therapy
5088566|NCT01264900|Aggression|aggression
5088567|NCT01264900|fMRI|fmri
5088568|NCT01264900|Behavioral Intervention|behavioral intervention
5088569|NCT01264887|analgesia|analgesia
5088570|NCT01264887|analgesics|analgesics
5088571|NCT01264887|chronic pain|chronic pain
5088572|NCT01264887|tumour related pain|tumour related pain
5088573|NCT01264887|chronic malignant tumor-related pain|chronic malignant tumor-related pain
5088676|NCT01264510|unilateral deafness implanted with a Baha|unilateral deafness implanted with a baha
5088574|NCT01264861|Evaluate dopamine and serotonin activity in the brain at 3 doses of Safinamide|evaluate dopamine and serotonin activity in the brain at 3 doses of safinamide
5088575|NCT01264848|multiple sclerosis|multiple sclerosis
5088576|NCT01264848|venous insufficiency|venous insufficiency
5088577|NCT01264822|Rabeprazole Sodium|rabeprazole sodium
5088578|NCT01264822|Helicobacter pylori|helicobacter pylori
5088579|NCT01264822|stomach neoplasms|stomach neoplasms
5088580|NCT01264809|diabetes|diabetes
5088581|NCT01264796|Korean American, type 2 diabetes, culturally tailored|korean american, type 2 diabetes, culturally tailored
5088582|NCT01264770|Rheumatoid Arthritis|rheumatoid arthritis
5088583|NCT01264770|OSKIRA|oskira
5088584|NCT01264770|fostamatinib|fostamatinib
5088585|NCT01264757|pedometer|pedometer
5088586|NCT01264757|accelerometer|accelerometer
5088587|NCT01264757|moderate-to-vigorous physical activity|moderate-to-vigorous physical activity
5088588|NCT01264757|adult|adult
5088589|NCT01264757|randomized trial|randomized trial
5088590|NCT01264744|Bladder cancer|bladder cancer
5088591|NCT01264744|Chromosomal aberrations|chromosomal aberrations
5088592|NCT01264744|FISH|fish
5088593|NCT01264744|Urine sample|urine sample
5088594|NCT01264731|melanoma|melanoma
5088595|NCT01264731|peptide vaccine|peptide vaccine
5088596|NCT01264731|aldara|aldara
5088597|NCT01264731|imiquimod|imiquimod
5088598|NCT01264731|immunotherapy|immunotherapy
5088599|NCT01264718|minority health|minority health
5088600|NCT01264718|child|child
5088601|NCT01264718|Medicaid|medicaid
5088602|NCT01264705|Cirrhosis|cirrhosis
5088603|NCT01264705|GI Cancer|gi cancer
5088604|NCT01264705|Hepatitis|hepatitis
5088605|NCT01264705|Oncology|oncology
5088606|NCT01264679|Iron deficiency anemia|iron deficiency anemia
5088607|NCT01264679|Feraheme|feraheme
5088608|NCT01264679|ferumoxytol|ferumoxytol
5088609|NCT01264679|chronic kidney disease|chronic kidney disease
5088611|NCT01264679|pediatric|pediatric
5088612|NCT01264679|dialysis-dependent|dialysis-dependent
5088613|NCT01264679|nondialysis-dependent|nondialysis-dependent
5088614|NCT01264666|Chinese tea flavor liquor|chinese tea flavor liquor
5088615|NCT01264666|postprandial|postprandial
5088616|NCT01264666|uric acid|uric acid
5088617|NCT01264666|high-sensitive C-reactive protein|high-sensitive c-reactive protein
5088618|NCT01264653|cataract|cataract
5088619|NCT01264640|Brain-derived neurotrophic factor (BDNF)|brain-derived neurotrophic factor (bdnf)
5088620|NCT01264640|Platelets|platelets
5088621|NCT01264640|Aspirin|aspirin
5088622|NCT01264640|Clopidogrel|clopidogrel
5088623|NCT01264627|Hypertension|hypertension
5088624|NCT01264627|Blood pressure|blood pressure
5088625|NCT01264627|Breathing|breathing
5088626|NCT01264627|PetCO2|petco2
5088627|NCT01264627|Stress|stress
5088628|NCT01264614|exercise|exercise
5088629|NCT01264614|neuropsychological|neuropsychological
5088630|NCT01264614|dementia|dementia
5088631|NCT01264614|Alzheimer's Disease|alzheimer's disease
5088632|NCT01264614|mild cognitive impairment|mild cognitive impairment
5088633|NCT01264614|strength|strength
5088634|NCT01264614|MCI|mci
5088635|NCT01264614|AD|ad
5088636|NCT01264614|EEG|eeg
5088637|NCT01264614|neurophysiological|neurophysiological
5088638|NCT01264614|growth factor|growth factor
5088639|NCT01264614|cognitive decline|cognitive decline
5088640|NCT01264614|executive function|executive function
5088641|NCT01264601|Anaphylaxis to Egg|anaphylaxis to egg
5088642|NCT01264601|Severe Egg Allergy|severe egg allergy
5088643|NCT01264575|spinal anesthesia|spinal anesthesia
5088644|NCT01264575|intrathecal bupivacaine|intrathecal bupivacaine
5088645|NCT01264575|epinephrine|epinephrine
5088646|NCT01264575|ED50|ed50
5088647|NCT01264575|ED95|ed95
5088648|NCT01264562|chemotherapy, adjuvant|chemotherapy, adjuvant
5088649|NCT01264562|adverse effects|adverse effects
5088650|NCT01264562|breast neoplasms|breast neoplasms
5088651|NCT01264562|cognition disorders|cognition disorders
5088652|NCT01264562|Stress Disorders, post-traumatic|stress disorders, post-traumatic
5088653|NCT01264562|cortisol|cortisol
5088654|NCT01264549|ischemic stroke|ischemic stroke
5088655|NCT01264549|stroke-associated infections|stroke-associated infections
5088656|NCT01264549|biomarkers|biomarkers
5088657|NCT01264549|PCT|pct
5088658|NCT01264549|immune and infection parameters|immune and infection parameters
5088659|NCT01264536|lactoferrin|lactoferrin
5088660|NCT01264536|sepsis|sepsis
5088661|NCT01264536|neonates|neonates
5088662|NCT01264536|prevention|prevention
5088663|NCT01264536|infections|infections
5088664|NCT01264523|chrononutrition|chrononutrition
5088665|NCT01264523|moderately high protein|moderately high protein
5088666|NCT01264523|glycemic index|glycemic index
5088667|NCT01264523|type-2 diabetes|type-2 diabetes
5088668|NCT01264523|overweight|overweight
5088669|NCT01264523|obesity|obesity
5088670|NCT01264523|weight management|weight management
5088671|NCT01264510|conductive hearing loss|conductive hearing loss
5088672|NCT01264510|mixed hearing loss|mixed hearing loss
5088673|NCT01264510|unilateral deafness|unilateral deafness
5088674|NCT01264510|implanted with Baha|implanted with baha
5088675|NCT01264510|conductive or mixed hearing loss implanted with a Baha or|conductive or mixed hearing loss implanted with a baha or
5088677|NCT01264484|Advantage|advantage
5088678|NCT01264484|Non-interventional|non-interventional
5088679|NCT01264484|Post market release study|post market release study
5088680|NCT01264484|Germany|germany
5088681|NCT01264484|Treated with Advantage prosthetic heart valve|treated with advantage prosthetic heart valve
5088682|NCT01264471|Gulf War Syndrome|gulf war syndrome
5088683|NCT01264471|Gulf War Illness|gulf war illness
5088684|NCT01264471|Mitochondrial defects|mitochondrial defects
5088685|NCT01264471|Mitochondrial disorders|mitochondrial disorders
5088686|NCT01264471|Persian Gulf Syndrome|persian gulf syndrome
5088687|NCT01264445|HIV|hiv
5088688|NCT01264328|Head and neck cancer, panitumumab, TTCC-2009-03|head and neck cancer, panitumumab, ttcc-2009-03
5088689|NCT01264315|Lenalidomide|lenalidomide
5088690|NCT01264315|Tandem Autologous-Allogeneic Transplant|tandem autologous-allogeneic transplant
5088691|NCT01264302|Bioequivalence|bioequivalence
5088692|NCT01264302|Finasteride|finasteride
5088693|NCT01264302|crossover|crossover
5088694|NCT01264289|Bioequivalence|bioequivalence
5088695|NCT01264289|Finasteride|finasteride
5088696|NCT01264289|crossover|crossover
5088697|NCT01264276|ROP|rop
5088698|NCT01264276|Retinopathy of Prematurity|retinopathy of prematurity
5088699|NCT01264276|Telemedicine|telemedicine
5088700|NCT01264263|cIMT|cimt
5088701|NCT01264263|hs CRP (C-reactive protein)|hs crp (c-reactive protein)
5088702|NCT01264263|DM (Diabetic Mellitus)|dm (diabetic mellitus)
5088703|NCT01264263|Korea|korea
5088704|NCT01264263|Corelation between cIMT (carotid intima media thickness)|corelation between cimt (carotid intima media thickness)
5088705|NCT01264263|Cardio Vascular risk in Diabetic Mellitus|cardio vascular risk in diabetic mellitus
5088706|NCT01264250|Safety|safety
5088707|NCT01264250|Tolerability|tolerability
5088708|NCT01264250|pharmacokinetics|pharmacokinetics
5088709|NCT01264250|drug metabolism|drug metabolism
5088710|NCT01264237|Postherpetic neuralgia|postherpetic neuralgia
5088711|NCT01264237|Neuropathic pain|neuropathic pain
5088712|NCT01264237|Etoricoxib|etoricoxib
5088713|NCT01264211|Efficacy of Diacerein|efficacy of diacerein
5088714|NCT01264211|Safety of Diacerein|safety of diacerein
5088715|NCT01264211|Carry-over effect of Diacerein|carry-over effect of diacerein
5088716|NCT01264172|Functional outcome|functional outcome
5088717|NCT01264172|Microcirculation|microcirculation
5088718|NCT01264172|Inflammatory response|inflammatory response
5088719|NCT01264159|Developing acute heart failure|developing acute heart failure
5088720|NCT01264146|hyperbaric oxygen therapy|hyperbaric oxygen therapy
5088721|NCT01264146|calcaneal fracture|calcaneal fracture
5088722|NCT01264146|calcaneal plating|calcaneal plating
5088723|NCT01264146|wound infection|wound infection
5088724|NCT01264146|microcirculation|microcirculation
5088725|NCT01264120|Obesity|obesity
5088726|NCT01264120|Bariatric surgery|bariatric surgery
5088727|NCT01264120|Health Psychology|health psychology
5088728|NCT01264081|Lapatinib|lapatinib
5088729|NCT01264081|Melanoma|melanoma
5088730|NCT01264081|ERBB4 Mutation|erbb4 mutation
5088731|NCT01264081|Malignant Melanoma|malignant melanoma
5088732|NCT01264081|Skin Cancer|skin cancer
5088733|NCT01264068|Suan-Tsao-Jen-Tang ,Jia-Wey-Shiau-Yau-San,metabolomics,menopause|suan-tsao-jen-tang ,jia-wey-shiau-yau-san,metabolomics,menopause
5088734|NCT01264055|Rare Diseases of Airways|rare diseases of airways
5088735|NCT01264055|Bronchiectasis|bronchiectasis
5088736|NCT01264055|Idiopathic Bronchiectasis|idiopathic bronchiectasis
5088737|NCT01264055|Chronic Cough|chronic cough
5088738|NCT01264055|Nontuberculous Mycobacteriam Infection|nontuberculous mycobacteriam infection
5088739|NCT01264042|Iron Supplementation,|iron supplementation,
5088740|NCT01264042|week 24 to 28 at study day|week 24 to 28 at study day
5088741|NCT01264029|Well-Being|well-being
5088742|NCT01264029|Tai Chi|tai chi
5088743|NCT01264029|Obesity|obesity
5088744|NCT01264029|Mindfulness|mindfulness
5088745|NCT01264029|Meditation|meditation
5088746|NCT01264029|Overweight|overweight
5088747|NCT01264003|inguinal hernia, antibiotic, prophylaxis|inguinal hernia, antibiotic, prophylaxis
5088748|NCT01263990|hemodynamic monitoring systems|hemodynamic monitoring systems
5088749|NCT01263990|stroke volume|stroke volume
5088750|NCT01263977|septic shock|septic shock
5088751|NCT01263977|goal directed volume therapy|goal directed volume therapy
5088752|NCT01263977|outcome|outcome
5088753|NCT01263964|ischemic stroke|ischemic stroke
5088754|NCT01263964|troponin elevation|troponin elevation
5088755|NCT01263964|transient apical ballooning|transient apical ballooning
5088756|NCT01263964|acute coronary syndrome|acute coronary syndrome
5088757|NCT01263964|troponin elevation,|troponin elevation,
5088758|NCT01263964|culprit lesion on coronary angiogram,|culprit lesion on coronary angiogram,
5088759|NCT01263964|troponin elevation and stroke localisation (temporal lobe?)|troponin elevation and stroke localisation (temporal lobe?)
5088760|NCT01263951|Differentiated metastatic thyroid cancer|differentiated metastatic thyroid cancer
5088761|NCT01263938|HIV|hiv
5088762|NCT01263938|monocytes|monocytes
5088763|NCT01263938|CD16+|cd16+
5088764|NCT01263938|statins|statins
5088765|NCT01263938|mcp1|mcp1
5088766|NCT01263938|inflammation|inflammation
5088767|NCT01263925|Alprostadil|alprostadil
5088768|NCT01263925|Prostaglandin E1|prostaglandin e1
5088769|NCT01263925|Prostavasin®|prostavasin®
5088770|NCT01263925|PAOD|paod
5088771|NCT01263912|Polyunsaturated fatty acids|polyunsaturated fatty acids
5088772|NCT01263912|Cognitive development|cognitive development
5088773|NCT01263912|Growth|growth
5088774|NCT01263912|Infection|infection
5088775|NCT01263899|Lymphoid malignancies|lymphoid malignancies
5088776|NCT01263899|Hodgkin lymphoma|hodgkin lymphoma
5088777|NCT01263899|Mantle Cell Lymphoma|mantle cell lymphoma
5088778|NCT01263899|Indolent Lymphoma|indolent lymphoma
5088779|NCT01263899|SB1518|sb1518
5088780|NCT01263847|Dietary Supplement: Galactooligosaccharide|dietary supplement: galactooligosaccharide
5088781|NCT01263834|Trabeculectomy|trabeculectomy
5088782|NCT01263834|bevacizumab|bevacizumab
5088783|NCT01263834|intraocular pressure|intraocular pressure
5088784|NCT01263821|glioma|glioma
5088785|NCT01263821|biologic imaging|biologic imaging
5088786|NCT01263821|magnetic resonance spectroscopy|magnetic resonance spectroscopy
5088787|NCT01263821|magnetic resonance imaging|magnetic resonance imaging
5088788|NCT01263821|perfusion imaging|perfusion imaging
5088789|NCT01263821|diffusion imaging|diffusion imaging
5088790|NCT01263821|functional magnetic resonance imaging|functional magnetic resonance imaging
5088791|NCT01263821|radiation therapy|radiation therapy
5088792|NCT01263821|intensity modulated radiation therapy|intensity modulated radiation therapy
5088793|NCT01263808|Indacaterol|indacaterol
5088794|NCT01263808|Moxifloxacin|moxifloxacin
5088795|NCT01263782|Non-Small Cell Lung Cancer|non-small cell lung cancer
5088796|NCT01263782|NSCLL|nscll
5088797|NCT01263782|Nonsquamous cell|nonsquamous cell
5088798|NCT01263782|Metastatic disease|metastatic disease
5088799|NCT01263782|Cixutumumab|cixutumumab
5088800|NCT01263782|IMC-A12|imc-a12
5088801|NCT01263782|Carboplatin|carboplatin
5088802|NCT01263782|Paraplatin|paraplatin
5088803|NCT01263782|Pemetrexed|pemetrexed
5088804|NCT01263782|LY231514|ly231514
5088805|NCT01263782|Alimta|alimta
5088806|NCT01263782|MTA|mta
5088807|NCT01263782|Multitargeted Antifolate|multitargeted antifolate
5088808|NCT01263782|NSC-698037|nsc-698037
5088809|NCT01263782|Bevacizumab|bevacizumab
5088810|NCT01263782|Avastin|avastin
5088811|NCT01263782|Anti-VEGF monoclonal antibody|anti-vegf monoclonal antibody
5088812|NCT01263782|rhuMAb-VEGF|rhumab-vegf
5088813|NCT01263769|Locally advanced clear cell renal cell carcinoma|locally advanced clear cell renal cell carcinoma
5088814|NCT01263769|AG-013736|ag-013736
5088815|NCT01263769|Axitinib|axitinib
5088816|NCT01263769|Radical nephrectomy|radical nephrectomy
5088817|NCT01263756|Driving|driving
5088818|NCT01263756|Autism Spectrum Disorders|autism spectrum disorders
5088819|NCT01263756|ASD|asd
5088820|NCT01263756|Attention Deficits|attention deficits
5088821|NCT01263756|Adults|adults
5088822|NCT01263756|Adolescents|adolescents
5088823|NCT01263756|Pervasive Developmental Disorders|pervasive developmental disorders
5088824|NCT01263743|Stage 1 hypertension|stage 1 hypertension
5088825|NCT01263717|HIV|hiv
5088826|NCT01263717|lipodystrophy|lipodystrophy
5088827|NCT01263717|tesamorelin|tesamorelin
5088828|NCT01263717|Egrifta|egrifta
5088829|NCT01263717|growth hormone releasing hormone|growth hormone releasing hormone
5088830|NCT01263691|AVA|ava
5088831|NCT01263691|AV7909|av7909
5088832|NCT01263691|Anthrax vaccine|anthrax vaccine
5088833|NCT01263678|Decisional Conflict|decisional conflict
5088834|NCT01263678|Coaching|coaching
5088835|NCT01263678|Decisional Regret|decisional regret
5088836|NCT01263665|stent-graft|stent-graft
5088837|NCT01263665|superficial femoral artery|superficial femoral artery
5088838|NCT01263665|SFA|sfa
5088839|NCT01263665|peripheral artery disease|peripheral artery disease
5088840|NCT01263665|PAD|pad
5088841|NCT01263652|Pain|pain
5088842|NCT01263652|intramuscular|intramuscular
5088843|NCT01263652|oral|oral
5088844|NCT01263652|spine|spine
5088845|NCT01263652|preference|preference
5088846|NCT01263639|patient satisfaction|patient satisfaction
5088847|NCT01263639|patient-physician relationship|patient-physician relationship
5088848|NCT01263639|orthopaedic trauma|orthopaedic trauma
5088849|NCT01263626|Cough|cough
5088850|NCT01263626|Chronic Cough|chronic cough
5088851|NCT01263626|Reflux|reflux
5088852|NCT01263600|Hepatitis B|hepatitis b
5088853|NCT01263600|HBV|hbv
5088854|NCT01263600|Pediatric|pediatric
5088855|NCT01263587|Hepatitis B|hepatitis b
5088856|NCT01263587|HBV|hbv
5088857|NCT01263587|Cohort Study|cohort study
5088858|NCT01263574|Catheter related infections prevention/control|catheter related infections prevention/control
5088859|NCT01263574|Anti infective agents|anti infective agents
5088860|NCT01263574|Catheter related infections prevention|catheter related infections prevention
5088861|NCT01263561|glaucoma|glaucoma
5088862|NCT01263561|filtration surgery|filtration surgery
5088863|NCT01263561|trabeculectomy|trabeculectomy
5088864|NCT01263561|ExPRESS shunt|express shunt
5088865|NCT01263522|primary prevention|primary prevention
5088866|NCT01263522|endurance|endurance
5088867|NCT01263522|cardiovascular risk factors|cardiovascular risk factors
5088868|NCT01263522|training|training
5088869|NCT01263522|exercise|exercise
5088870|NCT01263522|non-responder|non-responder
5088871|NCT01263509|Diabetes Mellitus - Type 2|diabetes mellitus - type 2
5088872|NCT01263509|Diabetes Mellitus|diabetes mellitus
5088873|NCT01263509|Drug Therapy|drug therapy
5088874|NCT01263496|Diabetes Mellitus - Type 2|diabetes mellitus - type 2
5088875|NCT01263496|Diabetes Mellitus|diabetes mellitus
5088876|NCT01263496|Drug Therapy|drug therapy
5088877|NCT01263483|Diabetes Mellitus - Type 2|diabetes mellitus - type 2
5088878|NCT01263483|Diabetes Mellitus|diabetes mellitus
5088879|NCT01263483|Drug Therapy|drug therapy
5088880|NCT01263470|Diabetes Mellitus - Type 2|diabetes mellitus - type 2
5088881|NCT01263470|Diabetes Mellitus|diabetes mellitus
5088882|NCT01263470|Drug Therapy|drug therapy
5088883|NCT01263457|Growth disorders|growth disorders
5088884|NCT01263457|Saizen|saizen
5088885|NCT01263457|EasypodTM|easypodtm
5088886|NCT01263457|Growth hormone|growth hormone
5088887|NCT01263457|Pediatric subject|pediatric subject
5088888|NCT01263444|AZARGA®|azarga®
5088889|NCT01263444|Open angle glaucoma|open angle glaucoma
5088890|NCT01263444|Prostaglandin Therapy|prostaglandin therapy
5088891|NCT01263431|Hemorrhoidectomy, haemorrhoidal dearterialisation, anopexy|hemorrhoidectomy, haemorrhoidal dearterialisation, anopexy
5088892|NCT01263418|Follicular Lymphoma|follicular lymphoma
5088893|NCT01263418|Marginal Zone Lymphoma|marginal zone lymphoma
5088894|NCT01263418|Non-Hodgkins Lymphoma|non-hodgkins lymphoma
5088895|NCT01263418|Elderly|elderly
5088896|NCT01263418|Newly Diagnosed|newly diagnosed
5088897|NCT01263418|Lineberger Comprehensive Cancer Center|lineberger comprehensive cancer center
5088898|NCT01263418|University of North Carolina|university of north carolina
5088899|NCT01263418|Ofatumumab|ofatumumab
5088900|NCT01263418|Arzerra|arzerra
5088901|NCT01263418|Phase 2|phase 2
5088902|NCT01263418|Geriatric|geriatric
5088903|NCT01263418|Lymphoma|lymphoma
5088904|NCT01263405|Sarcoma|sarcoma
5088905|NCT01263392|Neurogenic bladder|neurogenic bladder
5088906|NCT01263392|Spina bifida|spina bifida
5088907|NCT01263392|Intermittent catheterization|intermittent catheterization
5088908|NCT01263392|Urinary tract infections|urinary tract infections
5088909|NCT01263379|gene transfer|gene transfer
5088910|NCT01263366|Radiodermatitis|radiodermatitis
5088911|NCT01263366|Prevention|prevention
5088912|NCT01263366|Radiotherapy|radiotherapy
5088913|NCT01263366|Breast|breast
5088914|NCT01263366|Radiation Dermatitis|radiation dermatitis
5088915|NCT01263353|Carcinoid tumor,|carcinoid tumor,
5088916|NCT01263353|Gastroenteropancreatic Neuroendocrine Tumors,|gastroenteropancreatic neuroendocrine tumors,
5088917|NCT01263353|Pulmonary Neuroendocrine Tumors,|pulmonary neuroendocrine tumors,
5088918|NCT01263353|pasireotide LAR,|pasireotide lar,
5088919|NCT01263353|SOM230 LAR,|som230 lar,
5088920|NCT01263353|everolimus,|everolimus,
5088921|NCT01263353|RAD001,|rad001,
5088922|NCT01263353|Advanced Neuroendocrine Tumor,|advanced neuroendocrine tumor,
5088923|NCT01263353|Gastroenteropancreatic System|gastroenteropancreatic system
5088924|NCT01263340|COPD|copd
5088925|NCT01263340|observational study|observational study
5088926|NCT01263340|prevalence|prevalence
5088927|NCT01263340|characterisation|characterisation
5088928|NCT01263327|human papillomavirus vaccine|human papillomavirus vaccine
5088929|NCT01263314|Hypertension|hypertension
5088930|NCT01263301|subclavian steal|subclavian steal
5088931|NCT01263301|carotid duplex|carotid duplex
5088932|NCT01263301|subclavian stenosis|subclavian stenosis
5088933|NCT01263301|hemodialysis with vascular access in the upper limbs|hemodialysis with vascular access in the upper limbs
5088934|NCT01263301|the focus of this study is to see if duplex can be used as an tool to differentiate the different causes of subclavian steal syndromes|the focus of this study is to see if duplex can be used as an tool to differentiate the different causes of subclavian steal syndromes
5088935|NCT01263275|depression|depression
5088936|NCT01263275|direct current stimulation|direct current stimulation
5088937|NCT01263275|alternative electrode montage|alternative electrode montage
5088938|NCT01263262|Surgical site infection|surgical site infection
5088939|NCT01263262|Corneal toxicity|corneal toxicity
5088940|NCT01263262|Ototoxicity|ototoxicity
5088941|NCT01263262|Povidone-iodine|povidone-iodine
5088942|NCT01263262|Chlorhexidine-alcohol|chlorhexidine-alcohol
5088943|NCT01263249|Femoral|femoral
5088944|NCT01263249|Nerve Block|nerve block
5088945|NCT01263249|Anterior|anterior
5088946|NCT01263249|Posterior|posterior
5088947|NCT01263249|Continuous Infusion|continuous infusion
5088948|NCT01263249|Perineural Catheter|perineural catheter
5088949|NCT01263249|Volunteer|volunteer
5088950|NCT01263249|Lower Extremity Nerve Blocks|lower extremity nerve blocks
5088951|NCT01263236|Depression|depression
5088952|NCT01263210|Recurrent acute otitis media|recurrent acute otitis media
5088953|NCT01263210|Conjugate pneumococcal vaccine|conjugate pneumococcal vaccine
5088954|NCT01263210|Ventilation tube treatment|ventilation tube treatment
5088955|NCT01263210|Nasopharyngeal flora|nasopharyngeal flora
5088956|NCT01263184|shoulder|shoulder
5088957|NCT01263184|strength|strength
5088958|NCT01263184|quality of life|quality of life
5088959|NCT01263171|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5088960|NCT01263171|stage IIIB rectal cancer|stage iiib rectal cancer
5088961|NCT01263171|stage IIIC rectal cancer|stage iiic rectal cancer
5088962|NCT01263158|randomised controlled trial|randomised controlled trial
5088963|NCT01263158|nulliparous women|nulliparous women
5088964|NCT01263158|slow labour progress|slow labour progress
5088965|NCT01263158|prolonged labour|prolonged labour
5088966|NCT01263158|oxytocin augmentation|oxytocin augmentation
5088967|NCT01263158|operative delivery|operative delivery
5088968|NCT01263158|childbirth experience|childbirth experience
5088969|NCT01263132|Polyneuropathy|polyneuropathy
5088970|NCT01263132|Diabetes Mellitus|diabetes mellitus
5088971|NCT01263132|Diabetic peripheral neuropathy|diabetic peripheral neuropathy
5088972|NCT01263080|mirtazapine|mirtazapine
5088973|NCT01263080|folic acid|folic acid
5088974|NCT01263080|schizophrenia|schizophrenia
5088975|NCT01263067|Posttraumatic Stress Disorder|posttraumatic stress disorder
5088976|NCT01263067|PTSD|ptsd
5088977|NCT01263067|Car Accident|car accident
5088978|NCT01263067|Auto Accident|auto accident
5088979|NCT01263067|Lifespan Integration|lifespan integration
5088980|NCT01263054|Back Pain|back pain
5088981|NCT01263054|Low Back Pain|low back pain
5088982|NCT01263054|Discogenic Back Pain|discogenic back pain
5088983|NCT01263041|Glutamine, NEC, L-arginine,Preterm,Sepsis|glutamine, nec, l-arginine,preterm,sepsis
5088984|NCT01263015|GSK1349572|gsk1349572
5088985|NCT01263015|Abacavir/Lamivudine|abacavir/lamivudine
5088986|NCT01263015|Treatment-naive|treatment-naive
5088987|NCT01263015|HIV Infection|hiv infection
5088988|NCT01263015|Dolutegravir|dolutegravir
5088989|NCT01263015|integrase inhibitor|integrase inhibitor
5088990|NCT01263015|Atripla|atripla
5088991|NCT01262989|Bioequivalence|bioequivalence
5088992|NCT01262989|Tamsulosin|tamsulosin
5088993|NCT01262989|Healthy volunteers|healthy volunteers
5088994|NCT01262989|Fast conditions|fast conditions
5088995|NCT01262976|Tuberculosis vaccine|tuberculosis vaccine
5088996|NCT01262963|GSK2118436|gsk2118436
5088997|NCT01262963|BRAF inhibitor|braf inhibitor
5088998|NCT01262963|BRAF positive tumor|braf positive tumor
5088999|NCT01262963|ADME|adme
5089000|NCT01262963|Oncology|oncology
5089001|NCT01262937|confocal, biliary, esophagus|confocal, biliary, esophagus
5089002|NCT01262924|Booster vaccination|booster vaccination
5089003|NCT01262898|tolerability|tolerability
5089004|NCT01262898|pharmacokinetics|pharmacokinetics
5089005|NCT01262898|13 C oral breath test|13 c oral breath test
5089006|NCT01262898|Type I and II Diabetes mellitus|type i and ii diabetes mellitus
5089007|NCT01262898|gastroparesis|gastroparesis
5089008|NCT01262898|gut motility|gut motility
5089009|NCT01262898|phase II|phase ii
5089010|NCT01262898|pharmacodynamics|pharmacodynamics
5089011|NCT01262898|repeat dose|repeat dose
5089012|NCT01262898|gastric emptying|gastric emptying
5089013|NCT01262898|symptoms|symptoms
5089014|NCT01262898|GSK962040|gsk962040
5089015|NCT01262885|pharmacokinetics|pharmacokinetics
5089016|NCT01262885|tolerability|tolerability
5089017|NCT01262885|single dose|single dose
5089018|NCT01262885|antibiotics|antibiotics
5089019|NCT01262885|repeat dose|repeat dose
5089020|NCT01262885|GSK2251052|gsk2251052
5089021|NCT01262885|safety|safety
5089022|NCT01262872|Haemophilus influenzae|haemophilus influenzae
5089023|NCT01262872|Streptococcus pneumoniae|streptococcus pneumoniae
5089024|NCT01262872|The Gambia|the gambia
5089025|NCT01262872|immunogenicity|immunogenicity
5089026|NCT01262872|nasopharyngeal carriage|nasopharyngeal carriage
5089027|NCT01262872|infants|infants
5089028|NCT01262872|safety|safety
5089029|NCT01262872|Pneumococcal vaccine|pneumococcal vaccine
5089030|NCT01262872|children|children
5089031|NCT01262846|HIV|hiv
5089032|NCT01262846|Flu vaccination|flu vaccination
5089033|NCT01262846|HIV infected individuals|hiv infected individuals
5089034|NCT01262846|Fluzone SD|fluzone sd
5089035|NCT01262846|Fluzone HD|fluzone hd
5089036|NCT01262820|Pazopanib|pazopanib
5089037|NCT01262820|Non Squamous Non Small Cell Lung Cancer|non squamous non small cell lung cancer
5089038|NCT01262820|After Progress on first line therapy|after progress on first line therapy
5089039|NCT01262820|Using Bevacizumab|using bevacizumab
5089040|NCT01262807|fracture|fracture
5089041|NCT01262807|radius|radius
5089042|NCT01262807|adult|adult
5089043|NCT01262807|range of motion|range of motion
5089044|NCT01262794|Healthy volunteers|healthy volunteers
5089045|NCT01262794|Japanese|japanese
5089046|NCT01262781|neonatal adiposity|neonatal adiposity
5089047|NCT01262781|metabolic syndrome|metabolic syndrome
5089048|NCT01262781|fructose|fructose
5089049|NCT01262781|maternal diet|maternal diet
5089050|NCT01262768|Nutrition|nutrition
5089051|NCT01262768|Obesity|obesity
5089052|NCT01262768|Parent|parent
5089053|NCT01262768|Portion Size Estimation|portion size estimation
5089054|NCT01262768|Accuracy|accuracy
5089055|NCT01262755|GERD|gerd
5089056|NCT01262755|IBS|ibs
5089057|NCT01262755|Minority|minority
5089058|NCT01262742|pregnancy|pregnancy
5089059|NCT01262742|postpartum hemorrhage|postpartum hemorrhage
5089060|NCT01262742|Cesarean delivery|cesarean delivery
5089061|NCT01262742|carbetocin|carbetocin
5089062|NCT01262729|xenon inhalation|xenon inhalation
5089063|NCT01262729|therapeutical hypothermia|therapeutical hypothermia
5089064|NCT01262729|patients after cardiopulmonary resuscitation|patients after cardiopulmonary resuscitation
5089065|NCT01262729|efficacy|efficacy
5089066|NCT01262729|safety|safety
5089067|NCT01262716|Chest wall progression breast cancer|chest wall progression breast cancer
5089068|NCT01262716|PDT|pdt
5089069|NCT01262716|Photofrin|photofrin
5089070|NCT01262716|Photosensitizer|photosensitizer
5089071|NCT01262690|First-in-human (FIH)|first-in-human (fih)
5089072|NCT01262690|Single Ascending Dose (SAD) Study|single ascending dose (sad) study
5089073|NCT01262690|TAM-163|tam-163
5089074|NCT01262690|PF-05230901|pf-05230901
5089075|NCT01262690|Cachexia|cachexia
5089076|NCT01262677|Partial epilepsy|partial epilepsy
5089077|NCT01262677|partial seizures|partial seizures
5089078|NCT01262677|epilepsy|epilepsy
5089079|NCT01262677|seizures|seizures
5089080|NCT01262677|adjunctive therapy|adjunctive therapy
5089081|NCT01262677|intervention|intervention
5089082|NCT01262677|controlled-release|controlled-release
5089083|NCT01262677|placebo-controlled|placebo-controlled
5089084|NCT01262677|seizure|seizure
5089085|NCT01262664|Advanced prostate cancer|advanced prostate cancer
5089086|NCT01262664|Castrate-Resistant Prostate Cancer|castrate-resistant prostate cancer
5089087|NCT01262664|Prohibitin-TP01|prohibitin-tp01
5089088|NCT01262651|Cancer pain|cancer pain
5089089|NCT01262651|Opioid therapy|opioid therapy
5089090|NCT01262651|Inadequate analgesia|inadequate analgesia
5089091|NCT01262651|Optimized chronic opioid therapy|optimized chronic opioid therapy
5089092|NCT01262625|stable angina|stable angina
5089093|NCT01262625|recurrent chest pain|recurrent chest pain
5089094|NCT01262625|chest pain|chest pain
5089095|NCT01262625|angina equivalent|angina equivalent
5089096|NCT01262625|diagnosis|diagnosis
5089097|NCT01262625|coronary artery disease|coronary artery disease
5089098|NCT01262612|cediranib|cediranib
5089099|NCT01262612|malignant ascites|malignant ascites
5089100|NCT01262612|malignant pleural effusion|malignant pleural effusion
5089101|NCT01262599|Breast and abdomen morbidities after TRAM flap surgery|breast and abdomen morbidities after tram flap surgery
5089102|NCT01262599|TRAM flap surgery|tram flap surgery
5089225|NCT01262079|blood sample|blood sample
5089103|NCT01262599|Post-mastectomy breast reconstructive surgery|post-mastectomy breast reconstructive surgery
5089104|NCT01262586|Type II Diabetes Mellitus|type ii diabetes mellitus
5089105|NCT01262586|Vildagliptin|vildagliptin
5089106|NCT01262586|Glimepiride|glimepiride
5089107|NCT01262586|Continuous glucose monitoring|continuous glucose monitoring
5089108|NCT01262560|pain|pain
5089109|NCT01262560|dysphagia|dysphagia
5089110|NCT01262560|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5089111|NCT01262560|stage IA non-small cell lung cancer|stage ia non-small cell lung cancer
5089112|NCT01262560|stage IB non-small cell lung cancer|stage ib non-small cell lung cancer
5089113|NCT01262560|stage IIA non-small cell lung cancer|stage iia non-small cell lung cancer
5089114|NCT01262560|stage IIB non-small cell lung cancer|stage iib non-small cell lung cancer
5089115|NCT01262560|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5089116|NCT01262560|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5089117|NCT01262560|extensive stage small cell lung cancer|extensive stage small cell lung cancer
5089118|NCT01262560|limited stage small cell lung cancer|limited stage small cell lung cancer
5089119|NCT01262560|recurrent small cell lung cancer|recurrent small cell lung cancer
5089120|NCT01262560|esophagitis|esophagitis
5089121|NCT01262534|Psoriasis|psoriasis
5089122|NCT01262534|comorbidities, associated treatment, quality of life|comorbidities, associated treatment, quality of life
5089123|NCT01262521|Dietary nitrate|dietary nitrate
5089124|NCT01262508|autonomic nervous system|autonomic nervous system
5089125|NCT01262482|adenocarcinoma|adenocarcinoma
5089126|NCT01262482|gastric|gastric
5089127|NCT01262482|gastroesophageal junction|gastroesophageal junction
5089128|NCT01262482|Relapsed|relapsed
5089129|NCT01262482|sorafenib|sorafenib
5089130|NCT01262482|oxaliplatin|oxaliplatin
5089131|NCT01262443|Atrial flutter|atrial flutter
5089132|NCT01262430|Osteoarthritis|osteoarthritis
5089133|NCT01262417|colorectal cancer|colorectal cancer
5089134|NCT01262417|two stage surgery for the resection of hepatic metastases|two stage surgery for the resection of hepatic metastases
5089135|NCT01262417|resorbable barrier membrane|resorbable barrier membrane
5089136|NCT01262417|abdominal and peri-hepatic adhesion|abdominal and peri-hepatic adhesion
5089137|NCT01262391|Overactive bladder|overactive bladder
5089138|NCT01262391|Pediatric|pediatric
5089139|NCT01262391|Pharmacokinetics|pharmacokinetics
5089140|NCT01262391|Single-dose|single-dose
5089141|NCT01262391|Solifenacin suspension|solifenacin suspension
5089142|NCT01262365|Lupus|lupus
5089143|NCT01262365|Monoclonal antibody|monoclonal antibody
5089144|NCT01262365|B-Cell immunotherapy|b-cell immunotherapy
5089145|NCT01262365|Epratuzumab|epratuzumab
5089146|NCT01262339|Primary focal hyperhidrosis|primary focal hyperhidrosis
5089147|NCT01262339|interdermal injections|interdermal injections
5089148|NCT01262339|iontophoresis|iontophoresis
5089149|NCT01262339|BTX-A|btx-a
5089150|NCT01262300|Immunosenescence|immunosenescence
5089151|NCT01262300|Shingles|shingles
5089152|NCT01262300|Vitamin D|vitamin d
5089153|NCT01262300|Varicella Zoster Virus|varicella zoster virus
5089154|NCT01262300|Vaccine|vaccine
5089155|NCT01262300|Immune Response|immune response
5089156|NCT01262300|Geriatrics|geriatrics
5089157|NCT01262287|Randomized Trial|randomized trial
5089158|NCT01262287|Medication for Heavy Drinking|medication for heavy drinking
5089159|NCT01262287|Dutasteride Treatment|dutasteride treatment
5089160|NCT01262261|opioid dependence|opioid dependence
5089161|NCT01262261|opioid addiction|opioid addiction
5089162|NCT01262261|buprenorphine|buprenorphine
5089164|NCT01262261|methadone|methadone
5089165|NCT01262261|heroin|heroin
5089166|NCT01262261|suboxone|suboxone
5089167|NCT01262261|opioid pain medication|opioid pain medication
5089168|NCT01262261|opioid withdrawal|opioid withdrawal
5089169|NCT01262248|small colorectal polyps|small colorectal polyps
5089170|NCT01262248|narrow band imaging|narrow band imaging
5089171|NCT01262248|vascularization|vascularization
5089172|NCT01262248|computer-based classification|computer-based classification
5089173|NCT01262235|Solid tumor|solid tumor
5089174|NCT01262235|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
5089175|NCT01262235|Hodgkin's Disease|hodgkin's disease
5089176|NCT01262235|Neuroendocrine tumors (NET)|neuroendocrine tumors (net)
5089177|NCT01262235|Adrenocortical carcinoma (ACC)|adrenocortical carcinoma (acc)
5089178|NCT01262235|Carcinoid|carcinoid
5089179|NCT01262222|Predictive Value For Postoperative Cardiac Events|predictive value for postoperative cardiac events
5089180|NCT01262222|Endothelial Dysfunction|endothelial dysfunction
5089181|NCT01262222|10-206|10-206
5089182|NCT01262209|Vision loss|vision loss
5089183|NCT01262209|Chronic glaucoma|chronic glaucoma
5089184|NCT01262209|Low vision rehabilitation|low vision rehabilitation
5089185|NCT01262196|Trauma|trauma
5089186|NCT01262196|Hemorrhage|hemorrhage
5089187|NCT01262196|Hemorrhagic shock|hemorrhagic shock
5089188|NCT01262196|Lactic acidosis|lactic acidosis
5089189|NCT01262196|Oxygen carriers|oxygen carriers
5089190|NCT01262196|Oxygen therapeutics|oxygen therapeutics
5089191|NCT01262196|Hemoglobin solutions|hemoglobin solutions
5089192|NCT01262196|Red cell substitutes|red cell substitutes
5089193|NCT01262196|PEG-hemoglobin|peg-hemoglobin
5089194|NCT01262183|oesophagus cancer|oesophagus cancer
5089195|NCT01262183|chemoradiotherapy|chemoradiotherapy
5089196|NCT01262183|panitumumab|panitumumab
5089197|NCT01262183|irresectable|irresectable
5089198|NCT01262170|dietary supplement|dietary supplement
5089199|NCT01262170|nutraceutical|nutraceutical
5089200|NCT01262157|Erectile dysfunction|erectile dysfunction
5089201|NCT01262157|PDE5 Inhibitor|pde5 inhibitor
5089202|NCT01262157|Low intensity shock wave therapy.|low intensity shock wave therapy.
5089203|NCT01262144|Cervical Cancer|cervical cancer
5089204|NCT01262144|PET CT|pet ct
5089205|NCT01262144|SUV Max|suv max
5089206|NCT01262131|Fibromyalgia|fibromyalgia
5089207|NCT01262131|Pain associated with Fibromyalgia|pain associated with fibromyalgia
5089208|NCT01262118|Cholesterol metabolism|cholesterol metabolism
5089209|NCT01262118|Cholesterol flux|cholesterol flux
5089210|NCT01262118|Rheumatoid Arthritis|rheumatoid arthritis
5089211|NCT01262118|Tasocitinib|tasocitinib
5089212|NCT01262118|CP-690|cp-690
5089213|NCT01262118|550|550
5089214|NCT01262105|CFU|cfu
5089215|NCT01262105|surgery site|surgery site
5089216|NCT01262092|opioid dependent|opioid dependent
5089217|NCT01262092|detoxification|detoxification
5089218|NCT01262092|buprenorphine|buprenorphine
5089219|NCT01262092|suboxone|suboxone
5089220|NCT01262092|opiate|opiate
5089221|NCT01262079|influenza|influenza
5089222|NCT01262079|healthy volunteer|healthy volunteer
5089223|NCT01262079|immunity|immunity
5089224|NCT01262079|antibody|antibody
5089226|NCT01262066|hypertension|hypertension
5089227|NCT01262066|stress reduction|stress reduction
5089228|NCT01262053|Computerized Physician Order Entry|computerized physician order entry
5089229|NCT01262053|CPOE|cpoe
5089230|NCT01262053|Wrong Patient|wrong patient
5089231|NCT01262053|Juxtaposition|juxtaposition
5089232|NCT01262053|Patient Safety|patient safety
5089233|NCT01262053|Medical Errors|medical errors
5089234|NCT01262040|NBI|nbi
5089235|NCT01262040|ENDOMETRIUM|endometrium
5089236|NCT01262040|FALLOPIAN TUBE|fallopian tube
5089237|NCT01262040|OVARY|ovary
5089238|NCT01262040|PERITONEUM|peritoneum
5089239|NCT01262040|Surgery|surgery
5089240|NCT01262040|Lung|lung
5089241|NCT01262040|Pancreatic|pancreatic
5089242|NCT01262040|Esophageal|esophageal
5089243|NCT01262040|thorascopic|thorascopic
5089244|NCT01262040|laparoscopic|laparoscopic
5089245|NCT01262040|robotic|robotic
5089246|NCT01262040|10-180|10-180
5089247|NCT01262027|Metastatic inflammatory breast cancer|metastatic inflammatory breast cancer
5089248|NCT01262027|Stage IV disease|stage iv disease
5089249|NCT01262027|HER2-negative|her2-negative
5089250|NCT01262027|Dovitinib|dovitinib
5089251|NCT01262027|TKI258|tki258
5089252|NCT01262014|platinum|platinum
5089253|NCT01262014|resistant|resistant
5089254|NCT01262014|advanced|advanced
5089255|NCT01262014|ovarian|ovarian
5089256|NCT01262014|cancer|cancer
5089257|NCT01261975|Ocular Surgery|ocular surgery
5089258|NCT01261975|Intraocular Lens|intraocular lens
5089259|NCT01261962|Humoral immunity|humoral immunity
5089260|NCT01261962|Neutrophil function|neutrophil function
5089261|NCT01261962|Gene expression|gene expression
5089262|NCT01261949|Tinnitus|tinnitus
5089263|NCT01261949|chronic subjective tinnitus|chronic subjective tinnitus
5089264|NCT01261949|transcranial magnetic stimulation|transcranial magnetic stimulation
5089265|NCT01261949|sensation disorders|sensation disorders
5089266|NCT01261949|hearing disorders|hearing disorders
5089267|NCT01261936|Menorrhagia|menorrhagia
5089268|NCT01261936|Congenital Bleeding Disorders(CBDs)|congenital bleeding disorders(cbds)
5089269|NCT01261936|Diagnosis and treatment of menorrhagia in CBDs|diagnosis and treatment of menorrhagia in cbds
5089270|NCT01261897|Adductor-Canal-Blockade|adductor-canal-blockade
5089271|NCT01261897|postoperative pain|postoperative pain
5089272|NCT01261897|US-guided nerve block|us-guided nerve block
5089273|NCT01261897|total knee arthroplasty|total knee arthroplasty
5089274|NCT01261884|Pregnancy|pregnancy
5089275|NCT01261884|Exercise|exercise
5089276|NCT01261884|Hypertension|hypertension
5089277|NCT01261884|Preeclampsia|preeclampsia
5089278|NCT01261884|Resistance exercise|resistance exercise
5089279|NCT01261858|Sternal closure|sternal closure
5089280|NCT01261858|Coronary artery bypass grafting|coronary artery bypass grafting
5089281|NCT01261858|Biologic bone cement|biologic bone cement
5089282|NCT01261845|Delivery of Health Care|delivery of health care
5089283|NCT01261845|Equity in Health Services|equity in health services
5089284|NCT01261845|Ethnic Groups|ethnic groups
5089285|NCT01261845|Health Services Research|health services research
5089286|NCT01261845|Health Surveys|health surveys
5089287|NCT01261845|Immigration|immigration
5089288|NCT01261845|Referral and Consultation|referral and consultation
5089289|NCT01261845|Resource Allocation|resource allocation
5089290|NCT01261845|Social Justice|social justice
5089291|NCT01261845|Vulnerable Populations|vulnerable populations
5089292|NCT01261832|Acute Myocardial Infarction|acute myocardial infarction
5089293|NCT01261832|Percutaneous coronary intervention|percutaneous coronary intervention
5089294|NCT01261819|cystoscopy, minimally invasive hysterectomy|cystoscopy, minimally invasive hysterectomy
5089295|NCT01261793|Lupus|lupus
5089296|NCT01261793|Monoclonal antibody|monoclonal antibody
5089297|NCT01261793|B-Cell immunotherapy|b-cell immunotherapy
5089298|NCT01261793|Epratuzumab|epratuzumab
5089299|NCT01261780|neuropathy,paraneoplastic|neuropathy,paraneoplastic
5089300|NCT01261780|paraneoplastic peripheral neuropathy|paraneoplastic peripheral neuropathy
5089301|NCT01261780|pain|pain
5089302|NCT01261780|hyperalgesia|hyperalgesia
5089303|NCT01261754|Metastatic Prostate Adenocarcinoma|metastatic prostate adenocarcinoma
5089304|NCT01261728|Gemcitabine|gemcitabine
5089305|NCT01261728|Cisplatin|cisplatin
5089306|NCT01261728|Bladder|bladder
5089307|NCT01261728|radical nephroureterectomy|radical nephroureterectomy
5089308|NCT01261728|ureterectomy|ureterectomy
5089309|NCT01261728|10-208|10-208
5089310|NCT01261702|Magnesium sulphate|magnesium sulphate
5089311|NCT01261702|Post Pulmonary Resection|post pulmonary resection
5089312|NCT01261702|Pain|pain
5089313|NCT01261689|Epidural analgesia|epidural analgesia
5089314|NCT01261689|Instrumental delivery|instrumental delivery
5089315|NCT01261689|Maternal outcome|maternal outcome
5089316|NCT01261689|Neonatal outcome|neonatal outcome
5089317|NCT01261676|caesarean section|caesarean section
5089318|NCT01261676|labour, obstetric|labour, obstetric
5089319|NCT01261676|implementation guidelines|implementation guidelines
5089320|NCT01261676|quality indicators|quality indicators
5089321|NCT01261650|widespread chronic pain, transcranial direct current stimulation, fibromyalgia|widespread chronic pain, transcranial direct current stimulation, fibromyalgia
5089322|NCT01261637|cesarean, pain, transversus abdominus plane block|cesarean, pain, transversus abdominus plane block
5089323|NCT01261624|poly JIA|poly jia
5089324|NCT01261598|Positron-Emission Tomography|positron-emission tomography
5089325|NCT01261598|PET Scan|pet scan
5089326|NCT01261598|Non-Small-Cell Lung Carcinoma|non-small-cell lung carcinoma
5089327|NCT01261598|Radiation Oncology|radiation oncology
5089328|NCT01261598|SUV|suv
5089329|NCT01261585|Positron-Emission Tomography|positron-emission tomography
5089330|NCT01261585|PET Scan|pet scan
5089331|NCT01261585|FDG|fdg
5089332|NCT01261585|FLT|flt
5089333|NCT01261585|FMISO|fmiso
5089334|NCT01261585|Non-Small-Cell Lung Carcinoma|non-small-cell lung carcinoma
5089335|NCT01261585|chemo-Radiation Oncology|chemo-radiation oncology
5089336|NCT01261585|SUV|suv
5089337|NCT01261572|ASP3550|asp3550
5089338|NCT01261572|Degarelix|degarelix
5089339|NCT01261572|Prostate cancer|prostate cancer
5089340|NCT01261572|Prostatic neoplasms|prostatic neoplasms
5089341|NCT01261559|Computed tomography|computed tomography
5089342|NCT01261559|Radiation dose|radiation dose
5089343|NCT01261559|Dose reduction|dose reduction
5089344|NCT01261559|Breast displacement|breast displacement
5089345|NCT01261559|Chrysalis device|chrysalis device
5089346|NCT01261559|Image quality|image quality
5089347|NCT01261546|pleural effusion, empyema, corticoids, dexamethasone|pleural effusion, empyema, corticoids, dexamethasone
5089348|NCT01261533|vitreous body substitute|vitreous body substitute
5089349|NCT01261533|foldable capsular vitreous body|foldable capsular vitreous body
5089350|NCT01261507|lung neoplasm nodule image processing computer-assisted|lung neoplasm nodule image processing computer-assisted
5089351|NCT01261494|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
5089352|NCT01261494|Glucose Metabolism Disorders|glucose metabolism disorders
5089353|NCT01261494|Metabolic Diseases|metabolic diseases
5089354|NCT01261494|Cardiovascular Diseases|cardiovascular diseases
5089355|NCT01261494|PPARs|ppars
5089356|NCT01261494|OGTT|ogtt
5089357|NCT01261481|Bioavailability|bioavailability
5089358|NCT01261468|Chronic pain|chronic pain
5089359|NCT01261468|Electric Stimulation Therapy|electric stimulation therapy
5089360|NCT01261468|Neurologic Examination|neurologic examination
5090141|NCT01257867|Lithium|lithium
5089361|NCT01261442|distal symmetric polyneuropathy|distal symmetric polyneuropathy
5089362|NCT01261442|diabetic peripheral neuropathy|diabetic peripheral neuropathy
5089363|NCT01261442|posterior tibial nerve|posterior tibial nerve
5089364|NCT01261442|regional anesthesia|regional anesthesia
5089365|NCT01261442|nerve conduction study|nerve conduction study
5089366|NCT01261429|Pigmented villonodular synovitis|pigmented villonodular synovitis
5089367|NCT01261429|tenosynovial giant cell tumour|tenosynovial giant cell tumour
5089368|NCT01261429|nilotinib|nilotinib
5089369|NCT01261416|seizures|seizures
5089370|NCT01261416|epilepsy|epilepsy
5089371|NCT01261416|neonatal|neonatal
5089372|NCT01261416|levetiracetam|levetiracetam
5089373|NCT01261403|Human Placenta-Derived Cells|human placenta-derived cells
5089374|NCT01261390|Sleep Apnea|sleep apnea
5089375|NCT01261390|Heart Disease|heart disease
5089376|NCT01261390|Risk factors for heart disease|risk factors for heart disease
5089377|NCT01261377|COPD, obstructive sleep apnea, OSA, BPAP, CPAP|copd, obstructive sleep apnea, osa, bpap, cpap
5089378|NCT01261364|GeneSight|genesight
5089379|NCT01261364|Assurex|assurex
5089380|NCT01261364|AssureRx|assurerx
5089381|NCT01261351|Pre eclampsia|pre eclampsia
5089382|NCT01261351|Endogenous thrombin potential|endogenous thrombin potential
5089383|NCT01261338|PCBs|pcbs
5089384|NCT01261338|Olestra|olestra
5089385|NCT01261325|Epilepsy|epilepsy
5089386|NCT01261325|Brivaracetam|brivaracetam
5089387|NCT01261325|Partial Onset Seizures|partial onset seizures
5089388|NCT01261325|Adjunctive treatment|adjunctive treatment
5089389|NCT01261312|SGI-110|sgi-110
5089390|NCT01261312|DNA Hypomethylating Agent|dna hypomethylating agent
5089391|NCT01261312|Intermediate 1, Intermediate 2, CMML or High Risk MDS|intermediate 1, intermediate 2, cmml or high risk mds
5089393|NCT01261299|Phase 0 Clinical trial|phase 0 clinical trial
5089394|NCT01261299|Human microdosing trial|human microdosing trial
5089395|NCT01261299|Drug resistance, neoplasm|drug resistance, neoplasm
5089396|NCT01261299|Carcinoma, Non-small cell lung|carcinoma, non-small cell lung
5089397|NCT01261299|Urinary Bladder Neoplasm|urinary bladder neoplasm
5089398|NCT01261299|Individualized Medicine|individualized medicine
5089399|NCT01261299|Carboplatin|carboplatin
5089400|NCT01261299|Carboplatin-DNA adducts|carboplatin-dna adducts
5089401|NCT01261286|inflammation|inflammation
5089402|NCT01261286|receptor downregulation|receptor downregulation
5089403|NCT01261286|reduced response|reduced response
5089404|NCT01261286|calcium channels|calcium channels
5089405|NCT01261286|PK-PD relationship|pk-pd relationship
5089406|NCT01261273|PCI|pci
5089407|NCT01261273|observational registry|observational registry
5089408|NCT01261260|uridine|uridine
5089409|NCT01261260|gamma-amino butyric acid|gamma-amino butyric acid
5089410|NCT01261260|Magnetic Resonance Imaging|magnetic resonance imaging
5089411|NCT01261260|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
5089412|NCT01261260|Proton Echo-Planar Spectroscopic Imaging|proton echo-planar spectroscopic imaging
5089413|NCT01261234|Carotid Artery Disease|carotid artery disease
5089414|NCT01261234|Carotid Artery Stenting|carotid artery stenting
5089415|NCT01261234|In stent restenosis|in stent restenosis
5089416|NCT01261234|Cardiovascular event|cardiovascular event
5089417|NCT01261234|Intima Media Thickness|intima media thickness
5089418|NCT01261208|HIV, AIDS, Helicobacter pylori|hiv, aids, helicobacter pylori
5089419|NCT01261182|Malnutrition|malnutrition
5089420|NCT01261182|School feeding|school feeding
5089421|NCT01261182|Infant nutrition|infant nutrition
5089422|NCT01261182|Mother's nutrition|mother's nutrition
5089423|NCT01261182|Fortified food|fortified food
5089424|NCT01261182|Anemia|anemia
5089425|NCT01261182|Cluster randomized controlled trials|cluster randomized controlled trials
5089426|NCT01261182|Effectiveness|effectiveness
5089427|NCT01261182|Impact evaluation studies|impact evaluation studies
5089428|NCT01261182|Uganda|uganda
5089429|NCT01261169|Mycophenolate sodium (Myfortic®)|mycophenolate sodium (myfortic®)
5089430|NCT01261169|Corticosteroid-refractory autoimmune Uveitis|corticosteroid-refractory autoimmune uveitis
5089431|NCT01261130|Human Hookworm Vaccine Initiative|human hookworm vaccine initiative
5089432|NCT01261130|HHVI|hhvi
5089433|NCT01261130|Human Hookworm|human hookworm
5089434|NCT01261130|Hookworm|hookworm
5089435|NCT01261130|Hookworm Disease|hookworm disease
5089436|NCT01261130|N. americanus|n. americanus
5089437|NCT01261130|Soil-transmitted helminth infection|soil-transmitted helminth infection
5089438|NCT01261130|Intestinal blood loss|intestinal blood loss
5089439|NCT01261130|Iron deficiency anemia|iron deficiency anemia
5089440|NCT01261117|Patent ductus arteriosis|patent ductus arteriosis
5089441|NCT01261117|İbuprofen|ibuprofen
5089442|NCT01261117|Extremely Low Birth Weigh infant|extremely low birth weigh infant
5089443|NCT01261104|hearing loss|hearing loss
5089444|NCT01261104|handicap|handicap
5089445|NCT01261104|counseling|counseling
5089446|NCT01261091|Neurocritical Care|neurocritical care
5089447|NCT01261091|Ischemic Stroke|ischemic stroke
5089448|NCT01261091|Intracerebral Hemorrhage|intracerebral hemorrhage
5089449|NCT01261091|Subarachnoid Hemorrhage|subarachnoid hemorrhage
5089450|NCT01261091|Tracheostomy|tracheostomy
5089451|NCT01261091|Tracheotomy|tracheotomy
5089452|NCT01261091|Percutaneous Dilatative Tracheostomy|percutaneous dilatative tracheostomy
5089453|NCT01261091|Weaning|weaning
5089454|NCT01261091|Ventilation|ventilation
5089455|NCT01261078|intrathecal epinephrine|intrathecal epinephrine
5089456|NCT01261078|duration of anesthesia|duration of anesthesia
5089457|NCT01261078|quality of anesthesia|quality of anesthesia
5089458|NCT01261078|intrathecal fentanyl|intrathecal fentanyl
5089459|NCT01261065|beta blockers|beta blockers
5089460|NCT01261065|heart failure|heart failure
5089461|NCT01261065|contractility|contractility
5089462|NCT01261065|remodeling|remodeling
5089463|NCT01261052|glucose sensors|glucose sensors
5089464|NCT01261052|artificial pancreas|artificial pancreas
5089465|NCT01261052|Diabetes Mellitus|diabetes mellitus
5089466|NCT01261013|Keratoconus|keratoconus
5089467|NCT01261013|intrastromal corneal ring segment|intrastromal corneal ring segment
5089468|NCT01261013|To evaluate the visual and refractive outcomes of intrastromal corneal ring segment in keratoconic eyes at different stages|to evaluate the visual and refractive outcomes of intrastromal corneal ring segment in keratoconic eyes at different stages
5089469|NCT01261000|Acromegaly|acromegaly
5089470|NCT01260987|Moderate to severe actinic keratoses|moderate to severe actinic keratoses
5089471|NCT01260987|Difficult to treat nodular basal cell carcinomas|difficult to treat nodular basal cell carcinomas
5089472|NCT01260974|Invasive fungal infections|invasive fungal infections
5089473|NCT01260974|Liver Transplantation|liver transplantation
5089474|NCT01260974|Organ Transplantation|organ transplantation
5089475|NCT01260974|Mycoses|mycoses
5089476|NCT01260974|Fungus Diseases|fungus diseases
5089477|NCT01260974|Antifungal Agents|antifungal agents
5089478|NCT01260974|Invasive Mycosis|invasive mycosis
5089479|NCT01260948|Bioequivalence|bioequivalence
5089480|NCT01260948|Healthy Subjects|healthy subjects
5089481|NCT01260935|GERD|gerd
5089482|NCT01260935|laparoscopic surgery|laparoscopic surgery
5089483|NCT01260935|gastroesophageal|gastroesophageal
5089484|NCT01260935|reflux|reflux
5089485|NCT01260922|Bioequivalence|bioequivalence
5089486|NCT01260922|Healthy Subjects|healthy subjects
5089487|NCT01260896|Bioequivalence|bioequivalence
5089488|NCT01260896|Healthy Subjects|healthy subjects
5089489|NCT01260883|ketorolac pharmacokinetics|ketorolac pharmacokinetics
5089490|NCT01260883|ketorolac stereo-isomers|ketorolac stereo-isomers
5089491|NCT01260883|infants|infants
5089492|NCT01260883|postoperative analgesia|postoperative analgesia
5089493|NCT01260883|safety|safety
5089494|NCT01260857|Spirinolactone|spirinolactone
5089495|NCT01260857|Hydroflumethiazide|hydroflumethiazide
5089496|NCT01260857|Hypertension|hypertension
5089497|NCT01260857|Filipinos|filipinos
5089498|NCT01260857|Diabetes mellitus|diabetes mellitus
5089499|NCT01260857|Proteinuria|proteinuria
5089500|NCT01260831|BedsidePEWS|bedsidepews
5089501|NCT01260831|Intensive Care|intensive care
5089502|NCT01260818|Tranexamic Acid|tranexamic acid
5089503|NCT01260805|bioequivalence|bioequivalence
5089504|NCT01260805|study|study
5089505|NCT01260805|ethinylestradiol|ethinylestradiol
5089506|NCT01260805|gestodene|gestodene
5089507|NCT01260740|Traumatic Brain Injury|traumatic brain injury
5089508|NCT01260740|Explicit Learning|explicit learning
5089509|NCT01260740|Primary Motor Cortex|primary motor cortex
5089510|NCT01260740|Dorsolateral Prefrontal Cortex|dorsolateral prefrontal cortex
5089511|NCT01260740|Implicit Learning|implicit learning
5089512|NCT01260740|Healthy Volunteer|healthy volunteer
5089513|NCT01260740|HV|hv
5089514|NCT01260727|HIV Preventive Vaccine|hiv preventive vaccine
5089515|NCT01260675|phase 1 study|phase 1 study
5089516|NCT01260675|volunteers|volunteers
5089517|NCT01260662|Deep Procedural Sedation|deep procedural sedation
5089518|NCT01260662|Propofol|propofol
5089519|NCT01260662|Ketamine|ketamine
5089520|NCT01260662|Emergency Department|emergency department
5089521|NCT01260662|Monitoring|monitoring
5089522|NCT01260662|Capnography|capnography
5089523|NCT01260662|Procedural Sedation in the Emergency Department|procedural sedation in the emergency department
5089524|NCT01260649|Electroconvulsive treatment|electroconvulsive treatment
5089525|NCT01260649|ketamine|ketamine
5089526|NCT01260649|Major Depression|major depression
5089527|NCT01260649|Treatment-resistant Major Depressive Disorder|treatment-resistant major depressive disorder
5089528|NCT01260623|asthma|asthma
5089529|NCT01260623|pharmacokinetics|pharmacokinetics
5089530|NCT01260623|prednisone|prednisone
5089531|NCT01260623|prednisolone|prednisolone
5089532|NCT01260623|asthma exacerbation|asthma exacerbation
5089533|NCT01260623|pharmacokinetic profile|pharmacokinetic profile
5089534|NCT01260610|Hepatitis B, Tenofovir, Telbivudine|hepatitis b, tenofovir, telbivudine
5089535|NCT01260597|smoking|smoking
5089536|NCT01260597|quit line re-enrollment and IVR systems|quit line re-enrollment and ivr systems
5089537|NCT01260584|thienopyridine|thienopyridine
5089538|NCT01260584|antiplatelet|antiplatelet
5089539|NCT01260584|prasugrel|prasugrel
5089540|NCT01260584|clopidogrel|clopidogrel
5089541|NCT01260571|blackheads and pimples|blackheads and pimples
5089542|NCT01260571|Acne vulgaris grade II|acne vulgaris grade ii
5089543|NCT01260532|Autoimmune thyroid disease|autoimmune thyroid disease
5089544|NCT01260506|Relapsed Glioblastoma Multiforme, GBM|relapsed glioblastoma multiforme, gbm
5089545|NCT01260493|very frail|very frail
5089546|NCT01260493|case manager|case manager
5089547|NCT01260493|integrated care|integrated care
5089548|NCT01260493|multiprofessional|multiprofessional
5089549|NCT01260493|intervention|intervention
5089550|NCT01260480|Carcinoma, non-small-cell lung|carcinoma, non-small-cell lung
5089551|NCT01260480|Head and neck neoplasms|head and neck neoplasms
5089552|NCT01260480|Diagnostic imaging|diagnostic imaging
5089553|NCT01260467|recurrent|recurrent
5089554|NCT01260454|Qutenza|qutenza
5089555|NCT01260454|Capsaicin|capsaicin
5089556|NCT01260454|Remodulin|remodulin
5089557|NCT01260454|Treprostinil|treprostinil
5089558|NCT01260428|hypoxia|hypoxia
5089559|NCT01260428|O2 diffusion and convection|o2 diffusion and convection
5089560|NCT01260428|cardiac output|cardiac output
5089561|NCT01260428|PEEP|peep
5089562|NCT01260428|Effects of hypoxia|effects of hypoxia
5089563|NCT01260415|colorectal cancer|colorectal cancer
5089564|NCT01260415|liver metastases|liver metastases
5089565|NCT01260415|panitumumab|panitumumab
5089566|NCT01260415|FOLFOX|folfox
5089567|NCT01260415|Colorectal cancer with liver metastases|colorectal cancer with liver metastases
5089568|NCT01260402|heart failure|heart failure
5089569|NCT01260402|Cardiomyopathy, dilated|cardiomyopathy, dilated
5089570|NCT01260402|Coronary disease|coronary disease
5089571|NCT01260402|Cardiac Pacing, Artificial|cardiac pacing, artificial
5089572|NCT01260402|cardiac resynchronization therapy|cardiac resynchronization therapy
5089573|NCT01260402|Hemodynamics|hemodynamics
5089574|NCT01260402|Randomized Controlled Trials|randomized controlled trials
5089575|NCT01260402|Open Study|open study
5089576|NCT01260389|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5089577|NCT01260389|COPD|copd
5089578|NCT01260376|VLDL-TG|vldl-tg
5089579|NCT01260376|Metabolism|metabolism
5089580|NCT01260376|Exercise|exercise
5089581|NCT01260376|Free Fatty Acids|free fatty acids
5089582|NCT01260350|PSI-7977|psi-7977
5089583|NCT01260350|Sofosbuvir|sofosbuvir
5089584|NCT01260350|GS-7977|gs-7977
5089585|NCT01260350|GS-5885|gs-5885
5089586|NCT01260350|GS-9669|gs-9669
5089587|NCT01260350|FDC|fdc
5089588|NCT01260350|ribavirin|ribavirin
5089589|NCT01260350|RBV|rbv
5089590|NCT01260350|Pegylated Interferon|pegylated interferon
5089591|NCT01260350|PEG-IFN|peg-ifn
5089592|NCT01260350|Chronic Hepatitis C Infection|chronic hepatitis c infection
5089593|NCT01260350|HCV|hcv
5089594|NCT01260350|Hepatitis|hepatitis
5089595|NCT01260350|Genotype 1|genotype 1
5089596|NCT01260350|Genotype 2|genotype 2
5089597|NCT01260350|Genotype 3|genotype 3
5089598|NCT01260350|GT 1|gt 1
5089599|NCT01260350|GT 2|gt 2
5089600|NCT01260350|GT 3|gt 3
5089601|NCT01260350|Hemophilia|hemophilia
5089602|NCT01260337|Weight loss|weight loss
5089603|NCT01260337|Type 2 Diabetes|type 2 diabetes
5089604|NCT01260337|Behavior Modification|behavior modification
5089605|NCT01260337|portion control|portion control
5089606|NCT01260324|Phosphodiesterase type 5 inhibitors|phosphodiesterase type 5 inhibitors
5089607|NCT01260324|non-arteritic anterior ischemic optic neuropathy|non-arteritic anterior ischemic optic neuropathy
5089608|NCT01260324|descriptive epidemiology study|descriptive epidemiology study
5089609|NCT01260311|Observational|observational
5089610|NCT01260298|MC1 VASER VASERShape|mc1 vaser vasershape
5089611|NCT01260272|Cardiovascular|cardiovascular
5089612|NCT01260272|Risk Factors|risk factors
5089613|NCT01260272|Cardiovascular Disease|cardiovascular disease
5089614|NCT01260272|Glucose|glucose
5089615|NCT01260272|Blood Pressure|blood pressure
5089616|NCT01260272|BMI|bmi
5089617|NCT01260272|Weight|weight
5089618|NCT01260272|Waist Circumference|waist circumference
5089619|NCT01260259|Pediatric|pediatric
5089620|NCT01260259|Cardiac|cardiac
5089621|NCT01260259|Surgery|surgery
5089622|NCT01260259|Cardiopulmonary|cardiopulmonary
5089623|NCT01260259|Bypass|bypass
5089624|NCT01260259|Myocardial|myocardial
5089625|NCT01260259|Kidney|kidney
5089626|NCT01260259|Lung|lung
5089627|NCT01260259|Injury|injury
5089628|NCT01260233|smoking cessation|smoking cessation
5089629|NCT01260233|complications|complications
5089630|NCT01260233|cigarettes|cigarettes
5089631|NCT01260233|preoperative|preoperative
5089632|NCT01260233|perioperative|perioperative
5089633|NCT01260233|surgery|surgery
5089634|NCT01260233|education|education
5089635|NCT01260233|nicotine replacement therapy|nicotine replacement therapy
5089636|NCT01260207|Acute Coronary Syndrome|acute coronary syndrome
5089637|NCT01260207|Interactive Voice Response Technology|interactive voice response technology
5089638|NCT01260207|Best Practice Guidelines|best practice guidelines
5089639|NCT01260207|Compliance|compliance
5089640|NCT01260207|Health Care Utilization|health care utilization
5089641|NCT01260168|Cancer|cancer
5089642|NCT01260168|Colorectal Cancer|colorectal cancer
5089643|NCT01260168|Neoplasm|neoplasm
5089644|NCT01260168|Colorectal Neoplasm|colorectal neoplasm
5089645|NCT01260168|Intestinal Neoplasms|intestinal neoplasms
5089646|NCT01260168|Gastrointestinal Neoplasms|gastrointestinal neoplasms
5089647|NCT01260168|Digestive System Neoplasms|digestive system neoplasms
5089648|NCT01260168|Neoplasms by Site|neoplasms by site
5089649|NCT01260168|Neoplasms|neoplasms
5089650|NCT01260168|Digestive System Diseases|digestive system diseases
5089651|NCT01260168|Gastrointestinal Diseases|gastrointestinal diseases
5089652|NCT01260168|Colonic Diseases|colonic diseases
5089653|NCT01260168|Intestinal Diseases|intestinal diseases
5089654|NCT01260168|Rectal Diseases|rectal diseases
5089655|NCT01260129|BPH|bph
5089656|NCT01260129|silodosin|silodosin
5089657|NCT01260116|Efficacy,safety,ziprasidone,depressive symptoms ,schizophrenia|efficacy,safety,ziprasidone,depressive symptoms ,schizophrenia
5089658|NCT01260103|Optic pathway glioma, recurrent|optic pathway glioma, recurrent
5089659|NCT01260103|Optic pathway glioma, progressive|optic pathway glioma, progressive
5089660|NCT01260103|Temozolomide|temozolomide
5089661|NCT01260103|Temodar|temodar
5089662|NCT01260103|TMZ|tmz
5089663|NCT01260103|Antineoplastons|antineoplastons
5089664|NCT01260103|ANP therapy|anp therapy
5089665|NCT01260103|Atengenal (A10)|atengenal (a10)
5089666|NCT01260103|Astugenal (AS2-1)|astugenal (as2-1)
5089667|NCT01260090|Minimally conscious states|minimally conscious states
5089668|NCT01260090|Persistently vegetative states|persistently vegetative states
5089669|NCT01260090|Traumatic brain injury|traumatic brain injury
5089670|NCT01260064|Appendicitis|appendicitis
5089671|NCT01260064|Open appendectomy|open appendectomy
5089672|NCT01260064|Laparoscopic appendectomy|laparoscopic appendectomy
5089673|NCT01260064|Endoclip|endoclip
5089674|NCT01260064|Intracorporeal suture|intracorporeal suture
5089675|NCT01260064|Quality-of-life|quality-of-life
5089676|NCT01260038|Non Small Cell Lung Cancer|non small cell lung cancer
5089677|NCT01260038|observational study|observational study
5089678|NCT01260038|EGFR mutation analysis|egfr mutation analysis
5089679|NCT01260038|EGFR mutation status|egfr mutation status
5089680|NCT01260038|testing turn around time|testing turn around time
5089681|NCT01260025|Tolerability|tolerability
5089682|NCT01260025|Pharmacokinetics|pharmacokinetics
5089683|NCT01260025|Endostatin|endostatin
5089684|NCT01260025|antiangiogenesis|antiangiogenesis
5089685|NCT01260025|cancer|cancer
5089686|NCT01260012|Schistosoma mansoni|schistosoma mansoni
5089687|NCT01260012|Schistosomiasis|schistosomiasis
5089688|NCT01260012|periportal fibrosis|periportal fibrosis
5089689|NCT01260012|antioxidant|antioxidant
5089690|NCT01260012|fibrosis reversal|fibrosis reversal
5089691|NCT01259999|malnutrition|malnutrition
5089692|NCT01259999|oleic-acid|oleic-acid
5089693|NCT01259999|micronutrient supplement|micronutrient supplement
5089694|NCT01259999|old peoples home|old peoples home
5089695|NCT01259986|Vitiligo|vitiligo
5089696|NCT01259986|Laser|laser
5089697|NCT01259986|Segmental vitiligo|segmental vitiligo
5089698|NCT01259986|Acral vitiligo|acral vitiligo
5089699|NCT01259973|Pharmacogenetics|pharmacogenetics
5089700|NCT01259973|Antipsychotics|antipsychotics
5089701|NCT01259973|Extrapyramidal Symptoms|extrapyramidal symptoms
5089702|NCT01259947|headache|headache
5089703|NCT01259947|migraine|migraine
5089704|NCT01259947|medicinal plant|medicinal plant
5089705|NCT01259947|essential oil|essential oil
5089706|NCT01259947|phytotherapy|phytotherapy
5089707|NCT01259934|Randomized Phase III trial|randomized phase iii trial
5089708|NCT01259934|Adjuvant therapy|adjuvant therapy
5089709|NCT01259934|Interferon|interferon
5089710|NCT01259934|Melanoma|melanoma
5089711|NCT01259921|EEG biofeedback|eeg biofeedback
5089712|NCT01259921|neurofeedback|neurofeedback
5089713|NCT01259921|PTSD|ptsd
5089714|NCT01259921|Affect Regulation|affect regulation
5089715|NCT01259921|Chronic Trauma|chronic trauma
5089716|NCT01259908|laparoscopic aortic surgery|laparoscopic aortic surgery
5089717|NCT01259908|aorto-iliac occlusive disease|aorto-iliac occlusive disease
5089718|NCT01259882|Pharmacokinetics Safety Tolerability Pharmacodynamics|pharmacokinetics safety tolerability pharmacodynamics
5089719|NCT01259856|Polycythemia vera|polycythemia vera
5089720|NCT01259856|Essential thrombocythemia|essential thrombocythemia
5089721|NCT01259856|Hydroxyurea|hydroxyurea
5089722|NCT01259856|PEGASYS|pegasys
5089723|NCT01259856|Pegylated Interferon Alfa-2a|pegylated interferon alfa-2a
5089724|NCT01259843|Acute aortic syndrome|acute aortic syndrome
5089725|NCT01259830|fast-track|fast-track
5089726|NCT01259830|colon or rectal surgery|colon or rectal surgery
5089727|NCT01259830|pain relief|pain relief
5089728|NCT01259817|Polycythemia Vera|polycythemia vera
5089729|NCT01259817|Essential Thrombocythemia|essential thrombocythemia
5089730|NCT01259817|Hydroxyurea Resistant|hydroxyurea resistant
5089731|NCT01259817|Abdominal Vein Thrombosis|abdominal vein thrombosis
5089732|NCT01259817|PEGASYS|pegasys
5089733|NCT01259804|peanut|peanut
5089734|NCT01259804|food allergy|food allergy
5089735|NCT01259804|anaphylaxis|anaphylaxis
5089736|NCT01259804|immunotherapy|immunotherapy
5089737|NCT01259778|Growth disorders|growth disorders
5089738|NCT01259778|Saizen|saizen
5089739|NCT01259778|easypod™|easypod™
5089740|NCT01259778|Growth hormone|growth hormone
5089741|NCT01259778|Pediatric subject|pediatric subject
5089742|NCT01259765|llama antibody|llama antibody
5089743|NCT01259765|rotavirus diarrhoea|rotavirus diarrhoea
5089744|NCT01259765|children|children
5089745|NCT01259752|Trauma|trauma
5089746|NCT01259752|ankle sprain|ankle sprain
5089747|NCT01259752|emergency|emergency
5089748|NCT01259752|compression stocking|compression stocking
5089749|NCT01259739|trained cyclists|trained cyclists
5089750|NCT01259739|no medications|no medications
5089751|NCT01259739|no diseases|no diseases
5089752|NCT01259739|non-smokers|non-smokers
5089753|NCT01259726|Diarrhea|diarrhea
5089754|NCT01259726|Clostridium difficile|clostridium difficile
5089755|NCT01259726|Clostridium infections|clostridium infections
5089756|NCT01259726|Signs and Symptoms Digestive|signs and symptoms digestive
5089757|NCT01259726|Bacterial Infections|bacterial infections
5089758|NCT01259726|Pharmacologic Actions|pharmacologic actions
5089759|NCT01259713|Ambisome|ambisome
5089761|NCT01259713|invasive fungal infection|invasive fungal infection
5089762|NCT01259713|prophylaxis|prophylaxis
5089763|NCT01259713|liposomal amphotericin B|liposomal amphotericin b
5089764|NCT01259713|Invasive fungal infection prophylaxis|invasive fungal infection prophylaxis
5089765|NCT01259700|High blood pressure|high blood pressure
5089766|NCT01259700|Primary care|primary care
5089767|NCT01259700|Cardiovascular disease prevention|cardiovascular disease prevention
5089768|NCT01259700|Salt reduction|salt reduction
5089769|NCT01259687|Electrocardiogram|electrocardiogram
5089770|NCT01259687|Arterial line waveform|arterial line waveform
5089771|NCT01259687|Cardiac output|cardiac output
5089772|NCT01259674|Pediatric|pediatric
5089773|NCT01259674|children|children
5089774|NCT01259674|acute cough|acute cough
5089775|NCT01259674|treatment|treatment
5089776|NCT01259674|syrup|syrup
5089777|NCT01259674|protective natural extracts|protective natural extracts
5089778|NCT01259661|physical activity|physical activity
5089779|NCT01259661|metabolic syndrome|metabolic syndrome
5089780|NCT01259661|postmenopausal women|postmenopausal women
5089781|NCT01259661|exercise training|exercise training
5089782|NCT01259648|remifentanil|remifentanil
5089783|NCT01259648|anesthesia induction|anesthesia induction
5089784|NCT01259648|reactional tachycardia|reactional tachycardia
5089785|NCT01259635|Parkinson's disease|parkinson's disease
5089786|NCT01259635|freezing of gait|freezing of gait
5089787|NCT01259609|Diabetic Macular Edema|diabetic macular edema
5089788|NCT01259609|Ciliary Body|ciliary body
5089789|NCT01259609|Ultrasound Biomicroscopy|ultrasound biomicroscopy
5089790|NCT01259609|Vitrectomy|vitrectomy
5089791|NCT01259596|anxiety|anxiety
5089792|NCT01259596|rural|rural
5089793|NCT01259596|elderly|elderly
5089794|NCT01259544|CP-Chronic Pancreatitis|cp-chronic pancreatitis
5089795|NCT01259544|DPT-Di peptide breath test|dpt-di peptide breath test
5089796|NCT01259544|ePFT- Endoscopic pancreatic function test|epft- endoscopic pancreatic function test
5089797|NCT01259531|strong|strong
5089798|NCT01259531|silodosin|silodosin
5089799|NCT01259531|benign prostatic hyperplasia|benign prostatic hyperplasia
5089800|NCT01259531|BPH|bph
5089801|NCT01259531|lower urinary tract symptoms associated with severe BPH|lower urinary tract symptoms associated with severe bph
5089802|NCT01259505|no number|no number
5089803|NCT01259492|Attention Deficit /Hyperactivity Disorder, hyperactivity|attention deficit /hyperactivity disorder, hyperactivity
5089804|NCT01259479|Solid Tumors|solid tumors
5089805|NCT01259479|Maximum Tolerated Dose|maximum tolerated dose
5089806|NCT01259479|Parmacokinetics|parmacokinetics
5089807|NCT01259479|Pharmacogenomics|pharmacogenomics
5089808|NCT01259479|Satraplatin|satraplatin
5089809|NCT01259479|Cancer|cancer
5089810|NCT01259479|Solid Tumor|solid tumor
5089811|NCT01259479|Brain Tumor|brain tumor
5089812|NCT01259466|Smoking cessation|smoking cessation
5089813|NCT01259466|Overweight|overweight
5089814|NCT01259466|Obesity|obesity
5089815|NCT01259466|Internet treatment|internet treatment
5089816|NCT01259453|Hepatitis B vaccination|hepatitis b vaccination
5089817|NCT01259453|Syringe exchange programs|syringe exchange programs
5089818|NCT01259453|Injection drug users|injection drug users
5089819|NCT01259453|Hepatitis B prevention through vaccination|hepatitis b prevention through vaccination
5089820|NCT01259440|Telemedicine|telemedicine
5089821|NCT01259440|continuous positive airway pressure|continuous positive airway pressure
5089822|NCT01259440|treatment adherence|treatment adherence
5089823|NCT01259427|Mental Disorders|mental disorders
5089824|NCT01259427|Psychotic Disorders|psychotic disorders
5089825|NCT01259427|Schizophrenia|schizophrenia
5089826|NCT01259427|Stigmatization|stigmatization
5089827|NCT01259427|Mood Disorders|mood disorders
5089828|NCT01259427|Schizophrenia and Disorders with Psychotic Feature|schizophrenia and disorders with psychotic feature
5089829|NCT01259414|Carcinoma,Hepatocellular|carcinoma,hepatocellular
5089830|NCT01259414|Liver Neoplasms|liver neoplasms
5089831|NCT01259414|Survival analysis|survival analysis
5089832|NCT01259414|treatment outcome|treatment outcome
5089833|NCT01259414|administration drugs|administration drugs
5089834|NCT01259414|Chemoembolization,|chemoembolization,
5089835|NCT01259414|TACE|tace
5089836|NCT01259414|polyvinyl alcohol|polyvinyl alcohol
5089837|NCT01259414|water-soluble contrast mesium|water-soluble contrast mesium
5089838|NCT01259414|iopamidol|iopamidol
5089839|NCT01259414|lipiodol|lipiodol
5089840|NCT01259414|distilled water|distilled water
5089841|NCT01259401|Sleep|sleep
5089842|NCT01259401|Rehabilitation|rehabilitation
5089843|NCT01259401|Behavior therapy|behavior therapy
5089844|NCT01259401|Insomnia|insomnia
5089845|NCT01259388|Multiple sclerosis|multiple sclerosis
5089846|NCT01259388|Lithium|lithium
5089847|NCT01259349|cataract,|cataract,
5089848|NCT01259349|phacoemulsification,|phacoemulsification,
5089849|NCT01259349|one percent ultrasound|one percent ultrasound
5089850|NCT01259349|endothelial cell density|endothelial cell density
5089851|NCT01259336|Itraconazole|itraconazole
5089852|NCT01259336|chronic cavitary pulmonary aspergillosis|chronic cavitary pulmonary aspergillosis
5089853|NCT01259336|Aspergillosis|aspergillosis
5089854|NCT01259336|fungal ball|fungal ball
5089855|NCT01259336|mycetoma|mycetoma
5089856|NCT01259336|efficacy|efficacy
5089857|NCT01259336|safety|safety
5089858|NCT01259310|fertility|fertility
5089859|NCT01259310|women|women
5089860|NCT01259310|epilepsy|epilepsy
5089861|NCT01259310|pregnancy|pregnancy
5089862|NCT01259310|seizures|seizures
5089863|NCT01259310|seizure frequency|seizure frequency
5089864|NCT01259310|ovulation|ovulation
5089865|NCT01259310|menstruation|menstruation
5089866|NCT01259310|hormones|hormones
5089867|NCT01259310|progesterone|progesterone
5089868|NCT01259297|Aliskiren|aliskiren
5089869|NCT01259297|Elderly|elderly
5089870|NCT01259297|Major Cardiovascular Events|major cardiovascular events
5089871|NCT01259297|Effect of aliskiren-based regimen on major CV events (composite of CV death, non-fatal MI, non-fatal stroke and significant heart failure) in the elderly|effect of aliskiren-based regimen on major cv events (composite of cv death, non-fatal mi, non-fatal stroke and significant heart failure) in the elderly
5089872|NCT01259284|Breast cancer|breast cancer
5089873|NCT01259284|Colorectal cancer|colorectal cancer
5089874|NCT01259284|Genitourinary cancer|genitourinary cancer
5089875|NCT01259284|Head and neck cancers|head and neck cancers
5089876|NCT01259284|Lung cancer|lung cancer
5089877|NCT01259284|Melanoma|melanoma
5089878|NCT01259284|Sarcoma|sarcoma
5089879|NCT01259284|Atorvastatin|atorvastatin
5089880|NCT01259284|Lipitor|lipitor
5089881|NCT01259284|Fish Oil supplement|fish oil supplement
5089882|NCT01259284|Placebo|placebo
5089883|NCT01259258|varicocele, methylene blue, varicocelectomy, hydrocele,|varicocele, methylene blue, varicocelectomy, hydrocele,
5089884|NCT01259245|Chronic obstructive pulmonary disease COPD|chronic obstructive pulmonary disease copd
5089885|NCT01259245|pulmonary rehabilitation program PRP|pulmonary rehabilitation program prp
5089886|NCT01259245|Tai chi|tai chi
5089887|NCT01259219|HIV|hiv
5089888|NCT01259219|Completion of TB treamtment|completion of tb treamtment
5089889|NCT01259206|Calcaneal Spur, Diabetic Obese Patients|calcaneal spur, diabetic obese patients
5089890|NCT01259193|Hepatocellular Carcinoma|hepatocellular carcinoma
5089891|NCT01259193|Sorafenib|sorafenib
5089892|NCT01259193|Zoledronic Acid|zoledronic acid
5089893|NCT01259193|toxic reaction|toxic reaction
5089894|NCT01259180|acupuncture|acupuncture
5089895|NCT01259167|JOBA, Low Back Pain, Physical Exercise|joba, low back pain, physical exercise
5089896|NCT01259141|macrolide- resistant Mycoplasma pneumoniae,|macrolide- resistant mycoplasma pneumoniae,
5089897|NCT01259141|Mycoplasm pneumonia antibiotic therapy|mycoplasm pneumonia antibiotic therapy
5089898|NCT01259115|Healthy subjects|healthy subjects
5089899|NCT01259115|Opioid|opioid
5089900|NCT01259115|Transdermal|transdermal
5089901|NCT01259102|Healthy subjects|healthy subjects
5089902|NCT01259102|Opioid|opioid
5089903|NCT01259102|Transdermal|transdermal
5089904|NCT01259089|Adenocarcinoma of the Lung|adenocarcinoma of the lung
5089905|NCT01259089|Non-small Cell Lung Cancer|non-small cell lung cancer
5089906|NCT01259063|GEMCITABINE|gemcitabine
5089907|NCT01259063|RAD001(EVEROLIMUS)|rad001(everolimus)
5089908|NCT01259063|urinary|urinary
5089909|NCT01259063|BCG-Refractory|bcg-refractory
5089910|NCT01259063|Intravesical|intravesical
5089911|NCT01259063|10-165|10-165
5089912|NCT01259050|ALS treatment|als treatment
5089913|NCT01259050|Zinc|zinc
5089914|NCT01259050|Copper|copper
5089915|NCT01259050|BMAA|bmaa
5089916|NCT01259050|ALS|als
5089917|NCT01259037|Elastography|elastography
5089918|NCT01259037|Cutaneous|cutaneous
5089919|NCT01259037|Imaging|imaging
5089920|NCT01259024|hepatocellular carcinoma|hepatocellular carcinoma
5089921|NCT01259024|chemoembolization|chemoembolization
5089922|NCT01259024|transarterial chemoembolization|transarterial chemoembolization
5089923|NCT01259024|liver cancer|liver cancer
5089924|NCT01259024|doxorubicin|doxorubicin
5089925|NCT01259024|drug-eluting beads|drug-eluting beads
5089926|NCT01259024|LC Bead|lc bead
5089927|NCT01259011|end stage renal disease|end stage renal disease
5089928|NCT01259011|dialysis|dialysis
5089929|NCT01259011|end of life decision making|end of life decision making
5089930|NCT01259011|surrogate psychological morbidities|surrogate psychological morbidities
5089931|NCT01258985|Knee|knee
5089932|NCT01258985|Knee osteoarthritis|knee osteoarthritis
5089933|NCT01258985|osteoarthritis|osteoarthritis
5089934|NCT01258985|Knee pain|knee pain
5089935|NCT01258985|Tai Chi|tai chi
5089936|NCT01258985|Physical Therapy|physical therapy
5089937|NCT01258985|mind-body exercise|mind-body exercise
5089938|NCT01258972|Bifurcation lesions|bifurcation lesions
5089939|NCT01258959|Ultrasound, retrobulbar, parabulbar, ophthalmic surgery.|ultrasound, retrobulbar, parabulbar, ophthalmic surgery.
5089940|NCT01258946|epicardial adipose pcos|epicardial adipose pcos
5089941|NCT01258933|Leukemia|leukemia
5089942|NCT01258933|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
5089943|NCT01258933|CLL|cll
5089944|NCT01258933|Lymphoma|lymphoma
5089945|NCT01258933|Small Lymphocytic Lymphoma|small lymphocytic lymphoma
5089946|NCT01258933|SLL|sll
5089947|NCT01258933|Ofatumumab|ofatumumab
5089948|NCT01258920|Schizophrenia|schizophrenia
5089949|NCT01258920|Paliperidone palmitate|paliperidone palmitate
5089950|NCT01258920|Intramascular Injection|intramascular injection
5089951|NCT01258907|BI-204|bi-204
5089952|NCT01258868|Mesothelioma|mesothelioma
5089953|NCT01258868|Esophageal Cancer|esophageal cancer
5089954|NCT01258868|Lung Cancer|lung cancer
5089955|NCT01258868|Thoracic Malignancies|thoracic malignancies
5089956|NCT01258868|Tumor Cell Vaccine|tumor cell vaccine
5089957|NCT01258842|Influenza|influenza
5089958|NCT01258842|Prevention|prevention
5089959|NCT01258842|Probiotic|probiotic
5089960|NCT01258829|Heart Failure Cardiac Resynchronisation Therapy|heart failure cardiac resynchronisation therapy
5089961|NCT01258816|Acute Myeloid Leukaemia (AML)|acute myeloid leukaemia (aml)
5089962|NCT01258816|Pharmacokinetics|pharmacokinetics
5089963|NCT01258816|Elacytarabine|elacytarabine
5089964|NCT01258816|CP-4055|cp-4055
5089965|NCT01258803|asthma|asthma
5089966|NCT01258803|children|children
5089967|NCT01258803|persistent|persistent
5089968|NCT01258790|TS|ts
5089969|NCT01258790|tics|tics
5089970|NCT01258790|tourette|tourette
5089971|NCT01258777|Healthy volunteers|healthy volunteers
5089972|NCT01258777|Japanese male|japanese male
5089973|NCT01258777|Caucasian male|caucasian male
5089974|NCT01258777|Simponi|simponi
5089975|NCT01258764|hypertension|hypertension
5089976|NCT01258764|Blood Pressure control|blood pressure control
5089977|NCT01258764|hypertension treatment|hypertension treatment
5089978|NCT01258764|antihypertensive|antihypertensive
5089979|NCT01258764|N of 1 study|n of 1 study
5089980|NCT01258751|Healthy Volunteers|healthy volunteers
5089981|NCT01258738|Early ankylosing spondylitis (SpA) study; efficacy and safety and health out comes|early ankylosing spondylitis (spa) study; efficacy and safety and health out comes
5089982|NCT01258725|amnioinfusion, severe idiopahic oligohydramnios|amnioinfusion, severe idiopahic oligohydramnios
5089983|NCT01258673|Fimasartan|fimasartan
5089984|NCT01258673|Fimasartan/Hydrochlorothiazide combination|fimasartan/hydrochlorothiazide combination
5089985|NCT01258647|infant nutrition|infant nutrition
5089986|NCT01258647|complementary feeding|complementary feeding
5089987|NCT01258647|malnutrition|malnutrition
5089988|NCT01258647|stunting of growth|stunting of growth
5089989|NCT01258634|Osteosarcoma|osteosarcoma
5089990|NCT01258634|Surgically Resectable High Grade Osteosarcoma|surgically resectable high grade osteosarcoma
5089991|NCT01258634|Lung Metastases Only|lung metastases only
5089992|NCT01258621|distal pancreatectomy, laparoscopy, learning curve|distal pancreatectomy, laparoscopy, learning curve
5089993|NCT01258608|advanced hepatocellular carcinoma|advanced hepatocellular carcinoma
5089994|NCT01258608|Mapatumumab|mapatumumab
5089995|NCT01258608|HGS1012|hgs1012
5089996|NCT01258608|sorafenib|sorafenib
5089997|NCT01258595|Influenza|influenza
5089998|NCT01258595|Trivalent Inactivated Influenza Vaccine|trivalent inactivated influenza vaccine
5089999|NCT01258595|High-Dose Trivalent Inactivated Influenza Vaccine|high-dose trivalent inactivated influenza vaccine
5090000|NCT01258595|Influenza vaccines|influenza vaccines
5090001|NCT01258582|HIV|hiv
5090002|NCT01258582|Testing|testing
5090003|NCT01258582|HIV Seronegativity|hiv seronegativity
5090004|NCT01258569|laparoscopic|laparoscopic
5090005|NCT01258569|colon|colon
5090006|NCT01258569|resection|resection
5090007|NCT01258569|Entereg|entereg
5090008|NCT01258543|Global osteopathic evaluation|global osteopathic evaluation
5090009|NCT01258543|Non-specific back pain|non-specific back pain
5090010|NCT01258543|Inter-examiner reliability|inter-examiner reliability
5090011|NCT01258530|influenza, bioequivalence, oseltamivir, Tamiflu, over-encapsulation|influenza, bioequivalence, oseltamivir, tamiflu, over-encapsulation
5090012|NCT01258517|RDS|rds
5090013|NCT01258517|surfactant|surfactant
5090014|NCT01258517|cerebral oxygenation|cerebral oxygenation
5090015|NCT01258517|near infrared spectroscopy|near infrared spectroscopy
5090016|NCT01258504|Steady-state|steady-state
5090017|NCT01258504|Bosentan|bosentan
5090018|NCT01258504|St. Johns Wort|st. johns wort
5090019|NCT01258478|NSCLC, rehabilitation, CPET, lung resection|nsclc, rehabilitation, cpet, lung resection
5090020|NCT01258465|Communication|communication
5090021|NCT01258465|Pivotal Response Training|pivotal response training
5090022|NCT01258465|Picture Exchange Communication System|picture exchange communication system
5090023|NCT01258439|HIV|hiv
5090024|NCT01258439|cardiovascular disease|cardiovascular disease
5090025|NCT01258439|post prandial lipids|post prandial lipids
5090026|NCT01258439|ritonavir|ritonavir
5090027|NCT01258439|darunavir|darunavir
5090028|NCT01258439|raltegravir|raltegravir
5090029|NCT01258439|arterial stiffness|arterial stiffness
5090030|NCT01258439|tonometry|tonometry
5090031|NCT01258413|Cervical Cancer|cervical cancer
5090032|NCT01258413|Radical hysterectomy, Laparoscopic|radical hysterectomy, laparoscopic
5090033|NCT01258413|Overall survival|overall survival
5090034|NCT01258413|Disease-free five-years survival|disease-free five-years survival
5090035|NCT01258374|Pharmacokinetics, raltegravir, darunavir, NRTI sparing regimen|pharmacokinetics, raltegravir, darunavir, nrti sparing regimen
5090036|NCT01258361|preoperative fasting|preoperative fasting
5090037|NCT01258296|Postoperative pain|postoperative pain
5090038|NCT01258296|Breast reconstruction|breast reconstruction
5090039|NCT01258296|Abdominal flap breast reconstruction|abdominal flap breast reconstruction
5090040|NCT01258257|Aneurysm|aneurysm
5090343|NCT01256918|phacotip|phacotip
5090041|NCT01258257|Subarachnoid hemorrhage|subarachnoid hemorrhage
5090042|NCT01258257|Lumbar drain|lumbar drain
5090043|NCT01258257|Cerebral vasospasm|cerebral vasospasm
5090044|NCT01258257|Cerebral Ventricles|cerebral ventricles
5090045|NCT01258257|Cerebrospinal Fluid|cerebrospinal fluid
5090046|NCT01258257|Prospective Studies|prospective studies
5090047|NCT01258257|Drainage/methods*|drainage/methods*
5090048|NCT01258257|Humans|humans
5090049|NCT01258257|Subarachnoid Hemorrhage/cerebrospinal fluid*|subarachnoid hemorrhage/cerebrospinal fluid*
5090050|NCT01258257|Subarachnoid Hemorrhage/complications*|subarachnoid hemorrhage/complications*
5090051|NCT01258257|Subarachnoid Space/surgery*|subarachnoid space/surgery*
5090052|NCT01258257|Vasospasm, Intracranial/etiology|vasospasm, intracranial/etiology
5090053|NCT01258257|Vasospasm, Intracranial/surgery*|vasospasm, intracranial/surgery*
5090054|NCT01258244|Out-of-Hospital Cardiac Arrest, OHCA|out-of-hospital cardiac arrest, ohca
5090055|NCT01258205|Amgen|amgen
5090056|NCT01258205|AMG 139|amg 139
5090057|NCT01258205|Crohn's Disease|crohn's disease
5090058|NCT01258192|esophageal squamous cell carcinoma|esophageal squamous cell carcinoma
5090059|NCT01258192|neoadjuvant chemotherapy|neoadjuvant chemotherapy
5090060|NCT01258192|albumin-bound paclitaxel|albumin-bound paclitaxel
5090061|NCT01258192|cisplatin|cisplatin
5090062|NCT01258153|Infantile Colic|infantile colic
5090063|NCT01258153|tachykinin antagonist|tachykinin antagonist
5090064|NCT01258153|Nepadutant|nepadutant
5090065|NCT01258140|CT angiography|ct angiography
5090066|NCT01258140|radiation dose|radiation dose
5090067|NCT01258140|contrast medium|contrast medium
5090068|NCT01258127|Pemetrexed|pemetrexed
5090069|NCT01258127|Vinorelbine|vinorelbine
5090070|NCT01258127|Carboplatin|carboplatin
5090071|NCT01258114|Overweight|overweight
5090072|NCT01258114|Obesity|obesity
5090073|NCT01258114|Balneotherapy|balneotherapy
5090074|NCT01258114|Spa Therapy|spa therapy
5090075|NCT01258114|balneology|balneology
5090076|NCT01258114|hydrotherapy|hydrotherapy
5090077|NCT01258114|SF 12|sf 12
5090078|NCT01258114|Nutritional counselling|nutritional counselling
5090079|NCT01258114|Zelen double consent|zelen double consent
5090080|NCT01258114|Lifestyle modification program|lifestyle modification program
5090081|NCT01258114|IMC|imc
5090082|NCT01258088|psoriasis|psoriasis
5090083|NCT01258075|type 2 diabetes mellitus|type 2 diabetes mellitus
5090084|NCT01258075|blood glucose|blood glucose
5090085|NCT01258075|anti-diabetic|anti-diabetic
5090086|NCT01258075|bile acid sequestrant|bile acid sequestrant
5090087|NCT01258075|colesevelam HCl|colesevelam hcl
5090088|NCT01258075|oral suspension|oral suspension
5090089|NCT01258075|pediatric|pediatric
5090090|NCT01258075|add-on therapy|add-on therapy
5090091|NCT01258075|add-on to metformin|add-on to metformin
5090092|NCT01258075|metformin|metformin
5090093|NCT01258075|adolescent|adolescent
5090094|NCT01258075|lipid|lipid
5090095|NCT01258049|Plasmodium infections|plasmodium infections
5090096|NCT01258049|Remittent fever|remittent fever
5090097|NCT01258049|Artemether|artemether
5090098|NCT01258049|Artemesinins|artemesinins
5090099|NCT01258049|Quinine|quinine
5090100|NCT01258049|Malaria|malaria
5090101|NCT01258049|Protozoan infections|protozoan infections
5090102|NCT01258049|sublingual drug delivery|sublingual drug delivery
5090103|NCT01258049|Parasitic disease|parasitic disease
5090104|NCT01258049|Antiprotozoan agents|antiprotozoan agents
5090105|NCT01258036|Bone microarchitecture|bone microarchitecture
5090106|NCT01258036|Bone mineral density|bone mineral density
5090107|NCT01258036|Bone markers|bone markers
5090108|NCT01258036|hereditary determinism|hereditary determinism
5090109|NCT01258010|Red blood cell transfusion|red blood cell transfusion
5090110|NCT01258010|Neurosurgery|neurosurgery
5090111|NCT01258010|Orthopedic surgery|orthopedic surgery
5090112|NCT01258010|Tranexamic acid|tranexamic acid
5090113|NCT01258010|Surgical blood loss|surgical blood loss
5090114|NCT01257997|No specific experimental conditions|no specific experimental conditions
5090115|NCT01257971|Cholesterol|cholesterol
5090116|NCT01257971|HMG-CoA reductase inhibitor|hmg-coa reductase inhibitor
5090117|NCT01257971|cardiovascular risk|cardiovascular risk
5090118|NCT01257971|LDLl|ldll
5090119|NCT01257958|Vitamin D, 19 nor Vitamin D, Multiple Sclerosis|vitamin d, 19 nor vitamin d, multiple sclerosis
5090120|NCT01257932|Breast Cancer|breast cancer
5090121|NCT01257906|acne|acne
5090122|NCT01257906|Ziana|ziana
5090123|NCT01257906|clindamycin|clindamycin
5090124|NCT01257906|tretinoin|tretinoin
5090125|NCT01257893|migraine|migraine
5090126|NCT01257893|chronic migraine|chronic migraine
5090127|NCT01257893|migraine with aura|migraine with aura
5090128|NCT01257893|migraine without aura|migraine without aura
5090129|NCT01257893|aspirin|aspirin
5090130|NCT01257893|platelets|platelets
5090131|NCT01257880|Migraine|migraine
5090132|NCT01257880|Migraine with Aura|migraine with aura
5090133|NCT01257880|Aura|aura
5090134|NCT01257880|Patent Foramen Ovale|patent foramen ovale
5090135|NCT01257880|Platelets|platelets
5090136|NCT01257880|Sleep Apnea|sleep apnea
5090137|NCT01257880|Cognitive Function|cognitive function
5090138|NCT01257867|Brain-derived neurotrophic factor|brain-derived neurotrophic factor
5090139|NCT01257867|Oxidative stress|oxidative stress
5090140|NCT01257867|Neurogenesis|neurogenesis
5090142|NCT01257867|Lithia water|lithia water
5090143|NCT01257854|busulfan|busulfan
5090144|NCT01257854|pharmacogenetic|pharmacogenetic
5090145|NCT01257854|pharmacokinetic|pharmacokinetic
5090146|NCT01257854|toxicity|toxicity
5090147|NCT01257854|survival|survival
5090148|NCT01257841|Fasting|fasting
5090149|NCT01257841|Gut hormones|gut hormones
5090150|NCT01257841|Inflammatory Cytokines|inflammatory cytokines
5090151|NCT01257815|Diabetes mellitus|diabetes mellitus
5090152|NCT01257815|Diabetic retinopathy|diabetic retinopathy
5090153|NCT01257815|Macular oedema|macular oedema
5090154|NCT01257815|Visual acuity|visual acuity
5090155|NCT01257789|laparoscopic gastric bypass|laparoscopic gastric bypass
5090156|NCT01257789|learning curve|learning curve
5090157|NCT01257789|complications|complications
5090158|NCT01257789|operative time|operative time
5090159|NCT01257776|Critical Limb Ischemia (CLI)|critical limb ischemia (cli)
5090160|NCT01257776|Diabetes|diabetes
5090161|NCT01257776|Mesenchymal Stem Cells|mesenchymal stem cells
5090162|NCT01257776|Regenerative Therapy|regenerative therapy
5090163|NCT01257763|needles/adverse effects|needles/adverse effects
5090164|NCT01257763|administration, cutaneous|administration, cutaneous
5090165|NCT01257763|erythema|erythema
5090166|NCT01257763|pain measurement|pain measurement
5090167|NCT01257763|Safety|safety
5090168|NCT01257763|Microstructure Transdermal System|microstructure transdermal system
5090169|NCT01257750|corneal neovascularization|corneal neovascularization
5090170|NCT01257750|pazopanib|pazopanib
5090171|NCT01257750|votrient|votrient
5090172|NCT01257750|rosacea|rosacea
5090173|NCT01257737|Urea Cycle Disorders|urea cycle disorders
5090174|NCT01257737|GT4P|gt4p
5090175|NCT01257737|HPN-100|hpn-100
5090176|NCT01257737|Sodium Phenylbutyrate (NaPBA)|sodium phenylbutyrate (napba)
5090177|NCT01257737|Glyceryl tri-(4-phenylbutyrate)|glyceryl tri-(4-phenylbutyrate)
5090178|NCT01257737|Phenylbutyrate|phenylbutyrate
5090179|NCT01257737|Hyperion|hyperion
5090180|NCT01257737|BUPHENYL|buphenyl
5090181|NCT01257737|hyperammonemia|hyperammonemia
5090182|NCT01257724|Knowledge translation|knowledge translation
5090183|NCT01257724|Community based organizations|community based organizations
5090184|NCT01257724|HIV/AIDS|hiv/aids
5090185|NCT01257711|Gastric Cancer|gastric cancer
5090186|NCT01257711|Gastrectomy|gastrectomy
5090187|NCT01257711|Billroth 2|billroth 2
5090188|NCT01257711|Roux-en-Y|roux-en-y
5090189|NCT01257698|Vitrectomy|vitrectomy
5090190|NCT01257698|Gas bubble|gas bubble
5090191|NCT01257698|Retinal detachment|retinal detachment
5090192|NCT01257698|Macular hole|macular hole
5090193|NCT01257698|Aqueous suppressant|aqueous suppressant
5090194|NCT01257672|acute gastroenteritis|acute gastroenteritis
5090195|NCT01257672|vomiting|vomiting
5090196|NCT01257672|ondansetron|ondansetron
5090197|NCT01257672|domperidon|domperidon
5090198|NCT01257672|symptomatic treatment|symptomatic treatment
5090199|NCT01257659|Rectocele|rectocele
5090200|NCT01257659|Trans anal STARR resection|trans anal starr resection
5090201|NCT01257659|Transvaginal repair|transvaginal repair
5090202|NCT01257633|da Vinci surgical robot|da vinci surgical robot
5090203|NCT01257633|laryngeal cancer|laryngeal cancer
5090204|NCT01257620|Inflammatory Bowel Disease|inflammatory bowel disease
5090205|NCT01257620|Coeliac Disease|coeliac disease
5090206|NCT01257594|Gliomas|gliomas
5090207|NCT01257594|Erlotinib|erlotinib
5090208|NCT01257594|Glioblastoma|glioblastoma
5090209|NCT01257594|GBM|gbm
5090210|NCT01257594|Gliosarcoma|gliosarcoma
5090211|NCT01257594|Glioma|glioma
5090212|NCT01257581|ALS|als
5090213|NCT01257581|Lou Gehrig's Disease|lou gehrig's disease
5090214|NCT01257581|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
5090215|NCT01257581|Creatine|creatine
5090216|NCT01257581|Tamoxifen|tamoxifen
5090217|NCT01257581|Selection Design|selection design
5090218|NCT01257542|randomized|randomized
5090219|NCT01257542|parallel|parallel
5090220|NCT01257542|double-blind|double-blind
5090221|NCT01257542|placebo-controlled|placebo-controlled
5090222|NCT01257542|cough|cough
5090223|NCT01257542|efficacy|efficacy
5090224|NCT01257542|safety|safety
5090225|NCT01257542|dextromethorphan|dextromethorphan
5090226|NCT01257529|pregabalin|pregabalin
5090227|NCT01257529|pharmacokinetics|pharmacokinetics
5090228|NCT01257529|bioavailability|bioavailability
5090229|NCT01257529|bioequivalence|bioequivalence
5090230|NCT01257516|pregabalin|pregabalin
5090231|NCT01257516|pharmacokinetics|pharmacokinetics
5090232|NCT01257516|bioavailability|bioavailability
5090233|NCT01257516|bioequivalence|bioequivalence
5090234|NCT01257503|children|children
5090235|NCT01257503|upper respiratory tract infections|upper respiratory tract infections
5090236|NCT01257503|homeopathy|homeopathy
5090237|NCT01257477|Diarrhea|diarrhea
5090238|NCT01257477|IBS|ibs
5090239|NCT01257477|Irritable Bowel Syndrome|irritable bowel syndrome
5090240|NCT01257464|CFRD|cfrd
5090241|NCT01257464|sitagliptin|sitagliptin
5090242|NCT01257464|cystic fibrosis-related diabetes|cystic fibrosis-related diabetes
5090243|NCT01257464|incretins|incretins
5090244|NCT01257464|hyperglycemia|hyperglycemia
5090245|NCT01257464|GIP|gip
5090246|NCT01257464|GLP-1|glp-1
5090247|NCT01257451|Type 2 Diabetes Mellitus, Vildagliptin, Elderly Patients|type 2 diabetes mellitus, vildagliptin, elderly patients
5090248|NCT01257412|Phase III|phase iii
5090249|NCT01257412|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
5090250|NCT01257412|inadequate glycaemic control|inadequate glycaemic control
5090251|NCT01257360|RAS-Wildtype|ras-wildtype
5090252|NCT01257360|Radiotherapy|radiotherapy
5090253|NCT01257360|Neoadjuvant treatment|neoadjuvant treatment
5090254|NCT01257347|Medication adherence|medication adherence
5090255|NCT01257347|clinical inertia|clinical inertia
5090256|NCT01257347|treatment intensification|treatment intensification
5090257|NCT01257347|quality of care|quality of care
5090258|NCT01257334|type 2 diabetes|type 2 diabetes
5090259|NCT01257308|lung cancer|lung cancer
5090260|NCT01257295|dietary fiber|dietary fiber
5090261|NCT01257295|energy intake|energy intake
5090262|NCT01257295|appetite|appetite
5090263|NCT01257295|satiety hormones|satiety hormones
5090264|NCT01257295|glucose|glucose
5090265|NCT01257295|gastric emptying|gastric emptying
5090266|NCT01257269|Thrombotic thrombocytopenic purpura|thrombotic thrombocytopenic purpura
5090267|NCT01257269|ADAMTS13|adamts13
5090268|NCT01257269|Von Willebrand factor|von willebrand factor
5090269|NCT01257269|Von Willebrand factor cleaving protease|von willebrand factor cleaving protease
5090270|NCT01257269|Thrombocytopenia|thrombocytopenia
5090271|NCT01257269|Hemolytic anemia|hemolytic anemia
5090272|NCT01257256|infertile patients|infertile patients
5090273|NCT01257243|cough|cough
5090274|NCT01257243|symptoms|symptoms
5090275|NCT01257243|cold|cold
5090276|NCT01257243|flu|flu
5090277|NCT01257217|Intraocular Lens|intraocular lens
5090278|NCT01257217|Presbyopia|presbyopia
5090279|NCT01257217|multifocal|multifocal
5090280|NCT01257191|Vehicle Emissions|vehicle emissions
5090281|NCT01257191|Diesel Exhaust|diesel exhaust
5090282|NCT01257165|Automobile driving|automobile driving
5090283|NCT01257165|Zopiclone|zopiclone
5090284|NCT01257165|Drug safety|drug safety
5090285|NCT01257165|Traffic accidents|traffic accidents
5090286|NCT01257139|To evaluate a geriatric scale designed to help with treatment|to evaluate a geriatric scale designed to help with treatment
5090287|NCT01257139|allocation to dual-agent therapy based on platinum or to|allocation to dual-agent therapy based on platinum or to
5090288|NCT01257139|single-agent chemotherapy in elderly subjects with advancedstage|single-agent chemotherapy in elderly subjects with advancedstage
5090289|NCT01257139|NSCLC, based on the time to failure in the two arms|nsclc, based on the time to failure in the two arms
5090290|NCT01257126|Upper respiratory tract infections|upper respiratory tract infections
5090291|NCT01257126|diclofenac potassium|diclofenac potassium
5090292|NCT01257126|nimesulide|nimesulide
5090293|NCT01257126|fever|fever
5090294|NCT01257126|pain|pain
5090295|NCT01257113|shoulder pain|shoulder pain
5090296|NCT01257113|shoulder impingement|shoulder impingement
5090297|NCT01257113|rotatorcuff pathology|rotatorcuff pathology
5090298|NCT01257113|supervised exercise|supervised exercise
5090299|NCT01257113|homebased exercise|homebased exercise
5090300|NCT01257100|Nasopharyngeal Carcinoma|nasopharyngeal carcinoma
5090301|NCT01257100|Epstein-Barr Virus|epstein-barr virus
5090302|NCT01257100|NPC|npc
5090303|NCT01257087|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
5090304|NCT01257087|Obesity|obesity
5090305|NCT01257087|Bariatric Surgery|bariatric surgery
5090306|NCT01257087|Glycaemic control|glycaemic control
5090307|NCT01257087|Microvascular complications|microvascular complications
5090308|NCT01257087|Intensive|intensive
5090309|NCT01257087|Conservative|conservative
5090310|NCT01257074|Herpes Simplex|herpes simplex
5090311|NCT01257061|Dermatitis|dermatitis
5090312|NCT01257061|Dermatitis, Atopic|dermatitis, atopic
5090313|NCT01257048|Oxygen enhanced magnetic resonance imaging|oxygen enhanced magnetic resonance imaging
5090314|NCT01257048|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
5090315|NCT01257048|method evaluation|method evaluation
5090316|NCT01257035|Rectum cancer|rectum cancer
5090317|NCT01257035|FAZA|faza
5090318|NCT01257035|18F-FAZA-PET/CT|18f-faza-pet/ct
5090319|NCT01257035|Radiotherapy|radiotherapy
5090320|NCT01257035|Chemoradiotherapy|chemoradiotherapy
5090321|NCT01257022|Prevention|prevention
5090322|NCT01257022|HIV|hiv
5090323|NCT01257022|Substance use|substance use
5090324|NCT01257022|Hispanic|hispanic
5090325|NCT01257022|Adolescents|adolescents
5090326|NCT01257022|Unsafe sexual behavior|unsafe sexual behavior
5090327|NCT01257022|Behavioral intervention|behavioral intervention
5090328|NCT01257009|sympathetic activity|sympathetic activity
5090329|NCT01257009|chronic kidney disease|chronic kidney disease
5090330|NCT01257009|atorvastatin|atorvastatin
5090331|NCT01257009|lipitor|lipitor
5090332|NCT01256983|Sleep quality|sleep quality
5090333|NCT01256983|Daytime Sleepiness|daytime sleepiness
5090334|NCT01256944|PCOS|pcos
5090335|NCT01256944|DM|dm
5090336|NCT01256944|Hypertension|hypertension
5090337|NCT01256944|CVD|cvd
5090338|NCT01256931|2009 H1N1 influenza vaccine, organ transplant patients,|2009 h1n1 influenza vaccine, organ transplant patients,
5090339|NCT01256931|booster with Fluarix|booster with fluarix
5090340|NCT01256918|cataract|cataract
5090341|NCT01256918|phacoemulsification|phacoemulsification
5090342|NCT01256918|phacochop|phacochop
5090344|NCT01256879|cimetidine|cimetidine
5090345|NCT01256879|pharmacokinetics|pharmacokinetics
5090346|NCT01256879|formulation|formulation
5090347|NCT01256866|Dexmedetomidine|dexmedetomidine
5090348|NCT01256866|Midazolam|midazolam
5090349|NCT01256866|Sedation|sedation
5090350|NCT01256866|Mechanical ventilation|mechanical ventilation
5090351|NCT01256866|Critically ill patients|critically ill patients
5090352|NCT01256853|histologically confirmed EBV+ NPC patients|histologically confirmed ebv+ npc patients
5090353|NCT01256827|age-related macular degeneration|age-related macular degeneration
5090354|NCT01256827|ranibizumab|ranibizumab
5090355|NCT01256827|geographic atrophy|geographic atrophy
5090356|NCT01256827|ANCHOR Study|anchor study
5090357|NCT01256827|MARINA Study|marina study
5090358|NCT01256814|HIV/AIDS|hiv/aids
5090359|NCT01256814|Adult|adult
5090360|NCT01256814|Behavioral Intervention|behavioral intervention
5090361|NCT01256814|Sleep|sleep
5090362|NCT01256814|Physical Activity|physical activity
5090363|NCT01256801|Metastatic Breast Neoplasms|metastatic breast neoplasms
5090364|NCT01256801|Gene Expression Profiling|gene expression profiling
5090365|NCT01256801|immunotherapy|immunotherapy
5090366|NCT01256788|viscosupplementation|viscosupplementation
5090367|NCT01256788|meniscus tear|meniscus tear
5090368|NCT01256788|degenerative joint disease|degenerative joint disease
5090369|NCT01256775|atherosclerosis|atherosclerosis
5090370|NCT01256775|carotid intima-media thickness|carotid intima-media thickness
5090371|NCT01256775|intermittent claudication|intermittent claudication
5090372|NCT01256775|Nitric Oxide / NO|nitric oxide / no
5090373|NCT01256762|imetelstat|imetelstat
5090374|NCT01256762|imetelstat sodium|imetelstat sodium
5090375|NCT01256762|GRN163L|grn163l
5090376|NCT01256762|telomerase inhibitor|telomerase inhibitor
5090377|NCT01256762|telomerase inhibition|telomerase inhibition
5090378|NCT01256762|metastatic breast cancer|metastatic breast cancer
5090379|NCT01256762|locally recurrent breast cancer|locally recurrent breast cancer
5090380|NCT01256762|Bevacizumab|bevacizumab
5090381|NCT01256762|Paclitaxel|paclitaxel
5090382|NCT01256762|Avastin|avastin
5090383|NCT01256762|Taxol|taxol
5090384|NCT01256762|HER-2-negative|her-2-negative
5090385|NCT01256762|First-Line Chemotherapy|first-line chemotherapy
5090386|NCT01256762|Second-Line Chemotherapy|second-line chemotherapy
5090387|NCT01256723|drug eluting stent (DES)|drug eluting stent (des)
5090388|NCT01256723|unprotected left main coronary artery (ULMCA)|unprotected left main coronary artery (ulmca)
5090389|NCT01256684|Vulvar/vaginal atrophy|vulvar/vaginal atrophy
5090390|NCT01256684|Atrophic Vaginitis|atrophic vaginitis
5090391|NCT01256684|Dehydroepiandrosterone|dehydroepiandrosterone
5090392|NCT01256684|DHEA|dhea
5090393|NCT01256684|Prasterone|prasterone
5090394|NCT01256684|Vaginorm|vaginorm
5090395|NCT01256684|Menopause|menopause
5090396|NCT01256684|Intrarosa|intrarosa
5090397|NCT01256671|Vulvar/Vaginal Atrophy|vulvar/vaginal atrophy
5090398|NCT01256671|Atrophic Vaginitis|atrophic vaginitis
5090399|NCT01256671|Dehydroepiandrosterone|dehydroepiandrosterone
5090400|NCT01256671|DHEA|dhea
5090401|NCT01256671|Prasterone|prasterone
5090402|NCT01256671|Vaginorm|vaginorm
5090403|NCT01256671|Menopause|menopause
5090404|NCT01256671|Intrarosa|intrarosa
5090405|NCT01256658|P. falciparum|p. falciparum
5090406|NCT01256658|malaria|malaria
5090407|NCT01256658|asymptomatic carriers|asymptomatic carriers
5090408|NCT01256658|bed-nets|bed-nets
5090409|NCT01256658|ITN-insecticide-treated net|itn-insecticide-treated net
5090410|NCT01256658|idiopathic trigeminal neuralgia|idiopathic trigeminal neuralgia
5090411|NCT01256658|RDT-Rapid diagnostic test|rdt-rapid diagnostic test
5090412|NCT01256645|weaning|weaning
5090413|NCT01256645|mechanical ventilation|mechanical ventilation
5090414|NCT01256645|blood transfusion|blood transfusion
5090415|NCT01256645|spontaneous breathing trials|spontaneous breathing trials
5090416|NCT01256619|Marvelon|marvelon
5090417|NCT01256619|PMS|pms
5090418|NCT01256619|serum Lipids|serum lipids
5090419|NCT01256593|Lyrica|lyrica
5090420|NCT01256593|Regulatory Post Marketing Commitment Plan|regulatory post marketing commitment plan
5090421|NCT01256593|Safety|safety
5090422|NCT01256593|Neuropathic Pain|neuropathic pain
5090423|NCT01256593|Post Marketing Surveillance|post marketing surveillance
5090424|NCT01256554|Stereotactic Radiosurgery|stereotactic radiosurgery
5090425|NCT01256554|SSRS|ssrs
5090426|NCT01256554|Radiation|radiation
5090427|NCT01256554|Radiotherapy|radiotherapy
5090428|NCT01256554|Metastatic Epidural Spinal Cord Compression|metastatic epidural spinal cord compression
5090429|NCT01256554|MESCC|mescc
5090430|NCT01256528|Invasive breast carcinoma|invasive breast carcinoma
5090431|NCT01256528|Breast reconstruction|breast reconstruction
5090432|NCT01256528|Mastectomy|mastectomy
5090433|NCT01256528|Breast cancer|breast cancer
5090434|NCT01256528|Delayed-delayed breast reconstruction|delayed-delayed breast reconstruction
5090435|NCT01256528|Post-mastectomy radiation therapy|post-mastectomy radiation therapy
5090436|NCT01256515|Healthy adults aged 50 or older|healthy adults aged 50 or older
5090437|NCT01256489|KPro|kpro
5090438|NCT01256489|Keratoprosthesis|keratoprosthesis
5090439|NCT01256489|Stevens-Johnson Syndrome|stevens-johnson syndrome
5090440|NCT01256489|Infliximab|infliximab
5090441|NCT01256489|Corneal Blindness|corneal blindness
5090442|NCT01256450|buccal soluble film|buccal soluble film
5090443|NCT01256450|enriched enrollment|enriched enrollment
5090444|NCT01256450|randomized withdrawal|randomized withdrawal
5090445|NCT01256437|Acneiform eruption|acneiform eruption
5090446|NCT01256437|papulopustular|papulopustular
5090447|NCT01256437|EGFR|egfr
5090448|NCT01256437|cetuximab|cetuximab
5090449|NCT01256437|erlotinib|erlotinib
5090450|NCT01256437|gefitinib|gefitinib
5090451|NCT01256437|panitumumab|panitumumab
5090452|NCT01256437|eruption secondary to treatment with either cetuximab|eruption secondary to treatment with either cetuximab
5090453|NCT01256424|CIN|cin
5090454|NCT01256411|hypertension|hypertension
5090455|NCT01256411|blood pressure|blood pressure
5090456|NCT01256411|LCZ696|lcz696
5090457|NCT01256411|dual-acting|dual-acting
5090458|NCT01256411|neprilysin|neprilysin
5090459|NCT01256411|nep inhibitor|nep inhibitor
5090460|NCT01256411|vasopeptidase|vasopeptidase
5090461|NCT01256411|angiotensin receptor|angiotensin receptor
5090462|NCT01256411|angiotensin receptor neprilysin inhibitor (ARNi)|angiotensin receptor neprilysin inhibitor (arni)
5090463|NCT01256372|Cardiac surgery|cardiac surgery
5090464|NCT01256372|Acute kidney injury|acute kidney injury
5090465|NCT01256346|Premature|premature
5090466|NCT01256346|baby|baby
5090467|NCT01256346|heart rate|heart rate
5090468|NCT01256346|resuscitation|resuscitation
5090469|NCT01256307|Obstructive Sleep Apnea/Hypopnea Syndrome|obstructive sleep apnea/hypopnea syndrome
5090470|NCT01256307|Exercise training program|exercise training program
5090471|NCT01256307|Inflammation|inflammation
5090472|NCT01256307|Oxidative Stress|oxidative stress
5090473|NCT01256307|Insulin resistance|insulin resistance
5090474|NCT01256294|Renal transplant|renal transplant
5090475|NCT01256294|kidney transplant|kidney transplant
5090476|NCT01256294|immunosuppressive therapy|immunosuppressive therapy
5090477|NCT01256294|anti-rejection medication|anti-rejection medication
5090478|NCT01256294|pharmacokinetics|pharmacokinetics
5090479|NCT01256294|tacrolimus|tacrolimus
5090480|NCT01256281|Sickle Cell Disease|sickle cell disease
5090481|NCT01256281|Pain|pain
5090482|NCT01256281|Vasoocclusion|vasoocclusion
5090483|NCT01256281|Nerve Block|nerve block
5090484|NCT01256281|Regional Anesthesia|regional anesthesia
5090485|NCT01256268|metastatic|metastatic
5090486|NCT01256268|recurrent|recurrent
5090487|NCT01256268|Solid Cancer|solid cancer
5090488|NCT01256255|transplant|transplant
5090489|NCT01256255|influenza infection|influenza infection
5090490|NCT01256242|tendon|tendon
5090491|NCT01256242|shoulder|shoulder
5090492|NCT01256242|rotator cuff|rotator cuff
5090493|NCT01256242|Glenohumeral|glenohumeral
5090494|NCT01256229|deafness|deafness
5090495|NCT01256229|hearing loss|hearing loss
5090496|NCT01256229|developmental delay|developmental delay
5090497|NCT01256229|mental retardation|mental retardation
5090498|NCT01256216|Arthritis|arthritis
5090499|NCT01256216|Osteoarthritis|osteoarthritis
5090500|NCT01256216|Arthroplasty|arthroplasty
5090502|NCT01256203|Porfimer sodium|porfimer sodium
5090503|NCT01256203|Phototoxicity|phototoxicity
5090504|NCT01256203|Sunscreen|sunscreen
5090505|NCT01256177|Bipolar Depression|bipolar depression
5090506|NCT01256177|Mental disease,|mental disease,
5090507|NCT01256164|fibrin sealants|fibrin sealants
5090508|NCT01256164|hemostatics|hemostatics
5090509|NCT01256164|time to hemostasis|time to hemostasis
5090510|NCT01256151|Bioequivalence|bioequivalence
5090511|NCT01256151|sublingual|sublingual
5090512|NCT01256151|alprazolam|alprazolam
5090513|NCT01256151|pharmacokinetics|pharmacokinetics
5090514|NCT01256138|Allogene MSCs|allogene mscs
5090515|NCT01256138|transplantation|transplantation
5090516|NCT01256138|chronic liver diseases|chronic liver diseases
5090517|NCT01256138|portal vein|portal vein
5090518|NCT01256125|allogene MSCs|allogene mscs
5090519|NCT01256125|transplantation|transplantation
5090520|NCT01256125|chronic liver diseases|chronic liver diseases
5090521|NCT01256125|peripheral vein|peripheral vein
5090522|NCT01256112|obesity|obesity
5090523|NCT01256112|behavioral intervention|behavioral intervention
5090524|NCT01256112|family based|family based
5090525|NCT01256112|weight loss|weight loss
5090526|NCT01256099|Self-help treatment|self-help treatment
5090527|NCT01256099|Internet treatment|internet treatment
5090528|NCT01256099|CBT|cbt
5090529|NCT01256099|Prevention|prevention
5090530|NCT01256099|Comorbidity|comorbidity
5090531|NCT01256060|Autism Spectrum disorder|autism spectrum disorder
5090532|NCT01256060|Oxytocin|oxytocin
5090533|NCT01256060|Clinical Trial|clinical trial
5090534|NCT01256060|Children|children
5090535|NCT01256060|Pharmacology|pharmacology
5090536|NCT01256047|immunonutrition|immunonutrition
5090537|NCT01256047|hepatectomy|hepatectomy
5090538|NCT01256047|Th1|th1
5090539|NCT01256047|Th2|th2
5090540|NCT01256034|immunonutrition|immunonutrition
5090541|NCT01256034|pancreaticoduodenectomy|pancreaticoduodenectomy
5090542|NCT01256034|Th1|th1
5090543|NCT01256034|Th2|th2
5090544|NCT01256008|Breast Cancer|breast cancer
5090545|NCT01256008|Depression|depression
5090546|NCT01256008|Anxiety|anxiety
5090547|NCT01256008|Cognitive-Behavioral Therapy|cognitive-behavioral therapy
5090548|NCT01255995|PXF|pxf
5090549|NCT01255982|Bipolar depression|bipolar depression
5090550|NCT01255982|subsyndromal symptoms|subsyndromal symptoms
5090551|NCT01255982|functioning|functioning
5090552|NCT01255982|cognitive function|cognitive function
5090553|NCT01255969|Dialysis|dialysis
5090554|NCT01255969|Physical exercise|physical exercise
5090555|NCT01255969|Clinical Trial|clinical trial
5090556|NCT01255969|Quality of Life|quality of life
5090557|NCT01255969|Performance|performance
5090558|NCT01255969|Fitness|fitness
5090559|NCT01255969|Cardiovascular Mortality|cardiovascular mortality
5090560|NCT01255969|Vascular access|vascular access
5090561|NCT01255956|restenosis|restenosis
5090562|NCT01255956|ISR|isr
5090563|NCT01255956|in-stent restenosis|in-stent restenosis
5090564|NCT01255956|drug eluting stent|drug eluting stent
5090565|NCT01255956|rapamycin eluting stent|rapamycin eluting stent
5090566|NCT01255956|paclitaxel eluting balloon catheter|paclitaxel eluting balloon catheter
5090567|NCT01255943|MRSA|mrsa
5090568|NCT01255943|bloodstream infections|bloodstream infections
5090569|NCT01255943|hemodialysis|hemodialysis
5090570|NCT01255930|Pregnant Women|pregnant women
5090571|NCT01255930|Sonographic Textures|sonographic textures
5090572|NCT01255917|Tio identify role of NGF in pain in CP|tio identify role of ngf in pain in cp
5090573|NCT01255917|Identify biomarkers related to progression of CP|identify biomarkers related to progression of cp
5090574|NCT01255891|high risk localized adenocarcinoma of the prostate|high risk localized adenocarcinoma of the prostate
5090575|NCT01255878|Sleep bruxism|sleep bruxism
5090576|NCT01255878|Gabapentine|gabapentine
5090577|NCT01255878|Occlusal splint|occlusal splint
5090578|NCT01255878|Polysomnography|polysomnography
5090579|NCT01255865|Thermometry|thermometry
5090580|NCT01255865|Deep Tissue Temperature|deep tissue temperature
5090581|NCT01255865|Core Temperature|core temperature
5090582|NCT01255865|Body Temperature|body temperature
5090583|NCT01255865|Rectal Temperature|rectal temperature
5090584|NCT01255865|Oral Temperature|oral temperature
5090585|NCT01255852|atorvastatin|atorvastatin
5090586|NCT01255852|intracranial artery stenting|intracranial artery stenting
5090587|NCT01255852|restenosis|restenosis
5090588|NCT01255839|double-balloon|double-balloon
5090589|NCT01255839|balloon catheter|balloon catheter
5090590|NCT01255839|prostaglandin|prostaglandin
5090591|NCT01255839|minprostin|minprostin
5090592|NCT01255839|induction of labour|induction of labour
5090593|NCT01255839|fetal outcome|fetal outcome
5090594|NCT01255826|Preterm|preterm
5090595|NCT01255826|Neonates|neonates
5090596|NCT01255826|Delivery room|delivery room
5090597|NCT01255826|Resuscitation|resuscitation
5090598|NCT01255826|Ventilation|ventilation
5090599|NCT01255826|Neopuff|neopuff
5090600|NCT01255826|CPAP|cpap
5090601|NCT01255813|Chronic Cluster Headache|chronic cluster headache
5090602|NCT01255787|Major Depressive Disorder|major depressive disorder
5090603|NCT01255787|Depression|depression
5090604|NCT01255787|Melancholia|melancholia
5090605|NCT01255787|Drug Therapy|drug therapy
5090606|NCT01255774|subfoveal CNV|subfoveal cnv
5090607|NCT01255774|Wet (Exudative) AMD|wet (exudative) amd
5090608|NCT01255774|macular degeneration|macular degeneration
5090609|NCT01255761|Certolizumab Pegol|certolizumab pegol
5090610|NCT01255761|Cimzia|cimzia
5090611|NCT01255761|Rheumatoid Arthritis|rheumatoid arthritis
5090612|NCT01255761|CDAI|cdai
5090613|NCT01255761|RAPID3|rapid3
5090614|NCT01255748|cancer, proton, radiation|cancer, proton, radiation
5090615|NCT01255735|pediatrics|pediatrics
5090616|NCT01255735|voice|voice
5090617|NCT01255735|voice therapy|voice therapy
5090618|NCT01255735|vocal therapy|vocal therapy
5090619|NCT01255735|hoarseness|hoarseness
5090620|NCT01255722|iodinated contrast media, coronary artery disease|iodinated contrast media, coronary artery disease
5090621|NCT01255709|Asthma|asthma
5090622|NCT01255709|shortness of breath|shortness of breath
5090623|NCT01255709|wheezing|wheezing
5090624|NCT01255696|Celiac Disease|celiac disease
5090625|NCT01255696|Coeliac Disease|coeliac disease
5090626|NCT01255696|Celiac Sprue|celiac sprue
5090627|NCT01255696|Keliakia Disease|keliakia disease
5090628|NCT01255683|Chronic|chronic
5090629|NCT01255683|Sinusitis|sinusitis
5090630|NCT01255683|Steroid|steroid
5090631|NCT01255683|treatment|treatment
5090632|NCT01255670|Peritonsillar Abscess|peritonsillar abscess
5090633|NCT01255670|Quinsy|quinsy
5090634|NCT01255670|Penicillin|penicillin
5090635|NCT01255670|Metronidazole|metronidazole
5090636|NCT01255670|Recurrence|recurrence
5090637|NCT01255605|Intermittent preventive treatment with sulfadoxin-pyrimethamine|intermittent preventive treatment with sulfadoxin-pyrimethamine
5090638|NCT01255605|in Bobo-Dioulasso peri-urban areas, 5 years after its implementation|in bobo-dioulasso peri-urban areas, 5 years after its implementation
5090639|NCT01255605|Burkina Faso.|burkina faso.
5090640|NCT01255592|Bronchiectasis|bronchiectasis
5090641|NCT01255592|Neutrophil|neutrophil
5090642|NCT01255592|Respiratory disease|respiratory disease
5090643|NCT01255592|Sputum|sputum
5090644|NCT01255579|asthma|asthma
5090645|NCT01255579|small airways|small airways
5090646|NCT01255579|inhaled corticosteroids|inhaled corticosteroids
5090647|NCT01255540|Coronary heart disease in patients over|coronary heart disease in patients over
5090648|NCT01255540|80 years of age.|80 years of age.
5090649|NCT01255488|Search engine|search engine
5090650|NCT01255488|Clinical decision-making|clinical decision-making
5090651|NCT01255488|Research abstracts|research abstracts
5090652|NCT01255488|Full-text manuscripts|full-text manuscripts
5090653|NCT01255488|Family Nurse Practitioners|family nurse practitioners
5090654|NCT01255462|AMD,|amd,
5090655|NCT01255462|ARMD,|armd,
5090656|NCT01255462|Age-related Macular Degeneration,|age-related macular degeneration,
5090657|NCT01255462|Eye Disease,|eye disease,
5090658|NCT01255462|Wet AMD,|wet amd,
5090659|NCT01255462|Neovascular AMD,|neovascular amd,
5090660|NCT01255462|Choroidal Neovascular Membrane,|choroidal neovascular membrane,
5090661|NCT01255462|Choroidal Neovascularization,|choroidal neovascularization,
5090662|NCT01255462|Drusen,|drusen,
5090663|NCT01255462|Geographic Atrophy,|geographic atrophy,
5090664|NCT01255462|Complement,|complement,
5090665|NCT01255462|C5,|c5,
5090666|NCT01255462|Antibody|antibody
5090667|NCT01255449|Forced oscillation technique|forced oscillation technique
5090668|NCT01255449|Respiratory input impedance|respiratory input impedance
5090669|NCT01255449|Allogeneic hematopoietic stem cell transplantation|allogeneic hematopoietic stem cell transplantation
5090670|NCT01255449|Obliterative bronchiolitis|obliterative bronchiolitis
5090671|NCT01255423|Ankle sprain, soft tissue injury|ankle sprain, soft tissue injury
5090672|NCT01255397|male infertility|male infertility
5090673|NCT01255397|natural cycle IVF|natural cycle ivf
5090674|NCT01255397|in-vitro fertilization|in-vitro fertilization
5090675|NCT01255397|intrauterine inseminatio|intrauterine inseminatio
5090676|NCT01255371|HIV|hiv
5090677|NCT01255371|Second line antiretroviral treatment|second line antiretroviral treatment
5090678|NCT01255371|Sub saharian Africa|sub saharian africa
5090679|NCT01255371|Generic|generic
5090680|NCT01255358|Ataxia Teleangiectasia|ataxia teleangiectasia
5090681|NCT01255358|AT|at
5090682|NCT01255358|Ery-Dex|ery-dex
5090683|NCT01255358|Dexamethasone|dexamethasone
5090684|NCT01255358|Dexamethasone sodium phosphate|dexamethasone sodium phosphate
5090685|NCT01255345|Physiotherapy|physiotherapy
5090686|NCT01255345|Multidisciplinary Pain Centers|multidisciplinary pain centers
5090687|NCT01255345|Pain measurements|pain measurements
5090688|NCT01255345|Physical activity|physical activity
5090689|NCT01255345|Quality of life|quality of life
5090690|NCT01255332|ITP|itp
5090691|NCT01255319|MDS|mds
5090692|NCT01255306|Rhegmatogenous retinal detachment|rhegmatogenous retinal detachment
5090693|NCT01255306|Pars plana vitrectomy|pars plana vitrectomy
5090694|NCT01255306|Silicone oil|silicone oil
5090695|NCT01255306|Retinal nerve fibre layer|retinal nerve fibre layer
5090696|NCT01255293|Retinal detachment|retinal detachment
5090697|NCT01255293|Proliferative vitreoretinopathy|proliferative vitreoretinopathy
5090698|NCT01255293|Diabetic retinopathy|diabetic retinopathy
5090699|NCT01255293|Vitrectomy|vitrectomy
5090700|NCT01255293|Silicone oil|silicone oil
5090701|NCT01255280|Crystal methamphetamine abuse|crystal methamphetamine abuse
5090702|NCT01255280|Crystal methamphetamine dependence|crystal methamphetamine dependence
5090703|NCT01255280|Sexual risk behavior|sexual risk behavior
5090704|NCT01255280|Men who have sex with men (MSM)|men who have sex with men (msm)
5090705|NCT01255280|Behavioral activation|behavioral activation
5090706|NCT01255267|Acute coronary syndrome and chronic coronary artery disease patients|acute coronary syndrome and chronic coronary artery disease patients
5090707|NCT01255254|he effect of gingival scaling on Metabolic control|he effect of gingival scaling on metabolic control
5090708|NCT01255241|Lower Limbs Deformities|lower limbs deformities
5090709|NCT01255241|kinetics|kinetics
5090710|NCT01255241|kinematics|kinematics
5090711|NCT01255241|gait|gait
5090712|NCT01255241|energy expenditure|energy expenditure
5090713|NCT01255228|obesity|obesity
5090714|NCT01255228|body composition|body composition
5090715|NCT01255228|adipocyte-derived cytokine|adipocyte-derived cytokine
5090716|NCT01255228|low glycemic index|low glycemic index
5090717|NCT01255215|malaria|malaria
5090718|NCT01255215|children|children
5090719|NCT01255202|preeclampsia|preeclampsia
5090720|NCT01255202|toxemia|toxemia
5090721|NCT01255202|twin|twin
5090722|NCT01255202|pregnancy|pregnancy
5090723|NCT01255202|pp13|pp13
5090724|NCT01255202|prediction|prediction
5090725|NCT01255202|kongo red|kongo red
5090726|NCT01255189|NIRS|nirs
5090727|NCT01255176|Infant|infant
5090728|NCT01255176|Physical Therapy|physical therapy
5090729|NCT01255163|Alzheimer's|alzheimer's
5090730|NCT01255163|Brain insulin resistance|brain insulin resistance
5090731|NCT01255163|Diabetes|diabetes
5090732|NCT01255150|Genetic Ancestry Analysis|genetic ancestry analysis
5090733|NCT01255150|Molecular Profiling|molecular profiling
5090734|NCT01255150|Smoking Status|smoking status
5090735|NCT01255150|Wood Smoke Exposure|wood smoke exposure
5090736|NCT01255150|EGFR Mutation Analysis|egfr mutation analysis
5090737|NCT01255150|Non Small Cell Lung Cancer|non small cell lung cancer
5090738|NCT01255137|Selective VEGF Inhibitor|selective vegf inhibitor
5090739|NCT01255137|Clinical Activity|clinical activity
5090740|NCT01255137|Response Rate|response rate
5090741|NCT01255137|Measurable Disease|measurable disease
5090742|NCT01255137|Biological Markers|biological markers
5090743|NCT01255137|Adrenocortical Cancer|adrenocortical cancer
5091125|NCT01253460|Rituxan|rituxan
5090744|NCT01255111|Chronic respiratory failure|chronic respiratory failure
5090745|NCT01255111|Noninvasive ventilation|noninvasive ventilation
5090746|NCT01255111|Patient-ventilator interactions|patient-ventilator interactions
5090747|NCT01255111|Sleep|sleep
5090748|NCT01255111|Sleep fragmentation|sleep fragmentation
5090749|NCT01255085|Obesity|obesity
5090750|NCT01255085|Food intake regulation|food intake regulation
5090751|NCT01255085|blood glucose regulation|blood glucose regulation
5090752|NCT01255085|protein|protein
5090753|NCT01255085|fiber|fiber
5090754|NCT01255085|pulses|pulses
5090755|NCT01255085|yellow peas|yellow peas
5090756|NCT01255072|TMS|tms
5090757|NCT01255072|elderly|elderly
5090758|NCT01255072|depression|depression
5090759|NCT01255072|neuronavegation|neuronavegation
5090760|NCT01255072|neurocognition|neurocognition
5090761|NCT01255059|Genome-wide association studies(GWAS)|genome-wide association studies(gwas)
5090762|NCT01255059|Single nucleotide polymorphism(SNP)|single nucleotide polymorphism(snp)
5090763|NCT01255059|Lung cancer|lung cancer
5090764|NCT01255033|perioperative surgery|perioperative surgery
5090765|NCT01255033|regional oxygenation|regional oxygenation
5090766|NCT01255033|hypoxemia|hypoxemia
5090767|NCT01255033|brain hypoxemia|brain hypoxemia
5090768|NCT01255033|spectroscopy, near-infrared|spectroscopy, near-infrared
5090769|NCT01255020|α-Keto Acid|α-keto acid
5090770|NCT01255020|Restricted Protein Diet|restricted protein diet
5090771|NCT01255020|Residual Renal Function|residual renal function
5090772|NCT01255007|Colorectal|colorectal
5090773|NCT01255007|liver|liver
5090774|NCT01255007|metastases|metastases
5090775|NCT01255007|Primovist|primovist
5090776|NCT01255007|MRI|mri
5090777|NCT01255007|CT|ct
5090778|NCT01255007|cancer|cancer
5090779|NCT01255007|resection|resection
5090780|NCT01255007|MDCT|mdct
5090781|NCT01255007|Diffusion|diffusion
5090782|NCT01255007|Weighted|weighted
5090783|NCT01255007|3T|3t
5090784|NCT01254994|hepatitis B|hepatitis b
5090785|NCT01254994|acute on chronic liver failure (ACHBLF)|acute on chronic liver failure (achblf)
5090786|NCT01254994|entecavir|entecavir
5090787|NCT01254994|treatment|treatment
5090788|NCT01254994|predicting|predicting
5090789|NCT01254981|Percutaneous coronary intervention|percutaneous coronary intervention
5090790|NCT01254981|DES|des
5090791|NCT01254981|Angina pectoris|angina pectoris
5090792|NCT01254981|Stent|stent
5090793|NCT01254968|blood flow in the middle cerebral artery of brain|blood flow in the middle cerebral artery of brain
5090794|NCT01254955|2009 H1N1 influenza vaccine, organ transplant patients|2009 h1n1 influenza vaccine, organ transplant patients
5090795|NCT01254942|exercise|exercise
5090796|NCT01254942|hip fractures|hip fractures
5090797|NCT01254942|rehabilitation|rehabilitation
5090798|NCT01254942|aged|aged
5090799|NCT01254942|aged 80 and over|aged 80 and over
5090800|NCT01254929|Cancer|cancer
5090801|NCT01254929|Bone metastases|bone metastases
5090802|NCT01254916|Chronic Rhinosinusitis|chronic rhinosinusitis
5090803|NCT01254916|Sinonasal Outcome test 22|sinonasal outcome test 22
5090804|NCT01254903|Stereotactic Radiosurgery|stereotactic radiosurgery
5090805|NCT01254903|Radiation|radiation
5090806|NCT01254903|Radiotherapy|radiotherapy
5090807|NCT01254903|Metastatic Epidural Spinal Cord Compression|metastatic epidural spinal cord compression
5090808|NCT01254903|MESCC|mescc
5090809|NCT01254890|Relapsed Acute Leukemia|relapsed acute leukemia
5090810|NCT01254890|Chronic Myelomonocytic Leukemia|chronic myelomonocytic leukemia
5090811|NCT01254890|CMML|cmml
5090812|NCT01254890|Myelodysplastic Syndrome|myelodysplastic syndrome
5090813|NCT01254890|MDS|mds
5090814|NCT01254890|Acute myeloid leukemia|acute myeloid leukemia
5090815|NCT01254890|AML|aml
5090816|NCT01254890|5-azacitidine|5-azacitidine
5090817|NCT01254890|Azacitidine|azacitidine
5090818|NCT01254890|5-aza|5-aza
5090819|NCT01254890|Vidaza|vidaza
5090820|NCT01254890|5-AZC|5-azc
5090821|NCT01254890|AZA-CR|aza-cr
5090822|NCT01254890|Ladakamycin|ladakamycin
5090823|NCT01254890|NSC-102816|nsc-102816
5090824|NCT01254890|Sorafenib|sorafenib
5090825|NCT01254890|Nexavar|nexavar
5090826|NCT01254890|BAY43-9006|bay43-9006
5090827|NCT01254877|HIV|hiv
5090828|NCT01254864|Castrate resistant prostate cancer|castrate resistant prostate cancer
5090829|NCT01254864|Adenocarcinoma of the prostate|adenocarcinoma of the prostate
5090830|NCT01254864|Sunitinib Malate|sunitinib malate
5090831|NCT01254864|SUO11248|suo11248
5090832|NCT01254864|Sutent|sutent
5090833|NCT01254864|BMS-354825|bms-354825
5090834|NCT01254864|Sprycel|sprycel
5090835|NCT01254851|discharge criteria, gynecologic surgery, post-op ambulation|discharge criteria, gynecologic surgery, post-op ambulation
5090836|NCT01254825|Adductor Canal Block (ACB)|adductor canal block (acb)
5090837|NCT01254825|Diagnostic Knee Arthroscopy|diagnostic knee arthroscopy
5090838|NCT01254825|Saphenous nerve|saphenous nerve
5090839|NCT01254825|Pain|pain
5090840|NCT01254825|Ultrasound block|ultrasound block
5090841|NCT01254812|pulmonary function|pulmonary function
5090842|NCT01254812|BD-TAP-block|bd-tap-block
5090843|NCT01254786|VATS|vats
5090844|NCT01254786|one lung ventilation|one lung ventilation
5090845|NCT01254786|continuous positive pressure ventilation|continuous positive pressure ventilation
5090929|NCT01254565|Renal Dialysis|renal dialysis
5090846|NCT01254786|high frequency positive pressure ventilation|high frequency positive pressure ventilation
5090847|NCT01254721|Acute bipolar mania|acute bipolar mania
5090848|NCT01254721|Seroquel XR|seroquel xr
5090849|NCT01254721|Seroquel XR plus lithium|seroquel xr plus lithium
5090850|NCT01254721|Quetiapine fumarate|quetiapine fumarate
5090851|NCT01254695|Idiopathic Fecal Incontinence|idiopathic fecal incontinence
5090852|NCT01254695|Fecal Incontinence|fecal incontinence
5090853|NCT01254695|Sacral Nerve Stimulation|sacral nerve stimulation
5090854|NCT01254695|Sacral Nerve Neuromodulation|sacral nerve neuromodulation
5090855|NCT01254682|wrist|wrist
5090856|NCT01254682|joint|joint
5090857|NCT01254682|arthroscopy|arthroscopy
5090858|NCT01254682|hyaluronan|hyaluronan
5090859|NCT01254682|hyaluronic acid|hyaluronic acid
5090860|NCT01254682|Necessity of Arthroscopic surgery|necessity of arthroscopic surgery
5090861|NCT01254669|Haitian girls, African American girls|haitian girls, african american girls
5090862|NCT01254669|Brief Negotiated Interview|brief negotiated interview
5090863|NCT01254669|cognitive behavioral intervention|cognitive behavioral intervention
5090864|NCT01254669|HPV vaccine|hpv vaccine
5090865|NCT01254669|cervical cancer|cervical cancer
5090866|NCT01254643|Papillomavirus vaccines|papillomavirus vaccines
5090867|NCT01254643|Uterine cervical cancer|uterine cervical cancer
5090868|NCT01254643|Human Papilloma Virus infections|human papilloma virus infections
5090869|NCT01254630|Herpes zoster|herpes zoster
5090870|NCT01254630|vaccine|vaccine
5090871|NCT01254630|herpes-zoster-related complications|herpes-zoster-related complications
5090872|NCT01254630|immunocompromised|immunocompromised
5090873|NCT01254630|herpes zoster-associated pain|herpes zoster-associated pain
5090874|NCT01254630|solid tumor malignancy|solid tumor malignancy
5090875|NCT01254630|hematologic malignancy|hematologic malignancy
5090876|NCT01254604|Tafluprost|tafluprost
5090877|NCT01254604|Glaucoma|glaucoma
5090878|NCT01254604|Ocular Hypertension|ocular hypertension
5090879|NCT01254604|Timolol|timolol
5090880|NCT01254604|Eye Disorder|eye disorder
5090881|NCT01254604|Preservative-Free|preservative-free
5090882|NCT01254604|Prostaglandin Analogue|prostaglandin analogue
5090883|NCT01254591|stage IA non-small cell lung cancer|stage ia non-small cell lung cancer
5090884|NCT01254591|stage IB non-small cell lung cancer|stage ib non-small cell lung cancer
5090885|NCT01254591|stage IIA non-small cell lung cancer|stage iia non-small cell lung cancer
5090886|NCT01254591|stage IIB non-small cell lung cancer|stage iib non-small cell lung cancer
5090887|NCT01254591|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5090888|NCT01254591|stage I colon cancer|stage i colon cancer
5090889|NCT01254591|stage IIA colon cancer|stage iia colon cancer
5090890|NCT01254591|stage IIB colon cancer|stage iib colon cancer
5090891|NCT01254591|stage IIC colon cancer|stage iic colon cancer
5090892|NCT01254591|stage IIIA colon cancer|stage iiia colon cancer
5090893|NCT01254591|stage I rectal cancer|stage i rectal cancer
5090894|NCT01254591|stage IIA rectal cancer|stage iia rectal cancer
5090895|NCT01254591|stage IIB rectal cancer|stage iib rectal cancer
5090896|NCT01254591|stage IIC rectal cancer|stage iic rectal cancer
5090897|NCT01254591|stage IIIA rectal cancer|stage iiia rectal cancer
5090898|NCT01254591|stage IA breast cancer|stage ia breast cancer
5090899|NCT01254591|stage IB breast cancer|stage ib breast cancer
5090900|NCT01254591|stage II breast cancer|stage ii breast cancer
5090901|NCT01254591|stage IIIA breast cancer|stage iiia breast cancer
5090902|NCT01254591|stage IIIB breast cancer|stage iiib breast cancer
5090903|NCT01254591|stage I esophageal cancer|stage i esophageal cancer
5090904|NCT01254591|stage II esophageal cancer|stage ii esophageal cancer
5090905|NCT01254591|stage III esophageal cancer|stage iii esophageal cancer
5090906|NCT01254591|stage I hypopharyngeal cancer|stage i hypopharyngeal cancer
5090907|NCT01254591|stage II hypopharyngeal cancer|stage ii hypopharyngeal cancer
5090908|NCT01254591|stage III hypopharyngeal cancer|stage iii hypopharyngeal cancer
5090909|NCT01254591|stage I laryngeal cancer|stage i laryngeal cancer
5090910|NCT01254591|stage II laryngeal cancer|stage ii laryngeal cancer
5090911|NCT01254591|stage III laryngeal cancer|stage iii laryngeal cancer
5090912|NCT01254591|stage I lip and oral cavity cancer|stage i lip and oral cavity cancer
5090913|NCT01254591|stage II lip and oral cavity cancer|stage ii lip and oral cavity cancer
5090914|NCT01254591|stage III lip and oral cavity cancer|stage iii lip and oral cavity cancer
5090915|NCT01254591|stage I nasopharyngeal cancer|stage i nasopharyngeal cancer
5090916|NCT01254591|stage II nasopharyngeal cancer|stage ii nasopharyngeal cancer
5090917|NCT01254591|stage III nasopharyngeal cancer|stage iii nasopharyngeal cancer
5090918|NCT01254591|stage I oropharyngeal cancer|stage i oropharyngeal cancer
5090919|NCT01254591|stage II oropharyngeal cancer|stage ii oropharyngeal cancer
5090920|NCT01254591|stage III oropharyngeal cancer|stage iii oropharyngeal cancer
5090921|NCT01254591|stage I paranasal sinus and nasal cavity cancer|stage i paranasal sinus and nasal cavity cancer
5090922|NCT01254591|stage II paranasal sinus and nasal cavity cancer|stage ii paranasal sinus and nasal cavity cancer
5090923|NCT01254591|stage III paranasal sinus and nasal cavity cancer|stage iii paranasal sinus and nasal cavity cancer
5090924|NCT01254591|stage I salivary gland cancer|stage i salivary gland cancer
5090925|NCT01254591|stage II salivary gland cancer|stage ii salivary gland cancer
5090926|NCT01254591|stage III salivary gland cancer|stage iii salivary gland cancer
5090927|NCT01254591|tongue cancer|tongue cancer
5090928|NCT01254565|Clinical Trial, Phase 2|clinical trial, phase 2
5090930|NCT01254565|Secondary Hyperparathyroidism|secondary hyperparathyroidism
5090931|NCT01254565|Parathyroid hormone|parathyroid hormone
5090932|NCT01254539|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
5090933|NCT01254539|Bone marrow|bone marrow
5090934|NCT01254539|Stem cells|stem cells
5090935|NCT01254539|Autologous|autologous
5090936|NCT01254539|Safety|safety
5090937|NCT01254513|Metastatic Prostate cancer|metastatic prostate cancer
5090938|NCT01254513|Elderly patients|elderly patients
5090939|NCT01254513|Vulnerable and Frail (SIOG classification)|vulnerable and frail (siog classification)
5090940|NCT01254513|castration-resistant|castration-resistant
5090941|NCT01254500|patients with brain lesions|patients with brain lesions
5090942|NCT01254474|Depolarization, tissue|depolarization, tissue
5090943|NCT01254474|Repolarization, tissue|repolarization, tissue
5090944|NCT01254474|Cardiac Arrhythmias|cardiac arrhythmias
5090945|NCT01254474|Action potentials, monophasic|action potentials, monophasic
5090946|NCT01254474|Mapping, Catheter|mapping, catheter
5090947|NCT01254474|Cardiac activation|cardiac activation
5090948|NCT01254461|Phase 1|phase 1
5090949|NCT01254461|Drug-Drug interaction|drug-drug interaction
5090950|NCT01254461|pravastatin|pravastatin
5090951|NCT01254461|AZD1981|azd1981
5090952|NCT01254461|The pharmacokinetics resulting from AZD1981 and pravastatin interaction|the pharmacokinetics resulting from azd1981 and pravastatin interaction
5090953|NCT01254461|The effects of taking a combination of AZD1981 and pravastatin|the effects of taking a combination of azd1981 and pravastatin
5090954|NCT01254448|Alzheimer's Disease|alzheimer's disease
5090955|NCT01254435|Colonoscopy|colonoscopy
5090956|NCT01254435|Positioning in colonoscopy|positioning in colonoscopy
5090957|NCT01254435|Quality control|quality control
5090958|NCT01254422|Dengue fever|dengue fever
5090959|NCT01254422|Dengue hemorrhagic fever|dengue hemorrhagic fever
5090960|NCT01254422|CYD dengue vaccine|cyd dengue vaccine
5090961|NCT01254409|pulmonary, fibrosis|pulmonary, fibrosis
5090962|NCT01254396|Bioavailability Food Effect Oral Dissolving Tablet (ODT)|bioavailability food effect oral dissolving tablet (odt)
5090963|NCT01254383|Bioequivalence Oral Dissolving Tablet|bioequivalence oral dissolving tablet
5090964|NCT01254357|Burns|burns
5090965|NCT01254357|Trauma|trauma
5090966|NCT01254357|Outcomes|outcomes
5090967|NCT01254357|Quality of Life|quality of life
5090968|NCT01254344|Colorectal surgery|colorectal surgery
5090969|NCT01254318|hematological malignancy|hematological malignancy
5090970|NCT01254318|fungal infection|fungal infection
5090971|NCT01254318|leukemia|leukemia
5090972|NCT01254305|Depression|depression
5090973|NCT01254305|Fatigue|fatigue
5090974|NCT01254305|Major Depressive Disorder|major depressive disorder
5090975|NCT01254266|morbid obesity|morbid obesity
5090976|NCT01254266|adolescents|adolescents
5090977|NCT01254266|inpatient treatment|inpatient treatment
5090978|NCT01254253|percutaneous coronary intervention|percutaneous coronary intervention
5090979|NCT01254253|chronic total occlusion|chronic total occlusion
5090980|NCT01254253|coronary angiography|coronary angiography
5090981|NCT01254253|single photon emission CT|single photon emission ct
5090982|NCT01254253|Multislice coronary CT angiography|multislice coronary ct angiography
5090983|NCT01254227|Cardiac iron overload,|cardiac iron overload,
5090984|NCT01254227|deferasirox,|deferasirox,
5090985|NCT01254227|deferoxamine|deferoxamine
5090986|NCT01254214|Mindfulness|mindfulness
5090987|NCT01254214|Quality of life|quality of life
5090988|NCT01254214|Transplantation|transplantation
5090989|NCT01254214|Renal disease|renal disease
5090990|NCT01254188|Chronic myeloid leukemia,|chronic myeloid leukemia,
5090991|NCT01254188|CML,|cml,
5090992|NCT01254188|nilotinib,|nilotinib,
5090993|NCT01254188|myelogenous,|myelogenous,
5090994|NCT01254188|Philadelphia chromosome|philadelphia chromosome
5090995|NCT01254162|Oily Skin|oily skin
5090996|NCT01254162|Sebum|sebum
5090997|NCT01254123|Glucagon Like Peptide-1|glucagon like peptide-1
5090998|NCT01254123|Exenatide|exenatide
5090999|NCT01254123|myocardial infarction|myocardial infarction
5091000|NCT01254123|MRI|mri
5091001|NCT01254123|PCI|pci
5091002|NCT01254084|Herbal medicine; Type 2 diabetes; Gynostemma pentaphyllum Tea; Insulin sensitivity;|herbal medicine; type 2 diabetes; gynostemma pentaphyllum tea; insulin sensitivity;
5091003|NCT01254071|GI198745|gi198745
5091004|NCT01254071|Tamsulosin hydrochloride|tamsulosin hydrochloride
5091005|NCT01254071|Dutasteride|dutasteride
5091006|NCT01254071|food effect|food effect
5091007|NCT01254071|healthy male subjects|healthy male subjects
5091008|NCT01254071|north-east Asian ancestry|north-east asian ancestry
5091009|NCT01254071|Bioequivalence|bioequivalence
5091010|NCT01254071|cross-over design|cross-over design
5091011|NCT01254071|Pilot bioequivalence|pilot bioequivalence
5091012|NCT01254032|CAT|cat
5091013|NCT01254032|COPD|copd
5091014|NCT01254019|Duchenne Muscular Dystrophy|duchenne muscular dystrophy
5091015|NCT01254019|DMD|dmd
5091016|NCT01254019|968|968
5091017|NCT01254019|GSK|gsk
5091018|NCT01254019|Duchenne|duchenne
5091019|NCT01253993|Disruptive Behavior Disorders, Substance abuse,|disruptive behavior disorders, substance abuse,
5091020|NCT01253993|Iowa Gambling Task, Decision Making.|iowa gambling task, decision making.
5091021|NCT01253980|pneumonitis|pneumonitis
5091022|NCT01253980|paraffin|paraffin
5091023|NCT01253980|kerosene|kerosene
5091024|NCT01253967|Gastroenteritis|gastroenteritis
5091025|NCT01253967|Hospital surveillance|hospital surveillance
5091026|NCT01253967|Rotavirus gastroenteritis|rotavirus gastroenteritis
5091027|NCT01253954|invasive candida infection|invasive candida infection
5091028|NCT01253941|COPD, Intensive Resistive Breathing, Cytokine IL6,|copd, intensive resistive breathing, cytokine il6,
5091029|NCT01253928|body composition|body composition
5091030|NCT01253928|insulin sensitivity|insulin sensitivity
5091031|NCT01253928|protein metabolism|protein metabolism
5091032|NCT01253928|pioglitazone|pioglitazone
5091033|NCT01253889|Functional echocardiography|functional echocardiography
5091034|NCT01253889|oral glucose|oral glucose
5091035|NCT01253889|neonatal stress|neonatal stress
5091036|NCT01253863|Clinical Examination, Accuracy, Hand, Tendon, Injury.|clinical examination, accuracy, hand, tendon, injury.
5091037|NCT01253850|hiv|hiv
5091038|NCT01253850|antiretroviral|antiretroviral
5091039|NCT01253850|adherence|adherence
5091040|NCT01253850|adolescent|adolescent
5091041|NCT01253837|L19|l19
5091042|NCT01253837|antibody|antibody
5091043|NCT01253837|monoclonal|monoclonal
5091044|NCT01253837|tumor targeting|tumor targeting
5091045|NCT01253837|TNFa|tnfa
5091046|NCT01253837|colorectal cancer|colorectal cancer
5091047|NCT01253837|Phase I: Patients with relapsed or refractory locally advanced or metastatic solid tumors not amenable to standard systemic therapy.|phase i: patients with relapsed or refractory locally advanced or metastatic solid tumors not amenable to standard systemic therapy.
5091048|NCT01253837|Phase II: Patients with relapsed or refractory locally advanced or metastatic colorectal cancer not amenable to standard systemic therapy.|phase ii: patients with relapsed or refractory locally advanced or metastatic colorectal cancer not amenable to standard systemic therapy.
5091049|NCT01253824|NPC-01|npc-01
5091050|NCT01253824|IKH-01|ikh-01
5091051|NCT01253824|Pharmacodynamics|pharmacodynamics
5091052|NCT01253824|Norethisterone|norethisterone
5091053|NCT01253824|Ethinyl Estradiol|ethinyl estradiol
5091054|NCT01253824|Estradiol|estradiol
5091055|NCT01253824|Progesterone|progesterone
5091056|NCT01253824|FSH|fsh
5091057|NCT01253824|LH|lh
5091058|NCT01253798|exercise|exercise
5091059|NCT01253798|hydrotherapy|hydrotherapy
5091060|NCT01253759|Transpupillary thermotherapy|transpupillary thermotherapy
5091061|NCT01253759|Choroidal melanoma|choroidal melanoma
5091062|NCT01253759|ICG-Photodynamic therapy|icg-photodynamic therapy
5091063|NCT01253746|NTD|ntd
5091064|NCT01253746|open NTD|open ntd
5091065|NCT01253746|spina bifida|spina bifida
5091066|NCT01253746|anencephaly|anencephaly
5091067|NCT01253746|closed NTD|closed ntd
5091068|NCT01253746|lipomeningocele|lipomeningocele
5091069|NCT01253746|tethered cord.|tethered cord.
5091070|NCT01253733|Cystic Fibrosis|cystic fibrosis
5091071|NCT01253733|Inflammatory Bowel Disease|inflammatory bowel disease
5091072|NCT01253733|Type 1 Diabetes|type 1 diabetes
5091073|NCT01253733|Chronic Disease Management|chronic disease management
5091074|NCT01253733|SMS|sms
5091075|NCT01253733|Text messages|text messages
5091076|NCT01253733|Internet|internet
5091077|NCT01253733|Healthcare Interactions|healthcare interactions
5091078|NCT01253720|obesity|obesity
5091079|NCT01253720|text messages|text messages
5091080|NCT01253720|internet|internet
5091081|NCT01253720|cancer|cancer
5091082|NCT01253720|overweight|overweight
5091083|NCT01253707|Solid Tumors|solid tumors
5091084|NCT01253707|C-met inhibitor|c-met inhibitor
5091085|NCT01253694|Diabetes|diabetes
5091086|NCT01253694|edema|edema
5091087|NCT01253694|ranibizumab|ranibizumab
5091088|NCT01253694|bevacizumab|bevacizumab
5091089|NCT01253694|refractory|refractory
5091090|NCT01253681|AMG 386|amg 386
5091091|NCT01253681|Ovarian Cancer|ovarian cancer
5091092|NCT01253655|Healthy Volunteers|healthy volunteers
5091093|NCT01253629|Fragile X Syndrome|fragile x syndrome
5091094|NCT01253629|Martin-Bell Syndrome|martin-bell syndrome
5091095|NCT01253629|Genetic Diseases|genetic diseases
5091096|NCT01253629|X-Linked|x-linked
5091097|NCT01253603|Asthma|asthma
5091098|NCT01253590|atrial fibrillation|atrial fibrillation
5091099|NCT01253590|ECG monitor|ecg monitor
5091100|NCT01253590|Blood pressure device|blood pressure device
5091101|NCT01253590|Remote Cardiac Monitoring|remote cardiac monitoring
5091102|NCT01253551|VX-950HEP1001|vx-950hep1001
5091103|NCT01253551|hepatitis|hepatitis
5091104|NCT01253551|telaprevir|telaprevir
5091105|NCT01253551|raltegravir|raltegravir
5091106|NCT01253551|crossover|crossover
5091107|NCT01253551|healthy volunteers|healthy volunteers
5091108|NCT01253551|VX-950.|vx-950.
5091109|NCT01253525|Adenocarcinoma|adenocarcinoma
5091110|NCT01253525|Gastroesophageal Junction|gastroesophageal junction
5091111|NCT01253512|Ischemic Stroke|ischemic stroke
5091112|NCT01253512|Thrombolysis|thrombolysis
5091113|NCT01253486|expressive writing|expressive writing
5091114|NCT01253486|cardiac rehabilitation|cardiac rehabilitation
5091115|NCT01253473|COPD|copd
5091116|NCT01253460|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
5091117|NCT01253460|CLL|cll
5091118|NCT01253460|Small Lymphocytic Lymphoma|small lymphocytic lymphoma
5091119|NCT01253460|SLL|sll
5091120|NCT01253460|Cyclophosphamide|cyclophosphamide
5091121|NCT01253460|Rituximab|rituximab
5091122|NCT01253460|Sapacitabine|sapacitabine
5091123|NCT01253460|Cytoxan|cytoxan
5091124|NCT01253460|Neosar|neosar
5091126|NCT01253434|Transdermal Administration|transdermal administration
5091127|NCT01253421|MDD|mdd
5091128|NCT01253421|Major Depressive Disorder|major depressive disorder
5091129|NCT01253421|Amisulpride|amisulpride
5091130|NCT01253408|anandamide|anandamide
5091131|NCT01253408|cannabinoid|cannabinoid
5091132|NCT01253408|fatty acid amide hydrolase|fatty acid amide hydrolase
5091133|NCT01253408|gastric|gastric
5091134|NCT01253408|motility|motility
5091135|NCT01253408|small bowel|small bowel
5091136|NCT01253395|Exercise|exercise
5091137|NCT01253395|Pain|pain
5091138|NCT01253369|pazopanib|pazopanib
5091139|NCT01253317|Rett Syndrome|rett syndrome
5091140|NCT01253317|IGF-1|igf-1
5091141|NCT01253317|Increlex|increlex
5091142|NCT01253317|Mecasermin|mecasermin
5091143|NCT01253317|IGF1|igf1
5091144|NCT01253317|MECP2|mecp2
5091145|NCT01253317|RTT|rtt
5091146|NCT01253252|Abdominal Aortic Aneurysm|abdominal aortic aneurysm
5091147|NCT01253252|Prosthesis|prosthesis
5091148|NCT01253252|Fluorodeoxyglucose F18|fluorodeoxyglucose f18
5091149|NCT01253252|Positron-emission Tomography|positron-emission tomography
5091150|NCT01253252|Spiral computed tomography|spiral computed tomography
5091151|NCT01253252|Biological markers|biological markers
5091152|NCT01253239|Visual outcomes|visual outcomes
5091153|NCT01253239|Patient satisfaction|patient satisfaction
5091154|NCT01253213|Prostate cancer|prostate cancer
5091155|NCT01253213|Ultrasound molecular imaging|ultrasound molecular imaging
5091156|NCT01253213|Contrast agent|contrast agent
5091157|NCT01253213|BR55|br55
5091158|NCT01253213|VEGFR2|vegfr2
5091159|NCT01253200|Type 1 Atrial Flutter|type 1 atrial flutter
5091160|NCT01253200|Typical Atrial Flutter|typical atrial flutter
5091161|NCT01253200|Arrhythmias, Cardiac|arrhythmias, cardiac
5091162|NCT01253200|Heart Diseases|heart diseases
5091163|NCT01253200|Cardiovascular Diseases|cardiovascular diseases
5091164|NCT01253161|advanced|advanced
5091165|NCT01253161|metastatic|metastatic
5091166|NCT01253161|unresectable|unresectable
5091167|NCT01253161|carcinoma|carcinoma
5091168|NCT01253161|gastrointestinal tract|gastrointestinal tract
5091169|NCT01253161|lungs|lungs
5091170|NCT01253161|colon|colon
5091171|NCT01253161|liver|liver
5091172|NCT01253161|rectum|rectum
5091173|NCT01253161|small intestine|small intestine
5091174|NCT01253161|stomach|stomach
5091175|NCT01253161|pancreatic|pancreatic
5091176|NCT01253148|Liver|liver
5091177|NCT01253148|Bile Duct|bile duct
5091178|NCT01253135|Fibrin, white petrolatum, wound healing|fibrin, white petrolatum, wound healing
5091179|NCT01253096|Interleukin|interleukin
5091180|NCT01253096|IL2|il2
5091181|NCT01253096|monoclonal|monoclonal
5091182|NCT01253096|antibody|antibody
5091183|NCT01253096|cytokine|cytokine
5091184|NCT01253096|metastatic|metastatic
5091185|NCT01253096|melanoma|melanoma
5091186|NCT01253096|tumor targeting|tumor targeting
5091187|NCT01253096|intratumoral|intratumoral
5091188|NCT01253096|Malignant melanoma with presence of injectable soft-tissue metastases either in clinical stage III or stage IV without visceral metastases.|malignant melanoma with presence of injectable soft-tissue metastases either in clinical stage iii or stage iv without visceral metastases.
5091189|NCT01253083|Mobility|mobility
5091190|NCT01253083|Developmental Delay|developmental delay
5091191|NCT01253083|Cerebral Palsy|cerebral palsy
5091192|NCT01253083|Early Walking|early walking
5091193|NCT01253083|Postural Control|postural control
5091194|NCT01253057|cleaning staff|cleaning staff
5091195|NCT01253057|antineoplastic agents|antineoplastic agents
5091196|NCT01253044|OEF/OIF|oef/oif
5091197|NCT01253044|Veterans|veterans
5091198|NCT01253044|Psychotherapy|psychotherapy
5091199|NCT01253031|hearing loss|hearing loss
5091200|NCT01253031|aging|aging
5091201|NCT01253031|short term memory|short term memory
5091202|NCT01253031|attentional blink|attentional blink
5091203|NCT01253018|stroke|stroke
5091204|NCT01253018|robotics|robotics
5091205|NCT01253018|upper extremity rehabilitation|upper extremity rehabilitation
5091206|NCT01252992|Extrapulmonary|extrapulmonary
5091207|NCT01252992|Tuberculosis|tuberculosis
5091208|NCT01252992|Paradoxical reaction|paradoxical reaction
5091209|NCT01252992|Risk factors|risk factors
5091210|NCT01252992|Incidence|incidence
5091211|NCT01252992|CT scan|ct scan
5091212|NCT01252992|Natural history|natural history
5091213|NCT01252992|Immune system phenomena|immune system phenomena
5091214|NCT01252992|Immune markers|immune markers
5091215|NCT01252992|Gene Expression Profiling|gene expression profiling
5091216|NCT01252979|MELAS|melas
5091217|NCT01252979|Ketones|ketones
5091218|NCT01252979|Medium Chain Triglycerides|medium chain triglycerides
5091219|NCT01252979|MCT oil|mct oil
5091220|NCT01252979|Mitochondrial Disorder|mitochondrial disorder
5091221|NCT01252979|Heteroplasmy|heteroplasmy
5091222|NCT01252979|3243AG|3243ag
5091223|NCT01252979|Subject is informed and given ample opportunity to consider his/her participation and has given his/her written consent.|subject is informed and given ample opportunity to consider his/her participation and has given his/her written consent.
5091224|NCT01252979|Subject is willing and able to comply with all trial requirements.|subject is willing and able to comply with all trial requirements.
5091328|NCT01252589|Patient-Reported outcomes|patient-reported outcomes
5091225|NCT01252979|Subject harbors the 3243 A>G mtDNA mutation at a level detectable in blood.|subject harbors the 3243 a>g mtdna mutation at a level detectable in blood.
5091226|NCT01252979|Female subjects of child-bearing potential must not be pregnant.|female subjects of child-bearing potential must not be pregnant.
5091227|NCT01252979|Subjects must not have Diabetes Mellitus.|subjects must not have diabetes mellitus.
5091228|NCT01252966|Tobacco|tobacco
5091229|NCT01252966|Smoking|smoking
5091230|NCT01252966|Cognition|cognition
5091231|NCT01252966|Behavioral Training|behavioral training
5091232|NCT01252966|Relapse|relapse
5091233|NCT01252953|vascular disease|vascular disease
5091234|NCT01252953|lipids|lipids
5091235|NCT01252953|cholesteryl ester transfer protein (CETP) inhibition|cholesteryl ester transfer protein (cetp) inhibition
5091236|NCT01252953|anacetrapib|anacetrapib
5091237|NCT01252940|HIV-1|hiv-1
5091238|NCT01252940|HIV|hiv
5091239|NCT01252940|Treatment Experienced|treatment experienced
5091240|NCT01252914|Open angle|open angle
5091241|NCT01252914|Glaucoma|glaucoma
5091242|NCT01252914|Surgery|surgery
5091243|NCT01252914|Ocular Hypertension|ocular hypertension
5091244|NCT01252914|Eye Diseases|eye diseases
5091245|NCT01252901|WT1|wt1
5091246|NCT01252901|Wilms Tumor|wilms tumor
5091247|NCT01252901|Denys-Drash Syndrome|denys-drash syndrome
5091248|NCT01252901|Nephrotic Syndrome|nephrotic syndrome
5091249|NCT01252901|Proteinuria|proteinuria
5091250|NCT01252888|Open angle|open angle
5091251|NCT01252888|Glaucoma|glaucoma
5091252|NCT01252888|Surgery|surgery
5091253|NCT01252888|Glaucoma Open-Angle|glaucoma open-angle
5091254|NCT01252888|Ocular Hypertension|ocular hypertension
5091255|NCT01252888|Eye Diseases|eye diseases
5091256|NCT01252875|LDL-C|ldl-c
5091257|NCT01252875|Cholesterol|cholesterol
5091258|NCT01252875|Stroke|stroke
5091259|NCT01252875|Transient ischemic attack|transient ischemic attack
5091260|NCT01252875|Statin|statin
5091261|NCT01252875|Lipid lowering therapy|lipid lowering therapy
5091262|NCT01252862|Open angle|open angle
5091263|NCT01252862|Glaucoma|glaucoma
5091264|NCT01252862|Surgery|surgery
5091265|NCT01252862|Ocular Hypertension|ocular hypertension
5091266|NCT01252862|eye diseases|eye diseases
5091267|NCT01252849|Open angle|open angle
5091268|NCT01252849|Glaucoma|glaucoma
5091269|NCT01252849|surgery|surgery
5091270|NCT01252849|Glaucoma, Open-Angle|glaucoma, open-angle
5091271|NCT01252849|Ocular Hypertension|ocular hypertension
5091272|NCT01252849|Eye Diseases|eye diseases
5091273|NCT01252823|Hemodialysis|hemodialysis
5091274|NCT01252823|Cardiac Arrhythmia|cardiac arrhythmia
5091275|NCT01252823|Cardiac Death|cardiac death
5091276|NCT01252823|Implantable Loop Recorder|implantable loop recorder
5091277|NCT01252810|CATH Catheterization|cath catheterization
5091278|NCT01252810|CI-AKI Contrast-induced acute kidney injury|ci-aki contrast-induced acute kidney injury
5091279|NCT01252810|DM Diabetes mellitus|dm diabetes mellitus
5091280|NCT01252810|eGFR Estimated glomerular filtration rate|egfr estimated glomerular filtration rate
5091281|NCT01252810|MDRD Modification of Diet in Renal Disease|mdrd modification of diet in renal disease
5091282|NCT01252810|NYHA New York Heart Association|nyha new york heart association
5091283|NCT01252810|PCI Percutaneous coronary intervention|pci percutaneous coronary intervention
5091284|NCT01252810|SCr Serum creatinine|scr serum creatinine
5091285|NCT01252797|brain metastases|brain metastases
5091286|NCT01252784|higher risk MDS|higher risk mds
5091287|NCT01252771|phosphorus|phosphorus
5091288|NCT01252771|dialysis|dialysis
5091289|NCT01252771|PhosLo|phoslo
5091290|NCT01252732|ABSSSI|absssi
5091291|NCT01252732|Skin Infection|skin infection
5091292|NCT01252732|Abscess|abscess
5091293|NCT01252719|ABSSSI|absssi
5091294|NCT01252719|Skin Infection|skin infection
5091295|NCT01252719|Abscess|abscess
5091296|NCT01252706|brief intervention|brief intervention
5091297|NCT01252706|alcohol|alcohol
5091298|NCT01252706|nicotine|nicotine
5091299|NCT01252706|drug abuse|drug abuse
5091300|NCT01252654|Lasik|lasik
5091301|NCT01252654|Femtosecond Laser|femtosecond laser
5091302|NCT01252654|Visumax|visumax
5091303|NCT01252654|IntraLase|intralase
5091304|NCT01252654|Myopia|myopia
5091305|NCT01252654|Myopic Patients undergoing LASIK|myopic patients undergoing lasik
5091306|NCT01252641|HIV|hiv
5091307|NCT01252628|CRC|crc
5091308|NCT01252628|SCCHN|scchn
5091309|NCT01252628|PX-866|px-866
5091310|NCT01252628|Cetuximab|cetuximab
5091311|NCT01252628|ERBITUX|erbitux
5091312|NCT01252628|Colon|colon
5091313|NCT01252628|Head and Neck|head and neck
5091314|NCT01252628|Colorectal cancer|colorectal cancer
5091315|NCT01252628|Squamous cell carcinoma|squamous cell carcinoma
5091316|NCT01252628|PI-3K|pi-3k
5091317|NCT01252628|PI3 kinase|pi3 kinase
5091318|NCT01252628|PI3K|pi3k
5091319|NCT01252615|ICD|icd
5091320|NCT01252615|HF|hf
5091321|NCT01252615|cardiac arrest|cardiac arrest
5091322|NCT01252615|VF|vf
5091323|NCT01252615|cardiac arrhythmias|cardiac arrhythmias
5091324|NCT01252602|breastfeeding, EPDS, prenatal depression|breastfeeding, epds, prenatal depression
5091325|NCT01252589|Chronic Myeloid Leukemia|chronic myeloid leukemia
5091326|NCT01252589|Quality of Life|quality of life
5091327|NCT01252589|Symptoms|symptoms
5092216|NCT01248416|Growth|growth
5091329|NCT01252589|Questionnaire|questionnaire
5091330|NCT01252576|FSFI|fsfi
5091331|NCT01252576|female sexual function|female sexual function
5091332|NCT01252576|italian validation|italian validation
5091333|NCT01252563|ENTER10|enter10
5091334|NCT01252563|Hypertension|hypertension
5091335|NCT01252563|Japanese|japanese
5091336|NCT01252563|Norvasc 10mg|norvasc 10mg
5091337|NCT01252563|Post Marketing surveillance|post marketing surveillance
5091338|NCT01252550|IBS|ibs
5091339|NCT01252550|GI|gi
5091340|NCT01252550|QOL|qol
5091341|NCT01252550|Pathophysiology|pathophysiology
5091342|NCT01252550|Gut microbiota|gut microbiota
5091343|NCT01252550|Danone|danone
5091344|NCT01252550|Activia|activia
5091345|NCT01252550|Probiotics|probiotics
5091346|NCT01252537|HIV|hiv
5091347|NCT01252537|Tuberculosis|tuberculosis
5091348|NCT01252537|Immunosuppression|immunosuppression
5091349|NCT01252537|ART|art
5091350|NCT01252537|Ethiopia|ethiopia
5091351|NCT01252537|Primary health care|primary health care
5091352|NCT01252524|diabetes mellitus|diabetes mellitus
5091353|NCT01252524|fiber|fiber
5091354|NCT01252524|glycemic control|glycemic control
5091355|NCT01252524|calcium polycarbophil|calcium polycarbophil
5091356|NCT01252511|Malabsorption after RYGB|malabsorption after rygb
5091357|NCT01252511|Fat Malabsorption and maldigestion|fat malabsorption and maldigestion
5091358|NCT01252511|Obesity surgery|obesity surgery
5091359|NCT01252511|Bariatric surgery|bariatric surgery
5091360|NCT01252498|Cancer of the head and neck|cancer of the head and neck
5091361|NCT01252498|Radiotherapy|radiotherapy
5091362|NCT01252498|Prostaglandins|prostaglandins
5091363|NCT01252485|AML|aml
5091364|NCT01252485|Registry study|registry study
5091365|NCT01252485|Biology and Outcome|biology and outcome
5091366|NCT01252485|Higher Risk MDS|higher risk mds
5091367|NCT01252472|Flomax|flomax
5091368|NCT01252472|Floppy iris Syndrome|floppy iris syndrome
5091369|NCT01252472|Tamsulosin|tamsulosin
5091370|NCT01252459|AA-PET|aa-pet
5091371|NCT01252459|T1-Gd-MRI|t1-gd-mri
5091372|NCT01252459|re-irradiation|re-irradiation
5091373|NCT01252459|recurrent glioma|recurrent glioma
5091374|NCT01252446|ICD 10|icd 10
5091375|NCT01252446|Attention-Deficit-Hyperactivity-Disorder (ADHD)|attention-deficit-hyperactivity-disorder (adhd)
5091376|NCT01252446|Comorbidity|comorbidity
5091377|NCT01252446|Social-demographic profile|social-demographic profile
5091378|NCT01252420|Distal Vein Thrombosis|distal vein thrombosis
5091379|NCT01252420|Proximal Vein Thrombosis|proximal vein thrombosis
5091380|NCT01252420|Pulmonary Embolism|pulmonary embolism
5091381|NCT01252420|Post-thrombotic syndrome|post-thrombotic syndrome
5091382|NCT01252420|Limited duration treatment|limited duration treatment
5091383|NCT01252407|Transcutaneous electrical nerve stimulation|transcutaneous electrical nerve stimulation
5091384|NCT01252407|Sympathetic nervous system|sympathetic nervous system
5091385|NCT01252407|Parasympathetic nervous system|parasympathetic nervous system
5091386|NCT01252407|heart rate|heart rate
5091387|NCT01252342|Oxytocin|oxytocin
5091388|NCT01252342|Intramyometrial|intramyometrial
5091389|NCT01252329|high risk cutaneous squamous cell carcinoma|high risk cutaneous squamous cell carcinoma
5091390|NCT01252329|selective neck dissection|selective neck dissection
5091391|NCT01252329|elective lymph node management|elective lymph node management
5091392|NCT01252329|clinical nodal observation|clinical nodal observation
5091393|NCT01252303|Obesity, weight loss, meal replacements|obesity, weight loss, meal replacements
5091394|NCT01252264|biorepository|biorepository
5091395|NCT01252264|genetics|genetics
5091396|NCT01252264|craniofacial|craniofacial
5091397|NCT01252264|cleft lip|cleft lip
5091398|NCT01252264|cleft palate|cleft palate
5091399|NCT01252251|PASIREOTIDE (SOM230)|pasireotide (som230)
5091400|NCT01252251|RAD001 (EVEROLIMUS)|rad001 (everolimus)
5091401|NCT01252251|eye|eye
5091402|NCT01252251|10-123|10-123
5091403|NCT01252225|Chronic Cough|chronic cough
5091404|NCT01252225|Lidocaine|lidocaine
5091405|NCT01252212|HIV, antiretroviral, adherence, SMS, cell phone|hiv, antiretroviral, adherence, sms, cell phone
5091406|NCT01252199|Shigamabs|shigamabs
5091407|NCT01252199|Monoclonal|monoclonal
5091408|NCT01252199|Antibodies|antibodies
5091409|NCT01252199|Shiga|shiga
5091410|NCT01252199|Toxin|toxin
5091411|NCT01252199|E.coli|e.coli
5091412|NCT01252199|HUS|hus
5091413|NCT01252199|Bloody|bloody
5091414|NCT01252199|Diarrhea|diarrhea
5091415|NCT01252186|Contraception|contraception
5091416|NCT01252186|Hemostasis|hemostasis
5091417|NCT01252186|Blood Coagulation|blood coagulation
5091418|NCT01252173|endotracheal|endotracheal
5091419|NCT01252173|intubation|intubation
5091420|NCT01252173|tracheal|tracheal
5091421|NCT01252173|pressure|pressure
5091422|NCT01252173|cufflator|cufflator
5091423|NCT01252160|Neuralgia, Postherpetic|neuralgia, postherpetic
5091424|NCT01252160|QUTENZA|qutenza
5091425|NCT01252134|Soft Contact lens|soft contact lens
5091426|NCT01252134|Multi-purpose solution|multi-purpose solution
5091427|NCT01252134|Wettability|wettability
5091428|NCT01252121|Dry Eye|dry eye
5091429|NCT01252121|Ocular Retention Time|ocular retention time
5091430|NCT01252108|Helicobacter pylori|helicobacter pylori
5091431|NCT01252108|peptic ulcer disease|peptic ulcer disease
5091432|NCT01252108|stomach ulcers|stomach ulcers
5091433|NCT01252108|gastric cancer|gastric cancer
5091434|NCT01252095|PG545|pg545
5091435|NCT01252095|Phase I|phase i
5091436|NCT01252095|Progen|progen
5091437|NCT01252095|antimetastatic|antimetastatic
5091438|NCT01252095|antiangiogenic|antiangiogenic
5091439|NCT01252095|advanced cancer patients|advanced cancer patients
5091440|NCT01252095|solid tumors|solid tumors
5091441|NCT01252095|solid tumours|solid tumours
5091442|NCT01252082|metabolic control|metabolic control
5091443|NCT01252082|fasting plasma glucose|fasting plasma glucose
5091444|NCT01252082|glycated hemoglobin|glycated hemoglobin
5091445|NCT01252043|cholestasis|cholestasis
5091446|NCT01252043|children|children
5091447|NCT01252030|CAD, physical activity, rehabilitation, prevention|cad, physical activity, rehabilitation, prevention
5091448|NCT01252004|Left ventricular ballooning|left ventricular ballooning
5091449|NCT01251978|Choroidal melanoma|choroidal melanoma
5091450|NCT01251978|Ranibizumab|ranibizumab
5091451|NCT01251978|Transpupillary Thermotherapy|transpupillary thermotherapy
5091452|NCT01251978|CSTIP|cstip
5091453|NCT01251978|Indocyanine Green|indocyanine green
5091454|NCT01251965|Relapsed Acute Leukemia|relapsed acute leukemia
5091455|NCT01251965|Acute myeloid leukemia|acute myeloid leukemia
5091456|NCT01251965|AML|aml
5091457|NCT01251965|Acute lymphocytic leukemia|acute lymphocytic leukemia
5091458|NCT01251965|ALL|all
5091459|NCT01251965|Ruxolitinib|ruxolitinib
5091460|NCT01251965|Jakafi|jakafi
5091461|NCT01251965|INC424|inc424
5091462|NCT01251965|INCB018424|incb018424
5091463|NCT01251926|Bevacizumab|bevacizumab
5091464|NCT01251926|Camptothecin|camptothecin
5091465|NCT01251926|EZN-2208|ezn-2208
5091466|NCT01251926|Anti-Angiogenesis|anti-angiogenesis
5091467|NCT01251926|Advanced Cancer|advanced cancer
5091468|NCT01251926|Cancer|cancer
5091469|NCT01251926|Solid Tumor|solid tumor
5091470|NCT01251913|Tissue Harvest|tissue harvest
5091471|NCT01251913|Hospice|hospice
5091472|NCT01251913|Autopsy|autopsy
5091473|NCT01251913|Crainiotomy|crainiotomy
5091474|NCT01251913|Brain Tumor|brain tumor
5091475|NCT01251913|Glioma|glioma
5091476|NCT01251913|Astrocytoma|astrocytoma
5091477|NCT01251900|Triple Negative Disease|triple negative disease
5091478|NCT01251900|BRCA1|brca1
5091479|NCT01251900|BRCA2|brca2
5091480|NCT01251900|Hispanic/Latino|hispanic/latino
5091481|NCT01251900|Breast Cancer|breast cancer
5091482|NCT01251887|Lipids|lipids
5091483|NCT01251887|Obesity|obesity
5091484|NCT01251887|Omega-3 Fatty Acids|omega-3 fatty acids
5091485|NCT01251887|Overweight|overweight
5091486|NCT01251848|Sitaxentan|sitaxentan
5091487|NCT01251848|ritonavir|ritonavir
5091488|NCT01251848|drug interaction|drug interaction
5091489|NCT01251848|pharmacokinetics|pharmacokinetics
5091490|NCT01251835|Sitaxsentan|sitaxsentan
5091491|NCT01251835|Rifampin|rifampin
5091492|NCT01251835|Drug Interaction|drug interaction
5091493|NCT01251835|Pharmacokinetics|pharmacokinetics
5091494|NCT01251809|Asparaginase|asparaginase
5091495|NCT01251809|ALL|all
5091496|NCT01251783|term babies|term babies
5091497|NCT01251770|Hyponatremia|hyponatremia
5091498|NCT01251770|Water-Electrolyte Imbalance|water-electrolyte imbalance
5091499|NCT01251757|diabetes|diabetes
5091500|NCT01251757|cardiovascular disease|cardiovascular disease
5091501|NCT01251757|randomized clinical trial|randomized clinical trial
5091502|NCT01251757|medication adherence|medication adherence
5091503|NCT01251757|health information technology|health information technology
5091504|NCT01251757|adult|adult
5091505|NCT01251757|telephone calls|telephone calls
5091506|NCT01251757|IVR|ivr
5091507|NCT01251744|Pregnancy|pregnancy
5091508|NCT01251744|Congenital|congenital
5091509|NCT01251744|Cytomegalovirus infection|cytomegalovirus infection
5091510|NCT01251718|Donepezil hydrochloride|donepezil hydrochloride
5091511|NCT01251718|Alzheimer's Disease|alzheimer's disease
5091512|NCT01251705|Cornea|cornea
5091513|NCT01251705|SL OCT|sl oct
5091514|NCT01251705|Spectral OCT Cornea modul|spectral oct cornea modul
5091515|NCT01251705|ultrasound pachymetry|ultrasound pachymetry
5091516|NCT01251705|Pentacam|pentacam
5091517|NCT01251692|Corneal erosions|corneal erosions
5091518|NCT01251692|PTK|ptk
5091519|NCT01251679|handwashing|handwashing
5091520|NCT01251679|masks|masks
5091521|NCT01251679|infectious disease transmission|infectious disease transmission
5091522|NCT01251666|Colorectal cancer|colorectal cancer
5091523|NCT01251666|Screening|screening
5091524|NCT01251666|Average-risk population|average-risk population
5091525|NCT01251666|faecal occult blood tests|faecal occult blood tests
5091526|NCT01251640|pancreatic cancer,|pancreatic cancer,
5091527|NCT01251640|MEK-inhibitor|mek-inhibitor
5091528|NCT01251627|Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia, Decitabine|myelodysplastic syndromes, chronic myelomonocytic leukemia, decitabine
5091529|NCT01251614|Randomized|randomized
5091530|NCT01251614|Double-blind|double-blind
5091531|NCT01251614|Chronic plaque psoriasis|chronic plaque psoriasis
5091532|NCT01251614|Pediatric|pediatric
5091533|NCT01251588|Cartilage legions|cartilage legions
5091534|NCT01251588|Symptomatic focal cartilage defects|symptomatic focal cartilage defects
5091535|NCT01251588|Microfracture|microfracture
5091536|NCT01251588|MACI|maci
5091537|NCT01251588|Autologous chondrocyte|autologous chondrocyte
5091538|NCT01251549|ReWalk|rewalk
5091539|NCT01251549|Paraplegia|paraplegia
5091540|NCT01251549|Spinal Cord Injuries (SCI)|spinal cord injuries (sci)
5091541|NCT01251536|colorectal cancer|colorectal cancer
5091542|NCT01251536|K-Ras wildtype|k-ras wildtype
5091543|NCT01251536|first line metastatic|first line metastatic
5091544|NCT01251536|standard cetuximab + FOLFIRI|standard cetuximab + folfiri
5091545|NCT01251536|dose escalation cetuximab|dose escalation cetuximab
5091546|NCT01251523|Asthma|asthma
5091547|NCT01251471|major depressive disorder|major depressive disorder
5091548|NCT01251471|MDD|mdd
5091549|NCT01251471|imaging genetics|imaging genetics
5091550|NCT01251471|pharmacoMRI|pharmacomri
5091551|NCT01251432|otitis media|otitis media
5091552|NCT01251432|Eustachian tube|eustachian tube
5091553|NCT01251432|allergy|allergy
5091554|NCT01251432|gastroesophageal reflux|gastroesophageal reflux
5091555|NCT01251432|tympanostomy tube|tympanostomy tube
5091556|NCT01251419|Generic Medication|generic medication
5091557|NCT01251419|Brand Name Medication|brand name medication
5091558|NCT01251419|Conversion Rates|conversion rates
5091559|NCT01251419|Social Proximity|social proximity
5091560|NCT01251419|Behavioral Economics|behavioral economics
5091561|NCT01251406|Stable|stable
5091562|NCT01251406|Chronic Heart Failure|chronic heart failure
5091563|NCT01251406|Systolic|systolic
5091564|NCT01251393|Cocaine|cocaine
5091565|NCT01251393|crack|crack
5091566|NCT01251393|treatment|treatment
5091567|NCT01251393|dependence|dependence
5091568|NCT01251393|biperiden|biperiden
5091569|NCT01251341|inflammation|inflammation
5091570|NCT01251341|immune system|immune system
5091571|NCT01251341|cytokines|cytokines
5091572|NCT01251341|meditation|meditation
5091573|NCT01251341|compassion|compassion
5091574|NCT01251341|attention|attention
5091575|NCT01251315|Glutathione|glutathione
5091576|NCT01251315|Antioxidant|antioxidant
5091577|NCT01251315|Free radical|free radical
5091578|NCT01251315|Oxidative stress|oxidative stress
5091579|NCT01251315|N-Acetyl Cysteine|n-acetyl cysteine
5091580|NCT01251315|Glutathione precursor|glutathione precursor
5091581|NCT01251302|Corus CAD|corus cad
5091582|NCT01251302|Age/Sex/Gene Expression Score|age/sex/gene expression score
5091583|NCT01251302|Molecular Genetics|molecular genetics
5091584|NCT01251302|Atherosclerosis|atherosclerosis
5091585|NCT01251302|ASGES|asges
5091586|NCT01251302|Gene Expression|gene expression
5091587|NCT01251302|GES|ges
5091588|NCT01251302|CAD|cad
5091589|NCT01251302|CVD|cvd
5091590|NCT01251302|CHD|chd
5091591|NCT01251302|Clinical Utility|clinical utility
5091592|NCT01251302|Precision Medicine|precision medicine
5091593|NCT01251302|Coronary Artery Disease|coronary artery disease
5091594|NCT01251302|Angina Pectoris|angina pectoris
5091595|NCT01251302|Chest Pain|chest pain
5091596|NCT01251302|Cardiovascular Disease|cardiovascular disease
5091597|NCT01251302|Coronary Heart Disease|coronary heart disease
5091598|NCT01251302|IMPACT|impact
5091599|NCT01251302|IMPACT-CARD|impact-card
5091600|NCT01251263|headaches|headaches
5091601|NCT01251263|migraines|migraines
5091602|NCT01251263|breakthrough bleeding|breakthrough bleeding
5091603|NCT01251263|breakthrough spotting|breakthrough spotting
5091604|NCT01251263|menstrually associated migraines|menstrually associated migraines
5091605|NCT01251263|breakthrough bleeding or breakthrough spotting|breakthrough bleeding or breakthrough spotting
5091606|NCT01251224|asthma|asthma
5091607|NCT01251224|mouse allergen|mouse allergen
5091608|NCT01251224|environmental intervention|environmental intervention
5091609|NCT01251211|BOTULINUM TOXIN|botulinum toxin
5091610|NCT01251211|NEUROPATHIC PAIN|neuropathic pain
5091611|NCT01251211|RANDOMIZED CONTROLLED TRIAL|randomized controlled trial
5091612|NCT01251185|Extracorporeal Shockwave Therapy|extracorporeal shockwave therapy
5091613|NCT01251185|Heart Failure|heart failure
5091614|NCT01251185|Congestive Heart Failure|congestive heart failure
5091615|NCT01251185|Non-invasive|non-invasive
5091616|NCT01251185|Device Trial|device trial
5091617|NCT01251185|NYHA (New York Heart Association)|nyha (new york heart association)
5091618|NCT01251185|Ischemic cardiomyopathy|ischemic cardiomyopathy
5091619|NCT01251185|Ischemia|ischemia
5091620|NCT01251185|Myocardial contractility|myocardial contractility
5091621|NCT01251159|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5091622|NCT01251159|adult acute myeloid leukemia with del(5q)|adult acute myeloid leukemia with del(5q)
5091623|NCT01251159|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5091624|NCT01251159|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5091625|NCT01251159|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5091626|NCT01251159|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
5091627|NCT01251159|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
5091628|NCT01251159|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
5091629|NCT01251159|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
5091725|NCT01250691|infection control|infection control
5091630|NCT01251159|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
5091631|NCT01251159|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
5091632|NCT01251159|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
5091633|NCT01251159|adult erythroleukemia (M6a)|adult erythroleukemia (m6a)
5091634|NCT01251159|adult pure erythroid leukemia (M6b)|adult pure erythroid leukemia (m6b)
5091635|NCT01251159|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
5091636|NCT01251146|Hypertension|hypertension
5091637|NCT01251146|Bisoprolol|bisoprolol
5091638|NCT01251146|Atenolol|atenolol
5091639|NCT01251133|Communicable Diseases|communicable diseases
5091640|NCT01251133|Infection|infection
5091641|NCT01251133|Influenza|influenza
5091642|NCT01251133|Orthomyxoviridae Infections|orthomyxoviridae infections
5091643|NCT01251133|RNA Virus Infections|rna virus infections
5091644|NCT01251133|Virus Diseases|virus diseases
5091645|NCT01251133|Respiratory Tract Infections|respiratory tract infections
5091646|NCT01251133|Respiratory Tract Diseases|respiratory tract diseases
5091647|NCT01251107|Hodgkin lymphoma|hodgkin lymphoma
5091648|NCT01251107|ABVD|abvd
5091649|NCT01251107|BEACOPP|beacopp
5091650|NCT01251107|Salvage high dose chemotherapy|salvage high dose chemotherapy
5091651|NCT01251094|Dementia|dementia
5091652|NCT01251094|Parkinson's|parkinson's
5091653|NCT01251094|impairment|impairment
5091654|NCT01251094|Dementia Registry for Parkinson's Disease|dementia registry for parkinson's disease
5091655|NCT01251081|high volume hemofiltration|high volume hemofiltration
5091656|NCT01251081|sepsis|sepsis
5091657|NCT01251081|acute kidney injury|acute kidney injury
5091658|NCT01251081|survival|survival
5091659|NCT01251068|anemic preterms, cerebral oxygenation,somatic oxygenation, blood transfusion|anemic preterms, cerebral oxygenation,somatic oxygenation, blood transfusion
5091660|NCT01251055|N-methyl-D-aspartate receptor|n-methyl-d-aspartate receptor
5091661|NCT01251055|glycine transporter|glycine transporter
5091662|NCT01251055|schizophrenia|schizophrenia
5091663|NCT01251016|Type 2 diabetes mellitus|type 2 diabetes mellitus
5091664|NCT01251016|Y-Roux gastric bypass|y-roux gastric bypass
5091665|NCT01251016|Gut hormones|gut hormones
5091666|NCT01251016|Gene expression|gene expression
5091667|NCT01251016|Surgery|surgery
5091668|NCT01251003|Traumatic Brain Injury|traumatic brain injury
5091669|NCT01251003|TBI|tbi
5091670|NCT01251003|Pediatric|pediatric
5091671|NCT01251003|Chronic|chronic
5091672|NCT01250990|Niacin|niacin
5091673|NCT01250990|HDL|hdl
5091674|NCT01250990|Reverse cholesterol transport|reverse cholesterol transport
5091675|NCT01250977|Non-treatment seeking smokers, reporting consumption of at least|non-treatment seeking smokers, reporting consumption of at least
5091676|NCT01250977|10 cigarettes per day for at least the past 6 months|10 cigarettes per day for at least the past 6 months
5091677|NCT01250951|Iron Overload|iron overload
5091678|NCT01250951|hemotranfusion|hemotranfusion
5091679|NCT01250951|deferasirox|deferasirox
5091680|NCT01250951|ferritin|ferritin
5091681|NCT01250951|Rare anemia|rare anemia
5091682|NCT01250951|Transfusional Iron Overload|transfusional iron overload
5091683|NCT01250938|autism|autism
5091684|NCT01250938|autism spectrum disorders|autism spectrum disorders
5091685|NCT01250938|pervasive developmental disorders|pervasive developmental disorders
5091686|NCT01250938|intervention|intervention
5091687|NCT01250938|low-income|low-income
5091688|NCT01250938|underserved populations|underserved populations
5091689|NCT01250938|underrepresented populations|underrepresented populations
5091690|NCT01250925|Contact lens|contact lens
5091691|NCT01250925|Lens care|lens care
5091692|NCT01250912|Ablation|ablation
5091693|NCT01250912|Arrythmia|arrythmia
5091694|NCT01250912|Imaging|imaging
5091695|NCT01250899|HIV|hiv
5091696|NCT01250899|Vitamin D|vitamin d
5091697|NCT01250899|HAART|haart
5091698|NCT01250860|Manual therapy|manual therapy
5091699|NCT01250860|DoboMed exercise|dobomed exercise
5091700|NCT01250860|Spirometric test|spirometric test
5091701|NCT01250847|ARMS|arms
5091702|NCT01250847|Ultra High Risk|ultra high risk
5091703|NCT01250847|Quetiapine|quetiapine
5091704|NCT01250847|Verbal memory|verbal memory
5091705|NCT01250821|Infertility|infertility
5091706|NCT01250821|Anovulation|anovulation
5091707|NCT01250821|Ovulation induction|ovulation induction
5091708|NCT01250795|Prevention|prevention
5091709|NCT01250782|Glutamine, trauma patients, infections, mortality|glutamine, trauma patients, infections, mortality
5091710|NCT01250769|dental|dental
5091711|NCT01250769|dentist|dentist
5091712|NCT01250769|plaque|plaque
5091713|NCT01250769|IP Cleaning|ip cleaning
5091714|NCT01250756|vaccine|vaccine
5091715|NCT01250756|pneumococcal conjugate|pneumococcal conjugate
5091716|NCT01250743|genotype 1|genotype 1
5091717|NCT01250730|PK profile in Japanese healthy male volunteers|pk profile in japanese healthy male volunteers
5091718|NCT01250717|prostatectomy|prostatectomy
5091719|NCT01250717|docetaxel|docetaxel
5091720|NCT01250704|Neuromyotonia, Isaac's syndrome; Peripheral nerve hyperexcitability; Myokymia; Potassium channelopathy|neuromyotonia, isaac's syndrome; peripheral nerve hyperexcitability; myokymia; potassium channelopathy
5091721|NCT01250691|pneumonia|pneumonia
5091722|NCT01250691|ICU|icu
5091723|NCT01250691|isolation room|isolation room
5091724|NCT01250691|clinical epidemiology|clinical epidemiology
5091726|NCT01250678|multiple sclerosis|multiple sclerosis
5091727|NCT01250678|cognitive impairment|cognitive impairment
5091728|NCT01250678|natalizumab|natalizumab
5091729|NCT01250678|SDMT|sdmt
5091730|NCT01250665|multiple sclerosis|multiple sclerosis
5091731|NCT01250665|cognitive impairment|cognitive impairment
5091732|NCT01250665|interferon-beta 1b|interferon-beta 1b
5091733|NCT01250665|corpus callosum index|corpus callosum index
5091734|NCT01250652|Chronic urticaria|chronic urticaria
5091735|NCT01250652|Urticaria|urticaria
5091736|NCT01250652|Antihistamine|antihistamine
5091737|NCT01250639|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
5091738|NCT01250639|non-aboriginal Taiwanese|non-aboriginal taiwanese
5091739|NCT01250639|Genome-wide association study|genome-wide association study
5091740|NCT01250626|Inulin|inulin
5091741|NCT01250626|childhood GFR formula|childhood gfr formula
5091742|NCT01250587|Open label|open label
5091743|NCT01250587|dose-finding Phase 1 study|dose-finding phase 1 study
5091744|NCT01250574|CD64|cd64
5091745|NCT01250574|Procalcitonin|procalcitonin
5091746|NCT01250561|gabapentin|gabapentin
5091747|NCT01250561|valacyclovir|valacyclovir
5091748|NCT01250561|phn|phn
5091749|NCT01250561|shingles|shingles
5091750|NCT01250548|Rheumatoid arthritis|rheumatoid arthritis
5091751|NCT01250548|RA|ra
5091752|NCT01250548|Active rheumatoid arthritis|active rheumatoid arthritis
5091753|NCT01250535|Drug drug interactions|drug drug interactions
5091754|NCT01250535|Warfarin|warfarin
5091755|NCT01250535|Anticoagulants|anticoagulants
5091756|NCT01250535|Lovastatin|lovastatin
5091757|NCT01250535|Statins|statins
5091758|NCT01250535|CYP4F2|cyp4f2
5091759|NCT01250535|Vitamin K|vitamin k
5091760|NCT01250509|Obesity|obesity
5091761|NCT01250509|Mindfulness based stress reduction|mindfulness based stress reduction
5091762|NCT01250509|Mindful eating|mindful eating
5091763|NCT01250509|Stress|stress
5091764|NCT01250509|Overnutrition|overnutrition
5091765|NCT01250509|Nutrition Disorders|nutrition disorders
5091766|NCT01250509|Overweight|overweight
5091767|NCT01250509|Body Weight|body weight
5091768|NCT01250509|Signs and Symptoms|signs and symptoms
5091769|NCT01250496|regadenoson|regadenoson
5091770|NCT01250496|lexiscan|lexiscan
5091771|NCT01250496|aminophylline|aminophylline
5091772|NCT01250496|SPECT|spect
5091773|NCT01250496|Myocardial Perfusion Imaging|myocardial perfusion imaging
5091774|NCT01250496|pharmacologic stress test|pharmacologic stress test
5091775|NCT01250483|prostate|prostate
5091776|NCT01250483|prostate-specific antigen|prostate-specific antigen
5091777|NCT01250483|benign prostatic hyperplasia|benign prostatic hyperplasia
5091778|NCT01250483|adrenergic alpha-Antagonists|adrenergic alpha-antagonists
5091779|NCT01250444|Inspiratory Muscle Training|inspiratory muscle training
5091780|NCT01250444|Hypertension|hypertension
5091781|NCT01250444|Breathing Exercises|breathing exercises
5091782|NCT01250444|Cardiac Rehabilitation|cardiac rehabilitation
5091783|NCT01250418|Bispectral Index|bispectral index
5091784|NCT01250418|Ketamine|ketamine
5091785|NCT01250392|Active choice|active choice
5091786|NCT01250392|Nurse visits|nurse visits
5091787|NCT01250392|Behavioral economics|behavioral economics
5091788|NCT01250366|Safety and Pharmacokinetics|safety and pharmacokinetics
5091789|NCT01250353|ocular surface reconstruction|ocular surface reconstruction
5091790|NCT01250353|conjunctival healing|conjunctival healing
5091791|NCT01250353|pterygium|pterygium
5091792|NCT01250353|latex biomembrane|latex biomembrane
5091793|NCT01250353|pterygium surgery|pterygium surgery
5091794|NCT01250340|Diabetes|diabetes
5091795|NCT01250340|Isoprostanes|isoprostanes
5091796|NCT01250340|Thromboxane|thromboxane
5091797|NCT01250340|Aspirin|aspirin
5091798|NCT01250327|right ventricular outflow tract|right ventricular outflow tract
5091799|NCT01250327|endovascular valve insertion|endovascular valve insertion
5091800|NCT01250327|economic evaluation|economic evaluation
5091801|NCT01250327|valved stent|valved stent
5091802|NCT01250314|osteoporosis|osteoporosis
5091803|NCT01250314|men|men
5091804|NCT01250314|bone micro-architecture|bone micro-architecture
5091805|NCT01250314|bone markers|bone markers
5091806|NCT01250301|Smoking Cessation|smoking cessation
5091807|NCT01250301|Tobacco Dependence|tobacco dependence
5091808|NCT01250301|De-nicotinised cigarettes|de-nicotinised cigarettes
5091809|NCT01250288|Health Information Technology|health information technology
5091810|NCT01250288|Health Records, Personal|health records, personal
5091811|NCT01250288|Hospital Information Systems|hospital information systems
5091812|NCT01250288|Patient Access to Records|patient access to records
5091813|NCT01250288|Medical Records|medical records
5091814|NCT01250288|Medical Record Systems, Computerized|medical record systems, computerized
5091815|NCT01250275|Canola Oil|canola oil
5091816|NCT01250275|Peripheral Arterial Disease|peripheral arterial disease
5091817|NCT01250275|Peripheral Vascular Disease|peripheral vascular disease
5091818|NCT01250275|PAD|pad
5091819|NCT01250262|low back pain|low back pain
5091820|NCT01250262|obese|obese
5091821|NCT01250262|fear avoidance|fear avoidance
5091822|NCT01250262|disability and low back pain|disability and low back pain
5091823|NCT01250262|chronic low back pain in obese older adults|chronic low back pain in obese older adults
5091918|NCT01249833|Attention|attention
5091824|NCT01250249|To compare Safety and Reactogenecity of BCG vaccine of Green Signal Biopharma Private Limited with BCG vaccine of serum institute of India limited|to compare safety and reactogenecity of bcg vaccine of green signal biopharma private limited with bcg vaccine of serum institute of india limited
5091825|NCT01250236|brimonidine|brimonidine
5091826|NCT01250236|alpha-2 adrenoceptor|alpha-2 adrenoceptor
5091827|NCT01250236|cornea|cornea
5091828|NCT01250236|corneal thickness|corneal thickness
5091829|NCT01250223|Lymphoma, Follicular|lymphoma, follicular
5091830|NCT01250223|Prognosis|prognosis
5091831|NCT01250223|Progression-Free Survival|progression-free survival
5091832|NCT01250223|Outcome|outcome
5091833|NCT01250223|International Cooperation|international cooperation
5091834|NCT01250223|Data Collection|data collection
5091835|NCT01250223|Prospective studies|prospective studies
5091836|NCT01250223|Rare Diseases|rare diseases
5091837|NCT01250210|contraception|contraception
5091838|NCT01250210|pregnancy prevention|pregnancy prevention
5091839|NCT01250197|Normal Volunteers|normal volunteers
5091840|NCT01250184|Myofascial pain|myofascial pain
5091841|NCT01250184|Trigger points.|trigger points.
5091842|NCT01250184|Lidocaine injection.|lidocaine injection.
5091843|NCT01250184|Physical therapy|physical therapy
5091845|NCT01250171|IL17/ IL-1β|il17/ il-1β
5091846|NCT01250171|Biologic|biologic
5091847|NCT01250158|Liver Percutaneous Isolated Localized Perfusion|liver percutaneous isolated localized perfusion
5091848|NCT01250158|PILP|pilp
5091849|NCT01250158|Isolated Hepatic Perfusion|isolated hepatic perfusion
5091850|NCT01250158|IHP|ihp
5091851|NCT01250158|Liver metastases|liver metastases
5091852|NCT01250158|Unresectable liver metastases of different etiologies|unresectable liver metastases of different etiologies
5091853|NCT01250132|Traumatic brain injury|traumatic brain injury
5091854|NCT01250132|Paediatrics|paediatrics
5091855|NCT01250132|Hypopituitarism|hypopituitarism
5091856|NCT01250106|probiotics|probiotics
5091857|NCT01250106|prevention|prevention
5091858|NCT01250106|dietary intervention|dietary intervention
5091859|NCT01250106|insulin resistance|insulin resistance
5091860|NCT01250106|obesity|obesity
5091861|NCT01250106|type 2 diabetes|type 2 diabetes
5091862|NCT01250015|colorectal cancer|colorectal cancer
5091863|NCT01250015|consent|consent
5091864|NCT01250015|screening|screening
5091865|NCT01250002|Pain|pain
5091866|NCT01250002|MQOR 40|mqor 40
5091867|NCT01250002|Lidocaine|lidocaine
5091868|NCT01250002|Gynecologic|gynecologic
5091869|NCT01250002|Surgery|surgery
5091870|NCT01250002|Laparoscopic|laparoscopic
5091871|NCT01249989|Physical Activity|physical activity
5091872|NCT01249989|Sedentary Lifestyle|sedentary lifestyle
5091873|NCT01249989|Diet|diet
5091874|NCT01249989|Health Behavior|health behavior
5091875|NCT01249976|blood culture|blood culture
5091876|NCT01249976|central venous catheter|central venous catheter
5091877|NCT01249976|acridine orange leucocyte cytospin test|acridine orange leucocyte cytospin test
5091878|NCT01249976|semi-quantitative skin culture|semi-quantitative skin culture
5091879|NCT01249963|acute pancreatitis|acute pancreatitis
5091880|NCT01249963|enteral nutrition|enteral nutrition
5091881|NCT01249963|nutritional status|nutritional status
5091882|NCT01249963|pancreas|pancreas
5091883|NCT01249963|T-Diet plus Atémpero|t-diet plus atémpero
5091884|NCT01249950|Morbid obesity|morbid obesity
5091885|NCT01249950|teenagers|teenagers
5091886|NCT01249950|co-morbidities|co-morbidities
5091887|NCT01249950|bariatric surgery|bariatric surgery
5091888|NCT01249950|epidemiology|epidemiology
5091889|NCT01249937|Macular Degeneration|macular degeneration
5091890|NCT01249937|Age-related macular degeneration|age-related macular degeneration
5091891|NCT01249937|Anti-inflammatory|anti-inflammatory
5091892|NCT01249937|Anti-vascular endothelial growth factor (Anti-VEGF)|anti-vascular endothelial growth factor (anti-vegf)
5091893|NCT01249937|Lucentis|lucentis
5091894|NCT01249937|Ranibizumab|ranibizumab
5091895|NCT01249937|Kenalog|kenalog
5091896|NCT01249937|Triamcinolone Acetonide|triamcinolone acetonide
5091897|NCT01249937|Vision loss|vision loss
5091898|NCT01249924|Obstructive sleep apnea (OSA), continuous positive airway pressure(CPAP), surgery, anesthesia|obstructive sleep apnea (osa), continuous positive airway pressure(cpap), surgery, anesthesia
5091899|NCT01249911|Infants|infants
5091900|NCT01249898|Fracture in the Scaphoid fractures|fracture in the scaphoid fractures
5091901|NCT01249885|pacifier sucking|pacifier sucking
5091902|NCT01249885|children|children
5091903|NCT01249885|occlusion|occlusion
5091904|NCT01249885|drooling|drooling
5091905|NCT01249872|open gastric by-pass|open gastric by-pass
5091906|NCT01249872|super morbidly obese patients|super morbidly obese patients
5091907|NCT01249872|postoperative thoracic epidural analgesia|postoperative thoracic epidural analgesia
5091908|NCT01249872|different drug regimens (morphine and levobupivacaine)|different drug regimens (morphine and levobupivacaine)
5091909|NCT01249872|Lung function tests|lung function tests
5091910|NCT01249872|Postoperative Bowel recovery|postoperative bowel recovery
5091911|NCT01249872|Postoperative Ambulation|postoperative ambulation
5091912|NCT01249859|stomach disease|stomach disease
5091913|NCT01249859|signet ring cell carcinoma|signet ring cell carcinoma
5091914|NCT01249859|chemotherapy|chemotherapy
5091915|NCT01249859|Prognostic|prognostic
5091916|NCT01249833|Influenza|influenza
5091917|NCT01249833|Cognition|cognition
5091919|NCT01249833|Simple Reaction Time|simple reaction time
5091920|NCT01249833|Alertness|alertness
5091921|NCT01249833|Calmness|calmness
5091922|NCT01249833|Contentment|contentment
5091923|NCT01249833|Mood|mood
5091924|NCT01249820|anidulafungin|anidulafungin
5091925|NCT01249820|antifungal prophylaxis|antifungal prophylaxis
5091926|NCT01249820|allogeneic haematopoietic stem cell transplant|allogeneic haematopoietic stem cell transplant
5091927|NCT01249820|myeloablative chemotherapy|myeloablative chemotherapy
5091928|NCT01249820|AML-MDS|aml-mds
5091929|NCT01249820|pharmacokinetics|pharmacokinetics
5091930|NCT01249807|Cancer Screening|cancer screening
5091931|NCT01249807|health service utilization model|health service utilization model
5091932|NCT01249807|quality of health life|quality of health life
5091933|NCT01249794|NIV|niv
5091934|NCT01249794|non invasive ventilation|non invasive ventilation
5091935|NCT01249794|cardiac surgery|cardiac surgery
5091936|NCT01249794|continuous positive airway pressure|continuous positive airway pressure
5091937|NCT01249768|Prospective study|prospective study
5091938|NCT01249768|diagnostic accuracy|diagnostic accuracy
5091939|NCT01249768|CSF|csf
5091940|NCT01249768|MRI|mri
5091941|NCT01249742|diabetes mellitus|diabetes mellitus
5091942|NCT01249742|adolescent|adolescent
5091943|NCT01249742|online intervention|online intervention
5091944|NCT01249742|psychosocial|psychosocial
5091945|NCT01249742|quality of life|quality of life
5091946|NCT01249729|Magnetic Resonance Imaging, 3D reconstructed image|magnetic resonance imaging, 3d reconstructed image
5091947|NCT01249716|follow-up home visit|follow-up home visit
5091948|NCT01249716|Geriatric Disorder|geriatric disorder
5091949|NCT01249716|rehabilitation|rehabilitation
5091950|NCT01249690|Bortezomib,Thalidomide,bone metabolites|bortezomib,thalidomide,bone metabolites
5091951|NCT01249677|type 2 diabetes|type 2 diabetes
5091952|NCT01249677|first phase insulin secretion|first phase insulin secretion
5091953|NCT01249677|beta-cell rest|beta-cell rest
5091954|NCT01249677|basal insulin|basal insulin
5091955|NCT01249664|sham-controlled|sham-controlled
5091956|NCT01249664|pathologic myopia|pathologic myopia
5091957|NCT01249664|mCNV|mcnv
5091958|NCT01249664|choroidal neovascularization|choroidal neovascularization
5091959|NCT01249664|intravitreal injection|intravitreal injection
5091960|NCT01249664|vision loss|vision loss
5091961|NCT01249664|macular damage|macular damage
5091962|NCT01249651|Patients, Single|patients, single
5091963|NCT01249638|Bevacizumab|bevacizumab
5091964|NCT01249638|Capecitabine|capecitabine
5091965|NCT01249638|Irinotecan|irinotecan
5091966|NCT01249638|mCRC|mcrc
5091967|NCT01249625|Influenza|influenza
5091968|NCT01249625|H1N1|h1n1
5091969|NCT01249625|Respiratory protection|respiratory protection
5091970|NCT01249625|N95 respirator|n95 respirator
5091971|NCT01249625|Medical mask|medical mask
5091972|NCT01249625|Personal protective equipment|personal protective equipment
5091973|NCT01249625|Facial protective equipment|facial protective equipment
5091974|NCT01249625|Pandemic planning|pandemic planning
5091975|NCT01249612|Knee joint icing|knee joint icing
5091976|NCT01249612|knee-extension strength|knee-extension strength
5091977|NCT01249599|Takotsubo Syndrome|takotsubo syndrome
5091978|NCT01249599|apical balooning syndrome|apical balooning syndrome
5091979|NCT01249599|stress-cardiomyopathy|stress-cardiomyopathy
5091980|NCT01249599|endothelial function|endothelial function
5091981|NCT01249599|sympathetic nervous activity|sympathetic nervous activity
5091982|NCT01249599|platelet adhesion|platelet adhesion
5091983|NCT01249599|arterial compliance|arterial compliance
5091984|NCT01249573|fascia therapy|fascia therapy
5091985|NCT01249573|transcutaneous fibrolysis|transcutaneous fibrolysis
5091986|NCT01249573|acute ankle distortion|acute ankle distortion
5091987|NCT01249495|leg ulcer|leg ulcer
5091988|NCT01249495|wound therapy|wound therapy
5091989|NCT01249495|Pro-inflammatory interleukins|pro-inflammatory interleukins
5091990|NCT01249482|Helicobacter pylori|helicobacter pylori
5091991|NCT01249482|reflux|reflux
5091992|NCT01249482|acid rebound|acid rebound
5091993|NCT01249391|Hand|hand
5091994|NCT01249391|osteoarthritis|osteoarthritis
5091995|NCT01249391|splint|splint
5091996|NCT01249391|pain|pain
5091997|NCT01249391|deformity|deformity
5091998|NCT01249391|function|function
5091999|NCT01249378|Nutrition|nutrition
5092000|NCT01249378|Lipid|lipid
5092001|NCT01249378|Digestion|digestion
5092002|NCT01249378|Endotoxemia|endotoxemia
5092003|NCT01249378|Inflammation|inflammation
5092004|NCT01249378|Metabolism|metabolism
5092005|NCT01249378|Stable Isotope|stable isotope
5092006|NCT01249378|Obesity|obesity
5092007|NCT01249365|medically significant conditions|medically significant conditions
5092008|NCT01249365|cervical neoplasia|cervical neoplasia
5092009|NCT01249365|serious adverse events (SAEs)|serious adverse events (saes)
5092010|NCT01249365|HPV vaccine|hpv vaccine
5092011|NCT01249352|Esophageal Cancer|esophageal cancer
5092012|NCT01249352|Nimotuzumab|nimotuzumab
5092013|NCT01249352|EF024|ef024
5092014|NCT01249352|EF024-201|ef024-201
5092015|NCT01249339|smokeless tobacco|smokeless tobacco
5092016|NCT01249339|Nicotine|nicotine
5092017|NCT01249339|Cadmium|cadmium
5092018|NCT01249339|lead|lead
5092215|NCT01248416|Aromatase|aromatase
5092019|NCT01249339|Tobacco Specific Nitrosamines|tobacco specific nitrosamines
5092020|NCT01249326|Morbid obesity,|morbid obesity,
5092021|NCT01249326|Bariatric surgery, by-pass, sleeve gastrectomy,|bariatric surgery, by-pass, sleeve gastrectomy,
5092022|NCT01249326|Nitrogen balance,|nitrogen balance,
5092023|NCT01249326|Protein requirement,|protein requirement,
5092024|NCT01249326|Weight loss|weight loss
5092025|NCT01249326|Muscle wasting, muscle disability|muscle wasting, muscle disability
5092026|NCT01249313|Risk|risk
5092027|NCT01249313|outcome|outcome
5092028|NCT01249300|Dysphagia caused by cerebral vascular accidents|dysphagia caused by cerebral vascular accidents
5092029|NCT01249287|stroke|stroke
5092030|NCT01249287|stem cell|stem cell
5092031|NCT01249274|cocaine abuse|cocaine abuse
5092032|NCT01249274|cocaine dependence|cocaine dependence
5092033|NCT01249274|postpartum period|postpartum period
5092034|NCT01249261|Postmenopausal Women|postmenopausal women
5092035|NCT01249261|Osteoporosis|osteoporosis
5092036|NCT01249248|Heart rate variability|heart rate variability
5092037|NCT01249248|Autonomic dysfunction|autonomic dysfunction
5092038|NCT01249248|Exercise|exercise
5092039|NCT01249248|Sports|sports
5092040|NCT01249248|Competition|competition
5092041|NCT01249248|Athletes|athletes
5092042|NCT01249209|obesity|obesity
5092043|NCT01249209|adults|adults
5092044|NCT01249209|lifestyle intervention|lifestyle intervention
5092045|NCT01249209|effect after two years treatment for lifestyle change - morbid obesity adults|effect after two years treatment for lifestyle change - morbid obesity adults
5092046|NCT01249183|Diphtheria|diphtheria
5092047|NCT01249183|Tetanus|tetanus
5092048|NCT01249183|Pertussis (acellular, component)|pertussis (acellular, component)
5092049|NCT01249183|Diphteria|diphteria
5092050|NCT01249183|Biological / vaccine|biological / vaccine
5092051|NCT01249170|Communication skills|communication skills
5092052|NCT01249157|MRI|mri
5092053|NCT01249157|PEM|pem
5092054|NCT01249157|10-189|10-189
5092055|NCT01249144|Intraocular Lens (IOL)|intraocular lens (iol)
5092056|NCT01249144|Quarter Diopter|quarter diopter
5092057|NCT01249144|Biaspheric|biaspheric
5092058|NCT01249105|MK-2206|mk-2206
5092059|NCT01249105|GBM|gbm
5092060|NCT01249092|biliary cirrhosis|biliary cirrhosis
5092061|NCT01249066|AMP-activated protein kinase|amp-activated protein kinase
5092062|NCT01249066|lung adenocarcinomas|lung adenocarcinomas
5092063|NCT01249066|Prognosis|prognosis
5092064|NCT01249066|Observation study|observation study
5092065|NCT01249053|OPA1|opa1
5092066|NCT01249053|lung adenocarcinomas|lung adenocarcinomas
5092067|NCT01249053|Prognosis|prognosis
5092068|NCT01249053|Expression of optic atrophy type 1 (OPA1) protein in lung adenocarcinoma|expression of optic atrophy type 1 (opa1) protein in lung adenocarcinoma
5092069|NCT01249040|Frozen shoulder|frozen shoulder
5092070|NCT01249040|pain scale|pain scale
5092071|NCT01249040|range of motion(ROM)|range of motion(rom)
5092072|NCT01249040|muscle strength|muscle strength
5092073|NCT01249040|shoulder arthrography|shoulder arthrography
5092074|NCT01249027|Drug eluting stents|drug eluting stents
5092075|NCT01249027|Stents|stents
5092076|NCT01249027|China|china
5092077|NCT01249027|DES|des
5092078|NCT01249027|XIENCE V EECSS|xience v eecss
5092079|NCT01249001|pediatrics|pediatrics
5092080|NCT01249001|nausea|nausea
5092081|NCT01249001|vomiting|vomiting
5092082|NCT01249001|chemotherapy|chemotherapy
5092083|NCT01249001|antiemetic|antiemetic
5092084|NCT01248988|Pneumococcal vaccine|pneumococcal vaccine
5092085|NCT01248988|Safety|safety
5092086|NCT01248988|Synflorix|synflorix
5092087|NCT01248988|Pneumococcal diseases|pneumococcal diseases
5092088|NCT01248975|asthma|asthma
5092089|NCT01248975|GSK2190915|gsk2190915
5092090|NCT01248962|BEVACIZUMAB (AVASTIN)|bevacizumab (avastin)
5092091|NCT01248962|CARBOPLATIN|carboplatin
5092092|NCT01248962|DEXAMETHASONE|dexamethasone
5092093|NCT01248962|GEMCITABINE|gemcitabine
5092094|NCT01248962|LIPODOX(LIPOSOMAL DOXORUBICIN)|lipodox(liposomal doxorubicin)
5092095|NCT01248962|MONTELUKAST (SINGULAR)|montelukast (singular)
5092096|NCT01248962|TAXOL (PACLITAXEL|taxol (paclitaxel
5092097|NCT01248962|Fallopian Tubes|fallopian tubes
5092098|NCT01248962|10-184|10-184
5092099|NCT01248949|Advanced solid tumors|advanced solid tumors
5092100|NCT01248949|Advanced recurrent ovarian tumors|advanced recurrent ovarian tumors
5092101|NCT01248949|MEDI3617|medi3617
5092102|NCT01248949|Ang2|ang2
5092103|NCT01248949|Ovarian cancer|ovarian cancer
5092104|NCT01248949|Malignant glioma|malignant glioma
5092105|NCT01248923|relapsed multiple myeloma|relapsed multiple myeloma
5092106|NCT01248923|plasma cell dyscrasia|plasma cell dyscrasia
5092107|NCT01248923|plasmacytoma|plasmacytoma
5092108|NCT01248923|kinesin spindle protein|kinesin spindle protein
5092109|NCT01248923|anti-mitotic|anti-mitotic
5092110|NCT01248884|combination vaccine|combination vaccine
5092111|NCT01248884|Primary vaccination|primary vaccination
5092112|NCT01248871|renal|renal
5092113|NCT01248871|transplantation|transplantation
5092114|NCT01248871|Volatile|volatile
5092115|NCT01248871|anesthetic|anesthetic
5092116|NCT01248845|Mechanical ventilation|mechanical ventilation
5092117|NCT01248845|Electrical diaphragmatic activity|electrical diaphragmatic activity
5092118|NCT01248832|tobacco cessation|tobacco cessation
5092119|NCT01248832|smoking cessation|smoking cessation
5092120|NCT01248832|telephone|telephone
5092121|NCT01248832|self-help|self-help
5092122|NCT01248832|smoking abstinence|smoking abstinence
5092123|NCT01248832|tobacco use disorder|tobacco use disorder
5092124|NCT01248832|disparity|disparity
5092125|NCT01248819|Laparoscopic Cholecystectomy|laparoscopic cholecystectomy
5092126|NCT01248819|Nebulization|nebulization
5092127|NCT01248819|Ropivacaine|ropivacaine
5092128|NCT01248806|Lung nodule|lung nodule
5092129|NCT01248806|Screening|screening
5092130|NCT01248806|Spiral low - dose computed tomography|spiral low - dose computed tomography
5092131|NCT01248806|Lung cancer|lung cancer
5092132|NCT01248793|Ankylosing Sponylitis, injection, golimumab, simponi|ankylosing sponylitis, injection, golimumab, simponi
5092133|NCT01248780|Rheumatoid Arthritis|rheumatoid arthritis
5092134|NCT01248780|injection|injection
5092135|NCT01248780|golimumab|golimumab
5092136|NCT01248780|simponi|simponi
5092137|NCT01248767|Pathological gambling|pathological gambling
5092138|NCT01248767|"at risk gambling"|"at risk gambling"
5092139|NCT01248767|cohort|cohort
5092140|NCT01248767|cognitive distortions|cognitive distortions
5092141|NCT01248767|impulsivity|impulsivity
5092142|NCT01248767|psychiatric comorbidities|psychiatric comorbidities
5092143|NCT01248767|gambling trajectory|gambling trajectory
5092144|NCT01248767|gambling practice evolution|gambling practice evolution
5092145|NCT01248767|addiction|addiction
5092146|NCT01248754|Neurosurgery|neurosurgery
5092147|NCT01248754|Neuronavigation|neuronavigation
5092148|NCT01248754|Positron emission tomography|positron emission tomography
5092149|NCT01248754|FDOPA|fdopa
5092150|NCT01248741|prostate cancer|prostate cancer
5092151|NCT01248741|interstitial radiation,|interstitial radiation,
5092152|NCT01248741|brachytherapy|brachytherapy
5092153|NCT01248728|Autism Spectrum Disorder|autism spectrum disorder
5092154|NCT01248728|Clinical Trial|clinical trial
5092155|NCT01248728|Omega-3 Fatty Acids|omega-3 fatty acids
5092156|NCT01248728|Toddlers|toddlers
5092157|NCT01248715|pneumonia, bacterial|pneumonia, bacterial
5092158|NCT01248715|pneumonia, viral|pneumonia, viral
5092159|NCT01248715|respiratory tract infections|respiratory tract infections
5092160|NCT01248715|oseltamivir, therapeutic use|oseltamivir, therapeutic use
5092161|NCT01248702|Myocardial Infarction|myocardial infarction
5092162|NCT01248702|Heart Failure|heart failure
5092163|NCT01248702|Sudden Cardiac Death|sudden cardiac death
5092164|NCT01248702|Critical Pathways|critical pathways
5092165|NCT01248676|cancer radiation patient education|cancer radiation patient education
5092166|NCT01248663|pancreatic cancer|pancreatic cancer
5092167|NCT01248663|pylorus-preserving pancreaticoduodenectomy|pylorus-preserving pancreaticoduodenectomy
5092168|NCT01248663|delayed gastric emptying|delayed gastric emptying
5092169|NCT01248663|reconstruction|reconstruction
5092170|NCT01248650|Safety evaluation|safety evaluation
5092171|NCT01248650|Pharmacokinetic analysis|pharmacokinetic analysis
5092172|NCT01248637|pancreas|pancreas
5092173|NCT01248637|pancreatic cancer|pancreatic cancer
5092174|NCT01248637|pancreatic tumor|pancreatic tumor
5092175|NCT01248637|pimonidazole|pimonidazole
5092176|NCT01248637|hypoxia|hypoxia
5092177|NCT01248637|whipple's resection|whipple's resection
5092178|NCT01248624|Palliative Care|palliative care
5092179|NCT01248624|Quality of Life|quality of life
5092180|NCT01248624|Satisfaction with Care|satisfaction with care
5092181|NCT01248611|pain|pain
5092182|NCT01248611|adverse effects|adverse effects
5092183|NCT01248611|safety|safety
5092184|NCT01248611|feasibility|feasibility
5092185|NCT01248585|Symptom Control|symptom control
5092186|NCT01248572|Cataract|cataract
5092187|NCT01248572|Biaspheric intraocular lens|biaspheric intraocular lens
5092188|NCT01248572|Uniplanar intraocular lens|uniplanar intraocular lens
5092189|NCT01248572|Effective lens position|effective lens position
5092190|NCT01248546|Breast cancer|breast cancer
5092191|NCT01248546|Computer-aided detection|computer-aided detection
5092192|NCT01248546|Mammography screening|mammography screening
5092193|NCT01248546|Digital breast tomosynthesis|digital breast tomosynthesis
5092194|NCT01248533|Abdominal aortic aneurysm, atherosclerosis|abdominal aortic aneurysm, atherosclerosis
5092195|NCT01248520|Pregnancy|pregnancy
5092196|NCT01248520|Influenza Vaccination|influenza vaccination
5092197|NCT01248507|COPD|copd
5092198|NCT01248481|Acarbose/Glucobay®|acarbose/glucobay®
5092199|NCT01248481|Basal insulin|basal insulin
5092200|NCT01248481|PPG (Postprandial Glycaemia)|ppg (postprandial glycaemia)
5092201|NCT01248468|Pain, Migraine|pain, migraine
5092202|NCT01248455|Monoclonal Antibody|monoclonal antibody
5092203|NCT01248455|NK Cell Mediated Killing|nk cell mediated killing
5092204|NCT01248455|Response Rate|response rate
5092205|NCT01248455|Pharmacokinetics|pharmacokinetics
5092206|NCT01248455|Biological Activity|biological activity
5092207|NCT01248455|Smoldering Multiple Myeloma|smoldering multiple myeloma
5092208|NCT01248455|SMM|smm
5092209|NCT01248442|Vitamin D Deficiency|vitamin d deficiency
5092210|NCT01248442|Autoimmune disease|autoimmune disease
5092211|NCT01248442|Diabetes|diabetes
5092212|NCT01248429|thyrosine kinase inhibitor|thyrosine kinase inhibitor
5092213|NCT01248429|phosphokinase creatinin|phosphokinase creatinin
5092214|NCT01248429|myalgia|myalgia
5092217|NCT01248416|Letrozole|letrozole
5092218|NCT01248416|Anastrozole|anastrozole
5092219|NCT01248416|GH|gh
5092220|NCT01248416|Children|children
5092221|NCT01248416|Puberty|puberty
5092222|NCT01248403|RAD001|rad001
5092223|NCT01248403|Paclitaxel|paclitaxel
5092224|NCT01248403|gastric cancer|gastric cancer
5092225|NCT01248403|advanced gastric or esophagogastric junction cancer|advanced gastric or esophagogastric junction cancer
5092226|NCT01248390|traumatic brain injury|traumatic brain injury
5092227|NCT01248390|post-concussion|post-concussion
5092228|NCT01248377|Cephalosporins|cephalosporins
5092229|NCT01248377|Drug hypersensitivity|drug hypersensitivity
5092230|NCT01248351|aspirin, clopidogrel, pharmacodynamics, platelet transfusion|aspirin, clopidogrel, pharmacodynamics, platelet transfusion
5092231|NCT01248299|Chemotherapy|chemotherapy
5092232|NCT01248299|Best Supportive Care|best supportive care
5092233|NCT01248286|Diabetes|diabetes
5092234|NCT01248286|Prediabetes|prediabetes
5092235|NCT01248286|Prevention|prevention
5092236|NCT01248286|Whole grain|whole grain
5092237|NCT01248286|Advanced glycation end products|advanced glycation end products
5092238|NCT01248286|Insulin sensitivity|insulin sensitivity
5092239|NCT01248273|GLOBO H-KLH CONJUGATE|globo h-klh conjugate
5092240|NCT01248273|MUC-1 KLH|muc-1 klh
5092241|NCT01248273|QS-21|qs-21
5092242|NCT01248273|TF(C)-KLH|tf(c)-klh
5092243|NCT01248273|TN(C)-KLH|tn(c)-klh
5092244|NCT01248273|Immunization|immunization
5092245|NCT01248273|Vaccine|vaccine
5092246|NCT01248273|09-184|09-184
5092247|NCT01248260|Fetal body size|fetal body size
5092248|NCT01248260|Fetal brain size|fetal brain size
5092249|NCT01248260|Folic acid|folic acid
5092250|NCT01248247|Non small cell lung cancer|non small cell lung cancer
5092251|NCT01248247|Biopsy accessible tumor|biopsy accessible tumor
5092252|NCT01248247|Stage IIIB non small cell lung cancer|stage iiib non small cell lung cancer
5092253|NCT01248247|Stage IV non small cell lung cancer|stage iv non small cell lung cancer
5092254|NCT01248234|elderly|elderly
5092255|NCT01248234|hypertensive|hypertensive
5092256|NCT01248234|anesthesia|anesthesia
5092257|NCT01248221|Breath test|breath test
5092258|NCT01248221|Dyspepsia|dyspepsia
5092259|NCT01248221|Gastric Emptying|gastric emptying
5092260|NCT01248221|Gastroparesis|gastroparesis
5092261|NCT01248208|egg allergy|egg allergy
5092262|NCT01248208|influenza vaccine|influenza vaccine
5092263|NCT01248195|Schizophrenia|schizophrenia
5092264|NCT01248195|Schizophreniform disorder|schizophreniform disorder
5092265|NCT01248195|Schizoaffective disorder|schizoaffective disorder
5092266|NCT01248195|Imaging|imaging
5092267|NCT01248195|Prognosis|prognosis
5092268|NCT01248195|Treatment guidelines|treatment guidelines
5092269|NCT01248195|Pharmacogenetics|pharmacogenetics
5092270|NCT01248182|acetabular fracture|acetabular fracture
5092271|NCT01248182|pelvic ring injury|pelvic ring injury
5092272|NCT01248143|Green Tea|green tea
5092273|NCT01248143|Fermented papaya preparation|fermented papaya preparation
5092274|NCT01248143|Diabetes|diabetes
5092275|NCT01248143|Cardiovascular diseases|cardiovascular diseases
5092276|NCT01248143|Atherosclerotic plaques|atherosclerotic plaques
5092277|NCT01248143|Glucose|glucose
5092278|NCT01248143|Dietary supplements and functional foods|dietary supplements and functional foods
5092279|NCT01248130|Omega-3 Fatty Acid|omega-3 fatty acid
5092280|NCT01248130|Autism Spectrum Disorders|autism spectrum disorders
5092281|NCT01248130|Pervasive Developmental Disorders|pervasive developmental disorders
5092282|NCT01248130|Children|children
5092283|NCT01248130|Cognitive Functioning|cognitive functioning
5092284|NCT01248117|PCV|pcv
5092285|NCT01248117|polypoidal|polypoidal
5092286|NCT01248117|choroidal|choroidal
5092287|NCT01248117|vasculopathy|vasculopathy
5092288|NCT01248104|Cardiac Surgery|cardiac surgery
5092289|NCT01248104|Antifibrinolytic agents|antifibrinolytic agents
5092290|NCT01248104|Blood transfusion|blood transfusion
5092291|NCT01248104|epsilon aminocaproic acid|epsilon aminocaproic acid
5092292|NCT01248104|tranexamic acid|tranexamic acid
5092293|NCT01248091|IUD, Insertion, Decrease, Pain|iud, insertion, decrease, pain
5092294|NCT01248078|elective cesarean section|elective cesarean section
5092295|NCT01248078|antibiotic prophylaxis|antibiotic prophylaxis
5092296|NCT01248078|cefazoline|cefazoline
5092297|NCT01248078|wound infection|wound infection
5092298|NCT01248065|Asthma|asthma
5092299|NCT01248065|Vitamin D|vitamin d
5092300|NCT01248065|Corticosteroids|corticosteroids
5092301|NCT01248065|Treatment failure|treatment failure
5092302|NCT01248039|Muscle strength, functional performance, joint replacement|muscle strength, functional performance, joint replacement
5092303|NCT01248026|Cardiovascular disease|cardiovascular disease
5092304|NCT01248026|Buttermilk|buttermilk
5092305|NCT01248026|Blood lipids|blood lipids
5092306|NCT01248026|Cholesterol absorption|cholesterol absorption
5092307|NCT01248026|Cholesterol synthesis|cholesterol synthesis
5092308|NCT01248000|Hodgkin lymphoma|hodgkin lymphoma
5092309|NCT01248000|FDG-PET|fdg-pet
5092310|NCT01248000|prognostic factor|prognostic factor
5092311|NCT01248000|clinical trial|clinical trial
5092312|NCT01247987|IVF, assisted reproduction, embryo transfer|ivf, assisted reproduction, embryo transfer
5092313|NCT01247974|Coronary Artery Bypass Grafting|coronary artery bypass grafting
5092504|NCT01247207|Ataluren|ataluren
5092314|NCT01247974|New Onset Postoperative Atrial Fibrillation|new onset postoperative atrial fibrillation
5092315|NCT01247948|pedicle screw of fixation operation|pedicle screw of fixation operation
5092316|NCT01247948|spine surgery|spine surgery
5092317|NCT01247948|navigation assisted|navigation assisted
5092318|NCT01247935|Pain|pain
5092319|NCT01247935|Acupuncture|acupuncture
5092320|NCT01247935|Transcutaneous electrical nerve stimulation|transcutaneous electrical nerve stimulation
5092321|NCT01247935|Colonoscopy|colonoscopy
5092322|NCT01247922|Pediatric Ependymoma|pediatric ependymoma
5092323|NCT01247922|Ependymoma|ependymoma
5092324|NCT01247922|Erlotinib|erlotinib
5092325|NCT01247922|Tarceva|tarceva
5092326|NCT01247883|Phase 1|phase 1
5092327|NCT01247883|relative bioavailability|relative bioavailability
5092328|NCT01247883|healthy volunteers|healthy volunteers
5092329|NCT01247883|pharmacokinetics|pharmacokinetics
5092330|NCT01247883|solution|solution
5092331|NCT01247883|tablet|tablet
5092332|NCT01247870|Chronic obstructive pulmonary disease, COPD, metformin|chronic obstructive pulmonary disease, copd, metformin
5092333|NCT01247857|Laparoscopic Cholecystectomy|laparoscopic cholecystectomy
5092334|NCT01247857|Nebulization|nebulization
5092335|NCT01247857|Ropivacaine|ropivacaine
5092336|NCT01247844|adult Males|adult males
5092337|NCT01247844|circumcision|circumcision
5092338|NCT01247844|HIV prevention|hiv prevention
5092339|NCT01247844|device|device
5092340|NCT01247831|glaucoma, selective laser trabeculoplasty, ocular rigidity|glaucoma, selective laser trabeculoplasty, ocular rigidity
5092341|NCT01247805|Bioequivalence|bioequivalence
5092342|NCT01247805|Powder for oral suspention|powder for oral suspention
5092343|NCT01247792|sepsis|sepsis
5092344|NCT01247792|organ failure|organ failure
5092345|NCT01247792|end-of-life decisions|end-of-life decisions
5092346|NCT01247792|patient-centered communication|patient-centered communication
5092347|NCT01247779|gynecology|gynecology
5092348|NCT01247779|oncology|oncology
5092349|NCT01247779|coelioscopy|coelioscopy
5092350|NCT01247779|robot|robot
5092351|NCT01247779|morbidity|morbidity
5092352|NCT01247727|Heart rate variability|heart rate variability
5092353|NCT01247727|extracorporeal membrane oxygenation|extracorporeal membrane oxygenation
5092354|NCT01247714|T-Diet plus Diabet NP|t-diet plus diabet np
5092355|NCT01247714|Diabetic|diabetic
5092356|NCT01247714|Enteral Nutrition|enteral nutrition
5092357|NCT01247714|Glycaemic response|glycaemic response
5092358|NCT01247714|Metabolic Syndrome|metabolic syndrome
5092359|NCT01247714|Insulin resistance|insulin resistance
5092360|NCT01247714|Lipidic profile|lipidic profile
5092361|NCT01247701|UCB|ucb
5092362|NCT01247701|Umbilical Cord Blood|umbilical cord blood
5092363|NCT01247701|Transplant|transplant
5092364|NCT01247701|Umbilical Cord Blood Transplant|umbilical cord blood transplant
5092365|NCT01247701|Cord Blood Stem Cell Transplantation|cord blood stem cell transplantation
5092366|NCT01247701|Pediatric|pediatric
5092367|NCT01247701|Myeloid Hematological Malignancies|myeloid hematological malignancies
5092368|NCT01247701|Busulfan|busulfan
5092369|NCT01247701|Cytoxan|cytoxan
5092370|NCT01247701|Cyclophosphamide|cyclophosphamide
5092371|NCT01247701|Fludarabine|fludarabine
5092372|NCT01247688|Lymphoid|lymphoid
5092373|NCT01247688|hematologic malignancy|hematologic malignancy
5092374|NCT01247688|UCB|ucb
5092375|NCT01247688|Umbilical Cord Blood Transplant|umbilical cord blood transplant
5092376|NCT01247688|Total Body Irradiation|total body irradiation
5092377|NCT01247688|Cytoxan|cytoxan
5092378|NCT01247688|Cyclophosphamide|cyclophosphamide
5092379|NCT01247688|Fludarabine|fludarabine
5092380|NCT01247662|Autism spectrum disorder|autism spectrum disorder
5092381|NCT01247662|Social Responsiveness Scale|social responsiveness scale
5092382|NCT01247662|Childhood Asperger's Syndrome Test|childhood asperger's syndrome test
5092383|NCT01247662|Adult Autism Spectrum Quotient|adult autism spectrum quotient
5092384|NCT01247662|psychometric|psychometric
5092385|NCT01247649|Continuous glucose monitoring system|continuous glucose monitoring system
5092386|NCT01247649|Non invasive|non invasive
5092387|NCT01247649|Type 1 diabetes|type 1 diabetes
5092388|NCT01247649|Dielectric spectroscopy|dielectric spectroscopy
5092389|NCT01247636|HLRQ|hlrq
5092390|NCT01247636|Elderly|elderly
5092391|NCT01247636|Balance|balance
5092392|NCT01247636|Mobility|mobility
5092393|NCT01247636|Fear of falling|fear of falling
5092394|NCT01247623|Non-resectable, advanced malignant melanoma.|non-resectable, advanced malignant melanoma.
5092395|NCT01247597|Thyroid Cancer|thyroid cancer
5092396|NCT01247597|Germline DICER1 Mutation|germline dicer1 mutation
5092397|NCT01247597|MicroRNA Biogenesis|microrna biogenesis
5092398|NCT01247597|Pleuropulmonary Blastoma|pleuropulmonary blastoma
5092399|NCT01247597|PPB|ppb
5092400|NCT01247584|childhood acute myeloid leukemia/other myeloid malignancies|childhood acute myeloid leukemia/other myeloid malignancies
5092401|NCT01247584|childhood acute erythroleukemia (M6)|childhood acute erythroleukemia (m6)
5092402|NCT01247584|childhood acute megakaryocytic leukemia (M7)|childhood acute megakaryocytic leukemia (m7)
5092403|NCT01247584|childhood acute monoblastic leukemia (M5a)|childhood acute monoblastic leukemia (m5a)
5092404|NCT01247584|childhood acute monocytic leukemia (M5b)|childhood acute monocytic leukemia (m5b)
5092405|NCT01247584|childhood acute myeloblastic leukemia without maturation (M1)|childhood acute myeloblastic leukemia without maturation (m1)
5092505|NCT01247207|PTC124|ptc124
5092406|NCT01247584|childhood acute myelomonocytic leukemia (M4)|childhood acute myelomonocytic leukemia (m4)
5092407|NCT01247584|childhood acute myeloblastic leukemia with maturation (M2)|childhood acute myeloblastic leukemia with maturation (m2)
5092408|NCT01247558|Metanx®|metanx®
5092409|NCT01247558|diabetes|diabetes
5092410|NCT01247558|neuropathy|neuropathy
5092411|NCT01247558|peripheral neurological disorder|peripheral neurological disorder
5092412|NCT01247558|peripheral circulation disorder|peripheral circulation disorder
5092413|NCT01247558|folic acid|folic acid
5092414|NCT01247558|folate|folate
5092415|NCT01247558|L-methylfolate|l-methylfolate
5092416|NCT01247558|vitamin B6|vitamin b6
5092417|NCT01247558|Pyridoxal 5'-phosphate|pyridoxal 5'-phosphate
5092418|NCT01247558|vitamin B12|vitamin b12
5092419|NCT01247558|methylcobalamin|methylcobalamin
5092420|NCT01247545|Remote ischemic preconditioning|remote ischemic preconditioning
5092421|NCT01247545|Coronary artery bypass graft surgery|coronary artery bypass graft surgery
5092422|NCT01247545|Cardioprotection|cardioprotection
5092423|NCT01247545|Clinical Outcomes|clinical outcomes
5092424|NCT01247532|Cancer|cancer
5092425|NCT01247532|Fatigue|fatigue
5092426|NCT01247532|Mindfulness|mindfulness
5092427|NCT01247532|Meditation|meditation
5092428|NCT01247532|Neoplasms|neoplasms
5092429|NCT01247506|microRNA|microrna
5092430|NCT01247493|fludarabine|fludarabine
5092431|NCT01247493|AML|aml
5092432|NCT01247493|Efficacy|efficacy
5092433|NCT01247493|tolerability|tolerability
5092434|NCT01247454|CVD|cvd
5092435|NCT01247454|primary prevention|primary prevention
5092436|NCT01247454|ASA|asa
5092437|NCT01247454|physician behavioral change|physician behavioral change
5092438|NCT01247454|Patient behavioral change|patient behavioral change
5092439|NCT01247441|All breast cancer patients who were diagnosed or managed in NUH will be included into this registry|all breast cancer patients who were diagnosed or managed in nuh will be included into this registry
5092440|NCT01247428|Coronary Artery Disease|coronary artery disease
5092441|NCT01247428|Drug-eluting Stent|drug-eluting stent
5092442|NCT01247428|Sirolimus|sirolimus
5092443|NCT01247415|anaphylaxis|anaphylaxis
5092444|NCT01247415|allergy|allergy
5092445|NCT01247415|IgE mediated|ige mediated
5092446|NCT01247415|ORS|ors
5092447|NCT01247415|oculorespiratory syndrome|oculorespiratory syndrome
5092448|NCT01247415|Allergic-like reactions|allergic-like reactions
5092449|NCT01247415|H1N1|h1n1
5092450|NCT01247415|Arepanrix|arepanrix
5092451|NCT01247402|peripheral arterial disease|peripheral arterial disease
5092452|NCT01247402|in-stent restenosis|in-stent restenosis
5092453|NCT01247402|drug eluting balloon|drug eluting balloon
5092454|NCT01247389|laparoscopy|laparoscopy
5092455|NCT01247389|colon resection|colon resection
5092456|NCT01247389|incisional hernia|incisional hernia
5092457|NCT01247376|inflammation|inflammation
5092458|NCT01247376|arthroscopy|arthroscopy
5092459|NCT01247376|knee|knee
5092460|NCT01247376|microdialysis|microdialysis
5092461|NCT01247363|Diabetes glucokinase safety|diabetes glucokinase safety
5092462|NCT01247311|Vitamin D|vitamin d
5092463|NCT01247311|pulse wave velocity|pulse wave velocity
5092464|NCT01247298|Hepatocellular Carcinoma (HCC)|hepatocellular carcinoma (hcc)
5092465|NCT01247298|Trans-Arterial Chemobolizaion (TACE)|trans-arterial chemobolizaion (tace)
5092466|NCT01247298|Radiation Induced Liver Disease (RILD)|radiation induced liver disease (rild)
5092467|NCT01247298|Stereotactic Body Radiation Therapy (SBRT)|stereotactic body radiation therapy (sbrt)
5092468|NCT01247285|Bioequivalence|bioequivalence
5092469|NCT01247285|Healthy Subjects|healthy subjects
5092470|NCT01247272|Bioequivalence|bioequivalence
5092471|NCT01247272|Healthy Subjects|healthy subjects
5092472|NCT01247259|allergic rhinitis|allergic rhinitis
5092473|NCT01247259|immunotherapy|immunotherapy
5092474|NCT01247259|sublingual|sublingual
5092475|NCT01247246|Oral Mucositis|oral mucositis
5092476|NCT01247246|Head and Neck|head and neck
5092477|NCT01247246|Head and Neck Neoplasms|head and neck neoplasms
5092478|NCT01247246|Mucositis|mucositis
5092479|NCT01247246|Stomatitis|stomatitis
5092480|NCT01247246|Neoplasms by Site|neoplasms by site
5092481|NCT01247246|Neoplasms|neoplasms
5092482|NCT01247246|Gastroenteritis|gastroenteritis
5092483|NCT01247246|Gastrointestinal Diseases|gastrointestinal diseases
5092484|NCT01247246|Digestive System Diseases|digestive system diseases
5092485|NCT01247246|Mouth Diseases|mouth diseases
5092486|NCT01247246|Stomatognathic Diseases|stomatognathic diseases
5092487|NCT01247246|SCV-07|scv-07
5092488|NCT01247233|breast cancer|breast cancer
5092489|NCT01247233|Accelerated Partial Breast Irradiation|accelerated partial breast irradiation
5092490|NCT01247233|invasive cancer|invasive cancer
5092491|NCT01247233|Hypofractionated Irradiation|hypofractionated irradiation
5092492|NCT01247233|Lumpectomy|lumpectomy
5092493|NCT01247220|Macular Edema|macular edema
5092494|NCT01247220|Branch retinal vein occlusion|branch retinal vein occlusion
5092495|NCT01247220|Ranibizumab|ranibizumab
5092496|NCT01247207|Duchenne muscular dystrophy|duchenne muscular dystrophy
5092497|NCT01247207|Becker muscular dystrophy|becker muscular dystrophy
5092498|NCT01247207|Nonsense mutation|nonsense mutation
5092499|NCT01247207|Premature stop codon|premature stop codon
5092500|NCT01247207|DMD|dmd
5092501|NCT01247207|BMD|bmd
5092502|NCT01247207|nmDBMD|nmdbmd
5092503|NCT01247207|DBMD|dbmd
5092506|NCT01247194|hepatitis C|hepatitis c
5092507|NCT01247194|NS5A|ns5a
5092508|NCT01247194|HCV RNA|hcv rna
5092509|NCT01247181|compliance|compliance
5092510|NCT01247181|observance|observance
5092511|NCT01247181|mobile phone|mobile phone
5092512|NCT01247181|SMS|sms
5092513|NCT01247181|text message|text message
5092514|NCT01247181|ARV|arv
5092515|NCT01247181|HAART|haart
5092516|NCT01247181|AIDS|aids
5092517|NCT01247168|Refractory|refractory
5092518|NCT01247168|Solid tumors|solid tumors
5092519|NCT01247168|Cancer|cancer
5092520|NCT01247142|invasive pulmonary aspergillosis|invasive pulmonary aspergillosis
5092521|NCT01247142|exhaled breath condensate|exhaled breath condensate
5092522|NCT01247129|Superficial inferior epigastric artery flap, delay phenomenon|superficial inferior epigastric artery flap, delay phenomenon
5092523|NCT01247103|healthy volunteers|healthy volunteers
5092524|NCT01247103|safety|safety
5092525|NCT01247103|tolerability|tolerability
5092526|NCT01247090|hypertension|hypertension
5092527|NCT01247090|end stage renal disease|end stage renal disease
5092528|NCT01247090|vasopressin|vasopressin
5092529|NCT01247090|Arginine Vasopressin|arginine vasopressin
5092530|NCT01247090|AVP|avp
5092531|NCT01247090|Pitressin®|pitressin®
5092532|NCT01247077|selenium|selenium
5092533|NCT01247077|neuropsychological testing|neuropsychological testing
5092534|NCT01247077|autoantibodies|autoantibodies
5092535|NCT01247064|Bronchiolitis|bronchiolitis
5092536|NCT01247064|Hypertonic Saline|hypertonic saline
5092537|NCT01247051|priming|priming
5092538|NCT01247051|cardiac surgery|cardiac surgery
5092539|NCT01247051|cardio pulmonary bypass|cardio pulmonary bypass
5092540|NCT01247051|precoating|precoating
5092541|NCT01246999|Influenza|influenza
5092542|NCT01246999|A/California/7/2009-like (2009 H1N1)|a/california/7/2009-like (2009 h1n1)
5092543|NCT01246999|A/Perth/16/2009-like (H3N2)|a/perth/16/2009-like (h3n2)
5092544|NCT01246999|B/Brisbane/60/2008-like (B/Victoria lineage)|b/brisbane/60/2008-like (b/victoria lineage)
5092545|NCT01246973|Oral Curcumin|oral curcumin
5092546|NCT01246973|Radiation Dermatitis|radiation dermatitis
5092547|NCT01246973|Breast Cancer Patients|breast cancer patients
5092548|NCT01246960|cancer|cancer
5092549|NCT01246960|stomach|stomach
5092550|NCT01246960|esophagus|esophagus
5092551|NCT01246960|gastroesophageal|gastroesophageal
5092552|NCT01246947|Moderate Tricuspid Valve Regurgitation|moderate tricuspid valve regurgitation
5092553|NCT01246947|Tricuspid Valve Repair|tricuspid valve repair
5092554|NCT01246947|Mitral Value Surgery|mitral value surgery
5092555|NCT01246921|Vitiligo, repigmentation, satisfaction|vitiligo, repigmentation, satisfaction
5092556|NCT01246908|TRD|trd
5092557|NCT01246895|Cartilage repair|cartilage repair
5092558|NCT01246895|Cartilage|cartilage
5092559|NCT01246895|Knee|knee
5092560|NCT01246895|Knee Pain|knee pain
5092561|NCT01246895|Microfracture|microfracture
5092562|NCT01246895|Arthroscopy|arthroscopy
5092563|NCT01246895|Bone Marrow Stimulation|bone marrow stimulation
5092564|NCT01246895|Chondrogenesis|chondrogenesis
5092565|NCT01246895|Scaffold|scaffold
5092566|NCT01246895|Chitosan|chitosan
5092567|NCT01246895|Articular Cartilage Repair|articular cartilage repair
5092568|NCT01246882|Stroke, gait, walking, disability|stroke, gait, walking, disability
5092569|NCT01246882|wireless inertial sensing|wireless inertial sensing
5092570|NCT01246882|mobile health|mobile health
5092571|NCT01246869|brain, cancer,glioblastoma multiforme, meningioma, glioma|brain, cancer,glioblastoma multiforme, meningioma, glioma
5092572|NCT01246856|Cardiotoxicity|cardiotoxicity
5092573|NCT01246856|Breast cancer treatment|breast cancer treatment
5092574|NCT01246856|MIBG scintigraphy|mibg scintigraphy
5092575|NCT01246856|Strain Echocardiography|strain echocardiography
5092576|NCT01246856|patients who have been treated with TAC one year previously|patients who have been treated with tac one year previously
5092577|NCT01246843|sunitinib|sunitinib
5092578|NCT01246843|sorafenib|sorafenib
5092579|NCT01246843|cognitive functioning|cognitive functioning
5092580|NCT01246817|Carcinoma, Renal Cell|carcinoma, renal cell
5092581|NCT01246817|temsirolimus|temsirolimus
5092583|NCT01246817|FDG-PET|fdg-pet
5092584|NCT01246817|Adult patients with metastatic RCC (any histology and any MSKCC prognostic score), with documented|adult patients with metastatic rcc (any histology and any mskcc prognostic score), with documented
5092585|NCT01246817|progressive disease after more than two prior systemic treatments with any of the following: cytokines (±|progressive disease after more than two prior systemic treatments with any of the following: cytokines (±
5092586|NCT01246817|chemotherapy), sunitinib, sorafenib, or bevacizumab (± IFN).|chemotherapy), sunitinib, sorafenib, or bevacizumab (± ifn).
5092587|NCT01246804|HIV infections|hiv infections
5092588|NCT01246804|interaction|interaction
5092589|NCT01246804|pharmacokinetics|pharmacokinetics
5092590|NCT01246791|NPC-01|npc-01
5092591|NCT01246791|Pharmacokinetics|pharmacokinetics
5092592|NCT01246791|Healthy female volunteer|healthy female volunteer
5092593|NCT01246791|Norethisterone|norethisterone
5092594|NCT01246791|Ethinyl Estradiol|ethinyl estradiol
5092595|NCT01246765|Atypical Antipsychotics and pregnancy|atypical antipsychotics and pregnancy
5092596|NCT01246765|Pregnancy|pregnancy
5092597|NCT01246765|Medication use during pregnancy|medication use during pregnancy
5092598|NCT01246752|AML, Leukemia|aml, leukemia
5092599|NCT01246752|Acute Myeloid Leukemia|acute myeloid leukemia
5092600|NCT01246752|HSCT|hsct
5092601|NCT01246752|Stem Cell Transplantation|stem cell transplantation
5092602|NCT01246752|Tx|tx
5092603|NCT01246752|Chemotherapy|chemotherapy
5092604|NCT01246739|mild hypercortisolism|mild hypercortisolism
5092605|NCT01246739|adrenal tumour|adrenal tumour
5092606|NCT01246739|surgical procedures, elective|surgical procedures, elective
5092607|NCT01246739|indication|indication
5092608|NCT01246726|cancer, breast, radiotherapy, boost|cancer, breast, radiotherapy, boost
5092609|NCT01246713|acetaminophen|acetaminophen
5092610|NCT01246713|excipients|excipients
5092611|NCT01246700|Parkinson's disease|parkinson's disease
5092612|NCT01246700|Randomized single-blind crossover trial|randomized single-blind crossover trial
5092613|NCT01246700|Sensory Attention Focused Exercise|sensory attention focused exercise
5092614|NCT01246674|function, hip muscle strength, hip replacement, hip pain,|function, hip muscle strength, hip replacement, hip pain,
5092615|NCT01246609|acid base balance|acid base balance
5092616|NCT01246609|Percutaneous Lithotripsy|percutaneous lithotripsy
5092617|NCT01246583|Multi Site|multi site
5092618|NCT01246583|Randomized|randomized
5092619|NCT01246583|Placebo Controlled|placebo controlled
5092620|NCT01246583|Double Blind|double blind
5092621|NCT01246583|Parallel Group|parallel group
5092622|NCT01246583|chronic plaque psoriasis|chronic plaque psoriasis
5092623|NCT01246583|topical treatment|topical treatment
5092624|NCT01246583|skin diseases|skin diseases
5092625|NCT01246583|papulosquamous|papulosquamous
5092626|NCT01246570|exercise|exercise
5092627|NCT01246570|heart|heart
5092628|NCT01246570|coronary disease|coronary disease
5092629|NCT01246570|rehabilitation|rehabilitation
5092630|NCT01246557|Patients with Chronic Lymphatic Leukemia relapsing or resistant to treatment|patients with chronic lymphatic leukemia relapsing or resistant to treatment
5092631|NCT01246544|Patient Safety|patient safety
5092632|NCT01246544|The Helsinki Declaration on Patient Safety in Anaesthesiology|the helsinki declaration on patient safety in anaesthesiology
5092633|NCT01246544|Helsinki Declaration on Patient Safety|helsinki declaration on patient safety
5092634|NCT01246544|European Board of Anaesthesiology (EBA)|european board of anaesthesiology (eba)
5092635|NCT01246544|European Society of Anaesthesiology (ESA)|european society of anaesthesiology (esa)
5092636|NCT01246531|Urolithiasis|urolithiasis
5092637|NCT01246531|Renal calculi|renal calculi
5092638|NCT01246531|Aging|aging
5092639|NCT01246531|Osteoporosis|osteoporosis
5092640|NCT01246518|distal subungual onychomycosis|distal subungual onychomycosis
5092641|NCT01246466|Persistent Atrial Fibrillation, Longstanding Persistent Atrial Fibrillation, Ablation, catheter ablation|persistent atrial fibrillation, longstanding persistent atrial fibrillation, ablation, catheter ablation
5092642|NCT01246427|Adjuvant hormonal therapy|adjuvant hormonal therapy
5092643|NCT01246427|Homeopathic treatment|homeopathic treatment
5092644|NCT01246427|Hot flashes|hot flashes
5092645|NCT01246427|Quality of life|quality of life
5092646|NCT01246427|Hot flash score|hot flash score
5092647|NCT01246414|Asthma|asthma
5092648|NCT01246414|Exhaled breath condensates|exhaled breath condensates
5092649|NCT01246414|Cytokines|cytokines
5092650|NCT01246388|Fibrosis|fibrosis
5092651|NCT01246388|Steatosis|steatosis
5092652|NCT01246388|Liver biopsy|liver biopsy
5092653|NCT01246388|Elastography|elastography
5092654|NCT01246388|MRI|mri
5092655|NCT01246349|Motivational Interviewing|motivational interviewing
5092656|NCT01246349|Child and Adolescent Self-Efficacy|child and adolescent self-efficacy
5092657|NCT01246349|Health Behaviours|health behaviours
5092658|NCT01246336|Parkinson's disease, Parkinsonism|parkinson's disease, parkinsonism
5092659|NCT01246336|Biomarkers|biomarkers
5092660|NCT01246336|Exhaled breath|exhaled breath
5092661|NCT01246336|Nanothechnology|nanothechnology
5092662|NCT01246323|Visual analogue scale|visual analogue scale
5092663|NCT01246323|pain level|pain level
5092664|NCT01246323|analgesia|analgesia
5092665|NCT01246323|combined anesthesia|combined anesthesia
5092666|NCT01246284|Alopecia areata|alopecia areata
5092667|NCT01246284|Intralesional|intralesional
5092668|NCT01246284|Triamcinolone acetonide|triamcinolone acetonide
5092669|NCT01246284|Concentration|concentration
5092670|NCT01246258|primary ciliary dyskinesia|primary ciliary dyskinesia
5092671|NCT01246258|otolith|otolith
5092672|NCT01246258|vestibular tests|vestibular tests
5092673|NCT01246245|PIN SITE INFECTION AFTER EXTERNAL FIXATION|pin site infection after external fixation
5092674|NCT01246219|Idiopathic Short stature|idiopathic short stature
5092675|NCT01246219|Self Image|self image
5092676|NCT01246219|GH therapy|gh therapy
5092677|NCT01246219|Psychological distress|psychological distress
5092678|NCT01246206|● Non-Hodgkin lymphoma,|● non-hodgkin lymphoma,
5092679|NCT01246206|● Hodgkin disease,|● hodgkin disease,
5092680|NCT01246206|● Acute Myelogenous or Acute Lymphocytic Leukemia|● acute myelogenous or acute lymphocytic leukemia
5092681|NCT01246206|● Myelodysplastic Syndromes,|● myelodysplastic syndromes,
5092682|NCT01246206|● Chronic Myelogenous Leukemia|● chronic myelogenous leukemia
5092683|NCT01246206|● Multiple Myeloma|● multiple myeloma
5092684|NCT01246206|● Chronic Lymphocytic Leukemia|● chronic lymphocytic leukemia
5092685|NCT01246206|● Myelofibrosis and other myeloproliferative disorders;|● myelofibrosis and other myeloproliferative disorders;
5092686|NCT01246193|CKD-828|ckd-828
5092687|NCT01246193|Hypertension|hypertension
5092688|NCT01246193|Primary Hypertension|primary hypertension
5092689|NCT01246193|Healthy Volunteer|healthy volunteer
5092690|NCT01246193|S-Amlodipine|s-amlodipine
5092691|NCT01246193|Telmisartan|telmisartan
5092692|NCT01246193|Amlodipine|amlodipine
5092693|NCT01246193|Pharmacokinetic|pharmacokinetic
5092694|NCT01246193|Phase 1|phase 1
5092695|NCT01246180|Skin, microcirculation; ASIC, pressure ulcer|skin, microcirculation; asic, pressure ulcer
5092696|NCT01246167|Proximal humerus fracture|proximal humerus fracture
5092697|NCT01246167|conservative|conservative
5092698|NCT01246167|locking plate|locking plate
5092699|NCT01246167|Philos|philos
5092700|NCT01246167|Hemiprosthesis|hemiprosthesis
5092701|NCT01246154|ASTHMA|asthma
5092702|NCT01246141|tricuspid valve regurgitation|tricuspid valve regurgitation
5092703|NCT01246141|replacement|replacement
5092704|NCT01246141|repair|repair
5092705|NCT01246141|outcomes|outcomes
5092706|NCT01246128|Nicotinic Acetylcholine Receptors|nicotinic acetylcholine receptors
5092707|NCT01246128|Schizophrenia Smokers|schizophrenia smokers
5092708|NCT01246128|PET Imaging|pet imaging
5092709|NCT01246102|Targeted Therapy|targeted therapy
5092710|NCT01246102|HER2 Positive Cancer|her2 positive cancer
5092711|NCT01246102|Cancer|cancer
5092712|NCT01246102|Solid Tumor|solid tumor
5092713|NCT01246102|Breast Cancer|breast cancer
5092714|NCT01246089|Ranibizumab|ranibizumab
5092715|NCT01246089|Myopia|myopia
5092716|NCT01246089|Complications|complications
5092717|NCT01246089|Neovascularization|neovascularization
5092718|NCT01246089|OCT|oct
5092719|NCT01246050|Heart Failure|heart failure
5092720|NCT01246050|Outcome Assessment|outcome assessment
5092721|NCT01246050|Congestive Heart Failure|congestive heart failure
5092722|NCT01246037|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
5092723|NCT01246037|Beta-blocker|beta-blocker
5092724|NCT01246037|Adrenergic Receptor Antagonist|adrenergic receptor antagonist
5092725|NCT01245998|Thrombophlebitis|thrombophlebitis
5092726|NCT01245998|Venous thrombosis|venous thrombosis
5092727|NCT01245998|Pulmonary embolism|pulmonary embolism
5092728|NCT01245998|Anticoagulants|anticoagulants
5092729|NCT01245998|Low-Molecular-Weight Heparin|low-molecular-weight heparin
5092730|NCT01245985|SCCHN|scchn
5092731|NCT01245985|squamous cell carcinoma of the head and neck|squamous cell carcinoma of the head and neck
5092732|NCT01245985|oropharyngeal carcinoma|oropharyngeal carcinoma
5092733|NCT01245985|hypopharyngeal carcinoma|hypopharyngeal carcinoma
5092734|NCT01245985|laryngeal carcinoma|laryngeal carcinoma
5092735|NCT01245972|pulsed dye laser|pulsed dye laser
5092736|NCT01245972|PDL|pdl
5092737|NCT01245972|basal cell carcinoma|basal cell carcinoma
5092738|NCT01245972|squamous cell carcinoma|squamous cell carcinoma
5092739|NCT01245972|BCC|bcc
5092740|NCT01245972|SCC|scc
5092741|NCT01245972|594nM laser|594nm laser
5092742|NCT01245959|Nasopharyngeal carcinoma|nasopharyngeal carcinoma
5092743|NCT01245959|Concurrent chemoradiotherapy|concurrent chemoradiotherapy
5092744|NCT01245959|Induction chemotherapy|induction chemotherapy
5092745|NCT01245959|Clinical trial|clinical trial
5092746|NCT01245946|Acne moderate|acne moderate
5092747|NCT01245946|Photodynamic Therapy|photodynamic therapy
5092748|NCT01245946|Topical retinoids|topical retinoids
5092749|NCT01245946|Antimicrobial agents|antimicrobial agents
5092750|NCT01245933|COPD|copd
5092751|NCT01245933|register|register
5092752|NCT01245933|comorbidities|comorbidities
5092753|NCT01245933|systemic inflammation|systemic inflammation
5092754|NCT01245920|Dental implant|dental implant
5092755|NCT01245920|Alveolar bone|alveolar bone
5092756|NCT01245920|Clinical attachment Level|clinical attachment level
5092757|NCT01245907|Hot flashes|hot flashes
5092758|NCT01245907|Menopause|menopause
5092759|NCT01245907|HRQoL|hrqol
5092760|NCT01245907|Applied relaxation|applied relaxation
5092761|NCT01245907|Insomnia|insomnia
5092762|NCT01245907|Women's knowledge|women's knowledge
5092763|NCT01245894|Index of microcirculatory resistance|index of microcirculatory resistance
5092764|NCT01245894|Fractional Flow Reserve|fractional flow reserve
5092765|NCT01245881|controlled trial|controlled trial
5092766|NCT01245881|fractional photothermolysis|fractional photothermolysis
5092767|NCT01245881|laser surgery|laser surgery
5092768|NCT01245881|melasma|melasma
5092769|NCT01245881|pigment disorder|pigment disorder
5092770|NCT01245868|Spinal anaesthesia|spinal anaesthesia
5092771|NCT01245868|Bupivacaine|bupivacaine
5092772|NCT01245868|Lidocaine|lidocaine
5092773|NCT01245868|Duration of blockade|duration of blockade
5092774|NCT01245855|Prostaglandin E1|prostaglandin e1
5092775|NCT01245855|percutaneous coronary intervention|percutaneous coronary intervention
5092776|NCT01245855|Cardiac troponin T|cardiac troponin t
5092777|NCT01245855|Creatine kinase-MB|creatine kinase-mb
5092778|NCT01245829|Cross Infection|cross infection
5092779|NCT01245829|Nosocomial Infection|nosocomial infection
5092780|NCT01245829|Healthcare Acquired Infection|healthcare acquired infection
5092781|NCT01245829|Hospital Paperwork|hospital paperwork
5092782|NCT01245829|Observation Charts|observation charts
5092783|NCT01245829|Critical Care|critical care
5092784|NCT01245829|Contamination|contamination
5092785|NCT01245816|colon polyps|colon polyps
5092786|NCT01245803|rosuvastatin|rosuvastatin
5092787|NCT01245803|angioplasty|angioplasty
5092887|NCT01245348|adherence|adherence
5092788|NCT01245803|acute coronary syndrome|acute coronary syndrome
5092789|NCT01245790|Phase 1|phase 1
5092790|NCT01245790|healthy volunteers|healthy volunteers
5092791|NCT01245790|volunteers with renal impairment|volunteers with renal impairment
5092792|NCT01245790|pharmacokinetics|pharmacokinetics
5092793|NCT01245790|Rheumatoid arthritis|rheumatoid arthritis
5092794|NCT01245790|RA|ra
5092795|NCT01245790|fostamatinib|fostamatinib
5092796|NCT01245790|Patients|patients
5092797|NCT01245777|RLS|rls
5092798|NCT01245777|Pregnancy|pregnancy
5092799|NCT01245777|Iron Deficiency|iron deficiency
5092800|NCT01245777|Anaemia|anaemia
5092801|NCT01245764|Cervical cancer|cervical cancer
5092802|NCT01245764|vulvar cancer|vulvar cancer
5092803|NCT01245764|vaginal cancer|vaginal cancer
5092804|NCT01245764|genital warts|genital warts
5092805|NCT01245764|human papillomavirus|human papillomavirus
5092806|NCT01245751|Shingles|shingles
5092807|NCT01245751|Vaccine|vaccine
5092808|NCT01245712|Adenocarcinoma of the breast|adenocarcinoma of the breast
5092809|NCT01245712|Lumpectomy|lumpectomy
5092810|NCT01245712|Stage 0 breast cancer|stage 0 breast cancer
5092811|NCT01245712|Stage I breast cancer|stage i breast cancer
5092812|NCT01245712|Stage II breast cancer|stage ii breast cancer
5092813|NCT01245712|Accelerated partial breast irradiation|accelerated partial breast irradiation
5092814|NCT01245712|APBI|apbi
5092815|NCT01245699|Cardiac arrest, CPR, quality improvement|cardiac arrest, cpr, quality improvement
5092816|NCT01245686|Diet interventions|diet interventions
5092817|NCT01245686|Physical activity interventions|physical activity interventions
5092818|NCT01245686|Medication adherence|medication adherence
5092819|NCT01245686|Tailored interventions|tailored interventions
5092820|NCT01245673|Advanced Disease|advanced disease
5092949|NCT01245010|Metabolic Syndrome|metabolic syndrome
5092821|NCT01245673|MAGE-A3 Immunizations with Hiltonol|mage-a3 immunizations with hiltonol
5092822|NCT01245673|Vaccine-Primed Autologous T-Cells|vaccine-primed autologous t-cells
5092823|NCT01245673|Lenalidomide Maintenance|lenalidomide maintenance
5092824|NCT01245660|Phase 0|phase 0
5092825|NCT01245660|Bladder carcinoma|bladder carcinoma
5092826|NCT01245660|egf pathway|egf pathway
5092827|NCT01245660|infiltrative bladder carcinoma|infiltrative bladder carcinoma
5092828|NCT01245660|cystectomy|cystectomy
5092829|NCT01245660|LAPATINIB|lapatinib
5092830|NCT01245647|women|women
5092831|NCT01245647|HIV|hiv
5092832|NCT01245647|alcohol|alcohol
5092833|NCT01245647|medication|medication
5092834|NCT01245647|adherence|adherence
5092835|NCT01245647|acceptability|acceptability
5092836|NCT01245621|palliative care|palliative care
5092837|NCT01245621|end of life care|end of life care
5092838|NCT01245621|quality of life|quality of life
5092839|NCT01245621|caregivers|caregivers
5092840|NCT01245608|Atorvastatin|atorvastatin
5092841|NCT01245608|Aspirin|aspirin
5092842|NCT01245608|nonalcoholic steatohepatitis|nonalcoholic steatohepatitis
5092843|NCT01245608|nonalcoholic fatty liver disease|nonalcoholic fatty liver disease
5092844|NCT01245608|antihypertensive agents|antihypertensive agents
5092845|NCT01245595|Acute Kidney Injury (AKI)|acute kidney injury (aki)
5092846|NCT01245595|Cardiopulmonary bypass (CPB)|cardiopulmonary bypass (cpb)
5092847|NCT01245530|Alzheimer disease|alzheimer disease
5092848|NCT01245517|hyperphosphatemia or malnutrition|hyperphosphatemia or malnutrition
5092849|NCT01245478|Surgical Procedures, Elective|surgical procedures, elective
5092850|NCT01245452|Rheumatoid arthritis|rheumatoid arthritis
5092851|NCT01245452|Tocilizumab|tocilizumab
5092852|NCT01245452|Cardiorespiratory endurance|cardiorespiratory endurance
5092853|NCT01245426|Asthma|asthma
5092854|NCT01245426|GW870086|gw870086
5092855|NCT01245426|Efficacy|efficacy
5092856|NCT01245426|FEV1|fev1
5092857|NCT01245413|Stoma|stoma
5092858|NCT01245413|adhesive|adhesive
5092859|NCT01245413|warm|warm
5092860|NCT01245413|moist|moist
5092861|NCT01245413|cycling|cycling
5092862|NCT01245413|men|men
5092863|NCT01245413|peel-value|peel-value
5092864|NCT01245413|healthy men 50-70 years old|healthy men 50-70 years old
5092865|NCT01245413|men with colostoma, above 18 years|men with colostoma, above 18 years
5092866|NCT01245400|Z-Lig|z-lig
5092867|NCT01245400|allograft|allograft
5092868|NCT01245400|ACL|acl
5092869|NCT01245400|Anterior Cruciate Ligament|anterior cruciate ligament
5092870|NCT01245400|ACLR|aclr
5092871|NCT01245400|Anterior Cruciate Ligament Reconstruction|anterior cruciate ligament reconstruction
5092872|NCT01245400|EU|eu
5092873|NCT01245400|European Union|european union
5092874|NCT01245400|S. Africa|s. africa
5092875|NCT01245400|Reconstruction of ruptured anterior cruciate ligaments|reconstruction of ruptured anterior cruciate ligaments
5092876|NCT01245387|prospective|prospective
5092877|NCT01245387|observational|observational
5092878|NCT01245387|Phase 4|phase 4
5092879|NCT01245387|non-interventional|non-interventional
5092880|NCT01245387|open-label|open-label
5092881|NCT01245361|Undifferentiated Arthritis|undifferentiated arthritis
5092882|NCT01245361|Rheumatoid Arthritis|rheumatoid arthritis
5092883|NCT01245361|Infliximab|infliximab
5092884|NCT01245348|Schizophrenia|schizophrenia
5092885|NCT01245348|Bipolar Disorder|bipolar disorder
5092886|NCT01245348|atypical antipsychotic|atypical antipsychotic
5092888|NCT01245348|cost effectiveness|cost effectiveness
5092889|NCT01245348|pharmacogenetics|pharmacogenetics
5092890|NCT01245348|mental illness|mental illness
5092891|NCT01245348|SULT4A1|sult4a1
5092892|NCT01245335|CLI|cli
5092893|NCT01245335|Critical Limb Ischemia|critical limb ischemia
5092894|NCT01245335|PAOD|paod
5092895|NCT01245335|Peripheral Arterial Disease|peripheral arterial disease
5092896|NCT01245335|Stem Cells|stem cells
5092897|NCT01245335|Limb amputation|limb amputation
5092898|NCT01245335|Leg ulcers|leg ulcers
5092899|NCT01245322|treatment, lactobacilli|treatment, lactobacilli
5092900|NCT01245296|Umbilical cord|umbilical cord
5092901|NCT01245296|cord clamping|cord clamping
5092902|NCT01245296|iron|iron
5092903|NCT01245296|Ferritin|ferritin
5092904|NCT01245296|newborn|newborn
5092905|NCT01245296|jaundice|jaundice
5092906|NCT01245296|infant|infant
5092907|NCT01245296|development|development
5092908|NCT01245296|infections|infections
5092909|NCT01245283|knee|knee
5092910|NCT01245283|osteoarthritis|osteoarthritis
5092911|NCT01245283|pain|pain
5092912|NCT01245283|function|function
5092913|NCT01245283|impairment|impairment
5092914|NCT01245270|anthocyanin|anthocyanin
5092915|NCT01245270|blaeberries|blaeberries
5092916|NCT01245270|bilberries|bilberries
5092917|NCT01245270|blueberries|blueberries
5092918|NCT01245270|mirtoselect|mirtoselect
5092919|NCT01245270|glucose AUC|glucose auc
5092920|NCT01245257|Inflammation|inflammation
5092921|NCT01245257|Urea Synthesis|urea synthesis
5092922|NCT01245257|Catabolism|catabolism
5092923|NCT01245257|Nitrogen balance|nitrogen balance
5092924|NCT01245231|childhood acute myeloid leukemia/other myeloid malignancies|childhood acute myeloid leukemia/other myeloid malignancies
5092925|NCT01245179|sickle cell anemia|sickle cell anemia
5092926|NCT01245179|sickle cell thalassemia|sickle cell thalassemia
5092927|NCT01245179|HDAC inhibitor|hdac inhibitor
5092928|NCT01245179|hemoglobin F|hemoglobin f
5092929|NCT01245179|sickle beta thalassemia|sickle beta thalassemia
5092930|NCT01245179|Fetal Hemoglobin|fetal hemoglobin
5092931|NCT01245153|Urinary incontinence, Pelvic floor muscle training|urinary incontinence, pelvic floor muscle training
5092932|NCT01245140|Palmo-Plantar Pustolosis|palmo-plantar pustolosis
5092933|NCT01245127|Schnitzler syndrome|schnitzler syndrome
5092934|NCT01245101|HIV raltegravir intensification replication activation|hiv raltegravir intensification replication activation
5092935|NCT01245088|Crohn's disease|crohn's disease
5092936|NCT01245088|chondroitin sulfate|chondroitin sulfate
5092937|NCT01245062|MEK inhibitor|mek inhibitor
5092938|NCT01245062|Cancer|cancer
5092939|NCT01245062|Metastatic Melanoma|metastatic melanoma
5092940|NCT01245062|BRAF mutant metastatic melanoma|braf mutant metastatic melanoma
5092941|NCT01245062|GSK1120212|gsk1120212
5092942|NCT01245049|MMR|mmr
5092943|NCT01245049|dTpa-IPV|dtpa-ipv
5092944|NCT01245049|Boostrix Polio|boostrix polio
5092945|NCT01245049|Repevax|repevax
5092946|NCT01245049|Priorix|priorix
5092947|NCT01245036|Sarcoidosis|sarcoidosis
5092948|NCT01245036|Tuberculosis|tuberculosis
5092950|NCT01245010|Water|water
5092951|NCT01245010|Obesity|obesity
5092952|NCT01245010|Clinical trial|clinical trial
5092953|NCT01245010|Prevention|prevention
5092954|NCT01244997|Partial edentulism|partial edentulism
5092955|NCT01244997|Bone atrophy|bone atrophy
5092956|NCT01244997|Bone healing|bone healing
5092957|NCT01244984|asthma|asthma
5092958|NCT01244984|Fluticasone furoate|fluticasone furoate
5092959|NCT01244984|GW642444|gw642444
5092960|NCT01244958|Active rheumatoid arthritis|active rheumatoid arthritis
5092961|NCT01244958|leflunomide|leflunomide
5092962|NCT01244958|rituximab|rituximab
5092963|NCT01244958|inadequate clinical response to leflunomide|inadequate clinical response to leflunomide
5092964|NCT01244945|Functional Constipation|functional constipation
5092965|NCT01244945|Functional Foods|functional foods
5092966|NCT01244945|Probiotics|probiotics
5092967|NCT01244945|Lactobacillus reuteri|lactobacillus reuteri
5092968|NCT01244906|Chronic Myelogenous Leukemia|chronic myelogenous leukemia
5092969|NCT01244906|Acute Myelogenous Leukemia|acute myelogenous leukemia
5092970|NCT01244906|Myelodysplastic Syndrome|myelodysplastic syndrome
5092971|NCT01244906|Myelofibrosis|myelofibrosis
5092972|NCT01244906|Acute Lymphocytic Leukemia|acute lymphocytic leukemia
5092973|NCT01244906|Acute Lymphoblastic Lymphoma|acute lymphoblastic lymphoma
5092974|NCT01244906|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
5092975|NCT01244906|Prolymphocytic Leukemia|prolymphocytic leukemia
5092976|NCT01244906|Low-grade non-Hodgkin's Lymphoma|low-grade non-hodgkin's lymphoma
5092977|NCT01244906|Mantle Cell Lymphoma|mantle cell lymphoma
5092978|NCT01244906|Hodgkin Lymphoma|hodgkin lymphoma
5092979|NCT01244906|Myeloma|myeloma
5092980|NCT01244880|PF-02545920|pf-02545920
5092981|NCT01244880|ketamine|ketamine
5092982|NCT01244880|fMRI|fmri
5092983|NCT01244880|associative Learning|associative learning
5092984|NCT01244854|chronic mental disorders|chronic mental disorders
5092985|NCT01244854|cardiovascular disease|cardiovascular disease
5092986|NCT01244854|behavior change|behavior change
5092987|NCT01244841|ST elevation acute myocardial infarction|st elevation acute myocardial infarction
5092988|NCT01244841|Primary percutaneous coronary intervention|primary percutaneous coronary intervention
5092989|NCT01244841|Discharge|discharge
5092990|NCT01244841|Health status|health status
5092991|NCT01244841|Quality of care|quality of care
5092992|NCT01244815|Bi-polar I disorder|bi-polar i disorder
5092993|NCT01244815|antipsychotic|antipsychotic
5092994|NCT01244815|serotonin|serotonin
5092995|NCT01244815|dopamine|dopamine
5092996|NCT01244815|noradrenalin|noradrenalin
5092997|NCT01244815|histamine|histamine
5092998|NCT01244815|pediatric|pediatric
5092999|NCT01244802|yellow fever vaccine|yellow fever vaccine
5093000|NCT01244789|endometrial cancer|endometrial cancer
5093001|NCT01244789|chemotherapy|chemotherapy
5093002|NCT01244789|carboplatin|carboplatin
5093003|NCT01244789|paclitaxel|paclitaxel
5093004|NCT01244789|Stage 1 & 2|stage 1 & 2
5093005|NCT01244789|node-negative|node-negative
5093006|NCT01244789|intermediate risk|intermediate risk
5093007|NCT01244789|high risk|high risk
5093008|NCT01244763|Kidney|kidney
5093009|NCT01244763|Chronic Kidney Disease|chronic kidney disease
5093011|NCT01244763|Renal|renal
5093012|NCT01244763|Anemia|anemia
5093013|NCT01244763|Oral anemia treatment|oral anemia treatment
5093014|NCT01244763|Hemoglobin levels|hemoglobin levels
5093015|NCT01244763|Erythropoietin|erythropoietin
5093016|NCT01244763|Blood count|blood count
5093017|NCT01244763|Predialysis|predialysis
5093018|NCT01244763|Pre-dialysis|pre-dialysis
5093019|NCT01244763|Hb|hb
5093020|NCT01244763|Non-dialysis|non-dialysis
5093021|NCT01244750|Chronic Phase - Chronic Myeloid Leukemia|chronic phase - chronic myeloid leukemia
5093022|NCT01244737|Brain neoplasms|brain neoplasms
5093023|NCT01244737|Children|children
5093024|NCT01244737|Positron-Emission Tomography|positron-emission tomography
5093025|NCT01244737|18F-FLT|18f-flt
5093026|NCT01244711|Major Depression|major depression
5093027|NCT01244711|Generalized Anxiety Disorder|generalized anxiety disorder
5093028|NCT01244711|Benzodiazepine|benzodiazepine
5093029|NCT01244711|Quetiapine|quetiapine
5093030|NCT01244698|Surgical Site Infection, Breast Reconstruction, Antibiotics|surgical site infection, breast reconstruction, antibiotics
5093031|NCT01244685|bowel resection|bowel resection
5093032|NCT01244685|Deltex CardioQ Probe|deltex cardioq probe
5093033|NCT01244685|fluid management|fluid management
5093034|NCT01244672|Hemorrhoids|hemorrhoids
5093035|NCT01244672|THD|thd
5093036|NCT01244672|Ferguson|ferguson
5093037|NCT01244659|Tacrolimus|tacrolimus
5093038|NCT01244659|Immunosuppressive Agents|immunosuppressive agents
5093039|NCT01244659|Kidney transplantation|kidney transplantation
5093040|NCT01244646|Diabetes Mellitus|diabetes mellitus
5093041|NCT01244646|Type 2|type 2
5093042|NCT01244646|DMT2|dmt2
5093043|NCT01244646|T2DM|t2dm
5093044|NCT01244646|metformin|metformin
5093045|NCT01244646|sulfonylurea|sulfonylurea
5093046|NCT01244646|hypoglycemia|hypoglycemia
5093047|NCT01244646|weight|weight
5093048|NCT01244646|quality of life|quality of life
5093049|NCT01244646|compliance|compliance
5093050|NCT01244633|Tourette's|tourette's
5093051|NCT01244633|Ecopipam|ecopipam
5093052|NCT01244633|Dopamine receptors|dopamine receptors
5093053|NCT01244633|Efficacy|efficacy
5093054|NCT01244633|Safety|safety
5093055|NCT01244633|Adults|adults
5093056|NCT01244620|A pharmacokinetic drug-drug interaction study between sitaxsentan and tadalafil and between sitaxsentan and sildenafil at the steady-state|a pharmacokinetic drug-drug interaction study between sitaxsentan and tadalafil and between sitaxsentan and sildenafil at the steady-state
5093057|NCT01244594|Spinal Cord Injury|spinal cord injury
5093058|NCT01244594|Cycling|cycling
5093059|NCT01244594|Functional Electrical Stimulation|functional electrical stimulation
5093060|NCT01244581|middle ear effusion|middle ear effusion
5093061|NCT01244581|amoxicillin-clavulanate|amoxicillin-clavulanate
5093062|NCT01244581|tympanometry|tympanometry
5093063|NCT01244568|Prostate Cancer|prostate cancer
5093064|NCT01244568|Decision support interventions (DESI)|decision support interventions (desi)
5093065|NCT01244568|Comparative Effectiveness Research (CER)|comparative effectiveness research (cer)
5093066|NCT01244542|Schizophrenia|schizophrenia
5093067|NCT01244542|DSM IV criteria|dsm iv criteria
5093068|NCT01244542|Pain insensitivity|pain insensitivity
5093069|NCT01244542|Painful perception|painful perception
5093070|NCT01244542|Opioid receptors|opioid receptors
5093071|NCT01244490|ADHD|adhd
5093072|NCT01244477|Stress Disorders, Post Traumatic|stress disorders, post traumatic
5093073|NCT01244477|Trust|trust
5093074|NCT01244477|functional Magnetic Resonance Imaging (fMRI)|functional magnetic resonance imaging (fmri)
5093075|NCT01244464|Poliomyelitis|poliomyelitis
5093076|NCT01244464|IMOVAX POLIO™|imovax polio™
5093077|NCT01244464|Polio|polio
5093078|NCT01244451|CLL|cll
5093079|NCT01244451|relapsed|relapsed
5093080|NCT01244451|refractory|refractory
5093081|NCT01244451|Bendamustine|bendamustine
5093082|NCT01244451|Ofatumumab|ofatumumab
5093083|NCT01244438|endometrial cancer|endometrial cancer
5093084|NCT01244438|FGFR2 mutations|fgfr2 mutations
5093085|NCT01244412|Fundus photography|fundus photography
5093086|NCT01244399|inositol|inositol
5093087|NCT01244399|caffeine|caffeine
5093088|NCT01244399|NTDs|ntds
5093089|NCT01244386|Computed tomography|computed tomography
5093090|NCT01244386|Iterative reconstruction|iterative reconstruction
5093091|NCT01244386|Automatic tube current modulation|automatic tube current modulation
5093092|NCT01244386|Crohn's disease|crohn's disease
5093093|NCT01244386|Inflammatory bowel disease|inflammatory bowel disease
5093094|NCT01244386|Radiation dose optimization|radiation dose optimization
5093095|NCT01244386|C reactive protein|c reactive protein
5093096|NCT01244373|Best-corrected visual acuity|best-corrected visual acuity
5093097|NCT01244373|posterior capsule opacification|posterior capsule opacification
5093098|NCT01244373|QUATRIX® Aspheric Evolutive pre-loaded|quatrix® aspheric evolutive pre-loaded
5093099|NCT01244360|resveratrol|resveratrol
5093100|NCT01244360|insulin|insulin
5093101|NCT01244360|inflammation|inflammation
5093102|NCT01244360|cognition|cognition
5093103|NCT01244360|metabolism|metabolism
5093104|NCT01244347|folic acid|folic acid
5093105|NCT01244347|malformations|malformations
5093106|NCT01244347|prevention|prevention
5093107|NCT01244334|cataract surgery, vision, corneal edema, retinal thickness|cataract surgery, vision, corneal edema, retinal thickness
5093108|NCT01244321|End stage heart failure|end stage heart failure
5093109|NCT01244321|heart transplantation|heart transplantation
5093110|NCT01244321|Ventricular assist device|ventricular assist device
5093111|NCT01244321|Patients with end stage heart failure|patients with end stage heart failure
5093112|NCT01244321|awaiting heart transplantation|awaiting heart transplantation
5093113|NCT01244308|Phrenic nerve stimulation|phrenic nerve stimulation
5093114|NCT01244308|LV pacing configuration|lv pacing configuration
5093115|NCT01244308|CRT|crt
5093116|NCT01244308|Cardiac resynchronisation therapy|cardiac resynchronisation therapy
5093117|NCT01244308|Heart failure|heart failure
5093118|NCT01244295|Grief|grief
5093119|NCT01244295|Bereavement|bereavement
5093120|NCT01244295|Psychotherapy|psychotherapy
5093121|NCT01244295|Randomized controlled trial|randomized controlled trial
5093122|NCT01244295|Treatment study|treatment study
5093123|NCT01244282|brain imaging|brain imaging
5093124|NCT01244269|Parkinson's disease|parkinson's disease
5093125|NCT01244269|Methylphenidate|methylphenidate
5093126|NCT01244269|Non motor symptoms|non motor symptoms
5093127|NCT01244269|Postural control|postural control
5093128|NCT01244243|stroke|stroke
5093129|NCT01244243|rehabilitation|rehabilitation
5093130|NCT01244204|vitamin D deficiency|vitamin d deficiency
5093131|NCT01244204|tuberculin sin test|tuberculin sin test
5093132|NCT01244204|immunity|immunity
5093133|NCT01244204|tuberculosis|tuberculosis
5093134|NCT01244191|Non squamous, non-small-cell lung cancer|non squamous, non-small-cell lung cancer
5093135|NCT01244191|Epidermal growth factor receptor, wild type|epidermal growth factor receptor, wild type
5093136|NCT01244191|c-Met inhibitor|c-met inhibitor
5093137|NCT01244178|Sepsis|sepsis
5093138|NCT01244178|Insulin|insulin
5093139|NCT01244139|BIIB033|biib033
5093140|NCT01244139|Multiple Sclerosis|multiple sclerosis
5093141|NCT01244139|anti-LINGO-1 antibody|anti-lingo-1 antibody
5093142|NCT01244139|Relapsing Remitting MS|relapsing remitting ms
5093143|NCT01244139|remyelination|remyelination
5093144|NCT01244139|myelin repair|myelin repair
5093145|NCT01244139|Multiple ascending dose|multiple ascending dose
5093146|NCT01244139|Secondary progessive MS|secondary progessive ms
5093147|NCT01244126|otitis media|otitis media
5093148|NCT01244126|recurrent ear infections (otitis media)|recurrent ear infections (otitis media)
5093149|NCT01244100|Food-effects PK study in healthy subjects.|food-effects pk study in healthy subjects.
5093150|NCT01244087|Inquiry-based stress reduction|inquiry-based stress reduction
5093151|NCT01244087|Quality of life|quality of life
5093152|NCT01244087|breast cancer|breast cancer
5093153|NCT01244048|n3 LC-PUFA, yoghurt, inflammatory markers|n3 lc-pufa, yoghurt, inflammatory markers
5093154|NCT01244035|High blood pressure|high blood pressure
5093155|NCT01244022|Colorectal cancer|colorectal cancer
5093156|NCT01244022|Surgical stress response|surgical stress response
5093157|NCT01244022|interleukins|interleukins
5093158|NCT01244009|Poly (ADP-ribose) polymerase (PARP) inhibitor|poly (adp-ribose) polymerase (parp) inhibitor
5093159|NCT01243996|Patent ductus arteriosus, ibuprofen, preterm infants|patent ductus arteriosus, ibuprofen, preterm infants
5093160|NCT01243970|Spinal anaesthesia|spinal anaesthesia
5093161|NCT01243970|phenylephrine|phenylephrine
5093162|NCT01243970|ephedrine|ephedrine
5093163|NCT01243970|ECG changes|ecg changes
5093164|NCT01243970|Caesarean delivery|caesarean delivery
5093165|NCT01243970|Myocardial ischaemia|myocardial ischaemia
5093166|NCT01243970|Cardiac output|cardiac output
5093167|NCT01243970|hypotension|hypotension
5093168|NCT01243944|INCB018424|incb018424
5093169|NCT01243931|Phototherapeutic keratectomy|phototherapeutic keratectomy
5093170|NCT01243931|Optical coherence tomography|optical coherence tomography
5093171|NCT01243931|Corneal opacity|corneal opacity
5093172|NCT01243931|Corneal dystrophy|corneal dystrophy
5093173|NCT01243918|Acute respiratory failure|acute respiratory failure
5093174|NCT01243918|Oxygen therapy delivery systems|oxygen therapy delivery systems
5093175|NCT01243918|Non invasive ventilation|non invasive ventilation
5093176|NCT01243918|High concentration mask|high concentration mask
5093177|NCT01243918|Hypoxemic pneumonia|hypoxemic pneumonia
5093178|NCT01243879|fasting|fasting
5093179|NCT01243879|starvation|starvation
5093180|NCT01243879|calorie restriction|calorie restriction
5093181|NCT01243879|fMRI|fmri
5093182|NCT01243840|Central aortic pressure|central aortic pressure
5093183|NCT01243840|Aortic pulse wave velocity|aortic pulse wave velocity
5093184|NCT01243840|Aortic PWV using a single pressure recording|aortic pwv using a single pressure recording
5093185|NCT01243840|Vascular aging|vascular aging
5093186|NCT01243840|Left ventricular hypertrophy|left ventricular hypertrophy
5093187|NCT01243840|Left ventricular diastolic function|left ventricular diastolic function
5093188|NCT01243827|Hypertension, carvedilol, bisoprolol, central pulse pressure, pulse pressure amplification, reflection magnitude, LV mass index, LV diastolic function|hypertension, carvedilol, bisoprolol, central pulse pressure, pulse pressure amplification, reflection magnitude, lv mass index, lv diastolic function
5093189|NCT01243814|hyaluronate|hyaluronate
5093190|NCT01243814|hyaluronic acid|hyaluronic acid
5093191|NCT01243814|viscosupplementation|viscosupplementation
5093192|NCT01243801|chronic pain|chronic pain
5093193|NCT01243801|persistent postsurgical pain|persistent postsurgical pain
5093194|NCT01243801|hyperalgesia|hyperalgesia
5093195|NCT01243801|ketamine|ketamine
5093196|NCT01243801|quantitative sensory testing|quantitative sensory testing
5093198|NCT01243788|Seretide|seretide
5093199|NCT01243788|Combivent|combivent
5093200|NCT01243788|effect and safety|effect and safety
5093201|NCT01243788|Twelve weeks|twelve weeks
5093202|NCT01243775|NSCLC|nsclc
5093203|NCT01243762|Colorectal cancer|colorectal cancer
5093204|NCT01243762|Solid tumors|solid tumors
5093205|NCT01243762|Ovarian cancer|ovarian cancer
5093206|NCT01243762|Fallopian tube cancer|fallopian tube cancer
5093207|NCT01243762|Primary peritoneal cancer|primary peritoneal cancer
5093208|NCT01243749|Target Vessel Revascularization (TVR)|target vessel revascularization (tvr)
5093209|NCT01243749|Target Lesion Revascularization (TLR)|target lesion revascularization (tlr)
5093210|NCT01243749|Myocardial Infarction (MI)|myocardial infarction (mi)
5093211|NCT01243749|Target Vessel Failure (TVF)|target vessel failure (tvf)
5093212|NCT01243749|Target Lesion Failure (TLF)|target lesion failure (tlf)
5093213|NCT01243749|Stent Thrombosis|stent thrombosis
5093214|NCT01243749|Restenotic Lesion|restenotic lesion
5093215|NCT01243749|Percutaneous Coronary Intervention (PCI)|percutaneous coronary intervention (pci)
5093216|NCT01243749|Real-world|real-world
5093217|NCT01243736|anemic|anemic
5093218|NCT01243736|bleeding|bleeding
5093219|NCT01243736|blood in stool|blood in stool
5093220|NCT01243736|abdomen pain|abdomen pain
5093221|NCT01243736|Gastrointestinal bleeding|gastrointestinal bleeding
5093222|NCT01243736|capsule endoscopy (CE)|capsule endoscopy (ce)
5093223|NCT01243723|Dyschesia treatment|dyschesia treatment
5093224|NCT01243723|Inconfort related to dyschesia|inconfort related to dyschesia
5093225|NCT01243723|Quality of life|quality of life
5093226|NCT01243723|Bowel function index|bowel function index
5093227|NCT01243697|Desogestrel|desogestrel
5093228|NCT01243697|Chemosensitivity|chemosensitivity
5093229|NCT01243684|Spinal cord|spinal cord
5093230|NCT01243684|cervical spondylosis|cervical spondylosis
5093231|NCT01243684|myelopathy|myelopathy
5093232|NCT01243671|Behçet's, intestinal|behçet's, intestinal
5093233|NCT01243658|Oxytocin|oxytocin
5093234|NCT01243658|BPD|bpd
5093235|NCT01243658|Borderline|borderline
5093236|NCT01243632|malignant pleural mesothelioma|malignant pleural mesothelioma
5093237|NCT01243632|chemotherapy|chemotherapy
5093238|NCT01243632|gemcitabine|gemcitabine
5093239|NCT01243632|cisplatin|cisplatin
5093240|NCT01243632|long infusion|long infusion
5093241|NCT01243619|PET|pet
5093242|NCT01243619|CT|ct
5093243|NCT01243619|radiotherapy|radiotherapy
5093244|NCT01243606|Anxiety|anxiety
5093245|NCT01243606|Depression|depression
5093246|NCT01243606|Obsessive Compulsive Disorder|obsessive compulsive disorder
5093247|NCT01243606|Panic Disorder|panic disorder
5093248|NCT01243606|Generalized Anxiety Disorder|generalized anxiety disorder
5093249|NCT01243606|Social Anxiety Disorder|social anxiety disorder
5093250|NCT01243606|Transdiagnostic Treatment|transdiagnostic treatment
5093251|NCT01243606|CBT|cbt
5093252|NCT01243593|pediatrics|pediatrics
5093253|NCT01243593|anesthesia|anesthesia
5093254|NCT01243593|pyeloplasty|pyeloplasty
5093255|NCT01243593|Transversus Abdominis Plane Block|transversus abdominis plane block
5093256|NCT01243593|Regional Anesthesia|regional anesthesia
5093257|NCT01243580|PK and safety|pk and safety
5093258|NCT01243580|Pharmacokinetic profile (PK) and safety|pharmacokinetic profile (pk) and safety
5093259|NCT01243554|Exercise training|exercise training
5093260|NCT01243554|Pregnancy|pregnancy
5093261|NCT01243554|Obesity|obesity
5093262|NCT01243528|Malnutrition|malnutrition
5093263|NCT01243528|Infection|infection
5093264|NCT01243528|Neurological|neurological
5093265|NCT01243515|Central Venous Pressure|central venous pressure
5093266|NCT01243515|Kidney Diseases|kidney diseases
5093267|NCT01243515|Chronic Kidney Disease|chronic kidney disease
5093268|NCT01243515|Healthy Subjects|healthy subjects
5093269|NCT01243515|Non-Invasive Monitor|non-invasive monitor
5093270|NCT01243489|CML|cml
5093271|NCT01243489|compliance|compliance
5093272|NCT01243489|compliance supporting measures|compliance supporting measures
5093273|NCT01243489|complete cytogenetic response|complete cytogenetic response
5093274|NCT01243489|mayor molecular remission|mayor molecular remission
5093275|NCT01243489|Philadelphia chromosome|philadelphia chromosome
5093276|NCT01243489|BCR-ABL|bcr-abl
5093277|NCT01243489|Imatinib|imatinib
5093278|NCT01243489|tyrosine kinase inhibitor|tyrosine kinase inhibitor
5093279|NCT01243489|smart blister|smart blister
5093280|NCT01243476|myelodysplastic syndrome|myelodysplastic syndrome
5093281|NCT01243476|5q deletion|5q deletion
5093282|NCT01243476|anemia|anemia
5093283|NCT01243476|lenalidomide|lenalidomide
5093284|NCT01243476|red blood cells transfusion|red blood cells transfusion
5093285|NCT01243437|plague, ciprofloxacin|plague, ciprofloxacin
5093286|NCT01243411|Peyronie's Disease, penile plaque, penile curvature|peyronie's disease, penile plaque, penile curvature
5093287|NCT01243398|adenocarcinoma of the gastroesophageal junction|adenocarcinoma of the gastroesophageal junction
5093288|NCT01243398|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
5093289|NCT01243398|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
5093290|NCT01243398|recurrent esophageal cancer|recurrent esophageal cancer
5093291|NCT01243398|stage IA esophageal cancer|stage ia esophageal cancer
5093292|NCT01243398|stage IB esophageal cancer|stage ib esophageal cancer
5093293|NCT01243398|stage IIA esophageal cancer|stage iia esophageal cancer
5093294|NCT01243398|stage IIB esophageal cancer|stage iib esophageal cancer
5093295|NCT01243398|stage IIIA esophageal cancer|stage iiia esophageal cancer
5093296|NCT01243398|stage IIIB esophageal cancer|stage iiib esophageal cancer
5093297|NCT01243398|stage IIIC esophageal cancer|stage iiic esophageal cancer
5093298|NCT01243398|stage IV esophageal cancer|stage iv esophageal cancer
5093299|NCT01243385|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5093300|NCT01243385|hormone-resistant prostate cancer|hormone-resistant prostate cancer
5093301|NCT01243385|stage III prostate cancer|stage iii prostate cancer
5093302|NCT01243385|stage IV prostate cancer|stage iv prostate cancer
5093303|NCT01243385|recurrent prostate cancer|recurrent prostate cancer
5093304|NCT01243372|recurrent colon cancer|recurrent colon cancer
5093305|NCT01243372|stage IIIA colon cancer|stage iiia colon cancer
5093306|NCT01243372|stage IIIB colon cancer|stage iiib colon cancer
5093307|NCT01243372|stage IIIC colon cancer|stage iiic colon cancer
5093308|NCT01243372|stage IVA colon cancer|stage iva colon cancer
5093309|NCT01243372|stage IVB colon cancer|stage ivb colon cancer
5093310|NCT01243372|recurrent rectal cancer|recurrent rectal cancer
5093311|NCT01243372|stage III rectal cancer|stage iii rectal cancer
5093312|NCT01243372|stage IV rectal cancer|stage iv rectal cancer
5093313|NCT01243346|Gastrointestinal Stromal Tumor|gastrointestinal stromal tumor
5093314|NCT01243346|PDGFR Inhibitor|pdgfr inhibitor
5093315|NCT01243346|Crenolanib (CP-868,596)|crenolanib (cp-868,596)
5093316|NCT01243281|hepatitis B|hepatitis b
5093317|NCT01243281|HBeAg|hbeag
5093318|NCT01243281|pegylated interferon|pegylated interferon
5093319|NCT01243281|entecavir|entecavir
5093320|NCT01243255|hypercholesterolemia|hypercholesterolemia
5093321|NCT01243255|low density lipoprotein|low density lipoprotein
5093322|NCT01243255|undertreatment of hypercholesterolemia|undertreatment of hypercholesterolemia
5093323|NCT01243242|ADHD,Adults,MG01CI,METADOXINE|adhd,adults,mg01ci,metadoxine
5093324|NCT01243216|Pregnancy|pregnancy
5093325|NCT01243216|Labor|labor
5093326|NCT01243216|Epidural Analgesia|epidural analgesia
5093327|NCT01243216|Epidural Anesthesia|epidural anesthesia
5093328|NCT01243216|Spinal Anesthesia|spinal anesthesia
5093329|NCT01243216|Ultrasound|ultrasound
5093330|NCT01243216|Neuraxial Analgesia|neuraxial analgesia
5093331|NCT01243216|Neuraxial Anesthesia|neuraxial anesthesia
5093332|NCT01243216|Cesarean delivery|cesarean delivery
5093333|NCT01243203|Smoking, surgery, Anesthesia, quit|smoking, surgery, anesthesia, quit
5093334|NCT01243190|leukemia|leukemia
5093335|NCT01243190|small lymphocytic leukemia|small lymphocytic leukemia
5093336|NCT01243190|SLL|sll
5093337|NCT01243190|CLL|cll
5093338|NCT01243190|ofatumumab|ofatumumab
5093339|NCT01243190|untreated|untreated
5093340|NCT01243190|early stage|early stage
5093341|NCT01243190|high-risk|high-risk
5093342|NCT01243177|Lacosamide|lacosamide
5093343|NCT01243177|Vimpat®|vimpat®
5093344|NCT01243177|Epilepsy|epilepsy
5093345|NCT01243177|Monotherapy|monotherapy
5093346|NCT01243177|Velocity|velocity
5093347|NCT01243164|confidence|confidence
5093348|NCT01243164|wheelchair performance|wheelchair performance
5093349|NCT01243151|Hypercholesterolemia|hypercholesterolemia
5093350|NCT01243151|Dyslipidemia|dyslipidemia
5093351|NCT01243151|LDL|ldl
5093352|NCT01243151|High Cholesterol|high cholesterol
5093353|NCT01243151|Japanese Volunteers|japanese volunteers
5093354|NCT01243151|PF-04950615|pf-04950615
5093355|NCT01243151|RN316|rn316
5093356|NCT01243138|Cross-sectional|cross-sectional
5093357|NCT01243138|epidemiological study|epidemiological study
5093358|NCT01243138|to evaluate the prevalence of CV risk factors in patients attending general practice in AfME region|to evaluate the prevalence of cv risk factors in patients attending general practice in afme region
5093359|NCT01243125|Blockage|blockage
5093360|NCT01243125|Encrustation|encrustation
5093361|NCT01243125|Catheter|catheter
5093362|NCT01243125|Spinal Cord Injury|spinal cord injury
5093363|NCT01243125|SCI|sci
5093364|NCT01243086|Macular Degeneration|macular degeneration
5093365|NCT01243086|Age-related macular degeneration|age-related macular degeneration
5093366|NCT01243086|Anti-inflammatory|anti-inflammatory
5093367|NCT01243086|Anti-vascular endothelial growth factor (Anti-VEGF)|anti-vascular endothelial growth factor (anti-vegf)
5093368|NCT01243086|Lucentis|lucentis
5093369|NCT01243086|Ranibizumab|ranibizumab
5093370|NCT01243086|OZURDEX|ozurdex
5093371|NCT01243086|Dexamethasone|dexamethasone
5093372|NCT01243086|Vision loss|vision loss
5093373|NCT01243073|imetelstat|imetelstat
5093374|NCT01243073|imetelstat sodium|imetelstat sodium
5093375|NCT01243073|GRN163L|grn163l
5093376|NCT01243073|telomerase inhibitor|telomerase inhibitor
5093377|NCT01243073|telomerase|telomerase
5093378|NCT01243073|essential thrombocytosis|essential thrombocytosis
5093379|NCT01243073|essential thrombocythemia|essential thrombocythemia
5093380|NCT01243073|ET|et
5093381|NCT01243073|polycythemia vera|polycythemia vera
5093382|NCT01243073|PV|pv
5093383|NCT01243060|Sleep Aid|sleep aid
5093384|NCT01243047|Second line treatment for metastatic colorectal cancer|second line treatment for metastatic colorectal cancer
5093385|NCT01243008|Lyme disease|lyme disease
5093386|NCT01243008|Borreliosis|borreliosis
5093387|NCT01243008|Azithromycin|azithromycin
5093388|NCT01242982|5. metacarpal fracture/fractures|5. metacarpal fracture/fractures
5093389|NCT01242982|subcapital|subcapital
5093390|NCT01242982|shaft|shaft
5093391|NCT01242982|closed|closed
5093392|NCT01242956|stroke|stroke
5093393|NCT01242956|video-based training|video-based training
5093394|NCT01242956|rehabilitation|rehabilitation
5093395|NCT01242943|I131|i131
5093396|NCT01242943|L19|l19
5093397|NCT01242943|antibody|antibody
5093398|NCT01242943|monoclonal|monoclonal
5093399|NCT01242943|tumour targeting|tumour targeting
5093400|NCT01242943|radioimmunotherapy|radioimmunotherapy
5093401|NCT01242943|cancer|cancer
5093402|NCT01242930|imetelstat|imetelstat
5093403|NCT01242930|imetelstat sodium|imetelstat sodium
5093404|NCT01242930|GRN163L|grn163l
5093405|NCT01242930|telomerase inhibitor|telomerase inhibitor
5093406|NCT01242930|telomerase inhibition|telomerase inhibition
5093407|NCT01242930|multiple myeloma|multiple myeloma
5093408|NCT01242930|myeloma|myeloma
5093409|NCT01242930|myeloma progenitor cells|myeloma progenitor cells
5093410|NCT01242904|dialysis solutions|dialysis solutions
5093411|NCT01242904|renal replacement therapy|renal replacement therapy
5093412|NCT01242904|peritoneal dialysis|peritoneal dialysis
5093413|NCT01242904|bimodal solution|bimodal solution
5093414|NCT01242904|glucose sparing therapy|glucose sparing therapy
5093415|NCT01242891|Ventricular Assist Device|ventricular assist device
5093416|NCT01242891|Pediatric Ventricular Assist Device|pediatric ventricular assist device
5093417|NCT01242878|HbSS|hbss
5093418|NCT01242878|Sickle cell anemia|sickle cell anemia
5093419|NCT01242878|HbSC|hbsc
5093420|NCT01242878|HbSbetathalassemia|hbsbetathalassemia
5093421|NCT01242878|Hemoglobinopathy|hemoglobinopathy
5093422|NCT01242878|Hemoglobinopathies|hemoglobinopathies
5093423|NCT01242865|Stress|stress
5093424|NCT01242865|Anxiety|anxiety
5093425|NCT01242865|Resilience|resilience
5093426|NCT01242865|Mindfulness|mindfulness
5093427|NCT01242865|Quality of Life|quality of life
5093428|NCT01242865|Stress Management|stress management
5093429|NCT01242852|Hysteroscopy|hysteroscopy
5093430|NCT01242852|infertility|infertility
5093431|NCT01242852|subfertility|subfertility
5093432|NCT01242852|intrauterine abnormalities|intrauterine abnormalities
5093433|NCT01242852|intracavitary pathology|intracavitary pathology
5093434|NCT01242852|IVF|ivf
5093435|NCT01242852|ICSI|icsi
5093436|NCT01242852|in vitro fertilization|in vitro fertilization
5093437|NCT01242852|intracytoplasmic sperm injection|intracytoplasmic sperm injection
5093438|NCT01242839|CACICOL20|cacicol20
5093439|NCT01242813|TNF-receptor associated periodic syndrome|tnf-receptor associated periodic syndrome
5093440|NCT01242813|fevers|fevers
5093441|NCT01242813|rashes|rashes
5093442|NCT01242813|musculoskeletal and abdominal pain|musculoskeletal and abdominal pain
5093443|NCT01242813|periorbital edema|periorbital edema
5093444|NCT01242813|TNFR1|tnfr1
5093445|NCT01242800|male breast cancer|male breast cancer
5093446|NCT01242800|stage IV breast cancer|stage iv breast cancer
5093447|NCT01242787|Chronic hepatitis B|chronic hepatitis b
5093448|NCT01242787|LB80380|lb80380
5093449|NCT01242787|treatment-naive|treatment-naive
5093450|NCT01242787|entecavir|entecavir
5093451|NCT01242787|Extension|extension
5093452|NCT01242774|AML|aml
5093453|NCT01242774|bone marrow|bone marrow
5093454|NCT01242774|abnormal blast cells of myeloid|abnormal blast cells of myeloid
5093455|NCT01242774|acute leukemia|acute leukemia
5093456|NCT01242774|cytogenetic abnormalities|cytogenetic abnormalities
5093457|NCT01242774|HDACi|hdaci
5093458|NCT01242761|Accuracy of diagnostic ultrasound based in community or as part of a specialist hospital-based service|accuracy of diagnostic ultrasound based in community or as part of a specialist hospital-based service
5093459|NCT01242735|Obsessive Compulsive Disorder|obsessive compulsive disorder
5093460|NCT01242735|OCD|ocd
5093461|NCT01242735|Exercise|exercise
5093462|NCT01242735|Aerobic Exercise|aerobic exercise
5093463|NCT01242722|Heart failure|heart failure
5093464|NCT01242722|auto threshold|auto threshold
5093465|NCT01242722|pacing|pacing
5093466|NCT01242722|CRT-D recipients|crt-d recipients
5093467|NCT01242722|Left Ventricular (LV) evoked response signals|left ventricular (lv) evoked response signals
5093468|NCT01242696|Drug Eluting Stents|drug eluting stents
5093469|NCT01242696|Observational|observational
5093470|NCT01242696|All-Comers|all-comers
5093471|NCT01242657|Tobacco Use Cessation|tobacco use cessation
5093472|NCT01242657|Youth Tobacco Use|youth tobacco use
5093473|NCT01242657|Physical Activity|physical activity
5093474|NCT01242657|Smoking Cessation Intervention|smoking cessation intervention
5093475|NCT01242618|nasal cartilage diseases|nasal cartilage diseases
5093476|NCT01242605|unresectable|unresectable
5093477|NCT01242605|advanced|advanced
5093478|NCT01242566|Temozolomide|temozolomide
5093479|NCT01242566|Elderly|elderly
5093480|NCT01242566|Glioblastoma|glioblastoma
5093481|NCT01242566|Karnofsky performance score (KPS)|karnofsky performance score (kps)
5093482|NCT01242540|Pain|pain
5093483|NCT01242540|Functional Magnetic Resonance Imaging|functional magnetic resonance imaging
5093484|NCT01242527|dyslipidemia|dyslipidemia
5093485|NCT01242527|hyperlipidemia|hyperlipidemia
5093486|NCT01242527|omega-3 carboxylic acid|omega-3 carboxylic acid
5093487|NCT01242514|Rheumatoid Arthritis|rheumatoid arthritis
5093488|NCT01242514|OSKIRA|oskira
5093489|NCT01242514|Fostamatinib|fostamatinib
5093490|NCT01242501|Prevention|prevention
5093491|NCT01242501|Counseling|counseling
5093492|NCT01242501|Behavioral interventions|behavioral interventions
5093493|NCT01242501|HIV risk reduction|hiv risk reduction
5093494|NCT01242488|Rheumatoid Arthritis|rheumatoid arthritis
5093495|NCT01242488|CDP6038|cdp6038
5093496|NCT01242488|Interleukin-6|interleukin-6
5093497|NCT01242488|Tocilizumab|tocilizumab
5093498|NCT01242475|tuberculosis|tuberculosis
5093499|NCT01242475|rdESAT-6|rdesat-6
5093500|NCT01242475|CFP-10|cfp-10
5093501|NCT01242475|skin test|skin test
5093502|NCT01242475|diagnostic test|diagnostic test
5093503|NCT01242462|Conventional mechanical ventilation|conventional mechanical ventilation
5093504|NCT01242462|Mid-frequency ventilation|mid-frequency ventilation
5093505|NCT01242462|Respiratory Distress Syndrome|respiratory distress syndrome
5093506|NCT01242462|Preterm Newborn Infant|preterm newborn infant
5093507|NCT01242462|Mean Airway Pressure|mean airway pressure
5093508|NCT01242462|Mean Arterial Pressure|mean arterial pressure
5093509|NCT01242462|Mean Peak Inspiratory Pressure|mean peak inspiratory pressure
5093510|NCT01242449|Breast cancer|breast cancer
5093511|NCT01242449|Metastatic|metastatic
5093512|NCT01242449|HER2 positive|her2 positive
5093513|NCT01242449|vinorelbine|vinorelbine
5093514|NCT01242436|Ovarian Cancer|ovarian cancer
5093515|NCT01242436|Peritoneal Metastasis|peritoneal metastasis
5093516|NCT01242436|Whole body diffusion MRI|whole body diffusion mri
5093517|NCT01242436|therapy|therapy
5093518|NCT01242423|musculoskeletal shockwave therapy|musculoskeletal shockwave therapy
5093519|NCT01242410|Short cervix|short cervix
5093520|NCT01242410|Preterm birth|preterm birth
5093521|NCT01242410|Cervical pessary|cervical pessary
5093522|NCT01242410|Twins|twins
5093523|NCT01242371|Schizophrenia|schizophrenia
5093524|NCT01242371|Schizoaffective|schizoaffective
5093525|NCT01242371|Probiotic supplements|probiotic supplements
5093526|NCT01242371|Gliadin|gliadin
5093527|NCT01242371|Casein|casein
5093528|NCT01242358|hypoxaemia - capnography - integrated pulmonary index - PEG|hypoxaemia - capnography - integrated pulmonary index - peg
5093529|NCT01242345|Hypoxemia|hypoxemia
5093530|NCT01242345|Capnography|capnography
5093531|NCT01242345|Integrated pulmonary index|integrated pulmonary index
5093532|NCT01242345|Sedation|sedation
5093533|NCT01242345|Propofol|propofol
5093534|NCT01242345|Safety|safety
5093535|NCT01242332|perioperative|perioperative
5093536|NCT01242332|pregabalin|pregabalin
5093537|NCT01242332|arthroscopic anterior cruciate ligament reconstruction|arthroscopic anterior cruciate ligament reconstruction
5093538|NCT01242332|postoperative pain management|postoperative pain management
5093539|NCT01242319|quality improvement|quality improvement
5093540|NCT01242319|implementation trials|implementation trials
5093541|NCT01242319|cholesterol guidelines|cholesterol guidelines
5093542|NCT01242319|patient activation|patient activation
5093543|NCT01242306|endothelial dysfunction acetylcholine bms ses|endothelial dysfunction acetylcholine bms ses
5093544|NCT01242280|Acute variceal bleeding|acute variceal bleeding
5093545|NCT01242280|Massive bleeding|massive bleeding
5093546|NCT01242280|Liver Cirrhosis|liver cirrhosis
5093547|NCT01242280|Esophageal tamponade|esophageal tamponade
5093548|NCT01242280|Esophageal stent|esophageal stent
5093549|NCT01242267|multiple myeloma|multiple myeloma
5093550|NCT01242267|transplant|transplant
5093551|NCT01242267|Multiple myeloma patients undergoing transplant|multiple myeloma patients undergoing transplant
5093552|NCT01242254|KH902|kh902
5093553|NCT01242254|age-related macular degeneration|age-related macular degeneration
5093554|NCT01242254|choroidal neovascularization|choroidal neovascularization
5093555|NCT01242254|intravitreal injection|intravitreal injection
5093556|NCT01242254|multiple injections|multiple injections
5093557|NCT01242241|Propofol|propofol
5093558|NCT01242241|Childhood obesity|childhood obesity
5093559|NCT01242241|Pharmacodynamics|pharmacodynamics
5093560|NCT01242228|ASP1941|asp1941
5093561|NCT01242228|Diabetes mellitus|diabetes mellitus
5093562|NCT01242228|Dipeptidyl peptidase-4 inhibitor|dipeptidyl peptidase-4 inhibitor
5093563|NCT01242228|DPP-4 inhibitor|dpp-4 inhibitor
5093564|NCT01242228|long-term safety|long-term safety
5093565|NCT01242215|ASP1941|asp1941
5093566|NCT01242215|Diabetes mellitus|diabetes mellitus
5093567|NCT01242215|sulfonylurea|sulfonylurea
5093568|NCT01242202|ASP1941|asp1941
5093569|NCT01242202|Diabetes mellitus|diabetes mellitus
5093570|NCT01242202|alpha glucosidase inhibitor|alpha glucosidase inhibitor
5093571|NCT01242202|long-term safety|long-term safety
5093572|NCT01242150|Acute Respiratory Failure|acute respiratory failure
5093573|NCT01242150|Continuous Positive Airway Pressure|continuous positive airway pressure
5093574|NCT01242150|Infants|infants
5093575|NCT01242150|Helmet|helmet
5093576|NCT01242111|Mucopolysaccharidosis IV type A|mucopolysaccharidosis iv type a
5093577|NCT01242111|MPS IV Type A|mps iv type a
5093578|NCT01242111|Mucopolysaccharidosis IVA|mucopolysaccharidosis iva
5093579|NCT01242111|MPS IVA|mps iva
5093580|NCT01242111|Morquio A Syndrome|morquio a syndrome
5093581|NCT01242111|Lysosomal Storage Disorder|lysosomal storage disorder
5093582|NCT01242111|LSD|lsd
5093583|NCT01242111|N-acetylgalactosamine-6-sulfatase|n-acetylgalactosamine-6-sulfatase
5093584|NCT01242111|N-acetylgalactosamine-6-sulfate sulfatase|n-acetylgalactosamine-6-sulfate sulfatase
5093585|NCT01242111|galactose-6-sulfatase|galactose-6-sulfatase
5093586|NCT01242111|GALNS|galns
5093587|NCT01242111|enzyme replacement therapy|enzyme replacement therapy
5093588|NCT01242111|ERT|ert
5093589|NCT01242098|Asthma|asthma
5093590|NCT01242098|Combination therapy|combination therapy
5093591|NCT01242098|Primary care management|primary care management
5093592|NCT01242098|Switch|switch
5093593|NCT01242098|ICS/LABA|ics/laba
5093594|NCT01242098|Fostair|fostair
5093595|NCT01242098|Seretide|seretide
5093596|NCT01242085|alignment|alignment
5093597|NCT01242072|malignancy|malignancy
5093598|NCT01242072|etoposide and carboplatin|etoposide and carboplatin
5093599|NCT01242072|non small cell lung cancer|non small cell lung cancer
5093600|NCT01242072|small cell lung cancer|small cell lung cancer
5093601|NCT01242072|testicular cancer|testicular cancer
5093602|NCT01242072|thymoma|thymoma
5093603|NCT01242072|ovarian cancer|ovarian cancer
5093604|NCT01242072|osteosarcoma|osteosarcoma
5093605|NCT01242059|Obesity|obesity
5093606|NCT01242059|Food intake regulation|food intake regulation
5093607|NCT01242059|blood glucose regulation|blood glucose regulation
5093608|NCT01242059|protein|protein
5093609|NCT01242059|fiber|fiber
5093610|NCT01242059|pulses|pulses
5093611|NCT01242059|yellow peas|yellow peas
5093612|NCT01242046|female sexual arousal|female sexual arousal
5093613|NCT01242033|red raspberries|red raspberries
5093614|NCT01242033|post-prandial|post-prandial
5093615|NCT01242033|oxidative stress|oxidative stress
5093616|NCT01242033|antioxidants|antioxidants
5093617|NCT01242033|polyphenols|polyphenols
5093618|NCT01242033|vitamin C|vitamin c
5093619|NCT01242033|acute dietary intervention|acute dietary intervention
5093620|NCT01242007|Myotonic dystrophy|myotonic dystrophy
5093621|NCT01242007|Steinert's disease|steinert's disease
5093622|NCT01241981|Breast|breast
5093623|NCT01241981|Cancer|cancer
5093624|NCT01241981|Digital|digital
5093625|NCT01241981|Mammography|mammography
5093626|NCT01241981|Tomosynthesis|tomosynthesis
5093627|NCT01241968|Extracorporeal Shockwave Therapy|extracorporeal shockwave therapy
5093628|NCT01241968|Myocardial Ischemia|myocardial ischemia
5093629|NCT01241968|Refractory Angina|refractory angina
5093630|NCT01241955|CPR|cpr
5093631|NCT01241942|Lung Transplant|lung transplant
5093632|NCT01241942|Emphysema|emphysema
5093633|NCT01241942|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
5093634|NCT01241942|Cystic Fibrosis|cystic fibrosis
5093635|NCT01241942|Pulmonary Fibrosis|pulmonary fibrosis
5093636|NCT01241942|Bronchiectasis|bronchiectasis
5093637|NCT01241942|Sarcoidosis|sarcoidosis
5093638|NCT01241942|Pulmonary Hypertension|pulmonary hypertension
5093639|NCT01241942|Alpha-1 Antitrypsin Deficiency|alpha-1 antitrypsin deficiency
5093640|NCT01241929|advanced cancer|advanced cancer
5093641|NCT01241916|elbow, splint|elbow, splint
5093642|NCT01241903|Platelet activation|platelet activation
5093643|NCT01241903|platelet leukocyte aggregates|platelet leukocyte aggregates
5093644|NCT01241890|Cystic Fibrosis|cystic fibrosis
5093645|NCT01241890|Children|children
5093646|NCT01241890|Exhaled Breath Condensate|exhaled breath condensate
5093647|NCT01241890|Non-invasive Inflammatory Markers|non-invasive inflammatory markers
5093648|NCT01241890|Volatile Organic Compounds|volatile organic compounds
5093649|NCT01241890|Home monitoring|home monitoring
5093650|NCT01241890|Quality of life|quality of life
5093651|NCT01241838|Heart failure|heart failure
5093652|NCT01241838|Left ventricular hypertrophy|left ventricular hypertrophy
5093653|NCT01241838|Diastolic dysfunction|diastolic dysfunction
5093654|NCT01241825|capsule endoscopy|capsule endoscopy
5093655|NCT01241825|chewing gum|chewing gum
5093656|NCT01241825|small bowel transit time|small bowel transit time
5093657|NCT01241812|knee|knee
5093658|NCT01241812|osteoarthritis|osteoarthritis
5093659|NCT01241799|endoscopic ultrasound guided fine needle aspiration (EUS-FNA)|endoscopic ultrasound guided fine needle aspiration (eus-fna)
5093660|NCT01241799|pancreatic biopsy|pancreatic biopsy
5093661|NCT01241799|randomized|randomized
5093662|NCT01241799|single blind|single blind
5093663|NCT01241799|fine needle aspiration (FNA) adequacy|fine needle aspiration (fna) adequacy
5093865|NCT01241032|Udenafil|udenafil
5093664|NCT01241799|fine needle aspiration (FNA) accuracy|fine needle aspiration (fna) accuracy
5093665|NCT01241786|chronic lymphocytic leukemia (CLL)|chronic lymphocytic leukemia (cll)
5093666|NCT01241786|small lymphocytic lymphoma (SLL)|small lymphocytic lymphoma (sll)
5093667|NCT01241773|TMC435-TiDP16-C123|tmc435-tidp16-c123
5093668|NCT01241773|TMC435-C123|tmc435-c123
5093669|NCT01241773|TMC435|tmc435
5093670|NCT01241773|HCV|hcv
5093671|NCT01241773|Hepatitis C|hepatitis c
5093672|NCT01241760|Genotype 1 chronic hepatitis C|genotype 1 chronic hepatitis c
5093673|NCT01241760|VX-950-C211|vx-950-c211
5093674|NCT01241760|VX-950|vx-950
5093675|NCT01241760|IL28B|il28b
5093676|NCT01241760|Telaprevir|telaprevir
5093677|NCT01241760|Hepatitis C|hepatitis c
5093678|NCT01241760|BID|bid
5093679|NCT01241760|Q8h|q8h
5093680|NCT01241760|SOC|soc
5093681|NCT01241734|Diffuse Large B cell Lymphoma|diffuse large b cell lymphoma
5093682|NCT01241721|Breast Diseases|breast diseases
5093683|NCT01241721|Breast Neoplasms|breast neoplasms
5093684|NCT01241721|Neoplasms|neoplasms
5093685|NCT01241695|Oral nutritional supplement, diabetes mellitus type 2, glycaemic control|oral nutritional supplement, diabetes mellitus type 2, glycaemic control
5094060|NCT01240291|glutamine|glutamine
5093686|NCT01241695|Oral nutritional supplement (Food for special medical purposes)|oral nutritional supplement (food for special medical purposes)
5093687|NCT01241682|Mesothelioma|mesothelioma
5093688|NCT01241682|Dendritic cells|dendritic cells
5093689|NCT01241682|Cyclophosphamide|cyclophosphamide
5093690|NCT01241682|Tumor lysate-loaded|tumor lysate-loaded
5093691|NCT01241682|Immunotherapy|immunotherapy
5093692|NCT01241656|Prostate cancer|prostate cancer
5093693|NCT01241656|Decision support intervention (DESI)|decision support intervention (desi)
5093694|NCT01241656|Shared medical appointments (SMA)|shared medical appointments (sma)
5093695|NCT01241656|Comparative effectiveness research (CER)|comparative effectiveness research (cer)
5093696|NCT01241643|interleukin-7|interleukin-7
5093697|NCT01241643|immune-based therapies|immune-based therapies
5093698|NCT01241643|HIV|hiv
5093699|NCT01241643|infectious disease|infectious disease
5093700|NCT01241643|immune non-responders|immune non-responders
5093701|NCT01241630|Somato-sensory reflex arch|somato-sensory reflex arch
5093702|NCT01241630|Spinal cord injury|spinal cord injury
5093703|NCT01241630|Xiao Procedure|xiao procedure
5093704|NCT01241617|Lung disease|lung disease
5093705|NCT01241617|Lobectomy|lobectomy
5093706|NCT01241617|Pulmonary resection|pulmonary resection
5093707|NCT01241591|CP-690,550|cp-690,550
5093708|NCT01241591|Etanercept|etanercept
5093709|NCT01241591|Moderate|moderate
5093710|NCT01241591|Severe|severe
5093711|NCT01241591|Chronic|chronic
5093712|NCT01241591|Plaque|plaque
5093713|NCT01241591|Psoriasis|psoriasis
5093714|NCT01241591|Efficacy|efficacy
5093715|NCT01241591|Safety|safety
5093716|NCT01241591|Tofacitinib|tofacitinib
5093717|NCT01241591|Xeljanz|xeljanz
5093718|NCT01241591|OPT Compare|opt compare
5093719|NCT01241591|OPT|opt
5093720|NCT01241591|head-to-head|head-to-head
5093721|NCT01241591|non-inferiority|non-inferiority
5093722|NCT01241591|Psoriasis vulgaris|psoriasis vulgaris
5093723|NCT01241591|short-term|short-term
5093724|NCT01241591|Itch|itch
5093725|NCT01241591|Pruritus|pruritus
5093726|NCT01241591|Plaque psoriasis|plaque psoriasis
5093727|NCT01241591|DLQI|dlqi
5093728|NCT01241578|Obesity|obesity
5093729|NCT01241578|Behavior Therapy|behavior therapy
5093730|NCT01241578|Lifestyle|lifestyle
5093731|NCT01241578|Technology|technology
5093732|NCT01241578|Cellular Phone|cellular phone
5093733|NCT01241565|lung cancer|lung cancer
5093734|NCT01241565|lobectomy|lobectomy
5093735|NCT01241565|wedge resection|wedge resection
5093736|NCT01241552|Clostridium difficile|clostridium difficile
5093737|NCT01241552|recurrent Clostridium difficile|recurrent clostridium difficile
5093738|NCT01241552|vancomycin|vancomycin
5093739|NCT01241552|metronidazole|metronidazole
5093740|NCT01241552|monoclonal antibody|monoclonal antibody
5093741|NCT01241552|Clostridium difficile infection (CDI)|clostridium difficile infection (cdi)
5093742|NCT01241526|COPD|copd
5093743|NCT01241526|COMET|comet
5093744|NCT01241526|Disease management|disease management
5093745|NCT01241513|glutathione|glutathione
5093746|NCT01241513|redox status|redox status
5093747|NCT01241513|carotid body chemosensitivity|carotid body chemosensitivity
5093748|NCT01241513|ventilation|ventilation
5093749|NCT01241500|Myelodysplastic syndromes|myelodysplastic syndromes
5093750|NCT01241500|MDS|mds
5093751|NCT01241487|Hypertension, Valsartan/Amlodipine,|hypertension, valsartan/amlodipine,
5093752|NCT01241461|Advanced Cancer|advanced cancer
5093753|NCT01241461|Metastatic Cancer|metastatic cancer
5093754|NCT01241461|p70s6 inhibitor|p70s6 inhibitor
5093755|NCT01241448|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
5093756|NCT01241422|Asthma|asthma
5093757|NCT01241422|Mild asthma|mild asthma
5093758|NCT01241422|Singulair|singulair
5093759|NCT01241422|JNJ 40929837|jnj 40929837
5093760|NCT01241422|Montelukast|montelukast
5093761|NCT01241409|Healthy|healthy
5093762|NCT01241409|Sprinkle Capsule Formulation|sprinkle capsule formulation
5093763|NCT01241409|Rabeprazole sodium|rabeprazole sodium
5093764|NCT01241409|Pharmacokinetics|pharmacokinetics
5093765|NCT01241409|Bioequivalence|bioequivalence
5093766|NCT01241409|Safety|safety
5093767|NCT01241396|Multiple Myeloma|multiple myeloma
5093768|NCT01241396|observational|observational
5093769|NCT01241396|survey|survey
5093770|NCT01241396|non-interventional|non-interventional
5093771|NCT01241396|international|international
5093772|NCT01241396|epidemiology|epidemiology
5093773|NCT01241396|treatment|treatment
5093774|NCT01241396|routine clinical practice|routine clinical practice
5093775|NCT01241396|retrospective|retrospective
5093776|NCT01241396|prospective|prospective
5093777|NCT01241383|Scleroderma renal crisis|scleroderma renal crisis
5093778|NCT01241383|angiotensin converting enzyme inhibitors|angiotensin converting enzyme inhibitors
5093779|NCT01241383|bosentan|bosentan
5093780|NCT01241383|endothelin receptor antagonist|endothelin receptor antagonist
5093781|NCT01241370|Retinal endothelia dysfunction|retinal endothelia dysfunction
5093782|NCT01241370|Type 2 diabetes mellitus|type 2 diabetes mellitus
5093783|NCT01241370|Insulin-resistance|insulin-resistance
5093784|NCT01241370|micro-lightguide spectrophotometry|micro-lightguide spectrophotometry
5093785|NCT01241370|laserdopplerfluxmetry|laserdopplerfluxmetry
5093786|NCT01241357|Iron|iron
5093787|NCT01241357|Iron overload|iron overload
5093788|NCT01241357|Hepatic iron concentration|hepatic iron concentration
5093789|NCT01241357|High-temperature superconductivity|high-temperature superconductivity
5093790|NCT01241357|Magnetic susceptibility|magnetic susceptibility
5093791|NCT01241357|Susceptometer|susceptometer
5093792|NCT01241344|Adv|adv
5093793|NCT01241344|Hematopoeitic Stem cell Transplant|hematopoeitic stem cell transplant
5093794|NCT01241344|HSCT|hsct
5093795|NCT01241331|moderate to severe facial acne vulgaris|moderate to severe facial acne vulgaris
5093796|NCT01241318|neonate|neonate
5093797|NCT01241318|omphalitis|omphalitis
5093798|NCT01241318|neonatal mortality|neonatal mortality
5093799|NCT01241318|maternal health|maternal health
5093800|NCT01241318|umbilical cord infection|umbilical cord infection
5093801|NCT01241305|Vasculitis|vasculitis
5093802|NCT01241305|CSS|css
5093803|NCT01241305|EGPA|egpa
5093804|NCT01241305|GCA|gca
5093805|NCT01241305|GPA|gpa
5093806|NCT01241305|WG|wg
5093807|NCT01241305|MPA|mpa
5093808|NCT01241305|PAN|pan
5093809|NCT01241305|TAK|tak
5093810|NCT01241279|cataract surgery|cataract surgery
5093811|NCT01241279|intraocular lens|intraocular lens
5093812|NCT01241266|Peptic Ulcer Bleeding|peptic ulcer bleeding
5093813|NCT01241266|high risk|high risk
5093814|NCT01241266|None-Interventional Study|none-interventional study
5093815|NCT01241266|he proportion of peptic ulcer bleeding patients who are at high risk (Forrest Ia-IIb)|he proportion of peptic ulcer bleeding patients who are at high risk (forrest ia-iib)
5093816|NCT01241253|legumes|legumes
5093817|NCT01241253|glycemic response|glycemic response
5093818|NCT01241253|glucose|glucose
5093819|NCT01241253|type 2 diabetes mellitus|type 2 diabetes mellitus
5093820|NCT01241227|liver fibrosis|liver fibrosis
5093821|NCT01241227|survival|survival
5093822|NCT01241227|transient elastography|transient elastography
5093823|NCT01241214|Seasonal allergic rhinitis|seasonal allergic rhinitis
5093825|NCT01241214|Allergic rhinitis|allergic rhinitis
5093826|NCT01241214|Allergies|allergies
5093827|NCT01241201|intestinal health|intestinal health
5093828|NCT01241201|probiotics|probiotics
5093829|NCT01241201|inflammation|inflammation
5093830|NCT01241201|biomarkers|biomarkers
5093831|NCT01241188|tuberculosis|tuberculosis
5093832|NCT01241188|rdESAT-6|rdesat-6
5093833|NCT01241188|CFP-10|cfp-10
5093834|NCT01241188|skin test|skin test
5093835|NCT01241188|diagnostic test|diagnostic test
5093836|NCT01241175|IOP|iop
5093837|NCT01241175|ophthalmic anesthesia|ophthalmic anesthesia
5093838|NCT01241175|magnesium sulfate|magnesium sulfate
5093839|NCT01241162|Neuroblastoma|neuroblastoma
5093840|NCT01241162|Ewings sarcoma|ewings sarcoma
5093841|NCT01241162|osteogenic sarcoma|osteogenic sarcoma
5093842|NCT01241162|rhabdomyosarcoma|rhabdomyosarcoma
5093843|NCT01241162|synovial sarcoma|synovial sarcoma
5093844|NCT01241162|high-risk|high-risk
5093845|NCT01241162|relapsed|relapsed
5093846|NCT01241162|children|children
5093847|NCT01241149|Nissen fundoplication|nissen fundoplication
5093848|NCT01241149|non-acid reflux disease|non-acid reflux disease
5093849|NCT01241149|anti-reflux surgery|anti-reflux surgery
5093850|NCT01241136|pilonidal disease, cystectomy, recurrence|pilonidal disease, cystectomy, recurrence
5093851|NCT01241123|return of bowel function, post-operative, colon surgery|return of bowel function, post-operative, colon surgery
5093852|NCT01241110|PID, Ofloxacin, Azitromicine, Metronidazole|pid, ofloxacin, azitromicine, metronidazole
5093853|NCT01241097|endothelial function|endothelial function
5093854|NCT01241097|statins|statins
5093855|NCT01241097|ezetimibe|ezetimibe
5093856|NCT01241097|pleiotropism|pleiotropism
5093857|NCT01241084|asthmatic children|asthmatic children
5093858|NCT01241071|Lumbar region|lumbar region
5093859|NCT01241071|Pain|pain
5093860|NCT01241071|Fascia|fascia
5093861|NCT01241071|Electromyography|electromyography
5093862|NCT01241071|Goniometry|goniometry
5093863|NCT01241058|pediatrics, crohn's disease, disease course, therapy|pediatrics, crohn's disease, disease course, therapy
5093864|NCT01241032|DA-8159|da-8159
5093866|NCT01241032|Alcohol|alcohol
5093867|NCT01241019|asphyxia neonatorum, hypothermia, neuroprotection|asphyxia neonatorum, hypothermia, neuroprotection
5093868|NCT01241006|Relapse|relapse
5093869|NCT01241006|Corticosteroids|corticosteroids
5093870|NCT01240993|parenting intervention|parenting intervention
5093871|NCT01240993|mother-child relations|mother-child relations
5093872|NCT01240993|substance abuse|substance abuse
5093873|NCT01240993|attachment|attachment
5093874|NCT01240993|child development|child development
5093875|NCT01240967|Phase 1|phase 1
5093876|NCT01240967|healthy volunteers|healthy volunteers
5093877|NCT01240967|volunteers with renal impairment|volunteers with renal impairment
5093878|NCT01240967|pharmacokinetics|pharmacokinetics
5093879|NCT01240967|TC-5214|tc-5214
5093880|NCT01240954|Rhinitis|rhinitis
5093881|NCT01240954|Allergic|allergic
5093882|NCT01240954|Immunotherapy|immunotherapy
5093883|NCT01240915|safety efficacy MultiStem(r) moderate to severe Ulcerative Colitis|safety efficacy multistem(r) moderate to severe ulcerative colitis
5093884|NCT01240902|Valvular Heart Disease|valvular heart disease
5093885|NCT01240902|Critical Aortic Stenosis|critical aortic stenosis
5093886|NCT01240902|Severe Aortic Stenosis|severe aortic stenosis
5093887|NCT01240902|High Risk|high risk
5093888|NCT01240902|Aortic Valve Replacement|aortic valve replacement
5093889|NCT01240889|Ragweed allergies|ragweed allergies
5093890|NCT01240889|acoustic rhinometry|acoustic rhinometry
5093891|NCT01240889|nasal allergen challenge|nasal allergen challenge
5093892|NCT01240876|Sciatica|sciatica
5093893|NCT01240876|Pain|pain
5093894|NCT01240863|osteoarthritis|osteoarthritis
5093895|NCT01240863|low back pain|low back pain
5093896|NCT01240863|Moderate to Severe Pain|moderate to severe pain
5093897|NCT01240850|Retroperitoneal fibrosis|retroperitoneal fibrosis
5093898|NCT01240850|Inflammatory aneurysms|inflammatory aneurysms
5093899|NCT01240850|Methotrexate|methotrexate
5093900|NCT01240850|Prednisone|prednisone
5093901|NCT01240850|Aorta|aorta
5093902|NCT01240837|glycaemic index|glycaemic index
5093903|NCT01240837|arenga pinnata sugar|arenga pinnata sugar
5093904|NCT01240837|palm sugar|palm sugar
5093905|NCT01240837|diabetes|diabetes
5093906|NCT01240824|bladder cancer|bladder cancer
5093907|NCT01240824|urothelial carcinoma|urothelial carcinoma
5093908|NCT01240824|transitional cell carcinoma bladder|transitional cell carcinoma bladder
5093909|NCT01240824|ureter|ureter
5093910|NCT01240811|intrauterine device|intrauterine device
5093911|NCT01240811|IUD|iud
5093912|NCT01240811|levonorgestrel|levonorgestrel
5093913|NCT01240811|copper|copper
5093914|NCT01240811|CD4|cd4
5093915|NCT01240811|CCR5|ccr5
5093916|NCT01240811|microflora|microflora
5093917|NCT01240798|Depression|depression
5093918|NCT01240798|Anxiety|anxiety
5093919|NCT01240798|Coronary disease|coronary disease
5093920|NCT01240785|gestational diabetes|gestational diabetes
5093921|NCT01240785|metformin|metformin
5093922|NCT01240785|insulin|insulin
5093923|NCT01240772|Haemorrhoids, Surgery, Cost-effectiveness, Morbidity, Risk assessment,RCT, Stapled haemorrhoidopexy, Doppler-guided, Haemorrhoidal artery ligation, Outcome|haemorrhoids, surgery, cost-effectiveness, morbidity, risk assessment,rct, stapled haemorrhoidopexy, doppler-guided, haemorrhoidal artery ligation, outcome
5093924|NCT01240759|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
5093925|NCT01240759|Metformin|metformin
5093926|NCT01240746|Influenza|influenza
5093927|NCT01240746|Quadrivalent Influenza Vaccine|quadrivalent influenza vaccine
5093928|NCT01240746|Trivalent Influenza Vaccine|trivalent influenza vaccine
5093929|NCT01240746|Influenza viruses|influenza viruses
5093930|NCT01240746|Fluzone®|fluzone®
5093931|NCT01240720|I131|i131
5093932|NCT01240720|F16|f16
5093933|NCT01240720|antibody|antibody
5093934|NCT01240720|monoclonal|monoclonal
5093935|NCT01240720|tumor targeting|tumor targeting
5093936|NCT01240720|radioimmunotherapy|radioimmunotherapy
5093937|NCT01240720|lymphoma, breast and lung cancer|lymphoma, breast and lung cancer
5093938|NCT01240720|Patients with different cancer types|patients with different cancer types
5093939|NCT01240694|Lupus|lupus
5093941|NCT01240681|Locally Advanced Breast Cancer (LABC)|locally advanced breast cancer (labc)
5093942|NCT01240681|neoadjuvant chemotherapy|neoadjuvant chemotherapy
5093943|NCT01240681|Fluorothymidine Positron Emission Tomography (FLT PET)|fluorothymidine positron emission tomography (flt pet)
5093944|NCT01240681|Blood Oxygen Level Dependent Magnetic Resonance Imaging (BOLD MRI)|blood oxygen level dependent magnetic resonance imaging (bold mri)
5093945|NCT01240681|tumor response|tumor response
5093946|NCT01240681|mastectomy|mastectomy
5093947|NCT01240668|Hyponatremia|hyponatremia
5093948|NCT01240668|Euvolemia|euvolemia
5093949|NCT01240668|Hypervolemia|hypervolemia
5093950|NCT01240668|Euvolemic|euvolemic
5093951|NCT01240668|Hypervolemic|hypervolemic
5093952|NCT01240655|LCL161|lcl161
5093953|NCT01240655|solid tumors|solid tumors
5093954|NCT01240655|paclitaxel|paclitaxel
5093955|NCT01240642|Advanced or metastatic cancer|advanced or metastatic cancer
5093956|NCT01240642|refractory|refractory
5093957|NCT01240642|core phase|core phase
5093958|NCT01240642|extension phase|extension phase
5093959|NCT01240642|dose escalation|dose escalation
5093960|NCT01240642|standard chemotherapy|standard chemotherapy
5093961|NCT01240642|doctaxel|doctaxel
5093962|NCT01240642|paclitaxel|paclitaxel
5093963|NCT01240642|carboplatin|carboplatin
5093964|NCT01240642|safety|safety
5093965|NCT01240642|tolerability|tolerability
5093966|NCT01240616|Nicotine|nicotine
5093967|NCT01240616|Mecamylamine|mecamylamine
5093968|NCT01240616|Attention|attention
5093969|NCT01240616|fMRI|fmri
5093970|NCT01240616|Default Network|default network
5093971|NCT01240616|Healthy Volunteer|healthy volunteer
5093972|NCT01240616|HV|hv
5093973|NCT01240603|Artemisinin|artemisinin
5093974|NCT01240603|Malaria|malaria
5093975|NCT01240603|Drug Resistance|drug resistance
5093976|NCT01240603|Hemoglobin E|hemoglobin e
5093977|NCT01240590|Anaplastic Thyroid Cancer|anaplastic thyroid cancer
5093978|NCT01240590|Crolibulin|crolibulin
5093979|NCT01240590|Solid Tumors|solid tumors
5093980|NCT01240590|ATC|atc
5093981|NCT01240577|IPdR|ipdr
5093982|NCT01240577|Pharmacokinetics|pharmacokinetics
5093983|NCT01240577|Early Phase I|early phase i
5093984|NCT01240577|Cancer|cancer
5093985|NCT01240577|Solid Tumor|solid tumor
5093986|NCT01240577|Lymphoma|lymphoma
5093987|NCT01240551|Imaging|imaging
5093988|NCT01240551|Bone Metastasis|bone metastasis
5093989|NCT01240551|Bone Scan|bone scan
5093990|NCT01240551|Radiopharmaceutical|radiopharmaceutical
5093991|NCT01240551|Pet Scan|pet scan
5093992|NCT01240551|Prostate Cancer|prostate cancer
5093993|NCT01240525|graft versus host disease|graft versus host disease
5093994|NCT01240525|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5093995|NCT01240525|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5093996|NCT01240525|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5093997|NCT01240525|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5093998|NCT01240525|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5093999|NCT01240525|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
5094000|NCT01240525|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5094001|NCT01240525|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5094002|NCT01240525|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5094003|NCT01240525|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5094004|NCT01240525|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5094005|NCT01240525|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5094006|NCT01240525|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5094007|NCT01240525|Non-Hodgkin's lymphoma|non-hodgkin's lymphoma
5094008|NCT01240525|Hodgkin's lymphoma|hodgkin's lymphoma
5094009|NCT01240525|Chronic (Pro-)lymphocytic leukaemia|chronic (pro-)lymphocytic leukaemia
5094010|NCT01240525|Plasma cell myeloma|plasma cell myeloma
5094011|NCT01240525|Acute myeloid leukaemia|acute myeloid leukaemia
5094012|NCT01240525|Acute lymphoblastic leukaemia|acute lymphoblastic leukaemia
5094013|NCT01240525|Myelodysplastic syndrome|myelodysplastic syndrome
5094014|NCT01240525|Chronic myelomonocytic leukaemia|chronic myelomonocytic leukaemia
5094015|NCT01240499|Weight management|weight management
5094016|NCT01240499|New weight paradigm|new weight paradigm
5094017|NCT01240499|Overweight women|overweight women
5094018|NCT01240499|Eating behaviors|eating behaviors
5094019|NCT01240499|Appetite ratings|appetite ratings
5094020|NCT01240499|Blood lipids|blood lipids
5094021|NCT01240486|IRIS|iris
5094022|NCT01240486|HIV|hiv
5094023|NCT01240486|Immune|immune
5094024|NCT01240486|Reconstitution|reconstitution
5094025|NCT01240486|Inflammatory|inflammatory
5094026|NCT01240486|Syndrome|syndrome
5094027|NCT01240473|kala azar|kala azar
5094028|NCT01240473|visceral leishmaniasis|visceral leishmaniasis
5094029|NCT01240473|diagnosis|diagnosis
5094030|NCT01240473|drug resistance|drug resistance
5094031|NCT01240473|Therapeutics|therapeutics
5094032|NCT01240473|Capacity Building|capacity building
5094033|NCT01240447|NSCLC|nsclc
5094034|NCT01240447|lung cancer, small-cell|lung cancer, small-cell
5094035|NCT01240447|advanced lung cancer|advanced lung cancer
5094036|NCT01240434|trocar hernia closure laparoscopy|trocar hernia closure laparoscopy
5094037|NCT01240421|Metastatic breast cancer with no other treatment options|metastatic breast cancer with no other treatment options
5094038|NCT01240395|Multiple chemical sensitivities|multiple chemical sensitivities
5094039|NCT01240395|MCS|mcs
5094040|NCT01240395|Mindfulness-based cognitive therapy|mindfulness-based cognitive therapy
5094041|NCT01240395|MBCT|mbct
5094042|NCT01240369|VEGFC|vegfc
5094043|NCT01240369|CTTN|cttn
5094044|NCT01240369|miR326|mir326
5094045|NCT01240369|ESCC|escc
5094046|NCT01240369|NSCLC|nsclc
5094047|NCT01240356|transcranial doppler|transcranial doppler
5094048|NCT01240356|sonothrombolysis|sonothrombolysis
5094049|NCT01240356|ultrasound|ultrasound
5094050|NCT01240356|stroke|stroke
5094051|NCT01240343|Biobank|biobank
5094052|NCT01240343|Genetics|genetics
5094053|NCT01240330|Deep Vein Thrombosis|deep vein thrombosis
5094054|NCT01240330|Effects of compression therapy|effects of compression therapy
5094055|NCT01240330|Peak Flow Velocity|peak flow velocity
5094056|NCT01240317|expert system|expert system
5094057|NCT01240317|decision support system|decision support system
5094058|NCT01240317|human patient simulator|human patient simulator
5094059|NCT01240317|anesthesia|anesthesia
5094061|NCT01240291|trauma|trauma
5094062|NCT01240291|alanyl-glutamine|alanyl-glutamine
5094063|NCT01240265|Vitamin D deficiency|vitamin d deficiency
5094064|NCT01240265|Rickets|rickets
5094065|NCT01240265|Infant|infant
5094066|NCT01240265|Nutrition|nutrition
5094067|NCT01240252|diabetes|diabetes
5094068|NCT01240252|insulin resistance|insulin resistance
5094069|NCT01240239|Pre anesthesia consultation|pre anesthesia consultation
5094070|NCT01240239|telemedicine|telemedicine
5094071|NCT01240213|Vitamin D|vitamin d
5094072|NCT01240213|lifestyle intervention|lifestyle intervention
5094073|NCT01240213|postmenopausal women|postmenopausal women
5094074|NCT01240200|diabetes|diabetes
5094075|NCT01240200|elderly|elderly
5094076|NCT01240200|insulin injections|insulin injections
5094077|NCT01240187|epilepsy|epilepsy
5094078|NCT01240174|Antibiotic|antibiotic
5094079|NCT01240174|Antimicrobial|antimicrobial
5094080|NCT01240174|Prescribing|prescribing
5094081|NCT01240174|Cough|cough
5094082|NCT01240174|Acute Bronchitis|acute bronchitis
5094083|NCT01240161|Glioblastoma multiforme|glioblastoma multiforme
5094085|NCT01240161|PET|pet
5094086|NCT01240148|Allodynia|allodynia
5094087|NCT01240148|hyperalgesia|hyperalgesia
5094088|NCT01240148|paresthesia|paresthesia
5094089|NCT01240135|Contact Lens Wear|contact lens wear
5094090|NCT01240135|Contact Lens Solution|contact lens solution
5094091|NCT01240135|Multi-purpose disinfecting solution|multi-purpose disinfecting solution
5094092|NCT01240135|Myopia|myopia
5094093|NCT01240122|Corneal staining and comfort evaluation in normal, habitual contact lens wearers.|corneal staining and comfort evaluation in normal, habitual contact lens wearers.
5094094|NCT01240096|Functional dyspepsia|functional dyspepsia
5094095|NCT01240096|Weight loss|weight loss
5094096|NCT01240096|Mirtazapine|mirtazapine
5094097|NCT01240083|Depression|depression
5094098|NCT01240083|Transcranial magnetic stimulation|transcranial magnetic stimulation
5094099|NCT01240083|Thetaburst Stimulation|thetaburst stimulation
5094100|NCT01240083|Alternative treatment methods|alternative treatment methods
5094101|NCT01240070|diabetes,|diabetes,
5094102|NCT01240070|cardiovascular|cardiovascular
5094103|NCT01240070|risk factor|risk factor
5094104|NCT01240070|cardiovascular event|cardiovascular event
5094105|NCT01240070|intervention|intervention
5094106|NCT01240057|Isolated Congenital Diaphragmatic Hernia|isolated congenital diaphragmatic hernia
5094107|NCT01240057|Fetal Surgery|fetal surgery
5094108|NCT01240057|Pulmonary Hypoplasia|pulmonary hypoplasia
5094109|NCT01240044|Newborn Pain|newborn pain
5094110|NCT01240044|Respiratory Physiotherapy|respiratory physiotherapy
5094111|NCT01240044|Neonatal intensive care unit|neonatal intensive care unit
5094112|NCT01240031|Malnutrition|malnutrition
5094113|NCT01240031|Nutritional Risk|nutritional risk
5094114|NCT01240031|Intake|intake
5094115|NCT01240031|Food sensory|food sensory
5094116|NCT01240031|Nutritional therapy|nutritional therapy
5094117|NCT01240031|Energy|energy
5094118|NCT01240031|Protein|protein
5094119|NCT01240031|Handgrip strength|handgrip strength
5094120|NCT01240031|Reaction time|reaction time
5094121|NCT01240031|Quality of Life|quality of life
5094122|NCT01239979|coronary artery disease|coronary artery disease
5094123|NCT01239966|Acute Respiratory Distress syndrome|acute respiratory distress syndrome
5094124|NCT01239966|Acute renal Failure|acute renal failure
5094125|NCT01239953|In-stent restenosis|in-stent restenosis
5094126|NCT01239953|Drug-eluting balloon|drug-eluting balloon
5094127|NCT01239953|Drug-eluting stent|drug-eluting stent
5094128|NCT01239953|Angiography|angiography
5094129|NCT01239953|Minimal lumen diameter|minimal lumen diameter
5094130|NCT01239940|In-stent restenosis|in-stent restenosis
5094131|NCT01239940|Drug-eluting balloon|drug-eluting balloon
5094132|NCT01239940|Drug-eluting stent|drug-eluting stent
5094133|NCT01239940|Angiography|angiography
5094134|NCT01239940|Minimal lumen diameter|minimal lumen diameter
5094135|NCT01239927|diverticulitis|diverticulitis
5094136|NCT01239927|hartmann|hartmann
5094137|NCT01239927|anastomosis|anastomosis
5094138|NCT01239914|drug eluting stent|drug eluting stent
5094139|NCT01239914|coronary artery disease|coronary artery disease
5094140|NCT01239914|Korean registry|korean registry
5094141|NCT01239901|sickle cell disease|sickle cell disease
5094142|NCT01239901|sickle cell anemia|sickle cell anemia
5094143|NCT01239901|sickled cells|sickled cells
5094144|NCT01239901|blood vessel|blood vessel
5094145|NCT01239901|iron overload|iron overload
5094146|NCT01239888|Depression|depression
5094147|NCT01239888|Treatment resistant depression|treatment resistant depression
5094148|NCT01239888|Oxytocin|oxytocin
5094149|NCT01239888|Estrogen Modulators|estrogen modulators
5094150|NCT01239888|HPA axis|hpa axis
5094151|NCT01239888|Mental Disorders|mental disorders
5094152|NCT01239888|Estrogens|estrogens
5094153|NCT01239888|Tibolone|tibolone
5094154|NCT01239888|Estrogen Receptor Modulators|estrogen receptor modulators
5094155|NCT01239888|Androgens|androgens
5094156|NCT01239888|Hormones|hormones
5094157|NCT01239888|Hormone Substitutes|hormone substitutes
5094158|NCT01239888|Physiological Effects of Drugs|physiological effects of drugs
5094159|NCT01239888|Pharmacologic Actions|pharmacologic actions
5094160|NCT01239888|Hormone Antagonists|hormone antagonists
5094349|NCT01238835|Transapical|transapical
5094161|NCT01239888|Bone Density Conservation Agents|bone density conservation agents
5094162|NCT01239888|Estrogen Antagonists|estrogen antagonists
5094163|NCT01239862|pulmonary, silicosis, chronic and accelerated silicosis, autologous transplantation|pulmonary, silicosis, chronic and accelerated silicosis, autologous transplantation
5094164|NCT01239862|bone marrow cells, stem cells, cell therapy|bone marrow cells, stem cells, cell therapy
5094165|NCT01239849|Diabetes Mellitus, Hypercholesterolemia|diabetes mellitus, hypercholesterolemia
5094166|NCT01239836|urinary incontinence, self-management, cost, self-efficacy, continence promotion|urinary incontinence, self-management, cost, self-efficacy, continence promotion
5094167|NCT01239823|osteoarthritis|osteoarthritis
5094168|NCT01239823|whole body vibration|whole body vibration
5094169|NCT01239823|mobility|mobility
5094170|NCT01239823|rehabilitation|rehabilitation
5094171|NCT01239810|hyaluronic acid|hyaluronic acid
5094172|NCT01239810|cartilage|cartilage
5094173|NCT01239810|T2 mapping|t2 mapping
5094174|NCT01239810|quantitative|quantitative
5094175|NCT01239810|MRI|mri
5094176|NCT01239810|volume|volume
5094177|NCT01239784|pediatrics|pediatrics
5094178|NCT01239784|Heart Defects|heart defects
5094179|NCT01239784|Neurodevelopmental deficit|neurodevelopmental deficit
5094180|NCT01239784|Neurodevelopmental Rehabilitation|neurodevelopmental rehabilitation
5094181|NCT01239771|Safety|safety
5094182|NCT01239771|tolerability|tolerability
5094183|NCT01239771|healthy|healthy
5094184|NCT01239771|stable disease|stable disease
5094185|NCT01239771|oral|oral
5094186|NCT01239771|tablet|tablet
5094187|NCT01239745|Hormone adjuvant treatment of early breast cancer with aromatase inhibitors following 2-3 years of tamoxifen|hormone adjuvant treatment of early breast cancer with aromatase inhibitors following 2-3 years of tamoxifen
5094188|NCT01239719|Allergic dermatitis|allergic dermatitis
5094189|NCT01239693|Stunting|stunting
5094190|NCT01239693|Growth failure|growth failure
5094191|NCT01239693|Malnutrition|malnutrition
5094192|NCT01239693|Lipid based nutrient supplement|lipid based nutrient supplement
5094193|NCT01239693|LNS|lns
5094194|NCT01239693|Prevention|prevention
5094195|NCT01239693|Malawi|malawi
5094196|NCT01239693|Sub-Saharan Africa|sub-saharan africa
5094197|NCT01239693|Dietary supplementation|dietary supplementation
5094198|NCT01239693|Efficacy|efficacy
5094199|NCT01239693|Pregnancy|pregnancy
5094200|NCT01239693|Infancy|infancy
5094201|NCT01239693|Newborn|newborn
5094202|NCT01239680|hemorrhagic shock|hemorrhagic shock
5094203|NCT01239680|glutamine|glutamine
5094204|NCT01239680|trauma resuscitation|trauma resuscitation
5094205|NCT01239680|department of defense|department of defense
5094206|NCT01239680|trauma|trauma
5094207|NCT01239667|Health related quality of Life, Self Care behavior, activities of daily living|health related quality of life, self care behavior, activities of daily living
5094208|NCT01239654|acute|acute
5094209|NCT01239654|coronary|coronary
5094210|NCT01239654|syndrome|syndrome
5094211|NCT01239654|everolimus|everolimus
5094212|NCT01239654|zotarolimus|zotarolimus
5094213|NCT01239654|optical|optical
5094214|NCT01239654|coherence|coherence
5094215|NCT01239654|tomography|tomography
5094216|NCT01239641|Uterine Fibroids|uterine fibroids
5094217|NCT01239641|Myoectomy|myoectomy
5094218|NCT01239641|High Intensity Focused Ultrasound|high intensity focused ultrasound
5094219|NCT01239641|ablation|ablation
5094220|NCT01239602|changes in cortical excitability in subjects with chronic stroke after stem cell therapy|changes in cortical excitability in subjects with chronic stroke after stem cell therapy
5094221|NCT01239589|Patients admitted as for an acute bipolar manic episode|patients admitted as for an acute bipolar manic episode
5094222|NCT01239589|Description of management patterns and hospital stay in patients admitted for acute bipolar manic episode and treated with either quetiapine IR or quetiapine XR|description of management patterns and hospital stay in patients admitted for acute bipolar manic episode and treated with either quetiapine ir or quetiapine xr
5094223|NCT01239563|kidney transplantation|kidney transplantation
5094224|NCT01239563|donation after cardiac death|donation after cardiac death
5094225|NCT01239563|ischemia-reperfusion injury|ischemia-reperfusion injury
5094226|NCT01239563|thymoglobulin|thymoglobulin
5094227|NCT01239563|steroid avoidance|steroid avoidance
5094228|NCT01239563|lymphocyte|lymphocyte
5094229|NCT01239550|Insulin|insulin
5094230|NCT01239550|Detemir|detemir
5094231|NCT01239550|Dopamine, brain,neurotransmitter|dopamine, brain,neurotransmitter
5094232|NCT01239550|Diabetes|diabetes
5094233|NCT01239550|Obesity|obesity
5094234|NCT01239550|Neurotransmitters|neurotransmitters
5094235|NCT01239524|breast reconstruction, latissimus dorsi flap, thoracodorsal nerve, skeletal muscle disuse, breast MRI|breast reconstruction, latissimus dorsi flap, thoracodorsal nerve, skeletal muscle disuse, breast mri
5094236|NCT01239485|Pediatric refractory or relapsed acute leukemia|pediatric refractory or relapsed acute leukemia
5094237|NCT01239472|chronic allograft nephropathy|chronic allograft nephropathy
5094238|NCT01239472|cytokines|cytokines
5094239|NCT01239472|kidney transplant|kidney transplant
5094240|NCT01239472|calcineurin inhibitors withdrawn|calcineurin inhibitors withdrawn
5094241|NCT01239446|Hodgkin lymphoma|hodgkin lymphoma
5094242|NCT01239446|mediastinal irradiation|mediastinal irradiation
5094243|NCT01239446|Coronary Artery Disease|coronary artery disease
5094244|NCT01239394|NHL|nhl
5094245|NCT01239394|ofatumumab|ofatumumab
5094246|NCT01239381|proton radiation|proton radiation
5094454|NCT01238497|Transapical|transapical
5094247|NCT01239381|stereotactic body radiotherapy|stereotactic body radiotherapy
5094248|NCT01239381|SBRT|sbrt
5094249|NCT01239368|Multiple Myeloma|multiple myeloma
5094250|NCT01239368|High Risk|high risk
5094251|NCT01239368|Newly Diagnosed|newly diagnosed
5094252|NCT01239368|Adoptive Immunotherapy|adoptive immunotherapy
5094253|NCT01239368|Autologous|autologous
5094254|NCT01239329|Complex multiple disabilities|complex multiple disabilities
5094255|NCT01239329|Malnutrition|malnutrition
5094256|NCT01239277|muscle|muscle
5094257|NCT01239277|FSR|fsr
5094258|NCT01239277|protein|protein
5094259|NCT01239277|carbohydrate|carbohydrate
5094260|NCT01239277|leucine|leucine
5094261|NCT01239251|GlowCap|glowcap
5094262|NCT01239251|adjuvant endocrine therapy|adjuvant endocrine therapy
5094263|NCT01239238|asthma|asthma
5094264|NCT01239238|children|children
5094265|NCT01239238|home monitoring|home monitoring
5094266|NCT01239238|exhaled breath condensate|exhaled breath condensate
5094267|NCT01239238|non-invasive inflammatory markers|non-invasive inflammatory markers
5094268|NCT01239238|volatile organic compounds|volatile organic compounds
5094269|NCT01239225|Patients undergoing coronary angiography|patients undergoing coronary angiography
5094270|NCT01239212|seizures|seizures
5094271|NCT01239212|neonate|neonate
5094272|NCT01239212|levetiracetam|levetiracetam
5094273|NCT01239212|Epilepsy|epilepsy
5094274|NCT01239212|central nervous system diseases|central nervous system diseases
5094275|NCT01239212|anticonvulsants|anticonvulsants
5094276|NCT01239199|Infants|infants
5094277|NCT01239199|Exhaled Nitric Oxide|exhaled nitric oxide
5094278|NCT01239199|Asthma|asthma
5094279|NCT01239199|Tobacco smoke exposure|tobacco smoke exposure
5094280|NCT01239199|environment|environment
5094281|NCT01239186|methylation|methylation
5094282|NCT01239186|micro array|micro array
5094283|NCT01239186|locus H19|locus h19
5094284|NCT01239186|male infertility|male infertility
5094285|NCT01239173|Posttraumatic stress disorder|posttraumatic stress disorder
5094286|NCT01239173|functional Magnetic Resonance Imaging|functional magnetic resonance imaging
5094287|NCT01239173|Amygdala|amygdala
5094288|NCT01239173|emotion regulation|emotion regulation
5094289|NCT01239173|memory|memory
5094290|NCT01239160|lymphedema|lymphedema
5094291|NCT01239160|pneumatic compression device|pneumatic compression device
5094292|NCT01239160|randomised clinical trial|randomised clinical trial
5094293|NCT01239160|volume reduction|volume reduction
5094294|NCT01239147|weight maintenance|weight maintenance
5094295|NCT01239134|Malignant melanoma|malignant melanoma
5094296|NCT01239134|Metastatic|metastatic
5094297|NCT01239134|Unresectable|unresectable
5094298|NCT01239134|Stage III or Stage IV|stage iii or stage iv
5094299|NCT01239134|Solid tumor|solid tumor
5094300|NCT01239121|drug toxicity|drug toxicity
5094301|NCT01239121|drug interactions|drug interactions
5094302|NCT01239121|electronic health records|electronic health records
5094303|NCT01239121|medical errors|medical errors
5094304|NCT01239043|Meningitis|meningitis
5094305|NCT01239043|Meningococcal Meningitis|meningococcal meningitis
5094306|NCT01239043|Meningococcal Infections|meningococcal infections
5094307|NCT01239043|Menactra®|menactra®
5094308|NCT01239043|Menomune®|menomune®
5094309|NCT01239043|Meningococcal vaccine|meningococcal vaccine
5094310|NCT01239030|inattention|inattention
5094311|NCT01239030|impulsivity|impulsivity
5094312|NCT01239030|hyperactivity|hyperactivity
5094313|NCT01239030|ADHD|adhd
5094314|NCT01239004|dyslipidemia|dyslipidemia
5094315|NCT01239004|hyperlipidemia|hyperlipidemia
5094316|NCT01239004|hyperglycemia|hyperglycemia
5094317|NCT01239004|impaired fasting glucose|impaired fasting glucose
5094318|NCT01238978|Diabetes mellitus, vildagliptin, hypoglycemia, elderly|diabetes mellitus, vildagliptin, hypoglycemia, elderly
5094319|NCT01238952|solid tumors|solid tumors
5094320|NCT01238952|breast cancer|breast cancer
5094321|NCT01238952|triple negative breast cancer|triple negative breast cancer
5094322|NCT01238952|HER2 negative|her2 negative
5094323|NCT01238952|ER negative|er negative
5094324|NCT01238952|PR negative|pr negative
5094325|NCT01238939|solid tumors|solid tumors
5094326|NCT01238939|colorectal cancer|colorectal cancer
5094327|NCT01238926|Oxidative stress|oxidative stress
5094328|NCT01238926|Parkinson's disease|parkinson's disease
5094329|NCT01238926|Homocysteine|homocysteine
5094330|NCT01238926|Glutathione|glutathione
5094331|NCT01238926|B vitamins|b vitamins
5094332|NCT01238887|Satiety|satiety
5094333|NCT01238887|Food Intake|food intake
5094334|NCT01238887|Weight Loss|weight loss
5094335|NCT01238887|Oxidative Stress|oxidative stress
5094336|NCT01238887|botanicals|botanicals
5094337|NCT01238887|Garcinia Cambogia-derived hydroxycitric acid|garcinia cambogia-derived hydroxycitric acid
5094338|NCT01238861|Asthma|asthma
5094339|NCT01238861|Benralizumab|benralizumab
5094340|NCT01238861|MEDI-563|medi-563
5094341|NCT01238848|Hypertonic|hypertonic
5094342|NCT01238848|Saline|saline
5094343|NCT01238848|Bronchiolitis|bronchiolitis
5094344|NCT01238848|Efficacy|efficacy
5094345|NCT01238835|Sapien XT Valve|sapien xt valve
5094346|NCT01238835|Valvular Heart Disease|valvular heart disease
5094347|NCT01238835|Aortic Stenosis|aortic stenosis
5094348|NCT01238835|Heart Valve Therapy|heart valve therapy
5094350|NCT01238835|Transcatheter|transcatheter
5094351|NCT01238809|Compliance|compliance
5094352|NCT01238809|France|france
5094353|NCT01238796|telavancin|telavancin
5094354|NCT01238796|Pharmacokinetics|pharmacokinetics
5094355|NCT01238796|Severe renal disease|severe renal disease
5094356|NCT01238796|VIBATIV®|vibativ®
5094357|NCT01238796|ASP9809|asp9809
5094358|NCT01238770|Ovarian cancer|ovarian cancer
5094359|NCT01238757|Prospective Studies|prospective studies
5094360|NCT01238757|Humans, pediatric|humans, pediatric
5094361|NCT01238757|Positive-Pressure Respiration/methods*|positive-pressure respiration/methods*
5094362|NCT01238757|Respiration, Artificial/methods*|respiration, artificial/methods*
5094363|NCT01238757|Intensive Care|intensive care
5094364|NCT01238757|Intensive Care Units/statistics & numerical data*|intensive care units/statistics & numerical data*
5094365|NCT01238757|Respiration, Artificial/statistics & numerical data*|respiration, artificial/statistics & numerical data*
5094366|NCT01238757|Patients/statistics & numerical data*|patients/statistics & numerical data*
5094367|NCT01238757|Prevalence|prevalence
5094368|NCT01238757|Respiratory Muscles/innervation|respiratory muscles/innervation
5094369|NCT01238757|Child|child
5094370|NCT01238757|Child, Preschool|child, preschool
5094371|NCT01238757|Infant|infant
5094372|NCT01238757|Infant, Newborn|infant, newborn
5094373|NCT01238757|Intensive Care Units, Pediatric|intensive care units, pediatric
5094374|NCT01238757|Respiratory Rate*|respiratory rate*
5094375|NCT01238731|Valve replacement|valve replacement
5094376|NCT01238731|pulmonary hypertension|pulmonary hypertension
5094377|NCT01238731|long term follow up|long term follow up
5094378|NCT01238718|lidocaine|lidocaine
5094379|NCT01238718|anesthetic depth|anesthetic depth
5094380|NCT01238718|hemodynamics|hemodynamics
5094381|NCT01238718|rapid sequence induction|rapid sequence induction
5094382|NCT01238718|BIS|bis
5094383|NCT01238705|Hypertension|hypertension
5094384|NCT01238705|Antihypertensive Agents|antihypertensive agents
5094385|NCT01238705|Combination|combination
5094386|NCT01238705|Sexual Dysfunction|sexual dysfunction
5094387|NCT01238705|Oxidative Stress|oxidative stress
5094388|NCT01238692|Diffuse large B cell lymphoma|diffuse large b cell lymphoma
5094389|NCT01238692|DLBCL|dlbcl
5094390|NCT01238692|Relapsed B-cell lymphoma|relapsed b-cell lymphoma
5094391|NCT01238692|Refractory B-cell lymphoma|refractory b-cell lymphoma
5094392|NCT01238692|B-cell Lymphoma|b-cell lymphoma
5094393|NCT01238692|Panobinostat|panobinostat
5094394|NCT01238692|LBH589|lbh589
5094395|NCT01238692|Rituximab|rituximab
5094396|NCT01238692|Histone Deacetylase Inhibitors|histone deacetylase inhibitors
5094397|NCT01238679|safety|safety
5094398|NCT01238679|tolerability|tolerability
5094399|NCT01238679|pharmacokinetics|pharmacokinetics
5094400|NCT01238679|healthy volunteers|healthy volunteers
5094401|NCT01238666|liver|liver
5094402|NCT01238666|cancer|cancer
5094403|NCT01238666|tumor|tumor
5094404|NCT01238666|ablation|ablation
5094405|NCT01238666|Pathfinder|pathfinder
5094406|NCT01238653|liver|liver
5094407|NCT01238653|cancer|cancer
5094408|NCT01238653|tumor|tumor
5094409|NCT01238653|Pathfinder|pathfinder
5094410|NCT01238640|Smoking Cessation|smoking cessation
5094411|NCT01238640|Nicotine|nicotine
5094412|NCT01238627|Smoking Cessation|smoking cessation
5094413|NCT01238627|Nicotine pharmacokinetics|nicotine pharmacokinetics
5094414|NCT01238614|maternal depression|maternal depression
5094415|NCT01238614|clinical decision support|clinical decision support
5094416|NCT01238601|Breast augmentation|breast augmentation
5094417|NCT01238575|Pervasive Developmental Disorders|pervasive developmental disorders
5094418|NCT01238575|PDD|pdd
5094419|NCT01238575|PDD-NOS|pdd-nos
5094420|NCT01238575|Autistic Disorder|autistic disorder
5094421|NCT01238575|Autism|autism
5094422|NCT01238575|Asperger's Disorder|asperger's disorder
5094423|NCT01238575|Hyperactivity|hyperactivity
5094424|NCT01238575|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
5094425|NCT01238575|ADHD|adhd
5094426|NCT01238575|Medication|medication
5094427|NCT01238575|Drug|drug
5094428|NCT01238575|Guanfacine|guanfacine
5094429|NCT01238575|Intuniv|intuniv
5094430|NCT01238575|Placebo|placebo
5094431|NCT01238575|Methylphenidate|methylphenidate
5094432|NCT01238562|cancer patient|cancer patient
5094433|NCT01238562|chemotherapy|chemotherapy
5094434|NCT01238562|carboplatin|carboplatin
5094435|NCT01238562|taxol|taxol
5094436|NCT01238562|cyclophosphamide|cyclophosphamide
5094437|NCT01238562|pharmorubicin|pharmorubicin
5094438|NCT01238549|Spinal Cord Injuries|spinal cord injuries
5094439|NCT01238549|Quality of Life|quality of life
5094440|NCT01238536|Epidural Steroid Injection|epidural steroid injection
5094441|NCT01238536|Low Back Pain|low back pain
5094442|NCT01238536|Spinal Stenosis|spinal stenosis
5094443|NCT01238536|Elderly|elderly
5094444|NCT01238523|tibia|tibia
5094445|NCT01238523|shaft|shaft
5094446|NCT01238523|fracture|fracture
5094447|NCT01238523|children|children
5094448|NCT01238497|SAPIEN XT™|sapien xt™
5094449|NCT01238497|Transfemoral|transfemoral
5094450|NCT01238497|NovaFlex|novaflex
5094451|NCT01238497|NovaFlex+|novaflex+
5094452|NCT01238497|NF|nf
5094453|NCT01238497|NF+|nf+
5094455|NCT01238497|Transaortic|transaortic
5094456|NCT01238497|Ascendra2|ascendra2
5094457|NCT01238497|Ascendra+|ascendra+
5094458|NCT01238497|Asc+|asc+
5094459|NCT01238497|aortic stenosis|aortic stenosis
5094460|NCT01238497|aortic valve|aortic valve
5094461|NCT01238497|Transcatheter Heart Valve|transcatheter heart valve
5094462|NCT01238497|THV|thv
5094463|NCT01238484|Ankle Equinus|ankle equinus
5094464|NCT01238484|Ankle contracture|ankle contracture
5094465|NCT01238484|Diabetes Mellitus|diabetes mellitus
5094466|NCT01238484|Dynasplint|dynasplint
5094467|NCT01238484|AFD|afd
5094468|NCT01238471|retinopathy of prematurity|retinopathy of prematurity
5094469|NCT01238471|Propranolol|propranolol
5094470|NCT01238471|Vascular endothelial growth factor|vascular endothelial growth factor
5094471|NCT01238471|premature infant|premature infant
5094472|NCT01238458|[18F]AV-45 PET amyloid binding imaging|[18f]av-45 pet amyloid binding imaging
5094473|NCT01238458|Alzheimer's disease|alzheimer's disease
5094474|NCT01238458|mild cognitive impartment,|mild cognitive impartment,
5094475|NCT01238445|Pediatric|pediatric
5094476|NCT01238432|Pediatric|pediatric
5094477|NCT01238432|Polymorphism, Genetic|polymorphism, genetic
5094478|NCT01238432|Adrenergic beta-Agonists|adrenergic beta-agonists
5094479|NCT01238406|Type 1 diabetes|type 1 diabetes
5094480|NCT01238406|Closed loop|closed loop
5094481|NCT01238406|Artificial Pancreas|artificial pancreas
5094482|NCT01238380|Monogenic diabetes|monogenic diabetes
5094483|NCT01238380|HNF1A|hnf1a
5094484|NCT01238380|HNF4A|hnf4a
5094485|NCT01238380|GCK|gck
5094486|NCT01238380|genetic testing|genetic testing
5094487|NCT01238380|health economic model|health economic model
5094488|NCT01238354|Weight Loss|weight loss
5094489|NCT01238354|Social support|social support
5094490|NCT01238341|Pancreatobiliary disease in patients with altered gastric anatomy.|pancreatobiliary disease in patients with altered gastric anatomy.
5094491|NCT01238328|Mucopolysaccharidosis|mucopolysaccharidosis
5094492|NCT01238328|HSCT|hsct
5094493|NCT01238315|Batten's disease|batten's disease
5094494|NCT01238315|INCL|incl
5094495|NCT01238315|LINCL|lincl
5094496|NCT01238315|Neuronal Ceroid Lipofuscinosis|neuronal ceroid lipofuscinosis
5094497|NCT01238315|NCL|ncl
5094498|NCT01238289|peer education|peer education
5094499|NCT01238289|diabetes|diabetes
5094500|NCT01238289|randomized|randomized
5094501|NCT01238289|trial|trial
5094502|NCT01238276|soft tissue infection|soft tissue infection
5094503|NCT01238276|wound infection|wound infection
5094504|NCT01238276|cellulitis|cellulitis
5094505|NCT01238276|foot ulcer|foot ulcer
5094506|NCT01238276|Diabetes|diabetes
5094507|NCT01238276|antibiotics|antibiotics
5094508|NCT01238276|cefazolin|cefazolin
5094509|NCT01238276|cephazolin|cephazolin
5094510|NCT01238276|Ancef|ancef
5094511|NCT01238276|Kefzol|kefzol
5094512|NCT01238276|subcutaneous fluid administration|subcutaneous fluid administration
5094513|NCT01238276|ultrasound|ultrasound
5094514|NCT01238276|MRSA|mrsa
5094515|NCT01238276|Methicillin-resistant Staphylococcus aureus|methicillin-resistant staphylococcus aureus
5094516|NCT01238263|Atopic dermatitis, autologous serum skin testing, IgE autoantibodies|atopic dermatitis, autologous serum skin testing, ige autoantibodies
5094517|NCT01238250|16p11.2|16p11.2
5094518|NCT01238250|16p11.2 del|16p11.2 del
5094519|NCT01238250|16p11.2 deletion|16p11.2 deletion
5094520|NCT01238250|16p11.2 dup|16p11.2 dup
5094521|NCT01238250|16p11.2 duplication|16p11.2 duplication
5094522|NCT01238250|chromosome 16|chromosome 16
5094523|NCT01238250|chromosome 16p|chromosome 16p
5094524|NCT01238250|chromosome 16p11|chromosome 16p11
5094525|NCT01238250|chromosome 16p11.2|chromosome 16p11.2
5094526|NCT01238250|1q21.1|1q21.1
5094527|NCT01238250|1q21.1 del|1q21.1 del
5094528|NCT01238250|1q21.1 deletion|1q21.1 deletion
5094529|NCT01238250|1q21.1 dup|1q21.1 dup
5094530|NCT01238250|1q21.1 duplication|1q21.1 duplication
5094531|NCT01238250|chromosome 1|chromosome 1
5094532|NCT01238250|chromosome 1q|chromosome 1q
5094533|NCT01238250|chromosome 1q21|chromosome 1q21
5094534|NCT01238250|chromosome 1q21.1|chromosome 1q21.1
5094535|NCT01238250|genetic mutation|genetic mutation
5094536|NCT01238250|genetic variant|genetic variant
5094537|NCT01238250|gene variant|gene variant
5094538|NCT01238250|autism|autism
5094539|NCT01238250|ADNP|adnp
5094540|NCT01238250|ANKRD11|ankrd11
5094541|NCT01238250|ARID1B|arid1b
5094542|NCT01238250|ASXL3|asxl3
5094543|NCT01238250|ACTL6B|actl6b
5094544|NCT01238250|AHDC1|ahdc1
5094545|NCT01238250|BAF190|baf190
5094546|NCT01238250|ANK2|ank2
5094547|NCT01238250|ASH1L|ash1l
5094548|NCT01238250|BCL11A|bcl11a
5094549|NCT01238250|CHD2|chd2
5094550|NCT01238250|CHD8|chd8
5094551|NCT01238250|CTNNB1|ctnnb1
5094552|NCT01238250|CUL3|cul3
5094553|NCT01238250|DST|dst
5094554|NCT01238250|DYRK1A|dyrk1a
5094555|NCT01238250|FOXP1|foxp1
5094556|NCT01238250|GRIN2B|grin2b
5094557|NCT01238250|KDM6B|kdm6b
5094558|NCT01238250|KMT2E|kmt2e
5094559|NCT01238250|MBD5|mbd5
5094560|NCT01238250|MED13L|med13l
5094561|NCT01238250|PTEN|pten
5094562|NCT01238250|REST|rest
5094563|NCT01238250|SCN2A|scn2a
5094564|NCT01238250|SMARCC1|smarcc1
5094565|NCT01238250|SMARCC2|smarcc2
5094566|NCT01238250|SYNGAP1|syngap1
5094567|NCT01238250|HIVEP2|hivep2
5094568|NCT01238250|HNRNPH2|hnrnph2
5094569|NCT01238250|PPP2R5D|ppp2r5d
5094570|NCT01238250|CHAMP1|champ1
5094571|NCT01238250|CSNK2A1|csnk2a1
5094572|NCT01238250|CTBP1|ctbp1
5094573|NCT01238250|DDX3X|ddx3x
5094574|NCT01238250|DNMT3A|dnmt3a
5094575|NCT01238250|DSCAM|dscam
5094576|NCT01238250|GRIN2A|grin2a
5094577|NCT01238250|KAT6A|kat6a
5094578|NCT01238250|KATNAL2|katnal2
5094579|NCT01238250|KDM5B|kdm5b
5094580|NCT01238250|KMT2C|kmt2c
5094581|NCT01238250|KMT5B|kmt5b
5094582|NCT01238250|SUV420H1|suv420h1
5094583|NCT01238250|PACS1|pacs1
5094584|NCT01238250|PBRM1|pbrm1
5094585|NCT01238250|PTCHD1|ptchd1
5094586|NCT01238250|PURA|pura
5094587|NCT01238250|SETBP1|setbp1
5094588|NCT01238250|SETD5|setd5
5094589|NCT01238250|SMARCA4|smarca4
5094590|NCT01238250|STXBP1|stxbp1
5094591|NCT01238250|TBR1|tbr1
5094592|NCT01238237|Glioblastoma Multiforme|glioblastoma multiforme
5094593|NCT01238237|Anaplastic Astrocytoma|anaplastic astrocytoma
5094594|NCT01238237|High Grade Glial Neoplasms|high grade glial neoplasms
5094595|NCT01238237|Brain Tumor|brain tumor
5094596|NCT01238237|EGFR|egfr
5094597|NCT01238237|Epidermal Growth Factor Receptor|epidermal growth factor receptor
5094598|NCT01238237|EGFRvIII|egfrviii
5094599|NCT01238224|Insulin resistance|insulin resistance
5094600|NCT01238224|Phosphodiesterase-5 inhibition|phosphodiesterase-5 inhibition
5094601|NCT01238224|Microdialysis|microdialysis
5094602|NCT01238224|Type 2 diabetes|type 2 diabetes
5094603|NCT01238224|Endothelial dysfunction|endothelial dysfunction
5094604|NCT01238224|Oral hypoglycaemic agents|oral hypoglycaemic agents
5094605|NCT01238185|oral leukoplakia|oral leukoplakia
5094606|NCT01238172|stage I prostate cancer|stage i prostate cancer
5094607|NCT01238172|stage IIB prostate cancer|stage iib prostate cancer
5094608|NCT01238172|stage IIA prostate cancer|stage iia prostate cancer
5094609|NCT01238172|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5094610|NCT01238159|Natural killer cell|natural killer cell
5094611|NCT01238159|T cell|t cell
5094612|NCT01238159|Lymphoma|lymphoma
5094613|NCT01238159|Radiation|radiation
5094614|NCT01238159|Chemotherapy|chemotherapy
5094615|NCT01238120|Cancer|cancer
5094616|NCT01238120|Cognitive difficulties|cognitive difficulties
5094617|NCT01238107|Cachexia|cachexia
5094618|NCT01238107|Cancer|cancer
5094619|NCT01238094|colorectal cancer|colorectal cancer
5094620|NCT01238094|simvastatin|simvastatin
5094621|NCT01238094|second-line chemotherapy|second-line chemotherapy
5094622|NCT01238081|Cystic fibrosis|cystic fibrosis
5094623|NCT01238055|advanced gastric cancer|advanced gastric cancer
5094624|NCT01238055|sunitinib|sunitinib
5094625|NCT01238055|docetaxel|docetaxel
5094626|NCT01238055|fluoropyrimidine platinum based chemotherapy|fluoropyrimidine platinum based chemotherapy
5094627|NCT01238029|Dose finding study|dose finding study
5094628|NCT01238029|Combination|combination
5094629|NCT01237990|liver|liver
5094630|NCT01237990|cancer|cancer
5094631|NCT01237990|tumor|tumor
5094632|NCT01237951|Autologous Hematopoietic-Cell Support|autologous hematopoietic-cell support
5094633|NCT01237951|Stem Cell Transplant|stem cell transplant
5094634|NCT01237951|Busulfan|busulfan
5094635|NCT01237951|Myleran|myleran
5094636|NCT01237951|Busulfex|busulfex
5094637|NCT01237951|Gemcitabine|gemcitabine
5094638|NCT01237951|Gemzar|gemzar
5094639|NCT01237951|Melphalan|melphalan
5094640|NCT01237951|Alkeran|alkeran
5094641|NCT01237951|Decadron|decadron
5094642|NCT01237951|Dexamethasone|dexamethasone
5094643|NCT01237951|G-CSF|g-csf
5094644|NCT01237951|Filgrastim|filgrastim
5094645|NCT01237951|Neupogen|neupogen
5094646|NCT01237925|Sunburn|sunburn
5094647|NCT01237925|Dexchlorpheniramine|dexchlorpheniramine
5094648|NCT01237925|Gel|gel
5094649|NCT01237925|Cream|cream
5094650|NCT01237899|Kidney|kidney
5094651|NCT01237899|Renal|renal
5094652|NCT01237886|spontaneous breathing trial|spontaneous breathing trial
5094653|NCT01237886|heart rate variability|heart rate variability
5094654|NCT01237886|respiratory rate variability|respiratory rate variability
5094655|NCT01237873|Aliskiren|aliskiren
5094656|NCT01237873|Amlodipine|amlodipine
5094657|NCT01237873|Essential hypertension|essential hypertension
5094658|NCT01237873|Long term|long term
5094659|NCT01237860|Foot drop|foot drop
5094660|NCT01237860|Thigh muscle weakness|thigh muscle weakness
5094661|NCT01237860|Upper Motor Neuron injury or disease|upper motor neuron injury or disease
5094662|NCT01237847|inflammatory bowel disease|inflammatory bowel disease
5094663|NCT01237847|IBD|ibd
5094664|NCT01237847|Crohn's disease|crohn's disease
5094665|NCT01237847|ulcerative colitis|ulcerative colitis
5094666|NCT01237847|adolescent|adolescent
5094667|NCT01237808|AML|aml
5094668|NCT01237808|NPM1 Mutation|npm1 mutation
5094669|NCT01237808|elderly patients (>60 years)|elderly patients (>60 years)
5094670|NCT01237808|unfit for intensive chemotherapy|unfit for intensive chemotherapy
5094671|NCT01237795|Chloramine T|chloramine t
5094672|NCT01237795|Complete Denture|complete denture
5094673|NCT01237795|Dental Plaque Index|dental plaque index
5094674|NCT01237795|Dentifrice|dentifrice
5094675|NCT01237795|Denture Bases|denture bases
5094676|NCT01237795|Denture Cleansers|denture cleansers
5094677|NCT01237795|Edentulous Mouth|edentulous mouth
5094678|NCT01237795|Fluorosurfactant|fluorosurfactant
5094679|NCT01237795|Oral Health|oral health
5094680|NCT01237795|Toothpaste|toothpaste
5094681|NCT01237782|Candida|candida
5094682|NCT01237782|Complete Denture|complete denture
5094683|NCT01237782|Dental Plaque Index|dental plaque index
5094684|NCT01237782|Denture Bases|denture bases
5094685|NCT01237782|Denture Cleansers|denture cleansers
5094686|NCT01237782|Edentulous Mouth|edentulous mouth
5094687|NCT01237782|Mutans Streptococci|mutans streptococci
5094688|NCT01237782|Oral Health|oral health
5094689|NCT01237782|Propolis|propolis
5094690|NCT01237782|Streptococcus mutans|streptococcus mutans
5094691|NCT01237769|vitamin D|vitamin d
5094692|NCT01237769|Metabolic syndrome|metabolic syndrome
5094693|NCT01237769|Hypertension|hypertension
5094694|NCT01237769|Dyslipidemia|dyslipidemia
5094695|NCT01237769|Dysglycemia|dysglycemia
5094696|NCT01237769|Inflammation|inflammation
5094697|NCT01237756|pediatric anesthesia|pediatric anesthesia
5094698|NCT01237756|endotracheal tube|endotracheal tube
5094699|NCT01237756|electrical impedance tomography|electrical impedance tomography
5094700|NCT01237756|misplacement|misplacement
5094701|NCT01237756|endobronchial|endobronchial
5094702|NCT01237743|Embolism|embolism
5094703|NCT01237743|Nervous system|nervous system
5094704|NCT01237743|Aorta|aorta
5094705|NCT01237743|Valves|valves
5094706|NCT01237743|Ultrasonics|ultrasonics
5094707|NCT01237730|percutaneous endoscopic gastrostomy|percutaneous endoscopic gastrostomy
5094708|NCT01237730|peristomal wound infection|peristomal wound infection
5094709|NCT01237730|prophylactic antibiotics|prophylactic antibiotics
5094710|NCT01237717|hypertension|hypertension
5094711|NCT01237691|drug use|drug use
5094712|NCT01237691|drug arrests|drug arrests
5094713|NCT01237691|incarceration|incarceration
5094714|NCT01237678|Immunogen|immunogen
5094715|NCT01237678|Lung|lung
5094716|NCT01237678|Small Cell Lung Cancer|small cell lung cancer
5094717|NCT01237678|Carboplatin|carboplatin
5094718|NCT01237678|ADC|adc
5094719|NCT01237665|locally resectable advanced adenocarcinoma of the rectum|locally resectable advanced adenocarcinoma of the rectum
5094720|NCT01237652|Isolated Systolic Hypertension|isolated systolic hypertension
5094721|NCT01237652|Perioperative Myocardial Ischemia|perioperative myocardial ischemia
5094722|NCT01237652|Perioperative Cardiovascular adverse events|perioperative cardiovascular adverse events
5094723|NCT01237639|Red Cells|red cells
5094724|NCT01237639|Transfusion|transfusion
5094725|NCT01237639|Trigger|trigger
5094726|NCT01237639|Threshold|threshold
5094727|NCT01237639|Hematopoietic Stem cell Transplantation|hematopoietic stem cell transplantation
5094728|NCT01237626|Driving|driving
5094729|NCT01237626|Aging|aging
5094730|NCT01237626|Older drivers|older drivers
5094731|NCT01237626|Medical Fitness to drive|medical fitness to drive
5094732|NCT01237626|Health Status|health status
5094733|NCT01237626|At-fault collisions|at-fault collisions
5094734|NCT01237613|Achilles|achilles
5094735|NCT01237613|Rupture|rupture
5094736|NCT01237613|Tendon|tendon
5094737|NCT01237613|Artelon|artelon
5094738|NCT01237600|Ocular surface damage|ocular surface damage
5094739|NCT01237600|Limbal deficiency|limbal deficiency
5094740|NCT01237600|Cultivated corneal epithelial stem cell transplantation|cultivated corneal epithelial stem cell transplantation
5094741|NCT01237587|Adolescents|adolescents
5094742|NCT01237587|Juvenile Primary Fibromyalgia Syndrome|juvenile primary fibromyalgia syndrome
5094743|NCT01237574|Liver Diseases|liver diseases
5094744|NCT01237574|Alcoholic|alcoholic
5094745|NCT01237574|Metabolic Diseases|metabolic diseases
5094746|NCT01237574|cohort|cohort
5094747|NCT01237574|liver disease|liver disease
5094748|NCT01237561|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5094749|NCT01237561|COPD Guidelines|copd guidelines
5094750|NCT01237561|Patient Activation|patient activation
5094751|NCT01237561|Lung Age|lung age
5094752|NCT01237548|water pipe smoking|water pipe smoking
5094753|NCT01237548|acute effect|acute effect
5094754|NCT01237548|Endothelial|endothelial
5094755|NCT01237548|healthy adults who smoke narghile|healthy adults who smoke narghile
5094756|NCT01237535|Unexplained infertility|unexplained infertility
5094757|NCT01237535|Insemination|insemination
5094758|NCT01237535|Luteal phase support|luteal phase support
5094759|NCT01237535|Ovarian stimulation|ovarian stimulation
5094760|NCT01237522|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
5094761|NCT01237522|Metabolic Clearance Rate|metabolic clearance rate
5094762|NCT01237522|Pharmacokinetics|pharmacokinetics
5094763|NCT01237522|Pharmacogenetics|pharmacogenetics
5094764|NCT01237509|EEG|eeg
5094765|NCT01237509|Sleep|sleep
5094766|NCT01237509|device|device
5094767|NCT01237509|diabetes|diabetes
5094768|NCT01237509|hypoglycemia|hypoglycemia
5094769|NCT01237483|reirradiation with Erbitux|reirradiation with erbitux
5094770|NCT01237483|HNSCC|hnscc
5094771|NCT01237483|local recurrent inoperable Squamous Cell Cancer of the Head and Neck|local recurrent inoperable squamous cell cancer of the head and neck
5094772|NCT01237470|inguinal hernia|inguinal hernia
5094773|NCT01237470|hernia recurrence|hernia recurrence
5094774|NCT01237470|no mesh techniques|no mesh techniques
5094775|NCT01237470|Desarda technique|desarda technique
5094776|NCT01237444|Lopinavir/ritonavir plus 3TC as a dual therapy regimen.|lopinavir/ritonavir plus 3tc as a dual therapy regimen.
5094777|NCT01237431|Water drinking|water drinking
5094778|NCT01237431|osmoreceptors|osmoreceptors
5094779|NCT01237431|autonomic failure|autonomic failure
5094780|NCT01237431|syncope|syncope
5094781|NCT01237431|blood pressure|blood pressure
5094782|NCT01237431|liver transplant|liver transplant
5094783|NCT01237405|osteoarthritis|osteoarthritis
5094784|NCT01237405|nuclear medicine|nuclear medicine
5094785|NCT01237405|macrophages|macrophages
5094786|NCT01237392|wound debridement|wound debridement
5094787|NCT01237392|requiring debridement|requiring debridement
5094788|NCT01237366|HIV/AIDS|hiv/aids
5094789|NCT01237366|Methamphetamine|methamphetamine
5094790|NCT01237366|Trauma|trauma
5094791|NCT01237340|Adult Growth Hormone Deficiency (AGHD)|adult growth hormone deficiency (aghd)
5094792|NCT01237340|immunogenicity|immunogenicity
5094793|NCT01237340|growth hormone|growth hormone
5094794|NCT01237340|antibodies|antibodies
5094795|NCT01237340|GH biomarkers|gh biomarkers
5094796|NCT01237340|IGF-I|igf-i
5094797|NCT01237327|Metastatic Breast Cancer|metastatic breast cancer
5094798|NCT01237327|Advanced|advanced
5094799|NCT01237327|Postmenopausal|postmenopausal
5094800|NCT01237327|Exemestane vs Megestrol|exemestane vs megestrol
5094801|NCT01237314|type 2 diabetes|type 2 diabetes
5094802|NCT01237314|metformin|metformin
5094803|NCT01237314|glargine|glargine
5094804|NCT01237314|exenatide|exenatide
5094805|NCT01237314|glycemic impact of food|glycemic impact of food
5094806|NCT01237314|continuous glucose monitoring|continuous glucose monitoring
5094807|NCT01237301|Type 2 Diabetes|type 2 diabetes
5094808|NCT01237301|Continuous Glucose Monitoring|continuous glucose monitoring
5094809|NCT01237275|Pharmacogenomics|pharmacogenomics
5094810|NCT01237275|Prediction of Antidepressant Response|prediction of antidepressant response
5094811|NCT01237275|Depressed Patients|depressed patients
5094812|NCT01237262|psoriasis|psoriasis
5094813|NCT01237262|immune infiltrate|immune infiltrate
5094814|NCT01237262|dendritic cells|dendritic cells
5094815|NCT01237262|cytokine expression|cytokine expression
5094816|NCT01237249|Multiple Myeloma|multiple myeloma
5094817|NCT01237249|Velcade|velcade
5094818|NCT01237249|Revlimid|revlimid
5094819|NCT01237236|Advanced solid tumor|advanced solid tumor
5094820|NCT01237236|lymphoma|lymphoma
5094821|NCT01237223|Aliskiren|aliskiren
5094822|NCT01237223|Amlodipine|amlodipine
5094823|NCT01237223|Essential hypertension|essential hypertension
5094824|NCT01237210|Parkinson's Disease|parkinson's disease
5094825|NCT01237210|PD|pd
5094826|NCT01237210|magnetic resonance spectroscopy|magnetic resonance spectroscopy
5094827|NCT01237184|initial dental implant stability|initial dental implant stability
5094828|NCT01237184|maxillary sinus proximity|maxillary sinus proximity
5094829|NCT01237184|bicortical fixation|bicortical fixation
5094830|NCT01237171|Brachytherapy|brachytherapy
5094831|NCT01237171|Lung Brachytherapy|lung brachytherapy
5094832|NCT01237171|NSCLC|nsclc
5094833|NCT01237171|Sub-lobar resection|sub-lobar resection
5094834|NCT01237158|GAD1,|gad1,
5094835|NCT01237158|GAD67,|gad67,
5094836|NCT01237158|bipolar,|bipolar,
5094837|NCT01237158|GABA,|gaba,
5094838|NCT01237158|Glutamate,|glutamate,
5094839|NCT01237158|Reelin,|reelin,
5094840|NCT01237158|Rln,|rln,
5094841|NCT01237158|Spectroscopy|spectroscopy
5094842|NCT01237158|euthymic bipolar I patients|euthymic bipolar i patients
5094843|NCT01237145|pigeon|pigeon
5094844|NCT01237145|bird fancier|bird fancier
5094845|NCT01237145|extrinsic allergic alveolitis|extrinsic allergic alveolitis
5094846|NCT01237145|BAL|bal
5094847|NCT01237145|broncho-alveolar lavage|broncho-alveolar lavage
5094848|NCT01237145|elispot|elispot
5094849|NCT01237145|antigen|antigen
5094850|NCT01237106|PCOS|pcos
5094851|NCT01237106|IVM|ivm
5094852|NCT01237106|Polycystic ovarian syndrome|polycystic ovarian syndrome
5094853|NCT01237106|In Vitro Maturation|in vitro maturation
5094854|NCT01237106|IVF|ivf
5094855|NCT01237093|Fish Diet|fish diet
5094856|NCT01237093|Meat Diet|meat diet
5094857|NCT01237093|Biomarkers|biomarkers
5094858|NCT01237093|Stable Isotopes|stable isotopes
5094859|NCT01237093|Dietary Intake|dietary intake
5094860|NCT01237067|PARP inhibitor, womens's cancers, relapsed, recurrent|parp inhibitor, womens's cancers, relapsed, recurrent
5094861|NCT01237067|Ovarian, breast, endometrial, cervical|ovarian, breast, endometrial, cervical
5094862|NCT01237067|Carboplatin|carboplatin
5094863|NCT01237067|BRCA 1 and BRCA 2|brca 1 and brca 2
5094864|NCT01237067|Breast Cancer|breast cancer
5094865|NCT01237067|Ovarian Cancer|ovarian cancer
5094866|NCT01237067|Uterine Cancer|uterine cancer
5094867|NCT01237067|Cervical Cancer|cervical cancer
5094868|NCT01237067|Peritoneal Cancer|peritoneal cancer
5094869|NCT01237067|Endometrial Cancer|endometrial cancer
5094870|NCT01237067|Fallopian Tube Cancer|fallopian tube cancer
5094871|NCT01237054|18-FDG PET/CT|18-fdg pet/ct
5094872|NCT01237054|Abnormal Plasma Cells|abnormal plasma cells
5094873|NCT01237054|Serum Free Light-Chain Abnormality|serum free light-chain abnormality
5094874|NCT01237054|Serum M-Protein|serum m-protein
5094875|NCT01237054|DCE-MRI|dce-mri
5094876|NCT01237054|Multiple Myeloma|multiple myeloma
5094877|NCT01237054|Smoldering Multiple Myeloma|smoldering multiple myeloma
5094878|NCT01237054|SMM|smm
5094879|NCT01237054|MM|mm
5094880|NCT01237041|Child|child
5094881|NCT01237041|Body Fat|body fat
5094882|NCT01237041|Niacin|niacin
5094883|NCT01237041|Growth Hormone|growth hormone
5094884|NCT01237041|Obesity|obesity
5094885|NCT01237041|Growth Hormones|growth hormones
5094886|NCT01237041|Short Stature|short stature
5094887|NCT01237041|Children|children
5094888|NCT01237015|Neonate|neonate
5094889|NCT01237015|Oral feeding|oral feeding
5094890|NCT01237015|Nasal CPAP|nasal cpap
5094891|NCT01237015|Sucking|sucking
5094892|NCT01237015|Swallowing|swallowing
5094893|NCT01237015|Breathing|breathing
5094894|NCT01237002|Liver ischemia; Pringle time|liver ischemia; pringle time
5094895|NCT01236989|anatomical resection|anatomical resection
5094896|NCT01236989|non-anatomical resection|non-anatomical resection
5094897|NCT01236989|IOUS-guided finger compression|ious-guided finger compression
5094898|NCT01236963|Clinical trial|clinical trial
5094899|NCT01236963|Prevention mouthrinse|prevention mouthrinse
5094900|NCT01236963|Dental Floss|dental floss
5094901|NCT01236950|Clinical Trial|clinical trial
5094902|NCT01236950|Prevention Mouthrinse|prevention mouthrinse
5094903|NCT01236937|CT, lung nodule biopsy, Respiration Gated, Lung Cancer|ct, lung nodule biopsy, respiration gated, lung cancer
5094904|NCT01236911|Calcium , TBI,complications, days in hospital|calcium , tbi,complications, days in hospital
5094905|NCT01236898|N-acetylneuraminic acid,|n-acetylneuraminic acid,
5094906|NCT01236898|pharmacokinetics|pharmacokinetics
5094907|NCT01236898|hIBM|hibm
5094908|NCT01236872|Nitrate|nitrate
5094909|NCT01236872|Nitrite|nitrite
5094910|NCT01236872|Vegetable|vegetable
5094911|NCT01236872|Aortic stiffness|aortic stiffness
5094912|NCT01236859|Gabapentin|gabapentin
5094913|NCT01236859|prophylaxis|prophylaxis
5094914|NCT01236859|incidence of pruritus|incidence of pruritus
5094915|NCT01236859|intrathecal morphine|intrathecal morphine
5094916|NCT01236846|Vitamin D fortification|vitamin d fortification
5094917|NCT01236846|Yogurt Drink|yogurt drink
5094918|NCT01236846|Efficacy|efficacy
5094919|NCT01236833|Lactated Ringer's Solution|lactated ringer's solution
5094920|NCT01236833|Isotonic Solution|isotonic solution
5094921|NCT01236833|Intestinal Disease|intestinal disease
5094922|NCT01236833|Feeding Intolerance|feeding intolerance
5094923|NCT01236833|Necrotizing Enterocolitis|necrotizing enterocolitis
5094924|NCT01236833|Newborn|newborn
5094925|NCT01236833|Premature Infant|premature infant
5094926|NCT01236820|L5|l5
5094927|NCT01236820|LDL|ldl
5094928|NCT01236820|Cardiovascular disease|cardiovascular disease
5094929|NCT01236820|Chronic kidney disease|chronic kidney disease
5094930|NCT01236820|Hemodialysis|hemodialysis
5094931|NCT01236807|Adenosine|adenosine
5094932|NCT01236807|Magnetic Resonance Imaging|magnetic resonance imaging
5094933|NCT01236807|MR perfusion|mr perfusion
5094934|NCT01236807|Fractional Flow Reserve, Myocardial|fractional flow reserve, myocardial
5094935|NCT01236807|FFR|ffr
5094936|NCT01236807|Pressure wire|pressure wire
5094937|NCT01236807|Coronary Disease|coronary disease
5094938|NCT01236807|Heart Diseases|heart diseases
5094939|NCT01236807|Cardiovascular Diseases|cardiovascular diseases
5094940|NCT01236807|Arteriosclerosis|arteriosclerosis
5094941|NCT01236781|breast cancer|breast cancer
5094942|NCT01236781|screening|screening
5094943|NCT01236781|diagnostics|diagnostics
5094944|NCT01236781|diagnosis|diagnosis
5094945|NCT01236781|high-risk|high-risk
5094946|NCT01236781|breast neoplasms|breast neoplasms
5094947|NCT01236781|digital mammography|digital mammography
5094948|NCT01236781|mammography|mammography
5094949|NCT01236781|tomosynthesis|tomosynthesis
5094950|NCT01236781|dense breasts|dense breasts
5094951|NCT01236781|radiation dose|radiation dose
5094952|NCT01236781|comparison|comparison
5094953|NCT01236781|Hologic|hologic
5094954|NCT01236781|Pennsylvania|pennsylvania
5094955|NCT01236781|Philadelphia|philadelphia
5094956|NCT01236781|breast study|breast study
5094957|NCT01236781|mammo|mammo
5094958|NCT01236781|tomo|tomo
5094959|NCT01236781|mammary|mammary
5094960|NCT01236768|Contraceptive|contraceptive
5094961|NCT01236755|children|children
5094962|NCT01236755|corneal reshaping|corneal reshaping
5094963|NCT01236755|myopia|myopia
5094964|NCT01236755|myopia progression|myopia progression
5094965|NCT01236755|orthokeratology|orthokeratology
5094966|NCT01236742|children|children
5094967|NCT01236742|corneal reshaping|corneal reshaping
5094968|NCT01236742|myopia|myopia
5094969|NCT01236742|myopia progression|myopia progression
5094970|NCT01236742|orthokeratology|orthokeratology
5094971|NCT01236729|knee replacement|knee replacement
5094972|NCT01236729|disability|disability
5094973|NCT01236729|older people|older people
5094974|NCT01236716|squamous cell carcinoma of lung|squamous cell carcinoma of lung
5094975|NCT01236716|Albumin bound paclitaxel|albumin bound paclitaxel
5094976|NCT01236716|chemotherapy|chemotherapy
5094977|NCT01236703|SIRS|sirs
5094978|NCT01236703|Sepsis|sepsis
5094979|NCT01236703|hematological infection score|hematological infection score
5094980|NCT01236690|Transcatheter arterial embolization|transcatheter arterial embolization
5094981|NCT01236690|Cinobufacin injection|cinobufacin injection
5094982|NCT01236690|hepatoma|hepatoma
5094983|NCT01236677|Pathogen|pathogen
5094984|NCT01236664|memory training|memory training
5094985|NCT01236664|mnemonics|mnemonics
5094986|NCT01236664|cognition|cognition
5094987|NCT01236664|work|work
5094988|NCT01236638|Primary Myelofibrosis|primary myelofibrosis
5094989|NCT01236638|Post-Polycythemia Vera|post-polycythemia vera
5094990|NCT01236638|Post-Essential Thrombocythemia|post-essential thrombocythemia
5094991|NCT01236638|CYT387|cyt387
5094992|NCT01236625|Tissue Adhesions|tissue adhesions
5094993|NCT01236625|Adhesiolysis|adhesiolysis
5094994|NCT01236625|Inadvertent enterotomy|inadvertent enterotomy
5094995|NCT01236625|Prospective cohort study|prospective cohort study
5094996|NCT01236625|Quality of life|quality of life
5094997|NCT01236612|Plasmodium|plasmodium
5094998|NCT01236612|falciparum|falciparum
5094999|NCT01236612|malaria|malaria
5095000|NCT01236612|chloroquine|chloroquine
5095001|NCT01236612|immunity|immunity
5095002|NCT01236599|preterm infant, thermoregulation, polyethylene bag|preterm infant, thermoregulation, polyethylene bag
5095003|NCT01236586|Maximum Tolerated Dose|maximum tolerated dose
5095004|NCT01236586|Toxicity|toxicity
5095005|NCT01236586|Pharmacokinetics|pharmacokinetics
5095006|NCT01236586|NOTCH Signaling Pathway|notch signaling pathway
5095007|NCT01236586|Expression of JAGGED 1 and 2|expression of jagged 1 and 2
5095008|NCT01236586|Cancer|cancer
5095009|NCT01236586|Solid Tumor|solid tumor
5095010|NCT01236586|Brain Tumor|brain tumor
5095011|NCT01236586|Wilms Tumor|wilms tumor
5095012|NCT01236586|Osteosarcoma|osteosarcoma
5095013|NCT01236586|Lymphoma|lymphoma
5095014|NCT01236573|Gene Therapy|gene therapy
5095015|NCT01236573|Immunotherapy|immunotherapy
5095016|NCT01236573|Adoptive Cell Therapy|adoptive cell therapy
5095017|NCT01236573|Metastatic Melanoma|metastatic melanoma
5095018|NCT01236534|Multiple Sclerosis|multiple sclerosis
5095019|NCT01236534|Constipation|constipation
5095020|NCT01236534|Multiple Sclerosis Associated Constipation|multiple sclerosis associated constipation
5095021|NCT01236521|Back pain|back pain
5095022|NCT01236521|Care Management|care management
5095023|NCT01236521|Pain|pain
5095024|NCT01236521|Patient outcomes|patient outcomes
5095025|NCT01236521|Patient-center Care|patient-center care
5095026|NCT01236521|Primary care|primary care
5095027|NCT01236508|White Matter Hyperintensity|white matter hyperintensity
5095028|NCT01236508|Stroke|stroke
5095029|NCT01236508|Carotid Artery Plaque Inflammation|carotid artery plaque inflammation
5095030|NCT01236508|FDG PET|fdg pet
5095031|NCT01236508|MRI|mri
5095032|NCT01236508|TIA|tia
5095033|NCT01236495|thoracotomy|thoracotomy
5095034|NCT01236495|postoperative pain|postoperative pain
5095035|NCT01236495|spinal morphine|spinal morphine
5095036|NCT01236482|Pregnancy|pregnancy
5095037|NCT01236482|Postpartum hemorrhage|postpartum hemorrhage
5095038|NCT01236482|Uterine tone|uterine tone
5095039|NCT01236482|Oxytocin|oxytocin
5095040|NCT01236482|Ergometrine|ergometrine
5095041|NCT01236482|Pharmacokinetic-pharmacodynamic analysis|pharmacokinetic-pharmacodynamic analysis
5095042|NCT01236469|Aortic Valve|aortic valve
5095043|NCT01236456|chronic inflammatory demyelinating polyneuropathy|chronic inflammatory demyelinating polyneuropathy
5095044|NCT01236456|cyclophosphamide|cyclophosphamide
5095045|NCT01236456|autoimmune|autoimmune
5095046|NCT01236430|Hyperlipidemia|hyperlipidemia
5095047|NCT01236430|statin|statin
5095048|NCT01236430|Ezetimibe|ezetimibe
5095049|NCT01236430|Zetia|zetia
5095050|NCT01236430|Atorvastatin|atorvastatin
5095051|NCT01236430|Lipitor|lipitor
5095052|NCT01236391|Pharmacyclics|pharmacyclics
5095053|NCT01236391|Mantle|mantle
5095054|NCT01236391|Mantle Cell|mantle cell
5095055|NCT01236391|Lymphoma|lymphoma
5095056|NCT01236391|Non-Hodgkins|non-hodgkins
5095057|NCT01236391|Bortezomib|bortezomib
5095058|NCT01236391|Velcade|velcade
5095059|NCT01236391|Naive|naive
5095060|NCT01236391|PCYC|pcyc
5095061|NCT01236378|Organ Transplants|organ transplants
5095062|NCT01236378|Anti-Rejection Therapy|anti-rejection therapy
5095063|NCT01236378|Pharmacokinetics|pharmacokinetics
5095064|NCT01236365|Type 1 diabetes|type 1 diabetes
5095065|NCT01236365|Children|children
5095066|NCT01236365|Statins|statins
5095067|NCT01236365|Hypercholesterolemia|hypercholesterolemia
5095068|NCT01236365|Lipoproteins|lipoproteins
5095069|NCT01236365|C reactive protein|c reactive protein
5095070|NCT01236365|Continuous glucose monitors|continuous glucose monitors
5095071|NCT01236365|Adolescence|adolescence
5095072|NCT01236365|Abdominal magnetic resonance imaging|abdominal magnetic resonance imaging
5095073|NCT01236365|Toll like receptors|toll like receptors
5095074|NCT01236365|Receptors of advanced glycation end products|receptors of advanced glycation end products
5095075|NCT01236365|Nutrition|nutrition
5095076|NCT01236352|Advanced Cancer, Various, NOS|advanced cancer, various, nos
5095077|NCT01236313|TEE|tee
5095078|NCT01236313|Cardiac Surgery|cardiac surgery
5095079|NCT01236313|Pulse Pressure|pulse pressure
5095080|NCT01236300|Pancreatic cysts|pancreatic cysts
5095081|NCT01236274|Myocardial Infarction|myocardial infarction
5095082|NCT01236274|Antipsychotic agents|antipsychotic agents
5095083|NCT01236274|Self-controlled case series method|self-controlled case series method
5095084|NCT01236274|General Practice Research Database|general practice research database
5095085|NCT01236274|Myocardial Ischaemia National Audit Project|myocardial ischaemia national audit project
5095086|NCT01236274|CALIBER|caliber
5095087|NCT01236261|Fungemia, fungal infection, susceptibility, antifungal|fungemia, fungal infection, susceptibility, antifungal
5095088|NCT01236248|drugs|drugs
5095089|NCT01236248|youth|youth
5095090|NCT01236248|parent|parent
5095091|NCT01236248|computer|computer
5095092|NCT01236248|prevention|prevention
5095093|NCT01236222|commuter cycling|commuter cycling
5095094|NCT01236222|fitness|fitness
5095095|NCT01236222|metabolic syndrome|metabolic syndrome
5095096|NCT01236222|children|children
5095097|NCT01236196|pain|pain
5095098|NCT01236196|chronic pain|chronic pain
5095099|NCT01236196|cognitive therapy|cognitive therapy
5095100|NCT01236196|telehealth|telehealth
5095101|NCT01236183|manual skill|manual skill
5095102|NCT01236183|anesthesia residents|anesthesia residents
5095103|NCT01236170|Amputees|amputees
5095104|NCT01236170|spinal cord injuries|spinal cord injuries
5095105|NCT01236170|quality of life|quality of life
5095106|NCT01236170|satisfaction|satisfaction
5095107|NCT01236170|healthcare disparities|healthcare disparities
5095108|NCT01236170|wheelchairs|wheelchairs
5095109|NCT01236157|Cardiology|cardiology
5095110|NCT01236144|Myeloid|myeloid
5095111|NCT01236144|Leukaemia|leukaemia
5095112|NCT01236144|Acute|acute
5095113|NCT01236144|Myelodysplastic|myelodysplastic
5095114|NCT01236144|Pilot|pilot
5095115|NCT01236144|Cardiff|cardiff
5095116|NCT01236144|Haematology|haematology
5095117|NCT01236144|Burnett|burnett
5095118|NCT01236144|AC220|ac220
5095119|NCT01236144|Plerixafor|plerixafor
5095120|NCT01236144|Ganetespib|ganetespib
5095121|NCT01236092|resolution of low back pain|resolution of low back pain
5095122|NCT01236092|show measurable improvement in disc measurement|show measurable improvement in disc measurement
5095123|NCT01236092|conservative therapy vs. surgery in resolving low back pain|conservative therapy vs. surgery in resolving low back pain
5095124|NCT01236066|Rotavirus Gastroenteritis|rotavirus gastroenteritis
5095125|NCT01236066|Rotarix|rotarix
5095126|NCT01236066|RotaTeq|rotateq
5095127|NCT01236066|Gastroenteritis|gastroenteritis
5095128|NCT01236053|renal cancer|renal cancer
5095129|NCT01236053|pancreatic cancer|pancreatic cancer
5095130|NCT01236053|epidemiology|epidemiology
5095131|NCT01236053|renal cell carcinoma|renal cell carcinoma
5095132|NCT01236053|nervous system cancer|nervous system cancer
5095133|NCT01236053|lung cancer|lung cancer
5095134|NCT01236053|breast cancer|breast cancer
5095135|NCT01236053|case-control|case-control
5095136|NCT01236053|GPRD|gprd
5095137|NCT01236053|Gapabentin|gapabentin
5095138|NCT01236053|cancer|cancer
5095139|NCT01236053|anal cancer|anal cancer
5095140|NCT01236053|bone and joint cancer|bone and joint cancer
5095141|NCT01236053|renal pelvis cancer|renal pelvis cancer
5095142|NCT01236053|penis cancer|penis cancer
5095143|NCT01236053|stomach cancer|stomach cancer
5095144|NCT01236053|bladder cancer|bladder cancer
5095145|NCT01236040|H5N1|h5n1
5095146|NCT01236040|Influenza|influenza
5095147|NCT01236040|Pandemic|pandemic
5095148|NCT01236001|Lacosamide|lacosamide
5095149|NCT01236001|Vimpat®|vimpat®
5095150|NCT01235975|Neisseria meningitidis|neisseria meningitidis
5095151|NCT01235975|Meningococcal Vaccines|meningococcal vaccines
5095152|NCT01235975|serogroups A,C, W-135 or Y|serogroups a,c, w-135 or y
5095153|NCT01235975|meningococcal diseases|meningococcal diseases
5095154|NCT01235975|meningococcal conjugate vaccine|meningococcal conjugate vaccine
5095155|NCT01235975|Immunogenicity|immunogenicity
5095156|NCT01235962|anti-angiogenic agent|anti-angiogenic agent
5095157|NCT01235962|renal cell carcinoma|renal cell carcinoma
5095158|NCT01235962|pazopanib|pazopanib
5095159|NCT01235962|adjuvant therapy|adjuvant therapy
5095160|NCT01235962|VEGFR inhibitor|vegfr inhibitor
5095161|NCT01235949|Pneumococcal vaccine|pneumococcal vaccine
5095162|NCT01235949|Immunogenicity|immunogenicity
5095163|NCT01235949|Safety|safety
5095164|NCT01235949|Fever|fever
5095165|NCT01235949|Primary vaccination|primary vaccination
5095166|NCT01235949|Booster vaccination|booster vaccination
5095167|NCT01235949|Pneumococcal disease|pneumococcal disease
5095168|NCT01235949|Prophylactic antipyretic|prophylactic antipyretic
5095169|NCT01235936|anemia|anemia
5095170|NCT01235936|chronic kidney disease|chronic kidney disease
5095171|NCT01235936|CKD|ckd
5095172|NCT01235936|chronic renal insufficiency|chronic renal insufficiency
5095173|NCT01235936|renal impairment|renal impairment
5095174|NCT01235936|erythropoietin|erythropoietin
5095175|NCT01235936|safety|safety
5095176|NCT01235936|efficacy|efficacy
5095177|NCT01235936|tolerability|tolerability
5095178|NCT01235936|pharmacokinetics|pharmacokinetics
5095179|NCT01235923|anemia|anemia
5095180|NCT01235923|transfusions|transfusions
5095181|NCT01235923|erythropoiesis|erythropoiesis
5095182|NCT01235923|neonate|neonate
5095183|NCT01235923|preterm|preterm
5095184|NCT01235910|Hypertension|hypertension
5095185|NCT01235910|Cardiac transplantation|cardiac transplantation
5095186|NCT01235910|Aliskiren|aliskiren
5095187|NCT01235910|Cyclosporine|cyclosporine
5095188|NCT01235897|Neoplasms|neoplasms
5095189|NCT01235897|Paclitaxel|paclitaxel
5095190|NCT01235897|Trastuzumab|trastuzumab
5095191|NCT01235884|gaseous colic, regurgitation and of constipation|gaseous colic, regurgitation and of constipation
5095192|NCT01235871|Safety|safety
5095193|NCT01235871|Tolerability|tolerability
5095194|NCT01235871|SB1578|sb1578
5095195|NCT01235858|Epidural analgesia|epidural analgesia
5095196|NCT01235858|Epidural anesthesia labor|epidural anesthesia labor
5095197|NCT01235858|Aseptic technique|aseptic technique
5095198|NCT01235858|gown|gown
5095199|NCT01235858|no gown|no gown
5095200|NCT01235832|cholesterol|cholesterol
5095201|NCT01235832|triglycerides|triglycerides
5095202|NCT01235832|low-density lipoprotein|low-density lipoprotein
5095203|NCT01235832|high-density lipoprotein|high-density lipoprotein
5095204|NCT01235832|reverse cholesterol transport|reverse cholesterol transport
5095205|NCT01235819|type 1 diabetes|type 1 diabetes
5095206|NCT01235819|exenatide|exenatide
5095207|NCT01235819|sitagliptin|sitagliptin
5095208|NCT01235806|scaphoid|scaphoid
5095209|NCT01235806|MRI|mri
5095210|NCT01235806|ESAOTE|esaote
5095211|NCT01235793|Relapsed|relapsed
5095212|NCT01235793|Refractory|refractory
5095213|NCT01235793|Primary Central Nervous System B-cell Lymphoma|primary central nervous system b-cell lymphoma
5095214|NCT01235793|Autologous Stem Cell Transplant|autologous stem cell transplant
5095215|NCT01235793|Temozolomide|temozolomide
5095216|NCT01235793|B-Cell Lymphoma|b-cell lymphoma
5095217|NCT01235793|RBEAM|rbeam
5095218|NCT01235793|Conditioning Regimen|conditioning regimen
5095219|NCT01235780|corneal hysteresis, ocular response analyzer|corneal hysteresis, ocular response analyzer
5095220|NCT01235767|birth weight|birth weight
5095221|NCT01235767|prematurity|prematurity
5095222|NCT01235767|gestational age|gestational age
5095223|NCT01235767|low birth weight|low birth weight
5095224|NCT01235767|pregnancy|pregnancy
5095225|NCT01235767|nutrition|nutrition
5095226|NCT01235767|Vietnam|vietnam
5095227|NCT01235754|testosterone|testosterone
5095228|NCT01235754|hypoactive sexual desire disorder|hypoactive sexual desire disorder
5095229|NCT01235754|menopause|menopause
5095230|NCT01235741|Pramlintide|pramlintide
5095231|NCT01235741|Metreleptin|metreleptin
5095232|NCT01235741|Obesity|obesity
5095233|NCT01235741|Amylin|amylin
5095234|NCT01235741|Takeda|takeda
5095235|NCT01235715|osteoarthritis|osteoarthritis
5095236|NCT01235715|total knee replacement|total knee replacement
5095237|NCT01235702|high blood pressure, hypertension, African Americans, perceived stress|high blood pressure, hypertension, african americans, perceived stress
5095238|NCT01235676|obesity|obesity
5095239|NCT01235676|lifestyle|lifestyle
5095240|NCT01235676|pregnancy|pregnancy
5095241|NCT01235676|newborn infant|newborn infant
5095242|NCT01235663|obesity, insulin resistance|obesity, insulin resistance
5095243|NCT01235637|COMFORT B score|comfort b score
5095244|NCT01235637|Bis score|bis score
5095245|NCT01235624|Autosomal dominant retinitis pigmentosa|autosomal dominant retinitis pigmentosa
5095246|NCT01235624|Rare disease|rare disease
5095247|NCT01235624|Genetics|genetics
5095248|NCT01235598|Cimzia®|cimzia®
5095249|NCT01235598|CDP870|cdp870
5095250|NCT01235598|CZP|czp
5095251|NCT01235598|Certolizumab Pegol|certolizumab pegol
5095252|NCT01235598|Rheumatoid Arthritis|rheumatoid arthritis
5095253|NCT01235598|MRI|mri
5095254|NCT01235572|Acute myeloid leukemia with multilineage dysplasia following myelodysplastic syndrome|acute myeloid leukemia with multilineage dysplasia following myelodysplastic syndrome
5095255|NCT01235572|Adult acute eosinophilic leukemia|adult acute eosinophilic leukemia
5095256|NCT01235572|Adult acute basophilic leukemia|adult acute basophilic leukemia
5095257|NCT01235572|De|de
5095258|NCT01235572|novo myelodysplastic syndromes|novo myelodysplastic syndromes
5095259|NCT01235572|Secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5095260|NCT01235572|Untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
5095261|NCT01235546|Pregnancy|pregnancy
5095262|NCT01235546|Cesarean section|cesarean section
5095263|NCT01235546|Antibiotic|antibiotic
5095264|NCT01235546|Infections|infections
5095265|NCT01235533|late-life depression|late-life depression
5095266|NCT01235533|recurrence of depression|recurrence of depression
5095267|NCT01235533|cognition|cognition
5095268|NCT01235533|N-3 polyunsaturated fatty acids|n-3 polyunsaturated fatty acids
5095269|NCT01235481|pulmonary rehabilitation|pulmonary rehabilitation
5095270|NCT01235481|exercise therapy|exercise therapy
5095271|NCT01235481|chronic lung disease|chronic lung disease
5095272|NCT01235481|self-efficacy|self-efficacy
5095273|NCT01235468|umbilical cord blood|umbilical cord blood
5095274|NCT01235468|ex vivo expansion|ex vivo expansion
5095275|NCT01235468|engraftment|engraftment
5095276|NCT01235468|GVHD|gvhd
5095277|NCT01235455|Multiple Sclerosis|multiple sclerosis
5095278|NCT01235455|Adherence|adherence
5095279|NCT01235455|Interferon beta-1b|interferon beta-1b
5095280|NCT01235455|Coping styles|coping styles
5095281|NCT01235442|Psoriasis|psoriasis
5095282|NCT01235442|Topical|topical
5095283|NCT01235442|etanercept|etanercept
5095284|NCT01235442|clobetasol propionate|clobetasol propionate
5095285|NCT01235429|Diabetes|diabetes
5095286|NCT01235429|Behavioral intervention|behavioral intervention
5095287|NCT01235429|diabetes self-management|diabetes self-management
5095288|NCT01235429|Native Hawaiians|native hawaiians
5095289|NCT01235429|health disparities|health disparities
5095290|NCT01235403|Epilepsy treatment.|epilepsy treatment.
5095291|NCT01235403|Anti-epileptic drugs|anti-epileptic drugs
5095292|NCT01235403|Seizures|seizures
5095293|NCT01235390|Postmenopausal women|postmenopausal women
5095294|NCT01235390|walnuts|walnuts
5095295|NCT01235377|prescribing patterns|prescribing patterns
5095296|NCT01235377|thiazide|thiazide
5095297|NCT01235377|chlorthalidone|chlorthalidone
5095298|NCT01235377|hydrochlorothiazide|hydrochlorothiazide
5095299|NCT01235377|target dose|target dose
5095300|NCT01235377|cluster randomized trial|cluster randomized trial
5095301|NCT01235364|Foley catheter|foley catheter
5095302|NCT01235364|induction|induction
5095303|NCT01235364|labour|labour
5095304|NCT01235364|skin conductance|skin conductance
5095305|NCT01235364|visual analogue scale|visual analogue scale
5095306|NCT01235364|mechanical method|mechanical method
5095307|NCT01235351|Myocardial infarction|myocardial infarction
5095308|NCT01235351|Percutaneous coronary intervention|percutaneous coronary intervention
5095309|NCT01235351|Clopidogrel|clopidogrel
5095310|NCT01235351|Genetics|genetics
5095311|NCT01235351|Platelet Function|platelet function
5095312|NCT01235325|vitamin K|vitamin k
5095313|NCT01235325|supplementation|supplementation
5095314|NCT01235325|bone health indices|bone health indices
5095315|NCT01235325|adult|adult
5095316|NCT01235325|Crohn's disease|crohn's disease
5095317|NCT01235286|remote ischemic preconditioning, free flap, microcirculation|remote ischemic preconditioning, free flap, microcirculation
5095318|NCT01235260|REGRANEX (becaplermin)|regranex (becaplermin)
5095319|NCT01235260|Platelet-derived growth factor BB|platelet-derived growth factor bb
5095320|NCT01235260|Cancer|cancer
5095321|NCT01235260|Cancer incidence|cancer incidence
5095322|NCT01235260|Cancer mortality|cancer mortality
5095323|NCT01235260|Lower Extremity Diabetic Neuropathic Ulcer|lower extremity diabetic neuropathic ulcer
5095324|NCT01235234|Dry eye disease|dry eye disease
5095325|NCT01235234|KCS|kcs
5095326|NCT01235234|Aqueous Deficient Dry Eye|aqueous deficient dry eye
5095327|NCT01235208|Overweight|overweight
5095328|NCT01235208|Obesity|obesity
5095329|NCT01235208|Metabolic syndrome|metabolic syndrome
5095330|NCT01235208|Diet|diet
5095331|NCT01235208|Carbohydrate|carbohydrate
5095332|NCT01235208|Low glycemic index|low glycemic index
5095333|NCT01235208|Eurodiet|eurodiet
5095334|NCT01235195|bioequivalence study|bioequivalence study
5095335|NCT01235195|sertraline 50 mg|sertraline 50 mg
5095336|NCT01235195|capsules vs tablets|capsules vs tablets
5095337|NCT01235182|acute dyspnea|acute dyspnea
5095338|NCT01235182|prehospital emergency setting|prehospital emergency setting
5095339|NCT01235182|differential diagnosis|differential diagnosis
5095340|NCT01235182|ultrasound|ultrasound
5095341|NCT01235182|NT-proBNP|nt-probnp
5095342|NCT01235156|Premature ventricular contraction|premature ventricular contraction
5095343|NCT01235156|Frequent premature ventricular contraction, with or without a short array of non-sustained ventricular tachycardia|frequent premature ventricular contraction, with or without a short array of non-sustained ventricular tachycardia
5095344|NCT01235143|incidence|incidence
5095345|NCT01235143|emergence agitation|emergence agitation
5095346|NCT01235143|sevoflurane|sevoflurane
5095347|NCT01235143|desflurane|desflurane
5095348|NCT01235143|ambulatory pediatric surgery|ambulatory pediatric surgery
5095349|NCT01235117|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5095350|NCT01235091|HIV prevention|hiv prevention
5095351|NCT01235091|substance abuse|substance abuse
5095352|NCT01235091|high risk behaviors|high risk behaviors
5095353|NCT01235091|peer intervention|peer intervention
5095354|NCT01235065|airway management|airway management
5095355|NCT01235065|trauma|trauma
5095356|NCT01235065|intubation|intubation
5095357|NCT01235052|Head and neck neoplasms|head and neck neoplasms
5095358|NCT01235052|Positron Emission Tomography|positron emission tomography
5095359|NCT01235052|F18 fluoromisonidazole|f18 fluoromisonidazole
5095360|NCT01235026|Obesity|obesity
5095361|NCT01235026|Type-2 Diabetes|type-2 diabetes
5095362|NCT01235026|Metabolic syndrome|metabolic syndrome
5095363|NCT01235026|Low grade inflammation|low grade inflammation
5095364|NCT01235026|Metabolic endotoxinemia|metabolic endotoxinemia
5095365|NCT01235026|Insulin resistance|insulin resistance
5095366|NCT01235026|Lipopolysaccharide|lipopolysaccharide
5095367|NCT01235026|LPS-binding protein|lps-binding protein
5095368|NCT01235026|sCD14|scd14
5095369|NCT01235026|Synbiotic|synbiotic
5095370|NCT01235026|Oligofructose|oligofructose
5095371|NCT01235026|Bifidobacterium animalis subsp. lactis Bb12|bifidobacterium animalis subsp. lactis bb12
5095372|NCT01235026|probiotic|probiotic
5095373|NCT01235026|Prebiotic|prebiotic
5095374|NCT01235013|HIV-1 infection|hiv-1 infection
5095375|NCT01235013|Maraviroc|maraviroc
5095376|NCT01235013|CD4 lymphocyte count|cd4 lymphocyte count
5095377|NCT01235000|Influenza vaccines|influenza vaccines
5095378|NCT01235000|Infant|infant
5095763|NCT01233206|PCOS|pcos
5095379|NCT01235000|Dose-Response relationship, immunologic|dose-response relationship, immunologic
5095380|NCT01235000|Prime-boost response|prime-boost response
5095381|NCT01234987|Cancer|cancer
5095382|NCT01234987|Breast Cancer|breast cancer
5095383|NCT01234987|Colon cancer|colon cancer
5095384|NCT01234987|Lung Cancer|lung cancer
5095385|NCT01234974|multiple myeloma|multiple myeloma
5095386|NCT01234948|Halitosis|halitosis
5095387|NCT01234948|VSC|vsc
5095388|NCT01234948|Periodontitis|periodontitis
5095389|NCT01234948|Gingivitis|gingivitis
5095390|NCT01234948|Putative periodontal pathogens|putative periodontal pathogens
5095391|NCT01234948|Real-time PCR|real-time pcr
5095392|NCT01234909|Missed immunizations|missed immunizations
5095393|NCT01234896|Smoking Cessation, Nicotine pharmacokinetics|smoking cessation, nicotine pharmacokinetics
5095394|NCT01234883|dehydration|dehydration
5095395|NCT01234883|gastroenteritis|gastroenteritis
5095396|NCT01234870|Myocardial Perfusion Imaging|myocardial perfusion imaging
5095397|NCT01234870|Magnetic Resonance Imaging|magnetic resonance imaging
5095398|NCT01234857|mTOR|mtor
5095399|NCT01234857|breast cancer|breast cancer
5095400|NCT01234857|estrogen receptor positive|estrogen receptor positive
5095401|NCT01234844|pet-therapy|pet-therapy
5095402|NCT01234844|guinea-pigs|guinea-pigs
5095403|NCT01234844|rehabilitation|rehabilitation
5095404|NCT01234844|elderly|elderly
5095405|NCT01234831|MRSA|mrsa
5095406|NCT01234831|colonization|colonization
5095407|NCT01234831|nucleic acid amplification|nucleic acid amplification
5095408|NCT01234831|chromogenic agar|chromogenic agar
5095409|NCT01234818|Endometrial hyperplasia|endometrial hyperplasia
5095410|NCT01234818|LNG-IUS|lng-ius
5095411|NCT01234792|Smoking Cessation, Nicotine pharmacokinetics|smoking cessation, nicotine pharmacokinetics
5095412|NCT01234753|Adults with CHD|adults with chd
5095413|NCT01234753|GUCH|guch
5095414|NCT01234753|Congenital heart disease|congenital heart disease
5095415|NCT01234753|Computer-based education|computer-based education
5095416|NCT01234753|Nursing|nursing
5095417|NCT01234740|Los Angeles|los angeles
5095418|NCT01234727|diabetes, SMBG, glucose testing systems, accuracy|diabetes, smbg, glucose testing systems, accuracy
5095419|NCT01234714|Fatty Liver|fatty liver
5095420|NCT01234714|Liver|liver
5095421|NCT01234714|Magnetic Resonance Imaging|magnetic resonance imaging
5095422|NCT01234714|Surgery|surgery
5095423|NCT01234701|Liver|liver
5095424|NCT01234701|Neoplasms|neoplasms
5095425|NCT01234701|Magnetic Resonance Imaging|magnetic resonance imaging
5095426|NCT01234701|Surgery|surgery
5095427|NCT01234701|Pathology|pathology
5095428|NCT01234688|Exercise Tolerance|exercise tolerance
5095429|NCT01234688|Physical Endurance|physical endurance
5095430|NCT01234675|Fibromyalgia|fibromyalgia
5095431|NCT01234675|Sleep disorders|sleep disorders
5095432|NCT01234675|Forest Laboratories|forest laboratories
5095433|NCT01234675|Milnacipran|milnacipran
5095434|NCT01234662|Elective cesarean sections|elective cesarean sections
5095435|NCT01234662|Postoperative pain level|postoperative pain level
5095436|NCT01234662|Spinal anesthesia|spinal anesthesia
5095437|NCT01234662|Combined spinal epidural anesthesia|combined spinal epidural anesthesia
5095438|NCT01234662|Epidural catheter|epidural catheter
5095439|NCT01234649|gestational diabetes mellitus|gestational diabetes mellitus
5095440|NCT01234649|type 2 diabetes mellitus|type 2 diabetes mellitus
5095441|NCT01234649|metabolic dysfunction|metabolic dysfunction
5095442|NCT01234649|impaired fasting glucose|impaired fasting glucose
5095443|NCT01234649|impaired glucose tolerance|impaired glucose tolerance
5095444|NCT01234649|incretin mimetic|incretin mimetic
5095445|NCT01234636|Platelets|platelets
5095446|NCT01234636|Platelet aggregation|platelet aggregation
5095447|NCT01234636|Platelet activation|platelet activation
5095448|NCT01234636|Platelet function|platelet function
5095449|NCT01234636|Light transmission aggregometry|light transmission aggregometry
5095450|NCT01234636|Flow cytometry|flow cytometry
5095451|NCT01234636|Platelet function analyzer-100 (PFA-100)|platelet function analyzer-100 (pfa-100)
5095452|NCT01234636|Linoleic acid, conjugated|linoleic acid, conjugated
5095453|NCT01234636|cis9, trans11 conjugated linoleic acid|cis9, trans11 conjugated linoleic acid
5095454|NCT01234636|dietary supplement|dietary supplement
5095455|NCT01234636|short-term intervention|short-term intervention
5095456|NCT01234623|Umbilical cord serum, eyedrops, GVHD, SS-I, corneal healing|umbilical cord serum, eyedrops, gvhd, ss-i, corneal healing
5095457|NCT01234610|Exercise|exercise
5095458|NCT01234610|Aortic aneurysm|aortic aneurysm
5095459|NCT01234610|Feasibility|feasibility
5095460|NCT01234610|Vascular disease|vascular disease
5095461|NCT01234571|Pulmonary hypertension|pulmonary hypertension
5095462|NCT01234571|Remodulin (Treprostenil sodium)|remodulin (treprostenil sodium)
5095463|NCT01234571|End-stage renal disease|end-stage renal disease
5095464|NCT01234571|Hemo-dialysis|hemo-dialysis
5095465|NCT01234558|depression|depression
5095466|NCT01234558|NMDA antagonist|nmda antagonist
5095467|NCT01234558|treatment resistant|treatment resistant
5095468|NCT01234519|ureter cancer|ureter cancer
5095469|NCT01234519|renal pelvis cancer|renal pelvis cancer
5095470|NCT01234519|bladder cancer|bladder cancer
5095471|NCT01234519|urethra|urethra
5095472|NCT01234506|long term care|long term care
5095473|NCT01234506|lignans|lignans
5095474|NCT01234506|oxidative stress|oxidative stress
5095475|NCT01234506|inflammation|inflammation
5095476|NCT01234506|aging|aging
5095477|NCT01234506|dementia|dementia
5095478|NCT01234506|postural balance|postural balance
5095479|NCT01234506|depression|depression
5095480|NCT01234506|muscle weakness|muscle weakness
5095481|NCT01234506|quality of life|quality of life
5095482|NCT01234506|pain|pain
5095483|NCT01234493|ankle; fracture; syndesmosis;|ankle; fracture; syndesmosis;
5095484|NCT01234467|Diffuse Large B-Cell Lymphoma|diffuse large b-cell lymphoma
5095485|NCT01234467|Elderly|elderly
5095486|NCT01234467|Newly Diagnosed|newly diagnosed
5095487|NCT01234467|Lineberger Comprehensive Cancer Center|lineberger comprehensive cancer center
5095488|NCT01234467|University of North Carolina|university of north carolina
5095489|NCT01234467|Bendamustine|bendamustine
5095490|NCT01234467|Rituximab|rituximab
5095491|NCT01234467|Rituxan|rituxan
5095492|NCT01234467|Treanda|treanda
5095493|NCT01234467|Phase 2|phase 2
5095494|NCT01234467|Geriatric|geriatric
5095495|NCT01234467|Lymphoma|lymphoma
5095496|NCT01234428|laparoscopy|laparoscopy
5095497|NCT01234428|adjustable gastric banding|adjustable gastric banding
5095498|NCT01234428|morbid obesity|morbid obesity
5095499|NCT01234428|esophageal motility|esophageal motility
5095500|NCT01234428|esophageal dilatation|esophageal dilatation
5095501|NCT01234415|nasal|nasal
5095502|NCT01234415|septum|septum
5095503|NCT01234415|reconstruction|reconstruction
5095504|NCT01234402|Breast Cancer|breast cancer
5095505|NCT01234363|Renal allograft|renal allograft
5095506|NCT01234363|kidney|kidney
5095507|NCT01234363|fibrosis|fibrosis
5095508|NCT01234363|elastography|elastography
5095509|NCT01234363|elasticity|elasticity
5095510|NCT01234337|Breast Cancer|breast cancer
5095511|NCT01234337|HER2-neu|her2-neu
5095512|NCT01234324|Stomach Neoplasms|stomach neoplasms
5095513|NCT01234324|Gastroesophageal Junction Neoplasms|gastroesophageal junction neoplasms
5095514|NCT01234324|gastric cancer|gastric cancer
5095515|NCT01234324|cancer of the gastroesophageal junction|cancer of the gastroesophageal junction
5095516|NCT01234285|sepsis|sepsis
5095517|NCT01234285|septic shock|septic shock
5095518|NCT01234285|anticoagulation|anticoagulation
5095519|NCT01234285|intensive care unit|intensive care unit
5095520|NCT01234272|patients with|patients with
5095521|NCT01234272|undergoing|undergoing
5095522|NCT01234272|gastrectomy|gastrectomy
5095523|NCT01234259|Wrinkles|wrinkles
5095524|NCT01234259|rhytides|rhytides
5095525|NCT01234259|Cellulite|cellulite
5095526|NCT01234259|circumference reduction|circumference reduction
5095527|NCT01234246|Colorectal cancer|colorectal cancer
5095528|NCT01234246|Sexual function|sexual function
5095529|NCT01234246|Sexual dysfunction|sexual dysfunction
5095530|NCT01234246|Quality of (sexual) life|quality of (sexual) life
5095531|NCT01234246|Partners|partners
5095532|NCT01234246|Body image|body image
5095533|NCT01234246|Anxiety (state and trait)|anxiety (state and trait)
5095534|NCT01234246|Depressive symptoms|depressive symptoms
5095535|NCT01234246|Personality|personality
5095536|NCT01234233|hypothermia, accidental|hypothermia, accidental
5095537|NCT01234233|prewarming|prewarming
5095538|NCT01234233|body temperature monitoring|body temperature monitoring
5095539|NCT01234233|preoperative warming|preoperative warming
5095540|NCT01234233|sublingual temperature assessment|sublingual temperature assessment
5095541|NCT01234233|tympanic temperature assessment|tympanic temperature assessment
5095542|NCT01234220|Aldosterone|aldosterone
5095543|NCT01234220|Primary Aldosteronism|primary aldosteronism
5095544|NCT01234220|Aldosterone Producing Adenoma (APA)|aldosterone producing adenoma (apa)
5095545|NCT01234220|Idiopathic Adrenal Hyperplasia (IHA)|idiopathic adrenal hyperplasia (iha)
5095546|NCT01234220|Adrenal Venous Sampling|adrenal venous sampling
5095547|NCT01234207|Progressive addition lenses|progressive addition lenses
5095548|NCT01234207|Customized free-form|customized free-form
5095549|NCT01234207|Presbyopia|presbyopia
5095550|NCT01234207|Bifocals|bifocals
5095551|NCT01234207|Subjective assessment|subjective assessment
5095552|NCT01234207|Visual performance|visual performance
5095553|NCT01234207|Visual acuity|visual acuity
5095554|NCT01234207|Amsler grid|amsler grid
5095555|NCT01234194|Composite Variability Index|composite variability index
5095556|NCT01234194|Bispectral Index|bispectral index
5095557|NCT01234194|Electromyography|electromyography
5095558|NCT01234194|Nociception|nociception
5095559|NCT01234194|Pain|pain
5095560|NCT01234155|Exercise|exercise
5095561|NCT01234155|Diabetes|diabetes
5095562|NCT01234155|Obesity|obesity
5095563|NCT01234155|Insulin Sensitivity|insulin sensitivity
5095564|NCT01234155|Insulin Secretion|insulin secretion
5095565|NCT01234155|Beta-cell Function|beta-cell function
5095566|NCT01234155|Glycemic Control|glycemic control
5095567|NCT01234155|GIP|gip
5095568|NCT01234155|GLP-1|glp-1
5095569|NCT01234142|varenicline transdermal percutaneous transcutaneous transdermal delivery system patch|varenicline transdermal percutaneous transcutaneous transdermal delivery system patch
5095570|NCT01234129|multiple myeloma|multiple myeloma
5095571|NCT01234129|stem cell transplant|stem cell transplant
5095572|NCT01234129|zoledronic acid|zoledronic acid
5095573|NCT01234116|Post exposure prophylaxis|post exposure prophylaxis
5095574|NCT01234116|Health Care Workers|health care workers
5095575|NCT01234103|sexually transmitted infection|sexually transmitted infection
5095576|NCT01234103|sexual risk|sexual risk
5095577|NCT01234103|HIV|hiv
5095578|NCT01234103|young adults|young adults
5095579|NCT01234103|cognitive-behavioral intervention|cognitive-behavioral intervention
5095580|NCT01234090|Aphasia|aphasia
5095581|NCT01234090|Quality of Life|quality of life
5095582|NCT01234077|scheduled for a polysomnogram (overnight sleep study)|scheduled for a polysomnogram (overnight sleep study)
5095583|NCT01234064|Symptomatic Venous Thromboembolism|symptomatic venous thromboembolism
5095584|NCT01234064|Graduated Compression Stockings|graduated compression stockings
5095585|NCT01234064|Randomized Controlled Trial|randomized controlled trial
5095586|NCT01234064|Noncardiac Surgery|noncardiac surgery
5095587|NCT01234038|Non-small cell lung cancer|non-small cell lung cancer
5095588|NCT01234025|Castrate-Resistant Prostate Cancer|castrate-resistant prostate cancer
5095589|NCT01234012|melanoma|melanoma
5095590|NCT01234012|breast cancer|breast cancer
5095591|NCT01234012|ovarian cancer|ovarian cancer
5095592|NCT01234012|prostate cancer|prostate cancer
5095593|NCT01234012|esophageal cancer|esophageal cancer
5095594|NCT01234012|uterine cancer|uterine cancer
5095595|NCT01234012|sarcoma|sarcoma
5095596|NCT01234012|NY-ESO-1|ny-eso-1
5095597|NCT01233999|Scleroderma|scleroderma
5095598|NCT01233999|Raynaud's Syndrome|raynaud's syndrome
5095599|NCT01233986|Acute Ischemic Stroke|acute ischemic stroke
5095600|NCT01233986|Atherosclerosis|atherosclerosis
5095601|NCT01233986|Apolipoprotein B48|apolipoprotein b48
5095602|NCT01233973|nursing home|nursing home
5095603|NCT01233973|advance care planning|advance care planning
5095604|NCT01233960|Crohn's Disease|crohn's disease
5095605|NCT01233960|Adult Stem Cell Therapy|adult stem cell therapy
5095606|NCT01233960|inflammation of the gastrointestinal tract|inflammation of the gastrointestinal tract
5095607|NCT01233934|Insect bites|insect bites
5095608|NCT01233934|Dexchlorpheniramine|dexchlorpheniramine
5095609|NCT01233934|Gel|gel
5095610|NCT01233934|Cream|cream
5095611|NCT01233882|Renal impairment|renal impairment
5095612|NCT01233882|healthy volunteers|healthy volunteers
5095613|NCT01233869|Bosutinib|bosutinib
5095614|NCT01233869|Autosomal Dominant Polycystic Kidney Disease|autosomal dominant polycystic kidney disease
5095615|NCT01233843|induction chemotherapy|induction chemotherapy
5095616|NCT01233843|followed by irradiation and concurrent Erbitux, or radiochemotherapy|followed by irradiation and concurrent erbitux, or radiochemotherapy
5095617|NCT01233830|safety, tolerability, pharmacokinetics, AZD2423, Japanese|safety, tolerability, pharmacokinetics, azd2423, japanese
5095618|NCT01233817|Spinal muscular atrophy|spinal muscular atrophy
5095619|NCT01233817|Neuromuscular disorder|neuromuscular disorder
5095620|NCT01233817|Progressive strength training|progressive strength training
5095621|NCT01233817|Children|children
5095622|NCT01233804|influenza vaccination rates|influenza vaccination rates
5095623|NCT01233791|high tone pelvic floor dysfunction|high tone pelvic floor dysfunction
5095624|NCT01233791|levator pain|levator pain
5095625|NCT01233791|dyspareunia|dyspareunia
5095626|NCT01233778|Cardiovascular disease|cardiovascular disease
5095627|NCT01233778|Omega-3 fatty acids|omega-3 fatty acids
5095628|NCT01233778|Inflammation|inflammation
5095629|NCT01233778|Endothelial function|endothelial function
5095630|NCT01233778|Canola oil|canola oil
5095631|NCT01233765|Periodontitis|periodontitis
5095632|NCT01233765|Neutrophil|neutrophil
5095633|NCT01233765|Inflammation|inflammation
5095634|NCT01233752|systemic morphine analgesia|systemic morphine analgesia
5095635|NCT01233752|pharmacogenetics|pharmacogenetics
5095636|NCT01233752|pharmacokinetics|pharmacokinetics
5095637|NCT01233739|rhizarthrosis|rhizarthrosis
5095638|NCT01233739|Chondroitin sulfate|chondroitin sulfate
5095639|NCT01233739|Placebo|placebo
5095640|NCT01233726|Critical illness|critical illness
5095641|NCT01233726|Hyperglycemia|hyperglycemia
5095642|NCT01233726|Mechanical Ventilation|mechanical ventilation
5095643|NCT01233726|Enteral nutrition|enteral nutrition
5095644|NCT01233726|T-Diet plus Diabet IR|t-diet plus diabet ir
5095645|NCT01233726|Malnutrition|malnutrition
5095646|NCT01233726|Insulin resistance|insulin resistance
5095647|NCT01233726|Metabolic stress|metabolic stress
5095648|NCT01233713|Emergency Surgery|emergency surgery
5095649|NCT01233713|Bowel perforation|bowel perforation
5095650|NCT01233713|Diverticulitis|diverticulitis
5095651|NCT01233713|Neoplasms|neoplasms
5095652|NCT01233713|Postoperative Complications|postoperative complications
5095653|NCT01233713|Randomized Controlled Trial|randomized controlled trial
5095654|NCT01233700|living donation|living donation
5095655|NCT01233700|organ donation|organ donation
5095656|NCT01233700|psychological adaptation|psychological adaptation
5095657|NCT01233700|mental health|mental health
5095658|NCT01233700|physical well-being|physical well-being
5095659|NCT01233700|interpersonal relations|interpersonal relations
5095660|NCT01233700|quality of life|quality of life
5095661|NCT01233700|psychosocial factors|psychosocial factors
5095662|NCT01233687|Recurrent|recurrent
5095663|NCT01233687|progressive|progressive
5095664|NCT01233687|advanced|advanced
5095665|NCT01233648|heart failure|heart failure
5095666|NCT01233648|CRT-D|crt-d
5095667|NCT01233609|retinitis pigmentosa|retinitis pigmentosa
5095668|NCT01233609|valproic acid|valproic acid
5095669|NCT01233609|visual field|visual field
5095670|NCT01233596|congenital nasolacrimal duct obstruction|congenital nasolacrimal duct obstruction
5095671|NCT01233596|monocanalicular intubation|monocanalicular intubation
5095672|NCT01233596|bicanalicular intubation|bicanalicular intubation
5095673|NCT01233596|complications|complications
5095674|NCT01233583|Regulatory T-cells, psoriasis, IL-10.|regulatory t-cells, psoriasis, il-10.
5095675|NCT01233570|Cutaneous Crohns Disease|cutaneous crohns disease
5095676|NCT01233570|Topical Tacrolimus|topical tacrolimus
5095677|NCT01233570|Protopic|protopic
5095678|NCT01233570|Metastatic Crohns Disease|metastatic crohns disease
5095679|NCT01233570|Pyoderma Gangrenosum|pyoderma gangrenosum
5095680|NCT01233570|Granulomatous chelitis|granulomatous chelitis
5095681|NCT01233570|Oral crohns disease|oral crohns disease
5095682|NCT01233570|Perianal crohns disease|perianal crohns disease
5095683|NCT01233544|Colorectal carcinoma|colorectal carcinoma
5095684|NCT01233544|Liver metastases|liver metastases
5095685|NCT01233544|Stereotactic body radiation therapy|stereotactic body radiation therapy
5095686|NCT01233544|Radiofrequency ablation|radiofrequency ablation
5095687|NCT01233518|CCTA Coronary Artery Disease CAD|ccta coronary artery disease cad
5095688|NCT01233492|adult glioblastoma|adult glioblastoma
5095689|NCT01233492|adult giant cell glioblastoma|adult giant cell glioblastoma
5095690|NCT01233492|adult gliosarcoma|adult gliosarcoma
5095691|NCT01233479|untreated childhood medulloblastoma|untreated childhood medulloblastoma
5095692|NCT01233479|untreated childhood cerebellar astrocytoma|untreated childhood cerebellar astrocytoma
5095693|NCT01233479|untreated childhood cerebral astrocytoma|untreated childhood cerebral astrocytoma
5095694|NCT01233479|untreated childhood brain stem glioma|untreated childhood brain stem glioma
5095695|NCT01233479|childhood medulloepithelioma|childhood medulloepithelioma
5095696|NCT01233479|childhood infratentorial ependymoma|childhood infratentorial ependymoma
5095697|NCT01233479|newly diagnosed childhood ependymoma|newly diagnosed childhood ependymoma
5095824|NCT01232920|antimetabolite|antimetabolite
5095698|NCT01233479|childhood atypical teratoid/rhabdoid tumor|childhood atypical teratoid/rhabdoid tumor
5095699|NCT01233414|Pervasive Developmental Disorder|pervasive developmental disorder
5095700|NCT01233414|Autism|autism
5095701|NCT01233414|Children|children
5095702|NCT01233414|Behavior Therapy|behavior therapy
5095703|NCT01233414|Aggression|aggression
5095704|NCT01233414|Tantrums|tantrums
5095705|NCT01233414|Noncompliance|noncompliance
5095706|NCT01233401|Pertussis, Vaccination, Adult|pertussis, vaccination, adult
5095707|NCT01233375|cancer|cancer
5095708|NCT01233375|metastatic|metastatic
5095709|NCT01233375|pancreatic|pancreatic
5095710|NCT01233375|pancreas|pancreas
5095711|NCT01233375|adenocarcinoma|adenocarcinoma
5095712|NCT01233375|gemcitabine|gemcitabine
5095713|NCT01233375|human equilibrative nucleoside transporter-1 (hENT1)|human equilibrative nucleoside transporter-1 (hent1)
5095714|NCT01233375|CO-1.01|co-1.01
5095715|NCT01233375|CO-101|co-101
5095716|NCT01233375|CO101|co101
5095717|NCT01233375|Stage 4|stage 4
5095718|NCT01233375|Stage IV|stage iv
5095719|NCT01233375|Gemcitabine-Refractory|gemcitabine-refractory
5095720|NCT01233375|Second-Line Therapy|second-line therapy
5095721|NCT01233362|Cholera|cholera
5095722|NCT01233362|Vaccine|vaccine
5095723|NCT01233362|Kolkata|kolkata
5095724|NCT01233362|West Bengal|west bengal
5095725|NCT01233362|India|india
5095726|NCT01233362|Immunogenicity|immunogenicity
5095727|NCT01233362|Vaccination Schedules|vaccination schedules
5095728|NCT01233349|overweight|overweight
5095729|NCT01233349|obesity|obesity
5095730|NCT01233349|weight loss|weight loss
5095731|NCT01233349|body fat|body fat
5095732|NCT01233349|waist circumference|waist circumference
5095733|NCT01233349|satiety|satiety
5095734|NCT01233336|ACS,|acs,
5095735|NCT01233336|HGF,|hgf,
5095736|NCT01233336|myocardial infarction|myocardial infarction
5095737|NCT01233336|markers of myocardial injury|markers of myocardial injury
5095738|NCT01233336|acute coronary syndrome (ACS)|acute coronary syndrome (acs)
5095739|NCT01233336|prognostic factors in patients with ACS|prognostic factors in patients with acs
5095740|NCT01233323|Phrenic nerve stimulation|phrenic nerve stimulation
5095741|NCT01233323|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
5095742|NCT01233323|Heart Failure|heart failure
5095743|NCT01233323|Heart Diseases|heart diseases
5095744|NCT01233310|Crohn's Disease|crohn's disease
5095745|NCT01233297|wheeze|wheeze
5095746|NCT01233297|infections|infections
5095747|NCT01233271|algorithm|algorithm
5095748|NCT01233271|tight glycemic control|tight glycemic control
5095749|NCT01233271|glucose control|glucose control
5095750|NCT01233271|intensive care|intensive care
5095751|NCT01233271|insulin|insulin
5095752|NCT01233271|ICU|icu
5095753|NCT01233258|Haemophilia treatment|haemophilia treatment
5095754|NCT01233258|rFVIII|rfviii
5095755|NCT01233245|Multiple Sclerosis|multiple sclerosis
5095756|NCT01233245|Adherence|adherence
5095757|NCT01233245|Interferon beta-1b|interferon beta-1b
5095758|NCT01233245|Coping Styles|coping styles
5095759|NCT01233232|Chronic Obstructive Pulmonary Disease, Neutrophil, Respiratory Disease|chronic obstructive pulmonary disease, neutrophil, respiratory disease
5095760|NCT01233219|systemic morphine analgesia|systemic morphine analgesia
5095761|NCT01233219|pharmacogenetics|pharmacogenetics
5095762|NCT01233219|pharmacokinetics|pharmacokinetics
5095764|NCT01233206|Polycystic ovary syndrome|polycystic ovary syndrome
5095765|NCT01233206|Cancelled cycles|cancelled cycles
5095766|NCT01233206|OHSS|ohss
5095767|NCT01233206|Infertility|infertility
5095768|NCT01233193|Home blood pressure measurement|home blood pressure measurement
5095769|NCT01233193|Pharmaceutical Services|pharmaceutical services
5095770|NCT01233193|Medication adherence|medication adherence
5095771|NCT01233193|hypertension management|hypertension management
5095772|NCT01233193|Blood Pressure|blood pressure
5095773|NCT01233180|neck pain|neck pain
5095774|NCT01233180|massage|massage
5095775|NCT01233180|hyperthermia, induced|hyperthermia, induced
5095776|NCT01233180|touch perception|touch perception
5095777|NCT01233180|randomized controlled trial|randomized controlled trial
5095778|NCT01233167|dual antiplatelet therapy|dual antiplatelet therapy
5095779|NCT01233167|sirolimus drug-eluting stent|sirolimus drug-eluting stent
5095780|NCT01233167|major adverse cardiac events|major adverse cardiac events
5095781|NCT01233167|bleeding|bleeding
5095782|NCT01233141|peripheral artery disease stage IV (Fontaine's classification) or stage 5 and 6 (Rutherford's classification|peripheral artery disease stage iv (fontaine's classification) or stage 5 and 6 (rutherford's classification
5095783|NCT01233102|liver Cirrhosis|liver cirrhosis
5095784|NCT01233102|Mesenchymal stem cells|mesenchymal stem cells
5095785|NCT01233102|Hepatic artery infusion|hepatic artery infusion
5095786|NCT01233102|Intravenous infusion|intravenous infusion
5095787|NCT01233089|Myopia|myopia
5095788|NCT01233089|contact lenses|contact lenses
5095789|NCT01233089|children|children
5095790|NCT01233063|behavior change|behavior change
5095791|NCT01233063|physical activity|physical activity
5095792|NCT01233063|nutrition|nutrition
5095793|NCT01233063|fruits and vegetables|fruits and vegetables
5095794|NCT01233063|saturated fat|saturated fat
5095795|NCT01233063|trans fat|trans fat
5095796|NCT01233063|added sugars|added sugars
5095797|NCT01233063|email|email
5095798|NCT01233063|web|web
5095799|NCT01233063|obesity|obesity
5095800|NCT01233063|aging|aging
5095801|NCT01233050|undergoing elective colon and /or rectal surgical procedures involving an abdominal incision|undergoing elective colon and /or rectal surgical procedures involving an abdominal incision
5095802|NCT01233024|Adult|adult
5095803|NCT01233024|Women|women
5095804|NCT01233024|Dietary Fiber|dietary fiber
5095805|NCT01233024|Satiety Response|satiety response
5095806|NCT01233024|Food Intake|food intake
5095807|NCT01233011|Intubating laryngeal airway|intubating laryngeal airway
5095808|NCT01233011|Pediatric|pediatric
5095809|NCT01233011|Observational study|observational study
5095810|NCT01232998|Patient Satisfaction|patient satisfaction
5095811|NCT01232985|Atopic Dermatitis|atopic dermatitis
5095812|NCT01232985|Pruritus|pruritus
5095813|NCT01232972|vitrification|vitrification
5095814|NCT01232972|egg freezing|egg freezing
5095815|NCT01232972|oocyte cryopreservation|oocyte cryopreservation
5095816|NCT01232972|female fertility potential|female fertility potential
5095817|NCT01232972|fertility preservation|fertility preservation
5095818|NCT01232972|Fertility preservation, female|fertility preservation, female
5095819|NCT01232959|Gallbladder removal|gallbladder removal
5095820|NCT01232946|Diabetes|diabetes
5095821|NCT01232946|Myocardial metabolism|myocardial metabolism
5095822|NCT01232933|PICC|picc
5095823|NCT01232920|uveitis|uveitis
5095825|NCT01232920|immunosuppressive|immunosuppressive
5095826|NCT01232920|clinical trial|clinical trial
5095827|NCT01232907|Spinal Cord Injury (SCI)|spinal cord injury (sci)
5095828|NCT01232894|indacaterol|indacaterol
5095829|NCT01232894|COPD|copd
5095830|NCT01232894|Long-acting beta2-agonist (LABA)|long-acting beta2-agonist (laba)
5095831|NCT01232868|Innate immunity|innate immunity
5095832|NCT01232868|Adaptive immunity|adaptive immunity
5095833|NCT01232868|Slu shot|slu shot
5095834|NCT01232868|Elderly|elderly
5095835|NCT01232855|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5095836|NCT01232855|adult acute promyelocytic leukemia (M3)|adult acute promyelocytic leukemia (m3)
5095837|NCT01232855|childhood acute promyelocytic leukemia (M3)|childhood acute promyelocytic leukemia (m3)
5095838|NCT01232855|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5095839|NCT01232855|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
5095840|NCT01232855|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
5095841|NCT01232855|untreated childhood acute myeloid leukemia and other myeloid malignancies|untreated childhood acute myeloid leukemia and other myeloid malignancies
5095842|NCT01232842|adult acute myeloid leukemia|adult acute myeloid leukemia
5095843|NCT01232842|childhood acute myeloid leukemia/other myeloid malignancies|childhood acute myeloid leukemia/other myeloid malignancies
5095844|NCT01232803|Rectal Microbicides|rectal microbicides
5095845|NCT01232803|Tenofovir|tenofovir
5095846|NCT01232803|Rectal use|rectal use
5095847|NCT01232803|Rectal mucosal damage|rectal mucosal damage
5095848|NCT01232790|Schizophrenia|schizophrenia
5095849|NCT01232790|working memory|working memory
5095850|NCT01232790|N-Acetylcysteine|n-acetylcysteine
5095851|NCT01232777|Retinopathy of Prematurity|retinopathy of prematurity
5095852|NCT01232777|Bevacizumab|bevacizumab
5095853|NCT01232777|Avastin|avastin
5095854|NCT01232777|Vascular Endothelial Growth Factor|vascular endothelial growth factor
5095855|NCT01232751|health|health
5095856|NCT01232751|women|women
5095857|NCT01232725|BSID III|bsid iii
5095858|NCT01232725|Human Milk|human milk
5095859|NCT01232725|Donor Human Milk|donor human milk
5095860|NCT01232725|Preterm infant|preterm infant
5095861|NCT01232725|Breastfeeding|breastfeeding
5095862|NCT01232712|MUC1|muc1
5095863|NCT01232712|ImMucin|immucin
5095864|NCT01232712|Vaccine|vaccine
5095865|NCT01232712|Multiple Myeloma|multiple myeloma
5095866|NCT01232699|obesity|obesity
5095867|NCT01232699|weight loss|weight loss
5095868|NCT01232699|internet treatment|internet treatment
5095869|NCT01232699|motivational interviewing|motivational interviewing
5095870|NCT01232686|Communicable Diseases|communicable diseases
5095871|NCT01232686|Epidemiology|epidemiology
5095872|NCT01232686|Population surveillance|population surveillance
5095873|NCT01232686|Computerized Medical Record|computerized medical record
5095874|NCT01232686|Data collection|data collection
5095875|NCT01232673|Critical Limb Ischemia|critical limb ischemia
5095876|NCT01232673|Bone-Marrow Aspiration Concentrate|bone-marrow aspiration concentrate
5095877|NCT01232673|Diabetes Mellitus|diabetes mellitus
5095878|NCT01232673|Major Amputation|major amputation
5095879|NCT01232647|osteoporosis|osteoporosis
5095880|NCT01232647|vitamin K|vitamin k
5095881|NCT01232647|BONE MINERAL DENSITY|bone mineral density
5095882|NCT01232647|BIOCHEMICAL MARKERS OF BONE TURNOVER|biochemical markers of bone turnover
5095883|NCT01232634|pediatrics|pediatrics
5095884|NCT01232634|haemophilia|haemophilia
5095885|NCT01232634|ultrasound|ultrasound
5095886|NCT01232634|MRI|mri
5095887|NCT01232634|arthropathy|arthropathy
5095888|NCT01232608|Coronary Artery Disease|coronary artery disease
5095889|NCT01232608|Atherosclerosis.|atherosclerosis.
5095890|NCT01232608|Diabetes Mellitus, type 2|diabetes mellitus, type 2
5095891|NCT01232608|Exercise|exercise
5095892|NCT01232608|HbA1c|hba1c
5095893|NCT01232608|Carotid Atherosclerotic Disease|carotid atherosclerotic disease
5095894|NCT01232608|Inflammation|inflammation
5095895|NCT01232595|Clostridium difficile,|clostridium difficile,
5095896|NCT01232595|C. difficile,|c. difficile,
5095897|NCT01232595|CDI,|cdi,
5095898|NCT01232595|Clostridium difficile-associated disease,|clostridium difficile-associated disease,
5095899|NCT01232595|CDAD,|cdad,
5095900|NCT01232595|pseudomembranous colitis,|pseudomembranous colitis,
5095901|NCT01232595|PMC,|pmc,
5095902|NCT01232595|antibiotic-associated diarrhea|antibiotic-associated diarrhea
5095903|NCT01232582|Lower back pain, Facets joints Osteoarthritis|lower back pain, facets joints osteoarthritis
5095904|NCT01232556|inotuzumab ozogamicin|inotuzumab ozogamicin
5095905|NCT01232556|aggressive Non-Hodgkin lymphoma|aggressive non-hodgkin lymphoma
5095906|NCT01232556|diffuse large b-cell lymphoma|diffuse large b-cell lymphoma
5095907|NCT01232556|relapsed/refractory lymphoma|relapsed/refractory lymphoma
5095908|NCT01232543|Atopic Dermatitis|atopic dermatitis
5095909|NCT01232530|Malria, ACT, Safety, Efficacy, pregarnancy|malria, act, safety, efficacy, pregarnancy
5095910|NCT01232504|Allo-HSCT|allo-hsct
5095911|NCT01232504|rhGM-CSF|rhgm-csf
5095912|NCT01232504|Systemic fungal infection (SFI)|systemic fungal infection (sfi)
5095913|NCT01232478|Cystic Fibrosis|cystic fibrosis
5095914|NCT01232478|Adherence|adherence
5095915|NCT01232478|Problem-Solving|problem-solving
5095916|NCT01232478|Adolescents|adolescents
5095917|NCT01232478|Education|education
5095918|NCT01232478|Skills Remediation|skills remediation
5095919|NCT01232465|sperm DNA integrity|sperm dna integrity
5095920|NCT01232465|Toluidine blue assay (TBA)|toluidine blue assay (tba)
5095921|NCT01232465|IVF outcome|ivf outcome
5095922|NCT01232452|lung cancer|lung cancer
5095923|NCT01232452|advanced|advanced
5095924|NCT01232452|non-small cell|non-small cell
5095925|NCT01232413|Thorough QT (TQT)|thorough qt (tqt)
5095926|NCT01232413|ASP1941|asp1941
5095927|NCT01232400|subarachnoid hemorrhage|subarachnoid hemorrhage
5095928|NCT01232400|esmolol|esmolol
5095929|NCT01232400|cardiac function|cardiac function
5095930|NCT01232400|cardiac electrophysiology|cardiac electrophysiology
5095931|NCT01232387|Fetomaternal hemorrhage|fetomaternal hemorrhage
5095932|NCT01232387|neonatal anemia|neonatal anemia
5095933|NCT01232387|perinatal epidemiology|perinatal epidemiology
5095934|NCT01232387|Kleihauer-Betke|kleihauer-betke
5095935|NCT01232387|flow cytometry|flow cytometry
5095936|NCT01232374|Nimotuzumab|nimotuzumab
5095937|NCT01232374|local advanced esophageal squamous cell carcinoma|local advanced esophageal squamous cell carcinoma
5095938|NCT01232374|chemo-irradiation|chemo-irradiation
5095939|NCT01232361|ADHD|adhd
5095940|NCT01232361|HIV|hiv
5095941|NCT01232361|Pharmacokinetics|pharmacokinetics
5095942|NCT01232348|bronchial asthma|bronchial asthma
5095943|NCT01232348|Symbicort|symbicort
5095944|NCT01232335|bronchial asthma|bronchial asthma
5095945|NCT01232335|Symbicort|symbicort
5095946|NCT01232335|long term use,|long term use,
5095947|NCT01232322|bronchial asthma|bronchial asthma
5095948|NCT01232322|Pulmicort Respules|pulmicort respules
5095949|NCT01232322|long term use|long term use
5095950|NCT01232322|pediatrics|pediatrics
5095951|NCT01232309|Arterial Health|arterial health
5095952|NCT01232309|Fiber|fiber
5095953|NCT01232309|Chitin-glucan|chitin-glucan
5095954|NCT01232309|oxidized LDL|oxidized ldl
5095955|NCT01232296|Hepatocellular Carcinoma|hepatocellular carcinoma
5095956|NCT01232296|HCC|hcc
5095957|NCT01232296|Liver cancer|liver cancer
5095958|NCT01232296|Child Pugh A|child pugh a
5095959|NCT01232296|HCC Stage C|hcc stage c
5095960|NCT01232257|Chronic kidney disease|chronic kidney disease
5095961|NCT01232257|Chronic kidney failure|chronic kidney failure
5095962|NCT01232257|End stage kidney disease|end stage kidney disease
5095963|NCT01232257|End stage renal disease|end stage renal disease
5095964|NCT01232257|Hydrogen sulfide|hydrogen sulfide
5095965|NCT01232257|N-acetylcysteine|n-acetylcysteine
5095966|NCT01232257|Acetylcysteine|acetylcysteine
5095967|NCT01232244|Incretin hormones|incretin hormones
5095968|NCT01232244|Glucagon|glucagon
5095969|NCT01232244|Satiety|satiety
5095970|NCT01232244|Hunger|hunger
5095971|NCT01232244|Energy expenditure|energy expenditure
5095972|NCT01232231|methicillin-resistant Staphylococcus aureus|methicillin-resistant staphylococcus aureus
5095973|NCT01232231|decolonization|decolonization
5095974|NCT01232231|random allocation|random allocation
5095975|NCT01232231|outpatient|outpatient
5095976|NCT01232218|Cerebral Vascular Accident|cerebral vascular accident
5095977|NCT01232218|Stroke|stroke
5095978|NCT01232218|Hemiplegic|hemiplegic
5095979|NCT01232218|Shoulder pain|shoulder pain
5095980|NCT01232218|range of motion|range of motion
5095981|NCT01232218|scapula|scapula
5095982|NCT01232218|mobilization|mobilization
5095983|NCT01232205|antioxidant supplementation|antioxidant supplementation
5095984|NCT01232205|preeclampsia|preeclampsia
5095985|NCT01232153|chest tube|chest tube
5095986|NCT01232153|preoxygenation|preoxygenation
5095987|NCT01232153|NIV|niv
5095988|NCT01232153|out-of-hospital|out-of-hospital
5095989|NCT01232153|patients needing tracheal chest tube managed by Medical Mobile Emergency rescue services|patients needing tracheal chest tube managed by medical mobile emergency rescue services
5095990|NCT01232140|COPD|copd
5095991|NCT01232140|exacerbation|exacerbation
5095992|NCT01232140|antibiotic treatment|antibiotic treatment
5095993|NCT01232140|CRP|crp
5095994|NCT01232140|sputum|sputum
5095995|NCT01232140|inflammation|inflammation
5095996|NCT01232101|covered, uncovered, palliative treatment, stent|covered, uncovered, palliative treatment, stent
5095997|NCT01232088|drug labelling|drug labelling
5095998|NCT01232088|standardized drug syringe labelling|standardized drug syringe labelling
5095999|NCT01232088|European ICU|european icu
5096000|NCT01232075|Letrozole ,Clomiphene citrate , IUI,unexplained infertility|letrozole ,clomiphene citrate , iui,unexplained infertility
5096001|NCT01232062|breast neoplasm|breast neoplasm
5096002|NCT01232062|Neoplasm Metastasis|neoplasm metastasis
5096003|NCT01232062|Drug Therapy|drug therapy
5096004|NCT01232049|healthy volunteers|healthy volunteers
5096005|NCT01232036|healthy volunteers|healthy volunteers
5096006|NCT01232023|Indobufen|indobufen
5096007|NCT01232023|healthy volunteers|healthy volunteers
5096008|NCT01232010|SK-3530|sk-3530
5096009|NCT01232010|renal impairment|renal impairment
5096010|NCT01232010|healthy volunteers|healthy volunteers
5096011|NCT01231997|Udenafil|udenafil
5096012|NCT01231997|DA-8159|da-8159
5096013|NCT01231997|renal impairment|renal impairment
5096014|NCT01231997|healthy volunteers|healthy volunteers
5096015|NCT01231984|diabetes|diabetes
5096016|NCT01231984|obesity|obesity
5096017|NCT01231984|hypoglycemia|hypoglycemia
5096018|NCT01231984|hyperglycemia|hyperglycemia
5096019|NCT01231984|pen needle|pen needle
5096020|NCT01231971|amyloid|amyloid
5096021|NCT01231971|plaques|plaques
5096022|NCT01231971|neuroimaging|neuroimaging
5096023|NCT01231971|biomarkers|biomarkers
5096024|NCT01231971|cognition disorder|cognition disorder
5096025|NCT01231971|early detection|early detection
5096026|NCT01231971|Amnestic MCI|amnestic mci
5096027|NCT01231971|pre-dementia|pre-dementia
5096028|NCT01231971|dementia|dementia
5096029|NCT01231971|Alzheimer's disease|alzheimer's disease
5096030|NCT01231971|tau|tau
5096031|NCT01231958|Puerto Rican; CVD; Hispanic; health disparities; allostatic load; diet|puerto rican; cvd; hispanic; health disparities; allostatic load; diet
5096032|NCT01231945|Cervical Cancer|cervical cancer
5096033|NCT01231945|Human Papilloma Virus (HPV)|human papilloma virus (hpv)
5096034|NCT01231945|Cervical Intraepithelial Neoplasia (CIN)|cervical intraepithelial neoplasia (cin)
5096035|NCT01231932|Fatigue|fatigue
5096036|NCT01231932|Cancer|cancer
5096037|NCT01231932|Cancer Therapy|cancer therapy
5096038|NCT01231932|Cancer Treatment|cancer treatment
5096039|NCT01231932|Gene Expression Patterns|gene expression patterns
5096040|NCT01231893|human, spinal cord injury, olfactory ensheathing cells, transplantation|human, spinal cord injury, olfactory ensheathing cells, transplantation
5096041|NCT01231880|Malaria|malaria
5096042|NCT01231867|Coronary Heart Disease|coronary heart disease
5096043|NCT01231867|Acute Coronary Syndrome|acute coronary syndrome
5096044|NCT01231867|Drug interactions|drug interactions
5096045|NCT01231867|Clopidogrel|clopidogrel
5096046|NCT01231867|Proton Pump Inhibitors|proton pump inhibitors
5096047|NCT01231867|Gastrointestinal Hemorrhage|gastrointestinal hemorrhage
5096048|NCT01231854|atopic hand dermatitis|atopic hand dermatitis
5096049|NCT01231854|Chronic hand dermatitis|chronic hand dermatitis
5096050|NCT01231828|sleep|sleep
5096051|NCT01231828|cirrhosis|cirrhosis
5096052|NCT01231828|encephalopathy|encephalopathy
5096053|NCT01231828|simulated driving|simulated driving
5096054|NCT01231828|sleep disorders|sleep disorders
5096055|NCT01231815|Heart transplantation|heart transplantation
5096056|NCT01231789|cardiac surgery|cardiac surgery
5096057|NCT01231789|RIPC|ripc
5096058|NCT01231789|brain injury|brain injury
5096059|NCT01231776|cardiopulmonary bypass|cardiopulmonary bypass
5096060|NCT01231776|sleep|sleep
5096061|NCT01231776|acupuncture|acupuncture
5096062|NCT01231763|HIV prevention|hiv prevention
5096063|NCT01231763|Vaginal film|vaginal film
5096064|NCT01231763|Microbicide|microbicide
5096065|NCT01231763|Administration, intravaginal|administration, intravaginal
5096066|NCT01231737|Prophylasy|prophylasy
5096067|NCT01231737|recurrent urinary tract infection|recurrent urinary tract infection
5096068|NCT01231737|prulifloxacin|prulifloxacin
5096069|NCT01231737|phosphomycin|phosphomycin
5096070|NCT01231711|depression|depression
5096071|NCT01231711|post traumatic stress syndrome|post traumatic stress syndrome
5096072|NCT01231711|functional status|functional status
5096073|NCT01231711|veteran|veteran
5096074|NCT01231711|military|military
5096075|NCT01231711|stigma|stigma
5096076|NCT01231711|mental health self-efficacy|mental health self-efficacy
5096077|NCT01231698|septic shock|septic shock
5096078|NCT01231698|esmolol|esmolol
5096079|NCT01231698|tachycardia|tachycardia
5096080|NCT01231698|betablockers|betablockers
5096081|NCT01231685|Liver fibrosis|liver fibrosis
5096082|NCT01231685|HIV|hiv
5096083|NCT01231685|Hepatitis C Virus|hepatitis c virus
5096084|NCT01231685|Coinfection|coinfection
5096085|NCT01231659|RAD001 (Everolimus)|rad001 (everolimus)
5096086|NCT01231659|Letrozole|letrozole
5096087|NCT01231659|Breast cancer|breast cancer
5096088|NCT01231659|Metastatic Breast cancer|metastatic breast cancer
5096089|NCT01231659|Estrogen receptor positive|estrogen receptor positive
5096090|NCT01231659|Failure of Tamoxifen|failure of tamoxifen
5096091|NCT01231659|Anastrozole or Examestane|anastrozole or examestane
5096092|NCT01231646|Folate Receptor Autoantibodies|folate receptor autoantibodies
5096093|NCT01231646|Epilepsy|epilepsy
5096094|NCT01231646|Psychiatric conditions|psychiatric conditions
5096095|NCT01231633|Macular Edema|macular edema
5096096|NCT01231633|Central Retinal Vein Occlusion|central retinal vein occlusion
5096097|NCT01231620|Seasonal Influenza|seasonal influenza
5096098|NCT01231620|Pandemic|pandemic
5096099|NCT01231620|Orthomyxoviridae Infections|orthomyxoviridae infections
5096100|NCT01231620|Influenza|influenza
5096101|NCT01231620|Influenza A Virus, H1N1 Subtype|influenza a virus, h1n1 subtype
5096102|NCT01231620|Enzyme Inhibitors|enzyme inhibitors
5096103|NCT01231620|Influenza, seasonal|influenza, seasonal
5096104|NCT01231620|Respiratory Tract Diseases|respiratory tract diseases
5096105|NCT01231620|Zanamivir|zanamivir
5096106|NCT01231620|Pharmacologic Actions|pharmacologic actions
5096107|NCT01231620|Antiviral Agents|antiviral agents
5096108|NCT01231620|Anti-Infective Agents|anti-infective agents
5096109|NCT01231620|H1N1|h1n1
5096110|NCT01231620|Neuraminidase inhibitor|neuraminidase inhibitor
5096111|NCT01231620|Influenza B virus|influenza b virus
5096112|NCT01231594|BRAF Inhibitor|braf inhibitor
5096113|NCT01231594|Cancer|cancer
5096114|NCT01231594|Safety|safety
5096115|NCT01231594|GSK2118436|gsk2118436
5096116|NCT01231594|BRAF mutation positive tumors|braf mutation positive tumors
5096117|NCT01231568|food effect; high fat meal|food effect; high fat meal
5096118|NCT01231568|GSK2118436|gsk2118436
5096119|NCT01231568|pharmacokinetic|pharmacokinetic
5096120|NCT01231568|particle size|particle size
5096121|NCT01231568|BRAF inhibitor|braf inhibitor
5096122|NCT01231568|BRAF positive tumor|braf positive tumor
5096123|NCT01231555|antiretroviral|antiretroviral
5096124|NCT01231555|HAART|haart
5096125|NCT01231555|NNRTI|nnrti
5096126|NCT01231555|emtricitabine|emtricitabine
5096127|NCT01231555|Sexually Transmitted Disease|sexually transmitted disease
5096128|NCT01231555|antiretroviral therapy (ART)-naive adults|antiretroviral therapy (art)-naive adults
5096129|NCT01231555|Immunologic Deficiency Syndrome|immunologic deficiency syndrome
5096130|NCT01231555|tenofovir|tenofovir
5096131|NCT01231555|abacavir|abacavir
5096132|NCT01231555|Retroviridae Infections|retroviridae infections
5096133|NCT01231555|GSK2248761|gsk2248761
5096134|NCT01231555|lamivudine|lamivudine
5096135|NCT01231555|Acquired ImmunoDeficiency Syndrome (AIDS)|acquired immunodeficiency syndrome (aids)
5096136|NCT01231555|HIV infection|hiv infection
5096137|NCT01231555|efavirenz|efavirenz
5096138|NCT01231542|GSK1349572|gsk1349572
5096139|NCT01231542|pharmacokinetics|pharmacokinetics
5096140|NCT01231542|dolutegravir|dolutegravir
5096141|NCT01231542|integrase|integrase
5096142|NCT01231542|rifabutin|rifabutin
5096143|NCT01231542|rifampin|rifampin
5096144|NCT01231516|ART-experienced|art-experienced
5096145|NCT01231516|Integrase inhibitor|integrase inhibitor
5096146|NCT01231516|Raltegravir|raltegravir
5096147|NCT01231516|GSK1349572|gsk1349572
5096148|NCT01231516|Integrase inhibitor naive|integrase inhibitor naive
5096149|NCT01231503|Africa|africa
5096150|NCT01231503|malaria vaccine|malaria vaccine
5096151|NCT01231503|schedule|schedule
5096152|NCT01231503|EPI|epi
5096153|NCT01231503|Plasmodium falciparum|plasmodium falciparum
5096154|NCT01231477|anaesthetic techniques, inhalation|anaesthetic techniques, inhalation
5096155|NCT01231477|sevoflurane|sevoflurane
5096156|NCT01231477|Cytokines|cytokines
5096157|NCT01231477|Immune response|immune response
5096158|NCT01231464|safety|safety
5096159|NCT01231464|efficacy|efficacy
5096160|NCT01231464|placebo|placebo
5096161|NCT01231464|allergic rhinitis|allergic rhinitis
5096162|NCT01231464|fluticasone furoate|fluticasone furoate
5096163|NCT01231451|HIV Infection|hiv infection
5096164|NCT01231438|Renal failure stage 3B|renal failure stage 3b
5096165|NCT01231425|Back pain|back pain
5096166|NCT01231425|cervicalgia|cervicalgia
5096167|NCT01231425|dorsalgia|dorsalgia
5096168|NCT01231425|lumbalgia|lumbalgia
5096169|NCT01231425|acupuncture|acupuncture
5096170|NCT01231386|Female Breast Cancer|female breast cancer
5096171|NCT01231386|miRNA expression|mirna expression
5096172|NCT01231386|Neoadjuvant/Adjuvant Treatment|neoadjuvant/adjuvant treatment
5096173|NCT01231386|Locally and Inflammatory Breast Cancer|locally and inflammatory breast cancer
5096174|NCT01231373|varicose veins|varicose veins
5096175|NCT01231360|claudication|claudication
5096176|NCT01231360|peripheral artery disease|peripheral artery disease
5096177|NCT01231360|PAD|pad
5096178|NCT01231347|pancreas|pancreas
5096179|NCT01231347|gemcitabine|gemcitabine
5096180|NCT01231347|metastatic|metastatic
5096181|NCT01231347|jaundice|jaundice
5096182|NCT01231321|Adalimumab added to inadequate standard anti-rheumatic therapy in patients with active Rheumatoid Arthritis|adalimumab added to inadequate standard anti-rheumatic therapy in patients with active rheumatoid arthritis
5096183|NCT01231256|Quality of life|quality of life
5096184|NCT01231256|preventive health consultation|preventive health consultation
5096185|NCT01231256|General practice|general practice
5096186|NCT01231256|resources|resources
5096187|NCT01231256|life style|life style
5096188|NCT01231243|tooth bleaching, bleaching agent, hydrogen peroxide|tooth bleaching, bleaching agent, hydrogen peroxide
5096189|NCT01231230|asthma, corticosteroids, bronchodilator, airway blood flow|asthma, corticosteroids, bronchodilator, airway blood flow
5096190|NCT01231204|Breast Cancer|breast cancer
5096191|NCT01231204|Mastectomy|mastectomy
5096192|NCT01231204|UCSD|ucsd
5096193|NCT01231204|Surgery|surgery
5096194|NCT01231204|PVB Catheter|pvb catheter
5096195|NCT01231204|Paravertebral Catheter|paravertebral catheter
5096196|NCT01231204|Breast Pain|breast pain
5096197|NCT01231204|Mastectomy Pain|mastectomy pain
5096198|NCT01231204|Postoperative Pain|postoperative pain
5096199|NCT01231139|Brain Injury|brain injury
5096200|NCT01231139|Temperature|temperature
5096201|NCT01231139|Paracetamol|paracetamol
5096202|NCT01231139|Phase 2|phase 2
5096203|NCT01231139|TBI|tbi
5096204|NCT01231126|Induced labor|induced labor
5096205|NCT01231126|Misoprostol|misoprostol
5096206|NCT01231126|Postpartum blood|postpartum blood
5096207|NCT01231126|Erythrocyte indices|erythrocyte indices
5096208|NCT01231126|Vaginal delivery|vaginal delivery
5096209|NCT01231113|malaria,|malaria,
5096210|NCT01231113|pregnancy,|pregnancy,
5096211|NCT01231113|dihydroartemisinin-piperaquine,|dihydroartemisinin-piperaquine,
5096212|NCT01231113|efficacy,|efficacy,
5096213|NCT01231113|safety,|safety,
5096214|NCT01231113|Ghana|ghana
5096215|NCT01231087|energy expenditure|energy expenditure
5096216|NCT01231087|morbid obesity|morbid obesity
5096217|NCT01231087|bariatric surgery|bariatric surgery
5096218|NCT01231087|nutritional follow-up|nutritional follow-up
5096219|NCT01231074|obesity|obesity
5096220|NCT01231074|weight gain|weight gain
5096221|NCT01231074|metformin|metformin
5096222|NCT01231074|psychotropic drugs|psychotropic drugs
5096223|NCT01231061|spine metastasis|spine metastasis
5096224|NCT01231061|SBRT|sbrt
5096225|NCT01231061|Radiosurgery|radiosurgery
5096226|NCT01231035|acute cardiac syndrome|acute cardiac syndrome
5096227|NCT01231035|stent thrombosis|stent thrombosis
5096228|NCT01231035|platelet function|platelet function
5096229|NCT01231035|antiplatelet therapy|antiplatelet therapy
5096230|NCT01231022|breast neoplasm|breast neoplasm
5096231|NCT01231022|Neoplasm Metastasis|neoplasm metastasis
5096232|NCT01231022|Stem Cells|stem cells
5096233|NCT01231022|Drug-Induced Liver Injury|drug-induced liver injury
5096234|NCT01230996|cervical adenocarcinoma|cervical adenocarcinoma
5096235|NCT01230996|cervical adenosquamous cell carcinoma|cervical adenosquamous cell carcinoma
5096236|NCT01230996|cervical squamous cell carcinoma|cervical squamous cell carcinoma
5096237|NCT01230996|stage IB cervical cancer|stage ib cervical cancer
5096238|NCT01230996|stage IIA cervical cancer|stage iia cervical cancer
5096239|NCT01230996|stage IIB cervical cancer|stage iib cervical cancer
5096240|NCT01230996|stage III cervical cancer|stage iii cervical cancer
5096241|NCT01230996|stage IVA cervical cancer|stage iva cervical cancer
5096242|NCT01230983|stage III childhood lymphoblastic lymphoma|stage iii childhood lymphoblastic lymphoma
5096243|NCT01230983|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
5096244|NCT01230983|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
5096245|NCT01230983|T-cell childhood acute lymphoblastic leukemia|t-cell childhood acute lymphoblastic leukemia
5096246|NCT01230983|cardiac toxicity|cardiac toxicity
5096247|NCT01230957|Clostridium difficile infection|clostridium difficile infection
5096248|NCT01230957|Diarrhea|diarrhea
5096249|NCT01230957|Pseudomembranous colitis|pseudomembranous colitis
5096250|NCT01230957|Clostridium Difficile Toxoid Vaccine|clostridium difficile toxoid vaccine
5096251|NCT01230957|ACAM-CDIFF™ vaccine|acam-cdiff™ vaccine
5096252|NCT01230944|GERD|gerd
5096253|NCT01230944|LNF|lnf
5096254|NCT01230944|CNF|cnf
5096255|NCT01230944|Laparoscopic Nissen fundoplication|laparoscopic nissen fundoplication
5096256|NCT01230944|Open Nissen fundoplication|open nissen fundoplication
5096257|NCT01230944|Antireflux surgery|antireflux surgery
5096258|NCT01230931|Acetabulum|acetabulum
5096259|NCT01230931|Fracture|fracture
5096260|NCT01230931|Hemostatis|hemostatis
5096261|NCT01230931|Vitagel|vitagel
5096262|NCT01230931|Fibrin sealant|fibrin sealant
5096263|NCT01230918|Hypertrophic Cardiomyopathy|hypertrophic cardiomyopathy
5096264|NCT01230918|Acute Coronary Syndrome|acute coronary syndrome
5096265|NCT01230918|Myocardial Fibrosis|myocardial fibrosis
5096266|NCT01230918|Fibrogenesis|fibrogenesis
5096267|NCT01230918|Intimal Hyperplasia|intimal hyperplasia
5096268|NCT01230918|Sudden Death|sudden death
5096269|NCT01230918|avB3 Integrin Expression|avb3 integrin expression
5096270|NCT01230905|Androgen Suppression Therapy|androgen suppression therapy
5096271|NCT01230905|Hormonal Toxicity|hormonal toxicity
5096272|NCT01230905|Quantitative PET|quantitative pet
5096273|NCT01230905|Myocardial blood flow|myocardial blood flow
5096274|NCT01230905|Coronary blood flow reserve|coronary blood flow reserve
5096275|NCT01230905|Endothelial dysfunction|endothelial dysfunction
5096276|NCT01230905|Coronary Artery Disease|coronary artery disease
5096277|NCT01230879|Aging lung|aging lung
5096278|NCT01230879|Airway remodeling|airway remodeling
5096279|NCT01230879|Airway segmentation|airway segmentation
5096280|NCT01230879|Chest CT|chest ct
5096281|NCT01230866|Proton Radiation Prostate Cancer|proton radiation prostate cancer
5096282|NCT01230840|fiber|fiber
5096283|NCT01230840|calcium|calcium
5096284|NCT01230840|magnesium|magnesium
5096285|NCT01230827|Juvenile Idiopathic Arthritis|juvenile idiopathic arthritis
5096286|NCT01230827|golimumab|golimumab
5096287|NCT01230827|juvenile arthritis|juvenile arthritis
5096288|NCT01230827|GO KIDS|go kids
5096289|NCT01230827|anti TNF alpha medications|anti tnf alpha medications
5096290|NCT01230827|juvenile psoriatic arthritis|juvenile psoriatic arthritis
5096291|NCT01230814|Bacterial vaginosis, metronidazole, miconazole, vulvovaginal candidiasis, trichomonas vaginalis, women, Kenya|bacterial vaginosis, metronidazole, miconazole, vulvovaginal candidiasis, trichomonas vaginalis, women, kenya
5096292|NCT01230788|ALL|all
5096293|NCT01230788|Leukemia|leukemia
5096294|NCT01230788|Rituximab|rituximab
5096295|NCT01230788|Pediatrics|pediatrics
5096296|NCT01230762|Dapoxetine, Orgasmic disorder|dapoxetine, orgasmic disorder
5096297|NCT01230762|Premature ejaculation|premature ejaculation
5096298|NCT01230762|Sexual dysfunction|sexual dysfunction
5096299|NCT01230762|Sexual intercourse|sexual intercourse
5096300|NCT01230762|Ejaculation|ejaculation
5096301|NCT01230762|Erectile Dysfunction|erectile dysfunction
5096302|NCT01230749|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
5096303|NCT01230749|Diabetes Mellitus|diabetes mellitus
5096304|NCT01230749|Hyperglycemia|hyperglycemia
5096305|NCT01230749|JNJ-41443532|jnj-41443532
5096306|NCT01230749|Pioglitazone|pioglitazone
5096307|NCT01230749|Placebo|placebo
5096308|NCT01230697|Advanced|advanced
5096309|NCT01230697|hepatocarcinoma|hepatocarcinoma
5096310|NCT01230684|CEUS|ceus
5096311|NCT01230684|Endoleaks|endoleaks
5096312|NCT01230684|Abdominal Aortic Aneurysm|abdominal aortic aneurysm
5096313|NCT01230658|prophylactic enoxaparin|prophylactic enoxaparin
5096314|NCT01230658|Roux en Y gastric bypass surgery|roux en y gastric bypass surgery
5096315|NCT01230632|assisted reproduction technology|assisted reproduction technology
5096316|NCT01230632|Metabolic risk factors|metabolic risk factors
5096317|NCT01230632|In Vitro Fertilisation|in vitro fertilisation
5096318|NCT01230606|Percutaneous Intervention|percutaneous intervention
5096319|NCT01230606|Percutaneous Coronary Intervention|percutaneous coronary intervention
5096320|NCT01230606|Catheterization|catheterization
5096321|NCT01230606|Coronary Catheterization|coronary catheterization
5096322|NCT01230606|Same day Discharge|same day discharge
5096323|NCT01230606|Next Day Discharge|next day discharge
5096324|NCT01230606|Patient Satisfaction|patient satisfaction
5096325|NCT01230606|Multi-Center|multi-center
5096326|NCT01230606|Randomized|randomized
5096327|NCT01230606|Low-risk PCI|low-risk pci
5096328|NCT01230606|BlindedClosure device|blindedclosure device
5096329|NCT01230606|Vascular closure device|vascular closure device
5096330|NCT01230580|Protease Inhibitors|protease inhibitors
5096331|NCT01230580|RNA virus infections|rna virus infections
5096332|NCT01230580|Virus diseases|virus diseases
5096333|NCT01230580|Sexually Transmitted Diseases viral|sexually transmitted diseases viral
5096334|NCT01230580|Immune system diseases|immune system diseases
5096335|NCT01230580|Anti-infective Agents|anti-infective agents
5096336|NCT01230580|Drug resistance|drug resistance
5096337|NCT01230567|Problem wounds|problem wounds
5096338|NCT01230567|Non healing wounds|non healing wounds
5096340|NCT01230567|SCC|scc
5096341|NCT01230567|Vasculitis|vasculitis
5096342|NCT01230554|contact lens|contact lens
5096343|NCT01230541|Semen characteristics|semen characteristics
5096344|NCT01230541|Erectile Dysfunction|erectile dysfunction
5096443|NCT01230099|Caregivers|caregivers
5096444|NCT01230086|ICD|icd
5096345|NCT01230515|Oncology Pain Management in outpatient hospice setting|oncology pain management in outpatient hospice setting
5096346|NCT01230502|immunosuppression|immunosuppression
5096347|NCT01230502|anti-rejection|anti-rejection
5096348|NCT01230502|immune tolerance|immune tolerance
5096349|NCT01230476|Locally advanced nasopharyngeal carcinoma|locally advanced nasopharyngeal carcinoma
5096350|NCT01230476|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
5096351|NCT01230476|Chemoradiation|chemoradiation
5096352|NCT01230476|Cetuximab|cetuximab
5096353|NCT01230463|Pain, Postoperative|pain, postoperative
5096354|NCT01230463|Ketorolac|ketorolac
5096355|NCT01230463|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal
5096356|NCT01230463|Intraoperative Care|intraoperative care
5096357|NCT01230450|urodynamic urinary incontinence, sub-urethral tape|urodynamic urinary incontinence, sub-urethral tape
5096358|NCT01230437|montelukast|montelukast
5096359|NCT01230437|asthma|asthma
5096360|NCT01230437|allergic rhinitis|allergic rhinitis
5096361|NCT01230437|nasal epithelial cells|nasal epithelial cells
5096362|NCT01230437|inflammatory mediators|inflammatory mediators
5096363|NCT01230424|OA|oa
5096364|NCT01230424|Knee arthritis|knee arthritis
5096365|NCT01230424|MRI|mri
5096366|NCT01230424|Steroid|steroid
5096367|NCT01230411|Episodic migraine|episodic migraine
5096368|NCT01230385|lersivirine|lersivirine
5096369|NCT01230385|UK-453|uk-453
5096370|NCT01230385|061|061
5096371|NCT01230385|safety|safety
5096372|NCT01230385|tolerability|tolerability
5096373|NCT01230385|pharmacokinetics|pharmacokinetics
5096374|NCT01230385|HIV|hiv
5096375|NCT01230385|non-nucleoside reverse transcriptase inhibitor|non-nucleoside reverse transcriptase inhibitor
5096376|NCT01230385|NNRTI|nnrti
5096377|NCT01230359|Autism|autism
5096378|NCT01230359|Children|children
5096379|NCT01230359|ASD|asd
5096380|NCT01230359|Vitamin B6|vitamin b6
5096381|NCT01230359|Magnesium|magnesium
5096382|NCT01230320|Cost estimates|cost estimates
5096383|NCT01230320|Complete Denture|complete denture
5096384|NCT01230320|Dental Economics|dental economics
5096385|NCT01230320|Dental Impression Technique|dental impression technique
5096386|NCT01230320|Denture Retention|denture retention
5096387|NCT01230320|Edentulous|edentulous
5096388|NCT01230320|Edentulism|edentulism
5096389|NCT01230320|Oral Health-Related Quality of Life|oral health-related quality of life
5096390|NCT01230320|Patient Acceptance of Health Care|patient acceptance of health care
5096391|NCT01230320|Patient Satisfaction|patient satisfaction
5096392|NCT01230320|Quality of Health Care|quality of health care
5096393|NCT01230320|Quality of Life|quality of life
5096394|NCT01230307|Vitamin D|vitamin d
5096395|NCT01230307|Systolic failure|systolic failure
5096396|NCT01230307|Genomics|genomics
5096397|NCT01230307|Biomarkers|biomarkers
5096398|NCT01230307|Exercise|exercise
5096399|NCT01230307|Quality of Life|quality of life
5096400|NCT01230294|echocardiography of the right heart|echocardiography of the right heart
5096401|NCT01230294|3D 4D echocardiography|3d 4d echocardiography
5096402|NCT01230294|strain measurement|strain measurement
5096403|NCT01230294|chronic heart failure|chronic heart failure
5096404|NCT01230294|pulmonary hypertension|pulmonary hypertension
5096405|NCT01230281|C3G|c3g
5096406|NCT01230281|Oxidative stress|oxidative stress
5096407|NCT01230281|Antioxidant|antioxidant
5096408|NCT01230281|Black bean|black bean
5096409|NCT01230268|C3G|c3g
5096410|NCT01230268|Oxidative stress|oxidative stress
5096411|NCT01230268|Antioxidant|antioxidant
5096412|NCT01230268|Mulberry|mulberry
5096413|NCT01230255|intra-abdominal pressure|intra-abdominal pressure
5096414|NCT01230255|intra-abdominal hypertension|intra-abdominal hypertension
5096415|NCT01230255|abdominal compartment syndrome|abdominal compartment syndrome
5096416|NCT01230255|open abdomen|open abdomen
5096417|NCT01230255|percutaneous|percutaneous
5096418|NCT01230242|Mirena|mirena
5096419|NCT01230242|postplacental intrauterine device|postplacental intrauterine device
5096420|NCT01230242|postpartum insertion|postpartum insertion
5096421|NCT01230229|Intermittent claudication|intermittent claudication
5096422|NCT01230229|Superficial femoral artery|superficial femoral artery
5096423|NCT01230229|Stenting|stenting
5096424|NCT01230229|Medical treatment|medical treatment
5096425|NCT01230229|Quality of life|quality of life
5096426|NCT01230216|coronary artery disease|coronary artery disease
5096427|NCT01230216|hypertension|hypertension
5096428|NCT01230190|infants|infants
5096429|NCT01230190|adaptive immunology|adaptive immunology
5096430|NCT01230190|atopic dermatitis|atopic dermatitis
5096431|NCT01230190|probiotics|probiotics
5096432|NCT01230151|Deep Brain Stimulation|deep brain stimulation
5096433|NCT01230151|DBS|dbs
5096434|NCT01230151|Parkinson's disease|parkinson's disease
5096435|NCT01230151|PD|pd
5096436|NCT01230151|Patients who have a preexisting Deep Brain Stimulation (DBS) system for the treatment of Parkinson's disease (PD)|patients who have a preexisting deep brain stimulation (dbs) system for the treatment of parkinson's disease (pd)
5096437|NCT01230125|Inflammation|inflammation
5096438|NCT01230125|Pain|pain
5096439|NCT01230125|Ocular surgery|ocular surgery
5096440|NCT01230099|Critical Illness|critical illness
5096441|NCT01230099|Mechanical Ventilation|mechanical ventilation
5096442|NCT01230099|Palliative Care|palliative care
5096445|NCT01230086|DFT-testing|dft-testing
5096446|NCT01230073|ICD|icd
5096447|NCT01230073|Home-Monitoring|home-monitoring
5096448|NCT01230073|Quality of life|quality of life
5096449|NCT01230060|ocular surgery|ocular surgery
5096450|NCT01230060|phacoemulsification|phacoemulsification
5096451|NCT01230047|depression|depression
5096452|NCT01230047|anxiety|anxiety
5096453|NCT01230047|psychoeducation|psychoeducation
5096454|NCT01230047|self-help|self-help
5096455|NCT01230047|psychosocial|psychosocial
5096456|NCT01230034|Imidapril, Ramipril, Hypertension, Type 2 diabetes mellitus, Microalbuminuria|imidapril, ramipril, hypertension, type 2 diabetes mellitus, microalbuminuria
5096457|NCT01230008|primary mediastinal lymphoma|primary mediastinal lymphoma
5096458|NCT01230008|radiotherapy|radiotherapy
5096459|NCT01230008|chemotherapy|chemotherapy
5096460|NCT01230008|rituximab|rituximab
5096461|NCT01229969|falls, balance problems, gaming systems, balance assessments|falls, balance problems, gaming systems, balance assessments
5096462|NCT01229956|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
5096463|NCT01229956|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5096464|NCT01229956|untreated childhood acute myeloid leukemia and other myeloid malignancies|untreated childhood acute myeloid leukemia and other myeloid malignancies
5096465|NCT01229930|cervical adenocarcinoma|cervical adenocarcinoma
5096466|NCT01229930|cervical adenosquamous cell carcinoma|cervical adenosquamous cell carcinoma
5096467|NCT01229930|cervical squamous cell carcinoma|cervical squamous cell carcinoma
5096468|NCT01229930|recurrent cervical cancer|recurrent cervical cancer
5096469|NCT01229930|stage IVB cervical cancer|stage ivb cervical cancer
5096470|NCT01229930|stage IVA cervical cancer|stage iva cervical cancer
5096471|NCT01229891|vitamin D fortification|vitamin d fortification
5096472|NCT01229891|yogurt drink|yogurt drink
5096473|NCT01229891|type 2 diabetes|type 2 diabetes
5096474|NCT01229891|efficacy|efficacy
5096475|NCT01229852|Fibromyalgia|fibromyalgia
5096476|NCT01229852|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
5096477|NCT01229852|Pain|pain
5096478|NCT01229839|Carcinoma,Hepatocellular|carcinoma,hepatocellular
5096479|NCT01229839|Liver Neoplasms|liver neoplasms
5096480|NCT01229839|Therapeutic|therapeutic
5096481|NCT01229839|Chemoembolization,|chemoembolization,
5096482|NCT01229839|TACE|tace
5096483|NCT01229839|pharmacokinetics|pharmacokinetics
5096484|NCT01229839|Iodized Oil/administration & dosage|iodized oil/administration & dosage
5096485|NCT01229839|polyvinyl alcohol|polyvinyl alcohol
5096486|NCT01229839|Humans|humans
5096487|NCT01229826|Uterine fibroids|uterine fibroids
5096488|NCT01229826|Uterine leiomyomas|uterine leiomyomas
5096489|NCT01229826|MR Elastography|mr elastography
5096490|NCT01229826|MRI (Magnetic Resonance Imaging)|mri (magnetic resonance imaging)
5096491|NCT01229826|Symptomatic Uterine Fibroids|symptomatic uterine fibroids
5096492|NCT01229813|Untreated|untreated
5096493|NCT01229813|First line|first line
5096494|NCT01229813|Chemotherapy|chemotherapy
5096495|NCT01229813|Maintenance treatment|maintenance treatment
5096496|NCT01229813|KRAS wt|kras wt
5096497|NCT01229813|KRAS mutated|kras mutated
5096498|NCT01229813|Anti-angiogenetic treatment|anti-angiogenetic treatment
5096499|NCT01229813|Metronomic capecitabine|metronomic capecitabine
5096500|NCT01229813|bevacizumab|bevacizumab
5096501|NCT01229813|erlotinib|erlotinib
5096502|NCT01229813|Translational research|translational research
5096503|NCT01229800|Polyethylene Glycol, Sodium Phosphate, Bowel preparation, Efficacy|polyethylene glycol, sodium phosphate, bowel preparation, efficacy
5096504|NCT01229787|asthma|asthma
5096505|NCT01229787|allergies|allergies
5096506|NCT01229787|obesity|obesity
5096507|NCT01229761|HIV|hiv
5096508|NCT01229761|Trimethoprim-Sulfamethoxazole Combination|trimethoprim-sulfamethoxazole combination
5096509|NCT01229761|Breast Feeding|breast feeding
5096510|NCT01229761|Infant Mortality|infant mortality
5096511|NCT01229761|Morbidity|morbidity
5096512|NCT01229761|Botswana|botswana
5096513|NCT01229761|Africa|africa
5096514|NCT01229761|Infectious disease transmission, vertical|infectious disease transmission, vertical
5096515|NCT01229761|adverse drug event|adverse drug event
5096516|NCT01229735|levetiracetam|levetiracetam
5096517|NCT01229735|topiramate|topiramate
5096518|NCT01229735|epilepsy|epilepsy
5096519|NCT01229735|partial seizures|partial seizures
5096520|NCT01229722|adherence|adherence
5096521|NCT01229722|reminders|reminders
5096522|NCT01229722|text messages|text messages
5096523|NCT01229722|SMS|sms
5096524|NCT01229722|mHealth|mhealth
5096525|NCT01229709|Tinnitus|tinnitus
5096526|NCT01229709|Mindfulness|mindfulness
5096527|NCT01229709|MBSR|mbsr
5096528|NCT01229709|Mindfulness Based Stress Reduction|mindfulness based stress reduction
5096529|NCT01229709|MBTR|mbtr
5096530|NCT01229696|Popliteal|popliteal
5096531|NCT01229696|UCSD|ucsd
5096532|NCT01229696|Postoperative pain|postoperative pain
5096533|NCT01229696|Foot surgery|foot surgery
5096534|NCT01229696|Ankle surgery|ankle surgery
5096535|NCT01229696|Popliteal Catheter|popliteal catheter
5096536|NCT01229696|Popliteal Nerve Block|popliteal nerve block
5096537|NCT01229696|Lower extremity surgery|lower extremity surgery
5096538|NCT01229696|Bifurcation|bifurcation
5096539|NCT01229696|Catheter Insertion Site|catheter insertion site
5096540|NCT01229683|UCSD|ucsd
5096541|NCT01229683|Perineural Nerve Block|perineural nerve block
5096542|NCT01229683|Shoulder Surgery|shoulder surgery
5096543|NCT01229683|Pain|pain
5096544|NCT01229683|Grip Strength|grip strength
5096545|NCT01229683|Sensation|sensation
5096546|NCT01229683|Interscalene Nerve Block|interscalene nerve block
5096547|NCT01229670|Heart failure|heart failure
5096548|NCT01229670|Hemorheology|hemorheology
5096549|NCT01229670|Atherothrombosis|atherothrombosis
5096550|NCT01229670|Angiogenesis|angiogenesis
5096551|NCT01229657|Reopening of macular hole;|reopening of macular hole;
5096552|NCT01229657|Visual acuity;|visual acuity;
5096553|NCT01229657|Phacoemulsification cataract surgery;|phacoemulsification cataract surgery;
5096554|NCT01229657|Vitrectomy|vitrectomy
5096555|NCT01229644|Glioma|glioma
5096556|NCT01229644|Brain Cancer|brain cancer
5096557|NCT01229644|Recurrent glioma|recurrent glioma
5096558|NCT01229644|Low grade glioma|low grade glioma
5096559|NCT01229644|PDGFR Inhibitor|pdgfr inhibitor
5096560|NCT01229644|Crenolanib (CP-868,596)|crenolanib (cp-868,596)
5096561|NCT01229644|Neo-adjuvant Therapy|neo-adjuvant therapy
5096562|NCT01229631|Periodontitis|periodontitis
5096563|NCT01229631|Dietary supplementation|dietary supplementation
5096564|NCT01229618|Prostate Cancer|prostate cancer
5096565|NCT01229592|infection|infection
5096566|NCT01229592|catheter|catheter
5096567|NCT01229592|bacteriaemia|bacteriaemia
5096568|NCT01229592|ethanol|ethanol
5096569|NCT01229579|poliomyelitis|poliomyelitis
5096571|NCT01229579|zinc supplement|zinc supplement
5096572|NCT01229579|diarrhea|diarrhea
5096573|NCT01229579|placebo|placebo
5096574|NCT01229579|double blind randomized control trial|double blind randomized control trial
5096575|NCT01229579|elemental zinc|elemental zinc
5096576|NCT01229579|seroconversion|seroconversion
5096577|NCT01229579|bOPV|bopv
5096578|NCT01229579|infants|infants
5096579|NCT01229579|immunity|immunity
5096580|NCT01229527|Colonoscopy|colonoscopy
5096581|NCT01229527|Remifentanil|remifentanil
5096582|NCT01229527|Sedation|sedation
5096583|NCT01229514|Children|children
5096584|NCT01229514|before|before
5096585|NCT01229514|the age of 2 years|the age of 2 years
5096586|NCT01229475|Atrial fibrillation|atrial fibrillation
5096587|NCT01229475|recurrence|recurrence
5096588|NCT01229475|repeat procedure|repeat procedure
5096589|NCT01229475|linear ablation|linear ablation
5096590|NCT01229475|stepwise approach|stepwise approach
5096591|NCT01229449|Dental pain|dental pain
5096592|NCT01229449|Ibuprofen|ibuprofen
5096593|NCT01229449|Acetaminophen|acetaminophen
5096594|NCT01229449|Nurofen Plus®|nurofen plus®
5096595|NCT01229449|Panadeine® Extra|panadeine® extra
5096596|NCT01229436|Dupuytren's|dupuytren's
5096597|NCT01229436|treatment|treatment
5096598|NCT01229436|injection|injection
5096599|NCT01229436|recovery|recovery
5096600|NCT01229436|health care resources|health care resources
5096601|NCT01229397|Influenza|influenza
5096602|NCT01229397|Virus|virus
5096603|NCT01229397|Vaccination|vaccination
5096604|NCT01229397|Immunisation|immunisation
5096605|NCT01229371|Influenza|influenza
5096606|NCT01229371|Virus|virus
5096607|NCT01229371|Vaccination|vaccination
5096608|NCT01229371|Immunisation|immunisation
5096609|NCT01229358|vascular surgery|vascular surgery
5096610|NCT01229358|wound infection|wound infection
5096611|NCT01229358|wound complication|wound complication
5096612|NCT01229332|Motor fluctuations levodopa pharmacokinetics carbidopa solution continuous|motor fluctuations levodopa pharmacokinetics carbidopa solution continuous
5096613|NCT01229319|actinic keratosis, keratocytic lesion, keratoses, cryotherapy, imiquimod|actinic keratosis, keratocytic lesion, keratoses, cryotherapy, imiquimod
5096614|NCT01229293|Mechanical muscle function|mechanical muscle function
5096615|NCT01229293|Muscle strength|muscle strength
5096616|NCT01229293|Hip replacement|hip replacement
5096617|NCT01229293|Osteoarthritis|osteoarthritis
5096618|NCT01229293|Hip arthroplasty|hip arthroplasty
5096619|NCT01229280|Bioequivalence|bioequivalence
5096620|NCT01229280|Darifenacin|darifenacin
5096621|NCT01229280|Healthy volunteers|healthy volunteers
5096622|NCT01229280|Postprandial|postprandial
5096623|NCT01229267|Herpes zoster|herpes zoster
5096624|NCT01229267|vaccine|vaccine
5096625|NCT01229267|herpes zoster-related complications|herpes zoster-related complications
5096626|NCT01229267|immunocompromised|immunocompromised
5096627|NCT01229267|autologous hematopoietic cell transplants|autologous hematopoietic cell transplants
5096628|NCT01229254|Betrixaban|betrixaban
5096629|NCT01229254|MK-4448|mk-4448
5096630|NCT01229254|nonvalvular atrial fibrillation|nonvalvular atrial fibrillation
5096631|NCT01229241|local anesthetic|local anesthetic
5096632|NCT01229241|epidural|epidural
5096633|NCT01229241|pharmacokinetics|pharmacokinetics
5096634|NCT01229241|plasmatic concentration|plasmatic concentration
5096635|NCT01229241|epidural continuous infusion|epidural continuous infusion
5096636|NCT01229202|trabeculectomy|trabeculectomy
5096637|NCT01229202|glaucoma surgery|glaucoma surgery
5096638|NCT01229202|bevacizumab|bevacizumab
5096639|NCT01229202|Vascular Endothelial Growth Inhibitor|vascular endothelial growth inhibitor
5096640|NCT01229202|glaucoma|glaucoma
5096641|NCT01229189|Vitamin D|vitamin d
5096642|NCT01229189|Effectiveness|effectiveness
5096643|NCT01229189|Pregnant women and their neonates|pregnant women and their neonates
5096644|NCT01229163|Motivational Incentive|motivational incentive
5096645|NCT01229163|Automation|automation
5096646|NCT01229163|Contingency Management|contingency management
5096647|NCT01229163|Counseling Adherance|counseling adherance
5096648|NCT01229150|Kinase Signal Transduction Pathway|kinase signal transduction pathway
5096649|NCT01229150|Tumor Mutational Analysis|tumor mutational analysis
5096650|NCT01229150|Tissue Immunohistochemistry|tissue immunohistochemistry
5096651|NCT01229150|MIB-1 (Ki-67) Rate|mib-1 (ki-67) rate
5096652|NCT01229150|PERK Level|perk level
5096653|NCT01229150|Lung Cancer|lung cancer
5096654|NCT01229150|Non-Small Cell Lung Cancer|non-small cell lung cancer
5096655|NCT01229124|childhood acute myeloid leukemia/other myeloid malignancies|childhood acute myeloid leukemia/other myeloid malignancies
5096656|NCT01229085|Psoriasis, mometasone, salicylic acid.|psoriasis, mometasone, salicylic acid.
5096657|NCT01229072|Safety|safety
5096658|NCT01229072|Non-inferiority|non-inferiority
5096659|NCT01229059|FFA|ffa
5096660|NCT01229059|insulin resistance|insulin resistance
5096661|NCT01229059|mitochondria|mitochondria
5096662|NCT01229046|presumed sepsis|presumed sepsis
5096663|NCT01229033|Atrial fibrillation|atrial fibrillation
5096664|NCT01229033|ablation|ablation
5096665|NCT01229033|atrial flutter|atrial flutter
5096666|NCT01229020|Emphysema|emphysema
5096667|NCT01229020|COPD|copd
5096668|NCT01229020|lung sounds|lung sounds
5096669|NCT01229020|vibration response imaging|vibration response imaging
5096670|NCT01229007|Hemophilia A|hemophilia a
5096671|NCT01229007|Children|children
5096672|NCT01228994|smoking cessation treatment|smoking cessation treatment
5096673|NCT01228994|baclofen|baclofen
5096674|NCT01228994|Smoking cessation counselling|smoking cessation counselling
5096675|NCT01228968|obesity|obesity
5096676|NCT01228942|ovarian cancer|ovarian cancer
5096677|NCT01228942|fallopian tube cancer|fallopian tube cancer
5096678|NCT01228942|primary peritoneal cancer|primary peritoneal cancer
5096679|NCT01228929|Dry Eye|dry eye
5096680|NCT01228929|Non-invasive instruments|non-invasive instruments
5096681|NCT01228929|MGD|mgd
5096682|NCT01228929|Environment|environment
5096683|NCT01228929|Thermal Imaging|thermal imaging
5096684|NCT01228916|tobacco|tobacco
5096685|NCT01228916|smoking|smoking
5096686|NCT01228916|secondhand smoke|secondhand smoke
5096687|NCT01228903|uric acid kidney disease endothelial dysfunction|uric acid kidney disease endothelial dysfunction
5096688|NCT01228851|Parkinson's Disease|parkinson's disease
5096689|NCT01228851|Rehabilitation|rehabilitation
5096690|NCT01228851|Balance|balance
5096691|NCT01228851|Exercise|exercise
5096692|NCT01228851|Parkinson's disease with balance deficits|parkinson's disease with balance deficits
5096693|NCT01228851|H&Y 2.5-3|h&y 2.5-3
5096694|NCT01228838|postherpetic neuralgia|postherpetic neuralgia
5096695|NCT01228838|PHN|phn
5096696|NCT01228838|capsaicin|capsaicin
5096697|NCT01228838|herpes zoster|herpes zoster
5096698|NCT01228838|shingles|shingles
5096699|NCT01228838|analgesics|analgesics
5096700|NCT01228838|neuropathy|neuropathy
5096701|NCT01228825|Cardiac surgery|cardiac surgery
5096702|NCT01228825|Cardiopulmonary bypass|cardiopulmonary bypass
5096703|NCT01228825|Antibiotic prophylaxis|antibiotic prophylaxis
5096704|NCT01228825|Cefuroxime|cefuroxime
5096705|NCT01228812|Rheumatoid arthritis, physical activity|rheumatoid arthritis, physical activity
5096706|NCT01228799|trabeculectomy,|trabeculectomy,
5096707|NCT01228799|canaloplasty,|canaloplasty,
5096708|NCT01228799|glaucoma surgery|glaucoma surgery
5096709|NCT01228799|non-penetrating surgery|non-penetrating surgery
5096710|NCT01228786|VDR, CaSR, PTH, Cyclin D1, Ki67, PCNA|vdr, casr, pth, cyclin d1, ki67, pcna
5096711|NCT01228773|Cancer Survivors, Fatigue, web-based, tailored program|cancer survivors, fatigue, web-based, tailored program
5096712|NCT01228760|Castration-Resistant Prostate Cancer|castration-resistant prostate cancer
5096713|NCT01228760|ASG-5ME|asg-5me
5096714|NCT01228760|Pharmacokinetics of ASG-5ME|pharmacokinetics of asg-5me
5096715|NCT01228747|Levetiracetam|levetiracetam
5096716|NCT01228747|epilepsy|epilepsy
5096717|NCT01228747|generalized tonic-clonic|generalized tonic-clonic
5096718|NCT01228734|Metastatic colorectal cancer|metastatic colorectal cancer
5096719|NCT01228734|RAS wild type|ras wild type
5096720|NCT01228734|Cetuximab|cetuximab
5096721|NCT01228734|First line treatment|first line treatment
5096722|NCT01228734|First occurrence of metastatic colorectal cancer in Chinese subjects with RAS wildtype|first occurrence of metastatic colorectal cancer in chinese subjects with ras wildtype
5096723|NCT01228734|status|status
5096724|NCT01228708|Implementation strategy|implementation strategy
5096725|NCT01228708|Chronic disease management programme|chronic disease management programme
5096726|NCT01228708|COPD|copd
5096727|NCT01228695|steroids|steroids
5096728|NCT01228695|patients treated with systemic steroids|patients treated with systemic steroids
5096729|NCT01228682|Sodium|sodium
5096730|NCT01228682|SIADH|siadh
5096731|NCT01228682|Hyponatremia|hyponatremia
5096732|NCT01228682|Vasopressin|vasopressin
5096733|NCT01228682|Salt|salt
5096734|NCT01228682|Water|water
5096735|NCT01228656|Psoriasis|psoriasis
5096736|NCT01228643|Pancreatic enzymes.|pancreatic enzymes.
5096826|NCT01228227|Percutaneous Angioplasty|percutaneous angioplasty
5096737|NCT01228643|To evaluate the efficacy of drugs in chronic renal failure|to evaluate the efficacy of drugs in chronic renal failure
5096738|NCT01228630|rhinitis, loratadine, coated pill|rhinitis, loratadine, coated pill
5096739|NCT01228617|Smoking Cessation|smoking cessation
5096740|NCT01228617|Nicotine pharmacokinetics|nicotine pharmacokinetics
5096741|NCT01228604|open label|open label
5096742|NCT01228604|Ritalin®|ritalin®
5096743|NCT01228604|ADHD|adhd
5096744|NCT01228578|Multivitamins|multivitamins
5096745|NCT01228578|HIV/AIDS|hiv/aids
5096746|NCT01228578|Immune reconstitution|immune reconstitution
5096747|NCT01228578|Weight Gain|weight gain
5096748|NCT01228578|Quality of Life|quality of life
5096749|NCT01228565|Head and neck carcinoma treated by radiotherapy plus erbitux|head and neck carcinoma treated by radiotherapy plus erbitux
5096750|NCT01228552|Acute Migraine Treatment|acute migraine treatment
5096751|NCT01228552|Migraine Treatment|migraine treatment
5096752|NCT01228552|Migraine|migraine
5096753|NCT01228552|Headache|headache
5096754|NCT01228552|Treatment|treatment
5096755|NCT01228539|PTSD|ptsd
5096756|NCT01228539|Anger|anger
5096757|NCT01228539|Aggression|aggression
5096758|NCT01228539|Military|military
5096759|NCT01228487|Oxidative Dysbalance|oxidative dysbalance
5096760|NCT01228487|Oxidative Stress|oxidative stress
5096761|NCT01228487|Biomarker|biomarker
5096762|NCT01228461|Hodgkin Lymphoma Survivors|hodgkin lymphoma survivors
5096763|NCT01228461|Adolescent and Young Adults|adolescent and young adults
5096764|NCT01228448|external beam proton radiotherapy|external beam proton radiotherapy
5096765|NCT01228448|PET|pet
5096766|NCT01228435|NSCLC|nsclc
5096767|NCT01228435|IPI-504|ipi-504
5096768|NCT01228435|ALK translocation|alk translocation
5096769|NCT01228435|Hsp90 inhibitor|hsp90 inhibitor
5096770|NCT01228422|Will be studied 24 subjects divided Research and 2 parallel groups|will be studied 24 subjects divided research and 2 parallel groups
5096771|NCT01228422|The treatment is a dose of 3MUI of alpha interferon 2nd|the treatment is a dose of 3mui of alpha interferon 2nd
5096772|NCT01228422|There will be collection of blood at times: 0, 2, 4, 6, 8, 10, 12, 16, 24, 36, 48, 72 and 96 hours.|there will be collection of blood at times: 0, 2, 4, 6, 8, 10, 12, 16, 24, 36, 48, 72 and 96 hours.
5096773|NCT01228422|The volunteers will be hospitalized 24 hours.|the volunteers will be hospitalized 24 hours.
5096774|NCT01228422|Will be measured labels the AUC, Tmax, Cmax, neopterin and beta2-microglobulin|will be measured labels the auc, tmax, cmax, neopterin and beta2-microglobulin
5096775|NCT01228409|Psoriasis|psoriasis
5096776|NCT01228409|phototherapy|phototherapy
5096777|NCT01228409|soriatane|soriatane
5096778|NCT01228409|acitretin|acitretin
5096779|NCT01228409|retinoid-related adverse events|retinoid-related adverse events
5096780|NCT01228396|bladder|bladder
5096781|NCT01228396|optic neuritis|optic neuritis
5096782|NCT01228396|secondary progressive multiple sclerosis|secondary progressive multiple sclerosis
5096783|NCT01228396|AIMSPRO|aimspro
5096784|NCT01228396|hyperimmune caprine serum|hyperimmune caprine serum
5096785|NCT01228396|hyperimmune goat serum|hyperimmune goat serum
5096786|NCT01228383|Monoclonal antibody|monoclonal antibody
5096787|NCT01228383|Rabies|rabies
5096788|NCT01228383|Post-exposure prophylaxis|post-exposure prophylaxis
5096789|NCT01228370|sildosin|sildosin
5096790|NCT01228370|neurogenic bladder|neurogenic bladder
5096791|NCT01228370|voiding dysfunction|voiding dysfunction
5096792|NCT01228357|Pharmacogenomics|pharmacogenomics
5096793|NCT01228357|Depressed Patients|depressed patients
5096794|NCT01228344|Artemether-lumefantrine|artemether-lumefantrine
5096795|NCT01228344|demographics|demographics
5096796|NCT01228344|malaria|malaria
5096797|NCT01228331|childhood acute lymphoblastic leukemia|childhood acute lymphoblastic leukemia
5096798|NCT01228331|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
5096799|NCT01228318|HAART|haart
5096800|NCT01228318|Antiresorptive drugs|antiresorptive drugs
5096801|NCT01228318|HIV/AIDS|hiv/aids
5096802|NCT01228318|Bone loss|bone loss
5096803|NCT01228305|ventricular septal defect|ventricular septal defect
5096804|NCT01228305|atrioventricular septal defect|atrioventricular septal defect
5096805|NCT01228305|oxidative stress|oxidative stress
5096806|NCT01228305|cardiopulmonary bypass|cardiopulmonary bypass
5096807|NCT01228305|acetaminophen|acetaminophen
5096808|NCT01228305|hemolysis|hemolysis
5096809|NCT01228305|acute kidney injury|acute kidney injury
5096810|NCT01228305|Congenital heart disease undergoing cardiopulmonary bypass|congenital heart disease undergoing cardiopulmonary bypass
5096811|NCT01228292|Anticoagulation|anticoagulation
5096812|NCT01228292|Intensive Care Medicine|intensive care medicine
5096813|NCT01228292|Hemodialysis|hemodialysis
5096814|NCT01228292|Critical Ill Patients|critical ill patients
5096815|NCT01228279|Peritoneal Dialysis|peritoneal dialysis
5096816|NCT01228279|Dialysis Solutions|dialysis solutions
5096817|NCT01228279|Artificial Kidney|artificial kidney
5096818|NCT01228279|Renal Replacement Therapy|renal replacement therapy
5096819|NCT01228279|Renal Dialysis|renal dialysis
5096820|NCT01228279|Sympathetic Nervous System|sympathetic nervous system
5096821|NCT01228279|Leptin|leptin
5096822|NCT01228279|Icodextrin|icodextrin
5096823|NCT01228266|Multiple Sclerosis|multiple sclerosis
5096824|NCT01228240|Diabetes mellitus, type 2, Metformin, Generic, Efficacy|diabetes mellitus, type 2, metformin, generic, efficacy
5096825|NCT01228227|Myonecrosis|myonecrosis
5097490|NCT01224886|Diabetes|diabetes
5096827|NCT01228227|Myocardial Infarction|myocardial infarction
5096828|NCT01228188|FTMH|ftmh
5096829|NCT01228188|PPV|ppv
5096830|NCT01228188|inverted ILM repositioning|inverted ilm repositioning
5096831|NCT01228149|glaucoma|glaucoma
5096832|NCT01228149|trabeculectomy|trabeculectomy
5096833|NCT01228149|intraocular pressure|intraocular pressure
5096834|NCT01228136|Adenotonsillectomy|adenotonsillectomy
5096835|NCT01228136|Tranexamic acid|tranexamic acid
5096836|NCT01228136|Blood loss|blood loss
5096837|NCT01228136|Postoperative hemorrhage|postoperative hemorrhage
5096838|NCT01228084|sulforaphane|sulforaphane
5096839|NCT01228084|broccoli sprout extract (BSE)|broccoli sprout extract (bse)
5096840|NCT01228084|prostate cancer|prostate cancer
5096841|NCT01228084|recurrent prostate cancer|recurrent prostate cancer
5096842|NCT01228084|phase II|phase ii
5096843|NCT01228071|testosterone deficiency|testosterone deficiency
5096844|NCT01228071|hypogonadism|hypogonadism
5096845|NCT01228058|Trauma|trauma
5096846|NCT01228058|Coagulopathy|coagulopathy
5096847|NCT01228058|Coagulopathy in adult trauma patients|coagulopathy in adult trauma patients
5096848|NCT01228045|Patients with histologically proved adenocarcinoma of advanced gastric cancer|patients with histologically proved adenocarcinoma of advanced gastric cancer
5096849|NCT01228019|Usual practice re-examination|usual practice re-examination
5096850|NCT01228006|Reduction of stress and fatigue|reduction of stress and fatigue
5096851|NCT01227993|Central Serous Chorioretinopathy|central serous chorioretinopathy
5096852|NCT01227993|Finasteride|finasteride
5096853|NCT01227993|Proscar|proscar
5096854|NCT01227993|Retinal Eye Disease|retinal eye disease
5096855|NCT01227980|Addiction|addiction
5096856|NCT01227980|Alcohol|alcohol
5096857|NCT01227980|Alcohol Treatment|alcohol treatment
5096858|NCT01227980|Alcoholics|alcoholics
5096859|NCT01227980|Alcohol Dependence|alcohol dependence
5096860|NCT01227980|Anxiety Disorder|anxiety disorder
5096861|NCT01227980|Alcoholism|alcoholism
5096862|NCT01227967|Adaptive Design|adaptive design
5096863|NCT01227967|At Risk|at risk
5096864|NCT01227967|H1N1|h1n1
5096865|NCT01227967|Synergy|synergy
5096866|NCT01227967|TCAD|tcad
5096867|NCT01227954|cognitive/functional effects|cognitive/functional effects
5096868|NCT01227954|tumors metastatic to brain|tumors metastatic to brain
5096869|NCT01227954|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5096870|NCT01227941|advanced solid tumors|advanced solid tumors
5096871|NCT01227941|ovarian cancer|ovarian cancer
5096872|NCT01227941|pegylated liposomal doxorubicin|pegylated liposomal doxorubicin
5096873|NCT01227941|Doxil|doxil
5096874|NCT01227941|Caelyx|caelyx
5096875|NCT01227928|tyrosine kinase inhibitors|tyrosine kinase inhibitors
5096876|NCT01227928|Primary Peritoneal Carcinoma|primary peritoneal carcinoma
5096877|NCT01227928|primary peritoneal cancer|primary peritoneal cancer
5096878|NCT01227928|ovarian cancer|ovarian cancer
5096879|NCT01227928|Fallopian Tube Cancer|fallopian tube cancer
5096880|NCT01227928|gynecologic cancer|gynecologic cancer
5096881|NCT01227928|anti-angiogenesis|anti-angiogenesis
5096882|NCT01227928|pazopanib|pazopanib
5096883|NCT01227915|SIGNS AND SYMPTOMS OF ACUTE BACTERIAL CONJUNCTIVITIS|signs and symptoms of acute bacterial conjunctivitis
5096884|NCT01227902|Seizures|seizures
5096885|NCT01227902|retigabine IR|retigabine ir
5096886|NCT01227902|GW582892|gw582892
5096887|NCT01227902|Epilepsy|epilepsy
5096888|NCT01227902|Open label, flexible dose|open label, flexible dose
5096889|NCT01227902|Partial-onset seizures|partial-onset seizures
5096890|NCT01227889|Metastatic melanoma|metastatic melanoma
5096891|NCT01227889|melanoma|melanoma
5096892|NCT01227889|BRAF mutant|braf mutant
5096893|NCT01227889|Advanced melanoma|advanced melanoma
5096894|NCT01227876|Control of postoperative inflammation in cataract surgery by phacoemulsification|control of postoperative inflammation in cataract surgery by phacoemulsification
5096895|NCT01227863|SIGNS AND SYMPTOMS OF ACUTE BACTERIAL CONJUNCTIVITIS|signs and symptoms of acute bacterial conjunctivitis
5096896|NCT01227850|Leptin|leptin
5096897|NCT01227850|IGF1|igf1
5096898|NCT01227850|Refeeding Index|refeeding index
5096899|NCT01227850|Hypophosphataemia|hypophosphataemia
5096900|NCT01227850|Primary focus of the study was to detemine whether the 'Refeeding Index', could reliably predict,that the refeeding syndrome would occur|primary focus of the study was to detemine whether the 'refeeding index', could reliably predict,that the refeeding syndrome would occur
5096901|NCT01227837|omega 3|omega 3
5096902|NCT01227837|CRT_AICD|crt_aicd
5096903|NCT01227837|congestive heart failure|congestive heart failure
5096904|NCT01227837|CHF|chf
5096905|NCT01227824|integrase inhibitor|integrase inhibitor
5096906|NCT01227824|HIV Infection|hiv infection
5096907|NCT01227824|raltegravir|raltegravir
5096908|NCT01227824|GSK1349572|gsk1349572
5096909|NCT01227811|Darifenacin|darifenacin
5096910|NCT01227811|Bioequivalence|bioequivalence
5096911|NCT01227811|Healthy volunteers|healthy volunteers
5096912|NCT01227811|Postprandial|postprandial
5096913|NCT01227798|influenza A, H1N1|influenza a, h1n1
5096914|NCT01227772|gastric cancer vaccine|gastric cancer vaccine
5096915|NCT01227772|OTSGC-A24|otsgc-a24
5096916|NCT01227772|A Phase I/IIa study|a phase i/iia study
5096917|NCT01227772|HLA-A24-positive|hla-a24-positive
5096918|NCT01227746|Advanced gastro-intestinal stromal tumors|advanced gastro-intestinal stromal tumors
5097687|NCT01223898|nilotinib,|nilotinib,
5096919|NCT01227720|Smoking Cessation, Nicotine pharmacokinetics|smoking cessation, nicotine pharmacokinetics
5096920|NCT01227694|Cell therapy|cell therapy
5096921|NCT01227694|Regenerative therapy|regenerative therapy
5096922|NCT01227694|Advance therapy|advance therapy
5096923|NCT01227694|Bone marrow|bone marrow
5096924|NCT01227694|Mesenchymal stem cell|mesenchymal stem cell
5096925|NCT01227694|Autologous|autologous
5096926|NCT01227694|Interventional clinical trial|interventional clinical trial
5096927|NCT01227694|Osteoarthrosis|osteoarthrosis
5096928|NCT01227694|Osteoarthritis|osteoarthritis
5096929|NCT01227694|Knee|knee
5096930|NCT01227655|Parkinson|parkinson
5096931|NCT01227655|PD|pd
5096932|NCT01227655|Wearing-off|wearing-off
5096933|NCT01227655|Levodopa/DDCI|levodopa/ddci
5096934|NCT01227642|Prostate Cancer|prostate cancer
5096935|NCT01227642|Prostate brachytherapy|prostate brachytherapy
5096936|NCT01227642|Ultrasound treatment planning|ultrasound treatment planning
5096937|NCT01227616|Iron deficiency anemia (IDA), Feraheme, ferumoxytol, chronic kidney disease (CKD), hemodialysis, magnetic resonance imaging (MRI)|iron deficiency anemia (ida), feraheme, ferumoxytol, chronic kidney disease (ckd), hemodialysis, magnetic resonance imaging (mri)
5096938|NCT01227603|Bioequivalence|bioequivalence
5096939|NCT01227603|Nifedipine|nifedipine
5096940|NCT01227603|Candesartan|candesartan
5096941|NCT01227603|FDC|fdc
5096942|NCT01227590|Herbal medicine|herbal medicine
5096943|NCT01227590|African Potato|african potato
5096944|NCT01227590|Hypoxis obtusa|hypoxis obtusa
5096945|NCT01227590|Drug interaction|drug interaction
5096946|NCT01227590|HIV Infections|hiv infections
5096947|NCT01227590|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5096948|NCT01227590|Healthy Subjects|healthy subjects
5096949|NCT01227590|Anti-retroviral Agents|anti-retroviral agents
5096950|NCT01227590|Lopinavir|lopinavir
5096951|NCT01227590|Ritonavir|ritonavir
5096952|NCT01227577|CML|cml
5096953|NCT01227577|Chronic Myelogenous Leukemia|chronic myelogenous leukemia
5096954|NCT01227577|Leukemia|leukemia
5096955|NCT01227577|CML-CP|cml-cp
5096956|NCT01227577|Nilotinib|nilotinib
5096957|NCT01227564|Early Alzheimer's disease|early alzheimer's disease
5096958|NCT01227564|active immunization|active immunization
5096959|NCT01227564|amyloid imaging|amyloid imaging
5096960|NCT01227551|Melanoma|melanoma
5096961|NCT01227551|CALM|calm
5096962|NCT01227538|Beta cell reserve, urinary C peptide|beta cell reserve, urinary c peptide
5096963|NCT01227512|Hyponatremia|hyponatremia
5096964|NCT01227512|Dilutional Hyponatremia|dilutional hyponatremia
5096965|NCT01227512|Euvolemic Hyponatremia|euvolemic hyponatremia
5096966|NCT01227512|Hypervolemic Hyponatremia|hypervolemic hyponatremia
5096967|NCT01227512|Fluid Restriction|fluid restriction
5096968|NCT01227512|Tolvaptan|tolvaptan
5096969|NCT01227486|Intubation, intratracheal|intubation, intratracheal
5096970|NCT01227486|Ultrasonography|ultrasonography
5096971|NCT01227486|Auscultation|auscultation
5096972|NCT01227486|Capnography|capnography
5096973|NCT01227486|Obesity|obesity
5096974|NCT01227473|prediabetes|prediabetes
5096975|NCT01227473|African Americans|african americans
5096976|NCT01227473|mindfulness|mindfulness
5096977|NCT01227473|behavioral|behavioral
5096978|NCT01227473|diabetes|diabetes
5096979|NCT01227460|Type 1 diabetes, Sitagliptin|type 1 diabetes, sitagliptin
5096980|NCT01227434|Glioblastoma|glioblastoma
5096981|NCT01227434|Gliosarcoma|gliosarcoma
5096982|NCT01227434|Anaplastic astrocytoma|anaplastic astrocytoma
5096983|NCT01227434|Malignant astrocytoma NOS|malignant astrocytoma nos
5096984|NCT01227434|Malignant glioma|malignant glioma
5096985|NCT01227434|GBM|gbm
5096986|NCT01227421|influenza|influenza
5096987|NCT01227408|Patients with confirmed breast cancer for neoadjuvant chemotherapy|patients with confirmed breast cancer for neoadjuvant chemotherapy
5096988|NCT01227395|HIV|hiv
5096989|NCT01227395|Post Marketing Surveillance|post marketing surveillance
5096990|NCT01227369|Bisphosphonates|bisphosphonates
5096991|NCT01227369|OPSAT-Q|opsat-q
5096992|NCT01227356|Chronic myeloid leukemia, imatinib, interferon|chronic myeloid leukemia, imatinib, interferon
5096993|NCT01227343|Gender differences|gender differences
5096994|NCT01227343|nicotine|nicotine
5096995|NCT01227343|cigarette smoking habits|cigarette smoking habits
5096996|NCT01227343|behavior changes|behavior changes
5096997|NCT01227317|Dyspnea|dyspnea
5096998|NCT01227317|Mortality|mortality
5096999|NCT01227291|Glaucoma|glaucoma
5097000|NCT01227291|IOP|iop
5097001|NCT01227291|siRNAs|sirnas
5097002|NCT01227291|RNAi|rnai
5097003|NCT01227291|beta inhibitor|beta inhibitor
5097004|NCT01227278|Benralizumab|benralizumab
5097005|NCT01227278|MEDI-563|medi-563
5097006|NCT01227278|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
5097007|NCT01227226|Dry eye|dry eye
5097008|NCT01227187|Hemodialysis|hemodialysis
5097009|NCT01227187|Anticoagulation|anticoagulation
5097010|NCT01227187|Xigris|xigris
5097011|NCT01227187|PTT|ptt
5097012|NCT01227174|propofol only|propofol only
5097013|NCT01227174|safety and efficacy|safety and efficacy
5097014|NCT01227161|ASA I-II children between the age 0-7|asa i-ii children between the age 0-7
5097015|NCT01227161|general anesthesia|general anesthesia
5097016|NCT01227148|critical care, glycemic control, insulin, nitrogen balance|critical care, glycemic control, insulin, nitrogen balance
5097017|NCT01227135|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5097018|NCT01227135|chronic myelogenous leukemia, BCR-ABL1 positive|chronic myelogenous leukemia, bcr-abl1 positive
5097019|NCT01227122|NGAL plasmatic level|ngal plasmatic level
5097020|NCT01227122|Preoperative KIDNEY FAILURE, CHRONIC|preoperative kidney failure, chronic
5097021|NCT01227122|Postoperative KIDNEY FAILURE, ACUTE|postoperative kidney failure, acute
5097022|NCT01227122|Cardiac Surgery Procedures|cardiac surgery procedures
5097023|NCT01227109|Infections|infections
5097024|NCT01227109|Cancer|cancer
5097025|NCT01227109|Procalcitonin|procalcitonin
5097026|NCT01227109|C reactive protein|c reactive protein
5097027|NCT01227096|electroacupuncture pediatric cardioprotection|electroacupuncture pediatric cardioprotection
5097028|NCT01227083|AQLQ and cAQOL|aqlq and caqol
5097029|NCT01227070|Asthma, hospitalization, children, exhaled nitric oxide, lung function, breath condensate, cysteinyl leukotrienes|asthma, hospitalization, children, exhaled nitric oxide, lung function, breath condensate, cysteinyl leukotrienes
5097030|NCT01227057|exposure therapy|exposure therapy
5097031|NCT01227057|case management|case management
5097032|NCT01227057|older adults|older adults
5097033|NCT01227057|cognitive rehabilitation|cognitive rehabilitation
5097034|NCT01227044|Substance Abuse Counseling|substance abuse counseling
5097035|NCT01227044|Adherence (medication)|adherence (medication)
5097036|NCT01227044|Alcohol Abuse|alcohol abuse
5097037|NCT01227044|Highly Active Antiretroviral Therapy (HAART)|highly active antiretroviral therapy (haart)
5097038|NCT01227044|Naltrexone|naltrexone
5097039|NCT01227044|Vivitrol|vivitrol
5097040|NCT01227044|HIV|hiv
5097041|NCT01227031|Genetic susceptibility of androgenetic alopecia|genetic susceptibility of androgenetic alopecia
5097042|NCT01227031|Genetic difference in Finasteride response|genetic difference in finasteride response
5097043|NCT01227005|Transfusion|transfusion
5097044|NCT01227005|Whole Blood|whole blood
5097045|NCT01227005|Trauma|trauma
5097046|NCT01227005|Coagulopathy|coagulopathy
5097047|NCT01227005|Component Therapy|component therapy
5097048|NCT01227005|Civilian|civilian
5097049|NCT01227005|Military|military
5097050|NCT01226992|Clostridium difficile|clostridium difficile
5097051|NCT01226992|Fecal Transplant|fecal transplant
5097052|NCT01226992|Recurrent Diarrhea|recurrent diarrhea
5097053|NCT01226992|Abdominal distension/bloating|abdominal distension/bloating
5097054|NCT01226992|Fever|fever
5097055|NCT01226979|rectal cancer|rectal cancer
5097056|NCT01226979|high dose endorectal brachytherapy|high dose endorectal brachytherapy
5097057|NCT01226953|Haemophilus influenzae type b (Hib)|haemophilus influenzae type b (hib)
5097058|NCT01226953|Vaccine|vaccine
5097059|NCT01226953|Anti-PRP antibody|anti-prp antibody
5097060|NCT01226914|EVICEL, Fibrin Sealant, Thyroidectomy|evicel, fibrin sealant, thyroidectomy
5097061|NCT01226901|Poly (ADP-ribose) polymerase (PARP) inhibitor|poly (adp-ribose) polymerase (parp) inhibitor
5097062|NCT01226901|tumor|tumor
5097063|NCT01226901|cancer|cancer
5097064|NCT01226888|brown adipose tissue|brown adipose tissue
5097065|NCT01226888|androgen deprivation therapy|androgen deprivation therapy
5097066|NCT01226875|SWL|swl
5097067|NCT01226875|kidney stones|kidney stones
5097068|NCT01226875|renal calculi|renal calculi
5097069|NCT01226862|Stroke|stroke
5097070|NCT01226862|Telemedicine|telemedicine
5097071|NCT01226862|Telestroke|telestroke
5097072|NCT01226849|diffuse large B-cell lymphoma relapse refractory|diffuse large b-cell lymphoma relapse refractory
5097073|NCT01226836|Pulmonary Rehabilitation|pulmonary rehabilitation
5097074|NCT01226823|cholestasis|cholestasis
5097075|NCT01226823|pregnancy|pregnancy
5097076|NCT01226823|ursodeoxycholic acid|ursodeoxycholic acid
5097077|NCT01226823|ICP|icp
5097078|NCT01226797|Chronic HCV infection|chronic hcv infection
5097079|NCT01226797|raised ALT|raised alt
5097080|NCT01226797|transaminitis|transaminitis
5097081|NCT01226797|HCV infection|hcv infection
5097082|NCT01226771|hepatitis V virus|hepatitis v virus
5097083|NCT01226771|genotype 1|genotype 1
5097084|NCT01226771|ribavirin|ribavirin
5097085|NCT01226771|interferon|interferon
5097086|NCT01226771|Alternative ribavirin dosing|alternative ribavirin dosing
5097087|NCT01226758|Safety|safety
5097088|NCT01226758|Tolerability|tolerability
5097089|NCT01226758|Efficacy|efficacy
5097090|NCT01226758|Influenza|influenza
5097091|NCT01226758|Flu|flu
5097092|NCT01226758|Virus|virus
5097093|NCT01226758|Vaccine|vaccine
5097094|NCT01226745|Multiple sclerosis|multiple sclerosis
5097095|NCT01226745|ONO-4641|ono-4641
5097096|NCT01226745|MSC2430913A|msc2430913a
5097097|NCT01226745|Efficacy|efficacy
5097098|NCT01226732|Solid tumor|solid tumor
5097099|NCT01226732|Capecitabine|capecitabine
5097100|NCT01226732|Hsp90 inhibitor AUY922|hsp90 inhibitor auy922
5097101|NCT01226719|liver-only metastatic KRAS wild-type colorectal cancer|liver-only metastatic kras wild-type colorectal cancer
5097102|NCT01226719|Panitumumab|panitumumab
5097103|NCT01226719|Oxaliplatin|oxaliplatin
5097104|NCT01226719|Irinotecan|irinotecan
5097105|NCT01226719|Leucovorin|leucovorin
5097106|NCT01226719|5-Fluorouracil|5-fluorouracil
5097107|NCT01226706|Urinary incontinence, urge|urinary incontinence, urge
5097108|NCT01226706|detrusor hyperreflexia|detrusor hyperreflexia
5097109|NCT01226706|detrusor instability|detrusor instability
5097110|NCT01226706|non-neurogenic|non-neurogenic
5097111|NCT01226706|Female Urogenital Diseases and Pregnancy Complications|female urogenital diseases and pregnancy complications
5097112|NCT01226706|Female Urogenital Diseases|female urogenital diseases
5097113|NCT01226706|Urologic Diseases|urologic diseases
5097114|NCT01226706|Urination Disorders|urination disorders
5097115|NCT01226706|Urinary Incontinence|urinary incontinence
5097116|NCT01226693|pharmacokinetic|pharmacokinetic
5097117|NCT01226693|single dose bioequivalence study|single dose bioequivalence study
5097118|NCT01226693|balanced incomplete block design|balanced incomplete block design
5097119|NCT01226693|PH-797804|ph-797804
5097120|NCT01226693|P38 kinase inhibitor|p38 kinase inhibitor
5097121|NCT01226680|Dry Eye|dry eye
5097122|NCT01226680|Schirmer test|schirmer test
5097123|NCT01226680|corneal staining|corneal staining
5097124|NCT01226680|OSDI|osdi
5097125|NCT01226680|OCI|oci
5097126|NCT01226667|fibromyalgia|fibromyalgia
5097127|NCT01226667|lyrica|lyrica
5097128|NCT01226667|pregabalin|pregabalin
5097129|NCT01226654|Quantitative Imaging of Multiple Sclerosis|quantitative imaging of multiple sclerosis
5097130|NCT01226641|Obstructive Sleep Apnea Syndrome|obstructive sleep apnea syndrome
5097131|NCT01226641|SCORE|score
5097132|NCT01226641|Telemedicine|telemedicine
5097133|NCT01226641|Arterial blood pressure|arterial blood pressure
5097134|NCT01226641|Daily physical activity|daily physical activity
5097135|NCT01226628|Macular degeneration|macular degeneration
5097136|NCT01226628|Age-related macular degeneration|age-related macular degeneration
5097137|NCT01226628|Cell therapy|cell therapy
5097138|NCT01226628|CNTO 2476|cnto 2476
5097139|NCT01226628|Human umbilical tissue-derived cells|human umbilical tissue-derived cells
5097140|NCT01226628|hUTC|hutc
5097141|NCT01226628|Geographic Atrophy|geographic atrophy
5097142|NCT01226628|Subretinal|subretinal
5097143|NCT01226628|Visual Acuity|visual acuity
5097144|NCT01226615|Chondroitin sulphate|chondroitin sulphate
5097145|NCT01226615|Knee osteoarthritis|knee osteoarthritis
5097146|NCT01226615|Functional Magnetic Resonance Imaging|functional magnetic resonance imaging
5097147|NCT01226602|Ticagrelor|ticagrelor
5097148|NCT01226602|Healthy|healthy
5097149|NCT01226602|Coronary flow velocity|coronary flow velocity
5097150|NCT01226602|Adenosine|adenosine
5097151|NCT01226589|Cancer cancer|cancer cancer
5097152|NCT01226589|MRS|mrs
5097153|NCT01226589|Treatment response|treatment response
5097154|NCT01226589|Histologically confirmed diagnosed Breast cancer.|histologically confirmed diagnosed breast cancer.
5097155|NCT01226589|Patient is 18 years or older.|patient is 18 years or older.
5097156|NCT01226589|Karnofsky performance score is equal to or greater than 70.|karnofsky performance score is equal to or greater than 70.
5097157|NCT01226589|No previously irradiated or recurrent breast.|no previously irradiated or recurrent breast.
5097158|NCT01226589|No contraindication to MRS/MRI.|no contraindication to mrs/mri.
5097159|NCT01226576|MRgFUS|mrgfus
5097160|NCT01226576|Prostate Cancer|prostate cancer
5097161|NCT01226576|Low-Intermediate Risk Prostate Cancer|low-intermediate risk prostate cancer
5097162|NCT01226576|Localized Prostate Cancer|localized prostate cancer
5097163|NCT01226576|InSightec|insightec
5097164|NCT01226576|ExAblate|exablate
5097165|NCT01226563|STEMI|stemi
5097166|NCT01226563|Acute Myocardial Infarction|acute myocardial infarction
5097167|NCT01226563|Congestive Heart Failure|congestive heart failure
5097168|NCT01226563|Left Ventricular Remodeling|left ventricular remodeling
5097169|NCT01226563|Devices, Medical|devices, medical
5097288|NCT01225978|Variant Updates|variant updates
5097170|NCT01226550|hyperthermic intraoperative peritoneal chemotherapy (HIPEC)|hyperthermic intraoperative peritoneal chemotherapy (hipec)
5097171|NCT01226550|Irinotecan|irinotecan
5097172|NCT01226550|Pharmacokinetics|pharmacokinetics
5097173|NCT01226550|peritoneal carcinomatosis (PC)|peritoneal carcinomatosis (pc)
5097174|NCT01226537|Taurine,Diabetes mellitus,oxidative stress,glycemic control|taurine,diabetes mellitus,oxidative stress,glycemic control
5097175|NCT01226498|Blood Transfusion, Autologous|blood transfusion, autologous
5097176|NCT01226498|Blood Preservation/adverse effects|blood preservation/adverse effects
5097177|NCT01226498|Blood Transfusion/adverse effects|blood transfusion/adverse effects
5097178|NCT01226498|Endothelium, Vascular/physiopathology|endothelium, vascular/physiopathology
5097179|NCT01226498|Inflammation Mediators|inflammation mediators
5097180|NCT01226485|Cancer|cancer
5097181|NCT01226485|Terminal|terminal
5097182|NCT01226485|Solid Tumor|solid tumor
5097183|NCT01226485|End Stage|end stage
5097184|NCT01226485|Metastatic|metastatic
5097185|NCT01226472|PTCL|ptcl
5097186|NCT01226472|CTCL|ctcl
5097187|NCT01226472|MF|mf
5097188|NCT01226472|SS|ss
5097189|NCT01226459|Female Pattern Baldness|female pattern baldness
5097190|NCT01226433|AE adverse event|ae adverse event
5097191|NCT01226433|AIDS acquired immunodeficiency syndrome|aids acquired immunodeficiency syndrome
5097192|NCT01226433|ALT (SGPT) alanine aminotransferase|alt (sgpt) alanine aminotransferase
5097193|NCT01226433|ART antiretroviral therapy|art antiretroviral therapy
5097194|NCT01226433|AST (SGOT) aspartate aminotransferase|ast (sgot) aspartate aminotransferase
5097195|NCT01226433|DCF data collection forms|dcf data collection forms
5097196|NCT01226433|DMC Data Monitoring Committee|dmc data monitoring committee
5097197|NCT01226433|FDA (U.S.) Food and Drug Administration|fda (u.s.) food and drug administration
5097198|NCT01226433|GCP Good Clinical Practice guidelines|gcp good clinical practice guidelines
5097199|NCT01226433|HB sAg Hepatitis B surface antigen|hb sag hepatitis b surface antigen
5097200|NCT01226433|ICH International Conference of Harmonisation|ich international conference of harmonisation
5097201|NCT01226433|IND Investigational New Drug Application|ind investigational new drug application
5097202|NCT01226433|IRB Institutional Review Board|irb institutional review board
5097203|NCT01226433|IU International units|iu international units
5097204|NCT01226433|mg milligram(s)|mg milligram(s)
5097205|NCT01226433|mm3 cubic millimeter(s)|mm3 cubic millimeter(s)
5097206|NCT01226433|PCR polymerase chain reaction|pcr polymerase chain reaction
5097207|NCT01226433|SAE serious adverse event|sae serious adverse event
5097208|NCT01226433|µg microgram|µg microgram
5097209|NCT01226433|ULN upper limit of the normal range|uln upper limit of the normal range
5097210|NCT01226433|WB Western Blot|wb western blot
5097211|NCT01226420|GVHD|gvhd
5097212|NCT01226420|Alefacept|alefacept
5097213|NCT01226420|Amevive|amevive
5097214|NCT01226407|Solid Tumour|solid tumour
5097215|NCT01226394|peritoneal carcinomatosis|peritoneal carcinomatosis
5097216|NCT01226394|HIPEC|hipec
5097217|NCT01226394|controlled clinical trial|controlled clinical trial
5097218|NCT01226381|Paracetamol and setrons|paracetamol and setrons
5097219|NCT01226381|No disease, healthy volunteers|no disease, healthy volunteers
5097220|NCT01226368|HIV, HPV, cervical-vaginal smear|hiv, hpv, cervical-vaginal smear
5097221|NCT01226342|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
5097222|NCT01226329|Minority Groups|minority groups
5097223|NCT01226329|Decision Making|decision making
5097224|NCT01226329|Patient Participation|patient participation
5097225|NCT01226329|Mental Health Services|mental health services
5097226|NCT01226329|retention|retention
5097227|NCT01226329|attendance|attendance
5097228|NCT01226329|patient activation|patient activation
5097229|NCT01226329|Hispanic Americans|hispanic americans
5097230|NCT01226329|patient-provider communication|patient-provider communication
5097231|NCT01226316|Advanced solid malignancy,PIK3CA mutated,AKT1 mutated, PTEN mutation, PTEN alteration, metastatic,ER+,breast,ovarian,endometrial,AZD5363,AKT inhibitor,|advanced solid malignancy,pik3ca mutated,akt1 mutated, pten mutation, pten alteration, metastatic,er+,breast,ovarian,endometrial,azd5363,akt inhibitor,
5097232|NCT01226290|uterine fibroid RF ablation|uterine fibroid rf ablation
5097233|NCT01226290|intrauterine ultrasound|intrauterine ultrasound
5097234|NCT01226290|VizAblate|vizablate
5097235|NCT01226264|Uterine cervical cancer|uterine cervical cancer
5097236|NCT01226264|diffusion-weighted MRI|diffusion-weighted mri
5097237|NCT01226264|recurrence|recurrence
5097238|NCT01226251|oral malodour|oral malodour
5097239|NCT01226251|halitosis|halitosis
5097240|NCT01226251|Subjects consulting a bad breath clinic|subjects consulting a bad breath clinic
5097241|NCT01226225|Patients with recent coronary event|patients with recent coronary event
5097242|NCT01226212|Older people|older people
5097243|NCT01226212|Synbiotic|synbiotic
5097244|NCT01226212|Prebiotic|prebiotic
5097245|NCT01226212|Probiotic|probiotic
5097246|NCT01226212|Bacteria|bacteria
5097247|NCT01226212|Immune|immune
5097248|NCT01226186|Knee replacement|knee replacement
5097249|NCT01226186|Pain control|pain control
5097250|NCT01226186|Self medication|self medication
5097251|NCT01226173|Prospective screening of blood donors.|prospective screening of blood donors.
5097252|NCT01226147|Lupus Nephritis|lupus nephritis
5097253|NCT01226147|SLE|sle
5097254|NCT01226147|retinoid|retinoid
5097255|NCT01226147|tamibarotene|tamibarotene
5097256|NCT01226134|Functional Dyspepsia|functional dyspepsia
5097257|NCT01226134|Itopride|itopride
5097258|NCT01226134|Gastric Emptying|gastric emptying
5097259|NCT01226134|Gastric Accommodation|gastric accommodation
5097260|NCT01226134|Dyspeptic Symptoms|dyspeptic symptoms
5097261|NCT01226121|dupuytren|dupuytren
5097262|NCT01226121|dupuytren's|dupuytren's
5097263|NCT01226095|Osteoarthritis|osteoarthritis
5097264|NCT01226095|Pain|pain
5097265|NCT01226095|Morning stiffness|morning stiffness
5097266|NCT01226069|superficial phlebitis|superficial phlebitis
5097267|NCT01226069|cannula-related vein inflammation|cannula-related vein inflammation
5097268|NCT01226069|Glycerine magnesium sulphate|glycerine magnesium sulphate
5097269|NCT01226069|Hirudoid cream|hirudoid cream
5097270|NCT01226069|Nursing|nursing
5097271|NCT01226056|advanced solid tumors|advanced solid tumors
5097272|NCT01226056|Sorafenib (Nexavar®)|sorafenib (nexavar®)
5097273|NCT01226056|RAD001 (everolimus)|rad001 (everolimus)
5097274|NCT01226056|tumor molecular targets|tumor molecular targets
5097275|NCT01226030|Advanced Solid Tumors|advanced solid tumors
5097276|NCT01226017|Oxytocin|oxytocin
5097277|NCT01226017|Animal Assisted therapy|animal assisted therapy
5097278|NCT01226017|Farm animals|farm animals
5097279|NCT01226017|Healthy nursing students|healthy nursing students
5097280|NCT01226004|radiosurgery|radiosurgery
5097281|NCT01226004|prostate|prostate
5097282|NCT01226004|cancer|cancer
5097283|NCT01226004|early|early
5097284|NCT01226004|intermediate|intermediate
5097285|NCT01226004|CyberKnife|cyberknife
5097286|NCT01225991|Pain, Fatigue, Geriatric, Rheumatoid Arthritis, Milnacipran|pain, fatigue, geriatric, rheumatoid arthritis, milnacipran
5097287|NCT01225978|Genetic Information|genetic information
5097289|NCT01225978|Information Technology|information technology
5097290|NCT01225978|Hypertrophic Cardiomyopathy|hypertrophic cardiomyopathy
5097688|NCT01223898|midazolam|midazolam
5097291|NCT01225978|Hearing Loss|hearing loss
5097292|NCT01225978|Oncology|oncology
5097293|NCT01225965|Particulate Matter induced inflammation of the lung|particulate matter induced inflammation of the lung
5097294|NCT01225952|phacoemulsification|phacoemulsification
5097295|NCT01225952|intraocular lens|intraocular lens
5097296|NCT01225939|Type 2 diabetes mellitus|type 2 diabetes mellitus
5097297|NCT01225939|Healthy|healthy
5097298|NCT01225926|Intraocular Lens|intraocular lens
5097299|NCT01225926|Toric|toric
5097300|NCT01225913|asthma|asthma
5097301|NCT01225913|lung function|lung function
5097302|NCT01225913|inflammation|inflammation
5097303|NCT01225874|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
5097304|NCT01225874|B-cell childhood acute lymphoblastic leukemia|b-cell childhood acute lymphoblastic leukemia
5097305|NCT01225874|non-T, non-B, cALLa positive, pre-B childhood acute lymphoblastic leukemia|non-t, non-b, calla positive, pre-b childhood acute lymphoblastic leukemia
5097306|NCT01225809|AD01 follow-up extension|ad01 follow-up extension
5097307|NCT01225796|Bicarbonate|bicarbonate
5097308|NCT01225796|Chronic allograft nephropathy|chronic allograft nephropathy
5097309|NCT01225796|Urinary TGF-beta|urinary tgf-beta
5097310|NCT01225796|Urinary acid excretion|urinary acid excretion
5097311|NCT01225770|green tea|green tea
5097312|NCT01225770|gargling|gargling
5097313|NCT01225770|prophylaxis|prophylaxis
5097314|NCT01225770|influenza|influenza
5097315|NCT01225770|Respiratory Tract Infections|respiratory tract infections
5097316|NCT01225770|high school students|high school students
5097317|NCT01225757|Echocardiography|echocardiography
5097318|NCT01225757|HIPEC|hipec
5097319|NCT01225692|Brain Injury|brain injury
5097320|NCT01225692|Head Trauma|head trauma
5097321|NCT01225692|Trauma Systems|trauma systems
5097322|NCT01225692|Head Injury Guideline|head injury guideline
5097323|NCT01225692|Time to Tertiary Care|time to tertiary care
5097324|NCT01225679|Congenital Central Hypoventilation Syndrome|congenital central hypoventilation syndrome
5097325|NCT01225679|Phox2B gene|phox2b gene
5097326|NCT01225679|invasive ventilation|invasive ventilation
5097327|NCT01225679|genetics|genetics
5097328|NCT01225679|late-onset|late-onset
5097329|NCT01225679|sleep|sleep
5097330|NCT01225679|central sleep apnea|central sleep apnea
5097331|NCT01225666|MOD-4023|mod-4023
5097332|NCT01225666|Growth Hormone Deficient Adults|growth hormone deficient adults
5097333|NCT01225666|Phase II|phase ii
5097334|NCT01225653|Latanoprost|latanoprost
5097335|NCT01225653|vasodilation|vasodilation
5097336|NCT01225653|diabetic retinopathy|diabetic retinopathy
5097337|NCT01225640|Tuberculosis|tuberculosis
5097338|NCT01225640|EBA|eba
5097339|NCT01225640|WBA|wba
5097340|NCT01225627|Chronic disease management|chronic disease management
5097341|NCT01225627|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
5097342|NCT01225627|Discharge planning|discharge planning
5097343|NCT01225627|Discharge coordinator|discharge coordinator
5097344|NCT01225614|Home ventilation|home ventilation
5097345|NCT01225614|Myotonic dystrophy type 1 (DM1)|myotonic dystrophy type 1 (dm1)
5097346|NCT01225575|large cartilage defects|large cartilage defects
5097347|NCT01225575|knee joint|knee joint
5097348|NCT01225575|femoral condyle, tibia, trochlear, retropatellar|femoral condyle, tibia, trochlear, retropatellar
5097349|NCT01225562|Heart attack|heart attack
5097350|NCT01225562|Heart Disease|heart disease
5097351|NCT01225562|Acute coronary syndrome|acute coronary syndrome
5097352|NCT01225562|ACS|acs
5097353|NCT01225562|Cardiovascular Disease|cardiovascular disease
5097354|NCT01225549|Allergen Challenge|allergen challenge
5097355|NCT01225549|Asthma|asthma
5097356|NCT01225549|Inhaled selective glucocorticoid receptor agonist (iSEGRA)|inhaled selective glucocorticoid receptor agonist (isegra)
5097357|NCT01225536|BRAF mutations|braf mutations
5097358|NCT01225510|recurrent glioblastoma multiforme (GBM)|recurrent glioblastoma multiforme (gbm)
5097359|NCT01225510|CVX-060|cvx-060
5097360|NCT01225510|PF-04856884|pf-04856884
5097361|NCT01225510|phase 2|phase 2
5097362|NCT01225510|open-label|open-label
5097363|NCT01225510|bevacizumab|bevacizumab
5097364|NCT01225510|anti-angiogenic|anti-angiogenic
5097365|NCT01225497|Randomized|randomized
5097366|NCT01225497|Pilot study|pilot study
5097367|NCT01225497|VISA-A|visa-a
5097368|NCT01225497|VAS|vas
5097369|NCT01225484|Knee arthroplasty, perioperative analgesia|knee arthroplasty, perioperative analgesia
5097370|NCT01225471|novel epitope peptide|novel epitope peptide
5097371|NCT01225471|CTL|ctl
5097372|NCT01225471|advanced prostate cancer|advanced prostate cancer
5097373|NCT01225458|Elderly patients|elderly patients
5097374|NCT01225458|renal insufficiency|renal insufficiency
5097375|NCT01225458|systematized gerontologic evaluation|systematized gerontologic evaluation
5097376|NCT01225419|Plerixafor|plerixafor
5097377|NCT01225419|Hematopoietic Stem Cell Transplant mobilization|hematopoietic stem cell transplant mobilization
5097378|NCT01225419|children|children
5097379|NCT01225406|Third line ARV therapy|third line arv therapy
5097380|NCT01225406|HIV RNA|hiv rna
5097381|NCT01225406|Absolute CD4+ T cell count|absolute cd4+ t cell count
5097382|NCT01225406|serious adverse events (SAEs)|serious adverse events (saes)
5097383|NCT01225406|Drug resistance|drug resistance
5097384|NCT01225380|Hepatitis C|hepatitis c
5097385|NCT01225380|HCV|hcv
5097386|NCT01225380|Rapid Virologic Response|rapid virologic response
5097387|NCT01225380|Sustained Virologic Response|sustained virologic response
5097388|NCT01225380|Direct Acting Antiviral|direct acting antiviral
5097389|NCT01225380|Combination Therapy|combination therapy
5097390|NCT01225380|HCV RNA|hcv rna
5097391|NCT01225380|Polymerase inhibitor|polymerase inhibitor
5097392|NCT01225380|Protease inhibitor|protease inhibitor
5097393|NCT01225380|Treatment naïve|treatment naïve
5097394|NCT01225380|GS-9190|gs-9190
5097395|NCT01225380|GS-9256|gs-9256
5097396|NCT01225354|Cheek|cheek
5097397|NCT01225354|Cheek flattening|cheek flattening
5097398|NCT01225354|Malar deficiency|malar deficiency
5097399|NCT01225354|Filler|filler
5097400|NCT01225341|HSV-1|hsv-1
5097401|NCT01225341|Herpes labialis|herpes labialis
5097402|NCT01225341|Cold sores|cold sores
5097403|NCT01225341|Fever blisters|fever blisters
5097404|NCT01225289|Multiple Sclerosis|multiple sclerosis
5097405|NCT01225289|Vitamin A|vitamin a
5097406|NCT01225289|CD4-Positive T-Lymphocytes|cd4-positive t-lymphocytes
5097407|NCT01225289|Th1 Cells|th1 cells
5097408|NCT01225289|Th2 Cells|th2 cells
5097409|NCT01225276|CIDP|cidp
5097410|NCT01225276|IVIG|ivig
5097411|NCT01225263|Migraine disorders|migraine disorders
5097412|NCT01225263|Headache|headache
5097413|NCT01225263|Simvastatin|simvastatin
5097414|NCT01225263|Vitamin D|vitamin d
5097415|NCT01225250|Caudal septal extension graft|caudal septal extension graft
5097416|NCT01225250|Primary rhinoplasty|primary rhinoplasty
5097417|NCT01225250|Secondary rhinoplasty|secondary rhinoplasty
5097418|NCT01225237|diarrhea|diarrhea
5097419|NCT01225237|IBS|ibs
5097420|NCT01225237|Colonic disease|colonic disease
5097421|NCT01225237|YM060|ym060
5097422|NCT01225224|ASP015K|asp015k
5097423|NCT01225224|Ethnic difference|ethnic difference
5097424|NCT01225198|Vitamins|vitamins
5097425|NCT01225198|Minerals|minerals
5097426|NCT01225185|neurological complications|neurological complications
5097427|NCT01225185|brain blood flow autoregulation|brain blood flow autoregulation
5097428|NCT01225159|tight glycemic control|tight glycemic control
5097429|NCT01225159|cardiac surgery|cardiac surgery
5097430|NCT01225146|Ischemic|ischemic
5097431|NCT01225146|Central|central
5097432|NCT01225146|Retinal|retinal
5097433|NCT01225146|Vein|vein
5097434|NCT01225146|Occlusion|occlusion
5097435|NCT01225146|Ranibizumab|ranibizumab
5097436|NCT01225146|Lucentis|lucentis
5097437|NCT01225146|CRVO|crvo
5097438|NCT01225146|ISCRVO|iscrvo
5097439|NCT01225133|Osteoarthritis, Osteoarthrosis, Arthritis, Arthrosis|osteoarthritis, osteoarthrosis, arthritis, arthrosis
5097440|NCT01225107|Burns|burns
5097441|NCT01225107|Infections|infections
5097442|NCT01225107|Cranberry|cranberry
5097443|NCT01225094|AAA|aaa
5097444|NCT01225094|abdominal aortic aneurysm|abdominal aortic aneurysm
5097445|NCT01225094|acute kidney injury|acute kidney injury
5097446|NCT01225094|ischemia-reperfusion|ischemia-reperfusion
5097447|NCT01225081|ASP1941|asp1941
5097448|NCT01225081|Diabetes mellitus|diabetes mellitus
5097449|NCT01225081|pioglitazone|pioglitazone
5097450|NCT01225042|infectious diarrhea|infectious diarrhea
5097451|NCT01225042|probiotics|probiotics
5097452|NCT01225042|prevention|prevention
5097453|NCT01225042|dietary intervention|dietary intervention
5097454|NCT01225042|E. coli infection|e. coli infection
5097455|NCT01225042|intestinal infection|intestinal infection
5097456|NCT01225042|intestinal resistance|intestinal resistance
5097457|NCT01225029|premature birth|premature birth
5097458|NCT01225029|late preterm birth|late preterm birth
5097459|NCT01225029|respiratory distress of the newborn|respiratory distress of the newborn
5097460|NCT01225029|Transient tachypnea of the newborn|transient tachypnea of the newborn
5097461|NCT01225003|gliomas|gliomas
5097462|NCT01225003|magnetic resonance|magnetic resonance
5097463|NCT01225003|diffusion kurtosis imaging|diffusion kurtosis imaging
5097464|NCT01225003|MR spectroscopy|mr spectroscopy
5097465|NCT01225003|grading|grading
5097466|NCT01224990|gastro-intestinal tumor|gastro-intestinal tumor
5097467|NCT01224990|accurate staging|accurate staging
5097468|NCT01224990|whole-body diffusion weighted MRI|whole-body diffusion weighted mri
5097469|NCT01224990|non-invasive|non-invasive
5097470|NCT01224925|carious exposure|carious exposure
5097471|NCT01224925|pulp capping|pulp capping
5097472|NCT01224925|MTA|mta
5097473|NCT01224925|Dycal|dycal
5097474|NCT01224912|Insomnia|insomnia
5097475|NCT01224912|Intervention|intervention
5097476|NCT01224912|Self-help|self-help
5097477|NCT01224912|Internet|internet
5097478|NCT01224899|Heart Failure|heart failure
5097479|NCT01224899|Sympathetic Nervous System|sympathetic nervous system
5097480|NCT01224899|Sympathectomy|sympathectomy
5097481|NCT01224899|Adrenergic beta-Antagonists|adrenergic beta-antagonists
5097482|NCT01224899|Ventricular Dysfunction, Left|ventricular dysfunction, left
5097483|NCT01224886|Aging|aging
5097484|NCT01224886|Insulin resistance|insulin resistance
5097485|NCT01224886|Ectopic lipids|ectopic lipids
5097486|NCT01224886|Obesity|obesity
5097487|NCT01224886|Exercise|exercise
5097488|NCT01224886|Physical activity|physical activity
5097489|NCT01224886|Oxidative capacity|oxidative capacity
5097491|NCT01224886|Metabolic syndrome|metabolic syndrome
5097492|NCT01224873|breast cancer|breast cancer
5097493|NCT01224873|bone metastasis|bone metastasis
5097494|NCT01224873|comparison of diagnostic methods|comparison of diagnostic methods
5097495|NCT01224873|bone scintigraphy|bone scintigraphy
5097496|NCT01224873|fluoride PET/CT|fluoride pet/ct
5097497|NCT01224873|FDG-PET/CT|fdg-pet/ct
5097498|NCT01224860|Telmisartan|telmisartan
5097499|NCT01224860|Losartan|losartan
5097500|NCT01224860|Renal transplant|renal transplant
5097501|NCT01224847|AMD|amd
5097502|NCT01224847|Intravitreal Injection|intravitreal injection
5097503|NCT01224847|Anesthesia|anesthesia
5097504|NCT01224834|Ragweed, allergy, sublingual immunotherapy|ragweed, allergy, sublingual immunotherapy
5097505|NCT01224821|iodine I 131 tositumomab|iodine i 131 tositumomab
5097506|NCT01224821|anti-B1 Antibody|anti-b1 antibody
5097507|NCT01224821|Bexxar|bexxar
5097508|NCT01224821|radioimmunotherapy|radioimmunotherapy
5097509|NCT01224821|tositumomab|tositumomab
5097510|NCT01224808|von Willebrand Disease|von willebrand disease
5097511|NCT01224795|uncomplicated influenza|uncomplicated influenza
5097512|NCT01224782|Zemplar capsules|zemplar capsules
5097513|NCT01224782|Chronic kidney disease (CKD) stage 3 or 4|chronic kidney disease (ckd) stage 3 or 4
5097514|NCT01224782|Secondary hyperparathyroidism (SHPT)|secondary hyperparathyroidism (shpt)
5097515|NCT01224782|Postmarketing observational study (PMOS)|postmarketing observational study (pmos)
5097516|NCT01224756|Tonsillitis|tonsillitis
5097517|NCT01224756|Pharyngitis|pharyngitis
5097518|NCT01224756|Sore Throat|sore throat
5097519|NCT01224756|Drug Therapy|drug therapy
5097520|NCT01224717|Osteoporosis|osteoporosis
5097521|NCT01224704|Hypertonic Saline Infusion|hypertonic saline infusion
5097522|NCT01224704|Water Deprivation|water deprivation
5097523|NCT01224704|Thirst|thirst
5097524|NCT01224704|Water/Electrolytes Homeostasis|water/electrolytes homeostasis
5097525|NCT01224704|Obesity|obesity
5097526|NCT01224691|Respiratory Syncytial Virus|respiratory syncytial virus
5097527|NCT01224691|TGF Beta|tgf beta
5097528|NCT01224691|RSV|rsv
5097529|NCT01224691|Asthma|asthma
5097530|NCT01224691|Healthy Volunteer|healthy volunteer
5097531|NCT01224678|breast cancer|breast cancer
5097532|NCT01224665|stage II bladder cancer|stage ii bladder cancer
5097533|NCT01224665|stage III bladder cancer|stage iii bladder cancer
5097534|NCT01224665|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
5097535|NCT01224652|gastric cancer|gastric cancer
5097536|NCT01224652|paclitaxel|paclitaxel
5097537|NCT01224652|irinotecan|irinotecan
5097538|NCT01224639|dengue fever|dengue fever
5097539|NCT01224639|live attenuated tetravalent dengue vaccine|live attenuated tetravalent dengue vaccine
5097540|NCT01224639|TDV|tdv
5097541|NCT01224639|Drug therapy|drug therapy
5097542|NCT01224626|VRE|vre
5097543|NCT01224626|Japanese|japanese
5097544|NCT01224626|Post Marketing Surveillance|post marketing surveillance
5097545|NCT01224600|lower limbs|lower limbs
5097546|NCT01224600|Arterial Diseases|arterial diseases
5097547|NCT01224587|Imaging technique|imaging technique
5097548|NCT01224587|gastric transport through the gut|gastric transport through the gut
5097549|NCT01224574|atrial fribrillation, cardiovascular events, aging, D-dimer|atrial fribrillation, cardiovascular events, aging, d-dimer
5097550|NCT01224561|Thinness|thinness
5097551|NCT01224561|Leanness|leanness
5097552|NCT01224561|healthy volunteers|healthy volunteers
5097553|NCT01224561|Lipid metabolism disorder|lipid metabolism disorder
5097554|NCT01224548|vegan|vegan
5097555|NCT01224548|diet|diet
5097556|NCT01224548|diabetes|diabetes
5097557|NCT01224548|overweight|overweight
5097558|NCT01224548|workplace|workplace
5097559|NCT01224548|nutrition|nutrition
5097560|NCT01224548|diabetes and/or overweight|diabetes and/or overweight
5097561|NCT01224535|Complementary foods|complementary foods
5097562|NCT01224535|Amaranth|amaranth
5097563|NCT01224535|Food Based approaches|food based approaches
5097564|NCT01224535|Iron Deficiency anemia|iron deficiency anemia
5097565|NCT01224535|Arid Areas|arid areas
5097566|NCT01224535|Africa|africa
5097567|NCT01224522|Randomized Controlled Trial|randomized controlled trial
5097568|NCT01224522|Total Knee Arthroplasty|total knee arthroplasty
5097569|NCT01224522|Patient Matched Cutting Blocks|patient matched cutting blocks
5097570|NCT01224509|Cervix|cervix
5097571|NCT01224509|EP3 receptors|ep3 receptors
5097572|NCT01224509|Mifepristone|mifepristone
5097573|NCT01224509|Prostaglandin|prostaglandin
5097574|NCT01224509|Receptors|receptors
5097575|NCT01224509|Steroids|steroids
5097576|NCT01224496|Chronic cytopenic haematological diseases|chronic cytopenic haematological diseases
5097577|NCT01224496|Chinese herbal concoction|chinese herbal concoction
5097578|NCT01224496|Supportive management|supportive management
5097579|NCT01224444|colon polyps|colon polyps
5097580|NCT01224444|adenoma resection|adenoma resection
5097581|NCT01224444|colon cancer screening|colon cancer screening
5097582|NCT01224444|colonoscopy|colonoscopy
5097583|NCT01224431|pain|pain
5097584|NCT01224431|lidocaine|lidocaine
5097585|NCT01224431|lumbar puncture|lumbar puncture
5097586|NCT01224431|j-tip|j-tip
5097587|NCT01224418|Tacrolimus|tacrolimus
5097588|NCT01224418|Prograf|prograf
5097589|NCT01224418|Calcinurin inhibitor|calcinurin inhibitor
5097590|NCT01224418|Rheumatoid arthritis(RA)|rheumatoid arthritis(ra)
5097591|NCT01224392|colorectal cancer|colorectal cancer
5097592|NCT01224392|colorectal neoplasms|colorectal neoplasms
5097593|NCT01224392|radiotherapy|radiotherapy
5097594|NCT01224392|chemoradiotherapy|chemoradiotherapy
5097595|NCT01224392|T3-4 rectal cancer|t3-4 rectal cancer
5097596|NCT01224379|Lumbar spine|lumbar spine
5097597|NCT01224379|fusion|fusion
5097598|NCT01224379|adjacent instability|adjacent instability
5097599|NCT01224379|topping-off.|topping-off.
5097600|NCT01224366|Add-on to insulin|add-on to insulin
5097601|NCT01224327|Liver cirrhosis|liver cirrhosis
5097602|NCT01224327|Radiology|radiology
5097603|NCT01224327|Mesenchymal Stem Cells|mesenchymal stem cells
5097604|NCT01224327|Umbilical Cord|umbilical cord
5097605|NCT01224314|Haemodynamics|haemodynamics
5097606|NCT01224314|Hypotension|hypotension
5097607|NCT01224314|Potassium|potassium
5097608|NCT01224314|Haemodialysis|haemodialysis
5097609|NCT01224314|Dialysis fluids|dialysis fluids
5097610|NCT01224301|seasonal influenza vaccine|seasonal influenza vaccine
5097611|NCT01224301|school-based clinics|school-based clinics
5097612|NCT01224301|economic analysis of school based influenza vaccine delivery|economic analysis of school based influenza vaccine delivery
5097613|NCT01224301|pediatric influenza vaccine rates|pediatric influenza vaccine rates
5097614|NCT01224301|Influenza vaccine information for parents|influenza vaccine information for parents
5097615|NCT01224288|RCC|rcc
5097616|NCT01224288|Kidney cancer|kidney cancer
5097617|NCT01224288|Metastatic renal cell carcinoma|metastatic renal cell carcinoma
5097618|NCT01224288|mRCC|mrcc
5097619|NCT01224288|Dynamic contrast enhanced CT|dynamic contrast enhanced ct
5097620|NCT01224288|DCE-CT|dce-ct
5097621|NCT01224288|Tumor perfusion|tumor perfusion
5097622|NCT01224275|group based care|group based care
5097623|NCT01224275|antenatal care|antenatal care
5097624|NCT01224275|parents satisfaction|parents satisfaction
5097625|NCT01224275|Antenatal care´s organization and patient satisfaction|antenatal care´s organization and patient satisfaction
5097626|NCT01224262|influenza vaccine|influenza vaccine
5097627|NCT01224262|seasonal influenza|seasonal influenza
5097628|NCT01224262|novel vaccine|novel vaccine
5097629|NCT01224262|flu|flu
5097630|NCT01224249|Selenium|selenium
5097631|NCT01224249|Selenoprotein P|selenoprotein p
5097632|NCT01224249|Fish|fish
5097633|NCT01224249|Shellfish|shellfish
5097634|NCT01224249|Bioavailability|bioavailability
5097635|NCT01224223|asthma|asthma
5097636|NCT01224210|portopulmonary hypertension|portopulmonary hypertension
5097637|NCT01224210|portal hypertension|portal hypertension
5097638|NCT01224210|esophageal or gastric varices|esophageal or gastric varices
5097639|NCT01224210|right heart catheterization|right heart catheterization
5097640|NCT01224210|transpulmonary gradient|transpulmonary gradient
5097641|NCT01224210|Endothelin Receptor Antagonist|endothelin receptor antagonist
5097642|NCT01224210|Ambrisentan|ambrisentan
5097643|NCT01224210|Letairis|letairis
5097644|NCT01224210|pulmonary hemodynamics|pulmonary hemodynamics
5097645|NCT01224197|TMC435HPC1004|tmc435hpc1004
5097646|NCT01224197|TMC435|tmc435
5097647|NCT01224197|HCV|hcv
5097648|NCT01224197|Hepatitis C|hepatitis c
5097649|NCT01224197|Healthy Chinese volunteer|healthy chinese volunteer
5097650|NCT01224184|HIV|hiv
5097651|NCT01224184|Sexually Transmitted Diseases|sexually transmitted diseases
5097652|NCT01224184|Substance Abuse Detection|substance abuse detection
5097653|NCT01224184|Randomized Controlled Trial|randomized controlled trial
5097654|NCT01224132|Atopic dermatitis, probiotic, SCORAD index, prick tests, cytokines|atopic dermatitis, probiotic, scorad index, prick tests, cytokines
5097655|NCT01224119|foot ankle arthritis bone graft|foot ankle arthritis bone graft
5097656|NCT01224054|Tolerance alimentary|tolerance alimentary
5097657|NCT01224054|Morbid obesity|morbid obesity
5097658|NCT01224054|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
5097659|NCT01224041|Tacrolimus|tacrolimus
5097660|NCT01224041|Prograf|prograf
5097661|NCT01224041|Calcinurin inhibitor|calcinurin inhibitor
5097788|NCT01223391|orthostatic|orthostatic
5097662|NCT01224041|Rheumatoid arthritis (RA)|rheumatoid arthritis (ra)
5097663|NCT01224028|Tacrolimus|tacrolimus
5097664|NCT01224028|Prograf|prograf
5097665|NCT01224028|Calcinurin inhibitor|calcinurin inhibitor
5097666|NCT01224028|Albuminurea|albuminurea
5097667|NCT01224028|Proteinurea|proteinurea
5097668|NCT01224028|FK506|fk506
5097669|NCT01224002|Cross-Sectional|cross-sectional
5097670|NCT01224002|Observational|observational
5097671|NCT01224002|Comparative|comparative
5097672|NCT01224002|Retrospective|retrospective
5097673|NCT01224002|Feasibility|feasibility
5097674|NCT01224002|Dental Decay|dental decay
5097675|NCT01224002|Drug Abuse|drug abuse
5097676|NCT01224002|Survey|survey
5097677|NCT01223989|overweight|overweight
5097678|NCT01223989|obesity|obesity
5097679|NCT01223989|bread|bread
5097680|NCT01223989|hypocaloric diet|hypocaloric diet
5097681|NCT01223976|latent tuberculosis psoriasis arthritis TST QTF|latent tuberculosis psoriasis arthritis tst qtf
5097682|NCT01223976|Screening of latent tuberculosis in psoriasis|screening of latent tuberculosis in psoriasis
5097683|NCT01223963|Macrolane|macrolane
5097684|NCT01223963|Retrospective|retrospective
5097685|NCT01223924|cancer|cancer
5097686|NCT01223898|CML,|cml,
5097689|NCT01223859|Radiofrequency, ablation, RFA, RFTA, RFITT, soft palate.|radiofrequency, ablation, rfa, rfta, rfitt, soft palate.
5097690|NCT01223833|breast cancer|breast cancer
5097691|NCT01223833|postmenopausal|postmenopausal
5097692|NCT01223833|aromatase inhibitors|aromatase inhibitors
5097693|NCT01223833|tamoxifen|tamoxifen
5097694|NCT01223833|arthralgia|arthralgia
5097695|NCT01223833|IGF-I|igf-i
5097696|NCT01223833|BMI|bmi
5097697|NCT01223833|grip strength|grip strength
5097698|NCT01223807|COPD, diaphragm, rehabilitation|copd, diaphragm, rehabilitation
5097699|NCT01223794|Fall|fall
5097700|NCT01223794|all in surgical & Medical in-patient|all in surgical & medical in-patient
5097701|NCT01223781|Freezing|freezing
5097702|NCT01223781|biofeedback|biofeedback
5097703|NCT01223781|motor learning|motor learning
5097704|NCT01223781|freezing of gait in PD|freezing of gait in pd
5097705|NCT01223755|Autosomal dominant polycystic kidney disease|autosomal dominant polycystic kidney disease
5097706|NCT01223755|Sirolimus|sirolimus
5097707|NCT01223755|Renal insufficiency|renal insufficiency
5097708|NCT01223729|Acetyl-L-carnitine;|acetyl-l-carnitine;
5097709|NCT01223729|Minimal hepatic encephalopathy;|minimal hepatic encephalopathy;
5097710|NCT01223729|Quality of life;|quality of life;
5097711|NCT01223729|Depression.|depression.
5097712|NCT01223716|amblyopia treatment|amblyopia treatment
5097713|NCT01223716|neural plasticity|neural plasticity
5097714|NCT01223716|perceptual learning|perceptual learning
5097715|NCT01223716|vision therapy|vision therapy
5097716|NCT01223716|spatial vision|spatial vision
5097717|NCT01223716|video games|video games
5097718|NCT01223716|occlusion therapy|occlusion therapy
5097719|NCT01223703|n-3 PUFAs|n-3 pufas
5097720|NCT01223703|Heart Failure|heart failure
5097721|NCT01223703|Dilated cardiomyopathy|dilated cardiomyopathy
5097722|NCT01223703|Ejection Fraction|ejection fraction
5097723|NCT01223703|Exercise Capacity|exercise capacity
5097724|NCT01223690|sepsis|sepsis
5097725|NCT01223690|infection|infection
5097726|NCT01223690|bacteremia|bacteremia
5097727|NCT01223690|clarithromycin|clarithromycin
5097728|NCT01223664|ABMSC|abmsc
5097729|NCT01223664|Allogenic bone marrow mesenchymal stem cells|allogenic bone marrow mesenchymal stem cells
5097730|NCT01223664|Liver cirrhosis|liver cirrhosis
5097731|NCT01223664|Transplantation|transplantation
5097732|NCT01223651|Diabetes Mellitus, Type 1|diabetes mellitus, type 1
5097733|NCT01223651|Continuous Glucose Monitoring System|continuous glucose monitoring system
5097734|NCT01223651|Accuracy|accuracy
5097735|NCT01223651|Altitude|altitude
5097736|NCT01223638|Congenital hypothyroidism(CH)|congenital hypothyroidism(ch)
5097737|NCT01223638|Hearing loss among children with CH|hearing loss among children with ch
5097738|NCT01223612|Diabetes Mellitus|diabetes mellitus
5097739|NCT01223612|Diabetes Complications|diabetes complications
5097740|NCT01223612|Retinal Diseases|retinal diseases
5097741|NCT01223612|Edema|edema
5097742|NCT01223612|Endothelial Growth Factors|endothelial growth factors
5097743|NCT01223612|Monoclonal Antibodies|monoclonal antibodies
5097744|NCT01223612|Ranibizumab|ranibizumab
5097745|NCT01223612|Laser therapy|laser therapy
5097746|NCT01223599|pilonidal disease|pilonidal disease
5097747|NCT01223599|natal cleft|natal cleft
5097748|NCT01223599|limberg flap|limberg flap
5097749|NCT01223560|Artificial pancreas|artificial pancreas
5097750|NCT01223560|Model predictive control|model predictive control
5097751|NCT01223560|Virtual patient|virtual patient
5097752|NCT01223547|Carbohydrate counting|carbohydrate counting
5097753|NCT01223547|Insulin bolus calculation|insulin bolus calculation
5097754|NCT01223534|Tuberculosis|tuberculosis
5097755|NCT01223534|Latent tuberculosis infection|latent tuberculosis infection
5097756|NCT01223534|Tuberculin skin test|tuberculin skin test
5097757|NCT01223534|Interferon-gamma release assays|interferon-gamma release assays
5097758|NCT01223534|Contact-tracing study|contact-tracing study
5097759|NCT01223521|Contraception|contraception
5097760|NCT01223521|Abortion|abortion
5097761|NCT01223521|First trimester|first trimester
5097762|NCT01223521|Intrauterine device|intrauterine device
5097763|NCT01223482|Miscarriage|miscarriage
5097764|NCT01223482|Karyotyping|karyotyping
5097765|NCT01223482|Genetic testing|genetic testing
5097766|NCT01223469|Atrial Fibrillation|atrial fibrillation
5097767|NCT01223469|Supraventricular Tachycardia|supraventricular tachycardia
5097768|NCT01223469|Contact Force|contact force
5097769|NCT01223469|RF Ablation|rf ablation
5097770|NCT01223469|Radiofrequency|radiofrequency
5097771|NCT01223469|Pulmonary Vein Isolation|pulmonary vein isolation
5097772|NCT01223469|Paroxysmal Atrial Fibrillation|paroxysmal atrial fibrillation
5097773|NCT01223456|Saxagliptin|saxagliptin
5097774|NCT01223456|type 2 diabetes|type 2 diabetes
5097775|NCT01223456|clinical practice|clinical practice
5097776|NCT01223443|Coronary Artery Bypass Grafting|coronary artery bypass grafting
5097777|NCT01223443|Drug Eluting Stent|drug eluting stent
5097778|NCT01223443|Saphenous Vein Graft|saphenous vein graft
5097779|NCT01223430|septic shock|septic shock
5097780|NCT01223430|shock reversal|shock reversal
5097781|NCT01223430|ICU|icu
5097782|NCT01223430|traditional Chinese medicine|traditional chinese medicine
5097783|NCT01223404|nicotine|nicotine
5097784|NCT01223404|mecamylamine|mecamylamine
5097785|NCT01223404|attention|attention
5097786|NCT01223404|default network|default network
5097787|NCT01223404|fMRI|fmri
5097789|NCT01223391|abdominal compression|abdominal compression
5097790|NCT01223365|moderate to severe pain|moderate to severe pain
5097791|NCT01223365|diabetic peripheral neuropathy|diabetic peripheral neuropathy
5097792|NCT01223365|postherpetic neuralgia|postherpetic neuralgia
5097793|NCT01223365|traumatic injury|traumatic injury
5097794|NCT01223365|complex regional pain syndrome|complex regional pain syndrome
5097795|NCT01223365|back pain|back pain
5097796|NCT01223365|neck pain|neck pain
5097797|NCT01223365|osteoarthritis|osteoarthritis
5097798|NCT01223365|rheumatoid arthritis|rheumatoid arthritis
5097799|NCT01223352|pulmonary arterial hypertension|pulmonary arterial hypertension
5097800|NCT01223352|children|children
5097801|NCT01223352|pediatric|pediatric
5097802|NCT01223352|bosentan|bosentan
5097803|NCT01223339|Ertugliflozin|ertugliflozin
5097804|NCT01223339|Japanese and Western population|japanese and western population
5097805|NCT01223339|pharmacokinetics|pharmacokinetics
5097806|NCT01223339|pharmacodynamics|pharmacodynamics
5097807|NCT01223326|Acetylcysteine|acetylcysteine
5097808|NCT01223313|Contraception|contraception
5097809|NCT01223313|Woman's Condom|woman's condom
5097810|NCT01223313|Female Condom|female condom
5097811|NCT01223313|Condom|condom
5097812|NCT01223287|NICHD Neonatal Research Network|nichd neonatal research network
5097813|NCT01223287|Extremely Low Birth Weight (ELBW)|extremely low birth weight (elbw)
5097814|NCT01223287|Very Low Birth Weight (VLBW)|very low birth weight (vlbw)
5097815|NCT01223287|Prematurity|prematurity
5097816|NCT01223287|Mechanical ventilation|mechanical ventilation
5097817|NCT01223287|Chronic Lung Disease (CLD)|chronic lung disease (cld)
5097818|NCT01223274|NICHD Neonatal Research Network|nichd neonatal research network
5097819|NCT01223274|Extremely Low Birth Weight (ELBW)|extremely low birth weight (elbw)
5097820|NCT01223274|Very Low Birth Weight (VLBW)|very low birth weight (vlbw)
5097821|NCT01223274|Prematurity|prematurity
5097822|NCT01223274|Mechanical ventilation|mechanical ventilation
5097823|NCT01223274|Positive-Pressure Ventilation|positive-pressure ventilation
5097824|NCT01223274|Surfactant|surfactant
5097825|NCT01223274|Intubation|intubation
5097826|NCT01223274|Pulse oximetry|pulse oximetry
5097827|NCT01223274|Oxygen saturation|oxygen saturation
5097828|NCT01223261|NICHD Neonatal Research Network|nichd neonatal research network
5097829|NCT01223261|Very Low Birth Weight (VLBW)|very low birth weight (vlbw)
5097830|NCT01223261|Extremely Low Birth Weight (ELBW)|extremely low birth weight (elbw)
5097831|NCT01223261|Prematurity|prematurity
5097832|NCT01223261|Laparotomy|laparotomy
5097833|NCT01223261|Drainage|drainage
5097834|NCT01223261|Isolated intestinal perforation|isolated intestinal perforation
5097835|NCT01223261|Focal intestinal performation|focal intestinal performation
5097836|NCT01223248|radiation|radiation
5097837|NCT01223248|Hypofractionated Image- Guided|hypofractionated image- guided
5097838|NCT01223248|IGIMRT|igimrt
5097839|NCT01223248|RT|rt
5097840|NCT01223248|10-154|10-154
5097841|NCT01223235|FALLOPIAN TUBE|fallopian tube
5097842|NCT01223235|OVARY|ovary
5097843|NCT01223235|PERITONEUM|peritoneum
5097844|NCT01223235|BEVACIZUMAB (AVASTIN)|bevacizumab (avastin)
5097845|NCT01223235|GLOBO H-KLH CONJUGATE|globo h-klh conjugate
5097846|NCT01223235|MUC-1 KLH|muc-1 klh
5097847|NCT01223235|OPT-821|opt-821
5097848|NCT01223235|TF (C) - KLH|tf (c) - klh
5097849|NCT01223235|TN(C)-KLH|tn(c)-klh
5097850|NCT01223235|10-099|10-099
5097851|NCT01223222|Uncomplicated skin infections|uncomplicated skin infections
5097852|NCT01223222|Impetigo|impetigo
5097853|NCT01223222|Gram-negative|gram-negative
5097854|NCT01223222|Diagnosis of uncomplicated, Gram-positive, skin infection. This may include patients with mild eczema/dermatoses such as atopic dermatitis.|diagnosis of uncomplicated, gram-positive, skin infection. this may include patients with mild eczema/dermatoses such as atopic dermatitis.
5097855|NCT01223222|Gram-positive organisms which in the opinion of the investigator are causative for infection of the lesion(s),|gram-positive organisms which in the opinion of the investigator are causative for infection of the lesion(s),
5097856|NCT01223209|Cancer|cancer
5097857|NCT01223209|Carcinoma|carcinoma
5097858|NCT01223209|Curative surgery|curative surgery
5097859|NCT01223209|Curative surgery for carcinoma at least three months and not more than 5 years prior to treatment start|curative surgery for carcinoma at least three months and not more than 5 years prior to treatment start
5097860|NCT01223196|Type 2 Diabetes, Thiazolidinediones, TIMP-3, TACE, TNF-a,|type 2 diabetes, thiazolidinediones, timp-3, tace, tnf-a,
5097861|NCT01223196|insulin resistance|insulin resistance
5097862|NCT01223183|cystic fibrosis|cystic fibrosis
5097863|NCT01223183|nuclear medicine|nuclear medicine
5097864|NCT01223183|aerosol|aerosol
5097865|NCT01223183|nebulizer|nebulizer
5097866|NCT01223170|Tailoring|tailoring
5097867|NCT01223170|Cardiac rehabilitation|cardiac rehabilitation
5097868|NCT01223170|Internet based intervention|internet based intervention
5097869|NCT01223170|Exercise|exercise
5097870|NCT01223170|Cardiovascular Disease rehabilitation|cardiovascular disease rehabilitation
5097871|NCT01223157|obesity|obesity
5097872|NCT01223157|endocannabinoids|endocannabinoids
5097873|NCT01223144|Cognition|cognition
5097874|NCT01223144|orbitofrontal cortex|orbitofrontal cortex
5097875|NCT01223144|Iowa Gambling Task|iowa gambling task
5097876|NCT01223144|facial emotion recognition|facial emotion recognition
5097877|NCT01223118|Oocyte|oocyte
5097878|NCT01223118|vitrification|vitrification
5097879|NCT01223118|IVF|ivf
5097880|NCT01223118|PGD|pgd
5097881|NCT01223118|embryo biopsy|embryo biopsy
5097882|NCT01223105|slow freeze|slow freeze
5097883|NCT01223105|cryopreservation|cryopreservation
5097884|NCT01223105|vitrification|vitrification
5097885|NCT01223105|oocyte preservation|oocyte preservation
5097886|NCT01223092|IVF|ivf
5097887|NCT01223092|infertility|infertility
5097888|NCT01223092|DNA|dna
5097889|NCT01223079|r-hFSH|r-hfsh
5097890|NCT01223079|r-hLH|r-hlh
5097891|NCT01223066|Macrolane|macrolane
5097892|NCT01223053|Sprain|sprain
5097893|NCT01223053|Strain|strain
5097894|NCT01223053|Pain|pain
5097895|NCT01223053|Ankle Pain|ankle pain
5097896|NCT01223053|Knee Pain|knee pain
5097897|NCT01223053|Wrist Pain|wrist pain
5097898|NCT01223053|Hand Pain|hand pain
5097899|NCT01223027|Dovitinib|dovitinib
5097900|NCT01223027|TKI|tki
5097901|NCT01223027|Renal cell cancer|renal cell cancer
5097902|NCT01223027|RCC|rcc
5097903|NCT01223027|mRCC|mrcc
5097904|NCT01223014|Radioactive|radioactive
5097905|NCT01223014|ADME|adme
5097906|NCT01223014|Neuropathic pain|neuropathic pain
5097907|NCT01223001|Depression|depression
5097908|NCT01223001|Traumatic brain injury|traumatic brain injury
5097909|NCT01223001|Duloxetine|duloxetine
5097910|NCT01223001|Cymbalta|cymbalta
5097911|NCT01223001|impaired cognitive function|impaired cognitive function
5097912|NCT01222975|risperidone fasting study|risperidone fasting study
5097913|NCT01222936|LBH581|lbh581
5097914|NCT01222936|Panobinostat|panobinostat
5097915|NCT01222936|Small Cell Lung Carcinoma|small cell lung carcinoma
5097916|NCT01222923|Risperidone fed study|risperidone fed study
5097917|NCT01222910|Valacyclovir hydrochloride fasting study|valacyclovir hydrochloride fasting study
5097918|NCT01222897|Valacyclovir hydrochloride fed study|valacyclovir hydrochloride fed study
5097919|NCT01222871|Treatment|treatment
5097920|NCT01222858|Obesity|obesity
5097921|NCT01222858|Primary Care|primary care
5097922|NCT01222858|Internet|internet
5097923|NCT01222858|Technology|technology
5097924|NCT01222858|Behavior Modification|behavior modification
5097925|NCT01222819|Febrile neutropenia|febrile neutropenia
5097926|NCT01222819|growth factors|growth factors
5097927|NCT01222819|leukemia|leukemia
5097928|NCT01222806|Functional Magnetic Resonance Imaging (fMRI)|functional magnetic resonance imaging (fmri)
5097929|NCT01222806|Cocaine|cocaine
5097930|NCT01222806|Cue-Induced Craving|cue-induced craving
5097931|NCT01222806|Repetitive TMS (rTMS)|repetitive tms (rtms)
5097932|NCT01222806|Cocaine Craving|cocaine craving
5097933|NCT01222793|High Weight Gain Liability (HWLA)|high weight gain liability (hwla)
5097934|NCT01222793|Antipsychotic|antipsychotic
5097935|NCT01222793|Obesity|obesity
5097936|NCT01222793|Low Weight Gain|low weight gain
5097937|NCT01222793|Schizophrenia|schizophrenia
5097938|NCT01222793|Food Craving|food craving
5097939|NCT01222780|Hematologic Malignancies|hematologic malignancies
5097940|NCT01222780|Vincristine Sulfate|vincristine sulfate
5097941|NCT01222780|Maximum Tolerated Dose|maximum tolerated dose
5097942|NCT01222780|Pharmacokinetics|pharmacokinetics
5097943|NCT01222780|Solid Tumors|solid tumors
5097944|NCT01222780|Cancer|cancer
5097945|NCT01222780|Pediatrics|pediatrics
5097946|NCT01222780|Sarcoma|sarcoma
5097947|NCT01222780|Wilms Tumor|wilms tumor
5097948|NCT01222780|Leukemia|leukemia
5097949|NCT01222780|Lymphoma|lymphoma
5097950|NCT01222780|Brain Tumor|brain tumor
5097951|NCT01222767|EFT|eft
5097952|NCT01222767|PNET|pnet
5097953|NCT01222767|EOE|eoe
5097954|NCT01222754|Newly Diagnosed|newly diagnosed
5097955|NCT01222754|DIPG|dipg
5097956|NCT01222754|CC 5013|cc 5013
5097957|NCT01222754|Radiation Therapy|radiation therapy
5097958|NCT01222754|CC-5013|cc-5013
5097959|NCT01222754|XRT|xrt
5097960|NCT01222754|Brain Tumor|brain tumor
5097961|NCT01222754|Glioma|glioma
5097962|NCT01222754|Pediatrics|pediatrics
5097963|NCT01222741|AIRE- Autoimmune Regulator Gene|aire- autoimmune regulator gene
5097964|NCT01222741|APECED- Autoimmune Polyendocrinopathy-Candidiasis Ectodermal Dystrophy|apeced- autoimmune polyendocrinopathy-candidiasis ectodermal dystrophy
5097965|NCT01222741|CGD (Chronic Granulomatous Disease)|cgd (chronic granulomatous disease)
5097966|NCT01222741|CMC- Chronic Mucocutaneous Candidiasis|cmc- chronic mucocutaneous candidiasis
5097967|NCT01222728|PET Imaging|pet imaging
5097968|NCT01222728|Vestibular Schwannoma|vestibular schwannoma
5097969|NCT01222728|Neurofibromatosis|neurofibromatosis
5097970|NCT01222728|Neurofibromatosis Type 2|neurofibromatosis type 2
5097971|NCT01222728|NF2|nf2
5097972|NCT01222702|CDIFF|cdiff
5097973|NCT01222702|CDAD|cdad
5097974|NCT01222702|CDI|cdi
5097975|NCT01222702|Clostridium difficile infection|clostridium difficile infection
5097976|NCT01222676|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
5097977|NCT01222676|stage II bladder cancer|stage ii bladder cancer
5097978|NCT01222676|stage III bladder cancer|stage iii bladder cancer
5097979|NCT01222676|stage IV bladder cancer|stage iv bladder cancer
5097980|NCT01222663|peritonitis|peritonitis
5097981|NCT01222663|septic shock|septic shock
5097982|NCT01222663|hemoperfusion|hemoperfusion
5097983|NCT01222663|Polymyxin B|polymyxin b
5097984|NCT01222663|endotoxin|endotoxin
5097985|NCT01222650|Benign Prostatic Hyperplasia|benign prostatic hyperplasia
5097986|NCT01222650|I-PSS|i-pss
5097987|NCT01222650|α1A-AR antagonist|α1a-ar antagonist
5097988|NCT01222637|advanced solid cancers|advanced solid cancers
5097989|NCT01222637|metastatic solid cancers|metastatic solid cancers
5097990|NCT01222624|advanced solid malignancies|advanced solid malignancies
5097991|NCT01222611|HIV|hiv
5097992|NCT01222611|HCV|hcv
5097993|NCT01222611|HIV/HCV|hiv/hcv
5097994|NCT01222611|Coinfection|coinfection
5097995|NCT01222611|Fosamprenavir|fosamprenavir
5097996|NCT01222585|Metronidazole|metronidazole
5097997|NCT01222585|Neonate|neonate
5097998|NCT01222585|Premature|premature
5097999|NCT01222585|Sepsis|sepsis
5098000|NCT01222585|Necrotizing enterocolitis|necrotizing enterocolitis
5098001|NCT01222572|radiation therapy|radiation therapy
5098002|NCT01222572|stereotactic radiotherapy|stereotactic radiotherapy
5098003|NCT01222572|stereotactic boost|stereotactic boost
5098004|NCT01222559|Cartilage defects|cartilage defects
5098005|NCT01222559|Knee joint|knee joint
5098006|NCT01222559|Femoral Condyle|femoral condyle
5098007|NCT01222507|tinnitus|tinnitus
5098008|NCT01222507|cognition|cognition
5098009|NCT01222507|brain processing speed|brain processing speed
5098010|NCT01222507|Brain Fitness Program|brain fitness program
5098011|NCT01222507|Posit Science|posit science
5098012|NCT01222494|Child Psychiatry|child psychiatry
5098013|NCT01222494|Obesity|obesity
5098014|NCT01222494|Antipsychotic|antipsychotic
5098015|NCT01222481|Head and Neck Cancer|head and neck cancer
5098016|NCT01222481|Functional Status|functional status
5098017|NCT01222481|Cognitive Status|cognitive status
5098018|NCT01222481|Neurocognitive Assessments|neurocognitive assessments
5098019|NCT01222481|Performance-based Assessments|performance-based assessments
5098020|NCT01222481|Cancer|cancer
5098021|NCT01222481|Function|function
5098022|NCT01222481|Cognition|cognition
5098023|NCT01222481|Quality of Life|quality of life
5098024|NCT01222468|Spasticity, Spinal Cord Injury|spasticity, spinal cord injury
5098025|NCT01222455|Phase 1|phase 1
5098026|NCT01222455|Healthy volunteers|healthy volunteers
5098027|NCT01222455|Volunteers with hepatic impairment|volunteers with hepatic impairment
5098028|NCT01222455|Pharmacokinetics|pharmacokinetics
5098029|NCT01222455|Fostamatinib|fostamatinib
5098030|NCT01222442|Respiratory disease|respiratory disease
5098031|NCT01222442|Bronchiolitis|bronchiolitis
5098032|NCT01222442|Emphysema|emphysema
5098033|NCT01222442|Lung disease causing persistent narrowing of the airways|lung disease causing persistent narrowing of the airways
5098034|NCT01222390|Breast Cancer Reconstruction|breast cancer reconstruction
5098035|NCT01222390|Tissue Expander|tissue expander
5098036|NCT01222390|3-D Camera|3-d camera
5098037|NCT01222390|Breast Reconstruction|breast reconstruction
5098038|NCT01222390|Crescentric|crescentric
5098039|NCT01222390|Expander Profile|expander profile
5098040|NCT01222390|Fill-Volume|fill-volume
5098041|NCT01222390|Lower Pole|lower pole
5098042|NCT01222390|Upper Pole|upper pole
5098043|NCT01222390|Acellular Dermis|acellular dermis
5098044|NCT01222390|3-D Imaging|3-d imaging
5098045|NCT01222364|NICHD Neonatal Research Network|nichd neonatal research network
5098046|NCT01222364|Extremely Low Birth Weight (ELBW)|extremely low birth weight (elbw)
5098047|NCT01222364|Very Low Birth Weight (VLBW)|very low birth weight (vlbw)
5098048|NCT01222364|Prematurity|prematurity
5098049|NCT01222351|Alzheimer's disease|alzheimer's disease
5098050|NCT01222351|Positron emission tomography|positron emission tomography
5098051|NCT01222351|Biomarker|biomarker
5098052|NCT01222351|Plasma Aβ|plasma aβ
5098053|NCT01222351|Brain amyloid plaque load|brain amyloid plaque load
5098054|NCT01222338|Mycobacterium|mycobacterium
5098055|NCT01222338|MDR-TB|mdr-tb
5098056|NCT01222338|XDR-TB|xdr-tb
5098057|NCT01222338|HIV|hiv
5098058|NCT01222338|HCV|hcv
5098059|NCT01222325|kidney calculi|kidney calculi
5098060|NCT01222325|urolithiasis|urolithiasis
5098061|NCT01222325|urologic surgical procedures|urologic surgical procedures
5098062|NCT01222325|extracorporeal shockwave lithotripsy|extracorporeal shockwave lithotripsy
5098063|NCT01222312|advanced NSCLC|advanced nsclc
5098064|NCT01222312|oxaliplatin|oxaliplatin
5098065|NCT01222312|cisplatin|cisplatin
5098066|NCT01222312|docetaxel|docetaxel
5098067|NCT01222312|locally advanced or metastatic non small cell lung cancer (stage IIIB-IV)|locally advanced or metastatic non small cell lung cancer (stage iiib-iv)
5098068|NCT01222286|Smoldering Multiple Myeloma|smoldering multiple myeloma
5098069|NCT01222273|cystic fibrosis|cystic fibrosis
5098070|NCT01222273|Allergic bronchopulmonary aspergillosis|allergic bronchopulmonary aspergillosis
5098071|NCT01222273|A. fumigatus|a. fumigatus
5098072|NCT01222273|Immune response|immune response
5098073|NCT01222260|Amyloidosis|amyloidosis
5098074|NCT01222260|Dexamethasone|dexamethasone
5098075|NCT01222260|Bendamustine|bendamustine
5098076|NCT01222260|Relapsed AL Amyloidosis|relapsed al amyloidosis
5098077|NCT01222247|Betamethasone|betamethasone
5098078|NCT01222247|Celestone|celestone
5098079|NCT01222247|Steroids|steroids
5098080|NCT01222247|Perinatology|perinatology
5098081|NCT01222221|adult gliosarcoma|adult gliosarcoma
5098467|NCT01220713|OEF/OIF|oef/oif
5098082|NCT01222221|adult giant cell glioblastoma|adult giant cell glioblastoma
5098083|NCT01222221|adult glioblastoma|adult glioblastoma
5098084|NCT01222208|Bowel resection|bowel resection
5098085|NCT01222195|Myelodysplastic Syndrome|myelodysplastic syndrome
5098086|NCT01222195|Red cell transfusion independence|red cell transfusion independence
5098087|NCT01222195|Darbepoetin alfa|darbepoetin alfa
5098088|NCT01222195|Lenalidomide|lenalidomide
5098089|NCT01222195|CC-5013|cc-5013
5098090|NCT01222195|Revlimid|revlimid
5098091|NCT01222195|Aranesp|aranesp
5098092|NCT01222195|Erythropoietin|erythropoietin
5098093|NCT01222195|Erythropoiesis Stimulating Protein|erythropoiesis stimulating protein
5098094|NCT01222182|low density lipoprotein (LDL) cholesterol|low density lipoprotein (ldl) cholesterol
5098095|NCT01222182|statin|statin
5098096|NCT01222182|dose equivalent|dose equivalent
5098097|NCT01222182|Hypercholesterolemia (defined by LDL guidelines)|hypercholesterolemia (defined by ldl guidelines)
5098098|NCT01222169|Anesthesia|anesthesia
5098099|NCT01222169|Children|children
5098100|NCT01222169|Larynx|larynx
5098101|NCT01222156|Cardiac arrhythmias|cardiac arrhythmias
5098102|NCT01222156|Catheter ablation|catheter ablation
5098103|NCT01222156|Electrophysiology|electrophysiology
5098104|NCT01222156|Magnetic|magnetic
5098105|NCT01222156|Mapping|mapping
5098106|NCT01222156|Remote navigation|remote navigation
5098107|NCT01222143|AML|aml
5098108|NCT01222143|NOVE-HiDAC|nove-hidac
5098109|NCT01222143|Nilotinib|nilotinib
5098110|NCT01222130|HIV|hiv
5098111|NCT01222130|Infant infection|infant infection
5098112|NCT01222130|Diagnosis|diagnosis
5098113|NCT01222130|Non-virological algorithm|non-virological algorithm
5098114|NCT01222117|Acute Limb Ischemia|acute limb ischemia
5098115|NCT01222104|vascular closure|vascular closure
5098116|NCT01222104|Angio-Seal|angio-seal
5098117|NCT01222104|Interventional radiology|interventional radiology
5098118|NCT01222104|femoral artery|femoral artery
5098119|NCT01222078|newly diagnosed type 1 diabetes mellitus|newly diagnosed type 1 diabetes mellitus
5098120|NCT01222078|re-treatment|re-treatment
5098121|NCT01222078|intravenous otelixizumab|intravenous otelixizumab
5098122|NCT01222078|beta-cell preservation|beta-cell preservation
5098123|NCT01222065|Glaucoma|glaucoma
5098124|NCT01222065|Neurotubules|neurotubules
5098125|NCT01222065|Birefringence|birefringence
5098126|NCT01222065|Retinal Nerve Fiber Layer (RNFL)|retinal nerve fiber layer (rnfl)
5098127|NCT01222052|high risk breast cancer|high risk breast cancer
5098128|NCT01222052|low risk breast cancer|low risk breast cancer
5098129|NCT01222052|uPA|upa
5098130|NCT01222052|urokinase-type plasminogen activator|urokinase-type plasminogen activator
5098131|NCT01222052|PAI|pai
5098132|NCT01222052|plasminogen activator inhibitor-type|plasminogen activator inhibitor-type
5098133|NCT01222039|Graft versus host disease|graft versus host disease
5098134|NCT01222039|Mesenchymal stem cell|mesenchymal stem cell
5098135|NCT01222039|Allogeneic mesenchymal stem cell|allogeneic mesenchymal stem cell
5098136|NCT01222039|Adipose tissue|adipose tissue
5098137|NCT01222039|Allotransplant|allotransplant
5098138|NCT01222039|Allogenic|allogenic
5098139|NCT01222039|Mesenchymal Stem Cells|mesenchymal stem cells
5098140|NCT01222039|Immune System Diseases|immune system diseases
5098141|NCT01222039|Chronic|chronic
5098142|NCT01222039|Expanded|expanded
5098143|NCT01222026|Primary Hyperparathyroidism|primary hyperparathyroidism
5098144|NCT01222026|Osteopenia|osteopenia
5098145|NCT01222026|Osteoporosis|osteoporosis
5098146|NCT01221987|Human papillomavirus|human papillomavirus
5098147|NCT01221987|neoplasia|neoplasia
5098148|NCT01221974|Hydrosalpinx or infertility|hydrosalpinx or infertility
5098149|NCT01221961|Major spine surgery|major spine surgery
5098150|NCT01221961|Hemoglobin|hemoglobin
5098151|NCT01221961|Blood transfusion|blood transfusion
5098152|NCT01221948|Deep Brain Stimulation|deep brain stimulation
5098153|NCT01221948|Parkinson's Disease|parkinson's disease
5098154|NCT01221935|retrospective chart review study|retrospective chart review study
5098155|NCT01221935|desvenlafaxine utilization|desvenlafaxine utilization
5098156|NCT01221935|psychiatrists and primary care physicians|psychiatrists and primary care physicians
5098157|NCT01221935|treatment of major depressive disorder|treatment of major depressive disorder
5098158|NCT01221909|bleeding|bleeding
5098159|NCT01221909|dacryocystorhinostomy|dacryocystorhinostomy
5098160|NCT01221909|operative duration|operative duration
5098161|NCT01221896|Localization of a parathyroid adenoma in patients with primary hyperparathyroidism.|localization of a parathyroid adenoma in patients with primary hyperparathyroidism.
5098162|NCT01221883|Posttraumatic Stress|posttraumatic stress
5098163|NCT01221883|Prevention|prevention
5098164|NCT01221883|Diazepam|diazepam
5098165|NCT01221870|Metastatic breast cancer|metastatic breast cancer
5098166|NCT01221870|First-line therapy|first-line therapy
5098167|NCT01221870|Tesetaxel|tesetaxel
5098168|NCT01221870|Oral taxane|oral taxane
5098169|NCT01221857|Double Umbilical Cord Blood Stem Cell Transplantation|double umbilical cord blood stem cell transplantation
5098170|NCT01221857|Hematological Malignancies|hematological malignancies
5098171|NCT01221857|HLA Mismatched Donors|hla mismatched donors
5098172|NCT01221857|Cord Blood Transplantation|cord blood transplantation
5098173|NCT01221844|Lactoferrin|lactoferrin
5098174|NCT01221844|Pregnancy|pregnancy
5099648|NCT01215682|vitamin D|vitamin d
5098175|NCT01221844|Hereditary Thrombophilia|hereditary thrombophilia
5098176|NCT01221844|Iron deficiency|iron deficiency
5098177|NCT01221844|Iron deficiency anemia|iron deficiency anemia
5098178|NCT01221818|Inflammatory Bowel Disease|inflammatory bowel disease
5098179|NCT01221805|deep venous thrombosis|deep venous thrombosis
5098180|NCT01221805|pulmonary embolism|pulmonary embolism
5098181|NCT01221805|venous thromboembolism|venous thromboembolism
5098182|NCT01221805|D-dimer|d-dimer
5098183|NCT01221805|Wells score|wells score
5098184|NCT01221805|Wells clinical pretest probability|wells clinical pretest probability
5098185|NCT01221792|PTSD|ptsd
5098186|NCT01221792|Anxiety|anxiety
5098187|NCT01221792|Trauma|trauma
5098188|NCT01221792|Assault|assault
5098189|NCT01221792|Victim|victim
5098190|NCT01221792|Witness|witness
5098191|NCT01221792|Post Traumatic Stress Disorder|post traumatic stress disorder
5098192|NCT01221792|Combat veteran|combat veteran
5098193|NCT01221792|Flashbacks|flashbacks
5098194|NCT01221792|Nightmares|nightmares
5098195|NCT01221792|Sleep Disturbance|sleep disturbance
5098196|NCT01221792|Hyperarousal|hyperarousal
5098197|NCT01221792|Numbness|numbness
5098198|NCT01221792|Avoidance|avoidance
5098199|NCT01221779|Intensive language therapy|intensive language therapy
5098200|NCT01221779|Anomia|anomia
5098201|NCT01221779|Magnetic Resonance Imaging|magnetic resonance imaging
5098202|NCT01221766|adnexal|adnexal
5098203|NCT01221766|hair and nail|hair and nail
5098204|NCT01221766|chronic graft vs host disease|chronic graft vs host disease
5098205|NCT01221766|children|children
5098206|NCT01221753|SSCHN|sschn
5098207|NCT01221753|HPV|hpv
5098208|NCT01221753|IMRT|imrt
5098209|NCT01221740|To show that patients with greater pain sensitivity|to show that patients with greater pain sensitivity
5098210|NCT01221740|will show greater improvement in their symptoms|will show greater improvement in their symptoms
5098211|NCT01221740|(self-reported pain intensity, mood, sleep, and|(self-reported pain intensity, mood, sleep, and
5098212|NCT01221740|quality of life) than those with lower pain|quality of life) than those with lower pain
5098213|NCT01221740|sensitivity, based on QST, after taking milnacipran.|sensitivity, based on qst, after taking milnacipran.
5098214|NCT01221740|To compare outcome differences|to compare outcome differences
5098215|NCT01221740|(pain intensity, mood, activity interference,|(pain intensity, mood, activity interference,
5098216|NCT01221740|sleep, and side effects) with those patients|sleep, and side effects) with those patients
5098217|NCT01221740|who are either taking or not taking opioids for|who are either taking or not taking opioids for
5098218|NCT01221740|their pain 10 weeks after being prescribed milnacipran.|their pain 10 weeks after being prescribed milnacipran.
5098219|NCT01221740|To show that patients who are older, male,|to show that patients who are older, male,
5098220|NCT01221740|with more medical comorbidities, greater disability,|with more medical comorbidities, greater disability,
5098221|NCT01221740|and longer pain duration will report less improvement|and longer pain duration will report less improvement
5098222|NCT01221740|(pain, mood, sleep, health-related quality of life)|(pain, mood, sleep, health-related quality of life)
5098223|NCT01221740|and treatment satisfaction while taking milnacipran|and treatment satisfaction while taking milnacipran
5098224|NCT01221740|compared with others without such characteristics.|compared with others without such characteristics.
5098225|NCT01221740|identify patients back or neck pain|identify patients back or neck pain
5098226|NCT01221740|greater 6 months|greater 6 months
5098227|NCT01221740|QST|qst
5098228|NCT01221740|10 weeks|10 weeks
5098229|NCT01221740|milnacipran|milnacipran
5098230|NCT01221740|pain intensity|pain intensity
5098231|NCT01221740|mood|mood
5098232|NCT01221740|activity|activity
5098233|NCT01221740|interference|interference
5098234|NCT01221740|sleep|sleep
5098235|NCT01221740|side effects|side effects
5098236|NCT01221740|age|age
5098237|NCT01221740|gender|gender
5098238|NCT01221740|medical comorbidities|medical comorbidities
5098239|NCT01221740|pain diagnosis|pain diagnosis
5098240|NCT01221740|pain duration|pain duration
5098241|NCT01221740|disability status|disability status
5098242|NCT01221727|Amgen|amgen
5098243|NCT01221727|Phase 1|phase 1
5098244|NCT01221727|Postmenopausal|postmenopausal
5098245|NCT01221727|Osteoporosis|osteoporosis
5098246|NCT01221714|nutritional supplements|nutritional supplements
5098247|NCT01221714|supplements|supplements
5098248|NCT01221714|vitamins|vitamins
5098249|NCT01221714|omega-3|omega-3
5098250|NCT01221714|Amerisciences|amerisciences
5098251|NCT01221714|Carlos Montesinos|carlos montesinos
5098252|NCT01221701|depression|depression
5098253|NCT01221701|psychological treatments|psychological treatments
5098254|NCT01221701|Cognitive Behavioral Therapy|cognitive behavioral therapy
5098255|NCT01221701|child social/emotional functioning|child social/emotional functioning
5098256|NCT01221701|parenting|parenting
5098257|NCT01221701|home visitation|home visitation
5098258|NCT01221688|Sentinel lymph node biopsy (SLNB)|sentinel lymph node biopsy (slnb)
5098259|NCT01221688|large operable breast cancer|large operable breast cancer
5098260|NCT01221688|neoadjuvant chemotherapy|neoadjuvant chemotherapy
5098261|NCT01221688|patients with large operable breast cancer after neoadjuvant chemotherapy (NAC)|patients with large operable breast cancer after neoadjuvant chemotherapy (nac)
5098262|NCT01221675|Small Cell Lung Cancer or CEA-expressing Non Small Cell Lung Carcinoma (NSCLC)|small cell lung cancer or cea-expressing non small cell lung carcinoma (nsclc)
5098263|NCT01221675|Radio Immunotherapy|radio immunotherapy
5098264|NCT01221675|Lutetium|lutetium
5098265|NCT01221675|patient ≥ 18 years of age with CEA-positive SCLC in partial response|patient ≥ 18 years of age with cea-positive sclc in partial response
5098266|NCT01221675|or who failed at least two lines of standard radiation and/or chemotherapy|or who failed at least two lines of standard radiation and/or chemotherapy
5098267|NCT01221675|or Patients with histologic diagnosis of NSCLC|or patients with histologic diagnosis of nsclc
5098268|NCT01221662|Siwu tang|siwu tang
5098269|NCT01221662|brain hypoperfusion|brain hypoperfusion
5098270|NCT01221662|cognition function|cognition function
5098271|NCT01221623|Peyronie's Disease|peyronie's disease
5098272|NCT01221623|penile plaque|penile plaque
5098273|NCT01221623|penile curvature|penile curvature
5098274|NCT01221610|Stenosis|stenosis
5098275|NCT01221610|Occlusions|occlusions
5098276|NCT01221610|SFA|sfa
5098277|NCT01221610|PTA|pta
5098278|NCT01221610|POBA|poba
5098279|NCT01221610|DRB|drb
5098280|NCT01221597|Peyronie's Disease|peyronie's disease
5098281|NCT01221597|penile plaque|penile plaque
5098282|NCT01221597|penile curvature|penile curvature
5098283|NCT01221584|Dyslipidaemia|dyslipidaemia
5098284|NCT01221584|LDL-C goals|ldl-c goals
5098285|NCT01221584|guidelines|guidelines
5098286|NCT01221571|Phase I|phase i
5098287|NCT01221571|Dose escalation|dose escalation
5098288|NCT01221571|AFM 13|afm 13
5098289|NCT01221571|Natural killer cell|natural killer cell
5098290|NCT01221545|Diabetes Mellitus|diabetes mellitus
5098291|NCT01221519|Phase I|phase i
5098292|NCT01221519|Bioavailability|bioavailability
5098293|NCT01221519|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
5098294|NCT01221519|Diabetic treatment|diabetic treatment
5098295|NCT01221519|Metformin|metformin
5098296|NCT01221519|High blood sugar|high blood sugar
5098297|NCT01221506|unresectable|unresectable
5098298|NCT01221506|metastatic|metastatic
5098299|NCT01221506|clear cell renal carcinoma|clear cell renal carcinoma
5098300|NCT01221493|solitary pulmonary nodules|solitary pulmonary nodules
5098301|NCT01221493|transbronchial lung biopsy|transbronchial lung biopsy
5098302|NCT01221493|endobronchial ultrasound|endobronchial ultrasound
5098303|NCT01221454|ABMSC|abmsc
5098304|NCT01221454|Allogenic bone marrow mesenchymal stem cells|allogenic bone marrow mesenchymal stem cells
5098305|NCT01221454|Liver Failure|liver failure
5098306|NCT01221454|Transplantation|transplantation
5098307|NCT01221441|Cartilage|cartilage
5098308|NCT01221441|Knee|knee
5098309|NCT01221441|Osteoarthritis|osteoarthritis
5098310|NCT01221428|Ulcerative colitis|ulcerative colitis
5098311|NCT01221428|Mesenchymal Stem Cells|mesenchymal stem cells
5098312|NCT01221428|Umbilical Cord|umbilical cord
5098313|NCT01221389|hemorrhage|hemorrhage
5098314|NCT01221389|plasma|plasma
5098315|NCT01221389|coagulopathy|coagulopathy
5098316|NCT01221389|trauma|trauma
5098317|NCT01221363|Life style disease|life style disease
5098318|NCT01221363|Obesity|obesity
5098319|NCT01221363|Sedentary behaviour|sedentary behaviour
5098320|NCT01221363|Cardiovascular biomarkers|cardiovascular biomarkers
5098321|NCT01221350|Asthma|asthma
5098322|NCT01221350|Allergic rhinitis|allergic rhinitis
5098323|NCT01221350|Respiratory disease|respiratory disease
5098324|NCT01221350|Allergy|allergy
5098325|NCT01221350|Lipoic acid|lipoic acid
5098326|NCT01221350|Thioctic acid|thioctic acid
5098327|NCT01221350|Antioxidant|antioxidant
5098328|NCT01221350|Oxidative stress|oxidative stress
5098329|NCT01221311|stenosis|stenosis
5098330|NCT01221311|bile duct|bile duct
5098331|NCT01221311|chronic pancreatitis|chronic pancreatitis
5098332|NCT01221311|postoperative|postoperative
5098333|NCT01221311|post-liver transplant|post-liver transplant
5098334|NCT01221285|Cockroach|cockroach
5098335|NCT01221285|Immunotherapy|immunotherapy
5098336|NCT01221285|Subcutaneous immunotherapy|subcutaneous immunotherapy
5098337|NCT01221285|Inner city asthma|inner city asthma
5098338|NCT01221272|SPECT MPI|spect mpi
5098339|NCT01221246|Acute Middle Cerebral Artery Ischemic Stroke within 18 hours|acute middle cerebral artery ischemic stroke within 18 hours
5098340|NCT01221207|diabetic foot ulcers|diabetic foot ulcers
5098341|NCT01221207|casting|casting
5098342|NCT01221207|wound care|wound care
5098343|NCT01221194|diabetes|diabetes
5098344|NCT01221194|foot ulcer prevention|foot ulcer prevention
5098345|NCT01221194|therapeutic stockings|therapeutic stockings
5098346|NCT01221181|Dense deposit disease|dense deposit disease
5098347|NCT01221181|C3 nephropathy|c3 nephropathy
5098348|NCT01221181|Eculizumab|eculizumab
5098349|NCT01221168|prostate|prostate
5098350|NCT01221168|cancer|cancer
5098351|NCT01221168|genetic|genetic
5098352|NCT01221168|epidemiology|epidemiology
5098353|NCT01221168|susceptibility|susceptibility
5098354|NCT01221155|Musculoskeletal|musculoskeletal
5098355|NCT01221142|Hypothermia, ICH|hypothermia, ich
5098356|NCT01221129|zinc|zinc
5098357|NCT01221129|reticulocyte|reticulocyte
5098358|NCT01221129|PBMC|pbmc
5098359|NCT01221129|whole blood|whole blood
5098360|NCT01221129|transcriptome|transcriptome
5098361|NCT01221129|microarray|microarray
5098362|NCT01221116|coronary artery disease,|coronary artery disease,
5098363|NCT01221116|aortic stenosis,|aortic stenosis,
5098364|NCT01221116|heart failure|heart failure
5098365|NCT01221103|Dexamethasone|dexamethasone
5098366|NCT01221103|Ofatumumab|ofatumumab
5098367|NCT01221103|Bendamustine|bendamustine
5098368|NCT01221103|Lymphoma, Mantle-Cell|lymphoma, mantle-cell
5098369|NCT01221103|Non-Hodgkin lymphoma|non-hodgkin lymphoma
5098370|NCT01221090|Type 2 diabetes|type 2 diabetes
5098371|NCT01221090|Health disparities|health disparities
5098372|NCT01221090|Central Texas|central texas
5098373|NCT01221090|PDA|pda
5098374|NCT01221090|CDSMP|cdsmp
5098375|NCT01221077|NSCLC|nsclc
5098376|NCT01221077|Non-small cell lung cancer|non-small cell lung cancer
5098377|NCT01221077|OSI-906|osi-906
5098378|NCT01221077|IGF-IR|igf-ir
5098379|NCT01221077|Tarceva|tarceva
5098380|NCT01221077|Erlotinib|erlotinib
5098381|NCT01221077|Epidermal Growth Factor Receptor|epidermal growth factor receptor
5098382|NCT01221077|EGFR|egfr
5098383|NCT01221077|Chemonaive|chemonaive
5098384|NCT01221077|Activating mutations|activating mutations
5098385|NCT01221064|Breast cancer|breast cancer
5098386|NCT01221064|Axillary clearance|axillary clearance
5098387|NCT01221064|lymphorrhoea|lymphorrhoea
5098388|NCT01221051|third stage of labor,oxytocics, postpartum hemorrhage,|third stage of labor,oxytocics, postpartum hemorrhage,
5098389|NCT01221025|Parecoxib;|parecoxib;
5098390|NCT01221025|emergence delirium;|emergence delirium;
5098391|NCT01221025|postoperative pain;|postoperative pain;
5098392|NCT01221025|elderly patients;|elderly patients;
5098393|NCT01221025|abdominal surgery|abdominal surgery
5098394|NCT01221025|Parecoxib on emergence agitation and postoperative pain|parecoxib on emergence agitation and postoperative pain
5098395|NCT01220999|Clinical trial|clinical trial
5098396|NCT01220999|CS-1008 mAb|cs-1008 mab
5098397|NCT01220999|monoclonal antibody CS-1008|monoclonal antibody cs-1008
5098398|NCT01220999|Positron-Emission Tomography|positron-emission tomography
5098399|NCT01220999|Pharmacokinetics|pharmacokinetics
5098400|NCT01220999|Pharmacodynamics|pharmacodynamics
5098401|NCT01220999|apoptosis|apoptosis
5098402|NCT01220999|caspases|caspases
5098403|NCT01220986|Liver regeneration|liver regeneration
5098404|NCT01220986|Innate immune response|innate immune response
5098405|NCT01220973|stage IV prostate cancer|stage iv prostate cancer
5098406|NCT01220973|stage III prostate cancer|stage iii prostate cancer
5098407|NCT01220973|recurrent prostate cancer|recurrent prostate cancer
5098408|NCT01220973|stage IIB prostate cancer|stage iib prostate cancer
5098409|NCT01220973|stage IIA prostate cancer|stage iia prostate cancer
5098410|NCT01220960|art therapy|art therapy
5098411|NCT01220960|breast cancer|breast cancer
5098412|NCT01220960|women|women
5098413|NCT01220960|young women|young women
5098414|NCT01220960|older women|older women
5098415|NCT01220960|quality of life|quality of life
5098416|NCT01220960|meaning making|meaning making
5098417|NCT01220960|support group|support group
5098418|NCT01220960|art making|art making
5098419|NCT01220960|art symbols|art symbols
5098420|NCT01220908|LVRS (Lung Volume Reduction Surgery)|lvrs (lung volume reduction surgery)
5098421|NCT01220908|LVRC (Lung Volume Reduction Coil)|lvrc (lung volume reduction coil)
5098422|NCT01220908|Emphysema|emphysema
5098423|NCT01220908|coil|coil
5098424|NCT01220908|RePneu|repneu
5098425|NCT01220895|Adoptive cellular therapy|adoptive cellular therapy
5098426|NCT01220895|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
5098427|NCT01220882|Slipped capital femoral epiphysis|slipped capital femoral epiphysis
5098428|NCT01220856|Islet transplantation|islet transplantation
5098429|NCT01220856|Type 1 diabetes mellitus|type 1 diabetes mellitus
5098430|NCT01220843|chronic renal failure|chronic renal failure
5098431|NCT01220843|FGF23|fgf23
5098432|NCT01220843|Sevelamer carbonate|sevelamer carbonate
5098433|NCT01220830|Multiple sclerosis|multiple sclerosis
5098434|NCT01220830|RFQMR|rfqmr
5098435|NCT01220830|Cytotron|cytotron
5098436|NCT01220830|EDSS|edss
5098437|NCT01220830|QOL assessment with FAMS|qol assessment with fams
5098438|NCT01220817|prostate|prostate
5098439|NCT01220817|cancer|cancer
5098441|NCT01220817|psadt|psadt
5098442|NCT01220817|pomegranate|pomegranate
5098443|NCT01220817|POMx|pomx
5098444|NCT01220791|methylprednisolone|methylprednisolone
5098445|NCT01220791|IVF|ivf
5098446|NCT01220791|progesterone|progesterone
5098447|NCT01220791|corticosteroid|corticosteroid
5098448|NCT01220791|late follicular phase|late follicular phase
5098449|NCT01220791|pregnancy rates|pregnancy rates
5098450|NCT01220765|hypoxemia|hypoxemia
5098451|NCT01220765|capnography|capnography
5098452|NCT01220765|sedation|sedation
5098453|NCT01220752|IMRT|imrt
5098454|NCT01220752|carbon ion therapy|carbon ion therapy
5098455|NCT01220752|paranasal sinus|paranasal sinus
5098456|NCT01220752|nasal cavity|nasal cavity
5098457|NCT01220752|adenocarcinoma|adenocarcinoma
5098458|NCT01220752|squamous cell carcinoma|squamous cell carcinoma
5098459|NCT01220739|ischemic stroke|ischemic stroke
5098460|NCT01220739|transcranial laser|transcranial laser
5098461|NCT01220739|tissue plasminogen activator|tissue plasminogen activator
5098462|NCT01220739|therapy|therapy
5098463|NCT01220726|OAB|oab
5098464|NCT01220713|Traumatic Brain Injury|traumatic brain injury
5098465|NCT01220713|Veterans|veterans
5098466|NCT01220713|Hyperbaric Oxygen Treatment|hyperbaric oxygen treatment
5098468|NCT01220713|Post-Concussive Symptoms|post-concussive symptoms
5098469|NCT01220713|Blast Exposure|blast exposure
5098470|NCT01220687|Prematurity|prematurity
5098471|NCT01220687|Oxygen exposure|oxygen exposure
5098472|NCT01220687|Nitric Oxide|nitric oxide
5098473|NCT01220674|neuropsychological assessment|neuropsychological assessment
5098474|NCT01220674|cognitive impairment|cognitive impairment
5098475|NCT01220674|computer-aided diagnostic tool|computer-aided diagnostic tool
5098476|NCT01220661|Colorectal Surgery|colorectal surgery
5098477|NCT01220661|Surgical Wound Infection|surgical wound infection
5098478|NCT01220661|Laparoscopy|laparoscopy
5098479|NCT01220661|Anti-Bacterial Agents|anti-bacterial agents
5098480|NCT01220648|Chronic myeloid leukemia|chronic myeloid leukemia
5098481|NCT01220648|interferon alfa|interferon alfa
5098482|NCT01220648|nilotinib|nilotinib
5098483|NCT01220648|combination|combination
5098484|NCT01220648|CML|cml
5098485|NCT01220648|Philadelphia chromosome positive (Ph+) chronic myeloid leukemia patients in chronic phase (CML-CP) after switch from previous CML treatment|philadelphia chromosome positive (ph+) chronic myeloid leukemia patients in chronic phase (cml-cp) after switch from previous cml treatment
5098486|NCT01220635|Depressive Symptoms|depressive symptoms
5098487|NCT01220635|Depression prevention|depression prevention
5098488|NCT01220635|Adolescents|adolescents
5098489|NCT01220635|School-Based Services|school-based services
5098490|NCT01220635|Health Behavior|health behavior
5098491|NCT01220622|Stroke|stroke
5098492|NCT01220622|Mild cognitive impairment|mild cognitive impairment
5098493|NCT01220622|Nimodipine|nimodipine
5098494|NCT01220583|stage I salivary gland cancer|stage i salivary gland cancer
5098495|NCT01220583|stage II salivary gland cancer|stage ii salivary gland cancer
5098496|NCT01220583|stage III salivary gland cancer|stage iii salivary gland cancer
5098497|NCT01220583|high-grade salivary gland mucoepidermoid carcinoma|high-grade salivary gland mucoepidermoid carcinoma
5098498|NCT01220583|salivary gland adenocarcinoma|salivary gland adenocarcinoma
5098499|NCT01220583|stage IVA salivary gland cancer|stage iva salivary gland cancer
5098500|NCT01220583|stage IVB salivary gland cancer|stage ivb salivary gland cancer
5098501|NCT01220583|stage IVC salivary gland cancer|stage ivc salivary gland cancer
5098502|NCT01220570|breast cancer|breast cancer
5098503|NCT01220570|ridaforolimus|ridaforolimus
5098504|NCT01220570|ridaforolimus/dalotuzumab combination therapy|ridaforolimus/dalotuzumab combination therapy
5098505|NCT01220557|Diabetes mellitus, education, self management|diabetes mellitus, education, self management
5098506|NCT01220531|DiGeorge Anomaly|digeorge anomaly
5098507|NCT01220531|Thymus Transplantation|thymus transplantation
5098508|NCT01220531|DiGeorge Syndrome|digeorge syndrome
5098509|NCT01220531|Athymia|athymia
5098510|NCT01220531|Low T cell numbers|low t cell numbers
5098511|NCT01220531|Immunoreconstitution|immunoreconstitution
5098512|NCT01220531|Immunodeficiency|immunodeficiency
5098513|NCT01220531|Complete DiGeorge|complete digeorge
5098514|NCT01220531|Typical DiGeorge|typical digeorge
5098515|NCT01220531|Atypical DiGeorge|atypical digeorge
5098516|NCT01220531|Complete DiGeorge Anomaly|complete digeorge anomaly
5098517|NCT01220505|scoliosis|scoliosis
5098518|NCT01220505|kyphosis|kyphosis
5098519|NCT01220505|spinal deformity|spinal deformity
5098520|NCT01220505|curvature|curvature
5098521|NCT01220505|lordosis|lordosis
5098522|NCT01220492|liver cirrhosis|liver cirrhosis
5098523|NCT01220492|mesenchymal stem cells|mesenchymal stem cells
5098524|NCT01220492|longer term survival|longer term survival
5098525|NCT01220492|safety|safety
5098526|NCT01220479|Type 1 Diabetes, Bone mineral density, Growth|type 1 diabetes, bone mineral density, growth
5098527|NCT01220479|Cardiovascular diseases, Exercise, Training,|cardiovascular diseases, exercise, training,
5098528|NCT01220479|Child, Adolescent|child, adolescent
5098529|NCT01220440|ADHD|adhd
5098530|NCT01220440|Children|children
5098531|NCT01220440|Methylphenidate|methylphenidate
5098532|NCT01220440|Dextroamphetamine|dextroamphetamine
5098533|NCT01220440|Placebo|placebo
5098534|NCT01220440|Crossover|crossover
5098535|NCT01220440|Double Blind|double blind
5098536|NCT01220440|Neuropsychological tests|neuropsychological tests
5098537|NCT01220440|Behavioural Questionnaires|behavioural questionnaires
5098538|NCT01220427|high-risk prostate cancer|high-risk prostate cancer
5098539|NCT01220427|radical prostatectomy|radical prostatectomy
5098540|NCT01220427|micro-RNA|micro-rna
5098541|NCT01220401|Nightmare|nightmare
5098542|NCT01220401|PTSD|ptsd
5098543|NCT01220401|Posttraumatic stress disorder|posttraumatic stress disorder
5098544|NCT01220401|Suicide|suicide
5098545|NCT01220401|Exposure Relaxation Rescription Therapy|exposure relaxation rescription therapy
5098546|NCT01220401|Sleep|sleep
5098547|NCT01220388|Aldosterone|aldosterone
5098548|NCT01220388|L-lysine|l-lysine
5098549|NCT01220388|Cortisol|cortisol
5098550|NCT01220388|Adrenal glands|adrenal glands
5098551|NCT01220375|Mobilization of autologous peripheral blood progenitor cells PBPC|mobilization of autologous peripheral blood progenitor cells pbpc
5098552|NCT01220375|Autologous stem cell mobilization|autologous stem cell mobilization
5098553|NCT01220375|Multiple Myeloma|multiple myeloma
5098554|NCT01220375|Plerixafor|plerixafor
5098555|NCT01220362|Analgesia, Epidural|analgesia, epidural
5098556|NCT01220362|Urodynamics|urodynamics
5098557|NCT01220362|Urinary Retention|urinary retention
5098558|NCT01220284|solid tumors|solid tumors
5098559|NCT01220284|oral treatment|oral treatment
5098560|NCT01220284|platinum compound|platinum compound
5098561|NCT01220284|vinca alkaloid|vinca alkaloid
5098562|NCT01220284|drug combination|drug combination
5098563|NCT01220271|Glioma|glioma
5098564|NCT01220271|Glioblastoma|glioblastoma
5098565|NCT01220245|endoluminal|endoluminal
5098566|NCT01220245|surgical|surgical
5098567|NCT01220245|bypass|bypass
5098568|NCT01220245|patency|patency
5098569|NCT01220245|quality of life|quality of life
5098570|NCT01220245|multicentre|multicentre
5098571|NCT01220245|RCT|rct
5098572|NCT01220245|superficial femoral artery|superficial femoral artery
5098573|NCT01220245|vascular patency|vascular patency
5098574|NCT01220232|Lersivirine|lersivirine
5098575|NCT01220232|UK-453|uk-453
5098576|NCT01220232|061|061
5098577|NCT01220232|NNRTI|nnrti
5098578|NCT01220232|Abacavir|abacavir
5098579|NCT01220232|Lamivudine|lamivudine
5098580|NCT01220232|Combivir|combivir
5098581|NCT01220232|Pharmacokinetics|pharmacokinetics
5098582|NCT01220232|Drug Interaction|drug interaction
5098583|NCT01220232|HIV|hiv
5098584|NCT01220232|AIDS|aids
5098585|NCT01220219|pregabalin|pregabalin
5098586|NCT01220219|pharmacokinetics|pharmacokinetics
5098587|NCT01220219|bioavailability|bioavailability
5098588|NCT01220219|bioequivalence|bioequivalence
5098589|NCT01220206|ED|ed
5098590|NCT01220206|POMx|pomx
5098591|NCT01220206|Pomegranate|pomegranate
5098592|NCT01220206|Erectile dysfunction|erectile dysfunction
5098593|NCT01220180|epilepsy|epilepsy
5098594|NCT01220180|neuropathic pain|neuropathic pain
5098595|NCT01220180|fibromyalgia|fibromyalgia
5098596|NCT01220180|post-market surveillance|post-market surveillance
5098597|NCT01220180|prospective observational|prospective observational
5098598|NCT01220154|ovarian|ovarian
5098599|NCT01220154|cancer|cancer
5098600|NCT01220154|fallopian tube|fallopian tube
5098601|NCT01220154|peritoneal|peritoneal
5098602|NCT01220154|intraperitoneal|intraperitoneal
5098603|NCT01220154|bevacizumab|bevacizumab
5098604|NCT01220154|carboplatin|carboplatin
5098605|NCT01220154|paclitaxel|paclitaxel
5098606|NCT01220154|chemo-naive|chemo-naive
5098607|NCT01220128|WT1|wt1
5098608|NCT01220128|neoadjuvant|neoadjuvant
5098609|NCT01220128|tumor antigen|tumor antigen
5098610|NCT01220128|immunotherapy|immunotherapy
5098611|NCT01220128|breast cancer|breast cancer
5098612|NCT01220128|adult|adult
5098613|NCT01220115|sickle cell disease|sickle cell disease
5098614|NCT01220115|iron over load|iron over load
5098615|NCT01220102|acne|acne
5098616|NCT01220102|Epiduo|epiduo
5098617|NCT01220102|adapalene/ benzoyl peroxide|adapalene/ benzoyl peroxide
5098618|NCT01220089|obesity|obesity
5098619|NCT01220089|weight loss|weight loss
5098620|NCT01220076|Tamoxifen,|tamoxifen,
5098621|NCT01220076|Breat Cancer|breat cancer
5098622|NCT01220076|Pharmacogenetic|pharmacogenetic
5098623|NCT01220076|non metastatic breast cancer, HR +|non metastatic breast cancer, hr +
5098624|NCT01220063|RSHF|rshf
5098625|NCT01220063|Irinotecan|irinotecan
5098626|NCT01220063|Colorectal Cancer|colorectal cancer
5098627|NCT01220063|metastases|metastases
5098628|NCT01220050|Paricalcitol|paricalcitol
5098629|NCT01220050|Renal transplant|renal transplant
5098630|NCT01220050|Secondary Hyperparathyroidism|secondary hyperparathyroidism
5098631|NCT01220011|Fetoscopic Laser surgery|fetoscopic laser surgery
5098632|NCT01220011|Stage 1 Twin - twin transfusion syndrome|stage 1 twin - twin transfusion syndrome
5098633|NCT01219998|Postoperative Complications|postoperative complications
5098634|NCT01219998|Acute Kidney Failure|acute kidney failure
5098635|NCT01219998|Peritoneal Dialysis|peritoneal dialysis
5098636|NCT01219998|NGAL|ngal
5098637|NCT01219985|positron emission tomography / computed tomography|positron emission tomography / computed tomography
5098638|NCT01219985|18F-fluoro-2-deoxyglucose|18f-fluoro-2-deoxyglucose
5098639|NCT01219985|liver neoplasm|liver neoplasm
5098640|NCT01219985|respiratory motion|respiratory motion
5098641|NCT01219972|Bone marrow transplant|bone marrow transplant
5098642|NCT01219972|Pulmonary complications|pulmonary complications
5098643|NCT01219959|ESRD|esrd
5098644|NCT01219959|Diabetes|diabetes
5098645|NCT01219959|CAPD|capd
5098646|NCT01219946|Chronic Obstructive Pulmonary Disease, symptoms|chronic obstructive pulmonary disease, symptoms
5098647|NCT01219920|Metastatic colorectal cancer|metastatic colorectal cancer
5098648|NCT01219920|Phase III|phase iii
5098649|NCT01219920|FOLFOXIRI|folfoxiri
5098650|NCT01219920|FOLFIRI|folfiri
5098651|NCT01219894|Coronary Disease|coronary disease
5098652|NCT01219894|Stent|stent
5098653|NCT01219894|Healing|healing
5098654|NCT01219894|Anti-platelet therapy|anti-platelet therapy
5098655|NCT01219881|desflurane|desflurane
5098656|NCT01219881|sevoflurane|sevoflurane
5098657|NCT01219855|Parathyroid Diseases|parathyroid diseases
5098658|NCT01219855|Renal Insufficiency|renal insufficiency
5098659|NCT01219855|Kidney Failure, Chronic|kidney failure, chronic
5098660|NCT01219855|Hyperparathyroidism, Secondary|hyperparathyroidism, secondary
5098661|NCT01219855|Vitamin D|vitamin d
5098662|NCT01219855|Hyperparathyroidism|hyperparathyroidism
5098663|NCT01219855|Kidney Diseases|kidney diseases
5098664|NCT01219855|Kidney Failure|kidney failure
5098665|NCT01219855|Renal Insufficiency, Chronic|renal insufficiency, chronic
5098666|NCT01219842|Intermittent claudication|intermittent claudication
5098667|NCT01219842|Health Related Quality of Life|health related quality of life
5098668|NCT01219842|Walking performance|walking performance
5098669|NCT01219842|Daily walking capacity|daily walking capacity
5098670|NCT01219829|Pancreatic intraepithelial neoplasia (PanIN)|pancreatic intraepithelial neoplasia (panin)
5098671|NCT01219829|Pancreatic Cancer|pancreatic cancer
5098672|NCT01219829|Recurrence of pancreatic cancer|recurrence of pancreatic cancer
5098673|NCT01219829|Field Effect|field effect
5098674|NCT01219829|Genetic mutations in pancreatic cancer|genetic mutations in pancreatic cancer
5098675|NCT01219816|efficacy of Chemo-immunotherapy|efficacy of chemo-immunotherapy
5098676|NCT01219803|Dose-Response Relationship, type 2 diabetes,TCM|dose-response relationship, type 2 diabetes,tcm
5098677|NCT01219790|Patients with painful vertebral metastases with a prostate cancer with an indication of analgesic treatment.|patients with painful vertebral metastases with a prostate cancer with an indication of analgesic treatment.
5098678|NCT01219777|bevacizumab|bevacizumab
5098679|NCT01219777|paclitaxel|paclitaxel
5098680|NCT01219777|carboplatin|carboplatin
5098681|NCT01219777|ovarian|ovarian
5098682|NCT01219777|cancer|cancer
5098683|NCT01219777|fallopian tube|fallopian tube
5098684|NCT01219777|primary peritoneal|primary peritoneal
5098685|NCT01219764|Helicobacter pylori infection|helicobacter pylori infection
5098686|NCT01219764|quadruple therapy|quadruple therapy
5098687|NCT01219764|Amoxicillin|amoxicillin
5098688|NCT01219764|Metronidazole|metronidazole
5098689|NCT01219764|Clarithromycin|clarithromycin
5098690|NCT01219764|Rabeprazole|rabeprazole
5098691|NCT01219738|Asthma, airway blood flow, budesonide, glucocorticosteroid.|asthma, airway blood flow, budesonide, glucocorticosteroid.
5098692|NCT01219725|Body composition|body composition
5098693|NCT01219725|Endothelial function|endothelial function
5098694|NCT01219725|Lipoprotein profile|lipoprotein profile
5098695|NCT01219725|Inflammatory markers|inflammatory markers
5098696|NCT01219725|Aerobic capacity|aerobic capacity
5098697|NCT01219725|Thrombotic markers|thrombotic markers
5098698|NCT01219725|Arterial stiffness|arterial stiffness
5098699|NCT01219725|Cardiac function|cardiac function
5098700|NCT01219725|Traditional and emerging cardiovascular disease risk factors|traditional and emerging cardiovascular disease risk factors
5098701|NCT01219712|NT-proBNP|nt-probnp
5098702|NCT01219712|non-cardiac surgery|non-cardiac surgery
5098703|NCT01219712|left ventricular dysfunction|left ventricular dysfunction
5098704|NCT01219712|cardiac complications|cardiac complications
5098705|NCT01219699|advanced solid tumors|advanced solid tumors
5098706|NCT01219699|mutation|mutation
5098707|NCT01219699|amplification|amplification
5098708|NCT01219699|wild type|wild type
5098709|NCT01219699|PIK3CA gene|pik3ca gene
5098710|NCT01219699|dose-escalation|dose-escalation
5098711|NCT01219699|estrogen receptor positive breast cancer|estrogen receptor positive breast cancer
5098712|NCT01219686|unipolar depression, escitalopram, pindolol|unipolar depression, escitalopram, pindolol
5098713|NCT01219673|Epithelial carcinoma|epithelial carcinoma
5098714|NCT01219673|Oropharynx|oropharynx
5098715|NCT01219673|Larynx|larynx
5098716|NCT01219673|Symptom-management|symptom-management
5098717|NCT01219673|Chemoradiation|chemoradiation
5098718|NCT01219673|Placebo|placebo
5098719|NCT01219673|Armodafinil|armodafinil
5098720|NCT01219673|Nuvigil|nuvigil
5098721|NCT01219673|Bupropion|bupropion
5098722|NCT01219673|Wellbutrin|wellbutrin
5098723|NCT01219673|Wellbutrin SR|wellbutrin sr
5098724|NCT01219673|Zyban|zyban
5098725|NCT01219673|Minocycline|minocycline
5098726|NCT01219673|Dynacin|dynacin
5098727|NCT01219673|Minocin|minocin
5098728|NCT01219673|Minocin PAC|minocin pac
5098729|NCT01219673|Myrac|myrac
5098730|NCT01219673|Solodyn|solodyn
5098731|NCT01219660|sleep|sleep
5098732|NCT01219660|apnea|apnea
5098733|NCT01219647|Multiple Sclerosis|multiple sclerosis
5098734|NCT01219647|Exercise|exercise
5098735|NCT01219647|Cognition|cognition
5098736|NCT01219621|Symphony DR 2550,|symphony dr 2550,
5098737|NCT01219621|Dual Chamber Pacemaker,|dual chamber pacemaker,
5098738|NCT01219621|Sorin,|sorin,
5098739|NCT01219621|Ela Medical,|ela medical,
5098740|NCT01219621|DDD Mode,|ddd mode,
5098741|NCT01219621|AAIsafeR2 mode,|aaisafer2 mode,
5098742|NCT01219621|AV-Conduction,|av-conduction,
5098743|NCT01219621|Reducing Ventricular Pacing,|reducing ventricular pacing,
5098744|NCT01219621|Congestive Heart Failure,|congestive heart failure,
5098745|NCT01219621|Cardiac Function,|cardiac function,
5098746|NCT01219621|Atrial Arrhythmia,|atrial arrhythmia,
5098747|NCT01219621|Atrial Fibrillation,|atrial fibrillation,
5098748|NCT01219621|Atrial and Ventricular Hemodynamics,|atrial and ventricular hemodynamics,
5098749|NCT01219621|Long AV-delays.|long av-delays.
5098750|NCT01219621|Ventricular Function,|ventricular function,
5098751|NCT01219621|Implantation,|implantation,
5098752|NCT01219595|Urinary Tract Infection|urinary tract infection
5098753|NCT01219595|UTI|uti
5098754|NCT01219582|Diabetes Mellitus Type-2|diabetes mellitus type-2
5098755|NCT01219582|Acarbose|acarbose
5098756|NCT01219582|Metformin|metformin
5098757|NCT01219582|Drug Therapy, Combination|drug therapy, combination
5098758|NCT01219569|blindness|blindness
5098759|NCT01219569|ischemic optic neuropathy|ischemic optic neuropathy
5098760|NCT01219556|Hypertension|hypertension
5098761|NCT01219556|Antihypertensive Agents|antihypertensive agents
5098762|NCT01219556|Drug Therapy, Combination|drug therapy, combination
5098763|NCT01219556|Olmesartan Medoxomil|olmesartan medoxomil
5098764|NCT01219556|Hydrochlorothiazide|hydrochlorothiazide
5098765|NCT01219543|Advanced solid malignancies|advanced solid malignancies
5098766|NCT01219543|Child-Pugh A to B7 advanced hepatocellular carcinoma|child-pugh a to b7 advanced hepatocellular carcinoma
5098767|NCT01219543|EGFR and/or ROS mutant NSCLC|egfr and/or ros mutant nsclc
5098768|NCT01219543|Non-smokers with lung metastasis|non-smokers with lung metastasis
5098769|NCT01219543|Gastric cancer|gastric cancer
5098770|NCT01219543|Solid tumour|solid tumour
5098771|NCT01219543|AZD1480|azd1480
5098772|NCT01219543|JAK1/JAK2 kinase inhibitor|jak1/jak2 kinase inhibitor
5098773|NCT01219530|gestational carrier|gestational carrier
5098774|NCT01219530|intended parent|intended parent
5098775|NCT01219517|IVF|ivf
5098776|NCT01219517|embryo biopsy|embryo biopsy
5098777|NCT01219517|DNA fingerprinting|dna fingerprinting
5098778|NCT01219517|SNP|snp
5098779|NCT01219504|PGD|pgd
5098780|NCT01219504|IVF|ivf
5098781|NCT01219491|egg donor|egg donor
5098782|NCT01219491|recipients|recipients
5098783|NCT01219491|donor characteristics|donor characteristics
5098784|NCT01219478|To investigate the relationship between retinal thickness (RT) and metabolic risks (MRs) in patients without retinal lesion|to investigate the relationship between retinal thickness (rt) and metabolic risks (mrs) in patients without retinal lesion
5098785|NCT01219465|Diabetes Mellitus|diabetes mellitus
5098786|NCT01219465|Diabetes Mellitus, Type 1|diabetes mellitus, type 1
5098787|NCT01219465|mesenchymal stem cells|mesenchymal stem cells
5098788|NCT01219465|Umbilical cord|umbilical cord
5098789|NCT01219452|Dilated Cardiomyopathy|dilated cardiomyopathy
5098790|NCT01219452|Umbilical cord|umbilical cord
5098791|NCT01219452|Mesenchymal stem cells|mesenchymal stem cells
5098792|NCT01219452|Children|children
5098793|NCT01219439|discarded pathological specimens|discarded pathological specimens
5098794|NCT01219439|discarded media|discarded media
5098795|NCT01219439|IVF|ivf
5098796|NCT01219426|Gambling|gambling
5098797|NCT01219426|cognitive distortions|cognitive distortions
5098798|NCT01219426|assessment tool|assessment tool
5098799|NCT01219426|validation|validation
5098800|NCT01219426|French|french
5098801|NCT01219413|aliskiren|aliskiren
5098802|NCT01219413|renin inhibitor|renin inhibitor
5098803|NCT01219413|proteinuria|proteinuria
5098804|NCT01219413|chronic kidney diseases|chronic kidney diseases
5098805|NCT01219413|ACE inhibitor|ace inhibitor
5098806|NCT01219400|DPP-4|dpp-4
5098807|NCT01219400|GLP-1|glp-1
5098808|NCT01219400|Glucagon|glucagon
5098809|NCT01219400|Catecholamines|catecholamines
5098810|NCT01219400|Counterregulation|counterregulation
5098811|NCT01219400|Insulin-treatment|insulin-treatment
5098812|NCT01219400|Type 2 diabetes|type 2 diabetes
5098813|NCT01219387|AMH|amh
5098814|NCT01219387|inhibin B|inhibin b
5098815|NCT01219387|infertility|infertility
5098816|NCT01219374|egg donor|egg donor
5098817|NCT01219361|Donated embryos|donated embryos
5098818|NCT01219348|IDO enzyme|ido enzyme
5098819|NCT01219348|Vaccination trial|vaccination trial
5098820|NCT01219348|Immunotherapy|immunotherapy
5098821|NCT01219348|NSCLC, stage III_IV|nsclc, stage iii_iv
5098822|NCT01219348|Indeolamine 2,3 dioxygenase = IDO|indeolamine 2,3 dioxygenase = ido
5098823|NCT01219335|IVF|ivf
5098824|NCT01219322|general endotracheal anesthesia|general endotracheal anesthesia
5098825|NCT01219322|ASA I or II|asa i or ii
5098826|NCT01219309|Attention-deficit/hyperactivity disorder|attention-deficit/hyperactivity disorder
5098827|NCT01219309|Omega 3/6 fatty acids|omega 3/6 fatty acids
5098828|NCT01219309|Developmental coordination disorder|developmental coordination disorder
5098829|NCT01219309|Reading/writing difficulties.|reading/writing difficulties.
5098830|NCT01219296|infertility|infertility
5098831|NCT01219296|IVF|ivf
5098832|NCT01219283|PGD|pgd
5098833|NCT01219283|IVF|ivf
5098834|NCT01219270|Radiocontrast media,|radiocontrast media,
5098835|NCT01219270|hyponatremia|hyponatremia
5098836|NCT01219257|SpA|spa
5098837|NCT01219257|Anti-TNF alpha treatment|anti-tnf alpha treatment
5098838|NCT01219257|Ultrasonography|ultrasonography
5098839|NCT01219257|Synovitis|synovitis
5098840|NCT01219257|Enthesitis|enthesitis
5098841|NCT01219244|memory|memory
5098842|NCT01219244|diet|diet
5098843|NCT01219244|elderly|elderly
5098844|NCT01219244|cognition|cognition
5098845|NCT01219244|prevention|prevention
5098846|NCT01219244|lifestyle|lifestyle
5098847|NCT01219231|Exercise|exercise
5098848|NCT01219231|elderly|elderly
5098849|NCT01219231|cognition|cognition
5098850|NCT01219231|prevention|prevention
5098851|NCT01219231|cognitive decline|cognitive decline
5098852|NCT01219231|Lifestyle|lifestyle
5098853|NCT01219218|Extracorporeal Shockwave Therapy|extracorporeal shockwave therapy
5098854|NCT01219218|Myocardial Ischemia|myocardial ischemia
5098855|NCT01219218|Refractory Angina|refractory angina
5098856|NCT01219205|macular edema secondary to retinal benous occlusion|macular edema secondary to retinal benous occlusion
5098857|NCT01219179|Extremely Low Birth Weight Infants|extremely low birth weight infants
5098858|NCT01219179|Hypernatremia|hypernatremia
5099649|NCT01215682|sport|sport
5098859|NCT01219179|Enteral Sterile Water Feeds|enteral sterile water feeds
5098860|NCT01219153|Letrozole ,IVF, poor responders , GnRH antagonist|letrozole ,ivf, poor responders , gnrh antagonist
5098861|NCT01219140|POMx|pomx
5098862|NCT01219140|Osteopenia|osteopenia
5098863|NCT01219140|postmenopausal women|postmenopausal women
5098864|NCT01219140|Pomegranate|pomegranate
5098865|NCT01219127|Hyperbaric oxygen therapy|hyperbaric oxygen therapy
5098866|NCT01219114|Daptomycin|daptomycin
5098867|NCT01219114|endocarditis|endocarditis
5098868|NCT01219114|complicated skin and skin structure infection|complicated skin and skin structure infection
5098869|NCT01219101|Ethinyl estradiol|ethinyl estradiol
5098870|NCT01219101|Polycystic ovary syndrome|polycystic ovary syndrome
5098871|NCT01219101|Intrauterine insemination|intrauterine insemination
5098872|NCT01219049|Diet|diet
5098873|NCT01219049|Fibromyalgia|fibromyalgia
5098874|NCT01219049|Pain|pain
5098875|NCT01219049|Drug|drug
5098876|NCT01219049|Amino-acid|amino-acid
5098877|NCT01219049|Fatigue|fatigue
5098878|NCT01219036|Asthma|asthma
5098879|NCT01219036|Non-adherence|non-adherence
5098880|NCT01219036|Fractional exhaled nitric oxide|fractional exhaled nitric oxide
5098881|NCT01219023|Hand foot syndrome|hand foot syndrome
5098882|NCT01219023|Palmar Plantar Erythrodysesthesia|palmar plantar erythrodysesthesia
5098883|NCT01219023|chemotherapy|chemotherapy
5098884|NCT01219023|Sunitinib|sunitinib
5098885|NCT01219023|Capecitebine|capecitebine
5098886|NCT01219023|Sildenafil|sildenafil
5098887|NCT01219010|Monoclonal Gammopathy of Undetermined Significance|monoclonal gammopathy of undetermined significance
5098888|NCT01219010|Smoldering Multiple Myeloma|smoldering multiple myeloma
5098889|NCT01219010|Indolent Multiple Myeloma|indolent multiple myeloma
5098890|NCT01219010|QT|qt
5098891|NCT01219010|Siltuximab|siltuximab
5098892|NCT01219010|CNTO 328|cnto 328
5098893|NCT01219010|IL-6|il-6
5098894|NCT01219010|Monoclonal Antibody|monoclonal antibody
5098895|NCT01218997|Alcoholism|alcoholism
5098896|NCT01218997|Alcohol dependence|alcohol dependence
5098897|NCT01218984|Opiate Dependence|opiate dependence
5098898|NCT01218971|Alcohol Dependence|alcohol dependence
5098899|NCT01218958|Alcoholism|alcoholism
5098900|NCT01218932|primaquine|primaquine
5098901|NCT01218932|chloroquine|chloroquine
5098902|NCT01218932|pharmacokinetic|pharmacokinetic
5098903|NCT01218932|interactions|interactions
5098904|NCT01218906|Dengue Fever Fever Dengue Infection|dengue fever fever dengue infection
5098905|NCT01218867|Clinical Response|clinical response
5098906|NCT01218867|Metastatic Cancer|metastatic cancer
5098907|NCT01218867|Immunotherapy|immunotherapy
5098908|NCT01218867|Adoptive Cell Therapy|adoptive cell therapy
5098909|NCT01218867|Metastatic Melanoma|metastatic melanoma
5098910|NCT01218854|Biopsy|biopsy
5098911|NCT01218854|Surgical Navigation|surgical navigation
5098912|NCT01218854|Image-guided Therapy|image-guided therapy
5098913|NCT01218854|CT- Guided Biopsy|ct- guided biopsy
5098914|NCT01218854|Cancer|cancer
5098915|NCT01218841|Fish oil|fish oil
5098916|NCT01218841|Omega-3 fatty acids|omega-3 fatty acids
5098917|NCT01218841|Parenteral lipid emulsions|parenteral lipid emulsions
5098918|NCT01218841|Immune response|immune response
5098919|NCT01218841|Surgery|surgery
5098920|NCT01218828|Contrast|contrast
5098921|NCT01218828|nephropathy|nephropathy
5098922|NCT01218828|cardiac catheterization|cardiac catheterization
5098923|NCT01218828|angiography|angiography
5098924|NCT01218828|percutaneous coronary intervention is|percutaneous coronary intervention is
5098925|NCT01218802|HIV|hiv
5098926|NCT01218802|Heart Disease|heart disease
5098927|NCT01218802|Bone Density|bone density
5098928|NCT01218789|Blindness|blindness
5098929|NCT01218789|Eye Diseases|eye diseases
5098930|NCT01218789|Nap Disorders|nap disorders
5098931|NCT01218789|Circadian Rhythm Disorders|circadian rhythm disorders
5098932|NCT01218789|Sleep disorders|sleep disorders
5098933|NCT01218789|Circadian Rhythm Sleep Disorders|circadian rhythm sleep disorders
5098934|NCT01218789|Dyssomnias|dyssomnias
5098935|NCT01218789|Nervous System Diseases|nervous system diseases
5098936|NCT01218776|Acute Coronary Syndrome, Eastern Europe, Therapies|acute coronary syndrome, eastern europe, therapies
5098937|NCT01218763|Cardiac Event recorder|cardiac event recorder
5098938|NCT01218763|Sensitivity|sensitivity
5098939|NCT01218763|Efficacy|efficacy
5098940|NCT01218750|DDME, ppV, ILM peeling, bevacizumab injection|ddme, ppv, ilm peeling, bevacizumab injection
5098941|NCT01218685|Immunocompromised patients|immunocompromised patients
5098942|NCT01218685|Safety of pandemic influenza A (H1N1)vaccine|safety of pandemic influenza a (h1n1)vaccine
5098943|NCT01218685|Immunogenicity of pandemic influenza A (H1N1)vaccine|immunogenicity of pandemic influenza a (h1n1)vaccine
5098944|NCT01218672|BPH|bph
5098945|NCT01218672|Benign Prostatic Hyperplasia|benign prostatic hyperplasia
5098946|NCT01218659|Fabry Disease|fabry disease
5098947|NCT01218646|Influenza|influenza
5098948|NCT01218646|Quadrivalent Inactivated Influenza Vaccine|quadrivalent inactivated influenza vaccine
5098949|NCT01218646|Trivalent Inactivated Influenza Vaccine|trivalent inactivated influenza vaccine
5098950|NCT01218646|Influenza viruses|influenza viruses
5098951|NCT01218607|Heart Septal Defects, Atrial|heart septal defects, atrial
5098952|NCT01218607|Pulmonary Circulation|pulmonary circulation
5098953|NCT01218607|Ventricular Function, Right|ventricular function, right
5098954|NCT01218607|Echocardiography, Stress|echocardiography, stress
5098955|NCT01218607|Ergometry|ergometry
5098956|NCT01218607|Tissue Doppler Imaging|tissue doppler imaging
5098957|NCT01218594|Stage III|stage iii
5098958|NCT01218594|Unresectable|unresectable
5098959|NCT01218594|Non-small cell lung cancer|non-small cell lung cancer
5098960|NCT01218581|Adenomyosis, letrozole, GnRH-a|adenomyosis, letrozole, gnrh-a
5098961|NCT01218555|kidney cancer|kidney cancer
5098962|NCT01218555|adenoidcystic cancer|adenoidcystic cancer
5098963|NCT01218542|Secondary brain malignancies|secondary brain malignancies
5098964|NCT01218542|RapidArc|rapidarc
5098965|NCT01218542|Volumetric modulated arc therapy|volumetric modulated arc therapy
5098966|NCT01218529|Brain metastases from lung and breast tumors|brain metastases from lung and breast tumors
5098967|NCT01218490|surgery|surgery
5098968|NCT01218490|ovarian cancer|ovarian cancer
5098969|NCT01218490|lymphadectomy|lymphadectomy
5098970|NCT01218477|Leukemia|leukemia
5098971|NCT01218477|(Chronic Myeloid Leukemia-Chronic Phase and Advanced)|(chronic myeloid leukemia-chronic phase and advanced)
5098972|NCT01218464|Liver Failure|liver failure
5098973|NCT01218464|Mesenchymal Stem Cells|mesenchymal stem cells
5098974|NCT01218464|Model for End-Stage Liver Disease|model for end-stage liver disease
5098975|NCT01218464|Ascite|ascite
5098976|NCT01218464|Serum Albumin|serum albumin
5098977|NCT01218425|dopamine|dopamine
5098978|NCT01218425|EEG|eeg
5098979|NCT01218425|episodic memory|episodic memory
5098980|NCT01218425|contingent negative variation|contingent negative variation
5098981|NCT01218425|response preparation|response preparation
5098982|NCT01218425|levodopa|levodopa
5098983|NCT01218425|methylphenidate|methylphenidate
5098984|NCT01218412|Physical Activity|physical activity
5098985|NCT01218412|Motivational Interviewing|motivational interviewing
5098986|NCT01218412|Web-based|web-based
5098987|NCT01218412|Physician Referral|physician referral
5098988|NCT01218399|Asthma|asthma
5098989|NCT01218386|ICSI|icsi
5098990|NCT01218386|GnRH antagonists|gnrh antagonists
5098991|NCT01218386|planning|planning
5098992|NCT01218373|older people|older people
5098993|NCT01218373|living independently at home|living independently at home
5098994|NCT01218360|Crohn's disease|crohn's disease
5098995|NCT01218360|standard-of-care|standard-of-care
5098996|NCT01218360|Crohn Disease|crohn disease
5098997|NCT01218360|Active Crohn's Disease|active crohn's disease
5098998|NCT01218347|OATP1B1|oatp1b1
5098999|NCT01218347|rosuvastatin|rosuvastatin
5099000|NCT01218321|antiepileptic drugs|antiepileptic drugs
5099001|NCT01218321|mitochondria|mitochondria
5099002|NCT01218308|Influenza|influenza
5099003|NCT01218295|COPD|copd
5099004|NCT01218295|inspiratory muscles training|inspiratory muscles training
5099005|NCT01218282|COPD|copd
5099006|NCT01218282|home exercise training|home exercise training
5099007|NCT01218269|anastomoses|anastomoses
5099008|NCT01218256|diabetes mellitus|diabetes mellitus
5099009|NCT01218256|type 2 diabetes|type 2 diabetes
5099010|NCT01218256|T2DM|t2dm
5099011|NCT01218256|resistance training|resistance training
5099012|NCT01218256|hypertrophy training|hypertrophy training
5099013|NCT01218256|endurance training|endurance training
5099014|NCT01218243|Acupuncture|acupuncture
5099015|NCT01218243|Mild and moderate BPH|mild and moderate bph
5099016|NCT01218230|Pegaptanib, myopic CNVM, intravitreal anti-VEGF|pegaptanib, myopic cnvm, intravitreal anti-vegf
5099017|NCT01218217|TB|tb
5099018|NCT01218217|Tuberculosis|tuberculosis
5099019|NCT01218217|EBA|eba
5099020|NCT01218217|Pulmonary|pulmonary
5099021|NCT01218217|Early Bactericidal Activity|early bactericidal activity
5099022|NCT01218204|Pharmacodynamics|pharmacodynamics
5099023|NCT01218204|Lipids|lipids
5099024|NCT01218204|Dyslipidemia|dyslipidemia
5099025|NCT01218204|Safety|safety
5099026|NCT01218204|GSK1292263|gsk1292263
5099027|NCT01218204|Ezetimibe|ezetimibe
5099028|NCT01218204|Statin|statin
5099029|NCT01218204|Pharmacokinetics|pharmacokinetics
5099030|NCT01218204|Tolerability|tolerability
5099031|NCT01218204|Atorvastatin|atorvastatin
5099032|NCT01218191|subarachnoid hemorrhage|subarachnoid hemorrhage
5099033|NCT01218191|scintigraphy|scintigraphy
5099034|NCT01218191|neurocardiogenic injury|neurocardiogenic injury
5099035|NCT01218178|acute myocardial infarction|acute myocardial infarction
5099036|NCT01218178|acute kidney injury|acute kidney injury
5099037|NCT01218178|contrast induced nephropathy|contrast induced nephropathy
5099038|NCT01218178|primary PCI|primary pci
5099039|NCT01218178|sodium-bicarbonate|sodium-bicarbonate
5099040|NCT01218178|N-acetylcysteine|n-acetylcysteine
5099041|NCT01218165|Healthy Eldery People|healthy eldery people
5099043|NCT01218152|MPNST|mpnst
5099044|NCT01218152|plasma|plasma
5099045|NCT01218152|microarray CGH|microarray cgh
5099046|NCT01218139|neurofibroma|neurofibroma
5099047|NCT01218139|MPNST|mpnst
5099048|NCT01218139|array CGH|array cgh
5099049|NCT01218139|sequencing|sequencing
5099050|NCT01218113|Human Immunodeficiency Virus (HIV)-1|human immunodeficiency virus (hiv)-1
5099051|NCT01218113|safety|safety
5099052|NCT01218113|vaccine|vaccine
5099053|NCT01218113|immunogenicity|immunogenicity
5099054|NCT01218113|reactogenicity|reactogenicity
5099055|NCT01218113|HIV infection|hiv infection
5099056|NCT01218087|Positional Head Shape Deformity|positional head shape deformity
5099057|NCT01218074|bleeding|bleeding
5099058|NCT01218074|blood sparing procedure|blood sparing procedure
5099059|NCT01218074|desmopressin|desmopressin
5099060|NCT01218074|aggregometry|aggregometry
5099061|NCT01218074|thromboelastography|thromboelastography
5099062|NCT01218061|Pre-diabetes|pre-diabetes
5099063|NCT01218061|Type 2 diabetes|type 2 diabetes
5099064|NCT01218061|Biomarkers|biomarkers
5099065|NCT01218061|Cohort|cohort
5099066|NCT01218061|Diabetes Risk Score|diabetes risk score
5099067|NCT01218048|Carcinoma|carcinoma
5099068|NCT01218048|Head and Neck|head and neck
5099069|NCT01218048|Cetuximab|cetuximab
5099070|NCT01218048|Locally Advanced Head and Neck Squamous Cell Carcinoma|locally advanced head and neck squamous cell carcinoma
5099071|NCT01218035|Hip osteoarthritis|hip osteoarthritis
5099072|NCT01218035|Bisphophonate therapy|bisphophonate therapy
5099073|NCT01218035|Zoledronic acid|zoledronic acid
5099074|NCT01218035|Radiostereometric analysis|radiostereometric analysis
5099075|NCT01218035|Osteoporosis|osteoporosis
5099076|NCT01218009|asthma|asthma
5099077|NCT01218009|dry powder inhaler|dry powder inhaler
5099078|NCT01218009|short-acting beta2-agonist|short-acting beta2-agonist
5099079|NCT01218009|SABA|saba
5099080|NCT01218009|bronchoconstriction|bronchoconstriction
5099081|NCT01218009|bronchodilation|bronchodilation
5099082|NCT01218009|bronchodilator|bronchodilator
5099083|NCT01218009|metered dose inhaler|metered dose inhaler
5099084|NCT01217996|working memory intervention|working memory intervention
5099085|NCT01217996|memory impairment|memory impairment
5099086|NCT01217996|cognitive late effects|cognitive late effects
5099087|NCT01217996|Childhood Cancer Survivors|childhood cancer survivors
5099088|NCT01217970|methamphetamine|methamphetamine
5099089|NCT01217970|dependence|dependence
5099090|NCT01217970|stimulant|stimulant
5099091|NCT01217970|amphetamine|amphetamine
5099092|NCT01217970|los angeles|los angeles
5099093|NCT01217970|meth|meth
5099094|NCT01217970|speed|speed
5099095|NCT01217970|crank|crank
5099096|NCT01217970|abuse|abuse
5099097|NCT01217957|Drug therapy|drug therapy
5099098|NCT01217944|Pathologic myopia|pathologic myopia
5099099|NCT01217944|PM|pm
5099100|NCT01217944|choroidal neovascularization|choroidal neovascularization
5099101|NCT01217944|CNV|cnv
5099102|NCT01217944|ranibizumab|ranibizumab
5099103|NCT01217944|verteporfin PDT|verteporfin pdt
5099104|NCT01217931|Renal Cell Carcinoma|renal cell carcinoma
5099105|NCT01217931|Metastatic Renal Cell Carcinoma|metastatic renal cell carcinoma
5099106|NCT01217931|Clear cell component|clear cell component
5099107|NCT01217931|RCC|rcc
5099108|NCT01217931|Bevacizumab|bevacizumab
5099109|NCT01217931|Everolimus|everolimus
5099110|NCT01217931|Pazopanib|pazopanib
5099111|NCT01217931|GW786034|gw786034
5099112|NCT01217931|Avastin|avastin
5099113|NCT01217931|Anti-VEGF monoclonal antibody|anti-vegf monoclonal antibody
5099114|NCT01217931|rhuMAb-VEGF|rhumab-vegf
5099115|NCT01217931|Afinitor|afinitor
5099116|NCT01217931|RAD001|rad001
5099117|NCT01217918|PH-797804|ph-797804
5099118|NCT01217918|Japanese|japanese
5099119|NCT01217918|Phase 1|phase 1
5099120|NCT01217918|multiple dose study|multiple dose study
5099121|NCT01217905|Phase 1|phase 1
5099122|NCT01217905|Type 2 diabetes|type 2 diabetes
5099123|NCT01217905|obesity|obesity
5099124|NCT01217905|Japanese healthy volunteer|japanese healthy volunteer
5099125|NCT01217905|AZD7687|azd7687
5099126|NCT01217892|Type 2 diabetes|type 2 diabetes
5099127|NCT01217892|metformin treated|metformin treated
5099128|NCT01217892|inadequate control|inadequate control
5099129|NCT01217892|metformin treatment alone|metformin treatment alone
5099130|NCT01217879|Cough|cough
5099131|NCT01217879|Telmisartan|telmisartan
5099132|NCT01217879|Bradykinin|bradykinin
5099133|NCT01217879|Tolerability|tolerability
5099134|NCT01217866|laparoscopic|laparoscopic
5099135|NCT01217866|vaginal|vaginal
5099136|NCT01217866|hysterectomy|hysterectomy
5099137|NCT01217840|Adolescents, Vitamin D|adolescents, vitamin d
5099138|NCT01217788|Generalized Social Phobia|generalized social phobia
5099139|NCT01217788|Social Anxiety Disorder|social anxiety disorder
5099140|NCT01217788|Social Phobia|social phobia
5099141|NCT01217788|Phobic Disorders|phobic disorders
5099142|NCT01217788|Phobias|phobias
5099143|NCT01217775|PMDD, Premenstrual, Dysphoria, Mood Swings, Bloating.|pmdd, premenstrual, dysphoria, mood swings, bloating.
5099144|NCT01217762|Oraya|oraya
5099145|NCT01217762|Oraya Therapeutics, Inc.|oraya therapeutics, inc.
5099146|NCT01217762|low voltage stereotactic radiosurgery|low voltage stereotactic radiosurgery
5099147|NCT01217762|radiosurgery|radiosurgery
5099148|NCT01217762|radiotherapy|radiotherapy
5099149|NCT01217762|IRay|iray
5099150|NCT01217762|AMD|amd
5099151|NCT01217762|Macular Degeneration|macular degeneration
5099152|NCT01217762|Wet AMD|wet amd
5099153|NCT01217762|xray|xray
5099154|NCT01217762|radiation|radiation
5099155|NCT01217762|x ray|x ray
5099156|NCT01217762|external beam radiation|external beam radiation
5099157|NCT01217762|Ranibizumab|ranibizumab
5099158|NCT01217762|Lucentis|lucentis
5099159|NCT01217723|Acute leukemia (myeloid,lymphoid,or biphenotypic)|acute leukemia (myeloid,lymphoid,or biphenotypic)
5099160|NCT01217723|Chronic myeloid leukemia|chronic myeloid leukemia
5099161|NCT01217723|Chronic lymphocytic leukemia|chronic lymphocytic leukemia
5099162|NCT01217723|Lymphoma|lymphoma
5099163|NCT01217723|Myelodysplastic syndrome|myelodysplastic syndrome
5099164|NCT01217723|Myeloproliferative disorder|myeloproliferative disorder
5099165|NCT01217710|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5099166|NCT01217710|Physical Activity|physical activity
5099167|NCT01217710|Self Management|self management
5099168|NCT01217710|Exercise|exercise
5099169|NCT01217710|Technology|technology
5099170|NCT01217710|Motivational Interviewing|motivational interviewing
5099171|NCT01217697|Metastatic Castration-Resistant Prostate Cancer (CRPC)|metastatic castration-resistant prostate cancer (crpc)
5099172|NCT01217697|Abiraterone Acetate|abiraterone acetate
5099173|NCT01217671|Pulmonary, Emphysema|pulmonary, emphysema
5099174|NCT01217671|Alpha-1 Antitrypsin Deficiency|alpha-1 antitrypsin deficiency
5099175|NCT01217658|Randomized Trial|randomized trial
5099176|NCT01217658|Infant Colic|infant colic
5099177|NCT01217658|Abusive Head Trauma|abusive head trauma
5099178|NCT01217658|Shaken Baby Syndrome|shaken baby syndrome
5099179|NCT01217645|Major depression disorder|major depression disorder
5099180|NCT01217632|Connective tissue growth factor (CTGF)|connective tissue growth factor (ctgf)
5099181|NCT01217632|human IgG1 monoclonal antibody|human igg1 monoclonal antibody
5099182|NCT01217619|neoadjuvant treatment|neoadjuvant treatment
5099183|NCT01217593|mastectomy|mastectomy
5099184|NCT01217593|breast cancer|breast cancer
5099185|NCT01217593|breast surgery|breast surgery
5099186|NCT01217580|c-section|c-section
5099187|NCT01217580|cesarean section|cesarean section
5099188|NCT01217580|TAP block|tap block
5099189|NCT01217580|pain|pain
5099190|NCT01217580|pain after delivery|pain after delivery
5099191|NCT01217580|pain after C-section|pain after c-section
5099192|NCT01217580|pain after C-section delivery|pain after c-section delivery
5099193|NCT01217580|pain after cesarean delivery|pain after cesarean delivery
5099194|NCT01217580|pain after cesarean|pain after cesarean
5099195|NCT01217567|cicatrix|cicatrix
5099196|NCT01217567|cesarean section|cesarean section
5099197|NCT01217567|sutures|sutures
5099198|NCT01217567|surgical staples|surgical staples
5099199|NCT01217567|postoperative pain|postoperative pain
5099200|NCT01217567|Infection|infection
5099201|NCT01217554|Low Back Pain|low back pain
5099202|NCT01217554|Disability|disability
5099203|NCT01217554|Kinematic measures|kinematic measures
5099204|NCT01217541|Dementia|dementia
5099205|NCT01217541|BPSD|bpsd
5099206|NCT01217541|Quality of Life|quality of life
5099207|NCT01217541|Person-centred care|person-centred care
5099208|NCT01217541|Job satisfaction|job satisfaction
5099209|NCT01217541|Nursing home|nursing home
5099210|NCT01217541|Primary care|primary care
5099211|NCT01217528|ICD|icd
5099212|NCT01217528|CRTD|crtd
5099213|NCT01217528|Sudden cardiac death|sudden cardiac death
5099214|NCT01217528|Device settings|device settings
5099215|NCT01217528|Patients who received ICD/CRTD for primary prevention of sudden cardiac death|patients who received icd/crtd for primary prevention of sudden cardiac death
5099216|NCT01217502|Aged|aged
5099217|NCT01217502|Homes for the aged|homes for the aged
5099218|NCT01217502|Self management|self management
5099219|NCT01217502|Personal autonomy|personal autonomy
5099220|NCT01217502|Disease management|disease management
5099221|NCT01217502|Self efficacy|self efficacy
5099222|NCT01217502|Participation|participation
5099223|NCT01217489|breast|breast
5099224|NCT01217489|cancer|cancer
5099225|NCT01217489|diagnosis|diagnosis
5099226|NCT01217489|electrical|electrical
5099227|NCT01217489|non-invasive|non-invasive
5099228|NCT01217489|mammography|mammography
5099229|NCT01217476|Diabetic foot|diabetic foot
5099230|NCT01217476|Neuropathic|neuropathic
5099231|NCT01217476|Wound|wound
5099232|NCT01217476|Growth factor|growth factor
5099233|NCT01217463|Diabetic foot|diabetic foot
5099234|NCT01217463|Neuropathic|neuropathic
5099235|NCT01217463|Wound|wound
5099236|NCT01217463|Growth factor|growth factor
5099237|NCT01217424|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
5099238|NCT01217424|pain|pain
5099239|NCT01217424|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5099240|NCT01217398|ciliary body and choroid melanoma, medium/large size|ciliary body and choroid melanoma, medium/large size
5099241|NCT01217398|ciliary body and choroid melanoma, small size|ciliary body and choroid melanoma, small size
5099242|NCT01217398|iris melanoma|iris melanoma
5099243|NCT01217398|metastatic intraocular melanoma|metastatic intraocular melanoma
5099244|NCT01217398|stage IV intraocular melanoma|stage iv intraocular melanoma
5099245|NCT01217385|stage IIIA breast cancer|stage iiia breast cancer
5099246|NCT01217385|stage IIIB breast cancer|stage iiib breast cancer
5099247|NCT01217385|stage IIIC breast cancer|stage iiic breast cancer
5099248|NCT01217372|Recurrent idiopathic calcium oxalate nephrolithiasis.|recurrent idiopathic calcium oxalate nephrolithiasis.
5099249|NCT01217333|Telephones|telephones
5099250|NCT01217333|Community-Based Participatory Research|community-based participatory research
5099251|NCT01217333|Participation, Patient|participation, patient
5099252|NCT01217333|Rural health services|rural health services
5099253|NCT01217320|rheumatology|rheumatology
5099254|NCT01217320|creatine supplementation|creatine supplementation
5099255|NCT01217320|quality of life|quality of life
5099256|NCT01217320|strength|strength
5099257|NCT01217320|juvenile systemic lupus erythematosus|juvenile systemic lupus erythematosus
5099258|NCT01217320|juvenile dermatomyositis|juvenile dermatomyositis
5099259|NCT01217307|Metformin|metformin
5099260|NCT01217307|ST elevation myocardial infarction (STEMI)|st elevation myocardial infarction (stemi)
5099261|NCT01217307|Coronary artery disease|coronary artery disease
5099262|NCT01217307|Heart failure|heart failure
5099263|NCT01217307|Diabetes|diabetes
5099264|NCT01217294|anaesthetic techniques, regional|anaesthetic techniques, regional
5099265|NCT01217294|analgesia, post-operative|analgesia, post-operative
5099266|NCT01217294|fascia iliaca compartment block|fascia iliaca compartment block
5099267|NCT01217294|ultrasound guided|ultrasound guided
5099268|NCT01217294|surgery, orthopaedic|surgery, orthopaedic
5099269|NCT01217281|CKD, Renal, Chronic Kidney Disease, Periodontitis, Perio|ckd, renal, chronic kidney disease, periodontitis, perio
5099270|NCT01217255|Hemophilia|hemophilia
5099271|NCT01217255|Burden of Illness|burden of illness
5099272|NCT01217255|Pediatric|pediatric
5099273|NCT01217255|Quality of Life|quality of life
5099274|NCT01217255|Disability|disability
5099275|NCT01217255|Participation|participation
5099276|NCT01217242|cerebral palsy|cerebral palsy
5099277|NCT01217242|walking activity|walking activity
5099278|NCT01217242|physical activity|physical activity
5099279|NCT01217242|participation|participation
5099280|NCT01217242|activity performance|activity performance
5099281|NCT01217242|activity capacity|activity capacity
5099282|NCT01217229|Hodgkin Lymphoma|hodgkin lymphoma
5099283|NCT01217216|Breast Cancer|breast cancer
5099284|NCT01217216|Weight loss|weight loss
5099285|NCT01217216|Group Intervention|group intervention
5099286|NCT01217216|Telephone Intervention|telephone intervention
5099287|NCT01217177|Cervical cancer,|cervical cancer,
5099288|NCT01217177|radiotherapy,|radiotherapy,
5099289|NCT01217177|chemotherapy,|chemotherapy,
5099290|NCT01217177|rad001,|rad001,
5099291|NCT01217177|everolimus|everolimus
5099292|NCT01217164|nutrition|nutrition
5099293|NCT01217164|very low birth weight|very low birth weight
5099294|NCT01217164|premature|premature
5099295|NCT01217151|Hemodynamic Monitoring|hemodynamic monitoring
5099296|NCT01217151|Goal-Directed Therapy|goal-directed therapy
5099297|NCT01217138|Anaphylaxis, autoinjector, design, epinephrine|anaphylaxis, autoinjector, design, epinephrine
5099298|NCT01217125|tuberousclerosis, angiomyolipoma, rapamycin|tuberousclerosis, angiomyolipoma, rapamycin
5099299|NCT01217112|Dyslipidemias|dyslipidemias
5099300|NCT01217112|Diabetes|diabetes
5099301|NCT01217112|Liver Fat|liver fat
5099302|NCT01217112|Body Fat|body fat
5099303|NCT01217099|refractory mycoplasma pneumoniae pneumonia|refractory mycoplasma pneumoniae pneumonia
5099304|NCT01217060|Adenocarcinoma|adenocarcinoma
5099305|NCT01217060|Squamous cell carcinoma|squamous cell carcinoma
5099306|NCT01217060|Thoracic esophagus|thoracic esophagus
5099307|NCT01217060|Gastroesophageal junction|gastroesophageal junction
5099308|NCT01217060|Chemoradiotherapy|chemoradiotherapy
5099309|NCT01217060|Esophagectomy|esophagectomy
5099310|NCT01217060|5-Fluorouracil|5-fluorouracil
5099311|NCT01217060|Docetaxel|docetaxel
5099312|NCT01217060|Radiation|radiation
5099313|NCT01217060|Radiotherapy|radiotherapy
5099315|NCT01217060|IMRT|imrt
5099316|NCT01217060|Taxotere|taxotere
5099317|NCT01217060|Adrucil|adrucil
5099318|NCT01217060|Efudex|efudex
5099319|NCT01217060|Dexamethasone|dexamethasone
5099320|NCT01217060|Decadron|decadron
5099321|NCT01217047|Spinal cord injury|spinal cord injury
5099322|NCT01217047|Functional electrical stimulation|functional electrical stimulation
5099323|NCT01217047|Rehabilitation|rehabilitation
5099324|NCT01217047|Growth factors|growth factors
5099325|NCT01217047|Cytokines|cytokines
5099326|NCT01217034|Transcatheter arterial chemoembolization|transcatheter arterial chemoembolization
5099327|NCT01217034|TACE|tace
5099328|NCT01217034|sorafenib|sorafenib
5099329|NCT01217034|Time to untreatable progression|time to untreatable progression
5099330|NCT01217034|TTUP|ttup
5099331|NCT01217008|Spinal Cord Injury|spinal cord injury
5099332|NCT01217008|GRNOPC1|grnopc1
5099333|NCT01216995|Heart Attack|heart attack
5099334|NCT01216995|Regenerative Cells|regenerative cells
5099335|NCT01216995|Stem Cells|stem cells
5099336|NCT01216982|Mood Disorders|mood disorders
5099337|NCT01216982|Depression|depression
5099338|NCT01216982|Combat Disorders|combat disorders
5099339|NCT01216982|Stress Disorders|stress disorders
5099340|NCT01216982|Fatty Acids, Omega-3|fatty acids, omega-3
5099341|NCT01216982|Military Personnel|military personnel
5099342|NCT01216982|Docosahexaenoic Acids/*therapeutic use|docosahexaenoic acids/*therapeutic use
5099343|NCT01216982|Eicosapentaenoic Acid/*therapeutic use|eicosapentaenoic acid/*therapeutic use
5099344|NCT01216956|extended release nicotinic acid|extended release nicotinic acid
5099345|NCT01216956|non esterified fatty acid (NEFA)|non esterified fatty acid (nefa)
5099346|NCT01216956|insulin resistance|insulin resistance
5099347|NCT01216956|Cholesteryl ester transfer protein (CETP)|cholesteryl ester transfer protein (cetp)
5099348|NCT01216956|High density lipoprotein cholesterol|high density lipoprotein cholesterol
5099349|NCT01216891|Schizophrenia|schizophrenia
5099350|NCT01216891|Schizoaffective Disorder|schizoaffective disorder
5099351|NCT01216891|Schizophreniform Disorder|schizophreniform disorder
5099352|NCT01216891|Delusional Disorder|delusional disorder
5099353|NCT01216891|Psychosis|psychosis
5099354|NCT01216891|First episode|first episode
5099355|NCT01216865|Diabetic foot|diabetic foot
5099356|NCT01216865|critical limb ischemia|critical limb ischemia
5099357|NCT01216865|mesenchymal stem cells|mesenchymal stem cells
5099358|NCT01216865|umbilical cord|umbilical cord
5099359|NCT01216813|esophageal cancer|esophageal cancer
5099360|NCT01216813|gastric cancer|gastric cancer
5099361|NCT01216813|cervical cancer|cervical cancer
5099362|NCT01216813|fallopian tube cancer|fallopian tube cancer
5099363|NCT01216813|ovarian epithelial cancer|ovarian epithelial cancer
5099364|NCT01216813|ovarian germ cell tumor|ovarian germ cell tumor
5099365|NCT01216813|ovarian sarcoma|ovarian sarcoma
5099366|NCT01216813|ovarian stromal cancer|ovarian stromal cancer
5099367|NCT01216813|endometrial cancer|endometrial cancer
5099368|NCT01216813|uterine sarcoma|uterine sarcoma
5099369|NCT01216813|vaginal cancer|vaginal cancer
5099370|NCT01216813|vulvar cancer|vulvar cancer
5099371|NCT01216813|adenocarcinoma of the gastroesophageal junction|adenocarcinoma of the gastroesophageal junction
5099372|NCT01216800|ototoxicity|ototoxicity
5099373|NCT01216800|radiation toxicity|radiation toxicity
5099374|NCT01216800|stage I salivary gland cancer|stage i salivary gland cancer
5099375|NCT01216800|stage II salivary gland cancer|stage ii salivary gland cancer
5099376|NCT01216800|stage III salivary gland cancer|stage iii salivary gland cancer
5099377|NCT01216761|Bacteremia|bacteremia
5099378|NCT01216761|Blood culture|blood culture
5099379|NCT01216761|Contamination|contamination
5099380|NCT01216761|Antiseptic agents|antiseptic agents
5099381|NCT01216748|airway blood flow|airway blood flow
5099382|NCT01216748|albuterol|albuterol
5099383|NCT01216748|acidosis|acidosis
5099384|NCT01216748|alkalosis|alkalosis
5099385|NCT01216735|smokers|smokers
5099386|NCT01216735|inhaled corticosteroids|inhaled corticosteroids
5099387|NCT01216735|brachial flow|brachial flow
5099388|NCT01216735|airway blood flow|airway blood flow
5099389|NCT01216735|albuterol|albuterol
5099390|NCT01216735|spirometry|spirometry
5099391|NCT01216735|endothelial dysfunction|endothelial dysfunction
5099392|NCT01216722|Muscle Wasting|muscle wasting
5099393|NCT01216722|Strengthening|strengthening
5099394|NCT01216722|Liver Disease|liver disease
5099395|NCT01216722|Transplant|transplant
5099396|NCT01216709|Infant|infant
5099397|NCT01216709|Dietary Supplements|dietary supplements
5099398|NCT01216709|Food, Fortified|food, fortified
5099399|NCT01216709|Iron Absorption|iron absorption
5099400|NCT01216696|ipilimumab|ipilimumab
5099401|NCT01216696|melanoma|melanoma
5099402|NCT01216696|NY-ESO-1|ny-eso-1
5099403|NCT01216683|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
5099404|NCT01216683|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
5099405|NCT01216683|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
5099406|NCT01216683|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5099407|NCT01216683|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5099408|NCT01216683|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5099409|NCT01216683|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5099410|NCT01216683|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5099411|NCT01216683|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5099412|NCT01216683|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5099413|NCT01216683|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5099414|NCT01216683|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5099415|NCT01216670|Reveal® XT|reveal® xt
5099416|NCT01216670|Acute Heart Failure|acute heart failure
5099417|NCT01216670|Low Ejection Fraction|low ejection fraction
5099418|NCT01216670|Reveal® XT implanted|reveal® xt implanted
5099419|NCT01216657|melanoma|melanoma
5099420|NCT01216657|sunitinib|sunitinib
5099421|NCT01216644|gastric cancer|gastric cancer
5099422|NCT01216644|perioperative|perioperative
5099423|NCT01216644|FLOT|flot
5099424|NCT01216644|ECF|ecf
5099425|NCT01216644|pathological complete remission|pathological complete remission
5099426|NCT01216644|locally advanced resectable adenocarcinoma of the esophagogastric juction or the stomach|locally advanced resectable adenocarcinoma of the esophagogastric juction or the stomach
5099427|NCT01216631|seronegative|seronegative
5099428|NCT01216631|oligoarthritis|oligoarthritis
5099429|NCT01216631|infliximab|infliximab
5099430|NCT01216631|intraarticular|intraarticular
5099431|NCT01216618|MiniMed paradigm insulin pumps|minimed paradigm insulin pumps
5099432|NCT01216618|insulin Lispro|insulin lispro
5099433|NCT01216618|Insulin Asprt.|insulin asprt.
5099434|NCT01216592|COPD|copd
5099435|NCT01216592|Airway inflammation|airway inflammation
5099436|NCT01216592|Symptoms|symptoms
5099437|NCT01216592|Lung function|lung function
5099438|NCT01216592|Correlation|correlation
5099439|NCT01216553|Bronchiolitis|bronchiolitis
5099440|NCT01216553|Infants|infants
5099441|NCT01216553|Nebulized Inhalation|nebulized inhalation
5099442|NCT01216553|RSV|rsv
5099443|NCT01216553|Oxygen|oxygen
5099444|NCT01216540|vancomycin|vancomycin
5099445|NCT01216540|nephrotoxicity|nephrotoxicity
5099446|NCT01216540|length of stay|length of stay
5099447|NCT01216540|costs|costs
5099448|NCT01216527|Stage IIB or III squamous cell esophageal carcinoma.|stage iib or iii squamous cell esophageal carcinoma.
5099449|NCT01216514|chronic inflammatory bowel diseases|chronic inflammatory bowel diseases
5099450|NCT01216514|crohn disease|crohn disease
5099451|NCT01216514|hemorrhagic rectocolitis|hemorrhagic rectocolitis
5099452|NCT01216514|immunological markers|immunological markers
5099453|NCT01216514|serological markers|serological markers
5099454|NCT01216514|ANCA|anca
5099455|NCT01216514|ASCA|asca
5099456|NCT01216488|Forearm surgery|forearm surgery
5099457|NCT01216488|Hand surgery|hand surgery
5099458|NCT01216488|Anesthesia|anesthesia
5099459|NCT01216462|Acute Coronary Syndrome|acute coronary syndrome
5099460|NCT01216449|Citalopram|citalopram
5099461|NCT01216449|Functional Magnetic Resonance Imaging|functional magnetic resonance imaging
5099462|NCT01216449|fMRI|fmri
5099463|NCT01216449|Pharmacokinetics|pharmacokinetics
5099464|NCT01216449|Pharmacodynamics|pharmacodynamics
5099465|NCT01216449|Amygdala|amygdala
5099466|NCT01216449|Elderly|elderly
5099467|NCT01216436|melanoma|melanoma
5099468|NCT01216436|immunotherapy|immunotherapy
5099469|NCT01216436|dendritic cell|dendritic cell
5099470|NCT01216436|GITR-ligand|gitr-ligand
5099471|NCT01216436|CTLA-4|ctla-4
5099472|NCT01216423|Patent Foramen Ovale|patent foramen ovale
5099473|NCT01216423|Pulmonary embolism|pulmonary embolism
5099474|NCT01216423|Stroke|stroke
5099475|NCT01216410|Nausea|nausea
5099476|NCT01216410|Vomiting|vomiting
5099477|NCT01216371|carcinoma|carcinoma
5099478|NCT01216371|metastases|metastases
5099479|NCT01216371|renal|renal
5099480|NCT01216371|lung|lung
5099481|NCT01216358|Headache|headache
5099482|NCT01216358|Contraception|contraception
5099483|NCT01216319|Biodesign|biodesign
5099484|NCT01216319|Nipple Reconstruction|nipple reconstruction
5099485|NCT01216319|Breast Cancer|breast cancer
5099486|NCT01216319|Mastectomy|mastectomy
5099487|NCT01216306|Obesity|obesity
5099488|NCT01216306|Physical Activity|physical activity
5099489|NCT01216306|Sedentary Activity|sedentary activity
5099490|NCT01216306|Television viewing|television viewing
5099491|NCT01216306|Latino|latino
5099492|NCT01216306|Hispanic|hispanic
5099493|NCT01216306|Preschool|preschool
5099494|NCT01216306|School|school
5099495|NCT01216306|Head Start|head start
5099496|NCT01216293|Drug Therapy|drug therapy
5099497|NCT01216280|Natura-alpha|natura-alpha
5099498|NCT01216280|ulcerative colitis|ulcerative colitis
5099499|NCT01216280|cytokines|cytokines
5099500|NCT01216280|Th1|th1
5099501|NCT01216280|Th17|th17
5099502|NCT01216267|chromogranin A|chromogranin a
5099503|NCT01216267|neuroendocrine|neuroendocrine
5099504|NCT01216267|carcinoid|carcinoid
5099505|NCT01216267|Proton Pump Inhibitor|proton pump inhibitor
5099506|NCT01216254|breast cancer|breast cancer
5099507|NCT01216254|stage 2|stage 2
5099508|NCT01216254|breast conserving therapy|breast conserving therapy
5099509|NCT01216254|sentinel lymph node dissection|sentinel lymph node dissection
5099510|NCT01216254|high frequency electrocoagulation|high frequency electrocoagulation
5099511|NCT01216202|Rectal cancer|rectal cancer
5099512|NCT01216202|Preoperative radiotherapy|preoperative radiotherapy
5099513|NCT01216202|Pelvic surgery|pelvic surgery
5099514|NCT01216202|Sexual function|sexual function
5099515|NCT01216202|Wellbeing|wellbeing
5099516|NCT01216202|Hormone levels|hormone levels
5099517|NCT01216202|Spermatogenesis|spermatogenesis
5099518|NCT01216189|Rectal cancer|rectal cancer
5099519|NCT01216189|Preoperative radiotherapy|preoperative radiotherapy
5099520|NCT01216189|Pelvic surgery|pelvic surgery
5099521|NCT01216189|Sexual function|sexual function
5099522|NCT01216189|Wellbeing|wellbeing
5099523|NCT01216189|Hormone levels|hormone levels
5099524|NCT01216176|Breast Cancer|breast cancer
5099525|NCT01216176|Postmenopausal|postmenopausal
5099526|NCT01216176|Metastatic Phase I ONLY|metastatic phase i only
5099527|NCT01216176|AZD0530|azd0530
5099528|NCT01216176|Anastrozole|anastrozole
5099529|NCT01216176|Phase I for metastatic disease|phase i for metastatic disease
5099530|NCT01216176|Phase II for newly diagnosed breast cancer|phase ii for newly diagnosed breast cancer
5099531|NCT01216176|Pharmacokinetic|pharmacokinetic
5099533|NCT01216176|Hormone Receptor|hormone receptor
5099534|NCT01216176|Estrogen Receptor|estrogen receptor
5099535|NCT01216176|Progesterone Receptor|progesterone receptor
5099536|NCT01216176|ER+|er+
5099537|NCT01216176|PR+|pr+
5099538|NCT01216176|HER negative|her negative
5099539|NCT01216176|Aromatase Inhibitors|aromatase inhibitors
5099540|NCT01216163|Pain following third molar extraction (wisdom tooth)|pain following third molar extraction (wisdom tooth)
5099541|NCT01216150|antifibrinolytic drug|antifibrinolytic drug
5099542|NCT01216150|coronary surgery|coronary surgery
5099543|NCT01216150|hemorrhage|hemorrhage
5099544|NCT01216150|aspirin|aspirin
5099545|NCT01216150|clopidogrel|clopidogrel
5099650|NCT01215682|children|children
5099546|NCT01216137|Multiple Sclerosis|multiple sclerosis
5099547|NCT01216137|Fatigue|fatigue
5099548|NCT01216137|Balance|balance
5099549|NCT01216137|Upright Postural Control|upright postural control
5099550|NCT01216137|Dizziness|dizziness
5099551|NCT01216124|triple negative local advanced breast cancer(TNLABC),neoadjuvant chemotherapy|triple negative local advanced breast cancer(tnlabc),neoadjuvant chemotherapy
5099552|NCT01216111|triple negative breast cancer，local recurrence,distant metastasis|triple negative breast cancer，local recurrence,distant metastasis
5099553|NCT01216098|Intrapartum|intrapartum
5099554|NCT01216098|Clinical trial|clinical trial
5099555|NCT01216098|Perinatal|perinatal
5099556|NCT01216098|Doula|doula
5099557|NCT01216098|VBAC|vbac
5099558|NCT01216098|Perinatal Outcomes|perinatal outcomes
5099559|NCT01216072|Relapsing Forms of Multiple Sclerosis|relapsing forms of multiple sclerosis
5099560|NCT01216072|Disease Modifying Therapy|disease modifying therapy
5099561|NCT01216072|fingolimod|fingolimod
5099562|NCT01216072|Patient Reported Outcomes|patient reported outcomes
5099563|NCT01216059|adherence|adherence
5099564|NCT01216059|text message|text message
5099565|NCT01216059|reminder|reminder
5099566|NCT01216059|adolescents|adolescents
5099567|NCT01216033|Breast cancer|breast cancer
5099568|NCT01216033|Diagnostics|diagnostics
5099569|NCT01216033|HER2|her2
5099570|NCT01216033|Imaging|imaging
5099571|NCT01216033|Metastases|metastases
5099572|NCT01216033|SPECT|spect
5099573|NCT01216033|Imaging of metastases|imaging of metastases
5099574|NCT01216020|Head and Neck Cancer|head and neck cancer
5099575|NCT01216020|Radiotherapy|radiotherapy
5099576|NCT01216020|Cetuximab|cetuximab
5099577|NCT01216020|Cisplatin|cisplatin
5099578|NCT01216007|Plasma|plasma
5099579|NCT01216007|bupivacaine|bupivacaine
5099580|NCT01216007|concentration|concentration
5099581|NCT01216007|caudal|caudal
5099582|NCT01216007|epidural|epidural
5099583|NCT01216007|TIVA|tiva
5099584|NCT01216007|Inhalational|inhalational
5099585|NCT01216007|anesthesia|anesthesia
5099586|NCT01216007|Caudal epidural|caudal epidural
5099587|NCT01215981|influenza vaccine|influenza vaccine
5099588|NCT01215955|Type 2 Diabetes|type 2 diabetes
5099589|NCT01215955|Insulin|insulin
5099590|NCT01215955|Algorithms|algorithms
5099591|NCT01215955|Blood glucose levels|blood glucose levels
5099592|NCT01215942|Rheumatoid Arthritis|rheumatoid arthritis
5099593|NCT01215929|methamphetamine withdrawal|methamphetamine withdrawal
5099594|NCT01215929|mood|mood
5099595|NCT01215929|retention|retention
5099596|NCT01215929|sleep|sleep
5099597|NCT01215916|Solid tumors|solid tumors
5099598|NCT01215890|Crohn's disease|crohn's disease
5099599|NCT01215890|Low bone mineral density|low bone mineral density
5099600|NCT01215890|inflammatory bowel disease|inflammatory bowel disease
5099601|NCT01215890|bisphosphonate|bisphosphonate
5099602|NCT01215877|Bladder cancer|bladder cancer
5099603|NCT01215877|Previously treated patients|previously treated patients
5099604|NCT01215877|Tesetaxel|tesetaxel
5099605|NCT01215877|Oral taxane|oral taxane
5099606|NCT01215864|metastatic tumors|metastatic tumors
5099607|NCT01215864|refractory tumors|refractory tumors
5099608|NCT01215864|recurrent tumors|recurrent tumors
5099609|NCT01215851|Tuberculosis|tuberculosis
5099610|NCT01215851|EBA|eba
5099611|NCT01215851|TMC207|tmc207
5099612|NCT01215851|pretomanid|pretomanid
5099613|NCT01215851|Early Bactericidal Activity|early bactericidal activity
5099614|NCT01215851|Pulmonary Tuberculosis|pulmonary tuberculosis
5099615|NCT01215851|PA-824|pa-824
5099616|NCT01215851|bedaquiline|bedaquiline
5099617|NCT01215851|pyrazinamide|pyrazinamide
5099618|NCT01215851|moxifloxacin|moxifloxacin
5099619|NCT01215851|ethambutol|ethambutol
5099620|NCT01215851|rifafour|rifafour
5099621|NCT01215838|HCC|hcc
5099622|NCT01215838|hepatocellular carcinoma|hepatocellular carcinoma
5099623|NCT01215838|Eovist|eovist
5099624|NCT01215838|MR|mr
5099625|NCT01215838|MRI|mri
5099626|NCT01215838|magnetic resonance|magnetic resonance
5099627|NCT01215825|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
5099628|NCT01215825|systemic steroid|systemic steroid
5099629|NCT01215799|Hormone Refractory Prostate Cancer|hormone refractory prostate cancer
5099630|NCT01215799|HRPC|hrpc
5099631|NCT01215760|peripheral nerve injury|peripheral nerve injury
5099632|NCT01215760|sensory reeducation|sensory reeducation
5099633|NCT01215760|brain plasticity|brain plasticity
5099634|NCT01215760|training with a mirror|training with a mirror
5099635|NCT01215760|rehabilitation|rehabilitation
5099636|NCT01215747|Kiacta for AA amyloidosis|kiacta for aa amyloidosis
5099637|NCT01215721|Incontinence|incontinence
5099638|NCT01215721|Robotic Prostatectomy|robotic prostatectomy
5099639|NCT01215721|Prostate Cancer|prostate cancer
5099640|NCT01215708|Kidney calculi|kidney calculi
5099641|NCT01215708|Lithotripsy|lithotripsy
5099642|NCT01215708|Calcium channel blockers|calcium channel blockers
5099643|NCT01215708|Adrenergic alpha-antagonists.|adrenergic alpha-antagonists.
5099644|NCT01215695|Intubation, Endotracheal|intubation, endotracheal
5099645|NCT01215695|Endotracheal Intubation, adverse events|endotracheal intubation, adverse events
5099646|NCT01215682|infections|infections
5099647|NCT01215682|immune system|immune system
5099651|NCT01215669|Influenza|influenza
5099652|NCT01215669|Influenza Virus Vaccines|influenza virus vaccines
5099653|NCT01215669|Intradermal Injections|intradermal injections
5099654|NCT01215643|Chronic hepatitis C genotype 2|chronic hepatitis c genotype 2
5099655|NCT01215643|Chronic hepatitis C genotype 3|chronic hepatitis c genotype 3
5099656|NCT01215643|Cyclophilin inhibitor|cyclophilin inhibitor
5099658|NCT01215630|Exercise tests|exercise tests
5099659|NCT01215630|maximal oxygen uptake|maximal oxygen uptake
5099660|NCT01215630|VO2max|vo2max
5099661|NCT01215617|Randomized controlled study|randomized controlled study
5099662|NCT01215617|Exercise training|exercise training
5099663|NCT01215617|Lung function|lung function
5099664|NCT01215617|Heart function|heart function
5099665|NCT01215604|elderly patients|elderly patients
5099666|NCT01215604|acute infection|acute infection
5099667|NCT01215604|translation initiation factors|translation initiation factors
5099668|NCT01215604|eIF4E|eif4e
5099669|NCT01215604|eIF4G|eif4g
5099670|NCT01215591|Neonatal|neonatal
5099671|NCT01215591|Nasal CPAP|nasal cpap
5099672|NCT01215591|Randomized controlled trial|randomized controlled trial
5099673|NCT01215591|Weaning|weaning
5099674|NCT01215578|Neuroendocrine Tumors|neuroendocrine tumors
5099675|NCT01215578|Neuroectodermal Tumors|neuroectodermal tumors
5099676|NCT01215578|Neoplasms, Germ Cell and Embryonal|neoplasms, germ cell and embryonal
5099677|NCT01215578|Neoplasms by Histologic Type|neoplasms by histologic type
5099678|NCT01215578|Neoplasms|neoplasms
5099679|NCT01215578|Neoplasms, Glandular and Epithelial|neoplasms, glandular and epithelial
5099680|NCT01215578|Neoplasms, Nerve Tissue|neoplasms, nerve tissue
5099681|NCT01215578|Pancreatic Neoplasms|pancreatic neoplasms
5099682|NCT01215578|Digestive System Neoplasms|digestive system neoplasms
5099683|NCT01215578|Neoplasms by Site|neoplasms by site
5099684|NCT01215578|Endocrine Gland Neoplasms|endocrine gland neoplasms
5099685|NCT01215578|Adenoma, Islet Cell|adenoma, islet cell
5099686|NCT01215578|Adenocarcinoma|adenocarcinoma
5099687|NCT01215578|Carcinoma|carcinoma
5099688|NCT01215578|Adenoma|adenoma
5099689|NCT01215578|Digestive System Diseases|digestive system diseases
5099690|NCT01215578|Pancreatic Diseases|pancreatic diseases
5099691|NCT01215578|Endocrine System Diseases|endocrine system diseases
5099692|NCT01215578|Sunitinib|sunitinib
5099693|NCT01215578|Antineoplastic Agents|antineoplastic agents
5099694|NCT01215578|Therapeutic Uses|therapeutic uses
5099695|NCT01215578|Pharmacologic Actions|pharmacologic actions
5099696|NCT01215578|Angiogenesis Inhibitors|angiogenesis inhibitors
5099697|NCT01215578|Angiogenesis Modulating Agents|angiogenesis modulating agents
5099698|NCT01215578|Growth Substances|growth substances
5099699|NCT01215578|Physiological Effects of Drugs|physiological effects of drugs
5099700|NCT01215578|Growth Inhibitors|growth inhibitors
5099701|NCT01215565|Carcinoma, Hepatocellular|carcinoma, hepatocellular
5099702|NCT01215565|Carcinoma|carcinoma
5099703|NCT01215565|Fibrosis|fibrosis
5099704|NCT01215565|Liver Neoplasms|liver neoplasms
5099705|NCT01215565|Pathologic Processes|pathologic processes
5099706|NCT01215565|Digestive System Neoplasms|digestive system neoplasms
5099707|NCT01215565|Neoplasms by Site|neoplasms by site
5099708|NCT01215565|Neoplasms|neoplasms
5099709|NCT01215565|Liver Diseases|liver diseases
5099710|NCT01215565|Adenocarcinoma|adenocarcinoma
5099711|NCT01215565|Neoplasms, Glandular and Epithelial|neoplasms, glandular and epithelial
5099712|NCT01215565|Neoplasms by Histologic Type|neoplasms by histologic type
5099713|NCT01215565|Sunitinib|sunitinib
5099714|NCT01215565|Antineoplastic Agents|antineoplastic agents
5099715|NCT01215565|Therapeutic Uses|therapeutic uses
5099716|NCT01215565|Pharmacologic Actions|pharmacologic actions
5099717|NCT01215565|Angiogenesis Inhibitors|angiogenesis inhibitors
5099718|NCT01215565|Angiogenesis Modulating Agents|angiogenesis modulating agents
5099719|NCT01215565|Growth Substances|growth substances
5099720|NCT01215565|Physiological Effects of Drugs|physiological effects of drugs
5099721|NCT01215565|Growth Inhibitors|growth inhibitors
5099722|NCT01215500|solid tumor cancer|solid tumor cancer
5099723|NCT01215500|epithelial carcinoma|epithelial carcinoma
5099724|NCT01215487|CML Predictive Study|cml predictive study
5099725|NCT01215461|Neonatal mortality|neonatal mortality
5099726|NCT01215461|Preterm birth|preterm birth
5099727|NCT01215461|Low gestational age|low gestational age
5099728|NCT01215461|VLBW|vlbw
5099729|NCT01215448|Fatigue|fatigue
5099730|NCT01215448|Quality of life|quality of life
5099731|NCT01215448|Lifestyle|lifestyle
5099732|NCT01215448|Complementary medicine|complementary medicine
5099733|NCT01215422|Surgical procedures|surgical procedures
5099734|NCT01215422|Intubation|intubation
5099735|NCT01215422|Anesthesiologist|anesthesiologist
5099736|NCT01215422|Laryngoscope|laryngoscope
5099737|NCT01215422|Videolaryngoscope|videolaryngoscope
5099738|NCT01215409|Levitra|levitra
5099739|NCT01215409|Erectile dysfunction|erectile dysfunction
5099740|NCT01215409|Taiwan|taiwan
5099741|NCT01215396|Branched Chain Amino Acids|branched chain amino acids
5099742|NCT01215396|Mental Performance|mental performance
5099743|NCT01215396|Muscular Performance|muscular performance
5099744|NCT01215396|Central Fatigue Theory|central fatigue theory
5099745|NCT01215383|HDL|hdl
5099746|NCT01215383|psychiatric patients|psychiatric patients
5099939|NCT01214356|diabetes|diabetes
5099747|NCT01215383|psychiatric patients before and during antipsychotic therapy|psychiatric patients before and during antipsychotic therapy
5099748|NCT01215357|Pathological Gambling|pathological gambling
5099749|NCT01215357|ecopipam|ecopipam
5099750|NCT01215357|Dopamine|dopamine
5099751|NCT01215331|Gestational Diabetes Mellitus|gestational diabetes mellitus
5099752|NCT01215331|Treatment|treatment
5099753|NCT01215331|Insulin|insulin
5099754|NCT01215331|Metformin|metformin
5099755|NCT01215331|Glyburide|glyburide
5099756|NCT01215305|Gastroesophageal Reflux Disease, extraesophageal symptoms|gastroesophageal reflux disease, extraesophageal symptoms
5099757|NCT01215292|testosterone|testosterone
5099758|NCT01215292|acyline|acyline
5099759|NCT01215292|ketoconazole|ketoconazole
5099760|NCT01215292|dutasteride|dutasteride
5099761|NCT01215292|anastrazole|anastrazole
5099762|NCT01215292|Intratesticular hormone concentration|intratesticular hormone concentration
5099763|NCT01215279|Respiratory disease|respiratory disease
5099764|NCT01215279|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5099765|NCT01215266|Bladder cancer|bladder cancer
5099766|NCT01215266|Chemotherapy|chemotherapy
5099767|NCT01215266|Urothelium cancer|urothelium cancer
5099768|NCT01215253|Sudden Death|sudden death
5099769|NCT01215253|Ranolazine|ranolazine
5099770|NCT01215253|Heart failure|heart failure
5099771|NCT01215253|Ventricular tachycardia|ventricular tachycardia
5099772|NCT01215253|Ventricular fibrillation|ventricular fibrillation
5099773|NCT01215253|Implantable cardioverter-defibrillator|implantable cardioverter-defibrillator
5099774|NCT01215214|metabolite profiles|metabolite profiles
5099775|NCT01215214|pharmacokinetics|pharmacokinetics
5099776|NCT01215214|CYP3A|cyp3a
5099777|NCT01215214|metabolomics|metabolomics
5099778|NCT01215201|Periodontal maintenance|periodontal maintenance
5099779|NCT01215201|≥5mm probing depth|≥5mm probing depth
5099780|NCT01215201|bleeding on probing and/or suppuration|bleeding on probing and/or suppuration
5099781|NCT01215188|Invasive pneumococcal disease|invasive pneumococcal disease
5099782|NCT01215188|Pneumonia|pneumonia
5099783|NCT01215188|Pneumococcal conjugate vaccine|pneumococcal conjugate vaccine
5099784|NCT01215175|Pneumococcal disease|pneumococcal disease
5099785|NCT01215149|HIV|hiv
5099786|NCT01215110|Bedaquiline|bedaquiline
5099787|NCT01215110|Sirturo|sirturo
5099788|NCT01215110|Early Bactericidal Activity|early bactericidal activity
5099789|NCT01215110|EBA|eba
5099790|NCT01215110|Pulmonary Tuberculosis|pulmonary tuberculosis
5099791|NCT01215110|TMC207|tmc207
5099792|NCT01215084|Human Volunteers|human volunteers
5099793|NCT01215071|Lymphadenectomy|lymphadenectomy
5099794|NCT01215071|Extension|extension
5099795|NCT01215071|Bladder cancer|bladder cancer
5099796|NCT01215058|Compliance, France|compliance, france
5099797|NCT01215058|Gastrointestinal bleeding ulcer or symptomatic ulcer with NSAID|gastrointestinal bleeding ulcer or symptomatic ulcer with nsaid
5099798|NCT01215045|AcrySof ReSTOR Aspheric +4|acrysof restor aspheric +4
5099799|NCT01215032|castration-resistant prostate cancer|castration-resistant prostate cancer
5099800|NCT01215032|insulin levels|insulin levels
5099801|NCT01215032|metformin|metformin
5099802|NCT01215019|traumatic brain injury|traumatic brain injury
5099803|NCT01214993|GSK1349572|gsk1349572
5099804|NCT01214993|para-aminohippurate|para-aminohippurate
5099805|NCT01214993|iohexol|iohexol
5099806|NCT01214980|Low-frequency ultrasound|low-frequency ultrasound
5099807|NCT01214980|Wound healing|wound healing
5099808|NCT01214980|Split thickness wound healing|split thickness wound healing
5099809|NCT01214980|Skin graft donor site healing|skin graft donor site healing
5099810|NCT01214967|risk factors for maternal depression|risk factors for maternal depression
5099811|NCT01214954|Total Hip Replacement|total hip replacement
5099812|NCT01214954|Rehabilitation|rehabilitation
5099813|NCT01214954|Resistance training|resistance training
5099814|NCT01214928|vitamin D|vitamin d
5099815|NCT01214928|cholecalciferol|cholecalciferol
5099816|NCT01214928|hemodialysis|hemodialysis
5099817|NCT01214928|randomized controlled trial|randomized controlled trial
5099818|NCT01214928|pilot|pilot
5099819|NCT01214889|Diphtheria|diphtheria
5099820|NCT01214889|Tetanus|tetanus
5099821|NCT01214889|Pertussis|pertussis
5099822|NCT01214889|Haemophilus influenzae type B|haemophilus influenzae type b
5099823|NCT01214889|Poliomyelitis|poliomyelitis
5099824|NCT01214889|PENTAXIM™|pentaxim™
5099825|NCT01214889|TETRAXIM™|tetraxim™
5099826|NCT01214863|Toric Intraocular Lens (IOL)|toric intraocular lens (iol)
5099827|NCT01214850|Meningococcal vaccines|meningococcal vaccines
5099828|NCT01214850|Meningococcal B|meningococcal b
5099829|NCT01214850|Meningococcal ACWY serogroups|meningococcal acwy serogroups
5099830|NCT01214837|Meningococcal|meningococcal
5099831|NCT01214837|ACWY|acwy
5099832|NCT01214837|Conjugate Vaccine|conjugate vaccine
5099833|NCT01214837|Meningitis|meningitis
5099834|NCT01214837|Infants|infants
5099835|NCT01214837|Persistence|persistence
5099836|NCT01214824|Diabetes|diabetes
5099837|NCT01214824|Continuous Glucose Monitoring|continuous glucose monitoring
5099838|NCT01214811|The change in signs of inflammation/local infection|the change in signs of inflammation/local infection
5099839|NCT01214811|To evaluate the comfort, conformability,|to evaluate the comfort, conformability,
5099840|NCT01214811|Pain during wear|pain during wear
5100426|NCT01212341|Lymphomas|lymphomas
5099841|NCT01214798|sesamoid displacement,|sesamoid displacement,
5099842|NCT01214798|metacarpophalangeal joint,|metacarpophalangeal joint,
5099843|NCT01214798|radial condylar ridge of the metacarpal head.|radial condylar ridge of the metacarpal head.
5099844|NCT01214772|pregnancy|pregnancy
5099845|NCT01214772|heparin|heparin
5099846|NCT01214772|fertilization|fertilization
5099847|NCT01214759|HIV|hiv
5099848|NCT01214759|prevention|prevention
5099849|NCT01214759|prophylaxis|prophylaxis
5099850|NCT01214759|Raltegravir|raltegravir
5099851|NCT01214759|Truvada|truvada
5099852|NCT01214746|Statin|statin
5099853|NCT01214746|L-NMMA|l-nmma
5099854|NCT01214746|Healthy subjects|healthy subjects
5099855|NCT01214746|Nephrology|nephrology
5099856|NCT01214707|Exercise/No active Treatment|exercise/no active treatment
5099857|NCT01214694|TBI|tbi
5099858|NCT01214694|intracranial edema|intracranial edema
5099859|NCT01214694|brain edema|brain edema
5099860|NCT01214694|craniocerebral trauma|craniocerebral trauma
5099861|NCT01214694|head injury|head injury
5099862|NCT01214694|brain hemorrhage, traumatic|brain hemorrhage, traumatic
5099863|NCT01214694|subdural hematoma|subdural hematoma
5099864|NCT01214694|brain concussion|brain concussion
5099865|NCT01214694|head injuries, closed|head injuries, closed
5099866|NCT01214694|epidural hematoma|epidural hematoma
5099867|NCT01214694|extra-axial hemorrhage|extra-axial hemorrhage
5099868|NCT01214694|cortical contusion|cortical contusion
5099869|NCT01214694|Additional relevant MeSH terms:|additional relevant mesh terms:
5099870|NCT01214694|Nervous System Diseases|nervous system diseases
5099871|NCT01214694|Wounds and Injuries|wounds and injuries
5099872|NCT01214694|Disorders of Environmental Origin|disorders of environmental origin
5099873|NCT01214694|Central Nervous System Diseases|central nervous system diseases
5099874|NCT01214694|Trauma, Nervous System|trauma, nervous system
5099875|NCT01214694|Brain Diseases|brain diseases
5099876|NCT01214694|Brain Injuries|brain injuries
5099877|NCT01214681|Biomarkers|biomarkers
5099878|NCT01214681|Colorectal cancer|colorectal cancer
5099879|NCT01214681|Resistant starch|resistant starch
5099880|NCT01214681|Polydextrose|polydextrose
5099881|NCT01214681|Non-digestible carbohydrate|non-digestible carbohydrate
5099882|NCT01214655|Acute Myelogenous Leukemia|acute myelogenous leukemia
5099883|NCT01214655|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
5099884|NCT01214655|Chronic Myelogenous Leukemia,Blast Crisis|chronic myelogenous leukemia,blast crisis
5099885|NCT01214642|Advanced Cancer|advanced cancer
5099886|NCT01214642|Cancer|cancer
5099887|NCT01214629|Advanced Cancer|advanced cancer
5099888|NCT01214629|Metastatic Cancer|metastatic cancer
5099889|NCT01214629|Cancer|cancer
5099890|NCT01214603|Acute Myelogenous Leukemia, Acute Myeloid Leukemia, Acute|acute myelogenous leukemia, acute myeloid leukemia, acute
5099891|NCT01214603|Leukemia, Leukemia|leukemia, leukemia
5099892|NCT01214577|PEP005|pep005
5099893|NCT01214577|Peplin|peplin
5099894|NCT01214577|Photo-damage|photo-damage
5099895|NCT01214564|PEP005|pep005
5099896|NCT01214564|Peplin|peplin
5099897|NCT01214564|Seborrhoeic Keratosis|seborrhoeic keratosis
5099898|NCT01214538|Vaccine pneumococcal natural history Acute otitis media|vaccine pneumococcal natural history acute otitis media
5099899|NCT01214525|Meatal stenosis|meatal stenosis
5099900|NCT01214525|Meatotomy|meatotomy
5099901|NCT01214525|Uroflow|uroflow
5099902|NCT01214525|Postvoid residual|postvoid residual
5099903|NCT01214499|Refractory angina|refractory angina
5099904|NCT01214499|Transmyocardial revascularization|transmyocardial revascularization
5099905|NCT01214499|Stem cells|stem cells
5099906|NCT01214499|Diffuse coronary disease not amenable to percutaneous coronary intervention, and angina, despite proper medical treatment|diffuse coronary disease not amenable to percutaneous coronary intervention, and angina, despite proper medical treatment
5099907|NCT01214486|HIV|hiv
5099908|NCT01214486|RAL|ral
5099909|NCT01214486|Raltegravir|raltegravir
5099910|NCT01214486|Isentress|isentress
5099911|NCT01214486|Pharmacokinetics|pharmacokinetics
5099912|NCT01214473|Clinical sepsis|clinical sepsis
5099913|NCT01214473|Pneumonia|pneumonia
5099914|NCT01214473|Diarrhea|diarrhea
5099915|NCT01214473|Probiotics|probiotics
5099916|NCT01214473|Synbiotics|synbiotics
5099917|NCT01214460|MET|met
5099918|NCT01214447|Hemodialysis|hemodialysis
5099919|NCT01214447|Inflammation|inflammation
5099920|NCT01214447|Malnutrition|malnutrition
5099921|NCT01214447|Phase Angle|phase angle
5099922|NCT01214434|Cradle Cap|cradle cap
5099923|NCT01214434|Infantile seborrheic Dermatitis|infantile seborrheic dermatitis
5099924|NCT01214421|Kidney Disease|kidney disease
5099925|NCT01214421|ADPKD|adpkd
5099926|NCT01214421|Autosomal Dominant Polycystic Kidney Disease|autosomal dominant polycystic kidney disease
5099927|NCT01214421|Adult Polycystic Kidney Disease|adult polycystic kidney disease
5099928|NCT01214395|haemodialysis|haemodialysis
5099929|NCT01214395|peritoneal dialysis|peritoneal dialysis
5099930|NCT01214382|Gastric Bypass|gastric bypass
5099931|NCT01214382|Bariatric Surgery|bariatric surgery
5099932|NCT01214382|Sertraline|sertraline
5099933|NCT01214382|Zoloft|zoloft
5099934|NCT01214382|Pharmacokinetic|pharmacokinetic
5099935|NCT01214369|intraosseous injection|intraosseous injection
5099936|NCT01214369|X-tip|x-tip
5099937|NCT01214369|PDL injection|pdl injection
5099938|NCT01214369|Supplementary Injection|supplementary injection
5099940|NCT01214356|kidney disease|kidney disease
5099941|NCT01214356|vitamin D|vitamin d
5099942|NCT01214343|sorafenib|sorafenib
5099943|NCT01214343|Hepatic intraarterial infusion chemotherapy|hepatic intraarterial infusion chemotherapy
5099944|NCT01214343|HAIC|haic
5099945|NCT01214343|Low dose FP|low dose fp
5099946|NCT01214343|cisplatin|cisplatin
5099947|NCT01214343|fluorouracil|fluorouracil
5099948|NCT01214330|cervical cancer|cervical cancer
5099949|NCT01214317|multiple sclerosis|multiple sclerosis
5099950|NCT01214317|mitoxantrone|mitoxantrone
5099951|NCT01214317|plasmapheresis|plasmapheresis
5099952|NCT01214317|induction therapy|induction therapy
5099953|NCT01214304|Colposcopy|colposcopy
5099954|NCT01214291|fractures|fractures
5099955|NCT01214291|prostate cancer|prostate cancer
5099956|NCT01214291|androgen deprivation therapy|androgen deprivation therapy
5099957|NCT01214278|bioavailability|bioavailability
5099958|NCT01214278|marine n-3 fatty acids|marine n-3 fatty acids
5099959|NCT01214278|EPA|epa
5099960|NCT01214278|DHA|dha
5099961|NCT01214252|Repair of patients' abdominal wall defects|repair of patients' abdominal wall defects
5099962|NCT01214187|idiopathic pulmonary fibrosis|idiopathic pulmonary fibrosis
5099963|NCT01214187|IPF|ipf
5099964|NCT01214187|pulmonary fibrosis|pulmonary fibrosis
5099965|NCT01214187|carbon monoxide|carbon monoxide
5099966|NCT01214174|cataract|cataract
5099967|NCT01214174|inflammation|inflammation
5099968|NCT01214161|IUD|iud
5099969|NCT01214161|Lidocaine gel|lidocaine gel
5099970|NCT01214135|Mental disorder|mental disorder
5099971|NCT01214135|antipsychotic treatment|antipsychotic treatment
5099972|NCT01214122|Phase 1|phase 1
5099973|NCT01214122|Drug-Drug interaction|drug-drug interaction
5099974|NCT01214122|warfarin|warfarin
5099975|NCT01214122|AZD9668|azd9668
5099976|NCT01214122|resulting from AZD9668 and Warfarin interaction|resulting from azd9668 and warfarin interaction
5099977|NCT01214122|pharmacokinetics|pharmacokinetics
5099978|NCT01214122|pharmacodynamics|pharmacodynamics
5099979|NCT01214096|Chronic Heart failure|chronic heart failure
5099980|NCT01214096|rhNRG-1|rhnrg-1
5099981|NCT01214096|MRI|mri
5099982|NCT01214083|N-acetylcysteine|n-acetylcysteine
5099983|NCT01214083|naltrexone|naltrexone
5099984|NCT01214070|Visual Perception|visual perception
5099985|NCT01214070|Vision, Ocular|vision, ocular
5099986|NCT01214070|Neuronal Plasticity|neuronal plasticity
5099987|NCT01214057|chronic rhinosinusitis|chronic rhinosinusitis
5099988|NCT01214057|endoscopic sinus surgery|endoscopic sinus surgery
5099989|NCT01214057|TIVA|tiva
5099990|NCT01214057|surgical field visualization|surgical field visualization
5099991|NCT01214031|Confocal laser endomicroscope|confocal laser endomicroscope
5099992|NCT01214031|Adenomatous polyps|adenomatous polyps
5099993|NCT01214031|Colonoscopy|colonoscopy
5099994|NCT01214005|nicotine|nicotine
5099995|NCT01214005|reinforcement|reinforcement
5099996|NCT01214005|craving|craving
5099997|NCT01214005|relapse|relapse
5099998|NCT01213966|Acute uncomplicated Plasmodium Falciparum malaria|acute uncomplicated plasmodium falciparum malaria
5099999|NCT01213966|Blood stage Plasmodium Vivax malaria|blood stage plasmodium vivax malaria
5100000|NCT01213953|Vertebral disc, mesenchymal stem cell.|vertebral disc, mesenchymal stem cell.
5100001|NCT01213914|Burns|burns
5100002|NCT01213914|Hemofiltration|hemofiltration
5100003|NCT01213914|Vasopressins|vasopressins
5100004|NCT01213914|Kidney Failure Acute|kidney failure acute
5100005|NCT01213914|Shock, Septic|shock, septic
5100006|NCT01213901|Insulin absorption|insulin absorption
5100007|NCT01213901|Insulin injection technique|insulin injection technique
5100008|NCT01213888|Diabetic retinopathy|diabetic retinopathy
5100009|NCT01213888|pan-retinal photocoagulation|pan-retinal photocoagulation
5100010|NCT01213888|macular edema|macular edema
5100011|NCT01213875|heart failure|heart failure
5100012|NCT01213875|nursing|nursing
5100013|NCT01213875|home based intervention|home based intervention
5100014|NCT01213875|cost|cost
5100015|NCT01213875|efficacy|efficacy
5100016|NCT01213862|Home Based education|home based education
5100017|NCT01213862|Knowledge of Disease|knowledge of disease
5100018|NCT01213862|Self-Care Skills|self-care skills
5100019|NCT01213862|Quality of Life|quality of life
5100020|NCT01213862|Heart Failure|heart failure
5100021|NCT01213862|Randomized Clinical Trial|randomized clinical trial
5100022|NCT01213836|Stable schizophrenia|stable schizophrenia
5100023|NCT01213836|cognitive functioning|cognitive functioning
5100024|NCT01213823|invasive candidiasis|invasive candidiasis
5100025|NCT01213823|candidemia|candidemia
5100026|NCT01213823|severe hepatic injury|severe hepatic injury
5100027|NCT01213823|echinocandins|echinocandins
5100028|NCT01213823|anidulafungin|anidulafungin
5100029|NCT01213823|caspofungin|caspofungin
5100030|NCT01213823|micafungin|micafungin
5100031|NCT01213810|HIV|hiv
5100032|NCT01213810|VZV (Varicella zoster Virus)|vzv (varicella zoster virus)
5100033|NCT01213810|vaccine|vaccine
5100034|NCT01213810|T cell|t cell
5100035|NCT01213810|immunogenicity|immunogenicity
5100036|NCT01213810|safety|safety
5100037|NCT01213797|Suicide|suicide
5100038|NCT01213771|Preoperative|preoperative
5100039|NCT01213771|Intervention|intervention
5100040|NCT01213771|Support|support
5100041|NCT01213771|Care|care
5100042|NCT01213758|liver function|liver function
5100043|NCT01213758|galactose|galactose
5100044|NCT01213758|18-F-deoxy-galactose|18-f-deoxy-galactose
5100045|NCT01213758|PET/CT|pet/ct
5100046|NCT01213758|stereotactic body radiation therapy|stereotactic body radiation therapy
5100047|NCT01213758|SBRT|sbrt
5100048|NCT01213745|lung|lung
5100049|NCT01213745|cancer|cancer
5100050|NCT01213745|quality of life|quality of life
5100051|NCT01213732|L19, antibody, monoclonal, tumor targeting, TNFa, ILP, melanoma|l19, antibody, monoclonal, tumor targeting, tnfa, ilp, melanoma
5100052|NCT01213719|betaine, creatine, strength|betaine, creatine, strength
5100053|NCT01213706|airway blood flow|airway blood flow
5100054|NCT01213706|albuterol|albuterol
5100055|NCT01213706|Whole Body Periodic Acceleration (WBPA)|whole body periodic acceleration (wbpa)
5100056|NCT01213706|Nitric Oxide|nitric oxide
5100057|NCT01213706|Endothelial Dysfunction|endothelial dysfunction
5100058|NCT01213693|COPD|copd
5100059|NCT01213693|Bacteria|bacteria
5100060|NCT01213693|Virus|virus
5100061|NCT01213693|Inhaled Corticosteroids|inhaled corticosteroids
5100062|NCT01213680|Inflammatory Bowel Disease, IBD|inflammatory bowel disease, ibd
5100063|NCT01213654|Lung cancer|lung cancer
5100064|NCT01213654|VATS Lobectomy|vats lobectomy
5100065|NCT01213641|Cryopyrin-associated periodic syndromes(CAPS)|cryopyrin-associated periodic syndromes(caps)
5100066|NCT01213641|CIAS1 protein|cias1 protein
5100067|NCT01213641|NLRP3 protein|nlrp3 protein
5100068|NCT01213641|human cryopyrin protein|human cryopyrin protein
5100069|NCT01213641|Familial Cold Autoinflammatory Syndrome(FCAS)|familial cold autoinflammatory syndrome(fcas)
5100070|NCT01213641|Muckle-Wells Syndrome(MWS)|muckle-wells syndrome(mws)
5100071|NCT01213641|Neonatal Onset Multisystem Inflammatory disease(NOMID)|neonatal onset multisystem inflammatory disease(nomid)
5100072|NCT01213641|NALP3|nalp3
5100073|NCT01213641|canakinumab|canakinumab
5100074|NCT01213641|Interleukin-1(IL-1)|interleukin-1(il-1)
5100075|NCT01213628|abdominal surgery|abdominal surgery
5100076|NCT01213628|hypothermia|hypothermia
5100077|NCT01213628|wound desiccation|wound desiccation
5100078|NCT01213628|warming|warming
5100079|NCT01213602|Trauma patients|trauma patients
5100080|NCT01213589|descending|descending
5100081|NCT01213589|thoracic|thoracic
5100082|NCT01213589|aortic|aortic
5100083|NCT01213589|dissection|dissection
5100084|NCT01213589|Valiant|valiant
5100085|NCT01213589|Medtronic|medtronic
5100086|NCT01213589|Type B|type b
5100087|NCT01213589|VIRTUE|virtue
5100088|NCT01213589|stent|stent
5100089|NCT01213576|Lymphatic filariasis|lymphatic filariasis
5100090|NCT01213576|microfilaria|microfilaria
5100091|NCT01213576|Albendazole|albendazole
5100092|NCT01213576|ivermectin|ivermectin
5100093|NCT01213576|human immunodeficiency|human immunodeficiency
5100094|NCT01213563|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
5100095|NCT01213537|Heart failure|heart failure
5100096|NCT01213524|nicotine|nicotine
5100097|NCT01213524|craving|craving
5100098|NCT01213524|dual-diagnosis|dual-diagnosis
5100099|NCT01213524|comorbidity|comorbidity
5100100|NCT01213511|coronary artery disease; coronary artery bypass grafting; cardiopulmonary bypass; minimal extracorporeal circulation|coronary artery disease; coronary artery bypass grafting; cardiopulmonary bypass; minimal extracorporeal circulation
5100101|NCT01213498|Nephrology|nephrology
5100102|NCT01213498|Atorvastatin|atorvastatin
5100103|NCT01213498|L-NMMA|l-nmma
5100104|NCT01213498|NO|no
5100105|NCT01213472|ASCI|asci
5100106|NCT01213472|melanoma|melanoma
5100107|NCT01213472|tumor antigen|tumor antigen
5100108|NCT01213472|unresectable|unresectable
5100109|NCT01213472|progressive|progressive
5100110|NCT01213472|NY-ESO-1|ny-eso-1
5100111|NCT01213472|adult|adult
5100112|NCT01213472|cancer-testis antigen|cancer-testis antigen
5100113|NCT01213472|Immunotherapy|immunotherapy
5100114|NCT01213459|Human papillomavirus|human papillomavirus
5100115|NCT01213446|Von Willebrand Disease|von willebrand disease
5100116|NCT01213420|Donor sites after wound closure|donor sites after wound closure
5100117|NCT01213407|Dendritic cell|dendritic cell
5100118|NCT01213407|Cancer vaccine|cancer vaccine
5100119|NCT01213407|Anti-tumor immune therapy|anti-tumor immune therapy
5100120|NCT01213407|Interleukine-12|interleukine-12
5100121|NCT01213407|Individualised autologous therapy|individualised autologous therapy
5100122|NCT01213407|Brain cancer|brain cancer
5100123|NCT01213407|Temozolomide|temozolomide
5100124|NCT01213407|Radiotherapy|radiotherapy
5100125|NCT01213407|Irradiation|irradiation
5100126|NCT01213407|High-grade glioma|high-grade glioma
5100127|NCT01213407|Advanced therapy medicinal product ATMP|advanced therapy medicinal product atmp
5100128|NCT01213407|Somatic cell therapy|somatic cell therapy
5100129|NCT01213407|Leukocyte apheresis|leukocyte apheresis
5100130|NCT01213407|Neurosurgery|neurosurgery
5100131|NCT01213407|Neurooncology|neurooncology
5100132|NCT01213407|Neurology|neurology
5100133|NCT01213407|Immunology|immunology
5100134|NCT01213407|Tumor immunology|tumor immunology
5100135|NCT01213407|Transfusion medicine|transfusion medicine
5100136|NCT01213407|Monocyte|monocyte
5100137|NCT01213407|Killer cell|killer cell
5100138|NCT01213407|Cytotoxic T-cell|cytotoxic t-cell
5100139|NCT01213407|Cytotoxic T-lymphocyte|cytotoxic t-lymphocyte
5100140|NCT01213394|Framingham score|framingham score
5100141|NCT01213394|kidney transplant|kidney transplant
5100142|NCT01213394|immunosuppression|immunosuppression
5100143|NCT01213394|cardiovascular disease|cardiovascular disease
5100144|NCT01213394|CellCept|cellcept
5100145|NCT01213394|mycophenolate mofetil|mycophenolate mofetil
5100146|NCT01213355|Randomized|randomized
5100147|NCT01213355|double-blind|double-blind
5100148|NCT01213355|placebo-controlled|placebo-controlled
5100149|NCT01213355|5-way crossover|5-way crossover
5100150|NCT01213355|single oral administrations of PF 05212377|single oral administrations of pf 05212377
5100151|NCT01213355|scopolamine induced deficits in healthy subjects|scopolamine induced deficits in healthy subjects
5100152|NCT01213342|dry eye disease|dry eye disease
5100153|NCT01213316|HIV|hiv
5100154|NCT01213316|antiretroviral|antiretroviral
5100155|NCT01213316|human immunodeficiency virus|human immunodeficiency virus
5100156|NCT01213316|Raltegravir|raltegravir
5100157|NCT01213316|Adults with HIV-1 infection|adults with hiv-1 infection
5100158|NCT01213303|cardiovascular risk|cardiovascular risk
5100159|NCT01213303|metabolic syndrome|metabolic syndrome
5100160|NCT01213303|fatty acids|fatty acids
5100161|NCT01213303|oxysterols|oxysterols
5100162|NCT01213303|antioxidants|antioxidants
5100163|NCT01213303|oxidative stress|oxidative stress
5100164|NCT01213290|Endoscopic ultrasound-guided fine-needle aspiration (EUS-FNA)|endoscopic ultrasound-guided fine-needle aspiration (eus-fna)
5100165|NCT01213290|Stylet|stylet
5100166|NCT01213277|Diabetes Mellitus|diabetes mellitus
5100167|NCT01213277|HbA1c|hba1c
5100168|NCT01213277|Glycation Rate|glycation rate
5100169|NCT01213277|Fructosamine|fructosamine
5100170|NCT01213264|neuromuscular blockade, NMBA, sugammadex, Bridion, TOF,|neuromuscular blockade, nmba, sugammadex, bridion, tof,
5100171|NCT01213238|Liver metastasis|liver metastasis
5100172|NCT01213238|hepatic arterial infusion|hepatic arterial infusion
5100173|NCT01213238|HAI|hai
5100174|NCT01213238|Eloxatin|eloxatin
5100175|NCT01213238|Xeloda|xeloda
5100176|NCT01213238|Avastin|avastin
5100177|NCT01213238|Anti-VEGF monoclonal antibody|anti-vegf monoclonal antibody
5100178|NCT01213238|rhuMAb-VEGF|rhumab-vegf
5100179|NCT01213238|Oxaliplatin|oxaliplatin
5100180|NCT01213238|Capecitabine|capecitabine
5100181|NCT01213238|Bevacizumab|bevacizumab
5100182|NCT01213225|Elderly|elderly
5100183|NCT01213225|Hospitalization|hospitalization
5100184|NCT01213225|Geriatrics|geriatrics
5100185|NCT01213225|Mortality|mortality
5100186|NCT01213225|Readmission|readmission
5100187|NCT01213225|Length of Stay|length of stay
5100188|NCT01213212|Caloric restriction|caloric restriction
5100189|NCT01213212|type 2 diabetes|type 2 diabetes
5100190|NCT01213212|abdominal obesity|abdominal obesity
5100191|NCT01213212|renal disease|renal disease
5100192|NCT01213186|stem cell|stem cell
5100193|NCT01213186|hiv|hiv
5100194|NCT01213186|CD4|cd4
5100195|NCT01213186|immune activation|immune activation
5100196|NCT01213173|angina pectoris|angina pectoris
5100197|NCT01213173|chest pain|chest pain
5100198|NCT01213173|heart rate|heart rate
5100199|NCT01213160|Phase I|phase i
5100200|NCT01213160|cancer|cancer
5100201|NCT01213160|solid tumours|solid tumours
5100202|NCT01213160|advanced solid malignancies|advanced solid malignancies
5100203|NCT01213160|dose escalation|dose escalation
5100204|NCT01213160|FGFR TKI|fgfr tki
5100205|NCT01213160|Japanese|japanese
5100206|NCT01213147|Pregnancy|pregnancy
5100207|NCT01213147|Clomiphene Citrate|clomiphene citrate
5100208|NCT01213147|Fertilization|fertilization
5100209|NCT01213147|Buserelin|buserelin
5100210|NCT01213134|Medical Education|medical education
5100211|NCT01213134|Resident Training|resident training
5100212|NCT01213134|Portfolio|portfolio
5100213|NCT01213121|bipolar depression|bipolar depression
5100214|NCT01213121|heart rate variability|heart rate variability
5100215|NCT01213121|cardio-respiratory coupling|cardio-respiratory coupling
5100216|NCT01213121|electroencephalography|electroencephalography
5100217|NCT01213108|Örebro prevention program|örebro prevention program
5100218|NCT01213108|Youth drinking|youth drinking
5100219|NCT01213095|Lymphoma|lymphoma
5100220|NCT01213095|B-Cell|b-cell
5100221|NCT01213095|Marginal Zone|marginal zone
5100222|NCT01213095|Rituximab|rituximab
5100223|NCT01213082|Exudative Age-related Macular Degeneration|exudative age-related macular degeneration
5100224|NCT01213082|Proton beam irradiation|proton beam irradiation
5100225|NCT01213082|ranibizumab|ranibizumab
5100226|NCT01213082|bevacizumab|bevacizumab
5100227|NCT01213082|anti-VEGF therapy|anti-vegf therapy
5100228|NCT01213056|Mindfulness Based Cognitive Therapy|mindfulness based cognitive therapy
5100229|NCT01213056|Chronic Headache Pain|chronic headache pain
5100230|NCT01213056|Randomized Controlled Trial.|randomized controlled trial.
5100231|NCT01213043|emphysema|emphysema
5100232|NCT01213043|alpha 1-antitrypsin|alpha 1-antitrypsin
5100233|NCT01213043|alpha 1-antitrypsin deficiency (AATD)|alpha 1-antitrypsin deficiency (aatd)
5100234|NCT01213043|alpha 1-proteinase inhibitor (Alpha-1 PI)|alpha 1-proteinase inhibitor (alpha-1 pi)
5100235|NCT01213030|HX4|hx4
5100236|NCT01213030|[F-18]HX4|[f-18]hx4
5100237|NCT01213030|FMISO|fmiso
5100238|NCT01213030|[F-18]FMISO|[f-18]fmiso
5100239|NCT01213030|Solitary Tumor|solitary tumor
5100240|NCT01213030|Hypoxia|hypoxia
5100241|NCT01213017|Certolizumab pegol|certolizumab pegol
5100242|NCT01213017|Magnetic Resonance Imaging|magnetic resonance imaging
5100243|NCT01213017|Rheumatoid Arthritis|rheumatoid arthritis
5100244|NCT01213017|RAPID 3|rapid 3
5100245|NCT01213004|gastro-esophageal junction|gastro-esophageal junction
5100246|NCT01213004|lung|lung
5100247|NCT01213004|abdominal|abdominal
5100248|NCT01213004|cone-beam CT (CBCT)|cone-beam ct (cbct)
5100249|NCT01213004|10-146|10-146
5100250|NCT01212991|Progressive Metastatic Prostate Cancer|progressive metastatic prostate cancer
5100251|NCT01212978|Aging|aging
5100252|NCT01212978|Endothelium,Vascular|endothelium,vascular
5100253|NCT01212978|Arterial Remodeling|arterial remodeling
5100254|NCT01212978|Ventricular Vascular Coupling|ventricular vascular coupling
5100255|NCT01212978|Nitric Oxide|nitric oxide
5100256|NCT01212978|Walking|walking
5100257|NCT01212978|Software|software
5100258|NCT01212965|Selenium|selenium
5100259|NCT01212965|Lymphatic Malformations|lymphatic malformations
5100260|NCT01212965|Adolescents|adolescents
5100261|NCT01212939|Dead pulps and open root ends|dead pulps and open root ends
5100262|NCT01212939|Patients who have teeth with dead pulp and open root ends|patients who have teeth with dead pulp and open root ends
5100263|NCT01212900|Atherosclerosis|atherosclerosis
5100264|NCT01212900|Cardiovascular Disease|cardiovascular disease
5100265|NCT01212900|Cardiac MRI|cardiac mri
5100266|NCT01212900|Cardiac CT|cardiac ct
5100267|NCT01212900|Cholesterol|cholesterol
5100268|NCT01212887|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5100269|NCT01212887|recurrent colon cancer|recurrent colon cancer
5100270|NCT01212887|stage IIIA colon cancer|stage iiia colon cancer
5100271|NCT01212887|stage IIIB colon cancer|stage iiib colon cancer
5100272|NCT01212887|stage IIIC colon cancer|stage iiic colon cancer
5100273|NCT01212887|stage IV colon cancer|stage iv colon cancer
5100274|NCT01212887|stage IVB colon cancer|stage ivb colon cancer
5100275|NCT01212887|recurrent rectal cancer|recurrent rectal cancer
5100276|NCT01212887|stage IIIA rectal cancer|stage iiia rectal cancer
5100277|NCT01212887|stage IIIB rectal cancer|stage iiib rectal cancer
5100278|NCT01212887|stage IIIC rectal cancer|stage iiic rectal cancer
5100279|NCT01212887|stage IVA rectal cancer|stage iva rectal cancer
5100280|NCT01212887|stage IVB rectal cancer|stage ivb rectal cancer
5100281|NCT01212887|recurrent gastric cancer|recurrent gastric cancer
5100282|NCT01212887|stage IV gastric cancer|stage iv gastric cancer
5100283|NCT01212887|recurrent pancreatic cancer|recurrent pancreatic cancer
5100284|NCT01212887|stage III pancreatic cancer|stage iii pancreatic cancer
5100285|NCT01212887|stage IV pancreatic cancer|stage iv pancreatic cancer
5100286|NCT01212887|recurrent breast cancer|recurrent breast cancer
5100287|NCT01212887|stage IIIC breast cancer|stage iiic breast cancer
5100288|NCT01212887|stage IV breast cancer|stage iv breast cancer
5100289|NCT01212887|extensive stage small cell lung cancer|extensive stage small cell lung cancer
5100290|NCT01212887|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5100291|NCT01212887|recurrent small cell lung cancer|recurrent small cell lung cancer
5100292|NCT01212887|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5100293|NCT01212887|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5100294|NCT01212887|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5100295|NCT01212887|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5100296|NCT01212887|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
5100297|NCT01212887|stage IIIA ovarian epithelial cancer|stage iiia ovarian epithelial cancer
5100298|NCT01212887|stage IIIA ovarian germ cell tumor|stage iiia ovarian germ cell tumor
5100299|NCT01212887|stage IIIB ovarian epithelial cancer|stage iiib ovarian epithelial cancer
5100300|NCT01212887|stage IIIB ovarian germ cell tumor|stage iiib ovarian germ cell tumor
5100301|NCT01212887|stage IIIC ovarian epithelial cancer|stage iiic ovarian epithelial cancer
5100302|NCT01212887|stage IIIC ovarian germ cell tumor|stage iiic ovarian germ cell tumor
5100303|NCT01212887|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5100304|NCT01212887|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
5100305|NCT01212848|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
5100306|NCT01212848|Suicidal ideation|suicidal ideation
5100307|NCT01212835|Obesity|obesity
5100308|NCT01212835|gastroesophageal reflux disease|gastroesophageal reflux disease
5100309|NCT01212835|Morbid obesity|morbid obesity
5100310|NCT01212835|esophagitis|esophagitis
5100311|NCT01212835|GERD|gerd
5100312|NCT01212835|silastic ring|silastic ring
5100313|NCT01212835|Gastric bypass|gastric bypass
5100314|NCT01212796|allogeneic stem cell transplantation|allogeneic stem cell transplantation
5100315|NCT01212783|depression|depression
5100316|NCT01212783|psychological treatments|psychological treatments
5100317|NCT01212783|Cognitive Behavioral Therapy|cognitive behavioral therapy
5100318|NCT01212783|child development|child development
5100319|NCT01212783|parenting|parenting
5100320|NCT01212783|home visitation|home visitation
5100321|NCT01212770|Psoriatic Arthritis|psoriatic arthritis
5100322|NCT01212770|Psoriasis|psoriasis
5100323|NCT01212770|Arthritis|arthritis
5100324|NCT01212770|inflammation|inflammation
5100325|NCT01212770|skin condition|skin condition
5100326|NCT01212770|inflammatory cells|inflammatory cells
5100327|NCT01212770|apremilast|apremilast
5100328|NCT01212770|CC-10004|cc-10004
5100636|NCT01211470|ABSSSI|absssi
5100329|NCT01212770|phosphodiesterase type 4|phosphodiesterase type 4
5100330|NCT01212757|Psoriasis|psoriasis
5100331|NCT01212757|Arthritis|arthritis
5100332|NCT01212757|Psoriatic Arthritis|psoriatic arthritis
5100333|NCT01212757|inflammation|inflammation
5100334|NCT01212757|skin condition|skin condition
5100335|NCT01212757|inflammatory cells|inflammatory cells
5100336|NCT01212757|apremilast|apremilast
5100337|NCT01212757|CC-10004|cc-10004
5100338|NCT01212757|phosphodiesterase type 4|phosphodiesterase type 4
5100339|NCT01212744|PEG PAL; PKU; injection;|peg pal; pku; injection;
5100340|NCT01212731|Patients with malignancies of the skull base or patients with low grade glioma who require radiotherapy.|patients with malignancies of the skull base or patients with low grade glioma who require radiotherapy.
5100341|NCT01212718|Colorectal Cancer|colorectal cancer
5100342|NCT01212718|non resectable metastasis|non resectable metastasis
5100343|NCT01212718|reference lesion|reference lesion
5100344|NCT01212718|biopsy|biopsy
5100345|NCT01212718|thymidylate synthase quantitation|thymidylate synthase quantitation
5100346|NCT01212679|nerve growth factor|nerve growth factor
5100347|NCT01212679|traumatic brain injury|traumatic brain injury
5100348|NCT01212679|intranasal|intranasal
5100349|NCT01212679|prognosis|prognosis
5100350|NCT01212679|neurological function|neurological function
5100351|NCT01212666|Adductor Canal Block (ACB)|adductor canal block (acb)
5100352|NCT01212666|Anterior Cruciate Ligament (ACL) Reconstruction|anterior cruciate ligament (acl) reconstruction
5100353|NCT01212666|Saphenous nerve|saphenous nerve
5100354|NCT01212666|Pain|pain
5100355|NCT01212666|Ultrasound block|ultrasound block
5100356|NCT01212653|Ankylosing Spondylitis|ankylosing spondylitis
5100357|NCT01212653|Golimumab|golimumab
5100358|NCT01212653|Simponi|simponi
5100359|NCT01212653|Anti-TNF alpha|anti-tnf alpha
5100360|NCT01212653|EPCs|epcs
5100361|NCT01212653|Vascular stiffness|vascular stiffness
5100362|NCT01212640|Transfusion, distress|transfusion, distress
5100363|NCT01212627|Non-Small Cell Lung Cancer|non-small cell lung cancer
5100364|NCT01212601|safety|safety
5100365|NCT01212601|efficacy|efficacy
5100366|NCT01212601|Chinese patients|chinese patients
5100367|NCT01212601|practice|practice
5100368|NCT01212588|BPD|bpd
5100369|NCT01212588|Borderline|borderline
5100370|NCT01212588|personality disorder|personality disorder
5100371|NCT01212588|mifepristone|mifepristone
5100372|NCT01212575|Mental disorder|mental disorder
5100373|NCT01212575|Antipsychotic treatment|antipsychotic treatment
5100374|NCT01212562|basal cell carcinoma|basal cell carcinoma
5100375|NCT01212562|cryosurgery|cryosurgery
5100376|NCT01212562|imiquimod|imiquimod
5100377|NCT01212562|immunocryosurgery|immunocryosurgery
5100378|NCT01212549|basal cell carcinoma|basal cell carcinoma
5100379|NCT01212549|cryosurgery|cryosurgery
5100380|NCT01212549|imiquimod|imiquimod
5100381|NCT01212549|immunocryosurgery|immunocryosurgery
5100382|NCT01212536|children|children
5100383|NCT01212536|intubation|intubation
5100384|NCT01212536|laryngoscope|laryngoscope
5100385|NCT01212523|propofol|propofol
5100386|NCT01212523|isoflurane|isoflurane
5100387|NCT01212523|pulmonary hypertension|pulmonary hypertension
5100388|NCT01212523|congenital heart disease|congenital heart disease
5100389|NCT01212510|metastatic colorectal cancer|metastatic colorectal cancer
5100390|NCT01212510|circulating tumor markers|circulating tumor markers
5100391|NCT01212510|circulating tumor cell|circulating tumor cell
5100392|NCT01212510|circulating tumor DNA|circulating tumor dna
5100393|NCT01212510|marker's kinetic|marker's kinetic
5100394|NCT01212497|mindfulness|mindfulness
5100395|NCT01212497|meditation|meditation
5100396|NCT01212497|training|training
5100397|NCT01212497|coaching|coaching
5100398|NCT01212497|virtual coach|virtual coach
5100399|NCT01212471|Sign and symptoms of dry eye disease|sign and symptoms of dry eye disease
5100400|NCT01212458|gesunde Probanden|gesunde probanden
5100401|NCT01212432|Gram positive infection and CRRT|gram positive infection and crrt
5100402|NCT01212406|Organ rejection|organ rejection
5100403|NCT01212406|Lung transplantation|lung transplantation
5100404|NCT01212406|Bronchiolitis Obliterans|bronchiolitis obliterans
5100405|NCT01212406|Vitamin D|vitamin d
5100406|NCT01212406|Prevention|prevention
5100407|NCT01212393|venous thromboembolism disease|venous thromboembolism disease
5100408|NCT01212393|emergency|emergency
5100409|NCT01212393|prevention|prevention
5100410|NCT01212393|thromboprophylaxis|thromboprophylaxis
5100411|NCT01212393|medical|medical
5100412|NCT01212393|hosptitalization|hosptitalization
5100413|NCT01212393|health care risks|health care risks
5100414|NCT01212380|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
5100415|NCT01212380|Small Lymphocytic Lymphoma|small lymphocytic lymphoma
5100416|NCT01212380|Prolymphocytic Leukemia|prolymphocytic leukemia
5100417|NCT01212367|Gene transfer|gene transfer
5100418|NCT01212367|Immunology|immunology
5100419|NCT01212367|Cancer|cancer
5100420|NCT01212354|intensity modulated radiotherapy|intensity modulated radiotherapy
5100421|NCT01212354|selective dose escalation|selective dose escalation
5100422|NCT01212354|hypoxia|hypoxia
5100423|NCT01212354|head cancer|head cancer
5100424|NCT01212354|neck cancer|neck cancer
5100425|NCT01212341|Allogenetic NK cells|allogenetic nk cells
5100427|NCT01212341|Solid tumors|solid tumors
5100428|NCT01212328|T2DM|t2dm
5100429|NCT01212328|Decision support software|decision support software
5100430|NCT01212328|care coordinator|care coordinator
5100431|NCT01212315|Wound infection|wound infection
5100432|NCT01212315|SSI|ssi
5100433|NCT01212315|Suture|suture
5100434|NCT01212302|Clopidogrel|clopidogrel
5100435|NCT01212302|ASA|asa
5100436|NCT01212302|Low Response|low response
5100437|NCT01212302|Resistance|resistance
5100438|NCT01212263|PCOS|pcos
5100439|NCT01212263|Clomiphene resistance|clomiphene resistance
5100440|NCT01212263|ovulation induction|ovulation induction
5100441|NCT01212263|low dose uFSH|low dose ufsh
5100442|NCT01212263|uFSH step-up protocol|ufsh step-up protocol
5100443|NCT01212237|glioma|glioma
5100444|NCT01212237|meningioma|meningioma
5100445|NCT01212237|anaplastic astrocytoma|anaplastic astrocytoma
5100446|NCT01212211|Hyponatremia; Sodium level|hyponatremia; sodium level
5100447|NCT01212211|Falls|falls
5100448|NCT01212211|Gait|gait
5100449|NCT01212211|elderly|elderly
5100450|NCT01212185|oxytocin|oxytocin
5100451|NCT01212185|alcohol withdrawal|alcohol withdrawal
5100452|NCT01212185|lorazepam|lorazepam
5100453|NCT01212185|alcoholism|alcoholism
5100454|NCT01212185|intranasal administration|intranasal administration
5100455|NCT01212185|CIWA-Ar|ciwa-ar
5100456|NCT01212172|Hair removal|hair removal
5100457|NCT01212172|Laser|laser
5100458|NCT01212172|Diode laser|diode laser
5100459|NCT01212159|Internet based monitoring system|internet based monitoring system
5100460|NCT01212146|Artichokes|artichokes
5100461|NCT01212146|Constipation|constipation
5100462|NCT01212146|Functional Foods|functional foods
5100463|NCT01212146|Prebiotics|prebiotics
5100464|NCT01212146|Probiotics|probiotics
5100465|NCT01212120|Diabetic foot|diabetic foot
5100466|NCT01212107|Advanced cancer|advanced cancer
5100467|NCT01212107|Metastatic cancer|metastatic cancer
5100468|NCT01212107|Oncology|oncology
5100469|NCT01212094|Rituximab|rituximab
5100470|NCT01212094|Multiple Sclerosis|multiple sclerosis
5100471|NCT01212094|Intrathecal|intrathecal
5100472|NCT01212094|MS|ms
5100473|NCT01212094|Secondary-Progressive Multiple Sclerosis|secondary-progressive multiple sclerosis
5100474|NCT01212094|SP-MS|sp-ms
5100475|NCT01212081|Virtual Reality|virtual reality
5100476|NCT01212081|Schizophrenia|schizophrenia
5100477|NCT01212081|Cannabis|cannabis
5100478|NCT01212081|Assessment|assessment
5100479|NCT01212081|Craving|craving
5100480|NCT01212068|MEG|meg
5100481|NCT01212068|Epilepsy|epilepsy
5100482|NCT01212068|Brain Imaging|brain imaging
5100483|NCT01212068|Brain Scan|brain scan
5100484|NCT01212068|Auditory Processing|auditory processing
5100485|NCT01212068|Auditory Perceptual Disorder|auditory perceptual disorder
5100486|NCT01212055|PBSC Collection|pbsc collection
5100487|NCT01212055|Immunodeficiency|immunodeficiency
5100488|NCT01212055|Spectra Apheresis System|spectra apheresis system
5100489|NCT01212055|Stem Cell Mobilization|stem cell mobilization
5100490|NCT01212055|Leukapheresis|leukapheresis
5100491|NCT01212042|Pneumonia|pneumonia
5100492|NCT01212042|Pulmonary Pathogens|pulmonary pathogens
5100493|NCT01212042|HIV|hiv
5100494|NCT01212042|Immunocompromised Host|immunocompromised host
5100495|NCT01212042|Respiratory Infection|respiratory infection
5100496|NCT01212042|Mycobacteria|mycobacteria
5100497|NCT01212029|Near Infrared|near infrared
5100498|NCT01212029|Optical Imaging|optical imaging
5100499|NCT01212029|Brain Imaging|brain imaging
5100500|NCT01212029|Healthy Volunteer|healthy volunteer
5100501|NCT01212029|HV|hv
5100502|NCT01212016|Eosinophilic Esophagitis|eosinophilic esophagitis
5100503|NCT01212016|Eosinophilic Gastroenteritis|eosinophilic gastroenteritis
5100504|NCT01212016|Peanut Allergy|peanut allergy
5100505|NCT01212016|T Cell|t cell
5100506|NCT01212016|IgE|ige
5100507|NCT01212016|Food Allergy|food allergy
5100508|NCT01212003|Mycobacterium Tuberculosis|mycobacterium tuberculosis
5100509|NCT01212003|Active Tuberculosis|active tuberculosis
5100510|NCT01212003|Latent Tuberculosis|latent tuberculosis
5100511|NCT01212003|Tuberculosis|tuberculosis
5100512|NCT01212003|TB|tb
5100513|NCT01211990|Pediatric|pediatric
5100514|NCT01211990|Children|children
5100515|NCT01211990|Cancer|cancer
5100516|NCT01211990|Bone Marrow Transplant|bone marrow transplant
5100517|NCT01211977|Muckle Wells Syndrome|muckle wells syndrome
5100518|NCT01211977|Autoinflammatory|autoinflammatory
5100519|NCT01211977|Interleukin-1|interleukin-1
5100520|NCT01211951|Dry eye syndromes|dry eye syndromes
5100521|NCT01211951|Corneal diseases|corneal diseases
5100522|NCT01211951|Conjunctival diseases|conjunctival diseases
5100523|NCT01211938|phase II/III|phase ii/iii
5100524|NCT01211938|upper aerodigestive tract carcinoma|upper aerodigestive tract carcinoma
5100525|NCT01211938|re irradiation|re irradiation
5100526|NCT01211938|Recurrent or second upper aerodigestive tract carcinoma|recurrent or second upper aerodigestive tract carcinoma
5100527|NCT01211925|unreconstructable peripheral arterial disease|unreconstructable peripheral arterial disease
5100528|NCT01211912|Fetal movement|fetal movement
5100529|NCT01211912|Fetal breathing|fetal breathing
5100530|NCT01211912|Acetaminophen|acetaminophen
5101330|NCT01208493|proteins|proteins
5100531|NCT01211899|polymorphism,|polymorphism,
5100532|NCT01211899|plasminogen activator inhibitor,|plasminogen activator inhibitor,
5100533|NCT01211899|disseminated intravascular coagulation,|disseminated intravascular coagulation,
5100534|NCT01211886|Brain natriuretic peptide|brain natriuretic peptide
5100535|NCT01211886|Cardio-renal syndrome|cardio-renal syndrome
5100536|NCT01211873|CNS|cns
5100537|NCT01211873|Contrast Agent|contrast agent
5100538|NCT01211873|MRI|mri
5100539|NCT01211873|Dotarem|dotarem
5100540|NCT01211873|Magnevist|magnevist
5100541|NCT01211860|DCCR|dccr
5100542|NCT01211860|Diazoxide Chonline Controlled-Release Tablet = DCCR|diazoxide chonline controlled-release tablet = dccr
5100543|NCT01211860|Hypertriglyceridemia|hypertriglyceridemia
5100544|NCT01211860|Triglycerides|triglycerides
5100545|NCT01211860|Pharmacokinetics|pharmacokinetics
5100546|NCT01211847|triglycerides|triglycerides
5100547|NCT01211847|Apo B|apo b
5100548|NCT01211847|non-HDL|non-hdl
5100549|NCT01211847|statin|statin
5100550|NCT01211847|fenofibrate|fenofibrate
5100551|NCT01211795|Migraine|migraine
5100552|NCT01211795|Prevention|prevention
5100553|NCT01211795|Treatment|treatment
5100554|NCT01211795|Ketoprofen|ketoprofen
5100555|NCT01211795|Trigeminal nerve|trigeminal nerve
5100556|NCT01211782|Alzheimer's disease|alzheimer's disease
5100557|NCT01211782|AD|ad
5100558|NCT01211782|AC-1204|ac-1204
5100559|NCT01211782|ketogenic|ketogenic
5100560|NCT01211782|ketosis|ketosis
5100561|NCT01211769|PUFAs|pufas
5100562|NCT01211769|Alcoholism|alcoholism
5100563|NCT01211769|Treatment|treatment
5100564|NCT01211769|Effectiveness|effectiveness
5100565|NCT01211743|SILS|sils
5100566|NCT01211743|Oxidative Stress|oxidative stress
5100567|NCT01211743|8-epiPGF2a|8-epipgf2a
5100568|NCT01211743|SILS vs standard laparoscopic cholecystectomy|sils vs standard laparoscopic cholecystectomy
5100569|NCT01211730|Liver|liver
5100570|NCT01211730|transplantation|transplantation
5100571|NCT01211730|Glucose|glucose
5100572|NCT01211730|Hyperglycemia|hyperglycemia
5100573|NCT01211730|Insulin|insulin
5100574|NCT01211730|Rejection|rejection
5100575|NCT01211730|Hypoglycemia|hypoglycemia
5100576|NCT01211717|Branched Chained Amino Acids|branched chained amino acids
5100577|NCT01211717|Delayed Onset Muscle Soreness|delayed onset muscle soreness
5100578|NCT01211717|Diabetes|diabetes
5100579|NCT01211717|Muscle Damage|muscle damage
5100580|NCT01211704|Bipolar, Alcoholism|bipolar, alcoholism
5100581|NCT01211691|Hematologic|hematologic
5100582|NCT01211691|Leukemia|leukemia
5100583|NCT01211691|Malignancies|malignancies
5100584|NCT01211691|Myeloproliferative Neoplasms|myeloproliferative neoplasms
5100585|NCT01211665|IVMP|ivmp
5100586|NCT01211665|corticosteroids|corticosteroids
5100587|NCT01211665|IRIS|iris
5100588|NCT01211665|Progressive Multifocal Leukoencephalopathy|progressive multifocal leukoencephalopathy
5100589|NCT01211665|Immune reconstitution inflammatory syndrome|immune reconstitution inflammatory syndrome
5100590|NCT01211665|PML|pml
5100591|NCT01211652|Compliance|compliance
5100592|NCT01211652|France|france
5100593|NCT01211652|Self-administered questionnaire to patients|self-administered questionnaire to patients
5100594|NCT01211613|Manipulation|manipulation
5100595|NCT01211613|Chiropractic|chiropractic
5100596|NCT01211613|Low Back Pain|low back pain
5100597|NCT01211600|Staples|staples
5100598|NCT01211600|Sutures|sutures
5100599|NCT01211600|Wound infections|wound infections
5100600|NCT01211600|Cosmesis|cosmesis
5100601|NCT01211600|Aesthetic appearance of skin incision|aesthetic appearance of skin incision
5100602|NCT01211587|Parkinson's Disease|parkinson's disease
5100603|NCT01211587|Cognition|cognition
5100604|NCT01211587|Safinamide|safinamide
5100605|NCT01211587|Phase 2|phase 2
5100606|NCT01211587|Non-demented patients|non-demented patients
5100607|NCT01211587|Levodopa|levodopa
5100608|NCT01211587|Dopamine agonist|dopamine agonist
5100609|NCT01211535|Soft contact lenses|soft contact lenses
5100610|NCT01211535|Multi-purpose Solution|multi-purpose solution
5100611|NCT01211522|Delirium|delirium
5100612|NCT01211522|Intensive care|intensive care
5100613|NCT01211522|Mechanical ventilation|mechanical ventilation
5100614|NCT01211522|Antipsychotic|antipsychotic
5100615|NCT01211522|Haloperidol|haloperidol
5100616|NCT01211522|Ziprasidone|ziprasidone
5100617|NCT01211522|Randomized|randomized
5100618|NCT01211522|Placebo|placebo
5100619|NCT01211522|Sepsis|sepsis
5100620|NCT01211522|Sedation|sedation
5100621|NCT01211522|Long-term cognitive impairment|long-term cognitive impairment
5100622|NCT01211509|montelukast|montelukast
5100623|NCT01211509|cysteinyl leukotriene|cysteinyl leukotriene
5100624|NCT01211509|lung transplantation|lung transplantation
5100625|NCT01211509|bronchiolitis obliterans syndrome|bronchiolitis obliterans syndrome
5100626|NCT01211496|functional testing|functional testing
5100627|NCT01211496|resistance training|resistance training
5100628|NCT01211496|velocity training|velocity training
5100629|NCT01211496|elderly|elderly
5100630|NCT01211496|geriatric|geriatric
5100631|NCT01211496|knee|knee
5100632|NCT01211496|leg|leg
5100633|NCT01211496|leg strength|leg strength
5100634|NCT01211483|Lung cancer|lung cancer
5100635|NCT01211470|MRSA|mrsa
5100637|NCT01211470|Staphylococcus aureus|staphylococcus aureus
5100638|NCT01211444|Obstructive Sleep Apnea|obstructive sleep apnea
5100639|NCT01211444|OSA|osa
5100640|NCT01211444|Hypoglossal nerve stimulation|hypoglossal nerve stimulation
5100641|NCT01211444|Sleep apnea|sleep apnea
5100642|NCT01211431|cesarean section|cesarean section
5100643|NCT01211431|pain|pain
5100644|NCT01211431|ropivacain|ropivacain
5100645|NCT01211431|diclofena|diclofena
5100646|NCT01211431|morphine|morphine
5100647|NCT01211405|MDMA|mdma
5100648|NCT01211405|Psychotherapy|psychotherapy
5100649|NCT01211405|Veterans|veterans
5100650|NCT01211405|Posttraumatic Stress Disorder|posttraumatic stress disorder
5100651|NCT01211379|colorectal cancer screening|colorectal cancer screening
5100652|NCT01211379|primary care|primary care
5100653|NCT01211379|health disparities|health disparities
5100654|NCT01211366|cell saver|cell saver
5100655|NCT01211366|allogeneic RBCs|allogeneic rbcs
5100656|NCT01211366|washed cells|washed cells
5100657|NCT01211366|PRBC transfusion|prbc transfusion
5100658|NCT01211353|Alcohol|alcohol
5100659|NCT01211353|Brief Intervention|brief intervention
5100660|NCT01211353|Personalized Feedback|personalized feedback
5100661|NCT01211353|Veterans|veterans
5100662|NCT01211340|Hospice|hospice
5100663|NCT01211340|Caregivers|caregivers
5100664|NCT01211340|Interdisciplinary Team|interdisciplinary team
5100665|NCT01211340|Pain management|pain management
5100666|NCT01211314|hypertension|hypertension
5100667|NCT01211314|Fixed combination|fixed combination
5100668|NCT01211314|lercanidipine|lercanidipine
5100669|NCT01211314|enalapril|enalapril
5100670|NCT01211314|Blood Pressure Monitoring, Ambulatory|blood pressure monitoring, ambulatory
5100671|NCT01211301|obesity|obesity
5100672|NCT01211301|overweight|overweight
5100673|NCT01211301|weight loss|weight loss
5100674|NCT01211301|randomized controlled trial|randomized controlled trial
5100675|NCT01211301|Medifast|medifast
5100676|NCT01211288|HIV|hiv
5100677|NCT01211288|Implant|implant
5100678|NCT01211288|Crown|crown
5100679|NCT01211275|mesothelioma|mesothelioma
5100680|NCT01211275|chemotherapy|chemotherapy
5100681|NCT01211275|translational research|translational research
5100682|NCT01211275|axitinib|axitinib
5100683|NCT01211262|Melanoma|melanoma
5100684|NCT01211262|Phase I|phase i
5100685|NCT01211262|Biologic|biologic
5100686|NCT01211249|Methotrexate-refractory|methotrexate-refractory
5100687|NCT01211223|Chronic periodontitis|chronic periodontitis
5100688|NCT01211223|Metronidazole plus Amoxicillin|metronidazole plus amoxicillin
5100689|NCT01211223|Mechanical periodontal therapy|mechanical periodontal therapy
5100690|NCT01211223|Scaling and Root Planning|scaling and root planning
5100691|NCT01211223|Periodontal treatment|periodontal treatment
5100692|NCT01211210|rectal cancer|rectal cancer
5100693|NCT01211210|neoadjuvant therapy|neoadjuvant therapy
5100694|NCT01211210|oxaliplatin|oxaliplatin
5100695|NCT01211210|radiation|radiation
5100696|NCT01211184|Hip surgery|hip surgery
5100697|NCT01211184|Metabolism|metabolism
5100698|NCT01211184|Glucose|glucose
5100699|NCT01211184|Body fluids|body fluids
5100700|NCT01211184|Complications|complications
5100701|NCT01211171|Cough|cough
5100702|NCT01211171|Telmisartan|telmisartan
5100703|NCT01211171|Bradykinin|bradykinin
5100704|NCT01211171|Tolerability|tolerability
5100705|NCT01211158|emergency department|emergency department
5100706|NCT01211158|procedural sedation|procedural sedation
5100707|NCT01211158|ketofol|ketofol
5100708|NCT01211158|ketamine|ketamine
5100709|NCT01211158|propofol|propofol
5100710|NCT01211158|conscious sedation|conscious sedation
5100711|NCT01211145|Migraine|migraine
5100712|NCT01211145|Headache|headache
5100713|NCT01211145|Pain|pain
5100714|NCT01211145|Efficacy|efficacy
5100715|NCT01211145|Adolescents|adolescents
5100716|NCT01211132|Colon polyps|colon polyps
5100717|NCT01211132|Adenoma detection|adenoma detection
5100718|NCT01211132|Cap|cap
5100719|NCT01211132|Standard|standard
5100720|NCT01211132|Colon Cancer|colon cancer
5100721|NCT01211106|Treatment|treatment
5100722|NCT01211106|PTSD|ptsd
5100723|NCT01211106|Addiction|addiction
5100724|NCT01211093|vibration|vibration
5100725|NCT01211093|muscle|muscle
5100726|NCT01211093|cerebrovascular accident|cerebrovascular accident
5100727|NCT01211093|exercise|exercise
5100728|NCT01211093|rehabilitation|rehabilitation
5100729|NCT01211080|infancy hemangioma|infancy hemangioma
5100730|NCT01211080|propranolol|propranolol
5100731|NCT01211080|study design|study design
5100732|NCT01211080|side effects|side effects
5100733|NCT01211080|safety|safety
5100734|NCT01211067|Inguinal hernia|inguinal hernia
5100735|NCT01211067|Inguinal ring|inguinal ring
5100736|NCT01211067|Histology|histology
5100737|NCT01211067|Hernioplasty|hernioplasty
5100738|NCT01211067|Lichtenstein|lichtenstein
5100739|NCT01211041|Candida albicans, fungemia , prognostic factor|candida albicans, fungemia , prognostic factor
5100740|NCT01211028|Critical leg ischemia|critical leg ischemia
5100741|NCT01211028|Adipose derived Stroma/Stem Cells|adipose derived stroma/stem cells
5100742|NCT01211028|Autologous|autologous
5100743|NCT01211028|Angiogenesis|angiogenesis
5100744|NCT01211002|Radiotherapy|radiotherapy
5100745|NCT01211002|rh-endostatin|rh-endostatin
5100746|NCT01211002|chemotherapy|chemotherapy
5100747|NCT01211002|NSCLC|nsclc
5100748|NCT01210976|levosimendan|levosimendan
5100749|NCT01210976|CABG|cabg
5100750|NCT01210976|AVR|avr
5100751|NCT01210950|distraction|distraction
5100752|NCT01210950|osteogenesis|osteogenesis
5100753|NCT01210950|limb length discrepancy|limb length discrepancy
5100754|NCT01210950|callus|callus
5100755|NCT01210937|Internal Carotid Artery Stenosis|internal carotid artery stenosis
5100756|NCT01210937|Carotid Endarterectomy|carotid endarterectomy
5100757|NCT01210937|Stroke|stroke
5100758|NCT01210937|Cerebrovascular|cerebrovascular
5100759|NCT01210937|Atherosclerosis|atherosclerosis
5100760|NCT01210924|children|children
5100761|NCT01210924|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5100762|NCT01210924|antiretroviral therapy|antiretroviral therapy
5100763|NCT01210924|China|china
5100764|NCT01210924|Mortality|mortality
5100765|NCT01210911|pancreatic cancer|pancreatic cancer
5100766|NCT01210911|metformin|metformin
5100767|NCT01210911|MAPK pathway|mapk pathway
5100768|NCT01210911|PI3K/Akt pathway|pi3k/akt pathway
5100769|NCT01210911|gemcitabine|gemcitabine
5100770|NCT01210898|Influenza|influenza
5100771|NCT01210898|Trivalent|trivalent
5100772|NCT01210898|Adjuvanted|adjuvanted
5100773|NCT01210898|Vaccine|vaccine
5100774|NCT01210898|Children|children
5100775|NCT01210885|Meningococcal Disease|meningococcal disease
5100776|NCT01210885|Vaccines|vaccines
5100777|NCT01210885|Adolescents|adolescents
5100778|NCT01210872|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
5100893|NCT01210417|Hypovolemia|hypovolemia
5100779|NCT01210872|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
5100780|NCT01210872|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
5100781|NCT01210872|stage I lymphoepithelioma of the oropharynx|stage i lymphoepithelioma of the oropharynx
5100782|NCT01210872|stage II lymphoepithelioma of the oropharynx|stage ii lymphoepithelioma of the oropharynx
5100783|NCT01210872|stage III lymphoepithelioma of the oropharynx|stage iii lymphoepithelioma of the oropharynx
5100784|NCT01210872|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
5100785|NCT01210872|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
5100786|NCT01210872|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
5100787|NCT01210872|stage I lymphoepithelioma of the nasopharynx|stage i lymphoepithelioma of the nasopharynx
5100788|NCT01210872|stage II lymphoepithelioma of the nasopharynx|stage ii lymphoepithelioma of the nasopharynx
5100789|NCT01210872|stage III lymphoepithelioma of the nasopharynx|stage iii lymphoepithelioma of the nasopharynx
5100790|NCT01210872|stage I squamous cell carcinoma of the nasopharynx|stage i squamous cell carcinoma of the nasopharynx
5100791|NCT01210872|stage II squamous cell carcinoma of the nasopharynx|stage ii squamous cell carcinoma of the nasopharynx
5100792|NCT01210872|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
5100793|NCT01210872|stage I squamous cell carcinoma of the hypopharynx|stage i squamous cell carcinoma of the hypopharynx
5100794|NCT01210872|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
5100795|NCT01210872|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
5100796|NCT01210872|stage I squamous cell carcinoma of the larynx|stage i squamous cell carcinoma of the larynx
5100797|NCT01210872|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
5100798|NCT01210872|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
5100799|NCT01210872|stage I verrucous carcinoma of the larynx|stage i verrucous carcinoma of the larynx
5100800|NCT01210872|stage II verrucous carcinoma of the larynx|stage ii verrucous carcinoma of the larynx
5100801|NCT01210872|stage III verrucous carcinoma of the larynx|stage iii verrucous carcinoma of the larynx
5100802|NCT01210872|tongue cancer|tongue cancer
5100803|NCT01210859|detrusitol|detrusitol
5100804|NCT01210859|overactive|overactive
5100805|NCT01210859|bladder|bladder
5100806|NCT01210859|ureteral|ureteral
5100807|NCT01210859|stents|stents
5100808|NCT01210846|AV-951|av-951
5100809|NCT01210846|tivozanib|tivozanib
5100811|NCT01210846|advanced solid tumors|advanced solid tumors
5100812|NCT01210846|pharmacokinetics|pharmacokinetics
5100813|NCT01210833|Finger Fractures|finger fractures
5100814|NCT01210833|Tendon Injuries|tendon injuries
5100815|NCT01210833|Soft Tissue Injuries|soft tissue injuries
5100816|NCT01210781|All indication for deep brain stimulation (DBS)|all indication for deep brain stimulation (dbs)
5100817|NCT01210768|Phase II|phase ii
5100818|NCT01210768|Pegylated Liposomal Doxorubicin|pegylated liposomal doxorubicin
5100819|NCT01210768|Adjuvant Chemotherapy|adjuvant chemotherapy
5100820|NCT01210768|Breast Cancer|breast cancer
5100821|NCT01210755|Antithrombotics|antithrombotics
5100822|NCT01210755|Haemostatics|haemostatics
5100823|NCT01210755|Antidote|antidote
5100824|NCT01210729|stroke|stroke
5100825|NCT01210729|mechanical recanalization|mechanical recanalization
5100826|NCT01210729|self-expanding stent|self-expanding stent
5100827|NCT01210729|Solitaire|solitaire
5101331|NCT01208493|formula|formula
5100828|NCT01210716|Therapeutic plasma exchange|therapeutic plasma exchange
5100829|NCT01210716|Autoimmune diseases|autoimmune diseases
5100830|NCT01210716|Kidney transplant|kidney transplant
5100831|NCT01210716|Hematologic disorders|hematologic disorders
5100832|NCT01210716|Monoclonal gammopathy|monoclonal gammopathy
5100833|NCT01210716|Neurologic disorders|neurologic disorders
5100834|NCT01210703|Acoustic Pharyngometry|acoustic pharyngometry
5100835|NCT01210703|CPAP|cpap
5100836|NCT01210703|Obstructive Sleep Apnea Syndrome|obstructive sleep apnea syndrome
5100837|NCT01210690|Levetiracetam|levetiracetam
5100838|NCT01210690|Keppra® Oral Solution|keppra® oral solution
5100839|NCT01210690|Keppra® in Children|keppra® in children
5100840|NCT01210677|Cardiac Sarcoidosis|cardiac sarcoidosis
5100841|NCT01210677|Sarcoidosis|sarcoidosis
5100842|NCT01210664|Diabetes|diabetes
5100843|NCT01210664|Treg|treg
5100844|NCT01210651|Yoga|yoga
5100845|NCT01210651|Major Depression|major depression
5100846|NCT01210651|Self-Efficacy|self-efficacy
5100847|NCT01210651|Self-Esteem|self-esteem
5100848|NCT01210651|Hatha yoga|hatha yoga
5100849|NCT01210651|mind-body therapies|mind-body therapies
5100850|NCT01210651|depression|depression
5100851|NCT01210625|Constipation|constipation
5100852|NCT01210599|Back Pain|back pain
5100853|NCT01210599|Bisphosphonate|bisphosphonate
5100854|NCT01210599|Pamidronate|pamidronate
5100855|NCT01210599|Bone Pain|bone pain
5100856|NCT01210573|Heart Failure|heart failure
5100857|NCT01210573|Heart-Assist Devices|heart-assist devices
5100858|NCT01210573|Left Ventricular Assist Device|left ventricular assist device
5100859|NCT01210560|Kidney Disease|kidney disease
5100860|NCT01210560|Polycystic Kidney Disease|polycystic kidney disease
5100861|NCT01210521|Asthmatic Patients|asthmatic patients
5100862|NCT01210521|Vitamin D|vitamin d
5100863|NCT01210521|Steroid Resistant Asthmatic Patients|steroid resistant asthmatic patients
5100864|NCT01210521|cholecalciferol|cholecalciferol
5100865|NCT01210508|Cancer patients with metastases to the spinal column|cancer patients with metastases to the spinal column
5100866|NCT01210495|Hepatocellular Carcinoma|hepatocellular carcinoma
5100867|NCT01210482|Torisel|torisel
5100868|NCT01210482|Regulatory Post Marketing Commitment Plan|regulatory post marketing commitment plan
5100869|NCT01210469|elderly|elderly
5100870|NCT01210469|postural balance|postural balance
5100871|NCT01210469|musculoskeletal equilibrium|musculoskeletal equilibrium
5100872|NCT01210469|posture|posture
5100873|NCT01210469|muscle strength|muscle strength
5100874|NCT01210469|muscle stretching exercises|muscle stretching exercises
5100875|NCT01210456|Chronic Kidney Disease|chronic kidney disease
5100876|NCT01210456|Contrast Media|contrast media
5100877|NCT01210456|Acute Kidney Injury|acute kidney injury
5100878|NCT01210456|N-Acetylcysteine|n-acetylcysteine
5100879|NCT01210456|Bicarbonate|bicarbonate
5100880|NCT01210443|sitaxentan sodium pulmonary hypertension|sitaxentan sodium pulmonary hypertension
5100881|NCT01210430|Postural Tachycardia Syndrome|postural tachycardia syndrome
5100882|NCT01210430|Orthostatic Intolerance|orthostatic intolerance
5100883|NCT01210430|Reactive Oxygen Species|reactive oxygen species
5100884|NCT01210430|Oxidative Stress|oxidative stress
5100885|NCT01210430|Angiotensin II|angiotensin ii
5100886|NCT01210430|Nitric Oxide|nitric oxide
5100887|NCT01210430|Blood Flow|blood flow
5100888|NCT01210430|POTS|pots
5100889|NCT01210430|Ascorbic Acid|ascorbic acid
5100890|NCT01210430|Vitamin C|vitamin c
5100891|NCT01210430|Losartan|losartan
5100892|NCT01210417|Trauma|trauma
5100894|NCT01210417|Hemorrhage|hemorrhage
5100895|NCT01210417|Out of hospital trauma|out of hospital trauma
5100896|NCT01210404|Drug interaction with methadone.|drug interaction with methadone.
5100897|NCT01210378|NSCLC|nsclc
5100898|NCT01210378|Nitroglycerin|nitroglycerin
5100899|NCT01210378|Tumour perfusion|tumour perfusion
5100900|NCT01210378|Hypoxia|hypoxia
5100901|NCT01210378|Toxicity|toxicity
5100902|NCT01210378|Phase II|phase ii
5100903|NCT01210378|HX4|hx4
5100904|NCT01210365|CHF functional class II|chf functional class ii
5100905|NCT01210365|Patients with CHF|patients with chf
5100906|NCT01210365|Patients with CHF functional class II (NYHA) of any etiology|patients with chf functional class ii (nyha) of any etiology
5100907|NCT01210352|surgical pain|surgical pain
5100908|NCT01210352|acute pain|acute pain
5100909|NCT01210352|Acute Post Surgical Pain|acute post surgical pain
5100910|NCT01210339|phase 1|phase 1
5100911|NCT01210339|cross-over|cross-over
5100912|NCT01210339|drug-drug Interaction|drug-drug interaction
5100913|NCT01210339|esomeprazole|esomeprazole
5100914|NCT01210339|acetylsalicylic acid|acetylsalicylic acid
5100915|NCT01210339|clopidogrel|clopidogrel
5100916|NCT01210339|healthy volunteers|healthy volunteers
5100917|NCT01210339|cardiovascular disease|cardiovascular disease
5100918|NCT01210339|patients with acid associated gastrointestinal symptoms|patients with acid associated gastrointestinal symptoms
5100919|NCT01210326|TESE|tese
5100920|NCT01210326|TESA|tesa
5100921|NCT01210326|non obstructive|non obstructive
5100922|NCT01210326|azoospermi|azoospermi
5100923|NCT01210313|physical activity|physical activity
5100924|NCT01210300|caesarean section|caesarean section
5100925|NCT01210300|vaginal birth after caesarean section|vaginal birth after caesarean section
5102116|NCT01204918|Glutamate|glutamate
5100926|NCT01210300|repeat caesarean section|repeat caesarean section
5100927|NCT01210300|childbirth expectation|childbirth expectation
5100928|NCT01210300|childbirth experience|childbirth experience
5100929|NCT01210287|hepatitis B virus reactivation|hepatitis b virus reactivation
5100930|NCT01210287|HBsAg negative|hbsag negative
5100931|NCT01210287|HBcAb positive|hbcab positive
5100932|NCT01210287|lymphoma|lymphoma
5100933|NCT01210287|rituximab|rituximab
5100934|NCT01210261|OSA|osa
5100935|NCT01210261|CPAP|cpap
5100936|NCT01210261|APAP|apap
5100937|NCT01210261|SPAP|spap
5100938|NCT01210261|Obstructive Sleep Apnea|obstructive sleep apnea
5100939|NCT01210261|Sleep Apnea|sleep apnea
5100940|NCT01210235|colorectal cancer screening|colorectal cancer screening
5100941|NCT01210235|preventive health|preventive health
5100942|NCT01210235|primary care|primary care
5100943|NCT01210209|Ewing sarcoma|ewing sarcoma
5100944|NCT01210209|Ewing sarcoma/peripheral primitive neuroectodermal tumor (PNET)|ewing sarcoma/peripheral primitive neuroectodermal tumor (pnet)
5100945|NCT01210196|Fabry|fabry
5100946|NCT01210183|Dextrose|dextrose
5100947|NCT01210183|Cartilage|cartilage
5100948|NCT01210183|Regeneration|regeneration
5100949|NCT01210170|asthma,|asthma,
5100950|NCT01210170|inhaled corticosteroids,|inhaled corticosteroids,
5100951|NCT01210170|airway blood flow,|airway blood flow,
5100952|NCT01210170|mometasone,|mometasone,
5100953|NCT01210170|albuterol|albuterol
5100954|NCT01210170|spirometry|spirometry
5100955|NCT01210144|Infertility|infertility
5100956|NCT01210144|Gonal-f|gonal-f
5100957|NCT01210144|gene expression|gene expression
5100958|NCT01210144|Assisted Reproductive Technologies|assisted reproductive technologies
5100959|NCT01210144|Follitropin alfa|follitropin alfa
5100960|NCT01210144|endometrium|endometrium
5100961|NCT01210131|Toxicity|toxicity
5100962|NCT01210131|Progression|progression
5100963|NCT01210131|Survival|survival
5100964|NCT01210131|SCLC|sclc
5100965|NCT01210118|Pregnancy|pregnancy
5100966|NCT01210118|Smoking cessation|smoking cessation
5100967|NCT01210118|Cognitive-Behavioural interventions|cognitive-behavioural interventions
5100968|NCT01210105|intubation|intubation
5100969|NCT01210105|video laryngoscopes|video laryngoscopes
5100970|NCT01210079|opioid-induced hyperalgesia|opioid-induced hyperalgesia
5100971|NCT01210079|methadone|methadone
5100972|NCT01210079|gabapentin|gabapentin
5100973|NCT01210079|opioid addiction|opioid addiction
5100974|NCT01210066|inflammation|inflammation
5100975|NCT01210066|opioid-induced hyperalgesia|opioid-induced hyperalgesia
5100976|NCT01210066|bupenorphine|bupenorphine
5100977|NCT01210066|prescription opioid abuse|prescription opioid abuse
5100978|NCT01210053|Non-Small Cell Lung Cancer|non-small cell lung cancer
5100979|NCT01210040|Pregnancy|pregnancy
5100980|NCT01210040|Iron deficiency|iron deficiency
5100981|NCT01210040|Iron supplementation|iron supplementation
5100982|NCT01210040|Burkina Faso|burkina faso
5100983|NCT01210014|Recurrent aphthous stomatitis|recurrent aphthous stomatitis
5100984|NCT01210014|treatment|treatment
5100985|NCT01210014|zinc sulphate|zinc sulphate
5100986|NCT01209975|blood flow|blood flow
5100987|NCT01209975|glaucoma|glaucoma
5100988|NCT01209975|SLT|slt
5100989|NCT01209936|Body Fat|body fat
5100990|NCT01209936|Total body water|total body water
5100991|NCT01209923|Percent body fat|percent body fat
5100992|NCT01209923|Body Composition|body composition
5100993|NCT01209923|Stayhealthy|stayhealthy
5100994|NCT01209897|Smoking|smoking
5100995|NCT01209871|Lymphoplasmacytic Lymphoma|lymphoplasmacytic lymphoma
5100996|NCT01209871|Recombinant DNA|recombinant dna
5100997|NCT01209871|Fusion DNA Vaccine|fusion dna vaccine
5100998|NCT01209871|Waldenström macroglobulinemia|waldenström macroglobulinemia
5100999|NCT01209858|epilepsy|epilepsy
5101000|NCT01209845|depression|depression
5101001|NCT01209845|suicide ideation|suicide ideation
5101002|NCT01209845|emergency department|emergency department
5101003|NCT01209845|ketamine|ketamine
5101004|NCT01209832|Metastatic Tumors|metastatic tumors
5101005|NCT01209832|Lymphoma|lymphoma
5101006|NCT01209819|Bone Mineral Density|bone mineral density
5101007|NCT01209819|Adults|adults
5101008|NCT01209780|seasonal influenza, vaccine|seasonal influenza, vaccine
5101009|NCT01209767|Cellulite|cellulite
5101010|NCT01209767|Cryolipolysis|cryolipolysis
5101011|NCT01209767|Zeltiq|zeltiq
5101012|NCT01209767|Subcision|subcision
5101013|NCT01209754|Pregnancy|pregnancy
5101014|NCT01209754|Chemoprophylactic Exposure|chemoprophylactic exposure
5101015|NCT01209754|Mother|mother
5101016|NCT01209754|Infant|infant
5101017|NCT01209754|malformations|malformations
5101018|NCT01209754|HIV|hiv
5101019|NCT01209728|insomnia|insomnia
5101020|NCT01209728|insomniacs|insomniacs
5101021|NCT01209728|simulated driving|simulated driving
5101022|NCT01209728|alcohol|alcohol
5101023|NCT01209728|ethanol|ethanol
5101024|NCT01209715|airway blood flow,|airway blood flow,
5101025|NCT01209715|COPD,|copd,
5101026|NCT01209715|endothelial dysfunction|endothelial dysfunction
5101027|NCT01209715|inhaled corticosteroids|inhaled corticosteroids
5101028|NCT01209676|melanoma, with advanced unresectable|melanoma, with advanced unresectable
5101029|NCT01209663|General Surgery|general surgery
5101030|NCT01209663|Emergency treatment|emergency treatment
5101031|NCT01209663|Postoperative care|postoperative care
5101032|NCT01209663|Intermediate care unit|intermediate care unit
5101033|NCT01209663|High dependency unit|high dependency unit
5101034|NCT01209663|Mortality|mortality
5101035|NCT01209637|stable coronary artery disease|stable coronary artery disease
5101036|NCT01209637|significant coronary stenosis|significant coronary stenosis
5101037|NCT01209624|prospective|prospective
5101038|NCT01209624|non-interventional|non-interventional
5101039|NCT01209624|observational|observational
5101040|NCT01209624|multi-center|multi-center
5101041|NCT01209624|long-term|long-term
5101042|NCT01209598|soft tissue|soft tissue
5101043|NCT01209598|Palbociclib (PD0332991)|palbociclib (pd0332991)
5101044|NCT01209598|10-094|10-094
5101045|NCT01209572|energy expenditure|energy expenditure
5101046|NCT01209572|heart rate|heart rate
5101047|NCT01209572|accelerometry|accelerometry
5101048|NCT01209572|body temperature|body temperature
5101049|NCT01209572|heat flow galvanic response of skin|heat flow galvanic response of skin
5101050|NCT01209546|Bronchiectasis|bronchiectasis
5101051|NCT01209546|Pulmonary function|pulmonary function
5101052|NCT01209546|Respiratory muscle strength|respiratory muscle strength
5101053|NCT01209546|Respiratory secretions|respiratory secretions
5101054|NCT01209533|Asthma|asthma
5101055|NCT01209520|Lung Cancer|lung cancer
5101056|NCT01209520|Non-Small Cell Lung Carcinoma|non-small cell lung carcinoma
5101057|NCT01209520|NSCLC|nsclc
5101058|NCT01209520|Methylation Analysis|methylation analysis
5101059|NCT01209520|Hypermethylation|hypermethylation
5101060|NCT01209520|Targeted Genes|targeted genes
5101061|NCT01209520|Tumorigenesis|tumorigenesis
5101062|NCT01209520|Tumor Supressor Genes|tumor supressor genes
5101063|NCT01209507|Adrenal suppression|adrenal suppression
5101064|NCT01209507|Chemotherapy fatigue|chemotherapy fatigue
5101065|NCT01209507|Quality of life|quality of life
5101066|NCT01209494|sudden cardiac death|sudden cardiac death
5101067|NCT01209494|implantable cardioverter defibrillator|implantable cardioverter defibrillator
5101068|NCT01209494|ventricular arrhythmias|ventricular arrhythmias
5101069|NCT01209494|genetic syndromes|genetic syndromes
5101070|NCT01209494|calcium metabolism|calcium metabolism
5101071|NCT01209494|ventricular repolarization|ventricular repolarization
5101072|NCT01209494|ECG|ecg
5101073|NCT01209494|T wave|t wave
5101074|NCT01209494|programmed electrical stimulation|programmed electrical stimulation
5101075|NCT01209494|alternans|alternans
5101076|NCT01209494|late potentials|late potentials
5101077|NCT01209494|risk stratification|risk stratification
5101078|NCT01209481|fruits|fruits
5101079|NCT01209481|vegetables|vegetables
5101080|NCT01209481|primary health care|primary health care
5101081|NCT01209481|nutritional education|nutritional education
5101082|NCT01209455|Acetylcysteine|acetylcysteine
5101083|NCT01209455|Adverse effects|adverse effects
5101084|NCT01209455|Acetaminophen|acetaminophen
5101085|NCT01209455|Anaphylactoid reactions|anaphylactoid reactions
5101086|NCT01209442|Glioblastoma|glioblastoma
5101087|NCT01209442|Multiforme|multiforme
5101088|NCT01209429|Calorie restriction|calorie restriction
5101089|NCT01209429|GH/IGF-I axis|gh/igf-i axis
5101090|NCT01209429|STATb5|statb5
5101091|NCT01209429|SIRT1|sirt1
5101092|NCT01209429|Intracellular signaling peptides and proteins|intracellular signaling peptides and proteins
5101093|NCT01209429|Fasting|fasting
5101094|NCT01209429|Growth hormone|growth hormone
5101095|NCT01209429|IGF-1|igf-1
5101096|NCT01209416|ghrelin|ghrelin
5101097|NCT01209416|metabolism|metabolism
5101098|NCT01209416|type 2 diabetes|type 2 diabetes
5101099|NCT01209416|insulin resistance|insulin resistance
5101100|NCT01209403|Dialysis|dialysis
5101101|NCT01209403|Malnutrition|malnutrition
5101102|NCT01209403|Insulin-Like Growth Factor I|insulin-like growth factor i
5101103|NCT01209403|Insulin-Like Growth Factor Binding Protein 1|insulin-like growth factor binding protein 1
5101104|NCT01209403|Inflammation|inflammation
5101105|NCT01209390|osteochondral|osteochondral
5101106|NCT01209390|regenerative|regenerative
5101107|NCT01209390|repair|repair
5101108|NCT01209390|cartilage lesion|cartilage lesion
5101109|NCT01209377|standard|standard
5101110|NCT01209377|fixed|fixed
5101111|NCT01209377|no focus|no focus
5101112|NCT01209377|EMDR treatment with bilateral stimulation via eye movement|emdr treatment with bilateral stimulation via eye movement
5101113|NCT01209377|EMDR treatment with fixed eyes|emdr treatment with fixed eyes
5101114|NCT01209377|Trauma exposition without external stimulus|trauma exposition without external stimulus
5101115|NCT01209364|comparative|comparative
5101116|NCT01209364|randomized|randomized
5101117|NCT01209364|double-blind|double-blind
5101118|NCT01209364|non-inferior|non-inferior
5101119|NCT01209364|knee OA|knee oa
5101120|NCT01209351|Pharmacokinetics|pharmacokinetics
5101121|NCT01209351|Pharmacodynamics|pharmacodynamics
5101122|NCT01209351|teduglutide|teduglutide
5101123|NCT01209325|human papilloma virus infection|human papilloma virus infection
5101124|NCT01209325|anal cancer|anal cancer
5101125|NCT01209325|penile cancer|penile cancer
5101126|NCT01209325|HIV infection|hiv infection
5101127|NCT01209299|recurrent melanoma|recurrent melanoma
5101128|NCT01209299|stage IIIC melanoma|stage iiic melanoma
5101129|NCT01209299|stage IV melanoma|stage iv melanoma
5101130|NCT01209286|Blinatumomab|blinatumomab
5101131|NCT01209286|B-ALL|b-all
5101132|NCT01209286|adult ALL|adult all
5101133|NCT01209286|relapsed ALL|relapsed all
5101134|NCT01209286|refractory ALL|refractory all
5101135|NCT01209286|Leukemia|leukemia
5101136|NCT01209286|ALL|all
5101137|NCT01209286|Lymphatic diseases|lymphatic diseases
5101138|NCT01209286|Lymphoproliferative disorders|lymphoproliferative disorders
5101139|NCT01209286|bispecific antibody|bispecific antibody
5101140|NCT01209286|anti-CD19|anti-cd19
5101141|NCT01209286|Immunotherapeutic treatment|immunotherapeutic treatment
5101142|NCT01209273|Quality of Life|quality of life
5101143|NCT01209273|Automated Peritoneal Dialysis|automated peritoneal dialysis
5101144|NCT01209273|Continuous Ambulatory Peritoneal Dialysis|continuous ambulatory peritoneal dialysis
5101145|NCT01209273|End Stage Renal Disease|end stage renal disease
5101146|NCT01209260|Transseptal Puncture|transseptal puncture
5101147|NCT01209260|Radiofrequency Energy|radiofrequency energy
5101148|NCT01209260|Left Atrium Access|left atrium access
5101149|NCT01209260|Left Atrial Catheterization|left atrial catheterization
5101150|NCT01209260|Ablation|ablation
5101151|NCT01209260|Transseptal Catheterization|transseptal catheterization
5101152|NCT01209260|Electrocautery|electrocautery
5101153|NCT01209260|Catheter Ablation|catheter ablation
5101154|NCT01209260|Atrial Fibrillation|atrial fibrillation
5101155|NCT01209247|Fluoroquinolone -resistance|fluoroquinolone -resistance
5101156|NCT01209247|Commensal flora|commensal flora
5101157|NCT01209247|Emergence of resistance|emergence of resistance
5101158|NCT01209234|Methicillin-resistant Staphylococcus aureus|methicillin-resistant staphylococcus aureus
5101159|NCT01209234|MRSA|mrsa
5101160|NCT01209195|Ovarian cancer|ovarian cancer
5101161|NCT01209195|HER-2 negative breast cancer|her-2 negative breast cancer
5101162|NCT01209195|Breast cancer|breast cancer
5101163|NCT01209195|Fallopian tube cancer|fallopian tube cancer
5101164|NCT01209169|Kidney Renal|kidney renal
5101165|NCT01209117|formulation|formulation
5101166|NCT01209117|bioavailability|bioavailability
5101167|NCT01209117|pharmacokinetics|pharmacokinetics
5101168|NCT01209117|GSK2248761|gsk2248761
5101169|NCT01209104|omeprazole|omeprazole
5101170|NCT01209104|proton pump inhibitor|proton pump inhibitor
5101171|NCT01209104|COPD|copd
5101172|NCT01209104|CXCR2 inhibitor|cxcr2 inhibitor
5101173|NCT01209104|bioavailability|bioavailability
5101174|NCT01209104|food-effect|food-effect
5101175|NCT01209078|methicillin-resistant Staphylococcus aureus|methicillin-resistant staphylococcus aureus
5101176|NCT01209078|linezolid|linezolid
5101177|NCT01209078|repeat dose|repeat dose
5101178|NCT01209078|GSK1322322|gsk1322322
5101179|NCT01209065|integrase|integrase
5101180|NCT01209065|fosamprenavir|fosamprenavir
5101181|NCT01209065|ritonavir|ritonavir
5101182|NCT01209065|GSK1349572|gsk1349572
5101183|NCT01209052|COPD|copd
5101184|NCT01209052|CXCR2 inhibitor|cxcr2 inhibitor
5101185|NCT01209039|Schizophrenia|schizophrenia
5101187|NCT01209026|Fluticasone furoate (GW685698)|fluticasone furoate (gw685698)
5101188|NCT01209026|moxifloxacin|moxifloxacin
5101189|NCT01209026|QTc|qtc
5101190|NCT01209026|GW642444|gw642444
5101191|NCT01209026|pharmacokinetics|pharmacokinetics
5101192|NCT01209013|PDT|pdt
5101193|NCT01209013|porfimer sodium|porfimer sodium
5101194|NCT01209013|BE|be
5101195|NCT01209000|Focal and Segmental Glomerulosclerosis|focal and segmental glomerulosclerosis
5101196|NCT01209000|Focal & Segmental Glomerulosclerosis|focal & segmental glomerulosclerosis
5101197|NCT01209000|Focal Segmental Glomerulosclerosis|focal segmental glomerulosclerosis
5101198|NCT01209000|FSGS|fsgs
5101199|NCT01209000|Minimal change disease|minimal change disease
5101200|NCT01209000|MCD|mcd
5101201|NCT01209000|Membranous Nephropathy|membranous nephropathy
5101202|NCT01209000|MN|mn
5101203|NCT01209000|Nephrotic Syndrome|nephrotic syndrome
5101204|NCT01209000|Neph Syndrome|neph syndrome
5101205|NCT01209000|NEPTUNE|neptune
5101206|NCT01209000|NephCure|nephcure
5101207|NCT01209000|Halpin|halpin
5101208|NCT01208974|Breast Cancer|breast cancer
5101209|NCT01208974|Nipple Area Complex|nipple area complex
5101210|NCT01208974|Mastectomy|mastectomy
5101211|NCT01208974|Radiation Therapy|radiation therapy
5101212|NCT01208974|Nipple-Sparing|nipple-sparing
5101213|NCT01208974|Breast Reconstruction|breast reconstruction
5101214|NCT01208961|Eicosapentaenoic Acid|eicosapentaenoic acid
5101215|NCT01208961|Docosahexaenoic Acid|docosahexaenoic acid
5101216|NCT01208961|Hypertriglyceridemia|hypertriglyceridemia
5101217|NCT01208961|Omega-3 acid ethyl esters|omega-3 acid ethyl esters
5101218|NCT01208961|Omega-3 carboxylic acids|omega-3 carboxylic acids
5101219|NCT01208961|Epanova|epanova
5101220|NCT01208961|Lovaza|lovaza
5101221|NCT01208961|bioavailability|bioavailability
5101222|NCT01208961|pharmacokinetics|pharmacokinetics
5101223|NCT01208961|low-fat meal|low-fat meal
5101224|NCT01208961|high-fat meal|high-fat meal
5101225|NCT01208948|macular edema|macular edema
5101226|NCT01208948|diabetes mellitus|diabetes mellitus
5101227|NCT01208948|prevention alpha lipoic acid|prevention alpha lipoic acid
5101228|NCT01208935|Randomized|randomized
5101229|NCT01208935|Double blind|double blind
5101230|NCT01208935|double-dummy|double-dummy
5101231|NCT01208935|placebo-controlled|placebo-controlled
5101232|NCT01208896|Allogeneic hematopoietic stem cell transplantation|allogeneic hematopoietic stem cell transplantation
5101233|NCT01208896|Reduced-intensity conditioning|reduced-intensity conditioning
5101234|NCT01208896|Chemosensitive relapsed follicular lymphoma|chemosensitive relapsed follicular lymphoma
5101235|NCT01208883|Primary non-operated squamous cell carcinoma of the oral cavity, oropharynx, hypopharynx and larynx.|primary non-operated squamous cell carcinoma of the oral cavity, oropharynx, hypopharynx and larynx.
5101236|NCT01208831|Advanced tumors|advanced tumors
5101237|NCT01208831|hedgehog|hedgehog
5101238|NCT01208831|smoothened inhibitor|smoothened inhibitor
5101239|NCT01208792|Auto antibodies|auto antibodies
5101240|NCT01208792|Target antigens|target antigens
5101241|NCT01208792|2D-immunoblot|2d-immunoblot
5101242|NCT01208792|Reactive oxygen species|reactive oxygen species
5101243|NCT01208792|Pulmonary arterial hypertension|pulmonary arterial hypertension
5101244|NCT01208792|Systemic sclerosis|systemic sclerosis
5101245|NCT01208792|Human immunodeficiency virus infection|human immunodeficiency virus infection
5101246|NCT01208792|Porto pulmonary hypertension|porto pulmonary hypertension
5101247|NCT01208792|Congenital heart defect|congenital heart defect
5101248|NCT01208792|Systemic lupus erythematosus|systemic lupus erythematosus
5101249|NCT01208792|Mixed connective tissue disease|mixed connective tissue disease
5101250|NCT01208792|Sjögren's syndrome|sjögren's syndrome
5101251|NCT01208779|Compliance|compliance
5101252|NCT01208779|HR+ breast cancer|hr+ breast cancer
5101253|NCT01208779|epidemiology|epidemiology
5101254|NCT01208766|Multiple Myeloma (Kahler's disease)|multiple myeloma (kahler's disease)
5101255|NCT01208753|Safety|safety
5101256|NCT01208753|Tolerability|tolerability
5101257|NCT01208753|Pharmacokinetics|pharmacokinetics
5101258|NCT01208740|Gonadotropins|gonadotropins
5101259|NCT01208740|infertility|infertility
5101260|NCT01208740|IVF|ivf
5101261|NCT01208740|metformin|metformin
5101262|NCT01208740|PCOS|pcos
5101263|NCT01208740|poor prognosis|poor prognosis
5101264|NCT01208740|poor responder|poor responder
5101265|NCT01208727|Myocardial infarction|myocardial infarction
5101266|NCT01208727|Postconditioning|postconditioning
5101267|NCT01208727|Microvascular obstruction|microvascular obstruction
5101268|NCT01208727|No reflow|no reflow
5101269|NCT01208727|MRI|mri
5101270|NCT01208714|Renal artery stenosis|renal artery stenosis
5101271|NCT01208714|Atherosclerosis|atherosclerosis
5101272|NCT01208714|Arterial hypertension|arterial hypertension
5101273|NCT01208714|Percutaneous renal angioplasty|percutaneous renal angioplasty
5101274|NCT01208714|Stenting|stenting
5101275|NCT01208701|Atorvastatin|atorvastatin
5101277|NCT01208701|NO|no
5101278|NCT01208701|Nephrology|nephrology
5101279|NCT01208701|Diabetes Mellitus|diabetes mellitus
5101280|NCT01208688|Spinal Cord Injuries|spinal cord injuries
5101281|NCT01208662|Lenalidomide|lenalidomide
5101282|NCT01208662|Bortezomib|bortezomib
5101283|NCT01208662|Dexamethasone|dexamethasone
5101284|NCT01208662|Stem Cell Transplant|stem cell transplant
5101285|NCT01208662|Myeloma|myeloma
5101286|NCT01208662|Multiple Myeloma|multiple myeloma
5101287|NCT01208649|exenatide|exenatide
5101288|NCT01208649|hepatic steatosis|hepatic steatosis
5101289|NCT01208649|insulin resistance|insulin resistance
5101290|NCT01208649|insulin sensitizers|insulin sensitizers
5101291|NCT01208649|nonalcoholic fatty liver disease|nonalcoholic fatty liver disease
5101292|NCT01208649|- GLP1-Analog|- glp1-analog
5101293|NCT01208636|Vitamin D deficiency|vitamin d deficiency
5101294|NCT01208636|Sun|sun
5101295|NCT01208636|Genetics|genetics
5101296|NCT01208584|functional MRI,primary motor cortex,spinal cord injury|functional mri,primary motor cortex,spinal cord injury
5101297|NCT01208571|Harmful use|harmful use
5101298|NCT01208571|Hazardous use|hazardous use
5101299|NCT01208571|Dependence|dependence
5101300|NCT01208558|Blood pressure|blood pressure
5101301|NCT01208558|Cereals|cereals
5101302|NCT01208558|Diet Therapy|diet therapy
5101303|NCT01208558|Dietary carbohydrates|dietary carbohydrates
5101304|NCT01208558|Dietary fiber|dietary fiber
5101305|NCT01208558|Exercise Therapy|exercise therapy
5101306|NCT01208558|Food|food
5101307|NCT01208558|Glucose intolerance|glucose intolerance
5101308|NCT01208558|Lifestyle|lifestyle
5101309|NCT01208558|Physiotherapy|physiotherapy
5101310|NCT01208558|Stroke|stroke
5101311|NCT01208558|TIA|tia
5101312|NCT01208558|Waist circumference|waist circumference
5101313|NCT01208558|Weight loss|weight loss
5101314|NCT01208545|taxol|taxol
5101315|NCT01208545|vincristine|vincristine
5101316|NCT01208545|oxaliplatin|oxaliplatin
5101317|NCT01208545|chemotherapy|chemotherapy
5101318|NCT01208545|nerve degeneration|nerve degeneration
5101319|NCT01208545|nerve conduction|nerve conduction
5101320|NCT01208545|cancer|cancer
5101321|NCT01208545|nerve conduction studies|nerve conduction studies
5101322|NCT01208519|Drug resistance, Microbial|drug resistance, microbial
5101323|NCT01208519|Methicillin-Resistant Staphylococcus aureus|methicillin-resistant staphylococcus aureus
5101324|NCT01208519|ESBL|esbl
5101325|NCT01208519|Colonisation|colonisation
5101326|NCT01208519|Screening|screening
5101327|NCT01208519|Gram-negative|gram-negative
5101328|NCT01208493|prematurity|prematurity
5101329|NCT01208493|enteral feeding|enteral feeding
5101332|NCT01208480|stage II breast cancer|stage ii breast cancer
5101333|NCT01208480|stage IIIA breast cancer|stage iiia breast cancer
5101334|NCT01208480|stage IIIB breast cancer|stage iiib breast cancer
5101335|NCT01208480|stage IIIC breast cancer|stage iiic breast cancer
5101336|NCT01208480|triple-negative breast cancer|triple-negative breast cancer
5101337|NCT01208428|Depression|depression
5101338|NCT01208415|Zenith aortoiliac aneurysm|zenith aortoiliac aneurysm
5101339|NCT01208415|iliac aneurysm|iliac aneurysm
5101340|NCT01208415|branch|branch
5101341|NCT01208415|connections|connections
5101342|NCT01208415|endovascular graft|endovascular graft
5101343|NCT01208415|graft-iliac bifurcation|graft-iliac bifurcation
5101344|NCT01208415|Aneurysm|aneurysm
5101345|NCT01208415|Vascular Diseases|vascular diseases
5101346|NCT01208415|Cardiovascular Diseases|cardiovascular diseases
5101347|NCT01208363|Iron fortification|iron fortification
5101348|NCT01208363|polyphenols|polyphenols
5101349|NCT01208363|NaFeEDTA|nafeedta
5101350|NCT01208363|cowpea|cowpea
5101351|NCT01208363|school feeding program|school feeding program
5101352|NCT01208350|Weight Loss|weight loss
5101353|NCT01208350|Motivation|motivation
5101354|NCT01208350|Workplace|workplace
5101355|NCT01208350|Web platform|web platform
5101356|NCT01208337|Rejection|rejection
5101357|NCT01208324|Cognitive difficulties|cognitive difficulties
5101358|NCT01208324|memory impairment|memory impairment
5101359|NCT01208324|mood changes|mood changes
5101360|NCT01208324|brain activation|brain activation
5101361|NCT01208311|Alcoholic cirrhosis|alcoholic cirrhosis
5101362|NCT01208311|hepatitis c cirrhosis|hepatitis c cirrhosis
5101363|NCT01208311|cirrhosis|cirrhosis
5101364|NCT01208298|Cold Sore Patch|cold sore patch
5101365|NCT01208272|Body Mass Index|body mass index
5101366|NCT01208272|Bulimia/therapy|bulimia/therapy
5101367|NCT01208272|Comorbidity|comorbidity
5101368|NCT01208272|Interpersonal Relations|interpersonal relations
5101369|NCT01208272|Psychotherapy/methods|psychotherapy/methods
5101370|NCT01208259|Body Mass Index|body mass index
5101371|NCT01208259|Bulimia/therapy|bulimia/therapy
5101372|NCT01208259|Comorbidity|comorbidity
5101373|NCT01208259|Interpersonal Relations|interpersonal relations
5101374|NCT01208259|Psychotherapy/methods|psychotherapy/methods
5101375|NCT01208233|Phase 2 Ischemic stroke Safety and efficacy|phase 2 ischemic stroke safety and efficacy
5101376|NCT01208220|Collagenase Santyl|collagenase santyl
5101377|NCT01208220|Enzymatic debridement|enzymatic debridement
5101378|NCT01208220|maintenance debridement|maintenance debridement
5101379|NCT01208220|VAC|vac
5101380|NCT01208220|NPWT|npwt
5101381|NCT01208194|Advanced colorectal carcinoma|advanced colorectal carcinoma
5101382|NCT01208194|Maintenance therapy|maintenance therapy
5101383|NCT01208194|Immunomodulator|immunomodulator
5101384|NCT01208168|toenail fungus|toenail fungus
5101385|NCT01208168|onychomycosis|onychomycosis
5101386|NCT01208168|nail infection|nail infection
5101387|NCT01208155|Phase 1|phase 1
5101388|NCT01208155|Healthy|healthy
5101389|NCT01208155|pharmacokinetics|pharmacokinetics
5101390|NCT01208155|Fostamatinib|fostamatinib
5101391|NCT01208142|toe walker|toe walker
5101392|NCT01208142|Pediatric toe walking|pediatric toe walking
5101393|NCT01208142|ankle flexion|ankle flexion
5101394|NCT01208129|toenail fungus|toenail fungus
5101395|NCT01208129|onychomycosis|onychomycosis
5101396|NCT01208129|nail infection|nail infection
5101397|NCT01208116|Atherosclerosis|atherosclerosis
5101398|NCT01208116|Prognosis|prognosis
5101399|NCT01208116|Flow-mediated dilatation|flow-mediated dilatation
5101400|NCT01208116|Brachial-ankle pulse wave velocity|brachial-ankle pulse wave velocity
5101401|NCT01208116|Carotid Intimal-Medial Thickness|carotid intimal-medial thickness
5101402|NCT01208116|coronary artery calcification score|coronary artery calcification score
5101403|NCT01208116|Ankle-brachial index|ankle-brachial index
5101404|NCT01208103|Cancer|cancer
5101405|NCT01208103|Small bowel|small bowel
5101406|NCT01208103|Ampulla of Vater|ampulla of vater
5101407|NCT01208103|CAPOX Chemotherapy|capox chemotherapy
5101408|NCT01208103|Bevacizumab|bevacizumab
5101409|NCT01208103|Capecitabine|capecitabine
5101410|NCT01208103|Oxaliplatin|oxaliplatin
5101411|NCT01208103|Xeloda|xeloda
5101412|NCT01208103|Eloxatin|eloxatin
5101413|NCT01208103|Avastin|avastin
5101414|NCT01208103|Anti-VEGF monoclonal antibody|anti-vegf monoclonal antibody
5101415|NCT01208103|rhuMab-VEGF|rhumab-vegf
5101416|NCT01208090|psoriasis|psoriasis
5101417|NCT01208090|chronic plaque psoriasis|chronic plaque psoriasis
5101418|NCT01208090|Moderate to severe chronic plaque psoriasis|moderate to severe chronic plaque psoriasis
5101419|NCT01208077|ED hemodynamic profiles|ed hemodynamic profiles
5101420|NCT01208077|patients treated under current clinical standards|patients treated under current clinical standards
5101421|NCT01208077|Acute CHF|acute chf
5101422|NCT01208077|Stroke syndromes|stroke syndromes
5101423|NCT01208077|Systemic infection|systemic infection
5101424|NCT01208064|adenocarcinoma of the lung|adenocarcinoma of the lung
5101425|NCT01208064|adenosquamous cell lung cancer|adenosquamous cell lung cancer
5101426|NCT01208064|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
5101427|NCT01208064|large cell lung cancer|large cell lung cancer
5101428|NCT01208064|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5102117|NCT01204918|Riluzole|riluzole
5101429|NCT01208064|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5101430|NCT01208064|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5101431|NCT01208025|Plaque|plaque
5101432|NCT01208025|Imaging|imaging
5101433|NCT01208012|Diabetes Mellitus treatment Metformin|diabetes mellitus treatment metformin
5101434|NCT01207999|Human papillomavirus|human papillomavirus
5101435|NCT01207960|dental phobia|dental phobia
5101436|NCT01207960|psychotherapy|psychotherapy
5101437|NCT01207960|eye movement desensitization and reprocessing - EMDR|eye movement desensitization and reprocessing - emdr
5101438|NCT01207960|efficacy|efficacy
5101439|NCT01207960|wait-list control|wait-list control
5101440|NCT01207947|Vardenafil|vardenafil
5101441|NCT01207947|Erectile dysfunction|erectile dysfunction
5101442|NCT01207947|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors
5101443|NCT01207947|Combination use with alpha-blockers|combination use with alpha-blockers
5101444|NCT01207934|diabetes|diabetes
5101445|NCT01207934|obesity|obesity
5101446|NCT01207908|DMD|dmd
5101447|NCT01207908|Duchenne Muscular Dystrophy|duchenne muscular dystrophy
5101448|NCT01207908|Insulin like growth factor|insulin like growth factor
5101449|NCT01207908|6 minute walk test|6 minute walk test
5101450|NCT01207869|Bronchopulmonary dysplasia (BPD)|bronchopulmonary dysplasia (bpd)
5101451|NCT01207869|Extremely premature infant|extremely premature infant
5101452|NCT01207869|Mesenchymal stem cells (MSCs)|mesenchymal stem cells (mscs)
5101453|NCT01207869|umbilical cord|umbilical cord
5101454|NCT01207856|Multiple sclerosis|multiple sclerosis
5101455|NCT01207856|functional MRI|functional mri
5101456|NCT01207856|cognitive rehabilitation|cognitive rehabilitation
5101457|NCT01207856|ecological evaluation|ecological evaluation
5101458|NCT01207856|neuroplasticity|neuroplasticity
5101459|NCT01207843|Computed tomography|computed tomography
5101460|NCT01207830|Obesity|obesity
5101461|NCT01207817|a light flash in each eye for a total of 48 measurements|a light flash in each eye for a total of 48 measurements
5101462|NCT01207804|Obesity|obesity
5101463|NCT01207791|drug abuse|drug abuse
5101464|NCT01207791|emergency department|emergency department
5101465|NCT01207791|brief intervention|brief intervention
5101466|NCT01207791|motivational interviewing|motivational interviewing
5101467|NCT01207791|SBIRT|sbirt
5101468|NCT01207778|brain|brain
5101469|NCT01207778|development|development
5101470|NCT01207778|erythropoietin|erythropoietin
5101471|NCT01207778|neuroprotection|neuroprotection
5101472|NCT01207778|MRI|mri
5101473|NCT01207765|Multiple Myeloma|multiple myeloma
5101474|NCT01207765|Zevalin|zevalin
5101475|NCT01207752|dry eye, meibomian gland dysfunction, tear film break up time|dry eye, meibomian gland dysfunction, tear film break up time
5101476|NCT01207739|Prolonged antibiotic treatment in Lyme disease|prolonged antibiotic treatment in lyme disease
5101477|NCT01207739|Doxycycline|doxycycline
5101478|NCT01207739|Clarithromycin|clarithromycin
5101479|NCT01207739|Hydroxychloroquine|hydroxychloroquine
5101480|NCT01207700|post discharge intervention|post discharge intervention
5101481|NCT01207700|adherence|adherence
5101482|NCT01207700|compliance|compliance
5101483|NCT01207700|community health worker|community health worker
5101484|NCT01207674|Pathological gambling|pathological gambling
5101485|NCT01207674|"at risk gambling"|"at risk gambling"
5101486|NCT01207674|gambling practice evolution|gambling practice evolution
5101487|NCT01207674|psychiatric comorbidities|psychiatric comorbidities
5101488|NCT01207674|gambling trajectory|gambling trajectory
5101489|NCT01207674|cognitive distortions|cognitive distortions
5101490|NCT01207674|ADHD|adhd
5101491|NCT01207674|addiction|addiction
5101492|NCT01207674|recourse to care|recourse to care
5101493|NCT01207661|Mesenchymal cells|mesenchymal cells
5101494|NCT01207661|osteoarthritis|osteoarthritis
5101495|NCT01207661|intra articular injection|intra articular injection
5101496|NCT01207648|Interferon beta 1a|interferon beta 1a
5101497|NCT01207648|Autoimmune Diseases|autoimmune diseases
5101498|NCT01207648|Demyelinating Diseases|demyelinating diseases
5101499|NCT01207648|Immune System Diseases|immune system diseases
5101500|NCT01207648|Immunologic Factors|immunologic factors
5101501|NCT01207648|Nervous System Diseases|nervous system diseases
5101502|NCT01207648|Physiological Effects of Drugs|physiological effects of drugs
5101503|NCT01207648|Demyelinating Autoimmune Diseases, CNS|demyelinating autoimmune diseases, cns
5101504|NCT01207648|Autoimmune Diseases of the Nervous System|autoimmune diseases of the nervous system
5101505|NCT01207648|Retrospective Cohort Study|retrospective cohort study
5101506|NCT01207635|Cancer|cancer
5101507|NCT01207635|Arimidex|arimidex
5101508|NCT01207609|Obesity|obesity
5101509|NCT01207609|Morbid Obesity|morbid obesity
5101510|NCT01207609|Bariatric Surgery|bariatric surgery
5101511|NCT01207609|Laparoscopic Gastric Plication|laparoscopic gastric plication
5101512|NCT01207596|Pain|pain
5101513|NCT01207596|Neuropathy|neuropathy
5101514|NCT01207596|Neuropathic Pain|neuropathic pain
5101515|NCT01207596|Hydromorphone|hydromorphone
5101516|NCT01207583|vaccine|vaccine
5101517|NCT01207583|infant|infant
5101518|NCT01207583|healthy subjects|healthy subjects
5101519|NCT01207570|flexibility|flexibility
5101520|NCT01207570|muscle|muscle
5101521|NCT01207570|stretching|stretching
5101522|NCT01207570|cerebral palsy|cerebral palsy
5101523|NCT01207570|developmental|developmental
5101524|NCT01207557|Healthcare personnel|healthcare personnel
5101525|NCT01207557|influenza|influenza
5101526|NCT01207557|immunization|immunization
5101527|NCT01207557|flu|flu
5101528|NCT01207557|vaccine|vaccine
5101529|NCT01207544|motor|motor
5101530|NCT01207544|balance|balance
5101531|NCT01207544|developmental|developmental
5101532|NCT01207544|physiotherapy|physiotherapy
5101533|NCT01207531|sepsis|sepsis
5101534|NCT01207531|miRNA|mirna
5101535|NCT01207518|influenza|influenza
5101536|NCT01207518|immunization|immunization
5101537|NCT01207518|healthcare personnel|healthcare personnel
5101538|NCT01207505|bipolar disorder|bipolar disorder
5101539|NCT01207505|depression|depression
5101540|NCT01207505|mania|mania
5101541|NCT01207505|emotion regulation|emotion regulation
5101542|NCT01207505|dialectical behavior therapy|dialectical behavior therapy
5101543|NCT01207505|group therapy|group therapy
5101544|NCT01207505|mindfulness|mindfulness
5101545|NCT01207492|nilotinib|nilotinib
5101546|NCT01207453|Arthritis, Rheumatoid|arthritis, rheumatoid
5101547|NCT01207453|Milnacipran|milnacipran
5101548|NCT01207453|Pain|pain
5101549|NCT01207440|CML|cml
5101550|NCT01207440|ALL|all
5101551|NCT01207440|PH|ph
5101552|NCT01207440|ponatinib|ponatinib
5101553|NCT01207440|Ph+ALL|ph+all
5101554|NCT01207440|T315I mutation|t315i mutation
5101555|NCT01207440|Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia|philadelphia chromosome positive acute lymphoblastic leukemia
5101556|NCT01207427|opioid therapy|opioid therapy
5101557|NCT01207427|constipation|constipation
5101558|NCT01207427|chronic noncancer pain|chronic noncancer pain
5101559|NCT01207427|mu opioid receptor antagonist|mu opioid receptor antagonist
5101560|NCT01207427|ADL5945|adl5945
5101561|NCT01207414|Schizophrenia|schizophrenia
5101562|NCT01207414|iloperidone|iloperidone
5101563|NCT01207414|switch|switch
5101564|NCT01207414|gradual switch|gradual switch
5101565|NCT01207414|immediate switch|immediate switch
5101566|NCT01207401|intrauterine device|intrauterine device
5101567|NCT01207401|local anesthetic|local anesthetic
5101568|NCT01207388|Blinatumomab|blinatumomab
5101569|NCT01207388|MRD|mrd
5101570|NCT01207388|B-ALL|b-all
5101571|NCT01207388|Minimal residual disease|minimal residual disease
5101572|NCT01207388|adult ALL|adult all
5101573|NCT01207388|Leukemia|leukemia
5101574|NCT01207388|ALL|all
5101575|NCT01207388|Lymphatic diseases|lymphatic diseases
5101576|NCT01207388|Lymphoproliferative disorders|lymphoproliferative disorders
5101577|NCT01207388|bispecific antibody|bispecific antibody
5101578|NCT01207388|anti-CD19|anti-cd19
5101579|NCT01207388|Immunotherapeutic treatment|immunotherapeutic treatment
5101580|NCT01207375|memory|memory
5101581|NCT01207375|learning|learning
5101582|NCT01207375|Traumatic Brain Injury|traumatic brain injury
5101583|NCT01207375|cognition|cognition
5101584|NCT01207375|treatment|treatment
5101585|NCT01207375|therapy|therapy
5101586|NCT01207349|Type 2 diabetes|type 2 diabetes
5101587|NCT01207349|Secondary prevention|secondary prevention
5101588|NCT01207349|Physical activity|physical activity
5101589|NCT01207349|Nutritional education|nutritional education
5101590|NCT01207349|HbA1c|hba1c
5101591|NCT01207349|Reunion island|reunion island
5101592|NCT01207349|diabetic patients, both female and male, age >=18 years, able to practise a physical activity, in Saint Pierre (GHSR) and Saint Denis (CHD)|diabetic patients, both female and male, age >=18 years, able to practise a physical activity, in saint pierre (ghsr) and saint denis (chd)
5101593|NCT01207336|stroke|stroke
5101594|NCT01207336|rehabilitation|rehabilitation
5101595|NCT01207336|transcranial direct current stimulation|transcranial direct current stimulation
5101596|NCT01207336|nerve stimulation|nerve stimulation
5101597|NCT01207310|smoking|smoking
5101598|NCT01207310|smoking of 10 cigarettes per day|smoking of 10 cigarettes per day
5101599|NCT01207297|Lupus nephritis|lupus nephritis
5101600|NCT01207297|tacrolimus|tacrolimus
5101601|NCT01207297|cyclophosphamide|cyclophosphamide
5101602|NCT01207271|depression|depression
5101603|NCT01207271|community mental health|community mental health
5101604|NCT01207271|treatment|treatment
5101605|NCT01207271|psychotherapy|psychotherapy
5101606|NCT01207271|mediators|mediators
5101607|NCT01207258|Motivational Interviewing|motivational interviewing
5101608|NCT01207258|Brief Intervention|brief intervention
5101609|NCT01207258|Intimate Partner Violence|intimate partner violence
5101610|NCT01207258|Domestic Violence|domestic violence
5101611|NCT01207258|Alcohol Abuse|alcohol abuse
5101612|NCT01207245|Cystic fibrosis|cystic fibrosis
5101613|NCT01207245|Tobramycin|tobramycin
5101614|NCT01207245|Pharmacokinetics|pharmacokinetics
5101615|NCT01207245|Toxicity|toxicity
5101616|NCT01207232|seasonal influenza|seasonal influenza
5101617|NCT01207232|behavioral economics|behavioral economics
5101618|NCT01207232|implementation intentions|implementation intentions
5101619|NCT01207232|planning prompt|planning prompt
5101620|NCT01207232|nudge|nudge
5101621|NCT01207219|psychosis|psychosis
5101622|NCT01207219|yoga|yoga
5101623|NCT01207219|aerobic exercise|aerobic exercise
5101624|NCT01207219|memory|memory
5101625|NCT01207219|attention|attention
5101626|NCT01207219|neuro cognition|neuro cognition
5101627|NCT01207206|Patient suffering from severe cancer pain despite the opioid treatment|patient suffering from severe cancer pain despite the opioid treatment
5101628|NCT01207206|Opiate tolerance suspected on the basis of rapid escalation in opiate dose|opiate tolerance suspected on the basis of rapid escalation in opiate dose
5101629|NCT01207206|Severe opiate side effects|severe opiate side effects
5101630|NCT01207193|bone cyst bone defect mesenchymal cell|bone cyst bone defect mesenchymal cell
5101631|NCT01207180|emergency medicine|emergency medicine
5101632|NCT01207180|primary care physicians|primary care physicians
5101633|NCT01207141|Liver Transplantation|liver transplantation
5101634|NCT01207141|Thymoglobulin|thymoglobulin
5101635|NCT01207141|Rejection|rejection
5101636|NCT01207102|Breast cancer|breast cancer
5101637|NCT01207102|Triple negative|triple negative
5101638|NCT01207089|Safety|safety
5101639|NCT01207089|tolerability|tolerability
5101640|NCT01207089|PK|pk
5101641|NCT01207089|healthy|healthy
5101642|NCT01207089|overweight|overweight
5101643|NCT01207089|obese|obese
5101644|NCT01207076|CD45+ disease|cd45+ disease
5101645|NCT01207063|Radiotherapy|radiotherapy
5101646|NCT01207063|NSCLC|nsclc
5101647|NCT01207063|Stage II-III non-small cell lung cancer|stage ii-iii non-small cell lung cancer
5101648|NCT01207050|sleep disorders|sleep disorders
5101649|NCT01207050|traumatic brain injury|traumatic brain injury
5101650|NCT01207024|knee arthrosis|knee arthrosis
5101651|NCT01207024|obesity|obesity
5101652|NCT01207024|MRI|mri
5101653|NCT01207024|bariatric surgery|bariatric surgery
5101654|NCT01206998|preterm labor|preterm labor
5101655|NCT01206998|progesterone|progesterone
5101656|NCT01206998|tocolysis|tocolysis
5101657|NCT01206998|cervical length|cervical length
5101658|NCT01206985|Paracetamol|paracetamol
5101659|NCT01206985|per-oral mucosa PMB|per-oral mucosa pmb
5101660|NCT01206985|No disease, healthy volunteers|no disease, healthy volunteers
5101661|NCT01206972|venous thromboembolism|venous thromboembolism
5101662|NCT01206972|prevention|prevention
5101663|NCT01206972|orthopaedic surgery|orthopaedic surgery
5101664|NCT01206959|BP|bp
5101665|NCT01206946|Respiratory distress|respiratory distress
5101666|NCT01206946|Antenatal steroids|antenatal steroids
5101667|NCT01206946|late preterm|late preterm
5101668|NCT01206933|HIV/HCV Coinfection|hiv/hcv coinfection
5101669|NCT01206933|Tat Protein|tat protein
5101670|NCT01206933|HCV|hcv
5101671|NCT01206920|HIV|hiv
5101672|NCT01206920|AIDS|aids
5101673|NCT01206920|Co-morbidities|co-morbidities
5101674|NCT01206907|sickle cell anemia|sickle cell anemia
5101675|NCT01206907|juvenile rheumatoid arthritis|juvenile rheumatoid arthritis
5101676|NCT01206907|burn victim|burn victim
5101677|NCT01206907|cancer|cancer
5101678|NCT01206907|Chronic pain of malignant or non-malignant etiology|chronic pain of malignant or non-malignant etiology
5101679|NCT01206894|lung cancer|lung cancer
5101680|NCT01206894|chest wall invasion|chest wall invasion
5101681|NCT01206894|transthoracic ultrasound|transthoracic ultrasound
5101682|NCT01206881|breast cancer|breast cancer
5101683|NCT01206881|neoadjuvant|neoadjuvant
5101684|NCT01206881|liposomal doxorubicin|liposomal doxorubicin
5101685|NCT01206881|PET scan|pet scan
5101686|NCT01206868|kidney, transplantation, surgery, complications, lymphocele, fluid collections.|kidney, transplantation, surgery, complications, lymphocele, fluid collections.
5101687|NCT01206855|MIST Therapy|mist therapy
5101688|NCT01206842|functional capacity|functional capacity
5101689|NCT01206842|training|training
5101690|NCT01206842|neurocognition|neurocognition
5101691|NCT01206829|Hearing Impaired Persons|hearing impaired persons
5101692|NCT01206829|Tinnitus|tinnitus
5101693|NCT01206829|Life Change Events|life change events
5101694|NCT01206829|Adaptation, Psychological|adaptation, psychological
5101695|NCT01206829|Rehabilitation, Vocational|rehabilitation, vocational
5101696|NCT01206829|Cognitive Therapy|cognitive therapy
5101697|NCT01206829|Avoidance Learning|avoidance learning
5101698|NCT01206829|Escape Reaction|escape reaction
5101699|NCT01206803|ovarian stimulation|ovarian stimulation
5101700|NCT01206803|recombinant FSH|recombinant fsh
5101701|NCT01206803|GnRH-antagonist|gnrh-antagonist
5101702|NCT01206803|corifollitropin alfa|corifollitropin alfa
5101703|NCT01206790|PTSD|ptsd
5101704|NCT01206790|Narrative Exposure Therapy|narrative exposure therapy
5101705|NCT01206790|torture victims|torture victims
5101706|NCT01206790|immune system|immune system
5101707|NCT01206777|Hypersensitivity Reactions|hypersensitivity reactions
5101708|NCT01206777|B-cell malignancies|b-cell malignancies
5101709|NCT01206764|RCC,|rcc,
5101710|NCT01206764|mTOR pathway,|mtor pathway,
5101711|NCT01206764|angiogenesis,|angiogenesis,
5101712|NCT01206764|PFS,|pfs,
5101713|NCT01206764|partial response [PR] + complete response [CR])|partial response [pr] + complete response [cr])
5101714|NCT01206764|metastatic recurrent renal cell carcinoma|metastatic recurrent renal cell carcinoma
5101715|NCT01206764|metastatic unresectable renal cell carcinoma|metastatic unresectable renal cell carcinoma
5101716|NCT01206725|Diabetes type 2|diabetes type 2
5101717|NCT01206725|exercise|exercise
5101718|NCT01206725|tissue Doppler velocity|tissue doppler velocity
5101719|NCT01206712|Diabetes Mellitus Type 2|diabetes mellitus type 2
5101720|NCT01206712|insulin glargine|insulin glargine
5101721|NCT01206712|Metformin|metformin
5101722|NCT01206686|seasonal influenza|seasonal influenza
5101723|NCT01206686|behavioral economics|behavioral economics
5101724|NCT01206686|nudge|nudge
5101725|NCT01206686|implementations intentions|implementations intentions
5101726|NCT01206686|vaccination|vaccination
5101727|NCT01206621|dyspnea|dyspnea
5101728|NCT01206621|COPD|copd
5101729|NCT01206621|CHF|chf
5101730|NCT01206621|asthma|asthma
5101731|NCT01206608|Breast augmentation|breast augmentation
5101732|NCT01206608|Pain|pain
5101733|NCT01206608|Analgesia|analgesia
5101734|NCT01206595|Postoperative Pain|postoperative pain
5101735|NCT01206595|Bunionectomy|bunionectomy
5101736|NCT01206595|Analgesia|analgesia
5101737|NCT01206569|glomerulonephritis|glomerulonephritis
5101738|NCT01206569|systemic lupus erythematosus|systemic lupus erythematosus
5101739|NCT01206556|HUMAN PAPILLOMA VIRUS|human papilloma virus
5101740|NCT01206556|HPV|hpv
5101741|NCT01206543|Craniopharyngioma|craniopharyngioma
5101742|NCT01206543|Surgery|surgery
5101743|NCT01206543|Intraoperative imaging|intraoperative imaging
5101744|NCT01206543|Rate of total removal|rate of total removal
5101745|NCT01206530|histologically documented|histologically documented
5101746|NCT01206530|advanced|advanced
5101747|NCT01206530|metastatic|metastatic
5101748|NCT01206530|adenocarcinoma|adenocarcinoma
5101749|NCT01206530|colon|colon
5101750|NCT01206530|rectum|rectum
5101751|NCT01206517|asenapine|asenapine
5101752|NCT01206517|pediatric schizophrenia|pediatric schizophrenia
5101753|NCT01206517|bipolar I disorder|bipolar i disorder
5101754|NCT01206504|West Nile virus|west nile virus
5101755|NCT01206504|WNV|wnv
5101756|NCT01206504|Encephalitis|encephalitis
5101757|NCT01206504|Meningitis|meningitis
5101758|NCT01206504|Acute Flaccid Paralysis|acute flaccid paralysis
5101759|NCT01206504|Monoclonal Antibody|monoclonal antibody
5101760|NCT01206504|WNND|wnnd
5101761|NCT01206504|West Nile Neuroinvasive Disease|west nile neuroinvasive disease
5101762|NCT01206504|Accidental Exposure to West Nile Virus|accidental exposure to west nile virus
5101763|NCT01206452|Atrial Fibrillation; Ablation|atrial fibrillation; ablation
5101764|NCT01206426|Urothelial, cancer, cisplatin, neoadjuvant, chemotherapy, germline|urothelial, cancer, cisplatin, neoadjuvant, chemotherapy, germline
5101765|NCT01206413|overweight; treatment; women|overweight; treatment; women
5101766|NCT01206400|eugonadal, testosterone|eugonadal, testosterone
5101767|NCT01206374|Vitiligo Vulgaris|vitiligo vulgaris
5101768|NCT01206361|Real world|real world
5101769|NCT01206361|observational|observational
5101770|NCT01206361|retrospective|retrospective
5101771|NCT01206361|database analysis|database analysis
5101772|NCT01206348|Acne|acne
5101773|NCT01206335|Cancer Cachexia|cancer cachexia
5101774|NCT01206335|Anorexia|anorexia
5101775|NCT01206335|Advanced Malignancies|advanced malignancies
5101776|NCT01206335|Weight Loss|weight loss
5101777|NCT01206335|Fatigue|fatigue
5101778|NCT01206335|Karnofsky|karnofsky
5101779|NCT01206335|C-Reactive Protein|c-reactive protein
5101780|NCT01206335|Simmonds Functional Assessment|simmonds functional assessment
5101781|NCT01206322|diabetes, blood flow, brain perfusion, cognitive function|diabetes, blood flow, brain perfusion, cognitive function
5101782|NCT01206309|Graft vs Host Disease|graft vs host disease
5101783|NCT01206309|Allogeneic Hematopoietic Cell Transplantation|allogeneic hematopoietic cell transplantation
5101784|NCT01206309|Bone Marrow Transplantation|bone marrow transplantation
5101785|NCT01206309|Peripheral Blood Stem Cell Transplantation|peripheral blood stem cell transplantation
5101786|NCT01206309|Umbilical Cord Blood Stem Cell Transplantation|umbilical cord blood stem cell transplantation
5101787|NCT01206296|Adjuvant|adjuvant
5101788|NCT01206296|Intraperitoneal|intraperitoneal
5101789|NCT01206296|Gemcitabine|gemcitabine
5101790|NCT01206296|Pancreas|pancreas
5101791|NCT01206296|Adenocarcinoma|adenocarcinoma
5101792|NCT01206283|traumatic brain injury|traumatic brain injury
5101793|NCT01206283|subarachnoid hemorrhage|subarachnoid hemorrhage
5101794|NCT01206283|secondary brain ischemia|secondary brain ischemia
5101795|NCT01206283|microdialysis|microdialysis
5101796|NCT01206283|modified Lund concept|modified lund concept
5101797|NCT01206283|cerebral perfusion pressure|cerebral perfusion pressure
5101798|NCT01206283|intracranial pressure|intracranial pressure
5101799|NCT01206270|Klinefelter|klinefelter
5101800|NCT01206270|Leydig|leydig
5101801|NCT01206270|Testicular Tumor|testicular tumor
5101802|NCT01206270|LH|lh
5101803|NCT01206270|Infertility|infertility
5101804|NCT01206257|Survey|survey
5101805|NCT01206257|Angiography|angiography
5101806|NCT01206257|ADR|adr
5101807|NCT01206257|Image quality|image quality
5101808|NCT01206244|dry eye|dry eye
5101809|NCT01206244|tear meniscus|tear meniscus
5101810|NCT01206244|tear osmolarity|tear osmolarity
5101811|NCT01206231|Standard daily practice in managing patients with hypercholesterolemia|standard daily practice in managing patients with hypercholesterolemia
5101812|NCT01206218|Gastric Cancer, BRCA1|gastric cancer, brca1
5101813|NCT01206205|De novo Multiple Myeloma|de novo multiple myeloma
5101814|NCT01206205|Bortezomib|bortezomib
5101815|NCT01206205|Lenalidomide|lenalidomide
5101816|NCT01206205|induction therapy|induction therapy
5101817|NCT01206205|consolidation therapy|consolidation therapy
5101818|NCT01206205|maintenance therapy|maintenance therapy
5101819|NCT01206205|High dose therapy|high dose therapy
5101918|NCT01205854|rheumatoid arthritis|rheumatoid arthritis
5101820|NCT01206205|frontline therapy including new drugs and high dose therapy|frontline therapy including new drugs and high dose therapy
5101821|NCT01206192|Intimate Terrorism|intimate terrorism
5101822|NCT01206192|Situational couple violence|situational couple violence
5101823|NCT01206192|Mental health|mental health
5101824|NCT01206192|Chinese|chinese
5101825|NCT01206192|Women|women
5101826|NCT01206179|nonunion fracture bone formation pain relief|nonunion fracture bone formation pain relief
5101827|NCT01206166|Randomized trial|randomized trial
5101828|NCT01206166|Parental nutrition|parental nutrition
5101829|NCT01206166|Enteral nutrition|enteral nutrition
5101830|NCT01206166|Intensive care unit|intensive care unit
5101831|NCT01206166|BMI < 25 or ≥ 35|bmi < 25 or ≥ 35
5101832|NCT01206114|2009 H1N1 influenza|2009 h1n1 influenza
5101833|NCT01206114|vaccination|vaccination
5101834|NCT01206114|pandemic|pandemic
5101835|NCT01206114|effectiveness|effectiveness
5101836|NCT01206075|Beta Thalassemia Major|beta thalassemia major
5101837|NCT01206075|Hematopoietic Stem Cell Mobilization|hematopoietic stem cell mobilization
5101838|NCT01206075|Gene Transfer Techniques|gene transfer techniques
5101839|NCT01206062|blood pressure|blood pressure
5101840|NCT01206062|antihypertensive|antihypertensive
5101841|NCT01206062|systolic|systolic
5101842|NCT01206062|diastolic|diastolic
5101843|NCT01206062|heart failure|heart failure
5101844|NCT01206062|myocardial infarction|myocardial infarction
5101845|NCT01206062|stroke|stroke
5101846|NCT01206062|chronic kidney disease|chronic kidney disease
5101847|NCT01206062|dementia|dementia
5101848|NCT01206062|cognitive decline|cognitive decline
5101849|NCT01206049|Cholangiocarcinoma|cholangiocarcinoma
5101850|NCT01206049|Inoperable|inoperable
5101851|NCT01206049|KRAS mutation|kras mutation
5101852|NCT01206049|Biological treatment|biological treatment
5101853|NCT01206049|Combination chemotherapy|combination chemotherapy
5101854|NCT01206049|Monoclonal antibody|monoclonal antibody
5101855|NCT01206036|castration|castration
5101856|NCT01206036|prostate cancer|prostate cancer
5101857|NCT01206036|castration resistant prostate cancer|castration resistant prostate cancer
5101858|NCT01206036|PSA|psa
5101859|NCT01206036|Docetaxel|docetaxel
5101860|NCT01206036|Temsirolimus|temsirolimus
5101861|NCT01206036|disease progression free survival|disease progression free survival
5101862|NCT01206036|DPFS|dpfs
5101863|NCT01206036|dose escalation|dose escalation
5101864|NCT01206023|Multiple Sclerosis|multiple sclerosis
5101865|NCT01206023|Breath|breath
5101866|NCT01206023|Diagnosis|diagnosis
5101867|NCT01206023|Discrimination MS/healthy subj. via exhaled breath samples|discrimination ms/healthy subj. via exhaled breath samples
5101868|NCT01206010|Tobacco Dependence|tobacco dependence
5101869|NCT01206010|Smoking cessation|smoking cessation
5101870|NCT01206010|Varenicline|varenicline
5101871|NCT01206010|Tailored dosing|tailored dosing
5101872|NCT01205997|magnesium|magnesium
5101873|NCT01205997|fentanyl|fentanyl
5101874|NCT01205997|intrathecal|intrathecal
5101875|NCT01205997|pain|pain
5101876|NCT01205984|Chronic rhinosinusitis|chronic rhinosinusitis
5101877|NCT01205984|Computed tomography scan|computed tomography scan
5101878|NCT01205984|Methylprednisolone|methylprednisolone
5101879|NCT01205971|Motivational interviewing|motivational interviewing
5101880|NCT01205971|Community-based multimodal intervention|community-based multimodal intervention
5101881|NCT01205971|Dental Health Advocates|dental health advocates
5101882|NCT01205971|Prevention of ECC|prevention of ecc
5101883|NCT01205971|Randomized clinical trial|randomized clinical trial
5101884|NCT01205958|Cervical pain|cervical pain
5101885|NCT01205958|Neck pain|neck pain
5101886|NCT01205958|western medicine|western medicine
5101887|NCT01205958|oriental medicine|oriental medicine
5101888|NCT01205958|acupuncture|acupuncture
5101889|NCT01205958|needle|needle
5101890|NCT01205945|Aortic aneurysm, abdominal|aortic aneurysm, abdominal
5101891|NCT01205945|Screening|screening
5101892|NCT01205945|Mortality|mortality
5101893|NCT01205932|venous thromboembolism|venous thromboembolism
5101894|NCT01205932|prevention|prevention
5101895|NCT01205932|othopaedic surgery|othopaedic surgery
5101896|NCT01205919|Tinnitus|tinnitus
5101897|NCT01205919|Internet Training|internet training
5101898|NCT01205919|Cognitive-Behavior Therapy|cognitive-behavior therapy
5101899|NCT01205919|CBT|cbt
5101900|NCT01205906|Tinnitus|tinnitus
5101901|NCT01205906|Internet Training|internet training
5101902|NCT01205906|Cognitive-Behavior Therapy|cognitive-behavior therapy
5101903|NCT01205906|CBT|cbt
5101904|NCT01205880|combination treatment|combination treatment
5101905|NCT01205880|topical corticosteroid|topical corticosteroid
5101906|NCT01205880|vitamin D analogue|vitamin d analogue
5101907|NCT01205880|clobex|clobex
5101908|NCT01205880|vectical|vectical
5101909|NCT01205880|clobetasol|clobetasol
5101910|NCT01205880|calcitriol|calcitriol
5101911|NCT01205867|Butyrylcholinesterase deficiency|butyrylcholinesterase deficiency
5101912|NCT01205867|tolerability|tolerability
5101913|NCT01205867|safety|safety
5101914|NCT01205867|AZD8848|azd8848
5101915|NCT01205867|pharmacokinetics|pharmacokinetics
5101916|NCT01205867|pharmacodynamics|pharmacodynamics
5101917|NCT01205867|BChE deficient subjects and matched control subject|bche deficient subjects and matched control subject
5101919|NCT01205854|ultrasonography|ultrasonography
5101920|NCT01205854|remission|remission
5101921|NCT01205854|imaging remission|imaging remission
5101922|NCT01205854|tight control|tight control
5101923|NCT01205854|treat to target|treat to target
5101924|NCT01205841|Ottawa Ankle and Foot Rules|ottawa ankle and foot rules
5101925|NCT01205841|Buffalo Rule|buffalo rule
5101926|NCT01205841|Bernese Ankle Rules|bernese ankle rules
5101927|NCT01205841|Low Risk Exam|low risk exam
5101928|NCT01205841|Malleolar Zone Algorithm|malleolar zone algorithm
5101929|NCT01205841|Clinical decision rule|clinical decision rule
5101930|NCT01205841|Ankle injury|ankle injury
5101931|NCT01205841|Ankle sprain|ankle sprain
5101932|NCT01205841|Inversion trauma|inversion trauma
5101933|NCT01205828|liver cancer|liver cancer
5101934|NCT01205828|hepatocellular|hepatocellular
5101935|NCT01205828|temozolomide|temozolomide
5101936|NCT01205828|veliparib|veliparib
5101937|NCT01205802|patency, hepatic venous congestion, liver transplantation|patency, hepatic venous congestion, liver transplantation
5101938|NCT01205789|Drug eluting stents|drug eluting stents
5101939|NCT01205789|Stents|stents
5101940|NCT01205789|Angioplasty|angioplasty
5101941|NCT01205789|Left Main Coronary Artery Disease|left main coronary artery disease
5101942|NCT01205776|Drug eluting stents|drug eluting stents
5101943|NCT01205776|Stents|stents
5101944|NCT01205776|Unprotected Left Main Coronary Artery Disease|unprotected left main coronary artery disease
5101945|NCT01205776|Coronary artery bypass graft surgery|coronary artery bypass graft surgery
5101946|NCT01205737|DLBCL|dlbcl
5101947|NCT01205737|pharmacokinetics|pharmacokinetics
5101948|NCT01205737|pharmacodynamics|pharmacodynamics
5101949|NCT01205711|recurrent colon cancer|recurrent colon cancer
5101950|NCT01205711|stage IV colon cancer|stage iv colon cancer
5101951|NCT01205711|recurrent rectal cancer|recurrent rectal cancer
5101952|NCT01205711|stage IV rectal cancer|stage iv rectal cancer
5101953|NCT01205672|Endometrium|endometrium
5101954|NCT01205672|Gynecologic malignancy|gynecologic malignancy
5101955|NCT01205672|Endometrial adenocarcinoma|endometrial adenocarcinoma
5101956|NCT01205672|Insulin/glucose metabolism|insulin/glucose metabolism
5101957|NCT01205672|Metformin|metformin
5101958|NCT01205646|prostate cancer|prostate cancer
5101959|NCT01205646|metastatic|metastatic
5101960|NCT01205646|zoledronate|zoledronate
5101961|NCT01205646|zometa|zometa
5101962|NCT01205633|neurodegenerative disease|neurodegenerative disease
5101963|NCT01205633|neurovascular disease|neurovascular disease
5101964|NCT01205633|fatigue|fatigue
5101965|NCT01205633|Hubbard Foundation|hubbard foundation
5101966|NCT01205633|angioplasty|angioplasty
5101967|NCT01205620|CABG|cabg
5101968|NCT01205607|traumatic brain injury|traumatic brain injury
5101969|NCT01205594|CABG surgery|cabg surgery
5101970|NCT01205581|Fluzone|fluzone
5101971|NCT01205581|Trivalent Influenza Vaccine|trivalent influenza vaccine
5101972|NCT01205555|intra uterine insemination|intra uterine insemination
5101973|NCT01205529|Atrial Fibrillation|atrial fibrillation
5101974|NCT01205529|ST elevation|st elevation
5101975|NCT01205529|Genotype|genotype
5101976|NCT01205503|chemobrain|chemobrain
5101977|NCT01205503|Oxidative Stress|oxidative stress
5101978|NCT01205503|Mesna|mesna
5101979|NCT01205477|Anserine bursitis|anserine bursitis
5101980|NCT01205464|Persistent symptoms|persistent symptoms
5101981|NCT01205464|Doxycycline|doxycycline
5101982|NCT01205464|Placebo|placebo
5101983|NCT01205464|Neuroborreliosis|neuroborreliosis
5101984|NCT01205451|GSK1358820|gsk1358820
5101985|NCT01205451|upper limb|upper limb
5101986|NCT01205451|spasticity|spasticity
5101987|NCT01205451|post-stroke|post-stroke
5101988|NCT01205438|SLE|sle
5101989|NCT01205438|Systemic Lupus Erythematosis|systemic lupus erythematosis
5101990|NCT01205438|Lupus|lupus
5101991|NCT01205438|autoimmune disease|autoimmune disease
5101992|NCT01205438|LY2127399|ly2127399
5101993|NCT01205438|Immune System Disease|immune system disease
5101994|NCT01205425|Computed coronary angiography|computed coronary angiography
5101995|NCT01205425|Stent implantation|stent implantation
5101996|NCT01205425|IVUS|ivus
5101997|NCT01205386|CTO|cto
5101998|NCT01205386|peripheral artery occlusive disease|peripheral artery occlusive disease
5101999|NCT01205386|PAOD|paod
5102000|NCT01205386|SFA|sfa
5102001|NCT01205386|superficial femoral artery|superficial femoral artery
5102002|NCT01205360|Analgesia, labour;|analgesia, labour;
5102003|NCT01205360|Analgesic techniques, epidural;|analgesic techniques, epidural;
5102004|NCT01205360|Drug delivery, intermittent bolus;|drug delivery, intermittent bolus;
5102005|NCT01205360|Anesthetics local, Bupivacaine;|anesthetics local, bupivacaine;
5102006|NCT01205360|Analgesics opioid, Fentanyl;|analgesics opioid, fentanyl;
5102007|NCT01205347|Statin|statin
5102008|NCT01205347|Myocardial infarction|myocardial infarction
5102009|NCT01205347|Insulin sensitivity|insulin sensitivity
5102010|NCT01205334|Glioblastoma multiforme|glioblastoma multiforme
5102011|NCT01205334|GBM|gbm
5102012|NCT01205334|Brain Cancer|brain cancer
5102013|NCT01205334|CTL|ctl
5102014|NCT01205321|Neoplasm|neoplasm
5102015|NCT01205321|PET/CT diagnosis|pet/ct diagnosis
5102016|NCT01205321|PET tracer|pet tracer
5102017|NCT01205308|Plant stanols|plant stanols
5102018|NCT01205308|type 1 diabetes|type 1 diabetes
5102019|NCT01205308|sterol metabolism|sterol metabolism
5102020|NCT01205308|cholesterol|cholesterol
5102021|NCT01205295|hip|hip
5102022|NCT01205295|shoulder|shoulder
5102023|NCT01205295|mental disorders|mental disorders
5102024|NCT01205295|anxiety|anxiety
5102025|NCT01205295|concern|concern
5102026|NCT01205295|efficacy of treatment|efficacy of treatment
5102027|NCT01205282|ASD|asd
5102028|NCT01205269|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
5102029|NCT01205269|safety|safety
5102030|NCT01205269|inhalation|inhalation
5102031|NCT01205269|long-acting muscarinic receptor antagonist (LAMA)|long-acting muscarinic receptor antagonist (lama)
5102032|NCT01205256|Methadone pharmacokinetics in adolescents|methadone pharmacokinetics in adolescents
5102033|NCT01205243|Abacavir|abacavir
5102034|NCT01205243|post-marketing surveillance|post-marketing surveillance
5102035|NCT01205230|Esomeprazole|esomeprazole
5102036|NCT01205230|Pharmacogenetics|pharmacogenetics
5102037|NCT01205230|Pharmacokinetics|pharmacokinetics
5102038|NCT01205230|Ketoconazole|ketoconazole
5102039|NCT01205230|Pazopanib|pazopanib
5102040|NCT01205230|Drug Interaction|drug interaction
5102041|NCT01205230|Safety|safety
5102042|NCT01205230|Solid Tumors|solid tumors
5102043|NCT01205217|lapatinib|lapatinib
5102044|NCT01205217|epirubicin|epirubicin
5102045|NCT01205217|cyclophosphamide|cyclophosphamide
5102046|NCT01205217|trastuzumab|trastuzumab
5102047|NCT01205217|paclitaxel|paclitaxel
5102048|NCT01205217|neoadjuvant therapy|neoadjuvant therapy
5102049|NCT01205217|Breast Cancer|breast cancer
5102050|NCT01205204|Clonidine|clonidine
5102051|NCT01205204|Fentanyl|fentanyl
5102052|NCT01205204|Bupivacaine|bupivacaine
5102053|NCT01205204|Spinal Anesthesia|spinal anesthesia
5102054|NCT01205204|Lower Segment Caesarian Section|lower segment caesarian section
5102055|NCT01205191|Cognitive behavioural therapy|cognitive behavioural therapy
5102056|NCT01205191|Anxiety|anxiety
5102057|NCT01205191|Primary care|primary care
5102058|NCT01205191|Effectiveness trial|effectiveness trial
5102059|NCT01205191|Cell-phone supported therapy|cell-phone supported therapy
5102060|NCT01205152|Hypophosphatasia|hypophosphatasia
5102061|NCT01205152|HPP|hpp
5102062|NCT01205152|Bone disease|bone disease
5102063|NCT01205152|Soft bones|soft bones
5102064|NCT01205152|Low alkaline phosphatase|low alkaline phosphatase
5102065|NCT01205152|Genetic metabolic disorder|genetic metabolic disorder
5102066|NCT01205152|Alkaline phosphatase|alkaline phosphatase
5102067|NCT01205152|Tissue non-specific alkaline phosphatase|tissue non-specific alkaline phosphatase
5102068|NCT01205152|Rickets|rickets
5102069|NCT01205152|Osteomalacia|osteomalacia
5102070|NCT01205139|TMC435-TiDP16-C114|tmc435-tidp16-c114
5102071|NCT01205139|TMC435-C114|tmc435-c114
5102072|NCT01205139|TMC435|tmc435
5102073|NCT01205139|HCV|hcv
5102074|NCT01205139|Hepatitis C|hepatitis c
5102075|NCT01205126|Pain|pain
5102076|NCT01205126|Hydromorphone hydrochloride|hydromorphone hydrochloride
5102077|NCT01205126|Oxycodone hydrochloride|oxycodone hydrochloride
5102078|NCT01205100|Gastrointestinal Diseases|gastrointestinal diseases
5102079|NCT01205100|Irritable Bowel Syndrome|irritable bowel syndrome
5102080|NCT01205100|Behavioral Research|behavioral research
5102081|NCT01205100|Biofeedback|biofeedback
5102082|NCT01205074|Patients with chronic liver disease and cirrhosis|patients with chronic liver disease and cirrhosis
5102083|NCT01205035|Idiopathic Parafoveal Telangiectasia|idiopathic parafoveal telangiectasia
5102084|NCT01205035|Macular Telangiectasia|macular telangiectasia
5102085|NCT01205035|Macula Lutea/pathology|macula lutea/pathology
5102086|NCT01205035|Retinal Diseases/pathology|retinal diseases/pathology
5102087|NCT01205035|Retinal Pigments/metabolism|retinal pigments/metabolism
5102088|NCT01205035|Telangiectasis/metabolism|telangiectasis/metabolism
5102089|NCT01205035|Telangiectasis/pathology|telangiectasis/pathology
5102090|NCT01205009|in-vitro fertilization|in-vitro fertilization
5102091|NCT01205009|poor responders|poor responders
5102092|NCT01205009|human chorionic gonadotropin|human chorionic gonadotropin
5102093|NCT01205009|Fertility Agents, Female|fertility agents, female
5102094|NCT01204996|monoclonal antibody|monoclonal antibody
5102095|NCT01204996|solid tumor|solid tumor
5102096|NCT01204996|chemotherapy|chemotherapy
5102097|NCT01204996|standard of care|standard of care
5102098|NCT01204983|very low birth weight infant|very low birth weight infant
5102099|NCT01204983|donor human milk|donor human milk
5102100|NCT01204970|Confocal Laser Scanning Microendoscopy|confocal laser scanning microendoscopy
5102101|NCT01204970|Small airways|small airways
5102102|NCT01204970|COPD|copd
5102103|NCT01204970|Lung transplantation|lung transplantation
5102104|NCT01204957|Homocysteine|homocysteine
5102105|NCT01204957|Insulin-like growth factor|insulin-like growth factor
5102106|NCT01204957|Insulin-like growth factor binding protein|insulin-like growth factor binding protein
5102107|NCT01204957|Serum estrogen|serum estrogen
5102108|NCT01204957|Urinary phytoestrogens|urinary phytoestrogens
5102109|NCT01204957|Thyroid hormones|thyroid hormones
5102110|NCT01204931|reflux|reflux
5102111|NCT01204931|gastroesophageal reflux disease|gastroesophageal reflux disease
5102112|NCT01204931|GERD|gerd
5102113|NCT01204918|MDD|mdd
5102114|NCT01204918|Depression|depression
5102115|NCT01204918|Treatment refractory|treatment refractory
5102118|NCT01204918|Major depressive disorder|major depressive disorder
5102119|NCT01204918|psychopharmacology|psychopharmacology
5102120|NCT01204918|rilutek|rilutek
5102121|NCT01204905|HIV-1|hiv-1
5102122|NCT01204905|CD4|cd4
5102123|NCT01204905|Viral Load|viral load
5102124|NCT01204905|Human Immunodeficiency Virus (HIV)|human immunodeficiency virus (hiv)
5102125|NCT01204866|Allergic-Like Reaction|allergic-like reaction
5102126|NCT01204866|Selected Formulation Components|selected formulation components
5102127|NCT01204853|sitaxentan sodium hypertension|sitaxentan sodium hypertension
5102128|NCT01204840|in vitro fertilization|in vitro fertilization
5102129|NCT01204840|IVF|ivf
5102130|NCT01204840|poor responder|poor responder
5102131|NCT01204840|growth hormone|growth hormone
5102132|NCT01204840|Poor responders to in vitro fertilization treatments|poor responders to in vitro fertilization treatments
5102133|NCT01204827|Patients with chronic HBeAg negative hepatitis B virus infection treated with Sebivo (Telbivudine)|patients with chronic hbeag negative hepatitis b virus infection treated with sebivo (telbivudine)
5102134|NCT01204814|HIV|hiv
5102135|NCT01204814|Drug resistance|drug resistance
5102136|NCT01204814|mutations|mutations
5102137|NCT01204814|ARV's|arv's
5102138|NCT01204801|Cancer|cancer
5102139|NCT01204801|Breast Cancer|breast cancer
5102140|NCT01204801|Breast Tumor|breast tumor
5102141|NCT01204801|Breast Neoplasm|breast neoplasm
5102142|NCT01204801|Neoplasms by Site|neoplasms by site
5102143|NCT01204801|Neoplasms|neoplasms
5102144|NCT01204801|Breast Diseases|breast diseases
5102145|NCT01204801|Breast Conserving Surgery|breast conserving surgery
5102146|NCT01204801|Breast Conservation|breast conservation
5102147|NCT01204801|Partial Mastectomy|partial mastectomy
5102148|NCT01204801|Lumpectomy|lumpectomy
5102149|NCT01204801|Mastectomy|mastectomy
5102151|NCT01204801|Neoadjuvant Therapy|neoadjuvant therapy
5102152|NCT01204801|Primary Therapy|primary therapy
5102153|NCT01204801|Neoadjuvant Systemic Therapy|neoadjuvant systemic therapy
5102154|NCT01204801|Thermotherapy|thermotherapy
5102155|NCT01204801|Fever Therapy|fever therapy
5102156|NCT01204801|Hot Temperature|hot temperature
5102157|NCT01204801|Hyperthermia|hyperthermia
5102158|NCT01204801|Hyperthermia, Therapeutic|hyperthermia, therapeutic
5102159|NCT01204801|Hyperthermia, Local|hyperthermia, local
5102160|NCT01204801|Hyperthermia, Induced|hyperthermia, induced
5102161|NCT01204801|Therapeutic Hyperthermia|therapeutic hyperthermia
5102162|NCT01204801|Microwave|microwave
5102163|NCT01204801|Focused Microwave|focused microwave
5102164|NCT01204801|Focused Microwave Thermotherapy|focused microwave thermotherapy
5102165|NCT01204801|Minimally Invasive|minimally invasive
5102166|NCT01204801|Doxorubicin|doxorubicin
5102167|NCT01204801|Epirubicin|epirubicin
5102168|NCT01204801|Epidoxirubicin|epidoxirubicin
5102169|NCT01204801|Immunosuppresive Agent|immunosuppresive agent
5102170|NCT01204801|Immunologic Factors|immunologic factors
5102171|NCT01204801|Physiological Effects of Drugs|physiological effects of drugs
5102172|NCT01204801|Chemotherapy|chemotherapy
5102173|NCT01204801|Drug Therapy|drug therapy
5102174|NCT01204801|Pharmalogic Actions|pharmalogic actions
5102175|NCT01204801|Antirheumatic Agents|antirheumatic agents
5102176|NCT01204801|Therapeutic Uses|therapeutic uses
5102177|NCT01204801|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating
5102178|NCT01204801|Alkylating Agents|alkylating agents
5102179|NCT01204801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
5102180|NCT01204801|Antineoplastic Agents|antineoplastic agents
5102181|NCT01204801|Myeloblative Agonists|myeloblative agonists
5102182|NCT01204801|Antibiotics, Antineoplastic|antibiotics, antineoplastic
5102183|NCT01204801|Anthracycline Agents|anthracycline agents
5102184|NCT01204788|Acute myelogenous leukemia|acute myelogenous leukemia
5102185|NCT01204788|AML|aml
5102186|NCT01204788|Undifferentiated and bi-phenotypic leukemia|undifferentiated and bi-phenotypic leukemia
5102187|NCT01204788|High-risk myelodysplastic syndrome|high-risk myelodysplastic syndrome
5102188|NCT01204788|Chronic myelogenous leukemia|chronic myelogenous leukemia
5102189|NCT01204788|Infection|infection
5102190|NCT01204788|Radiated Prophylactic White Cell Transfusions|radiated prophylactic white cell transfusions
5102191|NCT01204788|Therapeutic Radiated White Cell Transfusion|therapeutic radiated white cell transfusion
5102192|NCT01204788|prophylactic antibiotics|prophylactic antibiotics
5102193|NCT01204749|AMGEN|amgen
5102194|NCT01204749|AMG 386|amg 386
5102195|NCT01204749|Angiogenesis Inhibitors|angiogenesis inhibitors
5102196|NCT01204749|Fallopian Tube Cancer|fallopian tube cancer
5102197|NCT01204749|Primary Peritoneal Cancer|primary peritoneal cancer
5102198|NCT01204749|Paclitaxel|paclitaxel
5102199|NCT01204749|Ovarian Cancer|ovarian cancer
5102200|NCT01204749|TRINOVA-1|trinova-1
5102201|NCT01204736|tendon transfer|tendon transfer
5102202|NCT01204736|elbow|elbow
5102203|NCT01204723|Marijuana Abuse|marijuana abuse
5102204|NCT01204723|Nicotine Dependence|nicotine dependence
5102205|NCT01204723|Nicotine Withdrawal|nicotine withdrawal
5102206|NCT01204723|neurokinin Receptor|neurokinin receptor
5102207|NCT01204723|NK1 Receptor antagonist|nk1 receptor antagonist
5102208|NCT01204723|Substance P|substance p
5102209|NCT01204723|Recurrence|recurrence
5102210|NCT01204723|Substance Withdrawal Syndrome|substance withdrawal syndrome
5102211|NCT01204723|Substance-Related Disorders|substance-related disorders
5102404|NCT01203930|CAL-101|cal-101
5102212|NCT01204723|Disorders of Environmental Origin|disorders of environmental origin
5102213|NCT01204723|Mental Disorders|mental disorders
5102214|NCT01204723|Disease Attributes|disease attributes
5102215|NCT01204723|Pathologic Processes|pathologic processes
5102216|NCT01204723|Tetrahydrocannabinol|tetrahydrocannabinol
5102217|NCT01204723|Therapeutic Uses|therapeutic uses
5102218|NCT01204723|Psychotropic Drugs|psychotropic drugs
5102219|NCT01204723|Analgesics, Non-Narcotic|analgesics, non-narcotic
5102220|NCT01204723|Analgesics|analgesics
5102221|NCT01204723|Sensory System Agents|sensory system agents
5102222|NCT01204723|Peripheral Nervous System Agents|peripheral nervous system agents
5102223|NCT01204723|Neurotransmitter Agents|neurotransmitter agents
5102224|NCT01204723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
5102225|NCT01204723|Narcotic Antagonists|narcotic antagonists
5102226|NCT01204723|cannabis|cannabis
5102227|NCT01204710|Prostate Cancer|prostate cancer
5102228|NCT01204684|dendritic cells|dendritic cells
5102229|NCT01204684|glioma|glioma
5102230|NCT01204684|vaccine|vaccine
5102231|NCT01204684|glioma of WHO Grade III or IV|glioma of who grade iii or iv
5102232|NCT01204671|influenza infection|influenza infection
5102233|NCT01204671|GSK Biologicals influenza vaccine GSK2321138A|gsk biologicals influenza vaccine gsk2321138a
5102234|NCT01204658|Haemophilus influenzae|haemophilus influenzae
5102235|NCT01204658|Streptococcus pneumoniae|streptococcus pneumoniae
5102236|NCT01204658|immunogenicity|immunogenicity
5102237|NCT01204658|Pneumococcal vaccine|pneumococcal vaccine
5102238|NCT01204658|infants|infants
5102239|NCT01204658|safety|safety
5102240|NCT01204619|peritoneal dialysis|peritoneal dialysis
5102241|NCT01204567|HLRQ|hlrq
5102242|NCT01204567|elderly|elderly
5102243|NCT01204567|aerobic fitness|aerobic fitness
5102244|NCT01204567|cognitive capacity|cognitive capacity
5102245|NCT01204554|perforator flaps|perforator flaps
5102246|NCT01204541|Non-exudative age-related macular degeneration|non-exudative age-related macular degeneration
5102247|NCT01204528|Dysfunction in CKD|dysfunction in ckd
5102248|NCT01204515|IBS|ibs
5102249|NCT01204515|irritable bowel syndrome|irritable bowel syndrome
5102250|NCT01204515|abdominal pain|abdominal pain
5102251|NCT01204515|urgency|urgency
5102252|NCT01204515|bloating|bloating
5102253|NCT01204515|diarrhea|diarrhea
5102254|NCT01204515|constipation|constipation
5102255|NCT01204502|Gene therapy|gene therapy
5102256|NCT01204502|Haploidentical|haploidentical
5102257|NCT01204502|Bone marrow transplant|bone marrow transplant
5102258|NCT01204502|Graft versus host disease|graft versus host disease
5102259|NCT01204502|haploidentical stem cell transplantation|haploidentical stem cell transplantation
5102260|NCT01204502|T-cell suicide gene therapy|t-cell suicide gene therapy
5102261|NCT01204450|recurrent childhood brain tumor|recurrent childhood brain tumor
5102262|NCT01204450|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
5102263|NCT01204450|recurrent childhood soft tissue sarcoma|recurrent childhood soft tissue sarcoma
5102264|NCT01204450|recurrent childhood supratentorial primitive neuroectodermal tumor|recurrent childhood supratentorial primitive neuroectodermal tumor
5102265|NCT01204450|recurrent Ewing sarcoma/peripheral primitive neuroectodermal tumor|recurrent ewing sarcoma/peripheral primitive neuroectodermal tumor
5102266|NCT01204450|recurrent neuroblastoma|recurrent neuroblastoma
5102267|NCT01204450|recurrent osteosarcoma|recurrent osteosarcoma
5102268|NCT01204450|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
5102269|NCT01204437|adjuvant chemotherapy|adjuvant chemotherapy
5102270|NCT01204437|primary carcinoma|primary carcinoma
5102271|NCT01204437|elderly non frail patients|elderly non frail patients
5102272|NCT01204437|EC|ec
5102273|NCT01204437|CMF|cmf
5102274|NCT01204437|Capecitabine|capecitabine
5102275|NCT01204437|Nab-Paclitaxel|nab-paclitaxel
5102276|NCT01204424|minimal invasive|minimal invasive
5102277|NCT01204424|sinus floor augmentation|sinus floor augmentation
5102278|NCT01204424|sinuslift|sinuslift
5102279|NCT01204424|dental implants|dental implants
5102280|NCT01204411|Efficacy|efficacy
5102281|NCT01204411|Safety|safety
5102282|NCT01204411|Artesunate-amodiaquine|artesunate-amodiaquine
5102283|NCT01204411|Malaria|malaria
5102284|NCT01204411|Plasmodium falciparum|plasmodium falciparum
5102285|NCT01204411|Malnutrition|malnutrition
5102286|NCT01204385|Non-typeable Haemophilus Influenzae|non-typeable haemophilus influenzae
5102287|NCT01204385|Acute Otitis Media|acute otitis media
5102288|NCT01204385|Streptococcus Pneumoniae|streptococcus pneumoniae
5102289|NCT01204385|etiology|etiology
5102290|NCT01204372|Metastatic pancreatic adenocarcinoma|metastatic pancreatic adenocarcinoma
5102291|NCT01204372|First-line chemotherapy|first-line chemotherapy
5102292|NCT01204372|Combination chemotherapy|combination chemotherapy
5102293|NCT01204372|Targeted agents|targeted agents
5102294|NCT01204346|adolescents|adolescents
5102295|NCT01204346|MBT|mbt
5102296|NCT01204346|depression|depression
5102297|NCT01204346|emerging personality disorder|emerging personality disorder
5102298|NCT01204333|Cerebral venous and sinus thrombosis|cerebral venous and sinus thrombosis
5102299|NCT01204333|Cerebral venous thrombosis|cerebral venous thrombosis
5102300|NCT01204333|Sinus Thrombosis, Intracranial|sinus thrombosis, intracranial
5102301|NCT01204333|Endovascular thrombolysis|endovascular thrombolysis
5102302|NCT01204333|Thrombolysis|thrombolysis
5102303|NCT01204333|Thrombectomy|thrombectomy
5102304|NCT01204320|Restenosis|restenosis
5102305|NCT01204320|POBA|poba
5102306|NCT01204320|Stenting|stenting
5102307|NCT01204320|Paclitaxel|paclitaxel
5102308|NCT01204281|Proportional Assist Ventilation plus|proportional assist ventilation plus
5102309|NCT01204281|Acute respiratory failure|acute respiratory failure
5102310|NCT01204281|Mechanical ventilation|mechanical ventilation
5102311|NCT01204268|cerebral ischemia|cerebral ischemia
5102312|NCT01204268|sevoflurane preconditioning|sevoflurane preconditioning
5102313|NCT01204268|intracranial aneurysm surgery|intracranial aneurysm surgery
5102314|NCT01204255|healthy, no evidence of disease|healthy, no evidence of disease
5102315|NCT01204242|Breast Cancer|breast cancer
5102316|NCT01204229|Alcohol Consumption|alcohol consumption
5102317|NCT01204229|Social Anxiety|social anxiety
5102318|NCT01204229|Depression|depression
5102319|NCT01204229|Brief Intervention|brief intervention
5102320|NCT01204229|Motivational Interviewing|motivational interviewing
5102321|NCT01204229|Cognitive Behavioral Therapy|cognitive behavioral therapy
5102322|NCT01204229|Sub-Clinical Social Anxiety|sub-clinical social anxiety
5102323|NCT01204229|Sub-Clinical Depression|sub-clinical depression
5102324|NCT01204216|Hemoglobin A1c|hemoglobin a1c
5102325|NCT01204216|HbA1c|hba1c
5102326|NCT01204216|glycated serum proteins|glycated serum proteins
5102327|NCT01204216|fructosamine|fructosamine
5102328|NCT01204216|glycated albumin|glycated albumin
5102329|NCT01204216|glycation gap|glycation gap
5102330|NCT01204203|mesothelioma|mesothelioma
5102331|NCT01204203|zoledronic acid|zoledronic acid
5102332|NCT01204203|zometa|zometa
5102333|NCT01204203|bisphosphonate therapy|bisphosphonate therapy
5102334|NCT01204203|CT scan|ct scan
5102335|NCT01204203|PET scan|pet scan
5102336|NCT01204190|Administration|administration
5102337|NCT01204190|Cutaneous|cutaneous
5102338|NCT01204177|Hepatocellular carcinoma (HCC)|hepatocellular carcinoma (hcc)
5102339|NCT01204177|MEK inhibitor|mek inhibitor
5102340|NCT01204177|Sorafenib|sorafenib
5102341|NCT01204177|Disease control rate (DCR)|disease control rate (dcr)
5102342|NCT01204177|Safety|safety
5102343|NCT01204164|AML|aml
5102344|NCT01204164|ALL|all
5102345|NCT01204164|MDS|mds
5102346|NCT01204164|CML in blast crisis|cml in blast crisis
5102347|NCT01204164|Multiple Myeloma|multiple myeloma
5102348|NCT01204164|Carfilzomib refractory|carfilzomib refractory
5102349|NCT01204138|RA, treatment, TNF, cytokines|ra, treatment, tnf, cytokines
5102350|NCT01204112|Drug-Drug Interaction|drug-drug interaction
5102351|NCT01204112|Tasocitinib (CP-690|tasocitinib (cp-690
5102352|NCT01204112|550)|550)
5102353|NCT01204112|Rifampin|rifampin
5102354|NCT01204112|Healthy Volunteers|healthy volunteers
5102355|NCT01204099|PX-866|px-866
5102356|NCT01204099|Non small cell lung cancer|non small cell lung cancer
5102357|NCT01204099|solid tumors|solid tumors
5102358|NCT01204099|Squamous cell cancer of the head and neck|squamous cell cancer of the head and neck
5102359|NCT01204099|docetaxel|docetaxel
5102360|NCT01204099|NSCLC|nsclc
5102361|NCT01204099|taxotere|taxotere
5102362|NCT01204099|SCCHN|scchn
5102363|NCT01204099|PI-3K|pi-3k
5102364|NCT01204099|PI3 kinase|pi3 kinase
5102365|NCT01204099|PI3K|pi3k
5102366|NCT01204086|Major Depressive Disorder|major depressive disorder
5102367|NCT01204086|Antidepressants|antidepressants
5102368|NCT01204086|Pharmacogenetics|pharmacogenetics
5102369|NCT01204086|venlafaxine|venlafaxine
5102370|NCT01204086|fluoxetine|fluoxetine
5102371|NCT01204060|Nasal Allergen Lipopolysaccharide Inflammation Asthma|nasal allergen lipopolysaccharide inflammation asthma
5102372|NCT01204034|COPD|copd
5102373|NCT01204034|Formoterol|formoterol
5102374|NCT01204034|Beclomethasone Dipropionate|beclomethasone dipropionate
5102375|NCT01204034|Computational Fluid Dynamics|computational fluid dynamics
5102376|NCT01204034|Functional Imaging|functional imaging
5102377|NCT01204034|Central and Peripheral Airways|central and peripheral airways
5102378|NCT01204034|BODE index|bode index
5102379|NCT01204034|COPD Assessment Test (CAT)|copd assessment test (cat)
5102380|NCT01204034|Borg CR10 scale|borg cr10 scale
5102381|NCT01204021|Stress|stress
5102382|NCT01204021|loneliness|loneliness
5102383|NCT01204021|social isolation|social isolation
5102384|NCT01204021|autonomic activity|autonomic activity
5102385|NCT01204021|inflammation|inflammation
5102386|NCT01204021|Perceived social isolation|perceived social isolation
5102387|NCT01204021|Chronic stress|chronic stress
5102388|NCT01203982|CIMT|cimt
5102389|NCT01203982|IVUS-VH|ivus-vh
5102390|NCT01203982|Coronary artery disease|coronary artery disease
5102391|NCT01203956|AutoAdjust|autoadjust
5102392|NCT01203956|SmartFlex|smartflex
5102393|NCT01203956|Apnea Hypopnea Index|apnea hypopnea index
5102394|NCT01203956|Patient reported outcomes|patient reported outcomes
5102395|NCT01203943|Idiopathic Pulmonary Fibrosis|idiopathic pulmonary fibrosis
5102396|NCT01203943|Pulmonary Fibrosis|pulmonary fibrosis
5102397|NCT01203943|Fibrosis|fibrosis
5102398|NCT01203943|Interstitial Lung Disease|interstitial lung disease
5102399|NCT01203943|Lung Diseases, Interstitial|lung diseases, interstitial
5102400|NCT01203943|CC-930|cc-930
5102401|NCT01203930|CLL|cll
5102402|NCT01203930|SLL|sll
5102403|NCT01203930|GS-1101|gs-1101
5102405|NCT01203930|Phosphatidylinositol 3-kinase (PI3K)|phosphatidylinositol 3-kinase (pi3k)
5102406|NCT01203930|Rituximab|rituximab
5102407|NCT01203930|Rituxan|rituxan
5102408|NCT01203917|Gefitinib|gefitinib
5102409|NCT01203917|EGFR TKI|egfr tki
5102410|NCT01203917|efficacy|efficacy
5102411|NCT01203917|Caucasian patients|caucasian patients
5102412|NCT01203917|EGFR mutation positive advanced NSCLC|egfr mutation positive advanced nsclc
5102413|NCT01203917|safety|safety
5102414|NCT01203904|bronchial asthma, Pulmicort, long term use, pediatrics|bronchial asthma, pulmicort, long term use, pediatrics
5102415|NCT01203891|SPECT|spect
5102416|NCT01203891|Imaging|imaging
5102417|NCT01203891|Healthy brain|healthy brain
5102418|NCT01203891|regional cerebral blood flow|regional cerebral blood flow
5102419|NCT01203878|Imiquimod|imiquimod
5102420|NCT01203878|Photodynamic therapy|photodynamic therapy
5102421|NCT01203878|Actinic keratoses|actinic keratoses
5102422|NCT01203878|Sequential therapy|sequential therapy
5102423|NCT01203878|Therapeutic uses|therapeutic uses
5102424|NCT01203865|Fibromyalgia|fibromyalgia
5102425|NCT01203865|Fatigue|fatigue
5102426|NCT01203852|hypertension|hypertension
5102427|NCT01203852|antihypertensive drug|antihypertensive drug
5102428|NCT01203852|pharmacogenetics|pharmacogenetics
5102429|NCT01203852|genetics|genetics
5102430|NCT01203852|blood pressure|blood pressure
5102431|NCT01203852|glucose|glucose
5102432|NCT01203839|stage 1 breast cancer|stage 1 breast cancer
5102433|NCT01203839|invasive ductal breast|invasive ductal breast
5102434|NCT01203839|Partial Breast Irradiation (PBI)|partial breast irradiation (pbi)
5102435|NCT01203839|radiation|radiation
5102436|NCT01203839|10-114|10-114
5102437|NCT01203826|Hypophosphatasia|hypophosphatasia
5102438|NCT01203826|HPP|hpp
5102439|NCT01203826|Bone Disease|bone disease
5102440|NCT01203826|Soft Bones|soft bones
5102441|NCT01203826|Low Alkaline Phosphatase|low alkaline phosphatase
5102442|NCT01203826|genetic metabolic disorder|genetic metabolic disorder
5102443|NCT01203826|alkaline phosphatase|alkaline phosphatase
5102444|NCT01203826|tissue non-specific alkaline phosphatase|tissue non-specific alkaline phosphatase
5102445|NCT01203826|rickets|rickets
5102446|NCT01203826|osteomalacia|osteomalacia
5102447|NCT01203813|Chronic kidney disease|chronic kidney disease
5102448|NCT01203813|Quality improvement|quality improvement
5102449|NCT01203813|Self management support|self management support
5102450|NCT01203813|Electronic health records|electronic health records
5102451|NCT01203813|Clinical decision support|clinical decision support
5102452|NCT01203813|Electronic reminders|electronic reminders
5102453|NCT01203813|Patient outreach|patient outreach
5102454|NCT01203787|Hepatocellular Carcinoma|hepatocellular carcinoma
5102455|NCT01203787|HCC|hcc
5102456|NCT01203787|Liver Cancer|liver cancer
5102457|NCT01203774|Diabetes|diabetes
5102458|NCT01203761|loneliness|loneliness
5102459|NCT01203735|Non-small-cell lung cancer|non-small-cell lung cancer
5102460|NCT01203735|Valproic acid|valproic acid
5102461|NCT01203735|Chemotherapy|chemotherapy
5102462|NCT01203735|Radiotherapy|radiotherapy
5102463|NCT01203722|Reduced intensity|reduced intensity
5102464|NCT01203722|partially HLA mismatched allogeneic BMT|partially hla mismatched allogeneic bmt
5102465|NCT01203722|Acute leukemias|acute leukemias
5102466|NCT01203722|Chronic leukemias|chronic leukemias
5102467|NCT01203722|Myelodysplasia|myelodysplasia
5102468|NCT01203722|Lymphomas|lymphomas
5102469|NCT01203722|Unrelated or non-first-degree related donors|unrelated or non-first-degree related donors
5102470|NCT01203709|lupus|lupus
5102471|NCT01203709|nephritis|nephritis
5102472|NCT01203709|glomerulonephritis|glomerulonephritis
5102473|NCT01203709|nephropathy|nephropathy
5102474|NCT01203709|refractory|refractory
5102475|NCT01203696|Clopidogrel|clopidogrel
5102476|NCT01203696|Platelet reactivity|platelet reactivity
5102477|NCT01203696|Amlodipine|amlodipine
5102478|NCT01203683|depression|depression
5102479|NCT01203670|Glomerular filtration rate (GFR)|glomerular filtration rate (gfr)
5102480|NCT01203670|Aspartate Amino Transferase (ASAT)|aspartate amino transferase (asat)
5102481|NCT01203670|Alanine Amino transferase (ALAT)|alanine amino transferase (alat)
5102482|NCT01203670|gamma Glutamyl transpeptidase (gamma GT)|gamma glutamyl transpeptidase (gamma gt)
5102483|NCT01203670|Lipase|lipase
5102484|NCT01203670|Amylase|amylase
5102485|NCT01203657|exercise|exercise
5102486|NCT01203657|physical activity|physical activity
5102487|NCT01203657|tai chi|tai chi
5102488|NCT01203644|Postoperative pain|postoperative pain
5102489|NCT01203644|Analgesia|analgesia
5102490|NCT01203618|Resectable, non-functioning pituitary adenoma|resectable, non-functioning pituitary adenoma
5102491|NCT01203618|Pituitary tumor|pituitary tumor
5102492|NCT01203618|Pituitary adenoma|pituitary adenoma
5102493|NCT01203618|Pituitary macroadenoma|pituitary macroadenoma
5102494|NCT01203605|Operative surgical procedures|operative surgical procedures
5102495|NCT01203605|mortality|mortality
5102496|NCT01203605|adverse effects|adverse effects
5102497|NCT01203605|Postoperative complications|postoperative complications
5102498|NCT01203605|Epidemiological Study|epidemiological study
5102499|NCT01203592|Congenital myasthenic syndrome|congenital myasthenic syndrome
5102500|NCT01203592|Albuterol|albuterol
5102501|NCT01203592|Neuromuscular transmission|neuromuscular transmission
5102502|NCT01203579|CDT-Lung,CT scan,lung cancer detection|cdt-lung,ct scan,lung cancer detection
5102503|NCT01203566|Single incision laparoscopic surgery|single incision laparoscopic surgery
5102504|NCT01203566|Single site access laparoscopic surgery|single site access laparoscopic surgery
5102505|NCT01203566|SILS|sils
5102506|NCT01203566|Single-port access|single-port access
5102507|NCT01203566|Laparoendoscopic single site surgery|laparoendoscopic single site surgery
5102508|NCT01203566|Appendectomy|appendectomy
5102509|NCT01203553|Incisional hernias|incisional hernias
5102510|NCT01203553|Prophylaxis|prophylaxis
5102511|NCT01203553|Preperitoneal mesh|preperitoneal mesh
5102512|NCT01203527|H1N1 influenza|h1n1 influenza
5102513|NCT01203527|Swine flu|swine flu
5102514|NCT01203527|Oseltamivir|oseltamivir
5102515|NCT01203527|Tamiflu|tamiflu
5102516|NCT01203527|Pregnancy|pregnancy
5102517|NCT01203514|NICHD Neonatal Research Network|nichd neonatal research network
5102518|NCT01203514|Extremely Low Birth Weight (ELBW)|extremely low birth weight (elbw)
5102519|NCT01203514|Prematurity|prematurity
5102520|NCT01203514|Erythrocyte transfusions|erythrocyte transfusions
5102521|NCT01203514|Erythropoietin (Epo)|erythropoietin (epo)
5102522|NCT01203514|Blood loss|blood loss
5102523|NCT01203514|Phlebotomy|phlebotomy
5102524|NCT01203501|NICHD Neonatal Research Network|nichd neonatal research network
5102525|NCT01203501|Extremely Low Birth Weight (ELBW)|extremely low birth weight (elbw)
5102526|NCT01203501|Prematurity|prematurity
5102527|NCT01203501|Antenatal Magnesium sulfate|antenatal magnesium sulfate
5102528|NCT01203488|NICHD Neonatal Research Network|nichd neonatal research network
5102529|NCT01203488|Extremely Low Birth Weight (ELBW)|extremely low birth weight (elbw)
5102530|NCT01203488|Prematurity|prematurity
5102531|NCT01203488|Vitamin A|vitamin a
5102532|NCT01203488|Chronic Lung Disease|chronic lung disease
5102533|NCT01203475|NICHD Neonatal Research Network|nichd neonatal research network
5102534|NCT01203475|Extremely Low Birth Weight (ELBW)|extremely low birth weight (elbw)
5102535|NCT01203475|Prematurity|prematurity
5102536|NCT01203475|Growth Curve|growth curve
5102537|NCT01203475|Head Circumference|head circumference
5102538|NCT01203475|Length|length
5102539|NCT01203449|NICHD Neonatal Research Network|nichd neonatal research network
5102540|NCT01203449|Extremely Low Birth Weight (ELBW)|extremely low birth weight (elbw)
5102541|NCT01203449|Prematurity|prematurity
5102542|NCT01203449|Gestational Age|gestational age
5102543|NCT01203436|NICHD Neonatal Research Network|nichd neonatal research network
5102544|NCT01203436|Very Low Birth Weight (VLBW)|very low birth weight (vlbw)
5102545|NCT01203436|Extremely Low Birth Weight (ELBW)|extremely low birth weight (elbw)
5102546|NCT01203436|Prematurity|prematurity
5102547|NCT01203423|NICHD Neonatal Research Network|nichd neonatal research network
5102548|NCT01203423|Extremely Low Birth Weight (ELBW)|extremely low birth weight (elbw)
5102549|NCT01203423|Prematurity|prematurity
5102550|NCT01203423|Persistent Pulmonary Hypertension of Newborn (PPHN)|persistent pulmonary hypertension of newborn (pphn)
5102551|NCT01203410|NICHD Neonatal Research Network|nichd neonatal research network
5102552|NCT01203410|Term infant|term infant
5102553|NCT01203410|Hyperbilirubinemia|hyperbilirubinemia
5102554|NCT01203397|SUPERFICIAL VARICOSE VEINS|superficial varicose veins
5102555|NCT01203371|naftopidil|naftopidil
5102556|NCT01203371|symptoms of lower urinary tract|symptoms of lower urinary tract
5102557|NCT01203371|benign prostate hyperplasia|benign prostate hyperplasia
5102558|NCT01203371|LUTS|luts
5102559|NCT01203358|NICHD Neonatal Research Network|nichd neonatal research network
5102560|NCT01203358|Extremely Low Birth Weight (ELBW)|extremely low birth weight (elbw)
5102561|NCT01203358|Prematurity|prematurity
5102562|NCT01203358|Respiratory distress syndrome|respiratory distress syndrome
5102563|NCT01203358|Surfactant|surfactant
5102564|NCT01203345|NICHD Neonatal Research Network|nichd neonatal research network
5102565|NCT01203345|Extremely Low Birth Weight (ELBW)|extremely low birth weight (elbw)
5102566|NCT01203345|Prematurity|prematurity
5102567|NCT01203345|Septicemia|septicemia
5102568|NCT01203345|Meningitis|meningitis
5102569|NCT01203345|Urinary tract infection|urinary tract infection
5102570|NCT01203345|Immune globulin|immune globulin
5102571|NCT01203332|HIV testing|hiv testing
5102572|NCT01203332|Latino|latino
5102573|NCT01203332|Latina|latina
5102574|NCT01203332|Men who have sex with men|men who have sex with men
5102575|NCT01203319|immunogenicity|immunogenicity
5102576|NCT01203319|safety|safety
5102577|NCT01203319|recombinant hepatitis B vaccine|recombinant hepatitis b vaccine
5102578|NCT01203319|nonresponders|nonresponders
5102579|NCT01203306|bevacizumab|bevacizumab
5102580|NCT01203306|somatostatin analogue|somatostatin analogue
5102581|NCT01203306|metronomic capecitabine|metronomic capecitabine
5102582|NCT01203306|neuroendocrine tumors|neuroendocrine tumors
5102583|NCT01203280|icing|icing
5102584|NCT01203280|boxer|boxer
5102585|NCT01203280|balance|balance
5102586|NCT01203280|neck range of motion|neck range of motion
5102587|NCT01203280|neck isometric strength|neck isometric strength
5102588|NCT01203280|balance performance|balance performance
5102589|NCT01203267|Breast Neoplasms|breast neoplasms
5102590|NCT01203267|Neoadjuvant|neoadjuvant
5102591|NCT01203267|Chemotherapy|chemotherapy
5102592|NCT01203267|Paclitaxel|paclitaxel
5102593|NCT01203267|Carboplatin|carboplatin
5102594|NCT01203267|Pathological Complete Remission|pathological complete remission
5102595|NCT01203254|Colesevelam|colesevelam
5102596|NCT01203254|IBD|ibd
5102597|NCT01203254|Bile Acid Malabsorption|bile acid malabsorption
5102598|NCT01203254|Crohns disease|crohns disease
5102599|NCT01203228|Reduced Intensity conditioning|reduced intensity conditioning
5102600|NCT01203228|Myeloablative conditionig|myeloablative conditionig
5102601|NCT01203228|Allogeneic stem cell transplantation|allogeneic stem cell transplantation
5102602|NCT01203228|MUD|mud
5102603|NCT01203215|exercise|exercise
5102604|NCT01203215|physical activity|physical activity
5102605|NCT01203215|women|women
5102606|NCT01203215|community|community
5102607|NCT01203202|PE|pe
5102608|NCT01203202|IELT|ielt
5102609|NCT01203202|DCIT|dcit
5102610|NCT01203189|dandruff, flaky scalp|dandruff, flaky scalp
5102611|NCT01203176|Endometrial polyp|endometrial polyp
5102612|NCT01203176|Endometrial carcinoma|endometrial carcinoma
5102613|NCT01203176|Endometrial hyperplasia|endometrial hyperplasia
5102614|NCT01203176|Postmenopausal symptomatic women|postmenopausal symptomatic women
5102615|NCT01203176|Postmenopausal asymptomatic women|postmenopausal asymptomatic women
5102616|NCT01203163|PDT|pdt
5102617|NCT01203163|porfimer sodium|porfimer sodium
5102618|NCT01203163|esophageal cancer|esophageal cancer
5102619|NCT01203163|NSCLC|nsclc
5102620|NCT01203163|HGD in BE|hgd in be
5102621|NCT01203137|tricuspid regurgitation, severe|tricuspid regurgitation, severe
5102622|NCT01203124|Intranasal|intranasal
5102623|NCT01203124|Biomarker|biomarker
5102624|NCT01203124|Healthy|healthy
5102625|NCT01203124|Effect of different doses and dosing regimens of AZD8848 on biomarkers|effect of different doses and dosing regimens of azd8848 on biomarkers
5102626|NCT01203124|Effect different doses and dosing frequency of AZD8848 on biomarkers|effect different doses and dosing frequency of azd8848 on biomarkers
5102627|NCT01203098|prevention|prevention
5102628|NCT01203098|venous thromboembolism|venous thromboembolism
5102629|NCT01203098|edoxaban|edoxaban
5102630|NCT01203098|anticoagulants|anticoagulants
5102631|NCT01203072|prevention|prevention
5102632|NCT01203072|venous thromboembolism|venous thromboembolism
5102633|NCT01203072|edoxaban|edoxaban
5102634|NCT01203072|factor Xa|factor xa
5102635|NCT01203046|DURATION OF THERAPY|duration of therapy
5102636|NCT01203046|PENETRATING ABDOMINAL TRAUMA|penetrating abdominal trauma
5102637|NCT01203033|acute myeloid leukemia|acute myeloid leukemia
5102638|NCT01203033|single cell network profiling|single cell network profiling
5102639|NCT01203033|AML|aml
5102640|NCT01203033|SCNP|scnp
5102641|NCT01203020|Hodgkin's|hodgkin's
5102642|NCT01203020|non-Hodgkin's|non-hodgkin's
5102643|NCT01203020|lymphomas|lymphomas
5102644|NCT01203020|allogeneic hematopoietic progenitor cell transplant|allogeneic hematopoietic progenitor cell transplant
5102645|NCT01203020|HPCT|hpct
5102646|NCT01203020|busulfex|busulfex
5102647|NCT01203020|fludarabine|fludarabine
5102648|NCT01203020|reduced-toxicity conditioning|reduced-toxicity conditioning
5102649|NCT01203020|reduced-intensity conditioning|reduced-intensity conditioning
5102650|NCT01202994|Alzheimer's disease|alzheimer's disease
5102651|NCT01202994|Mild cognitive impairment|mild cognitive impairment
5102652|NCT01202994|PET|pet
5102653|NCT01202994|Practice effects|practice effects
5102654|NCT01202981|glistenings|glistenings
5102655|NCT01202981|contrast sensitivity|contrast sensitivity
5102656|NCT01202981|visual quality|visual quality
5102657|NCT01202981|straylight|straylight
5102658|NCT01202981|AcrySof IOL|acrysof iol
5102659|NCT01202968|intubation electric stimulation deglutition disorder|intubation electric stimulation deglutition disorder
5102660|NCT01202955|Smoking, Abstinence|smoking, abstinence
5102661|NCT01202929|High Resolution Manometry|high resolution manometry
5102662|NCT01202929|achalasia|achalasia
5102663|NCT01202929|dysphagia|dysphagia
5102664|NCT01202929|GERD|gerd
5102665|NCT01202929|chest pain|chest pain
5102666|NCT01202929|Post fundoplication|post fundoplication
5102667|NCT01202916|children with congenital heart disease|children with congenital heart disease
5102668|NCT01202903|omalizumab|omalizumab
5102669|NCT01202903|asthma|asthma
5102670|NCT01202903|immunoglobulin E|immunoglobulin e
5102671|NCT01202903|IgE|ige
5102672|NCT01202890|lenalidomide|lenalidomide
5102673|NCT01202890|revlimid|revlimid
5102674|NCT01202890|liposomal doxorubicin|liposomal doxorubicin
5102675|NCT01202890|doxil|doxil
5102676|NCT01202890|bevacizumab|bevacizumab
5102677|NCT01202890|avastin|avastin
5102678|NCT01202890|platinum resistant ovarian cancer|platinum resistant ovarian cancer
5102679|NCT01202890|ovarian cancer|ovarian cancer
5102680|NCT01202877|Myelodysplastic Syndrome|myelodysplastic syndrome
5102681|NCT01202877|MDS|mds
5102682|NCT01202877|Refractory acute leukemias|refractory acute leukemias
5102683|NCT01202877|Relapsed acute leukemia|relapsed acute leukemia
5102684|NCT01202877|Acute myeloid leukemia|acute myeloid leukemia
5102685|NCT01202877|AML|aml
5102686|NCT01202877|5-Azacytidine|5-azacytidine
5102687|NCT01202877|Azacitidine|azacitidine
5102688|NCT01202877|5-aza|5-aza
5102689|NCT01202877|Vidaza|vidaza
5102690|NCT01202877|5-AZC|5-azc
5102691|NCT01202877|AZA-CR|aza-cr
5102692|NCT01202877|Ladakamycin|ladakamycin
5102693|NCT01202877|NSC-102816|nsc-102816
5102694|NCT01202877|PKC412|pkc412
5102695|NCT01202864|Intracerebral Hemorrhage|intracerebral hemorrhage
5102696|NCT01202864|ICH|ich
5102697|NCT01202864|Stroke|stroke
5102698|NCT01202864|Cerebrovascular accident|cerebrovascular accident
5102699|NCT01202851|radiotherapy|radiotherapy
5102700|NCT01202851|radiation therapy|radiation therapy
5102701|NCT01202851|stretching|stretching
5102702|NCT01202851|relaxation|relaxation
5102703|NCT01202851|quality of life|quality of life
5102704|NCT01202851|QOL|qol
5102705|NCT01202851|fatigue|fatigue
5102706|NCT01202851|sleep disturbances|sleep disturbances
5102707|NCT01202851|mental health|mental health
5102708|NCT01202851|cost-effectiveness analysis|cost-effectiveness analysis
5102709|NCT01202851|work productivity|work productivity
5102710|NCT01202851|home productivity|home productivity
5102711|NCT01202851|cortisol rhythmicity|cortisol rhythmicity
5102712|NCT01202838|Cranial bone reconstruction, composite|cranial bone reconstruction, composite
5102713|NCT01202825|HCV genotype 1 infected patients|hcv genotype 1 infected patients
5102714|NCT01202825|TMC647055HPC1001|tmc647055hpc1001
5102715|NCT01202825|TMC647055|tmc647055
5102716|NCT01202825|HPC|hpc
5102717|NCT01202825|Hepatitis C|hepatitis c
5102718|NCT01202825|Healthy volunteers|healthy volunteers
5102719|NCT01202825|TMC435|tmc435
5102720|NCT01202812|Sickle Cell Anemia|sickle cell anemia
5102721|NCT01202812|Sickle Cell Disease|sickle cell disease
5102722|NCT01202812|Hemoglobin SS Disease|hemoglobin ss disease
5102723|NCT01202812|Hemoglobin S beta-0 Thalassemia|hemoglobin s beta-0 thalassemia
5102724|NCT01202812|Inflammation|inflammation
5102725|NCT01202812|Quality of Life|quality of life
5102726|NCT01202812|Sickle Thalassemia|sickle thalassemia
5102727|NCT01202812|C-Reative Protein|c-reative protein
5102728|NCT01202812|Hemolytic Anemia|hemolytic anemia
5102729|NCT01202812|Hemostasis|hemostasis
5102730|NCT01202812|Biomarkers|biomarkers
5102731|NCT01202812|Coagulation|coagulation
5102732|NCT01202812|Omega-3 Fatty Acids|omega-3 fatty acids
5102733|NCT01202812|Eicosapentaenoic Acid|eicosapentaenoic acid
5102734|NCT01202812|Docosahexaenoic Acid|docosahexaenoic acid
5102735|NCT01202812|Fish Oils|fish oils
5102736|NCT01202812|Drug: Placebo|drug: placebo
5102737|NCT01202812|Drug: LOVAZA|drug: lovaza
5102738|NCT01202799|Pharmacokinetics|pharmacokinetics
5102739|NCT01202799|Healthy volunteers|healthy volunteers
5102740|NCT01202799|PENNSAID|pennsaid
5102741|NCT01202799|Topical NSAID|topical nsaid
5102742|NCT01202799|Diclofenac|diclofenac
5102743|NCT01202786|Cancer of Unknown Primary Site (CUP)|cancer of unknown primary site (cup)
5102744|NCT01202773|Rheumatoid Arthritis|rheumatoid arthritis
5102745|NCT01202760|Rheumatoid Arthritis|rheumatoid arthritis
5102746|NCT01202734|CONCERTA|concerta
5102747|NCT01202734|Methylphenidate HCl|methylphenidate hcl
5102748|NCT01202734|Pharmacokinetic|pharmacokinetic
5102749|NCT01202734|Safety|safety
5102750|NCT01202734|Adult|adult
5102751|NCT01202734|Men|men
5102752|NCT01202734|Male|male
5102753|NCT01202721|Congenital|congenital
5102754|NCT01202721|Aortic Valve|aortic valve
5102755|NCT01202721|Bicuspid|bicuspid
5102756|NCT01202721|Aortopathy|aortopathy
5102757|NCT01202721|bicuspid aortic valve aortopathy|bicuspid aortic valve aortopathy
5102758|NCT01202708|chronic renal failure|chronic renal failure
5102759|NCT01202708|hemodiafiltration|hemodiafiltration
5102760|NCT01202682|Healthy subject exercise study|healthy subject exercise study
5102761|NCT01202656|Fertility Agents, Female|fertility agents, female
5102762|NCT01202656|In vitro fertilization|in vitro fertilization
5102763|NCT01202643|Thin Endometrium|thin endometrium
5102764|NCT01202643|Asherman's Syndrome|asherman's syndrome
5102765|NCT01202643|Endometrial Scarring|endometrial scarring
5102766|NCT01202630|Clostridium difficile|clostridium difficile
5102767|NCT01202630|diarrhea|diarrhea
5102768|NCT01202617|Seroquel XR|seroquel xr
5102769|NCT01202617|schizophrenia|schizophrenia
5102770|NCT01202617|relapse prevention|relapse prevention
5102771|NCT01202604|Bipolar disorder I and II|bipolar disorder i and ii
5102772|NCT01202604|mood event|mood event
5102773|NCT01202604|manic or depressive|manic or depressive
5102774|NCT01202604|Greece|greece
5102775|NCT01202591|Breast Cancer|breast cancer
5102776|NCT01202591|ER+|er+
5102777|NCT01202591|FGFR1|fgfr1
5102778|NCT01202591|Exemestane|exemestane
5102779|NCT01202591|AZD4547|azd4547
5102780|NCT01202591|Fulvestrant|fulvestrant
5102781|NCT01202565|Post-marketing observational study (PMOS) Protocol|post-marketing observational study (pmos) protocol
5102782|NCT01202565|Moderate to Severe Plaque Psoriasis|moderate to severe plaque psoriasis
5102783|NCT01202565|Treatment of Scalp and Nail Affection|treatment of scalp and nail affection
5102784|NCT01202565|Effectiveness of Adalimumab (HUMIRA®)|effectiveness of adalimumab (humira®)
5102785|NCT01202552|influenza|influenza
5102786|NCT01202552|aged|aged
5102787|NCT01202552|intradermal injection|intradermal injection
5102788|NCT01202526|Insulin resistance|insulin resistance
5102789|NCT01202526|Gastric bypass|gastric bypass
5102790|NCT01202513|Vitiligo|vitiligo
5102791|NCT01202513|Repigmentation|repigmentation
5102792|NCT01202487|Laceration|laceration
5102793|NCT01202487|Lacerations|lacerations
5102794|NCT01202487|LET|let
5102795|NCT01202487|Lidocaine Epinephrine Tetracaine|lidocaine epinephrine tetracaine
5102796|NCT01202487|LAT|lat
5103195|NCT01200862|Obese|obese
5102797|NCT01202487|Lidocaine Adrenaline Tetracaine|lidocaine adrenaline tetracaine
5102798|NCT01202487|Tissue Adhesive|tissue adhesive
5102799|NCT01202487|Skin Glue|skin glue
5102800|NCT01202487|Pre-Treatment with LET|pre-treatment with let
5102801|NCT01202487|Pre-Treatment with LAT|pre-treatment with lat
5102802|NCT01202487|Pre-Treatment with Lidocaine Epinephrine Tetracaine|pre-treatment with lidocaine epinephrine tetracaine
5102803|NCT01202487|Pre-Treatment with Lidocaine Adrenaline Tetracaine|pre-treatment with lidocaine adrenaline tetracaine
5102804|NCT01202487|Use of LET with Skin Glue|use of let with skin glue
5102805|NCT01202487|Use of LET with Tissue Adhesive|use of let with tissue adhesive
5102806|NCT01202487|Histoacryl|histoacryl
5102807|NCT01202461|Diabetic macular edema|diabetic macular edema
5102808|NCT01202461|Combination therapy for DME|combination therapy for dme
5102809|NCT01202461|DME|dme
5102810|NCT01202448|Diffuse large B cell lymphoma|diffuse large b cell lymphoma
5102811|NCT01202448|central nervous system|central nervous system
5102812|NCT01202448|prognosis|prognosis
5102813|NCT01202435|pregabalin|pregabalin
5102814|NCT01202435|pharmacokinetics|pharmacokinetics
5102815|NCT01202435|bioavailability|bioavailability
5102816|NCT01202435|bioequivalence|bioequivalence
5102817|NCT01202422|pregabalin|pregabalin
5102818|NCT01202422|pharmacokinetics|pharmacokinetics
5102819|NCT01202422|bioavailability|bioavailability
5102820|NCT01202422|bioequivalence|bioequivalence
5102821|NCT01202409|Ampulla of Vater|ampulla of vater
5102822|NCT01202409|Adenocarcinoma of the small bowel|adenocarcinoma of the small bowel
5102823|NCT01202409|Metastatic|metastatic
5102824|NCT01202409|Kirsten rat sarcoma|kirsten rat sarcoma
5102825|NCT01202409|KRAS|kras
5102826|NCT01202409|Capecitabine|capecitabine
5102827|NCT01202409|Xeloda|xeloda
5102828|NCT01202409|Oxaliplatin|oxaliplatin
5102829|NCT01202409|Eloxatin|eloxatin
5102830|NCT01202409|CAPOX|capox
5102831|NCT01202409|Panitumumab|panitumumab
5102832|NCT01202409|Vectibix|vectibix
5102833|NCT01202396|pouch|pouch
5102834|NCT01202396|pouchitis|pouchitis
5102835|NCT01202396|ulcerative colitis|ulcerative colitis
5102836|NCT01202396|microbiota|microbiota
5102837|NCT01202396|defensins|defensins
5102838|NCT01202396|epithelial integrity|epithelial integrity
5102839|NCT01202370|Cancer|cancer
5102840|NCT01202370|Tumors|tumors
5102841|NCT01202357|Psychotic Disorders|psychotic disorders
5102842|NCT01202357|Psychosis|psychosis
5102843|NCT01202344|Angioplasty|angioplasty
5102844|NCT01202344|Stenosis|stenosis
5102845|NCT01202344|Restenosis|restenosis
5102846|NCT01202344|Elastic Recoil|elastic recoil
5102847|NCT01202344|cheduled for percutaneous dilation of a peripheral artery|cheduled for percutaneous dilation of a peripheral artery
5102848|NCT01202344|Target lesion in native artery|target lesion in native artery
5102849|NCT01202344|Baseline lumen diameter greater than 4 mm|baseline lumen diameter greater than 4 mm
5102850|NCT01202331|Bacterial Infections|bacterial infections
5102851|NCT01202331|Chlamydia Infections|chlamydia infections
5102852|NCT01202331|Eye Diseases|eye diseases
5102853|NCT01202318|Cerebrovascular Accident|cerebrovascular accident
5102854|NCT01202318|Stroke,Acute|stroke,acute
5102855|NCT01202305|HIV|hiv
5102856|NCT01202305|HIV persistence|hiv persistence
5102857|NCT01202305|Lymph node fibrosis|lymph node fibrosis
5102858|NCT01202292|overweight|overweight
5102859|NCT01202292|obesity|obesity
5102860|NCT01202292|motivational intervention|motivational intervention
5102861|NCT01202279|Acute Upper Respiratory Track Infection Who Seek Treatment|acute upper respiratory track infection who seek treatment
5102862|NCT01202266|Multiple Ascending Dose|multiple ascending dose
5102863|NCT01202266|Phase 1|phase 1
5102864|NCT01202266|Safety and Tolerability|safety and tolerability
5102865|NCT01202266|PK|pk
5102866|NCT01202266|Healthy Subjects|healthy subjects
5102867|NCT01202253|Ecalta|ecalta
5102868|NCT01202253|Eraxis|eraxis
5102869|NCT01202253|Candida|candida
5102870|NCT01202253|Candidemia|candidemia
5102871|NCT01202253|Systemic Candidiasis|systemic candidiasis
5102872|NCT01202253|ICU|icu
5102873|NCT01202253|Intensive Care Unit|intensive care unit
5102874|NCT01202253|Critical Care Unit|critical care unit
5102875|NCT01202240|Drug-Drug Interaction|drug-drug interaction
5102876|NCT01202240|Healthy Volunteers|healthy volunteers
5102877|NCT01202240|Tasocitinib (CP-690|tasocitinib (cp-690
5102878|NCT01202240|550)|550)
5102879|NCT01202240|Ketoconazole|ketoconazole
5102880|NCT01202227|Central Nervous System Diseases|central nervous system diseases
5102881|NCT01202227|Therapeutic Uses|therapeutic uses
5102882|NCT01202227|Wounds and Injuries|wounds and injuries
5102883|NCT01202227|Trauma|trauma
5102884|NCT01202227|Nervous System|nervous system
5102885|NCT01202227|pregabalin|pregabalin
5102886|NCT01202188|QVA149, COPD, combination bronchodilator, indacaterol, glycopyrronium bromide|qva149, copd, combination bronchodilator, indacaterol, glycopyrronium bromide
5102887|NCT01202175|Genetic risk of hypertension|genetic risk of hypertension
5102888|NCT01202162|Induction|induction
5102889|NCT01202162|Coughing|coughing
5102890|NCT01202162|Anesthesia|anesthesia
5102891|NCT01202149|eczema|eczema
5102892|NCT01202149|elidel|elidel
5102893|NCT01202149|non-medicated device|non-medicated device
5102894|NCT01202149|hylatopic plus|hylatopic plus
5102895|NCT01202149|pimecrolimus|pimecrolimus
5102896|NCT01202149|bilateral comparison study|bilateral comparison study
5102897|NCT01202149|topical therapy|topical therapy
5102898|NCT01202136|pancreatic cyst|pancreatic cyst
5102899|NCT01202136|IPMN|ipmn
5102900|NCT01202136|PAN INs|pan ins
5102901|NCT01202136|Pancreatic cancer|pancreatic cancer
5102902|NCT01202136|pancreatic neoplasia|pancreatic neoplasia
5102903|NCT01202071|Rabeprazole|rabeprazole
5102904|NCT01202071|proton pump inhibitor|proton pump inhibitor
5102905|NCT01202071|pharmacokinetics|pharmacokinetics
5102906|NCT01202071|pharmacodynamics|pharmacodynamics
5102907|NCT01202071|healthy adult male Japanese subjects|healthy adult male japanese subjects
5102908|NCT01202058|Coronary artery disease|coronary artery disease
5102909|NCT01202058|Drug-eluting stents|drug-eluting stents
5102910|NCT01202058|Reservoir technology|reservoir technology
5102911|NCT01202045|Echocardiography, Stress|echocardiography, stress
5102912|NCT01202045|right heart catheterization|right heart catheterization
5102913|NCT01202032|Metastatic renal cell carcinoma|metastatic renal cell carcinoma
5102914|NCT01202032|Advanced solid tumors|advanced solid tumors
5102915|NCT01202032|Dose escalation|dose escalation
5102916|NCT01202032|Association Pazopanib-Bevacizumab|association pazopanib-bevacizumab
5102917|NCT01202019|cardiovascular risk|cardiovascular risk
5102918|NCT01202019|exercise|exercise
5102919|NCT01202019|post-exercise diet supplementation|post-exercise diet supplementation
5102920|NCT01202006|Heart failure|heart failure
5102921|NCT01202006|Diagnosis|diagnosis
5102922|NCT01202006|Treatment|treatment
5102923|NCT01202006|Primary care|primary care
5102924|NCT01201993|syncope|syncope
5102925|NCT01201993|evaluation|evaluation
5102926|NCT01201993|recurrence|recurrence
5102927|NCT01201993|morbidity|morbidity
5102928|NCT01201980|essential arterial hypertension|essential arterial hypertension
5102929|NCT01201980|calcium antagonist|calcium antagonist
5102930|NCT01201967|Collaborative care|collaborative care
5102931|NCT01201967|Cardiovascular disease|cardiovascular disease
5102932|NCT01201967|Depression|depression
5102933|NCT01201967|Anxiety|anxiety
5102934|NCT01201954|pain|pain
5102935|NCT01201954|sucrose|sucrose
5102936|NCT01201954|newborn|newborn
5102937|NCT01201954|mechanical ventilation|mechanical ventilation
5102938|NCT01201876|Dental Caries|dental caries
5102939|NCT01201876|Assessments|assessments
5102940|NCT01201876|dental materials|dental materials
5102941|NCT01201863|Testosterone|testosterone
5102942|NCT01201863|Traumatic Brain Injury|traumatic brain injury
5102943|NCT01201863|Hypogonadism|hypogonadism
5102944|NCT01201863|Endocrine Dysfunction|endocrine dysfunction
5102945|NCT01201863|Low Testosterone in men with new Traumatic Brain Injury|low testosterone in men with new traumatic brain injury
5102946|NCT01201850|radiation necrosis|radiation necrosis
5102947|NCT01201850|Bevacizumab (Avastin®)|bevacizumab (avastin®)
5102948|NCT01201850|Central Nervous System Tumors|central nervous system tumors
5102949|NCT01201837|Acute coronary syndrome|acute coronary syndrome
5102950|NCT01201837|HDL mimetic|hdl mimetic
5102951|NCT01201837|ApoA-I|apoa-i
5102952|NCT01201824|lung cancer|lung cancer
5102953|NCT01201824|intracavitary ultrasound|intracavitary ultrasound
5102954|NCT01201824|pulmonary nodules|pulmonary nodules
5102955|NCT01201824|VATS procedures|vats procedures
5102956|NCT01201811|Myelodysplastic Syndromes|myelodysplastic syndromes
5102957|NCT01201811|Taiwan|taiwan
5102958|NCT01201811|Azacitidine|azacitidine
5102959|NCT01201811|Vidaza|vidaza
5102960|NCT01201811|Celgene|celgene
5102961|NCT01201811|Pathologic Processes|pathologic processes
5102962|NCT01201811|Neoplasms|neoplasms
5102963|NCT01201811|Bone Marrow Diseases|bone marrow diseases
5102964|NCT01201811|Hematologic Diseases|hematologic diseases
5102965|NCT01201811|Antineoplastic Agents|antineoplastic agents
5102966|NCT01201811|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic
5102967|NCT01201811|Antimetabolites|antimetabolites
5102968|NCT01201811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
5102969|NCT01201811|Pharmacologic Actions|pharmacologic actions
5102970|NCT01201811|Therapeutic Uses|therapeutic uses
5102971|NCT01201811|Enzyme inhibitors|enzyme inhibitors
5102972|NCT01201785|diabetes mellitus, coronary artery disease, aspirin therapy|diabetes mellitus, coronary artery disease, aspirin therapy
5102973|NCT01201772|coronary artery disease|coronary artery disease
5102974|NCT01201772|percutaneous coronary revascularization|percutaneous coronary revascularization
5102975|NCT01201772|prasugrel therapy|prasugrel therapy
5102976|NCT01201759|cardiovascular risk|cardiovascular risk
5102977|NCT01201746|Non-surgical periodontal therapy|non-surgical periodontal therapy
5102978|NCT01201746|Coronary heart disease (CHD)|coronary heart disease (chd)
5102979|NCT01201746|periodontal Disease|periodontal disease
5102980|NCT01201746|hsCRP|hscrp
5102981|NCT01201746|Fibrinogen|fibrinogen
5102982|NCT01201746|WBCs|wbcs
5102983|NCT01201720|cirrhosis|cirrhosis
5102984|NCT01201720|cirrhotic patients with acute on chronic liver failure|cirrhotic patients with acute on chronic liver failure
5102985|NCT01201707|Multiple Sclerosis|multiple sclerosis
5102986|NCT01201707|Angioplasty|angioplasty
5102987|NCT01201707|Vein|vein
5102988|NCT01201694|Advanced malignancies|advanced malignancies
5102989|NCT01201694|Surface-controlled water soluble curcumin|surface-controlled water soluble curcumin
5102990|NCT01201694|Turmeric|turmeric
5102991|NCT01201694|Dietary supplements|dietary supplements
5102992|NCT01201681|Post-operative pain|post-operative pain
5102993|NCT01201681|intra-operative pain|intra-operative pain
5102994|NCT01201681|root canal therapy|root canal therapy
5102995|NCT01201681|feasibility|feasibility
5102996|NCT01201681|post-surgical persistent pain|post-surgical persistent pain
5102997|NCT01201668|post-operative pain|post-operative pain
5102998|NCT01201668|root canal therapy|root canal therapy
5102999|NCT01201668|feasibility|feasibility
5103000|NCT01201668|post-surgical persistent pain|post-surgical persistent pain
5103001|NCT01201655|Posthepatitic cirrhosis;|posthepatitic cirrhosis;
5103002|NCT01201655|Hepatocarcinogenesis;|hepatocarcinogenesis;
5103003|NCT01201655|Splenectomy;|splenectomy;
5103004|NCT01201642|Bell's palsy|bell's palsy
5103005|NCT01201642|Prednisolone|prednisolone
5103006|NCT01201642|acupuncture|acupuncture
5103007|NCT01201629|Ischemic Strokes|ischemic strokes
5103008|NCT01201629|t DC stimulation|t dc stimulation
5103009|NCT01201629|Functional recovery|functional recovery
5103010|NCT01201616|Cognitive function|cognitive function
5103011|NCT01201616|mood|mood
5103012|NCT01201616|women|women
5103013|NCT01201616|high fat diet|high fat diet
5103014|NCT01201616|high carbohydrate diet|high carbohydrate diet
5103015|NCT01201603|Women|women
5103016|NCT01201603|Orange Juice|orange juice
5103017|NCT01201603|Insulin Resistance|insulin resistance
5103018|NCT01201603|Obesity|obesity
5103019|NCT01201590|Insulin resistance|insulin resistance
5103020|NCT01201590|obesity|obesity
5103021|NCT01201590|cocoa|cocoa
5103022|NCT01201590|women|women
5103023|NCT01201577|Quorum sensing|quorum sensing
5103024|NCT01201577|Prebiotics|prebiotics
5103025|NCT01201577|Probiotics|probiotics
5103026|NCT01201577|Sepsis|sepsis
5103027|NCT01201564|umbilical hernia,|umbilical hernia,
5103028|NCT01201564|wound complications,|wound complications,
5103029|NCT01201564|mesh repair, IPOM,|mesh repair, ipom,
5103030|NCT01201564|quality of life,|quality of life,
5103031|NCT01201564|sublay mesh repair,|sublay mesh repair,
5103032|NCT01201564|recurrence rate|recurrence rate
5103033|NCT01201551|Alphagan|alphagan
5103034|NCT01201551|Xalatan|xalatan
5103035|NCT01201551|corneal temperature|corneal temperature
5103036|NCT01201551|primary vascular dysregulation|primary vascular dysregulation
5103037|NCT01201512|TMJD pain|tmjd pain
5103038|NCT01201512|feasibility|feasibility
5103039|NCT01201486|Ultrasound|ultrasound
5103040|NCT01201486|Pregnancy|pregnancy
5103041|NCT01201486|Fetal heart defects|fetal heart defects
5103042|NCT01201486|Color doppler|color doppler
5103043|NCT01201473|effect of participation|effect of participation
5103044|NCT01201473|effect of association|effect of association
5103045|NCT01201460|glucose testing|glucose testing
5103046|NCT01201447|Assessment|assessment
5103047|NCT01201447|Questionable Caries|questionable caries
5103048|NCT01201434|cystic fibrosis|cystic fibrosis
5103049|NCT01201434|probiotics|probiotics
5103050|NCT01201434|pulmonary|pulmonary
5103051|NCT01201434|infections|infections
5103052|NCT01201421|patient satisfaction|patient satisfaction
5103053|NCT01201421|assessments|assessments
5103054|NCT01201421|dental caries|dental caries
5103055|NCT01201421|dental materials|dental materials
5103056|NCT01201408|Dental Caries|dental caries
5103057|NCT01201408|Assessments|assessments
5103058|NCT01201408|dental materials|dental materials
5103059|NCT01201395|Dental Caries|dental caries
5103060|NCT01201395|Assessment|assessment
5103061|NCT01201395|dental materials|dental materials
5103062|NCT01201382|Depression|depression
5103063|NCT01201382|Prevention|prevention
5103064|NCT01201382|Adolescents|adolescents
5103065|NCT01201369|Percutaneous Coronary Intervention|percutaneous coronary intervention
5103066|NCT01201369|Coronary Artery Stenosis|coronary artery stenosis
5103067|NCT01201369|Acute Myocardial Infarction|acute myocardial infarction
5103068|NCT01201369|Coronary Artery Stent|coronary artery stent
5103069|NCT01201369|Optical Coherence Tomography|optical coherence tomography
5103070|NCT01201356|Fingolimod|fingolimod
5103071|NCT01201356|FTY720|fty720
5103072|NCT01201356|Relapsing forms of MS|relapsing forms of ms
5103073|NCT01201356|Multiple Sclerosis|multiple sclerosis
5103074|NCT01201356|Efficacy|efficacy
5103075|NCT01201343|Multiple sclerosis, relapsing, remitting|multiple sclerosis, relapsing, remitting
5103076|NCT01201343|Interferon-beta|interferon-beta
5103077|NCT01201330|ONJ|onj
5103078|NCT01201317|Analgesic effect|analgesic effect
5103079|NCT01201304|Anxiety sensitivity|anxiety sensitivity
5103080|NCT01201304|Panic|panic
5103081|NCT01201291|TBI|tbi
5103082|NCT01201291|Normobaric hyperoxia|normobaric hyperoxia
5103083|NCT01201291|Outcome|outcome
5103084|NCT01201291|GOS|gos
5103085|NCT01201291|GOSE|gose
5103086|NCT01201278|intranasal insulin|intranasal insulin
5103087|NCT01201252|children|children
5103088|NCT01201252|gastroenteritis|gastroenteritis
5103089|NCT01201252|Rotavirus|rotavirus
5103090|NCT01201239|raltegravir|raltegravir
5103091|NCT01201239|HIV-1|hiv-1
5103092|NCT01201239|drug resistance|drug resistance
5103093|NCT01201226|Primordial ovarian follicles|primordial ovarian follicles
5103094|NCT01201226|PTEN|pten
5103196|NCT01200862|obesity|obesity
5103095|NCT01201226|PI3K activating peptide|pi3k activating peptide
5103096|NCT01201226|Low ovarian reserve|low ovarian reserve
5103097|NCT01201226|Gonadotrophins|gonadotrophins
5103098|NCT01201213|Bupivacaine|bupivacaine
5103099|NCT01201213|levobupivacaine|levobupivacaine
5103100|NCT01201213|ropivacaine|ropivacaine
5103101|NCT01201200|Obstructive Sleep Apnea|obstructive sleep apnea
5103102|NCT01201200|Right Ventricular Function|right ventricular function
5103103|NCT01201200|Pulmonary Hypertension|pulmonary hypertension
5103104|NCT01201187|ADHD(Attention Deficit Hyperactivity Disorder)|adhd(attention deficit hyperactivity disorder)
5103105|NCT01201174|Hemolysis in Patients with Hereditary Spherocytosis|hemolysis in patients with hereditary spherocytosis
5103106|NCT01201174|with documented family history of HS.|with documented family history of hs.
5103107|NCT01201174|spherocyte morphology,|spherocyte morphology,
5103108|NCT01201174|splenomegaly and non-immune mediated hemolysis.|splenomegaly and non-immune mediated hemolysis.
5103109|NCT01201161|Diabetic Retinopathy|diabetic retinopathy
5103110|NCT01201161|Retinal detachment|retinal detachment
5103111|NCT01201161|Vitreous Hemorrhage|vitreous hemorrhage
5103112|NCT01201161|Preoperative Ranibizumab|preoperative ranibizumab
5103113|NCT01201161|pars plana vitrectomy|pars plana vitrectomy
5103114|NCT01201148|depression|depression
5103115|NCT01201148|transcranial direct current stimulation (tDCS)|transcranial direct current stimulation (tdcs)
5103116|NCT01201148|random noise stimulation|random noise stimulation
5103117|NCT01201148|oscillatory tDCS|oscillatory tdcs
5103118|NCT01201148|intermittent tDCS|intermittent tdcs
5103119|NCT01201122|Pediatric|pediatric
5103120|NCT01201122|Ulcerative colitis|ulcerative colitis
5103121|NCT01201122|5-ASA|5-asa
5103122|NCT01201122|Mesalamine|mesalamine
5103123|NCT01201122|Dosing|dosing
5103124|NCT01201109|Carpal tunnel syndrome|carpal tunnel syndrome
5103125|NCT01201109|Entrapment neuropathies|entrapment neuropathies
5103126|NCT01201109|Diabetes|diabetes
5103127|NCT01201096|neuroendocrine tumor|neuroendocrine tumor
5103128|NCT01201096|liver metastasis|liver metastasis
5103129|NCT01201096|peptide receptor therapy|peptide receptor therapy
5103130|NCT01201096|gastro-entero-pancreatic system|gastro-entero-pancreatic system
5103131|NCT01201057|SPL7013|spl7013
5103132|NCT01201057|VivaGel|vivagel
5103133|NCT01201057|bacterial vaginosis|bacterial vaginosis
5103134|NCT01201057|BV|bv
5103135|NCT01201044|BAI|bai
5103136|NCT01201044|3DCRT|3dcrt
5103137|NCT01201031|for the active surveillance of VRE colinization and infection|for the active surveillance of vre colinization and infection
5103138|NCT01201018|Tumor|tumor
5103139|NCT01201018|cancer|cancer
5103140|NCT01201018|metastasis|metastasis
5103141|NCT01200992|Urinary Bladder Neoplasms|urinary bladder neoplasms
5103142|NCT01200992|Neoplasms|neoplasms
5103143|NCT01200992|Urologic Neoplasms|urologic neoplasms
5103144|NCT01200992|Urogenital Neoplasms|urogenital neoplasms
5103145|NCT01200992|Neoplasms by Site|neoplasms by site
5103146|NCT01200992|Urinary Bladder Diseases|urinary bladder diseases
5103147|NCT01200992|Urologic Diseases|urologic diseases
5103148|NCT01200992|Mycobacterial cell wall DNA complex|mycobacterial cell wall dna complex
5103149|NCT01200992|Intravesical drug administration|intravesical drug administration
5103150|NCT01200979|Cytokine|cytokine
5103151|NCT01200979|Lymphocyte|lymphocyte
5103152|NCT01200979|Toll-Like Receptor|toll-like receptor
5103153|NCT01200979|NK Cell|nk cell
5103154|NCT01200979|Innate Immunity|innate immunity
5103155|NCT01200979|Pregnancy|pregnancy
5103156|NCT01200979|Immune Function|immune function
5103157|NCT01200966|Essential Tremor|essential tremor
5103158|NCT01200966|Transcranial Magnetic Stimulation (TMS)|transcranial magnetic stimulation (tms)
5103159|NCT01200966|Ethanol|ethanol
5103160|NCT01200966|Alcohol|alcohol
5103161|NCT01200966|Alcohol Clamp|alcohol clamp
5103162|NCT01200966|ET|et
5103163|NCT01200953|Select Agents|select agents
5103164|NCT01200953|Biosafety|biosafety
5103165|NCT01200953|Bioterrorism|bioterrorism
5103166|NCT01200953|SCSU (Special Clinical Studies Unit)|scsu (special clinical studies unit)
5103167|NCT01200953|Infectious Disease|infectious disease
5103168|NCT01200953|Bioterrorism-Related Illness|bioterrorism-related illness
5103169|NCT01200940|GLP-1|glp-1
5103170|NCT01200940|Glucose Tolerance|glucose tolerance
5103171|NCT01200940|Gut Hormones|gut hormones
5103172|NCT01200940|Gastric Bypass|gastric bypass
5103173|NCT01200940|Roux-en-Y|roux-en-y
5103174|NCT01200940|Bariatric Surgery|bariatric surgery
5103175|NCT01200927|infant|infant
5103176|NCT01200927|sitting|sitting
5103177|NCT01200927|postural control|postural control
5103178|NCT01200914|Hemodialysis|hemodialysis
5103179|NCT01200914|Fistula|fistula
5103180|NCT01200914|Angiograph|angiograph
5103181|NCT01200914|Angiogram|angiogram
5103182|NCT01200901|depression|depression
5103183|NCT01200901|healthy|healthy
5103184|NCT01200875|PRP|prp
5103185|NCT01200875|platelet rich plasma|platelet rich plasma
5103186|NCT01200875|platelet|platelet
5103187|NCT01200875|growth hormone|growth hormone
5103188|NCT01200875|tendonitis|tendonitis
5103189|NCT01200875|tendinosis|tendinosis
5103190|NCT01200875|tendinopathy|tendinopathy
5103191|NCT01200875|enthesopathy|enthesopathy
5103192|NCT01200875|muscle|muscle
5103193|NCT01200875|sport|sport
5103194|NCT01200875|tendon|tendon
5103197|NCT01200862|hypogonadism|hypogonadism
5103198|NCT01200862|hypogonadotropic|hypogonadotropic
5103199|NCT01200862|hyperestrogenemic|hyperestrogenemic
5103200|NCT01200862|testosterone|testosterone
5103201|NCT01200862|hypogonadal|hypogonadal
5103202|NCT01200836|Statins|statins
5103203|NCT01200836|Immune Modulation|immune modulation
5103204|NCT01200836|Healthy Volunteer|healthy volunteer
5103205|NCT01200823|Laboratory Research|laboratory research
5103206|NCT01200823|Biologic Samples|biologic samples
5103207|NCT01200823|Tissue Collection|tissue collection
5103208|NCT01200823|Tissue Procurement|tissue procurement
5103209|NCT01200771|FDG-PET/CT|fdg-pet/ct
5103210|NCT01200771|FUO|fuo
5103211|NCT01200771|Chronic Inflammatory syndrome|chronic inflammatory syndrome
5103212|NCT01200771|Fever of unknown origin|fever of unknown origin
5103213|NCT01200745|neck pain|neck pain
5103214|NCT01200745|capsaicin|capsaicin
5103215|NCT01200745|dermal patch|dermal patch
5103216|NCT01200732|Tadalafil|tadalafil
5103217|NCT01200732|phosphodiesterase-5 inhibitor|phosphodiesterase-5 inhibitor
5103218|NCT01200732|Eisenmenger syndrome|eisenmenger syndrome
5103219|NCT01200719|brain electrical stimulation|brain electrical stimulation
5103220|NCT01200719|sub-acute post-stroke|sub-acute post-stroke
5103221|NCT01200719|rehabilitation|rehabilitation
5103222|NCT01200706|children aged under 5 years|children aged under 5 years
5103223|NCT01200706|Non-severe|non-severe
5103224|NCT01200693|Angioplasty, Transluminal, Percutaneous Coronary|angioplasty, transluminal, percutaneous coronary
5103225|NCT01200693|Drug-Eluting Stents|drug-eluting stents
5103226|NCT01200680|Pediatric and Adult|pediatric and adult
5103227|NCT01200680|Gene Identification|gene identification
5103228|NCT01200680|Rare Bone Cancer|rare bone cancer
5103229|NCT01200680|All Chordoma Sites|all chordoma sites
5103230|NCT01200680|Sporadic Chordoma|sporadic chordoma
5103231|NCT01200680|Bone Cancer|bone cancer
5103232|NCT01200654|Population pharmacokinetics|population pharmacokinetics
5103233|NCT01200654|Linezolid|linezolid
5103234|NCT01200654|Monolix|monolix
5103235|NCT01200654|nonlinear mixed effects models|nonlinear mixed effects models
5103236|NCT01200641|melatonin|melatonin
5103237|NCT01200641|gabapentin|gabapentin
5103238|NCT01200641|anxiety|anxiety
5103239|NCT01200641|pain|pain
5103240|NCT01200641|retrobulbar block|retrobulbar block
5103241|NCT01200628|posttraumatic stress disorder|posttraumatic stress disorder
5103242|NCT01200628|acute PTSD|acute ptsd
5103243|NCT01200628|PTSD|ptsd
5103244|NCT01200628|motor vehicle accident|motor vehicle accident
5103245|NCT01200615|nocebo side-effects SSRI informed consent|nocebo side-effects ssri informed consent
5103246|NCT01200589|Randomized trial|randomized trial
5103247|NCT01200589|Ofatumumab|ofatumumab
5103248|NCT01200589|Rituximab|rituximab
5103249|NCT01200589|Indolent B-Cell Non Hodgkin Lymphoma|indolent b-cell non hodgkin lymphoma
5103250|NCT01200576|CRF: Case Report Form|crf: case report form
5103251|NCT01200576|DM: Data Management|dm: data management
5103252|NCT01200576|FHI: FHI (formerly known as Family Health International)|fhi: fhi (formerly known as family health international)
5103253|NCT01200576|IRB: Institutional Review Board|irb: institutional review board
5103254|NCT01200576|IUD: Intra-uterine Device|iud: intra-uterine device
5103255|NCT01200576|LTPM: Long-term and Permanent Contraceptive Methods|ltpm: long-term and permanent contraceptive methods
5103256|NCT01200576|MSI: Marie Stopes International|msi: marie stopes international
5103257|NCT01200576|MSM: Marie Stopes Madagascar|msm: marie stopes madagascar
5103258|NCT01200576|PHSC: Protection of Human Subjects Committee|phsc: protection of human subjects committee
5103259|NCT01200576|PI: Principal Investigator|pi: principal investigator
5103260|NCT01200576|SAE: Serious Adverse Event|sae: serious adverse event
5103261|NCT01200576|Sino-Implant (II)|sino-implant (ii)
5103262|NCT01200576|SOP: Standard Operating Procedure|sop: standard operating procedure
5103263|NCT01200576|Zarin|zarin
5103264|NCT01200563|MIST Therapy|mist therapy
5103265|NCT01200563|Negative Pressure Wound Therapy|negative pressure wound therapy
5103266|NCT01200563|Wound care in long-term acute care hospital|wound care in long-term acute care hospital
5103267|NCT01200563|Wound care in skilled nursing facility setting|wound care in skilled nursing facility setting
5103268|NCT01200550|Gastroesophageal reflux disease|gastroesophageal reflux disease
5103269|NCT01200550|GERD Impact Scale|gerd impact scale
5103271|NCT01200537|poor responders|poor responders
5103272|NCT01200537|follicle synchrony|follicle synchrony
5103273|NCT01200537|IVF response|ivf response
5103274|NCT01200537|estrogen|estrogen
5103275|NCT01200537|estradiol (E2)|estradiol (e2)
5103276|NCT01200537|oral contraceptive pill (OCP)|oral contraceptive pill (ocp)
5103277|NCT01200537|birth control pill (BCP)|birth control pill (bcp)
5103278|NCT01200524|Analgesic effect|analgesic effect
5103279|NCT01200511|intraocular lens|intraocular lens
5103280|NCT01200511|multifocal|multifocal
5103281|NCT01200511|toric|toric
5103282|NCT01200498|Primary Polycythemia Vera|primary polycythemia vera
5103283|NCT01200498|Post Polycythemia Vera|post polycythemia vera
5103284|NCT01200498|Post Essential Thrombocythemia Myelofibrosis|post essential thrombocythemia myelofibrosis
5103285|NCT01200498|SB939|sb939
5103286|NCT01200498|PMF|pmf
5103287|NCT01200498|post-PV MF|post-pv mf
5103288|NCT01200498|post-ET MF|post-et mf
5103289|NCT01200485|Supportive Care|supportive care
5103483|NCT01199861|MS|ms
5103290|NCT01200485|Recombinant urate oxidase|recombinant urate oxidase
5103291|NCT01200485|Chemotherapy|chemotherapy
5103292|NCT01200485|Tumor Lysis Syndrome (TLS)|tumor lysis syndrome (tls)
5103293|NCT01200485|Hematologic malignancies|hematologic malignancies
5103294|NCT01200485|Acute myeloid leukemia|acute myeloid leukemia
5103295|NCT01200472|EHOA|ehoa
5103296|NCT01200459|Obesity|obesity
5103297|NCT01200459|Weight Loss|weight loss
5103298|NCT01200459|Healthy Lifestyle|healthy lifestyle
5103299|NCT01200459|Social|social
5103300|NCT01200459|Mobile|mobile
5103301|NCT01200459|Facebook|facebook
5103302|NCT01200459|Text Messages|text messages
5103303|NCT01200446|Asthma|asthma
5103304|NCT01200446|Exercise-Induced Bronchoconstriction|exercise-induced bronchoconstriction
5103305|NCT01200446|Inflammation|inflammation
5103306|NCT01200446|Airway|airway
5103307|NCT01200446|Fish Oil|fish oil
5103308|NCT01200446|Docosahexaenoic Acid|docosahexaenoic acid
5103309|NCT01200446|DHA|dha
5103310|NCT01200433|dexmedetomidine|dexmedetomidine
5103311|NCT01200433|propofol|propofol
5103312|NCT01200433|cerebral blood flow|cerebral blood flow
5103313|NCT01200433|brain oxygenation|brain oxygenation
5103314|NCT01200420|Antisense|antisense
5103315|NCT01200420|miR-122 antagonist|mir-122 antagonist
5103316|NCT01200420|host factor|host factor
5103317|NCT01200420|CHC|chc
5103318|NCT01200407|Hypertension|hypertension
5103319|NCT01200407|fixed drug combination|fixed drug combination
5103320|NCT01200407|Filipinos|filipinos
5103321|NCT01200407|Amlodipine|amlodipine
5103322|NCT01200407|Olmesartan medoxomil|olmesartan medoxomil
5103323|NCT01200407|uncontrolled hypertension|uncontrolled hypertension
5103324|NCT01200407|difficult to treat hypertension|difficult to treat hypertension
5103325|NCT01200394|Diabetic nephropathy|diabetic nephropathy
5103326|NCT01200394|chronic kidney disease|chronic kidney disease
5103327|NCT01200394|PF-00489791|pf-00489791
5103328|NCT01200394|phosphodiesterase|phosphodiesterase
5103329|NCT01200394|PDE5|pde5
5103330|NCT01200381|ICD|icd
5103331|NCT01200381|CRTD|crtd
5103332|NCT01200381|Remote care|remote care
5103333|NCT01200381|Remote monitoring|remote monitoring
5103334|NCT01200381|Heart failure|heart failure
5103335|NCT01200368|vaccine|vaccine
5103336|NCT01200368|pneumococcal conjugate|pneumococcal conjugate
5103337|NCT01200355|MICAFUNGIN|micafungin
5103338|NCT01200355|POSACONAZOLE|posaconazole
5103339|NCT01200355|antifungal|antifungal
5103340|NCT01200355|prolonged neutropenia|prolonged neutropenia
5103341|NCT01200355|10-038|10-038
5103342|NCT01200342|Uveal melanoma|uveal melanoma
5103343|NCT01200342|Carboplatin|carboplatin
5103344|NCT01200342|Genasense|genasense
5103345|NCT01200342|Paclitaxel|paclitaxel
5103346|NCT01200342|oblimersen|oblimersen
5103347|NCT01200342|GCP|gcp
5103348|NCT01200329|Hodgkin's disease|hodgkin's disease
5103349|NCT01200329|Relapsed|relapsed
5103350|NCT01200329|Refractory|refractory
5103351|NCT01200329|High-dose chemotherapy|high-dose chemotherapy
5103352|NCT01200329|Busulfan|busulfan
5103353|NCT01200329|Gemcitabine|gemcitabine
5103354|NCT01200329|Melphalan|melphalan
5103355|NCT01200316|Colon Cancer|colon cancer
5103356|NCT01200316|Abdominal Surgery|abdominal surgery
5103357|NCT01200316|Stress|stress
5103358|NCT01200316|Rocking Motion|rocking motion
5103359|NCT01200316|Salivary Cortisol|salivary cortisol
5103360|NCT01200316|Postoperative Ileus|postoperative ileus
5103361|NCT01200303|colon cancer|colon cancer
5103362|NCT01200303|adenomatous colonic polyps|adenomatous colonic polyps
5103363|NCT01200303|colon screening|colon screening
5103364|NCT01200303|CT Colonography (Virtual Colonoscopy)|ct colonography (virtual colonoscopy)
5103365|NCT01200303|Computer Aided Detection|computer aided detection
5103366|NCT01200303|Electronic Cleansing|electronic cleansing
5103367|NCT01200290|end stage renal disease|end stage renal disease
5103368|NCT01200290|end stage kidney disease|end stage kidney disease
5103369|NCT01200290|ESRD|esrd
5103370|NCT01200290|Uremia|uremia
5103371|NCT01200290|Renal Dialysis|renal dialysis
5103372|NCT01200277|osteoporosis|osteoporosis
5103373|NCT01200277|vertebral fracture|vertebral fracture
5103374|NCT01200277|vertebroplasty|vertebroplasty
5103375|NCT01200277|percutaneous|percutaneous
5103376|NCT01200238|STA9090|sta9090
5103377|NCT01200238|STA-9090|sta-9090
5103378|NCT01200238|HSP90|hsp90
5103379|NCT01200212|Palliative Therapy|palliative therapy
5103380|NCT01200212|bevacizimab|bevacizimab
5103381|NCT01200212|Avastin|avastin
5103382|NCT01200212|Xeloda|xeloda
5103383|NCT01200212|metastatic breast cancer|metastatic breast cancer
5103384|NCT01200212|Progression Free Survival|progression free survival
5103385|NCT01200212|Time to Progression|time to progression
5103386|NCT01200212|Overall survival|overall survival
5103387|NCT01200173|Probiotic - Lactobacillus casei DN-114 001 - dairy|probiotic - lactobacillus casei dn-114 001 - dairy
5103388|NCT01200173|product - infections - children|product - infections - children
5103389|NCT01200160|Low-Density Lipoprotein Cholesterol|low-density lipoprotein cholesterol
5103390|NCT01200160|Hypertriglyceridemia|hypertriglyceridemia
5103391|NCT01200160|Latin America|latin america
5103392|NCT01200160|Cardiovascular Diseases|cardiovascular diseases
5103393|NCT01200160|Cholesterol|cholesterol
5103394|NCT01200160|Sedentary Lifestyle|sedentary lifestyle
5103395|NCT01200160|High-Density Lipoprotein Cholesterol|high-density lipoprotein cholesterol
5103396|NCT01200134|glioma patients : anaplasic glioma (grade III) and GBM (grade IV)|glioma patients : anaplasic glioma (grade iii) and gbm (grade iv)
5103397|NCT01200121|Symptomatic malignant ascites due to advanced-stage gastrointestinal cancers|symptomatic malignant ascites due to advanced-stage gastrointestinal cancers
5103398|NCT01200108|Severe Asthma, requiring chronic oral steroid use|severe asthma, requiring chronic oral steroid use
5103399|NCT01200082|chronic hepatitis C/B|chronic hepatitis c/b
5103400|NCT01200082|alcoholic liver disease|alcoholic liver disease
5103401|NCT01200082|primary biliary cirrhosis|primary biliary cirrhosis
5103402|NCT01200082|primary sclerosing cholangitis|primary sclerosing cholangitis
5103403|NCT01200082|progressive familial intrahepatic cholestasis|progressive familial intrahepatic cholestasis
5103404|NCT01200069|depression,myalgia|depression,myalgia
5103405|NCT01200056|Volumetric virtual histology intravascular ultrasound.|volumetric virtual histology intravascular ultrasound.
5103406|NCT01200056|Statin-naive patient.|statin-naive patient.
5103407|NCT01200056|Varying doses atorvastatin.|varying doses atorvastatin.
5103408|NCT01200056|Clinical outcomes.|clinical outcomes.
5103409|NCT01200043|Childhood obesity|childhood obesity
5103410|NCT01200043|metabolic syndrome|metabolic syndrome
5103411|NCT01200043|insulin resistance|insulin resistance
5103412|NCT01200043|intrahepatic fat|intrahepatic fat
5103413|NCT01200043|hypertension|hypertension
5103414|NCT01200030|Sitting balance|sitting balance
5103415|NCT01200030|Stroke|stroke
5103416|NCT01200017|T cell depleted|t cell depleted
5103417|NCT01200017|Matched unrelated donors|matched unrelated donors
5103418|NCT01200017|Haplocompatible donors|haplocompatible donors
5103419|NCT01200017|Graft vs Host Disease|graft vs host disease
5103420|NCT01200017|Hemoglobinopathies|hemoglobinopathies
5103421|NCT01200017|Leukemia|leukemia
5103422|NCT01200017|Leukemia, Lymphoid|leukemia, lymphoid
5103423|NCT01200017|Precursor Cell Lymphoblastic Leukemia-Lymphoma|precursor cell lymphoblastic leukemia-lymphoma
5103424|NCT01200017|Leukemia, Myeloid, Acute|leukemia, myeloid, acute
5103425|NCT01200017|Leukemia, Myeloid|leukemia, myeloid
5103426|NCT01200017|Leukemia, Myelogenous, Chronic, BCR-ABL Positive|leukemia, myelogenous, chronic, bcr-abl positive
5103427|NCT01200017|Lymphoma|lymphoma
5103428|NCT01200017|Myelodysplastic Syndromes|myelodysplastic syndromes
5103429|NCT01200017|Preleukemia|preleukemia
5103430|NCT01200017|Osteopetrosis|osteopetrosis
5103431|NCT01200017|Pancytopenia|pancytopenia
5103432|NCT01200017|Immune System Diseases|immune system diseases
5103433|NCT01200017|Hematologic Diseases|hematologic diseases
5103434|NCT01200017|Genetic Diseases, Inborn|genetic diseases, inborn
5103435|NCT01200017|Neoplasms by Histologic Type|neoplasms by histologic type
5103436|NCT01200017|Neoplasms|neoplasms
5103437|NCT01200017|Lymphoproliferative Disorders|lymphoproliferative disorders
5103438|NCT01200017|Lymphatic Diseases|lymphatic diseases
5103439|NCT01200017|Immunoproliferative Disorders|immunoproliferative disorders
5103440|NCT01200017|Myeloproliferative Disorders|myeloproliferative disorders
5103441|NCT01200017|Bone Marrow Diseases|bone marrow diseases
5103442|NCT01200017|Precancerous Conditions|precancerous conditions
5103443|NCT01200017|Osteosclerosis|osteosclerosis
5103444|NCT01200017|Osteochondrodysplasias|osteochondrodysplasias
5103445|NCT01200017|Bone Diseases, Developmental|bone diseases, developmental
5103446|NCT01200017|Bone Diseases|bone diseases
5103447|NCT01200017|Musculoskeletal Diseases|musculoskeletal diseases
5103448|NCT01200017|Severe acquired and congenital cytopenias|severe acquired and congenital cytopenias
5103449|NCT01200017|White and red blood cell abnormalities|white and red blood cell abnormalities
5103450|NCT01200004|Advanced solid tumor|advanced solid tumor
5103451|NCT01200004|Azacitidine|azacitidine
5103452|NCT01200004|Grifola frondosa|grifola frondosa
5103453|NCT01200004|Basidiomycete fungus|basidiomycete fungus
5103454|NCT01200004|Lenalidomide|lenalidomide
5103455|NCT01199978|radiation|radiation
5103456|NCT01199978|fractionated proton radiation|fractionated proton radiation
5103457|NCT01199952|contraception|contraception
5103458|NCT01199939|Human Immunodeficiency Virus|human immunodeficiency virus
5103460|NCT01199939|Etravirine|etravirine
5103461|NCT01199939|Darunavir|darunavir
5103462|NCT01199939|Prezista|prezista
5103463|NCT01199939|Intelence|intelence
5103464|NCT01199939|Ritonavir|ritonavir
5103465|NCT01199939|INROADS|inroads
5103466|NCT01199926|25-hydroxyvitamin D|25-hydroxyvitamin d
5103467|NCT01199926|Parathyroid hormone|parathyroid hormone
5103468|NCT01199926|Lean mass|lean mass
5103469|NCT01199926|Muscular strength|muscular strength
5103470|NCT01199926|Glucose tolerance|glucose tolerance
5103471|NCT01199913|problems with thinking after surgery;|problems with thinking after surgery;
5103472|NCT01199900|Healthy People|healthy people
5103473|NCT01199900|Glucocorticoids|glucocorticoids
5103474|NCT01199900|Prednisone|prednisone
5103475|NCT01199887|safety, biologic effects, IPF, autoimmune|safety, biologic effects, ipf, autoimmune
5103476|NCT01199874|Rotavirus|rotavirus
5103477|NCT01199874|Rotavirus vaccine|rotavirus vaccine
5103478|NCT01199874|Dosing schedule|dosing schedule
5103479|NCT01199874|Immunogenicity|immunogenicity
5103480|NCT01199874|Breast feeding|breast feeding
5103481|NCT01199874|Pakistan|pakistan
5103482|NCT01199861|Relapsing multiple sclerosis|relapsing multiple sclerosis
5103484|NCT01199861|Immune response|immune response
5103485|NCT01199848|nutrition|nutrition
5103486|NCT01199848|polyphenolic|polyphenolic
5103487|NCT01199848|strawberry|strawberry
5103488|NCT01199848|insulin resistance|insulin resistance
5103489|NCT01199848|metabolic syndrome|metabolic syndrome
5103490|NCT01199835|obesity|obesity
5103491|NCT01199835|metabolic syndrome|metabolic syndrome
5103492|NCT01199835|fecal fat excretion|fecal fat excretion
5103493|NCT01199835|fecal calcium|fecal calcium
5103494|NCT01199835|weight loss|weight loss
5103495|NCT01199835|appetite regulation|appetite regulation
5103496|NCT01199835|intestinal micro flora|intestinal micro flora
5103497|NCT01199835|lipid profile|lipid profile
5103498|NCT01199835|energy balance|energy balance
5103499|NCT01199783|Diabetic Foot,MRSA,|diabetic foot,mrsa,
5103500|NCT01199783|Complicated skin and skin structure infections|complicated skin and skin structure infections
5103501|NCT01199783|Antimicrobial therapy|antimicrobial therapy
5103502|NCT01199783|Daptomycin|daptomycin
5103503|NCT01199770|pasta|pasta
5103504|NCT01199770|appetite|appetite
5103505|NCT01199770|hunger|hunger
5103506|NCT01199770|satiety|satiety
5103507|NCT01199770|nutrition|nutrition
5103508|NCT01199770|metabolic|metabolic
5103509|NCT01199770|gut peptide hormones|gut peptide hormones
5103510|NCT01199770|psychological phenomena and processes|psychological phenomena and processes
5103511|NCT01199757|ocular symptoms|ocular symptoms
5103512|NCT01199757|nasal symptoms|nasal symptoms
5103513|NCT01199757|Allergic Rhinitis|allergic rhinitis
5103514|NCT01199757|Symptom Free Days|symptom free days
5103515|NCT01199757|Quality of Life|quality of life
5103516|NCT01199744|Influenza|influenza
5103517|NCT01199744|Relenza®|relenza®
5103518|NCT01199744|SSMP|ssmp
5103519|NCT01199731|raltegravir|raltegravir
5103520|NCT01199731|NNRTI|nnrti
5103521|NCT01199731|ritonavir|ritonavir
5103522|NCT01199731|darunavir|darunavir
5103523|NCT01199731|HIV|hiv
5103524|NCT01199731|GSK2248761|gsk2248761
5103525|NCT01199731|antiretroviral|antiretroviral
5103526|NCT01199731|HIV Infection|hiv infection
5103527|NCT01199731|HAART|haart
5103528|NCT01199718|Multiple myeloma|multiple myeloma
5103529|NCT01199718|Plasmacytoma|plasmacytoma
5103530|NCT01199705|Immune globulin subcutaneous|immune globulin subcutaneous
5103531|NCT01199705|SCIG|scig
5103532|NCT01199705|Primary immunodeficiency|primary immunodeficiency
5103533|NCT01199705|PID|pid
5103534|NCT01199679|Gastroesophageal Reflux Disease|gastroesophageal reflux disease
5103535|NCT01199679|Heartburn|heartburn
5103536|NCT01199679|Regurgitation|regurgitation
5103537|NCT01199679|Dyspepsia|dyspepsia
5103538|NCT01199666|Underimmunization, text message, vaccination|underimmunization, text message, vaccination
5103539|NCT01199666|Underimmunization|underimmunization
5103540|NCT01199653|clavicle fractures|clavicle fractures
5103541|NCT01199653|midshaft|midshaft
5103542|NCT01199653|dislocated|dislocated
5103543|NCT01199653|operative treatment|operative treatment
5103544|NCT01199653|conservative treatment|conservative treatment
5103545|NCT01199653|non-operative treatment|non-operative treatment
5103546|NCT01199653|randomized controlled trial|randomized controlled trial
5103547|NCT01199653|bone plates|bone plates
5103548|NCT01199627|total hip replacement|total hip replacement
5103549|NCT01199627|tranexamic acid|tranexamic acid
5103550|NCT01199614|Hypoparathyroidism|hypoparathyroidism
5103551|NCT01199614|Hypopara|hypopara
5103552|NCT01199614|HPTH|hpth
5103553|NCT01199614|Hypocalcemia|hypocalcemia
5103554|NCT01199614|Hypercalciuria|hypercalciuria
5103555|NCT01199614|PTH|pth
5103556|NCT01199614|PTH(1-84)|pth(1-84)
5103557|NCT01199588|VLU|vlu
5103558|NCT01199588|Venous Leg Ulcers|venous leg ulcers
5103559|NCT01199588|Ulcers|ulcers
5103560|NCT01199588|chronic wounds|chronic wounds
5103561|NCT01199588|wounds|wounds
5103562|NCT01199588|Nexagon|nexagon
5103563|NCT01199588|CoDa|coda
5103564|NCT01199575|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
5103565|NCT01199575|CLL|cll
5103566|NCT01199575|Relapsed or Refractory|relapsed or refractory
5103567|NCT01199575|previously treated|previously treated
5103568|NCT01199536|Helicobacter-positive duodenal ulcer|helicobacter-positive duodenal ulcer
5103569|NCT01199523|YM178|ym178
5103570|NCT01199523|Mirabegron|mirabegron
5103571|NCT01199523|QT|qt
5103572|NCT01199497|cough, acute rhinitis, nasal congestion, common cold, nasal symptoms, children.|cough, acute rhinitis, nasal congestion, common cold, nasal symptoms, children.
5103573|NCT01199497|Nasal congestion and non-productive cough, with or without associate other nasal and extranasal symptoms.|nasal congestion and non-productive cough, with or without associate other nasal and extranasal symptoms.
5103574|NCT01199484|Cow's milk allergy|cow's milk allergy
5103575|NCT01199484|food allergy|food allergy
5103576|NCT01199484|oral desensitization|oral desensitization
5103577|NCT01199484|randomized trial|randomized trial
5103578|NCT01199484|specific oral tolerance induction.|specific oral tolerance induction.
5103579|NCT01199471|Sevoflurane|sevoflurane
5103580|NCT01199471|Physician's Practice Patterns|physician's practice patterns
5103581|NCT01199471|Economics, Pharmaceutical|economics, pharmaceutical
5103582|NCT01199471|Chinese|chinese
5103583|NCT01199458|Lower Esophageal Sphincter|lower esophageal sphincter
5103584|NCT01199458|Barrier pressure|barrier pressure
5103585|NCT01199445|vitamin A deficiency|vitamin a deficiency
5103586|NCT01199432|Primary Breast Cancer|primary breast cancer
5103587|NCT01199419|multivessel coronary artery disease|multivessel coronary artery disease
5103588|NCT01199419|drug-eluting stent|drug-eluting stent
5103589|NCT01199419|CABG|cabg
5103590|NCT01199419|cost-effectiveness|cost-effectiveness
5103591|NCT01199406|gallstone|gallstone
5103592|NCT01199406|gallbladder|gallbladder
5103593|NCT01199406|cholecystectomy|cholecystectomy
5103594|NCT01199406|laparoscopic|laparoscopic
5103595|NCT01199406|pain|pain
5103596|NCT01199393|breast neoplasm|breast neoplasm
5103597|NCT01199393|drug therapy|drug therapy
5103598|NCT01199393|polymorphism|polymorphism
5103599|NCT01199393|gene|gene
5103600|NCT01199380|Smoking, Smoking Cessation|smoking, smoking cessation
5103601|NCT01199367|advanced or metastatic breast cancer|advanced or metastatic breast cancer
5103602|NCT01199354|Invasive breast carcinoma|invasive breast carcinoma
5103603|NCT01199341|Phase 1|phase 1
5103604|NCT01199341|Drug-Drug interaction|drug-drug interaction
5103605|NCT01199341|warfarin|warfarin
5103606|NCT01199341|AZD1981|azd1981
5103607|NCT01199328|Nexium|nexium
5103608|NCT01199328|aspirin|aspirin
5103609|NCT01199328|peptic ulcers|peptic ulcers
5103610|NCT01199328|pharmacodynamic (PD)|pharmacodynamic (pd)
5103611|NCT01199328|Esomoeprazole|esomoeprazole
5103612|NCT01199315|safety|safety
5103613|NCT01199315|tolerability|tolerability
5103614|NCT01199315|AZD1446|azd1446
5103615|NCT01199315|AD|ad
5103616|NCT01199315|ADHD|adhd
5103617|NCT01199315|Japanese|japanese
5103618|NCT01199302|Amgen|amgen
5103619|NCT01199302|Crohn's|crohn's
5103620|NCT01199302|Inflammatory Bowel Disease|inflammatory bowel disease
5103621|NCT01199302|IBD|ibd
5103622|NCT01199302|Irritable Bowel Syndrome|irritable bowel syndrome
5103623|NCT01199302|IBS|ibs
5103624|NCT01199302|Inflammation|inflammation
5103625|NCT01199302|bowel|bowel
5103626|NCT01199302|colon|colon
5103627|NCT01199302|gastrointestinal|gastrointestinal
5103628|NCT01199289|Amgen|amgen
5103629|NCT01199289|chronic inflammatory disease|chronic inflammatory disease
5103630|NCT01199289|wheezing|wheezing
5103631|NCT01199276|Delirium|delirium
5103632|NCT01199276|Hip Fracture|hip fracture
5103633|NCT01199276|Elderly|elderly
5103634|NCT01199237|Reflex, Pharyngeal|reflex, pharyngeal
5103635|NCT01199237|Anesthetics, Inhalation|anesthetics, inhalation
5103636|NCT01199224|Solid Tumors|solid tumors
5103637|NCT01199224|veliparib|veliparib
5103638|NCT01199224|refractory|refractory
5103639|NCT01199224|relapsed|relapsed
5103640|NCT01199211|hypertrophy, exercise, HDL, lipids, cholesterol|hypertrophy, exercise, hdl, lipids, cholesterol
5103641|NCT01199198|Hyponatremia|hyponatremia
5103642|NCT01199198|Serum sodium|serum sodium
5103643|NCT01199198|Tolvaptan|tolvaptan
5103644|NCT01199198|Placebo|placebo
5103645|NCT01199172|Student teachers with normal or mildly disordered voices|student teachers with normal or mildly disordered voices
5103646|NCT01199159|misoprostol|misoprostol
5103647|NCT01199159|hysterectomy|hysterectomy
5103648|NCT01199159|operative blood loss|operative blood loss
5103649|NCT01199159|total abdominal hysterectomy|total abdominal hysterectomy
5103650|NCT01199146|Abiraterone acetate|abiraterone acetate
5103651|NCT01199120|Omega-3|omega-3
5103652|NCT01199120|Cognition|cognition
5103653|NCT01199120|Malnourishment|malnourishment
5103654|NCT01199107|PTSD|ptsd
5103655|NCT01199107|Anxiety|anxiety
5103656|NCT01199107|Behavior Therapy|behavior therapy
5103657|NCT01199107|Prolonged Exposure|prolonged exposure
5103658|NCT01199107|Exercise|exercise
5103659|NCT01199107|Wellness|wellness
5103660|NCT01199107|Posttraumatic|posttraumatic
5103661|NCT01199107|Stress|stress
5103662|NCT01199094|low density lipoprotein receptor 5|low density lipoprotein receptor 5
5103663|NCT01199094|high bone mass|high bone mass
5103664|NCT01199094|autosomal dominant osteopetrosis type I|autosomal dominant osteopetrosis type i
5103665|NCT01199094|bone turnover markers|bone turnover markers
5103666|NCT01199068|PPAR gamma agonist|ppar gamma agonist
5103667|NCT01199068|Tumor|tumor
5103668|NCT01199068|Cancer|cancer
5103669|NCT01199068|Antineoplastic Agent|antineoplastic agent
5103670|NCT01199068|Respiratory Tract Neoplasms|respiratory tract neoplasms
5103671|NCT01199068|Erlotinib|erlotinib
5103672|NCT01199068|Protein Kinase Inhibitors|protein kinase inhibitors
5103673|NCT01199068|Neoplasms|neoplasms
5103674|NCT01199055|PPAR gamma agonist|ppar gamma agonist
5103675|NCT01199055|Tumor|tumor
5103676|NCT01199055|Cancer|cancer
5103677|NCT01199055|Antineoplastic Agent|antineoplastic agent
5103678|NCT01199055|Respiratory Tract Neoplasms|respiratory tract neoplasms
5103679|NCT01199055|Carboplatin|carboplatin
5103680|NCT01199055|Paclitaxel|paclitaxel
5103681|NCT01199055|Neoplasms|neoplasms
5103682|NCT01199029|Healthy People|healthy people
5103683|NCT01199029|Glucocorticoids|glucocorticoids
5103684|NCT01199029|Prednisone|prednisone
5103685|NCT01199016|Acute otitis media|acute otitis media
5103686|NCT01199016|Prevnar 13|prevnar 13
5103687|NCT01199016|Streptococcus pneumoniae|streptococcus pneumoniae
5103885|NCT01198106|cinnarizine|cinnarizine
5103688|NCT01199016|nasopharyngeal colonization.|nasopharyngeal colonization.
5103689|NCT01198977|multiple sclerosis|multiple sclerosis
5103690|NCT01198977|Fatigue|fatigue
5103691|NCT01198977|exercise|exercise
5103692|NCT01198977|telemedicine|telemedicine
5103693|NCT01198977|motivational interviewing|motivational interviewing
5103694|NCT01198977|counseling|counseling
5103695|NCT01198977|depression|depression
5103696|NCT01198977|physical activity|physical activity
5103697|NCT01198964|ECoG|ecog
5103698|NCT01198964|Epilepsy|epilepsy
5103699|NCT01198964|cortical|cortical
5103700|NCT01198964|stimulation|stimulation
5103701|NCT01198964|Electrocorticography|electrocorticography
5103702|NCT01198964|electrodes|electrodes
5103703|NCT01198964|mapping|mapping
5103704|NCT01198938|Cardiac surgery, delirium, melatonin|cardiac surgery, delirium, melatonin
5103705|NCT01198925|Infectious disease|infectious disease
5103706|NCT01198925|piperacillin|piperacillin
5103707|NCT01198925|continuous infusion|continuous infusion
5103708|NCT01198925|extended infusion|extended infusion
5103709|NCT01198912|rhinosinusitis|rhinosinusitis
5103710|NCT01198912|doxycycline|doxycycline
5103711|NCT01198912|Chronic rhinosinusitis with or without nasal polyps|chronic rhinosinusitis with or without nasal polyps
5103712|NCT01198899|Fabry-Anderson disease|fabry-anderson disease
5103713|NCT01198899|gen mutation|gen mutation
5103714|NCT01198899|left ventricular hypertrophy|left ventricular hypertrophy
5103715|NCT01198886|Mobility disability|mobility disability
5103716|NCT01198886|Older adults|older adults
5103717|NCT01198886|Physical activity|physical activity
5103718|NCT01198886|Nutritional status|nutritional status
5103719|NCT01198860|HBsAg|hbsag
5103720|NCT01198847|child overweight|child overweight
5103721|NCT01198847|child obesity|child obesity
5103722|NCT01198847|prevention|prevention
5103723|NCT01198847|targeted intervention|targeted intervention
5103724|NCT01198847|development of overweight|development of overweight
5103725|NCT01198834|ankle sprains|ankle sprains
5103726|NCT01198821|pancreas|pancreas
5103727|NCT01198821|adenocarcinoma|adenocarcinoma
5103728|NCT01198821|metastatic|metastatic
5103729|NCT01198821|unresectable|unresectable
5103730|NCT01198808|Bladder cancer|bladder cancer
5103731|NCT01198808|chemotherapy|chemotherapy
5103732|NCT01198808|T cells|t cells
5103733|NCT01198808|Immunotherapy|immunotherapy
5103734|NCT01198808|Tumor-specific immunity in bladder cancer|tumor-specific immunity in bladder cancer
5103735|NCT01198795|depression|depression
5103736|NCT01198795|major depressive disorder|major depressive disorder
5103737|NCT01198795|escitalopram|escitalopram
5103738|NCT01198795|Lexapro|lexapro
5103739|NCT01198795|pediatric|pediatric
5103740|NCT01198769|Human rotavirus vaccine|human rotavirus vaccine
5103741|NCT01198756|Influenza|influenza
5103742|NCT01198743|Genetics modifications|genetics modifications
5103743|NCT01198743|colorectal cancer|colorectal cancer
5103744|NCT01198743|prognosis aim|prognosis aim
5103745|NCT01198743|DNA|dna
5103746|NCT01198743|Plasma|plasma
5103747|NCT01198730|DM|dm
5103748|NCT01198730|CAD|cad
5103749|NCT01198730|Meal tolerance test|meal tolerance test
5103750|NCT01198730|Acarbose|acarbose
5103751|NCT01198704|Hepatocellular carcinoma|hepatocellular carcinoma
5103752|NCT01198704|Cirrhosis|cirrhosis
5103753|NCT01198704|Transplantation|transplantation
5103754|NCT01198691|metallic staples|metallic staples
5103755|NCT01198691|absorbable staples|absorbable staples
5103756|NCT01198691|Cesarean Delivery|cesarean delivery
5103757|NCT01198665|RAD001|rad001
5103758|NCT01198665|chemotherpy|chemotherpy
5103759|NCT01198665|T cell lymphoma|t cell lymphoma
5103760|NCT01198626|community-acquired bacterial pneumonia|community-acquired bacterial pneumonia
5103761|NCT01198626|CABP|cabp
5103762|NCT01198626|CAP|cap
5103763|NCT01198626|pneumonia|pneumonia
5103764|NCT01198626|pneumonia, bacterial|pneumonia, bacterial
5103765|NCT01198626|bacterial infections|bacterial infections
5103766|NCT01198626|anti-bacterial agents|anti-bacterial agents
5103767|NCT01198626|anti-infective agents|anti-infective agents
5103768|NCT01198626|lung disease, interstitial|lung disease, interstitial
5103769|NCT01198626|respiratory tract diseases|respiratory tract diseases
5103770|NCT01198626|respiratory tract infections|respiratory tract infections
5103771|NCT01198626|community-acquired infections|community-acquired infections
5103772|NCT01198613|Ragweed allergy|ragweed allergy
5103773|NCT01198613|Rhinoconjunctivitis|rhinoconjunctivitis
5103774|NCT01198613|Exposure chamber|exposure chamber
5103775|NCT01198613|Immunotherapy|immunotherapy
5103776|NCT01198613|ToleroMune Ragweed|toleromune ragweed
5103777|NCT01198587|Diarrhea|diarrhea
5103778|NCT01198587|Gastroenteritis|gastroenteritis
5103779|NCT01198587|Zinc Supplementation|zinc supplementation
5103780|NCT01198574|anemia|anemia
5103781|NCT01198574|iron supplementation|iron supplementation
5103782|NCT01198574|sub-clinical inflammation|sub-clinical inflammation
5103783|NCT01198574|adolescents|adolescents
5103784|NCT01198561|repetitive Transcranial Magnetic Stimulation|repetitive transcranial magnetic stimulation
5103785|NCT01198561|Major Depressive Disorder|major depressive disorder
5103886|NCT01198093|Alzheimer's disease|alzheimer's disease
5103887|NCT01198093|Mild Cognitive Impairment|mild cognitive impairment
5103786|NCT01198522|Interleukin, IL2, Gemcitabine, monoclonal, antibody, cytokine, tumour targeting, dose finding, fusion protein, Pancreatic cancer,|interleukin, il2, gemcitabine, monoclonal, antibody, cytokine, tumour targeting, dose finding, fusion protein, pancreatic cancer,
5103787|NCT01198522|L19|l19
5103788|NCT01198509|rheumatoid arthritis|rheumatoid arthritis
5103789|NCT01198509|psoriatic arthritis|psoriatic arthritis
5103790|NCT01198509|periodontitis|periodontitis
5103791|NCT01198509|microbiota|microbiota
5103792|NCT01198509|microbiome|microbiome
5103793|NCT01198509|vancomycin|vancomycin
5103794|NCT01198509|doxycycline|doxycycline
5103795|NCT01198509|T cell|t cell
5103796|NCT01198509|Th17|th17
5103797|NCT01198496|hypertension|hypertension
5103798|NCT01198496|stroke|stroke
5103799|NCT01198496|blood pressure|blood pressure
5103800|NCT01198483|refraction|refraction
5103801|NCT01198483|refractive error|refractive error
5103802|NCT01198483|combined surgery|combined surgery
5103803|NCT01198483|microincision|microincision
5103804|NCT01198483|smallincision|smallincision
5103805|NCT01198483|cataract surgery|cataract surgery
5103806|NCT01198483|vitrectomy|vitrectomy
5103807|NCT01198470|Low back pain|low back pain
5103808|NCT01198470|Leg pain|leg pain
5103809|NCT01198470|Discogenic pain|discogenic pain
5103810|NCT01198470|Degenerative Disc Disease (DDD)|degenerative disc disease (ddd)
5103811|NCT01198470|Herniated disc|herniated disc
5103812|NCT01198470|Radiculopathy|radiculopathy
5103813|NCT01198457|Clodronate|clodronate
5103814|NCT01198457|Compliance|compliance
5103815|NCT01198444|Contraception|contraception
5103816|NCT01198444|Compliance|compliance
5103817|NCT01198431|Appetite regulation|appetite regulation
5103818|NCT01198431|Physical activity|physical activity
5103819|NCT01198431|Energy balance|energy balance
5103820|NCT01198418|STI|sti
5103821|NCT01198418|MSM|msm
5103822|NCT01198418|HIV|hiv
5103823|NCT01198418|Prevention|prevention
5103824|NCT01198418|Men having sex with men|men having sex with men
5103825|NCT01198405|coronary artery disease|coronary artery disease
5103826|NCT01198405|enhanced external counterpulsation|enhanced external counterpulsation
5103827|NCT01198392|gastric cancer|gastric cancer
5103828|NCT01198379|aspirin|aspirin
5103829|NCT01198379|aspirin resistance|aspirin resistance
5103830|NCT01198379|hemodialysis|hemodialysis
5103831|NCT01198379|cardiovascular|cardiovascular
5103832|NCT01198379|Prevalence of aspirin resistance, cardiovascular events, and safety profile|prevalence of aspirin resistance, cardiovascular events, and safety profile
5103833|NCT01198366|Tuberculosis|tuberculosis
5103834|NCT01198366|Vaccine|vaccine
5103835|NCT01198366|Immunogenicity|immunogenicity
5103836|NCT01198366|Prevention of Tuberculosis|prevention of tuberculosis
5103837|NCT01198353|Schizophrenia|schizophrenia
5103838|NCT01198353|Schizoaffective Disorder|schizoaffective disorder
5103839|NCT01198353|Ziprasidone|ziprasidone
5103840|NCT01198353|Switch|switch
5103841|NCT01198353|Metabolic syndrome|metabolic syndrome
5103842|NCT01198327|RVO|rvo
5103843|NCT01198327|CRVO|crvo
5103844|NCT01198327|BRVO|brvo
5103845|NCT01198327|Horizon|horizon
5103846|NCT01198327|Bravo|bravo
5103847|NCT01198327|Cruise|cruise
5103848|NCT01198314|long term|long term
5103849|NCT01198314|stable|stable
5103850|NCT01198314|recipients|recipients
5103851|NCT01198301|Metastatic Breast Neoplasms|metastatic breast neoplasms
5103852|NCT01198301|Gene Expression Profiling|gene expression profiling
5103853|NCT01198301|Drug Therapy|drug therapy
5103854|NCT01198288|COPD|copd
5103855|NCT01198288|Respiratory Physiotherapy|respiratory physiotherapy
5103856|NCT01198275|PUFA atrial fibrillation|pufa atrial fibrillation
5103857|NCT01198262|polymerase chain reaction|polymerase chain reaction
5103858|NCT01198236|hematological malignancy|hematological malignancy
5103859|NCT01198236|previous proven or probable invasive fungal infection|previous proven or probable invasive fungal infection
5103860|NCT01198223|denture stomatitis|denture stomatitis
5103861|NCT01198223|nystatin|nystatin
5103862|NCT01198223|garlic|garlic
5103863|NCT01198210|pain|pain
5103864|NCT01198210|tonsillectomy|tonsillectomy
5103865|NCT01198210|peritonsillar infiltration|peritonsillar infiltration
5103866|NCT01198210|postoperative pain|postoperative pain
5103867|NCT01198197|Nociceptin/Orphanin FQ Peptide (NOP)|nociceptin/orphanin fq peptide (nop)
5103868|NCT01198197|PET Imaging|pet imaging
5103869|NCT01198197|Brain Imaging|brain imaging
5103870|NCT01198197|Healthy Volunteer|healthy volunteer
5103871|NCT01198197|HV|hv
5103872|NCT01198145|diarrhea|diarrhea
5103873|NCT01198145|gastrointestinal complications|gastrointestinal complications
5103874|NCT01198145|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5103875|NCT01198132|Multiple Sclerosis Relapsing-Remitting|multiple sclerosis relapsing-remitting
5103876|NCT01198132|Relapsing Multiple Sclerosis (RMS)|relapsing multiple sclerosis (rms)
5103877|NCT01198132|Rebif|rebif
5103878|NCT01198132|Vitamin D3|vitamin d3
5103879|NCT01198132|Cholecalciferol|cholecalciferol
5103880|NCT01198119|oral cavity tumor|oral cavity tumor
5103881|NCT01198119|narrow band imaging|narrow band imaging
5103882|NCT01198119|subclinical cancer lesion|subclinical cancer lesion
5103883|NCT01198106|simulator sickness|simulator sickness
5103884|NCT01198106|scopolamine|scopolamine
5103888|NCT01198093|cohort study|cohort study
5103889|NCT01198080|Avascular osteonecrosis,CD133+,core decompression|avascular osteonecrosis,cd133+,core decompression
5103890|NCT01198067|Waldenstrom Macroglobulinemia|waldenstrom macroglobulinemia
5103891|NCT01198067|B-cell lymphoproliferative disorder|b-cell lymphoproliferative disorder
5103892|NCT01198067|Bone marrow|bone marrow
5103893|NCT01198067|Lymphoplasmacytic cells|lymphoplasmacytic cells
5103894|NCT01198067|Monoclonal gammopathy|monoclonal gammopathy
5103895|NCT01198067|Pomalidomide|pomalidomide
5103896|NCT01198067|Actimid|actimid
5103897|NCT01198067|CC-4047|cc-4047
5103898|NCT01198054|AML|aml
5103899|NCT01198054|Lenalidomide|lenalidomide
5103900|NCT01198028|Squamous cell carcinoma of the skin|squamous cell carcinoma of the skin
5103901|NCT01198028|Cutaneous squamous cell carcinoma|cutaneous squamous cell carcinoma
5103902|NCT01198028|CSCC|cscc
5103903|NCT01198028|epidermal growth factor receptor|epidermal growth factor receptor
5103904|NCT01198028|EGFR|egfr
5103905|NCT01198028|tyrosine kinase inhibitor|tyrosine kinase inhibitor
5103906|NCT01198028|recurrent|recurrent
5103907|NCT01198028|Erlotinib|erlotinib
5103908|NCT01198028|Erlotinib hydrochloride|erlotinib hydrochloride
5103909|NCT01198028|OSI-774|osi-774
5103910|NCT01198028|Tarceva|tarceva
5103911|NCT01198015|Rett syndrome|rett syndrome
5103912|NCT01198015|Nutritional status|nutritional status
5103913|NCT01198015|Creatine metabolism|creatine metabolism
5103914|NCT01198002|Rheumatoid Arthritis|rheumatoid arthritis
5103915|NCT01197989|pustulosis|pustulosis
5103916|NCT01197989|soles|soles
5103917|NCT01197989|teflon|teflon
5103918|NCT01197976|psoriasis|psoriasis
5103919|NCT01197976|soles|soles
5103920|NCT01197976|teflon|teflon
5103921|NCT01197963|Type 2 diabetes mellitus|type 2 diabetes mellitus
5103922|NCT01197950|acupuncture|acupuncture
5103923|NCT01197950|labour|labour
5103924|NCT01197950|pain|pain
5103925|NCT01197950|pain relief|pain relief
5103926|NCT01197950|complementary|complementary
5103927|NCT01197924|child cancer brain|child cancer brain
5103928|NCT01197898|Diabetic|diabetic
5103929|NCT01197898|Foot|foot
5103930|NCT01197898|Ulcers|ulcers
5103931|NCT01197898|Wounds|wounds
5103932|NCT01197833|varicose veins|varicose veins
5103933|NCT01197833|Great saphenous vein|great saphenous vein
5103934|NCT01197833|varicosities|varicosities
5103935|NCT01197820|HIFU|hifu
5103936|NCT01197820|mobile organs|mobile organs
5103937|NCT01197820|thermometry|thermometry
5103938|NCT01197820|MR|mr
5103939|NCT01197820|liver|liver
5103940|NCT01197820|kidney|kidney
5103941|NCT01197820|cancer|cancer
5103942|NCT01197820|Liver tumors, kidney carcinoma|liver tumors, kidney carcinoma
5103943|NCT01197807|Suctioning|suctioning
5103944|NCT01197807|Wiping|wiping
5103945|NCT01197807|Neonate|neonate
5103946|NCT01197807|Resuscitation|resuscitation
5103947|NCT01197794|Efficacy|efficacy
5103948|NCT01197794|safety|safety
5103949|NCT01197794|tolerability|tolerability
5103950|NCT01197794|dose finding|dose finding
5103951|NCT01197794|asthma patients|asthma patients
5103952|NCT01197781|Phase I|phase i
5103953|NCT01197781|FosD|fosd
5103954|NCT01197781|fostamatinib disodium|fostamatinib disodium
5103955|NCT01197781|verapamil|verapamil
5103956|NCT01197781|healthy volunteers|healthy volunteers
5103957|NCT01197755|Rheumatoid Arthritis|rheumatoid arthritis
5103958|NCT01197742|Diabetes|diabetes
5103959|NCT01197742|STEMI|stemi
5103960|NCT01197742|NSTEMI|nstemi
5103961|NCT01197742|Myocardial infarction|myocardial infarction
5103962|NCT01197729|Myocardial infarction|myocardial infarction
5103963|NCT01197729|ST-Elevation myocardial infarction|st-elevation myocardial infarction
5103964|NCT01197729|Non-ST-Elevation myocardial infarction|non-st-elevation myocardial infarction
5103965|NCT01197729|Register|register
5103966|NCT01197729|CARDS|cards
5103967|NCT01197716|Chest Pain Unit|chest pain unit
5103968|NCT01197716|Myocardial infarction|myocardial infarction
5103969|NCT01197716|Register|register
5103970|NCT01197716|Admission to a Chest Pain Unit for any reason|admission to a chest pain unit for any reason
5103971|NCT01197703|Clinical Practice Cardiac CT|clinical practice cardiac ct
5103972|NCT01197703|Clinical Implications Coronary CT Angiography|clinical implications coronary ct angiography
5103973|NCT01197703|Radiation Exposure of Coronary CT Angiography|radiation exposure of coronary ct angiography
5103974|NCT01197703|Registry|registry
5103975|NCT01197690|Bronchial asthma|bronchial asthma
5103976|NCT01197690|level of control of asthma|level of control of asthma
5103977|NCT01197690|fractional exhaled nitric oxide (FeNO)|fractional exhaled nitric oxide (feno)
5103978|NCT01197690|asthma control test (ACT)|asthma control test (act)
5103979|NCT01197677|CMR|cmr
5103980|NCT01197677|Register|register
5103981|NCT01197677|CAD|cad
5103982|NCT01197677|myocard scarring|myocard scarring
5103983|NCT01197651|Aorta|aorta
5103984|NCT01197651|Aorta-Stent-Graft|aorta-stent-graft
5103985|NCT01197651|Surgical operation|surgical operation
5103986|NCT01197651|Aortic dissection|aortic dissection
5103987|NCT01197638|Cardiac arrhythmia|cardiac arrhythmia
5103988|NCT01197638|Catheter ablation|catheter ablation
5103989|NCT01197638|Register|register
5104085|NCT01197209|REIC|reic
5103990|NCT01197625|Vaccination treatment, dendritic cells|vaccination treatment, dendritic cells
5103991|NCT01197599|Healthy Control|healthy control
5103992|NCT01197586|surfactant protein B|surfactant protein b
5103993|NCT01197586|differential diagnostics|differential diagnostics
5103994|NCT01197560|Diffuse Large B-Cell Lymphoma|diffuse large b-cell lymphoma
5103995|NCT01197560|Non Hodgkin's Lymphoma|non hodgkin's lymphoma
5103996|NCT01197560|relapsed|relapsed
5103997|NCT01197560|refractory|refractory
5103998|NCT01197560|relapsed/refractory|relapsed/refractory
5103999|NCT01197560|DLBCL|dlbcl
5104000|NCT01197560|Diffuse Large B Cell Lymphoma|diffuse large b cell lymphoma
5104001|NCT01197547|Menorrhagia|menorrhagia
5104002|NCT01197534|Rheumatoid Arthritis|rheumatoid arthritis
5104003|NCT01197521|Rheumatoid Arthritis|rheumatoid arthritis
5104004|NCT01197508|Major Depressive Disorder, MDD, Depression|major depressive disorder, mdd, depression
5104005|NCT01197482|asthma|asthma
5104006|NCT01197482|inhalation|inhalation
5104007|NCT01197469|Secondary Pulmonary Hypertension|secondary pulmonary hypertension
5104008|NCT01197456|Breast cancer|breast cancer
5104009|NCT01197456|Ovarian insufficiency|ovarian insufficiency
5104010|NCT01197456|Ovarian failure|ovarian failure
5104011|NCT01197456|Reproduction|reproduction
5104012|NCT01197443|obesity|obesity
5104013|NCT01197443|overweight|overweight
5104014|NCT01197443|overweight children|overweight children
5104015|NCT01197443|overweight parents|overweight parents
5104016|NCT01197443|families with overweight child|families with overweight child
5104017|NCT01197443|body mass index|body mass index
5104018|NCT01197443|BMI|bmi
5104019|NCT01197443|weight|weight
5104020|NCT01197443|childhood obesity|childhood obesity
5104021|NCT01197443|diet|diet
5104022|NCT01197443|treatment|treatment
5104023|NCT01197443|parent modeling|parent modeling
5104024|NCT01197443|traffic light diet|traffic light diet
5104025|NCT01197443|stop light diet|stop light diet
5104026|NCT01197430|volleyball|volleyball
5104027|NCT01197430|neck vertical stability training|neck vertical stability training
5104028|NCT01197430|eye-hand coordination|eye-hand coordination
5104029|NCT01197417|Sickle Cell Disease|sickle cell disease
5104030|NCT01197417|Magnesium Sulfate|magnesium sulfate
5104031|NCT01197417|Pediatric|pediatric
5104032|NCT01197404|HIV Prevention|hiv prevention
5104033|NCT01197378|cystinosis|cystinosis
5104034|NCT01197378|cysteamine|cysteamine
5104035|NCT01197378|inheritable disease|inheritable disease
5104036|NCT01197378|orphan disease|orphan disease
5104037|NCT01197378|CTNS protein, human|ctns protein, human
5104038|NCT01197378|metabolic disease|metabolic disease
5104039|NCT01197378|nephropathic cystinosis|nephropathic cystinosis
5104040|NCT01197365|Acidified milk|acidified milk
5104041|NCT01197365|Beta-palmitate|beta-palmitate
5104042|NCT01197365|Bifidobacteria|bifidobacteria
5104043|NCT01197365|Infant formula|infant formula
5104044|NCT01197365|Galacto-oligosaccharides|galacto-oligosaccharides
5104045|NCT01197365|Growth|growth
5104046|NCT01197365|Infants|infants
5104047|NCT01197365|Prebiotics|prebiotics
5104048|NCT01197352|Alcohol|alcohol
5104049|NCT01197352|Abuse|abuse
5104050|NCT01197352|Drinking|drinking
5104051|NCT01197352|Behavior|behavior
5104052|NCT01197352|Text|text
5104053|NCT01197352|Computer|computer
5104054|NCT01197339|acute phonotrauma|acute phonotrauma
5104055|NCT01197339|computer modeling|computer modeling
5104056|NCT01197339|resonant voice|resonant voice
5104057|NCT01197339|breathy voice|breathy voice
5104058|NCT01197339|voice rest|voice rest
5104059|NCT01197339|relaxation|relaxation
5104060|NCT01197326|patient deterioration|patient deterioration
5104061|NCT01197326|unplanned ICU admissions|unplanned icu admissions
5104062|NCT01197326|rapid response teams|rapid response teams
5104063|NCT01197313|chronic heart failure (CHF); anxiety and depression; quality of life (QOL); exercise|chronic heart failure (chf); anxiety and depression; quality of life (qol); exercise
5104064|NCT01197300|Osteoporosis, children and adolescents, zoledronic acid, chronic inflammation, Duchenne muscular dystrophy, glucocorticoids|osteoporosis, children and adolescents, zoledronic acid, chronic inflammation, duchenne muscular dystrophy, glucocorticoids
5104065|NCT01197287|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
5104066|NCT01197274|allergy|allergy
5104067|NCT01197274|skin prick test|skin prick test
5104068|NCT01197274|mite sensitivity|mite sensitivity
5104069|NCT01197261|Severe pain|severe pain
5104070|NCT01197261|Bladder Pain Syndrome|bladder pain syndrome
5104071|NCT01197261|Interstitial Cystitis|interstitial cystitis
5104072|NCT01197261|Painful Bladder Syndrome|painful bladder syndrome
5104073|NCT01197261|Severe pain due to Bladder Pain Syndrome/Interstitial Cystitis/Painful Bladder Syndrome|severe pain due to bladder pain syndrome/interstitial cystitis/painful bladder syndrome
5104074|NCT01197248|cystocele|cystocele
5104075|NCT01197248|voiding|voiding
5104076|NCT01197248|dysfunction|dysfunction
5104077|NCT01197235|darbepoetin, chronic kidney disease, coronary angiography|darbepoetin, chronic kidney disease, coronary angiography
5104078|NCT01197222|Laparoscopic|laparoscopic
5104079|NCT01197222|EndoClear|endoclear
5104080|NCT01197222|Lens Cleaning Device|lens cleaning device
5104081|NCT01197209|Prostate Cancer|prostate cancer
5104082|NCT01197209|Prostatectomy|prostatectomy
5104083|NCT01197209|Postectomy|postectomy
5104084|NCT01197209|Oncology|oncology
5104086|NCT01197209|Dikkoff|dikkoff
5104087|NCT01197209|Apoptosis|apoptosis
5104088|NCT01197196|Migraine|migraine
5104089|NCT01197196|Obesity|obesity
5104090|NCT01197196|Weight loss|weight loss
5104091|NCT01197196|Lifestyle|lifestyle
5104092|NCT01197196|Behavior|behavior
5104093|NCT01197183|Hypothyroidism|hypothyroidism
5104094|NCT01197183|Thyroid hormones|thyroid hormones
5104095|NCT01197170|Hormonal therapies|hormonal therapies
5104096|NCT01197170|Estrogen receptor|estrogen receptor
5104097|NCT01197170|Progesterone receptor|progesterone receptor
5104098|NCT01197170|Hormone blockade|hormone blockade
5104099|NCT01197170|Hormone-positive tumors|hormone-positive tumors
5104100|NCT01197170|Advanced cancer|advanced cancer
5104101|NCT01197170|Metastatic cancer|metastatic cancer
5104102|NCT01197170|Avastin|avastin
5104103|NCT01197170|Anti-VEGF monoclonal antibody|anti-vegf monoclonal antibody
5104104|NCT01197170|rhuMAB-VEGF|rhumab-vegf
5104105|NCT01197170|Afinitor|afinitor
5104106|NCT01197170|RAD001|rad001
5104107|NCT01197170|Nexavar|nexavar
5104108|NCT01197170|BAY43-9006|bay43-9006
5104109|NCT01197170|OSI-774|osi-774
5104110|NCT01197170|Tarceva|tarceva
5104111|NCT01197157|chronic hepatitis C|chronic hepatitis c
5104112|NCT01197157|genotype 4|genotype 4
5104113|NCT01197157|treatment naive patients|treatment naive patients
5104114|NCT01197157|Egypt|egypt
5104115|NCT01197144|TNF|tnf
5104116|NCT01197144|functional Magnetic Resonance Imaging|functional magnetic resonance imaging
5104117|NCT01197144|Autonomic|autonomic
5104118|NCT01197144|Vagus|vagus
5104119|NCT01197144|adalimumab|adalimumab
5104120|NCT01197131|autism|autism
5104121|NCT01197131|autism spectrum disorder|autism spectrum disorder
5104122|NCT01197131|steroids|steroids
5104123|NCT01197131|steroid metabolites|steroid metabolites
5104124|NCT01197131|urinary steroid metabolites|urinary steroid metabolites
5104125|NCT01197131|hormone formation|hormone formation
5104126|NCT01197131|androgen precursor|androgen precursor
5104127|NCT01197118|gastric cancer|gastric cancer
5104128|NCT01197118|sequence chemoradiotherapy|sequence chemoradiotherapy
5104129|NCT01197118|OLF regimen|olf regimen
5104130|NCT01197118|survival rate|survival rate
5104131|NCT01197105|gingivitis|gingivitis
5104132|NCT01197105|schinus terebinthifolius|schinus terebinthifolius
5104133|NCT01197105|natural products|natural products
5104134|NCT01197092|Diabetes|diabetes
5104135|NCT01197079|HPV|hpv
5104136|NCT01197079|Vaccine|vaccine
5104137|NCT01197079|Vaccine utilization|vaccine utilization
5104138|NCT01197079|Disease awareness|disease awareness
5104139|NCT01197053|Peanut Allergy|peanut allergy
5104140|NCT01197053|Food Allergy|food allergy
5104141|NCT01197053|Epicutaneous Immunotherapy (EPIT)|epicutaneous immunotherapy (epit)
5104142|NCT01197053|Food Challenge|food challenge
5104143|NCT01197040|Minimal Change Nephrotic Syndrome|minimal change nephrotic syndrome
5104144|NCT01197040|Complete remission|complete remission
5104145|NCT01197040|Myfortic|myfortic
5104146|NCT01197040|Minimal Change Disease|minimal change disease
5104147|NCT01197014|Amlodipine, Losartan|amlodipine, losartan
5104148|NCT01197001|Amlodipine, Losartan|amlodipine, losartan
5104149|NCT01196988|GSK Biologicals influenza vaccine GSK2321138A|gsk biologicals influenza vaccine gsk2321138a
5104150|NCT01196988|influenza infection|influenza infection
5104151|NCT01196975|Influenza|influenza
5104152|NCT01196962|central venous catheter|central venous catheter
5104153|NCT01196962|complications|complications
5104154|NCT01196962|internal jugular vein|internal jugular vein
5104155|NCT01196962|randomized trial|randomized trial
5104156|NCT01196962|subclavian vein|subclavian vein
5104157|NCT01196949|Ankle|ankle
5104158|NCT01196949|Chronic|chronic
5104159|NCT01196949|Instability|instability
5104160|NCT01196949|Manipulative|manipulative
5104161|NCT01196949|Rehabilitative|rehabilitative
5104162|NCT01196949|Manipulation|manipulation
5104163|NCT01196949|Rehabilitation|rehabilitation
5104164|NCT01196936|Cancer survivors|cancer survivors
5104165|NCT01196936|Low Dose Tamoxifen|low dose tamoxifen
5104166|NCT01196936|Breast Cancer Risk Reduction|breast cancer risk reduction
5104167|NCT01196897|Atrial fibrillation|atrial fibrillation
5104168|NCT01196897|Stroke|stroke
5104169|NCT01196897|Warfarin|warfarin
5104170|NCT01196897|Coumadin|coumadin
5104171|NCT01196897|TIA|tia
5104172|NCT01196897|Trans Ischemic Attack|trans ischemic attack
5104173|NCT01196884|Patients with primary Immune Thrombocytopenia (ITP)|patients with primary immune thrombocytopenia (itp)
5104174|NCT01196871|Fabry disease|fabry disease
5104175|NCT01196871|drug drug interaction|drug drug interaction
5104176|NCT01196845|adipose tissue|adipose tissue
5104177|NCT01196845|obese patients|obese patients
5104178|NCT01196845|inflammation|inflammation
5104179|NCT01196845|oxidative stress|oxidative stress
5104180|NCT01196845|sleep apnea syndrome|sleep apnea syndrome
5104181|NCT01196806|Non-Invasive Blood Pressure(NIBP)|non-invasive blood pressure(nibp)
5104182|NCT01196793|Feverish illness in children|feverish illness in children
5104183|NCT01196767|Sternotomy|sternotomy
5104184|NCT01196767|Pain|pain
5104185|NCT01196767|Respiratory function|respiratory function
5104186|NCT01196767|Opiates|opiates
5104187|NCT01196767|Patient-controlled|patient-controlled
5104188|NCT01196767|Scheduled cardiac surgery under general anaesthesia without any locoregional anaesthesia protocol other than this presently studied|scheduled cardiac surgery under general anaesthesia without any locoregional anaesthesia protocol other than this presently studied
5104189|NCT01196754|Pharmacokinetics|pharmacokinetics
5104190|NCT01196754|Sevoflurane|sevoflurane
5104191|NCT01196754|Fluorides|fluorides
5104192|NCT01196754|Sedation|sedation
5104193|NCT01196754|Adult patients with a predicted sedation more than 48 h|adult patients with a predicted sedation more than 48 h
5104194|NCT01196754|Stable respiratory and hemodynamic conditions for SBT|stable respiratory and hemodynamic conditions for sbt
5104195|NCT01196754|Consent of patients|consent of patients
5104196|NCT01196754|Arterial line|arterial line
5104197|NCT01196715|Quality of Life|quality of life
5104198|NCT01196715|Erythroid response|erythroid response
5104199|NCT01196715|disease progression|disease progression
5104200|NCT01196715|survival|survival
5104201|NCT01196715|Overall erythroid response at 24 weeks|overall erythroid response at 24 weeks
5104202|NCT01196715|Quality of life at 24 weeks|quality of life at 24 weeks
5104203|NCT01196715|Quality of life at 12, 36 and 52 weeks|quality of life at 12, 36 and 52 weeks
5104204|NCT01196715|Overall erythroid response at 12 and 52 weeks|overall erythroid response at 12 and 52 weeks
5104205|NCT01196715|Incidence of disease progression|incidence of disease progression
5104206|NCT01196715|Overall Survival|overall survival
5104207|NCT01196702|common variable immunodeficiency|common variable immunodeficiency
5104208|NCT01196702|granulomatous disease|granulomatous disease
5104209|NCT01196702|crohns disease|crohns disease
5104210|NCT01196702|bronchiectasis|bronchiectasis
5104211|NCT01196702|immunoglobulin replacement or treatment|immunoglobulin replacement or treatment
5104212|NCT01196702|B-cell immunophenotyping|b-cell immunophenotyping
5104213|NCT01196689|Pharmacokinetics AZD1981|pharmacokinetics azd1981
5104214|NCT01196689|Asthma|asthma
5104215|NCT01196676|AZD4451|azd4451
5104216|NCT01196676|Bipolar|bipolar
5104217|NCT01196676|depression|depression
5104218|NCT01196663|TMS|tms
5104219|NCT01196637|thoracic outlet syndrome|thoracic outlet syndrome
5104220|NCT01196637|brachial plexopathy|brachial plexopathy
5104221|NCT01196637|ultrasonography|ultrasonography
5104222|NCT01196624|PTSD|ptsd
5104223|NCT01196624|FLASHBACKS|flashbacks
5104224|NCT01196624|TMS|tms
5104225|NCT01196624|EXPOSURE|exposure
5104226|NCT01196611|Voice disorders|voice disorders
5104227|NCT01196611|Voice|voice
5104228|NCT01196598|pelvic floor|pelvic floor
5104229|NCT01196598|pelvic organ prolapse|pelvic organ prolapse
5104230|NCT01196585|Pleura|pleura
5104231|NCT01196585|biopsy|biopsy
5104232|NCT01196585|diagnosis|diagnosis
5104233|NCT01196585|CT|ct
5104234|NCT01196585|ultrasonography|ultrasonography
5104235|NCT01196572|stricture|stricture
5104236|NCT01196572|urethra|urethra
5104237|NCT01196572|laser|laser
5104238|NCT01196572|urethrotomy|urethrotomy
5104239|NCT01196572|holmium|holmium
5104240|NCT01196572|bladder outlet obstruction|bladder outlet obstruction
5104241|NCT01196559|ovarian cancer|ovarian cancer
5104242|NCT01196546|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
5104243|NCT01196546|vildagliptin|vildagliptin
5104244|NCT01196546|metformin|metformin
5104245|NCT01196533|Non Invasive, Invasive, optical, light source, color image sensor,|non invasive, invasive, optical, light source, color image sensor,
5104246|NCT01196533|, Hemodynamic, Arterial Systolic, Arterial Diastolic, MAP, PA Systolic,|, hemodynamic, arterial systolic, arterial diastolic, map, pa systolic,
5104247|NCT01196533|PA Diastolic, Heart rate, Stroke volume, CBC, WBC, RBC, Hgb, HCT ,Iron.|pa diastolic, heart rate, stroke volume, cbc, wbc, rbc, hgb, hct ,iron.
5104248|NCT01196533|PLT, PH, PCO2, PO2, HCO3, SaO2 , Na, K, Cl, CO2, Bun, Cr, Gluc, HGB (A1C),|plt, ph, pco2, po2, hco3, sao2 , na, k, cl, co2, bun, cr, gluc, hgb (a1c),
5104249|NCT01196533|TBiLi, LDL, HDL.|tbili, ldl, hdl.
5104250|NCT01196520|Burkitt Lymphoma|burkitt lymphoma
5104251|NCT01196520|Epstein-Barr Virus|epstein-barr virus
5104252|NCT01196520|Malaria|malaria
5104253|NCT01196494|Obstructive left-sided colonic cancer|obstructive left-sided colonic cancer
5104254|NCT01196494|Colorectal stent|colorectal stent
5104381|NCT01195987|Arthritis|arthritis
5104255|NCT01196494|Intraoperative colon lavage|intraoperative colon lavage
5104256|NCT01196494|Lavage|lavage
5104257|NCT01196494|Stent|stent
5104258|NCT01196468|HIV|hiv
5104259|NCT01196468|Testing|testing
5104260|NCT01196468|Targeted|targeted
5104261|NCT01196468|Indicator|indicator
5104262|NCT01196468|Diseases|diseases
5104263|NCT01196468|Anal dysplasia|anal dysplasia
5104264|NCT01196468|Cervical dysplasia|cervical dysplasia
5104265|NCT01196468|STI|sti
5104266|NCT01196468|Lymphoma|lymphoma
5104267|NCT01196468|Seborrhoeic dermatitis|seborrhoeic dermatitis
5104268|NCT01196468|Exanthema|exanthema
5104269|NCT01196468|Thrombocytpaenia|thrombocytpaenia
5104270|NCT01196468|Lymphopaenia|lymphopaenia
5104271|NCT01196468|Hypergammaglobulinaemia|hypergammaglobulinaemia
5104272|NCT01196455|Metastatic breast cancer patients|metastatic breast cancer patients
5104273|NCT01196403|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
5104274|NCT01196403|squamous cell carcinoma of the bladder|squamous cell carcinoma of the bladder
5104275|NCT01196403|adenocarcinoma of the bladder|adenocarcinoma of the bladder
5104276|NCT01196403|stage I bladder cancer|stage i bladder cancer
5104277|NCT01196403|stage II bladder cancer|stage ii bladder cancer
5104278|NCT01196403|stage III bladder cancer|stage iii bladder cancer
5104279|NCT01196377|Asthma|asthma
5104280|NCT01196377|Acute asthma|acute asthma
5104281|NCT01196377|Pediatrics|pediatrics
5104282|NCT01196364|Girls|girls
5104283|NCT01196351|boys|boys
5104284|NCT01196351|obesity|obesity
5104285|NCT01196351|physical activity|physical activity
5104286|NCT01196351|exercise|exercise
5104287|NCT01196338|Ankle fracture|ankle fracture
5104288|NCT01196338|Return to work|return to work
5104289|NCT01196338|Return to function|return to function
5104290|NCT01196338|Rehabilitation|rehabilitation
5104291|NCT01196338|Weight-bearing|weight-bearing
5104292|NCT01196325|Diabetes|diabetes
5104293|NCT01196325|Diabetic Macular Edema|diabetic macular edema
5104294|NCT01196325|Laser|laser
5104295|NCT01196325|Anti-VEGF|anti-vegf
5104296|NCT01196325|Morphology|morphology
5104297|NCT01196325|Blood Flow|blood flow
5104298|NCT01196325|Vision|vision
5104299|NCT01196312|anxiety sensitivity|anxiety sensitivity
5104300|NCT01196312|heroin|heroin
5104301|NCT01196299|diffusion tensor imaging|diffusion tensor imaging
5104302|NCT01196299|magnetic resonance spectroscopy|magnetic resonance spectroscopy
5104303|NCT01196299|traumatic brain injury|traumatic brain injury
5104304|NCT01196299|Metabolite changes|metabolite changes
5104305|NCT01196299|Cerebral perfusion|cerebral perfusion
5104306|NCT01196299|Hemorrhagic burden|hemorrhagic burden
5104307|NCT01196286|First-episode psychosis|first-episode psychosis
5104308|NCT01196286|cognitive remediation|cognitive remediation
5104309|NCT01196286|family psychoeducation|family psychoeducation
5104310|NCT01196273|Cardiac Diseases,|cardiac diseases,
5104311|NCT01196273|HIV-Infection,|hiv-infection,
5104312|NCT01196273|AIDS,|aids,
5104313|NCT01196273|Antiretroviral Therapy,|antiretroviral therapy,
5104314|NCT01196273|Cardiovascular Medication,|cardiovascular medication,
5104315|NCT01196273|Risk Factors,|risk factors,
5104316|NCT01196273|coronary heart disease,|coronary heart disease,
5104317|NCT01196273|heart failure,|heart failure,
5104318|NCT01196273|metabolic syndrome|metabolic syndrome
5104319|NCT01196260|efficiency|efficiency
5104320|NCT01196260|capecitabine|capecitabine
5104321|NCT01196260|oxaliplatin|oxaliplatin
5104322|NCT01196260|colorectal cancer|colorectal cancer
5104323|NCT01196247|pancreatic cancer|pancreatic cancer
5104324|NCT01196247|molecular profiling|molecular profiling
5104325|NCT01196247|SU2C|su2c
5104326|NCT01196247|Second line therapy|second line therapy
5104327|NCT01196247|Stage 4|stage 4
5104328|NCT01196208|Disease, Hodgkin|disease, hodgkin
5104329|NCT01196208|Lymphoma|lymphoma
5104330|NCT01196208|Monomethylauristatin E|monomethylauristatin e
5104331|NCT01196208|Lymphoma, Large-Cell, Anaplastic|lymphoma, large-cell, anaplastic
5104332|NCT01196208|Lymphoma, T-Cell, Cutaneous|lymphoma, t-cell, cutaneous
5104333|NCT01196208|Lymphoma, Non-Hodgkin|lymphoma, non-hodgkin
5104334|NCT01196208|Antibodies, Monoclonal|antibodies, monoclonal
5104335|NCT01196208|Antibody-Drug Conjugate|antibody-drug conjugate
5104336|NCT01196208|Antigens, CD30|antigens, cd30
5104337|NCT01196208|Hematologic Diseases|hematologic diseases
5104338|NCT01196208|Immunotherapy|immunotherapy
5104339|NCT01196195|antiretroviral therapy|antiretroviral therapy
5104340|NCT01196195|child|child
5104341|NCT01196195|HIV-1|hiv-1
5104342|NCT01196169|daptomycin|daptomycin
5104343|NCT01196169|vancomycin|vancomycin
5104344|NCT01196169|perioperative|perioperative
5104345|NCT01196169|prophylaxis|prophylaxis
5104346|NCT01196169|arthroplasty|arthroplasty
5104347|NCT01196169|prosthesis|prosthesis
5104348|NCT01196169|preoperative|preoperative
5104349|NCT01196156|Infant, Small for Gestational Age|infant, small for gestational age
5104350|NCT01196156|Dwarfism Pituitary|dwarfism pituitary
5104351|NCT01196156|Saizen|saizen
5104352|NCT01196156|Somatropin; Growth Hormone|somatropin; growth hormone
5104353|NCT01196156|Insulin resistance|insulin resistance
5104354|NCT01196143|Ovulation induction|ovulation induction
5104355|NCT01196143|Intrauterine insemination|intrauterine insemination
5104356|NCT01196143|Gonal-f|gonal-f
5104357|NCT01196143|Controlled ovarian stimulation|controlled ovarian stimulation
5104358|NCT01196143|Female infertility|female infertility
5104359|NCT01196130|Metastatic colorectal cancer|metastatic colorectal cancer
5104360|NCT01196130|CRC|crc
5104361|NCT01196130|Colorectal adenocarcinoma|colorectal adenocarcinoma
5104362|NCT01196130|Biomarker determination|biomarker determination
5104363|NCT01196130|Tumor tissue|tumor tissue
5104364|NCT01196130|Treatment protocols|treatment protocols
5104365|NCT01196117|automatic positive airway pressure (APAP)|automatic positive airway pressure (apap)
5104366|NCT01196117|continuous positive airway pressure (CPAP)|continuous positive airway pressure (cpap)
5104367|NCT01196117|Salivary Cortisol|salivary cortisol
5104368|NCT01196117|Apnea|apnea
5104369|NCT01196117|Sleep Apnea and/or any Sleep Disordered Breathing|sleep apnea and/or any sleep disordered breathing
5104370|NCT01196091|Lupus|lupus
5104371|NCT01196091|SLE|sle
5104372|NCT01196091|Systemic Lupus Erythematosis|systemic lupus erythematosis
5104373|NCT01196091|autoimmune disease|autoimmune disease
5104374|NCT01196091|LY2127399|ly2127399
5104375|NCT01196091|Immune system disease|immune system disease
5104376|NCT01196026|Influenza|influenza
5104377|NCT01196026|H1N1|h1n1
5104378|NCT01196026|Fluarix|fluarix
5104379|NCT01196026|Pandemrix|pandemrix
5104380|NCT01195987|Hepatitis C|hepatitis c
5104382|NCT01195974|oral contraceptive, drug interaction, pharmacokinetics|oral contraceptive, drug interaction, pharmacokinetics
5104383|NCT01195961|Direct Current Stimulation|direct current stimulation
5104384|NCT01195961|Learning|learning
5104385|NCT01195961|Cognitive Enhancement|cognitive enhancement
5104386|NCT01195961|Cognitive Tasks|cognitive tasks
5104387|NCT01195961|Cognitive Training|cognitive training
5104388|NCT01195961|Developmental Dyscalculia|developmental dyscalculia
5104389|NCT01195961|Learning Disability|learning disability
5104390|NCT01195961|Cognition Disorder|cognition disorder
5104391|NCT01195948|Uveitis|uveitis
5104392|NCT01195948|Oral Tolerance|oral tolerance
5104393|NCT01195922|Head and Neck Squamous Cell Carcinoma|head and neck squamous cell carcinoma
5104394|NCT01195922|Oral Cancer|oral cancer
5104395|NCT01195922|mTOR Inhibitors|mtor inhibitors
5104396|NCT01195922|Targeted Therapies|targeted therapies
5104397|NCT01195922|Signal Transduction Inhibitors|signal transduction inhibitors
5104398|NCT01195922|Head and Neck Cancer|head and neck cancer
5104399|NCT01195922|Squamous Cell Carcinoma|squamous cell carcinoma
5104400|NCT01195922|Tongue Cancer|tongue cancer
5104401|NCT01195883|IV fluid|iv fluid
5104402|NCT01195883|recovery|recovery
5104403|NCT01195883|goal directed fluid replacement|goal directed fluid replacement
5104404|NCT01195883|improved patient recovery|improved patient recovery
5104405|NCT01195870|Multiple sclerosis|multiple sclerosis
5104406|NCT01195870|Rebif|rebif
5104407|NCT01195870|Interferon beta-1a|interferon beta-1a
5104408|NCT01195857|Multiple sclerosis|multiple sclerosis
5104409|NCT01195857|Rebif|rebif
5104410|NCT01195857|Interferon beta-1a|interferon beta-1a
5104411|NCT01195844|Pediatric gastroenteritis, rotavirus infection|pediatric gastroenteritis, rotavirus infection
5104412|NCT01195818|Albuminuria, hyperfiltration, RAS inhibitors, ADMA|albuminuria, hyperfiltration, ras inhibitors, adma
5104413|NCT01195805|Blood pressure, PWV, HRV, PWV, potassium|blood pressure, pwv, hrv, pwv, potassium
5104414|NCT01195792|Opioid receptors|opioid receptors
5104415|NCT01195792|Body weight|body weight
5104416|NCT01195792|Over-eating behaviour|over-eating behaviour
5104417|NCT01195792|Obesity|obesity
5104418|NCT01195792|Fat mass|fat mass
5104419|NCT01195779|immunogenicity|immunogenicity
5104420|NCT01195779|safety|safety
5104421|NCT01195779|Influenza|influenza
5104422|NCT01195779|children|children
5104423|NCT01195779|vaccine|vaccine
5104424|NCT01195766|Hodgkin|hodgkin
5104425|NCT01195766|Ofatumumab|ofatumumab
5104426|NCT01195766|Lymphoma|lymphoma
5104427|NCT01195753|Urea cycle Disorders|urea cycle disorders
5104428|NCT01195740|Suicide Ideation|suicide ideation
5104429|NCT01195740|Depression|depression
5104430|NCT01195740|Family Conflict|family conflict
5104431|NCT01195701|female sexual dysfunction|female sexual dysfunction
5104432|NCT01195701|anorgasmia|anorgasmia
5104433|NCT01195701|clitoral complex|clitoral complex
5104434|NCT01195701|pelvic MRI|pelvic mri
5104435|NCT01195701|testosterone|testosterone
5104436|NCT01195662|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
5104437|NCT01195662|Diabetes Mellitus|diabetes mellitus
5104438|NCT01195662|Endocrine System Diseases|endocrine system diseases
5104439|NCT01195662|Glucose Metabolism Disorders|glucose metabolism disorders
5104440|NCT01195662|Metabolic Diseases|metabolic diseases
5104441|NCT01195662|Angiotensin Receptor Inhibitors|angiotensin receptor inhibitors
5104442|NCT01195662|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors
5104443|NCT01195662|Antihypertensive Agents|antihypertensive agents
5104444|NCT01195662|Cardiovascular Agents|cardiovascular agents
5104445|NCT01195662|Pharmacological Actions|pharmacological actions
5104446|NCT01195636|Pain from Shingles, PHN, Postherpetic Neuralgia|pain from shingles, phn, postherpetic neuralgia
5104447|NCT01195623|varicose veins|varicose veins
5104448|NCT01195623|venous insufficiency|venous insufficiency
5104449|NCT01195623|surgery|surgery
5104450|NCT01195623|duplex|duplex
5104451|NCT01195623|recurrence|recurrence
5104452|NCT01195597|electronic cigarette|electronic cigarette
5104453|NCT01195597|ENDD|endd
5104454|NCT01195597|nicotine|nicotine
5104455|NCT01195597|smoking cessation|smoking cessation
5104456|NCT01195597|smoking reduction|smoking reduction
5104457|NCT01195584|complication rate in 3 cohorts (BMI < 25, > 25 and > 30)|complication rate in 3 cohorts (bmi < 25, > 25 and > 30)
5104458|NCT01195558|Non-24|non-24
5104459|NCT01195558|N24HSWD|n24hswd
5104460|NCT01195558|Blindness|blindness
5104461|NCT01195558|Sleep|sleep
5104462|NCT01195558|Wake|wake
5104463|NCT01195558|Circadian Rhythm|circadian rhythm
5104464|NCT01195558|Nap|nap
5104465|NCT01195545|Veritas® Collagen Matrix, Hiatal hernia|veritas® collagen matrix, hiatal hernia
5104466|NCT01195532|hypoglycemic drug|hypoglycemic drug
5104467|NCT01195519|peritoneal dialysis|peritoneal dialysis
5104468|NCT01195519|hemodialysis patients|hemodialysis patients
5104469|NCT01195506|We Will Collect the Bone Marrow Specimens From AML Patients|we will collect the bone marrow specimens from aml patients
5104470|NCT01195493|Chronic periodontitis|chronic periodontitis
5104471|NCT01195480|Immunotherapy|immunotherapy
5104472|NCT01195480|Gene Therapy|gene therapy
5104473|NCT01195480|Paediatric|paediatric
5104574|NCT01195103|Midazolam|midazolam
5104474|NCT01195480|B cell Acute Lymphoblastic Leukaemia|b cell acute lymphoblastic leukaemia
5104475|NCT01195441|Preeclampsia|preeclampsia
5104476|NCT01195441|Doppler ultrasound|doppler ultrasound
5104477|NCT01195441|First trimester|first trimester
5104478|NCT01195441|Acetylsalicylic acid|acetylsalicylic acid
5104479|NCT01195402|COPD|copd
5104480|NCT01195402|pulmonary rehabilitation|pulmonary rehabilitation
5104481|NCT01195389|dementia|dementia
5104482|NCT01195389|memory loss|memory loss
5104483|NCT01195389|cognitive decline|cognitive decline
5104484|NCT01195376|PI3K|pi3k
5104485|NCT01195376|mTOR|mtor
5104486|NCT01195376|Advanced solid tumor|advanced solid tumor
5104487|NCT01195363|bipolar disorder, mania, depression|bipolar disorder, mania, depression
5104488|NCT01195350|Ischemic Stroke|ischemic stroke
5104489|NCT01195350|Hemorrhagic Stroke|hemorrhagic stroke
5104490|NCT01195350|Blood pressure|blood pressure
5104491|NCT01195350|Intensive care|intensive care
5104492|NCT01195337|Sedentary minority adult|sedentary minority adult
5104493|NCT01195337|Psychosocial factors|psychosocial factors
5104494|NCT01195337|Environmental factors|environmental factors
5104495|NCT01195337|Obesity|obesity
5104496|NCT01195337|Physical Activity|physical activity
5104497|NCT01195337|PA|pa
5104498|NCT01195337|Cancer Risk|cancer risk
5104499|NCT01195337|African Americans|african americans
5104500|NCT01195337|Latino|latino
5104501|NCT01195324|Canagliflozin (JNJ-28431754)|canagliflozin (jnj-28431754)
5104502|NCT01195324|Warfarin|warfarin
5104503|NCT01195324|Pharmacokinetic|pharmacokinetic
5104504|NCT01195324|Pharmacodynamic|pharmacodynamic
5104505|NCT01195324|Prothrombin time (PT)|prothrombin time (pt)
5104506|NCT01195324|International normalized ratio (INR)|international normalized ratio (inr)
5104507|NCT01195311|Refractory, Advanced malignancies|refractory, advanced malignancies
5104508|NCT01195298|metastatic breast cancer|metastatic breast cancer
5104509|NCT01195298|elderly patients|elderly patients
5104510|NCT01195298|chemoimmunotherapy|chemoimmunotherapy
5104511|NCT01195298|Triple negative metastatic breast cancer|triple negative metastatic breast cancer
5104512|NCT01195285|Laparoscopic cholecystectomy|laparoscopic cholecystectomy
5104513|NCT01195285|Quality of life|quality of life
5104514|NCT01195285|Biliary Cholic|biliary cholic
5104515|NCT01195285|Chronic Cholecystitis|chronic cholecystitis
5104516|NCT01195285|Symptomatic Cholelithiasis|symptomatic cholelithiasis
5104517|NCT01195259|rosiglitazone|rosiglitazone
5104518|NCT01195259|ADOPT|adopt
5104519|NCT01195259|metformin|metformin
5104520|NCT01195259|malignancy|malignancy
5104521|NCT01195259|RECORD|record
5104522|NCT01195246|end stage renal failure|end stage renal failure
5104523|NCT01195246|renal failure|renal failure
5104524|NCT01195246|kidney failure|kidney failure
5104525|NCT01195246|kidney failure, chronic|kidney failure, chronic
5104526|NCT01195246|chronic kidney failure|chronic kidney failure
5104527|NCT01195246|hepatitis B virus (HBV) vaccine|hepatitis b virus (hbv) vaccine
5104528|NCT01195246|hepatitis B vaccine|hepatitis b vaccine
5104529|NCT01195246|hepatitis B|hepatitis b
5104530|NCT01195246|hepatitis|hepatitis
5104532|NCT01195246|prevention and control|prevention and control
5104533|NCT01195246|dialysis|dialysis
5104534|NCT01195233|Xerostomia|xerostomia
5104535|NCT01195233|Radiotherapy of head and neck|radiotherapy of head and neck
5104536|NCT01195233|BioXtra|bioxtra
5104537|NCT01195220|STI screening|sti screening
5104538|NCT01195220|Emergency Department|emergency department
5104539|NCT01195220|Chlamydia|chlamydia
5104540|NCT01195220|Gonorrhea|gonorrhea
5104541|NCT01195220|HIV|hiv
5104542|NCT01195220|behavior|behavior
5104543|NCT01195220|teenagers|teenagers
5104544|NCT01195220|intervention|intervention
5104545|NCT01195207|CNTO 3157|cnto 3157
5104546|NCT01195207|healthy volunteers|healthy volunteers
5104547|NCT01195207|asthma|asthma
5104548|NCT01195194|T-cell lymphocyte allo-recognition|t-cell lymphocyte allo-recognition
5104549|NCT01195194|CNI-free immunosuppressive regimen|cni-free immunosuppressive regimen
5104550|NCT01195194|Enzyme-linked immunospot (ELISPOT)|enzyme-linked immunospot (elispot)
5104551|NCT01195181|peginterferon alfa 2a and 2b type|peginterferon alfa 2a and 2b type
5104552|NCT01195181|ribavirin|ribavirin
5104553|NCT01195181|chronic hepatitis C|chronic hepatitis c
5104554|NCT01195181|antiviral therapy cost/efficacy|antiviral therapy cost/efficacy
5104555|NCT01195181|viral kinetics|viral kinetics
5104556|NCT01195168|PCOS|pcos
5104557|NCT01195155|PCOS|pcos
5104558|NCT01195142|PCOS|pcos
5104559|NCT01195129|Stent|stent
5104560|NCT01195129|cerebral aneursym|cerebral aneursym
5104561|NCT01195129|neurology|neurology
5104562|NCT01195129|radiology|radiology
5104563|NCT01195116|Post-operative pain management|post-operative pain management
5104564|NCT01195116|Pain Management|pain management
5104565|NCT01195116|Painful bladder syndrome|painful bladder syndrome
5104566|NCT01195116|frequency and urgency|frequency and urgency
5104567|NCT01195116|Dexmedetomidine|dexmedetomidine
5104568|NCT01195116|hydrodistension|hydrodistension
5104569|NCT01195103|Procedural sedation|procedural sedation
5104570|NCT01195103|Regional Anesthesia block|regional anesthesia block
5104571|NCT01195103|Orthopedic surgery|orthopedic surgery
5104572|NCT01195103|Lusedra|lusedra
5104573|NCT01195103|Fospropofol disodium|fospropofol disodium
5104575|NCT01195090|sitagliptin|sitagliptin
5104576|NCT01195090|pioglitazone|pioglitazone
5104577|NCT01195090|type 2 diabetes|type 2 diabetes
5104578|NCT01195077|HIV|hiv
5104579|NCT01195077|Dietary intervention|dietary intervention
5104580|NCT01195077|Algae|algae
5104581|NCT01195077|HIV progression|hiv progression
5104582|NCT01195077|Algae specific kind|algae specific kind
5104583|NCT01195064|COPD patients|copd patients
5104584|NCT01195064|OSAS patients|osas patients
5104585|NCT01195064|cardiovascular surgery|cardiovascular surgery
5104586|NCT01195064|Endothelial function|endothelial function
5104587|NCT01195051|Medication Reconciliation|medication reconciliation
5104588|NCT01195051|Inpatient|inpatient
5104589|NCT01195051|Electronic Medical Records|electronic medical records
5104590|NCT01195038|Avian influenza, H5N1, pandemic, recombinant HA vaccine|avian influenza, h5n1, pandemic, recombinant ha vaccine
5104591|NCT01195025|Blood volume|blood volume
5104592|NCT01195025|blood coagulation|blood coagulation
5104593|NCT01195025|volume kinetics|volume kinetics
5104594|NCT01195012|child|child
5104595|NCT01195012|primary care|primary care
5104596|NCT01195012|treatment|treatment
5104597|NCT01195012|parenting|parenting
5104598|NCT01195012|lifestyle behaviors|lifestyle behaviors
5104599|NCT01194999|OAB|oab
5104600|NCT01194999|Urinary Bladder, Overactive|urinary bladder, overactive
5104601|NCT01194999|Overactive Bladder Syndrome|overactive bladder syndrome
5104602|NCT01194999|VESIcare|vesicare
5104603|NCT01194999|Urgency|urgency
5104604|NCT01194999|Nocturia|nocturia
5104605|NCT01194999|Frequency|frequency
5104606|NCT01194999|Urge Urinary Incontinence|urge urinary incontinence
5104607|NCT01194999|UUI|uui
5104608|NCT01194999|Pubovaginal Sling|pubovaginal sling
5104609|NCT01194999|PVS|pvs
5104610|NCT01194999|Incontinence|incontinence
5104611|NCT01194986|Receptor binding|receptor binding
5104612|NCT01194986|Histamine H3 receptor|histamine h3 receptor
5104613|NCT01194986|binding|binding
5104614|NCT01194986|radioligand|radioligand
5104615|NCT01194973|Atypical Hemolytic-Uremic Syndrome|atypical hemolytic-uremic syndrome
5104616|NCT01194960|cancer of prostate|cancer of prostate
5104617|NCT01194960|cancer of the prostate|cancer of the prostate
5104618|NCT01194960|neoplasms prostate|neoplasms prostate
5104619|NCT01194960|neoplasms prostatic|neoplasms prostatic
5104620|NCT01194960|prostate cancer|prostate cancer
5104621|NCT01194960|prostate neoplasms|prostate neoplasms
5104622|NCT01194960|prostatic cancer|prostatic cancer
5104623|NCT01194960|prostate specific antigen|prostate specific antigen
5104624|NCT01194960|prostatic hyperplasia|prostatic hyperplasia
5104625|NCT01194947|banal-appearing nevi|banal-appearing nevi
5104626|NCT01194947|NEVUS|nevus
5104627|NCT01194934|Stem Cell Transplantation|stem cell transplantation
5104628|NCT01194934|SDF-1|sdf-1
5104629|NCT01194934|L-oligonucleotide Aptamer|l-oligonucleotide aptamer
5104630|NCT01194934|Spiegelmer|spiegelmer
5104631|NCT01194934|Hematopoietic Stem Cells|hematopoietic stem cells
5104632|NCT01194908|Breast Cancer|breast cancer
5104633|NCT01194908|Breast Tumors|breast tumors
5104634|NCT01194908|Breast Neoplasms|breast neoplasms
5104635|NCT01194895|esophagectomy|esophagectomy
5104636|NCT01194895|acute lung injury|acute lung injury
5104637|NCT01194895|protective ventilation|protective ventilation
5104638|NCT01194869|Breast Cancer|breast cancer
5104639|NCT01194856|HIV|hiv
5104640|NCT01194856|Lipoatrophy|lipoatrophy
5104641|NCT01194856|mitochondrial dysfunction|mitochondrial dysfunction
5104642|NCT01194817|total knee arthroplasty|total knee arthroplasty
5104643|NCT01194817|total knee replacement|total knee replacement
5104644|NCT01194817|cementless TKA|cementless tka
5104645|NCT01194817|high flexion|high flexion
5104646|NCT01194817|trabecular metal|trabecular metal
5104647|NCT01194804|Hemolytic Paroxysmal Nocturnal Hemoglobinuria|hemolytic paroxysmal nocturnal hemoglobinuria
5104648|NCT01194804|Eculizumab|eculizumab
5104649|NCT01194804|PNH|pnh
5104650|NCT01194791|Amyloidosis|amyloidosis
5104651|NCT01194791|Lenalidomide|lenalidomide
5104652|NCT01194713|Alzheimer Disease|alzheimer disease
5104653|NCT01194713|Cerebrospinal fluid|cerebrospinal fluid
5104654|NCT01194713|Sleep|sleep
5104655|NCT01194713|Abeta|abeta
5104656|NCT01194700|lung bioavailability|lung bioavailability
5104657|NCT01194700|asthma|asthma
5104658|NCT01194700|seretide|seretide
5104659|NCT01194700|Spacer|spacer
5104660|NCT01194687|Estrogens|estrogens
5104661|NCT01194687|Fecal Microbiome|fecal microbiome
5104662|NCT01194687|Fecal Occult Blood|fecal occult blood
5104663|NCT01194674|Microplasmin|microplasmin
5104664|NCT01194674|Macular Edema|macular edema
5104665|NCT01194674|Uveitis|uveitis
5104666|NCT01194661|Inhibitory Control|inhibitory control
5104667|NCT01194661|Executive Function|executive function
5104668|NCT01194661|fMRI|fmri
5104669|NCT01194661|TMS|tms
5104670|NCT01194661|TBI|tbi
5104671|NCT01194661|Traumatic Brain Injury|traumatic brain injury
5104672|NCT01194661|Healthy Volunteer|healthy volunteer
5104673|NCT01194661|HV|hv
5104674|NCT01194648|urinary incontinence|urinary incontinence
5104675|NCT01194648|male erectile disorder|male erectile disorder
5104676|NCT01194648|therapy-related toxicity|therapy-related toxicity
5104677|NCT01194648|stage I prostate cancer|stage i prostate cancer
5104678|NCT01194648|stage IIB prostate cancer|stage iib prostate cancer
5104679|NCT01194648|stage IIA prostate cancer|stage iia prostate cancer
5104680|NCT01194635|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5104681|NCT01194635|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
5104682|NCT01194635|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
5104683|NCT01194635|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5104684|NCT01194635|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5104685|NCT01194635|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5104686|NCT01194635|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
5104687|NCT01194609|Low dose radiation|low dose radiation
5104688|NCT01194609|Adoptive immune cell therapy|adoptive immune cell therapy
5104689|NCT01194609|Cervical cancer|cervical cancer
5104690|NCT01194609|Pilot study|pilot study
5104691|NCT01194596|smoking cessation advice|smoking cessation advice
5104692|NCT01194596|spirometry|spirometry
5104693|NCT01194596|primary health care|primary health care
5104694|NCT01194583|electronic cigarette|electronic cigarette
5104695|NCT01194583|nicotine|nicotine
5104696|NCT01194583|smoking cessation|smoking cessation
5104697|NCT01194583|smoking reduction|smoking reduction
5104698|NCT01194557|history of fever|history of fever
5104699|NCT01194557|measured fever|measured fever
5104700|NCT01194557|appropriate treatment|appropriate treatment
5104701|NCT01194557|appropriate referral|appropriate referral
5104702|NCT01194531|Preimplantation Gentic Screening|preimplantation gentic screening
5104703|NCT01194531|PGS|pgs
5104704|NCT01194531|In Vitro Fertilization|in vitro fertilization
5104705|NCT01194531|IVF|ivf
5104706|NCT01194531|Preimplantation Genetic Diagnosis|preimplantation genetic diagnosis
5104707|NCT01194531|PGD|pgd
5104708|NCT01194518|Life experience|life experience
5104709|NCT01194518|Life style|life style
5104710|NCT01194518|Health behavior|health behavior
5104711|NCT01194518|Mixed method|mixed method
5104712|NCT01194505|anterior cruciate ligament reconstruction|anterior cruciate ligament reconstruction
5104713|NCT01194505|obturator nerve block|obturator nerve block
5104714|NCT01194505|sciatic nerve block|sciatic nerve block
5104715|NCT01194505|femoral nerve block|femoral nerve block
5104716|NCT01194505|posterior lumbar plexus block|posterior lumbar plexus block
5104717|NCT01194505|ultrasound guided nerve block|ultrasound guided nerve block
5104718|NCT01194492|plasma albumin|plasma albumin
5104719|NCT01194492|inflammatory reaction|inflammatory reaction
5104720|NCT01194492|systemic inflammatory response syndrome|systemic inflammatory response syndrome
5104721|NCT01194479|type 1 diabetes|type 1 diabetes
5104722|NCT01194479|hypoglycemia|hypoglycemia
5104723|NCT01194479|formoterol|formoterol
5104724|NCT01194466|Head and Neck Cancer|head and neck cancer
5104725|NCT01194466|Oral Cancer|oral cancer
5104726|NCT01194466|Laryngeal Cancer|laryngeal cancer
5104727|NCT01194466|Oropharyngeal Cancer|oropharyngeal cancer
5104728|NCT01194466|Transcutaneous Electrical Nerve Stimulation (TENS)|transcutaneous electrical nerve stimulation (tens)
5104729|NCT01194466|Oral Mucositis|oral mucositis
5104730|NCT01194466|Pain|pain
5104731|NCT01194466|Function|function
5104732|NCT01194466|TENS|tens
5104733|NCT01194466|Functional Pain|functional pain
5104734|NCT01194466|Non-pharamcologic|non-pharamcologic
5104735|NCT01194466|Quality of Life|quality of life
5104736|NCT01194427|Preoperative|preoperative
5104737|NCT01194427|Neoadjuvant|neoadjuvant
5104738|NCT01194388|Patients presenting with an intracranial aneurysm|patients presenting with an intracranial aneurysm
5104739|NCT01194362|aortic valve disease|aortic valve disease
5104740|NCT01194362|gene expression|gene expression
5104741|NCT01194349|S. pneumoniae|s. pneumoniae
5104742|NCT01194349|thrombocytosis|thrombocytosis
5104743|NCT01194349|pediatric patients|pediatric patients
5104744|NCT01194349|The study aimed to understand the diagnostic value of thrombocytosis in children with S. pneumoniae infection|the study aimed to understand the diagnostic value of thrombocytosis in children with s. pneumoniae infection
5104745|NCT01194336|Central nervous system|central nervous system
5104746|NCT01194336|Cholinesterase|cholinesterase
5104747|NCT01194336|Neurocognitive performance testing|neurocognitive performance testing
5104748|NCT01194323|esophageal erosion|esophageal erosion
5104749|NCT01194323|abnormal pH monitoring|abnormal ph monitoring
5104750|NCT01194310|glaucoma|glaucoma
5104751|NCT01194310|cataract|cataract
5104752|NCT01194297|influenza|influenza
5104753|NCT01194297|premature infant|premature infant
5104754|NCT01194297|very low birth weight infant|very low birth weight infant
5104755|NCT01194297|immunization|immunization
5104756|NCT01194297|vaccine|vaccine
5104757|NCT01194271|Hormone Ablation|hormone ablation
5104758|NCT01194271|Prostate adenocarcinoma|prostate adenocarcinoma
5104759|NCT01194271|Radical prostatectomy|radical prostatectomy
5104760|NCT01194271|Leuprolide Acetate|leuprolide acetate
5104761|NCT01194271|Lupron Depot|lupron depot
5104762|NCT01194271|Ipilimumab|ipilimumab
5104763|NCT01194271|BMS-734016|bms-734016
5104764|NCT01194271|MDX010|mdx010
5104765|NCT01194258|Type 2 diabetes|type 2 diabetes
5104766|NCT01194245|Type 1 diabetes|type 1 diabetes
5104767|NCT01194232|Cystic Fibrosis|cystic fibrosis
5104768|NCT01194232|CF|cf
5104769|NCT01194232|CMRI|cmri
5104770|NCT01194232|vascularization|vascularization
5104771|NCT01194232|perfusion|perfusion
5104772|NCT01194219|Plaque Psoriasis|plaque psoriasis
5104773|NCT01194193|Cancer|cancer
5104774|NCT01194193|Advanced solid tumours|advanced solid tumours
5104775|NCT01194193|lymphomas|lymphomas
5104776|NCT01194193|dose escalation|dose escalation
5104777|NCT01194193|preliminary anti-tumour activity|preliminary anti-tumour activity
5104778|NCT01194193|Tor kinase inhibitor|tor kinase inhibitor
5104779|NCT01194193|oral administration|oral administration
5104780|NCT01194193|intermittent dosing|intermittent dosing
5104781|NCT01194180|Mycobacterium tuberculosis|mycobacterium tuberculosis
5104782|NCT01194180|BCG|bcg
5104783|NCT01194180|MVA85A|mva85a
5104784|NCT01194167|Platelet refractory thrombocytopenia|platelet refractory thrombocytopenia
5104785|NCT01194141|Barth syndrome|barth syndrome
5104786|NCT01194141|cardiomyopathy|cardiomyopathy
5104787|NCT01194141|mitochondria|mitochondria
5104788|NCT01194141|cardiolipin|cardiolipin
5104789|NCT01194128|caregivers,|caregivers,
5104790|NCT01194128|institutionalization,|institutionalization,
5104791|NCT01194128|dementia patients,|dementia patients,
5104792|NCT01194128|bereavement,|bereavement,
5104793|NCT01194128|grief|grief
5104794|NCT01194128|complicated grief|complicated grief
5104795|NCT01194115|surgical site infection|surgical site infection
5104796|NCT01194115|obesity|obesity
5104797|NCT01194115|pregnancy|pregnancy
5104798|NCT01194115|cesarean section|cesarean section
5104799|NCT01194115|cesarean delivery|cesarean delivery
5104800|NCT01194102|Stroke|stroke
5104801|NCT01194102|Exercise|exercise
5104802|NCT01194102|Physical function|physical function
5104803|NCT01194102|Community program|community program
5104804|NCT01194102|Patient education|patient education
5104805|NCT01194102|Self-management|self-management
5104806|NCT01194089|Nicotine|nicotine
5104807|NCT01194089|Postoperative pain|postoperative pain
5104808|NCT01194089|Bariatric surgery|bariatric surgery
5104809|NCT01194076|cognitive behavior therapy|cognitive behavior therapy
5104810|NCT01194076|exposure and response prevention|exposure and response prevention
5104811|NCT01194076|pediatric|pediatric
5104812|NCT01194076|obsessive compulsive disorder|obsessive compulsive disorder
5104813|NCT01194076|child|child
5104814|NCT01194076|anxiety|anxiety
5104815|NCT01194076|intensive|intensive
5104816|NCT01194076|OCD|ocd
5104817|NCT01194076|CBT|cbt
5104818|NCT01194063|short bowel syndrome|short bowel syndrome
5104819|NCT01194063|parenteral nutrition associated liver disease|parenteral nutrition associated liver disease
5104820|NCT01194063|pediatric|pediatric
5104821|NCT01194037|Hepatitis C|hepatitis c
5104822|NCT01194037|HCV|hcv
5104823|NCT01194037|Interferon|interferon
5104824|NCT01194037|Hanferon|hanferon
5104825|NCT01194024|Inhalation Injury, Smoke|inhalation injury, smoke
5104826|NCT01194024|Inhalation Injury, Acute|inhalation injury, acute
5104827|NCT01194011|Health care quality, information openness, health care information website|health care quality, information openness, health care information website
5104828|NCT01193972|Smoking cessation|smoking cessation
5104829|NCT01193972|Smoking|smoking
5104830|NCT01193972|Tobacco|tobacco
5104831|NCT01193946|Protein requirement|protein requirement
5104832|NCT01193946|Elderly women|elderly women
5104833|NCT01193946|Indicator amino acid oxidation|indicator amino acid oxidation
5104834|NCT01193933|adult ALL|adult all
5104835|NCT01193933|Ph-negative|ph-negative
5104836|NCT01193933|dexamethasone|dexamethasone
5104837|NCT01193933|L-asparaginase|l-asparaginase
5104838|NCT01193920|Group B streptococcus|group b streptococcus
5104839|NCT01193920|GBS|gbs
5104840|NCT01193920|Vaccine|vaccine
5104841|NCT01193920|Prevention of group B streptococcus infection|prevention of group b streptococcus infection
5104842|NCT01193907|Typhoid fever|typhoid fever
5104843|NCT01193907|Glycoconjugate vaccine|glycoconjugate vaccine
5104844|NCT01193907|Vi polysaccharide|vi polysaccharide
5104845|NCT01193907|Immunogenicity|immunogenicity
5104846|NCT01193894|IBD|ibd
5104847|NCT01193894|UC|uc
5104848|NCT01193894|Profermin|profermin
5104849|NCT01193894|Fresubin|fresubin
5104850|NCT01193894|Probiotics|probiotics
5104851|NCT01193894|Dietetic|dietetic
5104852|NCT01193855|stage IIB prostate cancer|stage iib prostate cancer
5104853|NCT01193855|stage IIA prostate cancer|stage iia prostate cancer
5104854|NCT01193816|restlessness during mechanical ventilation weaning|restlessness during mechanical ventilation weaning
5104855|NCT01193803|Prosthetic Joint Infections|prosthetic joint infections
5104856|NCT01193803|Vertebral Osteomyelitis|vertebral osteomyelitis
5104857|NCT01193803|Septic arthritis|septic arthritis
5104858|NCT01193803|Molecular methods|molecular methods
5104859|NCT01193790|chronic tonsillitis|chronic tonsillitis
5104860|NCT01193790|radio-frequency coblation|radio-frequency coblation
5104861|NCT01193790|radio-frequency coblation in chronic tonsillitis treatment|radio-frequency coblation in chronic tonsillitis treatment
5104862|NCT01193777|Carnitine|carnitine
5104863|NCT01193777|Shock|shock
5104864|NCT01193777|Sepsis|sepsis
5104865|NCT01193764|acne|acne
5104866|NCT01193764|cocoa|cocoa
5104867|NCT01193764|chocolate|chocolate
5104868|NCT01193764|gelatin|gelatin
5104869|NCT01193764|pustule|pustule
5104870|NCT01193764|comedones|comedones
5104871|NCT01193764|papules|papules
5104872|NCT01193764|pustules|pustules
5104873|NCT01193751|Birth Asphyxia|birth asphyxia
5104874|NCT01193751|Newborn's Resuscitation|newborn's resuscitation
5104875|NCT01193751|Death|death
5104876|NCT01193751|Neurodevelopmental Impairment|neurodevelopmental impairment
5104877|NCT01193738|osteopathy|osteopathy
5104878|NCT01193725|Combat Disorders|combat disorders
5104879|NCT01193725|Exposure Therapy|exposure therapy
5104880|NCT01193725|Army Personnel|army personnel
5104881|NCT01193712|Electrophysiologic Techniques, Cardiac|electrophysiologic techniques, cardiac
5104882|NCT01193660|umbilical cord blood|umbilical cord blood
5104883|NCT01193660|stem cell|stem cell
5104884|NCT01193660|cerebral palsy|cerebral palsy
5104885|NCT01193634|ICD VR 9250, DR 9550 and CRT 9750 - PARADYM RF ICD|icd vr 9250, dr 9550 and crt 9750 - paradym rf icd
5104886|NCT01193621|early evaluation|early evaluation
5104887|NCT01193621|pharmacokinetics|pharmacokinetics
5104888|NCT01193621|pharmacodynamics|pharmacodynamics
5104889|NCT01193621|Biodistribution|biodistribution
5104890|NCT01193621|D2-receptor occupancy|d2-receptor occupancy
5104891|NCT01193608|Randomized|randomized
5104892|NCT01193608|Safety Study|safety study
5104893|NCT01193608|Adaptive|adaptive
5104894|NCT01193608|Double Blind|double blind
5104895|NCT01193582|Prevenar|prevenar
5104896|NCT01193582|catch-up|catch-up
5104897|NCT01193582|pneumococcal|pneumococcal
5104898|NCT01193582|pneumonia|pneumonia
5104899|NCT01193556|Tonsillectomy|tonsillectomy
5104900|NCT01193556|PlasmaBlade|plasmablade
5104901|NCT01193556|Electrosurgery|electrosurgery
5104902|NCT01193556|PEAK Surgical|peak surgical
5104903|NCT01193556|Medtronic Advanced Energy|medtronic advanced energy
5104904|NCT01193556|Medtronic|medtronic
5104905|NCT01193530|Sleep Disturbances|sleep disturbances
5104906|NCT01193530|Depression|depression
5104907|NCT01193530|Anxiety|anxiety
5104908|NCT01193530|Fatigue|fatigue
5104909|NCT01193530|Quality of life|quality of life
5104910|NCT01193517|Refractory metastatic colorectal cancer|refractory metastatic colorectal cancer
5104911|NCT01193517|CRC|crc
5104912|NCT01193517|colorectal adenocarcinoma with metastatic disease|colorectal adenocarcinoma with metastatic disease
5104913|NCT01193517|Azacitidine|azacitidine
5104914|NCT01193517|5-Azacytidine|5-azacytidine
5104915|NCT01193517|5-aza|5-aza
5104916|NCT01193517|Vidaza|vidaza
5104917|NCT01193517|5-AZC|5-azc
5104918|NCT01193517|AZA-CR|aza-cr
5104919|NCT01193517|Ladakamycin|ladakamycin
5104920|NCT01193517|NSC-102816|nsc-102816
5104921|NCT01193517|Capecitabine|capecitabine
5104922|NCT01193517|Oxaliplatin|oxaliplatin
5104923|NCT01193517|CAPOX|capox
5104924|NCT01193517|Xeloda|xeloda
5104925|NCT01193517|Eloxatin|eloxatin
5104926|NCT01193517|Hypermethylation|hypermethylation
5104927|NCT01193517|CpG island methylator phenotype|cpg island methylator phenotype
5104928|NCT01193504|Prevention of Retinal Thickening and CME Following Phacoemulsification|prevention of retinal thickening and cme following phacoemulsification
5104929|NCT01193504|Pseudophakia following cataract surgery|pseudophakia following cataract surgery
5104930|NCT01193491|Phase 1|phase 1
5104931|NCT01193491|AML|aml
5104932|NCT01193491|CML|cml
5104933|NCT01193491|MPD|mpd
5104934|NCT01193491|Client Proteins|client proteins
5104935|NCT01193491|Hsp90|hsp90
5104936|NCT01193478|Hepatitis C|hepatitis c
5104937|NCT01193478|HCV RNA|hcv rna
5104938|NCT01193478|multiple ascending dose|multiple ascending dose
5104939|NCT01193478|NS5A|ns5a
5104940|NCT01193478|GS-5885|gs-5885
5104941|NCT01193478|chronic genotype 1 HCV infection|chronic genotype 1 hcv infection
5104942|NCT01193465|Humidity|humidity
5104943|NCT01193465|Temperature|temperature
5104944|NCT01193465|Low Flow Anesthesia|low flow anesthesia
5104945|NCT01193452|elderly patients|elderly patients
5104946|NCT01193452|advanced colorectal cancer|advanced colorectal cancer
5104947|NCT01193452|chemotherapy|chemotherapy
5104948|NCT01193452|S-1|s-1
5104949|NCT01193452|5-fluorouracil|5-fluorouracil
5104950|NCT01193452|leucovorin|leucovorin
5104951|NCT01193439|thoracoscopy|thoracoscopy
5104952|NCT01193439|pleural diseases|pleural diseases
5104953|NCT01193439|complications|complications
5104954|NCT01193439|safety|safety
5104955|NCT01193426|Hepatic|hepatic
5104956|NCT01193426|cirrhosis|cirrhosis
5104957|NCT01193426|IL-6|il-6
5104958|NCT01193426|IL-8|il-8
5104959|NCT01193426|Leptine|leptine
5104960|NCT01193413|acute pancreatitis|acute pancreatitis
5104961|NCT01193413|Drainage|drainage
5104962|NCT01193413|Pancreatic surgery|pancreatic surgery
5104963|NCT01193413|Biological Markers/analysis|biological markers/analysis
5104964|NCT01193413|Infection diagnosis|infection diagnosis
5104965|NCT01193413|ROC Curve|roc curve
5104966|NCT01193413|Sensitivity and Specificity|sensitivity and specificity
5104967|NCT01193413|Endoscopic ultrasonography|endoscopic ultrasonography
5104968|NCT01193400|Acute myelogenous leukemia|acute myelogenous leukemia
5104969|NCT01193400|Clofarabine|clofarabine
5104970|NCT01193400|Cytarabine|cytarabine
5104971|NCT01193374|Childhood Obesity|childhood obesity
5104972|NCT01193374|Primary Care|primary care
5104973|NCT01193374|Counseling|counseling
5104974|NCT01193374|Screening|screening
5104975|NCT01193348|Atypical Hemolytic-Uremic Syndrome|atypical hemolytic-uremic syndrome
5104976|NCT01193335|13-valent pneumococcal conjugate vaccine|13-valent pneumococcal conjugate vaccine
5104977|NCT01193335|premature|premature
5104978|NCT01193335|immunization|immunization
5104979|NCT01193335|safety.|safety.
5104980|NCT01193296|Diabetes mellitus, vildagliptin, continuous glucose monitoring|diabetes mellitus, vildagliptin, continuous glucose monitoring
5104981|NCT01193283|Aplastic Anemia|aplastic anemia
5104982|NCT01193283|Immunosuppression|immunosuppression
5104983|NCT01193283|T-Cells|t-cells
5104984|NCT01193283|Hematopoiesis|hematopoiesis
5104985|NCT01193283|Autoimmunity|autoimmunity
5104986|NCT01193283|Severe Aplastic Anemia|severe aplastic anemia
5104987|NCT01193270|NICHD Neonatal Research Network|nichd neonatal research network
5104988|NCT01193270|Intraventricular Hemorrhage (IVH)|intraventricular hemorrhage (ivh)
5104989|NCT01193270|Very Low Birth Weight (VLBW)|very low birth weight (vlbw)
5104990|NCT01193270|Extremely Low Birth Weight (ELBW)|extremely low birth weight (elbw)
5104991|NCT01193270|Prematurity|prematurity
5104992|NCT01193231|Laser Vision Correction|laser vision correction
5104993|NCT01193231|Photorefractive Keratectomy|photorefractive keratectomy
5104994|NCT01193231|PRK|prk
5104995|NCT01193231|Nearsighted|nearsighted
5104996|NCT01193231|Myopia|myopia
5104997|NCT01193205|Borderline Personality Disorder|borderline personality disorder
5104998|NCT01193205|Skills Training|skills training
5104999|NCT01193205|Dialectical Behavior Therapy|dialectical behavior therapy
5105000|NCT01193205|Suicidal and parasuicidal behavior|suicidal and parasuicidal behavior
5105001|NCT01193192|Neevo|neevo
5105002|NCT01193192|Neevo DHA|neevo dha
5105003|NCT01193192|L-methylfolate|l-methylfolate
5105004|NCT01193192|anemia during pregnancy|anemia during pregnancy
5105005|NCT01193192|folic acid|folic acid
5105006|NCT01193192|vitamin B12|vitamin b12
5105007|NCT01193192|prenatal vitamins|prenatal vitamins
5105008|NCT01193192|hemoglobin|hemoglobin
5105009|NCT01193192|iron deficiency|iron deficiency
5105010|NCT01193192|Pregnancy|pregnancy
5105011|NCT01193166|Schizophrenia|schizophrenia
5105012|NCT01193166|Risperidone|risperidone
5105013|NCT01193166|Risperdal|risperdal
5105014|NCT01193166|Paliperidone palmitate|paliperidone palmitate
5105015|NCT01193166|Aripiprazole|aripiprazole
5105016|NCT01193166|Haloperidol|haloperidol
5105017|NCT01193166|Olanzapine|olanzapine
5105018|NCT01193166|Paliperidone|paliperidone
5105019|NCT01193166|Perphenazine|perphenazine
5105020|NCT01193166|Quetiapine|quetiapine
5105021|NCT01193153|schizoaffective disorder|schizoaffective disorder
5105022|NCT01193153|paliperidone palmitate|paliperidone palmitate
5105023|NCT01193153|INVEGA SUSTENNA|invega sustenna
5105024|NCT01193153|schizoaffective disorder relapse prevention|schizoaffective disorder relapse prevention
5105025|NCT01193140|veliparib|veliparib
5105026|NCT01193140|relapsed and refractory tumors|relapsed and refractory tumors
5105027|NCT01193140|Temodar|temodar
5105028|NCT01193140|temozolomide|temozolomide
5105029|NCT01193140|ABT-888|abt-888
5105030|NCT01193140|Solid Tumors|solid tumors
5105031|NCT01193114|substance abuse|substance abuse
5105032|NCT01193114|homeless mothers|homeless mothers
5105033|NCT01193101|hypertension|hypertension
5105034|NCT01193101|blood pressure|blood pressure
5105035|NCT01193101|LCZ696|lcz696
5105036|NCT01193101|dual-acting|dual-acting
5105037|NCT01193101|neprilysin|neprilysin
5105038|NCT01193101|nep inhibitor|nep inhibitor
5105039|NCT01193101|vasopeptidase|vasopeptidase
5105040|NCT01193101|angiotensin receptor|angiotensin receptor
5105041|NCT01193101|ARNi|arni
5105042|NCT01193101|Essential hypertension|essential hypertension
5105043|NCT01193088|CMT|cmt
5105044|NCT01193088|CMT1A|cmt1a
5105045|NCT01193075|Charcot Marie Tooth disease|charcot marie tooth disease
5105046|NCT01193075|CMT|cmt
5105047|NCT01193075|HMSN|hmsn
5105048|NCT01193075|HMN|hmn
5105049|NCT01193075|HSN|hsn
5105050|NCT01193075|CMT1|cmt1
5105051|NCT01193075|CMT2|cmt2
5105052|NCT01193062|healthy volunteers|healthy volunteers
5105053|NCT01193062|pharmacokinetics-pharmacodynamics|pharmacokinetics-pharmacodynamics
5105054|NCT01193062|cerebrospinal fluid|cerebrospinal fluid
5105055|NCT01193062|serial sampling|serial sampling
5105056|NCT01193049|Nasal Allergen Challenge, Inhaled Allergen Challenge, Asthma|nasal allergen challenge, inhaled allergen challenge, asthma
5105057|NCT01193036|Psychosocial|psychosocial
5105058|NCT01193036|Skin Problems|skin problems
5105059|NCT01193036|Supportive Care|supportive care
5105060|NCT01193036|Melanoma|melanoma
5105061|NCT01193036|Questionnaire|questionnaire
5105062|NCT01193023|Prospective Studies|prospective studies
5105063|NCT01193023|Humans, pediatric|humans, pediatric
5105064|NCT01193023|Positive-Pressure Respiration/methods*|positive-pressure respiration/methods*
5105065|NCT01193023|Respiration, Artificial/methods*|respiration, artificial/methods*
5105066|NCT01193023|Intensive Care|intensive care
5105067|NCT01193023|Intensive Care Units/statistics & numerical data*|intensive care units/statistics & numerical data*
5105068|NCT01193023|Respiration, Artificial/statistics & numerical data*|respiration, artificial/statistics & numerical data*
5105069|NCT01193023|Patients/statistics & numerical data*|patients/statistics & numerical data*
5105070|NCT01193023|Prevalence|prevalence
5105455|NCT01191736|hands only|hands only
5105071|NCT01193023|Respiratory Muscles/innervation|respiratory muscles/innervation
5105072|NCT01192997|Meningitis|meningitis
5105073|NCT01192997|Meningococci|meningococci
5105074|NCT01192997|Meningitis C|meningitis c
5105075|NCT01192997|Meningitis A|meningitis a
5105076|NCT01192997|Meningitis W135|meningitis w135
5105077|NCT01192997|Meningitis Y|meningitis y
5105078|NCT01192997|Antibody|antibody
5105079|NCT01192971|hcc, apatinib, phase II, cancer|hcc, apatinib, phase ii, cancer
5105080|NCT01192958|swine flu|swine flu
5105081|NCT01192958|novel h1n1v|novel h1n1v
5105082|NCT01192958|novel h1n1|novel h1n1
5105083|NCT01192958|h1n1|h1n1
5105084|NCT01192945|Azacitidin|azacitidin
5105085|NCT01192945|Vidaza|vidaza
5105086|NCT01192945|Piaza|piaza
5105087|NCT01192945|myelodysplastic syndrome|myelodysplastic syndrome
5105088|NCT01192945|MDS|mds
5105089|NCT01192945|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5105090|NCT01192945|CMML|cmml
5105091|NCT01192945|acute myeloid leukemia|acute myeloid leukemia
5105092|NCT01192945|AML|aml
5105093|NCT01192945|daily routine|daily routine
5105094|NCT01192945|concomitant antiemetic therapy|concomitant antiemetic therapy
5105095|NCT01192945|germany|germany
5105096|NCT01192945|non-interventional study|non-interventional study
5105097|NCT01192919|bronchial carcinoma|bronchial carcinoma
5105098|NCT01192919|registry|registry
5105099|NCT01192919|real life treatment|real life treatment
5105100|NCT01192919|cohort study|cohort study
5105101|NCT01192919|NSCLC|nsclc
5105102|NCT01192919|SCLC|sclc
5105103|NCT01192919|Germany|germany
5105104|NCT01192854|Clevudine|clevudine
5105105|NCT01192854|efficacy|efficacy
5105106|NCT01192854|safety|safety
5105107|NCT01192854|chronic hepatitis B|chronic hepatitis b
5105108|NCT01192841|physician uniform|physician uniform
5105109|NCT01192841|MRSA|mrsa
5105110|NCT01192841|bacterial contamination|bacterial contamination
5105111|NCT01192828|cystathionine beta-synthase (CBS)|cystathionine beta-synthase (cbs)
5105112|NCT01192802|albendazole|albendazole
5105113|NCT01192802|ascaris|ascaris
5105114|NCT01192802|trichiurus|trichiurus
5105115|NCT01192802|hookworms|hookworms
5105116|NCT01192789|Severe pneumonia|severe pneumonia
5105117|NCT01192789|Pneumonia|pneumonia
5105118|NCT01192789|Lady health workers|lady health workers
5105119|NCT01192789|Amoxicillin|amoxicillin
5105120|NCT01192789|Treatment failure|treatment failure
5105121|NCT01192789|Injectable Antibiotics|injectable antibiotics
5105122|NCT01192789|Referral treatment|referral treatment
5105123|NCT01192789|Health Facility|health facility
5105124|NCT01192789|Under five children|under five children
5105125|NCT01192789|home based management|home based management
5105126|NCT01192789|community case management|community case management
5105127|NCT01192776|NICHD Neonatal Research Network|nichd neonatal research network
5105128|NCT01192776|Hypoxic-ischemic encephalopathy (HIE)|hypoxic-ischemic encephalopathy (hie)
5105129|NCT01192776|Hypothermia|hypothermia
5105130|NCT01192776|Neonatal depression|neonatal depression
5105131|NCT01192776|Perinatal asphyxia|perinatal asphyxia
5105132|NCT01192776|Fetal acidosis|fetal acidosis
5105133|NCT01192750|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
5105134|NCT01192750|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
5105135|NCT01192750|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
5105136|NCT01192750|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
5105137|NCT01192750|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
5105138|NCT01192750|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
5105139|NCT01192750|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
5105140|NCT01192750|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5105141|NCT01192750|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5105142|NCT01192750|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5105143|NCT01192750|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
5105144|NCT01192750|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5105145|NCT01192750|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
5105146|NCT01192750|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
5105147|NCT01192750|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
5105148|NCT01192750|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
5105149|NCT01192750|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
5105150|NCT01192750|recurrent salivary gland cancer|recurrent salivary gland cancer
5105151|NCT01192750|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
5105152|NCT01192737|pandemic|pandemic
5105153|NCT01192737|A/H1N1|a/h1n1
5105154|NCT01192737|pregnancy|pregnancy
5105155|NCT01192737|cohort|cohort
5105156|NCT01192737|vaccine|vaccine
5105157|NCT01192737|Influenza and Pregnancy|influenza and pregnancy
5105158|NCT01192724|Antiplatelet|antiplatelet
5105159|NCT01192724|Coronary artery diseae|coronary artery diseae
5105160|NCT01192724|Percutaneous coronary intervention|percutaneous coronary intervention
5105161|NCT01192711|diabetes|diabetes
5105162|NCT01192711|telemedicine|telemedicine
5105163|NCT01192711|self monitoring blood glucose|self monitoring blood glucose
5105164|NCT01192698|cirrhosis|cirrhosis
5105165|NCT01192698|hepatitis C|hepatitis c
5105166|NCT01192685|Depression|depression
5105167|NCT01192685|Depressed|depressed
5105168|NCT01192685|TMS|tms
5105169|NCT01192685|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
5105170|NCT01192646|maternal health|maternal health
5105171|NCT01192646|birth preparedness|birth preparedness
5105172|NCT01192646|cost effectiveness|cost effectiveness
5105173|NCT01192646|male involvement|male involvement
5105174|NCT01192646|delivery at hospital|delivery at hospital
5105175|NCT01192646|complication readiness|complication readiness
5105176|NCT01192646|Health seeking behavior in pregnancy, labour and pregnancy complication|health seeking behavior in pregnancy, labour and pregnancy complication
5105177|NCT01192633|Sarcoma|sarcoma
5105178|NCT01192633|gemcitabine|gemcitabine
5105179|NCT01192633|vincristine|vincristine
5105180|NCT01192633|cisplatin|cisplatin
5105181|NCT01192633|chemotherapy|chemotherapy
5105182|NCT01192620|Pediatric Appendicitis|pediatric appendicitis
5105183|NCT01192620|Pathway|pathway
5105184|NCT01192594|symptom management|symptom management
5105185|NCT01192594|empowerment|empowerment
5105186|NCT01192594|medication adherence|medication adherence
5105187|NCT01192594|recovery|recovery
5105188|NCT01192594|schizophrenia|schizophrenia
5105189|NCT01192594|post-psychotic adjustment process|post-psychotic adjustment process
5105190|NCT01192594|psychological adjustment|psychological adjustment
5105191|NCT01192594|psychiatric case managers|psychiatric case managers
5105192|NCT01192594|psychosis|psychosis
5105193|NCT01192594|insight|insight
5105194|NCT01192594|cognitive function|cognitive function
5105195|NCT01192581|brain hypoperfusion|brain hypoperfusion
5105196|NCT01192581|Vuloven|vuloven
5105197|NCT01192581|computed tomography perfusion|computed tomography perfusion
5105198|NCT01192555|Neuroblastoma|neuroblastoma
5105199|NCT01192555|Chemotherapy|chemotherapy
5105200|NCT01192555|Pediatrics|pediatrics
5105201|NCT01192555|Cytoxan|cytoxan
5105202|NCT01192555|immunotherapy|immunotherapy
5105203|NCT01192555|vaccine|vaccine
5105204|NCT01192529|Senile|senile
5105205|NCT01192529|Dementia|dementia
5105206|NCT01192529|Neurodegenerative|neurodegenerative
5105207|NCT01192529|Supressi|supressi
5105208|NCT01192529|Specific diet|specific diet
5105209|NCT01192529|Cognitive Status|cognitive status
5105210|NCT01192529|Memory|memory
5105211|NCT01192529|Malnutrition|malnutrition
5105212|NCT01192529|Parkinson|parkinson
5105213|NCT01192529|Alzheimer|alzheimer
5105214|NCT01192516|Osteoarthritis|osteoarthritis
5105215|NCT01192516|Activity Pacing|activity pacing
5105216|NCT01192503|Restless Legs Syndrome|restless legs syndrome
5105217|NCT01192503|rasagiline|rasagiline
5105218|NCT01192503|futility|futility
5105219|NCT01192477|Air pollution|air pollution
5105220|NCT01192477|Ozone|ozone
5105221|NCT01192477|Health effects of ozone exposure|health effects of ozone exposure
5105222|NCT01192464|Hodgkin's Lymphoma|hodgkin's lymphoma
5105223|NCT01192464|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
5105224|NCT01192438|prostate|prostate
5105225|NCT01192438|cancer|cancer
5105226|NCT01192438|ablation|ablation
5105227|NCT01192438|laser-induced|laser-induced
5105228|NCT01192438|focal therapy|focal therapy
5105229|NCT01192425|PNH clone cells|pnh clone cells
5105230|NCT01192425|Aplastic Anemia|aplastic anemia
5105231|NCT01192425|AA|aa
5105232|NCT01192425|Myelodysplastic Syndromes|myelodysplastic syndromes
5105233|NCT01192425|MDS|mds
5105234|NCT01192425|bone marrow failure syndromes|bone marrow failure syndromes
5105235|NCT01192425|FLAER|flaer
5105236|NCT01192425|Paroxysmal Nocturnal Hemoglobinuria|paroxysmal nocturnal hemoglobinuria
5105237|NCT01192412|hypertension|hypertension
5105238|NCT01192412|pregnancy|pregnancy
5105239|NCT01192412|antihypertensive therapy|antihypertensive therapy
5105240|NCT01192412|perinatal outcome|perinatal outcome
5105241|NCT01192412|maternal outcome|maternal outcome
5105242|NCT01192412|Non-severe, non-proteinuric pre-existing or gestational hypertension in pregnancy|non-severe, non-proteinuric pre-existing or gestational hypertension in pregnancy
5105243|NCT01192399|Hemolytic Paroxysmal Nocturnal Hemoglobinuria|hemolytic paroxysmal nocturnal hemoglobinuria
5105244|NCT01192399|Eculizumab|eculizumab
5105245|NCT01192399|PNH|pnh
5105246|NCT01192399|Japan|japan
5105247|NCT01192360|pediatrics|pediatrics
5105248|NCT01192360|Heart Disease|heart disease
5105249|NCT01192360|Cystic Fibrosis|cystic fibrosis
5105250|NCT01192360|Severe Asthma|severe asthma
5105251|NCT01192360|Magnetic Resonance Imaging|magnetic resonance imaging
5105252|NCT01192334|knee osteoarthritis arthroplasty postural balance|knee osteoarthritis arthroplasty postural balance
5105253|NCT01192321|intraocular lens|intraocular lens
5105254|NCT01192321|Toric|toric
5105255|NCT01192308|Breast cancer|breast cancer
5105256|NCT01192308|Tamoxifen|tamoxifen
5105257|NCT01192308|Pharmacokinetics|pharmacokinetics
5105258|NCT01192308|Pharmacogenetics|pharmacogenetics
5105259|NCT01192308|CYP2D6|cyp2d6
5105260|NCT01192295|Malignant pain|malignant pain
5105261|NCT01192295|Nonmalignant pain|nonmalignant pain
5105262|NCT01192295|Pediatric|pediatric
5105263|NCT01192295|Opioid|opioid
5105264|NCT01192295|Moderate to severe malignant or nonmalignant pain|moderate to severe malignant or nonmalignant pain
5105265|NCT01192282|Female Genital Warts|female genital warts
5105266|NCT01192282|HPV Typing|hpv typing
5105267|NCT01192282|HIV Status|hiv status
5105268|NCT01192282|Treatment Modalities and Recurrence|treatment modalities and recurrence
5105269|NCT01192282|Socio-economic Burdens|socio-economic burdens
5105270|NCT01192269|cheek cells|cheek cells
5105271|NCT01192269|phospholipids|phospholipids
5105272|NCT01192269|fatty acids|fatty acids
5105273|NCT01192269|docosahexaenoic acid|docosahexaenoic acid
5105274|NCT01192269|Buccal Cheek cells|buccal cheek cells
5105275|NCT01192269|non invasive fatty acid status marker|non invasive fatty acid status marker
5105276|NCT01192256|smoking|smoking
5105277|NCT01192256|cessation|cessation
5105278|NCT01192256|mortality|mortality
5105279|NCT01192256|quality of life|quality of life
5105280|NCT01192243|Objective response rate|objective response rate
5105281|NCT01192243|Time to Progression|time to progression
5105282|NCT01192243|Quality of Live|quality of live
5105283|NCT01192230|Objective response rate|objective response rate
5105284|NCT01192230|Disease control rate|disease control rate
5105285|NCT01192230|Disease free survival|disease free survival
5105286|NCT01192230|Overall survival|overall survival
5105287|NCT01192230|Quality of Live|quality of live
5105288|NCT01192230|Nonsmall cell lung cancer|nonsmall cell lung cancer
5105289|NCT01192230|toxicity|toxicity
5105290|NCT01192217|video-assisted thoracic surgery|video-assisted thoracic surgery
5105291|NCT01192217|axillary mini-thoracotomy|axillary mini-thoracotomy
5105292|NCT01192217|bullectomy|bullectomy
5105293|NCT01192204|FBR, OSCC, chemoprevention|fbr, oscc, chemoprevention
5105294|NCT01192191|GW642444|gw642444
5105295|NCT01192191|COPD|copd
5105296|NCT01192191|Fluticasone Furoate|fluticasone furoate
5105297|NCT01192178|pediatric|pediatric
5105298|NCT01192178|exacerbation|exacerbation
5105299|NCT01192178|viral induced exacerbation|viral induced exacerbation
5105300|NCT01192178|asthma|asthma
5105301|NCT01192165|Taxotere|taxotere
5105302|NCT01192165|Cisplatin|cisplatin
5105303|NCT01192165|Carboplatin|carboplatin
5105304|NCT01192165|Trametinib|trametinib
5105305|NCT01192165|GSK1120212|gsk1120212
5105306|NCT01192165|Tarceva|tarceva
5105307|NCT01192165|KRAS|kras
5105308|NCT01192165|Pemetrexed|pemetrexed
5105309|NCT01192165|MEK inhibitor|mek inhibitor
5105310|NCT01192165|nab-Paclitaxel|nab-paclitaxel
5105311|NCT01192165|Docetaxel|docetaxel
5105312|NCT01192165|Alimta|alimta
5105313|NCT01192165|Abraxane|abraxane
5105314|NCT01192165|Erlotinib|erlotinib
5105315|NCT01192113|Mecobalamin|mecobalamin
5105316|NCT01192113|peripheral neuropathy|peripheral neuropathy
5105317|NCT01192113|diabetic neuropathy|diabetic neuropathy
5105318|NCT01192100|Protein-rich breakfast|protein-rich breakfast
5105319|NCT01192100|Breakfast Skipping|breakfast skipping
5105320|NCT01192100|Adolescents|adolescents
5105321|NCT01192100|Obesity|obesity
5105322|NCT01192100|Increased dietary protein|increased dietary protein
5105323|NCT01192100|Breakfast|breakfast
5105324|NCT01192100|fMRI|fmri
5105325|NCT01192100|Ghrelin|ghrelin
5105326|NCT01192100|PYY|pyy
5105327|NCT01192087|adenoid cystic carcinoma|adenoid cystic carcinoma
5105328|NCT01192087|carbon ion therapy|carbon ion therapy
5105329|NCT01192087|IMRT (intensity-modulated therapy)|imrt (intensity-modulated therapy)
5105330|NCT01192087|radioimmunotherapy|radioimmunotherapy
5105331|NCT01192087|Cetuximab|cetuximab
5105332|NCT01192074|Obstetric|obstetric
5105333|NCT01192074|Analgesia|analgesia
5105334|NCT01192074|Anesthesia|anesthesia
5105335|NCT01192074|Obstetric Anesthesia|obstetric anesthesia
5105336|NCT01192074|Obstetric Analgesia|obstetric analgesia
5105337|NCT01192074|ultrasound|ultrasound
5105338|NCT01192074|ultrasonography|ultrasonography
5105339|NCT01192074|epidural analgesia|epidural analgesia
5105340|NCT01192074|epidural anesthesia|epidural anesthesia
5105341|NCT01192074|spinal anesthesia|spinal anesthesia
5105342|NCT01192074|neuraxial anesthesia|neuraxial anesthesia
5105343|NCT01192074|neuraxial analgesia|neuraxial analgesia
5105344|NCT01192074|pregnancy|pregnancy
5105345|NCT01192074|labor|labor
5105346|NCT01192074|cesarean delivery|cesarean delivery
5105347|NCT01192074|cesarean section|cesarean section
5105348|NCT01192061|autonomic nervous system|autonomic nervous system
5105349|NCT01192061|heart rate variability|heart rate variability
5105350|NCT01192061|blood pressure variability|blood pressure variability
5105351|NCT01192061|retrobulbar hemodynamics|retrobulbar hemodynamics
5105352|NCT01192061|vascular dysregulation|vascular dysregulation
5105353|NCT01192048|Congenital Heart Disease|congenital heart disease
5105354|NCT01192048|birth defect|birth defect
5105355|NCT01192048|genetics|genetics
5105356|NCT01192048|gene|gene
5105357|NCT01192048|DNA|dna
5105358|NCT01192048|direct sequencing|direct sequencing
5105359|NCT01192048|microarray|microarray
5105456|NCT01191736|CPR|cpr
5105360|NCT01192048|single nucleotide polymorphism|single nucleotide polymorphism
5105361|NCT01192048|whole genome array comparative genomic hybridization|whole genome array comparative genomic hybridization
5105362|NCT01192048|chromosomal copy number change|chromosomal copy number change
5105363|NCT01192048|nucleotide sequence variation|nucleotide sequence variation
5105364|NCT01192048|exome sequencing|exome sequencing
5105365|NCT01192048|whole exome sequencing|whole exome sequencing
5105366|NCT01192035|Africa, Western|africa, western
5105367|NCT01192035|Antiretroviral Therapy, Highly Active|antiretroviral therapy, highly active
5105368|NCT01192022|Liver resection|liver resection
5105369|NCT01192022|Liver transplantation|liver transplantation
5105370|NCT01192022|Liver surgery|liver surgery
5105371|NCT01192022|Secondary hemostasis|secondary hemostasis
5105372|NCT01192009|Leucine|leucine
5105373|NCT01192009|Skeletal Muscle Disuse|skeletal muscle disuse
5105374|NCT01192009|Atrophy|atrophy
5105375|NCT01192009|Proteolysis|proteolysis
5105376|NCT01191996|SPMS|spms
5105377|NCT01191996|PPMS|ppms
5105378|NCT01191996|MS|ms
5105379|NCT01191996|Multiple Sclerosis|multiple sclerosis
5105380|NCT01191970|epidural|epidural
5105381|NCT01191970|beta-endorphins|beta-endorphins
5105382|NCT01191970|breast-feeding|breast-feeding
5105383|NCT01191970|colostrum|colostrum
5105384|NCT01191970|feeding|feeding
5105385|NCT01191957|Acute Myeloid Leukemia|acute myeloid leukemia
5105386|NCT01191957|Allogeneic hematopoietic stem cell transplantation|allogeneic hematopoietic stem cell transplantation
5105387|NCT01191918|acetylcholinesterase inhibitor|acetylcholinesterase inhibitor
5105388|NCT01191918|donepezil|donepezil
5105389|NCT01191918|bipolar disorder|bipolar disorder
5105390|NCT01191918|mania|mania
5105391|NCT01191918|lithium|lithium
5105392|NCT01191892|metastatic transitional cell cancer of the renal pelvis and ureter|metastatic transitional cell cancer of the renal pelvis and ureter
5105393|NCT01191892|regional transitional cell cancer of the renal pelvis and ureter|regional transitional cell cancer of the renal pelvis and ureter
5105394|NCT01191892|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
5105395|NCT01191892|stage III bladder cancer|stage iii bladder cancer
5105396|NCT01191892|stage IV bladder cancer|stage iv bladder cancer
5105397|NCT01191892|anterior urethral cancer|anterior urethral cancer
5105398|NCT01191892|posterior urethral cancer|posterior urethral cancer
5105399|NCT01191892|urethral cancer associated with invasive bladder cancer|urethral cancer associated with invasive bladder cancer
5105400|NCT01191892|ureter cancer|ureter cancer
5105401|NCT01191866|diabetes mellitus|diabetes mellitus
5105402|NCT01191866|psychosocial|psychosocial
5105403|NCT01191866|metabolic control|metabolic control
5105404|NCT01191866|quality of life questionnaires|quality of life questionnaires
5105405|NCT01191866|children|children
5105406|NCT01191866|adolescents|adolescents
5105407|NCT01191853|Post Swine Flu Blood Samples|post swine flu blood samples
5105408|NCT01191853|Biologic Samples|biologic samples
5105409|NCT01191853|Laboratory Research Samples|laboratory research samples
5105410|NCT01191853|Swine Flu|swine flu
5105411|NCT01191853|Immunization|immunization
5105412|NCT01191853|Healthy Volunteer|healthy volunteer
5105413|NCT01191853|HV|hv
5105414|NCT01191840|staphylococci|staphylococci
5105415|NCT01191814|pancreatic cancer|pancreatic cancer
5105416|NCT01191814|obstructive jaundice|obstructive jaundice
5105417|NCT01191814|Obstructive jaundice secondary to pancreatic cancer|obstructive jaundice secondary to pancreatic cancer
5105418|NCT01191801|Leukemia|leukemia
5105419|NCT01191801|Acute Myeloid Leukemia|acute myeloid leukemia
5105420|NCT01191801|Hematologic|hematologic
5105421|NCT01191801|Hematologic diseases|hematologic diseases
5105422|NCT01191801|Blood|blood
5105423|NCT01191801|Cancer|cancer
5105424|NCT01191801|Malignancy|malignancy
5105425|NCT01191801|Vosaroxin|vosaroxin
5105426|NCT01191801|Cytarabine|cytarabine
5105427|NCT01191801|First Relapsed AML|first relapsed aml
5105428|NCT01191801|Refractory AML|refractory aml
5105429|NCT01191801|VALOR|valor
5105430|NCT01191801|Sunesis|sunesis
5105431|NCT01191801|Voreloxin|voreloxin
5105432|NCT01191801|SNS-595|sns-595
5105433|NCT01191788|Depression|depression
5105434|NCT01191788|Substance Use|substance use
5105435|NCT01191788|Group Cognitive Behavioral Therapy|group cognitive behavioral therapy
5105436|NCT01191775|Oligonucleotide|oligonucleotide
5105437|NCT01191775|DNAi|dnai
5105438|NCT01191775|Oncology|oncology
5105439|NCT01191775|Antineoplastic agent|antineoplastic agent
5105440|NCT01191775|Lymphoma|lymphoma
5105441|NCT01191775|PNT2258|pnt2258
5105442|NCT01191762|secondary hyperparathyroidism|secondary hyperparathyroidism
5105443|NCT01191762|phosphate|phosphate
5105444|NCT01191762|calcium|calcium
5105445|NCT01191762|chronic kidney disease|chronic kidney disease
5105446|NCT01191749|Hematologic Disorder|hematologic disorder
5105447|NCT01191749|Aplastic Anemia|aplastic anemia
5105448|NCT01191749|T - Cell Large Granular Lymphocytic Leukemia|t - cell large granular lymphocytic leukemia
5105449|NCT01191749|T-LGL|t-lgl
5105450|NCT01191749|Myelodysplastic Syndrome|myelodysplastic syndrome
5105451|NCT01191749|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
5105452|NCT01191749|CLL|cll
5105453|NCT01191749|Chemotherapy|chemotherapy
5105454|NCT01191749|Alemtuzumab|alemtuzumab
5105457|NCT01191736|resuscitation|resuscitation
5105458|NCT01191736|cardiac arrest|cardiac arrest
5105459|NCT01191736|Education of general public regarding resuscitation methods|education of general public regarding resuscitation methods
5105460|NCT01191723|Healthy Volunteers|healthy volunteers
5105461|NCT01191710|progesterone|progesterone
5105462|NCT01191697|HER2 positive|her2 positive
5105463|NCT01191671|Child Development|child development
5105464|NCT01191671|Child|child
5105465|NCT01191671|Daycare centers|daycare centers
5105466|NCT01191671|Language|language
5105467|NCT01191645|Lower esophageal sphincter pressure|lower esophageal sphincter pressure
5105468|NCT01191645|Esophageal motility|esophageal motility
5105469|NCT01191645|Remifentanil|remifentanil
5105470|NCT01191645|Metoclopramide|metoclopramide
5105471|NCT01191645|Naloxone|naloxone
5105472|NCT01191645|High resolution solid state manometry|high resolution solid state manometry
5105473|NCT01191632|T cell|t cell
5105474|NCT01191632|surgery|surgery
5105475|NCT01191632|radiation|radiation
5105476|NCT01191619|McIvor retractor|mcivor retractor
5105477|NCT01191619|Proseal laryngeal mask airway|proseal laryngeal mask airway
5105478|NCT01191606|pressure controlled|pressure controlled
5105479|NCT01191606|volume controlled|volume controlled
5105480|NCT01191606|arterial oxygenation|arterial oxygenation
5105481|NCT01191606|one lung ventilation|one lung ventilation
5105482|NCT01191593|Adductor-Canal-Blockade|adductor-canal-blockade
5105483|NCT01191593|postoperative pain|postoperative pain
5105484|NCT01191593|US-guided nerve block|us-guided nerve block
5105485|NCT01191593|revision knee arthroplasty|revision knee arthroplasty
5105486|NCT01191567|acute wounds|acute wounds
5105487|NCT01191567|postoperative wounds|postoperative wounds
5105488|NCT01191541|ara-c|ara-c
5105489|NCT01191541|As2O3|as2o3
5105490|NCT01191541|pediatric|pediatric
5105491|NCT01191541|acute|acute
5105492|NCT01191528|Adult|adult
5105493|NCT01191528|Post|post
5105494|NCT01191528|operative|operative
5105495|NCT01191528|oximetry|oximetry
5105496|NCT01191528|capnometry|capnometry
5105497|NCT01191528|Integrated|integrated
5105498|NCT01191528|Pulmonary|pulmonary
5105499|NCT01191528|Index|index
5105500|NCT01191528|End-tidal|end-tidal
5105501|NCT01191528|Monitoring Respiratory status|monitoring respiratory status
5105502|NCT01191528|post-operative|post-operative
5105503|NCT01191515|Previous Cataract patients|previous cataract patients
5105504|NCT01191515|Monofocal IOL implant|monofocal iol implant
5105505|NCT01191515|Evaluation|evaluation
5105506|NCT01191502|Patients who have had binocular implantation of the Tecnis Multifocal IOL or the Crystalens™ HD Accommodating IOL.|patients who have had binocular implantation of the tecnis multifocal iol or the crystalens™ hd accommodating iol.
5105507|NCT01191476|Sevoflurane|sevoflurane
5105508|NCT01191476|Propofol|propofol
5105509|NCT01191476|Economics|economics
5105510|NCT01191476|Pharmaceutical|pharmaceutical
5105511|NCT01191476|Chinese|chinese
5105512|NCT01191450|chlortalidone|chlortalidone
5105513|NCT01191450|amiloride|amiloride
5105514|NCT01191450|arterial hypertension|arterial hypertension
5105515|NCT01191424|Asthma|asthma
5105516|NCT01191424|PK|pk
5105517|NCT01191424|Adolescents|adolescents
5105518|NCT01191424|Adults|adults
5105519|NCT01191411|colorectal neoplasms|colorectal neoplasms
5105520|NCT01191411|screening|screening
5105521|NCT01191398|Hypersalivation|hypersalivation
5105522|NCT01191398|Conscious Sedation|conscious sedation
5105523|NCT01191398|Procedural Sedation|procedural sedation
5105524|NCT01191398|Ketamine|ketamine
5105525|NCT01191398|Atropine|atropine
5105526|NCT01191398|Glycopyrrolate|glycopyrrolate
5105527|NCT01191385|HCC|hcc
5105528|NCT01191385|Liver cancer|liver cancer
5105529|NCT01191385|Cancer of liver|cancer of liver
5105530|NCT01191385|Cancer, liver|cancer, liver
5105531|NCT01191385|Hepatic cancer|hepatic cancer
5105532|NCT01191385|Cancer, hepatic|cancer, hepatic
5105533|NCT01191385|Carcinoma, hepatocellular|carcinoma, hepatocellular
5105534|NCT01191372|Hemophilia A|hemophilia a
5105535|NCT01191372|Hemophilia B|hemophilia b
5105536|NCT01191372|pharmacokinetics|pharmacokinetics
5105537|NCT01191372|pharmacodynamics|pharmacodynamics
5105538|NCT01191372|Tissue Factor Pathway Inhibitor|tissue factor pathway inhibitor
5105539|NCT01191333|Mood Disorder|mood disorder
5105540|NCT01191333|Depression|depression
5105541|NCT01191333|stress disorder, post-traumatic|stress disorder, post-traumatic
5105542|NCT01191333|Depressive Disorder|depressive disorder
5105543|NCT01191333|Stress Disorders, Traumatic|stress disorders, traumatic
5105544|NCT01191333|substance related disorders|substance related disorders
5105545|NCT01191333|Transcranial Magnetic Stimulation, repetitive|transcranial magnetic stimulation, repetitive
5105546|NCT01191333|transcranial magnetic stimulation|transcranial magnetic stimulation
5105547|NCT01191333|Veterans|veterans
5105548|NCT01191333|mental health|mental health
5105549|NCT01191320|Adult onset hypogonadotropic hypogonadism|adult onset hypogonadotropic hypogonadism
5105550|NCT01191307|Primary dystonia|primary dystonia
5105551|NCT01191307|Epilepsy|epilepsy
5105552|NCT01191307|Hydrocephalus|hydrocephalus
5105553|NCT01191307|Bladder Control|bladder control
5105554|NCT01191307|Deaf or Hearing Impaired|deaf or hearing impaired
5105555|NCT01191294|Melanoma|melanoma
5105556|NCT01191294|Simulation Training|simulation training
5105557|NCT01191294|Medical Students|medical students
5105558|NCT01191281|food habits|food habits
5105559|NCT01191281|nutrition requirements|nutrition requirements
5105560|NCT01191281|antiretroviral therapy|antiretroviral therapy
5105561|NCT01191255|ESRD|esrd
5105562|NCT01191255|end-stage renal disease|end-stage renal disease
5105563|NCT01191255|dialysis|dialysis
5105564|NCT01191255|hemodialysis|hemodialysis
5105565|NCT01191255|peritoneal dialysis|peritoneal dialysis
5105566|NCT01191255|hemodialysis (HD)|hemodialysis (hd)
5105567|NCT01191255|peritoneal dialysis (PD)|peritoneal dialysis (pd)
5105568|NCT01191255|chronic renal insufficiency|chronic renal insufficiency
5105569|NCT01191255|phosphate binder|phosphate binder
5105570|NCT01191255|kidney failure|kidney failure
5105571|NCT01191255|renal failure|renal failure
5105572|NCT01191242|methadone|methadone
5105573|NCT01191242|genetic|genetic
5105574|NCT01191203|Acceptability and Adherence to methods|acceptability and adherence to methods
5105575|NCT01191190|Leukemia|leukemia
5105576|NCT01191190|Chronic leukemia|chronic leukemia
5105577|NCT01191190|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
5105578|NCT01191190|Relapsed|relapsed
5105579|NCT01191190|Refractory|refractory
5105580|NCT01191177|oral fish oil|oral fish oil
5105581|NCT01191177|Lovaza|lovaza
5105582|NCT01191177|Omega-3-acid supplementation|omega-3-acid supplementation
5105583|NCT01191164|Brachytherapy, Partial Breast Irradiation, Breast Seed Implant, Palladium Seeds|brachytherapy, partial breast irradiation, breast seed implant, palladium seeds
5105584|NCT01191151|Orthopedic surgery|orthopedic surgery
5105585|NCT01191151|sports medicine|sports medicine
5105586|NCT01191138|Delayed Gastric emptying|delayed gastric emptying
5105587|NCT01191138|Gastric emptying scintigraphy|gastric emptying scintigraphy
5105588|NCT01191138|Pancreatic fistula|pancreatic fistula
5105589|NCT01191138|Pancreatic Neoplasms|pancreatic neoplasms
5105590|NCT01191138|Whipple Operation|whipple operation
5105591|NCT01191086|Epilepsy|epilepsy
5105592|NCT01191086|partial onset seizure|partial onset seizure
5105593|NCT01191086|adjunctive therapy|adjunctive therapy
5105594|NCT01191073|edentulous|edentulous
5105595|NCT01191060|Progression free survival prolongation|progression free survival prolongation
5105596|NCT01191060|Disease Progression|disease progression
5105597|NCT01191060|Overall survival|overall survival
5105598|NCT01191021|breath|breath
5105599|NCT01191021|propofol|propofol
5105600|NCT01191021|general anesthesia|general anesthesia
5105601|NCT01191008|Xalacom Regulatory post marketing commitment plan safety|xalacom regulatory post marketing commitment plan safety
5105602|NCT01190995|Pain|pain
5105603|NCT01190995|Neonate|neonate
5105604|NCT01190995|Procedure|procedure
5105605|NCT01190995|Neurobehavioural outcome|neurobehavioural outcome
5105606|NCT01190969|Elderly|elderly
5105607|NCT01190969|malnutrition|malnutrition
5105608|NCT01190969|nutritional supplement|nutritional supplement
5105609|NCT01190917|Autism|autism
5105610|NCT01190917|Autism Spectrum Disorder|autism spectrum disorder
5105611|NCT01190917|Disorder|disorder
5105612|NCT01190917|Autistic|autistic
5105613|NCT01190917|Asperger Syndrome|asperger syndrome
5105614|NCT01190917|social skills group|social skills group
5105615|NCT01190917|behavioral intervention|behavioral intervention
5105616|NCT01190917|Imaging, Magnetic Resonance|imaging, magnetic resonance
5105617|NCT01190917|fMRI|fmri
5105618|NCT01190917|Functional MRI|functional mri
5105619|NCT01190917|MRI, Functional|mri, functional
5105620|NCT01190917|Magnetic Resonance Imaging|magnetic resonance imaging
5105621|NCT01190917|Functional|functional
5105622|NCT01190904|Androgen deficiency|androgen deficiency
5105623|NCT01190904|Erectile dysfunction|erectile dysfunction
5105624|NCT01190904|Coronary Artery Disease|coronary artery disease
5105625|NCT01190904|Coronary Revascularization|coronary revascularization
5105626|NCT01190904|Diabetes mellitus|diabetes mellitus
5105627|NCT01190904|MI|mi
5105628|NCT01190904|Stroke|stroke
5105629|NCT01190904|MACCE|macce
5105630|NCT01190904|DM|dm
5105631|NCT01190904|ED|ed
5105632|NCT01190904|CAD|cad
5105633|NCT01190904|Development of predictive cardiovascular/cerebrovascular AE|development of predictive cardiovascular/cerebrovascular ae
5105634|NCT01190891|Rotator cuff tendonitis|rotator cuff tendonitis
5105635|NCT01190891|Shoulder pain|shoulder pain
5105636|NCT01190891|Shoulder impingement|shoulder impingement
5105637|NCT01190839|Crohn's Disease|crohn's disease
5105638|NCT01190839|Inflammatory Bowel Disease|inflammatory bowel disease
5105639|NCT01190839|infliximab|infliximab
5105640|NCT01190839|TNF-alpha|tnf-alpha
5105641|NCT01190826|Stable moderate asthma|stable moderate asthma
5105642|NCT01190813|amblyopia, levodopa|amblyopia, levodopa
5105643|NCT01190800|Alzheimer's Disease|alzheimer's disease
5105644|NCT01190800|Capacity assessment|capacity assessment
5105645|NCT01190800|Decision-making assessment|decision-making assessment
5105646|NCT01190800|Capacity to consent to treatment|capacity to consent to treatment
5105647|NCT01190800|Capacity to vote|capacity to vote
5105648|NCT01190800|Capacity to appoint a proxy|capacity to appoint a proxy
5105649|NCT01190787|Multiple Myeloma|multiple myeloma
5105650|NCT01190787|Elderly Patients|elderly patients
5105651|NCT01190787|Diagnosis|diagnosis
5105652|NCT01190787|Velcade subcutaneous|velcade subcutaneous
5105653|NCT01190787|Prednisone|prednisone
5105654|NCT01190787|Melphalan|melphalan
5105655|NCT01190787|Cyclophosphamide|cyclophosphamide
5105656|NCT01190774|dental anxiety|dental anxiety
5105657|NCT01190774|state anxiety|state anxiety
5105658|NCT01190774|randomised control trial|randomised control trial
5105659|NCT01190774|psychological intervention|psychological intervention
5105660|NCT01190761|Bioequivalence|bioequivalence
5105661|NCT01190761|Galantamine|galantamine
5105662|NCT01190761|Reminyl|reminyl
5105663|NCT01190761|Galantamine hydrobromide|galantamine hydrobromide
5105664|NCT01190761|Healthy subjects|healthy subjects
5105665|NCT01190748|Bioequivalence|bioequivalence
5105666|NCT01190748|Galantamine|galantamine
5105667|NCT01190748|Reminyl|reminyl
5105668|NCT01190748|Galantamine hydrobromide|galantamine hydrobromide
5105669|NCT01190748|Healthy subjects|healthy subjects
5105670|NCT01190735|Caffeine|caffeine
5105671|NCT01190735|Parkinson's Disease|parkinson's disease
5105672|NCT01190735|Parkinson Disease|parkinson disease
5105673|NCT01190735|Parkinsonian Disorders|parkinsonian disorders
5105674|NCT01190735|Basal Ganglia Diseases|basal ganglia diseases
5105675|NCT01190735|Brain Diseases|brain diseases
5105676|NCT01190735|Central Nervous System Diseases|central nervous system diseases
5105677|NCT01190735|Nervous System Diseases|nervous system diseases
5105678|NCT01190735|Movement Disorders|movement disorders
5105679|NCT01190735|Neurodegenerative Diseases|neurodegenerative diseases
5105680|NCT01190735|Caffeine citrate|caffeine citrate
5105681|NCT01190735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
5105682|NCT01190735|Pharmacologic Actions|pharmacologic actions
5105683|NCT01190735|Central Nervous System Stimulants|central nervous system stimulants
5105684|NCT01190735|Physiological Effects of Drugs|physiological effects of drugs
5105685|NCT01190735|Central Nervous System Agents|central nervous system agents
5105686|NCT01190735|Therapeutic Uses|therapeutic uses
5105687|NCT01190722|Day case surgery|day case surgery
5105688|NCT01190722|postoperative pain|postoperative pain
5105689|NCT01190722|NSAIDs|nsaids
5105690|NCT01190722|Coxibs|coxibs
5105691|NCT01190709|Close Fracture|close fracture
5105692|NCT01190709|Tibia|tibia
5105693|NCT01190709|Unreamed Intramedullary Nailing|unreamed intramedullary nailing
5105694|NCT01190709|Dynamic Compression Plate|dynamic compression plate
5105695|NCT01190696|Spica Cast|spica cast
5105696|NCT01190696|TEN|ten
5105697|NCT01190696|Femoral Shaft Fracture|femoral shaft fracture
5105698|NCT01190696|Children|children
5105699|NCT01190670|ASP015K|asp015k
5105700|NCT01190670|tacrolimus|tacrolimus
5105701|NCT01190670|healthy volunteers|healthy volunteers
5105702|NCT01190657|Teprenone|teprenone
5105703|NCT01190657|safety|safety
5105704|NCT01190657|efficacy|efficacy
5105705|NCT01190657|acute gastric lesion|acute gastric lesion
5105706|NCT01190657|chronic gastritis|chronic gastritis
5105707|NCT01190644|Red Blood Cell Mass|red blood cell mass
5105708|NCT01190644|Plasma Volume|plasma volume
5105709|NCT01190644|Solid Tumors|solid tumors
5105710|NCT01190631|intraocular lens|intraocular lens
5105711|NCT01190631|cataracts|cataracts
5105712|NCT01190631|total residual spherical aberration|total residual spherical aberration
5105713|NCT01190631|high order aberrations|high order aberrations
5105714|NCT01190605|HIV|hiv
5105715|NCT01190605|postpartum|postpartum
5105716|NCT01190605|postpartum entry into HIV care|postpartum entry into hiv care
5105717|NCT01190592|Resistance training|resistance training
5105718|NCT01190592|Body Composition|body composition
5105719|NCT01190592|Cardiovascular Risk factors|cardiovascular risk factors
5105720|NCT01190592|Dairy|dairy
5105721|NCT01190579|Coronary Artery Disease|coronary artery disease
5105722|NCT01190579|Chest Pain|chest pain
5105723|NCT01190579|Computed Tomography|computed tomography
5105724|NCT01190566|Magnetic Resonance Imaging, Functional|magnetic resonance imaging, functional
5105725|NCT01190566|Tomography, Positron-Emission|tomography, positron-emission
5105726|NCT01190566|chemotherapy|chemotherapy
5105727|NCT01190553|amantadine|amantadine
5105728|NCT01190553|parkinson disease|parkinson disease
5105729|NCT01190553|dyskinesia|dyskinesia
5105730|NCT01190540|On site support services.|on site support services.
5105731|NCT01190540|mid level health professionals.|mid level health professionals.
5105732|NCT01190540|cost effectiveness.|cost effectiveness.
5105733|NCT01190540|infectious disease.|infectious disease.
5105734|NCT01190540|capacity building.|capacity building.
5105735|NCT01190514|DVS SR|dvs sr
5105736|NCT01190514|healthy|healthy
5105737|NCT01190514|Bioequivalence study|bioequivalence study
5105738|NCT01190501|blood pressure|blood pressure
5105739|NCT01190501|antihypertensive treatments|antihypertensive treatments
5105740|NCT01190488|End of life decision making|end of life decision making
5105741|NCT01190488|End of life decision aid|end of life decision aid
5105742|NCT01190488|Palliative care decision making|palliative care decision making
5105743|NCT01190488|Palliative care decision aid|palliative care decision aid
5105744|NCT01190488|Advanced care planning|advanced care planning
5105745|NCT01190488|Decision Aid|decision aid
5105746|NCT01190475|Endometriosis|endometriosis
5105747|NCT01190475|Infertility|infertility
5105748|NCT01190475|Pain|pain
5105749|NCT01190475|Vaginal Diseases|vaginal diseases
5106527|NCT01186965|Diabetes|diabetes
5105750|NCT01190475|Uterine Diseases|uterine diseases
5105751|NCT01190462|recurrent colon cancer|recurrent colon cancer
5105752|NCT01190462|stage III colon cancer|stage iii colon cancer
5105753|NCT01190462|stage IV colon cancer|stage iv colon cancer
5105754|NCT01190462|recurrent rectal cancer|recurrent rectal cancer
5105755|NCT01190462|stage III rectal cancer|stage iii rectal cancer
5105756|NCT01190462|stage IV rectal cancer|stage iv rectal cancer
5105757|NCT01190449|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5105758|NCT01190449|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5105759|NCT01190449|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5105760|NCT01190449|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5105761|NCT01190449|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5105762|NCT01190449|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5105763|NCT01190449|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
5105764|NCT01190449|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
5105765|NCT01190449|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
5105766|NCT01190449|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5105767|NCT01190449|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5105768|NCT01190449|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5105769|NCT01190436|Hypertension|hypertension
5105770|NCT01190436|Diabetes Mellitus|diabetes mellitus
5105771|NCT01190436|Bisoprolol|bisoprolol
5105773|NCT01190410|Certolizumab Pegol|certolizumab pegol
5105774|NCT01190410|Cimzia®|cimzia®
5105775|NCT01190410|Crohn's Disease|crohn's disease
5105776|NCT01190410|Children and Adolescents with Crohn's Disease|children and adolescents with crohn's disease
5105777|NCT01190397|Warming goggles|warming goggles
5105778|NCT01190384|Metabolic Syndrome|metabolic syndrome
5105779|NCT01190384|Inflammation|inflammation
5105780|NCT01190384|Antioxidants|antioxidants
5105781|NCT01190384|Satiety|satiety
5105782|NCT01190384|Fiber|fiber
5105783|NCT01190371|Artemisinin tolerance|artemisinin tolerance
5105784|NCT01190345|breast cancer|breast cancer
5105785|NCT01190332|common bile duct stones|common bile duct stones
5105786|NCT01190319|blood pressure|blood pressure
5105787|NCT01190319|strawberry|strawberry
5105788|NCT01190319|fruit phenolics|fruit phenolics
5105789|NCT01190319|LDL oxidation|ldl oxidation
5105790|NCT01190319|Flow mediated dilation (FMD)|flow mediated dilation (fmd)
5105791|NCT01190254|Asenapine|asenapine
5105792|NCT01190254|adolescents|adolescents
5105793|NCT01190254|schizophrenia|schizophrenia
5105794|NCT01190254|phase IIIb|phase iiib
5105795|NCT01190254|placebo-controlled|placebo-controlled
5105796|NCT01190241|targeted therapy|targeted therapy
5105797|NCT01190241|individualized medicine|individualized medicine
5105798|NCT01190241|tyrosine kinase inhibitor|tyrosine kinase inhibitor
5105799|NCT01190241|kinome profiling|kinome profiling
5105800|NCT01190241|Metastasized|metastasized
5105801|NCT01190228|Japanese Encephalitis|japanese encephalitis
5105802|NCT01190228|Japanese encephalitis chimeric virus vaccine|japanese encephalitis chimeric virus vaccine
5105803|NCT01190228|Varicella|varicella
5105804|NCT01190228|Varicella vaccine|varicella vaccine
5105805|NCT01190215|Influenza|influenza
5105806|NCT01190215|Pandemrix|pandemrix
5105807|NCT01190215|H1N1|h1n1
5105808|NCT01190215|Fluarix|fluarix
5105809|NCT01190202|Malaria|malaria
5105810|NCT01190202|Plasmodium falciparum|plasmodium falciparum
5105811|NCT01190189|Serious adverse events (SAEs)|serious adverse events (saes)
5105812|NCT01190189|HPV vaccine|hpv vaccine
5105813|NCT01190189|Medically significant conditions|medically significant conditions
5105814|NCT01190189|Cervical neoplasia|cervical neoplasia
5105815|NCT01190176|HPV|hpv
5105816|NCT01190176|HPV vaccine|hpv vaccine
5105817|NCT01190176|Cervical neoplasia|cervical neoplasia
5105818|NCT01190176|Human papillomavirus|human papillomavirus
5105819|NCT01190176|Papillomavirus|papillomavirus
5105820|NCT01190176|Cervical cancer|cervical cancer
5105821|NCT01190176|Human papillomavirus (HPV) type 16/18 infections|human papillomavirus (hpv) type 16/18 infections
5105822|NCT01190163|Vaginal Birth delivery within 24 hours and C-section rate|vaginal birth delivery within 24 hours and c-section rate
5105823|NCT01190150|Cyclic Heavy Menstrual Bleed|cyclic heavy menstrual bleed
5105824|NCT01190150|Menorraghia|menorraghia
5105825|NCT01190137|Optimal vitamin D status|optimal vitamin d status
5105826|NCT01190137|25-hydroxy vitamin D|25-hydroxy vitamin d
5105827|NCT01190137|Rickets and bone mineralization|rickets and bone mineralization
5105828|NCT01190137|Breast fed infants|breast fed infants
5105829|NCT01190137|Cholecalciferol and ergocalciferol|cholecalciferol and ergocalciferol
5105830|NCT01190124|HIV infections|hiv infections
5105831|NCT01190124|HIV-1|hiv-1
5105832|NCT01190124|HIV-2|hiv-2
5105833|NCT01190124|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5105834|NCT01190124|AIDS|aids
5105835|NCT01190124|Anti-Retroviral Agents|anti-retroviral agents
5105836|NCT01190124|Raltegravir|raltegravir
5105837|NCT01190124|Integrase Inhibitors|integrase inhibitors
5105838|NCT01190124|multiple-experienced HIV infected patients|multiple-experienced hiv infected patients
5106528|NCT01186965|Second Life|second life
5105839|NCT01190111|interleukin-7|interleukin-7
5105840|NCT01190111|immune-based therapy|immune-based therapy
5105841|NCT01190111|HIV|hiv
5105842|NCT01190111|viral disease|viral disease
5105843|NCT01190098|Partial epilepsy|partial epilepsy
5105844|NCT01190098|Excessive daytime sleepiness|excessive daytime sleepiness
5105845|NCT01190098|Epworth Sleepiness Scale|epworth sleepiness scale
5105846|NCT01190098|Maintenance of Wakefulness Test|maintenance of wakefulness test
5105847|NCT01190085|alcoholism|alcoholism
5105848|NCT01190085|ghrelin|ghrelin
5105849|NCT01190085|craving|craving
5105850|NCT01190072|Blood lipids|blood lipids
5105851|NCT01190072|percutaneous coronary intervention|percutaneous coronary intervention
5105852|NCT01190072|lipid lowering treatment|lipid lowering treatment
5105853|NCT01190059|Lung|lung
5105854|NCT01190059|Transplantation|transplantation
5105855|NCT01190059|Lung Transplantation|lung transplantation
5105856|NCT01190059|Transplantation Lung|transplantation lung
5105857|NCT01190046|elderly|elderly
5105858|NCT01190046|muscle|muscle
5105859|NCT01190046|disuse|disuse
5105860|NCT01190046|osteoarthritis|osteoarthritis
5105861|NCT01190046|exercise|exercise
5105862|NCT01189994|Fibromyalgia|fibromyalgia
5105863|NCT01189994|Acupuncture|acupuncture
5105864|NCT01189994|Randomized Controlled Trial|randomized controlled trial
5105865|NCT01189994|Pain|pain
5105866|NCT01189994|Quality of Life|quality of life
5105867|NCT01189968|Phase 1,|phase 1,
5105868|NCT01189968|dose escalation,|dose escalation,
5105869|NCT01189968|histologically|histologically
5105870|NCT01189968|confirmed|confirmed
5105871|NCT01189968|malignancy|malignancy
5105872|NCT01189968|metastatic|metastatic
5105873|NCT01189955|thyroidectomy|thyroidectomy
5105874|NCT01189955|harmonic|harmonic
5105876|NCT01189942|Phase 1|phase 1
5105877|NCT01189942|dose escalation|dose escalation
5105878|NCT01189942|histologically|histologically
5105879|NCT01189942|confirmed|confirmed
5105880|NCT01189942|malignancy|malignancy
5105881|NCT01189942|metastatic|metastatic
5105882|NCT01189929|Phase 1,|phase 1,
5105883|NCT01189929|dose escalation,|dose escalation,
5105884|NCT01189929|histologically|histologically
5105885|NCT01189929|cytologically|cytologically
5105886|NCT01189929|confirmed|confirmed
5105887|NCT01189929|malignancy|malignancy
5105888|NCT01189929|metastatic|metastatic
5105889|NCT01189890|Type 2 Diabetes Mellitus, Hemoglobin A1C, glucagon-like peptide 1 (GLP-1), gastric inhibitory polypeptide (GIP), dipeptidyl peptidase 4 inhibitor (DPP-4)|type 2 diabetes mellitus, hemoglobin a1c, glucagon-like peptide 1 (glp-1), gastric inhibitory polypeptide (gip), dipeptidyl peptidase 4 inhibitor (dpp-4)
5105890|NCT01189877|Direct pO2 Measurements|direct po2 measurements
5105891|NCT01189877|10-121|10-121
5105892|NCT01189851|breast|breast
5105893|NCT01189851|IORT|iort
5105894|NCT01189851|electronic brachytherapy|electronic brachytherapy
5105895|NCT01189838|Cancer|cancer
5105896|NCT01189838|cysteine-rich 61|cysteine-rich 61
5105897|NCT01189838|prognosis|prognosis
5105898|NCT01189838|transitional cell carcinoma|transitional cell carcinoma
5105899|NCT01189825|Physiological|physiological
5105900|NCT01189825|Antidepressive Agents|antidepressive agents
5105901|NCT01189812|hopelessness|hopelessness
5105902|NCT01189812|alone|alone
5105903|NCT01189812|sad|sad
5105904|NCT01189812|troubled|troubled
5105905|NCT01189812|depression|depression
5105906|NCT01189799|Co-occurring Disorders|co-occurring disorders
5105907|NCT01189799|Depression|depression
5105908|NCT01189799|Substance Dependence|substance dependence
5105909|NCT01189799|Motivational Therapy|motivational therapy
5105910|NCT01189799|Aftercare|aftercare
5105911|NCT01189799|Cognitive Behavioral Therapy|cognitive behavioral therapy
5105912|NCT01189786|Haploidentical Stem Cell Transplant|haploidentical stem cell transplant
5105913|NCT01189786|CD34+ Selection|cd34+ selection
5105914|NCT01189786|CliniMACS CD34 Reagent system|clinimacs cd34 reagent system
5105915|NCT01189773|pain control|pain control
5105916|NCT01189773|limb trauma|limb trauma
5105917|NCT01189734|common bile duct stones|common bile duct stones
5105918|NCT01189734|laparoscopic common bile duct exploration|laparoscopic common bile duct exploration
5105919|NCT01189734|intraoperative ercp|intraoperative ercp
5105920|NCT01189734|Preoperatively diagnosed common bile duct stones|preoperatively diagnosed common bile duct stones
5105921|NCT01189721|remifentanil|remifentanil
5105922|NCT01189721|hyperalgesia|hyperalgesia
5105923|NCT01189708|Abdominal aortic aneurysm|abdominal aortic aneurysm
5105924|NCT01189708|Abdominal hernia|abdominal hernia
5105925|NCT01189695|HIV or AIDS|hiv or aids
5105926|NCT01189695|Lopinavir|lopinavir
5105927|NCT01189695|Ritonavir|ritonavir
5105928|NCT01189695|Anti-Retroviral Agents|anti-retroviral agents
5105929|NCT01189695|treatment failure|treatment failure
5105930|NCT01189695|treatment experienced|treatment experienced
5105931|NCT01189695|NNRTI failure|nnrti failure
5105932|NCT01189695|monotherapy|monotherapy
5105933|NCT01189682|catheter|catheter
5105934|NCT01189682|dressing|dressing
5105935|NCT01189682|chlorhexidine|chlorhexidine
5105936|NCT01189682|Patient admitted in ICU with a CVC or art. catheter|patient admitted in icu with a cvc or art. catheter
5105937|NCT01189669|PCOS|pcos
5105938|NCT01189656|Chronic hepatitis B patients|chronic hepatitis b patients
5105939|NCT01189643|BEVACIZUMAB (AVASTIN)|bevacizumab (avastin)
5105940|NCT01189643|IRINOTECAN (CPT-11) CAMPTOSAR|irinotecan (cpt-11) camptosar
5105941|NCT01189643|TEMOZOLOMIDE|temozolomide
5105942|NCT01189643|DSRCT|dsrct
5105943|NCT01189643|10-091|10-091
5105944|NCT01189630|"Real World Electronic Database with clinical information"|"real world electronic database with clinical information"
5105945|NCT01189630|related to Implantable Cardiac devices.|related to implantable cardiac devices.
5105946|NCT01189617|Personal Lubricant|personal lubricant
5105947|NCT01189604|propofol endoscopy sedation|propofol endoscopy sedation
5105948|NCT01189578|Recreational|recreational
5105949|NCT01189578|cocaine|cocaine
5105950|NCT01189578|fMRI|fmri
5105951|NCT01189578|neuroimaging|neuroimaging
5105952|NCT01189578|craving|craving
5105953|NCT01189578|impulsivity|impulsivity
5105954|NCT01189565|Total Hip Replacement/Revision|total hip replacement/revision
5105955|NCT01189526|Branch retinal vein occlusion|branch retinal vein occlusion
5105956|NCT01189526|macular edema|macular edema
5105957|NCT01189526|intravitreal injection|intravitreal injection
5105958|NCT01189526|ranibizumab|ranibizumab
5105959|NCT01189513|Recurrent Glioblastoma|recurrent glioblastoma
5105960|NCT01189513|Gliosarcoma|gliosarcoma
5105961|NCT01189513|SCH 900105|sch 900105
5105962|NCT01189500|Pharmacokinetic|pharmacokinetic
5105963|NCT01189500|safety and tolerability|safety and tolerability
5105964|NCT01189500|genetic testing|genetic testing
5105965|NCT01189500|CYP 2D6|cyp 2d6
5105966|NCT01189487|ampicillin sodium/sulbactam sodium|ampicillin sodium/sulbactam sodium
5105967|NCT01189487|Unasyn-S|unasyn-s
5105968|NCT01189487|community acquired pneumonia|community acquired pneumonia
5105969|NCT01189487|bacterial pneumonia|bacterial pneumonia
5105970|NCT01189474|Meibomian Gland Dysfunction|meibomian gland dysfunction
5105971|NCT01189461|pegaptanib sodium|pegaptanib sodium
5105972|NCT01189461|diabetic macular edema|diabetic macular edema
5105973|NCT01189448|Congenital Toxoplasmosis,|congenital toxoplasmosis,
5105974|NCT01189448|Pregnancy,|pregnancy,
5105975|NCT01189448|prenatal diagnosis,|prenatal diagnosis,
5105976|NCT01189448|mother-to-child transmission,|mother-to-child transmission,
5105977|NCT01189448|prevention,|prevention,
5105978|NCT01189448|spiramycine,|spiramycine,
5105979|NCT01189448|pyrimethamine-sulfadiazine|pyrimethamine-sulfadiazine
5105980|NCT01189435|OSI-774, TARCEVA (ERLOTINIB)|osi-774, tarceva (erlotinib)
5105981|NCT01189435|Lung|lung
5105982|NCT01189435|recurrent|recurrent
5105983|NCT01189435|10-097|10-097
5105984|NCT01189435|Gefitinib|gefitinib
5105985|NCT01189422|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
5105986|NCT01189422|T1DM|t1dm
5105987|NCT01189409|Constipation|constipation
5105988|NCT01189409|Opioids|opioids
5105989|NCT01189409|Cancer|cancer
5105990|NCT01189409|Polyethylene glycol|polyethylene glycol
5105991|NCT01189409|Sennosides|sennosides
5105992|NCT01189409|Opioid Therapy|opioid therapy
5105994|NCT01189396|bronchospasm|bronchospasm
5105995|NCT01189396|COPD|copd
5105996|NCT01189396|reversibility|reversibility
5105997|NCT01189396|efficacy|efficacy
5105998|NCT01189383|Melanoma|melanoma
5105999|NCT01189383|Vaccine|vaccine
5106000|NCT01189383|Dendritic Cell|dendritic cell
5106001|NCT01189383|Immune response|immune response
5106002|NCT01189383|Safety|safety
5106003|NCT01189383|Efficacy|efficacy
5106004|NCT01189370|carcinoma, renal cell|carcinoma, renal cell
5106005|NCT01189370|kidney|kidney
5106006|NCT01189370|cancer|cancer
5106007|NCT01189357|meniscal transplant|meniscal transplant
5106008|NCT01189344|Obesity|obesity
5106009|NCT01189344|LT4|lt4
5106010|NCT01189344|Absorption|absorption
5106011|NCT01189344|Thyroid function|thyroid function
5106012|NCT01189331|Coronary artery disease|coronary artery disease
5106013|NCT01189331|CT|ct
5106014|NCT01189331|Computational flow dynamics|computational flow dynamics
5106015|NCT01189305|Drug Abuse|drug abuse
5106016|NCT01189305|Female Patients|female patients
5106017|NCT01189292|postoperative nausea and vomitus|postoperative nausea and vomitus
5106018|NCT01189292|PONV|ponv
5106019|NCT01189292|thyroid surgery|thyroid surgery
5106020|NCT01189253|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
5106021|NCT01189253|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
5106022|NCT01189253|adult alveolar soft-part sarcoma|adult alveolar soft-part sarcoma
5106023|NCT01189253|adult angiosarcoma|adult angiosarcoma
5106024|NCT01189253|adult desmoplastic small round cell tumor|adult desmoplastic small round cell tumor
5106025|NCT01189253|adult epithelioid sarcoma|adult epithelioid sarcoma
5106026|NCT01189253|adult extraskeletal chondrosarcoma|adult extraskeletal chondrosarcoma
5106027|NCT01189253|adult extraskeletal osteosarcoma|adult extraskeletal osteosarcoma
5106028|NCT01189253|adult fibrosarcoma|adult fibrosarcoma
5106029|NCT01189253|adult leiomyosarcoma|adult leiomyosarcoma
5106030|NCT01189253|adult malignant fibrous histiocytoma|adult malignant fibrous histiocytoma
5106031|NCT01189253|adult malignant hemangiopericytoma|adult malignant hemangiopericytoma
5106032|NCT01189253|adult malignant mesenchymoma|adult malignant mesenchymoma
5106033|NCT01189253|adult neurofibrosarcoma|adult neurofibrosarcoma
5106034|NCT01189253|adult synovial sarcoma|adult synovial sarcoma
5106035|NCT01189227|stage IV colon cancer|stage iv colon cancer
5106036|NCT01189227|adenocarcinoma of the colon|adenocarcinoma of the colon
5106037|NCT01189227|stage IV rectal cancer|stage iv rectal cancer
5106038|NCT01189227|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5106039|NCT01189227|liver metastases|liver metastases
5106040|NCT01189162|Primary treatment of RDS and treatment of RDS post extubation|primary treatment of rds and treatment of rds post extubation
5106041|NCT01189136|Voiding dysfunction|voiding dysfunction
5106042|NCT01189123|influenza|influenza
5106043|NCT01189123|vaccine|vaccine
5106044|NCT01189123|cell mediated immunity|cell mediated immunity
5106045|NCT01189123|elderly|elderly
5106046|NCT01189123|high dose influenza vaccine|high dose influenza vaccine
5106047|NCT01189110|smoking cessation|smoking cessation
5106048|NCT01189110|veterans|veterans
5106049|NCT01189110|auriculotherapy|auriculotherapy
5106050|NCT01189084|Alzheimer's disease|alzheimer's disease
5106051|NCT01189084|amyloid beta|amyloid beta
5106052|NCT01189084|vaccine|vaccine
5106053|NCT01189071|Stents [E07.695.750]|stents [e07.695.750]
5106054|NCT01189071|Darifenacin (C101207)|darifenacin (c101207)
5106055|NCT01189071|Kidney calculi|kidney calculi
5106056|NCT01189058|Perinatal stroke|perinatal stroke
5106057|NCT01189058|Periventricular venous infarction|periventricular venous infarction
5106058|NCT01189058|Presumed perinatal stroke|presumed perinatal stroke
5106059|NCT01189058|Neonatal stroke|neonatal stroke
5106060|NCT01189058|Arterial ischemic stroke|arterial ischemic stroke
5106061|NCT01189058|Fetal stroke|fetal stroke
5106062|NCT01189058|Transcranial magnetic stimulation|transcranial magnetic stimulation
5106063|NCT01189058|Constraint-induced movement therapy|constraint-induced movement therapy
5106064|NCT01189058|CIMT|cimt
5106065|NCT01189058|Cerebral palsy|cerebral palsy
5106066|NCT01189058|Congenital hemiplegia|congenital hemiplegia
5106067|NCT01189058|Hemiplegic cerebral palsy|hemiplegic cerebral palsy
5106068|NCT01189058|Neuroplasticity|neuroplasticity
5106069|NCT01189058|Developmental plasticity|developmental plasticity
5106070|NCT01189045|Stroke|stroke
5106071|NCT01189045|Exercise|exercise
5106072|NCT01189045|Rehabilitation|rehabilitation
5106073|NCT01189045|Risk factors|risk factors
5106074|NCT01189019|ranibizumab|ranibizumab
5106075|NCT01189019|Wet macular degeneration|wet macular degeneration
5106076|NCT01189019|macular degeneration|macular degeneration
5106077|NCT01189019|PED|ped
5106078|NCT01189019|Retinal Pigment Epithelial Detachment|retinal pigment epithelial detachment
5106079|NCT01188967|Drugs, Investigational|drugs, investigational
5106080|NCT01188967|Nicotine Dependence|nicotine dependence
5106081|NCT01188967|Therapies for Relapse to Nicotine|therapies for relapse to nicotine
5106082|NCT01188967|Relapse Prevention|relapse prevention
5106083|NCT01188967|Smoking Cessation|smoking cessation
5106084|NCT01188967|Nicotine Cessation Therapies|nicotine cessation therapies
5106085|NCT01188954|Seroma|seroma
5106086|NCT01188954|Doxycycline|doxycycline
5106087|NCT01188954|Cardiopulmonary By-Pass|cardiopulmonary by-pass
5106088|NCT01188954|Femoral Artery/Vein Cannulation|femoral artery/vein cannulation
5106089|NCT01188954|Prevent Seroma Formation|prevent seroma formation
5106090|NCT01188915|Hodgkin disease|hodgkin disease
5106091|NCT01188915|Breast cancer|breast cancer
5106092|NCT01188889|Chronic Myeloid Leukemia|chronic myeloid leukemia
5106093|NCT01188876|carboplatin|carboplatin
5106094|NCT01188876|recurrent|recurrent
5106095|NCT01188876|platinum sensitive|platinum sensitive
5106096|NCT01188876|pralatrexate|pralatrexate
5106097|NCT01188850|CIN 2 or 3|cin 2 or 3
5106098|NCT01188850|cervical cancer|cervical cancer
5106099|NCT01188850|Human Papillomavirus (HPV)|human papillomavirus (hpv)
5106100|NCT01188837|Osteoarthritis, Knee|osteoarthritis, knee
5106101|NCT01188837|Manipulation Therapy|manipulation therapy
5106102|NCT01188811|Multiple Sclerosis|multiple sclerosis
5106103|NCT01188811|Multiple sclerosis, chronic progressive|multiple sclerosis, chronic progressive
5106104|NCT01188811|Neuroprotective agents|neuroprotective agents
5106105|NCT01188811|Magnetic resonance imaging|magnetic resonance imaging
5106106|NCT01188811|Optical coherence tomography|optical coherence tomography
5106107|NCT01188811|Gait|gait
5106108|NCT01188811|Thioctic acid|thioctic acid
5106109|NCT01188811|Alpha-lipoic acid|alpha-lipoic acid
5106110|NCT01188798|Allogeneic Bone Marrow Transplantation|allogeneic bone marrow transplantation
5106111|NCT01188798|Graft versus host disease|graft versus host disease
5106112|NCT01188798|Tacrolimus|tacrolimus
5106113|NCT01188798|Sirolimus|sirolimus
5106114|NCT01188798|Methotrexate|methotrexate
5106115|NCT01188798|Pentostatin|pentostatin
5106116|NCT01188785|siRNA|sirna
5106117|NCT01188785|RNA interference (RNAi)|rna interference (rnai)
5106118|NCT01188785|Cancer|cancer
5106119|NCT01188785|Pancreatic ductal adenocarcinoma|pancreatic ductal adenocarcinoma
5106120|NCT01188785|Pancreatic cancer|pancreatic cancer
5106121|NCT01188785|Solid tumor|solid tumor
5106122|NCT01188785|Operable pancreatic ductal adenocarcinoma|operable pancreatic ductal adenocarcinoma
5106123|NCT01188785|Non operable pancreatic ductal adenocarcinoma|non operable pancreatic ductal adenocarcinoma
5106124|NCT01188772|Hepatitis C Virus|hepatitis c virus
5106125|NCT01188772|HCV|hcv
5106126|NCT01188772|hepatitis|hepatitis
5106127|NCT01188772|Genotype 1|genotype 1
5106128|NCT01188772|Genotype 2|genotype 2
5106129|NCT01188772|Genotype 3|genotype 3
5106130|NCT01188759|Aspergillosis|aspergillosis
5106131|NCT01188759|Combination Therapy|combination therapy
5106132|NCT01188759|Voriconazole|voriconazole
5106133|NCT01188759|Anidulafungin|anidulafungin
5106134|NCT01188746|catheter|catheter
5106135|NCT01188746|palliative|palliative
5106136|NCT01188746|quality of life|quality of life
5106137|NCT01188746|10-059|10-059
5106138|NCT01188733|portal hypertension|portal hypertension
5106139|NCT01188733|varices|varices
5106140|NCT01188733|cirrhosis|cirrhosis
5106141|NCT01188733|octreotide|octreotide
5106142|NCT01188733|somatostatin analog|somatostatin analog
5106143|NCT01188733|Child Pugh Class A,B|child pugh class a,b
5106144|NCT01188707|Non small cell lung cancer|non small cell lung cancer
5106145|NCT01188707|Belinostat|belinostat
5106146|NCT01188707|Erlotinib|erlotinib
5106147|NCT01188707|HDAC inhibitor|hdac inhibitor
5106148|NCT01188707|Phase I/II|phase i/ii
5106149|NCT01188681|CLL|cll
5106150|NCT01188681|TRU-016|tru-016
5106151|NCT01188681|chronic lymphocytic leukemia|chronic lymphocytic leukemia
5106152|NCT01188681|relapsed CLL|relapsed cll
5106153|NCT01188681|bendamustine|bendamustine
5106154|NCT01188668|Pharmacokinetic|pharmacokinetic
5106155|NCT01188668|safety and tolerability|safety and tolerability
5106156|NCT01188668|genetic testing|genetic testing
5106157|NCT01188668|CYP 2D6 and CYP 3A4|cyp 2d6 and cyp 3a4
5106158|NCT01188655|Ankylosing Spondylitis|ankylosing spondylitis
5106159|NCT01188642|childhood obesity|childhood obesity
5106160|NCT01188642|adipocytokines|adipocytokines
5106161|NCT01188642|physical exercise|physical exercise
5106162|NCT01188642|nutrition education|nutrition education
5106163|NCT01188629|Preventive Care|preventive care
5106164|NCT01188629|Medication Management|medication management
5106165|NCT01188629|Electronic Medical Records|electronic medical records
5106166|NCT01188629|Automated Telephone System|automated telephone system
5106167|NCT01188616|Childhood Obesity|childhood obesity
5106168|NCT01188616|Obesity Intervention|obesity intervention
5106169|NCT01188590|Post operative Respiratory insufficiency|post operative respiratory insufficiency
5106170|NCT01188577|asthma|asthma
5106171|NCT01188577|bronchospasm|bronchospasm
5106172|NCT01188577|wheezing|wheezing
5106173|NCT01188577|shortness of breath|shortness of breath
5106174|NCT01188564|Hereditary Angioedema|hereditary angioedema
5106175|NCT01188564|HAE|hae
5106176|NCT01188564|Angioedema|angioedema
5106177|NCT01188564|Recombinant C1 Inhibitor|recombinant c1 inhibitor
5106178|NCT01188564|rhC1INH|rhc1inh
5106179|NCT01188551|myringotomy|myringotomy
5106180|NCT01188551|pressure equalization tubes|pressure equalization tubes
5106181|NCT01188538|P. acnes, Acne vulgaris|p. acnes, acne vulgaris
5106182|NCT01188525|pharmacokinetics|pharmacokinetics
5106183|NCT01188525|enzymes|enzymes
5106184|NCT01188525|metabolism prediction|metabolism prediction
5106185|NCT01188512|Live nasal vaccine for prevention of pertussis|live nasal vaccine for prevention of pertussis
5106186|NCT01188473|Status Asthmaticus|status asthmaticus
5106187|NCT01188473|Noninvasive Positive Pressure Ventilation|noninvasive positive pressure ventilation
5106188|NCT01188473|Asthma in Children|asthma in children
5106189|NCT01188460|Insomnia|insomnia
5106190|NCT01188460|Chronic pain|chronic pain
5106191|NCT01188447|cervical-spine injuries|cervical-spine injuries
5106192|NCT01188447|cervical-spine fractures|cervical-spine fractures
5106193|NCT01188447|spinal cord injury|spinal cord injury
5106194|NCT01188447|neck injury|neck injury
5106195|NCT01188447|Canadian C-Spine Rule|canadian c-spine rule
5106196|NCT01188447|paramedics|paramedics
5106197|NCT01188447|emergency medical services|emergency medical services
5106198|NCT01188434|Methamphetamine|methamphetamine
5106199|NCT01188434|Substance Abuse|substance abuse
5106200|NCT01188434|Child Neglect|child neglect
5106201|NCT01188434|Child Welfare|child welfare
5106202|NCT01188434|Evidence Based Practice|evidence based practice
5106203|NCT01188382|Intracranial pressure|intracranial pressure
5106204|NCT01188382|resistance|resistance
5106205|NCT01188382|CSF outflow|csf outflow
5106206|NCT01188382|elderly|elderly
5106207|NCT01188382|reference value|reference value
5106208|NCT01188369|levosimendan|levosimendan
5106209|NCT01188369|heart failure|heart failure
5106210|NCT01188369|inotropics|inotropics
5106211|NCT01188369|diastolic dysfunction|diastolic dysfunction
5106212|NCT01188369|left ventricular hypertrophy|left ventricular hypertrophy
5106213|NCT01188369|aortic valve stenosis|aortic valve stenosis
5106214|NCT01188356|Reply|reply
5106215|NCT01188356|Symphony|symphony
5106216|NCT01188356|Atrial arrhythmias|atrial arrhythmias
5106217|NCT01188356|V pacing|v pacing
5106218|NCT01188356|Evaluate the incidence and evolution over-time of co-morbidities|evaluate the incidence and evolution over-time of co-morbidities
5106219|NCT01188343|Japanese Encephalitis|japanese encephalitis
5106220|NCT01188343|Japanese encephalitis chimeric virus vaccine|japanese encephalitis chimeric virus vaccine
5106221|NCT01188343|Measles|measles
5106222|NCT01188343|Mumps|mumps
5106223|NCT01188343|Rubella|rubella
5106224|NCT01188330|acute myeloid leukemia|acute myeloid leukemia
5106225|NCT01188291|Optical Coherence Tomography|optical coherence tomography
5106226|NCT01188291|Retinal Nerve Fiber Layer Thickness|retinal nerve fiber layer thickness
5106227|NCT01188291|Obstructive Sleep Apnea|obstructive sleep apnea
5106228|NCT01188291|Hypopnea syndrome|hypopnea syndrome
5106229|NCT01188291|Glaucoma|glaucoma
5106230|NCT01188252|Phase I|phase i
5106231|NCT01188252|Dose escalation|dose escalation
5106232|NCT01188252|Kinase inhibitor|kinase inhibitor
5106233|NCT01188252|Cyclin-dependent kinases|cyclin-dependent kinases
5106234|NCT01188239|electronic cigarette|electronic cigarette
5106235|NCT01188239|nicotine|nicotine
5106236|NCT01188239|smoking cessation|smoking cessation
5106237|NCT01188239|smoking reduction|smoking reduction
5106238|NCT01188187|custirsen sodium|custirsen sodium
5106239|NCT01188187|prostate cancer|prostate cancer
5106240|NCT01188187|overall survival|overall survival
5106241|NCT01188187|Metastatic Castrate Resistant Prostate Cancer|metastatic castrate resistant prostate cancer
5106242|NCT01188174|AML|aml
5106243|NCT01188174|primary induction failure|primary induction failure
5106244|NCT01188161|Posturography|posturography
5106245|NCT01188161|Balance|balance
5106246|NCT01188161|Falls|falls
5106247|NCT01188161|Gyroscope|gyroscope
5106248|NCT01188161|Rotational Chair|rotational chair
5106249|NCT01188161|Vestibular|vestibular
5106250|NCT01188161|Movement Disorders|movement disorders
5106251|NCT01188135|depression|depression
5106252|NCT01188135|interactive voice messaging|interactive voice messaging
5106253|NCT01188135|patient persistence with antidepressant medication treatment|patient persistence with antidepressant medication treatment
5106254|NCT01188122|VAP|vap
5106255|NCT01188109|Pancreatic Neoplasms|pancreatic neoplasms
5106256|NCT01188109|Pancreatic cancer|pancreatic cancer
5106257|NCT01188096|glioma|glioma
5106258|NCT01188096|pediatrics|pediatrics
5106259|NCT01188096|cancer|cancer
5106260|NCT01188096|brain tumor|brain tumor
5106261|NCT01188096|low grade glioma|low grade glioma
5106262|NCT01188083|NASH|nash
5106263|NCT01188083|non-alcoholic fatty-liver disease|non-alcoholic fatty-liver disease
5106264|NCT01188083|Hispanic|hispanic
5106265|NCT01188083|overweight|overweight
5106266|NCT01188070|Behavioral/Social|behavioral/social
5106267|NCT01188070|Cardiology|cardiology
5106268|NCT01188070|Clinical Laboratory Methods|clinical laboratory methods
5106269|NCT01188070|Congestive Heart Failure|congestive heart failure
5106270|NCT01188070|Heart Disease|heart disease
5106271|NCT01188070|Knowledge Dissemination|knowledge dissemination
5106272|NCT01188070|Lipids|lipids
5106273|NCT01188070|Nursing|nursing
5106274|NCT01188070|Health Promotion|health promotion
5106275|NCT01188070|Alzheimer's Disease/Dementia|alzheimer's disease/dementia
5106276|NCT01188057|Bioequivalence|bioequivalence
5106277|NCT01188057|ALPRAZOLAM|alprazolam
5106278|NCT01188057|Healthy subjects|healthy subjects
5106279|NCT01188044|Motor activity|motor activity
5106280|NCT01188044|Infant|infant
5106281|NCT01188044|Validation studies|validation studies
5106282|NCT01188044|Malawi|malawi
5106283|NCT01188044|Sub-Saharan Africa|sub-saharan africa
5106284|NCT01188031|Bioequivalence|bioequivalence
5106285|NCT01188031|ALPRAZOLAM|alprazolam
5106286|NCT01188031|Healthy subjects|healthy subjects
5106287|NCT01188018|Smoking|smoking
5106288|NCT01188018|Smoking Cessation|smoking cessation
5106289|NCT01188018|Nicotine Dependence|nicotine dependence
5106290|NCT01188018|Tobacco Use Cessation|tobacco use cessation
5106291|NCT01188018|Health Education|health education
5106292|NCT01188018|Patient Education|patient education
5106293|NCT01188005|OSAS|osas
5106294|NCT01188005|Sleep Apnoea|sleep apnoea
5106295|NCT01188005|IL6|il6
5106296|NCT01188005|TNFα|tnfα
5106297|NCT01188005|Oxidative Stress|oxidative stress
5106298|NCT01188005|Antioxidants|antioxidants
5106299|NCT01187992|Atorvastatin|atorvastatin
5106300|NCT01187992|Acute coronary syndrome|acute coronary syndrome
5106301|NCT01187992|Advanced coronary artery disease|advanced coronary artery disease
5106302|NCT01187979|Cash incentive|cash incentive
5106303|NCT01187979|HIV prevention|hiv prevention
5106304|NCT01187979|Adolescents|adolescents
5106305|NCT01187979|South Africa|south africa
5106306|NCT01187979|HIV|hiv
5106307|NCT01187966|Parkinson's Disease|parkinson's disease
5106308|NCT01187966|PD|pd
5106309|NCT01187966|Levodopa|levodopa
5106310|NCT01187966|Patients with idiopathic Parkinson's disease with motor fluctuations|patients with idiopathic parkinson's disease with motor fluctuations
5106311|NCT01187953|Tacrolimus|tacrolimus
5106312|NCT01187953|Acute Rejection|acute rejection
5106313|NCT01187953|Kidney|kidney
5106314|NCT01187940|Autism Spectrum Disorder;|autism spectrum disorder;
5106315|NCT01187940|Psychoeducation|psychoeducation
5106316|NCT01187914|Paroxysmal Atrial Fibrillation|paroxysmal atrial fibrillation
5106317|NCT01187914|Radio-frequency Ablation|radio-frequency ablation
5106318|NCT01187914|Ablation|ablation
5106319|NCT01187914|Open irrigation cooled-tip|open irrigation cooled-tip
5106320|NCT01187901|Familial Adenomatous Polyposis|familial adenomatous polyposis
5106321|NCT01187901|Attenuated Familial Polyposis|attenuated familial polyposis
5106322|NCT01187888|PSP|psp
5106323|NCT01187888|Progressive Supranuclear Palsy|progressive supranuclear palsy
5106324|NCT01187888|Rasagiline|rasagiline
5106325|NCT01187888|Azilect|azilect
5106326|NCT01187888|PROSPERA|prospera
5106327|NCT01187875|satiety, dietary fiber|satiety, dietary fiber
5106328|NCT01187823|Chronic heart failure|chronic heart failure
5106329|NCT01187823|Central sleep apnea|central sleep apnea
5106330|NCT01187823|Obstructive sleep apnea|obstructive sleep apnea
5106331|NCT01187823|Adaptive servo ventilation|adaptive servo ventilation
5106332|NCT01187810|leukemia,lymphoma|leukemia,lymphoma
5106333|NCT01187758|antibiotic use|antibiotic use
5106334|NCT01187758|antibiotic prescription|antibiotic prescription
5106335|NCT01187758|antibiotic resistant S. pneumoniae|antibiotic resistant s. pneumoniae
5106336|NCT01187758|MRSA|mrsa
5106337|NCT01187745|renal calculi|renal calculi
5106338|NCT01187732|skin damage|skin damage
5106339|NCT01187732|intertrigo|intertrigo
5106340|NCT01187732|dermatitis|dermatitis
5106341|NCT01187732|erythema|erythema
5106342|NCT01187732|aggression|aggression
5106343|NCT01187732|body Wipes|body wipes
5106344|NCT01187732|soaps|soaps
5106345|NCT01187732|no rinse|no rinse
5106346|NCT01187732|cost effectiveness|cost effectiveness
5106347|NCT01187732|nursing home residents|nursing home residents
5106348|NCT01187732|nurse|nurse
5106349|NCT01187719|HIV|hiv
5106350|NCT01187719|pregnancy|pregnancy
5106351|NCT01187719|phenytoin|phenytoin
5106352|NCT01187719|ARV prophylaxis|arv prophylaxis
5106353|NCT01187719|nevirapine|nevirapine
5106354|NCT01187706|gynecological cancer survivors|gynecological cancer survivors
5106355|NCT01187706|quality of life|quality of life
5106356|NCT01187680|Tissue adhesions|tissue adhesions
5106357|NCT01187680|Laparoscopy|laparoscopy
5106358|NCT01187667|delirium|delirium
5106359|NCT01187667|prevention|prevention
5106360|NCT01187667|critical care|critical care
5106361|NCT01187667|haloperidol|haloperidol
5106362|NCT01187654|myocardial infarction|myocardial infarction
5106363|NCT01187654|bone marrow stem cell|bone marrow stem cell
5106364|NCT01187654|AC133|ac133
5106365|NCT01187654|mono nuclear cell|mono nuclear cell
5106366|NCT01187641|cancer, colon, MRI scan|cancer, colon, mri scan
5106367|NCT01187628|Long-term study in Chronic Kidney Disease|long-term study in chronic kidney disease
5106368|NCT01187628|Lanthanum Carbonate|lanthanum carbonate
5106369|NCT01187615|Nonsquamous Non-small cell lung cancer|nonsquamous non-small cell lung cancer
5106370|NCT01187615|Phase I|phase i
5106371|NCT01187576|Physical activity|physical activity
5106372|NCT01187576|Hypertension|hypertension
5106373|NCT01187576|Diabetes mellitus|diabetes mellitus
5106374|NCT01187576|Motivational interviewing|motivational interviewing
5106375|NCT01187563|Rheumatoid arthritis, tocilizumab|rheumatoid arthritis, tocilizumab
5106376|NCT01187550|Dwarfism, pituitary|dwarfism, pituitary
5106377|NCT01187550|Growth hormone|growth hormone
5106378|NCT01187537|Knee Replacement|knee replacement
5106379|NCT01187537|Analgesia|analgesia
5106380|NCT01187537|Analgesics|analgesics
5106381|NCT01187537|Nerve blocks|nerve blocks
5106382|NCT01187537|Recovery of functions|recovery of functions
5106383|NCT01187537|Post operative analgesia|post operative analgesia
5106384|NCT01187524|Patient Registry|patient registry
5106385|NCT01187524|FMR1 Gene|fmr1 gene
5106386|NCT01187524|Fragile X Syndrome|fragile x syndrome
5106387|NCT01187524|Primary Ovarian Insufficiency|primary ovarian insufficiency
5106388|NCT01187524|Premature Ovarian Failure|premature ovarian failure
5106389|NCT01187524|Premature Ovarian Insufficiency|premature ovarian insufficiency
5106390|NCT01187511|Addiction|addiction
5106391|NCT01187511|Alcohol Dependence|alcohol dependence
5106392|NCT01187511|Anxiety|anxiety
5106393|NCT01187511|CRH Antagonist|crh antagonist
5106394|NCT01187511|Stress Induced Craving|stress induced craving
5106395|NCT01187498|Overactive bladder|overactive bladder
5106396|NCT01187498|Behavioral treatment|behavioral treatment
5106397|NCT01187498|Drug therapy|drug therapy
5106398|NCT01187498|Lower urinary tract symptoms|lower urinary tract symptoms
5106399|NCT01187498|Urinary incontinence|urinary incontinence
5106400|NCT01187498|Clinical trial|clinical trial
5106401|NCT01187485|Androderm®|androderm®
5106402|NCT01187485|Testosterone|testosterone
5106403|NCT01187485|refractory|refractory
5106404|NCT01187485|prostate|prostate
5106405|NCT01187485|cancer|cancer
5106406|NCT01187485|"Patients with hormone refractory prostate cancer will be treated with a daily testosterone patch Androderm® applied every 24 hours to the skin"|"patients with hormone refractory prostate cancer will be treated with a daily testosterone patch androderm® applied every 24 hours to the skin"
5106407|NCT01187472|Head|head
5106408|NCT01187472|neck|neck
5106409|NCT01187472|cancer|cancer
5106410|NCT01187472|advanced|advanced
5106411|NCT01187472|oral cavity|oral cavity
5106412|NCT01187472|lip|lip
5106413|NCT01187472|larynx|larynx
5106414|NCT01187459|Vitamin D|vitamin d
5106415|NCT01187459|Crohn's Disease|crohn's disease
5106416|NCT01187459|Dose Response|dose response
5106417|NCT01187446|Cutaneous T-cell Lymphoma|cutaneous t-cell lymphoma
5106418|NCT01187433|Dengue|dengue
5106419|NCT01187433|Dengue hemorrhagic fever|dengue hemorrhagic fever
5106420|NCT01187433|CYD Dengue Vaccines|cyd dengue vaccines
5106421|NCT01187420|Cerebral vasospasm|cerebral vasospasm
5106422|NCT01187420|delayed cerebral ischemia (DCI)|delayed cerebral ischemia (dci)
5106423|NCT01187420|subarachnoid hemorrhage (SAH) patients|subarachnoid hemorrhage (sah) patients
5106424|NCT01187394|Frozen Plasma|frozen plasma
5106425|NCT01187394|Fresh Frozen Plasma|fresh frozen plasma
5106426|NCT01187394|Cardiac Surgery|cardiac surgery
5106427|NCT01187394|Bleeding|bleeding
5106428|NCT01187394|Knowledge Translation|knowledge translation
5106429|NCT01187368|heart failure|heart failure
5106430|NCT01187368|LVAS|lvas
5106431|NCT01187368|LVAD|lvad
5106432|NCT01187368|bridge-to-transplant|bridge-to-transplant
5106433|NCT01187368|rotary pump|rotary pump
5106434|NCT01187355|Symptomatic, Contact lens care|symptomatic, contact lens care
5106435|NCT01187355|Multi-purpose solution|multi-purpose solution
5106436|NCT01187342|Stroke|stroke
5106437|NCT01187329|Hyperglycemia|hyperglycemia
5106438|NCT01187329|open heart surgery|open heart surgery
5106439|NCT01187329|bypass|bypass
5106440|NCT01187316|Facial Pain|facial pain
5106441|NCT01187316|Temporomandibular Joint Disorders|temporomandibular joint disorders
5106442|NCT01187316|Transcutaneous Electric Nerve Stimulation|transcutaneous electric nerve stimulation
5106443|NCT01187316|Adolescent|adolescent
5106444|NCT01187290|Preoperative chemoradiotherapy|preoperative chemoradiotherapy
5106445|NCT01187290|stage IIIA, N2|stage iiia, n2
5106446|NCT01187277|stroke|stroke
5106447|NCT01187277|rehabilitation|rehabilitation
5106448|NCT01187277|gait training|gait training
5106449|NCT01187277|robot-assisted therapy|robot-assisted therapy
5106450|NCT01187251|tinnitus|tinnitus
5106451|NCT01187251|mp3 players|mp3 players
5106452|NCT01187251|noise induced hearing loss|noise induced hearing loss
5106453|NCT01187251|high frequencies audiometry|high frequencies audiometry
5106454|NCT01187251|acoustic otoemissions|acoustic otoemissions
5106455|NCT01187238|Nasopharyngeal carcinoma|nasopharyngeal carcinoma
5106456|NCT01187238|Stage II|stage ii
5106457|NCT01187238|Intensity-modulated radiotherapy|intensity-modulated radiotherapy
5106458|NCT01187238|Concurrent chemoradiotherapy|concurrent chemoradiotherapy
5106459|NCT01187238|Cisplatin|cisplatin
5106460|NCT01187225|Cardiac surgical procedures|cardiac surgical procedures
5106461|NCT01187225|Fibrinogen|fibrinogen
5106462|NCT01187225|Bleeding|bleeding
5106463|NCT01187225|Cryoprecipitate|cryoprecipitate
5106464|NCT01187212|First line chemotherapy in advanced gastric cancer|first line chemotherapy in advanced gastric cancer
5106465|NCT01187199|Metastatic cancer|metastatic cancer
5106466|NCT01187199|Chemotherapy|chemotherapy
5106467|NCT01187199|Avastin|avastin
5106468|NCT01187199|Carboplatin|carboplatin
5106469|NCT01187199|Paclitaxel|paclitaxel
5106470|NCT01187199|Sorafenib|sorafenib
5106471|NCT01187199|Temsirolimus|temsirolimus
5106472|NCT01187186|Liver disease|liver disease
5106473|NCT01187186|ASP1941|asp1941
5106474|NCT01187160|Obstructive sleep apnea|obstructive sleep apnea
5106475|NCT01187147|Asthma, green tea, antioxidants|asthma, green tea, antioxidants
5106476|NCT01187134|sepsis|sepsis
5106477|NCT01187134|shock, septic|shock, septic
5106478|NCT01187134|quality assurance, health care|quality assurance, health care
5106479|NCT01187134|quality control|quality control
5106480|NCT01187134|Survival Rate|survival rate
5106481|NCT01187134|Follow-Up Studies|follow-up studies
5106482|NCT01187134|Anti-Infective Agents/*therapeutic use|anti-infective agents/*therapeutic use
5106483|NCT01187121|Graduated Sanctions|graduated sanctions
5106484|NCT01187121|Probationary failure|probationary failure
5106485|NCT01187121|recidivism|recidivism
5106486|NCT01187121|drug relapse|drug relapse
5106487|NCT01187121|criminal justice|criminal justice
5106488|NCT01187108|Cobalt|cobalt
5106489|NCT01187108|Excessive Erythrocytosis|excessive erythrocytosis
5106490|NCT01187108|Monge's Disease|monge's disease
5106491|NCT01187108|Acetazolamide|acetazolamide
5106492|NCT01187108|N-acetylcysteine|n-acetylcysteine
5106493|NCT01187108|Altitude Sickness|altitude sickness
5106494|NCT01187108|Chronic Mountain Sickness|chronic mountain sickness
5106495|NCT01187095|Involuntary childlessness|involuntary childlessness
5106496|NCT01187095|Infertility|infertility
5106497|NCT01187095|IVF|ivf
5106498|NCT01187095|EWI|ewi
5106499|NCT01187095|Couples in IVF treatment|couples in ivf treatment
5106500|NCT01187095|Psychosocial intervention|psychosocial intervention
5106501|NCT01187082|overactive bladder|overactive bladder
5106502|NCT01187082|women|women
5106503|NCT01187082|bladder training|bladder training
5106504|NCT01187082|groups|groups
5106505|NCT01187069|Motivation|motivation
5106506|NCT01187069|patients with type 2 diabetes|patients with type 2 diabetes
5106507|NCT01187069|practice nurses|practice nurses
5106508|NCT01187069|general practice|general practice
5106509|NCT01187069|Self-determination Theory|self-determination theory
5106510|NCT01187056|Shared decision-making|shared decision-making
5106511|NCT01187056|Risk information|risk information
5106512|NCT01187056|Decision aids|decision aids
5106513|NCT01187043|Liver Function|liver function
5106514|NCT01187043|Steady State Exposure|steady state exposure
5106515|NCT01187030|Frozen Plasma|frozen plasma
5106516|NCT01187030|Fresh Frozen Plasma|fresh frozen plasma
5106517|NCT01187030|Prothrombin Complex Concentrates|prothrombin complex concentrates
5106518|NCT01187030|RAND UCLA|rand ucla
5106519|NCT01187030|Modified Delphi Methodology|modified delphi methodology
5106520|NCT01187030|Expert Panel|expert panel
5106521|NCT01187030|Appropriateness Rating|appropriateness rating
5106522|NCT01187017|Severe Aplastic Anemia|severe aplastic anemia
5106523|NCT01187017|Aplastic Anemia|aplastic anemia
5106524|NCT01187017|Immunosuppression|immunosuppression
5106525|NCT01187017|Immunosuppressive Therapy|immunosuppressive therapy
5106526|NCT01187017|T-Cells|t-cells
5106529|NCT01186965|virtual community|virtual community
5106530|NCT01186965|diabetes education|diabetes education
5106531|NCT01186965|diabetes support group|diabetes support group
5106532|NCT01186952|overweight|overweight
5106533|NCT01186952|obesity|obesity
5106534|NCT01186952|type 2 diabetes|type 2 diabetes
5106535|NCT01186952|caloric restriction|caloric restriction
5106536|NCT01186952|exercise program|exercise program
5106537|NCT01186952|epicardial fat|epicardial fat
5106538|NCT01186939|Myelodysplastic Syndromes|myelodysplastic syndromes
5106539|NCT01186939|MDS|mds
5106540|NCT01186926|Obstructive sleep apnea|obstructive sleep apnea
5106541|NCT01186926|OSA|osa
5106542|NCT01186926|hypoglossal nerve stimulation|hypoglossal nerve stimulation
5106543|NCT01186926|sleep apnea|sleep apnea
5106544|NCT01186913|SCID disorders|scid disorders
5106545|NCT01186913|natural history study|natural history study
5106546|NCT01186900|skin abscess|skin abscess
5106547|NCT01186900|needle aspiration|needle aspiration
5106548|NCT01186900|incision and drainage|incision and drainage
5106549|NCT01186887|primary ACL reconstruction with a hamstring graft|primary acl reconstruction with a hamstring graft
5106550|NCT01186861|NSCLC|nsclc
5106551|NCT01186861|Erlotinib|erlotinib
5106552|NCT01186861|OSI-906|osi-906
5106553|NCT01186861|Placebo|placebo
5106554|NCT01186861|Platinum-based chemotherapy|platinum-based chemotherapy
5106555|NCT01186848|Stretch marks|stretch marks
5106556|NCT01186848|Striae distensae|striae distensae
5106557|NCT01186809|hematologic malignancies (excluding Chronic Myeloid Leukemia)|hematologic malignancies (excluding chronic myeloid leukemia)
5106558|NCT01186796|Women|women
5106559|NCT01186796|Fulvestrant Study|fulvestrant study
5106560|NCT01186796|Post Menopausal Women|post menopausal women
5106561|NCT01186796|Hormones|hormones
5106562|NCT01186796|Healthy Adult Women|healthy adult women
5106563|NCT01186783|heart rate|heart rate
5106564|NCT01186783|multiple organ dysfunction syndrome|multiple organ dysfunction syndrome
5106565|NCT01186783|ivabradine|ivabradine
5106566|NCT01186783|sepsis|sepsis
5106567|NCT01186783|cardiogenic shock|cardiogenic shock
5106568|NCT01186770|Treatment of Opioid-Induced Constipation in Subjects with Chronic, Non-Malignant Pain|treatment of opioid-induced constipation in subjects with chronic, non-malignant pain
5106569|NCT01186744|OPT Retreatment|opt retreatment
5106570|NCT01186744|OPT|opt
5106571|NCT01186744|chronic|chronic
5106572|NCT01186744|moderate|moderate
5106573|NCT01186744|severe|severe
5106574|NCT01186744|treatment|treatment
5106575|NCT01186744|safety|safety
5106576|NCT01186744|treatment withdrawal|treatment withdrawal
5106577|NCT01186744|retreatment|retreatment
5106578|NCT01186744|retreatment withdrawal|retreatment withdrawal
5106579|NCT01186744|CP-690,550|cp-690,550
5106580|NCT01186744|Psoriasis Vulgaris|psoriasis vulgaris
5106581|NCT01186744|Plaque Psoriasis|plaque psoriasis
5106582|NCT01186744|tofacitinib|tofacitinib
5106583|NCT01186744|Xeljanz|xeljanz
5106584|NCT01186744|nail psoriasis|nail psoriasis
5106585|NCT01186744|Jak-inhibitor|jak-inhibitor
5106586|NCT01186744|oral treatment|oral treatment
5106587|NCT01186744|Pruritus|pruritus
5106588|NCT01186744|Itch|itch
5106589|NCT01186744|DLQI|dlqi
5106590|NCT01186744|rebound|rebound
5106591|NCT01186744|intermittent|intermittent
5106592|NCT01186744|retreat|retreat
5106593|NCT01186731|SPARC (secreted protein acid rich in cysteine)|sparc (secreted protein acid rich in cysteine)
5106594|NCT01186731|serum Carbohydrate Antigen CA 19-9|serum carbohydrate antigen ca 19-9
5106595|NCT01186718|Cervical, motions, kinematics|cervical, motions, kinematics
5106596|NCT01186705|MK-2206|mk-2206
5106597|NCT01186705|colon|colon
5106598|NCT01186705|rectal|rectal
5106599|NCT01186705|10-068|10-068
5106600|NCT01186666|Atherosclerosis|atherosclerosis
5106601|NCT01186666|Vulnerable plaque|vulnerable plaque
5106602|NCT01186666|Intravascular ultrasound|intravascular ultrasound
5106603|NCT01186666|Virtual histology|virtual histology
5106604|NCT01186666|Fluorodeoxyglucose|fluorodeoxyglucose
5106605|NCT01186666|Positron emission tomography|positron emission tomography
5106606|NCT01186666|Multidetector computed tomography|multidetector computed tomography
5106607|NCT01186640|T-PLL|t-pll
5106608|NCT01186640|Polychemotherapy|polychemotherapy
5106609|NCT01186640|Alemtuzumab|alemtuzumab
5106610|NCT01186640|Efficacy|efficacy
5106611|NCT01186627|Neurodevelopmental Impairment|neurodevelopmental impairment
5106612|NCT01186627|Intraventricular hemorrhage|intraventricular hemorrhage
5106613|NCT01186627|Retinopathy of prematurity|retinopathy of prematurity
5106614|NCT01186627|Mortality|mortality
5106615|NCT01186627|Apgar Score|apgar score
5106616|NCT01186614|cardiac arrest|cardiac arrest
5106617|NCT01186614|ECMO|ecmo
5106618|NCT01186614|hypothermia|hypothermia
5106619|NCT01186614|automated CPR|automated cpr
5106620|NCT01186614|coronary intervention|coronary intervention
5106621|NCT01186601|Prostatic Neoplasms|prostatic neoplasms
5106622|NCT01186601|Colorectal Neoplasms|colorectal neoplasms
5106623|NCT01186601|Head and Neck Neoplasms|head and neck neoplasms
5106624|NCT01186601|Melanoma|melanoma
5106625|NCT01186601|Neoplasm Metastasis|neoplasm metastasis
5106626|NCT01186588|Canagliflozin|canagliflozin
5106627|NCT01186588|JNJ-28431754|jnj-28431754
5106628|NCT01186588|Liver diseases|liver diseases
5106629|NCT01186588|Hepatic impairment|hepatic impairment
5106630|NCT01186588|Pharmacokinetic|pharmacokinetic
5106631|NCT01186588|Normal hepatic function|normal hepatic function
5106632|NCT01186575|HIV Infections|hiv infections
5106633|NCT01186575|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5106634|NCT01186575|Circumcision, Male|circumcision, male
5106635|NCT01186575|Coitus|coitus
5106636|NCT01186575|Patient Compliance|patient compliance
5106637|NCT01186575|Cellular Phone|cellular phone
5106638|NCT01186562|Pancreatitis|pancreatitis
5106639|NCT01186562|Pancreatectomy|pancreatectomy
5106640|NCT01186562|Islet autotransplant|islet autotransplant
5106641|NCT01186562|Sitagliptin|sitagliptin
5106642|NCT01186562|Diabetes|diabetes
5106643|NCT01186549|propofol|propofol
5106644|NCT01186549|ephedrine|ephedrine
5106645|NCT01186549|pain|pain
5106646|NCT01186536|Whey Protein|whey protein
5106647|NCT01186536|Soy Protein|soy protein
5106648|NCT01186536|Resistance training|resistance training
5106649|NCT01186536|Weight Management|weight management
5106650|NCT01186523|Obesity|obesity
5106651|NCT01186523|Weight Management|weight management
5106652|NCT01186523|Physical Activity|physical activity
5106653|NCT01186497|Healthy|healthy
5106654|NCT01186497|Rabeprazole sodium|rabeprazole sodium
5106655|NCT01186497|Rabeprazole sprinkle capsule granule formulation|rabeprazole sprinkle capsule granule formulation
5106656|NCT01186497|Pharmacokinetics|pharmacokinetics
5106657|NCT01186497|Bioavailability|bioavailability
5106658|NCT01186497|Safety|safety
5106659|NCT01186497|Adult|adult
5106660|NCT01186484|Castration-resistant prostate cancer|castration-resistant prostate cancer
5106661|NCT01186484|Abiraterone acetate|abiraterone acetate
5106662|NCT01186484|JNJ-212082|jnj-212082
5106663|NCT01186471|Symptomatic treatment|symptomatic treatment
5106664|NCT01186471|Cognition|cognition
5106665|NCT01186471|Cognitive deficits|cognitive deficits
5106666|NCT01186471|Schizophrenia|schizophrenia
5106667|NCT01186445|Acute Myocardial Infarction|acute myocardial infarction
5106668|NCT01186445|Cardioprotective effect|cardioprotective effect
5106669|NCT01186445|Pharmacological postconditioning|pharmacological postconditioning
5106670|NCT01186445|Morphine Chlorhydrate|morphine chlorhydrate
5106671|NCT01186445|Cardiac MRI|cardiac mri
5106672|NCT01186419|Beta-thalassemia|beta-thalassemia
5106673|NCT01186419|Sickle cell anemia|sickle cell anemia
5106674|NCT01186419|Transfusional iron overload|transfusional iron overload
5106675|NCT01186419|Iron overload|iron overload
5106676|NCT01186419|Iron chelation|iron chelation
5106677|NCT01186406|glioblastoma multiforme|glioblastoma multiforme
5106678|NCT01186406|gliosarcoma|gliosarcoma
5106679|NCT01186406|malignant glioma|malignant glioma
5106680|NCT01186406|glioma|glioma
5106681|NCT01186406|Gliadel|gliadel
5106682|NCT01186406|carmustine wafers|carmustine wafers
5106683|NCT01186406|Avastin|avastin
5106684|NCT01186406|bevacizumab|bevacizumab
5106685|NCT01186406|Temodar|temodar
5106686|NCT01186406|temozolomide|temozolomide
5106687|NCT01186406|Pro00025180|pro00025180
5106688|NCT01186406|Desjardins|desjardins
5106689|NCT01186406|Duke|duke
5106690|NCT01186406|Preston Robert Tisch Brain Tumor Center|preston robert tisch brain tumor center
5106691|NCT01186393|Weight Loss|weight loss
5106692|NCT01186393|Potatoes|potatoes
5106693|NCT01186393|Dietary Meetings|dietary meetings
5106694|NCT01186393|Glycemic Control|glycemic control
5106695|NCT01186380|TEE|tee
5106696|NCT01186380|Transesophageal|transesophageal
5106697|NCT01186380|Transducer|transducer
5106698|NCT01186380|Esophagus|esophagus
5106699|NCT01186380|Ease of passage and during transitioning into and down the esophagus to complete a normal TEE study|ease of passage and during transitioning into and down the esophagus to complete a normal tee study
5106700|NCT01186367|breast cancer|breast cancer
5106701|NCT01186367|Linear Versus Nonlinear Aerobic Training|linear versus nonlinear aerobic training
5106702|NCT01186367|15-147|15-147
5106703|NCT01186354|Type 2 diabetes|type 2 diabetes
5106704|NCT01186354|health literacy|health literacy
5106705|NCT01186354|genetic literacy|genetic literacy
5106706|NCT01186354|genetic risk|genetic risk
5106707|NCT01186341|Chronic Pain|chronic pain
5106708|NCT01186328|Relapse|relapse
5106709|NCT01186328|T cell|t cell
5106710|NCT01186328|Lymphoblastic|lymphoblastic
5106711|NCT01186328|Leukemia|leukemia
5106712|NCT01186328|EZN3042|ezn3042
5106713|NCT01186328|Refractory|refractory
5106714|NCT01186328|Precursor B|precursor b
5106715|NCT01186328|Pre B cell|pre b cell
5106716|NCT01186328|Survivan|survivan
5106717|NCT01186328|Acute|acute
5106718|NCT01186328|Childhood|childhood
5106719|NCT01186328|Pediatric|pediatric
5106720|NCT01186315|Addiction|addiction
5106721|NCT01186315|Posttraumatic Stress|posttraumatic stress
5106722|NCT01186315|substance abuse and posttraumatic stress|substance abuse and posttraumatic stress
5106723|NCT01186302|medical abortion|medical abortion
5106724|NCT01186302|Nepal|nepal
5106725|NCT01186302|midlevel providers|midlevel providers
5106726|NCT01186289|Neurocognitive Dysfunction|neurocognitive dysfunction
5106727|NCT01186263|liver metastases|liver metastases
5106728|NCT01186263|MAA|maa
5106729|NCT01186263|B20|b20
5106730|NCT01186263|SIR spheres|sir spheres
5106731|NCT01186263|SPECT|spect
5106732|NCT01186263|intra-hepatic distribution|intra-hepatic distribution
5106733|NCT01186250|cardiac allograft vasculopathy|cardiac allograft vasculopathy
5106734|NCT01186250|pioglitazone|pioglitazone
5106735|NCT01186250|insulin resistance|insulin resistance
5106736|NCT01186250|heart transplant|heart transplant
5106737|NCT01186237|Colon/Rectal Cancer Rectal Cancer|colon/rectal cancer rectal cancer
5106738|NCT01186237|Quality of Life|quality of life
5106739|NCT01186211|knee, joint|knee, joint
5106740|NCT01186198|Coronary Dilatation Catheter|coronary dilatation catheter
5106741|NCT01186198|Balloon Dilatation Catheter|balloon dilatation catheter
5106742|NCT01186198|Predilatation Balloon|predilatation balloon
5106743|NCT01186198|Angioplasty|angioplasty
5106744|NCT01186198|Myocardial Ischemia|myocardial ischemia
5106745|NCT01186198|Coronary Stenosis|coronary stenosis
5106746|NCT01186198|PCI|pci
5106747|NCT01186198|PTCA|ptca
5106748|NCT01186198|CTO|cto
5106749|NCT01186185|sudden|sudden
5106750|NCT01186185|sensorineural|sensorineural
5106751|NCT01186185|hearing loss|hearing loss
5106752|NCT01186185|fludrocortisone|fludrocortisone
5106753|NCT01186185|mineralocorticoid|mineralocorticoid
5106754|NCT01186185|steroid|steroid
5106755|NCT01186172|ethanol|ethanol
5106756|NCT01186172|lock therapy|lock therapy
5106757|NCT01186172|vascular access|vascular access
5106758|NCT01186172|central venous catheter|central venous catheter
5106759|NCT01186172|sepsis|sepsis
5106760|NCT01186159|COX-2|cox-2
5106761|NCT01186159|PMNL|pmnl
5106762|NCT01186159|pain|pain
5106763|NCT01186159|macrophages|macrophages
5106764|NCT01186159|NSAIDs|nsaids
5106765|NCT01186146|coronary disease|coronary disease
5106766|NCT01186146|stents|stents
5106767|NCT01186146|antiplatelet drugs|antiplatelet drugs
5106768|NCT01186146|drug-eluting stents|drug-eluting stents
5106769|NCT01186133|coronary disease|coronary disease
5106770|NCT01186133|drug eluting stent|drug eluting stent
5106771|NCT01186120|coronary disease|coronary disease
5106772|NCT01186120|stent|stent
5106773|NCT01186107|coronary disease|coronary disease
5106774|NCT01186107|stent|stent
5106775|NCT01186094|Coronary Artery Disease|coronary artery disease
5106776|NCT01186094|Stent|stent
5106777|NCT01186081|Rectal cancer|rectal cancer
5106778|NCT01186081|Preoperative CCRT|preoperative ccrt
5106779|NCT01186081|Postoperative CCRT|postoperative ccrt
5106780|NCT01186081|Capecitabine|capecitabine
5106781|NCT01186068|Rosacea, erythema|rosacea, erythema
5106782|NCT01186055|Smoking Relapse|smoking relapse
5106783|NCT01186055|Nicotine Abstinence|nicotine abstinence
5106784|NCT01186042|HIV|hiv
5106785|NCT01186042|Aging|aging
5106786|NCT01186042|Neuropsychological function|neuropsychological function
5106787|NCT01186042|Activity|activity
5106788|NCT01186042|Sleep patterns|sleep patterns
5106789|NCT01186042|Frailty|frailty
5106790|NCT01186042|Emotional well-being|emotional well-being
5106791|NCT01186042|Sexual health|sexual health
5106792|NCT01186029|Looking at adding drug to already established treatment regimen for|looking at adding drug to already established treatment regimen for
5106793|NCT01186029|Nausea and Vomiting|nausea and vomiting
5106794|NCT01186016|Genetic Education|genetic education
5106795|NCT01186016|Smoking Cessation|smoking cessation
5106796|NCT01186016|Quitting Smoking|quitting smoking
5106797|NCT01186016|Standard Smoking Cessation Program|standard smoking cessation program
5106798|NCT01186016|Genetic Education for Smoking Cessation|genetic education for smoking cessation
5106799|NCT01186003|Diabetes|diabetes
5106800|NCT01185977|Major Depressive Disorder|major depressive disorder
5106801|NCT01185977|Fluoxetine|fluoxetine
5106802|NCT01185977|QEEG|qeeg
5106803|NCT01185977|cordance|cordance
5106804|NCT01185977|ATR|atr
5106805|NCT01185964|Sarcoma, Soft Tissue|sarcoma, soft tissue
5106806|NCT01185964|Advanced Soft Tissue Sarcoma|advanced soft tissue sarcoma
5106807|NCT01185951|Achilles Tendon|achilles tendon
5106808|NCT01185951|Patella|patella
5106809|NCT01185951|Allergy|allergy
5106810|NCT01185951|Necrosis|necrosis
5106811|NCT01185951|Infection|infection
5106812|NCT01185938|statin|statin
5106813|NCT01185938|CIN|cin
5106814|NCT01185938|periprocedural damage|periprocedural damage
5106815|NCT01185925|PDE5-inhibition|pde5-inhibition
5106816|NCT01185925|exercise ventilation|exercise ventilation
5106817|NCT01185925|heart failure|heart failure
5106818|NCT01185925|sildenafil|sildenafil
5106819|NCT01185925|pulmonary hemodynamics|pulmonary hemodynamics
5106820|NCT01185912|Cardiac MRI|cardiac mri
5106821|NCT01185912|Cardiac ultrasound|cardiac ultrasound
5106822|NCT01185912|Cardiac surgery|cardiac surgery
5106823|NCT01185899|heart attack|heart attack
5106824|NCT01185899|acute myocardial infarction|acute myocardial infarction
5106825|NCT01185899|STEMI|stemi
5106826|NCT01185899|NSTEMI|nstemi
5106827|NCT01185899|Unstable Angina|unstable angina
5106828|NCT01185899|suspected acute coronary syndrome|suspected acute coronary syndrome
5106829|NCT01185899|Non-ischemic chest pain|non-ischemic chest pain
5106830|NCT01185886|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
5106831|NCT01185886|L1 childhood acute lymphoblastic leukemia|l1 childhood acute lymphoblastic leukemia
5106832|NCT01185886|L2 childhood acute lymphoblastic leukemia|l2 childhood acute lymphoblastic leukemia
5106833|NCT01185886|B-cell childhood acute lymphoblastic leukemia|b-cell childhood acute lymphoblastic leukemia
5106834|NCT01185886|T-cell childhood acute lymphoblastic leukemia|t-cell childhood acute lymphoblastic leukemia
5106835|NCT01185886|stage I childhood lymphoblastic lymphoma|stage i childhood lymphoblastic lymphoma
5106836|NCT01185886|stage II childhood lymphoblastic lymphoma|stage ii childhood lymphoblastic lymphoma
5106837|NCT01185886|stage III childhood lymphoblastic lymphoma|stage iii childhood lymphoblastic lymphoma
5106838|NCT01185886|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
5106839|NCT01185886|Philadelphia chromosome positive childhood precursor acute lymphoblastic leukemia|philadelphia chromosome positive childhood precursor acute lymphoblastic leukemia
5106840|NCT01185821|BAF312|baf312
5106841|NCT01185821|siponimod|siponimod
5106842|NCT01185821|Multiple Sclerosis|multiple sclerosis
5106843|NCT01185821|Relapsing remitting Multiple Sclerosis|relapsing remitting multiple sclerosis
5106844|NCT01185821|Demyelinating Autoimmune Diseases|demyelinating autoimmune diseases
5106845|NCT01185821|MS|ms
5106846|NCT01185821|RRMS|rrms
5106847|NCT01185821|inflammatory disease|inflammatory disease
5106848|NCT01185808|sinusitis|sinusitis
5106849|NCT01185808|chronic sinusitis with polyps|chronic sinusitis with polyps
5106850|NCT01185795|yogurt|yogurt
5106851|NCT01185795|probiotic|probiotic
5106852|NCT01185795|cholesterol|cholesterol
5106853|NCT01185782|Infertility|infertility
5106854|NCT01185782|Ovulation induction|ovulation induction
5106855|NCT01185782|Gonalef® (Follitropin alfa)|gonalef® (follitropin alfa)
5106856|NCT01185782|Purified pituitary gonadotropin (Fertinorm-P®)|purified pituitary gonadotropin (fertinorm-p®)
5106857|NCT01185782|gonadotropin|gonadotropin
5106858|NCT01185782|Reproductive technologies, assisted|reproductive technologies, assisted
5106859|NCT01185782|Polycystic ovary syndrome|polycystic ovary syndrome
5106860|NCT01185769|Vitamin E|vitamin e
5106861|NCT01185769|Absorption|absorption
5106862|NCT01185756|Heart failure|heart failure
5106863|NCT01185756|Sudden death|sudden death
5106864|NCT01185756|Implantable Cardioverter Defibrillator|implantable cardioverter defibrillator
5106865|NCT01185756|MIBG scintigraphy|mibg scintigraphy
5106866|NCT01185743|healthy volunteers|healthy volunteers
5106867|NCT01185743|antipsychotics|antipsychotics
5106868|NCT01185743|gene expression|gene expression
5106869|NCT01185730|Pulmonary hypertension|pulmonary hypertension
5106870|NCT01185730|Prognostic factors|prognostic factors
5106871|NCT01185730|Idiopathic pulmonary hypertension|idiopathic pulmonary hypertension
5106872|NCT01185730|Family pulmonary hypertension|family pulmonary hypertension
5106873|NCT01185730|use anorectics|use anorectics
5106874|NCT01185704|Cetrorelix acetate; follitropin alfa; human chorionic-gonadotropin alfa; follicular maturation; pregnancy; ovarian stimulation|cetrorelix acetate; follitropin alfa; human chorionic-gonadotropin alfa; follicular maturation; pregnancy; ovarian stimulation
5106875|NCT01185678|Contraception|contraception
5106876|NCT01185678|Compliance|compliance
5106877|NCT01185665|FBSS|fbss
5106878|NCT01185652|Smoking|smoking
5106879|NCT01185652|airflow obstruction|airflow obstruction
5106880|NCT01185652|pulmonary function tests|pulmonary function tests
5106881|NCT01185639|lung cancer|lung cancer
5106882|NCT01185639|metastatic|metastatic
5106883|NCT01185639|SBRT|sbrt
5106884|NCT01185639|Stereotactic body radiation therapy|stereotactic body radiation therapy
5106885|NCT01185639|liver|liver
5106886|NCT01185639|spine|spine
5106887|NCT01185639|adrenal|adrenal
5106888|NCT01185639|bone cancer|bone cancer
5106889|NCT01185639|Spinal Column|spinal column
5106890|NCT01185626|patients|patients
5106891|NCT01185600|transfusion complications|transfusion complications
5106892|NCT01185600|washed RBC|washed rbc
5106893|NCT01185600|microparticles|microparticles
5106894|NCT01185600|storage lesion|storage lesion
5106895|NCT01185587|SCN5A protein|scn5a protein
5106896|NCT01185587|voltage-gated Na+ channel|voltage-gated na+ channel
5106897|NCT01185561|Diabetes|diabetes
5106898|NCT01185561|SWEEP|sweep
5106899|NCT01185561|Dysphoria|dysphoria
5106900|NCT01185548|Advanced or Metastatic Solid Tumors or Lymphoma|advanced or metastatic solid tumors or lymphoma
5106901|NCT01185535|topical anesthesia|topical anesthesia
5106902|NCT01185535|tracheal intubation|tracheal intubation
5106903|NCT01185535|difficult airway|difficult airway
5106904|NCT01185509|HER2 negative|her2 negative
5106905|NCT01185509|HER2 positive|her2 positive
5106906|NCT01185496|diabetes mellitus|diabetes mellitus
5106907|NCT01185483|Endoscopic submucosal dissection|endoscopic submucosal dissection
5106908|NCT01185483|Submucosal tumor|submucosal tumor
5106909|NCT01185483|Minimal invasive|minimal invasive
5106910|NCT01185483|Gastroscopy|gastroscopy
5106911|NCT01185470|Chronic pain|chronic pain
5106912|NCT01185470|Morphine Sufate|morphine sufate
5106913|NCT01185470|Intrathecal|intrathecal
5106914|NCT01185470|Implantable drug delivery pumps|implantable drug delivery pumps
5106915|NCT01185457|Shoulder surgery|shoulder surgery
5106916|NCT01185457|Beach chair position|beach chair position
5106917|NCT01185457|Interscalene block|interscalene block
5106918|NCT01185457|HRV|hrv
5106919|NCT01185457|Autonomic nervous system|autonomic nervous system
5106920|NCT01185444|Knee Balance|knee balance
5106921|NCT01185444|Hyaluronate|hyaluronate
5106922|NCT01185444|Osteoarthritis|osteoarthritis
5106923|NCT01185444|Viscosupplementation|viscosupplementation
5106924|NCT01185431|Ficus Carica|ficus carica
5106925|NCT01185431|Functional Constipation|functional constipation
5106926|NCT01185431|Dietary Supplement|dietary supplement
5106927|NCT01185431|Fig Paste|fig paste
5106928|NCT01185405|Voriconazole|voriconazole
5106929|NCT01185405|Therapeutic drug monitoring|therapeutic drug monitoring
5106930|NCT01185405|Intensive care unit|intensive care unit
5106931|NCT01185392|Cardiac Resynchronisation Therapy in Heart Failure|cardiac resynchronisation therapy in heart failure
5106932|NCT01185379|Docosahexaenoic acid|docosahexaenoic acid
5106933|NCT01185379|omega 3|omega 3
5106934|NCT01185379|cerebral blood flow|cerebral blood flow
5106935|NCT01185379|Near Infrared spectroscopy|near infrared spectroscopy
5106936|NCT01185379|cognitive function|cognitive function
5106937|NCT01185379|mood|mood
5106938|NCT01185366|Advanced non-clear cell renal cell cancer (RCC)|advanced non-clear cell renal cell cancer (rcc)
5106939|NCT01185366|Clear-cell renal cell carcinoma|clear-cell renal cell carcinoma
5106940|NCT01185366|Collecting duct carcinoma|collecting duct carcinoma
5106941|NCT01185366|Translocation carcinoma|translocation carcinoma
5106942|NCT01185366|Chromophobe|chromophobe
5106943|NCT01185366|Everolimus|everolimus
5106944|NCT01185366|Sunitinib|sunitinib
5106945|NCT01185366|Afinitor|afinitor
5106946|NCT01185366|RAD001|rad001
5106947|NCT01185366|Sunitinib Malate|sunitinib malate
5106948|NCT01185366|SUO11248|suo11248
5106949|NCT01185366|Sutent|sutent
5106950|NCT01185366|ESPN|espn
5106951|NCT01185353|Rheumatoid Arthritis|rheumatoid arthritis
5106952|NCT01185353|RA|ra
5106953|NCT01185340|Depression|depression
5106954|NCT01185340|MDD|mdd
5106955|NCT01185327|Regurgitation|regurgitation
5106956|NCT01185327|Infants to Israeli Ethiopian-origin mothers|infants to israeli ethiopian-origin mothers
5106957|NCT01185314|NSCLC, EGFR mutation|nsclc, egfr mutation
5106958|NCT01185301|Arthritis|arthritis
5106959|NCT01185301|Erosion|erosion
5106960|NCT01185301|Humira|humira
5106961|NCT01185301|Adalimumab|adalimumab
5106962|NCT01185301|Injection|injection
5106963|NCT01185301|Rheumatoid|rheumatoid
5106964|NCT01185301|Methotrexate|methotrexate
5106965|NCT01185288|Rheumatoid Arthritis|rheumatoid arthritis
5106966|NCT01185262|Recurrent and refractory chronic lymphocytic leukemia|recurrent and refractory chronic lymphocytic leukemia
5106967|NCT01185249|CHF|chf
5106968|NCT01185249|congestive heart failure|congestive heart failure
5106969|NCT01185236|Diabetes mellitus|diabetes mellitus
5106970|NCT01185223|Valganciclovir|valganciclovir
5106971|NCT01185223|Ganciclovir|ganciclovir
5106972|NCT01185223|Antiviral Drug|antiviral drug
5106973|NCT01185223|CMV disease|cmv disease
5106974|NCT01185197|Minimal Change Nephrotic Syndrome|minimal change nephrotic syndrome
5106975|NCT01185197|Corticosteroid|corticosteroid
5106976|NCT01185197|Mycophenolate|mycophenolate
5106977|NCT01185197|Remission|remission
5106978|NCT01185197|Safety|safety
5106979|NCT01185184|Relative bioavailability|relative bioavailability
5106980|NCT01185184|controlled release|controlled release
5106981|NCT01185184|Phase 1|phase 1
5106982|NCT01185184|CP-690|cp-690
5106983|NCT01185184|550|550
5106984|NCT01185171|Larynx|larynx
5106985|NCT01185171|Lip|lip
5106986|NCT01185171|Oral Cavity and Pharynx|oral cavity and pharynx
5106987|NCT01185158|Larynx|larynx
5106988|NCT01185158|Lip|lip
5106989|NCT01185158|Oral Cavity and Pharynx|oral cavity and pharynx
5106990|NCT01185145|breast-conservation|breast-conservation
5106991|NCT01185145|accelerated partial breast irradiation|accelerated partial breast irradiation
5106992|NCT01185145|APBI|apbi
5106993|NCT01185145|IMRT|imrt
5106994|NCT01185145|Intensity modulated radiotherapy|intensity modulated radiotherapy
5106995|NCT01185145|breast brachytherapy|breast brachytherapy
5106996|NCT01185145|lumpectomy|lumpectomy
5106997|NCT01185145|early stage breast cancer|early stage breast cancer
5106998|NCT01185145|DCIS|dcis
5106999|NCT01185145|Mammosite|mammosite
5107000|NCT01185132|breast-conservation|breast-conservation
5107001|NCT01185132|adjuvant radiotherapy|adjuvant radiotherapy
5107002|NCT01185132|breast cancer|breast cancer
5107003|NCT01185132|early-stage breast cancer|early-stage breast cancer
5107004|NCT01185132|DCIS|dcis
5107005|NCT01185132|lumpectomy|lumpectomy
5107006|NCT01185132|accelerated partial breast irradiation|accelerated partial breast irradiation
5107007|NCT01185132|APBI|apbi
5107008|NCT01185132|three dimensional conformal external radiotherapy|three dimensional conformal external radiotherapy
5107009|NCT01185132|intensity modulated radiotherapy|intensity modulated radiotherapy
5107010|NCT01185132|3D CRT|3d crt
5107011|NCT01185132|IMRT|imrt
5107012|NCT01185119|glucose uptake and metabolism in brain|glucose uptake and metabolism in brain
5107013|NCT01185093|Cells|cells
5107014|NCT01185093|Prevention|prevention
5107015|NCT01185093|Cancer education|cancer education
5107016|NCT01185093|Nutrition|nutrition
5107017|NCT01185093|Healthy living|healthy living
5107018|NCT01185093|Physical activity|physical activity
5107019|NCT01185093|Dangers of tobacco|dangers of tobacco
5107020|NCT01185093|Sun protection|sun protection
5107021|NCT01185080|AZD8848|azd8848
5107022|NCT01185080|allergic rhinitis|allergic rhinitis
5107023|NCT01185080|efficacy|efficacy
5107024|NCT01185080|tolerability|tolerability
5107025|NCT01185080|safety|safety
5107026|NCT01185080|nasal symptoms|nasal symptoms
5107027|NCT01185067|Hypertension|hypertension
5107028|NCT01185067|Endothelial function|endothelial function
5107029|NCT01185067|Antioxidants|antioxidants
5107030|NCT01185067|Oxidative stress|oxidative stress
5107031|NCT01185067|Grapes|grapes
5107032|NCT01185067|Polyphenols|polyphenols
5107033|NCT01185067|Resveratrol|resveratrol
5107034|NCT01185067|Quercetin|quercetin
5107035|NCT01185067|Anthocyanins|anthocyanins
5107036|NCT01185067|Flavanols|flavanols
5107037|NCT01185067|Flavonols|flavonols
5107038|NCT01185067|Congestive heart failure|congestive heart failure
5107039|NCT01185067|Heart failure with normal ejection fraction|heart failure with normal ejection fraction
5107040|NCT01185067|Heart failure with preserved systolic function|heart failure with preserved systolic function
5107041|NCT01185067|HFNEF|hfnef
5107042|NCT01185067|HFPSF|hfpsf
5107043|NCT01185067|HFPEF|hfpef
5107044|NCT01185067|DHF|dhf
5107045|NCT01185054|Pediatrics|pediatrics
5107046|NCT01185054|Gastroenteritis|gastroenteritis
5107047|NCT01185054|Oral Rehydration|oral rehydration
5107048|NCT01185054|Electrolyte Maintenance Solution|electrolyte maintenance solution
5107049|NCT01185041|Arterial Stiffness|arterial stiffness
5107050|NCT01185041|Wave Reflection|wave reflection
5107051|NCT01185041|Watermelon Supplementation|watermelon supplementation
5107052|NCT01185041|Aortic Blood Pressure|aortic blood pressure
5107053|NCT01185041|Obesity|obesity
5107054|NCT01185028|Chronic HCV|chronic hcv
5107055|NCT01185028|HCV Treatment Nonresponders|hcv treatment nonresponders
5107056|NCT01185028|HCV Treatment Relapsers|hcv treatment relapsers
5107057|NCT01185028|HIV-HCV Co-Infection|hiv-hcv co-infection
5107058|NCT01185028|Nitazoxanide|nitazoxanide
5107059|NCT01185028|Hepatitis C|hepatitis c
5107060|NCT01185015|Angina Pectoris, Coronary disease|angina pectoris, coronary disease
5107061|NCT01185002|CE|ce
5107062|NCT01185002|colonoscopy|colonoscopy
5107063|NCT01185002|colon|colon
5107064|NCT01185002|Eligable for colon evaluation|eligable for colon evaluation
5107065|NCT01184976|H5N1|h5n1
5107066|NCT01184976|Avian Influenza|avian influenza
5107067|NCT01184976|DNA Vaccine|dna vaccine
5107068|NCT01184976|Electroporation|electroporation
5107069|NCT01184976|Intramuscular (IM) Injection|intramuscular (im) injection
5107070|NCT01184963|PCOS|pcos
5107071|NCT01184963|High protein diet|high protein diet
5107072|NCT01184924|Arthritis|arthritis
5107073|NCT01184924|Tai Chi|tai chi
5107074|NCT01184911|Malaria|malaria
5107075|NCT01184911|Pregnancy|pregnancy
5107076|NCT01184898|AML|aml
5107077|NCT01184898|mTOR|mtor
5107078|NCT01184898|rapamycin|rapamycin
5107079|NCT01184885|hyperCVAD|hypercvad
5107080|NCT01184885|rapamycin|rapamycin
5107081|NCT01184885|lymphoid malignancies|lymphoid malignancies
5107082|NCT01184885|lymphoblastic leukemia|lymphoblastic leukemia
5107083|NCT01184885|B and T cell|b and t cell
5107084|NCT01184885|philadelphia chromosome negative|philadelphia chromosome negative
5107085|NCT01184885|burkitt lymphoma|burkitt lymphoma
5107086|NCT01184885|burkitt-type lymphoma|burkitt-type lymphoma
5107087|NCT01184885|lymphoblastic lymphoma|lymphoblastic lymphoma
5107088|NCT01184885|mantle cell lymphoma|mantle cell lymphoma
5107089|NCT01184885|adult t cell leukemia|adult t cell leukemia
5107090|NCT01184885|adult t cell lymphoma|adult t cell lymphoma
5107091|NCT01184872|Skin infection|skin infection
5107092|NCT01184872|Daptomycin|daptomycin
5107093|NCT01184872|Elderly|elderly
5107094|NCT01184872|Gram positive|gram positive
5107095|NCT01184872|Complicated skin and soft tissue infections|complicated skin and soft tissue infections
5107096|NCT01184859|nocturia|nocturia
5107097|NCT01184859|bladder function|bladder function
5107098|NCT01184846|Chronic inflammatory demyelinating polyneuropathy|chronic inflammatory demyelinating polyneuropathy
5107099|NCT01184846|CIDP|cidp
5107100|NCT01184833|Multiple sclerosis|multiple sclerosis
5107101|NCT01184833|Interferon beta-1b|interferon beta-1b
5107102|NCT01184833|Compliance to treatment|compliance to treatment
5107103|NCT01184833|Premature treatment discontinuation|premature treatment discontinuation
5107104|NCT01184820|Pharmacokinetics|pharmacokinetics
5107105|NCT01184820|Safety|safety
5107106|NCT01184807|Advanced solid tumor|advanced solid tumor
5107107|NCT01184794|Analgesia laparoscopy|analgesia laparoscopy
5107108|NCT01184768|type 2 diabetes|type 2 diabetes
5107109|NCT01184768|HbA1c|hba1c
5107110|NCT01184768|vitamin D|vitamin d
5107111|NCT01184768|diagnosis|diagnosis
5107112|NCT01184755|Device-guided breathing|device-guided breathing
5107113|NCT01184755|hypertension|hypertension
5107114|NCT01184755|behavioral intervention|behavioral intervention
5107115|NCT01184755|stress reduction|stress reduction
5107116|NCT01184755|Heart Rate Variability (HRV) biofeedback|heart rate variability (hrv) biofeedback
5107117|NCT01184729|aerobic capacity|aerobic capacity
5107118|NCT01184716|Vitamin D status (serum 25-hydroxyvitamin D)|vitamin d status (serum 25-hydroxyvitamin d)
5107119|NCT01184703|Diabetes Mellitus, Type 1|diabetes mellitus, type 1
5107120|NCT01184703|Glycemic Index Diet|glycemic index diet
5107122|NCT01184703|Lipids|lipids
5107123|NCT01184690|double-balloon endoscopy|double-balloon endoscopy
5107124|NCT01184690|diagnostic yield|diagnostic yield
5107125|NCT01184664|Smoking cessation|smoking cessation
5107126|NCT01184664|Tobacco dependence|tobacco dependence
5107127|NCT01184664|Varenicline|varenicline
5107128|NCT01184664|Nicotine Replacement Therapy|nicotine replacement therapy
5107129|NCT01184664|Combination therapy|combination therapy
5107130|NCT01184651|Congenital Adrenal Hyperplasia|congenital adrenal hyperplasia
5107131|NCT01184651|CAH|cah
5107132|NCT01184651|sex differences|sex differences
5107133|NCT01184651|adolescence|adolescence
5107134|NCT01184651|androgen|androgen
5107135|NCT01184651|behavior|behavior
5107136|NCT01184651|gender development|gender development
5107137|NCT01184638|Cognitive Disorders|cognitive disorders
5107138|NCT01184638|General anesthesia|general anesthesia
5107139|NCT01184638|Sevoflurane|sevoflurane
5107140|NCT01184638|Propofol|propofol
5107141|NCT01184638|Memory|memory
5107142|NCT01184625|Myositis|myositis
5107143|NCT01184625|Physical exercise|physical exercise
5107144|NCT01184625|Disability|disability
5107145|NCT01184612|Inmates with heavy use of alcohol or drugs|inmates with heavy use of alcohol or drugs
5107146|NCT01184599|Aliskiren|aliskiren
5107147|NCT01184599|Albuminuria|albuminuria
5107148|NCT01184599|Angiotensinogen|angiotensinogen
5107149|NCT01184599|collagen type IV|collagen type iv
5107150|NCT01184599|Transforming Growth Factor beta|transforming growth factor beta
5107151|NCT01184599|aldosterone|aldosterone
5107152|NCT01184599|renin|renin
5107153|NCT01184599|prorenin receptor|prorenin receptor
5107154|NCT01184599|des-angiotensin I renin substrate|des-angiotensin i renin substrate
5107155|NCT01184599|oxidative stress|oxidative stress
5107156|NCT01184599|advanced glycosylation end-product receptor|advanced glycosylation end-product receptor
5107157|NCT01184599|N,N-dimethylarginine|n,n-dimethylarginine
5107158|NCT01184586|function|function
5107159|NCT01184586|DASH|dash
5107160|NCT01184586|MHQ|mhq
5107161|NCT01184586|pain|pain
5107162|NCT01184586|strength|strength
5107163|NCT01184573|chronic pancreatitis|chronic pancreatitis
5107164|NCT01184573|breath test|breath test
5107165|NCT01184573|bicarbonate|bicarbonate
5107166|NCT01184560|obesity|obesity
5107167|NCT01184534|Lung Biopsy|lung biopsy
5107168|NCT01184534|Multimedia patient education tool|multimedia patient education tool
5107169|NCT01184534|Multimedia Education Tool|multimedia education tool
5107170|NCT01184534|Computed tomography guided lung biopsy|computed tomography guided lung biopsy
5107171|NCT01184534|Computerized Tomography|computerized tomography
5107172|NCT01184534|CT|ct
5107173|NCT01184534|Questionnaire|questionnaire
5107174|NCT01184534|Lung nodules|lung nodules
5107175|NCT01184508|classic with aura|classic with aura
5107176|NCT01184508|common without aura|common without aura
5107177|NCT01184508|migraine|migraine
5107178|NCT01184508|headache|headache
5107179|NCT01184495|Erythropoietin|erythropoietin
5107180|NCT01184495|Chronic renal failure|chronic renal failure
5107181|NCT01184495|Hemodialysis|hemodialysis
5107182|NCT01184495|Anemia|anemia
5107183|NCT01184482|recurrent colorectal cancer|recurrent colorectal cancer
5107184|NCT01184482|recurrent head and neck cancer|recurrent head and neck cancer
5107185|NCT01184482|recurrent lung cancer|recurrent lung cancer
5107186|NCT01184482|cetuximab|cetuximab
5107187|NCT01184482|lapatinib|lapatinib
5107188|NCT01184456|AIDS|aids
5107189|NCT01184456|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5107190|NCT01184456|HIV|hiv
5107191|NCT01184456|Human Immunodeficiency Virus|human immunodeficiency virus
5107192|NCT01184443|Anorexia Nervosa|anorexia nervosa
5107193|NCT01184443|Eating Disorder Not Otherwise Specified|eating disorder not otherwise specified
5107194|NCT01184443|Olanzapine|olanzapine
5107195|NCT01184443|Pediatric|pediatric
5107196|NCT01184430|advanced hemodynamic monitoring|advanced hemodynamic monitoring
5107197|NCT01184430|goal-directed therapy|goal-directed therapy
5107198|NCT01184430|cardiac surgery|cardiac surgery
5107199|NCT01184430|hemodynamic monitoring|hemodynamic monitoring
5107200|NCT01184404|Congenital heart disease|congenital heart disease
5107201|NCT01184404|Cardiac surgery|cardiac surgery
5107202|NCT01184404|Bosentan|bosentan
5107203|NCT01184378|infant formula|infant formula
5107204|NCT01184378|dairy fat|dairy fat
5107205|NCT01184378|soluble milk protein|soluble milk protein
5107206|NCT01184365|fatigue|fatigue
5107207|NCT01184365|energy management|energy management
5107208|NCT01184365|spinal cord injury|spinal cord injury
5107209|NCT01184365|self-efficacy|self-efficacy
5107210|NCT01184365|environment|environment
5107211|NCT01184339|Staphylococcus|staphylococcus
5107212|NCT01184339|aureus|aureus
5107213|NCT01184339|methicillin|methicillin
5107214|NCT01184339|resistant|resistant
5107215|NCT01184339|MRSA|mrsa
5107216|NCT01184339|MSSA|mssa
5107217|NCT01184339|Blood Culture|blood culture
5107218|NCT01184339|diagnostic|diagnostic
5107219|NCT01184326|RAD001|rad001
5107220|NCT01184326|pazopanib|pazopanib
5107221|NCT01184326|everolimus|everolimus
5107222|NCT01184326|advanced cancer|advanced cancer
5107223|NCT01184313|aortic valve surgery|aortic valve surgery
5107224|NCT01184313|CPB|cpb
5107225|NCT01184313|lung injury|lung injury
5107226|NCT01184300|CYP2C19*2|cyp2c19*2
5107227|NCT01184300|Pharmacogenomics|pharmacogenomics
5107228|NCT01184300|Clopidogrel|clopidogrel
5107229|NCT01184300|Prasugrel|prasugrel
5107230|NCT01184300|Percutaneous Coronary Intervention|percutaneous coronary intervention
5107231|NCT01184287|Non Small Cell Lung Cancer, NSCLC, Lung Cancer|non small cell lung cancer, nsclc, lung cancer
5107232|NCT01184287|Previously untreated Non-Squamous, Non-Small Cell Lung Cancer|previously untreated non-squamous, non-small cell lung cancer
5107233|NCT01184235|Circadian Disorders|circadian disorders
5107234|NCT01184235|Autism Spectrum Disorders|autism spectrum disorders
5107235|NCT01184235|Mood Disorders|mood disorders
5107236|NCT01184235|Executive Functioning|executive functioning
5107237|NCT01184235|Pediatric Mood Disorders|pediatric mood disorders
5107238|NCT01184196|knee replacement|knee replacement
5107239|NCT01184196|knee arthroplasty|knee arthroplasty
5107240|NCT01184196|total knee replacement|total knee replacement
5107241|NCT01184196|arthroplasty, knee replacement|arthroplasty, knee replacement
5107242|NCT01184183|Patch for Carotid Endarterectomy|patch for carotid endarterectomy
5107243|NCT01184170|obesity|obesity
5107244|NCT01184170|metabolism|metabolism
5107245|NCT01184170|cardiovascular metabolic syndrome|cardiovascular metabolic syndrome
5107246|NCT01184144|Endometriosis|endometriosis
5107247|NCT01184144|Peritoneal fluid|peritoneal fluid
5107248|NCT01184144|Cytokines|cytokines
5107249|NCT01184144|Peroxisome Proliferator-Activated Receptors|peroxisome proliferator-activated receptors
5107250|NCT01184131|Mentor Training|mentor training
5107251|NCT01184131|Randomized trial of mentoring effectiveness|randomized trial of mentoring effectiveness
5107252|NCT01184131|Mentoring clinical researchers|mentoring clinical researchers
5107253|NCT01184118|asthma|asthma
5107254|NCT01184118|sleep apnea|sleep apnea
5107255|NCT01184092|Bioequivalence|bioequivalence
5107256|NCT01184092|healthy volunteer study|healthy volunteer study
5107257|NCT01184092|Rheumatoid Arthritis|rheumatoid arthritis
5107258|NCT01184079|human papillomavirus vaccine L1, type 6,11,16,18|human papillomavirus vaccine l1, type 6,11,16,18
5107259|NCT01184079|HPV Vaccines|hpv vaccines
5107260|NCT01184079|HPV L1 vaccine, quadrivalent 6,11,16,18|hpv l1 vaccine, quadrivalent 6,11,16,18
5107261|NCT01184066|Chemotherapy|chemotherapy
5107262|NCT01184066|Patient Adherence|patient adherence
5107263|NCT01184066|African Americans|african americans
5107264|NCT01184066|Cancer Survivor|cancer survivor
5107265|NCT01184066|Decision Making|decision making
5107266|NCT01184066|Communication|communication
5107267|NCT01184066|Quality of Life|quality of life
5107268|NCT01184066|Social Support|social support
5107269|NCT01184066|Patient Education|patient education
5107270|NCT01184053|endometrial|endometrial
5107271|NCT01184053|carcinoma|carcinoma
5107272|NCT01184053|recurrent|recurrent
5107273|NCT01184053|metastatic|metastatic
5107274|NCT01184053|Trisenox|trisenox
5107275|NCT01184053|arsenic trioxide|arsenic trioxide
5107276|NCT01184053|Phase II|phase ii
5107277|NCT01184053|VEGF|vegf
5107278|NCT01184053|gynecology|gynecology
5107279|NCT01184053|Lineberger|lineberger
5107280|NCT01184053|UNC|unc
5107281|NCT01184053|vascular endothelial growth factor|vascular endothelial growth factor
5107282|NCT01184053|University of North Carolina at Chapel Hill|university of north carolina at chapel hill
5107283|NCT01184027|head and neck cancer|head and neck cancer
5107284|NCT01184027|surgery|surgery
5107285|NCT01184027|nutrition|nutrition
5107286|NCT01184014|corticosteroid|corticosteroid
5107287|NCT01184014|hyperglycemia|hyperglycemia
5107288|NCT01184014|hospital|hospital
5107289|NCT01184014|corticosteroid induced hyperglycemia in the hospital|corticosteroid induced hyperglycemia in the hospital
5107290|NCT01184001|Healthy subjects|healthy subjects
5107291|NCT01184001|Food Effect Study|food effect study
5107292|NCT01183962|CAD|cad
5107293|NCT01183962|Vitamin D|vitamin d
5107294|NCT01183962|CVD|cvd
5107295|NCT01183949|Neoplasms|neoplasms
5107296|NCT01183949|Neoplasms, Plasma Cell|neoplasms, plasma cell
5107297|NCT01183949|Neoplasms by Histologic Type|neoplasms by histologic type
5107298|NCT01183949|Hemostatic Disorders|hemostatic disorders
5107299|NCT01183949|Paraproteinemias|paraproteinemias
5107300|NCT01183949|Blood Protein Disorders|blood protein disorders
5107301|NCT01183949|Hematologic Diseases|hematologic diseases
5107302|NCT01183949|Hemorrhagic Disorders|hemorrhagic disorders
5107303|NCT01183949|Lymphoproliferative Disorders|lymphoproliferative disorders
5107304|NCT01183949|Immunoproliferative Disorders|immunoproliferative disorders
5107305|NCT01183949|Immune System Diseases|immune system diseases
5107306|NCT01183949|Bortezomib|bortezomib
5107307|NCT01183949|Antineoplastic Agents|antineoplastic agents
5107308|NCT01183936|Melanoma/mortality/pathology/*surgery|melanoma/mortality/pathology/*surgery
5107309|NCT01183936|Randomized Controlled Trials as Topic|randomized controlled trials as topic
5107310|NCT01183936|Survival|survival
5107311|NCT01183936|Disease-Free Survival|disease-free survival
5107312|NCT01183923|asthma|asthma
5107313|NCT01183923|dietary interventions|dietary interventions
5107314|NCT01183923|mouse allergy|mouse allergy
5107315|NCT01183910|PURPURA|purpura
5107316|NCT01183910|SENILE PURPURA|senile purpura
5107317|NCT01183910|BATEMAN'S PURPURA|bateman's purpura
5107318|NCT01183897|GM-CSF|gm-csf
5107319|NCT01183897|MAB 3F8|mab 3f8
5107320|NCT01183897|RETINOIC ACID (CIS-9 & 13)|retinoic acid (cis-9 & 13)
5107321|NCT01183897|09-161|09-161
5107322|NCT01183884|GM-CSF|gm-csf
5107323|NCT01183884|MAB 3F8|mab 3f8
5107324|NCT01183884|RETINOIC ACID (CIS-9 & 13)|retinoic acid (cis-9 & 13)
5107325|NCT01183884|09-160|09-160
5107326|NCT01183871|Cerebral oxygenation|cerebral oxygenation
5107327|NCT01183871|thoracotomy|thoracotomy
5107328|NCT01183871|lung resection|lung resection
5107329|NCT01183871|pulmonary dysfunction|pulmonary dysfunction
5107330|NCT01183845|Crohn Disease|crohn disease
5107331|NCT01183845|Crohn's Disease Endoscopy Index of Severity|crohn's disease endoscopy index of severity
5107332|NCT01183845|Colon Capsule Endoscopy|colon capsule endoscopy
5107333|NCT01183845|Crohn's Disease located in colon and/or ileum|crohn's disease located in colon and/or ileum
5107334|NCT01183832|Breast cancer|breast cancer
5107335|NCT01183832|radiotherapy|radiotherapy
5107336|NCT01183832|hormonotherapy|hormonotherapy
5107337|NCT01183819|cognitive function|cognitive function
5107338|NCT01183819|fMRI|fmri
5107339|NCT01183819|apoE|apoe
5107340|NCT01183819|inflammatory markers|inflammatory markers
5107341|NCT01183819|exercise|exercise
5107342|NCT01183819|cognitive intervention|cognitive intervention
5107343|NCT01183819|Space Fortress|space fortress
5107344|NCT01183806|Alzheimer's disease|alzheimer's disease
5107345|NCT01183806|Exercise|exercise
5107346|NCT01183806|Rivastigmine|rivastigmine
5107347|NCT01183806|Quality of life|quality of life
5107348|NCT01183793|Gastrointestinal Tract [A03.556]|gastrointestinal tract [a03.556]
5107349|NCT01183780|second line|second line
5107350|NCT01183780|metastatic colorectal cancer|metastatic colorectal cancer
5107351|NCT01183780|FOLFIRI|folfiri
5107352|NCT01183780|ramucirumab|ramucirumab
5107353|NCT01183780|CRC|crc
5107354|NCT01183780|mCRC|mcrc
5107355|NCT01183767|Duchenne Muscular Dystrophy|duchenne muscular dystrophy
5107356|NCT01183767|Epigallocatechin-Gallate|epigallocatechin-gallate
5107357|NCT01183767|Green tea extract|green tea extract
5107358|NCT01183754|coronary disease|coronary disease
5107359|NCT01183754|platelet reactivity|platelet reactivity
5107360|NCT01183754|drug-eluting stent|drug-eluting stent
5107361|NCT01183741|Hypertension|hypertension
5107362|NCT01183741|Hypotension|hypotension
5107363|NCT01183741|Blood pressure|blood pressure
5107364|NCT01183728|Knee degenerative disease|knee degenerative disease
5107365|NCT01183728|osteoarthritis|osteoarthritis
5107366|NCT01183728|gonarthrosis|gonarthrosis
5107367|NCT01183728|stem cell|stem cell
5107368|NCT01183728|cellular therapy|cellular therapy
5107369|NCT01183728|regenerative therapy|regenerative therapy
5107370|NCT01183728|Mesenchymal stem cells|mesenchymal stem cells
5107371|NCT01183728|Bone marrow|bone marrow
5107372|NCT01183728|musculoskeletal Diseases|musculoskeletal diseases
5107373|NCT01183715|Single Ascending Dose|single ascending dose
5107374|NCT01183715|Phase 1|phase 1
5107375|NCT01183715|Safety and Tolerability|safety and tolerability
5107376|NCT01183715|PK|pk
5107377|NCT01183715|Healthy Subjects|healthy subjects
5107378|NCT01183702|LASIK vs. non-LASIK|lasik vs. non-lasik
5107379|NCT01183663|Lenalidomide|lenalidomide
5107380|NCT01183663|Bevacizumab|bevacizumab
5107381|NCT01183663|Sorafenib|sorafenib
5107382|NCT01183663|Temsirolimus|temsirolimus
5107383|NCT01183663|5-Fluorouracil|5-fluorouracil
5107384|NCT01183663|Leucovorin|leucovorin
5107385|NCT01183663|Oxaliplatin|oxaliplatin
5107386|NCT01183663|Avastin|avastin
5107387|NCT01183663|Anti-VEGF monoclonal antibody|anti-vegf monoclonal antibody
5107388|NCT01183663|rhuMAB-VEGF|rhumab-vegf
5107389|NCT01183663|CC-5013|cc-5013
5107390|NCT01183663|Revlimid|revlimid
5107391|NCT01183663|Nexavar|nexavar
5107392|NCT01183663|BAY 43-90006|bay 43-90006
5107393|NCT01183663|Metastatic cancer|metastatic cancer
5107394|NCT01183663|Metastatic colorectal cancer|metastatic colorectal cancer
5107395|NCT01183663|Advanced solid tumors|advanced solid tumors
5107396|NCT01183663|Hematologic malignancies|hematologic malignancies
5107397|NCT01183663|Colon cancer|colon cancer
5107398|NCT01183663|Advanced colorectal cancer|advanced colorectal cancer
5107399|NCT01183663|Breast cancer|breast cancer
5107400|NCT01183663|Pancreatic cancer|pancreatic cancer
5107401|NCT01183663|Gastric cancer|gastric cancer
5107402|NCT01183663|Advanced renal cell carcinoma|advanced renal cell carcinoma
5107403|NCT01183663|Prostate cancer|prostate cancer
5107404|NCT01183663|Melanoma|melanoma
5107405|NCT01183663|Unresectable hepatocellular carcinoma|unresectable hepatocellular carcinoma
5107406|NCT01183663|Renal cell carcinoma|renal cell carcinoma
5107407|NCT01183663|Metastatic breast cancer|metastatic breast cancer
5107408|NCT01183663|Glioblastoma|glioblastoma
5107409|NCT01183663|Multiple myeloma|multiple myeloma
5107410|NCT01183637|Cartilage|cartilage
5107411|NCT01183637|Knee|knee
5107412|NCT01183637|Osteochondral|osteochondral
5107413|NCT01183624|Osteoarthritis|osteoarthritis
5107414|NCT01183624|Pain|pain
5107415|NCT01183624|Herbal medicine|herbal medicine
5107416|NCT01183624|Topical administration|topical administration
5107417|NCT01183611|safety|safety
5107418|NCT01183611|immunogenicity|immunogenicity
5107419|NCT01183611|HBV vaccine|hbv vaccine
5107420|NCT01183611|perinatal transmission|perinatal transmission
5107421|NCT01183572|multivitamins|multivitamins
5107422|NCT01183572|folate|folate
5107423|NCT01183572|iron|iron
5107424|NCT01183572|periconception|periconception
5107620|NCT01182675|Transplant|transplant
5107425|NCT01183546|rehabilitation|rehabilitation
5107426|NCT01183546|spinal cord injury|spinal cord injury
5107427|NCT01183546|wheelchairs|wheelchairs
5107428|NCT01183533|Wake-Up Stroke|wake-up stroke
5107429|NCT01183533|Ischemic stroke|ischemic stroke
5107430|NCT01183533|ischemic stroke patients who wake-up with their symptoms|ischemic stroke patients who wake-up with their symptoms
5107431|NCT01183481|nausea|nausea
5107432|NCT01183481|vomiting|vomiting
5107433|NCT01183481|antiemetics|antiemetics
5107434|NCT01183481|radiotherapy|radiotherapy
5107435|NCT01183481|Radiation-induced nausea and vomiting|radiation-induced nausea and vomiting
5107436|NCT01183468|Diabetes Mellitus, Type 1 (new-onset)|diabetes mellitus, type 1 (new-onset)
5107437|NCT01183468|Diabetes Mellitus, Insulin-Dependent (new-onset)|diabetes mellitus, insulin-dependent (new-onset)
5107438|NCT01183468|new-onset T1DM|new-onset t1dm
5107439|NCT01183468|new-onset T1D|new-onset t1d
5107440|NCT01183468|Diabetes Mellitus, Juvenile-Onset|diabetes mellitus, juvenile-onset
5107441|NCT01183468|Diabetes, Autoimmune|diabetes, autoimmune
5107442|NCT01183468|Aralast NP|aralast np
5107443|NCT01183468|Alpha-1 Antitrypsin|alpha-1 antitrypsin
5107444|NCT01183468|AAT|aat
5107445|NCT01183455|Diabetes Mellitus, Type 1 (new-onset)|diabetes mellitus, type 1 (new-onset)
5107446|NCT01183455|T1DM (new-onset)|t1dm (new-onset)
5107447|NCT01183455|T1D (new-onset)|t1d (new-onset)
5107448|NCT01183455|Diabetes, Autoimmune|diabetes, autoimmune
5107449|NCT01183455|Alpha1-Proteinase Inhibitor|alpha1-proteinase inhibitor
5107450|NCT01183455|Alpha-1 Antitrypsin|alpha-1 antitrypsin
5107451|NCT01183455|AAT|aat
5107452|NCT01183442|endothelial function|endothelial function
5107453|NCT01183442|insulin sensitivity|insulin sensitivity
5107454|NCT01183429|MAB 3F8|mab 3f8
5107455|NCT01183429|RETINOIC ACID (CIS-9 & 13)|retinoic acid (cis-9 & 13)
5107456|NCT01183429|Bone Marrow|bone marrow
5107457|NCT01183429|09-159|09-159
5107458|NCT01183416|GM-CSF|gm-csf
5107459|NCT01183416|MAB 3F8|mab 3f8
5107460|NCT01183416|RETINOIC ACID (CIS-9 & 13)|retinoic acid (cis-9 & 13)
5107461|NCT01183416|09-158|09-158
5107462|NCT01183403|stricture|stricture
5107463|NCT01183403|anti-TNF|anti-tnf
5107464|NCT01183403|ileal Crohn'Disease|ileal crohn'disease
5107465|NCT01183403|patients with ileal Crohn's disease complicated by|patients with ileal crohn's disease complicated by
5107466|NCT01183403|symptomatic stricture after failure of corticosteroids|symptomatic stricture after failure of corticosteroids
5107467|NCT01183403|and/or immunosuppressives|and/or immunosuppressives
5107468|NCT01183390|Bioequivalence|bioequivalence
5107469|NCT01183390|Healthy Subjects|healthy subjects
5107470|NCT01183377|Female Athlete Triad syndrom|female athlete triad syndrom
5107471|NCT01183377|Eating disorder|eating disorder
5107472|NCT01183377|osteoprosis|osteoprosis
5107473|NCT01183364|solid tumor malignancies|solid tumor malignancies
5107474|NCT01183364|tumor|tumor
5107475|NCT01183364|cancer|cancer
5107476|NCT01183364|STA-9090|sta-9090
5107477|NCT01183364|ganetespib|ganetespib
5107478|NCT01183364|HSP90 inhibitor|hsp90 inhibitor
5107479|NCT01183351|Dementia|dementia
5107480|NCT01183351|Agitation|agitation
5107481|NCT01183351|Challenging behaviour|challenging behaviour
5107482|NCT01183351|Behavioural and psychological symptoms in dementia (BPSD)|behavioural and psychological symptoms in dementia (bpsd)
5107483|NCT01183338|SpO2|spo2
5107484|NCT01183338|Oxygen saturation|oxygen saturation
5107485|NCT01183325|Umbilical and small ventral hernias less than 3cm diameter|umbilical and small ventral hernias less than 3cm diameter
5107486|NCT01183312|Hypersomnia|hypersomnia
5107487|NCT01183312|Primary Hypersomnia|primary hypersomnia
5107488|NCT01183312|Idiopathic Hypersomnia|idiopathic hypersomnia
5107489|NCT01183312|Narcolepsy without Cataplexy|narcolepsy without cataplexy
5107490|NCT01183312|Flumazenil|flumazenil
5107491|NCT01183299|bone metabolism|bone metabolism
5107492|NCT01183299|salt intake|salt intake
5107493|NCT01183299|acid base balance|acid base balance
5107494|NCT01183299|bed rest|bed rest
5107495|NCT01183260|revision total hip arthroplasty|revision total hip arthroplasty
5107496|NCT01183260|bone mineral density|bone mineral density
5107497|NCT01183260|trabecular metal|trabecular metal
5107498|NCT01183260|DEXA|dexa
5107499|NCT01183247|Everolimus,|everolimus,
5107500|NCT01183247|rapamycin,|rapamycin,
5107501|NCT01183247|prednisone,|prednisone,
5107502|NCT01183247|tacrolimus,|tacrolimus,
5107503|NCT01183247|MMF,|mmf,
5107504|NCT01183247|steroid-free,|steroid-free,
5107505|NCT01183247|protocol biopsy|protocol biopsy
5107506|NCT01183182|Lung nodule|lung nodule
5107507|NCT01183182|Lung lesion|lung lesion
5107508|NCT01183169|Chronic hepatitis C|chronic hepatitis c
5107509|NCT01183169|Cyclophilin inhibitor|cyclophilin inhibitor
5107510|NCT01183156|Colorectal Cancer|colorectal cancer
5107511|NCT01183156|Screening|screening
5107512|NCT01183156|Colonoscopy|colonoscopy
5107513|NCT01183156|Attendance|attendance
5107514|NCT01183156|Participation|participation
5107515|NCT01183143|Infertility|infertility
5107516|NCT01183143|Ovulation induction|ovulation induction
5107517|NCT01183143|Gonal-F|gonal-f
5107518|NCT01183143|Follitropin alpha|follitropin alpha
5107519|NCT01183143|Controlled ovarian stimulation|controlled ovarian stimulation
5107520|NCT01183130|opiate dependence|opiate dependence
5107521|NCT01183130|compliance monitoring|compliance monitoring
5107621|NCT01182675|Alemtuzumab|alemtuzumab
5107522|NCT01183130|substitution treatment|substitution treatment
5107523|NCT01183104|Type 2 Diabetes|type 2 diabetes
5107524|NCT01183104|Sitagliptin|sitagliptin
5107525|NCT01183104|Glimepiride|glimepiride
5107526|NCT01183104|Elderly patients|elderly patients
5107527|NCT01183104|Japanese|japanese
5107528|NCT01183091|Atrial fibrillation|atrial fibrillation
5107529|NCT01183091|Ablation|ablation
5107530|NCT01183078|efficacy|efficacy
5107531|NCT01183078|drill placement|drill placement
5107532|NCT01183078|nail placement|nail placement
5107533|NCT01183078|radiation|radiation
5107534|NCT01183078|Operative time|operative time
5107535|NCT01183078|Reduction in exposure to radiation|reduction in exposure to radiation
5107536|NCT01183078|Accuracy for nail placement|accuracy for nail placement
5107537|NCT01183065|Pralatrexate|pralatrexate
5107538|NCT01183065|Vitamin B12|vitamin b12
5107539|NCT01183065|Folic Acid|folic acid
5107540|NCT01183065|10-112|10-112
5107541|NCT01183052|COPD|copd
5107542|NCT01183052|exercise tolerance|exercise tolerance
5107543|NCT01183052|oxidative stress|oxidative stress
5107544|NCT01183039|Sedentary|sedentary
5107545|NCT01183000|Formation of adhesions assessed at subsequent cs|formation of adhesions assessed at subsequent cs
5107546|NCT01182987|Quality improvement|quality improvement
5107547|NCT01182987|Quality of care|quality of care
5107548|NCT01182987|Health care utilization|health care utilization
5107549|NCT01182987|Behavioral change|behavioral change
5107550|NCT01182974|fever in severe sepsis|fever in severe sepsis
5107551|NCT01182961|Gait|gait
5107552|NCT01182961|Falls|falls
5107553|NCT01182961|Virtual reality|virtual reality
5107554|NCT01182948|aerobic training|aerobic training
5107555|NCT01182948|resistance training|resistance training
5107556|NCT01182948|type 2 diabetes|type 2 diabetes
5107557|NCT01182948|therapy|therapy
5107558|NCT01182935|vitamin D|vitamin d
5107559|NCT01182935|triglycerides|triglycerides
5107560|NCT01182935|type 2 diabetes|type 2 diabetes
5107561|NCT01182922|Attendance|attendance
5107562|NCT01182922|Colorectal cancer|colorectal cancer
5107563|NCT01182922|Screening|screening
5107564|NCT01182922|Invitation letter|invitation letter
5107565|NCT01182909|NPC|npc
5107566|NCT01182909|Environmental and Genetic|environmental and genetic
5107567|NCT01182909|evaluate putative environmental exposures and NPC|evaluate putative environmental exposures and npc
5107568|NCT01182909|assess the effect of genetic factors|assess the effect of genetic factors
5107569|NCT01182909|investigate gene-environment interactions|investigate gene-environment interactions
5107570|NCT01182909|examine the natural history of EBV infection|examine the natural history of ebv infection
5107571|NCT01182883|Maximum Tolerated Dose|maximum tolerated dose
5107572|NCT01182883|Dose Escalation|dose escalation
5107573|NCT01182883|Pharmacokinetics|pharmacokinetics
5107574|NCT01182883|Antitumor Activity|antitumor activity
5107575|NCT01182883|Biologic Activity|biologic activity
5107576|NCT01182870|vitamin D|vitamin d
5107577|NCT01182870|influenza|influenza
5107578|NCT01182870|prevention|prevention
5107579|NCT01182857|Quality of Life|quality of life
5107580|NCT01182857|Gene Therapy|gene therapy
5107581|NCT01182857|ADA-SCID|ada-scid
5107582|NCT01182857|SCID-ADA|scid-ada
5107583|NCT01182857|Severe Combined Immunodeficiency|severe combined immunodeficiency
5107584|NCT01182844|metabolic syndrome, probiotic|metabolic syndrome, probiotic
5107585|NCT01182831|carcinoma pancreas|carcinoma pancreas
5107586|NCT01182831|percutaneous celiac plexus neurolysis|percutaneous celiac plexus neurolysis
5107587|NCT01182831|endosonography guided celiac plexus neurolysis|endosonography guided celiac plexus neurolysis
5107588|NCT01182818|Cerebrovascular Accident|cerebrovascular accident
5107589|NCT01182818|Cerebrovascular Accident, Acute|cerebrovascular accident, acute
5107590|NCT01182818|Fabry Disease|fabry disease
5107591|NCT01182818|Fabry´s Disease|fabry´s disease
5107592|NCT01182818|Anderson-Fabry Disease|anderson-fabry disease
5107593|NCT01182818|CVA (Cerebrovascular Accident)|cva (cerebrovascular accident)
5107594|NCT01182818|Stroke, Acute|stroke, acute
5107595|NCT01182818|Cerebral Stroke|cerebral stroke
5107596|NCT01182792|Endothelial Function|endothelial function
5107597|NCT01182792|Chronic Hypoxia|chronic hypoxia
5107598|NCT01182792|Oxidative Stress|oxidative stress
5107599|NCT01182779|base of skull chordoma|base of skull chordoma
5107600|NCT01182779|radiation|radiation
5107601|NCT01182779|carbon ions|carbon ions
5107602|NCT01182779|protons|protons
5107603|NCT01182766|alcohol|alcohol
5107604|NCT01182766|alcoholism|alcoholism
5107605|NCT01182766|nicotine|nicotine
5107606|NCT01182766|cigarette|cigarette
5107607|NCT01182753|Chondrosarcoma|chondrosarcoma
5107608|NCT01182753|Radiation|radiation
5107609|NCT01182753|carbon ion|carbon ion
5107610|NCT01182727|schizophrenia|schizophrenia
5107611|NCT01182727|salsalate|salsalate
5107612|NCT01182727|obesity|obesity
5107613|NCT01182714|Hysterectomy|hysterectomy
5107614|NCT01182714|Catheterisation|catheterisation
5107615|NCT01182701|Type 2 Diabetes|type 2 diabetes
5107616|NCT01182701|Asian Pacific Islanders|asian pacific islanders
5107617|NCT01182701|Cognitive behavioral intervention|cognitive behavioral intervention
5107618|NCT01182688|utilization of Procalcitonin in the cardiac setting|utilization of procalcitonin in the cardiac setting
5107619|NCT01182675|SCID|scid
5107622|NCT01182675|Plerixafor|plerixafor
5107623|NCT01182662|Bone Marrow Disease|bone marrow disease
5107624|NCT01182662|Aplastic Anemia|aplastic anemia
5107625|NCT01182662|Umbilical Cord/placenta-Derived MSC|umbilical cord/placenta-derived msc
5107626|NCT01182662|Transplantation|transplantation
5107627|NCT01182649|Drug Eluting Stents|drug eluting stents
5107628|NCT01182649|Everolimus Eluting Stent|everolimus eluting stent
5107629|NCT01182649|Coronary Angioplasty|coronary angioplasty
5107630|NCT01182636|Bioequivalence|bioequivalence
5107631|NCT01182636|Acne Vulgaris|acne vulgaris
5107632|NCT01182623|FICE|fice
5107633|NCT01182623|Chromoendoscopy|chromoendoscopy
5107634|NCT01182623|Colonic polyps|colonic polyps
5107635|NCT01182623|Adenomas|adenomas
5107636|NCT01182623|Hyperplastic polyps|hyperplastic polyps
5107637|NCT01182597|Oral PPI treatment has similar benefit as proton pump inhibitor infusion in patient with bleeding ulcers after combined endoscopic hemostasis|oral ppi treatment has similar benefit as proton pump inhibitor infusion in patient with bleeding ulcers after combined endoscopic hemostasis
5107638|NCT01182571|Heart Transplantation|heart transplantation
5107639|NCT01182571|Symptom Distress|symptom distress
5107640|NCT01182571|Fatigue|fatigue
5107641|NCT01182571|Depression|depression
5107642|NCT01182571|Quality Of Life.|quality of life.
5107643|NCT01182558|Muscle|muscle
5107644|NCT01182558|Activation|activation
5107645|NCT01182558|Effect|effect
5107646|NCT01182558|Compound muscle action potential|compound muscle action potential
5107647|NCT01182545|Anaesthesia|anaesthesia
5107648|NCT01182545|laparoscopic cholecystectomy|laparoscopic cholecystectomy
5107649|NCT01182545|CO2 insufflation|co2 insufflation
5107650|NCT01182545|hemodynamic|hemodynamic
5107651|NCT01182545|hyperventilation|hyperventilation
5107652|NCT01182532|Mild type of hand, foot and mouth disease|mild type of hand, foot and mouth disease
5107653|NCT01182532|Traditional Chinese Medicine|traditional chinese medicine
5107654|NCT01182532|Effectiveness|effectiveness
5107655|NCT01182532|Safety|safety
5107656|NCT01182519|lung inflammation|lung inflammation
5107657|NCT01182519|lung metastases|lung metastases
5107658|NCT01182519|10-115|10-115
5107659|NCT01182506|Cogmed Working Memory Training (CWMT)|cogmed working memory training (cwmt)
5107660|NCT01182506|cognitive|cognitive
5107661|NCT01182506|10-105|10-105
5107662|NCT01182506|Breast cancer survivor|breast cancer survivor
5107663|NCT01182493|Diabetes Mellitus|diabetes mellitus
5107664|NCT01182493|MDI|mdi
5107665|NCT01182493|pump therapy|pump therapy
5107666|NCT01182467|Inflammatory bowel disease, PET scan, Crohn's disease|inflammatory bowel disease, pet scan, crohn's disease
5107667|NCT01182454|blood pressure|blood pressure
5107668|NCT01182441|atrial fibrillation|atrial fibrillation
5107669|NCT01182441|stroke|stroke
5107670|NCT01182441|TIA|tia
5107671|NCT01182441|trans ischemic attack|trans ischemic attack
5107672|NCT01182441|warfarin|warfarin
5107673|NCT01182441|Coumadin|coumadin
5107674|NCT01182428|Stents|stents
5107675|NCT01182428|Angioplasty|angioplasty
5107676|NCT01182428|Total coronary occlusions|total coronary occlusions
5107677|NCT01182428|Coronary restenosis|coronary restenosis
5107678|NCT01182428|Stent thrombosis|stent thrombosis
5107679|NCT01182428|Everolimus|everolimus
5107680|NCT01182415|CNS involvement|cns involvement
5107681|NCT01182402|opiate dependence|opiate dependence
5107682|NCT01182402|substitution treatment|substitution treatment
5107683|NCT01182402|unsupervised dosing|unsupervised dosing
5107684|NCT01182402|monitoring|monitoring
5107685|NCT01182389|Ventricular Tachycardia|ventricular tachycardia
5107686|NCT01182389|Implantable Cardioverter Defibrillator|implantable cardioverter defibrillator
5107687|NCT01182389|Catheter Ablation|catheter ablation
5107688|NCT01182389|Robotic|robotic
5107689|NCT01182376|Multaq|multaq
5107690|NCT01182376|dronedarone|dronedarone
5107691|NCT01182376|Atrial Fibrillation|atrial fibrillation
5107692|NCT01182363|maternal depression|maternal depression
5107693|NCT01182363|prematurity|prematurity
5107694|NCT01182363|early intervention|early intervention
5107695|NCT01182363|developmental delay|developmental delay
5107696|NCT01182350|Molecularly Determined Treatment|molecularly determined treatment
5107697|NCT01182324|Expectations|expectations
5107698|NCT01182324|Duchenne Muscular Dystrophy|duchenne muscular dystrophy
5107699|NCT01182324|Clinical Trial|clinical trial
5107700|NCT01182324|Motivations|motivations
5107701|NCT01182311|Hepatitis B Virus|hepatitis b virus
5107702|NCT01182311|Hepatitis B Vaccine|hepatitis b vaccine
5107703|NCT01182311|Immunity|immunity
5107704|NCT01182311|B-Cell Response|b-cell response
5107705|NCT01182311|T-Cell Response|t-cell response
5107706|NCT01182311|Hepatitis B Immunity|hepatitis b immunity
5107707|NCT01182311|Hepatitis B Virus Vaccine|hepatitis b virus vaccine
5107708|NCT01182298|Latino|latino
5107709|NCT01182298|HCV|hcv
5107710|NCT01182298|pegIFN|pegifn
5107711|NCT01182298|Viral Kinetics|viral kinetics
5107712|NCT01182298|IL-28 Haplotype|il-28 haplotype
5107713|NCT01182285|Depakote|depakote
5107714|NCT01182285|Poorly Differentiated Thyroid Cancer|poorly differentiated thyroid cancer
5107715|NCT01182285|RAI Uptake|rai uptake
5107716|NCT01182285|Thyrogen|thyrogen
5107717|NCT01182272|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
5107718|NCT01182272|localized resectable adult primary liver cancer|localized resectable adult primary liver cancer
5107719|NCT01182246|adenocarcinoma|adenocarcinoma
5107720|NCT01182246|Pancreatic cancer|pancreatic cancer
5107721|NCT01182233|Multiple Myeloma|multiple myeloma
5107722|NCT01182233|Autologous Hematopoietic Stem Cell Transplant|autologous hematopoietic stem cell transplant
5107723|NCT01182233|Total Skeletal Irradiation|total skeletal irradiation
5107724|NCT01182233|High dose chemotherapy|high dose chemotherapy
5107725|NCT01182220|epidural|epidural
5107726|NCT01182220|labor pain|labor pain
5107727|NCT01182220|ultrasound|ultrasound
5107728|NCT01182207|Bioequivalence|bioequivalence
5107729|NCT01182207|Healthy Subjects|healthy subjects
5107730|NCT01182194|Bioequivalence|bioequivalence
5107731|NCT01182194|Healthy Subjects|healthy subjects
5107732|NCT01182181|Healthy Subjects|healthy subjects
5107733|NCT01182181|Bioequivalence|bioequivalence
5107734|NCT01182168|CISPLATIN|cisplatin
5107735|NCT01182168|GEMCITABINE|gemcitabine
5107736|NCT01182168|RAD001 (EVEROLIMUS)|rad001 (everolimus)
5107737|NCT01182168|10-106|10-106
5107738|NCT01182155|Lung Cancer Non-Small Cell Cancer (NSCLC)|lung cancer non-small cell cancer (nsclc)
5107739|NCT01182155|Lung Cancer Small Cell Lung Cancer (SCLC)|lung cancer small cell lung cancer (sclc)
5107740|NCT01182129|Nicotine Polacrilex chewing gum versus Swedish Snus|nicotine polacrilex chewing gum versus swedish snus
5107741|NCT01182116|J pouch|j pouch
5107742|NCT01182116|colorectal|colorectal
5107743|NCT01182116|rectal cancer|rectal cancer
5107744|NCT01182116|coloplasty|coloplasty
5107745|NCT01182103|Major depression|major depression
5107746|NCT01182103|BDNF|bdnf
5107747|NCT01182103|DNA methylation|dna methylation
5107748|NCT01182103|Histone modification|histone modification
5107749|NCT01182090|pelvic organ prolapse|pelvic organ prolapse
5107750|NCT01182090|colposacropexy|colposacropexy
5107751|NCT01182090|surgery|surgery
5107752|NCT01182077|ASP015K|asp015k
5107753|NCT01182077|midazolam|midazolam
5107754|NCT01182077|healthy volunteers|healthy volunteers
5107755|NCT01182064|Heart injuries|heart injuries
5107756|NCT01182064|Posttraumatic myocardial infarction|posttraumatic myocardial infarction
5107757|NCT01182064|Echocardiography|echocardiography
5107758|NCT01182064|Coronary angiography|coronary angiography
5107759|NCT01182051|headache|headache
5107760|NCT01182051|anxiety|anxiety
5107761|NCT01182051|pediatric headache and anxiety|pediatric headache and anxiety
5107762|NCT01182038|birth seat|birth seat
5107763|NCT01182038|childbirth|childbirth
5107764|NCT01182038|instrumental delivery|instrumental delivery
5107765|NCT01182038|upright position|upright position
5107766|NCT01182025|Mild type of hand, foot and mouth disease|mild type of hand, foot and mouth disease
5107767|NCT01182025|Xiyanping Injection|xiyanping injection
5107768|NCT01182025|Effectiveness|effectiveness
5107769|NCT01182025|Safety|safety
5107770|NCT01182012|Cardiovascular risk factor|cardiovascular risk factor
5107771|NCT01182012|Severe mental illness|severe mental illness
5107772|NCT01182012|Drug appropriateness|drug appropriateness
5107773|NCT01182012|Drug compliance|drug compliance
5107774|NCT01182012|Lifestyle counseling|lifestyle counseling
5107775|NCT01181999|diffuse large B-cell lymphoma|diffuse large b-cell lymphoma
5107776|NCT01181999|elderly patients|elderly patients
5107777|NCT01181999|rituximab augmentation|rituximab augmentation
5107778|NCT01181986|Type 2 diabetes mellitus, Impaired glucose tolerance|type 2 diabetes mellitus, impaired glucose tolerance
5107779|NCT01181973|Relative bioavailability|relative bioavailability
5107780|NCT01181973|pegvisomant|pegvisomant
5107781|NCT01181960|Risperidone long acting injectable|risperidone long acting injectable
5107782|NCT01181960|Risperdal Consta|risperdal consta
5107783|NCT01181960|Paliperidone Palmitate|paliperidone palmitate
5107784|NCT01181960|Invega Sustenna|invega sustenna
5107785|NCT01181947|Stent graft|stent graft
5107786|NCT01181947|thoracic aorta|thoracic aorta
5107787|NCT01181947|dissection|dissection
5107788|NCT01181947|aneurysm|aneurysm
5107789|NCT01181947|TEVAR|tevar
5107790|NCT01181947|VALIANT|valiant
5107791|NCT01181947|CAPTIVIA|captivia
5107792|NCT01181947|endovascular|endovascular
5107793|NCT01181934|symptomatic treatment|symptomatic treatment
5107794|NCT01181934|cognition|cognition
5107795|NCT01181934|cognitive deficits|cognitive deficits
5107796|NCT01181934|Schizophrenia|schizophrenia
5107797|NCT01181921|Alzheimer Disease|alzheimer disease
5107798|NCT01181921|Dementia|dementia
5107799|NCT01181921|Sleep Disorders|sleep disorders
5107800|NCT01181921|Galantamine|galantamine
5107801|NCT01181921|Reminyl|reminyl
5107802|NCT01181908|alcohol|alcohol
5107803|NCT01181908|drug interaction|drug interaction
5107804|NCT01181908|pharmacodynamic|pharmacodynamic
5107805|NCT01181895|asthma|asthma
5107806|NCT01181882|Cardiovascular Disease|cardiovascular disease
5107807|NCT01181882|Aspirin Resistance|aspirin resistance
5107808|NCT01181882|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
5107809|NCT01181882|Platelet Function|platelet function
5107810|NCT01181882|Omega-3 Fatty Acids|omega-3 fatty acids
5107811|NCT01181882|Aspirin|aspirin
5107812|NCT01181882|Lysophospholipids|lysophospholipids
5107813|NCT01181882|Lysophosphatidic Acid|lysophosphatidic acid
5107814|NCT01181882|Lysophosphatidylcholine|lysophosphatidylcholine
5107815|NCT01181869|respiratory failure|respiratory failure
5107816|NCT01181869|oxygen|oxygen
5107817|NCT01181869|sleep apnoea|sleep apnoea
5107818|NCT01181869|ventilation|ventilation
5107819|NCT01181856|Vaccine|vaccine
5107820|NCT01181856|MVA 85A|mva 85a
5107821|NCT01181843|postoperative pain management|postoperative pain management
5107822|NCT01181843|respiratory depression|respiratory depression
5107823|NCT01181843|capnography|capnography
5107824|NCT01181843|duramorph|duramorph
5107825|NCT01181830|magnesium|magnesium
5107826|NCT01181830|metabolic syndrome|metabolic syndrome
5107827|NCT01181830|diabetes|diabetes
5107828|NCT01181830|family history|family history
5107829|NCT01181817|FBSS|fbss
5107830|NCT01181817|at least one prior spinal surgery|at least one prior spinal surgery
5107831|NCT01181804|boceprevir|boceprevir
5107832|NCT01181804|hepatitis C|hepatitis c
5107833|NCT01181804|bioequivalence|bioequivalence
5107834|NCT01181804|SCH 503034|sch 503034
5107835|NCT01181791|probiotics|probiotics
5107836|NCT01181791|premature infants|premature infants
5107837|NCT01181791|feeding tolerance|feeding tolerance
5107838|NCT01181778|hormonal contraceptive methods|hormonal contraceptive methods
5107839|NCT01181778|combined hormonal contraceptive methods|combined hormonal contraceptive methods
5107840|NCT01181778|physician counseling|physician counseling
5107841|NCT01181765|Crohn's Disease|crohn's disease
5107842|NCT01181765|infliximab|infliximab
5107843|NCT01181765|capsule endoscopy|capsule endoscopy
5107844|NCT01181752|proficiency|proficiency
5107845|NCT01181752|eye drop instillation|eye drop instillation
5107846|NCT01181752|postoperative cataract surgery|postoperative cataract surgery
5107847|NCT01181752|Ghana|ghana
5107848|NCT01181739|Colonoscopy|colonoscopy
5107849|NCT01181739|Virtual Colonoscopy|virtual colonoscopy
5107850|NCT01181739|Colonography|colonography
5107851|NCT01181739|Colorectal Cancer|colorectal cancer
5107852|NCT01181739|Colonic Polyps|colonic polyps
5107853|NCT01181739|Screening|screening
5107854|NCT01181726|Bioequivalence|bioequivalence
5107855|NCT01181726|Healthy Subjects|healthy subjects
5107856|NCT01181687|COMFORT behavioral scale|comfort behavioral scale
5107857|NCT01181687|pain assessment scale|pain assessment scale
5107858|NCT01181687|child|child
5107859|NCT01181687|validity|validity
5107860|NCT01181687|reliability|reliability
5107861|NCT01181674|Diabetes|diabetes
5107862|NCT01181674|Insulin|insulin
5107863|NCT01181674|Glargine|glargine
5107864|NCT01181674|Metformin|metformin
5107865|NCT01181674|Acarbose|acarbose
5107866|NCT01181674|Diet|diet
5107867|NCT01181674|Exercise|exercise
5107868|NCT01181674|Lifestyle|lifestyle
5107869|NCT01181661|Cigarette|cigarette
5107870|NCT01181661|Smoking|smoking
5107871|NCT01181661|Nicotine|nicotine
5107872|NCT01181661|Contingency Management|contingency management
5107873|NCT01181661|Voucher Reinforcement|voucher reinforcement
5107874|NCT01181661|Smoking Abstinence|smoking abstinence
5107875|NCT01181661|Internet|internet
5107876|NCT01181661|Internet-based Treatment|internet-based treatment
5107877|NCT01181661|Group Contingencies|group contingencies
5107878|NCT01181648|Survivor|survivor
5107879|NCT01181648|Human Papillomavirus (HPV)|human papillomavirus (hpv)
5107880|NCT01181648|Quality of Life|quality of life
5107881|NCT01181648|Surviving Oropharynx Cancer|surviving oropharynx cancer
5107882|NCT01181648|10-111|10-111
5107883|NCT01181596|neonates and infants, from the 23-week gestational (0.5 kg)|neonates and infants, from the 23-week gestational (0.5 kg)
5107884|NCT01181596|up to a 6 month old born at term (7 kg), for whom the PIV,|up to a 6 month old born at term (7 kg), for whom the piv,
5107885|NCT01181596|PAC, UAC, UVC or PICC catheter insertion is medically|pac, uac, uvc or picc catheter insertion is medically
5107886|NCT01181596|indicated.|indicated.
5107887|NCT01181570|psoriasis|psoriasis
5107888|NCT01181570|adalimumab|adalimumab
5107889|NCT01181570|obstructive sleep apnea|obstructive sleep apnea
5107890|NCT01181570|obesity|obesity
5107891|NCT01181557|quality of life|quality of life
5107892|NCT01181544|Anticoagulation|anticoagulation
5107893|NCT01181544|Heparin|heparin
5107894|NCT01181544|Hemodialysis|hemodialysis
5107895|NCT01181544|Dialysis|dialysis
5107896|NCT01181544|Renal Dialysis|renal dialysis
5107897|NCT01181531|Secondary Hyperthyroidism|secondary hyperthyroidism
5107898|NCT01181531|Hemodialysis|hemodialysis
5107899|NCT01181531|Parathyroid|parathyroid
5107900|NCT01181531|PARADIGM|paradigm
5107901|NCT01181518|Tamoxifen|tamoxifen
5107902|NCT01181518|Pharmacogenomics|pharmacogenomics
5107903|NCT01181518|Breast cancer|breast cancer
5107904|NCT01181505|HNF4a|hnf4a
5107905|NCT01181505|CYP2D6|cyp2d6
5107906|NCT01181505|Toterodine|toterodine
5107907|NCT01181505|Genetic polymorphism|genetic polymorphism
5107908|NCT01181492|gene polymorphism|gene polymorphism
5107909|NCT01181492|CYP3A4|cyp3a4
5107910|NCT01181492|fentanyl|fentanyl
5107911|NCT01181492|HPLC|hplc
5107912|NCT01181492|Analgesics|analgesics
5107913|NCT01181479|Contraceptive|contraceptive
5107914|NCT01181466|PLVR|plvr
5107915|NCT01181466|BLVR|blvr
5107916|NCT01181466|AeriSeal|aeriseal
5107917|NCT01181466|treatment|treatment
5107918|NCT01181466|device|device
5107919|NCT01181466|breathing|breathing
5107920|NCT01181466|COPD|copd
5107921|NCT01181466|emphysema|emphysema
5108017|NCT01181141|embolism|embolism
5107922|NCT01181466|polymeric lung volume reduction|polymeric lung volume reduction
5107923|NCT01181466|biologic lung volume reduction|biologic lung volume reduction
5107924|NCT01181466|heterogeneous|heterogeneous
5107925|NCT01181466|homogeneous|homogeneous
5107926|NCT01181466|Pathologic Processes|pathologic processes
5107927|NCT01181466|Respiratory Tract Diseases|respiratory tract diseases
5107928|NCT01181466|Lung Diseases|lung diseases
5107929|NCT01181466|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
5107930|NCT01181453|Diabetic foot ulcer|diabetic foot ulcer
5107931|NCT01181453|Randomized trial|randomized trial
5107932|NCT01181453|Clinical trial|clinical trial
5107933|NCT01181453|Dermagraft|dermagraft
5107934|NCT01181453|Standard care|standard care
5107935|NCT01181440|Diabetic foot ulcer|diabetic foot ulcer
5107936|NCT01181440|Randomized trial|randomized trial
5107937|NCT01181440|Clinical trial|clinical trial
5107938|NCT01181440|Dermagraft|dermagraft
5107939|NCT01181440|Conventional care|conventional care
5107940|NCT01181414|Permanent Atrial Fibrillation|permanent atrial fibrillation
5107941|NCT01181414|Resynchronization therapy|resynchronization therapy
5107942|NCT01181414|Ablation|ablation
5107943|NCT01181401|induction chemotherapy|induction chemotherapy
5107944|NCT01181401|radiotherapy|radiotherapy
5107945|NCT01181401|locally advanced head neck tumor|locally advanced head neck tumor
5107946|NCT01181401|toxicity|toxicity
5107947|NCT01181401|LA SCCHN|la scchn
5107948|NCT01181401|Unresectable squamous cell cancer of the head and neck,|unresectable squamous cell cancer of the head and neck,
5107949|NCT01181401|Stage IV (UICC)|stage iv (uicc)
5107950|NCT01181375|cervical cancer|cervical cancer
5107951|NCT01181375|assay|assay
5107952|NCT01181375|hypoxia|hypoxia
5107953|NCT01181362|Endoscopy|endoscopy
5107954|NCT01181362|Head and Neck region|head and neck region
5107955|NCT01181362|Scope|scope
5107956|NCT01181349|neuromuscular blockade; general anesthesia|neuromuscular blockade; general anesthesia
5107957|NCT01181336|Safety|safety
5107958|NCT01181336|Tolerability|tolerability
5107959|NCT01181336|Immunogenicity|immunogenicity
5107960|NCT01181336|Influenza|influenza
5107961|NCT01181336|Virus|virus
5107962|NCT01181336|Vaccine|vaccine
5107963|NCT01181323|influenza, vaccine, breastfeeding, post-partum women, infant, LAIV, TIV, parent protocol|influenza, vaccine, breastfeeding, post-partum women, infant, laiv, tiv, parent protocol
5107964|NCT01181310|dementia, cognitive impairment, neurodegeneration, Alzheimer's, acetylcholine, AchE|dementia, cognitive impairment, neurodegeneration, alzheimer's, acetylcholine, ache
5107965|NCT01181297|Confirmed milk allergy|confirmed milk allergy
5107966|NCT01181284|Pulmonary Arterial Hypertension (PAH)|pulmonary arterial hypertension (pah)
5107967|NCT01181271|Lymphoma|lymphoma
5107968|NCT01181271|non-hodgkins lymphoma|non-hodgkins lymphoma
5107969|NCT01181271|Hodgkin's lymphoma|hodgkin's lymphoma
5107970|NCT01181271|Hodgkin's disease|hodgkin's disease
5107971|NCT01181271|stem cell transplant|stem cell transplant
5107972|NCT01181271|High-risk diffuse large B cell|high-risk diffuse large b cell
5107973|NCT01181271|Transformed low grade lymphoma|transformed low grade lymphoma
5107974|NCT01181271|T-cell non-Hodgkin's lymphoma|t-cell non-hodgkin's lymphoma
5107975|NCT01181271|Mantle cell lymphoma at any time in therapy|mantle cell lymphoma at any time in therapy
5107976|NCT01181271|"Double-hit lymphoma"|"double-hit lymphoma"
5107977|NCT01181258|related HLA-haploidentical donor|related hla-haploidentical donor
5107978|NCT01181245|Pancreatic Cancer|pancreatic cancer
5107979|NCT01181232|insomnia|insomnia
5107980|NCT01181232|zolpidem|zolpidem
5107981|NCT01181206|Surgical site infections|surgical site infections
5107982|NCT01181206|Covering the abdominal wound edge in laparotomies|covering the abdominal wound edge in laparotomies
5107983|NCT01181193|glioblastoma multiforme|glioblastoma multiforme
5107984|NCT01181193|chemoradiotherapy|chemoradiotherapy
5107985|NCT01181193|vitamin D|vitamin d
5107986|NCT01181180|Ageing|ageing
5107987|NCT01181180|Balance control|balance control
5107988|NCT01181180|Falls|falls
5107989|NCT01181180|dehydration|dehydration
5107990|NCT01181167|Anticoagulants|anticoagulants
5107991|NCT01181167|Venous thromboembolism|venous thromboembolism
5107992|NCT01181167|Thromboembolism|thromboembolism
5107993|NCT01181167|Thrombosis|thrombosis
5107994|NCT01181167|enoxaparin sodium|enoxaparin sodium
5107995|NCT01181167|Embolism|embolism
5107996|NCT01181167|Deep vein thrombosis|deep vein thrombosis
5107997|NCT01181167|DU-176b|du-176b
5107998|NCT01181167|edoxaban|edoxaban
5107999|NCT01181167|factor Xa|factor xa
5108000|NCT01181167|total hip arthroplasty|total hip arthroplasty
5108001|NCT01181154|Auto-Immune|auto-immune
5108002|NCT01181154|Hemolytic|hemolytic
5108003|NCT01181154|Anemia|anemia
5108004|NCT01181154|AHA|aha
5108005|NCT01181154|AIHA|aiha
5108006|NCT01181154|Rituximab|rituximab
5108007|NCT01181141|Anticoagulants|anticoagulants
5108008|NCT01181141|Enoxaparin sodium|enoxaparin sodium
5108009|NCT01181141|venous thromboembolism.|venous thromboembolism.
5108010|NCT01181141|thromboembolism|thromboembolism
5108011|NCT01181141|Thrombosis|thrombosis
5108012|NCT01181141|deep vein thrombosis|deep vein thrombosis
5108013|NCT01181141|DU-176b|du-176b
5108014|NCT01181141|Edoxaban|edoxaban
5108015|NCT01181141|factor Xa|factor xa
5108016|NCT01181141|hip fracture surgery|hip fracture surgery
5108018|NCT01181115|Chinese Patients|chinese patients
5108019|NCT01181115|Relapsing MS|relapsing ms
5108020|NCT01181115|Safety|safety
5108021|NCT01181115|Avonex|avonex
5108022|NCT01181115|Tolerability|tolerability
5108023|NCT01181115|Gadolinium|gadolinium
5108024|NCT01181115|Interferon Beta 1a|interferon beta 1a
5108025|NCT01181102|anticoagulant|anticoagulant
5108026|NCT01181102|venus thromboembolism|venus thromboembolism
5108027|NCT01181102|thrombosis|thrombosis
5108028|NCT01181102|thromboembolism|thromboembolism
5108029|NCT01181102|embolism and thrombosis|embolism and thrombosis
5108030|NCT01181102|deep vein thrombosis|deep vein thrombosis
5108031|NCT01181102|DU-176b|du-176b
5108032|NCT01181102|Edoxaban|edoxaban
5108033|NCT01181102|factor Xa|factor xa
5108034|NCT01181102|total knee arthroplasty|total knee arthroplasty
5108035|NCT01181102|Enoxaparin sodium|enoxaparin sodium
5108036|NCT01181076|Stem cell transplantation|stem cell transplantation
5108037|NCT01181076|Individualized Nutrition|individualized nutrition
5108038|NCT01181076|Quality of life|quality of life
5108039|NCT01181076|Oral Mucositis|oral mucositis
5108040|NCT01181076|Adult|adult
5108041|NCT01181063|Asthma|asthma
5108042|NCT01181063|Easyhaler|easyhaler
5108043|NCT01181037|Displaced subcapital femoral fracture|displaced subcapital femoral fracture
5108044|NCT01181037|Bbipolar H.A.|bbipolar h.a.
5108045|NCT01181037|CRIF with Ttrochanteric Antegrade Nail|crif with ttrochanteric antegrade nail
5108046|NCT01180972|Obesity, diabetes, hispanic, physical activity, nutrition|obesity, diabetes, hispanic, physical activity, nutrition
5108047|NCT01180959|Advanced Liver Cancer|advanced liver cancer
5108048|NCT01180959|primary neoplasm of the liver|primary neoplasm of the liver
5108049|NCT01180959|Erlotinib|erlotinib
5108050|NCT01180959|Bevacizumab|bevacizumab
5108051|NCT01180959|Hepatocellular Carcinoma|hepatocellular carcinoma
5108052|NCT01180959|HCC|hcc
5108053|NCT01180959|Avastin|avastin
5108054|NCT01180959|Anti-VEGF monoclonal antibody|anti-vegf monoclonal antibody
5108055|NCT01180959|rhuMAb-VEGF|rhumab-vegf
5108056|NCT01180959|OSI-774|osi-774
5108057|NCT01180959|Tarceva|tarceva
5108058|NCT01180946|FGF23|fgf23
5108059|NCT01180946|FGF-23|fgf-23
5108060|NCT01180946|vitamin D|vitamin d
5108061|NCT01180946|vitamin D deficiency|vitamin d deficiency
5108062|NCT01180946|insulin resistance|insulin resistance
5108063|NCT01180946|Healthy volunteers|healthy volunteers
5108064|NCT01180933|docosahexaenoic acid|docosahexaenoic acid
5108065|NCT01180933|folate|folate
5108066|NCT01180933|neurological development|neurological development
5108067|NCT01180933|allergies|allergies
5108068|NCT01180933|long term consequences for the offspring|long term consequences for the offspring
5108069|NCT01180933|allergy risk|allergy risk
5108070|NCT01180920|Dental|dental
5108071|NCT01180920|Periodontal|periodontal
5108072|NCT01180920|Surgery|surgery
5108073|NCT01180920|Gums|gums
5108074|NCT01180907|18F-FAC|18f-fac
5108075|NCT01180907|imaging|imaging
5108076|NCT01180907|cancer|cancer
5108077|NCT01180907|inflammation|inflammation
5108078|NCT01180907|PET|pet
5108079|NCT01180894|Trauma|trauma
5108080|NCT01180894|Anemia|anemia
5108081|NCT01180894|Iron|iron
5108082|NCT01180894|Erythropoeisis|erythropoeisis
5108083|NCT01180881|Proton Radiation|proton radiation
5108084|NCT01180881|CNS tumors|cns tumors
5108085|NCT01180881|Brain Tumors|brain tumors
5108086|NCT01180881|Neurobehavioral functioning|neurobehavioral functioning
5108087|NCT01180868|imaging probe|imaging probe
5108088|NCT01180868|cancer|cancer
5108089|NCT01180868|inflammatory tissue|inflammatory tissue
5108090|NCT01180868|inflammatory diseases|inflammatory diseases
5108091|NCT01180855|Melatonin|melatonin
5108092|NCT01180855|Cognitive Behavior Therapy|cognitive behavior therapy
5108093|NCT01180842|CF|cf
5108094|NCT01180816|GBM|gbm
5108095|NCT01180816|AA|aa
5108096|NCT01180816|AO|ao
5108097|NCT01180816|Brain|brain
5108098|NCT01180816|Tumors|tumors
5108099|NCT01180816|Malignant|malignant
5108100|NCT01180816|Glioblastoma|glioblastoma
5108101|NCT01180816|Multiforme|multiforme
5108102|NCT01180816|Anaplastic|anaplastic
5108103|NCT01180816|Astrocytoma|astrocytoma
5108104|NCT01180803|COPD - long term oxygenotherapy|copd - long term oxygenotherapy
5108105|NCT01180803|COPD patients with respiratory failure|copd patients with respiratory failure
5108106|NCT01180790|HCV|hcv
5108107|NCT01180790|Hepatitis C Genotype 1|hepatitis c genotype 1
5108108|NCT01180764|hypertriglyceridemia|hypertriglyceridemia
5108109|NCT01180764|omega-3 acid ethyl esters|omega-3 acid ethyl esters
5108110|NCT01180764|high-density lipoproteins|high-density lipoproteins
5108111|NCT01180764|fish oil|fish oil
5108112|NCT01180751|Positron Emission Tomography|positron emission tomography
5108113|NCT01180751|Fluorodeoxyglucose|fluorodeoxyglucose
5108114|NCT01180751|FDG (18F-Fluorodeoxyglucose)|fdg (18f-fluorodeoxyglucose)
5108115|NCT01180751|Oncology|oncology
5108116|NCT01180751|Neurology|neurology
5108117|NCT01180738|chronic stroke|chronic stroke
5108118|NCT01180738|walking training|walking training
5108119|NCT01180738|rehabilitation|rehabilitation
5108120|NCT01180738|body weight supported treadmill training|body weight supported treadmill training
5108121|NCT01180738|physical therapy|physical therapy
5108122|NCT01180738|balance|balance
5108123|NCT01180725|To investigate and compare the effects of dried plums and psyllium on the overall relief of constipation symptoms|to investigate and compare the effects of dried plums and psyllium on the overall relief of constipation symptoms
5108124|NCT01180725|To investigate and compare the taste of dried plums and psyllium|to investigate and compare the taste of dried plums and psyllium
5108125|NCT01180725|To investigate and compare the quality of life of dried plums and psyllium|to investigate and compare the quality of life of dried plums and psyllium
5108126|NCT01180712|anthocyanin|anthocyanin
5108127|NCT01180712|blaeberries|blaeberries
5108128|NCT01180712|bilberries|bilberries
5108129|NCT01180712|blueberries|blueberries
5108130|NCT01180712|mirtoselect|mirtoselect
5108131|NCT01180712|type 2 diabetes|type 2 diabetes
5108132|NCT01180712|insulin resistance|insulin resistance
5108133|NCT01180712|Adipose tissue|adipose tissue
5108134|NCT01180712|inflammation|inflammation
5108135|NCT01180699|adult solid organ transplant patients|adult solid organ transplant patients
5108136|NCT01180686|low back pain|low back pain
5108137|NCT01180686|chiropractic|chiropractic
5108138|NCT01180686|manipulation|manipulation
5108139|NCT01180673|Hypertension|hypertension
5108140|NCT01180673|Older Adults|older adults
5108141|NCT01180673|Motivational Interviewing|motivational interviewing
5108142|NCT01180673|Lifestyle Counseling|lifestyle counseling
5108143|NCT01180673|Senior Centers|senior centers
5108144|NCT01180660|Gastric Surgery|gastric surgery
5108145|NCT01180660|Pain|pain
5108146|NCT01180660|Recovery|recovery
5108147|NCT01180660|Laparoscopic Surgery|laparoscopic surgery
5108148|NCT01180647|Extended-release naltrexone|extended-release naltrexone
5108149|NCT01180647|Prisoners|prisoners
5108150|NCT01180647|Opioid addiction prevention|opioid addiction prevention
5108151|NCT01180647|Medication Treatment Alternatives|medication treatment alternatives
5108152|NCT01180647|Prevention of Relapse to Opioid Addiction|prevention of relapse to opioid addiction
5108153|NCT01180621|vaccine|vaccine
5108154|NCT01180621|Seasonal Influenza Vaccine|seasonal influenza vaccine
5108155|NCT01180621|Influenza Vaccine|influenza vaccine
5108156|NCT01180621|Vaccine Safety|vaccine safety
5108157|NCT01180621|Vaccine Immunogenicity|vaccine immunogenicity
5108158|NCT01180621|Fluviral 2010-2011|fluviral 2010-2011
5108159|NCT01180608|neuropathic pain|neuropathic pain
5108160|NCT01180608|Diabetic Polyneuropathy|diabetic polyneuropathy
5108161|NCT01180595|osteoarthritis|osteoarthritis
5108162|NCT01180595|arthroplasty|arthroplasty
5108163|NCT01180595|knee joint|knee joint
5108164|NCT01180595|radiography|radiography
5108165|NCT01180595|surgery|surgery
5108166|NCT01180595|Bone Density|bone density
5108167|NCT01180595|Outcome Assessment (Health Care)|outcome assessment (health care)
5108168|NCT01180582|knee|knee
5108169|NCT01180582|arthroplasty|arthroplasty
5108171|NCT01180582|migration|migration
5108172|NCT01180582|micromotion|micromotion
5108173|NCT01180582|osteoarthritis|osteoarthritis
5108174|NCT01180569|Lenalidomide|lenalidomide
5108175|NCT01180569|10-022|10-022
5108176|NCT01180556|childhood|childhood
5108177|NCT01180556|abdominal pain|abdominal pain
5108178|NCT01180556|probiotics|probiotics
5108179|NCT01180517|Angioplasty Balloon|angioplasty balloon
5108180|NCT01180504|ovarian cancer|ovarian cancer
5108181|NCT01180504|whole-abdominal radiotherapy|whole-abdominal radiotherapy
5108182|NCT01180504|consolidation treatment|consolidation treatment
5108183|NCT01180504|helical tomotherapy|helical tomotherapy
5108184|NCT01180491|Discoloured and deformed nails resulting from onychomycosis|discoloured and deformed nails resulting from onychomycosis
5108185|NCT01180478|Bladder Cancer|bladder cancer
5108186|NCT01180478|Urothelial carcinoma|urothelial carcinoma
5108187|NCT01180478|Stage pTa or pT1|stage pta or pt1
5108188|NCT01180478|NMIBC Ta/T1|nmibc ta/t1
5108189|NCT01180478|Narrow Band Imaging|narrow band imaging
5108190|NCT01180478|White Light Cystoscopy|white light cystoscopy
5108191|NCT01180478|Transurethral resection|transurethral resection
5108192|NCT01180478|Superficial bladder tumor|superficial bladder tumor
5108193|NCT01180478|Positive urine cytology|positive urine cytology
5108194|NCT01180465|Treatment of abdominal adiposity|treatment of abdominal adiposity
5108195|NCT01180452|Crohn disease|crohn disease
5108196|NCT01180452|dysplasia|dysplasia
5108197|NCT01180452|adenocarcinoma|adenocarcinoma
5108198|NCT01180452|endoscopy|endoscopy
5108199|NCT01180452|jejunum|jejunum
5108200|NCT01180452|ileum|ileum
5108201|NCT01180439|Non-invasive ventilation|non-invasive ventilation
5108202|NCT01180439|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5108203|NCT01180439|Patient-ventilator synchronisation|patient-ventilator synchronisation
5108204|NCT01180439|Sleep study|sleep study
5108205|NCT01180439|Polysomnography|polysomnography
5108206|NCT01180426|Relapse Refractory Acute Myeloid Leukemia|relapse refractory acute myeloid leukemia
5108207|NCT01180413|Inward eutrophic remodelling|inward eutrophic remodelling
5108208|NCT01180400|Major Depressive Disorder|major depressive disorder
5108209|NCT01180400|MDD|mdd
5108210|NCT01180400|Depression|depression
5108211|NCT01180400|Safety|safety
5108212|NCT01180400|add-on therapy|add-on therapy
5108213|NCT01180374|Cannabis|cannabis
5108214|NCT01180374|Marijuana|marijuana
5108215|NCT01180374|Cannabidiol|cannabidiol
5108216|NCT01180374|CBD|cbd
5108217|NCT01180374|THC|thc
5108218|NCT01180374|Psychotic Disorders|psychotic disorders
5108219|NCT01180361|rheumatoid arthritis|rheumatoid arthritis
5108220|NCT01180361|systemic lupus erythematosus|systemic lupus erythematosus
5108221|NCT01180361|atherosclerosis|atherosclerosis
5108222|NCT01180361|adenosine|adenosine
5108223|NCT01180348|Wrinkles, glabellar, facial.|wrinkles, glabellar, facial.
5108224|NCT01180335|Genomic driven chemotherapy|genomic driven chemotherapy
5108225|NCT01180322|azacitidine|azacitidine
5108226|NCT01180322|Acute myeloid Leukemia (AML)|acute myeloid leukemia (aml)
5108227|NCT01180309|Tongue frenum|tongue frenum
5108228|NCT01180309|Lingual frenum|lingual frenum
5108229|NCT01180309|Audio Phonology|audio phonology
5108230|NCT01180309|Speech disorders|speech disorders
5108231|NCT01180296|Preterm birth, prevention, progesterone, oral|preterm birth, prevention, progesterone, oral
5108232|NCT01180283|Erectile dysfunction|erectile dysfunction
5108233|NCT01180283|Lodenafil carbonate|lodenafil carbonate
5108234|NCT01180283|Diabetes|diabetes
5108235|NCT01180270|Cervical dystonia|cervical dystonia
5108236|NCT01180270|torticollis spasmodicus|torticollis spasmodicus
5108237|NCT01180270|botulinum toxin|botulinum toxin
5108238|NCT01180270|Subjective visual vertical (SVV)|subjective visual vertical (svv)
5108239|NCT01180270|SVV|svv
5108240|NCT01180270|static graviceptive function|static graviceptive function
5108241|NCT01180244|fibromyalgia|fibromyalgia
5108242|NCT01180244|noninvasive|noninvasive
5108243|NCT01180244|electrical|electrical
5108244|NCT01180244|cortical|cortical
5108245|NCT01180244|stimulation|stimulation
5108246|NCT01180244|pain|pain
5108247|NCT01180244|brain|brain
5108248|NCT01180244|tender point|tender point
5108249|NCT01180231|Overweight or obese young adults (18 to 30 years old) with no previous history of cardiovascular disease/psychiatric illness, and not on medications|overweight or obese young adults (18 to 30 years old) with no previous history of cardiovascular disease/psychiatric illness, and not on medications
5108250|NCT01180218|myocardial revascularization|myocardial revascularization
5108251|NCT01180218|myocardial infarction|myocardial infarction
5108252|NCT01180205|FMD|fmd
5108253|NCT01180205|hypertension|hypertension
5108254|NCT01180205|Telmisartan|telmisartan
5108255|NCT01180205|Amlodipine|amlodipine
5108256|NCT01180192|blood loss|blood loss
5108257|NCT01180192|oxygen inhalation|oxygen inhalation
5108258|NCT01180179|H. pylori-negative idiopathic peptic ulcers|h. pylori-negative idiopathic peptic ulcers
5108259|NCT01180179|Recurrent ulcer bleeding|recurrent ulcer bleeding
5108260|NCT01180166|Gastric cancer|gastric cancer
5108261|NCT01180166|concurrent chemoradiotherapy|concurrent chemoradiotherapy
5108262|NCT01180166|target therapy|target therapy
5108263|NCT01180153|40 S-1/L-OHP|40 s-1/l-ohp
5108264|NCT01180153|biliary tract|biliary tract
5108265|NCT01180153|ampullary carcinoma|ampullary carcinoma
5108266|NCT01180140|Seamguard|seamguard
5108267|NCT01180140|staple-line reinforcement|staple-line reinforcement
5108268|NCT01180140|leak|leak
5108269|NCT01180140|bleeding|bleeding
5108270|NCT01180127|flavonol|flavonol
5108271|NCT01180127|exercise|exercise
5108272|NCT01180127|dentate gyrus|dentate gyrus
5108273|NCT01180127|cerebral blood volume|cerebral blood volume
5108274|NCT01180127|dentate gyrus CBV|dentate gyrus cbv
5108275|NCT01180114|economic empowerment model,|economic empowerment model,
5108276|NCT01180114|orphaned children and youth,|orphaned children and youth,
5108277|NCT01180114|Uganda,|uganda,
5108278|NCT01180114|sub-Saharan Africa|sub-saharan africa
5108279|NCT01180101|Obesity|obesity
5108280|NCT01180101|Chronic Kidney Disease|chronic kidney disease
5108281|NCT01180088|LIVER TUMOURS|liver tumours
5108282|NCT01180062|Latanoprost subconjunctival insert|latanoprost subconjunctival insert
5108283|NCT01180049|Mantle Cell Lymphoma|mantle cell lymphoma
5108284|NCT01180049|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
5108285|NCT01180049|temsirolimus|temsirolimus
5108286|NCT01180036|Membranous Nephropathy|membranous nephropathy
5108287|NCT01180023|GBS|gbs
5108288|NCT01180023|Membrane sweeping|membrane sweeping
5108289|NCT01180010|Hodgkin's Lymphoma|hodgkin's lymphoma
5108290|NCT01180010|Lung Cancer|lung cancer
5108291|NCT01180010|Lung Nodule|lung nodule
5108292|NCT01180010|CT scan|ct scan
5108293|NCT01179971|n-3 fatty acids|n-3 fatty acids
5108294|NCT01179971|n-6 fatty acids|n-6 fatty acids
5108295|NCT01179971|anti-inflammatory action|anti-inflammatory action
5108296|NCT01179971|clinical trial|clinical trial
5108297|NCT01179971|randomized double-blinded|randomized double-blinded
5108298|NCT01179971|incorporation of fatty acids|incorporation of fatty acids
5108299|NCT01179958|cognitive function|cognitive function
5108300|NCT01179958|fMRI|fmri
5108301|NCT01179958|apoE|apoe
5108302|NCT01179958|inflammatory markers|inflammatory markers
5108303|NCT01179958|exercise|exercise
5108304|NCT01179945|diabetes|diabetes
5108305|NCT01179945|benzoic acid|benzoic acid
5108306|NCT01179945|benzoate|benzoate
5108307|NCT01179945|soda|soda
5108308|NCT01179945|soft drink|soft drink
5108309|NCT01179945|preservative|preservative
5108310|NCT01179945|blood sugar|blood sugar
5108311|NCT01179932|Pilot|pilot
5108312|NCT01179932|Charting|charting
5108313|NCT01179932|Anesthesia Record|anesthesia record
5108314|NCT01179932|Cardiac surgical operating room|cardiac surgical operating room
5108315|NCT01179932|Cardiac surgical intensive care unit|cardiac surgical intensive care unit
5108316|NCT01179932|Electrophysiology lab|electrophysiology lab
5108317|NCT01179919|Oseltamivir|oseltamivir
5108318|NCT01179919|Obesity|obesity
5108319|NCT01179919|Influenza|influenza
5108320|NCT01179919|Pharmacokinetics in Obesity|pharmacokinetics in obesity
5108321|NCT01179906|CKD|ckd
5108322|NCT01179893|Myasthenia Gravis|myasthenia gravis
5108323|NCT01179893|IVIG|ivig
5108324|NCT01179893|PLEX|plex
5108325|NCT01179880|Dermatitis|dermatitis
5108326|NCT01179880|Atopic|atopic
5108327|NCT01179867|Medication reconciliation|medication reconciliation
5108328|NCT01179867|Adverse drug events|adverse drug events
5108329|NCT01179867|Hospital readmission|hospital readmission
5108330|NCT01179867|Medication management|medication management
5108331|NCT01179841|Autism Spectrum Disorder|autism spectrum disorder
5108332|NCT01179841|language|language
5108333|NCT01179841|social|social
5108334|NCT01179841|toddlers|toddlers
5108335|NCT01179828|Quantitative sensory testing|quantitative sensory testing
5108336|NCT01179828|Drug efficacy|drug efficacy
5108337|NCT01179828|Low back pain syndrome|low back pain syndrome
5108338|NCT01179828|Imipramine|imipramine
5108339|NCT01179828|Oxycodone|oxycodone
5108340|NCT01179828|Clobazam|clobazam
5108341|NCT01179828|Tolterodine|tolterodine
5108342|NCT01179815|Patients with type 1 or type 2 diabetes mellitus|patients with type 1 or type 2 diabetes mellitus
5108343|NCT01179815|Monogenetic diabetes|monogenetic diabetes
5108344|NCT01179815|Pancreatogenic diabetes,|pancreatogenic diabetes,
5108345|NCT01179815|Drug-induced diabetes, other forms|drug-induced diabetes, other forms
5108346|NCT01179815|Cohort Studies|cohort studies
5108347|NCT01179789|Healthy Elderly People|healthy elderly people
5108348|NCT01179776|ST-eleveation|st-eleveation
5108349|NCT01179776|Myocardial infarct|myocardial infarct
5108350|NCT01179776|Percutaneous coronary intervention|percutaneous coronary intervention
5108351|NCT01179776|Myocardial infarct STEMI patients|myocardial infarct stemi patients
5108352|NCT01179763|Amblyopia|amblyopia
5108353|NCT01179763|Retinal layer thickness|retinal layer thickness
5108354|NCT01179750|Ultrasonic coagulating shears in gastrectomy|ultrasonic coagulating shears in gastrectomy
5108355|NCT01179737|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
5108356|NCT01179737|Nilotinib|nilotinib
5108357|NCT01179737|6MWD|6mwd
5108358|NCT01179737|Pulmonary Hypertension|pulmonary hypertension
5108359|NCT01179711|accommodative esotropia|accommodative esotropia
5108360|NCT01179698|computer-assisted surgery|computer-assisted surgery
5108361|NCT01179698|bone tumor|bone tumor
5108362|NCT01179698|We will evaluate whether computer-assisted surgery|we will evaluate whether computer-assisted surgery
5108363|NCT01179698|will be feasible and safe for bone tumor resection|will be feasible and safe for bone tumor resection
5108364|NCT01179672|Diabetic Peripheral Neuropathic Pain|diabetic peripheral neuropathic pain
5108365|NCT01179659|Single dose crossover BE study|single dose crossover be study
5108366|NCT01179646|Bioequivalency|bioequivalency
5108367|NCT01179620|Hemodialysis, Certoparin|hemodialysis, certoparin
5108368|NCT01179581|Safety|safety
5108369|NCT01179581|Tolerability|tolerability
5108370|NCT01179581|Pharmacokinetics|pharmacokinetics
5108371|NCT01179568|Grief|grief
5108372|NCT01179568|Bereavement|bereavement
5108373|NCT01179568|Psychotherapy|psychotherapy
5108374|NCT01179568|Medication|medication
5108375|NCT01179568|Treatment study|treatment study
5108376|NCT01179555|Diabetic Complications|diabetic complications
5108377|NCT01179555|Intervention Studies|intervention studies
5108378|NCT01179555|African Americans|african americans
5108379|NCT01179555|Vision Screening|vision screening
5108380|NCT01179555|Vision, Low|vision, low
5108381|NCT01179555|Geriatric Assessment|geriatric assessment
5108382|NCT01179555|Outcomes Assessment|outcomes assessment
5108383|NCT01179555|Cultural Characteristics|cultural characteristics
5108384|NCT01179555|Cultural Competency|cultural competency
5108385|NCT01179555|Appointment Adherence|appointment adherence
5108386|NCT01179555|Cost-effectiveness|cost-effectiveness
5108387|NCT01179555|Personalization of care|personalization of care
5108388|NCT01179555|Follow-up Care|follow-up care
5108389|NCT01179542|iugr pet eIF4E Translation Initiation Factor|iugr pet eif4e translation initiation factor
5108390|NCT01179542|4E (eIF4E) in Human Placental Implantation and in the Pathological Pregnancies: Preeclampsia and IUGR|4e (eif4e) in human placental implantation and in the pathological pregnancies: preeclampsia and iugr
5108391|NCT01179529|Atopic dermatitis (atopic eczema)|atopic dermatitis (atopic eczema)
5108392|NCT01179516|Major Depressive Disorder|major depressive disorder
5108393|NCT01179516|Depression|depression
5108394|NCT01179516|Drug Therapy|drug therapy
5108395|NCT01179503|vitamin D|vitamin d
5108396|NCT01179503|physical performance|physical performance
5108397|NCT01179490|Multiple Myeloma|multiple myeloma
5108398|NCT01179477|Left heart pacing lead|left heart pacing lead
5108399|NCT01179477|Cardiac resynchronization therapy (CRT)|cardiac resynchronization therapy (crt)
5108400|NCT01179477|Heart failure|heart failure
5108401|NCT01179425|marijuana|marijuana
5108402|NCT01179425|dependence|dependence
5108403|NCT01179425|cognition|cognition
5108404|NCT01179425|stress|stress
5108405|NCT01179386|methylphenidate|methylphenidate
5108406|NCT01179386|ADHD|adhd
5108407|NCT01179386|driving|driving
5108408|NCT01179386|simulator|simulator
5108409|NCT01179386|pressure|pressure
5108410|NCT01179386|adolescent|adolescent
5108411|NCT01179360|Locally advanced|locally advanced
5108412|NCT01179360|HNSCC|hnscc
5108413|NCT01179334|Pulmonary Hypertension|pulmonary hypertension
5108414|NCT01179334|Riociguat|riociguat
5108415|NCT01179334|Blood Pressure|blood pressure
5108416|NCT01179308|regional analgesia|regional analgesia
5108417|NCT01179308|routine general anesthesia|routine general anesthesia
5108418|NCT01179308|immune system response|immune system response
5108419|NCT01179308|lung cancer (stage 1-3)|lung cancer (stage 1-3)
5108420|NCT01179295|MEK inhibitor|mek inhibitor
5108421|NCT01179295|BAY86-9766|bay86-9766
5108422|NCT01179295|RDEA 119|rdea 119
5108423|NCT01179295|Solid tumor|solid tumor
5108424|NCT01179282|DUST MITE ALLERGIES|dust mite allergies
5108425|NCT01179269|Non-small cell lung cancer|non-small cell lung cancer
5108426|NCT01179269|Pazopanib|pazopanib
5108427|NCT01179269|Stage IIIB/IV non small cell lung cancer|stage iiib/iv non small cell lung cancer
5108428|NCT01179256|ASTHMA|asthma
5108429|NCT01179243|microcirculatory alterations|microcirculatory alterations
5108430|NCT01179243|SDF imaging|sdf imaging
5108431|NCT01179230|CAD|cad
5108432|NCT01179230|chest pain|chest pain
5108433|NCT01179230|acute coronary syndrome|acute coronary syndrome
5108434|NCT01179230|Myocardial perfusion imaging|myocardial perfusion imaging
5108435|NCT01179217|Sickle Cell Anemia|sickle cell anemia
5108436|NCT01179217|Sickle Cell Pain Crises|sickle cell pain crises
5108437|NCT01179217|Painful Crises|painful crises
5108438|NCT01179217|Sickle Cell Pain|sickle cell pain
5108439|NCT01179217|Vaso-occlusive Crises|vaso-occlusive crises
5108440|NCT01179191|chronic pain|chronic pain
5108441|NCT01179191|Embeda|embeda
5108442|NCT01179191|opioid|opioid
5108443|NCT01179191|moderate pain|moderate pain
5108444|NCT01179191|severe pain|severe pain
5108445|NCT01179191|conversion|conversion
5108446|NCT01179191|converting|converting
5108447|NCT01179191|switching|switching
5108448|NCT01179191|morphine|morphine
5108449|NCT01179191|aberrant behavior|aberrant behavior
5108450|NCT01179191|Pain (DT) + Chronic Disease (DT)|pain (dt) + chronic disease (dt)
5108451|NCT01179152|asthma, september epidemic, children, preventive|asthma, september epidemic, children, preventive
5108452|NCT01179139|CRS|crs
5108453|NCT01179126|myocardial infarction|myocardial infarction
5108454|NCT01179126|primary angioplasty|primary angioplasty
5108455|NCT01179126|multivessel disease|multivessel disease
5108456|NCT01179126|stress echocardiography|stress echocardiography
5108457|NCT01179113|Laminectomy|laminectomy
5108458|NCT01179113|Esmolol Infusion|esmolol infusion
5108459|NCT01179113|Quality of recovery|quality of recovery
5108460|NCT01179113|beta-blockers|beta-blockers
5108461|NCT01179113|Pain management|pain management
5108462|NCT01179113|Postoperative pain|postoperative pain
5108463|NCT01179113|Opioid requirements|opioid requirements
5108464|NCT01179113|Intraoperative esmolol infusion|intraoperative esmolol infusion
5108465|NCT01179113|Return to normal activities of daily living|return to normal activities of daily living
5108466|NCT01179100|elderly|elderly
5108467|NCT01179100|general anesthesia|general anesthesia
5108468|NCT01179100|lidocaine infusion|lidocaine infusion
5108469|NCT01179100|lidocaine|lidocaine
5108470|NCT01179100|local anesthetic|local anesthetic
5108471|NCT01179100|pain management|pain management
5108472|NCT01179100|cognitive function|cognitive function
5108473|NCT01179087|sleep disordered breathing|sleep disordered breathing
5108474|NCT01179087|lung transplantation|lung transplantation
5108475|NCT01179074|palliation inoperable oesophageal cancer|palliation inoperable oesophageal cancer
5108476|NCT01179061|Apelin|apelin
5108477|NCT01179061|Heart failure|heart failure
5108478|NCT01179061|Pulmonary artery pressure|pulmonary artery pressure
5108479|NCT01179061|Inotropic|inotropic
5108480|NCT01179061|Diuretic|diuretic
5108481|NCT01179035|Post-release, community health|post-release, community health
5108482|NCT01179022|Bacteremia|bacteremia
5108483|NCT01179022|Argon Plasma Coagulation|argon plasma coagulation
5108484|NCT01179022|Endobronchial Lesions|endobronchial lesions
5108485|NCT01179009|depression|depression
5108486|NCT01178983|work related musculoskeletal disorders (WRMSD) among computer operators|work related musculoskeletal disorders (wrmsd) among computer operators
5108487|NCT01178957|Type 1 diabetes|type 1 diabetes
5108488|NCT01178957|Very-Low-Density-Lipoprotein(VLDL)|very-low-density-lipoprotein(vldl)
5108489|NCT01178957|Hyperglycemia|hyperglycemia
5108490|NCT01178931|IVF|ivf
5108491|NCT01178931|luteal phase support|luteal phase support
5108492|NCT01178931|oral progesterone|oral progesterone
5108493|NCT01178931|vaginal progesterone|vaginal progesterone
5108494|NCT01178931|pregnancy rate|pregnancy rate
5108495|NCT01178931|safety|safety
5108496|NCT01178931|tolerability|tolerability
5108497|NCT01178918|Influenza H1N1|influenza h1n1
5108498|NCT01178918|Vaccine|vaccine
5108499|NCT01178918|Adjuvant|adjuvant
5108500|NCT01178918|T Lymphocytes|t lymphocytes
5108501|NCT01178918|Non-specific response|non-specific response
5108502|NCT01178918|Interleukin-2|interleukin-2
5108503|NCT01178918|Non-specific T cell responce|non-specific t cell responce
5108504|NCT01178905|Postnatal CMV infection of preterm infants|postnatal cmv infection of preterm infants
5108505|NCT01178905|breast milk|breast milk
5108506|NCT01178892|Hot Flashes|hot flashes
5108507|NCT01178892|Menopause|menopause
5108508|NCT01178892|Vasomotor symptoms|vasomotor symptoms
5108509|NCT01178892|Yoga|yoga
5108510|NCT01178892|Exercise|exercise
5108511|NCT01178892|Omega-3|omega-3
5108512|NCT01178892|Fish oil|fish oil
5108513|NCT01178879|Telehealth|telehealth
5108514|NCT01178879|nurse consultation|nurse consultation
5108515|NCT01178879|outpatient clinic|outpatient clinic
5108516|NCT01178866|thoracic surgery|thoracic surgery
5108517|NCT01178866|myocardial revascularization|myocardial revascularization
5108518|NCT01178866|left ventricular dysfunction|left ventricular dysfunction
5108519|NCT01178866|tissue perfusion|tissue perfusion
5108520|NCT01178866|prognosis|prognosis
5108521|NCT01178853|Healthy Volunteers|healthy volunteers
5108522|NCT01178840|female condom|female condom
5108523|NCT01178840|condom|condom
5108524|NCT01178840|clinical failure|clinical failure
5108525|NCT01178840|prostate-specific antigen|prostate-specific antigen
5108526|NCT01178840|semen exposure|semen exposure
5108527|NCT01178840|acceptability|acceptability
5108528|NCT01178840|Prevention of semen exposure|prevention of semen exposure
5108529|NCT01178801|liver cancer|liver cancer
5108530|NCT01178801|data mining|data mining
5108531|NCT01178801|knowledge discovering|knowledge discovering
5108532|NCT01178801|The clinical data of the patients with liver cancer.|the clinical data of the patients with liver cancer.
5108533|NCT01178788|Progestagens|progestagens
5108534|NCT01178788|Tertiary Prophylaxis|tertiary prophylaxis
5108535|NCT01178788|Micronized Progesterone|micronized progesterone
5108536|NCT01178788|17 alpha hydroxy P|17 alpha hydroxy p
5108537|NCT01178788|Preterm Delivery|preterm delivery
5108538|NCT01178788|Cervical shortening|cervical shortening
5108539|NCT01178775|fatigue|fatigue
5108540|NCT01178775|meaning|meaning
5108541|NCT01178775|education|education
5108542|NCT01178775|walking program|walking program
5108543|NCT01178762|Oral Azithromycin|oral azithromycin
5108544|NCT01178762|Chlamydial Conjunctivitis|chlamydial conjunctivitis
5108545|NCT01178749|Hepatitis C|hepatitis c
5108546|NCT01178749|Interferon|interferon
5108547|NCT01178749|Symptom Distress|symptom distress
5108548|NCT01178749|Quality of Life|quality of life
5108549|NCT01178736|neoplasms|neoplasms
5108550|NCT01178723|breakfast size|breakfast size
5108551|NCT01178723|blood glucose balance|blood glucose balance
5108552|NCT01178723|hormonal profile|hormonal profile
5108553|NCT01178723|appetite hormones|appetite hormones
5108554|NCT01178723|adipokines|adipokines
5108555|NCT01178723|pro-inflammatory cytokines|pro-inflammatory cytokines
5108556|NCT01178684|ENFD|enfd
5108557|NCT01178684|epidermal nerve fiber density|epidermal nerve fiber density
5108558|NCT01178684|HIV|hiv
5108559|NCT01178684|HIV-infection|hiv-infection
5108560|NCT01178671|PTSD|ptsd
5108561|NCT01178671|trauma|trauma
5108562|NCT01178671|anxiety disorder|anxiety disorder
5108563|NCT01178671|medication|medication
5108564|NCT01178671|sertraline|sertraline
5108565|NCT01178671|mirtazapine|mirtazapine
5108566|NCT01178671|pharmacotherapy|pharmacotherapy
5108567|NCT01178632|Herbal|herbal
5108568|NCT01178632|Phytotherapy|phytotherapy
5108569|NCT01178632|Passiflora|passiflora
5108570|NCT01178632|Valeriana|valeriana
5108571|NCT01178632|Anxiety|anxiety
5108572|NCT01178619|IUGR fetuses|iugr fetuses
5108573|NCT01178619|symmetrical IUGR|symmetrical iugr
5108574|NCT01178619|asymmetrical IUGR|asymmetrical iugr
5108575|NCT01178606|echogenic halo around lateral fetal ventricles|echogenic halo around lateral fetal ventricles
5108576|NCT01178593|IBS|ibs
5108577|NCT01178593|RCT|rct
5108578|NCT01178593|psychology|psychology
5108579|NCT01178593|hypnosis|hypnosis
5108580|NCT01178593|psychotherapy|psychotherapy
5108581|NCT01178593|group therapy|group therapy
5108582|NCT01178580|fibrinolytic activity|fibrinolytic activity
5108583|NCT01178580|Community acquired pneumonia (CAP)|community acquired pneumonia (cap)
5108584|NCT01178580|Pleural effusion|pleural effusion
5108585|NCT01178567|laparoscopic sleeve gastrectomy|laparoscopic sleeve gastrectomy
5108586|NCT01178567|Gastrectomy|gastrectomy
5108587|NCT01178567|Pulmonary Complications|pulmonary complications
5108588|NCT01178554|anxiety disorders|anxiety disorders
5108589|NCT01178554|depression|depression
5108590|NCT01178554|depressive disorders|depressive disorders
5108591|NCT01178554|disruptive behavioral problems|disruptive behavioral problems
5108592|NCT01178554|conduct problems|conduct problems
5108593|NCT01178541|ventricles|ventricles
5108594|NCT01178541|fetal|fetal
5108595|NCT01178541|brain|brain
5108596|NCT01178541|asymmetry|asymmetry
5108597|NCT01178528|heart failure|heart failure
5108598|NCT01178528|heart rate|heart rate
5108599|NCT01178528|ivabradine|ivabradine
5108600|NCT01178528|carvedilol|carvedilol
5108601|NCT01178515|epidemiological risk|epidemiological risk
5108602|NCT01178515|diet|diet
5108603|NCT01178515|fat intake|fat intake
5108604|NCT01178450|Renal transplant|renal transplant
5108605|NCT01178450|Hypercalcemia|hypercalcemia
5108606|NCT01178437|seizure disorder,|seizure disorder,
5108607|NCT01178437|seizures,|seizures,
5108608|NCT01178437|convulsions,|convulsions,
5108609|NCT01178437|grand mal,|grand mal,
5108610|NCT01178437|petit mal,|petit mal,
5108611|NCT01178437|absence seizures,|absence seizures,
5108612|NCT01178437|repeated seizures,|repeated seizures,
5108613|NCT01178437|children's seizures,|children's seizures,
5108614|NCT01178437|secondary epilepsy,|secondary epilepsy,
5108615|NCT01178437|symptomatic epilepsy,|symptomatic epilepsy,
5108616|NCT01178437|generalized seizures,|generalized seizures,
5108617|NCT01178437|partial seizure,|partial seizure,
5108618|NCT01178437|focal seizure,|focal seizure,
5108619|NCT01178437|partial complex seizure,|partial complex seizure,
5108620|NCT01178437|anticonvulsant medication|anticonvulsant medication
5108621|NCT01178424|Unipolar depression|unipolar depression
5108622|NCT01178424|Mindfulness based cognitive therapy|mindfulness based cognitive therapy
5108623|NCT01178424|Cognitive behavioural Therapy|cognitive behavioural therapy
5108624|NCT01178424|Functional magnetic resonance imaging|functional magnetic resonance imaging
5108625|NCT01178424|Relapse|relapse
5108626|NCT01178424|Depressive relapse|depressive relapse
5108627|NCT01178424|Dysphoric|dysphoric
5108628|NCT01178424|Cognitive reactivity|cognitive reactivity
5108629|NCT01178424|Serotonin transporter gene|serotonin transporter gene
5108630|NCT01178411|hepatocellular carcinoma|hepatocellular carcinoma
5108631|NCT01178411|renal cell carcinoma|renal cell carcinoma
5108632|NCT01178411|melanoma|melanoma
5108633|NCT01178411|non-small cell lung cancer|non-small cell lung cancer
5108634|NCT01178411|breast cancer|breast cancer
5108635|NCT01178411|ovarian cancer|ovarian cancer
5108636|NCT01178411|MiT tumors|mit tumors
5108637|NCT01178398|fish|fish
5108638|NCT01178398|pregnancy|pregnancy
5108639|NCT01178398|nutrition|nutrition
5108640|NCT01178398|mercury|mercury
5108641|NCT01178398|focus group|focus group
5108642|NCT01178398|omega-3 fatty acid|omega-3 fatty acid
5108643|NCT01178398|docosahexaenoic acid (DHA)|docosahexaenoic acid (dha)
5108644|NCT01178385|Autism|autism
5108645|NCT01178385|Asperger's Syndrome|asperger's syndrome
5108646|NCT01178385|Treatment|treatment
5108647|NCT01178385|Cognitive-behavioral therapy|cognitive-behavioral therapy
5108648|NCT01178385|Anxiety|anxiety
5108649|NCT01178385|Children|children
5108650|NCT01178385|Therapy|therapy
5108651|NCT01178372|hepatic encephalopathy|hepatic encephalopathy
5108652|NCT01178372|lactulose|lactulose
5108653|NCT01178372|probiotics|probiotics
5108654|NCT01178359|cardiac arrest|cardiac arrest
5108655|NCT01178359|ventricular fibrillation|ventricular fibrillation
5108656|NCT01178359|nitrite|nitrite
5108657|NCT01178346|Pharmacoeconomic|pharmacoeconomic
5108658|NCT01178346|Quality of Life|quality of life
5108659|NCT01178346|Health Outcomes|health outcomes
5108660|NCT01178346|Smoking|smoking
5108661|NCT01178346|NicVAX|nicvax
5108662|NCT01178346|Smoking vaccine|smoking vaccine
5108663|NCT01178346|Smoking cessation|smoking cessation
5108664|NCT01178333|Thrombocytopenia|thrombocytopenia
5108665|NCT01178333|Heparin|heparin
5108666|NCT01178320|Magnetic Resonance Imaging|magnetic resonance imaging
5108667|NCT01178320|Atherosclerotic Plaque|atherosclerotic plaque
5108668|NCT01178320|Lipid Lowering Therapy|lipid lowering therapy
5108669|NCT01178307|GI cancers|gi cancers
5108670|NCT01178307|GIST|gist
5108671|NCT01178307|Symptom Severity|symptom severity
5108672|NCT01178307|Quality of Life|quality of life
5108673|NCT01178307|Questionnaire|questionnaire
5108674|NCT01178307|M.D. Anderson Symptom Inventory|m.d. anderson symptom inventory
5108675|NCT01178307|MDASI-GIST|mdasi-gist
5108676|NCT01178307|patient-reported outcomes|patient-reported outcomes
5108677|NCT01178294|hemophilia A|hemophilia a
5108678|NCT01178294|haemophilia A|haemophilia a
5108679|NCT01178294|blood coagulation disorders|blood coagulation disorders
5108680|NCT01178294|hemorrhagic disorders|hemorrhagic disorders
5108681|NCT01178294|coagulation protein disorder|coagulation protein disorder
5108682|NCT01178294|hematologic diseases|hematologic diseases
5108683|NCT01178294|Acquired Hemophilia A|acquired hemophilia a
5108684|NCT01178281|Myelofibrosis|myelofibrosis
5108685|NCT01178281|Post-polycythemia vera myelofibrosis|post-polycythemia vera myelofibrosis
5108686|NCT01178281|Post-essential thrombocythemia myelofibrosis|post-essential thrombocythemia myelofibrosis
5108687|NCT01178281|RBC-transfusion-dependence|rbc-transfusion-dependence
5108688|NCT01178281|Primary Myelofibrosis|primary myelofibrosis
5108689|NCT01178268|Drug eluting stents|drug eluting stents
5108690|NCT01178268|Stents|stents
5108691|NCT01178268|Angioplasty|angioplasty
5108692|NCT01178255|depression|depression
5108693|NCT01178255|homoeopathy|homoeopathy
5108694|NCT01178242|Labial mucous membrane|labial mucous membrane
5108695|NCT01178242|symblepharon|symblepharon
5108696|NCT01178242|dry eye|dry eye
5108697|NCT01178242|Stevens -Johnson syndrome|stevens -johnson syndrome
5108698|NCT01178242|salivary gland|salivary gland
5108699|NCT01178242|ocular surface disease|ocular surface disease
5108700|NCT01178242|transplantation|transplantation
5108701|NCT01178229|Sleep bruxism|sleep bruxism
5108702|NCT01178229|Airway remodeling|airway remodeling
5108703|NCT01178229|Physical therapy modalities|physical therapy modalities
5108704|NCT01178229|Child preschool.|child preschool.
5108705|NCT01178216|Kidney transplant|kidney transplant
5108706|NCT01178216|highly sensitized|highly sensitized
5108707|NCT01178203|Endodontics|endodontics
5108708|NCT01178203|pain|pain
5108709|NCT01178203|visual analogue scale|visual analogue scale
5108710|NCT01178203|NSAIDs|nsaids
5108711|NCT01178190|narrow band imaging|narrow band imaging
5108712|NCT01178190|malignant lesion|malignant lesion
5108713|NCT01178190|lung cancer|lung cancer
5108715|NCT01178177|Invasive pulmonary aspergillosis|invasive pulmonary aspergillosis
5108716|NCT01178177|Solid organ transplantation|solid organ transplantation
5108717|NCT01178177|Hematologic disease|hematologic disease
5108718|NCT01178164|chronic pains|chronic pains
5108719|NCT01178164|unknown aetiology|unknown aetiology
5108720|NCT01178151|Peutz-Jeghers syndrome|peutz-jeghers syndrome
5108721|NCT01178151|mTOR inhibition|mtor inhibition
5108722|NCT01178151|cancer|cancer
5108723|NCT01178138|substance abuse|substance abuse
5108724|NCT01178125|Pregnancy Prevention|pregnancy prevention
5108725|NCT01178125|Oral Contraceptives|oral contraceptives
5108726|NCT01178112|Metastasis|metastasis
5108727|NCT01178112|Carboplatin|carboplatin
5108728|NCT01178112|Trientine|trientine
5108729|NCT01178112|Chemotherapy|chemotherapy
5108730|NCT01178073|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
5108731|NCT01178073|Ambrisentan|ambrisentan
5108732|NCT01178073|Sponsor Rest of World: GSK|sponsor rest of world: gsk
5108733|NCT01178073|Tadalafil|tadalafil
5108734|NCT01178073|PAH|pah
5108735|NCT01178073|Sponsor US: Gilead|sponsor us: gilead
5108736|NCT01178060|Stroke|stroke
5108737|NCT01178060|Risk|risk
5108738|NCT01178060|Communication|communication
5108739|NCT01178060|Cardiovascular Disease Knowledge|cardiovascular disease knowledge
5108740|NCT01178060|Improve Risk Communication|improve risk communication
5108741|NCT01178034|Warfarin|warfarin
5108742|NCT01178034|Dose|dose
5108743|NCT01178034|Pharmacogenetic|pharmacogenetic
5108744|NCT01178034|INR|inr
5108745|NCT01178021|malaria|malaria
5108746|NCT01178021|vivax|vivax
5108747|NCT01178021|relapse|relapse
5108748|NCT01178008|Insomnia|insomnia
5108749|NCT01178008|Post-partum Depression|post-partum depression
5108750|NCT01178008|Electroacupuncture|electroacupuncture
5108751|NCT01178008|Acupuncture|acupuncture
5108752|NCT01178008|Randomized Clinical Trial|randomized clinical trial
5108753|NCT01178008|Traditional Chinese Medicine|traditional chinese medicine
5108754|NCT01177982|pregnancy, opioid, cocaine, alcohol, benzodiazepines, neonate|pregnancy, opioid, cocaine, alcohol, benzodiazepines, neonate
5108755|NCT01177969|Autism|autism
5108756|NCT01177969|Anxiety|anxiety
5108757|NCT01177969|Asperger's Syndrome|asperger's syndrome
5108758|NCT01177969|Cognitive-behavioral therapy|cognitive-behavioral therapy
5108759|NCT01177969|Treatment|treatment
5108760|NCT01177969|Obsessive-compulsive disorder|obsessive-compulsive disorder
5108761|NCT01177969|Fears|fears
5108762|NCT01177956|Recurrent and/or metastatic squamous cell carcinoma of the head and neck|recurrent and/or metastatic squamous cell carcinoma of the head and neck
5108763|NCT01177956|1st-line|1st-line
5108764|NCT01177956|Cetuximab|cetuximab
5108765|NCT01177956|Chemotherapy|chemotherapy
5108766|NCT01177956|EMR 62241 -055|emr 62241 -055
5108767|NCT01177956|Merck KGaA|merck kgaa
5108768|NCT01177956|Recurrent and/or metastatic squamous cell carcinoma of the head and neck (SCCHN)|recurrent and/or metastatic squamous cell carcinoma of the head and neck (scchn)
5108769|NCT01177865|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5108770|NCT01177865|stage I prostate cancer|stage i prostate cancer
5108771|NCT01177865|stage IIB prostate cancer|stage iib prostate cancer
5108772|NCT01177865|stage IIA prostate cancer|stage iia prostate cancer
5108773|NCT01177865|stage III prostate cancer|stage iii prostate cancer
5108774|NCT01177852|cough, acute rhinitis, common cold, nasal symptoms, children.|cough, acute rhinitis, common cold, nasal symptoms, children.
5108775|NCT01177852|Acute inflammation upper airway|acute inflammation upper airway
5108776|NCT01177826|Hospitalized|hospitalized
5108777|NCT01177826|Rotavirus|rotavirus
5108778|NCT01177826|Children|children
5108779|NCT01177826|effectiveness|effectiveness
5108780|NCT01177826|Gastroenteritis|gastroenteritis
5108781|NCT01177800|Psoriasis|psoriasis
5108782|NCT01177800|Infliximab|infliximab
5108783|NCT01177800|Remicade|remicade
5108784|NCT01177787|cryolipolysis fat zeltiq thigh Korean women|cryolipolysis fat zeltiq thigh korean women
5108785|NCT01177774|functional connectivity MRI|functional connectivity mri
5108786|NCT01177774|brain volumetry|brain volumetry
5108787|NCT01177774|negative reinforcement|negative reinforcement
5108788|NCT01177774|OCD|ocd
5108789|NCT01177774|ADHD|adhd
5108790|NCT01177761|Osteoporosis|osteoporosis
5108791|NCT01177761|exercise|exercise
5108792|NCT01177761|fractures|fractures
5108793|NCT01177761|Bone Mineral Density|bone mineral density
5108794|NCT01177761|CHD-risk|chd-risk
5108795|NCT01177748|Stroke|stroke
5108796|NCT01177748|Cardiac Monitoring|cardiac monitoring
5108797|NCT01177735|Pomalidomide|pomalidomide
5108798|NCT01177735|multiple myeloma|multiple myeloma
5108799|NCT01177735|relapsed|relapsed
5108800|NCT01177722|Diphtheria|diphtheria
5108801|NCT01177722|Tetanus|tetanus
5108802|NCT01177722|Whooping cough|whooping cough
5108803|NCT01177722|Hepatitis B|hepatitis b
5108804|NCT01177722|Poliomyelitis|poliomyelitis
5108805|NCT01177722|Diphtheria-Tetanus-acellular Pertussis Vaccines|diphtheria-tetanus-acellular pertussis vaccines
5108806|NCT01177709|schizophrenia|schizophrenia
5108807|NCT01177709|antipsychotics|antipsychotics
5108808|NCT01177709|obesity|obesity
5108809|NCT01177709|diabetes|diabetes
5108810|NCT01177696|caregivers|caregivers
5108811|NCT01177696|Family Health|family health
5108812|NCT01177696|Psychotherapeutic|psychotherapeutic
5108813|NCT01177696|Primary Health Care|primary health care
5108814|NCT01177670|Adiana Permanent Contraception System|adiana permanent contraception system
5108815|NCT01177670|women seeking permanent sterilization.|women seeking permanent sterilization.
5108816|NCT01177631|Carcinoma, hepatocellular|carcinoma, hepatocellular
5108817|NCT01177631|Portal vein|portal vein
5108818|NCT01177631|Proteomics|proteomics
5108819|NCT01177618|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5108820|NCT01177618|COPD|copd
5108821|NCT01177618|Emphysema|emphysema
5108822|NCT01177618|Chronic Bronchitis|chronic bronchitis
5108823|NCT01177618|Genetics|genetics
5108824|NCT01177618|Association Studies|association studies
5108825|NCT01177579|Bariatric surgery, copper deficiency, biomarkers|bariatric surgery, copper deficiency, biomarkers
5108826|NCT01177566|Atopic dermatitis|atopic dermatitis
5108827|NCT01177566|Elidel|elidel
5108828|NCT01177566|pimecrolimus cream 1%|pimecrolimus cream 1%
5108829|NCT01177566|Eletone|eletone
5108830|NCT01177566|medical device cream|medical device cream
5108831|NCT01177566|topical calcineurin inhibitor|topical calcineurin inhibitor
5108832|NCT01177553|Intrauterine Growth Retardation in Monochorionic Twins|intrauterine growth retardation in monochorionic twins
5108833|NCT01177527|Waldenstrom|waldenstrom
5108834|NCT01177527|myeloma|myeloma
5108835|NCT01177527|smoldering|smoldering
5108836|NCT01177527|lymphoma|lymphoma
5108837|NCT01177527|MGUS|mgus
5108838|NCT01177527|distinct B-cell lymphoproliferative disorder|distinct b-cell lymphoproliferative disorder
5108839|NCT01177514|Refractive surgery|refractive surgery
5108840|NCT01177514|PRK|prk
5108841|NCT01177514|PAIN|pain
5108842|NCT01177514|Gabapentin|gabapentin
5108843|NCT01177501|Ovarian cancer|ovarian cancer
5108844|NCT01177501|Topotecan|topotecan
5108845|NCT01177501|Carboplatine|carboplatine
5108846|NCT01177501|Higt dose chemotherapy|higt dose chemotherapy
5108847|NCT01177488|Military|military
5108848|NCT01177488|Health Service Delivery|health service delivery
5108849|NCT01177488|Behavioral Symptoms|behavioral symptoms
5108850|NCT01177488|Telepsychology|telepsychology
5108851|NCT01177488|Behavioral Activation|behavioral activation
5108852|NCT01177488|Exposure Therapy|exposure therapy
5108853|NCT01177488|Veterans|veterans
5108854|NCT01177488|Telemedicine|telemedicine
5108855|NCT01177475|kidney-transplant recipients|kidney-transplant recipients
5108856|NCT01177462|coordinate system|coordinate system
5108857|NCT01177462|normal|normal
5108858|NCT01177449|prolotherapy|prolotherapy
5108859|NCT01177436|prostate cancer|prostate cancer
5108860|NCT01177436|benign prostatic hypertrophy|benign prostatic hypertrophy
5108861|NCT01177423|restorative odontology|restorative odontology
5108862|NCT01177423|Patients cared in restorative odontology department|patients cared in restorative odontology department
5108864|NCT01177410|Diarrhea|diarrhea
5108865|NCT01177410|IBS-D|ibs-d
5108866|NCT01177410|Irritable Bowel Syndrome|irritable bowel syndrome
5108867|NCT01177410|Abdominal pain|abdominal pain
5108868|NCT01177410|Bloating|bloating
5108869|NCT01177397|Advanced solid malignant neoplasms,Non-Hodgkin Lymphoma,|advanced solid malignant neoplasms,non-hodgkin lymphoma,
5108870|NCT01177397|Multiple Myeloma|multiple myeloma
5108871|NCT01177384|Type 2 diabetes mellitus|type 2 diabetes mellitus
5108872|NCT01177384|T2DM|t2dm
5108873|NCT01177358|Scar|scar
5108874|NCT01177358|Botox|botox
5108875|NCT01177332|FFA|ffa
5108876|NCT01177332|Liver|liver
5108877|NCT01177332|steatosis|steatosis
5108878|NCT01177332|exercise|exercise
5108879|NCT01177319|Parkinson's Disease|parkinson's disease
5108880|NCT01177319|Glutathione|glutathione
5108881|NCT01177306|ADHD, working memory|adhd, working memory
5108882|NCT01177293|biological availability|biological availability
5108883|NCT01177293|bioavailability|bioavailability
5108884|NCT01177293|amlodipine|amlodipine
5108885|NCT01177293|orally disintegrating tablet|orally disintegrating tablet
5108886|NCT01177293|ODT|odt
5108887|NCT01177293|tablets|tablets
5108888|NCT01177280|retrospective chronic low back pain|retrospective chronic low back pain
5108889|NCT01177267|retrospective database analysis in osteoarthritis patients|retrospective database analysis in osteoarthritis patients
5108890|NCT01177254|retrospective chronic low back pain|retrospective chronic low back pain
5108891|NCT01177241|retrospective chronic low back pain|retrospective chronic low back pain
5108892|NCT01177215|Algorithm|algorithm
5108893|NCT01177215|Treatment Protocol|treatment protocol
5108894|NCT01177215|Thoracic Drainage Device|thoracic drainage device
5108895|NCT01177202|HAC1, H1N1|hac1, h1n1
5108896|NCT01177189|Oxidative Stress|oxidative stress
5108897|NCT01177189|Free radicals|free radicals
5108898|NCT01177189|Aging|aging
5108899|NCT01177176|Cigarette smoking|cigarette smoking
5108900|NCT01177176|Tobacco smoking|tobacco smoking
5108901|NCT01177163|Type 2 diabetes mellitus|type 2 diabetes mellitus
5108902|NCT01177163|Canagliflozin|canagliflozin
5108903|NCT01177163|JNJ-28431754|jnj-28431754
5108904|NCT01177163|Insulin|insulin
5108905|NCT01177163|Pharmacokinetic|pharmacokinetic
5108906|NCT01177163|Pharmacodynamic|pharmacodynamic
5108907|NCT01177163|SGLT-1|sglt-1
5108908|NCT01177150|Sodium-Glucose Transporter 2|sodium-glucose transporter 2
5108909|NCT01177150|Canagliflozin|canagliflozin
5108910|NCT01177150|Pharmacodynamic|pharmacodynamic
5108911|NCT01177150|Pharmacokinetic|pharmacokinetic
5108912|NCT01177150|Safety|safety
5108913|NCT01177150|Tolerability|tolerability
5108914|NCT01177137|tinnitus|tinnitus
5108915|NCT01177137|tinnitus retraining therapy|tinnitus retraining therapy
5108916|NCT01177137|standard of care|standard of care
5108917|NCT01177137|directive counseling|directive counseling
5108918|NCT01177137|sound therapy|sound therapy
5108919|NCT01177137|tinnitus questionnaire|tinnitus questionnaire
5108920|NCT01177137|tinnitus handicap inventory|tinnitus handicap inventory
5108921|NCT01177124|Breast cancer|breast cancer
5108922|NCT01177124|Survivors|survivors
5108923|NCT01177124|Mindfulness-Based Stress Reduction (MBSR)|mindfulness-based stress reduction (mbsr)
5108924|NCT01177124|Symptoms|symptoms
5108925|NCT01177124|Immune markers|immune markers
5108926|NCT01177085|obesity|obesity
5108927|NCT01177085|weight|weight
5108928|NCT01177085|weight-loss|weight-loss
5108929|NCT01177085|mushroom|mushroom
5108930|NCT01177085|oxidative|oxidative
5108931|NCT01177085|stress|stress
5108932|NCT01177085|immune|immune
5108933|NCT01177085|function|function
5108934|NCT01177085|inflammation|inflammation
5108935|NCT01177072|PTSD|ptsd
5108936|NCT01177059|Gene Therapy|gene therapy
5108937|NCT01177059|Anti-HIV-1 Ribozyme|anti-hiv-1 ribozyme
5108938|NCT01177059|OZ1|oz1
5108939|NCT01177059|HIV-1 Infections|hiv-1 infections
5108940|NCT01177046|Women receiving labour epidural for most recent delivery|women receiving labour epidural for most recent delivery
5108941|NCT01177007|Gastrointestinal Diseases|gastrointestinal diseases
5108942|NCT01177007|Colonic Diseases|colonic diseases
5108943|NCT01177007|Intestinal Diseases|intestinal diseases
5108944|NCT01177007|Rectal Diseases|rectal diseases
5108945|NCT01177007|Neoplastic Processes|neoplastic processes
5108946|NCT01177007|Pathologic Processes|pathologic processes
5108947|NCT01177007|Neuroendocrine Tumors|neuroendocrine tumors
5108948|NCT01177007|Neuroectodermal Tumors|neuroectodermal tumors
5108949|NCT01177007|Neoplasms, Germ Cell and Embryonal|neoplasms, germ cell and embryonal
5108950|NCT01177007|Adenocarcinoma|adenocarcinoma
5108951|NCT01177007|Neoplasms, Nerve Tissue|neoplasms, nerve tissue
5108952|NCT01177007|Liver Diseases|liver diseases
5108953|NCT01177007|Neoplasms|neoplasms
5108954|NCT01177007|Carcinoma|carcinoma
5108955|NCT01177007|Colorectal Neoplasms|colorectal neoplasms
5108956|NCT01177007|Neoplasm Metastasis|neoplasm metastasis
5108957|NCT01177007|Carcinoma, Neuroendocrine|carcinoma, neuroendocrine
5108958|NCT01177007|Liver Neoplasms|liver neoplasms
5108959|NCT01177007|Neoplasms, Glandular and Epithelial|neoplasms, glandular and epithelial
5108960|NCT01177007|Neoplasms by Histologic Type|neoplasms by histologic type
5108961|NCT01177007|Intestinal Neoplasms|intestinal neoplasms
5108962|NCT01177007|Gastrointestinal Neoplasms|gastrointestinal neoplasms
5108963|NCT01177007|Digestive System Neoplasms|digestive system neoplasms
5108964|NCT01177007|Neoplasms by Site|neoplasms by site
5108965|NCT01177007|Digestive System Diseases|digestive system diseases
5108966|NCT01176994|Patients with skin lesions that are treated by dermatologists with destructive modalities without histological evaluation.|patients with skin lesions that are treated by dermatologists with destructive modalities without histological evaluation.
5108967|NCT01176981|pediatrics|pediatrics
5108968|NCT01176981|Osteosarcoma|osteosarcoma
5108969|NCT01176981|Methotrexate|methotrexate
5108970|NCT01176981|Outpatient|outpatient
5108971|NCT01176968|Eplerenone|eplerenone
5108972|NCT01176968|myocardial infarction|myocardial infarction
5108973|NCT01176968|mortality|mortality
5108974|NCT01176968|morbidity|morbidity
5108975|NCT01176955|Acne|acne
5108976|NCT01176955|Acne vulgaris|acne vulgaris
5108977|NCT01176955|Adherence|adherence
5108978|NCT01176955|Compliance|compliance
5108979|NCT01176955|MEMS|mems
5108980|NCT01176955|Benzoyl peroxide|benzoyl peroxide
5108981|NCT01176929|Suicide, Attempted|suicide, attempted
5108982|NCT01176929|prevention suicidal act|prevention suicidal act
5108983|NCT01176929|telephone contact|telephone contact
5108984|NCT01176929|professional coordination|professional coordination
5108985|NCT01176916|breast cancer|breast cancer
5108986|NCT01176916|Aromasin|aromasin
5108987|NCT01176916|adjuvant chemotherapy|adjuvant chemotherapy
5108988|NCT01176916|endocrine therapy|endocrine therapy
5108989|NCT01176890|truncal vagotomy|truncal vagotomy
5108990|NCT01176890|GLP-1|glp-1
5108991|NCT01176890|gastric emptying|gastric emptying
5108992|NCT01176890|appetite|appetite
5108993|NCT01176890|food intake|food intake
5108994|NCT01176864|Small-Bowel Disorders|small-bowel disorders
5108995|NCT01176864|Double-balloon enteroscopy|double-balloon enteroscopy
5108996|NCT01176864|Single-balloon enteroscopy|single-balloon enteroscopy
5108997|NCT01176851|None (study in healthy volunteers)|none (study in healthy volunteers)
5108998|NCT01176838|Breast Cancer Quality of Life Survey|breast cancer quality of life survey
5108999|NCT01176825|bipolar disorder|bipolar disorder
5109000|NCT01176825|cognitive behavior therapy|cognitive behavior therapy
5109001|NCT01176825|alcohol abuse|alcohol abuse
5109002|NCT01176825|drug abuse|drug abuse
5109003|NCT01176825|high risk behaviors|high risk behaviors
5109004|NCT01176825|medication adherence|medication adherence
5109005|NCT01176825|psychosocial functioning|psychosocial functioning
5109006|NCT01176812|Facialwasting|facialwasting
5109007|NCT01176812|Juvederm|juvederm
5109008|NCT01176812|Restylane|restylane
5109009|NCT01176799|Breast cancer patients with measurable primary breast cancer tumor.|breast cancer patients with measurable primary breast cancer tumor.
5109010|NCT01176786|infection|infection
5109011|NCT01176786|tissue expander|tissue expander
5109012|NCT01176786|breast implant|breast implant
5109013|NCT01176786|breast reconstruction|breast reconstruction
5109014|NCT01176786|Infections rates|infections rates
5109015|NCT01176760|vagotomy|vagotomy
5109016|NCT01176760|vagus|vagus
5109017|NCT01176760|GLP-1|glp-1
5109018|NCT01176760|Insulin secretion|insulin secretion
5109019|NCT01176734|Pulsatile Tinnitus|pulsatile tinnitus
5109020|NCT01176734|Ringing-Buzzing-Tinnitus|ringing-buzzing-tinnitus
5109021|NCT01176734|Spontaneous Oto-Acoustic Emission Tinnitus|spontaneous oto-acoustic emission tinnitus
5109022|NCT01176734|Tensor Palatini Induced Tinnitus|tensor palatini induced tinnitus
5109023|NCT01176734|Tensor Tympani Induced Tinnitus|tensor tympani induced tinnitus
5109024|NCT01176734|Tinnitus of Vascular Origin|tinnitus of vascular origin
5109025|NCT01176734|Tinnitus, Clicking|tinnitus, clicking
5109026|NCT01176734|Tinnitus, Leudet|tinnitus, leudet
5109027|NCT01176734|Tinnitus, Leudet's|tinnitus, leudet's
5109028|NCT01176734|Tinnitus, Noise Induced|tinnitus, noise induced
5109029|NCT01176734|Tinnitus, Objective|tinnitus, objective
5109030|NCT01176734|Tinnitus, Spontaneous Oto-Acoustic Emission|tinnitus, spontaneous oto-acoustic emission
5109031|NCT01176734|Tinnitus, Subjective|tinnitus, subjective
5109032|NCT01176734|Tinnitus, Tensor Palatini Induced|tinnitus, tensor palatini induced
5109033|NCT01176734|Tinnitus, Tensor Tympani Induced|tinnitus, tensor tympani induced
5109034|NCT01176734|Vascular Origin Tinnitus|vascular origin tinnitus
5109035|NCT01176721|schizophrenic disorders|schizophrenic disorders
5109036|NCT01176721|psychosis|psychosis
5109037|NCT01176721|psychotic|psychotic
5109038|NCT01176721|dementia|dementia
5109039|NCT01176721|delusional|delusional
5109040|NCT01176721|delusions|delusions
5109041|NCT01176721|hallucinations|hallucinations
5109042|NCT01176721|residual-type schizophrenia|residual-type schizophrenia
5109043|NCT01176721|illusions|illusions
5109044|NCT01176721|split mind|split mind
5109045|NCT01176721|mental health disorder|mental health disorder
5109046|NCT01176721|schizoid|schizoid
5109047|NCT01176721|paranoid-type schizophrenia|paranoid-type schizophrenia
5109048|NCT01176721|disorganized-type schizophrenia|disorganized-type schizophrenia
5109049|NCT01176721|undifferentiated-type schizophrenia|undifferentiated-type schizophrenia
5109050|NCT01176721|catatonic-type schizophrenia|catatonic-type schizophrenia
5109051|NCT01176721|mental illness|mental illness
5109052|NCT01176721|tardive dyskinesia|tardive dyskinesia
5109053|NCT01176721|neuroleptic malignant syndrome|neuroleptic malignant syndrome
5109054|NCT01176721|NMS|nms
5109055|NCT01176721|antipsychotics|antipsychotics
5109056|NCT01176721|atypical antipsychotics|atypical antipsychotics
5109057|NCT01176721|psychosocial treatments|psychosocial treatments
5109058|NCT01176721|rehabilitation|rehabilitation
5109059|NCT01176708|liver transplantation|liver transplantation
5109060|NCT01176708|kidney transplanted|kidney transplanted
5109061|NCT01176708|glucagon-like peptide-1|glucagon-like peptide-1
5109062|NCT01176708|insulin secretion|insulin secretion
5109063|NCT01176708|vagotomy|vagotomy
5109064|NCT01176682|NSAID-treated patients|nsaid-treated patients
5109065|NCT01176682|gastrointestinal events|gastrointestinal events
5109066|NCT01176682|Non-steroid anti-inflammatory drug (NSAID)|non-steroid anti-inflammatory drug (nsaid)
5109067|NCT01176682|Gastrointestinal events (GI events)|gastrointestinal events (gi events)
5109068|NCT01176682|Proton Pump Inhibitors (PPI)|proton pump inhibitors (ppi)
5109069|NCT01176669|Apatinib|apatinib
5109070|NCT01176669|Triple-Negative Breast Cancer|triple-negative breast cancer
5109071|NCT01176669|Metastatic Breast Cancer|metastatic breast cancer
5109072|NCT01176669|ER/PR Negative|er/pr negative
5109073|NCT01176669|Her2/Neu Negative|her2/neu negative
5109074|NCT01176656|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
5109075|NCT01176656|Hypoglycemia|hypoglycemia
5109076|NCT01176643|SLE|sle
5109077|NCT01176643|Yoga|yoga
5109078|NCT01176630|metabolic syndrome, ESRD patient|metabolic syndrome, esrd patient
5109079|NCT01176617|Atrial Fibrillation|atrial fibrillation
5109080|NCT01176617|A-Fib|a-fib
5109081|NCT01176617|AF|af
5109082|NCT01176617|Persistent|persistent
5109083|NCT01176617|Permanent|permanent
5109084|NCT01176617|Pulmonary Vein isolation|pulmonary vein isolation
5109085|NCT01176617|Ablation|ablation
5109086|NCT01176604|Hepatocellular carcinoma (HCC) of the liver|hepatocellular carcinoma (hcc) of the liver
5109087|NCT01176604|Hepatocellular cancer|hepatocellular cancer
5109088|NCT01176604|Hepatocellular carcinoma|hepatocellular carcinoma
5109089|NCT01176604|Liver cancer|liver cancer
5109090|NCT01176604|HCC|hcc
5109091|NCT01176604|Humanitarian Device Exemption|humanitarian device exemption
5109092|NCT01176604|Liver Diseases|liver diseases
5109093|NCT01176604|(HDE)|(hde)
5109094|NCT01176604|Radioactive|radioactive
5109095|NCT01176604|TheraSphere|therasphere
5109096|NCT01176591|Cocaine and alcohol dependence (CAD)|cocaine and alcohol dependence (cad)
5109097|NCT01176565|Acute hypertensive response|acute hypertensive response
5109098|NCT01176565|intracerebral hemorrhage|intracerebral hemorrhage
5109099|NCT01176565|blood pressure|blood pressure
5109100|NCT01176565|outcome|outcome
5109101|NCT01176565|nicardipine|nicardipine
5109102|NCT01176552|Kidney Cancer|kidney cancer
5109103|NCT01176552|Renal cell carcinoma|renal cell carcinoma
5109104|NCT01176552|High risk|high risk
5109105|NCT01176552|Adjuvant therapy|adjuvant therapy
5109106|NCT01176526|Coping|coping
5109107|NCT01176526|Quality of Life|quality of life
5109108|NCT01176526|Prostate Cancer|prostate cancer
5109109|NCT01176513|Prostate Cancer|prostate cancer
5109110|NCT01176513|MRI|mri
5109111|NCT01176513|PET|pet
5109112|NCT01176513|GE-148 (18F)|ge-148 (18f)
5109113|NCT01176500|PET Imaging|pet imaging
5109114|NCT01176500|(18F)Fluciclatide|(18f)fluciclatide
5109115|NCT01176500|Anti-Angiogenic Therapies|anti-angiogenic therapies
5109116|NCT01176500|Solid Tumors|solid tumors
5109117|NCT01176487|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5109118|NCT01176487|recurrent small cell lung cancer|recurrent small cell lung cancer
5109119|NCT01176487|extensive stage small cell lung cancer|extensive stage small cell lung cancer
5109120|NCT01176487|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5109121|NCT01176487|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5109122|NCT01176487|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5109123|NCT01176474|stage IV melanoma|stage iv melanoma
5109124|NCT01176474|stage IIIC melanoma|stage iiic melanoma
5109125|NCT01176461|recurrent melanoma|recurrent melanoma
5109126|NCT01176461|stage IIIA melanoma|stage iiia melanoma
5109127|NCT01176461|stage IIIB melanoma|stage iiib melanoma
5109128|NCT01176461|stage IIIC melanoma|stage iiic melanoma
5109129|NCT01176461|stage IV melanoma|stage iv melanoma
5109130|NCT01176448|Cicatrix|cicatrix
5109131|NCT01176448|Dermabrasion|dermabrasion
5109132|NCT01176448|Coagulation, Laser|coagulation, laser
5109133|NCT01176435|Levodopa|levodopa
5109134|NCT01176435|Albinism|albinism
5109135|NCT01176435|Vision|vision
5109136|NCT01176422|AML|aml
5109137|NCT01176422|MDS|mds
5109138|NCT01176396|Dental Caries|dental caries
5109139|NCT01176396|Preventive Dentistry|preventive dentistry
5109140|NCT01176396|Dental Prophylaxis|dental prophylaxis
5109141|NCT01176396|Dental Care|dental care
5109142|NCT01176383|Nicotine addiction|nicotine addiction
5109143|NCT01176383|Behaviour|behaviour
5109144|NCT01176383|Gene test|gene test
5109145|NCT01176383|Lung cancer|lung cancer
5109146|NCT01176383|Lifetime risk of lung cancer in smokers|lifetime risk of lung cancer in smokers
5109147|NCT01176370|Heart Failure|heart failure
5109148|NCT01176370|Device|device
5109149|NCT01176370|Implantable|implantable
5109150|NCT01176370|Active|active
5109151|NCT01176370|Class III and Class IV|class iii and class iv
5109152|NCT01176370|Counterpulsation|counterpulsation
5109153|NCT01176357|Coronary artery disease (CAD)|coronary artery disease (cad)
5109154|NCT01176357|atherosclerosis|atherosclerosis
5109155|NCT01176357|mediastinal adipose tissue|mediastinal adipose tissue
5109156|NCT01176357|adiponectin, inflammatory mediators|adiponectin, inflammatory mediators
5109157|NCT01176344|Vitamin D supplementation|vitamin d supplementation
5109158|NCT01176344|Osteoarthritis|osteoarthritis
5109159|NCT01176344|Knee|knee
5109160|NCT01176344|Randomised clinical trial (RCT)|randomised clinical trial (rct)
5109161|NCT01176344|Cartilage|cartilage
5109162|NCT01176344|MRI|mri
5109163|NCT01176318|cough|cough
5109164|NCT01176318|exacerbation|exacerbation
5109165|NCT01176318|quality of life|quality of life
5109166|NCT01176305|Thromboembolic event|thromboembolic event
5109167|NCT01176292|total knee replacement|total knee replacement
5109168|NCT01176292|high flexion|high flexion
5109169|NCT01176292|range of motion|range of motion
5109170|NCT01176292|rotating platform|rotating platform
5109171|NCT01176292|TKA|tka
5109172|NCT01176279|Critical illness|critical illness
5109173|NCT01176279|Hyperglycemia|hyperglycemia
5109174|NCT01176279|Catheters, Indwelling|catheters, indwelling
5109175|NCT01176279|Intensive care unit|intensive care unit
5109176|NCT01176266|Hypophosphatasia|hypophosphatasia
5109177|NCT01176266|HPP|hpp
5109178|NCT01176266|Bone Disease|bone disease
5109179|NCT01176266|Soft Bones|soft bones
5109180|NCT01176266|Low Alkaline Phosphatase|low alkaline phosphatase
5109181|NCT01176266|Genetic metabolic disorder|genetic metabolic disorder
5109182|NCT01176266|Alkaline phosphatase|alkaline phosphatase
5109183|NCT01176266|Tissue-specific alkaline phosphatase (TNSALP)|tissue-specific alkaline phosphatase (tnsalp)
5109184|NCT01176266|Rickets|rickets
5109185|NCT01176266|Osteomalacia|osteomalacia
5109186|NCT01176253|Type I DM|type i dm
5109187|NCT01176240|lightheadedness|lightheadedness
5109188|NCT01176240|unsteadiness|unsteadiness
5109189|NCT01176240|dizziness|dizziness
5109190|NCT01176240|weak|weak
5109191|NCT01176240|fatigue|fatigue
5109192|NCT01176240|concentration|concentration
5109193|NCT01176240|head & neck pain|head & neck pain
5109194|NCT01176240|standing/walking for a short time|standing/walking for a short time
5109195|NCT01176240|standing/walking for a long time|standing/walking for a long time
5109196|NCT01176240|Neurogenic Orthostatic Hypotension|neurogenic orthostatic hypotension
5109197|NCT01176240|falls|falls
5109198|NCT01176240|NOH|noh
5109199|NCT01176240|Parkinson's disease|parkinson's disease
5109200|NCT01176240|weakness|weakness
5109201|NCT01176227|bloating|bloating
5109202|NCT01176227|constipation|constipation
5109203|NCT01176227|diarrhea|diarrhea
5109204|NCT01176227|gas|gas
5109205|NCT01176227|mucous|mucous
5109206|NCT01176227|cramping|cramping
5109207|NCT01176214|supratentorial intracerebral hemorrhage|supratentorial intracerebral hemorrhage
5109208|NCT01176214|tracheostomy|tracheostomy
5109209|NCT01176214|sedation|sedation
5109210|NCT01176214|weaning|weaning
5109211|NCT01176201|SLV337|slv337
5109212|NCT01176201|Diabetes|diabetes
5109213|NCT01176201|Relative bioavailability|relative bioavailability
5109214|NCT01176201|ADME|adme
5109215|NCT01176188|Pediatric Intensive Care Unit|pediatric intensive care unit
5109216|NCT01176188|Environmental Stressors|environmental stressors
5109217|NCT01176188|Sleep|sleep
5109218|NCT01176188|Psychological Outcomes|psychological outcomes
5109219|NCT01176188|Pediatrics|pediatrics
5109220|NCT01176175|Progesterone|progesterone
5109221|NCT01176175|Microspheres|microspheres
5109222|NCT01176175|postmenopausal|postmenopausal
5109223|NCT01176175|Luteal phase support|luteal phase support
5109224|NCT01176162|Non Invasive measurement|non invasive measurement
5109225|NCT01176162|Preterm infants|preterm infants
5109226|NCT01176162|Aldosterone resistance|aldosterone resistance
5109227|NCT01176149|Diabetes|diabetes
5109228|NCT01176149|Self monitoring blood glucose|self monitoring blood glucose
5109229|NCT01176136|ADHD|adhd
5109230|NCT01176136|School-Based|school-based
5109231|NCT01176136|Organizational Skills|organizational skills
5109232|NCT01176136|Homework|homework
5109233|NCT01176136|Time Management|time management
5109234|NCT01176123|Cognitive behavioral therapy|cognitive behavioral therapy
5109235|NCT01176123|Insomnia|insomnia
5109236|NCT01176123|Traumatic Stress|traumatic stress
5109237|NCT01176110|hypothermia|hypothermia
5109238|NCT01176110|minimal invasive valve replacement|minimal invasive valve replacement
5109239|NCT01176097|First in man study evaluating AZD5658 in Type 2 Diabetics.|first in man study evaluating azd5658 in type 2 diabetics.
5109240|NCT01176097|Effect of fasting|effect of fasting
5109241|NCT01176097|Safety|safety
5109242|NCT01176097|Tolerability|tolerability
5109243|NCT01176084|low carbohydrate diet|low carbohydrate diet
5109244|NCT01176084|obesity|obesity
5109245|NCT01176084|moderate exercise|moderate exercise
5109246|NCT01176084|men|men
5109247|NCT01176071|galactomannan|galactomannan
5109248|NCT01176071|beta-D-glucan|beta-d-glucan
5109249|NCT01176071|aspergillosis|aspergillosis
5109250|NCT01176071|outcome|outcome
5109251|NCT01176058|Phase 3b|phase 3b
5109252|NCT01176058|Efficacy and Safety evaluation of Anidulafungin|efficacy and safety evaluation of anidulafungin
5109253|NCT01176058|ICC|icc
5109254|NCT01176045|Dry Eye Disease|dry eye disease
5109255|NCT01176045|Osmolarity|osmolarity
5109256|NCT01176045|Refractive Surgery|refractive surgery
5109257|NCT01176045|Lasik|lasik
5109258|NCT01176045|TearLab|tearlab
5109259|NCT01176032|Aliskiren|aliskiren
5109260|NCT01176032|hypertension|hypertension
5109261|NCT01176032|concentric LVH|concentric lvh
5109262|NCT01176032|LV remodeling|lv remodeling
5109263|NCT01176032|LVMI|lvmi
5109264|NCT01176032|biomarkers|biomarkers
5109265|NCT01176032|PICP|picp
5109266|NCT01176032|CT-1|ct-1
5109267|NCT01176032|MMP-1|mmp-1
5109268|NCT01176032|TIMP-1|timp-1
5109269|NCT01176032|AnxA5|anxa5
5109270|NCT01176032|Aldosterone|aldosterone
5109271|NCT01176032|Essential hypertension with concentric left ventricle hypertrophy|essential hypertension with concentric left ventricle hypertrophy
5109272|NCT01176019|Amniocentesis|amniocentesis
5109273|NCT01176019|Chorionic Villus Sampling|chorionic villus sampling
5109274|NCT01176019|First trimester screening|first trimester screening
5109275|NCT01176019|Down syndrome|down syndrome
5109276|NCT01176006|DOCK8|dock8
5109277|NCT01176006|Molluscum|molluscum
5109278|NCT01176006|Transplant|transplant
5109279|NCT01176006|Immunodeficiency|immunodeficiency
5109280|NCT01175993|Motor Training|motor training
5109281|NCT01175993|Post-Traumatic Stress Disorder (PTSD)|post-traumatic stress disorder (ptsd)
5109282|NCT01175993|Balance|balance
5109283|NCT01175967|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
5109284|NCT01175967|perioperative/postoperative complications|perioperative/postoperative complications
5109285|NCT01175967|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5109286|NCT01175967|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5109287|NCT01175954|Partial Epilepsy|partial epilepsy
5109288|NCT01175928|Diabetic polyneuropathy|diabetic polyneuropathy
5109289|NCT01175928|Pneumatic Compression Device|pneumatic compression device
5109290|NCT01175915|Mild type of hand, foot and mouth disease|mild type of hand, foot and mouth disease
5109291|NCT01175915|Reduning Injection|reduning injection
5109292|NCT01175915|Effectiveness|effectiveness
5109293|NCT01175915|Safety|safety
5109597|NCT01174706|cold|cold
5109294|NCT01175902|Normal tension glaucoma|normal tension glaucoma
5109295|NCT01175876|MMSE|mmse
5109296|NCT01175876|NSE|nse
5109297|NCT01175876|S100B|s100b
5109298|NCT01175876|hsCRP|hscrp
5109299|NCT01175876|DWI-MRI|dwi-mri
5109300|NCT01175863|intravascular ultrasound|intravascular ultrasound
5109301|NCT01175863|fractional flow reserve|fractional flow reserve
5109302|NCT01175824|Metabolic Diseases|metabolic diseases
5109303|NCT01175824|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
5109304|NCT01175824|Glargine|glargine
5109305|NCT01175824|Diabetes Mellitus|diabetes mellitus
5109306|NCT01175824|Insulin LISPRO|insulin lispro
5109307|NCT01175824|Insulin|insulin
5109308|NCT01175811|Metabolic Diseases|metabolic diseases
5109309|NCT01175811|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
5109310|NCT01175811|Glargine|glargine
5109311|NCT01175811|Diabetes Mellitus|diabetes mellitus
5109312|NCT01175811|Insulin LISPRO|insulin lispro
5109313|NCT01175811|Insulin|insulin
5109314|NCT01175798|Vitamin D deficiency|vitamin d deficiency
5109315|NCT01175798|End-stage renal disease|end-stage renal disease
5109316|NCT01175798|Immunity|immunity
5109317|NCT01175772|Ovary|ovary
5109318|NCT01175772|Carcinoma|carcinoma
5109319|NCT01175772|Maintenance|maintenance
5109320|NCT01175772|Metronomic|metronomic
5109321|NCT01175772|Chemotherapy|chemotherapy
5109322|NCT01175772|Time to Progression|time to progression
5109323|NCT01175772|overall survival|overall survival
5109324|NCT01175759|Unexplained Recurrent Pregnancy Loss|unexplained recurrent pregnancy loss
5109325|NCT01175759|Recurrent Abortions|recurrent abortions
5109326|NCT01175759|Recurrent Miscarriages|recurrent miscarriages
5109327|NCT01175759|Hormones|hormones
5109328|NCT01175759|Skin tests|skin tests
5109329|NCT01175759|Allergen|allergen
5109330|NCT01175759|Immunotherapy|immunotherapy
5109331|NCT01175759|Hypersensitivity|hypersensitivity
5109332|NCT01175759|Skin reaction|skin reaction
5109333|NCT01175746|healthy adult patients|healthy adult patients
5109334|NCT01175746|ASA class I|asa class i
5109335|NCT01175746|hypotensive anesthesia|hypotensive anesthesia
5109336|NCT01175733|Panitumumab|panitumumab
5109337|NCT01175733|Chemoradiation|chemoradiation
5109338|NCT01175733|Pancreatic cancer|pancreatic cancer
5109339|NCT01175733|Locally advanced|locally advanced
5109340|NCT01175733|Inoperable|inoperable
5109341|NCT01175720|gingival recession|gingival recession
5109342|NCT01175720|acellular dermal matrix graft|acellular dermal matrix graft
5109343|NCT01175720|root coverage|root coverage
5109344|NCT01175694|Brachytherapy|brachytherapy
5109345|NCT01175694|APBI|apbi
5109346|NCT01175694|dose modification|dose modification
5109347|NCT01175694|local recurrences|local recurrences
5109348|NCT01175694|side effects|side effects
5109349|NCT01175694|cosmetic result|cosmetic result
5109350|NCT01175681|rheumatic heart disease|rheumatic heart disease
5109351|NCT01175681|degenerated heart valve disease|degenerated heart valve disease
5109352|NCT01175681|heart valve prolapse|heart valve prolapse
5109353|NCT01175655|Mesenchymal stromal cells|mesenchymal stromal cells
5109354|NCT01175655|Bronchiolitis obliterans|bronchiolitis obliterans
5109355|NCT01175655|Lung transplant|lung transplant
5109356|NCT01175642|Schizophrenia|schizophrenia
5109357|NCT01175642|Psychosis|psychosis
5109358|NCT01175642|Schizoaffective Disorder|schizoaffective disorder
5109359|NCT01175629|Stress Disorders, Post-Traumatic|stress disorders, post-traumatic
5109360|NCT01175629|Depression|depression
5109361|NCT01175629|Diabetes|diabetes
5109362|NCT01175629|Cardiovascular Disease|cardiovascular disease
5109363|NCT01175629|Depressive Disorder|depressive disorder
5109364|NCT01175629|Behavioral Symptoms|behavioral symptoms
5109365|NCT01175629|Metabolic Diseases|metabolic diseases
5109366|NCT01175629|Mental Disorders|mental disorders
5109367|NCT01175629|Anxiety Disorders|anxiety disorders
5109368|NCT01175616|Depression|depression
5109369|NCT01175616|Adults|adults
5109370|NCT01175603|depression, African American, home visiting, prevention|depression, african american, home visiting, prevention
5109371|NCT01175577|mixed carotenes|mixed carotenes
5109372|NCT01175564|TC-5214|tc-5214
5109373|NCT01175564|safety|safety
5109374|NCT01175564|pharmacokinetics|pharmacokinetics
5109375|NCT01175564|single dose|single dose
5109376|NCT01175564|repeated dose|repeated dose
5109377|NCT01175564|Japanese|japanese
5109378|NCT01175564|healthy subjects|healthy subjects
5109379|NCT01175551|Preterm Birth|preterm birth
5109380|NCT01175551|Cervix|cervix
5109381|NCT01175551|Cervical Shortening|cervical shortening
5109382|NCT01175551|Cervical remodeling|cervical remodeling
5109383|NCT01175551|PTB|ptb
5109384|NCT01175538|Hepatic encephalopathy|hepatic encephalopathy
5109385|NCT01175538|Lactulose|lactulose
5109386|NCT01175499|laryngoscopy|laryngoscopy
5109387|NCT01175499|Laryngoscopic Surgery|laryngoscopic surgery
5109388|NCT01175499|laryngoscopes|laryngoscopes
5109389|NCT01175499|upper aerodigestive tract lesions|upper aerodigestive tract lesions
5109390|NCT01175499|endoscopy|endoscopy
5109391|NCT01175499|biopsy|biopsy
5109392|NCT01175486|thiazolidinediones|thiazolidinediones
5109393|NCT01175486|diabetes|diabetes
5109394|NCT01175486|retinopathy|retinopathy
5109395|NCT01175486|nephropathy|nephropathy
5109396|NCT01175460|esophageal Cancer|esophageal cancer
5109397|NCT01175460|radiation|radiation
5109398|NCT01175460|s-1|s-1
5109399|NCT01175460|nedaplatin|nedaplatin
5109400|NCT01175447|S-1|s-1
5109401|NCT01175447|radiation|radiation
5109402|NCT01175447|esophageal Cancer|esophageal cancer
5109403|NCT01175434|Asthma|asthma
5109404|NCT01175421|snoring|snoring
5109405|NCT01175421|sleep apnea|sleep apnea
5109406|NCT01175421|sleep study|sleep study
5109407|NCT01175421|cardiovascular outcomes|cardiovascular outcomes
5109408|NCT01175408|Remote Blood Glucose Monitoring System,|remote blood glucose monitoring system,
5109409|NCT01175408|Continuous Glucose Monitoring System,|continuous glucose monitoring system,
5109410|NCT01175408|Self Monitoring Blood Glucose,|self monitoring blood glucose,
5109411|NCT01175408|Strip Counting,|strip counting,
5109412|NCT01175408|Type 2 Diabetes|type 2 diabetes
5109413|NCT01175395|Choroidal neovascular membranes|choroidal neovascular membranes
5109414|NCT01175395|CNV|cnv
5109415|NCT01175395|AMD|amd
5109416|NCT01175395|Age-relate Macular Degeneration|age-relate macular degeneration
5109417|NCT01175395|CNVM|cnvm
5109418|NCT01175395|subfoveal|subfoveal
5109419|NCT01175382|Male Urogenital Diseases|male urogenital diseases
5109420|NCT01175382|Urinary Bladder, overactive|urinary bladder, overactive
5109421|NCT01175382|Behavioral Medicine|behavioral medicine
5109422|NCT01175382|Drug Therapy|drug therapy
5109423|NCT01175369|Asthma|asthma
5109424|NCT01175330|Omega-3 fatty acid|omega-3 fatty acid
5109425|NCT01175330|Ischemic Heart Disease|ischemic heart disease
5109426|NCT01175330|Atrial Fibrillation|atrial fibrillation
5109427|NCT01175330|Subcutaneous cardiac monitoring|subcutaneous cardiac monitoring
5109428|NCT01175317|Hemodynamic optimization|hemodynamic optimization
5109429|NCT01175317|Enhanced recovery after surgery|enhanced recovery after surgery
5109430|NCT01175317|Goal-directed fluid|goal-directed fluid
5109431|NCT01175304|sleep|sleep
5109432|NCT01175304|sleep apnea|sleep apnea
5109433|NCT01175304|work|work
5109434|NCT01175304|sleep habits|sleep habits
5109435|NCT01175304|sleepiness|sleepiness
5109436|NCT01175291|colon|colon
5109437|NCT01175291|rectum|rectum
5109438|NCT01175291|colorectal|colorectal
5109439|NCT01175291|metastatic|metastatic
5109440|NCT01175291|adenocarcinoma|adenocarcinoma
5109441|NCT01175278|vertebral|vertebral
5109442|NCT01175278|compression|compression
5109443|NCT01175278|fracture|fracture
5109444|NCT01175278|VCF|vcf
5109445|NCT01175278|kyphoplasty|kyphoplasty
5109446|NCT01175278|spine|spine
5109447|NCT01175265|clinically stable|clinically stable
5109448|NCT01175265|COPD (GOLD-classification I-IV)|copd (gold-classification i-iv)
5109449|NCT01175265|COPD|copd
5109450|NCT01175265|breathing retraining|breathing retraining
5109451|NCT01175265|pulmonary rehabilitation|pulmonary rehabilitation
5109452|NCT01175265|cardiac autonomic function|cardiac autonomic function
5109453|NCT01175265|quality of life|quality of life
5109454|NCT01175265|exercise capacity|exercise capacity
5109455|NCT01175265|pulmonary function|pulmonary function
5109456|NCT01175252|Gastroenteritis|gastroenteritis
5109457|NCT01175239|X-linked severe combined immunodeficiency, gene therapy|x-linked severe combined immunodeficiency, gene therapy
5109458|NCT01175239|Patients will be enrolled following diagnosis and referral to Great Ormond Street Immunology Service.|patients will be enrolled following diagnosis and referral to great ormond street immunology service.
5109459|NCT01175226|Human rhinovirus|human rhinovirus
5109460|NCT01175226|Aviragen Therapeutics, Inc.|aviragen therapeutics, inc.
5109461|NCT01175226|Aviragen Therapeutics|aviragen therapeutics
5109462|NCT01175226|Aviragen|aviragen
5109463|NCT01175187|evron|evron
5109464|NCT01175174|asthma|asthma
5109465|NCT01175174|preschool children|preschool children
5109466|NCT01175174|adenosine provocation test|adenosine provocation test
5109467|NCT01175174|metacholine provocation test|metacholine provocation test
5109468|NCT01175174|pediatric emergency department|pediatric emergency department
5109469|NCT01175161|Postpartum Contraception|postpartum contraception
5109470|NCT01175161|Intrauterine device|intrauterine device
5109471|NCT01175161|feasibility|feasibility
5109472|NCT01175161|IUD|iud
5109473|NCT01175161|Immediate postpartum IUD|immediate postpartum iud
5109474|NCT01175148|HSCT|hsct
5109475|NCT01175148|HPC|hpc
5109476|NCT01175148|HCT|hct
5109477|NCT01175148|BMT|bmt
5109478|NCT01175148|lipitor|lipitor
5109479|NCT01175148|atorvastatin|atorvastatin
5109480|NCT01175148|HMG-CoA Reductase Inhibitor|hmg-coa reductase inhibitor
5109481|NCT01175148|Hematopoietic stem cell transplant|hematopoietic stem cell transplant
5109482|NCT01175148|allogeneic transplant|allogeneic transplant
5109483|NCT01175148|GVHD|gvhd
5109484|NCT01175148|graft-versus-host-disease|graft-versus-host-disease
5109485|NCT01175148|Graft vs Host Disease|graft vs host disease
5109486|NCT01175135|schizophrenia|schizophrenia
5109487|NCT01175135|acute exacerbation|acute exacerbation
5109488|NCT01175135|inpatient|inpatient
5109489|NCT01175109|Chordoma|chordoma
5109490|NCT01175096|neuroendocrine tumors|neuroendocrine tumors
5109491|NCT01175096|carcinoid tumor|carcinoid tumor
5109492|NCT01175096|RAD001 (everolimus, Afinitor®)|rad001 (everolimus, afinitor®)
5109493|NCT01175083|Catch-up vaccination|catch-up vaccination
5109494|NCT01175083|Pneumococcal vaccine|pneumococcal vaccine
5109495|NCT01175083|Sickle cell disease|sickle cell disease
5109496|NCT01175083|Booster vaccination|booster vaccination
5109497|NCT01175083|Safety|safety
5109498|NCT01175083|Immunogenicity|immunogenicity
5109499|NCT01175083|Pneumococcal disease|pneumococcal disease
5109500|NCT01175070|diabetic macular oedema|diabetic macular oedema
5109501|NCT01175070|ischaemia|ischaemia
5109502|NCT01175070|anti VEGF|anti vegf
5109503|NCT01175070|pegaptanib|pegaptanib
5109504|NCT01175070|Ischaemic diabetic macular oedema|ischaemic diabetic macular oedema
5109505|NCT01175057|feasibility|feasibility
5109506|NCT01175057|compliance|compliance
5109507|NCT01175057|telemedical home monitoring|telemedical home monitoring
5109508|NCT01175057|post stationary rehabilitation|post stationary rehabilitation
5109509|NCT01175057|patients with myocardial infarction|patients with myocardial infarction
5109510|NCT01175044|Revision|revision
5109511|NCT01175044|Knee|knee
5109512|NCT01175044|Arthroplasty|arthroplasty
5109513|NCT01175044|Betadine|betadine
5109514|NCT01175044|Lavage|lavage
5109515|NCT01175044|Infection|infection
5109516|NCT01175018|Acute myocardial infarction|acute myocardial infarction
5109517|NCT01175018|Heart Failure|heart failure
5109518|NCT01175018|Cardiac Remodeling|cardiac remodeling
5109519|NCT01175005|Fever|fever
5109520|NCT01175005|Central venous catheter|central venous catheter
5109521|NCT01175005|Procalcitonin|procalcitonin
5109522|NCT01175005|Fever with a central venous catheter|fever with a central venous catheter
5109523|NCT01174992|Fibrin sealant|fibrin sealant
5109524|NCT01174992|CSF leak|csf leak
5109525|NCT01174979|Morbus Meniere|morbus meniere
5109526|NCT01174979|Sudden hearing loss|sudden hearing loss
5109527|NCT01174979|Blast injury|blast injury
5109528|NCT01174979|Presbyacusis|presbyacusis
5109529|NCT01174979|Chron. Otitis Media|chron. otitis media
5109530|NCT01174966|oxygen challenge test|oxygen challenge test
5109531|NCT01174966|shock|shock
5109532|NCT01174966|mortality|mortality
5109533|NCT01174966|Oxygen Delivery Index|oxygen delivery index
5109534|NCT01174966|cardiac output index|cardiac output index
5109535|NCT01174953|prostate cancer|prostate cancer
5109536|NCT01174940|myelogenous leukemia|myelogenous leukemia
5109537|NCT01174940|lymphocytic leukemia|lymphocytic leukemia
5109538|NCT01174940|lymphoblastic leukemia|lymphoblastic leukemia
5109539|NCT01174940|myelodysplastic syndrome|myelodysplastic syndrome
5109540|NCT01174940|non-Hodgkin's lymphoma|non-hodgkin's lymphoma
5109541|NCT01174940|Hodgkin's disease|hodgkin's disease
5109542|NCT01174927|Substance use disorder|substance use disorder
5109543|NCT01174927|Stress|stress
5109544|NCT01174901|cephalalgia|cephalalgia
5109545|NCT01174901|copeptins|copeptins
5109546|NCT01174901|biomarkers|biomarkers
5109547|NCT01174901|headache|headache
5109548|NCT01174901|C-terminal provasopression|c-terminal provasopression
5109549|NCT01174901|physiological stress response|physiological stress response
5109550|NCT01174888|Acute Myeloid Leukemia|acute myeloid leukemia
5109551|NCT01174888|AML|aml
5109552|NCT01174875|Epigenetics|epigenetics
5109553|NCT01174875|Development|development
5109554|NCT01174875|Metabolic|metabolic
5109555|NCT01174875|Neurodevelopment|neurodevelopment
5109556|NCT01174862|aspirin|aspirin
5109557|NCT01174862|aspirin responsiveness|aspirin responsiveness
5109558|NCT01174862|long-term outcome|long-term outcome
5109559|NCT01174862|CABG|cabg
5109560|NCT01174849|otitis media|otitis media
5109561|NCT01174849|pneumococcal vaccines|pneumococcal vaccines
5109562|NCT01174849|randomised controlled trial|randomised controlled trial
5109563|NCT01174849|high-risk children|high-risk children
5109564|NCT01174849|indigenous|indigenous
5109565|NCT01174849|Australia|australia
5109566|NCT01174836|CT utilization|ct utilization
5109567|NCT01174836|physician attitudes|physician attitudes
5109568|NCT01174810|Parkinson's Disease|parkinson's disease
5109569|NCT01174810|PD|pd
5109570|NCT01174810|Moderate Parkinson's Disease|moderate parkinson's disease
5109571|NCT01174784|Chronic Total Occlusions|chronic total occlusions
5109572|NCT01174784|Superficial Femoral Artery|superficial femoral artery
5109573|NCT01174784|Popliteal Artery|popliteal artery
5109574|NCT01174771|Transcranial magnetic stimulation|transcranial magnetic stimulation
5109575|NCT01174771|Cortical excitability|cortical excitability
5109576|NCT01174771|parkinsonism|parkinsonism
5109577|NCT01174771|Progressive Supranuclear Palsy|progressive supranuclear palsy
5109578|NCT01174771|Corticobasal Degeneration|corticobasal degeneration
5109579|NCT01174771|PSP|psp
5109580|NCT01174771|CBD|cbd
5109581|NCT01174771|CBGD|cbgd
5109582|NCT01174758|balance|balance
5109583|NCT01174758|mobility|mobility
5109584|NCT01174758|ON/OFF Levodopa|on/off levodopa
5109585|NCT01174732|asthma|asthma
5109586|NCT01174732|bronchospasm|bronchospasm
5109587|NCT01174732|COPD|copd
5109588|NCT01174732|chronic respiratory disease|chronic respiratory disease
5109589|NCT01174719|Hydroxyethylstarch|hydroxyethylstarch
5109590|NCT01174719|Humanalbumin|humanalbumin
5109591|NCT01174719|Ringer Lactate|ringer lactate
5109592|NCT01174719|patients undergoing cardiac surgery|patients undergoing cardiac surgery
5109593|NCT01174706|infections|infections
5109594|NCT01174706|flu|flu
5109595|NCT01174706|abdominal pain|abdominal pain
5109596|NCT01174706|chest pain|chest pain
5109598|NCT01174706|fever|fever
5109599|NCT01174706|different acute care conditions|different acute care conditions
5109600|NCT01174693|prospective|prospective
5109601|NCT01174693|randomized|randomized
5109602|NCT01174693|open label|open label
5109603|NCT01174693|multi-center|multi-center
5109604|NCT01174693|double-blind for CYP2C19 genotypes|double-blind for cyp2c19 genotypes
5109605|NCT01174680|cardiogoniometry|cardiogoniometry
5109606|NCT01174680|stable angina pectoris patients|stable angina pectoris patients
5109607|NCT01174667|Myofascial pain|myofascial pain
5109608|NCT01174667|Trigger points|trigger points
5109609|NCT01174641|unilateral neglect|unilateral neglect
5109610|NCT01174641|TMS intervention|tms intervention
5109611|NCT01174628|Exercise Tolerance|exercise tolerance
5109612|NCT01174628|Venous Thrombosis|venous thrombosis
5109613|NCT01174628|Pulmonary Embolism|pulmonary embolism
5109614|NCT01174628|Quality of Life (QOL)|quality of life (qol)
5109615|NCT01174615|Blood/bone marrow collection, hematologic diseases, leukemia|blood/bone marrow collection, hematologic diseases, leukemia
5109616|NCT01174589|Lower limb strength training|lower limb strength training
5109617|NCT01174589|Randomized clinical trial|randomized clinical trial
5109618|NCT01174589|Patients with Hip fracture|patients with hip fracture
5109619|NCT01174589|6 vs. 12 weeks physical strength training|6 vs. 12 weeks physical strength training
5109620|NCT01174576|coffee|coffee
5109621|NCT01174576|appetite|appetite
5109622|NCT01174576|energy intake|energy intake
5109623|NCT01174576|inflammation|inflammation
5109624|NCT01174576|cortisol|cortisol
5109625|NCT01174576|glucose|glucose
5109626|NCT01174576|randomized controlled trial|randomized controlled trial
5109627|NCT01174550|chest pain|chest pain
5109628|NCT01174550|coronary artery disease|coronary artery disease
5109629|NCT01174550|CAD|cad
5109630|NCT01174537|NDV|ndv
5109631|NCT01174537|Metastatic|metastatic
5109632|NCT01174537|Refractory|refractory
5109633|NCT01174537|Cancer|cancer
5109634|NCT01174537|Progression-free|progression-free
5109635|NCT01174537|survival|survival
5109636|NCT01174537|recurrent|recurrent
5109637|NCT01174524|Quality of life|quality of life
5109638|NCT01174524|Menopause|menopause
5109639|NCT01174524|Contraception|contraception
5109640|NCT01174511|ATOPIC DERMATITIS|atopic dermatitis
5109641|NCT01174511|A-1 COOL CREAM|a-1 cool cream
5109642|NCT01174498|discomfort|discomfort
5109643|NCT01174498|distress|distress
5109644|NCT01174498|hurt|hurt
5109645|NCT01174498|sting|sting
5109646|NCT01174485|Liposuction|liposuction
5109647|NCT01174485|exercise|exercise
5109648|NCT01174485|metabolism|metabolism
5109649|NCT01174485|adiposity|adiposity
5109650|NCT01174472|Dialysis access|dialysis access
5109651|NCT01174472|angioplasty|angioplasty
5109652|NCT01174472|drug eluting balloon|drug eluting balloon
5109653|NCT01174433|Bifurcation coronary artery disease|bifurcation coronary artery disease
5109654|NCT01174433|Percutaneous coronary intervention|percutaneous coronary intervention
5109655|NCT01174433|Tryton Stent|tryton stent
5109656|NCT01174420|ologen|ologen
5109657|NCT01174420|Mitomycin-C|mitomycin-c
5109658|NCT01174420|Collagen Matrix|collagen matrix
5109659|NCT01174420|trabeculectomy|trabeculectomy
5109660|NCT01174420|glaucoma|glaucoma
5109661|NCT01174420|filtering surgery|filtering surgery
5109662|NCT01174394|Acupuncture|acupuncture
5109663|NCT01174394|Post Stroke Depression|post stroke depression
5109664|NCT01174394|Depressive Disorder|depressive disorder
5109665|NCT01174394|Cardiovascular Accident|cardiovascular accident
5109666|NCT01174394|Stroke|stroke
5109667|NCT01174394|Apoplexy|apoplexy
5109668|NCT01174394|CVA|cva
5109669|NCT01174381|Non communicable disease|non communicable disease
5109670|NCT01174381|Lifestyle Modification|lifestyle modification
5109671|NCT01174381|Community Based organization|community based organization
5109672|NCT01174381|community based study|community based study
5109673|NCT01174342|Intraocular pressure|intraocular pressure
5109674|NCT01174342|Ocular tonometry|ocular tonometry
5109675|NCT01174342|Obstetric delivery|obstetric delivery
5109676|NCT01174316|Acute exacerbation|acute exacerbation
5109677|NCT01174316|Respiratory insufficiency|respiratory insufficiency
5109678|NCT01174316|Respiratory failure|respiratory failure
5109679|NCT01174316|Hypercapnia|hypercapnia
5109680|NCT01174316|Hypoventilation|hypoventilation
5109681|NCT01174316|Sleep|sleep
5109682|NCT01174316|Hypoxia|hypoxia
5109683|NCT01174316|Titration|titration
5109684|NCT01174316|Non Invasive Ventilation|non invasive ventilation
5109685|NCT01174290|subsyndromal delirium|subsyndromal delirium
5109686|NCT01174290|delirium|delirium
5109687|NCT01174290|haloperidol|haloperidol
5109688|NCT01174290|antipsychotic|antipsychotic
5109689|NCT01174290|randomized controlled trial|randomized controlled trial
5109690|NCT01174290|placebo-controlled|placebo-controlled
5109691|NCT01174290|intensive care unit|intensive care unit
5109692|NCT01174290|critical care|critical care
5109693|NCT01174290|subsyndromal delirium in the intensive care unit|subsyndromal delirium in the intensive care unit
5109694|NCT01174277|chronic graft versus host disease|chronic graft versus host disease
5109695|NCT01174277|transplant|transplant
5109696|NCT01174277|stem cell|stem cell
5109697|NCT01174251|general anesthesia|general anesthesia
5109698|NCT01174251|electrocardiography|electrocardiography
5109699|NCT01174251|long QT syndrome, acquired|long qt syndrome, acquired
5109700|NCT01174238|Melanoma|melanoma
5109701|NCT01174238|Axitinib|axitinib
5109702|NCT01174238|Carboplatin|carboplatin
5109703|NCT01174238|Paclitaxel|paclitaxel
5109704|NCT01174225|Copper IUD|copper iud
5109705|NCT01174225|Nova T 200|nova t 200
5109706|NCT01174225|Flexi T 380|flexi t 380
5109707|NCT01174225|expulsion|expulsion
5109708|NCT01174225|contraception satisfaction|contraception satisfaction
5109709|NCT01174225|post-abortion contraception|post-abortion contraception
5109710|NCT01174212|revision|revision
5109711|NCT01174212|infection|infection
5109712|NCT01174212|knee|knee
5109713|NCT01174212|hip|hip
5109714|NCT01174212|replacement|replacement
5109715|NCT01174212|antibiotics|antibiotics
5109716|NCT01174173|Angina|angina
5109717|NCT01174173|Right Ventricular Ischemia|right ventricular ischemia
5109718|NCT01174173|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
5109719|NCT01174173|Pulmonary Hypertension|pulmonary hypertension
5109720|NCT01174160|Atrial Fibrillation|atrial fibrillation
5109721|NCT01174121|Digestive Tract Cancers|digestive tract cancers
5109722|NCT01174121|Breast Cancer|breast cancer
5109723|NCT01174121|Glioblastoma|glioblastoma
5109724|NCT01174121|Ovarian/Endometrial Cancer|ovarian/endometrial cancer
5109725|NCT01174121|Urothelial Cancers|urothelial cancers
5109726|NCT01174108|Myelodysplastic Syndrome (MDS)|myelodysplastic syndrome (mds)
5109727|NCT01174108|Severe Aplastic Anemia|severe aplastic anemia
5109728|NCT01174108|Pure Red Cell Aplasia|pure red cell aplasia
5109729|NCT01174108|Paroxysmal Nocturnal Hemoglobinuria (PNH)|paroxysmal nocturnal hemoglobinuria (pnh)
5109730|NCT01174108|Miltenyi CD34 Reagent System|miltenyi cd34 reagent system
5109731|NCT01174108|Allogeneic Stem Cell Transplant|allogeneic stem cell transplant
5109732|NCT01174095|Diffuse Coronary Artery Disease|diffuse coronary artery disease
5109733|NCT01174095|Ischemic Myocardium|ischemic myocardium
5109734|NCT01174095|Ischemia|ischemia
5109735|NCT01174082|Multiple Myeloma|multiple myeloma
5109736|NCT01174082|Vaccine|vaccine
5109737|NCT01174082|Lymphocyte Infusion|lymphocyte infusion
5109738|NCT01174069|NOTES|notes
5109739|NCT01174069|cholecystectomy|cholecystectomy
5109740|NCT01174069|endoscopic|endoscopic
5109741|NCT01174056|Lung inflammation|lung inflammation
5109742|NCT01174056|positron emission tomography|positron emission tomography
5109743|NCT01174056|fluorodeoxyglucose|fluorodeoxyglucose
5109744|NCT01174056|rosiglitazone|rosiglitazone
5109745|NCT01174056|zileuton|zileuton
5109746|NCT01174056|lung anti-inflammatory therapy|lung anti-inflammatory therapy
5109747|NCT01174043|Leukemia, Myelomonocytic, Acute|leukemia, myelomonocytic, acute
5109748|NCT01174043|Erlotinib|erlotinib
5109749|NCT01174017|prostate cancer|prostate cancer
5109750|NCT01174017|Iodine 125 brachytherapy|iodine 125 brachytherapy
5109751|NCT01174017|seed migration|seed migration
5109752|NCT01174017|seed migration in the first month after brachytherapy|seed migration in the first month after brachytherapy
5109753|NCT01173991|carbohydrate counting|carbohydrate counting
5109754|NCT01173991|continuous subcutaneous insulin infusion|continuous subcutaneous insulin infusion
5109755|NCT01173991|type 1 diabetes mellitus|type 1 diabetes mellitus
5109756|NCT01173978|Incretin hormones|incretin hormones
5109757|NCT01173978|Glucagon|glucagon
5109758|NCT01173978|Insulin/c-peptide|insulin/c-peptide
5109759|NCT01173978|Plasma glucose|plasma glucose
5109760|NCT01173978|Insulin resistance|insulin resistance
5109761|NCT01173978|Deteriorated glucose homeostasis|deteriorated glucose homeostasis
5109762|NCT01173978|Inactivity|inactivity
5109763|NCT01173939|Hypercholesterolemia with concomitant type 2 diabetes and hypertension|hypercholesterolemia with concomitant type 2 diabetes and hypertension
5109764|NCT01173913|oral docetaxel|oral docetaxel
5109765|NCT01173913|ModraDoc|modradoc
5109766|NCT01173913|pharmacokinetics|pharmacokinetics
5109767|NCT01173913|safety|safety
5109769|NCT01173913|DLT|dlt
5109770|NCT01173900|human papillomavirus|human papillomavirus
5109771|NCT01173900|vaccine|vaccine
5109772|NCT01173900|school girls|school girls
5109773|NCT01173900|Tanzania|tanzania
5109774|NCT01173900|acceptability|acceptability
5109775|NCT01173900|vaccine coverage|vaccine coverage
5109776|NCT01173900|Cervical cancer prevention|cervical cancer prevention
5109777|NCT01173874|Cognition|cognition
5109778|NCT01173874|Function|function
5109779|NCT01173874|Attention|attention
5109780|NCT01173874|Vigilance|vigilance
5109781|NCT01173874|Verbal Memory|verbal memory
5109782|NCT01173874|Visual Memory|visual memory
5109783|NCT01173874|Processing Speed|processing speed
5109784|NCT01173874|Problem Solving|problem solving
5109785|NCT01173874|Social Cognition|social cognition
5109786|NCT01173848|CKD|ckd
5109787|NCT01173848|Vitamin D|vitamin d
5109788|NCT01173835|Adolescent tobacco use|adolescent tobacco use
5109789|NCT01173835|Tobacco Free and Win|tobacco free and win
5109790|NCT01173835|Incentive-based intervention|incentive-based intervention
5109791|NCT01173835|Contingency Management|contingency management
5109792|NCT01173835|Smoking Prevention|smoking prevention
5109793|NCT01173835|Smoking cessation|smoking cessation
5109794|NCT01173822|cardiopulmonary bypass|cardiopulmonary bypass
5109795|NCT01173822|hemorrhage|hemorrhage
5109796|NCT01173822|trials|trials
5109797|NCT01173822|surgery|surgery
5109798|NCT01173809|AF|af
5109799|NCT01173809|Catheter Ablation|catheter ablation
5109800|NCT01173809|Recurrence of AF|recurrence of af
5109801|NCT01173809|Amiodarone|amiodarone
5109802|NCT01173783|Heart failure|heart failure
5109803|NCT01173783|Cardiac insufficiency|cardiac insufficiency
5109804|NCT01173783|Implantable Cardioverter/Defibrillator|implantable cardioverter/defibrillator
5109805|NCT01173783|Cardiac Resynchronization therapy|cardiac resynchronization therapy
5109806|NCT01173783|ICD|icd
5109807|NCT01173783|CRT|crt
5109808|NCT01173783|Register|register
5109809|NCT01173757|Healthy Volunteers|healthy volunteers
5109810|NCT01173744|Intertrochanteric femoral fractures - unstable|intertrochanteric femoral fractures - unstable
5109811|NCT01173731|Parkinson Disease|parkinson disease
5109812|NCT01173731|L-dopa|l-dopa
5109813|NCT01173731|Levodopa|levodopa
5109814|NCT01173731|Dyskinesia|dyskinesia
5109815|NCT01173731|involuntary movement|involuntary movement
5109816|NCT01173731|motor complication|motor complication
5109817|NCT01173718|Hemodialysis|hemodialysis
5109818|NCT01173718|Vascular Graft|vascular graft
5109819|NCT01173705|Obesity|obesity
5109820|NCT01173705|Insulin Resistance|insulin resistance
5109821|NCT01173705|Inflammation|inflammation
5109822|NCT01173692|Oropharynx Cancer|oropharynx cancer
5109823|NCT01173692|Radiation Therapy|radiation therapy
5109824|NCT01173692|XRT|xrt
5109825|NCT01173692|Radiotherapy|radiotherapy
5109826|NCT01173692|Minocycline|minocycline
5109827|NCT01173692|Symptoms|symptoms
5109828|NCT01173692|Head and Neck|head and neck
5109829|NCT01173679|CLL|cll
5109830|NCT01173679|fludarabine|fludarabine
5109831|NCT01173679|rituximab|rituximab
5109832|NCT01173679|dasatinib|dasatinib
5109833|NCT01173679|refractory|refractory
5109834|NCT01173679|relapsed|relapsed
5109835|NCT01173666|RAS|ras
5109836|NCT01173666|LVMI|lvmi
5109837|NCT01173666|Renal revascularization|renal revascularization
5109838|NCT01173653|smoking|smoking
5109839|NCT01173653|smoking cessation|smoking cessation
5109840|NCT01173653|health behavior|health behavior
5109841|NCT01173640|drug interactions|drug interactions
5109842|NCT01173640|midazolam|midazolam
5109843|NCT01173640|cytochrome P450|cytochrome p450
5109844|NCT01173640|resveratrol|resveratrol
5109845|NCT01173640|pharmacokinetics|pharmacokinetics
5109846|NCT01173627|Bioequivalence|bioequivalence
5109847|NCT01173627|Fentanyl|fentanyl
5109848|NCT01173588|bowel function|bowel function
5109849|NCT01173588|functional foods|functional foods
5109850|NCT01173562|Healthy volunteers|healthy volunteers
5109851|NCT01173562|Parasitic Diseases|parasitic diseases
5109852|NCT01173562|Mebendazole (VERMOX)|mebendazole (vermox)
5109853|NCT01173562|Anthelmintics|anthelmintics
5109854|NCT01173562|Antiparasitic Agents|antiparasitic agents
5109855|NCT01173562|Soil-transmitted helminth (STH) infections|soil-transmitted helminth (sth) infections
5109856|NCT01173562|Pediatric|pediatric
5109857|NCT01173549|Canagliflozin|canagliflozin
5109858|NCT01173549|Pharmacodynamic|pharmacodynamic
5109859|NCT01173549|Glucose absorption|glucose absorption
5109860|NCT01173549|Glucose metabolism|glucose metabolism
5109861|NCT01173523|Hsp90 Inhibitor|hsp90 inhibitor
5109862|NCT01173523|relapsed|relapsed
5109863|NCT01173523|refractory|refractory
5109864|NCT01173510|HIV|hiv
5109865|NCT01173510|AIDS|aids
5109866|NCT01173510|Atripla|atripla
5109867|NCT01173510|Truvada|truvada
5109868|NCT01173510|Raltegravir|raltegravir
5109869|NCT01173510|Human Immunodeficiency Virus|human immunodeficiency virus
5109870|NCT01173510|Acquired Immune Deficiency Syndrome Virus|acquired immune deficiency syndrome virus
5109871|NCT01173497|Triple negative breast cancer|triple negative breast cancer
5109872|NCT01173497|Brain metastasis|brain metastasis
5109873|NCT01173497|BSI-201|bsi-201
5109874|NCT01173497|iniparib|iniparib
5109875|NCT01173484|Idiopathic gastroparesis|idiopathic gastroparesis
5109876|NCT01173484|Vomiting|vomiting
5109877|NCT01173484|Dyspepsia|dyspepsia
5109878|NCT01173484|GERD|gerd
5109879|NCT01173471|Raised intraocular pressure|raised intraocular pressure
5109880|NCT01173458|cancer|cancer
5109881|NCT01173458|lung|lung
5109882|NCT01173458|small cell|small cell
5109883|NCT01173445|cancer|cancer
5109884|NCT01173445|kidney|kidney
5109885|NCT01173445|renal cell|renal cell
5109886|NCT01173445|tumor cells|tumor cells
5109887|NCT01173445|circulating tumor cells|circulating tumor cells
5109888|NCT01173445|circulating endothelial cells|circulating endothelial cells
5109889|NCT01173432|obstructive sleep apnea|obstructive sleep apnea
5109890|NCT01173432|metabolic dysfunction|metabolic dysfunction
5109891|NCT01173432|metabolic syndrome|metabolic syndrome
5109892|NCT01173432|adipocyte fatty acid binding protein|adipocyte fatty acid binding protein
5109893|NCT01173419|Great Saphenous Vein|great saphenous vein
5109894|NCT01173406|Continuous Positive Airway Pressure treatment|continuous positive airway pressure treatment
5109895|NCT01173406|Adherence|adherence
5109896|NCT01173406|Education|education
5109897|NCT01173393|out of hospital cardiac arrest|out of hospital cardiac arrest
5109898|NCT01173393|OHCA|ohca
5109899|NCT01173393|EMS|ems
5109995|NCT01172938|Psoriasis|psoriasis
5109900|NCT01173393|Emergency medical System|emergency medical system
5109901|NCT01173393|non-VF|non-vf
5109902|NCT01173393|non-ventricular fibrillation|non-ventricular fibrillation
5109903|NCT01173380|Soy|soy
5109904|NCT01173380|Equol|equol
5109905|NCT01173380|Metabolic syndrome|metabolic syndrome
5109906|NCT01173380|Endothelial function|endothelial function
5109907|NCT01173367|Fever|fever
5109908|NCT01173367|ICU|icu
5109909|NCT01173367|Acetaminophen|acetaminophen
5109910|NCT01173367|Inflammatory mediators|inflammatory mediators
5109911|NCT01173367|Safety|safety
5109912|NCT01173354|COPD|copd
5109913|NCT01173354|Protein metabolism|protein metabolism
5109914|NCT01173354|Essential amino acid intake|essential amino acid intake
5109915|NCT01173328|exercise tolerance|exercise tolerance
5109916|NCT01173328|dynamic hyperinflation|dynamic hyperinflation
5109917|NCT01173328|respiratory mechanics|respiratory mechanics
5109918|NCT01173315|Type 2 diabetes|type 2 diabetes
5109919|NCT01173315|micronutrients|micronutrients
5109920|NCT01173315|nephropathy|nephropathy
5109921|NCT01173315|neuropathy|neuropathy
5109922|NCT01173302|Rabies|rabies
5109923|NCT01173302|Anti-rabies antibody|anti-rabies antibody
5109924|NCT01173302|Persistence|persistence
5109925|NCT01173289|Thyroid Carcinoma|thyroid carcinoma
5109926|NCT01173289|External Beam Radiotherapy|external beam radiotherapy
5109927|NCT01173276|Acquired Immune Deficiency Syndrome|acquired immune deficiency syndrome
5109928|NCT01173276|Assisted Reproductive Technology|assisted reproductive technology
5109929|NCT01173276|Fertility|fertility
5109930|NCT01173276|HIV|hiv
5109931|NCT01173276|HIV Discordant|hiv discordant
5109932|NCT01173276|Infertility|infertility
5109933|NCT01173276|Intrauterine Insemination|intrauterine insemination
5109934|NCT01173276|Sexually Transmitted Diseases|sexually transmitted diseases
5109935|NCT01173276|Sperm Washing|sperm washing
5109936|NCT01173263|breathing machine|breathing machine
5109937|NCT01173263|mechanical ventilator|mechanical ventilator
5109938|NCT01173250|total proctocolectomy with ileal pouch anal anastomosis with and without ileostomy|total proctocolectomy with ileal pouch anal anastomosis with and without ileostomy
5109939|NCT01173237|tracheal intubation|tracheal intubation
5109940|NCT01173237|proseal laryngeal mask airway|proseal laryngeal mask airway
5109941|NCT01173237|neonate|neonate
5109942|NCT01173237|surfactant|surfactant
5109943|NCT01173237|respiratory distress syndrome|respiratory distress syndrome
5109944|NCT01173224|influenza, DAS181, antiviral|influenza, das181, antiviral
5109945|NCT01173211|pregnant, women, influenza, vaccine|pregnant, women, influenza, vaccine
5109946|NCT01173198|LOW TO MODERATE MYOPIC PATIENTS|low to moderate myopic patients
5109947|NCT01173172|Boron neutron capture therapy (BNCT)|boron neutron capture therapy (bnct)
5109948|NCT01173172|Head and neck cancer|head and neck cancer
5109949|NCT01173172|toxicities|toxicities
5109950|NCT01173172|response rate|response rate
5109951|NCT01173159|Parenteral Nutrition|parenteral nutrition
5109952|NCT01173159|Cholestasis|cholestasis
5109953|NCT01173146|Primary prostate cancer undergoing prostatectomy|primary prostate cancer undergoing prostatectomy
5109954|NCT01173133|Free Flap|free flap
5109955|NCT01173133|Surgery|surgery
5109956|NCT01173133|Ischemia|ischemia
5109957|NCT01173133|Outcome|outcome
5109958|NCT01173133|Reconstructive Plastic Surgery|reconstructive plastic surgery
5109959|NCT01173133|Monitoring|monitoring
5109960|NCT01173094|Critical limb ischemia|critical limb ischemia
5109961|NCT01173094|Diabetes Mellitus|diabetes mellitus
5109962|NCT01173094|Diabetes foot|diabetes foot
5109963|NCT01173081|Jones fracture|jones fracture
5109964|NCT01173081|fifth metatarsal fracture|fifth metatarsal fracture
5109965|NCT01173081|teriparatide|teriparatide
5109966|NCT01173081|fracture healing|fracture healing
5109967|NCT01173068|Ertapenem|ertapenem
5109968|NCT01173068|Clinical outcome|clinical outcome
5109969|NCT01173068|Complicated Urinary Tract Infections|complicated urinary tract infections
5109970|NCT01173042|Overweight|overweight
5109971|NCT01173042|Obese|obese
5109972|NCT01173029|Systemic arterial hypertension|systemic arterial hypertension
5109973|NCT01173029|Hypertension Resistant to Conventional Therapy|hypertension resistant to conventional therapy
5109974|NCT01173029|Genetic polymorphisms|genetic polymorphisms
5109975|NCT01173029|Renin-angiotensin-aldosterone system genetic polymorphism|renin-angiotensin-aldosterone system genetic polymorphism
5109976|NCT01173029|Risk markers|risk markers
5109977|NCT01173029|Adverse events|adverse events
5109978|NCT01173029|Acute myocardial infarction|acute myocardial infarction
5109979|NCT01173029|Stroke|stroke
5109980|NCT01173016|mucopolysaccharide IH (MPS IH)|mucopolysaccharide ih (mps ih)
5109981|NCT01173003|Medical abortion|medical abortion
5109982|NCT01173003|mifepristone|mifepristone
5109983|NCT01173003|misoprostol|misoprostol
5109984|NCT01173003|Tunisia|tunisia
5109985|NCT01172990|ST Depression|st depression
5109986|NCT01172977|Diabetes mellitus|diabetes mellitus
5109987|NCT01172977|Stroke|stroke
5109988|NCT01172964|Los Angeles|los angeles
5109989|NCT01172951|Post-prandial|post-prandial
5109990|NCT01172951|Nutrigenomic|nutrigenomic
5109991|NCT01172951|Test meal|test meal
5109992|NCT01172951|Oral glucose tolerance test|oral glucose tolerance test
5109993|NCT01172951|Oral lipid tolerance test|oral lipid tolerance test
5109994|NCT01172938|Psoriatic Arthritis|psoriatic arthritis
5109996|NCT01172938|Arthritis|arthritis
5109997|NCT01172938|inflammation|inflammation
5109998|NCT01172938|skin condition|skin condition
5109999|NCT01172938|inflammatory cells|inflammatory cells
5110000|NCT01172938|apremilast|apremilast
5110001|NCT01172938|CC-10004|cc-10004
5110002|NCT01172938|phosphodiesterase type 4|phosphodiesterase type 4
5110003|NCT01172925|NSCLC|nsclc
5110004|NCT01172925|dyspnea|dyspnea
5110005|NCT01172925|phase II|phase ii
5110006|NCT01172925|crossover|crossover
5110007|NCT01172925|tiotropium|tiotropium
5110008|NCT01172912|recurrent extragonadal germ cell tumor|recurrent extragonadal germ cell tumor
5110009|NCT01172912|recurrent extragonadal non-seminomatous germ cell tumor|recurrent extragonadal non-seminomatous germ cell tumor
5110010|NCT01172912|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
5110011|NCT01172912|stage IV extragonadal non-seminomatous germ cell tumor|stage iv extragonadal non-seminomatous germ cell tumor
5110012|NCT01172912|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
5110013|NCT01172912|recurrent extragonadal seminoma|recurrent extragonadal seminoma
5110014|NCT01172912|stage IV extragonadal seminoma|stage iv extragonadal seminoma
5110015|NCT01172912|testicular mature teratoma|testicular mature teratoma
5110016|NCT01172912|adult central nervous system germ cell tumor|adult central nervous system germ cell tumor
5110017|NCT01172912|testicular immature teratoma|testicular immature teratoma
5110018|NCT01172899|Bariatric Surgery|bariatric surgery
5110019|NCT01172899|Adolescent|adolescent
5110020|NCT01172886|Metabolic Syndrome obesity visceral adiposity breast cancer|metabolic syndrome obesity visceral adiposity breast cancer
5110021|NCT01172873|OCD|ocd
5110022|NCT01172873|DCS|dcs
5110023|NCT01172873|D-cycloserine|d-cycloserine
5110024|NCT01172873|CBT|cbt
5110025|NCT01172873|E/RP|e/rp
5110026|NCT01172873|exposure response prevention|exposure response prevention
5110027|NCT01172860|Inoperable|inoperable
5110028|NCT01172860|Colorectal|colorectal
5110029|NCT01172860|Endoscopic|endoscopic
5110030|NCT01172860|Electroporation|electroporation
5110031|NCT01172860|Outpatient|outpatient
5110032|NCT01172834|Nurses|nurses
5110033|NCT01172795|Whiplash associated disorder|whiplash associated disorder
5110034|NCT01172795|chronic pain|chronic pain
5110035|NCT01172795|neural inhibition|neural inhibition
5110036|NCT01172795|neuropsychological tests|neuropsychological tests
5110037|NCT01172769|HNSCC|hnscc
5110038|NCT01172756|Pulmonary Hypertension|pulmonary hypertension
5110039|NCT01172756|Left ventricular dysfunction|left ventricular dysfunction
5110040|NCT01172743|Diabetes Mellitus|diabetes mellitus
5110041|NCT01172743|Diabetes|diabetes
5110042|NCT01172743|Type-2|type-2
5110043|NCT01172743|Adult Onset|adult onset
5110044|NCT01172730|Post operative pain|post operative pain
5110045|NCT01172730|thoracic epidural|thoracic epidural
5110046|NCT01172730|acute pain|acute pain
5110047|NCT01172730|Ultrasound scanning of the thoracic spine|ultrasound scanning of the thoracic spine
5110048|NCT01172717|Carcinoid|carcinoid
5110049|NCT01172717|Carcinoid syndrome|carcinoid syndrome
5110050|NCT01172704|Motivational Interviewing|motivational interviewing
5110051|NCT01172704|Serious Mental Illness|serious mental illness
5110052|NCT01172704|HIV/AIDS|hiv/aids
5110053|NCT01172704|HIV Testing|hiv testing
5110054|NCT01172691|Liver transplant|liver transplant
5110055|NCT01172665|Celiac Disease|celiac disease
5110056|NCT01172652|Bipolar disorder|bipolar disorder
5110057|NCT01172652|Anxiety|anxiety
5110058|NCT01172652|Panic|panic
5110059|NCT01172652|GAD|gad
5110060|NCT01172652|Generalized Anxiety Disorder|generalized anxiety disorder
5110061|NCT01172639|CoBRA|cobra
5110062|NCT01172626|epilepsy|epilepsy
5110063|NCT01172626|valproate sodium|valproate sodium
5110064|NCT01172626|metabolic enzymes|metabolic enzymes
5110065|NCT01172626|adverse effects|adverse effects
5110066|NCT01172626|systemic adverse effects|systemic adverse effects
5110067|NCT01172613|allergic rhinitis|allergic rhinitis
5110068|NCT01172613|concentration of diagnostic reagent|concentration of diagnostic reagent
5110069|NCT01172613|allergen extract, house dust mites (Dp)|allergen extract, house dust mites (dp)
5110070|NCT01172613|skin prick test|skin prick test
5110071|NCT01172613|nasal allergen provocation test|nasal allergen provocation test
5110072|NCT01172600|radiating back pain|radiating back pain
5110073|NCT01172600|epidural block|epidural block
5110074|NCT01172600|steroid|steroid
5110075|NCT01172600|recurrent low back pain|recurrent low back pain
5110076|NCT01172600|Lumbar Epidural Steroid Block with 3 injections|lumbar epidural steroid block with 3 injections
5110077|NCT01172587|Cognitive Behavioral Therapy|cognitive behavioral therapy
5110078|NCT01172587|Couples Treatment|couples treatment
5110079|NCT01172587|Alcohol Use|alcohol use
5110080|NCT01172587|Effects on Youth|effects on youth
5110081|NCT01172574|Osteoporosis|osteoporosis
5110082|NCT01172574|Pain|pain
5110083|NCT01172574|Kyphosis|kyphosis
5110084|NCT01172574|Posture|posture
5110085|NCT01172574|Exercise therapy|exercise therapy
5110086|NCT01172548|Resected GIST|resected gist
5110087|NCT01172548|primary GIST|primary gist
5110088|NCT01172548|tumor recurrence|tumor recurrence
5110089|NCT01172548|KIT receptor|kit receptor
5110090|NCT01172548|KIT positive|kit positive
5110091|NCT01172548|advanced GIST|advanced gist
5110092|NCT01172548|minimal toxicity|minimal toxicity
5110093|NCT01172548|GIST|gist
5110094|NCT01172535|Lopinavir/ritonavir|lopinavir/ritonavir
5110095|NCT01172535|Pediatric dosing|pediatric dosing
5110096|NCT01172535|World Health Organization|world health organization
5110097|NCT01172522|Under eye dark circles|under eye dark circles
5110098|NCT01172522|Under eye puffiness|under eye puffiness
5110099|NCT01172509|plasticity|plasticity
5110100|NCT01172509|excitatory|excitatory
5110101|NCT01172509|inhibitory|inhibitory
5110102|NCT01172509|synaptic plasticity|synaptic plasticity
5110103|NCT01172509|R-Baclofen|r-baclofen
5110104|NCT01172509|TMS|tms
5110105|NCT01172509|transcranial magnetic stimulation|transcranial magnetic stimulation
5110106|NCT01172509|biomarker|biomarker
5110107|NCT01172509|autism|autism
5110108|NCT01172483|primary care|primary care
5110109|NCT01172483|physical and aquatic exercises|physical and aquatic exercises
5110110|NCT01172483|promotion physical activity|promotion physical activity
5110111|NCT01172483|chronic disorders|chronic disorders
5110112|NCT01172470|Recurrent head and neck cancer|recurrent head and neck cancer
5110113|NCT01172470|larynx, lip, oral cavity and pharynx|larynx, lip, oral cavity and pharynx
5110114|NCT01172457|low back pain|low back pain
5110115|NCT01172457|failed back surgery syndrome (FBSS)|failed back surgery syndrome (fbss)
5110116|NCT01172457|epidural fibrosis|epidural fibrosis
5110117|NCT01172457|ozone therapy|ozone therapy
5110118|NCT01172457|oxygen therapy|oxygen therapy
5110119|NCT01172457|epiduroscopy|epiduroscopy
5110120|NCT01172457|spinal endoscopy|spinal endoscopy
5110121|NCT01172444|Mild to Moderate Ulcerative Proctitis|mild to moderate ulcerative proctitis
5110122|NCT01172431|hypertension|hypertension
5110123|NCT01172431|renal insufficiency|renal insufficiency
5110124|NCT01172431|indapamide|indapamide
5110125|NCT01172431|hydrochlorothiazide|hydrochlorothiazide
5110126|NCT01172418|adult|adult
5110127|NCT01172418|primary kidney transplant recipient|primary kidney transplant recipient
5110128|NCT01172405|Headache|headache
5110129|NCT01172405|Migraine|migraine
5110130|NCT01172405|Ibuprofen|ibuprofen
5110131|NCT01172405|Caffeine|caffeine
5110132|NCT01172366|Open label, single dose, pharmacokinetic study|open label, single dose, pharmacokinetic study
5110133|NCT01172353|contras-induced nephropathy|contras-induced nephropathy
5110134|NCT01172340|behavioral|behavioral
5110135|NCT01172340|diet|diet
5110136|NCT01172340|exercise|exercise
5110137|NCT01172314|NSCLC|nsclc
5110138|NCT01172314|Weight loss|weight loss
5110139|NCT01172314|protein metabolism|protein metabolism
5110140|NCT01172314|essential amino acid intake|essential amino acid intake
5110141|NCT01172301|CF|cf
5110142|NCT01172301|protein metabolism|protein metabolism
5110143|NCT01172301|essential amino acid intake|essential amino acid intake
5110144|NCT01172288|Tic disorders,|tic disorders,
5110145|NCT01172288|Tourette syndrome|tourette syndrome
5110146|NCT01172288|Chronic Tic Disorders|chronic tic disorders
5110147|NCT01172275|Obsessive-Compulsive Disorder|obsessive-compulsive disorder
5110148|NCT01172275|OCD|ocd
5110149|NCT01172262|Tinnitus|tinnitus
5110150|NCT01172262|MRI|mri
5110151|NCT01172262|fMRI|fmri
5110152|NCT01172262|task based MRI|task based mri
5110153|NCT01172262|Otolaryngology|otolaryngology
5110154|NCT01172249|Osteoarthritis|osteoarthritis
5110155|NCT01172249|Knee|knee
5110156|NCT01172249|Glucosamine|glucosamine
5110157|NCT01172249|Chondroitin|chondroitin
5110158|NCT01172223|HER2-positive|her2-positive
5110159|NCT01172223|early breast cancer|early breast cancer
5110160|NCT01172197|local anesthetic|local anesthetic
5110161|NCT01172197|levobupivacaine|levobupivacaine
5110162|NCT01172197|ropivacaine|ropivacaine
5110163|NCT01172197|femoral perineural block|femoral perineural block
5110164|NCT01172184|Left atrial distensibility|left atrial distensibility
5110165|NCT01172184|Left ventricular filling pressure|left ventricular filling pressure
5110166|NCT01172184|Severe mitral regurgitation|severe mitral regurgitation
5110167|NCT01172184|Prognosis|prognosis
5110168|NCT01172184|Post-operation (mitral valve replacement or valvuloplasty) atrial fibrillation|post-operation (mitral valve replacement or valvuloplasty) atrial fibrillation
5110169|NCT01172171|Ischemia-reperfusion injury|ischemia-reperfusion injury
5110170|NCT01172171|Acute Myocardial Infarction|acute myocardial infarction
5110171|NCT01172171|Intracoronary melatonin|intracoronary melatonin
5110172|NCT01172158|forgotten ureteral stents, SMS Reminder|forgotten ureteral stents, sms reminder
5110173|NCT01172145|apathy|apathy
5110174|NCT01172145|Alzheimer's disease|alzheimer's disease
5110175|NCT01172145|activities of daily living performance|activities of daily living performance
5110176|NCT01172145|caregiver burden|caregiver burden
5110177|NCT01172132|Leukemia|leukemia
5110178|NCT01172132|Lymphoma|lymphoma
5110179|NCT01172132|Bone-Marrow Transplant|bone-marrow transplant
5110180|NCT01172132|Neutropenia|neutropenia
5110181|NCT01172132|Acute respiratory failure|acute respiratory failure
5110182|NCT01172132|Mechanical ventilation|mechanical ventilation
5110183|NCT01172132|Post ICU burden|post icu burden
5110184|NCT01172132|ICU triage|icu triage
5110185|NCT01172132|Dialysis|dialysis
5110186|NCT01172132|Septic shock|septic shock
5110187|NCT01172119|Coronary Disease, Coronary Stenosis, Angioplasty, Coronary restenosis, Drug Eluting Stent|coronary disease, coronary stenosis, angioplasty, coronary restenosis, drug eluting stent
5110188|NCT01172106|Postpartum psychosis|postpartum psychosis
5110189|NCT01172106|Perceived social support|perceived social support
5110190|NCT01172106|Family psychoeducation|family psychoeducation
5110191|NCT01172093|obstructive sleep apnea|obstructive sleep apnea
5110192|NCT01172093|prevalence|prevalence
5110193|NCT01172093|diabetes mellitus|diabetes mellitus
5110194|NCT01172093|Chinese|chinese
5110195|NCT01172080|colonoscopy|colonoscopy
5110196|NCT01172080|adherence|adherence
5110197|NCT01172080|reminders|reminders
5110198|NCT01172080|quality|quality
5110199|NCT01172067|CRT|crt
5110200|NCT01172067|heart failure|heart failure
5110201|NCT01172067|optimization|optimization
5110202|NCT01172067|Timing cycle optimization methods|timing cycle optimization methods
5110203|NCT01172054|influenza vaccine recombinant|influenza vaccine recombinant
5110204|NCT01172028|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5110205|NCT01172028|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5110206|NCT01172028|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5110207|NCT01172028|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5110208|NCT01172028|male breast cancer|male breast cancer
5110209|NCT01172028|stage IIIA breast cancer|stage iiia breast cancer
5110210|NCT01172028|stage IIIB breast cancer|stage iiib breast cancer
5110211|NCT01172028|stage IIIC breast cancer|stage iiic breast cancer
5110212|NCT01172028|stage IV breast cancer|stage iv breast cancer
5110213|NCT01172028|recurrent breast cancer|recurrent breast cancer
5110214|NCT01172028|stage III prostate cancer|stage iii prostate cancer
5110215|NCT01172028|stage IV prostate cancer|stage iv prostate cancer
5110216|NCT01172028|recurrent prostate cancer|recurrent prostate cancer
5110217|NCT01172028|stage III esophageal cancer|stage iii esophageal cancer
5110218|NCT01172028|stage IV esophageal cancer|stage iv esophageal cancer
5110219|NCT01172028|recurrent esophageal cancer|recurrent esophageal cancer
5110220|NCT01172028|recurrent adenoid cystic carcinoma of the oral cavity|recurrent adenoid cystic carcinoma of the oral cavity
5110221|NCT01172028|recurrent mucoepidermoid carcinoma of the oral cavity|recurrent mucoepidermoid carcinoma of the oral cavity
5110222|NCT01172028|stage III adenoid cystic carcinoma of the oral cavity|stage iii adenoid cystic carcinoma of the oral cavity
5110223|NCT01172028|stage III mucoepidermoid carcinoma of the oral cavity|stage iii mucoepidermoid carcinoma of the oral cavity
5110224|NCT01172028|stage IV adenoid cystic carcinoma of the oral cavity|stage iv adenoid cystic carcinoma of the oral cavity
5110225|NCT01172028|stage IV mucoepidermoid carcinoma of the oral cavity|stage iv mucoepidermoid carcinoma of the oral cavity
5110226|NCT01172028|recurrent basal cell carcinoma of the lip|recurrent basal cell carcinoma of the lip
5110227|NCT01172028|stage III basal cell carcinoma of the lip|stage iii basal cell carcinoma of the lip
5110228|NCT01172028|stage IV basal cell carcinoma of the lip|stage iv basal cell carcinoma of the lip
5110229|NCT01172028|recurrent lymphoepithelioma of the nasopharynx|recurrent lymphoepithelioma of the nasopharynx
5110230|NCT01172028|stage III lymphoepithelioma of the nasopharynx|stage iii lymphoepithelioma of the nasopharynx
5110231|NCT01172028|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
5110232|NCT01172028|recurrent lymphoepithelioma of the oropharynx|recurrent lymphoepithelioma of the oropharynx
5110233|NCT01172028|stage III lymphoepithelioma of the oropharynx|stage iii lymphoepithelioma of the oropharynx
5110234|NCT01172028|stage IV lymphoepithelioma of the oropharynx|stage iv lymphoepithelioma of the oropharynx
5110235|NCT01172028|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity
5110236|NCT01172028|recurrent inverted papilloma of the paranasal sinus and nasal cavity|recurrent inverted papilloma of the paranasal sinus and nasal cavity
5110237|NCT01172028|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity
5110238|NCT01172028|stage III esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iii esthesioneuroblastoma of the paranasal sinus and nasal cavity
5110239|NCT01172028|stage III inverted papilloma of the paranasal sinus and nasal cavity|stage iii inverted papilloma of the paranasal sinus and nasal cavity
5110240|NCT01172028|stage III midline lethal granuloma of the paranasal sinus and nasal cavity|stage iii midline lethal granuloma of the paranasal sinus and nasal cavity
5110241|NCT01172028|stage IV esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iv esthesioneuroblastoma of the paranasal sinus and nasal cavity
5110242|NCT01172028|stage IV inverted papilloma of the paranasal sinus and nasal cavity|stage iv inverted papilloma of the paranasal sinus and nasal cavity
5110243|NCT01172028|stage IV midline lethal granuloma of the paranasal sinus and nasal cavity|stage iv midline lethal granuloma of the paranasal sinus and nasal cavity
5110244|NCT01172028|recurrent salivary gland cancer|recurrent salivary gland cancer
5110245|NCT01172028|stage III salivary gland cancer|stage iii salivary gland cancer
5110246|NCT01172028|stage IV salivary gland cancer|stage iv salivary gland cancer
5110247|NCT01172028|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5110248|NCT01172028|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5110249|NCT01172028|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5110250|NCT01172028|stage III ovarian germ cell tumor|stage iii ovarian germ cell tumor
5110251|NCT01172028|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
5110252|NCT01172028|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
5110253|NCT01172028|stage III gastric cancer|stage iii gastric cancer
5110254|NCT01172028|stage IV gastric cancer|stage iv gastric cancer
5110255|NCT01172028|recurrent gastric cancer|recurrent gastric cancer
5110256|NCT01172028|recurrent hypopharyngeal cancer|recurrent hypopharyngeal cancer
5110257|NCT01172028|stage III hypopharyngeal cancer|stage iii hypopharyngeal cancer
5110258|NCT01172028|stage IV hypopharyngeal cancer|stage iv hypopharyngeal cancer
5110259|NCT01172028|recurrent laryngeal cancer|recurrent laryngeal cancer
5110260|NCT01172028|stage III laryngeal cancer|stage iii laryngeal cancer
5110261|NCT01172028|stage IV laryngeal cancer|stage iv laryngeal cancer
5110262|NCT01172002|Lupus Nephritis|lupus nephritis
5110263|NCT01172002|Leflunomide|leflunomide
5110264|NCT01172002|Azathioprine|azathioprine
5110265|NCT01171989|booster vaccination|booster vaccination
5110266|NCT01171989|combined vaccine|combined vaccine
5110267|NCT01171976|DME|dme
5110268|NCT01171976|Diabetic macula edema|diabetic macula edema
5110269|NCT01171976|RETAIN|retain
5110270|NCT01171976|ranibizumab|ranibizumab
5110271|NCT01171963|Liquid human retrovirus vaccine|liquid human retrovirus vaccine
5110272|NCT01171950|Thoratec Corporation|thoratec corporation
5110273|NCT01171937|ages 8-16|ages 8-16
5110274|NCT01171937|Repetitive Behaviors|repetitive behaviors
5110275|NCT01171924|Head and Neck Cancer|head and neck cancer
5110276|NCT01171924|Liver Cancer|liver cancer
5110277|NCT01171924|Breast Cancer|breast cancer
5110278|NCT01171924|Gastric Cancer|gastric cancer
5110279|NCT01171924|Non-Small Cell Lung Cancer|non-small cell lung cancer
5110280|NCT01171924|EGFR|egfr
5110281|NCT01171924|HDAC|hdac
5110282|NCT01171924|Her2|her2
5110283|NCT01171924|CUDC-101|cudc-101
5110284|NCT01171911|Endothelial shear stress|endothelial shear stress
5110285|NCT01171911|Calcium channel blocker|calcium channel blocker
5110286|NCT01171898|Non-Metastatic|non-metastatic
5110287|NCT01171898|Rising PSA|rising psa
5110288|NCT01171898|Castration-Resistant|castration-resistant
5110289|NCT01171898|Treatment-Naive|treatment-naive
5110290|NCT01171898|Post-abiraterone|post-abiraterone
5110291|NCT01171885|Superficial cervical block|superficial cervical block
5110292|NCT01171885|Thyroidectomy|thyroidectomy
5110293|NCT01171885|Pain|pain
5110294|NCT01171872|Inflammatory Bowel Disease|inflammatory bowel disease
5110295|NCT01171872|Inflammatory Bowel Disease (IBD)|inflammatory bowel disease (ibd)
5110296|NCT01171872|Crohn's Disease|crohn's disease
5110297|NCT01171872|Ulcerative Colitis|ulcerative colitis
5110298|NCT01171872|Indeterminate Colitis|indeterminate colitis
5110299|NCT01171872|IBD|ibd
5110300|NCT01171872|CD|cd
5110301|NCT01171872|UC|uc
5110302|NCT01171872|IC|ic
5110303|NCT01171859|amyloidosis|amyloidosis
5110304|NCT01171859|transthyretin|transthyretin
5110305|NCT01171859|doxycycline|doxycycline
5110306|NCT01171859|Tauroursodeoxycholic acid|tauroursodeoxycholic acid
5110307|NCT01171846|prevention|prevention
5110308|NCT01171846|pelvic floor muscle training|pelvic floor muscle training
5110309|NCT01171846|prolapse symptoms|prolapse symptoms
5110310|NCT01171846|urinary symptoms|urinary symptoms
5110311|NCT01171846|sexual function|sexual function
5110312|NCT01171846|randomised controlled trial|randomised controlled trial
5110313|NCT01171833|Anesthetic induction|anesthetic induction
5110314|NCT01171833|Desflurane|desflurane
5110315|NCT01171833|Isoflurane|isoflurane
5110316|NCT01171833|Sevoflurane|sevoflurane
5110317|NCT01171833|Ventilation|ventilation
5110318|NCT01171820|drug eluting stents|drug eluting stents
5110319|NCT01171820|stents|stents
5110320|NCT01171820|Angioplasty|angioplasty
5110321|NCT01171820|coronary artery disease|coronary artery disease
5110322|NCT01171820|total coronary occlusion|total coronary occlusion
5110323|NCT01171820|coronary artery restenosis|coronary artery restenosis
5110324|NCT01171820|stent thrombosis|stent thrombosis
5110325|NCT01171820|vascular disease|vascular disease
5110326|NCT01171820|myocardial ischemia|myocardial ischemia
5110327|NCT01171820|coronary artery stenosis|coronary artery stenosis
5110328|NCT01171807|Ulcerative colitis|ulcerative colitis
5110329|NCT01171807|Steroid-dependency|steroid-dependency
5110330|NCT01171807|Steroid adverse events|steroid adverse events
5110331|NCT01171807|Erythrocytes|erythrocytes
5110459|NCT01171352|dialysis|dialysis
5110332|NCT01171768|Vascular endothelial growth factor|vascular endothelial growth factor
5110333|NCT01171768|angiopoietin-2|angiopoietin-2
5110334|NCT01171729|Prostate cancer|prostate cancer
5110335|NCT01171729|PSA|psa
5110336|NCT01171729|Hormone refractory prostatic cancer|hormone refractory prostatic cancer
5110337|NCT01171716|overweight, protein intake, satiety, eating, meal patterns|overweight, protein intake, satiety, eating, meal patterns
5110338|NCT01171703|Critical limb ischemia|critical limb ischemia
5110339|NCT01171703|Diabetes|diabetes
5110340|NCT01171703|Femoropopliteal artery bypass|femoropopliteal artery bypass
5110341|NCT01171703|Stent|stent
5110342|NCT01171690|Hypoparathyroidism|hypoparathyroidism
5110343|NCT01171677|addiction|addiction
5110344|NCT01171677|exercise|exercise
5110345|NCT01171677|cognitive function|cognitive function
5110346|NCT01171677|mood|mood
5110347|NCT01171677|self efficacy|self efficacy
5110348|NCT01171664|Phase 2|phase 2
5110349|NCT01171664|SAR|sar
5110350|NCT01171664|STAHIST|stahist
5110351|NCT01171651|Vaccinia|vaccinia
5110352|NCT01171651|Vaccinia Virus|vaccinia virus
5110353|NCT01171651|JX-594|jx-594
5110354|NCT01171651|Jennerex|jennerex
5110759|NCT01170026|adolescents|adolescents
5110355|NCT01171651|Primary Hepatocellular Carcinoma|primary hepatocellular carcinoma
5110356|NCT01171651|Primary Liver Cancer|primary liver cancer
5110357|NCT01171651|Liver Cancer|liver cancer
5110358|NCT01171651|Sorafenib|sorafenib
5110359|NCT01171651|Nexavar|nexavar
5110360|NCT01171651|Pexa-Vec|pexa-vec
5110361|NCT01171638|near infrared spectroscopy|near infrared spectroscopy
5110362|NCT01171638|compartment syndrome|compartment syndrome
5110363|NCT01171638|fasciotomy|fasciotomy
5110364|NCT01171638|INVOS|invos
5110365|NCT01171625|PERIMOUNT, Aortic valve replacement/regurgitation|perimount, aortic valve replacement/regurgitation
5110366|NCT01171612|Coronary Stent|coronary stent
5110367|NCT01171612|BMS stent|bms stent
5110368|NCT01171612|DES stent|des stent
5110369|NCT01171612|Date of stent implantation|date of stent implantation
5110370|NCT01171612|cardiac event|cardiac event
5110371|NCT01171612|neurovascular event|neurovascular event
5110372|NCT01171612|Bleeding|bleeding
5110373|NCT01171612|transfusion|transfusion
5110374|NCT01171599|Weight Loss|weight loss
5110375|NCT01171599|Obesity|obesity
5110376|NCT01171599|Overweight|overweight
5110377|NCT01171599|Physical Activity|physical activity
5110378|NCT01171599|Nutrition|nutrition
5110379|NCT01171599|Youth|youth
5110380|NCT01171599|Adolescent|adolescent
5110381|NCT01171599|Technology|technology
5110382|NCT01171586|Obesity|obesity
5110383|NCT01171586|overweight|overweight
5110384|NCT01171586|weight loss|weight loss
5110385|NCT01171586|weight maintenance|weight maintenance
5110386|NCT01171586|SMS|sms
5110387|NCT01171586|technology|technology
5110388|NCT01171586|cell phone|cell phone
5110389|NCT01171586|physical activity|physical activity
5110390|NCT01171586|nutrition|nutrition
5110391|NCT01171573|Polymyositis|polymyositis
5110392|NCT01171573|Dermatomyositis|dermatomyositis
5110393|NCT01171573|Inclusion Body Myositis|inclusion body myositis
5110394|NCT01171560|EZ Blocker|ez blocker
5110395|NCT01171560|Double-lumen Tube|double-lumen tube
5110396|NCT01171560|Airway|airway
5110397|NCT01171560|thoracic surgery|thoracic surgery
5110398|NCT01171560|time for intubation|time for intubation
5110399|NCT01171560|blind insertion|blind insertion
5110400|NCT01171560|conditions of surgery|conditions of surgery
5110401|NCT01171560|postoperative sore throat|postoperative sore throat
5110402|NCT01171560|postoperative hoarseness|postoperative hoarseness
5110403|NCT01171547|pharmacokinetics|pharmacokinetics
5110404|NCT01171508|Circadian Rhythm Disorders|circadian rhythm disorders
5110405|NCT01171508|Breast Neoplasms Surgery|breast neoplasms surgery
5110406|NCT01171508|Sleep|sleep
5110407|NCT01171508|Heart Rate|heart rate
5110408|NCT01171495|HIV/AIDS|hiv/aids
5110409|NCT01171495|Nutrition Therapy|nutrition therapy
5110410|NCT01171495|Dietary Supplement|dietary supplement
5110411|NCT01171495|Antioxidant|antioxidant
5110412|NCT01171495|Immunity|immunity
5110413|NCT01171495|CD4 count|cd4 count
5110414|NCT01171495|Anthropometry|anthropometry
5110415|NCT01171495|Body Mass Index|body mass index
5110416|NCT01171469|Brain tumor|brain tumor
5110417|NCT01171469|Immunotherapy|immunotherapy
5110418|NCT01171469|Glioma|glioma
5110419|NCT01171456|GDM|gdm
5110420|NCT01171456|Gestational Diabetes|gestational diabetes
5110421|NCT01171456|Diabetes|diabetes
5110422|NCT01171456|Pregnancy|pregnancy
5110423|NCT01171430|multiple myeloma|multiple myeloma
5110424|NCT01171430|Autologous Stem Cell Transplantation|autologous stem cell transplantation
5110425|NCT01171417|Fulvestrant|fulvestrant
5110426|NCT01171417|Exemestane|exemestane
5110427|NCT01171417|postmenopausal patients|postmenopausal patients
5110428|NCT01171417|advanced HR+ breast cancer|advanced hr+ breast cancer
5110429|NCT01171417|Hormone Receptor positive|hormone receptor positive
5110430|NCT01171417|advanced breast cancer|advanced breast cancer
5110431|NCT01171404|Acute coronary syndrome|acute coronary syndrome
5110432|NCT01171404|heart attack|heart attack
5110433|NCT01171404|myocardial infarction|myocardial infarction
5110434|NCT01171404|ACS long-tem follow up|acs long-tem follow up
5110435|NCT01171404|antithrombotic management|antithrombotic management
5110436|NCT01171404|quality of life|quality of life
5110437|NCT01171404|Antithrombotic|antithrombotic
5110438|NCT01171391|Nocturia|nocturia
5110439|NCT01171391|Pharmacokinetics|pharmacokinetics
5110440|NCT01171391|Pharmacodynamics|pharmacodynamics
5110441|NCT01171391|Water-loading|water-loading
5110442|NCT01171391|Females|females
5110443|NCT01171378|Richter's Syndrome|richter's syndrome
5110444|NCT01171378|High-grade transformation in patients with B cell chronic lymphocytic leukemia|high-grade transformation in patients with b cell chronic lymphocytic leukemia
5110445|NCT01171378|Feasibility|feasibility
5110446|NCT01171378|Ofatumumab Induction and maintenance|ofatumumab induction and maintenance
5110447|NCT01171378|CHOP|chop
5110448|NCT01171378|CHOP-0|chop-0
5110449|NCT01171378|CHOP-OR|chop-or
5110450|NCT01171378|Non Hodgkin's lymphoma|non hodgkin's lymphoma
5110451|NCT01171365|Ciclesonide|ciclesonide
5110452|NCT01171365|Asthma|asthma
5110453|NCT01171365|Therapeutic Uses|therapeutic uses
5110454|NCT01171365|Pulmonary Eosinophilia|pulmonary eosinophilia
5110455|NCT01171365|Nitric Oxide|nitric oxide
5110456|NCT01171365|Lung Diseases|lung diseases
5110457|NCT01171365|Respiratory Tract Diseases|respiratory tract diseases
5110458|NCT01171352|hemodialysis|hemodialysis
5110460|NCT01171352|hypotension|hypotension
5110461|NCT01171352|CritLine|critline
5110462|NCT01171352|PiCCO|picco
5110463|NCT01171352|Thermodilution|thermodilution
5110464|NCT01171352|CVVHDF|cvvhdf
5110465|NCT01171352|IHD|ihd
5110466|NCT01171339|elderly|elderly
5110467|NCT01171339|multimorbidity|multimorbidity
5110468|NCT01171339|polypharmacy|polypharmacy
5110469|NCT01171339|multimedication|multimedication
5110470|NCT01171339|medication appropriateness|medication appropriateness
5110471|NCT01171339|medication appropriateness index|medication appropriateness index
5110472|NCT01171339|cluster-randomised controlled trial|cluster-randomised controlled trial
5110473|NCT01171339|pragmatic trial|pragmatic trial
5110474|NCT01171326|topical|topical
5110475|NCT01171326|minocycline|minocycline
5110476|NCT01171326|foam|foam
5110477|NCT01171326|phase II|phase ii
5110478|NCT01171326|impetigo|impetigo
5110479|NCT01171300|staged T3-4 N0 and T1-4N1-2|staged t3-4 n0 and t1-4n1-2
5110480|NCT01171300|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5110481|NCT01171300|rectum|rectum
5110482|NCT01171287|Automobile Driving|automobile driving
5110483|NCT01171287|Fracture Fixation/instrumentation|fracture fixation/instrumentation
5110484|NCT01171287|Lower Extremity|lower extremity
5110485|NCT01171287|Orthopedic Fixation Devices|orthopedic fixation devices
5110486|NCT01171287|Orthopedic Procedures|orthopedic procedures
5110487|NCT01171287|Reaction Time|reaction time
5110488|NCT01171287|Task Performance and Analysis|task performance and analysis
5110489|NCT01171287|Time Factors|time factors
5110490|NCT01171274|neck pain|neck pain
5110491|NCT01171274|yoga|yoga
5110492|NCT01171274|proprioception|proprioception
5110493|NCT01171274|sensory thresholds|sensory thresholds
5110494|NCT01171274|randomized controlled trial|randomized controlled trial
5110495|NCT01171261|Physical Activity|physical activity
5110496|NCT01171261|Sedentary Behavior|sedentary behavior
5110497|NCT01171261|Video Games|video games
5110498|NCT01171261|Exergames|exergames
5110499|NCT01171248|nocturnal blood pressure dip|nocturnal blood pressure dip
5110500|NCT01171248|complications|complications
5110501|NCT01171248|ambulatory blood pressure|ambulatory blood pressure
5110502|NCT01171235|Laryngeal Neoplasms|laryngeal neoplasms
5110503|NCT01171235|Pharyngeal Neoplasms|pharyngeal neoplasms
5110504|NCT01171222|soccer|soccer
5110505|NCT01171222|prevention|prevention
5110506|NCT01171222|veteran athletes|veteran athletes
5110507|NCT01171222|exercise|exercise
5110508|NCT01171222|Cardiovascular|cardiovascular
5110509|NCT01171209|MS|ms
5110510|NCT01171196|Sleep Apnea|sleep apnea
5110511|NCT01171196|Questionnaire|questionnaire
5110512|NCT01171183|cocaine dependence|cocaine dependence
5110513|NCT01171183|cocaine withdrawal|cocaine withdrawal
5110514|NCT01171170|non small cell lung cancer|non small cell lung cancer
5110515|NCT01171170|stage IV|stage iv
5110516|NCT01171170|nitroglycerin|nitroglycerin
5110517|NCT01171170|carboplatin|carboplatin
5110518|NCT01171170|paclitaxel|paclitaxel
5110519|NCT01171170|bevacizumab|bevacizumab
5110520|NCT01171157|Influenza-like illness|influenza-like illness
5110521|NCT01171157|vaccine effectiveness|vaccine effectiveness
5110522|NCT01171157|elderly|elderly
5110523|NCT01171157|Influenza|influenza
5110524|NCT01171131|TBI|tbi
5110525|NCT01171131|Brain Injury|brain injury
5110526|NCT01171118|Breathing|breathing
5110527|NCT01171118|Sedation|sedation
5110528|NCT01171105|AZD5213 Phase 1|azd5213 phase 1
5110529|NCT01171105|Safety|safety
5110530|NCT01171105|tolerability|tolerability
5110531|NCT01171092|stem cell|stem cell
5110532|NCT01171092|transplant|transplant
5110533|NCT01171092|myeloma|myeloma
5110534|NCT01171092|lymphoma|lymphoma
5110535|NCT01171092|BMT|bmt
5110536|NCT01171092|autologous|autologous
5110537|NCT01171079|postoperative adhesion after thyroidectomy|postoperative adhesion after thyroidectomy
5110538|NCT01171053|Cognitive behavior therapy|cognitive behavior therapy
5110539|NCT01171053|Internet|internet
5110540|NCT01171053|Cost-effectiveness|cost-effectiveness
5110541|NCT01171053|Irritable bowel syndrome|irritable bowel syndrome
5110542|NCT01171040|left atrial distensibility|left atrial distensibility
5110543|NCT01171040|mortality|mortality
5110544|NCT01171040|heart failure|heart failure
5110545|NCT01171040|atrial fibrillation|atrial fibrillation
5110546|NCT01171040|stroke|stroke
5110547|NCT01171040|prognosis|prognosis
5110548|NCT01171027|Cholecystectomy|cholecystectomy
5110549|NCT01171027|NOTES|notes
5110550|NCT01171027|Transvaginal|transvaginal
5110551|NCT01171027|Transgastric|transgastric
5110552|NCT01171027|Natural orifice|natural orifice
5110553|NCT01171027|Gallbladder removal|gallbladder removal
5110554|NCT01170988|patients scheduled for bypass grafting|patients scheduled for bypass grafting
5110555|NCT01170975|Advanced solid tumors|advanced solid tumors
5110556|NCT01170949|urticaria|urticaria
5110557|NCT01170936|Urticarial vasculitis|urticarial vasculitis
5110558|NCT01170936|anti-IL1ß therapy|anti-il1ß therapy
5110559|NCT01170923|non small cell lung cancer|non small cell lung cancer
5110560|NCT01170923|FDG PET|fdg pet
5110561|NCT01170910|Chronic renal failure|chronic renal failure
5110562|NCT01170910|Transplantation|transplantation
5110563|NCT01170910|Marginal kidney graft|marginal kidney graft
5110564|NCT01170910|Pulsatile perfusion machine|pulsatile perfusion machine
5110565|NCT01170897|PEGPH20|pegph20
5110566|NCT01170897|PEGylated Recombinant Human Hyaluronidase|pegylated recombinant human hyaluronidase
5110567|NCT01170897|Metastatic or Locally Advanced Solid Tumors|metastatic or locally advanced solid tumors
5110568|NCT01170845|Esophagectomy|esophagectomy
5110569|NCT01170845|Postoperative respiratory complications|postoperative respiratory complications
5110570|NCT01170845|neutrophil elastase inhibitor|neutrophil elastase inhibitor
5110571|NCT01170819|Cervical ripening|cervical ripening
5110572|NCT01170819|Induction of labor|induction of labor
5110573|NCT01170819|Prostaglandins|prostaglandins
5110574|NCT01170819|Mechanical methods|mechanical methods
5110575|NCT01170819|Balloon catheter|balloon catheter
5110576|NCT01170806|Intestinal lipase|intestinal lipase
5110577|NCT01170806|Orlistat|orlistat
5110578|NCT01170806|fecal fat|fecal fat
5110579|NCT01170806|obesity|obesity
5110580|NCT01170793|education, quality of life|education, quality of life
5110581|NCT01170780|Inguinal hernia|inguinal hernia
5110582|NCT01170780|Transabdominal preperitoneal hernia repair|transabdominal preperitoneal hernia repair
5110583|NCT01170780|TAPP|tapp
5110584|NCT01170780|Dexamethasone|dexamethasone
5110585|NCT01170780|Pain|pain
5110712|NCT01170286|Whole peanut extract|whole peanut extract
5110586|NCT01170767|Age-related Macular Degeneration|age-related macular degeneration
5110587|NCT01170767|Bevacizumab|bevacizumab
5110588|NCT01170767|Ranibizumab|ranibizumab
5110589|NCT01170754|PEG-3350, polyethylene glycol, colonoscopy|peg-3350, polyethylene glycol, colonoscopy
5110590|NCT01170728|Male Sling|male sling
5110591|NCT01170728|Fixation|fixation
5110592|NCT01170728|Stress Urinary Incontinence|stress urinary incontinence
5110593|NCT01170728|Urinary incontinence|urinary incontinence
5110594|NCT01170715|Psoriasis|psoriasis
5110595|NCT01170715|Co morbidities|co morbidities
5110596|NCT01170715|Inflammation|inflammation
5110597|NCT01170702|Cesarean Delivery|cesarean delivery
5110598|NCT01170702|Ropivicaine|ropivicaine
5110599|NCT01170702|TAP block|tap block
5110600|NCT01170689|Schizophrenia|schizophrenia
5110601|NCT01170689|inpatient|inpatient
5110602|NCT01170689|obesity|obesity
5110603|NCT01170689|prevalence|prevalence
5110604|NCT01170676|asthma|asthma
5110605|NCT01170676|smoking|smoking
5110606|NCT01170676|teens|teens
5110607|NCT01170663|Metastatic Adenocarcinoma|metastatic adenocarcinoma
5110608|NCT01170663|Gastric Adenocarcinoma|gastric adenocarcinoma
5110609|NCT01170663|Gastroesophageal Junction Adenocarcinoma|gastroesophageal junction adenocarcinoma
5110610|NCT01170650|cancer|cancer
5110611|NCT01170650|ovarian|ovarian
5110612|NCT01170650|platinum-resistant|platinum-resistant
5110613|NCT01170650|Phase III|phase iii
5110614|NCT01170650|EC145|ec145
5110615|NCT01170650|EC20|ec20
5110616|NCT01170624|PhD|phd
5110617|NCT01170624|EGM|egm
5110618|NCT01170624|CRT-D|crt-d
5110619|NCT01170624|The study will particularly focus on a new-based diagnostic feature, called PhD-Clinical Status (PhD)|the study will particularly focus on a new-based diagnostic feature, called phd-clinical status (phd)
5110620|NCT01170598|acute myeloid leukemia|acute myeloid leukemia
5110621|NCT01170598|AML|aml
5110622|NCT01170598|chemotherapy|chemotherapy
5110623|NCT01170598|exercise|exercise
5110624|NCT01170598|quality of life|quality of life
5110625|NCT01170598|cancer-related fatigue|cancer-related fatigue
5110626|NCT01170598|elderly|elderly
5110627|NCT01170598|physical fitness|physical fitness
5110628|NCT01170598|muscular strength|muscular strength
5110629|NCT01170598|Feasibility|feasibility
5110630|NCT01170598|Efficacy|efficacy
5110631|NCT01170598|Safety|safety
5110632|NCT01170546|anterior cruciate ligament|anterior cruciate ligament
5110633|NCT01170546|agility|agility
5110634|NCT01170546|knee stability|knee stability
5110635|NCT01170546|hamstring|hamstring
5110636|NCT01170546|knee internal rotator|knee internal rotator
5110637|NCT01170533|proton pump inhibitor|proton pump inhibitor
5110638|NCT01170533|clopidogrel|clopidogrel
5110639|NCT01170533|platelet function|platelet function
5110640|NCT01170520|adolescent resistant depression|adolescent resistant depression
5110641|NCT01170520|repetitive transcranial magnetic stimulation|repetitive transcranial magnetic stimulation
5110642|NCT01170520|treatment of resistant adolescent depression|treatment of resistant adolescent depression
5110643|NCT01170507|vitamin D3, 25 OH vitamin D3 level|vitamin d3, 25 oh vitamin d3 level
5110644|NCT01170494|vitamin D2, vitamin D3, 25 Oh vitamin D2, 25 Oh vitamin D3|vitamin d2, vitamin d3, 25 oh vitamin d2, 25 oh vitamin d3
5110645|NCT01170481|anterior and intermediate uveitis|anterior and intermediate uveitis
5110646|NCT01170481|papilloedema|papilloedema
5110647|NCT01170468|Prediabetics|prediabetics
5110648|NCT01170468|DM|dm
5110649|NCT01170468|vitamin D|vitamin d
5110650|NCT01170455|nasal|nasal
5110651|NCT01170455|intubation|intubation
5110652|NCT01170455|direct laryngoscope|direct laryngoscope
5110653|NCT01170455|blind|blind
5110654|NCT01170455|normal airway|normal airway
5110655|NCT01170429|Cough Variant Asthma|cough variant asthma
5110656|NCT01170429|Procaterol Hydrochloride|procaterol hydrochloride
5110657|NCT01170416|Ventricular Tachycardia|ventricular tachycardia
5110658|NCT01170416|Body Surface Mapping|body surface mapping
5110659|NCT01170403|coronary heart disease|coronary heart disease
5110660|NCT01170403|Multidetector row cardiac computed tomography|multidetector row cardiac computed tomography
5110661|NCT01170403|type 2 diabetes|type 2 diabetes
5110662|NCT01170403|metabolic syndrome|metabolic syndrome
5110663|NCT01170390|Obesity|obesity
5110664|NCT01170390|Body weight|body weight
5110665|NCT01170390|Oral contraception|oral contraception
5110666|NCT01170390|Efficacy|efficacy
5110667|NCT01170377|Intravenous sedation|intravenous sedation
5110668|NCT01170377|Dental treatment|dental treatment
5110669|NCT01170377|Mental retardation|mental retardation
5110670|NCT01170377|Antiepileptic drug|antiepileptic drug
5110671|NCT01170377|Valproate|valproate
5110672|NCT01170377|Propofol|propofol
5110673|NCT01170364|Obesity|obesity
5110674|NCT01170364|sibutramine|sibutramine
5110675|NCT01170364|eating behavior|eating behavior
5110676|NCT01170351|autoimmune hepatitis|autoimmune hepatitis
5110677|NCT01170351|corticosteroids|corticosteroids
5110678|NCT01170351|cysclosporine-A|cysclosporine-a
5110679|NCT01170351|treatment|treatment
5110680|NCT01170351|treatment-naive|treatment-naive
5110681|NCT01170351|induction of remossion|induction of remossion
5110682|NCT01170351|efficacy|efficacy
5110683|NCT01170351|tolerability|tolerability
5110684|NCT01170338|smoking|smoking
5110685|NCT01170338|tobacco abuse|tobacco abuse
5110686|NCT01170325|Valproic Acid|valproic acid
5110687|NCT01170325|Divalproex|divalproex
5110688|NCT01170325|Autism|autism
5110689|NCT01170325|EEG|eeg
5110690|NCT01170325|Electroencephalogram (EEG)|electroencephalogram (eeg)
5110691|NCT01170325|Depakote|depakote
5110692|NCT01170312|Arthroscopic repair|arthroscopic repair
5110693|NCT01170312|Rotator cuff|rotator cuff
5110694|NCT01170312|Platelet rich plasma|platelet rich plasma
5110695|NCT01170312|Randomized|randomized
5110696|NCT01170312|Pilot|pilot
5110697|NCT01170299|radiation toxicity|radiation toxicity
5110698|NCT01170299|gastrointestinal complications|gastrointestinal complications
5110699|NCT01170299|cervical cancer|cervical cancer
5110700|NCT01170299|fallopian tube cancer|fallopian tube cancer
5110701|NCT01170299|ovarian epithelial cancer|ovarian epithelial cancer
5110702|NCT01170299|ovarian germ cell tumor|ovarian germ cell tumor
5110703|NCT01170299|ovarian sarcoma|ovarian sarcoma
5110704|NCT01170299|ovarian stromal cancer|ovarian stromal cancer
5110705|NCT01170299|uterine sarcoma|uterine sarcoma
5110706|NCT01170299|bladder cancer|bladder cancer
5110707|NCT01170299|colon cancer|colon cancer
5110708|NCT01170299|rectal cancer|rectal cancer
5110709|NCT01170299|anal cancer|anal cancer
5110710|NCT01170286|Food allergy|food allergy
5110711|NCT01170286|Immediate hypersensitivity|immediate hypersensitivity
5110713|NCT01170286|Allergenic product|allergenic product
5110714|NCT01170286|Specific Immunotherapy|specific immunotherapy
5110715|NCT01170286|Epicutaneous Immunotherapy (EPIT)|epicutaneous immunotherapy (epit)
5110716|NCT01170286|Safety|safety
5110717|NCT01170273|aged|aged
5110718|NCT01170273|vitamin d deficiency|vitamin d deficiency
5110719|NCT01170247|Procedural Sedation|procedural sedation
5110720|NCT01170234|Exhaled nitric oxide|exhaled nitric oxide
5110721|NCT01170234|Eosinophilic esophagitis|eosinophilic esophagitis
5110722|NCT01170221|ABSSSI|absssi
5110723|NCT01170221|Tedizolid Phosphate|tedizolid phosphate
5110724|NCT01170221|TR-701|tr-701
5110725|NCT01170221|Acute Bacterial Skin and Skin Structure Infections|acute bacterial skin and skin structure infections
5110726|NCT01170208|insulin|insulin
5110727|NCT01170208|dosage software|dosage software
5110728|NCT01170195|Postmenopausal|postmenopausal
5110729|NCT01170195|licorice|licorice
5110730|NCT01170195|vaginal complaints|vaginal complaints
5110731|NCT01170156|deep sedation|deep sedation
5110732|NCT01170156|respiratory resuscitation|respiratory resuscitation
5110733|NCT01170156|Hi-Lo Evac tube|hi-lo evac tube
5110734|NCT01170156|suctioning manoeuvre|suctioning manoeuvre
5110735|NCT01170143|IIB-IIIB Breast Cancer|iib-iiib breast cancer
5110736|NCT01170143|Her2 positive|her2 positive
5110737|NCT01170130|Cataract|cataract
5110738|NCT01170130|Mydriasis|mydriasis
5110739|NCT01170130|Lidocaine|lidocaine
5110740|NCT01170117|Eating Disorders|eating disorders
5110741|NCT01170117|Anorexia Nervosa|anorexia nervosa
5110742|NCT01170104|Hepatocellular Carcinoma|hepatocellular carcinoma
5110743|NCT01170104|Sorafenib|sorafenib
5110744|NCT01170104|TACE|tace
5110745|NCT01170104|locally, advanced Hepatocellular Carcinoma|locally, advanced hepatocellular carcinoma
5110746|NCT01170078|chronic renal failure requiring hemodialysis|chronic renal failure requiring hemodialysis
5110747|NCT01170052|Relapsed Mantle Cell Lymphoma|relapsed mantle cell lymphoma
5110748|NCT01170052|Refractory Mantle Cell Lymphoma|refractory mantle cell lymphoma
5110749|NCT01170052|Non-Hodgkins Lymphoma|non-hodgkins lymphoma
5110750|NCT01170052|Temsirolimus|temsirolimus
5110751|NCT01170052|Bendamustine|bendamustine
5110752|NCT01170052|Phase 1/2|phase 1/2
5110753|NCT01170039|Constipation|constipation
5110754|NCT01170039|Diabetes|diabetes
5110755|NCT01170039|Lubiprostone|lubiprostone
5110756|NCT01170039|Amitiza|amitiza
5110757|NCT01170039|African Americans|african americans
5110758|NCT01170026|substance use|substance use
5110760|NCT01170026|intervention|intervention
5110761|NCT01170026|truancy|truancy
5110762|NCT01170026|sexual risk behavior|sexual risk behavior
5110763|NCT01170013|substance use|substance use
5110764|NCT01170013|adolescents|adolescents
5110765|NCT01170013|initiation|initiation
5110766|NCT01169987|Multicenter study|multicenter study
5110767|NCT01169974|Microcirculation|microcirculation
5110768|NCT01169974|laser flowmetry|laser flowmetry
5110769|NCT01169974|Skin|skin
5110770|NCT01169974|Physiology|physiology
5110771|NCT01169961|IRON OVERLOAD IN HEMODIALYSIS PATIENTS|iron overload in hemodialysis patients
5110772|NCT01169948|Coronary disease|coronary disease
5110773|NCT01169948|Coronary artery bypass|coronary artery bypass
5110774|NCT01169948|Cardiac surgery|cardiac surgery
5110775|NCT01169948|Computed tomography|computed tomography
5110776|NCT01169948|Coronary angiography|coronary angiography
5110777|NCT01169935|MRI|mri
5110778|NCT01169935|SPIO|spio
5110779|NCT01169935|Healthy Volunteer|healthy volunteer
5110780|NCT01169909|Pterygium|pterygium
5110781|NCT01169896|Impact of ventricular pacing on the incidence of VT/VF episodes for each models|impact of ventricular pacing on the incidence of vt/vf episodes for each models
5110782|NCT01169883|adherence|adherence
5110783|NCT01169883|asthma|asthma
5110784|NCT01169883|pediatrics|pediatrics
5110785|NCT01169883|behavioral intervention|behavioral intervention
5110786|NCT01169883|inner city|inner city
5110787|NCT01169870|metastatic|metastatic
5110788|NCT01169857|Proliferative lupus nephritis|proliferative lupus nephritis
5110789|NCT01169857|WHO class III/IV/V lupus nephritis|who class iii/iv/v lupus nephritis
5110790|NCT01169857|Proteinuria|proteinuria
5110791|NCT01169857|Hematuria|hematuria
5110792|NCT01169857|Velcade|velcade
5110793|NCT01169857|SLE|sle
5110794|NCT01169857|Bortezomib|bortezomib
5110795|NCT01169857|Proteasome inhibitor|proteasome inhibitor
5110796|NCT01169844|Psoriatic arthritis|psoriatic arthritis
5110797|NCT01169844|IgG1K monoclonal antibody|igg1k monoclonal antibody
5110798|NCT01169844|Interleukin -17A neutralizing|interleukin -17a neutralizing
5110799|NCT01169792|Tamoxifen|tamoxifen
5110800|NCT01169792|Cytochrome P-450 CYP2D6|cytochrome p-450 cyp2d6
5110801|NCT01169792|Polymorphism|polymorphism
5110802|NCT01169792|Single nucleotide|single nucleotide
5110803|NCT01169792|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal
5110804|NCT01169753|Chronic Myeloid Leukemia|chronic myeloid leukemia
5110805|NCT01169753|CML|cml
5110806|NCT01169753|Nuvigil|nuvigil
5110807|NCT01169753|Armodafinil|armodafinil
5110808|NCT01169753|Fatigue|fatigue
5110809|NCT01169740|Hyperbilirubinemia|hyperbilirubinemia
5110810|NCT01169740|Neonatal|neonatal
5110811|NCT01169740|Serum bilirubin|serum bilirubin
5110812|NCT01169740|Transcutaneous bilirubin|transcutaneous bilirubin
5110813|NCT01169740|Skin color|skin color
5110814|NCT01169727|COPD and CCQ score|copd and ccq score
5110815|NCT01169727|Changes in PEF,overall CCQ score|changes in pef,overall ccq score
5110816|NCT01169714|multiple dose|multiple dose
5110817|NCT01169714|healthy volunteer|healthy volunteer
5110818|NCT01169714|healthy elderly volunteer|healthy elderly volunteer
5110819|NCT01169714|safety|safety
5110820|NCT01169714|pharmacokinetic|pharmacokinetic
5110821|NCT01169701|Renal transplant, everolimus, cardiovascular profile, CNI-free immunosuppression, left ventricular hypertrophy, biopsy proved acute rejection (BPAR)|renal transplant, everolimus, cardiovascular profile, cni-free immunosuppression, left ventricular hypertrophy, biopsy proved acute rejection (bpar)
5110822|NCT01169688|Cataract Surgery|cataract surgery
5110823|NCT01169688|Pupillary Dilation|pupillary dilation
5110824|NCT01169649|MK-2206|mk-2206
5110825|NCT01169649|Neuroendocrine Tumors|neuroendocrine tumors
5110826|NCT01169649|10-067|10-067
5110827|NCT01169636|Chemotherapy|chemotherapy
5110828|NCT01169636|Panobinostat|panobinostat
5110829|NCT01169636|Ifosfamide|ifosfamide
5110830|NCT01169636|Mesna|mesna
5110831|NCT01169636|Etoposide|etoposide
5110832|NCT01169636|Carboplatin|carboplatin
5110833|NCT01169636|Pegfilgrastim|pegfilgrastim
5110834|NCT01169636|ICE|ice
5110835|NCT01169623|Supportive leadership behaviour|supportive leadership behaviour
5110836|NCT01169623|Nurse Performance|nurse performance
5110837|NCT01169623|Educational Intervention|educational intervention
5110838|NCT01169610|Alcohol|alcohol
5110839|NCT01169610|Smoking|smoking
5110840|NCT01169597|polymyalgia rheumatica|polymyalgia rheumatica
5110841|NCT01169597|prednisone|prednisone
5110842|NCT01169597|clinical examination|clinical examination
5110843|NCT01169597|remission|remission
5110844|NCT01169597|ultrasonography|ultrasonography
5110845|NCT01169584|Phase I|phase i
5110846|NCT01169584|advanced metastatic pediatric solid tumors|advanced metastatic pediatric solid tumors
5110847|NCT01169584|pediatric|pediatric
5110848|NCT01169584|vaccinia virus|vaccinia virus
5110849|NCT01169584|oncolytic virus|oncolytic virus
5110850|NCT01169584|neuroblastoma|neuroblastoma
5110851|NCT01169584|rhabdomyosarcoma|rhabdomyosarcoma
5110852|NCT01169584|lymphoma|lymphoma
5110853|NCT01169584|Wilm's tumor|wilm's tumor
5110854|NCT01169584|Ewing's sarcoma|ewing's sarcoma
5110855|NCT01169584|osteosarcoma|osteosarcoma
5110856|NCT01169584|non-rhabdomyosarcoma soft tissue sarcomas|non-rhabdomyosarcoma soft tissue sarcomas
5110857|NCT01169584|malignant peripheral nerve sheath tumors|malignant peripheral nerve sheath tumors
5110858|NCT01169584|Pexa-Vec|pexa-vec
5110859|NCT01169571|Initially intubated|initially intubated
5110860|NCT01169571|Mechanically ventilated|mechanically ventilated
5110861|NCT01169571|Post-surgical|post-surgical
5110862|NCT01169545|any type of cancer|any type of cancer
5110863|NCT01169519|Hypoplastic left heart syndrome|hypoplastic left heart syndrome
5110864|NCT01169519|Hypoplastic right heart syndrome|hypoplastic right heart syndrome
5110865|NCT01169519|Superior cavopulmonary anastomosis|superior cavopulmonary anastomosis
5110866|NCT01169519|Total cavopulmonary anastomosis|total cavopulmonary anastomosis
5110867|NCT01169519|Children with single ventricle anatomy|children with single ventricle anatomy
5110868|NCT01169506|blood gas analysis|blood gas analysis
5110869|NCT01169506|ventilatory insufficiency|ventilatory insufficiency
5110870|NCT01169493|Heart Failure|heart failure
5110871|NCT01169493|Right Bundle-Branch Block|right bundle-branch block
5110872|NCT01169493|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
5110873|NCT01169480|Massage|massage
5110874|NCT01169480|Therapist, Massage|therapist, massage
5110875|NCT01169480|DASS|dass
5110876|NCT01169480|Depression|depression
5110877|NCT01169480|Anxiety, State|anxiety, state
5110878|NCT01169480|Anxiety, Trait|anxiety, trait
5110879|NCT01169480|Stress|stress
5110880|NCT01169480|Touch|touch
5110881|NCT01169480|Therapeutic Relationship|therapeutic relationship
5110882|NCT01169454|Cerebral Spinal Fluid|cerebral spinal fluid
5110883|NCT01169454|Ventriculostomy|ventriculostomy
5110884|NCT01169454|Subarachnoid hemorrhage|subarachnoid hemorrhage
5110885|NCT01169454|Vasospasm|vasospasm
5110886|NCT01169454|Human Subjects|human subjects
5110887|NCT01169441|ICD leads|icd leads
5110888|NCT01169441|Removal|removal
5110889|NCT01169441|Extraction|extraction
5110890|NCT01169441|Ventricular leads|ventricular leads
5110891|NCT01169441|Extract|extract
5110892|NCT01169441|laser|laser
5110893|NCT01169441|Observe the lead with x-ray during movement and collect information on current ways of removing an ICD lead.|observe the lead with x-ray during movement and collect information on current ways of removing an icd lead.
5110894|NCT01169428|Mindfulness-Based Weight Loss Maintenance|mindfulness-based weight loss maintenance
5110895|NCT01169428|prevention of weight regain|prevention of weight regain
5110896|NCT01169428|Obesity|obesity
5110897|NCT01169415|Randomized|randomized
5110898|NCT01169415|Dexamethasone|dexamethasone
5110899|NCT01169415|Abbreviated|abbreviated
5110900|NCT01169415|Protracted|protracted
5110901|NCT01169415|Post-operatively|post-operatively
5110902|NCT01169402|extracorporeal membrane oxygenation|extracorporeal membrane oxygenation
5110903|NCT01169402|ECMO|ecmo
5110904|NCT01169402|extracorporeal life support|extracorporeal life support
5110905|NCT01169402|fluconazole|fluconazole
5110906|NCT01169402|diflucan|diflucan
5110907|NCT01169402|pharmacokinetics|pharmacokinetics
5110908|NCT01169402|pharmacodynamics|pharmacodynamics
5110909|NCT01169376|disseminated neuroblastoma|disseminated neuroblastoma
5110910|NCT01169376|localized resectable neuroblastoma|localized resectable neuroblastoma
5110911|NCT01169376|localized unresectable neuroblastoma|localized unresectable neuroblastoma
5110912|NCT01169376|regional neuroblastoma|regional neuroblastoma
5110913|NCT01169376|stage 4S neuroblastoma|stage 4s neuroblastoma
5110914|NCT01169363|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5110915|NCT01169363|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5110916|NCT01169363|adult erythroleukemia (M6a)|adult erythroleukemia (m6a)
5110917|NCT01169363|adult pure erythroid leukemia (M6b)|adult pure erythroid leukemia (m6b)
5110918|NCT01169363|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
5110919|NCT01169363|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
5110920|NCT01169363|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
5110921|NCT01169363|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
5110922|NCT01169363|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
5110923|NCT01169363|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
5110924|NCT01169363|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
5110925|NCT01169363|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5110926|NCT01169363|adult acute myeloid leukemia with del(5q)|adult acute myeloid leukemia with del(5q)
5110927|NCT01169363|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5110928|NCT01169363|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5110929|NCT01169363|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5110930|NCT01169324|Parkinson's disease|parkinson's disease
5110931|NCT01169324|Tremor|tremor
5110932|NCT01169324|Dystonia|dystonia
5110933|NCT01169324|DBS|dbs
5110934|NCT01169324|Sleep|sleep
5110935|NCT01169311|Hemorrhoids|hemorrhoids
5110936|NCT01169311|Hemorrhoid|hemorrhoid
5110937|NCT01169311|grade II, III, IV|grade ii, iii, iv
5110938|NCT01169298|Adult T-cell Leukemia-Lymphoma|adult t-cell leukemia-lymphoma
5110939|NCT01169298|Peripheral T-cell Lymphoma|peripheral t-cell lymphoma
5110940|NCT01169298|PTCL|ptcl
5110941|NCT01169298|HTLV-1|htlv-1
5110942|NCT01169285|Burn Department Nursing Staff|burn department nursing staff
5110943|NCT01169272|ICD CRT 9770 - PARADYM RF ICD - SonR atrial lead|icd crt 9770 - paradym rf icd - sonr atrial lead
5110944|NCT01169259|vitamin D3|vitamin d3
5110945|NCT01169259|omega-3 fatty acids|omega-3 fatty acids
5110946|NCT01169259|fish oil|fish oil
5110947|NCT01169259|cardiovascular disease|cardiovascular disease
5110948|NCT01169259|cancer|cancer
5110949|NCT01169259|primary prevention|primary prevention
5110950|NCT01169246|ATP,CRT, ICD PARADYM|atp,crt, icd paradym
5110951|NCT01169233|Sleep|sleep
5110952|NCT01169233|Alertness|alertness
5110953|NCT01169233|fatigue|fatigue
5110954|NCT01169233|performance|performance
5110955|NCT01169233|spaceflight|spaceflight
5110956|NCT01169233|isolation|isolation
5110957|NCT01169233|light|light
5110958|NCT01169233|Sleep , alertness and performance during a simulated spaceflight mission|sleep , alertness and performance during a simulated spaceflight mission
5110959|NCT01169220|Colonoscopy|colonoscopy
5110960|NCT01169220|Bowel preparation|bowel preparation
5110961|NCT01169207|Inflammatory Bowel Disease|inflammatory bowel disease
5110962|NCT01169207|Crohn's Disease|crohn's disease
5110963|NCT01169207|Ulcerative Colitis|ulcerative colitis
5110964|NCT01169207|Indeterminate Colitis|indeterminate colitis
5110965|NCT01169207|IBD|ibd
5110966|NCT01169207|CD|cd
5110967|NCT01169207|UC|uc
5110968|NCT01169207|IC|ic
5110969|NCT01169194|Inflammatory Bowel Disease|inflammatory bowel disease
5110970|NCT01169194|Crohn's Disease|crohn's disease
5110971|NCT01169194|Ulcerative Colitis|ulcerative colitis
5110972|NCT01169194|Indeterminate Colitis|indeterminate colitis
5110973|NCT01169194|IBD|ibd
5110974|NCT01169194|CD|cd
5110975|NCT01169194|UC|uc
5110976|NCT01169194|IC|ic
5110977|NCT01169194|African American IBD|african american ibd
5110978|NCT01169194|African American CD|african american cd
5110979|NCT01169194|African American UC|african american uc
5110980|NCT01169194|African American IC|african american ic
5110981|NCT01169194|Black IBD|black ibd
5110982|NCT01169194|Black CD|black cd
5110983|NCT01169194|Black UC|black uc
5110984|NCT01169194|Black IC|black ic
5110985|NCT01169194|African American Inflammatory Bowel Disease|african american inflammatory bowel disease
5110986|NCT01169194|African American Crohn's Disease|african american crohn's disease
5110987|NCT01169194|African American Ulcerative Colitis|african american ulcerative colitis
5110988|NCT01169194|African American Indeterminate Colitis|african american indeterminate colitis
5110989|NCT01169194|Black Inflammatory Bowel Disease|black inflammatory bowel disease
5110990|NCT01169194|Black Crohn's Disease|black crohn's disease
5110991|NCT01169194|Black Ulcerative Colitis|black ulcerative colitis
5110992|NCT01169194|Black Indeterminate Colitis|black indeterminate colitis
5110993|NCT01169181|Stroke|stroke
5110994|NCT01169181|Cerebrovascular Accident|cerebrovascular accident
5110995|NCT01169181|Plegia|plegia
5110996|NCT01169181|Upper Extremity|upper extremity
5110997|NCT01169181|rTMS|rtms
5110998|NCT01169181|tDCS|tdcs
5110999|NCT01169168|fibrinogen|fibrinogen
5111000|NCT01169168|SIRS|sirs
5111001|NCT01169168|sepsis|sepsis
5111002|NCT01169168|liver disease|liver disease
5111003|NCT01169168|chronic liver disease|chronic liver disease
5111004|NCT01169168|septic shock|septic shock
5111005|NCT01169155|Smoke inhalation injury|smoke inhalation injury
5111006|NCT01169155|Burns|burns
5111007|NCT01169155|Injuries|injuries
5111008|NCT01169142|Vitamin D|vitamin d
5111009|NCT01169142|Schizophrenia|schizophrenia
5111010|NCT01169142|Severely Mentally Ill|severely mentally ill
5111011|NCT01169129|brain metastases|brain metastases
5111012|NCT01169129|radiosurgery|radiosurgery
5111013|NCT01169129|neurosurgery|neurosurgery
5111014|NCT01169129|surgery|surgery
5111015|NCT01169129|radiotherapy|radiotherapy
5111016|NCT01169129|resectable brain metastases|resectable brain metastases
5111017|NCT01169116|radiotherapy|radiotherapy
5111018|NCT01169116|radiation oncology|radiation oncology
5111019|NCT01169116|brain metastasis|brain metastasis
5111020|NCT01169116|metastases|metastases
5111021|NCT01169116|radiosurgery|radiosurgery
5111022|NCT01169116|neurosurgery|neurosurgery
5111023|NCT01169116|hypofractionation|hypofractionation
5111024|NCT01169116|stereotaxy|stereotaxy
5111025|NCT01169103|Obesity|obesity
5111026|NCT01169103|Adolescent|adolescent
5111027|NCT01169103|Insulin resistance|insulin resistance
5111028|NCT01169103|Growth hormone|growth hormone
5111029|NCT01169103|Visceral fat|visceral fat
5111030|NCT01169103|Adolescent obesity|adolescent obesity
5111031|NCT01169077|malaria, plasmodium falciparum, electroporation|malaria, plasmodium falciparum, electroporation
5111032|NCT01169064|Wound infection prevention|wound infection prevention
5111033|NCT01169064|Silver-containing surgical dressing|silver-containing surgical dressing
5111034|NCT01169064|Cesarean delivery infection prevention|cesarean delivery infection prevention
5111035|NCT01169051|Esophagectomy|esophagectomy
5111036|NCT01169051|Pulmonary wedge resection|pulmonary wedge resection
5111037|NCT01169051|Pulmonary lobectomy|pulmonary lobectomy
5111038|NCT01169051|Pulmonary pneumonectomy|pulmonary pneumonectomy
5111039|NCT01169051|Thoracic Surgery|thoracic surgery
5111040|NCT01169051|Lung Cancer|lung cancer
5111041|NCT01169051|Esophageal Cancer|esophageal cancer
5111042|NCT01169038|sarcoidosis|sarcoidosis
5111043|NCT01169038|mycobacteria|mycobacteria
5111044|NCT01169038|lung|lung
5111045|NCT01169038|pulmonary|pulmonary
5111046|NCT01169038|radiographic improvement|radiographic improvement
5111047|NCT01169025|Analgesia|analgesia
5111048|NCT01169025|Pain|pain
5111049|NCT01169012|Myelodysplastic syndrome|myelodysplastic syndrome
5111050|NCT01169012|Acute Myeloid Leukemia|acute myeloid leukemia
5111051|NCT01169012|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
5111052|NCT01169012|Chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5111053|NCT01169012|Clofarabine|clofarabine
5111054|NCT01169012|Clolar|clolar
5111055|NCT01169012|University of North Carolina at Chapel Hill|university of north carolina at chapel hill
5111056|NCT01169012|Lineberger Comprehensive Cancer Center|lineberger comprehensive cancer center
5111057|NCT01168999|low back pain|low back pain
5111058|NCT01168999|spinal manipulation|spinal manipulation
5111059|NCT01168999|manual therapy|manual therapy
5111060|NCT01168999|placebo|placebo
5111061|NCT01168986|neck pain|neck pain
5111062|NCT01168986|manual therapy|manual therapy
5111063|NCT01168986|exercise|exercise
5111064|NCT01168973|second line|second line
5111065|NCT01168973|non small cell lung cancer|non small cell lung cancer
5111066|NCT01168973|NSCLC|nsclc
5111067|NCT01168973|phase 3|phase 3
5111068|NCT01168973|ramucirumab|ramucirumab
5111069|NCT01168973|lung cancer|lung cancer
5111070|NCT01168973|docetaxel|docetaxel
5111071|NCT01168973|taxotere|taxotere
5111072|NCT01168947|sodium|sodium
5111073|NCT01168947|hypertension|hypertension
5111074|NCT01168947|fluid overload|fluid overload
5111075|NCT01168947|hemodialysis|hemodialysis
5111076|NCT01168947|dialysate|dialysate
5111077|NCT01168947|interdialytic weight gain|interdialytic weight gain
5111078|NCT01168947|intradialytic hypotension|intradialytic hypotension
5111079|NCT01168934|healthy volunteers|healthy volunteers
5111080|NCT01168934|crizotinib|crizotinib
5111081|NCT01168934|absolute bioavailability|absolute bioavailability
5111082|NCT01168934|pharmacokinetics|pharmacokinetics
5111083|NCT01168921|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
5111084|NCT01168921|CLL|cll
5111085|NCT01168921|Thrombocytopenia|thrombocytopenia
5111086|NCT01168921|Small lymphocytic lymphoma|small lymphocytic lymphoma
5111087|NCT01168921|SLL|sll
5111088|NCT01168921|Eltrombopag|eltrombopag
5111089|NCT01168921|Promacta|promacta
5111090|NCT01168921|thrombopoietin (TPO)-receptor agonist|thrombopoietin (tpo)-receptor agonist
5111091|NCT01168921|platelets|platelets
5111092|NCT01168908|Clinical trial|clinical trial
5111093|NCT01168908|Revatio|revatio
5111094|NCT01168908|Sildenafil|sildenafil
5111095|NCT01168908|Muscular Dystrophy|muscular dystrophy
5111096|NCT01168908|Duchenne|duchenne
5111097|NCT01168908|Becker|becker
5111098|NCT01168908|Adult|adult
5111099|NCT01168908|Adolescent|adolescent
5111100|NCT01168895|75 mg dose strength|75 mg dose strength
5111101|NCT01168895|Safety|safety
5111102|NCT01168895|Pharmacokinetics|pharmacokinetics
5111103|NCT01168882|RGB-286638|rgb-286638
5111104|NCT01168882|Hematological Malignancies|hematological malignancies
5111105|NCT01168869|Manifestation|manifestation
5111106|NCT01168869|Coronary Heart Disease|coronary heart disease
5111107|NCT01168869|Myocardial infarction|myocardial infarction
5111108|NCT01168869|Angina pectoris|angina pectoris
5111109|NCT01168869|Unheralded|unheralded
5111110|NCT01168869|General Practice Research Database|general practice research database
5111111|NCT01168869|Myocardial Ischaemia National Audit Project|myocardial ischaemia national audit project
5111112|NCT01168869|CALIBER|caliber
5111113|NCT01168817|Combination Drug Therapy|combination drug therapy
5111114|NCT01168817|Phosphodiesterase inhibitors|phosphodiesterase inhibitors
5111115|NCT01168804|multiple myeloma|multiple myeloma
5111116|NCT01168804|bendamustine|bendamustine
5111117|NCT01168804|bortezomib|bortezomib
5111118|NCT01168804|dexamethasone|dexamethasone
5111119|NCT01168791|Metastatic|metastatic
5111120|NCT01168791|Front line|front line
5111121|NCT01168765|Physical Activity, Mexican-American, Obesity, Diabetes, Nutrition, Border Health|physical activity, mexican-american, obesity, diabetes, nutrition, border health
5111122|NCT01168752|Cancer|cancer
5111123|NCT01168752|solid tumour|solid tumour
5111124|NCT01168752|lymphoma|lymphoma
5111125|NCT01168752|dose-escalation|dose-escalation
5111126|NCT01168752|Hsp90 inhibitor|hsp90 inhibitor
5111127|NCT01168739|thermotolerance|thermotolerance
5111128|NCT01168739|heat acclimation|heat acclimation
5111129|NCT01168739|quercetin|quercetin
5111130|NCT01168739|exertional heat illness|exertional heat illness
5111131|NCT01168739|gastrointestinal barrier permeability|gastrointestinal barrier permeability
5111132|NCT01168713|Adults with Community-Acquired Bacterial Pneumonia|adults with community-acquired bacterial pneumonia
5111133|NCT01168700|Metabolic syndrome, Aged Garlic Extract, Insulin, inflammation, endothelium.|metabolic syndrome, aged garlic extract, insulin, inflammation, endothelium.
5111134|NCT01168687|keppra|keppra
5111135|NCT01168687|levetiracetam|levetiracetam
5111136|NCT01168687|alcoholism|alcoholism
5111137|NCT01168687|genetics|genetics
5111138|NCT01168687|subjective report|subjective report
5111139|NCT01168674|Major Depressive Disorder|major depressive disorder
5111140|NCT01168674|MDD|mdd
5111141|NCT01168674|Bipolar Disorder|bipolar disorder
5111142|NCT01168674|BD|bd
5111143|NCT01168674|Depression|depression
5111144|NCT01168674|Major Depressive Disorder with Bipolar features|major depressive disorder with bipolar features
5111145|NCT01168661|Stress|stress
5111146|NCT01168661|Burnout|burnout
5111147|NCT01168661|Anxiety|anxiety
5111148|NCT01168661|Depression|depression
5111149|NCT01168648|Yoga|yoga
5111150|NCT01168648|Stress|stress
5111151|NCT01168648|Stress management|stress management
5111152|NCT01168648|Hypothalamus-pituitary-adrenal axis|hypothalamus-pituitary-adrenal axis
5111153|NCT01168635|Asthma|asthma
5111154|NCT01168635|Spirometry|spirometry
5111155|NCT01168635|Pediatric|pediatric
5111156|NCT01168635|Primary Health Care|primary health care
5111157|NCT01168635|Education, Distance|education, distance
5111158|NCT01168609|Left atrial distensibility|left atrial distensibility
5111159|NCT01168609|left ventricular filling pressure|left ventricular filling pressure
5111160|NCT01168609|tissue Doppler|tissue doppler
5111161|NCT01168609|prognosis|prognosis
5111162|NCT01168609|acute myocardial infarction|acute myocardial infarction
5111163|NCT01168596|Parkinson's Disease|parkinson's disease
5111164|NCT01168596|Fatigue|fatigue
5111165|NCT01168570|familial Mediterranean fever|familial mediterranean fever
5111166|NCT01168570|amyloidosis AA|amyloidosis aa
5111167|NCT01168570|serum amyloid A|serum amyloid a
5111168|NCT01168570|renal failure|renal failure
5111169|NCT01168570|nephrotic syndrome|nephrotic syndrome
5111170|NCT01168557|electric impedance tomography|electric impedance tomography
5111171|NCT01168557|stress-echocardiography|stress-echocardiography
5111172|NCT01168557|ventilation|ventilation
5111173|NCT01168557|perfusion|perfusion
5111174|NCT01168544|Vitamin D|vitamin d
5111175|NCT01168544|Colecalciferol|colecalciferol
5111176|NCT01168544|Nursing home|nursing home
5111177|NCT01168544|Loading dose|loading dose
5111178|NCT01168531|patients undergoing lumbar spinal surgery|patients undergoing lumbar spinal surgery
5111179|NCT01168518|Evaluate the Sorin Group new passive- and active- fixation pacing leads|evaluate the sorin group new passive- and active- fixation pacing leads
5111180|NCT01168492|pediatric|pediatric
5111181|NCT01168492|gastroscopy|gastroscopy
5111182|NCT01168492|colonoscopy|colonoscopy
5111183|NCT01168492|sedation|sedation
5111184|NCT01168492|ketamine|ketamine
5111185|NCT01168479|prostate cancer|prostate cancer
5111186|NCT01168479|external beam radiotherapy|external beam radiotherapy
5111187|NCT01168479|dose escalation|dose escalation
5111188|NCT01168479|dose painting|dose painting
5111189|NCT01168479|95Gy in 35 fractions|95gy in 35 fractions
5111190|NCT01168479|MRI|mri
5111191|NCT01168479|FLAME|flame
5111192|NCT01168466|Frontotemporal Lobar Degeneration|frontotemporal lobar degeneration
5111193|NCT01168466|EEG Biofeedback|eeg biofeedback
5111194|NCT01168466|Cerebral oxygenation biofeedback|cerebral oxygenation biofeedback
5111195|NCT01168466|Frontotemporal Dementia|frontotemporal dementia
5111196|NCT01168466|Peak Alpha Amplitude|peak alpha amplitude
5111197|NCT01168466|Quantitative EEG Assessment|quantitative eeg assessment
5111198|NCT01168453|jugular vein|jugular vein
5111199|NCT01168453|anatomy|anatomy
5111200|NCT01168453|ultrasonography|ultrasonography
5111201|NCT01168440|von Hippel-Lindau|von hippel-lindau
5111202|NCT01168440|VHL|vhl
5111203|NCT01168440|sunitinib|sunitinib
5111204|NCT01168401|Prevention of acute gastroenteritis due to infection with noroviruses|prevention of acute gastroenteritis due to infection with noroviruses
5111205|NCT01168388|Dystonia|dystonia
5111206|NCT01168388|Hemifacial spasm|hemifacial spasm
5111207|NCT01168388|Cervical dystonia|cervical dystonia
5111208|NCT01168388|Blepharospasm|blepharospasm
5111209|NCT01168362|coronary artery disease|coronary artery disease
5111210|NCT01168362|cardiovascular risk|cardiovascular risk
5111211|NCT01168362|pericardial fat|pericardial fat
5111212|NCT01168336|betahistine olanzapine weight sleepiness|betahistine olanzapine weight sleepiness
5111213|NCT01168336|olanzapine induced weight gain and sleepiness|olanzapine induced weight gain and sleepiness
5111214|NCT01168323|Medical Education|medical education
5111215|NCT01168323|Educational Technology|educational technology
5111216|NCT01168323|Clinical Practice Guideline|clinical practice guideline
5111217|NCT01168323|Prostate specific antigen|prostate specific antigen
5111218|NCT01168310|Pulmonary, Obstructive, lungs, COPD|pulmonary, obstructive, lungs, copd
5111219|NCT01168297|Obesity|obesity
5111220|NCT01168297|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
5111221|NCT01168297|Genetics|genetics
5111222|NCT01168297|Energy Expenditure|energy expenditure
5111223|NCT01168297|Physical Activity|physical activity
5111224|NCT01168284|Autism Spectrum Disorders|autism spectrum disorders
5111225|NCT01168271|Observational|observational
5111226|NCT01168271|Newborns|newborns
5111227|NCT01168271|Hospitalized|hospitalized
5111228|NCT01168271|Febrile|febrile
5111229|NCT01168271|Resistance|resistance
5111230|NCT01168258|Diabetic Retinopathy|diabetic retinopathy
5111231|NCT01168258|Diabetes|diabetes
5111232|NCT01168258|Single Nucleotide Polymorphism (SNP)|single nucleotide polymorphism (snp)
5111233|NCT01168258|Diabetic Macular Edema|diabetic macular edema
5111234|NCT01168245|Alzheimer Disease|alzheimer disease
5111235|NCT01168245|Dementia|dementia
5111236|NCT01168245|Brain Diseases|brain diseases
5111237|NCT01168245|Central Nervous System Diseases|central nervous system diseases
5111238|NCT01168245|Nervous System Disease|nervous system disease
5111239|NCT01168245|Cognitive Training|cognitive training
5111240|NCT01168245|Cortical Reorganization|cortical reorganization
5111241|NCT01168245|Brain Plasticity|brain plasticity
5111242|NCT01168193|surgery|surgery
5111243|NCT01168193|post operative|post operative
5111244|NCT01168193|complications|complications
5111245|NCT01168193|length of stay|length of stay
5111246|NCT01168180|Traditional Thai Massage|traditional thai massage
5111247|NCT01168180|Scapulocostal Syndrome|scapulocostal syndrome
5111248|NCT01168167|Antiretroviral Therapy, Highly Active|antiretroviral therapy, highly active
5111249|NCT01168167|MK 0518|mk 0518
5111250|NCT01168167|HIV-1 DNA species|hiv-1 dna species
5111251|NCT01168167|viral slope|viral slope
5111252|NCT01168167|Ribonucleic Acid|ribonucleic acid
5111253|NCT01168167|DNA, Complementary|dna, complementary
5111254|NCT01168154|Diverticula|diverticula
5111255|NCT01168154|Diverticular disease|diverticular disease
5111256|NCT01168154|Diverticulitis|diverticulitis
5111257|NCT01168154|Probiotics|probiotics
5111258|NCT01168141|Castrate-resistant prostate cancer with bone metastasis|castrate-resistant prostate cancer with bone metastasis
5111259|NCT01168128|Enteral Nutrition|enteral nutrition
5111260|NCT01168128|Parenteral Nutrition|parenteral nutrition
5111261|NCT01168128|Critically ill|critically ill
5111262|NCT01168128|Nutrition Therapy|nutrition therapy
5111263|NCT01168128|Nutrition Support|nutrition support
5111264|NCT01168128|Practice Guidelines as Topic|practice guidelines as topic
5111265|NCT01168128|Guideline Adherence|guideline adherence
5111266|NCT01168128|Quality Assurance, Health Care|quality assurance, health care
5111267|NCT01168128|Nutrition Surveys|nutrition surveys
5111268|NCT01168128|Questionnaires|questionnaires
5111269|NCT01168063|Helicobacter pylori|helicobacter pylori
5111270|NCT01168063|Diagnostic molecular testing|diagnostic molecular testing
5111271|NCT01168063|Antibiotic resistance|antibiotic resistance
5111272|NCT01168063|Treatment protocols|treatment protocols
5111273|NCT01168050|Malignant Skin Melanoma T0|malignant skin melanoma t0
5111274|NCT01168050|stage III unresectable melanomas,|stage iii unresectable melanomas,
5111275|NCT01168050|or stage IV melanomas with c-KIT mutation|or stage iv melanomas with c-kit mutation
5111276|NCT01168050|or amplification.|or amplification.
5111277|NCT01168037|Aorta|aorta
5111278|NCT01168037|Aneurysm|aneurysm
5111279|NCT01168037|endovascular|endovascular
5111280|NCT01168037|stent-graft|stent-graft
5111281|NCT01168024|Acute Kidney Injury|acute kidney injury
5111282|NCT01168024|Iodinated Contrast Agent Retrieval|iodinated contrast agent retrieval
5111283|NCT01168024|Coronary Sinus Cannulation|coronary sinus cannulation
5111284|NCT01167985|antibacterial polyethyleneimine nanoparticles|antibacterial polyethyleneimine nanoparticles
5111285|NCT01167985|quaternary ammonium|quaternary ammonium
5111286|NCT01167985|dental|dental
5111287|NCT01167985|Endodotnic|endodotnic
5111288|NCT01167985|pulp|pulp
5111289|NCT01167985|bacteria|bacteria
5111290|NCT01167985|Root canal sealer|root canal sealer
5111291|NCT01167985|temporary filling|temporary filling
5111292|NCT01167985|provisional restoration|provisional restoration
5111293|NCT01167972|M + mutation|m + mutation
5111294|NCT01167972|Non Small Cell Lung Cancer adenocarcinoma|non small cell lung cancer adenocarcinoma
5111295|NCT01167972|To determine the proportion of patients with M + mutation status among patients with NSCLC adenocarcinoma|to determine the proportion of patients with m + mutation status among patients with nsclc adenocarcinoma
5111296|NCT01167959|Obesity|obesity
5111297|NCT01167959|Diabetes|diabetes
5111298|NCT01167959|Bariatric surgery|bariatric surgery
5111299|NCT01167946|Alopecia Areata|alopecia areata
5111300|NCT01167946|Alopecia totalis|alopecia totalis
5111301|NCT01167946|Alopecia Universalis|alopecia universalis
5111302|NCT01167946|Ophiasic alopecia|ophiasic alopecia
5111303|NCT01167946|Oral Pulse steroid|oral pulse steroid
5111304|NCT01167946|Methylprednisolone|methylprednisolone
5111305|NCT01167933|Bioequivalence|bioequivalence
5111306|NCT01167933|Crossover|crossover
5111307|NCT01167933|Simvastatin|simvastatin
5111308|NCT01167920|High Blood Pressure|high blood pressure
5111309|NCT01167920|Hypertension|hypertension
5111310|NCT01167920|Home Blood Pressure Measurements|home blood pressure measurements
5111311|NCT01167920|Wireless communication of measurements|wireless communication of measurements
5111312|NCT01167920|Wireless communication of blood pressure measurements|wireless communication of blood pressure measurements
5111313|NCT01167907|ankle|ankle
5111314|NCT01167907|arthrodesis|arthrodesis
5111315|NCT01167907|internal fixation|internal fixation
5111316|NCT01167907|bi/tri malleolar fracture|bi/tri malleolar fracture
5111317|NCT01167894|Bioequivalence|bioequivalence
5111318|NCT01167894|Crossover|crossover
5111319|NCT01167894|Simvastatin|simvastatin
5111320|NCT01167868|fostamatinib disodium|fostamatinib disodium
5111321|NCT01167868|FosD|fosd
5111322|NCT01167868|Japanese|japanese
5111323|NCT01167868|Healthy volunteers|healthy volunteers
5111324|NCT01167868|Phase 1|phase 1
5111325|NCT01167868|Single and Multiple Ascending Dose Study|single and multiple ascending dose study
5111326|NCT01167868|Healthy Japanese volunteers|healthy japanese volunteers
5111327|NCT01167868|Healthy White volunteers|healthy white volunteers
5111328|NCT01167855|Pediatric Asthma|pediatric asthma
5111329|NCT01167855|Low-income|low-income
5111330|NCT01167855|Arkansas Delta Region|arkansas delta region
5111331|NCT01167829|Experimental|experimental
5111332|NCT01167829|Acyline plus 27 oral testosterone pills|acyline plus 27 oral testosterone pills
5111333|NCT01167829|taken 3x/day|taken 3x/day
5111334|NCT01167803|Bariatric surgery|bariatric surgery
5111335|NCT01167803|Anesthesia|anesthesia
5111336|NCT01167790|Precancerous lesions of the oral mucosa|precancerous lesions of the oral mucosa
5111337|NCT01167790|Fluorescence visualization|fluorescence visualization
5111338|NCT01167777|CT|ct
5111339|NCT01167777|GC|gc
5111340|NCT01167777|NG|ng
5111341|NCT01167777|chlamydia|chlamydia
5111342|NCT01167777|gonorrhoeae|gonorrhoeae
5111343|NCT01167764|hemoptysis|hemoptysis
5111344|NCT01167764|recurrence|recurrence
5111345|NCT01167751|Myocardial infarction|myocardial infarction
5111346|NCT01167751|Bone marrow stem cells|bone marrow stem cells
5111347|NCT01167751|AC133|ac133
5111348|NCT01167738|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
5111349|NCT01167738|stage IV pancreatic cancer|stage iv pancreatic cancer
5111350|NCT01167725|mucinous adenocarcinoma of the colon|mucinous adenocarcinoma of the colon
5111351|NCT01167725|stage III colon cancer|stage iii colon cancer
5111352|NCT01167725|stage IV colon cancer|stage iv colon cancer
5111353|NCT01167699|Oxycodone/naloxone|oxycodone/naloxone
5111354|NCT01167699|patient preference|patient preference
5111355|NCT01167699|WHO step I/II|who step i/ii
5111356|NCT01167699|Moderate to severe non-malignant pain|moderate to severe non-malignant pain
5111357|NCT01167686|Respiratory infection|respiratory infection
5111358|NCT01167686|Viral infection|viral infection
5111359|NCT01167686|Food supplement|food supplement
5111360|NCT01167686|Goldtrain Plus (GT+)|goldtrain plus (gt+)
5111361|NCT01167673|irritable bowel syndrome|irritable bowel syndrome
5111362|NCT01167673|selenium|selenium
5111363|NCT01167673|curcumin|curcumin
5111364|NCT01167673|green tea|green tea
5111365|NCT01167660|Coagulation tests|coagulation tests
5111366|NCT01167660|Neonates|neonates
5111367|NCT01167660|Non invasive|non invasive
5111368|NCT01167647|Tuberculosis, culture, bronchoscopy|tuberculosis, culture, bronchoscopy
5111369|NCT01167634|Weight Loss|weight loss
5111370|NCT01167634|Motivation|motivation
5111371|NCT01167634|Contracts|contracts
5111372|NCT01167621|Refractory Acute Respiratory Distress Syndrome|refractory acute respiratory distress syndrome
5111373|NCT01167621|Indexed Extra-vascular Lung Water|indexed extra-vascular lung water
5111374|NCT01167621|HFO-ventilation|hfo-ventilation
5111375|NCT01167608|Parkinson's disease|parkinson's disease
5111376|NCT01167608|Depression|depression
5111377|NCT01167608|Anxiety|anxiety
5111378|NCT01167608|Treatment|treatment
5111379|NCT01167595|Critically ill|critically ill
5111380|NCT01167595|Nutrition therapy|nutrition therapy
5111381|NCT01167595|Enteral nutrition|enteral nutrition
5111382|NCT01167582|blood transfusion|blood transfusion
5111383|NCT01167582|red blood cell transfusion|red blood cell transfusion
5111384|NCT01167582|myocardial infarction|myocardial infarction
5111385|NCT01167582|acute coronary syndrome|acute coronary syndrome
5111386|NCT01167582|anemia|anemia
5111387|NCT01167569|Free Radicals|free radicals
5111388|NCT01167569|Ascorbic Acid|ascorbic acid
5111389|NCT01167569|Cardiac Surgery|cardiac surgery
5111390|NCT01167569|Prevention of Reperfusion Injury|prevention of reperfusion injury
5111391|NCT01167556|Family intervention|family intervention
5111392|NCT01167556|Recent-onset schizophrenia|recent-onset schizophrenia
5111393|NCT01167556|Motivational Interviewing|motivational interviewing
5111394|NCT01167556|Cannabis use|cannabis use
5111395|NCT01167530|Everolimus|everolimus
5111396|NCT01167530|Radiotherapy|radiotherapy
5111397|NCT01167530|Chemotherapy|chemotherapy
5111398|NCT01167517|Breast milk|breast milk
5111399|NCT01167517|Feeding|feeding
5111400|NCT01167517|Prematurity|prematurity
5111401|NCT01167517|Low birth weight infant|low birth weight infant
5111402|NCT01167517|Low maternal breast milk feeding|low maternal breast milk feeding
5111403|NCT01167504|saliva|saliva
5111404|NCT01167504|food|food
5111405|NCT01167504|sensory|sensory
5111406|NCT01167504|oral health|oral health
5111407|NCT01167504|film|film
5111408|NCT01167504|pellicle|pellicle
5111409|NCT01167491|Wegener|wegener
5111410|NCT01167491|CD4+ T cells|cd4+ t cells
5111411|NCT01167491|DAP12|dap12
5111412|NCT01167491|NKG2D|nkg2d
5111413|NCT01167478|Exercise|exercise
5111414|NCT01167478|Caffeine|caffeine
5111415|NCT01167478|Reserve|reserve
5111416|NCT01167465|Diaper Dermatitis|diaper dermatitis
5111417|NCT01167465|Diaper Rash|diaper rash
5111418|NCT01167465|Erythema|erythema
5111419|NCT01167452|Obesity|obesity
5111420|NCT01167452|Pharmacokinetics|pharmacokinetics
5111421|NCT01167452|MRSA|mrsa
5111422|NCT01167452|Tuberculosis|tuberculosis
5111423|NCT01167452|PCP|pcp
5111424|NCT01167439|OPMD, dysphagia|opmd, dysphagia
5111425|NCT01167439|Dysphagia severity|dysphagia severity
5111426|NCT01167439|Nutritional state|nutritional state
5111427|NCT01167439|Speech quality|speech quality
5111428|NCT01167439|Upper esophageal sphincter myotomy|upper esophageal sphincter myotomy
5111429|NCT01167426|Relapsing Remitting Multiple Sclerosis|relapsing remitting multiple sclerosis
5111430|NCT01167426|RRMS|rrms
5112562|NCT01162408|ICU|icu
5111431|NCT01167426|Clinically Isolated Syndrome|clinically isolated syndrome
5111432|NCT01167426|CIS|cis
5111433|NCT01167426|Copaxone|copaxone
5111434|NCT01167426|glatiramer acetate|glatiramer acetate
5111435|NCT01167426|Autoject 2|autoject 2
5111436|NCT01167400|exercise|exercise
5111437|NCT01167400|executive function|executive function
5111438|NCT01167400|older adults|older adults
5111439|NCT01167387|carbohydrate|carbohydrate
5111440|NCT01167387|glucose metabolism|glucose metabolism
5111441|NCT01167387|surgery, outcome|surgery, outcome
5111442|NCT01167387|major elective surgery|major elective surgery
5111443|NCT01167387|urology|urology
5111444|NCT01167387|hyperglicemia|hyperglicemia
5111445|NCT01167374|HCC|hcc
5111446|NCT01167361|upper respiratory tract infection|upper respiratory tract infection
5111447|NCT01167361|lower respiratory tract infection|lower respiratory tract infection
5111448|NCT01167348|auricular acupressure|auricular acupressure
5111449|NCT01167348|obesity|obesity
5111450|NCT01167348|schizophrenia|schizophrenia
5111451|NCT01167348|body weight|body weight
5111452|NCT01167335|partial onset seizure|partial onset seizure
5111453|NCT01167335|seizure frequency|seizure frequency
5111454|NCT01167335|nervous system diseases|nervous system diseases
5111455|NCT01167335|central nervous system diseases|central nervous system diseases
5111456|NCT01167335|CNS|cns
5111457|NCT01167335|brain diseases|brain diseases
5111458|NCT01167335|neurologic manifestations|neurologic manifestations
5111459|NCT01167335|adjunctive treatment|adjunctive treatment
5111460|NCT01167335|AEDs|aeds
5111461|NCT01167335|antiepileptic drug|antiepileptic drug
5111462|NCT01167322|NPC-07, 5-ALA, photodynamic diagnosis, pharmacokinetics|npc-07, 5-ala, photodynamic diagnosis, pharmacokinetics
5111463|NCT01167309|Safety and tolerability of LEO 27847|safety and tolerability of leo 27847
5111464|NCT01167296|Intrauterine adhesion|intrauterine adhesion
5111465|NCT01167296|Cook balloon uterine stent|cook balloon uterine stent
5111466|NCT01167283|COPD|copd
5111467|NCT01167270|Infant Diet|infant diet
5111468|NCT01167270|Toddler Diet|toddler diet
5111469|NCT01167270|Responsive Feeding|responsive feeding
5111470|NCT01167270|Infant Temperament|infant temperament
5111471|NCT01167270|Parent competency|parent competency
5111472|NCT01167270|Childhood Obesity prevention|childhood obesity prevention
5111473|NCT01167270|Rapid infant weight gain|rapid infant weight gain
5111474|NCT01167257|Overactive bladder|overactive bladder
5111475|NCT01167257|Detrusor overactivity|detrusor overactivity
5111476|NCT01167257|Liposome|liposome
5111477|NCT01167257|Botulinum toxin A|botulinum toxin a
5111478|NCT01167231|Diabetes|diabetes
5111479|NCT01167231|Acarbose|acarbose
5111480|NCT01167218|verify now assay for hematological disorders|verify now assay for hematological disorders
5111481|NCT01167205|Healthy adults with BMI over 25.0 kg/m2|healthy adults with bmi over 25.0 kg/m2
5111482|NCT01167179|head and neck cancer|head and neck cancer
5111483|NCT01167179|nurse-led care|nurse-led care
5111484|NCT01167179|follow-up care|follow-up care
5111485|NCT01167179|professional-patient relations|professional-patient relations
5111486|NCT01167179|psychosocial adjustment|psychosocial adjustment
5111487|NCT01167179|quasi-experimental|quasi-experimental
5111488|NCT01167179|prospective|prospective
5111489|NCT01167179|quality of life|quality of life
5111490|NCT01167166|Acute Myelocytic Leukemia|acute myelocytic leukemia
5111491|NCT01167166|Acute Lymphocytic Leukemia|acute lymphocytic leukemia
5111492|NCT01167166|Myeloproliferative Disease|myeloproliferative disease
5111493|NCT01167166|Myelofibrosis|myelofibrosis
5111494|NCT01167166|Essential thrombocythemia|essential thrombocythemia
5111495|NCT01167166|Polycythemia vera|polycythemia vera
5111496|NCT01167166|Chronic Myeloid Leukemia|chronic myeloid leukemia
5111497|NCT01167153|Hypertension|hypertension
5111498|NCT01167153|Valsartan Amlodipine single pill combination|valsartan amlodipine single pill combination
5111499|NCT01167153|BP control|bp control
5111500|NCT01167153|ABPM|abpm
5111501|NCT01167153|Hypertensive patients not adequately controlled by mono antihypertensive drugs|hypertensive patients not adequately controlled by mono antihypertensive drugs
5111502|NCT01167127|Oxycodone/naloxone|oxycodone/naloxone
5111503|NCT01167127|pain relief|pain relief
5111504|NCT01167127|bowel function|bowel function
5111505|NCT01167127|moderate to severe non-malignant pain|moderate to severe non-malignant pain
5111506|NCT01167114|STA-9090|sta-9090
5111507|NCT01167101|Rebamipide|rebamipide
5111508|NCT01167101|gastric ulcer|gastric ulcer
5111509|NCT01167101|healing rate|healing rate
5111510|NCT01167101|iatrogenic gastric ulcer after endoscopic submucosal dissection|iatrogenic gastric ulcer after endoscopic submucosal dissection
5111511|NCT01167088|Double-blind|double-blind
5111512|NCT01167088|Placebo-controlled|placebo-controlled
5111513|NCT01167088|Non-alcoholic fatty liver disease|non-alcoholic fatty liver disease
5111514|NCT01167088|NAFLD|nafld
5111515|NCT01167075|critically ill|critically ill
5111516|NCT01167075|sepsis|sepsis
5111517|NCT01167075|antioxidants|antioxidants
5111518|NCT01167075|enteral nutrition|enteral nutrition
5111519|NCT01167075|SIRS (APACHE score 10-30)|sirs (apache score 10-30)
5111520|NCT01167075|enteral feeding within 48 h of admission|enteral feeding within 48 h of admission
5111521|NCT01167049|gastric cancer with liver metastasis|gastric cancer with liver metastasis
5111522|NCT01167036|Myofascial pain syndrome|myofascial pain syndrome
5111523|NCT01167036|Trigger points, Myofascial|trigger points, myofascial
5111524|NCT01167036|Chiropractic|chiropractic
5111525|NCT01167036|Massage|massage
5111526|NCT01167036|Musculoskeletal manipulation|musculoskeletal manipulation
5111527|NCT01167023|Sickle Cell Disease|sickle cell disease
5111528|NCT01167023|Sickle Cell Anemia|sickle cell anemia
5111529|NCT01167023|Adult|adult
5111530|NCT01166997|Pulmonary embolism|pulmonary embolism
5111531|NCT01166997|Pulmonary thromboembolism|pulmonary thromboembolism
5111532|NCT01166997|anticoagulation|anticoagulation
5111533|NCT01166997|thrombolysis|thrombolysis
5111534|NCT01166997|ultrasound accelerated thrombolysis|ultrasound accelerated thrombolysis
5111535|NCT01166984|sepsis|sepsis
5111536|NCT01166984|septic shock|septic shock
5111537|NCT01166971|presbyopia|presbyopia
5111538|NCT01166971|intraocular lens|intraocular lens
5111539|NCT01166945|Child|child
5111540|NCT01166945|Child, preschool|child, preschool
5111541|NCT01166945|Sinusitis|sinusitis
5111542|NCT01166945|Antimicrobial agents|antimicrobial agents
5111543|NCT01166932|pneumonia|pneumonia
5111544|NCT01166932|children|children
5111545|NCT01166932|antibiotics|antibiotics
5111546|NCT01166906|pain blocking|pain blocking
5111547|NCT01166893|burn wound|burn wound
5111548|NCT01166880|assessment|assessment
5111549|NCT01166867|assessment|assessment
5111550|NCT01166854|muscle and bone disease|muscle and bone disease
5111551|NCT01166841|minimally invasive cardiac surgery|minimally invasive cardiac surgery
5111552|NCT01166841|cardiac surgery|cardiac surgery
5111553|NCT01166841|near infrared spectroscopy|near infrared spectroscopy
5111554|NCT01166841|mitral valve repair|mitral valve repair
5111555|NCT01166841|mitral valve replacement|mitral valve replacement
5111556|NCT01166828|Spinal cord injury|spinal cord injury
5111557|NCT01166828|telehealth|telehealth
5111558|NCT01166828|pressure ulcers|pressure ulcers
5111559|NCT01166828|quality of life|quality of life
5111560|NCT01166815|diarrhea morbidity|diarrhea morbidity
5111561|NCT01166815|malaria incidence|malaria incidence
5111562|NCT01166815|zinc supplementation|zinc supplementation
5111563|NCT01166802|questionnaire development|questionnaire development
5111564|NCT01166802|hypervigilance|hypervigilance
5111565|NCT01166802|pain sensitivity|pain sensitivity
5111566|NCT01166789|IBS|ibs
5111567|NCT01166789|pain threshold|pain threshold
5111568|NCT01166789|constipation|constipation
5111569|NCT01166776|Wharton's jelly|wharton's jelly
5111570|NCT01166776|umbilical cord|umbilical cord
5111571|NCT01166776|decellularization|decellularization
5111572|NCT01166763|breast atypia|breast atypia
5111573|NCT01166763|high risk for breast cancer|high risk for breast cancer
5111574|NCT01166763|random periareolar fine needle aspiration|random periareolar fine needle aspiration
5111575|NCT01166763|RPFNA|rpfna
5111576|NCT01166763|breast epithelial hyperplasia|breast epithelial hyperplasia
5111577|NCT01166763|ki-67|ki-67
5111578|NCT01166763|chemoprevention|chemoprevention
5111579|NCT01166763|vitamin D3|vitamin d3
5111580|NCT01166763|Additional relevant MeSH terms:|additional relevant mesh terms:
5111581|NCT01166763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
5111582|NCT01166763|Physiological Effects of Drugs|physiological effects of drugs
5111583|NCT01166763|Breast Neoplasms|breast neoplasms
5111584|NCT01166763|Pharmacologic Actions|pharmacologic actions
5111585|NCT01166763|Hyperplasia|hyperplasia
5111586|NCT01166763|high risk for development of breast cancer|high risk for development of breast cancer
5111587|NCT01166763|Neoplasms|neoplasms
5111588|NCT01166763|Neoplasms by Site|neoplasms by site
5111589|NCT01166763|Pathologic Processes|pathologic processes
5111590|NCT01166763|Antirheumatic Agents|antirheumatic agents
5111591|NCT01166763|Breast Diseases|breast diseases
5111592|NCT01166737|Ovarian Cancer|ovarian cancer
5111593|NCT01166737|Cancer of the fallopian tube|cancer of the fallopian tube
5111594|NCT01166737|Primary peritoneal cancer|primary peritoneal cancer
5111595|NCT01166737|Recurrent disease|recurrent disease
5111596|NCT01166737|Platinum-sensitive|platinum-sensitive
5111597|NCT01166737|Surgery|surgery
5111598|NCT01166737|Chemotherapy|chemotherapy
5111599|NCT01166737|Quality of Life|quality of life
5111600|NCT01166737|First recurrence of platinum sensitive:|first recurrence of platinum sensitive:
5111601|NCT01166737|Fallopian Tube Cancer|fallopian tube cancer
5111602|NCT01166737|or Ovarian Cancer|or ovarian cancer
5111603|NCT01166737|or Peritoneal Cavity Cancer|or peritoneal cavity cancer
5111604|NCT01166724|Kidney transplant|kidney transplant
5111605|NCT01166698|Safety|safety
5111606|NCT01166698|tolerability|tolerability
5111607|NCT01166698|healthy|healthy
5111608|NCT01166698|inhalation|inhalation
5111609|NCT01166685|coronary artery disease|coronary artery disease
5111610|NCT01166685|drug-eluting stent|drug-eluting stent
5111611|NCT01166685|anti-thrombotic therapy|anti-thrombotic therapy
5111612|NCT01166685|bare-metal stent|bare-metal stent
5111613|NCT01166685|long-term outcome|long-term outcome
5111614|NCT01166672|obese women (BMI greater than or equal to 30), do not already have a diagnosis of lymphedema, who are done|obese women (bmi greater than or equal to 30), do not already have a diagnosis of lymphedema, who are done
5111615|NCT01166672|with surgery, chemotherapy, and radiation therapy, and who were diagnosed with breast cancer within the|with surgery, chemotherapy, and radiation therapy, and who were diagnosed with breast cancer within the
5111616|NCT01166672|past 2 years will be invited to participate.|past 2 years will be invited to participate.
5111617|NCT01166659|Glaucoma|glaucoma
5111618|NCT01166659|Glaucoma device|glaucoma device
5111619|NCT01166659|Glaucoma surgery|glaucoma surgery
5111620|NCT01166659|Intraocular pressure|intraocular pressure
5111621|NCT01166633|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors
5111622|NCT01166633|hyperlipidemia|hyperlipidemia
5111623|NCT01166594|Glaucoma|glaucoma
5111624|NCT01166594|Elevated Intraocular Pressure (IOP)|elevated intraocular pressure (iop)
5111625|NCT01166594|Optic Neuropathy|optic neuropathy
5111626|NCT01166594|Bleb Failure|bleb failure
5111627|NCT01166594|Avastin (Bevacizumab)|avastin (bevacizumab)
5111628|NCT01166581|early stage breast cancer|early stage breast cancer
5111629|NCT01166581|preoperative breast MRI|preoperative breast mri
5111630|NCT01166581|mastectomy|mastectomy
5111631|NCT01166568|Presbyopia|presbyopia
5111632|NCT01166568|Reading Vision|reading vision
5111633|NCT01166568|Near Vision|near vision
5111634|NCT01166555|Safety and tolerability|safety and tolerability
5111635|NCT01166555|Pharmacokinetics|pharmacokinetics
5111636|NCT01166555|PF-04236921|pf-04236921
5111637|NCT01166555|Rheumatoid Arthritis|rheumatoid arthritis
5111638|NCT01166542|carcinoma|carcinoma
5111639|NCT01166542|squamous cell|squamous cell
5111640|NCT01166542|head|head
5111641|NCT01166542|neck|neck
5111642|NCT01166542|REOLYSIN (Reovirus Type 3 Dearing)|reolysin (reovirus type 3 dearing)
5111643|NCT01166542|chemotherapy|chemotherapy
5111644|NCT01166542|Carboplatin|carboplatin
5111645|NCT01166542|Paclitaxel|paclitaxel
5111646|NCT01166542|metastatic|metastatic
5111647|NCT01166542|recurrent|recurrent
5111648|NCT01166516|Prolonged air leak|prolonged air leak
5111649|NCT01166516|lobectomy|lobectomy
5111650|NCT01166516|segmentectomy|segmentectomy
5111651|NCT01166516|lung volume reduction surgery (LVRS)|lung volume reduction surgery (lvrs)
5111652|NCT01166503|pediatrics|pediatrics
5111653|NCT01166503|Esotropia|esotropia
5111654|NCT01166503|Surgery|surgery
5111655|NCT01166490|Monomethyl auristatin E (MMAE)|monomethyl auristatin e (mmae)
5111656|NCT01166490|Immunotherapy|immunotherapy
5111657|NCT01166490|AGS-5 Antigen|ags-5 antigen
5111658|NCT01166490|SLC44A4 Antigen|slc44a4 antigen
5111659|NCT01166490|Gastric Neoplasms|gastric neoplasms
5111660|NCT01166490|Pancreatic Neoplasms|pancreatic neoplasms
5111661|NCT01166490|Antibody-Drug Conjugate|antibody-drug conjugate
5111662|NCT01166490|Antibodies, Monoclonal|antibodies, monoclonal
5111663|NCT01166490|Drug Therapy|drug therapy
5111664|NCT01166464|tobacco|tobacco
5111665|NCT01166464|smoking|smoking
5111666|NCT01166464|text message|text message
5111667|NCT01166464|therapy|therapy
5111668|NCT01166451|iron deficiency anemia|iron deficiency anemia
5111669|NCT01166451|cognitive development|cognitive development
5111670|NCT01166451|motor development|motor development
5111671|NCT01166438|incontinence|incontinence
5111672|NCT01166438|overactive bladder|overactive bladder
5111673|NCT01166438|botox|botox
5111674|NCT01166438|anticholinergic|anticholinergic
5111675|NCT01166399|Fecal Incontinence,|fecal incontinence,
5111676|NCT01166399|bowel incontinence,|bowel incontinence,
5111677|NCT01166399|pelvic floor disorder|pelvic floor disorder
5111678|NCT01166386|rehabilitation|rehabilitation
5111679|NCT01166386|brain injury|brain injury
5111680|NCT01166373|prolapse|prolapse
5111681|NCT01166373|urinary incontinence|urinary incontinence
5111682|NCT01166373|uterosacral vaginal vault ligament suspension|uterosacral vaginal vault ligament suspension
5111683|NCT01166373|sacrospinous ligament fixation|sacrospinous ligament fixation
5111684|NCT01166373|behavioral therapy|behavioral therapy
5111685|NCT01166373|pelvic muscle training|pelvic muscle training
5111686|NCT01166360|Risk prediction|risk prediction
5111687|NCT01166360|Euroscore|euroscore
5111688|NCT01166360|GDF-15|gdf-15
5111689|NCT01166360|hsTnT|hstnt
5111690|NCT01166360|cardiac surgery|cardiac surgery
5111691|NCT01166334|Smoking|smoking
5111692|NCT01166334|Smoke|smoke
5111693|NCT01166334|Cigarette|cigarette
5111694|NCT01166334|Cessation|cessation
5111695|NCT01166334|Quit|quit
5111696|NCT01166334|Online|online
5111697|NCT01166334|Web|web
5111698|NCT01166334|Stop|stop
5111699|NCT01166321|Atypical Meningioma|atypical meningioma
5111700|NCT01166308|Recurrent Glioma|recurrent glioma
5111701|NCT01166282|inflammatory back pain|inflammatory back pain
5111702|NCT01166282|ankylosing spondylitis|ankylosing spondylitis
5111703|NCT01166282|sacroiliitis|sacroiliitis
5111704|NCT01166282|Juvenile Idiopathic Arthritis|juvenile idiopathic arthritis
5111705|NCT01166282|enthesitis|enthesitis
5111706|NCT01166282|arthritis|arthritis
5111707|NCT01166269|grass-pollen allergy|grass-pollen allergy
5111708|NCT01166256|respiratory failure|respiratory failure
5111709|NCT01166243|Hemostasis|hemostasis
5111710|NCT01166217|Single Dose Study in Healthy Subjects|single dose study in healthy subjects
5111711|NCT01166204|Radiotherapy|radiotherapy
5111712|NCT01166204|NSCLC|nsclc
5111713|NCT01166191|Radiotherapy|radiotherapy
5111714|NCT01166191|SCLC|sclc
5111715|NCT01166178|Multiple Sclerosis|multiple sclerosis
5111716|NCT01166178|Osteoporosis|osteoporosis
5111717|NCT01166178|Zoledronic Acid|zoledronic acid
5111718|NCT01166165|Hypertension|hypertension
5111719|NCT01166165|blood pressure|blood pressure
5111720|NCT01166165|vitamin d|vitamin d
5111721|NCT01166165|winter|winter
5111722|NCT01166165|cholecalciferol|cholecalciferol
5111723|NCT01166165|arterial stiffness|arterial stiffness
5111724|NCT01166165|renin|renin
5111725|NCT01166165|angiotensin|angiotensin
5111726|NCT01166165|aldosterone|aldosterone
5111727|NCT01166165|calcium|calcium
5111728|NCT01166152|autistic spectrum disorders|autistic spectrum disorders
5111729|NCT01166152|developmental disorders|developmental disorders
5111730|NCT01166139|Systemic Sclerosis|systemic sclerosis
5111731|NCT01166113|Pomalidomide|pomalidomide
5111732|NCT01166113|Relapsed/Refractory to Lenalidomide|relapsed/refractory to lenalidomide
5111733|NCT01166100|Bioequivalence|bioequivalence
5111734|NCT01166100|Crossover|crossover
5111735|NCT01166100|Fluoxetine Hydrochloride|fluoxetine hydrochloride
5111736|NCT01166087|Bioequivalence|bioequivalence
5111737|NCT01166087|Crossover|crossover
5111738|NCT01166087|Fluoxetine Hydrochloride|fluoxetine hydrochloride
5111739|NCT01166061|Grass Allergy|grass allergy
5111740|NCT01166061|Immunotherapy|immunotherapy
5111741|NCT01166061|Rhinoconjunctivitis|rhinoconjunctivitis
5111742|NCT01166061|ToleroMune Grass|toleromune grass
5111743|NCT01166048|Chronic Low Back Pain|chronic low back pain
5111744|NCT01166048|Radicular component|radicular component
5111745|NCT01166048|neuropathic pain|neuropathic pain
5111746|NCT01166048|duloxetine|duloxetine
5111747|NCT01166048|CLBP|clbp
5111748|NCT01166035|Solid tumors|solid tumors
5111749|NCT01166035|Lenalidomide|lenalidomide
5111750|NCT01166035|Cetuximab|cetuximab
5111751|NCT01166035|Colorectal Cancer|colorectal cancer
5111752|NCT01166035|Non-Small Cell Lung Cancer|non-small cell lung cancer
5111753|NCT01166035|Head and Neck Cancer|head and neck cancer
5111754|NCT01166022|Spinal Muscular Atrophy|spinal muscular atrophy
5111755|NCT01166022|Exercise|exercise
5111756|NCT01166022|Conditioning|conditioning
5111757|NCT01166022|Strengthening|strengthening
5111758|NCT01166009|Data Collection|data collection
5111759|NCT01166009|CIBMTR|cibmtr
5111760|NCT01166009|NMDP|nmdp
5111761|NCT01166009|Stem Cell Transplantation|stem cell transplantation
5111762|NCT01165996|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5111763|NCT01165996|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5111764|NCT01165970|enamel|enamel
5111765|NCT01165970|dentin|dentin
5111766|NCT01165970|saliva substitute|saliva substitute
5111767|NCT01165970|demineralization|demineralization
5111768|NCT01165970|remineralization|remineralization
5111769|NCT01165957|Knee replacement|knee replacement
5111770|NCT01165957|Mobile and fixed bearings|mobile and fixed bearings
5111771|NCT01165957|Volumetric wear|volumetric wear
5111772|NCT01165957|Micro-CT analysis|micro-ct analysis
5111773|NCT01165957|Articular and backside wear|articular and backside wear
5111774|NCT01165944|Post transplant diabetes mellitus|post transplant diabetes mellitus
5111775|NCT01165931|Coronary artery disease|coronary artery disease
5111776|NCT01165905|cancer|cancer
5111777|NCT01165905|solid malignancy|solid malignancy
5111778|NCT01165905|tumor|tumor
5111779|NCT01165905|malignant neoplasm|malignant neoplasm
5111780|NCT01165905|histologically confirmed solid malignancy|histologically confirmed solid malignancy
5111781|NCT01165892|Pulmonary embolism|pulmonary embolism
5111782|NCT01165892|contrast agent|contrast agent
5111783|NCT01165879|Pregnancy|pregnancy
5111784|NCT01165879|Term|term
5111785|NCT01165879|Preterm|preterm
5111786|NCT01165879|Uterine Contractions|uterine contractions
5111787|NCT01165866|Ondansetron|ondansetron
5111788|NCT01165866|Metoclopramide|metoclopramide
5111789|NCT01165866|Gastroenteritis|gastroenteritis
5111790|NCT01165840|Obesity|obesity
5111791|NCT01165840|Pharmacokinetics|pharmacokinetics
5111792|NCT01165840|Dapsone|dapsone
5111793|NCT01165840|Leprosy|leprosy
5111794|NCT01165840|Tuberculosis|tuberculosis
5111795|NCT01165827|Aortic Valve Insufficiency|aortic valve insufficiency
5111796|NCT01165827|Aortic Valve Stenosis|aortic valve stenosis
5111797|NCT01165827|Aortic Valve Valvuloplasty|aortic valve valvuloplasty
5111798|NCT01165827|Aortic valve Replacement|aortic valve replacement
5111799|NCT01165827|Aortic valve Intervention|aortic valve intervention
5111800|NCT01165814|Pain control after cesarean section|pain control after cesarean section
5111801|NCT01165801|AMD|amd
5111802|NCT01165801|Cataract surgery|cataract surgery
5111803|NCT01165801|Size of AMD|size of amd
5111804|NCT01165801|Influence of cataract surgery on AMD Size|influence of cataract surgery on amd size
5111805|NCT01165788|Blood and Marrow Transplant (BMT)|blood and marrow transplant (bmt)
5111806|NCT01165736|pharmacokinetics|pharmacokinetics
5111807|NCT01165736|safety|safety
5111808|NCT01165736|tolerability|tolerability
5111809|NCT01165736|Chronic Pain|chronic pain
5111810|NCT01165723|safety|safety
5111811|NCT01165723|tolerability|tolerability
5111812|NCT01165723|pharmacokinetics|pharmacokinetics
5111813|NCT01165723|pharmacodynamics|pharmacodynamics
5111814|NCT01165723|chronic pain|chronic pain
5111815|NCT01165710|Irregular heart beat|irregular heart beat
5111816|NCT01165697|Fabry Disease|fabry disease
5111817|NCT01165697|vascular disease|vascular disease
5111818|NCT01165697|storage endotheliopathy|storage endotheliopathy
5111819|NCT01165671|Primary Glioblastoma|primary glioblastoma
5111820|NCT01165658|non-small cell lung cancer|non-small cell lung cancer
5111821|NCT01165658|NSCLC|nsclc
5111822|NCT01165658|small cell lung cancer|small cell lung cancer
5111823|NCT01165658|SCLC|sclc
5111824|NCT01165658|carcinoid|carcinoid
5111825|NCT01165658|thymic cancer|thymic cancer
5111826|NCT01165658|lung cancer|lung cancer
5111827|NCT01165658|radiation therapy|radiation therapy
5111828|NCT01165658|radiotherapy|radiotherapy
5111829|NCT01165658|proton therapy|proton therapy
5111830|NCT01165645|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5111831|NCT01165554|Amyloid|amyloid
5111832|NCT01165554|PET-Positron Emission Tomography|pet-positron emission tomography
5111833|NCT01165554|SUVR-Standard uptake value ratios|suvr-standard uptake value ratios
5111834|NCT01165502|MAD study CM3.1-AC100|mad study cm3.1-ac100
5111835|NCT01165502|Healthy men, age 18 - 50|healthy men, age 18 - 50
5111836|NCT01165489|Laryngomalacia|laryngomalacia
5111837|NCT01165489|Congenital Anomalies|congenital anomalies
5111838|NCT01165489|Associated Health Problems|associated health problems
5111839|NCT01165476|treprostinil|treprostinil
5111840|NCT01165476|bioavailability|bioavailability
5111841|NCT01165476|bioequivalence|bioequivalence
5111842|NCT01165463|Aging|aging
5111843|NCT01165463|Healthy|healthy
5111844|NCT01165450|persistent epithelial defect|persistent epithelial defect
5111845|NCT01165450|cornea|cornea
5111846|NCT01165437|Peripheral|peripheral
5111847|NCT01165437|Arterial|arterial
5111848|NCT01165437|Vascular|vascular
5111849|NCT01165411|Central Catheterization|central catheterization
5111850|NCT01165411|Central Line|central line
5111851|NCT01165411|Database|database
5111852|NCT01165411|Registry|registry
5111853|NCT01165411|Registries|registries
5111854|NCT01165398|Education|education
5111855|NCT01165398|central lines|central lines
5111856|NCT01165398|infections|infections
5111857|NCT01165398|complications|complications
5111858|NCT01165398|Bundles|bundles
5111859|NCT01165385|Relapsed or refractory solid tumors|relapsed or refractory solid tumors
5111860|NCT01165385|Pazopanib|pazopanib
5111861|NCT01165385|Cisplatin|cisplatin
5111862|NCT01165372|Malaria|malaria
5111863|NCT01165372|Drug resistance|drug resistance
5111864|NCT01165346|liver cancer|liver cancer
5111865|NCT01165346|hepatocellular carcinoma|hepatocellular carcinoma
5111866|NCT01165333|Paediatric oncology|paediatric oncology
5111867|NCT01165333|Cilengitide|cilengitide
5111868|NCT01165333|Glioma|glioma
5111869|NCT01165307|Menorrhagia|menorrhagia
5111870|NCT01165307|Endometrial ablation|endometrial ablation
5111871|NCT01165307|Heavy menstrual bleeding|heavy menstrual bleeding
5111872|NCT01165294|Ketamine|ketamine
5111873|NCT01165281|Pain|pain
5111874|NCT01165281|R331333 (JNS024ER, CG5503), tapentadol (NUCYNTA)|r331333 (jns024er, cg5503), tapentadol (nucynta)
5111875|NCT01165281|Opioid analgesic|opioid analgesic
5111876|NCT01165281|Oxycodone CR (OXYCONTIN CR)|oxycodone cr (oxycontin cr)
5111877|NCT01165281|Chronic malignant tumor related cancer pain|chronic malignant tumor related cancer pain
5111878|NCT01165255|congenital malformation|congenital malformation
5111879|NCT01165255|cardiovascular malformation|cardiovascular malformation
5111880|NCT01165255|cardiovascular defect|cardiovascular defect
5111881|NCT01165255|antidepressants|antidepressants
5111882|NCT01165255|pregnancy|pregnancy
5111883|NCT01165255|first trimester|first trimester
5111884|NCT01165255|Bupropion|bupropion
5111885|NCT01165255|prevalence|prevalence
5111886|NCT01165242|Neisseria meningitidis|neisseria meningitidis
5111887|NCT01165242|Adult|adult
5111888|NCT01165242|Adolescent|adolescent
5111889|NCT01165242|Safety|safety
5111890|NCT01165242|Vaccines, conjugate|vaccines, conjugate
5111891|NCT01165242|Meningococcal vaccines|meningococcal vaccines
5111892|NCT01165242|Immunogenicity|immunogenicity
5111893|NCT01165229|Immunogenicity|immunogenicity
5111894|NCT01165229|Subjects 70 years and older|subjects 70 years and older
5111895|NCT01165229|Efficacy|efficacy
5111896|NCT01165229|Herpes Zoster|herpes zoster
5111897|NCT01165229|Safety|safety
5111898|NCT01165229|Adults|adults
5111899|NCT01165229|Vaccine|vaccine
5111900|NCT01165203|immunogenicity|immunogenicity
5111901|NCT01165203|vaccine|vaccine
5111902|NCT01165203|safety|safety
5111903|NCT01165203|HIV|hiv
5111904|NCT01165203|Herpes Zoster|herpes zoster
5111905|NCT01165177|subjects 50 years and older|subjects 50 years and older
5111906|NCT01165177|vaccine|vaccine
5111907|NCT01165177|immunogenicity|immunogenicity
5111908|NCT01165177|efficacy|efficacy
5111909|NCT01165177|Herpes Zoster|herpes zoster
5111910|NCT01165177|safety|safety
5111911|NCT01165164|Dry eye|dry eye
5111912|NCT01165164|artificial tears|artificial tears
5111913|NCT01165151|obesity|obesity
5111914|NCT01165151|weight loss|weight loss
5111915|NCT01165151|group size|group size
5111916|NCT01165138|GW642444|gw642444
5111917|NCT01165138|Vilanterol|vilanterol
5111918|NCT01165138|Asthma|asthma
5111919|NCT01165138|Fluticasone Furoate|fluticasone furoate
5111920|NCT01165125|pharmacodynamics|pharmacodynamics
5111921|NCT01165125|drug interaction|drug interaction
5111922|NCT01165125|ketoconazole|ketoconazole
5111923|NCT01165125|pharmacokinetics|pharmacokinetics
5111924|NCT01165125|Fluticasone furoate|fluticasone furoate
5111925|NCT01165125|GW642444|gw642444
5111926|NCT01165099|acupuncture|acupuncture
5111927|NCT01165099|induced labour|induced labour
5111928|NCT01165099|labour outcome|labour outcome
5111929|NCT01165099|nulliparae|nulliparae
5111930|NCT01165099|pain-relief|pain-relief
5111931|NCT01165099|epidural during labour|epidural during labour
5111932|NCT01165073|Cirrhosis|cirrhosis
5111933|NCT01165073|Malnutrition|malnutrition
5111934|NCT01165073|Enteral nutrition|enteral nutrition
5111935|NCT01165060|X-ALD|x-ald
5111936|NCT01165060|AMN|amn
5111937|NCT01165060|adrenomyeloneuropathy phenotype|adrenomyeloneuropathy phenotype
5111938|NCT01164995|MK-1775|mk-1775
5111939|NCT01164995|Carboplatin|carboplatin
5111940|NCT01164995|epithelial ovarian cancer|epithelial ovarian cancer
5111941|NCT01164995|p53|p53
5111942|NCT01164956|methylphenidate|methylphenidate
5111943|NCT01164956|fatigue|fatigue
5111944|NCT01164917|Lupus|lupus
5111945|NCT01164917|Discoid Lupus|discoid lupus
5111946|NCT01164917|Cutaneous Lupus|cutaneous lupus
5111947|NCT01164904|Inflammatory Bowel Disease|inflammatory bowel disease
5111948|NCT01164904|Amgen|amgen
5111949|NCT01164878|Cholestasis|cholestasis
5111950|NCT01164878|Liver damage|liver damage
5111951|NCT01164878|Parenteral Nutrition|parenteral nutrition
5111952|NCT01164878|Aggressive Nutrition|aggressive nutrition
5111953|NCT01164878|Preterm|preterm
5111954|NCT01164878|Extreme low birth weight infant|extreme low birth weight infant
5111955|NCT01164878|Parenteral Nutrition Associated Cholestasis|parenteral nutrition associated cholestasis
5111956|NCT01164865|Soft Contact lens|soft contact lens
5111957|NCT01164865|Multi-Purpose Solution|multi-purpose solution
5111958|NCT01164865|Hydrogen Peroxide|hydrogen peroxide
5111959|NCT01164839|coronary artery|coronary artery
5111960|NCT01164839|CT angiography|ct angiography
5111961|NCT01164839|image quality|image quality
5111962|NCT01164839|multicenter trial|multicenter trial
5111963|NCT01164826|Bioequivalence|bioequivalence
5111964|NCT01164826|Crossover|crossover
5111965|NCT01164826|Nabumetone|nabumetone
5111966|NCT01164813|Bioequivalence|bioequivalence
5111967|NCT01164813|Crossover|crossover
5111968|NCT01164813|Nabumetone|nabumetone
5111969|NCT01164800|Bioequivalence|bioequivalence
5111970|NCT01164800|Crossover|crossover
5111971|NCT01164800|Trandolapril|trandolapril
5111972|NCT01164787|Bioequivalence|bioequivalence
5111973|NCT01164787|Crossover|crossover
5111974|NCT01164787|Trandolapril|trandolapril
5111975|NCT01164774|Bioavailability|bioavailability
5111976|NCT01164774|Crossover|crossover
5111977|NCT01164774|Ramipril|ramipril
5111978|NCT01164761|Bioavailability|bioavailability
5111979|NCT01164761|Crossover|crossover
5111980|NCT01164761|Ramipril|ramipril
5111981|NCT01164722|anal cancer|anal cancer
5111982|NCT01164722|HIV infection|hiv infection
5111983|NCT01164722|human papilloma virus infection|human papilloma virus infection
5111984|NCT01164722|neoplasm of uncertain malignant potential|neoplasm of uncertain malignant potential
5111985|NCT01164722|high-grade squamous intraepithelial lesion|high-grade squamous intraepithelial lesion
5111986|NCT01164709|refractory multiple myeloma|refractory multiple myeloma
5111987|NCT01164709|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5111988|NCT01164709|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5111989|NCT01164709|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5111990|NCT01164709|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5111991|NCT01164709|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5111992|NCT01164709|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
5111993|NCT01164709|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
5111994|NCT01164709|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
5111995|NCT01164709|peripheral T-cell lymphoma|peripheral t-cell lymphoma
5111996|NCT01164709|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
5111997|NCT01164709|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5111998|NCT01164709|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5111999|NCT01164709|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5112000|NCT01164709|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5112001|NCT01164709|aggressive NK-cell leukemia|aggressive nk-cell leukemia
5112002|NCT01164709|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5112003|NCT01164709|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5112004|NCT01164709|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5112005|NCT01164709|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5112006|NCT01164709|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5112007|NCT01164709|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5112008|NCT01164709|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5112009|NCT01164709|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5112762|NCT01161446|HIV|hiv
5112010|NCT01164709|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5112011|NCT01164709|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5112012|NCT01164709|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5112013|NCT01164709|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5112014|NCT01164709|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
5112015|NCT01164709|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
5112016|NCT01164709|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5112017|NCT01164709|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5112018|NCT01164709|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
5112019|NCT01164709|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
5112020|NCT01164709|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
5112021|NCT01164709|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
5112022|NCT01164709|prolymphocytic leukemia|prolymphocytic leukemia
5112023|NCT01164696|Quality of Life, Health Care Costs|quality of life, health care costs
5112024|NCT01164683|sleep apnea|sleep apnea
5112025|NCT01164683|adherence|adherence
5112026|NCT01164657|upright position|upright position
5112027|NCT01164657|birth position|birth position
5112028|NCT01164657|childbirth|childbirth
5112029|NCT01164657|instrumental deliveries|instrumental deliveries
5112030|NCT01164657|primiparous|primiparous
5112031|NCT01164644|ecchymosis|ecchymosis
5112032|NCT01164644|bruising|bruising
5112033|NCT01164644|rhinoplasty|rhinoplasty
5112034|NCT01164644|nose job|nose job
5112035|NCT01164644|arnica|arnica
5112036|NCT01164644|arnica montana|arnica montana
5112037|NCT01164631|Sleep Apnea Syndrome|sleep apnea syndrome
5112038|NCT01164631|Orthodontics|orthodontics
5112039|NCT01164631|Tonsillectomy|tonsillectomy
5112040|NCT01164631|Child|child
5112041|NCT01164618|pediatrics|pediatrics
5112042|NCT01164618|Remote ischemic preconditioning|remote ischemic preconditioning
5112043|NCT01164605|NRTI-regimen|nrti-regimen
5112044|NCT01164605|Raltegravir|raltegravir
5112045|NCT01164605|Elvitegravir|elvitegravir
5112046|NCT01164605|HIV-1 integrase inhibitor|hiv-1 integrase inhibitor
5112047|NCT01164605|Fat Waste|fat waste
5112048|NCT01164592|Heart failure (HF)|heart failure (hf)
5112049|NCT01164592|Sleep disordered breathing (SDB)|sleep disordered breathing (sdb)
5112050|NCT01164592|Cheyne Stokes Respiration (CSR)|cheyne stokes respiration (csr)
5112051|NCT01164592|Adaptive Servoventilation (ASV)|adaptive servoventilation (asv)
5112052|NCT01164579|Early Rheumatoid Arthritis|early rheumatoid arthritis
5112053|NCT01164579|Joint Structure|joint structure
5112054|NCT01164579|Magnetic Resonance Imaging|magnetic resonance imaging
5112055|NCT01164579|Janus Kinase (JAK) Inhibitor|janus kinase (jak) inhibitor
5112056|NCT01164579|Tasocitinib|tasocitinib
5112057|NCT01164579|Tofacitinib|tofacitinib
5112058|NCT01164553|influenza, pediatric, vaccine|influenza, pediatric, vaccine
5112059|NCT01164540|Deep venous thrombosis|deep venous thrombosis
5112060|NCT01164540|Pulmonary embolism|pulmonary embolism
5112061|NCT01164540|rosuvastatin treatment|rosuvastatin treatment
5112062|NCT01164514|bacterial sepsis, septicemia, vaccine|bacterial sepsis, septicemia, vaccine
5112063|NCT01164449|algorithm|algorithm
5112064|NCT01164449|tight glycemic control|tight glycemic control
5112065|NCT01164449|glucose control|glucose control
5112066|NCT01164449|intensive care|intensive care
5112067|NCT01164449|insulin|insulin
5112068|NCT01164449|ICU|icu
5112069|NCT01164423|algorithm|algorithm
5112070|NCT01164423|tight glycemic control|tight glycemic control
5112071|NCT01164423|glucose control|glucose control
5112072|NCT01164423|intensive care|intensive care
5112073|NCT01164423|insulin|insulin
5112074|NCT01164423|ICU|icu
5112075|NCT01164397|Hypercholesterolemia|hypercholesterolemia
5112076|NCT01164397|Statins|statins
5112077|NCT01164371|coronary disease|coronary disease
5112078|NCT01164371|cardiovascular disease|cardiovascular disease
5112079|NCT01164371|cardiovascular risk|cardiovascular risk
5112080|NCT01164371|cardiovascular risk management|cardiovascular risk management
5112081|NCT01164371|primary care|primary care
5112082|NCT01164371|angina|angina
5112083|NCT01164371|stable angina|stable angina
5112084|NCT01164371|angina pectoris|angina pectoris
5112085|NCT01164371|acute coronary syndrome|acute coronary syndrome
5112086|NCT01164371|coronary death|coronary death
5112087|NCT01164371|unheralded acute coronary syndrome|unheralded acute coronary syndrome
5112088|NCT01164371|unheralded coronary death|unheralded coronary death
5112089|NCT01164371|gender differences|gender differences
5112090|NCT01164371|sex differences|sex differences
5112091|NCT01164371|myocardial infarction|myocardial infarction
5112092|NCT01164371|ST elevation myocardial infarction|st elevation myocardial infarction
5112093|NCT01164371|non ST elevation myocardial infarction|non st elevation myocardial infarction
5112094|NCT01164371|STEMI|stemi
5112095|NCT01164371|nSTEMI|nstemi
5112096|NCT01164371|unstable angina|unstable angina
5112097|NCT01164358|Presbyopia|presbyopia
5112098|NCT01164358|INTRACOR|intracor
5112099|NCT01164358|patient satisfaction|patient satisfaction
5112100|NCT01164358|long term|long term
5112101|NCT01164345|non-Hodgkin's lymphoma|non-hodgkin's lymphoma
5112102|NCT01164345|Hodgkin's lymphoma|hodgkin's lymphoma
5112103|NCT01164345|stem cell mobilization|stem cell mobilization
5112104|NCT01164345|autologous stem cell transplantation|autologous stem cell transplantation
5112105|NCT01164319|Atrial fibrillation|atrial fibrillation
5112106|NCT01164319|Percutaneous continous monitoring|percutaneous continous monitoring
5112107|NCT01164319|ablation|ablation
5112108|NCT01164306|LifeSkills Training|lifeskills training
5112109|NCT01164306|Tobacco prevention|tobacco prevention
5112110|NCT01164306|Tobacco cessation|tobacco cessation
5112111|NCT01164306|Healthy lifestyles|healthy lifestyles
5112112|NCT01164306|Tobacco control|tobacco control
5112113|NCT01164293|Atopy patch test|atopy patch test
5112114|NCT01164254|Exposure Assessment|exposure assessment
5112115|NCT01164254|Web-Based Dietary Assessment|web-based dietary assessment
5112116|NCT01164254|Web-Based Physical Activity Assessment|web-based physical activity assessment
5112117|NCT01164241|Eczema|eczema
5112118|NCT01164241|Allergy|allergy
5112119|NCT01164241|Immunodeficiency|immunodeficiency
5112120|NCT01164241|Netherton's Syndrome|netherton's syndrome
5112121|NCT01164241|Piebaldism|piebaldism
5112122|NCT01164228|recurrent renal cell cancer|recurrent renal cell cancer
5112123|NCT01164228|stage IV renal cell cancer|stage iv renal cell cancer
5112124|NCT01164228|clear cell renal cell carcinoma|clear cell renal cell carcinoma
5112125|NCT01164228|papillary renal cell carcinoma|papillary renal cell carcinoma
5112126|NCT01164228|clear cell sarcoma of the kidney|clear cell sarcoma of the kidney
5112127|NCT01164215|neutropenia|neutropenia
5112128|NCT01164215|diarrhea|diarrhea
5112129|NCT01164215|stage I colon cancer|stage i colon cancer
5112130|NCT01164215|stage II colon cancer|stage ii colon cancer
5112131|NCT01164215|stage III colon cancer|stage iii colon cancer
5112132|NCT01164215|stage IV colon cancer|stage iv colon cancer
5112133|NCT01164215|recurrent colon cancer|recurrent colon cancer
5112134|NCT01164215|stage I rectal cancer|stage i rectal cancer
5112135|NCT01164215|stage II rectal cancer|stage ii rectal cancer
5112136|NCT01164215|stage III rectal cancer|stage iii rectal cancer
5112137|NCT01164215|stage IV rectal cancer|stage iv rectal cancer
5112138|NCT01164215|recurrent rectal cancer|recurrent rectal cancer
5112139|NCT01164202|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
5112140|NCT01164202|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
5112141|NCT01164202|advanced adult primary liver cancer|advanced adult primary liver cancer
5112142|NCT01164189|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5112143|NCT01164189|adult diffuse astrocytoma|adult diffuse astrocytoma
5112144|NCT01164189|adult pilocytic astrocytoma|adult pilocytic astrocytoma
5112145|NCT01164189|adult pineal gland astrocytoma|adult pineal gland astrocytoma
5112146|NCT01164189|adult subependymal giant cell astrocytoma|adult subependymal giant cell astrocytoma
5112147|NCT01164189|adult oligodendroglioma|adult oligodendroglioma
5112148|NCT01164189|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
5112149|NCT01164189|recurrent adult brain tumor|recurrent adult brain tumor
5112150|NCT01164189|adult giant cell glioblastoma|adult giant cell glioblastoma
5112151|NCT01164189|adult glioblastoma|adult glioblastoma
5112152|NCT01164189|adult gliosarcoma|adult gliosarcoma
5112153|NCT01164189|adult mixed glioma|adult mixed glioma
5112154|NCT01164176|anaplastic thyroid cancer|anaplastic thyroid cancer
5112155|NCT01164176|insular thyroid cancer|insular thyroid cancer
5112156|NCT01164176|recurrent thyroid cancer|recurrent thyroid cancer
5112157|NCT01164176|stage III follicular thyroid cancer|stage iii follicular thyroid cancer
5112158|NCT01164176|stage III papillary thyroid cancer|stage iii papillary thyroid cancer
5112159|NCT01164176|stage IV follicular thyroid cancer|stage iv follicular thyroid cancer
5112160|NCT01164176|stage IV papillary thyroid cancer|stage iv papillary thyroid cancer
5112161|NCT01164176|thyroid gland medullary carcinoma|thyroid gland medullary carcinoma
5112162|NCT01164163|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
5112163|NCT01164163|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5112164|NCT01164163|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5112165|NCT01164163|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5112166|NCT01164163|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5112167|NCT01164163|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
5112168|NCT01164163|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5112169|NCT01164163|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
5112170|NCT01164163|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5112171|NCT01164163|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
5112172|NCT01164163|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
5112173|NCT01164163|polycythemia vera|polycythemia vera
5112174|NCT01164163|essential thrombocythemia|essential thrombocythemia
5112175|NCT01164163|childhood acute promyelocytic leukemia (M3)|childhood acute promyelocytic leukemia (m3)
5112176|NCT01164163|acute myeloid leukemia/transient myeloproliferative disorder|acute myeloid leukemia/transient myeloproliferative disorder
5112177|NCT01164163|primary myelofibrosis|primary myelofibrosis
5112178|NCT01164150|gastrointestinal complications|gastrointestinal complications
5112179|NCT01164150|urinary complications|urinary complications
5112180|NCT01164150|radiation toxicity|radiation toxicity
5113826|NCT01156792|GSK2190915|gsk2190915
5112181|NCT01164150|recurrent endometrial carcinoma|recurrent endometrial carcinoma
5112182|NCT01164150|endometrial adenocarcinoma|endometrial adenocarcinoma
5112183|NCT01164150|stage IA endometrial carcinoma|stage ia endometrial carcinoma
5112184|NCT01164150|stage IB endometrial carcinoma|stage ib endometrial carcinoma
5112185|NCT01164150|stage II endometrial carcinoma|stage ii endometrial carcinoma
5112186|NCT01164150|stage IIIA endometrial carcinoma|stage iiia endometrial carcinoma
5112187|NCT01164150|stage IIIB endometrial carcinoma|stage iiib endometrial carcinoma
5112188|NCT01164150|stage IIIC endometrial carcinoma|stage iiic endometrial carcinoma
5112189|NCT01164137|Adverse Drug Events|adverse drug events
5112190|NCT01164137|Medication Reconciliation|medication reconciliation
5112191|NCT01164137|Pharmacist-led Intervention|pharmacist-led intervention
5112192|NCT01164124|extremely low birth weight|extremely low birth weight
5112193|NCT01164124|probiotics|probiotics
5112194|NCT01164124|growth|growth
5112195|NCT01164124|nutrition|nutrition
5112196|NCT01164124|premature infants|premature infants
5112197|NCT01164124|growth in extremely low birth weight infants|growth in extremely low birth weight infants
5112198|NCT01164111|osteoarthritis|osteoarthritis
5112199|NCT01164111|hip arthroplasty|hip arthroplasty
5112200|NCT01164111|resistance training|resistance training
5112201|NCT01164111|preoperative training|preoperative training
5112202|NCT01164085|Inflammation|inflammation
5112203|NCT01164085|Macular Edema|macular edema
5112204|NCT01164072|electronic cigarette|electronic cigarette
5112205|NCT01164072|nicotine|nicotine
5112206|NCT01164072|smoking cessation|smoking cessation
5112207|NCT01164072|smoking reduction|smoking reduction
5112208|NCT01164059|Schizophrenia|schizophrenia
5112209|NCT01164059|atypical antipsychotic drugs|atypical antipsychotic drugs
5112210|NCT01164059|conventional antipsychotic drugs|conventional antipsychotic drugs
5112211|NCT01164059|olanzapine|olanzapine
5112212|NCT01164059|quetiapine|quetiapine
5112213|NCT01164059|aripiprazole|aripiprazole
5112214|NCT01164059|haloperidol|haloperidol
5112215|NCT01164059|flupentixol|flupentixol
5112216|NCT01164046|anticoagulants|anticoagulants
5112217|NCT01164046|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight
5112218|NCT01164046|4-Hydroxycoumarins|4-hydroxycoumarins
5112219|NCT01164046|recurrent venous thrombosis|recurrent venous thrombosis
5112220|NCT01164020|cognition|cognition
5112221|NCT01164020|supplementation creatine|supplementation creatine
5112222|NCT01164020|resistance training|resistance training
5112223|NCT01164020|aging|aging
5112224|NCT01163994|erythema migrans|erythema migrans
5112225|NCT01163994|Lyme borreliosis|lyme borreliosis
5112226|NCT01163994|ceftriaxone treatment|ceftriaxone treatment
5112227|NCT01163994|doxycycline treatment|doxycycline treatment
5112228|NCT01163994|outcome|outcome
5112229|NCT01163994|subjective symptoms|subjective symptoms
5112230|NCT01163981|duplex Ultrasound|duplex ultrasound
5112231|NCT01163981|Haemodialysis|haemodialysis
5112232|NCT01163981|Vascular Access|vascular access
5112233|NCT01163968|Weight reduction|weight reduction
5112234|NCT01163968|Cardiac revascularization|cardiac revascularization
5112235|NCT01163968|Percutaneous Coronary Intervention|percutaneous coronary intervention
5112236|NCT01163968|Cardiac Rehabilitation|cardiac rehabilitation
5112237|NCT01163968|Rural|rural
5112238|NCT01163955|Posture analysis|posture analysis
5112239|NCT01163955|Video gaming|video gaming
5112240|NCT01163955|Forward Head Position|forward head position
5112241|NCT01163955|Rounded Shoulder Position|rounded shoulder position
5112242|NCT01163955|Spine Posture|spine posture
5112243|NCT01163929|breast cancer|breast cancer
5112244|NCT01163929|HER2 positive|her2 positive
5112245|NCT01163929|Phase II|phase ii
5112246|NCT01163929|RAD001|rad001
5112247|NCT01163929|paclitaxel|paclitaxel
5112248|NCT01163929|trastuzumab|trastuzumab
5112249|NCT01163929|everolimus|everolimus
5112250|NCT01163916|Rheumatoid Arthritis|rheumatoid arthritis
5112251|NCT01163916|Psoriatic Arthritis|psoriatic arthritis
5112252|NCT01163916|Ankylosing Spondylitis|ankylosing spondylitis
5112253|NCT01163903|Advanced solid tumours|advanced solid tumours
5112254|NCT01163903|Pantoprazole|pantoprazole
5112255|NCT01163903|Doxorubicin|doxorubicin
5112256|NCT01163903|PANTO IV|panto iv
5112257|NCT01163903|Adriamycin|adriamycin
5112258|NCT01163903|no standard treatment options|no standard treatment options
5112259|NCT01163903|dose-escalation schedule|dose-escalation schedule
5112260|NCT01163903|Phase I|phase i
5112261|NCT01163903|single-centre|single-centre
5112262|NCT01163903|open label|open label
5112263|NCT01163903|dose finding|dose finding
5112264|NCT01163903|recommended phase II dose|recommended phase ii dose
5112265|NCT01163903|proton pump inhibitor|proton pump inhibitor
5112266|NCT01163903|advanced cancer|advanced cancer
5112267|NCT01163903|anthracycline|anthracycline
5112268|NCT01163903|gastric acid secretion|gastric acid secretion
5112269|NCT01163890|Depression|depression
5112270|NCT01163890|Work Performance and Productivity|work performance and productivity
5112271|NCT01163890|Worksite Intervention|worksite intervention
5112272|NCT01163877|iron absorption|iron absorption
5112273|NCT01163877|iron utilization|iron utilization
5112274|NCT01163877|malaria|malaria
5112275|NCT01163877|helminth|helminth
5112276|NCT01163877|Ivory Coast|ivory coast
5112277|NCT01163877|Acute symptomatic uncomplicated falciparum malaria|acute symptomatic uncomplicated falciparum malaria
5112278|NCT01163877|Asymptomatic falciparum malaria|asymptomatic falciparum malaria
5112279|NCT01163877|Moderate to heavy hookworm infection|moderate to heavy hookworm infection
5112280|NCT01163877|Heavy Schistosoma haematobium infection|heavy schistosoma haematobium infection
5112281|NCT01163864|smoking|smoking
5112282|NCT01163864|smoking relapse|smoking relapse
5112283|NCT01163864|smoking cessation|smoking cessation
5112284|NCT01163864|pregnancy|pregnancy
5112285|NCT01163864|smoking cessation in pregnant women|smoking cessation in pregnant women
5112286|NCT01163851|Hypercholesterolemia|hypercholesterolemia
5112287|NCT01163851|Dyslipidemia|dyslipidemia
5112288|NCT01163851|LDL|ldl
5112289|NCT01163851|Cholesterol|cholesterol
5112290|NCT01163851|High Cholesterol|high cholesterol
5112291|NCT01163851|PF-04950615|pf-04950615
5112292|NCT01163851|RN316|rn316
5112293|NCT01163838|Hypercholesterolemia|hypercholesterolemia
5112294|NCT01163838|Dyslipidemia|dyslipidemia
5112295|NCT01163838|LDL|ldl
5112296|NCT01163838|Cholesterol|cholesterol
5112297|NCT01163838|High Cholesterol|high cholesterol
5112298|NCT01163812|D2 lymph node dissection|d2 lymph node dissection
5112299|NCT01163799|Kidney|kidney
5112300|NCT01163799|Transplant|transplant
5112301|NCT01163799|Northwestern|northwestern
5112302|NCT01163799|Calcineurin Inhibitor|calcineurin inhibitor
5112303|NCT01163799|Corticosteroids|corticosteroids
5112304|NCT01163799|Steroid avoidance|steroid avoidance
5112305|NCT01163786|Bortezomib GVHD Bronchiolitis Obliterans|bortezomib gvhd bronchiolitis obliterans
5112306|NCT01163773|Cardiovascular disease|cardiovascular disease
5112307|NCT01163773|Milk|milk
5112308|NCT01163773|Metabolic syndrome|metabolic syndrome
5112309|NCT01163773|Blood lipids|blood lipids
5112310|NCT01163773|Menopausal women|menopausal women
5112311|NCT01163734|Heart Failure with Preserved Ejection Fraction (HFpEF)|heart failure with preserved ejection fraction (hfpef)
5112312|NCT01163734|Coronary Artery Disease (CAD)|coronary artery disease (cad)
5112313|NCT01163721|Type 2 diabetes mellitus|type 2 diabetes mellitus
5112314|NCT01163721|T2DM|t2dm
5112315|NCT01163721|Ranolazine|ranolazine
5112316|NCT01163721|Ranexa|ranexa
5112317|NCT01163721|HbA1c|hba1c
5112318|NCT01163695|economic empowerment model, orphans, sub-Saharan Africa|economic empowerment model, orphans, sub-saharan africa
5112319|NCT01163682|Taxane induced neuropathy|taxane induced neuropathy
5112320|NCT01163669|hyperparathyroidism|hyperparathyroidism
5112321|NCT01163656|Neonate|neonate
5112322|NCT01163656|Laryngoscopes|laryngoscopes
5112323|NCT01163630|open label, randomized|open label, randomized
5112324|NCT01163630|single-center|single-center
5112325|NCT01163630|2-way crossover|2-way crossover
5112326|NCT01163630|food interaction study|food interaction study
5112327|NCT01163617|Rheumatoid|rheumatoid
5112328|NCT01163617|Arthritis|arthritis
5112329|NCT01163604|Argatroban|argatroban
5112330|NCT01163604|intracranial artery stenting|intracranial artery stenting
5112331|NCT01163604|extracranial artery stenting|extracranial artery stenting
5112332|NCT01163604|occlusion|occlusion
5112333|NCT01163604|restenosis|restenosis
5112334|NCT01163591|Diabetes|diabetes
5112335|NCT01163591|Nephropathy|nephropathy
5112336|NCT01163591|Screening|screening
5112337|NCT01163578|Transplantation|transplantation
5112338|NCT01163578|Rejection|rejection
5112339|NCT01163565|Thyroidectomy|thyroidectomy
5112340|NCT01163552|pleural metastases|pleural metastases
5112341|NCT01163513|ethnicity|ethnicity
5112342|NCT01163513|prognosis|prognosis
5112343|NCT01163474|Telemedicine|telemedicine
5112344|NCT01163474|Surgery, Cardiac|surgery, cardiac
5112345|NCT01163448|Prostate|prostate
5112346|NCT01163448|Radiation|radiation
5112347|NCT01163448|Radical prostatectomy|radical prostatectomy
5112348|NCT01163448|09-013|09-013
5112349|NCT01163435|Helicobacter pylori|helicobacter pylori
5112350|NCT01163435|antibiotic resistance|antibiotic resistance
5112351|NCT01163435|high dose dual therapy|high dose dual therapy
5112352|NCT01163435|sequential therapy|sequential therapy
5112353|NCT01163435|clarithromycin-based triple therapy|clarithromycin-based triple therapy
5112354|NCT01163435|levofloxacin-based triple therapy|levofloxacin-based triple therapy
5112355|NCT01163422|Right ventricular failure|right ventricular failure
5112356|NCT01163422|Pacemaker|pacemaker
5112357|NCT01163422|Cardiac resynchronization therapy|cardiac resynchronization therapy
5112358|NCT01163422|Pulmonary hypertension|pulmonary hypertension
5112359|NCT01163409|juvenile fibromyalgia|juvenile fibromyalgia
5112360|NCT01163409|acupuncture|acupuncture
5112361|NCT01163409|exercise training|exercise training
5112362|NCT01163383|Refractory Neuroblastoma|refractory neuroblastoma
5112363|NCT01163383|Recurrent Neuroblastoma|recurrent neuroblastoma
5112364|NCT01163383|Neuroblastoma|neuroblastoma
5112365|NCT01163383|stage IV neuroblastoma|stage iv neuroblastoma
5112366|NCT01163383|metastatic pheochromocytoma|metastatic pheochromocytoma
5112367|NCT01163383|paraganglioma|paraganglioma
5112368|NCT01163370|creatine supplementation|creatine supplementation
5112369|NCT01163370|resistance training|resistance training
5112370|NCT01163370|osteopenia|osteopenia
5112371|NCT01163370|osteoporosis|osteoporosis
5112372|NCT01163370|bone mineral density|bone mineral density
5114266|NCT01155128|proteinuria|proteinuria
5112373|NCT01163344|Gait, balance, Parkinson's Disease|gait, balance, parkinson's disease
5112374|NCT01163331|Parkinson's Disease, voice quality, vocal strength, voice loudness|parkinson's disease, voice quality, vocal strength, voice loudness
5112375|NCT01163318|Rheumatoid Arthritis|rheumatoid arthritis
5112376|NCT01163305|Identifying an early indicator of drug efficacy|identifying an early indicator of drug efficacy
5112377|NCT01163292|Rheumatoid Arthritis|rheumatoid arthritis
5112378|NCT01163279|Age-related changes|age-related changes
5112379|NCT01163266|Major Depressive Disorder|major depressive disorder
5112380|NCT01163266|Depression|depression
5112381|NCT01163266|Melancholia|melancholia
5112382|NCT01163266|Drug Therapy|drug therapy
5112383|NCT01163253|chronic|chronic
5112384|NCT01163253|severe|severe
5112385|NCT01163253|treatment|treatment
5112386|NCT01163253|safety|safety
5112387|NCT01163253|CP-690,55|cp-690,55
5112388|NCT01163253|Plaque Psoriasis|plaque psoriasis
5112389|NCT01163253|Psoriasis Vulgaris|psoriasis vulgaris
5112390|NCT01163253|Xeljanz|xeljanz
5112391|NCT01163253|Tofacitinib|tofacitinib
5112392|NCT01163240|hepatitis B|hepatitis b
5112393|NCT01163240|HBV|hbv
5112394|NCT01163240|chronic hepatitis B|chronic hepatitis b
5112395|NCT01163240|pediatric|pediatric
5112396|NCT01163227|Hallucinations,|hallucinations,
5112397|NCT01163227|psychotic,|psychotic,
5112398|NCT01163227|delusions,|delusions,
5112399|NCT01163227|cognitive deficits|cognitive deficits
5112400|NCT01163188|very low birthweight/ very preterm children|very low birthweight/ very preterm children
5112401|NCT01163188|Bavarian Longitudinal Study (BLS)|bavarian longitudinal study (bls)
5112402|NCT01163188|Quality of life and social adjustment in adulthood|quality of life and social adjustment in adulthood
5112403|NCT01163175|Cardiovascular disease|cardiovascular disease
5112404|NCT01163175|Trans fatty acids|trans fatty acids
5112405|NCT01163175|Ruminant|ruminant
5112406|NCT01163175|Blood lipids|blood lipids
5112407|NCT01163162|Chronic Kidney Disease|chronic kidney disease
5112408|NCT01163162|Vitamin D|vitamin d
5112409|NCT01163149|Hypophosphatasia|hypophosphatasia
5112410|NCT01163149|HPP|hpp
5112411|NCT01163149|Bone Disease|bone disease
5112412|NCT01163149|Soft Bones|soft bones
5112413|NCT01163149|Low Alkaline Phosphatase|low alkaline phosphatase
5112414|NCT01163149|genetic metabolic disorder|genetic metabolic disorder
5112415|NCT01163149|alkaline phosphatase|alkaline phosphatase
5112416|NCT01163149|tissue-specific alkaline phosphatase (TNSALP)|tissue-specific alkaline phosphatase (tnsalp)
5112417|NCT01163149|rickets|rickets
5112418|NCT01163149|osteomalacia|osteomalacia
5112419|NCT01163136|Parental decision making|parental decision making
5112420|NCT01163136|Decision Making in Serious Pediatric Illness (DSPI)|decision making in serious pediatric illness (dspi)
5112421|NCT01163136|palliative care decision making|palliative care decision making
5112422|NCT01163123|Subclinical infection of Japanese encephalitis virus|subclinical infection of japanese encephalitis virus
5112423|NCT01163045|neurostimulation|neurostimulation
5112424|NCT01163045|intraoperative neuromonitoring|intraoperative neuromonitoring
5112425|NCT01163045|recurrent laryngeal nerve|recurrent laryngeal nerve
5112426|NCT01163045|palsy of recurrent laryngeal nerve|palsy of recurrent laryngeal nerve
5112427|NCT01163045|RCT|rct
5112428|NCT01163032|Blindness|blindness
5112429|NCT01163032|Eye Diseases|eye diseases
5112430|NCT01163032|Nap Disorders|nap disorders
5112431|NCT01163032|Circadian Rhythm Disorders|circadian rhythm disorders
5112432|NCT01163032|Sleep disorders|sleep disorders
5112433|NCT01163032|Circadian Rhythm Sleep Disorders|circadian rhythm sleep disorders
5112434|NCT01163032|Dyssomnias|dyssomnias
5112435|NCT01163032|Nervous System Diseases|nervous system diseases
5112436|NCT01163019|Chest pain|chest pain
5112437|NCT01163019|acute coronary syndrome|acute coronary syndrome
5112438|NCT01163019|Emergency department|emergency department
5112439|NCT01163019|speckle tracking imaging|speckle tracking imaging
5112440|NCT01163019|2D strain|2d strain
5112441|NCT01163019|Echocardiography|echocardiography
5112442|NCT01162993|Electric stimulation therapy|electric stimulation therapy
5112443|NCT01162993|Diabetic Neuropathies|diabetic neuropathies
5112444|NCT01162980|ACE inhibitors|ace inhibitors
5112445|NCT01162980|ARBs|arbs
5112446|NCT01162954|Eye drop, Dry eye|eye drop, dry eye
5112447|NCT01162941|ITP|itp
5112448|NCT01162928|critically ill, mechanically ventilated patients requiring enteral and parenteral nutritional support|critically ill, mechanically ventilated patients requiring enteral and parenteral nutritional support
5112449|NCT01162915|Spinal Cord Injury|spinal cord injury
5112450|NCT01162889|pharmacokinetics|pharmacokinetics
5112451|NCT01162889|Crohn's disease|crohn's disease
5112452|NCT01162876|Diabetes, Type 2|diabetes, type 2
5112453|NCT01162863|IBSC|ibsc
5112454|NCT01162863|irritable bowel syndrome|irritable bowel syndrome
5112455|NCT01162863|constipation|constipation
5112456|NCT01162850|Melasma|melasma
5112457|NCT01162837|Acne|acne
5112458|NCT01162824|Endothelial Dysfunction|endothelial dysfunction
5112459|NCT01162824|Microvascular dysfunction|microvascular dysfunction
5112460|NCT01162824|Coronary artery spasm|coronary artery spasm
5112461|NCT01162824|Inflammation|inflammation
5112462|NCT01162824|CD4+CD28null T cells|cd4+cd28null t cells
5112463|NCT01162824|Myocardial ischemia|myocardial ischemia
5112464|NCT01162824|Early atherosclerosis|early atherosclerosis
5112465|NCT01162811|Visualization|visualization
5112466|NCT01162811|relaxation|relaxation
5112467|NCT01162811|self hypnotic relaxation|self hypnotic relaxation
5112468|NCT01162811|hypnosis|hypnosis
5112469|NCT01162811|invasive medical procedures|invasive medical procedures
5112470|NCT01162811|atrial fibrillation|atrial fibrillation
5112471|NCT01162811|ablation|ablation
5112472|NCT01162811|catheter ablation|catheter ablation
5112473|NCT01162811|pain|pain
5112474|NCT01162811|anxiety|anxiety
5112475|NCT01162798|infant formula|infant formula
5112476|NCT01162798|premature infants|premature infants
5112477|NCT01162798|Growth and Development|growth and development
5112478|NCT01162785|BCG Refractory Superficial Bladder Cancer|bcg refractory superficial bladder cancer
5112479|NCT01162785|SCH 721015|sch 721015
5112480|NCT01162785|Syn3|syn3
5112481|NCT01162785|novel excipient|novel excipient
5112482|NCT01162785|interferon -alpha-2b|interferon -alpha-2b
5112483|NCT01162785|Intravesical|intravesical
5112484|NCT01162785|urine IFNa|urine ifna
5112485|NCT01162785|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
5112486|NCT01162785|superficial non-muscle invasive tumor|superficial non-muscle invasive tumor
5112487|NCT01162759|hypertension, intervention|hypertension, intervention
5112488|NCT01162733|Vancomycin|vancomycin
5112489|NCT01162733|Therapeutic Levels|therapeutic levels
5112490|NCT01162733|Infectious Disease|infectious disease
5112491|NCT01162733|Recommendations|recommendations
5112492|NCT01162720|Primary knee replacement|primary knee replacement
5112493|NCT01162720|Unilateral knee replacement|unilateral knee replacement
5112494|NCT01162694|Remote Blood Glucose Monitoring System,|remote blood glucose monitoring system,
5112495|NCT01162694|Continuous Glucose Monitoring System,|continuous glucose monitoring system,
5112496|NCT01162694|Type 2 Diabetes|type 2 diabetes
5112497|NCT01162681|SLE|sle
5112498|NCT01162681|Lupus|lupus
5112499|NCT01162681|Lupus Erythematosus, Systemic|lupus erythematosus, systemic
5112500|NCT01162681|Autoimmune Diseases|autoimmune diseases
5112501|NCT01162681|A-623|a-623
5112502|NCT01162681|Blisibimod|blisibimod
5112503|NCT01162668|bariatric surgery|bariatric surgery
5112504|NCT01162668|obesity|obesity
5112505|NCT01162668|outcomes|outcomes
5112506|NCT01162655|Insomnia|insomnia
5112507|NCT01162655|Cognitive-Behavioral Therapy|cognitive-behavioral therapy
5112508|NCT01162655|Internet|internet
5112509|NCT01162655|Telehealth|telehealth
5112510|NCT01162642|Healthy moderately heavy smokers|healthy moderately heavy smokers
5112511|NCT01162629|bounded saddles|bounded saddles
5112512|NCT01162629|missing teeth|missing teeth
5112513|NCT01162629|dental implants|dental implants
5112514|NCT01162629|Tooth, Nonvital|tooth, nonvital
5112515|NCT01162616|iron absorption|iron absorption
5112516|NCT01162616|polyphenols|polyphenols
5112517|NCT01162616|sodium iron EDTA|sodium iron edta
5112518|NCT01162616|sorghum|sorghum
5112519|NCT01162590|Human Rotavirus vaccine|human rotavirus vaccine
5112520|NCT01162577|Weight|weight
5112521|NCT01162577|Smoking|smoking
5112522|NCT01162577|Quitline|quitline
5112523|NCT01162551|Leukemia|leukemia
5112524|NCT01162551|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
5112525|NCT01162538|Raltegravir, non B subtype, naive patients|raltegravir, non b subtype, naive patients
5112526|NCT01162525|Fecal Incontinence|fecal incontinence
5112527|NCT01162525|Fecal Urge Incontinence|fecal urge incontinence
5112528|NCT01162525|Percutaneous tibial nerve stimulation|percutaneous tibial nerve stimulation
5112529|NCT01162512|physical activity|physical activity
5112530|NCT01162512|obesity|obesity
5112531|NCT01162512|adolescents|adolescents
5112532|NCT01162512|telephone|telephone
5112533|NCT01162512|BMI|bmi
5112534|NCT01162512|body mass index|body mass index
5112535|NCT01162499|Post prandial hypoglycemia|post prandial hypoglycemia
5112536|NCT01162499|hypoglycemia|hypoglycemia
5112537|NCT01162499|Nissen fundoplication|nissen fundoplication
5112538|NCT01162499|Dumping|dumping
5112539|NCT01162486|Anti-infective agents|anti-infective agents
5112540|NCT01162486|Anti-bacterial agents|anti-bacterial agents
5112541|NCT01162486|Rifampin|rifampin
5112542|NCT01162486|Rifapentine|rifapentine
5112543|NCT01162486|Midazolam|midazolam
5112544|NCT01162486|Molecular mechanisms of pharmacological action|molecular mechanisms of pharmacological action
5112545|NCT01162486|Antitubercular agents|antitubercular agents
5112546|NCT01162486|Pharmacologic actions|pharmacologic actions
5112547|NCT01162473|Food hypersensitivity|food hypersensitivity
5112548|NCT01162473|Milk hypersensitivity|milk hypersensitivity
5112549|NCT01162473|Milk allergy|milk allergy
5112550|NCT01162473|Food allergy|food allergy
5112551|NCT01162447|BMP- 4 and 7, polycystic ovarian syndrome|bmp- 4 and 7, polycystic ovarian syndrome
5112552|NCT01162434|Treatment resistant depression|treatment resistant depression
5112553|NCT01162434|Deep brain stimulation|deep brain stimulation
5112554|NCT01162434|Brain volumetric analysis|brain volumetric analysis
5112555|NCT01162421|Rheumatoid Arthritis|rheumatoid arthritis
5112556|NCT01162421|Anti-Inflammatory|anti-inflammatory
5112557|NCT01162421|Biological Therapy|biological therapy
5112558|NCT01162421|adalimumab|adalimumab
5112559|NCT01162421|Disease-Modifying Antirheumatic Drugs|disease-modifying antirheumatic drugs
5112560|NCT01162421|Antirheumatic Agents|antirheumatic agents
5112561|NCT01162421|Agents|agents
5112563|NCT01162395|Prostate Cancer|prostate cancer
5112564|NCT01162395|Tumour|tumour
5112565|NCT01162395|Castration Resistant|castration resistant
5112566|NCT01162395|Prostate Androgen Receptor Down Regulator|prostate androgen receptor down regulator
5112567|NCT01162395|Metastatic|metastatic
5112568|NCT01162382|transcranial magnetic stimulation|transcranial magnetic stimulation
5112569|NCT01162382|TMS|tms
5112570|NCT01162382|rTMS|rtms
5112571|NCT01162382|depression|depression
5112572|NCT01162382|fcMRI|fcmri
5112573|NCT01162382|EEG|eeg
5112574|NCT01162369|Delirium, diagnosis, elderly, hospitalization|delirium, diagnosis, elderly, hospitalization
5112575|NCT01162356|Vitrectomy|vitrectomy
5112576|NCT01162356|Glaucoma|glaucoma
5112577|NCT01162356|Macula|macula
5112578|NCT01162356|Optic nerve|optic nerve
5112579|NCT01162356|Ocular Coherence Tomography|ocular coherence tomography
5112580|NCT01162343|Delirium, diagnosis, elderly, hospitalization|delirium, diagnosis, elderly, hospitalization
5112581|NCT01162330|Screening|screening
5112582|NCT01162330|Congenital Cytomegalovirus|congenital cytomegalovirus
5112583|NCT01162330|CMV|cmv
5112584|NCT01162330|Hearing loss|hearing loss
5112585|NCT01162317|Acupuncture|acupuncture
5112586|NCT01162317|Sleep|sleep
5112587|NCT01162317|Traumatic brain injury|traumatic brain injury
5112588|NCT01162304|Chronic Pain|chronic pain
5112589|NCT01162304|This clinical trial will compare immediate-release (IR)|this clinical trial will compare immediate-release (ir)
5112590|NCT01162304|oxycodone and extended-release (ER) oxycodone in the|oxycodone and extended-release (er) oxycodone in the
5112591|NCT01162304|management of chronic pain|management of chronic pain
5112592|NCT01162291|intramuscular|intramuscular
5112593|NCT01162291|distribution|distribution
5112594|NCT01162291|NaCl|nacl
5112595|NCT01162291|botulinum toxin|botulinum toxin
5112596|NCT01162291|muscle|muscle
5112597|NCT01162291|volume|volume
5112598|NCT01162291|movement|movement
5112599|NCT01162291|biceps brachii|biceps brachii
5112600|NCT01162291|primary distribution of intramuscular NaCl representative for primary distribution of intramuscular botulinum toxin|primary distribution of intramuscular nacl representative for primary distribution of intramuscular botulinum toxin
5112601|NCT01162291|shift from extracellular to intracellular viewed by DTI technology|shift from extracellular to intracellular viewed by dti technology
5112602|NCT01162291|effect of volume|effect of volume
5112603|NCT01162291|effect of muscle movement|effect of muscle movement
5112604|NCT01162278|liver metastases|liver metastases
5112605|NCT01162278|Stereotactic Body Radiation Therapy|stereotactic body radiation therapy
5112606|NCT01162265|Tuberculosis|tuberculosis
5112607|NCT01162265|IGRA|igra
5112608|NCT01162265|latent|latent
5112609|NCT01162252|psoriasis|psoriasis
5112610|NCT01162252|mindfulness|mindfulness
5112611|NCT01162252|MBSR|mbsr
5112612|NCT01162252|stress|stress
5112613|NCT01162252|living well|living well
5112614|NCT01162239|smoking|smoking
5112615|NCT01162239|tobacco|tobacco
5112616|NCT01162239|nicotine|nicotine
5112617|NCT01162239|smoking cessation|smoking cessation
5112618|NCT01162226|gait|gait
5112619|NCT01162226|movement disorders|movement disorders
5112620|NCT01162226|balance|balance
5112621|NCT01162226|function|function
5112622|NCT01162213|Postmenopausal Women|postmenopausal women
5112623|NCT01162213|Healthy Males|healthy males
5112624|NCT01162213|Cardiovascular|cardiovascular
5112625|NCT01162213|Flavanols|flavanols
5112626|NCT01162187|secondary prevention|secondary prevention
5112627|NCT01162187|aspirin|aspirin
5112628|NCT01162187|beta blocker|beta blocker
5112629|NCT01162187|ACE inhibitor|ace inhibitor
5112630|NCT01162187|statin|statin
5112631|NCT01162187|acute coronary syndrome|acute coronary syndrome
5112632|NCT01162187|myocardial infarction|myocardial infarction
5112633|NCT01162187|unstable angina|unstable angina
5112634|NCT01162187|trends|trends
5112635|NCT01162174|Flavanols|flavanols
5112636|NCT01162174|cardiovascular|cardiovascular
5112637|NCT01162161|sphingolipid|sphingolipid
5112638|NCT01162161|ceramide|ceramide
5112639|NCT01162161|sphingomyelinase|sphingomyelinase
5112640|NCT01162148|inspiratory muscle training|inspiratory muscle training
5112641|NCT01162148|pulmonary rehabilitation|pulmonary rehabilitation
5112642|NCT01162135|Digoxin|digoxin
5112643|NCT01162135|Recurrent Prostate Cancer|recurrent prostate cancer
5112644|NCT01162135|Prostate Specific Antigen|prostate specific antigen
5112645|NCT01162122|Elderly|elderly
5112646|NCT01162122|Influenza|influenza
5112647|NCT01162122|Immunogenicity|immunogenicity
5112648|NCT01162122|Safety|safety
5112649|NCT01162122|Adjuvant|adjuvant
5112650|NCT01162122|Adjuvanted|adjuvanted
5112651|NCT01162122|Adjuvants|adjuvants
5112652|NCT01162122|Vaccines|vaccines
5112653|NCT01162109|Zinc|zinc
5112654|NCT01162109|sepsis|sepsis
5112655|NCT01162109|critical illness|critical illness
5112656|NCT01162109|mechanical ventilation|mechanical ventilation
5112657|NCT01162109|ICU|icu
5112658|NCT01162096|Reduced Intensity Haploidentical Transplant|reduced intensity haploidentical transplant
5112659|NCT01162083|Exercise Physiology|exercise physiology
5112660|NCT01162083|Cardiopulmonary Interaction|cardiopulmonary interaction
5112661|NCT01162083|Heart Failure|heart failure
5112662|NCT01162070|Uveitis|uveitis
5112663|NCT01162070|etiological diagnosis|etiological diagnosis
5112664|NCT01162070|standardized strategy|standardized strategy
5112665|NCT01162057|Hemodialysis|hemodialysis
5112666|NCT01162057|Hearing|hearing
5112667|NCT01162057|Hemodialysis patients|hemodialysis patients
5112668|NCT01162044|PTSD|ptsd
5112669|NCT01162044|prevention|prevention
5112670|NCT01162005|Primary Nephrotic syndrome|primary nephrotic syndrome
5112671|NCT01161992|Primary Sclerosing Cholangitis|primary sclerosing cholangitis
5112672|NCT01161992|PSC|psc
5112673|NCT01161992|Cholestatic Liver Disease|cholestatic liver disease
5112674|NCT01161953|Primary Biliary Cirrhosis|primary biliary cirrhosis
5112675|NCT01161953|PBC|pbc
5112676|NCT01161953|Cholestatic Liver Disease|cholestatic liver disease
5112677|NCT01161940|Bioavailability|bioavailability
5112678|NCT01161940|Nizatidine|nizatidine
5112679|NCT01161940|Crossover|crossover
5112680|NCT01161927|Bioavailability|bioavailability
5112681|NCT01161927|Nizatidine|nizatidine
5112682|NCT01161927|Crossover|crossover
5112683|NCT01161914|Type I Gaucher|type i gaucher
5112684|NCT01161901|ARDS|ards
5112685|NCT01161901|Plasmatic biomarkers|plasmatic biomarkers
5112686|NCT01161901|Lung Morphology|lung morphology
5112687|NCT01161901|Mechanical ventilation|mechanical ventilation
5112688|NCT01161901|CT scan|ct scan
5112689|NCT01161862|Closed-loop|closed-loop
5112690|NCT01161862|Artificial pancreas|artificial pancreas
5112691|NCT01161862|Bi-hormonal|bi-hormonal
5112692|NCT01161862|Insulin|insulin
5112693|NCT01161862|Glucagon|glucagon
5112694|NCT01161862|Diabetes mellitus type 1|diabetes mellitus type 1
5112695|NCT01161849|lactate|lactate
5112696|NCT01161849|urgent surgery|urgent surgery
5112697|NCT01161849|major surgery|major surgery
5112698|NCT01161849|surgical complications|surgical complications
5112699|NCT01161849|possum|possum
5112700|NCT01161849|sapsII|sapsii
5112701|NCT01161849|relaparotomy|relaparotomy
5112702|NCT01161810|Burn|burn
5112703|NCT01161810|Rehabilitation|rehabilitation
5112704|NCT01161797|1,5-Anhydroglucitol|1,5-anhydroglucitol
5112705|NCT01161784|Functional constipation|functional constipation
5112706|NCT01161784|Probiotic|probiotic
5112707|NCT01161784|Probiotic microorganism|probiotic microorganism
5112708|NCT01161784|Lactobacillus casei Shirota (LcS)|lactobacillus casei shirota (lcs)
5112709|NCT01161758|physical therapy|physical therapy
5112710|NCT01161758|pain threshold|pain threshold
5112711|NCT01161758|electromyography|electromyography
5112712|NCT01161758|musculoskeletal manipulation|musculoskeletal manipulation
5112713|NCT01161758|neck muscles|neck muscles
5112714|NCT01161745|sepsis|sepsis
5112715|NCT01161732|aortic stenosis|aortic stenosis
5112716|NCT01161732|surgery, survival|surgery, survival
5112717|NCT01161719|ADHD|adhd
5112718|NCT01161719|Parent training|parent training
5112719|NCT01161719|Videoconference|videoconference
5112720|NCT01161706|vegetable juice|vegetable juice
5112721|NCT01161706|cardiovascular|cardiovascular
5112722|NCT01161706|blood pressure|blood pressure
5112723|NCT01161693|Cesarean section|cesarean section
5112724|NCT01161693|spinal anesthesia|spinal anesthesia
5112725|NCT01161693|CSE|cse
5112726|NCT01161693|ramped up position|ramped up position
5112727|NCT01161693|TROOP pillow|troop pillow
5112728|NCT01161693|elevation pillow|elevation pillow
5112729|NCT01161693|maternal comfort|maternal comfort
5112730|NCT01161693|Maternal Comfort after CSE during elective Cesarean Section in relation to adequate height of Anesthetic Block|maternal comfort after cse during elective cesarean section in relation to adequate height of anesthetic block
5112731|NCT01161680|Cross sectional and Longitudinal Observational study|cross sectional and longitudinal observational study
5112732|NCT01161641|Protein Losing Enteropathy|protein losing enteropathy
5112733|NCT01161628|Chronic Graft versus Host Disease|chronic graft versus host disease
5112734|NCT01161628|allogeneic stem cell transplant|allogeneic stem cell transplant
5112735|NCT01161615|tendonitis and/or bursitis of the shoulder|tendonitis and/or bursitis of the shoulder
5112736|NCT01161615|acute tendonitis and/or bursitis of the shoulder|acute tendonitis and/or bursitis of the shoulder
5112737|NCT01161602|Symptoms of Gastroesophageal Reflux Disease (GERD)|symptoms of gastroesophageal reflux disease (gerd)
5112738|NCT01161589|sensing|sensing
5112739|NCT01161589|S-ICD|s-icd
5112740|NCT01161589|ICD|icd
5112741|NCT01161589|CRT D|crt d
5112742|NCT01161576|Batten Disease|batten disease
5112743|NCT01161576|Late Infantile Neuronal Lipofuscinosis|late infantile neuronal lipofuscinosis
5112744|NCT01161576|gene transfer|gene transfer
5112745|NCT01161563|palliative treatment|palliative treatment
5112746|NCT01161563|prostate cancer|prostate cancer
5112747|NCT01161511|CLL|cll
5112748|NCT01161511|SLL|sll
5112749|NCT01161511|CD19|cd19
5112750|NCT01161498|squamous cell|squamous cell
5112751|NCT01161498|OncoVEX^GM-CSF|oncovex^gm-csf
5112752|NCT01161498|Oncovex|oncovex
5112753|NCT01161498|chemoradiation|chemoradiation
5112754|NCT01161498|Cisplatin|cisplatin
5112755|NCT01161485|HIV Infections|hiv infections
5112756|NCT01161485|Treatment|treatment
5112757|NCT01161485|Methamphetamine|methamphetamine
5112758|NCT01161459|Idiopathic Membranous Nephropathy|idiopathic membranous nephropathy
5112759|NCT01161459|Treatment|treatment
5112760|NCT01161459|FK506|fk506
5112761|NCT01161459|Tripterygium wilfordii|tripterygium wilfordii
5112763|NCT01161446|Home testing|home testing
5112764|NCT01161446|Self-testing|self-testing
5112765|NCT01161446|HIV Infections/diagnosis|hiv infections/diagnosis
5112766|NCT01161446|HIV Infections/prevention and control|hiv infections/prevention and control
5112767|NCT01161446|AIDS Serodiagnosis|aids serodiagnosis
5112768|NCT01161446|Oral fluids|oral fluids
5112769|NCT01161446|Homosexuality, Male|homosexuality, male
5112770|NCT01161446|Sexually transmitted diseases|sexually transmitted diseases
5112771|NCT01161446|Sexual behavior|sexual behavior
5112772|NCT01161433|Asthma|asthma
5112773|NCT01161433|Spirometry|spirometry
5112774|NCT01161433|Pediatric|pediatric
5112775|NCT01161433|Primary Health Care|primary health care
5112776|NCT01161433|Education, Distance|education, distance
5112777|NCT01161420|tongue|tongue
5112778|NCT01161420|surgery|surgery
5112779|NCT01161420|neurostimulation|neurostimulation
5112780|NCT01161420|hypoglossal nerve|hypoglossal nerve
5112781|NCT01161420|upper airway stimulation|upper airway stimulation
5112782|NCT01161381|OSAHS|osahs
5112783|NCT01161381|nonlinear analysis|nonlinear analysis
5112784|NCT01161381|polysomnography|polysomnography
5112785|NCT01161381|biosignal analysis|biosignal analysis
5112786|NCT01161381|DFA|dfa
5112787|NCT01161381|APEN|apen
5112788|NCT01161381|LLE|lle
5112789|NCT01161368|Metastatic Breast Cancer|metastatic breast cancer
5112790|NCT01161355|Safety|safety
5112791|NCT01161355|tolerability|tolerability
5112792|NCT01161355|healthy|healthy
5112793|NCT01161355|microdose|microdose
5112794|NCT01161342|Malnutrition|malnutrition
5112795|NCT01161342|Aged|aged
5112796|NCT01161342|Aged 80 and over|aged 80 and over
5112797|NCT01161342|Prevalence|prevalence
5112798|NCT01161342|Mortality|mortality
5112799|NCT01161329|stroke|stroke
5112800|NCT01161329|physical activity|physical activity
5112801|NCT01161329|balance|balance
5112802|NCT01161329|muscle-strength|muscle-strength
5112803|NCT01161316|metastatic colorectal cancer|metastatic colorectal cancer
5112804|NCT01161316|wild-type KRAS tumours|wild-type kras tumours
5112805|NCT01161316|cetuximab|cetuximab
5112806|NCT01161316|mFOLFOX-6|mfolfox-6
5112807|NCT01161303|Asthma|asthma
5112808|NCT01161303|TNF alpha|tnf alpha
5112809|NCT01161303|epithelial cell culture|epithelial cell culture
5112810|NCT01161290|Telemedicine|telemedicine
5112811|NCT01161290|Internet|internet
5112812|NCT01161290|Dyspnea|dyspnea
5112813|NCT01161290|Self care|self care
5112814|NCT01161290|Breathing Exercises|breathing exercises
5112815|NCT01161290|Real-Time Systems|real-time systems
5112816|NCT01161277|Aripiprazole|aripiprazole
5112817|NCT01161277|Haloperidol|haloperidol
5112818|NCT01161277|Ventral striatum|ventral striatum
5112819|NCT01161277|Reward|reward
5112820|NCT01161277|fMRI|fmri
5112821|NCT01161264|Elderly|elderly
5112822|NCT01161264|Influenza|influenza
5112823|NCT01161264|Immunogenicity|immunogenicity
5112824|NCT01161264|Safety|safety
5112825|NCT01161264|Influenza vaccine|influenza vaccine
5112826|NCT01161251|Atrial Fibrillation|atrial fibrillation
5112827|NCT01161251|ABI|abi
5112828|NCT01161251|PAD|pad
5112829|NCT01161251|Registry|registry
5112830|NCT01161251|Italian|italian
5112831|NCT01161225|Adolescents|adolescents
5112832|NCT01161225|Peer leader program|peer leader program
5112833|NCT01161225|asthma camp|asthma camp
5112834|NCT01161225|asthma control|asthma control
5112835|NCT01161225|quality of life|quality of life
5112836|NCT01161225|self-efficacy|self-efficacy
5112837|NCT01161225|knowledge|knowledge
5112838|NCT01161225|attitudes|attitudes
5112839|NCT01161225|barrier perceptions|barrier perceptions
5112840|NCT01161212|body mass index|body mass index
5112841|NCT01161212|health-related quality of life|health-related quality of life
5112842|NCT01161212|physical education|physical education
5112843|NCT01161212|children|children
5112844|NCT01161212|cluster randomized controlled trial|cluster randomized controlled trial
5112845|NCT01161212|prevention|prevention
5112846|NCT01161212|Child|child
5112847|NCT01161212|French|french
5112848|NCT01161212|Schoolchildren|schoolchildren
5112849|NCT01161199|HIV|hiv
5112850|NCT01161199|latent reservoir|latent reservoir
5112851|NCT01161199|functional cure|functional cure
5112852|NCT01161199|leukapheresis|leukapheresis
5112853|NCT01161186|pancreas|pancreas
5112854|NCT01161186|cancer|cancer
5112855|NCT01161186|abraxane|abraxane
5112856|NCT01161186|metastatic|metastatic
5112857|NCT01161186|gemcitabine|gemcitabine
5112858|NCT01161186|capecitabine|capecitabine
5112859|NCT01161186|adenocarcinoma|adenocarcinoma
5112860|NCT01161160|H1N1|h1n1
5112861|NCT01161160|Influenza|influenza
5112862|NCT01161160|Pandemic|pandemic
5112863|NCT01161160|GSK Bio's influenza vaccines GSK2340274A and GSK234072A|gsk bio's influenza vaccines gsk2340274a and gsk234072a
5112864|NCT01161121|Fractional flow reserve|fractional flow reserve
5112865|NCT01161121|adenosine|adenosine
5112866|NCT01161121|regadenoson|regadenoson
5112867|NCT01161108|Pediatrics|pediatrics
5112868|NCT01161108|Epilepsy|epilepsy
5112869|NCT01161108|Insomnia|insomnia
5112870|NCT01161108|Melatonin|melatonin
5112871|NCT01161095|Intrauterine Device|intrauterine device
5112872|NCT01161095|Postpartum contraception|postpartum contraception
5112873|NCT01161095|Long-acting reversible contraception|long-acting reversible contraception
5112874|NCT01161069|phase 1|phase 1
5112875|NCT01161069|healthy young adult volunteers|healthy young adult volunteers
5112876|NCT01161069|healthy elderly adult volunteers|healthy elderly adult volunteers
5112877|NCT01161043|diabetes|diabetes
5112878|NCT01161043|glucose|glucose
5112879|NCT01161043|sensor|sensor
5112880|NCT01161017|migraine patients|migraine patients
5112881|NCT01160991|schizophrenia|schizophrenia
5112882|NCT01160991|olanzapine|olanzapine
5112883|NCT01160991|atypical antipsychotic drugs|atypical antipsychotic drugs
5112884|NCT01160991|amisulpride|amisulpride
5112885|NCT01160991|diabetes|diabetes
5112886|NCT01160991|insulin resistance|insulin resistance
5112887|NCT01160991|insulin secretion|insulin secretion
5112888|NCT01160991|glucose|glucose
5112889|NCT01160991|euglycemic hyperinsulinemic clamp|euglycemic hyperinsulinemic clamp
5112890|NCT01160991|hyperglycemic clamp|hyperglycemic clamp
5112891|NCT01160978|Transplantation|transplantation
5112892|NCT01160978|Simvastatin treatment|simvastatin treatment
5112893|NCT01160978|Ischemia-reperfusion injury|ischemia-reperfusion injury
5112894|NCT01160978|Rejection|rejection
5112895|NCT01160965|epidural top-up|epidural top-up
5112896|NCT01160965|emergency Caesarean section|emergency caesarean section
5112897|NCT01160952|primary prophylaxis|primary prophylaxis
5112898|NCT01160952|itraconazole|itraconazole
5112899|NCT01160952|stem cell transplantation|stem cell transplantation
5112900|NCT01160939|Exercise|exercise
5112901|NCT01160939|heart failure|heart failure
5112902|NCT01160939|rehabilitation|rehabilitation
5112903|NCT01160926|rectal cancer|rectal cancer
5112904|NCT01160926|capecitabine|capecitabine
5112905|NCT01160926|radiotherapy|radiotherapy
5112906|NCT01160926|AZD6244|azd6244
5112907|NCT01160926|MEK inhibitor|mek inhibitor
5112908|NCT01160926|AZD2171|azd2171
5112909|NCT01160926|Cediranib|cediranib
5112910|NCT01160926|VEGFR inhibitor|vegfr inhibitor
5112911|NCT01160926|FLT-PET (fluoro-l-pyrimidine positron emission tomography)|flt-pet (fluoro-l-pyrimidine positron emission tomography)
5112912|NCT01160926|DCE-MRI (dynamic contrast enhanced magnetic resonance imaging)|dce-mri (dynamic contrast enhanced magnetic resonance imaging)
5112913|NCT01160900|cardiovascular diseases|cardiovascular diseases
5112914|NCT01160900|heart disease|heart disease
5112915|NCT01160900|hemorrhage|hemorrhage
5112916|NCT01160900|coronary angioplasty|coronary angioplasty
5112917|NCT01160900|drug eluting stents|drug eluting stents
5112918|NCT01160874|Attention Deficit Disorder / Hyperactivity (ADHD)|attention deficit disorder / hyperactivity (adhd)
5112919|NCT01160874|Cognition|cognition
5112920|NCT01160874|Sleepiness|sleepiness
5112921|NCT01160874|Driving|driving
5112922|NCT01160848|Moderate to severe Acne Vulgaris|moderate to severe acne vulgaris
5112923|NCT01160835|total knee arthroplasty|total knee arthroplasty
5112924|NCT01160835|minimally invasive|minimally invasive
5112925|NCT01160835|quadriceps-sparing|quadriceps-sparing
5112926|NCT01160835|Quadriceps-sparing total knee arthroplasty|quadriceps-sparing total knee arthroplasty
5112927|NCT01160822|Osteo arthritis|osteo arthritis
5112928|NCT01160822|pain control|pain control
5112929|NCT01160822|intra- articular injections|intra- articular injections
5112930|NCT01160822|Knee OA|knee oa
5112931|NCT01160809|Malaria|malaria
5112932|NCT01160809|Mosquito repellent|mosquito repellent
5112933|NCT01160809|LLINs|llins
5112934|NCT01160783|Autism|autism
5112935|NCT01160783|Asperger's Syndrome|asperger's syndrome
5112936|NCT01160783|Asperger Syndrome|asperger syndrome
5112937|NCT01160783|Autistic Disorder|autistic disorder
5112938|NCT01160783|Autism Spectrum Disorder|autism spectrum disorder
5112939|NCT01160783|Pervasive Developmental Disorders|pervasive developmental disorders
5112940|NCT01160783|Pervasive Developmental Disorder-Not Otherwise Specified|pervasive developmental disorder-not otherwise specified
5112941|NCT01160783|Child Development Disorders, Pervasive|child development disorders, pervasive
5112942|NCT01160783|PDD-NOS|pdd-nos
5112943|NCT01160770|Lennox-Gastaut Syndrome (LGS)|lennox-gastaut syndrome (lgs)
5112944|NCT01160770|Epilepsy|epilepsy
5112945|NCT01160770|Drop Seizures|drop seizures
5112946|NCT01160770|Clobazam|clobazam
5112947|NCT01160744|Lung neoplasms|lung neoplasms
5112948|NCT01160744|Lung cancer|lung cancer
5112949|NCT01160744|Non-small Cell Lung Cancer|non-small cell lung cancer
5112950|NCT01160744|pemetrexed|pemetrexed
5112951|NCT01160744|ALIMTA®|alimta®
5112952|NCT01160744|squamous|squamous
5112953|NCT01160744|nonsquamous|nonsquamous
5112954|NCT01160731|extensive stage small cell lung cancer|extensive stage small cell lung cancer
5112955|NCT01160718|estrogen receptor-positive breast cancer|estrogen receptor-positive breast cancer
5112956|NCT01160718|HER2-positive breast cancer|her2-positive breast cancer
5112957|NCT01160718|HER2-negative breast cancer|her2-negative breast cancer
5112958|NCT01160718|progesterone receptor-positive breast cancer|progesterone receptor-positive breast cancer
5112959|NCT01160718|recurrent breast cancer|recurrent breast cancer
5112960|NCT01160718|stage IIIA breast cancer|stage iiia breast cancer
5112961|NCT01160718|stage IIIB breast cancer|stage iiib breast cancer
5112962|NCT01160718|stage IIIC breast cancer|stage iiic breast cancer
5112963|NCT01160718|stage IV breast cancer|stage iv breast cancer
5113068|NCT01160354|elderly patients|elderly patients
5112964|NCT01160705|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5112965|NCT01160705|recurrent prostate cancer|recurrent prostate cancer
5112966|NCT01160705|stage III prostate cancer|stage iii prostate cancer
5112967|NCT01160705|stage IV prostate cancer|stage iv prostate cancer
5112968|NCT01160705|bone metastases|bone metastases
5112969|NCT01160705|liver metastases|liver metastases
5112970|NCT01160705|lung metastases|lung metastases
5112971|NCT01160705|hormone-resistant prostate cancer|hormone-resistant prostate cancer
5112972|NCT01160692|Memory|memory
5112973|NCT01160692|Cognitive Function|cognitive function
5112974|NCT01160692|Elderly|elderly
5112975|NCT01160692|Gingko|gingko
5112976|NCT01160692|Age Associated Memory Impairment (AAMI)|age associated memory impairment (aami)
5112977|NCT01160679|anhedonic features in patients with schizophrenia|anhedonic features in patients with schizophrenia
5112978|NCT01160666|Belimumab|belimumab
5112979|NCT01160666|Sjögren's syndrome|sjögren's syndrome
5112980|NCT01160666|Sjögren disease|sjögren disease
5112981|NCT01160653|stroke|stroke
5112982|NCT01160653|Gait training|gait training
5112983|NCT01160653|Cognitive Training|cognitive training
5112984|NCT01160640|PID|pid
5112985|NCT01160640|Pelvic Inflammatory Disease|pelvic inflammatory disease
5112986|NCT01160627|CIN STEMI|cin stemi
5112987|NCT01160614|Pediatric|pediatric
5112988|NCT01160614|Post-operative|post-operative
5112989|NCT01160614|Nonsurgical|nonsurgical
5112990|NCT01160614|patients|patients
5112991|NCT01160614|Opioid|opioid
5112992|NCT01160601|NSCLC|nsclc
5112993|NCT01160601|lung cancer|lung cancer
5112994|NCT01160601|non small cell lung cancer|non small cell lung cancer
5112995|NCT01160601|bavituximab|bavituximab
5112996|NCT01160601|monoclonal antibody|monoclonal antibody
5112997|NCT01160588|Anxiety|anxiety
5112998|NCT01160588|Social Phobia|social phobia
5112999|NCT01160588|Social Anxiety|social anxiety
5113000|NCT01160588|Generalized Anxiety|generalized anxiety
5113001|NCT01160588|Separation Anxiety|separation anxiety
5113002|NCT01160575|Counseling|counseling
5113003|NCT01160575|Epidemiology|epidemiology
5113004|NCT01160575|HIV|hiv
5113005|NCT01160575|AIDS|aids
5113006|NCT01160575|Prevention|prevention
5113007|NCT01160562|Prevalence|prevalence
5113008|NCT01160562|Incidence|incidence
5113009|NCT01160562|Children|children
5113010|NCT01160562|Adults|adults
5113011|NCT01160562|Global Positioning system|global positioning system
5113012|NCT01160549|Pregnancy|pregnancy
5113013|NCT01160549|Hormones|hormones
5113014|NCT01160549|Mongolia|mongolia
5113015|NCT01160549|Asian|asian
5113016|NCT01160549|Breast Cancer|breast cancer
5113017|NCT01160536|Hypertrophic Cardiomyopathy (HCM)|hypertrophic cardiomyopathy (hcm)
5113018|NCT01160536|Genetic Testing|genetic testing
5113019|NCT01160523|Podoconiosis|podoconiosis
5113020|NCT01160523|Genetic Education|genetic education
5113021|NCT01160523|Primary Prevention|primary prevention
5113022|NCT01160523|Ethiopa|ethiopa
5113023|NCT01160523|Youth|youth
5113024|NCT01160510|Breast|breast
5113025|NCT01160510|Mammographic Density|mammographic density
5113026|NCT01160484|multiple myeloma|multiple myeloma
5113027|NCT01160484|refractory|refractory
5113028|NCT01160484|relapsed|relapsed
5113029|NCT01160484|bortezomib|bortezomib
5113030|NCT01160484|doxil|doxil
5113031|NCT01160471|Heart Failure|heart failure
5113032|NCT01160471|Computed Tomography|computed tomography
5113033|NCT01160471|Ultrasound|ultrasound
5113034|NCT01160471|Fibrosis|fibrosis
5113035|NCT01160471|Biomarker|biomarker
5113036|NCT01160458|Monoclonal Antibody|monoclonal antibody
5113037|NCT01160458|Pleural Mesothelioma|pleural mesothelioma
5113038|NCT01160458|Peritoneal Mesothelioma|peritoneal mesothelioma
5113039|NCT01160445|Metastatic Melanoma|metastatic melanoma
5113040|NCT01160445|Metastatic Kidney Cancer|metastatic kidney cancer
5113041|NCT01160445|Clinical Performance|clinical performance
5113042|NCT01160445|Tumor Regression|tumor regression
5113043|NCT01160445|Toxicity|toxicity
5113044|NCT01160432|opiate dependence|opiate dependence
5113045|NCT01160432|methadone|methadone
5113046|NCT01160432|naloxone|naloxone
5113047|NCT01160432|withdrawal symptom|withdrawal symptom
5113048|NCT01160432|substitution treatment|substitution treatment
5113049|NCT01160406|silent paroxysmal atrial fibrillation|silent paroxysmal atrial fibrillation
5113050|NCT01160406|stroke|stroke
5113051|NCT01160406|tele ECG|tele ecg
5113052|NCT01160393|Atrial fibrillation|atrial fibrillation
5113053|NCT01160393|Cardiac surgery|cardiac surgery
5113054|NCT01160393|Prevention|prevention
5113055|NCT01160393|Conventional bypass system|conventional bypass system
5113056|NCT01160393|Miniaturized bypass system|miniaturized bypass system
5113057|NCT01160393|Arrhythmia|arrhythmia
5113058|NCT01160393|The Incidence of atrial fibrillation after cardiac surgery|the incidence of atrial fibrillation after cardiac surgery
5113059|NCT01160380|cancer related fatigue|cancer related fatigue
5113060|NCT01160380|fatigue|fatigue
5113061|NCT01160380|multiple myeloma|multiple myeloma
5113062|NCT01160380|cancer|cancer
5113063|NCT01160380|quality of life|quality of life
5113064|NCT01160354|Leukemia|leukemia
5113066|NCT01160354|Clofarabine|clofarabine
5113067|NCT01160354|Plerixafor|plerixafor
5113531|NCT01158196|scar|scar
5113069|NCT01160354|previously untreated|previously untreated
5113070|NCT01160354|unfavorable prognostic factors|unfavorable prognostic factors
5113071|NCT01160341|Metabolic syndrome|metabolic syndrome
5113072|NCT01160341|Hypogonadism|hypogonadism
5113073|NCT01160341|Testosterone|testosterone
5113074|NCT01160328|Regional Fat Storage|regional fat storage
5113075|NCT01160328|Fat Oxidation|fat oxidation
5113076|NCT01160328|Testosterone|testosterone
5113077|NCT01160328|Male|male
5113078|NCT01160315|ovarian failure, chemotherapy, lymphoma, GnRH agonist|ovarian failure, chemotherapy, lymphoma, gnrh agonist
5113079|NCT01160302|cancer|cancer
5113080|NCT01160276|renal graft|renal graft
5113081|NCT01160276|colchicine|colchicine
5113082|NCT01160276|drug interaction|drug interaction
5113083|NCT01160276|cyclosporine|cyclosporine
5113084|NCT01160276|tacrolimus|tacrolimus
5113085|NCT01160276|renal transplantation|renal transplantation
5113086|NCT01160276|renal transplant|renal transplant
5113087|NCT01160276|ABCB1|abcb1
5113088|NCT01160276|CYP3A5|cyp3a5
5113089|NCT01160276|SLCO1B1|slco1b1
5113090|NCT01160263|ALS|als
5113091|NCT01160263|serotonin|serotonin
5113092|NCT01160263|dopamine|dopamine
5113093|NCT01160237|H1N1|h1n1
5113094|NCT01160237|Pandemrix|pandemrix
5113095|NCT01160237|Fluarix|fluarix
5113096|NCT01160237|Influenza|influenza
5113097|NCT01160224|Asthma|asthma
5113098|NCT01160224|CCR3 receptor antagonists|ccr3 receptor antagonists
5113099|NCT01160224|GW766944|gw766944
5113100|NCT01160211|1st line MBC|1st line mbc
5113101|NCT01160211|MBC|mbc
5113102|NCT01160211|hormone receptor positive|hormone receptor positive
5113103|NCT01160211|lapatinib|lapatinib
5113104|NCT01160211|trastuzumab|trastuzumab
5113105|NCT01160211|HER2 positive|her2 positive
5113106|NCT01160211|aromatase inhibitor|aromatase inhibitor
5113107|NCT01160172|vaccine|vaccine
5113108|NCT01160172|young adults|young adults
5113109|NCT01160172|Staphylococcus aureus|staphylococcus aureus
5113110|NCT01160159|Venous thrombosis|venous thrombosis
5113111|NCT01160159|Women|women
5113112|NCT01160159|Vasodilatation endothelium-dependent|vasodilatation endothelium-dependent
5113113|NCT01160159|IMT|imt
5113114|NCT01160159|Arterial stiffness|arterial stiffness
5113115|NCT01160159|Arterial compliance|arterial compliance
5113116|NCT01160159|Capillary density|capillary density
5113117|NCT01160146|Obestiy|obestiy
5113118|NCT01160146|Over weight|over weight
5113119|NCT01160146|referral patterns|referral patterns
5113120|NCT01160146|Continuing Medical Education|continuing medical education
5113121|NCT01160133|Systane|systane
5113122|NCT01160133|Refresh Tears|refresh tears
5113123|NCT01160133|Dry Eye|dry eye
5113124|NCT01160133|Moderate to Severe Dry Eye|moderate to severe dry eye
5113125|NCT01160120|fixed dose combinations|fixed dose combinations
5113126|NCT01160120|tenofovir|tenofovir
5113127|NCT01160120|lamivudine|lamivudine
5113128|NCT01160120|efavirenz|efavirenz
5113129|NCT01160120|therapeutic drug levels|therapeutic drug levels
5113130|NCT01160120|safety and efficacy|safety and efficacy
5113131|NCT01160120|HIV|hiv
5113132|NCT01160120|To evaluation new formulations of FDC of TDF/3TC/EFV|to evaluation new formulations of fdc of tdf/3tc/efv
5113133|NCT01160107|Diagnosis|diagnosis
5113134|NCT01160107|Elderly Patients|elderly patients
5113135|NCT01160107|Imids|imids
5113136|NCT01160107|Chemotherapy|chemotherapy
5113137|NCT01160094|Trastuzumab|trastuzumab
5113138|NCT01160094|Metastatic Breast Cancer|metastatic breast cancer
5113139|NCT01160094|Breast Cancer|breast cancer
5113140|NCT01160094|Observational Study|observational study
5113141|NCT01160094|Lapatinib|lapatinib
5113142|NCT01160003|ACTH stimulation test|acth stimulation test
5113143|NCT01160003|Pharmacokinetics|pharmacokinetics
5113144|NCT01160003|Nebules|nebules
5113145|NCT01160003|Cortisol|cortisol
5113146|NCT01159990|HIV Preventive Vaccine|hiv preventive vaccine
5113147|NCT01159990|HIV Seronegativity|hiv seronegativity
5113148|NCT01159964|Antigen-Specific Cancer Immunotherapeutic (ASCI)|antigen-specific cancer immunotherapeutic (asci)
5113149|NCT01159964|PRAME|prame
5113150|NCT01159964|PRAME-positive stage IB, II or IIIA Non-Small Cell Lung Cancer patients after complete surgical resection|prame-positive stage ib, ii or iiia non-small cell lung cancer patients after complete surgical resection
5113151|NCT01159964|Non-Small Cell Lung Cancer|non-small cell lung cancer
5113152|NCT01159912|fluticasone propionate|fluticasone propionate
5113153|NCT01159912|Fluticasone furoate|fluticasone furoate
5113154|NCT01159899|Osteoarthritis|osteoarthritis
5113155|NCT01159899|knee arthritis|knee arthritis
5113156|NCT01159899|Knee arthrosis|knee arthrosis
5113157|NCT01159899|articular cartilage defects|articular cartilage defects
5113158|NCT01159899|osteochondral defects|osteochondral defects
5113159|NCT01159899|mesenchymal stem cells|mesenchymal stem cells
5113160|NCT01159899|stem cells|stem cells
5113161|NCT01159899|cellules souches,|cellules souches,
5113162|NCT01159899|genou|genou
5113163|NCT01159899|arthrose genou|arthrose genou
5113164|NCT01159899|PRP platelet rich plasma|prp platelet rich plasma
5113165|NCT01159899|thérapie cellulaire|thérapie cellulaire
5113166|NCT01159899|implantation cellules souches mésenchymateuses|implantation cellules souches mésenchymateuses
5113167|NCT01159899|régénération cartilage|régénération cartilage
5113168|NCT01159899|cicatrisation ménisque|cicatrisation ménisque
5113169|NCT01159899|ligament|ligament
5113170|NCT01159899|plasma riche plaquettaire|plasma riche plaquettaire
5113171|NCT01159899|platelet rich plasma|platelet rich plasma
5113172|NCT01159899|stem cell|stem cell
5113173|NCT01159899|regrowt cartilage|regrowt cartilage
5113174|NCT01159899|cellules souches|cellules souches
5113175|NCT01159899|PRP|prp
5113176|NCT01159886|Tuberculosis|tuberculosis
5113177|NCT01159886|IBD|ibd
5113178|NCT01159886|endoscopy|endoscopy
5113179|NCT01159860|seborrheic keratoses|seborrheic keratoses
5113180|NCT01159860|cryosurgery|cryosurgery
5113181|NCT01159860|curettage|curettage
5113182|NCT01159847|sitagliptin|sitagliptin
5113183|NCT01159847|LADA|lada
5113184|NCT01159847|C-Peptide|c-peptide
5113185|NCT01159847|Flow Cytometry|flow cytometry
5113186|NCT01159847|ELISPOT|elispot
5113187|NCT01159834|HPV infection|hpv infection
5113188|NCT01159834|Cervical cancer|cervical cancer
5113189|NCT01159834|HPV vaccine|hpv vaccine
5113190|NCT01159821|31001074|31001074
5113191|NCT01159821|Paroxetine|paroxetine
5113192|NCT01159821|CYP2D6 inhibitor|cyp2d6 inhibitor
5113193|NCT01159808|Safety and Pharmacokinetics|safety and pharmacokinetics
5113194|NCT01159795|Respiratory Syncytial Virus|respiratory syncytial virus
5113195|NCT01159795|Infant|infant
5113196|NCT01159795|Interferon|interferon
5113197|NCT01159769|Allergic conjunctivitis|allergic conjunctivitis
5113198|NCT01159756|Travacom|travacom
5113199|NCT01159756|Glaucoma|glaucoma
5113200|NCT01159756|Travoprost|travoprost
5113201|NCT01159756|Timolol|timolol
5113202|NCT01159743|lipodystrophy|lipodystrophy
5113203|NCT01159743|Lipoatrophy|lipoatrophy
5113204|NCT01159743|antiretroviral treatment|antiretroviral treatment
5113205|NCT01159704|HIV infection|hiv infection
5113206|NCT01159704|Intervention|intervention
5113207|NCT01159704|Risk-reduction|risk-reduction
5113208|NCT01159704|Injection drug users|injection drug users
5113209|NCT01159691|Rotigotine|rotigotine
5113210|NCT01159691|Neupro®|neupro®
5113211|NCT01159691|Parkinson's disease|parkinson's disease
5113212|NCT01159691|Gastrointestinal|gastrointestinal
5113213|NCT01159691|Switch from oral therapy to patch|switch from oral therapy to patch
5113214|NCT01159652|sleep|sleep
5113215|NCT01159652|memory|memory
5113216|NCT01159652|hypnotics|hypnotics
5113217|NCT01159652|zaleplon|zaleplon
5113218|NCT01159652|zolpidem|zolpidem
5113219|NCT01159652|Sonata|sonata
5113220|NCT01159652|Ambien|ambien
5113221|NCT01159652|Hypnotics and Sedatives|hypnotics and sedatives
5113222|NCT01159652|Polysomnography|polysomnography
5113223|NCT01159652|Monitoring, sleep|monitoring, sleep
5113224|NCT01159639|aspirin resistance|aspirin resistance
5113225|NCT01159639|coronary artery bypass grafting|coronary artery bypass grafting
5113226|NCT01159639|multiple electrode aggregometry|multiple electrode aggregometry
5113227|NCT01159639|multiplate|multiplate
5113228|NCT01159626|Phase1|phase1
5113229|NCT01159626|Pharmacokinetics|pharmacokinetics
5113230|NCT01159626|Healthy Male|healthy male
5113231|NCT01159626|Japanese|japanese
5113232|NCT01159626|Schizophrenia|schizophrenia
5113233|NCT01159613|SVR|svr
5113234|NCT01159613|Cholesterol level|cholesterol level
5113235|NCT01159613|fibrosis score|fibrosis score
5113236|NCT01159613|HDL|hdl
5113237|NCT01159535|substance use|substance use
5113238|NCT01159535|addiction|addiction
5113239|NCT01159535|meditation|meditation
5113240|NCT01159535|mindfulness|mindfulness
5113241|NCT01159535|relapse prevention|relapse prevention
5113242|NCT01159522|Advanced Solid Tumors Who Have Failed Standard Therapy|advanced solid tumors who have failed standard therapy
5113243|NCT01159509|hypertrophic pyloric stenosis|hypertrophic pyloric stenosis
5113244|NCT01159509|sodium intake|sodium intake
5113245|NCT01159509|Healthy children with no chronic diseases|healthy children with no chronic diseases
5113246|NCT01159509|Status post HPS|status post hps
5113247|NCT01159483|safety|safety
5113248|NCT01159483|tolerability|tolerability
5113249|NCT01159483|pharmacokinetics|pharmacokinetics
5113250|NCT01159470|CRP velocity|crp velocity
5113251|NCT01159457|Celiac Disease|celiac disease
5113252|NCT01159457|Hepatitis B vaccination|hepatitis b vaccination
5113253|NCT01159444|noninvasive ventilation|noninvasive ventilation
5113254|NCT01159444|ventilator software|ventilator software
5113255|NCT01159444|ventilator settings|ventilator settings
5113256|NCT01159444|domiciliary ventilation|domiciliary ventilation
5113257|NCT01159431|partial seizures|partial seizures
5113258|NCT01159431|poorly controlled epilepsy|poorly controlled epilepsy
5113259|NCT01159431|intractable epilepsy|intractable epilepsy
5113260|NCT01159431|treatment resistant epilepsy|treatment resistant epilepsy
5113261|NCT01159431|Trigeminal Nerve|trigeminal nerve
5113262|NCT01159431|Trigeminal Nerve Stimulation|trigeminal nerve stimulation
5113263|NCT01159418|solid tumors|solid tumors
5113264|NCT01159418|Panobinostat|panobinostat
5113265|NCT01159418|histone deacetylase inhibitors|histone deacetylase inhibitors
5113266|NCT01159392|brain injury|brain injury
5113267|NCT01159392|mechanical ventilation|mechanical ventilation
5113268|NCT01159392|acute lung injury|acute lung injury
5113269|NCT01159392|lung recruitment|lung recruitment
5113532|NCT01158183|Outcomes|outcomes
5113270|NCT01159379|IgE-mediated allergy|ige-mediated allergy
5113271|NCT01159379|Beta-lactams|beta-lactams
5113272|NCT01159379|Ertapenem|ertapenem
5113273|NCT01159379|Cross-reactivity|cross-reactivity
5113274|NCT01159379|Immediate-type skin tests|immediate-type skin tests
5113275|NCT01159379|Intravenous tolerance tests|intravenous tolerance tests
5113276|NCT01159366|myocardial infarction|myocardial infarction
5113277|NCT01159366|coronary occlusion|coronary occlusion
5113278|NCT01159366|myocardial revascularization|myocardial revascularization
5113279|NCT01159366|collaterals|collaterals
5113280|NCT01159366|prognosis|prognosis
5113281|NCT01159327|Sorafenib (nexavar)|sorafenib (nexavar)
5113282|NCT01159327|ED-SCLC|ed-sclc
5113283|NCT01159327|Maintenance|maintenance
5113284|NCT01159327|Extensive Disease Small cell lung cancer|extensive disease small cell lung cancer
5113285|NCT01159314|glaucoma|glaucoma
5113286|NCT01159314|Baerveldt Implants|baerveldt implants
5113287|NCT01159288|Advanced unresectable non small cell lung cancer|advanced unresectable non small cell lung cancer
5113288|NCT01159288|Responding or stabilized after induction chemotherapy|responding or stabilized after induction chemotherapy
5113289|NCT01159275|lopinavir/ritonavir|lopinavir/ritonavir
5113290|NCT01159275|pharmacokinetics|pharmacokinetics
5113291|NCT01159275|HIV-1 infected adults|hiv-1 infected adults
5113292|NCT01159275|aim to investigate the lower dose of boosted lopinavir in Thais and to compare the levels of lopinavir/ritonavir from Abbot and GPO|aim to investigate the lower dose of boosted lopinavir in thais and to compare the levels of lopinavir/ritonavir from abbot and gpo
5113411|NCT01158755|Meningitis, tuberculous|meningitis, tuberculous
5113293|NCT01159262|Initially intubated and mechanically ventilated neonates|initially intubated and mechanically ventilated neonates
5113294|NCT01159249|Vildagliptin, Type 2 Diabetes, HbA1c, Fasting Plasma Glucose, Long-Term Safety|vildagliptin, type 2 diabetes, hba1c, fasting plasma glucose, long-term safety
5113295|NCT01159236|Gene signatures|gene signatures
5113296|NCT01159236|HER-2 normal stage I-III breast cancer|her-2 normal stage i-iii breast cancer
5113297|NCT01159236|Estrogen Receptor|estrogen receptor
5113298|NCT01159236|ER-positive|er-positive
5113299|NCT01159236|ER-negative|er-negative
5113300|NCT01159236|RCB categories II-III|rcb categories ii-iii
5113301|NCT01159236|Neoadjuvant Chemotherapy|neoadjuvant chemotherapy
5113302|NCT01159236|adjuvant systemic therapy|adjuvant systemic therapy
5113303|NCT01159236|molecular testing|molecular testing
5113304|NCT01159236|Fluorouracil|fluorouracil
5113305|NCT01159236|5-fluorouracil|5-fluorouracil
5113306|NCT01159236|5-FU|5-fu
5113307|NCT01159236|Doxorubicin|doxorubicin
5113308|NCT01159236|Adriamycin|adriamycin
5113309|NCT01159236|Rubex|rubex
5113310|NCT01159236|Epirubicin|epirubicin
5113311|NCT01159236|Ellence|ellence
5113312|NCT01159236|Cyclophosphamide|cyclophosphamide
5113313|NCT01159236|Cytoxan|cytoxan
5113314|NCT01159236|Neosar|neosar
5113315|NCT01159236|Bevacizumab|bevacizumab
5113316|NCT01159236|Avastin|avastin
5113317|NCT01159236|Anti-VEGF monoclonal|anti-vegf monoclonal
5113318|NCT01159236|rhu-MAb-VEGF|rhu-mab-vegf
5113319|NCT01159223|atazanavir / ritonavir|atazanavir / ritonavir
5113320|NCT01159223|low dose|low dose
5113321|NCT01159223|noninferiority|noninferiority
5113322|NCT01159223|safety and efficacy|safety and efficacy
5113323|NCT01159223|efficacy and safety of lower dose atazanavir/ritonavir in suppressed HIV-infected adults|efficacy and safety of lower dose atazanavir/ritonavir in suppressed hiv-infected adults
5113324|NCT01159197|sleep disturbance|sleep disturbance
5113325|NCT01159197|cognitive behavioral therapy|cognitive behavioral therapy
5113326|NCT01159197|inflammation|inflammation
5113327|NCT01159197|oxidative stress|oxidative stress
5113328|NCT01159197|hemodialysis|hemodialysis
5113329|NCT01159184|stress|stress
5113330|NCT01159184|coping methods|coping methods
5113331|NCT01159184|social support|social support
5113332|NCT01159184|diabetes mellitus|diabetes mellitus
5113333|NCT01159145|Healthy volunteer|healthy volunteer
5113334|NCT01159145|Japanese males|japanese males
5113335|NCT01159145|homo-EM/hetero-EM/PM|homo-em/hetero-em/pm
5113336|NCT01159132|pharmacokinetics|pharmacokinetics
5113337|NCT01159132|low dose raltegravir|low dose raltegravir
5113338|NCT01159132|HIV|hiv
5113339|NCT01159132|To study the pharmacokinetics profile of low dose raltegravir (RAL) (400mg OD and 800mg OD) and standard dose of 400mg BID in Thai HIV-infected patients.|to study the pharmacokinetics profile of low dose raltegravir (ral) (400mg od and 800mg od) and standard dose of 400mg bid in thai hiv-infected patients.
5113340|NCT01159119|Chronic Abdominal Pain|chronic abdominal pain
5113341|NCT01159119|Exocrine Pancreatic Insufficiency|exocrine pancreatic insufficiency
5113342|NCT01159106|Positive Pressure Ventilation|positive pressure ventilation
5113343|NCT01159106|Neurally Adjusted Ventilatory Assist|neurally adjusted ventilatory assist
5113344|NCT01159106|Patient/ventilator Asynchrony|patient/ventilator asynchrony
5113345|NCT01159106|Pediatric patient|pediatric patient
5113346|NCT01159106|Infant|infant
5113347|NCT01159093|Clinical Decision Support Systems|clinical decision support systems
5113348|NCT01159080|immunosuppression control in kidney transplantation|immunosuppression control in kidney transplantation
5113349|NCT01159067|hematopoietic stem cell transplant, iron overload, deferasirox, labile plasma iron|hematopoietic stem cell transplant, iron overload, deferasirox, labile plasma iron
5113350|NCT01159041|Depression, children, adolescent, family|depression, children, adolescent, family
5113351|NCT01159028|Liposomal Grb-2 treatment of CML, AML, CLL, MDS|liposomal grb-2 treatment of cml, aml, cll, mds
5113352|NCT01159028|Liposomal Grb-2 with LDAC for AML|liposomal grb-2 with ldac for aml
5113353|NCT01159002|Endoscopy, Video Capsule|endoscopy, video capsule
5113354|NCT01159002|Motility, Gastrointestinal|motility, gastrointestinal
5113355|NCT01158989|Critical care|critical care
5113356|NCT01158989|Endoscopy, Video Capsule|endoscopy, video capsule
5113357|NCT01158989|Nutrition, Enteral|nutrition, enteral
5113358|NCT01158937|meropenem|meropenem
5113359|NCT01158937|cystic fibrosis|cystic fibrosis
5113360|NCT01158937|extended infusion|extended infusion
5113361|NCT01158937|pharmacokinetic|pharmacokinetic
5113362|NCT01158911|kidney disease|kidney disease
5113363|NCT01158911|uric acid|uric acid
5113364|NCT01158911|outcomes|outcomes
5113365|NCT01158911|cardiovascular|cardiovascular
5113366|NCT01158911|mortality|mortality
5113367|NCT01158911|kidney failure|kidney failure
5113368|NCT01158911|Uric Acid levels in patients with Chronic Kidney Disease|uric acid levels in patients with chronic kidney disease
5113369|NCT01158898|Mild to moderate asthma|mild to moderate asthma
5113370|NCT01158898|Allergen inhalation challenge|allergen inhalation challenge
5113371|NCT01158885|relapsed|relapsed
5113372|NCT01158885|relapse|relapse
5113373|NCT01158885|refractory|refractory
5113374|NCT01158885|Minimal Residual disease|minimal residual disease
5113375|NCT01158885|MRD|mrd
5113376|NCT01158885|MRD positive|mrd positive
5113377|NCT01158885|MRD+|mrd+
5113378|NCT01158885|ALL|all
5113379|NCT01158885|Acute lymphoblastic leukemia|acute lymphoblastic leukemia
5113380|NCT01158885|AML|aml
5113381|NCT01158885|Acute myelogenous leukemia|acute myelogenous leukemia
5113382|NCT01158885|Relapsed AML|relapsed aml
5113383|NCT01158859|Anesthesia, General|anesthesia, general
5113384|NCT01158859|Propofol|propofol
5113385|NCT01158859|Pregabalin|pregabalin
5113386|NCT01158859|Preoperative care|preoperative care
5113387|NCT01158859|Laparoscopic surgery|laparoscopic surgery
5113388|NCT01158846|STEMI|stemi
5113389|NCT01158846|Primary PCI|primary pci
5113390|NCT01158846|anticoagulants|anticoagulants
5113391|NCT01158846|antiplatelets|antiplatelets
5113392|NCT01158833|Cerebral palsy|cerebral palsy
5113393|NCT01158833|diplegia|diplegia
5113394|NCT01158833|gait|gait
5113395|NCT01158833|classification|classification
5113396|NCT01158820|bronchoscopy|bronchoscopy
5113397|NCT01158807|Hereditary Hemorrhagic Telangiectasia|hereditary hemorrhagic telangiectasia
5113398|NCT01158807|Cerebral arteriovenous malformations|cerebral arteriovenous malformations
5113399|NCT01158794|Iron overload|iron overload
5113400|NCT01158794|Blood Transfusion|blood transfusion
5113401|NCT01158781|TBI|tbi
5113402|NCT01158781|motor learning|motor learning
5113403|NCT01158781|robotics|robotics
5113404|NCT01158781|Functional electrical stimulation|functional electrical stimulation
5113405|NCT01158768|domestic violence in childhood/adolescence|domestic violence in childhood/adolescence
5113406|NCT01158768|comorbidities|comorbidities
5113407|NCT01158768|climactery|climactery
5113408|NCT01158768|domestic violence against women|domestic violence against women
5113409|NCT01158768|trauma questionnaire|trauma questionnaire
5113410|NCT01158768|Violence|violence
5113412|NCT01158755|Intensified Regimen|intensified regimen
5113413|NCT01158755|PK/PD and tolerability|pk/pd and tolerability
5113414|NCT01158755|Outcome|outcome
5113415|NCT01158742|Glomerular Filtration Rate|glomerular filtration rate
5113416|NCT01158729|Antithrombin III|antithrombin iii
5113417|NCT01158729|Postoperative Hemorrhage|postoperative hemorrhage
5113418|NCT01158729|Cardiopulmonary Bypass|cardiopulmonary bypass
5113419|NCT01158729|Pediatrics|pediatrics
5113420|NCT01158729|Blood Transfusion|blood transfusion
5113421|NCT01158716|percutaneous coronary intervention|percutaneous coronary intervention
5113422|NCT01158716|remote ischemic preconditioning|remote ischemic preconditioning
5113423|NCT01158703|aspirin|aspirin
5113424|NCT01158703|clopidogrel|clopidogrel
5113425|NCT01158703|coronary artery bypass graft|coronary artery bypass graft
5113426|NCT01158703|Plavix|plavix
5113427|NCT01158690|Intimate partner violence|intimate partner violence
5113428|NCT01158677|meniscectomy|meniscectomy
5113429|NCT01158664|dental implants|dental implants
5113430|NCT01158664|different tread pitch design|different tread pitch design
5113431|NCT01158651|NF1|nf1
5113432|NCT01158651|low-grade glioma|low-grade glioma
5113433|NCT01158651|progressive|progressive
5113434|NCT01158651|children|children
5113435|NCT01158651|Participants studied have NF Type 1 and a low grade glioma that has either not responded to one or more standard treatments.|participants studied have nf type 1 and a low grade glioma that has either not responded to one or more standard treatments.
5113436|NCT01158638|Physical Activity Enhancement|physical activity enhancement
5113437|NCT01158599|Japanese Encephalitis|japanese encephalitis
5113438|NCT01158599|Vaccination|vaccination
5113439|NCT01158599|Ixiaro|ixiaro
5113440|NCT01158599|elderly population|elderly population
5113441|NCT01158586|post total knee replacement|post total knee replacement
5113442|NCT01158586|patient control|patient control
5113443|NCT01158586|epidural analgesia|epidural analgesia
5113444|NCT01158573|Asthma|asthma
5113445|NCT01158573|Obesity|obesity
5113446|NCT01158560|upper respiratory tract infections|upper respiratory tract infections
5113447|NCT01158560|rhinovirus infections|rhinovirus infections
5113448|NCT01158560|vitamin D|vitamin d
5113449|NCT01158534|recurrent renal cell cancer|recurrent renal cell cancer
5113450|NCT01158508|cerebral aneurysm|cerebral aneurysm
5113451|NCT01158508|cerebral vasospasm|cerebral vasospasm
5113452|NCT01158508|subarachnoid hemorrhage|subarachnoid hemorrhage
5113453|NCT01158508|remote ischemic preconditioning|remote ischemic preconditioning
5113454|NCT01158456|smoking|smoking
5113455|NCT01158456|lung cancer|lung cancer
5113456|NCT01158456|ethnic racial differences|ethnic racial differences
5113457|NCT01158456|tobacco specific nitrosamines|tobacco specific nitrosamines
5113458|NCT01158456|metabolism of carcinogens|metabolism of carcinogens
5113459|NCT01158443|HIV+|hiv+
5113460|NCT01158443|fatigue|fatigue
5113461|NCT01158443|return to work|return to work
5113462|NCT01158430|Hypochondriasis|hypochondriasis
5113463|NCT01158430|Acceptance and Commitment Therapy|acceptance and commitment therapy
5113464|NCT01158430|ACT|act
5113465|NCT01158417|Type 2 Diabetes|type 2 diabetes
5113466|NCT01158417|Obesity|obesity
5113467|NCT01158417|Insulin Resistance|insulin resistance
5113468|NCT01158417|Resveratrol|resveratrol
5113469|NCT01158417|Inflammation|inflammation
5113470|NCT01158404|Metastatic Cancer|metastatic cancer
5113471|NCT01158404|Solid Tumors|solid tumors
5113472|NCT01158391|Premature Birth|premature birth
5113473|NCT01158378|Adherus Dural Sealant|adherus dural sealant
5113474|NCT01158378|Adherus AutoSpray Dural Sealant|adherus autospray dural sealant
5113475|NCT01158352|Growth|growth
5113476|NCT01158352|Low weight|low weight
5113477|NCT01158352|Low height|low height
5113478|NCT01158352|Nutritional Formula|nutritional formula
5113479|NCT01158339|Low back pain|low back pain
5113480|NCT01158339|Cognitive behavioural therapy|cognitive behavioural therapy
5113481|NCT01158339|Group therapy|group therapy
5113482|NCT01158339|Exposure in session|exposure in session
5113483|NCT01158326|reducing symptoms|reducing symptoms
5113484|NCT01158326|events|events
5113485|NCT01158326|Common Cold|common cold
5113486|NCT01158326|flu syndrome|flu syndrome
5113487|NCT01158326|Symptomatic treatment of the Common Cold and Flu syndrome|symptomatic treatment of the common cold and flu syndrome
5113488|NCT01158300|recurrent childhood malignant germ cell tumor|recurrent childhood malignant germ cell tumor
5113489|NCT01158300|recurrent childhood brain stem glioma|recurrent childhood brain stem glioma
5113490|NCT01158300|recurrent childhood brain tumor|recurrent childhood brain tumor
5113491|NCT01158300|recurrent childhood central nervous system embryonal tumor|recurrent childhood central nervous system embryonal tumor
5113492|NCT01158300|recurrent childhood cerebellar astrocytoma|recurrent childhood cerebellar astrocytoma
5113493|NCT01158300|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
5113494|NCT01158300|recurrent childhood ependymoma|recurrent childhood ependymoma
5113495|NCT01158300|recurrent childhood medulloblastoma|recurrent childhood medulloblastoma
5113496|NCT01158300|recurrent childhood pineoblastoma|recurrent childhood pineoblastoma
5113497|NCT01158300|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
5113498|NCT01158300|recurrent childhood spinal cord neoplasm|recurrent childhood spinal cord neoplasm
5113499|NCT01158300|recurrent childhood subependymal giant cell astrocytoma|recurrent childhood subependymal giant cell astrocytoma
5113500|NCT01158300|recurrent childhood visual pathway and hypothalamic glioma|recurrent childhood visual pathway and hypothalamic glioma
5113501|NCT01158300|recurrent childhood visual pathway glioma|recurrent childhood visual pathway glioma
5113502|NCT01158300|childhood central nervous system choriocarcinoma|childhood central nervous system choriocarcinoma
5113503|NCT01158300|childhood central nervous system germ cell tumor|childhood central nervous system germ cell tumor
5113504|NCT01158300|childhood central nervous system germinoma|childhood central nervous system germinoma
5113505|NCT01158300|childhood central nervous system mixed germ cell tumor|childhood central nervous system mixed germ cell tumor
5113506|NCT01158300|childhood central nervous system teratoma|childhood central nervous system teratoma
5113507|NCT01158300|childhood central nervous system yolk sac tumor|childhood central nervous system yolk sac tumor
5113508|NCT01158300|childhood astrocytoma|childhood astrocytoma
5113509|NCT01158300|childhood medulloepithelioma|childhood medulloepithelioma
5113510|NCT01158300|childhood meningioma|childhood meningioma
5113511|NCT01158300|childhood mixed glioma|childhood mixed glioma
5113512|NCT01158300|childhood oligodendroglioma|childhood oligodendroglioma
5113513|NCT01158300|childhood pineal parenchymal tumor|childhood pineal parenchymal tumor
5113514|NCT01158287|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
5113515|NCT01158287|recurrent esophageal cancer|recurrent esophageal cancer
5113516|NCT01158287|recurrent gastric cancer|recurrent gastric cancer
5113517|NCT01158287|adenocarcinoma of the stomach|adenocarcinoma of the stomach
5113518|NCT01158261|hemostasis|hemostasis
5113519|NCT01158248|cervical adenocarcinoma|cervical adenocarcinoma
5113520|NCT01158248|cervical adenosquamous cell carcinoma|cervical adenosquamous cell carcinoma
5113521|NCT01158248|cervical small cell carcinoma|cervical small cell carcinoma
5113522|NCT01158248|stage IB cervical cancer|stage ib cervical cancer
5113523|NCT01158248|stage IIA cervical cancer|stage iia cervical cancer
5113772|NCT01157039|glutamine|glutamine
5113524|NCT01158248|stage IIB cervical cancer|stage iib cervical cancer
5113525|NCT01158248|stage III cervical cancer|stage iii cervical cancer
5113526|NCT01158248|cervical squamous cell carcinoma|cervical squamous cell carcinoma
5113527|NCT01158235|MRSA|mrsa
5113528|NCT01158235|nose|nose
5113529|NCT01158196|laser|laser
5113530|NCT01158196|keloid|keloid
5113533|NCT01158183|real world and web tool|real world and web tool
5113534|NCT01158183|electronic data capture|electronic data capture
5113535|NCT01158170|nonsmall cell lung cancer|nonsmall cell lung cancer
5113536|NCT01158170|brain metastasis|brain metastasis
5113537|NCT01158170|prophylactic cranial irradiation|prophylactic cranial irradiation
5113538|NCT01158144|Non-small cell lung cancer|non-small cell lung cancer
5113539|NCT01158144|Locally advanced|locally advanced
5113540|NCT01158144|Radiotherapy|radiotherapy
5113541|NCT01158144|Concomitant Chemotherapy|concomitant chemotherapy
5113542|NCT01158144|Endostar|endostar
5113543|NCT01158131|Gestational diabetes mellitus (GDM) in the most recent pregnancy|gestational diabetes mellitus (gdm) in the most recent pregnancy
5113544|NCT01158118|Precursor Cell Lymphoblastic Leukemia-Lymphoma|precursor cell lymphoblastic leukemia-lymphoma
5113545|NCT01158118|Leukemia, Myelogenous, Chronic, BCR-ABL Positive|leukemia, myelogenous, chronic, bcr-abl positive
5113546|NCT01158105|Steroid refractory chronic graft vs host disease (cGVHD)|steroid refractory chronic graft vs host disease (cgvhd)
5113547|NCT01158105|Bortezomib|bortezomib
5113548|NCT01158105|Velcade|velcade
5113549|NCT01158079|Liver|liver
5113550|NCT01158079|Solid Tumors|solid tumors
5113551|NCT01158079|Advanced Solid Tumors with Liver Involvement|advanced solid tumors with liver involvement
5113552|NCT01158066|NAFLD|nafld
5113553|NCT01158066|Calcium score|calcium score
5113554|NCT01158066|Liver Fat|liver fat
5113555|NCT01158066|Visceral fat|visceral fat
5113556|NCT01158066|excessive visceral fat|excessive visceral fat
5113557|NCT01158066|excessive liver fat accumulation|excessive liver fat accumulation
5113558|NCT01158066|Biomarkers of insulin resistance (HOMA), inflammation (CRP) and (MDA-Paraoxonase)|biomarkers of insulin resistance (homa), inflammation (crp) and (mda-paraoxonase)
5113559|NCT01158040|Maternal intrapartum glycemic control|maternal intrapartum glycemic control
5113560|NCT01158040|Pregestational diabetes|pregestational diabetes
5113561|NCT01158014|pterygium|pterygium
5113562|NCT01158014|conjunctival graft|conjunctival graft
5113563|NCT01158014|recurrence|recurrence
5113564|NCT01158014|primary pterygium|primary pterygium
5113565|NCT01158001|Posttraumatic stress disorders|posttraumatic stress disorders
5113566|NCT01158001|Telemedicine|telemedicine
5113567|NCT01158001|Psychotherapy|psychotherapy
5113568|NCT01158001|Neuropsychological test|neuropsychological test
5113569|NCT01158001|Depression|depression
5113570|NCT01157988|bulky diffuse large B cell lymphoma|bulky diffuse large b cell lymphoma
5113571|NCT01157988|90Y-ibritumomab tiuxetan|90y-ibritumomab tiuxetan
5113572|NCT01157988|clinical response|clinical response
5113573|NCT01157988|Safety and toxicity|safety and toxicity
5113574|NCT01157962|Sentinel Concept|sentinel concept
5113575|NCT01157962|Lymphadenectomy|lymphadenectomy
5113576|NCT01157962|Early Stage Cervical Cancer|early stage cervical cancer
5113577|NCT01157962|Overall Survive|overall survive
5113578|NCT01157962|Improvement Therapy|improvement therapy
5113579|NCT01157936|hypertension|hypertension
5113580|NCT01157936|hyperuricemia|hyperuricemia
5113581|NCT01157936|metabolic syndrome|metabolic syndrome
5113582|NCT01157923|Type 1 diabetes|type 1 diabetes
5113583|NCT01157923|Insulin Pump Therapy|insulin pump therapy
5113584|NCT01157910|Ear infection|ear infection
5113585|NCT01157910|Chronic|chronic
5113586|NCT01157897|Malaria|malaria
5113587|NCT01157897|Plasmodium Vivax|plasmodium vivax
5113588|NCT01157897|Vaccine|vaccine
5113589|NCT01157884|body composition|body composition
5113590|NCT01157884|obesity|obesity
5113591|NCT01157884|kidney transplantation|kidney transplantation
5113592|NCT01157858|liver cyst|liver cyst
5113593|NCT01157832|water pipe smoking acute effect|water pipe smoking acute effect
5113594|NCT01157819|swimmer's ear|swimmer's ear
5113595|NCT01157819|ear drops|ear drops
5113596|NCT01157819|ear foam|ear foam
5113597|NCT01157819|otic foam|otic foam
5113598|NCT01157819|ear infection|ear infection
5113599|NCT01157819|ear pain|ear pain
5113600|NCT01157819|ear inflammation|ear inflammation
5113601|NCT01157806|rectal cancer|rectal cancer
5113602|NCT01157806|unresectable synchronous metastases|unresectable synchronous metastases
5113603|NCT01157806|pelvic radiochemotherapy|pelvic radiochemotherapy
5113604|NCT01157793|Dwarfism|dwarfism
5113605|NCT01157793|Growth hormone deficiency|growth hormone deficiency
5113606|NCT01157793|Growth hormone|growth hormone
5113607|NCT01157780|Fish oil|fish oil
5113608|NCT01157767|exercise|exercise
5113609|NCT01157767|lymphedema|lymphedema
5113610|NCT01157767|post-operative chemotherapy|post-operative chemotherapy
5113611|NCT01157767|post-operative radiation|post-operative radiation
5113612|NCT01157767|10-062|10-062
5113613|NCT01157754|Infertility patients requiring IVF|infertility patients requiring ivf
5113614|NCT01157754|good prognosis|good prognosis
5113615|NCT01157741|Community based follow up, severely underweight children|community based follow up, severely underweight children
5113616|NCT01157728|Multiple sclerosis|multiple sclerosis
5113617|NCT01157728|Cognitive impairment|cognitive impairment
5113618|NCT01157715|KH902|kh902
5113619|NCT01157715|age-related macular degeneration (AMD)|age-related macular degeneration (amd)
5113620|NCT01157715|choroidal neovascularization (CNV)|choroidal neovascularization (cnv)
5113621|NCT01157715|intravitreal injection|intravitreal injection
5113622|NCT01157715|best corrected visual acuity (BCVA)|best corrected visual acuity (bcva)
5113825|NCT01156792|asthma|asthma
5113623|NCT01157715|central retinal thickness|central retinal thickness
5113624|NCT01157689|malaria|malaria
5113625|NCT01157689|children|children
5113626|NCT01157689|Guinea-Bissau|guinea-bissau
5113627|NCT01157689|artemether|artemether
5113628|NCT01157689|lumefantrine|lumefantrine
5113629|NCT01157689|effectiveness|effectiveness
5113630|NCT01157676|open cystectomy|open cystectomy
5113631|NCT01157676|robotic assisted radical cystectomy|robotic assisted radical cystectomy
5113632|NCT01157676|bladder cancer|bladder cancer
5113633|NCT01157663|Functional ankle instability|functional ankle instability
5113634|NCT01157650|Fistulizing Crohn's disease|fistulizing crohn's disease
5113635|NCT01157650|stem cells implant|stem cells implant
5113636|NCT01157624|hypoxia or hypercarbia during surgery under the drape|hypoxia or hypercarbia during surgery under the drape
5113637|NCT01157611|online based mentoring program,|online based mentoring program,
5113638|NCT01157611|type 1 diabetes,|type 1 diabetes,
5113639|NCT01157611|blood glucose,|blood glucose,
5113640|NCT01157611|satisfaction score|satisfaction score
5113641|NCT01157598|gastric adenoma|gastric adenoma
5113642|NCT01157598|early gastric cancer|early gastric cancer
5113643|NCT01157572|Aortic valve insufficiency|aortic valve insufficiency
5113644|NCT01157572|Beta-blocker|beta-blocker
5113645|NCT01157533|Vancomycin|vancomycin
5113646|NCT01157533|Pharmacokinetic testing|pharmacokinetic testing
5113647|NCT01157533|PK|pk
5113648|NCT01157507|Botulinum A toxin|botulinum a toxin
5113649|NCT01157507|Painful Bladder Syndrome (PBS)|painful bladder syndrome (pbs)
5113650|NCT01157507|Bladder overdistention|bladder overdistention
5113651|NCT01157494|cerebral palsy|cerebral palsy
5113652|NCT01157494|hemiplegia|hemiplegia
5113653|NCT01157494|upper limb|upper limb
5113654|NCT01157494|assessment|assessment
5113655|NCT01157494|classification system|classification system
5113656|NCT01157481|Diastolic Heart Failure|diastolic heart failure
5113657|NCT01157481|Heart failure with preserved ejection fraction|heart failure with preserved ejection fraction
5113658|NCT01157481|nifedipine|nifedipine
5113659|NCT01157468|Systemic Lupus Erythematosus in Martinique|systemic lupus erythematosus in martinique
5113660|NCT01157468|Hydrolase and DNase activities|hydrolase and dnase activities
5113661|NCT01157455|Stent|stent
5113662|NCT01157455|Coronary artery diseases|coronary artery diseases
5113663|NCT01157442|prevention of maternal to child transmission of HIV|prevention of maternal to child transmission of hiv
5113664|NCT01157442|mhealth|mhealth
5113665|NCT01157442|access to antenatal care|access to antenatal care
5113666|NCT01157442|pregnancy|pregnancy
5113667|NCT01157429|Cognitive Behavior Therapy|cognitive behavior therapy
5113668|NCT01157429|Children|children
5113669|NCT01157429|Adolescents|adolescents
5113670|NCT01157429|Pharmacotherapy|pharmacotherapy
5113671|NCT01157416|Cognitive Behavior Therapy|cognitive behavior therapy
5113672|NCT01157416|Children|children
5113673|NCT01157416|Pharmacotherapy|pharmacotherapy
5113674|NCT01157403|mesenchymal stem cells|mesenchymal stem cells
5113675|NCT01157390|Term-infant|term-infant
5113676|NCT01157390|sn-2 palmitic acid|sn-2 palmitic acid
5113677|NCT01157390|infant formula|infant formula
5113678|NCT01157351|Schizophrenia|schizophrenia
5113679|NCT01157351|Risperidone|risperidone
5113680|NCT01157351|Risperdal|risperdal
5113681|NCT01157351|Paliperidone palmitate|paliperidone palmitate
5113682|NCT01157351|Aripiprazole|aripiprazole
5113683|NCT01157351|Haloperidol|haloperidol
5113684|NCT01157351|Olanzapine|olanzapine
5113685|NCT01157351|Paliperidone|paliperidone
5113686|NCT01157351|Perphenazine|perphenazine
5113687|NCT01157351|Quetiapine|quetiapine
5113688|NCT01157338|Catheter|catheter
5113689|NCT01157338|coronary artery disease|coronary artery disease
5113690|NCT01157338|embolus|embolus
5113691|NCT01157338|stroke|stroke
5113692|NCT01157338|retinal emboli|retinal emboli
5113693|NCT01157325|Epidural analgesia|epidural analgesia
5113694|NCT01157325|Latent analgesia|latent analgesia
5113695|NCT01157325|Active analgesia|active analgesia
5113696|NCT01157325|Cesarean section|cesarean section
5113697|NCT01157312|Polycystic ovary syndrome|polycystic ovary syndrome
5113698|NCT01157312|clomiphene citrate|clomiphene citrate
5113699|NCT01157312|minimal stimulation|minimal stimulation
5113700|NCT01157312|infertility treatment|infertility treatment
5113701|NCT01157299|Hemodynamics|hemodynamics
5113702|NCT01157299|Pediatric Intensive Care Unit|pediatric intensive care unit
5113703|NCT01157299|Low cardiac output|low cardiac output
5113704|NCT01157299|Thermodilution|thermodilution
5113705|NCT01157299|Stroke volume|stroke volume
5113706|NCT01157299|Global end-diastolic volume|global end-diastolic volume
5113707|NCT01157299|Fluid responsiveness|fluid responsiveness
5113708|NCT01157299|Passive leg raising|passive leg raising
5113709|NCT01157299|Infant|infant
5113710|NCT01157286|OBSTRUCTIVE SLEEP APNEA LARINGECTOMY CPAP|obstructive sleep apnea laringectomy cpap
5113711|NCT01157273|Behavior|behavior
5113712|NCT01157273|Anxiety|anxiety
5113713|NCT01157273|Communication|communication
5113714|NCT01157273|Voice|voice
5113715|NCT01157260|Indoxyl sulfate|indoxyl sulfate
5113716|NCT01157260|AST-120|ast-120
5113717|NCT01157247|Anesthetic techniques|anesthetic techniques
5113718|NCT01157247|regional, spinal|regional, spinal
5113719|NCT01157247|Pain|pain
5113720|NCT01157247|lumbar puncture|lumbar puncture
5113721|NCT01157247|Analgesia, local|analgesia, local
5113722|NCT01157247|Analgesia, intravenous|analgesia, intravenous
5113723|NCT01157234|Hypertension|hypertension
5113724|NCT01157234|Kidney transplantation|kidney transplantation
5113725|NCT01157234|Renal function|renal function
5113726|NCT01157234|Nitric Oxide|nitric oxide
5113727|NCT01157234|Nebivolol|nebivolol
5113728|NCT01157208|chronic pain|chronic pain
5113729|NCT01157208|headache|headache
5113730|NCT01157208|nutrition|nutrition
5113731|NCT01157208|inflammation|inflammation
5113732|NCT01157208|complementary medicine|complementary medicine
5113733|NCT01157195|stroke|stroke
5113734|NCT01157195|chronic|chronic
5113735|NCT01157195|arm|arm
5113736|NCT01157195|rehabilitation|rehabilitation
5113737|NCT01157195|tele-health|tele-health
5113738|NCT01157182|Healthy|healthy
5113739|NCT01157182|Bioequivalence|bioequivalence
5113740|NCT01157182|Post-Menopausal|post-menopausal
5113741|NCT01157169|Bioequivalence|bioequivalence
5113742|NCT01157169|Healthy|healthy
5113743|NCT01157130|Breast Cancer|breast cancer
5113744|NCT01157130|Exercise|exercise
5113745|NCT01157130|CRP|crp
5113746|NCT01157130|C-reactive protein|c-reactive protein
5113747|NCT01157130|BMI|bmi
5113748|NCT01157130|Nevada Cancer Institute|nevada cancer institute
5113749|NCT01157130|Rehabilitation|rehabilitation
5113750|NCT01157130|Prescriptive exercise|prescriptive exercise
5113751|NCT01157130|Physical Activity|physical activity
5113752|NCT01157130|DEXA|dexa
5113753|NCT01157130|Obesity|obesity
5113754|NCT01157130|lifestyle intervention|lifestyle intervention
5113755|NCT01157130|Early Stage Breast Cancer Patients (stage 0-III)|early stage breast cancer patients (stage 0-iii)
5113756|NCT01157117|food allergy|food allergy
5113757|NCT01157104|HCV|hcv
5113758|NCT01157104|Hepatitis C|hepatitis c
5113759|NCT01157078|Major Depressive Disorder|major depressive disorder
5113760|NCT01157078|MDD|mdd
5113761|NCT01157078|Depression|depression
5113762|NCT01157078|Safety|safety
5113763|NCT01157078|add-on therapy|add-on therapy
5113764|NCT01157065|Wet AMD|wet amd
5113765|NCT01157065|Intravitreal Injection|intravitreal injection
5113766|NCT01157065|Macular Degeneration|macular degeneration
5113767|NCT01157065|VEGF treatment|vegf treatment
5113768|NCT01157052|magnesium|magnesium
5113769|NCT01157052|calcium|calcium
5113770|NCT01157052|adverse effects|adverse effects
5113771|NCT01157052|kinetics, drug|kinetics, drug
5113773|NCT01157039|oxaliplatin|oxaliplatin
5113774|NCT01157039|adverse effects|adverse effects
5113775|NCT01157026|Breast cancer|breast cancer
5113776|NCT01157026|Tocotrienol-rich fraction with tamoxifen|tocotrienol-rich fraction with tamoxifen
5113777|NCT01157013|Positron Emission Tomography|positron emission tomography
5113778|NCT01157013|Hepatocellular carcinoma|hepatocellular carcinoma
5113779|NCT01157013|Liver Cancer|liver cancer
5113780|NCT01157013|Sorafenib|sorafenib
5113781|NCT01157013|Response Evaluation|response evaluation
5113782|NCT01157000|Canagliflozin|canagliflozin
5113783|NCT01157000|Pharmacokinetic|pharmacokinetic
5113784|NCT01157000|Bioavailability|bioavailability
5113785|NCT01156974|care management|care management
5113786|NCT01156974|chronic disease|chronic disease
5113787|NCT01156974|outpatient|outpatient
5113788|NCT01156948|misoprostol|misoprostol
5113789|NCT01156948|nulliparous|nulliparous
5113790|NCT01156948|hysteroscopy|hysteroscopy
5113791|NCT01156935|Neoplasm|neoplasm
5113792|NCT01156935|Laugh-Yoga|laugh-yoga
5113793|NCT01156935|Mood|mood
5113794|NCT01156935|Quality of life|quality of life
5113795|NCT01156922|Chronic fatigue syndrome|chronic fatigue syndrome
5113796|NCT01156922|CFS|cfs
5113797|NCT01156922|Myalgic encephalomyelitis|myalgic encephalomyelitis
5113798|NCT01156922|Rituximab|rituximab
5113799|NCT01156922|B-cell depletion|b-cell depletion
5113800|NCT01156909|Chronic fatigue syndrome|chronic fatigue syndrome
5113801|NCT01156909|CFS|cfs
5113802|NCT01156909|Myalgic encephalomyelitis|myalgic encephalomyelitis
5113803|NCT01156909|Rituximab|rituximab
5113804|NCT01156909|B-cell depletion|b-cell depletion
5113805|NCT01156896|Non-transferrin-bound iron|non-transferrin-bound iron
5113806|NCT01156896|Iron stable isotopes|iron stable isotopes
5113807|NCT01156896|Iron deficiency|iron deficiency
5113808|NCT01156896|Malaria|malaria
5113809|NCT01156896|Iron supplementation|iron supplementation
5113810|NCT01156896|Iron fortification|iron fortification
5113811|NCT01156883|B-cell adult acute lymphoblastic leukemia|b-cell adult acute lymphoblastic leukemia
5113812|NCT01156883|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5113813|NCT01156883|T-cell adult acute lymphoblastic leukemia|t-cell adult acute lymphoblastic leukemia
5113814|NCT01156883|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
5113815|NCT01156844|Indacaterol|indacaterol
5113816|NCT01156844|Asthma|asthma
5113817|NCT01156844|Bronchodilation|bronchodilation
5113818|NCT01156844|Beta-agonist|beta-agonist
5113819|NCT01156831|Esophageal cancer|esophageal cancer
5113820|NCT01156831|PET-CT planning|pet-ct planning
5113821|NCT01156818|Wheeze measurements|wheeze measurements
5113822|NCT01156805|Children|children
5113823|NCT01156805|School-based program|school-based program
5113824|NCT01156805|Obesity|obesity
5113827|NCT01156779|SR-Exenatide|sr-exenatide
5113828|NCT01156766|Fracture|fracture
5113829|NCT01156766|Radius|radius
5113830|NCT01156766|Osteosynthesis|osteosynthesis
5113831|NCT01156766|Metaphyseal|metaphyseal
5113832|NCT01156766|Pinning|pinning
5113833|NCT01156766|Locking anterior plate|locking anterior plate
5113834|NCT01156753|CR011-vcMMAE|cr011-vcmmae
5113835|NCT01156753|locally advanced breast cancer|locally advanced breast cancer
5113836|NCT01156753|metastatic breast cancer|metastatic breast cancer
5113837|NCT01156753|breast cancer|breast cancer
5113838|NCT01156753|CDX-011|cdx-011
5113839|NCT01156753|GPNMB|gpnmb
5113840|NCT01156753|Targeted treatment for breast cancer|targeted treatment for breast cancer
5113841|NCT01156753|Locally advanced or metastatic breast cancer|locally advanced or metastatic breast cancer
5113842|NCT01156740|streptococcal pharyngitis|streptococcal pharyngitis
5113843|NCT01156740|randomized clinical trial|randomized clinical trial
5113844|NCT01156740|amoxicillin|amoxicillin
5113845|NCT01156740|intramuscular benzathine penicillin G.|intramuscular benzathine penicillin g.
5113846|NCT01156727|OEF/OIF|oef/oif
5113847|NCT01156727|Mental Health|mental health
5113848|NCT01156727|Veterans|veterans
5113849|NCT01156714|Parkinson's Disease|parkinson's disease
5113850|NCT01156714|Treadmill Training|treadmill training
5113851|NCT01156714|Exercise|exercise
5113852|NCT01156714|Cognitive Training|cognitive training
5113853|NCT01156714|Executive Function|executive function
5113854|NCT01156714|Dual Task|dual task
5113855|NCT01156701|Influenza|influenza
5113856|NCT01156701|Zanamivir|zanamivir
5113857|NCT01156701|Influenza prophylaxis|influenza prophylaxis
5113858|NCT01156701|Relenza|relenza
5113859|NCT01156688|medical abortion for pregnancy of less than 9 weeks gestation|medical abortion for pregnancy of less than 9 weeks gestation
5113860|NCT01156675|Back pain|back pain
5113861|NCT01156675|Pain|pain
5113862|NCT01156675|Spinal Diseases|spinal diseases
5113863|NCT01156675|Spinal Stenosis|spinal stenosis
5113864|NCT01156675|Lumbar Vertebrae|lumbar vertebrae
5113865|NCT01156675|Spinal Canal|spinal canal
5113866|NCT01156662|Thrombus aspiration|thrombus aspiration
5113867|NCT01156662|Percutaneous coronary intervention|percutaneous coronary intervention
5113868|NCT01156649|Obstructive sleep apnea|obstructive sleep apnea
5113869|NCT01156649|neurocognitive function|neurocognitive function
5113870|NCT01156649|cognition|cognition
5113871|NCT01156649|pediatrics|pediatrics
5113872|NCT01156649|children|children
5113873|NCT01156649|continuous positive airway pressure therapy|continuous positive airway pressure therapy
5113874|NCT01156649|sham treatment|sham treatment
5113875|NCT01156649|randomized clinical trial|randomized clinical trial
5113876|NCT01156649|behavior|behavior
5113877|NCT01156649|treatment|treatment
5113878|NCT01156636|Diastolic Heart Failure|diastolic heart failure
5113879|NCT01156636|Pulmonary Hypertension|pulmonary hypertension
5113880|NCT01156623|EBUS-TBNA|ebus-tbna
5113881|NCT01156623|NSCLC|nsclc
5113882|NCT01156623|Mediastinal lymph node|mediastinal lymph node
5113883|NCT01156623|tuberculosis|tuberculosis
5113884|NCT01156610|Smoking|smoking
5113885|NCT01156610|Smoking Cessation|smoking cessation
5113886|NCT01156610|Electronic Health Record|electronic health record
5113887|NCT01156610|Telephone|telephone
5113888|NCT01156597|diabetes|diabetes
5113889|NCT01156597|dyslipidemia|dyslipidemia
5113890|NCT01156597|pioglitazone|pioglitazone
5113891|NCT01156597|HDL-Cholesterol|hdl-cholesterol
5113892|NCT01156597|Reverse cholesterol transport|reverse cholesterol transport
5113893|NCT01156584|glioma|glioma
5113894|NCT01156584|glioblastoma|glioblastoma
5113895|NCT01156584|glioblastoma multiforme|glioblastoma multiforme
5113896|NCT01156584|Grade IV astrocytoma|grade iv astrocytoma
5113897|NCT01156584|brain cancer|brain cancer
5113898|NCT01156584|recurrent glioblastoma|recurrent glioblastoma
5113900|NCT01156584|AA|aa
5113901|NCT01156584|AOD|aod
5113902|NCT01156584|anaplastic astrocytoma|anaplastic astrocytoma
5113903|NCT01156584|anaplastic oligodendroglioma|anaplastic oligodendroglioma
5113904|NCT01156584|anaplastic oligoastrocytoma|anaplastic oligoastrocytoma
5113905|NCT01156584|malignant glioma|malignant glioma
5113906|NCT01156584|high grade glioma|high grade glioma
5113907|NCT01156545|BIBW 2992|bibw 2992
5113908|NCT01156545|Simvastatin|simvastatin
5113909|NCT01156545|NSCLC|nsclc
5113910|NCT01156545|advanced stage|advanced stage
5113911|NCT01156545|previously treated patients|previously treated patients
5113912|NCT01156545|non-adenocarcinoma|non-adenocarcinoma
5113913|NCT01156532|adalimumab therapy|adalimumab therapy
5113914|NCT01156532|Psoriasis|psoriasis
5113915|NCT01156532|observational study|observational study
5113916|NCT01156519|Infra-clinic cortisol adenoma|infra-clinic cortisol adenoma
5113917|NCT01156519|Salivary cortisol|salivary cortisol
5113918|NCT01156519|Obesity|obesity
5113919|NCT01156506|quality of life|quality of life
5113920|NCT01156506|patient education|patient education
5113921|NCT01156506|rehabilitation|rehabilitation
5113922|NCT01156506|focus group interview|focus group interview
5113923|NCT01156493|feeding intolerance|feeding intolerance
5113924|NCT01156493|prematurity|prematurity
5113925|NCT01156480|necrotizing enterocolitis|necrotizing enterocolitis
5113926|NCT01156480|NEC|nec
5113927|NCT01156480|premature|premature
5113928|NCT01156480|hydrocortisone|hydrocortisone
5113929|NCT01156480|steroids|steroids
5113930|NCT01156480|anti-inflammatory|anti-inflammatory
5113931|NCT01156467|Neurally adjusted ventilatory assist NAVA|neurally adjusted ventilatory assist nava
5113932|NCT01156467|Premature infant|premature infant
5113933|NCT01156467|Edi-signal|edi-signal
5113934|NCT01156454|sentinel lymph node dissection|sentinel lymph node dissection
5113935|NCT01156454|radiology|radiology
5113936|NCT01156454|X-ray identification of nodes in a surgical specimen|x-ray identification of nodes in a surgical specimen
5113937|NCT01156441|Myocardial Infarction|myocardial infarction
5113938|NCT01156441|Mitral Regurgitation|mitral regurgitation
5113939|NCT01156441|Percutaneous Coronary Intervention|percutaneous coronary intervention
5113940|NCT01156428|Nephritic syndrome|nephritic syndrome
5113941|NCT01156428|Nephrotic syndrome|nephrotic syndrome
5113942|NCT01156428|Proteinuria|proteinuria
5113943|NCT01156428|Acute kidney injury|acute kidney injury
5113944|NCT01156428|Chronic kidney disease|chronic kidney disease
5113945|NCT01156428|Lupus nephritis|lupus nephritis
5113946|NCT01156415|agomelatine|agomelatine
5113947|NCT01156415|Major Depressive Disorder|major depressive disorder
5113948|NCT01156415|MDD|mdd
5113949|NCT01156415|depression|depression
5113950|NCT01156402|Obesity|obesity
5113951|NCT01156402|Pediatric Obesity|pediatric obesity
5113952|NCT01156389|malaria|malaria
5113953|NCT01156389|artemisinin-based combination therapy|artemisinin-based combination therapy
5113954|NCT01156350|Neuroblastoma - Haplo HSCT - Reduced Intensity Conditioning - immunotherapy NK|neuroblastoma - haplo hsct - reduced intensity conditioning - immunotherapy nk
5113955|NCT01156337|Heart failure III NYHA class|heart failure iii nyha class
5113956|NCT01156337|Furosemide|furosemide
5113957|NCT01156337|Sodium|sodium
5113958|NCT01156337|water restriction|water restriction
5113959|NCT01156337|decompensated heart failure|decompensated heart failure
5113960|NCT01156337|Hypertonic saline solution|hypertonic saline solution
5113961|NCT01156337|Moderate sodium restriction|moderate sodium restriction
5113962|NCT01156324|IVF|ivf
5113963|NCT01156324|Stress management|stress management
5113964|NCT01156311|BG00012|bg00012
5113965|NCT01156311|MS|ms
5113966|NCT01156311|RRMS|rrms
5113967|NCT01156272|Isolated aortic valve replacement|isolated aortic valve replacement
5113968|NCT01156272|heart valve|heart valve
5113969|NCT01156259|B cell cll/lymphoma, human|b cell cll/lymphoma, human
5113970|NCT01156246|Healthy volunteers|healthy volunteers
5113971|NCT01156246|Dapagliflozin|dapagliflozin
5113972|NCT01156246|Diabetes Type 2|diabetes type 2
5113973|NCT01156246|Food interaction|food interaction
5113974|NCT01156233|evaluating precision of tube tip position with two methods|evaluating precision of tube tip position with two methods
5113975|NCT01156220|gender, diuretics, furosemide, aminohippuric acid|gender, diuretics, furosemide, aminohippuric acid
5113976|NCT01156207|To establish the coupling between components of arterial load ( and components of LV myocardial deformations at baseline and 6 months after randomization.|to establish the coupling between components of arterial load ( and components of lv myocardial deformations at baseline and 6 months after randomization.
5113977|NCT01156207|To establish the role of EPCs on modulation of the components of arterial load and LV myocardial deformations and their coupling.|to establish the role of epcs on modulation of the components of arterial load and lv myocardial deformations and their coupling.
5113978|NCT01156194|third stage, labor, postpartum hemorrhage, homeopathy, arnica, bellis perennis|third stage, labor, postpartum hemorrhage, homeopathy, arnica, bellis perennis
5113979|NCT01156181|Cervical mucus, Embryo transfer, ICSI cycle, Pregnancy rate|cervical mucus, embryo transfer, icsi cycle, pregnancy rate
5113980|NCT01156168|male breast cancer|male breast cancer
5113981|NCT01156168|stage IV breast cancer|stage iv breast cancer
5113982|NCT01156168|recurrent breast cancer|recurrent breast cancer
5113983|NCT01156155|rheumatoid arthritis|rheumatoid arthritis
5113984|NCT01156155|osteoarthritis|osteoarthritis
5113985|NCT01156155|periodontal disease|periodontal disease
5113986|NCT01156142|oral complications of radiation therapy|oral complications of radiation therapy
5113987|NCT01156142|mucositis|mucositis
5113988|NCT01156142|pain|pain
5113989|NCT01156142|stage I squamous cell carcinoma of the paranasal sinus and nasal cavity|stage i squamous cell carcinoma of the paranasal sinus and nasal cavity
5113990|NCT01156142|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
5113991|NCT01156142|squamous cell carcinoma of the hypopharynx|squamous cell carcinoma of the hypopharynx
5113992|NCT01156142|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
5113993|NCT01156142|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
5113994|NCT01156142|squamous cell carcinoma of the larynx|squamous cell carcinoma of the larynx
5113995|NCT01156142|verrucous carcinoma of the larynx|verrucous carcinoma of the larynx
5113996|NCT01156142|recurrent adenoid cystic carcinoma of the oral cavity|recurrent adenoid cystic carcinoma of the oral cavity
5113997|NCT01156142|recurrent mucoepidermoid carcinoma of the oral cavity|recurrent mucoepidermoid carcinoma of the oral cavity
5113998|NCT01156142|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
5113999|NCT01156142|adenoid cystic carcinoma of the oral cavity|adenoid cystic carcinoma of the oral cavity
5114000|NCT01156142|mucoepidermoid carcinoma of the oral cavity|mucoepidermoid carcinoma of the oral cavity
5114001|NCT01156142|verrucous carcinoma of the oral cavity|verrucous carcinoma of the oral cavity
5114002|NCT01156142|squamous cell carcinoma of the lip and oral cavity|squamous cell carcinoma of the lip and oral cavity
5114267|NCT01155128|progression|progression
5114003|NCT01156142|recurrent basal cell carcinoma of the lip|recurrent basal cell carcinoma of the lip
5114004|NCT01156142|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
5114005|NCT01156142|basal cell carcinoma of the lip|basal cell carcinoma of the lip
5114117|NCT01155713|Tumors|tumors
5114006|NCT01156142|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
5114007|NCT01156142|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
5114008|NCT01156142|untreated metastatic squamous neck cancer with occult primary|untreated metastatic squamous neck cancer with occult primary
5114009|NCT01156142|recurrent lymphoepithelioma of the nasopharynx|recurrent lymphoepithelioma of the nasopharynx
5114010|NCT01156142|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
5114011|NCT01156142|lymphoepithelioma of the nasopharynx|lymphoepithelioma of the nasopharynx
5114012|NCT01156142|squamous cell carcinoma of the nasopharynx|squamous cell carcinoma of the nasopharynx
5114013|NCT01156142|recurrent lymphoepithelioma of the oropharynx|recurrent lymphoepithelioma of the oropharynx
5114014|NCT01156142|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
5114015|NCT01156142|lymphoepithelioma of the oropharynx|lymphoepithelioma of the oropharynx
5114016|NCT01156142|squamous cell carcinoma of the oropharynx|squamous cell carcinoma of the oropharynx
5114017|NCT01156142|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity
5114018|NCT01156142|recurrent inverted papilloma of the paranasal sinus and nasal cavity|recurrent inverted papilloma of the paranasal sinus and nasal cavity
5114019|NCT01156142|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity
5114020|NCT01156142|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
5114021|NCT01156142|esthesioneuroblastoma of the paranasal sinus and nasal cavity|esthesioneuroblastoma of the paranasal sinus and nasal cavity
5114022|NCT01156142|inverted papilloma of the paranasal sinus and nasal cavity|inverted papilloma of the paranasal sinus and nasal cavity
5114023|NCT01156142|midline lethal granuloma of the paranasal sinus and nasal cavity|midline lethal granuloma of the paranasal sinus and nasal cavity
5114024|NCT01156142|squamous cell carcinoma of the paranasal sinus and nasal cavity|squamous cell carcinoma of the paranasal sinus and nasal cavity
5114025|NCT01156142|high-grade salivary gland mucoepidermoid carcinoma|high-grade salivary gland mucoepidermoid carcinoma
5114026|NCT01156142|low-grade salivary gland mucoepidermoid carcinoma|low-grade salivary gland mucoepidermoid carcinoma
5114027|NCT01156142|recurrent salivary gland cancer|recurrent salivary gland cancer
5114028|NCT01156142|salivary gland acinic cell tumor|salivary gland acinic cell tumor
5114029|NCT01156142|salivary gland adenocarcinoma|salivary gland adenocarcinoma
5114030|NCT01156142|salivary gland adenoid cystic carcinoma|salivary gland adenoid cystic carcinoma
5114031|NCT01156142|salivary gland anaplastic carcinoma|salivary gland anaplastic carcinoma
5114032|NCT01156142|salivary gland malignant mixed cell type tumor|salivary gland malignant mixed cell type tumor
5114033|NCT01156142|salivary gland poorly differentiated carcinoma|salivary gland poorly differentiated carcinoma
5114034|NCT01156142|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
5114035|NCT01156142|salivary gland cancer|salivary gland cancer
5114036|NCT01156142|tongue cancer|tongue cancer
5114037|NCT01156129|liver transplant|liver transplant
5114038|NCT01156129|liver resection|liver resection
5114039|NCT01156116|CPAP|cpap
5114040|NCT01156116|diabetes|diabetes
5114041|NCT01156116|sleep apnea|sleep apnea
5114042|NCT01156103|obesity|obesity
5114043|NCT01156103|minority|minority
5114044|NCT01156103|child|child
5114045|NCT01156103|physical fitness|physical fitness
5114046|NCT01156103|school|school
5114047|NCT01156103|physical activity|physical activity
5114048|NCT01156090|vectibix|vectibix
5114049|NCT01156077|antibiotic|antibiotic
5114050|NCT01156077|Adolescents receiving antibiotics|adolescents receiving antibiotics
5114051|NCT01156064|Endoscopy|endoscopy
5114052|NCT01156064|Confocal laser endomicroscopy|confocal laser endomicroscopy
5114053|NCT01156064|Digestive Diseases|digestive diseases
5114054|NCT01156051|ADHD|adhd
5114055|NCT01156051|ADD|add
5114056|NCT01156051|sleep disturbance|sleep disturbance
5114057|NCT01156038|Atopy patch test|atopy patch test
5114058|NCT01156025|GV550|gv550
5114059|NCT01156025|Acute adenoviral keratoconjunctivitis|acute adenoviral keratoconjunctivitis
5114060|NCT01155986|analgesic|analgesic
5114061|NCT01155986|analgesics|analgesics
5114062|NCT01155986|pain|pain
5114063|NCT01155986|chronic pain|chronic pain
5114064|NCT01155986|localized pain|localized pain
5114065|NCT01155986|focal pain|focal pain
5114066|NCT01155986|neuropathic pain|neuropathic pain
5114067|NCT01155986|postoperative pain|postoperative pain
5114068|NCT01155986|topical analgesia|topical analgesia
5114069|NCT01155973|Hypertension.|hypertension.
5114070|NCT01155973|Cardiovascular risk.|cardiovascular risk.
5114071|NCT01155973|Monitoring.|monitoring.
5114072|NCT01155973|Primary health care.|primary health care.
5114073|NCT01155973|Randomised controlled trial.|randomised controlled trial.
5114074|NCT01155973|Cluster analysis|cluster analysis
5114075|NCT01155960|Bioavailability|bioavailability
5114076|NCT01155960|Anastrozole|anastrozole
5114077|NCT01155960|Crossover|crossover
5114078|NCT01155947|Bioavailability|bioavailability
5114079|NCT01155947|Anastrozole|anastrozole
5114080|NCT01155947|Crossover|crossover
5114081|NCT01155934|Bioavailability|bioavailability
5114082|NCT01155934|Crossover|crossover
5114083|NCT01155934|Risperidone|risperidone
5114084|NCT01155921|Bioavailability|bioavailability
5114085|NCT01155921|Crossover|crossover
5114086|NCT01155921|Risperidone|risperidone
5114087|NCT01155908|Bioavailability|bioavailability
5114088|NCT01155908|10 mg Amlodipine besylate/20 mg benazepril hydrochloride capsules|10 mg amlodipine besylate/20 mg benazepril hydrochloride capsules
5114089|NCT01155908|Crossover|crossover
5114090|NCT01155895|Bioavailability|bioavailability
5114091|NCT01155895|10 mg Amlopdipine besylate /20 mg Benazepril Hydrochloride|10 mg amlopdipine besylate /20 mg benazepril hydrochloride
5114092|NCT01155895|Crossover|crossover
5114093|NCT01155869|alcohol dependence|alcohol dependence
5114094|NCT01155869|homelessness|homelessness
5114095|NCT01155869|naltrexone|naltrexone
5114096|NCT01155856|telemedicine|telemedicine
5114097|NCT01155856|COPD|copd
5114098|NCT01155830|inflammatory cytokines|inflammatory cytokines
5114099|NCT01155830|extracorporeal membrane oxygenation|extracorporeal membrane oxygenation
5114100|NCT01155830|ECMO|ecmo
5114101|NCT01155804|preparation of the delivery|preparation of the delivery
5114102|NCT01155804|lumbago|lumbago
5114103|NCT01155804|anxiety|anxiety
5114104|NCT01155804|urinary incontinence|urinary incontinence
5114105|NCT01155778|Sanfilippo Syndrome Type A (MPS IIIA)|sanfilippo syndrome type a (mps iiia)
5114106|NCT01155778|Recombinant Human Heparan N-Sulfatase (rhHNS)|recombinant human heparan n-sulfatase (rhhns)
5114107|NCT01155778|Lysosomal Storage Disease (LSD)|lysosomal storage disease (lsd)
5114108|NCT01155778|Intrathecal Drug Delivery Device (IDDD)|intrathecal drug delivery device (iddd)
5114109|NCT01155765|Clopidogrel Resistance|clopidogrel resistance
5114110|NCT01155765|prasugrel|prasugrel
5114111|NCT01155765|Hemodialysis|hemodialysis
5114112|NCT01155752|sinusitis|sinusitis
5114113|NCT01155752|cystic fibrosis|cystic fibrosis
5114114|NCT01155752|therapy|therapy
5114115|NCT01155713|Neoplasms|neoplasms
5114116|NCT01155713|Cancer|cancer
5114118|NCT01155713|Administration, oral|administration, oral
5114119|NCT01155713|Capsules|capsules
5114120|NCT01155713|CHIR258, CHIR-258, CHIR 258, TKI258, TKI-258, TKI 258,|chir258, chir-258, chir 258, tki258, tki-258, tki 258,
5114121|NCT01155713|Bioavailability,|bioavailability,
5114122|NCT01155713|Food|food
5114123|NCT01155700|omalizumab|omalizumab
5114124|NCT01155700|allergic asthma|allergic asthma
5114125|NCT01155700|pediatric patients|pediatric patients
5114126|NCT01155687|afghanistan|afghanistan
5114127|NCT01155687|depression|depression
5114128|NCT01155687|anxiety|anxiety
5114129|NCT01155687|social stress|social stress
5114130|NCT01155687|counseling|counseling
5114131|NCT01155687|medication|medication
5114132|NCT01155687|psychotherapy|psychotherapy
5114133|NCT01155687|mental health|mental health
5114134|NCT01155674|Innate immunity|innate immunity
5114135|NCT01155674|Neutrophils|neutrophils
5114136|NCT01155674|Band forms|band forms
5114137|NCT01155648|Mechanical ventilation|mechanical ventilation
5114138|NCT01155648|Chest physiotherapy|chest physiotherapy
5114139|NCT01155648|Chest wall compression|chest wall compression
5114140|NCT01155635|Myocardial infarction|myocardial infarction
5114141|NCT01155635|Adrenergic beta-Antagonists|adrenergic beta-antagonists
5114142|NCT01155635|Percutaneous coronary intervention|percutaneous coronary intervention
5114143|NCT01155622|Hypothermia, induced|hypothermia, induced
5114144|NCT01155622|Cardiac arrest|cardiac arrest
5114145|NCT01155622|Disability evaluation|disability evaluation
5114146|NCT01155622|Cardiac arrhythmia|cardiac arrhythmia
5114147|NCT01155622|Ventricular function|ventricular function
5114148|NCT01155622|Internal cooling|internal cooling
5114149|NCT01155622|Out-of-hospital cardiac arrest|out-of-hospital cardiac arrest
5114150|NCT01155622|Post-cardiac arrest syndrome|post-cardiac arrest syndrome
5114151|NCT01155596|Acute respiratory failure patients in medical ICUs.|acute respiratory failure patients in medical icus.
5114152|NCT01155570|Psoriasis|psoriasis
5114153|NCT01155557|Tension-Type Headache|tension-type headache
5114154|NCT01155557|Strength Capacity|strength capacity
5114155|NCT01155557|Neck and Shoulder|neck and shoulder
5114156|NCT01155544|Aripiprazole|aripiprazole
5114157|NCT01155544|Psychotic experiences|psychotic experiences
5114158|NCT01155544|Substance abuse|substance abuse
5114159|NCT01155544|Substance dependence|substance dependence
5114160|NCT01155544|Craving|craving
5114161|NCT01155544|Mood|mood
5114162|NCT01155544|Substance use|substance use
5114163|NCT01155531|Obesity|obesity
5114164|NCT01155531|Overweight|overweight
5114165|NCT01155531|Sertraline|sertraline
5114166|NCT01155531|Telenzepine|telenzepine
5114167|NCT01155531|Decrease appetite|decrease appetite
5114168|NCT01155531|Reduce appetite|reduce appetite
5114169|NCT01155531|Lose weight|lose weight
5114170|NCT01155518|hypogonadism|hypogonadism
5114171|NCT01155518|diabetes|diabetes
5114172|NCT01155518|spermatogenesis|spermatogenesis
5114173|NCT01155518|insulin resistance|insulin resistance
5114174|NCT01155492|lipopolysaccharides|lipopolysaccharides
5114175|NCT01155492|etiology|etiology
5114176|NCT01155492|inflammation|inflammation
5114177|NCT01155492|colonic bacteria|colonic bacteria
5114178|NCT01155492|intestinal permeability|intestinal permeability
5114179|NCT01155466|Idiopathic Parkinson Disease|idiopathic parkinson disease
5114180|NCT01155466|Idiopathic Parkinson's Disease|idiopathic parkinson's disease
5114181|NCT01155453|BKM120|bkm120
5114182|NCT01155453|RAS RAF mutations,|ras raf mutations,
5114183|NCT01155453|triple negative breast cancer,|triple negative breast cancer,
5114184|NCT01155453|pancreatic cancer,|pancreatic cancer,
5114185|NCT01155453|PI3K inhibitor,|pi3k inhibitor,
5114186|NCT01155453|MEK inhibitor|mek inhibitor
5114187|NCT01155440|60 patients scheduled to have a colorectal surgery|60 patients scheduled to have a colorectal surgery
5114188|NCT01155440|recruit at Montreal General Hospital|recruit at montreal general hospital
5114189|NCT01155401|acute upper gastrointestinal bleeding|acute upper gastrointestinal bleeding
5114190|NCT01155401|patients with drug-induced upper gastrointestinal bleeding|patients with drug-induced upper gastrointestinal bleeding
5114191|NCT01155401|routine management|routine management
5114192|NCT01155388|Iron deficiency anemia|iron deficiency anemia
5114193|NCT01155388|Feraheme|feraheme
5114194|NCT01155388|ferumoxytol|ferumoxytol
5114195|NCT01155388|CKD|ckd
5114196|NCT01155388|pediatric|pediatric
5114197|NCT01155388|nondialysis-dependent|nondialysis-dependent
5114198|NCT01155375|Iron deficiency anemia|iron deficiency anemia
5114199|NCT01155375|Feraheme|feraheme
5114200|NCT01155375|ferumoxytol|ferumoxytol
5114201|NCT01155375|CKD|ckd
5114202|NCT01155375|pediatric|pediatric
5114203|NCT01155375|dialysis-dependent|dialysis-dependent
5114204|NCT01155375|nondialysis-dependent|nondialysis-dependent
5114205|NCT01155362|Human Placenta-Derived Cells for the Treatment of Moderate-to-Severe Crohn's Disease|human placenta-derived cells for the treatment of moderate-to-severe crohn's disease
5114206|NCT01155349|brain fitness|brain fitness
5114207|NCT01155349|cognitive training|cognitive training
5114208|NCT01155349|cognitive intervention|cognitive intervention
5114209|NCT01155349|speed of processing training|speed of processing training
5114210|NCT01155349|Parkinson's disease|parkinson's disease
5114211|NCT01155336|Acute Coronary Syndrome|acute coronary syndrome
5114212|NCT01155336|Fish Oils|fish oils
5114213|NCT01155336|Platelet Function Tests|platelet function tests
5114214|NCT01155336|Cardiac Electrophysiology|cardiac electrophysiology
5114215|NCT01155310|Exacerbation of COPD|exacerbation of copd
5114216|NCT01155310|Helium/Oxygen|helium/oxygen
5114217|NCT01155310|ICU|icu
5114218|NCT01155310|Non-Invasive Ventilation|non-invasive ventilation
5114219|NCT01155310|Patient with known or suspected COPD|patient with known or suspected copd
5114220|NCT01155310|patient Admitted in an ICU|patient admitted in an icu
5114221|NCT01155310|Patient presenting current exacerbation of COPD|patient presenting current exacerbation of copd
5114222|NCT01155297|Quality of Life|quality of life
5114223|NCT01155297|Biological Markers|biological markers
5114224|NCT01155297|Renal Insufficiency|renal insufficiency
5114225|NCT01155297|Resistance Training|resistance training
5114226|NCT01155297|Exercise|exercise
5114227|NCT01155297|Chronic Kidney Failure|chronic kidney failure
5114228|NCT01155284|diabetes|diabetes
5114229|NCT01155284|HGB A1C|hgb a1c
5114230|NCT01155284|Beta Cell Regeneration|beta cell regeneration
5114231|NCT01155245|osteoporosis|osteoporosis
5114232|NCT01155245|HR-pQCT|hr-pqct
5114233|NCT01155245|PTH|pth
5114234|NCT01155232|osteoporosis|osteoporosis
5114235|NCT01155232|Forteo|forteo
5114236|NCT01155232|Parathyroid hormone|parathyroid hormone
5114237|NCT01155232|HR-pQCT|hr-pqct
5114238|NCT01155219|Bilateral Glaucoma|bilateral glaucoma
5114239|NCT01155219|Bilateral ocular hypertension|bilateral ocular hypertension
5114363|NCT01154829|first episode|first episode
5114240|NCT01155219|Bilateral primary open angle glaucoma|bilateral primary open angle glaucoma
5114241|NCT01155219|Bilateral ocular hypertension already treated and controlled by mono-therapy of Xalatan® (1drop per day)|bilateral ocular hypertension already treated and controlled by mono-therapy of xalatan® (1drop per day)
5114242|NCT01155219|With local intolerance signs in at least one eye|with local intolerance signs in at least one eye
5114243|NCT01155206|glucagon,|glucagon,
5114244|NCT01155206|high physiological dose and basal dose of glucagon|high physiological dose and basal dose of glucagon
5114245|NCT01155206|hepatic lipoprotein production,|hepatic lipoprotein production,
5114246|NCT01155206|free fatty acid|free fatty acid
5114247|NCT01155206|intestinal lipoprotein production|intestinal lipoprotein production
5114248|NCT01155206|particle|particle
5114249|NCT01155206|glucagon affects production of fat in intestine and liver.|glucagon affects production of fat in intestine and liver.
5114250|NCT01155193|Children|children
5114251|NCT01155193|Pre-term infants|pre-term infants
5114252|NCT01155193|Congenital heart disease|congenital heart disease
5114253|NCT01155193|Infection|infection
5114254|NCT01155193|Respiratory syncytial virus|respiratory syncytial virus
5114255|NCT01155167|radial artery spasm|radial artery spasm
5114256|NCT01155154|wounds and lacerations|wounds and lacerations
5114257|NCT01155154|hand|hand
5114258|NCT01155154|infection|infection
5114259|NCT01155154|Antibiotics|antibiotics
5114260|NCT01155154|antibacterial agents|antibacterial agents
5114261|NCT01155128|physical activity|physical activity
5114262|NCT01155128|exercise|exercise
5114263|NCT01155128|sedentarism|sedentarism
5114264|NCT01155128|chronic renal disease|chronic renal disease
5114265|NCT01155128|failure renal chronic|failure renal chronic
5114268|NCT01155128|Renal Protective Effects of Exercise|renal protective effects of exercise
5114269|NCT01155128|quality of life changes with exercise in CKD|quality of life changes with exercise in ckd
5114270|NCT01155128|Endothelial progenitor cells in CKD|endothelial progenitor cells in ckd
5114271|NCT01155128|Chronic Kidney Disease and Ankle Brachial Index|chronic kidney disease and ankle brachial index
5114272|NCT01155115|pediatrics|pediatrics
5114273|NCT01155115|CF|cf
5114274|NCT01155115|PCD|pcd
5114275|NCT01155115|exacerbation|exacerbation
5114276|NCT01155115|inflammatory markers|inflammatory markers
5114277|NCT01155115|induced sputum|induced sputum
5114278|NCT01155063|Exemestane|exemestane
5114279|NCT01155063|Adjuvant Treatment In Postmenopausal Women|adjuvant treatment in postmenopausal women
5114280|NCT01155063|Estrogen Receptor Positive Early Breast Cancer|estrogen receptor positive early breast cancer
5114281|NCT01155063|Tamoxifen|tamoxifen
5114282|NCT01155050|overweight|overweight
5114283|NCT01155050|obese|obese
5114284|NCT01155050|type II diabetes|type ii diabetes
5114285|NCT01155050|hypertension|hypertension
5114286|NCT01155037|HIV, influenza A H1N1, vaccine|hiv, influenza a h1n1, vaccine
5114287|NCT01155024|Lower extremity amputation|lower extremity amputation
5114288|NCT01155024|Prosthetic Sockets|prosthetic sockets
5114289|NCT01155024|Direct Manufactured (DM)|direct manufactured (dm)
5114290|NCT01155011|Older adults|older adults
5114291|NCT01155011|physical activity|physical activity
5114292|NCT01155011|sedentary|sedentary
5114293|NCT01155011|retirement communities|retirement communities
5114294|NCT01155011|advocacy|advocacy
5114295|NCT01155011|built environment|built environment
5114296|NCT01155011|peer mentoring|peer mentoring
5114297|NCT01155011|walkability|walkability
5114298|NCT01154998|non-specific interstitial pneumonia|non-specific interstitial pneumonia
5114299|NCT01154985|omega-3 fatty acids|omega-3 fatty acids
5114300|NCT01154985|alanine transaminase|alanine transaminase
5114301|NCT01154985|triglycerides|triglycerides
5114302|NCT01154985|lipids|lipids
5114303|NCT01154985|EPA|epa
5114304|NCT01154985|ethyl-EPA|ethyl-epa
5114305|NCT01154985|ethyl icosapentate|ethyl icosapentate
5114306|NCT01154985|Non Alcoholic steatohepatitis|non alcoholic steatohepatitis
5114307|NCT01154985|Non Alcoholic fatty liver disease|non alcoholic fatty liver disease
5114308|NCT01154985|fatty acids|fatty acids
5114309|NCT01154972|breast|breast
5114310|NCT01154972|cancer|cancer
5114311|NCT01154972|sentinel lymph node|sentinel lymph node
5114312|NCT01154959|Pulmonary TB|pulmonary tb
5114313|NCT01154959|Immune response|immune response
5114314|NCT01154959|ATT|att
5114315|NCT01154959|Immune responses in pulmonary tuberculosis|immune responses in pulmonary tuberculosis
5114316|NCT01154959|Predictors for relapse|predictors for relapse
5114317|NCT01154946|detrusor after-contraction|detrusor after-contraction
5114318|NCT01154946|urodynamic|urodynamic
5114319|NCT01154946|LUTS|luts
5114320|NCT01154946|urinary bladder, overactive|urinary bladder, overactive
5114321|NCT01154946|bladder dysfunction|bladder dysfunction
5114322|NCT01154933|type 2 diabetes|type 2 diabetes
5114323|NCT01154933|obesity|obesity
5114324|NCT01154920|Head and Neck Cancer|head and neck cancer
5114325|NCT01154920|HNSCC|hnscc
5114326|NCT01154920|Paclitaxel|paclitaxel
5114327|NCT01154920|Carboplatin|carboplatin
5114328|NCT01154920|Cetuximab|cetuximab
5114329|NCT01154920|Docetaxel|docetaxel
5114330|NCT01154920|Taxotere|taxotere
5114331|NCT01154920|Cisplatin|cisplatin
5114332|NCT01154920|Platinol-AQ|platinol-aq
5114333|NCT01154920|Platinol|platinol
5114334|NCT01154920|CDDP|cddp
5114335|NCT01154920|Fluorouracil|fluorouracil
5114336|NCT01154920|5-FU|5-fu
5114337|NCT01154920|Adrucil|adrucil
5114338|NCT01154920|Efudex|efudex
5114339|NCT01154920|chemotherapy|chemotherapy
5114340|NCT01154920|radiation|radiation
5114341|NCT01154920|Chemoradiotherapy|chemoradiotherapy
5114342|NCT01154907|Uro-genital schistosomiasis|uro-genital schistosomiasis
5114343|NCT01154907|Female|female
5114344|NCT01154907|South Africa|south africa
5114345|NCT01154907|Rural|rural
5114346|NCT01154907|Sexually transmitted diseases|sexually transmitted diseases
5114347|NCT01154894|arachidonic acid|arachidonic acid
5114348|NCT01154894|autism spectrum disorders|autism spectrum disorders
5114349|NCT01154894|social interaction|social interaction
5114350|NCT01154894|randomized controlled trial|randomized controlled trial
5114351|NCT01154894|DHA|dha
5114352|NCT01154855|Periodontal disease|periodontal disease
5114353|NCT01154855|Gum disease|gum disease
5114354|NCT01154855|Dental|dental
5114355|NCT01154855|Inflammation|inflammation
5114356|NCT01154855|Microorganisms|microorganisms
5114357|NCT01154855|Bacteria|bacteria
5114358|NCT01154842|FGF-23|fgf-23
5114359|NCT01154842|Dialysis|dialysis
5114360|NCT01154842|plasma FGF-23 levels|plasma fgf-23 levels
5114361|NCT01154842|echocardiography|echocardiography
5114362|NCT01154829|dopamine|dopamine
5114364|NCT01154829|reward|reward
5114365|NCT01154829|cognition|cognition
5114366|NCT01154829|MRI|mri
5114367|NCT01154829|fMRI|fmri
5114368|NCT01154829|PPI|ppi
5114369|NCT01154829|P300|p300
5114370|NCT01154829|P50 gating|p50 gating
5114371|NCT01154829|endophenotypes|endophenotypes
5114372|NCT01154803|Supplementation|supplementation
5114373|NCT01154803|RUTF|rutf
5114374|NCT01154803|Micronutrients|micronutrients
5114375|NCT01154803|Plumpynut|plumpynut
5114376|NCT01154803|Mixme|mixme
5114377|NCT01154803|sprinkles|sprinkles
5114378|NCT01154803|convalescence|convalescence
5114379|NCT01154803|weight|weight
5114380|NCT01154803|morbidity|morbidity
5114381|NCT01154790|healthy volunteers|healthy volunteers
5114382|NCT01154777|Neurofeedback|neurofeedback
5114383|NCT01154777|Braintraining|braintraining
5114384|NCT01154777|Autism|autism
5114385|NCT01154777|Mild|mild
5114386|NCT01154777|Moderate|moderate
5114387|NCT01154777|Mild to Moderate Autism|mild to moderate autism
5114388|NCT01154764|healthy male volunteers|healthy male volunteers
5114389|NCT01154751|Femoral artery stenosis|femoral artery stenosis
5114390|NCT01154751|Peripheral vascular Disease|peripheral vascular disease
5114391|NCT01154725|Patient education|patient education
5114392|NCT01154725|Health-Related Quality of Life|health-related quality of life
5114393|NCT01154725|patients with stomas|patients with stomas
5114394|NCT01154725|stomatherapy|stomatherapy
5114395|NCT01154725|health economics|health economics
5114396|NCT01154712|Gambling|gambling
5114397|NCT01154712|Deep TMS|deep tms
5114398|NCT01154712|addiction|addiction
5114399|NCT01154712|Brain stimulation|brain stimulation
5114400|NCT01154699|Asthma|asthma
5114401|NCT01154699|Nocturnal Asthma|nocturnal asthma
5114402|NCT01154699|Lung volumes|lung volumes
5114403|NCT01154699|Deep inspiration|deep inspiration
5114404|NCT01154699|Obstructive sleep apnea|obstructive sleep apnea
5114405|NCT01154660|any operation that required for general anesthesia|any operation that required for general anesthesia
5114406|NCT01154634|Pharmacodynamic effect|pharmacodynamic effect
5114407|NCT01154634|Reflux inhibition|reflux inhibition
5114408|NCT01154621|Phase I|phase i
5114409|NCT01154621|Double-blind|double-blind
5114410|NCT01154621|Randomized|randomized
5114411|NCT01154621|Placebo-controlled study|placebo-controlled study
5114412|NCT01154621|Safety and tolerability of single intravenous dose of AZD9742 in healthy elderly volunteers|safety and tolerability of single intravenous dose of azd9742 in healthy elderly volunteers
5114413|NCT01154608|Protein absorption in pancreatitis|protein absorption in pancreatitis
5114414|NCT01154608|Protein metabolism in pancreatitis|protein metabolism in pancreatitis
5114415|NCT01154595|moderate acute malnutrition, prevention, Lipid-based supplement|moderate acute malnutrition, prevention, lipid-based supplement
5114416|NCT01154582|ingestive behavior|ingestive behavior
5114417|NCT01154569|drug absorption|drug absorption
5114418|NCT01154569|azithromycin|azithromycin
5114419|NCT01154569|obesity|obesity
5114420|NCT01154569|bariatric surgery|bariatric surgery
5114421|NCT01154556|Antiretroviral therapy experienced|antiretroviral therapy experienced
5114422|NCT01154556|failed NNRTI regime|failed nnrti regime
5114423|NCT01154543|Recurrent genital Herpes Simplex Virus|recurrent genital herpes simplex virus
5114424|NCT01154530|Gastroscopy|gastroscopy
5114425|NCT01154530|Bacteria|bacteria
5114426|NCT01154530|Chlorhexidine|chlorhexidine
5114427|NCT01154530|General surgery|general surgery
5114428|NCT01154504|adrenomedullin|adrenomedullin
5114429|NCT01154504|heart failure|heart failure
5114430|NCT01154504|ultrafiltration|ultrafiltration
5114431|NCT01154504|hemofiltration|hemofiltration
5114432|NCT01154491|hip fractures|hip fractures
5114433|NCT01154491|blood substitutes|blood substitutes
5114434|NCT01154491|blood transfusion|blood transfusion
5114435|NCT01154491|intravenous infusion|intravenous infusion
5114436|NCT01154491|erythropoietin, recombinant|erythropoietin, recombinant
5114437|NCT01154491|frail elderly|frail elderly
5114438|NCT01154478|polyphenols omega-3 postprandial lipemia adipose tissue|polyphenols omega-3 postprandial lipemia adipose tissue
5114439|NCT01154465|Central venous catheterization|central venous catheterization
5114440|NCT01154465|Obese|obese
5114441|NCT01154465|Ultrasound guidance|ultrasound guidance
5114442|NCT01154465|Jugular|jugular
5114443|NCT01154465|Randomized|randomized
5114444|NCT01154465|Intensive Care Unit|intensive care unit
5114445|NCT01154439|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5114446|NCT01154439|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
5114447|NCT01154439|adult acute basophilic leukemia|adult acute basophilic leukemia
5114448|NCT01154439|adult acute eosinophilic leukemia|adult acute eosinophilic leukemia
5114449|NCT01154439|adult erythroleukemia (M6a)|adult erythroleukemia (m6a)
5114450|NCT01154439|adult pure erythroid leukemia (M6b)|adult pure erythroid leukemia (m6b)
5114451|NCT01154439|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
5114452|NCT01154439|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
5114453|NCT01154439|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
5114454|NCT01154439|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
5114455|NCT01154439|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
5114456|NCT01154439|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
5114457|NCT01154439|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
5114458|NCT01154439|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5114560|NCT01154010|iritis|iritis
5114459|NCT01154439|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5114460|NCT01154439|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5114461|NCT01154439|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5114462|NCT01154400|casein protein|casein protein
5114463|NCT01154400|whey protein|whey protein
5114464|NCT01154400|hydrolysates|hydrolysates
5114465|NCT01154400|leucine|leucine
5114466|NCT01154400|protein metabolism|protein metabolism
5114467|NCT01154400|COPD|copd
5114468|NCT01154387|Kidney|kidney
5114469|NCT01154387|Renal|renal
5114470|NCT01154387|Transplant|transplant
5114471|NCT01154387|Kidney Transplant|kidney transplant
5114472|NCT01154387|Kidney Failure|kidney failure
5114473|NCT01154387|Induction|induction
5114474|NCT01154387|Monoclonal|monoclonal
5114475|NCT01154387|Antibody|antibody
5114476|NCT01154387|T cell|t cell
5114477|NCT01154387|Anti-rejection|anti-rejection
5114478|NCT01154387|Immunosuppression|immunosuppression
5114479|NCT01154374|Diabetic Foot Ulcers (DFUs)|diabetic foot ulcers (dfus)
5114480|NCT01154361|ACE inhibitor induced angioedema|ace inhibitor induced angioedema
5114481|NCT01154361|Bradykinin|bradykinin
5114482|NCT01154361|Non-itching edema|non-itching edema
5114483|NCT01154361|Non-allergic angioedema|non-allergic angioedema
5114484|NCT01154361|Quincke edema|quincke edema
5114485|NCT01154361|Drug induced angioedema|drug induced angioedema
5114486|NCT01154361|Bradykinin B2 receptor antagonist|bradykinin b2 receptor antagonist
5114487|NCT01154361|Icatibant|icatibant
5114488|NCT01154361|HOE 140|hoe 140
5114489|NCT01154348|Metformin|metformin
5114490|NCT01154335|refractory metastatic colorectal cancer|refractory metastatic colorectal cancer
5114491|NCT01154309|Depression|depression
5114492|NCT01154309|Substance Use|substance use
5114493|NCT01154309|Group Cognitive Behavioral Therapy|group cognitive behavioral therapy
5114494|NCT01154296|HIV|hiv
5114495|NCT01154296|Rapid Testing|rapid testing
5114496|NCT01154296|Counseling|counseling
5114497|NCT01154296|STD|std
5114498|NCT01154296|U.S.|u.s.
5114499|NCT01154270|cancer of the salivary glands|cancer of the salivary glands
5114500|NCT01154270|radiation|radiation
5114501|NCT01154270|carbon ion therapy|carbon ion therapy
5114502|NCT01154257|Dental plaque|dental plaque
5114503|NCT01154257|Gingivitis|gingivitis
5114504|NCT01154244|Insulin resistance|insulin resistance
5114505|NCT01154244|Insulin deficiency|insulin deficiency
5114506|NCT01154244|HOMA-IR|homa-ir
5114507|NCT01154244|Drug naive|drug naive
5114508|NCT01154244|Diabetes mellitus, type II|diabetes mellitus, type ii
5114509|NCT01154231|BeneFIX Regulatory Post Marketing Commitment Plan|benefix regulatory post marketing commitment plan
5114510|NCT01154218|bioequivalence|bioequivalence
5114511|NCT01154218|food effect|food effect
5114512|NCT01154218|pharmacokinetics|pharmacokinetics
5114513|NCT01154218|crizotinib|crizotinib
5114514|NCT01154192|PCOS|pcos
5114515|NCT01154192|oligomenorrhea|oligomenorrhea
5114516|NCT01154192|irregular menses|irregular menses
5114517|NCT01154192|hyperandrogenemia|hyperandrogenemia
5114518|NCT01154192|elevated testosterone|elevated testosterone
5114519|NCT01154192|adolescents|adolescents
5114520|NCT01154192|androgens|androgens
5114521|NCT01154192|ovary|ovary
5114522|NCT01154192|LH|lh
5114523|NCT01154179|permissive underfeeding|permissive underfeeding
5114524|NCT01154179|hypocaloric feeding|hypocaloric feeding
5114525|NCT01154179|artificial nutrition|artificial nutrition
5114526|NCT01154140|open label|open label
5114527|NCT01154140|randomized Phase 3|randomized phase 3
5114528|NCT01154140|first line treatment|first line treatment
5114529|NCT01154140|non squamous lung cancer|non squamous lung cancer
5114530|NCT01154140|ALK translocation event positive|alk translocation event positive
5114531|NCT01154127|NVA237|nva237
5114532|NCT01154127|COPD|copd
5114533|NCT01154127|bronchodilator|bronchodilator
5114534|NCT01154127|exercise endurance|exercise endurance
5114535|NCT01154114|healthy volunteer|healthy volunteer
5114536|NCT01154114|hepatic impairment|hepatic impairment
5114537|NCT01154114|darapladib|darapladib
5114538|NCT01154114|atherosclerosis|atherosclerosis
5114539|NCT01154088|Adolescent|adolescent
5114540|NCT01154088|Vaccine, conjugate|vaccine, conjugate
5114541|NCT01154088|Adult|adult
5114542|NCT01154088|Neisseria meningitidis|neisseria meningitidis
5114543|NCT01154088|Immunogenicity|immunogenicity
5114544|NCT01154088|Meningococcal vaccine|meningococcal vaccine
5114545|NCT01154088|Safety|safety
5114546|NCT01154075|Liver transplant|liver transplant
5114547|NCT01154075|Adherence|adherence
5114548|NCT01154075|Compliance|compliance
5114549|NCT01154075|Tacrolimus|tacrolimus
5114550|NCT01154062|age-related macular degeneration|age-related macular degeneration
5114551|NCT01154062|pazopanib|pazopanib
5114552|NCT01154062|choroidal neovascularization|choroidal neovascularization
5114553|NCT01154062|GW786034|gw786034
5114554|NCT01154049|Schistosomiasis|schistosomiasis
5114555|NCT01154049|Vaccine|vaccine
5114556|NCT01154049|sm14|sm14
5114557|NCT01154023|Sleep Initiation and Maintenance Disorders|sleep initiation and maintenance disorders
5114558|NCT01154023|Behavior Therapy|behavior therapy
5114559|NCT01154010|PEMF|pemf
5114561|NCT01154010|anterior uveitis|anterior uveitis
5114562|NCT01153958|Vaginosis, Bacterial|vaginosis, bacterial
5114563|NCT01153958|Colposeptine|colposeptine
5114564|NCT01153958|Metronidazole|metronidazole
5114565|NCT01153945|Hypothyroid and non hypothyroid|hypothyroid and non hypothyroid
5114566|NCT01153932|968|968
5114567|NCT01153932|muscular dystrophy|muscular dystrophy
5114568|NCT01153932|duchenne|duchenne
5114569|NCT01153932|DMD|dmd
5114570|NCT01153906|autoimmune diseases|autoimmune diseases
5114571|NCT01153906|HPV vaccine|hpv vaccine
5114572|NCT01153906|papillomavirus|papillomavirus
5114573|NCT01153906|human papillomavirus|human papillomavirus
5114574|NCT01153906|HPV|hpv
5114575|NCT01153893|Pneumococcal disease|pneumococcal disease
5114576|NCT01153893|Pneumococcal vaccine|pneumococcal vaccine
5114577|NCT01153893|Catch-up vaccination|catch-up vaccination
5114578|NCT01153893|Immunogenicity|immunogenicity
5114579|NCT01153893|Booster vaccination|booster vaccination
5114580|NCT01153893|Safety|safety
5114581|NCT01153880|Altabax|altabax
5114582|NCT01153880|United States|united states
5114583|NCT01153880|topical|topical
5114584|NCT01153880|Mupirocin|mupirocin
5114585|NCT01153880|Retapamulin|retapamulin
5114586|NCT01153880|Bactroban|bactroban
5114587|NCT01153867|Schema Focused Therapy|schema focused therapy
5114588|NCT01153867|Chronic Depression|chronic depression
5114589|NCT01153867|Mechanisms of Change|mechanisms of change
5114590|NCT01153854|acute diarrhea|acute diarrhea
5114591|NCT01153854|Acute diarrhea (three or more watery or semi-watery bowel movements for at least one day lasting no more than 5 days before being admitted)|acute diarrhea (three or more watery or semi-watery bowel movements for at least one day lasting no more than 5 days before being admitted)
5114592|NCT01153841|Pneumococcal vaccine|pneumococcal vaccine
5114593|NCT01153828|Altargo|altargo
5114594|NCT01153828|Bactroban|bactroban
5114595|NCT01153828|Fucidin|fucidin
5114596|NCT01153828|Fusidic acid|fusidic acid
5114597|NCT01153828|Mupirocin|mupirocin
5114598|NCT01153828|topical|topical
5114599|NCT01153828|Retapamulin|retapamulin
5114600|NCT01153828|United Kingdom|united kingdom
5114601|NCT01153815|efficacy|efficacy
5114602|NCT01153815|Spasticity, Post-Stroke|spasticity, post-stroke
5114603|NCT01153815|safety|safety
5114604|NCT01153815|Botulinum toxin type A|botulinum toxin type a
5114605|NCT01153815|placebo|placebo
5114606|NCT01153815|spasticity|spasticity
5114607|NCT01153802|Positron Emission Tomography|positron emission tomography
5114608|NCT01153802|serotonin|serotonin
5114609|NCT01153802|inhibitor of the neurotransmitters|inhibitor of the neurotransmitters
5114610|NCT01153802|safety of single oral doses|safety of single oral doses
5114611|NCT01153802|norepinephrine|norepinephrine
5114612|NCT01153802|dopamine|dopamine
5114613|NCT01153789|Vergence-accommodation evaluation|vergence-accommodation evaluation
5114614|NCT01153789|Vergence and postural control|vergence and postural control
5114615|NCT01153789|Dynamic visual acuity|dynamic visual acuity
5114616|NCT01153776|Arterial switch operation|arterial switch operation
5114617|NCT01153776|Transposition of the great arteries|transposition of the great arteries
5114618|NCT01153776|Congenital heart diseases|congenital heart diseases
5114619|NCT01153776|CT coronary angiography|ct coronary angiography
5114620|NCT01153763|Metastatic melanoma|metastatic melanoma
5114621|NCT01153763|BRAF mutant|braf mutant
5114622|NCT01153763|Melanoma|melanoma
5114623|NCT01153763|BRAF mutant metastatic melanoma|braf mutant metastatic melanoma
5114624|NCT01153750|cholangiocellular carcinoma|cholangiocellular carcinoma
5114625|NCT01153750|bile duct cancer|bile duct cancer
5114626|NCT01153737|Neck pain|neck pain
5114627|NCT01153737|Primary Health Care|primary health care
5114628|NCT01153737|Manual Therapy|manual therapy
5114630|NCT01153685|Fluviral®Influenza|fluviral®influenza
5114631|NCT01153659|rabeprazole|rabeprazole
5114632|NCT01153659|esomeprazole|esomeprazole
5114633|NCT01153659|h. pylori-negative|h. pylori-negative
5114634|NCT01153659|nocturnal acid breakthrough|nocturnal acid breakthrough
5114635|NCT01153659|intragastric pH, PK/PD|intragastric ph, pk/pd
5114636|NCT01153659|effect on gastric pH in healthy, H. pylori-Negative subjects|effect on gastric ph in healthy, h. pylori-negative subjects
5114637|NCT01153646|HIV|hiv
5114638|NCT01153646|Gene Transfer|gene transfer
5114639|NCT01153646|T-Cell Immunotherapy|t-cell immunotherapy
5114640|NCT01153646|HIV-1 infected patients who have failed anti-retroviral therapy|hiv-1 infected patients who have failed anti-retroviral therapy
5114641|NCT01153620|Acute traumatic wounds|acute traumatic wounds
5114642|NCT01153607|Alzheimer's disease|alzheimer's disease
5114643|NCT01153607|Diagnostic imaging|diagnostic imaging
5114644|NCT01153607|PET diagnosis|pet diagnosis
5114645|NCT01153607|PET tracer|pet tracer
5114646|NCT01153594|Substance Use Disorders|substance use disorders
5114647|NCT01153594|Relapse|relapse
5114648|NCT01153594|Recovery|recovery
5114649|NCT01153594|Disease Management|disease management
5114650|NCT01153594|Long term outcomes|long term outcomes
5114651|NCT01153594|Addiction Treatment|addiction treatment
5114652|NCT01153568|Vitamin D|vitamin d
5114653|NCT01153568|osteoporosis|osteoporosis
5114654|NCT01153568|african american women|african american women
5114655|NCT01153529|PTSD|ptsd
5114656|NCT01153516|Type 2 diabetes|type 2 diabetes
5114657|NCT01153516|Bariatric surgery|bariatric surgery
5114658|NCT01153516|Obesity|obesity
5114659|NCT01153516|Weight loss|weight loss
5114660|NCT01153503|Postoperative pain, TAP block, Hysterectomy|postoperative pain, tap block, hysterectomy
5114661|NCT01153490|Quetiapine|quetiapine
5114662|NCT01153490|Psychotic experiences|psychotic experiences
5114663|NCT01153490|Cannabis dependence|cannabis dependence
5114664|NCT01153490|Craving|craving
5114665|NCT01153490|Mood|mood
5114666|NCT01153490|Substance use|substance use
5114667|NCT01153451|Pending tests|pending tests
5114668|NCT01153451|Discharge|discharge
5114669|NCT01153451|Awareness|awareness
5114670|NCT01153451|Care transitions|care transitions
5114671|NCT01153438|Diabetes|diabetes
5114672|NCT01153438|Obesity|obesity
5114673|NCT01153438|Bariatric surgery|bariatric surgery
5114674|NCT01153438|Gut hormones|gut hormones
5114675|NCT01153438|Glucagon like peptide 1|glucagon like peptide 1
5114676|NCT01153438|Insulin|insulin
5114677|NCT01153425|Osteoporosis|osteoporosis
5114678|NCT01153425|Osteopenia|osteopenia
5114679|NCT01153425|Fracture Risk|fracture risk
5114680|NCT01153425|teriparatide or Forteo|teriparatide or forteo
5114681|NCT01153425|zoledronic acid or Reclast|zoledronic acid or reclast
5114682|NCT01153399|Non Small Cell Lung Cancer|non small cell lung cancer
5114683|NCT01153399|EGFR mutations|egfr mutations
5114684|NCT01153386|Pulmonary arterial hypertension|pulmonary arterial hypertension
5114685|NCT01153386|Treprostinil|treprostinil
5114686|NCT01153386|Pharmacokinetics|pharmacokinetics
5114687|NCT01153373|Detection of tobacco, alcohol, and drug use.|detection of tobacco, alcohol, and drug use.
5114688|NCT01153347|Major Depressive Disorder|major depressive disorder
5114689|NCT01153347|MDD|mdd
5114690|NCT01153347|Depression|depression
5114691|NCT01153347|Safety|safety
5114692|NCT01153347|add-on therapy|add-on therapy
5114693|NCT01153321|Respiratory disease|respiratory disease
5114694|NCT01153321|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
5114695|NCT01153308|Morbid Obesity|morbid obesity
5114696|NCT01153308|Obesity|obesity
5114697|NCT01153308|Weight Loss|weight loss
5114698|NCT01153308|Bariatric Surgery|bariatric surgery
5114699|NCT01153295|IBS|ibs
5114700|NCT01153295|Irritable bowel syndrome|irritable bowel syndrome
5114701|NCT01153295|diagnosis|diagnosis
5114702|NCT01153295|safety|safety
5114703|NCT01153295|Health related quality of life|health related quality of life
5114704|NCT01153282|Breast Cancer patients|breast cancer patients
5114705|NCT01153269|Human Immunodeficiency Virus|human immunodeficiency virus
5114706|NCT01153269|Co-infection with Hepatitis B or Hepatitis C|co-infection with hepatitis b or hepatitis c
5114707|NCT01153269|Tolerability|tolerability
5114708|NCT01153269|Effectiveness|effectiveness
5114709|NCT01153243|inflammatory markers|inflammatory markers
5114710|NCT01153230|PQ|pq
5114711|NCT01153217|Tenofovir|tenofovir
5114712|NCT01153217|HIV-infection|hiv-infection
5114713|NCT01153217|BMD|bmd
5114714|NCT01153217|Osteoporosis|osteoporosis
5114715|NCT01153217|Osteopenia|osteopenia
5114716|NCT01153204|Erectile Dysfunction|erectile dysfunction
5114717|NCT01153204|Group Psychotherapy|group psychotherapy
5114718|NCT01153204|Sildenafil [Substance Name]|sildenafil [substance name]
5114719|NCT01153204|Patient Satisfaction|patient satisfaction
5114720|NCT01153204|Efficacy|efficacy
5114721|NCT01153204|Randomized Controlled Trial [Publication Type]|randomized controlled trial [publication type]
5114722|NCT01153191|colorectal surgery|colorectal surgery
5114723|NCT01153165|Refractory|refractory
5114724|NCT01153165|Asthma|asthma
5114725|NCT01153165|Depression|depression
5114726|NCT01153152|wisdom teeth|wisdom teeth
5114727|NCT01153152|acute pulpitis|acute pulpitis
5114728|NCT01153152|extraction|extraction
5114729|NCT01153152|pain|pain
5114730|NCT01153152|Pain Following Removal of Wisdom Teeth with Acute Pulpitis|pain following removal of wisdom teeth with acute pulpitis
5114731|NCT01153139|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
5114732|NCT01153139|Depression|depression
5114733|NCT01153139|Theta Burst Stimulation|theta burst stimulation
5114734|NCT01153126|Diagnostic Imaging|diagnostic imaging
5114735|NCT01153126|Breast Screening|breast screening
5114736|NCT01153126|Breast Cancer|breast cancer
5114737|NCT01153126|To be eligible for the study, subjects must:|to be eligible for the study, subjects must:
5114738|NCT01153126|Be females at least 18 years of age,|be females at least 18 years of age,
5114739|NCT01153126|Have had their screening mammogram performed at the UW Breast Center,|have had their screening mammogram performed at the uw breast center,
5114740|NCT01153126|Be able to read and write English at the 6th grade level (as shown by their, ability to understand the informed consent),|be able to read and write english at the 6th grade level (as shown by their, ability to understand the informed consent),
5114741|NCT01153126|Have access to a computer with internet capability.|have access to a computer with internet capability.
5114742|NCT01153113|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5114743|NCT01153113|metastatic prostate adenocarcinoma, Stage (T1-4, N+, M0) or (T1-4, N0-3, M+)|metastatic prostate adenocarcinoma, stage (t1-4, n+, m0) or (t1-4, n0-3, m+)
5114744|NCT01153113|rising PSA levels while maintained on LHRH analogues|rising psa levels while maintained on lhrh analogues
5114745|NCT01153100|Diabetes|diabetes
5114746|NCT01153074|Bronchopleural fistula|bronchopleural fistula
5114747|NCT01153074|Bronchoscopy|bronchoscopy
5114748|NCT01153048|Intensification of Education|intensification of education
5114749|NCT01153048|learning nest methodology|learning nest methodology
5114750|NCT01153048|peer educators|peer educators
5114751|NCT01153048|type 2 diabetes|type 2 diabetes
5114752|NCT01153048|Mali|mali
5114753|NCT01153048|the focus of this study is on the intensification of education on the treatment of type 2 diabetes|the focus of this study is on the intensification of education on the treatment of type 2 diabetes
5114754|NCT01153035|Breast Conservation Therapy|breast conservation therapy
5114755|NCT01153035|Lumpectomy|lumpectomy
5114756|NCT01153035|Radiofrequency Ablation|radiofrequency ablation
5114757|NCT01153035|Radiation|radiation
5114758|NCT01153022|Musculoskeletal manipulations|musculoskeletal manipulations
5114759|NCT01153022|Muscle spasticity|muscle spasticity
5114760|NCT01153009|Major Depressive Disorder|major depressive disorder
5114761|NCT01153009|Depression|depression
5114762|NCT01153009|Melancholia|melancholia
5114763|NCT01153009|Drug Therapy|drug therapy
5114764|NCT01152996|Depression|depression
5114765|NCT01152996|Melancholia|melancholia
5114766|NCT01152996|Paraphrenia|paraphrenia
5114767|NCT01152996|Drug Therapy|drug therapy
5114768|NCT01152983|Finger sticks|finger sticks
5114769|NCT01152983|Rapid Ring|rapid ring
5114770|NCT01152983|Finger sticks method of obtaining blood for diagnostic testing|finger sticks method of obtaining blood for diagnostic testing
5114771|NCT01152957|diabetes|diabetes
5114772|NCT01152957|cardiovascular|cardiovascular
5114773|NCT01152957|chronic|chronic
5114774|NCT01152957|Community Health Workers|community health workers
5114775|NCT01152957|behavioral|behavioral
5114776|NCT01152957|social|social
5114777|NCT01152957|diet|diet
5114778|NCT01152957|exercise|exercise
5114779|NCT01152957|patient|patient
5114780|NCT01152957|cholesterol|cholesterol
5114781|NCT01152957|A1C|a1c
5114782|NCT01152957|glucose|glucose
5114783|NCT01152944|Symptomatic intracranial atherosclerotic disease enrolled in the medical arm of SAMMPRIS|symptomatic intracranial atherosclerotic disease enrolled in the medical arm of sammpris
5114784|NCT01152931|Antioxidants|antioxidants
5114785|NCT01152931|Micronutrients|micronutrients
5114786|NCT01152931|Malaria|malaria
5114787|NCT01152931|focus is to determine the effect of antioxidant micronutrients in malaria|focus is to determine the effect of antioxidant micronutrients in malaria
5114788|NCT01152918|HIV Prevention|hiv prevention
5114789|NCT01152918|HIV Treatment|hiv treatment
5114790|NCT01152918|HIV Test and Treat Model of Prevention|hiv test and treat model of prevention
5114791|NCT01152918|ART for Prevention|art for prevention
5114792|NCT01152918|Prevention for HIV Positives|prevention for hiv positives
5114793|NCT01152918|Financial Incentives|financial incentives
5114794|NCT01152918|Computer-delivered risk-reduction counseling|computer-delivered risk-reduction counseling
5114795|NCT01152905|Neuromuscular blockade|neuromuscular blockade
5114796|NCT01152905|Neuromuscular blocking agents|neuromuscular blocking agents
5114797|NCT01152905|Atracurium|atracurium
5114798|NCT01152905|Nitrous oxide|nitrous oxide
5114799|NCT01152892|end stage renal disease|end stage renal disease
5114800|NCT01152892|chronic kidney disease|chronic kidney disease
5114801|NCT01152892|cardiovascular event|cardiovascular event
5114802|NCT01152892|sudden cardiac death|sudden cardiac death
5114803|NCT01152892|autonomic function|autonomic function
5114804|NCT01152879|Parenteral Nutrition|parenteral nutrition
5114805|NCT01152879|Quality of Life|quality of life
5114806|NCT01152866|Multifollicular stimulation|multifollicular stimulation
5114807|NCT01152866|Pregnancy|pregnancy
5114808|NCT01152866|Reproductive Techniques, Assisted|reproductive techniques, assisted
5114809|NCT01152866|Fertilization in Vitro|fertilization in vitro
5114810|NCT01152866|Infertility|infertility
5114811|NCT01152853|advanced gastric cancer|advanced gastric cancer
5114812|NCT01152853|HER2|her2
5114813|NCT01152853|PF00299804|pf00299804
5114814|NCT01152840|Adenoid cystic carcinoma|adenoid cystic carcinoma
5114815|NCT01152840|RAD001|rad001
5114816|NCT01152827|Pheochromocytoma|pheochromocytoma
5114817|NCT01152827|extra-adrenal paraganglioma|extra-adrenal paraganglioma
5114818|NCT01152827|non-functioning carcinoid|non-functioning carcinoid
5114819|NCT01152827|RAD001|rad001
5114820|NCT01152814|Seasonal influenza|seasonal influenza
5114821|NCT01152814|Vaccine|vaccine
5114822|NCT01152801|mRCC,|mrcc,
5114823|NCT01152801|everolimus,|everolimus,
5114824|NCT01152801|mTOR,|mtor,
5114825|NCT01152801|intolerant of VEGF-therapies|intolerant of vegf-therapies
5114826|NCT01152775|partnered surgical decision-making|partnered surgical decision-making
5114827|NCT01152775|impact of multimedia-based teaching|impact of multimedia-based teaching
5114828|NCT01152775|patient education|patient education
5114829|NCT01152775|understanding and retention by patients|understanding and retention by patients
5114830|NCT01152762|Physiotherapy, COPD, effectiveness, primary care|physiotherapy, copd, effectiveness, primary care
5114831|NCT01152749|Smoking Cessation|smoking cessation
5114832|NCT01152749|Nicotine pharmacokinetics|nicotine pharmacokinetics
5114833|NCT01152736|Smoking Cessation, Nicotine pharmacokinetics|smoking cessation, nicotine pharmacokinetics
5114834|NCT01152723|Smoking Cessation, Nicotine pharmacokinetics|smoking cessation, nicotine pharmacokinetics
5114835|NCT01152710|capecitabine|capecitabine
5114836|NCT01152710|chemoradiation|chemoradiation
5114837|NCT01152710|rectal cancer|rectal cancer
5114838|NCT01152710|phase II study|phase ii study
5114839|NCT01152697|nonadherence|nonadherence
5114840|NCT01152697|noncompliance|noncompliance
5114841|NCT01152697|homeless|homeless
5114842|NCT01152697|schizophrenia|schizophrenia
5114843|NCT01152697|schizoaffective|schizoaffective
5114844|NCT01152684|CAM|cam
5114845|NCT01152684|HIV-Positive|hiv-positive
5114846|NCT01152684|Latinos|latinos
5114847|NCT01152684|US-Mexico Border region|us-mexico border region
5114848|NCT01152684|San Diego-Tijuana|san diego-tijuana
5114849|NCT01152684|Identify the nature and extent of complementary and alternative medicine use among HIV-positive Latinos in the US-Mexico border region|identify the nature and extent of complementary and alternative medicine use among hiv-positive latinos in the us-mexico border region
5114850|NCT01152658|Partial supraspinatus tear|partial supraspinatus tear
5114851|NCT01152658|partial tear ssp per echo|partial tear ssp per echo
5114852|NCT01152645|Advanced/recurrent gastric cancer|advanced/recurrent gastric cancer
5114853|NCT01152632|acupuncture|acupuncture
5114854|NCT01152632|migraine|migraine
5114855|NCT01152632|specific acupoints|specific acupoints
5114856|NCT01152632|brain network|brain network
5114857|NCT01152580|melatonin|melatonin
5114858|NCT01152580|menopause|menopause
5114859|NCT01152580|perimenopause|perimenopause
5114860|NCT01152580|sleep|sleep
5114861|NCT01152580|osteoporosis|osteoporosis
5114862|NCT01152580|osteopenia|osteopenia
5114863|NCT01152580|anxiety|anxiety
5114864|NCT01152580|depression|depression
5114865|NCT01152580|hypertension|hypertension
5114866|NCT01152567|Hypertension|hypertension
5114867|NCT01152567|ACE|ace
5114868|NCT01152567|ARB|arb
5114869|NCT01152567|real life data|real life data
5114870|NCT01152567|CVD|cvd
5114871|NCT01152567|cost effectiveness|cost effectiveness
5114872|NCT01152554|Major Depressive Disorder|major depressive disorder
5114873|NCT01152554|MDD|mdd
5114874|NCT01152554|Depression|depression
5114875|NCT01152554|Safety|safety
5114876|NCT01152554|add-on therapy|add-on therapy
5114877|NCT01152541|Keratoconus|keratoconus
5114878|NCT01152541|Corneal Ectasia|corneal ectasia
5114879|NCT01152541|Collagen Crosslinking|collagen crosslinking
5114880|NCT01152541|Riboflavin|riboflavin
5114881|NCT01152528|bacterial vaginosis|bacterial vaginosis
5114882|NCT01152528|screening|screening
5114883|NCT01152528|abortion|abortion
5114884|NCT01152528|preterm delivery|preterm delivery
5114885|NCT01152515|safety and efficacy of maintaining a remifentanil infusion during extubation in propofol-remifentanil sedated patients after surgery|safety and efficacy of maintaining a remifentanil infusion during extubation in propofol-remifentanil sedated patients after surgery
5114886|NCT01152502|Post operative conditions, paracetamol metabolites|post operative conditions, paracetamol metabolites
5114887|NCT01152489|Pain|pain
5114888|NCT01152476|healthy pediatric patients undergoing tonsillectomy and adenoidectomy|healthy pediatric patients undergoing tonsillectomy and adenoidectomy
5114889|NCT01152463|thoracic ultrasound (US)|thoracic ultrasound (us)
5114890|NCT01152463|post-op care|post-op care
5114891|NCT01152463|pneumothorax|pneumothorax
5114892|NCT01152463|pleural effusion|pleural effusion
5114893|NCT01152424|Acute eosinophilic pneumonia|acute eosinophilic pneumonia
5114894|NCT01152424|Exhaled nitric oxide|exhaled nitric oxide
5114895|NCT01152411|Renal Failure|renal failure
5114896|NCT01152411|Chronic Kidney Disease|chronic kidney disease
5114897|NCT01152411|Chronic Renal Failure|chronic renal failure
5114898|NCT01152398|Breast cancer|breast cancer
5114899|NCT01152398|Vaccine|vaccine
5114900|NCT01152398|Metastatic|metastatic
5114901|NCT01152398|HER-2-positive|her-2-positive
5114902|NCT01152398|Phase I|phase i
5114903|NCT01152398|HER-2 Positive Breast Cancer|her-2 positive breast cancer
5114904|NCT01152385|Type 2 diabetes mellitus|type 2 diabetes mellitus
5114905|NCT01152385|Japanese|japanese
5114906|NCT01152385|phase 2|phase 2
5114907|NCT01152385|AZD1656|azd1656
5114908|NCT01152385|efficacy|efficacy
5114909|NCT01152385|dose regimen|dose regimen
5114910|NCT01152385|pharmacokinetics|pharmacokinetics
5114911|NCT01152359|obesity|obesity
5114912|NCT01152359|diet, low carbohydrate|diet, low carbohydrate
5114913|NCT01152359|diet, fat-restricted|diet, fat-restricted
5114914|NCT01152359|food preferences|food preferences
5114915|NCT01152359|quality of life|quality of life
5114916|NCT01152359|patient compliance|patient compliance
5114917|NCT01152346|Bioequivalence|bioequivalence
5114918|NCT01152346|Myelodysplastic Syndrome|myelodysplastic syndrome
5114919|NCT01152346|MDS|mds
5114920|NCT01152346|Azacitidine|azacitidine
5114921|NCT01152320|Asthma|asthma
5114922|NCT01152320|Spirometry|spirometry
5114923|NCT01152320|Pediatric|pediatric
5114924|NCT01152320|Primary Health Care|primary health care
5114925|NCT01152320|Education, Distance|education, distance
5114926|NCT01152307|Depression|depression
5114927|NCT01152307|Depressive disorder|depressive disorder
5114928|NCT01152307|Decision Making|decision making
5114929|NCT01152307|Decision Aids|decision aids
5114930|NCT01152307|Decision Quality Instrument|decision quality instrument
5114931|NCT01152294|Menopause|menopause
5114932|NCT01152294|Decision making|decision making
5114933|NCT01152294|Decision aids|decision aids
5114934|NCT01152294|Decision quality instrument|decision quality instrument
5114935|NCT01152281|retention|retention
5114936|NCT01152281|attrition|attrition
5114937|NCT01152281|empowering|empowering
5114938|NCT01152281|reactance|reactance
5114939|NCT01152281|motivational|motivational
5114940|NCT01152281|goals|goals
5114941|NCT01152281|Basic control|basic control
5114942|NCT01152281|Control with stories of people with AIDS|control with stories of people with aids
5114943|NCT01152281|Instrumental|instrumental
5114944|NCT01152281|Instrumental and Empowering|instrumental and empowering
5114945|NCT01152268|sperm banking|sperm banking
5114946|NCT01152268|Adolescent males|adolescent males
5114947|NCT01152268|Infertility|infertility
5114948|NCT01152268|Adolescents diagnosed with cancer|adolescents diagnosed with cancer
5114949|NCT01152255|Treatment of HIV-1 Infection|treatment of hiv-1 infection
5114950|NCT01152242|Insulin|insulin
5114951|NCT01152203|Bendamustine|bendamustine
5114952|NCT01152203|Bevacizumab|bevacizumab
5114953|NCT01152177|Heading Health Plan Implementation|heading health plan implementation
5114954|NCT01152177|General Practice|general practice
5114955|NCT01152177|Point of care testing|point of care testing
5114956|NCT01152177|education|education
5114957|NCT01152164|quality of life|quality of life
5114958|NCT01152164|rectal cancer|rectal cancer
5114959|NCT01152151|Heading Health Plan Implementation|heading health plan implementation
5114960|NCT01152151|General Practice|general practice
5114961|NCT01152151|Point of care testing|point of care testing
5114962|NCT01152151|education|education
5114963|NCT01152138|Acute myocardial infarction|acute myocardial infarction
5114964|NCT01152138|Closed cell stent|closed cell stent
5114965|NCT01152138|Open cell stent|open cell stent
5114966|NCT01152138|primary percutaneous coronary intervention|primary percutaneous coronary intervention
5114967|NCT01152125|Osteoarthritis|osteoarthritis
5114968|NCT01152125|stem cell implantation|stem cell implantation
5114969|NCT01152125|bone marrow|bone marrow
5114970|NCT01152125|autologous|autologous
5114971|NCT01152112|morcellator|morcellator
5114972|NCT01152112|hysteroscope|hysteroscope
5114973|NCT01152112|myomectomy|myomectomy
5114974|NCT01152112|polypectomy|polypectomy
5114975|NCT01152112|uterine fibroids|uterine fibroids
5114976|NCT01152112|uterine polyps|uterine polyps
5114977|NCT01152112|office|office
5114978|NCT01152112|cost|cost
5114979|NCT01152112|local anesthetic|local anesthetic
5114980|NCT01152112|cervical block|cervical block
5114981|NCT01152112|pain management|pain management
5114982|NCT01152099|Postmastectomy|postmastectomy
5114983|NCT01152086|Physical activity|physical activity
5114984|NCT01152086|mountain hiking|mountain hiking
5114985|NCT01152086|exercise|exercise
5114986|NCT01152086|training program|training program
5114987|NCT01152086|hopelessness|hopelessness
5114988|NCT01152086|chronic suicidality|chronic suicidality
5114989|NCT01152086|depression|depression
5114990|NCT01152086|suicide attempt|suicide attempt
5114991|NCT01152086|suicide|suicide
5114992|NCT01152073|Cholesterol|cholesterol
5114993|NCT01152073|Statin|statin
5114994|NCT01152073|Nutraceuticals|nutraceuticals
5114995|NCT01152073|Niacin|niacin
5114996|NCT01152073|Hyperlipidemia|hyperlipidemia
5114997|NCT01152073|Liquid|liquid
5114998|NCT01152060|remission of proteinuria|remission of proteinuria
5114999|NCT01152060|HBVe-antigen|hbve-antigen
5115000|NCT01152047|oxytocin|oxytocin
5115001|NCT01152047|satiety|satiety
5115002|NCT01152047|dyspepsia|dyspepsia
5115003|NCT01152034|Bipolar disorder|bipolar disorder
5115004|NCT01152034|psychosocial intervention|psychosocial intervention
5115005|NCT01152034|group therapy|group therapy
5115006|NCT01152034|relapse prevention|relapse prevention
5115007|NCT01152034|parasuicide|parasuicide
5115008|NCT01152034|Recurrence|recurrence
5115009|NCT01152034|hospitalization|hospitalization
5115010|NCT01152034|Medication adherence|medication adherence
5115011|NCT01152034|Self-Injurious Behavior|self-injurious behavior
5115012|NCT01152034|Quality of Life|quality of life
5115013|NCT01152021|dexmedetomidine|dexmedetomidine
5115014|NCT01152021|propofol|propofol
5115015|NCT01152021|sedation|sedation
5115016|NCT01152021|MRI|mri
5115017|NCT01152021|scanning|scanning
5115018|NCT01152021|pediatric|pediatric
5115019|NCT01152021|children|children
5115020|NCT01152021|Magnetic Resonance Imaging|magnetic resonance imaging
5115021|NCT01152008|Microcirculation|microcirculation
5115022|NCT01152008|laser flowmetry|laser flowmetry
5115023|NCT01152008|Skin|skin
5115024|NCT01152008|Physiology|physiology
5115025|NCT01151995|Clinical Trial Monitoring|clinical trial monitoring
5115026|NCT01151995|Effectiveness of remote monitoring|effectiveness of remote monitoring
5115027|NCT01151995|Efficiency of remote monitoring|efficiency of remote monitoring
5115028|NCT01151995|Costs of remote monitoring|costs of remote monitoring
5115029|NCT01151982|Depression|depression
5115030|NCT01151982|Primary prevention.|primary prevention.
5115031|NCT01151982|Primary health care.|primary health care.
5115032|NCT01151982|Randomised controlled trial.|randomised controlled trial.
5115033|NCT01151969|Health Service Misuse|health service misuse
5115034|NCT01151969|Overutilization of Health Services|overutilization of health services
5115035|NCT01151969|Primary Health Care|primary health care
5115036|NCT01151969|Cost Effectiveness|cost effectiveness
5115037|NCT01151969|Quality of life|quality of life
5115038|NCT01151969|Randomised Controlled Trial|randomised controlled trial
5115039|NCT01151969|Multilevel analysis|multilevel analysis
5115040|NCT01151956|observational study|observational study
5115041|NCT01151956|actinic keratosis|actinic keratosis
5115042|NCT01151956|imiquimod|imiquimod
5115043|NCT01151943|cesarean section|cesarean section
5115044|NCT01151943|continuous wound infiltration|continuous wound infiltration
5115045|NCT01151943|transversus abdominis plane block|transversus abdominis plane block
5115046|NCT01151930|Advanced solid tumor failed with standard therapy|advanced solid tumor failed with standard therapy
5115047|NCT01151917|Bilio-pancreatic diversion|bilio-pancreatic diversion
5115048|NCT01151917|morbid obesity|morbid obesity
5115049|NCT01151917|insulin resistance|insulin resistance
5115050|NCT01151917|proteomics|proteomics
5115051|NCT01151891|Pedal puncture wounds|pedal puncture wounds
5115052|NCT01151891|Infection in pedal puncture wounds|infection in pedal puncture wounds
5115053|NCT01151891|Diabetes education and pedal puncture wounds|diabetes education and pedal puncture wounds
5115054|NCT01151878|constipation|constipation
5115055|NCT01151878|children|children
5115056|NCT01151865|Delirium|delirium
5115057|NCT01151865|Intensive Care Unit|intensive care unit
5115058|NCT01151865|Dexmedetomidine|dexmedetomidine
5115059|NCT01151852|Imatinib|imatinib
5115060|NCT01151852|Re-challenge|re-challenge
5115061|NCT01151839|Esophagus|esophagus
5115062|NCT01151839|squamous cell carcinoma|squamous cell carcinoma
5115063|NCT01151839|neoadjuvant chemoradiation|neoadjuvant chemoradiation
5115064|NCT01151826|Lung transplantation|lung transplantation
5115065|NCT01151826|Primary Graft Dysfunction|primary graft dysfunction
5115066|NCT01151826|Extravascular Lung Water|extravascular lung water
5115067|NCT01151826|Receptor for Advanced Glycation Endproducts (RAGE)|receptor for advanced glycation endproducts (rage)
5115068|NCT01151826|Intercellular Adhesion Molecule-1 (ICAM-1)|intercellular adhesion molecule-1 (icam-1)
5115069|NCT01151800|ACS|acs
5115070|NCT01151800|Interactive Voice Response Technology|interactive voice response technology
5115071|NCT01151800|Best Practice Guidelines|best practice guidelines
5115072|NCT01151800|Health Care Utilization|health care utilization
5115073|NCT01151800|Outcome Assessment|outcome assessment
5115074|NCT01151787|migraine|migraine
5115075|NCT01151735|Angioedema|angioedema
5115076|NCT01151735|Hereditary Diseases|hereditary diseases
5115077|NCT01151735|Orphan Disease|orphan disease
5115078|NCT01151735|HAE|hae
5115079|NCT01151709|Gout|gout
5115080|NCT01151709|Chronic condition management|chronic condition management
5115081|NCT01151709|Gout management|gout management
5115082|NCT01151696|Pain|pain
5115083|NCT01151696|morphine|morphine
5115084|NCT01151696|hydroxyzine|hydroxyzine
5115085|NCT01151696|acute pain|acute pain
5115086|NCT01151696|traumatic pain|traumatic pain
5115087|NCT01151696|anxiety|anxiety
5115088|NCT01151696|post trauma stress|post trauma stress
5115089|NCT01151696|post trauma anxiety|post trauma anxiety
5115090|NCT01151696|post trauma disorders|post trauma disorders
5115091|NCT01151683|hypertension|hypertension
5115092|NCT01151683|endothelial dysfunction|endothelial dysfunction
5115093|NCT01151670|radiation therapy|radiation therapy
5115094|NCT01151670|cognitive dysfunction|cognitive dysfunction
5115095|NCT01151670|brain tumor|brain tumor
5115096|NCT01151670|memory problems|memory problems
5115097|NCT01151670|short term memory loss|short term memory loss
5115099|NCT01151657|Irritable bowel syndrome|irritable bowel syndrome
5115100|NCT01151657|Probiotics|probiotics
5115101|NCT01151657|Treatment|treatment
5115102|NCT01151657|Adequate relief|adequate relief
5115103|NCT01151644|H1N1 VACCINE|h1n1 vaccine
5115104|NCT01151644|INFLUENZA|influenza
5115105|NCT01151644|RHEUMATIC DISEASES|rheumatic diseases
5115106|NCT01151644|ANTI-H1N1 IMMUNIZATION|anti-h1n1 immunization
5115107|NCT01151592|Iron deficiency anemia in Chronic Kidney Disease Patients|iron deficiency anemia in chronic kidney disease patients
5115108|NCT01151579|Tachycardia|tachycardia
5115109|NCT01151579|tachyarrhythmias|tachyarrhythmias
5115110|NCT01151579|bronchodilator therapy|bronchodilator therapy
5115111|NCT01151579|Critically ill patients|critically ill patients
5115112|NCT01151566|Ultrasound|ultrasound
5115113|NCT01151566|Contrast enhanced Ultrasound (CEUS)|contrast enhanced ultrasound (ceus)
5115114|NCT01151566|Nephrotoxicity|nephrotoxicity
5115115|NCT01151566|CT contrast agents|ct contrast agents
5115116|NCT01151553|Cardiology|cardiology
5115117|NCT01151553|Cardiomyopathy|cardiomyopathy
5115118|NCT01151553|Cardiovascular Disease|cardiovascular disease
5115119|NCT01151553|Cardiac Resynchronization Therapy (CRT)|cardiac resynchronization therapy (crt)
5115120|NCT01151540|Epilepsy|epilepsy
5115121|NCT01151540|Seizures|seizures
5115122|NCT01151514|No referral|no referral
5115123|NCT01151514|Late referral|late referral
5115124|NCT01151514|Acute kidney injury|acute kidney injury
5115125|NCT01151514|Intensive care unit|intensive care unit
5115126|NCT01151514|In-hospital mortality|in-hospital mortality
5115127|NCT01151514|Renal outcome|renal outcome
5115128|NCT01151514|Requirement for renal replacement therapy|requirement for renal replacement therapy
5115129|NCT01151514|Length of hospital stay|length of hospital stay
5115130|NCT01151514|Impact|impact
5115131|NCT01151514|Incidence|incidence
5115132|NCT01151501|acute hypoxemic respiratory failure|acute hypoxemic respiratory failure
5115133|NCT01151501|intermittent positive-pressure ventilation|intermittent positive-pressure ventilation
5115134|NCT01151501|noninvasive positive pressure ventilation|noninvasive positive pressure ventilation
5115135|NCT01151501|ventilator weaning|ventilator weaning
5115136|NCT01151475|liver cirrhosis|liver cirrhosis
5115137|NCT01151475|hepatic encephalopathy|hepatic encephalopathy
5115138|NCT01151475|ammonia|ammonia
5115139|NCT01151475|cerebral blood flow|cerebral blood flow
5115140|NCT01151462|Postnatal HCMV infection in very preterm infants|postnatal hcmv infection in very preterm infants
5115141|NCT01151462|Neurodevelopmental disabilities|neurodevelopmental disabilities
5115142|NCT01151462|Hearing loss|hearing loss
5115143|NCT01151462|Mental retardation|mental retardation
5115144|NCT01151462|Microcephaly|microcephaly
5115145|NCT01151462|Chorioretinitis|chorioretinitis
5115146|NCT01151462|Growth|growth
5115147|NCT01151436|Facial wrinkle correction|facial wrinkle correction
5115148|NCT01151410|Pediatric hypertension|pediatric hypertension
5115149|NCT01151410|primary hypertension|primary hypertension
5115150|NCT01151410|secondary|secondary
5115151|NCT01151410|hypertension|hypertension
5115152|NCT01151397|SVR|svr
5115153|NCT01151397|VITAMIN D|vitamin d
5115154|NCT01151397|Hepatitis C|hepatitis c
5115155|NCT01151397|Genotype 2,3|genotype 2,3
5115156|NCT01151397|Naive|naive
5115157|NCT01151397|RVR|rvr
5115158|NCT01151384|Cancer Patients|cancer patients
5115159|NCT01151358|radioimmunotherapy|radioimmunotherapy
5115160|NCT01151358|follicular non-Hodgkin´s lymphoma|follicular non-hodgkin´s lymphoma
5115161|NCT01151358|FDG-PET|fdg-pet
5115162|NCT01151358|prognostic factors|prognostic factors
5115163|NCT01151358|multicenter study|multicenter study
5115164|NCT01151345|diltiazem|diltiazem
5115165|NCT01151345|angiotrofin|angiotrofin
5115166|NCT01151345|bioequivalence|bioequivalence
5115167|NCT01151293|Type D personality|type d personality
5115168|NCT01151293|diabetes|diabetes
5115169|NCT01151293|medical compliance|medical compliance
5115170|NCT01151293|HbA1c|hba1c
5115171|NCT01151293|complication|complication
5115172|NCT01151293|mortality|mortality
5115173|NCT01151293|T2DM|t2dm
5115174|NCT01151267|Isocapnic hyperpnoea (IH)|isocapnic hyperpnoea (ih)
5115175|NCT01151267|Anesthesia|anesthesia
5115176|NCT01151267|Accelerate elimination of inhalation agents|accelerate elimination of inhalation agents
5115177|NCT01151267|Recovery from anesthesia|recovery from anesthesia
5115178|NCT01151254|Cardiac Surgery|cardiac surgery
5115179|NCT01151254|Sedation|sedation
5115180|NCT01151254|Intensive care|intensive care
5115181|NCT01151254|Volatile anesthesia|volatile anesthesia
5115182|NCT01151254|Intravenous anesthesia|intravenous anesthesia
5115183|NCT01151254|Pre and post conditioning after cardiac surgery|pre and post conditioning after cardiac surgery
5115184|NCT01151241|elbow surgery|elbow surgery
5115185|NCT01151241|infraclavicular nerve block|infraclavicular nerve block
5115186|NCT01151241|continuous passive motion|continuous passive motion
5115187|NCT01151241|ultrasound guided regional anesthesia|ultrasound guided regional anesthesia
5115188|NCT01151241|early discharge|early discharge
5115189|NCT01151228|gastroscopy|gastroscopy
5115190|NCT01151228|ultrasound|ultrasound
5115191|NCT01151228|stomach volume|stomach volume
5115192|NCT01151228|patients having gastroscopy|patients having gastroscopy
5115193|NCT01151215|Cancer|cancer
5115194|NCT01151215|tumour|tumour
5115195|NCT01151215|breast cancer|breast cancer
5115196|NCT01151215|metastatic|metastatic
5115197|NCT01151215|secondary|secondary
5115198|NCT01151215|locally advanced|locally advanced
5115199|NCT01151202|acute upper respiratory tract infection, chronic inflamatory bronchitis|acute upper respiratory tract infection, chronic inflamatory bronchitis
5115200|NCT01151189|HIV|hiv
5115201|NCT01151189|Tuberculosis|tuberculosis
5115202|NCT01151189|Vaccine|vaccine
5115203|NCT01151176|Intensive Insulin Therapy|intensive insulin therapy
5115204|NCT01151176|Glucose control|glucose control
5115205|NCT01151176|Acute Coronary Syndrome|acute coronary syndrome
5115206|NCT01151176|Intensive Care|intensive care
5115207|NCT01150916|natriuretic peptide|natriuretic peptide
5115208|NCT01150916|heart failure|heart failure
5115209|NCT01150916|ascites|ascites
5115210|NCT01150916|liver cirrhosis|liver cirrhosis
5115211|NCT01150838|intubation of children without neuromuscular blockade|intubation of children without neuromuscular blockade
5115212|NCT01149226|pediatric patients|pediatric patients
5115213|NCT01149226|ASA physical status I or II|asa physical status i or ii
5115214|NCT01149226|aged between 1-5 yrs|aged between 1-5 yrs
5115215|NCT01151163|Fibromyalgia, Peripheral arterial tonometry, sleep|fibromyalgia, peripheral arterial tonometry, sleep
5115216|NCT01151111|Parkinson's disease|parkinson's disease
5115217|NCT01151111|Relaxation|relaxation
5115218|NCT01151111|Visual imagery|visual imagery
5115219|NCT01151111|Motor fluctuations|motor fluctuations
5115220|NCT01151111|Treatment|treatment
5115221|NCT01151098|Chronic nonmalignant pain|chronic nonmalignant pain
5115222|NCT01151098|Opioid|opioid
5115223|NCT01151098|Transdermal|transdermal
5115224|NCT01151098|Butrans (BTDS)|butrans (btds)
5115225|NCT01151085|Systemic Mycosis|systemic mycosis
5115226|NCT01151085|Aspergillus infection|aspergillus infection
5115227|NCT01151085|Candidiasis|candidiasis
5115228|NCT01151085|Cryptococcal infections|cryptococcal infections
5115229|NCT01151085|Japanese|japanese
5115230|NCT01151085|voriconazole|voriconazole
5115231|NCT01151085|VFEND|vfend
5115232|NCT01151085|Regulatory Post Marketing Commitment Plan.|regulatory post marketing commitment plan.
5115233|NCT01151059|seasonal influenza|seasonal influenza
5115234|NCT01151059|vaccine|vaccine
5115235|NCT01151046|Breast Cancer|breast cancer
5115236|NCT01151046|Her2 negative|her2 negative
5115237|NCT01151046|Estrogen Receptor Positive|estrogen receptor positive
5115238|NCT01151046|Progesterone Receptor Positive|progesterone receptor positive
5115239|NCT01151046|MM-121|mm-121
5115240|NCT01151046|Exemestane|exemestane
5115241|NCT01151046|Postmenopausal Women|postmenopausal women
5115242|NCT01151033|ProNOVA XR Polymer Free Drug Eluting Coronary Stent System|pronova xr polymer free drug eluting coronary stent system
5115243|NCT01151033|DES|des
5115244|NCT01151033|stent|stent
5115245|NCT01151033|coronary artery lesions|coronary artery lesions
5115246|NCT01151033|ProNOVA|pronova
5115247|NCT01151033|stent implantation|stent implantation
5115248|NCT01151020|Aortic Aneurysm|aortic aneurysm
5115249|NCT01151020|Aneurysm|aneurysm
5115250|NCT01151020|Vascular Prosthesis|vascular prosthesis
5115251|NCT01151020|Vascular Disease|vascular disease
5115252|NCT01151020|Blood Vessel Prosthesis Implantation|blood vessel prosthesis implantation
5115253|NCT01151007|Kras mutation|kras mutation
5115254|NCT01151007|colorectal carcinoma|colorectal carcinoma
5115255|NCT01151007|Martinique|martinique
5115256|NCT01150994|Suicide screening among ED patients|suicide screening among ed patients
5115257|NCT01150955|Resveratrol|resveratrol
5115258|NCT01150955|Diabetes|diabetes
5115259|NCT01150955|SIRT1|sirt1
5115260|NCT01150955|STAT5|stat5
5115261|NCT01150955|IGF-I|igf-i
5115262|NCT01150955|Growth hormone|growth hormone
5115263|NCT01150955|NAFLD|nafld
5115264|NCT01150955|Longevity|longevity
5115265|NCT01150955|Substrate metabolism|substrate metabolism
5115266|NCT01150955|Calorie restriction|calorie restriction
5115267|NCT01150942|JEV|jev
5115268|NCT01150942|vero cell|vero cell
5115269|NCT01150929|Knee arthroplasty|knee arthroplasty
5115270|NCT01150929|RSA|rsa
5115271|NCT01150929|DXA|dxa
5115272|NCT01150929|Gait analysis|gait analysis
5115273|NCT01150929|Motion analysis|motion analysis
5115274|NCT01150903|erectile dysfunction|erectile dysfunction
5115275|NCT01150903|phosphodiesterase inhibitor|phosphodiesterase inhibitor
5115276|NCT01150903|cardiovascular diseases|cardiovascular diseases
5115277|NCT01150890|Ileal Crohn's Disease|ileal crohn's disease
5115278|NCT01150890|Ileo-colonic Crohn's Disease|ileo-colonic crohn's disease
5115279|NCT01150890|Colonic Chron's Disease|colonic chron's disease
5115280|NCT01150877|Vitamin D|vitamin d
5115281|NCT01150877|Vitamin D3|vitamin d3
5115282|NCT01150877|colon cancer|colon cancer
5115283|NCT01150877|rectal cancer|rectal cancer
5115284|NCT01150877|Cholecalciferol|cholecalciferol
5115285|NCT01150864|Hot water humidifier, Passive heat and moisture exchangers|hot water humidifier, passive heat and moisture exchangers
5115286|NCT01150825|STEMI|stemi
5115287|NCT01150825|NSTEMI|nstemi
5115288|NCT01150825|acute ischemia|acute ischemia
5115289|NCT01150825|non-invasive diagnosis|non-invasive diagnosis
5115290|NCT01150825|elevated troponin|elevated troponin
5115291|NCT01150812|First time in man|first time in man
5115292|NCT01150812|healthy|healthy
5115293|NCT01150812|thrombin inhibitor|thrombin inhibitor
5115294|NCT01150786|inflammation|inflammation
5115295|NCT01150786|oxidative stress|oxidative stress
5115296|NCT01150786|selenium|selenium
5115297|NCT01150786|hemodialysis|hemodialysis
5115298|NCT01150760|GI recovery after bowel resection|gi recovery after bowel resection
5115299|NCT01150760|morbidity after bowel resection|morbidity after bowel resection
5115300|NCT01150760|mortality|mortality
5115301|NCT01150760|readmission|readmission
5115302|NCT01150760|length of stay|length of stay
5115303|NCT01150734|differences of Muscle evoked potentials (MEP) in psychiatric illnesses|differences of muscle evoked potentials (mep) in psychiatric illnesses
5115304|NCT01150734|differences in neuromodulation|differences in neuromodulation
5115305|NCT01150734|normalization of neuromodulation after pharmacological treatment|normalization of neuromodulation after pharmacological treatment
5115306|NCT01150721|Atypical Mycobacterium Infection|atypical mycobacterium infection
5115307|NCT01150721|Microbial Tests|microbial tests
5115308|NCT01150721|Molecular Tests|molecular tests
5115309|NCT01150721|Inflammation|inflammation
5115310|NCT01150721|Respiratory Secretions|respiratory secretions
5115311|NCT01150708|Syringomyelia|syringomyelia
5115312|NCT01150708|Magnetic Resonance Imaging|magnetic resonance imaging
5115313|NCT01150708|Natural History Study|natural history study
5115314|NCT01150708|Neurological Examination|neurological examination
5115315|NCT01150695|vaccine, Francisella tularensis, Tularemia, rabbit fever, parent protocol|vaccine, francisella tularensis, tularemia, rabbit fever, parent protocol
5115316|NCT01150682|endometrial adenocarcinoma|endometrial adenocarcinoma
5115317|NCT01150682|stage II endometrial carcinoma|stage ii endometrial carcinoma
5115318|NCT01150682|stage III endometrial carcinoma|stage iii endometrial carcinoma
5115319|NCT01150682|stage IV endometrial carcinoma|stage iv endometrial carcinoma
5115320|NCT01150682|endometrial adenosquamous cell carcinoma|endometrial adenosquamous cell carcinoma
5115321|NCT01150682|endometrial clear cell carcinoma|endometrial clear cell carcinoma
5115322|NCT01150682|endometrial papillary serous carcinoma|endometrial papillary serous carcinoma
5115418|NCT01150318|Radioisotopes Therapy|radioisotopes therapy
5115323|NCT01150656|childhood acute myeloid leukemia/other myeloid malignancies|childhood acute myeloid leukemia/other myeloid malignancies
5115324|NCT01150643|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5115325|NCT01150643|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5115326|NCT01150643|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5115327|NCT01150643|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5115328|NCT01150630|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
5115329|NCT01150630|stage I pancreatic cancer|stage i pancreatic cancer
5115330|NCT01150630|stage II pancreatic cancer|stage ii pancreatic cancer
5115331|NCT01150617|Type 2 diabetes mellitus|type 2 diabetes mellitus
5115332|NCT01150617|Normoglycemia|normoglycemia
5115333|NCT01150617|Peripheral angioplasty|peripheral angioplasty
5115334|NCT01150604|Cognitive Behavioral Therapy|cognitive behavioral therapy
5115335|NCT01150604|Mood Management|mood management
5115336|NCT01150604|Self-help|self-help
5115337|NCT01150604|Internet|internet
5115338|NCT01150578|Echocardiography, 2D|echocardiography, 2d
5115339|NCT01150578|speckle tracking|speckle tracking
5115340|NCT01150578|Lexiscan|lexiscan
5115341|NCT01150578|regadenoson|regadenoson
5115342|NCT01150578|Myocardial ischemia|myocardial ischemia
5115343|NCT01150578|Myocardial perfusion imaging|myocardial perfusion imaging
5115344|NCT01150578|cost and cost analysis|cost and cost analysis
5115345|NCT01150578|Cardiac-Gated SPECT Imaging|cardiac-gated spect imaging
5115346|NCT01150578|Echocardiography|echocardiography
5115347|NCT01150552|Serology|serology
5115348|NCT01150552|Poultry|poultry
5115349|NCT01150552|H5N1 virus|h5n1 virus
5115350|NCT01150552|HPAI virus|hpai virus
5115351|NCT01150526|Acute Exercise|acute exercise
5115352|NCT01150526|Muscle Inflammation|muscle inflammation
5115353|NCT01150526|CaHMB|cahmb
5115354|NCT01150526|HMB Free Acid Gel|hmb free acid gel
5115355|NCT01150526|Healthy Subjects|healthy subjects
5115356|NCT01150513|TRIPLE-NEGATIVE|triple-negative
5115357|NCT01150513|BREAST CANCER|breast cancer
5115358|NCT01150500|Medtronic|medtronic
5115359|NCT01150500|Japan|japan
5115360|NCT01150500|Arterial Occlusive Diseases|arterial occlusive diseases
5115361|NCT01150500|Myocardial Ischemia|myocardial ischemia
5115362|NCT01150500|Cardiovascular Diseases|cardiovascular diseases
5115363|NCT01150500|Coronary Artery Disease|coronary artery disease
5115364|NCT01150500|Small Vessel Stent|small vessel stent
5115365|NCT01150487|kidney transplant|kidney transplant
5115366|NCT01150474|Belladonna|belladonna
5115367|NCT01150474|Morphine|morphine
5115368|NCT01150474|Suppositories|suppositories
5115369|NCT01150474|Vaginal|vaginal
5115370|NCT01150474|Surgery|surgery
5115371|NCT01150474|Postoperative|postoperative
5115372|NCT01150474|Pain|pain
5115373|NCT01150461|Hypertrophic nonobstructive cardiomyopathy|hypertrophic nonobstructive cardiomyopathy
5115374|NCT01150448|Paliperidone palmitate|paliperidone palmitate
5115375|NCT01150448|paliperidone ER (INVEGA)|paliperidone er (invega)
5115376|NCT01150448|R092670PSY1008|r092670psy1008
5115377|NCT01150448|Risperidone|risperidone
5115378|NCT01150448|Risperdal (RISPERDAL CONSTA)|risperdal (risperdal consta)
5115379|NCT01150448|Pharmacokinetics|pharmacokinetics
5115380|NCT01150422|medical abortion|medical abortion
5115381|NCT01150409|Sepsis|sepsis
5115382|NCT01150409|hydrocortisone|hydrocortisone
5115383|NCT01150396|extremely premature infant|extremely premature infant
5115384|NCT01150396|outcome|outcome
5115385|NCT01150396|follow-up|follow-up
5115386|NCT01150383|Lung Diseases, Obstructive|lung diseases, obstructive
5115387|NCT01150383|Respiratory Tract Diseases|respiratory tract diseases
5115388|NCT01150383|Lung Diseases|lung diseases
5115389|NCT01150383|Respiration Disorders|respiration disorders
5115390|NCT01150383|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
5115391|NCT01150383|COPD|copd
5115392|NCT01150383|Chronic Obstructive Lung Disease|chronic obstructive lung disease
5115393|NCT01150383|Chronic Obstructive Airway Disease|chronic obstructive airway disease
5115394|NCT01150383|Chronic Airflow Obstruction|chronic airflow obstruction
5115395|NCT01150383|oxygen|oxygen
5115396|NCT01150383|oxygen supplementation|oxygen supplementation
5115397|NCT01150370|male circumcision|male circumcision
5115398|NCT01150370|HIV|hiv
5115399|NCT01150370|Rwanda|rwanda
5115400|NCT01150370|HIV Seronegativity|hiv seronegativity
5115401|NCT01150357|Pediatric hypertension|pediatric hypertension
5115402|NCT01150357|primary hypertension|primary hypertension
5115403|NCT01150357|secondary hypertension|secondary hypertension
5115404|NCT01150344|Multicentric study|multicentric study
5115405|NCT01150344|Antimalarial|antimalarial
5115406|NCT01150344|P. falciparum|p. falciparum
5115407|NCT01150344|Efficacy|efficacy
5115408|NCT01150344|Failures|failures
5115409|NCT01150344|Malarone|malarone
5115410|NCT01150344|RIAMET|riamet
5115411|NCT01150331|status epilepticus|status epilepticus
5115412|NCT01150331|generalised convulsive status epilepticus|generalised convulsive status epilepticus
5115413|NCT01150331|first line treatments|first line treatments
5115414|NCT01150331|double-blind randomized controlled trial|double-blind randomized controlled trial
5115415|NCT01150331|prehospital treatment|prehospital treatment
5115416|NCT01150318|Male|male
5115417|NCT01150318|Infertility|infertility
5115419|NCT01150318|Follicular thyroid cancer|follicular thyroid cancer
5115420|NCT01150305|Autosomal dominant inheritance|autosomal dominant inheritance
5115421|NCT01150305|Mutation|mutation
5115422|NCT01150305|Prevalence|prevalence
5115423|NCT01150292|DHA supplementation|dha supplementation
5115424|NCT01150292|Type 2 diabetic patient|type 2 diabetic patient
5115425|NCT01150292|Platelet function|platelet function
5115426|NCT01150279|medical abortion|medical abortion
5115427|NCT01150279|Medical Abortion Follow Up Care|medical abortion follow up care
5115428|NCT01150266|stroke|stroke
5115429|NCT01150266|ischemia|ischemia
5115430|NCT01150266|thrombolysis|thrombolysis
5115431|NCT01150266|thrombolytics|thrombolytics
5115432|NCT01150266|tPA|tpa
5115433|NCT01150266|rt-PA|rt-pa
5115434|NCT01150266|t-PA|t-pa
5115435|NCT01150266|Activase®|activase®
5115436|NCT01150266|Alteplase|alteplase
5115437|NCT01150266|wake-up stroke|wake-up stroke
5115438|NCT01150266|waking onset stroke|waking onset stroke
5115439|NCT01150266|sleep|sleep
5115440|NCT01150240|Primary Immunodeficiency Disease|primary immunodeficiency disease
5115441|NCT01150214|atrial fibrillation|atrial fibrillation
5115442|NCT01150214|af|af
5115443|NCT01150214|magnetic resonance imaging|magnetic resonance imaging
5115444|NCT01150214|mri|mri
5115445|NCT01150214|left atrium|left atrium
5115446|NCT01150214|fibrosis|fibrosis
5115447|NCT01150214|structural remodeling|structural remodeling
5115448|NCT01150201|CKD|ckd
5115449|NCT01150201|proteinuria|proteinuria
5115450|NCT01150201|eGFR|egfr
5115451|NCT01150201|Progression of chronic kidney disease|progression of chronic kidney disease
5115452|NCT01150188|aging|aging
5115453|NCT01150188|lipid metabolism|lipid metabolism
5115454|NCT01150188|very low density lipoproteins|very low density lipoproteins
5115455|NCT01150188|amino acids|amino acids
5115456|NCT01150188|dietary supplements|dietary supplements
5115457|NCT01150175|END-HF|end-hf
5115458|NCT01150149|Influenza|influenza
5115459|NCT01150149|Humans|humans
5115460|NCT01150149|Experimental|experimental
5115461|NCT01150149|Challenge|challenge
5115462|NCT01150136|choline|choline
5115463|NCT01150136|cystic fibrosis|cystic fibrosis
5115464|NCT01150136|methyl metabolism|methyl metabolism
5115465|NCT01150136|oxidative stress|oxidative stress
5115466|NCT01150123|Group B streptococcus|group b streptococcus
5115467|NCT01150123|GBS|gbs
5115468|NCT01150123|Vaccine|vaccine
5115469|NCT01150123|Group B streptococcus (GBS) disease|group b streptococcus (gbs) disease
5115470|NCT01150110|Temporomandibular disorders|temporomandibular disorders
5115471|NCT01150110|occlusal splints|occlusal splints
5115472|NCT01150110|electromyography|electromyography
5115473|NCT01150110|TMD (muscle and joint dysfunction)|tmd (muscle and joint dysfunction)
5115474|NCT01150110|masseteres e anterior temporalis muscles.|masseteres e anterior temporalis muscles.
5115475|NCT01150097|Liver transplantation|liver transplantation
5115476|NCT01150097|Everolimus|everolimus
5115477|NCT01150097|Calcineurin inhibitors|calcineurin inhibitors
5115478|NCT01150097|Tacrolimus|tacrolimus
5115479|NCT01150097|Renal function|renal function
5115480|NCT01150097|Progression of HCV related allograft fibrosis|progression of hcv related allograft fibrosis
5115481|NCT01150084|increasing physical activity in sedentary employees|increasing physical activity in sedentary employees
5115482|NCT01150071|extremely premature infant|extremely premature infant
5115483|NCT01150071|follow-up|follow-up
5115484|NCT01150071|behavior|behavior
5115485|NCT01150071|growth|growth
5115486|NCT01150071|mental health|mental health
5115487|NCT01150071|lung function|lung function
5115488|NCT01150071|spirometry|spirometry
5115489|NCT01150071|muscle mass|muscle mass
5115490|NCT01150071|bone density|bone density
5115491|NCT01150071|magnetic Resonance imaging|magnetic resonance imaging
5115492|NCT01150058|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5115493|NCT01150058|adult acute myeloid leukemia with del(5q)|adult acute myeloid leukemia with del(5q)
5115494|NCT01150058|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5115495|NCT01150058|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5115496|NCT01150058|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5115497|NCT01150058|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5115498|NCT01150058|childhood acute myeloid leukemia/other myeloid malignancies|childhood acute myeloid leukemia/other myeloid malignancies
5115499|NCT01150058|adult acute myeloid leukemia|adult acute myeloid leukemia
5115500|NCT01150045|adenocarcinoma of the colon|adenocarcinoma of the colon
5115501|NCT01150045|stage III colon cancer|stage iii colon cancer
5115502|NCT01150032|Osteoporosis|osteoporosis
5115503|NCT01150032|Fracture|fracture
5115504|NCT01150032|Bone microarchitecture|bone microarchitecture
5115505|NCT01150019|atherosclerosis|atherosclerosis
5115506|NCT01150019|vascular inflammation|vascular inflammation
5115507|NCT01150019|resistin|resistin
5115508|NCT01150019|adiponectin|adiponectin
5115509|NCT01150019|18FDG-PET|18fdg-pet
5115510|NCT01150006|atherosclerosis|atherosclerosis
5115511|NCT01150006|vascular inflammation|vascular inflammation
5115512|NCT01150006|adipocyte fatty acid binding protein|adipocyte fatty acid binding protein
5115513|NCT01150006|adiponectin|adiponectin
5115514|NCT01150006|leptin|leptin
5115515|NCT01150006|18FDG-PET|18fdg-pet
5115516|NCT01149993|living donation|living donation
5115517|NCT01149993|kidney transplantation|kidney transplantation
5115518|NCT01149993|delayed graft function|delayed graft function
5115519|NCT01149993|ischemia reperfusion injury|ischemia reperfusion injury
5115520|NCT01149980|Bioequivalence|bioequivalence
5115521|NCT01149980|Crossover|crossover
5115522|NCT01149980|Citalopram|citalopram
5115523|NCT01149967|Bioequivalence|bioequivalence
5115524|NCT01149967|Citalopram|citalopram
5115525|NCT01149967|Crossover|crossover
5115526|NCT01149954|Bioequivalence|bioequivalence
5115527|NCT01149954|Crossover|crossover
5115528|NCT01149954|Ibuprofen|ibuprofen
5115529|NCT01149941|Bioequivalence|bioequivalence
5115530|NCT01149941|Crossover|crossover
5115531|NCT01149941|Ibuprofen|ibuprofen
5115532|NCT01149928|Fetal lung fluid|fetal lung fluid
5115533|NCT01149928|Pulmonary adaptation|pulmonary adaptation
5115534|NCT01149928|Transient tachypnea of the newborn|transient tachypnea of the newborn
5115535|NCT01149928|Epinephrine|epinephrine
5115536|NCT01149928|Stress hormones|stress hormones
5115537|NCT01149915|Advanced Leukemias|advanced leukemias
5115538|NCT01149915|Relapsed/Refractory Leukemias|relapsed/refractory leukemias
5115539|NCT01149915|AML|aml
5115540|NCT01149915|ALL|all
5115541|NCT01149915|CML|cml
5115542|NCT01149915|MDS|mds
5115543|NCT01149915|CLL|cll
5115544|NCT01149915|MF|mf
5115545|NCT01149915|Evofosfamide|evofosfamide
5115546|NCT01149863|Autologous Transplantation|autologous transplantation
5115547|NCT01149850|adult giant cell glioblastoma|adult giant cell glioblastoma
5115548|NCT01149850|adult glioblastoma|adult glioblastoma
5115549|NCT01149850|adult gliosarcoma|adult gliosarcoma
5115550|NCT01149837|HTLV|htlv
5115551|NCT01149837|HTLV I|htlv i
5115552|NCT01149837|HTLV II|htlv ii
5115553|NCT01149837|HTLV Type I and/or HTLV Type II antibody|htlv type i and/or htlv type ii antibody
5115554|NCT01149824|Salvia divinorum|salvia divinorum
5115555|NCT01149824|Salvinorin A|salvinorin a
5115556|NCT01149811|Dyskinesia|dyskinesia
5115557|NCT01149798|metastatic breast cancer|metastatic breast cancer
5115558|NCT01149798|combined chemotherapy|combined chemotherapy
5115559|NCT01149785|crizotinib|crizotinib
5115560|NCT01149785|healthy volunteers|healthy volunteers
5115561|NCT01149785|ketoconazole|ketoconazole
5115562|NCT01149785|pharmacokinetics|pharmacokinetics
5115563|NCT01149785|single dose|single dose
5115564|NCT01149772|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5115565|NCT01149772|Heart Failure|heart failure
5115566|NCT01149772|Anxiety|anxiety
5115567|NCT01149772|Depression|depression
5115568|NCT01149759|Atopic Dermatitis|atopic dermatitis
5115569|NCT01149759|Eczema|eczema
5115570|NCT01149720|Relative bioavailability|relative bioavailability
5115571|NCT01149720|ARQ 197|arq 197
5115572|NCT01149707|PUR 0110|pur 0110
5115573|NCT01149707|PUR 0110 Rectal Enema|pur 0110 rectal enema
5115574|NCT01149707|Distal Ulcerative Colitis|distal ulcerative colitis
5115575|NCT01149707|Left-Sided Ulcerative Colitis|left-sided ulcerative colitis
5115576|NCT01149707|Mild|mild
5115577|NCT01149707|Moderate|moderate
5115578|NCT01149694|PurGenesis Technologies Inc.|purgenesis technologies inc.
5115579|NCT01149694|PUR 0110 rectal enema|pur 0110 rectal enema
5115580|NCT01149694|Ulcerative colitis|ulcerative colitis
5115581|NCT01149694|Distal|distal
5115582|NCT01149694|Normal healthy volunteers|normal healthy volunteers
5115583|NCT01149681|Aplidin|aplidin
5115584|NCT01149681|Plitidepsin|plitidepsin
5115585|NCT01149681|Myelofibrosis|myelofibrosis
5115586|NCT01149681|Pharma Mar|pharma mar
5115587|NCT01149668|PCI-24781|pci-24781
5115588|NCT01149668|Lymphoma|lymphoma
5115589|NCT01149668|Non-Hodgkin's|non-hodgkin's
5115590|NCT01149668|Hodgkin Disease|hodgkin disease
5115591|NCT01149668|Multiple Myeloma|multiple myeloma
5115592|NCT01149668|Leukemia|leukemia
5115593|NCT01149668|Lymphocytic|lymphocytic
5115594|NCT01149668|Chronic|chronic
5115595|NCT01149655|Adolescent|adolescent
5115596|NCT01149655|Schizophrenia|schizophrenia
5115597|NCT01149629|Droxidopa|droxidopa
5115598|NCT01149629|Randomized|randomized
5115599|NCT01149629|Crossover|crossover
5115600|NCT01149629|Open Label|open label
5115601|NCT01149629|Bioequivalence|bioequivalence
5115602|NCT01149629|Fed Fast|fed fast
5115603|NCT01149629|TID|tid
5115604|NCT01149603|failing Fontan|failing fontan
5115605|NCT01149603|single-ventricle|single-ventricle
5115606|NCT01149603|destination therapy|destination therapy
5115607|NCT01149603|HeartMate II|heartmate ii
5115608|NCT01149603|HMII|hmii
5115609|NCT01149603|cardiac congenital anomaly|cardiac congenital anomaly
5115610|NCT01149603|ventricular assist device|ventricular assist device
5115611|NCT01149603|VAD|vad
5115612|NCT01149590|Angina|angina
5115613|NCT01149590|Coronary Heart Disease|coronary heart disease
5115614|NCT01149590|Computed Tomography|computed tomography
5115615|NCT01149590|Angiogram|angiogram
5115616|NCT01149590|Coronary Artery Calcium Score|coronary artery calcium score
5115617|NCT01149590|Chest Pain|chest pain
5115714|NCT01149122|Erlotinib|erlotinib
5115618|NCT01149590|Angina Pectoris due to Coronary Heart Disease|angina pectoris due to coronary heart disease
5115619|NCT01149577|Olanzapine|olanzapine
5115620|NCT01149577|Schizophrenia|schizophrenia
5115621|NCT01149577|Polysomnography|polysomnography
5115622|NCT01149577|Slow wave sleep|slow wave sleep
5115623|NCT01149551|Schizophrenia|schizophrenia
5115624|NCT01149551|Bipolar disorder|bipolar disorder
5115625|NCT01149551|Genetic research|genetic research
5115626|NCT01149538|FASD|fasd
5115627|NCT01149538|FAS|fas
5115628|NCT01149538|Alcohol|alcohol
5115629|NCT01149538|Prenatal Alcohol|prenatal alcohol
5115630|NCT01149525|Multiple Sclerosis/complications|multiple sclerosis/complications
5115631|NCT01149525|Fatigue Syndrome|fatigue syndrome
5115632|NCT01149525|Chronic/drug therapy|chronic/drug therapy
5115633|NCT01149486|Bioequivalence|bioequivalence
5115634|NCT01149486|Healthy Subjects|healthy subjects
5115635|NCT01149473|Bioequivalence|bioequivalence
5115636|NCT01149473|Healthy Subjects|healthy subjects
5115637|NCT01149447|cryptogenic stroke|cryptogenic stroke
5115638|NCT01149447|percutaneous closure of PFO|percutaneous closure of pfo
5115639|NCT01149447|follow-up exams|follow-up exams
5115640|NCT01149434|Low grade endocrine tumors|low grade endocrine tumors
5115641|NCT01149434|ovarian cancers|ovarian cancers
5115642|NCT01149434|K-RAS mutant colon cancers|k-ras mutant colon cancers
5115643|NCT01149421|Type 2 Diabetes|type 2 diabetes
5115644|NCT01149421|Diabetes|diabetes
5115645|NCT01149421|Ambulatory Blood Pressure Monitoring|ambulatory blood pressure monitoring
5115646|NCT01149421|ABPM|abpm
5115647|NCT01149421|Blood Pressure|blood pressure
5115648|NCT01149421|Heart Rate|heart rate
5115649|NCT01149408|AML|aml
5115650|NCT01149408|Decitabine|decitabine
5115651|NCT01149408|Acute Myeloid Leukemia|acute myeloid leukemia
5115652|NCT01149408|Elderly Patients|elderly patients
5115653|NCT01149408|Cancer|cancer
5115654|NCT01149395|Heartburn|heartburn
5115655|NCT01149395|Gastroesophageal Reflux Disease|gastroesophageal reflux disease
5115656|NCT01149382|flu shot|flu shot
5115657|NCT01149382|islet cell transplant recipients|islet cell transplant recipients
5115658|NCT01149369|gastroparesis|gastroparesis
5115659|NCT01149369|nausea|nausea
5115660|NCT01149369|vomiting|vomiting
5115661|NCT01149343|PRAME|prame
5115662|NCT01149343|Cancer immunotherapeutic|cancer immunotherapeutic
5115663|NCT01149343|Malignant melanoma|malignant melanoma
5115664|NCT01149343|ASCI (Antigen-Specific Cancer Immunotherapeutic)|asci (antigen-specific cancer immunotherapeutic)
5115665|NCT01149330|Adapalene|adapalene
5115666|NCT01149330|Benzoyl Peroxide|benzoyl peroxide
5115667|NCT01149330|Acne Vulgaris|acne vulgaris
5115668|NCT01149317|acupuncture|acupuncture
5115669|NCT01149317|health services research|health services research
5115670|NCT01149317|chronic pain|chronic pain
5115671|NCT01149317|health disparities|health disparities
5115672|NCT01149304|brachytherapy|brachytherapy
5115673|NCT01149304|liver metastases|liver metastases
5115674|NCT01149304|irradiation|irradiation
5115675|NCT01149304|radiation induced liver disease|radiation induced liver disease
5115676|NCT01149304|dosimetry|dosimetry
5115677|NCT01149291|high sensitivity C-reactive protein (hsCRP)|high sensitivity c-reactive protein (hscrp)
5115678|NCT01149291|cardiorenal|cardiorenal
5115679|NCT01149291|end stage renal disease (ESRD)|end stage renal disease (esrd)
5115680|NCT01149291|Secondary hyperparathyroidism (SHPT)|secondary hyperparathyroidism (shpt)
5115681|NCT01149291|dialysis|dialysis
5115682|NCT01149291|paricalcitol|paricalcitol
5115683|NCT01149291|osteodystrophy|osteodystrophy
5115684|NCT01149291|selective Vitamin D receptor activators (sVDRA)|selective vitamin d receptor activators (svdra)
5115685|NCT01149291|chronic kidney disease|chronic kidney disease
5115686|NCT01149252|Psoriasis|psoriasis
5115687|NCT01149213|Major depressive disorder|major depressive disorder
5115688|NCT01149213|follow-up|follow-up
5115689|NCT01149213|relapse|relapse
5115690|NCT01149213|remission|remission
5115691|NCT01149213|transcranial direct current stimulation|transcranial direct current stimulation
5115692|NCT01149200|Irritable Bowel Syndrome|irritable bowel syndrome
5115693|NCT01149200|IBS-C|ibs-c
5115694|NCT01149174|intravesical chemotherapy|intravesical chemotherapy
5115695|NCT01149174|early single instillation|early single instillation
5115696|NCT01149174|mitomycin-C|mitomycin-c
5115697|NCT01149174|electromotive drug administration|electromotive drug administration
5115698|NCT01149161|neck dissection|neck dissection
5115699|NCT01149161|sentinel lymph node|sentinel lymph node
5115700|NCT01149161|Carcinoma|carcinoma
5115701|NCT01149161|Papillary|papillary
5115702|NCT01149161|thyroid|thyroid
5115703|NCT01149161|dissection|dissection
5115704|NCT01149148|Aortic Surgeries|aortic surgeries
5115705|NCT01149148|Deep Hypothermic Circulatory Arrest|deep hypothermic circulatory arrest
5115706|NCT01149135|Seasonal Affective Disorder|seasonal affective disorder
5115707|NCT01149135|phototherapy|phototherapy
5115708|NCT01149135|circadian rhythms|circadian rhythms
5115709|NCT01149135|blue enriched light|blue enriched light
5115710|NCT01149135|melanopsin|melanopsin
5115711|NCT01149135|low intensity|low intensity
5115712|NCT01149122|unresectable, metastatic biliary tract carcinoma|unresectable, metastatic biliary tract carcinoma
5115713|NCT01149122|Gemcitabine/Oxaliplatin (GEMOX)|gemcitabine/oxaliplatin (gemox)
5115715|NCT01149109|MGMT promotor status|mgmt promotor status
5115716|NCT01149109|overall survival|overall survival
5115717|NCT01149070|Infertility|infertility
5115718|NCT01149070|Controlled ovarian stimulation|controlled ovarian stimulation
5115719|NCT01149070|Reproductive techniques, assisted|reproductive techniques, assisted
5115720|NCT01149070|Sperm injections, intracytoplasmic|sperm injections, intracytoplasmic
5115721|NCT01149070|Gonal-f|gonal-f
5115722|NCT01149070|Ovitrelle|ovitrelle
5115723|NCT01149044|Acute Coronary Syndrome|acute coronary syndrome
5115724|NCT01149044|PCI|pci
5115725|NCT01149044|Percutaneous Coronary Intervention|percutaneous coronary intervention
5115726|NCT01149044|STEMI|stemi
5115727|NCT01149044|Thrombectomy|thrombectomy
5115728|NCT01149031|Provoked Vestibulodynia|provoked vestibulodynia
5115729|NCT01149031|Low Level Laser Therapy|low level laser therapy
5115730|NCT01149018|Fibromyalgia|fibromyalgia
5115731|NCT01149018|Tetrahydrocannabinol|tetrahydrocannabinol
5115732|NCT01149018|Chronic Widespread Pain|chronic widespread pain
5115733|NCT01149005|Normal Glucose Tolerance Test|normal glucose tolerance test
5115734|NCT01149005|Mixed Meal Tolerance Test|mixed meal tolerance test
5115735|NCT01149005|Cystic Fibrosis|cystic fibrosis
5115736|NCT01149005|Pulmonary Exacerbation|pulmonary exacerbation
5115737|NCT01149005|Impaired Glucose Tolerance Test|impaired glucose tolerance test
5115738|NCT01149005|Insulin Therapy|insulin therapy
5115739|NCT01148979|Major Depressive Disorder|major depressive disorder
5115740|NCT01148979|Cognitive Impairment|cognitive impairment
5115741|NCT01148979|Partial Response|partial response
5115742|NCT01148979|Residual Symptoms|residual symptoms
5115743|NCT01148940|sickle cell trait|sickle cell trait
5115744|NCT01148940|thrombosis|thrombosis
5115745|NCT01148940|D-Dimer|d-dimer
5115746|NCT01148914|Inflammatory biomarkers|inflammatory biomarkers
5115747|NCT01148914|Atrial fibrillation|atrial fibrillation
5115748|NCT01148914|Catheter ablation|catheter ablation
5115749|NCT01148914|To assess if pre-ablation levels of inflammatory biomarkers serve as independent predictors of procedure outcome|to assess if pre-ablation levels of inflammatory biomarkers serve as independent predictors of procedure outcome
5115750|NCT01148914|To evaluate the inflammatory activation following catheter ablation and examine its predictive role in procedure success|to evaluate the inflammatory activation following catheter ablation and examine its predictive role in procedure success
5115751|NCT01148914|To determine if a change in the baseline level of biomarkers at 3-months follow-up has any correlation with long-term outcome|to determine if a change in the baseline level of biomarkers at 3-months follow-up has any correlation with long-term outcome
5115752|NCT01148914|To study the association of certain biomarkers with specific types of AF (paroxysmal or persistent or long standing persistent)|to study the association of certain biomarkers with specific types of af (paroxysmal or persistent or long standing persistent)
5115753|NCT01148901|Ankylosing spondylitis|ankylosing spondylitis
5115754|NCT01148901|Hip arthritis|hip arthritis
5115755|NCT01148901|Infliximab|infliximab
5115756|NCT01148888|pediatrics|pediatrics
5115757|NCT01148888|Anaesthesia|anaesthesia
5115758|NCT01148888|Scoliosis|scoliosis
5115759|NCT01148888|Magnesium|magnesium
5115760|NCT01148875|breast cancer screening|breast cancer screening
5115761|NCT01148875|mammography adherence|mammography adherence
5115762|NCT01148875|non-adherent|non-adherent
5115763|NCT01148862|ASPIRE (Automation to Simulate Pancreatic Insulin Response)|aspire (automation to simulate pancreatic insulin response)
5115764|NCT01148862|X54|x54
5115765|NCT01148862|Medtronic Diabetes|medtronic diabetes
5115766|NCT01148862|Diabetes Mellitus|diabetes mellitus
5115767|NCT01148862|Type 1|type 1
5115768|NCT01148849|HER2 positive|her2 positive
5115769|NCT01148849|breast cancer|breast cancer
5115770|NCT01148849|gastric cancer|gastric cancer
5115771|NCT01148836|Coenzyme Q-10|coenzyme q-10
5115772|NCT01148836|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
5115773|NCT01148836|Pulmonary Arterial Hypertension Class I (Venice 2003)|pulmonary arterial hypertension class i (venice 2003)
5115774|NCT01148823|breast|breast
5115775|NCT01148823|plastic surgery|plastic surgery
5115776|NCT01148823|bandages|bandages
5115777|NCT01148823|surgical site infection|surgical site infection
5115778|NCT01148823|skin colonization|skin colonization
5115779|NCT01148810|Inflammatory muscle disease|inflammatory muscle disease
5115780|NCT01148810|Muscle weakness|muscle weakness
5115781|NCT01148810|Myositis|myositis
5115782|NCT01148797|FMF, Colchicine resistant|fmf, colchicine resistant
5115783|NCT01148797|Colchicine intolerant|colchicine intolerant
5115784|NCT01148797|Flare rate|flare rate
5115785|NCT01148797|Canakinumab|canakinumab
5115786|NCT01148784|anterior cruciate ligament tear|anterior cruciate ligament tear
5115787|NCT01148784|ACL|acl
5115788|NCT01148784|ligament|ligament
5115789|NCT01148784|knee|knee
5115790|NCT01148784|allograft|allograft
5115791|NCT01148771|Pharmacokinetics|pharmacokinetics
5115792|NCT01148771|Safety|safety
5115793|NCT01148732|Endotracheal tube|endotracheal tube
5115794|NCT01148732|ultrasonography|ultrasonography
5115795|NCT01148719|Heart Failure|heart failure
5115796|NCT01148719|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5115797|NCT01148719|Dyspnea|dyspnea
5115798|NCT01148719|Elderly|elderly
5115799|NCT01148719|Diagnosis|diagnosis
5115800|NCT01148719|Primary health care|primary health care
5115801|NCT01148706|thorax|thorax
5115802|NCT01148706|abdomen|abdomen
5115803|NCT01148693|Cholangitis; Cholangiopancreatography, Endoscopic Retrograde; stents; cholestasis|cholangitis; cholangiopancreatography, endoscopic retrograde; stents; cholestasis
5115804|NCT01148680|Islet Cell Transplantation|islet cell transplantation
5115805|NCT01148680|Metabolic Diseases|metabolic diseases
5115806|NCT01148680|Endocrine System Diseases|endocrine system diseases
5115807|NCT01148667|atopic dermatitis|atopic dermatitis
5115808|NCT01148667|barrier function|barrier function
5115809|NCT01148667|gut|gut
5115810|NCT01148667|probiotics|probiotics
5115811|NCT01148667|skin|skin
5115812|NCT01148654|preterm birth|preterm birth
5115813|NCT01148654|preterm labor|preterm labor
5115814|NCT01148654|PTB|ptb
5115815|NCT01148654|PTL|ptl
5115816|NCT01148641|Lipid-based supplements|lipid-based supplements
5115817|NCT01148641|LNS|lns
5115818|NCT01148641|Acceptability|acceptability
5115819|NCT01148641|Infant nutrition|infant nutrition
5115820|NCT01148641|Guatemala|guatemala
5115821|NCT01148641|Malnutrition|malnutrition
5115822|NCT01148602|Acute stroke|acute stroke
5115823|NCT01148602|Emergency departments|emergency departments
5115824|NCT01148602|Quality Improvement|quality improvement
5115825|NCT01148602|Improved Processes|improved processes
5115826|NCT01148602|tPA|tpa
5115827|NCT01148602|door-to-needle|door-to-needle
5115828|NCT01148602|door-to-treatment|door-to-treatment
5115955|NCT01148108|canfosfamide|canfosfamide
5115829|NCT01148576|hepatic steatosis, chronic hepatitis B, entecavir|hepatic steatosis, chronic hepatitis b, entecavir
5115830|NCT01148563|congestive heart failure|congestive heart failure
5115831|NCT01148563|systolic|systolic
5115832|NCT01148563|chronic disease|chronic disease
5115833|NCT01148563|heart failure|heart failure
5115834|NCT01148550|neonatal acute liver failure|neonatal acute liver failure
5115835|NCT01148550|late-onset liver failure|late-onset liver failure
5115836|NCT01148550|cholestasis,|cholestasis,
5115837|NCT01148550|fatty liver,|fatty liver,
5115838|NCT01148550|liver dysfunction,|liver dysfunction,
5115839|NCT01148550|cirrhosis|cirrhosis
5115840|NCT01148537|Healthy subjects|healthy subjects
5115841|NCT01148537|Opioid|opioid
5115842|NCT01148537|Transdermal|transdermal
5115843|NCT01148524|Meningococcal disease|meningococcal disease
5115844|NCT01148524|Vaccines|vaccines
5115845|NCT01148524|Adolescents|adolescents
5115846|NCT01148511|Macula degeneration|macula degeneration
5115847|NCT01148511|Ranibizumab|ranibizumab
5115848|NCT01148511|Choroidal neovascularisation|choroidal neovascularisation
5115849|NCT01148511|Treat and extend|treat and extend
5115850|NCT01148511|Treat and observe|treat and observe
5115851|NCT01148485|- Staphylococcus aureus Carriage among Athletes|- staphylococcus aureus carriage among athletes
5115852|NCT01148472|Depressive disorder, major|depressive disorder, major
5115853|NCT01148472|Randomized controlled trials|randomized controlled trials
5115854|NCT01148472|Antidepressive agents|antidepressive agents
5115855|NCT01148459|Plasmodium falciparum|plasmodium falciparum
5115856|NCT01148459|schedule|schedule
5115857|NCT01148459|HIV|hiv
5115858|NCT01148459|malaria vaccine|malaria vaccine
5115859|NCT01148459|EPI|epi
5115860|NCT01148459|Africa|africa
5115861|NCT01148446|DLBCL|dlbcl
5115862|NCT01148446|R-CHOP|r-chop
5115863|NCT01148446|R-CEOP|r-ceop
5115864|NCT01148446|Elderly patients|elderly patients
5115865|NCT01148407|breast cancer|breast cancer
5115866|NCT01148407|platelets|platelets
5115867|NCT01148407|metastatic cancer|metastatic cancer
5115868|NCT01148407|malignancy|malignancy
5115869|NCT01148394|Colorectal surgery|colorectal surgery
5115870|NCT01148394|multimodal rehabilitation|multimodal rehabilitation
5115871|NCT01148394|fast track|fast track
5115872|NCT01148394|early feeding|early feeding
5115873|NCT01148381|Genotype|genotype
5115874|NCT01148381|Phenotype|phenotype
5115875|NCT01148381|Characterization|characterization
5115876|NCT01148368|fimasartan|fimasartan
5115877|NCT01148368|renal impairment|renal impairment
5115878|NCT01148368|hypertension|hypertension
5115879|NCT01148355|Craving|craving
5115880|NCT01148355|Moods|moods
5115881|NCT01148355|Adolescents|adolescents
5115882|NCT01148355|Nicotine|nicotine
5115883|NCT01148355|Reinforcement|reinforcement
5115884|NCT01148342|Ecstacy|ecstacy
5115885|NCT01148342|fMRI|fmri
5115886|NCT01148342|Alternative Matrices|alternative matrices
5115887|NCT01148342|Cognitive Training|cognitive training
5115888|NCT01148342|Brain Imaging|brain imaging
5115889|NCT01148329|Coronary stenting|coronary stenting
5115890|NCT01148329|Drug-eluting stent|drug-eluting stent
5115891|NCT01148329|Post-market surveillance study|post-market surveillance study
5115892|NCT01148329|Promus Element stent|promus element stent
5115893|NCT01148316|Developmental Psychiatry|developmental psychiatry
5115894|NCT01148316|Sequential Randomized Clinical Trial|sequential randomized clinical trial
5115895|NCT01148316|Obsessive-Compulsive Disorder D009771|obsessive-compulsive disorder d009771
5115896|NCT01148303|Headache|headache
5115897|NCT01148303|Fasting|fasting
5115898|NCT01148303|Fasting Headache|fasting headache
5115899|NCT01148303|Ramadan|ramadan
5115900|NCT01148303|Ramadan Headache|ramadan headache
5115901|NCT01148303|Yom Kippur|yom kippur
5115902|NCT01148303|Yom Kippur Headache|yom kippur headache
5115903|NCT01148290|bulking agent|bulking agent
5115904|NCT01148290|emivulvectomy|emivulvectomy
5115905|NCT01148290|radical vulvectomy|radical vulvectomy
5115906|NCT01148290|TVT|tvt
5115907|NCT01148290|urinary incontinence|urinary incontinence
5115908|NCT01148290|vulvar cancer|vulvar cancer
5115909|NCT01148277|Endoscopies|endoscopies
5115910|NCT01148277|Liver diseases|liver diseases
5115911|NCT01148277|Propofol|propofol
5115912|NCT01148277|Midazolam and remifentanyl|midazolam and remifentanyl
5115913|NCT01148264|break-through|break-through
5115914|NCT01148264|emesis|emesis
5115915|NCT01148264|break through emesis after prophylaxis with dexamethasone, 5-HT 3RA and aprepitant|break through emesis after prophylaxis with dexamethasone, 5-ht 3ra and aprepitant
5115916|NCT01148238|Autoimmune diabetes|autoimmune diabetes
5115917|NCT01148238|LADA|lada
5115918|NCT01148238|T-reg|t-reg
5115919|NCT01148238|cytokine|cytokine
5115920|NCT01148225|Intermediate-Uveitis|intermediate-uveitis
5115921|NCT01148225|Non-infectious Uveitis|non-infectious uveitis
5115922|NCT01148225|Posterior-Uveitis|posterior-uveitis
5115923|NCT01148225|Active Uveitis|active uveitis
5115924|NCT01148225|Pan-uveitis|pan-uveitis
5115925|NCT01148225|Uveitis|uveitis
5115926|NCT01148199|biliary anastomotic stricture|biliary anastomotic stricture
5115927|NCT01148199|orthotopic liver transplantation|orthotopic liver transplantation
5115928|NCT01148199|ERCP|ercp
5115929|NCT01148186|Polypharmacy|polypharmacy
5115930|NCT01148186|Benzodiazepine use|benzodiazepine use
5115931|NCT01148186|Oxybutynin use|oxybutynin use
5115932|NCT01148186|cognition disorders/drug therapy|cognition disorders/drug therapy
5115933|NCT01148186|incontinence|incontinence
5115934|NCT01148173|CNS relapse|cns relapse
5115935|NCT01148173|aggressive lymphoma|aggressive lymphoma
5115936|NCT01148173|HD-ASCT|hd-asct
5115937|NCT01148160|voriconazole|voriconazole
5115938|NCT01148160|invasive pulmonary aspergillosis|invasive pulmonary aspergillosis
5115939|NCT01148160|hematologic malignancy|hematologic malignancy
5115940|NCT01148160|therapeutic drug monitoring|therapeutic drug monitoring
5115941|NCT01148160|genetic polymorphism|genetic polymorphism
5115942|NCT01148160|efficacy|efficacy
5115943|NCT01148160|safety|safety
5115944|NCT01148147|Adenosine|adenosine
5115945|NCT01148147|randomized trial|randomized trial
5115946|NCT01148147|periprocedural myocardial necrosis|periprocedural myocardial necrosis
5115947|NCT01148147|elective coronary angioplasty|elective coronary angioplasty
5115948|NCT01148108|NHL|nhl
5115949|NCT01148108|Non-Hodgkins Lymphoma|non-hodgkins lymphoma
5115950|NCT01148108|Lymphoma|lymphoma
5115951|NCT01148108|Mantle Cell|mantle cell
5115952|NCT01148108|Diffuse Large B Cell|diffuse large b cell
5115953|NCT01148108|Multiple Myeloma|multiple myeloma
5115954|NCT01148108|Telcyta|telcyta
5115956|NCT01148108|TLK286|tlk286
5115957|NCT01148108|Prodrug|prodrug
5115958|NCT01148108|Enzyme activated drug|enzyme activated drug
5115959|NCT01148108|Glutathione Transferase P1-1 activated drug|glutathione transferase p1-1 activated drug
5115960|NCT01148108|GSTp1-1 activated drug|gstp1-1 activated drug
5115961|NCT01148108|Glutathione Transferase activated drug|glutathione transferase activated drug
5115962|NCT01148108|Glutathione|glutathione
5115963|NCT01148108|Glutathione analong|glutathione analong
5115964|NCT01148095|AZD2516|azd2516
5115965|NCT01148095|Phase 1|phase 1
5115966|NCT01148095|Healthy volunteer|healthy volunteer
5115967|NCT01148095|pharmacokinetics|pharmacokinetics
5115968|NCT01148095|safety|safety
5115969|NCT01148095|tolerability|tolerability
5115970|NCT01148095|Multiple ascending doses|multiple ascending doses
5115971|NCT01148082|Carcinomas (including Squamous Cell and Adenocarcinoma)|carcinomas (including squamous cell and adenocarcinoma)
5115972|NCT01148069|IMRT-IGRT|imrt-igrt
5115973|NCT01148069|radiotherapy toxicity|radiotherapy toxicity
5115974|NCT01148069|seminal vesicles|seminal vesicles
5115975|NCT01148056|IMRT|imrt
5115976|NCT01148056|radiation therapy|radiation therapy
5115977|NCT01148017|Meningococcal|meningococcal
5115978|NCT01148017|ACWY|acwy
5115979|NCT01148017|Conjugate Vaccine|conjugate vaccine
5115980|NCT01148017|Meningitis|meningitis
5115981|NCT01148017|Children|children
5115982|NCT01148017|Persistence|persistence
5115983|NCT01148017|Booster dose|booster dose
5115984|NCT01148004|HIV|hiv
5115985|NCT01148004|Hypertriglyceridemia|hypertriglyceridemia
5115986|NCT01148004|Protease Inhibitors|protease inhibitors
5115987|NCT01148004|Healthy Volunteer|healthy volunteer
5115988|NCT01148004|HV|hv
5115989|NCT01147991|Epstein-Barr virus infection|epstein-barr virus infection
5115990|NCT01147991|stage I nasopharyngeal cancer|stage i nasopharyngeal cancer
5115991|NCT01147991|stage II nasopharyngeal cancer|stage ii nasopharyngeal cancer
5115992|NCT01147991|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
5115993|NCT01147991|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
5115994|NCT01147991|post-transplant lymphoproliferative disorder|post-transplant lymphoproliferative disorder
5115995|NCT01147991|stage I gastric cancer|stage i gastric cancer
5115996|NCT01147991|stage II gastric cancer|stage ii gastric cancer
5115997|NCT01147991|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
5115998|NCT01147991|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
5115999|NCT01147991|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
5116000|NCT01147991|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
5116001|NCT01147991|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
5116002|NCT01147991|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
5116003|NCT01147978|ICU|icu
5116004|NCT01147978|Anxiety|anxiety
5116005|NCT01147978|Depression|depression
5116006|NCT01147978|PTSD|ptsd
5116007|NCT01147965|Colon Cancer|colon cancer
5116008|NCT01147965|Lung Cancer|lung cancer
5116009|NCT01147965|Breast Cancer|breast cancer
5116010|NCT01147965|CEA|cea
5116011|NCT01147952|angina|angina
5116012|NCT01147952|gene expression|gene expression
5116013|NCT01147952|depression|depression
5116014|NCT01147952|anxiety|anxiety
5116015|NCT01147939|Acute Myeloid Leukaemia|acute myeloid leukaemia
5116016|NCT01147939|AML|aml
5116017|NCT01147939|Haematology|haematology
5116018|NCT01147939|Investigator's Choice|investigator's choice
5116019|NCT01147939|Elacytarabine|elacytarabine
5116020|NCT01147939|Refractory or relapsed AML|refractory or relapsed aml
5116021|NCT01147939|Phase III|phase iii
5116022|NCT01147939|Randomized|randomized
5116023|NCT01147939|CLAVELA|clavela
5116024|NCT01147939|CP4055-306|cp4055-306
5116025|NCT01147939|Elacyt|elacyt
5116026|NCT01147926|Constipation|constipation
5116027|NCT01147926|Male|male
5116028|NCT01147913|Major Depression|major depression
5116029|NCT01147913|Depression|depression
5116030|NCT01147913|Anxiety|anxiety
5116031|NCT01147913|Dysthymia|dysthymia
5116032|NCT01147900|Immune persistence|immune persistence
5116033|NCT01147900|Boostrix|boostrix
5116034|NCT01147900|dTpa booster study|dtpa booster study
5116035|NCT01147887|26489112|26489112
5116036|NCT01147887|Omeprazole|omeprazole
5116037|NCT01147887|Tolbutamide|tolbutamide
5116038|NCT01147874|non-therapeutic|non-therapeutic
5116039|NCT01147874|interventional|interventional
5116040|NCT01147861|T2DM|t2dm
5116041|NCT01147861|Pharmacodynamics|pharmacodynamics
5116042|NCT01147861|GSK256073|gsk256073
5116043|NCT01147848|Salmeterol|salmeterol
5116044|NCT01147848|fluticasone furoate|fluticasone furoate
5116045|NCT01147848|Vilanterol|vilanterol
5116046|NCT01147848|fluticasone propionate|fluticasone propionate
5116047|NCT01147848|GW642444|gw642444
5116048|NCT01147835|Herbal lollipops|herbal lollipops
5116049|NCT01147835|Asthma|asthma
5116050|NCT01147835|Dental Caries|dental caries
5116051|NCT01147835|Streptococcus mutans levels|streptococcus mutans levels
5116052|NCT01147835|DMFT/dmft scores|dmft/dmft scores
5116053|NCT01147822|SUTENT|sutent
5116054|NCT01147822|GW76034|gw76034
5116055|NCT01147822|Sunitinib|sunitinib
5116056|NCT01147822|Renal cell carcinoma|renal cell carcinoma
5116057|NCT01147822|Pazopanib|pazopanib
5116058|NCT01147809|Solid Tumor|solid tumor
5116059|NCT01147809|Eltrombopag|eltrombopag
5116060|NCT01147809|chemotherapy-induced thrombocytopenia|chemotherapy-induced thrombocytopenia
5116061|NCT01147809|Thrombocytopenia|thrombocytopenia
5116062|NCT01147796|Thrombus|thrombus
5116063|NCT01147796|computed tomography|computed tomography
5116064|NCT01147796|Transoesophageal echocardiography|transoesophageal echocardiography
5116065|NCT01147770|progesterone|progesterone
5116066|NCT01147770|antagonist|antagonist
5116067|NCT01147770|rec FSH|rec fsh
5116068|NCT01147770|IVF|ivf
5116069|NCT01147770|pregnancy|pregnancy
5116070|NCT01147757|pediatric patients (ASA physical status I or II) aged between|pediatric patients (asa physical status i or ii) aged between
5116071|NCT01147744|Efficacy|efficacy
5116072|NCT01147744|Asthma|asthma
5116073|NCT01147744|Safety|safety
5116074|NCT01147744|Fluticasone Propionate|fluticasone propionate
5116075|NCT01147744|FLAP|flap
5116076|NCT01147744|Beta-agonists|beta-agonists
5116077|NCT01147744|GSK2190915|gsk2190915
5116078|NCT01147744|Montelukast|montelukast
5116079|NCT01147744|Placebo|placebo
5116080|NCT01147744|FLAIR|flair
5116081|NCT01147731|pharmacokinetics|pharmacokinetics
5116082|NCT01147731|albiglutide|albiglutide
5116083|NCT01147731|warfarin|warfarin
5116084|NCT01147731|Healthy volunteers|healthy volunteers
5116085|NCT01147718|pharmacokinetics|pharmacokinetics
5116086|NCT01147718|albiglutide|albiglutide
5116087|NCT01147718|Healthy volunteer|healthy volunteer
5116089|NCT01147705|Peripheral arterial disease|peripheral arterial disease
5116090|NCT01147705|Allopurinol|allopurinol
5116091|NCT01147692|albiglutide|albiglutide
5116092|NCT01147692|simvastatin|simvastatin
5116093|NCT01147692|healthy volunteers|healthy volunteers
5116094|NCT01147692|pharmacokinetics|pharmacokinetics
5116095|NCT01147679|Frontotemporal dementia|frontotemporal dementia
5116096|NCT01147679|Alzheimer's disease|alzheimer's disease
5116097|NCT01147679|Young-Onset|young-onset
5116098|NCT01147679|Frontotemporal degeneration|frontotemporal degeneration
5116099|NCT01147679|control|control
5116100|NCT01147679|social|social
5116101|NCT01147679|behavior|behavior
5116102|NCT01147679|observation|observation
5116103|NCT01147679|emotion|emotion
5116104|NCT01147679|morality|morality
5116105|NCT01147679|dementia|dementia
5116106|NCT01147679|brain|brain
5116107|NCT01147679|relationships|relationships
5116108|NCT01147679|caregiver|caregiver
5116109|NCT01147679|MRI|mri
5116110|NCT01147679|neurology|neurology
5116111|NCT01147666|Kidney|kidney
5116112|NCT01147666|End Stage Renal Disease|end stage renal disease
5116113|NCT01147666|ESRD|esrd
5116114|NCT01147666|Chronic Kidney Disease|chronic kidney disease
5116115|NCT01147666|CKD|ckd
5116116|NCT01147666|Renal|renal
5116117|NCT01147666|Anemia|anemia
5116118|NCT01147666|Oral anemia treatment|oral anemia treatment
5116119|NCT01147666|Hemoglobin levels|hemoglobin levels
5116120|NCT01147666|Blood count|blood count
5116121|NCT01147666|Erythropoietin|erythropoietin
5116122|NCT01147666|Hemodialysis|hemodialysis
5116123|NCT01147666|Normoresponder|normoresponder
5116124|NCT01147666|Hyporesponder|hyporesponder
5116125|NCT01147653|Cerebral Palsy|cerebral palsy
5116126|NCT01147653|CP|cp
5116127|NCT01147653|Spastic Cerebral Palsy|spastic cerebral palsy
5116128|NCT01147653|Cord Blood|cord blood
5116129|NCT01147653|Umbilical Cord Blood|umbilical cord blood
5116130|NCT01147653|Autologous Cord Blood|autologous cord blood
5116131|NCT01147627|diabetes mellitus, type 2|diabetes mellitus, type 2
5116132|NCT01147627|newly diagnosed|newly diagnosed
5116133|NCT01147627|exenatide|exenatide
5116134|NCT01147627|premixed insulin analog|premixed insulin analog
5116135|NCT01147627|thiazolidinedione|thiazolidinedione
5116136|NCT01147627|β-cell function|β-cell function
5116137|NCT01147627|glycemic control|glycemic control
5116138|NCT01147614|Child|child
5116139|NCT01147614|adolescent|adolescent
5116140|NCT01147614|anxiety|anxiety
5116141|NCT01147614|depression|depression
5116142|NCT01147614|internalizing|internalizing
5116143|NCT01147614|cognitive behavioral therapy|cognitive behavioral therapy
5116144|NCT01147614|pediatric primary care|pediatric primary care
5116145|NCT01147601|topical 0.5% Timolol|topical 0.5% timolol
5116146|NCT01147601|infantile hemangioma (IH)|infantile hemangioma (ih)
5116147|NCT01147588|open label|open label
5116148|NCT01147588|randomized|randomized
5116149|NCT01147588|4-treatment|4-treatment
5116150|NCT01147588|3-period|3-period
5116151|NCT01147588|crossover|crossover
5116152|NCT01147588|interaction study|interaction study
5116153|NCT01147588|Safety|safety
5116154|NCT01147588|tolerability|tolerability
5116155|NCT01147588|pharmacokinetics|pharmacokinetics
5116156|NCT01147588|pharmacodynamics|pharmacodynamics
5116157|NCT01147575|Rett Syndrome, Randomized, Methylation|rett syndrome, randomized, methylation
5116158|NCT01147562|Lung cancer|lung cancer
5116159|NCT01147562|Biopsy|biopsy
5116160|NCT01147562|Biomarker|biomarker
5116161|NCT01147562|Tissue Collection|tissue collection
5116162|NCT01147549|ADME|adme
5116163|NCT01147523|nonalcoholic fatty liver disease|nonalcoholic fatty liver disease
5116164|NCT01147523|nonalcoholic steatohepatitis|nonalcoholic steatohepatitis
5116165|NCT01147523|adipokines|adipokines
5116166|NCT01147523|spironolactone|spironolactone
5116167|NCT01147523|vitamin E|vitamin e
5116168|NCT01147523|adiponectin|adiponectin
5116169|NCT01147523|visfatin|visfatin
5116170|NCT01147523|leptin|leptin
5116171|NCT01147523|resistin|resistin
5116172|NCT01147523|TNF-alpha|tnf-alpha
5116173|NCT01147523|IL-6|il-6
5116174|NCT01147523|IL-1|il-1
5116175|NCT01147510|asthma control in elderly patients|asthma control in elderly patients
5116176|NCT01147510|age 60-75|age 60-75
5116177|NCT01147497|IUD insertion|iud insertion
5116178|NCT01147497|nulliparous women|nulliparous women
5116179|NCT01147497|contraception|contraception
5116180|NCT01147497|family planning|family planning
5116181|NCT01147497|IUD insertion in nulliparous women|iud insertion in nulliparous women
5116182|NCT01147484|Breast Cancer|breast cancer
5116183|NCT01147471|flail chest|flail chest
5116184|NCT01147471|rib fixation|rib fixation
5116185|NCT01147458|Cross-over|cross-over
5116186|NCT01147458|safety|safety
5116187|NCT01147458|efficacy|efficacy
5116188|NCT01147458|tolerability|tolerability
5116189|NCT01147458|osteoarthritis|osteoarthritis
5116190|NCT01147458|knee|knee
5116191|NCT01147458|pain|pain
5116192|NCT01147445|Enterotoxigenic Escherichia coli, vaccine|enterotoxigenic escherichia coli, vaccine
5116193|NCT01147432|Healthy male volunteers|healthy male volunteers
5116194|NCT01147432|capsaicin challenge|capsaicin challenge
5116195|NCT01147432|safety|safety
5116196|NCT01147432|toleration|toleration
5116197|NCT01147419|critical limb ischemia|critical limb ischemia
5116198|NCT01147419|peripheral artery occlusive disease|peripheral artery occlusive disease
5116199|NCT01147419|femoropopliteal artery bypass|femoropopliteal artery bypass
5116200|NCT01147419|Stent|stent
5116201|NCT01147367|exercise|exercise
5116202|NCT01147367|breast cancer|breast cancer
5116203|NCT01147367|physical activity|physical activity
5116204|NCT01147367|fatigue|fatigue
5116205|NCT01147367|sleep dysfunction|sleep dysfunction
5116206|NCT01147367|cytokines|cytokines
5116207|NCT01147367|muscle strength|muscle strength
5116208|NCT01147367|inflammation|inflammation
5116209|NCT01147354|Hemodialysis|hemodialysis
5116210|NCT01147354|oxidative stress|oxidative stress
5116211|NCT01147354|selenium|selenium
5116212|NCT01147354|inflammation|inflammation
5116213|NCT01147341|rheumatoid arthritis|rheumatoid arthritis
5116214|NCT01147341|anti-TNF therapy|anti-tnf therapy
5116215|NCT01147328|Health information technology|health information technology
5116216|NCT01147328|Health information exchange|health information exchange
5116217|NCT01147328|Virtual health record|virtual health record
5116218|NCT01147328|Health care utilization|health care utilization
5116219|NCT01147315|mandibular osteoradionecrosis|mandibular osteoradionecrosis
5116220|NCT01147315|hybrid bone substitution|hybrid bone substitution
5116221|NCT01147315|calcium-phosphate ceramic biomaterial|calcium-phosphate ceramic biomaterial
5116222|NCT01147315|autologous bone marrow|autologous bone marrow
5116223|NCT01147289|lumbar sciatic pain|lumbar sciatic pain
5116224|NCT01147289|moderate to severe lumbar sciatic pain within the last three days|moderate to severe lumbar sciatic pain within the last three days
5116225|NCT01147276|DPP-4|dpp-4
5116226|NCT01147276|GLP-1|glp-1
5116227|NCT01147276|Glucagon|glucagon
5116228|NCT01147276|Catecholamines|catecholamines
5116229|NCT01147276|Counterregulation|counterregulation
5116230|NCT01147276|Type 1 diabetes|type 1 diabetes
5116231|NCT01147263|Fibromyalgia|fibromyalgia
5116232|NCT01147263|Autonomic dysfunction|autonomic dysfunction
5116233|NCT01147263|Tachycardia|tachycardia
5116234|NCT01147263|Palpitations|palpitations
5116235|NCT01147224|Asthma|asthma
5116236|NCT01147224|Allergy|allergy
5116237|NCT01147224|Ciclesonide|ciclesonide
5116238|NCT01147224|Alvesco|alvesco
5116239|NCT01147224|Inhaled steroids|inhaled steroids
5116240|NCT01147211|dose defining|dose defining
5116241|NCT01147211|MK-2206|mk-2206
5116242|NCT01147211|NSCLC With EGFR Mutation|nsclc with egfr mutation
5116243|NCT01147211|NSCLC|nsclc
5116244|NCT01147198|Moderate|moderate
5116245|NCT01147198|Wasting|wasting
5116246|NCT01147198|Malnutrition|malnutrition
5116247|NCT01147198|Ready to Use Food|ready to use food
5116248|NCT01147198|Fortified Blended Flour|fortified blended flour
5116249|NCT01147185|Spinal Cord Injuries, Locomotor training, Dose-Response|spinal cord injuries, locomotor training, dose-response
5116250|NCT01147172|Nasolabial Folds|nasolabial folds
5116251|NCT01147172|Cosmetic|cosmetic
5116252|NCT01147172|Injectable Dermal Filler|injectable dermal filler
5116253|NCT01147172|Hyaluronic Acid with Lidocaine|hyaluronic acid with lidocaine
5116254|NCT01147146|transurethral surgery|transurethral surgery
5116255|NCT01147133|Platelet aggregation|platelet aggregation
5116256|NCT01147133|Generic|generic
5116257|NCT01147133|Clopidogrel|clopidogrel
5116258|NCT01147133|Comparison|comparison
5116259|NCT01147133|VASP-PRI|vasp-pri
5116260|NCT01147107|HIV/HCV co-infection|hiv/hcv co-infection
5116261|NCT01147107|Antiretroviral therapy|antiretroviral therapy
5116262|NCT01147081|Influenza vaccine|influenza vaccine
5116263|NCT01147081|Vaccine|vaccine
5116264|NCT01147068|Influenza|influenza
5116265|NCT01147055|crizotinib|crizotinib
5116266|NCT01147055|healthy volunteers|healthy volunteers
5116267|NCT01147055|rifampin|rifampin
5116268|NCT01147055|pharmacokinetics|pharmacokinetics
5116269|NCT01147055|single dose|single dose
5116270|NCT01147042|NADPH Oxidase-Nicotinamide Adenine Dinucleotide Phosphate|nadph oxidase-nicotinamide adenine dinucleotide phosphate
5116271|NCT01147042|Chronic Granulomatous Disease|chronic granulomatous disease
5116272|NCT01147042|Gene Mutation|gene mutation
5116273|NCT01147042|Superoxide by Phagocytes|superoxide by phagocytes
5116274|NCT01147042|Interferon-Gamma|interferon-gamma
5116275|NCT01147029|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5116276|NCT01147016|estrogen receptor-negative breast cancer|estrogen receptor-negative breast cancer
5116277|NCT01147016|HER2-negative breast cancer|her2-negative breast cancer
5116278|NCT01147016|male breast cancer|male breast cancer
5116279|NCT01147016|progesterone receptor-negative breast cancer|progesterone receptor-negative breast cancer
5116280|NCT01147016|recurrent breast cancer|recurrent breast cancer
5116281|NCT01147016|stage IIA breast cancer|stage iia breast cancer
5116282|NCT01147016|stage IIB breast cancer|stage iib breast cancer
5116283|NCT01147016|stage IIIA breast cancer|stage iiia breast cancer
5116284|NCT01147016|stage IIIB breast cancer|stage iiib breast cancer
5116285|NCT01147016|triple-negative breast cancer|triple-negative breast cancer
5116286|NCT01147003|Seizure frequency|seizure frequency
5116287|NCT01147003|nervous system diseases|nervous system diseases
5116288|NCT01147003|brain diseases|brain diseases
5116289|NCT01147003|neurologic manifestations|neurologic manifestations
5116290|NCT01147003|adjunctive treatment|adjunctive treatment
5116291|NCT01147003|AEDs|aeds
5116292|NCT01147003|antiepileptic drug|antiepileptic drug
5116293|NCT01146990|17P Efficacy Trial Follow up|17p efficacy trial follow up
5116294|NCT01146977|CBF(+)|cbf(+)
5116295|NCT01146964|Age related cataract|age related cataract
5116296|NCT01146964|Phacoemulsification|phacoemulsification
5116297|NCT01146964|Manual super small incision cataract surgery|manual super small incision cataract surgery
5116298|NCT01146951|Epilepsy|epilepsy
5116299|NCT01146951|Seizures|seizures
5116300|NCT01146938|fimasartan|fimasartan
5116301|NCT01146938|hepatic impairment|hepatic impairment
5116302|NCT01146925|Acute Kidney Injury|acute kidney injury
5116303|NCT01146925|Contrast-Induced Nephropathy|contrast-induced nephropathy
5116304|NCT01146925|Labile Iron|labile iron
5116305|NCT01146925|Iron Chelation|iron chelation
5116306|NCT01146925|Deferiprone|deferiprone
5116307|NCT01146912|Influenza, text message, vaccination|influenza, text message, vaccination
5116308|NCT01146899|influenza, vaccine, clinical decision support|influenza, vaccine, clinical decision support
5116309|NCT01146860|BNO 1016, acute rhinosinusitis|bno 1016, acute rhinosinusitis
5116310|NCT01146847|algorithm|algorithm
5116311|NCT01146847|tight glycemic control|tight glycemic control
5116312|NCT01146847|glucose control|glucose control
5116313|NCT01146847|intensive care|intensive care
5116314|NCT01146847|insulin|insulin
5116315|NCT01146847|ICU|icu
5116316|NCT01146808|Vaccination|vaccination
5116317|NCT01146808|Immunocompromised Host|immunocompromised host
5116318|NCT01146808|Antiviral Agents|antiviral agents
5116319|NCT01146808|Drug Resistance, Viral|drug resistance, viral
5116320|NCT01146808|Resource Allocation|resource allocation
5116321|NCT01146769|Cancer of rectum|cancer of rectum
5116322|NCT01146769|Physiotherapy|physiotherapy
5116323|NCT01146756|MEK inhibitor|mek inhibitor
5116324|NCT01146756|thoracic radiotherapy|thoracic radiotherapy
5116325|NCT01146756|lung cancer|lung cancer
5116326|NCT01146743|EUS-guided transmural cholecystostomy|eus-guided transmural cholecystostomy
5116327|NCT01146730|Anxiety|anxiety
5116328|NCT01146730|Depression|depression
5116329|NCT01146730|Vocational Rehabilitation|vocational rehabilitation
5116330|NCT01146730|Common Mental Disorders|common mental disorders
5116331|NCT01146730|Mental Health Problems|mental health problems
5116332|NCT01146730|Work Related Therapy|work related therapy
5116333|NCT01146717|Mild Cognitive Impairment|mild cognitive impairment
5116334|NCT01146717|Exercise|exercise
5116335|NCT01146704|Obesity|obesity
5116336|NCT01146691|Organizational models|organizational models
5116337|NCT01146691|Intensive care units|intensive care units
5116338|NCT01146691|Physicians|physicians
5116339|NCT01146691|Staffing and scheduling|staffing and scheduling
5116340|NCT01146691|Burnout, professional|burnout, professional
5116341|NCT01146691|Job satisfaction|job satisfaction
5116342|NCT01146691|Education, medical|education, medical
5116343|NCT01146691|Patient satisfaction|patient satisfaction
5116344|NCT01146665|alcohol consumption|alcohol consumption
5116345|NCT01146665|personalized assessment feedback|personalized assessment feedback
5116346|NCT01146665|youth|youth
5116347|NCT01146665|emergency department|emergency department
5116348|NCT01146639|EVAR DynaCT|evar dynact
5116349|NCT01146626|Vitamin D|vitamin d
5116350|NCT01146626|Hepatitis C|hepatitis c
5116351|NCT01146626|Genotype2,3|genotype2,3
5116352|NCT01146626|SVR|svr
5116353|NCT01146626|Naive|naive
5116354|NCT01146626|RVR rate|rvr rate
5116355|NCT01146626|EVR rate|evr rate
5116356|NCT01146626|SVR rate|svr rate
5116357|NCT01146613|Alcohol|alcohol
5116358|NCT01146613|Alcohol abuse|alcohol abuse
5116359|NCT01146613|Alcoholism|alcoholism
5116360|NCT01146613|Alcohol Dependence|alcohol dependence
5116361|NCT01146613|Varenicline|varenicline
5116362|NCT01146613|Drinking|drinking
5116363|NCT01146600|Primary hypersomnia|primary hypersomnia
5116364|NCT01146600|CNS hypersomnia|cns hypersomnia
5116365|NCT01146600|hypersomnia|hypersomnia
5116366|NCT01146600|idiopathic hypersomnia|idiopathic hypersomnia
5116367|NCT01146600|clarithromycin|clarithromycin
5116368|NCT01146600|Narcolepsy without Cataplexy|narcolepsy without cataplexy
5116369|NCT01146587|Stroke|stroke
5116370|NCT01146587|Robotics|robotics
5116371|NCT01146587|Gait|gait
5116372|NCT01146587|Rehabilitation|rehabilitation
5116373|NCT01146574|End-Stage Renal Disease|end-stage renal disease
5116374|NCT01146574|Anemia|anemia
5116375|NCT01146574|Hemodialysis|hemodialysis
5116376|NCT01146574|Renal Anemia|renal anemia
5116377|NCT01146574|ESRD|esrd
5116378|NCT01146548|Fluoxetine effect|fluoxetine effect
5116379|NCT01146548|Multiple System Atrophy|multiple system atrophy
5116380|NCT01146548|MSA|msa
5116381|NCT01146535|interferon-alpha|interferon-alpha
5116382|NCT01146535|oseltamivir|oseltamivir
5116383|NCT01146535|drug therapy, combination|drug therapy, combination
5116384|NCT01146535|influenza|influenza
5116385|NCT01146535|therapies, investigational|therapies, investigational
5116386|NCT01146522|Familial hyperchylomicronemia|familial hyperchylomicronemia
5116387|NCT01146522|Lipoprotein lipase deficiency|lipoprotein lipase deficiency
5116388|NCT01146522|Hyperlipoproteinemia|hyperlipoproteinemia
5116389|NCT01146522|Triglycerides|triglycerides
5116390|NCT01146522|Hypertriglyceridemia|hypertriglyceridemia
5116391|NCT01146522|LCQ908|lcq908
5116392|NCT01146522|Hyperlipoproteinemia associated with lipoprotein lipase deficiency|hyperlipoproteinemia associated with lipoprotein lipase deficiency
5116393|NCT01146509|migraine|migraine
5116394|NCT01146509|headache|headache
5116395|NCT01146496|Pesticide poisoning|pesticide poisoning
5116396|NCT01146496|Suicide|suicide
5116397|NCT01146496|Unintentional poisoning|unintentional poisoning
5116398|NCT01146496|Prevention|prevention
5116399|NCT01146496|Cluster randomised controlled trial|cluster randomised controlled trial
5116400|NCT01146457|Obstetric anesthesia|obstetric anesthesia
5116401|NCT01146457|labor analgesia|labor analgesia
5116402|NCT01146457|morphine|morphine
5116403|NCT01146457|epidural analgesia|epidural analgesia
5116404|NCT01146444|Sunscreening Agents|sunscreening agents
5116405|NCT01146418|Reproductive Techniques, Assisted|reproductive techniques, assisted
5116500|NCT01145950|Etanercept|etanercept
5116406|NCT01146418|Follicle Stimulating Hormone, Human|follicle stimulating hormone, human
5116407|NCT01146418|Fertilization In Vitro|fertilization in vitro
5116408|NCT01146405|Laparoscopic|laparoscopic
5116409|NCT01146392|Epidemiological|epidemiological
5116410|NCT01146392|COPD health care|copd health care
5116411|NCT01146392|treatment in primary care|treatment in primary care
5116412|NCT01146379|stroke|stroke
5116413|NCT01146379|upper extremity|upper extremity
5116414|NCT01146379|paresis|paresis
5116415|NCT01146379|function|function
5116416|NCT01146379|translational research|translational research
5116417|NCT01146366|Early stage lung cancer|early stage lung cancer
5116418|NCT01146366|Cervical mediastinoscopy|cervical mediastinoscopy
5116419|NCT01146366|Observational study|observational study
5116420|NCT01146366|clinical stage T2N0M0 and select T1N0M0 (suvMAX on FDG-PET of >/=10)|clinical stage t2n0m0 and select t1n0m0 (suvmax on fdg-pet of >/=10)
5116421|NCT01146353|peramivir|peramivir
5116422|NCT01146353|CVVH|cvvh
5116423|NCT01146353|CRRT|crrt
5116424|NCT01146353|CVVHD|cvvhd
5116425|NCT01146353|influenza|influenza
5116426|NCT01146353|sieving coefficient|sieving coefficient
5116427|NCT01146353|clearance|clearance
5116428|NCT01146340|Prostatic Neoplasms|prostatic neoplasms
5116429|NCT01146340|Radiotherapy|radiotherapy
5116430|NCT01146340|Hypofractionation|hypofractionation
5116431|NCT01146340|Low and Intermediate Risk Prostate Cancer|low and intermediate risk prostate cancer
5116432|NCT01146327|Multiple Dose Study in Overweight Healthy Subjects|multiple dose study in overweight healthy subjects
5116433|NCT01146327|body weight|body weight
5116434|NCT01146314|family-focused intervention|family-focused intervention
5116435|NCT01146314|pediatric obesity|pediatric obesity
5116436|NCT01146314|diabetes prevention|diabetes prevention
5116437|NCT01146301|Platelet Aggregation Inhibitors|platelet aggregation inhibitors
5116438|NCT01146301|Coronary Artery Bypass Grafting|coronary artery bypass grafting
5116439|NCT01146288|obesity|obesity
5116440|NCT01146288|acetazolamide|acetazolamide
5116441|NCT01146288|furosemide|furosemide
5116442|NCT01146275|Patients who participated in pilot study (31GB0601) and performed breast augmentation with previous formulation of Macrolane|patients who participated in pilot study (31gb0601) and performed breast augmentation with previous formulation of macrolane
5116443|NCT01146262|Antitumoral immune response after autologous dendritic cells vaccination|antitumoral immune response after autologous dendritic cells vaccination
5116444|NCT01146249|Multisensorial integration|multisensorial integration
5116445|NCT01146249|Postural control|postural control
5116446|NCT01146249|Visual reliance|visual reliance
5116447|NCT01146236|Surgical|surgical
5116448|NCT01146236|Infection|infection
5116449|NCT01146236|Post-operative|post-operative
5116450|NCT01146236|Sutures|sutures
5116451|NCT01146236|Staples|staples
5116452|NCT01146197|Hypokalemia|hypokalemia
5116453|NCT01146197|Hypomagnesemia|hypomagnesemia
5116454|NCT01146197|Salt loosing nephropathy|salt loosing nephropathy
5116455|NCT01146184|Cholelithiasis|cholelithiasis
5116456|NCT01146184|Single Incision|single incision
5116457|NCT01146184|Flexible Endoscope|flexible endoscope
5116458|NCT01146184|Ethicon Manually Articulating Device|ethicon manually articulating device
5116459|NCT01146184|Pain|pain
5116460|NCT01146158|Axillary dissection|axillary dissection
5116461|NCT01146145|postoperative|postoperative
5116462|NCT01146145|pain|pain
5116463|NCT01146145|analgesia|analgesia
5116464|NCT01146145|morphine|morphine
5116465|NCT01146145|titration|titration
5116466|NCT01146145|ketamine|ketamine
5116467|NCT01146132|Nutrition|nutrition
5116468|NCT01146132|Physical activity|physical activity
5116469|NCT01146132|Cerebrovascular disease|cerebrovascular disease
5116470|NCT01146132|wine consumption|wine consumption
5116471|NCT01146132|BMI|bmi
5116472|NCT01146132|Pulse transit time|pulse transit time
5116473|NCT01146132|transcranial Doppler sonography|transcranial doppler sonography
5116474|NCT01146119|HAI|hai
5116475|NCT01146119|Influenza|influenza
5116476|NCT01146119|prime|prime
5116477|NCT01146119|boost|boost
5116478|NCT01146119|immune response|immune response
5116479|NCT01146119|seroconversion|seroconversion
5116480|NCT01146119|universal|universal
5116481|NCT01146119|vaccine|vaccine
5116482|NCT01146080|drug eluting stent|drug eluting stent
5116483|NCT01146080|everolimus eluting stent|everolimus eluting stent
5116484|NCT01146080|optical coherence tomography|optical coherence tomography
5116485|NCT01146080|intravascular ultrasound|intravascular ultrasound
5116486|NCT01146067|Bioequivalence|bioequivalence
5116487|NCT01146041|Bioequivalence|bioequivalence
5116488|NCT01146015|Influenza|influenza
5116489|NCT01146015|Vaccine|vaccine
5116490|NCT01146015|CHMP criteria|chmp criteria
5116491|NCT01146002|Attention-deficit/hyperactivity disorder, primarily inattentive or combined type.|attention-deficit/hyperactivity disorder, primarily inattentive or combined type.
5116492|NCT01145989|Relapsed or Refractory Multiple Myeloma|relapsed or refractory multiple myeloma
5116493|NCT01145976|aplastic anemia, fludarabine, cyclophosphamide, thymoglobulin|aplastic anemia, fludarabine, cyclophosphamide, thymoglobulin
5116494|NCT01145963|pasta|pasta
5116495|NCT01145963|appetite|appetite
5116496|NCT01145963|hunger|hunger
5116497|NCT01145963|satiation|satiation
5116498|NCT01145963|nutrition|nutrition
5116499|NCT01145963|Psychological Phenomena and Processes|psychological phenomena and processes
5116501|NCT01145950|Enbrel|enbrel
5116502|NCT01145950|healthy volunteers|healthy volunteers
5116503|NCT01145937|Keratoconus|keratoconus
5116504|NCT01145937|Corneal grafting|corneal grafting
5116505|NCT01145937|Corneal transplantation|corneal transplantation
5116506|NCT01145937|Anterior Lamellar Keratoplasty|anterior lamellar keratoplasty
5116507|NCT01145924|bronchoscopy|bronchoscopy
5116508|NCT01145924|endobronchial ultrasound|endobronchial ultrasound
5116509|NCT01145924|transbronchial needle aspiration|transbronchial needle aspiration
5116510|NCT01145924|lung cancer|lung cancer
5116511|NCT01145924|staging|staging
5116512|NCT01145911|Glaucoma|glaucoma
5116513|NCT01145911|Blood Flow|blood flow
5116514|NCT01145911|Progression|progression
5116515|NCT01145898|Glaucoma|glaucoma
5116516|NCT01145898|Cosopt|cosopt
5116517|NCT01145898|blood flow|blood flow
5116518|NCT01145898|progression|progression
5116519|NCT01145872|Mindfulness|mindfulness
5116520|NCT01145872|clinical trial|clinical trial
5116521|NCT01145872|intervention|intervention
5116522|NCT01145872|prevention|prevention
5116523|NCT01145859|Venous Thrombosis|venous thrombosis
5116524|NCT01145859|Pediatrics|pediatrics
5116525|NCT01145833|obesity|obesity
5116526|NCT01145833|guided self help treatment|guided self help treatment
5116527|NCT01145833|treatment method|treatment method
5116528|NCT01145833|overweight|overweight
5116529|NCT01145833|overweight children and parents|overweight children and parents
5116530|NCT01145833|families with overweight child|families with overweight child
5116531|NCT01145833|efficacy|efficacy
5116532|NCT01145833|body mass index|body mass index
5116533|NCT01145833|weight|weight
5116534|NCT01145820|third molar|third molar
5116535|NCT01145820|trauma|trauma
5116536|NCT01145820|pain|pain
5116537|NCT01145820|wound healing|wound healing
5116538|NCT01145820|post operative morbidity|post operative morbidity
5116539|NCT01145820|acute trauma|acute trauma
5116540|NCT01145820|short-term wound healing|short-term wound healing
5116541|NCT01145807|Distal Subungual Toenail Onychomycosis|distal subungual toenail onychomycosis
5116542|NCT01145794|SHS|shs
5116543|NCT01145781|ectocervical CIN lesions|ectocervical cin lesions
5116544|NCT01145768|Double-blind|double-blind
5116545|NCT01145768|randomized|randomized
5116546|NCT01145768|placebo-controlled|placebo-controlled
5116547|NCT01145768|parallel-group study|parallel-group study
5116548|NCT01145768|Safety|safety
5116549|NCT01145768|pharmacokinetics|pharmacokinetics
5116550|NCT01145755|Depression|depression
5116551|NCT01145742|Type 2 diabetes|type 2 diabetes
5116552|NCT01145742|Hypertension|hypertension
5116553|NCT01145742|Health services research|health services research
5116554|NCT01145742|Health disparities|health disparities
5116555|NCT01145742|Behavior change|behavior change
5116556|NCT01145729|Biomarker feedback|biomarker feedback
5116557|NCT01145729|Smoking cessation|smoking cessation
5116558|NCT01145729|Childhood secondhand smoke exposure|childhood secondhand smoke exposure
5116559|NCT01145716|TFCC injuries|tfcc injuries
5116560|NCT01145716|Distal radius fractures|distal radius fractures
5116561|NCT01145703|Body Composition|body composition
5116562|NCT01145703|Cardiovascular Risk|cardiovascular risk
5116563|NCT01145703|Cognitive Function|cognitive function
5116564|NCT01145690|cognitive behaviour therapy|cognitive behaviour therapy
5116565|NCT01145677|Alcohol dependence|alcohol dependence
5116566|NCT01145677|Alcoholism|alcoholism
5116567|NCT01145677|Topiramate|topiramate
5116568|NCT01145664|Chinese medicines|chinese medicines
5116569|NCT01145664|Severe hand-foot-mouth diseases|severe hand-foot-mouth diseases
5116570|NCT01145664|effectiveness|effectiveness
5116571|NCT01145664|safety|safety
5116572|NCT01145638|cancer|cancer
5116573|NCT01145638|chemotherapy induced anaemia|chemotherapy induced anaemia
5116574|NCT01145638|iron|iron
5116575|NCT01145638|Patients with non-myeloid malignancies and Chemotherapy Induced Anaemia (CIA)|patients with non-myeloid malignancies and chemotherapy induced anaemia (cia)
5116576|NCT01145638|CIA|cia
5116577|NCT01145625|Female Pattern Baldness|female pattern baldness
5116578|NCT01145612|Aortic dilation|aortic dilation
5116579|NCT01145612|Marfan syndrome|marfan syndrome
5116580|NCT01145612|Losartan|losartan
5116581|NCT01145612|Atenolol|atenolol
5116582|NCT01145573|calcium|calcium
5116583|NCT01145573|vitamin D|vitamin d
5116585|NCT01145573|pregnancy|pregnancy
5116586|NCT01145560|severe sepsis|severe sepsis
5116587|NCT01145560|TNF neutralisation|tnf neutralisation
5116588|NCT01145560|septic shock patients|septic shock patients
5116589|NCT01145547|glycemic index|glycemic index
5116590|NCT01145547|Diabetes Mellitus|diabetes mellitus
5116591|NCT01145547|continuous glucose monitoring|continuous glucose monitoring
5116592|NCT01145534|diabetes,|diabetes,
5116593|NCT01145534|medicinal plants,|medicinal plants,
5116594|NCT01145534|glucose|glucose
5116595|NCT01145482|Memory Disorders|memory disorders
5116596|NCT01145482|Alzheimer's Disease|alzheimer's disease
5116597|NCT01145469|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
5116598|NCT01145469|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
5116599|NCT01145469|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5116600|NCT01145469|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5116601|NCT01145469|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
5116602|NCT01145443|Organizational models|organizational models
5116603|NCT01145443|Intensive care units|intensive care units
5116604|NCT01145443|Physicians|physicians
5116605|NCT01145443|Staffing and scheduling|staffing and scheduling
5116606|NCT01145443|Burnout, professional|burnout, professional
5116607|NCT01145443|Job satisfaction|job satisfaction
5116608|NCT01145417|peripheral neuropathic pain|peripheral neuropathic pain
5116609|NCT01145417|pregabalin|pregabalin
5116610|NCT01145417|safety|safety
5116611|NCT01145404|Her2 Gastro Gastric Esophageal Cancer|her2 gastro gastric esophageal cancer
5116612|NCT01145391|hypertension|hypertension
5116613|NCT01145391|blood pressure|blood pressure
5116614|NCT01145391|primary care|primary care
5116615|NCT01145391|patient centered medical home|patient centered medical home
5116616|NCT01145391|health information technology|health information technology
5116617|NCT01145391|clinical inertia|clinical inertia
5116618|NCT01145365|Crohns|crohns
5116619|NCT01145365|Fistula|fistula
5116620|NCT01145365|Perianal Abscess|perianal abscess
5116621|NCT01145365|Perianal|perianal
5116622|NCT01145352|Enbrel-JIA|enbrel-jia
5116623|NCT01145326|venipuncture|venipuncture
5116624|NCT01145326|phlebotomy|phlebotomy
5116625|NCT01145326|pain perception|pain perception
5116626|NCT01145300|COPD|copd
5116627|NCT01145300|Inflammation|inflammation
5116628|NCT01145300|Small airways|small airways
5116629|NCT01145287|Celiac disease|celiac disease
5116630|NCT01145287|Gluten-free diet|gluten-free diet
5116631|NCT01145287|Screen-detected|screen-detected
5116632|NCT01145287|Asymptomatic|asymptomatic
5116633|NCT01145287|Quality of life|quality of life
5116634|NCT01145287|Self-perceived health|self-perceived health
5116635|NCT01145287|Healthcare resource utilization|healthcare resource utilization
5116636|NCT01145274|allopurinol|allopurinol
5116637|NCT01145274|chronic kidney diseae|chronic kidney diseae
5116638|NCT01145261|Anxiety,|anxiety,
5116639|NCT01145261|Emotional Regulation|emotional regulation
5116640|NCT01145248|Cholangiocellular Carcinoma|cholangiocellular carcinoma
5116641|NCT01145235|Breast augmentation with Macrolane|breast augmentation with macrolane
5116642|NCT01145222|CNS 7056|cns 7056
5116643|NCT01145222|Procedural Sedation|procedural sedation
5116644|NCT01145222|Colonoscopy|colonoscopy
5116645|NCT01145209|Arzerra|arzerra
5116646|NCT01145209|Chemoimmunotherapy|chemoimmunotherapy
5116647|NCT01145209|CLL (Chronic Lymphocytic Leukemia)|cll (chronic lymphocytic leukemia)
5116648|NCT01145209|SLL|sll
5116649|NCT01145209|Small Lymphocytic Lymphoma (SLL)|small lymphocytic lymphoma (sll)
5116650|NCT01145196|Retinal Disease|retinal disease
5116651|NCT01145196|Plaquenil-Induced|plaquenil-induced
5116652|NCT01145183|Cocaine Dependence|cocaine dependence
5116653|NCT01145183|Substance Related Disorders|substance related disorders
5116654|NCT01145183|genotype|genotype
5116655|NCT01145170|brainstem gliomas|brainstem gliomas
5116656|NCT01145170|pediatric patients|pediatric patients
5116657|NCT01145157|knee|knee
5116658|NCT01145157|arthroplasty|arthroplasty
5116659|NCT01145144|Dehydroepiandrosterone|dehydroepiandrosterone
5116660|NCT01145144|DHEA|dhea
5116661|NCT01145144|IVF outcome|ivf outcome
5116662|NCT01145144|long protocol IVF|long protocol ivf
5116663|NCT01145144|poor-responder|poor-responder
5116664|NCT01145144|recombinant LH|recombinant lh
5116665|NCT01145144|embryo quality|embryo quality
5116666|NCT01145144|pregnancy rate|pregnancy rate
5116667|NCT01145144|live birth rate|live birth rate
5116668|NCT01145144|poor response to ovarian stimulation|poor response to ovarian stimulation
5116669|NCT01145131|muscle|muscle
5116670|NCT01145131|FSR|fsr
5116671|NCT01145131|protein|protein
5116672|NCT01145131|meat|meat
5116673|NCT01145118|Plantar Fasciitis|plantar fasciitis
5116674|NCT01145118|Physiotherapy|physiotherapy
5116675|NCT01145105|Low back pain|low back pain
5116676|NCT01145105|Sciatica|sciatica
5116677|NCT01145105|Pain|pain
5116678|NCT01145105|Physiotherapy|physiotherapy
5116679|NCT01145092|type 2 diabetes|type 2 diabetes
5116680|NCT01145092|exercise training|exercise training
5116681|NCT01145092|ATP-synthesis|atp-synthesis
5116682|NCT01145092|intramyocellular lipids|intramyocellular lipids
5116683|NCT01145092|hepatocellular lipids|hepatocellular lipids
5116684|NCT01145092|first degree relatives of T2DM patients|first degree relatives of t2dm patients
5116685|NCT01145066|diabetes|diabetes
5116686|NCT01145066|metabolic syndrome|metabolic syndrome
5116687|NCT01145066|inflammation|inflammation
5116688|NCT01145066|botanical oils|botanical oils
5116689|NCT01145040|Overt primary hypothyroidism|overt primary hypothyroidism
5116690|NCT01145040|Overt primary hyperthyroidism|overt primary hyperthyroidism
5116691|NCT01145040|Thyrotropic feedback control|thyrotropic feedback control
5116692|NCT01145040|Mathematical modelling|mathematical modelling
5116693|NCT01145040|Nonlinear modelling|nonlinear modelling
5116694|NCT01145040|Thyroid|thyroid
5116695|NCT01145040|Pituitary|pituitary
5116696|NCT01145040|Physiological cybernetics|physiological cybernetics
5116697|NCT01145040|Full-dose levothyroxine substitution therapy|full-dose levothyroxine substitution therapy
5116698|NCT01145040|Syndrome T|syndrome t
5116699|NCT01145027|Capillary recruitment|capillary recruitment
5116700|NCT01145027|Cephalic Phase of Insulin Secretion|cephalic phase of insulin secretion
5116701|NCT01145027|Dietary Intake|dietary intake
5116702|NCT01145001|smoking|smoking
5116703|NCT01145001|adolescents|adolescents
5116704|NCT01145001|contingency management|contingency management
5116705|NCT01145001|nicotine replacement therapy|nicotine replacement therapy
5116706|NCT01144988|Recurrent Malignant Glioma|recurrent malignant glioma
5116707|NCT01144988|Bevacizumab / Irinotecan|bevacizumab / irinotecan
5116708|NCT01144988|Functional MR Imaging|functional mr imaging
5116709|NCT01144988|Metabolic Imaging (FET/FLT-PET)|metabolic imaging (fet/flt-pet)
5116710|NCT01144975|Diabetes|diabetes
5116711|NCT01144975|Type 2|type 2
5116712|NCT01144975|Mellitus|mellitus
5116713|NCT01144962|Crohn's Disease|crohn's disease
5116714|NCT01144962|Fistula|fistula
5116715|NCT01144962|Mesenchymal Stem Cell|mesenchymal stem cell
5116716|NCT01144962|Mesenchymal Stromal Cell|mesenchymal stromal cell
5116717|NCT01144962|MSC|msc
5116718|NCT01144962|IBD|ibd
5116719|NCT01144949|ureteral calculi|ureteral calculi
5116720|NCT01144949|renal colic|renal colic
5116721|NCT01144949|ureteral stones|ureteral stones
5116722|NCT01144949|kidney stones|kidney stones
5116723|NCT01144949|medical expulsive therapy|medical expulsive therapy
5116724|NCT01144923|epidural steroid injection|epidural steroid injection
5116725|NCT01144923|neck pain|neck pain
5116726|NCT01144923|pharmacotherapy|pharmacotherapy
5116727|NCT01144923|radiculopathy|radiculopathy
5116728|NCT01144910|asthma|asthma
5116729|NCT01144910|preschool child|preschool child
5116730|NCT01144910|bronchial hyperresponsiveness|bronchial hyperresponsiveness
5116731|NCT01144910|methacholine challenge test|methacholine challenge test
5116732|NCT01144910|atopy|atopy
5116733|NCT01144897|Castrate resistant|castrate resistant
5116734|NCT01144897|Prostate cancer|prostate cancer
5116735|NCT01144897|Docetaxel|docetaxel
5116736|NCT01144897|Taxotere|taxotere
5116737|NCT01144897|PET Acetate|pet acetate
5116738|NCT01144884|Neck pain|neck pain
5116739|NCT01144884|education|education
5116740|NCT01144884|exercise|exercise
5116741|NCT01144884|clinical prediction rule|clinical prediction rule
5116742|NCT01144871|adolescent|adolescent
5116743|NCT01144871|reproductive health|reproductive health
5116744|NCT01144871|parents|parents
5116745|NCT01144871|STIs|stis
5116746|NCT01144871|confidentiality|confidentiality
5116747|NCT01144871|Examine parental knowledge/attitudes of confidential health services/STI care for adolescents.|examine parental knowledge/attitudes of confidential health services/sti care for adolescents.
5116748|NCT01144871|Examine how parental knowledge/attitudes affects parent's behavioral intentions to support adolescent's access to confidential care.|examine how parental knowledge/attitudes affects parent's behavioral intentions to support adolescent's access to confidential care.
5116749|NCT01144871|Identify key mechanisms to form an intervention to parents knowledge/skills to facilitate teen's access to confidential STI services.|identify key mechanisms to form an intervention to parents knowledge/skills to facilitate teen's access to confidential sti services.
5116750|NCT01144858|atrial fibrillation|atrial fibrillation
5116751|NCT01144858|ablation catheter|ablation catheter
5116752|NCT01144858|left atrial appendage peak emptying velocity|left atrial appendage peak emptying velocity
5116753|NCT01144858|tool for predicting successful catheter ablation|tool for predicting successful catheter ablation
5116754|NCT01144845|Thoracotomy|thoracotomy
5116755|NCT01144845|Thoracic Surgery|thoracic surgery
5116756|NCT01144845|Thoracic Surgical Procedures|thoracic surgical procedures
5116757|NCT01144845|Thoracic Surgery, Video-Assisted|thoracic surgery, video-assisted
5116758|NCT01144845|Lung Neoplasms|lung neoplasms
5116759|NCT01144845|Thoracic Nerves|thoracic nerves
5116760|NCT01144832|visceral hypersensitivity|visceral hypersensitivity
5116761|NCT01144832|mast cells|mast cells
5116762|NCT01144819|STEMI|stemi
5116763|NCT01144819|Acute myocardial infarction|acute myocardial infarction
5116764|NCT01144819|Antiplatelet therapy|antiplatelet therapy
5116765|NCT01144819|aspirin|aspirin
5116766|NCT01144819|clopidogrel|clopidogrel
5116767|NCT01144819|VerifyNow aggregometry|verifynow aggregometry
5116768|NCT01144819|Multiplate aggregometry|multiplate aggregometry
5116769|NCT01144806|SAM|sam
5116770|NCT01144806|RUTF|rutf
5116771|NCT01144806|BIA|bia
5116772|NCT01144806|D2O|d2o
5116773|NCT01144806|Children with severe malnutrition|children with severe malnutrition
5116774|NCT01144741|rehabilitation|rehabilitation
5116775|NCT01144741|surgery|surgery
5116776|NCT01144741|therapy|therapy
5116777|NCT01144741|Quality Of Life|quality of life
5116778|NCT01144741|Health-Related Quality Of Life|health-related quality of life
5116779|NCT01144741|Health Status|health status
5116780|NCT01144741|Depressive Symptoms|depressive symptoms
5116781|NCT01144741|Situational Depression|situational depression
5116782|NCT01144715|Stroke Rehabilitation|stroke rehabilitation
5116783|NCT01144715|Home rehabilitation|home rehabilitation
5116784|NCT01144715|robotic therapy|robotic therapy
5116785|NCT01144702|malaria|malaria
5116786|NCT01144702|Plasmodium falciparum|plasmodium falciparum
5116787|NCT01144702|artesunate and mefloquine combination (ASMQ)|artesunate and mefloquine combination (asmq)
5116788|NCT01144702|treatment|treatment
5116789|NCT01144702|Juruá Valley|juruá valley
5116790|NCT01144702|Brazil|brazil
5116791|NCT01144702|multidrug resistance 1 gene of Plasmodium falciparum -Pfmdr1|multidrug resistance 1 gene of plasmodium falciparum -pfmdr1
5116792|NCT01144689|mindfulness|mindfulness
5116793|NCT01144689|smoking|smoking
5116794|NCT01144689|stress|stress
5116795|NCT01144663|Infants|infants
5116796|NCT01144663|conjugate vaccine|conjugate vaccine
5116797|NCT01144663|immunogenicity|immunogenicity
5116798|NCT01144663|meningococcal vaccine|meningococcal vaccine
5116799|NCT01144663|non-inferiority|non-inferiority
5116800|NCT01144663|co-administration|co-administration
5116801|NCT01144650|Dapsone|dapsone
5116802|NCT01144650|Cerebrovascular Accident, Acute|cerebrovascular accident, acute
5116803|NCT01144650|Neuroprotection|neuroprotection
5116804|NCT01144624|TNF neutralisation|tnf neutralisation
5116805|NCT01144611|valve replacement|valve replacement
5116806|NCT01144611|CABG|cabg
5116807|NCT01144611|SIRTS|sirts
5116808|NCT01144611|Combined aortic valve replacement and CABG surgery|combined aortic valve replacement and cabg surgery
5116809|NCT01144598|Rheumatoid Arthritis|rheumatoid arthritis
5116810|NCT01144598|Disease-Modifying Anti-Rheumatic Drug|disease-modifying anti-rheumatic drug
5116811|NCT01144598|Work Limitation|work limitation
5116812|NCT01144585|RIPC|ripc
5116813|NCT01144585|lung protection|lung protection
5116814|NCT01144585|ischemic reperfusion injury|ischemic reperfusion injury
5116815|NCT01144585|cardiopulmonary bypass|cardiopulmonary bypass
5116816|NCT01144572|Quality of Life|quality of life
5116817|NCT01144572|postmenopausal HR(+)|postmenopausal hr(+)
5116818|NCT01144572|Early Breast Cancer|early breast cancer
5116819|NCT01144572|adjuvant AI treatment|adjuvant ai treatment
5116820|NCT01144572|Quality of Life in Chinese postmenopausal HR(+) EBC patients during adjuvant Aromatase Inhibitors(AIs) treatment|quality of life in chinese postmenopausal hr(+) ebc patients during adjuvant aromatase inhibitors(ais) treatment
5116821|NCT01144559|Femoral|femoral
5116822|NCT01144559|Nerve Block|nerve block
5116823|NCT01144559|Bolus|bolus
5116824|NCT01144559|Continuous Infusion|continuous infusion
5116825|NCT01144559|UCSD|ucsd
5116826|NCT01144559|Perineural Catheter|perineural catheter
5116827|NCT01144559|Volunteer|volunteer
5116828|NCT01144559|lower extremity nerve blocks|lower extremity nerve blocks
5116829|NCT01144546|Passive leg raising|passive leg raising
5116830|NCT01144546|FloTrac/Vigileo|flotrac/vigileo
5116831|NCT01144546|Anesthesia hypotension|anesthesia hypotension
5116832|NCT01144507|Cystic Fibrosis|cystic fibrosis
5116833|NCT01144507|Pancreatic insufficiency|pancreatic insufficiency
5116834|NCT01144494|Aqueous Humor Dynamics|aqueous humor dynamics
5116835|NCT01144494|Aqueous Humor Dynamics and Circadian Rhythms|aqueous humor dynamics and circadian rhythms
5116836|NCT01144481|bone metastasis|bone metastasis
5116837|NCT01144481|breast cancer|breast cancer
5116838|NCT01144481|skeletal related event|skeletal related event
5116839|NCT01144481|HR-pQCT|hr-pqct
5116840|NCT01144481|VFA|vfa
5116841|NCT01144468|breast cancer prevention|breast cancer prevention
5116842|NCT01144468|osteoporosis|osteoporosis
5116843|NCT01144455|Locally Advanced Unresectable Pancreatic Adenocarcinoma|locally advanced unresectable pancreatic adenocarcinoma
5116844|NCT01144455|Metastatic Pancreatic Adenocarcinoma|metastatic pancreatic adenocarcinoma
5116845|NCT01144455|Locally Advanced Unresectable or Metastatic Pancreatic Adenocarcinoma|locally advanced unresectable or metastatic pancreatic adenocarcinoma
5116846|NCT01144442|recurrent ovarian cancer|recurrent ovarian cancer
5116847|NCT01144442|recurrent fallopian tube cancer|recurrent fallopian tube cancer
5116848|NCT01144442|recurrent peritoneal carcinoma|recurrent peritoneal carcinoma
5116849|NCT01144429|Allergic Rhinitis +- intermittent asthma|allergic rhinitis +- intermittent asthma
5116850|NCT01144429|Allergic Rhinoconjunctivitis +- intermittent asthma|allergic rhinoconjunctivitis +- intermittent asthma
5116851|NCT01144429|Specific Immunotherapy|specific immunotherapy
5116852|NCT01144416|Reproductive Techniques, Assisted|reproductive techniques, assisted
5116853|NCT01144416|Follicle Stimulating Hormone, Human|follicle stimulating hormone, human
5116854|NCT01144416|Fertilization In Vitro|fertilization in vitro
5116855|NCT01144390|heroin dependence|heroin dependence
5116856|NCT01144390|community-based|community-based
5116857|NCT01144390|MMT|mmt
5116858|NCT01144377|osteoporosis|osteoporosis
5116859|NCT01144351|MS|ms
5116860|NCT01144351|SPMS|spms
5116861|NCT01144351|RRMS|rrms
5116862|NCT01144351|Relapsing Forms of Secondary Progressive Multiple Sclerosis (SPMS)|relapsing forms of secondary progressive multiple sclerosis (spms)
5116863|NCT01144351|or Relapsing-Remitting Multiple Sclerosis (RRMS)|or relapsing-remitting multiple sclerosis (rrms)
5116864|NCT01144338|exenatide once weekly|exenatide once weekly
5116865|NCT01144338|cardiovascular|cardiovascular
5116866|NCT01144338|Bydureon|bydureon
5116867|NCT01144338|Amylin|amylin
5116868|NCT01144325|Minimally Invasive Esophagectomy|minimally invasive esophagectomy
5116869|NCT01144312|LDLT|ldlt
5116870|NCT01144299|Influenza|influenza
5116871|NCT01144286|VVC|vvc
5116872|NCT01144286|candidiasis|candidiasis
5116873|NCT01144286|vaginal candidiasis|vaginal candidiasis
5116874|NCT01144260|CLL|cll
5116875|NCT01144260|leukemia|leukemia
5116876|NCT01144260|chronic lymphocytic leukemia|chronic lymphocytic leukemia
5116877|NCT01144247|Recurrent Grade III or Grade IV Gliomas|recurrent grade iii or grade iv gliomas
5116878|NCT01144247|anaplastic astrocytoma|anaplastic astrocytoma
5116879|NCT01144247|anaplastic oligodendroglioma|anaplastic oligodendroglioma
5116880|NCT01144247|anaplastic mixed glioma|anaplastic mixed glioma
5116881|NCT01144247|glioblastoma multiforme|glioblastoma multiforme
5116882|NCT01144247|biotherapy|biotherapy
5116883|NCT01144247|malignant meningioma|malignant meningioma
5116884|NCT01144234|Prevention of mother-to-child transmission of HIV-1|prevention of mother-to-child transmission of hiv-1
5116885|NCT01144221|Chronic Ischemic Heart Disease|chronic ischemic heart disease
5116886|NCT01144208|Radius fracture|radius fracture
5116887|NCT01144208|Adverse effects|adverse effects
5116888|NCT01144208|Wrist|wrist
5116889|NCT01144208|Postoperative complications|postoperative complications
5116890|NCT01144208|Colles' fracture|colles' fracture
5116891|NCT01144208|Intraoperative complications|intraoperative complications
5116892|NCT01144208|Osteoporosis|osteoporosis
5116893|NCT01144208|Dual-energy x-ray absorptiometry (DXA)|dual-energy x-ray absorptiometry (dxa)
5116894|NCT01144208|Bone Density|bone density
5116895|NCT01144182|heart failure|heart failure
5116896|NCT01144182|quality of life|quality of life
5116897|NCT01144182|readmissions|readmissions
5116898|NCT01144169|Renal cell carcinoma|renal cell carcinoma
5116899|NCT01144169|Hydroxychloroquine|hydroxychloroquine
5116900|NCT01144169|Nephrectomy|nephrectomy
5116901|NCT01144169|Autophagy|autophagy
5116902|NCT01144156|Crohn's disease|crohn's disease
5116903|NCT01144156|Small bowel|small bowel
5116904|NCT01144156|Mucosal healing|mucosal healing
5116905|NCT01144156|Capsule endoscopy|capsule endoscopy
5116906|NCT01144156|Adalimumab|adalimumab
5116907|NCT01144156|Small bowel Crohn's disease|small bowel crohn's disease
5116908|NCT01144143|Mild to moderate osteoarthritis of the knee|mild to moderate osteoarthritis of the knee
5116909|NCT01144117|Progressive Multiple Sclerosis|progressive multiple sclerosis
5116910|NCT01144091|diabetes mellitus|diabetes mellitus
5116911|NCT01144091|creatinin level|creatinin level
5116912|NCT01144091|contrast induced nephropathy|contrast induced nephropathy
5116913|NCT01144091|prevention contrast induced nephropathy in high risk patients|prevention contrast induced nephropathy in high risk patients
5116914|NCT01144078|Adiposity|adiposity
5116915|NCT01144078|Exercise training|exercise training
5116916|NCT01144078|Older adults|older adults
5116917|NCT01144065|Myocardial infarction|myocardial infarction
5116918|NCT01144065|Cortisol|cortisol
5116919|NCT01144065|Testosterone|testosterone
5116920|NCT01144052|Natalizumab|natalizumab
5116921|NCT01144052|Interferon-beta 1b|interferon-beta 1b
5116922|NCT01144052|De-escalation|de-escalation
5116923|NCT01144052|Ticino|ticino
5116924|NCT01144026|HIV|hiv
5116925|NCT01144026|vaccine|vaccine
5116926|NCT01144026|lipopeptide|lipopeptide
5116927|NCT01144026|Tat|tat
5116928|NCT01144026|TUTI-16|tuti-16
5116929|NCT01144026|THYMON|thymon
5116930|NCT01144000|Prosthetic joint infection|prosthetic joint infection
5116931|NCT01144000|daptomycin|daptomycin
5116932|NCT01144000|staphylococcus|staphylococcus
5116933|NCT01143987|hyperparathyroidism|hyperparathyroidism
5116934|NCT01143987|pulse wave velocity|pulse wave velocity
5116935|NCT01143987|end-stage renal disease|end-stage renal disease
5116936|NCT01143987|arterial stiffness|arterial stiffness
5116937|NCT01143974|progress free survival|progress free survival
5116938|NCT01143974|response rate|response rate
5116939|NCT01143974|safety|safety
5116940|NCT01143961|Positive pressure ventilation|positive pressure ventilation
5116941|NCT01143961|Electrical impedance tomography|electrical impedance tomography
5116942|NCT01143948|Diabetes|diabetes
5116943|NCT01143948|Cirrhosis|cirrhosis
5116944|NCT01143948|Insulin|insulin
5116945|NCT01143948|Inpatient|inpatient
5116946|NCT01143935|Liver volume estimation|liver volume estimation
5116947|NCT01143935|Indian population|indian population
5116948|NCT01143922|Intraoperative ultrasound|intraoperative ultrasound
5116949|NCT01143922|GI tract malignancies|gi tract malignancies
5116950|NCT01143922|modality|modality
5116951|NCT01143922|ultrasound|ultrasound
5116952|NCT01143922|staging modality|staging modality
5116953|NCT01143909|Fresh frozen plasma|fresh frozen plasma
5116954|NCT01143909|Coagulopathy|coagulopathy
5116955|NCT01143909|Intensive care|intensive care
5116956|NCT01143909|Adverse effects|adverse effects
5116957|NCT01143909|Lung injury|lung injury
5116958|NCT01143896|Hepatitis C|hepatitis c
5116959|NCT01143896|Depression|depression
5116960|NCT01143896|Collaborative care|collaborative care
5116961|NCT01143896|Antiviral treatment|antiviral treatment
5116962|NCT01143883|All patients undergoing a colorectal resection|all patients undergoing a colorectal resection
5116963|NCT01143883|surgical site infections|surgical site infections
5116964|NCT01143844|Oncofertility|oncofertility
5116965|NCT01143844|Fertility|fertility
5116966|NCT01143844|Late effects|late effects
5116967|NCT01143844|cancer|cancer
5116968|NCT01143844|chemotherapy|chemotherapy
5116969|NCT01143844|radiation therapy|radiation therapy
5116970|NCT01143844|survivor|survivor
5116971|NCT01143844|ovarian reserve|ovarian reserve
5116972|NCT01143844|premature ovarian failure|premature ovarian failure
5116973|NCT01143844|early menopause|early menopause
5116974|NCT01143844|healthy volunteers|healthy volunteers
5116975|NCT01143844|perimenopause|perimenopause
5116976|NCT01143844|middle age|middle age
5116977|NCT01143844|pediatric survivors|pediatric survivors
5116978|NCT01143844|healthy women|healthy women
5116979|NCT01143831|Vitamin K|vitamin k
5116980|NCT01143831|Thrombosis|thrombosis
5116981|NCT01143818|Male hypogonadism|male hypogonadism
5116982|NCT01143805|Absolute Bioavailability|absolute bioavailability
5116983|NCT01143805|Rheumatoid Arthritis|rheumatoid arthritis
5116984|NCT01143792|Substance abuse|substance abuse
5116985|NCT01143792|Homelessness|homelessness
5116986|NCT01143792|HIV risk behavior|hiv risk behavior
5116987|NCT01143779|Advanced Malignancy|advanced malignancy
5116988|NCT01143779|FLT-PET Scan|flt-pet scan
5116989|NCT01143779|[F-18]-fluoro-L-thymidine|[f-18]-fluoro-l-thymidine
5116990|NCT01143779|FLT|flt
5116991|NCT01143779|Positron emission tomography|positron emission tomography
5116992|NCT01143779|PET|pet
5116993|NCT01143779|Imaging Biomarker|imaging biomarker
5116994|NCT01143779|Temsirolimus|temsirolimus
5116995|NCT01143779|Topotecan|topotecan
5116996|NCT01143779|Bortezomib|bortezomib
5116997|NCT01143766|Sedation|sedation
5116998|NCT01143766|Gabapentin|gabapentin
5116999|NCT01143766|ERCP|ercp
5117000|NCT01143766|Endoscopy|endoscopy
5117001|NCT01143675|Humerus fractures|humerus fractures
5117002|NCT01143675|Tomography, x-ray computed|tomography, x-ray computed
5117003|NCT01143675|Bone and bones|bone and bones
5117004|NCT01143675|Orthopedic fixation devices|orthopedic fixation devices
5117005|NCT01143675|Surgery|surgery
5117006|NCT01143675|Postoperative complications|postoperative complications
5117007|NCT01143675|Osteoporosis|osteoporosis
5117008|NCT01143675|Intraoperative complications|intraoperative complications
5117009|NCT01143675|Bone density|bone density
5117010|NCT01143675|Radiography, dual-energy scanned projection|radiography, dual-energy scanned projection
5117011|NCT01143662|peginterferon|peginterferon
5117012|NCT01143662|interferon|interferon
5117013|NCT01143662|Pegasys|pegasys
5117014|NCT01143662|HBV|hbv
5117015|NCT01143662|Hepatitis B|hepatitis b
5117016|NCT01143662|HBeAg positive|hbeag positive
5117017|NCT01143649|Stroke|stroke
5117018|NCT01143649|Transcranial direct current stimulation|transcranial direct current stimulation
5117019|NCT01143649|Motor function|motor function
5117020|NCT01143636|Transcranial direct current stimulation|transcranial direct current stimulation
5117021|NCT01143636|Chronic Pelvic Pain|chronic pelvic pain
5117022|NCT01143623|antibiotic|antibiotic
5117023|NCT01143623|diarrhea|diarrhea
5117024|NCT01143623|probiotic|probiotic
5117025|NCT01143610|Root coverage|root coverage
5117026|NCT01143610|Graft|graft
5117027|NCT01143610|Soft tissue|soft tissue
5117028|NCT01143610|Periodontal regeneration|periodontal regeneration
5117029|NCT01143597|task-specific training|task-specific training
5117030|NCT01143597|arm and hand function|arm and hand function
5117031|NCT01143597|corticomotor plasticity|corticomotor plasticity
5117032|NCT01143597|individuals with motor-incomplete spinal cord injury|individuals with motor-incomplete spinal cord injury
5117033|NCT01143584|Prolactin|prolactin
5117034|NCT01143584|Cabergoline|cabergoline
5117035|NCT01143584|Macroadenomas|macroadenomas
5117036|NCT01143584|escalation|escalation
5117037|NCT01143571|Microbiome|microbiome
5117038|NCT01143571|Samples|samples
5117039|NCT01143558|Borrelia Burgdorferi|borrelia burgdorferi
5117040|NCT01143558|Xenodiagnosis|xenodiagnosis
5117041|NCT01143558|Ticks|ticks
5117042|NCT01143558|Skin Biopsy|skin biopsy
5117043|NCT01143558|Lyme Disease|lyme disease
5117044|NCT01143545|Cancer Vaccine|cancer vaccine
5117045|NCT01143545|Immunotherapy|immunotherapy
5117046|NCT01143545|Adjuvant Therapy|adjuvant therapy
5117047|NCT01143545|Surgical Intervention|surgical intervention
5117048|NCT01143545|Lung Cancer|lung cancer
5117049|NCT01143545|Esophageal Cancer|esophageal cancer
5117050|NCT01143545|Thymic Carcinoma|thymic carcinoma
5117051|NCT01143545|Malignant Pleural Mesothelioma|malignant pleural mesothelioma
5117052|NCT01143532|African-Americans|african-americans
5117053|NCT01143532|MYH9|myh9
5117054|NCT01143532|Chronic Kidney Disease|chronic kidney disease
5117055|NCT01143532|Focal Segmental Glomerulosclerosis|focal segmental glomerulosclerosis
5117056|NCT01143532|Proteinuria|proteinuria
5117057|NCT01143532|Kidney Disease|kidney disease
5117058|NCT01143532|Kidney Transplant|kidney transplant
5117059|NCT01143532|African-American|african-american
5117060|NCT01143519|p53|p53
5117061|NCT01143519|Inflammatory Response|inflammatory response
5117062|NCT01143519|Gene Association|gene association
5117063|NCT01143519|Nutlin|nutlin
5117064|NCT01143519|Doxorubicin|doxorubicin
5117065|NCT01143519|Healthy Volunteer|healthy volunteer
5117066|NCT01143519|HV|hv
5117067|NCT01143506|Sense of Agency|sense of agency
5117068|NCT01143506|Ulnar Nerve Block|ulnar nerve block
5117069|NCT01143506|Healthy Volunteer|healthy volunteer
5117070|NCT01143506|fMRI|fmri
5117071|NCT01143506|EEG|eeg
5117072|NCT01143493|Genetic Polymorphism|genetic polymorphism
5117073|NCT01143493|Glucocorticoid|glucocorticoid
5117074|NCT01143493|Health Volunteer|health volunteer
5117076|NCT01143480|Endotoxin|endotoxin
5117077|NCT01143480|Cytokines|cytokines
5117078|NCT01143480|Gene Association|gene association
5117079|NCT01143480|Inflammatory Response|inflammatory response
5117080|NCT01143480|Healthy Volunteer|healthy volunteer
5117081|NCT01143480|HV|hv
5117082|NCT01143467|Fatigue|fatigue
5117083|NCT01143467|Mitochondria|mitochondria
5117084|NCT01143467|Mitochondrial Abnormality|mitochondrial abnormality
5117085|NCT01143467|Oxidative Stress|oxidative stress
5117086|NCT01143467|Gene Expression|gene expression
5117087|NCT01143467|Prostate Cancer|prostate cancer
5117088|NCT01143454|Cardiac Disease|cardiac disease
5117089|NCT01143454|iPS Cells|ips cells
5117090|NCT01143454|Cardiac Risk Factors|cardiac risk factors
5117091|NCT01143454|Cardiac Disease Discovery|cardiac disease discovery
5117092|NCT01143454|Heart Disease|heart disease
5117093|NCT01143454|Heart Disease Risk|heart disease risk
5117094|NCT01143441|Multiple Sclerosis|multiple sclerosis
5117095|NCT01143441|Daclizumab|daclizumab
5117096|NCT01143428|Motor Neuron Disease|motor neuron disease
5117097|NCT01143428|Primary Lateral Sclerosis|primary lateral sclerosis
5117098|NCT01143428|Oxidative Stress|oxidative stress
5117099|NCT01143428|Physiology|physiology
5117100|NCT01143428|PLS|pls
5117101|NCT01143389|Keratoconus|keratoconus
5117102|NCT01143389|Ectasia|ectasia
5117103|NCT01143389|cross linking|cross linking
5117104|NCT01143389|collagen cross linking|collagen cross linking
5117105|NCT01143376|Obesity|obesity
5117106|NCT01143376|exercise|exercise
5117107|NCT01143376|body composition|body composition
5117108|NCT01143376|insulin sensitivity|insulin sensitivity
5117109|NCT01143376|appetite|appetite
5117110|NCT01143376|food intake|food intake
5117111|NCT01143363|Obesity|obesity
5117112|NCT01143363|exercise|exercise
5117113|NCT01143363|appetite|appetite
5117114|NCT01143363|hunger|hunger
5117115|NCT01143363|satiety|satiety
5117116|NCT01143363|food intake|food intake
5117117|NCT01143337|Rheumatoid Arthritis|rheumatoid arthritis
5117118|NCT01143324|Single or double level instrumented fusion|single or double level instrumented fusion
5117119|NCT01143324|Degenerative lumbar spine|degenerative lumbar spine
5117120|NCT01143324|PLIF|plif
5117121|NCT01143324|TLIF|tlif
5117122|NCT01143324|MAST procedure|mast procedure
5117123|NCT01143285|Active nutritional and dietary management|active nutritional and dietary management
5117124|NCT01143285|Metastatic colorectal cancer|metastatic colorectal cancer
5117125|NCT01143285|Non surgical metastatic colorectal cancer|non surgical metastatic colorectal cancer
5117126|NCT01143272|antibiotic|antibiotic
5117127|NCT01143272|associated|associated
5117128|NCT01143272|diarrhoea|diarrhoea
5117129|NCT01143272|saccharomyces boulardii|saccharomyces boulardii
5117130|NCT01143272|Antibiotic-associated diarrhoea (AAD)|antibiotic-associated diarrhoea (aad)
5117131|NCT01143272|Clostridium difficile-associated-diarrhoea (CDAD)|clostridium difficile-associated-diarrhoea (cdad)
5117132|NCT01143259|Ileus|ileus
5117133|NCT01143259|Post operative ileus|post operative ileus
5117134|NCT01143246|Hepatorenal syndrome|hepatorenal syndrome
5117135|NCT01143246|Renal failure|renal failure
5117136|NCT01143246|Cirrhosis|cirrhosis
5117137|NCT01143246|Alcoholic hepatitis|alcoholic hepatitis
5117138|NCT01143246|Ascites|ascites
5117139|NCT01143220|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
5117140|NCT01143220|Heart Failure|heart failure
5117141|NCT01143220|Pathologic Processes|pathologic processes
5117142|NCT01143220|Heart Diseases|heart diseases
5117143|NCT01143220|Tachycardia|tachycardia
5117144|NCT01143220|Cardiovascular Diseases|cardiovascular diseases
5117145|NCT01143220|Ventricular Flutter|ventricular flutter
5117146|NCT01143220|Tachycardia, Ventricular|tachycardia, ventricular
5117147|NCT01143220|Ventricular Fibrillation|ventricular fibrillation
5117148|NCT01143220|Arrhythmias, Cardiac|arrhythmias, cardiac
5117149|NCT01143220|Ease of Use|ease of use
5117150|NCT01143207|AE adverse event|ae adverse event
5117151|NCT01143207|DCF data collection forms|dcf data collection forms
5117152|NCT01143207|DMC Data Monitoring Committee|dmc data monitoring committee
5117153|NCT01143207|FDA U.S.) Food and Drug Administration|fda u.s.) food and drug administration
5117154|NCT01143207|GCP Good Clinical Practice guidelines|gcp good clinical practice guidelines
5117155|NCT01143207|ICH International Conference of Harmonisation|ich international conference of harmonisation
5117156|NCT01143207|IND Investigational New Drug Application|ind investigational new drug application
5117157|NCT01143207|IRB Institutional Review Board|irb institutional review board
5117158|NCT01143207|IU International units|iu international units
5117159|NCT01143207|mg milligram(s)|mg milligram(s)
5117160|NCT01143207|SAE serious adverse event|sae serious adverse event
5117161|NCT01143207|µg microgram|µg microgram
5117162|NCT01143207|ULN upper limit of the normal range|uln upper limit of the normal range
5117163|NCT01143194|Attention|attention
5117164|NCT01143194|Vigilance|vigilance
5117165|NCT01143194|Concentration|concentration
5117166|NCT01143194|Memory|memory
5117167|NCT01143194|Healthy Volunteer|healthy volunteer
5117168|NCT01143181|CMV, ADV, HSV, VAVC, VARV|cmv, adv, hsv, vavc, varv
5117169|NCT01143181|life threatening|life threatening
5117170|NCT01143168|stem cells;|stem cells;
5117171|NCT01143168|diabetes mellitus;|diabetes mellitus;
5117172|NCT01143168|treatment.|treatment.
5117173|NCT01143155|Pneumonia|pneumonia
5117174|NCT01143155|Community-acquired pneumonia|community-acquired pneumonia
5117175|NCT01143155|Healthcare-associated pneumonia|healthcare-associated pneumonia
5117176|NCT01143155|Failure|failure
5117177|NCT01143155|Cardiovascular events|cardiovascular events
5117178|NCT01143155|Outcome|outcome
5117179|NCT01143142|Human papillomavirus|human papillomavirus
5117180|NCT01143142|HPV|hpv
5117181|NCT01143142|Prevention|prevention
5117182|NCT01143142|Tailoring|tailoring
5117183|NCT01143142|Persuasive communication|persuasive communication
5117184|NCT01143142|Adolescent|adolescent
5117185|NCT01143129|Atrial fibrillation|atrial fibrillation
5117186|NCT01143129|Cardiac surgery|cardiac surgery
5117187|NCT01143129|Cardiopulmonary bypass|cardiopulmonary bypass
5117188|NCT01143129|New-onset|new-onset
5117189|NCT01143103|Respiratory therapy in neurologic disorder|respiratory therapy in neurologic disorder
5117190|NCT01143090|Schizophrenia|schizophrenia
5117191|NCT01143090|Lurasidone|lurasidone
5117192|NCT01143090|Latuda|latuda
5117193|NCT01143077|Lurasidone|lurasidone
5117194|NCT01143077|Schizophrenia|schizophrenia
5117195|NCT01143077|Latuda|latuda
5117196|NCT01143064|Brain Injury|brain injury
5117197|NCT01143064|Trauma|trauma
5117198|NCT01143051|Asthma|asthma
5117199|NCT01143051|Pharmacokinetics|pharmacokinetics
5117200|NCT01143051|Epinephrine|epinephrine
5117201|NCT01143051|Bronchodilator|bronchodilator
5117202|NCT01143051|metered dose inhaler|metered dose inhaler
5117203|NCT01143038|ITP|itp
5117204|NCT01143025|Laparoscopic Cholecystectomy|laparoscopic cholecystectomy
5117205|NCT01143025|Nebulization|nebulization
5117206|NCT01143025|Ropivacaine|ropivacaine
5117207|NCT01143012|Group eczema education|group eczema education
5117208|NCT01142986|Methadone|methadone
5117209|NCT01142986|Syringe exchange|syringe exchange
5117210|NCT01142986|Treatment retention|treatment retention
5117211|NCT01142986|Voucher incentives|voucher incentives
5117212|NCT01142947|Inhaled corticosteroids|inhaled corticosteroids
5117213|NCT01142947|Asthma|asthma
5117214|NCT01142947|Pharmacogenomics|pharmacogenomics
5117215|NCT01142947|Genome wide association study|genome wide association study
5117216|NCT01142947|Admixture mapping|admixture mapping
5117217|NCT01142947|Continental population groups|continental population groups
5117218|NCT01142934|Catheter-related bloodstream infections|catheter-related bloodstream infections
5117219|NCT01142934|Chlorhexidine|chlorhexidine
5117220|NCT01142934|Transparent dressings|transparent dressings
5117221|NCT01142921|Stent Occlusion|stent occlusion
5117222|NCT01142921|Biliary Bleeding|biliary bleeding
5117223|NCT01142921|Biliary Perforation|biliary perforation
5117224|NCT01142908|Cardiovascular Disease|cardiovascular disease
5117225|NCT01142908|Hypertension|hypertension
5117226|NCT01142908|Diabetes|diabetes
5117227|NCT01142908|Hyperlipidemia|hyperlipidemia
5117228|NCT01142908|Adherence|adherence
5117229|NCT01142882|adolescent HIV prevention|adolescent hiv prevention
5117230|NCT01142882|web-based interventions|web-based interventions
5117231|NCT01142882|adolescent substance abuse treatment|adolescent substance abuse treatment
5117232|NCT01142882|comparative effectiveness research|comparative effectiveness research
5117233|NCT01142882|HIV prevention|hiv prevention
5117234|NCT01142882|hepatitis prevention|hepatitis prevention
5117235|NCT01142882|STI prevention|sti prevention
5117236|NCT01142869|Carcinoma, Squamous Cell|carcinoma, squamous cell
5117237|NCT01142869|Erbitux|erbitux
5117238|NCT01142869|Neoplasms, Squamous Cell|neoplasms, squamous cell
5117239|NCT01142843|clinical trial|clinical trial
5117240|NCT01142843|mouthwash|mouthwash
5117241|NCT01142843|green propolis|green propolis
5117242|NCT01142843|dental plaque|dental plaque
5117243|NCT01142843|gingivitis|gingivitis
5117244|NCT01142830|Craniotomy|craniotomy
5117245|NCT01142830|Pain|pain
5117246|NCT01142830|Children|children
5117247|NCT01142817|HIV|hiv
5117248|NCT01142817|Women|women
5117249|NCT01142817|Menopause|menopause
5117250|NCT01142817|Dyslipidemia|dyslipidemia
5117251|NCT01142817|Bone Mineral Density|bone mineral density
5117252|NCT01142804|Walking programs|walking programs
5117253|NCT01142804|Physical Activity|physical activity
5117254|NCT01142804|Behavior Modification|behavior modification
5117255|NCT01142804|Social Support|social support
5117256|NCT01142791|Uterine fibroids|uterine fibroids
5117257|NCT01142791|MRgFUS|mrgfus
5117258|NCT01142791|ExAblate|exablate
5117259|NCT01142791|Focused Ultrasound|focused ultrasound
5117260|NCT01142791|Symptomatic uterine fibroids|symptomatic uterine fibroids
5117261|NCT01142765|Vaccine|vaccine
5117262|NCT01142765|Safety|safety
5117263|NCT01142765|Immunogenicity|immunogenicity
5117264|NCT01142765|Protection|protection
5117265|NCT01142765|Sporozoite challenge|sporozoite challenge
5117266|NCT01142713|Small Bowel Radiotherapy Dose|small bowel radiotherapy dose
5117267|NCT01142713|This is a prospective non-randomized open study to evaluate the impact of patient's positioning and use of belly board in rectal radiotherapy|this is a prospective non-randomized open study to evaluate the impact of patient's positioning and use of belly board in rectal radiotherapy
5117268|NCT01142687|Resting energy expenditure (REE)|resting energy expenditure (ree)
5117269|NCT01142687|metabolic rate|metabolic rate
5117270|NCT01142674|Lymphoma, T-Cell, Peripheral|lymphoma, t-cell, peripheral
5117271|NCT01142674|Prognosis|prognosis
5117272|NCT01142674|Outcome|outcome
5117273|NCT01142674|International Cooperation|international cooperation
5117274|NCT01142674|Biological Characteristics|biological characteristics
5117275|NCT01142674|Heterogeneity|heterogeneity
5117276|NCT01142674|Rare Diseases|rare diseases
5117277|NCT01142661|Advanced breast cancer refractory to all commercially available therapies|advanced breast cancer refractory to all commercially available therapies
5117278|NCT01142648|Electroencephalogram|electroencephalogram
5117279|NCT01142648|Electromyogram|electromyogram
5117280|NCT01142648|Entropy Index|entropy index
5117281|NCT01142648|Bispectral Index|bispectral index
5117282|NCT01142648|Reversal of neuromuscular blockade|reversal of neuromuscular blockade
5117283|NCT01142635|Electroencephalogram|electroencephalogram
5117284|NCT01142635|Electromyogram|electromyogram
5117285|NCT01142635|Entropy Index|entropy index
5117286|NCT01142635|Bispectral Index|bispectral index
5117287|NCT01142635|Neuromuscular blockade; rocuronium|neuromuscular blockade; rocuronium
5117288|NCT01142635|Propofol|propofol
5117289|NCT01142635|Intubation|intubation
5117290|NCT01142622|Ovarian Cysts|ovarian cysts
5117291|NCT01142622|Nebulization|nebulization
5117292|NCT01142622|Ropivacaine|ropivacaine
5117293|NCT01142609|Web based videoconferencing|web based videoconferencing
5117294|NCT01142609|methadone|methadone
5117295|NCT01142609|substance abuse counseling|substance abuse counseling
5117296|NCT01142583|Multiple sclerosis|multiple sclerosis
5117297|NCT01142583|Expanded Disability Status Scale|expanded disability status scale
5117298|NCT01142583|Multiple Sclerosis, Relapsing-Remitting|multiple sclerosis, relapsing-remitting
5117299|NCT01142570|Mechanical Ventilation|mechanical ventilation
5117300|NCT01142557|Multiple sclerosis|multiple sclerosis
5117301|NCT01142557|Rebif|rebif
5117302|NCT01142557|Interferon-beta|interferon-beta
5117303|NCT01142544|acute lung injury|acute lung injury
5117304|NCT01142544|incidence|incidence
5117305|NCT01142544|lung damage|lung damage
5117306|NCT01142544|PaO2/FiO2 ratio|pao2/fio2 ratio
5117307|NCT01142518|Interferon beta-1a|interferon beta-1a
5117308|NCT01142518|Multiple Sclerosis|multiple sclerosis
5117309|NCT01142505|wheeze|wheeze
5117310|NCT01142505|preschool|preschool
5117311|NCT01142505|leukotriene|leukotriene
5117312|NCT01142505|montelukast|montelukast
5117313|NCT01142505|5-lipoxygenase|5-lipoxygenase
5117314|NCT01142492|Interferon beta|interferon beta
5117315|NCT01142492|Multiple Sclerosis|multiple sclerosis
5117316|NCT01142479|Breast Cancer|breast cancer
5117317|NCT01142479|Radiotherapy|radiotherapy
5117318|NCT01142479|Chinese herbal medicine|chinese herbal medicine
5117319|NCT01142479|TPE-1|tpe-1
5117320|NCT01142479|Leukopenia|leukopenia
5117321|NCT01142466|Multiple sclerosis|multiple sclerosis
5117322|NCT01142466|Expanded Disability Status Scale|expanded disability status scale
5117323|NCT01142466|Multiple Sclerosis, Relapsing-Remitting|multiple sclerosis, relapsing-remitting
5117324|NCT01142466|Rebif|rebif
5117325|NCT01142466|Beta-1, interferon|beta-1, interferon
5117326|NCT01142453|Multiple sclerosis|multiple sclerosis
5117327|NCT01142453|Rebif|rebif
5117328|NCT01142453|Interferon|interferon
5117329|NCT01142414|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
5117330|NCT01142414|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5117331|NCT01142414|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
5117332|NCT01142414|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5117333|NCT01142414|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
5117334|NCT01142414|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5117335|NCT01142414|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
5117336|NCT01142414|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5117337|NCT01142414|tongue cancer|tongue cancer
5117338|NCT01142375|AML|aml
5117339|NCT01142362|H5N1|h5n1
5117340|NCT01142362|Avian Influenza|avian influenza
5117341|NCT01142362|DNA Vaccine|dna vaccine
5117342|NCT01142362|Intramuscular (IM) Injection|intramuscular (im) injection
5117343|NCT01142362|Electroporation|electroporation
5117344|NCT01142362|Healthy Adults|healthy adults
5117345|NCT01142349|Arthritis|arthritis
5117346|NCT01142349|Group Program|group program
5117347|NCT01142349|Pain|pain
5117348|NCT01142349|Insomnia|insomnia
5117349|NCT01142349|Pain dysfunction and sleep disturbance among older adults with osteoarthritis.|pain dysfunction and sleep disturbance among older adults with osteoarthritis.
5117350|NCT01142336|Alzheimer's Disease|alzheimer's disease
5117351|NCT01142336|Prevention|prevention
5117352|NCT01142336|Spinal Fluid|spinal fluid
5117353|NCT01142336|Biomarkers|biomarkers
5117354|NCT01142336|Simvastatin|simvastatin
5117355|NCT01142297|dental implant|dental implant
5117356|NCT01142297|implant stabilization|implant stabilization
5117357|NCT01142297|type 2 diabetes|type 2 diabetes
5117358|NCT01142297|glycated hemoglobin 8.0-12.0%|glycated hemoglobin 8.0-12.0%
5117359|NCT01142284|Biomarker|biomarker
5117360|NCT01142284|Endothelial Function|endothelial function
5117361|NCT01142284|Peripheral Artery Disease|peripheral artery disease
5117362|NCT01142284|Coronary Artery Disease|coronary artery disease
5117363|NCT01142284|Flow Mediated Dilation|flow mediated dilation
5117364|NCT01142284|Cilostazol|cilostazol
5117365|NCT01142284|Probucol|probucol
5117366|NCT01142271|Distal gastrectomy|distal gastrectomy
5117367|NCT01142271|Reconstruction|reconstruction
5117368|NCT01142271|Reflux|reflux
5117369|NCT01142271|subtotal gastrectomy|subtotal gastrectomy
5117370|NCT01142258|Sleep Disturbances|sleep disturbances
5117371|NCT01142258|Alzheimer disease|alzheimer disease
5117372|NCT01142258|Insomnia|insomnia
5117373|NCT01142258|Trazodone|trazodone
5117374|NCT01142258|Treatment|treatment
5117375|NCT01142245|ulcer bleeding|ulcer bleeding
5117376|NCT01142245|endoscopic therapy|endoscopic therapy
5117377|NCT01142232|autologous stem cell transplantation|autologous stem cell transplantation
5117378|NCT01142219|sickle cell disease|sickle cell disease
5117379|NCT01142219|L-arginine|l-arginine
5117380|NCT01142219|hemolysis|hemolysis
5117381|NCT01142219|nitric oxide|nitric oxide
5117382|NCT01142219|pulmonary arterial hypertension|pulmonary arterial hypertension
5117383|NCT01142206|Obesity|obesity
5117384|NCT01142206|Weight Loss|weight loss
5117385|NCT01142206|Leisure-time activities|leisure-time activities
5117386|NCT01142206|Physical Activity|physical activity
5117387|NCT01142206|Television watching|television watching
5117388|NCT01142206|Dietary Intake|dietary intake
5117389|NCT01142206|Energy|energy
5117390|NCT01142206|Behavioral|behavioral
5117391|NCT01142206|Healthy Eating|healthy eating
5117392|NCT01142193|Epilepsy|epilepsy
5117393|NCT01142193|partial onset seizure|partial onset seizure
5117394|NCT01142193|adjunctive therapy|adjunctive therapy
5117395|NCT01142180|Bleeding peptic ulcer|bleeding peptic ulcer
5117396|NCT01142180|Active bleeding|active bleeding
5117397|NCT01142180|Trans-arterial angiographic embolization|trans-arterial angiographic embolization
5117398|NCT01142167|Ultra-thin colonoscope|ultra-thin colonoscope
5117399|NCT01142154|Cockayne Syndrome|cockayne syndrome
5117400|NCT01142154|Ageing|ageing
5117401|NCT01142154|pediatrics|pediatrics
5117402|NCT01142154|Pharmacokinetics|pharmacokinetics
5117403|NCT01142154|Prodarsan|prodarsan
5117404|NCT01142154|Dwarfism|dwarfism
5117405|NCT01142154|Genetic disease, inborn|genetic disease, inborn
5117406|NCT01142154|DNA Repair-Deficiency Disorders|dna repair-deficiency disorders
5117407|NCT01142154|Tolerability|tolerability
5117408|NCT01142154|Safety|safety
5117409|NCT01142102|Bladder|bladder
5117410|NCT01142102|Radiotherapy|radiotherapy
5117411|NCT01142102|Online|online
5117412|NCT01142102|Adaptive|adaptive
5117413|NCT01142089|traveler's|traveler's
5117414|NCT01142089|diarrhea|diarrhea
5117415|NCT01142089|Rifamycin SV MMX|rifamycin sv mmx
5117416|NCT01142089|Rifamycin|rifamycin
5117417|NCT01142089|MMX|mmx
5117418|NCT01142089|Traveler's Diarrhea|traveler's diarrhea
5117419|NCT01142076|adiposity|adiposity
5117420|NCT01142063|Neratinib|neratinib
5117421|NCT01142050|stem cells;|stem cells;
5117422|NCT01142050|diabetes mellitus;|diabetes mellitus;
5117423|NCT01142050|treatment.|treatment.
5117424|NCT01142037|Healthy volunteer|healthy volunteer
5117425|NCT01142024|contrast medium induced nephropathy|contrast medium induced nephropathy
5117426|NCT01142024|polymorphism of oxidative stress genes|polymorphism of oxidative stress genes
5117427|NCT01142024|antioxidant prevention|antioxidant prevention
5117428|NCT01142011|Waldenstroms|waldenstroms
5117429|NCT01142011|Belimumab|belimumab
5117430|NCT01142011|anti Blys|anti blys
5117431|NCT01142011|monoclonal antibody|monoclonal antibody
5117432|NCT01141985|cataract|cataract
5117433|NCT01141985|cornea|cornea
5117434|NCT01141985|keratoplasty|keratoplasty
5117435|NCT01141972|Vitamin D|vitamin d
5117436|NCT01141972|Obesity|obesity
5117437|NCT01141972|Menopause|menopause
5117438|NCT01141972|Hot Flashes|hot flashes
5117439|NCT01141959|hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
5117440|NCT01141959|cyclophosphamide|cyclophosphamide
5117441|NCT01141959|fludarabine|fludarabine
5117442|NCT01141959|mycophenolate mofetil|mycophenolate mofetil
5117443|NCT01141959|mycophenolic acid|mycophenolic acid
5117444|NCT01141959|biomarkers|biomarkers
5117445|NCT01141946|lung cancer|lung cancer
5117446|NCT01141946|pleural effusion|pleural effusion
5117447|NCT01141946|post-op care|post-op care
5117448|NCT01141946|diaphragmatic ultrasound|diaphragmatic ultrasound
5117449|NCT01141933|Creating meaning|creating meaning
5117450|NCT01141933|Therapy|therapy
5117451|NCT01141933|Cancer|cancer
5117452|NCT01141933|Oncology|oncology
5117453|NCT01141933|Existential|existential
5117454|NCT01141933|Spirituality|spirituality
5117455|NCT01141933|Quality of life|quality of life
5117457|NCT01141933|Psycho-oncology|psycho-oncology
5117458|NCT01141933|French-canadian|french-canadian
5117459|NCT01141933|Cognitive therapy|cognitive therapy
5117460|NCT01141933|Existentialism|existentialism
5117461|NCT01141920|treatment retention|treatment retention
5117462|NCT01141920|methadone maintenance|methadone maintenance
5117463|NCT01141920|treatment induction|treatment induction
5117464|NCT01141920|Retention in methadone maintenance treatment|retention in methadone maintenance treatment
5117465|NCT01141907|heart failure|heart failure
5117466|NCT01141907|self care|self care
5117467|NCT01141907|decision support|decision support
5117468|NCT01141907|telemonitoring|telemonitoring
5117469|NCT01141907|navigator|navigator
5117470|NCT01141894|Proximal Femoral Fracture|proximal femoral fracture
5117471|NCT01141881|Tissue Plasminogen activator,|tissue plasminogen activator,
5117472|NCT01141881|Clinically significant macular edema,|clinically significant macular edema,
5117473|NCT01141881|Refractory Diabetic macular edema ,|refractory diabetic macular edema ,
5117474|NCT01141881|posterior vitreous detachment|posterior vitreous detachment
5117475|NCT01141868|insomnia|insomnia
5117476|NCT01141868|breast cancer survivor|breast cancer survivor
5117477|NCT01141868|Internet intervention|internet intervention
5117478|NCT01141855|Cardiovascular Diseases|cardiovascular diseases
5117479|NCT01141855|Peripheral Vascular Diseases|peripheral vascular diseases
5117480|NCT01141855|Cerebrovascular Stroke|cerebrovascular stroke
5117481|NCT01141855|Lung Diseases, Obstructive|lung diseases, obstructive
5117482|NCT01141855|Asthma|asthma
5117483|NCT01141855|Tobacco Use Disorder|tobacco use disorder
5117484|NCT01141855|Smoking|smoking
5117485|NCT01141855|Smoking Cessation|smoking cessation
5117486|NCT01141842|lung cancer|lung cancer
5117487|NCT01141842|exhalation analysis|exhalation analysis
5117488|NCT01141842|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
5117489|NCT01141842|cancer screening test|cancer screening test
5117490|NCT01141829|NADPH oxidase|nadph oxidase
5117491|NCT01141816|renal cell carcinoma|renal cell carcinoma
5117492|NCT01141816|radiofrequency ablation|radiofrequency ablation
5117493|NCT01141816|contrast enhanced ultrasound|contrast enhanced ultrasound
5117494|NCT01141816|monitoring|monitoring
5117495|NCT01141816|follow up|follow up
5117496|NCT01141803|Apple|apple
5117497|NCT01141803|Apple pomace|apple pomace
5117498|NCT01141803|Metabolomics|metabolomics
5117499|NCT01141803|Gene expression|gene expression
5117500|NCT01141803|Lipid metabolism|lipid metabolism
5117501|NCT01141803|Prevention|prevention
5117502|NCT01141803|Antiinflammatory effect|antiinflammatory effect
5117503|NCT01141790|Glasgow Coma Scale|glasgow coma scale
5117504|NCT01141790|Glasgow Outcome Scale|glasgow outcome scale
5117505|NCT01141790|Ethics|ethics
5117506|NCT01141777|Spirulina platensis|spirulina platensis
5117507|NCT01141777|Insulin resistance|insulin resistance
5117508|NCT01141777|HIV/AIDS|hiv/aids
5117509|NCT01141777|HAART|haart
5117510|NCT01141777|Soya beans|soya beans
5117511|NCT01141764|pediatrics|pediatrics
5117512|NCT01141764|Epilepsy|epilepsy
5117513|NCT01141764|Deep Brain Stimulation|deep brain stimulation
5117514|NCT01141764|Positron Emission Tomography|positron emission tomography
5117515|NCT01141751|Multiple sclerosis|multiple sclerosis
5117516|NCT01141751|Expanded Disability Status Scale|expanded disability status scale
5117517|NCT01141751|Multiple Sclerosis, Relapsing-Remitting; Rebif|multiple sclerosis, relapsing-remitting; rebif
5117518|NCT01141751|Beta-1, interferon|beta-1, interferon
5117519|NCT01141738|stroke|stroke
5117520|NCT01141738|caregiver|caregiver
5117521|NCT01141738|depression|depression
5117522|NCT01141738|mediators|mediators
5117523|NCT01141738|problem-solving|problem-solving
5117524|NCT01141712|HIV|hiv
5117525|NCT01141712|B-cell Lymphoma|b-cell lymphoma
5117526|NCT01141712|Burkitt's Lymphoma|burkitt's lymphoma
5117527|NCT01141712|Follicular Lymphoma|follicular lymphoma
5117528|NCT01141712|Hodgkin's Lymphoma|hodgkin's lymphoma
5117529|NCT01141699|women health behaviors|women health behaviors
5117530|NCT01141686|lung cancer|lung cancer
5117531|NCT01141673|FLT3-ITD|flt3-itd
5117532|NCT01141673|acute myeloid leukemia|acute myeloid leukemia
5117533|NCT01141673|FLT3|flt3
5117534|NCT01141673|D835|d835
5117535|NCT01141647|Adult|adult
5117536|NCT01141647|Depression|depression
5117537|NCT01141647|Supported Employment|supported employment
5117538|NCT01141647|Health Service|health service
5117539|NCT01141647|Humans|humans
5117540|NCT01141647|Outcomes|outcomes
5117541|NCT01141647|Quality of Life|quality of life
5117542|NCT01141647|Veterans/rh (rehabilitation)|veterans/rh (rehabilitation)
5117543|NCT01141647|Workplace|workplace
5117544|NCT01141647|Spinal Cord Injuries|spinal cord injuries
5117545|NCT01141634|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
5117546|NCT01141634|Attention Deficit Disorder|attention deficit disorder
5117547|NCT01141634|ADHD|adhd
5117548|NCT01141634|ADD|add
5117549|NCT01141634|Homeopathy|homeopathy
5117550|NCT01141621|HS|hs
5117551|NCT01141621|congenital hemolytic anemia|congenital hemolytic anemia
5117552|NCT01141621|splenectomy|splenectomy
5117553|NCT01141621|quality of life|quality of life
5117554|NCT01141556|selenium|selenium
5117555|NCT01141556|clinical outcome|clinical outcome
5117556|NCT01141556|heart surgery|heart surgery
5117557|NCT01141543|Plerixafor injection|plerixafor injection
5117558|NCT01141530|Identify novel genes and predict putative proteins in breast cancer.|identify novel genes and predict putative proteins in breast cancer.
5117559|NCT01141530|Find biomarkers that can be used for early detection, diagnosis, and prognosis.|find biomarkers that can be used for early detection, diagnosis, and prognosis.
5117560|NCT01141517|adolescent quit-smoking program.|adolescent quit-smoking program.
5117561|NCT01141504|Supplemental ATP|supplemental atp
5117562|NCT01141504|Muscle Work Performed|muscle work performed
5117563|NCT01141504|Muscle Fatigue|muscle fatigue
5117564|NCT01141491|Sarcoma|sarcoma
5117565|NCT01141491|Metastatic|metastatic
5117566|NCT01141491|Vaccine|vaccine
5117567|NCT01141491|Adjuvant|adjuvant
5117568|NCT01141478|Carcinoma, Hepatocellular|carcinoma, hepatocellular
5117569|NCT01141478|Proton Beam Radiotherapy|proton beam radiotherapy
5117570|NCT01141478|Sorafenib|sorafenib
5117571|NCT01141465|Primary care|primary care
5117572|NCT01141465|Asthma management|asthma management
5117573|NCT01141465|Combined therapy|combined therapy
5117574|NCT01141465|Real-world|real-world
5117575|NCT01141465|Effectiveness|effectiveness
5117576|NCT01141465|Control|control
5117577|NCT01141465|Exacerbations|exacerbations
5117578|NCT01141452|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
5117579|NCT01141452|inhaled corticosteroid|inhaled corticosteroid
5117580|NCT01141452|increase|increase
5117581|NCT01141452|initiate|initiate
5117582|NCT01141452|exacerbations|exacerbations
5117583|NCT01141452|treatment success|treatment success
5117584|NCT01141439|Primary care|primary care
5117585|NCT01141439|Asthma management|asthma management
5117586|NCT01141439|Inhaled corticosteroids|inhaled corticosteroids
5117587|NCT01141439|Beclomethasone dipropionate|beclomethasone dipropionate
5117588|NCT01141439|Fluticasone propionate|fluticasone propionate
5117589|NCT01141439|Metred dose inhaler|metred dose inhaler
5117590|NCT01141439|Extra-fine hydrofluoroalkane|extra-fine hydrofluoroalkane
5117591|NCT01141439|Chlorofluorocarbon|chlorofluorocarbon
5117592|NCT01141426|depression|depression
5117593|NCT01141426|treatment-resistance|treatment-resistance
5117594|NCT01141426|psychodynamic psychotherapy|psychodynamic psychotherapy
5117595|NCT01141426|Treatment refractory depression|treatment refractory depression
5117596|NCT01141374|Stress|stress
5117597|NCT01141361|Claudication|claudication
5117598|NCT01141361|Artery|artery
5117599|NCT01141361|Ambulatory technique|ambulatory technique
5117600|NCT01141361|GPS|gps
5117601|NCT01141335|shrinkage|shrinkage
5117602|NCT01141335|postoperative pain and discomfort|postoperative pain and discomfort
5117603|NCT01141322|drug-induced liver injury|drug-induced liver injury
5117604|NCT01141322|hepatitis, toxic|hepatitis, toxic
5117605|NCT01141322|ursodeoxycholic acid|ursodeoxycholic acid
5117606|NCT01141309|Everolimus|everolimus
5117607|NCT01141309|Sorafenib|sorafenib
5117608|NCT01141309|Thyroid|thyroid
5117609|NCT01141309|10-060|10-060
5117610|NCT01141283|Osteoarthritis|osteoarthritis
5117611|NCT01141283|Opioid|opioid
5117612|NCT01141283|Transdermal|transdermal
5117613|NCT01141270|recombinant human follicle stimulating hormone|recombinant human follicle stimulating hormone
5117614|NCT01141270|pharmacokinetics|pharmacokinetics
5117615|NCT01141270|bioequivalence|bioequivalence
5117616|NCT01141257|Angiocal®; PRS-050-PEG40; Solid tumor; Phase I|angiocal®; prs-050-peg40; solid tumor; phase i
5117617|NCT01141231|hypopharyngeal cancer|hypopharyngeal cancer
5117618|NCT01141231|laryngeal cancer|laryngeal cancer
5117619|NCT01141231|lip and oral cavity cancer|lip and oral cavity cancer
5117620|NCT01141231|nasopharyngeal cancer|nasopharyngeal cancer
5117621|NCT01141231|oropharyngeal cancer|oropharyngeal cancer
5117622|NCT01141231|paranasal sinus and nasal cavity cancer|paranasal sinus and nasal cavity cancer
5117623|NCT01141231|salivary gland cancer|salivary gland cancer
5117624|NCT01141231|radiation toxicity|radiation toxicity
5117625|NCT01141231|xerostomia|xerostomia
5117626|NCT01141231|long-term effects of cancer treatment|long-term effects of cancer treatment
5117627|NCT01141231|oral complications of radiation therapy|oral complications of radiation therapy
5117628|NCT01141218|non-small cell lung cancer|non-small cell lung cancer
5117629|NCT01141205|AIDS vaccines|aids vaccines
5117630|NCT01141205|HIV-1 vaccine|hiv-1 vaccine
5117631|NCT01141205|Therapeutic vaccine|therapeutic vaccine
5117632|NCT01141205|Cellular immunity|cellular immunity
5117633|NCT01141192|vitamin D status|vitamin d status
5117634|NCT01141192|25-OH D|25-oh d
5117635|NCT01141192|ionized calcium|ionized calcium
5117636|NCT01141192|fasting glucose|fasting glucose
5117637|NCT01141192|hemoglobin A1c|hemoglobin a1c
5117638|NCT01141192|fasting insulin|fasting insulin
5117639|NCT01141192|glucose metabolism|glucose metabolism
5117640|NCT01141192|HOMA index|homa index
5117641|NCT01141192|blood lipids|blood lipids
5117642|NCT01141192|type 2 diabetes|type 2 diabetes
5117643|NCT01141192|PTH|pth
5117644|NCT01141192|adiposity|adiposity
5117645|NCT01141192|body fat percentage|body fat percentage
5117646|NCT01141192|dual energy x-ray absorptiometry|dual energy x-ray absorptiometry
5117647|NCT01141192|pulse wave velocity|pulse wave velocity
5117648|NCT01141192|arterial stiffness|arterial stiffness
5117649|NCT01141192|flow-mediated dilation|flow-mediated dilation
5117650|NCT01141192|African American|african american
5117651|NCT01141192|inflammatory markers|inflammatory markers
5117652|NCT01141166|ELDERLY|elderly
5117653|NCT01141166|NUTRITION|nutrition
5117654|NCT01141153|atrial fibrillation|atrial fibrillation
5117655|NCT01141153|Coronary Stent implantation|coronary stent implantation
5117656|NCT01141153|Low-moderate risk of stroke|low-moderate risk of stroke
5117657|NCT01141153|dual antiplatelet therapy|dual antiplatelet therapy
5117658|NCT01141153|anticoagulation|anticoagulation
5117659|NCT01141127|tranexamic acid in pediatric surgery|tranexamic acid in pediatric surgery
5117660|NCT01141127|fibrinolysis and paediatric cardiac surgery|fibrinolysis and paediatric cardiac surgery
5117661|NCT01141114|community health centers|community health centers
5117662|NCT01141114|colorectal cancer screening|colorectal cancer screening
5117663|NCT01141114|urban health|urban health
5117664|NCT01141101|Methicillin-resistant Staphylococcus aureus|methicillin-resistant staphylococcus aureus
5117665|NCT01141101|Neonatal|neonatal
5117666|NCT01141101|Vertical transmission|vertical transmission
5117667|NCT01141101|Horizontal transmission|horizontal transmission
5117668|NCT01141101|MRSA colonization in enrolled infants|mrsa colonization in enrolled infants
5117669|NCT01141101|MRSA colonization obtained from maternal source|mrsa colonization obtained from maternal source
5117670|NCT01141101|MRSA colonization obtained from source other that mother|mrsa colonization obtained from source other that mother
5117671|NCT01141062|Uterine Fibroids|uterine fibroids
5117672|NCT01141049|Alcohol Withdrawal|alcohol withdrawal
5117673|NCT01141049|Reducing Alcohol Consumption|reducing alcohol consumption
5117674|NCT01141049|Promoting abstinence in alcohol-dependent patients|promoting abstinence in alcohol-dependent patients
5117675|NCT01141049|Gabapentin|gabapentin
5117676|NCT01141036|Propofol|propofol
5117677|NCT01141036|Midazolam|midazolam
5117678|NCT01141036|sedation|sedation
5117679|NCT01141036|cirrhosis|cirrhosis
5117680|NCT01141036|endoscopy|endoscopy
5117681|NCT01141036|recovery time|recovery time
5117682|NCT01141036|efficacy and safety of sedation|efficacy and safety of sedation
5117683|NCT01141036|patient satisfaction|patient satisfaction
5117684|NCT01141036|return to baseline function|return to baseline function
5117685|NCT01141036|saturation of oxygen|saturation of oxygen
5117686|NCT01141023|Parkinson|parkinson
5117687|NCT01141023|Bio-markers|bio-markers
5117688|NCT01141023|Neurodegenerative disorder|neurodegenerative disorder
5117689|NCT01141023|Imaging|imaging
5117690|NCT01141023|Prodromal|prodromal
5117691|NCT01141010|Linguistic|linguistic
5117692|NCT01141010|Stress response|stress response
5117693|NCT01141010|Corticosteroid|corticosteroid
5117694|NCT01141010|Cesarean section|cesarean section
5117695|NCT01141010|Anxiety|anxiety
5117696|NCT01141010|Depression|depression
5117697|NCT01141010|Maternal psychosis|maternal psychosis
5117698|NCT01140997|HCV|hcv
5117699|NCT01140997|CHC|chc
5117700|NCT01140997|Hepatitis C, Chronic|hepatitis c, chronic
5117701|NCT01140997|Liver Diseases|liver diseases
5117702|NCT01140997|Hepatitis, Chronic|hepatitis, chronic
5117703|NCT01140997|Hepatitis, Viral, Human|hepatitis, viral, human
5117704|NCT01140997|Hepadnaviridae Infections|hepadnaviridae infections
5117705|NCT01140997|Antiviral Agents|antiviral agents
5117706|NCT01140997|Virus Diseases|virus diseases
5117707|NCT01140997|Peginterferon alfa|peginterferon alfa
5117708|NCT01140984|acute graft versus host disease|acute graft versus host disease
5117709|NCT01140984|intra arterial steroid infusion|intra arterial steroid infusion
5117710|NCT01140984|steroid resistant acute hepatic graft versus host disease|steroid resistant acute hepatic graft versus host disease
5117711|NCT01140971|Balloon dilatation,|balloon dilatation,
5117712|NCT01140971|misoprostol,|misoprostol,
5117713|NCT01140971|cervical ripening,|cervical ripening,
5117714|NCT01140971|obstetric labor,|obstetric labor,
5117715|NCT01140971|labor induced.|labor induced.
5117716|NCT01140958|lung cancer|lung cancer
5117717|NCT01140958|pharmacoeconomics|pharmacoeconomics
5117718|NCT01140958|new agents|new agents
5117719|NCT01140932|Retina|retina
5117720|NCT01140932|Electroretinography|electroretinography
5117721|NCT01140932|Diabetes Mellitus|diabetes mellitus
5117722|NCT01140932|Glucose Intolerance|glucose intolerance
5117723|NCT01140932|Physiology|physiology
5117724|NCT01140906|Major depressive disorder|major depressive disorder
5117725|NCT01140906|Placebo-controlled|placebo-controlled
5117726|NCT01140906|Active reference|active reference
5117727|NCT01140906|Multicenter study|multicenter study
5117728|NCT01140906|Randomised study|randomised study
5117729|NCT01140906|Acute treatment|acute treatment
5117730|NCT01140893|Type 2 diabetes|type 2 diabetes
5117731|NCT01140893|CSII|csii
5117732|NCT01140893|Exenatide|exenatide
5117733|NCT01140893|Double Blind Placebo Controlled Study|double blind placebo controlled study
5117734|NCT01140880|Methamphetamine|methamphetamine
5117735|NCT01140880|Amphetamine|amphetamine
5117736|NCT01140880|Cocaine|cocaine
5117737|NCT01140880|HIV|hiv
5117738|NCT01140880|Post-exposure prophylaxis|post-exposure prophylaxis
5117739|NCT01140880|HIV seronegativity|hiv seronegativity
5117740|NCT01140854|hypertension|hypertension
5117741|NCT01140854|hypotension|hypotension
5117742|NCT01140854|cognitive|cognitive
5117743|NCT01140854|neurocognitive|neurocognitive
5117744|NCT01140854|cognitive dysfunction|cognitive dysfunction
5117745|NCT01140854|postoperative cognitive dysfunction (POCD)|postoperative cognitive dysfunction (pocd)
5117746|NCT01140854|neuropsychometric|neuropsychometric
5117747|NCT01140841|Dyskinesia|dyskinesia
5117748|NCT01140828|Arthritis|arthritis
5117749|NCT01140828|Bone pain|bone pain
5117750|NCT01140828|dyspepsia|dyspepsia
5117751|NCT01140815|Total Knee Arthroplasty|total knee arthroplasty
5117752|NCT01140815|Bicompartmental Knee Arthroplasty|bicompartmental knee arthroplasty
5117753|NCT01140802|First degree relatives|first degree relatives
5117754|NCT01140802|Crohn's disease|crohn's disease
5117755|NCT01140802|Ulcerative colitis|ulcerative colitis
5117756|NCT01140802|Healthy control|healthy control
5117757|NCT01140776|metastasis|metastasis
5117758|NCT01140776|molecular pathology|molecular pathology
5117759|NCT01140763|metastasis|metastasis
5117760|NCT01140750|Heart Rate Variability|heart rate variability
5117761|NCT01140750|Temperature Curve Complexity|temperature curve complexity
5117762|NCT01140750|Autonomic Dysfunction|autonomic dysfunction
5119245|NCT01135693|Detention|detention
5117763|NCT01140750|Prolonged Mechanical Ventilation|prolonged mechanical ventilation
5117764|NCT01140750|Failure to Wean|failure to wean
5117765|NCT01140737|advanced soft tissue sarcoma|advanced soft tissue sarcoma
5117766|NCT01140724|pain|pain
5117767|NCT01140724|genes|genes
5117768|NCT01140724|morphine|morphine
5117769|NCT01140724|respiratory depression|respiratory depression
5117770|NCT01140724|tonsillectomy|tonsillectomy
5117771|NCT01140724|children|children
5117772|NCT01140724|Opioid adverse effects|opioid adverse effects
5117773|NCT01140724|Pharmacogenetics of morphine|pharmacogenetics of morphine
5117774|NCT01140724|Pharmacokinetics of morphine|pharmacokinetics of morphine
5117775|NCT01140724|Personalizing analgesia|personalizing analgesia
5117776|NCT01140685|mucus-stimulated (induced sputum)|mucus-stimulated (induced sputum)
5117777|NCT01140685|lung disease (asthma, COPD, ILD and OLD)|lung disease (asthma, copd, ild and old)
5117778|NCT01140685|HO-1 (heme oxigenase-1)|ho-1 (heme oxigenase-1)
5117779|NCT01140685|oxidative stress|oxidative stress
5117780|NCT01140685|CO (carbon monoxide)|co (carbon monoxide)
5117781|NCT01140685|The oxidative stress in lung diseases|the oxidative stress in lung diseases
5117782|NCT01140672|Healthy volunteers|healthy volunteers
5117783|NCT01140672|pharmacokinetics|pharmacokinetics
5117784|NCT01140672|safety|safety
5117785|NCT01140672|tolerability|tolerability
5117786|NCT01140672|multiple dosing|multiple dosing
5117787|NCT01140672|Diabetic Nephropathies|diabetic nephropathies
5117788|NCT01140659|Hyperhidrosis|hyperhidrosis
5117789|NCT01140659|Thoracic sympathectomy|thoracic sympathectomy
5117790|NCT01140659|Objective measurement of sweat|objective measurement of sweat
5117791|NCT01140646|Hot flashes, dietary supplements, symptom management|hot flashes, dietary supplements, symptom management
5117792|NCT01140633|HIV/AIDS|hiv/aids
5117793|NCT01140633|pediatric|pediatric
5117794|NCT01140633|wireless adherence monitoring|wireless adherence monitoring
5117795|NCT01140633|HIV Infections|hiv infections
5117796|NCT01140620|NMDA receptor antagonism|nmda receptor antagonism
5117797|NCT01140620|cognitive processes|cognitive processes
5117798|NCT01140620|healthy volunteers|healthy volunteers
5117799|NCT01140620|dopamine antagonist|dopamine antagonist
5117800|NCT01140620|schizophrenia|schizophrenia
5117801|NCT01140568|glioma|glioma
5117802|NCT01140568|PDGFR|pdgfr
5117803|NCT01140568|kinase|kinase
5117804|NCT01140568|inhibitor|inhibitor
5117805|NCT01140568|malignant|malignant
5117806|NCT01140568|nilotinib|nilotinib
5117807|NCT01140542|Diabetes Mellitus Type 2|diabetes mellitus type 2
5117808|NCT01140542|Roflumilast|roflumilast
5117809|NCT01140529|Dexmedetomidine|dexmedetomidine
5117810|NCT01140516|Antenatal|antenatal
5117811|NCT01140490|Hemodialysis|hemodialysis
5117812|NCT01140490|Sub-total Parathyroidectomy|sub-total parathyroidectomy
5117813|NCT01140464|Adolescents|adolescents
5117814|NCT01140438|Latent autoimmune diabetes|latent autoimmune diabetes
5117815|NCT01140438|adults|adults
5117816|NCT01140438|Beta cell rest|beta cell rest
5117817|NCT01140438|Insulin secretion|insulin secretion
5117818|NCT01140425|PF-00232798|pf-00232798
5117819|NCT01140425|CCR5|ccr5
5117820|NCT01140425|QT|qt
5117821|NCT01140425|QTc|qtc
5117822|NCT01140425|pharmacokinetics|pharmacokinetics
5117823|NCT01140412|maraviroc|maraviroc
5117824|NCT01140412|fosamprenavir|fosamprenavir
5117825|NCT01140412|drug interaction|drug interaction
5117826|NCT01140412|pharmacokinetics|pharmacokinetics
5117827|NCT01140412|HIV|hiv
5117828|NCT01140412|AIDS|aids
5117829|NCT01140412|CCR5|ccr5
5117830|NCT01140412|protease inhibitor|protease inhibitor
5117831|NCT01140399|1 Acute Decompensated Heart Failure|1 acute decompensated heart failure
5117832|NCT01140399|2 Cardiorenal Syndrome|2 cardiorenal syndrome
5117833|NCT01140399|3 Ultrafiltration|3 ultrafiltration
5117834|NCT01140399|4 Dopamine|4 dopamine
5117835|NCT01140386|venous thromboembolism|venous thromboembolism
5117836|NCT01140386|duplex ultrasound|duplex ultrasound
5117837|NCT01140386|pediatric population|pediatric population
5117838|NCT01140386|Vascular lab duplex ultrasound database|vascular lab duplex ultrasound database
5117839|NCT01140386|Inpatient hospital admission/discharge ICD-9 database|inpatient hospital admission/discharge icd-9 database
5117840|NCT01140386|PTSF pediatric trauma database|ptsf pediatric trauma database
5117841|NCT01140373|Prostate|prostate
5117842|NCT01140373|Autologous T Cells|autologous t cells
5117843|NCT01140373|Castrate Metastatic Prostate Cancer|castrate metastatic prostate cancer
5117844|NCT01140373|cyclophosphamide|cyclophosphamide
5117845|NCT01140373|09-036|09-036
5117846|NCT01140360|Neurofibromas|neurofibromas
5117847|NCT01140347|Hepatocellular carcinoma (HCC)|hepatocellular carcinoma (hcc)
5117848|NCT01140347|recombinant human immunoglobulin G|recombinant human immunoglobulin g
5117849|NCT01140347|subclass 1 (IgG1) monoclonal antibody (MAb)|subclass 1 (igg1) monoclonal antibody (mab)
5117850|NCT01140347|Hepatocellular Carcinoma (HCC) following First-Line Therapy With Sorafenib|hepatocellular carcinoma (hcc) following first-line therapy with sorafenib
5117851|NCT01140334|Psychiatric adherence|psychiatric adherence
5117852|NCT01140334|Voucher incentives|voucher incentives
5117853|NCT01140334|Methadone treatment|methadone treatment
5117854|NCT01140321|Thalassemia|thalassemia
5117855|NCT01140321|Neridronate|neridronate
5117856|NCT01140321|Osteopenia|osteopenia
5117857|NCT01140321|Osteoporosis|osteoporosis
5117858|NCT01140308|Statin Myopathy|statin myopathy
5117859|NCT01140308|CoEnzyme Q10|coenzyme q10
5117860|NCT01140308|CoQ10|coq10
5117861|NCT01140308|Statin Myalgia|statin myalgia
5117862|NCT01140295|Preparation|preparation
5117863|NCT01140295|Pediatric|pediatric
5117864|NCT01140295|Colonoscopy|colonoscopy
5117865|NCT01140282|cancer survivor|cancer survivor
5117866|NCT01140269|Burn|burn
5117867|NCT01140269|Sepsis|sepsis
5117868|NCT01140269|Infection|infection
5117869|NCT01140256|Zinc|zinc
5117870|NCT01140256|SGA|sga
5117871|NCT01140256|AGA|aga
5117872|NCT01140256|stable isotope|stable isotope
5117873|NCT01140243|fat formulation|fat formulation
5117874|NCT01140230|rotator cuff tear|rotator cuff tear
5117875|NCT01140230|rotator cuff repair|rotator cuff repair
5117876|NCT01140230|age|age
5117877|NCT01140230|timing to surgery|timing to surgery
5117878|NCT01140217|contraception|contraception
5117879|NCT01140217|pregnancy|pregnancy
5117880|NCT01140204|stent|stent
5117881|NCT01140204|contrast media|contrast media
5117882|NCT01140204|paclitaxel|paclitaxel
5117883|NCT01140204|stent implantation|stent implantation
5117884|NCT01140191|leishmaniasis|leishmaniasis
5117885|NCT01140191|cutaneous|cutaneous
5117886|NCT01140191|WR 279,396|wr 279,396
5117887|NCT01140191|paromomycin|paromomycin
5117888|NCT01140191|gentamicin|gentamicin
5117889|NCT01140191|pharmacokinetics|pharmacokinetics
5117890|NCT01140191|safety|safety
5117891|NCT01140191|efficacy|efficacy
5117892|NCT01140191|military|military
5117893|NCT01140178|Photodynamic Therapy|photodynamic therapy
5117894|NCT01140178|Oral dysplasia|oral dysplasia
5117895|NCT01140178|oral cavity carcinoma|oral cavity carcinoma
5117896|NCT01140178|oropharynx carcinoma.|oropharynx carcinoma.
5117897|NCT01140152|intestinal transplantation|intestinal transplantation
5117898|NCT01140152|rejection|rejection
5117899|NCT01140152|proteomics|proteomics
5117900|NCT01140152|innate immunity|innate immunity
5117901|NCT01140126|HIV-1, CD4, antibody, immunotherapy|hiv-1, cd4, antibody, immunotherapy
5117902|NCT01140113|hemoconcentration|hemoconcentration
5117903|NCT01140113|ultrafiltration|ultrafiltration
5117904|NCT01140113|coronary artery disease|coronary artery disease
5117905|NCT01140087|Face Transplant|face transplant
5117906|NCT01140087|Composite Tissue Allograft|composite tissue allograft
5117907|NCT01140087|Facial Allotransplantation|facial allotransplantation
5117908|NCT01140074|acute diarrhoea, children|acute diarrhoea, children
5117909|NCT01140048|Asthma|asthma
5117910|NCT01140035|Insulin|insulin
5117911|NCT01140035|Deceased donors|deceased donors
5117912|NCT01140035|Renal Allograft Function|renal allograft function
5117913|NCT01140035|Transplanted Allograft Outcomes|transplanted allograft outcomes
5117914|NCT01140022|Chlamydia, Screening, young women, kiosk, computer module|chlamydia, screening, young women, kiosk, computer module
5117915|NCT01140009|Vaccine|vaccine
5117916|NCT01140009|Seasonal Influenza vaccine|seasonal influenza vaccine
5117917|NCT01140009|Influenza vaccine|influenza vaccine
5117918|NCT01140009|Vaccine safety|vaccine safety
5117919|NCT01140009|Vaccine immunogenicity|vaccine immunogenicity
5117920|NCT01140009|Fluviral 2010/11|fluviral 2010/11
5117921|NCT01139983|osteosarcoma|osteosarcoma
5117922|NCT01139944|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5117923|NCT01139944|stage I non-small cell lung cancer|stage i non-small cell lung cancer
5117924|NCT01139944|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
5117925|NCT01139944|squamous cell lung cancer|squamous cell lung cancer
5117926|NCT01139931|childhood acute myeloid leukemia/other myeloid malignancies|childhood acute myeloid leukemia/other myeloid malignancies
5117927|NCT01139918|psoriatic arthritis|psoriatic arthritis
5117928|NCT01139918|psoriasis|psoriasis
5117929|NCT01139918|Quality of life|quality of life
5117930|NCT01139905|Lopinavir/ritonavir|lopinavir/ritonavir
5117931|NCT01139905|pharmacokinetic|pharmacokinetic
5117932|NCT01139905|low dose|low dose
5117933|NCT01139905|HIV-infected children|hiv-infected children
5117934|NCT01139905|pharmacokinetics of low-dose lopinavir/ritonavir in HIV-1 infected Thai children.|pharmacokinetics of low-dose lopinavir/ritonavir in hiv-1 infected thai children.
5117935|NCT01139892|Unruptured aneurysm|unruptured aneurysm
5117936|NCT01139892|endovascular treatment|endovascular treatment
5117937|NCT01139892|surgical treatment|surgical treatment
5117938|NCT01139892|randomized|randomized
5117939|NCT01139892|intracranial aneurysm|intracranial aneurysm
5117940|NCT01139879|Pressure Ulcer treatment Mattresses|pressure ulcer treatment mattresses
5117941|NCT01139879|Home Care|home care
5117942|NCT01139879|Extended Care|extended care
5117943|NCT01139879|Wound measurements|wound measurements
5117944|NCT01139866|Long-term Safety|long-term safety
5117945|NCT01139866|Shoulder Surgery|shoulder surgery
5117946|NCT01139866|bupivacaine|bupivacaine
5117947|NCT01139853|pyloric stenosis|pyloric stenosis
5117948|NCT01139853|nasogastric tube|nasogastric tube
5117949|NCT01139853|pyloromyotomy|pyloromyotomy
5117950|NCT01139840|vitamin D2|vitamin d2
5117951|NCT01139840|vitamin D3|vitamin d3
5117952|NCT01139840|ergocalciferol|ergocalciferol
5117953|NCT01139840|cholecalciferol|cholecalciferol
5117954|NCT01139840|vitamin D status|vitamin d status
5118048|NCT01139502|cognitive therapy|cognitive therapy
5118049|NCT01139502|cognitive training|cognitive training
5117955|NCT01139840|To determine relative potency of vitamins D2 and D3 under conditions of continuous administration|to determine relative potency of vitamins d2 and d3 under conditions of continuous administration
5117956|NCT01139840|To determine change in vitamin D content of subcutaneous fat after 12 weeks' administration|to determine change in vitamin d content of subcutaneous fat after 12 weeks' administration
5117957|NCT01139827|atherosclerosis|atherosclerosis
5117958|NCT01139827|inflammation|inflammation
5117959|NCT01139827|hsCRP|hscrp
5117960|NCT01139827|Framingham risk score|framingham risk score
5117961|NCT01139827|positron emission tomography|positron emission tomography
5117962|NCT01139827|inflammation in FDG-PET|inflammation in fdg-pet
5117963|NCT01139814|atrial flutter|atrial flutter
5117964|NCT01139814|AVNRT|avnrt
5117965|NCT01139814|right sided accessory pathway|right sided accessory pathway
5117966|NCT01139814|ventricular tachycardia|ventricular tachycardia
5117967|NCT01139814|Patients who have one or more standard indications for a right-sided diagnostic electrophysiology procedure.|patients who have one or more standard indications for a right-sided diagnostic electrophysiology procedure.
5117968|NCT01139801|Cervical Ripening|cervical ripening
5117969|NCT01139801|Rate of Cesearean Section|rate of cesearean section
5117970|NCT01139788|Cancer|cancer
5117971|NCT01139775|solid tumors|solid tumors
5117972|NCT01139775|Mesothelioma|mesothelioma
5117973|NCT01139775|Carcinoma|carcinoma
5117974|NCT01139762|Benign Prostatic Hyperplasia (BPH)|benign prostatic hyperplasia (bph)
5117975|NCT01139762|Enlarged Prostate|enlarged prostate
5117976|NCT01139749|oral isotretinoin|oral isotretinoin
5117977|NCT01139749|sebaceous secretion|sebaceous secretion
5117978|NCT01139749|seborrhea|seborrhea
5117979|NCT01139749|seborrheic dermatitis|seborrheic dermatitis
5117980|NCT01139749|quality of life|quality of life
5117981|NCT01139749|Malassezia|malassezia
5117982|NCT01139736|Irritable bowel syndrome|irritable bowel syndrome
5117983|NCT01139736|IBS|ibs
5117984|NCT01139736|probiotics|probiotics
5117985|NCT01139736|rectal sensitivity|rectal sensitivity
5117986|NCT01139736|gut flora|gut flora
5117987|NCT01139736|gut bacteria|gut bacteria
5117988|NCT01139710|SARCOIDOSIS|sarcoidosis
5117989|NCT01139710|PULMONARY HYPERTENSION|pulmonary hypertension
5117990|NCT01139710|outpatients clinic at Meir medical center|outpatients clinic at meir medical center
5117991|NCT01139697|Heart failure|heart failure
5117992|NCT01139697|Cortisol|cortisol
5117993|NCT01139697|Testosterone|testosterone
5117994|NCT01139684|Exercise test|exercise test
5117995|NCT01139671|Remifentanil|remifentanil
5117996|NCT01139671|Sufentanil|sufentanil
5117997|NCT01139671|Surgical removal of three to four wisdom teeth|surgical removal of three to four wisdom teeth
5117998|NCT01139671|General anaesthesia|general anaesthesia
5117999|NCT01139671|Ambulatory oral surgery|ambulatory oral surgery
5118000|NCT01139671|Target Controlled Infusion (TCI)|target controlled infusion (tci)
5118001|NCT01139671|Opioid induced hyperalgesia|opioid induced hyperalgesia
5118002|NCT01139671|Postoperative nausea and vomiting|postoperative nausea and vomiting
5118003|NCT01139671|Postoperative Morphine consumption|postoperative morphine consumption
5118004|NCT01139671|Under General anaesthesia|under general anaesthesia
5118005|NCT01139671|In Ambulatory surgery|in ambulatory surgery
5118006|NCT01139645|Calcium|calcium
5118007|NCT01139645|bone|bone
5118008|NCT01139645|metabolism|metabolism
5118009|NCT01139645|Proton Pump Inhibitors|proton pump inhibitors
5118010|NCT01139645|Rabeprazole|rabeprazole
5118011|NCT01139645|Esomeprazole|esomeprazole
5118012|NCT01139645|Lanzoprazole|lanzoprazole
5118013|NCT01139645|Vitamin D|vitamin d
5118014|NCT01139645|bone and bones|bone and bones
5118015|NCT01139632|NAFLD|nafld
5118016|NCT01139632|lP-pla2|lp-pla2
5118017|NCT01139632|Coronary Arthery Disease|coronary arthery disease
5118018|NCT01139619|Biopsy Mapping|biopsy mapping
5118019|NCT01139619|Non small cell lung cancer|non small cell lung cancer
5118020|NCT01139619|NSCLC|nsclc
5118021|NCT01139619|Lung cancer diagnosis|lung cancer diagnosis
5118022|NCT01139619|Retrospective|retrospective
5118023|NCT01139619|Inoperable Non Small Cell Lung Cancer|inoperable non small cell lung cancer
5118024|NCT01139593|IVF|ivf
5118025|NCT01139593|ICSI|icsi
5118026|NCT01139593|gonadotropin|gonadotropin
5118027|NCT01139593|am dose|am dose
5118028|NCT01139593|pm dose|pm dose
5118029|NCT01139593|pregnancy|pregnancy
5118030|NCT01139593|implantation|implantation
5118031|NCT01139593|live birth|live birth
5118032|NCT01139580|Plaque Psoriasis|plaque psoriasis
5118033|NCT01139580|Psoriasis|psoriasis
5118034|NCT01139567|Diabetic Wounds|diabetic wounds
5118035|NCT01139567|Hyperbaric Oxygen|hyperbaric oxygen
5118036|NCT01139567|Laser Speckle Imaging|laser speckle imaging
5118037|NCT01139567|Hyperbaric Oxygenation|hyperbaric oxygenation
5118038|NCT01139528|Fracture|fracture
5118039|NCT01139528|5th metacarpal bone|5th metacarpal bone
5118040|NCT01139528|Bouquet pinning|bouquet pinning
5118041|NCT01139528|Fractures of the neck of the 5th metacarpal bone|fractures of the neck of the 5th metacarpal bone
5118042|NCT01139515|pharmacokinetic|pharmacokinetic
5118043|NCT01139515|eletriptan|eletriptan
5118044|NCT01139515|Korean|korean
5118045|NCT01139515|crossover|crossover
5118046|NCT01139502|schizophrenia spectrum disorders|schizophrenia spectrum disorders
5118047|NCT01139502|work rehabilitation|work rehabilitation
5118050|NCT01139502|Adaptation to work|adaptation to work
5118051|NCT01139502|Work as a treatment factor|work as a treatment factor
5118052|NCT01139489|Procalcitonin|procalcitonin
5118053|NCT01139489|antibiotic therapy|antibiotic therapy
5118054|NCT01139489|antibiotics|antibiotics
5118055|NCT01139489|sepsis|sepsis
5118056|NCT01139489|infections|infections
5118057|NCT01139489|biomarker|biomarker
5118058|NCT01139476|Multiple Myeloma|multiple myeloma
5118059|NCT01139476|MGUS|mgus
5118060|NCT01139476|Leukemia|leukemia
5118061|NCT01139476|Biorepository|biorepository
5118062|NCT01139463|antipsychotics|antipsychotics
5118063|NCT01139463|lactates|lactates
5118064|NCT01139463|side effects|side effects
5118065|NCT01139450|Atopic Dermatitis|atopic dermatitis
5118066|NCT01139437|Vaccine|vaccine
5118067|NCT01139437|HPIV2|hpiv2
5118068|NCT01139437|Infants|infants
5118069|NCT01139424|surgical leak|surgical leak
5118070|NCT01139424|endoscopic suturing|endoscopic suturing
5118071|NCT01139424|Anastomotic leakage|anastomotic leakage
5118072|NCT01139424|esophageal or gastric resection|esophageal or gastric resection
5118073|NCT01139398|Cholesterol|cholesterol
5118074|NCT01139398|LDL-cholesterol|ldl-cholesterol
5118075|NCT01139398|Coronary artery disease|coronary artery disease
5118076|NCT01139398|Red yeast rice|red yeast rice
5118077|NCT01139398|Plants extract|plants extract
5118078|NCT01139398|Cholesterol excess.|cholesterol excess.
5118079|NCT01139372|Dry eye, artificial tears|dry eye, artificial tears
5118080|NCT01139359|Lymphoma|lymphoma
5118081|NCT01139359|Darinaparsin|darinaparsin
5118082|NCT01139359|CHOP|chop
5118083|NCT01139359|Frontline|frontline
5118084|NCT01139359|PTCL|ptcl
5118085|NCT01139359|B-cell|b-cell
5118086|NCT01139346|carcinoma|carcinoma
5118087|NCT01139346|sarcoma|sarcoma
5118088|NCT01139346|metastatic|metastatic
5118089|NCT01139346|solid tumor|solid tumor
5118090|NCT01139333|childhood acute myeloid leukemia/other myeloid malignancies|childhood acute myeloid leukemia/other myeloid malignancies
5118091|NCT01139320|untreated childhood acute myeloid leukemia and other myeloid malignancies|untreated childhood acute myeloid leukemia and other myeloid malignancies
5118092|NCT01139307|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
5118093|NCT01139307|childhood acute megakaryocytic leukemia (M7)|childhood acute megakaryocytic leukemia (m7)
5118094|NCT01139307|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5118095|NCT01139307|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5118096|NCT01139307|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
5118097|NCT01139307|untreated childhood acute myeloid leukemia and other myeloid malignancies|untreated childhood acute myeloid leukemia and other myeloid malignancies
5118098|NCT01139294|cardiac output|cardiac output
5118099|NCT01139294|dehydration|dehydration
5118100|NCT01139294|pediatrics|pediatrics
5118101|NCT01139281|Ear protection|ear protection
5118102|NCT01139281|Ginkgo Biloba Extract|ginkgo biloba extract
5118103|NCT01139281|Distortion-product otoacoustic emission|distortion-product otoacoustic emission
5118104|NCT01139281|Ototoxicity|ototoxicity
5118105|NCT01139281|Cisplatin|cisplatin
5118106|NCT01139268|embryo viability|embryo viability
5118107|NCT01139242|CRC screening status|crc screening status
5118108|NCT01139242|physical activity level|physical activity level
5118109|NCT01139242|fruit and vegetable consumption|fruit and vegetable consumption
5118110|NCT01139242|Early Detection of Cancer|early detection of cancer
5118111|NCT01139242|Colorectal Cancer (CRC) screening status|colorectal cancer (crc) screening status
5118112|NCT01139229|Esophagogastrostomy|esophagogastrostomy
5118113|NCT01139229|Circular everted anastomosis|circular everted anastomosis
5118114|NCT01139229|Side-side anastomosis|side-side anastomosis
5118115|NCT01139229|Randomized clinical trial|randomized clinical trial
5118116|NCT01139216|Digestive system diseases|digestive system diseases
5118117|NCT01139216|Gastrointestinal diseases|gastrointestinal diseases
5118118|NCT01139216|Intestinal diseases|intestinal diseases
5118119|NCT01139216|Colonic inertia|colonic inertia
5118120|NCT01139203|HBV recurrence|hbv recurrence
5118121|NCT01139203|entecavir|entecavir
5118122|NCT01139190|NSAID-induced gastroduodenal ulcerations or erosion|nsaid-induced gastroduodenal ulcerations or erosion
5118123|NCT01139177|Peripheral vascular disease - SFA and popliteal arteries.|peripheral vascular disease - sfa and popliteal arteries.
5118124|NCT01139164|high-risk hematological malignancies|high-risk hematological malignancies
5118125|NCT01139151|Advanced Hematologic Malignancies|advanced hematologic malignancies
5118126|NCT01139151|4'-Thio-araC|4'-thio-arac
5118127|NCT01139151|Thiarabine|thiarabine
5118128|NCT01139151|4'-thio-â-D-arabinofuranosylcytosine|4'-thio-â-d-arabinofuranosylcytosine
5118129|NCT01139151|deoxycytidine nucleoside analog|deoxycytidine nucleoside analog
5118130|NCT01139151|poor-risk myelodysplasia|poor-risk myelodysplasia
5118131|NCT01139151|MDS|mds
5118132|NCT01139151|refractory anemia|refractory anemia
5118133|NCT01139151|Excess blasts|excess blasts
5118134|NCT01139151|RAEB-1|raeb-1
5118135|NCT01139151|RAEB-2|raeb-2
5118136|NCT01139151|Chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5118137|NCT01139151|CMML|cmml
5118138|NCT01139151|Relapsed/refractory leukemia|relapsed/refractory leukemia
5118139|NCT01139151|Acute non-lymphocytic leukemia|acute non-lymphocytic leukemia
5118140|NCT01139151|AML|aml
5119037|NCT01136655|Foradil|foradil
5118141|NCT01139151|Acute lymphocytic leukemia|acute lymphocytic leukemia
5118142|NCT01139151|ALL|all
5118143|NCT01139151|Chronic lymphocytic leukemia|chronic lymphocytic leukemia
5118144|NCT01139151|CLL|cll
5118145|NCT01139151|Chronic myelogenous leukemia|chronic myelogenous leukemia
5118146|NCT01139151|CML|cml
5118147|NCT01139151|blast crisis|blast crisis
5118148|NCT01139138|Colorectal Cancer|colorectal cancer
5118149|NCT01139138|Colorectal Carcinoma|colorectal carcinoma
5118150|NCT01139138|Colorectal Tumors|colorectal tumors
5118151|NCT01139138|Neoplasms, Colorectal|neoplasms, colorectal
5118152|NCT01139112|Necrotizing Fasciitis, Klebsiella Pneumoniae|necrotizing fasciitis, klebsiella pneumoniae
5118153|NCT01139086|chronic heart failure|chronic heart failure
5118154|NCT01139086|isokinetic test|isokinetic test
5118155|NCT01139086|near-infrared spectroscopy|near-infrared spectroscopy
5118156|NCT01139086|laser Doppler flowmetry|laser doppler flowmetry
5118157|NCT01139086|endothelial function|endothelial function
5118158|NCT01139073|Halitosis|halitosis
5118159|NCT01139060|chronic or recurrent depression|chronic or recurrent depression
5118160|NCT01139021|Children|children
5118161|NCT01139021|Meningococcal disease|meningococcal disease
5118162|NCT01139021|Prevention|prevention
5118163|NCT01139021|Vaccination|vaccination
5118164|NCT01138995|Poststroke/CVA hemiparesis|poststroke/cva hemiparesis
5118165|NCT01138995|Drop Foot|drop foot
5118166|NCT01138995|Gait Disorders, Neurological|gait disorders, neurological
5118167|NCT01138995|Gait, Drop foot|gait, drop foot
5118168|NCT01138982|Youth mentoring|youth mentoring
5118169|NCT01138982|Effectiveness|effectiveness
5118170|NCT01138982|Sweden|sweden
5118171|NCT01138982|low-risk youth|low-risk youth
5118172|NCT01138969|proton pump inhibitor|proton pump inhibitor
5118173|NCT01138969|peptic ulcer|peptic ulcer
5118174|NCT01138969|clopidogrel|clopidogrel
5118175|NCT01138969|prevention|prevention
5118176|NCT01138956|Visceral leishmaniasis|visceral leishmaniasis
5118177|NCT01138956|N-acetylcysteine|n-acetylcysteine
5118178|NCT01138956|Antimony|antimony
5118179|NCT01138956|Immune response|immune response
5118180|NCT01138943|Chlorhexidine mouthrinse|chlorhexidine mouthrinse
5118181|NCT01138943|Plaque control|plaque control
5118182|NCT01138930|Polycystic Ovary Syndrome|polycystic ovary syndrome
5118183|NCT01138930|Obesity|obesity
5118184|NCT01138904|gastric cancer|gastric cancer
5118185|NCT01138904|oxaliplatin|oxaliplatin
5118186|NCT01138904|irinotecan|irinotecan
5118187|NCT01138904|sequential treatment|sequential treatment
5118188|NCT01138891|Breast implants|breast implants
5118189|NCT01138891|capsular contraction|capsular contraction
5118190|NCT01138891|sonication|sonication
5118191|NCT01138891|biofilm|biofilm
5118192|NCT01138891|Complications|complications
5118193|NCT01138891|surgery|surgery
5118194|NCT01138878|HIV|hiv
5118195|NCT01138878|testing|testing
5118196|NCT01138878|non traditional settings|non traditional settings
5118197|NCT01138878|acceptability|acceptability
5118198|NCT01138878|feasibility|feasibility
5118199|NCT01138865|Obstructive sleep apnea|obstructive sleep apnea
5118200|NCT01138865|Cytokine levels|cytokine levels
5118201|NCT01138865|Insulin resistance|insulin resistance
5118202|NCT01138865|Hypertension|hypertension
5118203|NCT01138865|Dyslipidemia|dyslipidemia
5118204|NCT01138865|Albumin-creatinine ratio|albumin-creatinine ratio
5118205|NCT01138865|Continuous positive airway pressure (CPAP)|continuous positive airway pressure (cpap)
5118206|NCT01138852|post-cesarean infections|post-cesarean infections
5118207|NCT01138852|ampicillin-sulbactam|ampicillin-sulbactam
5118208|NCT01138852|cefuroxime|cefuroxime
5118209|NCT01138852|cesarean|cesarean
5118210|NCT01138839|HELLP 1|hellp 1
5118211|NCT01138839|Dexamethasone|dexamethasone
5118212|NCT01138839|Clinical trial|clinical trial
5118213|NCT01138826|biological availability|biological availability
5118214|NCT01138826|bioavailability|bioavailability
5118215|NCT01138826|amlodipine|amlodipine
5118216|NCT01138826|orally disintegrating tablet|orally disintegrating tablet
5118217|NCT01138826|ODT|odt
5118218|NCT01138826|tablets|tablets
5118219|NCT01138813|magnetic resonance spectroscopy (MRS)|magnetic resonance spectroscopy (mrs)
5118220|NCT01138813|lactate editing|lactate editing
5118221|NCT01138813|metabolite content|metabolite content
5118222|NCT01138813|glioma|glioma
5118223|NCT01138774|Obesity|obesity
5118224|NCT01138774|Calorie restriction|calorie restriction
5118225|NCT01138774|Eicosapentaenoic acid (EPA)|eicosapentaenoic acid (epa)
5118226|NCT01138774|Lipoic acid|lipoic acid
5118227|NCT01138774|Weight loss|weight loss
5118228|NCT01138774|Insulin sensitivity|insulin sensitivity
5118229|NCT01138774|Lipid metabolism|lipid metabolism
5118230|NCT01138774|Adipokines|adipokines
5118231|NCT01138774|Inflammation|inflammation
5118232|NCT01138774|Oxidative stress|oxidative stress
5118233|NCT01138774|Adipose tissue gene profile|adipose tissue gene profile
5118234|NCT01138774|Metabolomic profile|metabolomic profile
5118235|NCT01138761|pediatric atopic dermatitis|pediatric atopic dermatitis
5118236|NCT01138761|EASI|easi
5118237|NCT01138761|REALM-SF|realm-sf
5118238|NCT01138761|nurse instruction|nurse instruction
5118239|NCT01138761|health literacy|health literacy
5118240|NCT01138748|inoperable early stage non-small cell lung cancer|inoperable early stage non-small cell lung cancer
5118241|NCT01138748|radiation therapy|radiation therapy
5118242|NCT01138722|early stage non-small cell lung cancer|early stage non-small cell lung cancer
5118243|NCT01138722|hypofractionated radiation therapy|hypofractionated radiation therapy
5118244|NCT01138696|ACL|acl
5118245|NCT01138683|Acute decompensated heart failure|acute decompensated heart failure
5118246|NCT01138683|ultrafiltration|ultrafiltration
5118247|NCT01138683|diuretics|diuretics
5118248|NCT01138683|AKI|aki
5118249|NCT01138657|inflammation of uvea|inflammation of uvea
5118250|NCT01138644|Atrial Fibrillation|atrial fibrillation
5118251|NCT01138644|Atrial Flutter|atrial flutter
5118252|NCT01138631|IVF, Infertility, embryo selection, embryoscope, time-lapse|ivf, infertility, embryo selection, embryoscope, time-lapse
5118253|NCT01138618|Clozapine|clozapine
5118254|NCT01138618|hematological monitoring|hematological monitoring
5118255|NCT01138618|CHEMPAQ|chempaq
5118256|NCT01138618|Granulocytes|granulocytes
5118257|NCT01138618|WBC|wbc
5118258|NCT01138605|TMC114|tmc114
5118259|NCT01138605|TMC114-TiDP29-C232|tmc114-tidp29-c232
5118260|NCT01138605|TMC114-C232|tmc114-c232
5118261|NCT01138605|Darunavir|darunavir
5118262|NCT01138605|PREZISTA|prezista
5118263|NCT01138579|FBTA05|fbta05
5118264|NCT01138579|CD20|cd20
5118265|NCT01138579|CLL|cll
5118266|NCT01138579|NHL|nhl
5118267|NCT01138579|DLI|dli
5118268|NCT01138579|allogeneic transplantation|allogeneic transplantation
5118269|NCT01138579|CD20 positive chronic lymphocytic leukemia (CLL)|cd20 positive chronic lymphocytic leukemia (cll)
5118270|NCT01138579|low and high grade non-Hodgkin´s lymphoma (NHL) after allogeneic stem cell transplantation with active disease|low and high grade non-hodgkin´s lymphoma (nhl) after allogeneic stem cell transplantation with active disease
5118271|NCT01138566|community-onset urinary tract infections caused by Enterobacteriaceae|community-onset urinary tract infections caused by enterobacteriaceae
5118272|NCT01138553|biomarker|biomarker
5118273|NCT01138553|breast cancer|breast cancer
5118274|NCT01138553|antiprogesterone|antiprogesterone
5118275|NCT01138540|VAP|vap
5118276|NCT01138527|multi-parametric MRI approach|multi-parametric mri approach
5118277|NCT01138475|PTH|pth
5118278|NCT01138475|Gastric bypass surgery|gastric bypass surgery
5118279|NCT01138475|vitamin D|vitamin d
5118280|NCT01138475|paricalcitol|paricalcitol
5118281|NCT01138462|Methicillin-Resistant Staphylococcus aureus|methicillin-resistant staphylococcus aureus
5118282|NCT01138462|Decolonisation|decolonisation
5118283|NCT01138462|Nursing homes|nursing homes
5118284|NCT01138462|Infection Control|infection control
5118285|NCT01138449|Vitamin A|vitamin a
5118286|NCT01138449|Neonatal mortality|neonatal mortality
5118287|NCT01138449|Infant mortality|infant mortality
5118288|NCT01138436|Venous Leg Ulcers, VLU|venous leg ulcers, vlu
5118289|NCT01138423|Hypertension|hypertension
5118290|NCT01138423|Metabolic Syndrome X|metabolic syndrome x
5118291|NCT01138423|Obesity|obesity
5118292|NCT01138423|Adiposity|adiposity
5118293|NCT01138423|Clinical trial|clinical trial
5118294|NCT01138410|Immunotherapy|immunotherapy
5118295|NCT01138410|Melanoma|melanoma
5118296|NCT01138410|Gene therapy|gene therapy
5118297|NCT01138410|DNA plasmid|dna plasmid
5118298|NCT01138410|Cancer vaccine|cancer vaccine
5118299|NCT01138410|Electroporation|electroporation
5118300|NCT01138410|CTL response|ctl response
5118301|NCT01138397|Influenza|influenza
5118302|NCT01138397|Influenza vaccine|influenza vaccine
5118303|NCT01138397|Influenza virus|influenza virus
5118304|NCT01138397|Intradermal|intradermal
5118305|NCT01138384|Breast Cancer|breast cancer
5118306|NCT01138371|LDL apheresis|ldl apheresis
5118307|NCT01138371|Familial hypercholesterolemia|familial hypercholesterolemia
5118308|NCT01138371|Inflammatory markers|inflammatory markers
5118309|NCT01138371|Hyperlipidemia|hyperlipidemia
5118310|NCT01138371|Cardiovascular disease|cardiovascular disease
5118312|NCT01138358|lung metastases|lung metastases
5118313|NCT01138358|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5118314|NCT01138358|recurrent small cell lung cancer|recurrent small cell lung cancer
5118315|NCT01138358|extensive stage small cell lung cancer|extensive stage small cell lung cancer
5118316|NCT01138358|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5118317|NCT01138358|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5118318|NCT01138358|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5118319|NCT01138345|cancer survivor|cancer survivor
5118320|NCT01138345|stage I breast cancer|stage i breast cancer
5118321|NCT01138345|stage II breast cancer|stage ii breast cancer
5118322|NCT01138345|stage IIIA breast cancer|stage iiia breast cancer
5118323|NCT01138345|stage IIIB breast cancer|stage iiib breast cancer
5118324|NCT01138345|stage IIIC breast cancer|stage iiic breast cancer
5118325|NCT01138332|childhood acute myeloid leukemia/other myeloid malignancies|childhood acute myeloid leukemia/other myeloid malignancies
5118326|NCT01138319|adult acute myeloid leukemia|adult acute myeloid leukemia
5118327|NCT01138319|childhood acute myeloid leukemia/other myeloid malignancies|childhood acute myeloid leukemia/other myeloid malignancies
5118328|NCT01138306|childhood acute myeloid leukemia/other myeloid malignancies|childhood acute myeloid leukemia/other myeloid malignancies
5118329|NCT01138293|differences between patients´ self-assessment and objective perception of physical activity and eating habits|differences between patients´ self-assessment and objective perception of physical activity and eating habits
5119038|NCT01136642|Nicotine|nicotine
5118330|NCT01138280|biofilm formation|biofilm formation
5118331|NCT01138280|proinflammatory cytokines|proinflammatory cytokines
5118332|NCT01138280|high sensitive c reactive protein|high sensitive c reactive protein
5118333|NCT01138280|cardiovascular events|cardiovascular events
5118334|NCT01138280|overall mortality|overall mortality
5118335|NCT01138280|hemodialysis|hemodialysis
5118336|NCT01138267|pharmacogenomics|pharmacogenomics
5118337|NCT01138267|ATV|atv
5118338|NCT01138267|EFV|efv
5118339|NCT01138267|pharmacogenomics of ATV and EFV|pharmacogenomics of atv and efv
5118340|NCT01138254|flow,echocardiography,far infrared therapy,nitric oxide|flow,echocardiography,far infrared therapy,nitric oxide
5118341|NCT01138241|HIV|hiv
5118342|NCT01138241|Chronic kidney disease|chronic kidney disease
5118343|NCT01138241|Glomerular Filtration Rate (GFR)|glomerular filtration rate (gfr)
5118344|NCT01138241|Tenofovir|tenofovir
5118345|NCT01138241|Serum creatinine (sCr)|serum creatinine (scr)
5118346|NCT01138241|24 hr urine creatinine clearance|24 hr urine creatinine clearance
5118347|NCT01138241|Serum Cystatin C[40]|serum cystatin c[40]
5118348|NCT01138241|Modification of Diet in Renal Disease (MDRD)|modification of diet in renal disease (mdrd)
5118349|NCT01138241|Cockcroft Gault Equation|cockcroft gault equation
5118350|NCT01138241|Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI)|chronic kidney disease epidemiology collaboration (ckd-epi)
5118351|NCT01138241|99mTc-diethylenetriaminepentaacetic acid (Tc-99m DTPA) scan|99mtc-diethylenetriaminepentaacetic acid (tc-99m dtpa) scan
5118352|NCT01138241|Validate which renal function assessments can accurately detect GFR and assess the effect of TDF concentration on renal function|validate which renal function assessments can accurately detect gfr and assess the effect of tdf concentration on renal function
5118353|NCT01138228|intravenous cannulation|intravenous cannulation
5118354|NCT01138228|vein identification|vein identification
5118355|NCT01138228|vascular identification|vascular identification
5118356|NCT01138228|vein cannulation|vein cannulation
5118357|NCT01138215|varicella-zoster virus vaccine|varicella-zoster virus vaccine
5118358|NCT01138215|varicella-zoster virus antibody|varicella-zoster virus antibody
5118359|NCT01138215|immunogenicity|immunogenicity
5118360|NCT01138215|safety and efficacy|safety and efficacy
5118361|NCT01138215|HIV-infected children|hiv-infected children
5118362|NCT01138215|Assess protective VZV Antibody|assess protective vzv antibody
5118363|NCT01138215|Adverse events from VZV vaccine|adverse events from vzv vaccine
5118364|NCT01138202|pharmacokinetics|pharmacokinetics
5118365|NCT01138202|safety|safety
5118366|NCT01138202|efficacy|efficacy
5118367|NCT01138202|Lopinavir/ritonavir|lopinavir/ritonavir
5118368|NCT01138202|HIV/TB|hiv/tb
5118369|NCT01138202|rifampicin containing anti-tuberculosis therapy|rifampicin containing anti-tuberculosis therapy
5118370|NCT01138202|Pharmacokinetics and safety of Lopinavir/ritonavir with rifampicin containing anti-tuberculosis therapy|pharmacokinetics and safety of lopinavir/ritonavir with rifampicin containing anti-tuberculosis therapy
5118371|NCT01138189|Wavefront-guided LASIK.|wavefront-guided lasik.
5118372|NCT01138189|Wavefront-optimized LASIK.|wavefront-optimized lasik.
5118373|NCT01138189|Custom LASIK|custom lasik
5118374|NCT01138176|Neonatal encephalopathy|neonatal encephalopathy
5118375|NCT01138176|Therapeutic hypothermia|therapeutic hypothermia
5118376|NCT01138176|Phase changing material|phase changing material
5118377|NCT01138176|MR imaging|mr imaging
5118378|NCT01138163|NSCLC|nsclc
5118379|NCT01138163|second-line|second-line
5118380|NCT01138163|lung cancer|lung cancer
5118381|NCT01138163|non small cell lung cancer|non small cell lung cancer
5118382|NCT01138163|bavituximab|bavituximab
5118383|NCT01138163|monoclonal antibody|monoclonal antibody
5118384|NCT01138150|migraine, headache, sumatriptan, naproxen sodium|migraine, headache, sumatriptan, naproxen sodium
5118385|NCT01138137|ovarian cancer|ovarian cancer
5118386|NCT01138137|epithelial ovarian cancer|epithelial ovarian cancer
5118387|NCT01138137|peritoneal cancer|peritoneal cancer
5118388|NCT01138124|renal cell carcinoma|renal cell carcinoma
5118389|NCT01138124|epidemiology|epidemiology
5118390|NCT01138124|pancreatic cancer|pancreatic cancer
5118391|NCT01138124|renal cancer|renal cancer
5118392|NCT01138124|renal pelvis cancer|renal pelvis cancer
5118393|NCT01138124|GPRD|gprd
5118394|NCT01138124|case-control|case-control
5118395|NCT01138124|Gapabentin|gapabentin
5118396|NCT01138111|Florbetaben|florbetaben
5118397|NCT01138111|Amyloid beta-protein|amyloid beta-protein
5118398|NCT01138111|MCI|mci
5118399|NCT01138111|Alzheimer's disease|alzheimer's disease
5118400|NCT01138098|Persistence|persistence
5118401|NCT01138098|challenge dose|challenge dose
5118402|NCT01138098|Engerix-B|engerix-b
5118403|NCT01138098|immune response|immune response
5118404|NCT01138085|Triple negative breast cancer|triple negative breast cancer
5118405|NCT01138085|BRAF wild-type melanoma|braf wild-type melanoma
5118406|NCT01138085|Solid tumors|solid tumors
5118407|NCT01138085|Endometrial Cancer|endometrial cancer
5118408|NCT01138085|Oncology|oncology
5118409|NCT01138085|GSK2141795|gsk2141795
5118410|NCT01138085|AKT Inhibitor|akt inhibitor
5118411|NCT01138085|GSK1120212|gsk1120212
5118412|NCT01138072|GSK2248761, atorvastatin, rosuvastatin, simvastatin, drug interaction, pharmacokinetics|gsk2248761, atorvastatin, rosuvastatin, simvastatin, drug interaction, pharmacokinetics
5118413|NCT01138059|Acute ischemic stroke with unclear onset time|acute ischemic stroke with unclear onset time
5118414|NCT01138046|advanced/metastatic breast cancer|advanced/metastatic breast cancer
5118415|NCT01138046|lapatinib|lapatinib
5118417|NCT01138046|ErbB2-overexpressing|erbb2-overexpressing
5118418|NCT01138046|pharmacokinetics|pharmacokinetics
5118419|NCT01138046|dual kinase inhibitor|dual kinase inhibitor
5118420|NCT01138046|HER-2/neu|her-2/neu
5118421|NCT01138046|EGFR|egfr
5118422|NCT01138046|ErbB1|erbb1
5118423|NCT01138033|pharmacodynamics|pharmacodynamics
5118424|NCT01138033|cancer|cancer
5118425|NCT01138033|focal adhesion kinase inhibitor|focal adhesion kinase inhibitor
5118426|NCT01138033|pharmacokinetics|pharmacokinetics
5118427|NCT01138033|solid tumors|solid tumors
5118428|NCT01138033|Phase 1|phase 1
5118429|NCT01138020|Rehabilitation Outcome|rehabilitation outcome
5118430|NCT01138020|Cognitive treatment|cognitive treatment
5118431|NCT01138020|TBI|tbi
5118432|NCT01138007|Bupropion|bupropion
5118433|NCT01138007|323U66 Sustained Release (SR)|323u66 sustained release (sr)
5118434|NCT01138007|MDD (Major Depressive Disorder)|mdd (major depressive disorder)
5118435|NCT01138007|IVRS HAM-D|ivrs ham-d
5118436|NCT01138007|IDS-SR|ids-sr
5118437|NCT01138007|MADRS|madrs
5118438|NCT01137994|ErbB2|erbb2
5118439|NCT01137994|Trastuzumab|trastuzumab
5118440|NCT01137994|p95HER2|p95her2
5118441|NCT01137994|Metastatic Breast Cancer|metastatic breast cancer
5118442|NCT01137994|HER2|her2
5118443|NCT01137994|Lapatinib|lapatinib
5118444|NCT01137981|Combivir (Zidovudine+Lamivudine)|combivir (zidovudine+lamivudine)
5118445|NCT01137981|Antiretrovirals|antiretrovirals
5118446|NCT01137981|ARV|arv
5118447|NCT01137981|HAART|haart
5118448|NCT01137981|Maraviroc|maraviroc
5118449|NCT01137981|Delavirdine|delavirdine
5118450|NCT01137981|Lamivudine|lamivudine
5118451|NCT01137981|Antiretroviral Pregnancy Registry|antiretroviral pregnancy registry
5118452|NCT01137981|Fosamprenavir|fosamprenavir
5118453|NCT01137981|APR|apr
5118454|NCT01137981|Zidovudine|zidovudine
5118455|NCT01137981|pregnancy registry|pregnancy registry
5118456|NCT01137981|Amprenavir|amprenavir
5118457|NCT01137981|HIV|hiv
5118458|NCT01137981|Trizivir (Abacavir+Lamivudine+Zidovudine)|trizivir (abacavir+lamivudine+zidovudine)
5118459|NCT01137981|Epzicom (Abacavir+Lamivudine)|epzicom (abacavir+lamivudine)
5118460|NCT01137968|imetelstat|imetelstat
5118461|NCT01137968|imetelstat sodium|imetelstat sodium
5118462|NCT01137968|GRN163L|grn163l
5118463|NCT01137968|telomerase inhibitor|telomerase inhibitor
5118464|NCT01137968|telomerase inhibition|telomerase inhibition
5118465|NCT01137968|maintenance therapy|maintenance therapy
5118466|NCT01137968|non-small cell lung cancer|non-small cell lung cancer
5118467|NCT01137968|relapsed non-small cell lung cancer|relapsed non-small cell lung cancer
5118468|NCT01137968|advanced non-small cell lung cancer|advanced non-small cell lung cancer
5118469|NCT01137968|NSCLC, cancer stem cells|nsclc, cancer stem cells
5118470|NCT01137968|Bevacizumab|bevacizumab
5118471|NCT01137968|post induction chemotherapy|post induction chemotherapy
5118472|NCT01137955|Gastrointestinal Symptom Rating Scale (GSRS)|gastrointestinal symptom rating scale (gsrs)
5118473|NCT01137955|Poorly responsive|poorly responsive
5118474|NCT01137955|Refractory|refractory
5118475|NCT01137955|Small intestine bacterial overgrowth|small intestine bacterial overgrowth
5118476|NCT01137955|Breath test|breath test
5118477|NCT01137942|helicobacter pylori|helicobacter pylori
5118478|NCT01137942|eradication failure|eradication failure
5118479|NCT01137929|Vesicoureteral reflux|vesicoureteral reflux
5118480|NCT01137929|Kidney|kidney
5118481|NCT01137929|Renal Scar|renal scar
5118482|NCT01137929|Urinary tract infection|urinary tract infection
5118483|NCT01137903|Diabetic foot|diabetic foot
5118484|NCT01137903|Osteomyelitis|osteomyelitis
5118485|NCT01137903|Diabetic foot ulcers|diabetic foot ulcers
5118486|NCT01137903|Foot infections|foot infections
5118487|NCT01137890|cocaine|cocaine
5118488|NCT01137890|addiction|addiction
5118489|NCT01137890|drug dependence|drug dependence
5118490|NCT01137890|anticonvulsant|anticonvulsant
5118491|NCT01137890|zonisamide|zonisamide
5118492|NCT01137890|drug self-administration|drug self-administration
5118493|NCT01137890|nicotine withdrawal|nicotine withdrawal
5118494|NCT01137890|neurocognition|neurocognition
5118495|NCT01137864|Emergency wards|emergency wards
5118496|NCT01137864|Hospitalization|hospitalization
5118497|NCT01137864|Adults|adults
5118498|NCT01137864|Antimicrobial therapy|antimicrobial therapy
5118499|NCT01137825|cognitive/functional effects|cognitive/functional effects
5118500|NCT01137825|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5118501|NCT01137825|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5118502|NCT01137825|acute undifferentiated leukemia|acute undifferentiated leukemia
5118503|NCT01137825|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5118504|NCT01137825|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5118505|NCT01137825|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5118506|NCT01137825|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5118507|NCT01137825|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5118508|NCT01137825|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5118509|NCT01137825|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5118510|NCT01137825|atypical chronic myeloid leukemia, BCR-ABL negative|atypical chronic myeloid leukemia, bcr-abl negative
5118511|NCT01137825|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5118512|NCT01137825|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5118513|NCT01137825|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5118514|NCT01137825|mast cell leukemia|mast cell leukemia
5118515|NCT01137825|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
5118516|NCT01137825|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
5118517|NCT01137825|prolymphocytic leukemia|prolymphocytic leukemia
5118518|NCT01137825|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5118519|NCT01137825|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5118520|NCT01137825|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
5118521|NCT01137825|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5118522|NCT01137825|refractory hairy cell leukemia|refractory hairy cell leukemia
5118523|NCT01137825|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5118524|NCT01137825|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5118525|NCT01137825|stage 0 chronic lymphocytic leukemia|stage 0 chronic lymphocytic leukemia
5118526|NCT01137825|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
5118527|NCT01137825|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
5118528|NCT01137825|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
5118529|NCT01137825|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
5118530|NCT01137825|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
5118531|NCT01137825|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5118532|NCT01137825|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
5118533|NCT01137825|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5118534|NCT01137825|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
5118535|NCT01137825|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
5118536|NCT01137825|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
5118537|NCT01137825|untreated hairy cell leukemia|untreated hairy cell leukemia
5118538|NCT01137825|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5118539|NCT01137825|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
5118540|NCT01137825|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
5118541|NCT01137825|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5118542|NCT01137825|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5118543|NCT01137825|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5118544|NCT01137825|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
5118545|NCT01137825|cutaneous B-cell non-Hodgkin lymphoma|cutaneous b-cell non-hodgkin lymphoma
5118546|NCT01137825|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5118547|NCT01137825|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
5118548|NCT01137825|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
5118549|NCT01137825|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
5118550|NCT01137825|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
5118551|NCT01137825|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5118552|NCT01137825|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
5118553|NCT01137825|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
5118554|NCT01137825|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
5118555|NCT01137825|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
5118556|NCT01137825|adult grade III lymphomatoid granulomatosis|adult grade iii lymphomatoid granulomatosis
5118557|NCT01137825|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
5118558|NCT01137825|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
5118559|NCT01137825|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5118560|NCT01137825|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5118561|NCT01137825|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5118562|NCT01137825|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
5118563|NCT01137825|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
5118564|NCT01137825|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
5118565|NCT01137825|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
5118566|NCT01137825|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
5118567|NCT01137825|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
5118568|NCT01137825|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
5118569|NCT01137825|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
5118570|NCT01137825|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
5118571|NCT01137825|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
5118572|NCT01137825|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
5118573|NCT01137825|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
5118574|NCT01137825|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
5118575|NCT01137825|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
5118576|NCT01137825|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
5118577|NCT01137825|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
5118578|NCT01137825|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
5118579|NCT01137825|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
5118580|NCT01137825|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
5118581|NCT01137825|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
5118582|NCT01137825|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
5118583|NCT01137825|stage I mantle cell lymphoma|stage i mantle cell lymphoma
5118584|NCT01137825|stage I marginal zone lymphoma|stage i marginal zone lymphoma
5118585|NCT01137825|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
5118586|NCT01137825|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
5118587|NCT01137825|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5118588|NCT01137825|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
5118589|NCT01137825|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
5118590|NCT01137825|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
5118591|NCT01137825|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
5118592|NCT01137825|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5118593|NCT01137825|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5118594|NCT01137825|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5118595|NCT01137825|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5118596|NCT01137825|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
5118597|NCT01137825|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
5118598|NCT01137825|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5118599|NCT01137825|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5118600|NCT01137825|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5118601|NCT01137825|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5118602|NCT01137825|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5118603|NCT01137825|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5118604|NCT01137825|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5118605|NCT01137825|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5118606|NCT01137825|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5118607|NCT01137825|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5118608|NCT01137825|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5118609|NCT01137825|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5118610|NCT01137825|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5118611|NCT01137825|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5118612|NCT01137825|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5118613|NCT01137825|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5118614|NCT01137825|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5118615|NCT01137825|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5118616|NCT01137825|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5118617|NCT01137825|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5118618|NCT01137825|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5118619|NCT01137825|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5118620|NCT01137825|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5118621|NCT01137825|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5118622|NCT01137825|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5118623|NCT01137825|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5118624|NCT01137825|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5118625|NCT01137825|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5118626|NCT01137825|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
5118627|NCT01137825|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5118628|NCT01137825|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5118629|NCT01137825|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5118630|NCT01137825|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5118631|NCT01137825|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5118632|NCT01137825|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5118633|NCT01137825|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5118634|NCT01137825|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5118635|NCT01137825|intraocular lymphoma|intraocular lymphoma
5118636|NCT01137825|post-transplant lymphoproliferative disorder|post-transplant lymphoproliferative disorder
5118637|NCT01137825|chronic eosinophilic leukemia|chronic eosinophilic leukemia
5118638|NCT01137825|chronic neutrophilic leukemia|chronic neutrophilic leukemia
5118639|NCT01137825|primary myelofibrosis|primary myelofibrosis
5118640|NCT01137825|essential thrombocythemia|essential thrombocythemia
5118641|NCT01137825|polycythemia vera|polycythemia vera
5118642|NCT01137825|extramedullary plasmacytoma|extramedullary plasmacytoma
5118643|NCT01137825|isolated plasmacytoma of bone|isolated plasmacytoma of bone
5118644|NCT01137825|stage I multiple myeloma|stage i multiple myeloma
5118645|NCT01137825|stage II multiple myeloma|stage ii multiple myeloma
5118646|NCT01137825|stage III multiple myeloma|stage iii multiple myeloma
5118647|NCT01137825|primary systemic amyloidosis|primary systemic amyloidosis
5118648|NCT01137825|refractory multiple myeloma|refractory multiple myeloma
5118649|NCT01137825|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5118650|NCT01137825|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5118651|NCT01137825|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5118652|NCT01137825|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
5118653|NCT01137812|Canagliflozin|canagliflozin
5118654|NCT01137812|Sitagliptin (Januvia)|sitagliptin (januvia)
5118655|NCT01137812|Metformin|metformin
5118656|NCT01137812|Sulphonylurea|sulphonylurea
5118657|NCT01137812|Hemoglobin A1c|hemoglobin a1c
5118658|NCT01137812|Type 2 diabetes mellitus|type 2 diabetes mellitus
5118659|NCT01137799|symptomatic treatment|symptomatic treatment
5118660|NCT01137799|cognition|cognition
5118661|NCT01137799|cognitive deficits|cognitive deficits
5118662|NCT01137799|schizophrenia|schizophrenia
5118663|NCT01137799|Alzheimer's Disease|alzheimer's disease
5118664|NCT01137773|SAH (Subarachnoid Hemorrhage)|sah (subarachnoid hemorrhage)
5118665|NCT01137773|Brain Hemorrhage|brain hemorrhage
5118666|NCT01137773|Traumatic Brain Injury|traumatic brain injury
5118667|NCT01137773|SAH|sah
5118668|NCT01137773|ICH|ich
5118669|NCT01137760|adults|adults
5118670|NCT01137760|fiber|fiber
5118671|NCT01137760|cold|cold
5118672|NCT01137760|flu|flu
5118673|NCT01137760|stress|stress
5118674|NCT01137760|microbiota|microbiota
5118675|NCT01137747|carfilzomib|carfilzomib
5118676|NCT01137747|acute myeloid leukemia|acute myeloid leukemia
5118677|NCT01137747|acute lymphoblastic leukemia|acute lymphoblastic leukemia
5118678|NCT01137747|phase I|phase i
5118679|NCT01137734|Heart Diseases|heart diseases
5118680|NCT01137734|Heart Valve Diseases|heart valve diseases
5118681|NCT01137734|Cardiovascular Diseases|cardiovascular diseases
5118682|NCT01137721|magnetic resonance imaging|magnetic resonance imaging
5118683|NCT01137721|sickle cell disease|sickle cell disease
5118684|NCT01137721|hydroxyurea therapy|hydroxyurea therapy
5118685|NCT01137708|drug interactions|drug interactions
5118686|NCT01137708|CYP3A|cyp3a
5118687|NCT01137708|oral contraceptive|oral contraceptive
5118688|NCT01137708|anti-rheumatic agents|anti-rheumatic agents
5118689|NCT01137695|pramlintide|pramlintide
5118690|NCT01137695|glucose|glucose
5118691|NCT01137695|type 2 diabetes mellitus|type 2 diabetes mellitus
5118692|NCT01137695|amylin|amylin
5118693|NCT01137682|Acromegaly|acromegaly
5118694|NCT01137682|hormone disorder|hormone disorder
5118695|NCT01137682|growth hormone|growth hormone
5118696|NCT01137682|insulin like growth factor-1|insulin like growth factor-1
5118697|NCT01137682|pituitary tumor|pituitary tumor
5118698|NCT01137682|pasireotide|pasireotide
5118699|NCT01137682|SOM230|som230
5118700|NCT01137669|immunocompromised,parent protocol,shingles,varicella-zoster virus,ZOSTAVAX®|immunocompromised,parent protocol,shingles,varicella-zoster virus,zostavax®
5118701|NCT01137656|Blood storage|blood storage
5118702|NCT01137656|Blood transfusion|blood transfusion
5118703|NCT01137656|Aged blood|aged blood
5118704|NCT01137656|Blood Forearm|blood forearm
5118705|NCT01137656|Storage lesion in blood|storage lesion in blood
5118706|NCT01137643|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5118707|NCT01137643|acute undifferentiated leukemia|acute undifferentiated leukemia
5118708|NCT01137643|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5118709|NCT01137643|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5118710|NCT01137643|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5118711|NCT01137643|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5118712|NCT01137643|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5118713|NCT01137643|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5118714|NCT01137643|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5118715|NCT01137643|atypical chronic myeloid leukemia, BCR-ABL negative|atypical chronic myeloid leukemia, bcr-abl negative
5118716|NCT01137643|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5118717|NCT01137643|mast cell leukemia|mast cell leukemia
5118718|NCT01137643|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
5118719|NCT01137643|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
5118720|NCT01137643|prolymphocytic leukemia|prolymphocytic leukemia
5118721|NCT01137643|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5118722|NCT01137643|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5118723|NCT01137643|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
5118724|NCT01137643|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5118725|NCT01137643|refractory hairy cell leukemia|refractory hairy cell leukemia
5118726|NCT01137643|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5118727|NCT01137643|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5118728|NCT01137643|stage 0 chronic lymphocytic leukemia|stage 0 chronic lymphocytic leukemia
5118729|NCT01137643|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
5118730|NCT01137643|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
5118731|NCT01137643|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
5118732|NCT01137643|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
5118733|NCT01137643|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
5118734|NCT01137643|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5118735|NCT01137643|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
5118736|NCT01137643|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5118737|NCT01137643|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
5118738|NCT01137643|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
5118739|NCT01137643|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
5118740|NCT01137643|untreated hairy cell leukemia|untreated hairy cell leukemia
5118741|NCT01137643|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5118742|NCT01137643|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
5118743|NCT01137643|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
5118744|NCT01137643|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5118745|NCT01137643|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5118746|NCT01137643|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5118747|NCT01137643|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
5118748|NCT01137643|cutaneous B-cell non-Hodgkin lymphoma|cutaneous b-cell non-hodgkin lymphoma
5118749|NCT01137643|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5118750|NCT01137643|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
5118751|NCT01137643|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
5118752|NCT01137643|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
5118753|NCT01137643|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
5118754|NCT01137643|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5118755|NCT01137643|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
5118756|NCT01137643|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
5118757|NCT01137643|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
5118758|NCT01137643|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
5118759|NCT01137643|adult grade III lymphomatoid granulomatosis|adult grade iii lymphomatoid granulomatosis
5118760|NCT01137643|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
5118761|NCT01137643|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
5118762|NCT01137643|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5118763|NCT01137643|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5118764|NCT01137643|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5118765|NCT01137643|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
5118766|NCT01137643|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
5118767|NCT01137643|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
5118768|NCT01137643|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
5118769|NCT01137643|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
5118770|NCT01137643|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
5118771|NCT01137643|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
5118772|NCT01137643|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
5118773|NCT01137643|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
5118774|NCT01137643|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
5118775|NCT01137643|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
5118776|NCT01137643|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
5118777|NCT01137643|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
5118778|NCT01137643|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
5118779|NCT01137643|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
5118780|NCT01137643|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
5118781|NCT01137643|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
5119244|NCT01135693|Police|police
5118782|NCT01137643|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
5118783|NCT01137643|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
5118784|NCT01137643|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
5118785|NCT01137643|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
5118786|NCT01137643|stage I mantle cell lymphoma|stage i mantle cell lymphoma
5118787|NCT01137643|stage I marginal zone lymphoma|stage i marginal zone lymphoma
5118788|NCT01137643|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
5118789|NCT01137643|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
5118790|NCT01137643|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5118791|NCT01137643|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
5118792|NCT01137643|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
5118793|NCT01137643|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
5118794|NCT01137643|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
5118795|NCT01137643|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5118796|NCT01137643|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5118797|NCT01137643|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5118798|NCT01137643|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5118799|NCT01137643|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
5118800|NCT01137643|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
5118801|NCT01137643|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5118802|NCT01137643|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5118803|NCT01137643|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5118804|NCT01137643|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5118805|NCT01137643|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5118806|NCT01137643|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5118807|NCT01137643|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5118808|NCT01137643|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5118809|NCT01137643|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5118810|NCT01137643|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5118811|NCT01137643|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5118812|NCT01137643|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5118813|NCT01137643|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5118814|NCT01137643|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5118815|NCT01137643|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5118816|NCT01137643|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5118817|NCT01137643|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5118818|NCT01137643|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5118819|NCT01137643|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5118820|NCT01137643|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5118821|NCT01137643|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5118822|NCT01137643|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5118823|NCT01137643|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5118824|NCT01137643|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5118825|NCT01137643|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5118826|NCT01137643|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5118827|NCT01137643|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5118828|NCT01137643|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5118829|NCT01137643|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
5118830|NCT01137643|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5118831|NCT01137643|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5118832|NCT01137643|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5118833|NCT01137643|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5118834|NCT01137643|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5118835|NCT01137643|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5118836|NCT01137643|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5118837|NCT01137643|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5118838|NCT01137643|intraocular lymphoma|intraocular lymphoma
5118839|NCT01137643|post-transplant lymphoproliferative disorder|post-transplant lymphoproliferative disorder
5118840|NCT01137643|chronic eosinophilic leukemia|chronic eosinophilic leukemia
5118841|NCT01137643|chronic neutrophilic leukemia|chronic neutrophilic leukemia
5118842|NCT01137643|primary myelofibrosis|primary myelofibrosis
5118843|NCT01137643|essential thrombocythemia|essential thrombocythemia
5118844|NCT01137643|polycythemia vera|polycythemia vera
5118845|NCT01137643|extramedullary plasmacytoma|extramedullary plasmacytoma
5118846|NCT01137643|isolated plasmacytoma of bone|isolated plasmacytoma of bone
5118847|NCT01137643|stage I multiple myeloma|stage i multiple myeloma
5118848|NCT01137643|stage II multiple myeloma|stage ii multiple myeloma
5118849|NCT01137643|stage III multiple myeloma|stage iii multiple myeloma
5118850|NCT01137643|primary systemic amyloidosis|primary systemic amyloidosis
5118851|NCT01137643|refractory multiple myeloma|refractory multiple myeloma
5118852|NCT01137643|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5118853|NCT01137643|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5118854|NCT01137643|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5118855|NCT01137643|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
5118856|NCT01137643|aplastic anemia|aplastic anemia
5118857|NCT01137630|seborrhoeic dermatitis|seborrhoeic dermatitis
5118858|NCT01137630|scalp|scalp
5118859|NCT01137630|K40a|k40a
5118860|NCT01137630|K40b|k40b
5118861|NCT01137617|spinal cord stimualtor|spinal cord stimualtor
5118862|NCT01137591|Acetaminophen|acetaminophen
5118863|NCT01137591|Acetylcysteine|acetylcysteine
5118864|NCT01137591|Antidotes|antidotes
5118865|NCT01137565|Amgen|amgen
5118866|NCT01137565|Adolescent|adolescent
5118867|NCT01137565|Safety|safety
5118868|NCT01137552|First-In-Human|first-in-human
5118869|NCT01137552|Dose Escalation|dose escalation
5118870|NCT01137552|Dose Expansion|dose expansion
5118871|NCT01137552|Advance Solid Tumors|advance solid tumors
5118872|NCT01137552|Anti-Angiopoietin|anti-angiopoietin
5118873|NCT01137552|Advance Malignancy|advance malignancy
5118874|NCT01137552|Cancer|cancer
5118875|NCT01137552|Oncology|oncology
5118876|NCT01137552|Oncology Patients|oncology patients
5118877|NCT01137552|Phase 1|phase 1
5118878|NCT01137552|Clinical Trial|clinical trial
5118879|NCT01137552|Tumors|tumors
5118880|NCT01137552|Solid Tumors|solid tumors
5118881|NCT01137552|Angiogenesis Inhibitors|angiogenesis inhibitors
5118882|NCT01137539|urinary incontinence|urinary incontinence
5118883|NCT01137539|stress urinary incontinence|stress urinary incontinence
5118884|NCT01137539|mid-urethral slings|mid-urethral slings
5118885|NCT01137539|Tension-free vaginal taping|tension-free vaginal taping
5118886|NCT01137539|TVT|tvt
5118887|NCT01137513|Chest Pain|chest pain
5118888|NCT01137513|Acute coronary syndrome|acute coronary syndrome
5118889|NCT01137513|AMI|ami
5118890|NCT01137487|mechanical ventilation|mechanical ventilation
5118891|NCT01137487|enteral nutrition|enteral nutrition
5118892|NCT01137487|Ventilation-Associated Pneumonia|ventilation-associated pneumonia
5118893|NCT01137487|residual gastric volume measurement|residual gastric volume measurement
5118894|NCT01137487|vomiting|vomiting
5118895|NCT01137487|gastro-oesophageal reflux|gastro-oesophageal reflux
5118896|NCT01137487|early enteral nutrition|early enteral nutrition
5118897|NCT01137487|Intensive care unit|intensive care unit
5118898|NCT01137487|Enteral Feeding|enteral feeding
5118899|NCT01137474|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
5118900|NCT01137474|Diabetes Mellitus|diabetes mellitus
5118901|NCT01137474|Endocrine System Diseases|endocrine system diseases
5118902|NCT01137474|Glucose Metabolism Disorders|glucose metabolism disorders
5118903|NCT01137474|Metabolic Diseases|metabolic diseases
5118904|NCT01137474|Angiotensin Receptor Antagonists|angiotensin receptor antagonists
5118905|NCT01137474|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors
5118906|NCT01137474|Hypoglycemic Agents|hypoglycemic agents
5118907|NCT01137474|Pharmacologic Actions|pharmacologic actions
5118908|NCT01137474|Physiological Effects of Drugs|physiological effects of drugs
5118909|NCT01137461|Female infertility with indication of oocyte reception|female infertility with indication of oocyte reception
5118910|NCT01137448|Psoriasis|psoriasis
5118911|NCT01137448|Obesity|obesity
5118912|NCT01137435|Adacel|adacel
5118913|NCT01137435|Diphtheria|diphtheria
5118914|NCT01137435|Tetanus|tetanus
5118915|NCT01137435|Pertussis|pertussis
5118916|NCT01137383|Hepatitis C|hepatitis c
5118917|NCT01137331|seborrhoeic eczema|seborrhoeic eczema
5118918|NCT01137331|scalp|scalp
5118919|NCT01137331|dandruff|dandruff
5118920|NCT01137331|K301|k301
5118921|NCT01137331|K40|k40
5118922|NCT01137318|ADHD|adhd
5118923|NCT01137318|Impairment|impairment
5118924|NCT01137318|Treatment|treatment
5118925|NCT01137318|Cognitive Remediation|cognitive remediation
5118926|NCT01137318|Behavioral Parent Training|behavioral parent training
5118927|NCT01137305|Virtual reality|virtual reality
5118928|NCT01137305|surgical training|surgical training
5118929|NCT01137305|Health Care [N]|health care [n]
5118930|NCT01137292|observational study|observational study
5118931|NCT01137292|voriconazole|voriconazole
5118932|NCT01137292|high-risk patients|high-risk patients
5119056|NCT01136603|Adhesion formation|adhesion formation
5118933|NCT01137266|chronic pain osteo-arthritis in one or both knees, adults|chronic pain osteo-arthritis in one or both knees, adults
5118934|NCT01137253|Nitric Oxide|nitric oxide
5118935|NCT01137253|Autonomic Nervous System|autonomic nervous system
5118936|NCT01137240|subjects suffering from mitochondrial disorders with one or more gastrointestinal symptoms would be the focus of the study|subjects suffering from mitochondrial disorders with one or more gastrointestinal symptoms would be the focus of the study
5118937|NCT01137227|Physical activity|physical activity
5118938|NCT01137227|Epidemiology|epidemiology
5118939|NCT01137227|Questionnaire|questionnaire
5118940|NCT01137227|Cross-sectional study|cross-sectional study
5118941|NCT01137214|complex sleep apnea|complex sleep apnea
5118942|NCT01137201|Small bowel obstruction|small bowel obstruction
5118943|NCT01137201|Laparoscopic gastric bypass|laparoscopic gastric bypass
5118944|NCT01137201|Internal Hernia|internal hernia
5118945|NCT01137201|Mesenteric defect|mesenteric defect
5118946|NCT01137201|Morbid obesity|morbid obesity
5118947|NCT01137175|Rickettsioses|rickettsioses
5118948|NCT01137175|Scrub Typhus|scrub typhus
5118949|NCT01137175|Q fever|q fever
5118950|NCT01137175|Typhus fever|typhus fever
5118951|NCT01137175|Spotted fever|spotted fever
5118952|NCT01137175|Rickettsioses reported cases|rickettsioses reported cases
5118953|NCT01137149|Adolescent Depression|adolescent depression
5118954|NCT01137149|Treatment of depression in adolescents|treatment of depression in adolescents
5118955|NCT01137149|Behavioral activation treatment for depressed adolescents|behavioral activation treatment for depressed adolescents
5118956|NCT01137123|esophageal squamous cell carcinoma|esophageal squamous cell carcinoma
5118957|NCT01137110|Subarachnoid Hemorrhage|subarachnoid hemorrhage
5118958|NCT01137110|Seizure Prophylaxis|seizure prophylaxis
5118959|NCT01137110|Levetiracetam|levetiracetam
5118960|NCT01137045|rabies vaccine|rabies vaccine
5118961|NCT01137045|vero cells|vero cells
5118962|NCT01137045|serology|serology
5118963|NCT01137045|safety|safety
5118964|NCT01137032|Psoriasis|psoriasis
5118965|NCT01137032|Atopic Dermatitis|atopic dermatitis
5118966|NCT01137019|Drug-eluting stents|drug-eluting stents
5118967|NCT01137019|Tomography, Optical Coherence|tomography, optical coherence
5118968|NCT01137006|Melanoma|melanoma
5118969|NCT01137006|Phase I|phase i
5118970|NCT01137006|antibody|antibody
5118971|NCT01137006|melanin|melanin
5118972|NCT01137006|tyrosinase related protein 1|tyrosinase related protein 1
5118973|NCT01137006|glycoprotein|glycoprotein
5118974|NCT01137006|20D7S|20d7s
5118975|NCT01136993|Stroke|stroke
5118976|NCT01136993|Thrombolysis|thrombolysis
5118977|NCT01136993|Telestroke|telestroke
5118978|NCT01136980|GERD|gerd
5118979|NCT01136980|Esophagitis|esophagitis
5118980|NCT01136980|Fundoplication|fundoplication
5118981|NCT01136980|Anti-reflux surgery|anti-reflux surgery
5118982|NCT01136980|PPI dependent|ppi dependent
5118983|NCT01136928|Antiretroviral therapy|antiretroviral therapy
5118984|NCT01136928|American ginseng|american ginseng
5118985|NCT01136928|Efavirenz|efavirenz
5118986|NCT01136928|Cytochrome P450 enzymes|cytochrome p450 enzymes
5118987|NCT01136928|Complementary and Alternative Medicine|complementary and alternative medicine
5118988|NCT01136928|Herbal|herbal
5118989|NCT01136928|Pharmacikinetics|pharmacikinetics
5118990|NCT01136928|Healthy volunteers|healthy volunteers
5118991|NCT01136902|Diabetes Mellitus|diabetes mellitus
5118992|NCT01136902|Retinal Vessels|retinal vessels
5118993|NCT01136902|Physiology|physiology
5118994|NCT01136889|PFMT|pfmt
5118995|NCT01136889|Vaginal pessary|vaginal pessary
5118996|NCT01136889|Pelvic Organ Prolapse|pelvic organ prolapse
5118997|NCT01136863|hypertension|hypertension
5118998|NCT01136863|felodipine|felodipine
5118999|NCT01136863|moderate to high risk patients|moderate to high risk patients
5119000|NCT01136850|Plasmodium falciparum|plasmodium falciparum
5119001|NCT01136850|Plasmodium vivax|plasmodium vivax
5119002|NCT01136850|azithromycin|azithromycin
5119003|NCT01136850|sulphadoxine pyrimethamine|sulphadoxine pyrimethamine
5119004|NCT01136850|low birth weight|low birth weight
5119005|NCT01136850|haemoglobin|haemoglobin
5119006|NCT01136850|Chlamydia trachomatis|chlamydia trachomatis
5119007|NCT01136850|Neisseria gonorrhoeae|neisseria gonorrhoeae
5119008|NCT01136850|Treponema pallidum|treponema pallidum
5119009|NCT01136824|Sarcoma|sarcoma
5119010|NCT01136824|questionnaire|questionnaire
5119011|NCT01136824|doxorubicin plus ifosfamide (AI)|doxorubicin plus ifosfamide (ai)
5119012|NCT01136798|slow wave sleep|slow wave sleep
5119013|NCT01136798|exenatide and sleep|exenatide and sleep
5119014|NCT01136759|Prevention|prevention
5119015|NCT01136759|Microbicide|microbicide
5119016|NCT01136759|Mother-to-Child-Transmission|mother-to-child-transmission
5119017|NCT01136759|Pregnancy|pregnancy
5119018|NCT01136746|Hyperglycemia|hyperglycemia
5119019|NCT01136746|Diabetes|diabetes
5119020|NCT01136746|Hospital|hospital
5119021|NCT01136746|Diabetic|diabetic
5119022|NCT01136733|Unresectable advanced or metastatic renal cell carcinoma|unresectable advanced or metastatic renal cell carcinoma
5119023|NCT01136681|Anonymised Electronic Cohort|anonymised electronic cohort
5119024|NCT01136681|Record Linkage|record linkage
5119025|NCT01136681|Routine Data|routine data
5119026|NCT01136681|Environment|environment
5119027|NCT01136681|Childhood Obesity|childhood obesity
5119028|NCT01136681|Low birth weight|low birth weight
5119029|NCT01136681|Premature birth|premature birth
5119030|NCT01136668|pediatrics|pediatrics
5119031|NCT01136668|Transversus Abdominis Plane Block|transversus abdominis plane block
5119032|NCT01136668|Ostomy Surgery|ostomy surgery
5119033|NCT01136668|Anesthesia|anesthesia
5119034|NCT01136668|Regional Anesthetic|regional anesthetic
5119035|NCT01136655|asthmatic children|asthmatic children
5119036|NCT01136655|Symbicort|symbicort
5119039|NCT01136642|Nicotine Nasal Spray|nicotine nasal spray
5119040|NCT01136642|Attention|attention
5119041|NCT01136642|Smoking|smoking
5119042|NCT01136629|Hyper-pigmented spots|hyper-pigmented spots
5119043|NCT01136629|Lentigines|lentigines
5119044|NCT01136629|Mealsma|mealsma
5119045|NCT01136629|RNA extraction|rna extraction
5119046|NCT01136629|Isolation of Keratinocytes|isolation of keratinocytes
5119047|NCT01136629|Isolation of Melanocytes|isolation of melanocytes
5119048|NCT01136616|Nasal fracture|nasal fracture
5119049|NCT01136616|Nasal buttresses|nasal buttresses
5119050|NCT01136616|Septal deviation|septal deviation
5119051|NCT01136616|Nasal morphology|nasal morphology
5119052|NCT01136616|CT Scan|ct scan
5119053|NCT01136603|Abdominal wall defects|abdominal wall defects
5119054|NCT01136603|Inflammation reactions|inflammation reactions
5119055|NCT01136603|Amount of tissue ingrowth|amount of tissue ingrowth
5119057|NCT01136603|Shrinkage profiles of the implant|shrinkage profiles of the implant
5119058|NCT01136590|Spinal deformity correction|spinal deformity correction
5119059|NCT01136590|Surgical bleeding|surgical bleeding
5119060|NCT01136590|Transfusion practice|transfusion practice
5119061|NCT01136590|Spinal Fusion|spinal fusion
5119062|NCT01136590|Antifibrinolytic Agents|antifibrinolytic agents
5119063|NCT01136590|Hemorrhage|hemorrhage
5119064|NCT01136590|Blood Transfusion|blood transfusion
5119065|NCT01136577|Jaundice|jaundice
5119066|NCT01136577|Hyperbilirubinemia|hyperbilirubinemia
5119067|NCT01136577|Phototherapy|phototherapy
5119068|NCT01136577|term newborn|term newborn
5119069|NCT01136577|LED|led
5119070|NCT01136577|Fluorescent lamps|fluorescent lamps
5119071|NCT01136564|paricalcitol|paricalcitol
5119072|NCT01136564|vitamin d|vitamin d
5119073|NCT01136564|kidney disease|kidney disease
5119074|NCT01136564|renin|renin
5119075|NCT01136564|proteinuria|proteinuria
5119076|NCT01136551|Pharmacokinetic profile of controlled release formulation of Huperzine A|pharmacokinetic profile of controlled release formulation of huperzine a
5119077|NCT01136551|Bioequivalence of Huperzine A IR formulation and CR formulation|bioequivalence of huperzine a ir formulation and cr formulation
5119078|NCT01136538|Bioequivalence|bioequivalence
5119079|NCT01136538|Crossover|crossover
5119080|NCT01136538|Valacyclovir Hydrochloride|valacyclovir hydrochloride
5119081|NCT01136525|Bioequivalence|bioequivalence
5119082|NCT01136525|Crossover|crossover
5119083|NCT01136525|Valacyclovir Hydrochloride|valacyclovir hydrochloride
5119084|NCT01136512|metformin|metformin
5119085|NCT01136512|vitamin B12|vitamin b12
5119086|NCT01136512|type 2 diabetes|type 2 diabetes
5119087|NCT01136512|methylmalonic acid|methylmalonic acid
5119088|NCT01136512|deficiency|deficiency
5119089|NCT01136499|Sarcoma|sarcoma
5119090|NCT01136499|Safety|safety
5119091|NCT01136499|Efficacy|efficacy
5119092|NCT01136499|PANOBINOSTAT|panobinostat
5119093|NCT01136486|head trauma; traumatic brain injury|head trauma; traumatic brain injury
5119094|NCT01136473|congenital cataract|congenital cataract
5119095|NCT01136473|aphakic|aphakic
5119096|NCT01136473|pseudophakic glaucoma|pseudophakic glaucoma
5119097|NCT01136473|pediatric patients|pediatric patients
5119098|NCT01136460|Primary congenital glaucoma|primary congenital glaucoma
5119099|NCT01136460|neonatal|neonatal
5119100|NCT01136460|Genotype correlation|genotype correlation
5119101|NCT01136460|Phenotype correlation|phenotype correlation
5119102|NCT01136447|Brachial plexus|brachial plexus
5119103|NCT01136447|Ultrasound|ultrasound
5119104|NCT01136421|COPD exacerbation|copd exacerbation
5119105|NCT01136421|Magnesium sulfate|magnesium sulfate
5119106|NCT01136421|Ipratropium bromide|ipratropium bromide
5119107|NCT01136421|Emergency departement|emergency departement
5119108|NCT01136395|Kidney Transplantation|kidney transplantation
5119109|NCT01136395|Rituximab|rituximab
5119110|NCT01136395|Living Donor|living donor
5119111|NCT01136395|ABO Incompatible Transplantation|abo incompatible transplantation
5119112|NCT01136395|Immunology|immunology
5119113|NCT01136395|CMV|cmv
5119114|NCT01136395|EBV|ebv
5119115|NCT01136395|Polyomavirus|polyomavirus
5119116|NCT01136382|asthma, children, budesonide pMDI|asthma, children, budesonide pmdi
5119117|NCT01136369|metastasis|metastasis
5119118|NCT01136369|molecular pathology|molecular pathology
5119119|NCT01136356|opioid pharmacology|opioid pharmacology
5119120|NCT01136356|buprenorphine|buprenorphine
5119121|NCT01136356|morphine|morphine
5119122|NCT01136356|withdrawal|withdrawal
5119123|NCT01136356|human research|human research
5119124|NCT01136343|women|women
5119125|NCT01136343|middle age|middle age
5119126|NCT01136343|risk factor|risk factor
5119127|NCT01136330|Myotonic dystrophy|myotonic dystrophy
5119128|NCT01136330|Prognosis|prognosis
5119129|NCT01136330|Sudden death|sudden death
5119130|NCT01136330|Respiratory failure|respiratory failure
5119131|NCT01136304|Gaucher disease|gaucher disease
5119132|NCT01136304|Imiglucerase|imiglucerase
5119133|NCT01136304|Cerezyme|cerezyme
5119134|NCT01136304|Severity score|severity score
5119135|NCT01136291|pregnancy|pregnancy
5119136|NCT01136291|obesity|obesity
5119137|NCT01136291|physical exercise|physical exercise
5119138|NCT01136291|quality of life|quality of life
5119139|NCT01136278|MDMA|mdma
5119140|NCT01136278|norepinephrine|norepinephrine
5119141|NCT01136278|alpha2 receptor|alpha2 receptor
5119142|NCT01136278|Ecstasy|ecstasy
5119143|NCT01136278|stimulant|stimulant
5119144|NCT01136265|dual-time PET/CT|dual-time pet/ct
5119145|NCT01136265|sentinel node|sentinel node
5119146|NCT01136239|COPD|copd
5119147|NCT01136239|N-acetylcysteine|n-acetylcysteine
5119148|NCT01136239|airtrapping|airtrapping
5119149|NCT01136239|airway resistance|airway resistance
5119150|NCT01136239|antioxidant|antioxidant
5119151|NCT01136226|Prostate Cancer|prostate cancer
5119152|NCT01136200|Surgical and medical wards|surgical and medical wards
5119153|NCT01136200|Adults|adults
5119154|NCT01136200|Antimicrobial therapy|antimicrobial therapy
5119155|NCT01136187|Myocardial infarction|myocardial infarction
5119156|NCT01136187|Primary percutaneous coronary intervention|primary percutaneous coronary intervention
5119157|NCT01136187|Radial|radial
5119158|NCT01136187|Bleeding|bleeding
5119159|NCT01136161|LTBI (Latent Tuberculosis Infection)|ltbi (latent tuberculosis infection)
5119160|NCT01136161|TB (Tuberculosis)|tb (tuberculosis)
5119161|NCT01136161|Vaccine|vaccine
5119162|NCT01136148|Mental Health|mental health
5119163|NCT01136148|Aged|aged
5119164|NCT01136148|Hospitals, general|hospitals, general
5119165|NCT01136148|Dementia|dementia
5119166|NCT01136148|Delirium|delirium
5119167|NCT01136148|Dementia and confusion|dementia and confusion
5119168|NCT01136135|Heart transplant rejection|heart transplant rejection
5119169|NCT01136135|cardiac MRI|cardiac mri
5119170|NCT01136135|diagnosis|diagnosis
5119171|NCT01136096|diabetes|diabetes
5119172|NCT01136096|physical activity|physical activity
5119173|NCT01136096|adiponectin|adiponectin
5119174|NCT01136096|metabolic risks|metabolic risks
5119175|NCT01136096|exercise|exercise
5119176|NCT01136096|primary prevention|primary prevention
5119177|NCT01136083|Tumor|tumor
5119178|NCT01136083|Angiogenesis|angiogenesis
5119179|NCT01136083|Exercise training|exercise training
5119180|NCT01136083|VEGF|vegf
5119181|NCT01136083|Myostatin|myostatin
5119182|NCT01136070|Psychological Functioning in Burn Patients|psychological functioning in burn patients
5119183|NCT01136044|tensor fasciae latae|tensor fasciae latae
5119184|NCT01136044|septocutaneous perforators|septocutaneous perforators
5119185|NCT01136031|advanced gastric cancer|advanced gastric cancer
5119186|NCT01136031|1st-line failure|1st-line failure
5119187|NCT01136005|receptor, epidermal growth factor|receptor, epidermal growth factor
5119188|NCT01136005|skin reactions|skin reactions
5119189|NCT01136005|quality of life|quality of life
5119190|NCT01136005|adherence|adherence
5119191|NCT01135966|COPD|copd
5119192|NCT01135966|Whole Body Vibration training|whole body vibration training
5119193|NCT01135966|Conventional resistance training|conventional resistance training
5119194|NCT01135953|Brain excitation|brain excitation
5119195|NCT01135953|transcranial Direct Stimulation|transcranial direct stimulation
5119196|NCT01135953|administration pattern|administration pattern
5119197|NCT01135940|neuromuscular scoliosis|neuromuscular scoliosis
5119198|NCT01135940|dermabond|dermabond
5119199|NCT01135940|infection|infection
5119200|NCT01135940|wound closure|wound closure
5119202|NCT01135914|visual impairment|visual impairment
5119203|NCT01135914|diabetes|diabetes
5119204|NCT01135914|macular edema|macular edema
5119205|NCT01135914|diabetic macular edema|diabetic macular edema
5119206|NCT01135914|ranibizumab|ranibizumab
5119207|NCT01135914|laser|laser
5119208|NCT01135914|photocoagulation|photocoagulation
5119209|NCT01135914|retinopathy|retinopathy
5119210|NCT01135914|retina|retina
5119211|NCT01135901|prevention|prevention
5119212|NCT01135901|public health|public health
5119213|NCT01135901|community health services|community health services
5119214|NCT01135901|Norway|norway
5119215|NCT01135888|hypohidrotic ectodermal dysplasia|hypohidrotic ectodermal dysplasia
5119216|NCT01135888|exertional hyperthermia|exertional hyperthermia
5119217|NCT01135888|cooling device|cooling device
5119218|NCT01135875|GBM|gbm
5119219|NCT01135875|Brain Tumor|brain tumor
5119220|NCT01135875|Brain Neoplasm|brain neoplasm
5119221|NCT01135875|Control|control
5119222|NCT01135875|Normal Control|normal control
5119223|NCT01135875|Volunteer|volunteer
5119224|NCT01135836|Shoulder pain|shoulder pain
5119225|NCT01135836|Gynecologic laparoscopic surgery|gynecologic laparoscopic surgery
5119226|NCT01135836|Nausea|nausea
5119227|NCT01135836|Vomiting|vomiting
5119228|NCT01135836|Abdominal fullness|abdominal fullness
5119229|NCT01135810|healthy subjects|healthy subjects
5119230|NCT01135771|glucose monitoring|glucose monitoring
5119231|NCT01135771|diabetes|diabetes
5119232|NCT01135771|glucose monitoring in patients with diabetes|glucose monitoring in patients with diabetes
5119233|NCT01135758|depression, ketamine, fMRI|depression, ketamine, fmri
5119234|NCT01135732|late development cholangiocarcinoma|late development cholangiocarcinoma
5119235|NCT01135719|Myopia|myopia
5119236|NCT01135719|Hyperopia|hyperopia
5119237|NCT01135719|Astigmatism|astigmatism
5119238|NCT01135719|PRK|prk
5119239|NCT01135719|LASIK|lasik
5119240|NCT01135706|Pulmonary Hypertension|pulmonary hypertension
5119241|NCT01135706|Fractal dimension|fractal dimension
5119242|NCT01135693|Section 136|section 136
5119243|NCT01135693|Mental Health Act 1983|mental health act 1983
5119246|NCT01135693|Failure of community care|failure of community care
5119247|NCT01135667|clopidogrel|clopidogrel
5119248|NCT01135667|prasugrel|prasugrel
5119249|NCT01135667|low responder|low responder
5119250|NCT01135667|multiplate|multiplate
5119251|NCT01135667|verify now|verify now
5119252|NCT01135654|alcohol dependence|alcohol dependence
5119253|NCT01135654|unhealthy drinking|unhealthy drinking
5119254|NCT01135654|SBIRT|sbirt
5119255|NCT01135641|Adult patients (≥18 years)|adult patients (≥18 years)
5119256|NCT01135641|first allogeneic stem cell transplantation|first allogeneic stem cell transplantation
5119257|NCT01135641|first episode of chronic GVHD requiring systemic immunosuppressive therapy|first episode of chronic gvhd requiring systemic immunosuppressive therapy
5119258|NCT01135628|Hepatic cirrhosis|hepatic cirrhosis
5119259|NCT01135628|Minimal hepatic encephalopathy|minimal hepatic encephalopathy
5119260|NCT01135628|Hyperproteic and fiber-rich diet|hyperproteic and fiber-rich diet
5119261|NCT01135628|Lactobacillus reuteri|lactobacillus reuteri
5119262|NCT01135628|Psychometric Hepatic Encephalopathy Score (PHES)|psychometric hepatic encephalopathy score (phes)
5119263|NCT01135628|Critical Flicker Frequency (CFF)|critical flicker frequency (cff)
5119264|NCT01135615|FGF-23, endothelial dysfunction, sevelamer|fgf-23, endothelial dysfunction, sevelamer
5119265|NCT01135602|Alcohol dependence|alcohol dependence
5119266|NCT01135602|Alcoholism|alcoholism
5119267|NCT01135602|Topiramate|topiramate
5119268|NCT01135589|pediatric|pediatric
5119269|NCT01135589|adolescent|adolescent
5119270|NCT01135589|micafungin|micafungin
5119271|NCT01135576|Ferric pyrophosphate|ferric pyrophosphate
5119272|NCT01135576|Fortification|fortification
5119273|NCT01135576|Fruit juice|fruit juice
5119274|NCT01135576|Functional food|functional food
5119275|NCT01135576|Bioavailability|bioavailability
5119276|NCT01135576|iron status|iron status
5119277|NCT01135576|Women|women
5119278|NCT01135576|iron-deficiency anemia|iron-deficiency anemia
5119279|NCT01135563|pediatrics|pediatrics
5119280|NCT01135563|Solid Tumors|solid tumors
5119281|NCT01135563|CNS Tumors|cns tumors
5119282|NCT01135563|Vinblastine|vinblastine
5119283|NCT01135563|Sirolimus|sirolimus
5119284|NCT01135563|Recurrent|recurrent
5119285|NCT01135563|Refractory|refractory
5119286|NCT01135550|Pediatrics|pediatrics
5119287|NCT01135550|Vomiting|vomiting
5119288|NCT01135550|Headache|headache
5119289|NCT01135550|Radiation Therapy|radiation therapy
5119290|NCT01135537|allogeneic hematopoietic stem cell transplantation|allogeneic hematopoietic stem cell transplantation
5119291|NCT01135537|pharmacokinetics|pharmacokinetics
5119292|NCT01135537|pediatrics|pediatrics
5119293|NCT01135524|Osteoarthritis|osteoarthritis
5119294|NCT01135524|Opioid|opioid
5119295|NCT01135524|Transdermal|transdermal
5119296|NCT01135511|Dry eye|dry eye
5119297|NCT01135472|NEXIUM|nexium
5119298|NCT01135472|HEALTHY VOLUNTEERS|healthy volunteers
5119299|NCT01135472|BLOOD DRAW|blood draw
5119300|NCT01135472|to measure gastrin levels in healthy volunteers while taking nexium|to measure gastrin levels in healthy volunteers while taking nexium
5119301|NCT01135459|Lupus|lupus
5119302|NCT01135433|ASP1941|asp1941
5119303|NCT01135433|Diabetes mellitus|diabetes mellitus
5119304|NCT01135433|Metformin|metformin
5119305|NCT01135407|Parkinson's disease|parkinson's disease
5119306|NCT01135407|Deep brain stimulation|deep brain stimulation
5119307|NCT01135407|Subthalamic nucleus|subthalamic nucleus
5119308|NCT01135407|Levodopa|levodopa
5119309|NCT01135407|Selective visual attention|selective visual attention
5119310|NCT01135407|Basal ganglia diseases|basal ganglia diseases
5119311|NCT01135394|Pioglitazone|pioglitazone
5119312|NCT01135394|Type 2 diabetes|type 2 diabetes
5119313|NCT01135394|Insulin sensitivity|insulin sensitivity
5119314|NCT01135394|Healthy adults|healthy adults
5119315|NCT01135394|Thiazolidinediones|thiazolidinediones
5119316|NCT01135394|Pharmacogenetics|pharmacogenetics
5119317|NCT01135381|care transitions|care transitions
5119318|NCT01135381|information technology|information technology
5119320|NCT01135368|Gastroesophageal Reflux Disease|gastroesophageal reflux disease
5119321|NCT01135368|Drug Therapy|drug therapy
5119322|NCT01135342|Insomnia|insomnia
5119323|NCT01135342|Weight loss|weight loss
5119324|NCT01135342|Adults|adults
5119325|NCT01135329|Lymphoma|lymphoma
5119326|NCT01135329|Hodgkin's lymphoma|hodgkin's lymphoma
5119327|NCT01135329|Non hodgkin's lymphoma|non hodgkin's lymphoma
5119328|NCT01135329|Leukemia|leukemia
5119329|NCT01135329|Acute myeloid leukemia (AML)|acute myeloid leukemia (aml)
5119330|NCT01135329|Acute lymphoblastic leukemia(ALL)|acute lymphoblastic leukemia(all)
5119331|NCT01135329|Chronic myeloid leukemia (CML)|chronic myeloid leukemia (cml)
5119332|NCT01135329|Chronic Myelomonocytic (CMML)|chronic myelomonocytic (cmml)
5119333|NCT01135329|Myelodysplastic syndrome (MDS)|myelodysplastic syndrome (mds)
5119334|NCT01135329|High-risk acute leukemia in first remission|high-risk acute leukemia in first remission
5119335|NCT01135329|Relapsed leukemia in remission|relapsed leukemia in remission
5119336|NCT01135329|Cyclophosphamide|cyclophosphamide
5119337|NCT01135329|High-dose cyclophosphamide|high-dose cyclophosphamide
5119338|NCT01135329|Fludarabine|fludarabine
5119339|NCT01135329|Busulfan|busulfan
5119340|NCT01135329|Allogeneic|allogeneic
5119341|NCT01135329|Nonmyeloablative|nonmyeloablative
5119342|NCT01135329|Reduced intensity|reduced intensity
5119343|NCT01135329|Haploidentical|haploidentical
5119344|NCT01135329|Bone marrow transplant (BMT)|bone marrow transplant (bmt)
5119345|NCT01135316|NSF, Ablavar, Kidney Disease, Magnetic Resonance Imaging (MRI),|nsf, ablavar, kidney disease, magnetic resonance imaging (mri),
5119346|NCT01135303|Sleep Apnea Syndromes|sleep apnea syndromes
5119347|NCT01135303|Polysomnography|polysomnography
5119348|NCT01135303|Holter ECG|holter ecg
5119349|NCT01135303|Thoracic impedance|thoracic impedance
5119350|NCT01135303|Heart rate variability|heart rate variability
5119351|NCT01135290|The management of post-treatment symptoms for subjects that had either a medium grade chemical peel or fractional resurfacing|the management of post-treatment symptoms for subjects that had either a medium grade chemical peel or fractional resurfacing
5119352|NCT01135251|Neuropathic pain|neuropathic pain
5119353|NCT01135251|AIDS|aids
5119354|NCT01135251|Dimiracetam|dimiracetam
5119355|NCT01135251|Treatment related painful neuropathy in AIDS patients|treatment related painful neuropathy in aids patients
5119356|NCT01135238|adrenalectomy|adrenalectomy
5119357|NCT01135238|metastasis|metastasis
5119358|NCT01135238|morbidity|morbidity
5119359|NCT01135238|mortality|mortality
5119360|NCT01135238|survival|survival
5119361|NCT01135225|Drug-eluting stent|drug-eluting stent
5119362|NCT01135225|Percutaneous coronary intervention|percutaneous coronary intervention
5119363|NCT01135225|Stent implantation|stent implantation
5119364|NCT01135225|Evolution Stent System|evolution stent system
5119365|NCT01135225|Biodegradable polymer coating|biodegradable polymer coating
5119366|NCT01135225|Feasibility study|feasibility study
5119367|NCT01135212|Hypertension|hypertension
5119368|NCT01135212|ARB|arb
5119369|NCT01135212|Fimasartan|fimasartan
5119370|NCT01135173|Smoking Cessation, Waterpipe|smoking cessation, waterpipe
5119371|NCT01135160|weight bearing|weight bearing
5119372|NCT01135160|pain|pain
5119373|NCT01135160|total hip arthroplasty|total hip arthroplasty
5119374|NCT01135160|total knee arthroplasty|total knee arthroplasty
5119375|NCT01135160|weight bearing after TKA or THA|weight bearing after tka or tha
5119376|NCT01135108|Analgesics. Non-narcotic / therapeutic use|analgesics. non-narcotic / therapeutic use
5119377|NCT01135108|Spinal Cord Injuries|spinal cord injuries
5119378|NCT01135108|Pain|pain
5119379|NCT01135108|Pain measurement / drug effect|pain measurement / drug effect
5119380|NCT01135108|Pain postoperative / drug therapy|pain postoperative / drug therapy
5119381|NCT01135095|Myocardial perfusion|myocardial perfusion
5119382|NCT01135095|Low radiation dose|low radiation dose
5119383|NCT01135095|Single photon emission computed tomography|single photon emission computed tomography
5119384|NCT01135082|immunogenicity|immunogenicity
5119385|NCT01135082|safety|safety
5119386|NCT01135082|Pneumococcal conjugate vaccine|pneumococcal conjugate vaccine
5119387|NCT01135082|HIV infected children|hiv infected children
5119388|NCT01135082|objective of this study is to assess the safety and immunogenicity of a 7 - valent PCV vaccine among HIV - infected compared with HIV - exposed children|objective of this study is to assess the safety and immunogenicity of a 7 - valent pcv vaccine among hiv - infected compared with hiv - exposed children
5119389|NCT01135056|Hepatocellular Carcinoma|hepatocellular carcinoma
5119390|NCT01135056|Randomized|randomized
5119391|NCT01135056|Open-label|open-label
5119392|NCT01135056|Multi-Centre|multi-centre
5119393|NCT01135056|Phase III|phase iii
5119394|NCT01135056|Sorafenib|sorafenib
5119395|NCT01135056|SIR-Spheres|sir-spheres
5119396|NCT01135043|acceptable sputum|acceptable sputum
5119397|NCT01135043|AFB culture|afb culture
5119398|NCT01135043|pulmonary tuberculosis|pulmonary tuberculosis
5119399|NCT01135030|total knee arthroplasty|total knee arthroplasty
5119400|NCT01135004|pneumothorax|pneumothorax
5119401|NCT01135004|thoracoscopy|thoracoscopy
5119402|NCT01135004|pathogenesis|pathogenesis
5119403|NCT01135004|blebs|blebs
5119404|NCT01135004|surgery|surgery
5119405|NCT01134991|rosacea|rosacea
5119406|NCT01134991|topical|topical
5119407|NCT01134991|minocycline|minocycline
5119408|NCT01134991|foam|foam
5119409|NCT01134991|phase II|phase ii
5119410|NCT01134978|repeated measures design|repeated measures design
5119411|NCT01134978|random assignment to groups|random assignment to groups
5119412|NCT01134952|sirolimus|sirolimus
5119413|NCT01134952|everolimus|everolimus
5119414|NCT01134952|mycophenolic acid|mycophenolic acid
5119415|NCT01134952|hepatitis C virus|hepatitis c virus
5119416|NCT01134952|tacrolimus|tacrolimus
5119417|NCT01134952|viral load|viral load
5119418|NCT01134926|Retained products of conception|retained products of conception
5119419|NCT01134926|residua|residua
5119420|NCT01134926|misoprostol|misoprostol
5119421|NCT01134926|expectant management|expectant management
5119422|NCT01134913|ACS|acs
5119423|NCT01134913|Acute Coronary Syndrome|acute coronary syndrome
5119424|NCT01134913|Emergency Department|emergency department
5119425|NCT01134900|Medication Errors|medication errors
5119426|NCT01134900|Adverse Drug Events|adverse drug events
5119427|NCT01134900|Decision Support Systems, Clinical|decision support systems, clinical
5119428|NCT01134887|hypertension|hypertension
5119429|NCT01134887|physician-patient relations|physician-patient relations
5119430|NCT01134887|communication|communication
5119431|NCT01134861|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
5119432|NCT01134861|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5119626|NCT01133951|Incidence|incidence
5119433|NCT01134861|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5119434|NCT01134848|Bile ducts|bile ducts
5119435|NCT01134848|Sphincter of Oddi|sphincter of oddi
5119436|NCT01134848|Pancreatic ducts|pancreatic ducts
5119437|NCT01134822|Idiopathic Pulmonary Fibrosis|idiopathic pulmonary fibrosis
5119438|NCT01134822|IPF|ipf
5119439|NCT01134822|Lung Fibrosis|lung fibrosis
5119440|NCT01134822|Biomarkers|biomarkers
5119441|NCT01134809|Major abdominal surgery|major abdominal surgery
5119442|NCT01134770|Prenatal Substance Use|prenatal substance use
5119443|NCT01134770|Cocaine|cocaine
5119444|NCT01134770|Cigarette Smoking|cigarette smoking
5119445|NCT01134770|Mothers|mothers
5119446|NCT01134770|Pregnant women|pregnant women
5119447|NCT01134770|Smoking Mothers|smoking mothers
5119448|NCT01134757|EAR|ear
5119449|NCT01134757|LAR|lar
5119450|NCT01134757|BHR|bhr
5119451|NCT01134757|house dust mite|house dust mite
5119452|NCT01134757|alternaria|alternaria
5119453|NCT01134744|CXray|cxray
5119454|NCT01134731|depression|depression
5119455|NCT01134731|suicidality|suicidality
5119456|NCT01134731|Major Depressive Disorder, current episode, with suicidality|major depressive disorder, current episode, with suicidality
5119457|NCT01134718|TMC435-TiDP16-C119|tmc435-tidp16-c119
5119458|NCT01134718|TMC435-C119|tmc435-c119
5119459|NCT01134718|TMC435|tmc435
5119460|NCT01134718|Protease inhibitor|protease inhibitor
5119461|NCT01134718|HCV|hcv
5119462|NCT01134718|Hepatitis C|hepatitis c
5119463|NCT01134718|Bioavailability|bioavailability
5119464|NCT01134692|Patients with cirrhosis who have large esophageal varices with No history of upper GI bleeding in the past|patients with cirrhosis who have large esophageal varices with no history of upper gi bleeding in the past
5119465|NCT01134679|Drug Eluting Stent|drug eluting stent
5119466|NCT01134679|Clopidogrel|clopidogrel
5119467|NCT01134679|Aspirin|aspirin
5119468|NCT01134666|Colorectal neoplasms|colorectal neoplasms
5119469|NCT01134666|Intestinal neoplasms|intestinal neoplasms
5119470|NCT01134666|Neoplasms|neoplasms
5119471|NCT01134666|cetuximab|cetuximab
5119472|NCT01134666|Erbitux|erbitux
5119473|NCT01134653|Acute ankle sprain in children and young adults|acute ankle sprain in children and young adults
5119474|NCT01134640|metastatic colorectal cancer|metastatic colorectal cancer
5119475|NCT01134640|mCRC|mcrc
5119476|NCT01134640|post marketing surveillance|post marketing surveillance
5119477|NCT01134640|Erbitux|erbitux
5119478|NCT01134640|Cetuximab|cetuximab
5119479|NCT01134640|KRAS|kras
5119480|NCT01134627|Multiple Sclerosis, Relapsing-Remitting|multiple sclerosis, relapsing-remitting
5119481|NCT01134627|Interferon-β|interferon-β
5119482|NCT01134627|Rebif®|rebif®
5119483|NCT01134627|Minocycline|minocycline
5119484|NCT01134601|Rectal Cancer|rectal cancer
5119485|NCT01134601|Radiation Therapy|radiation therapy
5119486|NCT01134601|Capecitabine|capecitabine
5119487|NCT01134601|AZD6244|azd6244
5119488|NCT01134575|Relapsed|relapsed
5119489|NCT01134575|Refractory|refractory
5119490|NCT01134575|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
5119491|NCT01134575|ALL|all
5119492|NCT01134575|Burkitt's lymphoma|burkitt's lymphoma
5119493|NCT01134575|Lymphoblastic lymphoma|lymphoblastic lymphoma
5119494|NCT01134575|CMC-544|cmc-544
5119495|NCT01134575|Inotuzumab Ozogamycin|inotuzumab ozogamycin
5119496|NCT01134575|Rituxan|rituxan
5119497|NCT01134575|Rituximab|rituximab
5119498|NCT01134562|Clinical Trial, Phase 1|clinical trial, phase 1
5119499|NCT01134562|Renal Dialysis|renal dialysis
5119500|NCT01134562|Secondary Hyperparathyroidism|secondary hyperparathyroidism
5119501|NCT01134562|Parathyroid hormone|parathyroid hormone
5119502|NCT01134536|Pain, Postoperative|pain, postoperative
5119503|NCT01134536|Postoperative Pain|postoperative pain
5119504|NCT01134536|Tapentadol|tapentadol
5119505|NCT01134536|NUCYNTA|nucynta
5119506|NCT01134536|CG5503|cg5503
5119507|NCT01134536|R331333|r331333
5119508|NCT01134536|Pharmacokinetics|pharmacokinetics
5119509|NCT01134536|Postsurgical pain|postsurgical pain
5119510|NCT01134536|Children|children
5119511|NCT01134536|Adolescents|adolescents
5119512|NCT01134523|positive lymph node|positive lymph node
5119513|NCT01134510|Kidney transplantation|kidney transplantation
5119514|NCT01134484|autologous stem cell transplantation|autologous stem cell transplantation
5119515|NCT01134484|complete remission|complete remission
5119516|NCT01134484|bortezomib|bortezomib
5119517|NCT01134484|thalidomide|thalidomide
5119518|NCT01134484|progression free survival|progression free survival
5119519|NCT01134484|induction and consolidation therapy|induction and consolidation therapy
5119520|NCT01134458|cardiovascular disease|cardiovascular disease
5119521|NCT01134445|Arthroplasty|arthroplasty
5119522|NCT01134445|Replacement|replacement
5119523|NCT01134445|Hip|hip
5119524|NCT01134445|Conservative|conservative
5119525|NCT01134445|Anatomic|anatomic
5119526|NCT01134445|Cementless|cementless
5119527|NCT01134432|autoimmune hemolytic anemia|autoimmune hemolytic anemia
5119528|NCT01134432|hemolytic anemia|hemolytic anemia
5119529|NCT01134432|Rituximab|rituximab
5119530|NCT01134432|Treatment of autoimmune hemolytic anemia|treatment of autoimmune hemolytic anemia
5119531|NCT01134432|warm antibody dependant autoimmune hemolytic anemia|warm antibody dependant autoimmune hemolytic anemia
5119532|NCT01134419|Patient Safety|patient safety
5119533|NCT01134419|Medical Errors|medical errors
5119534|NCT01134419|Handoff|handoff
5119535|NCT01134419|Sign-out|sign-out
5119536|NCT01134419|Resident|resident
5119537|NCT01134419|Intern|intern
5119538|NCT01134419|Graduate Medical Education|graduate medical education
5119539|NCT01134406|Osteoarthritis|osteoarthritis
5119540|NCT01134406|knee|knee
5119541|NCT01134380|Percutaneous coronary intervention|percutaneous coronary intervention
5119542|NCT01134380|Acute coronary syndrome|acute coronary syndrome
5119543|NCT01134380|Dual antiplatelet therapy|dual antiplatelet therapy
5119544|NCT01134380|clopidogrel/prasugrel|clopidogrel/prasugrel
5119545|NCT01134380|genotyping|genotyping
5119546|NCT01134380|stent|stent
5119547|NCT01134380|compliance|compliance
5119548|NCT01134367|gastroesophageal reflux disease (GERD)|gastroesophageal reflux disease (gerd)
5119549|NCT01134354|Validation study|validation study
5119550|NCT01134354|Outcome Measures|outcome measures
5119551|NCT01134354|Patient Outcomes Assessment|patient outcomes assessment
5119552|NCT01134354|Patient expectations|patient expectations
5119553|NCT01134354|Physician patient relationship|physician patient relationship
5119554|NCT01134341|Relapsed|relapsed
5119555|NCT01134341|Refractory|refractory
5119556|NCT01134315|Evaluating incidence of hypercalcemia in pediatric patients|evaluating incidence of hypercalcemia in pediatric patients
5119557|NCT01134302|Hybrid|hybrid
5119558|NCT01134302|Norwood|norwood
5119559|NCT01134302|congenital heart disease|congenital heart disease
5119560|NCT01134302|single ventricle|single ventricle
5119561|NCT01134289|complex regional pain syndrome|complex regional pain syndrome
5119562|NCT01134289|lumbar sympathetic blockade|lumbar sympathetic blockade
5119563|NCT01134289|photoplethysmography|photoplethysmography
5119564|NCT01134289|diagnostic lumbar sympathetic blockade|diagnostic lumbar sympathetic blockade
5119565|NCT01134263|Dengue Fever|dengue fever
5119566|NCT01134263|Dengue Hemorrhagic Fever|dengue hemorrhagic fever
5119567|NCT01134263|CYD Dengue Vaccine|cyd dengue vaccine
5119568|NCT01134263|Lot Consistency|lot consistency
5119569|NCT01134250|Interleukin, IL2, F16, monoclonal, antibody, cytokine Paclitaxel, breast cancer,solid tumour|interleukin, il2, f16, monoclonal, antibody, cytokine paclitaxel, breast cancer,solid tumour
5119570|NCT01134250|metastatic melanoma, non-small cell lung cancer (NSCLC)|metastatic melanoma, non-small cell lung cancer (nsclc)
5119571|NCT01134237|non-surgical rate|non-surgical rate
5119572|NCT01134198|Cocaine Dependence|cocaine dependence
5119573|NCT01134185|Two groups of 8 hepatically impaired subjects, one group of 8 matched healthy subjects|two groups of 8 hepatically impaired subjects, one group of 8 matched healthy subjects
5119574|NCT01134172|Sociodemographic|sociodemographic
5119575|NCT01134172|Ethnicity|ethnicity
5119576|NCT01134172|Work-related|work-related
5119577|NCT01134172|Health system|health system
5119578|NCT01134172|QOL|qol
5119579|NCT01134172|Questionnaires|questionnaires
5119580|NCT01134172|10-071|10-071
5119581|NCT01134146|Intensity Modulated Radiotherapy|intensity modulated radiotherapy
5119582|NCT01134146|IMRT|imrt
5119583|NCT01134146|Malignant Pleural Mesothelioma|malignant pleural mesothelioma
5119584|NCT01134146|Radical Pleurectomy|radical pleurectomy
5119585|NCT01134146|Decortication|decortication
5119586|NCT01134146|PD|pd
5119587|NCT01134146|pleurectomy|pleurectomy
5119588|NCT01134146|lung surgery|lung surgery
5119589|NCT01134146|pleura|pleura
5119590|NCT01134094|Undisplaced|undisplaced
5119591|NCT01134094|Ankle Fracture|ankle fracture
5119592|NCT01134094|Weber B|weber b
5119593|NCT01134081|gum|gum
5119594|NCT01134081|recession|recession
5119595|NCT01134068|D-dimer|d-dimer
5119596|NCT01134068|Pulmonary embolism|pulmonary embolism
5119597|NCT01134068|Diagnostic strategy|diagnostic strategy
5119598|NCT01134068|Safety of ruling PE with and age-adjusted DD cut-off|safety of ruling pe with and age-adjusted dd cut-off
5119599|NCT01134055|ranibizumab|ranibizumab
5119600|NCT01134055|wet AMD|wet amd
5119601|NCT01134055|MD7110852|md7110852
5119602|NCT01134055|age related macular degeneration|age related macular degeneration
5119603|NCT01134055|age-related macular degeneration|age-related macular degeneration
5119604|NCT01134055|macular degeneration|macular degeneration
5119605|NCT01134055|pazopanib|pazopanib
5119606|NCT01134042|Fluticasone propionate|fluticasone propionate
5119607|NCT01134042|asthma|asthma
5119608|NCT01134042|vilanterol|vilanterol
5119609|NCT01134042|GW642444|gw642444
5119610|NCT01134042|Fluticasone furoate|fluticasone furoate
5119611|NCT01134029|obesity|obesity
5119612|NCT01134029|weight management and cardiovascular risk factors|weight management and cardiovascular risk factors
5119613|NCT01134016|Lung cancer|lung cancer
5119614|NCT01134016|NSCLC|nsclc
5119615|NCT01134003|Gynecare Prolift|gynecare prolift
5119616|NCT01134003|Pelvic organ prolapse|pelvic organ prolapse
5119617|NCT01134003|forming a large database of women who have recieve Gynecare prolift system|forming a large database of women who have recieve gynecare prolift system
5119618|NCT01133964|Dairy proteins|dairy proteins
5119619|NCT01133964|Appetite regulation|appetite regulation
5119620|NCT01133964|Energy expenditure|energy expenditure
5119621|NCT01133951|Helicobacter Infections|helicobacter infections
5119622|NCT01133951|Helicobacter pylori|helicobacter pylori
5119623|NCT01133951|Drug Therapy|drug therapy
5119624|NCT01133951|Precancerous Conditions|precancerous conditions
5119625|NCT01133951|Stomach Neoplasms|stomach neoplasms
5119627|NCT01133925|Coronary Artery Disease|coronary artery disease
5119628|NCT01133925|Percutaneous Coronary Intervention|percutaneous coronary intervention
5119629|NCT01133925|Drug Eluting Stent|drug eluting stent
5119630|NCT01133925|Optical Coherence Tomography|optical coherence tomography
5119631|NCT01133925|Thrombosi|thrombosi
5119632|NCT01133925|Long lesions in native vessels requiring overlap|long lesions in native vessels requiring overlap
5119633|NCT01133912|Patients with HER2 Positive Operable Breast Cancer|patients with her2 positive operable breast cancer
5119634|NCT01133899|strength, anaerobic performance, recovery, ergogenic|strength, anaerobic performance, recovery, ergogenic
5119635|NCT01133860|inherited thrombocytopenia|inherited thrombocytopenia
5119636|NCT01133860|MYH9 mutations|myh9 mutations
5119637|NCT01133860|eltrombopag|eltrombopag
5119638|NCT01133834|meningococcal disease|meningococcal disease
5119639|NCT01133834|cytokines|cytokines
5119640|NCT01133821|Bipolar II Disorder|bipolar ii disorder
5119641|NCT01133821|Bipolar II Depression|bipolar ii depression
5119642|NCT01133821|Psychotherapy|psychotherapy
5119643|NCT01133821|IPSRT|ipsrt
5119644|NCT01133821|Seroquel|seroquel
5119645|NCT01133821|Quetiapine|quetiapine
5119646|NCT01133821|Placebo|placebo
5119647|NCT01133821|Sugar Pill|sugar pill
5119648|NCT01133808|diarrhea|diarrhea
5119649|NCT01133808|childhood|childhood
5119650|NCT01133808|rotavirus|rotavirus
5119651|NCT01133808|vaccine|vaccine
5119652|NCT01133808|Nicaragua|nicaragua
5119653|NCT01133795|cirrhosis|cirrhosis
5119654|NCT01133795|renal failure|renal failure
5119655|NCT01133795|hepatorenal syndrome|hepatorenal syndrome
5119656|NCT01133795|albumine|albumine
5119657|NCT01133795|midodrine|midodrine
5119658|NCT01133769|Clavicle fracture|clavicle fracture
5119659|NCT01133769|fixation|fixation
5119660|NCT01133769|polytrauma|polytrauma
5119661|NCT01133769|Clavicle fracture patients with chest injury|clavicle fracture patients with chest injury
5119662|NCT01133743|Lenalidomide|lenalidomide
5119663|NCT01133743|Dexamethasone|dexamethasone
5119664|NCT01133743|Immunomodulatory Drugs(IMiD™)|immunomodulatory drugs(imid™)
5119665|NCT01133743|Thalidomide analogues|thalidomide analogues
5119666|NCT01133730|supraclavicular nerve block|supraclavicular nerve block
5119667|NCT01133730|regional anesthesia|regional anesthesia
5119668|NCT01133730|transversalis fascia plane block|transversalis fascia plane block
5119669|NCT01133730|ultrasound guided|ultrasound guided
5119670|NCT01133730|opioid consumption|opioid consumption
5119788|NCT01133015|MLA|mla
5119671|NCT01133730|iliac crest bone harvest|iliac crest bone harvest
5119672|NCT01133730|hand surgery|hand surgery
5119673|NCT01133730|wrist surgery|wrist surgery
5119674|NCT01133730|Upper limb surgery combined with iliac crest bone harvest.|upper limb surgery combined with iliac crest bone harvest.
5119675|NCT01133717|Sleep Apnea|sleep apnea
5119676|NCT01133717|Cerebrovascular Reactivity|cerebrovascular reactivity
5119677|NCT01133704|asymptomatic metastatic hormone-refractory prostate cancer|asymptomatic metastatic hormone-refractory prostate cancer
5119678|NCT01133691|gastric emptying|gastric emptying
5119679|NCT01133691|children|children
5119680|NCT01133691|gastric fluid volume|gastric fluid volume
5119681|NCT01133691|preoperative fasting|preoperative fasting
5119682|NCT01133678|Squamous Cell Carcinoma|squamous cell carcinoma
5119683|NCT01133665|Head and Neck, Squamous Cell|head and neck, squamous cell
5119684|NCT01133665|Recurrent or metastatic squamous cell or undifferentiated carcinoma of the head and neck that is not amenable to curative therapy|recurrent or metastatic squamous cell or undifferentiated carcinoma of the head and neck that is not amenable to curative therapy
5119685|NCT01133652|Venipuncture|venipuncture
5119686|NCT01133652|Randomized Controlled Trial|randomized controlled trial
5119687|NCT01133652|Intravenous access|intravenous access
5119688|NCT01133652|Children|children
5119689|NCT01133652|Pediatric Emergency Department|pediatric emergency department
5119690|NCT01133652|Peripheral intravenous catheterization|peripheral intravenous catheterization
5119691|NCT01133652|Catheterization, Peripheral Phlebotomy|catheterization, peripheral phlebotomy
5119692|NCT01133587|Schizophrenia|schizophrenia
5119693|NCT01133587|bipolar disorder|bipolar disorder
5119694|NCT01133587|Long term care|long term care
5119695|NCT01133587|patient admission|patient admission
5119696|NCT01133574|Healthy volunteers|healthy volunteers
5119697|NCT01133574|SLV354|slv354
5119698|NCT01133574|Phase I|phase i
5119699|NCT01133574|SRDT|srdt
5119700|NCT01133561|psoriasis|psoriasis
5119701|NCT01133561|insulin resistance|insulin resistance
5119702|NCT01133561|metabolic syndrome|metabolic syndrome
5119703|NCT01133561|pioglitazone|pioglitazone
5119704|NCT01133561|randomized control trial|randomized control trial
5119705|NCT01133548|testosterone, hypogonadal, males|testosterone, hypogonadal, males
5119706|NCT01133522|AMG145|amg145
5119707|NCT01133522|Multiple Dose|multiple dose
5119708|NCT01133522|Statin|statin
5119709|NCT01133522|Ascending|ascending
5119710|NCT01133496|Bioequivalence|bioequivalence
5119711|NCT01133496|Alendronate Sodium|alendronate sodium
5119712|NCT01133496|crossover|crossover
5119713|NCT01133483|Bioequivalence|bioequivalence
5119714|NCT01133483|Fexofenadine Hydrochloride + Pseudoephedrine Hydrochloride|fexofenadine hydrochloride + pseudoephedrine hydrochloride
5119715|NCT01133470|Bioequivalence|bioequivalence
5119809|NCT01132911|Pediatric Cancer|pediatric cancer
5119716|NCT01133470|Fexofenadine Hydrochloride + Pseudoephedrine Hydrochloride|fexofenadine hydrochloride + pseudoephedrine hydrochloride
5119717|NCT01133457|Bioequivalence,Finasteride,Crossover|bioequivalence,finasteride,crossover
5119718|NCT01133444|Bioequivalence,Finasteride,Crossover|bioequivalence,finasteride,crossover
5119719|NCT01133431|CKD-501|ckd-501
5119720|NCT01133431|Glimepiride|glimepiride
5119721|NCT01133431|Placebo|placebo
5119722|NCT01133431|Healthy male volunteer|healthy male volunteer
5119723|NCT01133431|Pharmacokinetic|pharmacokinetic
5119724|NCT01133431|Metabolite|metabolite
5119725|NCT01133392|insulin|insulin
5119726|NCT01133392|lispro|lispro
5119727|NCT01133366|ISIS301012|isis301012
5119728|NCT01133366|antisense|antisense
5119729|NCT01133366|ApoB (Apolipoprotein B)|apob (apolipoprotein b)
5119730|NCT01133366|LDL (low density lipoprotein)|ldl (low density lipoprotein)
5119731|NCT01133366|mipomersen|mipomersen
5119732|NCT01133340|RADIOTHERAPY|radiotherapy
5119733|NCT01133340|CT simulation|ct simulation
5119734|NCT01133340|MRI simulation|mri simulation
5119735|NCT01133340|Endoscopic clip placement|endoscopic clip placement
5119736|NCT01133340|Rectal cancer|rectal cancer
5119737|NCT01133340|Accuracy of MRI Simulation for target delineation and planning|accuracy of mri simulation for target delineation and planning
5119738|NCT01133327|Carotid Artery Stenting|carotid artery stenting
5119739|NCT01133327|High Risk patient|high risk patient
5119740|NCT01133327|Carotid artery stenosis|carotid artery stenosis
5119741|NCT01133327|stroke|stroke
5119742|NCT01133327|Carotid artery disease|carotid artery disease
5119743|NCT01133327|ASTI study|asti study
5119744|NCT01133327|Adapt Carotid Stent system|adapt carotid stent system
5119745|NCT01133327|FilterWire EZ Embolic Protection System|filterwire ez embolic protection system
5119746|NCT01133301|Borderline Personality Disorder|borderline personality disorder
5119747|NCT01133301|Dissociation|dissociation
5119748|NCT01133301|Naltrexone|naltrexone
5119749|NCT01133249|total hip|total hip
5119750|NCT01133236|Salt restriction|salt restriction
5119751|NCT01133236|Fluid restriction|fluid restriction
5119752|NCT01133236|Congestion|congestion
5119753|NCT01133236|Heart Failure|heart failure
5119754|NCT01133223|Stroke, mecanical thrombectomy|stroke, mecanical thrombectomy
5119755|NCT01133210|hypertriglyceridemia|hypertriglyceridemia
5119756|NCT01133210|triglyceride|triglyceride
5119757|NCT01133210|cholesterol|cholesterol
5119758|NCT01133210|Maraviroc|maraviroc
5119759|NCT01133197|thumb|thumb
5119760|NCT01133197|arthritis|arthritis
5119761|NCT01133197|Impact of thumb arthritis on health|impact of thumb arthritis on health
5119762|NCT01133184|HBV transmission PreS1/PreS2/S HBV vaccine|hbv transmission pres1/pres2/s hbv vaccine
5119763|NCT01133171|Cardiovascular Disease|cardiovascular disease
5119764|NCT01133171|Stroke|stroke
5119765|NCT01133158|Follicular non-Hodgkin's lymphoma in relapse or refractory to standard first-line immunochemotherapy|follicular non-hodgkin's lymphoma in relapse or refractory to standard first-line immunochemotherapy
5119766|NCT01133145|composite tissue allotransplantation|composite tissue allotransplantation
5119767|NCT01133145|hand transplantation|hand transplantation
5119768|NCT01133145|knee transplantation|knee transplantation
5119769|NCT01133145|face transplantation|face transplantation
5119770|NCT01133132|Colon cancer patients who have completed treatment|colon cancer patients who have completed treatment
5119771|NCT01133119|cardiac catheterization|cardiac catheterization
5119772|NCT01133119|local anesthetic|local anesthetic
5119773|NCT01133119|pain experienced post-operatively|pain experienced post-operatively
5119774|NCT01133119|pediatric patients|pediatric patients
5119775|NCT01133106|stroke recovery|stroke recovery
5119776|NCT01133106|quality of life|quality of life
5119777|NCT01133093|Cardiovascular risk factors|cardiovascular risk factors
5119778|NCT01133093|Nutritional assessment|nutritional assessment
5119779|NCT01133093|Epidemiology|epidemiology
5119780|NCT01133067|lung cancer|lung cancer
5119781|NCT01133067|followup|followup
5119782|NCT01133067|physical follow up|physical follow up
5119783|NCT01133067|telephonic followup|telephonic followup
5119784|NCT01133054|Coronary Vessel Anomalies|coronary vessel anomalies
5119785|NCT01133028|Attention Deficit Hyperactivity Disorder (ADHD)|attention deficit hyperactivity disorder (adhd)
5119786|NCT01133015|FFR|ffr
5119787|NCT01133015|IVUS|ivus
5119789|NCT01132989|Patients with cutaneous T cell lymphoma|patients with cutaneous t cell lymphoma
5119790|NCT01132976|Personality disorders|personality disorders
5119791|NCT01132976|Personal Concerns Inventory|personal concerns inventory
5119792|NCT01132976|Non completion|non completion
5119793|NCT01132937|Diffusion/Perfusion-MRI|diffusion/perfusion-mri
5119794|NCT01132937|Magnetic Resonance Imaging (MRI)|magnetic resonance imaging (mri)
5119795|NCT01132937|Traumatic Brain Injury|traumatic brain injury
5119796|NCT01132937|Brain Imaging|brain imaging
5119797|NCT01132937|Brain Injuries|brain injuries
5119798|NCT01132937|TBI|tbi
5119799|NCT01132924|Early Pregnancy|early pregnancy
5119800|NCT01132924|Gestational Age|gestational age
5119801|NCT01132924|Fecundability|fecundability
5119802|NCT01132924|Ovulation|ovulation
5119803|NCT01132924|Recall|recall
5119804|NCT01132911|Solid Tumors|solid tumors
5119805|NCT01132911|Maximum Tolerated Dose|maximum tolerated dose
5119806|NCT01132911|Lymphoma|lymphoma
5119807|NCT01132911|Dose Escalation|dose escalation
5119808|NCT01132911|Pharmacokinetics|pharmacokinetics
5119810|NCT01132911|Solid Tumor|solid tumor
5119811|NCT01132911|Sarcoma|sarcoma
5119812|NCT01132911|Wilms Tumor|wilms tumor
5119813|NCT01132911|Neuroblastoma|neuroblastoma
5119814|NCT01132898|Traumatic Brain Injury|traumatic brain injury
5119815|NCT01132898|Biomarkers|biomarkers
5119816|NCT01132898|Magnetic Resonance Imaging (MRI)|magnetic resonance imaging (mri)
5119817|NCT01132898|DTI|dti
5119818|NCT01132898|Functional Capacity|functional capacity
5119819|NCT01132898|TBI|tbi
5119820|NCT01132885|MRI|mri
5119821|NCT01132885|Children|children
5119822|NCT01132885|Williams Syndrome|williams syndrome
5119823|NCT01132885|Phenotype|phenotype
5119824|NCT01132885|Brain|brain
5119825|NCT01132885|Healthy Volunteer|healthy volunteer
5119826|NCT01132885|HV|hv
5119827|NCT01132872|Serotonin 1A Receptor|serotonin 1a receptor
5119828|NCT01132872|Positron Emission Tomograhy (PET)|positron emission tomograhy (pet)
5119829|NCT01132872|Dosimetry|dosimetry
5119830|NCT01132872|Healthy Volunteer|healthy volunteer
5119831|NCT01132872|HV|hv
5119832|NCT01132859|Specimen Collection|specimen collection
5119833|NCT01132859|Mucosal Immunity|mucosal immunity
5119834|NCT01132859|Immune Responses|immune responses
5119835|NCT01132859|Immunity|immunity
5119836|NCT01132859|Vaccines|vaccines
5119837|NCT01132859|Healthy Volunteer|healthy volunteer
5119838|NCT01132859|HV|hv
5119839|NCT01132833|thromboembolism|thromboembolism
5119840|NCT01132833|stage I multiple myeloma|stage i multiple myeloma
5119841|NCT01132833|stage II multiple myeloma|stage ii multiple myeloma
5119842|NCT01132833|stage III multiple myeloma|stage iii multiple myeloma
5119843|NCT01132807|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
5119844|NCT01132807|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
5119845|NCT01132794|Pain relief and sedation condition|pain relief and sedation condition
5119846|NCT01132781|rhinosinusitis|rhinosinusitis
5119847|NCT01132781|asthma|asthma
5119848|NCT01132781|allergic rhinitis|allergic rhinitis
5119849|NCT01132781|theophylline|theophylline
5119850|NCT01132755|gastric|gastric
5119851|NCT01132755|pancreas|pancreas
5119852|NCT01132755|laparoscopy|laparoscopy
5119853|NCT01132755|peritoneal lavage|peritoneal lavage
5119854|NCT01132755|10-011|10-011
5119855|NCT01132755|gastric and pancreatic cancer|gastric and pancreatic cancer
5119856|NCT01132742|Malnutrition|malnutrition
5119857|NCT01132742|children|children
5119858|NCT01132742|Hospital Stay|hospital stay
5119859|NCT01132742|Screening Tools|screening tools
5119860|NCT01132742|Anthropometry|anthropometry
5119861|NCT01132690|gaucher disease|gaucher disease
5119862|NCT01132690|pediatric|pediatric
5119863|NCT01132677|OA of Knee|oa of knee
5119864|NCT01132677|Osteoarthritis of Knee|osteoarthritis of knee
5119865|NCT01132677|Viscosupplementation and Osteoarthritis|viscosupplementation and osteoarthritis
5119866|NCT01132677|Viscosupplementation and OA|viscosupplementation and oa
5119867|NCT01132677|Hyaluronic Acid|hyaluronic acid
5119868|NCT01132677|Corticosteroid injection versus hyaluronic acid|corticosteroid injection versus hyaluronic acid
5119869|NCT01132677|Synvisc One and Knee OA|synvisc one and knee oa
5119870|NCT01132677|viscosupplementation and knee pain|viscosupplementation and knee pain
5119871|NCT01132677|knee Pain from OA|knee pain from oa
5119872|NCT01132664|HER2|her2
5119873|NCT01132664|BKM120|bkm120
5119874|NCT01132664|PIK3|pik3
5119875|NCT01132664|metastatic breast cancer|metastatic breast cancer
5119876|NCT01132664|brain metastases|brain metastases
5119877|NCT01132664|Herceptin|herceptin
5119878|NCT01132664|trastuzumab|trastuzumab
5119879|NCT01132664|capecitabine|capecitabine
5119880|NCT01132664|open-label|open-label
5119881|NCT01132664|maximum tolerated dose|maximum tolerated dose
5119882|NCT01132664|Phase I/Phase ll|phase i/phase ll
5119883|NCT01132651|eczema|eczema
5119884|NCT01132651|itch|itch
5119885|NCT01132651|pruritus|pruritus
5119886|NCT01132651|head|head
5119887|NCT01132651|neck|neck
5119888|NCT01132638|Gastroesophageal|gastroesophageal
5119889|NCT01132638|Pantoprazole|pantoprazole
5119890|NCT01132638|erosive|erosive
5119891|NCT01132638|Erosive GERD grades A-D, acc. to Los Angeles classification|erosive gerd grades a-d, acc. to los angeles classification
5119892|NCT01132625|HSP90|hsp90
5119893|NCT01132625|molecular chaperone|molecular chaperone
5119894|NCT01132625|advanced solid tumors|advanced solid tumors
5119895|NCT01132625|Japan|japan
5119896|NCT01132612|Chronic plaque-type psoriasis|chronic plaque-type psoriasis
5119897|NCT01132612|AIN457|ain457
5119898|NCT01132612|dermatology|dermatology
5119899|NCT01132612|Moderate to severe chronic plaque-type psoriasis|moderate to severe chronic plaque-type psoriasis
5119900|NCT01132599|stage IV prostate cancer|stage iv prostate cancer
5119901|NCT01132560|ductal breast carcinoma in situ|ductal breast carcinoma in situ
5119902|NCT01132547|cachexia|cachexia
5119903|NCT01132547|weight changes|weight changes
5119904|NCT01132547|nausea and vomiting|nausea and vomiting
5119905|NCT01132547|alveolar childhood rhabdomyosarcoma|alveolar childhood rhabdomyosarcoma
5119906|NCT01132547|anaplastic osteosarcoma|anaplastic osteosarcoma
5119907|NCT01132547|childhood alveolar soft-part sarcoma|childhood alveolar soft-part sarcoma
5119908|NCT01132547|childhood angiosarcoma|childhood angiosarcoma
5119909|NCT01132547|childhood epithelioid sarcoma|childhood epithelioid sarcoma
5119910|NCT01132547|childhood fibrosarcoma|childhood fibrosarcoma
5119911|NCT01132547|childhood gliosarcoma|childhood gliosarcoma
5119912|NCT01132547|childhood leiomyosarcoma|childhood leiomyosarcoma
5119913|NCT01132547|childhood liposarcoma|childhood liposarcoma
5119914|NCT01132547|childhood neurofibrosarcoma|childhood neurofibrosarcoma
5119915|NCT01132547|childhood synovial sarcoma|childhood synovial sarcoma
5119916|NCT01132547|chondrosarcoma|chondrosarcoma
5119917|NCT01132547|chondrosarcomatous osteosarcoma|chondrosarcomatous osteosarcoma
5119918|NCT01132547|clear cell sarcoma of the kidney|clear cell sarcoma of the kidney
5119919|NCT01132547|embryonal childhood rhabdomyosarcoma|embryonal childhood rhabdomyosarcoma
5119920|NCT01132547|embryonal-botryoid childhood rhabdomyosarcoma|embryonal-botryoid childhood rhabdomyosarcoma
5119921|NCT01132547|endometrial stromal sarcoma|endometrial stromal sarcoma
5119922|NCT01132547|extraosseous Ewing sarcoma|extraosseous ewing sarcoma
5119923|NCT01132547|peripheral primitive neuroectodermal tumor|peripheral primitive neuroectodermal tumor
5119924|NCT01132547|fibrosarcomatous osteosarcoma|fibrosarcomatous osteosarcoma
5119925|NCT01132547|localized Ewing sarcoma|localized ewing sarcoma
5119926|NCT01132547|localized osteosarcoma|localized osteosarcoma
5119927|NCT01132547|mast cell sarcoma|mast cell sarcoma
5119928|NCT01132547|metastatic childhood soft tissue sarcoma|metastatic childhood soft tissue sarcoma
5119929|NCT01132547|metastatic Ewing sarcoma|metastatic ewing sarcoma
5119930|NCT01132547|metastatic osteosarcoma|metastatic osteosarcoma
5119931|NCT01132547|mixed childhood rhabdomyosarcoma|mixed childhood rhabdomyosarcoma
5119932|NCT01132547|mixed osteosarcoma|mixed osteosarcoma
5119933|NCT01132547|nonmetastatic childhood soft tissue sarcoma|nonmetastatic childhood soft tissue sarcoma
5119934|NCT01132547|osteoblastic osteosarcoma|osteoblastic osteosarcoma
5119935|NCT01132547|ovarian carcinosarcoma|ovarian carcinosarcoma
5119936|NCT01132547|ovarian sarcoma|ovarian sarcoma
5119937|NCT01132547|pleomorphic childhood rhabdomyosarcoma|pleomorphic childhood rhabdomyosarcoma
5119938|NCT01132547|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
5119939|NCT01132547|previously untreated childhood rhabdomyosarcoma|previously untreated childhood rhabdomyosarcoma
5119940|NCT01132547|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
5119941|NCT01132547|recurrent childhood gliosarcoma|recurrent childhood gliosarcoma
5119942|NCT01132547|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
5119943|NCT01132547|recurrent childhood soft tissue sarcoma|recurrent childhood soft tissue sarcoma
5119944|NCT01132547|recurrent Ewing sarcoma|recurrent ewing sarcoma
5119945|NCT01132547|recurrent osteosarcoma|recurrent osteosarcoma
5119946|NCT01132547|recurrent uterine sarcoma|recurrent uterine sarcoma
5119947|NCT01132547|small intestine leiomyosarcoma|small intestine leiomyosarcoma
5119948|NCT01132547|stage I uterine sarcoma|stage i uterine sarcoma
5119949|NCT01132547|stage II uterine sarcoma|stage ii uterine sarcoma
5119950|NCT01132547|stage III uterine sarcoma|stage iii uterine sarcoma
5119951|NCT01132547|stage IV uterine sarcoma|stage iv uterine sarcoma
5119952|NCT01132547|telangiectatic osteosarcoma|telangiectatic osteosarcoma
5119953|NCT01132547|untreated childhood gliosarcoma|untreated childhood gliosarcoma
5119954|NCT01132547|uterine carcinosarcoma|uterine carcinosarcoma
5119955|NCT01132547|uterine leiomyosarcoma|uterine leiomyosarcoma
5119956|NCT01132547|localized resectable neuroblastoma|localized resectable neuroblastoma
5119957|NCT01132547|localized unresectable neuroblastoma|localized unresectable neuroblastoma
5119958|NCT01132547|recurrent neuroblastoma|recurrent neuroblastoma
5119959|NCT01132547|regional neuroblastoma|regional neuroblastoma
5119960|NCT01132547|stage 4S neuroblastoma|stage 4s neuroblastoma
5119961|NCT01132547|recurrent Wilms tumor|recurrent wilms tumor
5119962|NCT01132547|childhood kidney tumors|childhood kidney tumors
5119963|NCT01132547|stage III Wilms tumor|stage iii wilms tumor
5119964|NCT01132547|stage IV Wilms tumor|stage iv wilms tumor
5119965|NCT01132547|childhood hepatoblastoma|childhood hepatoblastoma
5119966|NCT01132547|childhood extracranial germ cell tumor|childhood extracranial germ cell tumor
5119967|NCT01132547|childhood extragonadal germ cell tumor|childhood extragonadal germ cell tumor
5119968|NCT01132547|childhood gonadal germ cell tumor|childhood gonadal germ cell tumor
5119969|NCT01132547|childhood malignant ovarian germ cell tumor|childhood malignant ovarian germ cell tumor
5119970|NCT01132547|childhood malignant testicular germ cell tumor|childhood malignant testicular germ cell tumor
5119971|NCT01132547|recurrent childhood malignant germ cell tumor|recurrent childhood malignant germ cell tumor
5119972|NCT01132547|recurrent extragonadal germ cell tumor|recurrent extragonadal germ cell tumor
5119973|NCT01132547|recurrent extragonadal non-seminomatous germ cell tumor|recurrent extragonadal non-seminomatous germ cell tumor
5119974|NCT01132547|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
5119975|NCT01132547|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
5119976|NCT01132547|stage III extragonadal non-seminomatous germ cell tumor|stage iii extragonadal non-seminomatous germ cell tumor
5119977|NCT01132547|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
5119978|NCT01132547|stage IIIA ovarian germ cell tumor|stage iiia ovarian germ cell tumor
5119979|NCT01132547|stage IIIB ovarian germ cell tumor|stage iiib ovarian germ cell tumor
5119980|NCT01132547|stage IIIC ovarian germ cell tumor|stage iiic ovarian germ cell tumor
5119981|NCT01132547|stage IV extragonadal non-seminomatous germ cell tumor|stage iv extragonadal non-seminomatous germ cell tumor
5119982|NCT01132547|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
5119983|NCT01132547|recurrent childhood medulloblastoma|recurrent childhood medulloblastoma
5119984|NCT01132547|untreated childhood medulloblastoma|untreated childhood medulloblastoma
5119985|NCT01132547|childhood ependymoblastoma|childhood ependymoblastoma
5119986|NCT01132547|childhood infratentorial ependymoma|childhood infratentorial ependymoma
5119987|NCT01132547|newly diagnosed childhood ependymoma|newly diagnosed childhood ependymoma
5119988|NCT01132547|recurrent childhood ependymoma|recurrent childhood ependymoma
5119989|NCT01132547|recurrent childhood subependymal giant cell astrocytoma|recurrent childhood subependymal giant cell astrocytoma
5119990|NCT01132547|untreated childhood subependymal giant cell astrocytoma|untreated childhood subependymal giant cell astrocytoma
5119991|NCT01132547|peripheral primitive neuroectodermal tumor of the kidney|peripheral primitive neuroectodermal tumor of the kidney
5119992|NCT01132547|childhood supratentorial primitive neuroectodermal tumor|childhood supratentorial primitive neuroectodermal tumor
5119993|NCT01132547|recurrent childhood brain stem glioma|recurrent childhood brain stem glioma
5119994|NCT01132547|recurrent childhood brain tumor|recurrent childhood brain tumor
5119995|NCT01132547|untreated childhood brain stem glioma|untreated childhood brain stem glioma
5119996|NCT01132547|recurrent childhood anaplastic astrocytoma|recurrent childhood anaplastic astrocytoma
5119997|NCT01132547|recurrent childhood anaplastic oligoastrocytoma|recurrent childhood anaplastic oligoastrocytoma
5119998|NCT01132547|recurrent childhood anaplastic oligodendroglioma|recurrent childhood anaplastic oligodendroglioma
5119999|NCT01132547|stage I childhood anaplastic large cell lymphoma|stage i childhood anaplastic large cell lymphoma
5120000|NCT01132547|stage II childhood anaplastic large cell lymphoma|stage ii childhood anaplastic large cell lymphoma
5120001|NCT01132547|stage III childhood anaplastic large cell lymphoma|stage iii childhood anaplastic large cell lymphoma
5120002|NCT01132547|stage IV childhood anaplastic large cell lymphoma|stage iv childhood anaplastic large cell lymphoma
5120003|NCT01132547|untreated childhood anaplastic astrocytoma|untreated childhood anaplastic astrocytoma
5120004|NCT01132547|untreated childhood anaplastic oligoastrocytoma|untreated childhood anaplastic oligoastrocytoma
5120005|NCT01132547|untreated childhood anaplastic oligodendroglioma|untreated childhood anaplastic oligodendroglioma
5120006|NCT01132547|childhood high-grade cerebellar astrocytoma|childhood high-grade cerebellar astrocytoma
5120007|NCT01132547|childhood low-grade cerebellar astrocytoma|childhood low-grade cerebellar astrocytoma
5120008|NCT01132547|recurrent childhood astrocytoma|recurrent childhood astrocytoma
5120009|NCT01132547|other tumor of glial origin|other tumor of glial origin
5120010|NCT01132547|recurrent childhood cerebellar astrocytoma|recurrent childhood cerebellar astrocytoma
5120011|NCT01132547|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
5120118|NCT01132209|surgery|surgery
5120012|NCT01132547|recurrent childhood diffuse astrocytoma|recurrent childhood diffuse astrocytoma
5120013|NCT01132547|recurrent childhood fibrillary astrocytoma|recurrent childhood fibrillary astrocytoma
5120014|NCT01132547|recurrent childhood gemistocytic astrocytoma|recurrent childhood gemistocytic astrocytoma
5120015|NCT01132547|recurrent childhood oligoastrocytoma|recurrent childhood oligoastrocytoma
5120016|NCT01132547|recurrent childhood pilocytic astrocytoma|recurrent childhood pilocytic astrocytoma
5120017|NCT01132547|recurrent childhood pilomyxoid astrocytoma|recurrent childhood pilomyxoid astrocytoma
5120018|NCT01132547|recurrent childhood pleomorphic xanthoastrocytoma|recurrent childhood pleomorphic xanthoastrocytoma
5120019|NCT01132547|recurrent childhood protoplasmic astrocytoma|recurrent childhood protoplasmic astrocytoma
5120020|NCT01132547|untreated childhood cerebellar astrocytoma|untreated childhood cerebellar astrocytoma
5120021|NCT01132547|untreated childhood cerebral astrocytoma|untreated childhood cerebral astrocytoma
5120022|NCT01132547|untreated childhood diffuse astrocytoma|untreated childhood diffuse astrocytoma
5120023|NCT01132547|untreated childhood fibrillary astrocytoma|untreated childhood fibrillary astrocytoma
5120024|NCT01132547|untreated childhood gemistocytic astrocytoma|untreated childhood gemistocytic astrocytoma
5120025|NCT01132547|untreated childhood oligoastrocytoma|untreated childhood oligoastrocytoma
5120026|NCT01132547|untreated childhood pilocytic astrocytoma|untreated childhood pilocytic astrocytoma
5120027|NCT01132547|untreated childhood pilomyxoid astrocytoma|untreated childhood pilomyxoid astrocytoma
5120028|NCT01132547|untreated childhood pleomorphic xanthoastrocytoma|untreated childhood pleomorphic xanthoastrocytoma
5120029|NCT01132547|untreated childhood protoplasmic astrocytoma|untreated childhood protoplasmic astrocytoma
5120030|NCT01132547|recurrent childhood gliomatosis cerebri|recurrent childhood gliomatosis cerebri
5120031|NCT01132547|recurrent childhood oligodendroglioma|recurrent childhood oligodendroglioma
5120032|NCT01132547|recurrent childhood visual pathway|recurrent childhood visual pathway
5120033|NCT01132547|hypothalamic glioma|hypothalamic glioma
5120034|NCT01132547|recurrent childhood visual pathway glioma|recurrent childhood visual pathway glioma
5120035|NCT01132547|untreated childhood gliomatosis cerebri|untreated childhood gliomatosis cerebri
5120036|NCT01132547|untreated childhood oligodendroglioma|untreated childhood oligodendroglioma
5120037|NCT01132547|untreated childhood visual pathway|untreated childhood visual pathway
5120038|NCT01132547|untreated childhood visual pathway glioma|untreated childhood visual pathway glioma
5120039|NCT01132547|recurrent childhood giant cell glioblastoma|recurrent childhood giant cell glioblastoma
5120040|NCT01132547|recurrent childhood glioblastoma|recurrent childhood glioblastoma
5120041|NCT01132547|untreated childhood giant cell glioblastoma|untreated childhood giant cell glioblastoma
5120042|NCT01132547|untreated childhood glioblastoma|untreated childhood glioblastoma
5120043|NCT01132547|childhood choroid plexus tumor|childhood choroid plexus tumor
5120044|NCT01132547|childhood grade I meningioma|childhood grade i meningioma
5120045|NCT01132547|childhood grade II meningioma|childhood grade ii meningioma
5120324|NCT01131247|cephalon|cephalon
5120046|NCT01132547|childhood grade III meningioma|childhood grade iii meningioma
5120047|NCT01132547|minimally differentiated myeloid leukemia (M0)|minimally differentiated myeloid leukemia (m0)
5120048|NCT01132547|myeloblastic leukemia with maturation (M2)|myeloblastic leukemia with maturation (m2)
5120049|NCT01132547|myeloblastic leukemia without maturation (M1)|myeloblastic leukemia without maturation (m1)
5120050|NCT01132547|childhood acute myelomonocytic leukemia (M4)|childhood acute myelomonocytic leukemia (m4)
5120051|NCT01132547|childhood acute promyelocytic leukemia (M3)|childhood acute promyelocytic leukemia (m3)
5120052|NCT01132547|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5120053|NCT01132547|untreated childhood acute myeloid leukemia|untreated childhood acute myeloid leukemia
5120054|NCT01132547|other myeloid malignancies|other myeloid malignancies
5120055|NCT01132547|childhood acute monoblastic leukemia (M5a)|childhood acute monoblastic leukemia (m5a)
5120056|NCT01132547|childhood acute monocytic leukemia (M5b)|childhood acute monocytic leukemia (m5b)
5120057|NCT01132547|childhood acute erythroleukemia (M6)|childhood acute erythroleukemia (m6)
5120058|NCT01132547|childhood acute megakaryocytic leukemia (M7)|childhood acute megakaryocytic leukemia (m7)
5120059|NCT01132547|unspecified childhood solid tumor|unspecified childhood solid tumor
5120060|NCT01132534|OGD|ogd
5120061|NCT01132534|NBI|nbi
5120062|NCT01132534|AFI|afi
5120063|NCT01132534|Videoendoscopy|videoendoscopy
5120064|NCT01132534|Narrow Band Imaging|narrow band imaging
5120065|NCT01132534|Autofluorescence Imaging|autofluorescence imaging
5120066|NCT01132521|ulinastatin|ulinastatin
5120067|NCT01132521|severe acute pancreatitis|severe acute pancreatitis
5120068|NCT01132508|Tibial plateau fracture|tibial plateau fracture
5120069|NCT01132508|Orthopaedic Trauma Association (OTA) B2 B3 C3|orthopaedic trauma association (ota) b2 b3 c3
5120070|NCT01132508|Bone Void|bone void
5120071|NCT01132495|Stable angina|stable angina
5120072|NCT01132495|angina pectoris|angina pectoris
5120073|NCT01132495|PCI|pci
5120074|NCT01132495|FAME|fame
5120075|NCT01132495|FAME II|fame ii
5120076|NCT01132495|FFR|ffr
5120077|NCT01132495|Fractional Flow Reserve|fractional flow reserve
5120078|NCT01132495|Pressure wire|pressure wire
5120079|NCT01132482|Cystic fibrosis|cystic fibrosis
5120080|NCT01132482|CFTR|cftr
5120081|NCT01132482|Phosphodiesterase inhibitor|phosphodiesterase inhibitor
5120082|NCT01132482|Nasal potential difference|nasal potential difference
5120083|NCT01132482|Sweat test|sweat test
5120084|NCT01132456|TARGET VESSEL REVASCULARIZATION (TVR)|target vessel revascularization (tvr)
5120085|NCT01132456|MYOCARDIAL INFARCTION (MI)|myocardial infarction (mi)
5120086|NCT01132456|TARGET VESSEL FAILURE (TVF)|target vessel failure (tvf)
5120087|NCT01132456|TARGET LESION REVASCULARIZATION (TLR)|target lesion revascularization (tlr)
5120088|NCT01132456|TARGET LESION FAILURE (TLF)|target lesion failure (tlf)
5120089|NCT01132456|STENT THROMBOSIS|stent thrombosis
5120090|NCT01132456|RESTENOTIC LESION|restenotic lesion
5120091|NCT01132456|PERCUTANEOUS CORONARY INTERVENTION (PCI)|percutaneous coronary intervention (pci)
5120092|NCT01132456|LONG LESION|long lesion
5120093|NCT01132456|DUAL VESSEL|dual vessel
5120094|NCT01132430|ADHERENCE|adherence
5120095|NCT01132430|ASTHMA CONTROL|asthma control
5120096|NCT01132430|ASTHMA QUALITY OF LIFE|asthma quality of life
5120097|NCT01132430|MOTIVATIONAL INTERVIEWING|motivational interviewing
5120098|NCT01132417|Tigecycline, MDR|tigecycline, mdr
5120099|NCT01132417|Patient infected with multidrug resistance bacteria|patient infected with multidrug resistance bacteria
5120100|NCT01132391|anal fissure|anal fissure
5120101|NCT01132391|nitroglycerin|nitroglycerin
5120102|NCT01132391|medical treatment|medical treatment
5120103|NCT01132378|Total knee arthroplasty|total knee arthroplasty
5120104|NCT01132365|knee arthroplasty|knee arthroplasty
5120105|NCT01132352|Bioavailability|bioavailability
5120106|NCT01132352|Crossover|crossover
5120107|NCT01132352|Levetiracetam|levetiracetam
5120108|NCT01132339|Adverse reactions to Gadolinium-based contrast agents.|adverse reactions to gadolinium-based contrast agents.
5120109|NCT01132339|Adverse reactions to Iodine-basedcontrast agents.|adverse reactions to iodine-basedcontrast agents.
5120110|NCT01132326|Symptomatic NOH|symptomatic noh
5120111|NCT01132287|Contact lens wear|contact lens wear
5120112|NCT01132287|lubricant eye drops|lubricant eye drops
5120113|NCT01132274|Supraventricular arrhythmia catheter ablation|supraventricular arrhythmia catheter ablation
5120114|NCT01132248|schistosomiasis, schistosoma haematobium|schistosomiasis, schistosoma haematobium
5120115|NCT01132222|Bioequivalence|bioequivalence
5120116|NCT01132222|Crossover|crossover
5120117|NCT01132222|Ibuprofen and Pseudoephedrine|ibuprofen and pseudoephedrine
5120119|NCT01132209|incisional hernia|incisional hernia
5120120|NCT01132209|woundinfection|woundinfection
5120121|NCT01132209|burst abdomen|burst abdomen
5120122|NCT01132209|pain|pain
5120123|NCT01132196|Bioequivalence|bioequivalence
5120124|NCT01132196|Crossover|crossover
5120125|NCT01132196|Divalproex Sodium|divalproex sodium
5120126|NCT01132170|Bioequivalence|bioequivalence
5120127|NCT01132170|Crossover|crossover
5120128|NCT01132170|Divalproex Sodium|divalproex sodium
5120129|NCT01132157|Healthy Kidney Donors and Their Recipients with End Stage Renal Disease|healthy kidney donors and their recipients with end stage renal disease
5120130|NCT01132144|Reproductive Techniques|reproductive techniques
5120131|NCT01132144|Embryo Implantation|embryo implantation
5120132|NCT01132144|Endometrium|endometrium
5120133|NCT01132144|Ultrasonography|ultrasonography
5120134|NCT01132131|Urinary tract infection|urinary tract infection
5120135|NCT01132131|Cystitis|cystitis
5120136|NCT01132131|Bacteruria|bacteruria
5120137|NCT01132118|rheumatoid arthritis|rheumatoid arthritis
5120138|NCT01132118|insulin resistance|insulin resistance
5120139|NCT01132118|hydroxychloroquine|hydroxychloroquine
5120140|NCT01132118|cholesterol|cholesterol
5120141|NCT01132092|Evoked Potentials, Adult, Hearing Loss|evoked potentials, adult, hearing loss
5120142|NCT01132079|atopic dermatitis|atopic dermatitis
5120143|NCT01132079|barrier function|barrier function
5120144|NCT01132079|pimecrolimus|pimecrolimus
5120145|NCT01132066|swallowing|swallowing
5120146|NCT01132066|stroke|stroke
5120147|NCT01132053|JC Virus|jc virus
5120148|NCT01132040|Bioequivalence|bioequivalence
5120149|NCT01132040|Crossover|crossover
5120150|NCT01132040|Primidone|primidone
5120151|NCT01132027|Bioavailability, crossover, tacrolimus|bioavailability, crossover, tacrolimus
5120152|NCT01132014|Subjects with recurrent ovarian, fallopian tube or primary peritoneal cancer,|subjects with recurrent ovarian, fallopian tube or primary peritoneal cancer,
5120153|NCT01132014|from whom solid tumor or ascites have been harvested and are available and|from whom solid tumor or ascites have been harvested and are available and
5120154|NCT01132014|sufficient for tumorlysate preparation;and whose largest tumor nodule is 4.5|sufficient for tumorlysate preparation;and whose largest tumor nodule is 4.5
5120155|NCT01132014|cm. Subjects may have undergone chemotherapy or other therapy following|cm. subjects may have undergone chemotherapy or other therapy following
5120156|NCT01132014|tumor harvesting and prior to enrollment.|tumor harvesting and prior to enrollment.
5120157|NCT01131988|Bioavailability, crossover, tacrolimus|bioavailability, crossover, tacrolimus
5120158|NCT01131975|Bioequivalence|bioequivalence
5120159|NCT01131975|Crossover|crossover
5120160|NCT01131975|Lamotrigine (chewable, dispersible)|lamotrigine (chewable, dispersible)
5120161|NCT01131962|esophageal varices|esophageal varices
5120162|NCT01131962|hematemesis|hematemesis
5120163|NCT01131962|endoscopy|endoscopy
5120164|NCT01131949|Bioequivalence|bioequivalence
5120165|NCT01131949|Crossover|crossover
5120166|NCT01131949|Lamotrigine (chewable, dispersible)|lamotrigine (chewable, dispersible)
5120167|NCT01131936|Bioequivalence|bioequivalence
5120168|NCT01131936|Amlodipine Besylate|amlodipine besylate
5120169|NCT01131923|Bioequivalence|bioequivalence
5120170|NCT01131923|Amlodipine Besylate|amlodipine besylate
5120171|NCT01131910|Rheumatoid arthritis|rheumatoid arthritis
5120172|NCT01131910|TBE-vaccine|tbe-vaccine
5120173|NCT01131910|Immunosuppression|immunosuppression
5120174|NCT01131897|Bioavailability|bioavailability
5120175|NCT01131897|Crossover|crossover
5120176|NCT01131897|Levetiracetam|levetiracetam
5120177|NCT01131884|ASIA A or ASIA B Spinal Cord Injury|asia a or asia b spinal cord injury
5120178|NCT01131871|obesity|obesity
5120179|NCT01131871|overweight|overweight
5120180|NCT01131832|Cholesterol, Plant sterols, Non-response, SNPs,|cholesterol, plant sterols, non-response, snps,
5120181|NCT01131819|Trans-tibial Amputation|trans-tibial amputation
5120182|NCT01131806|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
5120183|NCT01131806|lung function change FEV1 FVC|lung function change fev1 fvc
5120184|NCT01131806|acute exacerbation|acute exacerbation
5120185|NCT01131806|life quality questionnaire|life quality questionnaire
5120186|NCT01131793|Coronary Artery Chronic Total Occlusion In-Stent|coronary artery chronic total occlusion in-stent
5120187|NCT01131780|Bioequivalence|bioequivalence
5120188|NCT01131780|Crossover|crossover
5120189|NCT01131780|Ibuprofen and Pseudoephedrine|ibuprofen and pseudoephedrine
5120190|NCT01131767|Bioequivalence|bioequivalence
5120191|NCT01131767|Crossover|crossover
5120192|NCT01131767|Naproxen Sodium and Pseudoephedrine Hydrochloride|naproxen sodium and pseudoephedrine hydrochloride
5120193|NCT01131754|Peripheral venous catheter complications|peripheral venous catheter complications
5120194|NCT01131754|PVC occlusion|pvc occlusion
5120195|NCT01131754|PVC phlebitis|pvc phlebitis
5120196|NCT01131741|anesthesia, general|anesthesia, general
5120197|NCT01131741|blood pressure|blood pressure
5120198|NCT01131741|epinephrine|epinephrine
5120199|NCT01131741|heart rate|heart rate
5120200|NCT01131741|injections, intravenous|injections, intravenous
5120201|NCT01131728|Bioequivalence|bioequivalence
5120202|NCT01131728|Crossover|crossover
5120203|NCT01131728|Naproxen Sodium and Pseudoephedrine Hydrochloride|naproxen sodium and pseudoephedrine hydrochloride
5120204|NCT01131715|Qualitetive interview|qualitetive interview
5120205|NCT01131715|Coronary heart disease (CHD)|coronary heart disease (chd)
5120206|NCT01131715|Patient experience|patient experience
5120207|NCT01131715|Patient perception|patient perception
5120208|NCT01131702|Bioequivalence|bioequivalence
5120209|NCT01131702|Crossover|crossover
5120210|NCT01131702|Ranitidine|ranitidine
5120211|NCT01131689|metastatic HCC|metastatic hcc
5120212|NCT01131663|Infants, aerosol, acceptance, face mask, drug delivery|infants, aerosol, acceptance, face mask, drug delivery
5120213|NCT01131650|Prevalence of diabetic retinopathy|prevalence of diabetic retinopathy
5120214|NCT01131650|Diabetes|diabetes
5120215|NCT01131650|Retinopathy|retinopathy
5120216|NCT01131650|Prevalence|prevalence
5120217|NCT01131650|Population|population
5120218|NCT01131637|chronic heart failure|chronic heart failure
5120219|NCT01131637|rhNRG-1|rhnrg-1
5120220|NCT01131637|mortality|mortality
5120221|NCT01131624|Iron deficiency|iron deficiency
5120222|NCT01131611|Spinal Stenosis|spinal stenosis
5120223|NCT01131611|Rehabilitation|rehabilitation
5120224|NCT01131611|Physical Therapy (specialty)|physical therapy (specialty)
5120225|NCT01131611|Cognitive Behavior Therapy|cognitive behavior therapy
5120226|NCT01131611|Behavioral Research|behavioral research
5120227|NCT01131598|ALI|ali
5120228|NCT01131598|SDRA|sdra
5120229|NCT01131585|Diabetic macular edema|diabetic macular edema
5120230|NCT01131585|DME|dme
5120231|NCT01131585|Proliferative diabetic retinopathy|proliferative diabetic retinopathy
5120232|NCT01131585|PDR|pdr
5120233|NCT01131585|ranibizumab|ranibizumab
5120234|NCT01131585|laser|laser
5120235|NCT01131559|bipolar disorder|bipolar disorder
5120236|NCT01131559|manic depression|manic depression
5120237|NCT01131559|depression|depression
5120238|NCT01131559|Bipolar I or II|bipolar i or ii
5120239|NCT01131546|Essential Hypertension|essential hypertension
5120240|NCT01131546|Levamlodipine Besylate|levamlodipine besylate
5120241|NCT01131546|Amlodipine Maleate|amlodipine maleate
5120242|NCT01131520|SBIRT|sbirt
5120243|NCT01131520|Drug abuse|drug abuse
5120244|NCT01131507|Exocrine Pancreatic Insufficiency|exocrine pancreatic insufficiency
5120245|NCT01131507|Infants with CF|infants with cf
5120246|NCT01131494|Parkinson's disease|parkinson's disease
5120247|NCT01131494|Dysphagia|dysphagia
5120248|NCT01131494|Treatment|treatment
5120249|NCT01131481|cataracts,glistenings,intraocular lenses.|cataracts,glistenings,intraocular lenses.
5120250|NCT01131468|ototoxicity|ototoxicity
5120251|NCT01131468|aminoglycoside|aminoglycoside
5120252|NCT01131468|vancomycine|vancomycine
5120253|NCT01131468|peritoneal dialysis|peritoneal dialysis
5120254|NCT01131468|peritonitis|peritonitis
5120255|NCT01131442|immune|immune
5120256|NCT01131429|mutation analysis|mutation analysis
5120257|NCT01131429|first-line|first-line
5120258|NCT01131429|second-line|second-line
5120259|NCT01131429|targeted therapy|targeted therapy
5120260|NCT01131403|IL-1α, skin care; baby wet wipes; full-term newborn; skin barrier function|il-1α, skin care; baby wet wipes; full-term newborn; skin barrier function
5120261|NCT01131377|mechanical ventilation weaning phase patients with metabolic alkalosis|mechanical ventilation weaning phase patients with metabolic alkalosis
5120262|NCT01131364|Interleukin|interleukin
5120263|NCT01131364|IL2|il2
5120264|NCT01131364|F16|f16
5120265|NCT01131364|monoclonal|monoclonal
5120266|NCT01131364|antibody|antibody
5120267|NCT01131364|cytokine|cytokine
5120268|NCT01131364|doxorubicin|doxorubicin
5120269|NCT01131364|breast cancer|breast cancer
5120270|NCT01131364|solid tumour|solid tumour
5120271|NCT01131364|Phase I: Advanced Solid Tumour Patients|phase i: advanced solid tumour patients
5120272|NCT01131364|Phase II: Breast Cancer Patients Amenable to anthracyclin Therapy|phase ii: breast cancer patients amenable to anthracyclin therapy
5120273|NCT01131351|MDR-TB|mdr-tb
5120274|NCT01131351|Dose Escalation|dose escalation
5120275|NCT01131351|Phase II|phase ii
5120276|NCT01131351|Open Label|open label
5120277|NCT01131351|Non Controlled|non controlled
5120278|NCT01131351|Pulmonary Multidrug-Resistant Tuberculosis (MDR TB)|pulmonary multidrug-resistant tuberculosis (mdr tb)
5120279|NCT01131325|Philadelphia chromosome positive|philadelphia chromosome positive
5120280|NCT01131325|Ph+|ph+
5120281|NCT01131325|chronic myelogenous leukemia chronic phase|chronic myelogenous leukemia chronic phase
5120282|NCT01131325|CML-CP|cml-cp
5120283|NCT01131325|low imatinib trough levels|low imatinib trough levels
5120284|NCT01131312|Cervix|cervix
5120285|NCT01131312|CIN|cin
5120286|NCT01131312|HPV|hpv
5120287|NCT01131312|Triage|triage
5120288|NCT01131312|ASCUS/LSIL|ascus/lsil
5120289|NCT01131312|Pap Smear|pap smear
5120290|NCT01131312|HPV Test|hpv test
5120291|NCT01131299|HDL|hdl
5120292|NCT01131299|Cholesterol|cholesterol
5120293|NCT01131299|Lipoproteins|lipoproteins
5120294|NCT01131299|Serum Lipids|serum lipids
5120295|NCT01131299|Alpha-Cyclodextrin|alpha-cyclodextrin
5120296|NCT01131299|Atherosclerosis|atherosclerosis
5120297|NCT01131299|Heart Disease|heart disease
5120298|NCT01131273|buprenorphine injecting|buprenorphine injecting
5120299|NCT01131273|opiate dependence|opiate dependence
5120300|NCT01131273|HIV risk|hiv risk
5120301|NCT01131273|treatment outcome|treatment outcome
5120302|NCT01131273|opiate dependence with buprenorphine injecting|opiate dependence with buprenorphine injecting
5120303|NCT01131260|STAN|stan
5120304|NCT01131260|Fetal monitoring|fetal monitoring
5120305|NCT01131260|Fetal acidosis|fetal acidosis
5120306|NCT01131260|Fetal heart rate monitoring|fetal heart rate monitoring
5120307|NCT01131260|Perinatology|perinatology
5120308|NCT01131247|CLL|cll
5120309|NCT01131247|bendamustine|bendamustine
5120310|NCT01131247|ofatumumab|ofatumumab
5120311|NCT01131247|blood cancer|blood cancer
5120312|NCT01131247|leukemia|leukemia
5120313|NCT01131247|lymphoma|lymphoma
5120314|NCT01131247|lymphocyte|lymphocyte
5120315|NCT01131247|refractory|refractory
5120316|NCT01131247|Advanced|advanced
5120317|NCT01131247|relapsed|relapsed
5120318|NCT01131247|hematologic|hematologic
5120319|NCT01131247|hematology|hematology
5120320|NCT01131247|antibody|antibody
5120321|NCT01131247|non-Hodgkin lymphoma|non-hodgkin lymphoma
5120322|NCT01131247|small lymphocytic lymphoma|small lymphocytic lymphoma
5120323|NCT01131247|nevada cancer institute|nevada cancer institute
5120325|NCT01131247|Glaxosmithkline|glaxosmithkline
5120326|NCT01131221|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
5120327|NCT01131221|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
5120328|NCT01131221|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
5120329|NCT01131221|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5120330|NCT01131221|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5120331|NCT01131221|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5120332|NCT01131221|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5120333|NCT01131221|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5120334|NCT01131221|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5120335|NCT01131221|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5120336|NCT01131221|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5120337|NCT01131221|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5120338|NCT01131208|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
5120339|NCT01131208|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5120340|NCT01131208|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5120341|NCT01131208|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
5120342|NCT01131208|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5120343|NCT01131208|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5120344|NCT01131195|HER2-negative breast cancer|her2-negative breast cancer
5120345|NCT01131195|recurrent breast cancer|recurrent breast cancer
5120346|NCT01131195|stage IIIB breast cancer|stage iiib breast cancer
5120347|NCT01131195|stage IIIC breast cancer|stage iiic breast cancer
5120348|NCT01131195|stage IV breast cancer|stage iv breast cancer
5120349|NCT01131169|Myeloma|myeloma
5120350|NCT01131169|Busulfan|busulfan
5120351|NCT01131169|Melphalan|melphalan
5120352|NCT01131169|Fludarabine|fludarabine
5120353|NCT01131169|T-Cell|t-cell
5120354|NCT01131169|Stem Cell Transplantation|stem cell transplantation
5120355|NCT01131169|10-051|10-051
5120356|NCT01131156|postpartum|postpartum
5120357|NCT01131156|smoking|smoking
5120358|NCT01131156|relapse|relapse
5120359|NCT01131156|breastfeeding|breastfeeding
5120360|NCT01131143|Urban community centers|urban community centers
5120361|NCT01131143|Obesity|obesity
5120362|NCT01131143|Obesity counseling|obesity counseling
5120363|NCT01131143|Low-cost intervention|low-cost intervention
5120364|NCT01131130|Contact lens|contact lens
5120365|NCT01131117|healthy|healthy
5120366|NCT01131117|women|women
5120367|NCT01131117|pregnancy|pregnancy
5120368|NCT01131104|NAION|naion
5120369|NCT01131065|Hepatitis B|hepatitis b
5120370|NCT01131065|HBV|hbv
5120371|NCT01131065|Orthotopic liver transplantation|orthotopic liver transplantation
5120372|NCT01131065|Liver transplantation|liver transplantation
5120373|NCT01131065|Recurrence|recurrence
5120374|NCT01131065|Reinfection|reinfection
5120375|NCT01131065|Protective titers|protective titers
5120376|NCT01131065|HBsAb|hbsab
5120377|NCT01131065|Hepatitis B virus immune globulin|hepatitis b virus immune globulin
5120378|NCT01131065|Niuliva|niuliva
5120379|NCT01131052|elderly populations|elderly populations
5120380|NCT01131052|diabetes|diabetes
5120381|NCT01131039|Ovarian Cancer|ovarian cancer
5120382|NCT01131026|Helicobacter pylori|helicobacter pylori
5120383|NCT01131026|levofloxacin|levofloxacin
5120384|NCT01131026|amoxicillin|amoxicillin
5120385|NCT01131026|lansoprazole|lansoprazole
5120386|NCT01131026|efficacy|efficacy
5120387|NCT01131026|safety|safety
5120388|NCT01131026|triple therapy|triple therapy
5120389|NCT01130987|resident|resident
5120390|NCT01130987|intern|intern
5120391|NCT01130987|patient safety|patient safety
5120392|NCT01130987|medical error|medical error
5120393|NCT01130987|time motion|time motion
5120394|NCT01130987|handoff|handoff
5120395|NCT01130987|sign-out|sign-out
5120396|NCT01130987|Resident Workflow|resident workflow
5120397|NCT01130987|Resident Communications|resident communications
5120398|NCT01130961|Advanced NSCLC|advanced nsclc
5120399|NCT01130961|Gefitinib|gefitinib
5120400|NCT01130961|Thai patient|thai patient
5120401|NCT01130948|hypoxia|hypoxia
5120402|NCT01130948|altitude|altitude
5120403|NCT01130948|sleep|sleep
5120404|NCT01130948|sleep apnea|sleep apnea
5120405|NCT01130948|periodic breathing|periodic breathing
5120406|NCT01130948|vigilance|vigilance
5120407|NCT01130948|psychomotor|psychomotor
5120408|NCT01130948|endothelial function|endothelial function
5120409|NCT01130935|GERD|gerd
5120410|NCT01130935|gastric and duodenal ulcers|gastric and duodenal ulcers
5120411|NCT01130935|NSAID therapy|nsaid therapy
5120412|NCT01130922|Roux-and-Y gastric bypass surgery|roux-and-y gastric bypass surgery
5120413|NCT01130922|stable body weight|stable body weight
5120414|NCT01130909|Healthy|healthy
5120415|NCT01130909|Effect of a single dose on gamma-band qEEG|effect of a single dose on gamma-band qeeg
5120416|NCT01130896|MRI, pacemakers, Defibrillator|mri, pacemakers, defibrillator
5120417|NCT01130883|acute tracheitis|acute tracheitis
5120418|NCT01130883|acute tracheobronchitis or acute bronchitis|acute tracheobronchitis or acute bronchitis
5120419|NCT01130883|acute exacerbation of chronic bronchitis|acute exacerbation of chronic bronchitis
5120420|NCT01130883|mild community-acquired pneumonia|mild community-acquired pneumonia
5120421|NCT01130870|Fecal incontinence|fecal incontinence
5120422|NCT01130870|Sacral nerve stimulation|sacral nerve stimulation
5120423|NCT01130870|Quality of life|quality of life
5120424|NCT01130870|DR15.9 Incontinentia alva|dr15.9 incontinentia alva
5120425|NCT01130818|Safety|safety
5120426|NCT01130818|Tolerability|tolerability
5120427|NCT01130818|Pharmacokinetics|pharmacokinetics
5120428|NCT01130818|Bioavailability (solid vs solution, fasting vs fed)|bioavailability (solid vs solution, fasting vs fed)
5120429|NCT01130818|Young healthy subjects|young healthy subjects
5120430|NCT01130818|Elderly healthy subjects|elderly healthy subjects
5120431|NCT01130805|gastric cancer pazopanib capecitabine, oxaliplatin|gastric cancer pazopanib capecitabine, oxaliplatin
5120432|NCT01130805|Metastatic or recurrent gastric cancer|metastatic or recurrent gastric cancer
5120433|NCT01130792|rotavirus|rotavirus
5120434|NCT01130792|cryptosporidium|cryptosporidium
5120435|NCT01130792|probiotics|probiotics
5120436|NCT01130792|intestinal function|intestinal function
5120437|NCT01130792|immune response|immune response
5120438|NCT01130779|Non-small Cell Lung Cancer|non-small cell lung cancer
5120439|NCT01130779|Erlotinib|erlotinib
5120440|NCT01130779|brain metastasis|brain metastasis
5120441|NCT01130766|Non-small Cell Lung Cancer|non-small cell lung cancer
5120442|NCT01130766|Asymptomatic brain metastasis|asymptomatic brain metastasis
5120443|NCT01130766|Stereotactic radiosurgery (SRS)|stereotactic radiosurgery (srs)
5120444|NCT01130740|Osteoarthritis|osteoarthritis
5120445|NCT01130740|Exercise|exercise
5120446|NCT01130740|Diet|diet
5120447|NCT01130740|Coping Skills|coping skills
5120448|NCT01130740|Education, Medical|education, medical
5120449|NCT01130727|diabetes mellitus|diabetes mellitus
5120450|NCT01130727|diabetic nephropathy|diabetic nephropathy
5120451|NCT01130727|hypertension|hypertension
5120452|NCT01130727|green tea|green tea
5120453|NCT01130727|cocoa|cocoa
5120454|NCT01130727|polyphenol|polyphenol
5120455|NCT01130727|nitric oxide|nitric oxide
5120456|NCT01130714|inflammation|inflammation
5120457|NCT01130714|chemotherapy|chemotherapy
5120458|NCT01130714|lung cancer|lung cancer
5120459|NCT01130701|Pancreatic Cancer|pancreatic cancer
5120460|NCT01130701|Neoadjuvant|neoadjuvant
5120461|NCT01130701|Panitumumab|panitumumab
5120462|NCT01130701|Capecitabine|capecitabine
5120463|NCT01130688|Leukemia|leukemia
5120464|NCT01130688|Zileuton|zileuton
5120465|NCT01130688|myeloproliferative neoplasm|myeloproliferative neoplasm
5120466|NCT01130662|acute myeloid leukemia|acute myeloid leukemia
5120467|NCT01130662|AML|aml
5120468|NCT01130662|Relapsed AML|relapsed aml
5120469|NCT01130662|Refractory AML|refractory aml
5120470|NCT01130649|Epilepsy|epilepsy
5120471|NCT01130649|Tracking|tracking
5120472|NCT01130649|Electronic diary|electronic diary
5120473|NCT01130636|oseltamivir carboxylate|oseltamivir carboxylate
5120474|NCT01130636|oseltamivir phosphate|oseltamivir phosphate
5120475|NCT01130636|Tamiflu pharmacokinetics in lactating women with influenza|tamiflu pharmacokinetics in lactating women with influenza
5120476|NCT01130623|VEGF Inhibitor|vegf inhibitor
5120477|NCT01130623|Maximum Tolerated Dose|maximum tolerated dose
5120478|NCT01130623|Dose Escalation|dose escalation
5120479|NCT01130623|Pharmacokinetics|pharmacokinetics
5120480|NCT01130623|Antitumor Activity|antitumor activity
5120481|NCT01130623|Pediatric Cancer|pediatric cancer
5120482|NCT01130623|Solid Tumor|solid tumor
5120483|NCT01130623|Sarcoma|sarcoma
5120484|NCT01130623|Neuroblastoma|neuroblastoma
5120485|NCT01130623|Wilms Tumor|wilms tumor
5120486|NCT01130623|Osteosarcoma|osteosarcoma
5120487|NCT01130623|Brain Tumor|brain tumor
5120488|NCT01130610|preoperative period|preoperative period
5120489|NCT01130610|preoperative care|preoperative care
5120490|NCT01130610|anesthesia|anesthesia
5120491|NCT01130610|program evaluation|program evaluation
5120492|NCT01130597|HF|hf
5120493|NCT01130597|Heart failure|heart failure
5120494|NCT01130597|hyperkalemia|hyperkalemia
5120495|NCT01130597|chronic kidney disease|chronic kidney disease
5120496|NCT01130597|prevention of hyperkalemia in heart failure participants|prevention of hyperkalemia in heart failure participants
5120497|NCT01130584|Cancer Patients|cancer patients
5120498|NCT01130558|type 2 diabetes mellitus|type 2 diabetes mellitus
5120499|NCT01130558|basal-bolus insulin|basal-bolus insulin
5120500|NCT01130558|insulin ordering|insulin ordering
5120501|NCT01130545|Magnetic Resonance Imaging|magnetic resonance imaging
5120502|NCT01130545|Gadolinium|gadolinium
5120503|NCT01130545|Healthy Volunteer|healthy volunteer
5120504|NCT01130545|HV|hv
5120505|NCT01130532|Erectile Dysfunction|erectile dysfunction
5120506|NCT01130532|ED|ed
5120507|NCT01130532|Impotence|impotence
5120508|NCT01130519|Advanced HLRCC|advanced hlrcc
5120509|NCT01130519|Sporadic Papillary Renal Cell Cancer|sporadic papillary renal cell cancer
5120510|NCT01130519|Papillary Kidney Cancer|papillary kidney cancer
5120511|NCT01130519|Bevacizumab|bevacizumab
5120512|NCT01130519|Erlotinib|erlotinib
5120513|NCT01130519|Kidney Cancer|kidney cancer
5120514|NCT01130519|Renal Cell Cancer|renal cell cancer
5120515|NCT01130519|Hereditary Leiomyomatosis and Renal Cell Cancer|hereditary leiomyomatosis and renal cell cancer
5120516|NCT01130519|HLRCC|hlrcc
5120517|NCT01130467|Attention Deficit Disorders with Hyperactivity|attention deficit disorders with hyperactivity
5120518|NCT01130467|Attention Deficit Disorder|attention deficit disorder
5120519|NCT01130467|Event related potential|event related potential
5120520|NCT01130454|Unfavorable effect of environmental factors, stressors|unfavorable effect of environmental factors, stressors
5120521|NCT01130441|adolescent behavior|adolescent behavior
5120522|NCT01130441|harm reduction|harm reduction
5120523|NCT01130428|Mechanical stimulation|mechanical stimulation
5120524|NCT01130428|Vibration platform|vibration platform
5120525|NCT01130428|Bone metabolism|bone metabolism
5120526|NCT01130428|ATP release|atp release
5120527|NCT01130415|Sacral neuromodulation|sacral neuromodulation
5120528|NCT01130415|Screening|screening
5120529|NCT01130415|Percutaneous nerve evaluation|percutaneous nerve evaluation
5120530|NCT01130415|Tined lead|tined lead
5120531|NCT01130402|age|age
5120532|NCT01130402|lymphadenopathy|lymphadenopathy
5120533|NCT01130402|fine needle aspiration|fine needle aspiration
5120534|NCT01130402|sonography|sonography
5120535|NCT01130389|ONJ|onj
5120536|NCT01130376|Immune based therapy|immune based therapy
5120537|NCT01130376|Therapeutic vaccination|therapeutic vaccination
5120538|NCT01130376|cytokine therapy|cytokine therapy
5120539|NCT01130376|HIV therapeutic vaccine|hiv therapeutic vaccine
5120540|NCT01130363|Proton Pump Inhibitor|proton pump inhibitor
5120541|NCT01130363|Gastric carcinoid tumors|gastric carcinoid tumors
5120542|NCT01130363|Gastric cancer|gastric cancer
5120543|NCT01130363|Fundic Gland Polyps|fundic gland polyps
5120544|NCT01130324|VIBATIV|vibativ
5120545|NCT01130324|telavancin|telavancin
5120546|NCT01130324|Pregnancy|pregnancy
5120547|NCT01130324|Registry|registry
5120548|NCT01130298|testosterone,|testosterone,
5120549|NCT01130298|Pharmacokinetics|pharmacokinetics
5120550|NCT01130298|replacement,|replacement,
5120551|NCT01130298|therapy|therapy
5120552|NCT01130285|Lung Cancer|lung cancer
5120553|NCT01130272|Irritable bowel syndrome with diarrhea|irritable bowel syndrome with diarrhea
5120554|NCT01130272|Irritable bowel syndrome|irritable bowel syndrome
5120555|NCT01130272|Diarrhea predominant irritable bowel syndrome|diarrhea predominant irritable bowel syndrome
5120556|NCT01130272|Colonic diseases|colonic diseases
5120557|NCT01130272|Colonic diseases, functional|colonic diseases, functional
5120558|NCT01130272|Digestive system disease|digestive system disease
5120559|NCT01130272|Gastrointestinal disease|gastrointestinal disease
5120560|NCT01130272|Intestinal disease|intestinal disease
5120561|NCT01130272|Colonic pseudo-obstruction|colonic pseudo-obstruction
5120562|NCT01130272|Diarrhea|diarrhea
5120563|NCT01130272|Signs and Symptoms, Digestive|signs and symptoms, digestive
5120564|NCT01130259|mTNBC|mtnbc
5120565|NCT01130259|triple negative breast cancer|triple negative breast cancer
5120566|NCT01130259|metastatic triple negative breast cancer|metastatic triple negative breast cancer
5120567|NCT01130259|metastatic breast cancer that is ER-, PR-, and HER2-negative|metastatic breast cancer that is er-, pr-, and her2-negative
5120568|NCT01130233|rectal cancer|rectal cancer
5120569|NCT01130220|Brain Tumor|brain tumor
5120570|NCT01130220|Brain Neoplasm|brain neoplasm
5120571|NCT01130207|Obesity|obesity
5120572|NCT01130207|Diabetes|diabetes
5120573|NCT01130207|Periodontal disease|periodontal disease
5120574|NCT01130194|follicular lymphoma|follicular lymphoma
5120575|NCT01130194|radioimmunotherapy|radioimmunotherapy
5120576|NCT01130194|rituximab|rituximab
5120577|NCT01130194|C-MOPP-R|c-mopp-r
5120578|NCT01130194|autologous transplant|autologous transplant
5120579|NCT01130155|Antimalarials|antimalarials
5120580|NCT01130155|Diagnosis|diagnosis
5120581|NCT01130155|Access to treatment|access to treatment
5120582|NCT01130155|Quality of care|quality of care
5120583|NCT01130129|Flavonoids|flavonoids
5120584|NCT01130129|Platelets|platelets
5120585|NCT01130103|PTSD|ptsd
5120586|NCT01130103|anxiety disorders|anxiety disorders
5120587|NCT01130103|trauma|trauma
5120588|NCT01130077|Pediatric glioma|pediatric glioma
5120589|NCT01130077|Vaccine therapy|vaccine therapy
5120590|NCT01130064|Asthma|asthma
5120591|NCT01130064|QAX576|qax576
5120592|NCT01130051|bioavailability|bioavailability
5120593|NCT01130038|Characteristic of play|characteristic of play
5120594|NCT01130038|DCD|dcd
5120595|NCT01130038|children|children
5120596|NCT01130038|Typical Development|typical development
5120597|NCT01130038|Whether there are any differences in the issue of Characteristic of play between Children with DCD and Children with Typical Development|whether there are any differences in the issue of characteristic of play between children with dcd and children with typical development
5120598|NCT01130012|Gestational diabetes mellitus|gestational diabetes mellitus
5120599|NCT01130012|Lifestyle intervention|lifestyle intervention
5120600|NCT01130012|Oral glucose tolerance test|oral glucose tolerance test
5120601|NCT01130012|Insulin treatment|insulin treatment
5120602|NCT01130012|Pregnancy outcomes|pregnancy outcomes
5120727|NCT01129336|CTCs|ctcs
5120603|NCT01129999|smoking cessation, CBT, hypnotherapy|smoking cessation, cbt, hypnotherapy
5120604|NCT01129986|venous ulcer Dermastream|venous ulcer dermastream
5120605|NCT01129973|speech and language|speech and language
5120606|NCT01129973|phonoaudiology|phonoaudiology
5120607|NCT01129973|marketing|marketing
5120608|NCT01129960|Diabetic Neuropathic Pain|diabetic neuropathic pain
5120609|NCT01129934|Low Back Pain,|low back pain,
5120610|NCT01129934|Emergency medicine,|emergency medicine,
5120611|NCT01129934|Promethazine,|promethazine,
5120612|NCT01129934|Morphine,|morphine,
5120613|NCT01129934|Pain relief|pain relief
5120614|NCT01129921|Lumbar Spine Stenosis|lumbar spine stenosis
5120615|NCT01129921|Decompression|decompression
5120616|NCT01129908|oral health in children with celiac disease|oral health in children with celiac disease
5120617|NCT01129882|Schizophrenia|schizophrenia
5120618|NCT01129869|Survey|survey
5120619|NCT01129869|Perception|perception
5120620|NCT01129869|Perception of Clinical Research Participation|perception of clinical research participation
5120621|NCT01129869|Research Participant Perception|research participant perception
5120622|NCT01129856|Dry eye|dry eye
5120623|NCT01129856|Keratoconjunctivitis sicca|keratoconjunctivitis sicca
5120624|NCT01129856|Iontophoresis|iontophoresis
5120625|NCT01129856|Ophthalmic drug delivery|ophthalmic drug delivery
5120626|NCT01129856|EGP-437|egp-437
5120627|NCT01129856|Dexamethasone phosphate|dexamethasone phosphate
5120628|NCT01129843|anemia|anemia
5120629|NCT01129843|iron deficiency|iron deficiency
5120630|NCT01129843|nutritional|nutritional
5120631|NCT01129843|iron supplementation|iron supplementation
5120632|NCT01129843|cluster randomized control trial|cluster randomized control trial
5120633|NCT01129830|ovarian reserve|ovarian reserve
5120634|NCT01129830|FSH|fsh
5120635|NCT01129830|anti-mullerian hormone|anti-mullerian hormone
5120636|NCT01129830|estradiol|estradiol
5120637|NCT01129830|oocyte|oocyte
5120638|NCT01129830|IVF|ivf
5120639|NCT01129830|embryo transfer|embryo transfer
5120640|NCT01129817|Cognitive Functional Therapy|cognitive functional therapy
5120641|NCT01129817|Manual Therapy and Exercise|manual therapy and exercise
5120642|NCT01129817|Chronic Low Back Pain|chronic low back pain
5120643|NCT01129817|Randomized Controlled Trial|randomized controlled trial
5120644|NCT01129817|Subclassification|subclassification
5120645|NCT01129804|Alcohol dependence|alcohol dependence
5120646|NCT01129804|Network Support|network support
5120647|NCT01129804|Cognitive-behavioral treatment|cognitive-behavioral treatment
5120648|NCT01129804|Relapse prevention|relapse prevention
5120649|NCT01129804|Consequences of drinking|consequences of drinking
5120650|NCT01129804|Social network development|social network development
5120651|NCT01129791|Lactose intolerance|lactose intolerance
5120652|NCT01129791|Dairy products|dairy products
5120653|NCT01129791|Raw milk|raw milk
5120654|NCT01129791|Adults|adults
5120655|NCT01129765|Nasal suction|nasal suction
5120656|NCT01129765|Nasal aspiration|nasal aspiration
5120657|NCT01129765|Nasal saline irrigation|nasal saline irrigation
5120658|NCT01129765|Nasal lavage|nasal lavage
5120659|NCT01129739|Bone Marrow Disease|bone marrow disease
5120660|NCT01129739|MDS-RA|mds-ra
5120661|NCT01129739|MDS-RARS|mds-rars
5120662|NCT01129739|Umbilical Cord/placenta-Derived MSC|umbilical cord/placenta-derived msc
5120663|NCT01129739|Transplant|transplant
5120664|NCT01129726|Transillumination-guided|transillumination-guided
5120665|NCT01129726|Fiberoptic Intubation|fiberoptic intubation
5120666|NCT01129726|time|time
5120667|NCT01129726|success rate|success rate
5120668|NCT01129726|intubation|intubation
5120669|NCT01129713|GERD|gerd
5120670|NCT01129713|Acid Reflux|acid reflux
5120671|NCT01129713|Heartburn|heartburn
5120672|NCT01129713|Regurgitation|regurgitation
5120673|NCT01129713|Indigestion|indigestion
5120674|NCT01129700|rectal cancer, short-course, chemoradiotherapy|rectal cancer, short-course, chemoradiotherapy
5120675|NCT01129648|Hyperuricemia, gout|hyperuricemia, gout
5120676|NCT01129635|Heart failure|heart failure
5120677|NCT01129635|Cardiac resynchronization therapy|cardiac resynchronization therapy
5120678|NCT01129635|Regional left ventricular dyssynchrony|regional left ventricular dyssynchrony
5120679|NCT01129635|CRT|crt
5120680|NCT01129622|Letrozole|letrozole
5120681|NCT01129622|Breast MRI|breast mri
5120682|NCT01129622|Postmenopausal women|postmenopausal women
5120683|NCT01129609|Post-approval observation of patients being treated according to the indications for use for the Talent Converter Stent Graft|post-approval observation of patients being treated according to the indications for use for the talent converter stent graft
5120684|NCT01129583|Botulinum Toxin|botulinum toxin
5120685|NCT01129583|Elbow Stiffness|elbow stiffness
5120686|NCT01129544|Severe combined immunodeficiency|severe combined immunodeficiency
5120687|NCT01129544|SCID|scid
5120688|NCT01129544|XSCID|xscid
5120689|NCT01129544|SCID-X1|scid-x1
5120690|NCT01129518|meningococcal serogroup C|meningococcal serogroup c
5120691|NCT01129518|vaccine|vaccine
5120692|NCT01129518|conjugate|conjugate
5120693|NCT01129505|pregnancy|pregnancy
5120694|NCT01129505|intervention|intervention
5120695|NCT01129505|exercise|exercise
5120696|NCT01129505|nutrition|nutrition
5120697|NCT01129505|infants|infants
5120698|NCT01129492|Autoimmune Thyroiditis, Laser, Therapy, Thyroid, Ultrasound|autoimmune thyroiditis, laser, therapy, thyroid, ultrasound
5120699|NCT01129479|Aphasia|aphasia
5120700|NCT01129479|treatment|treatment
5120701|NCT01129479|cholinesterase inhibitor|cholinesterase inhibitor
5120702|NCT01129479|stroke|stroke
5120703|NCT01129453|Salmonella|salmonella
5120704|NCT01129453|Vaccine|vaccine
5120705|NCT01129440|Children|children
5120706|NCT01129440|Fluoride varnish|fluoride varnish
5120707|NCT01129440|Glass ionomer sealant|glass ionomer sealant
5120708|NCT01129440|Prevention|prevention
5120709|NCT01129401|methamphetamine|methamphetamine
5120710|NCT01129401|men who have sex with men|men who have sex with men
5120711|NCT01129401|HIV/AIDS|hiv/aids
5120712|NCT01129362|Pertussis|pertussis
5120713|NCT01129362|Whooping Cough|whooping cough
5120714|NCT01129362|Pertussis Vaccine|pertussis vaccine
5120715|NCT01129349|Solid Tumors|solid tumors
5120716|NCT01129336|HER2-negative|her2-negative
5120717|NCT01129336|HER2|her2
5120718|NCT01129336|Metastatic breast cancer|metastatic breast cancer
5120719|NCT01129336|First Line breast cancer|first line breast cancer
5120720|NCT01129336|Second Line breast cancer|second line breast cancer
5120721|NCT01129336|Breast cancer|breast cancer
5120722|NCT01129336|Metastatic|metastatic
5120723|NCT01129336|Stage IV breast cancer|stage iv breast cancer
5120724|NCT01129336|Progression free survival|progression free survival
5120725|NCT01129336|PFS|pfs
5120726|NCT01129336|Circulating Tumor Cells|circulating tumor cells
5120728|NCT01129336|Zoledronic acid|zoledronic acid
5120729|NCT01129336|HER2-negative metastatic breast cancer patients without bone metastasis|her2-negative metastatic breast cancer patients without bone metastasis
5120730|NCT01129323|Anemia, Severe, Aplastic, Reduced-Intensity, Allogeneic, Stem, Cell, Transplantation|anemia, severe, aplastic, reduced-intensity, allogeneic, stem, cell, transplantation
5120731|NCT01129310|irinotecan|irinotecan
5120732|NCT01129310|capecitabine|capecitabine
5120733|NCT01129310|oxaliplatin|oxaliplatin
5120734|NCT01129310|health-related quality of life|health-related quality of life
5120735|NCT01129310|gastroesophageal(GE) junction adenocarcinoma|gastroesophageal(ge) junction adenocarcinoma
5120736|NCT01129297|Obesity|obesity
5120737|NCT01129297|surgery|surgery
5120738|NCT01129297|genetic expression|genetic expression
5120739|NCT01129297|collection of samples|collection of samples
5120740|NCT01129284|Treatment Resistance|treatment resistance
5120741|NCT01129284|Nephrotic Syndrome|nephrotic syndrome
5120742|NCT01129284|Focal Segmental Glomerulosclerosis|focal segmental glomerulosclerosis
5120743|NCT01129284|lipoid nephrosis|lipoid nephrosis
5120744|NCT01129284|Membranous nephropathy|membranous nephropathy
5120745|NCT01129284|IgA nephropathy|iga nephropathy
5120746|NCT01129284|proteinuria|proteinuria
5120747|NCT01129258|phase 1|phase 1
5120748|NCT01129258|safety and tolerability|safety and tolerability
5120749|NCT01129258|pharmacokinetics|pharmacokinetics
5120750|NCT01129258|PK|pk
5120751|NCT01129258|pharmacodynamics|pharmacodynamics
5120752|NCT01129258|PD|pd
5120753|NCT01129258|type 2 diabetes mellitus|type 2 diabetes mellitus
5120754|NCT01129245|Celebrex|celebrex
5120755|NCT01129245|prostoglandin inhibitor|prostoglandin inhibitor
5120756|NCT01129245|ovulation|ovulation
5120757|NCT01129245|emergency contraception|emergency contraception
5120758|NCT01129232|insulin|insulin
5120759|NCT01129219|Strength|strength
5120760|NCT01129219|Function|function
5120761|NCT01129219|Mobility|mobility
5120762|NCT01129206|Gastroesophageal Cancer|gastroesophageal cancer
5120763|NCT01129206|Gastroesophageal Carcinoma|gastroesophageal carcinoma
5120764|NCT01129206|Adenocarcinoma|adenocarcinoma
5120765|NCT01129180|T-Cell Lymphoma|t-cell lymphoma
5120766|NCT01129167|Pancreatic adenocarcinoma|pancreatic adenocarcinoma
5120767|NCT01129167|Local invasion by pancreatic adenocarcinoma|local invasion by pancreatic adenocarcinoma
5120768|NCT01129167|Recurrence of pancreatic cancer|recurrence of pancreatic cancer
5120769|NCT01129167|Surgical resection of pancreatic cancer|surgical resection of pancreatic cancer
5120770|NCT01129154|Squamous cell carcinoma|squamous cell carcinoma
5120771|NCT01129141|Tinnitus|tinnitus
5120772|NCT01129141|Traumatic Brain Injury Counseling|traumatic brain injury counseling
5120773|NCT01129141|Counseling|counseling
5120774|NCT01129141|Education|education
5120775|NCT01129141|Evaluation studies|evaluation studies
5120776|NCT01129141|Quality of health care|quality of health care
5120777|NCT01129128|Echinacea|echinacea
5120778|NCT01129128|immune modulation|immune modulation
5120779|NCT01129128|prevention|prevention
5120780|NCT01129089|Acceptability|acceptability
5120781|NCT01129089|Lipid-based nutrient supplements|lipid-based nutrient supplements
5120782|NCT01129089|Micronutrient powder|micronutrient powder
5120783|NCT01129089|Malnutrition|malnutrition
5120784|NCT01129076|Thalassemia Major|thalassemia major
5120785|NCT01129076|Stigma|stigma
5120786|NCT01129076|Singapore|singapore
5120787|NCT01129076|Qualitative|qualitative
5120788|NCT01129050|Fish oil|fish oil
5120789|NCT01129050|Omega-3 fatty acids|omega-3 fatty acids
5120790|NCT01129050|Metabolic syndrome|metabolic syndrome
5120791|NCT01129050|Adults|adults
5120792|NCT01129037|Oncology|oncology
5120793|NCT01129024|Splenectomy|splenectomy
5120794|NCT01129024|Low Platelet Count|low platelet count
5120795|NCT01129024|Thrombopoiesis|thrombopoiesis
5120796|NCT01129024|Thrombocytopaenia|thrombocytopaenia
5120797|NCT01129024|Idiopathic Thrombocytopenic Purpura|idiopathic thrombocytopenic purpura
5120798|NCT01129024|Immune Thrombocytopenia (ITP)|immune thrombocytopenia (itp)
5120799|NCT01129024|Thrombotic Thrombocytopenic Purpura (ITP)|thrombotic thrombocytopenic purpura (itp)
5120800|NCT01129024|Hematologic Disease|hematologic disease
5120801|NCT01129024|Auto-immune Thrombocytopenic Purpura|auto-immune thrombocytopenic purpura
5120802|NCT01129024|S-888711|s-888711
5120803|NCT01129024|Blood Platelet Disorders|blood platelet disorders
5120804|NCT01129024|Relapsed Persistent or Chronic ITP|relapsed persistent or chronic itp
5120805|NCT01129024|ITP|itp
5120806|NCT01129011|NSAID|nsaid
5120807|NCT01129011|gastric ulcers|gastric ulcers
5120808|NCT01129011|Vimovo|vimovo
5120809|NCT01129011|Esomeprazole|esomeprazole
5120810|NCT01129011|Naproxen|naproxen
5120811|NCT01128998|Sorafenib|sorafenib
5120812|NCT01128998|S1|s1
5120813|NCT01128998|Advanced Solid Tumors|advanced solid tumors
5120814|NCT01128998|RD|rd
5120815|NCT01128998|MTD|mtd
5120816|NCT01128998|DLT|dlt
5120817|NCT01128998|PK|pk
5120818|NCT01128998|PG|pg
5120819|NCT01128998|Biomarker|biomarker
5120820|NCT01128985|Canagliflozin|canagliflozin
5120821|NCT01128985|Placebo|placebo
5120822|NCT01128985|Type 2 diabetes mellitus|type 2 diabetes mellitus
5120823|NCT01128985|Pharmacokinetic|pharmacokinetic
5120824|NCT01128985|Pharmacodynamic|pharmacodynamic
5120825|NCT01128972|enamel erosion|enamel erosion
5120826|NCT01128972|tooth remineralization|tooth remineralization
5120827|NCT01128972|tooth erosion|tooth erosion
5120828|NCT01128959|Epilepsy|epilepsy
5120829|NCT01128959|Intravenous Carbamazepine|intravenous carbamazepine
5120830|NCT01128959|Oral Carbamazepine|oral carbamazepine
5120831|NCT01128946|Enamel remineralization|enamel remineralization
5120832|NCT01128946|Fluoride|fluoride
5120833|NCT01128946|caries|caries
5120834|NCT01128933|Fractional flow reserve|fractional flow reserve
5120835|NCT01128933|Revascularization|revascularization
5120836|NCT01128933|Prognosis|prognosis
5120837|NCT01128933|Hemodynamics|hemodynamics
5120838|NCT01128933|Hypertension|hypertension
5120839|NCT01128920|bacterial infections|bacterial infections
5120840|NCT01128920|skin infections|skin infections
5120841|NCT01128920|HIV|hiv
5120842|NCT01128920|Hepatitis C|hepatitis c
5120843|NCT01128920|risk reduction intervention|risk reduction intervention
5120844|NCT01128907|Invasive Aspergillosis in neutropenic patients|invasive aspergillosis in neutropenic patients
5120845|NCT01128894|GSK716155|gsk716155
5120846|NCT01128894|liraglutide|liraglutide
5120847|NCT01128894|albiglutide|albiglutide
5120848|NCT01128894|open-label|open-label
5120849|NCT01128868|Reverse oblique intertrochanteric fractures|reverse oblique intertrochanteric fractures
5120850|NCT01128868|Reverse oblique subtrochanteric fractures|reverse oblique subtrochanteric fractures
5120851|NCT01128855|Duchenne|duchenne
5120852|NCT01128855|Duchenne Muscular Dystrophy|duchenne muscular dystrophy
5120853|NCT01128855|DMD|dmd
5120854|NCT01128855|968|968
5120855|NCT01128842|Neratinib|neratinib
5120856|NCT01128842|Capecitabine|capecitabine
5120857|NCT01128842|Combination|combination
5120858|NCT01128842|Solid Tumor|solid tumor
5120859|NCT01128829|obesity|obesity
5120860|NCT01128829|diabetes|diabetes
5120861|NCT01128829|artificial sweeteners|artificial sweeteners
5120862|NCT01128816|obstructive sleep apnea|obstructive sleep apnea
5120863|NCT01128816|central sleep apnea|central sleep apnea
5120864|NCT01128816|heart failure|heart failure
5120865|NCT01128816|congestive heart failure|congestive heart failure
5120866|NCT01128816|adaptive servo ventilation|adaptive servo ventilation
5120867|NCT01128816|ASV|asv
5120868|NCT01128803|Hepatocellular carcinoma|hepatocellular carcinoma
5120869|NCT01128803|immunotherapy|immunotherapy
5120870|NCT01128803|alpha foetoprotein|alpha foetoprotein
5120871|NCT01128803|dendritic cells|dendritic cells
5120872|NCT01128790|exercise|exercise
5120873|NCT01128790|remote ischemic preconditioning|remote ischemic preconditioning
5120874|NCT01128790|heart failure|heart failure
5120875|NCT01128790|left ventricular dysfunction|left ventricular dysfunction
5120876|NCT01128777|depression|depression
5120877|NCT01128777|anxiety|anxiety
5120878|NCT01128777|family conflict|family conflict
5120879|NCT01128777|behavior problems|behavior problems
5120880|NCT01128751|Cognition|cognition
5120881|NCT01128751|Neuroprotection|neuroprotection
5120882|NCT01128751|Cardiopulmonary bypass|cardiopulmonary bypass
5120883|NCT01128751|Aortic valve replacement|aortic valve replacement
5120884|NCT01128751|Micro-emboli|micro-emboli
5120885|NCT01128738|Neuromuscular Agents|neuromuscular agents
5120886|NCT01128738|Botulinum Toxin Type A|botulinum toxin type a
5120887|NCT01128738|Sweating|sweating
5120888|NCT01128738|Sweat Gland Disease|sweat gland disease
5120889|NCT01128738|Axillary Hyperhidrosis|axillary hyperhidrosis
5120890|NCT01128738|Skin Disease|skin disease
5120891|NCT01128699|Ahmed valve|ahmed valve
5120892|NCT01128699|Neovascular Glaucoma|neovascular glaucoma
5120893|NCT01128699|Uveitic glaucoma|uveitic glaucoma
5120894|NCT01128699|Failed glaucoma|failed glaucoma
5120895|NCT01128699|VEGF-A|vegf-a
5120896|NCT01128699|Intraocular pressure|intraocular pressure
5120897|NCT01128699|Subconjunctival Avastin|subconjunctival avastin
5120898|NCT01128686|retrospective|retrospective
5120899|NCT01128686|naïve Chronic Hepatitis B (CHB) patients|naïve chronic hepatitis b (chb) patients
5120900|NCT01128686|cohort study|cohort study
5120901|NCT01128686|lamivudine|lamivudine
5121000|NCT01128283|Sepsis|sepsis
5120902|NCT01128673|Hypoxic Ischemic encephalopathy|hypoxic ischemic encephalopathy
5120903|NCT01128673|Magnet resonance imaging|magnet resonance imaging
5120904|NCT01128673|Selective Head cooling|selective head cooling
5120905|NCT01128673|Therapeutic hypothermia|therapeutic hypothermia
5120906|NCT01128660|Prescription, General practitioner, Pharmacy|prescription, general practitioner, pharmacy
5120907|NCT01128634|Verapamil|verapamil
5120908|NCT01128634|Anticholinergic, β2 agonist|anticholinergic, β2 agonist
5120909|NCT01128634|P-GP|p-gp
5120910|NCT01128634|LABA|laba
5120911|NCT01128634|Muscarinic Receptor Antagonist|muscarinic receptor antagonist
5120912|NCT01128634|LAMA|lama
5120913|NCT01128621|Pharmacokinetics|pharmacokinetics
5120914|NCT01128621|Glucose|glucose
5120915|NCT01128621|Safety|safety
5120916|NCT01128621|Male|male
5120917|NCT01128621|Female|female
5120918|NCT01128621|Metformin|metformin
5120919|NCT01128621|Pharmacodynamics|pharmacodynamics
5120920|NCT01128621|Tolerability|tolerability
5120921|NCT01128621|Type II Diabetes|type ii diabetes
5120922|NCT01128608|GERD|gerd
5120923|NCT01128608|Heartburn|heartburn
5120924|NCT01128608|Acid Reflux|acid reflux
5120925|NCT01128595|allergen challenge|allergen challenge
5120926|NCT01128595|early asthmatic response|early asthmatic response
5120927|NCT01128595|mild asthma|mild asthma
5120928|NCT01128595|late asthmatic response|late asthmatic response
5120929|NCT01128582|GERD|gerd
5120930|NCT01128582|Insomnia|insomnia
5120931|NCT01128582|Acid Reflux|acid reflux
5120932|NCT01128582|Heartburn|heartburn
5120933|NCT01128569|mild asthma|mild asthma
5120934|NCT01128569|allergen challenge|allergen challenge
5120935|NCT01128569|early asthmatic response|early asthmatic response
5120936|NCT01128556|allergic conjunctivitis|allergic conjunctivitis
5120937|NCT01128556|histamine skin testing|histamine skin testing
5120938|NCT01128543|lapatinib|lapatinib
5120939|NCT01128543|breast cancer|breast cancer
5120940|NCT01128530|cSSSI|csssi
5120941|NCT01128530|complicated skin and skin structure infections|complicated skin and skin structure infections
5120942|NCT01128530|acute bacterial skin and skin structure infections|acute bacterial skin and skin structure infections
5120943|NCT01128530|abscess|abscess
5120944|NCT01128530|cellulitis|cellulitis
5120945|NCT01128530|bacterial infections|bacterial infections
5120946|NCT01128530|anti-bacterial agents|anti-bacterial agents
5120947|NCT01128530|anti-infective agents|anti-infective agents
5120948|NCT01128530|skin diseases, infectious|skin diseases, infectious
5120949|NCT01128530|skin diseases|skin diseases
5120950|NCT01128530|wound infection|wound infection
5120951|NCT01128517|Maternal education|maternal education
5120952|NCT01128517|Complementary food|complementary food
5120953|NCT01128517|Infant growth|infant growth
5120954|NCT01128478|Acute pancreatitis|acute pancreatitis
5120955|NCT01128478|Enteral nutrition|enteral nutrition
5120956|NCT01128478|Pancreas rest|pancreas rest
5120957|NCT01128465|propofol|propofol
5120958|NCT01128465|awake craniotomy|awake craniotomy
5120959|NCT01128465|patients requiring an awake craniotomy for brain tumor/lesion resection|patients requiring an awake craniotomy for brain tumor/lesion resection
5120960|NCT01128452|Treatment-Resistant Depression|treatment-resistant depression
5120961|NCT01128439|Pneumococcal conjugate vaccine|pneumococcal conjugate vaccine
5120962|NCT01128426|Pneumococcal conjugate vaccine|pneumococcal conjugate vaccine
5120963|NCT01128413|Shock|shock
5120964|NCT01128413|Resuscitation|resuscitation
5120965|NCT01128413|Hemodynamics|hemodynamics
5120966|NCT01128413|Emergencies|emergencies
5120967|NCT01128413|Critical Care|critical care
5120968|NCT01128413|Lactic Acid|lactic acid
5120969|NCT01128413|Plasma volume|plasma volume
5120970|NCT01128400|obesity|obesity
5120971|NCT01128400|orlistat|orlistat
5120972|NCT01128400|taste perception|taste perception
5120973|NCT01128387|esophageal cancer|esophageal cancer
5120974|NCT01128387|Locally advanced esophageal cancer|locally advanced esophageal cancer
5120975|NCT01128374|Periodontal disease|periodontal disease
5120976|NCT01128374|Nonsurgical therapy|nonsurgical therapy
5120977|NCT01128374|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
5120978|NCT01128374|Bacterial burden|bacterial burden
5120979|NCT01128374|Gene polymorphisms|gene polymorphisms
5120980|NCT01128348|asthma|asthma
5120981|NCT01128348|adherence|adherence
5120982|NCT01128348|quality of life|quality of life
5120983|NCT01128348|health literacy|health literacy
5120984|NCT01128348|health disparities|health disparities
5120985|NCT01128335|Liver transplantation|liver transplantation
5120986|NCT01128335|HCV-negative recipient|hcv-negative recipient
5120987|NCT01128335|deceased donor|deceased donor
5120988|NCT01128335|sotrastaurin|sotrastaurin
5120989|NCT01128335|oran transplantation|oran transplantation
5120990|NCT01128335|tacrolimus|tacrolimus
5120991|NCT01128322|CKD-828|ckd-828
5120992|NCT01128322|Hypertension|hypertension
5120993|NCT01128322|Primary Hypertension|primary hypertension
5120994|NCT01128322|S-Amlodipine|s-amlodipine
5120995|NCT01128322|Telmisartan|telmisartan
5120996|NCT01128322|Amlodipine|amlodipine
5120997|NCT01128322|Factorial|factorial
5120998|NCT01128322|Phase 2|phase 2
5120999|NCT01128296|high risk stage IIb or III adenocarcinoma of the pancreas|high risk stage iib or iii adenocarcinoma of the pancreas
5121001|NCT01128283|organ failure|organ failure
5121002|NCT01128283|cytokines|cytokines
5121003|NCT01128283|clotting factors|clotting factors
5121004|NCT01128270|Dichloroacetate|dichloroacetate
5121005|NCT01128270|Chloral Hydrate|chloral hydrate
5121006|NCT01128270|Metabolism|metabolism
5121007|NCT01128244|oral contraceptives|oral contraceptives
5121008|NCT01128244|Vitamin B6|vitamin b6
5121009|NCT01128244|birth control pills|birth control pills
5121010|NCT01128244|amino acids|amino acids
5121011|NCT01128244|Vitamin B6 deficiency|vitamin b6 deficiency
5121012|NCT01128244|Vitamin B6 deficiency in women on oral contraceptives|vitamin b6 deficiency in women on oral contraceptives
5121013|NCT01128218|Brain Neoplasms|brain neoplasms
5121014|NCT01128218|5-ALA|5-ala
5121015|NCT01128218|Aminolevulinic acid|aminolevulinic acid
5121016|NCT01128218|Fluorescence|fluorescence
5121017|NCT01128218|Gliomas|gliomas
5121018|NCT01128218|Glioblastoma|glioblastoma
5121019|NCT01128218|Surgery|surgery
5121020|NCT01128205|diabetes|diabetes
5121021|NCT01128205|cardiovascular risk factors|cardiovascular risk factors
5121022|NCT01128205|blood pressure|blood pressure
5121023|NCT01128205|blood lipid|blood lipid
5121024|NCT01128205|blood glucose|blood glucose
5121025|NCT01128166|Heart Failure|heart failure
5121026|NCT01128166|Decompensation|decompensation
5121027|NCT01128166|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
5121028|NCT01128153|Type 2 Diabetes|type 2 diabetes
5121029|NCT01128153|Inadequate Glycaemic Control|inadequate glycaemic control
5121030|NCT01128153|Saxagliptin|saxagliptin
5121031|NCT01128153|Metformin|metformin
5121032|NCT01128153|Sulfonylurea|sulfonylurea
5121033|NCT01128153|Triple Oral Therapy|triple oral therapy
5121034|NCT01128140|motivational enhancement therapy|motivational enhancement therapy
5121035|NCT01128127|knowledge translation|knowledge translation
5121036|NCT01128127|prescription|prescription
5121037|NCT01128127|primary care|primary care
5121038|NCT01128127|NSAID|nsaid
5121039|NCT01128127|PPI|ppi
5121040|NCT01128127|Gastrointestinal damage|gastrointestinal damage
5121041|NCT01128127|Inappropriate prescription|inappropriate prescription
5121042|NCT01128114|Acute bipolar mania|acute bipolar mania
5121043|NCT01128114|Seroquel XR|seroquel xr
5121044|NCT01128114|Quetiapine fumarate|quetiapine fumarate
5121045|NCT01128114|Add-on therapy|add-on therapy
5121046|NCT01128101|spironolactone|spironolactone
5121047|NCT01128101|chronic kidney disease|chronic kidney disease
5121048|NCT01128101|dialysis|dialysis
5121049|NCT01128101|LHV|lhv
5121050|NCT01128088|Enhanced recovery program in laparoscopic surgery|enhanced recovery program in laparoscopic surgery
5121051|NCT01128075|RebiSmart|rebismart
5121052|NCT01128075|Rebif|rebif
5121053|NCT01128075|Adherence|adherence
5121054|NCT01128075|Multidose|multidose
5121055|NCT01128075|Relapsing Multiple Sclerosis|relapsing multiple sclerosis
5121056|NCT01128075|RMS|rms
5121057|NCT01128062|Canthaxanthin retinopathy|canthaxanthin retinopathy
5121058|NCT01128049|Aqueous deficient dry eye (ADDE)|aqueous deficient dry eye (adde)
5121059|NCT01128049|Meibomium Gland Dysfunction (MGD)|meibomium gland dysfunction (mgd)
5121060|NCT01128049|Normal/Control (Non Dry Eye)|normal/control (non dry eye)
5121061|NCT01128036|Congestive Heart failure|congestive heart failure
5121062|NCT01128036|Cardiomyopathy|cardiomyopathy
5121063|NCT01128023|myocardial perfusion imaging|myocardial perfusion imaging
5121064|NCT01128023|rubidium-82|rubidium-82
5121065|NCT01128023|medical isotope production|medical isotope production
5121066|NCT01128023|Positron emission tomography|positron emission tomography
5121067|NCT01128023|clinically useful|clinically useful
5121068|NCT01127984|pacemaker|pacemaker
5121069|NCT01127984|pocket haematoma|pocket haematoma
5121070|NCT01127984|antiplatelet therapy|antiplatelet therapy
5121071|NCT01127984|fibrin glue|fibrin glue
5121072|NCT01127971|patients|patients
5121073|NCT01127971|receiving|receiving
5121074|NCT01127971|irradiation|irradiation
5121075|NCT01127971|device|device
5121076|NCT01127971|External Beam|external beam
5121077|NCT01127958|In-stent restenosis|in-stent restenosis
5121078|NCT01127958|Minimal lumen diameter|minimal lumen diameter
5121079|NCT01127958|Drug eluting balloon|drug eluting balloon
5121080|NCT01127958|Drug eluting stent|drug eluting stent
5121081|NCT01127932|Cognitive Behavioral Therapy|cognitive behavioral therapy
5121082|NCT01127919|Exercise|exercise
5121083|NCT01127919|Activity|activity
5121084|NCT01127919|Adherence|adherence
5121085|NCT01127919|Genetics|genetics
5121086|NCT01127906|Healthy Volunteers|healthy volunteers
5121087|NCT01127906|cross-over|cross-over
5121088|NCT01127906|randomized|randomized
5121089|NCT01127906|placebo and active controlled|placebo and active controlled
5121090|NCT01127906|heat pain|heat pain
5121091|NCT01127906|UVB-Induced pain model|uvb-induced pain model
5121092|NCT01127893|Musculoskeletal Diseases|musculoskeletal diseases
5121093|NCT01127893|Joint Diseases|joint diseases
5121094|NCT01127893|Arthritis|arthritis
5121095|NCT01127893|Rheumatic Diseases|rheumatic diseases
5121096|NCT01127880|Traumatic Hemopneumothorax|traumatic hemopneumothorax
5121097|NCT01127880|Thoracotomy|thoracotomy
5121098|NCT01127880|Antibiotics|antibiotics
5121099|NCT01127854|kidney stone|kidney stone
5121100|NCT01127854|urolithiasis|urolithiasis
5121101|NCT01127854|calcium oxalate kidney stone|calcium oxalate kidney stone
5121102|NCT01127854|calcium oxalate stone|calcium oxalate stone
5121103|NCT01127854|calcium oxalate|calcium oxalate
5121104|NCT01127828|IBS (Irritable Bowel Syndrome)|ibs (irritable bowel syndrome)
5121105|NCT01127828|Probiotic yoghurt|probiotic yoghurt
5121106|NCT01127828|Symptom severity|symptom severity
5121107|NCT01127815|Peritoneal washing cytology|peritoneal washing cytology
5121108|NCT01127815|pancreatic cancer|pancreatic cancer
5121109|NCT01127815|peritoneal metastasis|peritoneal metastasis
5121110|NCT01127815|anoikis|anoikis
5121111|NCT01127815|to determine the relationship between PWC results and clinicopathologic parameters of pancreatic cancers|to determine the relationship between pwc results and clinicopathologic parameters of pancreatic cancers
5121112|NCT01127815|to identify the predictive value of PWC and postoperative drainage cytology on the peritoneal recurrence or outcomes|to identify the predictive value of pwc and postoperative drainage cytology on the peritoneal recurrence or outcomes
5121113|NCT01127815|to dissect the molecular mechanism of peritoneal recurrence, especially on the PWC-inducing peritoneal seeding process.|to dissect the molecular mechanism of peritoneal recurrence, especially on the pwc-inducing peritoneal seeding process.
5121114|NCT01127802|CABG|cabg
5121115|NCT01127802|functional status|functional status
5121116|NCT01127802|symptoms distress|symptoms distress
5121117|NCT01127802|quality of life|quality of life
5121118|NCT01127802|the trajectory of functional status|the trajectory of functional status
5121119|NCT01127802|the changes of symptoms distress|the changes of symptoms distress
5121120|NCT01127802|the changes of quality of life|the changes of quality of life
5121121|NCT01127776|patient after bi-trimalleolar fracture of ankle|patient after bi-trimalleolar fracture of ankle
5121122|NCT01127763|metastatic|metastatic
5121123|NCT01127763|breast|breast
5121124|NCT01127763|cancer|cancer
5121125|NCT01127750|Relapsing multiple sclerosis|relapsing multiple sclerosis
5121126|NCT01127750|MS|ms
5121127|NCT01127750|safety|safety
5121128|NCT01127750|tolerability|tolerability
5121129|NCT01127750|health outcomes|health outcomes
5121130|NCT01127737|SCCs|sccs
5121131|NCT01127737|Squamous Cell Carcinoma|squamous cell carcinoma
5121132|NCT01127737|Skin Self Exam|skin self exam
5121133|NCT01127737|SSE|sse
5121134|NCT01127737|Organ Transplant|organ transplant
5121135|NCT01127737|Performance of SSE with our written educational intervention|performance of sse with our written educational intervention
5121136|NCT01127737|Time after organ transplantation to deliver intervention|time after organ transplantation to deliver intervention
5121137|NCT01127737|Evaluate internation information|evaluate internation information
5121138|NCT01127724|Vitamin B12|vitamin b12
5121139|NCT01127724|Aphthous stomatitis|aphthous stomatitis
5121140|NCT01127724|Cobalamin|cobalamin
5121141|NCT01127724|Doses|doses
5121142|NCT01127685|weight bearing|weight bearing
5121143|NCT01127685|acl|acl
5121144|NCT01127672|plantar fasciitis|plantar fasciitis
5121145|NCT01127672|PRP|prp
5121146|NCT01127672|platelet rich plasma|platelet rich plasma
5121147|NCT01127659|diabetes|diabetes
5121148|NCT01127659|hypogonadism|hypogonadism
5121149|NCT01127659|obesity|obesity
5121150|NCT01127659|testosterone|testosterone
5121151|NCT01127659|insulin sensitivity|insulin sensitivity
5121152|NCT01127659|inflammation|inflammation
5121153|NCT01127620|Allergic Rhinoconjunctivitis|allergic rhinoconjunctivitis
5121154|NCT01127620|Persistent allergic rhinitis|persistent allergic rhinitis
5121155|NCT01127620|Hay fever|hay fever
5121156|NCT01127620|Allergic Rhinitis|allergic rhinitis
5121157|NCT01127620|Sneezing|sneezing
5121158|NCT01127620|Nasal congestion|nasal congestion
5121159|NCT01127620|Rhinorrhea|rhinorrhea
5121160|NCT01127620|Nasal itching|nasal itching
5121161|NCT01127620|Ocular itching|ocular itching
5121162|NCT01127620|Ocular tearing|ocular tearing
5121163|NCT01127620|Antihistamine|antihistamine
5121164|NCT01127607|parenting|parenting
5121165|NCT01127594|Melanoma|melanoma
5121166|NCT01127581|Misoprostol vaginal insert|misoprostol vaginal insert
5121167|NCT01127581|Dinoprostone vaginal insert|dinoprostone vaginal insert
5121168|NCT01127581|Cervidil|cervidil
5121169|NCT01127581|Cervical ripening|cervical ripening
5121170|NCT01127581|Induction of labor|induction of labor
5121171|NCT01127581|Rate of cesarean section|rate of cesarean section
5121172|NCT01127568|Post-Traumatic Stress Disorders|post-traumatic stress disorders
5121173|NCT01127568|Posttraumatic Stress Disorders|posttraumatic stress disorders
5121174|NCT01127568|PTSD|ptsd
5121175|NCT01127568|Stress Disorder, Post Traumatic|stress disorder, post traumatic
5121176|NCT01127568|Stress Disorders, Posttraumatic|stress disorders, posttraumatic
5121177|NCT01127568|Chronic Post Traumatic Stress Disorder|chronic post traumatic stress disorder
5121178|NCT01127555|Biliary Tract Cancer|biliary tract cancer
5121179|NCT01127555|Salvage therapy|salvage therapy
5121180|NCT01127555|FOLFOX|folfox
5121181|NCT01127516|Susceptibility testing|susceptibility testing
5121182|NCT01127516|Antimicrobial stewardship|antimicrobial stewardship
5121183|NCT01127503|Patients with velocardiofacial syndrome and psychosis|patients with velocardiofacial syndrome and psychosis
5121184|NCT01127477|Hypovolemia, surgical blood loss|hypovolemia, surgical blood loss
5121185|NCT01127464|HIV-1|hiv-1
5121186|NCT01127464|HIV preventative vaccine|hiv preventative vaccine
5121187|NCT01127464|Healthy Volunteers|healthy volunteers
5121188|NCT01127451|Neoplasms|neoplasms
5121189|NCT01127438|Monitored anesthesia care sedation|monitored anesthesia care sedation
5121190|NCT01127425|nursing hours|nursing hours
5121191|NCT01127425|length of hospital stay|length of hospital stay
5121192|NCT01127425|reconvalescence|reconvalescence
5121193|NCT01127425|colorectal surgery|colorectal surgery
5121194|NCT01127425|laparoscopic|laparoscopic
5121195|NCT01127425|sigmoid neoplasms|sigmoid neoplasms
5121196|NCT01127412|overweight|overweight
5121197|NCT01127412|physical activity|physical activity
5121198|NCT01127412|infancy|infancy
5121199|NCT01127412|body composition|body composition
5121200|NCT01127412|motor development|motor development
5121201|NCT01127412|motor activity|motor activity
5121202|NCT01127373|Breast|breast
5121203|NCT01127373|Radiation|radiation
5121204|NCT01127373|Multi-Beam Intensity-Modulated Radiation|multi-beam intensity-modulated radiation
5121205|NCT01127373|post mastectomy|post mastectomy
5121206|NCT01127373|post partial mastectomy|post partial mastectomy
5121207|NCT01127373|node-positive breast cancer|node-positive breast cancer
5121208|NCT01127373|10-025|10-025
5121209|NCT01127360|Anti-VEGF|anti-vegf
5121210|NCT01127360|Ranibizumab|ranibizumab
5121211|NCT01127360|Bevacizumab|bevacizumab
5121212|NCT01127360|exudative|exudative
5121213|NCT01127360|macular degeneration|macular degeneration
5121214|NCT01127334|Dyssynchrony|dyssynchrony
5121215|NCT01127334|Cardiac resynchronization therapy|cardiac resynchronization therapy
5121216|NCT01127321|Systemic lupus erythematosus|systemic lupus erythematosus
5121217|NCT01127321|SLE|sle
5121218|NCT01127321|MEDI-570|medi-570
5121219|NCT01127308|Absorption|absorption
5121220|NCT01127308|Distribution|distribution
5121221|NCT01127308|Metabolism|metabolism
5121222|NCT01127308|and Excretion|and excretion
5121223|NCT01127308|Mass Balance|mass balance
5121224|NCT01127308|Metabolic Profile|metabolic profile
5121225|NCT01127308|Radiolabel Study|radiolabel study
5121226|NCT01127295|Pharmacokinetics|pharmacokinetics
5121227|NCT01127295|Pharmacogenetic|pharmacogenetic
5121228|NCT01127295|tamoxifen|tamoxifen
5121229|NCT01127295|anti-aromatases|anti-aromatases
5121230|NCT01127295|breast cancer|breast cancer
5121231|NCT01127295|pharmacodynamy|pharmacodynamy
5121232|NCT01127295|Observance|observance
5121233|NCT01127282|influenza|influenza
5121234|NCT01127282|vitamin|vitamin
5121235|NCT01127282|improvement of symptom|improvement of symptom
5121236|NCT01127243|Hysterectomy|hysterectomy
5121237|NCT01127243|laparoscopy|laparoscopy
5121238|NCT01127243|day-case surgery|day-case surgery
5121239|NCT01127243|quality of life|quality of life
5121240|NCT01127243|Ambulatory Surgical Procedures|ambulatory surgical procedures
5121241|NCT01127230|ADRC|adrc
5121242|NCT01127230|adipocyte derived regenerative cells|adipocyte derived regenerative cells
5121243|NCT01127230|stem cells|stem cells
5121244|NCT01127230|liposuction|liposuction
5121245|NCT01127230|Cytori|cytori
5121246|NCT01127230|Celution|celution
5121247|NCT01127230|Lipoaspirate is obtained from patients who have opted for liposuction and consent to donate the lipoasirate for this study, which would otherwise be discarded.|lipoaspirate is obtained from patients who have opted for liposuction and consent to donate the lipoasirate for this study, which would otherwise be discarded.
5121248|NCT01127217|amlodipine|amlodipine
5121249|NCT01127217|losartan|losartan
5121250|NCT01127217|hypertension|hypertension
5121251|NCT01127217|stage 2|stage 2
5121252|NCT01127204|HIV|hiv
5121253|NCT01127204|Antiretroviral therapy|antiretroviral therapy
5121254|NCT01127204|Infant|infant
5121255|NCT01127204|Sub Saharian Africa|sub saharian africa
5121256|NCT01127191|military exercises|military exercises
5121257|NCT01127191|neuromuscular fatigue|neuromuscular fatigue
5121258|NCT01127191|physiological responses|physiological responses
5121259|NCT01127191|biomechanical responses|biomechanical responses
5121260|NCT01127191|simulated military effort|simulated military effort
5121261|NCT01127191|high load carriage|high load carriage
5121262|NCT01127191|Healthy voluntary|healthy voluntary
5121263|NCT01127152|Noradrenalin relays|noradrenalin relays
5121264|NCT01127152|Automatic relays|automatic relays
5121265|NCT01127152|Manual relays|manual relays
5121266|NCT01127152|Hypotension|hypotension
5121267|NCT01127152|Intensive care unit|intensive care unit
5121268|NCT01127139|Essential hypertension|essential hypertension
5121269|NCT01127113|Myocardial infarction|myocardial infarction
5121270|NCT01127113|Magnetic resonance imaging|magnetic resonance imaging
5121271|NCT01127113|Nanoparticles|nanoparticles
5121272|NCT01127113|Mononuclear cells|mononuclear cells
5121273|NCT01127113|Cell tracking|cell tracking
5121274|NCT01127100|neuropathic pain|neuropathic pain
5121275|NCT01127100|gabapentin|gabapentin
5121276|NCT01127100|transdermal fentanyl matrix|transdermal fentanyl matrix
5121277|NCT01127100|multicenter|multicenter
5121278|NCT01127100|non-inferiority trial|non-inferiority trial
5121279|NCT01127087|Hyperoxaluria|hyperoxaluria
5121280|NCT01127087|Oxazyme|oxazyme
5121281|NCT01127087|oxalate|oxalate
5121282|NCT01127087|enteric hyperoxaluria|enteric hyperoxaluria
5121283|NCT01127074|metastatic breast cancer|metastatic breast cancer
5121284|NCT01127074|breast cancer stage IV|breast cancer stage iv
5121285|NCT01127074|vaccination|vaccination
5121286|NCT01127074|CD80|cd80
5121287|NCT01127074|immunotherapy|immunotherapy
5121288|NCT01127061|Hypertrophic Cardiomyopathy|hypertrophic cardiomyopathy
5121289|NCT01127061|Exercise|exercise
5121290|NCT01127061|Oxygen consumption|oxygen consumption
5121291|NCT01127048|bronchitis|bronchitis
5121292|NCT01127048|coughing|coughing
5121293|NCT01127048|children|children
5121294|NCT01127048|Ivy|ivy
5121295|NCT01127048|Hedera helix L.|hedera helix l.
5121296|NCT01127035|allergic rhinitis|allergic rhinitis
5121297|NCT01127035|alternaria alternata|alternaria alternata
5121298|NCT01127035|symptom score|symptom score
5121299|NCT01127022|Pregnancy|pregnancy
5121300|NCT01127022|Lactation|lactation
5121301|NCT01127022|Choline|choline
5121302|NCT01127022|Cognition|cognition
5121303|NCT01127022|Biomarkers|biomarkers
5121304|NCT01126996|MenC conjugate vaccine|menc conjugate vaccine
5121305|NCT01126996|Healthy children previously vaccinated against MenC|healthy children previously vaccinated against menc
5121306|NCT01126970|reduced calorie diet|reduced calorie diet
5121307|NCT01126970|orlistat|orlistat
5121308|NCT01126970|velneperit|velneperit
5121309|NCT01126944|heart failure|heart failure
5121310|NCT01126944|resynchronization|resynchronization
5121311|NCT01126944|left ventricular assist device|left ventricular assist device
5121312|NCT01126931|Crohn disease|crohn disease
5121313|NCT01126931|Involuntary weight loss in cancer|involuntary weight loss in cancer
5121314|NCT01126931|IgA nephropathy|iga nephropathy
5121315|NCT01126931|Depression with reduced appetite|depression with reduced appetite
5121316|NCT01126918|Eating Disorders|eating disorders
5121317|NCT01126918|Obesity|obesity
5121318|NCT01126918|Body Dissatisfaction|body dissatisfaction
5121319|NCT01126918|Female|female
5121320|NCT01126905|Reticulated Haemoglobin Equivalent|reticulated haemoglobin equivalent
5121321|NCT01126905|Functional Iron Deficiency|functional iron deficiency
5121322|NCT01126905|Response to therapy|response to therapy
5121323|NCT01126905|Iron deficiency|iron deficiency
5121324|NCT01126892|Advanced Disease,|advanced disease,
5121325|NCT01126892|Resistance,|resistance,
5121326|NCT01126892|Intolerance|intolerance
5121327|NCT01126866|advanced colorectal carcinoma|advanced colorectal carcinoma
5121328|NCT01126866|CRC|crc
5121329|NCT01126866|UICC Stages IV|uicc stages iv
5121330|NCT01126866|liver and/or lung only metastases|liver and/or lung only metastases
5121331|NCT01126853|Immunization|immunization
5121332|NCT01126853|Immunity|immunity
5121333|NCT01126853|Prevention|prevention
5121334|NCT01126840|Lynch Syndrome|lynch syndrome
5121335|NCT01126840|Families|families
5121336|NCT01126840|Quality of life|quality of life
5121337|NCT01126840|QOL|qol
5121338|NCT01126840|First-degree relatives|first-degree relatives
5121339|NCT01126840|Questionnaire|questionnaire
5121340|NCT01126840|Interview|interview
5121341|NCT01126827|Bipolar Disorder|bipolar disorder
5121342|NCT01126827|Mood Disorders|mood disorders
5121343|NCT01126827|Residual Symptoms|residual symptoms
5121344|NCT01126827|Depression|depression
5121345|NCT01126827|Mania|mania
5121346|NCT01126827|Hypomania|hypomania
5121347|NCT01126827|Bipolar|bipolar
5121348|NCT01126827|Bipolar I|bipolar i
5121349|NCT01126827|Bipolar II|bipolar ii
5121350|NCT01126814|Gleevec|gleevec
5121351|NCT01126814|c-kit|c-kit
5121353|NCT01126775|Systematic prevention, stroke, vascular dementia, silent strokes, cerebral microangiopathy.|systematic prevention, stroke, vascular dementia, silent strokes, cerebral microangiopathy.
5121354|NCT01126762|Docosahexaenoic acid|docosahexaenoic acid
5121355|NCT01126762|fish|fish
5121356|NCT01126762|pregnancy|pregnancy
5121357|NCT01126762|methylmercury|methylmercury
5121358|NCT01126762|n-3 polyunsaturated fatty acid|n-3 polyunsaturated fatty acid
5121359|NCT01126749|Locally Advanced or Metastatic Bladder Cancer, including other transitional cell cancers of the urothelium (prostate, urethra, ureter, and renal pelvis)|locally advanced or metastatic bladder cancer, including other transitional cell cancers of the urothelium (prostate, urethra, ureter, and renal pelvis)
5121360|NCT01126736|neoplams|neoplams
5121361|NCT01126736|lung neoplasms|lung neoplasms
5121362|NCT01126736|Stage IIIB|stage iiib
5121363|NCT01126736|IV Nonsquamous Non Small Cell Lung Cancer|iv nonsquamous non small cell lung cancer
5121364|NCT01126710|infiltration|infiltration
5121365|NCT01126710|extravasation|extravasation
5121366|NCT01126710|optical monitoring|optical monitoring
5121367|NCT01126697|Cardiac|cardiac
5121368|NCT01126697|Muscular Dystrophy|muscular dystrophy
5121369|NCT01126697|Randomized|randomized
5121370|NCT01126684|essential hypertension|essential hypertension
5121371|NCT01126671|vitamin D|vitamin d
5121372|NCT01126658|pressure-volume curve|pressure-volume curve
5121373|NCT01126658|intracranial pressure|intracranial pressure
5121374|NCT01126658|volume pressure response|volume pressure response
5121375|NCT01126658|pressure-volume relationship|pressure-volume relationship
5121376|NCT01126658|mathematical model|mathematical model
5121377|NCT01126645|Liver|liver
5121378|NCT01126645|HCC|hcc
5121379|NCT01126632|Colonoscopy|colonoscopy
5121380|NCT01126619|Psoriasis|psoriasis
5121381|NCT01126567|Phase 1 Clinical Trials, Cerebrospinal Fluid, Biomarker|phase 1 clinical trials, cerebrospinal fluid, biomarker
5121382|NCT01126554|Prognostic value|prognostic value
5121383|NCT01126528|Vitamin D|vitamin d
5121384|NCT01126528|cholecalciferol|cholecalciferol
5121385|NCT01126528|Micronutrients|micronutrients
5121386|NCT01126528|Developing countries|developing countries
5121387|NCT01126528|Bangladesh|bangladesh
5121388|NCT01126528|Infant, Newborn|infant, newborn
5121389|NCT01126528|Reproductive Health|reproductive health
5121390|NCT01126528|Infant, Newborn, Diseases|infant, newborn, diseases
5121391|NCT01126528|Perinatology|perinatology
5121392|NCT01126528|Immunology|immunology
5121393|NCT01126528|cathelicidin|cathelicidin
5121394|NCT01126528|Maternal Nutrition Physiology|maternal nutrition physiology
5121395|NCT01126515|brain injury|brain injury
5121396|NCT01126515|sequelae|sequelae
5121397|NCT01126515|stroke|stroke
5121398|NCT01126515|anoxia|anoxia
5121399|NCT01126515|trauma|trauma
5121400|NCT01126476|Adults with non-CNS recurrent tumors who have been previously irradiated|adults with non-cns recurrent tumors who have been previously irradiated
5121401|NCT01126476|and have a tumor recurrence in or near prior radiation fields|and have a tumor recurrence in or near prior radiation fields
5121402|NCT01126463|Hepatocellular carcinomas|hepatocellular carcinomas
5121403|NCT01126463|lipiodol|lipiodol
5121404|NCT01126463|rhenium|rhenium
5121405|NCT01126463|Non operable Hepatocellular carcinomas|non operable hepatocellular carcinomas
5121406|NCT01126450|recurrent colon cancer|recurrent colon cancer
5121407|NCT01126450|recurrent rectal cancer|recurrent rectal cancer
5121408|NCT01126424|Anti-muscarinics|anti-muscarinics
5121409|NCT01126424|Anti-cholinergics|anti-cholinergics
5121410|NCT01126424|Cognition|cognition
5121411|NCT01126424|Solifenacin|solifenacin
5121412|NCT01126411|pulmonary hypertension|pulmonary hypertension
5121413|NCT01126411|autoantibodies|autoantibodies
5121414|NCT01126411|immunoadsorption|immunoadsorption
5121415|NCT01126411|immunoglobulin substitution|immunoglobulin substitution
5121416|NCT01126411|right ventricular function|right ventricular function
5121417|NCT01126385|Spinal Diseases|spinal diseases
5121418|NCT01126385|Bone strength|bone strength
5121419|NCT01126385|Transpedicular fixation|transpedicular fixation
5121420|NCT01126385|Dorsal instrumentation|dorsal instrumentation
5121421|NCT01126385|DensiProbe|densiprobe
5121422|NCT01126372|Prostaglandin-dependent Congenital Heart Disease|prostaglandin-dependent congenital heart disease
5121423|NCT01126372|Prematurity|prematurity
5121424|NCT01126372|Feeding intolerances|feeding intolerances
5121425|NCT01126372|Necrotizing Enterocolitis|necrotizing enterocolitis
5121426|NCT01126372|Regional Oxygen Saturation|regional oxygen saturation
5121427|NCT01126372|Near Infrared Spectroscopy|near infrared spectroscopy
5121428|NCT01126372|Somanetics INVOS Oxyalert|somanetics invos oxyalert
5121429|NCT01126359|Wound Vacuum Assisted Dressings|wound vacuum assisted dressings
5121430|NCT01126359|Lidocaine|lidocaine
5121431|NCT01126359|Dressing change|dressing change
5121432|NCT01126359|Pain management|pain management
5121433|NCT01126359|palliative care|palliative care
5121434|NCT01126333|Nephrotoxicity, Kidney Transplantation, Graft Survival|nephrotoxicity, kidney transplantation, graft survival
5121435|NCT01126333|Kidney transplant survival.|kidney transplant survival.
5121436|NCT01126320|VAP|vap
5121437|NCT01126307|refractory epilepsy- greater than 4 seizures in 2 month baseline period|refractory epilepsy- greater than 4 seizures in 2 month baseline period
5121438|NCT01126294|lumbar laminectomy, melatonin, perioperative, pain, anxiety, analgesia, VAS score|lumbar laminectomy, melatonin, perioperative, pain, anxiety, analgesia, vas score
5121439|NCT01126268|Eczema|eczema
5121440|NCT01126268|Atopic dermatitis|atopic dermatitis
5121441|NCT01126268|Infection|infection
5121442|NCT01126268|Impetigo|impetigo
5121443|NCT01126268|Folliculitis|folliculitis
5121444|NCT01126255|vulvar lichen sclerosus|vulvar lichen sclerosus
5121445|NCT01126255|progesterone|progesterone
5121446|NCT01126255|clobetasol|clobetasol
5121447|NCT01126255|randomized controlled trial|randomized controlled trial
5121448|NCT01126242|Ankle|ankle
5121449|NCT01126242|ligament injuries|ligament injuries
5121450|NCT01126242|non-surgical treatment|non-surgical treatment
5121451|NCT01126242|tape|tape
5121452|NCT01126242|brace|brace
5121453|NCT01126242|orthotic device|orthotic device
5121454|NCT01126242|bandage|bandage
5121455|NCT01126242|cost-effectiveness|cost-effectiveness
5121456|NCT01126242|randomized trial|randomized trial
5121457|NCT01126229|Resveratrol|resveratrol
5121458|NCT01126229|Grape|grape
5121459|NCT01126229|Aging|aging
5121460|NCT01126229|functional MRI (fMRI)|functional mri (fmri)
5121461|NCT01126229|Anti-Aging therapeutic|anti-aging therapeutic
5121462|NCT01126229|Oxidative Stress|oxidative stress
5121463|NCT01126229|Functional Performance|functional performance
5121464|NCT01126216|Radiochemotherapy|radiochemotherapy
5121465|NCT01126216|head and neck cancer|head and neck cancer
5121466|NCT01126216|Paclitaxel|paclitaxel
5121467|NCT01126216|Cisplatin|cisplatin
5121468|NCT01126216|5-FU|5-fu
5121469|NCT01126203|Pseudoexfoliation|pseudoexfoliation
5121470|NCT01126203|Glaucoma|glaucoma
5121471|NCT01126203|Ocular Hypertension|ocular hypertension
5121472|NCT01126203|SLT|slt
5121473|NCT01126203|Selective Laser Trabeculoplasy (SLT)|selective laser trabeculoplasy (slt)
5121474|NCT01126203|Argon Laser Trabeculoplasty (ALT)|argon laser trabeculoplasty (alt)
5121475|NCT01126177|asthma|asthma
5121476|NCT01126164|parents|parents
5121477|NCT01126164|peer|peer
5121478|NCT01126164|basics|basics
5121479|NCT01126164|college student drinking|college student drinking
5121480|NCT01126151|drinking|drinking
5121481|NCT01126151|alcohol consequences|alcohol consequences
5121482|NCT01126138|unresectable|unresectable
5121483|NCT01126138|locally advanced|locally advanced
5121484|NCT01126138|metastatic|metastatic
5121485|NCT01126138|breast cancer|breast cancer
5121486|NCT01126125|iodine|iodine
5121487|NCT01126125|infant|infant
5121488|NCT01126125|breastfeeding|breastfeeding
5121489|NCT01126125|deficiency|deficiency
5121490|NCT01126112|advanced colorectal cancer; K-RAS; panitumumab|advanced colorectal cancer; k-ras; panitumumab
5121491|NCT01126112|advanced Wild Type K-RAS colorectal cancer|advanced wild type k-ras colorectal cancer
5121492|NCT01126099|double-blind|double-blind
5121493|NCT01126099|treatment|treatment
5121494|NCT01126099|prazosin|prazosin
5121495|NCT01126099|Disruptive behaviors in Alzheimer's Disease|disruptive behaviors in alzheimer's disease
5121496|NCT01126073|niacin/laropiprant|niacin/laropiprant
5121497|NCT01126073|endothelial function|endothelial function
5121498|NCT01126060|Neck dissection|neck dissection
5121499|NCT01126047|Lung Diseases|lung diseases
5121500|NCT01126034|Metoclopramide|metoclopramide
5121501|NCT01126034|Randomized Controlled Trial|randomized controlled trial
5121502|NCT01126021|Senior citizens|senior citizens
5121503|NCT01126021|mental acuity|mental acuity
5121504|NCT01126021|memory|memory
5121505|NCT01126008|locally advanced Squamous cell carcinoma|locally advanced squamous cell carcinoma
5121506|NCT01125995|limited disease|limited disease
5121507|NCT01125969|diabetes|diabetes
5121508|NCT01125969|glucose|glucose
5121509|NCT01125969|peer mentor|peer mentor
5121510|NCT01125969|incentives|incentives
5121511|NCT01125969|behavioral economics|behavioral economics
5121512|NCT01125969|cost-effectiveness|cost-effectiveness
5121513|NCT01125956|Diabetes|diabetes
5121514|NCT01125956|Diabetes mellitus|diabetes mellitus
5121515|NCT01125956|HbA1c|hba1c
5121516|NCT01125930|rosacea|rosacea
5121517|NCT01125930|tretinoin|tretinoin
5121518|NCT01125930|atralin|atralin
5121519|NCT01125917|Low back pain|low back pain
5121520|NCT01125917|Opioid|opioid
5121521|NCT01125917|Transdermal|transdermal
5121522|NCT01125904|Crizotinib|crizotinib
5121523|NCT01125891|gemcitabine hydrochloride|gemcitabine hydrochloride
5121524|NCT01125891|Gemzar|gemzar
5121525|NCT01125891|ON 01910.Na|on 01910.na
5121526|NCT01125878|satiety|satiety
5121527|NCT01125878|appetite|appetite
5121528|NCT01125878|fiber|fiber
5121529|NCT01125878|starch|starch
5121530|NCT01125878|nutrition|nutrition
5121531|NCT01125865|Malignant hilar stricture|malignant hilar stricture
5121532|NCT01125852|Peptic ulcer hemorrhage|peptic ulcer hemorrhage
5121533|NCT01125852|Peptic ulcer bleeding|peptic ulcer bleeding
5121534|NCT01125852|Angiographic embolization|angiographic embolization
5121535|NCT01125852|Arterial embolization|arterial embolization
5121536|NCT01125852|Angiography|angiography
5121537|NCT01125839|osteomyelitis|osteomyelitis
5121538|NCT01125839|16S rRNA|16s rrna
5121539|NCT01125839|spine|spine
5121540|NCT01125839|Magnetic resonance imaging|magnetic resonance imaging
5121541|NCT01125800|Recurrent,|recurrent,
5121542|NCT01125800|refractory,|refractory,
5121543|NCT01125800|medulloblastoma,|medulloblastoma,
5121544|NCT01125800|rhabdomyosarcoma,|rhabdomyosarcoma,
5121545|NCT01125800|neuroblastoma,|neuroblastoma,
5121546|NCT01125800|hepatoblastoma,|hepatoblastoma,
5121547|NCT01125800|astrocytoma,|astrocytoma,
5121548|NCT01125800|children,|children,
5121549|NCT01125800|pediatric,|pediatric,
5121550|NCT01125800|hedgehog pathway inhibitor, adult|hedgehog pathway inhibitor, adult
5121551|NCT01125787|CLL|cll
5121552|NCT01125787|bendamustine|bendamustine
5121553|NCT01125787|ofatumumab|ofatumumab
5121554|NCT01125787|blood cancer|blood cancer
5121555|NCT01125787|leukemia|leukemia
5121556|NCT01125787|lymphocyte|lymphocyte
5121557|NCT01125787|hematology|hematology
5121558|NCT01125787|non-Hodgkin lymphoma|non-hodgkin lymphoma
5121559|NCT01125787|small lymphocytic lymphoma|small lymphocytic lymphoma
5121560|NCT01125787|nevada cancer institute|nevada cancer institute
5121561|NCT01125787|cephalon|cephalon
5121562|NCT01125787|Glaxosmithkline|glaxosmithkline
5121563|NCT01125774|Menstrually related migraine|menstrually related migraine
5121564|NCT01125774|migraine|migraine
5121565|NCT01125774|Premenstrual migraine|premenstrual migraine
5121566|NCT01125761|Allergic dermatitis|allergic dermatitis
5121567|NCT01125722|Urinary Incontinence|urinary incontinence
5121568|NCT01125722|Overactive Bladder|overactive bladder
5121569|NCT01125722|Frequency|frequency
5121570|NCT01125722|Urgency|urgency
5121571|NCT01125709|Neuromuscular disease|neuromuscular disease
5121572|NCT01125709|Duchenne|duchenne
5121573|NCT01125709|Muscular Dystrophy|muscular dystrophy
5121574|NCT01125709|DMD|dmd
5121575|NCT01125709|Strength assessment|strength assessment
5121576|NCT01125709|CINRG Quantitative Measurement System|cinrg quantitative measurement system
5121577|NCT01125709|CQMS|cqms
5121578|NCT01125709|Hand Held Myometry|hand held myometry
5121579|NCT01125709|HHM|hhm
5121580|NCT01125696|mother-to-child transmission|mother-to-child transmission
5121581|NCT01125696|HIV|hiv
5121582|NCT01125696|Hepatitis B|hepatitis b
5121583|NCT01125696|Pregnant women|pregnant women
5121584|NCT01125696|Tenofovir|tenofovir
5121585|NCT01125696|Infants|infants
5121586|NCT01125683|Phase II|phase ii
5121587|NCT01125683|Alzheimer's disease|alzheimer's disease
5121588|NCT01125683|EEG|eeg
5121589|NCT01125683|cognition|cognition
5121590|NCT01125683|pharmacodynamic|pharmacodynamic
5121591|NCT01125670|YM150|ym150
5121592|NCT01125670|Food effect|food effect
5121593|NCT01125657|YM150|ym150
5121594|NCT01125657|bioequivalence study|bioequivalence study
5121595|NCT01125644|necrotic pulmonary infections|necrotic pulmonary infections
5121596|NCT01125631|Alzheimer's disease|alzheimer's disease
5121597|NCT01125631|amyloid|amyloid
5121598|NCT01125631|antibody|antibody
5121599|NCT01125631|Japanese|japanese
5121600|NCT01125618|child mortality|child mortality
5121601|NCT01125618|intervention|intervention
5121602|NCT01125618|Poverty|poverty
5121603|NCT01125618|Africa|africa
5121604|NCT01125618|Millennium Development Goal|millennium development goal
5121605|NCT01125618|Millennium Development Goals|millennium development goals
5121606|NCT01125605|PASCONAL|pasconal
5121607|NCT01125605|nervousness|nervousness
5121608|NCT01125605|nervosity|nervosity
5121609|NCT01125605|sleep disorder|sleep disorder
5121610|NCT01125592|assess the ability of the IonCleanse machine to remove heavy metals through the feet|assess the ability of the ioncleanse machine to remove heavy metals through the feet
5121611|NCT01125579|nervousness|nervousness
5121612|NCT01125579|restlessness|restlessness
5121613|NCT01125579|depression|depression
5121614|NCT01125579|affective disorder|affective disorder
5121615|NCT01125540|Allergic conjunctivitis|allergic conjunctivitis
5121616|NCT01125527|Haemophilus influenzae type b (Hib)|haemophilus influenzae type b (hib)
5121617|NCT01125527|Vaccine|vaccine
5121618|NCT01125527|Anti PRP antibody|anti prp antibody
5121619|NCT01125514|Heart failure,|heart failure,
5121620|NCT01125514|aliskiren,|aliskiren,
5121621|NCT01125514|furosemide,|furosemide,
5121622|NCT01125514|diuretic efficacy,|diuretic efficacy,
5121623|NCT01125514|interaction|interaction
5121624|NCT01125488|Maintenance therapy|maintenance therapy
5121625|NCT01125488|LNG-IUS|lng-ius
5121626|NCT01125488|recurrence,endometriosis|recurrence,endometriosis
5121627|NCT01125488|Recurrence|recurrence
5121628|NCT01125475|Relapsing Remitting Multiple Sclerosis|relapsing remitting multiple sclerosis
5121629|NCT01125475|RebiSmart|rebismart
5121630|NCT01125475|Rebif|rebif
5121631|NCT01125475|Adherence|adherence
5121632|NCT01125462|Ovulation Induction|ovulation induction
5121633|NCT01125462|Infertility|infertility
5121634|NCT01125462|Gonal-f|gonal-f
5121635|NCT01125462|FertiQoL|fertiqol
5121636|NCT01125462|Quality of Life|quality of life
5121637|NCT01125449|ascorbic acid|ascorbic acid
5121638|NCT01125449|vitamin C|vitamin c
5121639|NCT01125449|antioxidants|antioxidants
5121640|NCT01125449|vitamins|vitamins
5121641|NCT01125423|Female|female
5121642|NCT01125423|age 18 to 70|age 18 to 70
5121643|NCT01125410|Fluomizin|fluomizin
5121644|NCT01125410|Dequalinium chloride|dequalinium chloride
5121645|NCT01125410|Bacterial vaginosis|bacterial vaginosis
5121646|NCT01125410|vaginal therapy|vaginal therapy
5121647|NCT01125397|bariatric surgery|bariatric surgery
5121648|NCT01125397|behavioral weight management|behavioral weight management
5121649|NCT01125397|psychosocial outcomes following bariatric surgery|psychosocial outcomes following bariatric surgery
5121650|NCT01125371|Hazardous alcohol use|hazardous alcohol use
5121651|NCT01125371|Binge drinking|binge drinking
5121652|NCT01125371|High risk sexual behaviors|high risk sexual behaviors
5121653|NCT01125371|HIV risk reduction|hiv risk reduction
5121654|NCT01125345|hydrophobic acrylic|hydrophobic acrylic
5121655|NCT01125345|PCO|pco
5121656|NCT01125345|posterior capsule opacification|posterior capsule opacification
5121657|NCT01125345|hydrophilic acrylic IO|hydrophilic acrylic io
5121658|NCT01125306|Drug consumption|drug consumption
5121659|NCT01125306|The Xal-Ease device|the xal-ease device
5121660|NCT01125306|Patient's compliance|patient's compliance
5121661|NCT01125306|Using a novel Pfizer-Pharmacia device to facilitate the Xalatan/Xalacom instillation and to avoid loss of eye drops|using a novel pfizer-pharmacia device to facilitate the xalatan/xalacom instillation and to avoid loss of eye drops
5121662|NCT01125293|everolimus|everolimus
5121663|NCT01125293|rituximab|rituximab
5121664|NCT01125293|bortezomib|bortezomib
5121665|NCT01125293|RAD001|rad001
5121666|NCT01125293|Rituxan|rituxan
5121667|NCT01125293|Velcade|velcade
5121668|NCT01125280|Small bowel occlusion|small bowel occlusion
5121669|NCT01125280|Conservative treatment for small bowel occlusion|conservative treatment for small bowel occlusion
5121670|NCT01125280|Surgical treatment for small bowel occlusion|surgical treatment for small bowel occlusion
5121671|NCT01125280|Small bowel resection|small bowel resection
5121672|NCT01125280|Score of severity of small bowel occlusion|score of severity of small bowel occlusion
5121673|NCT01125267|medication adherence|medication adherence
5121674|NCT01125267|schizophrenia|schizophrenia
5121675|NCT01125267|Mexican American|mexican american
5121676|NCT01125267|multifamily groups|multifamily groups
5121677|NCT01125254|thalassemia major|thalassemia major
5121678|NCT01125254|calcium channel blockade|calcium channel blockade
5121679|NCT01125254|magnetic resonance imaging|magnetic resonance imaging
5121680|NCT01125241|wuling capsule|wuling capsule
5121681|NCT01125241|epilepsy|epilepsy
5121682|NCT01125241|depression|depression
5121683|NCT01125241|superiority clinical research|superiority clinical research
5121684|NCT01125228|AIDS|aids
5121685|NCT01125228|Antiretroviral|antiretroviral
5121686|NCT01125228|Kaposi's Sarcoma|kaposi's sarcoma
5121687|NCT01125215|Painful diabetic neuropathy|painful diabetic neuropathy
5121688|NCT01125215|Capsaicin|capsaicin
5121689|NCT01125215|Nanoparticle|nanoparticle
5121690|NCT01125215|Quantitative Sensory Testing|quantitative sensory testing
5121691|NCT01125202|Intervention studies|intervention studies
5121692|NCT01125202|Computers, handheld|computers, handheld
5121693|NCT01125202|Randomized controlled trial|randomized controlled trial
5121694|NCT01125202|Sodium, dietary|sodium, dietary
5121695|NCT01125176|CLL|cll
5121696|NCT01125163|very low birth weight infants|very low birth weight infants
5121697|NCT01125163|anemia|anemia
5121698|NCT01125163|iron supplementation|iron supplementation
5121699|NCT01125150|diffuse reflectance spectroscopy|diffuse reflectance spectroscopy
5121700|NCT01125137|Keloid|keloid
5121701|NCT01125137|MMP|mmp
5121702|NCT01125137|Matrix metalloproteinase|matrix metalloproteinase
5121703|NCT01125137|dermatology|dermatology
5121704|NCT01125124|Pleurodesis|pleurodesis
5121705|NCT01125124|Malignant pleural effusion|malignant pleural effusion
5121706|NCT01125124|Silver Nitrate|silver nitrate
5121707|NCT01125124|Pain|pain
5121708|NCT01125098|COPD|copd
5121709|NCT01125098|PRO-CT|pro-ct
5121710|NCT01125098|antibiotics|antibiotics
5121711|NCT01125085|I131|i131
5121712|NCT01125085|L19|l19
5121713|NCT01125085|antibody|antibody
5121714|NCT01125085|monoclonal|monoclonal
5121715|NCT01125085|multiple brain metastasis|multiple brain metastasis
5121716|NCT01125085|tumor targeting|tumor targeting
5121717|NCT01125085|radioimmunotherapy|radioimmunotherapy
5121718|NCT01125085|Patients with brain metastases of solid tumors (>1), who are not amenable for surgical excision or stereotactic radiosurgery.|patients with brain metastases of solid tumors (>1), who are not amenable for surgical excision or stereotactic radiosurgery.
5121719|NCT01125072|chest pain|chest pain
5121720|NCT01125072|echocardiography|echocardiography
5121721|NCT01125072|strain imaging|strain imaging
5121722|NCT01125059|hydromorphone|hydromorphone
5121723|NCT01125059|lumbar posterior spinal fusion|lumbar posterior spinal fusion
5121724|NCT01125059|lumbosacral spondylosis|lumbosacral spondylosis
5121725|NCT01125059|Spinal Fusion|spinal fusion
5121726|NCT01125033|Dialysis, Restless legs syndrome, Ascorbic acid, Vitamin E|dialysis, restless legs syndrome, ascorbic acid, vitamin e
5121727|NCT01125007|Dental plaque|dental plaque
5121728|NCT01125007|Gingival abrasion|gingival abrasion
5121729|NCT01125007|toothbrushing|toothbrushing
5121730|NCT01124994|Barrett's oesophagus|barrett's oesophagus
5121731|NCT01124994|High grade intraepithelial neoplasia (HGIEN)|high grade intraepithelial neoplasia (hgien)
5121732|NCT01124981|Fibrinogen concentrate|fibrinogen concentrate
5121733|NCT01124981|Coagulopathy|coagulopathy
5121734|NCT01124968|User-Computer Interface|user-computer interface
5121735|NCT01124968|Office Visits|office visits
5121736|NCT01124968|Primary Health Care|primary health care
5121737|NCT01124968|Patient Satisfaction|patient satisfaction
5121738|NCT01124968|Job Satisfaction|job satisfaction
5121739|NCT01124968|Health Services Research|health services research
5121740|NCT01124955|treatment|treatment
5121741|NCT01124955|acupuncture|acupuncture
5121742|NCT01124955|spine|spine
5121743|NCT01124929|Intestinal tuberculosis|intestinal tuberculosis
5121744|NCT01124929|Tuberculous peritonitis|tuberculous peritonitis
5121745|NCT01124929|Abdominal tuberculosis|abdominal tuberculosis
5121746|NCT01124916|incontinence|incontinence
5121747|NCT01124916|prolapse|prolapse
5121748|NCT01124916|Abdominal sacrocolpopexy|abdominal sacrocolpopexy
5121749|NCT01124903|dehydration|dehydration
5121750|NCT01124903|hypohydration|hypohydration
5121751|NCT01124903|diagnostic accuracy|diagnostic accuracy
5121752|NCT01124903|biological variation|biological variation
5121753|NCT01124903|hydration assessment|hydration assessment
5121754|NCT01124903|body mass|body mass
5121755|NCT01124903|osmolality|osmolality
5121756|NCT01124903|plasma|plasma
5121757|NCT01124903|saliva|saliva
5121758|NCT01124903|urine|urine
5121759|NCT01124890|acute myocardial infarction|acute myocardial infarction
5121760|NCT01124890|thrombolysis|thrombolysis
5121761|NCT01124890|percutaneous coronary interention|percutaneous coronary interention
5121762|NCT01124877|Children and Adolescents with Bipolar I Disorder (manic or mixed)|children and adolescents with bipolar i disorder (manic or mixed)
5121763|NCT01124864|Non-small-cell lung cancer|non-small-cell lung cancer
5121764|NCT01124864|HSP90|hsp90
5121765|NCT01124864|2nd to 3rd line treatment|2nd to 3rd line treatment
5121766|NCT01124851|Sleep disorder|sleep disorder
5121767|NCT01124838|Uveitis|uveitis
5121768|NCT01124825|Anesthesia induction and maintenance|anesthesia induction and maintenance
5121769|NCT01124825|Surgery|surgery
5121770|NCT01124812|I131|i131
5121771|NCT01124812|L19|l19
5121772|NCT01124812|antibody|antibody
5121773|NCT01124812|monoclonal|monoclonal
5121774|NCT01124812|NSCLC|nsclc
5121775|NCT01124812|lung|lung
5121776|NCT01124812|tumor targeting|tumor targeting
5121777|NCT01124812|radioimmunotherapy|radioimmunotherapy
5121873|NCT01124500|10-020|10-020
5121874|NCT01124487|fat|fat
5121778|NCT01124812|Patients with newly diagnosed inoperable, locally-advanced (stage III) NSCLC|patients with newly diagnosed inoperable, locally-advanced (stage iii) nsclc
5121779|NCT01124799|Hepatitis C virus|hepatitis c virus
5121780|NCT01124799|TMC435-TiDP16-C125|tmc435-tidp16-c125
5121781|NCT01124799|TMC435-C125|tmc435-c125
5121782|NCT01124799|TMC435|tmc435
5121783|NCT01124799|TMC435350|tmc435350
5121784|NCT01124799|protease inhibitor|protease inhibitor
5121785|NCT01124799|HCV|hcv
5121786|NCT01124799|Hepatitis C|hepatitis c
5121787|NCT01124799|photosensitivity|photosensitivity
5121788|NCT01124799|phototoxicity|phototoxicity
5121789|NCT01124786|cancer|cancer
5121790|NCT01124786|metastatic|metastatic
5121791|NCT01124786|pancreatic|pancreatic
5121792|NCT01124786|pancreas|pancreas
5121793|NCT01124786|adenocarcinoma|adenocarcinoma
5121794|NCT01124786|gemcitabine|gemcitabine
5121795|NCT01124786|human equilibrative nucleoside transporter-1 (hENT1)|human equilibrative nucleoside transporter-1 (hent1)
5121796|NCT01124786|CO-1.01|co-1.01
5121797|NCT01124786|CO-101|co-101
5121798|NCT01124786|CO101|co101
5121799|NCT01124786|Stage 4|stage 4
5121800|NCT01124786|Stage IV|stage iv
5121801|NCT01124773|cognition|cognition
5121802|NCT01124773|memory|memory
5121803|NCT01124773|hormone therapy|hormone therapy
5121804|NCT01124760|open label|open label
5121805|NCT01124760|2-consecutive-group|2-consecutive-group
5121806|NCT01124760|2-period|2-period
5121807|NCT01124760|1-sequence crossover study|1-sequence crossover study
5121808|NCT01124747|ASP1585|asp1585
5121809|NCT01124747|Healthy Volunteers|healthy volunteers
5121810|NCT01124734|metastatic melanoma|metastatic melanoma
5121811|NCT01124721|Cognitive training|cognitive training
5121812|NCT01124708|ADHD|adhd
5121813|NCT01124708|Attention Deficit Hyperactive Disorder|attention deficit hyperactive disorder
5121814|NCT01124695|estrogen receptor-positive breast cancer|estrogen receptor-positive breast cancer
5121815|NCT01124695|male breast cancer|male breast cancer
5121816|NCT01124695|progesterone receptor-positive breast cancer|progesterone receptor-positive breast cancer
5121817|NCT01124695|recurrent breast cancer|recurrent breast cancer
5121818|NCT01124695|stage IV breast cancer|stage iv breast cancer
5121819|NCT01124682|adenocarcinoma of the bladder|adenocarcinoma of the bladder
5121820|NCT01124682|squamous cell carcinoma of the bladder|squamous cell carcinoma of the bladder
5121821|NCT01124682|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
5121822|NCT01124682|recurrent bladder cancer|recurrent bladder cancer
5121823|NCT01124682|stage II bladder cancer|stage ii bladder cancer
5121824|NCT01124682|stage III bladder cancer|stage iii bladder cancer
5121825|NCT01124682|stage IV bladder cancer|stage iv bladder cancer
5121826|NCT01124669|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5121827|NCT01124669|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5121828|NCT01124669|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5121829|NCT01124656|angiotensin II receptor blocker|angiotensin ii receptor blocker
5121830|NCT01124656|thiazolidinediones|thiazolidinediones
5121831|NCT01124656|combination|combination
5121832|NCT01124656|Actos|actos
5121833|NCT01124656|HbA1c|hba1c
5121834|NCT01124656|Type 2 diabetes|type 2 diabetes
5121835|NCT01124656|Drug Therapy|drug therapy
5121836|NCT01124656|Hypertension|hypertension
5121837|NCT01124643|Replagal|replagal
5121838|NCT01124643|Agalsidase alfa|agalsidase alfa
5121839|NCT01124643|Alpha-Galactosidase|alpha-galactosidase
5121840|NCT01124643|Enzyme Replacement Therapy|enzyme replacement therapy
5121841|NCT01124617|Chronic pain|chronic pain
5121842|NCT01124617|Diabetic Neuropathic Pain|diabetic neuropathic pain
5121843|NCT01124617|Neuralgia, Postherpetic|neuralgia, postherpetic
5121844|NCT01124617|Tapentadol hydrochloride extended-release|tapentadol hydrochloride extended-release
5121845|NCT01124617|JNS024ER|jns024er
5121846|NCT01124617|Placebo|placebo
5121847|NCT01124604|Pain|pain
5121848|NCT01124604|Low Back Pain|low back pain
5121849|NCT01124604|Back Pain|back pain
5121850|NCT01124604|Osteoarthritis, Knee|osteoarthritis, knee
5121851|NCT01124604|Tapentadol|tapentadol
5121852|NCT01124604|Tapentadol Hydrochloride Extended Release|tapentadol hydrochloride extended release
5121853|NCT01124578|Ventilators, Mechanical|ventilators, mechanical
5121854|NCT01124565|Lateral Canthal Lines|lateral canthal lines
5121855|NCT01124565|Crow's Feet|crow's feet
5121856|NCT01124565|Facial Wrinkles|facial wrinkles
5121857|NCT01124552|Lateral Canthal Lines|lateral canthal lines
5121858|NCT01124552|Crow's Feet Wrinkles|crow's feet wrinkles
5121859|NCT01124552|Facial Wrinkles|facial wrinkles
5121860|NCT01124539|Adult Patients|adult patients
5121861|NCT01124539|Recurrence of Glioblastoma Multiforme|recurrence of glioblastoma multiforme
5121862|NCT01124539|Recurrence of GBM|recurrence of gbm
5121863|NCT01124539|Gliosarcoma|gliosarcoma
5121864|NCT01124526|R F C treatment in patients with Non Hodgkin Lymphoma|r f c treatment in patients with non hodgkin lymphoma
5121865|NCT01124513|Melanin Index|melanin index
5121866|NCT01124513|Fitzpatrick Skin Phototype|fitzpatrick skin phototype
5121867|NCT01124513|Videodermoscopy|videodermoscopy
5121868|NCT01124513|Spectrophotometry|spectrophotometry
5121869|NCT01124500|methylphenidate|methylphenidate
5121870|NCT01124500|transdermal patch|transdermal patch
5121871|NCT01124500|placebo|placebo
5121872|NCT01124500|fatigue|fatigue
5121875|NCT01124487|inflammation|inflammation
5121876|NCT01124487|lipids|lipids
5121877|NCT01124487|total cholesterol|total cholesterol
5121878|NCT01124487|Triglycerides|triglycerides
5121879|NCT01124487|insulin sensitivity|insulin sensitivity
5121880|NCT01124461|Malignant Brain Tumors|malignant brain tumors
5121881|NCT01124461|Cancer of the Brain|cancer of the brain
5121882|NCT01124435|Carboplatin plus Celecoxib|carboplatin plus celecoxib
5121883|NCT01124435|Pre-treated Recurrent Ovarian Cancer Patients|pre-treated recurrent ovarian cancer patients
5121884|NCT01124435|The antitumor activity and potential adverse effects|the antitumor activity and potential adverse effects
5121885|NCT01124435|tumor response rate|tumor response rate
5121886|NCT01124435|toxicity|toxicity
5121887|NCT01124435|progression free survival|progression free survival
5121888|NCT01124435|duration of response|duration of response
5121889|NCT01124435|quality of life|quality of life
5121890|NCT01124422|endurance shuttle walk test|endurance shuttle walk test
5121891|NCT01124422|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
5121892|NCT01124422|fluticasone propionate|fluticasone propionate
5121893|NCT01124422|dyspnea|dyspnea
5121894|NCT01124422|exercise endurance time|exercise endurance time
5121895|NCT01124422|tiotropium|tiotropium
5121896|NCT01124422|salmeterol|salmeterol
5121897|NCT01124422|exercise inspiratory capacity|exercise inspiratory capacity
5121898|NCT01124422|quality of life|quality of life
5121899|NCT01124409|IGRT|igrt
5121900|NCT01124409|3DCRT|3dcrt
5121901|NCT01124409|EPID|epid
5121902|NCT01124409|CBCT|cbct
5121903|NCT01124409|HNSCC|hnscc
5121904|NCT01124383|Glycine absorption|glycine absorption
5121905|NCT01124383|Operative hysteroscopy|operative hysteroscopy
5121906|NCT01124383|Endometrial resection|endometrial resection
5121907|NCT01124383|General anesthesia|general anesthesia
5121908|NCT01124383|Local anesthesia|local anesthesia
5121909|NCT01124370|Sleep Disordered Breathing|sleep disordered breathing
5121910|NCT01124370|Cheyne Stokes Respiration|cheyne stokes respiration
5121911|NCT01124370|Periodic Breathing|periodic breathing
5121912|NCT01124370|Sleep Apnea|sleep apnea
5121913|NCT01124370|Central Sleep Apnea|central sleep apnea
5121914|NCT01124357|Heavy menstrual bleeding|heavy menstrual bleeding
5121915|NCT01124357|menorrhagia|menorrhagia
5121916|NCT01124357|ThermachoiceTM|thermachoicetm
5121917|NCT01124357|NovaSureTM|novasuretm
5121918|NCT01124357|Endometrail Ablation|endometrail ablation
5121919|NCT01124331|prospective meta-analysis|prospective meta-analysis
5121920|NCT01124331|preterm infant|preterm infant
5121921|NCT01124331|pulse oximetry|pulse oximetry
5121922|NCT01124331|oxygen saturation|oxygen saturation
5121923|NCT01124318|Lactofiltrum|lactofiltrum
5121924|NCT01124318|atopic dermatitis|atopic dermatitis
5121925|NCT01124318|itching|itching
5121926|NCT01124318|Dermatological Index of Life Quality|dermatological index of life quality
5121927|NCT01124318|SCORAD|scorad
5121928|NCT01124318|Behavioral Rating Scores|behavioral rating scores
5121929|NCT01124305|Total Knee Arthroplasty|total knee arthroplasty
5121930|NCT01124305|Instrumentation|instrumentation
5121931|NCT01124292|Disability|disability
5121932|NCT01124292|Quadriplegia|quadriplegia
5121933|NCT01124292|Paralysis|paralysis
5121934|NCT01124292|Assistive technology|assistive technology
5121935|NCT01124292|Quality of life|quality of life
5121936|NCT01124292|Computer access|computer access
5121937|NCT01124292|Wheeled mobility|wheeled mobility
5121938|NCT01124279|Amgen|amgen
5121939|NCT01124279|Healthy|healthy
5121940|NCT01124279|Adult|adult
5121941|NCT01124266|polyp|polyp
5121942|NCT01124266|adenoma|adenoma
5121943|NCT01124266|screening|screening
5121944|NCT01124266|colonoscopy|colonoscopy
5121945|NCT01124266|diagnosis|diagnosis
5121946|NCT01124253|adjuvant therapy|adjuvant therapy
5121947|NCT01124253|non-small cell lung cancer|non-small cell lung cancer
5121948|NCT01124253|vinorelbine|vinorelbine
5121949|NCT01124253|cisplatin|cisplatin
5121950|NCT01124253|recombinant human endostatin|recombinant human endostatin
5121951|NCT01124253|endostar|endostar
5121952|NCT01124240|Glioblastoma Multiforme|glioblastoma multiforme
5121953|NCT01124227|Congestive Heart Failure|congestive heart failure
5121954|NCT01124227|Peritoneal Dialysis|peritoneal dialysis
5121955|NCT01124227|Symptomatic improvement|symptomatic improvement
5121956|NCT01124227|Renal function|renal function
5121957|NCT01124214|Barrett's|barrett's
5121958|NCT01124214|BE|be
5121959|NCT01124214|esophageal cancer|esophageal cancer
5121960|NCT01124214|esophageal dysplasia|esophageal dysplasia
5121961|NCT01124201|low back pain|low back pain
5121962|NCT01124201|clinical trial|clinical trial
5121963|NCT01124201|stabilization|stabilization
5121964|NCT01124201|muscle stretching exercises|muscle stretching exercises
5121965|NCT01124201|exercise therapy|exercise therapy
5121966|NCT01124188|Geriatric psychiatry|geriatric psychiatry
5121967|NCT01124188|Aged|aged
5121968|NCT01124188|Elderly|elderly
5121969|NCT01124188|Venlafaxine|venlafaxine
5121970|NCT01124188|Self efficacy|self efficacy
5121971|NCT01124188|Pain|pain
5121972|NCT01124188|Psychotherapy|psychotherapy
5121973|NCT01124188|Effexor|effexor
5121974|NCT01124175|Bioequivalence|bioequivalence
5121975|NCT01124175|Healthy Subjects|healthy subjects
5121976|NCT01124162|Bioequivalence|bioequivalence
5121977|NCT01124162|Healthy Subjects|healthy subjects
5121978|NCT01124136|Chronic Heart Failure|chronic heart failure
5121979|NCT01124136|Neurostimulation|neurostimulation
5121980|NCT01124123|Pharmacokinetics|pharmacokinetics
5121981|NCT01124123|Oral bioavailability|oral bioavailability
5121982|NCT01124123|absorption|absorption
5121983|NCT01124123|AUC|auc
5121984|NCT01124123|Bioequivalence|bioequivalence
5121985|NCT01124123|Bioavailability study|bioavailability study
5121986|NCT01124110|Operating Engineers|operating engineers
5121987|NCT01124110|Smoking Cessation|smoking cessation
5121988|NCT01124097|post herpetic neuralgia|post herpetic neuralgia
5121989|NCT01124071|Korean Diet|korean diet
5121990|NCT01124058|restarting warfarin|restarting warfarin
5121991|NCT01124058|time to therapeutic INR|time to therapeutic inr
5121992|NCT01124045|Pediatric|pediatric
5121993|NCT01124045|Cataracts|cataracts
5121994|NCT01124045|Inflammation|inflammation
5121995|NCT01124045|Durezol|durezol
5121996|NCT01124045|Pred Forte|pred forte
5121997|NCT01124045|Difluprednate|difluprednate
5121998|NCT01124045|Prednisolone|prednisolone
5121999|NCT01124019|Women undergoing screening mammography will be chosen if they are between the ages of 40 and 65.|women undergoing screening mammography will be chosen if they are between the ages of 40 and 65.
5122000|NCT01123993|Thai traditional music|thai traditional music
5122001|NCT01123993|dementia|dementia
5122002|NCT01123993|Cognitive function|cognitive function
5122003|NCT01123993|behavioural problem|behavioural problem
5122004|NCT01123993|sleep quality|sleep quality
5122005|NCT01123993|psychological health|psychological health
5122006|NCT01123993|quality of sleep|quality of sleep
5122007|NCT01123967|nicotine replacement therapy|nicotine replacement therapy
5122008|NCT01123967|smoking cessation|smoking cessation
5122009|NCT01123967|tobacco dependent|tobacco dependent
5122010|NCT01123954|Seasonal influenza|seasonal influenza
5122011|NCT01123954|Vaccine|vaccine
5122012|NCT01123941|Typhoid fever|typhoid fever
5122013|NCT01123941|Glycoconjugate vaccine|glycoconjugate vaccine
5122014|NCT01123941|Carrier protein|carrier protein
5122015|NCT01123941|Immunogenicity|immunogenicity
5122016|NCT01123928|cataract|cataract
5122017|NCT01123928|counseling|counseling
5122018|NCT01123928|surgical uptake|surgical uptake
5122019|NCT01123928|follow-up|follow-up
5122020|NCT01123915|HIV|hiv
5122021|NCT01123915|Therapeutic|therapeutic
5122022|NCT01123915|Immunotherapy|immunotherapy
5122023|NCT01123915|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5122024|NCT01123915|Virus Diseases|virus diseases
5122025|NCT01123915|Lentivirus Infections|lentivirus infections
5122026|NCT01123915|Human Immunodeficiency Virus|human immunodeficiency virus
5122027|NCT01123902|Breathlessness|breathlessness
5122028|NCT01123902|Dyspnea|dyspnea
5122029|NCT01123902|Hand-held fan|hand-held fan
5122030|NCT01123902|Palliative Care|palliative care
5122031|NCT01123889|subacromial impingement|subacromial impingement
5122032|NCT01123889|partial thickness rotator cuff|partial thickness rotator cuff
5122033|NCT01123889|PRP|prp
5122034|NCT01123889|platelet rich plasma|platelet rich plasma
5122035|NCT01123876|Gastric Cancer|gastric cancer
5122036|NCT01123863|Neuro cognitive deficits;|neuro cognitive deficits;
5122037|NCT01123863|Brigance pre-school screen;|brigance pre-school screen;
5122038|NCT01123850|CopiOs|copios
5122039|NCT01123850|Degenerative spondylolisthesis,|degenerative spondylolisthesis,
5122040|NCT01123850|stenosis with instability, or|stenosis with instability, or
5122041|NCT01123850|degenerative disc disease as diagnosed by radicular signs and/or imaging studies|degenerative disc disease as diagnosed by radicular signs and/or imaging studies
5122042|NCT01123824|healthy subjects|healthy subjects
5122043|NCT01123811|adenocarcinoma|adenocarcinoma
5122044|NCT01123811|gastric cancer|gastric cancer
5122045|NCT01123811|esophagogastric junction cancer|esophagogastric junction cancer
5122046|NCT01123798|near infrared spectroscopy|near infrared spectroscopy
5122047|NCT01123798|lower extremity injury|lower extremity injury
5122048|NCT01123785|glaucoma|glaucoma
5122049|NCT01123785|ocular hypertension|ocular hypertension
5122050|NCT01123785|adenosine agonist|adenosine agonist
5122051|NCT01123785|eye drop|eye drop
5122052|NCT01123785|primary open angle glaucoma|primary open angle glaucoma
5122053|NCT01123772|adenosine agonist|adenosine agonist
5122054|NCT01123772|eye drop|eye drop
5122055|NCT01123772|elderly volunteer|elderly volunteer
5122056|NCT01123772|older healthy volunteer|older healthy volunteer
5122057|NCT01123759|Fish|fish
5122058|NCT01123759|mercury|mercury
5122059|NCT01123759|omega-3 fatty acids|omega-3 fatty acids
5122060|NCT01123759|infant|infant
5122061|NCT01123759|brain development|brain development
5122062|NCT01123759|pregnancy|pregnancy
5122063|NCT01123759|nursing mother|nursing mother
5122064|NCT01123759|dietary recommendations|dietary recommendations
5122065|NCT01123759|Hair mercury|hair mercury
5122066|NCT01123759|Blood mercury|blood mercury
5122067|NCT01123759|Recommendations for pregnant or nursing women|recommendations for pregnant or nursing women
5122068|NCT01123759|Infant brain health|infant brain health
5122069|NCT01123746|Seizure|seizure
5122070|NCT01123746|electrolyte|electrolyte
5122071|NCT01123746|risk factor|risk factor
5122072|NCT01123733|Baby-friendly hospitals|baby-friendly hospitals
5122073|NCT01123733|Non baby-friendly hospitals|non baby-friendly hospitals
5122074|NCT01123733|Breastfeeding|breastfeeding
5122075|NCT01123733|Ten steps for successful breastfeeding|ten steps for successful breastfeeding
5122076|NCT01123707|Major Depressive Disorder|major depressive disorder
5122077|NCT01123707|MDD|mdd
5122078|NCT01123707|Depression|depression
5122079|NCT01123694|xeroderma pigmentosum|xeroderma pigmentosum
5122080|NCT01123694|quality of life|quality of life
5122081|NCT01123694|DLQI|dlqi
5122082|NCT01123694|CDLQI|cdlqi
5122083|NCT01123681|Respiration, Artificial|respiration, artificial
5122084|NCT01123681|Pneumonia, Ventilator-Associated|pneumonia, ventilator-associated
5122085|NCT01123681|Critical Illness|critical illness
5122086|NCT01123668|Smoking|smoking
5122087|NCT01123668|ADHD|adhd
5122088|NCT01123668|Nicotine|nicotine
5122089|NCT01123668|Methylphenidate|methylphenidate
5122090|NCT01123668|function Magnetic Resonance Imaging|function magnetic resonance imaging
5122216|NCT01123161|Vascular Diseases|vascular diseases
5122091|NCT01123668|Neurobiological basis of abstinence-induced deficits in response inhibition|neurobiological basis of abstinence-induced deficits in response inhibition
5122092|NCT01123642|post-traumatic stress disorder|post-traumatic stress disorder
5122093|NCT01123642|depressive disorder|depressive disorder
5122094|NCT01123642|alcoholism|alcoholism
5122095|NCT01123642|Longitudinal studies|longitudinal studies
5122096|NCT01123642|readjustment|readjustment
5122097|NCT01123616|surgical site infection|surgical site infection
5122098|NCT01123616|elective colorectal surgery|elective colorectal surgery
5122099|NCT01123616|level of surgical site infection|level of surgical site infection
5122100|NCT01123616|complication of surgical site infection|complication of surgical site infection
5122101|NCT01123616|type of changed bandage|type of changed bandage
5122102|NCT01123616|frequency of bandage changing|frequency of bandage changing
5122103|NCT01123603|frequency|frequency
5122104|NCT01123603|women|women
5122105|NCT01123603|fibroids|fibroids
5122106|NCT01123603|uterine artery embolization|uterine artery embolization
5122107|NCT01123603|myomectomy|myomectomy
5122108|NCT01123603|hysterectomy|hysterectomy
5122109|NCT01123590|Thymoma|thymoma
5122110|NCT01123590|Autoimmune diseases|autoimmune diseases
5122111|NCT01123590|Immunodeficiency|immunodeficiency
5122112|NCT01123577|Self Blood Pressure Monitoring|self blood pressure monitoring
5122113|NCT01123577|SBPM|sbpm
5122114|NCT01123577|Randomized Control Trial|randomized control trial
5122115|NCT01123577|Hypertension (HTN)|hypertension (htn)
5122116|NCT01123577|Cardiovascular Disease (CVD)|cardiovascular disease (cvd)
5122117|NCT01123577|HTN|htn
5122118|NCT01123577|CVD|cvd
5122119|NCT01123564|macular edema secondary to retinal vein occlusion|macular edema secondary to retinal vein occlusion
5122120|NCT01123551|Nebulized morphine|nebulized morphine
5122121|NCT01123551|Intravenous morphine|intravenous morphine
5122122|NCT01123551|Post traumatic|post traumatic
5122123|NCT01123551|Pain|pain
5122124|NCT01123551|Emergency department|emergency department
5122125|NCT01123512|Vertebral Compression Fracture|vertebral compression fracture
5122126|NCT01123512|Kyphoplasty|kyphoplasty
5122127|NCT01123512|Spine|spine
5122128|NCT01123512|Vertebral Body Compression Fracture|vertebral body compression fracture
5122129|NCT01123512|Back Pain|back pain
5122130|NCT01123499|G-CSF|g-csf
5122131|NCT01123499|Plerixafor|plerixafor
5122132|NCT01123499|Normal Volunteer|normal volunteer
5122133|NCT01123499|Apheresis|apheresis
5122134|NCT01123499|Healthy Volunteer|healthy volunteer
5122135|NCT01123499|HV|hv
5122136|NCT01123486|Intravenous opioids|intravenous opioids
5122137|NCT01123486|Patient Controlled Analgesia|patient controlled analgesia
5122138|NCT01123486|volunteer pharmacokinetic-pharmacodynamic study|volunteer pharmacokinetic-pharmacodynamic study
5122139|NCT01123473|adenocarcinoma of the gastroesophageal junction|adenocarcinoma of the gastroesophageal junction
5122140|NCT01123473|adenocarcinoma of the stomach|adenocarcinoma of the stomach
5122141|NCT01123473|stage IIIA gastric cancer|stage iiia gastric cancer
5122142|NCT01123473|stage IIIB gastric cancer|stage iiib gastric cancer
5122143|NCT01123473|stage IIIC gastric cancer|stage iiic gastric cancer
5122144|NCT01123473|stage IV gastric cancer|stage iv gastric cancer
5122145|NCT01123460|non-small cell lung cancer|non-small cell lung cancer
5122146|NCT01123434|prostate cancer|prostate cancer
5122147|NCT01123434|adjuvant|adjuvant
5122148|NCT01123434|hormonal|hormonal
5122149|NCT01123421|osteoporosis|osteoporosis
5122150|NCT01123421|fracture risk|fracture risk
5122151|NCT01123421|aging|aging
5122152|NCT01123421|tibia|tibia
5122153|NCT01123421|sonometer|sonometer
5122154|NCT01123421|ultrasound|ultrasound
5122155|NCT01123421|BMD|bmd
5122156|NCT01123421|bone mineral density|bone mineral density
5122157|NCT01123421|DXA|dxa
5122158|NCT01123421|3D-HRpQT|3d-hrpqt
5122159|NCT01123421|waveform profiles|waveform profiles
5122160|NCT01123408|schizophrenia|schizophrenia
5122161|NCT01123408|aggression|aggression
5122162|NCT01123408|clozapine|clozapine
5122163|NCT01123408|olanzapine|olanzapine
5122164|NCT01123395|bioavailability|bioavailability
5122165|NCT01123382|Stroke|stroke
5122166|NCT01123382|Shoulder pain|shoulder pain
5122167|NCT01123382|Electrical stimulation|electrical stimulation
5122168|NCT01123382|Neuromuscular stimulation|neuromuscular stimulation
5122169|NCT01123382|Intramuscular stimulation|intramuscular stimulation
5122170|NCT01123369|Sickle Cell Disease|sickle cell disease
5122171|NCT01123356|Relapsed chronic lymphocytic leukemia|relapsed chronic lymphocytic leukemia
5122172|NCT01123343|limbal relaxing incision|limbal relaxing incision
5122173|NCT01123343|LRI|lri
5122174|NCT01123343|capsulorhexis|capsulorhexis
5122175|NCT01123343|surgical guidance|surgical guidance
5122176|NCT01123343|3d visualization|3d visualization
5122177|NCT01123317|Schizophrenia|schizophrenia
5122178|NCT01123317|PET|pet
5122179|NCT01123317|Oxytocin|oxytocin
5122180|NCT01123304|melanoma|melanoma
5122181|NCT01123291|follow-up coronary angiography|follow-up coronary angiography
5122182|NCT01123278|Adiponectin|adiponectin
5122183|NCT01123278|Resistin|resistin
5122184|NCT01123278|Adipocytes|adipocytes
5122185|NCT01123278|Testosterone|testosterone
5122186|NCT01123278|Aging|aging
5122187|NCT01123278|HOMA-IR|homa-ir
5122188|NCT01123278|Insulin|insulin
5122189|NCT01123278|Hypogonadism|hypogonadism
5122190|NCT01123278|Metabolic Syndrome|metabolic syndrome
5122191|NCT01123278|Obesity|obesity
5122192|NCT01123278|Erectile Dysfunction|erectile dysfunction
5122193|NCT01123265|PsA|psa
5122194|NCT01123265|methotrexate|methotrexate
5122195|NCT01123265|Anti-TNF|anti-tnf
5122196|NCT01123265|TNF|tnf
5122197|NCT01123265|DC-Stamp|dc-stamp
5122198|NCT01123252|Lactobacillus casei|lactobacillus casei
5122199|NCT01123239|Healthcare Disparities|healthcare disparities
5122200|NCT01123213|pelvic organ prolapse|pelvic organ prolapse
5122201|NCT01123213|pessary fitting|pessary fitting
5122202|NCT01123187|diabetes type 1|diabetes type 1
5122203|NCT01123187|kidney transplantation|kidney transplantation
5122204|NCT01123187|islet|islet
5122205|NCT01123187|hypoglycemia|hypoglycemia
5122206|NCT01123174|Suicide|suicide
5122207|NCT01123174|case management algorithm|case management algorithm
5122208|NCT01123174|suicidal behaviors|suicidal behaviors
5122209|NCT01123174|prevention of suicide|prevention of suicide
5122210|NCT01123161|Hypothermia|hypothermia
5122211|NCT01123161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
5122212|NCT01123161|Cerebral Infarction|cerebral infarction
5122213|NCT01123161|Hematologic Agents|hematologic agents
5122214|NCT01123161|Stroke|stroke
5122215|NCT01123161|Nervous System Diseases|nervous system diseases
5122217|NCT01123161|Tissue Plasminogen Activator|tissue plasminogen activator
5122218|NCT01123161|Central Nervous System Diseases|central nervous system diseases
5122219|NCT01123161|Fibrinolytic Agents|fibrinolytic agents
5122220|NCT01123161|Cardiovascular Agents|cardiovascular agents
5122221|NCT01123161|Body Temperature Changes|body temperature changes
5122222|NCT01123161|Brain Diseases|brain diseases
5122223|NCT01123161|Cerebrovascular Disorders|cerebrovascular disorders
5122224|NCT01123161|Pharmacologic Actions|pharmacologic actions
5122225|NCT01123161|Signs and Symptoms|signs and symptoms
5122226|NCT01123161|Fibrin Modulating Agents|fibrin modulating agents
5122227|NCT01123161|Therapeutic Uses|therapeutic uses
5122228|NCT01123161|Brain Ischemia|brain ischemia
5122229|NCT01123161|Cardiovascular Diseases|cardiovascular diseases
5122230|NCT01123161|Brain Infarction|brain infarction
5122231|NCT01123161|Plasminogen|plasminogen
5122232|NCT01123161|cooling|cooling
5122234|NCT01123161|thrombolysis|thrombolysis
5122235|NCT01123148|Brain computer interface|brain computer interface
5122236|NCT01123148|wheelchair control|wheelchair control
5122237|NCT01123135|urodynamic stress incontinence|urodynamic stress incontinence
5122238|NCT01123135|postmenopausal women|postmenopausal women
5122239|NCT01123109|nulliparous women|nulliparous women
5122240|NCT01123096|Stress urinary incontinence|stress urinary incontinence
5122241|NCT01123083|new onset type 1 diabetes|new onset type 1 diabetes
5122242|NCT01123083|juvenile diabetes|juvenile diabetes
5122243|NCT01123083|T1DM|t1dm
5122244|NCT01123083|Type 1 diabetes|type 1 diabetes
5122245|NCT01123057|keratoconus|keratoconus
5122246|NCT01123057|collagen cross-linking|collagen cross-linking
5122247|NCT01123057|LASIK ectasia|lasik ectasia
5122248|NCT01123057|keratoconus,lasik ectasia|keratoconus,lasik ectasia
5122249|NCT01123018|Memory Loss|memory loss
5122250|NCT01122992|Limbal relaxing incision|limbal relaxing incision
5122251|NCT01122992|Astigmatic correction|astigmatic correction
5122252|NCT01122992|Phacoemulsification surgery|phacoemulsification surgery
5122253|NCT01122992|Chinese eyes|chinese eyes
5122254|NCT01122966|trabeculectomy|trabeculectomy
5122255|NCT01122953|Bioequivalence|bioequivalence
5122256|NCT01122953|EPAMIN|epamin
5122257|NCT01122953|PHENYTOIN|phenytoin
5122258|NCT01122940|Bioequivalence|bioequivalence
5122259|NCT01122940|Phenytoin|phenytoin
5122260|NCT01122940|Epamin|epamin
5122261|NCT01122927|schizophrenia|schizophrenia
5122262|NCT01122927|adolescent|adolescent
5122263|NCT01122927|bipolar|bipolar
5122264|NCT01122914|Kineret|kineret
5122265|NCT01122914|Anakinra|anakinra
5122266|NCT01122914|Atopic Dermatitis|atopic dermatitis
5122267|NCT01122914|Eczema|eczema
5122268|NCT01122914|Allergic Disease|allergic disease
5122269|NCT01122862|tooth plaque|tooth plaque
5122270|NCT01122849|trouble with sleep|trouble with sleep
5122271|NCT01122849|night time nasal congestion|night time nasal congestion
5122272|NCT01122836|Massage|massage
5122273|NCT01122836|Chronic Neck Pain|chronic neck pain
5122274|NCT01122836|Dosing Study|dosing study
5122275|NCT01122823|Chronic Disease Self-Management Program (CDSMP)|chronic disease self-management program (cdsmp)
5122276|NCT01122810|Diagnostic accuracy of coronary angiography|diagnostic accuracy of coronary angiography
5122277|NCT01122810|Transplant heart patients|transplant heart patients
5122278|NCT01122810|X-Ray and contrast agent exposure|x-ray and contrast agent exposure
5122279|NCT01122810|Coronary stenosis|coronary stenosis
5122280|NCT01122797|PNPLA3|pnpla3
5122281|NCT01122797|fibrosis|fibrosis
5122282|NCT01122797|cirrhosis|cirrhosis
5122283|NCT01122797|alcoholic liver disease|alcoholic liver disease
5122284|NCT01122784|Plague|plague
5122285|NCT01122784|Vaccine|vaccine
5122286|NCT01122771|visceral leishmaniasis|visceral leishmaniasis
5122287|NCT01122771|phase III|phase iii
5122288|NCT01122771|randomised ccontrolled trial|randomised ccontrolled trial
5122289|NCT01122771|Bangladesh|bangladesh
5122290|NCT01122771|Combination treatment|combination treatment
5122291|NCT01122771|Ambisome|ambisome
5122292|NCT01122771|miltefosine|miltefosine
5122293|NCT01122771|paromomycin|paromomycin
5122294|NCT01122758|Cohort|cohort
5122295|NCT01122758|COPD|copd
5122296|NCT01122758|Natural history|natural history
5122297|NCT01122758|Phenotyping|phenotyping
5122298|NCT01122758|Smoking|smoking
5122299|NCT01122745|continuous block|continuous block
5122300|NCT01122745|single shot|single shot
5122301|NCT01122745|interscalene|interscalene
5122302|NCT01122745|rotator cuff surgery|rotator cuff surgery
5122303|NCT01122732|nerve block|nerve block
5122304|NCT01122732|continuous catheter|continuous catheter
5122305|NCT01122732|shoulder surgery|shoulder surgery
5122306|NCT01122732|pain control after total shoulder arthroplasty|pain control after total shoulder arthroplasty
5122307|NCT01122719|Optima|optima
5122308|NCT01122719|Tacrolimus|tacrolimus
5122309|NCT01122719|Drug eluting stent|drug eluting stent
5122310|NCT01122706|tai ji|tai ji
5122311|NCT01122706|psychosocial stress|psychosocial stress
5122312|NCT01122706|primary prevention|primary prevention
5122313|NCT01122706|Trier Social Stress Test|trier social stress test
5122314|NCT01122706|salivary cortisol|salivary cortisol
5122315|NCT01122706|salivary alpha amylase|salivary alpha amylase
5122316|NCT01122706|heart rate variability|heart rate variability
5122317|NCT01122706|stress management|stress management
5122318|NCT01122693|Regional Anesthesia|regional anesthesia
5122319|NCT01122693|Pain Medicine|pain medicine
5122320|NCT01122693|Ultrasound|ultrasound
5122321|NCT01122693|Nerve Blocks|nerve blocks
5122322|NCT01122667|Renal Insufficiency|renal insufficiency
5122323|NCT01122641|Insulin resistance|insulin resistance
5122324|NCT01122641|incretins|incretins
5122325|NCT01122641|DPP4 inhibitors|dpp4 inhibitors
5122326|NCT01122641|vildagliptin|vildagliptin
5122327|NCT01122641|microcirculation|microcirculation
5122328|NCT01122628|Distal Radial Fracture|distal radial fracture
5122329|NCT01122628|Volar Locking Plate|volar locking plate
5122330|NCT01122615|Kidney|kidney
5122331|NCT01122615|metastatic renal cell carcinoma|metastatic renal cell carcinoma
5122332|NCT01122615|RCC|rcc
5122333|NCT01122615|Sunitinib|sunitinib
5122334|NCT01122615|Sunitinib Malate|sunitinib malate
5122335|NCT01122615|Sutent|sutent
5122336|NCT01122615|Temsirolimus|temsirolimus
5122337|NCT01122615|Torisel|torisel
5122338|NCT01122602|Aspirin|aspirin
5122339|NCT01122589|Smoking Abstinence|smoking abstinence
5122340|NCT01122589|Smoking Cessation|smoking cessation
5122341|NCT01122576|Intra Ocular Lens|intra ocular lens
5122342|NCT01122576|Ocular surgery|ocular surgery
5122343|NCT01122576|Phacoemulsification|phacoemulsification
5122344|NCT01122563|OABSS|oabss
5122345|NCT01122563|IPSS|ipss
5122346|NCT01122563|PPBC|ppbc
5122347|NCT01122563|3-day micturition diary|3-day micturition diary
5122348|NCT01122563|Solifenacin|solifenacin
5122349|NCT01122550|OABSS|oabss
5122350|NCT01122550|IPSS|ipss
5122351|NCT01122550|PPBC|ppbc
5122352|NCT01122550|3-day micturition diary|3-day micturition diary
5122353|NCT01122537|Meningitis|meningitis
5122354|NCT01122537|infection|infection
5122355|NCT01122537|cerebrospinal fluid|cerebrospinal fluid
5122356|NCT01122537|procalcitonin|procalcitonin
5122357|NCT01122537|adenosine deaminase|adenosine deaminase
5122358|NCT01122524|Trisomy 21|trisomy 21
5122359|NCT01122472|lenalidomide (Revlimid)|lenalidomide (revlimid)
5122360|NCT01122472|diffuse large B-cell lymphoma|diffuse large b-cell lymphoma
5122361|NCT01122472|phase III study|phase iii study
5122362|NCT01122472|after R-CHOP|after r-chop
5122363|NCT01122472|Maintenance treatment|maintenance treatment
5122364|NCT01122472|Maintenance|maintenance
5122365|NCT01122459|Perioperative intravenous fluids|perioperative intravenous fluids
5122366|NCT01122446|Alum-GAD|alum-gad
5122367|NCT01122446|Type 1 diabetes|type 1 diabetes
5122368|NCT01122446|prevention|prevention
5122369|NCT01122446|immune tolerance|immune tolerance
5122370|NCT01122446|glucose tolerance|glucose tolerance
5122371|NCT01122446|glutamate decarboxylase autoantibodies|glutamate decarboxylase autoantibodies
5122372|NCT01122433|difficult airway|difficult airway
5122373|NCT01122433|indirect laryngoscopy|indirect laryngoscopy
5122374|NCT01122433|C-MAC video laryngoscope|c-mac video laryngoscope
5122375|NCT01122420|Obesity|obesity
5122376|NCT01122394|stroke|stroke
5122377|NCT01122394|recurrence|recurrence
5122378|NCT01122394|blood pressure|blood pressure
5122379|NCT01122394|prevention|prevention
5122380|NCT01122381|headache, migraine|headache, migraine
5122381|NCT01122381|depression|depression
5122382|NCT01122381|disability evaluation|disability evaluation
5122383|NCT01122381|weight gain|weight gain
5122384|NCT01122368|mycoses|mycoses
5122385|NCT01122368|Micafungin|micafungin
5122386|NCT01122368|intra-abdominal surgery|intra-abdominal surgery
5122387|NCT01122368|invasive fungal infection|invasive fungal infection
5122388|NCT01122368|intra-abdominal infection|intra-abdominal infection
5122389|NCT01122342|Testosterone|testosterone
5122390|NCT01122342|Vaginal administration|vaginal administration
5122391|NCT01122342|Aromatase inhibitors|aromatase inhibitors
5122392|NCT01122329|dementia|dementia
5122393|NCT01122316|Heart Failure|heart failure
5122394|NCT01122316|Diabetes|diabetes
5122395|NCT01122316|Metformin|metformin
5122396|NCT01122303|Autologous serum eye drops|autologous serum eye drops
5122397|NCT01122303|EGF|egf
5122398|NCT01122303|TGF-β1|tgf-β1
5122399|NCT01122303|TGF-β2|tgf-β2
5122400|NCT01122303|Fibronectin|fibronectin
5122401|NCT01122303|Stevens-Johnson syndrome|stevens-johnson syndrome
5122402|NCT01122303|Dry eye|dry eye
5122403|NCT01122290|Emotional eating|emotional eating
5122404|NCT01122290|Eating in the absence of hunger|eating in the absence of hunger
5122405|NCT01122290|emotion induction|emotion induction
5122406|NCT01122277|Volume therapy|volume therapy
5122407|NCT01122277|Fluid therapy|fluid therapy
5122408|NCT01122277|Patients in ICU|patients in icu
5122409|NCT01122264|Erectile Dysfunction|erectile dysfunction
5122410|NCT01122251|hypertension|hypertension
5122411|NCT01122251|lercanidipine|lercanidipine
5122412|NCT01122251|valsartan|valsartan
5122413|NCT01122238|Smoking|smoking
5122414|NCT01122238|Smoking Cessation|smoking cessation
5122415|NCT01122238|Motivation|motivation
5122416|NCT01122238|Nicotine Dependence|nicotine dependence
5122417|NCT01122225|septic shock|septic shock
5122418|NCT01122225|medical intensive care|medical intensive care
5122419|NCT01122212|intracerebral hemorrhage|intracerebral hemorrhage
5122420|NCT01122212|ct scans|ct scans
5122421|NCT01122212|protein s100|protein s100
5122422|NCT01122212|inpatient treatment|inpatient treatment
5122423|NCT01122186|Medication Adherence|medication adherence
5122424|NCT01122186|Methamphetamine Use|methamphetamine use
5122425|NCT01122186|Sexual Risk|sexual risk
5122426|NCT01122186|Poly-substance Use|poly-substance use
5122427|NCT01122186|HIV|hiv
5122428|NCT01122186|Treatment|treatment
5122429|NCT01122186|Motivational Interviewing|motivational interviewing
5122430|NCT01122186|Cognitive Behavioral Skills Training|cognitive behavioral skills training
5122431|NCT01122186|Men Who Have Sex With Men|men who have sex with men
5122432|NCT01122173|Atrial Fibrillation|atrial fibrillation
5122433|NCT01122173|Robotic Control|robotic control
5122434|NCT01122173|Remote Control|remote control
5122435|NCT01122160|anthocyanin|anthocyanin
5122436|NCT01122160|omeprazole|omeprazole
5122437|NCT01122160|Prilosec|prilosec
5122438|NCT01122160|gastric pH|gastric ph
5122439|NCT01122160|proton pump inhibitor|proton pump inhibitor
5122440|NCT01122160|PPI|ppi
5122441|NCT01122160|nutrition|nutrition
5122442|NCT01122147|Aphthous stomatitis; Herbal medicines; Matricaria Chamomilla|aphthous stomatitis; herbal medicines; matricaria chamomilla
5122443|NCT01122134|severe|severe
5122444|NCT01122134|malaria|malaria
5122445|NCT01122134|artesunate|artesunate
5122446|NCT01122134|intravenous|intravenous
5122447|NCT01122121|Drug Therapy|drug therapy
5122448|NCT01122121|Radiotherapy|radiotherapy
5122449|NCT01122108|Bile Acid Sequestrant|bile acid sequestrant
5122450|NCT01122108|Resin|resin
5122451|NCT01122108|Lipids|lipids
5122452|NCT01122108|Glucose|glucose
5122453|NCT01122108|Cholesterol|cholesterol
5122454|NCT01122108|Diabetes Mellitus|diabetes mellitus
5122455|NCT01122108|Bile Acid Sequestrant Acceptability Scale|bile acid sequestrant acceptability scale
5122456|NCT01122095|Psoriasis|psoriasis
5122457|NCT01122095|Cardiovascular risk|cardiovascular risk
5122458|NCT01122082|energy intake|energy intake
5122459|NCT01122082|energy expenditure|energy expenditure
5122460|NCT01122082|macronutrient selection|macronutrient selection
5122461|NCT01122056|Multiple Sclerosis|multiple sclerosis
5122462|NCT01122056|b1b-interferon|b1b-interferon
5122463|NCT01122056|Fatigue|fatigue
5122464|NCT01122056|Exercise|exercise
5122465|NCT01122043|Endoglide|endoglide
5122466|NCT01122043|Endothelial Keratoplasty|endothelial keratoplasty
5122467|NCT01122043|Donor Insertion|donor insertion
5122468|NCT01122043|DSAEK|dsaek
5122469|NCT01122043|Corneal Transplant|corneal transplant
5122470|NCT01122043|Patients with Bullous Keratopathy|patients with bullous keratopathy
5122471|NCT01122030|Chronic pain|chronic pain
5122472|NCT01122030|Opioid physical dependence|opioid physical dependence
5122473|NCT01121991|Infertility|infertility
5122474|NCT01121991|Ovarian Stimulation|ovarian stimulation
5122475|NCT01121991|Luveris|luveris
5122476|NCT01121991|Lutropin alpha|lutropin alpha
5123277|NCT01118559|Food effect|food effect
5122477|NCT01121991|Controlled ovarian stimulation|controlled ovarian stimulation
5122478|NCT01121991|Reproductive techniques, assisted|reproductive techniques, assisted
5122479|NCT01121978|macular tractional maculopathy|macular tractional maculopathy
5122480|NCT01121978|pathologic myopia|pathologic myopia
5122481|NCT01121965|macular hole|macular hole
5122482|NCT01121965|impending macular hole|impending macular hole
5122483|NCT01121965|stage 1 macular hole|stage 1 macular hole
5122484|NCT01121952|Ankle joint|ankle joint
5122485|NCT01121952|Talo-crural joint|talo-crural joint
5122486|NCT01121952|Vertical jump|vertical jump
5122487|NCT01121952|Chiropractic manipulation (HVLA)|chiropractic manipulation (hvla)
5122489|NCT01121952|Proprioception|proprioception
5122490|NCT01121952|Pain|pain
5122491|NCT01121939|advanced neuroendocrine|advanced neuroendocrine
5122492|NCT01121939|Gastrointestinal|gastrointestinal
5122493|NCT01121939|Bevacizumab|bevacizumab
5122494|NCT01121939|Avastin|avastin
5122495|NCT01121939|Pertuzumab|pertuzumab
5122496|NCT01121939|Omnitarg|omnitarg
5122497|NCT01121939|2C4|2c4
5122498|NCT01121939|Sandostatin|sandostatin
5122499|NCT01121939|Octreotide|octreotide
5122500|NCT01121926|Healthy subjects|healthy subjects
5122501|NCT01121926|Bioavailability|bioavailability
5122502|NCT01121926|Pharmacokinetics|pharmacokinetics
5122503|NCT01121926|Trazodone|trazodone
5122504|NCT01121926|Steady-state|steady-state
5122505|NCT01121913|Healthy subjects|healthy subjects
5122506|NCT01121900|Healthy subjects|healthy subjects
5122507|NCT01121887|smoking cessation|smoking cessation
5122508|NCT01121887|telephone counselling|telephone counselling
5122509|NCT01121887|motivational interviewing|motivational interviewing
5122510|NCT01121887|treatment integrity|treatment integrity
5122511|NCT01121887|Tobacco Smoking|tobacco smoking
5122512|NCT01121874|CMC arthritis|cmc arthritis
5122513|NCT01121874|thumb carpometacarpal arthritis|thumb carpometacarpal arthritis
5122514|NCT01121874|basal joint arthritis|basal joint arthritis
5122515|NCT01121874|thumb CMC arthritis|thumb cmc arthritis
5122516|NCT01121861|efficacy|efficacy
5122517|NCT01121861|safety|safety
5122518|NCT01121861|predictability|predictability
5122519|NCT01121861|stability|stability
5122520|NCT01121861|toric IOL|toric iol
5122521|NCT01121861|refractive astigmatism|refractive astigmatism
5122522|NCT01121861|phacoemulsification|phacoemulsification
5122523|NCT01121822|Influenza|influenza
5122524|NCT01121822|Influenza vaccine|influenza vaccine
5122525|NCT01121822|Influenza virus|influenza virus
5122526|NCT01121822|Intramuscular|intramuscular
5122527|NCT01121809|Raltegravir|raltegravir
5122528|NCT01121809|etravirine|etravirine
5122529|NCT01121809|pharmacokinetics|pharmacokinetics
5122530|NCT01121809|intracellular|intracellular
5122531|NCT01121757|relapsed|relapsed
5122532|NCT01121757|refractory|refractory
5122533|NCT01121757|lymphoma|lymphoma
5122534|NCT01121757|follicular|follicular
5122535|NCT01121757|marginal zone|marginal zone
5122536|NCT01121744|Coronary Artery Disease|coronary artery disease
5122537|NCT01121744|Drug Eluting Stents (DES)|drug eluting stents (des)
5122538|NCT01121744|Pharmacokinetic (PK)|pharmacokinetic (pk)
5122539|NCT01121731|Chronic Hepatitis C Viral Infection|chronic hepatitis c viral infection
5122540|NCT01121731|Interferon alfa-5|interferon alfa-5
5122541|NCT01121731|Interferon|interferon
5122542|NCT01121718|lymph node|lymph node
5122543|NCT01121705|genotype 3|genotype 3
5122544|NCT01121705|Combination treatment|combination treatment
5122545|NCT01121705|Short treatment|short treatment
5122546|NCT01121692|Couples|couples
5122547|NCT01121692|Alcohol use|alcohol use
5122548|NCT01121692|HIV risk|hiv risk
5122549|NCT01121692|Outreach|outreach
5122550|NCT01121679|Older patients|older patients
5122551|NCT01121679|Aged, 80 and Over|aged, 80 and over
5122552|NCT01121679|Cardiology|cardiology
5122553|NCT01121666|Assisted reproductive treatment|assisted reproductive treatment
5122554|NCT01121666|Superovulation|superovulation
5122555|NCT01121666|Follitropin alfa|follitropin alfa
5122556|NCT01121666|r-hFSH|r-hfsh
5122557|NCT01121666|AFOLIA|afolia
5122558|NCT01121653|Neuropathic pain, magnesium|neuropathic pain, magnesium
5122559|NCT01121640|Ovarian Cancer|ovarian cancer
5122560|NCT01121640|Screening|screening
5122561|NCT01121640|Biomarkers|biomarkers
5122562|NCT01121627|Computerized Cognitive training|computerized cognitive training
5122563|NCT01121627|Quality of life|quality of life
5122564|NCT01121627|Gait Function|gait function
5122565|NCT01121627|Executive Function|executive function
5122566|NCT01121614|Harmonic scalpel|harmonic scalpel
5122567|NCT01121614|ultrasonic scalpel|ultrasonic scalpel
5122568|NCT01121614|LOTUS|lotus
5122569|NCT01121614|LigaSure|ligasure
5122570|NCT01121614|vessel sealing|vessel sealing
5122571|NCT01121614|burst pressure|burst pressure
5122572|NCT01121614|collateral damage|collateral damage
5122573|NCT01121588|neoplasm malignant|neoplasm malignant
5122574|NCT01121588|lymphoma|lymphoma
5122575|NCT01121588|neuroblastoma|neuroblastoma
5122576|NCT01121588|Crizotinib|crizotinib
5122577|NCT01121588|anaplastic lymphoma kinase|anaplastic lymphoma kinase
5122578|NCT01121588|ALK|alk
5122675|NCT01121094|Liver, spleen , T2* , MRI, fetus|liver, spleen , t2* , mri, fetus
5123384|NCT01118130|genomics|genomics
5122579|NCT01121575|Phase 1 acquired resistance to erlotinib or gefitinib cMET inhibitor EGFR inhibitor panHER inhibitor combination trial Crizotinib|phase 1 acquired resistance to erlotinib or gefitinib cmet inhibitor egfr inhibitor panher inhibitor combination trial crizotinib
5122580|NCT01121562|Neuroendocrine tumors|neuroendocrine tumors
5122581|NCT01121549|Prospective|prospective
5122582|NCT01121549|non-comparative|non-comparative
5122583|NCT01121549|NIS|nis
5122584|NCT01121549|600|600
5122585|NCT01121549|postmenopausal|postmenopausal
5122586|NCT01121549|hormone-receptor|hormone-receptor
5122587|NCT01121549|positive|positive
5122588|NCT01121549|EBC|ebc
5122589|NCT01121549|tamoxifen|tamoxifen
5122590|NCT01121549|current medical practice.|current medical practice.
5122591|NCT01121536|Bipolar I Disorder|bipolar i disorder
5122592|NCT01121523|Prematurity|prematurity
5122593|NCT01121523|massage|massage
5122594|NCT01121523|stress|stress
5122595|NCT01121523|parenting|parenting
5122596|NCT01121523|infancy|infancy
5122597|NCT01121523|sleep|sleep
5122598|NCT01121523|intervention|intervention
5122599|NCT01121510|vascular closure device|vascular closure device
5122600|NCT01121497|Sedation|sedation
5122601|NCT01121497|Cognitive decline|cognitive decline
5122602|NCT01121497|Physostigmine|physostigmine
5122603|NCT01121497|Colonoscopy|colonoscopy
5122604|NCT01121471|diabetes|diabetes
5122605|NCT01121471|conjugated linoleic acid|conjugated linoleic acid
5122606|NCT01121458|pulmonary artery|pulmonary artery
5122607|NCT01121458|vascular resistance|vascular resistance
5122608|NCT01121445|Sleep apnea|sleep apnea
5122609|NCT01121445|CPAP|cpap
5122610|NCT01121445|Saline irrigation|saline irrigation
5122611|NCT01121419|Neuroblastoma|neuroblastoma
5122612|NCT01121419|IMP3|imp3
5122613|NCT01121419|Prognosis|prognosis
5122614|NCT01121380|Healthy|healthy
5122615|NCT01121380|Volunteers|volunteers
5122616|NCT01121367|emphysema; pulmonary fibrosis;chemokine;sputum|emphysema; pulmonary fibrosis;chemokine;sputum
5122617|NCT01121354|Cefazolin|cefazolin
5122618|NCT01121354|Caphalosporin|caphalosporin
5122619|NCT01121354|antibiotic|antibiotic
5122620|NCT01121354|gram positive|gram positive
5122621|NCT01121354|Infection control|infection control
5122622|NCT01121341|Endoscopic vein harvesting|endoscopic vein harvesting
5122623|NCT01121341|Saphenous vein|saphenous vein
5122624|NCT01121341|Conventional vein harvesting|conventional vein harvesting
5122625|NCT01121328|Preterm neonates.|preterm neonates.
5122626|NCT01121328|Autologous cord blood transfusion.|autologous cord blood transfusion.
5122627|NCT01121315|Epidemiological|epidemiological
5122628|NCT01121315|Diabetes|diabetes
5122629|NCT01121315|Glucose Lowering Drug Treatment in Primary care|glucose lowering drug treatment in primary care
5122630|NCT01121315|CVD|cvd
5122631|NCT01121302|AZD5213|azd5213
5122632|NCT01121302|Phase 1|phase 1
5122633|NCT01121302|Safety|safety
5122634|NCT01121263|coronary arteriosclerosis|coronary arteriosclerosis
5122635|NCT01121263|coronary heart disease|coronary heart disease
5122636|NCT01121263|coronary artery bypass|coronary artery bypass
5122637|NCT01121263|coronary artery bypass, off-pump|coronary artery bypass, off-pump
5122638|NCT01121263|coronary angiography|coronary angiography
5122639|NCT01121263|drug-eluting stents|drug-eluting stents
5122640|NCT01121250|Combat disorders|combat disorders
5122641|NCT01121250|Spouses|spouses
5122642|NCT01121250|Support|support
5122643|NCT01121250|Military personnel|military personnel
5122644|NCT01121237|chronic kidney disease|chronic kidney disease
5122645|NCT01121237|end-stage renal disease|end-stage renal disease
5122646|NCT01121237|renal anaemia|renal anaemia
5122647|NCT01121237|epoetin alfa|epoetin alfa
5122648|NCT01121224|Saphenous vein graft|saphenous vein graft
5122649|NCT01121224|Percutaneous coronary intervention|percutaneous coronary intervention
5122650|NCT01121224|Stents|stents
5122651|NCT01121211|Testosterone|testosterone
5122652|NCT01121211|Hormones|hormones
5122653|NCT01121211|Mental Health|mental health
5122654|NCT01121198|Food effect|food effect
5122655|NCT01121185|Hepatitis C virus (HCV)|hepatitis c virus (hcv)
5122656|NCT01121185|Liver transplantation|liver transplantation
5122657|NCT01121185|Human Monoclonal Antibody|human monoclonal antibody
5122658|NCT01121146|Osteolysis|osteolysis
5122659|NCT01121146|Polyethylene|polyethylene
5122660|NCT01121146|Crosslinked Polyethylene|crosslinked polyethylene
5122661|NCT01121146|Total Hip Replacement|total hip replacement
5122662|NCT01121146|CT|ct
5122663|NCT01121120|Lymphoma, Non-Hodgkin|lymphoma, non-hodgkin
5122664|NCT01121120|Hodgkin Disease|hodgkin disease
5122665|NCT01121120|Multiple myeloma|multiple myeloma
5122666|NCT01121120|Peripheral Blood Stem Cell Transplant|peripheral blood stem cell transplant
5122667|NCT01121120|Autologous Peripheral Blood Stem Cell Transplant|autologous peripheral blood stem cell transplant
5122668|NCT01121120|Limited re-infusion of CD34+ cells|limited re-infusion of cd34+ cells
5122669|NCT01121107|Heart Failure|heart failure
5122670|NCT01121107|Decompensated Heart Failure|decompensated heart failure
5122671|NCT01121107|Acute Decompensated Heart Failure|acute decompensated heart failure
5122672|NCT01121107|Hemodynamic Monitoring|hemodynamic monitoring
5122673|NCT01121107|Implantable Pressure Monitor|implantable pressure monitor
5122674|NCT01121107|Left Atrial Pressure Monitoring|left atrial pressure monitoring
5123173|NCT01118819|Metastases|metastases
5122676|NCT01121081|Male or female subjects|male or female subjects
5122677|NCT01121081|≥18 to ≤75 years of age|≥18 to ≤75 years of age
5122678|NCT01121081|who have a diagnosis of plaque or guttate psoriasis|who have a diagnosis of plaque or guttate psoriasis
5122679|NCT01121068|IGRA|igra
5122680|NCT01121068|variability|variability
5122681|NCT01121068|Long-term variability of IGRA|long-term variability of igra
5122682|NCT01121055|Fiberoptic Bronchoscopy|fiberoptic bronchoscopy
5122683|NCT01121055|Patient|patient
5122684|NCT01121055|Satisfaction|satisfaction
5122685|NCT01121055|Lorazepam|lorazepam
5122686|NCT01121016|NAEB, chronic cough, montelukast, induced sputum|naeb, chronic cough, montelukast, induced sputum
5122687|NCT01121003|Fructose|fructose
5122688|NCT01121003|VLDL-triglycerides|vldl-triglycerides
5122689|NCT01121003|de novo lipogenesis|de novo lipogenesis
5122690|NCT01121003|Human metabolism|human metabolism
5122691|NCT01120990|Blood pressure measuring devices|blood pressure measuring devices
5122692|NCT01120990|Essential Hypertension|essential hypertension
5122693|NCT01120990|Automated blood pressure measurement|automated blood pressure measurement
5122694|NCT01120951|Respiratory rate R8 Anaxsys|respiratory rate r8 anaxsys
5122695|NCT01120938|AIrways, Patency, Infant death|airways, patency, infant death
5122696|NCT01120925|Cirrhotic|cirrhotic
5122697|NCT01120925|Stem Cells|stem cells
5122698|NCT01120925|Bone marrow stem cells|bone marrow stem cells
5122699|NCT01120925|Decompensate Cirrhotic Patients|decompensate cirrhotic patients
5122700|NCT01120912|oral insulin|oral insulin
5122701|NCT01120899|Diabetic Macular Edema|diabetic macular edema
5122702|NCT01120899|Microglia|microglia
5122703|NCT01120899|Minocycline|minocycline
5122704|NCT01120899|Diabetes|diabetes
5122705|NCT01120886|Ion channelopathy,|ion channelopathy,
5122706|NCT01120886|Still birth|still birth
5122707|NCT01120886|Sudden death|sudden death
5122708|NCT01120873|Hyperglycemia|hyperglycemia
5122709|NCT01120873|dyslipidemia|dyslipidemia
5122710|NCT01120873|Hypertension|hypertension
5122711|NCT01120873|Obesity|obesity
5122712|NCT01120860|Cognitive Aging|cognitive aging
5122713|NCT01120860|Apolipoproteins E|apolipoproteins e
5122714|NCT01120860|Magnetic Resonance Imaging|magnetic resonance imaging
5122715|NCT01120834|diffuse large b cell lymphoma|diffuse large b cell lymphoma
5122716|NCT01120821|PV|pv
5122717|NCT01120769|Myocardial Infarction|myocardial infarction
5122718|NCT01120769|Percutaneous Coronary Intervention|percutaneous coronary intervention
5122719|NCT01120769|Acetaminophen|acetaminophen
5122720|NCT01120769|Lipid Peroxidation|lipid peroxidation
5122721|NCT01120756|executive dysfunction|executive dysfunction
5122722|NCT01120756|brain injury|brain injury
5122723|NCT01120756|attention|attention
5122724|NCT01120756|rehabilitation|rehabilitation
5122725|NCT01120756|fMRI|fmri
5122726|NCT01120743|liver failure|liver failure
5122727|NCT01120743|cytokines|cytokines
5122728|NCT01120743|hemodynamic instability|hemodynamic instability
5122729|NCT01120717|QVA149|qva149
5122730|NCT01120717|COPD|copd
5122731|NCT01120717|combination bronchodilator|combination bronchodilator
5122732|NCT01120704|Smoking|smoking
5122733|NCT01120704|Smoking Cessation|smoking cessation
5122734|NCT01120704|Adherence|adherence
5122735|NCT01120704|Nicotine|nicotine
5122736|NCT01120704|Motivation|motivation
5122737|NCT01120691|QVA149|qva149
5122738|NCT01120691|NVA237|nva237
5122739|NCT01120691|COPD|copd
5122740|NCT01120691|exacerbation|exacerbation
5122741|NCT01120691|combination bronchodilator|combination bronchodilator
5122742|NCT01120678|cytokines|cytokines
5122743|NCT01120678|late-onset neonatal sepsis|late-onset neonatal sepsis
5122744|NCT01120678|neonatal sepsis|neonatal sepsis
5122745|NCT01120678|diagnosis of sepsis|diagnosis of sepsis
5122746|NCT01120678|bacteremia|bacteremia
5122747|NCT01120678|blood culture|blood culture
5122748|NCT01120678|clinical sepsis|clinical sepsis
5122749|NCT01120665|women's health|women's health
5122750|NCT01120665|hormone replacement therapy|hormone replacement therapy
5122751|NCT01120665|exercise|exercise
5122752|NCT01120613|Nocturnal Hypertension|nocturnal hypertension
5122753|NCT01120613|Nondipping|nondipping
5122754|NCT01120613|Renal Transplant|renal transplant
5122755|NCT01120613|Chronotherapy|chronotherapy
5122756|NCT01120587|Deglutition|deglutition
5122757|NCT01120587|Fluoroscopy|fluoroscopy
5122758|NCT01120574|Nocturnal hypercapnic response to oxygen|nocturnal hypercapnic response to oxygen
5122759|NCT01120574|Home mechanical ventilation|home mechanical ventilation
5122760|NCT01120574|COPD|copd
5122761|NCT01120561|TDM-1 EAP|tdm-1 eap
5122762|NCT01120561|T-DM1 EAP|t-dm1 eap
5122763|NCT01120561|TDM1 EAP|tdm1 eap
5122764|NCT01120561|Trastuzumab-MCC-DM1 EAP|trastuzumab-mcc-dm1 eap
5122765|NCT01120561|Trastuzumab emtansine|trastuzumab emtansine
5122766|NCT01120561|EAP|eap
5122767|NCT01120561|T-PAS|t-pas
5122768|NCT01120548|CARDIAC REHABILITATION|cardiac rehabilitation
5122769|NCT01120548|Nocturnal Ventilation|nocturnal ventilation
5122770|NCT01120548|Apnea hypopnea index is > 15/h|apnea hypopnea index is > 15/h
5122771|NCT01120535|Vena Cava|vena cava
5122772|NCT01120535|Vena Cava Filter|vena cava filter
5122773|NCT01120535|Pulmonary Embolism|pulmonary embolism
5122774|NCT01120535|Venous Thromboembolism|venous thromboembolism
5123275|NCT01118572|NSAIDs|nsaids
5122775|NCT01120535|Risk of Pulmonary Embolism|risk of pulmonary embolism
5122776|NCT01120522|Vena Cava|vena cava
5122777|NCT01120522|Vena Cava Filter|vena cava filter
5122778|NCT01120522|Pulmonary Embolism|pulmonary embolism
5122779|NCT01120522|Venous Thromboembolism|venous thromboembolism
5122780|NCT01120522|Risk of Pulmonary Embolism|risk of pulmonary embolism
5122781|NCT01120509|Vena Cava|vena cava
5122782|NCT01120509|Vena Cava Filter|vena cava filter
5122783|NCT01120509|Pulmonary Embolism|pulmonary embolism
5122784|NCT01120509|Venous Thromboembolism|venous thromboembolism
5122785|NCT01120509|Risk of Pulmonary Embolism|risk of pulmonary embolism
5122786|NCT01120496|Hypertonic saline solution, bronchiolitis, RSV|hypertonic saline solution, bronchiolitis, rsv
5122787|NCT01120483|mortality|mortality
5122788|NCT01120483|functional status|functional status
5122789|NCT01120470|Castration Resistant|castration resistant
5122790|NCT01120470|Prostate Cancer|prostate cancer
5122791|NCT01120470|OGX-427|ogx-427
5122792|NCT01120444|Diabetes|diabetes
5122793|NCT01120444|Insulin|insulin
5122794|NCT01120444|Blood Glucose|blood glucose
5122795|NCT01120431|dehydration|dehydration
5122796|NCT01120431|fluid therapy|fluid therapy
5122797|NCT01120431|hyaluronoglucosaminidase|hyaluronoglucosaminidase
5122798|NCT01120431|hyaluronidase|hyaluronidase
5122799|NCT01120431|hypodermoclysis|hypodermoclysis
5122800|NCT01120431|clysis|clysis
5122801|NCT01120431|subcutaneous hydration|subcutaneous hydration
5122802|NCT01120431|subcutaneous rehydration|subcutaneous rehydration
5122803|NCT01120431|hyaluronan|hyaluronan
5122804|NCT01120431|rHuPH20|rhuph20
5122805|NCT01120431|pediatric|pediatric
5122806|NCT01120431|ORT|ort
5122807|NCT01120418|Endothelial cell density|endothelial cell density
5122808|NCT01120418|screening|screening
5122809|NCT01120405|Xenon|xenon
5122810|NCT01120405|Cardiac safety|cardiac safety
5122811|NCT01120405|Cardiovascular risk|cardiovascular risk
5122812|NCT01120405|Non cardiac surgery|non cardiac surgery
5122813|NCT01120405|Atherosclerotic vascular surgery|atherosclerotic vascular surgery
5122814|NCT01120392|Parkinson's disease|parkinson's disease
5122815|NCT01120392|Physical therapy|physical therapy
5122816|NCT01120392|Virtual Reality|virtual reality
5122817|NCT01120392|Quality of life|quality of life
5122818|NCT01120392|Motor performance|motor performance
5122819|NCT01120379|drug eluting stents|drug eluting stents
5122820|NCT01120379|Stents|stents
5122821|NCT01120379|Angioplasty|angioplasty
5122822|NCT01120379|Stent thrombosis|stent thrombosis
5122823|NCT01120353|Childhood cancer|childhood cancer
5122824|NCT01120353|Young Children|young children
5122825|NCT01120353|Adults|adults
5122826|NCT01120301|stroke|stroke
5122827|NCT01120288|Anti-Angiogenesis|anti-angiogenesis
5122828|NCT01120288|Targeted Therapy|targeted therapy
5122829|NCT01120288|HIF|hif
5122830|NCT01120288|Antisense|antisense
5122831|NCT01120288|VEGF|vegf
5122832|NCT01120288|Cancer|cancer
5122833|NCT01120288|Solid Tumor|solid tumor
5122834|NCT01120288|Liver Metastasis|liver metastasis
5122835|NCT01120262|recurrent prostate cancer|recurrent prostate cancer
5122836|NCT01120262|stage IV prostate cancer|stage iv prostate cancer
5122837|NCT01120249|stage I renal cell cancer|stage i renal cell cancer
5122838|NCT01120249|stage II renal cell cancer|stage ii renal cell cancer
5122839|NCT01120249|stage III renal cell cancer|stage iii renal cell cancer
5122840|NCT01120249|clear cell renal cell carcinoma|clear cell renal cell carcinoma
5122841|NCT01120249|papillary renal cell carcinoma|papillary renal cell carcinoma
5122842|NCT01120210|Heart Failure|heart failure
5122843|NCT01120210|Cardiac Failure|cardiac failure
5122844|NCT01120197|randomized controlled trial|randomized controlled trial
5122845|NCT01120197|osteoporosis|osteoporosis
5122846|NCT01120197|moderate-intensity circuit exercises|moderate-intensity circuit exercises
5122847|NCT01120197|balance|balance
5122848|NCT01120197|health-related quality of life|health-related quality of life
5122849|NCT01120171|Breast cancer|breast cancer
5122850|NCT01120171|Elderly|elderly
5122851|NCT01120171|Chemotherapy|chemotherapy
5122852|NCT01120171|Cardiotoxicity|cardiotoxicity
5122853|NCT01120158|Breast cancer|breast cancer
5122854|NCT01120158|Elderly|elderly
5122855|NCT01120158|Chemotherapy|chemotherapy
5122856|NCT01120158|Anti-angiogenesis therapy|anti-angiogenesis therapy
5122857|NCT01120145|Malaria|malaria
5122858|NCT01120145|Pregnancy|pregnancy
5122859|NCT01120145|Sulphadoxine-pyrimethamine|sulphadoxine-pyrimethamine
5122860|NCT01120106|levosimendan|levosimendan
5122861|NCT01120106|pediatric cardiac surgery|pediatric cardiac surgery
5122862|NCT01120106|low cardiac output syndrome|low cardiac output syndrome
5122863|NCT01120106|transposition of the great arteries|transposition of the great arteries
5122864|NCT01120093|COPD|copd
5122865|NCT01120080|Smoking|smoking
5122866|NCT01120080|Tobacco|tobacco
5122867|NCT01120080|Drinking|drinking
5122868|NCT01120067|Psychology|psychology
5122869|NCT01120067|Pain|pain
5122870|NCT01120067|Veterans|veterans
5122871|NCT01120067|Stress Disorders, Post-Traumatic|stress disorders, post-traumatic
5122872|NCT01120054|Traumatic Brain Injury|traumatic brain injury
5122873|NCT01120054|Homelessness|homelessness
5122874|NCT01120015|OA|oa
5122875|NCT01120015|knee|knee
5123276|NCT01118559|YM150|ym150
5122876|NCT01120002|mild to moderate Alzheimer's Disease|mild to moderate alzheimer's disease
5122877|NCT01119989|hepatic fat content|hepatic fat content
5122878|NCT01119989|hepatic de novo lipogenesis|hepatic de novo lipogenesis
5122879|NCT01119963|Preterm delivery|preterm delivery
5122880|NCT01119950|COPD|copd
5122881|NCT01119937|COPD|copd
5122882|NCT01119937|NVA237|nva237
5122883|NCT01119924|Mirtazapine|mirtazapine
5122884|NCT01119924|Smilon|smilon
5122885|NCT01119924|Depression|depression
5122886|NCT01119924|Pain|pain
5122887|NCT01119911|Blood sampling|blood sampling
5122888|NCT01119911|Venipuncture|venipuncture
5122889|NCT01119911|Peripheral venous catheter|peripheral venous catheter
5122890|NCT01119911|Complete blood count|complete blood count
5122891|NCT01119911|Basic chemistry|basic chemistry
5122892|NCT01119911|Hemolysis|hemolysis
5122893|NCT01119911|Peripheral venous catheter replaces venipuncture.|peripheral venous catheter replaces venipuncture.
5122894|NCT01119911|Peripheral venous catheter blood sampling reduces pain.|peripheral venous catheter blood sampling reduces pain.
5122895|NCT01119898|Osteoarthritis|osteoarthritis
5122896|NCT01119898|Arthritis|arthritis
5122897|NCT01119898|NSAIDs|nsaids
5122898|NCT01119898|Topical NSAID|topical nsaid
5122899|NCT01119898|Diclofenac|diclofenac
5122900|NCT01119898|PENNSAID|pennsaid
5122901|NCT01119885|chronic pain|chronic pain
5122902|NCT01119885|fentanyl matrix|fentanyl matrix
5122903|NCT01119885|arthritis|arthritis
5122904|NCT01119885|osteoarthritis|osteoarthritis
5122905|NCT01119872|Positive-Pressure Respiration|positive-pressure respiration
5122906|NCT01119872|Respiration, Artificial|respiration, artificial
5122907|NCT01119846|Tolerability|tolerability
5122908|NCT01119846|Pharmacokinetics|pharmacokinetics
5122909|NCT01119846|Safety|safety
5122910|NCT01119846|Pharmacodynamics|pharmacodynamics
5122911|NCT01119846|Glucose|glucose
5122912|NCT01119833|Sickle Cell Disease|sickle cell disease
5122913|NCT01119820|elective obstetric or gynecologic surgery|elective obstetric or gynecologic surgery
5122914|NCT01119807|Intraosseous infusion|intraosseous infusion
5122915|NCT01119807|Emergency Medical Services|emergency medical services
5122916|NCT01119794|B-cell small lymphocytic lymphoma|b-cell small lymphocytic lymphoma
5122917|NCT01119794|marginal zone lymphoma|marginal zone lymphoma
5122918|NCT01119794|follicular lymphoma|follicular lymphoma
5122919|NCT01119794|mantle cell lymphoma|mantle cell lymphoma
5122920|NCT01119794|Waldenström macroglobulinemia.|waldenström macroglobulinemia.
5122921|NCT01119794|Low Grade B cell Non-Hodgkins Lymphoma|low grade b cell non-hodgkins lymphoma
5122922|NCT01119768|GI|gi
5122923|NCT01119768|Nexium|nexium
5122924|NCT01119768|Phase IV|phase iv
5122925|NCT01119768|Co-diagnosed NERD|co-diagnosed nerd
5122926|NCT01119755|TREATMENT OF HYPERTENSION|treatment of hypertension
5122927|NCT01119742|Tinea Pedis|tinea pedis
5122928|NCT01119742|Interdigital|interdigital
5122929|NCT01119729|Cardiac Diseases • HIV-Infection • AIDS • Antiretroviral Therapy|cardiac diseases • hiv-infection • aids • antiretroviral therapy
5122930|NCT01119716|Atrial Fibrillation|atrial fibrillation
5122931|NCT01119716|Afib|afib
5122932|NCT01119716|cardioversion|cardioversion
5122933|NCT01119716|normal sinus rhythm|normal sinus rhythm
5122934|NCT01119716|arrhythmia|arrhythmia
5122935|NCT01119716|AF|af
5122936|NCT01119703|Vaccine Hyporesponse|vaccine hyporesponse
5122937|NCT01119690|Dietary|dietary
5122938|NCT01119690|Cross-Over Study|cross-over study
5122939|NCT01119690|Lipids|lipids
5122940|NCT01119690|Rapeseed oil|rapeseed oil
5122941|NCT01119690|Butter|butter
5122942|NCT01119690|Milk Fat|milk fat
5122943|NCT01119690|Unsaturated Fat|unsaturated fat
5122944|NCT01119690|Saturated Fat|saturated fat
5122945|NCT01119690|Oxidized LDL|oxidized ldl
5122946|NCT01119690|Platelet Function|platelet function
5122947|NCT01119690|Arterial Elasticity|arterial elasticity
5122948|NCT01119664|Adult subjects with malignant pleural mesothelioma who present for first (front) line or second line chemotherapy,|adult subjects with malignant pleural mesothelioma who present for first (front) line or second line chemotherapy,
5122949|NCT01119651|Healthy Volunteer Subjects|healthy volunteer subjects
5122950|NCT01119638|Alzheimer's disease|alzheimer's disease
5122951|NCT01119638|BPSD|bpsd
5122952|NCT01119638|escitalopram|escitalopram
5122953|NCT01119638|Risperidone|risperidone
5122954|NCT01119638|Agitation|agitation
5122955|NCT01119638|Psychosis|psychosis
5122956|NCT01119638|Dementia|dementia
5122957|NCT01119638|Elderly|elderly
5122958|NCT01119625|safety|safety
5122959|NCT01119625|Streptococcus pneumoniae|streptococcus pneumoniae
5122960|NCT01119625|immunogenicity|immunogenicity
5122961|NCT01119625|Pneumococcal conjugate vaccine|pneumococcal conjugate vaccine
5122962|NCT01119625|Haemophilus influenzae|haemophilus influenzae
5122963|NCT01119612|Malaria|malaria
5122964|NCT01119612|Iron|iron
5122965|NCT01119612|Pregnancy|pregnancy
5122966|NCT01119612|Anemia|anemia
5122967|NCT01119612|Birth Weight|birth weight
5122968|NCT01119586|B-cell adult acute lymphoblastic leukemia|b-cell adult acute lymphoblastic leukemia
5122969|NCT01119586|B-cell childhood acute lymphoblastic leukemia|b-cell childhood acute lymphoblastic leukemia
5122970|NCT01119586|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
5123097|NCT01119066|fludarabine|fludarabine
5122971|NCT01119586|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
5122972|NCT01119573|stage I endometrial carcinoma|stage i endometrial carcinoma
5122973|NCT01119573|stage III endometrial carcinoma|stage iii endometrial carcinoma
5122974|NCT01119547|Musculoskeletal Diseases|musculoskeletal diseases
5122975|NCT01119547|Osteoarthritis|osteoarthritis
5122976|NCT01119547|Joint Diseases|joint diseases
5122977|NCT01119547|Arthritis|arthritis
5122978|NCT01119547|Rheumatic Diseases|rheumatic diseases
5122979|NCT01119534|Cough treatment|cough treatment
5122980|NCT01119521|South Africa,tuberculosis,vaccine|south africa,tuberculosis,vaccine
5122981|NCT01119508|Advanced|advanced
5122982|NCT01119508|Inoperable|inoperable
5122983|NCT01119508|Melanoma|melanoma
5122984|NCT01119508|Ipilimumab|ipilimumab
5122985|NCT01119508|MDX010|mdx010
5122986|NCT01119508|BMS-734016|bms-734016
5122987|NCT01119508|Temozolomide|temozolomide
5122988|NCT01119508|Temodar|temodar
5122989|NCT01119508|TMZ|tmz
5122990|NCT01119508|skin|skin
5122991|NCT01119508|mucosal|mucosal
5122992|NCT01119482|Serogroup A meningococcal vaccine|serogroup a meningococcal vaccine
5122993|NCT01119482|meningococcal carriage|meningococcal carriage
5122994|NCT01119482|incidence|incidence
5122995|NCT01119482|prevalence|prevalence
5122996|NCT01119469|Hypochondriasis|hypochondriasis
5122997|NCT01119469|Health Anxiety|health anxiety
5122998|NCT01119469|randomized controlled trial|randomized controlled trial
5122999|NCT01119469|Cognitive Therapy|cognitive therapy
5123000|NCT01119469|Exposure Therapy|exposure therapy
5123001|NCT01119456|Tumors|tumors
5123002|NCT01119456|Macrophage stimulating 1 receptor, human|macrophage stimulating 1 receptor, human
5123003|NCT01119456|RON protein|ron protein
5123004|NCT01119456|RON receptor protein tyrosine kinase|ron receptor protein tyrosine kinase
5123005|NCT01119430|major depression|major depression
5123006|NCT01119430|DU 125530|du 125530
5123007|NCT01119430|Treatment depression|treatment depression
5123008|NCT01119430|Latency antidepressant|latency antidepressant
5123009|NCT01119417|supine Hypertension|supine hypertension
5123010|NCT01119417|autonomic failure|autonomic failure
5123011|NCT01119417|BQ123|bq123
5123012|NCT01119417|BQ-123|bq-123
5123013|NCT01119417|endothelin|endothelin
5123014|NCT01119404|Metabolic Syndrome|metabolic syndrome
5123015|NCT01119404|Coronary Heart Disease|coronary heart disease
5123016|NCT01119404|Erectile Dysfunction|erectile dysfunction
5123017|NCT01119404|Arterial Elasticity|arterial elasticity
5123018|NCT01119404|Oxidized Low Density Lipoprotein|oxidized low density lipoprotein
5123019|NCT01119404|Cardiovascular Diseases|cardiovascular diseases
5123020|NCT01119404|Risk Assessment|risk assessment
5123021|NCT01119404|Endothelial Dysfunction|endothelial dysfunction
5123022|NCT01119404|Diabetes Mellitus|diabetes mellitus
5123023|NCT01119404|Surrogate Markers|surrogate markers
5123024|NCT01119404|Risk Factors|risk factors
5123025|NCT01119391|IVF|ivf
5123026|NCT01119391|Lifestyle habits|lifestyle habits
5123027|NCT01119378|Post menopausal|post menopausal
5123028|NCT01119378|Vitamin D sufficiency|vitamin d sufficiency
5123029|NCT01119378|Calcium absorption efficiency|calcium absorption efficiency
5123030|NCT01119378|Dual isotope technique|dual isotope technique
5123031|NCT01119365|Healthy controls|healthy controls
5123032|NCT01119352|Safety|safety
5123033|NCT01119352|tolerability|tolerability
5123034|NCT01119352|PK|pk
5123035|NCT01119352|healthy|healthy
5123036|NCT01119352|overweight|overweight
5123037|NCT01119352|obese|obese
5123038|NCT01119339|psoriasis|psoriasis
5123039|NCT01119339|topical|topical
5123040|NCT01119339|psoriasis plaques test|psoriasis plaques test
5123041|NCT01119326|scar prevention|scar prevention
5123042|NCT01119326|healing|healing
5123043|NCT01119326|tissue|tissue
5123044|NCT01119326|AFT|aft
5123045|NCT01119326|scar analysis|scar analysis
5123046|NCT01119300|Venous Thromboembolism (VTE)|venous thromboembolism (vte)
5123047|NCT01119300|Atrial Fibrillation (AF)|atrial fibrillation (af)
5123048|NCT01119287|Conjunctivitis|conjunctivitis
5123049|NCT01119287|ocular allergy|ocular allergy
5123050|NCT01119261|Venous thromboembolism (VTE)|venous thromboembolism (vte)
5123051|NCT01119261|Atrial fibrillation (AF)|atrial fibrillation (af)
5123052|NCT01119248|Children MRI General Anesthesia|children mri general anesthesia
5123053|NCT01119235|Pharmacokinetics|pharmacokinetics
5123054|NCT01119235|tablet performance|tablet performance
5123055|NCT01119235|healthy volunteers|healthy volunteers
5123056|NCT01119235|open label|open label
5123057|NCT01119222|Cold pain methodology|cold pain methodology
5123058|NCT01119222|Healthy male volunteers|healthy male volunteers
5123059|NCT01119222|gabapentin|gabapentin
5123060|NCT01119222|Diphenhydramine|diphenhydramine
5123061|NCT01119222|morphine|morphine
5123062|NCT01119209|Hip fracture|hip fracture
5123063|NCT01119209|intertrochanteric|intertrochanteric
5123064|NCT01119196|Peritoneal Dialysis|peritoneal dialysis
5123065|NCT01119196|Insulin resistance|insulin resistance
5123066|NCT01119183|Patient understanding and counseling|patient understanding and counseling
5123067|NCT01119170|nutrition|nutrition
5123068|NCT01119170|infant formula|infant formula
5123069|NCT01119170|probiotics|probiotics
5123070|NCT01119157|influenza vaccine|influenza vaccine
5123071|NCT01119157|cellular immune response|cellular immune response
5123072|NCT01119157|humoral immune response|humoral immune response
5123073|NCT01119144|Orbital|orbital
5123074|NCT01119144|fractures|fractures
5123075|NCT01119144|enophthalmos|enophthalmos
5123076|NCT01119144|diplopia|diplopia
5123077|NCT01119144|eye|eye
5123078|NCT01119131|Vitamin D|vitamin d
5123079|NCT01119131|Parkinson disease|parkinson disease
5123080|NCT01119131|accidental falls|accidental falls
5123081|NCT01119118|Metastatic|metastatic
5123082|NCT01119118|castrate-resistant prostate cancer|castrate-resistant prostate cancer
5123083|NCT01119118|bone metastasis|bone metastasis
5123084|NCT01119105|acute bacterial skin and skin structure infection|acute bacterial skin and skin structure infection
5123085|NCT01119105|bacteria|bacteria
5123086|NCT01119092|Ankle Sprain|ankle sprain
5123087|NCT01119092|Joint Mobilization|joint mobilization
5123088|NCT01119092|Manual Therapy|manual therapy
5123089|NCT01119092|Range of Motion|range of motion
5123090|NCT01119079|labor pain|labor pain
5123091|NCT01119079|epidural|epidural
5123092|NCT01119066|Leukemia|leukemia
5123093|NCT01119066|Multiple Myeloma|multiple myeloma
5123094|NCT01119066|radiation|radiation
5123095|NCT01119066|Thiotepa|thiotepa
5123096|NCT01119066|cyclophosphamide|cyclophosphamide
5123098|NCT01119066|Clofarabine|clofarabine
5123099|NCT01119066|CliniMACS device|clinimacs device
5123100|NCT01119066|GCSF|gcsf
5123101|NCT01119066|10-050|10-050
5123102|NCT01119053|VNS|vns
5123103|NCT01119053|Depression|depression
5123104|NCT01119053|Personality-Disorder|personality-disorder
5123105|NCT01119053|Stimulation|stimulation
5123106|NCT01119040|Dislodged PEG tube|dislodged peg tube
5123107|NCT01119040|NOTES|notes
5123108|NCT01119027|Laparoscopic Colectomy|laparoscopic colectomy
5123109|NCT01119027|Colorectal Skills Training|colorectal skills training
5123110|NCT01119014|Aripiprazole|aripiprazole
5123111|NCT01119014|Quetiapine|quetiapine
5123112|NCT01119014|Psychosis|psychosis
5123113|NCT01119014|Child|child
5123114|NCT01119014|Adolescent|adolescent
5123115|NCT01118988|Peer Support|peer support
5123116|NCT01118988|Social Support|social support
5123117|NCT01118988|Chronic Pain|chronic pain
5123118|NCT01118988|Behavioral Interventions for Pain|behavioral interventions for pain
5123119|NCT01118988|Adolescents|adolescents
5123120|NCT01118988|Children|children
5123121|NCT01118988|Pediatric|pediatric
5123122|NCT01118988|Mentorship|mentorship
5123123|NCT01118988|Complementary and Alternative Medicine|complementary and alternative medicine
5123124|NCT01118988|CAM|cam
5123125|NCT01118988|Pain|pain
5123126|NCT01118988|Pain Management|pain management
5123127|NCT01118988|Behavioral|behavioral
5123128|NCT01118975|lapatinib ditosylate|lapatinib ditosylate
5123129|NCT01118975|Zolinza (vorinostat)|zolinza (vorinostat)
5123130|NCT01118975|Cancer Stem Cells|cancer stem cells
5123131|NCT01118962|Primary Generalized Tonic-Clonic (PGTC) Seizures|primary generalized tonic-clonic (pgtc) seizures
5123132|NCT01118962|Absence Seizures|absence seizures
5123133|NCT01118962|Myoclonic Seizures|myoclonic seizures
5123134|NCT01118962|Idiopathic Generalized Epilepsy (IGE)|idiopathic generalized epilepsy (ige)
5123135|NCT01118949|Primary Generalized Tonic-Clonic (PGTC) Seizures|primary generalized tonic-clonic (pgtc) seizures
5123136|NCT01118949|Absence Seizures|absence seizures
5123137|NCT01118949|Myoclonic Seizures|myoclonic seizures
5123138|NCT01118949|Idiopathic Generalized Epilepsy (IGE)|idiopathic generalized epilepsy (ige)
5123139|NCT01118936|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5123140|NCT01118936|Daily magnesium supplement|daily magnesium supplement
5123141|NCT01118936|EQ-5D|eq-5d
5123142|NCT01118923|Bronchial challenge test|bronchial challenge test
5123143|NCT01118923|Hyperreactivity|hyperreactivity
5123144|NCT01118923|PD20 for metacholine|pd20 for metacholine
5123145|NCT01118923|Daily magnesium supplement|daily magnesium supplement
5123146|NCT01118910|Intertrigo|intertrigo
5123147|NCT01118910|Vusion|vusion
5123148|NCT01118897|Gall bladder|gall bladder
5123149|NCT01118897|Pancreatic cancers|pancreatic cancers
5123150|NCT01118897|Tomotherapy|tomotherapy
5123151|NCT01118884|Midazolam|midazolam
5123152|NCT01118884|Nitrous oxide|nitrous oxide
5123153|NCT01118884|Behaviour management|behaviour management
5123154|NCT01118871|Treatment experienced|treatment experienced
5123155|NCT01118858|CYP2D6|cyp2d6
5123156|NCT01118858|CYP3A4|cyp3a4
5123157|NCT01118858|cytochrome P450|cytochrome p450
5123158|NCT01118858|children|children
5123159|NCT01118858|pediatrics|pediatrics
5123160|NCT01118858|dextromethorphan|dextromethorphan
5123161|NCT01118858|phenotype|phenotype
5123162|NCT01118858|genotype|genotype
5123163|NCT01118845|Non-Hodgkin's lymphoma|non-hodgkin's lymphoma
5123164|NCT01118845|Lymphoma, Large B-Cell|lymphoma, large b-cell
5123165|NCT01118845|Diffuse, Mantle cell lymphoma, Lymphoma|diffuse, mantle cell lymphoma, lymphoma
5123166|NCT01118845|Follicular, Lymphoma|follicular, lymphoma
5123167|NCT01118845|Large B-Cell, Diffuse|large b-cell, diffuse
5123168|NCT01118832|Thermography|thermography
5123169|NCT01118819|Phase I|phase i
5123170|NCT01118819|Metastatic Disease|metastatic disease
5123171|NCT01118819|Solid Tumor|solid tumor
5123172|NCT01118819|Malignancy|malignancy
5123174|NCT01118819|Clinical trial|clinical trial
5123175|NCT01118819|Hypoxia|hypoxia
5123176|NCT01118819|Necrosis|necrosis
5123177|NCT01118780|GAD|gad
5123178|NCT01118780|Generalized Anxiety Disorder|generalized anxiety disorder
5123179|NCT01118780|Anxiety|anxiety
5123180|NCT01118767|Adherence|adherence
5123181|NCT01118767|Appointment|appointment
5123182|NCT01118767|Cell Phone|cell phone
5123183|NCT01118767|Cellular Phone|cellular phone
5123184|NCT01118767|Clinic|clinic
5123185|NCT01118767|Computers|computers
5123186|NCT01118767|Controlled Clinical Trials, Randomized|controlled clinical trials, randomized
5123187|NCT01118767|HIV/AIDS|hiv/aids
5123188|NCT01118767|Health Informatics|health informatics
5123189|NCT01118767|Health behavior|health behavior
5123190|NCT01118767|Information Technology|information technology
5123191|NCT01118767|Internet|internet
5123192|NCT01118767|Intervention|intervention
5123193|NCT01118767|Medication|medication
5123194|NCT01118767|Patient Satisfaction|patient satisfaction
5123195|NCT01118767|Patient Self-Report|patient self-report
5123196|NCT01118767|Patients|patients
5123197|NCT01118767|Peru|peru
5123198|NCT01118767|Phone|phone
5123199|NCT01118767|Public Health|public health
5123200|NCT01118767|Public Health Informatics|public health informatics
5123201|NCT01118767|Randomized|randomized
5123202|NCT01118767|Randomized Controlled Clinical Trials|randomized controlled clinical trials
5123203|NCT01118767|Randomized Controlled Trials|randomized controlled trials
5123204|NCT01118767|Research|research
5123205|NCT01118767|Secondary Prevention|secondary prevention
5123206|NCT01118767|Self-Report|self-report
5123207|NCT01118767|Sex Behavior|sex behavior
5123208|NCT01118767|Sexual Behavior|sexual behavior
5123209|NCT01118767|Sexually Transmitted Diseases|sexually transmitted diseases
5123210|NCT01118767|Sexually Transmitted Infection|sexually transmitted infection
5123211|NCT01118767|Survey Instrument|survey instrument
5123212|NCT01118767|Surveys|surveys
5123213|NCT01118767|Telephone|telephone
5123214|NCT01118767|Telephone, Cellular|telephone, cellular
5123215|NCT01118767|Text|text
5123216|NCT01118767|Unprotected Sex|unprotected sex
5123217|NCT01118767|Viral Load result|viral load result
5123218|NCT01118767|Vulnerable Populations|vulnerable populations
5123219|NCT01118767|WWW|www
5123220|NCT01118767|anti-retroviral therapy|anti-retroviral therapy
5123221|NCT01118767|consumer informatics|consumer informatics
5123222|NCT01118767|evidence base|evidence base
5123223|NCT01118767|follow-up|follow-up
5123224|NCT01118767|medication adherence|medication adherence
5123225|NCT01118767|medication compliance|medication compliance
5123226|NCT01118767|randomization|randomization
5123227|NCT01118767|randomized controlled study|randomized controlled study
5123228|NCT01118767|randomized trial|randomized trial
5123229|NCT01118767|randomly assigned|randomly assigned
5123230|NCT01118767|safer sex|safer sex
5123231|NCT01118767|treatment adherence|treatment adherence
5123232|NCT01118767|user centered design|user centered design
5123234|NCT01118767|world wide web|world wide web
5123235|NCT01118754|Santen|santen
5123236|NCT01118754|Dry|dry
5123237|NCT01118754|Eye|eye
5123238|NCT01118741|Rising PSA|rising psa
5123239|NCT01118741|Recurrent Non Metastatic Prostate Cancer|recurrent non metastatic prostate cancer
5123240|NCT01118715|distal radius fracture|distal radius fracture
5123241|NCT01118715|post-traumatic carpal tunnel syndrome|post-traumatic carpal tunnel syndrome
5123242|NCT01118715|complex regional pain syndrome|complex regional pain syndrome
5123243|NCT01118715|compression glove|compression glove
5123244|NCT01118715|edema glove|edema glove
5123245|NCT01118702|Pharmacokinetic|pharmacokinetic
5123246|NCT01118702|Methylphenidate|methylphenidate
5123247|NCT01118702|Novo-methylphenidate ER-C|novo-methylphenidate er-c
5123248|NCT01118702|Ritalin-SR|ritalin-sr
5123249|NCT01118702|CONCERTA|concerta
5123250|NCT01118702|Plasma profile|plasma profile
5123251|NCT01118676|locally advanced non small cell lung cancer (NSCLC), locally advanced, Phase I, Cilengitide, concomitant radiochemotherapy|locally advanced non small cell lung cancer (nsclc), locally advanced, phase i, cilengitide, concomitant radiochemotherapy
5123252|NCT01118663|Acetaminophen overdose; induced hepatotoxicity, liver injury|acetaminophen overdose; induced hepatotoxicity, liver injury
5123253|NCT01118650|Inattention|inattention
5123254|NCT01118650|Hyperactivity|hyperactivity
5123255|NCT01118650|Impulsivity|impulsivity
5123256|NCT01118637|trichotillomania|trichotillomania
5123257|NCT01118637|self-help|self-help
5123258|NCT01118637|web-based|web-based
5123259|NCT01118637|habit reversal|habit reversal
5123260|NCT01118637|behavior therapy|behavior therapy
5123261|NCT01118624|Female|female
5123262|NCT01118624|Advanced|advanced
5123263|NCT01118624|Metastatic|metastatic
5123264|NCT01118611|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5123265|NCT01118598|PCOS|pcos
5123266|NCT01118585|GERD|gerd
5123267|NCT01118585|Esophagitis|esophagitis
5123268|NCT01118585|Fundoplication|fundoplication
5123269|NCT01118585|Anti-reflux surgery|anti-reflux surgery
5123270|NCT01118585|PPI dependent|ppi dependent
5123271|NCT01118572|Celecoxib|celecoxib
5123272|NCT01118572|Celecox|celecox
5123273|NCT01118572|Pain|pain
5123274|NCT01118572|Surgery|surgery
5123278|NCT01118559|Healthy volunteer|healthy volunteer
5123279|NCT01118546|aspirin|aspirin
5123280|NCT01118546|coronary artery disease|coronary artery disease
5123281|NCT01118546|hypersensitivity|hypersensitivity
5123282|NCT01118546|Platelet aggregation|platelet aggregation
5123283|NCT01118533|Intubation|intubation
5123284|NCT01118533|Sore throat|sore throat
5123285|NCT01118533|Blades|blades
5123286|NCT01118533|Laryngoscopy|laryngoscopy
5123287|NCT01118533|Morbidity|morbidity
5123288|NCT01118520|abdominal aortic aneurysm|abdominal aortic aneurysm
5123289|NCT01118520|ACE Inhibition|ace inhibition
5123290|NCT01118507|Trisomy of chromosome 21 diagnosis|trisomy of chromosome 21 diagnosis
5123291|NCT01118507|first trimester of pregnancy|first trimester of pregnancy
5123292|NCT01118507|maternal blood|maternal blood
5123293|NCT01118507|High output shotgun sequencing|high output shotgun sequencing
5123294|NCT01118494|CKD|ckd
5123295|NCT01118494|RAS|ras
5123296|NCT01118494|AGT|agt
5123297|NCT01118481|Coronary stenosis|coronary stenosis
5123298|NCT01118481|Wave intensity analysis|wave intensity analysis
5123299|NCT01118481|Instantaneous Flow Reserve|instantaneous flow reserve
5123300|NCT01118481|iFR|ifr
5123301|NCT01118481|Fractional Flow Reserve|fractional flow reserve
5123302|NCT01118468|Competitive Flow|competitive flow
5123303|NCT01118468|Coronary artery bypass|coronary artery bypass
5123304|NCT01118468|Wave Intensity Analysis|wave intensity analysis
5123305|NCT01118442|Aortic Stenosis|aortic stenosis
5123306|NCT01118442|Coronary Flow|coronary flow
5123307|NCT01118442|Wave Intensity Analysis|wave intensity analysis
5123308|NCT01118429|hyperhidrosis|hyperhidrosis
5123309|NCT01118429|axillary|axillary
5123310|NCT01118429|osmidrosis|osmidrosis
5123311|NCT01118429|oxybutynin|oxybutynin
5123312|NCT01118416|sexual risk|sexual risk
5123313|NCT01118416|substance use|substance use
5123314|NCT01118416|HIV|hiv
5123315|NCT01118416|prevention|prevention
5123316|NCT01118416|intervention|intervention
5123317|NCT01118416|Motivational Enhancement Therapy|motivational enhancement therapy
5123318|NCT01118416|young men who have sex with men|young men who have sex with men
5123319|NCT01118403|Ventilator associated pneumonia|ventilator associated pneumonia
5123320|NCT01118403|Coma|coma
5123321|NCT01118403|Brain Injuries|brain injuries
5123322|NCT01118403|Intensive care units|intensive care units
5123323|NCT01118403|antibiotic prophylaxis|antibiotic prophylaxis
5123324|NCT01118390|telangiectasias|telangiectasias
5123325|NCT01118390|leg|leg
5123326|NCT01118390|sclerotherapy|sclerotherapy
5123327|NCT01118390|laser|laser
5123328|NCT01118390|glycose|glycose
5123329|NCT01118364|Social circumstances|social circumstances
5123330|NCT01118325|Stable Coronary Artery Disease|stable coronary artery disease
5123331|NCT01118325|Platelet Aggregation|platelet aggregation
5123332|NCT01118312|Asthma|asthma
5123333|NCT01118312|Rhinitis|rhinitis
5123334|NCT01118312|Sinusitis|sinusitis
5123335|NCT01118312|Chronic|chronic
5123336|NCT01118312|ACRC|acrc
5123337|NCT01118312|STAN|stan
5123338|NCT01118312|Nasal steroid|nasal steroid
5123339|NCT01118312|Mometasone|mometasone
5123340|NCT01118312|Nasal spray|nasal spray
5123341|NCT01118299|ACP|acp
5123342|NCT01118299|Atrial Fibrillation|atrial fibrillation
5123343|NCT01118299|AF|af
5123344|NCT01118299|A Fib|a fib
5123345|NCT01118299|Stroke|stroke
5123346|NCT01118299|Coumadin|coumadin
5123347|NCT01118299|Warfarin|warfarin
5123348|NCT01118299|Dabigatran|dabigatran
5123349|NCT01118299|Pradaxa|pradaxa
5123350|NCT01118299|Blood thinning medication|blood thinning medication
5123351|NCT01118299|Left atrial appendage|left atrial appendage
5123352|NCT01118299|LAA|laa
5123353|NCT01118286|Hypertension|hypertension
5123354|NCT01118286|Drug therapy, combination|drug therapy, combination
5123355|NCT01118273|Naproxen sodium|naproxen sodium
5123356|NCT01118273|Diphenhydramine|diphenhydramine
5123357|NCT01118273|Drugs, Investigational|drugs, investigational
5123358|NCT01118260|prostata hyperplasia|prostata hyperplasia
5123359|NCT01118260|transurethral resection|transurethral resection
5123360|NCT01118260|TIVA|tiva
5123361|NCT01118260|spinal anaesthesia|spinal anaesthesia
5123362|NCT01118247|Uncemented THA|uncemented tha
5123363|NCT01118247|alumina-on-alumina|alumina-on-alumina
5123364|NCT01118247|survival|survival
5123365|NCT01118247|HHS|hhs
5123366|NCT01118247|Patient satisfaction|patient satisfaction
5123367|NCT01118234|CLL|cll
5123368|NCT01118234|Rituximab|rituximab
5123369|NCT01118234|Maintenance|maintenance
5123370|NCT01118221|oxidant stress|oxidant stress
5123371|NCT01118221|exercise|exercise
5123372|NCT01118208|Medication adherence|medication adherence
5123373|NCT01118208|Accidental overdose|accidental overdose
5123374|NCT01118208|Deliberate overdose|deliberate overdose
5123375|NCT01118208|Suicide, attempted|suicide, attempted
5123376|NCT01118182|Traumatic Brain Injury|traumatic brain injury
5123377|NCT01118182|Veterans|veterans
5123378|NCT01118182|Psychiatric Disorders|psychiatric disorders
5123379|NCT01118182|Suicide|suicide
5123380|NCT01118169|Personal values|personal values
5123381|NCT01118169|Suicidal thoughts|suicidal thoughts
5123382|NCT01118156|Suicide Nomenclature|suicide nomenclature
5123383|NCT01118130|Genetics|genetics
5123385|NCT01118130|Multiple Sclerosis|multiple sclerosis
5123386|NCT01118130|beta-interferons|beta-interferons
5123387|NCT01118117|atherosclerotic stenosis|atherosclerotic stenosis
5123388|NCT01118117|occlusions|occlusions
5123389|NCT01118117|Superficial Femoral Artery|superficial femoral artery
5123390|NCT01118117|SFA|sfa
5123391|NCT01118091|Immunotherapy|immunotherapy
5123392|NCT01118091|Metastatic Melanoma|metastatic melanoma
5123393|NCT01118091|Randomized|randomized
5123394|NCT01118091|Cell Therapy|cell therapy
5123395|NCT01118091|Skin Cancer|skin cancer
5123396|NCT01118091|Melanoma|melanoma
5123397|NCT01118065|anaplastic thyroid cancer|anaplastic thyroid cancer
5123398|NCT01118065|recurrent thyroid cancer|recurrent thyroid cancer
5123399|NCT01118065|stage III follicular thyroid cancer|stage iii follicular thyroid cancer
5123400|NCT01118065|stage III papillary thyroid cancer|stage iii papillary thyroid cancer
5123401|NCT01118065|stage IV follicular thyroid cancer|stage iv follicular thyroid cancer
5123402|NCT01118065|stage IV papillary thyroid cancer|stage iv papillary thyroid cancer
5123403|NCT01118065|thyroid gland medullary carcinoma|thyroid gland medullary carcinoma
5123404|NCT01118039|localized transitional cell cancer of the renal pelvis and ureter|localized transitional cell cancer of the renal pelvis and ureter
5123405|NCT01118039|metastatic transitional cell cancer of the renal pelvis and ureter|metastatic transitional cell cancer of the renal pelvis and ureter
5123406|NCT01118039|recurrent transitional cell cancer of the renal pelvis and ureter|recurrent transitional cell cancer of the renal pelvis and ureter
5123407|NCT01118039|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
5123408|NCT01118039|distal urethral cancer|distal urethral cancer
5123409|NCT01118039|proximal urethral cancer|proximal urethral cancer
5123410|NCT01118039|recurrent urethral cancer|recurrent urethral cancer
5123411|NCT01118039|recurrent bladder cancer|recurrent bladder cancer
5123412|NCT01118039|stage IV bladder cancer|stage iv bladder cancer
5123413|NCT01118039|stage III bladder cancer|stage iii bladder cancer
5123414|NCT01118039|urethral cancer associated with invasive bladder cancer|urethral cancer associated with invasive bladder cancer
5123415|NCT01118039|stage III urethral cancer|stage iii urethral cancer
5123416|NCT01118039|stage IV urethral cancer|stage iv urethral cancer
5123417|NCT01118026|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
5123418|NCT01118026|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
5123419|NCT01118026|adult favorable prognosis Hodgkin lymphoma|adult favorable prognosis hodgkin lymphoma
5123420|NCT01118026|adult lymphocyte depletion Hodgkin lymphoma|adult lymphocyte depletion hodgkin lymphoma
5123421|NCT01118026|adult lymphocyte predominant Hodgkin lymphoma|adult lymphocyte predominant hodgkin lymphoma
5123422|NCT01118026|adult mixed cellularity Hodgkin lymphoma|adult mixed cellularity hodgkin lymphoma
5123423|NCT01118026|adult nodular sclerosis Hodgkin lymphoma|adult nodular sclerosis hodgkin lymphoma
5123424|NCT01118026|adult unfavorable prognosis Hodgkin lymphoma|adult unfavorable prognosis hodgkin lymphoma
5123425|NCT01118013|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5123426|NCT01118013|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5123427|NCT01118013|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5123428|NCT01118013|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5123429|NCT01118013|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5123430|NCT01118013|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
5123431|NCT01118013|prolymphocytic leukemia|prolymphocytic leukemia
5123432|NCT01118013|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5123433|NCT01118013|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
5123434|NCT01118013|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5123435|NCT01118013|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5123436|NCT01118013|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5123437|NCT01118013|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5123438|NCT01118013|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5123439|NCT01118013|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5123440|NCT01118013|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5123441|NCT01118013|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
5123442|NCT01118013|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5123443|NCT01118013|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5123444|NCT01118013|recurrent childhood grade III lymphomatoid granulomatosis|recurrent childhood grade iii lymphomatoid granulomatosis
5123445|NCT01118013|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
5123446|NCT01118013|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
5123447|NCT01118013|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
5123448|NCT01118013|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5123449|NCT01118013|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5123450|NCT01118013|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5123451|NCT01118013|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5123452|NCT01118013|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5123453|NCT01118013|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5123454|NCT01118013|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5123455|NCT01118013|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5123456|NCT01118013|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
5123567|NCT01117649|pancreatic head|pancreatic head
5123457|NCT01118013|childhood diffuse large cell lymphoma|childhood diffuse large cell lymphoma
5123458|NCT01118013|childhood grade III lymphomatoid granulomatosis|childhood grade iii lymphomatoid granulomatosis
5123459|NCT01118013|childhood immunoblastic large cell lymphoma|childhood immunoblastic large cell lymphoma
5123460|NCT01118013|childhood nasal type extranodal NK/T-cell lymphoma|childhood nasal type extranodal nk/t-cell lymphoma
5123461|NCT01118013|post-transplant lymphoproliferative disorder|post-transplant lymphoproliferative disorder
5123462|NCT01118013|stage I multiple myeloma|stage i multiple myeloma
5123463|NCT01118013|stage II multiple myeloma|stage ii multiple myeloma
5123464|NCT01118013|stage III multiple myeloma|stage iii multiple myeloma
5123465|NCT01118013|refractory multiple myeloma|refractory multiple myeloma
5123466|NCT01118013|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5123467|NCT01118013|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5123468|NCT01118013|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5123469|NCT01118013|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
5123470|NCT01118013|recurrent childhood anaplastic large cell lymphoma|recurrent childhood anaplastic large cell lymphoma
5123471|NCT01118013|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
5123472|NCT01118013|childhood acute myelomonocytic leukemia (M4)|childhood acute myelomonocytic leukemia (m4)
5123473|NCT01118013|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
5123474|NCT01118013|childhood acute minimally differentiated myeloid leukemia (M0)|childhood acute minimally differentiated myeloid leukemia (m0)
5123475|NCT01118013|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
5123476|NCT01118013|childhood acute myeloblastic leukemia without maturation (M1)|childhood acute myeloblastic leukemia without maturation (m1)
5123477|NCT01118013|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
5123478|NCT01118013|childhood acute myeloblastic leukemia with maturation (M2)|childhood acute myeloblastic leukemia with maturation (m2)
5123479|NCT01118013|adult acute promyelocytic leukemia (M3)|adult acute promyelocytic leukemia (m3)
5123480|NCT01118013|childhood acute promyelocytic leukemia (M3)|childhood acute promyelocytic leukemia (m3)
5123481|NCT01118013|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
5123482|NCT01118013|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
5123483|NCT01118013|childhood acute monoblastic leukemia (M5a)|childhood acute monoblastic leukemia (m5a)
5123484|NCT01118013|childhood acute monocytic leukemia (M5b)|childhood acute monocytic leukemia (m5b)
5123485|NCT01118013|adult erythroleukemia (M6a)|adult erythroleukemia (m6a)
5123486|NCT01118013|adult pure erythroid leukemia (M6b)|adult pure erythroid leukemia (m6b)
5123487|NCT01118013|childhood acute erythroleukemia (M6)|childhood acute erythroleukemia (m6)
5123488|NCT01118013|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
5123489|NCT01118013|childhood acute megakaryocytic leukemia (M7)|childhood acute megakaryocytic leukemia (m7)
5123490|NCT01118013|childhood Burkitt lymphoma|childhood burkitt lymphoma
5123491|NCT01118013|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
5123492|NCT01118013|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5123493|NCT01118013|cutaneous B-cell non-Hodgkin lymphoma|cutaneous b-cell non-hodgkin lymphoma
5123494|NCT01118013|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5123495|NCT01118013|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5123496|NCT01118013|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5123497|NCT01118013|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
5123498|NCT01118000|ischemic preconditioning,serum proteins,human|ischemic preconditioning,serum proteins,human
5123499|NCT01117987|Pulmonary arterial hypertension, imatinib, 6MWD, pulmonary hypertension|pulmonary arterial hypertension, imatinib, 6mwd, pulmonary hypertension
5123500|NCT01117961|Excessive gestational weight gain|excessive gestational weight gain
5123501|NCT01117935|IMRT|imrt
5123502|NCT01117935|prostate cancer|prostate cancer
5123503|NCT01117935|radiation therapy|radiation therapy
5123504|NCT01117935|external beam|external beam
5123505|NCT01117935|recurrent prostate cancer|recurrent prostate cancer
5123506|NCT01117922|preterm birth|preterm birth
5123507|NCT01117922|interconceptional intervention|interconceptional intervention
5123508|NCT01117922|pregnancy outcomes|pregnancy outcomes
5123509|NCT01117909|ankle sprain|ankle sprain
5123510|NCT01117909|athletic injury|athletic injury
5123511|NCT01117909|arthritis|arthritis
5123512|NCT01117896|CPR|cpr
5123513|NCT01117896|Rescuer fatigue|rescuer fatigue
5123514|NCT01117896|Chest Compression effectiveness|chest compression effectiveness
5123515|NCT01117883|Perfusion pressures|perfusion pressures
5123516|NCT01117883|central venous pressure|central venous pressure
5123517|NCT01117883|cardiac output|cardiac output
5123518|NCT01117883|CPR|cpr
5123519|NCT01117883|cardiac arrest|cardiac arrest
5123520|NCT01117883|Leaning|leaning
5123521|NCT01117883|incomplete release|incomplete release
5123522|NCT01117870|chronic|chronic
5123523|NCT01117870|pain|pain
5123524|NCT01117870|lumbar|lumbar
5123525|NCT01117870|Radicular|radicular
5123526|NCT01117831|Diabetes mellitus|diabetes mellitus
5123527|NCT01117805|Asthma|asthma
5123528|NCT01117779|kidney tumors|kidney tumors
5123529|NCT01117779|renal tumors|renal tumors
5123530|NCT01117779|renal cell carcinoma|renal cell carcinoma
5123531|NCT01117779|kidney lesions|kidney lesions
5123532|NCT01117779|renal lesions|renal lesions
5123533|NCT01117779|cryoablation|cryoablation
5123534|NCT01117779|cryotherapy|cryotherapy
5123535|NCT01117779|cryosurgery|cryosurgery
5123536|NCT01117766|Methodology|methodology
5123537|NCT01117766|Quantitative Sensory Testing|quantitative sensory testing
5123538|NCT01117766|Neuropathies Pain|neuropathies pain
5123539|NCT01117766|Pregabalin|pregabalin
5123540|NCT01117740|Malignant Pleural Effusions|malignant pleural effusions
5123541|NCT01117740|MPE|mpe
5123542|NCT01117740|Lungs|lungs
5123543|NCT01117740|Quality of Life|quality of life
5123544|NCT01117740|M. D. Anderson Symptom Inventory|m. d. anderson symptom inventory
5123545|NCT01117740|MDASI|mdasi
5123546|NCT01117740|Indwelling Pleural Catheters|indwelling pleural catheters
5123547|NCT01117740|Thoracoscopic Pleurodesis|thoracoscopic pleurodesis
5123548|NCT01117740|Symptom burden|symptom burden
5123549|NCT01117740|Pleurodesis efficacy|pleurodesis efficacy
5123550|NCT01117740|Complications|complications
5123551|NCT01117740|Health care resource utilization|health care resource utilization
5123552|NCT01117714|Lung cancer|lung cancer
5123553|NCT01117714|Lung neoplasm|lung neoplasm
5123554|NCT01117714|Pulmonary cancer|pulmonary cancer
5123555|NCT01117714|Pulmonary neoplasm|pulmonary neoplasm
5123556|NCT01117714|Lung cancer staging|lung cancer staging
5123557|NCT01117688|Ureteroscopy|ureteroscopy
5123558|NCT01117675|Telemedicine|telemedicine
5123559|NCT01117675|Home care|home care
5123560|NCT01117675|Chronic HIV infection|chronic hiv infection
5123561|NCT01117675|HIV-infected patients|hiv-infected patients
5123562|NCT01117662|transplantation|transplantation
5123563|NCT01117662|acute rejection|acute rejection
5123564|NCT01117662|kidney|kidney
5123565|NCT01117649|PVR|pvr
5123566|NCT01117649|HES 130|hes 130
5123568|NCT01117649|goal-directed|goal-directed
5123569|NCT01117649|intraoperative PVR in elective surgery of the pancreatic head|intraoperative pvr in elective surgery of the pancreatic head
5123570|NCT01117636|Aspirin|aspirin
5123571|NCT01117623|Oncology patients with advanced disease|oncology patients with advanced disease
5123572|NCT01117623|BAY73-4506|bay73-4506
5123573|NCT01117610|pain|pain
5123574|NCT01117610|preemptive|preemptive
5123575|NCT01117610|postoperative|postoperative
5123576|NCT01117610|epidural injection|epidural injection
5123577|NCT01117610|laminectomy|laminectomy
5123578|NCT01117597|Healthy subjects|healthy subjects
5123579|NCT01117584|Type 2 diabetes|type 2 diabetes
5123580|NCT01117584|ASP1941|asp1941
5123581|NCT01117584|diabetes|diabetes
5123582|NCT01117584|metformin|metformin
5123583|NCT01117571|knee|knee
5123584|NCT01117571|osteoarthritis|osteoarthritis
5123585|NCT01117571|unicompartmental|unicompartmental
5123586|NCT01117571|arthroplasty|arthroplasty
5123587|NCT01117571|knee resurfacing|knee resurfacing
5123588|NCT01117571|Conformis|conformis
5123589|NCT01117571|patient specific|patient specific
5123590|NCT01117558|PCOS,|pcos,
5123591|NCT01117558|DM,|dm,
5123592|NCT01117558|Hypertension,|hypertension,
5123593|NCT01117558|CVD|cvd
5123594|NCT01117545|veterans,|veterans,
5123595|NCT01117545|PTSD,|ptsd,
5123596|NCT01117545|EFT (Emotional Freedom Techniques),|eft (emotional freedom techniques),
5123597|NCT01117545|depression,|depression,
5123598|NCT01117545|anxiety|anxiety
5123599|NCT01117532|students,|students,
5123600|NCT01117532|depression,|depression,
5123601|NCT01117532|group therapy,|group therapy,
5123602|NCT01117532|EFT (Emotional Freedom Techniques),|eft (emotional freedom techniques),
5123603|NCT01117532|energy psychology|energy psychology
5123604|NCT01117519|fluid and volume management|fluid and volume management
5123605|NCT01117519|acid-base balance|acid-base balance
5123606|NCT01117519|goal-directed therapy|goal-directed therapy
5123607|NCT01117519|transoesophageal doppler|transoesophageal doppler
5123608|NCT01117506|Angina Pectoris|angina pectoris
5123609|NCT01117506|Myocardial Ischemia|myocardial ischemia
5123610|NCT01117506|Molecular Genetics|molecular genetics
5123611|NCT01117506|Atherosclerosis|atherosclerosis
5123612|NCT01117506|Corus CAD|corus cad
5123613|NCT01117506|ASGES|asges
5123614|NCT01117506|Age/Sex/Gene Expression Score|age/sex/gene expression score
5123615|NCT01117506|Gene Expression|gene expression
5123616|NCT01117506|GES|ges
5123617|NCT01117506|CAD|cad
5123618|NCT01117506|CVD|cvd
5123619|NCT01117506|CHD|chd
5123620|NCT01117506|Precision Medicine|precision medicine
5123621|NCT01117506|Clinical Validity|clinical validity
5123622|NCT01117506|Myocardial Perfusion Imaging|myocardial perfusion imaging
5123623|NCT01117506|Coronary Artery Disease|coronary artery disease
5123624|NCT01117506|Chest Pain|chest pain
5123625|NCT01117506|Cardiovascular Disease|cardiovascular disease
5123626|NCT01117506|Coronary Heart Disease|coronary heart disease
5123627|NCT01117506|MPI|mpi
5123628|NCT01117506|COMPASS|compass
5123629|NCT01117480|Moderate Rheumatoid Arthritis|moderate rheumatoid arthritis
5123630|NCT01117480|Rheumatoid Arthritis|rheumatoid arthritis
5123631|NCT01117480|Severe Rheumatoid Arthritis|severe rheumatoid arthritis
5123632|NCT01117480|Adalimumab|adalimumab
5123633|NCT01117480|Clinical Effectiveness|clinical effectiveness
5123634|NCT01117467|Simulation|simulation
5123635|NCT01117467|Learning|learning
5123636|NCT01117467|Medical Students|medical students
5123637|NCT01117467|Empathy|empathy
5123638|NCT01117467|Anxiety|anxiety
5123639|NCT01117454|Catecholaminergic Polymorphic Ventricular Tachycardia|catecholaminergic polymorphic ventricular tachycardia
5123640|NCT01117454|implantable cardioverter-defibrillator|implantable cardioverter-defibrillator
5123641|NCT01117454|flecainide|flecainide
5123642|NCT01117428|Advanced solid tumors|advanced solid tumors
5123643|NCT01117428|Metastatic colorectal Cancer|metastatic colorectal cancer
5123644|NCT01117415|Gall Bladder|gall bladder
5123645|NCT01117415|Cholecystectomy|cholecystectomy
5123646|NCT01117402|recurrent carcinoma cervix|recurrent carcinoma cervix
5123647|NCT01117402|Vault carcinoma|vault carcinoma
5123648|NCT01117402|Tomotherapy|tomotherapy
5123649|NCT01117402|Brachytherapy|brachytherapy
5123650|NCT01117389|Human Papillomavirus Vaccination|human papillomavirus vaccination
5123651|NCT01117389|Childhood cancer survivors|childhood cancer survivors
5123652|NCT01117389|cervical cancer|cervical cancer
5123653|NCT01117389|sexually transmitted infection|sexually transmitted infection
5123654|NCT01117376|Gastroparesis|gastroparesis
5123655|NCT01117376|Erythromycin|erythromycin
5123656|NCT01117376|Methylnaltrexone|methylnaltrexone
5123657|NCT01117376|ICU|icu
5123658|NCT01117363|Appetite whole grain|appetite whole grain
5123659|NCT01117337|Hernia, laparoscopic, recurrence, pain, inguinal|hernia, laparoscopic, recurrence, pain, inguinal
5123660|NCT01117324|Bone density|bone density
5123661|NCT01117324|infant of diabetic mother|infant of diabetic mother
5123662|NCT01117324|large birth weight|large birth weight
5123663|NCT01117311|Vagus|vagus
5123664|NCT01117311|Diabetes|diabetes
5123665|NCT01117311|Obesity|obesity
5123666|NCT01117298|Raynaud's phenomenon|raynaud's phenomenon
5123667|NCT01117298|ischemic ulcers|ischemic ulcers
5123668|NCT01117298|digital ulcers|digital ulcers
5123669|NCT01117298|digital infarcts|digital infarcts
5123670|NCT01117298|gangrene|gangrene
5123671|NCT01117298|vasodilators|vasodilators
5123672|NCT01117298|endothelial dysfunction|endothelial dysfunction
5123673|NCT01117298|scleroderma|scleroderma
5123674|NCT01117285|Occupational Therapy|occupational therapy
5123675|NCT01117285|Evidence-Based Practice|evidence-based practice
5123676|NCT01117285|Continuing Education|continuing education
5123677|NCT01117285|utilization|utilization
5123678|NCT01117285|Guideline|guideline
5123679|NCT01117285|Dementia|dementia
5123680|NCT01117285|Guideline implementation|guideline implementation
5123681|NCT01117272|PCOS|pcos
5123682|NCT01117272|hyperprolactinemia|hyperprolactinemia
5123683|NCT01117272|obesity|obesity
5123684|NCT01117272|hyperandrogenic|hyperandrogenic
5123685|NCT01117246|bone metastasis|bone metastasis
5123686|NCT01117246|pain palliation|pain palliation
5123687|NCT01117233|Healthy volunteers|healthy volunteers
5123688|NCT01117233|PK|pk
5123689|NCT01117233|PD|pd
5123690|NCT01117233|safety and toleration|safety and toleration
5123691|NCT01117220|pediatric|pediatric
5123692|NCT01117220|bipolar|bipolar
5123693|NCT01117181|Alzheimer's disease|alzheimer's disease
5123694|NCT01117181|Apathy|apathy
5123695|NCT01117181|Methylphenidate|methylphenidate
5123696|NCT01117181|Dopaminergic agents|dopaminergic agents
5123697|NCT01117181|Apathy Evaluation Scale|apathy evaluation scale
5123698|NCT01117181|Dementia|dementia
5123699|NCT01117168|Children's Oncology Group|children's oncology group
5123700|NCT01117168|Pediatric Oncology|pediatric oncology
5123701|NCT01117168|Pediatric Cancer|pediatric cancer
5123702|NCT01117168|Registration|registration
5123703|NCT01117168|Leukemia|leukemia
5123704|NCT01117168|Brain Tumor|brain tumor
5123705|NCT01117168|Sarcoma|sarcoma
5123706|NCT01117155|Brain Tumor|brain tumor
5123707|NCT01117155|Imaging|imaging
5123708|NCT01117155|FLT|flt
5123709|NCT01117155|FDG|fdg
5123710|NCT01117155|Spectroscopy|spectroscopy
5123711|NCT01117155|Glioma|glioma
5123712|NCT01117155|Glioblastoma Multiforme|glioblastoma multiforme
5123713|NCT01117155|Astrocytoma|astrocytoma
5123714|NCT01117142|CLL (Chronic Lymphocytic Leukemia)|cll (chronic lymphocytic leukemia)
5123715|NCT01117142|Monoclonal B Cell Lymphocytosis|monoclonal b cell lymphocytosis
5123716|NCT01117142|CLL|cll
5123717|NCT01117142|MBL|mbl
5123718|NCT01117142|SLL|sll
5123719|NCT01117142|MCL|mcl
5123720|NCT01117142|Growth|growth
5123721|NCT01117142|Development|development
5123722|NCT01117142|Aging|aging
5123723|NCT01117142|Lymphoma, Mantle-Cell|lymphoma, mantle-cell
5123724|NCT01117142|Small Lymphocytic Lymphoma|small lymphocytic lymphoma
5123725|NCT01117142|Mantle Cell Lymphoma|mantle cell lymphoma
5123726|NCT01117142|Cellular Proliferation|cellular proliferation
5123727|NCT01117142|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
5123728|NCT01117142|Monoclonal B-Cell Lymphocytosis|monoclonal b-cell lymphocytosis
5123729|NCT01117142|Healthy Volunteer|healthy volunteer
5123730|NCT01117142|HV|hv
5123731|NCT01117103|Type 2 diabetes|type 2 diabetes
5123732|NCT01117103|Diabetes Mellitus|diabetes mellitus
5123733|NCT01117103|Glucophage|glucophage
5123734|NCT01117103|Metformin|metformin
5123735|NCT01117090|Feasibility|feasibility
5123736|NCT01117090|SynchroMed II|synchromed ii
5123737|NCT01117090|Intrathecal catheter|intrathecal catheter
5123738|NCT01117090|Baclofen|baclofen
5123739|NCT01117077|liver transplantation|liver transplantation
5123740|NCT01117077|aspergillus infection|aspergillus infection
5123741|NCT01117077|interleukin-17|interleukin-17
5123742|NCT01117077|Treg cell|treg cell
5123743|NCT01117077|immune tolerance|immune tolerance
5123744|NCT01117064|Sleep Apnea|sleep apnea
5123745|NCT01117064|OSA|osa
5123746|NCT01117064|CPAP|cpap
5123747|NCT01117051|Opioid induced constipation/prucalopride chronic non-cancer pain|opioid induced constipation/prucalopride chronic non-cancer pain
5123748|NCT01117051|Subjects with chronic non-cancer pain suffering from OIC|subjects with chronic non-cancer pain suffering from oic
5123749|NCT01117038|ED|ed
5123750|NCT01117038|Erectile Dysfunction|erectile dysfunction
5123751|NCT01117025|Resistant hypertension|resistant hypertension
5123752|NCT01117025|Atrial Fibrillation|atrial fibrillation
5123753|NCT01117025|Percutaneous renal denervation|percutaneous renal denervation
5123754|NCT01116986|Smoking|smoking
5123755|NCT01116986|Smoking Cessation|smoking cessation
5123756|NCT01116986|Nicotine|nicotine
5123757|NCT01116973|CVP monitoring compared with peripheral monitoring|cvp monitoring compared with peripheral monitoring
5123758|NCT01116960|P4P|p4p
5123759|NCT01116947|Hypoalbuminemia|hypoalbuminemia
5123760|NCT01116947|Hyperphosphatemia|hyperphosphatemia
5123761|NCT01116947|Phosphorus|phosphorus
5123762|NCT01116947|Protein|protein
5123763|NCT01116947|CKD|ckd
5123764|NCT01116947|Dialysis|dialysis
5123765|NCT01116947|Meals|meals
5123766|NCT01116947|Lanthanum|lanthanum
5123767|NCT01116947|End-Stage Renal Disease (ESRD)|end-stage renal disease (esrd)
5123768|NCT01116947|Dietary Protein Intake (DPI)|dietary protein intake (dpi)
5123769|NCT01116947|Dietary Phosphorus Binding (DPB)|dietary phosphorus binding (dpb)
5123770|NCT01116947|Protein-Energy Wasting (PEW)|protein-energy wasting (pew)
5123771|NCT01116947|Sources of Dietary Phosphorus|sources of dietary phosphorus
5123772|NCT01116934|blood culture, IL-1β, IL-6, IL-8, IP-10, interferon-gamma|blood culture, il-1β, il-6, il-8, ip-10, interferon-gamma
5123773|NCT01116921|laryngeal mask airway|laryngeal mask airway
5123774|NCT01116921|surfactant|surfactant
5123775|NCT01116921|respiratory distress syndrome|respiratory distress syndrome
5123776|NCT01116921|neonate|neonate
5123777|NCT01116908|Diarrhea|diarrhea
5123778|NCT01116908|Water|water
5123779|NCT01116908|Household Water Treatment|household water treatment
5123780|NCT01116908|HIV|hiv
5123781|NCT01116908|Infant Health|infant health
5123782|NCT01116895|Psoriasis Vulgaris|psoriasis vulgaris
5123783|NCT01116895|Systemic|systemic
5123784|NCT01116895|Anti-psoriatic|anti-psoriatic
5123785|NCT01116882|PCI|pci
5123786|NCT01116882|heart disease|heart disease
5123787|NCT01116882|ischemic heart disease|ischemic heart disease
5123788|NCT01116869|MBC|mbc
5123789|NCT01116869|Healthy|healthy
5123790|NCT01116869|Benign disease|benign disease
5123791|NCT01116869|Confirmed metastatic breast cancer patient with at least one measurable solid tumor according to the RECIST guideline|confirmed metastatic breast cancer patient with at least one measurable solid tumor according to the recist guideline
5123792|NCT01116869|Medical examinations detect no breast benign and malignant tumors|medical examinations detect no breast benign and malignant tumors
5123793|NCT01116869|Benign Breast Disease|benign breast disease
5123794|NCT01116869|Pathology diagnosed breast benign tumor disease|pathology diagnosed breast benign tumor disease
5123795|NCT01116856|Exercise|exercise
5123796|NCT01116856|Training|training
5123797|NCT01116856|Obesity|obesity
5123798|NCT01116856|Overweight|overweight
5123799|NCT01116856|Body composition|body composition
5123800|NCT01116856|Lipidic profile|lipidic profile
5123801|NCT01116856|Nutrition|nutrition
5123802|NCT01116856|Polymorphisms|polymorphisms
5123803|NCT01116843|Oral cavity cancer|oral cavity cancer
5123804|NCT01116843|No prior treatment|no prior treatment
5123805|NCT01116817|Long-term Lopinavir/ritonavir monotherapy|long-term lopinavir/ritonavir monotherapy
5123806|NCT01116817|neurocognitive performance|neurocognitive performance
5123807|NCT01116817|ultrasensitive CSF-viraemia|ultrasensitive csf-viraemia
5123808|NCT01116804|Primary liver cancer|primary liver cancer
5123809|NCT01116791|cytoreductive surgery|cytoreductive surgery
5123810|NCT01116791|peritoneal chemotherapy|peritoneal chemotherapy
5123811|NCT01116791|cisplatin|cisplatin
5123812|NCT01116791|cancer|cancer
5123813|NCT01116791|gastric|gastric
5123814|NCT01116791|biliary|biliary
5123815|NCT01116791|pancreas|pancreas
5123816|NCT01116791|peritoneal metastases|peritoneal metastases
5123817|NCT01116791|liver metastases|liver metastases
5123818|NCT01116791|peritoneal carcinomatosis from upper gastrointestinal cancer|peritoneal carcinomatosis from upper gastrointestinal cancer
5123819|NCT01116778|perennial allergic rhinitis|perennial allergic rhinitis
5123820|NCT01116778|probiotics|probiotics
5123821|NCT01116778|Lactobacillus paracasei GMNL-32 (eN-Lac®)|lactobacillus paracasei gmnl-32 (en-lac®)
5123822|NCT01116778|efficacy and safety|efficacy and safety
5123922|NCT01116388|Self injurious behavior|self injurious behavior
5123823|NCT01116765|preterm infants born between 26 to 29 weeks of gestation age.|preterm infants born between 26 to 29 weeks of gestation age.
5123824|NCT01116752|Intensive Care|intensive care
5123825|NCT01116752|Critical care|critical care
5123826|NCT01116752|Glycemic Control|glycemic control
5123827|NCT01116752|Hypoglycemia|hypoglycemia
5123828|NCT01116752|Hyperglycemia|hyperglycemia
5123829|NCT01116752|Insulin treatment|insulin treatment
5123830|NCT01116752|Organ Function|organ function
5123831|NCT01116752|PELOD|pelod
5123832|NCT01116752|Outcomes|outcomes
5123833|NCT01116752|Pediatrics|pediatrics
5123834|NCT01116713|Mastectomy|mastectomy
5123835|NCT01116713|Breast cancer|breast cancer
5123836|NCT01116713|Postoperative pain|postoperative pain
5123837|NCT01116713|Postoperative nausea and vomiting|postoperative nausea and vomiting
5123838|NCT01116700|Epilepsy|epilepsy
5123839|NCT01116700|Dexmedetomidine|dexmedetomidine
5123840|NCT01116700|Seizure|seizure
5123841|NCT01116674|Intensive critical care, glycemic control, hypoglycemia, hyperglycemia , insulin treatment, intensive care outcomes, pediatrics|intensive critical care, glycemic control, hypoglycemia, hyperglycemia , insulin treatment, intensive care outcomes, pediatrics
5123842|NCT01116661|glioma|glioma
5123843|NCT01116661|high grade glioma, low grade glioma|high grade glioma, low grade glioma
5123844|NCT01116635|chemoembolization|chemoembolization
5123845|NCT01116635|drug eluting microsphere|drug eluting microsphere
5123846|NCT01116635|hepato|hepato
5123847|NCT01116635|embolotherapy|embolotherapy
5123848|NCT01116635|downstage|downstage
5123849|NCT01116622|Aerodigestive|aerodigestive
5123850|NCT01116622|Targretin|targretin
5123851|NCT01116622|Tarceva|tarceva
5123852|NCT01116609|Phenylalanine|phenylalanine
5123853|NCT01116609|Palmitate|palmitate
5123854|NCT01116609|hyperinsulinemic-euglycemic-clamp|hyperinsulinemic-euglycemic-clamp
5123855|NCT01116609|Effects of epinephrine in healthy volunteers|effects of epinephrine in healthy volunteers
5123856|NCT01116596|Glutathione|glutathione
5123857|NCT01116596|Paracetamol|paracetamol
5123858|NCT01116596|elderly people|elderly people
5123859|NCT01116583|Gabapentin|gabapentin
5123860|NCT01116583|Thoracotomy|thoracotomy
5123861|NCT01116583|Pain, Postoperative|pain, postoperative
5123862|NCT01116583|Analgesia|analgesia
5123863|NCT01116583|Recovery of Function|recovery of function
5123864|NCT01116583|Quality of Life|quality of life
5123865|NCT01116570|Muscular Dystrophy|muscular dystrophy
5123866|NCT01116570|Facioscapulohumeral|facioscapulohumeral
5123867|NCT01116570|Physical training|physical training
5123868|NCT01116570|Exercise|exercise
5123869|NCT01116557|radiofrequency|radiofrequency
5123870|NCT01116557|ablation|ablation
5123871|NCT01116557|atrial fibrillation|atrial fibrillation
5123872|NCT01116557|CARTO|carto
5123873|NCT01116557|THERMOCOOL|thermocool
5123874|NCT01116557|LASSO|lasso
5123875|NCT01116557|PVAC|pvac
5123876|NCT01116544|AMES device|ames device
5123877|NCT01116544|Cerebrovascular Accident|cerebrovascular accident
5123878|NCT01116544|Chronic Stroke|chronic stroke
5123879|NCT01116544|Rehabilitation|rehabilitation
5123880|NCT01116544|Upper Extremity|upper extremity
5123881|NCT01116544|Biofeedback|biofeedback
5123882|NCT01116531|Pharmacokinetics|pharmacokinetics
5123883|NCT01116531|Pharmacodynamics|pharmacodynamics
5123884|NCT01116531|Interaction|interaction
5123885|NCT01116531|tramadol|tramadol
5123886|NCT01116531|duloxetine|duloxetine
5123887|NCT01116531|pregabalin|pregabalin
5123888|NCT01116505|Celiac disease|celiac disease
5123889|NCT01116505|Endomysial antibodies|endomysial antibodies
5123890|NCT01116505|Gluten-free diet|gluten-free diet
5123891|NCT01116505|Screen-detected|screen-detected
5123892|NCT01116505|Asymptomatic|asymptomatic
5123893|NCT01116505|Bone mineral density|bone mineral density
5123894|NCT01116492|SILS|sils
5123895|NCT01116492|Inflammatory reaction|inflammatory reaction
5123896|NCT01116492|a-defensins|a-defensins
5123897|NCT01116492|SILS vs standard laparoscopic cholecystectomy|sils vs standard laparoscopic cholecystectomy
5123898|NCT01116479|Anaemia, transfusion, cancer, chemotherapy, Quality of life|anaemia, transfusion, cancer, chemotherapy, quality of life
5123899|NCT01116453|dysmenorrhea|dysmenorrhea
5123900|NCT01116453|acupuncture|acupuncture
5123901|NCT01116453|randomized controlled trial|randomized controlled trial
5123902|NCT01116440|Menstrual pain|menstrual pain
5123903|NCT01116440|Refractory endometriosis|refractory endometriosis
5123904|NCT01116440|Pelvic pain|pelvic pain
5123905|NCT01116427|MS|ms
5123906|NCT01116427|multiple sclerosis|multiple sclerosis
5123907|NCT01116427|relapsing-remitting multiple sclerosis|relapsing-remitting multiple sclerosis
5123908|NCT01116427|RRMS|rrms
5123909|NCT01116401|Hot Flashes|hot flashes
5123910|NCT01116401|Sleep disturbance|sleep disturbance
5123911|NCT01116401|Lupron|lupron
5123912|NCT01116401|Menopause|menopause
5123913|NCT01116388|Autism|autism
5123914|NCT01116388|Gastrointestinal Disorders|gastrointestinal disorders
5123915|NCT01116388|Food Allergy|food allergy
5123916|NCT01116388|Gluten free, casein free diet|gluten free, casein free diet
5123917|NCT01116388|Diarrhea|diarrhea
5123918|NCT01116388|Constipation|constipation
5123919|NCT01116388|Reflux|reflux
5123920|NCT01116388|Abdominal pain|abdominal pain
5123921|NCT01116388|Pain after eating|pain after eating
5123923|NCT01116375|Obesity|obesity
5123924|NCT01116375|OSA|osa
5123925|NCT01116375|PAP therapy|pap therapy
5123926|NCT01116362|ulna|ulna
5123927|NCT01116362|median|median
5123928|NCT01116362|repair|repair
5123929|NCT01116362|primary|primary
5123930|NCT01116349|humeral diaphysis fracture|humeral diaphysis fracture
5123931|NCT01116349|plate and screws for humeral diaphysis fracture|plate and screws for humeral diaphysis fracture
5123932|NCT01116349|nailing for humerus diaphysis fracture|nailing for humerus diaphysis fracture
5123933|NCT01116349|Hanging Support System|hanging support system
5123934|NCT01116336|Pre-cancerous conditions|pre-cancerous conditions
5123935|NCT01116336|Head and neck tumors|head and neck tumors
5123936|NCT01116336|Cancer of head and neck|cancer of head and neck
5123937|NCT01116323|Adverse events|adverse events
5123938|NCT01116323|Adverse effects|adverse effects
5123939|NCT01116323|Emergency Service, Hospital|emergency service, hospital
5123940|NCT01116323|Emergency department|emergency department
5123941|NCT01116323|Crowding|crowding
5123942|NCT01116310|Hot flushes|hot flushes
5123943|NCT01116310|Hot flashes|hot flashes
5123944|NCT01116310|menopause|menopause
5123945|NCT01116310|postmenopause|postmenopause
5123946|NCT01116310|Soy isoflavones|soy isoflavones
5123947|NCT01116310|Red clover|red clover
5123948|NCT01116310|Equol|equol
5123949|NCT01116297|breast reconstruction|breast reconstruction
5123950|NCT01116297|breast cancer|breast cancer
5123951|NCT01116297|near infrared imaging|near infrared imaging
5123952|NCT01116284|Weight Loss|weight loss
5123953|NCT01116284|Obesity|obesity
5123954|NCT01116284|Gastric Bypass|gastric bypass
5123955|NCT01116271|colorectal|colorectal
5123956|NCT01116271|second line therapy|second line therapy
5123957|NCT01116271|K-ras or B-raf mutations|k-ras or b-raf mutations
5123958|NCT01116271|response rate|response rate
5123959|NCT01116271|Progression Free Survival|progression free survival
5123960|NCT01116258|Safety|safety
5123961|NCT01116245|Cervical Intraepithelial Neoplasia Stage 2/3|cervical intraepithelial neoplasia stage 2/3
5123962|NCT01116232|graft versus host disease|graft versus host disease
5123963|NCT01116232|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5123964|NCT01116232|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5123965|NCT01116232|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5123966|NCT01116232|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5123967|NCT01116232|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5123968|NCT01116232|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5123969|NCT01116232|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5123970|NCT01116232|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5123971|NCT01116232|atypical chronic myeloid leukemia, BCR-ABL negative|atypical chronic myeloid leukemia, bcr-abl negative
5123972|NCT01116232|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5123973|NCT01116232|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5123974|NCT01116232|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5123975|NCT01116232|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
5123976|NCT01116232|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
5123977|NCT01116232|prolymphocytic leukemia|prolymphocytic leukemia
5123978|NCT01116232|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5123979|NCT01116232|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5123980|NCT01116232|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
5123981|NCT01116232|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5123982|NCT01116232|refractory hairy cell leukemia|refractory hairy cell leukemia
5123983|NCT01116232|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5123984|NCT01116232|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
5123985|NCT01116232|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
5123986|NCT01116232|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
5123987|NCT01116232|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
5123988|NCT01116232|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
5123989|NCT01116232|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5123990|NCT01116232|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
5123991|NCT01116232|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5123992|NCT01116232|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
5123993|NCT01116232|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
5123994|NCT01116232|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
5123995|NCT01116232|untreated hairy cell leukemia|untreated hairy cell leukemia
5123996|NCT01116232|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5123997|NCT01116232|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
5123998|NCT01116232|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
5123999|NCT01116232|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5124000|NCT01116232|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5124001|NCT01116232|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5124002|NCT01116232|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
5124003|NCT01116232|cutaneous B-cell non-Hodgkin lymphoma|cutaneous b-cell non-hodgkin lymphoma
5124004|NCT01116232|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5124005|NCT01116232|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
5124006|NCT01116232|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
5124007|NCT01116232|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
5124008|NCT01116232|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
5124009|NCT01116232|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5124010|NCT01116232|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
5124011|NCT01116232|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
5124012|NCT01116232|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
5124013|NCT01116232|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
5124014|NCT01116232|adult grade III lymphomatoid granulomatosis|adult grade iii lymphomatoid granulomatosis
5124015|NCT01116232|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
5124016|NCT01116232|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
5124017|NCT01116232|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5124018|NCT01116232|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5124019|NCT01116232|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5124020|NCT01116232|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
5124021|NCT01116232|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
5124022|NCT01116232|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
5124023|NCT01116232|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
5124024|NCT01116232|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
5124025|NCT01116232|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
5124026|NCT01116232|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
5124027|NCT01116232|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
5124028|NCT01116232|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
5124029|NCT01116232|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
5124030|NCT01116232|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
5124031|NCT01116232|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
5124032|NCT01116232|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
5124033|NCT01116232|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
5124034|NCT01116232|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
5124035|NCT01116232|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
5124036|NCT01116232|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
5124037|NCT01116232|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
5124038|NCT01116232|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
5124039|NCT01116232|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
5124040|NCT01116232|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
5124041|NCT01116232|stage I mantle cell lymphoma|stage i mantle cell lymphoma
5124042|NCT01116232|stage I marginal zone lymphoma|stage i marginal zone lymphoma
5124043|NCT01116232|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
5124044|NCT01116232|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
5124045|NCT01116232|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5124046|NCT01116232|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
5124047|NCT01116232|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
5124048|NCT01116232|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
5124049|NCT01116232|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
5124050|NCT01116232|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5124051|NCT01116232|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5124052|NCT01116232|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5124053|NCT01116232|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5124054|NCT01116232|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
5124055|NCT01116232|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
5124056|NCT01116232|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5124057|NCT01116232|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5124058|NCT01116232|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5124059|NCT01116232|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5124231|NCT01115478|Anemia|anemia
5124060|NCT01116232|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5124061|NCT01116232|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5124062|NCT01116232|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5124063|NCT01116232|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5124064|NCT01116232|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5124065|NCT01116232|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5124066|NCT01116232|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5124067|NCT01116232|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5124068|NCT01116232|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5124069|NCT01116232|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5124070|NCT01116232|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5124071|NCT01116232|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5124072|NCT01116232|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5124073|NCT01116232|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5124074|NCT01116232|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5124075|NCT01116232|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5124076|NCT01116232|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5124077|NCT01116232|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5124078|NCT01116232|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5124079|NCT01116232|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5124080|NCT01116232|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5124081|NCT01116232|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5124082|NCT01116232|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5124083|NCT01116232|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5124084|NCT01116232|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
5124085|NCT01116232|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5124086|NCT01116232|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5124087|NCT01116232|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5124088|NCT01116232|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5124089|NCT01116232|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5124090|NCT01116232|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5124091|NCT01116232|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5124092|NCT01116232|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5124093|NCT01116232|intraocular lymphoma|intraocular lymphoma
5124094|NCT01116232|post-transplant lymphoproliferative disorder|post-transplant lymphoproliferative disorder
5124095|NCT01116232|chronic eosinophilic leukemia|chronic eosinophilic leukemia
5124096|NCT01116232|chronic neutrophilic leukemia|chronic neutrophilic leukemia
5124097|NCT01116232|primary myelofibrosis|primary myelofibrosis
5124098|NCT01116232|stage I multiple myeloma|stage i multiple myeloma
5124099|NCT01116232|stage II multiple myeloma|stage ii multiple myeloma
5124100|NCT01116232|stage III multiple myeloma|stage iii multiple myeloma
5124101|NCT01116232|refractory multiple myeloma|refractory multiple myeloma
5124102|NCT01116232|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5124103|NCT01116232|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5124104|NCT01116232|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
5124105|NCT01116219|adenocarcinoma of the lung|adenocarcinoma of the lung
5124106|NCT01116219|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
5124107|NCT01116219|large cell lung cancer|large cell lung cancer
5124108|NCT01116219|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5124109|NCT01116219|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5124110|NCT01116206|Constipation|constipation
5124111|NCT01116206|Prucalopride|prucalopride
5124112|NCT01116206|Resolor|resolor
5124113|NCT01116193|antileukemic therapy|antileukemic therapy
5124114|NCT01116193|lymphoblastic leukemia|lymphoblastic leukemia
5124115|NCT01116193|lenalidomide|lenalidomide
5124116|NCT01116193|dexamethasone|dexamethasone
5124117|NCT01116180|Type 1 diabetes|type 1 diabetes
5124118|NCT01116180|Hypoglycaemia|hypoglycaemia
5124119|NCT01116180|genetic susceptibility|genetic susceptibility
5124120|NCT01116180|Renin angiotensin system activity|renin angiotensin system activity
5124121|NCT01116167|Polycystic Ovary Syndrome|polycystic ovary syndrome
5124122|NCT01116141|rheumatoid arthritis|rheumatoid arthritis
5124123|NCT01116141|MTX|mtx
5124124|NCT01116141|CH-405|ch-405
5124125|NCT01116141|antifolates|antifolates
5124126|NCT01116128|relapsed/refractory myeloma patients|relapsed/refractory myeloma patients
5124127|NCT01116128|Progression free survival|progression free survival
5124128|NCT01116128|Overall survival|overall survival
5124129|NCT01116128|dasatinib|dasatinib
5124130|NCT01116115|Term Infants|term infants
5124131|NCT01116115|Intestine flora|intestine flora
5124132|NCT01116115|Stool characteristics|stool characteristics
5124133|NCT01116102|dehydration|dehydration
5124134|NCT01116102|fluid therapy|fluid therapy
5124135|NCT01116102|hyaluronoglucosaminidase|hyaluronoglucosaminidase
5124136|NCT01116102|hyaluronidase|hyaluronidase
5124137|NCT01116102|hypodermoclysis|hypodermoclysis
5124138|NCT01116102|clysis|clysis
5124139|NCT01116102|subcutaneous hydration|subcutaneous hydration
5124140|NCT01116102|subcutaneous rehydration|subcutaneous rehydration
5124141|NCT01116102|hyaluronan|hyaluronan
5124142|NCT01116102|rHuPH20|rhuph20
5124143|NCT01116089|Cystic fibrosis, tobramycin,nebulizer, PK|cystic fibrosis, tobramycin,nebulizer, pk
5124144|NCT01116063|COPD, Pulmonary hypertension|copd, pulmonary hypertension
5124145|NCT01116037|Diseased Heart Valve, Replacement, Aortic, Stentless|diseased heart valve, replacement, aortic, stentless
5124146|NCT01116024|Diseased Heart Valve, Replacement, Aortic|diseased heart valve, replacement, aortic
5124147|NCT01116011|Phase I|phase i
5124148|NCT01116011|Japanese Healthy volunteer|japanese healthy volunteer
5124149|NCT01115998|cerebral palsy|cerebral palsy
5124150|NCT01115998|wheelchair|wheelchair
5124151|NCT01115998|disabled children|disabled children
5124152|NCT01115985|ASP1585|asp1585
5124153|NCT01115985|Drug-drug interaction|drug-drug interaction
5124154|NCT01115985|Atorvastatin|atorvastatin
5124155|NCT01115985|Healthy volunteer|healthy volunteer
5124156|NCT01115972|ASP1585|asp1585
5124157|NCT01115972|Drug-drug interaction|drug-drug interaction
5124158|NCT01115972|valsartan|valsartan
5124159|NCT01115972|Healthy volunteer|healthy volunteer
5124160|NCT01115946|ASP1585|asp1585
5124161|NCT01115946|Drug-drug interaction|drug-drug interaction
5124162|NCT01115946|enalapril|enalapril
5124163|NCT01115946|Healthy volunteer|healthy volunteer
5124164|NCT01115933|drug eluting stents|drug eluting stents
5124165|NCT01115933|small vessel|small vessel
5124166|NCT01115933|Stents|stents
5124167|NCT01115933|Everolimus|everolimus
5124168|NCT01115933|Angioplasty|angioplasty
5124169|NCT01115920|Drug Safety|drug safety
5124170|NCT01115920|Clinical Trial, Phase I|clinical trial, phase i
5124171|NCT01115920|Nontherapeutic Human Experimentation|nontherapeutic human experimentation
5124172|NCT01115920|Heading Pharmacokinetics|heading pharmacokinetics
5124173|NCT01115920|Phase I Safety and Tolerability|phase i safety and tolerability
5124174|NCT01115907|Aortic|aortic
5124175|NCT01115907|Valve replacement|valve replacement
5124176|NCT01115894|problem drinking|problem drinking
5124177|NCT01115894|alcohol|alcohol
5124178|NCT01115881|To examine the relationship between signal strength and macular thickness measured by stratus OCT|to examine the relationship between signal strength and macular thickness measured by stratus oct
5124179|NCT01115855|Double-blind|double-blind
5124180|NCT01115855|eplerenone|eplerenone
5124181|NCT01115855|Japanese|japanese
5124182|NCT01115842|Vitamin D|vitamin d
5124183|NCT01115842|Acute coronary syndrome|acute coronary syndrome
5124184|NCT01115842|inflammatory cytokines|inflammatory cytokines
5124185|NCT01115803|Advanced Cancer|advanced cancer
5124186|NCT01115803|Metastatic Cancer|metastatic cancer
5124187|NCT01115803|Non-Small Cell Lung Cancer|non-small cell lung cancer
5124188|NCT01115803|Renal Cell Carcinoma|renal cell carcinoma
5124189|NCT01115803|Neuroendocrine Tumors|neuroendocrine tumors
5124190|NCT01115777|Pediatric patients|pediatric patients
5124191|NCT01115777|treated with|treated with
5124192|NCT01115777|radiation therapy|radiation therapy
5124193|NCT01115777|for brain tumors|for brain tumors
5124194|NCT01115777|and non-CNS malignancies|and non-cns malignancies
5124195|NCT01115764|diastolic dysfunction|diastolic dysfunction
5124196|NCT01115751|Advanced Cancer|advanced cancer
5124197|NCT01115751|Metastatic Cancer|metastatic cancer
5124198|NCT01115751|Solid Tumors|solid tumors
5124199|NCT01115738|Plavix, Effient|plavix, effient
5124200|NCT01115725|Follitropin alfa|follitropin alfa
5124201|NCT01115725|Fertilization in vitro|fertilization in vitro
5124202|NCT01115725|Intracytoplasmic sperm injection|intracytoplasmic sperm injection
5124203|NCT01115725|Reproductive techniques, assisted|reproductive techniques, assisted
5124204|NCT01115712|Healthy Volunteers|healthy volunteers
5124205|NCT01115699|Depression|depression
5124206|NCT01115699|rTMS|rtms
5124207|NCT01115660|stroke|stroke
5124208|NCT01115660|patient education|patient education
5124209|NCT01115660|medication adherence|medication adherence
5124210|NCT01115647|Malnutrition|malnutrition
5124211|NCT01115647|Nutritional intervention|nutritional intervention
5124212|NCT01115647|Behavioural intervention|behavioural intervention
5124213|NCT01115647|Burkina Faso|burkina faso
5124214|NCT01115647|Cluster randomize trial|cluster randomize trial
5124215|NCT01115634|Fibroblast|fibroblast
5124216|NCT01115634|Cell transplantation|cell transplantation
5124217|NCT01115634|Facial deformities|facial deformities
5124218|NCT01115608|Preventive Health Services|preventive health services
5124219|NCT01115595|Allergic rhinitis|allergic rhinitis
5124220|NCT01115595|Allergen injection immunotherapy|allergen injection immunotherapy
5124221|NCT01115595|Efficacy|efficacy
5124222|NCT01115582|Inborn Errors|inborn errors
5124223|NCT01115582|Bile Acid|bile acid
5124224|NCT01115582|Pediatrics|pediatrics
5124225|NCT01115582|Liver Disease|liver disease
5124226|NCT01115569|chronic pain|chronic pain
5124227|NCT01115504|Thiamine|thiamine
5124228|NCT01115504|heart failure|heart failure
5124229|NCT01115478|Malaria|malaria
5124230|NCT01115478|Low birth weight|low birth weight
5124232|NCT01115478|Perinatal mortality|perinatal mortality
5124233|NCT01115478|Vitamin A|vitamin a
5124234|NCT01115478|Zinc|zinc
5124235|NCT01115465|Stress Urinary Incontinence|stress urinary incontinence
5124236|NCT01115465|silicone elastomer|silicone elastomer
5124237|NCT01115452|potassium nitrate|potassium nitrate
5124238|NCT01115452|tooth sensitivity|tooth sensitivity
5124239|NCT01115452|dentin sensitivity|dentin sensitivity
5124240|NCT01115439|falciparum malaria|falciparum malaria
5124241|NCT01115439|artemisinin combination treatments|artemisinin combination treatments
5124242|NCT01115413|teenage|teenage
5124243|NCT01115413|pregnancy|pregnancy
5124244|NCT01115413|obstetrical risk|obstetrical risk
5124245|NCT01115400|Abdominal Wall Hernia|abdominal wall hernia
5124246|NCT01115400|quality of life|quality of life
5124247|NCT01115387|Age-related macular degeneration|age-related macular degeneration
5124248|NCT01115387|AMD|amd
5124249|NCT01115387|Genetic risk|genetic risk
5124250|NCT01115387|Environmental risk factors|environmental risk factors
5124251|NCT01115387|Complex genetic disorder|complex genetic disorder
5124252|NCT01115387|Age-related maculopathy|age-related maculopathy
5124253|NCT01115387|Risk modeling|risk modeling
5124254|NCT01115387|Smoking|smoking
5124255|NCT01115387|Light exposure|light exposure
5124256|NCT01115387|Sleep apnea|sleep apnea
5124257|NCT01115387|Fundus Photography|fundus photography
5124258|NCT01115387|Macula|macula
5124259|NCT01115387|Drusen|drusen
5124260|NCT01115387|Wet AMD|wet amd
5124261|NCT01115387|Dry AMD|dry amd
5124262|NCT01115387|Geographic atrophy|geographic atrophy
5124263|NCT01115387|Vitamins & supplements|vitamins & supplements
5124264|NCT01115361|family planning|family planning
5124265|NCT01115361|postpartum|postpartum
5124266|NCT01115361|immunization|immunization
5124267|NCT01115361|integration|integration
5124268|NCT01115361|Contraceptive behavior|contraceptive behavior
5124269|NCT01115335|neonatal male circumcision|neonatal male circumcision
5124270|NCT01115335|Gomco|gomco
5124271|NCT01115335|Plastibell|plastibell
5124272|NCT01115335|Mogen|mogen
5124273|NCT01115335|Safety|safety
5124274|NCT01115335|Uptake|uptake
5124275|NCT01115335|Acceptability|acceptability
5124276|NCT01115335|Feasibility|feasibility
5124277|NCT01115335|Zambia|zambia
5124278|NCT01115322|Healthy volunteer study|healthy volunteer study
5124279|NCT01115322|phototoxicity|phototoxicity
5124280|NCT01115309|Sinusitis|sinusitis
5124281|NCT01115296|Helicobacter Pylori|helicobacter pylori
5124282|NCT01115296|gastritis|gastritis
5124283|NCT01115296|Probiotics|probiotics
5124284|NCT01115296|Lactobacillus Reuteri|lactobacillus reuteri
5124285|NCT01115283|amblyopia treatment|amblyopia treatment
5124286|NCT01115283|neural plasticity|neural plasticity
5124287|NCT01115283|perceptual learning|perceptual learning
5124288|NCT01115283|vision therapy|vision therapy
5124289|NCT01115283|spatial vision|spatial vision
5124290|NCT01115283|video games|video games
5124291|NCT01115283|occlusion therapy|occlusion therapy
5124292|NCT01115270|Normal Pressure Hydrocephalus|normal pressure hydrocephalus
5124293|NCT01115257|severe proliferative diabetic retinopathy|severe proliferative diabetic retinopathy
5124294|NCT01115257|vitrectomy|vitrectomy
5124295|NCT01115257|panretinalphotocoagulation|panretinalphotocoagulation
5124296|NCT01115244|Dermatitis herpetiformis|dermatitis herpetiformis
5124297|NCT01115244|Dapsone|dapsone
5124298|NCT01115231|Age-Related Macular Degeneration|age-related macular degeneration
5124299|NCT01115231|Age-Related Maculopathies|age-related maculopathies
5124300|NCT01115231|Age-Related Maculopathy|age-related maculopathy
5124301|NCT01115231|Macular Dystrophy|macular dystrophy
5124302|NCT01115231|Maculopathies, Age-Related|maculopathies, age-related
5124303|NCT01115231|Maculopathy, Age-Related|maculopathy, age-related
5124304|NCT01115218|Glaucoma|glaucoma
5124305|NCT01115205|Exercise, Walking, Type 2 diabetes, Therapy|exercise, walking, type 2 diabetes, therapy
5124306|NCT01115179|propofol|propofol
5124307|NCT01115179|inflammation|inflammation
5124308|NCT01115179|perioperative|perioperative
5124309|NCT01115179|lipids|lipids
5124310|NCT01115179|Apolipoprotein A-I|apolipoprotein a-i
5124311|NCT01115166|blood volume|blood volume
5124312|NCT01115153|Acute appendicitis|acute appendicitis
5124313|NCT01115153|Antibiotic prophylaxis|antibiotic prophylaxis
5124314|NCT01115153|Wound infection|wound infection
5124315|NCT01115153|Nosocomial infection|nosocomial infection
5124316|NCT01115140|Folate|folate
5124317|NCT01115140|Metformin|metformin
5124318|NCT01115140|PCOS|pcos
5124319|NCT01115140|Pregnancy|pregnancy
5124320|NCT01115140|Trophoblastic invasion|trophoblastic invasion
5124321|NCT01115140|Uterine artery velocimetry|uterine artery velocimetry
5124322|NCT01115127|pre-menopause|pre-menopause
5124323|NCT01115127|melatonin|melatonin
5124324|NCT01115127|myo-inositol|myo-inositol
5124325|NCT01115101|pain after cesarean|pain after cesarean
5124326|NCT01115101|visual analog scale|visual analog scale
5124327|NCT01115101|oxycodon|oxycodon
5124328|NCT01115101|piritramid|piritramid
5124329|NCT01115075|Leptin|leptin
5124330|NCT01115075|Changes in leptin may precede the|changes in leptin may precede the
5124331|NCT01115075|phasing of oscillations of dietary fat intake|phasing of oscillations of dietary fat intake
5124332|NCT01115062|Pain|pain
5124333|NCT01115062|Children|children
5124334|NCT01115062|Local anesthetics|local anesthetics
5124335|NCT01115036|glioblastoma|glioblastoma
5124336|NCT01115036|recurrent|recurrent
5124337|NCT01115036|surgical resection|surgical resection
5124338|NCT01115023|iron deficiency anemia|iron deficiency anemia
5124339|NCT01115023|dietary intervention|dietary intervention
5124340|NCT01115023|To evaluate a cheap and sustainable dietary intervention to improve the iron status of the entire family of the index case of non-severe iron deficiency anemia.|to evaluate a cheap and sustainable dietary intervention to improve the iron status of the entire family of the index case of non-severe iron deficiency anemia.
5124341|NCT01115010|intubation rate|intubation rate
5124342|NCT01115010|intubation time|intubation time
5124343|NCT01115010|stiffening device|stiffening device
5124344|NCT01115010|stiffening wire|stiffening wire
5124345|NCT01114997|Lidocaine Infusion|lidocaine infusion
5124346|NCT01114997|Esmolol Infusion|esmolol infusion
5124347|NCT01114997|Anesthetic adjuvant|anesthetic adjuvant
5124348|NCT01114997|Abdominal surgery|abdominal surgery
5124349|NCT01114997|Pain management|pain management
5124350|NCT01114997|Hemodynamic stability|hemodynamic stability
5124351|NCT01114997|Perioperative outcomes|perioperative outcomes
5124352|NCT01114984|Pain management|pain management
5124353|NCT01114984|Radical mastectomy|radical mastectomy
5124354|NCT01114984|Breast surgery|breast surgery
5124355|NCT01114984|post-operative pain|post-operative pain
5124356|NCT01114971|Labetalol|labetalol
5124357|NCT01114971|Esmolol|esmolol
5124358|NCT01114971|Fentanyl|fentanyl
5124359|NCT01114971|Anesthetic adjuvant|anesthetic adjuvant
5124360|NCT01114971|Ambulatory surgery|ambulatory surgery
5124361|NCT01114971|Outpatient surgery|outpatient surgery
5124362|NCT01114971|Pain management|pain management
5124363|NCT01114971|Hemodynamic stability|hemodynamic stability
5124364|NCT01114971|Perioperative outcomes|perioperative outcomes
5124365|NCT01114958|Lung cancer|lung cancer
5124366|NCT01114958|Non-small cell lung cancer|non-small cell lung cancer
5124367|NCT01114958|Small-cell lung cancer|small-cell lung cancer
5124368|NCT01114958|Lung metastases|lung metastases
5124369|NCT01114958|Metastatic cancer|metastatic cancer
5124370|NCT01114958|Stage IIIA|stage iiia
5124371|NCT01114958|Stage IIIB|stage iiib
5124372|NCT01114958|Stage III|stage iii
5124373|NCT01114958|Stage 3|stage 3
5124374|NCT01114945|Direct Laryngoscopy|direct laryngoscopy
5124375|NCT01114945|Video-Mac|video-mac
5124376|NCT01114945|GlideScope|glidescope
5124377|NCT01114945|McGrath|mcgrath
5124378|NCT01114945|Laryngoscopy|laryngoscopy
5124379|NCT01114945|Bariatrics|bariatrics
5124380|NCT01114945|Glottic view|glottic view
5124381|NCT01114945|Airway intubating devices|airway intubating devices
5124382|NCT01114945|Tracheal intubation|tracheal intubation
5124383|NCT01114932|pre-oxygenation|pre-oxygenation
5124384|NCT01114932|body mass index|body mass index
5124385|NCT01114932|end-tidal O2|end-tidal o2
5124386|NCT01114932|anesthesia induction|anesthesia induction
5124387|NCT01114919|Problem drinking|problem drinking
5124388|NCT01114919|Alcohol dependence|alcohol dependence
5124389|NCT01114919|Alcohol abuse|alcohol abuse
5124390|NCT01114919|Internet based intervention|internet based intervention
5124391|NCT01114919|Treatment|treatment
5124392|NCT01114919|Alcohol Use Disorders Identification Test|alcohol use disorders identification test
5124393|NCT01114906|Asthma|asthma
5124394|NCT01114906|Resource use|resource use
5124395|NCT01114880|ankylosing spondylitis|ankylosing spondylitis
5124396|NCT01114880|China|china
5124397|NCT01114867|ultrasound|ultrasound
5124398|NCT01114867|penis length|penis length
5124399|NCT01114867|corpus cavernosum|corpus cavernosum
5124400|NCT01114867|length of fetal penis and fetal corpus cavernosum|length of fetal penis and fetal corpus cavernosum
5124401|NCT01114841|Healthy Volunteer Subjects|healthy volunteer subjects
5124402|NCT01114828|Cirrhosis|cirrhosis
5124403|NCT01114828|ascites|ascites
5124404|NCT01114828|Tolvaptan|tolvaptan
5124405|NCT01114828|OPC-41061|opc-41061
5124406|NCT01114815|CADASIL|cadasil
5124407|NCT01114815|cerebral|cerebral
5124408|NCT01114815|autosomal dominant|autosomal dominant
5124409|NCT01114815|arteriopathy|arteriopathy
5124410|NCT01114815|subcortical infarcts|subcortical infarcts
5124411|NCT01114815|leukoencephalopathy|leukoencephalopathy
5124412|NCT01114802|Cancer survivors|cancer survivors
5124413|NCT01114802|Anxiety|anxiety
5124414|NCT01114802|Depression|depression
5124415|NCT01114802|Technology Assisted|technology assisted
5124416|NCT01114802|Internet|internet
5124417|NCT01114789|chronic renal failure|chronic renal failure
5124418|NCT01114789|hemodialysis|hemodialysis
5124419|NCT01114789|obesity|obesity
5124420|NCT01114789|proteolysis|proteolysis
5124421|NCT01114763|Metabolic Syndrome|metabolic syndrome
5124422|NCT01114763|Oxidized Low Density Lipoprotein|oxidized low density lipoprotein
5124423|NCT01114763|Arterial Elasticity|arterial elasticity
5124424|NCT01114763|Diabetes Mellitus|diabetes mellitus
5124425|NCT01114763|Cardiovascular Diseases|cardiovascular diseases
5124426|NCT01114750|blood glucose|blood glucose
5124427|NCT01114750|blood insulin|blood insulin
5124428|NCT01114750|dextran|dextran
5124429|NCT01114750|diabetes|diabetes
5124430|NCT01114750|hyperglycemia|hyperglycemia
5124431|NCT01114750|hypoglycemia|hypoglycemia
5124432|NCT01114750|oral delivery|oral delivery
5124433|NCT01114750|portal delivery|portal delivery
5124434|NCT01114737|Phenylketonuria|phenylketonuria
5124435|NCT01114737|PKU|pku
5124436|NCT01114737|Kuvan|kuvan
5124437|NCT01114737|Sapropterin dihydrochloride|sapropterin dihydrochloride
5124438|NCT01114737|Neuropsychiatric disorder|neuropsychiatric disorder
5124439|NCT01114737|ADHD|adhd
5124440|NCT01114724|Thoracic dissection|thoracic dissection
5124441|NCT01114724|Endovascular aortic repair|endovascular aortic repair
5124442|NCT01114711|Menstrual Migraine|menstrual migraine
5124443|NCT01114711|Frova|frova
5124444|NCT01114711|Imaging|imaging
5124445|NCT01114711|fMRI|fmri
5124446|NCT01114711|Pain|pain
5124447|NCT01114698|Depression|depression
5124448|NCT01114698|Major Depressive Disorder|major depressive disorder
5124449|NCT01114698|Venlafaxine XR (EFFEXOR XR)|venlafaxine xr (effexor xr)
5124450|NCT01114698|26489112|26489112
5124451|NCT01114698|JNJ26489112|jnj26489112
5124452|NCT01114672|Pruritis in hemodialysis patients|pruritis in hemodialysis patients
5124453|NCT01114672|25-Vitamin D in chronic kidney disease|25-vitamin d in chronic kidney disease
5124454|NCT01114646|Hemiarthroplasty|hemiarthroplasty
5124455|NCT01114646|Cemented|cemented
5124456|NCT01114646|Press Fit|press fit
5124457|NCT01114646|Mortality|mortality
5124458|NCT01114646|Morbidity|morbidity
5124459|NCT01114646|Functional Status|functional status
5124460|NCT01114646|Displaced femoral neck fracture|displaced femoral neck fracture
5124461|NCT01114633|PCOS|pcos
5124462|NCT01114633|Acne|acne
5124463|NCT01114633|Hirsutism|hirsutism
5124464|NCT01114620|elderly|elderly
5124465|NCT01114620|post-marketing|post-marketing
5124466|NCT01114620|H1N1|h1n1
5124467|NCT01114620|Clinical trial|clinical trial
5124468|NCT01114620|pandemic influenza|pandemic influenza
5124469|NCT01114607|GSK1605786|gsk1605786
5124470|NCT01114607|relative bioavailability|relative bioavailability
5124471|NCT01114607|CCR9 receptor antagonist|ccr9 receptor antagonist
5124472|NCT01114594|Chronic Kidney Disease (CKD)|chronic kidney disease (ckd)
5124473|NCT01114594|Autosomal Dominant Polycystic Kidney Disease (ADPKD)|autosomal dominant polycystic kidney disease (adpkd)
5124474|NCT01114581|Acute Respiratory Infection|acute respiratory infection
5124475|NCT01114581|Mucociliary|mucociliary
5124476|NCT01114581|Cough Clearance|cough clearance
5124477|NCT01114581|Guaifenesin|guaifenesin
5124478|NCT01114568|Relative Bioavailability|relative bioavailability
5124479|NCT01114568|Pharmacokinetics|pharmacokinetics
5124480|NCT01114568|Pharmacodynamics|pharmacodynamics
5124481|NCT01114555|Bevacizumab|bevacizumab
5124482|NCT01114555|Irinotecan|irinotecan
5124483|NCT01114555|Temozolomide|temozolomide
5124484|NCT01114555|10-015|10-015
5124485|NCT01114529|de novo renal allograft recipients|de novo renal allograft recipients
5124486|NCT01114529|renal allograft function|renal allograft function
5124487|NCT01114529|CNI-free regimen|cni-free regimen
5124488|NCT01114516|cervical insufficiency|cervical insufficiency
5124489|NCT01114503|GSK2136525|gsk2136525
5124490|NCT01114503|Pharmacodynamics|pharmacodynamics
5124491|NCT01114503|Safety|safety
5124492|NCT01114503|Otelixizumab|otelixizumab
5124493|NCT01114503|Thyroid eye disease|thyroid eye disease
5124494|NCT01114503|Graves' ophthalmopathy|graves' ophthalmopathy
5124495|NCT01114503|Repeat dose|repeat dose
5124496|NCT01114503|Intravenous infusion|intravenous infusion
5124497|NCT01114503|Tolerability|tolerability
5124498|NCT01114503|EUGOGO|eugogo
5124499|NCT01114490|Hepatic Insufficiency|hepatic insufficiency
5124500|NCT01114477|Transcranial magnetic stimulation|transcranial magnetic stimulation
5124501|NCT01114477|TMS|tms
5124502|NCT01114477|Observational study|observational study
5124503|NCT01114477|Major Depression|major depression
5124504|NCT01114464|Breast cancer|breast cancer
5124505|NCT01114464|Ovarian reserve|ovarian reserve
5124506|NCT01114464|Anti-Mullerian Hormone (AMH)|anti-mullerian hormone (amh)
5124507|NCT01114464|Chemotherapy|chemotherapy
5124508|NCT01114451|Cesarean delivery|cesarean delivery
5124509|NCT01114451|Obesity|obesity
5124510|NCT01114451|Skin staples|skin staples
5124511|NCT01114451|Wound complications|wound complications
5124512|NCT01114425|tolerability of post exposure to HIV infection prophylaxis|tolerability of post exposure to hiv infection prophylaxis
5124513|NCT01114412|focus groups|focus groups
5124514|NCT01114412|overactive bladder|overactive bladder
5124515|NCT01114412|bladder sensations|bladder sensations
5124516|NCT01114399|Cardiovascular Disease|cardiovascular disease
5124517|NCT01114399|Cardiovascular Disease risk (mild to moderate)|cardiovascular disease risk (mild to moderate)
5124518|NCT01114399|Cholesterol|cholesterol
5124519|NCT01114399|Ambulatory blood pressure|ambulatory blood pressure
5124520|NCT01114399|Arterial Stiffness|arterial stiffness
5124521|NCT01114386|Smoking|smoking
5124522|NCT01114386|Dyspnea|dyspnea
5124523|NCT01114386|Cough|cough
5124524|NCT01114386|Exercise|exercise
5124525|NCT01114373|Melatonin|melatonin
5124526|NCT01114373|Hypertension|hypertension
5124527|NCT01114373|Blood Pressure|blood pressure
5124528|NCT01114373|Cardiovascular|cardiovascular
5124529|NCT01114373|Sleep|sleep
5124530|NCT01114373|Nighttime|nighttime
5124531|NCT01114373|Nocturnal|nocturnal
5124532|NCT01114373|Catecholamines|catecholamines
5124533|NCT01114373|Sympathetic Nervous System|sympathetic nervous system
5124534|NCT01114373|Endothelial Function|endothelial function
5124535|NCT01114373|African American|african american
5124536|NCT01114360|Melatonin|melatonin
5124537|NCT01114360|Hypertension|hypertension
5124538|NCT01114360|Blood Pressure|blood pressure
5124539|NCT01114360|Cardiovascular|cardiovascular
5124540|NCT01114360|Sleep|sleep
5124541|NCT01114360|Nighttime|nighttime
5124542|NCT01114360|Nocturnal|nocturnal
5124543|NCT01114360|Catecholamines|catecholamines
5124544|NCT01114360|Sympathetic Nervous System|sympathetic nervous system
5124545|NCT01114360|Endothelial function|endothelial function
5124546|NCT01114360|African American|african american
5124547|NCT01114321|Idiopathic Parkinson's disease|idiopathic parkinson's disease
5124548|NCT01114321|Glucose intolerance|glucose intolerance
5124549|NCT01114321|Diabetes|diabetes
5124550|NCT01114321|OGTT|ogtt
5124551|NCT01114321|Patient with an Idiopathic Parkinson's disease|patient with an idiopathic parkinson's disease
5124552|NCT01114308|opioid dependence|opioid dependence
5124553|NCT01114308|opioid addiction|opioid addiction
5124554|NCT01114308|buprenorphine|buprenorphine
5124555|NCT01114308|implant|implant
5124556|NCT01114308|methadone|methadone
5124557|NCT01114308|heroin|heroin
5124558|NCT01114308|suboxone|suboxone
5124559|NCT01114308|opioid pain medication|opioid pain medication
5124560|NCT01114308|opioid withdrawal|opioid withdrawal
5124561|NCT01114295|overt|overt
5124562|NCT01114295|obscure|obscure
5124563|NCT01114295|gastrointestinal|gastrointestinal
5124564|NCT01114295|bleeding|bleeding
5124565|NCT01114295|hemorrhage|hemorrhage
5124566|NCT01114269|Coronary Artery Disease|coronary artery disease
5124567|NCT01114269|Sudden Cardiac Death|sudden cardiac death
5124568|NCT01114269|Myocardial Infarction|myocardial infarction
5124569|NCT01114269|Percutaneous Coronary Intervention|percutaneous coronary intervention
5124570|NCT01114269|Implantable Cardiac Defibrillator|implantable cardiac defibrillator
5124571|NCT01114230|Advanced Renal Cell Carcinoma|advanced renal cell carcinoma
5124572|NCT01114230|Advanced Kidney Cancer|advanced kidney cancer
5124573|NCT01114230|AGS-16M8F|ags-16m8f
5124574|NCT01114217|Iron deficiency anemia|iron deficiency anemia
5124575|NCT01114217|Feraheme|feraheme
5124576|NCT01114217|Ferumoxytol|ferumoxytol
5124577|NCT01114217|IDA|ida
5124578|NCT01114204|Iron deficiency anemia|iron deficiency anemia
5124579|NCT01114204|Feraheme|feraheme
5124580|NCT01114204|ferumoxytol|ferumoxytol
5124581|NCT01114204|iron sucrose|iron sucrose
5124582|NCT01114204|Venofer|venofer
5124583|NCT01114204|IDA|ida
5124584|NCT01114178|questionnaire|questionnaire
5124585|NCT01114178|peripheral artery disease|peripheral artery disease
5124586|NCT01114178|exercise|exercise
5124587|NCT01114165|Neutropenia|neutropenia
5124588|NCT01114165|Febrile Neutropenia|febrile neutropenia
5124589|NCT01114165|Sepsis|sepsis
5124590|NCT01114165|Polymerase Chain Reaction|polymerase chain reaction
5124591|NCT01114152|AZD9742|azd9742
5124592|NCT01114152|Japanese Healthy Volunteers|japanese healthy volunteers
5124593|NCT01114152|Phase I|phase i
5124594|NCT01114152|Single and Multiple Ascending Dose|single and multiple ascending dose
5124595|NCT01114139|Iron deficiency anemia|iron deficiency anemia
5124596|NCT01114139|Feraheme|feraheme
5124597|NCT01114139|ferumoxytol|ferumoxytol
5124598|NCT01114139|IDA|ida
5124599|NCT01114126|Neu-P11|neu-p11
5124600|NCT01114126|Insomnia|insomnia
5124601|NCT01114126|PSG|psg
5124602|NCT01114126|safety|safety
5124603|NCT01114113|IBS-D|ibs-d
5124604|NCT01114113|Post meal Diarrhea|post meal diarrhea
5124605|NCT01114113|Trigger meals|trigger meals
5124606|NCT01114100|chest pain|chest pain
5124607|NCT01114100|panic attacks|panic attacks
5124608|NCT01114100|palpitations|palpitations
5124609|NCT01114100|depression|depression
5124610|NCT01114100|panic disorder|panic disorder
5124611|NCT01114100|depressive disorder|depressive disorder
5124612|NCT01114100|non cardiac chest pain|non cardiac chest pain
5124613|NCT01114087|Spermatogenesis|spermatogenesis
5124614|NCT01114087|Inhibitors of tyrosine kinase|inhibitors of tyrosine kinase
5124615|NCT01114087|Fragmentation of the spermatic DNA|fragmentation of the spermatic dna
5124616|NCT01114074|Thrombosis|thrombosis
5124617|NCT01114074|Blood coagulation|blood coagulation
5124618|NCT01114074|Perfusion flow experiments|perfusion flow experiments
5124619|NCT01114074|Factor XII|factor xii
5124620|NCT01114074|Factor XI|factor xi
5124621|NCT01114074|Prekallikrein|prekallikrein
5124622|NCT01114074|High molecular weight kininogen|high molecular weight kininogen
5124623|NCT01114061|diabetes|diabetes
5124624|NCT01114061|postprandial glucose level|postprandial glucose level
5124625|NCT01114061|insulin pharmacodynamics|insulin pharmacodynamics
5124626|NCT01114061|Insulin Pharmacokinetics|insulin pharmacokinetics
5124627|NCT01114048|age under 65|age under 65
5124628|NCT01114048|Previous untreated|previous untreated
5124629|NCT01114035|intestinal epithelial dysplasia|intestinal epithelial dysplasia
5124630|NCT01114035|characterization phenotypic|characterization phenotypic
5124631|NCT01114035|genetic study|genetic study
5124632|NCT01114035|"or  tufting enteropathy "|"or  tufting enteropathy "
5124633|NCT01114022|Acute respiratory failure|acute respiratory failure
5124634|NCT01114009|recruitment maneuvers|recruitment maneuvers
5124635|NCT01114009|ARDS|ards
5124636|NCT01114009|lung protective strategy|lung protective strategy
5124637|NCT01114009|ARDS, Human|ards, human
5124638|NCT01113996|Obesity|obesity
5124639|NCT01113996|Gastric by-pass|gastric by-pass
5124640|NCT01113996|Body composition|body composition
5124641|NCT01113996|Nutrition|nutrition
5124642|NCT01113996|Physical activity|physical activity
5124643|NCT01113983|SAPIEN XT Valve, Cardiovascular Disease, Valvular Heart Disease, Aortic Stenosis, Heart Valve Therapy, Transapical, Transcatheter, Transfemoral|sapien xt valve, cardiovascular disease, valvular heart disease, aortic stenosis, heart valve therapy, transapical, transcatheter, transfemoral
5124644|NCT01113970|breast cancer|breast cancer
5124645|NCT01113970|Indibulin|indibulin
5124646|NCT01113970|unresectable, locally advanced breast cancer|unresectable, locally advanced breast cancer
5124647|NCT01113957|Ovarian Cancer|ovarian cancer
5124648|NCT01113931|Chlamydia|chlamydia
5124649|NCT01113918|Obesity,|obesity,
5124650|NCT01113918|PCOS,|pcos,
5124651|NCT01113918|HA,|ha,
5124652|NCT01113918|CVD|cvd
5124653|NCT01113905|Fatigue|fatigue
5124654|NCT01113905|Breast Cancer|breast cancer
5124655|NCT01113879|rehabilitation|rehabilitation
5124656|NCT01113879|aphasia|aphasia
5124657|NCT01113879|exercise|exercise
5124658|NCT01113879|fMRI|fmri
5124659|NCT01113879|BDNF|bdnf
5124660|NCT01113853|asthma|asthma
5124661|NCT01113853|exhaled nitric oxide|exhaled nitric oxide
5124662|NCT01113853|lung function|lung function
5124663|NCT01113840|elderly|elderly
5124664|NCT01113840|heart failure|heart failure
5124665|NCT01113840|exercise|exercise
5124666|NCT01113840|diastolic dysfunction|diastolic dysfunction
5124667|NCT01113827|Olive|olive
5124668|NCT01113827|antioxidant|antioxidant
5124669|NCT01113827|exercise|exercise
5124670|NCT01113827|inflammation|inflammation
5124671|NCT01113827|recovery|recovery
5124672|NCT01113827|Healthy men|healthy men
5124673|NCT01113801|Chronic Kidney Disease|chronic kidney disease
5124674|NCT01113801|Diabetic Kidney Disease|diabetic kidney disease
5124675|NCT01113801|End-Stage Renal Disease|end-stage renal disease
5124676|NCT01113801|Transforming Growth Factor beta 1 Monoclonal Antibody|transforming growth factor beta 1 monoclonal antibody
5124677|NCT01113801|Type 1 Diabetes|type 1 diabetes
5124678|NCT01113801|Type 2 Diabetes|type 2 diabetes
5124679|NCT01113788|atrial flutter, tricuspid isthmus, ablation|atrial flutter, tricuspid isthmus, ablation
5124680|NCT01113775|pulmonary embolism|pulmonary embolism
5124681|NCT01113775|computed tomography|computed tomography
5124682|NCT01113762|Arthroplasty, Replacement, Hip|arthroplasty, replacement, hip
5124683|NCT01113762|Bone Density|bone density
5124684|NCT01113762|Rehabilitation|rehabilitation
5124685|NCT01113762|T-Lymphocytes|t-lymphocytes
5124686|NCT01113762|Chromium Alloys|chromium alloys
5124687|NCT01113749|Dementia|dementia
5124688|NCT01113749|Nutrition|nutrition
5124689|NCT01113749|Feeding|feeding
5124690|NCT01113736|Ileostomy|ileostomy
5124691|NCT01113736|Stenosis|stenosis
5124692|NCT01113736|Surgical Wound Dehiscence|surgical wound dehiscence
5124693|NCT01113736|Peritoneal|peritoneal
5124694|NCT01113736|Colorectal Surgery|colorectal surgery
5124695|NCT01113723|C-MAC|c-mac
5124696|NCT01113723|Fiberoptic bronchoscope|fiberoptic bronchoscope
5124697|NCT01113723|Laryngoscopy|laryngoscopy
5124698|NCT01113723|Cervical spine injury|cervical spine injury
5124699|NCT01113723|Glottic view|glottic view
5124700|NCT01113723|Tracheal intubation|tracheal intubation
5124701|NCT01113710|Rotigotine|rotigotine
5124702|NCT01113710|Neupro®|neupro®
5124703|NCT01113710|Restless Legs Syndrome|restless legs syndrome
5124704|NCT01113697|allergen challenge|allergen challenge
5124705|NCT01113697|blood draw|blood draw
5124706|NCT01113697|gene expression analysis|gene expression analysis
5124707|NCT01113697|protein analysis|protein analysis
5124708|NCT01113697|genetics|genetics
5124709|NCT01113671|Diabetes Mellitus type 2|diabetes mellitus type 2
5124710|NCT01113671|Haptoglobin phenotype|haptoglobin phenotype
5124711|NCT01113671|Vitamin E|vitamin e
5124712|NCT01113658|negative pressure wound therapy|negative pressure wound therapy
5124713|NCT01113658|NPWT|npwt
5124714|NCT01113658|Spiracur|spiracur
5124715|NCT01113658|SNaP Wound Care System|snap wound care system
5124716|NCT01113645|Decompressive craniectomy|decompressive craniectomy
5124717|NCT01113645|Cranioplasty|cranioplasty
5124718|NCT01113645|Cerebral blood flow|cerebral blood flow
5124719|NCT01113645|Cerebral hemodynamic|cerebral hemodynamic
5124720|NCT01113645|Neurological-cognitive test GOS, FAB, MMSE,|neurological-cognitive test gos, fab, mmse,
5124721|NCT01113645|Transcranial Doppler|transcranial doppler
5124722|NCT01113632|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
5124723|NCT01113632|Small Lymphocytic Lymphoma|small lymphocytic lymphoma
5124724|NCT01113632|Ofatumumab|ofatumumab
5124725|NCT01113619|lactose maldigestion|lactose maldigestion
5124726|NCT01113619|dairy intolerance|dairy intolerance
5124727|NCT01113619|intolerance to milk|intolerance to milk
5124728|NCT01113619|intolerance to dairy|intolerance to dairy
5124729|NCT01113619|milk intolerance|milk intolerance
5124730|NCT01113619|GI disorder|gi disorder
5124731|NCT01113619|lactose metabolism|lactose metabolism
5124732|NCT01113619|GI symptoms after dairy ingestion|gi symptoms after dairy ingestion
5124733|NCT01113606|Moderate to severe facial photo damage|moderate to severe facial photo damage
5124734|NCT01113606|Periocular or perioral fine wrinkles|periocular or perioral fine wrinkles
5124735|NCT01113593|COPD|copd
5124736|NCT01113567|Hepatic Encephalopathy|hepatic encephalopathy
5124737|NCT01113567|Liver Cirrhosis|liver cirrhosis
5124738|NCT01113567|Disaccharides|disaccharides
5124739|NCT01113567|Lactose|lactose
5124740|NCT01113567|Quality of Life|quality of life
5124741|NCT01113541|Ziprasidone|ziprasidone
5124742|NCT01113541|Bipolar Disorder|bipolar disorder
5124743|NCT01113541|Metabolic Syndrome|metabolic syndrome
5124744|NCT01113528|Bone allograft|bone allograft
5124745|NCT01113528|IL-1|il-1
5124746|NCT01113528|IL-10|il-10
5124747|NCT01113528|periodontal regeneration|periodontal regeneration
5124748|NCT01113528|omega-3|omega-3
5124749|NCT01113528|aspirin|aspirin
5124750|NCT01113515|Diabetic foot ulcer|diabetic foot ulcer
5124751|NCT01113515|Diabetic wound|diabetic wound
5124752|NCT01113515|chronic non healing ulcer|chronic non healing ulcer
5124753|NCT01113476|Advanced Malignancies|advanced malignancies
5124754|NCT01113476|Nab-paclitaxel|nab-paclitaxel
5124755|NCT01113476|Gemcitabine|gemcitabine
5124756|NCT01113476|Bevacizumab|bevacizumab
5124757|NCT01113463|Brain Tumor|brain tumor
5124758|NCT01113463|Central Nervous System|central nervous system
5124759|NCT01113463|CNS|cns
5124760|NCT01113463|Glioblastoma Multiforme|glioblastoma multiforme
5124761|NCT01113463|GBM|gbm
5124762|NCT01113463|TPI 287|tpi 287
5124763|NCT01113463|Radiation Therapy|radiation therapy
5124764|NCT01113463|Temozolomide|temozolomide
5124765|NCT01113463|Chemotherapy|chemotherapy
5124766|NCT01113463|taxanes|taxanes
5124767|NCT01113450|hearing, newborn, screening|hearing, newborn, screening
5124768|NCT01113437|Bronchial Asthma|bronchial asthma
5124769|NCT01113437|Allergy|allergy
5124770|NCT01113424|Smoking Cessation|smoking cessation
5124771|NCT01113424|Nicotine pharmacokinetics|nicotine pharmacokinetics
5124772|NCT01113411|humerus fracture|humerus fracture
5124773|NCT01113411|locked plate|locked plate
5124774|NCT01113398|glioblastoma multiforme|glioblastoma multiforme
5124775|NCT01113398|gliosarcoma|gliosarcoma
5124776|NCT01113398|malignant glioma|malignant glioma
5124777|NCT01113398|glioma|glioma
5124778|NCT01113398|Avastin|avastin
5124779|NCT01113398|bevacizumab|bevacizumab
5124780|NCT01113398|AMG 102|amg 102
5124781|NCT01113398|rilotumumab|rilotumumab
5124782|NCT01113398|recurrent|recurrent
5124783|NCT01113398|Duke|duke
5124784|NCT01113398|Pro00022491|pro00022491
5124785|NCT01113385|Nephrotic syndrome|nephrotic syndrome
5124786|NCT01113385|Focal Segmental glomerulosclerosis|focal segmental glomerulosclerosis
5124787|NCT01113385|FSGS|fsgs
5124788|NCT01113385|Minimal change|minimal change
5124789|NCT01113385|Steroid resistant|steroid resistant
5124790|NCT01113385|Pediatric|pediatric
5124791|NCT01113385|Proteinuria|proteinuria
5124792|NCT01113385|Galactose|galactose
5124793|NCT01113385|FSPF|fspf
5124794|NCT01113372|Coronary, Disease|coronary, disease
5124795|NCT01113359|HCMV infection|hcmv infection
5124796|NCT01113359|Hypertension|hypertension
5124797|NCT01113359|The Potential Link Between HCMV Infection and Essential Hypertension|the potential link between hcmv infection and essential hypertension
5124798|NCT01113346|enterosorbent|enterosorbent
5124799|NCT01113346|sorbent|sorbent
5124800|NCT01113346|gastrointestinal decontamination|gastrointestinal decontamination
5124801|NCT01113346|viral diarrhea|viral diarrhea
5124802|NCT01113346|rotavirus|rotavirus
5124803|NCT01113346|Filtrum|filtrum
5124804|NCT01113346|Filtrum-STI|filtrum-sti
5124805|NCT01113346|lignin|lignin
5124806|NCT01113320|Safinamide - Parkinson's disease - Levodopa induced dyskinesia|safinamide - parkinson's disease - levodopa induced dyskinesia
5124807|NCT01113320|Advanced idiopathic PD patients treated with L-dopa and suffering from temporally predictable L-dopa induced peak-dose dyskinesia.|advanced idiopathic pd patients treated with l-dopa and suffering from temporally predictable l-dopa induced peak-dose dyskinesia.
5124808|NCT01113307|Chronic ulcers|chronic ulcers
5124809|NCT01113307|pressure ulcers|pressure ulcers
5124810|NCT01113307|venous ulcers|venous ulcers
5124811|NCT01113307|diabetic foot ulcers|diabetic foot ulcers
5124812|NCT01113307|post operative ulcers|post operative ulcers
5124813|NCT01113307|hard to heal ulcers|hard to heal ulcers
5124814|NCT01113281|Tuberculosis|tuberculosis
5124815|NCT01113281|Vaccine|vaccine
5124816|NCT01113281|Live Vaccine|live vaccine
5124817|NCT01113281|rBCG|rbcg
5124818|NCT01113268|Patient collection|patient collection
5124819|NCT01113268|Cardiac remodelling|cardiac remodelling
5124820|NCT01113268|Echography|echography
5124821|NCT01113268|Magnetic Resonance Imaging|magnetic resonance imaging
5124822|NCT01113268|Gene polymorphisms|gene polymorphisms
5124823|NCT01113268|Biomarkers|biomarkers
5124824|NCT01113255|VENTILATORS|ventilators
5124825|NCT01113255|BENCH EVALUATION|bench evaluation
5124826|NCT01113255|MECHANICAL VENTILATION|mechanical ventilation
5124827|NCT01113242|Parkinson Disease Dementia|parkinson disease dementia
5124828|NCT01113242|Observational|observational
5124829|NCT01113242|Case control|case control
5124830|NCT01113242|Neuropsychological assessment|neuropsychological assessment
5124831|NCT01113229|Post Partum Haemorrhage,|post partum haemorrhage,
5124832|NCT01113229|oxytocin,|oxytocin,
5124833|NCT01113229|misoprostol,|misoprostol,
5124834|NCT01113229|prevention,|prevention,
5124835|NCT01113229|delivery.|delivery.
5124836|NCT01113216|CF|cf
5124837|NCT01113216|CFRD|cfrd
5124838|NCT01113216|Diabetes|diabetes
5124839|NCT01113216|Genetic Modifiers|genetic modifiers
5124840|NCT01113203|resistance training|resistance training
5124841|NCT01113203|blood pressure|blood pressure
5124842|NCT01113203|hemodynamics|hemodynamics
5124843|NCT01113203|autonomic|autonomic
5124844|NCT01113203|Elderly Subjects|elderly subjects
5124845|NCT01113177|Mandibular growth temporomandibular arthritis|mandibular growth temporomandibular arthritis
5124846|NCT01113164|ondansetron|ondansetron
5124847|NCT01113164|sertraline|sertraline
5124848|NCT01113164|lab studies|lab studies
5124849|NCT01113164|alcoholism|alcoholism
5124850|NCT01113164|alcohol dependence|alcohol dependence
5124851|NCT01113151|Steroid-resistant|steroid-resistant
5124852|NCT01113151|Severe asthmatics|severe asthmatics
5124853|NCT01113151|Annual symptoms|annual symptoms
5124854|NCT01113151|Daily magnesium supplement|daily magnesium supplement
5124855|NCT01113151|ACT (asthma control test)|act (asthma control test)
5124856|NCT01113138|Clearance|clearance
5124857|NCT01113138|Half-life|half-life
5124858|NCT01113138|Absorption fraction|absorption fraction
5124859|NCT01113138|Pharmacokinetics|pharmacokinetics
5124860|NCT01113125|hypertrophic scar|hypertrophic scar
5124861|NCT01113125|keloid|keloid
5124862|NCT01113125|central venous catheter|central venous catheter
5124863|NCT01113125|children|children
5124864|NCT01113125|cancer|cancer
5124865|NCT01113112|Ovarian Neoplasms|ovarian neoplasms
5124866|NCT01113086|Parkinson|parkinson
5124867|NCT01113086|Transcranial direct current stimulation|transcranial direct current stimulation
5124868|NCT01113086|Motor function|motor function
5124869|NCT01113086|Cognitive function|cognitive function
5124870|NCT01113086|Affective function|affective function
5124871|NCT01113073|pulse pressure variation|pulse pressure variation
5124872|NCT01113073|hemodynamic monitoring|hemodynamic monitoring
5124873|NCT01113073|fluid responsiveness|fluid responsiveness
5124874|NCT01113073|mechanical ventilation|mechanical ventilation
5124875|NCT01113073|fluid therapy|fluid therapy
5124876|NCT01113060|Coronary Artery Disease|coronary artery disease
5124877|NCT01113060|Aspirin|aspirin
5124878|NCT01113060|Secondary Prevention|secondary prevention
5124879|NCT01113047|Hypertension|hypertension
5124880|NCT01113047|Aliskiren|aliskiren
5124881|NCT01113047|Amlodipine|amlodipine
5124882|NCT01113034|Asthma|asthma
5124883|NCT01113034|Bronchiectasis|bronchiectasis
5124884|NCT01113008|Myocardial Reperfusion Injury/mortality|myocardial reperfusion injury/mortality
5124885|NCT01113008|Coronary angioplasty|coronary angioplasty
5124886|NCT01113008|Reperfusion|reperfusion
5124887|NCT01113008|Myocardial Reperfusion Injury/prevention & control|myocardial reperfusion injury/prevention & control
5124888|NCT01112995|Probiotic|probiotic
5124889|NCT01112995|Lactobacillus|lactobacillus
5124890|NCT01112995|Antibiotic resistance|antibiotic resistance
5124891|NCT01112982|Gout|gout
5124892|NCT01112982|Synovial pannus|synovial pannus
5124893|NCT01112982|Magnetic resonance imaging|magnetic resonance imaging
5124894|NCT01112969|Internet-based supportive coaching|internet-based supportive coaching
5124895|NCT01112969|guided self-help|guided self-help
5124896|NCT01112969|Caregivers|caregivers
5124897|NCT01112969|Brain Injury|brain injury
5124898|NCT01112969|Caregiver Burden|caregiver burden
5124899|NCT01112969|Coping|coping
5124900|NCT01112969|Stress|stress
5124901|NCT01112969|Depression|depression
5124902|NCT01112956|HSV-2|hsv-2
5124903|NCT01112956|HSV-1|hsv-1
5124904|NCT01112956|Sensitivity|sensitivity
5124905|NCT01112956|Specificity|specificity
5124906|NCT01112956|Testing algorithm|testing algorithm
5124907|NCT01112956|Test evaluation|test evaluation
5124908|NCT01112943|Acupuncture, Pulmonary Rehabilitation, Inflammation, COPD|acupuncture, pulmonary rehabilitation, inflammation, copd
5124909|NCT01112930|essential fatty acids|essential fatty acids
5124910|NCT01112930|DHA|dha
5124911|NCT01112930|preschool children|preschool children
5124912|NCT01112930|docosahexanoic acid (DHA)|docosahexanoic acid (dha)
5124913|NCT01112904|essential fatty acids|essential fatty acids
5124914|NCT01112904|DHA status|dha status
5124915|NCT01112904|preschool children|preschool children
5124916|NCT01112904|gestation|gestation
5124917|NCT01112891|Vitamin D|vitamin d
5124918|NCT01112891|Infant|infant
5124919|NCT01112891|Lactation|lactation
5124920|NCT01112891|Dose-Response|dose-response
5124921|NCT01112878|Shoulder arthroscopy|shoulder arthroscopy
5124922|NCT01112878|Knee arthroscopy|knee arthroscopy
5124923|NCT01112878|Clonidine|clonidine
5124924|NCT01112878|Gabapentin|gabapentin
5124925|NCT01112878|Pain management|pain management
5124926|NCT01112878|Ambulatory surgery|ambulatory surgery
5124927|NCT01112878|Perioperative outcome|perioperative outcome
5124928|NCT01112878|Analgesia|analgesia
5124929|NCT01112865|Growth Hormone Deficiency|growth hormone deficiency
5124930|NCT01112865|Somatropin|somatropin
5124931|NCT01112865|Injection Pen|injection pen
5124932|NCT01112865|Medical Device|medical device
5124933|NCT01112865|Cross Over Study|cross over study
5124934|NCT01112865|Preference|preference
5124935|NCT01112865|Convenience|convenience
5124936|NCT01112865|Children|children
5124937|NCT01112865|Dyads|dyads
5124938|NCT01112865|Adults|adults
5124939|NCT01112852|control of bleed|control of bleed
5124940|NCT01112839|Overweight|overweight
5124941|NCT01112839|Obese|obese
5124942|NCT01112839|Breast cancer survivors|breast cancer survivors
5124943|NCT01112839|Weight loss|weight loss
5124944|NCT01112839|Exercise|exercise
5124945|NCT01112839|Physical activity|physical activity
5124946|NCT01112826|triple-negative breast cancer|triple-negative breast cancer
5124947|NCT01112826|metronomic chemotherapy|metronomic chemotherapy
5124948|NCT01112826|capecitabine (xeloda)|capecitabine (xeloda)
5124949|NCT01112813|Stroke|stroke
5124950|NCT01112813|lithium|lithium
5124951|NCT01112813|MRI|mri
5124952|NCT01112813|gray matter|gray matter
5124953|NCT01112800|Anthracycline|anthracycline
5124954|NCT01112800|Cardiac Muscle Injury|cardiac muscle injury
5124955|NCT01112800|Doxorubicin|doxorubicin
5124956|NCT01112800|Doppler Imaging|doppler imaging
5124957|NCT01112800|Intermediate non-rhabdomyosarcoma soft tissue sarcomas|intermediate non-rhabdomyosarcoma soft tissue sarcomas
5124958|NCT01112800|High-risk non-rhabdomyosarcoma soft tissue sarcomas|high-risk non-rhabdomyosarcoma soft tissue sarcomas
5124959|NCT01112787|Healthy Volunteer Subjects|healthy volunteer subjects
5124960|NCT01112774|Transcranial direct current stimulation|transcranial direct current stimulation
5124961|NCT01112774|Spinal cord injury|spinal cord injury
5124962|NCT01112774|Chronic pain|chronic pain
5124963|NCT01112774|Brain excitability|brain excitability
5124964|NCT01112761|Athletes|athletes
5124965|NCT01112761|Multiple Concussions|multiple concussions
5124966|NCT01112761|Transcranial Stimulation|transcranial stimulation
5124967|NCT01112748|Focal neuropathic pain|focal neuropathic pain
5124968|NCT01112735|Abdominoplasty|abdominoplasty
5124969|NCT01112735|Flap adherence in subjects undergoing abdominoplasty to eliminate dead space and reduce seroma/hematoma formation|flap adherence in subjects undergoing abdominoplasty to eliminate dead space and reduce seroma/hematoma formation
5124970|NCT01112722|honeybee toxin|honeybee toxin
5124971|NCT01112722|Apitox|apitox
5124972|NCT01112722|pain|pain
5124973|NCT01112722|inflammation|inflammation
5124974|NCT01112722|osteoarthritis|osteoarthritis
5124975|NCT01112722|Apitoxin|apitoxin
5124976|NCT01112709|Diabetes|diabetes
5124977|NCT01112709|Prediabetes|prediabetes
5124978|NCT01112709|Resistance training|resistance training
5124979|NCT01112709|behavior|behavior
5124980|NCT01112709|behavioral change theory|behavioral change theory
5124981|NCT01112696|diabetes|diabetes
5124982|NCT01112696|glucose sensor|glucose sensor
5124983|NCT01112696|CGM|cgm
5124984|NCT01112683|Down syndrome|down syndrome
5124985|NCT01112683|Trisomy 21|trisomy 21
5124986|NCT01112683|Pattern Recognition Memory (PRM)|pattern recognition memory (prm)
5124987|NCT01112683|Paired Associates Learning (PAL)|paired associates learning (pal)
5124988|NCT01112683|California Verbal Learning Test (CVLT)|california verbal learning test (cvlt)
5124989|NCT01112683|Test of Reception of Grammar (TROG-II)|test of reception of grammar (trog-ii)
5124990|NCT01112683|Peabody Picture Vocabulary Test (PPVT-III)|peabody picture vocabulary test (ppvt-iii)
5124991|NCT01112683|Scales of Independent Behavior revised (SIB-R)|scales of independent behavior revised (sib-r)
5124992|NCT01112670|Healthy volunteers|healthy volunteers
5124993|NCT01112657|Multiple Sclerosis|multiple sclerosis
5124994|NCT01112657|Clinical isolated syndrome|clinical isolated syndrome
5124995|NCT01112657|Demyelination|demyelination
5124996|NCT01112631|NSCLC,|nsclc,
5124997|NCT01112631|PORT,|port,
5124998|NCT01112631|Quality of Life,|quality of life,
5124999|NCT01112631|Pulmonary function after RT|pulmonary function after rt
5125000|NCT01112618|Infertility|infertility
5125001|NCT01112618|Reproductive technologies, Assisted|reproductive technologies, assisted
5125002|NCT01112618|r-hFSH|r-hfsh
5125003|NCT01112618|r-hLH|r-hlh
5125004|NCT01112618|Pergoveris|pergoveris
5125005|NCT01112605|achilles tendon|achilles tendon
5125006|NCT01112605|sural nerve|sural nerve
5125007|NCT01112605|distance|distance
5125008|NCT01112605|US|us
5125009|NCT01112605|ultrasound|ultrasound
5125010|NCT01112605|Distance between Sural nerve and the Achilles tendon|distance between sural nerve and the achilles tendon
5125011|NCT01112592|NETs|nets
5125012|NCT01112592|Infections|infections
5125013|NCT01112592|Neutrophil function|neutrophil function
5125014|NCT01112553|Acute Migraine|acute migraine
5125015|NCT01112553|Treximet|treximet
5125016|NCT01112553|Imaging|imaging
5125017|NCT01112553|fMRI|fmri
5125018|NCT01112553|Pain|pain
5125019|NCT01112553|Heat Stimulus|heat stimulus
5125020|NCT01112540|to evaluate the anal. efficacy of IV morph. vs. place. for elderly presenting to the ED with UAP and determine if it has an impact on diag. accu. and phy. exam|to evaluate the anal. efficacy of iv morph. vs. place. for elderly presenting to the ed with uap and determine if it has an impact on diag. accu. and phy. exam
5125021|NCT01112527|PF-00299804|pf-00299804
5125022|NCT01112514|ICG|icg
5125023|NCT01112514|indocyanine green|indocyanine green
5125024|NCT01112501|Diagnosis|diagnosis
5125025|NCT01112501|Dementia|dementia
5125026|NCT01112501|Imaging|imaging
5125027|NCT01112488|stroke|stroke
5125228|NCT01111526|GVHD|gvhd
5125028|NCT01112488|patient engagement programme|patient engagement programme
5125029|NCT01112488|community rehabilitation|community rehabilitation
5125030|NCT01112488|new carer|new carer
5125031|NCT01112462|Nasal congestion, Headache|nasal congestion, headache
5125032|NCT01112449|selenium|selenium
5125033|NCT01112449|oxidative stress|oxidative stress
5125034|NCT01112449|prostate cancer|prostate cancer
5125035|NCT01112449|PSA|psa
5125036|NCT01112449|glucose|glucose
5125037|NCT01112436|Pain|pain
5125038|NCT01112436|preemptive|preemptive
5125039|NCT01112436|Postoperative|postoperative
5125040|NCT01112436|delirium|delirium
5125041|NCT01112410|Bronchiectasis|bronchiectasis
5125042|NCT01112410|Hypertonic saline|hypertonic saline
5125043|NCT01112397|Jak2|jak2
5125044|NCT01112397|cancer|cancer
5125045|NCT01112397|jak 1|jak 1
5125046|NCT01112397|stat 3|stat 3
5125047|NCT01112397|Phase 1|phase 1
5125048|NCT01112371|scars after abdominal Caesarean section|scars after abdominal caesarean section
5125049|NCT01112358|Lutropin alfa|lutropin alfa
5125050|NCT01112358|Fertilization in vitro|fertilization in vitro
5125051|NCT01112358|Intracytoplasmic sperm injection|intracytoplasmic sperm injection
5125052|NCT01112358|Reproductive techniques, assisted|reproductive techniques, assisted
5125053|NCT01112345|Multiple Sclerosis, Relapsing-Remitting|multiple sclerosis, relapsing-remitting
5125054|NCT01112345|Interferon-beta|interferon-beta
5125055|NCT01112319|COLD HOT or Electrotherapy treatment|cold hot or electrotherapy treatment
5125056|NCT01112306|Open-label|open-label
5125057|NCT01112306|PAH|pah
5125058|NCT01112306|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
5125059|NCT01112293|Subjects who have pleural malignant mesothelioma|subjects who have pleural malignant mesothelioma
5125060|NCT01112280|Colorectal neoplasm|colorectal neoplasm
5125061|NCT01112280|Colonoscopy|colonoscopy
5125062|NCT01112280|chromoendoscopy|chromoendoscopy
5125063|NCT01112280|cap-assisted colonoscopy|cap-assisted colonoscopy
5125064|NCT01112267|Chronic low back pain|chronic low back pain
5125065|NCT01112267|Tramadol Hydrochloride (HCl)|tramadol hydrochloride (hcl)
5125066|NCT01112267|acetaminophen|acetaminophen
5125067|NCT01112254|Ductal Carcinoma In Situ (DCIS) breast cancer|ductal carcinoma in situ (dcis) breast cancer
5125068|NCT01112241|Obliterative bronchiolitis|obliterative bronchiolitis
5125069|NCT01112241|Bronchodilator responsiveness|bronchodilator responsiveness
5125070|NCT01112241|Partial forced expiratory flow|partial forced expiratory flow
5125071|NCT01112241|Lung volumes|lung volumes
5125072|NCT01112215|SLE|sle
5125073|NCT01112215|non-renal manifestations|non-renal manifestations
5125074|NCT01112202|direct thrombin inhibitors|direct thrombin inhibitors
5125075|NCT01112202|Dabigatran|dabigatran
5125076|NCT01112202|Coagulation parameters|coagulation parameters
5125077|NCT01112189|Lymphedema|lymphedema
5125078|NCT01112189|Stem cells|stem cells
5125079|NCT01112189|Mastectomy|mastectomy
5125080|NCT01112189|Breast Cancer|breast cancer
5125081|NCT01112176|Strain|strain
5125082|NCT01112176|Ejection fraction|ejection fraction
5125083|NCT01112176|Diastolic function|diastolic function
5125084|NCT01112163|ischemic heart disease|ischemic heart disease
5125085|NCT01112150|Edema|edema
5125086|NCT01112150|Heart failure|heart failure
5125087|NCT01112150|Pulmonary hypertension|pulmonary hypertension
5125088|NCT01112150|Edema in legs|edema in legs
5125089|NCT01112124|Typical|typical
5125090|NCT01112124|Development|development
5125091|NCT01112124|Microwave|microwave
5125092|NCT01112124|Children|children
5125093|NCT01112124|Behavior|behavior
5125094|NCT01112085|Diabetic macular edema|diabetic macular edema
5125095|NCT01112085|Ranibizumab|ranibizumab
5125096|NCT01112072|keratoconus|keratoconus
5125097|NCT01112072|corneal ectasia|corneal ectasia
5125098|NCT01112072|collagen crosslinking|collagen crosslinking
5125099|NCT01112072|riboflavin|riboflavin
5125100|NCT01112072|cornea|cornea
5125101|NCT01112072|ultraviolet|ultraviolet
5125102|NCT01112059|cystic fibrosis|cystic fibrosis
5125103|NCT01112046|Early colorectal neoplasms|early colorectal neoplasms
5125104|NCT01112033|biliverdin reductase|biliverdin reductase
5125105|NCT01112033|BLVRA|blvra
5125106|NCT01112033|hepatitis C|hepatitis c
5125107|NCT01112033|HCV|hcv
5125108|NCT01112033|peripheral blood mononuclear cells|peripheral blood mononuclear cells
5125109|NCT01112033|PBMC|pbmc
5125110|NCT01112033|liver|liver
5125111|NCT01112033|genetic polymorphisms|genetic polymorphisms
5125112|NCT01112020|Chlorhexidine digluconate (CHG)|chlorhexidine digluconate (chg)
5125113|NCT01112020|Biopatch Protective Disk|biopatch protective disk
5125114|NCT01112020|Tegaderm CHG IV (intravenous) Securement Dressing|tegaderm chg iv (intravenous) securement dressing
5125115|NCT01112020|parachloroaniline (PCA)|parachloroaniline (pca)
5125116|NCT01112020|No condition being studied.|no condition being studied.
5125117|NCT01112020|Assessing components of CHG-containing dressings after use.|assessing components of chg-containing dressings after use.
5125118|NCT01112007|Insulin Resistance|insulin resistance
5125119|NCT01112007|Hypertension|hypertension
5125120|NCT01112007|Blood pressure|blood pressure
5125121|NCT01112007|Aldosterone|aldosterone
5125122|NCT01112007|Renin|renin
5125123|NCT01111994|hyperpigmentation|hyperpigmentation
5125124|NCT01111981|alopecia|alopecia
5125227|NCT01111526|Graft versus host disease|graft versus host disease
5125125|NCT01111981|CCCA - Central Centrifugal Cicatricial Alopecia|ccca - central centrifugal cicatricial alopecia
5125126|NCT01111968|vaccine|vaccine
5125127|NCT01111968|pandemic influenza A|pandemic influenza a
5125128|NCT01111968|adjuvant|adjuvant
5125129|NCT01111968|safety|safety
5125130|NCT01111942|head and neck cancer|head and neck cancer
5125131|NCT01111942|chemotherapy|chemotherapy
5125132|NCT01111942|radiation|radiation
5125133|NCT01111929|Emergency contraception|emergency contraception
5125134|NCT01111929|pregnancy during breastfeeding|pregnancy during breastfeeding
5125135|NCT01111929|Lactational amenorrhea Method|lactational amenorrhea method
5125136|NCT01111929|unplanned pregnancy|unplanned pregnancy
5125137|NCT01111877|ear tubes|ear tubes
5125138|NCT01111877|ear drainage|ear drainage
5125139|NCT01111877|ear infection|ear infection
5125140|NCT01111877|ear drops|ear drops
5125141|NCT01111877|tympanostomy tubes|tympanostomy tubes
5125142|NCT01111877|Pediatric patients|pediatric patients
5125143|NCT01111851|NK1-receptor occupancy|nk1-receptor occupancy
5125144|NCT01111838|STA-9090|sta-9090
5125145|NCT01111838|colon|colon
5125146|NCT01111838|rectal|rectal
5125147|NCT01111838|10-029|10-029
5125148|NCT01111825|HKI-272 (NERATINIB)|hki-272 (neratinib)
5125149|NCT01111825|TEMSIROLIMUS (CCI-779)|temsirolimus (cci-779)
5125150|NCT01111825|HER2-Amplified|her2-amplified
5125151|NCT01111825|Triple-negative|triple-negative
5125152|NCT01111825|invasive adenocarcinoma|invasive adenocarcinoma
5125153|NCT01111825|10-005|10-005
5125154|NCT01111825|Nerlynx|nerlynx
5125155|NCT01111825|PB-272|pb-272
5125156|NCT01111812|overweight|overweight
5125157|NCT01111812|obese|obese
5125158|NCT01111812|children|children
5125159|NCT01111812|weighing|weighing
5125160|NCT01111812|weight|weight
5125161|NCT01111799|endometrial biopsy|endometrial biopsy
5125162|NCT01111799|implantation|implantation
5125163|NCT01111799|uterine receptivity|uterine receptivity
5125164|NCT01111799|infertility|infertility
5125165|NCT01111799|controled ovarian hyperstimulation|controled ovarian hyperstimulation
5125166|NCT01111799|intra uterine insemination|intra uterine insemination
5125167|NCT01111786|scleroderma|scleroderma
5125168|NCT01111786|skin|skin
5125169|NCT01111786|tightness|tightness
5125170|NCT01111786|durometer|durometer
5125171|NCT01111773|Patellar tendonitis|patellar tendonitis
5125172|NCT01111760|cardiovascular disease|cardiovascular disease
5125173|NCT01111760|heart CT scan|heart ct scan
5125174|NCT01111760|CT scan|ct scan
5125175|NCT01111760|pulmonary embolisms|pulmonary embolisms
5125176|NCT01111760|aortography|aortography
5125177|NCT01111747|platelet-rich plasma|platelet-rich plasma
5125178|NCT01111747|patellar ligament|patellar ligament
5125179|NCT01111747|regeneration|regeneration
5125180|NCT01111747|growth substances|growth substances
5125181|NCT01111734|self harm|self harm
5125182|NCT01111734|self injury|self injury
5125183|NCT01111734|self mutilation|self mutilation
5125184|NCT01111734|N-Acetylcysteine|n-acetylcysteine
5125185|NCT01111734|adolescents|adolescents
5125186|NCT01111734|impulse control disorder|impulse control disorder
5125187|NCT01111734|borderline personality disorder|borderline personality disorder
5125188|NCT01111734|fMRI|fmri
5125189|NCT01111721|Sexually Transmitted Diseases|sexually transmitted diseases
5125190|NCT01111721|HIV Infections|hiv infections
5125191|NCT01111721|Genital Diseases, Female|genital diseases, female
5125192|NCT01111721|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5125193|NCT01111721|Risk Reduction Behavior|risk reduction behavior
5125194|NCT01111721|HIV prevention|hiv prevention
5125195|NCT01111695|wound healing|wound healing
5125196|NCT01111695|granulation tissue|granulation tissue
5125197|NCT01111695|Varicose Ulcer|varicose ulcer
5125198|NCT01111682|traumatic brain injury|traumatic brain injury
5125199|NCT01111682|hypertonic saline therapy|hypertonic saline therapy
5125200|NCT01111682|intracranial pressure|intracranial pressure
5125201|NCT01111669|Functional Endoscopic Sinus Surgery|functional endoscopic sinus surgery
5125202|NCT01111669|Tranexamic Acid|tranexamic acid
5125203|NCT01111656|Multi-center|multi-center
5125204|NCT01111656|randomized|randomized
5125205|NCT01111656|prospective|prospective
5125206|NCT01111656|parallel-group|parallel-group
5125207|NCT01111656|rater-blinded|rater-blinded
5125208|NCT01111656|RR-MS|rr-ms
5125209|NCT01111630|chronic renal failure|chronic renal failure
5125210|NCT01111630|Anaemia|anaemia
5125211|NCT01111604|Colonic Neoplasms|colonic neoplasms
5125212|NCT01111604|Rectal Neoplasms|rectal neoplasms
5125213|NCT01111604|Adenocarcinoma|adenocarcinoma
5125214|NCT01111604|Antibodies, Monoclonal|antibodies, monoclonal
5125215|NCT01111591|Cyclooxygenase-2 inhibitor (Celecoxib)|cyclooxygenase-2 inhibitor (celecoxib)
5125216|NCT01111591|Extrahepatic bile duct cancer|extrahepatic bile duct cancer
5125217|NCT01111591|Pancreas cancer|pancreas cancer
5125218|NCT01111565|Major Depressive Disorder|major depressive disorder
5125219|NCT01111565|MDD|mdd
5125220|NCT01111565|Depression|depression
5125221|NCT01111552|Major Depressive Disorder|major depressive disorder
5125222|NCT01111552|MDD|mdd
5125223|NCT01111552|Depression|depression
5125224|NCT01111539|Major Depressive Disorder|major depressive disorder
5125225|NCT01111539|MDD|mdd
5125226|NCT01111539|Depression|depression
5125229|NCT01111526|allogeneic transplant|allogeneic transplant
5125230|NCT01111526|acute GVHD|acute gvhd
5125231|NCT01111526|chronic GVHD|chronic gvhd
5125232|NCT01111513|knee surgery|knee surgery
5125233|NCT01111513|total knee arthroplasty|total knee arthroplasty
5125234|NCT01111513|total knee replacement|total knee replacement
5125235|NCT01111513|ropivacaine|ropivacaine
5125236|NCT01111513|femoral nerve block|femoral nerve block
5125237|NCT01111487|COPD|copd
5125238|NCT01111487|Electromyography|electromyography
5125239|NCT01111487|Inspiratory muscles|inspiratory muscles
5125240|NCT01111474|dentin hypersensitivity|dentin hypersensitivity
5125241|NCT01111474|cyanoacrylate|cyanoacrylate
5125242|NCT01111474|laser|laser
5125243|NCT01111461|Advanced Endometrial Cancer|advanced endometrial cancer
5125244|NCT01111448|Myelodysplastic Syndromes of all IPSS subgroups|myelodysplastic syndromes of all ipss subgroups
5125245|NCT01111422|Antioxidant|antioxidant
5125246|NCT01111422|Epithelial to Mesenchymal Transition|epithelial to mesenchymal transition
5125247|NCT01111422|peritoneal fibrosis|peritoneal fibrosis
5125248|NCT01111422|Peritoneal Dialysis, Continuous Ambulatory|peritoneal dialysis, continuous ambulatory
5125249|NCT01111396|ALL|all
5125250|NCT01111396|GMALL 2003|gmall 2003
5125251|NCT01111396|Chemotherapy|chemotherapy
5125252|NCT01111396|Hippocampus|hippocampus
5125253|NCT01111383|cystic fibrosis|cystic fibrosis
5125254|NCT01111383|P. aeruginosa|p. aeruginosa
5125255|NCT01111383|tobramycin|tobramycin
5125256|NCT01111370|diabetes mellitus requiring insulin|diabetes mellitus requiring insulin
5125257|NCT01111357|Rheumatoid Arthritis|rheumatoid arthritis
5125258|NCT01111357|Rheumatoid Arthritis according to ACR criteria of diagnosis|rheumatoid arthritis according to acr criteria of diagnosis
5125259|NCT01111344|Dietary supplement|dietary supplement
5125260|NCT01111344|Anogenital warts|anogenital warts
5125261|NCT01111344|Viusid|viusid
5125262|NCT01111344|Glizigen|glizigen
5125263|NCT01111305|Filariasis|filariasis
5125264|NCT01111305|Post-Treatment Reactions|post-treatment reactions
5125265|NCT01111305|Monoclonal Antibody|monoclonal antibody
5125266|NCT01111305|Loa Loa|loa loa
5125267|NCT01111305|Loiasis|loiasis
5125268|NCT01111266|in vivo KUF|in vivo kuf
5125269|NCT01111266|ß2M|ß2m
5125270|NCT01111266|leptin|leptin
5125271|NCT01111253|multicenter randomized, open label, clinical trial|multicenter randomized, open label, clinical trial
5125272|NCT01111253|acute uncomplicated (mild) diverticulitis|acute uncomplicated (mild) diverticulitis
5125273|NCT01111253|treatment strategies|treatment strategies
5125274|NCT01111253|management of diverticulitis|management of diverticulitis
5125275|NCT01111253|antibiotics|antibiotics
5125276|NCT01111253|observation and supportive care|observation and supportive care
5125277|NCT01111253|cost analysis|cost analysis
5125278|NCT01111253|economic evaluation|economic evaluation
5125279|NCT01111240|Humira|humira
5125280|NCT01111240|Long-term safety and effectiveness|long-term safety and effectiveness
5125281|NCT01111240|Psoriatic Arthritis|psoriatic arthritis
5125282|NCT01111227|cytokines|cytokines
5125283|NCT01111227|propofol|propofol
5125284|NCT01111227|isoflurane|isoflurane
5125285|NCT01111227|flow cytometry|flow cytometry
5125286|NCT01111227|Types of General Anesthesia|types of general anesthesia
5125287|NCT01111214|Invasive Pneumococcal Disease (IPD)|invasive pneumococcal disease (ipd)
5125288|NCT01111214|pneumococcal serotypes|pneumococcal serotypes
5125289|NCT01111201|Autologous Bone Marrow Transplant|autologous bone marrow transplant
5125290|NCT01111201|Breast|breast
5125291|NCT01111201|Lymphoma|lymphoma
5125292|NCT01111201|International travel|international travel
5125293|NCT01111201|questionnaire|questionnaire
5125294|NCT01111201|Hematopoietic Stem Cell Transplant (HSCT) recipients|hematopoietic stem cell transplant (hsct) recipients
5125295|NCT01111175|Locally recurrent breast cancer|locally recurrent breast cancer
5125296|NCT01111162|HIV|hiv
5125297|NCT01111162|H1N1 vaccination|h1n1 vaccination
5125298|NCT01111162|HIV infected individuals|hiv infected individuals
5125299|NCT01111149|Schizophrenia|schizophrenia
5125300|NCT01111149|Smoking cessation|smoking cessation
5125301|NCT01111149|Varenicline|varenicline
5125302|NCT01111149|Bupropion|bupropion
5125303|NCT01111136|Urticaria|urticaria
5125304|NCT01111136|Hives|hives
5125305|NCT01111136|Stress|stress
5125306|NCT01111123|plaque psoriasis|plaque psoriasis
5125307|NCT01111123|lac-hydrin|lac-hydrin
5125308|NCT01111123|ammonium lactate|ammonium lactate
5125309|NCT01111123|Ultravate|ultravate
5125310|NCT01111123|halobetasol propionate|halobetasol propionate
5125311|NCT01111123|weekend only application|weekend only application
5125312|NCT01111123|topical therapy|topical therapy
5125313|NCT01111123|topical corticosteroid|topical corticosteroid
5125314|NCT01111123|class I steroid|class i steroid
5125315|NCT01111097|Brain tumors, Glioblastoma and DCA|brain tumors, glioblastoma and dca
5125316|NCT01111097|Brain tumor,Glioblastoma recurrent|brain tumor,glioblastoma recurrent
5125317|NCT01111084|Ovulation induction|ovulation induction
5125318|NCT01111084|Ovarian Hyperstimulation Syndrome|ovarian hyperstimulation syndrome
5125319|NCT01111084|Pregnancy|pregnancy
5125320|NCT01111084|Fertility|fertility
5125321|NCT01111071|hospital variation|hospital variation
5125322|NCT01111071|30 day mortality|30 day mortality
5125323|NCT01111071|in hospital mortality|in hospital mortality
5125903|NCT01108757|catheter|catheter
5125324|NCT01111071|acute coronary syndrome|acute coronary syndrome
5125325|NCT01111071|myocardial infarction|myocardial infarction
5125326|NCT01111071|unstable angina|unstable angina
5125327|NCT01111071|hospital performance|hospital performance
5125328|NCT01111071|trends|trends
5125329|NCT01111058|Squamous Cell Cancer|squamous cell cancer
5125330|NCT01111032|Treadmill|treadmill
5125331|NCT01111032|Exercise|exercise
5125332|NCT01111032|Cancer|cancer
5125333|NCT01111032|Validity|validity
5125334|NCT01111032|Reliability|reliability
5125335|NCT01111019|Hypochondroplasia|hypochondroplasia
5125336|NCT01111019|Skeletal dysplasia|skeletal dysplasia
5125337|NCT01111019|Growth|growth
5125338|NCT01111019|Growth Hormone|growth hormone
5125339|NCT01111019|Recombinant-human Growth Hormone|recombinant-human growth hormone
5125340|NCT01111006|Electronic toilet|electronic toilet
5125341|NCT01111006|Bidet|bidet
5125342|NCT01111006|Anorectal resting pressure|anorectal resting pressure
5125343|NCT01110993|Multiple Sclerosis, Interferon-beta 1-a|multiple sclerosis, interferon-beta 1-a
5125344|NCT01110980|Head and Neck neoplasms|head and neck neoplasms
5125345|NCT01110980|Radiotherapy|radiotherapy
5125346|NCT01110980|Diet counselling|diet counselling
5125347|NCT01110980|Swallow therapy|swallow therapy
5125348|NCT01110980|Food intake|food intake
5125349|NCT01110941|S-1|s-1
5125350|NCT01110941|leucovorin|leucovorin
5125351|NCT01110941|oxaliplatin|oxaliplatin
5125352|NCT01110941|colorectal cancer|colorectal cancer
5125353|NCT01110941|SOL|sol
5125354|NCT01110941|unresectable or recurrent colorectal cancer|unresectable or recurrent colorectal cancer
5125355|NCT01110902|Agomelatine|agomelatine
5125356|NCT01110902|Major Depressive Disorder|major depressive disorder
5125357|NCT01110902|MDD|mdd
5125358|NCT01110902|depression|depression
5125359|NCT01110889|Agomelatine|agomelatine
5125360|NCT01110889|Major Depressive Disorder|major depressive disorder
5125361|NCT01110889|MDD|mdd
5125362|NCT01110889|depression|depression
5125363|NCT01110876|Recurrent Glioblastoma Multiforme|recurrent glioblastoma multiforme
5125364|NCT01110876|GBM|gbm
5125365|NCT01110876|Brain|brain
5125366|NCT01110876|Central Nervous Center|central nervous center
5125367|NCT01110876|Malignant glioma|malignant glioma
5125368|NCT01110876|Glioblastoma multiforme|glioblastoma multiforme
5125369|NCT01110876|Gliosarcoma|gliosarcoma
5125370|NCT01110876|Anaplastic astrocytoma|anaplastic astrocytoma
5125371|NCT01110876|Anaplastic oligodendroglioma|anaplastic oligodendroglioma
5125372|NCT01110876|Anaplastic oligoastrocytoma|anaplastic oligoastrocytoma
5125373|NCT01110876|Vorinostat|vorinostat
5125374|NCT01110876|SAHA|saha
5125375|NCT01110876|Suberoylanilide Hydroxamic Acid|suberoylanilide hydroxamic acid
5125376|NCT01110876|MSK-390|msk-390
5125377|NCT01110876|Zolinza|zolinza
5125378|NCT01110876|Erlotinib|erlotinib
5125379|NCT01110876|Erlotinib Hydrochloride|erlotinib hydrochloride
5125380|NCT01110876|OSI-774|osi-774
5125381|NCT01110876|Tarceva|tarceva
5125382|NCT01110876|Temozolomide|temozolomide
5125383|NCT01110876|Temodar|temodar
5125384|NCT01110863|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
5125385|NCT01110850|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
5125386|NCT01110837|Allergic rhinitis|allergic rhinitis
5125387|NCT01110837|Allergen|allergen
5125388|NCT01110824|Prevention|prevention
5125389|NCT01110824|ventricular dysfunction|ventricular dysfunction
5125390|NCT01110824|chemotherapy|chemotherapy
5125391|NCT01110824|acute myeloid leukemia|acute myeloid leukemia
5125392|NCT01110824|precursor-cell lymphoblastic leukemia|precursor-cell lymphoblastic leukemia
5125393|NCT01110824|multiple myeloma|multiple myeloma
5125394|NCT01110824|lymphoma|lymphoma
5125395|NCT01110824|ejection fraction|ejection fraction
5125396|NCT01110824|Autologous hematopoietic stem cell transplantation|autologous hematopoietic stem cell transplantation
5125397|NCT01110811|GERD|gerd
5125398|NCT01110811|Esophagitis|esophagitis
5125399|NCT01110811|Fundoplication|fundoplication
5125400|NCT01110811|Anti-reflux surgery|anti-reflux surgery
5125401|NCT01110811|PPI dependent|ppi dependent
5125402|NCT01110798|perioperative/postoperative complications|perioperative/postoperative complications
5125403|NCT01110798|gastrointestinal complications|gastrointestinal complications
5125404|NCT01110798|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5125405|NCT01110798|stage I rectal cancer|stage i rectal cancer
5125406|NCT01110798|stage II rectal cancer|stage ii rectal cancer
5125407|NCT01110798|stage III rectal cancer|stage iii rectal cancer
5125408|NCT01110785|recurrent colon cancer|recurrent colon cancer
5125409|NCT01110785|stage III colon cancer|stage iii colon cancer
5125410|NCT01110785|stage IV colon cancer|stage iv colon cancer
5125411|NCT01110785|recurrent rectal cancer|recurrent rectal cancer
5125412|NCT01110785|stage III rectal cancer|stage iii rectal cancer
5125413|NCT01110785|stage IV rectal cancer|stage iv rectal cancer
5125414|NCT01110772|Surgical site infection|surgical site infection
5125415|NCT01110772|Skin preparation|skin preparation
5125416|NCT01110772|Cost analysis|cost analysis
5125417|NCT01110759|pain management|pain management
5125418|NCT01110759|ambulatory surgery|ambulatory surgery
5125419|NCT01110759|opioid|opioid
5125420|NCT01110759|local anesthesia|local anesthesia
5125421|NCT01110759|hand surgery|hand surgery
5125422|NCT01110759|postoperative pain|postoperative pain
5125423|NCT01110733|Non-Hodgkins Lymphoma|non-hodgkins lymphoma
5125424|NCT01110733|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
5125425|NCT01110733|Lymphoma|lymphoma
5125426|NCT01110707|Reproductive technology, Assisted|reproductive technology, assisted
5125427|NCT01110707|Recombinant human follicle stimulating hormone (r-hFSH)|recombinant human follicle stimulating hormone (r-hfsh)
5125428|NCT01110707|Recombinant leutinizing hormone (r-hLH)|recombinant leutinizing hormone (r-hlh)
5125429|NCT01110707|Ovulation induction|ovulation induction
5125430|NCT01110707|Infertility|infertility
5125431|NCT01110694|Idiopathic pulmonary fibrosis|idiopathic pulmonary fibrosis
5125432|NCT01110694|Interstitial lung disease|interstitial lung disease
5125433|NCT01110694|Prognosis|prognosis
5125434|NCT01110694|Biomarkers|biomarkers
5125435|NCT01110694|Mortality|mortality
5125436|NCT01110694|Acute exacerbations|acute exacerbations
5125437|NCT01110668|Unresectable|unresectable
5125438|NCT01110668|metastatic gastrointestinal stromal tumor|metastatic gastrointestinal stromal tumor
5125439|NCT01110668|disease progression|disease progression
5125440|NCT01110668|progression-free survival|progression-free survival
5125441|NCT01110655|Exercise-associated hyponatremia|exercise-associated hyponatremia
5125442|NCT01110655|Randomized treatment trial|randomized treatment trial
5125443|NCT01110655|Endurance runners|endurance runners
5125444|NCT01110629|Chronic kidney disease not on dialysis|chronic kidney disease not on dialysis
5125445|NCT01110629|Lanthanum carbonate|lanthanum carbonate
5125446|NCT01110616|EEG Standardization|eeg standardization
5125447|NCT01110603|Cancer|cancer
5125448|NCT01110603|Advanced Solid Tumors|advanced solid tumors
5125449|NCT01110590|Erectile Dysfunction|erectile dysfunction
5125450|NCT01110577|MRI|mri
5125451|NCT01110577|Hepatic Steatosis Study|hepatic steatosis study
5125452|NCT01110564|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5125453|NCT01110564|daily symptom variability|daily symptom variability
5125454|NCT01110564|effects of symptom on morning activities|effects of symptom on morning activities
5125455|NCT01110551|Dengue, vaccine, flavivirus|dengue, vaccine, flavivirus
5125456|NCT01110525|Phase I|phase i
5125457|NCT01110525|Drug-drug interaction|drug-drug interaction
5125458|NCT01110525|Oral contraceptives|oral contraceptives
5125459|NCT01110525|AZD 1981|azd 1981
5125460|NCT01110512|Improvement of CVI parameters|improvement of cvi parameters
5125461|NCT01110447|Hepatic Encephalopathy, probiotics|hepatic encephalopathy, probiotics
5125462|NCT01110421|Doripenem|doripenem
5125463|NCT01110421|Child, Hospitalized|child, hospitalized
5125464|NCT01110421|Cefepime|cefepime
5125465|NCT01110421|Infusions, Intravenous|infusions, intravenous
5125466|NCT01110421|Severe community acquired pneumonia|severe community acquired pneumonia
5125467|NCT01110421|Nosocomial pneumonia|nosocomial pneumonia
5125468|NCT01110421|Ventilator associated pneumonia|ventilator associated pneumonia
5125469|NCT01110408|Antibiotic|antibiotic
5125470|NCT01110408|Child, Hospitalized|child, hospitalized
5125471|NCT01110408|Complicated Urinary Tract Infection|complicated urinary tract infection
5125472|NCT01110408|Pyelonephritis|pyelonephritis
5125473|NCT01110408|Doripenem|doripenem
5125474|NCT01110408|Cefepime|cefepime
5125475|NCT01110382|Anti-Infective Agents|anti-infective agents
5125476|NCT01110382|Doripenem|doripenem
5125477|NCT01110382|Meropenem|meropenem
5125478|NCT01110382|Child, Hospitalized|child, hospitalized
5125479|NCT01110382|Complicated Intra-Abdominal Infections|complicated intra-abdominal infections
5125480|NCT01110369|sarcopenia|sarcopenia
5125481|NCT01110369|frail elderly|frail elderly
5125482|NCT01110369|protein drink|protein drink
5125483|NCT01110369|resistance exercise|resistance exercise
5125484|NCT01110369|Skeletal muscle mass|skeletal muscle mass
5125485|NCT01110369|muscle mass in elderly|muscle mass in elderly
5125486|NCT01110343|parent stress|parent stress
5125487|NCT01110343|parent coping|parent coping
5125488|NCT01110343|parent anxiety|parent anxiety
5125489|NCT01110343|parent health|parent health
5125490|NCT01110343|parent depression|parent depression
5125491|NCT01110330|Tinea Pedis|tinea pedis
5125492|NCT01110330|Ketoconazole (NIZORAL)|ketoconazole (nizoral)
5125493|NCT01110330|Antifungal Agents|antifungal agents
5125494|NCT01110330|Miconazole (DAKTARIN)|miconazole (daktarin)
5125495|NCT01110317|Paliperidone palmitate|paliperidone palmitate
5125496|NCT01110317|R092670PSY1001|r092670psy1001
5125497|NCT01110317|Pharmacokinetics|pharmacokinetics
5125498|NCT01110317|Risperdal (CONSTA)|risperdal (consta)
5125499|NCT01110317|Risperidone, Paliperidone|risperidone, paliperidone
5125500|NCT01110304|acromio-clavicular joint dislocation|acromio-clavicular joint dislocation
5125501|NCT01110304|type III acromio-clavicular joint dislocation|type iii acromio-clavicular joint dislocation
5125502|NCT01110304|joint dislocation|joint dislocation
5125503|NCT01110304|clavicle hook plate|clavicle hook plate
5125504|NCT01110291|docetaxel toxicity|docetaxel toxicity
5125505|NCT01110291|CYP3A activity|cyp3a activity
5125506|NCT01110291|CYP3A5|cyp3a5
5125507|NCT01110291|MDR1|mdr1
5125508|NCT01110291|peroral midazolam|peroral midazolam
5125509|NCT01110278|Urge Urinary Incontinence|urge urinary incontinence
5125510|NCT01110278|Magnetic Resonance Imaging|magnetic resonance imaging
5125511|NCT01110278|Diffusion Tensor Imaging|diffusion tensor imaging
5125512|NCT01110278|Brain Connectivity|brain connectivity
5125513|NCT01110278|Bladder Control|bladder control
5125514|NCT01110278|fMRI|fmri
5125515|NCT01110252|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5125516|NCT01110252|Emphysema|emphysema
5125517|NCT01110252|Cell therapy|cell therapy
5125518|NCT01110252|Bone marrow mononuclear cells|bone marrow mononuclear cells
5125519|NCT01110252|stem cells|stem cells
5125520|NCT01110239|limb preconditioning|limb preconditioning
5125521|NCT01110239|remote preconditioning|remote preconditioning
5125522|NCT01110239|ischemic preconditioning|ischemic preconditioning
5125523|NCT01110226|non small cell lung cancer|non small cell lung cancer
5125524|NCT01110226|small cell lung cancer|small cell lung cancer
5125525|NCT01110226|Platinum Responsive|platinum responsive
5125526|NCT01110226|solid tumor malignancies|solid tumor malignancies
5125527|NCT01110213|Aging|aging
5125528|NCT01110213|physical activity|physical activity
5125529|NCT01110213|diet|diet
5125530|NCT01110213|goal setting|goal setting
5125531|NCT01110200|Hospitalization|hospitalization
5125532|NCT01110200|Exacerbations of COPD|exacerbations of copd
5125533|NCT01110200|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
5125534|NCT01110187|Lacosamide|lacosamide
5125535|NCT01110187|Fosphenytoin|fosphenytoin
5125536|NCT01110187|traumatic brain injury|traumatic brain injury
5125537|NCT01110187|Glasgow coma scale|glasgow coma scale
5125538|NCT01110187|Disability Rating Scale|disability rating scale
5125539|NCT01110187|Resource Utilization Questionnaire|resource utilization questionnaire
5125540|NCT01110187|Continuous EEG|continuous eeg
5125541|NCT01110187|seizures|seizures
5125542|NCT01110161|Abdominal Fat|abdominal fat
5125543|NCT01110161|Visceral Fat|visceral fat
5125544|NCT01110161|Subcutaneous Fat|subcutaneous fat
5125545|NCT01110161|Dual-energy x-ray absorptiometry|dual-energy x-ray absorptiometry
5125546|NCT01110161|DXA|dxa
5125547|NCT01110161|Computed Tomography|computed tomography
5125548|NCT01110161|CT|ct
5125549|NCT01110161|Body Mass Index|body mass index
5125550|NCT01110161|Body composition|body composition
5125551|NCT01110161|Percent fat|percent fat
5125552|NCT01110161|Waist circumference|waist circumference
5125553|NCT01110161|Hip circumference|hip circumference
5125554|NCT01110148|skin biopsy|skin biopsy
5125555|NCT01110148|informed consent|informed consent
5125556|NCT01110148|patient education|patient education
5125557|NCT01110148|video education|video education
5125558|NCT01110148|patients requiring skin biopsies|patients requiring skin biopsies
5125559|NCT01110122|Muscle recovery|muscle recovery
5125560|NCT01110122|Intermittent exercise|intermittent exercise
5125561|NCT01110122|Whey protein|whey protein
5125562|NCT01110122|Soccer|soccer
5125563|NCT01110109|Adult|adult
5125564|NCT01110109|Surgery|surgery
5125565|NCT01110109|Endotracheal Tube|endotracheal tube
5125566|NCT01110109|Ventilator|ventilator
5125567|NCT01110109|Pneumonia|pneumonia
5125568|NCT01110109|Suctioning|suctioning
5125569|NCT01110096|Obesity|obesity
5125570|NCT01110096|Child|child
5125571|NCT01110096|Parent|parent
5125572|NCT01110096|Family|family
5125573|NCT01110083|Phase 1|phase 1
5125574|NCT01110083|advanced solid tumors|advanced solid tumors
5125575|NCT01110083|refractory to standard therapy|refractory to standard therapy
5125576|NCT01110083|Patients with solid tumors, either refractory to standard therapy or for which no effective standard therapy is available|patients with solid tumors, either refractory to standard therapy or for which no effective standard therapy is available
5125577|NCT01110070|articular|articular
5125578|NCT01110070|cartilage|cartilage
5125579|NCT01110070|microfracture|microfracture
5125580|NCT01110070|knee pain|knee pain
5125581|NCT01110070|cartilage repair|cartilage repair
5125582|NCT01110070|Subjects with an articular cartilage defect in the knee.|subjects with an articular cartilage defect in the knee.
5125583|NCT01110057|p38 kinase inhibitor|p38 kinase inhibitor
5125584|NCT01110057|male and female|male and female
5125585|NCT01110057|patients|patients
5125586|NCT01110044|Neonatal vaccination|neonatal vaccination
5125587|NCT01110031|Chronic lymphocytic leukemia|chronic lymphocytic leukemia
5125588|NCT01110031|Cardiac Repolarization (QTc)|cardiac repolarization (qtc)
5125589|NCT01110018|Tolerability|tolerability
5125590|NCT01110018|COPD|copd
5125591|NCT01110018|Safety|safety
5125592|NCT01110018|Muscarinic receptor (mAChR) antagonist|muscarinic receptor (machr) antagonist
5125593|NCT01110018|GSK573719|gsk573719
5125594|NCT01110018|Healthy subjects|healthy subjects
5125595|NCT01110018|Pharmacokinetics|pharmacokinetics
5125596|NCT01110018|IV study|iv study
5125597|NCT01110005|D5LR|d5lr
5125598|NCT01110005|glucose containing IV solution|glucose containing iv solution
5125599|NCT01110005|LR|lr
5125600|NCT01110005|non glucose IV solution|non glucose iv solution
5125601|NCT01109992|coronary artery disease|coronary artery disease
5125602|NCT01109992|exercise|exercise
5125603|NCT01109992|regadenoson|regadenoson
5125604|NCT01109992|positron emission tomography|positron emission tomography
5125605|NCT01109979|Cardiovascular, vascular|cardiovascular, vascular
5125606|NCT01109966|Allergy|allergy
5125607|NCT01109966|Cow's Milk|cow's milk
5125608|NCT01109966|Infants|infants
5125609|NCT01109966|Food Allergy|food allergy
5125610|NCT01109953|Lung|lung
5125611|NCT01109953|PET/CT scan|pet/ct scan
5125612|NCT01109953|10-054|10-054
5125613|NCT01109940|Ankylosing spondylitis|ankylosing spondylitis
5125614|NCT01109940|IgG1K monoclonal antibody|igg1k monoclonal antibody
5125615|NCT01109940|Interleukin -17A neutralizing|interleukin -17a neutralizing
5125616|NCT01109914|Renal transplantation|renal transplantation
5125617|NCT01109914|Immunosuppression|immunosuppression
5125618|NCT01109914|ETEC|etec
5125619|NCT01109914|Dukoral|dukoral
5125620|NCT01109914|Vaccination|vaccination
5125621|NCT01109914|Immunity, Humoral|immunity, humoral
5125622|NCT01109901|Cubital tunnel,subcutaneous transposition,submuscular|cubital tunnel,subcutaneous transposition,submuscular
5125623|NCT01109862|Femoral neck fractures|femoral neck fractures
5125624|NCT01109862|Hip fractures|hip fractures
5125625|NCT01109862|Elderly|elderly
5125626|NCT01109862|Total hip arthroplasty|total hip arthroplasty
5125627|NCT01109862|Bipolar hemiarthroplasty|bipolar hemiarthroplasty
5125628|NCT01109849|ADHD|adhd
5125629|NCT01109849|growth|growth
5125630|NCT01109849|BMI|bmi
5125631|NCT01109849|stimulant medication|stimulant medication
5125632|NCT01109836|prevention|prevention
5125633|NCT01109836|cognitive decline|cognitive decline
5125634|NCT01109836|post-stroke dementia|post-stroke dementia
5125635|NCT01109836|life-style intervention|life-style intervention
5125636|NCT01109836|vascular risk factors|vascular risk factors
5125637|NCT01109836|polyintervention|polyintervention
5125638|NCT01109836|multifactorial treatment|multifactorial treatment
5125639|NCT01109823|Patients hospitalized at Intensive Care Unit treated with levofloxacin IV|patients hospitalized at intensive care unit treated with levofloxacin iv
5125640|NCT01109784|coronary angioplasty|coronary angioplasty
5125641|NCT01109784|clopidogrel resistance|clopidogrel resistance
5125642|NCT01109784|prasugrel|prasugrel
5125643|NCT01109771|Ventral hernia|ventral hernia
5125644|NCT01109758|Fenofibrate|fenofibrate
5125645|NCT01109758|Gene Expression|gene expression
5125646|NCT01109758|DNA methylation|dna methylation
5125647|NCT01109745|Asthma|asthma
5125648|NCT01109745|health-related quality of life|health-related quality of life
5125649|NCT01109745|patient-centred care|patient-centred care
5125650|NCT01109719|Protocol|protocol
5125651|NCT01109719|Critical pathway|critical pathway
5125652|NCT01109719|Intensive care units|intensive care units
5125653|NCT01109706|Acute coronary syndrome|acute coronary syndrome
5125654|NCT01109706|PCSK9|pcsk9
5125655|NCT01109706|cardiovascular safety|cardiovascular safety
5125656|NCT01109667|Thromboplastin, Prothrombin, Diagnostic Reagent Kits, International Normalized Ratio, Laboratory Tests.|thromboplastin, prothrombin, diagnostic reagent kits, international normalized ratio, laboratory tests.
5125657|NCT01109654|Fertilization in Vitro|fertilization in vitro
5125658|NCT01109654|Reproductive Techniques, Assisted|reproductive techniques, assisted
5125659|NCT01109654|Follicle Stimulating Hormone|follicle stimulating hormone
5125660|NCT01109654|Cetrotide|cetrotide
5125661|NCT01109654|Gonal-f|gonal-f
5125662|NCT01109628|sarcopenia|sarcopenia
5125663|NCT01109628|frail elderly|frail elderly
5125664|NCT01109628|protein drink|protein drink
5125665|NCT01109628|skeletal muscle mass|skeletal muscle mass
5125666|NCT01109628|muscle mass in elderly|muscle mass in elderly
5125667|NCT01109615|Colorectal cancer|colorectal cancer
5125668|NCT01109615|Metastatic colorectal cancer|metastatic colorectal cancer
5125669|NCT01109615|Treatment resistant|treatment resistant
5125670|NCT01109615|Chemotherapy refractory|chemotherapy refractory
5125671|NCT01109615|KRAS mutation|kras mutation
5125672|NCT01109602|Stroke|stroke
5125673|NCT01109602|accidental falls|accidental falls
5125674|NCT01109602|Yoga|yoga
5125675|NCT01109602|Blood pressure|blood pressure
5125676|NCT01109602|Range of Motion|range of motion
5125677|NCT01109602|Rehabilitation|rehabilitation
5125678|NCT01109602|Exercise|exercise
5125679|NCT01109602|balance|balance
5125680|NCT01109602|quality of life|quality of life
5125681|NCT01109602|mobility|mobility
5125682|NCT01109589|antibiotics|antibiotics
5125683|NCT01109589|prescriptions|prescriptions
5125684|NCT01109589|pregnancy|pregnancy
5125685|NCT01109589|children|children
5125686|NCT01109576|deafness-blindness|deafness-blindness
5125687|NCT01109576|pilot study|pilot study
5125688|NCT01109576|self management education|self management education
5125689|NCT01109576|dual sensory loss|dual sensory loss
5125690|NCT01109576|rehabilitation|rehabilitation
5125691|NCT01109576|peer support groups|peer support groups
5125692|NCT01109576|age related|age related
5125693|NCT01109563|cannabis use disorder|cannabis use disorder
5125694|NCT01109563|marijuana|marijuana
5125695|NCT01109563|motivational enhancement treatment|motivational enhancement treatment
5125696|NCT01109563|cognitive behavioral treatment|cognitive behavioral treatment
5125697|NCT01109563|continuing care|continuing care
5125698|NCT01109537|Restless Legs Syndrome (RLS)|restless legs syndrome (rls)
5125699|NCT01109537|GABA|gaba
5125700|NCT01109537|Glutamate|glutamate
5125701|NCT01109537|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
5125702|NCT01109498|LPLD|lpld
5125703|NCT01109498|Lipoprotein Lipase Deficiency|lipoprotein lipase deficiency
5125704|NCT01109498|Chylomicronaemia|chylomicronaemia
5125705|NCT01109498|Genetherapy|genetherapy
5125706|NCT01109498|AAV|aav
5125707|NCT01109498|Alipogene Tiparvovec|alipogene tiparvovec
5125708|NCT01109498|AMT-011|amt-011
5125709|NCT01109498|Lipoprotein Lipase|lipoprotein lipase
5125710|NCT01109485|Allergic conjunctivitis|allergic conjunctivitis
5125711|NCT01109459|preschool|preschool
5125712|NCT01109459|screening|screening
5125713|NCT01109459|cluster randomized|cluster randomized
5125714|NCT01109459|physician practice patterns|physician practice patterns
5125715|NCT01109459|behavior|behavior
5125716|NCT01109459|knowledge|knowledge
5125717|NCT01109459|attitudes|attitudes
5125718|NCT01109459|guideline adherence|guideline adherence
5125719|NCT01109446|Lateral Epicondylitis|lateral epicondylitis
5125720|NCT01109446|Tennis Elbow|tennis elbow
5125721|NCT01109446|Epicondylitis Lateralis|epicondylitis lateralis
5125722|NCT01109433|Behcet's Disease|behcet's disease
5125723|NCT01109433|Intermediate Uveitis|intermediate uveitis
5125724|NCT01109433|Uveitis|uveitis
5125725|NCT01109433|Immunogenetics|immunogenetics
5125726|NCT01109420|Hereditary Cancer|hereditary cancer
5125727|NCT01109420|Susceptibility Gene(s) for Thyroid Cancer|susceptibility gene(s) for thyroid cancer
5125728|NCT01109420|Screening at Risk Family Members|screening at risk family members
5125729|NCT01109420|Inherited Thyroid Cancer|inherited thyroid cancer
5125730|NCT01109420|Thyroid Cancer|thyroid cancer
5125731|NCT01109407|Plasma Cell Neoplasm|plasma cell neoplasm
5125732|NCT01109407|Natural History|natural history
5125733|NCT01109407|Translational Studies|translational studies
5125734|NCT01109407|Gene Expression Profiling|gene expression profiling
5125735|NCT01109407|Protein Markers|protein markers
5125736|NCT01109407|Smoldering Myeloma|smoldering myeloma
5125737|NCT01109407|SMM|smm
5125738|NCT01109407|Monoclonal Gammopathy of Undetermined Significance|monoclonal gammopathy of undetermined significance
5125739|NCT01109407|MGUS|mgus
5125740|NCT01109394|Genomics|genomics
5125741|NCT01109394|Proteomics|proteomics
5125742|NCT01109394|Tissue Repository|tissue repository
5125743|NCT01109394|Omics|omics
5125744|NCT01109394|Cell Lines|cell lines
5125745|NCT01109394|Pediatric Cancer|pediatric cancer
5125746|NCT01109394|Solid Tumor|solid tumor
5125747|NCT01109394|Sarcoma|sarcoma
5125748|NCT01109394|Kidney Cancer|kidney cancer
5125749|NCT01109394|Neuroblastoma|neuroblastoma
5125750|NCT01109381|bacterial infections|bacterial infections
5125751|NCT01109381|anti-infective agents|anti-infective agents
5125752|NCT01109381|gastrointestinal agents|gastrointestinal agents
5125753|NCT01109381|antibacterial agents|antibacterial agents
5125754|NCT01109381|omeprazole|omeprazole
5125755|NCT01109381|lauric acid|lauric acid
5125756|NCT01109381|n-acetylcysteine|n-acetylcysteine
5125757|NCT01109381|helicobacter infections|helicobacter infections
5125758|NCT01109381|helicobacter pylori|helicobacter pylori
5125759|NCT01109381|non-antibiotic treatment|non-antibiotic treatment
5125760|NCT01109368|Autosomal Dominant Familial Hypercholesterolemia|autosomal dominant familial hypercholesterolemia
5125761|NCT01109355|PEEP|peep
5125762|NCT01109355|Patients with hemorrhage stroke under mechanical ventilation|patients with hemorrhage stroke under mechanical ventilation
5125763|NCT01109342|HIV Prevention|hiv prevention
5125764|NCT01109342|Vaccine|vaccine
5125765|NCT01109342|Recombinant Adenovirus-5|recombinant adenovirus-5
5125766|NCT01109342|HIV Preventative Vaccine|hiv preventative vaccine
5125767|NCT01109329|Vaccine|vaccine
5125768|NCT01109303|ankle fracture with syndesmotic ligament rupture|ankle fracture with syndesmotic ligament rupture
5125769|NCT01109303|ankle syndesmosis rupture|ankle syndesmosis rupture
5125770|NCT01109264|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
5125771|NCT01109264|Bendamustine Hydrochloride|bendamustine hydrochloride
5125772|NCT01109264|Chlorambucil|chlorambucil
5125773|NCT01109238|Refractory Neuroblastoma|refractory neuroblastoma
5125774|NCT01109238|Relapsed Neuroblastoma|relapsed neuroblastoma
5125775|NCT01109225|aldosterone|aldosterone
5125776|NCT01109225|myocardial infarction|myocardial infarction
5125777|NCT01109225|cardiac remodeling|cardiac remodeling
5125778|NCT01109212|Type 2-Diabetic Nephrophaty|type 2-diabetic nephrophaty
5125779|NCT01109212|bindarit|bindarit
5125780|NCT01109212|albuminuria|albuminuria
5125781|NCT01109212|MCP-1|mcp-1
5125782|NCT01109199|viscous|viscous
5125783|NCT01109199|fibre|fibre
5125784|NCT01109199|polysaccharide|polysaccharide
5125785|NCT01109199|appetite|appetite
5125786|NCT01109199|hunger|hunger
5125787|NCT01109199|satiety|satiety
5125788|NCT01109199|weight management|weight management
5125789|NCT01109186|patient with a kidney transplantation since less than 30 days|patient with a kidney transplantation since less than 30 days
5125790|NCT01109160|azithromycin|azithromycin
5125791|NCT01109160|lymphocytic bronchitis or bronchiolitis|lymphocytic bronchitis or bronchiolitis
5125792|NCT01109160|lung transplantation|lung transplantation
5125793|NCT01109160|acute allograft rejection|acute allograft rejection
5125794|NCT01109160|chronic allograft rejection|chronic allograft rejection
5125795|NCT01109160|bronchiolitis obliterans syndrome|bronchiolitis obliterans syndrome
5125796|NCT01109147|Schizophrenic Disorders|schizophrenic disorders
5125797|NCT01109147|Schizophrenia|schizophrenia
5125798|NCT01109147|Affect|affect
5125799|NCT01109147|Emotional Blunting|emotional blunting
5125800|NCT01109134|primary angioplasty|primary angioplasty
5125801|NCT01109134|tirofiban|tirofiban
5125802|NCT01109134|microcirculation|microcirculation
5125803|NCT01109121|Moderate to severe gout|moderate to severe gout
5125804|NCT01109121|Hyperuricemia|hyperuricemia
5125805|NCT01109108|pneumococcal vaccine|pneumococcal vaccine
5125806|NCT01109108|nasopharyngeal carriage|nasopharyngeal carriage
5125807|NCT01109095|Glioblastoma Multiforme (GBM)|glioblastoma multiforme (gbm)
5125808|NCT01109095|HER2|her2
5125809|NCT01109095|CMV|cmv
5125810|NCT01109095|Brain Cancer|brain cancer
5125811|NCT01109095|Autologous HER2.CAR CMV-specific cytotoxic CTL|autologous her2.car cmv-specific cytotoxic ctl
5125812|NCT01109095|CMV-specific cytotoxic CTL|cmv-specific cytotoxic ctl
5125813|NCT01109082|Scoliosis|scoliosis
5125814|NCT01109082|gait|gait
5125815|NCT01109082|posture|posture
5125816|NCT01109082|balance|balance
5125817|NCT01109069|PCI-32765|pci-32765
5125818|NCT01109069|Lymphoma, B-Cell|lymphoma, b-cell
5125819|NCT01109069|Leukemia, Lymphoid|leukemia, lymphoid
5125820|NCT01109069|Leukemia, B-Cell|leukemia, b-cell
5125821|NCT01109069|Bruton's Tyrosine Kinase|bruton's tyrosine kinase
5125822|NCT01109043|Hypertension|hypertension
5125823|NCT01109043|Bisoprolol|bisoprolol
5125824|NCT01109043|Antihypertensive drugs|antihypertensive drugs
5125825|NCT01109043|Blood pressure|blood pressure
5125826|NCT01109043|Quality of life|quality of life
5125827|NCT01109043|Diabetes|diabetes
5125828|NCT01109043|Ketohexokinase|ketohexokinase
5125829|NCT01109030|Major depressive disorder|major depressive disorder
5125830|NCT01109030|pioglitazone|pioglitazone
5125831|NCT01109030|double blind|double blind
5125832|NCT01109030|placebo controlled|placebo controlled
5125833|NCT01109004|Symptomatic Multiple Myeloma|symptomatic multiple myeloma
5125834|NCT01109004|Lenalidomide|lenalidomide
5125835|NCT01109004|Anti-Myeloma Agents|anti-myeloma agents
5125836|NCT01109004|Hematologic Disorders|hematologic disorders
5125837|NCT01109004|Maintenance Therapy|maintenance therapy
5125838|NCT01109004|Progression|progression
5125839|NCT01109004|Autologous Transplant|autologous transplant
5125840|NCT01109004|RVD Consolidation|rvd consolidation
5125841|NCT01108991|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
5125842|NCT01108991|Randomized controlled trial|randomized controlled trial
5125843|NCT01108991|Self-management support|self-management support
5125844|NCT01108991|Physical activity|physical activity
5125845|NCT01108978|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
5125846|NCT01108978|Cardiovascular Disease|cardiovascular disease
5125847|NCT01108978|hypercholesterolemia|hypercholesterolemia
5125848|NCT01108965|Hydrocephalus|hydrocephalus
5125849|NCT01108965|Shunt Dysfunction|shunt dysfunction
5125850|NCT01108965|Shunt Flow|shunt flow
5125851|NCT01108952|Chemotherapy|chemotherapy
5125852|NCT01108952|Memory|memory
5125853|NCT01108952|Methotrexate|methotrexate
5125854|NCT01108952|Glucocorticoids|glucocorticoids
5125855|NCT01108952|Trauma|trauma
5125856|NCT01108952|pediatric oncology|pediatric oncology
5125857|NCT01108952|traumatization|traumatization
5125858|NCT01108939|Malaria, Iron absorption, Iron utilization, Benin|malaria, iron absorption, iron utilization, benin
5125859|NCT01108913|COPD|copd
5125860|NCT01108900|Erectile Dysfunction udenafil sildenafil treatment satisfaction|erectile dysfunction udenafil sildenafil treatment satisfaction
5125861|NCT01108887|Multiple Sclerosis, Relapsing-Remitting|multiple sclerosis, relapsing-remitting
5125862|NCT01108887|RebiSmart|rebismart
5125863|NCT01108887|Rebif|rebif
5125864|NCT01108887|Interferon beta-1a|interferon beta-1a
5125865|NCT01108874|Cesarean section|cesarean section
5125866|NCT01108874|Hypotension|hypotension
5125867|NCT01108874|Metaraminol|metaraminol
5125868|NCT01108874|Vasoconstrictor Agents|vasoconstrictor agents
5125869|NCT01108874|Adult|adult
5125870|NCT01108874|Female|female
5125871|NCT01108874|Pregnancy|pregnancy
5125872|NCT01108874|Anesthesia, Obstetrical/adverse effects|anesthesia, obstetrical/adverse effects
5125873|NCT01108874|Anesthesia,Spinal|anesthesia,spinal
5125874|NCT01108874|Blood Pressure/drug effects|blood pressure/drug effects
5125875|NCT01108874|Nausea|nausea
5125876|NCT01108874|Vomiting|vomiting
5125877|NCT01108861|Peripheral Vascular Disease|peripheral vascular disease
5125878|NCT01108861|In-stent restenosis|in-stent restenosis
5125879|NCT01108861|Endoprosthesis|endoprosthesis
5125880|NCT01108861|Plain old balloon angioplasty|plain old balloon angioplasty
5125881|NCT01108848|C1-esterase Inhibitor|c1-esterase inhibitor
5125882|NCT01108848|Hereditary angioedema|hereditary angioedema
5125883|NCT01108848|Acute HAE attack|acute hae attack
5125884|NCT01108835|COPD|copd
5125885|NCT01108835|Comprehensive care|comprehensive care
5125886|NCT01108783|Rhinitis|rhinitis
5125887|NCT01108783|Allergic|allergic
5125888|NCT01108783|Seasonal|seasonal
5125889|NCT01108783|Hay Fever|hay fever
5125890|NCT01108783|Pollen Allergy|pollen allergy
5125891|NCT01108783|Pollinosis|pollinosis
5125892|NCT01108783|Rhinoconjunctivitis|rhinoconjunctivitis
5125893|NCT01108783|Sneezing|sneezing
5125894|NCT01108783|Nasal itching|nasal itching
5125895|NCT01108783|Nasal Congestion|nasal congestion
5125896|NCT01108783|Rhinorrhea|rhinorrhea
5125897|NCT01108783|Ocular itching|ocular itching
5125898|NCT01108783|Ocular redness|ocular redness
5125899|NCT01108783|Tearing|tearing
5125900|NCT01108770|HED|hed
5125901|NCT01108770|XLHED|xlhed
5125902|NCT01108770|Hypohidrotic Ectodermal Dysplasia|hypohidrotic ectodermal dysplasia
5125904|NCT01108757|urinary tract infection|urinary tract infection
5125905|NCT01108744|clinical trial|clinical trial
5125906|NCT01108744|mannitol|mannitol
5125907|NCT01108744|intracranial pressure (ICP)|intracranial pressure (icp)
5125908|NCT01108744|hypertonic saline|hypertonic saline
5125909|NCT01108744|cerebral edema|cerebral edema
5125910|NCT01108744|traumatic brain injury (TBI)|traumatic brain injury (tbi)
5125911|NCT01108718|Mattress|mattress
5125912|NCT01108718|Tempur-Pedic|tempur-pedic
5125913|NCT01108718|Fibromyalgia|fibromyalgia
5125914|NCT01108718|Sleep patterns|sleep patterns
5125915|NCT01108692|atrial fibrillation|atrial fibrillation
5125916|NCT01108692|supraventricular arrhythmia|supraventricular arrhythmia
5125917|NCT01108692|antithrombotic treatment|antithrombotic treatment
5125918|NCT01108692|antiarrhythmic drugs|antiarrhythmic drugs
5125919|NCT01108692|medical reaction time|medical reaction time
5125920|NCT01108692|telecardiology|telecardiology
5125921|NCT01108692|early detection|early detection
5125922|NCT01108692|holters memories|holters memories
5125923|NCT01108692|Pacemaker|pacemaker
5125924|NCT01108666|Adult subjects with a confirmed diagnosis of Stage IIIA or IIIB NSCLC, with adequate bone marrow, liver and renal function.|adult subjects with a confirmed diagnosis of stage iiia or iiib nsclc, with adequate bone marrow, liver and renal function.
5125925|NCT01108653|Cardiovascular diseases|cardiovascular diseases
5125926|NCT01108653|Heart diseases|heart diseases
5125927|NCT01108653|Myocardial infarction|myocardial infarction
5125928|NCT01108653|Rehabilitation|rehabilitation
5125929|NCT01108653|Health Economy|health economy
5125930|NCT01108653|Randomized controlled trials|randomized controlled trials
5125931|NCT01108653|Non ST Elevation Myocardial Infarction (NSTEMI)|non st elevation myocardial infarction (nstemi)
5125932|NCT01108653|Cost analysis|cost analysis
5125933|NCT01108653|Sick-leave|sick-leave
5125934|NCT01108653|Quality of Life|quality of life
5125935|NCT01108614|Methadone maintenance treatment|methadone maintenance treatment
5125936|NCT01108614|drug users|drug users
5125937|NCT01108614|heroin|heroin
5125938|NCT01108614|HIV|hiv
5125939|NCT01108614|HCV|hcv
5125940|NCT01108614|Syphilis|syphilis
5125941|NCT01108614|HSV-2|hsv-2
5125942|NCT01108601|Ringer's|ringer's
5125943|NCT01108601|lactate|lactate
5125944|NCT01108601|cisplatin|cisplatin
5125945|NCT01108601|ototoxicity|ototoxicity
5125946|NCT01108601|hearing loss|hearing loss
5125947|NCT01108575|Mechanical ventilation|mechanical ventilation
5125948|NCT01108575|mechanical ventilation weaning|mechanical ventilation weaning
5125949|NCT01108575|inspiratory muscle strength training|inspiratory muscle strength training
5125950|NCT01108575|Patients admitted to a surgical intensive care unit who are expected to receive mechanical ventilation for more than three days.|patients admitted to a surgical intensive care unit who are expected to receive mechanical ventilation for more than three days.
5125951|NCT01108562|postoperative pain management|postoperative pain management
5125952|NCT01108549|Fibromyalgia|fibromyalgia
5125953|NCT01108549|Chronic Fatigue Syndrome|chronic fatigue syndrome
5125954|NCT01108549|D-ribose|d-ribose
5125955|NCT01108549|fatigue|fatigue
5125956|NCT01108536|prosthetics|prosthetics
5125957|NCT01108536|socket comfort|socket comfort
5125958|NCT01108536|amputation stump|amputation stump
5125959|NCT01108536|amputee rehabilitation|amputee rehabilitation
5125960|NCT01108523|Moisture Associated Skin Damage|moisture associated skin damage
5125961|NCT01108510|Treatment Naive|treatment naive
5125962|NCT01108510|HIV 1 Infected|hiv 1 infected
5125963|NCT01108484|Cancer survivors, exercise, diet, emotional support|cancer survivors, exercise, diet, emotional support
5125964|NCT01108471|cesarean section; hemoglobin; postpartum hemorrhage;|cesarean section; hemoglobin; postpartum hemorrhage;
5125965|NCT01108445|cancer|cancer
5125966|NCT01108445|kidney cancer|kidney cancer
5125967|NCT01108445|sutent|sutent
5125968|NCT01108445|everolimus|everolimus
5125969|NCT01108445|renal cancer|renal cancer
5125970|NCT01108445|papillary renal cell|papillary renal cell
5125971|NCT01108445|chromophobe renal cell|chromophobe renal cell
5125972|NCT01108445|papillary|papillary
5125973|NCT01108445|chromophobe|chromophobe
5125974|NCT01108432|Tobacco cessation counseling|tobacco cessation counseling
5125975|NCT01108419|healthy adults|healthy adults
5125976|NCT01108406|Hearing Loss|hearing loss
5125977|NCT01108406|Unilateral Hearing Loss|unilateral hearing loss
5125978|NCT01108406|Single Sided Deafness|single sided deafness
5125979|NCT01108393|Obsessive Compulsive Disorder|obsessive compulsive disorder
5125980|NCT01108393|Agomelatine|agomelatine
5125981|NCT01108380|Liver cirrhosis|liver cirrhosis
5125982|NCT01108380|liver regeneration|liver regeneration
5125983|NCT01108380|liver volume|liver volume
5125984|NCT01108380|liver function|liver function
5125985|NCT01108380|hepatocellular carcinoma, extensive|hepatocellular carcinoma, extensive
5125986|NCT01108380|hepatectomy|hepatectomy
5125987|NCT01108328|viscous|viscous
5125988|NCT01108328|fibre|fibre
5125989|NCT01108328|polysaccharide|polysaccharide
5125990|NCT01108328|blood glucose|blood glucose
5125991|NCT01108328|postprandial|postprandial
5125992|NCT01108328|appetite|appetite
5125993|NCT01108328|hunger|hunger
5125994|NCT01108328|satiety|satiety
5125995|NCT01108315|Patient Reported Outcomes (PRO)|patient reported outcomes (pro)
5125996|NCT01108315|Web-based|web-based
5125997|NCT01108315|Phone-based|phone-based
5125998|NCT01108315|Breast Cancer|breast cancer
5125999|NCT01108302|uterotonic|uterotonic
5126000|NCT01108302|oxytocin|oxytocin
5126001|NCT01108302|randomized trial|randomized trial
5126002|NCT01108302|India|india
5126003|NCT01108302|community|community
5126004|NCT01108302|hemorrhage|hemorrhage
5126005|NCT01108289|hemorrhage|hemorrhage
5126006|NCT01108289|uterotonic|uterotonic
5126007|NCT01108289|oxytocin|oxytocin
5126008|NCT01108289|blood loss|blood loss
5126009|NCT01108289|community|community
5126010|NCT01108289|Ghana|ghana
5126011|NCT01108289|randomized trial|randomized trial
5126012|NCT01108237|Arthroplasties, Knee Replacement|arthroplasties, knee replacement
5126013|NCT01108237|Arthroplasties, Replacement, Knee|arthroplasties, replacement, knee
5126014|NCT01108237|Arthroplasty, Knee Replacement|arthroplasty, knee replacement
5126015|NCT01108237|Knee Replacement Arthroplasties|knee replacement arthroplasties
5126016|NCT01108237|Knee Replacement Arthroplasty|knee replacement arthroplasty
5126017|NCT01108237|Knee Replacement, Total|knee replacement, total
5126018|NCT01108237|Replacement Arthroplasties, Knee|replacement arthroplasties, knee
5126019|NCT01108237|Replacement Arthroplasty, Knee|replacement arthroplasty, knee
5126020|NCT01108237|Replacement, Total Knee|replacement, total knee
5126021|NCT01108237|Total Knee Replacement|total knee replacement
5126022|NCT01108224|Quality of life|quality of life
5126023|NCT01108224|Coping|coping
5126024|NCT01108224|Social relations|social relations
5126025|NCT01108224|Survival|survival
5126026|NCT01108224|Psychotherapy|psychotherapy
5126027|NCT01108211|Adolescent Idiopathic Scoliosis|adolescent idiopathic scoliosis
5126028|NCT01108211|AIS|ais
5126029|NCT01108211|Vibration Therapy|vibration therapy
5126030|NCT01108211|Low bone mass|low bone mass
5126031|NCT01108211|osteopenia|osteopenia
5126032|NCT01108198|phimosis,|phimosis,
5126033|NCT01108198|non-retractable foreskin|non-retractable foreskin
5126034|NCT01108198|topical steroids|topical steroids
5126035|NCT01108198|children|children
5126036|NCT01108185|treatment with Klacid®SR|treatment with klacid®sr
5126037|NCT01108185|tracheitis|tracheitis
5126038|NCT01108185|tracheobronchitis|tracheobronchitis
5126039|NCT01108185|bronchitis|bronchitis
5126040|NCT01108185|chronic bronchitis|chronic bronchitis
5126041|NCT01108185|community-acquired pneumonia|community-acquired pneumonia
5126042|NCT01108133|Posttraumatic Stress Disorder|posttraumatic stress disorder
5126043|NCT01108133|Traumatic Memories|traumatic memories
5126044|NCT01108133|fMRI|fmri
5126045|NCT01108120|diabetic foot ulcer|diabetic foot ulcer
5126046|NCT01108120|artery mini-pump|artery mini-pump
5126047|NCT01108120|continuous infusion of urokinase|continuous infusion of urokinase
5126048|NCT01108120|femoral artery|femoral artery
5126049|NCT01108107|Colon cancer|colon cancer
5126050|NCT01108107|Neoadjuvant treatment|neoadjuvant treatment
5126051|NCT01108107|KRAS mutation|kras mutation
5126052|NCT01108107|BRAF mutation|braf mutation
5126053|NCT01108107|PIK3CA mutation|pik3ca mutation
5126054|NCT01108107|Possibly avoid chemotherapy after operation|possibly avoid chemotherapy after operation
5126055|NCT01108081|Sleep apnea|sleep apnea
5126056|NCT01108081|Sleep symptoms|sleep symptoms
5126057|NCT01108081|Quality of Life|quality of life
5126058|NCT01108068|Osteoporosis-pseudoglioma syndrome, OPPG, LRP5 mutation|osteoporosis-pseudoglioma syndrome, oppg, lrp5 mutation
5126059|NCT01108029|Parkinson's disease|parkinson's disease
5126060|NCT01108029|Freezing of Gait|freezing of gait
5126061|NCT01108029|Memantine|memantine
5126062|NCT01108029|NMDA receptor|nmda receptor
5126063|NCT01108029|glutamate|glutamate
5126064|NCT01108029|No Dementia|no dementia
5126065|NCT01107964|Dry Eye Syndrome|dry eye syndrome
5126066|NCT01107964|Recent Diagnosis of Dry Eye Syndrome|recent diagnosis of dry eye syndrome
5126067|NCT01107951|Rituximab|rituximab
5126068|NCT01107951|Dexamethasone|dexamethasone
5126069|NCT01107951|Low-dose|low-dose
5126070|NCT01107951|ITP|itp
5126071|NCT01107938|GERD|gerd
5126072|NCT01107925|Platelet function|platelet function
5126073|NCT01107912|Platelet function|platelet function
5126074|NCT01107899|Acute Coronary Syndromes|acute coronary syndromes
5126075|NCT01107899|Angina|angina
5126076|NCT01107899|Platelet Function|platelet function
5126077|NCT01107899|Coronary Angiography|coronary angiography
5126078|NCT01107899|Clinical Symptoms of Angina|clinical symptoms of angina
5126079|NCT01107899|Positive Stress Test|positive stress test
5126080|NCT01107886|Risk of cardiovascular disease and death in patients with type 2 diabetes mellitus|risk of cardiovascular disease and death in patients with type 2 diabetes mellitus
5126081|NCT01107873|Twenty (ASA status I) unpremedicated children, ages 1 to 5 yr old|twenty (asa status i) unpremedicated children, ages 1 to 5 yr old
5126082|NCT01107847|electrical impedance tomography|electrical impedance tomography
5126083|NCT01107847|EIT|eit
5126084|NCT01107847|acute lung injury|acute lung injury
5126085|NCT01107847|regional lung opening pressure|regional lung opening pressure
5126086|NCT01107847|regional lung closing pressure|regional lung closing pressure
5126087|NCT01107834|HIV|hiv
5126088|NCT01107834|heart function|heart function
5126089|NCT01107834|HAART|haart
5126090|NCT01107834|in utero|in utero
5126091|NCT01107834|children|children
5126092|NCT01107821|Pressure sores grade III and IV|pressure sores grade iii and iv
5126187|NCT01107431|insulin|insulin
5126093|NCT01107821|Traumatic wounds with considerable soft tissue loss|traumatic wounds with considerable soft tissue loss
5126094|NCT01107821|Wounds after necrotizing fasciitis|wounds after necrotizing fasciitis
5126095|NCT01107821|Abdominal wounds|abdominal wounds
5126096|NCT01107808|Adolescents|adolescents
5126097|NCT01107808|African American|african american
5126098|NCT01107808|Female|female
5126099|NCT01107782|sildenafil|sildenafil
5126100|NCT01107782|FGR|fgr
5126101|NCT01107743|Hypertension|hypertension
5126102|NCT01107743|Angina pectoris|angina pectoris
5126103|NCT01107743|Hypercholesterolemia|hypercholesterolemia
5126104|NCT01107743|Familial hypercholesterolemia|familial hypercholesterolemia
5126105|NCT01107743|Japanese|japanese
5126106|NCT01107743|caduet|caduet
5126107|NCT01107743|Regulatory Post Marketing Commitment Plan|regulatory post marketing commitment plan
5126108|NCT01107730|Atrial fibrillation|atrial fibrillation
5126109|NCT01107730|Cardiac valve repair|cardiac valve repair
5126110|NCT01107730|Aneurysm repair|aneurysm repair
5126111|NCT01107730|CABG|cabg
5126112|NCT01107730|On-pump|on-pump
5126113|NCT01107730|Cardiac surgery|cardiac surgery
5126114|NCT01107730|Vitamin C|vitamin c
5126115|NCT01107717|type 2 diabetes|type 2 diabetes
5126116|NCT01107717|new onset|new onset
5126117|NCT01107717|combination therapy|combination therapy
5126118|NCT01107717|new onset type 2 diabetes|new onset type 2 diabetes
5126119|NCT01107704|Intensive Care Units|intensive care units
5126120|NCT01107704|Surrogates|surrogates
5126121|NCT01107704|Family Members|family members
5126122|NCT01107704|Physicians|physicians
5126123|NCT01107704|Critically Ill|critically ill
5126124|NCT01107704|Depression|depression
5126125|NCT01107704|Anxiety|anxiety
5126126|NCT01107704|Emotional|emotional
5126127|NCT01107704|Support|support
5126128|NCT01107704|Multi-faceted communication|multi-faceted communication
5126129|NCT01107704|Grief|grief
5126130|NCT01107704|Prognosis|prognosis
5126131|NCT01107704|Family Support Counselor|family support counselor
5126132|NCT01107691|resistance and weight loss training|resistance and weight loss training
5126133|NCT01107678|YMCA; Preventative child obesity|ymca; preventative child obesity
5126134|NCT01107665|pazopanib|pazopanib
5126135|NCT01107665|paclitaxel|paclitaxel
5126136|NCT01107665|melanoma|melanoma
5126137|NCT01107639|stage IIB esophageal cancer|stage iib esophageal cancer
5126138|NCT01107639|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
5126139|NCT01107639|adenocarcinoma of the gastroesophageal junction|adenocarcinoma of the gastroesophageal junction
5126140|NCT01107639|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
5126141|NCT01107639|stage IIIA esophageal cancer|stage iiia esophageal cancer
5126142|NCT01107639|stage IIIB esophageal cancer|stage iiib esophageal cancer
5126143|NCT01107639|stage IIIC esophageal cancer|stage iiic esophageal cancer
5126144|NCT01107626|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5126145|NCT01107626|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5126146|NCT01107626|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5126147|NCT01107626|adenocarcinoma of the lung|adenocarcinoma of the lung
5126148|NCT01107626|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
5126149|NCT01107626|large cell lung cancer|large cell lung cancer
5126150|NCT01107613|opinion leader|opinion leader
5126151|NCT01107613|COPD|copd
5126152|NCT01107613|Emergency Department|emergency department
5126153|NCT01107613|relapse|relapse
5126154|NCT01107613|follow-up|follow-up
5126155|NCT01107613|evidence-based guidelines|evidence-based guidelines
5126156|NCT01107613|Exacerbation of COPD|exacerbation of copd
5126157|NCT01107600|Dental Implants, Single-Tooth|dental implants, single-tooth
5126158|NCT01107600|Bone Regeneration|bone regeneration
5126159|NCT01107600|Dental Restoration|dental restoration
5126160|NCT01107600|Socket preservation|socket preservation
5126161|NCT01107587|Human rotavirus vaccine|human rotavirus vaccine
5126162|NCT01107574|Chronic Pain, tenderpoints, insomnia, mood disorder, fatigue|chronic pain, tenderpoints, insomnia, mood disorder, fatigue
5126163|NCT01107561|cricothyroidotomy|cricothyroidotomy
5126164|NCT01107561|intubation|intubation
5126165|NCT01107561|airway|airway
5126166|NCT01107561|emergency medicine|emergency medicine
5126167|NCT01107561|education|education
5126168|NCT01107535|Synagis (palivizumab) immunoprophylaxis|synagis (palivizumab) immunoprophylaxis
5126169|NCT01107535|Respiratory syncytial virus infection|respiratory syncytial virus infection
5126170|NCT01107535|Preterm infants|preterm infants
5126171|NCT01107509|Renal cell carcinoma|renal cell carcinoma
5126172|NCT01107509|Metastatic|metastatic
5126173|NCT01107509|everolimus|everolimus
5126174|NCT01107509|neo-adjuvant|neo-adjuvant
5126175|NCT01107509|biomarkers|biomarkers
5126176|NCT01107509|nephrectomy|nephrectomy
5126177|NCT01107509|Locally advanced clear cell renal carcinoma|locally advanced clear cell renal carcinoma
5126178|NCT01107509|Metastatic clear cell renal carcinoma|metastatic clear cell renal carcinoma
5126179|NCT01107509|Clear Cell Renal Carcinoma|clear cell renal carcinoma
5126180|NCT01107483|endotoxaemia|endotoxaemia
5126181|NCT01107470|Infertility IVF ART|infertility ivf art
5126182|NCT01107457|Moderate|moderate
5126183|NCT01107457|Severe|severe
5126184|NCT01107457|Plaque|plaque
5126185|NCT01107457|Chronic|chronic
5126186|NCT01107431|glucose|glucose
5126188|NCT01107431|L-arabinose|l-arabinose
5126189|NCT01107431|Chromium|chromium
5126190|NCT01107366|lupiae techinque|lupiae techinque
5126191|NCT01107366|aortic aneurism|aortic aneurism
5126192|NCT01107366|aortic dissection|aortic dissection
5126193|NCT01107327|cancer|cancer
5126194|NCT01107301|ADHD|adhd
5126195|NCT01107288|Aged|aged
5126196|NCT01107288|Balance|balance
5126197|NCT01107288|Dual-task|dual-task
5126198|NCT01107288|Exercise|exercise
5126199|NCT01107288|Falls|falls
5126200|NCT01107288|Gait|gait
5126201|NCT01107288|Music|music
5126202|NCT01107275|Rabies|rabies
5126203|NCT01107275|PCECV|pcecv
5126204|NCT01107275|pre-exposure immunization|pre-exposure immunization
5126205|NCT01107275|intradermal|intradermal
5126206|NCT01107275|children|children
5126207|NCT01107262|H5N1 Subtype|h5n1 subtype
5126208|NCT01107262|Avian viruses|avian viruses
5126209|NCT01107262|Highly pathogenic avian influenza (HPAI)|highly pathogenic avian influenza (hpai)
5126210|NCT01107249|esophageal|esophageal
5126211|NCT01107249|stenting|stenting
5126212|NCT01107249|perforations|perforations
5126213|NCT01107249|gastric|gastric
5126214|NCT01107249|esophageal stenting|esophageal stenting
5126215|NCT01107236|Healthy subjects|healthy subjects
5126216|NCT01107223|Antibiotic|antibiotic
5126217|NCT01107223|Prescribing behaviour|prescribing behaviour
5126218|NCT01107223|Guidelines|guidelines
5126219|NCT01107223|Respiratory tract infections|respiratory tract infections
5126220|NCT01107223|Non-antibiotic prescription|non-antibiotic prescription
5126221|NCT01107210|stroke|stroke
5126222|NCT01107210|physical fitness|physical fitness
5126223|NCT01107210|evolution|evolution
5126224|NCT01107210|determinants|determinants
5126225|NCT01107197|Pressure ulcers|pressure ulcers
5126226|NCT01107197|Healing|healing
5126227|NCT01107197|Malnutrition|malnutrition
5126228|NCT01107197|Nutritional support|nutritional support
5126229|NCT01107197|Micronutrients|micronutrients
5126230|NCT01107184|Remote ischemic conditioning|remote ischemic conditioning
5126231|NCT01107184|CABG surgery|cabg surgery
5126232|NCT01107184|Atrial fibrillation|atrial fibrillation
5126233|NCT01107184|Coronary Artery Bypass|coronary artery bypass
5126234|NCT01107184|Ischemic Preconditioning|ischemic preconditioning
5126235|NCT01107171|Tang-min-ling pills;|tang-min-ling pills;
5126236|NCT01107171|overweight type 2 diabetes mellitus;|overweight type 2 diabetes mellitus;
5126237|NCT01107171|blood glucose|blood glucose
5126238|NCT01107171|Traditional Chinese Medicine|traditional chinese medicine
5126239|NCT01107171|Clinical Trial|clinical trial
5126240|NCT01107171|Intervention Studies|intervention studies
5126241|NCT01107145|Plasmodium|plasmodium
5126242|NCT01107145|Vivax|vivax
5126243|NCT01107145|Malaria|malaria
5126244|NCT01107145|Pregnancy|pregnancy
5126245|NCT01107145|Brazil|brazil
5126246|NCT01107145|Treatment|treatment
5126247|NCT01107119|Frail elderly|frail elderly
5126248|NCT01107119|Chronic illness|chronic illness
5126249|NCT01107119|Integrated care model|integrated care model
5126250|NCT01107119|Clinical pathways|clinical pathways
5126251|NCT01107119|Home care services|home care services
5126252|NCT01107106|Contraceptive Methods|contraceptive methods
5126253|NCT01107106|Female Contraception|female contraception
5126254|NCT01107080|breast cancer|breast cancer
5126255|NCT01107080|breast carcinoma in situ|breast carcinoma in situ
5126256|NCT01107080|ductal breast carcinoma in situ|ductal breast carcinoma in situ
5126257|NCT01107080|invasive carcinoma|invasive carcinoma
5126258|NCT01107080|invasive ductal carcinoma|invasive ductal carcinoma
5126259|NCT01107080|invasive lobular carcinoma|invasive lobular carcinoma
5126260|NCT01107067|hypogonadism|hypogonadism
5126261|NCT01107067|paraoxonase|paraoxonase
5126262|NCT01107067|Hipogonadism|hipogonadism
5126263|NCT01107054|QTC|qtc
5126264|NCT01107041|Depression|depression
5126265|NCT01107041|Technology Assisted|technology assisted
5126266|NCT01107041|Mobile Phone|mobile phone
5126267|NCT01107028|Idiopathic pulmonary fibrosis|idiopathic pulmonary fibrosis
5126268|NCT01107028|Dyspnea|dyspnea
5126269|NCT01107028|Functional capacity|functional capacity
5126270|NCT01107028|Quality of life|quality of life
5126271|NCT01107015|Diabetes|diabetes
5126272|NCT01107015|Glucose control|glucose control
5126273|NCT01107015|Diabetes monitoring|diabetes monitoring
5126274|NCT01107015|Care management|care management
5126275|NCT01107015|Electronic communication|electronic communication
5126276|NCT01107015|Mobile phone technology|mobile phone technology
5126277|NCT01107015|Self care|self care
5126278|NCT01107002|infertility|infertility
5126279|NCT01107002|Embryo transfer|embryo transfer
5126280|NCT01106976|PET|pet
5126281|NCT01106976|acetylcholine|acetylcholine
5126282|NCT01106963|knee|knee
5126283|NCT01106963|tibial fractures|tibial fractures
5126284|NCT01106963|pain|pain
5126285|NCT01106963|osteosynthesis|osteosynthesis
5126286|NCT01106963|intramedullary nailing|intramedullary nailing
5126287|NCT01106950|acute myelogenous leukemia|acute myelogenous leukemia
5126288|NCT01106950|primary acute myelogenous leukemia|primary acute myelogenous leukemia
5126289|NCT01106950|secondary acute myelogenous leukemia|secondary acute myelogenous leukemia
5126580|NCT01105780|JNJ-41443532|jnj-41443532
5126290|NCT01106950|relapsed acute myelogenous leukemia|relapsed acute myelogenous leukemia
5126291|NCT01106924|Probiotics, Weight control, Body composition|probiotics, weight control, body composition
5126292|NCT01106911|digital breast tomosynthesis|digital breast tomosynthesis
5126293|NCT01106911|baseline screening mammography|baseline screening mammography
5126294|NCT01106911|recall rates|recall rates
5126295|NCT01106885|Diabetes|diabetes
5126296|NCT01106885|Depression|depression
5126297|NCT01106885|Telephone Care Management|telephone care management
5126298|NCT01106885|Medication Care Management (MCM)|medication care management (mcm)
5126299|NCT01106885|Cognitive Behavioral Therapy (CBT)|cognitive behavioral therapy (cbt)
5126300|NCT01106872|Sarcoma|sarcoma
5126301|NCT01106872|Soft Tissue Sarcoma|soft tissue sarcoma
5126302|NCT01106872|Locally Advanced Sarcoma|locally advanced sarcoma
5126303|NCT01106872|Unresectable Sarcoma|unresectable sarcoma
5126304|NCT01106872|Metastatic Sarcoma|metastatic sarcoma
5126305|NCT01106872|Valproic Acid|valproic acid
5126306|NCT01106872|Bevacizumab|bevacizumab
5126307|NCT01106872|Histone Deacetylase Inhibitor|histone deacetylase inhibitor
5126308|NCT01106859|insomnia|insomnia
5126309|NCT01106846|Ketamine|ketamine
5126310|NCT01106846|Anesthesia|anesthesia
5126311|NCT01106846|Pain|pain
5126312|NCT01106846|Outpatient surgery|outpatient surgery
5126313|NCT01106833|Chronic Graft-versus-Host Disease (cGVHD)|chronic graft-versus-host disease (cgvhd)
5126314|NCT01106794|diffuse intrinsic pontine glioma|diffuse intrinsic pontine glioma
5126315|NCT01106794|DIPG|dipg
5126316|NCT01106794|childhood brainstem glioma|childhood brainstem glioma
5126317|NCT01106794|pediatric brainstem glioma|pediatric brainstem glioma
5126318|NCT01106794|brainstem glioma|brainstem glioma
5126319|NCT01106794|BSG|bsg
5126320|NCT01106781|EGFR mutation test|egfr mutation test
5126321|NCT01106781|NSCLC|nsclc
5126322|NCT01106781|Non-Interventional Study|non-interventional study
5126323|NCT01106781|EGFR mutation status|egfr mutation status
5126324|NCT01106768|oral health needs|oral health needs
5126325|NCT01106768|children|children
5126326|NCT01106768|attention deficit disorder with or without hyperactivity|attention deficit disorder with or without hyperactivity
5126327|NCT01106755|kinematic|kinematic
5126328|NCT01106755|hemiparesis|hemiparesis
5126329|NCT01106755|gait|gait
5126330|NCT01106755|Body weight support|body weight support
5126331|NCT01106755|Functional electrical stimulation|functional electrical stimulation
5126332|NCT01106742|Inflammatory|inflammatory
5126333|NCT01106742|AbM|abm
5126334|NCT01106742|IBD|ibd
5126335|NCT01106729|Flavonoids|flavonoids
5126336|NCT01106729|Anthocyanin|anthocyanin
5126337|NCT01106729|Cyanidin 3 glucoside|cyanidin 3 glucoside
5126338|NCT01106729|Acute feeding trial|acute feeding trial
5126339|NCT01106729|Stable isotope|stable isotope
5126340|NCT01106729|Metabolism|metabolism
5126341|NCT01106729|Clearance|clearance
5126342|NCT01106729|Bioavailability|bioavailability
5126343|NCT01106729|Pharmacokinetics|pharmacokinetics
5126344|NCT01106716|Lidocaine|lidocaine
5126345|NCT01106716|Lignocaine|lignocaine
5126346|NCT01106716|Analgesics. Non-narcotic / therapeutic use|analgesics. non-narcotic / therapeutic use
5126347|NCT01106716|Neuralgia, Postherpetic|neuralgia, postherpetic
5126348|NCT01106716|Pain|pain
5126349|NCT01106716|Pain measurement / drug effect|pain measurement / drug effect
5126350|NCT01106716|Pain postoperative / drug therapy|pain postoperative / drug therapy
5126351|NCT01106716|PHN|phn
5126352|NCT01106703|atopy, IgE|atopy, ige
5126353|NCT01106690|Canagliflozin|canagliflozin
5126354|NCT01106690|Placebo|placebo
5126355|NCT01106690|Sitagliptin (Januvia)|sitagliptin (januvia)
5126356|NCT01106690|Metformin|metformin
5126357|NCT01106690|Pioglitazone (Actos)|pioglitazone (actos)
5126358|NCT01106690|Hemoglobin A1c|hemoglobin a1c
5126359|NCT01106690|Type 2 diabetes mellitus|type 2 diabetes mellitus
5126360|NCT01106677|Type 2 diabetes mellitus|type 2 diabetes mellitus
5126361|NCT01106677|Canagliflozin|canagliflozin
5126362|NCT01106677|Placebo|placebo
5126363|NCT01106677|Sitagliptin|sitagliptin
5126364|NCT01106677|Januvia|januvia
5126365|NCT01106677|Metformin Immediate Release (IR)|metformin immediate release (ir)
5126366|NCT01106677|Hemoglobin A1c|hemoglobin a1c
5126367|NCT01106664|ONO-7746|ono-7746
5126368|NCT01106664|Healthy adult subjects|healthy adult subjects
5126369|NCT01106651|Canagliflozin|canagliflozin
5126370|NCT01106651|Placebo|placebo
5126371|NCT01106651|Hemoglobin A1c|hemoglobin a1c
5126372|NCT01106651|Bone|bone
5126373|NCT01106651|Type 2 diabetes mellitus|type 2 diabetes mellitus
5126374|NCT01106638|HIV|hiv
5126375|NCT01106638|AIDS|aids
5126376|NCT01106638|Smoking|smoking
5126377|NCT01106638|Tobacco|tobacco
5126378|NCT01106638|Cessation|cessation
5126379|NCT01106638|Tobacco use in persons living with HIV/AIDS|tobacco use in persons living with hiv/aids
5126380|NCT01106625|Canagliflozin|canagliflozin
5126381|NCT01106625|Placebo|placebo
5126382|NCT01106625|Metformin|metformin
5126383|NCT01106625|Sulphonylurea|sulphonylurea
5126384|NCT01106625|Hemoglobin A1c|hemoglobin a1c
5126385|NCT01106625|Type 2 diabetes mellitus|type 2 diabetes mellitus
5126386|NCT01106612|randomized controlled trial|randomized controlled trial
5126387|NCT01106612|controlled clinical trial|controlled clinical trial
5126765|NCT01105013|tonaftato|tonaftato
5126388|NCT01106612|comparative effectiveness research|comparative effectiveness research
5126389|NCT01106612|chest pain|chest pain
5126390|NCT01106612|angina pectoris|angina pectoris
5126391|NCT01106612|non-invasive cardiac imaging|non-invasive cardiac imaging
5126392|NCT01106612|nuclear stress testing|nuclear stress testing
5126393|NCT01106612|coronary CT angiography|coronary ct angiography
5126394|NCT01106612|coronary catheterization|coronary catheterization
5126395|NCT01106612|coronary revascularization|coronary revascularization
5126396|NCT01106586|HIV 1 Infection|hiv 1 infection
5126397|NCT01106586|Treatment Naive|treatment naive
5126398|NCT01106573|Diabetes Mellitus|diabetes mellitus
5126399|NCT01106573|Arteriosclerosis|arteriosclerosis
5126400|NCT01106573|Intima media thickness|intima media thickness
5126401|NCT01106573|arterial stiffness|arterial stiffness
5126402|NCT01106573|pulsewave velocity|pulsewave velocity
5126403|NCT01106573|fibulin-1|fibulin-1
5126404|NCT01106547|abdominal hysterectomy|abdominal hysterectomy
5126405|NCT01106547|glucocorticoids|glucocorticoids
5126406|NCT01106547|rehabilitation|rehabilitation
5126407|NCT01106547|postoperative pain|postoperative pain
5126408|NCT01106547|analgetics|analgetics
5126409|NCT01106534|drug eluting stents|drug eluting stents
5126410|NCT01106534|Stents|stents
5126411|NCT01106534|Angioplasty|angioplasty
5126412|NCT01106534|Stent thrombosis|stent thrombosis
5126413|NCT01106534|antiplatelet treatment|antiplatelet treatment
5126414|NCT01106521|Infiltrating ductal carcinoma|infiltrating ductal carcinoma
5126415|NCT01106521|Brachytherapy|brachytherapy
5126416|NCT01106508|Advanced solid tumors|advanced solid tumors
5126417|NCT01106508|recurrent or refractory medulloblastoma|recurrent or refractory medulloblastoma
5126418|NCT01106508|locally advanced or metastatic basal cell carcinoma|locally advanced or metastatic basal cell carcinoma
5126419|NCT01106508|hedgehog pathway inhibitor|hedgehog pathway inhibitor
5126420|NCT01106495|Atherosclerosis|atherosclerosis
5126421|NCT01106495|Vascular Endothelium|vascular endothelium
5126422|NCT01106495|Counterpulsation, External|counterpulsation, external
5126423|NCT01106482|TBE|tbe
5126424|NCT01106482|Tick Borne Encephalitis|tick borne encephalitis
5126425|NCT01106469|Healthy Volunteers|healthy volunteers
5126426|NCT01106469|Healthy|healthy
5126427|NCT01106469|JNJ-41443532|jnj-41443532
5126428|NCT01106469|Pharmacokinetics|pharmacokinetics
5126429|NCT01106443|Indeterminate thyroid nodule|indeterminate thyroid nodule
5126430|NCT01106443|fine needle aspirate biopsy|fine needle aspirate biopsy
5126431|NCT01106443|thyroidectomy|thyroidectomy
5126432|NCT01106443|central lymph node dissection|central lymph node dissection
5126433|NCT01106430|ADHD|adhd
5126434|NCT01106417|Cervical Degenerative Disc Disease|cervical degenerative disc disease
5126435|NCT01106417|Degenerative Spondylolisthesis|degenerative spondylolisthesis
5126436|NCT01106417|Spinal Stenosis|spinal stenosis
5126437|NCT01106417|Stem cells|stem cells
5126438|NCT01106417|Adult Stem Cells|adult stem cells
5126439|NCT01106417|Anterior cervical discectomy and Fusion (ACDF)|anterior cervical discectomy and fusion (acdf)
5126440|NCT01106417|Anterior Cervical Plate Fixation|anterior cervical plate fixation
5126441|NCT01106391|Abdominal aortic aneurysm|abdominal aortic aneurysm
5126442|NCT01106391|AAA|aaa
5126443|NCT01106391|Safety|safety
5126444|NCT01106391|Performance|performance
5126445|NCT01106391|Stent graft system|stent graft system
5126446|NCT01106391|First in Human|first in human
5126447|NCT01106391|Endovascular repair|endovascular repair
5126448|NCT01106378|Coronary artery disease|coronary artery disease
5126449|NCT01106378|drug-eluting stents|drug-eluting stents
5126450|NCT01106378|sirolimus-eluting coronary stents|sirolimus-eluting coronary stents
5126451|NCT01106365|multiple sclerosis|multiple sclerosis
5126452|NCT01106365|fatigue|fatigue
5126453|NCT01106365|depressivity|depressivity
5126454|NCT01106365|repetitive deep transcranial magnetic stimulation|repetitive deep transcranial magnetic stimulation
5126455|NCT01106352|The target population is patients with bone metastasis from castration-resistant prostate cancer intended for treatment with docetaxel|the target population is patients with bone metastasis from castration-resistant prostate cancer intended for treatment with docetaxel
5126456|NCT01106339|humans|humans
5126457|NCT01106339|patients|patients
5126458|NCT01106339|somatoform disorders|somatoform disorders
5126459|NCT01106339|fibromyalgia|fibromyalgia
5126460|NCT01106339|myofascial pain syndrome diffuse|myofascial pain syndrome diffuse
5126461|NCT01106339|depression|depression
5126462|NCT01106339|chronic fatigue syndrome|chronic fatigue syndrome
5126463|NCT01106339|inflammation|inflammation
5126464|NCT01106339|inflammatory response|inflammatory response
5126465|NCT01106339|biomarkers|biomarkers
5126466|NCT01106339|cytokines|cytokines
5126467|NCT01106339|cell surface markers|cell surface markers
5126468|NCT01106339|functional polymorphisms|functional polymorphisms
5126469|NCT01106326|Asthma|asthma
5126470|NCT01106248|tumor|tumor
5126471|NCT01106209|premature infants|premature infants
5126472|NCT01106209|polymorphonuclear leukocytes|polymorphonuclear leukocytes
5126473|NCT01106209|PMNs|pmns
5126474|NCT01106209|neutrophil extracellular traps|neutrophil extracellular traps
5126475|NCT01106209|NET formation|net formation
5126476|NCT01106209|necrotizing enterocolitis|necrotizing enterocolitis
5126477|NCT01106196|Influenza, Human|influenza, human
5126478|NCT01106196|Influenza, Human/complications|influenza, human/complications
5126479|NCT01106196|Myocardial infarction/etiology|myocardial infarction/etiology
5126480|NCT01106196|Cardiovascular Diseases/mortality|cardiovascular diseases/mortality
5126481|NCT01106157|Autoimmune, Diabetes Mellitus, Glucose Metabolism|autoimmune, diabetes mellitus, glucose metabolism
5126482|NCT01106079|Early psoriatic arthritis|early psoriatic arthritis
5126483|NCT01106079|Tight control|tight control
5126484|NCT01106079|Intensive management|intensive management
5126485|NCT01106053|Binge eating disorder|binge eating disorder
5126486|NCT01106053|Food craving|food craving
5126487|NCT01106053|Obesity|obesity
5126488|NCT01106053|Pramipexole|pramipexole
5126489|NCT01106053|Mirapex|mirapex
5126490|NCT01106053|Binge|binge
5126491|NCT01106040|Lymphoseek|lymphoseek
5126492|NCT01106040|Breast Cancer|breast cancer
5126493|NCT01106040|Melanoma|melanoma
5126494|NCT01106040|Experimental|experimental
5126495|NCT01106014|pulmonary arterial hypertension|pulmonary arterial hypertension
5126496|NCT01106014|PAH|pah
5126497|NCT01106001|total hip arthroplasty|total hip arthroplasty
5126498|NCT01106001|periarticular injection|periarticular injection
5126499|NCT01106001|pain|pain
5126500|NCT01105988|GBM|gbm
5126501|NCT01105988|PET scans|pet scans
5126502|NCT01105988|MRI scans|mri scans
5126503|NCT01105975|Dyslipidemias|dyslipidemias
5126504|NCT01105975|Mixed dyslipidemia|mixed dyslipidemia
5126505|NCT01105975|Hypercholesterolemia|hypercholesterolemia
5126506|NCT01105975|Atherosclerosis|atherosclerosis
5126507|NCT01105975|Atorvastatin|atorvastatin
5126508|NCT01105975|Simvastatin|simvastatin
5126509|NCT01105975|Rosuvastatin|rosuvastatin
5126510|NCT01105975|Metabolic Diseases|metabolic diseases
5126511|NCT01105975|Antilipemic Agents|antilipemic agents
5126512|NCT01105975|Enzyme Inhibitors|enzyme inhibitors
5126513|NCT01105975|Anticholesteremic Agents|anticholesteremic agents
5126514|NCT01105975|Cholesteryl Ester Transfer Protein Inhibitors|cholesteryl ester transfer protein inhibitors
5126515|NCT01105975|Cholesteryl Ester|cholesteryl ester
5126516|NCT01105975|Lipid Metabolism Disorders|lipid metabolism disorders
5126517|NCT01105962|traumatic|traumatic
5126518|NCT01105962|brain|brain
5126519|NCT01105962|injury|injury
5126520|NCT01105962|post-traumatic|post-traumatic
5126521|NCT01105962|stress|stress
5126522|NCT01105962|hyperbaric|hyperbaric
5126523|NCT01105962|oxygen|oxygen
5126524|NCT01105962|HBOT|hbot
5126525|NCT01105962|TBI|tbi
5126526|NCT01105962|PTSD|ptsd
5126527|NCT01105949|nasal patency|nasal patency
5126528|NCT01105949|acoustic rhinometry|acoustic rhinometry
5126529|NCT01105949|nasal strip|nasal strip
5126530|NCT01105936|osteoarthritis|osteoarthritis
5126531|NCT01105936|pain|pain
5126532|NCT01105936|paracetamol|paracetamol
5126533|NCT01105936|Blood-Oxygen-Level-Dependent functional magnetic resonance imaging|blood-oxygen-level-dependent functional magnetic resonance imaging
5126534|NCT01105910|Dry Eye, Post Menopausal dry eye|dry eye, post menopausal dry eye
5126535|NCT01105897|endometriosis|endometriosis
5126536|NCT01105897|deep endometriosis|deep endometriosis
5126537|NCT01105897|surgery|surgery
5126538|NCT01105897|laparoscopy|laparoscopy
5126539|NCT01105897|chronic pain|chronic pain
5126540|NCT01105897|quality of life|quality of life
5126541|NCT01105897|sexual function|sexual function
5126542|NCT01105897|complications|complications
5126543|NCT01105897|recurrence|recurrence
5126544|NCT01105884|Wound healing, type 2 diabetes, diabetic foot ulcers, different dressings|wound healing, type 2 diabetes, diabetic foot ulcers, different dressings
5126545|NCT01105871|Pain relief|pain relief
5126546|NCT01105858|Diabetes Mellitus|diabetes mellitus
5126547|NCT01105858|Obesity|obesity
5126548|NCT01105858|Diabetic Complications|diabetic complications
5126549|NCT01105858|Genetics|genetics
5126550|NCT01105858|Molecular Profiling|molecular profiling
5126551|NCT01105845|Motor Learning|motor learning
5126552|NCT01105845|Genetic Analysis|genetic analysis
5126553|NCT01105845|BDNF|bdnf
5126554|NCT01105845|Parkinson Disease|parkinson disease
5126555|NCT01105845|Movement Disorders|movement disorders
5126556|NCT01105845|Dystonia|dystonia
5126557|NCT01105845|Healthy Volunteer|healthy volunteer
5126558|NCT01105845|HV|hv
5126559|NCT01105832|Teriparatide|teriparatide
5126560|NCT01105832|fracture healing|fracture healing
5126561|NCT01105832|proximal humeral fractures|proximal humeral fractures
5126562|NCT01105819|Probiotics|probiotics
5126563|NCT01105819|Lactobacillus plantarum 299|lactobacillus plantarum 299
5126564|NCT01105819|Ventilator-associated pneumonia VAP|ventilator-associated pneumonia vap
5126565|NCT01105819|Chlorhexidine|chlorhexidine
5126566|NCT01105819|Tracheal secretions|tracheal secretions
5126567|NCT01105819|Oropharyngeal secretions|oropharyngeal secretions
5126568|NCT01105806|advance directive|advance directive
5126569|NCT01105806|CPR Intervention|cpr intervention
5126570|NCT01105806|Video|video
5126571|NCT01105806|Narrative|narrative
5126572|NCT01105806|10-043|10-043
5126573|NCT01105793|cyclic mastalgia|cyclic mastalgia
5126574|NCT01105793|cyclic breast pain|cyclic breast pain
5126575|NCT01105793|fibrocystic breast disease|fibrocystic breast disease
5126576|NCT01105780|Healthy Volunteers|healthy volunteers
5126577|NCT01105780|Healthy|healthy
5126578|NCT01105780|Japanese|japanese
5126579|NCT01105780|Pharmacokinetics|pharmacokinetics
5126581|NCT01105767|Staphylococcus aureus|staphylococcus aureus
5126582|NCT01105767|MRSA Skin Infection|mrsa skin infection
5126583|NCT01105767|Staphylococcal Skin Infections|staphylococcal skin infections
5126584|NCT01105767|Chlorhexidine gluconate|chlorhexidine gluconate
5126585|NCT01105741|Crohn's disease|crohn's disease
5126586|NCT01105741|Adalimumab|adalimumab
5126587|NCT01105741|Metabolome|metabolome
5126588|NCT01105728|Gastric subepitelial mass|gastric subepitelial mass
5126589|NCT01105728|Endoscopic full thickness resection|endoscopic full thickness resection
5126590|NCT01105715|Rheumatoid Arthritis|rheumatoid arthritis
5126591|NCT01105715|cLDL|cldl
5126592|NCT01105715|Cardiovascular disease|cardiovascular disease
5126593|NCT01105702|brain tumor|brain tumor
5126594|NCT01105702|brain cancer|brain cancer
5126595|NCT01105702|glioma|glioma
5126596|NCT01105689|Urine Calcium to Creatinine Ratio|urine calcium to creatinine ratio
5126597|NCT01105689|Hypocalciuria|hypocalciuria
5126598|NCT01105689|Infants|infants
5126599|NCT01105689|Toddlers|toddlers
5126600|NCT01105676|vascular malformation|vascular malformation
5126601|NCT01105676|vascular anomalies|vascular anomalies
5126602|NCT01105676|abnormalities of growth|abnormalities of growth
5126603|NCT01105676|overgrowth|overgrowth
5126604|NCT01105676|subjects with vascular malformations abnormalities of growth.|subjects with vascular malformations abnormalities of growth.
5126605|NCT01105663|sedated|sedated
5126606|NCT01105663|intubated|intubated
5126607|NCT01105663|mechanically ventilated|mechanically ventilated
5126608|NCT01105663|pediatric|pediatric
5126609|NCT01105663|lung injury|lung injury
5126610|NCT01105650|recurrent ovarian cancer|recurrent ovarian cancer
5126611|NCT01105650|recurrent fallopian tube cancer|recurrent fallopian tube cancer
5126612|NCT01105650|recurrent primary peritoneal cancer|recurrent primary peritoneal cancer
5126613|NCT01105650|refractory ovarian cancer|refractory ovarian cancer
5126614|NCT01105650|refractory fallopian tube cancer|refractory fallopian tube cancer
5126615|NCT01105650|refractory peritoneal cancer|refractory peritoneal cancer
5126616|NCT01105650|metastatic breast cancer|metastatic breast cancer
5126617|NCT01105637|burn injuries|burn injuries
5126618|NCT01105637|exercise|exercise
5126619|NCT01105611|HIV|hiv
5126620|NCT01105611|Hepatitis C|hepatitis c
5126621|NCT01105611|Co-infection|co-infection
5126622|NCT01105611|Intravenous drug users|intravenous drug users
5126623|NCT01105611|Treatment-naïve|treatment-naïve
5126624|NCT01105611|Methadone|methadone
5126625|NCT01105585|Cataracts|cataracts
5126626|NCT01105585|aspheric|aspheric
5126627|NCT01105585|IOL|iol
5126628|NCT01105585|ocular aberrations|ocular aberrations
5126629|NCT01105572|Congestive Heart Failure|congestive heart failure
5126630|NCT01105559|Diphtheria|diphtheria
5126631|NCT01105559|Tetanus|tetanus
5126632|NCT01105559|Whooping cough|whooping cough
5126633|NCT01105559|Hepatitis B|hepatitis b
5126634|NCT01105559|Poliomyelitis|poliomyelitis
5126635|NCT01105559|Diphtheria-Tetanus-acellular Pertussis Vaccines|diphtheria-tetanus-acellular pertussis vaccines
5126636|NCT01105546|hemophilia A|hemophilia a
5126637|NCT01105546|inhibitors|inhibitors
5126638|NCT01105546|prophylaxis|prophylaxis
5126639|NCT01105546|immune tolerance induction|immune tolerance induction
5126640|NCT01105533|VGEF inhibitor|vgef inhibitor
5126641|NCT01105533|Anti angiogenesis|anti angiogenesis
5126642|NCT01105533|Advanced Solid Tumors|advanced solid tumors
5126643|NCT01105520|Intraspinal processes (tumor or vascular malformation AVM)|intraspinal processes (tumor or vascular malformation avm)
5126644|NCT01105507|Canakinumab|canakinumab
5126645|NCT01105507|Cryopyrin-associated periodic syndromes|cryopyrin-associated periodic syndromes
5126646|NCT01105507|Familial Cold Autoinflammatory Syndrome (FCAS)|familial cold autoinflammatory syndrome (fcas)
5126647|NCT01105507|Familial Cold Urticaria (FCU)|familial cold urticaria (fcu)
5126648|NCT01105507|Muckle-Wells Syndrome (MWS)|muckle-wells syndrome (mws)
5126649|NCT01105507|Neonatal-Onset Multisystem Inflammatory Disease (NOMID)|neonatal-onset multisystem inflammatory disease (nomid)
5126650|NCT01105507|Chronic Infantile Neurological|chronic infantile neurological
5126651|NCT01105507|Cutaneous|cutaneous
5126652|NCT01105507|Articular Syndrome (CINCA)|articular syndrome (cinca)
5126653|NCT01105507|Treatment of patients diagnosed with CAPS (Cryopyrin associated periodic syndrome)|treatment of patients diagnosed with caps (cryopyrin associated periodic syndrome)
5126654|NCT01105481|treatment-resistant schizophrenia|treatment-resistant schizophrenia
5126655|NCT01105481|clozapine|clozapine
5126656|NCT01105481|amisulpride|amisulpride
5126657|NCT01105468|Breath gas analysis|breath gas analysis
5126658|NCT01105468|Volatile components in exhaled breath|volatile components in exhaled breath
5126659|NCT01105455|Randomized clinical trial|randomized clinical trial
5126660|NCT01105455|Gestational diabetes|gestational diabetes
5126661|NCT01105455|Carbohydrates|carbohydrates
5126662|NCT01105455|Glycemic index|glycemic index
5126663|NCT01105442|Post-operative pain treatment|post-operative pain treatment
5126664|NCT01105442|Fast-track colonic surgery patients|fast-track colonic surgery patients
5126665|NCT01105442|Surgery|surgery
5126666|NCT01105416|Pediatric Emergency Department|pediatric emergency department
5126667|NCT01105416|Parental monitoring|parental monitoring
5126668|NCT01105416|Adolescent|adolescent
5126669|NCT01105416|Parents|parents
5126670|NCT01105416|Communication|communication
5126671|NCT01105416|Alcohol Drinking|alcohol drinking
5126672|NCT01105403|Hematopoietic stem cells|hematopoietic stem cells
5126673|NCT01105403|Mobilisation|mobilisation
5126674|NCT01105403|Autologous transplantation|autologous transplantation
5126675|NCT01105364|recurrent renal cell cancer|recurrent renal cell cancer
5126676|NCT01105364|stage IV renal cell cancer|stage iv renal cell cancer
5126677|NCT01105364|liver metastases|liver metastases
5126678|NCT01105351|Folate|folate
5126679|NCT01105351|MTHFR|mthfr
5126680|NCT01105351|Homocysteine|homocysteine
5126681|NCT01105338|prostate cancer|prostate cancer
5126682|NCT01105325|acute coronary syndrome|acute coronary syndrome
5126683|NCT01105325|treatment compliance|treatment compliance
5126684|NCT01105325|cardiac intensive care unit|cardiac intensive care unit
5126685|NCT01105325|secondary prevention|secondary prevention
5126686|NCT01105325|cardiac intensive care unit (CIC)|cardiac intensive care unit (cic)
5126687|NCT01105325|compliance|compliance
5126688|NCT01105325|intensive care|intensive care
5126689|NCT01105312|male breast cancer|male breast cancer
5126690|NCT01105312|estrogen receptor-negative breast cancer|estrogen receptor-negative breast cancer
5126691|NCT01105312|estrogen receptor-positive breast cancer|estrogen receptor-positive breast cancer
5126692|NCT01105312|HER2-negative breast cancer|her2-negative breast cancer
5126693|NCT01105312|HER2-positive breast cancer|her2-positive breast cancer
5126694|NCT01105312|progesterone receptor-negative breast cancer|progesterone receptor-negative breast cancer
5126695|NCT01105312|progesterone receptor-positive breast cancer|progesterone receptor-positive breast cancer
5126696|NCT01105312|triple-negative breast cancer|triple-negative breast cancer
5126697|NCT01105312|recurrent breast cancer|recurrent breast cancer
5126698|NCT01105312|stage IV breast cancer|stage iv breast cancer
5126699|NCT01105299|bioequivalence|bioequivalence
5126700|NCT01105299|anastrozole|anastrozole
5126701|NCT01105299|Healthy subjects|healthy subjects
5126702|NCT01105299|Antineoplastic Agents|antineoplastic agents
5126703|NCT01105299|Therapeutic Uses|therapeutic uses
5126704|NCT01105299|Enzyme Inhibitors|enzyme inhibitors
5126705|NCT01105273|Aplastic anemia|aplastic anemia
5126706|NCT01105273|Fludarabine|fludarabine
5126707|NCT01105273|CD3±CD19 depletion|cd3±cd19 depletion
5126708|NCT01105273|Haploidentical hematopoietic stem cell transplantation|haploidentical hematopoietic stem cell transplantation
5126709|NCT01105260|early reconditioning program|early reconditioning program
5126710|NCT01105260|spinal cord injury|spinal cord injury
5126711|NCT01105260|early rehabilitation|early rehabilitation
5126712|NCT01105260|wheelchair|wheelchair
5126713|NCT01105247|PCI-32765|pci-32765
5126714|NCT01105247|Lymphoma, B-Cell|lymphoma, b-cell
5126715|NCT01105247|Leukemia, Lymphoid|leukemia, lymphoid
5126716|NCT01105247|Leukemia, B-Cell|leukemia, b-cell
5126717|NCT01105247|Bruton's Tyrosine Kinase|bruton's tyrosine kinase
5126718|NCT01105234|Healthy volunteers|healthy volunteers
5126719|NCT01105221|Acupuncture|acupuncture
5126720|NCT01105221|Dry eye|dry eye
5126721|NCT01105221|Artificial tear drop|artificial tear drop
5126722|NCT01105221|Mixed method approach|mixed method approach
5126723|NCT01105221|Qualitative study|qualitative study
5126724|NCT01105221|Cost effectiveness analysis|cost effectiveness analysis
5126725|NCT01105221|Tear cytokine analysis|tear cytokine analysis
5126726|NCT01105195|DuraPrep|duraprep
5126727|NCT01105195|ChloraPrep|chloraprep
5126728|NCT01105195|Lumbar Spine|lumbar spine
5126729|NCT01105182|Radiofrequency Ablation|radiofrequency ablation
5126730|NCT01105169|Personalized prevention|personalized prevention
5126731|NCT01105169|Colorectal cancer|colorectal cancer
5126732|NCT01105169|Investigational Nutrigenetic Studies|investigational nutrigenetic studies
5126733|NCT01105169|Magnesium|magnesium
5126734|NCT01105169|Gene polymorphism|gene polymorphism
5126735|NCT01105156|Gastric band|gastric band
5126736|NCT01105156|Questionnaire|questionnaire
5126737|NCT01105156|Post operative management|post operative management
5126738|NCT01105156|Adjustment|adjustment
5126739|NCT01105143|weight loss|weight loss
5126740|NCT01105143|muscle mass|muscle mass
5126741|NCT01105130|radiation toxicity|radiation toxicity
5126742|NCT01105130|male erectile disorder|male erectile disorder
5126743|NCT01105130|prostate cancer|prostate cancer
5126744|NCT01105117|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
5126746|NCT01105117|EPITOME-1|epitome-1
5126747|NCT01105091|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
5126748|NCT01105091|PAH|pah
5126749|NCT01105091|EPITOME-1|epitome-1
5126750|NCT01105078|cardiopulmonary bypass flow rate outcome tissue perfusion oxygenation l/min/m2|cardiopulmonary bypass flow rate outcome tissue perfusion oxygenation l/min/m2
5126751|NCT01105065|Normal Pressure Glaucoma|normal pressure glaucoma
5126752|NCT01105052|Insomnia|insomnia
5126753|NCT01105052|Co-morbid|co-morbid
5126754|NCT01105052|CBT|cbt
5126755|NCT01105052|Self-help|self-help
5126756|NCT01105052|Bibliotherapy|bibliotherapy
5126757|NCT01105039|Pain pattern|pain pattern
5126758|NCT01105039|overall pain|overall pain
5126759|NCT01105039|incisional pain|incisional pain
5126760|NCT01105039|shoulder pain|shoulder pain
5126761|NCT01105039|visceral pain|visceral pain
5126762|NCT01105026|alveolar ridge preservation, bioactive glass, tooth extraction, graft material|alveolar ridge preservation, bioactive glass, tooth extraction, graft material
5126763|NCT01105013|fungal infections|fungal infections
5126764|NCT01105013|tinea|tinea
5126766|NCT01105000|HPV|hpv
5126767|NCT01105000|HPV vaccine|hpv vaccine
5126768|NCT01104987|Ankylosing spondylitis|ankylosing spondylitis
5126769|NCT01104987|spondarthritis|spondarthritis
5126770|NCT01104987|Osteoporosis|osteoporosis
5126771|NCT01104987|Bone mineral density|bone mineral density
5126772|NCT01104987|Dual energy x-ray absorptiometry|dual energy x-ray absorptiometry
5126773|NCT01104987|Quantitative computed tomography|quantitative computed tomography
5126774|NCT01104974|HIV|hiv
5126775|NCT01104974|HIV providers|hiv providers
5126776|NCT01104974|Infectious Disease|infectious disease
5126777|NCT01104974|HIV and pregnancy|hiv and pregnancy
5126778|NCT01104961|Bacterial infection|bacterial infection
5126779|NCT01104961|Loss of epithelial cells|loss of epithelial cells
5126780|NCT01104922|Re-irradiation with Fractionated Stereotactic Radiosurgery for Head and Neck|re-irradiation with fractionated stereotactic radiosurgery for head and neck
5126781|NCT01104909|Dry weight|dry weight
5126782|NCT01104909|Blood Pressure|blood pressure
5126783|NCT01104909|Chronic Kidney disease|chronic kidney disease
5126784|NCT01104896|Cigarette|cigarette
5126785|NCT01104896|tobacco|tobacco
5126786|NCT01104896|mechanical ventilation|mechanical ventilation
5126787|NCT01104896|nicotine|nicotine
5126788|NCT01104883|Adductor-Canal-Blockade|adductor-canal-blockade
5126789|NCT01104883|postoperative pain|postoperative pain
5126790|NCT01104883|US-guided nerve block|us-guided nerve block
5126791|NCT01104883|total knee arthroplasty|total knee arthroplasty
5126792|NCT01104857|Respiratory muscle|respiratory muscle
5126793|NCT01104857|Myosin|myosin
5126794|NCT01104857|Mechanical ventilation|mechanical ventilation
5126795|NCT01104844|dental pain|dental pain
5126796|NCT01104844|Analgesia|analgesia
5126797|NCT01104831|Tibial Plateau Fracture|tibial plateau fracture
5126798|NCT01104831|AO/OTA 41|ao/ota 41
5126799|NCT01104818|Sibling relationship quality|sibling relationship quality
5126800|NCT01104818|Foster Care|foster care
5126801|NCT01104818|Parent Management Training|parent management training
5126802|NCT01104818|Mental health outcomes|mental health outcomes
5126803|NCT01104805|Drug Abuse|drug abuse
5126804|NCT01104805|Substance Abuse|substance abuse
5126805|NCT01104805|Substance Use Disorder|substance use disorder
5126806|NCT01104805|Addiction|addiction
5126807|NCT01104805|Behavioral Treatment|behavioral treatment
5126808|NCT01104792|Schizophrenia|schizophrenia
5126809|NCT01104792|Acute Schizophrenia|acute schizophrenia
5126810|NCT01104792|Psychotropic Drugs|psychotropic drugs
5126811|NCT01104792|Antipsychotic Agents|antipsychotic agents
5126812|NCT01104792|Mental Disorders|mental disorders
5126813|NCT01104792|Dopamine Agents|dopamine agents
5126814|NCT01104792|Central Nervous System Agents|central nervous system agents
5126815|NCT01104779|Schizophrenia|schizophrenia
5126816|NCT01104779|Acute Schizophrenia|acute schizophrenia
5126817|NCT01104779|Psychotropic Drugs|psychotropic drugs
5126818|NCT01104779|Antipsychotic Agents|antipsychotic agents
5126819|NCT01104779|Mental Disorders|mental disorders
5126820|NCT01104779|Dopamine Agents|dopamine agents
5126821|NCT01104779|Central Nervous System Agents|central nervous system agents
5126822|NCT01104766|Schizophrenia|schizophrenia
5126823|NCT01104766|Acute Schizophrenia|acute schizophrenia
5126824|NCT01104766|Psychotropic Drugs|psychotropic drugs
5126825|NCT01104766|Aripiprazole|aripiprazole
5126826|NCT01104766|Antipsychotic Agents|antipsychotic agents
5126827|NCT01104766|Mental Disorders|mental disorders
5126828|NCT01104766|Dopamine Agents|dopamine agents
5126829|NCT01104766|Central Nervous System Agents|central nervous system agents
5126830|NCT01104727|SINGLE PORT SURGERY|single port surgery
5126831|NCT01104727|LAPAROSCOPY, CHOLECYSTECTOMY|laparoscopy, cholecystectomy
5126832|NCT01104701|Exenatide|exenatide
5126833|NCT01104701|Amylin|amylin
5126834|NCT01104701|Lilly|lilly
5126835|NCT01104701|Byetta|byetta
5126836|NCT01104701|Exenatide Once Weekly|exenatide once weekly
5126837|NCT01104688|Abdominal Aortic Aneurysm|abdominal aortic aneurysm
5126838|NCT01104688|Wall Stress|wall stress
5126839|NCT01104688|Shear Stress|shear stress
5126840|NCT01104688|Inflammation|inflammation
5126841|NCT01104688|Magnetic Resonance Imaging|magnetic resonance imaging
5126842|NCT01104675|ovarian|ovarian
5126843|NCT01104675|platinum resistant ovarian cancer|platinum resistant ovarian cancer
5126844|NCT01104649|Spinocerebellar ataxia|spinocerebellar ataxia
5126845|NCT01104649|Friedreich ataxia|friedreich ataxia
5126846|NCT01104623|ADHD|adhd
5126847|NCT01104597|Healthy Asian Indians and Caucasians|healthy asian indians and caucasians
5126848|NCT01104584|Breast Cancer|breast cancer
5126849|NCT01104584|Gadobutrol-enhanced MRI|gadobutrol-enhanced mri
5126850|NCT01104584|Mammography|mammography
5126851|NCT01104584|Diagnostic Imaging|diagnostic imaging
5126852|NCT01104571|HER2-positive breast cancer|her2-positive breast cancer
5126853|NCT01104571|stage IA breast cancer|stage ia breast cancer
5126854|NCT01104571|stage IB breast cancer|stage ib breast cancer
5126855|NCT01104571|stage II breast cancer|stage ii breast cancer
5126856|NCT01104571|stage IIIA breast cancer|stage iiia breast cancer
5126857|NCT01104571|estrogen receptor-negative breast cancer|estrogen receptor-negative breast cancer
5126858|NCT01104571|estrogen receptor-positive breast cancer|estrogen receptor-positive breast cancer
5126859|NCT01104558|Bisoprolol|bisoprolol
5126860|NCT01104558|Chronic Heart failure|chronic heart failure
5126861|NCT01104532|ASP1941|asp1941
5126862|NCT01104532|Januvia|januvia
5126863|NCT01104532|sitagliptin|sitagliptin
5126864|NCT01104480|Relapsing Polychondritis|relapsing polychondritis
5126865|NCT01104480|Unremitting|unremitting
5126866|NCT01104480|Inflammation|inflammation
5126867|NCT01104480|IL6|il6
5126868|NCT01104467|Acute Ischemic Stroke|acute ischemic stroke
5126869|NCT01104467|Desmoteplase|desmoteplase
5126870|NCT01104467|Japan|japan
5126871|NCT01104467|Safety|safety
5126872|NCT01104467|Stroke|stroke
5126873|NCT01104467|Tolerability|tolerability
5126874|NCT01104454|healthy pregnant women|healthy pregnant women
5126875|NCT01104441|critical limb ischaemia|critical limb ischaemia
5126876|NCT01104441|Aspirin resistance|aspirin resistance
5126877|NCT01104428|Hench-schonlein purpura|hench-schonlein purpura
5126878|NCT01104428|Renal damage|renal damage
5126879|NCT01104428|Relapse|relapse
5126880|NCT01104428|End event|end event
5126881|NCT01104428|TCM syndrome|tcm syndrome
5126882|NCT01104415|Carcinoid syndrome|carcinoid syndrome
5126883|NCT01104402|telemedicine|telemedicine
5126884|NCT01104402|spirometer|spirometer
5126885|NCT01104402|CF|cf
5126886|NCT01104402|pulmonary|pulmonary
5126887|NCT01104402|home monitoring|home monitoring
5126888|NCT01104376|Cytochrome P450|cytochrome p450
5126889|NCT01104376|CYP2B6|cyp2b6
5126890|NCT01104376|Voriconazole|voriconazole
5126891|NCT01104376|Efavirenz|efavirenz
5126892|NCT01104376|Pharmacokinetics|pharmacokinetics
5126893|NCT01104376|Drug-Interactions|drug-interactions
5126894|NCT01104376|Pharmacogenetics|pharmacogenetics
5126895|NCT01104376|Healthy volunteers|healthy volunteers
5126896|NCT01104363|Dental implants|dental implants
5126897|NCT01104350|Bladder|bladder
5126898|NCT01104350|Radiotherapy|radiotherapy
5126899|NCT01104350|Gemcitabine|gemcitabine
5126900|NCT01104350|Chemotherapy|chemotherapy
5126901|NCT01104350|10-031|10-031
5126902|NCT01104337|paracetamol|paracetamol
5126903|NCT01104337|warfarin|warfarin
5126904|NCT01104337|drug interaction|drug interaction
5126905|NCT01104337|pathogenic mechanism|pathogenic mechanism
5126906|NCT01104324|bone health|bone health
5126907|NCT01104324|Osteonecrosis|osteonecrosis
5126908|NCT01104324|acute lymphoblastic leukemia|acute lymphoblastic leukemia
5126909|NCT01104311|Blood Pressure|blood pressure
5126910|NCT01104311|Atherosclerosis|atherosclerosis
5126911|NCT01104311|Brain Ischemia|brain ischemia
5126912|NCT01104298|metastatic STS|metastatic sts
5126913|NCT01104298|Trabectedin|trabectedin
5126914|NCT01104298|doxorrubicin|doxorrubicin
5126915|NCT01104298|soft tissue sarcoma|soft tissue sarcoma
5126916|NCT01104298|non operable sarcoma|non operable sarcoma
5126917|NCT01104272|Ultrasound Treatment of Subcutaneous Adipose Tissue|ultrasound treatment of subcutaneous adipose tissue
5126918|NCT01104246|Hypogonadism|hypogonadism
5126919|NCT01104246|Testosterone|testosterone
5126920|NCT01104246|Hormone replacement therapy|hormone replacement therapy
5126921|NCT01104233|Video-assisted Thoracoscopic Surgery|video-assisted thoracoscopic surgery
5126922|NCT01104233|Soft spreading|soft spreading
5126923|NCT01104233|LAP Protector|lap protector
5126924|NCT01104220|NAFLD|nafld
5126925|NCT01104220|Obesity|obesity
5126926|NCT01104220|Metabolic syndrome|metabolic syndrome
5126927|NCT01104207|tinnitus|tinnitus
5126928|NCT01104207|TMS|tms
5126929|NCT01104207|transcranial magnetic stimulation|transcranial magnetic stimulation
5126930|NCT01104194|depression|depression
5126931|NCT01104194|cognition|cognition
5126932|NCT01104194|heart rate variability|heart rate variability
5126933|NCT01104194|omega-3 fatty acids|omega-3 fatty acids
5126934|NCT01104194|Depression (in remission) (vulnerability to depression)|depression (in remission) (vulnerability to depression)
5126935|NCT01104181|Anal HPV|anal hpv
5126936|NCT01104181|Anal Dysplasia|anal dysplasia
5126937|NCT01104181|Ana Cancer|ana cancer
5126938|NCT01104168|diabetes|diabetes
5126939|NCT01104168|elderly|elderly
5126940|NCT01104168|nursing home resident|nursing home resident
5126941|NCT01104155|NSCLC|nsclc
5126942|NCT01104129|Pancreatic Cancer|pancreatic cancer
5126943|NCT01104129|Intraductal Papillary Mucinous Neoplasm (IPMN)|intraductal papillary mucinous neoplasm (ipmn)
5126944|NCT01104129|Stool-based digital melt curve (DMC) assay|stool-based digital melt curve (dmc) assay
5126945|NCT01104129|Surgical resection for pancreatic cancer|surgical resection for pancreatic cancer
5126946|NCT01104129|Hereditary Pancreatic Cancer Syndrome|hereditary pancreatic cancer syndrome
5126947|NCT01104129|Genetic mutations linked to pancreatic cancer|genetic mutations linked to pancreatic cancer
5126948|NCT01104116|Pancreatic Cancer|pancreatic cancer
5126949|NCT01104116|Intraductal Papillary Mucinous Neoplasm|intraductal papillary mucinous neoplasm
5126950|NCT01104116|Pre-cancerous pancreatic lesion|pre-cancerous pancreatic lesion
5126951|NCT01104116|PET Scan|pet scan
5126952|NCT01104116|Pancreatic Cancer Screening|pancreatic cancer screening
5126953|NCT01104103|Catheterization, Peripheral|catheterization, peripheral
5126954|NCT01104103|Disposable Equipment|disposable equipment
5126955|NCT01104103|Emergency Medical Technicians|emergency medical technicians
5126956|NCT01104103|Emergency Nursing|emergency nursing
5126957|NCT01104090|C-MAC|c-mac
5126958|NCT01104090|direct laryngoscopy|direct laryngoscopy
5126959|NCT01104090|indirect laryngoscopy|indirect laryngoscopy
5126960|NCT01104090|to determine the safety and efficacy of the C-MAC|to determine the safety and efficacy of the c-mac
5126961|NCT01104077|Pancreatic Cancer|pancreatic cancer
5126962|NCT01104077|Family History|family history
5126963|NCT01104077|Pre-cancerous lesion|pre-cancerous lesion
5126964|NCT01104077|Intraductal Papillary Mucinous Neoplasm (IPMN)|intraductal papillary mucinous neoplasm (ipmn)
5126965|NCT01104077|Intraductal Papillary Mucinous Neoplasm|intraductal papillary mucinous neoplasm
5126966|NCT01104064|Stroke|stroke
5126967|NCT01104038|physical activity|physical activity
5126968|NCT01104038|cardiometabolic risk|cardiometabolic risk
5126969|NCT01104038|children|children
5126970|NCT01104025|hemophagocytic lymphohistiocytosis|hemophagocytic lymphohistiocytosis
5126971|NCT01104025|hybrid immunotherapy|hybrid immunotherapy
5126972|NCT01104025|dexamethasone|dexamethasone
5126973|NCT01104025|Etoposide|etoposide
5126974|NCT01104025|ATG,rabbit|atg,rabbit
5126975|NCT01103999|spleen|spleen
5126976|NCT01103986|health literacy|health literacy
5126977|NCT01103986|consumer health information|consumer health information
5126978|NCT01103986|patient education as topics/methods|patient education as topics/methods
5126979|NCT01103986|patient participation|patient participation
5126980|NCT01103973|IVF, Mind/Body|ivf, mind/body
5126981|NCT01103947|Anesthesia induction|anesthesia induction
5126982|NCT01103947|Facemask|facemask
5126983|NCT01103947|surgery|surgery
5126984|NCT01103921|sugar|sugar
5126985|NCT01103921|fructose|fructose
5126986|NCT01103921|glucose|glucose
5126987|NCT01103921|HFCS|hfcs
5126988|NCT01103921|metabolism|metabolism
5126989|NCT01103908|cardiac output|cardiac output
5126990|NCT01103908|cardiopulmonary bypass|cardiopulmonary bypass
5126991|NCT01103908|ultrasound dilution|ultrasound dilution
5126992|NCT01103895|cardiac output|cardiac output
5126993|NCT01103895|cardiopulmonary bypass|cardiopulmonary bypass
5126994|NCT01103895|ultrasound dilution|ultrasound dilution
5126995|NCT01103856|HIV|hiv
5126996|NCT01103856|adherence to care|adherence to care
5126997|NCT01103856|retention in care|retention in care
5126998|NCT01103856|patient navigation|patient navigation
5126999|NCT01103843|Coronary artery disease|coronary artery disease
5127000|NCT01103843|clopidogrel|clopidogrel
5127001|NCT01103843|prasugrel|prasugrel
5127002|NCT01103843|Verify Now|verify now
5127003|NCT01103843|PRU measurements|pru measurements
5127004|NCT01103843|Drug eluting stents (EDS)|drug eluting stents (eds)
5127005|NCT01103843|P2Y12|p2y12
5127006|NCT01103843|Platelet reactivity|platelet reactivity
5127007|NCT01103830|P. falciparum Malaria, Eurartesim, ACT|p. falciparum malaria, eurartesim, act
5127008|NCT01103817|Type 1 Diabetes|type 1 diabetes
5127009|NCT01103817|Adolescents and Young Adults|adolescents and young adults
5127010|NCT01103817|Vitamin D|vitamin d
5127011|NCT01103817|Cardiovascular Disease|cardiovascular disease
5127012|NCT01103804|GerdQ questionnaire|gerdq questionnaire
5127013|NCT01103778|Chronic kidney disease|chronic kidney disease
5127014|NCT01103778|IgA nephropathy|iga nephropathy
5127015|NCT01103778|Velcade®|velcade®
5127016|NCT01103778|Proteinuria|proteinuria
5127017|NCT01103778|Bortezomib|bortezomib
5127018|NCT01103778|Proteasome inhibitor|proteasome inhibitor
5127019|NCT01103765|Post-dilatation|post-dilatation
5127020|NCT01103765|noncompliant balloon|noncompliant balloon
5127021|NCT01103765|optimal stent deployment of drug-eluting stent|optimal stent deployment of drug-eluting stent
5127022|NCT01103765|Intravascular ultrasound (IVUS)|intravascular ultrasound (ivus)
5127023|NCT01103765|Optimal stent deployment defined by intravascular ultrasound analysis|optimal stent deployment defined by intravascular ultrasound analysis
5127024|NCT01103739|pharmacokinetics|pharmacokinetics
5127025|NCT01103739|drug-drug interaction|drug-drug interaction
5127026|NCT01103726|FDG-PET|fdg-pet
5127027|NCT01103726|regional cerebral glucose metabolism|regional cerebral glucose metabolism
5127028|NCT01103726|striatum|striatum
5127029|NCT01103726|PDE10 inhibitor|pde10 inhibitor
5127030|NCT01103713|P. falciparum malaria|p. falciparum malaria
5127031|NCT01103713|asymptomatic parasitemia|asymptomatic parasitemia
5127032|NCT01103713|parasitological clearance|parasitological clearance
5127033|NCT01103713|Intermittent Preventive Treatment of Falciparum Malaria in Pregnant Women (IPTp)|intermittent preventive treatment of falciparum malaria in pregnant women (iptp)
5127034|NCT01103700|Quality of dying and death of terminal cancer patients|quality of dying and death of terminal cancer patients
5127035|NCT01103687|HIV Preventive Vaccine|hiv preventive vaccine
5127036|NCT01103674|Paroxysmal Atrial Fibrillation|paroxysmal atrial fibrillation
5127037|NCT01103674|AF|af
5127038|NCT01103674|Atrial Fibrillation|atrial fibrillation
5127039|NCT01103674|RF ablation|rf ablation
5127040|NCT01103661|Longstanding Persistent Atrial Fibrillation|longstanding persistent atrial fibrillation
5127041|NCT01103661|AF|af
5127042|NCT01103661|Chronic AF|chronic af
5127043|NCT01103661|RF Ablation|rf ablation
5127044|NCT01103661|nContact Surgical|ncontact surgical
5127045|NCT01103661|Therapy Cool Path Ablation Catheter|therapy cool path ablation catheter
5127046|NCT01103661|St. Jude Medical|st. jude medical
5127047|NCT01103648|Prediabetes|prediabetes
5127048|NCT01103648|Statin|statin
5127049|NCT01103648|Ezetimibe|ezetimibe
5127050|NCT01103648|Pleiotropic effects|pleiotropic effects
5127051|NCT01103648|Cardiometabolic risk|cardiometabolic risk
5127052|NCT01103622|Diabetes|diabetes
5127053|NCT01103622|Type 2|type 2
5127054|NCT01103622|Digoxin|digoxin
5127055|NCT01103622|drug-drug interaction|drug-drug interaction
5127056|NCT01103609|Diabetes|diabetes
5127057|NCT01103609|Type 2|type 2
5127058|NCT01103609|Warfarin|warfarin
5127059|NCT01103609|drug-drug interaction|drug-drug interaction
5127060|NCT01103596|Evaluation of the impact of Kaletra on antiretroviral resistance|evaluation of the impact of kaletra on antiretroviral resistance
5127061|NCT01103570|Laparoscopic cholecystectomy|laparoscopic cholecystectomy
5127062|NCT01103570|Intra-operative cholangiography|intra-operative cholangiography
5127063|NCT01103557|Papillary thyroid carcinoma with neck metastasis|papillary thyroid carcinoma with neck metastasis
5127064|NCT01103557|neck dissection|neck dissection
5127065|NCT01103544|TCCU|tccu
5127066|NCT01103544|advanced TCCU|advanced tccu
5127067|NCT01103544|metastatic TCCU|metastatic tccu
5127068|NCT01103544|transitional cell carcinoma of the urothelium|transitional cell carcinoma of the urothelium
5127069|NCT01103544|advanced transitional cell carcinoma of the urothelium|advanced transitional cell carcinoma of the urothelium
5127070|NCT01103544|metastatic transitional cell carcinoma of the urothelium|metastatic transitional cell carcinoma of the urothelium
5127071|NCT01103544|Cisplatinum failure|cisplatinum failure
5127072|NCT01103544|Vinflunine|vinflunine
5127073|NCT01103544|Javlor|javlor
5127074|NCT01103544|daily routine|daily routine
5127075|NCT01103544|concomitant antiemetic treatment|concomitant antiemetic treatment
5127076|NCT01103544|concomitant antiobstipative treatment|concomitant antiobstipative treatment
5127077|NCT01103544|concomitant antiobstipative diet|concomitant antiobstipative diet
5127078|NCT01103544|patient compliance|patient compliance
5127079|NCT01103544|quality of life|quality of life
5127080|NCT01103544|non-interventional study|non-interventional study
5127081|NCT01103544|Germany|germany
5127082|NCT01103544|Advanced / metastatic TCCU after Cisplatinum-failure|advanced / metastatic tccu after cisplatinum-failure
5127083|NCT01103531|Methamphetamine|methamphetamine
5127084|NCT01103531|Methamphetamine Dependence|methamphetamine dependence
5127085|NCT01103531|Methamphetamine Treatment|methamphetamine treatment
5127086|NCT01103531|Aerobic Exercise|aerobic exercise
5127087|NCT01103531|Resistance Exercise|resistance exercise
5127088|NCT01103531|Brain Imaging|brain imaging
5127089|NCT01103531|D2 and D3 receptor availability|d2 and d3 receptor availability
5127090|NCT01103518|Menstrual irregularity|menstrual irregularity
5127091|NCT01103518|Menstruation disturbances|menstruation disturbances
5127092|NCT01103518|Hyperandrogenism|hyperandrogenism
5127093|NCT01103505|AMD|amd
5127094|NCT01103505|CNV|cnv
5127095|NCT01103492|prostate cancer|prostate cancer
5127096|NCT01103492|endometrial cancer|endometrial cancer
5127097|NCT01103492|radiation proctitis|radiation proctitis
5127098|NCT01103492|pelvic radiotherapy|pelvic radiotherapy
5127099|NCT01103492|rectal bleeding|rectal bleeding
5127100|NCT01103479|Early Detection of Cancer|early detection of cancer
5127101|NCT01103479|Colorectal Cancer Screening|colorectal cancer screening
5127102|NCT01103466|Ileostomy base plate|ileostomy base plate
5127103|NCT01103453|MCI|mci
5127104|NCT01103453|Executive Function|executive function
5127105|NCT01103453|ADL|adl
5127106|NCT01103453|Virtual Supermarket|virtual supermarket
5127107|NCT01103440|Major Adverse Cardiovascular Event|major adverse cardiovascular event
5127108|NCT01103440|MACE|mace
5127109|NCT01103440|Death|death
5127110|NCT01103440|MI|mi
5127111|NCT01103440|CK MB greater 3x Normal|ck mb greater 3x normal
5127112|NCT01103440|Urgent Revascularization|urgent revascularization
5127113|NCT01103440|Stent Thrombosis|stent thrombosis
5127114|NCT01103440|Bleeding|bleeding
5127115|NCT01103427|smoking cessation|smoking cessation
5127116|NCT01103427|telemedicine|telemedicine
5127117|NCT01103427|smoking|smoking
5127118|NCT01103427|prevention intervention|prevention intervention
5127119|NCT01103427|internet-based|internet-based
5127120|NCT01103427|text messages|text messages
5127121|NCT01103427|behavioral|behavioral
5127122|NCT01103414|Diabetes|diabetes
5127123|NCT01103388|Rituximab|rituximab
5127124|NCT01103388|Rituxan|rituxan
5127125|NCT01103388|Lymphoma|lymphoma
5127126|NCT01103388|High dose chemotherapy|high dose chemotherapy
5127127|NCT01103388|Autologous transplantation|autologous transplantation
5127128|NCT01103388|Autologous stem cell transplant|autologous stem cell transplant
5127129|NCT01103388|ASCT|asct
5127130|NCT01103336|Patients with chronic renal failure undergoing coronary angiography|patients with chronic renal failure undergoing coronary angiography
5127131|NCT01103323|Metastatic Colorectal Cancer|metastatic colorectal cancer
5127132|NCT01103310|Neoplasm|neoplasm
5127133|NCT01103310|PET/CT diagnosis|pet/ct diagnosis
5127134|NCT01103310|PET tracer|pet tracer
5127135|NCT01103297|Distal radius fracture|distal radius fracture
5127136|NCT01103297|Double row plate|double row plate
5127137|NCT01103297|Volar approach|volar approach
5127138|NCT01103297|DVR plate|dvr plate
5127139|NCT01103297|Postoperative complications [MeSH]|postoperative complications [mesh]
5127140|NCT01103284|beta-cells|beta-cells
5127141|NCT01103284|autoimmune|autoimmune
5127142|NCT01103284|Diabetes|diabetes
5127143|NCT01103284|immunomodulation|immunomodulation
5127144|NCT01103271|depression|depression
5127145|NCT01103271|placebo effect|placebo effect
5127146|NCT01103271|complementary therapies|complementary therapies
5127448|NCT01101867|hospital|hospital
5127147|NCT01103271|alternative therapies|alternative therapies
5127148|NCT01103258|Incompetence of the great saphenous vein.|incompetence of the great saphenous vein.
5127149|NCT01103245|Glucose|glucose
5127150|NCT01103245|Insulin|insulin
5127151|NCT01103232|Cross education|cross education
5127152|NCT01103232|Muscle training|muscle training
5127153|NCT01103219|VLBW|vlbw
5127154|NCT01103219|nutrition|nutrition
5127155|NCT01103219|vitamin A|vitamin a
5127156|NCT01103219|long-chain unsaturated fatty acids|long-chain unsaturated fatty acids
5127157|NCT01103219|growth|growth
5127158|NCT01103219|cognitive functions|cognitive functions
5127159|NCT01103219|Very low birth weight infants (birth weight below 1,500 grams).|very low birth weight infants (birth weight below 1,500 grams).
5127160|NCT01103206|Parathyroid hormone|parathyroid hormone
5127161|NCT01103206|Cinacalcet|cinacalcet
5127162|NCT01103206|Primary hyperparathyroidism|primary hyperparathyroidism
5127163|NCT01103206|Diagnosis|diagnosis
5127164|NCT01103193|ASA class I/II patients, with surgery under general anesthesia|asa class i/ii patients, with surgery under general anesthesia
5127165|NCT01103180|Selective Serotonin Reuptake Inhibitor|selective serotonin reuptake inhibitor
5127166|NCT01103180|Escitalopram|escitalopram
5127167|NCT01103180|Borderline Personality Disorder|borderline personality disorder
5127168|NCT01103180|Major Depressive Disorder|major depressive disorder
5127169|NCT01103180|Self-harm|self-harm
5127170|NCT01103167|body composition|body composition
5127171|NCT01103167|blood pressure|blood pressure
5127172|NCT01103167|hemodialysis|hemodialysis
5127173|NCT01103154|beta blocker|beta blocker
5127174|NCT01103154|variceal rebleeding|variceal rebleeding
5127175|NCT01103154|efficacy and safety in reducing variceal rebleeding|efficacy and safety in reducing variceal rebleeding
5127176|NCT01103141|Vascular Surgical Procedures|vascular surgical procedures
5127177|NCT01103141|Angioplasty|angioplasty
5127178|NCT01103141|Radiology, Interventional|radiology, interventional
5127179|NCT01103128|Pancreatic Cancer|pancreatic cancer
5127180|NCT01103128|Pre-neoplastic lesions|pre-neoplastic lesions
5127181|NCT01103128|Breast and Ovarian Cancer Syndrome|breast and ovarian cancer syndrome
5127182|NCT01103128|BRCA1/2|brca1/2
5127183|NCT01103128|Mouse model for pancreatic cancer|mouse model for pancreatic cancer
5127184|NCT01103115|Adolescent Idiopathic Scoliosis|adolescent idiopathic scoliosis
5127185|NCT01103115|AIS|ais
5127186|NCT01103115|low bone mass|low bone mass
5127187|NCT01103115|osteopenia|osteopenia
5127188|NCT01103115|bone health|bone health
5127189|NCT01103115|bone density|bone density
5127190|NCT01103102|Gingivitis|gingivitis
5127191|NCT01103102|Biological Markers|biological markers
5127192|NCT01103089|NSCLC|nsclc
5127193|NCT01103089|EGFR|egfr
5127194|NCT01103089|gefitinib|gefitinib
5127195|NCT01103089|observational|observational
5127196|NCT01103076|Immune dysfunction|immune dysfunction
5127197|NCT01103076|Hemodialysis|hemodialysis
5127198|NCT01103076|HBV|hbv
5127199|NCT01103076|Vaccination|vaccination
5127200|NCT01103076|Immune response|immune response
5127201|NCT01103063|P. falciparum malaria|p. falciparum malaria
5127202|NCT01103063|IPTp|iptp
5127203|NCT01103050|Allergic inflammation|allergic inflammation
5127204|NCT01103050|Seasonal rhinitis|seasonal rhinitis
5127205|NCT01103037|Mild|mild
5127206|NCT01103037|Moderate|moderate
5127207|NCT01103037|Asthma|asthma
5127208|NCT01103024|Active uveitis|active uveitis
5127209|NCT01103024|intermediate uveitis|intermediate uveitis
5127210|NCT01103024|panuveitis|panuveitis
5127211|NCT01103024|posterior uveitis|posterior uveitis
5127212|NCT01103024|uveitis|uveitis
5127213|NCT01102998|Sleep complaints|sleep complaints
5127214|NCT01102998|Brain Tumor Survivors|brain tumor survivors
5127215|NCT01102985|exercise|exercise
5127216|NCT01102985|physical activity|physical activity
5127217|NCT01102985|intervention|intervention
5127218|NCT01102985|cancer survivor|cancer survivor
5127219|NCT01102972|HIV-1|hiv-1
5127220|NCT01102972|HIV|hiv
5127221|NCT01102959|EDUCATION|education
5127222|NCT01102959|DIABETES MELLITUS|diabetes mellitus
5127223|NCT01102959|ADOLESCENT|adolescent
5127224|NCT01102959|DIABETIC DIET|diabetic diet
5127225|NCT01102946|proliferative diabetic retinopathy|proliferative diabetic retinopathy
5127226|NCT01102946|retinal neovascularization|retinal neovascularization
5127227|NCT01102946|Angiogenesis Inhibitors|angiogenesis inhibitors
5127228|NCT01102946|ranibizumab|ranibizumab
5127229|NCT01102946|laser|laser
5127230|NCT01102920|Obstructive sleep apnea|obstructive sleep apnea
5127231|NCT01102920|Obesity|obesity
5127232|NCT01102920|Behavioural medicine|behavioural medicine
5127233|NCT01102920|Physical therapy|physical therapy
5127234|NCT01102920|Health behaviour change|health behaviour change
5127235|NCT01102920|Physical activity|physical activity
5127236|NCT01102920|Eating habits|eating habits
5127237|NCT01102907|Appetite|appetite
5127238|NCT01102907|Satiety|satiety
5127239|NCT01102907|Gastric Emptying Time|gastric emptying time
5127240|NCT01102907|Food Intake|food intake
5127241|NCT01102907|Food Form|food form
5127242|NCT01102881|Healthy adults|healthy adults
5127243|NCT01102829|Knee Joint|knee joint
5127244|NCT01102829|Arthroplasty|arthroplasty
5127245|NCT01102829|Replacement|replacement
5127246|NCT01102829|Knee|knee
5127247|NCT01102816|hemodialysis|hemodialysis
5127248|NCT01102816|end-stage renal disease|end-stage renal disease
5127249|NCT01102816|pain|pain
5127250|NCT01102816|acupuncture|acupuncture
5127251|NCT01102803|Phobias|phobias
5127252|NCT01102803|Anxiety Disorders|anxiety disorders
5127253|NCT01102803|D-Cycloserine|d-cycloserine
5127254|NCT01102803|Phobic Disorders|phobic disorders
5127255|NCT01102803|Mental Disorders|mental disorders
5127256|NCT01102803|Heights|heights
5127257|NCT01102803|Acrophobia|acrophobia
5127258|NCT01102790|HIT|hit
5127259|NCT01102777|internet|internet
5127260|NCT01102777|walking|walking
5127261|NCT01102764|Anxiety Disorders: PTSD|anxiety disorders: ptsd
5127262|NCT01102764|Prolong Exposure (PE)|prolong exposure (pe)
5127263|NCT01102764|Telemedicine|telemedicine
5127264|NCT01102764|cost effectiveness|cost effectiveness
5127265|NCT01102764|deployment related problems|deployment related problems
5127266|NCT01102764|mental health care delivery|mental health care delivery
5127267|NCT01102751|fibroblast growth factor 23|fibroblast growth factor 23
5127268|NCT01102751|Osteomalacia|osteomalacia
5127269|NCT01102751|vitamin D|vitamin d
5127270|NCT01102725|Colon Surgery|colon surgery
5127271|NCT01102725|Rectal Surgery|rectal surgery
5127272|NCT01102725|Colorectal Surgery|colorectal surgery
5127273|NCT01102712|Emphysema|emphysema
5127274|NCT01102712|COPD|copd
5127275|NCT01102712|Lung Volume Reduction|lung volume reduction
5127276|NCT01102712|BTVA|btva
5127277|NCT01102699|Diabetes|diabetes
5127278|NCT01102699|stem cells|stem cells
5127279|NCT01102699|bone marrow|bone marrow
5127280|NCT01102699|mobilization|mobilization
5127281|NCT01102686|Late-onset GM2-gangliosidosis|late-onset gm2-gangliosidosis
5127282|NCT01102686|pyrimethamine|pyrimethamine
5127283|NCT01102673|phase 1|phase 1
5127284|NCT01102673|safety and tolerability|safety and tolerability
5127285|NCT01102673|PK|pk
5127286|NCT01102673|T2DM|t2dm
5127287|NCT01102673|type 2 diabetes mellitus|type 2 diabetes mellitus
5127288|NCT01102660|Knee osteoarthritis|knee osteoarthritis
5127289|NCT01102660|clinical trial|clinical trial
5127290|NCT01102660|cross-over|cross-over
5127291|NCT01102621|hearing loss|hearing loss
5127292|NCT01102621|head and neck cancer|head and neck cancer
5127293|NCT01102621|radiotherapy|radiotherapy
5127294|NCT01102621|hearing complaint|hearing complaint
5127295|NCT01102621|Hearing loss due to the exposure of radiotherapy|hearing loss due to the exposure of radiotherapy
5127296|NCT01102608|sarcoma|sarcoma
5127297|NCT01102608|ifosfamide|ifosfamide
5127298|NCT01102595|Unresectable/inoperable glioblastomas|unresectable/inoperable glioblastomas
5127299|NCT01102582|Parkinson's disease dementia, neuropsychiatric symptoms|parkinson's disease dementia, neuropsychiatric symptoms
5127300|NCT01102569|Hereditary pancreatic cancer|hereditary pancreatic cancer
5127301|NCT01102569|Breast and Ovarian Cancer Syndrome|breast and ovarian cancer syndrome
5127302|NCT01102569|BRCA1/2|brca1/2
5127303|NCT01102569|Ashkenazi Jewish patients|ashkenazi jewish patients
5127304|NCT01102556|Pancreatic Cancer|pancreatic cancer
5127305|NCT01102556|Pre-Neoplastic Lesions|pre-neoplastic lesions
5127306|NCT01102556|Pancreatic Cancer Surgery|pancreatic cancer surgery
5127307|NCT01102556|High-Risk for Pancreatic Cancer|high-risk for pancreatic cancer
5127308|NCT01102556|Tissue and Blood Bank for Pancreatic Cancer|tissue and blood bank for pancreatic cancer
5127309|NCT01102556|Pancreatic Cancer Questionnaire|pancreatic cancer questionnaire
5127310|NCT01102543|pulmonary surfactant|pulmonary surfactant
5127311|NCT01102543|Respiratory distress syndrome|respiratory distress syndrome
5127312|NCT01102543|Newborn|newborn
5127313|NCT01102543|prophylaxis|prophylaxis
5127314|NCT01102517|NSCLC|nsclc
5127315|NCT01102517|Clinical|clinical
5127316|NCT01102517|Early-stage|early-stage
5127317|NCT01102504|carotid atheroma|carotid atheroma
5127318|NCT01102504|plaque vulnerability|plaque vulnerability
5127319|NCT01102504|stroke risk|stroke risk
5127320|NCT01102491|postoperative nausea and vomiting|postoperative nausea and vomiting
5127321|NCT01102439|Clopidogrel|clopidogrel
5127322|NCT01102439|Aspirin|aspirin
5127323|NCT01102439|Interaction|interaction
5127324|NCT01102426|Multiple Myeloma|multiple myeloma
5127325|NCT01102426|Aplidin|aplidin
5127326|NCT01102426|plitidepsin|plitidepsin
5127327|NCT01102426|dexamethasone|dexamethasone
5127328|NCT01102400|cancer|cancer
5127329|NCT01102400|tumor|tumor
5127330|NCT01102400|hepatocellular carcinoma|hepatocellular carcinoma
5127331|NCT01102387|Candida infections in intertriginous areas|candida infections in intertriginous areas
5127332|NCT01102374|Vitamin D Deficiency|vitamin d deficiency
5127333|NCT01102374|Respiratory Infection|respiratory infection
5127334|NCT01102374|Nursing Home Residents|nursing home residents
5127335|NCT01102374|Geriatrics|geriatrics
5127336|NCT01102374|Immunosenescence|immunosenescence
5127337|NCT01102374|Prevention|prevention
5127338|NCT01102348|Critically Ill|critically ill
5127339|NCT01102348|Nutrition Therapy|nutrition therapy
5127340|NCT01102348|Enteral Nutrition|enteral nutrition
5127341|NCT01102335|hepatitis B virus|hepatitis b virus
5127342|NCT01102335|Antiviral Agents|antiviral agents
5127343|NCT01102335|Liver Neoplasms|liver neoplasms
5127344|NCT01102335|Drug Toxicity|drug toxicity
5127345|NCT01102335|Survival|survival
5127751|NCT01101230|cholesterol|cholesterol
5127346|NCT01102322|Acute respiratory distress syndrome|acute respiratory distress syndrome
5127347|NCT01102309|cerebrovascular accident|cerebrovascular accident
5127348|NCT01102309|hemiparesis|hemiparesis
5127349|NCT01102309|recovery of function|recovery of function
5127350|NCT01102309|rehabilitation|rehabilitation
5127351|NCT01102309|robotics|robotics
5127352|NCT01102309|subacute therapy|subacute therapy
5127353|NCT01102309|training|training
5127354|NCT01102296|hepatitis A vaccine|hepatitis a vaccine
5127355|NCT01102296|male homosexual|male homosexual
5127356|NCT01102296|HIV infection|hiv infection
5127357|NCT01102296|male homosexuals who are seronegative for hepatitis A virus|male homosexuals who are seronegative for hepatitis a virus
5127358|NCT01102283|Colonic obstruction|colonic obstruction
5127359|NCT01102270|Obstructive sleep apnea|obstructive sleep apnea
5127360|NCT01102270|Arousal threshold|arousal threshold
5127361|NCT01102270|Sedative medication|sedative medication
5127362|NCT01102270|upper airway|upper airway
5127363|NCT01102257|Dry Eye Disease|dry eye disease
5127364|NCT01102257|DED|ded
5127365|NCT01102257|Keratoconjunctivitis Sicca|keratoconjunctivitis sicca
5127366|NCT01102257|Omega-3|omega-3
5127367|NCT01102244|blepharitis|blepharitis
5127368|NCT01102244|moderate to severe chronic blepharitis|moderate to severe chronic blepharitis
5127369|NCT01102218|Anemia, ESRD|anemia, esrd
5127370|NCT01102192|Myasthenia gravis|myasthenia gravis
5127371|NCT01102192|Thymoma|thymoma
5127372|NCT01102192|T-cells|t-cells
5127373|NCT01102192|Thymectomy|thymectomy
5127374|NCT01102166|This study was conducted in healthy subjects|this study was conducted in healthy subjects
5127375|NCT01102153|sudden cardiac arrest|sudden cardiac arrest
5127376|NCT01102153|Hypothermia|hypothermia
5127377|NCT01102153|Coolgard|coolgard
5127378|NCT01102153|arctic sun|arctic sun
5127379|NCT01102153|neurological outcome|neurological outcome
5127380|NCT01102153|neuron specific enolase|neuron specific enolase
5127381|NCT01102140|Cardiomyopathy|cardiomyopathy
5127382|NCT01102140|Heart Failure|heart failure
5127383|NCT01102127|elastography|elastography
5127384|NCT01102127|thyroid nodule|thyroid nodule
5127385|NCT01102127|fine-needle aspiration|fine-needle aspiration
5127386|NCT01102114|Smoking Cessation|smoking cessation
5127387|NCT01102114|NicVAX|nicvax
5127388|NCT01102114|Smoking Vaccine|smoking vaccine
5127389|NCT01102114|Smoking Abstinence|smoking abstinence
5127390|NCT01102114|Smoking|smoking
5127391|NCT01102114|Tobacco Cessation|tobacco cessation
5127392|NCT01102101|Remifentanil|remifentanil
5127393|NCT01102101|Hyperalgesia|hyperalgesia
5127394|NCT01102101|Zoster|zoster
5127395|NCT01102101|Postherpetic neuralgia|postherpetic neuralgia
5127396|NCT01102088|Cancer|cancer
5127397|NCT01102088|Gastroesophageal|gastroesophageal
5127398|NCT01102088|Simultaneous Integrated Boost|simultaneous integrated boost
5127399|NCT01102088|SIB|sib
5127400|NCT01102088|5-Fluorouracil|5-fluorouracil
5127401|NCT01102088|5-FU|5-fu
5127402|NCT01102088|Adrucil|adrucil
5127403|NCT01102088|Efudex|efudex
5127404|NCT01102088|Docetaxel|docetaxel
5127405|NCT01102088|Taxotere|taxotere
5127406|NCT01102088|Radiation|radiation
5127407|NCT01102088|chemoradiation|chemoradiation
5127408|NCT01102075|Obesity|obesity
5127409|NCT01102075|Electroacupuncture|electroacupuncture
5127410|NCT01102075|Sham electroacupuncture|sham electroacupuncture
5127411|NCT01102075|Waist circumference|waist circumference
5127412|NCT01102075|Thickness of subcutaneous fat|thickness of subcutaneous fat
5127413|NCT01102036|Transit time|transit time
5127414|NCT01102036|constipation|constipation
5127415|NCT01102036|gut regularity|gut regularity
5127416|NCT01102036|defecation frequency|defecation frequency
5127417|NCT01102036|Colonic transit time|colonic transit time
5127418|NCT01102010|Blood transfusion|blood transfusion
5127419|NCT01102010|Hip fracture|hip fracture
5127420|NCT01102010|Elderly|elderly
5127421|NCT01102010|Geriatrics|geriatrics
5127422|NCT01102010|Hospitalization|hospitalization
5127423|NCT01102010|Frail elderly|frail elderly
5127424|NCT01101997|Lipolysis|lipolysis
5127425|NCT01101997|Cryolipolysis|cryolipolysis
5127426|NCT01101997|Fat Reduction|fat reduction
5127427|NCT01101971|Education, Medical|education, medical
5127428|NCT01101971|Students, Medical|students, medical
5127429|NCT01101971|Gynecology|gynecology
5127430|NCT01101971|Physical Examination|physical examination
5127431|NCT01101971|Computer-Assisted Instruction|computer-assisted instruction
5127432|NCT01101945|diabetes|diabetes
5127433|NCT01101945|DPP4 inhibitor|dpp4 inhibitor
5127434|NCT01101945|dutogliptin|dutogliptin
5127435|NCT01101945|PHX1149|phx1149
5127436|NCT01101932|Safety|safety
5127437|NCT01101932|Tolerability|tolerability
5127438|NCT01101932|Pharmacokinetics/Pharmacodynamics|pharmacokinetics/pharmacodynamics
5127439|NCT01101932|Rheumatoid Arthritis|rheumatoid arthritis
5127440|NCT01101932|healthy volunteers|healthy volunteers
5127441|NCT01101919|Rheumatoid Arthritis|rheumatoid arthritis
5127442|NCT01101906|OSI-906|osi-906
5127443|NCT01101906|HCC|hcc
5127444|NCT01101906|Hepatocellular Carcinoma|hepatocellular carcinoma
5127445|NCT01101893|GSK2248761, raltegravir, drug interaction, pharmacokinetics|gsk2248761, raltegravir, drug interaction, pharmacokinetics
5127446|NCT01101867|diabetes|diabetes
5127447|NCT01101867|glucose|glucose
5127449|NCT01101854|gene expression in wounds|gene expression in wounds
5127450|NCT01101854|healing wounds|healing wounds
5127451|NCT01101854|non-healing wounds|non-healing wounds
5127452|NCT01101854|punch biopsy|punch biopsy
5127453|NCT01101854|debridement|debridement
5127454|NCT01101841|Vasomotor Symptoms|vasomotor symptoms
5127455|NCT01101841|Menopause|menopause
5127456|NCT01101841|Hot Flashes|hot flashes
5127457|NCT01101841|Perimenopause|perimenopause
5127458|NCT01101841|Nonhormonal therapies|nonhormonal therapies
5127459|NCT01101841|Climacteric symptoms|climacteric symptoms
5127460|NCT01101841|Mesafem|mesafem
5127461|NCT01101841|Low-Dose Mesylate salt of Paroxetine (LDMP)|low-dose mesylate salt of paroxetine (ldmp)
5127462|NCT01101815|Viral Loads|viral loads
5127463|NCT01101815|Naltrexone|naltrexone
5127464|NCT01101815|HIV Risk|hiv risk
5127465|NCT01101815|Substance Abuse|substance abuse
5127466|NCT01101802|SLE|sle
5127467|NCT01101802|Atherosclerosis|atherosclerosis
5127468|NCT01101802|Endothelial function|endothelial function
5127469|NCT01101802|Mycophenolate mofetil|mycophenolate mofetil
5127470|NCT01101789|surgical wound infection|surgical wound infection
5127471|NCT01101789|triclosan-coated suture|triclosan-coated suture
5127472|NCT01101776|Multiple Sclerosis, relapsing|multiple sclerosis, relapsing
5127473|NCT01101776|Rebif New Formulation|rebif new formulation
5127474|NCT01101776|Interferon beta-1a|interferon beta-1a
5127475|NCT01101750|Gardasil|gardasil
5127476|NCT01101750|HPV|hpv
5127477|NCT01101750|transplant|transplant
5127478|NCT01101750|adolescent|adolescent
5127479|NCT01101750|prevention|prevention
5127480|NCT01101750|vaccine|vaccine
5127481|NCT01101750|immunogenicity|immunogenicity
5127482|NCT01101750|vaccination|vaccination
5127483|NCT01101737|Hypertension, clinical trial, nurse-led clinic, primary care|hypertension, clinical trial, nurse-led clinic, primary care
5127801|NCT01100996|intestinal damage|intestinal damage
5127484|NCT01101724|mild traumatic brain injury|mild traumatic brain injury
5127485|NCT01101724|Concussion|concussion
5127486|NCT01101724|postconcussive syndrome|postconcussive syndrome
5127487|NCT01101698|Vitamin K|vitamin k
5127488|NCT01101698|chronic kidney disease|chronic kidney disease
5127489|NCT01101698|coronary artery calcification|coronary artery calcification
5127490|NCT01101698|intima media thickness|intima media thickness
5127491|NCT01101685|non-dysphoric|non-dysphoric
5127492|NCT01101685|Dysphoric|dysphoric
5127493|NCT01101672|Single port laparoscopic colectomy|single port laparoscopic colectomy
5127494|NCT01101659|Activity of JNJ-40411813|activity of jnj-40411813
5127495|NCT01101659|Challenge study|challenge study
5127496|NCT01101646|Rabeprazole sodium|rabeprazole sodium
5127497|NCT01101646|Pharmacokinetics|pharmacokinetics
5127498|NCT01101646|Biological Availability|biological availability
5127499|NCT01101646|Safety|safety
5127500|NCT01101646|Adult|adult
5127501|NCT01101633|Appetite|appetite
5127502|NCT01101633|Energy intake|energy intake
5127503|NCT01101633|gastric emptying|gastric emptying
5127504|NCT01101633|well being|well being
5127505|NCT01101633|Body weight|body weight
5127506|NCT01101607|Pediatrics|pediatrics
5127507|NCT01101607|Distal Forearm fractures|distal forearm fractures
5127508|NCT01101607|Pediatric Emergency Medicine|pediatric emergency medicine
5127509|NCT01101607|Pediatric Orthopedics|pediatric orthopedics
5127510|NCT01101594|Treatment|treatment
5127511|NCT01101594|Multiple Myeloma|multiple myeloma
5127512|NCT01101594|Relapsed, refractory multiple myeloma|relapsed, refractory multiple myeloma
5127513|NCT01101581|Diffuse Large cell NHL|diffuse large cell nhl
5127514|NCT01101581|Mantle cell NHL|mantle cell nhl
5127515|NCT01101581|Lymphoblastic lymphoma|lymphoblastic lymphoma
5127516|NCT01101581|Diffuse mixed cell lymphoma|diffuse mixed cell lymphoma
5127517|NCT01101581|Diffuse large cell lymphoma|diffuse large cell lymphoma
5127518|NCT01101581|large noncleaved cell lymphoma|large noncleaved cell lymphoma
5127519|NCT01101568|GSK1292263, rosuvastatin, simvastatin, pharmacokinetics, drug interaction|gsk1292263, rosuvastatin, simvastatin, pharmacokinetics, drug interaction
5127520|NCT01101555|Rheumatoid arthritis|rheumatoid arthritis
5127521|NCT01101555|repeat dose|repeat dose
5127522|NCT01101555|pharmacodynamics|pharmacodynamics
5127523|NCT01101555|pharmacokinetics|pharmacokinetics
5127524|NCT01101555|subcutaneous|subcutaneous
5127525|NCT01101555|safety|safety
5127526|NCT01101555|Otelixizumab|otelixizumab
5127527|NCT01101555|long term follow up|long term follow up
5127528|NCT01101555|tolerability|tolerability
5127529|NCT01101542|Post-marketing surveillance|post-marketing surveillance
5127530|NCT01101542|Human papillomavirus|human papillomavirus
5127531|NCT01101542|Korea|korea
5127532|NCT01101542|Safety|safety
5127533|NCT01101542|Prescribing Information|prescribing information
5127534|NCT01101529|Chemotherapy-induced nausea and vomiting CINV|chemotherapy-induced nausea and vomiting cinv
5127535|NCT01101503|Newly diagnosed type 2 diabetes|newly diagnosed type 2 diabetes
5127536|NCT01101503|Endothelial dysfunction|endothelial dysfunction
5127537|NCT01101503|Intensive therapy|intensive therapy
5127538|NCT01101503|Metabolic Memorial Effect|metabolic memorial effect
5127539|NCT01101490|To compare the change of cerebral oxygen saturation and blood flow between right and left side in lateral decubitus position during nephrectomy|to compare the change of cerebral oxygen saturation and blood flow between right and left side in lateral decubitus position during nephrectomy
5127540|NCT01101477|Target-controlled infusion,|target-controlled infusion,
5127541|NCT01101477|bronchoscopy,|bronchoscopy,
5127542|NCT01101477|sedation,|sedation,
5127543|NCT01101477|propofol|propofol
5127544|NCT01101438|stage I breast cancer|stage i breast cancer
5127545|NCT01101438|stage II breast cancer|stage ii breast cancer
5127546|NCT01101438|stage IIIA breast cancer|stage iiia breast cancer
5127547|NCT01101438|stage IIIC breast cancer|stage iiic breast cancer
5127548|NCT01101438|male breast cancer|male breast cancer
5127549|NCT01101438|HER2-negative breast cancer|her2-negative breast cancer
5127550|NCT01101438|estrogen receptor-positive breast cancer|estrogen receptor-positive breast cancer
5127551|NCT01101438|HER2-positive breast cancer|her2-positive breast cancer
5127552|NCT01101438|progesterone receptor-positive breast cancer|progesterone receptor-positive breast cancer
5127553|NCT01101425|male|male
5127554|NCT01101425|breast cancer|breast cancer
5127555|NCT01101412|infection|infection
5127556|NCT01101412|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5127557|NCT01101412|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5127558|NCT01101412|acute undifferentiated leukemia|acute undifferentiated leukemia
5127559|NCT01101412|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5127560|NCT01101412|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5127561|NCT01101412|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5127562|NCT01101412|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5127563|NCT01101412|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5127564|NCT01101412|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5127565|NCT01101412|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5127566|NCT01101412|atypical chronic myeloid leukemia, BCR-ABL negative|atypical chronic myeloid leukemia, bcr-abl negative
5127567|NCT01101412|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5127568|NCT01101412|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5127569|NCT01101412|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5127570|NCT01101412|mast cell leukemia|mast cell leukemia
5127571|NCT01101412|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
5127572|NCT01101412|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
5127573|NCT01101412|prolymphocytic leukemia|prolymphocytic leukemia
5127574|NCT01101412|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5127575|NCT01101412|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5127576|NCT01101412|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
5127577|NCT01101412|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5127578|NCT01101412|refractory hairy cell leukemia|refractory hairy cell leukemia
5127579|NCT01101412|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5127580|NCT01101412|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5127581|NCT01101412|stage 0 chronic lymphocytic leukemia|stage 0 chronic lymphocytic leukemia
5127582|NCT01101412|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
5127583|NCT01101412|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
5127584|NCT01101412|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
5127585|NCT01101412|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
5127586|NCT01101412|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
5127587|NCT01101412|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5127588|NCT01101412|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
5127589|NCT01101412|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5127590|NCT01101412|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
5127591|NCT01101412|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
5127592|NCT01101412|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
5127593|NCT01101412|untreated hairy cell leukemia|untreated hairy cell leukemia
5127594|NCT01101412|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5127595|NCT01101412|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
5127596|NCT01101412|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
5127597|NCT01101412|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5127598|NCT01101412|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5127599|NCT01101412|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5127600|NCT01101412|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
5127601|NCT01101412|cutaneous B-cell non-Hodgkin lymphoma|cutaneous b-cell non-hodgkin lymphoma
5127602|NCT01101412|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5127603|NCT01101412|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
5127604|NCT01101412|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
5127605|NCT01101412|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
5127606|NCT01101412|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
5127607|NCT01101412|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5127752|NCT01101230|low-density|low-density
5127608|NCT01101412|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
5127609|NCT01101412|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
5127610|NCT01101412|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
5127611|NCT01101412|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
5127612|NCT01101412|adult grade III lymphomatoid granulomatosis|adult grade iii lymphomatoid granulomatosis
5127613|NCT01101412|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
5127614|NCT01101412|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
5127615|NCT01101412|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5127616|NCT01101412|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5127617|NCT01101412|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5127618|NCT01101412|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
5127619|NCT01101412|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
5127620|NCT01101412|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
5127621|NCT01101412|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
5127622|NCT01101412|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
5127623|NCT01101412|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
5127624|NCT01101412|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
5127625|NCT01101412|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
5127626|NCT01101412|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
5127627|NCT01101412|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
5127628|NCT01101412|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
5127629|NCT01101412|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
5127630|NCT01101412|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
5127631|NCT01101412|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
5127632|NCT01101412|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
5127633|NCT01101412|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
5127634|NCT01101412|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
5127635|NCT01101412|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
5127636|NCT01101412|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
5127637|NCT01101412|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
5127638|NCT01101412|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
5127639|NCT01101412|stage I mantle cell lymphoma|stage i mantle cell lymphoma
5127640|NCT01101412|stage I marginal zone lymphoma|stage i marginal zone lymphoma
5127641|NCT01101412|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
5127642|NCT01101412|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
5127643|NCT01101412|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5127644|NCT01101412|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
5127645|NCT01101412|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
5127646|NCT01101412|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
5127647|NCT01101412|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
5127648|NCT01101412|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5127649|NCT01101412|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5127650|NCT01101412|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5127651|NCT01101412|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5127652|NCT01101412|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
5127653|NCT01101412|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
5127654|NCT01101412|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5127655|NCT01101412|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5127656|NCT01101412|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5127657|NCT01101412|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5127658|NCT01101412|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5127659|NCT01101412|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5127660|NCT01101412|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5127661|NCT01101412|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5127662|NCT01101412|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5127663|NCT01101412|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5127664|NCT01101412|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5127665|NCT01101412|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5127666|NCT01101412|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5127667|NCT01101412|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5127668|NCT01101412|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5127669|NCT01101412|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5127670|NCT01101412|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5127671|NCT01101412|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5127672|NCT01101412|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5127673|NCT01101412|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5127674|NCT01101412|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5127675|NCT01101412|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5127676|NCT01101412|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5127677|NCT01101412|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5127678|NCT01101412|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5127679|NCT01101412|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5127680|NCT01101412|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5127681|NCT01101412|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5127682|NCT01101412|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
5127683|NCT01101412|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5127684|NCT01101412|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5127685|NCT01101412|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5127686|NCT01101412|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5127687|NCT01101412|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5127688|NCT01101412|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5127689|NCT01101412|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5127690|NCT01101412|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5127691|NCT01101412|intraocular lymphoma|intraocular lymphoma
5127692|NCT01101412|post-transplant lymphoproliferative disorder|post-transplant lymphoproliferative disorder
5127693|NCT01101412|chronic eosinophilic leukemia|chronic eosinophilic leukemia
5127694|NCT01101412|chronic neutrophilic leukemia|chronic neutrophilic leukemia
5127695|NCT01101412|primary myelofibrosis|primary myelofibrosis
5127696|NCT01101412|essential thrombocythemia|essential thrombocythemia
5127697|NCT01101412|polycythemia vera|polycythemia vera
5127698|NCT01101412|extramedullary plasmacytoma|extramedullary plasmacytoma
5127699|NCT01101412|isolated plasmacytoma of bone|isolated plasmacytoma of bone
5127700|NCT01101412|stage I multiple myeloma|stage i multiple myeloma
5127701|NCT01101412|stage II multiple myeloma|stage ii multiple myeloma
5127702|NCT01101412|stage III multiple myeloma|stage iii multiple myeloma
5127703|NCT01101412|primary systemic amyloidosis|primary systemic amyloidosis
5127704|NCT01101412|refractory multiple myeloma|refractory multiple myeloma
5127705|NCT01101412|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5127706|NCT01101412|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5127707|NCT01101412|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5127708|NCT01101412|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
5127709|NCT01101399|Anemia|anemia
5127710|NCT01101399|Lymphoproliferative Disorders|lymphoproliferative disorders
5127711|NCT01101399|Chemotherapy|chemotherapy
5127712|NCT01101399|ferric carboxymaltose|ferric carboxymaltose
5127713|NCT01101399|iron|iron
5127714|NCT01101386|Voriconazole|voriconazole
5127715|NCT01101386|SBECD|sbecd
5127716|NCT01101386|pharmacokinetics|pharmacokinetics
5127717|NCT01101386|Renal Failure|renal failure
5127718|NCT01101373|Limbic surgery|limbic surgery
5127719|NCT01101373|Stereotactic surgery|stereotactic surgery
5127720|NCT01101373|Major Depressive Disorder: Treatment Refractory|major depressive disorder: treatment refractory
5127721|NCT01101360|port wine stains|port wine stains
5127722|NCT01101360|radiofrequency|radiofrequency
5127723|NCT01101360|Pulse Dye Laser|pulse dye laser
5127724|NCT01101334|NSCLC|nsclc
5127725|NCT01101321|Healthy subjects|healthy subjects
5127726|NCT01101321|Opioid|opioid
5127727|NCT01101321|Healthy volunteers|healthy volunteers
5127728|NCT01101308|Healthy subjects|healthy subjects
5127729|NCT01101308|Opioid|opioid
5127730|NCT01101308|Healthy volunteers|healthy volunteers
5127731|NCT01101295|Immune Thrombocytopenia|immune thrombocytopenia
5127732|NCT01101295|Rituximab|rituximab
5127733|NCT01101295|side effects|side effects
5127734|NCT01101295|tolerance|tolerance
5127735|NCT01101295|safety|safety
5127736|NCT01101295|splenectomy|splenectomy
5127737|NCT01101295|serum sickness|serum sickness
5127738|NCT01101282|PEP|pep
5127739|NCT01101282|exacerbation|exacerbation
5127740|NCT01101282|physiotherapy|physiotherapy
5127741|NCT01101282|airway clearance|airway clearance
5127742|NCT01101282|sputum|sputum
5127743|NCT01101282|physical Therapy modalities|physical therapy modalities
5127744|NCT01101269|Diabetic nephropathy|diabetic nephropathy
5127745|NCT01101243|Vitamin D|vitamin d
5127746|NCT01101243|UVB|uvb
5127747|NCT01101243|Frequency|frequency
5127748|NCT01101243|Body surface area|body surface area
5127749|NCT01101243|Dose-Response|dose-response
5127750|NCT01101230|Cardiovascular disease|cardiovascular disease
5127753|NCT01101230|lipoprotein|lipoprotein
5127754|NCT01101230|high-density lipoprotein|high-density lipoprotein
5127755|NCT01101230|triglycerides|triglycerides
5127756|NCT01101217|hemocystein zinc renal failure|hemocystein zinc renal failure
5127757|NCT01101191|Healthy subjects|healthy subjects
5127758|NCT01101191|Opioid|opioid
5127759|NCT01101191|Healthy volunteers|healthy volunteers
5127760|NCT01101178|Healthy subjects|healthy subjects
5127761|NCT01101178|Opioid|opioid
5127762|NCT01101178|Healthy volunteers|healthy volunteers
5127763|NCT01101165|Healthy subjects|healthy subjects
5127764|NCT01101165|Opioid|opioid
5127765|NCT01101165|Healthy volunteers|healthy volunteers
5127766|NCT01101152|Antidepressant|antidepressant
5127767|NCT01101152|healthy volunteers|healthy volunteers
5127768|NCT01101152|desvenlafaxine succinate|desvenlafaxine succinate
5127769|NCT01101152|norepinephrine reuptake|norepinephrine reuptake
5127770|NCT01101152|serotonin reuptake|serotonin reuptake
5127771|NCT01101152|tyramine test|tyramine test
5127772|NCT01101126|Chronic obstructive pulmonary disease (COPD)|chronic obstructive pulmonary disease (copd)
5127773|NCT01101126|Asthma|asthma
5127774|NCT01101113|peritoneal dialysis|peritoneal dialysis
5127775|NCT01101100|Psoriasis|psoriasis
5127776|NCT01101087|Dialysis|dialysis
5127777|NCT01101074|Swine Flu A (H1N1) vaccine|swine flu a (h1n1) vaccine
5127778|NCT01101074|Adjuvanted flu egg derived|adjuvanted flu egg derived
5127779|NCT01101074|Novel influenza A (H1N1): a new flu virus of swine origin|novel influenza a (h1n1): a new flu virus of swine origin
5127780|NCT01101061|Amgen|amgen
5127781|NCT01101061|Phase 1|phase 1
5127782|NCT01101061|Postmenopausal|postmenopausal
5127783|NCT01101061|Japanese|japanese
5127784|NCT01101048|Amgen|amgen
5127785|NCT01101048|Phase 1b|phase 1b
5127786|NCT01101048|Postmenopausal|postmenopausal
5127787|NCT01101048|Bone Mineral Density|bone mineral density
5127788|NCT01101035|Cardiovascular Outcomes|cardiovascular outcomes
5127789|NCT01101035|Heart Attack|heart attack
5127790|NCT01101035|Stroke|stroke
5127791|NCT01101035|Drug Therapy|drug therapy
5127792|NCT01101035|Physiology|physiology
5127793|NCT01101035|Hyperuricemia|hyperuricemia
5127794|NCT01101035|Uric Acid|uric acid
5127795|NCT01101009|Sevikar®|sevikar®
5127796|NCT01101009|Central Arterial Blood Pressure|central arterial blood pressure
5127797|NCT01100996|enteral nutrition|enteral nutrition
5127798|NCT01100996|endotoxemia|endotoxemia
5127799|NCT01100996|innate immunity|innate immunity
5127800|NCT01100996|nutritional anti-inflammatory pathway|nutritional anti-inflammatory pathway
5127802|NCT01100970|Caesarean section|caesarean section
5127803|NCT01100970|cortisol|cortisol
5127804|NCT01100970|stress|stress
5127805|NCT01100970|unipolar electric needle|unipolar electric needle
5127806|NCT01100970|bipolar electric needle|bipolar electric needle
5127807|NCT01100944|Gene Expression|gene expression
5127808|NCT01100944|HDAC Class I and II enzymes|hdac class i and ii enzymes
5127809|NCT01100944|Thymoma|thymoma
5127810|NCT01100944|Chemotherapy|chemotherapy
5127811|NCT01100944|Hydroxamic Acid Deacetylase Inhibitor|hydroxamic acid deacetylase inhibitor
5127812|NCT01100944|Thymic Cancer|thymic cancer
5127813|NCT01100931|NSCLC|nsclc
5127814|NCT01100931|Solid Tumors|solid tumors
5127815|NCT01100931|YM155|ym155
5127816|NCT01100931|Survivin|survivin
5127817|NCT01100931|Non Small-Cell Lung Cancer|non small-cell lung cancer
5127818|NCT01100931|Solid Tumor|solid tumor
5127819|NCT01100918|Cardiac resynchronisation therapy|cardiac resynchronisation therapy
5127820|NCT01100918|Tissue Doppler Imaging|tissue doppler imaging
5127821|NCT01100918|Dyssynchrony|dyssynchrony
5127822|NCT01100905|Iron|iron
5127823|NCT01100905|Iron status|iron status
5127824|NCT01100905|Iron deficiency|iron deficiency
5127825|NCT01100905|Iron deficiency anemia|iron deficiency anemia
5127826|NCT01100892|Pediatrics|pediatrics
5127827|NCT01100892|Pancreas|pancreas
5127828|NCT01100879|Anemia|anemia
5127829|NCT01100879|Lymphoproliferative Disorders|lymphoproliferative disorders
5127830|NCT01100879|Chemotherapy|chemotherapy
5127831|NCT01100879|ferric carboxymaltose|ferric carboxymaltose
5127832|NCT01100879|iron|iron
5127833|NCT01100866|clinically localized Prostate Cancer|clinically localized prostate cancer
5127834|NCT01100866|low and intermediate risk for relapse|low and intermediate risk for relapse
5127835|NCT01100866|candidates for radical prostatectomy|candidates for radical prostatectomy
5127836|NCT01100853|amphetamine dependence|amphetamine dependence
5127837|NCT01100853|amphetamine injection|amphetamine injection
5127838|NCT01100853|VIVITROL/VIVITROL placebo|vivitrol/vivitrol placebo
5127839|NCT01100853|amphetamine craving|amphetamine craving
5127840|NCT01100827|EGFR mutation status in patients with advanced stage adenocarcinoma NSCLC|egfr mutation status in patients with advanced stage adenocarcinoma nsclc
5127841|NCT01100827|The association between EGFR mutation status and demographic data in advanced stage adenocarcinoma NSCLC patients.|the association between egfr mutation status and demographic data in advanced stage adenocarcinoma nsclc patients.
5127842|NCT01100801|advanced|advanced
5127843|NCT01100801|metastatic|metastatic
5127844|NCT01100775|Galantamine|galantamine
5127845|NCT01100775|Schizophrenia|schizophrenia
5127846|NCT01100775|working memory|working memory
5127847|NCT01100775|cognitive|cognitive
5127848|NCT01100762|Parkinson's Disease|parkinson's disease
5127849|NCT01100762|Cranial Electric Stimulation|cranial electric stimulation
5127850|NCT01100762|Gait|gait
5127851|NCT01100749|Hepatitis C|hepatitis c
5127852|NCT01100749|Genotype 3|genotype 3
5127853|NCT01100749|Demographics|demographics
5127854|NCT01100749|Genetics|genetics
5127855|NCT01100749|Metabolic status|metabolic status
5127856|NCT01100736|Forearm Blood Flow|forearm blood flow
5127857|NCT01100736|Vasodilation|vasodilation
5127858|NCT01100736|Vasoconstriction|vasoconstriction
5127859|NCT01100736|Endothelin System|endothelin system
5127860|NCT01100736|Endothelin-1|endothelin-1
5127861|NCT01100736|Endothelin-3|endothelin-3
5127862|NCT01100736|Endothelin antagonists|endothelin antagonists
5127863|NCT01100736|Bosentan|bosentan
5127864|NCT01100736|Sitaxsentan|sitaxsentan
5127865|NCT01100736|Endothelin|endothelin
5127866|NCT01100736|Regional Blood Flow|regional blood flow
5127867|NCT01100723|secondary hyperparathyroidism|secondary hyperparathyroidism
5127868|NCT01100723|calcium|calcium
5127869|NCT01100723|phosphorus|phosphorus
5127870|NCT01100723|ESRD|esrd
5127871|NCT01100723|CKD|ckd
5127872|NCT01100723|mineral disorder|mineral disorder
5127873|NCT01100710|Age Gender left ventricular mass high sensitive Troponin T|age gender left ventricular mass high sensitive troponin t
5127874|NCT01100697|prenatal diagnosis|prenatal diagnosis
5127875|NCT01100697|ultrasound|ultrasound
5127876|NCT01100697|outcome|outcome
5127877|NCT01100697|spina bifida|spina bifida
5127878|NCT01100697|neural tube defect|neural tube defect
5127879|NCT01100684|diarrhea predominant irritable bowel syndrome|diarrhea predominant irritable bowel syndrome
5127880|NCT01100671|atherosclerosis|atherosclerosis
5127881|NCT01100671|vascular inflammation|vascular inflammation
5127882|NCT01100671|MDCT|mdct
5127883|NCT01100671|18FDG-PET|18fdg-pet
5127884|NCT01100606|Exocrine Pancreatic Insufficiency|exocrine pancreatic insufficiency
5127885|NCT01100606|Infants with CF|infants with cf
5127886|NCT01100593|Ultrasound|ultrasound
5127887|NCT01100593|IV catheters|iv catheters
5127888|NCT01100593|Extravasation|extravasation
5127889|NCT01100580|Low-salt diet|low-salt diet
5127890|NCT01100580|calciuria|calciuria
5127891|NCT01100580|blood pressure|blood pressure
5127892|NCT01100580|nephrolithiasis|nephrolithiasis
5127893|NCT01100580|hypertension|hypertension
5127894|NCT01100580|BMI|bmi
5127895|NCT01100580|urinary stone risk factors|urinary stone risk factors
5127896|NCT01100567|skeletal health|skeletal health
5127897|NCT01100567|bone turnover|bone turnover
5127898|NCT01100567|bone geometry|bone geometry
5127899|NCT01100567|malnutrition|malnutrition
5127900|NCT01100541|Therapeutic Hyperthermia|therapeutic hyperthermia
5127901|NCT01100541|Thermotherapy|thermotherapy
5127902|NCT01100541|Polymers|polymers
5127903|NCT01100541|Castor Oil|castor oil
5127904|NCT01100515|intoxication|intoxication
5127905|NCT01100515|carbon monoxide|carbon monoxide
5127906|NCT01100515|adults|adults
5127907|NCT01100515|domestic accident|domestic accident
5127908|NCT01100515|acute domestic carbon monoxide poisoning|acute domestic carbon monoxide poisoning
5127909|NCT01100502|Antigens, CD30|antigens, cd30
5127910|NCT01100502|Antibody-Drug Conjugate|antibody-drug conjugate
5127911|NCT01100502|Antibodies, Monoclonal|antibodies, monoclonal
5127912|NCT01100502|Disease, Hodgkin|disease, hodgkin
5127913|NCT01100502|Drug Therapy|drug therapy
5127914|NCT01100502|Hematologic Diseases|hematologic diseases
5127915|NCT01100502|Immunotherapy|immunotherapy
5127916|NCT01100502|Lymphoma|lymphoma
5127917|NCT01100502|Monomethylauristatin E|monomethylauristatin e
5127918|NCT01100476|Closure Device|closure device
5127919|NCT01100476|endovascular procedures|endovascular procedures
5127920|NCT01100476|sealing femoral arterial access|sealing femoral arterial access
5127921|NCT01100476|Mynx M5|mynx m5
5127922|NCT01100463|HFS, Hand-Foot Syndrome, Capecitabine, Breast Cancer|hfs, hand-foot syndrome, capecitabine, breast cancer
5127923|NCT01100450|bariatric surgery|bariatric surgery
5127924|NCT01100450|class III obesity|class iii obesity
5127925|NCT01100450|resistance training|resistance training
5127926|NCT01100450|strength|strength
5127927|NCT01100450|fitness|fitness
5127928|NCT01100437|opioid|opioid
5127929|NCT01100437|morphine|morphine
5127930|NCT01100437|naltrexone|naltrexone
5127931|NCT01100437|withdrawal signs|withdrawal signs
5127932|NCT01100437|withdrawal symptoms|withdrawal symptoms
5127933|NCT01100424|Contact lenses|contact lenses
5127934|NCT01100424|Contact lens solution|contact lens solution
5127935|NCT01100424|Corneal staining|corneal staining
5127936|NCT01100411|Contact lenses, myopia, lens geometry|contact lenses, myopia, lens geometry
5127937|NCT01100398|Fatty liver disease|fatty liver disease
5127938|NCT01100385|Healthy adults|healthy adults
5127939|NCT01100372|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5127940|NCT01100372|recurrent fallopian tube cancer|recurrent fallopian tube cancer
5127941|NCT01100372|recurrent primary peritoneal cavity cancer|recurrent primary peritoneal cavity cancer
5127942|NCT01100359|endometrial clear cell carcinoma|endometrial clear cell carcinoma
5127943|NCT01100359|recurrent endometrial carcinoma|recurrent endometrial carcinoma
5127944|NCT01100359|stage IIIA endometrial carcinoma|stage iiia endometrial carcinoma
5127945|NCT01100359|stage IIIB endometrial carcinoma|stage iiib endometrial carcinoma
5127946|NCT01100359|stage IIIC endometrial carcinoma|stage iiic endometrial carcinoma
5127947|NCT01100359|stage IVA endometrial carcinoma|stage iva endometrial carcinoma
5127948|NCT01100359|stage IVB endometrial carcinoma|stage ivb endometrial carcinoma
5127949|NCT01100346|Ovulation induction|ovulation induction
5127950|NCT01100346|Intrauterine insemination|intrauterine insemination
5127951|NCT01100346|Gonal-f|gonal-f
5127952|NCT01100346|Controlled ovarian stimulation|controlled ovarian stimulation
5127953|NCT01100346|Infertility|infertility
5127954|NCT01100333|Infertility|infertility
5127955|NCT01100333|Reproductive technologies, Assisted|reproductive technologies, assisted
5127956|NCT01100333|r-hFSH|r-hfsh
5127957|NCT01100333|Gonal-f|gonal-f
5127958|NCT01100320|Healthy subjects|healthy subjects
5127959|NCT01100320|Opioid|opioid
5127960|NCT01100307|diabetic macular edema|diabetic macular edema
5127961|NCT01100307|Macugen|macugen
5127962|NCT01100307|sham-controlled study|sham-controlled study
5127963|NCT01100294|Influenza|influenza
5127964|NCT01100294|Pandemic vaccine|pandemic vaccine
5127965|NCT01100294|Seasonal vaccine|seasonal vaccine
5127966|NCT01100294|Prevention|prevention
5127967|NCT01100294|Influenza vaccine|influenza vaccine
5127968|NCT01100294|Influenza in humans|influenza in humans
5127969|NCT01100294|Pandemic influenza in humans|pandemic influenza in humans
5127970|NCT01100294|Influenza vaccine for children|influenza vaccine for children
5127971|NCT01100281|prefrontal cortex|prefrontal cortex
5127972|NCT01100268|Hoarding|hoarding
5127973|NCT01100255|OCD|ocd
5127974|NCT01100242|Renal Cell Carcinoma|renal cell carcinoma
5127975|NCT01100242|metastatic renal cell cancer|metastatic renal cell cancer
5127976|NCT01100242|kidney cancer|kidney cancer
5127977|NCT01100216|smokeless tobacco|smokeless tobacco
5127978|NCT01100216|nicotine|nicotine
5127979|NCT01100216|snus|snus
5127980|NCT01100216|snuff|snuff
5127981|NCT01100216|chewing tobacco|chewing tobacco
5127982|NCT01100216|oral tobacco|oral tobacco
5127983|NCT01100203|aldosterone receptor inhibition|aldosterone receptor inhibition
5127984|NCT01100203|arterial stiffness|arterial stiffness
5127985|NCT01100203|ambulatory arterial stiffness index|ambulatory arterial stiffness index
5127986|NCT01100190|Facelift|facelift
5127987|NCT01100190|Rhytidectomy|rhytidectomy
5127988|NCT01100190|Ptosis|ptosis
5127989|NCT01100177|Patients with non resectable Glioblastoma who have only a|patients with non resectable glioblastoma who have only a
5127990|NCT01100177|biopsy as surgical treatment|biopsy as surgical treatment
5127991|NCT01100164|INSOMNIA|insomnia
5127992|NCT01100164|FOR THE TREATMENT OF INSOMNIA|for the treatment of insomnia
5127993|NCT01100151|Opioid-induced constipation|opioid-induced constipation
5127994|NCT01100151|RDC-1036|rdc-1036
5127995|NCT01100151|ALKS 37|alks 37
5127996|NCT01100125|Diabetes|diabetes
5127997|NCT01100125|Sitagliptin|sitagliptin
5127998|NCT01100125|insulin|insulin
5127999|NCT01100125|C-peptide|c-peptide
5128000|NCT01100112|ulcerative colitis|ulcerative colitis
5128001|NCT01100112|Budesonide|budesonide
5128002|NCT01100099|Celiac disease.|celiac disease.
5128003|NCT01100099|Food intolerance.|food intolerance.
5128004|NCT01100099|Gluten intolerance without celiac disease.|gluten intolerance without celiac disease.
5128005|NCT01100086|Healthy subjects|healthy subjects
5128006|NCT01100086|Opioid|opioid
5128007|NCT01100060|Azithromycin|azithromycin
5128008|NCT01100060|chloroquine|chloroquine
5128009|NCT01100060|microsphere|microsphere
5128010|NCT01100060|pharmacokinetics|pharmacokinetics
5128011|NCT01100060|bioavailability|bioavailability
5128012|NCT01100047|Phase I|phase i
5128013|NCT01100047|Japanese healthy volunteer|japanese healthy volunteer
5128014|NCT01100047|AZD5069|azd5069
5128015|NCT01100034|pediatric psoriasis|pediatric psoriasis
5128016|NCT01100034|etanercept|etanercept
5128017|NCT01100034|PASS|pass
5128018|NCT01100034|safety|safety
5128019|NCT01100034|effectiveness|effectiveness
5128020|NCT01100008|Pulmonary arterial hypertension|pulmonary arterial hypertension
5128021|NCT01100008|cardiac MRI (magnetic resonance imaging)|cardiac mri (magnetic resonance imaging)
5128022|NCT01100008|severity|severity
5128023|NCT01100008|prognosis|prognosis
5128024|NCT01099995|domestic accident|domestic accident
5128025|NCT01099995|coma|coma
5128026|NCT01099995|carbon monoxide|carbon monoxide
5128027|NCT01099995|intoxication|intoxication
5128028|NCT01099995|acute domestic carbon monoxide poisoning|acute domestic carbon monoxide poisoning
5128029|NCT01099982|Congestive Heart Failure|congestive heart failure
5128030|NCT01099982|Left Ventricular Assist Device|left ventricular assist device
5128031|NCT01099982|LVAD|lvad
5128032|NCT01099982|Myocardium|myocardium
5128033|NCT01099982|Remodeling|remodeling
5128034|NCT01099982|Microvasculature|microvasculature
5128035|NCT01099982|Fibrosis|fibrosis
5128036|NCT01099982|Cardiac Transplant|cardiac transplant
5128037|NCT01099969|Endotrol Endotracheal tube|endotrol endotracheal tube
5128038|NCT01099969|Regular endotracheal tube|regular endotracheal tube
5128039|NCT01099969|gliderite stylet|gliderite stylet
5128040|NCT01099969|McGrath videolaryngoscope|mcgrath videolaryngoscope
5128041|NCT01099969|Glidescope|glidescope
5128042|NCT01099956|type 1 diabetes|type 1 diabetes
5128043|NCT01099956|children|children
5128044|NCT01099956|low grade inflammation|low grade inflammation
5128045|NCT01099956|cytokine|cytokine
5128046|NCT01099956|CRP|crp
5128047|NCT01099930|immunoablation|immunoablation
5128048|NCT01099930|stem cell transplantation|stem cell transplantation
5128049|NCT01099917|MDS|mds
5128050|NCT01099917|Maitake|maitake
5128051|NCT01099917|mushroom|mushroom
5128052|NCT01099917|09-094|09-094
5128053|NCT01099878|Cycling Exercise|cycling exercise
5128054|NCT01099878|Functional Electrical Stimulation|functional electrical stimulation
5128055|NCT01099878|Stroke|stroke
5128056|NCT01099852|dengue|dengue
5128057|NCT01099852|fever|fever
5128058|NCT01099852|dengue hemorrhagic fever|dengue hemorrhagic fever
5128059|NCT01099852|dengue virus|dengue virus
5128060|NCT01099852|Chikungunya virus|chikungunya virus
5128061|NCT01099852|Zika Virus|zika virus
5128062|NCT01099852|Joint pain|joint pain
5128063|NCT01099839|ASP1941|asp1941
5128064|NCT01099839|Miglitol|miglitol
5128065|NCT01099826|colorectal cancer screening|colorectal cancer screening
5128066|NCT01099826|tailored education|tailored education
5128067|NCT01099826|motivational interview|motivational interview
5128068|NCT01099826|patient education|patient education
5128069|NCT01099813|Critical Illness|critical illness
5128070|NCT01099813|Sepsis|sepsis
5128071|NCT01099813|Duration|duration
5128072|NCT01099813|Severity of Illness Scores|severity of illness scores
5128073|NCT01099813|Trajectory|trajectory
5128074|NCT01099800|asthma|asthma
5128075|NCT01099800|health disparities|health disparities
5128076|NCT01099800|illness representations|illness representations
5128077|NCT01099800|CAM|cam
5128078|NCT01099800|Latino|latino
5128079|NCT01099748|Drug interaction|drug interaction
5128080|NCT01099748|pharmacokinetics|pharmacokinetics
5128081|NCT01099748|lersivirine|lersivirine
5128082|NCT01099748|methadone|methadone
5128083|NCT01099735|Bariatric Surgery|bariatric surgery
5128084|NCT01099735|Sleep Apnea|sleep apnea
5128085|NCT01099735|Gastroesophageal Reflux Disease|gastroesophageal reflux disease
5128086|NCT01099735|GERD|gerd
5128087|NCT01099722|moderate to severe persistent reversible asthma|moderate to severe persistent reversible asthma
5128088|NCT01099709|healthy subjects|healthy subjects
5128089|NCT01099709|opioid|opioid
5128090|NCT01099696|abdominal discomfort and bloating|abdominal discomfort and bloating
5128091|NCT01099644|Peritoneum|peritoneum
5128092|NCT01099644|Desmoplastic Small Round Cell Tumors|desmoplastic small round cell tumors
5128093|NCT01099644|Intraperitoneal Radioimmunotherapy|intraperitoneal radioimmunotherapy
5128094|NCT01099644|131 I-8H9|131 i-8h9
5128095|NCT01099644|09-090|09-090
5128096|NCT01099631|Salmonella typhimurium|salmonella typhimurium
5128097|NCT01099631|unresectable hepatic cancer|unresectable hepatic cancer
5128098|NCT01099631|attenuated Salmonella typhimurium|attenuated salmonella typhimurium
5128099|NCT01099631|IL-2|il-2
5128100|NCT01099605|hemorrhoidectomy|hemorrhoidectomy
5128101|NCT01099605|pain management|pain management
5128102|NCT01099579|HIV, Pediatric|hiv, pediatric
5128103|NCT01099566|human endotoxemia|human endotoxemia
5128104|NCT01099566|tissue factor induced coagulation|tissue factor induced coagulation
5128105|NCT01099566|platelet activation|platelet activation
5128106|NCT01099566|thienopyridines|thienopyridines
5128107|NCT01099553|Educational video|educational video
5128108|NCT01099553|colonoscopy|colonoscopy
5128109|NCT01099553|bowel preparation|bowel preparation
5128110|NCT01099553|Bowel preparation for colonoscopy|bowel preparation for colonoscopy
5128111|NCT01099540|neuroendocrine tumor|neuroendocrine tumor
5128112|NCT01099527|gastric cancer|gastric cancer
5128113|NCT01099527|refractory|refractory
5128114|NCT01099527|metastatic|metastatic
5128115|NCT01099501|Mechanical Ventilation|mechanical ventilation
5128116|NCT01099488|Immunological assays|immunological assays
5128117|NCT01099475|liver surgery|liver surgery
5128118|NCT01099475|pringle manoeuvre|pringle manoeuvre
5128119|NCT01099475|hepatocellular damage|hepatocellular damage
5128120|NCT01099475|surgical complications|surgical complications
5128121|NCT01099475|patients requiring liver surgery|patients requiring liver surgery
5128122|NCT01099462|fever|fever
5128123|NCT01099462|Ibuprofen|ibuprofen
5128124|NCT01099449|neurotoxicity|neurotoxicity
5128125|NCT01099449|neuropathy|neuropathy
5128126|NCT01099449|chemotherapeutic agent toxicity|chemotherapeutic agent toxicity
5128127|NCT01099449|stage II colon cancer|stage ii colon cancer
5128128|NCT01099449|stage III colon cancer|stage iii colon cancer
5128129|NCT01099449|stage IV colon cancer|stage iv colon cancer
5128130|NCT01099449|stage II rectal cancer|stage ii rectal cancer
5128131|NCT01099449|stage III rectal cancer|stage iii rectal cancer
5128132|NCT01099449|stage IV rectal cancer|stage iv rectal cancer
5128133|NCT01099449|adenocarcinoma of the colon|adenocarcinoma of the colon
5128134|NCT01099449|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5128135|NCT01099436|HER2-negative breast cancer|her2-negative breast cancer
5128136|NCT01099436|stage II breast cancer|stage ii breast cancer
5128137|NCT01099436|stage IIIA breast cancer|stage iiia breast cancer
5128138|NCT01099436|stage IIIB breast cancer|stage iiib breast cancer
5128139|NCT01099436|stage IIIC breast cancer|stage iiic breast cancer
5128140|NCT01099423|clear cell renal cell carcinoma|clear cell renal cell carcinoma
5128141|NCT01099423|stage IV renal cell cancer|stage iv renal cell cancer
5128637|NCT01097512|AS703569|as703569
5128142|NCT01099410|macrophages, alveolar|macrophages, alveolar
5128143|NCT01099410|monocytes|monocytes
5128144|NCT01099410|Receptor Protein-Tyrosine Kinases|receptor protein-tyrosine kinases
5128145|NCT01099410|Humans|humans
5128146|NCT01099410|Phagocytosis|phagocytosis
5128147|NCT01099410|Lung|lung
5128148|NCT01099410|in vitro|in vitro
5128149|NCT01099397|Glucose|glucose
5128150|NCT01099397|Glucose Tolerance Test|glucose tolerance test
5128151|NCT01099397|Insulin Resistance|insulin resistance
5128152|NCT01099397|Metabolic adverse effects|metabolic adverse effects
5128153|NCT01099397|Hypertension|hypertension
5128154|NCT01099397|Beta-blocker|beta-blocker
5128155|NCT01099397|Atenolol|atenolol
5128156|NCT01099397|Diuretic|diuretic
5128157|NCT01099397|Hydrochlorothiazide|hydrochlorothiazide
5128158|NCT01099397|Blood pressure|blood pressure
5128159|NCT01099371|Knee|knee
5128160|NCT01099371|Osteoarthritis|osteoarthritis
5128161|NCT01099371|Exercise|exercise
5128162|NCT01099358|Cancer of Head|cancer of head
5128163|NCT01099358|Cancer of Head and Neck|cancer of head and neck
5128164|NCT01099358|Cancer of Neck|cancer of neck
5128165|NCT01099358|Cancer of the Head|cancer of the head
5128166|NCT01099358|Cancer of the Head and Neck|cancer of the head and neck
5128167|NCT01099358|Cancer of the Neck|cancer of the neck
5128168|NCT01099358|Head and Neck Cancer|head and neck cancer
5128169|NCT01099358|Head Cancer|head cancer
5128170|NCT01099358|Head Neoplasms|head neoplasms
5128171|NCT01099358|Head, Neck Neoplasms|head, neck neoplasms
5128172|NCT01099358|Neck Cancer|neck cancer
5128173|NCT01099358|Neck Neoplasms|neck neoplasms
5128174|NCT01099358|Solid Neoplasm|solid neoplasm
5128175|NCT01099358|Carcinoma|carcinoma
5128176|NCT01099358|Sarcoma|sarcoma
5128177|NCT01099345|OAB|oab
5128178|NCT01099345|Nocturia|nocturia
5128179|NCT01099345|Bladder function|bladder function
5128180|NCT01099345|cystometry|cystometry
5128181|NCT01099345|polysomnography|polysomnography
5128182|NCT01099332|Alzheimer's disease|alzheimer's disease
5128183|NCT01099332|Mild Cognitive Impairment|mild cognitive impairment
5128184|NCT01099332|Copper metabolism|copper metabolism
5128185|NCT01099332|Zinc metabolism|zinc metabolism
5128186|NCT01099332|Ceruloplasmin|ceruloplasmin
5128187|NCT01099319|Dietary supplement|dietary supplement
5128188|NCT01099319|Renalof|renalof
5128189|NCT01099319|gallstones|gallstones
5128190|NCT01099319|elderly|elderly
5128191|NCT01099293|Hepatic Encephalopathy|hepatic encephalopathy
5128192|NCT01099293|Psychometric Hepatic Encephalopathy Score|psychometric hepatic encephalopathy score
5128193|NCT01099293|Critical Flicker Frequency|critical flicker frequency
5128194|NCT01099293|Cerebrovascular Reactivity|cerebrovascular reactivity
5128195|NCT01099293|Endotoxemia|endotoxemia
5128196|NCT01099293|Transcranial Doppler|transcranial doppler
5128197|NCT01099293|Liver Cirrhosis|liver cirrhosis
5128198|NCT01099280|induction of labor in term|induction of labor in term
5128199|NCT01099280|premature rupture of membranes|premature rupture of membranes
5128200|NCT01099280|dinoprostone|dinoprostone
5128201|NCT01099280|oxytocin|oxytocin
5128202|NCT01099267|MDS|mds
5128203|NCT01099254|CVP|cvp
5128204|NCT01099254|US|us
5128205|NCT01099254|Trendelenburg position|trendelenburg position
5128206|NCT01099254|Ultrasound|ultrasound
5128207|NCT01099254|Head Down Tilt|head down tilt
5128208|NCT01099241|CVP|cvp
5128209|NCT01099241|US|us
5128210|NCT01099241|Ultrasonography|ultrasonography
5128211|NCT01099228|Neuroendocrine Tumor|neuroendocrine tumor
5128212|NCT01099228|Imaging|imaging
5128213|NCT01099215|peripheral artery disease|peripheral artery disease
5128214|NCT01099215|percutaneous transluminal angioplasty|percutaneous transluminal angioplasty
5128215|NCT01099215|stent|stent
5128216|NCT01099215|balloon/stent|balloon/stent
5128217|NCT01099215|superficial femoral artery|superficial femoral artery
5128218|NCT01099202|Procrit|procrit
5128219|NCT01099202|Acute Lymphocytic Leukemia|acute lymphocytic leukemia
5128220|NCT01099202|Lymphoblastic Lymphoma|lymphoblastic lymphoma
5128221|NCT01099202|Burkitt's|burkitt's
5128222|NCT01099202|Chemotherapy|chemotherapy
5128223|NCT01099202|Hyper-CVAD|hyper-cvad
5128224|NCT01099202|augmented BFM|augmented bfm
5128225|NCT01099202|Epoetin alfa|epoetin alfa
5128226|NCT01099202|Epogen|epogen
5128227|NCT01099202|Erythropoietin|erythropoietin
5128228|NCT01099189|Histology|histology
5128229|NCT01099189|Compliance|compliance
5128230|NCT01099189|Dialysis|dialysis
5128231|NCT01099189|Arteriovenous access fistula|arteriovenous access fistula
5128232|NCT01099189|vein|vein
5128233|NCT01099176|hyperlipidemia|hyperlipidemia
5128234|NCT01099176|impaired fasting glycemia|impaired fasting glycemia
5128235|NCT01099176|adipokines|adipokines
5128236|NCT01099176|atorvastatin|atorvastatin
5128237|NCT01099176|fenofibrate|fenofibrate
5128238|NCT01099163|Diabetes mellitus|diabetes mellitus
5128239|NCT01099163|CLA|cla
5128240|NCT01099163|Antioxidant|antioxidant
5128241|NCT01099163|Glycemic control|glycemic control
5128242|NCT01099150|Platelets|platelets
5128243|NCT01099150|Platelet aggregation|platelet aggregation
5128244|NCT01099150|Platelet activation|platelet activation
5128245|NCT01099150|Platelet function|platelet function
5128638|NCT01097512|MSC1992371A|msc1992371a
5128246|NCT01099150|Light transmission aggregometry|light transmission aggregometry
5128247|NCT01099150|Platelet Function Analyzer-100 (PFA-100)|platelet function analyzer-100 (pfa-100)
5128248|NCT01099150|P-selectin|p-selectin
5128249|NCT01099150|Fibrinogen receptor|fibrinogen receptor
5128250|NCT01099150|Glycoprotein IIb-IIIa|glycoprotein iib-iiia
5128251|NCT01099150|Chocolate|chocolate
5128252|NCT01099150|Cocoa|cocoa
5128253|NCT01099150|Flavan-3-ols|flavan-3-ols
5128254|NCT01099150|Procyanidins|procyanidins
5128255|NCT01099137|Diabetes|diabetes
5128256|NCT01099137|Vildagliptin|vildagliptin
5128257|NCT01099137|insulin|insulin
5128258|NCT01099137|C-peptide|c-peptide
5128259|NCT01099124|M2ES|m2es
5128260|NCT01099124|NSCLC|nsclc
5128261|NCT01099124|Phase I Trial|phase i trial
5128262|NCT01099124|Advanced NSCLC|advanced nsclc
5128263|NCT01099124|Recurrent NSCLC|recurrent nsclc
5128264|NCT01099111|IBS|ibs
5128265|NCT01099111|UC|uc
5128266|NCT01099111|CD|cd
5128267|NCT01099111|CRAP/CRC|crap/crc
5128268|NCT01099098|People who have fibrosis or nodules in their upper lobe of the lung|people who have fibrosis or nodules in their upper lobe of the lung
5128269|NCT01099085|gastric cancer, unresectable/metastatic|gastric cancer, unresectable/metastatic
5128270|NCT01099072|ADHD|adhd
5128271|NCT01099072|carnitine|carnitine
5128272|NCT01099072|methylphenidate|methylphenidate
5128273|NCT01099059|Attention-deficit/hyperactivity disorder|attention-deficit/hyperactivity disorder
5128274|NCT01099059|Clinical Trial|clinical trial
5128275|NCT01099059|Amantadine|amantadine
5128276|NCT01099059|Methylphenidate|methylphenidate
5128277|NCT01099046|Meniere's disease|meniere's disease
5128278|NCT01099046|stress management|stress management
5128279|NCT01099046|vasopressin|vasopressin
5128280|NCT01099046|V2 receptor|v2 receptor
5128281|NCT01099046|water intake|water intake
5128282|NCT01099046|tympanic tubing|tympanic tubing
5128283|NCT01099046|regular sleep under dark|regular sleep under dark
5128284|NCT01099033|hiatal hernia|hiatal hernia
5128285|NCT01099033|paraesophageal hernia|paraesophageal hernia
5128286|NCT01099033|biologic mesh|biologic mesh
5128287|NCT01099033|MMPs|mmps
5128288|NCT01099033|Hiatal/Paraesophageal hernia|hiatal/paraesophageal hernia
5128289|NCT01099020|Subjects receiving large volumes of Radiation|subjects receiving large volumes of radiation
5128290|NCT01099007|Women|women
5128291|NCT01099007|Menopause|menopause
5128292|NCT01099007|Cardiovascular Disease|cardiovascular disease
5128293|NCT01099007|Physical Activity|physical activity
5128294|NCT01099007|Weight Loss|weight loss
5128295|NCT01098994|Type 1 diabetes|type 1 diabetes
5128296|NCT01098994|Haptoglobin genotype|haptoglobin genotype
5128297|NCT01098994|HDL function|hdl function
5128298|NCT01098994|Heart disease|heart disease
5128299|NCT01098994|Feasibility of clinical trial|feasibility of clinical trial
5128300|NCT01098955|Cancer|cancer
5128301|NCT01098955|Smoking Cessation Treatment|smoking cessation treatment
5128302|NCT01098955|Acceptance and Commitment Therapy|acceptance and commitment therapy
5128303|NCT01098955|ACT Theory|act theory
5128304|NCT01098955|Motivational and Behavioral Counseling|motivational and behavioral counseling
5128305|NCT01098955|MBC|mbc
5128306|NCT01098955|abstinence|abstinence
5128307|NCT01098955|Varenicline|varenicline
5128308|NCT01098955|Chantix|chantix
5128309|NCT01098942|bariatric surgery|bariatric surgery
5128310|NCT01098929|genes|genes
5128311|NCT01098929|genetic|genetic
5128312|NCT01098929|chromosome|chromosome
5128313|NCT01098929|chromosome microarray|chromosome microarray
5128314|NCT01098916|hospital at home|hospital at home
5128315|NCT01098916|radiology at home|radiology at home
5128316|NCT01098916|frail elderly|frail elderly
5128317|NCT01098903|sunitinib|sunitinib
5128318|NCT01098903|cancer|cancer
5128319|NCT01098903|pharmacogenomics|pharmacogenomics
5128320|NCT01098903|pharmacokinetics|pharmacokinetics
5128321|NCT01098903|Patients who have a malignancy and are going to be treated with sunitinib|patients who have a malignancy and are going to be treated with sunitinib
5128322|NCT01098903|doseindividualism|doseindividualism
5128323|NCT01098877|Phase1|phase1
5128324|NCT01098877|pharmacokinetics|pharmacokinetics
5128325|NCT01098877|safety|safety
5128326|NCT01098877|toleration|toleration
5128327|NCT01098877|pharmacodynamics|pharmacodynamics
5128328|NCT01098864|Behavior|behavior
5128329|NCT01098864|Impulsivity|impulsivity
5128330|NCT01098864|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
5128331|NCT01098851|Obstructive Sleep Apnea|obstructive sleep apnea
5128332|NCT01098851|Pulse Oximetry|pulse oximetry
5128333|NCT01098838|Cancer|cancer
5128334|NCT01098838|adults|adults
5128335|NCT01098838|solid tumor|solid tumor
5128336|NCT01098838|apoptosis|apoptosis
5128337|NCT01098838|programmed cell death|programmed cell death
5128338|NCT01098838|LCL161|lcl161
5128339|NCT01098825|vaccine hesitancy|vaccine hesitancy
5128340|NCT01098825|vaccine refusal|vaccine refusal
5128341|NCT01098812|Cataract, Intraocular lens|cataract, intraocular lens
5128342|NCT01098799|Urotensin II,Chronic renal disease|urotensin ii,chronic renal disease
5128343|NCT01098786|Influenza A|influenza a
5128344|NCT01098786|H1N1 subtype|h1n1 subtype
5128345|NCT01098786|Vaccine|vaccine
5128346|NCT01098786|Adjuvant|adjuvant
5128347|NCT01098786|Cell culture|cell culture
5128348|NCT01098773|Weaning from mechanical ventilation|weaning from mechanical ventilation
5128349|NCT01098773|BNP|bnp
5128350|NCT01098773|Lung ultrasound|lung ultrasound
5128351|NCT01098773|Echocardiography|echocardiography
5128352|NCT01098760|Sorafenib|sorafenib
5128353|NCT01098760|Hepatocellular Carcinoma (HCC)|hepatocellular carcinoma (hcc)
5128354|NCT01098747|Pain following third molar extraction|pain following third molar extraction
5128355|NCT01098734|non-steroid|non-steroid
5128356|NCT01098734|anti-inflammatory|anti-inflammatory
5128357|NCT01098734|skin disease|skin disease
5128358|NCT01098734|topical cream|topical cream
5128359|NCT01098734|small molecule|small molecule
5128360|NCT01098734|atopic dermatitis|atopic dermatitis
5128361|NCT01098734|eczema|eczema
5128362|NCT01098721|plaque psoriasis|plaque psoriasis
5128363|NCT01098721|skin diseases|skin diseases
5128364|NCT01098721|anti-inflammatory|anti-inflammatory
5128365|NCT01098721|non-steroid|non-steroid
5128366|NCT01098721|topical cream|topical cream
5128367|NCT01098708|DMD|dmd
5128368|NCT01098708|non ambulatory|non ambulatory
5128369|NCT01098695|parenting interventions|parenting interventions
5128370|NCT01098695|Family Check-Up|family check-up
5128371|NCT01098695|Early Intervention|early intervention
5128372|NCT01098695|Self-Regulation|self-regulation
5128373|NCT01098669|cancer survivor|cancer survivor
5128374|NCT01098669|lymphedema|lymphedema
5128375|NCT01098669|head and neck cancer|head and neck cancer
5128376|NCT01098656|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
5128377|NCT01098656|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
5128378|NCT01098656|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
5128379|NCT01098656|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
5128380|NCT01098656|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
5128381|NCT01098656|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
5128382|NCT01098643|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5128383|NCT01098617|endoscopic sphincterotomy|endoscopic sphincterotomy
5128384|NCT01098617|hemorrhage|hemorrhage
5128385|NCT01098617|nonsteroidal antiinflammatory agents|nonsteroidal antiinflammatory agents
5128386|NCT01098617|antiaggregants|antiaggregants
5128387|NCT01098617|anticoagulants|anticoagulants
5128388|NCT01098617|Endoscopic biliary sphincterotomy induced bleeding|endoscopic biliary sphincterotomy induced bleeding
5128389|NCT01098591|meta-analysis|meta-analysis
5128390|NCT01098591|stem cell|stem cell
5128391|NCT01098591|cardiac|cardiac
5128392|NCT01098591|remodeling|remodeling
5128393|NCT01098591|MESS|mess
5128394|NCT01098578|Posterior Epistaxis|posterior epistaxis
5128395|NCT01098552|Prostate Cancer|prostate cancer
5128396|NCT01098539|sitagliptin|sitagliptin
5128397|NCT01098539|albiglutide|albiglutide
5128398|NCT01098539|renal impairment|renal impairment
5128399|NCT01098526|GSK1349572|gsk1349572
5128400|NCT01098526|efavirenz|efavirenz
5128401|NCT01098526|integrase|integrase
5128402|NCT01098526|pharmacokinetics|pharmacokinetics
5128403|NCT01098513|HIV|hiv
5128404|NCT01098513|healthy|healthy
5128405|NCT01098513|GSK1349572|gsk1349572
5128406|NCT01098500|Liver function|liver function
5128407|NCT01098500|Tyrosine Kinase Inhibitor|tyrosine kinase inhibitor
5128408|NCT01098487|Immune (idiopathic) thrombocytopenic purpura (ITP)|immune (idiopathic) thrombocytopenic purpura (itp)
5128409|NCT01098487|bone marrow fibers|bone marrow fibers
5128410|NCT01098487|eltrombopag olamine|eltrombopag olamine
5128411|NCT01098487|thrombopoietin receptor agonist|thrombopoietin receptor agonist
5128412|NCT01098474|Tuberculosis vaccine|tuberculosis vaccine
5128413|NCT01098461|dose-ranging|dose-ranging
5128414|NCT01098461|pharmacokinetics|pharmacokinetics
5128415|NCT01098461|GSK716155|gsk716155
5128416|NCT01098461|Japan|japan
5128417|NCT01098461|albiglutide|albiglutide
5128418|NCT01098448|Amoxicillin|amoxicillin
5128419|NCT01098448|antibiotics|antibiotics
5128420|NCT01098448|chronic periodontitis|chronic periodontitis
5128421|NCT01098448|local drug delivery|local drug delivery
5128422|NCT01098448|metronidazol|metronidazol
5128423|NCT01098448|randomized controlled trial|randomized controlled trial
5128424|NCT01098448|subgingival scaling|subgingival scaling
5128425|NCT01098448|surgery|surgery
5128426|NCT01098448|tetracycline|tetracycline
5128427|NCT01098448|moderate to advanced chronic periodontitis|moderate to advanced chronic periodontitis
5128428|NCT01098435|Binge eating disorder|binge eating disorder
5128429|NCT01098435|RDC-0313|rdc-0313
5128430|NCT01098422|liver|liver
5128431|NCT01098422|colorectal|colorectal
5128432|NCT01098422|metastasis|metastasis
5128433|NCT01098422|carcinoma|carcinoma
5128434|NCT01098422|Yttrium-90|yttrium-90
5128435|NCT01098422|microspheres|microspheres
5128436|NCT01098409|sodium nitrite|sodium nitrite
5128437|NCT01098409|coronary artery bypass surgery|coronary artery bypass surgery
5128438|NCT01098409|cardioprotection|cardioprotection
5128439|NCT01098409|myocardial injury|myocardial injury
5128440|NCT01098396|parkinson disease|parkinson disease
5128441|NCT01098396|gait|gait
5128442|NCT01098383|Autism|autism
5128443|NCT01098357|rhPDGF, diabetic foot ulcer,|rhpdgf, diabetic foot ulcer,
5128444|NCT01098344|stage III pancreatic cancer|stage iii pancreatic cancer
5128445|NCT01098344|stage IV pancreatic cancer|stage iv pancreatic cancer
5128446|NCT01098344|duct cell adenocarcinoma of the pancreas|duct cell adenocarcinoma of the pancreas
5128447|NCT01098331|stage I prostate cancer|stage i prostate cancer
5128448|NCT01098331|stage IIB prostate cancer|stage iib prostate cancer
5128449|NCT01098331|stage IIA prostate cancer|stage iia prostate cancer
5128450|NCT01098318|Depression|depression
5128451|NCT01098318|Antidepressant Therapy|antidepressant therapy
5128452|NCT01098318|Herbal Treatment|herbal treatment
5128453|NCT01098318|Rhodiola rosea|rhodiola rosea
5128454|NCT01098318|Alternative Therapy|alternative therapy
5128455|NCT01098305|nicotine smokeless tobacco chewing tobacco varenicline|nicotine smokeless tobacco chewing tobacco varenicline
5128456|NCT01098292|Fibromyalgia|fibromyalgia
5128457|NCT01098292|Irritable Bowel Syndrome|irritable bowel syndrome
5128458|NCT01098292|Chronic Fatigue Syndrome|chronic fatigue syndrome
5128459|NCT01098292|Interstitial Cystitis|interstitial cystitis
5128460|NCT01098292|Chronic Prostatitis|chronic prostatitis
5128461|NCT01098292|Urological Chronic Pelvic Pain|urological chronic pelvic pain
5128462|NCT01098292|Painful Bladder Syndrome|painful bladder syndrome
5128463|NCT01098279|Interstitial Cystitis|interstitial cystitis
5128464|NCT01098279|Chronic Prostatitis|chronic prostatitis
5128465|NCT01098279|Urological Chronic Pelvic Pain|urological chronic pelvic pain
5128466|NCT01098279|Painful Bladder Syndrome|painful bladder syndrome
5128467|NCT01098266|MPM|mpm
5128468|NCT01098266|NGR-hTNF|ngr-htnf
5128469|NCT01098266|NGR-hTNF plus BIC|ngr-htnf plus bic
5128470|NCT01098266|Randomized double-blind phase III study|randomized double-blind phase iii study
5128471|NCT01098253|adherence|adherence
5128472|NCT01098253|diabetes mellitus|diabetes mellitus
5128473|NCT01098253|depression|depression
5128474|NCT01098253|primary health care|primary health care
5128475|NCT01098240|Antidepressant Augmentation|antidepressant augmentation
5128476|NCT01098227|RSV Bronchiolitis|rsv bronchiolitis
5128477|NCT01098227|Lower Respiratory Viral infection|lower respiratory viral infection
5128478|NCT01098227|Exhaled Nitric Oxide|exhaled nitric oxide
5128479|NCT01098214|Normal pregnancy|normal pregnancy
5128480|NCT01098214|Amniotic fluid|amniotic fluid
5128481|NCT01098214|Cytokines|cytokines
5128482|NCT01098214|Biomarkers|biomarkers
5128483|NCT01098201|Certolizumab|certolizumab
5128484|NCT01098201|TNF|tnf
5128485|NCT01098201|RA|ra
5128486|NCT01098201|Cizmia|cizmia
5128487|NCT01098175|laparotomy|laparotomy
5128488|NCT01098175|thoracotomy|thoracotomy
5128489|NCT01098175|peritoneal conditioning|peritoneal conditioning
5128490|NCT01098175|humidification|humidification
5128491|NCT01098175|temperature control|temperature control
5128492|NCT01098162|Lacosamide|lacosamide
5128493|NCT01098162|Vimpat®|vimpat®
5128494|NCT01098162|Epilepsy|epilepsy
5128495|NCT01098162|Partial-Onset Seizures|partial-onset seizures
5128496|NCT01098162|Adjunctive therapy|adjunctive therapy
5128497|NCT01098149|Haemodialysis treatment tolerance|haemodialysis treatment tolerance
5128498|NCT01098149|acetate free biofiltration|acetate free biofiltration
5128499|NCT01098149|frequency of hypotensive events during dialysis|frequency of hypotensive events during dialysis
5128500|NCT01098149|nurse intervention during dialysis|nurse intervention during dialysis
5128501|NCT01098136|Pelvic girdle pain|pelvic girdle pain
5128502|NCT01098136|Chiropractic|chiropractic
5128503|NCT01098136|Single-blinded|single-blinded
5128504|NCT01098136|Outcome study|outcome study
5128505|NCT01098084|Decitabine, chronic myelomonocytic leukemia|decitabine, chronic myelomonocytic leukemia
5128506|NCT01098058|Adult attention deficit hyperactivity disorder|adult attention deficit hyperactivity disorder
5128507|NCT01098058|cognitive-behavioural therapy|cognitive-behavioural therapy
5128508|NCT01098058|randomised controlled trial|randomised controlled trial
5128509|NCT01098045|HIV|hiv
5128510|NCT01098045|fat redistribution|fat redistribution
5128511|NCT01098045|brown adipose tissue|brown adipose tissue
5128512|NCT01098045|PET|pet
5128513|NCT01098032|Contrast media|contrast media
5128514|NCT01098032|Kidney|kidney
5128515|NCT01098032|Complication|complication
5128516|NCT01098019|Notalgia paresthetica|notalgia paresthetica
5128517|NCT01098019|Xeomin|xeomin
5128518|NCT01098019|Botulinum Toxin A|botulinum toxin a
5128519|NCT01098019|Pruritus|pruritus
5128520|NCT01098019|Upper Back|upper back
5128521|NCT01098019|Hyperpigmentation|hyperpigmentation
5128522|NCT01098006|Immunological assays|immunological assays
5128523|NCT01098006|Chronic hepatitis B|chronic hepatitis b
5128524|NCT01097980|trazodone|trazodone
5128525|NCT01097980|SSRI|ssri
5128526|NCT01097980|sexual dysfunction|sexual dysfunction
5128527|NCT01097980|5-HT2A polymorphism|5-ht2a polymorphism
5128528|NCT01097967|Sleep disordered breathing|sleep disordered breathing
5128529|NCT01097967|Continuous Positive Airway Pressure|continuous positive airway pressure
5128530|NCT01097967|Sleep apnoea|sleep apnoea
5128531|NCT01097967|Markers of atherosclerosis|markers of atherosclerosis
5128532|NCT01097954|Exercise induced asthma|exercise induced asthma
5128533|NCT01097954|Exercise induced bronchospasm|exercise induced bronchospasm
5128534|NCT01097954|exhaled Nitric Oxide|exhaled nitric oxide
5128535|NCT01097941|Influenza|influenza
5128536|NCT01097941|H1N1|h1n1
5128537|NCT01097915|PROP taste sensitivity|prop taste sensitivity
5128538|NCT01097915|Gustin (CAVI) polymorphism|gustin (cavi) polymorphism
5128539|NCT01097915|Salivary zinc|salivary zinc
5128540|NCT01097915|BMI|bmi
5128541|NCT01097915|Electrophysiological recording from the tongue|electrophysiological recording from the tongue
5128542|NCT01097889|United Nations World Food Programme|united nations world food programme
5128543|NCT01097889|blended food (CSB)|blended food (csb)
5128544|NCT01097889|ready-to-use supplementary foods (RUSF)|ready-to-use supplementary foods (rusf)
5128545|NCT01097889|Plumpy®|plumpy®
5128546|NCT01097876|healthy volunteer|healthy volunteer
5128547|NCT01097876|pharmacokinetic|pharmacokinetic
5128548|NCT01097876|safety|safety
5128549|NCT01097850|hand foot skin syndrome|hand foot skin syndrome
5128550|NCT01097850|palmar plantar erythrodysesthesia|palmar plantar erythrodysesthesia
5128551|NCT01097850|doxorubicin|doxorubicin
5128552|NCT01097850|capecitabine|capecitabine
5128553|NCT01097837|Epilepsy|epilepsy
5128554|NCT01097837|Contraceptive|contraceptive
5128555|NCT01097837|Birth Control|birth control
5128556|NCT01097837|Seizure|seizure
5128557|NCT01097837|This study is looking at the use of different birth control measures in women with epilepsy.|this study is looking at the use of different birth control measures in women with epilepsy.
5128558|NCT01097811|Hepatic Encephalopathy|hepatic encephalopathy
5128559|NCT01097811|Hypertension, Portal|hypertension, portal
5128560|NCT01097811|Liver Cirrhosis|liver cirrhosis
5128561|NCT01097811|Bacterial Overgrowth Syndrome|bacterial overgrowth syndrome
5128562|NCT01097798|muscle injury|muscle injury
5128563|NCT01097772|abdominal|abdominal
5128564|NCT01097772|aortic|aortic
5128565|NCT01097772|aneurysm|aneurysm
5128566|NCT01097759|hemorrhoids|hemorrhoids
5128567|NCT01097759|prolapsed|prolapsed
5128568|NCT01097759|hemorrhoidectomy|hemorrhoidectomy
5128569|NCT01097759|Hemorrhoidopexy|hemorrhoidopexy
5128570|NCT01097759|LigaSure|ligasure
5128571|NCT01097759|Stapled|stapled
5128572|NCT01097746|Cancer|cancer
5128573|NCT01097746|Fallopian Tube|fallopian tube
5128574|NCT01097746|Ovary|ovary
5128575|NCT01097746|Peritoneum|peritoneum
5128576|NCT01097746|Epithelial ovarian|epithelial ovarian
5128577|NCT01097746|Paclitaxel|paclitaxel
5128578|NCT01097746|Carboplatin|carboplatin
5128579|NCT01097746|Bevacizumab|bevacizumab
5128580|NCT01097746|Taxol|taxol
5128581|NCT01097746|Avastin|avastin
5128582|NCT01097746|Paraplatin|paraplatin
5128583|NCT01097746|Carcinoma|carcinoma
5128584|NCT01097746|Surgery|surgery
5128585|NCT01097720|Valproate|valproate
5128586|NCT01097720|Lamotrigine|lamotrigine
5128587|NCT01097720|Carbamazepine|carbamazepine
5128588|NCT01097720|Anticonvulsant|anticonvulsant
5128589|NCT01097720|Antiepileptic|antiepileptic
5128590|NCT01097720|Teratogen|teratogen
5128591|NCT01097720|Autism|autism
5128592|NCT01097720|Developmental Delay|developmental delay
5128593|NCT01097694|cKIT inhibition in Asthma|ckit inhibition in asthma
5128594|NCT01097694|Efficacy of Imatinib in severe resistent asthma.|efficacy of imatinib in severe resistent asthma.
5128595|NCT01097681|ASP1941|asp1941
5128596|NCT01097681|Diabetes mellitus|diabetes mellitus
5128597|NCT01097681|Urinary glucose excretion|urinary glucose excretion
5128598|NCT01097668|Multiple sclerosis|multiple sclerosis
5128599|NCT01097668|Immunomodulation|immunomodulation
5128600|NCT01097668|Phase 1|phase 1
5128601|NCT01097655|Tablets|tablets
5128602|NCT01097655|Infection|infection
5128603|NCT01097655|Non Nucleoside Reverse Transcriptase Inhibitor|non nucleoside reverse transcriptase inhibitor
5128604|NCT01097655|Tolerability|tolerability
5128605|NCT01097655|Viral load|viral load
5128606|NCT01097655|Human immunodeficiency Virus|human immunodeficiency virus
5128607|NCT01097655|Effectiveness|effectiveness
5128608|NCT01097655|Treatment-naïve|treatment-naïve
5128609|NCT01097603|Non-Invasive Blood Pressure|non-invasive blood pressure
5128610|NCT01097590|ulcerative colitis|ulcerative colitis
5128611|NCT01097590|leukapheresis treatment|leukapheresis treatment
5128612|NCT01097577|photorefractive keratectomy|photorefractive keratectomy
5128613|NCT01097577|excimer laser|excimer laser
5128614|NCT01097577|PRK|prk
5128615|NCT01097577|pain, postoperative|pain, postoperative
5128616|NCT01097577|pregabalin|pregabalin
5128617|NCT01097564|Genetic|genetic
5128618|NCT01097564|Cerebral angiopathy|cerebral angiopathy
5128619|NCT01097564|Retinal angiopathy|retinal angiopathy
5128620|NCT01097564|COL4A1 gene|col4a1 gene
5128621|NCT01097564|Infantile Cerebral Palsy|infantile cerebral palsy
5128622|NCT01097564|Congenital porencephaly|congenital porencephaly
5128623|NCT01097564|Congenital cataract|congenital cataract
5128624|NCT01097564|Leukoencephalopathy|leukoencephalopathy
5128625|NCT01097564|COL4A1 gene related cerebra-retinal angiopathy|col4a1 gene related cerebra-retinal angiopathy
5128626|NCT01097551|Type 1 diabetes mellitus|type 1 diabetes mellitus
5128627|NCT01097551|Diabetic retinopathy|diabetic retinopathy
5128628|NCT01097551|Pathogenesis|pathogenesis
5128629|NCT01097551|Dynamic Vessel Analyser|dynamic vessel analyser
5128630|NCT01097551|Endothelial dysfunction|endothelial dysfunction
5128631|NCT01097538|exercise|exercise
5128632|NCT01097538|rehabilitation|rehabilitation
5128633|NCT01097538|progressive multiple sclerosis|progressive multiple sclerosis
5128634|NCT01097538|functional ability|functional ability
5128635|NCT01097538|fatigue|fatigue
5128636|NCT01097538|quality of life|quality of life
5128639|NCT01097512|Aurora kinase inhibitor|aurora kinase inhibitor
5128640|NCT01097512|Cancer treatable with gemcitabine|cancer treatable with gemcitabine
5128641|NCT01097499|Dental implant initial stability|dental implant initial stability
5128642|NCT01097499|Initial bone resorption post implant placement|initial bone resorption post implant placement
5128643|NCT01097499|Analgesia effect of LED intervention|analgesia effect of led intervention
5128644|NCT01097486|Cervical Degenerative Disc Disease|cervical degenerative disc disease
5128645|NCT01097486|Degenerative Spondylolisthesis|degenerative spondylolisthesis
5128646|NCT01097486|Spinal Stenosis|spinal stenosis
5128647|NCT01097486|Stem cells|stem cells
5128648|NCT01097486|Adult Stem Cells|adult stem cells
5128649|NCT01097486|Anterior cervical discectomy and Fusion (ACDF)|anterior cervical discectomy and fusion (acdf)
5128650|NCT01097486|Cervical Allograft Spacer|cervical allograft spacer
5128651|NCT01097486|Anterior Cervical Plate Fixation|anterior cervical plate fixation
5128652|NCT01097460|HER2/HER3|her2/her3
5128653|NCT01097460|Bispecific Antibody|bispecific antibody
5128654|NCT01097460|Breast Cancer|breast cancer
5128655|NCT01097460|Advanced Breast Cancer|advanced breast cancer
5128656|NCT01097460|Metastatic Breast Cancer|metastatic breast cancer
5128657|NCT01097460|HER2 Positive Breast Cancer|her2 positive breast cancer
5128658|NCT01097460|Trastuzumab|trastuzumab
5128659|NCT01097460|Herceptin|herceptin
5128660|NCT01097447|Diagnosis of keratoconus, post-LASIK ectasia, FFKC, or pellucid marginal degeneration|diagnosis of keratoconus, post-lasik ectasia, ffkc, or pellucid marginal degeneration
5128661|NCT01097395|ribavirin|ribavirin
5128662|NCT01097395|pharmacokinetics|pharmacokinetics
5128663|NCT01097395|Hepatitis C virus|hepatitis c virus
5128664|NCT01097343|Clopidogrel pharmacogenomics study|clopidogrel pharmacogenomics study
5128665|NCT01097343|Performing genetic study looking at clopidogrel resistance|performing genetic study looking at clopidogrel resistance
5128666|NCT01097330|Defibrillators, Implantable|defibrillators, implantable
5128667|NCT01097330|Tachycardia, Ventricular|tachycardia, ventricular
5128668|NCT01097330|Catheter Ablation|catheter ablation
5128669|NCT01097330|Amiodarone|amiodarone
5128670|NCT01097317|chemotherapeutic agent toxicity|chemotherapeutic agent toxicity
5128671|NCT01097317|musculoskeletal complications|musculoskeletal complications
5128672|NCT01097317|fatigue|fatigue
5128673|NCT01097317|stage I non-small cell lung cancer|stage i non-small cell lung cancer
5128674|NCT01097317|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
5128675|NCT01097317|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5128676|NCT01097317|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5128677|NCT01097317|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5128678|NCT01097317|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5128679|NCT01097278|breast cancer|breast cancer
5128680|NCT01097278|ductal breast carcinoma in situ|ductal breast carcinoma in situ
5128681|NCT01097278|lobular breast carcinoma in situ|lobular breast carcinoma in situ
5128682|NCT01097278|BRCA1 mutation carrier|brca1 mutation carrier
5128683|NCT01097278|BRCA2 mutation carrier|brca2 mutation carrier
5128684|NCT01097265|stage I colon cancer|stage i colon cancer
5128685|NCT01097265|stage II colon cancer|stage ii colon cancer
5128686|NCT01097252|Cervical Neoplasm|cervical neoplasm
5128687|NCT01097252|chemoradiation|chemoradiation
5128688|NCT01097252|compliance|compliance
5128689|NCT01097252|toxicity|toxicity
5128690|NCT01097239|High Intensity Focused Ultrasound|high intensity focused ultrasound
5128691|NCT01097239|HIFU|hifu
5128692|NCT01097239|Rectal Cancer|rectal cancer
5128693|NCT01097239|Sonablate 500|sonablate 500
5128694|NCT01097239|Transrectal|transrectal
5128695|NCT01097226|Dietary intervention|dietary intervention
5128696|NCT01097226|bioavailability|bioavailability
5128697|NCT01097226|Healthy volunteers|healthy volunteers
5128698|NCT01097200|sacrocolpopexy|sacrocolpopexy
5128699|NCT01097200|meshes|meshes
5128700|NCT01097200|sacrospinous ligament|sacrospinous ligament
5128701|NCT01097174|Glaucoma|glaucoma
5128702|NCT01097174|Glaucoma device|glaucoma device
5128703|NCT01097174|Glaucoma surgery|glaucoma surgery
5128704|NCT01097174|Intraocular pressure|intraocular pressure
5128705|NCT01097161|Stuttering|stuttering
5128706|NCT01097161|Apraxia of speech|apraxia of speech
5128707|NCT01097161|Motor control|motor control
5128708|NCT01097161|Prosody|prosody
5128709|NCT01097161|Pitch range|pitch range
5128710|NCT01097161|Speech rate|speech rate
5128711|NCT01097161|fluency disorders|fluency disorders
5128712|NCT01097148|Obese|obese
5128713|NCT01097148|Atracurium|atracurium
5128714|NCT01097148|Cefazolin|cefazolin
5128715|NCT01097148|Morfine|morfine
5128716|NCT01097148|Nadroparin|nadroparin
5128717|NCT01097122|bone|bone
5128718|NCT01097122|motor neuron excitability|motor neuron excitability
5128719|NCT01097122|forearm vibration|forearm vibration
5128720|NCT01097122|mechanical loading|mechanical loading
5128721|NCT01097122|muscle electrical activity|muscle electrical activity
5128722|NCT01097109|Effect of Somatic Dysfunctions of Pelvis|effect of somatic dysfunctions of pelvis
5128723|NCT01097109|Effect of Somatic Dysfunctions of Sacrum|effect of somatic dysfunctions of sacrum
5128724|NCT01097109|Effect of Somatic Dysfunctions of Lower Lumbar Spine|effect of somatic dysfunctions of lower lumbar spine
5128725|NCT01097109|Weight-Bearing|weight-bearing
5128726|NCT01097096|Active immunization|active immunization
5128727|NCT01097096|Alzheimer disease|alzheimer disease
5128728|NCT01097096|Antibody|antibody
5128729|NCT01097096|Central Nervous System Diseases|central nervous system diseases
5128730|NCT01097096|Neurodegenerative diseases|neurodegenerative diseases
5128731|NCT01097096|Vaccine|vaccine
5128732|NCT01097083|Patients With Child-Pugh C Unresectable Hepatocellular Carcinoma|patients with child-pugh c unresectable hepatocellular carcinoma
5128733|NCT01097083|Patients who are unfit for standard therapy|patients who are unfit for standard therapy
5128734|NCT01097044|Erythropoietic Protoporphyria|erythropoietic protoporphyria
5128735|NCT01097044|EPP|epp
5128736|NCT01097044|Afamelanotide|afamelanotide
5128737|NCT01097031|blood pressure|blood pressure
5128738|NCT01097031|pediatric|pediatric
5128739|NCT01097031|nursing|nursing
5128740|NCT01097031|maintenance arterial catheter|maintenance arterial catheter
5128741|NCT01097005|Mycobacterium Infections, Atypical|mycobacterium infections, atypical
5128742|NCT01096992|Chronic lymphocytic leukemia|chronic lymphocytic leukemia
5128743|NCT01096992|CLL|cll
5128744|NCT01096992|Bendamustine|bendamustine
5128745|NCT01096992|Fludarabine|fludarabine
5128746|NCT01096992|Fludara|fludara
5128747|NCT01096992|Fludarabine Phosphate|fludarabine phosphate
5128748|NCT01096992|Rituximab|rituximab
5128749|NCT01096992|Rituxan|rituxan
5128750|NCT01096979|Subcutaneous Adipose Tissue Reduction|subcutaneous adipose tissue reduction
5128751|NCT01096966|chronic low back pain|chronic low back pain
5128752|NCT01096953|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
5128753|NCT01096953|ADHD|adhd
5128754|NCT01096953|attention deficit|attention deficit
5128755|NCT01096940|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
5128756|NCT01096940|Glucose lowering|glucose lowering
5128757|NCT01096927|Lower Abdominal Pain|lower abdominal pain
5128758|NCT01096927|Right Iliac Fossa Pain|right iliac fossa pain
5128759|NCT01096927|Acute Appendicitis|acute appendicitis
5128760|NCT01096927|Antibiotic Therapy|antibiotic therapy
5128761|NCT01096927|Conservative Management|conservative management
5128762|NCT01096927|Appendectomy|appendectomy
5128763|NCT01096927|Recurrence|recurrence
5128764|NCT01096927|Length of hospital stay|length of hospital stay
5128765|NCT01096927|Sick leave time|sick leave time
5128766|NCT01096927|Short and Long Term Abdominal pain evaluation|short and long term abdominal pain evaluation
5128767|NCT01096888|WIC|wic
5128768|NCT01096888|Weight loss|weight loss
5128769|NCT01096888|Overweight|overweight
5128770|NCT01096888|Post Partum|post partum
5128771|NCT01096888|Internet based weight loss intervention for Mothers in the WIC program.|internet based weight loss intervention for mothers in the wic program.
5128772|NCT01096875|Endothelial progenitor cells|endothelial progenitor cells
5128773|NCT01096875|Atorvastatin|atorvastatin
5128774|NCT01096875|Coronary surgery|coronary surgery
5128775|NCT01096862|Psoriasis|psoriasis
5128776|NCT01096862|ASP015K|asp015k
5128777|NCT01096849|urinary tract infection|urinary tract infection
5128778|NCT01096849|UTI|uti
5128779|NCT01096849|cUTI|cuti
5128780|NCT01096849|pyelonephritis|pyelonephritis
5128781|NCT01096849|AP|ap
5128782|NCT01096849|ACHN-490|achn-490
5128783|NCT01096836|resistance exercise|resistance exercise
5128784|NCT01096836|body mass index|body mass index
5128785|NCT01096836|hypertrophy|hypertrophy
5128786|NCT01096836|endothelial function|endothelial function
5128787|NCT01096836|blood lipids|blood lipids
5128788|NCT01096823|Rheumatoid Arthritis|rheumatoid arthritis
5128789|NCT01096823|Yoga|yoga
5128790|NCT01096823|Adolescents|adolescents
5128791|NCT01096823|Young Adults|young adults
5128792|NCT01096810|Asymptomatic|asymptomatic
5128793|NCT01096784|insulin-like growth factor|insulin-like growth factor
5128795|NCT01096784|IGF-I|igf-i
5128796|NCT01096784|BPD|bpd
5128797|NCT01096784|bronchopulmonary dysplasia|bronchopulmonary dysplasia
5128798|NCT01096784|retinopathy of prematurity|retinopathy of prematurity
5128799|NCT01096771|ARDS|ards
5128800|NCT01096771|Parenteral|parenteral
5128801|NCT01096771|Pharmaconutrition|pharmaconutrition
5128802|NCT01096758|PKU|pku
5128803|NCT01096758|phenylketonuria|phenylketonuria
5128804|NCT01096758|adult|adult
5128805|NCT01096758|patient|patient
5128806|NCT01096758|development|development
5128807|NCT01096758|nutritional deficiencies|nutritional deficiencies
5128808|NCT01096758|neurological outcome|neurological outcome
5128809|NCT01096758|psychological and neurological development|psychological and neurological development
5128810|NCT01096758|comparison with healthy adults|comparison with healthy adults
5128811|NCT01096758|longitudinal development|longitudinal development
5128812|NCT01096758|quality of life|quality of life
5128813|NCT01096745|Gemcitabine|gemcitabine
5128814|NCT01096745|Cisplatin|cisplatin
5128815|NCT01096745|S-1|s-1
5128816|NCT01096745|bile duct cancer|bile duct cancer
5128817|NCT01096732|Pancreatic|pancreatic
5128818|NCT01096732|adenocarcinoma|adenocarcinoma
5128819|NCT01096732|cancer|cancer
5128820|NCT01096719|Weight|weight
5128821|NCT01096719|Dietary intake|dietary intake
5128822|NCT01096719|Energy Density|energy density
5128823|NCT01096719|Behavioral|behavioral
5128824|NCT01096719|Satiety|satiety
5128825|NCT01096719|Deprivation|deprivation
5128826|NCT01096719|Hunger|hunger
5128827|NCT01096719|Fruit|fruit
5128828|NCT01096719|Vegetable|vegetable
5128829|NCT01096706|Urocortin 2|urocortin 2
5128830|NCT01096706|Urocortin 3|urocortin 3
5128831|NCT01096706|Nitric Oxide|nitric oxide
5128832|NCT01096706|Plethysmography|plethysmography
5128833|NCT01096706|Forearm blood flow|forearm blood flow
5128834|NCT01096706|Vascular|vascular
5128835|NCT01096706|Heart failure|heart failure
5128836|NCT01096706|endothelium|endothelium
5128837|NCT01096706|Cyclo-oxygenase pathway|cyclo-oxygenase pathway
5128838|NCT01096706|EDHF|edhf
5128839|NCT01096693|Urocortin 2|urocortin 2
5128840|NCT01096693|Urocortin 3|urocortin 3
5128841|NCT01096693|Astressin 2B|astressin 2b
5128842|NCT01096693|forearm blood flow|forearm blood flow
5128843|NCT01096693|plethysmography|plethysmography
5128844|NCT01096693|vascular|vascular
5128845|NCT01096693|heart failure|heart failure
5128846|NCT01096667|type 2 diabetes|type 2 diabetes
5128847|NCT01096667|hypertension|hypertension
5128848|NCT01096667|ambulatory blood pressure monitoring|ambulatory blood pressure monitoring
5128849|NCT01096654|endocrine hypertension|endocrine hypertension
5128850|NCT01096654|primary hyperaldosteronism|primary hyperaldosteronism
5128851|NCT01096654|aldosterone|aldosterone
5128852|NCT01096654|aldosterone-producing adenoma|aldosterone-producing adenoma
5128853|NCT01096654|bilateral adrenal hyperplasia|bilateral adrenal hyperplasia
5128854|NCT01096654|computed tomography|computed tomography
5128855|NCT01096654|adrenal vein sampling|adrenal vein sampling
5128856|NCT01096641|Fatigued disease-free Cancer Patients|fatigued disease-free cancer patients
5128857|NCT01096641|cancer treatment finished > one year and < ten years ago|cancer treatment finished > one year and < ten years ago
5128858|NCT01096628|adolescent|adolescent
5128859|NCT01096628|low back pain|low back pain
5128860|NCT01096628|chiropractic|chiropractic
5128861|NCT01096628|exercise|exercise
5128862|NCT01096615|Allergic rhinitis-Probiotic Lactobacillus paracasei LP-33-|allergic rhinitis-probiotic lactobacillus paracasei lp-33-
5128863|NCT01096602|Dendritic Cell/AML vaccine|dendritic cell/aml vaccine
5128864|NCT01096602|CT-011|ct-011
5128865|NCT01096589|lymphoedema|lymphoedema
5128866|NCT01096589|lymphedema|lymphedema
5128867|NCT01096563|Phase I|phase i
5128868|NCT01096563|Japanese healthy volunteer|japanese healthy volunteer
5128869|NCT01096563|AZD9164|azd9164
5128870|NCT01096550|opioid dependence|opioid dependence
5128871|NCT01096550|outpatient treatment|outpatient treatment
5128872|NCT01096550|intensive outpatient treatment|intensive outpatient treatment
5128873|NCT01096537|incidence|incidence
5128874|NCT01096537|young workers|young workers
5128875|NCT01096537|occupations at risk|occupations at risk
5128876|NCT01096537|public health|public health
5128877|NCT01096537|epidemiology|epidemiology
5128878|NCT01096537|polymorphisms|polymorphisms
5128879|NCT01096537|gentic|gentic
5128880|NCT01096524|Kneehab|kneehab
5128881|NCT01096524|NMES|nmes
5128882|NCT01096524|Total Knee Arthroplasty|total knee arthroplasty
5128883|NCT01096524|Total Knee Replacement|total knee replacement
5128884|NCT01096524|TKA|tka
5128885|NCT01096524|Disuse atrophy|disuse atrophy
5128886|NCT01096524|muscle hypertrophy|muscle hypertrophy
5128887|NCT01096524|TKR|tkr
5128888|NCT01096524|Atrophy Prevention|atrophy prevention
5128889|NCT01096511|Moxifloxacin,|moxifloxacin,
5128890|NCT01096511|cIAI|ciai
5128891|NCT01096511|non-interventional|non-interventional
5128892|NCT01096472|Tinea pedis|tinea pedis
5128893|NCT01096459|spina|spina
5128894|NCT01096459|bifida|bifida
5128895|NCT01096459|restore|restore
5128896|NCT01096459|urinary|urinary
5128897|NCT01096459|function|function
5128898|NCT01096459|nerve|nerve
5128899|NCT01096459|reroute|reroute
5128900|NCT01096433|Sleep apnea|sleep apnea
5128901|NCT01096433|CPAP|cpap
5128902|NCT01096433|Prostaglandins|prostaglandins
5128903|NCT01096433|Circadian variations|circadian variations
5128904|NCT01096420|chronic migraine|chronic migraine
5128905|NCT01096420|acupuncture|acupuncture
5128906|NCT01096420|Topiramate|topiramate
5128907|NCT01096420|Randomized trial|randomized trial
5128908|NCT01096407|pain|pain
5128909|NCT01096407|arthralgia|arthralgia
5128910|NCT01096407|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5128911|NCT01096394|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5128912|NCT01096394|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5128913|NCT01096381|cardiovascular complications|cardiovascular complications
5128914|NCT01096381|stage I breast cancer|stage i breast cancer
5128915|NCT01096381|stage II breast cancer|stage ii breast cancer
5128916|NCT01096381|stage IIIA breast cancer|stage iiia breast cancer
5128917|NCT01096381|stage IIIB breast cancer|stage iiib breast cancer
5128918|NCT01096381|stage IIIC breast cancer|stage iiic breast cancer
5128919|NCT01096381|stage IV breast cancer|stage iv breast cancer
5128920|NCT01096381|stage I colon cancer|stage i colon cancer
5128921|NCT01096381|stage II colon cancer|stage ii colon cancer
5128922|NCT01096381|stage III colon cancer|stage iii colon cancer
5128923|NCT01096381|stage IV colon cancer|stage iv colon cancer
5128924|NCT01096381|stage I rectal cancer|stage i rectal cancer
5128925|NCT01096381|stage II rectal cancer|stage ii rectal cancer
5128926|NCT01096381|stage III rectal cancer|stage iii rectal cancer
5128927|NCT01096381|stage IV rectal cancer|stage iv rectal cancer
5128928|NCT01096381|stage I non-small cell lung cancer|stage i non-small cell lung cancer
5128929|NCT01096381|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
5128930|NCT01096381|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5128931|NCT01096381|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5128932|NCT01096381|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5128933|NCT01096381|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5128934|NCT01096381|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
5128935|NCT01096381|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5128936|NCT01096381|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
5128937|NCT01096381|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5128938|NCT01096381|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
5128939|NCT01096381|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
5128940|NCT01096381|recurrent adenoid cystic carcinoma of the oral cavity|recurrent adenoid cystic carcinoma of the oral cavity
5128941|NCT01096381|recurrent mucoepidermoid carcinoma of the oral cavity|recurrent mucoepidermoid carcinoma of the oral cavity
5128942|NCT01096381|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
5128943|NCT01096381|stage IV adenoid cystic carcinoma of the oral cavity|stage iv adenoid cystic carcinoma of the oral cavity
5128944|NCT01096381|stage IV mucoepidermoid carcinoma of the oral cavity|stage iv mucoepidermoid carcinoma of the oral cavity
5128945|NCT01096381|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
5128946|NCT01096381|recurrent basal cell carcinoma of the lip|recurrent basal cell carcinoma of the lip
5128947|NCT01096381|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
5128948|NCT01096381|stage IV basal cell carcinoma of the lip|stage iv basal cell carcinoma of the lip
5128949|NCT01096381|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5128950|NCT01096381|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
5128951|NCT01096381|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
5128952|NCT01096381|untreated metastatic squamous neck cancer with occult primary|untreated metastatic squamous neck cancer with occult primary
5128953|NCT01096381|recurrent lymphoepithelioma of the nasopharynx|recurrent lymphoepithelioma of the nasopharynx
5128954|NCT01096381|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
5128955|NCT01096381|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
5128956|NCT01096381|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
5128957|NCT01096381|recurrent lymphoepithelioma of the oropharynx|recurrent lymphoepithelioma of the oropharynx
5128958|NCT01096381|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
5128959|NCT01096381|stage IV lymphoepithelioma of the oropharynx|stage iv lymphoepithelioma of the oropharynx
5128960|NCT01096381|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5128961|NCT01096381|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity
5128962|NCT01096381|recurrent inverted papilloma of the paranasal sinus and nasal cavity|recurrent inverted papilloma of the paranasal sinus and nasal cavity
5128963|NCT01096381|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity
5128964|NCT01096381|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
5128965|NCT01096381|stage IV esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iv esthesioneuroblastoma of the paranasal sinus and nasal cavity
5128966|NCT01096381|stage IV inverted papilloma of the paranasal sinus and nasal cavity|stage iv inverted papilloma of the paranasal sinus and nasal cavity
5128967|NCT01096381|stage IV midline lethal granuloma of the paranasal sinus and nasal cavity|stage iv midline lethal granuloma of the paranasal sinus and nasal cavity
5128968|NCT01096381|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
5128969|NCT01096381|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
5128970|NCT01096381|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5128971|NCT01096381|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5128972|NCT01096381|fallopian tube cancer|fallopian tube cancer
5128973|NCT01096381|peritoneal cavity cancer|peritoneal cavity cancer
5128974|NCT01096329|postmenopausal|postmenopausal
5128975|NCT01096329|hormone replacement therapy|hormone replacement therapy
5128976|NCT01096316|mood disorders|mood disorders
5128977|NCT01096316|depressive disorder|depressive disorder
5128978|NCT01096316|women|women
5128979|NCT01096316|depression|depression
5128980|NCT01096303|COPD|copd
5128981|NCT01096303|pulmonary function|pulmonary function
5128982|NCT01096303|tobacco and marihuana smoking|tobacco and marihuana smoking
5128983|NCT01096290|constipation|constipation
5128984|NCT01096290|lubiprostone|lubiprostone
5128985|NCT01096290|healthy volunteers|healthy volunteers
5128986|NCT01096264|Arterial stiffness|arterial stiffness
5128987|NCT01096264|Pulse wave velocity|pulse wave velocity
5128988|NCT01096264|Ultrafastecho|ultrafastecho
5128989|NCT01096264|Supersonic shear imaging|supersonic shear imaging
5128990|NCT01096251|Obesity|obesity
5128991|NCT01096251|Binge Eating Disorder|binge eating disorder
5128992|NCT01096251|Cognitive Behavioural Therapy|cognitive behavioural therapy
5128993|NCT01096251|Brief Strategic Therapy|brief strategic therapy
5128994|NCT01096251|Telepsychology|telepsychology
5128995|NCT01096238|The immunogenicity of Influenza Virus Vaccine, AdimFlu-S (A/H1N1), in adults after half a year will be analyzed and discussed.|the immunogenicity of influenza virus vaccine, adimflu-s (a/h1n1), in adults after half a year will be analyzed and discussed.
5128996|NCT01096225|the antibody response|the antibody response
5128997|NCT01096225|T-cell response|t-cell response
5128998|NCT01096225|S-OIV|s-oiv
5128999|NCT01096225|vaccine|vaccine
5129000|NCT01096225|Immunogenicity assessment|immunogenicity assessment
5129001|NCT01096212|Efficacy|efficacy
5129002|NCT01096212|Minimum alveolar concentration|minimum alveolar concentration
5129003|NCT01096212|Safety|safety
5129004|NCT01096212|Sevoflurane|sevoflurane
5129005|NCT01096199|The purpose of the study is to evaluate the safety and feasibility of combining TS-1/CDDP with RAD001. Primary|the purpose of the study is to evaluate the safety and feasibility of combining ts-1/cddp with rad001. primary
5129006|NCT01096199|Objectives|objectives
5129007|NCT01096199|To determine the MTD/recommended phase II dose of TS-1/CDDP/RAD001 combination —To determine|to determine the mtd/recommended phase ii dose of ts-1/cddp/rad001 combination —to determine
5129008|NCT01096199|the safety of TS-1/CDDP/RAD001 combination Secondary Objectives —To preliminarily describe any clinical activity in|the safety of ts-1/cddp/rad001 combination secondary objectives —to preliminarily describe any clinical activity in
5129009|NCT01096199|platinum refractory disease|platinum refractory disease
5129010|NCT01096199|To assess to effect of concurrent TS-1/CDDP on RAD001 pharmacokinetics —To explore|to assess to effect of concurrent ts-1/cddp on rad001 pharmacokinetics —to explore
5129011|NCT01096199|the relationship of tumour biomarkers and treatment response|the relationship of tumour biomarkers and treatment response
5129012|NCT01096186|motor Symptoms|motor symptoms
5129013|NCT01096186|efficacy|efficacy
5129014|NCT01096186|IPX066|ipx066
5129015|NCT01096186|Parkinson's Disease|parkinson's disease
5129016|NCT01096173|Sputum|sputum
5129017|NCT01096173|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
5129018|NCT01096160|Hypertension|hypertension
5129019|NCT01096147|FBSS|fbss
5129020|NCT01096147|chronic pain|chronic pain
5129021|NCT01096147|leg pain|leg pain
5129022|NCT01096147|low back pain|low back pain
5129023|NCT01096147|spinal cord stimulation|spinal cord stimulation
5129024|NCT01096121|Angiotensin-converting enzyme inhibitors (ACE)|angiotensin-converting enzyme inhibitors (ace)
5129025|NCT01096121|Renal disease|renal disease
5129026|NCT01096121|Microalbuminemia|microalbuminemia
5129027|NCT01096108|Smoking cessation|smoking cessation
5129028|NCT01096108|Quit smoking|quit smoking
5129029|NCT01096108|Quit & Win|quit & win
5129030|NCT01096095|SCA|sca
5129031|NCT01096095|Spinocerebellar Ataxia|spinocerebellar ataxia
5129032|NCT01096095|Sodium Phenylbutyrate|sodium phenylbutyrate
5129033|NCT01096095|Machado-Joseph Disease|machado-joseph disease
5129034|NCT01096095|Treatment|treatment
5129035|NCT01096082|spinocerebellar ataxia|spinocerebellar ataxia
5129036|NCT01096082|Treatment|treatment
5129037|NCT01096082|Lithium carbonate|lithium carbonate
5129038|NCT01096069|Rituximab, rheumatoid arthritis, CD55, CD59|rituximab, rheumatoid arthritis, cd55, cd59
5129039|NCT01096056|Children|children
5129040|NCT01096056|Influenza|influenza
5129041|NCT01096056|Safety|safety
5129042|NCT01096056|Immunogenicity|immunogenicity
5129043|NCT01096056|Vaccine|vaccine
5129044|NCT01096043|Heart Failure|heart failure
5129045|NCT01096043|ADHF|adhf
5129046|NCT01096030|Regorafenib|regorafenib
5129047|NCT01096030|Advanced|advanced
5129048|NCT01096030|Refractory solid tumors|refractory solid tumors
5129049|NCT01096017|Terbutaline|terbutaline
5129050|NCT01096017|Turbuhaler|turbuhaler
5129051|NCT01096017|Efficacy|efficacy
5129052|NCT01096017|Asthma|asthma
5129053|NCT01096017|Japanese|japanese
5129054|NCT01096017|salbutamol|salbutamol
5129055|NCT01096017|Bricanyl|bricanyl
5129056|NCT01096004|Pharmacodynamic method evaluation|pharmacodynamic method evaluation
5129057|NCT01095991|Type 2 Diabetes Mellitus, Sitagliptin|type 2 diabetes mellitus, sitagliptin
5129058|NCT01095978|Klacid SR|klacid sr
5129059|NCT01095978|Clarithromycin|clarithromycin
5129060|NCT01095978|Respiratory tract infections|respiratory tract infections
5129061|NCT01095978|Bronchitis|bronchitis
5129062|NCT01095978|Pneumonia|pneumonia
5129063|NCT01095965|Nutrition education intervention|nutrition education intervention
5129064|NCT01095965|Type 2 diabetes mellitus|type 2 diabetes mellitus
5129065|NCT01095952|atrial fibrillation|atrial fibrillation
5129066|NCT01095952|inappropriate shock|inappropriate shock
5129067|NCT01095952|AV-node stimulation|av-node stimulation
5129068|NCT01095952|ventricular arrhythmia|ventricular arrhythmia
5129069|NCT01095939|Renal function consecutive to pre-eclampsia|renal function consecutive to pre-eclampsia
5129070|NCT01095926|pharmacokinetic|pharmacokinetic
5129071|NCT01095926|doxorubicin|doxorubicin
5129072|NCT01095926|cancer|cancer
5129073|NCT01095926|troponin|troponin
5129074|NCT01095926|natriuretic peptide|natriuretic peptide
5129075|NCT01095926|cardiotoxicity|cardiotoxicity
5129076|NCT01095926|anthracyclines|anthracyclines
5129077|NCT01095926|Ewing|ewing
5129078|NCT01095926|ALL|all
5129079|NCT01095913|Near-Infrared Imaging|near-infrared imaging
5129080|NCT01095913|Fluorescent Dyes|fluorescent dyes
5129081|NCT01095913|Lymph Node Mapping|lymph node mapping
5129082|NCT01095913|Indocyanine green|indocyanine green
5129083|NCT01095913|IC-Green|ic-green
5129084|NCT01095913|nonradioactive optical imaging|nonradioactive optical imaging
5129085|NCT01095913|fluorescent contrast agent|fluorescent contrast agent
5129086|NCT01095913|ICG|icg
5129087|NCT01095913|lymph nodes|lymph nodes
5129088|NCT01095913|axillary nodal dissection|axillary nodal dissection
5129089|NCT01095900|Pain after treatment|pain after treatment
5129090|NCT01095900|healing of fissure after treatment|healing of fissure after treatment
5129091|NCT01095900|continence scores after treatment|continence scores after treatment
5129092|NCT01095887|ABO incompatibility|abo incompatibility
5129093|NCT01095887|living donor kidney transplant|living donor kidney transplant
5129094|NCT01095887|kidney transplant|kidney transplant
5129095|NCT01095887|ABO blood type incompatible|abo blood type incompatible
5129096|NCT01095874|myelodysplasia|myelodysplasia
5129097|NCT01095874|allogeneic hematopoietic stem cell transplantation|allogeneic hematopoietic stem cell transplantation
5129098|NCT01095874|Survival|survival
5129099|NCT01095874|Transplantation|transplantation
5129100|NCT01095861|endotracheal tube|endotracheal tube
5129101|NCT01095848|vaccine|vaccine
5129102|NCT01095848|cancer|cancer
5129103|NCT01095848|ovarian|ovarian
5129104|NCT01095848|breast|breast
5129105|NCT01095848|prostate|prostate
5129106|NCT01095848|tumor|tumor
5129107|NCT01095848|Immunotherapy|immunotherapy
5129108|NCT01095822|Diabetes|diabetes
5129109|NCT01095822|Hypertension|hypertension
5129110|NCT01095822|Platelets|platelets
5129111|NCT01095822|Hemostasis|hemostasis
5129112|NCT01095822|Aliskiren|aliskiren
5129113|NCT01095822|Valsartan|valsartan
5129114|NCT01095796|Treatment Naive|treatment naive
5129115|NCT01095796|HIV 1 Infected|hiv 1 infected
5129116|NCT01095783|low back pain|low back pain
5129117|NCT01095783|physiotherapy|physiotherapy
5129118|NCT01095783|hemodialysis|hemodialysis
5129119|NCT01095783|end-stage renal disease|end-stage renal disease
5129120|NCT01095770|Atrial Fibrillation|atrial fibrillation
5129121|NCT01095770|Atrial Fibrillation Ablation|atrial fibrillation ablation
5129122|NCT01095770|Atrial Fibrillation monitoring|atrial fibrillation monitoring
5129123|NCT01095770|Ablation Frontiers|ablation frontiers
5129124|NCT01095770|Reveal XT|reveal xt
5129125|NCT01095770|LASSO|lasso
5129126|NCT01095757|Myeloma|myeloma
5129127|NCT01095757|Lymphoma|lymphoma
5129128|NCT01095757|Stem cell transplantation|stem cell transplantation
5129129|NCT01095744|PIB imaging,|pib imaging,
5129130|NCT01095744|brain atrophy|brain atrophy
5129131|NCT01095744|cognitive impairment|cognitive impairment
5129132|NCT01095744|Pet imaging|pet imaging
5129133|NCT01095744|Alzheimer's disease|alzheimer's disease
5129134|NCT01095744|amyloid protein|amyloid protein
5129135|NCT01095731|aneurysm|aneurysm
5129136|NCT01095731|aneurysmal|aneurysmal
5129137|NCT01095731|subarachnoid|subarachnoid
5129138|NCT01095731|hemorrhage|hemorrhage
5129139|NCT01095731|haemorrhage|haemorrhage
5129140|NCT01095731|neuroprotection|neuroprotection
5129141|NCT01095731|3-aminopropanal|3-aminopropanal
5129142|NCT01095731|3AP|3ap
5129143|NCT01095731|polyamine oxidase|polyamine oxidase
5129144|NCT01095731|spermine|spermine
5129145|NCT01095731|spermidine|spermidine
5129146|NCT01095731|vasospasm|vasospasm
5129147|NCT01095731|cerebral ischemia|cerebral ischemia
5129148|NCT01095731|neurosurgery|neurosurgery
5129149|NCT01095731|neurological intensive care unit|neurological intensive care unit
5129150|NCT01095731|NICU|nicu
5129151|NCT01095731|Tiopronin|tiopronin
5129152|NCT01095731|Thiola|thiola
5129153|NCT01095731|FDA|fda
5129154|NCT01095731|Thiopronin|thiopronin
5129155|NCT01095731|Thiosol|thiosol
5129156|NCT01095731|Tioglis|tioglis
5129157|NCT01095731|Acadione|acadione
5129158|NCT01095731|Capen|capen
5129159|NCT01095731|Captimer|captimer
5129160|NCT01095731|Epatiol|epatiol
5129161|NCT01095731|Vincol|vincol
5129162|NCT01095731|Mucolysin|mucolysin
5129163|NCT01095731|Sutilan|sutilan
5129164|NCT01095731|Meprin|meprin
5129165|NCT01095731|Thiolpropionamidoacetic acid|thiolpropionamidoacetic acid
5129166|NCT01095731|Mercaptopropionyl glycine|mercaptopropionyl glycine
5129167|NCT01095731|2 MPG|2 mpg
5129168|NCT01095705|Hypnosis|hypnosis
5129169|NCT01095705|Transesophageal Echocardiography|transesophageal echocardiography
5129170|NCT01095705|Efficiency of Hypnosis|efficiency of hypnosis
5129171|NCT01095692|Occult stress Incontinence,|occult stress incontinence,
5129172|NCT01095692|Pelvic Organ Prolapse,|pelvic organ prolapse,
5129173|NCT01095692|Prevention of stress urinary incontinence,|prevention of stress urinary incontinence,
5129174|NCT01095692|Postoperative incontinence,|postoperative incontinence,
5129175|NCT01095692|Sub-urethral tape|sub-urethral tape
5129176|NCT01095679|CHEYNE Stokes respiration|cheyne stokes respiration
5129177|NCT01095679|Periodic ventilation|periodic ventilation
5129178|NCT01095679|baclofen|baclofen
5129179|NCT01095679|hypoxia|hypoxia
5129180|NCT01095679|healthy subject|healthy subject
5129181|NCT01095640|acne|acne
5129182|NCT01095640|adapalene|adapalene
5129183|NCT01095640|Differin|differin
5129184|NCT01095614|Women|women
5129185|NCT01095614|Hormonal status|hormonal status
5129186|NCT01095614|Exercise|exercise
5129187|NCT01095614|Substrate utilization|substrate utilization
5129188|NCT01095614|Women Hormonal Status (with oral contraception or without any contraception)|women hormonal status (with oral contraception or without any contraception)
5129189|NCT01095601|avanafil|avanafil
5129190|NCT01095601|absoprion|absoprion
5129191|NCT01095601|bioavailability|bioavailability
5129192|NCT01095601|food effect|food effect
5129193|NCT01095601|dose-proportionality|dose-proportionality
5129194|NCT01095601|TA-1790|ta-1790
5129195|NCT01095601|Pharmacokinetics of avanafil|pharmacokinetics of avanafil
5129196|NCT01095588|ED|ed
5129197|NCT01095575|Epidural|epidural
5129198|NCT01095575|Morphine|morphine
5129199|NCT01095575|Preoperative|preoperative
5129200|NCT01095575|Postoperative|postoperative
5129201|NCT01095575|Analgesia|analgesia
5129202|NCT01095575|Tolerance|tolerance
5129203|NCT01095575|Preoperative, Postoperative Analgesia|preoperative, postoperative analgesia
5129204|NCT01095549|ankle-brachial index (ABI)|ankle-brachial index (abi)
5129205|NCT01095549|brachial-ankle pulse wave velocity (baPWV)|brachial-ankle pulse wave velocity (bapwv)
5129206|NCT01095549|far infrared therapy (FIR)|far infrared therapy (fir)
5129207|NCT01095549|hemodialysis (HD)|hemodialysis (hd)
5129208|NCT01095549|peripheral artery disease (PAD)|peripheral artery disease (pad)
5129209|NCT01095549|Peripheral artery disease in hemodialysis|peripheral artery disease in hemodialysis
5129210|NCT01095536|laparoscopic cholecystectomy, elective|laparoscopic cholecystectomy, elective
5129211|NCT01095536|anesthesia, general|anesthesia, general
5129212|NCT01095536|shoulder pain|shoulder pain
5129213|NCT01095536|nausea|nausea
5129214|NCT01095536|vomiting|vomiting
5129215|NCT01095536|laparoscopic cholecystectomy|laparoscopic cholecystectomy
5129216|NCT01095536|general anesthesia|general anesthesia
5129217|NCT01095523|Colon Cancer|colon cancer
5129218|NCT01095523|Rectal Cancer|rectal cancer
5129219|NCT01095523|Peritoneal Perfusion|peritoneal perfusion
5129220|NCT01095523|Metastatic Cancer|metastatic cancer
5129221|NCT01095523|Recurrence|recurrence
5129222|NCT01095523|Colorectal Cancer|colorectal cancer
5129223|NCT01095510|HAE|hae
5129224|NCT01095510|CINRYZE|cinryze
5129225|NCT01095510|C1 INH|c1 inh
5129226|NCT01095510|C1 inhibitor|c1 inhibitor
5129227|NCT01095510|Pediatric|pediatric
5129228|NCT01095510|PK/PD|pk/pd
5129229|NCT01095497|HAE|hae
5129230|NCT01095497|C1 inhibitor (C1INH)|c1 inhibitor (c1inh)
5129231|NCT01095497|Subcutaneous|subcutaneous
5129232|NCT01095484|Rotigotine|rotigotine
5129233|NCT01095484|Neupro®|neupro®
5129234|NCT01095471|7 valent Pneumococcal conjugate vaccine|7 valent pneumococcal conjugate vaccine
5129235|NCT01095471|13 valent Pneumococcal conjugate vaccine|13 valent pneumococcal conjugate vaccine
5129236|NCT01095471|PCV13|pcv13
5129237|NCT01095471|PCV7|pcv7
5129238|NCT01095458|Obesity|obesity
5129239|NCT01095458|Phone vs Clinical methods|phone vs clinical methods
5129240|NCT01095445|hepatitis C|hepatitis c
5129241|NCT01095445|genotype 3|genotype 3
5129242|NCT01095445|end of treatment response|end of treatment response
5129243|NCT01095445|relapse rate|relapse rate
5129244|NCT01095445|rapid virologic response|rapid virologic response
5129245|NCT01095445|complete early virologic response|complete early virologic response
5129246|NCT01095432|Colonoscopy|colonoscopy
5129247|NCT01095432|Flexible Sigmoidoscopy|flexible sigmoidoscopy
5129248|NCT01095419|massage therapy|massage therapy
5129249|NCT01095419|sleep quality|sleep quality
5129250|NCT01095419|coronary artery bypass grafting surgery|coronary artery bypass grafting surgery
5129251|NCT01095419|Patients after Coronary Artery Bypass Graft Surgery|patients after coronary artery bypass graft surgery
5129252|NCT01095406|Weaning|weaning
5129253|NCT01095406|closed loop|closed loop
5129254|NCT01095406|mechanical ventilation|mechanical ventilation
5129255|NCT01095406|children|children
5129256|NCT01095393|Certolizumab Pegol|certolizumab pegol
5129257|NCT01095393|CZP|czp
5129258|NCT01095393|Cimzia®|cimzia®
5129259|NCT01095393|NDB|ndb
5129260|NCT01095393|registry|registry
5129261|NCT01095380|task-specific training|task-specific training
5129262|NCT01095380|walking|walking
5129263|NCT01095380|locomotion|locomotion
5129264|NCT01095380|function|function
5129265|NCT01095380|body weight support|body weight support
5129266|NCT01095380|Individuals with motor-incomplete spinal cord injury|individuals with motor-incomplete spinal cord injury
5129267|NCT01095367|Adhesion barrier sheets|adhesion barrier sheets
5129268|NCT01095367|ovarian cancer|ovarian cancer
5129269|NCT01095367|Advanced stage epithelial ovarian cancer|advanced stage epithelial ovarian cancer
5129270|NCT01095354|pediatric|pediatric
5129271|NCT01095354|lung ventilation inhomogeneity|lung ventilation inhomogeneity
5129272|NCT01095341|hyperthyroidism|hyperthyroidism
5129273|NCT01095341|tertiary hyperparathyroidism|tertiary hyperparathyroidism
5129274|NCT01095341|palpation thyroiditis|palpation thyroiditis
5129275|NCT01095341|parathyroidectomy|parathyroidectomy
5129276|NCT01095341|thyroglobulin|thyroglobulin
5129277|NCT01095341|rate of postoperative hyperthyroidism|rate of postoperative hyperthyroidism
5129278|NCT01095328|Q fever|q fever
5129279|NCT01095328|Pregnancy|pregnancy
5129280|NCT01095328|Screening|screening
5129281|NCT01095328|Cost-effectiveness|cost-effectiveness
5129282|NCT01095289|electromyography|electromyography
5129283|NCT01095289|laryngeal neoplasms|laryngeal neoplasms
5129284|NCT01095289|masticatory muscles|masticatory muscles
5129285|NCT01095276|Mechanical Ventilation|mechanical ventilation
5129286|NCT01095276|Extubation|extubation
5129287|NCT01095276|dornase alpha|dornase alpha
5129288|NCT01095276|oxygenation|oxygenation
5129289|NCT01095276|chest x ray|chest x ray
5129290|NCT01095250|Active uveitis|active uveitis
5129291|NCT01095250|intermediate uveitis|intermediate uveitis
5129292|NCT01095250|panuveitis|panuveitis
5129293|NCT01095250|posterior uveitis|posterior uveitis
5129294|NCT01095250|uveitis|uveitis
5129295|NCT01095237|Peripheral Arterial Disease|peripheral arterial disease
5129296|NCT01095237|Peripheral Vascular Disease|peripheral vascular disease
5129297|NCT01095237|PAD|pad
5129298|NCT01095237|vascular prosthesis|vascular prosthesis
5129299|NCT01095237|revascularization|revascularization
5129300|NCT01095237|patency|patency
5129301|NCT01095237|blood vessel|blood vessel
5129302|NCT01095237|Rutherford|rutherford
5129303|NCT01095237|ABI|abi
5129304|NCT01095237|Ankle Brachial Index|ankle brachial index
5129305|NCT01095237|Vascular Graft|vascular graft
5129306|NCT01095237|Carbothane|carbothane
5129307|NCT01095237|ProEndoTecc|proendotecc
5129308|NCT01095237|implantation|implantation
5129309|NCT01095224|HIV Preventive Vaccine|hiv preventive vaccine
5129310|NCT01095211|folic acid|folic acid
5129311|NCT01095211|homocysteine|homocysteine
5129312|NCT01095211|MMSE scores|mmse scores
5129313|NCT01095211|methyl malonic acid|methyl malonic acid
5129314|NCT01095211|betaine|betaine
5129315|NCT01095198|vaginal self collection|vaginal self collection
5129316|NCT01095198|human papillomavirus (hpv)|human papillomavirus (hpv)
5129317|NCT01095198|cervical intraepithelial neoplasia|cervical intraepithelial neoplasia
5129318|NCT01095172|Immunosuppression|immunosuppression
5129319|NCT01095172|Rituximab|rituximab
5129320|NCT01095172|B cell|b cell
5129321|NCT01095159|TVTO|tvto
5129322|NCT01095159|TVTSecur|tvtsecur
5129323|NCT01095159|Mini sling|mini sling
5129324|NCT01095159|stress urinary incontinence|stress urinary incontinence
5129325|NCT01095146|MAS|mas
5129326|NCT01095146|Hemophagocytosis|hemophagocytosis
5129327|NCT01095146|Reactive HLH|reactive hlh
5129328|NCT01095146|Macrophage activation syndrome|macrophage activation syndrome
5129329|NCT01095146|Systemic onset juvenile idiopathic arthritis|systemic onset juvenile idiopathic arthritis
5129330|NCT01095146|SoJIA|sojia
5129331|NCT01095146|JIA|jia
5129332|NCT01095133|Gastroesophageal reflux disease|gastroesophageal reflux disease
5129333|NCT01095133|Heartburn|heartburn
5129334|NCT01095107|Determining whether adjustments in the amounts of fat grams within the current inpatient protocol meal plans will lead to a change in the hospital stay duration|determining whether adjustments in the amounts of fat grams within the current inpatient protocol meal plans will lead to a change in the hospital stay duration
5129335|NCT01095107|Alter their recovery by affecting vital signs|alter their recovery by affecting vital signs
5129336|NCT01095107|Rate of weight change or need for supplemental feeds/medications|rate of weight change or need for supplemental feeds/medications
5129337|NCT01095107|Effect gastrointestinal symptoms (bloating, gastroesophageal reflux, constipation, diarrhea, abdominal pain|effect gastrointestinal symptoms (bloating, gastroesophageal reflux, constipation, diarrhea, abdominal pain
5129338|NCT01095107|And/or effect their perceived body image or cause any changes in their mood.|and/or effect their perceived body image or cause any changes in their mood.
5129339|NCT01095094|adult brain tumor|adult brain tumor
5129340|NCT01095094|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5129341|NCT01095094|adult anaplastic ependymoma|adult anaplastic ependymoma
5129342|NCT01095094|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
5129343|NCT01095094|adult brain stem glioma|adult brain stem glioma
5129344|NCT01095094|adult giant cell glioblastoma|adult giant cell glioblastoma
5129345|NCT01095094|adult glioblastoma|adult glioblastoma
5129346|NCT01095094|adult gliosarcoma|adult gliosarcoma
5129347|NCT01095094|adult mixed glioma|adult mixed glioma
5129348|NCT01095094|recurrent adult brain tumor|recurrent adult brain tumor
5129349|NCT01095042|HRV|hrv
5129350|NCT01095042|emotion|emotion
5129351|NCT01095042|cognition|cognition
5129352|NCT01095042|stress|stress
5129353|NCT01095042|cortisol|cortisol
5129354|NCT01095042|Autonomic nervous system|autonomic nervous system
5129355|NCT01095029|Positron emission tomography (PET)|positron emission tomography (pet)
5129356|NCT01095029|Idiopathic Faecal Incontinence|idiopathic faecal incontinence
5129357|NCT01095029|Bilateral Sacral Nerve Stimulation|bilateral sacral nerve stimulation
5129358|NCT01095029|Sacral Nerve Stimulation|sacral nerve stimulation
5129359|NCT01095029|Sacral Nervemodulation|sacral nervemodulation
5129360|NCT01094990|crossover; double blinded; intrathecal chemotherapy; dexamethasone; ketamine;vomiting|crossover; double blinded; intrathecal chemotherapy; dexamethasone; ketamine;vomiting
5129361|NCT01094977|Blood Loss and Transfusion|blood loss and transfusion
5129362|NCT01094977|Craniosynostoses|craniosynostoses
5129363|NCT01094977|Tranexamic Acid|tranexamic acid
5129364|NCT01094977|Children|children
5129365|NCT01094964|recurrent bladder cancer|recurrent bladder cancer
5129366|NCT01094964|stage 0 bladder cancer|stage 0 bladder cancer
5129944|NCT01092676|Emergency|emergency
5129367|NCT01094964|stage I bladder cancer|stage i bladder cancer
5129368|NCT01094964|adenocarcinoma of the bladder|adenocarcinoma of the bladder
5129369|NCT01094964|squamous cell carcinoma of the bladder|squamous cell carcinoma of the bladder
5129370|NCT01094951|Depression|depression
5129371|NCT01094938|Aortic aneurysm repair|aortic aneurysm repair
5129372|NCT01094925|Cesarean section|cesarean section
5129373|NCT01094925|Gabapentin|gabapentin
5129374|NCT01094912|Cancer pain|cancer pain
5129375|NCT01094899|diabetes|diabetes
5129376|NCT01094899|osteopenia|osteopenia
5129377|NCT01094899|neuropathy|neuropathy
5129378|NCT01094899|foot|foot
5129379|NCT01094899|AGE|age
5129380|NCT01094886|Total Hip Replacement|total hip replacement
5129381|NCT01094886|Total Knee Replacement|total knee replacement
5129382|NCT01094886|Hip Implant|hip implant
5129383|NCT01094886|Knee Implant|knee implant
5129384|NCT01094886|Joint Prosthesis|joint prosthesis
5129385|NCT01094886|Orthopedic Surgery|orthopedic surgery
5129386|NCT01094886|Rivaroxaban|rivaroxaban
5129387|NCT01094886|Xarelto|xarelto
5129388|NCT01094886|Blood Clot|blood clot
5129389|NCT01094873|Hepatitis C|hepatitis c
5129390|NCT01094873|HCV|hcv
5129391|NCT01094873|Adenovirus|adenovirus
5129392|NCT01094873|Vaccine|vaccine
5129393|NCT01094860|Relapsed/Refractory Lymphoid Malignancies|relapsed/refractory lymphoid malignancies
5129394|NCT01094860|Chronic lymphocytic leukemia|chronic lymphocytic leukemia
5129395|NCT01094860|CLL|cll
5129396|NCT01094860|Small lymphocytic lymphoma|small lymphocytic lymphoma
5129397|NCT01094860|SLL|sll
5129398|NCT01094860|B-prolymphocytic leukemia|b-prolymphocytic leukemia
5129399|NCT01094860|Follicular lymphoma|follicular lymphoma
5129400|NCT01094860|Mantle cell lymphoma|mantle cell lymphoma
5129401|NCT01094860|Lymphoplasmacytoid lymphoma|lymphoplasmacytoid lymphoma
5129402|NCT01094860|Marginal zone lymphoma|marginal zone lymphoma
5129403|NCT01094860|T-cell prolymphocytic leukemia|t-cell prolymphocytic leukemia
5129404|NCT01094860|large granular lymphocyte leukemia|large granular lymphocyte leukemia
5129405|NCT01094860|mycosis fungoides|mycosis fungoides
5129406|NCT01094860|Sezary syndrome|sezary syndrome
5129407|NCT01094860|peripheral T-cell lymphoma|peripheral t-cell lymphoma
5129408|NCT01094860|Chemotherapy|chemotherapy
5129409|NCT01094860|Monoclonal antibody therapy|monoclonal antibody therapy
5129410|NCT01094860|T-cell or B-cell acute lymphoblastic leukemia (ALL)|t-cell or b-cell acute lymphoblastic leukemia (all)
5129411|NCT01094860|Continuous Infusion Nelarabine|continuous infusion nelarabine
5129412|NCT01094860|Arranon|arranon
5129413|NCT01094821|Healthy volunteers|healthy volunteers
5129414|NCT01094821|ATI-7505|ati-7505
5129415|NCT01094821|Scintigraphy|scintigraphy
5129416|NCT01094821|Gastrointestinal transit|gastrointestinal transit
5129417|NCT01094808|pregabalin|pregabalin
5129418|NCT01094808|motor|motor
5129419|NCT01094808|sensation|sensation
5129420|NCT01094808|colon|colon
5129421|NCT01094808|pain|pain
5129422|NCT01094808|gas|gas
5129423|NCT01094782|Pain|pain
5129424|NCT01094782|Pain management|pain management
5129425|NCT01094756|Obesity|obesity
5129426|NCT01094717|psoriasis|psoriasis
5129427|NCT01094717|excimer|excimer
5129428|NCT01094717|acitretin|acitretin
5129429|NCT01094717|tazarotene|tazarotene
5129430|NCT01094704|cystic fibrosis|cystic fibrosis
5129431|NCT01094704|mucociliary clearance|mucociliary clearance
5129432|NCT01094704|hypertonic saline|hypertonic saline
5129433|NCT01094678|Peripheral Aterial Disease (PAD)|peripheral aterial disease (pad)
5129434|NCT01094678|Peripheral Vascular Disease|peripheral vascular disease
5129435|NCT01094678|Drug-Eluting Stent|drug-eluting stent
5129436|NCT01094678|Drug-Coated Stent|drug-coated stent
5129437|NCT01094678|Vascular Diseases|vascular diseases
5129438|NCT01094678|Cardiovascular Diseases|cardiovascular diseases
5129439|NCT01094652|Adolescent|adolescent
5129440|NCT01094652|Whole grain|whole grain
5129441|NCT01094652|Digestive health|digestive health
5129442|NCT01094652|Dietary fiber|dietary fiber
5129443|NCT01094652|Grain|grain
5129444|NCT01094652|Microbiota|microbiota
5129445|NCT01094652|Inflammation|inflammation
5129446|NCT01094652|Mucosal Immunity|mucosal immunity
5129447|NCT01094626|Pancreatic adenocarcinoma|pancreatic adenocarcinoma
5129448|NCT01094626|Intraductal papillary mucinous neoplasm|intraductal papillary mucinous neoplasm
5129449|NCT01094626|Imaging techniques|imaging techniques
5129450|NCT01094626|Pancreatic surgical resection|pancreatic surgical resection
5129451|NCT01094626|Synthetic human secretin|synthetic human secretin
5129452|NCT01094613|Crohn's Disease|crohn's disease
5129453|NCT01094613|Delayed Release|delayed release
5129454|NCT01094613|Targeted Ileal Delivery|targeted ileal delivery
5129455|NCT01094600|Pancreatic cancer|pancreatic cancer
5129456|NCT01094600|Pancreatic resection|pancreatic resection
5129457|NCT01094600|Synthetic human secretin|synthetic human secretin
5129458|NCT01094600|Secretin-enhanced MRCP|secretin-enhanced mrcp
5129459|NCT01094600|Endoscopic pancreatic function test|endoscopic pancreatic function test
5129460|NCT01094600|Pancreatic exocrine insufficiency|pancreatic exocrine insufficiency
5129461|NCT01094561|Family history of pancreatic cancer|family history of pancreatic cancer
5129462|NCT01094561|Pancreatic adenocarcinoma|pancreatic adenocarcinoma
5129463|NCT01094561|Imaging techniques|imaging techniques
5129464|NCT01094561|Synthetic human secretin|synthetic human secretin
5129465|NCT01094561|Pancreatic abnormalities|pancreatic abnormalities
5129466|NCT01094561|Early detection and prevention|early detection and prevention
5129467|NCT01094548|L-BLP25 liposome|l-blp25 liposome
5129468|NCT01094548|Multiple myeloma|multiple myeloma
5129469|NCT01094535|Pancreatic adenocarcinoma|pancreatic adenocarcinoma
5129470|NCT01094535|Synthetic human secretin|synthetic human secretin
5129471|NCT01094535|Secretin-enhanced MRCP|secretin-enhanced mrcp
5129472|NCT01094535|Pancreatic insufficiency|pancreatic insufficiency
5129473|NCT01094535|Endoscopic Pancreatic Function Test (ePFT)|endoscopic pancreatic function test (epft)
5129474|NCT01094535|Endocrine pancreatic function test|endocrine pancreatic function test
5129475|NCT01094535|Exocrine pancreatic function test|exocrine pancreatic function test
5129476|NCT01094496|bladder cancer|bladder cancer
5129477|NCT01094496|immunotherapy|immunotherapy
5129478|NCT01094496|cystectomy|cystectomy
5129479|NCT01094496|cancer vaccine|cancer vaccine
5129480|NCT01094496|human chorionic gonadotropin|human chorionic gonadotropin
5129481|NCT01094496|hCG|hcg
5129482|NCT01094496|urogenital neoplasms|urogenital neoplasms
5129483|NCT01094496|urinary bladder neoplasms|urinary bladder neoplasms
5129484|NCT01094496|muscle invasive|muscle invasive
5129485|NCT01094496|non-metastatic|non-metastatic
5129486|NCT01094496|transitional cell (urothelial) bladder cancer|transitional cell (urothelial) bladder cancer
5129487|NCT01094483|Thromboxane B2|thromboxane b2
5129488|NCT01094470|gait|gait
5129489|NCT01094470|ambulation|ambulation
5129490|NCT01094470|kinematics|kinematics
5129491|NCT01094457|antiplatelet therapy|antiplatelet therapy
5129492|NCT01094457|clopidogrel low responsiveness|clopidogrel low responsiveness
5129493|NCT01094457|acute coronary syndromes|acute coronary syndromes
5129494|NCT01094457|percutaneous coronary intervention|percutaneous coronary intervention
5129495|NCT01094457|cilostazol|cilostazol
5129496|NCT01094444|Vitamin K3 lotion|vitamin k3 lotion
5129497|NCT01094444|Cetuximab induced folliculitis|cetuximab induced folliculitis
5129498|NCT01094431|Fever|fever
5129499|NCT01094431|Etiology|etiology
5129500|NCT01094431|Children under five years of age|children under five years of age
5129501|NCT01094431|IMCI|imci
5129502|NCT01094418|polyneuropathy|polyneuropathy
5129503|NCT01094418|Nerve conduction study|nerve conduction study
5129504|NCT01094418|Impaired glucose tolerance test|impaired glucose tolerance test
5129505|NCT01094418|Diabetes mellitus|diabetes mellitus
5129506|NCT01094405|NPC with persistent, recurrent or metastatic disease patients|npc with persistent, recurrent or metastatic disease patients
5129507|NCT01094392|ALL|all
5129508|NCT01094392|PEG-asparaginase|peg-asparaginase
5129509|NCT01094392|prolonged treatment|prolonged treatment
5129510|NCT01094392|Thrombosis|thrombosis
5129511|NCT01094392|Central venous line|central venous line
5129512|NCT01094392|Echocardiography|echocardiography
5129513|NCT01094379|cholecystectomy|cholecystectomy
5129514|NCT01094379|laparoscopic|laparoscopic
5129515|NCT01094379|pain|pain
5129516|NCT01094379|single incision|single incision
5129517|NCT01094366|Paracervical Block|paracervical block
5129518|NCT01094366|pain control|pain control
5129519|NCT01094366|abortion|abortion
5129520|NCT01094353|Urodynamic Stress urinary incontinence|urodynamic stress urinary incontinence
5129521|NCT01094353|Minisling|minisling
5129522|NCT01094353|Ophira™|ophira™
5129523|NCT01094353|Unitape™|unitape™
5129524|NCT01094327|focal segmental glomerulosclerosis|focal segmental glomerulosclerosis
5129525|NCT01094301|electrical stimulation|electrical stimulation
5129526|NCT01094301|neurostimulation|neurostimulation
5129527|NCT01094301|neuromodulation|neuromodulation
5129528|NCT01094301|shoulder pain|shoulder pain
5129529|NCT01094301|post-stroke shoulder pain|post-stroke shoulder pain
5129530|NCT01094301|hemiplegic shoulder pain|hemiplegic shoulder pain
5129531|NCT01094275|drug resistance|drug resistance
5129532|NCT01094275|gene polymorphism|gene polymorphism
5129533|NCT01094262|Osteoarthritis pain of the knee|osteoarthritis pain of the knee
5129534|NCT01094262|Osteoarthritis|osteoarthritis
5129535|NCT01094262|Osteoarthritis, Knee|osteoarthritis, knee
5129536|NCT01094262|Pain|pain
5129537|NCT01094262|Arthralgia|arthralgia
5129538|NCT01094262|Joint Pain|joint pain
5129539|NCT01094262|JNJ-42160443|jnj-42160443
5129540|NCT01094249|Paliperidone ER|paliperidone er
5129541|NCT01094249|INVEGA|invega
5129542|NCT01094249|Divalproex sodium|divalproex sodium
5129543|NCT01094249|Depakote ER|depakote er
5129544|NCT01094249|Valproic acid|valproic acid
5129545|NCT01094249|Pharmacokinetics|pharmacokinetics
5129546|NCT01094249|R076477BIM1004|r076477bim1004
5129547|NCT01094236|behavior management|behavior management
5129548|NCT01094236|academic performance|academic performance
5129549|NCT01094236|playground supervision|playground supervision
5129550|NCT01094236|harm reduction|harm reduction
5129551|NCT01094236|Behavioral Research|behavioral research
5129552|NCT01094223|Stimulant|stimulant
5129553|NCT01094223|Addiction|addiction
5129554|NCT01094223|Mindfulness|mindfulness
5129555|NCT01094223|Treatment|treatment
5129556|NCT01094210|Anti-erosion dental benefits|anti-erosion dental benefits
5129557|NCT01094197|Transfusion-associated microchimerism|transfusion-associated microchimerism
5129558|NCT01094197|Injuries|injuries
5129559|NCT01094197|Leukocytes|leukocytes
5129945|NCT01092663|Colesevelam|colesevelam
5129560|NCT01094171|poliomyelitis|poliomyelitis
5129561|NCT01094171|diphtheria|diphtheria
5129562|NCT01094171|Primary immunization|primary immunization
5129563|NCT01094171|pertussis|pertussis
5129564|NCT01094171|Children|children
5129565|NCT01094171|tetanus|tetanus
5129566|NCT01094158|NAFLD|nafld
5129567|NCT01094158|NASH|nash
5129568|NCT01094158|Fatty Liver|fatty liver
5129569|NCT01094158|Metabolic Syndrome|metabolic syndrome
5129570|NCT01094158|Endothelial Dysfunction|endothelial dysfunction
5129571|NCT01094158|Insulin Resistance|insulin resistance
5129572|NCT01094158|Liver Fat|liver fat
5129573|NCT01094145|(light to moderate)|(light to moderate)
5129574|NCT01094132|cervical cancer|cervical cancer
5129575|NCT01094132|cervical intraepithelial neoplasia grade 1|cervical intraepithelial neoplasia grade 1
5129576|NCT01094132|cervical intraepithelial neoplasia grade 2|cervical intraepithelial neoplasia grade 2
5129577|NCT01094132|cervical intraepithelial neoplasia grade 3|cervical intraepithelial neoplasia grade 3
5129578|NCT01094132|Nonmalignant Condition|nonmalignant condition
5129579|NCT01094119|heated blanket|heated blanket
5129580|NCT01094119|heated pad|heated pad
5129581|NCT01094106|postoperative pain|postoperative pain
5129582|NCT01094106|infiltration analgesia|infiltration analgesia
5129583|NCT01094106|ropivacaine|ropivacaine
5129584|NCT01094106|Caesarean Section|caesarean section
5129585|NCT01094093|Amgen|amgen
5129586|NCT01094093|AMG 139|amg 139
5129587|NCT01094080|fully formula fed|fully formula fed
5129588|NCT01094080|fully breast fed|fully breast fed
5129589|NCT01094041|Gluten|gluten
5129590|NCT01094041|Diarrhea or diarrhea predominant irritable bowel syndrome|diarrhea or diarrhea predominant irritable bowel syndrome
5129591|NCT01094041|Colonic permeability|colonic permeability
5129592|NCT01094041|Small bowel permeability|small bowel permeability
5129593|NCT01094041|Colonic inflammatory response|colonic inflammatory response
5129594|NCT01094041|Small bowel inflammatory response|small bowel inflammatory response
5129595|NCT01094028|Blood loss in the third and fourth stage of labor and the duration of third stage of labor|blood loss in the third and fourth stage of labor and the duration of third stage of labor
5129596|NCT01094015|hysteroscopy|hysteroscopy
5129597|NCT01094015|local anaesthetic|local anaesthetic
5129598|NCT01094015|pain relief|pain relief
5129599|NCT01094015|gynecological pathology|gynecological pathology
5129600|NCT01094002|OCCUPATIONAL THERAPY|occupational therapy
5129601|NCT01094002|RANDOMISED CLINICAL TRIAL|randomised clinical trial
5129602|NCT01094002|AGED|aged
5129603|NCT01094002|PATIENT CARE|patient care
5129604|NCT01093976|Skin Picking|skin picking
5129605|NCT01093976|OCD|ocd
5129606|NCT01093976|Trichotillomania|trichotillomania
5129607|NCT01093976|Pathological Skin Picking|pathological skin picking
5129608|NCT01093950|anthropometric|anthropometric
5129609|NCT01093950|white light scanner|white light scanner
5129610|NCT01093950|extraction profiles|extraction profiles
5129611|NCT01093950|Body lipodystrophy|body lipodystrophy
5129612|NCT01093937|Bipolar disorder|bipolar disorder
5129613|NCT01093937|Bipolar-I|bipolar-i
5129614|NCT01093937|Varenicline|varenicline
5129615|NCT01093937|Champix|champix
5129616|NCT01093937|Chantix|chantix
5129617|NCT01093937|Nicotine|nicotine
5129618|NCT01093937|Nicotinic receptor|nicotinic receptor
5129619|NCT01093937|Nicotinic receptor dysregulation|nicotinic receptor dysregulation
5129620|NCT01093937|Dopamine|dopamine
5129621|NCT01093937|Acetylcholine|acetylcholine
5129622|NCT01093937|Cigarette|cigarette
5129623|NCT01093937|Smoking|smoking
5129624|NCT01093937|Tobacco|tobacco
5129625|NCT01093937|Dependence|dependence
5129626|NCT01093937|Neuropsychological function|neuropsychological function
5129872|NCT01092962|Children|children
5129627|NCT01093924|Behavioral weight loss maintenance intervention|behavioral weight loss maintenance intervention
5129628|NCT01093924|Weight loss|weight loss
5129629|NCT01093924|Weight loss maintenance|weight loss maintenance
5129630|NCT01093911|Lupus|lupus
5129631|NCT01093911|SLE|sle
5129632|NCT01093859|acetylcholinesterase|acetylcholinesterase
5129633|NCT01093846|uveitis|uveitis
5129634|NCT01093833|Diabetes|diabetes
5129635|NCT01093833|Type 1 diabetes|type 1 diabetes
5129636|NCT01093833|Type 2 diabetes|type 2 diabetes
5129637|NCT01093833|Diabetes mellitus|diabetes mellitus
5129638|NCT01093833|Blood glucose|blood glucose
5129639|NCT01093833|Continuous blood glucose monitoring|continuous blood glucose monitoring
5129640|NCT01093833|CGM|cgm
5129641|NCT01093820|acute myocardial infarction|acute myocardial infarction
5129642|NCT01093820|continuous erythropoetin receptor activator|continuous erythropoetin receptor activator
5129643|NCT01093820|Mircera|mircera
5129644|NCT01093820|hemoglobin kinetics|hemoglobin kinetics
5129645|NCT01093807|Hypertension|hypertension
5129646|NCT01093807|Lercanidipine|lercanidipine
5129647|NCT01093807|Calcium antagonist|calcium antagonist
5129648|NCT01093807|Enalapril|enalapril
5129649|NCT01093794|Type 2 Diabetes|type 2 diabetes
5129650|NCT01093781|membranous nephropathy aliskiren proteinuria, glomerulonephritis|membranous nephropathy aliskiren proteinuria, glomerulonephritis
5129651|NCT01093768|Oxytocin|oxytocin
5129652|NCT01093768|Vasopressin|vasopressin
5129653|NCT01093768|Autism|autism
5129654|NCT01093768|Amygdala|amygdala
5129655|NCT01093768|Social Cognition|social cognition
5130141|NCT01091831|CD 34|cd 34
5129656|NCT01093768|Autism Spectrum Disorders|autism spectrum disorders
5129657|NCT01093768|ASD|asd
5129658|NCT01093768|Healthy Volunteer|healthy volunteer
5129659|NCT01093768|HV|hv
5129660|NCT01093755|Barrett's Esophagus|barrett's esophagus
5129661|NCT01093755|Radiofrequency ablation|radiofrequency ablation
5129662|NCT01093755|Patients post-radiofrequency ablation for Barrett's Esophagus.|patients post-radiofrequency ablation for barrett's esophagus.
5129663|NCT01093742|Healthy|healthy
5129664|NCT01093729|Exendin-4|exendin-4
5129665|NCT01093716|Alcohol dependence|alcohol dependence
5129666|NCT01093716|Craving|craving
5129667|NCT01093716|rTMS|rtms
5129668|NCT01093716|Dorsolateral prefrontal cortex|dorsolateral prefrontal cortex
5129669|NCT01093703|kidney transplantation|kidney transplantation
5129670|NCT01093703|hypertension|hypertension
5129671|NCT01093703|chronotherapy|chronotherapy
5129672|NCT01093703|graft function|graft function
5129673|NCT01093703|circadian pattern|circadian pattern
5129674|NCT01093690|chemotherapy induced nausea and vomiting, metoclopramide|chemotherapy induced nausea and vomiting, metoclopramide
5129675|NCT01093612|HER2-positive breast cancer|her2-positive breast cancer
5129676|NCT01093599|Smoking|smoking
5129677|NCT01093599|Smoking cessation|smoking cessation
5129678|NCT01093599|Nicotine|nicotine
5129679|NCT01093599|Tobacco|tobacco
5129680|NCT01093599|Mindfulness|mindfulness
5129681|NCT01093599|Meditation|meditation
5129682|NCT01093599|MBSR|mbsr
5129683|NCT01093599|Mindfulness Training|mindfulness training
5129684|NCT01093599|Behavioral Intervention|behavioral intervention
5129685|NCT01093599|Nicotine Patch|nicotine patch
5129686|NCT01093599|Quit Line|quit line
5129687|NCT01093599|Phone counseling|phone counseling
5129688|NCT01093573|Untreated myelodysplastic syndromes|untreated myelodysplastic syndromes
5129689|NCT01093560|metabolic syndrome|metabolic syndrome
5129690|NCT01093560|premenopausal women|premenopausal women
5129691|NCT01093560|fat feeding|fat feeding
5129692|NCT01093534|Vesicare|vesicare
5129693|NCT01093534|Solifenacin|solifenacin
5129694|NCT01093534|Detrusor Overactivity|detrusor overactivity
5129695|NCT01093534|Urinary Nerve Growth Factor|urinary nerve growth factor
5129696|NCT01093534|Overactive Bladder|overactive bladder
5129697|NCT01093534|Bladder wall thickness|bladder wall thickness
5129698|NCT01093521|IV Gallium|iv gallium
5129699|NCT01093521|Gallium|gallium
5129700|NCT01093521|Ganite|ganite
5129701|NCT01093521|Cystic Fibrosis|cystic fibrosis
5129702|NCT01093521|Gallium Infusion|gallium infusion
5129703|NCT01093495|Nasal Continuous positive Airway pressure|nasal continuous positive airway pressure
5129704|NCT01093495|Nasal Cannula|nasal cannula
5129705|NCT01093495|CPAP|cpap
5129706|NCT01093495|Premature|premature
5129707|NCT01093495|RDS|rds
5129708|NCT01093495|HMD|hmd
5129709|NCT01093495|NICU|nicu
5129710|NCT01093482|mechanical ventilation|mechanical ventilation
5129711|NCT01093482|epidemiology|epidemiology
5129712|NCT01093482|outcomes|outcomes
5129713|NCT01093482|mortality|mortality
5129714|NCT01093482|weaning|weaning
5129715|NCT01093482|sedation|sedation
5129716|NCT01093482|non-invasive positive pressure ventilation|non-invasive positive pressure ventilation
5129717|NCT01093469|Atopic Dermatitis|atopic dermatitis
5129718|NCT01093469|Wake Forest|wake forest
5129719|NCT01093469|Dermatology|dermatology
5129720|NCT01093469|Skin|skin
5129721|NCT01093469|Over-the-counter|over-the-counter
5129722|NCT01093469|Moisturizer|moisturizer
5129723|NCT01093469|Children|children
5129724|NCT01093456|diurnal variation|diurnal variation
5129725|NCT01093456|peritoneal dialysis|peritoneal dialysis
5129726|NCT01093456|uremic retention solutes|uremic retention solutes
5129727|NCT01093456|phosphorous|phosphorous
5129728|NCT01093456|indoxyl sulfate|indoxyl sulfate
5129729|NCT01093456|p-cresol sulfate|p-cresol sulfate
5129730|NCT01093443|IVF|ivf
5129731|NCT01093443|ICSI|icsi
5129732|NCT01093443|GnRH antagonist|gnrh antagonist
5129733|NCT01093443|pretreatment|pretreatment
5129734|NCT01093430|Gynecological surgery|gynecological surgery
5129735|NCT01093430|laparoscopic ports|laparoscopic ports
5129736|NCT01093430|neuropathy|neuropathy
5129737|NCT01093417|Vitamin D|vitamin d
5129738|NCT01093417|Human Immunodeficiency Virus (HIV)|human immunodeficiency virus (hiv)
5129739|NCT01093417|Complementary Therapies|complementary therapies
5129740|NCT01093404|Heart disease|heart disease
5129741|NCT01093404|Myocardial infarction|myocardial infarction
5129742|NCT01093404|Angioplasty|angioplasty
5129743|NCT01093404|Thrombus aspiration|thrombus aspiration
5129744|NCT01093391|coronary artery|coronary artery
5129745|NCT01093391|thrombosis|thrombosis
5129746|NCT01093391|stent|stent
5129747|NCT01093378|Infertility|infertility
5129748|NCT01093378|Obesity|obesity
5129749|NCT01093378|Dietary intake|dietary intake
5129750|NCT01093378|Fertility|fertility
5129751|NCT01093378|nutrition|nutrition
5129752|NCT01093378|diet|diet
5129753|NCT01093378|weight|weight
5129754|NCT01093365|Schizophrenia|schizophrenia
5129755|NCT01093365|Schizoaffective Disorder|schizoaffective disorder
5129756|NCT01093365|Varenicline|varenicline
5129757|NCT01093365|Champix|champix
5129758|NCT01093365|Chantix|chantix
5129759|NCT01093365|Nicotine|nicotine
5130329|NCT01090882|Pain scores|pain scores
5129760|NCT01093365|Nicotinic receptor|nicotinic receptor
5129761|NCT01093365|Dopamine|dopamine
5129762|NCT01093365|Acetylcholine|acetylcholine
5129763|NCT01093365|Cigarette|cigarette
5129764|NCT01093365|Smoking|smoking
5129765|NCT01093365|Tobacco|tobacco
5129766|NCT01093365|Executive function|executive function
5129767|NCT01093365|Working memory|working memory
5129768|NCT01093365|Verbal memory|verbal memory
5129769|NCT01093365|Cognitive function|cognitive function
5129770|NCT01093365|Neuropsychological function|neuropsychological function
5129771|NCT01093352|Alveolar-decortication|alveolar-decortication
5129772|NCT01093352|Corticotomy assisted orthodontics|corticotomy assisted orthodontics
5129773|NCT01093352|Palatally impacted canine|palatally impacted canine
5129774|NCT01093352|Surgical exposure of canines|surgical exposure of canines
5129775|NCT01093352|Velocity of tooth movement|velocity of tooth movement
5129776|NCT01093339|GERD|gerd
5129777|NCT01093339|SLEEP DEPRIVATION|sleep deprivation
5129778|NCT01093339|APPETITE REGULATION|appetite regulation
5129779|NCT01093339|GHRELIN|ghrelin
5129780|NCT01093339|LEPTIN|leptin
5129781|NCT01093274|colonoscopy|colonoscopy
5129782|NCT01093274|Cathartics|cathartics
5129783|NCT01093274|Sodium picosulfate|sodium picosulfate
5129784|NCT01093274|Polyethylene Glycol|polyethylene glycol
5129785|NCT01093261|trauma|trauma
5129786|NCT01093261|trauma brain injury|trauma brain injury
5129787|NCT01093261|multiple trauma|multiple trauma
5129788|NCT01093261|head trauma|head trauma
5129789|NCT01093261|hydrocortisone|hydrocortisone
5129790|NCT01093261|fludrocortisone|fludrocortisone
5129791|NCT01093261|glucocorticoid insufficiency related to ICU|glucocorticoid insufficiency related to icu
5129792|NCT01093261|adrenal Insufficiency|adrenal insufficiency
5129793|NCT01093261|pneumonia|pneumonia
5129794|NCT01093261|intensive care unit|intensive care unit
5129795|NCT01093261|shock|shock
5129796|NCT01093261|neurological recovery|neurological recovery
5129797|NCT01093235|cardiac toxicity|cardiac toxicity
5129798|NCT01093235|perioperative/postoperative complications|perioperative/postoperative complications
5129799|NCT01093235|HER2-negative breast cancer|her2-negative breast cancer
5129800|NCT01093235|male breast cancer|male breast cancer
5129801|NCT01093235|estrogen receptor-negative breast cancer|estrogen receptor-negative breast cancer
5129802|NCT01093235|estrogen receptor-positive breast cancer|estrogen receptor-positive breast cancer
5129803|NCT01093235|progesterone receptor-negative breast cancer|progesterone receptor-negative breast cancer
5129804|NCT01093235|progesterone receptor-positive breast cancer|progesterone receptor-positive breast cancer
5129805|NCT01093235|stage II breast cancer|stage ii breast cancer
5129806|NCT01093235|stage IIIA breast cancer|stage iiia breast cancer
5129807|NCT01093235|stage IIIB breast cancer|stage iiib breast cancer
5129808|NCT01093235|inflammatory breast cancer|inflammatory breast cancer
5129809|NCT01093209|Carpal Tunnel Syndrome|carpal tunnel syndrome
5129810|NCT01093209|Interferential laser therapy|interferential laser therapy
5129811|NCT01093209|Low-level laser therapy|low-level laser therapy
5129812|NCT01093209|Neuropathic pain|neuropathic pain
5129813|NCT01093209|Median nerve compression|median nerve compression
5129814|NCT01093196|Multiple Myeloma|multiple myeloma
5129815|NCT01093196|Elderly Patients|elderly patients
5129816|NCT01093196|Diagnosis|diagnosis
5129817|NCT01093196|Lenalidomide|lenalidomide
5129818|NCT01093196|Prednisone|prednisone
5129819|NCT01093196|Melphalan|melphalan
5129820|NCT01093196|Dexamethasone|dexamethasone
5129821|NCT01093196|Cyclophosphamide|cyclophosphamide
5129822|NCT01093157|Kidney disease, Glomerulonephritis|kidney disease, glomerulonephritis
5129823|NCT01093144|Delivery mode|delivery mode
5129824|NCT01093144|pelvic measurement|pelvic measurement
5129825|NCT01093131|Contrast induced nephropathy|contrast induced nephropathy
5129826|NCT01093131|Percutaneous transluminal coronary angioplasty|percutaneous transluminal coronary angioplasty
5129827|NCT01093131|chronic kidney disease|chronic kidney disease
5129828|NCT01093131|Prevention|prevention
5129829|NCT01093131|Equivalence|equivalence
5129830|NCT01093118|Distal subungual onychomycosis|distal subungual onychomycosis
5129831|NCT01093105|Leukodystrophy, Globoid Cell|leukodystrophy, globoid cell
5129832|NCT01093105|Classic Globoid Cell Leukodystrophy|classic globoid cell leukodystrophy
5129833|NCT01093105|Early-Onset Globoid Cell Leukodystrophy|early-onset globoid cell leukodystrophy
5129834|NCT01093105|Globoid Cell Leukodystrophy|globoid cell leukodystrophy
5129835|NCT01093105|Globoid Cell Leukoencephalopathy|globoid cell leukoencephalopathy
5129836|NCT01093105|Infantile Globoid Cell Leukodystrophy|infantile globoid cell leukodystrophy
5129837|NCT01093105|Late-Onset Globoid Cell Leukodystrophy|late-onset globoid cell leukodystrophy
5129838|NCT01093105|Leukodystrophy, Globoid Cell, Classic|leukodystrophy, globoid cell, classic
5129839|NCT01093105|Leukodystrophy, Globoid Cell, Early-Onset|leukodystrophy, globoid cell, early-onset
5129840|NCT01093105|Leukodystrophy, Globoid Cell, Infantile|leukodystrophy, globoid cell, infantile
5129841|NCT01093105|Leukodystrophy, Globoid Cell, Late-Onset|leukodystrophy, globoid cell, late-onset
5129842|NCT01093105|Psychosine|psychosine
5129843|NCT01093105|galactosylsphingosine (psychosine) beta-galactosidase|galactosylsphingosine (psychosine) beta-galactosidase
5129844|NCT01093105|Psychosine-UDP galactosyltransferase|psychosine-udp galactosyltransferase
5129845|NCT01093105|Krabbe Disease|krabbe disease
5129846|NCT01093105|Krabbe Leukodystrophy|krabbe leukodystrophy
5130330|NCT01090882|Bupivocaine|bupivocaine
5129847|NCT01093105|Krabbe's Disease|krabbe's disease
5129848|NCT01093105|Krabbe's Leukodystrophy|krabbe's leukodystrophy
5129849|NCT01093079|Renal tumor, RCC, Partial nephrectomy, Laparoscopy|renal tumor, rcc, partial nephrectomy, laparoscopy
5129850|NCT01093066|urothelial carcinoma|urothelial carcinoma
5129851|NCT01093066|TURB|turb
5129852|NCT01093066|chemotherapy|chemotherapy
5129853|NCT01093053|Mind-Body Therapies|mind-body therapies
5129854|NCT01093027|Essential Tremor|essential tremor
5129855|NCT01093027|Cooling|cooling
5129856|NCT01093027|Temperature|temperature
5129857|NCT01093027|Patients with Essential Tremor involving the upper limbs with at least moderate tremor.|patients with essential tremor involving the upper limbs with at least moderate tremor.
5129858|NCT01093014|Quadriceps Muscle|quadriceps muscle
5129859|NCT01093014|RNA, Messenger|rna, messenger
5129860|NCT01093014|Hypertrophy|hypertrophy
5129861|NCT01093014|Electric Stimulation Therapy|electric stimulation therapy
5129862|NCT01093001|Reduce Tricuspid Regurgitation|reduce tricuspid regurgitation
5129863|NCT01093001|Reduce Right Ventricular pacing|reduce right ventricular pacing
5129864|NCT01093001|Lead position|lead position
5129865|NCT01093001|Lead size|lead size
5129866|NCT01092988|Uterine Fibroids|uterine fibroids
5129867|NCT01092988|Bleeding|bleeding
5129868|NCT01092988|Pain|pain
5129869|NCT01092988|Quality of life|quality of life
5129870|NCT01092988|MR guided focused ultrasound|mr guided focused ultrasound
5129871|NCT01092975|radiotherapy|radiotherapy
5129873|NCT01092962|Mycophenolate mofetil|mycophenolate mofetil
5129874|NCT01092962|Cyclophosphamide|cyclophosphamide
5129875|NCT01092962|Idiopathic nephrotic steroid sensitive syndrome|idiopathic nephrotic steroid sensitive syndrome
5129876|NCT01092949|Placenta|placenta
5129877|NCT01092949|perfusion|perfusion
5129878|NCT01092949|MRI|mri
5129879|NCT01092949|spin tagging|spin tagging
5129880|NCT01092949|Gadolinium|gadolinium
5129881|NCT01092949|placental insufficiency|placental insufficiency
5129882|NCT01092949|urinary tract, sexual organs and pregnancy conditions|urinary tract, sexual organs and pregnancy conditions
5129883|NCT01092936|Comparative fit index|comparative fit index
5129884|NCT01092936|Movement Disorders' Society|movement disorders' society
5129885|NCT01092936|Unified Parkinson's Disease Rating Scale|unified parkinson's disease rating scale
5129886|NCT01092923|Nitrous Oxide|nitrous oxide
5129887|NCT01092923|washin|washin
5129888|NCT01092923|washout|washout
5129889|NCT01092923|second gas effect|second gas effect
5129890|NCT01092923|sevoflurane|sevoflurane
5129891|NCT01092923|induction|induction
5129892|NCT01092923|emergence|emergence
5129893|NCT01092910|Sensorineural|sensorineural
5129894|NCT01092910|Hearing Loss|hearing loss
5129895|NCT01092884|melasma|melasma
5129896|NCT01092884|sunscreen|sunscreen
5129897|NCT01092884|polypodium leucotomos|polypodium leucotomos
5129898|NCT01092858|Testosterone undecanoate|testosterone undecanoate
5129899|NCT01092858|Hypogonadism|hypogonadism
5129900|NCT01092845|Double-Blind|double-blind
5129901|NCT01092845|Randomized|randomized
5129902|NCT01092845|Placebo-Controlled|placebo-controlled
5129903|NCT01092845|2-Way Crossover|2-way crossover
5129904|NCT01092845|Polysomnographic Endpoints|polysomnographic endpoints
5129905|NCT01092832|Invasive Candidiasis Candidemia Esophageal Candidiasis|invasive candidiasis candidemia esophageal candidiasis
5129906|NCT01092819|acute ischemic stroke, large vessel occlusion, natural history, functional outcome|acute ischemic stroke, large vessel occlusion, natural history, functional outcome
5129907|NCT01092806|tacrolimus|tacrolimus
5129908|NCT01092806|pharmacokinetics|pharmacokinetics
5129909|NCT01092806|formulations|formulations
5129910|NCT01092806|once daily|once daily
5129911|NCT01092806|twice daily|twice daily
5129912|NCT01092806|renal transplant recipients|renal transplant recipients
5129913|NCT01092806|Kidney transplantation|kidney transplantation
5129914|NCT01092793|Fish oil|fish oil
5129915|NCT01092793|Krill|krill
5129916|NCT01092793|CAD|cad
5129917|NCT01092767|Thoracic Aneurysm|thoracic aneurysm
5129918|NCT01092767|Thoracic Transection|thoracic transection
5129919|NCT01092767|Endovascular Aortic Repair|endovascular aortic repair
5129920|NCT01092754|brain, spine, liver, MRI, Pediatric|brain, spine, liver, mri, pediatric
5129921|NCT01092741|Leukemia|leukemia
5129922|NCT01092741|Gleevec|gleevec
5129923|NCT01092741|STI571|sti571
5129924|NCT01092741|CML|cml
5129925|NCT01092741|Chronic Myelogenous Leukemia|chronic myelogenous leukemia
5129926|NCT01092728|Acral lentiginous melanoma|acral lentiginous melanoma
5129927|NCT01092728|Mucosal melanoma|mucosal melanoma
5129928|NCT01092728|Chronic sun-damaged melanoma|chronic sun-damaged melanoma
5129929|NCT01092728|Surgically removed tumor|surgically removed tumor
5129930|NCT01092728|biopsied|biopsied
5129931|NCT01092728|Sprycel|sprycel
5129932|NCT01092728|Dasatinib|dasatinib
5129933|NCT01092715|Neck pain|neck pain
5129934|NCT01092715|Spinal manipulation|spinal manipulation
5129935|NCT01092715|Massage|massage
5129936|NCT01092702|Tobacco Dependence|tobacco dependence
5129937|NCT01092702|Smoking|smoking
5129938|NCT01092702|Tobacco Cessation|tobacco cessation
5129939|NCT01092689|heterocyclic amines|heterocyclic amines
5129940|NCT01092689|PhIP|phip
5129941|NCT01092689|Meat|meat
5129942|NCT01092689|pancreas neoplasms|pancreas neoplasms
5129943|NCT01092676|Pediatrics|pediatrics
5129946|NCT01092663|type 2 diabetes|type 2 diabetes
5129947|NCT01092663|sitagliptin|sitagliptin
5129948|NCT01092663|glucose metabolism|glucose metabolism
5129949|NCT01092650|Tobacco toxicants|tobacco toxicants
5129950|NCT01092650|Polycyclic aromatic hydrocarbons|polycyclic aromatic hydrocarbons
5129951|NCT01092650|Smoking|smoking
5129952|NCT01092624|voiding dysfunction|voiding dysfunction
5129953|NCT01092624|defecatory dysfunction|defecatory dysfunction
5129954|NCT01092624|vaginal bulge symptoms|vaginal bulge symptoms
5129955|NCT01092611|long-term follow-up study|long-term follow-up study
5129956|NCT01092611|HIV-infected subjects|hiv-infected subjects
5129957|NCT01092611|HIV therapeutic vaccine|hiv therapeutic vaccine
5129958|NCT01092572|cystic fibrosis|cystic fibrosis
5129959|NCT01092572|adult cystic fibrosis|adult cystic fibrosis
5129960|NCT01092559|Diagnostic Techniques and Procedures|diagnostic techniques and procedures
5129961|NCT01092546|Amyloid|amyloid
5129962|NCT01092546|Normal pressure hydrocephalus (NPH)|normal pressure hydrocephalus (nph)
5129963|NCT01092546|Positron Emission Tomography (PET)|positron emission tomography (pet)
5129964|NCT01092546|Standard uptake value ratios (SUVR)|standard uptake value ratios (suvr)
5129965|NCT01092520|Gabapentin|gabapentin
5129966|NCT01092520|Burn Injuries in Children|burn injuries in children
5129967|NCT01092520|pruritus|pruritus
5129968|NCT01092507|Encephalitis|encephalitis
5129969|NCT01092507|Japanese Encephalitis|japanese encephalitis
5129970|NCT01092507|Japanese Encephalitis Vaccines|japanese encephalitis vaccines
5129971|NCT01092507|Infant|infant
5129972|NCT01092494|Endometrioma recurrence|endometrioma recurrence
5129973|NCT01092494|oral contraceptives|oral contraceptives
5129974|NCT01092494|gonadotropin-releasing hormone agonist|gonadotropin-releasing hormone agonist
5129975|NCT01092481|Adjuvant FOLFOX or CAPOX Therapy|adjuvant folfox or capox therapy
5129976|NCT01092481|Stage II/III Colon Cancer|stage ii/iii colon cancer
5129977|NCT01092481|Adjuvant Therapy|adjuvant therapy
5129978|NCT01092468|cancer|cancer
5129979|NCT01092468|reconstruction|reconstruction
5129980|NCT01092468|free flap|free flap
5129981|NCT01092468|surgery|surgery
5129982|NCT01092455|End Stage Renal Disease|end stage renal disease
5129983|NCT01092455|Renal Dialysis|renal dialysis
5129984|NCT01092455|Hemodialysis therapy|hemodialysis therapy
5129985|NCT01092455|Heparin|heparin
5129986|NCT01092455|Citrasate|citrasate
5129987|NCT01092455|Anticoagulant|anticoagulant
5129988|NCT01092442|Pulmonary Valve|pulmonary valve
5129989|NCT01092442|Right Ventricular Outflow Tract Reconstruction|right ventricular outflow tract reconstruction
5129990|NCT01092442|Ross Procedure|ross procedure
5129991|NCT01092429|CAD|cad
5129992|NCT01092416|CAD|cad
5129993|NCT01092416|Severely calcified lesion|severely calcified lesion
5129994|NCT01092390|randomized trial|randomized trial
5129995|NCT01092390|omega three fatty acids|omega three fatty acids
5129996|NCT01092364|Young adults|young adults
5129997|NCT01092351|urinary tract infection|urinary tract infection
5129998|NCT01092351|nitrofurantoin|nitrofurantoin
5129999|NCT01092338|Human Immunodeficiency Virus|human immunodeficiency virus
5130000|NCT01092338|Acquired Immune Deficiency Syndrome|acquired immune deficiency syndrome
5130001|NCT01092338|Vitamin D|vitamin d
5130002|NCT01092338|HIV|hiv
5130003|NCT01092338|Complementary therapies|complementary therapies
5130004|NCT01092325|Heart Failure|heart failure
5130005|NCT01092312|knee|knee
5130006|NCT01092312|arthroplasty|arthroplasty
5130007|NCT01092299|Phase I|phase i
5130008|NCT01092299|Relative bioavailability|relative bioavailability
5130009|NCT01092299|Pharmacokinetic study|pharmacokinetic study
5130010|NCT01092299|AZD1446|azd1446
5130011|NCT01092299|healthy volunteers|healthy volunteers
5130012|NCT01092286|Knee injury|knee injury
5130013|NCT01092286|ankle sprain|ankle sprain
5130014|NCT01092286|anterior cruciate ligament|anterior cruciate ligament
5130015|NCT01092286|adolescent|adolescent
5130016|NCT01092286|soccer|soccer
5130017|NCT01092286|basketball|basketball
5130018|NCT01092286|prevention|prevention
5130019|NCT01092273|Glaucoma and Ocular Hypertension|glaucoma and ocular hypertension
5130020|NCT01092260|Glomerular Filtration Rate|glomerular filtration rate
5130021|NCT01092260|Kidney disease|kidney disease
5130022|NCT01092260|Child|child
5130023|NCT01092260|Iohexol|iohexol
5130024|NCT01092260|Cystatin C|cystatin c
5130025|NCT01092260|Measurement of kidney function in children|measurement of kidney function in children
5130026|NCT01092247|Patients with malignant tumors|patients with malignant tumors
5130027|NCT01092234|Observational units|observational units
5130028|NCT01092234|Length of stay (LOS)|length of stay (los)
5130029|NCT01092234|Readmission|readmission
5130030|NCT01092221|mania, allopurinol, add-on treatment|mania, allopurinol, add-on treatment
5130031|NCT01092208|Autism|autism
5130032|NCT01092208|iPS Cells|ips cells
5130033|NCT01092208|Fibroblasts|fibroblasts
5130034|NCT01092208|Gene Networks|gene networks
5130035|NCT01092208|Tuberous Sclerosis|tuberous sclerosis
5130036|NCT01092208|Healthy Volunteer|healthy volunteer
5130037|NCT01092208|HV|hv
5130038|NCT01092195|Women's Health|women's health
5130039|NCT01092195|Genital Precancer|genital precancer
5130040|NCT01092195|Stem Cell Donor|stem cell donor
5130041|NCT01092195|Cervical Cytology|cervical cytology
5130042|NCT01092195|Healthy Volunteers|healthy volunteers
5130808|NCT01088906|First line|first line
5130043|NCT01092195|Stem Cell Transplant|stem cell transplant
5130044|NCT01092195|Healthy Volunteer|healthy volunteer
5130045|NCT01092195|HV|hv
5130046|NCT01092182|Microarray|microarray
5130047|NCT01092182|Toxicity|toxicity
5130048|NCT01092182|Therapeutic Index|therapeutic index
5130049|NCT01092182|HIV Positive|hiv positive
5130050|NCT01092182|HIV Negative|hiv negative
5130051|NCT01092182|Lymphoma|lymphoma
5130052|NCT01092182|Burkitt Lymphoma|burkitt lymphoma
5130053|NCT01092182|Diffuse Large B-Cell Lymphoma|diffuse large b-cell lymphoma
5130054|NCT01092182|HIV Infections|hiv infections
5130055|NCT01092156|Nipple pain during lactation|nipple pain during lactation
5130056|NCT01092130|Heart failure|heart failure
5130057|NCT01092130|Vitamin D|vitamin d
5130058|NCT01092130|Plasma renin activity|plasma renin activity
5130059|NCT01092130|Renin angiotensin system|renin angiotensin system
5130060|NCT01092117|abdominal|abdominal
5130061|NCT01092117|aortic|aortic
5130062|NCT01092117|aneurysm|aneurysm
5130063|NCT01092091|Neoplasm|neoplasm
5130064|NCT01092091|Hepatocellular Carcinoma|hepatocellular carcinoma
5130065|NCT01092078|hypertension|hypertension
5130066|NCT01092078|colon cancer screening|colon cancer screening
5130067|NCT01092078|african american|african american
5130068|NCT01092078|men|men
5130069|NCT01092078|motivational interviewing|motivational interviewing
5130070|NCT01092078|patient navigation|patient navigation
5130071|NCT01092065|Parkinson's Disease|parkinson's disease
5130072|NCT01092065|Dyskinesia|dyskinesia
5130073|NCT01092065|Drug-induced|drug-induced
5130074|NCT01092065|Levodopa|levodopa
5130075|NCT01092065|L-dopa|l-dopa
5130076|NCT01092052|Phase I study|phase i study
5130077|NCT01092052|Advanced/Metastatic Solid Tumors|advanced/metastatic solid tumors
5130078|NCT01092052|Cdc7 kinase inhibitor|cdc7 kinase inhibitor
5130079|NCT01092039|Common Cold|common cold
5130080|NCT01092039|Cold Virus|cold virus
5130081|NCT01092039|Feeling sick|feeling sick
5130082|NCT01092039|Influenza|influenza
5130083|NCT01092000|Health Promotion, Dietary Guidelines, Physical Activity Guidelines|health promotion, dietary guidelines, physical activity guidelines
5130084|NCT01091987|Insomnia|insomnia
5130085|NCT01091974|Insomnia|insomnia
5130086|NCT01091974|Fatigue|fatigue
5130087|NCT01091974|QOL|qol
5130088|NCT01091974|CBT|cbt
5130089|NCT01091974|Breast cancer|breast cancer
5130090|NCT01091974|Survivors|survivors
5130091|NCT01091974|Chemotherapy|chemotherapy
5130092|NCT01091961|ACE inhibitor|ace inhibitor
5130093|NCT01091961|ARB|arb
5130094|NCT01091961|Non-cardiac surgery|non-cardiac surgery
5130095|NCT01091961|Perioperative|perioperative
5130096|NCT01091961|Preoperative|preoperative
5130097|NCT01091961|Hypotension|hypotension
5130098|NCT01091961|Congestive heart failure|congestive heart failure
5130099|NCT01091961|Hypertension|hypertension
5130100|NCT01091961|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors
5130101|NCT01091961|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers
5130102|NCT01091961|Perioperative Care|perioperative care
5130103|NCT01091948|elective general surgery|elective general surgery
5130104|NCT01091948|orotracheal intubation|orotracheal intubation
5130105|NCT01091948|Patients would be eligible for inclusion if they were at least 18 years old and scheduled for elective surgery requiring orotracheal intubation.|patients would be eligible for inclusion if they were at least 18 years old and scheduled for elective surgery requiring orotracheal intubation.
5130106|NCT01091935|Lidocaine,Intravenous Infusions,Neuropathic Pain,Side Effects|lidocaine,intravenous infusions,neuropathic pain,side effects
5130107|NCT01091922|flavonoids|flavonoids
5130108|NCT01091922|flavanols|flavanols
5130109|NCT01091922|bacteria|bacteria
5130110|NCT01091909|type 2 diabetes|type 2 diabetes
5130111|NCT01091909|wound healing|wound healing
5130112|NCT01091909|neutrophil count|neutrophil count
5130113|NCT01091909|dental extraction|dental extraction
5130114|NCT01091896|bevacizumab|bevacizumab
5130115|NCT01091896|vitreous hemorrhage|vitreous hemorrhage
5130116|NCT01091896|diabetes mellitus|diabetes mellitus
5130117|NCT01091883|Bone cancer|bone cancer
5130118|NCT01091883|Bone Metastases|bone metastases
5130119|NCT01091883|pain palliation|pain palliation
5130120|NCT01091883|metastasis|metastasis
5130121|NCT01091883|breast cancer|breast cancer
5130122|NCT01091883|lung cancer|lung cancer
5130123|NCT01091883|prostate cancer|prostate cancer
5130124|NCT01091883|cancer related pain|cancer related pain
5130125|NCT01091883|tumors|tumors
5130126|NCT01091870|Aneurysm|aneurysm
5130127|NCT01091870|Vasospasm|vasospasm
5130128|NCT01091870|sildenafil|sildenafil
5130129|NCT01091870|Viagra|viagra
5130130|NCT01091857|Exercise|exercise
5130131|NCT01091857|Transdisciplinary|transdisciplinary
5130132|NCT01091857|Physiology|physiology
5130133|NCT01091857|Mood|mood
5130134|NCT01091857|Motivation|motivation
5130135|NCT01091844|voiding trial, urinary retention, catheterization|voiding trial, urinary retention, catheterization
5130136|NCT01091844|Urinary retention after gynecologic surgery|urinary retention after gynecologic surgery
5130137|NCT01091831|Multiple Myeloma|multiple myeloma
5130138|NCT01091831|Lenalidomide|lenalidomide
5130139|NCT01091831|High dose melphalan|high dose melphalan
5130140|NCT01091831|Mobilization|mobilization
5130142|NCT01091831|Newly Diagnosed patients|newly diagnosed patients
5130143|NCT01091818|To see if sedation with dexmedetomidine results in faster emergence after end of intensive care treatment in children|to see if sedation with dexmedetomidine results in faster emergence after end of intensive care treatment in children
5130144|NCT01091818|treatment|treatment
5130145|NCT01091792|GBM|gbm
5130146|NCT01091792|Grade IV|grade iv
5130147|NCT01091792|glioma|glioma
5130148|NCT01091779|Male patients scheduled to have spinal anaesthesia for TURP|male patients scheduled to have spinal anaesthesia for turp
5130149|NCT01091766|local anaesthetics toxicity|local anaesthetics toxicity
5130150|NCT01091766|heart arrhythmia|heart arrhythmia
5130151|NCT01091766|heart rate|heart rate
5130152|NCT01091766|heart conduction|heart conduction
5130153|NCT01091766|regional anaesthesia|regional anaesthesia
5130154|NCT01091766|paediatric anaesthesia|paediatric anaesthesia
5130155|NCT01091766|cardio-vascular system|cardio-vascular system
5130156|NCT01091766|prevention|prevention
5130157|NCT01091753|Non-dipper HTN patient|non-dipper htn patient
5130158|NCT01091740|Drug eluting stent|drug eluting stent
5130159|NCT01091740|Tomography, optical coherence|tomography, optical coherence
5130160|NCT01091727|Neurogenic|neurogenic
5130161|NCT01091727|Detrusor|detrusor
5130162|NCT01091727|Overactive|overactive
5130163|NCT01091727|Overactivity|overactivity
5130164|NCT01091727|Bladder|bladder
5130165|NCT01091727|Spinal|spinal
5130166|NCT01091727|Cord|cord
5130167|NCT01091727|Injury|injury
5130168|NCT01091701|Ischemic Cerebral Stroke|ischemic cerebral stroke
5130169|NCT01091688|neonatal|neonatal
5130170|NCT01091688|discharge planning|discharge planning
5130171|NCT01091688|health transition|health transition
5130172|NCT01091688|educational needs assessment|educational needs assessment
5130173|NCT01091688|Intensive care, neonatal|intensive care, neonatal
5130174|NCT01091675|ankylosing spondylitis|ankylosing spondylitis
5130175|NCT01091675|biologic therapies|biologic therapies
5130176|NCT01091675|ASAS|asas
5130177|NCT01091675|ASASBIO|asasbio
5130178|NCT01091675|etoricoxib|etoricoxib
5130179|NCT01091675|NSAIDs|nsaids
5130180|NCT01091675|COX-2 Inhibitor|cox-2 inhibitor
5130181|NCT01091675|ARCOXIA 90 mg|arcoxia 90 mg
5130182|NCT01091675|BASDAI Bath Ankylosing Spondylitis Disease Activity Index|basdai bath ankylosing spondylitis disease activity index
5130183|NCT01091662|Seizures|seizures
5130184|NCT01091662|Epilepsy|epilepsy
5130185|NCT01091662|Anticonvulsant|anticonvulsant
5130186|NCT01091662|Monotherapy|monotherapy
5130187|NCT01091662|Historical control|historical control
5130188|NCT01091649|Pharmacokinetics, Safety|pharmacokinetics, safety
5130189|NCT01091623|improvement of exercise capacity in patients with COPD|improvement of exercise capacity in patients with copd
5130190|NCT01091610|retrospective study|retrospective study
5130191|NCT01091610|wounds and injuries/epidemiology|wounds and injuries/epidemiology
5130192|NCT01091610|emergency medical technicians|emergency medical technicians
5130193|NCT01091610|human|human
5130194|NCT01091610|emergency medical services|emergency medical services
5130195|NCT01091610|ambulance|ambulance
5130196|NCT01091610|health personnel|health personnel
5130197|NCT01091610|emergency medicine|emergency medicine
5130198|NCT01091610|risk factors|risk factors
5130199|NCT01091571|Adenosine|adenosine
5130200|NCT01091571|Endotoxin|endotoxin
5130201|NCT01091571|Innate Immunity|innate immunity
5130202|NCT01091571|Dipyridamole|dipyridamole
5130203|NCT01091558|ulcerative colitis|ulcerative colitis
5130204|NCT01091558|colon cancer|colon cancer
5130205|NCT01091558|endoscopy|endoscopy
5130206|NCT01091558|screening|screening
5130207|NCT01091545|breast cancer|breast cancer
5130208|NCT01091545|screening|screening
5130209|NCT01091545|sensitivity|sensitivity
5130210|NCT01091545|tomosynthesis|tomosynthesis
5130211|NCT01091519|Non-interventional study fesoterodine educational materials|non-interventional study fesoterodine educational materials
5130212|NCT01091506|L-methylfolate|l-methylfolate
5130213|NCT01091506|Deplin|deplin
5130214|NCT01091506|schizophrenia|schizophrenia
5130215|NCT01091506|folate|folate
5130216|NCT01091506|folic acid|folic acid
5130217|NCT01091506|homocysteine|homocysteine
5130218|NCT01091506|methionine|methionine
5130219|NCT01091506|MTHFR genotype|mthfr genotype
5130220|NCT01091506|C677T mutation|c677t mutation
5130221|NCT01091506|vitamin B6|vitamin b6
5130222|NCT01091506|vitamin B12|vitamin b12
5130223|NCT01091506|psychotic symptoms|psychotic symptoms
5130224|NCT01091506|MTHFR C677T Polymorphism|mthfr c677t polymorphism
5130225|NCT01091493|COPD|copd
5130226|NCT01091480|Hypertrophic cardiomyopathy|hypertrophic cardiomyopathy
5130227|NCT01091480|Observatory|observatory
5130228|NCT01091480|LVH|lvh
5130229|NCT01091467|Heart Failure|heart failure
5130230|NCT01091467|Ejection Fraction|ejection fraction
5130231|NCT01091467|Echocardiography|echocardiography
5130232|NCT01091454|stage IV breast cancer|stage iv breast cancer
5130233|NCT01091454|triple-negative breast cancer|triple-negative breast cancer
5130234|NCT01091454|male breast cancer|male breast cancer
5130235|NCT01091441|therapeutic education|therapeutic education
5130236|NCT01091428|RECIST: Response Evaluation Criteria in Solid Tumors|recist: response evaluation criteria in solid tumors
5130237|NCT01091428|OC: Ovarian Cancer|oc: ovarian cancer
5130810|NCT01088893|everolimus|everolimus
5130238|NCT01091428|GCIG: Gynecologic Cancer Intergroup|gcig: gynecologic cancer intergroup
5130239|NCT01091428|Breast carcinoma (Phase 1)|breast carcinoma (phase 1)
5130240|NCT01091428|Drug therapy|drug therapy
5130241|NCT01091402|autologous serum skin test, IL-18|autologous serum skin test, il-18
5130242|NCT01091389|Atrial Fibrillation|atrial fibrillation
5130243|NCT01091389|Totally Thoracoscopic PV isolation|totally thoracoscopic pv isolation
5130244|NCT01091376|Non-small cell lung cancer|non-small cell lung cancer
5130245|NCT01091376|EGFR-TKI|egfr-tki
5130246|NCT01091376|Erlotinib|erlotinib
5130247|NCT01091376|Radiotherapy|radiotherapy
5130248|NCT01091363|smoking cessation|smoking cessation
5130249|NCT01091363|tobacco dependence treatment|tobacco dependence treatment
5130250|NCT01091363|cultural adaptation|cultural adaptation
5130251|NCT01091363|Asian Americans|asian americans
5130252|NCT01091324|CKD, proteinuria, dextromethorphan, silymarin|ckd, proteinuria, dextromethorphan, silymarin
5130253|NCT01091324|patients with 15 ml<eGFR< 60ml and 0.5 g/day<proteinuria<3g/day|patients with 15 ml<egfr< 60ml and 0.5 g/day<proteinuria<3g/day
5130254|NCT01091311|Meibomian Gland Dysfunction|meibomian gland dysfunction
5130255|NCT01091298|Safety of vaccine|safety of vaccine
5130256|NCT01091272|healthy volunteer|healthy volunteer
5130257|NCT01091272|safety|safety
5130258|NCT01091272|pharmacokinetic|pharmacokinetic
5130259|NCT01091259|antibody therapy|antibody therapy
5130260|NCT01091259|chemotherapy|chemotherapy
5130261|NCT01091259|biologic therapy|biologic therapy
5130262|NCT01091259|combination therapy|combination therapy
5130263|NCT01091233|Critically ill patients|critically ill patients
5130264|NCT01091233|liver cirrhosis|liver cirrhosis
5130265|NCT01091233|ascites requiring Paracentesis|ascites requiring paracentesis
5130266|NCT01091220|certolizumab pegol|certolizumab pegol
5130267|NCT01091220|Cimzia®|cimzia®
5130268|NCT01091220|healthy male volunteers|healthy male volunteers
5130269|NCT01091220|sperm|sperm
5130270|NCT01091207|Sorafenib|sorafenib
5130271|NCT01091207|GIST|gist
5130272|NCT01091207|Refractory|refractory
5130273|NCT01091207|advanced GIST failed after both imatinib and sunitinib|advanced gist failed after both imatinib and sunitinib
5130274|NCT01091194|Heart Transplantation|heart transplantation
5130275|NCT01091194|Aerobic Exercise|aerobic exercise
5130276|NCT01091194|Exercise, Physical|exercise, physical
5130277|NCT01091194|Exercise Test|exercise test
5130278|NCT01091194|Treadmill Test|treadmill test
5130279|NCT01091194|VO2 peak|vo2 peak
5130280|NCT01091194|Muscle Strength|muscle strength
5130281|NCT01091194|Quality of Life|quality of life
5130282|NCT01091194|Reinnervation|reinnervation
5130283|NCT01091194|Heart Rate|heart rate
5130284|NCT01091194|Myocardial Function|myocardial function
5130285|NCT01091181|Caesarean|caesarean
5130286|NCT01091155|Colon Anastomosis|colon anastomosis
5130287|NCT01091155|Rectum Anastomosis|rectum anastomosis
5130288|NCT01091155|Intestine|intestine
5130289|NCT01091155|Colorectal Surgery|colorectal surgery
5130290|NCT01091155|Colorectal Anastomosis|colorectal anastomosis
5130291|NCT01091129|hyperhidrosis|hyperhidrosis
5130292|NCT01091116|Injections, Intra-Articular|injections, intra-articular
5130293|NCT01091090|Smoking cessation|smoking cessation
5130294|NCT01091090|Nicotine dependence|nicotine dependence
5130295|NCT01091090|Chronic pain|chronic pain
5130296|NCT01091077|dietary supplement|dietary supplement
5130297|NCT01091051|Ustekinumab, Palmo-Plantar, Pustular Psoriasis, Pustulosis|ustekinumab, palmo-plantar, pustular psoriasis, pustulosis
5130298|NCT01091038|Adverse drug events|adverse drug events
5130299|NCT01091038|medical errors|medical errors
5130300|NCT01091038|computerized physician order entry|computerized physician order entry
5130301|NCT01091038|clinical decision support|clinical decision support
5130302|NCT01091025|Adults|adults
5130303|NCT01091025|Cystic Fibrosis Related Diabetes|cystic fibrosis related diabetes
5130304|NCT01091025|Screening|screening
5130305|NCT01091025|Oral glucose tolerance test|oral glucose tolerance test
5130306|NCT01091025|Royal Brompton & Harefield Foundation Trust|royal brompton & harefield foundation trust
5130307|NCT01090999|COPD|copd
5130308|NCT01090999|Pulmonary Rehabilitation|pulmonary rehabilitation
5130309|NCT01090986|Restrictive pulmonary disease with hypercapnic chronic respiratory failure.|restrictive pulmonary disease with hypercapnic chronic respiratory failure.
5130310|NCT01090986|COPD patients who need NIV hypercapnic chronic respiratory failure.|copd patients who need niv hypercapnic chronic respiratory failure.
5130311|NCT01090973|relapsed|relapsed
5130312|NCT01090973|refractory|refractory
5130313|NCT01090973|CLL|cll
5130314|NCT01090973|chronic lymphocytic leukemia|chronic lymphocytic leukemia
5130315|NCT01090973|MCL|mcl
5130316|NCT01090973|mantle cell lymphoma|mantle cell lymphoma
5130317|NCT01090934|Diagnosis|diagnosis
5130318|NCT01090934|Partial Epilepsy|partial epilepsy
5130319|NCT01090921|Multiple Myeloma|multiple myeloma
5130320|NCT01090921|Bortezomib|bortezomib
5130321|NCT01090921|Newly diagnosed|newly diagnosed
5130322|NCT01090921|Newly diagnosed Multiple Myeloma|newly diagnosed multiple myeloma
5130323|NCT01090895|Percutaneous Coronary Intervention|percutaneous coronary intervention
5130324|NCT01090895|Vitamin C|vitamin c
5130325|NCT01090895|Biomarkers|biomarkers
5130326|NCT01090895|Magnetic Risonance|magnetic risonance
5130327|NCT01090882|Local anaesthetic|local anaesthetic
5130328|NCT01090882|Laparoscopic cholecystectomy|laparoscopic cholecystectomy
5130331|NCT01090882|Day case surgery|day case surgery
5130332|NCT01090856|Bifurcations|bifurcations
5130333|NCT01090856|Drug eluting-stents|drug eluting-stents
5130334|NCT01090856|Provisional stenting|provisional stenting
5130335|NCT01090843|Obscure digestive bleeding (ODB)|obscure digestive bleeding (odb)
5130336|NCT01090843|Chronic anaemia of unknown origin|chronic anaemia of unknown origin
5130337|NCT01090843|Chronic diarrhoea|chronic diarrhoea
5130338|NCT01090830|Non small cell lung cancer|non small cell lung cancer
5130339|NCT01090830|Belinostat|belinostat
5130340|NCT01090830|carboplatin|carboplatin
5130341|NCT01090830|Paclitaxel|paclitaxel
5130342|NCT01090830|Bevacizumab|bevacizumab
5130343|NCT01090830|chemotherapy|chemotherapy
5130344|NCT01090830|Maximum Tolerated Dose|maximum tolerated dose
5130345|NCT01090830|Neoplasms, Pulmonary|neoplasms, pulmonary
5130346|NCT01090830|Lung Cancer|lung cancer
5130347|NCT01090830|Event Free Survival|event free survival
5130348|NCT01090830|Disease free survival|disease free survival
5130349|NCT01090830|Progression Free Survival|progression free survival
5130350|NCT01090830|Histone Deacetylase Inhibitors|histone deacetylase inhibitors
5130351|NCT01090830|Treatment Efficacy|treatment efficacy
5130352|NCT01090817|mesenchymal stromal cells|mesenchymal stromal cells
5130353|NCT01090817|ileitis|ileitis
5130354|NCT01090817|colitis|colitis
5130355|NCT01090804|BreatheMAX breathing device|breathemax breathing device
5130356|NCT01090804|Secretion clearance|secretion clearance
5130357|NCT01090804|Ventilatory dependence|ventilatory dependence
5130358|NCT01090804|Intubated patients|intubated patients
5130359|NCT01090791|critically ill patient|critically ill patient
5130360|NCT01090778|growth hormone deficiency|growth hormone deficiency
5130361|NCT01090778|circadian variation|circadian variation
5130362|NCT01090765|Prostate|prostate
5130363|NCT01090765|Tumor|tumor
5130364|NCT01090765|Cancer|cancer
5130365|NCT01090765|Hormone|hormone
5130366|NCT01090765|Androgen|androgen
5130367|NCT01090765|Prostate Cancer|prostate cancer
5130368|NCT01090752|diabetes|diabetes
5130369|NCT01090752|blood pressure|blood pressure
5130370|NCT01090752|pioglitazone|pioglitazone
5130371|NCT01090752|sodium|sodium
5130372|NCT01090752|insulin resistance, renal function, sodium, pioglitazone|insulin resistance, renal function, sodium, pioglitazone
5130373|NCT01090739|Fecal incontinence|fecal incontinence
5130374|NCT01090739|Accidental bowel leakage|accidental bowel leakage
5130375|NCT01090739|Failure conservative therapy|failure conservative therapy
5130376|NCT01090739|Women|women
5130377|NCT01090739|Class III medical device|class iii medical device
5130378|NCT01090739|Surgical mesh|surgical mesh
5130379|NCT01090700|TMC435-TiDP16-C112|tmc435-tidp16-c112
5130380|NCT01090700|TMC435-C112|tmc435-c112
5130381|NCT01090700|TMC435|tmc435
5130382|NCT01090700|HCV|hcv
5130383|NCT01090700|Hepatitis C|hepatitis c
5130384|NCT01090687|breast cancer, CT scans, mammography|breast cancer, ct scans, mammography
5130385|NCT01090674|Diaphragmatic force|diaphragmatic force
5130386|NCT01090674|mobility|mobility
5130387|NCT01090661|antisense|antisense
5130388|NCT01090661|ApoB (Apolipoprotein B)|apob (apolipoprotein b)
5130389|NCT01090661|LDL (low density lipoprotein)|ldl (low density lipoprotein)
5130390|NCT01090661|thorough QT|thorough qt
5130391|NCT01090648|TMC125HIV1083|tmc125hiv1083
5130392|NCT01090648|TMC125|tmc125
5130393|NCT01090648|HIV|hiv
5130394|NCT01090648|Etravirine|etravirine
5130395|NCT01090648|ETR|etr
5130396|NCT01090648|Intelence|intelence
5130397|NCT01090648|HIV Infections|hiv infections
5130398|NCT01090635|Cervical Intraepithelial Neoplasia|cervical intraepithelial neoplasia
5130399|NCT01090609|Coronary Stent|coronary stent
5130400|NCT01090609|Cobalt-Chromium coronary stent|cobalt-chromium coronary stent
5130401|NCT01090583|Cytokines|cytokines
5130402|NCT01090583|Pregnancy|pregnancy
5130403|NCT01090583|Cesarean|cesarean
5130404|NCT01090544|COPD|copd
5130405|NCT01090544|TNI|tni
5130406|NCT01090544|PaCO2|paco2
5130407|NCT01090492|Raynaud's phenomenon|raynaud's phenomenon
5130408|NCT01090492|vasospasm|vasospasm
5130409|NCT01090492|scleroderma|scleroderma
5130410|NCT01090492|systemic sclerosis|systemic sclerosis
5130411|NCT01090492|CREST|crest
5130412|NCT01090492|phosphodiesterase inhibitor|phosphodiesterase inhibitor
5130413|NCT01090479|Surgical site infections|surgical site infections
5130414|NCT01090479|Chlorhexidine|chlorhexidine
5130415|NCT01090479|Shoulder surgery|shoulder surgery
5130416|NCT01090466|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
5130417|NCT01090466|recurrent bladder cancer|recurrent bladder cancer
5130418|NCT01090466|recurrent urethral cancer|recurrent urethral cancer
5130419|NCT01090466|recurrent transitional cell cancer of the renal pelvis and ureter|recurrent transitional cell cancer of the renal pelvis and ureter
5130420|NCT01090466|stage IV bladder cancer|stage iv bladder cancer
5130421|NCT01090466|metastatic transitional cell cancer of the renal pelvis and ureter|metastatic transitional cell cancer of the renal pelvis and ureter
5130422|NCT01090466|regional transitional cell cancer of the renal pelvis and ureter|regional transitional cell cancer of the renal pelvis and ureter
5130423|NCT01090466|distal urethral cancer|distal urethral cancer
5130424|NCT01090466|proximal urethral cancer|proximal urethral cancer
5130425|NCT01090466|urethral cancer associated with invasive bladder cancer|urethral cancer associated with invasive bladder cancer
5130426|NCT01090466|stage IV urethral cancer|stage iv urethral cancer
5130427|NCT01090440|schizophrenia|schizophrenia
5130428|NCT01090440|GSK1144814|gsk1144814
5130429|NCT01090440|effect of food|effect of food
5130430|NCT01090440|healthy subjects|healthy subjects
5130431|NCT01090440|depressive disorder|depressive disorder
5130432|NCT01090440|pharmacokinetics|pharmacokinetics
5130433|NCT01090427|Ustekinumab|ustekinumab
5130434|NCT01090427|Injection|injection
5130435|NCT01090427|CNTO 1275|cnto 1275
5130436|NCT01090427|Stelara|stelara
5130437|NCT01090427|Pediatric psoriasis|pediatric psoriasis
5130438|NCT01090427|Adolescents|adolescents
5130439|NCT01090414|Idelalisib|idelalisib
5130440|NCT01090414|Chronic lymphocytic leukemia (CLL)|chronic lymphocytic leukemia (cll)
5130441|NCT01090414|Non-Hodgkin lymphoma (NHL)|non-hodgkin lymphoma (nhl)
5130442|NCT01090414|Phosphatidylinositol 3-kinase (PI3K)|phosphatidylinositol 3-kinase (pi3k)
5130443|NCT01090388|Cross-sectional survey|cross-sectional survey
5130444|NCT01090388|Health-related quality of life|health-related quality of life
5130445|NCT01090388|Symptom management|symptom management
5130446|NCT01090375|osteoarthritis|osteoarthritis
5130447|NCT01090375|biochemical markers|biochemical markers
5130448|NCT01090375|cartilage|cartilage
5130449|NCT01090375|inflammation|inflammation
5130450|NCT01090375|microdialysis|microdialysis
5130451|NCT01090362|Atrial fibrillation|atrial fibrillation
5130452|NCT01090362|Anticoagulation|anticoagulation
5130453|NCT01090362|Stroke|stroke
5130454|NCT01090362|Stroke prevention|stroke prevention
5130455|NCT01090362|Health Economics|health economics
5130456|NCT01090349|ICD, CRTD, Remote Care|icd, crtd, remote care
5130457|NCT01090336|platelet aggregation inhibition|platelet aggregation inhibition
5130458|NCT01090336|prasugrel|prasugrel
5130459|NCT01090336|clopidogrel|clopidogrel
5130460|NCT01090336|ACS|acs
5130461|NCT01090323|Deferasirox|deferasirox
5130462|NCT01090323|ICL670A|icl670a
5130463|NCT01090323|Iron chelators|iron chelators
5130464|NCT01090323|Sickle Cell Disease|sickle cell disease
5130465|NCT01090323|Transfusional Hemosiderosis|transfusional hemosiderosis
5130466|NCT01090310|Quiescent uveitis|quiescent uveitis
5130467|NCT01090310|intermediate uveitis|intermediate uveitis
5130468|NCT01090310|panuveitis|panuveitis
5130469|NCT01090310|posterior uveitis|posterior uveitis
5130470|NCT01090310|uveitis|uveitis
5130471|NCT01090310|NVS Definition: Words or phrases that best describe the protocol. Keywords help users find studies in the database.|nvs definition: words or phrases that best describe the protocol. keywords help users find studies in the database.
5130472|NCT01090310|Avoid acronyms, abbreviations and trade names.|avoid acronyms, abbreviations and trade names.
5130473|NCT01090310|Examples: Heart failure, aliskiren, heart attack, cardiovascular diseases|examples: heart failure, aliskiren, heart attack, cardiovascular diseases
5130474|NCT01090310|Psoriasis, inflammatory skin disease, scaly patches|psoriasis, inflammatory skin disease, scaly patches
5130475|NCT01090297|Obstructive Sleep Apnea Syndrome|obstructive sleep apnea syndrome
5130476|NCT01090297|Blood pressure|blood pressure
5130477|NCT01090297|Continuous Positive Airway Pressure|continuous positive airway pressure
5130478|NCT01090284|Inguinal hernia|inguinal hernia
5130479|NCT01090284|Immune system|immune system
5130480|NCT01090284|Cytokines|cytokines
5130481|NCT01090284|Prosthetic repair|prosthetic repair
5130482|NCT01090284|Oxidative Stress|oxidative stress
5130483|NCT01090271|Subacromial impingement syndrome|subacromial impingement syndrome
5130484|NCT01090271|Muscle Strength|muscle strength
5130485|NCT01090271|Resistance Training|resistance training
5130486|NCT01090258|cardiac surgery|cardiac surgery
5130487|NCT01090258|mechanical ventilation|mechanical ventilation
5130488|NCT01090258|automation|automation
5130489|NCT01090258|weaning|weaning
5130490|NCT01090245|contingency management|contingency management
5130491|NCT01090245|substance abuse treatment|substance abuse treatment
5130492|NCT01090245|criminal justice populations|criminal justice populations
5130493|NCT01090245|substance abuse treatment retention|substance abuse treatment retention
5130494|NCT01090245|HIV prevention in criminal justice settings|hiv prevention in criminal justice settings
5130495|NCT01090245|voucher based reinforcement therapy|voucher based reinforcement therapy
5130496|NCT01090245|Parole treatment admission for substance abusing parolees|parole treatment admission for substance abusing parolees
5130497|NCT01090245|Parole treatment retention for substance abusing parolees|parole treatment retention for substance abusing parolees
5130498|NCT01090245|HIV testing and counseling for substance abusing parolees|hiv testing and counseling for substance abusing parolees
5130499|NCT01090219|Inguinal Hernia|inguinal hernia
5130500|NCT01090219|contraction of two different meshes in the repair of inguinal hernias in men|contraction of two different meshes in the repair of inguinal hernias in men
5130501|NCT01090206|Hemophilia|hemophilia
5130502|NCT01090206|Vitamin D|vitamin d
5130503|NCT01090193|Obstructive jaundice|obstructive jaundice
5130504|NCT01090193|kidney histopathology|kidney histopathology
5130505|NCT01090193|lactulose|lactulose
5130506|NCT01090180|PTSD|ptsd
5130507|NCT01090180|combat|combat
5130508|NCT01090180|stress disorders|stress disorders
5130509|NCT01090180|veteran|veteran
5130510|NCT01090154|Ulcerative colitis|ulcerative colitis
5130511|NCT01090154|UC|uc
5130512|NCT01090154|Inflammatory Bowel Disease|inflammatory bowel disease
5130513|NCT01090141|Micafungin|micafungin
5130514|NCT01090141|Body Weight|body weight
5130811|NCT01088893|neoadjuvant|neoadjuvant
5130515|NCT01090141|Anti-Infective Agents|anti-infective agents
5130516|NCT01090141|Signs and Symptoms|signs and symptoms
5130517|NCT01090141|Mycoses|mycoses
5130518|NCT01090141|Therapeutic Uses|therapeutic uses
5130519|NCT01090141|Antifungal Agents|antifungal agents
5130520|NCT01090141|Overnutrition|overnutrition
5130521|NCT01090141|Pharmacologic Actions|pharmacologic actions
5130522|NCT01090076|Pressure Ulcer Wound|pressure ulcer wound
5130523|NCT01090076|Specialized Amino Acid Mixture|specialized amino acid mixture
5130524|NCT01090063|Palmar Plantar Psoriasis|palmar plantar psoriasis
5130525|NCT01090050|Chronic Migraine|chronic migraine
5130526|NCT01090050|Migraine|migraine
5130527|NCT01090050|Treximet|treximet
5130528|NCT01090050|naproxen|naproxen
5130529|NCT01090050|sumatriptan|sumatriptan
5130530|NCT01090037|ESRD|esrd
5130531|NCT01090037|Chronic Renal Failure|chronic renal failure
5130532|NCT01090037|Prostaglandin|prostaglandin
5130533|NCT01090037|Prostacyclin|prostacyclin
5130534|NCT01090037|Asian Multinational Study|asian multinational study
5130535|NCT01089998|Neoplasm|neoplasm
5130536|NCT01089998|PET/CT diagnosis|pet/ct diagnosis
5130537|NCT01089998|PET tracer|pet tracer
5130538|NCT01089998|Inflammation|inflammation
5130539|NCT01089972|radial artery|radial artery
5130540|NCT01089972|ulnar artery|ulnar artery
5130541|NCT01089972|catheterization|catheterization
5130542|NCT01089972|regional blood flow|regional blood flow
5130543|NCT01089959|Acid re-flux,GERD|acid re-flux,gerd
5130544|NCT01089959|sleep related arousals due to GERD|sleep related arousals due to gerd
5130545|NCT01089959|Treatment of acid reflux during sleep in patients with GERD.|treatment of acid reflux during sleep in patients with gerd.
5130546|NCT01089946|Mobilization|mobilization
5130547|NCT01089946|Hip arthroplasty|hip arthroplasty
5130548|NCT01089946|cardiovascular|cardiovascular
5130549|NCT01089933|Anesthesia|anesthesia
5130550|NCT01089933|Local Anesthetics|local anesthetics
5130551|NCT01089933|Analgesia|analgesia
5130552|NCT01089933|Quality of life|quality of life
5130553|NCT01089933|Paravertebral blocks|paravertebral blocks
5130554|NCT01089933|Arm morbidity|arm morbidity
5130555|NCT01089907|genomic|genomic
5130556|NCT01089907|childhood|childhood
5130557|NCT01089907|acute lymphoblastic leukemia|acute lymphoblastic leukemia
5130558|NCT01089894|18F-FLT|18f-flt
5130559|NCT01089894|PET|pet
5130560|NCT01089894|non-small cell lung cancer|non-small cell lung cancer
5130561|NCT01089894|cell proliferation|cell proliferation
5130562|NCT01089894|therapeutic response|therapeutic response
5130563|NCT01089894|18F-3'-fluoro-3'-deoxy-L-thymidine (18F-FLT)|18f-3'-fluoro-3'-deoxy-l-thymidine (18f-flt)
5130564|NCT01089881|prostate cancer|prostate cancer
5130565|NCT01089881|18F-fluorocholine|18f-fluorocholine
5130566|NCT01089881|PET|pet
5130567|NCT01089881|recurrence|recurrence
5130568|NCT01089881|metastases|metastases
5130569|NCT01089868|Glioblastoma multiforme|glioblastoma multiforme
5130570|NCT01089868|Microsurgery|microsurgery
5130571|NCT01089868|Stereotactic biopsy|stereotactic biopsy
5130572|NCT01089868|Radiochemotherapy|radiochemotherapy
5130573|NCT01089868|Temodar|temodar
5130574|NCT01089868|FET PET|fet pet
5130575|NCT01089868|Molecular imaging|molecular imaging
5130576|NCT01089855|Neuropathic Pain|neuropathic pain
5130577|NCT01089855|Brief Pain Inventory|brief pain inventory
5130578|NCT01089855|DN4 questionnaire|dn4 questionnaire
5130579|NCT01089855|ElectroCardioGram|electrocardiogram
5130580|NCT01089842|Secondary Prevention|secondary prevention
5130581|NCT01089842|Health Promotion|health promotion
5130582|NCT01089842|Behavioral Medicine|behavioral medicine
5130583|NCT01089842|Exercise Therapy|exercise therapy
5130584|NCT01089829|CKD|ckd
5130585|NCT01089829|Foot Ulceration|foot ulceration
5130586|NCT01089829|Diabetes|diabetes
5130587|NCT01089816|Influenza infections|influenza infections
5130588|NCT01089816|Orthomyxoviridae infections|orthomyxoviridae infections
5130589|NCT01089816|Influenza Human|influenza human
5130590|NCT01089803|laryngectomy|laryngectomy
5130591|NCT01089803|larynx|larynx
5130592|NCT01089803|hypopharynx|hypopharynx
5130593|NCT01089764|breast neoplasm|breast neoplasm
5130594|NCT01089764|breast cancer|breast cancer
5130595|NCT01089764|behavioral intervention|behavioral intervention
5130596|NCT01089764|online support|online support
5130597|NCT01089764|relationship distress|relationship distress
5130598|NCT01089764|dyadic coping|dyadic coping
5130599|NCT01089738|mulitple dose|mulitple dose
5130600|NCT01089738|pharmacokinetics|pharmacokinetics
5130601|NCT01089738|safety|safety
5130602|NCT01089738|healthy elderly volunteers|healthy elderly volunteers
5130603|NCT01089725|safety|safety
5130604|NCT01089725|efficacy|efficacy
5130605|NCT01089725|parallel group|parallel group
5130606|NCT01089725|double-blind|double-blind
5130607|NCT01089725|multicenter|multicenter
5130608|NCT01089725|injection|injection
5130609|NCT01089725|infusion|infusion
5130610|NCT01089725|osteoarthritis|osteoarthritis
5130611|NCT01089725|bridging|bridging
5130612|NCT01089725|subcutaneous|subcutaneous
5130613|NCT01089725|intravenous|intravenous
5130614|NCT01089725|tanezumab|tanezumab
5130615|NCT01089712|Infection|infection
5130616|NCT01089712|Cardiac Surgery|cardiac surgery
5130617|NCT01089712|Post Operative Cardiac Surgery Infection|post operative cardiac surgery infection
5130618|NCT01089712|Management Practices|management practices
5130619|NCT01089699|breast cancer|breast cancer
5130620|NCT01089699|support groups|support groups
5130621|NCT01089699|Primary diagnosis of breast cancer within the past three years.|primary diagnosis of breast cancer within the past three years.
5130622|NCT01089686|Chronic Cerebrospinal Venous Insufficiency|chronic cerebrospinal venous insufficiency
5130623|NCT01089673|retrospective data collection|retrospective data collection
5130624|NCT01089660|Influenza|influenza
5130625|NCT01089660|Pandemic Flu|pandemic flu
5130626|NCT01089660|Swine-origin Influenza|swine-origin influenza
5130627|NCT01089660|Inactivated split-virion vaccine|inactivated split-virion vaccine
5130628|NCT01089647|OSA|osa
5130629|NCT01089647|Medical treatment|medical treatment
5130630|NCT01089634|LV measurement|lv measurement
5130631|NCT01089634|CRT|crt
5130632|NCT01089634|Concerto|concerto
5130633|NCT01089634|LVCM|lvcm
5130634|NCT01089634|LV threshold|lv threshold
5130635|NCT01089634|new CRT|new crt
5130636|NCT01089608|Azyter in patients affected by chronic blepharitis.|azyter in patients affected by chronic blepharitis.
5130637|NCT01089595|Imatinib Resistance|imatinib resistance
5130638|NCT01089595|GIST|gist
5130639|NCT01089595|Advanced Disease|advanced disease
5130640|NCT01089595|Nilotinib|nilotinib
5130641|NCT01089582|non-interventional|non-interventional
5130642|NCT01089582|mild to moderate Alzheimer's|mild to moderate alzheimer's
5130643|NCT01089582|ARICEPT.|aricept.
5130644|NCT01089569|diabetes|diabetes
5130645|NCT01089569|continuous glucose monitoring|continuous glucose monitoring
5130646|NCT01089569|exenatide|exenatide
5130647|NCT01089569|insulin glargine|insulin glargine
5130648|NCT01089543|dyspepsia|dyspepsia
5130649|NCT01089543|rabeprazole|rabeprazole
5130650|NCT01089543|Japan|japan
5130651|NCT01089530|Fibrinogen|fibrinogen
5130652|NCT01089530|Cholesterol|cholesterol
5130653|NCT01089530|Cardiovascular risk factors|cardiovascular risk factors
5130654|NCT01089530|Primary prevention|primary prevention
5130655|NCT01089530|High levels fibrinogen|high levels fibrinogen
5130656|NCT01089530|High plasma fibrinogen|high plasma fibrinogen
5130657|NCT01089504|phenobarbital|phenobarbital
5130658|NCT01089504|neonate|neonate
5130659|NCT01089504|antiepileptic drugs|antiepileptic drugs
5130660|NCT01089504|neurodevelopmental outcome|neurodevelopmental outcome
5130661|NCT01089504|seizure|seizure
5130662|NCT01089491|Low back pain|low back pain
5130663|NCT01089491|Epiduroscopy|epiduroscopy
5130664|NCT01089491|Cytology|cytology
5130665|NCT01089491|Electrical stimulation|electrical stimulation
5130666|NCT01089478|Back pain|back pain
5130667|NCT01089478|Low back pain|low back pain
5130668|NCT01089478|Cytology|cytology
5130669|NCT01089478|Epiduroscopy|epiduroscopy
5130670|NCT01089478|Pain|pain
5130671|NCT01089478|Radiculopathy|radiculopathy
5130672|NCT01089465|Bed bugs|bed bugs
5130673|NCT01089465|Cimex|cimex
5130674|NCT01089465|insects|insects
5130675|NCT01089465|bites|bites
5130676|NCT01089452|Mild to moderate hypertension|mild to moderate hypertension
5130677|NCT01089439|Nitric oxide|nitric oxide
5130678|NCT01089426|Pediatric patients with Parenteral Nutrition (PN) induced Liver Injury|pediatric patients with parenteral nutrition (pn) induced liver injury
5130679|NCT01089400|influenza|influenza
5130680|NCT01089400|H1N1|h1n1
5130681|NCT01089400|lymphocytes|lymphocytes
5130682|NCT01089400|T cell|t cell
5130683|NCT01089400|CD4|cd4
5130684|NCT01089400|CD8|cd8
5130685|NCT01089400|cytokine|cytokine
5130686|NCT01089400|serology|serology
5130687|NCT01089400|broncho-alveolar lavage|broncho-alveolar lavage
5130688|NCT01089400|acute respiratory distress syndrome|acute respiratory distress syndrome
5130689|NCT01089400|ventilation|ventilation
5130690|NCT01089400|intensive care unit|intensive care unit
5130691|NCT01089387|radical prostatectomy|radical prostatectomy
5130692|NCT01089374|Phyllodes|phyllodes
5130693|NCT01089361|systemic inflammatory syndrome|systemic inflammatory syndrome
5130694|NCT01089361|sepsis syndrome|sepsis syndrome
5130695|NCT01089361|septic shock|septic shock
5130696|NCT01089361|Cytokine|cytokine
5130697|NCT01089361|Ketamine|ketamine
5130698|NCT01089348|Vaginosis, Bacterial|vaginosis, bacterial
5130699|NCT01089348|Prebiotics|prebiotics
5130700|NCT01089348|Lactofiltrum|lactofiltrum
5130701|NCT01089348|Therapy|therapy
5130702|NCT01089335|Sentinel node|sentinel node
5130703|NCT01089335|Thyroid cancer|thyroid cancer
5130704|NCT01089335|Thyroid neoplasia|thyroid neoplasia
5130705|NCT01089335|Follicular neoplasia|follicular neoplasia
5130706|NCT01089322|SEVERE ASTHMA|severe asthma
5130707|NCT01089322|RISK FACTORS|risk factors
5130708|NCT01089322|CHARACTERIZATION|characterization
5130709|NCT01089322|CLINICAL CONTROL|clinical control
5130710|NCT01089322|INFLAMMATORY MARKERS|inflammatory markers
5130711|NCT01089322|SEVERE|severe
5130712|NCT01089322|CONTROL|control
5130713|NCT01089309|Aldosterone Blockade|aldosterone blockade
5130714|NCT01089309|Arterial elasticity|arterial elasticity
5130715|NCT01089309|Glycemic control|glycemic control
5130716|NCT01089296|Infants born preterm|infants born preterm
5130809|NCT01088906|Non-squamous|non-squamous
5130717|NCT01089296|Early physiotherapy intervention|early physiotherapy intervention
5130718|NCT01089296|Motor development|motor development
5130719|NCT01089296|Parental participation|parental participation
5130720|NCT01089296|Parental competency|parental competency
5130721|NCT01089283|parkinson|parkinson
5130722|NCT01089283|fdg pet-ct|fdg pet-ct
5130723|NCT01089283|i123 dat scan|i123 dat scan
5130724|NCT01089283|LRRK2|lrrk2
5130725|NCT01089283|GBA|gba
5130726|NCT01089283|parkinson patients with known genetic characteristic|parkinson patients with known genetic characteristic
5130727|NCT01089270|Parkinson|parkinson
5130728|NCT01089270|fdg pet-ct|fdg pet-ct
5130729|NCT01089270|i123 dat scan|i123 dat scan
5130730|NCT01089270|first degree relatives of diagnosed Parkinson patients|first degree relatives of diagnosed parkinson patients
5130851|NCT01088737|prevention|prevention
5130731|NCT01089270|with no clinical evidence of movement disorders|with no clinical evidence of movement disorders
5130732|NCT01089257|Cardiovascular risks|cardiovascular risks
5130733|NCT01089257|Oxidative stress|oxidative stress
5130734|NCT01089257|Systemic inflammation|systemic inflammation
5130735|NCT01089257|Endothelial function|endothelial function
5130736|NCT01089257|Peripheral Arterial Tone|peripheral arterial tone
5130737|NCT01089257|Positive Airway Pressure|positive airway pressure
5130738|NCT01089244|Low grade glioma|low grade glioma
5130739|NCT01089244|Astrocytoma|astrocytoma
5130740|NCT01089244|Molecular imaging|molecular imaging
5130741|NCT01089244|FET PET|fet pet
5130742|NCT01089244|Therapy monitoring|therapy monitoring
5130743|NCT01089244|Temodar|temodar
5130744|NCT01089231|Hyperlipidemia|hyperlipidemia
5130745|NCT01089231|coronary heart disease|coronary heart disease
5130746|NCT01089231|gene expression|gene expression
5130747|NCT01089231|fish oil|fish oil
5130748|NCT01089231|DHA, EPA|dha, epa
5130749|NCT01089218|bronchoscopy|bronchoscopy
5130750|NCT01089218|post-bronchoscopy fever|post-bronchoscopy fever
5130751|NCT01089218|pneumonia|pneumonia
5130752|NCT01089218|cytokines|cytokines
5130753|NCT01089218|amoxicillin/clavulanate|amoxicillin/clavulanate
5130754|NCT01089218|prophylaxis|prophylaxis
5130755|NCT01089153|human blood, urine and fecal samples|human blood, urine and fecal samples
5130756|NCT01089140|pediatrics|pediatrics
5130757|NCT01089140|scoliosis|scoliosis
5130758|NCT01089140|tranexamic acid|tranexamic acid
5130759|NCT01089140|Investigating non-idiopathic scoliosis|investigating non-idiopathic scoliosis
5130760|NCT01089127|Indacaterol|indacaterol
5130761|NCT01089127|COPD|copd
5130762|NCT01089127|salmeterol|salmeterol
5130763|NCT01089114|Cardiac Imaging|cardiac imaging
5130764|NCT01089114|MR Spectroscopy|mr spectroscopy
5130765|NCT01089114|HIV|hiv
5130766|NCT01089114|Lipid Metabolism|lipid metabolism
5130767|NCT01089114|HIV Infection|hiv infection
5130768|NCT01089114|Cardiovascular Disease|cardiovascular disease
5130769|NCT01089114|HIV Infections|hiv infections
5130770|NCT01089088|recurrent urethral cancer|recurrent urethral cancer
5130771|NCT01089088|recurrent transitional cell cancer of the renal pelvis and ureter|recurrent transitional cell cancer of the renal pelvis and ureter
5130772|NCT01089088|metastatic transitional cell cancer of the renal pelvis and ureter|metastatic transitional cell cancer of the renal pelvis and ureter
5130773|NCT01089088|regional transitional cell cancer of the renal pelvis and ureter|regional transitional cell cancer of the renal pelvis and ureter
5130774|NCT01089088|posterior urethral cancer|posterior urethral cancer
5130775|NCT01089088|urethral cancer associated with invasive bladder cancer|urethral cancer associated with invasive bladder cancer
5130776|NCT01089088|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
5130777|NCT01089088|stage IV bladder cancer|stage iv bladder cancer
5130778|NCT01089088|recurrent bladder cancer|recurrent bladder cancer
5130779|NCT01089088|anterior urethral cancer|anterior urethral cancer
5130780|NCT01089075|neuropsychological effects of hydrocortisone replacement|neuropsychological effects of hydrocortisone replacement
5130781|NCT01089062|Healthy volunteers|healthy volunteers
5130782|NCT01089049|Urinary Estrogen Metabolites|urinary estrogen metabolites
5130783|NCT01089049|2-OH Estrone|2-oh estrone
5130784|NCT01089049|16-alpha-OH Estrone|16-alpha-oh estrone
5130785|NCT01089049|Urinary 2/16a Estrogen Metabolite Ratio|urinary 2/16a estrogen metabolite ratio
5130786|NCT01089036|ECMO|ecmo
5130787|NCT01089036|cardiogenic shock|cardiogenic shock
5130788|NCT01089036|ROS|ros
5130789|NCT01089036|GPx|gpx
5130790|NCT01089036|cytokines|cytokines
5130791|NCT01088997|Persistent pulmonary hypertension of newborn|persistent pulmonary hypertension of newborn
5130792|NCT01088997|PPHN|pphn
5130793|NCT01088997|Persistent pulmonary hypertension|persistent pulmonary hypertension
5130794|NCT01088997|Pulmonary hypertension|pulmonary hypertension
5130795|NCT01088997|Pulmonary hypertension of newborn|pulmonary hypertension of newborn
5130796|NCT01088958|Kenya|kenya
5130797|NCT01088958|Child Nutrition Disorders|child nutrition disorders
5130798|NCT01088958|Social marketing|social marketing
5130799|NCT01088945|Infant, Premature, Diseases|infant, premature, diseases
5130800|NCT01088932|Safety in Healthy Volunteers|safety in healthy volunteers
5130801|NCT01088919|ASP1941|asp1941
5130802|NCT01088919|Actos|actos
5130803|NCT01088919|pioglitazone hydrochloride|pioglitazone hydrochloride
5130804|NCT01088906|Phalcis|phalcis
5130805|NCT01088906|BRCA1|brca1
5130806|NCT01088906|RAP80|rap80
5130807|NCT01088906|TS|ts
5130812|NCT01088893|m-TOR inhibitor|m-tor inhibitor
5130813|NCT01088880|Familial Mediterranean Fever|familial mediterranean fever
5130814|NCT01088880|canakinumab|canakinumab
5130815|NCT01088880|colchicine resistance|colchicine resistance
5130816|NCT01088867|Pain|pain
5130817|NCT01088867|Acupuncture|acupuncture
5130818|NCT01088867|DNIC|dnic
5130819|NCT01088867|Electroacupuncture|electroacupuncture
5130820|NCT01088828|MRI, clubfoot, CTEV, Congenital Talipes Equinovarus|mri, clubfoot, ctev, congenital talipes equinovarus
5130821|NCT01088815|Adenocarcinoma|adenocarcinoma
5130822|NCT01088815|Hedgehog|hedgehog
5130823|NCT01088815|Neoplasms|neoplasms
5130824|NCT01088815|Digestive System Diseases|digestive system diseases
5130825|NCT01088815|Neoplasms by Site|neoplasms by site
5130826|NCT01088815|Digestive System Neoplasms|digestive system neoplasms
5130827|NCT01088815|Neoplasms by Histologic Type|neoplasms by histologic type
5130828|NCT01088815|Pancreatic Neoplasms|pancreatic neoplasms
5130829|NCT01088815|Pancreatic Diseases|pancreatic diseases
5130830|NCT01088815|Carcinoma|carcinoma
5130831|NCT01088802|Squamous Cell Carcinoma|squamous cell carcinoma
5130832|NCT01088802|Oropharynx|oropharynx
5130833|NCT01088789|Adenocarcinoma|adenocarcinoma
5130834|NCT01088789|Cyclophosphamide|cyclophosphamide
5130835|NCT01088789|Immunotherapy|immunotherapy
5130836|NCT01088789|Neo-Adjuvant|neo-adjuvant
5130837|NCT01088789|Pancreatic tumor vaccine|pancreatic tumor vaccine
5130838|NCT01088789|GM-CSF|gm-csf
5130839|NCT01088789|Randomize|randomize
5130840|NCT01088776|CKD|ckd
5130841|NCT01088776|hypertriglyceridemia|hypertriglyceridemia
5130842|NCT01088776|Fatty Acid Supplementation|fatty acid supplementation
5130843|NCT01088776|Children|children
5130844|NCT01088776|Omega-3|omega-3
5130845|NCT01088750|childhood nodular lymphocyte predominant Hodgkin lymphoma|childhood nodular lymphocyte predominant hodgkin lymphoma
5130846|NCT01088750|stage I childhood Hodgkin lymphoma|stage i childhood hodgkin lymphoma
5130847|NCT01088750|stage II childhood Hodgkin lymphoma|stage ii childhood hodgkin lymphoma
5130848|NCT01088737|Lentigo maligna|lentigo maligna
5130849|NCT01088737|melanoma|melanoma
5130850|NCT01088737|imiquimod|imiquimod
5130852|NCT01088711|Type 2 diabetes (T2D)|type 2 diabetes (t2d)
5130853|NCT01088698|psoriasis|psoriasis
5130854|NCT01088698|golimumab|golimumab
5130855|NCT01088698|TNF-alpha inhibition|tnf-alpha inhibition
5130856|NCT01088698|phototherapy|phototherapy
5130857|NCT01088698|311-nm|311-nm
5130858|NCT01088672|Stroke|stroke
5130859|NCT01088672|Ischemic|ischemic
5130860|NCT01088672|Thrombus|thrombus
5130861|NCT01088672|Embolectomy|embolectomy
5130862|NCT01088672|Thrombectomy|thrombectomy
5130863|NCT01088672|Concentric|concentric
5130864|NCT01088672|Embolus|embolus
5130865|NCT01088672|Mechanical|mechanical
5130866|NCT01088672|Trevo|trevo
5130867|NCT01088646|capsule endoscopy|capsule endoscopy
5130868|NCT01088646|small bowel disease|small bowel disease
5130869|NCT01088646|inflammatory bowel disease|inflammatory bowel disease
5130870|NCT01088646|Subjects indicated for EGD endoscopy|subjects indicated for egd endoscopy
5130871|NCT01088633|COPD|copd
5130872|NCT01088620|NSCLC|nsclc
5130873|NCT01088620|Stage IIIb or IV|stage iiib or iv
5130874|NCT01088620|Nonsquamous|nonsquamous
5130875|NCT01088620|KRAS-Wildtype|kras-wildtype
5130876|NCT01088607|Primary sclerosing cholangitis|primary sclerosing cholangitis
5130877|NCT01088607|Autoimmune hepatitis|autoimmune hepatitis
5130878|NCT01088607|Cholestatic liver disease|cholestatic liver disease
5130879|NCT01088607|Cirrhosis|cirrhosis
5130880|NCT01088607|Children|children
5130881|NCT01088607|Primary Sclerosing Cholangitis/Autoimmune Hepatitis Overlap|primary sclerosing cholangitis/autoimmune hepatitis overlap
5130882|NCT01088594|urinary sodium excretion|urinary sodium excretion
5130883|NCT01088594|Pioglitazone|pioglitazone
5130884|NCT01088594|Rosiglitazone|rosiglitazone
5130885|NCT01088594|Methodological study|methodological study
5130886|NCT01088581|hepatocellular carcinoma|hepatocellular carcinoma
5130887|NCT01088581|hepatic arterial infusion chemotherapy|hepatic arterial infusion chemotherapy
5130888|NCT01088581|5-fluorouracil|5-fluorouracil
5130889|NCT01088581|cisplatin|cisplatin
5130890|NCT01088581|adjuvant chemotherapy|adjuvant chemotherapy
5130891|NCT01088581|hepatectomy|hepatectomy
5130892|NCT01088568|Keratomileusis, laser in situ|keratomileusis, laser in situ
5130893|NCT01088568|Phakic Intraocular Lenses|phakic intraocular lenses
5130894|NCT01088568|myopia|myopia
5130895|NCT01088568|astigmatism|astigmatism
5130896|NCT01088568|Implantable Collamer Lens, Toric|implantable collamer lens, toric
5130897|NCT01088555|nephrolithiasis|nephrolithiasis
5130898|NCT01088555|calcium stones|calcium stones
5130899|NCT01088555|kidney stones|kidney stones
5130900|NCT01088555|hypercalciuria|hypercalciuria
5130901|NCT01088555|sodium thiosulfate|sodium thiosulfate
5130902|NCT01088555|Calcium containing kidney stones|calcium containing kidney stones
5130903|NCT01088542|substance use|substance use
5130904|NCT01088542|delinquency|delinquency
5130905|NCT01088542|risky sexual behavior|risky sexual behavior
5130906|NCT01088542|risk factors|risk factors
5130907|NCT01088542|protective factors|protective factors
5130908|NCT01088542|prevention|prevention
5130909|NCT01088542|community coalitions|community coalitions
5130910|NCT01088542|systems transformation|systems transformation
5130911|NCT01088542|violence|violence
5130912|NCT01088529|Neoadjuvant Prostate Cancer|neoadjuvant prostate cancer
5130913|NCT01088529|Abiraterone Acetate|abiraterone acetate
5130914|NCT01088529|LHRHa|lhrha
5130915|NCT01088529|high risk prostate cancer|high risk prostate cancer
5130916|NCT01088529|Radical prostatectomy|radical prostatectomy
5130917|NCT01088529|Prednisone|prednisone
5130918|NCT01088529|Luteinizing Hormone-Releasing Hormone|luteinizing hormone-releasing hormone
5130919|NCT01088529|LHRH analogue|lhrh analogue
5130920|NCT01088516|Human Immunodeficiency Virus|human immunodeficiency virus
5130921|NCT01088516|Vertical Transmission|vertical transmission
5130922|NCT01088516|Pregnancy|pregnancy
5130923|NCT01088516|Breastfeeding|breastfeeding
5130924|NCT01088516|Prevention of mother to child transmission|prevention of mother to child transmission
5130925|NCT01088516|HAART|haart
5130926|NCT01088516|Aluvia|aluvia
5130927|NCT01088516|Lopinavir|lopinavir
5130928|NCT01088516|Africa|africa
5130929|NCT01088516|Infectious Disease Transmission, Vertical|infectious disease transmission, vertical
5130930|NCT01088490|Hydrogen sulfide|hydrogen sulfide
5130931|NCT01088490|critically ill|critically ill
5130932|NCT01088490|mortality|mortality
5130933|NCT01088477|Acquired anti-hormonal resistant breast cancer|acquired anti-hormonal resistant breast cancer
5130934|NCT01088464|Human Immunoglobulin Gamma-1 (IgG1)|human immunoglobulin gamma-1 (igg1)
5130935|NCT01088464|Monoclonal Antibody (MAb)|monoclonal antibody (mab)
5130936|NCT01088464|Epidermal Growth Factor Receptor (EGFR)|epidermal growth factor receptor (egfr)
5130937|NCT01088464|Advanced Solid Tumors|advanced solid tumors
5130938|NCT01088451|Diabetes Mellitus, Type 1|diabetes mellitus, type 1
5130939|NCT01088451|Prandial Glycemia|prandial glycemia
5130940|NCT01088451|Rapid Acting Insulin Analogue|rapid acting insulin analogue
5130941|NCT01088451|Human Insulin|human insulin
5130942|NCT01088438|medical education|medical education
5130943|NCT01088438|decision making|decision making
5130944|NCT01088438|diagnostic error|diagnostic error
5130945|NCT01088438|contextualization|contextualization
5130946|NCT01088425|vitrification|vitrification
5130947|NCT01088425|2PN oocyte|2pn oocyte
5130948|NCT01088425|maternal and infant health|maternal and infant health
5130949|NCT01088425|embryo survival, clinical pregnancy rate|embryo survival, clinical pregnancy rate
5130950|NCT01088425|mode of delivery|mode of delivery
5130951|NCT01088425|injury during delivery|injury during delivery
5130952|NCT01088425|infant development|infant development
5130953|NCT01088425|infant morbidity|infant morbidity
5130954|NCT01088425|slow- rate freezing|slow- rate freezing
5130955|NCT01088347|TRAIL|trail
5130956|NCT01088347|TRM1|trm1
5130957|NCT01088347|advanced cervical cancer|advanced cervical cancer
5130958|NCT01088347|mapatumumab|mapatumumab
5130959|NCT01088347|Uterine cervical neoplasm|uterine cervical neoplasm
5130960|NCT01088347|Radiotherapy|radiotherapy
5130961|NCT01088347|Cisplatin|cisplatin
5130962|NCT01088334|Idiopathic venous thromboembolism|idiopathic venous thromboembolism
5130963|NCT01088334|Malignancy|malignancy
5130964|NCT01088334|screening|screening
5130965|NCT01088295|Metabolic|metabolic
5130966|NCT01088295|HIV|hiv
5130967|NCT01088295|Fat accumulation|fat accumulation
5130968|NCT01088295|AIDS|aids
5130969|NCT01088295|Metabolic abnormalities in HIV infection|metabolic abnormalities in hiv infection
5130970|NCT01088295|HIV Infections|hiv infections
5130971|NCT01088282|Diffractive multifocal IOL|diffractive multifocal iol
5130972|NCT01088269|Blood Pressure Measurement|blood pressure measurement
5130973|NCT01088269|Atrial Fibrillation|atrial fibrillation
5130974|NCT01088269|Blood pressure measurement in atrial fibrillation|blood pressure measurement in atrial fibrillation
5130975|NCT01088269|Atrial Fibrillation diagnosis|atrial fibrillation diagnosis
5130976|NCT01088256|CRPS|crps
5130977|NCT01088256|Morbus Sudeck|morbus sudeck
5130978|NCT01088256|Causalgia|causalgia
5130979|NCT01088256|Etoricoxib|etoricoxib
5130980|NCT01088256|Polyneuropathy|polyneuropathy
5130981|NCT01088256|post herpetic neuralgia|post herpetic neuralgia
5130982|NCT01088256|peripheral nerve injury|peripheral nerve injury
5130983|NCT01088256|radiculopathy|radiculopathy
5130984|NCT01088256|Nervenverletzung|nervenverletzung
5130985|NCT01088256|postherpetische Neuralgie|postherpetische neuralgie
5130986|NCT01088256|COX-2-Inhibitor|cox-2-inhibitor
5130987|NCT01088243|Berylliosis|berylliosis
5130988|NCT01088243|Beryllium Disease|beryllium disease
5130989|NCT01088230|hemiparesis|hemiparesis
5130990|NCT01088230|robotics|robotics
5130991|NCT01088230|stroke|stroke
5130992|NCT01088230|Botox®|botox®
5130993|NCT01088230|rehabilitation|rehabilitation
5130994|NCT01088230|wrist spasticity|wrist spasticity
5130995|NCT01088217|Idiopathic Pulmonary Fibrosis|idiopathic pulmonary fibrosis
5130996|NCT01088217|Familial Pulmonary Fibrosis|familial pulmonary fibrosis
5130997|NCT01088217|Idiopathic Interstitial Pneumonia|idiopathic interstitial pneumonia
5130998|NCT01088217|Familial Interstitial Pneumonia|familial interstitial pneumonia
5130999|NCT01088217|Pulmonary Fibrosis|pulmonary fibrosis
5131000|NCT01088191|Acute Anterior Cruciate Ligament Injury|acute anterior cruciate ligament injury
5131001|NCT01088191|Anterior Cruciate Ligament Reconstruction|anterior cruciate ligament reconstruction
5131002|NCT01088191|Adult Stem Cells|adult stem cells
5131003|NCT01088191|Mesenchymal precursor cells|mesenchymal precursor cells
5131004|NCT01088178|Long-Acting Reversible Contraception|long-acting reversible contraception
5131005|NCT01088178|Contraceptive Agents|contraceptive agents
5131006|NCT01088178|Therapeutic Uses|therapeutic uses
5131007|NCT01088178|Contraceptive Agents, Female|contraceptive agents, female
5131008|NCT01088178|Reproductive Control Agents|reproductive control agents
5131009|NCT01088178|Pharmacologic Actions|pharmacologic actions
5131010|NCT01088178|Levonorgestrel|levonorgestrel
5131011|NCT01088165|Psoriasis|psoriasis
5131012|NCT01088165|Cardiovascular Diseases|cardiovascular diseases
5131013|NCT01088165|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
5131014|NCT01088165|Adalimumab|adalimumab
5131015|NCT01088165|Fumaric acid esters|fumaric acid esters
5131016|NCT01088152|Celiac disease|celiac disease
5131017|NCT01088152|Education|education
5131018|NCT01088152|Sweden|sweden
5131019|NCT01088152|Gluten-free diet|gluten-free diet
5131020|NCT01088139|Nutritional support|nutritional support
5131021|NCT01088139|Rehabilitation outcomes|rehabilitation outcomes
5131022|NCT01088113|Tai Chi|tai chi
5131023|NCT01088113|Qigong|qigong
5131024|NCT01088113|Heart rate variability|heart rate variability
5131025|NCT01088113|Near Infrared Spectroscopy|near infrared spectroscopy
5131026|NCT01088113|blood pressure|blood pressure
5131027|NCT01088100|POCD|pocd
5131028|NCT01088100|clock-gene genotypes|clock-gene genotypes
5131029|NCT01088100|HPER3|hper3
5131030|NCT01088074|Total Knee Replacement|total knee replacement
5131031|NCT01088074|Closure Methods|closure methods
5131032|NCT01088048|CLL|cll
5131033|NCT01088048|non-Hodgkin lymphoma (NHL)|non-hodgkin lymphoma (nhl)
5131034|NCT01088048|mantle cell lymphoma (MCL)|mantle cell lymphoma (mcl)
5131035|NCT01088048|phosphatidylinositol 3-kinase|phosphatidylinositol 3-kinase
5131036|NCT01088048|bendamustine|bendamustine
5131037|NCT01088048|CD20 mAb|cd20 mab
5131038|NCT01088048|rituximab|rituximab
5131039|NCT01088048|CAL-101|cal-101
5131040|NCT01088048|Ofatumumab|ofatumumab
5131041|NCT01088048|indolent non-Hodgkin lymphoma (iNHL)|indolent non-hodgkin lymphoma (inhl)
5131042|NCT01088048|fludarabine|fludarabine
5131043|NCT01088048|everolimus|everolimus
5131044|NCT01088048|bortezomib|bortezomib
5131045|NCT01088048|chlorambucil|chlorambucil
5131046|NCT01088048|lenalidomide|lenalidomide
5131047|NCT01088035|Childhood ependymoma|childhood ependymoma
5131048|NCT01088035|Ependymoma|ependymoma
5131049|NCT01088035|Survivin|survivin
5131050|NCT01088022|the complete response (CR) rate defined as the number of patients with no emetic episodes and no rescue medication in the first 120 hours post-chemotherapy|the complete response (cr) rate defined as the number of patients with no emetic episodes and no rescue medication in the first 120 hours post-chemotherapy
5131051|NCT01088009|chronic hepatitis B|chronic hepatitis b
5131052|NCT01087996|Chronic Ischemic Left Ventricular|chronic ischemic left ventricular
5131053|NCT01087983|Metastatic cancer|metastatic cancer
5131054|NCT01087983|Lapatinib|lapatinib
5131055|NCT01087983|Tykerb|tykerb
5131056|NCT01087983|Metformin|metformin
5131057|NCT01087983|Glucophage|glucophage
5131058|NCT01087983|Sirolimus|sirolimus
5131059|NCT01087983|Rapamune|rapamune
5131060|NCT01087970|Pharynx|pharynx
5131061|NCT01087970|Larynx|larynx
5131062|NCT01087970|Nose|nose
5131063|NCT01087970|Parathyroid|parathyroid
5131064|NCT01087931|Local anesthetic|local anesthetic
5131065|NCT01087931|Iliac crest bone harvest|iliac crest bone harvest
5131066|NCT01087931|Patients undergoing spine surgery that require use of iliac crest bone autograft|patients undergoing spine surgery that require use of iliac crest bone autograft
5131067|NCT01087918|ASIA C and D|asia c and d
5131068|NCT01087905|Smoking|smoking
5131069|NCT01087905|Smoking cessation|smoking cessation
5131070|NCT01087905|Medication adherence|medication adherence
5131071|NCT01087879|oral glucose tolerance test|oral glucose tolerance test
5131072|NCT01087879|hormonal contraception|hormonal contraception
5131073|NCT01087879|androgens|androgens
5131074|NCT01087879|crp|crp
5131075|NCT01087866|Gestational diabetes mellitus|gestational diabetes mellitus
5131076|NCT01087866|treatment|treatment
5131077|NCT01087866|metformin|metformin
5131078|NCT01087853|Fluid Therapy|fluid therapy
5131079|NCT01087853|Water Electrolyte Imbalance|water electrolyte imbalance
5131080|NCT01087853|Acid Base Imbalance|acid base imbalance
5131081|NCT01087853|Renal Circulation|renal circulation
5131082|NCT01087853|Magnetic Resonance Imaging|magnetic resonance imaging
5131083|NCT01087840|HIV|hiv
5131084|NCT01087840|nonoccupational|nonoccupational
5131085|NCT01087840|postexposure|postexposure
5131086|NCT01087840|prophylaxis|prophylaxis
5131087|NCT01087840|HIV Seronegativity|hiv seronegativity
5131088|NCT01087827|oscillometric blood pressure|oscillometric blood pressure
5131089|NCT01087827|cuff site|cuff site
5131090|NCT01087827|forearm blood pressure|forearm blood pressure
5131091|NCT01087827|upper arm blood pressure|upper arm blood pressure
5131092|NCT01087827|anthropometric measurements|anthropometric measurements
5131093|NCT01087827|tonometry|tonometry
5131094|NCT01087827|site of blood pressure measurement|site of blood pressure measurement
5131095|NCT01087827|measurement accuracy|measurement accuracy
5131096|NCT01087814|efavirenz|efavirenz
5131097|NCT01087814|Sustiva|sustiva
5131098|NCT01087814|pharmacokinetics|pharmacokinetics
5131099|NCT01087801|Genetic End Marker|genetic end marker
5131100|NCT01087788|Certolizumab Pegol|certolizumab pegol
5131101|NCT01087788|Cimzia|cimzia
5131102|NCT01087762|Certolizumab Pegol|certolizumab pegol
5131103|NCT01087762|Cimzia|cimzia
5131104|NCT01087736|PTSD|ptsd
5131105|NCT01087736|Alcohol abuse|alcohol abuse
5131106|NCT01087736|Alcoholism|alcoholism
5131107|NCT01087736|Topiramate|topiramate
5131108|NCT01087736|Stress Disorder, Post Traumatic|stress disorder, post traumatic
5131109|NCT01087736|Chronic Post-Traumatic Stress Disorder|chronic post-traumatic stress disorder
5131110|NCT01087723|EUROMAX|euromax
5131111|NCT01087723|STEMI|stemi
5131112|NCT01087723|STE-ACS|ste-acs
5131113|NCT01087723|UFH|ufh
5131114|NCT01087723|bivalirudin|bivalirudin
5131115|NCT01087723|PCI|pci
5131116|NCT01087723|ambulance study|ambulance study
5131117|NCT01087723|STE-MI participants|ste-mi participants
5131118|NCT01087697|bladder cancer|bladder cancer
5131119|NCT01087697|radical cystectomy|radical cystectomy
5131120|NCT01087697|incontinent urinary diversion|incontinent urinary diversion
5131121|NCT01087684|Glaucoma|glaucoma
5131122|NCT01087684|laser trabeculoplasty|laser trabeculoplasty
5131123|NCT01087684|intraocular pressure|intraocular pressure
5131124|NCT01087632|Metabolic Syndrome Insulin-resistance Endothelial Function|metabolic syndrome insulin-resistance endothelial function
5131125|NCT01087619|Hyperparathyroidism, primary|hyperparathyroidism, primary
5131126|NCT01087619|Aged 66 years or older|aged 66 years or older
5131127|NCT01087619|Mild hypercalcaemia|mild hypercalcaemia
5131128|NCT01087619|Surgical Procedures, Elective|surgical procedures, elective
5131129|NCT01087619|Indication|indication
5131130|NCT01087619|Osteoporosis|osteoporosis
5131131|NCT01087619|Cognitive function|cognitive function
5131132|NCT01087619|Atherosclerosis|atherosclerosis
5131133|NCT01087619|Follow-up|follow-up
5131134|NCT01087619|Randomized trial|randomized trial
5131135|NCT01087593|estrogen|estrogen
5131136|NCT01087593|substitution|substitution
5131137|NCT01087593|pain|pain
5131138|NCT01087593|hormonal levels|hormonal levels
5131139|NCT01087593|quantitative sensory testing|quantitative sensory testing
5131140|NCT01087580|Prostate Cancer|prostate cancer
5131141|NCT01087580|non metastatic prostate cancer|non metastatic prostate cancer
5131142|NCT01087580|oligometastatic prostate cancer|oligometastatic prostate cancer
5131143|NCT01087567|diabetes|diabetes
5131144|NCT01087567|insulin|insulin
5131145|NCT01087567|rescue therapy|rescue therapy
5131146|NCT01087554|Advanced Cancer|advanced cancer
5131147|NCT01087554|Sirolimus|sirolimus
5131148|NCT01087554|Rapamune|rapamune
5131149|NCT01087554|mTOR Inhibitor|mtor inhibitor
5131150|NCT01087554|Histone Deacetylase Inhibitor|histone deacetylase inhibitor
5131151|NCT01087554|Vorinostat|vorinostat
5131152|NCT01087554|SAHA|saha
5131153|NCT01087554|Suberoylanilide Hydroxamic Acid|suberoylanilide hydroxamic acid
5131154|NCT01087554|MSK-390|msk-390
5131155|NCT01087554|Zolinza|zolinza
5131156|NCT01087554|Everolimus|everolimus
5131157|NCT01087554|Afinitor|afinitor
5131158|NCT01087554|Zortress|zortress
5131159|NCT01087554|RAD001|rad001
5131160|NCT01087554|Temsirolimus|temsirolimus
5131161|NCT01087554|CCI-779|cci-779
5131162|NCT01087554|Torisel|torisel
5131163|NCT01087541|Patient's Safety|patient's safety
5131164|NCT01087541|Diabetes mellitus|diabetes mellitus
5131165|NCT01087541|Public Health for professionals|public health for professionals
5131166|NCT01087541|Safety|safety
5131167|NCT01087541|Public health|public health
5131168|NCT01087528|Colonic Diseases|colonic diseases
5131169|NCT01087528|bowel diseases|bowel diseases
5131170|NCT01087528|large bowel diseases|large bowel diseases
5131171|NCT01087489|pain|pain
5131172|NCT01087489|discomfort|discomfort
5131173|NCT01087489|anesthetic drugs|anesthetic drugs
5131174|NCT01087489|topical drug administration|topical drug administration
5131175|NCT01087489|injections, intraocular|injections, intraocular
5131176|NCT01087489|lidocaine|lidocaine
5131177|NCT01087489|intraocular pressure|intraocular pressure
5131178|NCT01087489|keratopathy|keratopathy
5131179|NCT01087476|oral mucositis|oral mucositis
5131180|NCT01087476|chemotherapy|chemotherapy
5131181|NCT01087476|acute leukemia|acute leukemia
5131182|NCT01087476|salivary flow.|salivary flow.
5131183|NCT01087450|Erythropoietin|erythropoietin
5131184|NCT01087450|Sepsis|sepsis
5131185|NCT01087450|Septic shock|septic shock
5131186|NCT01087450|Orthogonal Polarization Spectroscopy|orthogonal polarization spectroscopy
5131187|NCT01087450|Severe sepsis or Septic shock|severe sepsis or septic shock
5131188|NCT01087437|Distraction osteogenesis|distraction osteogenesis
5131189|NCT01087424|Diffuse Large B-Cell Lymphoma|diffuse large b-cell lymphoma
5131190|NCT01087411|accelerometry|accelerometry
5131191|NCT01087411|physical activity|physical activity
5131192|NCT01087411|obesity|obesity
5131193|NCT01087411|children|children
5131194|NCT01087411|cardiovascular risk markers|cardiovascular risk markers
5131195|NCT01087411|metabolic risk markers|metabolic risk markers
5131196|NCT01087411|DXA|dxa
5131197|NCT01087411|obesity prevention|obesity prevention
5131198|NCT01087411|omega 3|omega 3
5131199|NCT01087411|fish liver oil|fish liver oil
5131200|NCT01087411|motivational interviewing|motivational interviewing
5131201|NCT01087398|Osteopetrosis|osteopetrosis
5131202|NCT01087398|HSCT|hsct
5131203|NCT01087385|peripheral arterial occlusive disease|peripheral arterial occlusive disease
5131204|NCT01087385|mortality|mortality
5131205|NCT01087385|cardiovascular events|cardiovascular events
5131206|NCT01087385|amputation|amputation
5131207|NCT01087385|peripheral arterial revascularization|peripheral arterial revascularization
5131208|NCT01087372|Stress hyperglycemia|stress hyperglycemia
5131209|NCT01087372|Incretins|incretins
5131210|NCT01087372|GLP-1|glp-1
5131211|NCT01087372|GIP|gip
5131212|NCT01087372|glucoregulatory hormones|glucoregulatory hormones
5131213|NCT01087346|Risk Perception|risk perception
5131214|NCT01087346|Obesity Risk|obesity risk
5131215|NCT01087346|Healthy Volunteer|healthy volunteer
5131216|NCT01087346|HV|hv
5131217|NCT01087333|Cytotoxicity Assay|cytotoxicity assay
5131218|NCT01087333|Neutralizing Antibodies|neutralizing antibodies
5131219|NCT01087333|Apheresis|apheresis
5131220|NCT01087333|Flow Cytometry|flow cytometry
5131221|NCT01087333|Hemolytic Uremic Syndrome (HUS)|hemolytic uremic syndrome (hus)
5131222|NCT01087333|Leukemia|leukemia
5131223|NCT01087333|Lymphoma|lymphoma
5131224|NCT01087333|Hairy Cell Leukemia|hairy cell leukemia
5131225|NCT01087333|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
5131226|NCT01087333|Non-Hodgkin Lymphoma|non-hodgkin lymphoma
5131227|NCT01087333|Cutaneous T Cell Lymphoma|cutaneous t cell lymphoma
5131228|NCT01087333|Adult T Cell Lymphoma|adult t cell lymphoma
5131229|NCT01087320|Genetic Counseling|genetic counseling
5131230|NCT01087320|Genetic Disorders|genetic disorders
5131231|NCT01087320|Genetic Testing|genetic testing
5131232|NCT01087320|Genetic/Genomic Researchers|genetic/genomic researchers
5131233|NCT01087320|Human Genetic Variation|human genetic variation
5131234|NCT01087320|Congenital Disorders|congenital disorders
5131235|NCT01087320|Inherited Diseases|inherited diseases
5131236|NCT01087307|Biospecimen|biospecimen
5131237|NCT01087307|Registry|registry
5131238|NCT01087307|Assay Development|assay development
5131239|NCT01087307|Assay Validation|assay validation
5131240|NCT01087307|Specimen Collection|specimen collection
5131241|NCT01087294|CD19|cd19
5131242|NCT01087294|Chimeric-Antigen-Receptor|chimeric-antigen-receptor
5131243|NCT01087294|Gene Therapy|gene therapy
5131244|NCT01087294|Adoptive T Cell Therapy|adoptive t cell therapy
5131245|NCT01087294|Allogeneic Stem Cell Transplantation|allogeneic stem cell transplantation
5131246|NCT01087294|B Cell Cancer|b cell cancer
5131247|NCT01087294|Allogenic Stem Cell Transplant|allogenic stem cell transplant
5131248|NCT01087281|Visual Attention|visual attention
5131249|NCT01087281|Visual Cortex|visual cortex
5131250|NCT01087281|Focal Lesions|focal lesions
5131251|NCT01087281|Neurological Disorder|neurological disorder
5131252|NCT01087281|Functional Magnetic Resonance Imaging (fMRI)|functional magnetic resonance imaging (fmri)
5131253|NCT01087281|Focal Brain Lesion|focal brain lesion
5131254|NCT01087281|Healthy Volunteer|healthy volunteer
5131255|NCT01087281|HV|hv
5131256|NCT01087268|gastrointestinal complications|gastrointestinal complications
5131257|NCT01087268|radiation toxicity|radiation toxicity
5131258|NCT01087268|long-term effects secondary to cancer therapy in adults|long-term effects secondary to cancer therapy in adults
5131259|NCT01087268|stage I rectal cancer|stage i rectal cancer
5131260|NCT01087268|stage II rectal cancer|stage ii rectal cancer
5131261|NCT01087268|stage III rectal cancer|stage iii rectal cancer
5131262|NCT01087268|stage I prostate cancer|stage i prostate cancer
5131263|NCT01087268|stage IIB prostate cancer|stage iib prostate cancer
5131264|NCT01087268|stage IIA prostate cancer|stage iia prostate cancer
5131265|NCT01087268|stage III prostate cancer|stage iii prostate cancer
5131266|NCT01087268|stage IV prostate cancer|stage iv prostate cancer
5131267|NCT01087268|stage I bladder cancer|stage i bladder cancer
5131268|NCT01087268|stage II bladder cancer|stage ii bladder cancer
5131269|NCT01087268|stage III bladder cancer|stage iii bladder cancer
5131270|NCT01087268|stage IV bladder cancer|stage iv bladder cancer
5131271|NCT01087268|stage IA cervical cancer|stage ia cervical cancer
5131272|NCT01087268|stage IB cervical cancer|stage ib cervical cancer
5131273|NCT01087268|stage IIA cervical cancer|stage iia cervical cancer
5131274|NCT01087268|stage IIB cervical cancer|stage iib cervical cancer
5131275|NCT01087268|stage III cervical cancer|stage iii cervical cancer
5131276|NCT01087268|stage I vaginal cancer|stage i vaginal cancer
5131277|NCT01087268|stage II vaginal cancer|stage ii vaginal cancer
5131278|NCT01087268|stage III vaginal cancer|stage iii vaginal cancer
5131279|NCT01087268|stage I malignant testicular germ cell tumor|stage i malignant testicular germ cell tumor
5131280|NCT01087268|stage II malignant testicular germ cell tumor|stage ii malignant testicular germ cell tumor
5131281|NCT01087268|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
5131282|NCT01087268|stage I endometrial carcinoma|stage i endometrial carcinoma
5131283|NCT01087268|stage II endometrial carcinoma|stage ii endometrial carcinoma
5131284|NCT01087268|stage III endometrial carcinoma|stage iii endometrial carcinoma
5131285|NCT01087268|stage I uterine sarcoma|stage i uterine sarcoma
5131286|NCT01087268|stage II uterine sarcoma|stage ii uterine sarcoma
5131287|NCT01087268|stage III uterine sarcoma|stage iii uterine sarcoma
5131288|NCT01087268|stage IA ovarian epithelial cancer|stage ia ovarian epithelial cancer
5131289|NCT01087268|stage IB ovarian epithelial cancer|stage ib ovarian epithelial cancer
5131290|NCT01087268|stage IC ovarian epithelial cancer|stage ic ovarian epithelial cancer
5131291|NCT01087268|stage IIA ovarian epithelial cancer|stage iia ovarian epithelial cancer
5131292|NCT01087268|stage IIB ovarian epithelial cancer|stage iib ovarian epithelial cancer
5131293|NCT01087268|stage IIC ovarian epithelial cancer|stage iic ovarian epithelial cancer
5131294|NCT01087268|stage IIIA ovarian epithelial cancer|stage iiia ovarian epithelial cancer
5131295|NCT01087268|stage IIIB ovarian epithelial cancer|stage iiib ovarian epithelial cancer
5131296|NCT01087268|stage IIIC ovarian epithelial cancer|stage iiic ovarian epithelial cancer
5131297|NCT01087268|stage IA ovarian germ cell tumor|stage ia ovarian germ cell tumor
5131298|NCT01087268|stage IB ovarian germ cell tumor|stage ib ovarian germ cell tumor
5131299|NCT01087268|stage IC ovarian germ cell tumor|stage ic ovarian germ cell tumor
5131300|NCT01087268|stage IIA ovarian germ cell tumor|stage iia ovarian germ cell tumor
5131301|NCT01087268|stage IIB ovarian germ cell tumor|stage iib ovarian germ cell tumor
5131302|NCT01087268|stage IIC ovarian germ cell tumor|stage iic ovarian germ cell tumor
5131303|NCT01087268|stage IIIA ovarian germ cell tumor|stage iiia ovarian germ cell tumor
5131304|NCT01087268|stage IIIB ovarian germ cell tumor|stage iiib ovarian germ cell tumor
5131305|NCT01087268|stage IIIC ovarian germ cell tumor|stage iiic ovarian germ cell tumor
5131306|NCT01087255|Caregiver-based interventions|caregiver-based interventions
5131307|NCT01087255|Chronic Kidney Disease|chronic kidney disease
5131308|NCT01087255|Medication Adherence|medication adherence
5131309|NCT01087242|Tang-min Lin pills|tang-min lin pills
5131310|NCT01087242|type 2 diabetes|type 2 diabetes
5131311|NCT01087242|liver and stomach heat retention|liver and stomach heat retention
5131312|NCT01087242|Evaluate the safety and efficacy of Tang-min Lin pills|evaluate the safety and efficacy of tang-min lin pills
5131313|NCT01087203|diabetic peripheral neuropathy|diabetic peripheral neuropathy
5131314|NCT01087203|tanezumab|tanezumab
5131315|NCT01087203|diabetic neuropathies|diabetic neuropathies
5131316|NCT01087203|diabetic polyneuropathy|diabetic polyneuropathy
5131317|NCT01087203|diabetic neuropathy painful|diabetic neuropathy painful
5131318|NCT01087190|kidney|kidney
5131319|NCT01087190|transplantation|transplantation
5131320|NCT01087190|tuberculosis|tuberculosis
5131321|NCT01087190|ELISPOT|elispot
5131322|NCT01087190|isoniazid|isoniazid
5131323|NCT01087177|Smoking|smoking
5131324|NCT01087177|Tobacco|tobacco
5131325|NCT01087177|Pediatrics|pediatrics
5131326|NCT01087164|Vaccine acceptance|vaccine acceptance
5131327|NCT01087164|human papillomavirus|human papillomavirus
5131328|NCT01087164|brief messages|brief messages
5131329|NCT01087164|social compliance|social compliance
5131330|NCT01087164|Message sidedness|message sidedness
5131331|NCT01087151|Rituxan|rituxan
5131332|NCT01087151|Apoptosis|apoptosis
5131333|NCT01087151|BCl-2|bcl-2
5131334|NCT01087138|bone health|bone health
5131335|NCT01087138|bone density|bone density
5131336|NCT01087138|bone mass|bone mass
5131337|NCT01087112|MIP|mip
5131338|NCT01087112|RCT|rct
5131339|NCT01087112|postnatal depression|postnatal depression
5131340|NCT01087112|Mother-child relationship|mother-child relationship
5131341|NCT01087086|Metabolic syndrome|metabolic syndrome
5131342|NCT01087086|Oxidative stress|oxidative stress
5131343|NCT01087086|Proinflammatory state|proinflammatory state
5131344|NCT01087086|Insulin resistance|insulin resistance
5131345|NCT01087086|Hypertension|hypertension
5131346|NCT01087086|Dyslipidemia|dyslipidemia
5131347|NCT01087086|Mediterranean diet|mediterranean diet
5131348|NCT01087086|Glycemic index|glycemic index
5131349|NCT01087086|Hypocaloric diet|hypocaloric diet
5131350|NCT01087086|Hyperproteic diet|hyperproteic diet
5131351|NCT01087086|Macronutrient distribution|macronutrient distribution
5131352|NCT01087086|Antioxidant capacity of the diet|antioxidant capacity of the diet
5131353|NCT01087086|Crononutrition|crononutrition
5131354|NCT01087086|Dietary and psychological support|dietary and psychological support
5131355|NCT01087086|Waist circumference|waist circumference
5131356|NCT01087073|Healthcare Disparities|healthcare disparities
5131357|NCT01087073|Health Care Quality Improvement|health care quality improvement
5131358|NCT01087073|Shared Decision-Making|shared decision-making
5131359|NCT01087073|Patient Education|patient education
5131360|NCT01087073|Patient Activation|patient activation
5131361|NCT01087073|Community Outreach|community outreach
5131362|NCT01087073|Provider Training|provider training
5131363|NCT01087047|Pregnancy|pregnancy
5131364|NCT01087047|Upper airways|upper airways
5131365|NCT01087047|Acoustic reflection method|acoustic reflection method
5131366|NCT01087034|Infantile scoliosis|infantile scoliosis
5131367|NCT01087034|bracing|bracing
5131368|NCT01087034|acoustic reflection method|acoustic reflection method
5131369|NCT01087034|EOS™|eos™
5131370|NCT01087034|noninvasive|noninvasive
5131371|NCT01087034|upper airways|upper airways
5131372|NCT01087034|thoracic penetration index|thoracic penetration index
5131373|NCT01087034|Idiopathic juvenile evolutive thoracic scoliosis|idiopathic juvenile evolutive thoracic scoliosis
5131374|NCT01087008|Multiple Myeloma|multiple myeloma
5131375|NCT01087008|Zoledronic acid|zoledronic acid
5131376|NCT01086995|extubation|extubation
5131377|NCT01086995|weaning|weaning
5131378|NCT01086995|mechanical ventilation|mechanical ventilation
5131379|NCT01086969|Meningococcal Infection|meningococcal infection
5131380|NCT01086969|Meningitis, Bacterial|meningitis, bacterial
5131381|NCT01086969|Menactra®|menactra®
5131382|NCT01086956|patients of prostatic cancer aged more than 65 years|patients of prostatic cancer aged more than 65 years
5131383|NCT01086917|Malaria Challenge|malaria challenge
5131384|NCT01086917|Plasmodium falciparum|plasmodium falciparum
5131385|NCT01086917|Controlled human malaria infection|controlled human malaria infection
5131386|NCT01086917|PfSPZ Challenge|pfspz challenge
5131387|NCT01086904|renal transplantation|renal transplantation
5131388|NCT01086904|immunosuppression|immunosuppression
5131389|NCT01086904|inflenza A (H1N1)|inflenza a (h1n1)
5131390|NCT01086904|vaccine|vaccine
5131391|NCT01086878|Antiretroviral Therapy, Highly Active|antiretroviral therapy, highly active
5131392|NCT01086878|Trimethoprim-Sulfamethoxazole Combination|trimethoprim-sulfamethoxazole combination
5131393|NCT01086878|anemia|anemia
5131394|NCT01086878|neutropenia|neutropenia
5131395|NCT01086878|safety|safety
5131396|NCT01086878|hematologic toxicity|hematologic toxicity
5131397|NCT01086865|inappetence|inappetence
5131398|NCT01086865|apetiviton BC|apetiviton bc
5131399|NCT01086852|Factor X deficiency|factor x deficiency
5131400|NCT01086852|surgery|surgery
5131401|NCT01086852|Factor X deficiency subjects requiring surgery|factor x deficiency subjects requiring surgery
5131402|NCT01086839|Cystic Fibrosis|cystic fibrosis
5131403|NCT01086839|chronic rhinosinusitis|chronic rhinosinusitis
5131404|NCT01086813|Safety|safety
5131405|NCT01086813|Tolerability|tolerability
5131406|NCT01086813|Pharmacokinetics|pharmacokinetics
5131407|NCT01086813|Sedation|sedation
5131408|NCT01086787|Heart failure|heart failure
5131409|NCT01086787|Bone marrow|bone marrow
5131410|NCT01086787|Bone marrow mononuclear cells|bone marrow mononuclear cells
5131411|NCT01086787|Surgery|surgery
5131412|NCT01086787|Orthopedic surgery|orthopedic surgery
5131413|NCT01086787|Cardiac surgery|cardiac surgery
5131414|NCT01086774|Dry eye|dry eye
5131415|NCT01086774|Tear Film Stability|tear film stability
5131416|NCT01086735|hematological malignancy|hematological malignancy
5131417|NCT01086735|allogeneic hematopoietic stem cell transplantation|allogeneic hematopoietic stem cell transplantation
5131418|NCT01086735|donor lymphocyte infusion|donor lymphocyte infusion
5131419|NCT01086735|antitumor immunotherapy|antitumor immunotherapy
5131420|NCT01086735|graft-versus-tumor effect|graft-versus-tumor effect
5131421|NCT01086735|gene therapy|gene therapy
5131422|NCT01086735|relapse|relapse
5131423|NCT01086735|adult|adult
5131424|NCT01086709|Human Papillomavirus|human papillomavirus
5131425|NCT01086709|Vaccine|vaccine
5131426|NCT01086709|Crossover|crossover
5131427|NCT01086709|Hepatitis A|hepatitis a
5131428|NCT01086709|Hepatitis B|hepatitis b
5131429|NCT01086696|PET Imaging|pet imaging
5131430|NCT01086696|F-18 Paclitaxel (FPAC)|f-18 paclitaxel (fpac)
5131431|NCT01086696|Breast Cancer|breast cancer
5131432|NCT01086696|Lung Cancer|lung cancer
5131433|NCT01086696|Renal and Adrenal Cancers|renal and adrenal cancers
5131434|NCT01086696|Kidney Cancer|kidney cancer
5131435|NCT01086696|Adrenal Cancer|adrenal cancer
5131436|NCT01086683|neoplasms|neoplasms
5131437|NCT01086683|rehabilitation|rehabilitation
5131438|NCT01086683|intervention|intervention
5131439|NCT01086683|quality of life|quality of life
5131440|NCT01086683|lifestyle|lifestyle
5131441|NCT01086670|Coordination|coordination
5131442|NCT01086670|Neuroimaging|neuroimaging
5131443|NCT01086670|Motion Analysis|motion analysis
5131444|NCT01086670|Locomotor|locomotor
5131445|NCT01086670|Cerebral Palsy|cerebral palsy
5131446|NCT01086670|Pediatrics|pediatrics
5131447|NCT01086657|Bird Flu|bird flu
5131448|NCT01086657|Avian Influenza|avian influenza
5131449|NCT01086657|Healthy|healthy
5131450|NCT01086657|Immunity|immunity
5131451|NCT01086657|Prevention|prevention
5131452|NCT01086657|Healthy Volunteer|healthy volunteer
5131453|NCT01086657|HV|hv
5131454|NCT01086631|Autoimmune Retinopathy|autoimmune retinopathy
5131455|NCT01086631|RITUXAN|rituxan
5131456|NCT01086631|Rituximab|rituximab
5131457|NCT01086631|Immunosuppression|immunosuppression
5131458|NCT01086618|stage IV colon cancer|stage iv colon cancer
5131459|NCT01086618|stage IV rectal cancer|stage iv rectal cancer
5131460|NCT01086605|HER2-negative breast cancer|her2-negative breast cancer
5131461|NCT01086605|male breast cancer|male breast cancer
5131462|NCT01086605|recurrent breast cancer|recurrent breast cancer
5131463|NCT01086605|stage IV breast cancer|stage iv breast cancer
5131464|NCT01086605|stage IIIC breast cancer|stage iiic breast cancer
5131465|NCT01086592|Aged|aged
5131466|NCT01086592|Strength|strength
5131467|NCT01086592|Balance|balance
5131468|NCT01086592|Electrotherapy|electrotherapy
5131469|NCT01086592|Quality of life|quality of life
5131470|NCT01086579|paclitaxel PTCA drug-eluting balloon|paclitaxel ptca drug-eluting balloon
5131471|NCT01086579|provisional spot stenting|provisional spot stenting
5131472|NCT01086579|coronary artery disease|coronary artery disease
5131473|NCT01086579|Late Lumen Loss|late lumen loss
5131474|NCT01086579|Minimal lumen diameter|minimal lumen diameter
5131475|NCT01086579|coronary artery disease in a small vessel|coronary artery disease in a small vessel
5131476|NCT01086566|Influenza, H5N1, avian influenza, parent protocol|influenza, h5n1, avian influenza, parent protocol
5131477|NCT01086553|Crohn´s disease|crohn´s disease
5131478|NCT01086553|budesonide|budesonide
5131852|NCT01084941|pregnancy|pregnancy
5131479|NCT01086553|induction of remission|induction of remission
5131480|NCT01086540|Systemic Sclerosis-Associated Pulmonary Arterial Hypertension|systemic sclerosis-associated pulmonary arterial hypertension
5131481|NCT01086540|Autoimmune Disease|autoimmune disease
5131482|NCT01086540|Systemic Scleroderma|systemic scleroderma
5131483|NCT01086540|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
5131484|NCT01086527|Pharmacogenetics|pharmacogenetics
5131485|NCT01086527|Singulair|singulair
5131486|NCT01086527|montelukast|montelukast
5131487|NCT01086527|Leukotriene Antagonists|leukotriene antagonists
5131488|NCT01086527|Anti-Asthmatic Agents|anti-asthmatic agents
5131489|NCT01086527|Intestinal Absorption|intestinal absorption
5131490|NCT01086527|pharmacokinetics|pharmacokinetics
5131491|NCT01086527|absorption|absorption
5131492|NCT01086527|biochemical transport|biochemical transport
5131493|NCT01086527|Membrane Transport Proteins|membrane transport proteins
5131494|NCT01086514|Breast|breast
5131495|NCT01086514|mammography|mammography
5131496|NCT01086514|MRI|mri
5131497|NCT01086514|Digital Mammography|digital mammography
5131498|NCT01086514|10-024|10-024
5131499|NCT01086501|open, non-interventional|open, non-interventional
5131500|NCT01086488|recurrent or persistent Nasopharyngeal Carcinoma|recurrent or persistent nasopharyngeal carcinoma
5131501|NCT01086488|treatment of patients with squamous cell carcinoma of the head and neck|treatment of patients with squamous cell carcinoma of the head and neck
5131502|NCT01086488|Foscan-PDT|foscan-pdt
5131503|NCT01086488|Brachytherapy|brachytherapy
5131504|NCT01086475|Autism Spectrum Disorder|autism spectrum disorder
5131505|NCT01086475|D-cycloserine|d-cycloserine
5131506|NCT01086475|Social Skills Training|social skills training
5131507|NCT01086462|GSK2239633|gsk2239633
5131508|NCT01086462|RADIOLABEL|radiolabel
5131509|NCT01086462|PHARMACOKINETICS|pharmacokinetics
5131510|NCT01086462|INTRAVENOUS|intravenous
5131511|NCT01086462|MICRODOSE|microdose
5131512|NCT01086449|safety|safety
5131513|NCT01086449|Japanese|japanese
5131514|NCT01086449|Herpes Zoster|herpes zoster
5131515|NCT01086449|immunogenicity|immunogenicity
5131516|NCT01086449|Herpes Zoster in healthy ethnic Japanese adults|herpes zoster in healthy ethnic japanese adults
5131517|NCT01086449|Vaccine|vaccine
5131518|NCT01086436|Human Rotavirus vaccine|human rotavirus vaccine
5131519|NCT01086423|Infanrix-IPV+Hib|infanrix-ipv+hib
5131520|NCT01086410|HPA axis|hpa axis
5131521|NCT01086397|pneumococcal pneumonia|pneumococcal pneumonia
5131522|NCT01086397|community-acquired pneumonia|community-acquired pneumonia
5131523|NCT01086371|Multiple Sclerosis|multiple sclerosis
5131524|NCT01086371|gait|gait
5131525|NCT01086358|Productivity|productivity
5131526|NCT01086358|Migraine|migraine
5131527|NCT01086358|Treximet|treximet
5131528|NCT01086358|Triptan|triptan
5131529|NCT01086345|adult giant cell glioblastoma|adult giant cell glioblastoma
5131530|NCT01086345|adult gliosarcoma|adult gliosarcoma
5131531|NCT01086345|recurrent adult brain tumor|recurrent adult brain tumor
5131532|NCT01086332|radiotherapy|radiotherapy
5131533|NCT01086332|gemcitabine|gemcitabine
5131534|NCT01086332|nelfinavir|nelfinavir
5131535|NCT01086332|neoplasms|neoplasms
5131536|NCT01086241|Tomography|tomography
5131537|NCT01086241|Mammography|mammography
5131538|NCT01086241|Breast Neoplasms|breast neoplasms
5131539|NCT01086241|Prevention and Control|prevention and control
5131540|NCT01086228|Drug eluting stents|drug eluting stents
5131541|NCT01086228|Stents|stents
5131542|NCT01086228|Angioplasty|angioplasty
5131543|NCT01086202|irreparable rotator cuff tears|irreparable rotator cuff tears
5131544|NCT01086163|Omacor|omacor
5131545|NCT01086163|Simvastatin|simvastatin
5131546|NCT01086163|Aspirin|aspirin
5131547|NCT01086163|Platelet activity|platelet activity
5131548|NCT01086163|Coronary artery disease|coronary artery disease
5131549|NCT01086137|salivary biomarker|salivary biomarker
5131550|NCT01086137|metabolic syndrome|metabolic syndrome
5131551|NCT01086137|prediabetes|prediabetes
5131552|NCT01086137|diabetes hypertension|diabetes hypertension
5131553|NCT01086124|echocardiography|echocardiography
5131554|NCT01086124|ST elevation myocardial infarction|st elevation myocardial infarction
5131555|NCT01086124|Heart failure|heart failure
5131556|NCT01086124|Coronary artery disease|coronary artery disease
5131557|NCT01086124|Cardiovascular diseases|cardiovascular diseases
5131558|NCT01086111|type 2 diabetes|type 2 diabetes
5131559|NCT01086111|gastric bypass|gastric bypass
5131560|NCT01086111|sleeve gastrectomy|sleeve gastrectomy
5131561|NCT01086111|clamp study|clamp study
5131562|NCT01086111|weight loss surgery|weight loss surgery
5131563|NCT01086098|Pacemakers|pacemakers
5131564|NCT01086098|Survival|survival
5131565|NCT01086059|Autoimmune diseases|autoimmune diseases
5131566|NCT01086059|adalimumab|adalimumab
5131567|NCT01086059|pregnancy|pregnancy
5131568|NCT01086059|birth defects|birth defects
5131569|NCT01086059|TNF|tnf
5131570|NCT01086059|Tumor necrosis factor|tumor necrosis factor
5131571|NCT01086046|platelet|platelet
5131572|NCT01086046|thrombozyme|thrombozyme
5131573|NCT01086046|ASD|asd
5131574|NCT01086046|Heparin|heparin
5131575|NCT01086046|Enoxaparin|enoxaparin
5131576|NCT01086033|Evaluation of safety and efficacy|evaluation of safety and efficacy
5131577|NCT01086033|Adalimumab treatment|adalimumab treatment
5131853|NCT01084941|weight gain|weight gain
5131578|NCT01086033|Rheumatoid Arthritis|rheumatoid arthritis
5131579|NCT01086020|IVUS|ivus
5131580|NCT01086020|coronary plaque|coronary plaque
5131581|NCT01086020|regression|regression
5131582|NCT01086007|Groin hernia|groin hernia
5131583|NCT01086007|chronic pain|chronic pain
5131584|NCT01086007|Persistent postoperative pain|persistent postoperative pain
5131585|NCT01086007|Laparoscopic inguinal herniotomy|laparoscopic inguinal herniotomy
5131586|NCT01086007|Sexual dysfunction|sexual dysfunction
5131587|NCT01085994|antibiotics|antibiotics
5131588|NCT01085994|resistance|resistance
5131589|NCT01085994|bio-marker|bio-marker
5131590|NCT01085994|procalcitonin|procalcitonin
5131591|NCT01085994|algorithm|algorithm
5131592|NCT01085994|critically ill|critically ill
5131593|NCT01085981|quantitative assessment of the effects of a topically|quantitative assessment of the effects of a topically
5131594|NCT01085981|applied vasodilating cream to the clitoris using doppler|applied vasodilating cream to the clitoris using doppler
5131595|NCT01085981|flow plethysmography|flow plethysmography
5131596|NCT01085968|Parkinson's disease|parkinson's disease
5131597|NCT01085968|Cognitive deficits|cognitive deficits
5131598|NCT01085968|fMRI|fmri
5131599|NCT01085968|neuro rehabilitation|neuro rehabilitation
5131600|NCT01085968|Age Matched Controls|age matched controls
5131601|NCT01085955|peripartum|peripartum
5131602|NCT01085955|cardiomyopathy|cardiomyopathy
5131603|NCT01085955|post pregnancy|post pregnancy
5131604|NCT01085955|myocardial recovery|myocardial recovery
5131605|NCT01085955|pregnant women with peripartum cardiomyopathy|pregnant women with peripartum cardiomyopathy
5131606|NCT01085942|rotator cuff tear|rotator cuff tear
5131607|NCT01085942|asymptomatic|asymptomatic
5131608|NCT01085942|natural course|natural course
5131609|NCT01085942|tear characteristics|tear characteristics
5131610|NCT01085942|Asymptomatic rotator cuff tears|asymptomatic rotator cuff tears
5131611|NCT01085942|Natural course of rotator cuff tears|natural course of rotator cuff tears
5131612|NCT01085929|abscess|abscess
5131613|NCT01085929|infection|infection
5131614|NCT01085929|ultrasound guidance|ultrasound guidance
5131615|NCT01085929|incision and drainage|incision and drainage
5131616|NCT01085929|needle aspiration|needle aspiration
5131617|NCT01085929|skin|skin
5131618|NCT01085929|ultrasound|ultrasound
5131619|NCT01085916|prevalence of asthma and Rhinitis symptoms among secondary school students in Saudi Arabia|prevalence of asthma and rhinitis symptoms among secondary school students in saudi arabia
5131620|NCT01085903|Spatial Neglect|spatial neglect
5131621|NCT01085903|Dysphagia|dysphagia
5131622|NCT01085903|Arousal|arousal
5131623|NCT01085903|Modafinil|modafinil
5131624|NCT01085903|Stroke|stroke
5131625|NCT01085890|Blood Pressure|blood pressure
5131626|NCT01085890|Life Style|life style
5131627|NCT01085890|Body Mass Index|body mass index
5131628|NCT01085890|Obesity, Abdominal|obesity, abdominal
5131629|NCT01085890|Blood Chemical Analysis|blood chemical analysis
5131630|NCT01085864|Lung Nodules|lung nodules
5131631|NCT01085864|A need exists for non-invasive testing to aid in clinical decision-making for CT scan detected lung nodules of indeterminate etiology.|a need exists for non-invasive testing to aid in clinical decision-making for ct scan detected lung nodules of indeterminate etiology.
5131632|NCT01085851|Sunburn|sunburn
5131633|NCT01085851|Dexchlorpheniramine|dexchlorpheniramine
5131634|NCT01085851|Lotion|lotion
5131635|NCT01085851|Cream|cream
5131636|NCT01085838|Erlotinib|erlotinib
5131637|NCT01085838|myelodysplastic syndrome|myelodysplastic syndrome
5131638|NCT01085825|induced abortion|induced abortion
5131639|NCT01085825|termination of pregnancy|termination of pregnancy
5131640|NCT01085825|manual vacuum aspiration|manual vacuum aspiration
5131641|NCT01085825|electric vacuum aspiration|electric vacuum aspiration
5131642|NCT01085799|Educational activities|educational activities
5131643|NCT01085799|Cluster-randomized controlled trial|cluster-randomized controlled trial
5131644|NCT01085799|Albendazole|albendazole
5131645|NCT01085799|Deworming|deworming
5131646|NCT01085799|School-age children|school-age children
5131647|NCT01085799|Peru|peru
5131648|NCT01085799|Ascaris lumbricoides|ascaris lumbricoides
5131649|NCT01085799|Trichuris trichiura|trichuris trichiura
5131650|NCT01085799|Hookworm|hookworm
5131651|NCT01085799|STH infections|sth infections
5131652|NCT01085799|Intestinal helminth infections|intestinal helminth infections
5131653|NCT01085786|Helicobacter pylori infection|helicobacter pylori infection
5131654|NCT01085773|HbA1c|hba1c
5131655|NCT01085773|Type 2 Diabetes|type 2 diabetes
5131656|NCT01085773|Lifestyle changes|lifestyle changes
5131657|NCT01085773|Exercise|exercise
5131658|NCT01085747|Chronic pancreatitis|chronic pancreatitis
5131659|NCT01085747|Biliary stricture|biliary stricture
5131660|NCT01085747|Endoscopic treatment|endoscopic treatment
5131661|NCT01085747|SEMS|sems
5131662|NCT01085721|allergic rhinitis|allergic rhinitis
5131663|NCT01085721|viral infections of the upper respiratory tract|viral infections of the upper respiratory tract
5131664|NCT01085721|dexchlorpheniramine|dexchlorpheniramine
5131665|NCT01085721|pseudoephedrine|pseudoephedrine
5131666|NCT01085721|guaifenesin|guaifenesin
5131667|NCT01085708|Rabeprazole|rabeprazole
5131668|NCT01085708|Japan|japan
5131669|NCT01085708|healthy Japanese male|healthy japanese male
5131670|NCT01085695|Rabeprazole|rabeprazole
5131671|NCT01085695|Japan|japan
5131672|NCT01085695|healthy Japanese male|healthy japanese male
5131673|NCT01085682|Diabetes prevention|diabetes prevention
5131674|NCT01085682|Lifestyle modification|lifestyle modification
5131675|NCT01085682|Obesity|obesity
5131676|NCT01085682|Impaired glucose tolerance|impaired glucose tolerance
5131677|NCT01085682|Diet|diet
5131678|NCT01085682|Physical activity|physical activity
5131679|NCT01085669|Infection rate of VEPTR-Implants|infection rate of veptr-implants
5131680|NCT01085669|VEPTR. Vertical Expandable|veptr. vertical expandable
5131681|NCT01085669|Prosthetic Titanium Rib|prosthetic titanium rib
5131682|NCT01085643|IBS|ibs
5131683|NCT01085643|Lubiprostone|lubiprostone
5131684|NCT01085643|Small Bowel|small bowel
5131685|NCT01085643|High Resolution Manometry|high resolution manometry
5131686|NCT01085643|Delayed Intestinal Transit|delayed intestinal transit
5131687|NCT01085630|epithelial mesothelioma|epithelial mesothelioma
5131688|NCT01085630|sarcomatous mesothelioma|sarcomatous mesothelioma
5131689|NCT01085630|stage II malignant mesothelioma|stage ii malignant mesothelioma
5131690|NCT01085630|stage III malignant mesothelioma|stage iii malignant mesothelioma
5131691|NCT01085630|stage IV malignant mesothelioma|stage iv malignant mesothelioma
5131692|NCT01085617|oral complications|oral complications
5131693|NCT01085617|mucositis|mucositis
5131694|NCT01085617|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
5131695|NCT01085617|B-cell adult acute lymphoblastic leukemia|b-cell adult acute lymphoblastic leukemia
5131696|NCT01085617|T-cell adult acute lymphoblastic leukemia|t-cell adult acute lymphoblastic leukemia
5131697|NCT01085617|Philadelphia chromosome positive adult precursor acute lymphoblastic leukemia|philadelphia chromosome positive adult precursor acute lymphoblastic leukemia
5131698|NCT01085604|low back pain|low back pain
5131699|NCT01085604|clinical instability|clinical instability
5131700|NCT01085604|neuromuscular control|neuromuscular control
5131701|NCT01085604|core stabilization|core stabilization
5131702|NCT01085604|physical therapy|physical therapy
5131703|NCT01085591|CDI|cdi
5131704|NCT01085591|Clostridium difficile Infection|clostridium difficile infection
5131705|NCT01085591|Diarrhea|diarrhea
5131706|NCT01085578|healthy male volunteers|healthy male volunteers
5131707|NCT01085578|fasted and fed state|fasted and fed state
5131708|NCT01085565|Bone cancer|bone cancer
5131709|NCT01085565|Bone Metastases|bone metastases
5131710|NCT01085565|pain palliation|pain palliation
5131711|NCT01085565|metastasis|metastasis
5131712|NCT01085565|breast cancer|breast cancer
5131713|NCT01085565|lung cancer|lung cancer
5131714|NCT01085565|prostate cancer|prostate cancer
5131715|NCT01085565|cancer related pain|cancer related pain
5131716|NCT01085565|tumors|tumors
5131717|NCT01085552|NeoRecormon®|neorecormon®
5131718|NCT01085552|Caucasian|caucasian
5131719|NCT01085552|Japanese|japanese
5131720|NCT01085552|Bioequivalence|bioequivalence
5131721|NCT01085552|Ethnic|ethnic
5131722|NCT01085539|neonatal intensive care|neonatal intensive care
5131723|NCT01085539|infant pulse oximetry|infant pulse oximetry
5131724|NCT01085526|basophil activity|basophil activity
5131725|NCT01085526|plasma cells|plasma cells
5131726|NCT01085526|IgE|ige
5131727|NCT01085526|IgG1|igg1
5131728|NCT01085526|IgG4|igg4
5131729|NCT01085526|mast cells|mast cells
5131730|NCT01085526|IgE receptor|ige receptor
5131731|NCT01085526|allergic rhinoconjunctivitis|allergic rhinoconjunctivitis
5131732|NCT01085526|grass pollen allergy|grass pollen allergy
5131733|NCT01085513|intestinal abnormalities|intestinal abnormalities
5131734|NCT01085500|laparoscopic|laparoscopic
5131735|NCT01085500|totally extraperitoneal inguinal hernia repair|totally extraperitoneal inguinal hernia repair
5131736|NCT01085487|Menorrhagia|menorrhagia
5131737|NCT01085474|Asthma|asthma
5131738|NCT01085474|Pharmaceutical intervention|pharmaceutical intervention
5131739|NCT01085474|Effect of a pharmaceutical intervention on the level of control of the asthmatic patient|effect of a pharmaceutical intervention on the level of control of the asthmatic patient
5131740|NCT01085448|low back pain|low back pain
5131741|NCT01085448|core stabilization|core stabilization
5131742|NCT01085448|physical therapy|physical therapy
5131743|NCT01085435|ICD|icd
5131744|NCT01085435|defibrillator|defibrillator
5131745|NCT01085422|Prostate Cancer|prostate cancer
5131746|NCT01085409|experienced utility|experienced utility
5131747|NCT01085409|decision utility|decision utility
5131748|NCT01085409|subjective well-being|subjective well-being
5131749|NCT01085409|experience sampling method|experience sampling method
5131750|NCT01085409|day reconstruction method|day reconstruction method
5131751|NCT01085409|Quality of life|quality of life
5131752|NCT01085396|Fiber Optic|fiber optic
5131753|NCT01085396|Melanoma|melanoma
5131754|NCT01085396|UV Exposure|uv exposure
5131755|NCT01085383|Antipsychotic|antipsychotic
5131756|NCT01085383|hyperprolactinemia|hyperprolactinemia
5131757|NCT01085383|hypogonadism|hypogonadism
5131758|NCT01085383|aripiprazole|aripiprazole
5131759|NCT01085370|posttraumatic stress|posttraumatic stress
5131760|NCT01085370|prevention|prevention
5131761|NCT01085370|children|children
5131762|NCT01085370|acute stress disorder due to burn injury or injuries associated with road traffic accidents|acute stress disorder due to burn injury or injuries associated with road traffic accidents
5131763|NCT01085357|Glaucoma|glaucoma
5131764|NCT01085357|Glaucoma device|glaucoma device
5131765|NCT01085357|Glaucoma surgery|glaucoma surgery
5131766|NCT01085357|Intraocular pressure|intraocular pressure
5131767|NCT01085344|hemophilia, prophylaxis, cost effectiveness|hemophilia, prophylaxis, cost effectiveness
5131768|NCT01085331|Mek Inhibitor|mek inhibitor
5131769|NCT01085331|Metastatic Colorectal Cancer|metastatic colorectal cancer
5131770|NCT01085331|K-Ras Mutation|k-ras mutation
5131771|NCT01085331|Phase II|phase ii
5131772|NCT01085331|Second line K-Ras mutated metastatic colorectal cancer|second line k-ras mutated metastatic colorectal cancer
5131773|NCT01085305|Behavior problems|behavior problems
5131774|NCT01085305|Parent-Child Interaction|parent-child interaction
5131775|NCT01085305|Locus of control|locus of control
5131776|NCT01085305|Psychiatric symptoms|psychiatric symptoms
5131777|NCT01085305|Depressive symptoms|depressive symptoms
5131778|NCT01085305|Attachment|attachment
5131779|NCT01085279|fractional laser|fractional laser
5131780|NCT01085279|melasma|melasma
5131781|NCT01085279|topical bleaching|topical bleaching
5131782|NCT01085253|Parkinson's|parkinson's
5131783|NCT01085253|supranuclear palsy|supranuclear palsy
5131784|NCT01085253|substantia nigra|substantia nigra
5131785|NCT01085253|sub thalamic nucleus|sub thalamic nucleus
5131786|NCT01085253|MRI|mri
5131787|NCT01085227|Parkinson's disease|parkinson's disease
5131788|NCT01085227|LRRK2|lrrk2
5131789|NCT01085227|asymptomatic carriers|asymptomatic carriers
5131790|NCT01085201|lexiscan|lexiscan
5131791|NCT01085175|Heart Failure,|heart failure,
5131792|NCT01085175|PET Imaging,|pet imaging,
5131793|NCT01085175|Implantable Cardioverter-Defibrillator,|implantable cardioverter-defibrillator,
5131794|NCT01085175|Sudden Cardiac Death|sudden cardiac death
5131795|NCT01085162|Coronary Artery Disease|coronary artery disease
5131796|NCT01085162|PET imaging|pet imaging
5131797|NCT01085162|SPECT imaging|spect imaging
5131798|NCT01085149|simvastatin|simvastatin
5131799|NCT01085149|alveolar bone|alveolar bone
5131800|NCT01085149|tooth extraction|tooth extraction
5131801|NCT01085149|remodeling|remodeling
5131802|NCT01085149|alveolar bone remodeling|alveolar bone remodeling
5131803|NCT01085123|Migraine|migraine
5131804|NCT01085123|ZOMIG® Rapimelt|zomig® rapimelt
5131805|NCT01085110|Groin hernia|groin hernia
5131806|NCT01085110|Chronic pain|chronic pain
5131807|NCT01085110|QST|qst
5131808|NCT01085110|Quantitative sensory testing|quantitative sensory testing
5131809|NCT01085110|Persistent postoperative pain|persistent postoperative pain
5131810|NCT01085110|Laparoscopic inguinal herniotomy|laparoscopic inguinal herniotomy
5131811|NCT01085110|Postherniotomy Pain after laparoscopic inguinal herniotomy|postherniotomy pain after laparoscopic inguinal herniotomy
5131812|NCT01085110|laparoscopic inguinal hernia repair|laparoscopic inguinal hernia repair
5131813|NCT01085097|Systemic Lupus Erythematosus (SLE)|systemic lupus erythematosus (sle)
5131814|NCT01085097|Lupus Nephritis|lupus nephritis
5131815|NCT01085097|Laquinimod|laquinimod
5131816|NCT01085084|Systemic Lupus Erythematosus (SLE)|systemic lupus erythematosus (sle)
5131817|NCT01085084|Lupus Arthritis|lupus arthritis
5131818|NCT01085084|Laquinimod|laquinimod
5131819|NCT01085071|intensive care unit|intensive care unit
5131820|NCT01085071|potassium|potassium
5131821|NCT01085071|atrial fibrillation|atrial fibrillation
5131822|NCT01085071|cardiac surgery|cardiac surgery
5131823|NCT01085071|Critically ill patients post CABG and/or valvular surgery|critically ill patients post cabg and/or valvular surgery
5131824|NCT01085071|Critically ill patients not post CABG and/or valvular surgery|critically ill patients not post cabg and/or valvular surgery
5131825|NCT01085071|coronary artery bypass graft|coronary artery bypass graft
5131826|NCT01085058|Lymphoproliferative diseases (Hodgkin's disease, non-Hodgkin's lymphomas, multiple myelomas) and high-dose therapy|lymphoproliferative diseases (hodgkin's disease, non-hodgkin's lymphomas, multiple myelomas) and high-dose therapy
5131827|NCT01085045|COPD|copd
5131828|NCT01085032|Smoking Cessation|smoking cessation
5131829|NCT01085032|Substance Withdrawal Syndrome|substance withdrawal syndrome
5131830|NCT01085032|Depression|depression
5131831|NCT01085019|Endothelial function|endothelial function
5131832|NCT01085019|Cardiovascular risk factors|cardiovascular risk factors
5131833|NCT01085019|Spices|spices
5131834|NCT01085019|Herbs|herbs
5131835|NCT01085019|Antioxidant|antioxidant
5131836|NCT01085006|cesarean delivery|cesarean delivery
5131837|NCT01085006|Tranexamic acid|tranexamic acid
5131838|NCT01085006|hemorrhage|hemorrhage
5131839|NCT01085006|Spinal analgesia|spinal analgesia
5131840|NCT01085006|1-the amount of hemorrhage during cesarean delivery|1-the amount of hemorrhage during cesarean delivery
5131841|NCT01085006|2-the amount of hemorrhage in the first 2 hours of cesarean delivery|2-the amount of hemorrhage in the first 2 hours of cesarean delivery
5131842|NCT01085006|3-the amount of hemorrhage in the first 24 hour after cesarean delivery|3-the amount of hemorrhage in the first 24 hour after cesarean delivery
5131843|NCT01084993|Coronary artery stenting, transradial, intracoronary|coronary artery stenting, transradial, intracoronary
5131844|NCT01084980|minimal change disease|minimal change disease
5131845|NCT01084980|tacrolimus|tacrolimus
5131846|NCT01084980|corticosteroid|corticosteroid
5131847|NCT01084967|obesity|obesity
5131848|NCT01084967|metabolic syndrome|metabolic syndrome
5131849|NCT01084967|genetic risk markers|genetic risk markers
5131850|NCT01084967|copy number variation|copy number variation
5131851|NCT01084954|HIV validation helicase-dependent amplification|hiv validation helicase-dependent amplification
5131854|NCT01084941|obesity|obesity
5131855|NCT01084941|pregnancy and weight gain|pregnancy and weight gain
5131856|NCT01084928|diabetes|diabetes
5131857|NCT01084928|obesity|obesity
5131858|NCT01084928|pre-diabetes|pre-diabetes
5131859|NCT01084928|South Asian|south asian
5131860|NCT01084915|Weight loss after SAGB VC band placement|weight loss after sagb vc band placement
5131861|NCT01084902|POAG|poag
5131862|NCT01084902|OH|oh
5131863|NCT01084902|Xalatan|xalatan
5131864|NCT01084902|Azopt|azopt
5131865|NCT01084902|Primary Open Angle Study|primary open angle study
5131866|NCT01084889|polypropylene mesh|polypropylene mesh
5131867|NCT01084889|Prolapse|prolapse
5131868|NCT01084889|Cystocele|cystocele
5131869|NCT01084889|Surgical Mesh|surgical mesh
5131870|NCT01084876|Herceptin|herceptin
5131871|NCT01084876|metastatic breast cancer|metastatic breast cancer
5131872|NCT01084876|CT-P6|ct-p6
5131873|NCT01084863|Herceptin|herceptin
5131874|NCT01084863|Her 2-positive|her 2-positive
5131875|NCT01084863|metastatic breast cancer|metastatic breast cancer
5131876|NCT01084863|CT-P6|ct-p6
5131877|NCT01084850|Corneal endothelium|corneal endothelium
5131878|NCT01084850|diabetes mellitus|diabetes mellitus
5131879|NCT01084850|corneal thickness|corneal thickness
5131880|NCT01084837|Multiple myeloma|multiple myeloma
5131881|NCT01084837|Renal failure|renal failure
5131882|NCT01084824|Warts|warts
5131883|NCT01084824|Verruca vulgaris|verruca vulgaris
5131884|NCT01084824|Liquid Nitrogen|liquid nitrogen
5131885|NCT01084824|Cantharidin|cantharidin
5131886|NCT01084824|combination treatment|combination treatment
5131887|NCT01084798|Multiple sclerosis|multiple sclerosis
5131888|NCT01084798|Expanded Disability Status Scale|expanded disability status scale
5131889|NCT01084798|Sclerosis|sclerosis
5131890|NCT01084785|Cancer|cancer
5131891|NCT01084785|genomics|genomics
5131892|NCT01084785|proteomics|proteomics
5131893|NCT01084746|Colorectal Cancer Screening|colorectal cancer screening
5131894|NCT01084746|Computer Interactive Intervention|computer interactive intervention
5131895|NCT01084746|Predictors|predictors
5131896|NCT01084746|Cost Effective Analysis|cost effective analysis
5131897|NCT01084746|Transtheoretical Model|transtheoretical model
5131898|NCT01084707|Smoking Cessation, Nicotine pharmacokinetics|smoking cessation, nicotine pharmacokinetics
5131899|NCT01084694|HSCT|hsct
5131900|NCT01084694|Caregiver|caregiver
5131901|NCT01084694|Caregiver Burden|caregiver burden
5131902|NCT01084694|Allogeneic Transplant|allogeneic transplant
5131903|NCT01084694|Autologous Transplant|autologous transplant
5131904|NCT01084694|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
5131905|NCT01084681|SILK flow diverter, intracranial stents, intracranial aneurysms|silk flow diverter, intracranial stents, intracranial aneurysms
5131906|NCT01084668|moderate to severe chronic plaque psoriasis|moderate to severe chronic plaque psoriasis
5131907|NCT01084668|adalimumab|adalimumab
5131908|NCT01084668|Psoriasis Area and Severity Index (PASI)|psoriasis area and severity index (pasi)
5131909|NCT01084668|Disease Life Quality Index (DLQI)|disease life quality index (dlqi)
5131910|NCT01084668|Nail Psoriasis Severity Index (NAPSI)|nail psoriasis severity index (napsi)
5131911|NCT01084668|biologic disease modifying anti-rheumatic drug (BDMARD)|biologic disease modifying anti-rheumatic drug (bdmard)
5131912|NCT01084668|antibodies|antibodies
5131913|NCT01084668|monoclonals|monoclonals
5131914|NCT01084642|Survey|survey
5131915|NCT01084642|Sexual Health Issues|sexual health issues
5131916|NCT01084642|10-034|10-034
5131917|NCT01084629|Barrett's Esophagus|barrett's esophagus
5131918|NCT01084629|Surveillance|surveillance
5131919|NCT01084603|Smoking Cessation|smoking cessation
5131920|NCT01084603|Nicotine pharmacokinetics|nicotine pharmacokinetics
5131921|NCT01084590|Prevention|prevention
5131922|NCT01084590|Obesity|obesity
5131923|NCT01084590|Safety|safety
5131924|NCT01084590|Unhealthy weight gain|unhealthy weight gain
5131925|NCT01084590|Injury prevention|injury prevention
5131926|NCT01084564|Cost-effectiveness analysis|cost-effectiveness analysis
5131927|NCT01084564|Colombia|colombia
5131928|NCT01084538|paricalcitol iv|paricalcitol iv
5131929|NCT01084538|vitamin D|vitamin d
5131930|NCT01084538|secondary hyperparathyroidism|secondary hyperparathyroidism
5131931|NCT01084538|hemodialysis|hemodialysis
5131932|NCT01084525|Meniere's Disease|meniere's disease
5131933|NCT01084525|Vertigo|vertigo
5131934|NCT01084525|Definitive vertigo|definitive vertigo
5131935|NCT01084525|Vertigo episodes|vertigo episodes
5131936|NCT01084525|Vertigo frequency|vertigo frequency
5131937|NCT01084525|Tinnitus|tinnitus
5131938|NCT01084525|Hearing loss|hearing loss
5131939|NCT01084525|Aural Fullness|aural fullness
5131940|NCT01084512|kinematic analysis,|kinematic analysis,
5131941|NCT01084512|three-compartment model,|three-compartment model,
5131942|NCT01084512|chest wall motion,|chest wall motion,
5131943|NCT01084512|spinal cord injury.|spinal cord injury.
5131944|NCT01084499|Healthy Subjects|healthy subjects
5132067|NCT01083966|Acoustic|acoustic
5131945|NCT01084486|nonalcoholic fatty liver disease|nonalcoholic fatty liver disease
5131946|NCT01084486|Pulse wave velocity|pulse wave velocity
5131947|NCT01084486|augmentation index|augmentation index
5131948|NCT01084486|metformin|metformin
5131949|NCT01084473|Dexmedetomidine|dexmedetomidine
5131950|NCT01084473|gastric emptying|gastric emptying
5131951|NCT01084473|oro-cecal transit time|oro-cecal transit time
5131952|NCT01084473|Sedation in intensive care|sedation in intensive care
5131953|NCT01084473|Gastrointestinal effects of sedation|gastrointestinal effects of sedation
5131954|NCT01084460|Gastrointestinal stromal tumor,endoscopic ultrasound,submucosal tumor|gastrointestinal stromal tumor,endoscopic ultrasound,submucosal tumor
5131955|NCT01084447|obesity|obesity
5131956|NCT01084447|gastroplasty|gastroplasty
5131957|NCT01084447|respiratory muscle training|respiratory muscle training
5131958|NCT01084447|muscle strength|muscle strength
5131959|NCT01084447|physical therapy|physical therapy
5131960|NCT01084421|Adolescents|adolescents
5131961|NCT01084421|Parents|parents
5131962|NCT01084421|Computer Based|computer based
5131963|NCT01084421|Latino|latino
5131964|NCT01084421|Sexual Communication|sexual communication
5131965|NCT01084408|de-novo|de-novo
5131966|NCT01084408|coronary stenoses|coronary stenoses
5131967|NCT01084408|PEPCAD|pepcad
5131968|NCT01084408|DEBonly|debonly
5131969|NCT01084408|Paclitaxel|paclitaxel
5131970|NCT01084395|Parent|parent
5131971|NCT01084395|Adolescent|adolescent
5131972|NCT01084395|Mexico|mexico
5131973|NCT01084395|Safer Sex Communication|safer sex communication
5131974|NCT01084395|Randomized Controlled Trial|randomized controlled trial
5131975|NCT01084395|HIV/AIDS|hiv/aids
5131976|NCT01084395|STD|std
5131977|NCT01084395|Sexual Behavior|sexual behavior
5131978|NCT01084382|Arthrospira platensis|arthrospira platensis
5131979|NCT01084382|female HIV patient|female hiv patient
5131980|NCT01084382|Yaounde|yaounde
5131981|NCT01084382|Redox potential|redox potential
5131982|NCT01084382|Life quality|life quality
5131983|NCT01084382|female patient infected by HIV in Yaounde: Cameroon|female patient infected by hiv in yaounde: cameroon
5131984|NCT01084369|Type 2 diabetes|type 2 diabetes
5131985|NCT01084369|Hypogonadism|hypogonadism
5131986|NCT01084369|Testosterone|testosterone
5131987|NCT01084369|Endothelial dysfunction|endothelial dysfunction
5131988|NCT01084356|CZT|czt
5131989|NCT01084356|sentinel node|sentinel node
5131990|NCT01084356|osseous processes|osseous processes
5131991|NCT01084343|vaccination|vaccination
5131992|NCT01084343|prophylaxis|prophylaxis
5131993|NCT01084330|gastric cancer|gastric cancer
5131994|NCT01084330|metastatic gastric cancer|metastatic gastric cancer
5131995|NCT01084330|advanced gastric cancer|advanced gastric cancer
5131996|NCT01084317|asthma|asthma
5131997|NCT01084317|children|children
5131998|NCT01084317|delay in asthma diagnosis|delay in asthma diagnosis
5131999|NCT01084304|Pregnancy|pregnancy
5132000|NCT01084304|Ovulation tests|ovulation tests
5132001|NCT01084304|stress|stress
5132002|NCT01084304|Wishing to become pregnant|wishing to become pregnant
5132003|NCT01084291|Vaccine|vaccine
5132004|NCT01084291|Dengue Hemorrhagic Fever|dengue hemorrhagic fever
5132005|NCT01084265|Hypogonadism|hypogonadism
5132006|NCT01084265|Recombinant human follicle stimulating hormone (r-hFSH)|recombinant human follicle stimulating hormone (r-hfsh)
5132007|NCT01084265|Recombinant leutinizing hormone (r-hLH)|recombinant leutinizing hormone (r-hlh)
5132008|NCT01084239|acute chest pain|acute chest pain
5132009|NCT01084239|emergency department|emergency department
5132010|NCT01084239|cardiac computed tomography|cardiac computed tomography
5132011|NCT01084226|Rye fiber|rye fiber
5132012|NCT01084226|Alkylresorcinols|alkylresorcinols
5132013|NCT01084226|Plant sterols|plant sterols
5132014|NCT01084226|Cholesterol|cholesterol
5132015|NCT01084226|Antioxidant|antioxidant
5132016|NCT01084226|Effects of plant sterols in rye bread on serum lipids|effects of plant sterols in rye bread on serum lipids
5132017|NCT01084226|Effects of alkylresorcinols in rye fiber on LDL particles|effects of alkylresorcinols in rye fiber on ldl particles
5132018|NCT01084213|Low birth weight|low birth weight
5132019|NCT01084213|Placenta malaria|placenta malaria
5132020|NCT01084213|Anaemia|anaemia
5132021|NCT01084213|Intermittent preventive treatment|intermittent preventive treatment
5132022|NCT01084213|Intermittent screening and treatment|intermittent screening and treatment
5132023|NCT01084213|Rapid diagnostic test|rapid diagnostic test
5132024|NCT01084200|Postoperative pain|postoperative pain
5132025|NCT01084200|Sevoflurane|sevoflurane
5132026|NCT01084200|Propofol|propofol
5132027|NCT01084200|Female|female
5132028|NCT01084200|Elective gynaecological surgery|elective gynaecological surgery
5132029|NCT01084200|Laparoscopic and hysteroscopic surgery|laparoscopic and hysteroscopic surgery
5132030|NCT01084200|Female patients|female patients
5132031|NCT01084200|Undergoing elective laparoscopic and hysteroscopic surgery|undergoing elective laparoscopic and hysteroscopic surgery
5132032|NCT01084187|erectile dysfunction|erectile dysfunction
5132033|NCT01084187|arterial hypertension|arterial hypertension
5132034|NCT01084187|flow mediated vasodilation|flow mediated vasodilation
5132035|NCT01084187|endothelial dysfunction|endothelial dysfunction
5132036|NCT01084187|carotid intima media thickness|carotid intima media thickness
5132037|NCT01084187|vardenafil|vardenafil
5132038|NCT01084174|Peanut Allergy|peanut allergy
5132039|NCT01084135|Clinical trial|clinical trial
5132040|NCT01084135|Down syndrome|down syndrome
5132041|NCT01084135|adolescents|adolescents
5132042|NCT01084135|cognitive|cognitive
5132043|NCT01084135|rivastigmine|rivastigmine
5132044|NCT01084122|Intravenous iron sucrose|intravenous iron sucrose
5132045|NCT01084122|Anemia|anemia
5132046|NCT01084122|Transfusion|transfusion
5132047|NCT01084109|Complementary feeding|complementary feeding
5132048|NCT01084109|Infant growth|infant growth
5132049|NCT01084109|Developing countries|developing countries
5132050|NCT01084096|Antenatal Corticosteroids, Preterm Birth, Diffusion|antenatal corticosteroids, preterm birth, diffusion
5132051|NCT01084083|human papilloma virus infection|human papilloma virus infection
5132052|NCT01084083|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
5132053|NCT01084083|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5132054|NCT01084083|tongue cancer|tongue cancer
5132055|NCT01084070|early feeding|early feeding
5132056|NCT01084070|postoperative care|postoperative care
5132057|NCT01084070|emergency surgery|emergency surgery
5132058|NCT01084018|acute postoperative pain|acute postoperative pain
5132059|NCT01084018|nursing intervention|nursing intervention
5132060|NCT01083992|NAFLD|nafld
5132061|NCT01083992|Galvus|galvus
5132062|NCT01083992|vitamin D|vitamin d
5132063|NCT01083966|Vestibular|vestibular
5132064|NCT01083966|Schwannoma|schwannoma
5132065|NCT01083966|earing-loss|earing-loss
5132066|NCT01083966|brain-tumor|brain-tumor
5132068|NCT01083966|Neuroma|neuroma
5132069|NCT01083953|end tidal concentration|end tidal concentration
5132070|NCT01083927|Pterygium|pterygium
5132071|NCT01083914|extracorporeal circulation, off-pump CABG|extracorporeal circulation, off-pump cabg
5132072|NCT01083888|Pharmacokinetics|pharmacokinetics
5132073|NCT01083888|Safety and tolerability|safety and tolerability
5132074|NCT01083888|Plasma concentration|plasma concentration
5132075|NCT01083888|ASP1517|asp1517
5132076|NCT01083888|FG-4592|fg-4592
5132077|NCT01083875|Radiation|radiation
5132078|NCT01083875|mucositis|mucositis
5132079|NCT01083875|head and neck carcinoma|head and neck carcinoma
5132080|NCT01083875|oral rinse|oral rinse
5132081|NCT01083875|amlexanox|amlexanox
5132082|NCT01083875|MuGard|mugard
5132083|NCT01083862|Health literacy|health literacy
5132084|NCT01083862|patient education|patient education
5132085|NCT01083862|health behaviors|health behaviors
5132086|NCT01083862|chronic disease management|chronic disease management
5132087|NCT01083862|shared decision-making|shared decision-making
5132088|NCT01083862|patient-centered decision making|patient-centered decision making
5132089|NCT01083849|Observational study|observational study
5132090|NCT01083849|Paricalcitol|paricalcitol
5132091|NCT01083849|Treatment of Hyperparathyroidism|treatment of hyperparathyroidism
5132092|NCT01083849|Chronic kidney disease stage 3, 4 and 5 (CKD stage 3, 4 and 5)|chronic kidney disease stage 3, 4 and 5 (ckd stage 3, 4 and 5)
5132093|NCT01083849|Chronic Kidney Disease|chronic kidney disease
5132094|NCT01083849|Zemplar|zemplar
5132095|NCT01083849|sHPT|shpt
5132096|NCT01083849|Secondary|secondary
5132097|NCT01083823|Mental health telemetry|mental health telemetry
5132098|NCT01083823|Mood telemetry|mood telemetry
5132099|NCT01083823|Mood|mood
5132100|NCT01083823|Bipolar disorder|bipolar disorder
5132101|NCT01083823|Affective instability|affective instability
5132102|NCT01083823|Cyclothymia|cyclothymia
5132103|NCT01083823|Electronic diaries|electronic diaries
5132104|NCT01083823|Mood diaries|mood diaries
5132105|NCT01083823|Mood swings|mood swings
5132106|NCT01083810|Human Immunodeficiency Virus|human immunodeficiency virus
5132107|NCT01083810|Infection|infection
5132108|NCT01083810|Kaletra|kaletra
5132109|NCT01083810|Resistance|resistance
5132110|NCT01083810|Mutations|mutations
5132111|NCT01083810|alternative Therapy regimen|alternative therapy regimen
5132112|NCT01083797|Sedation|sedation
5132113|NCT01083797|Electroencephalography|electroencephalography
5132114|NCT01083797|Dexmedetomidine|dexmedetomidine
5132115|NCT01083797|Chloral hydrate|chloral hydrate
5132116|NCT01083784|Cardiac arrest|cardiac arrest
5132117|NCT01083784|Prophylactic anticonvulsant|prophylactic anticonvulsant
5132118|NCT01083719|Glioblastoma|glioblastoma
5132119|NCT01083719|FDG-PET|fdg-pet
5132120|NCT01083719|MRI|mri
5132121|NCT01083693|Monoclonals|monoclonals
5132122|NCT01083693|Antibodies|antibodies
5132123|NCT01083693|Ankylosing Spondylitis|ankylosing spondylitis
5132124|NCT01083693|Antirheumatic Agents|antirheumatic agents
5132125|NCT01083693|Quality of Life|quality of life
5132126|NCT01083693|Adalimumab|adalimumab
5132127|NCT01083693|rheumatoid arthritis|rheumatoid arthritis
5132128|NCT01083693|psoriatic arthritis|psoriatic arthritis
5132129|NCT01083680|Routine clinical setting|routine clinical setting
5132130|NCT01083680|Long-term efficacy and safety|long-term efficacy and safety
5132131|NCT01083680|Crohn's Disease|crohn's disease
5132132|NCT01083680|Humira®|humira®
5132133|NCT01083680|Adalimumab|adalimumab
5132134|NCT01083667|ALS|als
5132135|NCT01083667|Familial ALS|familial als
5132136|NCT01083667|SOD1 Gene Mutation|sod1 gene mutation
5132137|NCT01083654|Smoking|smoking
5132138|NCT01083654|Smoking cessation|smoking cessation
5132139|NCT01083641|Breast Cancer|breast cancer
5132140|NCT01083615|CRPC patients with cancer related pain|crpc patients with cancer related pain
5132141|NCT01083615|CRPC|crpc
5132142|NCT01083615|HRPC|hrpc
5132143|NCT01083602|Multiple Myeloma|multiple myeloma
5132144|NCT01083602|Relapsed Multiple Myeloma|relapsed multiple myeloma
5132145|NCT01083602|Refractory Multiple Myeloma|refractory multiple myeloma
5132146|NCT01083589|Lung Cancer|lung cancer
5132147|NCT01083589|Metastatic NSCLC|metastatic nsclc
5132148|NCT01083589|Tumor|tumor
5132149|NCT01083589|Imatinib Mesylate|imatinib mesylate
5132150|NCT01083589|Gleevec|gleevec
5132151|NCT01083589|Docetaxel|docetaxel
5132152|NCT01083589|Taxotere|taxotere
5132153|NCT01083576|leishmaniasis|leishmaniasis
5132154|NCT01083576|cutaneous|cutaneous
5132155|NCT01083576|WR 279,396|wr 279,396
5132156|NCT01083576|paromomycin|paromomycin
5132157|NCT01083576|gentamicin|gentamicin
5132158|NCT01083576|pharmacokinetics|pharmacokinetics
5132159|NCT01083576|safety|safety
5132160|NCT01083576|efficacy|efficacy
5132161|NCT01083563|TNF|tnf
5132162|NCT01083563|CD20|cd20
5132163|NCT01083563|RA|ra
5132164|NCT01083550|thyroid carcinoma|thyroid carcinoma
5132165|NCT01083550|thyroid cancer|thyroid cancer
5132166|NCT01083550|therapeutic radioisotopes|therapeutic radioisotopes
5132167|NCT01083550|radioactive iodine|radioactive iodine
5132168|NCT01083537|malignant bowel obstruction|malignant bowel obstruction
5132169|NCT01083537|ovarian cancer|ovarian cancer
5132170|NCT01083537|Peritoneal cancer|peritoneal cancer
5132171|NCT01083537|Fallopian Tube cancer|fallopian tube cancer
5132172|NCT01083524|Pulmonary arterial hypertension|pulmonary arterial hypertension
5132173|NCT01083524|Pulmonary hypertension|pulmonary hypertension
5132174|NCT01083524|Dichloroacetate|dichloroacetate
5132175|NCT01083524|Dichloroacetate Sodium|dichloroacetate sodium
5132176|NCT01083524|DCA|dca
5132177|NCT01083511|Influenza|influenza
5132178|NCT01083511|Influenza A|influenza a
5132179|NCT01083511|Influenza B|influenza b
5132180|NCT01083511|Swine Influenza A/H1N1|swine influenza a/h1n1
5132181|NCT01083511|Respiratory Virus|respiratory virus
5132182|NCT01083498|Becker's nevus|becker's nevus
5132183|NCT01083498|ablative fractional laser therapy|ablative fractional laser therapy
5132184|NCT01083498|randomized controlled trial|randomized controlled trial
5132185|NCT01083498|split-lesion design|split-lesion design
5132186|NCT01083485|Oxycodone|oxycodone
5132187|NCT01083485|Naloxone|naloxone
5132188|NCT01083485|Postoperative pain|postoperative pain
5132189|NCT01083485|Arthroplasty|arthroplasty
5132190|NCT01083485|Efficacy|efficacy
5132191|NCT01083472|dehiscence|dehiscence
5132192|NCT01083472|laparotomy|laparotomy
5132193|NCT01083472|Hernia repair|hernia repair
5132194|NCT01083472|surgical wound|surgical wound
5132195|NCT01083472|surgical mesh|surgical mesh
5132196|NCT01083446|Encephalopathy|encephalopathy
5132197|NCT01083446|Cirrhotics|cirrhotics
5132198|NCT01083433|Continuous Glucose Monitor|continuous glucose monitor
5132199|NCT01083433|Adherence|adherence
5132200|NCT01083433|Adolescents|adolescents
5132201|NCT01083433|Diabetes Education|diabetes education
5132202|NCT01083420|Oral lichen planus|oral lichen planus
5132203|NCT01083420|Minocycline|minocycline
5132204|NCT01083420|Dexamethasone|dexamethasone
5132205|NCT01083407|Oral care.|oral care.
5132206|NCT01083407|Chlorhexidine.|chlorhexidine.
5132207|NCT01083407|Pediatric Nursing|pediatric nursing
5132208|NCT01083407|Intensive Care|intensive care
5132209|NCT01083407|Nosocomial infection|nosocomial infection
5132210|NCT01083407|Pneumonia|pneumonia
5132211|NCT01083407|Oropharyngeal colonization|oropharyngeal colonization
5132212|NCT01083407|Tracheal colonization|tracheal colonization
5132213|NCT01083394|PTA|pta
5132214|NCT01083394|paclitaxel|paclitaxel
5132215|NCT01083394|restenosis|restenosis
5132216|NCT01083381|Schizophrenia treatment MS14 randomized clinical trial|schizophrenia treatment ms14 randomized clinical trial
5132217|NCT01083368|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5132218|NCT01083368|hormone-resistant prostate cancer|hormone-resistant prostate cancer
5132219|NCT01083368|recurrent prostate cancer|recurrent prostate cancer
5132220|NCT01083368|stage IV prostate cancer|stage iv prostate cancer
5132221|NCT01083355|Variable ventilation|variable ventilation
5132222|NCT01083355|Pressure regulated volume control ventilation|pressure regulated volume control ventilation
5132223|NCT01083355|Airway pressure release ventilation|airway pressure release ventilation
5132224|NCT01083342|primary CNS lymphoma|primary cns lymphoma
5132225|NCT01083342|MTX: Methotrexate,Leucovorin|mtx: methotrexate,leucovorin
5132226|NCT01083342|MVD: Methotrexate,Vincristine,Dexamethasone|mvd: methotrexate,vincristine,dexamethasone
5132227|NCT01083342|VIA: VP-16 (Etoposide),Ifosfamide,Mesna, Cytarabine (ara-C)|via: vp-16 (etoposide),ifosfamide,mesna, cytarabine (ara-c)
5132228|NCT01083342|Newly diagnosed primary CNS lymphoma patients|newly diagnosed primary cns lymphoma patients
5132229|NCT01083329|nicotinic acid|nicotinic acid
5132230|NCT01083329|lipolysis|lipolysis
5132231|NCT01083329|training program|training program
5132232|NCT01083329|adipose tissue inflammation|adipose tissue inflammation
5132233|NCT01083329|obese|obese
5132234|NCT01083316|Amyloid|amyloid
5132235|NCT01083316|Amyloidosis|amyloidosis
5132236|NCT01083316|AL Amyloidosis|al amyloidosis
5132237|NCT01083316|Primary Amyloidosis|primary amyloidosis
5132238|NCT01083316|Stem Cell Transplant|stem cell transplant
5132239|NCT01083303|energy expenditure|energy expenditure
5132240|NCT01083303|hypothermia|hypothermia
5132241|NCT01083303|body temperature|body temperature
5132242|NCT01083303|weaning|weaning
5132243|NCT01083303|preterm infants|preterm infants
5132244|NCT01083290|spironolactone|spironolactone
5132245|NCT01083290|linearity of pharmacokinetics|linearity of pharmacokinetics
5132246|NCT01083290|Healthy volunteers|healthy volunteers
5132247|NCT01083277|oxygenation|oxygenation
5132248|NCT01083277|ventilation|ventilation
5132249|NCT01083277|tidal volume|tidal volume
5132250|NCT01083277|patterns of breathing|patterns of breathing
5132251|NCT01083277|variable ventilation|variable ventilation
5132252|NCT01083277|mechanical ventilation|mechanical ventilation
5132253|NCT01083264|Pharmacokinetics|pharmacokinetics
5132254|NCT01083251|HBV|hbv
5132255|NCT01083251|VITAMIN D|vitamin d
5132256|NCT01083251|PEGITERFERON|pegiterferon
5132257|NCT01083251|Telbivudine|telbivudine
5132258|NCT01083238|pharmacokinetics|pharmacokinetics
5132259|NCT01083238|fasting or after a high fat meal|fasting or after a high fat meal
5132260|NCT01083238|adult|adult
5132261|NCT01083238|elderly adult|elderly adult
5132262|NCT01083238|COPD|copd
5132263|NCT01083212|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
5132264|NCT01083212|Gemfibrozil|gemfibrozil
5132265|NCT01083199|Prostate Cancer|prostate cancer
5132266|NCT01083199|Radical Prostatectomy|radical prostatectomy
5132267|NCT01083199|Vesico-Urethral Anastomosis|vesico-urethral anastomosis
5132268|NCT01083186|Secondary Hyperparathyroidism|secondary hyperparathyroidism
5132269|NCT01083186|Chronic Kidney Failure|chronic kidney failure
5132270|NCT01083173|Postmarketing Drug Surveillance|postmarketing drug surveillance
5132271|NCT01083173|HIV-1 infection|hiv-1 infection
5132272|NCT01083173|Kaletra|kaletra
5132273|NCT01083160|Rheumatoid Arthritis|rheumatoid arthritis
5132274|NCT01083160|Anti-TNF|anti-tnf
5132275|NCT01083160|Adalimumab|adalimumab
5132276|NCT01083160|Infliximab|infliximab
5132277|NCT01083160|Etanercept|etanercept
5132278|NCT01083147|Intermediate AMD|intermediate amd
5132279|NCT01083134|CAD|cad
5132280|NCT01083121|Postmarketing Drug Surveillance|postmarketing drug surveillance
5132281|NCT01083108|Behavioral Weight Loss Treatment|behavioral weight loss treatment
5132282|NCT01083108|Bariatric Surgery|bariatric surgery
5132283|NCT01083108|Diabetes Type II|diabetes type ii
5132284|NCT01083108|Obesity|obesity
5132285|NCT01083108|Adult|adult
5132286|NCT01083108|Type 2 Diabetes|type 2 diabetes
5132287|NCT01083095|Malaria|malaria
5132288|NCT01083095|Sporozoite|sporozoite
5132289|NCT01083095|Challenge Model|challenge model
5132290|NCT01083095|Plasmodium vivax|plasmodium vivax
5132291|NCT01083095|Human Volunteers|human volunteers
5132292|NCT01083082|lifestyles|lifestyles
5132293|NCT01083082|diet|diet
5132294|NCT01083082|exercise|exercise
5132295|NCT01083082|central blood pressure|central blood pressure
5132296|NCT01083082|arterial stiffness|arterial stiffness
5132297|NCT01083082|endothelial dysfunction|endothelial dysfunction
5132298|NCT01083082|Healthy people|healthy people
5132299|NCT01083069|Sudden cardiac arrest|sudden cardiac arrest
5132300|NCT01083069|hypothermia|hypothermia
5132301|NCT01083069|neurological outcome|neurological outcome
5132302|NCT01083056|retina|retina
5132303|NCT01083056|gliosis|gliosis
5132304|NCT01083056|macula|macula
5132305|NCT01083056|membrane|membrane
5132306|NCT01083056|ILM|ilm
5132307|NCT01083043|Glycemic Variability|glycemic variability
5132308|NCT01083043|Endothelial Dysfunction|endothelial dysfunction
5132309|NCT01083030|pAVK|pavk
5132310|NCT01083030|PTA|pta
5132311|NCT01083030|drug coated balloon|drug coated balloon
5132312|NCT01083004|dye|dye
5132313|NCT01083004|internal limiting membrane|internal limiting membrane
5132314|NCT01083004|macular hole|macular hole
5132315|NCT01083004|macular pucker|macular pucker
5132316|NCT01082978|Quality of Life|quality of life
5132317|NCT01082978|Health Care Quality and Safety|health care quality and safety
5132318|NCT01082978|Randomized controlled trial|randomized controlled trial
5132319|NCT01082965|ASL MRI|asl mri
5132320|NCT01082965|perfusion|perfusion
5132321|NCT01082965|cognition|cognition
5132322|NCT01082965|donepezil|donepezil
5132323|NCT01082965|alzheimer's disease|alzheimer's disease
5132324|NCT01082965|translational medicine|translational medicine
5132325|NCT01082939|Chronic lymphocytic leukemia|chronic lymphocytic leukemia
5132326|NCT01082939|Refractory CLL|refractory cll
5132327|NCT01082939|CFAR|cfar
5132328|NCT01082939|Alemtuzumab|alemtuzumab
5132329|NCT01082939|Campath-1H|campath-1h
5132330|NCT01082939|Campath|campath
5132331|NCT01082939|Cyclophosphamide|cyclophosphamide
5132332|NCT01082939|Cytoxan|cytoxan
5132333|NCT01082939|Neosar|neosar
5132334|NCT01082939|Fludarabine|fludarabine
5132335|NCT01082939|Fludara|fludara
5132336|NCT01082939|Fludarabine Phosphate|fludarabine phosphate
5132337|NCT01082939|Rituximab|rituximab
5132338|NCT01082939|Rituxan|rituxan
5132339|NCT01082939|CLL|cll
5132340|NCT01082926|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5132341|NCT01082926|adult anaplastic ependymoma|adult anaplastic ependymoma
5132342|NCT01082926|adult anaplastic meningioma|adult anaplastic meningioma
5132343|NCT01082926|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
5132344|NCT01082926|adult brain stem glioma|adult brain stem glioma
5132345|NCT01082926|adult ependymoblastoma|adult ependymoblastoma
5132346|NCT01082926|adult giant cell glioblastoma|adult giant cell glioblastoma
5132932|NCT01080768|amlodipine|amlodipine
5132347|NCT01082926|adult glioblastoma|adult glioblastoma
5132348|NCT01082926|adult gliosarcoma|adult gliosarcoma
5132349|NCT01082926|adult grade III meningioma|adult grade iii meningioma
5132350|NCT01082926|adult meningeal hemangiopericytoma|adult meningeal hemangiopericytoma
5132351|NCT01082926|adult mixed glioma|adult mixed glioma
5132352|NCT01082926|adult pineal gland astrocytoma|adult pineal gland astrocytoma
5132353|NCT01082926|recurrent adult brain tumor|recurrent adult brain tumor
5132354|NCT01082926|Los Angeles|los angeles
5132355|NCT01082900|Transient Tachypnea of the Newborn|transient tachypnea of the newborn
5132356|NCT01082900|Elective Cesarean section|elective cesarean section
5132357|NCT01082900|Late preterm|late preterm
5132358|NCT01082900|CPAP|cpap
5132359|NCT01082900|Delivery Room|delivery room
5132360|NCT01082887|Immunotherapy TIL (Tumor Infiltrating Lymphocytes)|immunotherapy til (tumor infiltrating lymphocytes)
5132361|NCT01082887|Intra-tumoral injection|intra-tumoral injection
5132362|NCT01082887|Interferon gamma-adenovirus(Ad-IFNg)|interferon gamma-adenovirus(ad-ifng)
5132363|NCT01082887|Metastatic melanoma|metastatic melanoma
5132364|NCT01082887|A stage IIIc/IV metastatic melanoma with nodal relapse|a stage iiic/iv metastatic melanoma with nodal relapse
5132365|NCT01082887|in transit metastasis|in transit metastasis
5132366|NCT01082887|cutaneous unresectable metastases|cutaneous unresectable metastases
5132367|NCT01082887|visceral metastases|visceral metastases
5132368|NCT01082874|Randomized Controlled Trial|randomized controlled trial
5132369|NCT01082874|Blinded|blinded
5132370|NCT01082874|Clonidine|clonidine
5132371|NCT01082874|acetyl-salicylic acid (ASA)|acetyl-salicylic acid (asa)
5132372|NCT01082874|Perioperative vascular complications|perioperative vascular complications
5132373|NCT01082874|Noncardiac surgery|noncardiac surgery
5132374|NCT01082861|1998 female birth cohort eligible for HPV vaccination in 2011 within the Dutch NIP|1998 female birth cohort eligible for hpv vaccination in 2011 within the dutch nip
5132375|NCT01082835|Chinese herbs|chinese herbs
5132376|NCT01082822|cell sheet PDLSC periodontitis|cell sheet pdlsc periodontitis
5132377|NCT01082809|advanced biliary tract carcinoma|advanced biliary tract carcinoma
5132378|NCT01082809|Sunitinib|sunitinib
5132379|NCT01082783|stroke-induced immunodepression|stroke-induced immunodepression
5132380|NCT01082783|acute media infarct|acute media infarct
5132381|NCT01082783|acute intracerebral bleeding|acute intracerebral bleeding
5132382|NCT01082783|leucocytes|leucocytes
5132383|NCT01082783|autoaggressive T-cells|autoaggressive t-cells
5132384|NCT01082783|acute media infarct or acute intracerebral bleeding|acute media infarct or acute intracerebral bleeding
5132385|NCT01082757|Colorectal neoplasms|colorectal neoplasms
5132386|NCT01082757|metastasis|metastasis
5132387|NCT01082757|colorectal cancer|colorectal cancer
5132388|NCT01082744|Paravertebral Block|paravertebral block
5132389|NCT01082744|Regional Anesthesia|regional anesthesia
5132390|NCT01082744|Anesthetics Local|anesthetics local
5132391|NCT01082744|Ropivacaine|ropivacaine
5132392|NCT01082744|Sufentanil|sufentanil
5132393|NCT01082744|Pain Postoperative|pain postoperative
5132394|NCT01082744|Chronic Pain|chronic pain
5132395|NCT01082744|Thoracic Surgery Video-Assisted.|thoracic surgery video-assisted.
5132396|NCT01082731|Malaria|malaria
5132397|NCT01082731|Plasmodium falciparum|plasmodium falciparum
5132398|NCT01082731|Treatment|treatment
5132399|NCT01082731|Brazil|brazil
5132400|NCT01082718|Malaria|malaria
5132401|NCT01082718|Pregnancy|pregnancy
5132402|NCT01082718|Pharmacokinetics|pharmacokinetics
5132403|NCT01082718|Brazil|brazil
5132404|NCT01082705|malaria|malaria
5132405|NCT01082705|treatment|treatment
5132406|NCT01082705|artemisinin combination therapy|artemisinin combination therapy
5132407|NCT01082705|Tanzania|tanzania
5132408|NCT01082705|P. falciparum malaria in children age 6-59 months|p. falciparum malaria in children age 6-59 months
5132409|NCT01082692|HIV Infection|hiv infection
5132410|NCT01082692|DNA vaccine|dna vaccine
5132411|NCT01082692|Electroporation|electroporation
5132412|NCT01082692|HIV therapeutic vaccine|hiv therapeutic vaccine
5132413|NCT01082679|opioid dependent|opioid dependent
5132414|NCT01082679|methadone|methadone
5132415|NCT01082679|Suboxone|suboxone
5132416|NCT01082679|buprenorphine|buprenorphine
5132417|NCT01082666|Cuff pressure|cuff pressure
5132418|NCT01082666|microaspiration|microaspiration
5132419|NCT01082666|pepsin|pepsin
5132420|NCT01082666|VAP|vap
5132421|NCT01082666|Mechanical ventilation|mechanical ventilation
5132422|NCT01082653|ALS|als
5132423|NCT01082653|Lou Gehrig's Disease|lou gehrig's disease
5132424|NCT01082640|Gout|gout
5132425|NCT01082640|physiology|physiology
5132426|NCT01082640|Hyperuricemia|hyperuricemia
5132427|NCT01082640|Uric Acid|uric acid
5132428|NCT01082640|Drug Therapy|drug therapy
5132429|NCT01082627|Somatostatin small bowel obstruction|somatostatin small bowel obstruction
5132430|NCT01082601|Catheter Ablation|catheter ablation
5132431|NCT01082601|Atrial Fibrillation|atrial fibrillation
5132432|NCT01082601|Congestive heart failure|congestive heart failure
5132433|NCT01082588|schizophrenia|schizophrenia
5132434|NCT01082588|pravastatin|pravastatin
5132435|NCT01082588|inflammation|inflammation
5132436|NCT01082588|cognition|cognition
5132437|NCT01082588|antipsychotics|antipsychotics
5132438|NCT01082588|cholesterol|cholesterol
5132439|NCT01082575|Post Op Patients|post op patients
5132528|NCT01082211|recurrent breast cancer|recurrent breast cancer
5132440|NCT01082575|Continuous Pulse Oximetry Monitoring|continuous pulse oximetry monitoring
5132441|NCT01082575|Major Surgery|major surgery
5132561|NCT01082042|Accidental falls|accidental falls
5132442|NCT01082549|Patients with Previously Untreated Advanced Squamous Cell Lung Cancer|patients with previously untreated advanced squamous cell lung cancer
5132443|NCT01082536|Pediatrics|pediatrics
5132444|NCT01082536|Congenital heart disease|congenital heart disease
5132446|NCT01082536|Brain oxygenation|brain oxygenation
5132447|NCT01082510|UFT|uft
5132448|NCT01082510|BCG|bcg
5132449|NCT01082497|Mindfulness|mindfulness
5132450|NCT01082497|Stress|stress
5132451|NCT01082497|Burnout|burnout
5132452|NCT01082497|Ward atmosphere|ward atmosphere
5132453|NCT01082497|Stress and burnout among staff, psychosocial atmosphere at the ward|stress and burnout among staff, psychosocial atmosphere at the ward
5132454|NCT01082484|Healthy volunteers|healthy volunteers
5132455|NCT01082484|iontophoresis|iontophoresis
5132456|NCT01082471|Morphine 6-glucuronide|morphine 6-glucuronide
5132457|NCT01082471|Morphine|morphine
5132458|NCT01082471|Patient Controlled Analgesia|patient controlled analgesia
5132459|NCT01082471|Post Operative Nausea and Vomiting|post operative nausea and vomiting
5132460|NCT01082458|Patients scheduled to undergo thyroidectomy|patients scheduled to undergo thyroidectomy
5132461|NCT01082445|stage C|stage c
5132462|NCT01082445|grade 0 (Texas University)|grade 0 (texas university)
5132463|NCT01082432|thumb|thumb
5132464|NCT01082432|Ulnar collateral ligament|ulnar collateral ligament
5132465|NCT01082432|superimposed electrical stimulation|superimposed electrical stimulation
5132466|NCT01082432|stiffness|stiffness
5132467|NCT01082432|adhesions|adhesions
5132468|NCT01082419|Liver stiffness measurement|liver stiffness measurement
5132469|NCT01082419|ARFI|arfi
5132470|NCT01082419|fibrosis|fibrosis
5132471|NCT01082419|hepatopathy|hepatopathy
5132472|NCT01082393|vitiligo|vitiligo
5132473|NCT01082380|radiolabeled|radiolabeled
5132474|NCT01082380|healthy volunteers|healthy volunteers
5132475|NCT01082367|Tobramycin Inhalation solution|tobramycin inhalation solution
5132476|NCT01082367|Cystic fibrosis|cystic fibrosis
5132477|NCT01082367|Lung disease|lung disease
5132478|NCT01082367|anti-bacterial agents|anti-bacterial agents
5132479|NCT01082354|Infant, Low birth weight|infant, low birth weight
5132480|NCT01082354|Infant, Low birth height|infant, low birth height
5132481|NCT01082354|Infant, Small for Gestational Age|infant, small for gestational age
5132482|NCT01082341|GCP Good Clinical Practice|gcp good clinical practice
5132483|NCT01082341|IFAT Indirect Immunofluorescence antibody test|ifat indirect immunofluorescence antibody test
5132484|NCT01082341|MFA Membrane Feeding Assay|mfa membrane feeding assay
5132485|NCT01082341|N Number (typically refers to subjects)|n number (typically refers to subjects)
5132486|NCT01082341|RBC Red Blood Cells|rbc red blood cells
5132487|NCT01082341|SOP Standard Operating Procedure|sop standard operating procedure
5132488|NCT01082341|TBS Thick blood smear|tbs thick blood smear
5132489|NCT01082341|P. Vivax|p. vivax
5132490|NCT01082341|irradiated sporozoite vaccination.|irradiated sporozoite vaccination.
5132491|NCT01082328|Phenylketonuria (PKU)|phenylketonuria (pku)
5132492|NCT01082328|Hyperphenylalaninemia (HPA)|hyperphenylalaninemia (hpa)
5132493|NCT01082328|Kuvan®|kuvan®
5132494|NCT01082328|Sapropterin dihydrochloride|sapropterin dihydrochloride
5132495|NCT01082328|Kuvan responder|kuvan responder
5132496|NCT01082328|Tetrahydrobiopterin (BH4)|tetrahydrobiopterin (bh4)
5132497|NCT01082315|Colorectal cancer|colorectal cancer
5132498|NCT01082315|Neoplasm metastasis|neoplasm metastasis
5132499|NCT01082315|Cetuximab|cetuximab
5132500|NCT01082315|Erbitux|erbitux
5132501|NCT01082315|EGFR|egfr
5132502|NCT01082302|green tea extract|green tea extract
5132503|NCT01082302|Polyphenon E|polyphenon e
5132504|NCT01082302|Pharmacokinetics|pharmacokinetics
5132505|NCT01082289|Lurasidone|lurasidone
5132506|NCT01082289|Schizophrenia|schizophrenia
5132507|NCT01082289|Latuda|latuda
5132508|NCT01082276|Rifampin DDI with Lurasidone HCl|rifampin ddi with lurasidone hcl
5132509|NCT01082263|DDI study between Midazolam and Lurasidone HCl|ddi study between midazolam and lurasidone hcl
5132510|NCT01082263|Male and Female|male and female
5132511|NCT01082250|Bioequivalence|bioequivalence
5132512|NCT01082250|Male/Female Patient|male/female patient
5132513|NCT01082250|Reference/Test Formulation|reference/test formulation
5132514|NCT01082250|Schizophrenia Patients|schizophrenia patients
5132515|NCT01082237|Major Depressive Disorder|major depressive disorder
5132516|NCT01082237|EEG|eeg
5132517|NCT01082237|SSRI|ssri
5132518|NCT01082224|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
5132519|NCT01082224|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
5132520|NCT01082224|recurrent adult primary liver cancer|recurrent adult primary liver cancer
5132521|NCT01082211|invasive ductal breast carcinoma|invasive ductal breast carcinoma
5132522|NCT01082211|medullary ductal breast carcinoma with lymphocytic infiltrate|medullary ductal breast carcinoma with lymphocytic infiltrate
5132523|NCT01082211|invasive lobular breast carcinoma|invasive lobular breast carcinoma
5132524|NCT01082211|tubular ductal breast carcinoma|tubular ductal breast carcinoma
5132525|NCT01082211|mucinous ductal breast carcinoma|mucinous ductal breast carcinoma
5132526|NCT01082211|ductal breast carcinoma in situ|ductal breast carcinoma in situ
5132527|NCT01082211|lobular breast carcinoma in situ|lobular breast carcinoma in situ
5132529|NCT01082198|stage III melanoma|stage iii melanoma
5132530|NCT01082185|abdominal|abdominal
5132531|NCT01082185|aortic|aortic
5132532|NCT01082185|aneurysm|aneurysm
5132533|NCT01082185|AAA|aaa
5132534|NCT01082172|thoracic|thoracic
5132535|NCT01082172|aortic|aortic
5132536|NCT01082172|aneurysm|aneurysm
5132537|NCT01082172|TAA|taa
5132538|NCT01082159|Spinal Stenosis|spinal stenosis
5132539|NCT01082159|Lumbar Spinal Stenosis|lumbar spinal stenosis
5132540|NCT01082146|pharmacokinetics, lurasidone|pharmacokinetics, lurasidone
5132541|NCT01082133|Fanconi Anemia|fanconi anemia
5132542|NCT01082120|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
5132543|NCT01082120|Pioglitazone|pioglitazone
5132544|NCT01082094|Ischemic heart failure|ischemic heart failure
5132545|NCT01082094|Congestive heart failure|congestive heart failure
5132546|NCT01082094|Stromal cell-derived factor 1|stromal cell-derived factor 1
5132547|NCT01082094|SDF-1|sdf-1
5132548|NCT01082094|Gene therapy|gene therapy
5132549|NCT01082081|paracetamol|paracetamol
5132550|NCT01082081|dental pain|dental pain
5132551|NCT01082081|Post-surgical dental pain|post-surgical dental pain
5132552|NCT01082068|HER2 negative|her2 negative
5132553|NCT01082068|Hormone Receptor Positive|hormone receptor positive
5132554|NCT01082068|Breast Neoplasms|breast neoplasms
5132555|NCT01082055|Cardiac|cardiac
5132556|NCT01082055|Dysrhythmia|dysrhythmia
5132557|NCT01082055|Safety|safety
5132558|NCT01082042|Balance, postural|balance, postural
5132559|NCT01082042|Aged, over 70|aged, over 70
5132560|NCT01082042|Exercise|exercise
5132562|NCT01082016|Sleep|sleep
5132563|NCT01082016|Critical Illness|critical illness
5132564|NCT01082016|Sleep promotion during recovery form illness|sleep promotion during recovery form illness
5132565|NCT01082003|Capsular contractures in breast cancer patients|capsular contractures in breast cancer patients
5132566|NCT01081977|Delayed cord clamping|delayed cord clamping
5132567|NCT01081977|Ferritin|ferritin
5132568|NCT01081977|Hemoglobin|hemoglobin
5132569|NCT01081977|Neonatal anemia|neonatal anemia
5132570|NCT01081977|Postpartum haemorrhage|postpartum haemorrhage
5132571|NCT01081977|Neonatal jaundice|neonatal jaundice
5132572|NCT01081964|pneumonia|pneumonia
5132573|NCT01081964|Community acquired pneumonia of moderate severity|community acquired pneumonia of moderate severity
5132574|NCT01081951|Poly(ADP ribose)|poly(adp ribose)
5132575|NCT01081951|polymerisation (PARP)|polymerisation (parp)
5132576|NCT01081951|Platinum sensitive|platinum sensitive
5132577|NCT01081951|Advanced Serous Ovarian cancer|advanced serous ovarian cancer
5132578|NCT01081951|olaparib|olaparib
5132579|NCT01081951|PARP inhibitors|parp inhibitors
5132580|NCT01081951|Platinum Sensitive Advanced Serous Ovarian Cancer|platinum sensitive advanced serous ovarian cancer
5132581|NCT01081925|Congestive Heart Failure|congestive heart failure
5132582|NCT01081925|Cardiac Failure|cardiac failure
5132583|NCT01081912|chronic pain|chronic pain
5132584|NCT01081912|back pain|back pain
5132585|NCT01081899|dying patients|dying patients
5132586|NCT01081899|cancer|cancer
5132587|NCT01081899|hospital|hospital
5132588|NCT01081899|Liverpool Care Pathways|liverpool care pathways
5132589|NCT01081886|Total knee arthroplasty|total knee arthroplasty
5132590|NCT01081886|PlasmaBlade|plasmablade
5132591|NCT01081886|Electrosurgery|electrosurgery
5132592|NCT01081886|PEAK Surgical|peak surgical
5132593|NCT01081886|Medtronic Advanced Energy|medtronic advanced energy
5132594|NCT01081886|Medtronic|medtronic
5132595|NCT01081873|Multicenter study|multicenter study
5132596|NCT01081860|Carpal tunnel syndrome|carpal tunnel syndrome
5132597|NCT01081860|CTS|cts
5132598|NCT01081860|Skinstiffness|skinstiffness
5132599|NCT01081860|Jointstiffness|jointstiffness
5132600|NCT01081847|Malaria|malaria
5132601|NCT01081847|Synthetic peptides|synthetic peptides
5132602|NCT01081847|Plasmodium vivax|plasmodium vivax
5132603|NCT01081847|Human volunteers|human volunteers
5132604|NCT01081834|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
5132605|NCT01081834|Canagliflozin|canagliflozin
5132606|NCT01081834|Placebo|placebo
5132607|NCT01081834|Hemoglobin A1c|hemoglobin a1c
5132608|NCT01081834|Type 2 diabetes mellitus|type 2 diabetes mellitus
5132609|NCT01081821|JNJ 39758979|jnj 39758979
5132610|NCT01081821|Japanese descent|japanese descent
5132611|NCT01081808|PhaseI|phasei
5132612|NCT01081808|Solid Tumor|solid tumor
5132613|NCT01081808|biomarkers|biomarkers
5132614|NCT01081808|T cell|t cell
5132615|NCT01081808|Cetuximab|cetuximab
5132616|NCT01081808|Epidermal Growth Factor Receptor|epidermal growth factor receptor
5132617|NCT01081808|Aldesleukin|aldesleukin
5132618|NCT01081808|Lymphocytes|lymphocytes
5132619|NCT01081808|Autologous|autologous
5132620|NCT01081808|Recurrent|recurrent
5132621|NCT01081808|Refractory|refractory
5132622|NCT01081808|Metastatic|metastatic
5132623|NCT01081808|Immunotherapy|immunotherapy
5132624|NCT01081808|Antibodies|antibodies
5132625|NCT01081808|Neoplasms by Site|neoplasms by site
5132626|NCT01081808|Anti-Retroviral Agents|anti-retroviral agents
5132627|NCT01081808|Therapeutic Uses|therapeutic uses
5132628|NCT01081808|Anti-Infective Agents|anti-infective agents
5132629|NCT01081808|Neoplasms by Histologic Type|neoplasms by histologic type
5132630|NCT01081808|Antineoplastic Agents|antineoplastic agents
5132631|NCT01081808|Antiviral Agents|antiviral agents
5132632|NCT01081808|Pharmacologic Actions|pharmacologic actions
5132633|NCT01081808|Carcinoma|carcinoma
5132634|NCT01081808|Neoplasms|neoplasms
5132635|NCT01081795|Topiramate|topiramate
5132636|NCT01081795|Migraine|migraine
5132637|NCT01081782|Multiple Sclerosis|multiple sclerosis
5132638|NCT01081782|ONO-4641|ono-4641
5132639|NCT01081769|Schizophrenia|schizophrenia
5132640|NCT01081769|paliperidone palmitate|paliperidone palmitate
5132641|NCT01081769|Invega|invega
5132642|NCT01081769|Intramuscular injection|intramuscular injection
5132643|NCT01081769|Oral antipsychotics|oral antipsychotics
5132644|NCT01081769|Relapse|relapse
5132645|NCT01081756|Reproductive technology; Assisted|reproductive technology; assisted
5132646|NCT01081756|recombinant human chorionic hormone (r-hCG)|recombinant human chorionic hormone (r-hcg)
5132647|NCT01081743|Alzheimer|alzheimer
5132648|NCT01081743|Dementia|dementia
5132649|NCT01081743|Mild to moderately severe|mild to moderately severe
5132650|NCT01081743|New diagnosis|new diagnosis
5132651|NCT01081743|Prevention of behavioural problems|prevention of behavioural problems
5132652|NCT01081730|psoriasis|psoriasis
5132653|NCT01081730|ustekinumab|ustekinumab
5132654|NCT01081730|anti-TNF biologics|anti-tnf biologics
5132655|NCT01081730|non-anti-TNF biologics|non-anti-tnf biologics
5132656|NCT01081730|systemic non-biological treatments|systemic non-biological treatments
5132657|NCT01081717|Rheumatoid arthritis|rheumatoid arthritis
5132658|NCT01081717|psoriatic arthritis|psoriatic arthritis
5132659|NCT01081717|ankylosing spondylitis|ankylosing spondylitis
5132660|NCT01081717|golimumab|golimumab
5132661|NCT01081717|anti-TNF biologics|anti-tnf biologics
5132662|NCT01081717|non-anti-TNF biologics|non-anti-tnf biologics
5132663|NCT01081717|non-biological treatments|non-biological treatments
5132664|NCT01081704|Healthy volunteer|healthy volunteer
5132665|NCT01081704|Chinese male|chinese male
5132666|NCT01081704|Stelara|stelara
5132667|NCT01081691|CNTO 5825|cnto 5825
5132668|NCT01081691|Safety|safety
5132669|NCT01081691|Phase I|phase i
5132670|NCT01081691|Healthy adults|healthy adults
5132671|NCT01081691|Healthy Atopic adults|healthy atopic adults
5132672|NCT01081678|AMG 785|amg 785
5132673|NCT01081678|Proximal Femur|proximal femur
5132674|NCT01081678|Fracture Healing|fracture healing
5132675|NCT01081678|Hip Fracture|hip fracture
5132676|NCT01081665|Chronic Kidney Failure|chronic kidney failure
5132677|NCT01081665|Secondary Hyperparathyroidism|secondary hyperparathyroidism
5132678|NCT01081665|Paricalcitol IV treatment|paricalcitol iv treatment
5132679|NCT01081665|Safety and efficacy assessment|safety and efficacy assessment
5132680|NCT01081652|Fertilisation, In vitro|fertilisation, in vitro
5132681|NCT01081652|Embryo transfer|embryo transfer
5132682|NCT01081652|progesterone|progesterone
5132683|NCT01081652|Reproductive technologies, Assisted|reproductive technologies, assisted
5132684|NCT01081639|Follitropin alfa|follitropin alfa
5132685|NCT01081639|Follitropin beta|follitropin beta
5132686|NCT01081639|Fertilization, in vitro|fertilization, in vitro
5132687|NCT01081639|Intracytoplasmic sperm injection|intracytoplasmic sperm injection
5132688|NCT01081639|Assisted reproductive techniques|assisted reproductive techniques
5132689|NCT01081639|Polycystic ovary syndrome|polycystic ovary syndrome
5132690|NCT01081626|Infertility|infertility
5132691|NCT01081626|Ovulation induction|ovulation induction
5132692|NCT01081626|Gonal-f|gonal-f
5132693|NCT01081626|Follitropin alpha|follitropin alpha
5132694|NCT01081626|Polycystic ovarian syndrome|polycystic ovarian syndrome
5132695|NCT01081626|Anovulatory infertility|anovulatory infertility
5132696|NCT01081613|heat shock protein|heat shock protein
5132697|NCT01081613|breast cancer|breast cancer
5132698|NCT01081613|PET imaging|pet imaging
5132699|NCT01081613|bevacizumab|bevacizumab
5132700|NCT01081600|Heat shock protein|heat shock protein
5132701|NCT01081600|breast cancer|breast cancer
5132702|NCT01081600|PET imaging|pet imaging
5132703|NCT01081600|trastuzumab|trastuzumab
5132704|NCT01081587|Non MeSH terms:|non mesh terms:
5132705|NCT01081587|Children|children
5132706|NCT01081587|Malnutrition|malnutrition
5132707|NCT01081587|Computer Clinical Decision Support System|computer clinical decision support system
5132708|NCT01081587|Cluster randomized trial|cluster randomized trial
5132709|NCT01081587|Healthcare workers|healthcare workers
5132710|NCT01081587|Guideline adherence|guideline adherence
5132711|NCT01081587|Patient safety|patient safety
5132712|NCT01081587|MeSH terms:|mesh terms:
5132713|NCT01081587|Nutrition Surveys|nutrition surveys
5132714|NCT01081587|Secondary Prevention|secondary prevention
5132715|NCT01081587|Pediatrics|pediatrics
5132716|NCT01081587|Child Care|child care
5132717|NCT01081587|Health Personnel|health personnel
5132718|NCT01081587|Reminder Systems|reminder systems
5132719|NCT01081587|Intervention Studies|intervention studies
5132720|NCT01081587|Quality of Health Care|quality of health care
5132721|NCT01081574|Allergic Rhinitis|allergic rhinitis
5132722|NCT01081574|Seasonal Allergic Rhinitis|seasonal allergic rhinitis
5132723|NCT01081574|Perennial Allergic Rhinitis|perennial allergic rhinitis
5132724|NCT01081574|Urticaria|urticaria
5132725|NCT01081574|Chronic Idiopathic Urticaria|chronic idiopathic urticaria
5132726|NCT01081574|Allergy|allergy
5132727|NCT01081574|Sneezing|sneezing
5132728|NCT01081574|Nasal Itching|nasal itching
5132729|NCT01081574|Rhinorrhea|rhinorrhea
5132730|NCT01081574|Nasal Congestion|nasal congestion
5132731|NCT01081574|Wheals|wheals
5132732|NCT01081574|Hives|hives
5132733|NCT01081574|Skin itching|skin itching
5132734|NCT01081574|Flare|flare
5132735|NCT01081574|Erythema|erythema
5132736|NCT01081535|Pediatric patients (6 months-5 years) scheduled elective ureteroneocystostomy|pediatric patients (6 months-5 years) scheduled elective ureteroneocystostomy
5132737|NCT01081509|adherence|adherence
5132738|NCT01081509|early breast cancer|early breast cancer
5132739|NCT01081509|Arimidex|arimidex
5132740|NCT01081509|Therapy adherence|therapy adherence
5132741|NCT01081496|EGFR mutation, Non-small cell lung carcinoma, Spain|egfr mutation, non-small cell lung carcinoma, spain
5132742|NCT01081496|Evaluate the prevalence of EGFR mutation status in patients with newly diagnosed locally advanced or metastatic NSCLC|evaluate the prevalence of egfr mutation status in patients with newly diagnosed locally advanced or metastatic nsclc
5132743|NCT01081483|Healthy Volunteers|healthy volunteers
5132744|NCT01081483|HCV Infections|hcv infections
5132745|NCT01081457|Parkinson's disease|parkinson's disease
5132746|NCT01081457|deep brain stimulation|deep brain stimulation
5132747|NCT01081457|GI motility|gi motility
5132748|NCT01081444|repetitive transcranial stimulation|repetitive transcranial stimulation
5132749|NCT01081431|Myelodysplastic Syndromes|myelodysplastic syndromes
5132750|NCT01081431|MDS|mds
5132751|NCT01081431|deletion 5q|deletion 5q
5132752|NCT01081431|del 5q|del 5q
5132753|NCT01081431|IPSS|ipss
5132754|NCT01081431|low risk|low risk
5132755|NCT01081431|intermediate-1 risk|intermediate-1 risk
5132756|NCT01081431|GMIHO|gmiho
5132757|NCT01081431|ClinAssess|clinassess
5132758|NCT01081431|Germing|germing
5132759|NCT01081431|Düsseldorf|düsseldorf
5132760|NCT01081431|MDS-LE-MON-5|mds-le-mon-5
5132761|NCT01081431|Lenalidomide|lenalidomide
5132762|NCT01081431|Revlimid|revlimid
5132763|NCT01081418|Schizophrenia, assertive community treatment, quetiapine|schizophrenia, assertive community treatment, quetiapine
5132764|NCT01081405|ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION|allogeneic hematopoietic cell transplantation
5132765|NCT01081405|TOTAL LYMPHOID IRRADIATION|total lymphoid irradiation
5132766|NCT01081405|ANTI-THYMOCYTE GLOBULIN|anti-thymocyte globulin
5132767|NCT01081392|LPS|lps
5132768|NCT01081392|endotoxin|endotoxin
5132769|NCT01081392|inflammatory markers|inflammatory markers
5132770|NCT01081392|healthy volunteers|healthy volunteers
5132771|NCT01081392|neutrophils in sputum|neutrophils in sputum
5132772|NCT01081379|Cytomegalovirus Infections|cytomegalovirus infections
5132773|NCT01081379|Pregnancy|pregnancy
5132774|NCT01081379|T-Lymphocytes|t-lymphocytes
5132775|NCT01081379|Transmission|transmission
5132776|NCT01081353|Aspirin|aspirin
5132777|NCT01081353|Acetylsalicylic Acid|acetylsalicylic acid
5132778|NCT01081340|gestational weight gain|gestational weight gain
5132779|NCT01081340|postpartum weight loss|postpartum weight loss
5132780|NCT01081340|breastfeeding|breastfeeding
5132781|NCT01081340|overfeeding|overfeeding
5132782|NCT01081327|Atrial Fibrillation|atrial fibrillation
5132783|NCT01081327|Warfarin|warfarin
5132784|NCT01081327|Safety|safety
5132785|NCT01081301|hope|hope
5132786|NCT01081301|quality of life|quality of life
5132787|NCT01081301|caregivers|caregivers
5132788|NCT01081288|Breast cancer|breast cancer
5132789|NCT01081288|Breast screening|breast screening
5132790|NCT01081288|Mammography|mammography
5132791|NCT01081288|Routine screening programme|routine screening programme
5132792|NCT01081275|Multiple Sclerosis|multiple sclerosis
5132793|NCT01081275|MS|ms
5132794|NCT01081275|CI Therapy|ci therapy
5132795|NCT01081275|CIMT|cimt
5132796|NCT01081275|Constraint-Induced Movement Therapy|constraint-induced movement therapy
5132797|NCT01081275|Complementary and Alternative Medicine|complementary and alternative medicine
5132798|NCT01081275|CAM|cam
5132799|NCT01081275|Physical Therapy|physical therapy
5132800|NCT01081275|Occupational Therapy|occupational therapy
5132801|NCT01081275|Relaxation|relaxation
5132802|NCT01081275|Exercise|exercise
5132803|NCT01081275|Massage|massage
5132804|NCT01081275|Yoga|yoga
5132805|NCT01081275|Pool Therapy|pool therapy
5132806|NCT01081275|Aquatherapy|aquatherapy
5132807|NCT01081275|Aquatic Therapy|aquatic therapy
5132808|NCT01081249|psychotherapy|psychotherapy
5132809|NCT01081236|liver cirrhosis|liver cirrhosis
5132810|NCT01081236|intestinal permeability|intestinal permeability
5132811|NCT01081236|microbiota|microbiota
5132812|NCT01081236|complications|complications
5132813|NCT01081223|Brain Neoplasms|brain neoplasms
5132814|NCT01081223|Central Nervous System Neoplasms|central nervous system neoplasms
5132815|NCT01081223|Brain Diseases|brain diseases
5132816|NCT01081223|Neoplasms|neoplasms
5132817|NCT01081223|Nervous System Neoplasms|nervous system neoplasms
5132818|NCT01081223|Glioblastoma|glioblastoma
5132819|NCT01081223|Astrocytoma|astrocytoma
5132820|NCT01081223|Nervous System Diseases|nervous system diseases
5132821|NCT01081223|Central Nervous System Diseases|central nervous system diseases
5132822|NCT01081223|Glioma|glioma
5132823|NCT01081223|Recurrent astrocytoma|recurrent astrocytoma
5132824|NCT01081223|Recurrent glioma|recurrent glioma
5132825|NCT01081223|Cancer vaccine|cancer vaccine
5132931|NCT01080768|aliskiren|aliskiren
5132826|NCT01081223|Immunotherapy|immunotherapy
5132827|NCT01081223|Killer T cells|killer t cells
5132828|NCT01081223|Activated T cells|activated t cells
5132829|NCT01081223|GM-CSF|gm-csf
5132830|NCT01081223|Low dose IL-2|low dose il-2
5132831|NCT01081223|Activated lymphocytes|activated lymphocytes
5132832|NCT01081210|Echocardiography|echocardiography
5132833|NCT01081210|Heart failure|heart failure
5132834|NCT01081210|Kidney|kidney
5132835|NCT01081210|Lung|lung
5132836|NCT01081210|Aorta|aorta
5132837|NCT01081197|heart failure|heart failure
5132838|NCT01081197|liver|liver
5132839|NCT01081197|depression|depression
5132840|NCT01081197|neuropathy|neuropathy
5132841|NCT01081184|primary Sjögren syndrome|primary sjögren syndrome
5132842|NCT01081184|neurotrophins|neurotrophins
5132843|NCT01081184|B cell|b cell
5132844|NCT01081184|sicca syndrome|sicca syndrome
5132845|NCT01081184|T cell|t cell
5132846|NCT01081119|adolescent|adolescent
5132847|NCT01081119|middle school|middle school
5132848|NCT01081119|prevention|prevention
5132849|NCT01081119|alcohol|alcohol
5132850|NCT01081119|cigarettes|cigarettes
5132851|NCT01081119|marijuana|marijuana
5132852|NCT01081106|Breast Cancer|breast cancer
5132853|NCT01081093|Hypertrophic Cardiomyopathy Diastolic Ventricular Interaction|hypertrophic cardiomyopathy diastolic ventricular interaction
5132854|NCT01081093|Biventricular Pacemaker cardiac surgery aortic valve replacement|biventricular pacemaker cardiac surgery aortic valve replacement
5132855|NCT01081080|cardiac|cardiac
5132856|NCT01081080|muscle|muscle
5132857|NCT01081080|pediatric|pediatric
5132858|NCT01081080|dystrophy|dystrophy
5132859|NCT01081054|Diverticulitis|diverticulitis
5132860|NCT01081054|Not complicated diverticulitis|not complicated diverticulitis
5132861|NCT01081028|Multiple Myeloma|multiple myeloma
5132862|NCT01081028|MM|mm
5132863|NCT01081028|disease registry|disease registry
5132864|NCT01081028|Connect®|connect®
5132865|NCT01081015|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
5132866|NCT01081015|CLL|cll
5132867|NCT01081015|disease registry|disease registry
5132868|NCT01081015|Connect™|connect™
5132869|NCT01081002|Propofol|propofol
5132870|NCT01081002|Conscious sedation|conscious sedation
5132871|NCT01081002|Topical pharyngeal anesthesia|topical pharyngeal anesthesia
5132872|NCT01081002|Anesthetics, Local|anesthetics, local
5132873|NCT01081002|Gastrointestinal Endoscopy|gastrointestinal endoscopy
5132874|NCT01080989|solomon islands|solomon islands
5132875|NCT01080989|malaria|malaria
5132876|NCT01080989|flavivirus|flavivirus
5132877|NCT01080989|alphavirus|alphavirus
5132878|NCT01080989|parasite|parasite
5132879|NCT01080989|leptospirosis|leptospirosis
5132880|NCT01080963|Prophylaxis|prophylaxis
5132881|NCT01080963|Antibiotic|antibiotic
5132882|NCT01080963|Sternotomy|sternotomy
5132883|NCT01080963|Heart-Lung Machine|heart-lung machine
5132884|NCT01080950|zinc|zinc
5132885|NCT01080950|sepsis|sepsis
5132886|NCT01080950|fever|fever
5132887|NCT01080950|vitamin d|vitamin d
5132888|NCT01080937|acute heart failure|acute heart failure
5132889|NCT01080911|Spinal morphine|spinal morphine
5132890|NCT01080911|Vaginal hysterectomy|vaginal hysterectomy
5132891|NCT01080898|Age - Related Macular Degeneration|age - related macular degeneration
5132892|NCT01080898|Optical Coherence Tomography|optical coherence tomography
5132893|NCT01080898|Choroidal neovascularization|choroidal neovascularization
5132894|NCT01080898|FLORESCEIN Angiography|florescein angiography
5132895|NCT01080898|Fundus photographs|fundus photographs
5132896|NCT01080885|Prevention|prevention
5132897|NCT01080885|Prevention of unhealthy weight gain|prevention of unhealthy weight gain
5132898|NCT01080872|acute coronary syndrome|acute coronary syndrome
5132899|NCT01080872|coronary flow reserve|coronary flow reserve
5132900|NCT01080872|OCT|oct
5132901|NCT01080872|healing|healing
5132902|NCT01080872|drug eluting stent|drug eluting stent
5132903|NCT01080859|titanium|titanium
5132904|NCT01080859|everolimus|everolimus
5132905|NCT01080859|oct|oct
5132906|NCT01080859|acute coronary syndrome|acute coronary syndrome
5132907|NCT01080859|stent|stent
5132908|NCT01080859|pci|pci
5132909|NCT01080859|stenting|stenting
5132910|NCT01080846|Primary postpartum hemorrhage|primary postpartum hemorrhage
5132911|NCT01080846|PPH|pph
5132912|NCT01080846|uterine atony|uterine atony
5132913|NCT01080846|high fever|high fever
5132914|NCT01080846|hyperpyrexia|hyperpyrexia
5132915|NCT01080833|EMS|ems
5132916|NCT01080833|ERCP|ercp
5132917|NCT01080833|Training|training
5132918|NCT01080833|Trainees|trainees
5132919|NCT01080820|Healthy adult volunteers|healthy adult volunteers
5132920|NCT01080820|Pharmacokinetics|pharmacokinetics
5132921|NCT01080794|Parkinson's Disease|parkinson's disease
5132922|NCT01080794|Depression|depression
5132923|NCT01080794|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
5132924|NCT01080781|Cardiomyopathy|cardiomyopathy
5132925|NCT01080781|Ephrin-B1 expression|ephrin-b1 expression
5132926|NCT01080781|cell-cell junctions|cell-cell junctions
5132927|NCT01080781|heart rate variability|heart rate variability
5132928|NCT01080781|right appendage|right appendage
5132929|NCT01080768|Pedal edema|pedal edema
5132930|NCT01080768|hypertension|hypertension
5132933|NCT01080755|Adult Growth Hormone Deficiency|adult growth hormone deficiency
5132934|NCT01080755|Pituitary|pituitary
5132935|NCT01080755|Saizen|saizen
5132936|NCT01080755|Somatropin|somatropin
5132937|NCT01080755|Growth Hormone|growth hormone
5132938|NCT01080742|Hypertension|hypertension
5132939|NCT01080742|Lodoz|lodoz
5132940|NCT01080742|Bisoprolol|bisoprolol
5132941|NCT01080742|Hydrochlorothiazide|hydrochlorothiazide
5132942|NCT01080729|Ovulation induction|ovulation induction
5132943|NCT01080729|Ovarian Hyperstimulation Syndrome|ovarian hyperstimulation syndrome
5132944|NCT01080729|Multifollicular stimulation|multifollicular stimulation
5132945|NCT01080729|Pregnancy|pregnancy
5132946|NCT01080729|Sperm injections, intracytoplasmic|sperm injections, intracytoplasmic
5132947|NCT01080729|Fertility|fertility
5132948|NCT01080703|Lung Transplant|lung transplant
5132949|NCT01080703|Quadriceps Strength|quadriceps strength
5132950|NCT01080703|Quality of Life|quality of life
5132951|NCT01080703|Patients with pulmonary disease awaiting lung transplant.|patients with pulmonary disease awaiting lung transplant.
5132952|NCT01080690|endosonography, right side abdominal pain|endosonography, right side abdominal pain
5132953|NCT01080690|Endosonography (diagnostic value in right side abdominal pain)|endosonography (diagnostic value in right side abdominal pain)
5132954|NCT01080664|AS703569|as703569
5132955|NCT01080664|Aurora Kinase Inhibitor|aurora kinase inhibitor
5132956|NCT01080664|Haematological malignancies|haematological malignancies
5132957|NCT01080638|abciximab|abciximab
5132958|NCT01080638|Myocardial Infarction|myocardial infarction
5132959|NCT01080638|angioplasty|angioplasty
5132960|NCT01080638|Platelet|platelet
5132961|NCT01080625|postreperfusion syndrome|postreperfusion syndrome
5132962|NCT01080625|phenylephrine|phenylephrine
5132963|NCT01080625|epinephrine|epinephrine
5132964|NCT01080625|liver transplantation|liver transplantation
5132965|NCT01080612|pregabalin|pregabalin
5132966|NCT01080612|pharmacokinetics|pharmacokinetics
5132967|NCT01080612|bioavailability|bioavailability
5132968|NCT01080599|obturator nerve block in TURB|obturator nerve block in turb
5132969|NCT01080586|Bioequivalence study in healthy volunteers|bioequivalence study in healthy volunteers
5132970|NCT01080573|Multiple sclerosis|multiple sclerosis
5132971|NCT01080573|Rebif|rebif
5132972|NCT01080573|Interferon beta-1a|interferon beta-1a
5132973|NCT01080560|Bioequivalence study in healthy volunteers|bioequivalence study in healthy volunteers
5132974|NCT01080534|Bioequivalence study in healthy volunteers|bioequivalence study in healthy volunteers
5132975|NCT01080508|pressure pattern|pressure pattern
5132976|NCT01080508|esophageal and tracheal ventilation.|esophageal and tracheal ventilation.
5132977|NCT01080508|esophageal intubation.|esophageal intubation.
5132978|NCT01080495|left ventricular function|left ventricular function
5132979|NCT01080495|radial strain|radial strain
5132980|NCT01080495|fractional shortening|fractional shortening
5132981|NCT01080495|fractional area change|fractional area change
5132982|NCT01080482|Bioequivalence study in healthy volunteers|bioequivalence study in healthy volunteers
5132983|NCT01080469|Bioequivalence study in healthy volunteers|bioequivalence study in healthy volunteers
5132984|NCT01080456|Bioequivalence study in healthy volunteers|bioequivalence study in healthy volunteers
5132985|NCT01080443|Bioequivalence study in healthy volunteers|bioequivalence study in healthy volunteers
5132986|NCT01080430|vestibular|vestibular
5132987|NCT01080430|vertigo|vertigo
5132988|NCT01080430|rehabilitation|rehabilitation
5132989|NCT01080430|rotation|rotation
5132990|NCT01080430|balance|balance
5132991|NCT01080417|Bioequivalence study in healthy volunteers|bioequivalence study in healthy volunteers
5132992|NCT01080404|Obstructive sleep apnea|obstructive sleep apnea
5132993|NCT01080404|Obesity|obesity
5132994|NCT01080404|Metabolism|metabolism
5132995|NCT01080404|Bariatric surgery|bariatric surgery
5132996|NCT01080404|CPAP|cpap
5132997|NCT01080391|Multiple Myeloma|multiple myeloma
5132998|NCT01080352|Prostate cancer|prostate cancer
5132999|NCT01080352|palliative care|palliative care
5133000|NCT01080352|antioxidants|antioxidants
5133001|NCT01080352|ascorbic acid|ascorbic acid
5133002|NCT01080352|rna expression|rna expression
5133003|NCT01080339|insulin resistance|insulin resistance
5133004|NCT01080339|cardiovascular risk|cardiovascular risk
5133005|NCT01080339|physical activity|physical activity
5133006|NCT01080339|child|child
5133007|NCT01080326|ulcer repair surgery|ulcer repair surgery
5133008|NCT01080326|transluminal omental patch|transluminal omental patch
5133009|NCT01080300|Hot Flushes|hot flushes
5133010|NCT01080300|Vasomotor Symptoms|vasomotor symptoms
5133011|NCT01080300|Menopausal Hot Flashes|menopausal hot flashes
5133012|NCT01080287|autonomic|autonomic
5133013|NCT01080287|orthostatic|orthostatic
5133014|NCT01080287|syncope|syncope
5133015|NCT01080287|biopsy|biopsy
5133016|NCT01080287|prevalence of autonomic dysfunction in migraineurs with orthostatic intolerance|prevalence of autonomic dysfunction in migraineurs with orthostatic intolerance
5133017|NCT01080287|characterize autonomic findings utilizing neurocardiac testing, neurophysiological testing and skin biopsies to analyze autonomic fibers in the dermis|characterize autonomic findings utilizing neurocardiac testing, neurophysiological testing and skin biopsies to analyze autonomic fibers in the dermis
5133018|NCT01080274|ergometry|ergometry
5133019|NCT01080274|vitamin d|vitamin d
5133020|NCT01080274|zinc|zinc
5133021|NCT01080261|Atherosclerosis|atherosclerosis
5134036|NCT01076179|Raltegravir|raltegravir
5133022|NCT01080261|Coronary Artery Disease|coronary artery disease
5133023|NCT01080248|Pancreas|pancreas
5133024|NCT01080235|quality improvement|quality improvement
5133025|NCT01080235|geriatric care|geriatric care
5133026|NCT01080235|residency training|residency training
5133027|NCT01080222|VX-950|vx-950
5133028|NCT01080196|Falling risk|falling risk
5133029|NCT01080196|muscle conditioning|muscle conditioning
5133030|NCT01080196|muscle size|muscle size
5133031|NCT01080196|isometric strength|isometric strength
5133032|NCT01080196|Incidence in falls|incidence in falls
5133033|NCT01080183|Health-related quality of life|health-related quality of life
5133034|NCT01080183|physical activity|physical activity
5133035|NCT01080170|Aromatase Inhibitor|aromatase inhibitor
5133036|NCT01080170|Anastrazole|anastrazole
5133037|NCT01080170|Arimidex|arimidex
5133038|NCT01080170|Heart disease|heart disease
5133039|NCT01080170|Lipids|lipids
5133040|NCT01080170|Body composition|body composition
5133041|NCT01080170|Breast cancer.|breast cancer.
5133042|NCT01080157|Diabetes|diabetes
5133043|NCT01080157|Diabetes Screening|diabetes screening
5133044|NCT01080157|Experimental Medical Device|experimental medical device
5133045|NCT01080144|Cirrhosis|cirrhosis
5133046|NCT01080144|TIPS (Transjugular intrahepatic portosystemic shunt)|tips (transjugular intrahepatic portosystemic shunt)
5133047|NCT01080144|Encephalopathy|encephalopathy
5133048|NCT01080131|Frequent flares|frequent flares
5133049|NCT01080131|Gout|gout
5133050|NCT01080131|Anti-interleukin-1β monoclonal antibody|anti-interleukin-1β monoclonal antibody
5133051|NCT01080118|Teaching|teaching
5133052|NCT01080118|Video Scope|video scope
5133053|NCT01080118|Intubation|intubation
5133054|NCT01080105|Depression Prevention|depression prevention
5133055|NCT01080105|Prevention|prevention
5133056|NCT01080105|Major Depressive Disorder|major depressive disorder
5133057|NCT01080105|Internet|internet
5133058|NCT01080105|Technology Assisted|technology assisted
5133059|NCT01080092|smokers|smokers
5133060|NCT01080079|Onychomycosis|onychomycosis
5133061|NCT01080066|Carcinoma|carcinoma
5133062|NCT01080066|Squamous cell|squamous cell
5133063|NCT01080066|Erbitux|erbitux
5133064|NCT01080066|cetuximab|cetuximab
5133065|NCT01080066|Head|head
5133066|NCT01080066|Neck|neck
5133067|NCT01080053|Multiple Sclerosis, Relapsing Remitting|multiple sclerosis, relapsing remitting
5133068|NCT01080053|Sexual dysfunction|sexual dysfunction
5133069|NCT01080040|Multiple Sclerosis, Relapsing Remitting|multiple sclerosis, relapsing remitting
5133070|NCT01080040|Quality of life|quality of life
5133071|NCT01080027|Multiple sclerosis|multiple sclerosis
5133072|NCT01080027|Relapsing remitting|relapsing remitting
5133073|NCT01080027|Rebif|rebif
5133074|NCT01080014|Relapsing-remitting multiple sclerosis (RRMS)|relapsing-remitting multiple sclerosis (rrms)
5133075|NCT01080014|primary progressive multiple sclerosis (PPMS)|primary progressive multiple sclerosis (ppms)
5133076|NCT01080014|secondary progressive multiple sclerosis (SPMS)|secondary progressive multiple sclerosis (spms)
5133077|NCT01080014|Multiple Sclerosis Functional Composite (MSFC)|multiple sclerosis functional composite (msfc)
5133078|NCT01080014|Expanded Disability Status Scale (EDSS)|expanded disability status scale (edss)
5133079|NCT01080001|Multiple sclerosis|multiple sclerosis
5133080|NCT01080001|Multiple sclerosis, Relapsing-remitting|multiple sclerosis, relapsing-remitting
5133081|NCT01080001|Expanded Disability Status Scale|expanded disability status scale
5133082|NCT01080001|Fatigue|fatigue
5133083|NCT01080001|Hamilton Depression Inventory|hamilton depression inventory
5133084|NCT01080001|Depression|depression
5133085|NCT01079988|Psoriasis|psoriasis
5133086|NCT01079988|Discontinuation of efalizumab|discontinuation of efalizumab
5133087|NCT01079988|Managing inflammatory recurrence|managing inflammatory recurrence
5133088|NCT01079975|Multiple sclerosis|multiple sclerosis
5133089|NCT01079975|Depression|depression
5133090|NCT01079962|Bisoprolol|bisoprolol
5133091|NCT01079962|Atenolol|atenolol
5133092|NCT01079962|Hypertension|hypertension
5133093|NCT01079962|Blood pressure|blood pressure
5133094|NCT01079949|Infertility|infertility
5133095|NCT01079949|Ovulation induction|ovulation induction
5133096|NCT01079949|Luveris|luveris
5133097|NCT01079949|Lutropin alfa|lutropin alfa
5133098|NCT01079949|Controlled ovarian stimulation|controlled ovarian stimulation
5133099|NCT01079949|Reproductive technologies, Assisted|reproductive technologies, assisted
5133100|NCT01079936|Multiple Myeloma|multiple myeloma
5133101|NCT01079936|Lenalidomide|lenalidomide
5133102|NCT01079936|Revlimid|revlimid
5133103|NCT01079936|Melphalan|melphalan
5133104|NCT01079936|Alkeran|alkeran
5133105|NCT01079936|Autologous stem cell transplantation|autologous stem cell transplantation
5133106|NCT01079936|High-dose chemotherapy|high-dose chemotherapy
5133107|NCT01079923|healthy volunteers|healthy volunteers
5133108|NCT01079923|healthy subjects|healthy subjects
5133109|NCT01079923|vitamin D|vitamin d
5133110|NCT01079923|cholecalciferol|cholecalciferol
5133111|NCT01079923|vitamin D3|vitamin d3
5133112|NCT01079923|total vitamin D|total vitamin d
5133113|NCT01079910|Plaque|plaque
5133114|NCT01079910|Toothpaste|toothpaste
5133115|NCT01079910|Gingivitis|gingivitis
5133116|NCT01079897|Atopic dermatitis|atopic dermatitis
5133117|NCT01079897|Ectoine|ectoine
5133118|NCT01079897|Treatment|treatment
5133119|NCT01079897|Atopiclair|atopiclair
5133120|NCT01079897|Medical device|medical device
5133121|NCT01079871|Sjogren's Syndrome|sjogren's syndrome
5133122|NCT01079871|Dry Eye|dry eye
5133123|NCT01079858|Meibomian Gland Dysfunction|meibomian gland dysfunction
5133124|NCT01079858|Dry Eye|dry eye
5133125|NCT01079845|Diet|diet
5133126|NCT01079845|Nutrition|nutrition
5133127|NCT01079845|Adolescent|adolescent
5133128|NCT01079845|Young Adult|young adult
5133129|NCT01079845|Overweight|overweight
5133130|NCT01079845|Obesity|obesity
5133131|NCT01079793|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5133132|NCT01079793|stage III prostate cancer|stage iii prostate cancer
5133133|NCT01079780|mucinous adenocarcinoma of the colon|mucinous adenocarcinoma of the colon
5133134|NCT01079780|recurrent colon cancer|recurrent colon cancer
5133135|NCT01079780|signet ring adenocarcinoma of the colon|signet ring adenocarcinoma of the colon
5133136|NCT01079780|stage III colon cancer|stage iii colon cancer
5133137|NCT01079780|stage IV colon cancer|stage iv colon cancer
5133138|NCT01079780|mucinous adenocarcinoma of the rectum|mucinous adenocarcinoma of the rectum
5133139|NCT01079780|recurrent rectal cancer|recurrent rectal cancer
5133140|NCT01079780|signet ring adenocarcinoma of the rectum|signet ring adenocarcinoma of the rectum
5133141|NCT01079780|stage III rectal cancer|stage iii rectal cancer
5133142|NCT01079780|stage IV rectal cancer|stage iv rectal cancer
5133143|NCT01079767|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
5133144|NCT01079767|advanced adult primary liver cancer|advanced adult primary liver cancer
5133145|NCT01079767|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
5133146|NCT01079767|recurrent adult primary liver cancer|recurrent adult primary liver cancer
5133147|NCT01079754|Spinal morphine 0.05 mg|spinal morphine 0.05 mg
5133148|NCT01079754|Spinal morphine|spinal morphine
5133149|NCT01079741|Melanoma|melanoma
5133150|NCT01079741|Skin Cancer|skin cancer
5133151|NCT01079741|Adjuvant Therapy|adjuvant therapy
5133152|NCT01079741|Oncogenesis|oncogenesis
5133153|NCT01079741|LAGE|lage
5133154|NCT01079741|Cancer Immunity|cancer immunity
5133155|NCT01079741|Neoplasms|neoplasms
5133156|NCT01079741|Immunogenicity|immunogenicity
5133157|NCT01079741|Vaccine|vaccine
5133158|NCT01079741|Immunotherapy|immunotherapy
5133159|NCT01079728|ischemic stroke|ischemic stroke
5133160|NCT01079728|stroke-associated pneumonia|stroke-associated pneumonia
5133161|NCT01079728|prediction|prediction
5133162|NCT01079728|immune and infection parameters|immune and infection parameters
5133163|NCT01079715|Newborn|newborn
5133164|NCT01079715|Retinal Diseases|retinal diseases
5133165|NCT01079715|Angiogenesis Modulating Agents|angiogenesis modulating agents
5133166|NCT01079715|Adrenergic beta-Antagonists|adrenergic beta-antagonists
5133167|NCT01079689|basic science|basic science
5133168|NCT01079689|healthy volunteers|healthy volunteers
5133169|NCT01079650|children|children
5133170|NCT01079637|Sella and Barrete Stage 0 1 or 2|sella and barrete stage 0 1 or 2
5133171|NCT01079624|Incretin hormones|incretin hormones
5133172|NCT01079624|Glucose-insulinotropic peptide|glucose-insulinotropic peptide
5133173|NCT01079624|Glucagon-like peptide-1|glucagon-like peptide-1
5133174|NCT01079624|Gastric emptying|gastric emptying
5133175|NCT01079624|Appetite|appetite
5133176|NCT01079624|Glucose disposal|glucose disposal
5133177|NCT01079624|Gut hormones|gut hormones
5133178|NCT01079598|IPV|ipv
5133179|NCT01079598|RadioFrequency|radiofrequency
5133180|NCT01079598|QOL|qol
5133181|NCT01079572|osteoarthritis|osteoarthritis
5133182|NCT01079572|arthroplasty|arthroplasty
5133183|NCT01079572|web-based|web-based
5133184|NCT01079572|electronic follow-up|electronic follow-up
5133185|NCT01079559|total knee arthroplasty|total knee arthroplasty
5133186|NCT01079559|infection|infection
5133187|NCT01079559|antibiotic bone cement|antibiotic bone cement
5133188|NCT01079546|HPV, Israel, Squamous cell carcinoma of head and neck|hpv, israel, squamous cell carcinoma of head and neck
5133189|NCT01079533|Colorectal Neoplasms|colorectal neoplasms
5133190|NCT01079533|Mass Screening|mass screening
5133191|NCT01079533|Patient Compliance|patient compliance
5133192|NCT01079533|Intervention Studies|intervention studies
5133193|NCT01079533|Clinical Trial|clinical trial
5133194|NCT01079520|Cancer|cancer
5133195|NCT01079520|Lung Cancer|lung cancer
5133196|NCT01079520|Ultrasound|ultrasound
5133197|NCT01079520|Surgery|surgery
5133198|NCT01079507|single nucleotide polymorphism|single nucleotide polymorphism
5133199|NCT01079507|adult acute lymphoblastic leukemia|adult acute lymphoblastic leukemia
5133200|NCT01079494|Uncontrolled blood pressure|uncontrolled blood pressure
5133201|NCT01079481|Relapsed or Refractory Small Cell Lung Cancer|relapsed or refractory small cell lung cancer
5133202|NCT01079481|Paclitaxel|paclitaxel
5133203|NCT01079481|Everolimus|everolimus
5133204|NCT01079468|Transient cognitive decline following orthopaedic surgery|transient cognitive decline following orthopaedic surgery
5133205|NCT01079455|Coxarthrosis|coxarthrosis
5133206|NCT01079455|Hip|hip
5133207|NCT01079455|Infiltration|infiltration
5133208|NCT01079455|Hyaluronic Acid|hyaluronic acid
5133209|NCT01079455|Corticosterone|corticosterone
5133210|NCT01079442|postoperative ileus after colonic resections|postoperative ileus after colonic resections
5133211|NCT01079429|Monoclonal gammopathy of undetermined significance|monoclonal gammopathy of undetermined significance
5133212|NCT01079429|MGUS|mgus
5133213|NCT01079429|Smoldering myeloma|smoldering myeloma
5133214|NCT01079429|SMM|smm
5133215|NCT01079429|Multiple myeloma|multiple myeloma
5133216|NCT01079416|Esophageal Capsule Endoscopy, Screening|esophageal capsule endoscopy, screening
5133217|NCT01079390|acupuncture|acupuncture
5133218|NCT01079390|osteoarthritis|osteoarthritis
5133219|NCT01079390|fMRI|fmri
5133220|NCT01079377|Adolescents|adolescents
5133221|NCT01079377|Bariatric Surgery|bariatric surgery
5133222|NCT01079377|Psychological Symptoms|psychological symptoms
5133223|NCT01079377|Cognitive Behavioral Therapy|cognitive behavioral therapy
5133224|NCT01079377|Telemedicine|telemedicine
5133225|NCT01079377|Longitudinal|longitudinal
5133226|NCT01079351|Epilepsy|epilepsy
5133227|NCT01079351|Intravenous Carbamazepine|intravenous carbamazepine
5133228|NCT01079351|Oral Carbamazepine|oral carbamazepine
5133229|NCT01079338|sensitivity to caffeine|sensitivity to caffeine
5133230|NCT01079325|Diabetic neuropathy|diabetic neuropathy
5133231|NCT01079325|Diabetes Type 1 or 2|diabetes type 1 or 2
5133232|NCT01079325|Moderately severe sensorimotor diabetic polyneuropathy|moderately severe sensorimotor diabetic polyneuropathy
5133233|NCT01079312|ERCP|ercp
5133234|NCT01079312|patient-controlled sedation|patient-controlled sedation
5133235|NCT01079312|propofol|propofol
5133236|NCT01079312|remifentanil|remifentanil
5133237|NCT01079312|sedation level|sedation level
5133238|NCT01079299|venous ulcer|venous ulcer
5133239|NCT01079299|secondary lymphedema|secondary lymphedema
5133240|NCT01079299|chronic lower leg ulceration|chronic lower leg ulceration
5133241|NCT01079286|mTOR inhibition|mtor inhibition
5133242|NCT01079286|advanced malignancies|advanced malignancies
5133243|NCT01079286|pharmacokinetics|pharmacokinetics
5133244|NCT01079286|Akt inhibition|akt inhibition
5133245|NCT01079286|Advanced malignancies, including metastatic renal cell cancer|advanced malignancies, including metastatic renal cell cancer
5133246|NCT01079273|Influenza|influenza
5133247|NCT01079273|Vaccines|vaccines
5133248|NCT01079273|A/H1N1|a/h1n1
5133249|NCT01079273|Influenza Vaccines|influenza vaccines
5133250|NCT01079260|Malnourished|malnourished
5133251|NCT01079260|Elderly|elderly
5133252|NCT01079260|Nutrition support|nutrition support
5133253|NCT01079247|Burn|burn
5133254|NCT01079247|Transfusion|transfusion
5133255|NCT01079247|blood|blood
5133256|NCT01079247|hemoglobin|hemoglobin
5133257|NCT01079221|exercise|exercise
5133258|NCT01079221|Knee extensor|knee extensor
5133259|NCT01079208|infant formula, synbiotics, probiotics, nutrition|infant formula, synbiotics, probiotics, nutrition
5133260|NCT01079195|Effectiveness and tolerability of Tarka|effectiveness and tolerability of tarka
5133261|NCT01079195|Hypertensive patients|hypertensive patients
5133262|NCT01079195|Diabetes mellitus|diabetes mellitus
5133263|NCT01079195|Observational study|observational study
5133264|NCT01079182|Daily practice|daily practice
5133265|NCT01079182|Humira|humira
5133266|NCT01079182|Efficacy|efficacy
5133267|NCT01079182|Safety|safety
5133268|NCT01079182|Ankylosing spondylitis|ankylosing spondylitis
5133269|NCT01079169|urinary tract infection|urinary tract infection
5133270|NCT01079169|prevention|prevention
5133271|NCT01079169|rehabilitation|rehabilitation
5133272|NCT01079169|spinal cord injury|spinal cord injury
5133273|NCT01079143|De Novo renal transplantation|de novo renal transplantation
5133274|NCT01079130|Indacaterol|indacaterol
5133275|NCT01079130|asthma|asthma
5133276|NCT01079130|salmeterol|salmeterol
5133277|NCT01079117|Opiate|opiate
5133278|NCT01079117|Methadone|methadone
5133279|NCT01079117|Slow Release Oral Morphine (SORM)|slow release oral morphine (sorm)
5133280|NCT01079117|Sevre-Long™|sevre-long™
5133281|NCT01079104|Liver failure|liver failure
5133282|NCT01079104|Hepatic insufficiency|hepatic insufficiency
5133283|NCT01079104|Artificial liver|artificial liver
5133284|NCT01079104|Albumin dialysis|albumin dialysis
5133285|NCT01079091|Liver failure|liver failure
5133286|NCT01079091|Hepatic insufficiency|hepatic insufficiency
5133287|NCT01079091|Liver Cirrhosis|liver cirrhosis
5133288|NCT01079091|Artificial liver|artificial liver
5133289|NCT01079091|Albumin dialysis|albumin dialysis
5133290|NCT01079078|Acetaminophen fed study|acetaminophen fed study
5133291|NCT01079065|Famotidine tablets fasting study|famotidine tablets fasting study
5133292|NCT01079052|Famotidine tablets fed study|famotidine tablets fed study
5133293|NCT01079026|biomarker|biomarker
5133294|NCT01079026|epidural steroid|epidural steroid
5133295|NCT01079026|radiculopathy|radiculopathy
5133296|NCT01079026|hnp|hnp
5133297|NCT01079000|asthma|asthma
5133298|NCT01079000|exacerbation|exacerbation
5133299|NCT01079000|emergency department|emergency department
5133300|NCT01079000|relapse|relapse
5133301|NCT01078987|Nephrogenic Fibrosing Dermopathy (NFD)|nephrogenic fibrosing dermopathy (nfd)
5133664|NCT01077479|Insulin resistance|insulin resistance
5133302|NCT01078987|Nephrogenic Systemic Fibrosis (NSF)|nephrogenic systemic fibrosis (nsf)
5133303|NCT01078974|WM|wm
5133304|NCT01078974|pomalidomide|pomalidomide
5133305|NCT01078974|dexamethasone|dexamethasone
5133306|NCT01078974|rituximab|rituximab
5133307|NCT01078961|bortezomib|bortezomib
5133308|NCT01078961|sorafenib|sorafenib
5133309|NCT01078961|advanced melanoma|advanced melanoma
5133310|NCT01078948|tDCS|tdcs
5133311|NCT01078948|transcranial direct current stimulation|transcranial direct current stimulation
5133312|NCT01078948|major depression|major depression
5133313|NCT01078948|double-blind|double-blind
5133314|NCT01078948|randomized|randomized
5133315|NCT01078948|placebo-controlled|placebo-controlled
5133316|NCT01078948|treatment|treatment
5133317|NCT01078935|Crohn's disease activity index|crohn's disease activity index
5133318|NCT01078935|CDAI|cdai
5133319|NCT01078922|ofatumumab diffuse B cell non hodgkins lymphoma DLBCL|ofatumumab diffuse b cell non hodgkins lymphoma dlbcl
5133320|NCT01078922|refractory DLBCL|refractory dlbcl
5133321|NCT01078922|relapsed DLBCL|relapsed dlbcl
5133322|NCT01078909|Cardiovascular disease|cardiovascular disease
5133323|NCT01078909|Inflammation|inflammation
5133324|NCT01078909|Fish Oil|fish oil
5133325|NCT01078909|Omega-3 Fatty Acids|omega-3 fatty acids
5133326|NCT01078909|LPS|lps
5133327|NCT01078909|Endotoxin|endotoxin
5133328|NCT01078883|Lung cancer|lung cancer
5133329|NCT01078883|Respiratory muscle strength|respiratory muscle strength
5133330|NCT01078883|Dyspnea|dyspnea
5133331|NCT01078883|Functional capacity|functional capacity
5133332|NCT01078870|Negative symptom|negative symptom
5133333|NCT01078857|Chronic kidney disease|chronic kidney disease
5133334|NCT01078857|Small-fiber neuropathy|small-fiber neuropathy
5133335|NCT01078857|Skin biopsy|skin biopsy
5133336|NCT01078857|Contact heat evoked potential|contact heat evoked potential
5133337|NCT01078857|Autonomic neuropathy|autonomic neuropathy
5133338|NCT01078857|Neuropathy in late stage chronic kidney disease|neuropathy in late stage chronic kidney disease
5133339|NCT01078844|Autism|autism
5133340|NCT01078844|Asperger's Disorder|asperger's disorder
5133341|NCT01078844|Pervasive Developmental Disorder NOS|pervasive developmental disorder nos
5133342|NCT01078844|Adult|adult
5133343|NCT01078844|Memantine|memantine
5133344|NCT01078818|Cardiac surgery|cardiac surgery
5133345|NCT01078818|Extracorporeal circulation|extracorporeal circulation
5133346|NCT01078818|Anaemia|anaemia
5133347|NCT01078818|Intravenous iron|intravenous iron
5133348|NCT01078818|Oral Iron|oral iron
5133349|NCT01078779|Influenza|influenza
5133350|NCT01078779|Prevention|prevention
5133351|NCT01078779|Chloroquine|chloroquine
5133352|NCT01078779|Randomised controlled trial|randomised controlled trial
5133353|NCT01078779|Respiratory virus infection|respiratory virus infection
5133354|NCT01078766|cerebral palsy|cerebral palsy
5133355|NCT01078740|cystic fibrosis|cystic fibrosis
5133356|NCT01078740|cystic fibrosis transmembrane conductance regulator|cystic fibrosis transmembrane conductance regulator
5133357|NCT01078740|biomarkers|biomarkers
5133358|NCT01078740|Intestinal Current Measurement|intestinal current measurement
5133359|NCT01078727|Thermal Stimulation|thermal stimulation
5133360|NCT01078727|Upper Extremity|upper extremity
5133361|NCT01078727|Motor Recovery|motor recovery
5133362|NCT01078727|Stroke|stroke
5133363|NCT01078714|Autism|autism
5133364|NCT01078714|Bumetanide|bumetanide
5133365|NCT01078714|GABA|gaba
5133366|NCT01078714|NKCC1|nkcc1
5133367|NCT01078701|live attenuated flu vaccines|live attenuated flu vaccines
5133368|NCT01078701|Influenza A (H1N1)|influenza a (h1n1)
5133369|NCT01078701|intranasal application|intranasal application
5133370|NCT01078701|replication-deficient influenza virus|replication-deficient influenza virus
5133371|NCT01078688|Limitations of activities|limitations of activities
5133372|NCT01078688|persistent asthma|persistent asthma
5133373|NCT01078688|general practitioner|general practitioner
5133374|NCT01078688|frequency of limitations of activities|frequency of limitations of activities
5133375|NCT01078688|depending on gender and age-group|depending on gender and age-group
5133376|NCT01078675|Familial Hypercholesterolaemia|familial hypercholesterolaemia
5133377|NCT01078675|pediatric|pediatric
5133378|NCT01078662|olaparib|olaparib
5133379|NCT01078662|PARP inhibitors|parp inhibitors
5133380|NCT01078662|genetic BRCA1 mutation|genetic brca1 mutation
5133381|NCT01078662|BRCA2 mutation|brca2 mutation
5133382|NCT01078662|solid tumour refractory|solid tumour refractory
5133383|NCT01078649|cancer|cancer
5133384|NCT01078649|solid tumors|solid tumors
5133385|NCT01078649|lymphoma|lymphoma
5133386|NCT01078649|smac mimetic|smac mimetic
5133387|NCT01078649|IAP inhibitor|iap inhibitor
5133388|NCT01078649|Phase I|phase i
5133389|NCT01078649|Dose escalation|dose escalation
5133390|NCT01078636|amyloid|amyloid
5133391|NCT01078636|plaques|plaques
5133392|NCT01078636|imaging|imaging
5133393|NCT01078636|early detection|early detection
5133394|NCT01078636|Amnestic MCI|amnestic mci
5133395|NCT01078636|pre-dementia|pre-dementia
5133396|NCT01078623|Bronchitis|bronchitis
5133397|NCT01078623|Chronic|chronic
5133398|NCT01078623|Emphysema|emphysema
5133399|NCT01078610|Psoriatic Arthritis|psoriatic arthritis
5133400|NCT01078610|Long-term Observation|long-term observation
5133401|NCT01078610|Humira|humira
5133402|NCT01078610|Safety|safety
5133403|NCT01078610|Effectiveness|effectiveness
5133404|NCT01078610|Quality of Life|quality of life
5133405|NCT01078610|Work Productivity|work productivity
5133406|NCT01078597|anti-MCV|anti-mcv
5133407|NCT01078597|anti-CCP|anti-ccp
5133408|NCT01078597|Biomarkers|biomarkers
5133409|NCT01078597|Rheumatoid Arthritis|rheumatoid arthritis
5133410|NCT01078584|Uncontrolled hypertension|uncontrolled hypertension
5133411|NCT01078584|trandolapril|trandolapril
5133412|NCT01078571|Rheumatoid Arthritis|rheumatoid arthritis
5133413|NCT01078571|Biologic|biologic
5133414|NCT01078571|Tumor Necrosis Factors blockers agents Monoclonal antibody|tumor necrosis factors blockers agents monoclonal antibody
5133415|NCT01078558|Multicenter study|multicenter study
5133416|NCT01078545|Prostate cancer|prostate cancer
5133417|NCT01078545|Lower urinary tract symptoms|lower urinary tract symptoms
5133418|NCT01078545|Hormonotherapy|hormonotherapy
5133419|NCT01078545|LHRH analogue|lhrh analogue
5133420|NCT01078545|Androgen deprivation therapy (ADT)|androgen deprivation therapy (adt)
5133421|NCT01078532|medically complex diseases that increase cardiovascular risk|medically complex diseases that increase cardiovascular risk
5133422|NCT01078519|Fever|fever
5133423|NCT01078519|anesthesia|anesthesia
5133424|NCT01078519|Labor|labor
5133425|NCT01078506|Chinese|chinese
5133426|NCT01078506|intracranial aneurysm|intracranial aneurysm
5133885|NCT01077063|Pleurx catheter|pleurx catheter
5133427|NCT01078506|magnetic resonance imaging|magnetic resonance imaging
5133428|NCT01078493|Platelet rich plasma|platelet rich plasma
5133429|NCT01078493|PRP|prp
5133430|NCT01078493|wrinkles|wrinkles
5133431|NCT01078493|MyCells®|mycells®
5133432|NCT01078493|CREATE|create
5133433|NCT01078493|Life Source Medical Centre|life source medical centre
5133434|NCT01078493|Dr Tan Kok leong|dr tan kok leong
5133435|NCT01078480|Fracture|fracture
5133436|NCT01078480|Collar bone|collar bone
5133437|NCT01078467|Wound Healing|wound healing
5133438|NCT01078467|Oral Wounds|oral wounds
5133439|NCT01078467|Cutaneous Wounds|cutaneous wounds
5133440|NCT01078467|Gene Array Analysis|gene array analysis
5133441|NCT01078467|Proteomic Analysis|proteomic analysis
5133442|NCT01078467|Healthy Volunteer|healthy volunteer
5133443|NCT01078467|HV|hv
5133444|NCT01078454|Melphalan|melphalan
5133445|NCT01078454|Dexamethasone|dexamethasone
5133446|NCT01078454|Bortezomib|bortezomib
5133447|NCT01078454|Systemic Light-chain (AL) Amyloidosis|systemic light-chain (al) amyloidosis
5133448|NCT01078441|Bortezomib|bortezomib
5133449|NCT01078441|Liposomal Doxorubicin|liposomal doxorubicin
5133450|NCT01078441|Dexamethasone|dexamethasone
5133451|NCT01078441|Cyclophosphamide|cyclophosphamide
5133452|NCT01078441|refractory multiple myeloma|refractory multiple myeloma
5133453|NCT01078428|Hypertrophic scars|hypertrophic scars
5133454|NCT01078428|Topical silicone gel|topical silicone gel
5133455|NCT01078428|Scar thickness|scar thickness
5133456|NCT01078428|Scar Color|scar color
5133457|NCT01078428|Scar pliability|scar pliability
5133458|NCT01078428|Scar appearance|scar appearance
5133459|NCT01078415|HCC|hcc
5133460|NCT01078415|Hepatocellular Carcinoma|hepatocellular carcinoma
5133461|NCT01078415|Early Stage|early stage
5133462|NCT01078415|Prospective|prospective
5133463|NCT01078415|Multicenter|multicenter
5133464|NCT01078415|Irreversible Electroporation (IRE)|irreversible electroporation (ire)
5133465|NCT01078415|Electroporation|electroporation
5133466|NCT01078415|Low Energy Direct Current|low energy direct current
5133467|NCT01078415|LEDC|ledc
5133468|NCT01078415|Nonthermal ablation|nonthermal ablation
5133469|NCT01078415|NTIRE (nonthermal IRE)|ntire (nonthermal ire)
5133470|NCT01078415|Ablation|ablation
5133471|NCT01078415|Soft Tissue|soft tissue
5133472|NCT01078402|Treatment compliance and tolerability of Humira in patients|treatment compliance and tolerability of humira in patients
5133473|NCT01078402|Eastern European countries|eastern european countries
5133474|NCT01078402|Rheumatoid Arthritis|rheumatoid arthritis
5133475|NCT01078402|Psoriatic Arthritis|psoriatic arthritis
5133476|NCT01078402|Adalimumab|adalimumab
5133477|NCT01078402|Ankylosing Spondylitis|ankylosing spondylitis
5133478|NCT01078402|Evaluation of clinical outcome|evaluation of clinical outcome
5133479|NCT01078389|Gout|gout
5133480|NCT01078389|Hyperuricemia|hyperuricemia
5133481|NCT01078389|Uric Acid|uric acid
5133482|NCT01078389|Drug Therapy|drug therapy
5133483|NCT01078376|Pediatrics|pediatrics
5133484|NCT01078376|Blood Pressure, High|blood pressure, high
5133485|NCT01078376|Drug Therapy|drug therapy
5133486|NCT01078363|Heart Transplantation|heart transplantation
5133487|NCT01078350|Lymphoma|lymphoma
5133488|NCT01078350|Hodgkin Disease|hodgkin disease
5133489|NCT01078311|Patients with advanced hepatocellular cancer|patients with advanced hepatocellular cancer
5133490|NCT01078298|smoking|smoking
5133491|NCT01078298|smoking cessation|smoking cessation
5133492|NCT01078298|smoking cessation in depressed subjects|smoking cessation in depressed subjects
5133493|NCT01078285|Integrated program on adherence using counseling|integrated program on adherence using counseling
5133494|NCT01078285|support services including cost-sharing where appropriate and educational materials mailed monthly.|support services including cost-sharing where appropriate and educational materials mailed monthly.
5133495|NCT01078272|Coronary Atherosclerosis|coronary atherosclerosis
5133496|NCT01078272|Percutaneous Coronary Intervention|percutaneous coronary intervention
5133497|NCT01078272|Coronary Stenting|coronary stenting
5133498|NCT01078272|Coronary Stenosis|coronary stenosis
5133499|NCT01078272|Remote Ischemic Preconditioning|remote ischemic preconditioning
5133500|NCT01078246|HIV|hiv
5133501|NCT01078233|HIV|hiv
5133502|NCT01078233|antiretroviral treatment|antiretroviral treatment
5133503|NCT01078233|HIV Cohort|hiv cohort
5133504|NCT01078233|Treatment|treatment
5133505|NCT01078220|Human Papillomavirus (HPV)|human papillomavirus (hpv)
5133506|NCT01078194|Weight regain|weight regain
5133507|NCT01078194|Weight loss failure|weight loss failure
5133508|NCT01078194|Gastric bypass|gastric bypass
5133509|NCT01078181|gastric bypass|gastric bypass
5133510|NCT01078181|banded gastric bypass|banded gastric bypass
5133511|NCT01078181|weight loss|weight loss
5133512|NCT01078181|weight regain|weight regain
5133513|NCT01078181|bariatric surgery|bariatric surgery
5133514|NCT01078168|Alzheimer`s Disease|alzheimer`s disease
5133515|NCT01078155|Bone mineral density|bone mineral density
5133516|NCT01078155|Bone turnover markers|bone turnover markers
5133517|NCT01078155|Rheumatoid arthritis|rheumatoid arthritis
5133518|NCT01078155|Osteoporosis|osteoporosis
5133519|NCT01078142|temsirolimus|temsirolimus
5133520|NCT01078142|bendamustine|bendamustine
5133521|NCT01078142|rituximab|rituximab
5133522|NCT01078142|mantle cell lymphoma|mantle cell lymphoma
5133523|NCT01078142|follicular lymphoma|follicular lymphoma
5133524|NCT01078129|cognitive deficits|cognitive deficits
5133525|NCT01078116|Rheumatoid Arthritis|rheumatoid arthritis
5133526|NCT01078116|Adalimumab treatment|adalimumab treatment
5133527|NCT01078116|Evaluation of the patients' Health Related Quality of Life|evaluation of the patients' health related quality of life
5133528|NCT01078116|Cost of the disease management|cost of the disease management
5133529|NCT01078103|Diabetes Mellitus|diabetes mellitus
5133530|NCT01078103|cornea endothelium|cornea endothelium
5133531|NCT01078103|cell loss|cell loss
5133532|NCT01078103|cataract surgery|cataract surgery
5133533|NCT01078090|Safety|safety
5133534|NCT01078090|Rheumatoid Arthritis|rheumatoid arthritis
5133535|NCT01078090|Effectiveness|effectiveness
5133536|NCT01078077|healthy females ages twentyfive through sixty|healthy females ages twentyfive through sixty
5133537|NCT01078064|Gastroesophageal reflux disease, gastric motility|gastroesophageal reflux disease, gastric motility
5133538|NCT01078051|chronic total occlusion|chronic total occlusion
5133539|NCT01078051|stent|stent
5133540|NCT01078051|medical therapy|medical therapy
5133541|NCT01078038|Coronary Artery Disease|coronary artery disease
5133542|NCT01078038|Stent|stent
5133543|NCT01078025|transvaginal access for cholecystectomy|transvaginal access for cholecystectomy
5133544|NCT01077999|chemoradiation|chemoradiation
5133545|NCT01077999|panitumumab|panitumumab
5133546|NCT01077999|esophageal cancer|esophageal cancer
5133665|NCT01077466|Primary Progressive Multiple Sclerosis|primary progressive multiple sclerosis
5133547|NCT01077999|Resectable squamous cell carcinoma, adenocarcinoma or undifferentiated carcinoma of the intrathoracic esophagus or gastro esophageal junction|resectable squamous cell carcinoma, adenocarcinoma or undifferentiated carcinoma of the intrathoracic esophagus or gastro esophageal junction
5133548|NCT01077986|mTOR inhibition|mtor inhibition
5133549|NCT01077986|EGFR inhibition|egfr inhibition
5133550|NCT01077986|pancreatic cancer|pancreatic cancer
5133551|NCT01077986|pharmacodynamics|pharmacodynamics
5133552|NCT01077973|Headache|headache
5133553|NCT01077960|Serostim|serostim
5133554|NCT01077960|HARS|hars
5133555|NCT01077947|low back pain|low back pain
5133556|NCT01077947|spinal fusion|spinal fusion
5133557|NCT01077947|Primarily axial low back pain|primarily axial low back pain
5133558|NCT01077934|All Patients admitted to Grady Memorial Hospital with Unilateral Lower leg injury at risk for compartment syndrome|all patients admitted to grady memorial hospital with unilateral lower leg injury at risk for compartment syndrome
5133559|NCT01077921|sickle|sickle
5133560|NCT01077921|adhesion|adhesion
5133561|NCT01077921|propranolol|propranolol
5133562|NCT01077908|Adoptive cellular therapy|adoptive cellular therapy
5133563|NCT01077908|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
5133564|NCT01077895|Critically ill patients with positive fluid balance, IAH and AKI requiring RRT|critically ill patients with positive fluid balance, iah and aki requiring rrt
5133565|NCT01077882|Moderate and severe psoriasis and atopic dermatitis|moderate and severe psoriasis and atopic dermatitis
5133566|NCT01077869|oropharynx and lymph node metastases from an unknown primary tumor|oropharynx and lymph node metastases from an unknown primary tumor
5133567|NCT01077856|congenital anomaly|congenital anomaly
5133568|NCT01077856|pregnancy|pregnancy
5133569|NCT01077856|GARDASIL®|gardasil®
5133570|NCT01077856|Nordic|nordic
5133571|NCT01077856|population-based|population-based
5133572|NCT01077843|Ankylosing Spondylitis|ankylosing spondylitis
5133573|NCT01077830|New Incidence of Cancer|new incidence of cancer
5133574|NCT01077791|Schizophrenia|schizophrenia
5133575|NCT01077791|social cognition|social cognition
5133576|NCT01077791|theory of mind|theory of mind
5133577|NCT01077791|cognitive therapy|cognitive therapy
5133578|NCT01077791|therapeutic trial|therapeutic trial
5133579|NCT01077791|magnetoencephalography (MEG)|magnetoencephalography (meg)
5133580|NCT01077778|Magnetic Resonance Imaging/methods|magnetic resonance imaging/methods
5133581|NCT01077778|Magnetic Resonance Angiography|magnetic resonance angiography
5133582|NCT01077778|Perfusion Imaging|perfusion imaging
5133583|NCT01077778|Pulmonary Embolism/diagnosis|pulmonary embolism/diagnosis
5133584|NCT01077765|HIV-associated Lipodystrophy|hiv-associated lipodystrophy
5133585|NCT01077765|Polyacrylamide hydrogel|polyacrylamide hydrogel
5133586|NCT01077752|Pain, postoperative|pain, postoperative
5133587|NCT01077752|Local infiltration|local infiltration
5133588|NCT01077752|Hyperalgesia, postoperative|hyperalgesia, postoperative
5134037|NCT01076179|Kaletra|kaletra
5133589|NCT01077752|Local anesthetic, ropivacaine, lidocaine|local anesthetic, ropivacaine, lidocaine
5133590|NCT01077752|Colorectal laparoscopic surgery|colorectal laparoscopic surgery
5133591|NCT01077752|Pain management after colorectal laparoscopic surgery|pain management after colorectal laparoscopic surgery
5133592|NCT01077687|schizophrenia|schizophrenia
5133593|NCT01077687|genome-wide association study (GWAS)|genome-wide association study (gwas)
5133594|NCT01077687|single-nucleotide polymorphisms (SNPs)|single-nucleotide polymorphisms (snps)
5133595|NCT01077687|Han Chinese population|han chinese population
5133596|NCT01077687|trio families|trio families
5133597|NCT01077687|Schizophrenia with trio families|schizophrenia with trio families
5133598|NCT01077674|Electroencephalogram|electroencephalogram
5133599|NCT01077674|Entropy|entropy
5133600|NCT01077674|BIS|bis
5133601|NCT01077674|Sevoflurane|sevoflurane
5133602|NCT01077661|Nebivolol|nebivolol
5133603|NCT01077661|PMS (post-marketing surveillance)|pms (post-marketing surveillance)
5133604|NCT01077648|Breast Cancer|breast cancer
5133605|NCT01077648|Treatment|treatment
5133606|NCT01077648|Brain metastases|brain metastases
5133607|NCT01077648|ErbB2 expression|erbb2 expression
5133608|NCT01077635|HIV|hiv
5133609|NCT01077635|Antiretroviral therapy|antiretroviral therapy
5133610|NCT01077635|protease inbitor|protease inbitor
5133611|NCT01077635|fosamprenavir|fosamprenavir
5133612|NCT01077635|paediatrics|paediatrics
5133613|NCT01077609|Intranasal steroids|intranasal steroids
5133614|NCT01077609|beclometasone diproprionate|beclometasone diproprionate
5133615|NCT01077609|steroid-related outcomes|steroid-related outcomes
5133616|NCT01077596|Carcinogenicity|carcinogenicity
5133617|NCT01077596|Case control|case control
5133618|NCT01077596|Bupropion|bupropion
5133619|NCT01077583|Pregnancy test|pregnancy test
5133620|NCT01077583|Wishing to become pregnant|wishing to become pregnant
5133621|NCT01077557|Combivir (Zidovudine+Lamivudine)|combivir (zidovudine+lamivudine)
5133622|NCT01077557|Trizivir (Abacavir+Lamivudine+Zidovudine)|trizivir (abacavir+lamivudine+zidovudine)
5133623|NCT01077557|Zidovudine|zidovudine
5133624|NCT01077557|Epzicom (Abacavir+Lamivudine)|epzicom (abacavir+lamivudine)
5133625|NCT01077557|Fracture|fracture
5133626|NCT01077557|Amprenavir|amprenavir
5133627|NCT01077557|human immunodeficiency virus (HIV) infection|human immunodeficiency virus (hiv) infection
5133628|NCT01077557|antiretroviral (ARV) therapy|antiretroviral (arv) therapy
5133629|NCT01077557|Lamivudine|lamivudine
5133630|NCT01077557|incidence|incidence
5133631|NCT01077557|Abacavir|abacavir
5133632|NCT01077557|risk|risk
5133633|NCT01077557|Fosamprenavir|fosamprenavir
5133634|NCT01077544|Chronic Myeloid Leukemia|chronic myeloid leukemia
5133635|NCT01077544|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
5133636|NCT01077544|Ph+ CML|ph+ cml
5133637|NCT01077544|Ph+ ALL|ph+ all
5133638|NCT01077544|pediatric|pediatric
5133639|NCT01077544|nilotinib|nilotinib
5133640|NCT01077544|imatinib|imatinib
5133641|NCT01077544|chronic phase|chronic phase
5133642|NCT01077544|accelerated phase|accelerated phase
5133643|NCT01077544|newly diagnosed Ph+ CML|newly diagnosed ph+ cml
5133644|NCT01077544|dasatinib|dasatinib
5133645|NCT01077531|Rheumatoid arthritis|rheumatoid arthritis
5133646|NCT01077531|intravenous infusion|intravenous infusion
5133647|NCT01077531|long-term followup|long-term followup
5133648|NCT01077518|Refractory|refractory
5133649|NCT01077518|Safety|safety
5133650|NCT01077518|Efficacy|efficacy
5133651|NCT01077518|Rituximab refractory|rituximab refractory
5133652|NCT01077518|Oncology|oncology
5133653|NCT01077505|pharmacokinetics|pharmacokinetics
5133654|NCT01077505|GSK716155|gsk716155
5133655|NCT01077505|Brevicon|brevicon
5133656|NCT01077505|albiglutide|albiglutide
5133657|NCT01077505|healthy female volunteers|healthy female volunteers
5133658|NCT01077505|oral contraceptive|oral contraceptive
5133659|NCT01077492|lung cancer|lung cancer
5133660|NCT01077492|mediastinal lymph nodes|mediastinal lymph nodes
5133661|NCT01077492|TBNA|tbna
5133662|NCT01077492|staging lung cancer|staging lung cancer
5133663|NCT01077479|body fat mass gain|body fat mass gain
5133666|NCT01077466|Secondary Progressive Multiple Sclerosis|secondary progressive multiple sclerosis
5133667|NCT01077466|Natalizumab|natalizumab
5133668|NCT01077466|Treatment|treatment
5133669|NCT01077466|Safety|safety
5133670|NCT01077466|Efficacy|efficacy
5133671|NCT01077466|Cerebrospinal fluid|cerebrospinal fluid
5133672|NCT01077466|Osteopontin|osteopontin
5133673|NCT01077440|cancer survivor|cancer survivor
5133674|NCT01077440|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5133675|NCT01077440|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5133676|NCT01077440|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5133677|NCT01077440|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5133678|NCT01077440|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5133679|NCT01077440|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5133680|NCT01077440|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5133681|NCT01077440|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5133682|NCT01077440|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5134805|NCT01073176|Memory|memory
5133683|NCT01077440|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5133684|NCT01077440|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5133685|NCT01077440|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5133686|NCT01077440|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5133687|NCT01077440|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5133688|NCT01077440|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5133689|NCT01077440|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5133690|NCT01077440|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5133691|NCT01077440|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5133692|NCT01077440|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5133693|NCT01077440|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5133694|NCT01077440|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5133695|NCT01077440|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5133696|NCT01077440|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5133697|NCT01077440|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5133698|NCT01077440|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5133699|NCT01077440|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5133700|NCT01077440|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5133701|NCT01077440|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5133702|NCT01077440|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5133703|NCT01077440|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5133704|NCT01077440|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5133705|NCT01077440|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5133706|NCT01077440|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5133707|NCT01077440|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5133708|NCT01077440|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5133709|NCT01077440|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5133710|NCT01077440|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5133711|NCT01077440|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5133712|NCT01077440|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5133713|NCT01077440|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5133714|NCT01077440|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5133715|NCT01077440|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5133716|NCT01077440|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5133717|NCT01077440|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5133718|NCT01077440|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
5133719|NCT01077440|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5133720|NCT01077440|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
5133721|NCT01077440|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
5133722|NCT01077440|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
5133723|NCT01077440|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
5133724|NCT01077440|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5133725|NCT01077440|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5133726|NCT01077440|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5133727|NCT01077440|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5133728|NCT01077440|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
5133729|NCT01077440|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
5133730|NCT01077440|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5133731|NCT01077440|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5133732|NCT01077440|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5133733|NCT01077440|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5133734|NCT01077440|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5133735|NCT01077440|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5133736|NCT01077440|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5133737|NCT01077440|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5133738|NCT01077440|atypical chronic myeloid leukemia, BCR-ABL negative|atypical chronic myeloid leukemia, bcr-abl negative
5133739|NCT01077440|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5133740|NCT01077440|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5133741|NCT01077440|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5133742|NCT01077440|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5134806|NCT01073176|Attention|attention
5133743|NCT01077440|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5133744|NCT01077440|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5133745|NCT01077440|refractory hairy cell leukemia|refractory hairy cell leukemia
5133746|NCT01077440|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5133747|NCT01077440|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5133748|NCT01077440|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5133749|NCT01077440|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5133750|NCT01077440|chronic eosinophilic leukemia|chronic eosinophilic leukemia
5133751|NCT01077440|primary myelofibrosis|primary myelofibrosis
5133752|NCT01077440|chronic neutrophilic leukemia|chronic neutrophilic leukemia
5133753|NCT01077440|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5133754|NCT01077440|disseminated neuroblastoma|disseminated neuroblastoma
5133755|NCT01077440|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
5133756|NCT01077440|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5133757|NCT01077440|recurrent neuroblastoma|recurrent neuroblastoma
5133758|NCT01077440|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
5133759|NCT01077440|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5133760|NCT01077440|stage I multiple myeloma|stage i multiple myeloma
5133761|NCT01077440|stage II multiple myeloma|stage ii multiple myeloma
5133762|NCT01077440|stage III multiple myeloma|stage iii multiple myeloma
5133763|NCT01077440|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
5133764|NCT01077440|refractory multiple myeloma|refractory multiple myeloma
5133765|NCT01077427|pancreatic cancer|pancreatic cancer
5133766|NCT01077427|adjuvant treatment|adjuvant treatment
5133767|NCT01077427|hyperthermia|hyperthermia
5133768|NCT01077414|Psychosocial Functioning|psychosocial functioning
5133769|NCT01077414|Psychosocial Stress|psychosocial stress
5133770|NCT01077414|Palliative Care|palliative care
5133771|NCT01077414|Spirituality|spirituality
5133772|NCT01077414|Cancer|cancer
5133773|NCT01077401|Diabetic|diabetic
5133774|NCT01077401|edema|edema
5133775|NCT01077401|DME|dme
5133776|NCT01077388|CVD|cvd
5133777|NCT01077388|uncontrolled HTN|uncontrolled htn
5133778|NCT01077375|Milnacipran|milnacipran
5133779|NCT01077375|Duloxetine|duloxetine
5133780|NCT01077375|Switch|switch
5133781|NCT01077375|Forest Research Institute|forest research institute
5133782|NCT01077362|Ustekinumab|ustekinumab
5133783|NCT01077362|CNTO 1275|cnto 1275
5133784|NCT01077362|Stelara|stelara
5133785|NCT01077362|Psoriatic Arthritis|psoriatic arthritis
5133786|NCT01077362|Psoriasis|psoriasis
5133787|NCT01077362|TNF alpha|tnf alpha
5133788|NCT01077349|Cardiac surgery|cardiac surgery
5133789|NCT01077349|Shock|shock
5133790|NCT01077349|Continuous Veno-Venous Haemofiltration|continuous veno-venous haemofiltration
5133791|NCT01077349|Continuous Renal Replacement Therapy|continuous renal replacement therapy
5133792|NCT01077349|Renal Insufficiency|renal insufficiency
5133793|NCT01077349|Acute|acute
5133794|NCT01077336|susceptibility testing|susceptibility testing
5133795|NCT01077323|pancreatitis|pancreatitis
5133796|NCT01077323|exenatide|exenatide
5133797|NCT01077323|Byetta|byetta
5133798|NCT01077323|Amylin|amylin
5133799|NCT01077323|Lilly|lilly
5133800|NCT01077310|HIV|hiv
5133801|NCT01077310|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5133802|NCT01077310|Alcohol dependence|alcohol dependence
5133803|NCT01077310|CD4|cd4
5133804|NCT01077310|HIV-1 RNA|hiv-1 rna
5133805|NCT01077310|Alcohol treatment outcomes|alcohol treatment outcomes
5133806|NCT01077284|Kidney Calculi|kidney calculi
5133807|NCT01077284|Kidney Stones|kidney stones
5133808|NCT01077284|Nephrolithiasis|nephrolithiasis
5133809|NCT01077284|Drug Therapy|drug therapy
5133810|NCT01077284|Uric Acid|uric acid
5133811|NCT01077271|Premature infants|premature infants
5133812|NCT01077271|Respiratory Syncytial Virus (RSV)|respiratory syncytial virus (rsv)
5133813|NCT01077271|Compliance|compliance
5133814|NCT01077271|Palivizumab|palivizumab
5133815|NCT01077258|Safety|safety
5133816|NCT01077258|Long-term observation|long-term observation
5133817|NCT01077258|Routine Clinical Setting|routine clinical setting
5133818|NCT01077258|Rheumatoid Arthritis|rheumatoid arthritis
5133819|NCT01077258|Effectiveness|effectiveness
5133820|NCT01077245|Clostridium difficile|clostridium difficile
5133821|NCT01077245|Clostridium Infections|clostridium infections
5133822|NCT01077245|Gram-Positive Bacterial Infections|gram-positive bacterial infections
5133823|NCT01077245|Bacterial Infections|bacterial infections
5133824|NCT01077245|Anti-Infective Agents|anti-infective agents
5133825|NCT01077245|Clostridium butyricum|clostridium butyricum
5133826|NCT01077245|Metronidazole|metronidazole
5133827|NCT01077245|Vancomycin|vancomycin
5133828|NCT01077245|Gastrointestinal Diseases|gastrointestinal diseases
5133829|NCT01077245|Physiological Effects of Drugs|physiological effects of drugs
5133830|NCT01077245|Colonic Diseases|colonic diseases
5133831|NCT01077245|Enterocolitis, Pseudomembranous|enterocolitis, pseudomembranous
5133832|NCT01077245|Intestinal Diseases|intestinal diseases
5133833|NCT01077245|Enterocolitis|enterocolitis
5133834|NCT01077245|Pharmacologic Actions|pharmacologic actions
5133835|NCT01077245|Digestive System Diseases|digestive system diseases
5133836|NCT01077245|Therapeutic Uses|therapeutic uses
5133837|NCT01077245|Gastroenteritis|gastroenteritis
5133838|NCT01077245|Colitis|colitis
5133839|NCT01077245|Diarrhea|diarrhea
5133840|NCT01077245|Probiotics|probiotics
5133841|NCT01077245|Gastrointestinal Agents|gastrointestinal agents
5133842|NCT01077232|Moderate to Severe Plaque Psoriasis|moderate to severe plaque psoriasis
5133843|NCT01077232|Humira|humira
5133844|NCT01077232|Safety|safety
5133845|NCT01077232|Efficacy|efficacy
5133846|NCT01077232|Work Productivity|work productivity
5133847|NCT01077219|healthy female|healthy female
5133848|NCT01077206|Aneurysm|aneurysm
5133849|NCT01077206|statin|statin
5133850|NCT01077206|subarachnoid hemorrhage|subarachnoid hemorrhage
5133851|NCT01077193|Bariatric|bariatric
5133852|NCT01077193|Obesity|obesity
5133853|NCT01077167|Omecamtiv mecarbil|omecamtiv mecarbil
5133854|NCT01077167|pharmacokinetics|pharmacokinetics
5133855|NCT01077154|Early Stage Breast Cancer|early stage breast cancer
5133856|NCT01077154|Bone Metastasis|bone metastasis
5133857|NCT01077154|Adjuvant treatment|adjuvant treatment
5133858|NCT01077154|Neoadjuvant treatment|neoadjuvant treatment
5133859|NCT01077154|Denosumab|denosumab
5133860|NCT01077154|Stage II breast cancer|stage ii breast cancer
5133861|NCT01077154|Stage III breast cancer|stage iii breast cancer
5133862|NCT01077154|Stage IIA breast cancer|stage iia breast cancer
5133863|NCT01077154|Stage IIB breast cancer|stage iib breast cancer
5133864|NCT01077154|Stage IIIA breast cancer|stage iiia breast cancer
5133865|NCT01077154|Stage IIIB breast cancer|stage iiib breast cancer
5133866|NCT01077154|Stage IIIC breast cancer|stage iiic breast cancer
5133867|NCT01077154|Early breast cancer|early breast cancer
5133868|NCT01077154|Breast Tumors|breast tumors
5133869|NCT01077154|Breast Neoplasms|breast neoplasms
5133870|NCT01077128|Psoriasis|psoriasis
5133871|NCT01077128|Quality of life|quality of life
5133872|NCT01077115|Cholecystectomy|cholecystectomy
5133873|NCT01077115|Cholecystitis|cholecystitis
5133874|NCT01077115|Laparoscopy|laparoscopy
5133875|NCT01077115|Cholelithiasis|cholelithiasis
5133876|NCT01077115|Operative trauma|operative trauma
5133877|NCT01077102|COPD|copd
5133878|NCT01077102|eccentric exercise training|eccentric exercise training
5133879|NCT01077102|cycle ergometer|cycle ergometer
5133880|NCT01077102|muscle function|muscle function
5133881|NCT01077089|traumatic brain injury|traumatic brain injury
5133882|NCT01077089|In-hospital transport|in-hospital transport
5133883|NCT01077076|Gastric Acid|gastric acid
5133884|NCT01077076|Human Experimentation|human experimentation
5133886|NCT01077063|malignant ascites|malignant ascites
5133887|NCT01077024|Stimulant treatment|stimulant treatment
5133888|NCT01077024|Smoking Cessation|smoking cessation
5133889|NCT01077011|Dry eye|dry eye
5133890|NCT01077011|artificial tears|artificial tears
5133891|NCT01076998|Dry eye|dry eye
5133892|NCT01076998|artificial tears|artificial tears
5133893|NCT01076985|Human Immunodeficiency Virus|human immunodeficiency virus
5133894|NCT01076972|Human Immunodeficiency Virus|human immunodeficiency virus
5133895|NCT01076959|Rheumatoid Arthritis|rheumatoid arthritis
5133896|NCT01076946|ballooning|ballooning
5133897|NCT01076946|TLVBS|tlvbs
5133898|NCT01076933|Borderline Personality Disorder|borderline personality disorder
5133899|NCT01076933|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
5133900|NCT01076933|Neuropsychological Test|neuropsychological test
5133901|NCT01076933|Randomised Control Trial|randomised control trial
5133902|NCT01076907|colonoscopy|colonoscopy
5133903|NCT01076907|polyps|polyps
5133904|NCT01076894|pain|pain
5133905|NCT01076894|thoracotomy|thoracotomy
5133906|NCT01076894|pulmonary function|pulmonary function
5133907|NCT01076894|epidural anesthesia|epidural anesthesia
5133908|NCT01076894|intercostal nerve block|intercostal nerve block
5133909|NCT01076868|vivax|vivax
5133910|NCT01076868|malaria|malaria
5133911|NCT01076868|relapse|relapse
5133912|NCT01076842|Diabetes|diabetes
5133913|NCT01076829|MDA|mda
5133914|NCT01076829|Spice|spice
5133915|NCT01076816|Patients with single-organ failure in need of mechanical ventilation|patients with single-organ failure in need of mechanical ventilation
5133916|NCT01076803|Malignant intestinal obstruction in inoperable patients|malignant intestinal obstruction in inoperable patients
5133917|NCT01076790|Nociception|nociception
5133918|NCT01076790|Dexmedetomidine|dexmedetomidine
5133919|NCT01076790|Electroencephalogram|electroencephalogram
5133920|NCT01076790|Electromyogram|electromyogram
5133921|NCT01076790|Entropy Index|entropy index
5133922|NCT01076790|Bispectral Index|bispectral index
5133923|NCT01076790|Electrocardiogram|electrocardiogram
5133924|NCT01076790|Plethysmogram|plethysmogram
5133925|NCT01076790|Heart|heart
5133926|NCT01076790|Heart rate|heart rate
5133927|NCT01076790|Heart rate variability|heart rate variability
5133928|NCT01076790|Surgery|surgery
5133929|NCT01076777|Panic disorder|panic disorder
5133930|NCT01076777|Physical exercise|physical exercise
5133931|NCT01076777|Cognitive-behavioral therapy|cognitive-behavioral therapy
5133932|NCT01076777|Manualized|manualized
5133933|NCT01076725|ProSeal LMA|proseal lma
5133934|NCT01076725|standard insertion|standard insertion
5133935|NCT01076725|rotational insertion|rotational insertion
5133936|NCT01076699|abdominal pain|abdominal pain
5133937|NCT01076699|bloating|bloating
5133938|NCT01076699|diarrhea|diarrhea
5133939|NCT01076699|irritable bowel|irritable bowel
5133940|NCT01076686|Augmentation mammoplasty|augmentation mammoplasty
5133941|NCT01076686|Breast augmentation|breast augmentation
5133942|NCT01076686|Postoperative pain|postoperative pain
5133943|NCT01076686|Analgesia|analgesia
5133944|NCT01076660|Ischemic cardiomyopathy|ischemic cardiomyopathy
5133945|NCT01076660|Nonischemic cardiomyopathy|nonischemic cardiomyopathy
5133946|NCT01076660|Implantable cardioverter defibrillator|implantable cardioverter defibrillator
5133947|NCT01076660|Sudden Cardiac Death|sudden cardiac death
5133948|NCT01076660|Ventricular tachycardia|ventricular tachycardia
5133949|NCT01076660|Ventricular fibrillation|ventricular fibrillation
5133950|NCT01076608|primary care patients|primary care patients
5133951|NCT01076595|Multiple sclerosis|multiple sclerosis
5133952|NCT01076595|BetaPlus program|betaplus program
5133953|NCT01076595|Recurrent/remittent multiple sclerosis patients|recurrent/remittent multiple sclerosis patients
5133954|NCT01076595|Adherence to treatment regimen|adherence to treatment regimen
5133955|NCT01076582|hormone withdrawal associated symptoms|hormone withdrawal associated symptoms
5133956|NCT01076504|SCLC|sclc
5133957|NCT01076504|Amrubicin|amrubicin
5133958|NCT01076504|Carboplatin|carboplatin
5133959|NCT01076504|Pegfilgrastim|pegfilgrastim
5133960|NCT01076504|Neulasta|neulasta
5133961|NCT01076478|Symmetric Diabetic Polyneuropathy|symmetric diabetic polyneuropathy
5133962|NCT01076465|Heart failure|heart failure
5133963|NCT01076465|Elderly|elderly
5133964|NCT01076465|Disease management|disease management
5133965|NCT01076452|Parkinson's Disease|parkinson's disease
5133966|NCT01076452|levo-dopa|levo-dopa
5133967|NCT01076452|tremor|tremor
5133968|NCT01076452|dyskinesia|dyskinesia
5133969|NCT01076452|subthalamic nucleus|subthalamic nucleus
5133970|NCT01076452|globus pallidus|globus pallidus
5133971|NCT01076426|probiotic|probiotic
5133972|NCT01076426|peritoneal dialysis|peritoneal dialysis
5133973|NCT01076426|peritonitis|peritonitis
5133974|NCT01076426|nutrition status|nutrition status
5133975|NCT01076413|gait|gait
5133976|NCT01076413|exercise|exercise
5133977|NCT01076413|skill-based|skill-based
5133978|NCT01076413|aerobic|aerobic
5133979|NCT01076387|Bladder|bladder
5133980|NCT01076387|Cystectomy|cystectomy
5133981|NCT01076387|Robotic|robotic
5133982|NCT01076387|Open Radical|open radical
5133983|NCT01076387|10-016|10-016
5133984|NCT01076374|pacemaker|pacemaker
5133985|NCT01076361|Epicardial|epicardial
5133986|NCT01076361|Pacing Lead|pacing lead
5133987|NCT01076348|Epicardial|epicardial
5133988|NCT01076348|Pacing Lead|pacing lead
5133989|NCT01076335|Neoadjuvant Hormonal Therapy|neoadjuvant hormonal therapy
5133990|NCT01076335|Docetaxel|docetaxel
5133991|NCT01076335|Taxotere|taxotere
5133992|NCT01076335|Chemotherapy|chemotherapy
5133993|NCT01076335|Radical Prostatectomy|radical prostatectomy
5133994|NCT01076335|Node-positive Prostate Cancer|node-positive prostate cancer
5133995|NCT01076335|Androgen-dependent prostate cancer|androgen-dependent prostate cancer
5133996|NCT01076335|Lymph node metastases|lymph node metastases
5133997|NCT01076309|cataract surgery|cataract surgery
5133998|NCT01076309|tamsulosin|tamsulosin
5133999|NCT01076309|endothelium cell|endothelium cell
5134000|NCT01076283|baclofen|baclofen
5134001|NCT01076283|alcoholism|alcoholism
5134002|NCT01076283|urge|urge
5134003|NCT01076283|craving|craving
5134004|NCT01076283|alcohol drinking|alcohol drinking
5134005|NCT01076283|biobehavioral mechanisms of baclofen in alcoholism|biobehavioral mechanisms of baclofen in alcoholism
5134006|NCT01076257|brain damage|brain damage
5134007|NCT01076257|constraint induced movement therapy|constraint induced movement therapy
5134008|NCT01076257|kinematic|kinematic
5134009|NCT01076257|function|function
5134010|NCT01076257|outcome|outcome
5134011|NCT01076257|Quality of life|quality of life
5134012|NCT01076218|Continuous Glucose Monitoring|continuous glucose monitoring
5134013|NCT01076218|Accuracy|accuracy
5134014|NCT01076218|Continuous Glucose Error-Grid Analysis|continuous glucose error-grid analysis
5134015|NCT01076205|Work Productivity|work productivity
5134016|NCT01076205|Long-term Observation|long-term observation
5134017|NCT01076205|Humira|humira
5134018|NCT01076205|Quality of Life|quality of life
5134019|NCT01076205|Rheumatoid Arthritis|rheumatoid arthritis
5134020|NCT01076192|Moderate Psoriasis|moderate psoriasis
5134021|NCT01076192|Psoriasis|psoriasis
5134022|NCT01076192|Severe Psoriasis|severe psoriasis
5134023|NCT01076192|Adalimumab|adalimumab
5134024|NCT01076192|Effectiveness|effectiveness
5134025|NCT01076192|Safety|safety
5134026|NCT01076192|Clinical practice|clinical practice
5134027|NCT01076179|Infection|infection
5134028|NCT01076179|Rilpivirine|rilpivirine
5134029|NCT01076179|CCR5 antagonists|ccr5 antagonists
5134030|NCT01076179|Etravirine|etravirine
5134031|NCT01076179|Human Immunodeficiency Virus|human immunodeficiency virus
5134032|NCT01076179|Maraviroc|maraviroc
5134033|NCT01076179|Safety and efficacy|safety and efficacy
5134034|NCT01076179|Non nucleoside reverse transcriptase inhibitors (NNRTIs)|non nucleoside reverse transcriptase inhibitors (nnrtis)
5134035|NCT01076179|Integrase inhibitors|integrase inhibitors
5134038|NCT01076166|Post-marketing observational study|post-marketing observational study
5134039|NCT01076166|Lower respiratory tract infections|lower respiratory tract infections
5134040|NCT01076166|Klacid Granules for Oral Suspension|klacid granules for oral suspension
5134041|NCT01076153|Post-marketing observational study|post-marketing observational study
5134042|NCT01076153|Upper or lower respiratory tract infection|upper or lower respiratory tract infection
5134043|NCT01076153|Klacid MR|klacid mr
5134044|NCT01076140|Hypertension as a result of bevacizumab therapy|hypertension as a result of bevacizumab therapy
5134045|NCT01076101|SLE|sle
5134046|NCT01076101|sister|sister
5134047|NCT01076101|autoimmune disease|autoimmune disease
5134048|NCT01076075|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
5134049|NCT01076062|Pregnancy Maintenance|pregnancy maintenance
5134050|NCT01076062|Labor, Induced|labor, induced
5134051|NCT01076062|spontaneous labor|spontaneous labor
5134052|NCT01076062|cesarean delivery|cesarean delivery
5134053|NCT01076036|ischemia|ischemia
5134054|NCT01076036|stent|stent
5134055|NCT01076023|Diabetes|diabetes
5134056|NCT01076023|Cardiovascular disease|cardiovascular disease
5134057|NCT01076023|Observational study|observational study
5134058|NCT01076023|China|china
5134059|NCT01075997|Diabetes Mellitus|diabetes mellitus
5134060|NCT01075984|Antifungal Agents pharmacokinetics|antifungal agents pharmacokinetics
5134061|NCT01075984|Mycoses prevention and control|mycoses prevention and control
5134062|NCT01075971|Buprenorphine tablet|buprenorphine tablet
5134063|NCT01075971|Fast dissolving tablet|fast dissolving tablet
5134064|NCT01075971|Opioid dependant patients|opioid dependant patients
5134065|NCT01075958|n-3 PUFAs|n-3 pufas
5134066|NCT01075958|Fish oil|fish oil
5134067|NCT01075958|Cognitive function|cognitive function
5134068|NCT01075958|Healthy young adults|healthy young adults
5134069|NCT01075945|antimalarials|antimalarials
5134070|NCT01075945|ACTs|acts
5134071|NCT01075945|Piperaquine|piperaquine
5134072|NCT01075945|uncomplicated|uncomplicated
5134073|NCT01075932|cerebral blood flow|cerebral blood flow
5134074|NCT01075932|NIRS|nirs
5134075|NCT01075932|n-3 PUFAs|n-3 pufas
5134076|NCT01075932|fish oil|fish oil
5134077|NCT01075932|cognitive function|cognitive function
5134078|NCT01075919|n-3 PUFAs|n-3 pufas
5134079|NCT01075919|Cognitive function|cognitive function
5134080|NCT01075919|Healthy young adults|healthy young adults
5134081|NCT01075919|Fish oil|fish oil
5134082|NCT01075919|Mood|mood
5134083|NCT01075906|pharmacokinetics|pharmacokinetics
5134084|NCT01075893|Colorectal cancer|colorectal cancer
5134085|NCT01075893|Stem cells|stem cells
5134086|NCT01075893|Ulcerative colitis|ulcerative colitis
5134087|NCT01075893|Polyps|polyps
5134088|NCT01075880|Multiple Sclerosis, Relapsing-Remitting|multiple sclerosis, relapsing-remitting
5134089|NCT01075880|Rebif|rebif
5134090|NCT01075880|Interferon beta-1a|interferon beta-1a
5134091|NCT01075854|Gonal-F|gonal-f
5134092|NCT01075854|Multifollicular stimulation|multifollicular stimulation
5134093|NCT01075854|Pregnancy|pregnancy
5134094|NCT01075854|Ovarian hyperstimulation|ovarian hyperstimulation
5134095|NCT01075854|In vitro fertilization|in vitro fertilization
5134096|NCT01075854|Intracytoplasmic sperm injection|intracytoplasmic sperm injection
5134097|NCT01075854|Infertility|infertility
5134098|NCT01075841|Head and neck neoplasms|head and neck neoplasms
5134099|NCT01075841|Carcinoma, squamous cell|carcinoma, squamous cell
5134100|NCT01075841|Cetuximab|cetuximab
5134101|NCT01075828|Head and Neck Neoplasms|head and neck neoplasms
5134102|NCT01075828|Neoplasms, Squamous Cell|neoplasms, squamous cell
5134103|NCT01075828|Cetuximab|cetuximab
5134104|NCT01075815|Infertility|infertility
5134105|NCT01075815|Ovulation induction|ovulation induction
5134106|NCT01075815|Luveris|luveris
5134107|NCT01075815|Controlled ovarian stimulation|controlled ovarian stimulation
5134108|NCT01075815|Reproductive technologies, assisted|reproductive technologies, assisted
5134109|NCT01075802|Breast cancer|breast cancer
5134110|NCT01075802|Tamoxifen|tamoxifen
5134111|NCT01075802|Endoxifen|endoxifen
5134112|NCT01075802|polymorphism of CYP2D6|polymorphism of cyp2d6
5134113|NCT01075789|Pain|pain
5134114|NCT01075789|Discomfort|discomfort
5134115|NCT01075789|Insertion|insertion
5134116|NCT01075789|Nasogastric tube|nasogastric tube
5134117|NCT01075763|Alzheimer's|alzheimer's
5134118|NCT01075763|Dementia|dementia
5134119|NCT01075763|Interferon beta-1a|interferon beta-1a
5134120|NCT01075763|Rebif|rebif
5134121|NCT01075750|hyperkalaemia|hyperkalaemia
5134122|NCT01075750|metabolic acidosis|metabolic acidosis
5134123|NCT01075750|renal transplantation|renal transplantation
5134124|NCT01075750|normal saline|normal saline
5134125|NCT01075750|elomel isoton|elomel isoton
5134126|NCT01075750|fluid management in renal transplantation|fluid management in renal transplantation
5134127|NCT01075737|Multiple sclerosis|multiple sclerosis
5134128|NCT01075737|Sclerosis|sclerosis
5134129|NCT01075737|Quality of life|quality of life
5134130|NCT01075724|Perioperative Hypothermia Prevention|perioperative hypothermia prevention
5134131|NCT01075724|Accidental Perioperative Hypothermia|accidental perioperative hypothermia
5134132|NCT01075711|Arthritis, Rheumatoid|arthritis, rheumatoid
5134133|NCT01075711|Prednisone|prednisone
5134134|NCT01075698|Type 2 Diabetes|type 2 diabetes
5134135|NCT01075698|Cerebrovascular disease|cerebrovascular disease
5134136|NCT01075698|Coronary Artery Disease|coronary artery disease
5134137|NCT01075698|Chronic Kidney Disease|chronic kidney disease
5134138|NCT01075698|Peripheral Artery Disease|peripheral artery disease
5134139|NCT01075672|OCD|ocd
5134140|NCT01075672|BDD|bdd
5134141|NCT01075672|Tourette syndrome|tourette syndrome
5134142|NCT01075672|trichotillomania|trichotillomania
5134143|NCT01075672|Compulsive Skin Picking|compulsive skin picking
5134144|NCT01075672|panic disorder|panic disorder
5134145|NCT01075672|social phobia|social phobia
5134146|NCT01075672|generalized anxiety disorder|generalized anxiety disorder
5134147|NCT01075672|depression|depression
5134148|NCT01075672|PTSD|ptsd
5134149|NCT01075672|ADHD|adhd
5134150|NCT01075672|eating disorder|eating disorder
5134151|NCT01075672|Specific Phobia|specific phobia
5134152|NCT01075659|Smoking Cessation|smoking cessation
5134153|NCT01075659|VAS|vas
5134154|NCT01075659|Urges to smoke|urges to smoke
5134155|NCT01075646|postoperative pain|postoperative pain
5134156|NCT01075646|wound infusion|wound infusion
5134157|NCT01075646|local anesthesia|local anesthesia
5134158|NCT01075633|FOBT|fobt
5134159|NCT01075633|colonoscopy|colonoscopy
5134160|NCT01075633|familiar risk|familiar risk
5134161|NCT01075633|colorectal cancer|colorectal cancer
5134162|NCT01075633|advanced adenoma|advanced adenoma
5134163|NCT01075620|rotating platform|rotating platform
5134164|NCT01075620|posterior stabilized|posterior stabilized
5134165|NCT01075620|non-posterior stabilized|non-posterior stabilized
5134166|NCT01075607|Lymph fluid collection|lymph fluid collection
5134167|NCT01075594|Dyslipidemia|dyslipidemia
5134168|NCT01075594|Target cholesterol|target cholesterol
5134169|NCT01075594|Undertreatment|undertreatment
5134170|NCT01075581|Hemodynamic instability|hemodynamic instability
5134171|NCT01075581|Hemostasis|hemostasis
5134172|NCT01075555|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
5134173|NCT01075555|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
5134174|NCT01075555|advanced adult primary liver cancer|advanced adult primary liver cancer
5134175|NCT01075555|recurrent adult primary liver cancer|recurrent adult primary liver cancer
5134176|NCT01075542|Corneal astigmatism|corneal astigmatism
5134177|NCT01075542|Intraocular lens|intraocular lens
5134178|NCT01075529|major depressive disorder, fluoxetine, Hamilton Rating Scale for Depression (HAM-D-17)|major depressive disorder, fluoxetine, hamilton rating scale for depression (ham-d-17)
5134179|NCT01075516|Remote Monitoring|remote monitoring
5134180|NCT01075516|ICD patients|icd patients
5134181|NCT01075516|EQ-5D questionnaire|eq-5d questionnaire
5134182|NCT01075516|remote follow up|remote follow up
5134183|NCT01075503|Supraclavicular|supraclavicular
5134184|NCT01075503|Interscalene|interscalene
5134185|NCT01075503|Infraclavicular|infraclavicular
5134186|NCT01075503|Brachial plexus block|brachial plexus block
5134187|NCT01075503|Ropivacaine|ropivacaine
5134188|NCT01075490|spinal anesthesia|spinal anesthesia
5134189|NCT01075490|neonates|neonates
5134190|NCT01075490|clonidine|clonidine
5134191|NCT01075490|post operative apnea|post operative apnea
5134192|NCT01075464|Solid Tumor|solid tumor
5134193|NCT01075451|Staphylococcus aureus|staphylococcus aureus
5134194|NCT01075451|Antimicrobial Stewardship|antimicrobial stewardship
5134195|NCT01075451|Antibacterial resistance|antibacterial resistance
5134196|NCT01075451|Vancomycin|vancomycin
5134197|NCT01075438|ataxia telangiectasia|ataxia telangiectasia
5134198|NCT01075438|Pneumococcal Vaccines|pneumococcal vaccines
5134199|NCT01075425|leukemia|leukemia
5134200|NCT01075425|acute leukemia|acute leukemia
5134201|NCT01075425|chronic myelogenous leukemia|chronic myelogenous leukemia
5134202|NCT01075425|myelodysplastic syndrome|myelodysplastic syndrome
5134203|NCT01075425|relapsed acute leukemia|relapsed acute leukemia
5134204|NCT01075425|refractory acute leukemia|refractory acute leukemia
5134205|NCT01075425|belinostat|belinostat
5134206|NCT01075425|bortezomib|bortezomib
5134207|NCT01075425|Velcade|velcade
5134208|NCT01075425|PXD-101|pxd-101
5134209|NCT01075412|Positron-Emission Tomography|positron-emission tomography
5134210|NCT01075412|Radiotherapy, Intensity-Modulated|radiotherapy, intensity-modulated
5134211|NCT01075399|[F 18]HX4|[f 18]hx4
5134212|NCT01075399|HX4|hx4
5134213|NCT01075399|Hypoxia|hypoxia
5134214|NCT01075399|Head/Neck Cancer|head/neck cancer
5134215|NCT01075399|Lung Cancer|lung cancer
5134216|NCT01075399|Liver Cancer|liver cancer
5134217|NCT01075399|Rectal Cancer|rectal cancer
5134218|NCT01075399|Cervical Cancer|cervical cancer
5134219|NCT01075399|HIF1 alpha|hif1 alpha
5134220|NCT01075399|CAIX|caix
5134221|NCT01075386|Hysterectomy|hysterectomy
5134222|NCT01075386|Endometrial cancer|endometrial cancer
5134223|NCT01075386|Benign|benign
5134224|NCT01075386|Endocrine system|endocrine system
5134225|NCT01075386|Tissue collection|tissue collection
5134226|NCT01075373|early stage schizophrenia|early stage schizophrenia
5134227|NCT01075373|drug naïve schizophrenia|drug naïve schizophrenia
5134228|NCT01075373|treatment response|treatment response
5134229|NCT01075373|Aripiprazole|aripiprazole
5134230|NCT01075373|pharmacogenetics|pharmacogenetics
5134231|NCT01075373|Disrupted-in-Schizophrenia 1 gene (DISC1)|disrupted-in-schizophrenia 1 gene (disc1)
5134232|NCT01075373|Neuregulin 1 gene (NRG1)|neuregulin 1 gene (nrg1)
5134233|NCT01075373|Dopamine receptor type 2 gene (DRD2)|dopamine receptor type 2 gene (drd2)
5134234|NCT01075373|Catechol-O-Methyltransferase gene (COMT)|catechol-o-methyltransferase gene (comt)
5134235|NCT01075373|neurocognitive function|neurocognitive function
5134236|NCT01075373|event-related evoked potential (ERP)|event-related evoked potential (erp)
5134237|NCT01075373|Niacin skin test|niacin skin test
5134238|NCT01075373|plasma neurotransmitter level|plasma neurotransmitter level
5134239|NCT01075373|plasma cytokine level|plasma cytokine level
5134240|NCT01075373|plasma signaling protein level|plasma signaling protein level
5134241|NCT01075373|AKT1 protein level in the peripheral lymphocytes|akt1 protein level in the peripheral lymphocytes
5134242|NCT01075373|16-45 y/o|16-45 y/o
5134243|NCT01075373|without mental retardation or epilepsy|without mental retardation or epilepsy
5134244|NCT01075360|Neuroblastoma, MYCN, AHR|neuroblastoma, mycn, ahr
5134245|NCT01075347|autoserum|autoserum
5134246|NCT01075347|ocular surgery|ocular surgery
5134247|NCT01075347|corneal epithelium healing|corneal epithelium healing
5134248|NCT01075334|sperm|sperm
5134249|NCT01075334|male infertility|male infertility
5134250|NCT01075334|Carnitine|carnitine
5134251|NCT01075334|food supplementation|food supplementation
5134252|NCT01075334|insemination|insemination
5134253|NCT01075308|hormone-resistant prostate cancer|hormone-resistant prostate cancer
5134254|NCT01075308|recurrent prostate cancer|recurrent prostate cancer
5134255|NCT01075308|stage IV prostate cancer|stage iv prostate cancer
5134256|NCT01075308|stage III prostate cancer|stage iii prostate cancer
5134257|NCT01075308|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5134258|NCT01075295|Schizophreniform Disorder|schizophreniform disorder
5134259|NCT01075295|Schizophrenia, Schizoaffective disorder|schizophrenia, schizoaffective disorder
5134260|NCT01075295|Bipolar I Disorder|bipolar i disorder
5134261|NCT01075295|Bipolar II Disorder|bipolar ii disorder
5134262|NCT01075295|Major Depressive Disorder with Psychotic Features,|major depressive disorder with psychotic features,
5134263|NCT01075295|Substance-Induced Psychoses|substance-induced psychoses
5134264|NCT01075295|Psychosis Not Otherwise Specified|psychosis not otherwise specified
5134265|NCT01075295|antipsychotic|antipsychotic
5134266|NCT01075295|weight gain|weight gain
5134267|NCT01075295|body mass index|body mass index
5134268|NCT01075295|BMI|bmi
5134269|NCT01075295|waist circumference|waist circumference
5134270|NCT01075295|WC|wc
5134271|NCT01075295|coronary heart disease|coronary heart disease
5134272|NCT01075295|CHD|chd
5134273|NCT01075269|robotic thyroidectomy, comparative study, cosmetic result, postoperative neck discomfort, swallowing symptom|robotic thyroidectomy, comparative study, cosmetic result, postoperative neck discomfort, swallowing symptom
5134274|NCT01075269|Robotic thyroidectomy, cosmetic effect, postoperative distress, surgical outcome|robotic thyroidectomy, cosmetic effect, postoperative distress, surgical outcome
5134275|NCT01075256|sensitivity|sensitivity
5134276|NCT01075256|occlusion|occlusion
5134277|NCT01075243|dental pain|dental pain
5134278|NCT01075243|paracetamol|paracetamol
5134279|NCT01075243|Post-surgical dental pain|post-surgical dental pain
5134280|NCT01075230|PRP, TKA, pain scale, hemoglobin, hematocrit, narcotics|prp, tka, pain scale, hemoglobin, hematocrit, narcotics
5134281|NCT01075217|Peripheral arterial occlusive disease (PAOD)|peripheral arterial occlusive disease (paod)
5134282|NCT01075204|Respiratory Tract Infection|respiratory tract infection
5134283|NCT01075204|Clarithromycin|clarithromycin
5134284|NCT01075204|Recovery|recovery
5134285|NCT01075191|Viral load|viral load
5134286|NCT01075191|Resistance|resistance
5134287|NCT01075191|Double protease inhibitors|double protease inhibitors
5134288|NCT01075191|Mutations|mutations
5134289|NCT01075191|Immune system|immune system
5134290|NCT01075191|Infection|infection
5134291|NCT01075191|Nucleoside Reverse Transcriptase Inhibitors-free|nucleoside reverse transcriptase inhibitors-free
5134292|NCT01075191|Human Immunodeficiency Virus|human immunodeficiency virus
5134293|NCT01075178|Infection|infection
5134294|NCT01075178|Arrhythmia|arrhythmia
5134295|NCT01075178|Death|death
5134296|NCT01075178|Palivizumab|palivizumab
5134297|NCT01075178|Safety|safety
5134298|NCT01075178|Hemodynamically Significant Congenital Heart Disease|hemodynamically significant congenital heart disease
5134299|NCT01075178|Pediatric|pediatric
5134300|NCT01075178|Observational|observational
5134301|NCT01075165|silicone|silicone
5134302|NCT01075165|burn scar|burn scar
5134303|NCT01075165|hypertrophic scar|hypertrophic scar
5134304|NCT01075165|keloid|keloid
5134305|NCT01075165|scar assessment|scar assessment
5134306|NCT01075165|abnormal scarring|abnormal scarring
5134307|NCT01075165|Burn patients|burn patients
5134308|NCT01075152|cryptococcal meningitis|cryptococcal meningitis
5134309|NCT01075152|cryptococcus|cryptococcus
5134310|NCT01075152|cryptococcosis|cryptococcosis
5134311|NCT01075152|HIV|hiv
5134312|NCT01075152|AIDS|aids
5134313|NCT01075152|strategy|strategy
5134314|NCT01075139|Motivational interviewing|motivational interviewing
5134315|NCT01075139|Physical activity|physical activity
5134316|NCT01075139|Diet|diet
5134317|NCT01075126|bipolar affective disorder|bipolar affective disorder
5134318|NCT01075126|African American|african american
5134319|NCT01075126|antimanic|antimanic
5134320|NCT01075126|lithium|lithium
5134321|NCT01075126|depakote|depakote
5134322|NCT01075113|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
5134323|NCT01075113|advanced adult primary liver cancer|advanced adult primary liver cancer
5134324|NCT01075113|recurrent adult primary liver cancer|recurrent adult primary liver cancer
5134325|NCT01075100|metastatic|metastatic
5134326|NCT01075100|breast|breast
5134327|NCT01075100|cancer|cancer
5134328|NCT01075087|TAP Block|tap block
5134329|NCT01075087|Pain|pain
5134330|NCT01075087|Obesity|obesity
5134331|NCT01075087|Surgery|surgery
5134332|NCT01075087|Laparoscopic Banding|laparoscopic banding
5134333|NCT01075074|Pain|pain
5134334|NCT01075074|TAP block|tap block
5134335|NCT01075074|Laparoscopic|laparoscopic
5134336|NCT01075074|Gynecologic|gynecologic
5134337|NCT01075061|Congenital mirror movement, physiopathology, imaging, transcranial magnetic stimulation, candidate gene|congenital mirror movement, physiopathology, imaging, transcranial magnetic stimulation, candidate gene
5134338|NCT01075048|Colorectal cancer|colorectal cancer
5134339|NCT01075048|wild-type KRAS|wild-type kras
5134340|NCT01075048|irinotecan|irinotecan
5134341|NCT01075048|cetuximab|cetuximab
5134342|NCT01075048|second-line therapy|second-line therapy
5134343|NCT01075035|Traumatic Brain Injury|traumatic brain injury
5134344|NCT01075035|TBI|tbi
5134345|NCT01075035|Military|military
5134346|NCT01075035|Imaging|imaging
5134347|NCT01075035|MEG|meg
5134348|NCT01075035|PET/CT|pet/ct
5134349|NCT01075035|MRI|mri
5134350|NCT01075035|fMRI|fmri
5134351|NCT01075035|DTI|dti
5134352|NCT01075035|SANIC|sanic
5134353|NCT01075035|veteran|veteran
5134354|NCT01075009|Antibiotics|antibiotics
5134355|NCT01075009|Resistance|resistance
5134356|NCT01075009|Epidemiology|epidemiology
5134357|NCT01075009|Gram-negative bacteria|gram-negative bacteria
5134358|NCT01075009|Epidemiology of antibiotic use|epidemiology of antibiotic use
5134359|NCT01074996|Pancreatic cancer|pancreatic cancer
5134360|NCT01074996|S-1|s-1
5134361|NCT01074996|S-1 plus Leucovorin|s-1 plus leucovorin
5134362|NCT01074996|second-line therapy|second-line therapy
5134363|NCT01074983|Prehospital, Oxygen, Trauma, Hypoxemia|prehospital, oxygen, trauma, hypoxemia
5134364|NCT01074970|PARP inhibition + breast cancer|parp inhibition + breast cancer
5134365|NCT01074970|breast cancer|breast cancer
5134366|NCT01074970|PARP inhibitor|parp inhibitor
5134367|NCT01074970|Triple negative|triple negative
5134368|NCT01074944|Gaucher disease|gaucher disease
5134369|NCT01074944|Genz-112638|genz-112638
5134370|NCT01074944|beta-glucosidase|beta-glucosidase
5134371|NCT01074944|acid β-glucosidase|acid β-glucosidase
5134372|NCT01074944|glucocerebrosidase|glucocerebrosidase
5134373|NCT01074944|glucosylceramide|glucosylceramide
5134374|NCT01074944|D-glucosyl-N-acylsphingosine glucohydrolase|d-glucosyl-n-acylsphingosine glucohydrolase
5134375|NCT01074944|substrate reduction therapy|substrate reduction therapy
5134376|NCT01074931|Lopinavir/ritonavir|lopinavir/ritonavir
5134377|NCT01074918|Pre-hypertension|pre-hypertension
5134378|NCT01074918|Hypertension|hypertension
5134379|NCT01074905|vivax malaria|vivax malaria
5134380|NCT01074905|artesunate|artesunate
5134381|NCT01074905|chloroquine|chloroquine
5134382|NCT01074905|primaquine|primaquine
5134383|NCT01074905|relapse|relapse
5134384|NCT01074892|endometrial hyperplasia treatment MPA per os LNG-IUD|endometrial hyperplasia treatment mpa per os lng-iud
5134385|NCT01074879|Elderly|elderly
5134386|NCT01074879|protein consumption|protein consumption
5134387|NCT01074879|resistance exercise|resistance exercise
5134388|NCT01074879|muscle mass|muscle mass
5134389|NCT01074866|Mechanical ventilation|mechanical ventilation
5134390|NCT01074866|Non invasive Ventilation|non invasive ventilation
5134391|NCT01074866|Patient-ventilator interaction|patient-ventilator interaction
5134392|NCT01074866|Pressure support|pressure support
5134393|NCT01074866|Neurally adjusted ventilatory assist|neurally adjusted ventilatory assist
5134394|NCT01074840|Food Hypersensitivity|food hypersensitivity
5134395|NCT01074840|Hypersensitivity|hypersensitivity
5134396|NCT01074840|Immune System Diseases|immune system diseases
5134397|NCT01074840|Hypersensitivity, Immediate|hypersensitivity, immediate
5134398|NCT01074840|Peanut Hypersensitivity|peanut hypersensitivity
5134399|NCT01074840|Food Allergy|food allergy
5134400|NCT01074827|Multiple Sclerosis|multiple sclerosis
5134401|NCT01074827|Walking ability|walking ability
5134402|NCT01074827|Strength|strength
5134403|NCT01074827|Balance|balance
5134404|NCT01074827|Treadmill walking|treadmill walking
5134405|NCT01074814|Metastatic Breast Cancer|metastatic breast cancer
5134406|NCT01074814|Molecular profiling|molecular profiling
5134407|NCT01074801|Closed-loop systems|closed-loop systems
5134408|NCT01074801|day-and-night glucose control|day-and-night glucose control
5134409|NCT01074788|rehabilitation|rehabilitation
5134410|NCT01074788|mind body therapy|mind body therapy
5134411|NCT01074788|integrative medicine|integrative medicine
5134412|NCT01074775|innate immunity|innate immunity
5134413|NCT01074775|mycobacterium bovis|mycobacterium bovis
5134414|NCT01074775|mucosal immunity|mucosal immunity
5134415|NCT01074775|adaptive immunity|adaptive immunity
5134416|NCT01074775|genomics|genomics
5134417|NCT01074762|Diabetes mellitus|diabetes mellitus
5134418|NCT01074762|Quality of health care|quality of health care
5134419|NCT01074762|Health services research|health services research
5134421|NCT01074749|Automatic Mode Switch|automatic mode switch
5134422|NCT01074749|FFRW|ffrw
5134423|NCT01074749|paroxysmal AF|paroxysmal af
5134424|NCT01074736|influenza A/H5N1|influenza a/h5n1
5134425|NCT01074736|host genetic susceptibility|host genetic susceptibility
5134426|NCT01074736|genotyping|genotyping
5134427|NCT01074723|b-cryptoxanthin|b-cryptoxanthin
5134428|NCT01074723|cholesterol|cholesterol
5134429|NCT01074723|bone markers|bone markers
5134430|NCT01074723|Osteoporosis|osteoporosis
5134431|NCT01074723|cardiovascular risk|cardiovascular risk
5134432|NCT01074723|post-menopausal women|post-menopausal women
5134433|NCT01074697|Randomized Controlled Trial|randomized controlled trial
5134434|NCT01074697|Serotonin Agonists|serotonin agonists
5134435|NCT01074697|Dexamethasone|dexamethasone
5134436|NCT01074697|Receptors, Neurokinin-1|receptors, neurokinin-1
5134437|NCT01074697|Radiotherapy|radiotherapy
5134438|NCT01074697|Cisplatin|cisplatin
5134439|NCT01074697|Prevention & control|prevention & control
5134440|NCT01074684|diagnosis|diagnosis
5134441|NCT01074684|nodules|nodules
5134442|NCT01074684|fine needle aspiration|fine needle aspiration
5134443|NCT01074658|Advance|advance
5134444|NCT01074658|Medtronic CoreValve System|medtronic corevalve system
5134445|NCT01074658|International|international
5134446|NCT01074658|Interventional|interventional
5134447|NCT01074658|Post Market Study|post market study
5134448|NCT01074645|Acute-on -chronic liver failure|acute-on -chronic liver failure
5134449|NCT01074645|Reactivation of hepatitis B|reactivation of hepatitis b
5134450|NCT01074645|Spontaneous reactivation of chronic hepatitis B presenting as to acute-on-chronic liver failure|spontaneous reactivation of chronic hepatitis b presenting as to acute-on-chronic liver failure
5134451|NCT01074606|Cataract|cataract
5134452|NCT01074593|PHARMACOKINETICS AND PHARMACODYNAMICS OF DRUG INTERFERON BETA-1A|pharmacokinetics and pharmacodynamics of drug interferon beta-1a
5134453|NCT01074580|Crohn's disease|crohn's disease
5134454|NCT01074580|sonography|sonography
5134455|NCT01074580|contrast enhanced ultrasound|contrast enhanced ultrasound
5134456|NCT01074554|sarcoidosis|sarcoidosis
5134457|NCT01074554|mycobacteria|mycobacteria
5134458|NCT01074554|cutaneous lesions|cutaneous lesions
5134459|NCT01074541|Vitamin D|vitamin d
5134460|NCT01074541|UVB|uvb
5134461|NCT01074541|Dose-Response|dose-response
5134462|NCT01074541|UV intensity|uv intensity
5134463|NCT01074541|Skin cancer|skin cancer
5134464|NCT01074528|cancer patients|cancer patients
5134465|NCT01074528|relatives or partners of cancer patients|relatives or partners of cancer patients
5134466|NCT01074515|COPD|copd
5134467|NCT01074515|Depression|depression
5134468|NCT01074515|Inflammation|inflammation
5134469|NCT01074515|Genetics|genetics
5134470|NCT01074515|Functioning|functioning
5134471|NCT01074515|Dyspnea|dyspnea
5134472|NCT01074515|Physical activity|physical activity
5134473|NCT01074502|acne|acne
5134474|NCT01074489|GDM|gdm
5134475|NCT01074489|Gestational Diabetes|gestational diabetes
5134476|NCT01074489|GTT|gtt
5134477|NCT01074489|CGMS|cgms
5134478|NCT01074476|Knee osteoarthritis|knee osteoarthritis
5134479|NCT01074476|glucosamine|glucosamine
5134480|NCT01074476|synovial fluid|synovial fluid
5134481|NCT01074476|viscosity|viscosity
5134482|NCT01074476|viscoelasticity|viscoelasticity
5134483|NCT01074476|WOMAC|womac
5134484|NCT01074463|Bioequivalence|bioequivalence
5134485|NCT01074463|Healthy Subjects|healthy subjects
5134486|NCT01074450|Bioequivalence|bioequivalence
5134487|NCT01074450|Healthy Subjects|healthy subjects
5134488|NCT01074424|stage IIB cervical cancer|stage iib cervical cancer
5134489|NCT01074424|stage III cervical cancer|stage iii cervical cancer
5134490|NCT01074424|stage IVA cervical cancer|stage iva cervical cancer
5134491|NCT01074424|cervical adenocarcinoma|cervical adenocarcinoma
5134492|NCT01074424|cervical adenosquamous cell carcinoma|cervical adenosquamous cell carcinoma
5134493|NCT01074424|cervical squamous cell carcinoma|cervical squamous cell carcinoma
5134494|NCT01074398|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5134495|NCT01074398|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5134496|NCT01074398|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5134497|NCT01074398|fallopian tube cancer|fallopian tube cancer
5134498|NCT01074398|peritoneal cavity cancer|peritoneal cavity cancer
5134499|NCT01074385|Stage IV Colorectal Cancer|stage iv colorectal cancer
5134500|NCT01074359|A3243G Mitochondrial DNA Point Mutation|a3243g mitochondrial dna point mutation
5134501|NCT01074346|Multiple sclerosis|multiple sclerosis
5134502|NCT01074346|Interferon-beta 1-a|interferon-beta 1-a
5134503|NCT01074333|Colorectal cancer|colorectal cancer
5134504|NCT01074333|Metastasis|metastasis
5134505|NCT01074333|Cetuximab|cetuximab
5134506|NCT01074333|Erbitux|erbitux
5134507|NCT01074333|Epidermal growth factor receptor|epidermal growth factor receptor
5134508|NCT01074320|breast cancer|breast cancer
5134509|NCT01074320|aromatase inhibitors|aromatase inhibitors
5134510|NCT01074320|musculoskeletal symptoms|musculoskeletal symptoms
5134511|NCT01074307|Systolic heart failure|systolic heart failure
5134512|NCT01074307|Bisoprolol|bisoprolol
5134513|NCT01074307|Concor|concor
5134514|NCT01074307|Echocardiogram|echocardiogram
5134515|NCT01074294|Inattention|inattention
5134516|NCT01074294|Hyperactivity|hyperactivity
5134517|NCT01074294|Impulsivity|impulsivity
5134518|NCT01074294|Distractibility|distractibility
5134519|NCT01074294|Procrastination|procrastination
5134520|NCT01074294|Disorganized|disorganized
5134521|NCT01074294|ADHD|adhd
5134522|NCT01074281|Hypertension|hypertension
5134523|NCT01074281|Isolated systolic hypertonia|isolated systolic hypertonia
5134524|NCT01074281|Eneas|eneas
5134525|NCT01074255|Nausea|nausea
5134526|NCT01074255|Vomiting|vomiting
5134527|NCT01074255|Chemotherapy|chemotherapy
5134528|NCT01074255|Post-chemotherapy|post-chemotherapy
5134529|NCT01074242|Gastroenteritis rotavirus|gastroenteritis rotavirus
5134530|NCT01074229|Pain|pain
5134531|NCT01074229|Post Operative|post operative
5134532|NCT01074229|Opioids|opioids
5134533|NCT01074229|Laparoscopic|laparoscopic
5134534|NCT01074229|Surgery|surgery
5134535|NCT01074229|Hysterectomy|hysterectomy
5134536|NCT01074216|Vitamin D|vitamin d
5134537|NCT01074216|Vitamin D3|vitamin d3
5134538|NCT01074216|colon cancer|colon cancer
5134539|NCT01074216|rectum cancer|rectum cancer
5134540|NCT01074216|Cholecalciferol|cholecalciferol
5134541|NCT01074216|09-143|09-143
5134542|NCT01074203|nitazoxanide|nitazoxanide
5134543|NCT01074203|liver transplantation|liver transplantation
5134544|NCT01074203|HCV recurrence|hcv recurrence
5134545|NCT01074190|Epidural Labor Analgesia|epidural labor analgesia
5134546|NCT01074190|Pain|pain
5134547|NCT01074190|Infant|infant
5134548|NCT01074190|Breastfeeding|breastfeeding
5134549|NCT01074177|BIBW 2992|bibw 2992
5134550|NCT01074177|NSCLC|nsclc
5134551|NCT01074164|eczema|eczema
5134552|NCT01074164|atopic dermatitis|atopic dermatitis
5134553|NCT01074164|itch|itch
5134554|NCT01074164|pruritus|pruritus
5134555|NCT01074164|acupressure|acupressure
5134556|NCT01074164|acupuncture|acupuncture
5134557|NCT01074151|Pregnancy|pregnancy
5134558|NCT01074151|pregnant|pregnant
5134559|NCT01074151|Cymbalta|cymbalta
5134560|NCT01074151|Pregnancy Outcomes|pregnancy outcomes
5134561|NCT01074138|CPRC|cprc
5134562|NCT01074125|Hyperphosphatemia|hyperphosphatemia
5134563|NCT01074125|ESRD|esrd
5134564|NCT01074125|Dialysis|dialysis
5134565|NCT01074125|End Stage Renal Disease|end stage renal disease
5134566|NCT01074125|Phosphorus|phosphorus
5134567|NCT01074125|Renal|renal
5134568|NCT01074125|Kidney|kidney
5134569|NCT01074112|Ultrasound|ultrasound
5134570|NCT01074112|Prehospital|prehospital
5134571|NCT01074112|Trauma|trauma
5134572|NCT01074112|EMS|ems
5134573|NCT01074112|Paramedics|paramedics
5134574|NCT01074112|Sonography|sonography
5134575|NCT01074112|Ultrasonography|ultrasonography
5134576|NCT01074112|Ambulance|ambulance
5134577|NCT01074112|FAST|fast
5134578|NCT01074112|EFAST|efast
5134579|NCT01074086|RAD 001 in relapsed AML|rad 001 in relapsed aml
5134580|NCT01074073|Lithium DDI with Lurasidone HCl|lithium ddi with lurasidone hcl
5134581|NCT01074073|Male/Female, Schizophrenia Patients|male/female, schizophrenia patients
5134582|NCT01074047|Acute Myeloid Leukemia|acute myeloid leukemia
5134583|NCT01074047|Cytarabine|cytarabine
5134584|NCT01074047|Vidaza|vidaza
5134585|NCT01074047|azacitidine|azacitidine
5134586|NCT01074047|Intensive Chemotherapy|intensive chemotherapy
5134587|NCT01074047|Low Dose Cytarabine|low dose cytarabine
5134588|NCT01074047|Celgene|celgene
5134589|NCT01074021|Nimotuzumab|nimotuzumab
5134590|NCT01074021|Nasopharyngeal cancer|nasopharyngeal cancer
5134591|NCT01074021|chemoradiation|chemoradiation
5134592|NCT01073995|Radiculopathy|radiculopathy
5134593|NCT01073995|Sciatica|sciatica
5134594|NCT01073995|Lumbar Disc Herniation|lumbar disc herniation
5134595|NCT01073995|Surgical Alternative|surgical alternative
5134596|NCT01073982|pain|pain
5134597|NCT01073982|inflammation|inflammation
5134598|NCT01073982|osteoarthritis|osteoarthritis
5134599|NCT01073969|prebiotic study|prebiotic study
5134600|NCT01073969|modulating colonic bacteria|modulating colonic bacteria
5134601|NCT01073956|Subacromial Impingement Syndrome|subacromial impingement syndrome
5134602|NCT01073956|Shoulder Pain|shoulder pain
5134603|NCT01073956|Physical therapy|physical therapy
5134604|NCT01073956|Electrotherapy|electrotherapy
5134605|NCT01073956|Ultrasonic therapy|ultrasonic therapy
5134606|NCT01073956|Medium-wave 448 kHz therapy|medium-wave 448 khz therapy
5134607|NCT01073943|Bowel Preparation|bowel preparation
5134608|NCT01073943|Colonoscopy|colonoscopy
5134609|NCT01073930|Bowel Preparation|bowel preparation
5134610|NCT01073930|Colonoscopy|colonoscopy
5134611|NCT01073917|Ventilation|ventilation
5134612|NCT01073917|General Anesthesia|general anesthesia
5134613|NCT01073917|electrical impedance tomography|electrical impedance tomography
5134614|NCT01073917|pressure support|pressure support
5134615|NCT01073917|spontaneous breathing|spontaneous breathing
5134616|NCT01073917|laryngeal mask|laryngeal mask
5134617|NCT01073917|Patients who are scheduled for elective knee or ankle surgery|patients who are scheduled for elective knee or ankle surgery
5134618|NCT01073891|Pharmacokinetics|pharmacokinetics
5134619|NCT01073891|Bioavailability|bioavailability
5134620|NCT01073891|Food effect|food effect
5134621|NCT01073891|Oral liquid formulation|oral liquid formulation
5134622|NCT01073878|Urinary Urge Incontinence|urinary urge incontinence
5134623|NCT01073878|Urinary Stress Incontinence|urinary stress incontinence
5134624|NCT01073878|Urinary Mixed Incontinence|urinary mixed incontinence
5134625|NCT01073865|ZOLADEX|zoladex
5134626|NCT01073865|Pre-menopausal|pre-menopausal
5134627|NCT01073865|Oestrogen Receptor|oestrogen receptor
5134628|NCT01073865|Advanced Breast Cancer|advanced breast cancer
5134629|NCT01073865|Progression Free Survival|progression free survival
5134630|NCT01073852|Chronic Urticaria|chronic urticaria
5134631|NCT01073852|Hives|hives
5134632|NCT01073852|Hydroxychloroquine|hydroxychloroquine
5134633|NCT01073813|Minocycline|minocycline
5134634|NCT01073813|Retinal nerve fibre layer thickness|retinal nerve fibre layer thickness
5134635|NCT01073813|Macular volume|macular volume
5134636|NCT01073813|Visual outcomes|visual outcomes
5134637|NCT01073800|atorvastatin|atorvastatin
5134638|NCT01073800|vascular occlusion|vascular occlusion
5134639|NCT01073800|myocardial infarction|myocardial infarction
5134640|NCT01073800|stroke|stroke
5134641|NCT01073800|renal failure|renal failure
5134642|NCT01073800|critically ill|critically ill
5134643|NCT01073800|Vascular occlusive events among the critically ill|vascular occlusive events among the critically ill
5134644|NCT01073787|migraine|migraine
5134645|NCT01073787|headache|headache
5134646|NCT01073787|pediatric|pediatric
5134647|NCT01073787|children|children
5134648|NCT01073787|Emergency Department|emergency department
5134649|NCT01073774|breast cancer couples coping|breast cancer couples coping
5134650|NCT01073748|Asthma|asthma
5134651|NCT01073748|Acetaminophen|acetaminophen
5134652|NCT01073748|paracetamol|paracetamol
5134653|NCT01073748|FeNO|feno
5134654|NCT01073748|Spirometry|spirometry
5134655|NCT01073748|Lung function|lung function
5134656|NCT01073735|Needs assessment|needs assessment
5134657|NCT01073735|Health-related needs|health-related needs
5134658|NCT01073735|Childhood cancer survivors|childhood cancer survivors
5134659|NCT01073722|thoracic surgery|thoracic surgery
5134660|NCT01073722|one-lung ventilation|one-lung ventilation
5134661|NCT01073722|double lumen tube|double lumen tube
5134662|NCT01073722|endobronchial blocker|endobronchial blocker
5134663|NCT01073709|Acetaminophen fasting study|acetaminophen fasting study
5134664|NCT01073696|Sancuso|sancuso
5134665|NCT01073696|granisetron|granisetron
5134666|NCT01073696|Pharmacokinetics|pharmacokinetics
5134667|NCT01073683|TPF|tpf
5134668|NCT01073683|INDUCTION CHEMOTHERAPY|induction chemotherapy
5134669|NCT01073683|LARYNX PRESERVATION|larynx preservation
5134670|NCT01073683|SUPACRICOID LARYNGECTOMY|supacricoid laryngectomy
5134671|NCT01073683|Stage 3 and 4 larynx cancer|stage 3 and 4 larynx cancer
5134672|NCT01073670|NSAIDs|nsaids
5134673|NCT01073670|bleeding|bleeding
5134674|NCT01073670|thromboelastography|thromboelastography
5134675|NCT01073670|cardiac surgery|cardiac surgery
5134676|NCT01073670|Indomethacin|indomethacin
5134677|NCT01073670|acetaminophen|acetaminophen
5134678|NCT01073657|Rehabilitation|rehabilitation
5134679|NCT01073644|imatinib resistant or intolerant|imatinib resistant or intolerant
5134680|NCT01073631|voriconazole|voriconazole
5134681|NCT01073631|Korea|korea
5134682|NCT01073631|invasive fungal infection|invasive fungal infection
5134683|NCT01073618|voriconazole|voriconazole
5134684|NCT01073618|Korea|korea
5134685|NCT01073618|invasive fungal infection|invasive fungal infection
5134686|NCT01073605|Short height|short height
5134687|NCT01073605|intra-uterine growth retardation|intra-uterine growth retardation
5134688|NCT01073605|Genotonorm|genotonorm
5134689|NCT01073605|continuous treatment|continuous treatment
5134690|NCT01073605|intermittent treatment|intermittent treatment
5134691|NCT01073592|HMP|hmp
5134692|NCT01073592|CNV|cnv
5134693|NCT01073592|AMD|amd
5134694|NCT01073592|PHP|php
5134695|NCT01073592|HPHP|hphp
5134696|NCT01073592|FORESEE HOME|foresee home
5134697|NCT01073579|Cryptogenic Infantile Spasms|cryptogenic infantile spasms
5134698|NCT01073579|Cryptogenic West Syndrome|cryptogenic west syndrome
5134699|NCT01073579|Hypsarrhythmia|hypsarrhythmia
5134700|NCT01073579|Infantile Spasms|infantile spasms
5134701|NCT01073579|Symptomatic Infantile Spasms|symptomatic infantile spasms
5134702|NCT01073579|Symptomatic West Syndrome|symptomatic west syndrome
5134703|NCT01073579|West Syndrome|west syndrome
5134704|NCT01073579|Refractory Complex Partial Seizures|refractory complex partial seizures
5134705|NCT01073579|Complex Partial Epilepsy|complex partial epilepsy
5134706|NCT01073579|Complex Partial Seizure Disorder|complex partial seizure disorder
5134707|NCT01073579|Cryptogenic Partial Complex Epilepsy|cryptogenic partial complex epilepsy
5134708|NCT01073579|Disorder, Complex Partial Seizures|disorder, complex partial seizures
5134709|NCT01073579|Epilepsy, Cryptogenic, Partial Complex|epilepsy, cryptogenic, partial complex
5134710|NCT01073579|Epilepsy, Psychic Equivalent|epilepsy, psychic equivalent
5134711|NCT01073579|Epilepsy, Psychomotor|epilepsy, psychomotor
5134712|NCT01073579|Epilepsy, Symptomatic, Partial Complex|epilepsy, symptomatic, partial complex
5134713|NCT01073579|Partial Complex Epilepsy, Cryptogenic|partial complex epilepsy, cryptogenic
5134714|NCT01073579|Partial Complex Epilepsy, Symptomatic|partial complex epilepsy, symptomatic
5134715|NCT01073579|Seizure Disorder, Complex Partial|seizure disorder, complex partial
5134716|NCT01073579|Symptomatic Partial Complex Epilepsy|symptomatic partial complex epilepsy
5134717|NCT01073566|Autoimmune Diseases|autoimmune diseases
5134718|NCT01073566|Diabetes Mellitus|diabetes mellitus
5134719|NCT01073566|Endocrine System Diseases|endocrine system diseases
5134720|NCT01073566|Glucose Metabolism Disorders|glucose metabolism disorders
5134721|NCT01073566|Immune System Diseases|immune system diseases
5134722|NCT01073566|Insulin|insulin
5134723|NCT01073566|Metabolic Diseases|metabolic diseases
5134724|NCT01073527|Child, preschool|child, preschool
5134725|NCT01073527|Pediatric emergency department|pediatric emergency department
5134726|NCT01073514|Malignant biliary obstruction (MBO)|malignant biliary obstruction (mbo)
5134727|NCT01073501|UREMIC PRURITUS|uremic pruritus
5134728|NCT01073501|PREGABALIN|pregabalin
5134729|NCT01073501|UP|up
5134730|NCT01073488|Pregnancy|pregnancy
5134731|NCT01073488|Maternal child health|maternal child health
5134732|NCT01073488|Developing countries|developing countries
5134733|NCT01073488|Stillbirth|stillbirth
5134734|NCT01073488|Neonatal mortality|neonatal mortality
5134735|NCT01073488|Maternal mortality|maternal mortality
5134736|NCT01073488|Community intervention|community intervention
5134737|NCT01073488|Community mobilization|community mobilization
5134738|NCT01073488|Home-based Life Saving Skills|home-based life saving skills
5134739|NCT01073475|Pregnancy|pregnancy
5134740|NCT01073475|Maternal mortality|maternal mortality
5134741|NCT01073475|Neonatal mortality|neonatal mortality
5134742|NCT01073475|Stillbirth|stillbirth
5134743|NCT01073475|Maternal Near Miss|maternal near miss
5134744|NCT01073475|Maternal Cause of Death|maternal cause of death
5134745|NCT01073475|Neonatal Cause of Death|neonatal cause of death
5134746|NCT01073462|Secondary Hyperparathyroidism (sHPT)|secondary hyperparathyroidism (shpt)
5134747|NCT01073462|Paricalcitol|paricalcitol
5134748|NCT01073462|Chronic kidney disease stage 5 (CKD stage 5)|chronic kidney disease stage 5 (ckd stage 5)
5134749|NCT01073449|Cardiac devices|cardiac devices
5134750|NCT01073449|In-Hospital Follow-up|in-hospital follow-up
5134751|NCT01073449|Analytical|analytical
5134752|NCT01073436|diagnosis of Ph+) CML in chronic phase.|diagnosis of ph+) cml in chronic phase.
5134753|NCT01073436|prior therapy with interferon-alpha for at least 2 years, and achieved at least a partial cytogenetic response|prior therapy with interferon-alpha for at least 2 years, and achieved at least a partial cytogenetic response
5134754|NCT01073436|receiving a TKI (imatinib mesylate, dasatinib, nilotinib)|receiving a tki (imatinib mesylate, dasatinib, nilotinib)
5134755|NCT01073436|WBC ≤ 10 x 109/L.|wbc ≤ 10 x 109/l.
5134756|NCT01073436|Platelet count < 450,000 x 109/L.|platelet count < 450,000 x 109/l.
5134757|NCT01073436|No blasts or promyelocytes in peripheral blood.|no blasts or promyelocytes in peripheral blood.
5134758|NCT01073436|No evidence of disease-related symptoms and extramedullary disease|no evidence of disease-related symptoms and extramedullary disease
5134759|NCT01073436|complete cytogenetic response (CCyR) on a TKI for a minimum of 1 yr|complete cytogenetic response (ccyr) on a tki for a minimum of 1 yr
5134760|NCT01073436|major molecular remission on a TKI for a minimum of 1 yr|major molecular remission on a tki for a minimum of 1 yr
5134761|NCT01073436|18 years of age or older|18 years of age or older
5134762|NCT01073436|ECOG performance status of 0-2 (Appendix 13.1)|ecog performance status of 0-2 (appendix 13.1)
5134763|NCT01073436|Informed Consent|informed consent
5134764|NCT01073423|HIV|hiv
5134765|NCT01073423|sleep|sleep
5134766|NCT01073423|insomnia|insomnia
5134767|NCT01073423|yoga|yoga
5134768|NCT01073423|music|music
5134769|NCT01073397|Menopause|menopause
5134770|NCT01073397|Hot Flashes|hot flashes
5134771|NCT01073397|Vasomotor symptoms|vasomotor symptoms
5134772|NCT01073397|Yoga|yoga
5134773|NCT01073371|Liposome|liposome
5134774|NCT01073371|Prilocaine|prilocaine
5134775|NCT01073371|Dental anesthesia|dental anesthesia
5134776|NCT01073358|resectable hepatic metastases of colorectal cancer|resectable hepatic metastases of colorectal cancer
5134777|NCT01073345|Patients undergoing elective hepatic resection|patients undergoing elective hepatic resection
5134778|NCT01073319|Methamphetamine|methamphetamine
5134779|NCT01073319|Rivastigmine|rivastigmine
5134780|NCT01073306|Vaccine|vaccine
5134781|NCT01073306|Dengue Hemorrhagic Fever|dengue hemorrhagic fever
5134782|NCT01073280|Cerebral and subarachnoid biopsy|cerebral and subarachnoid biopsy
5134783|NCT01073280|flexible endoscopy|flexible endoscopy
5134784|NCT01073280|Patients with neurological findings without diagnosis.|patients with neurological findings without diagnosis.
5134785|NCT01073267|Stage IB-IIIA Mycosis fungoides|stage ib-iiia mycosis fungoides
5134786|NCT01073267|Total Skin Electron Beam Therapy|total skin electron beam therapy
5134787|NCT01073267|TSEBT|tsebt
5134788|NCT01073241|benign prostatic hyperplasia|benign prostatic hyperplasia
5134789|NCT01073241|Transurethral Resection of Prostate|transurethral resection of prostate
5134790|NCT01073241|transurethral enucleation of prostate|transurethral enucleation of prostate
5134791|NCT01073228|Alzheimer's disease|alzheimer's disease
5134792|NCT01073228|Central Nervous System diseases|central nervous system diseases
5134793|NCT01073228|Cognition|cognition
5134794|NCT01073215|Adolescents|adolescents
5134795|NCT01073215|Obesity|obesity
5134796|NCT01073215|Weight Management|weight management
5134797|NCT01073215|Family-based Lifestyle Modification|family-based lifestyle modification
5134798|NCT01073189|Acute kidney injury|acute kidney injury
5134799|NCT01073189|Fenoldopam mesylate|fenoldopam mesylate
5134800|NCT01073189|Benephit catheter|benephit catheter
5134801|NCT01073176|ADHD|adhd
5134802|NCT01073176|Executive function|executive function
5134803|NCT01073176|Preschool children|preschool children
5134804|NCT01073176|Treatment|treatment
5134807|NCT01073176|Training|training
5134808|NCT01073176|Cognitive enhancement|cognitive enhancement
5134809|NCT01073150|Tea Tree Oil|tea tree oil
5134810|NCT01073150|Chronic Blepharitis|chronic blepharitis
5134811|NCT01073137|diabetes|diabetes
5134812|NCT01073072|bovine pericardium bioprosthesis|bovine pericardium bioprosthesis
5134813|NCT01073072|contamination|contamination
5134814|NCT01073072|hernia repair|hernia repair
5134815|NCT01073072|abdominal wall reconstruction|abdominal wall reconstruction
5134816|NCT01073072|Tutomesh|tutomesh
5134817|NCT01073072|Tutopatch|tutopatch
5134818|NCT01073072|Potentially Contaminated Hernia Repair|potentially contaminated hernia repair
5134819|NCT01073072|Potentially Contaminated Abdominal Wall Reconstruction|potentially contaminated abdominal wall reconstruction
5134820|NCT01073059|valproic acid|valproic acid
5134821|NCT01073059|ertapenem|ertapenem
5134822|NCT01073046|Naso-Gastric/Jejunal Tube|naso-gastric/jejunal tube
5134823|NCT01073046|Sub-total Gastrectomy|sub-total gastrectomy
5134824|NCT01073046|Gastric Cancer|gastric cancer
5134825|NCT01073046|Decompression|decompression
5134826|NCT01073046|Discomfort|discomfort
5134827|NCT01073046|Complications|complications
5134828|NCT01073033|pregnancy|pregnancy
5134829|NCT01073033|lactation|lactation
5134830|NCT01073033|oral supplement|oral supplement
5134831|NCT01073033|probiotics|probiotics
5134832|NCT01073033|early infections|early infections
5134833|NCT01073020|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
5134834|NCT01073020|Obesity|obesity
5134835|NCT01073020|Lifestyle|lifestyle
5134836|NCT01073020|Bariatric Surgery|bariatric surgery
5134837|NCT01073020|Laparoscopic Adjustable Gastric Band|laparoscopic adjustable gastric band
5134838|NCT01073020|Laparoscopic Roux-en-Y Gastric Bypass|laparoscopic roux-en-y gastric bypass
5134839|NCT01073007|Acute Stroke|acute stroke
5134840|NCT01073007|tissue plasminogen activator|tissue plasminogen activator
5134841|NCT01073007|simvastatin|simvastatin
5134842|NCT01072994|Myocardium|myocardium
5134843|NCT01072994|Phospholipid|phospholipid
5134844|NCT01072994|Fish oil|fish oil
5134845|NCT01072994|Cardiolipin|cardiolipin
5134846|NCT01072994|Transplantation|transplantation
5134847|NCT01072981|Pancreatic Cancer|pancreatic cancer
5134848|NCT01072981|Vaccine Therapy|vaccine therapy
5134849|NCT01072968|Multicenter|multicenter
5134850|NCT01072968|Randomized|randomized
5134851|NCT01072968|Double-blind|double-blind
5134852|NCT01072968|Efficacy and safety study|efficacy and safety study
5134853|NCT01072968|BF2.649 versus placebo|bf2.649 versus placebo
5134854|NCT01072968|Patients suffering from Obstructive Sleep Apnea|patients suffering from obstructive sleep apnea
5134855|NCT01072968|Complaining from Excessive Daytime Sleepiness|complaining from excessive daytime sleepiness
5134856|NCT01072968|Refusing nasal Continuous Positive Airway Pressure|refusing nasal continuous positive airway pressure
5134857|NCT01072942|Chronic Obstructive|chronic obstructive
5134858|NCT01072942|Phase I|phase i
5134859|NCT01072942|Pharmacokinetics|pharmacokinetics
5134860|NCT01072942|Microbiology|microbiology
5134861|NCT01072929|Bipolar I Disorder|bipolar i disorder
5134862|NCT01072916|Colon, Irritable|colon, irritable
5134863|NCT01072916|Microbiota|microbiota
5134864|NCT01072903|inflammation|inflammation
5134865|NCT01072903|colon, irritable|colon, irritable
5134866|NCT01072903|Colonic Diseases, Functional|colonic diseases, functional
5134867|NCT01072903|Irritable Bowel Syndrome|irritable bowel syndrome
5134868|NCT01072890|Temsirolimus, Pazopanib|temsirolimus, pazopanib
5134869|NCT01072877|Varicose Veins|varicose veins
5134870|NCT01072864|Postmenopausal|postmenopausal
5134871|NCT01072851|colorectal cancer screening|colorectal cancer screening
5134872|NCT01072851|multimedia education|multimedia education
5134873|NCT01072851|print education|print education
5134874|NCT01072851|culturally competent|culturally competent
5134875|NCT01072838|breast cancer|breast cancer
5134876|NCT01072838|APBI|apbi
5134877|NCT01072838|brachytherapy|brachytherapy
5134878|NCT01072838|Contura|contura
5134879|NCT01072812|Alzheimer's|alzheimer's
5134880|NCT01072812|Amnestic Mild Cognitive Impairment|amnestic mild cognitive impairment
5134881|NCT01072812|Pharmacokinetics|pharmacokinetics
5134882|NCT01072812|Pharmacodynamics|pharmacodynamics
5134883|NCT01072812|Biomarkers|biomarkers
5134884|NCT01072799|A (H1N1)|a (h1n1)
5134885|NCT01072786|Dengue Virus|dengue virus
5134886|NCT01072786|Dengue Fever|dengue fever
5134887|NCT01072786|Dengue Vaccine|dengue vaccine
5134888|NCT01072786|Dengue Hemorrhagic Fever|dengue hemorrhagic fever
5134889|NCT01072786|Dengue Shock Syndrome|dengue shock syndrome
5134890|NCT01072760|Mallet finger|mallet finger
5134891|NCT01072760|extensor tendon|extensor tendon
5134892|NCT01072760|Kirschner wire|kirschner wire
5134893|NCT01072760|Fracture Fixation|fracture fixation
5134894|NCT01072734|Lupus|lupus
5134895|NCT01072734|CXCR4 on leucocytes of patients with SLE|cxcr4 on leucocytes of patients with sle
5134896|NCT01072734|Influenza vaccine|influenza vaccine
5134897|NCT01072721|Liver|liver
5134898|NCT01072721|Fibrosis|fibrosis
5134899|NCT01072721|Elastometry|elastometry
5134900|NCT01072721|FIBROSCANN|fibroscann
5134901|NCT01072721|Children|children
5134996|NCT01072344|Complementary and Alternative Medicine|complementary and alternative medicine
5134997|NCT01072331|insulin resistance|insulin resistance
5134902|NCT01072708|Cystic fibrosis -diabetes - glucose tolerance - reversibility - oral glucose tolerance test - predictive factors|cystic fibrosis -diabetes - glucose tolerance - reversibility - oral glucose tolerance test - predictive factors
5134903|NCT01072695|Hepatitis C|hepatitis c
5134904|NCT01072695|HCV|hcv
5134905|NCT01072695|GS-9256|gs-9256
5134906|NCT01072695|GS-9190|gs-9190
5134907|NCT01072695|Genotype 1|genotype 1
5134908|NCT01072682|Acute Renal Failure|acute renal failure
5134909|NCT01072682|Acute tubular necrosis|acute tubular necrosis
5134910|NCT01072682|Continuous Renal Replacement Therapy|continuous renal replacement therapy
5134911|NCT01072682|Selective cytopheretic device|selective cytopheretic device
5134912|NCT01072669|Ambrisentan increases digital micro-vascular flow (measured by LDPI) in patients with Raynaud's phenomenon (RP) and digital ischemia secondary to SSc.|ambrisentan increases digital micro-vascular flow (measured by ldpi) in patients with raynaud's phenomenon (rp) and digital ischemia secondary to ssc.
5134913|NCT01072643|Sedation|sedation
5134914|NCT01072643|Pulmonary Hypertension|pulmonary hypertension
5134915|NCT01072643|Pediatric|pediatric
5134916|NCT01072643|Cardiac Catheterization|cardiac catheterization
5134917|NCT01072643|Pulmonary Vascular Resistance|pulmonary vascular resistance
5134918|NCT01072630|Bipolar I Disorder|bipolar i disorder
5134919|NCT01072604|Aspirin|aspirin
5134920|NCT01072604|Acetylsalicylic Acid|acetylsalicylic acid
5134921|NCT01072591|anti-NGF|anti-ngf
5134922|NCT01072591|OA|oa
5134923|NCT01072591|pain|pain
5134924|NCT01072578|Healthy volunteers|healthy volunteers
5134925|NCT01072578|Inhibition of glucose re-absorption|inhibition of glucose re-absorption
5134926|NCT01072578|diabetes|diabetes
5134927|NCT01072578|dapagliflozin|dapagliflozin
5134928|NCT01072565|Type 2 Diabetes|type 2 diabetes
5134929|NCT01072565|A1c|a1c
5134930|NCT01072565|Continuous Glucose Monitoring|continuous glucose monitoring
5134931|NCT01072565|Blood Glucose|blood glucose
5134932|NCT01072552|recurrent wheezing|recurrent wheezing
5134933|NCT01072552|asthma|asthma
5134934|NCT01072552|preterm infants|preterm infants
5134935|NCT01072552|palivizumab|palivizumab
5134936|NCT01072552|atopic diseases|atopic diseases
5134937|NCT01072539|infection|infection
5134938|NCT01072539|Tygacil|tygacil
5134939|NCT01072539|PMS|pms
5134940|NCT01072526|Dry Eye Syndromes|dry eye syndromes
5134941|NCT01072526|Lacrimal Apparatus Diseases|lacrimal apparatus diseases
5134942|NCT01072513|Semen Analysis, Prostate Cancer, Proton Radiation|semen analysis, prostate cancer, proton radiation
5134943|NCT01072500|Aging|aging
5134944|NCT01072500|Physical Activity|physical activity
5134945|NCT01072500|Exercise|exercise
5134946|NCT01072500|Sedentary Lifestyle|sedentary lifestyle
5134947|NCT01072500|Mobility|mobility
5134948|NCT01072500|Disability|disability
5134949|NCT01072500|Falls|falls
5134950|NCT01072500|Cost effectiveness|cost effectiveness
5134951|NCT01072500|Behavioral counseling|behavioral counseling
5134952|NCT01072487|Safety|safety
5134953|NCT01072487|Sedation|sedation
5134954|NCT01072487|Gastrointestinal endoscopy|gastrointestinal endoscopy
5134955|NCT01072487|Colonoscopy|colonoscopy
5134956|NCT01072474|Safety|safety
5134957|NCT01072474|Sedation|sedation
5134958|NCT01072474|Gastrointestinal endoscopy|gastrointestinal endoscopy
5134959|NCT01072474|Colonoscopy|colonoscopy
5134960|NCT01072461|Cerebrovascular Accident|cerebrovascular accident
5134961|NCT01072461|Robotics|robotics
5134962|NCT01072461|Virtual Reality|virtual reality
5134963|NCT01072461|Rehabilitation|rehabilitation
5134964|NCT01072461|Neuroplasticity|neuroplasticity
5134965|NCT01072448|COPD|copd
5134966|NCT01072448|indacaterol|indacaterol
5134967|NCT01072435|ERCP|ercp
5134968|NCT01072435|patient-controlled sedation|patient-controlled sedation
5134969|NCT01072435|target-controlled infusion|target-controlled infusion
5134970|NCT01072435|propofol|propofol
5134971|NCT01072435|Sedation with propofol for ERCP|sedation with propofol for ercp
5134972|NCT01072435|Endoscopic Retrograde Cholangiopancreatography|endoscopic retrograde cholangiopancreatography
5134973|NCT01072422|Smoking|smoking
5134974|NCT01072422|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
5134975|NCT01072422|Questionnaires|questionnaires
5134976|NCT01072422|Nurses|nurses
5134977|NCT01072422|Primary Health Care|primary health care
5134978|NCT01072409|Speech perception ability in the CI alone condition|speech perception ability in the ci alone condition
5134979|NCT01072383|chronic plaque psoriasis|chronic plaque psoriasis
5134980|NCT01072383|psoriasis vulgaris|psoriasis vulgaris
5134981|NCT01072383|autoimmune disease|autoimmune disease
5134982|NCT01072370|Umbilical Cord Blood|umbilical cord blood
5134983|NCT01072370|Stem Cells|stem cells
5134984|NCT01072370|Autologous Blood Transfusion|autologous blood transfusion
5134985|NCT01072370|Cerebral Palsy|cerebral palsy
5134986|NCT01072357|High-Risk Corneal Transplantation|high-risk corneal transplantation
5134987|NCT01072357|Penetrating Keratoplasty|penetrating keratoplasty
5134988|NCT01072357|Neovascularization|neovascularization
5134989|NCT01072357|Corneal Blood Vessels|corneal blood vessels
5134990|NCT01072357|Avastin|avastin
5134991|NCT01072357|Bevacizumab|bevacizumab
5134992|NCT01072357|Corneal Graft|corneal graft
5134993|NCT01072344|Anxiety|anxiety
5134994|NCT01072344|Chamomile|chamomile
5134995|NCT01072344|Herbal Remedy|herbal remedy
5134998|NCT01072318|Breast cancer|breast cancer
5134999|NCT01072318|extended adjuvant hormonal therapy|extended adjuvant hormonal therapy
5135000|NCT01072318|letrozole|letrozole
5135001|NCT01072318|Toremifene|toremifene
5135002|NCT01072305|fluid restriction|fluid restriction
5135003|NCT01072305|fluid therapy|fluid therapy
5135004|NCT01072305|intraoperative care|intraoperative care
5135005|NCT01072279|Malnutrition;|malnutrition;
5135006|NCT01072279|Infant nutrition;|infant nutrition;
5135007|NCT01072279|Fortified food|fortified food
5135008|NCT01072279|Linear growth|linear growth
5135009|NCT01072279|Cluster randomized controlled trials|cluster randomized controlled trials
5135010|NCT01072279|Effectiveness|effectiveness
5135011|NCT01072279|Impact evaluation studies|impact evaluation studies
5135012|NCT01072279|Burundi|burundi
5135013|NCT01072279|Guatemala|guatemala
5135014|NCT01072266|Refractory, Advanced malignancies|refractory, advanced malignancies
5135015|NCT01072227|Non-typeable Haemophilus Influenzae|non-typeable haemophilus influenzae
5135016|NCT01072227|Acute Otitis Media|acute otitis media
5135017|NCT01072227|Streptococcus Pneumoniae|streptococcus pneumoniae
5135018|NCT01072227|Etiology|etiology
5135019|NCT01072214|Pazopanib|pazopanib
5135020|NCT01072214|Tolerability|tolerability
5135021|NCT01072214|Pharmacokinetics|pharmacokinetics
5135022|NCT01072214|GW786034|gw786034
5135023|NCT01072214|Safety|safety
5135024|NCT01072175|drug-drug interaction|drug-drug interaction
5135025|NCT01072175|BRAF inhibitor|braf inhibitor
5135026|NCT01072175|expansion cohorts|expansion cohorts
5135027|NCT01072175|melanoma|melanoma
5135028|NCT01072175|dose escalation|dose escalation
5135029|NCT01072175|MEK inhibitor|mek inhibitor
5135030|NCT01072162|healthy|healthy
5135031|NCT01072162|powder for suspension|powder for suspension
5135032|NCT01072162|tablets|tablets
5135033|NCT01072162|bioavailibility|bioavailibility
5135034|NCT01072162|eltrombopag|eltrombopag
5135035|NCT01072149|COPD|copd
5135036|NCT01072149|Safety|safety
5135037|NCT01072149|FEV1|fev1
5135038|NCT01072149|Efficacy|efficacy
5135039|NCT01072136|mucopurulent cervicitis, chlamydia, gonorrhea, women|mucopurulent cervicitis, chlamydia, gonorrhea, women
5135040|NCT01072110|Patients with diarrhea|patients with diarrhea
5135041|NCT01072097|PCOS|pcos
5135042|NCT01072097|Atorvastatin|atorvastatin
5135043|NCT01072097|Androgens|androgens
5135044|NCT01072097|Glucose metabolism|glucose metabolism
5135045|NCT01072097|Inflammatory markers|inflammatory markers
5135046|NCT01072084|food allergy|food allergy
5135047|NCT01072084|confocal laser endoscope|confocal laser endoscope
5135048|NCT01072084|diagnosis|diagnosis
5135049|NCT01072084|Diagnosis of food allergy|diagnosis of food allergy
5135050|NCT01072071|abdominal compartment syndrome|abdominal compartment syndrome
5135051|NCT01072071|intra-abdominal pressure|intra-abdominal pressure
5135052|NCT01072071|furosemide|furosemide
5135053|NCT01072071|fluid balance|fluid balance
5135054|NCT01072058|Infliximab|infliximab
5135055|NCT01072058|Adalimumab|adalimumab
5135056|NCT01072058|Etanercept|etanercept
5135057|NCT01072058|Heart failure|heart failure
5135058|NCT01072058|Diastolic disfunction|diastolic disfunction
5135059|NCT01072058|TNF blocker|tnf blocker
5135060|NCT01072058|Anti-TNF|anti-tnf
5135061|NCT01072058|Echocardiography|echocardiography
5135062|NCT01072058|Tissue doppler imaging|tissue doppler imaging
5135063|NCT01072058|Brain Natriuretic Peptide|brain natriuretic peptide
5135064|NCT01072058|NT-proBNP|nt-probnp
5135065|NCT01072045|Hemangioma|hemangioma
5135066|NCT01072045|Proliferative hemangioma|proliferative hemangioma
5135067|NCT01072045|Treatment|treatment
5135068|NCT01072045|Propranolol|propranolol
5135069|NCT01072045|Corticosteroid|corticosteroid
5135070|NCT01072032|EEG|eeg
5135071|NCT01072032|Robotics (ankle)|robotics (ankle)
5135072|NCT01072032|Motor-learning|motor-learning
5135073|NCT01072032|Brain Plasticity|brain plasticity
5135074|NCT01072006|TBI (Traumatic Brain Injury)|tbi (traumatic brain injury)
5135075|NCT01072006|PTSD|ptsd
5135076|NCT01072006|fMRI|fmri
5135077|NCT01072006|attention|attention
5135078|NCT01071993|prevention|prevention
5135079|NCT01071993|nephropathy|nephropathy
5135080|NCT01071967|Community Health Nursing|community health nursing
5135081|NCT01071967|Nursing Care Management|nursing care management
5135082|NCT01071967|Aged|aged
5135083|NCT01071967|Aged, 80 and over|aged, 80 and over
5135084|NCT01071967|Health Services for the Aged|health services for the aged
5135085|NCT01071967|Geriatric Nursing|geriatric nursing
5135086|NCT01071967|Geriatric Assessment|geriatric assessment
5135087|NCT01071967|Longevity|longevity
5135088|NCT01071967|Mortality|mortality
5135089|NCT01071954|Immune thrombocytopenic Purpura|immune thrombocytopenic purpura
5135090|NCT01071954|Pediatric|pediatric
5135091|NCT01071954|Thrombocytopenia|thrombocytopenia
5135092|NCT01071941|rRp450|rrp450
5135093|NCT01071941|Herpes virus|herpes virus
5135094|NCT01071941|Gene therapy|gene therapy
5135095|NCT01071928|Advanced Urothelial Carcinoma|advanced urothelial carcinoma
5135096|NCT01071902|ear tubes|ear tubes
5135097|NCT01071902|ear drainage|ear drainage
5135098|NCT01071902|ear infection|ear infection
5135099|NCT01071902|ear drops|ear drops
5135100|NCT01071902|acute otitis media|acute otitis media
5135101|NCT01071889|Healthy Volunteers|healthy volunteers
5135102|NCT01071876|Sleep disorder|sleep disorder
5135103|NCT01071876|obstructive sleep apnea|obstructive sleep apnea
5135104|NCT01071876|excessive daytime sleepiness|excessive daytime sleepiness
5135105|NCT01071876|patients with OSA treated by CPAP presenting EDS|patients with osa treated by cpap presenting eds
5135106|NCT01071850|ASP1941|asp1941
5135107|NCT01071850|Metformin|metformin
5135108|NCT01071850|Type 2 diabetes|type 2 diabetes
5135109|NCT01071850|diabetes|diabetes
5135110|NCT01071837|Glioblastoma Multiforme|glioblastoma multiforme
5135111|NCT01071824|size|size
5135112|NCT01071824|limb|limb
5135113|NCT01071824|transverse coloplasty pouch|transverse coloplasty pouch
5135114|NCT01071824|rectal resection|rectal resection
5135115|NCT01071824|mesorectal excision|mesorectal excision
5135116|NCT01071824|treatment outcome|treatment outcome
5135117|NCT01071811|Randomized controlled trial|randomized controlled trial
5135118|NCT01071811|Pedometer|pedometer
5135119|NCT01071811|Physical activity|physical activity
5135120|NCT01071811|Health measurement|health measurement
5135121|NCT01071811|Self-rated health|self-rated health
5135123|NCT01071811|Sleep quality|sleep quality
5135124|NCT01071785|Metabolic Syndrome|metabolic syndrome
5135125|NCT01071785|diet|diet
5135126|NCT01071785|fiber|fiber
5135127|NCT01071785|Serum lipids|serum lipids
5135128|NCT01071785|Albuminuria|albuminuria
5135129|NCT01071759|Pregnancy|pregnancy
5135130|NCT01071759|anemia|anemia
5135131|NCT01071759|Helicobacter pylori|helicobacter pylori
5135132|NCT01071759|Hemoglobin|hemoglobin
5135133|NCT01071759|Iron|iron
5135134|NCT01071759|Ferritin|ferritin
5135135|NCT01071720|Healthy subjects|healthy subjects
5135136|NCT01071707|IPF|ipf
5135137|NCT01071707|Idiopathic Pulmonary Fibrosis|idiopathic pulmonary fibrosis
5135138|NCT01071694|Multiple Sclerosis,|multiple sclerosis,
5135139|NCT01071694|Relapsing-Remitting,|relapsing-remitting,
5135140|NCT01071694|Interferon beta-1b,|interferon beta-1b,
5135141|NCT01071694|Quality of life|quality of life
5135142|NCT01071681|Arterial hypertension|arterial hypertension
5135143|NCT01071668|onset of labor|onset of labor
5135144|NCT01071668|metabolomics|metabolomics
5135145|NCT01071668|vaginal secretions|vaginal secretions
5135146|NCT01071668|urine|urine
5135147|NCT01071668|blood|blood
5135148|NCT01071655|colorectal cancer|colorectal cancer
5135149|NCT01071655|Bevacizumab|bevacizumab
5135150|NCT01071655|Oxaliplatin|oxaliplatin
5135151|NCT01071655|Irinotecan|irinotecan
5135152|NCT01071655|5FU|5fu
5135153|NCT01071655|capecitabine|capecitabine
5135154|NCT01071642|Change in eGFR from baseline to 72 hours following the exposure to the contrast.|change in egfr from baseline to 72 hours following the exposure to the contrast.
5135155|NCT01071642|Rate of eGFR decrease>25% from the baseline|rate of egfr decrease>25% from the baseline
5135156|NCT01071642|Length of hospitalization.|length of hospitalization.
5135157|NCT01071642|Requirement of unplanned therapy for elevated blood pressure|requirement of unplanned therapy for elevated blood pressure
5135158|NCT01071629|interval training|interval training
5135159|NCT01071629|strength training|strength training
5135160|NCT01071629|exercise capacity|exercise capacity
5135161|NCT01071629|chronic heart failure|chronic heart failure
5135162|NCT01071629|Cardiac rehabilitation|cardiac rehabilitation
5135163|NCT01071616|Cannabinoids|cannabinoids
5135164|NCT01071616|Oral Fluid|oral fluid
5135165|NCT01071616|Pharmacokinetics|pharmacokinetics
5135166|NCT01071616|Stability|stability
5135167|NCT01071616|Smoked Cannabis|smoked cannabis
5135168|NCT01071603|Biomarkers|biomarkers
5135169|NCT01071603|Extrapulmonary TB|extrapulmonary tb
5135170|NCT01071603|NTM|ntm
5135171|NCT01071603|HRCT|hrct
5135172|NCT01071603|MDRTB|mdrtb
5135173|NCT01071603|Tuberculosis|tuberculosis
5135174|NCT01071590|Parkinson's Disease|parkinson's disease
5135175|NCT01071590|Sensory Input|sensory input
5135176|NCT01071590|Gait|gait
5135177|NCT01071590|Imagery|imagery
5135178|NCT01071590|Parkinson Disease|parkinson disease
5135179|NCT01071590|PD|pd
5135180|NCT01071577|Bone Marrow Stromal Cells|bone marrow stromal cells
5135181|NCT01071577|Mesenchymal Stem Cells|mesenchymal stem cells
5135182|NCT01071577|Immune Modulation|immune modulation
5135183|NCT01071577|Tissue Regeneration|tissue regeneration
5135184|NCT01071551|Children|children
5135185|NCT01071551|Obesity|obesity
5135186|NCT01071551|Lifestyle|lifestyle
5135187|NCT01071551|LSES|lses
5135188|NCT01071551|Caries|caries
5135189|NCT01071538|Depressive Disorder, Major|depressive disorder, major
5135190|NCT01071538|Late-Life Depression|late-life depression
5135191|NCT01071538|Geriatrics|geriatrics
5135192|NCT01071538|Buprenorphine|buprenorphine
5135193|NCT01071512|MRI|mri
5135194|NCT01071512|OCT|oct
5135195|NCT01071512|Tysabri|tysabri
5135196|NCT01071512|Multiple Sclerosis|multiple sclerosis
5135197|NCT01071512|cognition|cognition
5135198|NCT01071499|pharmacokinetics|pharmacokinetics
5135199|NCT01071499|pharmacogenetics|pharmacogenetics
5135200|NCT01071499|morphine|morphine
5135201|NCT01071499|children|children
5135202|NCT01071486|Busulfan|busulfan
5135203|NCT01071486|Glutathione S-transferase|glutathione s-transferase
5135504|NCT01070017|Peru|peru
5135204|NCT01071486|Genetic polymorphism|genetic polymorphism
5135205|NCT01071486|HVOD|hvod
5135206|NCT01071486|GVHD|gvhd
5135207|NCT01071473|Childhood cancer|childhood cancer
5135208|NCT01071473|Anthracyclines|anthracyclines
5135209|NCT01071473|Cardiomyopathy|cardiomyopathy
5135210|NCT01071460|PAD|pad
5135211|NCT01071447|Rheumatic diseases|rheumatic diseases
5135212|NCT01071447|Biologic treatment|biologic treatment
5135213|NCT01071447|Nurse-led|nurse-led
5135214|NCT01071421|Sleep apnea syndrome|sleep apnea syndrome
5135215|NCT01071421|community acquired pneumonia|community acquired pneumonia
5135216|NCT01071421|prevalence|prevalence
5135217|NCT01071408|chronic care model|chronic care model
5135218|NCT01071408|stroke prevention|stroke prevention
5135219|NCT01071408|health services research|health services research
5135220|NCT01071395|Parkinson's disease|parkinson's disease
5135221|NCT01071395|Dyskinesia|dyskinesia
5135222|NCT01071395|Dyskinesia Rating Scales|dyskinesia rating scales
5135223|NCT01071395|Amantadine|amantadine
5135224|NCT01071395|Placebo|placebo
5135225|NCT01071382|Aeromedical Evacuation|aeromedical evacuation
5135226|NCT01071382|Repatriation|repatriation
5135227|NCT01071356|methamphetamine|methamphetamine
5135228|NCT01071356|motivational interviewing|motivational interviewing
5135229|NCT01071343|muscular atrophy|muscular atrophy
5135230|NCT01071343|recovery of function|recovery of function
5135231|NCT01071343|rehabilitation|rehabilitation
5135232|NCT01071343|Intensive care unit|intensive care unit
5135233|NCT01071304|Relapsed or refractory advanced cancer, metastatic cancer, locally advanced cancer|relapsed or refractory advanced cancer, metastatic cancer, locally advanced cancer
5135234|NCT01071278|Lipid metabolism disorder|lipid metabolism disorder
5135235|NCT01071252|Moderate to severe chronic plaque-type psoriasis|moderate to severe chronic plaque-type psoriasis
5135236|NCT01071252|AIN457|ain457
5135237|NCT01071252|dermatology|dermatology
5135238|NCT01071239|Fanconi Anemia|fanconi anemia
5135239|NCT01071239|Hematopoietic stem cell transplant|hematopoietic stem cell transplant
5135240|NCT01071226|Malignant and non-malignant diseases|malignant and non-malignant diseases
5135241|NCT01071226|Hematopoietic stem cell transplant|hematopoietic stem cell transplant
5135242|NCT01071226|Peripheral blood progenitor cell transplant|peripheral blood progenitor cell transplant
5135243|NCT01071226|CliniMACS device|clinimacs device
5135244|NCT01071226|T cell depletion|t cell depletion
5135245|NCT01071200|Reproductive Techniques, Assisted|reproductive techniques, assisted
5135246|NCT01071200|Recombinant human follicle stimulating hormone (r-hFSH)|recombinant human follicle stimulating hormone (r-hfsh)
5135247|NCT01071200|Recombinant leutinizing hormone (r-hLH)|recombinant leutinizing hormone (r-hlh)
5135248|NCT01071187|alcohol dependence|alcohol dependence
5135249|NCT01071187|addiction|addiction
5135250|NCT01071187|alcohol|alcohol
5135251|NCT01071187|relapse prevention|relapse prevention
5135252|NCT01071174|HIV infections|hiv infections
5135253|NCT01071174|Anti-HIV agents|anti-hiv agents
5135254|NCT01071174|HIV-1|hiv-1
5135255|NCT01071161|chronic cough|chronic cough
5135256|NCT01071161|COPD|copd
5135257|NCT01071161|Azithromycin|azithromycin
5135258|NCT01071161|Zithromax|zithromax
5135259|NCT01071161|LCQ|lcq
5135260|NCT01071148|Infertility|infertility
5135261|NCT01071148|Gonal-f|gonal-f
5135262|NCT01071148|Pergoveris|pergoveris
5135263|NCT01071148|Luveris|luveris
5135264|NCT01071122|Central blood pressure|central blood pressure
5135265|NCT01071122|Nifedipine|nifedipine
5135266|NCT01071122|Valsartan|valsartan
5135267|NCT01071109|Therapeutic massage|therapeutic massage
5135268|NCT01071109|massage|massage
5135269|NCT01071109|inflammation|inflammation
5135270|NCT01071109|fatigue|fatigue
5135271|NCT01071109|insomnia|insomnia
5135272|NCT01071109|radiation therapy|radiation therapy
5135273|NCT01071109|breast cancer|breast cancer
5135274|NCT01071109|Breast Cancer patients receiving radiation therapy|breast cancer patients receiving radiation therapy
5135275|NCT01071096|Botox|botox
5135276|NCT01071096|OnabotulinumtoxinA|onabotulinumtoxina
5135277|NCT01071096|Chronic Migraine|chronic migraine
5135278|NCT01071096|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide
5135279|NCT01071096|Saliva|saliva
5135280|NCT01071083|MS|ms
5135281|NCT01071070|Chronic Kidney Disease|chronic kidney disease
5135282|NCT01071070|Secondary hyperparathyroidism|secondary hyperparathyroidism
5135283|NCT01071057|opioid-induced pruritus|opioid-induced pruritus
5135284|NCT01071057|naloxone|naloxone
5135285|NCT01071044|Chronic Fatigue Syndrome|chronic fatigue syndrome
5135286|NCT01071031|Safety|safety
5135287|NCT01071031|Tolerability|tolerability
5135288|NCT01071031|Immunogenicity|immunogenicity
5135289|NCT01071031|Human Immunodeficiency Virus|human immunodeficiency virus
5135290|NCT01071031|HIV-1|hiv-1
5135291|NCT01071031|Vaccine|vaccine
5135292|NCT01071031|CD4|cd4
5135293|NCT01071031|Viral Load|viral load
5135294|NCT01071031|HIV|hiv
5135295|NCT01071018|locally advanced or metastatic solid tumors|locally advanced or metastatic solid tumors
5135296|NCT01071005|Decrease serum levels of luteinizing hormone, FSH and Testosterone|decrease serum levels of luteinizing hormone, fsh and testosterone
5135297|NCT01070966|Atherosclerosis|atherosclerosis
5135298|NCT01070953|Hypercholesterolemia|hypercholesterolemia
5135299|NCT01070940|L-NMMA|l-nmma
5135300|NCT01070940|blood pressure|blood pressure
5135301|NCT01070940|arterial stiffness|arterial stiffness
5135302|NCT01070940|pulse wave velocity|pulse wave velocity
5135303|NCT01070940|augmentation index|augmentation index
5135304|NCT01070940|dose-response|dose-response
5135305|NCT01070940|healthy subjects|healthy subjects
5135306|NCT01070940|GFR|gfr
5135307|NCT01070914|Cilia|cilia
5135308|NCT01070914|Phenotyping|phenotyping
5135309|NCT01070914|Diagnosis|diagnosis
5135310|NCT01070914|Nitric Oxide|nitric oxide
5135311|NCT01070914|Bronchiectasis|bronchiectasis
5135312|NCT01070888|Asthma|asthma
5135313|NCT01070888|Exercise Induced Asthma|exercise induced asthma
5135314|NCT01070875|Antithrombotic prophylaxis|antithrombotic prophylaxis
5135315|NCT01070862|multiple myeloma, treatment, first line|multiple myeloma, treatment, first line
5135316|NCT01070849|exercise|exercise
5135317|NCT01070849|physical activity|physical activity
5135318|NCT01070836|JCV|jcv
5135319|NCT01070836|Sample Collection|sample collection
5135320|NCT01070836|PML|pml
5135321|NCT01070836|Antibody|antibody
5135322|NCT01070823|Sample Collection|sample collection
5135323|NCT01070823|JCV|jcv
5135324|NCT01070823|PML|pml
5135325|NCT01070810|Septic Shock|septic shock
5135326|NCT01070810|Sepsis|sepsis
5135327|NCT01070797|Epstein-Barr virus|epstein-barr virus
5135328|NCT01070797|CTL|ctl
5135329|NCT01070797|cytotoxic T Lymphocytes|cytotoxic t lymphocytes
5135330|NCT01070797|CMV|cmv
5135331|NCT01070797|Adenovirus Infection|adenovirus infection
5135332|NCT01070797|viral infection|viral infection
5135333|NCT01070797|hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
5135334|NCT01070784|Symbicort|symbicort
5135335|NCT01070784|Safety|safety
5135336|NCT01070784|Efficacy|efficacy
5135337|NCT01070784|COPD|copd
5135338|NCT01070784|Japanese|japanese
5135339|NCT01070771|Pressure wire|pressure wire
5135340|NCT01070771|Fractional flow reserve|fractional flow reserve
5135341|NCT01070758|Congenital hyperinsulinism|congenital hyperinsulinism
5135342|NCT01070758|Somatostatin analog|somatostatin analog
5135343|NCT01070758|Lanreotide autogel|lanreotide autogel
5135344|NCT01070758|Hypoglycemia|hypoglycemia
5135345|NCT01070745|PDA|pda
5135346|NCT01070745|Indomethacin|indomethacin
5135347|NCT01070745|Ibuprofen|ibuprofen
5135348|NCT01070732|Fever|fever
5135349|NCT01070732|Infectious diseases|infectious diseases
5135350|NCT01070732|Neoplasia|neoplasia
5135351|NCT01070732|Pain|pain
5135352|NCT01070732|cholecystectomy|cholecystectomy
5135353|NCT01070732|Colectomy|colectomy
5135354|NCT01070719|Multiple Sclerosis, relapsing forms|multiple sclerosis, relapsing forms
5135355|NCT01070706|Patients with HER2- stage II/III breast cancer|patients with her2- stage ii/iii breast cancer
5135356|NCT01070693|Inguinal hernia|inguinal hernia
5135357|NCT01070693|Open mesh repair|open mesh repair
5135358|NCT01070693|Long term outcome|long term outcome
5135359|NCT01070693|Recurrence|recurrence
5135360|NCT01070693|Discomfort|discomfort
5135361|NCT01070680|ERCP|ercp
5135362|NCT01070680|dexmedetomidine|dexmedetomidine
5135363|NCT01070680|propofol|propofol
5135364|NCT01070680|patient-controlled sedation|patient-controlled sedation
5135365|NCT01070680|Chronic Alcoholic pancreatitis|chronic alcoholic pancreatitis
5135366|NCT01070667|PAF|paf
5135367|NCT01070667|AF|af
5135368|NCT01070667|Dronedarone|dronedarone
5135369|NCT01070667|AF Burden|af burden
5135370|NCT01070667|AFB|afb
5135371|NCT01070667|PPM|ppm
5135372|NCT01070667|Permanent Pacemaker|permanent pacemaker
5135373|NCT01070667|Atrial Fibrillation Burden in Paroxysmal Atrial Fibrillation|atrial fibrillation burden in paroxysmal atrial fibrillation
5135374|NCT01070654|ARDS|ards
5135375|NCT01070654|Recruitment Manoeuvres|recruitment manoeuvres
5135376|NCT01070654|PEEP|peep
5135377|NCT01070654|Cytokines|cytokines
5135378|NCT01070654|Respiratory Insufficiency|respiratory insufficiency
5135379|NCT01070641|CARVEDILOL|carvedilol
5135380|NCT01070641|VARICEAL BAND LIGATION|variceal band ligation
5135381|NCT01070641|PRIMARY PROPHYLAXIS|primary prophylaxis
5135382|NCT01070628|Pharmacokinetic|pharmacokinetic
5135383|NCT01070602|IFIS|ifis
5135384|NCT01070589|Obesity|obesity
5135385|NCT01070589|Growth hormone secretion|growth hormone secretion
5135386|NCT01070589|Anaerobic exercise|anaerobic exercise
5135387|NCT01070576|non union|non union
5135388|NCT01070576|fracture|fracture
5135389|NCT01070576|healing|healing
5135390|NCT01070576|arginine|arginine
5135391|NCT01070576|NO|no
5135392|NCT01070563|Brain death|brain death
5135393|NCT01070563|CT angiography|ct angiography
5135394|NCT01070563|Ultrasonography, doppler, transcranial|ultrasonography, doppler, transcranial
5135395|NCT01070537|Otolaryngology|otolaryngology
5135396|NCT01070537|Equipment and Supplies|equipment and supplies
5135397|NCT01070537|Intubation|intubation
5135398|NCT01070511|Muscular Dystrophy|muscular dystrophy
5135399|NCT01070511|Tadalafil|tadalafil
5135400|NCT01070498|peanut hypersensitivity|peanut hypersensitivity
5135401|NCT01070498|tree nut hypersensitivity|tree nut hypersensitivity
5135402|NCT01070498|allergy|allergy
5135403|NCT01070498|Trichuris suis|trichuris suis
5135404|NCT01070498|hygiene hypothesis|hygiene hypothesis
5135405|NCT01070498|treatment|treatment
5135406|NCT01070498|clinical trial|clinical trial
5135407|NCT01070498|food/adverse effect|food/adverse effect
5135408|NCT01070498|peanut allergy (mild to moderate)|peanut allergy (mild to moderate)
5135409|NCT01070498|tree nut allergy (mild to moderate)|tree nut allergy (mild to moderate)
5135410|NCT01070472|labor induction at term using a titrated oral misoprostol solution|labor induction at term using a titrated oral misoprostol solution
5135411|NCT01070459|Stroke aerobic exercise daily functioning rehabilitation|stroke aerobic exercise daily functioning rehabilitation
5135412|NCT01070446|choline|choline
5135413|NCT01070446|cystic fibrosis|cystic fibrosis
5135414|NCT01070446|methyl metabolism|methyl metabolism
5135415|NCT01070446|fatty acids|fatty acids
5135416|NCT01070446|oxidative stress|oxidative stress
5135417|NCT01070446|pulmonary function|pulmonary function
5135418|NCT01070433|Diabetic Foot Ulcers (DFUs)|diabetic foot ulcers (dfus)
5135419|NCT01070420|Adenosine|adenosine
5135420|NCT01070420|Fractional flow reserve, Hyperemia|fractional flow reserve, hyperemia
5135421|NCT01070420|Fractional Flow Reserve, Myocardial|fractional flow reserve, myocardial
5135422|NCT01070407|Hepatitis C virus|hepatitis c virus
5135423|NCT01070407|HCV|hcv
5135424|NCT01070407|Adenovirus|adenovirus
5135425|NCT01070407|Vaccine|vaccine
5135426|NCT01070394|ADHD|adhd
5135427|NCT01070394|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate
5135428|NCT01070394|Amphetamine|amphetamine
5135429|NCT01070368|skin test|skin test
5135430|NCT01070368|open wheat challenge|open wheat challenge
5135431|NCT01070355|Colorectal Neoplasms|colorectal neoplasms
5135432|NCT01070355|Fish Oils|fish oils
5135433|NCT01070355|Fatty Acids, Omega-3|fatty acids, omega-3
5135434|NCT01070355|Eicosapentaenoic Acid|eicosapentaenoic acid
5135435|NCT01070355|Liver Metastases|liver metastases
5135436|NCT01070355|Randomised Controlled Trial|randomised controlled trial
5135437|NCT01070316|Epilepsy|epilepsy
5135438|NCT01070316|Tuberous Sclerosis Complex|tuberous sclerosis complex
5135439|NCT01070316|Everolimus|everolimus
5135440|NCT01070316|RAD001|rad001
5135441|NCT01070316|Mammalian Target of Rapamycin (MTOR)|mammalian target of rapamycin (mtor)
5135442|NCT01070303|HUMIRA|humira
5135443|NCT01070303|adalimumab|adalimumab
5135444|NCT01070303|Inflammatory Bowel Disease|inflammatory bowel disease
5135445|NCT01070290|gastric carcinoma|gastric carcinoma
5135446|NCT01070290|Locally Advanced or Metastatic Gastric Cancer|locally advanced or metastatic gastric cancer
5135447|NCT01070277|chronic diarrhea|chronic diarrhea
5135448|NCT01070277|travelers|travelers
5135449|NCT01070277|Parasites|parasites
5135450|NCT01070277|albendazole|albendazole
5135451|NCT01070277|tinidazole|tinidazole
5135452|NCT01070264|Osteoarthritis|osteoarthritis
5135453|NCT01070238|Isomaltulose|isomaltulose
5135454|NCT01070238|Slow Released Carbohydrates|slow released carbohydrates
5135455|NCT01070238|Postprandial Glucose Metabolism|postprandial glucose metabolism
5135456|NCT01070238|Type 2 diabetes|type 2 diabetes
5135457|NCT01070212|human, chewing, appetite,|human, chewing, appetite,
5135458|NCT01070199|obese, liquid, solid, fitness, humans, appetite|obese, liquid, solid, fitness, humans, appetite
5135459|NCT01070186|nephrectomy|nephrectomy
5135460|NCT01070186|T1b|t1b
5135461|NCT01070186|T2|t2
5135462|NCT01070186|T3|t3
5135463|NCT01070186|T4|t4
5135464|NCT01070186|N1|n1
5135465|NCT01070186|Kidney Cancer|kidney cancer
5135466|NCT01070173|Ghrelin|ghrelin
5135467|NCT01070173|short stature|short stature
5135468|NCT01070173|failure to thrive|failure to thrive
5135469|NCT01070160|Polycystic Ovarian Syndrome (PCOS)|polycystic ovarian syndrome (pcos)
5135470|NCT01070160|Metformin|metformin
5135471|NCT01070160|Endometrin|endometrin
5135472|NCT01070147|asthma|asthma
5135473|NCT01070147|emergency medicine|emergency medicine
5135474|NCT01070147|medical informatics|medical informatics
5135475|NCT01070147|computerized reminder systems|computerized reminder systems
5135476|NCT01070121|Rheumatoid Arthritis|rheumatoid arthritis
5135477|NCT01070121|RA|ra
5135478|NCT01070121|Autoimmune Disease|autoimmune disease
5135479|NCT01070121|Muscular Skeletal Disease|muscular skeletal disease
5135480|NCT01070108|Preemption, ketamine, escalating, dose, pain, analgesia|preemption, ketamine, escalating, dose, pain, analgesia
5135481|NCT01070082|adult ICU patients|adult icu patients
5135482|NCT01070082|procedural pain|procedural pain
5135483|NCT01070082|pain intensity|pain intensity
5135484|NCT01070082|pain distress|pain distress
5135485|NCT01070082|pain behaviors|pain behaviors
5135486|NCT01070082|pain|pain
5135487|NCT01070082|ICU procedures|icu procedures
5135488|NCT01070069|Percutaneous|percutaneous
5135489|NCT01070069|Preclose|preclose
5135490|NCT01070069|Endologix|endologix
5135491|NCT01070069|Abbott Vascular|abbott vascular
5135492|NCT01070069|Endovascular|endovascular
5135493|NCT01070069|PEVAR|pevar
5135494|NCT01070069|Stent graft|stent graft
5135495|NCT01070069|Suture mediated closure devices|suture mediated closure devices
5135496|NCT01070056|Blood Pressure|blood pressure
5135497|NCT01070056|Lifestyle Changes|lifestyle changes
5135498|NCT01070056|African American|african american
5135499|NCT01070043|Hypertension|hypertension
5135500|NCT01070043|valsartan|valsartan
5135501|NCT01070043|amlodipine|amlodipine
5135502|NCT01070043|high blood pressure|high blood pressure
5135503|NCT01070030|Stage II Hypertension, Aliskiren, Amlodipine, Hydrochlorothiazide|stage ii hypertension, aliskiren, amlodipine, hydrochlorothiazide
5135505|NCT01070017|DOT|dot
5135506|NCT01070017|HIV|hiv
5135507|NCT01070017|AIDS|aids
5135508|NCT01070017|Community based|community based
5135509|NCT01070017|social capital|social capital
5135510|NCT01070004|sleepiness|sleepiness
5135511|NCT01070004|driving|driving
5135512|NCT01070004|countermeasures|countermeasures
5135513|NCT01070004|coffee|coffee
5135514|NCT01070004|blue light exposure|blue light exposure
5135515|NCT01070004|physical activity|physical activity
5135516|NCT01069991|Asthma|asthma
5135517|NCT01069991|Adolescents|adolescents
5135518|NCT01069991|Patient Education|patient education
5135519|NCT01069991|Schools|schools
5135520|NCT01069965|Type 2|type 2
5135521|NCT01069952|Deep Brain Stimulation|deep brain stimulation
5135522|NCT01069952|Treatment Refractory|treatment refractory
5135523|NCT01069952|Neurosurgery|neurosurgery
5135524|NCT01069952|Implantable Neurostimulator (INS)|implantable neurostimulator (ins)
5135525|NCT01069952|Internal Capsule|internal capsule
5135526|NCT01069939|Gastric ulcer|gastric ulcer
5135527|NCT01069939|Duodenal ulcer|duodenal ulcer
5135528|NCT01069939|Low-dose aspirin|low-dose aspirin
5135529|NCT01069926|Diabetes|diabetes
5135530|NCT01069913|Healthy Volunteer|healthy volunteer
5135531|NCT01069900|Intra-abdominal infection|intra-abdominal infection
5135532|NCT01069900|Pediatric infection|pediatric infection
5135533|NCT01069887|febrile events|febrile events
5135534|NCT01069887|invasive fungal infections|invasive fungal infections
5135535|NCT01069887|hematological patients|hematological patients
5135536|NCT01069874|Bone Density Conservation Agents|bone density conservation agents
5135537|NCT01069874|Cholecalciferol|cholecalciferol
5135538|NCT01069874|Communicable Diseases|communicable diseases
5135539|NCT01069874|Growth Substances|growth substances
5135540|NCT01069874|Housing for the Elderly|housing for the elderly
5135541|NCT01069874|Infection|infection
5135542|NCT01069874|Micronutrients|micronutrients
5135543|NCT01069874|Pharmacologic Actions|pharmacologic actions
5135544|NCT01069874|Physiological Effects of Drugs|physiological effects of drugs
5135545|NCT01069874|Respiratory Tract Diseases|respiratory tract diseases
5135546|NCT01069874|Vitamins|vitamins
5135547|NCT01069874|Respiratory Tract Infections/prevention & control*|respiratory tract infections/prevention & control*
5135548|NCT01069874|Vitamin D|vitamin d
5135549|NCT01069861|PPHN|pphn
5135550|NCT01069861|neonates|neonates
5135551|NCT01069861|sildanefil IV|sildanefil iv
5135552|NCT01069835|Non small cell lung cancer|non small cell lung cancer
5135553|NCT01069835|EGFR mutation|egfr mutation
5135554|NCT01069835|NSCLC|nsclc
5135555|NCT01069822|Midazolam|midazolam
5135556|NCT01069822|Pharmacokinetics|pharmacokinetics
5135557|NCT01069796|triple negative|triple negative
5135558|NCT01069796|metastatic|metastatic
5135559|NCT01069796|breast cancer|breast cancer
5135560|NCT01069796|First line chemotherapy|first line chemotherapy
5135561|NCT01069783|dyslipidemia|dyslipidemia
5135562|NCT01069783|cholesterol|cholesterol
5135563|NCT01069783|LDL|ldl
5135564|NCT01069770|Neoadjuvant Therapy|neoadjuvant therapy
5135565|NCT01069770|Sunitinib|sunitinib
5135566|NCT01069770|Clear Cell Renal Cell Carcinoma|clear cell renal cell carcinoma
5135567|NCT01069770|Metastasis|metastasis
5135568|NCT01069757|Advanced/recurrent non-small-cell lung cancer|advanced/recurrent non-small-cell lung cancer
5135569|NCT01069705|Tobramycin Inhalation Powder|tobramycin inhalation powder
5135570|NCT01069705|Cystic fibrosis|cystic fibrosis
5135571|NCT01069705|Lung diseases|lung diseases
5135572|NCT01069705|Anti-Bacterial Agents|anti-bacterial agents
5135573|NCT01069705|Treatment of pulmonary infections with P. aeruginosa in cystic fibrosis patients|treatment of pulmonary infections with p. aeruginosa in cystic fibrosis patients
5135574|NCT01069692|Chronic Kidney Disease|chronic kidney disease
5135575|NCT01069692|Hemodialysis|hemodialysis
5135576|NCT01069692|Hyperphosphatemia|hyperphosphatemia
5135577|NCT01069692|Hyperphosphatemia patients with chronic kidney disease on 3x/week hemodialysis|hyperphosphatemia patients with chronic kidney disease on 3x/week hemodialysis
5135578|NCT01069666|atopic dermatitis|atopic dermatitis
5135579|NCT01069666|Thai pediatricians|thai pediatricians
5135580|NCT01069653|CDCA1|cdca1
5135581|NCT01069653|KIF20A|kif20a
5135582|NCT01069653|lung cancer|lung cancer
5135583|NCT01069653|vaccine|vaccine
5135584|NCT01069653|HLA-A*2402|hla-a*2402
5135585|NCT01069640|URLC10|urlc10
5135586|NCT01069640|lung cancer|lung cancer
5135587|NCT01069640|vaccine|vaccine
5135588|NCT01069640|HLA-A*0201|hla-a*0201
5135589|NCT01069640|HLA-A*0206|hla-a*0206
5135590|NCT01069614|Equipment and supplies|equipment and supplies
5135591|NCT01069601|solid organ transplantation|solid organ transplantation
5135592|NCT01069601|bone marrow transplantation|bone marrow transplantation
5135593|NCT01069601|adults|adults
5135594|NCT01069601|adults with solid organ transplantation|adults with solid organ transplantation
5135595|NCT01069601|adults with bone marrow transplantation|adults with bone marrow transplantation
5135596|NCT01069588|bioabsorbable screw|bioabsorbable screw
5135597|NCT01069588|acl reconstruction|acl reconstruction
5135598|NCT01069575|URLC10|urlc10
5135599|NCT01069575|CDCA1|cdca1
5135600|NCT01069575|KIF20A|kif20a
5135601|NCT01069575|lung cancer|lung cancer
5135602|NCT01069575|vaccine|vaccine
5135603|NCT01069575|HLA-A*2402|hla-a*2402
5135604|NCT01069562|closed loop control of anesthesia|closed loop control of anesthesia
5135605|NCT01069562|isoflurane|isoflurane
5135606|NCT01069562|open heart surgery|open heart surgery
5135607|NCT01069549|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
5135608|NCT01069549|Diabetic Nephropathy|diabetic nephropathy
5135609|NCT01069549|Angiotensin II type 1 receptor gene polymorphism|angiotensin ii type 1 receptor gene polymorphism
5135610|NCT01069549|Acetyl coA carboxylase beta gene polymorphism.|acetyl coa carboxylase beta gene polymorphism.
5135611|NCT01069536|metoclopramide|metoclopramide
5135612|NCT01069536|akathisia|akathisia
5135613|NCT01069536|nausea|nausea
5135614|NCT01069536|vomiting|vomiting
5135615|NCT01069536|antiemetic|antiemetic
5135616|NCT01069536|improvement of nausea|improvement of nausea
5135617|NCT01069523|Attention Deficit Disorder with Hyperactivity|attention deficit disorder with hyperactivity
5135618|NCT01069523|Guanfacine|guanfacine
5135619|NCT01069523|Event Related Potentials|event related potentials
5135620|NCT01069497|Infection control|infection control
5135621|NCT01069497|Urinary Tract Infections|urinary tract infections
5135622|NCT01069497|Respiratory Tract Infections|respiratory tract infections
5135623|NCT01069484|Randomized controlled trial|randomized controlled trial
5135624|NCT01069484|Post partum pelvic floor muscle training|post partum pelvic floor muscle training
5135625|NCT01069484|Urinary incontinence|urinary incontinence
5135626|NCT01069484|Pelvic floor dysfunction|pelvic floor dysfunction
5135627|NCT01069484|Pelvic floor muscle injury|pelvic floor muscle injury
5135628|NCT01069484|Pelvic floor muscle strength|pelvic floor muscle strength
5135629|NCT01069484|Pelvic floor muscle morphology|pelvic floor muscle morphology
5135630|NCT01069471|S.dysenteriae|s.dysenteriae
5135631|NCT01069471|Healthy volunteers|healthy volunteers
5135632|NCT01069471|Conjugate vaccine|conjugate vaccine
5135633|NCT01069471|Safety|safety
5135634|NCT01069471|Immunogenicity|immunogenicity
5135635|NCT01069471|Dose scaling|dose scaling
5135636|NCT01069458|Dietary intervention|dietary intervention
5135637|NCT01069458|Smoking cessation|smoking cessation
5135638|NCT01069458|Body weight|body weight
5135639|NCT01069445|diet|diet
5135640|NCT01069445|probiotics|probiotics
5135641|NCT01069445|inflammaging|inflammaging
5135642|NCT01069445|oxidative stress|oxidative stress
5135643|NCT01069445|gut microbiota|gut microbiota
5135644|NCT01069445|food complements|food complements
5135645|NCT01069432|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
5135646|NCT01069432|CLL|cll
5135647|NCT01069432|Normal Volunteers|normal volunteers
5135648|NCT01069419|Certolizumab Pegol|certolizumab pegol
5135649|NCT01069419|Cimzia|cimzia
5135650|NCT01069406|notch|notch
5135651|NCT01069406|uterine|uterine
5135652|NCT01069406|first|first
5135653|NCT01069406|bleeding|bleeding
5135654|NCT01069380|resting metabolic rate|resting metabolic rate
5135655|NCT01069380|bed ridden, vegetative|bed ridden, vegetative
5135656|NCT01069380|low conscious|low conscious
5135657|NCT01069380|minimal conscious state|minimal conscious state
5135658|NCT01069380|immobilized|immobilized
5135659|NCT01069380|resting energy expenditure|resting energy expenditure
5135660|NCT01069367|Influenza A|influenza a
5135661|NCT01069367|H1N1 subtype|h1n1 subtype
5135662|NCT01069367|Children/adolescent|children/adolescent
5135663|NCT01069367|Vaccine|vaccine
5135664|NCT01069367|Adjuvant|adjuvant
5135665|NCT01069367|Cell culture|cell culture
5135666|NCT01069354|Moderate to severe wrinkles and folds such as nasolabial folds|moderate to severe wrinkles and folds such as nasolabial folds
5135667|NCT01069341|Rubeosis|rubeosis
5135668|NCT01069341|Neovascularization of iris|neovascularization of iris
5135669|NCT01069341|Proliferative diabetic retinopathy|proliferative diabetic retinopathy
5135670|NCT01069341|PDR|pdr
5135671|NCT01069341|Cataract|cataract
5135672|NCT01069328|Lung|lung
5135673|NCT01069328|cancer|cancer
5135674|NCT01069328|NSCLC|nsclc
5135675|NCT01069315|open wound|open wound
5135676|NCT01069315|solution|solution
5135677|NCT01069315|pressure|pressure
5135678|NCT01069315|randomized|randomized
5135679|NCT01069302|Coronary artery disease|coronary artery disease
5135680|NCT01069289|Symbicort|symbicort
5135681|NCT01069289|Oxis|oxis
5135682|NCT01069289|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5135683|NCT01069289|COPD|copd
5135684|NCT01069289|Efficacy|efficacy
5135685|NCT01069276|Stroke|stroke
5135686|NCT01069276|prehospital ultrasound|prehospital ultrasound
5135687|NCT01069263|Interstitial cystitis|interstitial cystitis
5135688|NCT01069263|Painful bladder syndrome|painful bladder syndrome
5135689|NCT01069263|Chronic pelvic pain|chronic pelvic pain
5135690|NCT01069263|DMSO|dmso
5135691|NCT01069263|Hyperbaric oxygen therapy|hyperbaric oxygen therapy
5135692|NCT01069250|dynamic cerebrovascular autoregulation|dynamic cerebrovascular autoregulation
5135693|NCT01069250|static cerebrovascular autoregulation|static cerebrovascular autoregulation
5135694|NCT01069250|acute brain injury|acute brain injury
5135695|NCT01069250|transcranial Doppler ultrasound|transcranial doppler ultrasound
5135696|NCT01069250|critical care|critical care
5135697|NCT01069237|contact lens wear|contact lens wear
5135698|NCT01069237|multi-purpose solution|multi-purpose solution
5135699|NCT01069237|corneal staining|corneal staining
5135700|NCT01069224|rotator cuff|rotator cuff
5135701|NCT01069224|synovial fluid|synovial fluid
5135702|NCT01069224|proinflammatory cytokines|proinflammatory cytokines
5135703|NCT01069211|Breast cancer, Letrozole|breast cancer, letrozole
5135704|NCT01069211|postmenopause|postmenopause
5135705|NCT01069211|hormone receptor positive breast cancer|hormone receptor positive breast cancer
5135706|NCT01069198|Visceral leishmaniasis|visceral leishmaniasis
5135707|NCT01069198|Kala-azar|kala-azar
5135708|NCT01069198|Bangladesh|bangladesh
5135709|NCT01069198|Malnutrition|malnutrition
5135710|NCT01069198|Asymptomatic|asymptomatic
5135711|NCT01069198|Albendazole|albendazole
5135712|NCT01069198|Iron|iron
5135713|NCT01069198|Zinc|zinc
5135714|NCT01069198|Vitamin A|vitamin a
5135715|NCT01069185|Unplanned extubation|unplanned extubation
5135716|NCT01069185|Length of stay in PICU|length of stay in picu
5135717|NCT01069185|Length of mechanical ventilation|length of mechanical ventilation
5135718|NCT01069172|Cataract|cataract
5135719|NCT01069172|Surgery, cataract extraction|surgery, cataract extraction
5135720|NCT01069172|Optical devices, laser|optical devices, laser
5135721|NCT01069159|Traumatic memory|traumatic memory
5135722|NCT01069159|Traumatic memories|traumatic memories
5135723|NCT01069159|Traumatic memories and associated symptoms|traumatic memories and associated symptoms
5135724|NCT01069159|Posttraumatic Stress Disorder|posttraumatic stress disorder
5135725|NCT01069159|PTSD|ptsd
5135726|NCT01069146|sepsis,|sepsis,
5135727|NCT01069146|septic shock,|septic shock,
5135728|NCT01069146|therapeutic hypothermia|therapeutic hypothermia
5135729|NCT01069133|minimal hepatic encephalopathy|minimal hepatic encephalopathy
5135730|NCT01069133|cirrhosis|cirrhosis
5135731|NCT01069133|complications|complications
5135732|NCT01069120|Uterine Fibroids|uterine fibroids
5135733|NCT01069107|community hospital|community hospital
5135734|NCT01069107|alternative acute admissions|alternative acute admissions
5135735|NCT01069094|Uterine fibroids|uterine fibroids
5135736|NCT01069081|Metastasis Breast Cancer|metastasis breast cancer
5135737|NCT01069081|Proton Pump Inhibitor|proton pump inhibitor
5135738|NCT01069081|Chemotherapy|chemotherapy
5135739|NCT01069081|Phase II study|phase ii study
5135740|NCT01069081|TTP|ttp
5135863|NCT01068431|conservative treatment|conservative treatment
5135741|NCT01069068|To evaluate the effect of advancing Jaw on airway dimension|to evaluate the effect of advancing jaw on airway dimension
5135742|NCT01069055|inguinal hernia|inguinal hernia
5135743|NCT01069055|surgery|surgery
5135744|NCT01069055|general anesthesia|general anesthesia
5135745|NCT01069055|analgesia|analgesia
5135746|NCT01069055|pre-emptive|pre-emptive
5135747|NCT01069055|SF36|sf36
5135748|NCT01069042|Rho kinase activity|rho kinase activity
5135749|NCT01069042|Heart failure|heart failure
5135750|NCT01069042|ACE inhibitor|ace inhibitor
5135751|NCT01069042|LVEF change|lvef change
5135752|NCT01069042|Rho kinase activity change|rho kinase activity change
5135753|NCT01069029|Macular Hole|macular hole
5135754|NCT01069029|Cataract surgery|cataract surgery
5135755|NCT01069029|Vitreoretinal surgery|vitreoretinal surgery
5135756|NCT01069029|Combined surgery|combined surgery
5135757|NCT01069029|Idiopathic|idiopathic
5135758|NCT01069016|Fecal Incontinence|fecal incontinence
5135759|NCT01069016|Colorectal surgery|colorectal surgery
5135760|NCT01069016|Sacral nerve stimulation|sacral nerve stimulation
5135761|NCT01069016|Pudendal nerve stimulation|pudendal nerve stimulation
5135762|NCT01069003|Heart Disease|heart disease
5135763|NCT01069003|Cardiovascular Disease|cardiovascular disease
5135764|NCT01069003|Platelet Aggregation Inhibitors|platelet aggregation inhibitors
5135765|NCT01069003|Dual Antiplatelet Therapy|dual antiplatelet therapy
5135766|NCT01069003|Clopidogrel|clopidogrel
5135767|NCT01069003|Prasugrel|prasugrel
5135768|NCT01069003|Vascular Disease|vascular disease
5135769|NCT01069003|Myocardial Ischemia|myocardial ischemia
5135770|NCT01068990|pneumonia|pneumonia
5135771|NCT01068951|type 1 diabetes|type 1 diabetes
5135772|NCT01068951|mesenchymal stem cells|mesenchymal stem cells
5135773|NCT01068951|intervention|intervention
5135774|NCT01068938|visual field|visual field
5135775|NCT01068938|perimetry|perimetry
5135776|NCT01068938|glaucoma progression|glaucoma progression
5135777|NCT01068938|grid|grid
5135778|NCT01068938|POAG and glaucoma suspects with prostaglandin monotherapy|poag and glaucoma suspects with prostaglandin monotherapy
5135779|NCT01068925|healthy volunteer|healthy volunteer
5135780|NCT01068925|pharmacokinetics|pharmacokinetics
5135781|NCT01068925|HIV, GSK1349572, tipranavir, ritonavir, drug interaction|hiv, gsk1349572, tipranavir, ritonavir, drug interaction
5135782|NCT01068912|Influenza|influenza
5135783|NCT01068899|healthy adults|healthy adults
5135784|NCT01068899|healthy children|healthy children
5135785|NCT01068886|Pancreaticoduodenectomy|pancreaticoduodenectomy
5135787|NCT01068873|Protease Inhibitor|protease inhibitor
5135788|NCT01068873|CCR5 Co-receptor Antagonist|ccr5 co-receptor antagonist
5135789|NCT01068873|treatment naive|treatment naive
5135790|NCT01068860|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
5135791|NCT01068860|canakinumab|canakinumab
5135792|NCT01068860|Pre diabetic|pre diabetic
5135793|NCT01068860|glucose intolerant|glucose intolerant
5135794|NCT01068860|oral anti diabetic medication|oral anti diabetic medication
5135795|NCT01068860|insulin treatment|insulin treatment
5135796|NCT01068860|metabolic syndrome|metabolic syndrome
5135797|NCT01068847|Opioid dependence|opioid dependence
5135798|NCT01068847|methadone|methadone
5135799|NCT01068847|opioid|opioid
5135800|NCT01068834|Adherence|adherence
5135801|NCT01068834|Statins|statins
5135802|NCT01068834|Kinesin-like protein 6|kinesin-like protein 6
5135803|NCT01068821|Slide|slide
5135804|NCT01068821|Trendelenburg's position|trendelenburg's position
5135805|NCT01068821|Postoperative|postoperative
5135806|NCT01068821|neurologic complaints|neurologic complaints
5135807|NCT01068808|Nonallergic rhinitis|nonallergic rhinitis
5135808|NCT01068808|Allergic rhinitis|allergic rhinitis
5135809|NCT01068808|Development|development
5135810|NCT01068795|placental syndrome|placental syndrome
5135811|NCT01068795|maternal thromboembolic event|maternal thromboembolic event
5135812|NCT01068795|enoxaparin|enoxaparin
5135813|NCT01068795|anti-factor Xa|anti-factor xa
5135814|NCT01068782|Glioblastoma|glioblastoma
5135815|NCT01068782|Glioma|glioma
5135816|NCT01068782|Brain Cancer|brain cancer
5135817|NCT01068782|Brain Tumor|brain tumor
5135818|NCT01068782|Astrocytoma|astrocytoma
5135819|NCT01068769|regorafenib|regorafenib
5135820|NCT01068769|GIST|gist
5135821|NCT01068691|aortic dissection|aortic dissection
5135822|NCT01068691|ambulatory blood pressure|ambulatory blood pressure
5135823|NCT01068691|obstructive sleep apnea syndrome|obstructive sleep apnea syndrome
5135824|NCT01068691|patients undergoing surgery for a dissection of the thoracic aorta|patients undergoing surgery for a dissection of the thoracic aorta
5135825|NCT01068613|COPD|copd
5135826|NCT01068613|Long acting muscarinic antagonist|long acting muscarinic antagonist
5135827|NCT01068600|COPD|copd
5135828|NCT01068600|Indacaterol|indacaterol
5135829|NCT01068587|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5135830|NCT01068587|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5135831|NCT01068587|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5135832|NCT01068587|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5135833|NCT01068574|Acute illnesses in children under five|acute illnesses in children under five
5135834|NCT01068561|Retinitis pigmentosa|retinitis pigmentosa
5135835|NCT01068561|stem cell|stem cell
5135836|NCT01068561|bone marrow|bone marrow
5135837|NCT01068535|metabolic syndrome|metabolic syndrome
5135838|NCT01068535|MetS|mets
5135839|NCT01068535|premenopausal women|premenopausal women
5135840|NCT01068535|vascular risk|vascular risk
5135841|NCT01068535|atherosclerosis detection|atherosclerosis detection
5135842|NCT01068522|Intracranial pressure|intracranial pressure
5135843|NCT01068522|Intracranial pressure monitoring|intracranial pressure monitoring
5135844|NCT01068522|Head injury|head injury
5135845|NCT01068509|Cvac|cvac
5135846|NCT01068483|Advanced solid tumors|advanced solid tumors
5135847|NCT01068483|Breast Cancer|breast cancer
5135848|NCT01068483|Colon Cancer|colon cancer
5135849|NCT01068483|Ovarian Cancer|ovarian cancer
5135850|NCT01068483|Endometrium cancer|endometrium cancer
5135851|NCT01068470|Interleukin-2|interleukin-2
5135852|NCT01068470|Melanoma|melanoma
5135853|NCT01068470|Kidney Cancer|kidney cancer
5135854|NCT01068470|Lymphokine Activated Killer cells|lymphokine activated killer cells
5135855|NCT01068457|persistent pain|persistent pain
5135856|NCT01068457|neuropathic pain|neuropathic pain
5135857|NCT01068457|Thoracic Surgery, Video Assisted|thoracic surgery, video assisted
5135858|NCT01068457|Chronic Pain|chronic pain
5135859|NCT01068444|NASH|nash
5135860|NCT01068444|Pioglitazone|pioglitazone
5135861|NCT01068444|Treatment|treatment
5135862|NCT01068431|lymphedema|lymphedema
5135864|NCT01068431|compression therapy|compression therapy
5135865|NCT01068431|interface pressure|interface pressure
5135866|NCT01068418|Obesity|obesity
5135867|NCT01068418|Renin Angiotensin System|renin angiotensin system
5135868|NCT01068418|Vitamin D deficiency|vitamin d deficiency
5135869|NCT01068418|Hypertension|hypertension
5135870|NCT01068392|relapsed|relapsed
5135871|NCT01068392|marginal zone B-cell lymphoma|marginal zone b-cell lymphoma
5135872|NCT01068392|oxaliplatin|oxaliplatin
5135873|NCT01068392|prednisolone|prednisolone
5135874|NCT01068379|rhegmatogenous retinal detachment|rhegmatogenous retinal detachment
5135875|NCT01068379|cryopexy|cryopexy
5135876|NCT01068379|photocoagulation|photocoagulation
5135877|NCT01068366|Nickel Allergic Syndrome|nickel allergic syndrome
5135878|NCT01068366|Septal Closure Devices|septal closure devices
5135879|NCT01068353|Alzheimer's disease|alzheimer's disease
5135880|NCT01068353|Dementia|dementia
5135881|NCT01068353|TNF-alpha|tnf-alpha
5135882|NCT01068353|Etanercept|etanercept
5135883|NCT01068340|Adhesions|adhesions
5135884|NCT01068340|Small Bowel Obstruction|small bowel obstruction
5135885|NCT01068340|Ileus|ileus
5135886|NCT01068314|Endothelium|endothelium
5135887|NCT01068314|Vasodilatation|vasodilatation
5135888|NCT01068314|Vein|vein
5135889|NCT01068314|Compliance|compliance
5135890|NCT01068314|Arteriovenous shunt, surgical|arteriovenous shunt, surgical
5135891|NCT01068301|Allogeneic Stem Cell transplantation|allogeneic stem cell transplantation
5135892|NCT01068301|Plerixafor|plerixafor
5135988|NCT01067950|intensive insulin therapy|intensive insulin therapy
5135893|NCT01068301|Acute Lymphoblastic leukemia|acute lymphoblastic leukemia
5135894|NCT01068301|Acute Myeloid leukemia|acute myeloid leukemia
5135895|NCT01068301|Chronic Myeloid leukemia|chronic myeloid leukemia
5135896|NCT01068301|Myelodysplastic Syndrome|myelodysplastic syndrome
5135897|NCT01068301|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
5135898|NCT01068301|Other Leukemia|other leukemia
5135899|NCT01068288|laparoscopic appendectomy|laparoscopic appendectomy
5135900|NCT01068288|open appendectomy|open appendectomy
5135901|NCT01068288|expectant management|expectant management
5135902|NCT01068288|paediatric|paediatric
5135903|NCT01068275|anterior cruciate ligament|anterior cruciate ligament
5135904|NCT01068275|pain, postoperative|pain, postoperative
5135905|NCT01068275|peripheral nerve catheter|peripheral nerve catheter
5135906|NCT01068275|nerve block|nerve block
5135907|NCT01068275|Children undergoing anterior cruciate ligament repair|children undergoing anterior cruciate ligament repair
5135908|NCT01068249|Advanced|advanced
5135909|NCT01068249|Recurrent|recurrent
5135910|NCT01068249|Progressive|progressive
5135911|NCT01068249|Endometrial Cancer|endometrial cancer
5135912|NCT01068249|Letrozole|letrozole
5135913|NCT01068249|RAD001|rad001
5135914|NCT01068249|Afinitor|afinitor
5135915|NCT01068249|Everolimus|everolimus
5135916|NCT01068249|Femara|femara
5135917|NCT01068236|Teen girls|teen girls
5135918|NCT01068236|weightloss|weightloss
5135919|NCT01068236|healthy lifestyle|healthy lifestyle
5135920|NCT01068236|yoga|yoga
5135921|NCT01068236|Weight loss and healthy lifestyle|weight loss and healthy lifestyle
5135922|NCT01068223|Cetirizine, CR016609|cetirizine, cr016609
5135923|NCT01068210|Exercise Intervention|exercise intervention
5135924|NCT01068210|Lung Cancer|lung cancer
5135925|NCT01068210|15-215|15-215
5135926|NCT01068197|Low Glycemic Load diet|low glycemic load diet
5135927|NCT01068197|Low Glycemic Index diet|low glycemic index diet
5135928|NCT01068197|Low Fat diet|low fat diet
5135929|NCT01068197|Obese Hispanic American children and adolescents|obese hispanic american children and adolescents
5135930|NCT01068197|At risk for type 2 diabetes mellitus|at risk for type 2 diabetes mellitus
5135931|NCT01068184|AZD6553|azd6553
5135932|NCT01068184|Chronic|chronic
5135933|NCT01068184|obstructive|obstructive
5135934|NCT01068184|pulmonary|pulmonary
5135935|NCT01068184|lung|lung
5135936|NCT01068184|respiratory disease|respiratory disease
5135937|NCT01068184|placebo-controlled|placebo-controlled
5135938|NCT01068184|COPD|copd
5135939|NCT01068184|Healthy Volunteers|healthy volunteers
5135940|NCT01068184|COPD Patients|copd patients
5135941|NCT01068171|diabetes|diabetes
5135942|NCT01068171|foot ulcers|foot ulcers
5135943|NCT01068171|off-loading|off-loading
5135944|NCT01068171|collagen|collagen
5135945|NCT01068171|Wagner 1|wagner 1
5135946|NCT01068158|Head lice infestation|head lice infestation
5135947|NCT01068158|Pediculus humanus capitis|pediculus humanus capitis
5135948|NCT01068145|COPD|copd
5135949|NCT01068132|Colorectal Neoplasms|colorectal neoplasms
5135950|NCT01068132|KRAS|kras
5135951|NCT01068132|PTEN|pten
5135952|NCT01068119|Acute coronary syndrome|acute coronary syndrome
5135953|NCT01068119|percutaneous coronary angioplasty|percutaneous coronary angioplasty
5135954|NCT01068119|Troponin negative|troponin negative
5135955|NCT01068119|cardiac|cardiac
5135956|NCT01068080|fatty acid metabolism|fatty acid metabolism
5135957|NCT01068080|insulin resistance|insulin resistance
5135958|NCT01068080|cardiac death|cardiac death
5135959|NCT01068080|hemodialysis|hemodialysis
5135960|NCT01068080|normal coronary arteries|normal coronary arteries
5135961|NCT01068080|Predictive values of impaired myocardial fatty acid metabolism or insulin resistance for cardiac death of hemodialysis patients with normal coronary arteries|predictive values of impaired myocardial fatty acid metabolism or insulin resistance for cardiac death of hemodialysis patients with normal coronary arteries
5135962|NCT01068054|vernal keratoconjunctivitis|vernal keratoconjunctivitis
5135963|NCT01068054|FK-506|fk-506
5135964|NCT01068054|tacrolimus|tacrolimus
5135965|NCT01068054|cyclosporine|cyclosporine
5135966|NCT01068054|children|children
5135967|NCT01068028|Healthy volunteer study|healthy volunteer study
5135968|NCT01068015|MSM|msm
5135969|NCT01068015|Intervention|intervention
5135970|NCT01068015|Popular Opinion Leader|popular opinion leader
5135971|NCT01068015|Male Circumcision|male circumcision
5135972|NCT01068015|HIV|hiv
5135973|NCT01068015|Syphilis|syphilis
5135974|NCT01068015|HSV-2|hsv-2
5135975|NCT01068002|Hypertension Pregnancy|hypertension pregnancy
5135976|NCT01067989|metronomic chemotherapy|metronomic chemotherapy
5135977|NCT01067989|anti-angiogenic effect|anti-angiogenic effect
5135978|NCT01067989|Breast cancer|breast cancer
5135979|NCT01067976|Breast Cancer|breast cancer
5135980|NCT01067976|Gadobutrol-enhanced MRI|gadobutrol-enhanced mri
5135981|NCT01067976|Mammography|mammography
5135982|NCT01067963|self-care|self-care
5135983|NCT01067963|self-management|self-management
5135984|NCT01067963|health behavior change|health behavior change
5135985|NCT01067963|motivational interviewing|motivational interviewing
5135986|NCT01067963|computer assisted learning|computer assisted learning
5136109|NCT01067404|Influenza vaccines|influenza vaccines
5135987|NCT01067950|isolated pancreas transplant|isolated pancreas transplant
5136279|NCT01066728|prematurity|prematurity
5135989|NCT01067937|Appendicitis|appendicitis
5135990|NCT01067937|children|children
5135991|NCT01067924|Type 2 diabetes, motivational interviewing, physical activity maintenance, physical activity adherence|type 2 diabetes, motivational interviewing, physical activity maintenance, physical activity adherence
5135992|NCT01067911|Postprandial lipids|postprandial lipids
5135993|NCT01067911|test meal|test meal
5135994|NCT01067911|fatty acids|fatty acids
5135995|NCT01067898|vitamin D supplementation|vitamin d supplementation
5135996|NCT01067898|cholecalciferol|cholecalciferol
5135997|NCT01067898|PTH|pth
5135998|NCT01067898|bone turnover markers|bone turnover markers
5135999|NCT01067898|elderly women|elderly women
5136000|NCT01067885|Nitinol Stent|nitinol stent
5136001|NCT01067885|Superficial femoral artery|superficial femoral artery
5136002|NCT01067885|SFA|sfa
5136003|NCT01067885|Angioplasty|angioplasty
5136004|NCT01067885|peripheral artery disease|peripheral artery disease
5136005|NCT01067885|peripheral artery obstructive disease|peripheral artery obstructive disease
5136006|NCT01067885|PAOD|paod
5136007|NCT01067885|PAD|pad
5136008|NCT01067885|Peripheral Vascular Disease|peripheral vascular disease
5136009|NCT01067859|Heart Failure|heart failure
5136010|NCT01067846|cocaine dependence|cocaine dependence
5136011|NCT01067846|relapse prevention|relapse prevention
5136012|NCT01067846|computerized cognitive behavioral therapy (CBT)|computerized cognitive behavioral therapy (cbt)
5136013|NCT01067846|D-cycloserine (DCS)|d-cycloserine (dcs)
5136014|NCT01067833|atrial fibrillation|atrial fibrillation
5136015|NCT01067833|AF|af
5136016|NCT01067820|ApolipoproteinA1|apolipoproteina1
5136017|NCT01067820|HDL-C|hdl-c
5136018|NCT01067820|Atherosclerosis|atherosclerosis
5136019|NCT01067807|Pharmacokinetics|pharmacokinetics
5136020|NCT01067794|Metastatic|metastatic
5136021|NCT01067794|Advanced|advanced
5136022|NCT01067794|Stage IIIB-IV|stage iiib-iv
5136023|NCT01067794|daily|daily
5136024|NCT01067794|hospital|hospital
5136025|NCT01067794|practice|practice
5136026|NCT01067794|setting|setting
5136027|NCT01067781|Prevention of Travelers' Diarrhea|prevention of travelers' diarrhea
5136028|NCT01067768|Urinary Tract Infections|urinary tract infections
5136029|NCT01067768|Catheter-associated urinary tract infections|catheter-associated urinary tract infections
5136030|NCT01067768|Prevention and control|prevention and control
5136031|NCT01067768|Controlled clinical trial|controlled clinical trial
5136032|NCT01067755|navigation|navigation
5136033|NCT01067755|bronchoscopy|bronchoscopy
5136034|NCT01067755|lymphadenopathy|lymphadenopathy
5136035|NCT01067742|Mucolipidosis, retinal dystrophy, mucolipin-1,|mucolipidosis, retinal dystrophy, mucolipin-1,
5136036|NCT01067742|lysosomal storage disease, gastrin, mental retardation,|lysosomal storage disease, gastrin, mental retardation,
5136037|NCT01067742|dysmyelination, dysplastic corpus callosum,corneal clouding|dysmyelination, dysplastic corpus callosum,corneal clouding
5136038|NCT01067729|Burn|burn
5136039|NCT01067729|Superficial burns|superficial burns
5136040|NCT01067729|Partial thickness burns|partial thickness burns
5136041|NCT01067729|Rate of healing|rate of healing
5136042|NCT01067729|Infection rate|infection rate
5136043|NCT01067729|Pain perception|pain perception
5136044|NCT01067729|Non adherence|non adherence
5136045|NCT01067729|Scarring|scarring
5136046|NCT01067703|remote ischaemic preconditioning, cardiac surgery|remote ischaemic preconditioning, cardiac surgery
5136047|NCT01067690|classical Kaposi's sarcoma|classical kaposi's sarcoma
5136048|NCT01067690|chemotherapy|chemotherapy
5136049|NCT01067690|indinavir|indinavir
5136050|NCT01067690|HIV protease inhibitor|hiv protease inhibitor
5136051|NCT01067690|Advanced classical (non HIV-associated) Kaposi's sarcoma|advanced classical (non hiv-associated) kaposi's sarcoma
5136052|NCT01067677|PONV|ponv
5136053|NCT01067677|Post operative nausea and vomiting|post operative nausea and vomiting
5136054|NCT01067677|rescue emetic therapy|rescue emetic therapy
5136055|NCT01067599|Biomarkers of tobacco exposure|biomarkers of tobacco exposure
5136056|NCT01067599|Smokeless Tobacco|smokeless tobacco
5136057|NCT01067586|Smokeless Tobacco|smokeless tobacco
5136058|NCT01067586|Biomarkers of tobacco exposure|biomarkers of tobacco exposure
5136059|NCT01067573|MS|ms
5136060|NCT01067573|Serum Leptin Levels during relapse|serum leptin levels during relapse
5136061|NCT01067573|Multiple sclerosis|multiple sclerosis
5136062|NCT01067573|relapse|relapse
5136063|NCT01067560|Glucose|glucose
5136064|NCT01067560|CSF|csf
5136065|NCT01067560|Cesarean section, spinal anesthesia|cesarean section, spinal anesthesia
5136066|NCT01067560|Nova Stat Strip|nova stat strip
5136067|NCT01067560|Abbott Precision Xtra|abbott precision xtra
5136068|NCT01067560|Roche Accucheck Inform 2|roche accucheck inform 2
5136069|NCT01067547|Iron deficiency|iron deficiency
5136070|NCT01067547|Inflammatory Bowel Disease|inflammatory bowel disease
5136071|NCT01067547|Crohn's Disease|crohn's disease
5136072|NCT01067547|Ulcerative colitis|ulcerative colitis
5136073|NCT01067521|Relapsing Remitting Multiple Sclerosis|relapsing remitting multiple sclerosis
5136074|NCT01067521|Glatiramer Acetate|glatiramer acetate
5136075|NCT01067495|stroke|stroke
5136076|NCT01067495|rehabilitation|rehabilitation
5136077|NCT01067495|exercise|exercise
5136078|NCT01067495|walking|walking
5136079|NCT01067495|risk factors|risk factors
5136080|NCT01067482|OCT|oct
5136081|NCT01067482|spectral domain cirrus|spectral domain cirrus
5136082|NCT01067482|glaucoma|glaucoma
5136083|NCT01067482|glaucoma suspect|glaucoma suspect
5136084|NCT01067482|normal population|normal population
5136085|NCT01067469|CNS|cns
5136086|NCT01067469|Central Nervous System|central nervous system
5136087|NCT01067469|malignant brain tumor|malignant brain tumor
5136088|NCT01067469|Recurrent Glioblastoma Multiforme|recurrent glioblastoma multiforme
5136089|NCT01067469|GBM|gbm
5136090|NCT01067469|Bevacizumab|bevacizumab
5136091|NCT01067469|Lomustine|lomustine
5136092|NCT01067469|CCNU|ccnu
5136093|NCT01067443|Phase II|phase ii
5136094|NCT01067443|Randomised clinical trial|randomised clinical trial
5136095|NCT01067443|Visceral Leishmaniasis|visceral leishmaniasis
5136096|NCT01067430|Rheumatoid Arthritis|rheumatoid arthritis
5136097|NCT01067430|Etoricoxib|etoricoxib
5136098|NCT01067430|Diclofenac|diclofenac
5136099|NCT01067430|Pain|pain
5136100|NCT01067430|Stiffness|stiffness
5136101|NCT01067417|Hydroxychloroquine|hydroxychloroquine
5136102|NCT01067417|Chloroquine|chloroquine
5136103|NCT01067417|HIV Infection|hiv infection
5136104|NCT01067417|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5136105|NCT01067417|Immune Activation|immune activation
5136106|NCT01067417|inflammation|inflammation
5136107|NCT01067417|treatment naive|treatment naive
5136108|NCT01067417|disease progression|disease progression
5136110|NCT01067404|Infant|infant
5136111|NCT01067404|Dose-Response relationship, immunologic|dose-response relationship, immunologic
5136112|NCT01067391|Hypotension in SCI males|hypotension in sci males
5136113|NCT01067391|Erectile Dysfunction|erectile dysfunction
5136114|NCT01067378|Interdisciplinary Health Team|interdisciplinary health team
5136115|NCT01067378|Training|training
5136116|NCT01067365|Secondary Hypogonadism|secondary hypogonadism
5136117|NCT01067352|Infant, small for gestational age|infant, small for gestational age
5136118|NCT01067352|Growth hormone|growth hormone
5136119|NCT01067352|Saizen|saizen
5136120|NCT01067339|coronary endothelial dysfunction|coronary endothelial dysfunction
5136121|NCT01067339|coronary vasospasm|coronary vasospasm
5136122|NCT01067326|Endothelial Dysfunction|endothelial dysfunction
5136123|NCT01067326|Endothelial Function|endothelial function
5136124|NCT01067326|Tekturna|tekturna
5136125|NCT01067326|Endothelial Peripheral Arterial Tomography (EndoPAT)|endothelial peripheral arterial tomography (endopat)
5136126|NCT01067326|Progenitor Cells|progenitor cells
5136127|NCT01067326|renin inhibition|renin inhibition
5136128|NCT01067326|endothelial progenitor cells|endothelial progenitor cells
5136129|NCT01067326|early atherosclerosis|early atherosclerosis
5136130|NCT01067313|Intensive Care Unit|intensive care unit
5136131|NCT01067313|continuous hemodialysis|continuous hemodialysis
5136132|NCT01067313|continuous hemofiltration|continuous hemofiltration
5136133|NCT01067313|High Cut-off membrane|high cut-off membrane
5136134|NCT01067313|"Enhanced middle molecule clearance membrane"|"enhanced middle molecule clearance membrane"
5136135|NCT01067313|Septic shock|septic shock
5136136|NCT01067313|Acute kidney injury|acute kidney injury
5136137|NCT01067313|Blood purification|blood purification
5136138|NCT01067313|Renal replacement therapy|renal replacement therapy
5136139|NCT01067300|young|young
5136140|NCT01067300|acute leukemia in remission|acute leukemia in remission
5136141|NCT01067300|Children or young adults (< 35 years) with acute leukemia in remission|children or young adults (< 35 years) with acute leukemia in remission
5136142|NCT01067287|dendritic cell fusion vaccine|dendritic cell fusion vaccine
5136143|NCT01067287|CT-011|ct-011
5136144|NCT01067287|autologous stem cell transplant|autologous stem cell transplant
5136145|NCT01067274|Acute Myeloid Leukemia|acute myeloid leukemia
5136146|NCT01067274|Aged of 65 to 79 years|aged of 65 to 79 years
5136147|NCT01067274|Older Patients with Acute Myeloblastic Leukemia|older patients with acute myeloblastic leukemia
5136148|NCT01067261|Nerve stimulation|nerve stimulation
5136149|NCT01067261|TMNS|tmns
5136150|NCT01067261|Prostatectomy|prostatectomy
5136151|NCT01067261|Prevention|prevention
5136152|NCT01067261|Restoration|restoration
5136153|NCT01067261|Treatment|treatment
5136154|NCT01067261|Vibration|vibration
5136155|NCT01067261|Non-invasive|non-invasive
5136156|NCT01067248|COPD|copd
5136157|NCT01067248|Osteoporosis|osteoporosis
5136158|NCT01067248|Pathophysiology|pathophysiology
5136159|NCT01067248|Mechanism|mechanism
5136160|NCT01067248|Bone markers|bone markers
5136161|NCT01067248|Bone turnover|bone turnover
5136162|NCT01067248|Protein turnover|protein turnover
5136163|NCT01067248|Ageing|ageing
5136164|NCT01067248|Endocrinology|endocrinology
5136165|NCT01067248|Vitamin D|vitamin d
5136166|NCT01067235|Narcolespy|narcolespy
5136167|NCT01067235|Cataplexy|cataplexy
5136168|NCT01067235|Excesssive daytime Sleepiness|excesssive daytime sleepiness
5136169|NCT01067235|Sleep Disorders|sleep disorders
5136170|NCT01067235|Sleep attacks|sleep attacks
5136171|NCT01067235|Orphan Drug|orphan drug
5136172|NCT01067235|Pitolisant|pitolisant
5136173|NCT01067222|Narcolepsy|narcolepsy
5136174|NCT01067222|Excessive daytime Sleepiness|excessive daytime sleepiness
5136175|NCT01067222|Cataplexy|cataplexy
5136176|NCT01067222|Sleep Disorders|sleep disorders
5136177|NCT01067222|Sleep attacks|sleep attacks
5136178|NCT01067222|Orphan Drug|orphan drug
5136179|NCT01067222|Pitolisant|pitolisant
5136280|NCT01066715|Diabetes|diabetes
5136180|NCT01067209|Reversal of Obesity-related and Diabetic Cardiomyopathy|reversal of obesity-related and diabetic cardiomyopathy
5136181|NCT01067196|Proton Radiation|proton radiation
5136182|NCT01067196|Central Nervous System (CNS) Tumors|central nervous system (cns) tumors
5136183|NCT01067196|Brain|brain
5136184|NCT01067196|Spine|spine
5136185|NCT01067196|Cancer|cancer
5136186|NCT01067196|Radiation Therapy (RT)|radiation therapy (rt)
5136187|NCT01067183|stress reduction|stress reduction
5136188|NCT01067183|physician wellness|physician wellness
5136189|NCT01067170|Hemodialysis|hemodialysis
5136190|NCT01067170|Intradialytic hypotension|intradialytic hypotension
5136191|NCT01067157|Obesity|obesity
5136192|NCT01067157|overweight|overweight
5136193|NCT01067157|childhood|childhood
5136194|NCT01067157|adolescence|adolescence
5136195|NCT01067157|inpatient therapy|inpatient therapy
5136196|NCT01067157|lifestyle intervention|lifestyle intervention
5136197|NCT01067157|cardiovascular risk|cardiovascular risk
5136198|NCT01067157|gene-lifestyle-interaction|gene-lifestyle-interaction
5136199|NCT01067157|Obesity and associated cardiovascular risk in childhood and adolescence,|obesity and associated cardiovascular risk in childhood and adolescence,
5136200|NCT01067157|health behaviour|health behaviour
5136201|NCT01067131|Candida albicans|candida albicans
5136202|NCT01067131|Fungal vaginal infection|fungal vaginal infection
5136203|NCT01067131|Vulvovaginal candidiasis|vulvovaginal candidiasis
5136204|NCT01067131|Candidose|candidose
5136205|NCT01067131|Vaccine|vaccine
5136206|NCT01067131|Virosome|virosome
5136207|NCT01067105|Perennial allergic rhinitis|perennial allergic rhinitis
5136208|NCT01067105|allergic rhinitis|allergic rhinitis
5136209|NCT01067105|ciclesonide|ciclesonide
5136210|NCT01067079|Rabies vaccine|rabies vaccine
5136211|NCT01067079|Long-term Immunogenicity|long-term immunogenicity
5136212|NCT01067066|TPI 287|tpi 287
5136213|NCT01067066|microtubule inhibitor|microtubule inhibitor
5136214|NCT01067066|Temozolomide|temozolomide
5136215|NCT01067066|Temodar|temodar
5136216|NCT01067066|cytotoxic agent|cytotoxic agent
5136217|NCT01067066|unresectable Stage III|unresectable stage iii
5136218|NCT01067066|Stage IV|stage iv
5136219|NCT01067066|Metastatic Melanoma|metastatic melanoma
5136220|NCT01067053|Bevacizumab|bevacizumab
5136221|NCT01067053|Capecitabine|capecitabine
5136222|NCT01067053|Oxaliplatin|oxaliplatin
5136223|NCT01067053|Metastatic colorectal cancer|metastatic colorectal cancer
5136224|NCT01067027|Colic|colic
5136225|NCT01067027|Colic in Breast-fed Infants|colic in breast-fed infants
5136226|NCT01067014|Lumbar spinal stenosis|lumbar spinal stenosis
5136227|NCT01067014|Decompression|decompression
5136228|NCT01067014|Lumbar spinal decompression|lumbar spinal decompression
5136229|NCT01067014|Lumbar spinal decompressive surgery|lumbar spinal decompressive surgery
5136230|NCT01066988|lipid layer thickness|lipid layer thickness
5136231|NCT01066975|loaded backpack|loaded backpack
5136232|NCT01066975|unloaded backpack|unloaded backpack
5136233|NCT01066962|HIV-infected antiretroviral naïve subjects|hiv-infected antiretroviral naïve subjects
5136234|NCT01066949|hemodialysis|hemodialysis
5136235|NCT01066949|behavior change|behavior change
5136236|NCT01066949|patient adherence|patient adherence
5136237|NCT01066949|self management|self management
5136238|NCT01066923|firefighter|firefighter
5136239|NCT01066923|heat stress|heat stress
5136240|NCT01066923|platelet activation|platelet activation
5136241|NCT01066923|aspirin|aspirin
5136242|NCT01066910|Obesity|obesity
5136243|NCT01066910|Childhood Obesity|childhood obesity
5136244|NCT01066910|Exercise|exercise
5136245|NCT01066910|Nutrition|nutrition
5136246|NCT01066871|Knee cartilage injury|knee cartilage injury
5136247|NCT01066871|fibroblast growth factor 18|fibroblast growth factor 18
5136248|NCT01066871|FGF18|fgf18
5136249|NCT01066858|tenofovir|tenofovir
5136250|NCT01066858|renal and bone toxicity|renal and bone toxicity
5136251|NCT01066858|pregnancy|pregnancy
5136252|NCT01066858|breastfeeding|breastfeeding
5136253|NCT01066858|mother to child transmission|mother to child transmission
5136254|NCT01066832|Drug-eluting balloon|drug-eluting balloon
5136255|NCT01066832|Paclitaxel|paclitaxel
5136256|NCT01066832|DIOR|dior
5136257|NCT01066832|short term registry|short term registry
5136258|NCT01066832|Valentines Trial|valentines trial
5136259|NCT01066832|Drug-eluting balloon treatment of in-stent restenosis|drug-eluting balloon treatment of in-stent restenosis
5136260|NCT01066780|cochlear implant|cochlear implant
5136261|NCT01066780|adults|adults
5136262|NCT01066780|HiResolution|hiresolution
5136263|NCT01066780|Fidelity 120|fidelity 120
5136264|NCT01066780|listening benefits|listening benefits
5136265|NCT01066780|noise|noise
5136266|NCT01066780|cochlear implant benefit|cochlear implant benefit
5136267|NCT01066741|Epidermoid carcinoma|epidermoid carcinoma
5136268|NCT01066741|Hypopharynx|hypopharynx
5136269|NCT01066741|Oropharynx|oropharynx
5136270|NCT01066741|Oral cavity|oral cavity
5136271|NCT01066741|Oral mucosa|oral mucosa
5136272|NCT01066741|Cavum|cavum
5136273|NCT01066741|Severe Oral mucositis|severe oral mucositis
5136274|NCT01066741|Radiotherapy|radiotherapy
5136275|NCT01066741|Phytotherapy|phytotherapy
5136276|NCT01066728|apnea|apnea
5136277|NCT01066728|premature|premature
5136278|NCT01066728|infant|infant
5136281|NCT01066715|Type 2|type 2
5136282|NCT01066715|Mellitus|mellitus
5136283|NCT01066689|kidney transplantation, acute humoral rejection, rituximab|kidney transplantation, acute humoral rejection, rituximab
5136284|NCT01066663|CLL|cll
5136285|NCT01066663|SLL|sll
5136286|NCT01066663|relapsed|relapsed
5136287|NCT01066663|pyrimethamine|pyrimethamine
5136288|NCT01066650|TWENTE|twente
5136289|NCT01066650|randomized study|randomized study
5136290|NCT01066650|stent|stent
5136291|NCT01066650|coronary stent|coronary stent
5136292|NCT01066650|drug-eluting stent|drug-eluting stent
5136293|NCT01066650|Zotarolimus|zotarolimus
5136294|NCT01066650|Everolimus|everolimus
5136295|NCT01066650|Xience V|xience v
5136296|NCT01066650|Endeavor Resolute|endeavor resolute
5136297|NCT01066650|head to head comparison|head to head comparison
5136298|NCT01066650|real world patients|real world patients
5136299|NCT01066650|target vessel failure|target vessel failure
5136300|NCT01066650|investigator initiated study|investigator initiated study
5136301|NCT01066650|coronary artery disease|coronary artery disease
5136302|NCT01066650|coronary arteries|coronary arteries
5136303|NCT01066650|atherosclerosis|atherosclerosis
5136304|NCT01066650|non inferiority|non inferiority
5136305|NCT01066637|Heart transplant patients|heart transplant patients
5136306|NCT01066624|Mucositis|mucositis
5136307|NCT01066624|Multiple myeloma|multiple myeloma
5136308|NCT01066624|Autologous hematopoietic stem cell transplantation|autologous hematopoietic stem cell transplantation
5136309|NCT01066611|Allergic Rhinitis|allergic rhinitis
5136310|NCT01066611|Allergy|allergy
5136311|NCT01066611|Phosphatidylinositol 3-kinase|phosphatidylinositol 3-kinase
5136312|NCT01066598|graft versus host disease|graft versus host disease
5136313|NCT01066598|chronic graft versus host disease|chronic graft versus host disease
5136314|NCT01066598|cGVHD|cgvhd
5136315|NCT01066585|Head lice|head lice
5136316|NCT01066585|Pediculus humanus capitis|pediculus humanus capitis
5136317|NCT01066546|Delirium|delirium
5136318|NCT01066546|Dementia|dementia
5136319|NCT01066546|Amnestic|amnestic
5136320|NCT01066546|Cognitive Disorders|cognitive disorders
5136321|NCT01066546|Mental Disorders|mental disorders
5136322|NCT01066546|Nervous System Diseases|nervous system diseases
5136323|NCT01066546|Central Nervous System Diseases|central nervous system diseases
5136324|NCT01066533|MTA|mta
5136325|NCT01066533|NEC|nec
5136326|NCT01066533|Immunohistochemistry|immunohistochemistry
5136327|NCT01066533|fibronectin|fibronectin
5136328|NCT01066533|tenascin|tenascin
5136329|NCT01066520|ankle sprain|ankle sprain
5136330|NCT01066520|traumeel|traumeel
5136331|NCT01066520|diclofenac|diclofenac
5136332|NCT01066520|antiinflammatory|antiinflammatory
5136333|NCT01066520|time to normal function|time to normal function
5136334|NCT01066507|Her2|her2
5136335|NCT01066507|FISH|fish
5136336|NCT01066507|Breast cancer|breast cancer
5136337|NCT01066507|Amplification|amplification
5136338|NCT01066494|AML|aml
5136339|NCT01066494|Pgp|pgp
5136340|NCT01066494|MDR|mdr
5136341|NCT01066494|sAML|saml
5136342|NCT01066494|AS1413|as1413
5136343|NCT01066494|Amonafide|amonafide
5136344|NCT01066481|Alzheimer's disease|alzheimer's disease
5136345|NCT01066481|clinical trial|clinical trial
5136346|NCT01066481|memory loss|memory loss
5136347|NCT01066481|investigational drug|investigational drug
5136348|NCT01066481|neurodegenerative disease|neurodegenerative disease
5136349|NCT01066481|dementia|dementia
5136350|NCT01066468|Chronic myeloid leukemia|chronic myeloid leukemia
5136351|NCT01066468|CML|cml
5136352|NCT01066468|Philadelphia chromosome positive|philadelphia chromosome positive
5136353|NCT01066468|acute lymphoblastic leukemia|acute lymphoblastic leukemia
5136354|NCT01066468|PhGlivec,|phglivec,
5136355|NCT01066468|Gleevec,|gleevec,
5136356|NCT01066468|hypereosinophilic syndrome,|hypereosinophilic syndrome,
5136357|NCT01066468|HES,|hes,
5136358|NCT01066468|chronic eosinophilic leukemia,|chronic eosinophilic leukemia,
5136359|NCT01066468|CEL,|cel,
5136360|NCT01066468|myelodysplastic syndrome,|myelodysplastic syndrome,
5136361|NCT01066468|MDS,|mds,
5136362|NCT01066468|myeloproliferative disease,|myeloproliferative disease,
5136363|NCT01066468|MPD+ ALL|mpd+ all
5136364|NCT01066455|Cardiac|cardiac
5136365|NCT01066455|Muscular Dystrophy|muscular dystrophy
5136366|NCT01066455|Prospective|prospective
5136367|NCT01066455|Pediatric|pediatric
5136368|NCT01066455|Echocardiogram|echocardiogram
5136369|NCT01066442|Excessive Daytime Sleepiness (EDS)|excessive daytime sleepiness (eds)
5136370|NCT01066442|Parkinson's Disease|parkinson's disease
5136371|NCT01066429|poor-prognosis diffuse large B-cell lymphoma|poor-prognosis diffuse large b-cell lymphoma
5136372|NCT01066429|dose-adjusted|dose-adjusted
5136373|NCT01066429|R-EDOCH-14|r-edoch-14
5136374|NCT01066429|rituximab|rituximab
5136375|NCT01066429|age-adjusted IPI|age-adjusted ipi
5136376|NCT01066429|toxicity|toxicity
5136377|NCT01066403|schizophrenia|schizophrenia
5136378|NCT01066403|cognitive deficits|cognitive deficits
5136379|NCT01066403|dopamine|dopamine
5136380|NCT01066403|dopamine agonists|dopamine agonists
5136381|NCT01066403|prefrontal cortex|prefrontal cortex
5136382|NCT01066403|D1 specific modulation|d1 specific modulation
5136383|NCT01066403|pergolide|pergolide
5136384|NCT01066403|executive control|executive control
5136385|NCT01066403|working memory|working memory
5136386|NCT01066403|Influence of pergolide on cognition in Schizophrenia|influence of pergolide on cognition in schizophrenia
5136387|NCT01066403|D1-specific modulation of prefrontal functions|d1-specific modulation of prefrontal functions
5136388|NCT01066403|Influence of pergolide on psychopathology and depression|influence of pergolide on psychopathology and depression
5136389|NCT01066403|Influence of pergolide on extrapyramidal symptoms|influence of pergolide on extrapyramidal symptoms
5136390|NCT01066390|stage IIIC/IV melanoma|stage iiic/iv melanoma
5136391|NCT01066377|prebiotic|prebiotic
5136392|NCT01066377|probiotic|probiotic
5136393|NCT01066377|influenza|influenza
5136394|NCT01066377|vaccination|vaccination
5136395|NCT01066377|ageing|ageing
5136396|NCT01066377|immunosenescence|immunosenescence
5136397|NCT01066364|NASH|nash
5136398|NCT01066364|NAFLD|nafld
5136399|NCT01066364|Steatohepatitis|steatohepatitis
5136400|NCT01066364|Nonalcoholic|nonalcoholic
5136401|NCT01066364|Fatty Liver Disease|fatty liver disease
5136402|NCT01066351|acute kidney injury|acute kidney injury
5136403|NCT01066351|erythropoietin|erythropoietin
5136404|NCT01066351|cardiac surgery|cardiac surgery
5136405|NCT01066338|SNP array|snp array
5136406|NCT01066338|prognosis|prognosis
5136407|NCT01066338|acute myeloid leukemia|acute myeloid leukemia
5136408|NCT01066338|normal karyotype|normal karyotype
5136409|NCT01066338|acute myeloid leukemia with normal karyotype|acute myeloid leukemia with normal karyotype
5136410|NCT01066325|Sit-n-Reach Test|sit-n-reach test
5136411|NCT01066325|Flexibility|flexibility
5136412|NCT01066325|Hamstring|hamstring
5136413|NCT01066325|Mindbody|mindbody
5136414|NCT01066325|Complementary and Alternative Medicine|complementary and alternative medicine
5136415|NCT01066325|Neuro Emotional Technique (NET)|neuro emotional technique (net)
5136416|NCT01066312|Muscle testing|muscle testing
5136417|NCT01066312|Kinesiology|kinesiology
5136418|NCT01066312|Muscles|muscles
5136419|NCT01066312|Complementary and Alternative Medicine|complementary and alternative medicine
5136420|NCT01066312|Practitioner Experience|practitioner experience
5136421|NCT01066312|This study is actually not a randomised controlled trial,|this study is actually not a randomised controlled trial,
5136422|NCT01066312|but an assessment of diagnostic test accuracy. We will be|but an assessment of diagnostic test accuracy. we will be
5136423|NCT01066312|looking at the accuracy of MMT to distinguish congruent from|looking at the accuracy of mmt to distinguish congruent from
5136424|NCT01066312|incongruent statements under varying levels of blinding.|incongruent statements under varying levels of blinding.
5136425|NCT01066299|oxytocin|oxytocin
5136426|NCT01066299|psychophysiology|psychophysiology
5136427|NCT01066299|startle|startle
5136428|NCT01066299|anxiety|anxiety
5136429|NCT01066299|emotion|emotion
5136430|NCT01066299|physiology|physiology
5136431|NCT01066286|genome wide SNP-array|genome wide snp-array
5136432|NCT01066286|micro-cytogenetic lesion|micro-cytogenetic lesion
5136433|NCT01066286|KIT mutation|kit mutation
5136434|NCT01066286|core binding factor|core binding factor
5136435|NCT01066286|acute myeloid leukemia|acute myeloid leukemia
5136436|NCT01066286|The Approval status was changed from Pending to Approved.|the approval status was changed from pending to approved.
5136437|NCT01066260|Probiotics|probiotics
5136438|NCT01066260|Energy balance|energy balance
5136439|NCT01066247|spinal anesthesia|spinal anesthesia
5136440|NCT01066247|heart rate variability|heart rate variability
5136441|NCT01066247|premedication|premedication
5136442|NCT01066247|heart rate|heart rate
5136443|NCT01066247|blood pressure|blood pressure
5136444|NCT01066234|Microscopic N2 Non-small Cell Lung Cancer|microscopic n2 non-small cell lung cancer
5136445|NCT01066234|Paclitaxel|paclitaxel
5136446|NCT01066234|Carboplatin|carboplatin
5136447|NCT01066234|Cisplatin|cisplatin
5136448|NCT01066221|clostridium difficile|clostridium difficile
5136449|NCT01066208|Classification criteria|classification criteria
5136450|NCT01066208|Diagnostic criteria|diagnostic criteria
5136451|NCT01066195|Non-Small Cell Lung Cancer|non-small cell lung cancer
5136452|NCT01066195|Never-Smoker and Adenocarcinoma patients|never-smoker and adenocarcinoma patients
5136453|NCT01066195|Pemetrexed (ALIMTA)|pemetrexed (alimta)
5136454|NCT01066195|Gefitinib (IRESSA®)|gefitinib (iressa®)
5136455|NCT01066182|DHA|dha
5136456|NCT01066182|Learning|learning
5136457|NCT01066182|Reading|reading
5136458|NCT01066182|Memory|memory
5136459|NCT01066182|Children|children
5136460|NCT01066182|Omega 3|omega 3
5136461|NCT01066182|Education|education
5136462|NCT01066182|Learning and behaviour in children|learning and behaviour in children
5136463|NCT01066169|Pandemic Influenza A/H1N1|pandemic influenza a/h1n1
5136464|NCT01066169|HIV|hiv
5136465|NCT01066169|Antibodies|antibodies
5136466|NCT01066169|Replicaton|replicaton
5136467|NCT01066156|Post-traumatic Stress Disorder|post-traumatic stress disorder
5136468|NCT01066156|PTSD|ptsd
5136469|NCT01066156|Seroquel|seroquel
5136470|NCT01066156|fMRI|fmri
5136471|NCT01066143|Seroquel|seroquel
5136472|NCT01066143|Generalized Anxiety Disorder|generalized anxiety disorder
5136473|NCT01066143|fMRI|fmri
5136474|NCT01066130|Diabetes Mellitus|diabetes mellitus
5136475|NCT01066130|Arthritis, Rheumatoid|arthritis, rheumatoid
5136966|NCT01063998|Carcinoma|carcinoma
5136476|NCT01066130|psychosocial aspects|psychosocial aspects
5136477|NCT01066130|Patient Adherence|patient adherence
5136478|NCT01066130|Social Work|social work
5136479|NCT01066130|Coping Behavior|coping behavior
5136480|NCT01066130|Coping Skills|coping skills
5136481|NCT01066130|Adaptation, Psychological|adaptation, psychological
5136482|NCT01066117|urinary incontinent|urinary incontinent
5136483|NCT01066091|Inflammatory response|inflammatory response
5136484|NCT01066091|High-fat meal|high-fat meal
5136485|NCT01066091|cytokines|cytokines
5136486|NCT01066091|Body composition|body composition
5136487|NCT01066078|heart failure - congestive|heart failure - congestive
5136488|NCT01066078|Cardiovascular imaging agents/Techniques]|cardiovascular imaging agents/techniques]
5136489|NCT01066078|Echocardiography|echocardiography
5136490|NCT01066078|Other diagnostic testing|other diagnostic testing
5136491|NCT01066078|Other Treatment|other treatment
5136492|NCT01066078|Recipients of cardiac resynchronization therapy systems|recipients of cardiac resynchronization therapy systems
5136493|NCT01066065|cardiovascular disease|cardiovascular disease
5136495|NCT01066065|metabolic disorder|metabolic disorder
5136496|NCT01066065|HIV naive patients initiating HAART with Raltegravir or boosted Darunavir|hiv naive patients initiating haart with raltegravir or boosted darunavir
5136497|NCT01066052|Growth hormone|growth hormone
5136498|NCT01066052|Turner syndrome|turner syndrome
5136499|NCT01066052|r-hGH|r-hgh
5136500|NCT01066052|early treatment|early treatment
5136501|NCT01066039|Bisoprolol|bisoprolol
5136502|NCT01066039|Hypertension|hypertension
5136503|NCT01066039|Diabetes mellitus, Type II|diabetes mellitus, type ii
5136504|NCT01066039|Blood pressure|blood pressure
5136505|NCT01066039|Glycemic level|glycemic level
5136506|NCT01066026|metallic cannula|metallic cannula
5136507|NCT01066026|Hyaluronic acid|hyaluronic acid
5136508|NCT01066013|Antimicrobial De escalation|antimicrobial de escalation
5136509|NCT01066013|Meropenem|meropenem
5136510|NCT01066013|Piperacillin tazobactam|piperacillin tazobactam
5136511|NCT01066013|Medical patients|medical patients
5136512|NCT01066013|Appropriate use|appropriate use
5136513|NCT01066013|Cost savings|cost savings
5136514|NCT01066013|Antimicrobial De-escalation strategy|antimicrobial de-escalation strategy
5136515|NCT01065974|Nutritional Intake|nutritional intake
5136516|NCT01065974|Psychosocial Outcome|psychosocial outcome
5136517|NCT01065961|anterior|anterior
5136518|NCT01065961|cervical|cervical
5136519|NCT01065961|fusion|fusion
5136520|NCT01065961|swallowing|swallowing
5136521|NCT01065961|Swallowing after anterior cervical discectomy and fusion|swallowing after anterior cervical discectomy and fusion
5136522|NCT01065961|Bony fusion rates post anterior cervical discectomy and fusion|bony fusion rates post anterior cervical discectomy and fusion
5136523|NCT01065948|subcutaneous glucose monitoring|subcutaneous glucose monitoring
5136524|NCT01065948|diabetes|diabetes
5136525|NCT01065948|fluorescence|fluorescence
5136526|NCT01065948|affinity|affinity
5136527|NCT01065948|biosensor|biosensor
5136528|NCT01065948|type I Diabetes|type i diabetes
5136529|NCT01065948|type II diabetes|type ii diabetes
5136530|NCT01065935|ALN-RSV01|aln-rsv01
5136531|NCT01065935|RSV|rsv
5136532|NCT01065935|Respiratory Syncytial Virus|respiratory syncytial virus
5136533|NCT01065896|spinal cord injury|spinal cord injury
5136534|NCT01065896|coronary artery disease|coronary artery disease
5136535|NCT01065857|Colonoscopy, Preparation, Evacuating, Bowel Cleansing.|colonoscopy, preparation, evacuating, bowel cleansing.
5136536|NCT01065844|Nelfinavir|nelfinavir
5136537|NCT01065831|motivational interviewing, lay health advisers|motivational interviewing, lay health advisers
5136538|NCT01065818|Esophageal cancer|esophageal cancer
5136539|NCT01065818|Non-small cell lung cancer|non-small cell lung cancer
5136540|NCT01065818|FLT-PET|flt-pet
5136541|NCT01065818|Chemoradiotherapy|chemoradiotherapy
5136542|NCT01065805|18F-FLT|18f-flt
5136543|NCT01065805|Positive Emission Tomography|positive emission tomography
5136544|NCT01065805|Cancer|cancer
5136545|NCT01065792|HIV Infection|hiv infection
5136546|NCT01065766|Diabetes Mellitus|diabetes mellitus
5136547|NCT01065766|Non-Insulin-Dependent|non-insulin-dependent
5136548|NCT01065753|Rho kinase|rho kinase
5136549|NCT01065753|Brain-derived neurotrophic factor|brain-derived neurotrophic factor
5136550|NCT01065740|Peripheral arterial disease|peripheral arterial disease
5136551|NCT01065740|Patient education|patient education
5136552|NCT01065740|Physical activity coaching|physical activity coaching
5136553|NCT01065740|Lifestyle modifications|lifestyle modifications
5136554|NCT01065740|Walking capacity|walking capacity
5136555|NCT01065740|6 minutes walking test|6 minutes walking test
5136556|NCT01065727|Reemitting aggressive multiple sclerosis|reemitting aggressive multiple sclerosis
5136557|NCT01065714|Transepidermal water loss|transepidermal water loss
5136558|NCT01065714|Epidermal barrier|epidermal barrier
5136559|NCT01065714|Skin hydration|skin hydration
5136560|NCT01065688|distal gastrectomy|distal gastrectomy
5136561|NCT01065688|Billroth-I reconstruction|billroth-i reconstruction
5136562|NCT01065688|gastric cancer|gastric cancer
5136563|NCT01065688|QOL|qol
5136564|NCT01065675|Medication Reconciliation|medication reconciliation
5136565|NCT01065675|Emergency Department|emergency department
5136566|NCT01065675|Nurse|nurse
5136567|NCT01065675|Pharmacist|pharmacist
5136568|NCT01065675|Certified Pharmacy Technician|certified pharmacy technician
5136569|NCT01065675|Medication reconciliation: inpatients admitted from the ED|medication reconciliation: inpatients admitted from the ed
5136570|NCT01065662|AZD2171|azd2171
5136571|NCT01065662|temsirolimus|temsirolimus
5136572|NCT01065662|advanced gynecological malignancies|advanced gynecological malignancies
5136573|NCT01065649|reflux disease|reflux disease
5136574|NCT01065649|heartburn|heartburn
5136575|NCT01065623|Phase I|phase i
5136576|NCT01065623|Dose escalation|dose escalation
5136577|NCT01065623|Immunoconjugate|immunoconjugate
5136578|NCT01065597|electroconvulsive therapy|electroconvulsive therapy
5136579|NCT01065597|seizure|seizure
5136580|NCT01065597|nonconvulsive|nonconvulsive
5136581|NCT01065597|subconvulsive|subconvulsive
5136582|NCT01065597|major depression|major depression
5136583|NCT01065597|bipolar disorder|bipolar disorder
5136584|NCT01065584|liver transplantation|liver transplantation
5136585|NCT01065584|Patients undergoing liver transplantation|patients undergoing liver transplantation
5136586|NCT01065571|relapse|relapse
5136587|NCT01065571|carrageenan|carrageenan
5136588|NCT01065571|inflammation|inflammation
5136589|NCT01065558|Ecopipam|ecopipam
5136590|NCT01065558|Lesch-Nyhan Disease|lesch-nyhan disease
5136591|NCT01065558|Safety|safety
5136592|NCT01065558|Self-Injurious Behavior|self-injurious behavior
5136593|NCT01065545|leukemia|leukemia
5136594|NCT01065532|Restenosis|restenosis
5136595|NCT01065532|PCI|pci
5136596|NCT01065532|Drug-eluting stent|drug-eluting stent
5136597|NCT01065532|Drug-eluting balloon|drug-eluting balloon
5136598|NCT01065532|Optical Coherence Tomography|optical coherence tomography
5136599|NCT01065519|Coronary stent|coronary stent
5136600|NCT01065519|Optical coherence tomography|optical coherence tomography
5136601|NCT01065519|Intravascular ultrasound|intravascular ultrasound
5136602|NCT01065480|Training|training
5136603|NCT01065480|Substance Abuse|substance abuse
5136604|NCT01065480|Counseling|counseling
5136605|NCT01065480|Motivational Interviewing|motivational interviewing
5136607|NCT01065467|panobinostat|panobinostat
5136608|NCT01065454|Pulmonary Hypertension|pulmonary hypertension
5136609|NCT01065454|Left ventricular dysfunction|left ventricular dysfunction
5136610|NCT01065441|breast cancer|breast cancer
5136611|NCT01065441|colorectal cancer|colorectal cancer
5136612|NCT01065441|prostate cancer|prostate cancer
5136613|NCT01065441|melanoma|melanoma
5136614|NCT01065441|ovarian cancer|ovarian cancer
5136615|NCT01065441|GI cancer|gi cancer
5136616|NCT01065441|Sarcoma|sarcoma
5136617|NCT01065441|Renal Cell Carcinoma|renal cell carcinoma
5136618|NCT01065428|neuromechanical efficiency|neuromechanical efficiency
5136619|NCT01065428|neuroventilatory efficiency|neuroventilatory efficiency
5136620|NCT01065428|weaning|weaning
5136621|NCT01065428|Respiration, Artificial|respiration, artificial
5136622|NCT01065415|Magnetic Resonance Imaging/Positron Emission Tomography|magnetic resonance imaging/positron emission tomography
5136623|NCT01065415|Whole body imaging|whole body imaging
5136624|NCT01065415|Non-small cell lung cancer|non-small cell lung cancer
5136625|NCT01065415|staging|staging
5136626|NCT01065415|Diagnostic accuracy|diagnostic accuracy
5136627|NCT01065402|Diabetes mellitus|diabetes mellitus
5136628|NCT01065402|continuous glucose monitoring system (CGMS)|continuous glucose monitoring system (cgms)
5136629|NCT01065389|Intradialysis|intradialysis
5136630|NCT01065389|Resistance training|resistance training
5136631|NCT01065389|Protein Catabolic Rate|protein catabolic rate
5136632|NCT01065389|Urea kinetics|urea kinetics
5136633|NCT01065389|Quality of life|quality of life
5136634|NCT01065389|VO2 max|vo2 max
5136635|NCT01065376|IVF|ivf
5136636|NCT01065376|OHSS|ohss
5136637|NCT01065376|cabergoline|cabergoline
5136638|NCT01065363|Hepatitis B virus DNA|hepatitis b virus dna
5136639|NCT01065363|Metabolic factor|metabolic factor
5136640|NCT01065363|Body mass index|body mass index
5136641|NCT01065363|Obesity|obesity
5136642|NCT01065363|Insulin resistance|insulin resistance
5136643|NCT01065363|Lifestyle factor|lifestyle factor
5136644|NCT01065363|Preventive Medicine|preventive medicine
5136645|NCT01065363|Health Promotion|health promotion
5136646|NCT01065350|ketofol|ketofol
5136647|NCT01065350|hemodynamics|hemodynamics
5136648|NCT01065350|propofol|propofol
5136649|NCT01065350|anesthesia|anesthesia
5136650|NCT01065337|peripheral arterial occlusion disease (PAD)|peripheral arterial occlusion disease (pad)
5136651|NCT01065337|diabetic foot|diabetic foot
5136652|NCT01065337|critical limb ischemia (CLI)|critical limb ischemia (cli)
5136653|NCT01065337|stem cell therapy|stem cell therapy
5136654|NCT01065324|balloon|balloon
5136655|NCT01065324|enteroscopy|enteroscopy
5136656|NCT01065324|bacteremia|bacteremia
5136657|NCT01065311|Depressive Disorder|depressive disorder
5136658|NCT01065311|Psychotherapy|psychotherapy
5136659|NCT01065285|Influenza|influenza
5136660|NCT01065285|autoimmune diseases|autoimmune diseases
5136661|NCT01065285|vaccination|vaccination
5136662|NCT01065285|H1N1|h1n1
5136663|NCT01065272|Dexamethasone|dexamethasone
5136664|NCT01065272|Bronchiolitis|bronchiolitis
5136665|NCT01065259|attention deficit hyperactivity disorder|attention deficit hyperactivity disorder
5136666|NCT01065259|executive function|executive function
5136667|NCT01065259|OROS MPH|oros mph
5136668|NCT01065259|atomoxetine|atomoxetine
5136669|NCT01065246|malignant ascites|malignant ascites
5136670|NCT01065246|second cycle|second cycle
5136671|NCT01065246|trifunctional|trifunctional
5136672|NCT01065220|Serotonin Transporter|serotonin transporter
5136673|NCT01065220|Hormone therapy|hormone therapy
5136674|NCT01065220|Gender Dysphoria|gender dysphoria
5136675|NCT01065220|Transsexualism|transsexualism
5136676|NCT01065181|shoulder|shoulder
5136677|NCT01065181|posterior inferior glenohumeral ligament|posterior inferior glenohumeral ligament
5136678|NCT01065181|posterior capsule|posterior capsule
5136679|NCT01065181|capsular contracture|capsular contracture
5136680|NCT01065181|baseball|baseball
5136681|NCT01065181|throwing injury|throwing injury
5136682|NCT01065168|endometriosis|endometriosis
5136683|NCT01065168|endometrioma|endometrioma
5136684|NCT01065168|antimullerian hormone|antimullerian hormone
5136685|NCT01065168|cystectomy|cystectomy
5136686|NCT01065142|Heart Failure|heart failure
5136687|NCT01065142|Patient Education as Topic|patient education as topic
5136688|NCT01065142|Primary Health Care|primary health care
5136689|NCT01065142|Quality of Life|quality of life
5136690|NCT01065116|Malaria|malaria
5136691|NCT01065103|STEMI|stemi
5136692|NCT01065103|Primary angioplasty|primary angioplasty
5136693|NCT01065103|Non-culprit vessel at STEMI|non-culprit vessel at stemi
5136694|NCT01065103|Fractional Flow Reserve|fractional flow reserve
5136695|NCT01065103|ST-elevation myocardial infarction|st-elevation myocardial infarction
5136696|NCT01065103|Fractional Flow Reserve in non-culprit vessel at STEMI|fractional flow reserve in non-culprit vessel at stemi
5136697|NCT01065090|Capacity for Work Questionnaire|capacity for work questionnaire
5136698|NCT01065090|exercise|exercise
5136699|NCT01065090|AVONEX|avonex
5136700|NCT01065090|SDMT: Symbol Digit Modalities Test|sdmt: symbol digit modalities test
5136701|NCT01065090|FSMC: Fatigue Scale for Motor and Cognitive functions|fsmc: fatigue scale for motor and cognitive functions
5136702|NCT01065090|effects of exercise|effects of exercise
5136703|NCT01065090|EDSS: Expanded Disability Status Scale|edss: expanded disability status scale
5136704|NCT01065077|Heart Failure|heart failure
5136705|NCT01065064|Multifocal IOL|multifocal iol
5136706|NCT01065064|ReSTOR IOL|restor iol
5136707|NCT01065051|Pulmonary Hypertension|pulmonary hypertension
5136708|NCT01065051|Left ventricular dysfunction|left ventricular dysfunction
5136709|NCT01065025|4SC-205|4sc-205
5136710|NCT01065025|Solid tumors|solid tumors
5136711|NCT01065025|Lymphomas|lymphomas
5136712|NCT01065025|Phase I|phase i
5136713|NCT01064999|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
5136714|NCT01064999|locally advanced rectal cancer|locally advanced rectal cancer
5136715|NCT01064999|intensity-modulated radiation therapy|intensity-modulated radiation therapy
5136716|NCT01064999|pathological complete response|pathological complete response
5136717|NCT01064986|Immune System|immune system
5136718|NCT01064973|autism|autism
5136719|NCT01064960|Neoplasms, Connective and Soft Tissue|neoplasms, connective and soft tissue
5136720|NCT01064960|Neoplasms, Muscle Tissue|neoplasms, muscle tissue
5136721|NCT01064960|Neoplasms|neoplasms
5136722|NCT01064960|Myofibroma|myofibroma
5136723|NCT01064960|Neoplasms by Histologic Type|neoplasms by histologic type
5136724|NCT01064960|Connective Tissue Diseases|connective tissue diseases
5136725|NCT01064960|Neoplasms, Connective Tissue|neoplasms, connective tissue
5136726|NCT01064960|Leiomyoma|leiomyoma
5136727|NCT01064934|coronary heart disease|coronary heart disease
5136728|NCT01064934|cerebrovascular disease|cerebrovascular disease
5136729|NCT01064934|peripheral arterial disease|peripheral arterial disease
5136730|NCT01064934|atherosclerosis|atherosclerosis
5136731|NCT01064934|hyperlipoproteinemia|hyperlipoproteinemia
5136732|NCT01064921|oropharyngeal cancer|oropharyngeal cancer
5136733|NCT01064921|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
5136734|NCT01064908|Endarterectomy, Carotid|endarterectomy, carotid
5136735|NCT01064908|Carotid stenosis|carotid stenosis
5136736|NCT01064908|Oxygen mask|oxygen mask
5136737|NCT01064895|Benephit|benephit
5136738|NCT01064895|Acute Kidney Injury|acute kidney injury
5136739|NCT01064895|Acute Renal Failure|acute renal failure
5136740|NCT01064895|Contrast Induced Nephropathy|contrast induced nephropathy
5136741|NCT01064895|Chronic Kidney Disease|chronic kidney disease
5136742|NCT01064869|Adherence|adherence
5136743|NCT01064869|Asthma|asthma
5136744|NCT01064869|medication|medication
5136745|NCT01064856|peripheral spondyloarthritis|peripheral spondyloarthritis
5136746|NCT01064856|adalimumab|adalimumab
5136747|NCT01064856|humira|humira
5136748|NCT01064843|Edentulous|edentulous
5136749|NCT01064843|Edentulism|edentulism
5136750|NCT01064843|Lower denture|lower denture
5136751|NCT01064843|Mini dental implant|mini dental implant
5136752|NCT01064843|Imtec MDI|imtec mdi
5136753|NCT01064843|Denture stabilization|denture stabilization
5136754|NCT01064843|Case success rate of overdentures stabilized by MDI|case success rate of overdentures stabilized by mdi
5136755|NCT01064843|General satisfaction of patients with this treatment|general satisfaction of patients with this treatment
5136756|NCT01064843|Oral health-related quality of life of these patients|oral health-related quality of life of these patients
5136757|NCT01064843|Cost estimates|cost estimates
5136758|NCT01064830|brittle nail|brittle nail
5136759|NCT01064817|glaucoma, trabeculectomy|glaucoma, trabeculectomy
5136760|NCT01064791|Renal transplantation|renal transplantation
5136967|NCT01063998|Biomarkers|biomarkers
5136761|NCT01064778|Glycemic Index|glycemic index
5136762|NCT01064778|Brain|brain
5136763|NCT01064778|Intake Regulation|intake regulation
5136764|NCT01064778|Weight Loss|weight loss
5136765|NCT01064778|Hunger|hunger
5136766|NCT01064778|Diet|diet
5136767|NCT01064765|Heart failure|heart failure
5136768|NCT01064765|Self management|self management
5136769|NCT01064765|cognitive dysfunction|cognitive dysfunction
5136770|NCT01064765|Self management of heart failure|self management of heart failure
5136771|NCT01064752|Minocycline|minocycline
5136772|NCT01064752|HIV-1|hiv-1
5136773|NCT01064752|Immune activation|immune activation
5136774|NCT01064752|Cerebrospinal fluid|cerebrospinal fluid
5136775|NCT01064752|Observational|observational
5136776|NCT01064739|Healthy Volunteers|healthy volunteers
5136777|NCT01064739|Fava bean consumption|fava bean consumption
5136778|NCT01064739|L-Dopa content in Fava Beans|l-dopa content in fava beans
5136779|NCT01064739|Sodium|sodium
5136780|NCT01064739|Potassium|potassium
5136781|NCT01064739|Electrolyte Balance|electrolyte balance
5136782|NCT01064739|Natriuresis|natriuresis
5136783|NCT01064726|Allergic Rhinitis Nasal Allergen Challenge Inflammatory Markers|allergic rhinitis nasal allergen challenge inflammatory markers
5136784|NCT01064713|Tesetaxel|tesetaxel
5136785|NCT01064713|Second-line therapy|second-line therapy
5136786|NCT01064713|Metastatic melanoma|metastatic melanoma
5136787|NCT01064713|Normal serum LDH|normal serum ldh
5136788|NCT01064700|Anxiety|anxiety
5136789|NCT01064700|Phototherapy|phototherapy
5136790|NCT01064700|Psychic Anxiety|psychic anxiety
5136791|NCT01064674|renal transplantation|renal transplantation
5136792|NCT01064674|cardiovascular morbidity|cardiovascular morbidity
5136793|NCT01064674|evaluation before renal transplantation|evaluation before renal transplantation
5136794|NCT01064661|Probiotics|probiotics
5136795|NCT01064661|abdominal pain|abdominal pain
5136796|NCT01064661|abdominal discomfort|abdominal discomfort
5136797|NCT01064661|bloating|bloating
5136798|NCT01064661|Functional Bowel Disorders|functional bowel disorders
5136799|NCT01064635|stage IA breast cancer|stage ia breast cancer
5136800|NCT01064635|stage IB breast cancer|stage ib breast cancer
5136801|NCT01064635|stage II breast cancer|stage ii breast cancer
5136802|NCT01064635|stage IIIA breast cancer|stage iiia breast cancer
5136803|NCT01064635|stage IIIB breast cancer|stage iiib breast cancer
5136804|NCT01064635|stage IIIC breast cancer|stage iiic breast cancer
5136805|NCT01064596|obesity|obesity
5136806|NCT01064596|fondaparinux|fondaparinux
5136807|NCT01064596|surgery|surgery
5136808|NCT01064596|anti-Xa activity|anti-xa activity
5136809|NCT01064570|Acute Promyelocytic Leukemia|acute promyelocytic leukemia
5136810|NCT01064570|APL|apl
5136811|NCT01064557|Acute promyelocytic Leukemia|acute promyelocytic leukemia
5136812|NCT01064544|Sleep problems|sleep problems
5136813|NCT01064544|melatonin|melatonin
5136814|NCT01064544|mood|mood
5136815|NCT01064544|Hemodialysis|hemodialysis
5136816|NCT01064518|Lateral Canthal Lines|lateral canthal lines
5136817|NCT01064518|Crow's Feet Wrinkles|crow's feet wrinkles
5136818|NCT01064518|Facial Wrinkles|facial wrinkles
5136819|NCT01064505|Ocular Neuroprotection|ocular neuroprotection
5136820|NCT01064505|ocular neuroprotectant|ocular neuroprotectant
5136821|NCT01064505|NAION|naion
5136822|NCT01064505|NAAION|naaion
5136823|NCT01064505|Non-arteritic ischemic optic neuropathy|non-arteritic ischemic optic neuropathy
5136824|NCT01064505|Non-arteritic anterior ischemic optic neuropathy|non-arteritic anterior ischemic optic neuropathy
5136825|NCT01064505|chronic optic nerve atrophy|chronic optic nerve atrophy
5136826|NCT01064505|optic nerve atrophy|optic nerve atrophy
5136827|NCT01064505|retinal degeneration|retinal degeneration
5136828|NCT01064505|optic neuritis|optic neuritis
5136829|NCT01064505|end stage glaucoma|end stage glaucoma
5136830|NCT01064505|Leber's hereditary optic neuropathy|leber's hereditary optic neuropathy
5136831|NCT01064479|SCCHN|scchn
5136832|NCT01064479|Oral cavity|oral cavity
5136833|NCT01064479|Oropharynx|oropharynx
5136834|NCT01064479|Hypopharynx|hypopharynx
5136835|NCT01064479|Larynx|larynx
5136836|NCT01064479|Tarceva|tarceva
5136837|NCT01064479|Erlotinib|erlotinib
5136838|NCT01064479|OSI-774|osi-774
5136839|NCT01064479|Docetaxel|docetaxel
5136840|NCT01064479|Taxotere|taxotere
5136841|NCT01064479|Cisplatin|cisplatin
5136842|NCT01064479|Platinol|platinol
5136843|NCT01064479|CDDP|cddp
5136844|NCT01064479|Placebo|placebo
5136845|NCT01064479|Chemotherapy|chemotherapy
5136846|NCT01064466|SCLC|sclc
5136847|NCT01064466|Etoposide|etoposide
5136848|NCT01064466|SNP|snp
5136849|NCT01064466|Topo|topo
5136850|NCT01064466|CYP|cyp
5136851|NCT01064466|Genotype|genotype
5136852|NCT01064466|Oncology|oncology
5136853|NCT01064466|Genetics|genetics
5136854|NCT01064466|Lung|lung
5136855|NCT01064466|Cancer|cancer
5136856|NCT01064453|Menopause|menopause
5136857|NCT01064453|Menopausal symptoms|menopausal symptoms
5136858|NCT01064453|Prevention of osteoporosis in menopausal women|prevention of osteoporosis in menopausal women
5136859|NCT01064453|Estrogen deficiency symptoms|estrogen deficiency symptoms
5136860|NCT01064453|Hormone replacement therapy|hormone replacement therapy
5136861|NCT01064440|Painful legs|painful legs
5136862|NCT01064440|Ischemic legs|ischemic legs
5136863|NCT01064440|Treatment for Claudication|treatment for claudication
5136864|NCT01064440|Gene therapy|gene therapy
5136865|NCT01064427|breast cancer|breast cancer
5136866|NCT01064427|fatigue|fatigue
5136867|NCT01064427|adjuvant chemotherapy|adjuvant chemotherapy
5136868|NCT01064427|quality of life|quality of life
5136869|NCT01064414|Canagliflozin|canagliflozin
5136870|NCT01064414|JNJ 28431754|jnj 28431754
5136871|NCT01064414|Placebo|placebo
5136872|NCT01064414|Sodium-Glucose Transporter 2|sodium-glucose transporter 2
5136873|NCT01064414|hemoglobin A1c protein, Blood Glucose|hemoglobin a1c protein, blood glucose
5136874|NCT01064414|reduced kidney function, Type 2 diabetes mellitus|reduced kidney function, type 2 diabetes mellitus
5136875|NCT01064388|Safety|safety
5136876|NCT01064375|DNA vaccine|dna vaccine
5136877|NCT01064375|Electroporation|electroporation
5136878|NCT01064362|Haemorrhage|haemorrhage
5136879|NCT01064362|Thromboprophylaxis|thromboprophylaxis
5136880|NCT01064349|brain metastases|brain metastases
5136881|NCT01064349|ErbB2 treatment|erbb2 treatment
5136882|NCT01064349|ErbB2+ breast cancer|erbb2+ breast cancer
5136883|NCT01064336|Thrombocytopenia|thrombocytopenia
5136884|NCT01064336|Pregnancy|pregnancy
5136885|NCT01064323|intermittent pneumatic leg compression|intermittent pneumatic leg compression
5136886|NCT01064323|nitric oxide|nitric oxide
5136887|NCT01064323|vascular endothelial cells|vascular endothelial cells
5136888|NCT01064323|IPC|ipc
5136889|NCT01064323|EECP|eecp
5136890|NCT01064323|atherosclerosis|atherosclerosis
5136891|NCT01064310|renal cell carcinoma|renal cell carcinoma
5136892|NCT01064310|Votrient|votrient
5136893|NCT01064310|cancer|cancer
5136894|NCT01064310|pazopanib|pazopanib
5136895|NCT01064310|patient preference|patient preference
5136896|NCT01064310|quality of life|quality of life
5136897|NCT01064297|Pregnancy registry|pregnancy registry
5136898|NCT01064297|Major congenital malformations|major congenital malformations
5136899|NCT01064297|Pregnancy outcomes|pregnancy outcomes
5136900|NCT01064297|Pregnancy|pregnancy
5136901|NCT01064297|First trimester|first trimester
5136902|NCT01064297|Lamotrigine|lamotrigine
5136903|NCT01064284|Hemophilia A|hemophilia a
5136904|NCT01064284|Factor VIII inhibitors|factor viii inhibitors
5136905|NCT01064284|vWF/FVIII|vwf/fviii
5136906|NCT01064284|rFVIII|rfviii
5136907|NCT01064258|treatment|treatment
5136908|NCT01064258|CPAP|cpap
5136909|NCT01064258|sleep apnea|sleep apnea
5136910|NCT01064245|Asthma|asthma
5136911|NCT01064245|Cough Variant Asthma|cough variant asthma
5136912|NCT01064245|Mannitol|mannitol
5136913|NCT01064245|Methacholine|methacholine
5136914|NCT01064245|Cough|cough
5136915|NCT01064245|Hypersensitivity|hypersensitivity
5136916|NCT01064219|hCG|hcg
5136917|NCT01064219|Treg cells|treg cells
5136918|NCT01064219|implantation|implantation
5136919|NCT01064219|pinopodes|pinopodes
5136920|NCT01064219|endometrium|endometrium
5136921|NCT01064206|thrombangiitis obliterans|thrombangiitis obliterans
5136922|NCT01064206|Buerger's disease|buerger's disease
5136923|NCT01064206|atheromatous arteritis|atheromatous arteritis
5136924|NCT01064206|psychiatric disorders|psychiatric disorders
5136925|NCT01064206|personality disorders|personality disorders
5136926|NCT01064206|addictive profile|addictive profile
5136927|NCT01064206|addiction|addiction
5136928|NCT01064206|tobacco|tobacco
5136929|NCT01064206|cannabis|cannabis
5136930|NCT01064193|In Vitro Fertilization|in vitro fertilization
5136931|NCT01064193|biopsy|biopsy
5136932|NCT01064193|pregnancy|pregnancy
5136933|NCT01064193|Implantation|implantation
5136934|NCT01064193|Embryo|embryo
5136935|NCT01064193|first or second IVF tentative|first or second ivf tentative
5136936|NCT01064167|Tranexamic Acid|tranexamic acid
5136937|NCT01064167|off-pump coronary Artery Bypass|off-pump coronary artery bypass
5136938|NCT01064141|Dengue Fever|dengue fever
5136939|NCT01064141|Dengue Hemorrhagic Fever|dengue hemorrhagic fever
5136940|NCT01064141|CYD Dengue Vaccine|cyd dengue vaccine
5136941|NCT01064141|Toddlers|toddlers
5136942|NCT01064128|Single-port|single-port
5136943|NCT01064128|Laparoscopy|laparoscopy
5136944|NCT01064128|Hysterectomy|hysterectomy
5136945|NCT01064128|Pain|pain
5136946|NCT01064128|Cosmesis|cosmesis
5136947|NCT01064128|Analgesics|analgesics
5136948|NCT01064089|HSP990|hsp990
5136949|NCT01064089|HSP90|hsp90
5136950|NCT01064089|Japan/Korea|japan/korea
5136951|NCT01064089|Phase I|phase i
5136952|NCT01064089|advanced solid tumors|advanced solid tumors
5136953|NCT01064089|dose escalation|dose escalation
5136954|NCT01064089|maximum tolerated dose|maximum tolerated dose
5136955|NCT01064089|MTD|mtd
5136956|NCT01064089|Japanese paatients|japanese paatients
5136957|NCT01064089|Korean patients|korean patients
5136958|NCT01064076|ICD, defibrillator|icd, defibrillator
5136959|NCT01064050|tumoral obstruction of the main stem bronchus|tumoral obstruction of the main stem bronchus
5136960|NCT01064050|bronchoscopy|bronchoscopy
5136961|NCT01064050|silicone stent|silicone stent
5136962|NCT01064037|Heart Failure|heart failure
5136963|NCT01064024|uUTI|uuti
5136964|NCT01064024|Pain or burning associated with Uncomplicated Urinary Tract Infections|pain or burning associated with uncomplicated urinary tract infections
5136965|NCT01063998|Renal cell|renal cell
5136968|NCT01063985|Skin testing for mouse allergies|skin testing for mouse allergies
5136969|NCT01063959|Laparoscopic Sleeve Gastrectomy|laparoscopic sleeve gastrectomy
5136970|NCT01063959|Laparoscopic Gastric Bypass|laparoscopic gastric bypass
5136971|NCT01063933|influenza, Peramivir, children, pharmacokinetic, pharmacodynamic|influenza, peramivir, children, pharmacokinetic, pharmacodynamic
5136972|NCT01063920|LT-NS001|lt-ns001
5136973|NCT01063920|Gastric Ulcers|gastric ulcers
5136974|NCT01063920|NSAID|nsaid
5136975|NCT01063920|Osteoarthritis|osteoarthritis
5136976|NCT01063920|Naproxen|naproxen
5136977|NCT01063907|Leukemia|leukemia
5136978|NCT01063907|Immunoproliferative Disorder|immunoproliferative disorder
5136979|NCT01063907|Neoplasma by Histologic Type|neoplasma by histologic type
5136980|NCT01063907|Immune System Diseases|immune system diseases
5136981|NCT01063907|Hematologic Diseases|hematologic diseases
5136982|NCT01063907|Blood Protein Disorders|blood protein disorders
5136983|NCT01063907|Paraproteinemias|paraproteinemias
5136984|NCT01063907|Multiple Myeloma|multiple myeloma
5136985|NCT01063907|Hematologic Disorders|hematologic disorders
5136986|NCT01063907|Leukemia, Chronic, B-cell|leukemia, chronic, b-cell
5136987|NCT01063907|Leukemia, B-cell|leukemia, b-cell
5136988|NCT01063907|Leukemia, Chronic|leukemia, chronic
5136989|NCT01063907|Neoplasms, Plasma Cell|neoplasms, plasma cell
5136990|NCT01063907|Monoclonal Gammopathy of unknown significance (MGUS)|monoclonal gammopathy of unknown significance (mgus)
5136991|NCT01063881|Sexual Dysfunction, physiological|sexual dysfunction, physiological
5136992|NCT01063881|R096769|r096769
5136993|NCT01063881|Dapoxetine|dapoxetine
5136994|NCT01063881|Phase 3b|phase 3b
5136995|NCT01063881|Premature Ejaculation|premature ejaculation
5136996|NCT01063868|Diabetic neuropathy|diabetic neuropathy
5136997|NCT01063868|Painful|painful
5136998|NCT01063868|Polyneuropathy|polyneuropathy
5136999|NCT01063868|Peripheral neuropathy|peripheral neuropathy
5137000|NCT01063855|Erectile Dysfunction|erectile dysfunction
5137001|NCT01063855|Sexual Dysfunction|sexual dysfunction
5137002|NCT01063855|Dapoxetine hydrochloride|dapoxetine hydrochloride
5137003|NCT01063855|PRILIGY|priligy
5137004|NCT01063855|Premature ejaculation|premature ejaculation
5137005|NCT01063855|Serotonin Uptake Inhibitors|serotonin uptake inhibitors
5137006|NCT01063855|Sildenafil (Viagra)|sildenafil (viagra)
5137007|NCT01063855|Vardenafil (Levitra)|vardenafil (levitra)
5137008|NCT01063855|Tadalafil (Cialis)|tadalafil (cialis)
5137009|NCT01063842|Drop-out rate|drop-out rate
5137010|NCT01063842|Osteoarthritis|osteoarthritis
5137011|NCT01063842|Tolerability|tolerability
5137012|NCT01063842|Tramadol|tramadol
5137013|NCT01063842|Acetaminophen|acetaminophen
5137014|NCT01063829|HCMV|hcmv
5137015|NCT01063816|PARP Inhibitors|parp inhibitors
5137016|NCT01063803|Open-label|open-label
5137017|NCT01063803|Long-term safety study of ATN-103 in RA|long-term safety study of atn-103 in ra
5137018|NCT01063790|Post-operative pain|post-operative pain
5137019|NCT01063790|inguinal hernia repair surgery|inguinal hernia repair surgery
5137020|NCT01063790|Patient education|patient education
5137021|NCT01063777|Hip Osteoarthritis, Exercise therapy, Patient Education|hip osteoarthritis, exercise therapy, patient education
5137022|NCT01063764|Keppra|keppra
5137023|NCT01063764|Levetiracetam|levetiracetam
5137024|NCT01063764|Children|children
5137025|NCT01063764|Epilepsy|epilepsy
5137026|NCT01063764|Partial Seizures|partial seizures
5137027|NCT01063751|Osteoarthritis|osteoarthritis
5137028|NCT01063751|Traumatic arthritis|traumatic arthritis
5137029|NCT01063751|Avascular Necrosis|avascular necrosis
5137030|NCT01063738|Rehabilitation|rehabilitation
5137031|NCT01063738|Intensive Care|intensive care
5137032|NCT01063738|Critical illness|critical illness
5137033|NCT01063738|Physiotherapy|physiotherapy
5137034|NCT01063738|Nutritional supplementation|nutritional supplementation
5137035|NCT01063725|menopause|menopause
5137036|NCT01063725|hot flashes|hot flashes
5137037|NCT01063725|vasomotor symptoms|vasomotor symptoms
5137038|NCT01063725|femarelle|femarelle
5137039|NCT01063725|soy extract|soy extract
5137040|NCT01063725|SERM|serm
5137041|NCT01063712|Ductus|ductus
5137042|NCT01063712|Patent ductus Arterious|patent ductus arterious
5137043|NCT01063712|"Nit-Occlud® PDA-R"|"nit-occlud® pda-r"
5137044|NCT01063712|Interventional closure of PDA|interventional closure of pda
5137045|NCT01063712|Percutaneous closure|percutaneous closure
5137046|NCT01063699|biliary atresia - laparoscopy - kasai - portoenterostomy|biliary atresia - laparoscopy - kasai - portoenterostomy
5137047|NCT01063686|Pregnancy|pregnancy
5137048|NCT01063673|Running, overuse injury, limits humans|running, overuse injury, limits humans
5137049|NCT01063660|Treosulfan|treosulfan
5137050|NCT01063660|Fludarabine|fludarabine
5137051|NCT01063660|ATG|atg
5137052|NCT01063660|AML|aml
5137053|NCT01063647|Treosulfan|treosulfan
5137054|NCT01063647|Allogeneic stem cell transplantation|allogeneic stem cell transplantation
5137055|NCT01063647|Conditioning therapy|conditioning therapy
5137056|NCT01063634|malignant biliary obstruction|malignant biliary obstruction
5137057|NCT01063634|viaduct|viaduct
5137058|NCT01063634|self-expandable metal stents|self-expandable metal stents
5137059|NCT01063595|Octaplas LG|octaplas lg
5137060|NCT01063595|Octaplas SD|octaplas sd
5137061|NCT01063582|echocardiogram|echocardiogram
5137062|NCT01063582|electrocardiographic|electrocardiographic
5137063|NCT01063582|risk factors|risk factors
5137064|NCT01063582|noise|noise
5137065|NCT01063569|Addison's disease|addison's disease
5137066|NCT01063569|Glucocorticoid treatment|glucocorticoid treatment
5137067|NCT01063569|Continuous subcutaneous hydrocortisone infusion|continuous subcutaneous hydrocortisone infusion
5137068|NCT01063569|CSHI|cshi
5137069|NCT01063569|Quality of Life|quality of life
5137070|NCT01063569|Sleep|sleep
5137071|NCT01063556|end-stage renal disease hemodialysis donepezil hydrochloride pharmacokinetics Cross-Over Study|end-stage renal disease hemodialysis donepezil hydrochloride pharmacokinetics cross-over study
5137072|NCT01063543|fondaparinux|fondaparinux
5137073|NCT01063543|orthopedic surgery|orthopedic surgery
5137074|NCT01063543|patients with major orthopedic surgery|patients with major orthopedic surgery
5137075|NCT01063530|FLuoride|fluoride
5137076|NCT01063530|Dental Sensitivity|dental sensitivity
5137077|NCT01063530|Abfraction|abfraction
5137078|NCT01063530|Cervical lesions|cervical lesions
5137079|NCT01063517|Poly(ADP ribose)|poly(adp ribose)
5137080|NCT01063517|polymerase (PARP)|polymerase (parp)
5137081|NCT01063517|Gastric cancer|gastric cancer
5137082|NCT01063517|olaparib|olaparib
5137083|NCT01063517|PARP inhibitor|parp inhibitor
5137084|NCT01063517|ATM AZD2281|atm azd2281
5137085|NCT01063517|Ku0059436|ku0059436
5137086|NCT01063517|Homologous Recombination deficiency (HRD)|homologous recombination deficiency (hrd)
5137087|NCT01063517|Recurrent gastric cancer|recurrent gastric cancer
5137088|NCT01063517|metastatic gastric cancer|metastatic gastric cancer
5137089|NCT01063491|coronary artery bypass graft surgery|coronary artery bypass graft surgery
5137090|NCT01063491|bypass grafts|bypass grafts
5137091|NCT01063491|angiography|angiography
5137092|NCT01063491|percutaneous coronary intervention|percutaneous coronary intervention
5137093|NCT01063491|coronary imaging|coronary imaging
5137094|NCT01063491|coronary artery bypass graft surgery, bypass graft patency|coronary artery bypass graft surgery, bypass graft patency
5137095|NCT01063478|Non-Small Cell|non-small cell
5137096|NCT01063478|Lung Cancer|lung cancer
5137097|NCT01063478|Unresectable advanced NSCLC|unresectable advanced nsclc
5137098|NCT01063465|Achilles|achilles
5137099|NCT01063465|Tendon|tendon
5137100|NCT01063465|weightbearing|weightbearing
5137101|NCT01063452|Urinary Catheterization|urinary catheterization
5137102|NCT01063452|Urinary Tract Infections|urinary tract infections
5137103|NCT01063439|DLBCL|dlbcl
5137104|NCT01063439|NHL|nhl
5137105|NCT01063426|Statin|statin
5137106|NCT01063426|Vein|vein
5137107|NCT01063413|Behavioral Research|behavioral research
5137108|NCT01063413|Community-Based Participatory Research|community-based participatory research
5137109|NCT01063387|cervical cancer,semaphorin 4C (Sema4C),|cervical cancer,semaphorin 4c (sema4c),
5137110|NCT01063387|Prophylactic Irradiation|prophylactic irradiation
5137111|NCT01063348|N-Acetyl Cysteine|n-acetyl cysteine
5137112|NCT01063348|Picking|picking
5137113|NCT01063348|Impulse Control Disorder|impulse control disorder
5137114|NCT01063348|Obsessive Compulsive Disorder|obsessive compulsive disorder
5137115|NCT01063335|CB1 Receptor|cb1 receptor
5137116|NCT01063335|Schizophrenia|schizophrenia
5137117|NCT01063335|Positron Emission Tomography (PET)|positron emission tomography (pet)
5137118|NCT01063335|Healthy Volunteers|healthy volunteers
5137119|NCT01063335|HV|hv
5137120|NCT01063322|Mitral Regurgitation|mitral regurgitation
5137121|NCT01063322|Echocardiography|echocardiography
5137122|NCT01063322|Cardiac Magnetic Resonance|cardiac magnetic resonance
5137123|NCT01063322|Regurgitant Volume|regurgitant volume
5137124|NCT01063322|Mitral Valve Regurgitation|mitral valve regurgitation
5137125|NCT01063309|Chronic Granulomatous Disease (CGD)|chronic granulomatous disease (cgd)
5137126|NCT01063309|Atherosclerosis|atherosclerosis
5137127|NCT01063309|Inflammatory Bowel Disease|inflammatory bowel disease
5137128|NCT01063309|Immune Deficiencies|immune deficiencies
5137129|NCT01063309|Immune System Deficiences|immune system deficiences
5137130|NCT01063309|Chronic Granulomatous Disease|chronic granulomatous disease
5137131|NCT01063309|CGD|cgd
5137132|NCT01063296|cervical cancer|cervical cancer
5137133|NCT01063283|Non-squamous Non-Small Cell Lung Cancer|non-squamous non-small cell lung cancer
5137134|NCT01063283|Bevacizumab|bevacizumab
5137135|NCT01063283|Ambulatory Blood Pressure Monitoring|ambulatory blood pressure monitoring
5137136|NCT01063270|Hidradenitis Suppurativa|hidradenitis suppurativa
5137137|NCT01063270|Antibiotics|antibiotics
5137138|NCT01063270|Laser|laser
5137139|NCT01063257|Myelodysplastic Syndrome|myelodysplastic syndrome
5137140|NCT01063244|pregnancy|pregnancy
5137141|NCT01063244|induction of Labor|induction of labor
5137142|NCT01063244|Cervical ripening|cervical ripening
5137143|NCT01063244|Foley balloon|foley balloon
5137144|NCT01063231|Colonic Diseases|colonic diseases
5137145|NCT01063231|bowel diseases|bowel diseases
5137146|NCT01063218|Dermatitis, Atopic|dermatitis, atopic
5137147|NCT01063218|Corticoids, topic|corticoids, topic
5137148|NCT01063218|Corticosteroids|corticosteroids
5137149|NCT01063205|Methamphetamine|methamphetamine
5137150|NCT01063205|NAC|nac
5137151|NCT01063205|N-acetylcysteine|n-acetylcysteine
5137152|NCT01063192|Locally Advanced Pancreatic Cancer|locally advanced pancreatic cancer
5137153|NCT01063179|Elderly patients|elderly patients
5137154|NCT01063179|Bortezomib|bortezomib
5137155|NCT01063179|Thalidomide|thalidomide
5137156|NCT01063153|ADHD|adhd
5137157|NCT01063153|Adults|adults
5137158|NCT01063153|Electroencephalography (EEG)|electroencephalography (eeg)
5137159|NCT01063153|Concerta|concerta
5137160|NCT01063140|Rabies Immune Globulin|rabies immune globulin
5137161|NCT01063140|Source Plasma Donors|source plasma donors
5137162|NCT01063140|Booster Immunization|booster immunization
5137163|NCT01063127|Morbid obesity|morbid obesity
5137164|NCT01063127|Insulin resistance|insulin resistance
5137165|NCT01063127|Euglycemic clamp|euglycemic clamp
5137166|NCT01063114|proton beam radiation|proton beam radiation
5137167|NCT01063088|Prophylaxis of seasonal influenza in adults|prophylaxis of seasonal influenza in adults
5137168|NCT01063075|Cancer of Head|cancer of head
5137169|NCT01063075|Cancer of Head and Neck|cancer of head and neck
5137170|NCT01063075|Cancer of Neck|cancer of neck
5137171|NCT01063075|Head and Neck Cancer|head and neck cancer
5137172|NCT01063075|Head Cancer|head cancer
5137173|NCT01063075|Head Neoplasms|head neoplasms
5137174|NCT01063075|Head, Neck Neoplasms|head, neck neoplasms
5137175|NCT01063075|Neck Cancer|neck cancer
5137176|NCT01063075|Neck Neoplasms|neck neoplasms
5137177|NCT01063075|Solid Neoplasm|solid neoplasm
5137178|NCT01063075|Carcinoma|carcinoma
5137179|NCT01063075|Sarcoma|sarcoma
5137180|NCT01063010|sepsis|sepsis
5137181|NCT01063010|septic shock|septic shock
5137182|NCT01063010|Bevacizumab|bevacizumab
5137183|NCT01063010|Avastin|avastin
5137184|NCT01062984|Renal Replacement Therapy|renal replacement therapy
5137185|NCT01062971|Open-angle glaucoma|open-angle glaucoma
5137186|NCT01062971|Ocular hypertension|ocular hypertension
5137187|NCT01062971|POAG|poag
5137188|NCT01062971|Treatment|treatment
5137189|NCT01062958|Neevo|neevo
5137190|NCT01062958|Neevo DHA|neevo dha
5137191|NCT01062958|L-methylfolate|l-methylfolate
5137192|NCT01062958|anemia during pregnancy|anemia during pregnancy
5137193|NCT01062958|folic acid|folic acid
5137194|NCT01062958|vitamin B12|vitamin b12
5137195|NCT01062958|prenatal vitamins|prenatal vitamins
5137196|NCT01062958|hemoglobin|hemoglobin
5137197|NCT01062958|iron deficiency|iron deficiency
5137198|NCT01062958|Pregnancy|pregnancy
5137199|NCT01062945|Cocaine|cocaine
5137200|NCT01062945|Doxazosin|doxazosin
5137201|NCT01062932|Cycloserine|cycloserine
5137202|NCT01062932|Nicotine|nicotine
5137203|NCT01062932|Smoking|smoking
5137204|NCT01062906|intravenous lidocaine|intravenous lidocaine
5137205|NCT01062906|postoperative pain|postoperative pain
5137206|NCT01062906|laparoscopic surgery|laparoscopic surgery
5137207|NCT01062906|opioids|opioids
5137208|NCT01062906|opioids side-effects|opioids side-effects
5137209|NCT01062893|labor pain treatment|labor pain treatment
5137210|NCT01062893|duration analgesia|duration analgesia
5137211|NCT01062893|Analgesic duration with normal saline injection.|analgesic duration with normal saline injection.
5137212|NCT01062893|Analgesic duration without normal saline injection|analgesic duration without normal saline injection
5137213|NCT01062867|Anaesthetic|anaesthetic
5137214|NCT01062854|snoring, sleep disordered breathing, polysomnography, sleep fragmentation|snoring, sleep disordered breathing, polysomnography, sleep fragmentation
5137215|NCT01062841|Long-Term Care|long-term care
5137216|NCT01062841|Nursing Homes|nursing homes
5137217|NCT01062841|Infection Control|infection control
5137218|NCT01062841|Multi-drug resistant pathogens|multi-drug resistant pathogens
5137219|NCT01062841|Long-term care residents with in-dwelling devices|long-term care residents with in-dwelling devices
5137220|NCT01062828|Prematurity|prematurity
5137221|NCT01062828|Necrotizing Enterocolitis|necrotizing enterocolitis
5137222|NCT01062828|Feeding Intolerance|feeding intolerance
5137223|NCT01062815|PNALD|pnald
5137224|NCT01062815|PNAC|pnac
5137225|NCT01062815|Parenteral Nutrition-Associated Cholestasis|parenteral nutrition-associated cholestasis
5137226|NCT01062815|Congenital Anomalies of Gastrointestinal Tract|congenital anomalies of gastrointestinal tract
5137227|NCT01062789|lung biopsy|lung biopsy
5137228|NCT01062789|computed tomograph|computed tomograph
5137229|NCT01062789|respiratory motion|respiratory motion
5137230|NCT01062789|Controlling respiratory motion in CT guided lung biopsies|controlling respiratory motion in ct guided lung biopsies
5137231|NCT01062789|biopsy|biopsy
5137232|NCT01062776|dehydration|dehydration
5137233|NCT01062776|fluid therapy|fluid therapy
5137234|NCT01062776|pharmacokinetics|pharmacokinetics
5137235|NCT01062776|hemoglobin|hemoglobin
5137236|NCT01062763|hypertension|hypertension
5137237|NCT01062763|spironolactone|spironolactone
5137238|NCT01062763|antihypertensive treatment|antihypertensive treatment
5137239|NCT01062763|Type-2 diabetes|type-2 diabetes
5137240|NCT01062750|Liver Cirrhosis|liver cirrhosis
5137241|NCT01062724|Cholestasis|cholestasis
5137242|NCT01062724|TPN|tpn
5137243|NCT01062724|Neonates|neonates
5137244|NCT01062724|Primene|primene
5137245|NCT01062724|Trophamine|trophamine
5137246|NCT01062724|Methionine|methionine
5137247|NCT01062724|Cysteine|cysteine
5137248|NCT01062724|Taurine|taurine
5137249|NCT01062724|Total Parenteral Nutrition|total parenteral nutrition
5137250|NCT01062711|sarcopenia|sarcopenia
5137251|NCT01062711|muscle|muscle
5137252|NCT01062711|protein|protein
5137253|NCT01062711|muscle protein synthesis|muscle protein synthesis
5137254|NCT01062711|muscle protein breakdown|muscle protein breakdown
5137255|NCT01062711|whey|whey
5137256|NCT01062711|soy|soy
5137257|NCT01062711|casein|casein
5137258|NCT01062711|dose response|dose response
5137259|NCT01062711|resistance exercise|resistance exercise
5137260|NCT01062711|unilateral|unilateral
5137261|NCT01062711|knee extension|knee extension
5137262|NCT01062711|whole body protein|whole body protein
5137263|NCT01062698|mechanical Thrombectomy|mechanical thrombectomy
5137264|NCT01062698|CVA (Cerebrovascular Accident)|cva (cerebrovascular accident)
5137265|NCT01062698|Cerebrovascular Accident, Acute|cerebrovascular accident, acute
5137266|NCT01062685|septic shock|septic shock
5137267|NCT01062685|sepsis|sepsis
5137268|NCT01062685|St02|st02
5137269|NCT01062685|Near Infrared Spectroscopy|near infrared spectroscopy
5137270|NCT01062685|NIRS|nirs
5137271|NCT01062672|plasticity|plasticity
5137272|NCT01062672|reorganization|reorganization
5137273|NCT01062672|cortical|cortical
5137274|NCT01062672|fMRI|fmri
5137275|NCT01062672|rehabilitation|rehabilitation
5137276|NCT01062659|HCV|hcv
5137277|NCT01062659|hepatitis C virus|hepatitis c virus
5137278|NCT01062659|CHC|chc
5137279|NCT01062659|chronic hepatitis c|chronic hepatitis c
5137280|NCT01062659|interferon|interferon
5137281|NCT01062659|ribavirin|ribavirin
5137282|NCT01062659|Hepatitis, Viral, Human|hepatitis, viral, human
5137283|NCT01062659|Anti-Infective Agents|anti-infective agents
5137284|NCT01062659|peginterferon alfa-2a|peginterferon alfa-2a
5137285|NCT01062659|peginterferon alfa-2b|peginterferon alfa-2b
5137286|NCT01062646|music therapy|music therapy
5137287|NCT01062646|multimodal psychotherapy|multimodal psychotherapy
5137288|NCT01062646|children|children
5137289|NCT01062646|anxiety disorders|anxiety disorders
5137290|NCT01062646|pediatric anxiety|pediatric anxiety
5137291|NCT01062633|dental caries|dental caries
5137292|NCT01062633|prevention|prevention
5137293|NCT01062633|dietary supplements|dietary supplements
5137294|NCT01062607|bipolar disorders|bipolar disorders
5137295|NCT01062607|everyday setting|everyday setting
5137296|NCT01062607|treatment adherence|treatment adherence
5137297|NCT01062607|global|global
5137298|NCT01062581|Recipient|recipient
5137299|NCT01062581|Donor|donor
5137300|NCT01062581|Organ Transplant|organ transplant
5137301|NCT01062581|Registry|registry
5137302|NCT01062581|University of Minnesota|university of minnesota
5137303|NCT01062568|adolescents|adolescents
5137304|NCT01062568|puberty|puberty
5137305|NCT01062568|androgens|androgens
5137306|NCT01062568|hyperandrogenemia|hyperandrogenemia
5137307|NCT01062529|GH signalling|gh signalling
5137308|NCT01062529|insulin resistance|insulin resistance
5137309|NCT01062529|somatostatin|somatostatin
5137310|NCT01062529|acromegaly|acromegaly
5137311|NCT01062516|acute coronary syndrome|acute coronary syndrome
5137312|NCT01062516|acute myocardial infarction|acute myocardial infarction
5137313|NCT01062516|percutaneous coronary intervention|percutaneous coronary intervention
5137314|NCT01062516|aspirin|aspirin
5137315|NCT01062516|clopidogrel|clopidogrel
5137316|NCT01062516|esomeprazole|esomeprazole
5137317|NCT01062516|famotidine|famotidine
5137318|NCT01062516|platelet function|platelet function
5137319|NCT01062503|Cancer|cancer
5137320|NCT01062503|Prostate|prostate
5137321|NCT01062503|metastatic|metastatic
5137322|NCT01062490|Treosulfan|treosulfan
5137323|NCT01062490|MDS|mds
5137324|NCT01062490|allogeneic stem cell transplantation|allogeneic stem cell transplantation
5137325|NCT01062490|leukemia|leukemia
5137326|NCT01062490|Conditioning|conditioning
5137327|NCT01062477|Diphtheria Tetanus Pertussis Haemophilus Influenzae Type B|diphtheria tetanus pertussis haemophilus influenzae type b
5137328|NCT01062451|Methamphetamine|methamphetamine
5137329|NCT01062451|Perindopril|perindopril
5137330|NCT01062451|Candesartan|candesartan
5137331|NCT01062451|Angiotensin receptor blocker|angiotensin receptor blocker
5137332|NCT01062451|ACE Inhibitor|ace inhibitor
5137333|NCT01062438|localized osteosarcoma|localized osteosarcoma
5137334|NCT01062438|metastatic osteosarcoma|metastatic osteosarcoma
5137335|NCT01062399|adult glioblastoma|adult glioblastoma
5137336|NCT01062399|adult giant cell glioblastoma|adult giant cell glioblastoma
5137337|NCT01062399|adult gliosarcoma|adult gliosarcoma
5137338|NCT01062386|prevalence|prevalence
5137339|NCT01062386|transmission|transmission
5137340|NCT01062386|knowledge|knowledge
5137341|NCT01062386|attitude|attitude
5137342|NCT01062386|practice|practice
5137343|NCT01062373|Premature Newborns|premature newborns
5137344|NCT01062373|Human Milk|human milk
5137345|NCT01062373|DHA|dha
5137346|NCT01062373|Mother-child|mother-child
5137347|NCT01062360|Sore Throat|sore throat
5137348|NCT01062360|Upper Respiratory Tract Infections|upper respiratory tract infections
5137349|NCT01062360|Nasal Congestion|nasal congestion
5137350|NCT01062347|To identify a new bio-marker for zinc status|to identify a new bio-marker for zinc status
5137351|NCT01062334|Anastomotic leakage after LAR|anastomotic leakage after lar
5137352|NCT01062321|Hepatitis E Virus|hepatitis e virus
5137353|NCT01062321|Cytokines|cytokines
5137354|NCT01062321|Pregnancy|pregnancy
5137355|NCT01062308|Stroke|stroke
5137356|NCT01062308|Taping|taping
5137357|NCT01062308|Pain|pain
5137358|NCT01062308|Shoulder Injury|shoulder injury
5137359|NCT01062295|passenger,|passenger,
5137360|NCT01062295|sleep,|sleep,
5137361|NCT01062295|rest,|rest,
5137362|NCT01062282|Pulmonary Hypertension|pulmonary hypertension
5137363|NCT01062269|Bile acid sequestrant|bile acid sequestrant
5137364|NCT01062269|Resin|resin
5137365|NCT01062269|Cholesterol|cholesterol
5137366|NCT01062269|Diabetes mellitus|diabetes mellitus
5137367|NCT01062269|Lipids|lipids
5137368|NCT01062269|Glucose|glucose
5137369|NCT01062269|Bile Acid Sequestrant Acceptability Scale (BASA)validation study|bile acid sequestrant acceptability scale (basa)validation study
5137370|NCT01062256|Cough assessment in upper respiratory infection|cough assessment in upper respiratory infection
5137371|NCT01062256|guaifenesin|guaifenesin
5137372|NCT01062256|honey|honey
5137373|NCT01062243|brain injury|brain injury
5137374|NCT01062243|family treatment|family treatment
5137375|NCT01062230|Cancer|cancer
5137376|NCT01062230|Hematologic malignancy|hematologic malignancy
5137377|NCT01062204|Skin Graft donor sites|skin graft donor sites
5137378|NCT01062191|hydrogel|hydrogel
5137379|NCT01062191|dressing|dressing
5137380|NCT01062191|burn|burn
5137381|NCT01062191|joint|joint
5137382|NCT01062178|Small renal Mass|small renal mass
5137383|NCT01062178|Contrast Enhanced Ultrasound|contrast enhanced ultrasound
5137384|NCT01062178|Renal Cell Carcinoma|renal cell carcinoma
5137385|NCT01062178|noninvasive diagnosis of RCC|noninvasive diagnosis of rcc
5137386|NCT01062165|Echinocandin|echinocandin
5137387|NCT01062165|Obesity|obesity
5137388|NCT01062165|Pharmacokinetics|pharmacokinetics
5137389|NCT01062165|Pharmacodynamics|pharmacodynamics
5137390|NCT01062165|Fungal infection|fungal infection
5137391|NCT01062152|Hematology|hematology
5137392|NCT01062152|MDS|mds
5137393|NCT01062152|Myelodysplastic Syndrome|myelodysplastic syndrome
5137394|NCT01062152|Low risk MDS|low risk mds
5137395|NCT01062152|Patients with non-deletion(5q)|patients with non-deletion(5q)
5137396|NCT01062152|Non-deletion 5q|non-deletion 5q
5137397|NCT01062152|Non del(5q)|non del(5q)
5137398|NCT01062152|Revlimid|revlimid
5137399|NCT01062152|lenalidomide|lenalidomide
5137400|NCT01062152|Telintra|telintra
5137401|NCT01062152|ezatiostat hydrochloride|ezatiostat hydrochloride
5137402|NCT01062152|ezatiostat|ezatiostat
5137403|NCT01062152|TLK199|tlk199
5137404|NCT01062152|Glutathione|glutathione
5137405|NCT01062152|Glutathione analog|glutathione analog
5137406|NCT01062152|Glutathione Transferase|glutathione transferase
5137407|NCT01062152|Glutathione Transferase inhibitor|glutathione transferase inhibitor
5137408|NCT01062152|Glutathione Transferase P1-1 inhibitor|glutathione transferase p1-1 inhibitor
5137409|NCT01062152|GSTp1-1 inhibitor|gstp1-1 inhibitor
5137410|NCT01062152|Apoptosis|apoptosis
5137411|NCT01062152|Differentiation|differentiation
5137412|NCT01062152|Enzyme inhibitor|enzyme inhibitor
5137413|NCT01062126|Pacemaker|pacemaker
5137414|NCT01062126|Advanced Features|advanced features
5137415|NCT01062126|Clinical Outcomes|clinical outcomes
5137416|NCT01062113|Acute pain after oral surgery lateral mandibular Impacted third molar tooth extraction|acute pain after oral surgery lateral mandibular impacted third molar tooth extraction
5137417|NCT01062100|breast cancer|breast cancer
5137418|NCT01062100|molecular breast imaging|molecular breast imaging
5137419|NCT01062100|MRI|mri
5137420|NCT01062100|gamma camera|gamma camera
5137421|NCT01062087|postoperative pain|postoperative pain
5137422|NCT01062087|tubal ligation|tubal ligation
5137423|NCT01062087|local anesthetic|local anesthetic
5137424|NCT01062061|Varicella|varicella
5137425|NCT01062035|Advanced colon polyp|advanced colon polyp
5137426|NCT01062035|Adenomatous colon polyp|adenomatous colon polyp
5137427|NCT01062035|Adenoma, villous colon polyp|adenoma, villous colon polyp
5137428|NCT01062035|Advanced colorectal adenomas|advanced colorectal adenomas
5137429|NCT01062035|Colonic neoplasms|colonic neoplasms
5137430|NCT01062035|High grade dysplasia|high grade dysplasia
5137431|NCT01062035|Telomere blood testing|telomere blood testing
5137432|NCT01062022|intervention|intervention
5137433|NCT01062022|combat wounded|combat wounded
5137434|NCT01062022|family|family
5137435|NCT01062022|Focus-CI|focus-ci
5137436|NCT01061996|Ulcerative Colitis|ulcerative colitis
5137437|NCT01061983|Deep brain stimulation|deep brain stimulation
5137438|NCT01061983|Treatment refractory|treatment refractory
5137439|NCT01061983|Ventral internal capsule/ventral striatum|ventral internal capsule/ventral striatum
5137440|NCT01061983|Neurosurgery|neurosurgery
5137441|NCT01061983|Neuroimaging|neuroimaging
5137442|NCT01061970|Hypogonadism|hypogonadism
5137443|NCT01061970|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5137444|NCT01061970|COPD|copd
5137445|NCT01061957|Treatment outcome|treatment outcome
5137446|NCT01061957|HIV treatment|hiv treatment
5137447|NCT01061944|biopsy|biopsy
5137448|NCT01061944|tumor biopsy|tumor biopsy
5137449|NCT01061944|genetic studies|genetic studies
5137450|NCT01061931|MRI|mri
5137451|NCT01061931|left-sided atrial catheter ablation|left-sided atrial catheter ablation
5137452|NCT01061931|paroxysmal atrial fibrillation|paroxysmal atrial fibrillation
5137453|NCT01061931|cryoballoon technique|cryoballoon technique
5137454|NCT01061931|mesh ablator catheter|mesh ablator catheter
5137455|NCT01061931|stroke|stroke
5137456|NCT01061931|silent stroke|silent stroke
5137457|NCT01061931|major complications|major complications
5137458|NCT01061918|Compare the visual outcomes with bilateral implantation of Tecnis MF and ReSTOR IOLs 6 months post cataract surgery.|compare the visual outcomes with bilateral implantation of tecnis mf and restor iols 6 months post cataract surgery.
5137459|NCT01061905|health behavior|health behavior
5137460|NCT01061905|behavioral economics|behavioral economics
5137461|NCT01061905|calorie labeling|calorie labeling
5137462|NCT01061905|exercise|exercise
5137463|NCT01061879|umbilical cord|umbilical cord
5137464|NCT01061879|umbilical cord blood collection|umbilical cord blood collection
5137465|NCT01061879|pregnancy|pregnancy
5137466|NCT01061866|Thalidomide|thalidomide
5137467|NCT01061866|Antiepileptic drugs|antiepileptic drugs
5137468|NCT01061866|Refractory epilepsy|refractory epilepsy
5137469|NCT01061866|Sedative drugs|sedative drugs
5137470|NCT01061853|Oral lichen planus|oral lichen planus
5137471|NCT01061853|chronic inflammatory|chronic inflammatory
5137472|NCT01061853|mucous membranes|mucous membranes
5137473|NCT01061853|erosive lesions|erosive lesions
5137474|NCT01061840|Ewings Sarcoma|ewings sarcoma
5137475|NCT01061840|Non Small Cell Lung Cancer|non small cell lung cancer
5137476|NCT01061840|Liver Cancer|liver cancer
5137477|NCT01061827|GMS-package;dementia;depression|gms-package;dementia;depression
5137478|NCT01061814|ApoB (Apolipoprotein B)|apob (apolipoprotein b)
5137479|NCT01061814|LDL (low density lipoprotein)|ldl (low density lipoprotein)
5137480|NCT01061814|mipomersen|mipomersen
5137481|NCT01061814|ISIS301012|isis301012
5137482|NCT01061814|antisense|antisense
5137483|NCT01061801|caregivers|caregivers
5137484|NCT01061801|cancer|cancer
5137485|NCT01061801|emotion|emotion
5137486|NCT01061801|protective buffering|protective buffering
5137487|NCT01061788|Phase I|phase i
5137488|NCT01061788|Solid Tumor|solid tumor
5137489|NCT01061788|AMG 479|amg 479
5137490|NCT01061788|Panitumumab|panitumumab
5137491|NCT01061788|Everolimus|everolimus
5137492|NCT01061788|RAD001|rad001
5137493|NCT01061788|Duke|duke
5137494|NCT01061788|Subjects with refractory advanced solid tumors|subjects with refractory advanced solid tumors
5137495|NCT01061788|non-small cell lung cancer|non-small cell lung cancer
5137496|NCT01061775|Hypothalamic Obesity|hypothalamic obesity
5137497|NCT01061775|Exenatide|exenatide
5137498|NCT01061775|Byetta|byetta
5137499|NCT01061775|Craniopharyngioma|craniopharyngioma
5137500|NCT01061762|Treatment adherence|treatment adherence
5137501|NCT01061762|Low literacy skills|low literacy skills
5137502|NCT01061762|HIV treatment|hiv treatment
5137503|NCT01061710|Smoking|smoking
5137504|NCT01061710|smoking cessation|smoking cessation
5137505|NCT01061710|Japanese|japanese
5137506|NCT01061710|varenicline|varenicline
5137507|NCT01061710|retreatment|retreatment
5137508|NCT01061710|Regulatory Post Marketing Commitment Plan|regulatory post marketing commitment plan
5137509|NCT01061684|fatty liver disease|fatty liver disease
5137510|NCT01061684|NASH|nash
5137511|NCT01061684|NAFLD|nafld
5137512|NCT01061684|non-alcoholic steatohepatitis|non-alcoholic steatohepatitis
5137513|NCT01061671|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5137514|NCT01061671|COPD|copd
5137515|NCT01061671|Exacerbation|exacerbation
5137516|NCT01061671|Lung function|lung function
5137517|NCT01061671|Cardiovascular|cardiovascular
5137518|NCT01061671|Smoking|smoking
5137519|NCT01061671|Statins|statins
5137520|NCT01061671|Simvastatin|simvastatin
5137521|NCT01061645|MDT and DLT|mdt and dlt
5137522|NCT01061632|deadlift|deadlift
5137523|NCT01061632|motor control|motor control
5137524|NCT01061632|exercises|exercises
5137525|NCT01061632|pain|pain
5137526|NCT01061632|function|function
5137527|NCT01061632|functional capacity|functional capacity
5137528|NCT01061619|prediagnostic symptoms|prediagnostic symptoms
5137529|NCT01061619|sentinel events|sentinel events
5137530|NCT01061619|pathway to diagnosis|pathway to diagnosis
5137531|NCT01061593|TB|tb
5137532|NCT01061593|MDR-TB|mdr-tb
5137533|NCT01061593|XDR-TB|xdr-tb
5137534|NCT01061593|TB/HIV|tb/hiv
5137535|NCT01061580|Bone Marrow Concentrate|bone marrow concentrate
5137536|NCT01061580|CABG|cabg
5137537|NCT01061580|Cardiac|cardiac
5137538|NCT01061580|Stem Cell|stem cell
5137539|NCT01061554|Bioavailability|bioavailability
5137540|NCT01061554|Eicosapentaenoic acid|eicosapentaenoic acid
5137541|NCT01061554|Docosahexaenoic acid|docosahexaenoic acid
5137542|NCT01061554|Soft gel capsules|soft gel capsules
5137543|NCT01061554|Gastric stable emulsion|gastric stable emulsion
5137544|NCT01061554|Omega-3|omega-3
5137545|NCT01061554|Tri-glycerides|tri-glycerides
5137546|NCT01061554|Marine phospholipids|marine phospholipids
5137547|NCT01061541|Pertussis|pertussis
5137548|NCT01061541|Tetanus|tetanus
5137549|NCT01061541|Hiberix™|hiberix™
5137550|NCT01061541|Hepatitis B|hepatitis b
5137551|NCT01061541|DTPw-HBV vaccine|dtpw-hbv vaccine
5137552|NCT01061541|Tritanrix™-HepB|tritanrix™-hepb
5137553|NCT01061541|Haemophilus influenzae type b|haemophilus influenzae type b
5137554|NCT01061541|Diphtheria|diphtheria
5137555|NCT01061541|Hib vaccine|hib vaccine
5137556|NCT01061528|cigarette smoking|cigarette smoking
5137557|NCT01061528|smoking cessation|smoking cessation
5137558|NCT01061528|nicotine dependence|nicotine dependence
5137559|NCT01061502|Burns|burns
5137560|NCT01061502|Wounds and Injuries|wounds and injuries
5137561|NCT01061502|Skin Grafts, Bioelectric|skin grafts, bioelectric
5137562|NCT01061502|Grafting, skin|grafting, skin
5137563|NCT01061489|neuroplasticity|neuroplasticity
5137564|NCT01061489|Mild Cognitive Impairment (MCI)|mild cognitive impairment (mci)
5137565|NCT01061489|Alzheimer|alzheimer
5137566|NCT01061489|sensory-cognitive training|sensory-cognitive training
5137567|NCT01061489|physical fitness|physical fitness
5137568|NCT01061476|sleep apnea|sleep apnea
5137569|NCT01061476|treatment|treatment
5137570|NCT01061476|collapsibility|collapsibility
5137571|NCT01061476|expiratory nasal resistance|expiratory nasal resistance
5137572|NCT01061463|Radiation cataracts|radiation cataracts
5137573|NCT01061463|Lens opacities|lens opacities
5137574|NCT01061463|X-rays|x-rays
5137575|NCT01061463|Interventional Cardiologists|interventional cardiologists
5137576|NCT01061463|Electrophysiologists|electrophysiologists
5137577|NCT01061450|Diastolic dysfunction|diastolic dysfunction
5137578|NCT01061450|hypertension|hypertension
5137579|NCT01061450|Statins|statins
5137580|NCT01061450|ACE inhibitor|ace inhibitor
5137581|NCT01061450|Echocardiography|echocardiography
5137582|NCT01061437|H. pylori|h. pylori
5137583|NCT01061424|pediatric asthma|pediatric asthma
5137584|NCT01061398|cardiac ct|cardiac ct
5137585|NCT01061398|stress testing|stress testing
5137586|NCT01061398|coronary artery disease|coronary artery disease
5137587|NCT01061372|RLS|rls
5137588|NCT01061359|Breast Cancer|breast cancer
5137589|NCT01061359|Neoadjuvant Treatment|neoadjuvant treatment
5137590|NCT01061359|Chemotherapy|chemotherapy
5137591|NCT01061359|Adjuvant|adjuvant
5137592|NCT01061359|Epirubicin|epirubicin
5137593|NCT01061346|Fructose|fructose
5137594|NCT01061346|Glucose|glucose
5137595|NCT01061320|Alpha-Tocopherol (Vitamin E)|alpha-tocopherol (vitamin e)
5137596|NCT01061320|Contrast induced nephropathy|contrast induced nephropathy
5137597|NCT01061320|Chronic kidney disease|chronic kidney disease
5137598|NCT01061320|Coronary procedures|coronary procedures
5137599|NCT01061307|Fe deficiency, Zn deficiency, vitamin A deficiency|fe deficiency, zn deficiency, vitamin a deficiency
5137600|NCT01061294|Assess the efficacy, predictability and safety of the Advanced CustomVue™ iLASIK procedure.|assess the efficacy, predictability and safety of the advanced customvue™ ilasik procedure.
5137601|NCT01061281|Aphakia following refractive lensectomy to treat presbyopia|aphakia following refractive lensectomy to treat presbyopia
5137602|NCT01061268|Relief of dry eye symptoms following implantation of TMF IOL|relief of dry eye symptoms following implantation of tmf iol
5137603|NCT01061255|Stress|stress
5137604|NCT01061255|Cortisol|cortisol
5137605|NCT01061255|Clinical reasoning|clinical reasoning
5137606|NCT01061255|Ambulatory setting|ambulatory setting
5137607|NCT01061255|Medical students|medical students
5137608|NCT01061255|Year 6 medical students|year 6 medical students
5137609|NCT01061242|Neurocognitive function|neurocognitive function
5137610|NCT01061242|Sleep quality|sleep quality
5137611|NCT01061242|Critical care|critical care
5137612|NCT01061242|Quality Assurance, health care|quality assurance, health care
5137613|NCT01061216|Diabetes|diabetes
5137614|NCT01061216|Insulin Therapy|insulin therapy
5137615|NCT01061216|Blood Glucose|blood glucose
5137616|NCT01061216|Basal insulin|basal insulin
5137617|NCT01061216|Diabetics|diabetics
5137618|NCT01061203|Rhinitis|rhinitis
5137619|NCT01061203|allergic|allergic
5137620|NCT01061203|Seasonal|seasonal
5137621|NCT01061203|grass|grass
5137622|NCT01061203|Asthma|asthma
5137623|NCT01061190|Stroke|stroke
5137624|NCT01061177|Leukemia|leukemia
5137625|NCT01061177|myeloid|myeloid
5137626|NCT01061177|myelogenous|myelogenous
5137627|NCT01061177|chronic BCR-ABL positive|chronic bcr-abl positive
5137628|NCT01061177|Nilotinib|nilotinib
5137629|NCT01061177|Philadelphia chromosome|philadelphia chromosome
5137630|NCT01061177|CML in chronic phase|cml in chronic phase
5137631|NCT01061151|Mother to Child Transmission|mother to child transmission
5137632|NCT01061151|HIV Infection|hiv infection
5137633|NCT01061151|HAART|haart
5137634|NCT01061151|Maternal Health|maternal health
5137635|NCT01061151|Breastfeeding|breastfeeding
5137636|NCT01061151|Perinatal transmission|perinatal transmission
5137637|NCT01061138|breast cancer|breast cancer
5137638|NCT01061138|screening mammograms|screening mammograms
5137639|NCT01061138|breast biopsy|breast biopsy
5137640|NCT01061125|atrial fibrillation|atrial fibrillation
5137641|NCT01061125|implantable loop recorder|implantable loop recorder
5137642|NCT01061125|TTM|ttm
5137643|NCT01061112|drug interactions|drug interactions
5137644|NCT01061112|genetics|genetics
5137645|NCT01061112|healthy volunteers|healthy volunteers
5137646|NCT01061112|normal controls|normal controls
5137647|NCT01061112|CYP2C9|cyp2c9
5137648|NCT01061099|Type II or Type III Osteogenesis imperfecta|type ii or type iii osteogenesis imperfecta
5137649|NCT01061099|OI|oi
5137650|NCT01061099|Mesenchymal Stromal Cells|mesenchymal stromal cells
5137651|NCT01061099|MSC|msc
5137652|NCT01061086|Acute Coronary Syndromes|acute coronary syndromes
5137653|NCT01061086|Epidemiology|epidemiology
5137654|NCT01061086|Management of disease|management of disease
5137655|NCT01061086|Outcomes|outcomes
5137656|NCT01061086|Greece|greece
5137657|NCT01061060|Prostaglandin I2|prostaglandin i2
5137658|NCT01061060|Beraprost Na|beraprost na
5137659|NCT01061060|Endothelial cell function|endothelial cell function
5137660|NCT01061047|patients infected with a bacteria sensible to ertapeneme|patients infected with a bacteria sensible to ertapeneme
5137661|NCT01061034|pharmacokinetics|pharmacokinetics
5137662|NCT01061034|aspirin|aspirin
5137663|NCT01061034|proton pump inhiditor|proton pump inhiditor
5137664|NCT01061021|HIV prevention|hiv prevention
5137665|NCT01061021|Treatment adherence|treatment adherence
5137666|NCT01061021|Treatment for Prevention|treatment for prevention
5137667|NCT01061008|Exercise; arteriovenous fistula; chronic kidney disease|exercise; arteriovenous fistula; chronic kidney disease
5137668|NCT01060995|Informed Consent|informed consent
5137669|NCT01060995|Oral Health|oral health
5137670|NCT01060995|Patient Decision-making|patient decision-making
5137671|NCT01060982|Primary hyperparathyroidism|primary hyperparathyroidism
5137672|NCT01060982|High Intensity Focused Ultrasound|high intensity focused ultrasound
5137673|NCT01060982|Parathyroid tumor|parathyroid tumor
5137674|NCT01060982|Parathyroid hormone|parathyroid hormone
5137675|NCT01060982|Calcium|calcium
5137676|NCT01060969|Acute Mountain Sickness|acute mountain sickness
5137677|NCT01060969|travellers|travellers
5137678|NCT01060969|Acetazolamide|acetazolamide
5137679|NCT01060969|Tadalafil|tadalafil
5137680|NCT01060969|Acute Mountain Sickness assessed by Lake Louise score|acute mountain sickness assessed by lake louise score
5137681|NCT01060969|High altitude pulmonary edema|high altitude pulmonary edema
5137682|NCT01060969|High altitude cerebral edema|high altitude cerebral edema
5137683|NCT01060956|Urinary tract infection with two bacteria in culture|urinary tract infection with two bacteria in culture
5137684|NCT01060943|injectable collagen filler|injectable collagen filler
5137685|NCT01060943|correction of wrinkles and folds|correction of wrinkles and folds
5137686|NCT01060943|enrolled : 73|enrolled : 73
5137687|NCT01060943|withdrawal : 4|withdrawal : 4
5137688|NCT01060943|ongoing : 0|ongoing : 0
5137689|NCT01060943|completed : 69|completed : 69
5137690|NCT01060930|Nitric oxide|nitric oxide
5137691|NCT01060930|Diesel exhaust|diesel exhaust
5137692|NCT01060930|Air pollution|air pollution
5137693|NCT01060930|Cardiac output|cardiac output
5137694|NCT01060930|Healthy volunteers|healthy volunteers
5137695|NCT01060917|diabetes|diabetes
5137696|NCT01060904|Antibodies, Monoclonal|antibodies, monoclonal
5137697|NCT01060904|Antibody-Drug Conjugate|antibody-drug conjugate
5137698|NCT01060904|Antigens, CD30|antigens, cd30
5137699|NCT01060904|Disease, Hodgkin|disease, hodgkin
5137700|NCT01060904|Hematologic Diseases|hematologic diseases
5137701|NCT01060904|Immunotherapy|immunotherapy
5137702|NCT01060904|Lymphoma|lymphoma
5137703|NCT01060904|monomethyl auristatin E|monomethyl auristatin e
5137704|NCT01060891|patients infected with with multiresistant gram-negative bacteria|patients infected with with multiresistant gram-negative bacteria
5137705|NCT01060878|Early-stage|early-stage
5137706|NCT01060865|hypertension|hypertension
5137707|NCT01060865|aliskiren|aliskiren
5137708|NCT01060865|Blood Pressure Monitoring, Ambulatory|blood pressure monitoring, ambulatory
5137709|NCT01060839|counseling|counseling
5137710|NCT01060826|acute pancreatits|acute pancreatits
5137711|NCT01060813|cirrhosis|cirrhosis
5137712|NCT01060813|exercise|exercise
5137713|NCT01060813|leucin|leucin
5137714|NCT01060813|glutamine synthetase|glutamine synthetase
5137715|NCT01060800|Chiari|chiari
5137716|NCT01060800|Chiari Type I|chiari type i
5137717|NCT01060800|Chiari Type I Malformation|chiari type i malformation
5137718|NCT01060800|Familial Chiari|familial chiari
5137719|NCT01060774|Bupivacaine|bupivacaine
5137720|NCT01060774|Inflammation|inflammation
5137721|NCT01060774|Pain|pain
5137722|NCT01060774|Local Anesthetic|local anesthetic
5137723|NCT01060774|peripheral sensitization|peripheral sensitization
5137724|NCT01060761|cancer|cancer
5137725|NCT01060761|Rehabilitation program (patient and a relative together)|rehabilitation program (patient and a relative together)
5137726|NCT01060761|counselling|counselling
5137727|NCT01060761|retreat weekend|retreat weekend
5137728|NCT01060748|Vaccination|vaccination
5137729|NCT01060748|Challenge|challenge
5137730|NCT01060748|Diarrhea|diarrhea
5137731|NCT01060748|ETEC illness|etec illness
5137732|NCT01060748|Travelers diarrhea|travelers diarrhea
5137733|NCT01060748|ETEC|etec
5137734|NCT01060748|Enterotoxigenic E.coli|enterotoxigenic e.coli
5137735|NCT01060735|Vitamin D|vitamin d
5137736|NCT01060735|pregnancy|pregnancy
5137737|NCT01060735|children|children
5137738|NCT01060735|bone|bone
5137739|NCT01060735|quantitative ultrasound|quantitative ultrasound
5137740|NCT01060735|Healthy pregnant women|healthy pregnant women
5137741|NCT01060722|Healthy Male Volunteers|healthy male volunteers
5137742|NCT01060709|Carbon dioxide|carbon dioxide
5137743|NCT01060709|TcC02|tcc02
5137744|NCT01060709|Hypoventilation|hypoventilation
5137745|NCT01060709|endoscopic|endoscopic
5137746|NCT01060709|elective colonoscopy and requiring sedation|elective colonoscopy and requiring sedation
5137747|NCT01060696|Infertility|infertility
5137748|NCT01060696|Saline infusion sonohysterography|saline infusion sonohysterography
5137749|NCT01060696|Pain|pain
5137750|NCT01060696|Hyoscine|hyoscine
5137751|NCT01060696|Mefenamic acid|mefenamic acid
5137752|NCT01060696|women|women
5137753|NCT01060683|hemoglobin|hemoglobin
5137754|NCT01060683|Coagulation variables|coagulation variables
5137755|NCT01060683|blood chemistry|blood chemistry
5137756|NCT01060683|Blood gas analysis|blood gas analysis
5137757|NCT01060670|Foot Ulcer|foot ulcer
5137758|NCT01060670|Diabetic|diabetic
5137759|NCT01060670|Wound Healing|wound healing
5137760|NCT01060670|Integra Dermal Regeneration Template|integra dermal regeneration template
5137761|NCT01060670|Full Thickness|full thickness
5137762|NCT01060670|Neuropathic|neuropathic
5137763|NCT01060670|Omnigraft|omnigraft
5137764|NCT01060657|X-ray Computed Tomography|x-ray computed tomography
5137765|NCT01060657|Coronary vessels|coronary vessels
5137766|NCT01060657|Radiation dosage|radiation dosage
5137767|NCT01060644|Maxillary Sinus|maxillary sinus
5137768|NCT01060644|Bone Augmentation|bone augmentation
5137769|NCT01060644|Dental Implant|dental implant
5137770|NCT01060644|Sinus Membrane|sinus membrane
5137771|NCT01060631|bispectral index|bispectral index
5137772|NCT01060631|lesions|lesions
5137773|NCT01060631|consciousness|consciousness
5137774|NCT01060605|islet transplantation|islet transplantation
5137775|NCT01060605|insulin independence|insulin independence
5137776|NCT01060605|C-peptide secretion|c-peptide secretion
5137777|NCT01060592|Gastric Band|gastric band
5137778|NCT01060592|LapBand|lapband
5137779|NCT01060592|Bariatric Surgery|bariatric surgery
5137780|NCT01060579|Glaucoma|glaucoma
5137781|NCT01060553|Post-traumatic stress disorders|post-traumatic stress disorders
5137782|NCT01060553|Acupuncture|acupuncture
5137783|NCT01060553|Quality of life|quality of life
5137784|NCT01060553|sleep disorder|sleep disorder
5137785|NCT01060540|genetic screening|genetic screening
5137786|NCT01060527|irritable bowel syndrome,protease activity,China|irritable bowel syndrome,protease activity,china
5137787|NCT01060514|Lung cancer|lung cancer
5137788|NCT01060514|Breast cancer|breast cancer
5137789|NCT01060501|rectal cancer|rectal cancer
5137790|NCT01060501|adjuvant chemoradiotherapy|adjuvant chemoradiotherapy
5137791|NCT01060501|5-FU, interferon-alpha|5-fu, interferon-alpha
5137792|NCT01060501|Locally advanced resectable rectal cancer (UICC stage II and III)|locally advanced resectable rectal cancer (uicc stage ii and iii)
5137793|NCT01060488|GH secretion tests|gh secretion tests
5137794|NCT01060488|adverse effects|adverse effects
5137795|NCT01060488|adult growth hormone deficiency|adult growth hormone deficiency
5137796|NCT01060488|growth-hormone releasing hormone and arginine test|growth-hormone releasing hormone and arginine test
5137797|NCT01060488|insulin tolerance test|insulin tolerance test
5137798|NCT01060488|GHRH + Arginine test|ghrh + arginine test
5137799|NCT01060475|Transplant|transplant
5137800|NCT01060462|Defervescence rate|defervescence rate
5137801|NCT01060462|Defervescence timing|defervescence timing
5137802|NCT01060462|Itraconazole|itraconazole
5137803|NCT01060449|cardiac resynchronization therapy|cardiac resynchronization therapy
5137804|NCT01060449|congestive heart failure|congestive heart failure
5137805|NCT01060436|sleep apnea|sleep apnea
5137806|NCT01060436|sleep disordered breathing|sleep disordered breathing
5137807|NCT01060436|CPAP|cpap
5137808|NCT01060436|BiPAP|bipap
5137809|NCT01060436|treatment outcomes|treatment outcomes
5137810|NCT01060423|colorectal|colorectal
5137811|NCT01060423|liver metastasis|liver metastasis
5137812|NCT01060423|KRAS wildtype|kras wildtype
5137813|NCT01060423|chemoembolization|chemoembolization
5137814|NCT01060423|irinotecan eluting beads|irinotecan eluting beads
5137815|NCT01060410|Myelosuppression|myelosuppression
5137816|NCT01060410|Infection|infection
5137817|NCT01060410|Nausea|nausea
5137818|NCT01060397|Alcohol|alcohol
5137819|NCT01060397|nurse|nurse
5137820|NCT01060397|alcohol dependence|alcohol dependence
5137821|NCT01060397|acute hospital|acute hospital
5137822|NCT01060397|brief interventions|brief interventions
5137823|NCT01060371|Spinocerebellar Ataxia|spinocerebellar ataxia
5137824|NCT01060371|Natural History|natural history
5137825|NCT01060371|Genetic Modifiers|genetic modifiers
5137826|NCT01060371|DNA testing|dna testing
5137827|NCT01060358|lumbar spine|lumbar spine
5137828|NCT01060358|low back pain|low back pain
5137829|NCT01060345|DCIS|dcis
5137830|NCT01060293|Heart Failure|heart failure
5137831|NCT01060293|Dopamine|dopamine
5137832|NCT01060293|Furosemide|furosemide
5137833|NCT01060293|Worsening Renal Function|worsening renal function
5137834|NCT01060293|Hypokalemia|hypokalemia
5137835|NCT01060293|Outcomes|outcomes
5137836|NCT01060293|Prognosis|prognosis
5137837|NCT01060280|low back pain|low back pain
5137838|NCT01060280|physiotherapy|physiotherapy
5137839|NCT01060280|exercise|exercise
5137840|NCT01060280|active management|active management
5137841|NCT01060254|Interstitial cystitis (IC) and/or painful bladder syndrome (PBS)-related pain|interstitial cystitis (ic) and/or painful bladder syndrome (pbs)-related pain
5137842|NCT01060254|Moderate to severe chronic bladder pain|moderate to severe chronic bladder pain
5137843|NCT01060254|JNJ-42160443|jnj-42160443
5137844|NCT01060241|Remote Blood Glucose Monitoring System, Type 2 Diabetes|remote blood glucose monitoring system, type 2 diabetes
5137845|NCT01060228|Paliperidone ER|paliperidone er
5137846|NCT01060228|INVEGA|invega
5137847|NCT01060228|Divalproex sodium|divalproex sodium
5137848|NCT01060228|Depakote ER|depakote er
5137849|NCT01060228|Pharmacokinetics|pharmacokinetics
5137850|NCT01060228|Valproic Acid|valproic acid
5137851|NCT01060228|Human Experimentation|human experimentation
5137852|NCT01060215|effusion|effusion
5137853|NCT01060215|osteoarthritis|osteoarthritis
5137854|NCT01060215|knee|knee
5137855|NCT01060202|Multiple Myeloma|multiple myeloma
5137856|NCT01060202|Bortezomib|bortezomib
5137857|NCT01060202|Velcade|velcade
5137858|NCT01060202|QoL|qol
5137859|NCT01060202|Proteasome inhibitor|proteasome inhibitor
5137860|NCT01060202|EORTC QLQ C30|eortc qlq c30
5137861|NCT01060202|EQ 5D|eq 5d
5137862|NCT01060189|ulinastatin|ulinastatin
5137863|NCT01060189|tranexamic acid|tranexamic acid
5137864|NCT01060189|cardiac surgery procedures|cardiac surgery procedures
5137865|NCT01060189|hemostasis|hemostasis
5137866|NCT01060189|anti-inflammation|anti-inflammation
5137867|NCT01060176|tranexamic acid|tranexamic acid
5137868|NCT01060176|cardiac surgery procedures|cardiac surgery procedures
5137869|NCT01060176|hemostasis|hemostasis
5137870|NCT01060176|anti-inflammation|anti-inflammation
5137871|NCT01060163|Clopidogrel|clopidogrel
5137872|NCT01060163|Tranexamic Acid|tranexamic acid
5137873|NCT01060163|Cardiac Surgical Procedures|cardiac surgical procedures
5137874|NCT01060163|Hemostasis|hemostasis
5137875|NCT01060150|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
5137876|NCT01060150|Methylphenidate hydrochloride|methylphenidate hydrochloride
5137877|NCT01060150|Methylphenidate|methylphenidate
5137878|NCT01060150|CONCERTA|concerta
5137879|NCT01060137|fentanyl matrix|fentanyl matrix
5137880|NCT01060124|Pain; Cancer|pain; cancer
5137881|NCT01060124|TTS-Fentanyl D-trans|tts-fentanyl d-trans
5137882|NCT01060124|Durogesic D-trans|durogesic d-trans
5137883|NCT01060111|Migraine|migraine
5137884|NCT01060111|Topiramate|topiramate
5137885|NCT01060111|Propranolol|propranolol
5137886|NCT01060085|Breast Cancer|breast cancer
5137887|NCT01060059|diabetes; exenatide; Byetta; basal insulin; Amylin; Lilly|diabetes; exenatide; byetta; basal insulin; amylin; lilly
5137888|NCT01060046|biologic mesh|biologic mesh
5137889|NCT01060046|ventral hernia repair|ventral hernia repair
5137890|NCT01060046|breast reconstruction|breast reconstruction
5137891|NCT01060046|MMPs|mmps
5137892|NCT01060033|Squamous cell cervical cancer|squamous cell cervical cancer
5137893|NCT01060020|Aortic valve stenosis|aortic valve stenosis
5137894|NCT01060020|Sildenafil|sildenafil
5137895|NCT01060020|Phosphodiesterase inhibitors|phosphodiesterase inhibitors
5137896|NCT01060020|Hypertension, Pulmonary|hypertension, pulmonary
5137897|NCT01059994|fatigue|fatigue
5137898|NCT01059994|aging|aging
5137899|NCT01059968|bone density|bone density
5137900|NCT01059968|energy availability|energy availability
5137901|NCT01059968|menstrual status|menstrual status
5137902|NCT01059968|female|female
5137903|NCT01059968|adolescent|adolescent
5137904|NCT01059955|scleritis|scleritis
5137905|NCT01059955|anterior scleritis|anterior scleritis
5137906|NCT01059955|nodular anterior scleritis|nodular anterior scleritis
5137907|NCT01059955|diffuse anterior scleritis|diffuse anterior scleritis
5137908|NCT01059942|communication barriers|communication barriers
5137909|NCT01059942|clinical competence|clinical competence
5137910|NCT01059942|medical education|medical education
5137911|NCT01059942|internship and residency|internship and residency
5137912|NCT01059942|hospitalist|hospitalist
5137913|NCT01059942|Quality Assurance, Healthcare|quality assurance, healthcare
5137914|NCT01059942|Patient Care|patient care
5137915|NCT01059942|Internal Medicine|internal medicine
5137916|NCT01059929|Hypnotics and Sedatives|hypnotics and sedatives
5137917|NCT01059929|Respiration, Artificial|respiration, artificial
5137918|NCT01059929|Ventilators, Mechanical|ventilators, mechanical
5137919|NCT01059929|Critical care|critical care
5137920|NCT01059929|Intensive care|intensive care
5137921|NCT01059929|Physical therapy|physical therapy
5137922|NCT01059929|Occupational therapy|occupational therapy
5137923|NCT01059929|Sedative medications|sedative medications
5137924|NCT01059903|Rotigotine|rotigotine
5137925|NCT01059903|Neupro®|neupro®
5137926|NCT01059903|Transdermal Patch|transdermal patch
5137927|NCT01059877|dementia alzheimers frontotemporal lyme,|dementia alzheimers frontotemporal lyme,
5137928|NCT01059877|lewy body cognitive impairment|lewy body cognitive impairment
5137929|NCT01059864|cholesterol|cholesterol
5137930|NCT01059864|lipids|lipids
5137931|NCT01059864|rheumatoid arthritis|rheumatoid arthritis
5137932|NCT01059864|CP-690|cp-690
5137933|NCT01059864|550|550
5137934|NCT01059838|pediatrics|pediatrics
5137935|NCT01059838|cochlear implant|cochlear implant
5137936|NCT01059825|Phase 2|phase 2
5137937|NCT01059825|safety and efficacy study with ertugliflozin (PF-04971729, MK-8835)|safety and efficacy study with ertugliflozin (pf-04971729, mk-8835)
5137938|NCT01059825|Type 2 diabetes mellitus|type 2 diabetes mellitus
5137939|NCT01059786|Monoclonal Antibody|monoclonal antibody
5137940|NCT01059786|Purine Analog|purine analog
5137941|NCT01059786|Soluble CD25|soluble cd25
5137942|NCT01059786|Minimal Residual Disease MRD|minimal residual disease mrd
5137943|NCT01059786|CD20|cd20
5137944|NCT01059786|Hairy Cell Leukemia|hairy cell leukemia
5137945|NCT01059773|Psoriasis|psoriasis
5137946|NCT01059773|Ustekinumab|ustekinumab
5137947|NCT01059773|Stelara|stelara
5137948|NCT01059773|Methotrexate|methotrexate
5137949|NCT01059773|Biologic|biologic
5137950|NCT01059760|Fasting|fasting
5137951|NCT01059760|Short-term starvation|short-term starvation
5137952|NCT01059760|Diet|diet
5137953|NCT01059760|Coronary artery disease|coronary artery disease
5137954|NCT01059734|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5137955|NCT01059734|adult acute myeloid leukemia with del(5q)|adult acute myeloid leukemia with del(5q)
5137956|NCT01059734|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5137957|NCT01059734|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5137958|NCT01059734|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5137959|NCT01059734|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5137960|NCT01059734|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
5137961|NCT01059734|adult erythroleukemia (M6a)|adult erythroleukemia (m6a)
5137962|NCT01059734|adult pure erythroid leukemia (M6b)|adult pure erythroid leukemia (m6b)
5137963|NCT01059734|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
5137964|NCT01059734|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
5137965|NCT01059734|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
5138090|NCT01059279|Inflammatory proteins|inflammatory proteins
5137966|NCT01059734|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
5137967|NCT01059734|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
5137968|NCT01059734|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5137969|NCT01059734|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
5137970|NCT01059734|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
5137971|NCT01059721|Centralisation|centralisation
5137972|NCT01059721|Patella dislocation|patella dislocation
5137973|NCT01059721|Open epiphyses|open epiphyses
5137974|NCT01059721|Malalignment syndrome|malalignment syndrome
5137975|NCT01059721|Relapse rate|relapse rate
5137976|NCT01059708|outcomes carbon monoxide poisoning children pediatric|outcomes carbon monoxide poisoning children pediatric
5137977|NCT01059695|cervical cancer|cervical cancer
5137978|NCT01059695|retrospective|retrospective
5137979|NCT01059695|quality of life|quality of life
5137980|NCT01059695|treatment|treatment
5137981|NCT01059669|Chronic pancreatitis|chronic pancreatitis
5137982|NCT01059669|Pain|pain
5137983|NCT01059669|Exocrine insufficiency|exocrine insufficiency
5137984|NCT01059669|Diabetes|diabetes
5137985|NCT01059669|Nutrition|nutrition
5137986|NCT01059669|Ultrasound|ultrasound
5137987|NCT01059656|Dermatofibrosarcoma|dermatofibrosarcoma
5137988|NCT01059656|Pazopanib¨|pazopanib¨
5137989|NCT01059656|Phase II|phase ii
5137990|NCT01059630|follicular|follicular
5137991|NCT01059630|follicular lymphoma|follicular lymphoma
5137992|NCT01059617|Pandemic|pandemic
5137993|NCT01059617|GSK Bio's influenza vaccine GSK2340274A|gsk bio's influenza vaccine gsk2340274a
5137994|NCT01059617|H1N1|h1n1
5137995|NCT01059617|Influenza|influenza
5137996|NCT01059604|pregnancy outcomes|pregnancy outcomes
5137997|NCT01059604|pregnancy|pregnancy
5137998|NCT01059604|first trimester|first trimester
5137999|NCT01059604|Sumatriptan|sumatriptan
5138000|NCT01059604|major congenital malformations|major congenital malformations
5138001|NCT01059604|naratriptan|naratriptan
5138002|NCT01059604|sumatriptan-naproxen combination|sumatriptan-naproxen combination
5138003|NCT01059604|pregnancy registry|pregnancy registry
5138004|NCT01059591|NK1 antagonist and SSRI|nk1 antagonist and ssri
5138005|NCT01059591|Healthy subjects|healthy subjects
5138006|NCT01059591|Safety|safety
5138007|NCT01059591|First time in Human|first time in human
5138008|NCT01059578|Nk1 Antagonist and SSRI|nk1 antagonist and ssri
5138009|NCT01059578|Safety|safety
5138010|NCT01059578|First Time in Humans|first time in humans
5138011|NCT01059578|Healthy Subjects|healthy subjects
5138012|NCT01059565|Cystic Fibrosis|cystic fibrosis
5138013|NCT01059565|Aztreonam Lysine|aztreonam lysine
5138014|NCT01059565|lung infection|lung infection
5138015|NCT01059565|Burkholderia|burkholderia
5138016|NCT01059565|CFQ-R|cfq-r
5138017|NCT01059565|inhaled antibiotic|inhaled antibiotic
5138018|NCT01059552|lung cancer|lung cancer
5138019|NCT01059552|locally advanced lung cancer|locally advanced lung cancer
5138020|NCT01059539|mania|mania
5138021|NCT01059539|acute mania|acute mania
5138022|NCT01059539|bipolar I disorder|bipolar i disorder
5138023|NCT01059526|HAE|hae
5138024|NCT01059513|T1c|t1c
5138025|NCT01059513|T2a|t2a
5138026|NCT01059513|T2b|t2b
5138027|NCT01059500|Computer-derived, quantitative pretest probability (PTP)|computer-derived, quantitative pretest probability (ptp)
5138028|NCT01059500|Overtesting|overtesting
5138029|NCT01059500|Radiation|radiation
5138030|NCT01059500|Intravenous Contrast|intravenous contrast
5138031|NCT01059500|Anticoagulation|anticoagulation
5138032|NCT01059487|Traditional Chinese Medicine|traditional chinese medicine
5138033|NCT01059487|Acupuncture|acupuncture
5138034|NCT01059474|DMPS|dmps
5138035|NCT01059474|mercury|mercury
5138036|NCT01059461|Hypoxic Ischemic Encephalopathy (HIE)|hypoxic ischemic encephalopathy (hie)
5138037|NCT01059461|Perinatal Asphyxia|perinatal asphyxia
5138038|NCT01059461|Nerve growth factor|nerve growth factor
5138039|NCT01059461|Cerebrolysin|cerebrolysin
5138040|NCT01059461|Cerebral palsy|cerebral palsy
5138041|NCT01059448|Amgen|amgen
5138042|NCT01059448|RA|ra
5138043|NCT01059448|AMG 827|amg 827
5138044|NCT01059448|20090061|20090061
5138045|NCT01059435|Amgen|amgen
5138046|NCT01059435|First in Human|first in human
5138047|NCT01059435|Postmenopausal|postmenopausal
5138048|NCT01059435|Phase 1|phase 1
5138049|NCT01059409|Meniscal Allografts|meniscal allografts
5138050|NCT01059409|Osteoarthritis|osteoarthritis
5138051|NCT01059383|Gastroesophageal Reflux|gastroesophageal reflux
5138052|NCT01059383|GERD|gerd
5138053|NCT01059383|Nocturnal GERD|nocturnal gerd
5138054|NCT01059383|Heartburn|heartburn
5138055|NCT01059383|Nighttime Heartburn|nighttime heartburn
5138056|NCT01059370|Autonomic dysfunction|autonomic dysfunction
5138057|NCT01059370|Spinal cord injured|spinal cord injured
5138058|NCT01059370|Neurogenic bowel|neurogenic bowel
5138059|NCT01059370|Neurogenic bladder|neurogenic bladder
5138060|NCT01059344|Mesalamine|mesalamine
5138061|NCT01059344|Asacol|asacol
5138062|NCT01059344|Ulcerative colitis|ulcerative colitis
5138063|NCT01059344|induction therapy|induction therapy
5138064|NCT01059344|acute disease|acute disease
5138065|NCT01059344|mild to moderate|mild to moderate
5138066|NCT01059344|Active Ulcerative Colitis (mild to moderate)|active ulcerative colitis (mild to moderate)
5138067|NCT01059331|Kidney|kidney
5138068|NCT01059318|Lymphangioleiomyomatosis,|lymphangioleiomyomatosis,
5138069|NCT01059318|High Resolution CT scan,|high resolution ct scan,
5138070|NCT01059318|chest x-ray,|chest x-ray,
5138071|NCT01059318|6 minute walk test,|6 minute walk test,
5138072|NCT01059318|pulse oximetry,|pulse oximetry,
5138073|NCT01059318|renal MRI,|renal mri,
5138074|NCT01059318|Pikometer|pikometer
5138075|NCT01059305|Erlotinib|erlotinib
5138076|NCT01059305|Erlotinib Hydrochloride|erlotinib hydrochloride
5138077|NCT01059305|OSI-774|osi-774
5138078|NCT01059305|Tarceva|tarceva
5138079|NCT01059305|Squamous cell carcinoma of the skin|squamous cell carcinoma of the skin
5138080|NCT01059305|Aggressive cutaneous squamous cell carcinoma|aggressive cutaneous squamous cell carcinoma
5138081|NCT01059305|CSCC|cscc
5138082|NCT01059305|Local surgery|local surgery
5138083|NCT01059305|Radiation therapy|radiation therapy
5138084|NCT01059305|Epidermal growth factor receptor|epidermal growth factor receptor
5138085|NCT01059305|EGFR|egfr
5138086|NCT01059305|Small Molecule Tyrosine Kinase Inhibitor|small molecule tyrosine kinase inhibitor
5138087|NCT01059292|we have complieted party research|we have complieted party research
5138088|NCT01059279|Familial Mediterranean fever|familial mediterranean fever
5138089|NCT01059279|Cytokines|cytokines
5138091|NCT01059279|MEFV|mefv
5138092|NCT01059279|mutations|mutations
5138093|NCT01059279|Heat Intolerance|heat intolerance
5138094|NCT01059279|Heat Tolerance Test|heat tolerance test
5138095|NCT01059266|immunotherapy|immunotherapy
5138096|NCT01059266|grass pollen|grass pollen
5138097|NCT01059266|seasonal allergy|seasonal allergy
5138098|NCT01059266|dose tolerability|dose tolerability
5138099|NCT01059253|Falls|falls
5138100|NCT01059253|Balance|balance
5138101|NCT01059253|Elderly|elderly
5138102|NCT01059253|Aged|aged
5138103|NCT01059240|Survival Motor Neuron 1 (SMN1)|survival motor neuron 1 (smn1)
5138104|NCT01059240|Survival Motor Neuron 2 (SMN2)|survival motor neuron 2 (smn2)
5138105|NCT01059240|Spinal Muscular Atrophy (SMA)|spinal muscular atrophy (sma)
5138106|NCT01059240|SMN Copy Number in Mali|smn copy number in mali
5138107|NCT01059240|Spinal Muscular Antrophy|spinal muscular antrophy
5138108|NCT01059240|SMA|sma
5138109|NCT01059227|Treatment|treatment
5138110|NCT01059227|Anxiety|anxiety
5138111|NCT01059227|Fear|fear
5138112|NCT01059227|Fear Potentiated Startle|fear potentiated startle
5138113|NCT01059227|Healthy Volunteer|healthy volunteer
5138114|NCT01059227|HV|hv
5138115|NCT01059214|Acute Myocardial Infarction|acute myocardial infarction
5138116|NCT01059214|Reperfusion|reperfusion
5138117|NCT01059214|MRI|mri
5138118|NCT01059214|Heart Attack|heart attack
5138119|NCT01059201|Autism Spectrum Disorder|autism spectrum disorder
5138120|NCT01059201|Cholesterol|cholesterol
5138121|NCT01059201|Exome Sequencing|exome sequencing
5138122|NCT01059201|Autistic Spectrum Disorder|autistic spectrum disorder
5138123|NCT01059201|ASD|asd
5138124|NCT01059188|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5138125|NCT01059188|adenocarcinoma of the lung|adenocarcinoma of the lung
5138126|NCT01059188|adenosquamous cell lung cancer|adenosquamous cell lung cancer
5138127|NCT01059188|large cell lung cancer|large cell lung cancer
5138128|NCT01059188|squamous cell lung cancer|squamous cell lung cancer
5138129|NCT01059175|Heart failure|heart failure
5138130|NCT01059175|Cardiac resynchronization therapy|cardiac resynchronization therapy
5138131|NCT01059175|Biventricular stimulation|biventricular stimulation
5138132|NCT01059175|Multisite stimulation|multisite stimulation
5138133|NCT01059175|Non responders|non responders
5138134|NCT01059162|Glaucoma Surgery|glaucoma surgery
5138135|NCT01059162|Filtering Surgery|filtering surgery
5138136|NCT01059162|Non Penetrating glaucoma surgery|non penetrating glaucoma surgery
5138137|NCT01059149|Rehabilitation|rehabilitation
5138138|NCT01059149|Transcranial magnetic stimulation|transcranial magnetic stimulation
5138139|NCT01059149|Brain magnetic stimulation|brain magnetic stimulation
5138140|NCT01059149|Repetitive|repetitive
5138141|NCT01059149|Stroke|stroke
5138142|NCT01059149|Subacute|subacute
5138143|NCT01059136|Myocardial infarction|myocardial infarction
5138144|NCT01059136|Outcome|outcome
5138145|NCT01059136|Aldosterone|aldosterone
5138146|NCT01059136|Spironolactone|spironolactone
5138147|NCT01059123|Amoxicillin|amoxicillin
5138148|NCT01059123|Erysipelas|erysipelas
5138149|NCT01059123|Short course|short course
5138150|NCT01059110|Occlusive dressings|occlusive dressings
5138151|NCT01059110|Salicylate ointment|salicylate ointment
5138152|NCT01059110|Cryotherapy|cryotherapy
5138153|NCT01059110|Topical 5-fluoro-uracil|topical 5-fluoro-uracil
5138154|NCT01059110|Imiquimod|imiquimod
5138155|NCT01059110|Randomized clinical trial|randomized clinical trial
5138156|NCT01059110|Plantar warts|plantar warts
5138157|NCT01059084|HIV|hiv
5138158|NCT01059084|Valacyclovir|valacyclovir
5138159|NCT01059084|Valtrex®|valtrex®
5138160|NCT01059071|Refractory Neuroblastoma|refractory neuroblastoma
5138161|NCT01059071|Relapsed neuroblastoma|relapsed neuroblastoma
5138162|NCT01059058|MI Paste Plus|mi paste plus
5138163|NCT01059058|Fluoride Varnish|fluoride varnish
5138164|NCT01059058|CPP-ACP|cpp-acp
5138165|NCT01059058|White Spot Lesions|white spot lesions
5138166|NCT01059058|Remineralization|remineralization
5138167|NCT01059058|Orthodontic Treatment|orthodontic treatment
5138168|NCT01059019|Refractive Surgery|refractive surgery
5138169|NCT01059019|PRK|prk
5138170|NCT01059019|Photorefractive Keratectomy|photorefractive keratectomy
5138171|NCT01059019|Omega 3 Fatty Acids|omega 3 fatty acids
5138172|NCT01059019|Cornea|cornea
5138173|NCT01059006|Reflective Surgery|reflective surgery
5138174|NCT01059006|Presbyopia|presbyopia
5138175|NCT01059006|PresbyLASIK|presbylasik
5138176|NCT01058993|neutropenia|neutropenia
5138177|NCT01058993|myelokathexis|myelokathexis
5138178|NCT01058993|WHIM syndrome|whim syndrome
5138179|NCT01058993|AMD 3100|amd 3100
5138180|NCT01058993|plerixafor|plerixafor
5138181|NCT01058993|Myelokathexis syndrome|myelokathexis syndrome
5138182|NCT01058993|Neutropenia due to mutations of CXCR-4|neutropenia due to mutations of cxcr-4
5138183|NCT01058980|catheter ablation|catheter ablation
5138184|NCT01058980|atrial fibrillation|atrial fibrillation
5138185|NCT01058980|adenosine|adenosine
5138186|NCT01058967|Code III trauma (highest acuity)|code iii trauma (highest acuity)
5138187|NCT01058967|Life Flight aeromedical ambulance service|life flight aeromedical ambulance service
5138188|NCT01058941|Alzheimer's disease|alzheimer's disease
5138189|NCT01058941|fish oil|fish oil
5138190|NCT01058941|lipoic acid|lipoic acid
5138191|NCT01058928|Tracheal tube|tracheal tube
5138192|NCT01058928|Size|size
5138193|NCT01058915|ST-Segment Elevation Myocardial Infarction|st-segment elevation myocardial infarction
5138194|NCT01058902|Non small cell lung cancer|non small cell lung cancer
5138195|NCT01058902|survival|survival
5138196|NCT01058902|aspirin|aspirin
5138197|NCT01058889|Diabetes mellitus Type 2|diabetes mellitus type 2
5138198|NCT01058889|Telemedicine|telemedicine
5138199|NCT01058889|Insulin|insulin
5138200|NCT01058876|Smoking|smoking
5138201|NCT01058876|nicotine|nicotine
5138202|NCT01058837|Sudden Cardiac Death|sudden cardiac death
5138203|NCT01058837|Implantable Cardioverter Defibrillator|implantable cardioverter defibrillator
5138204|NCT01058837|Ventricular Fibrillation|ventricular fibrillation
5138205|NCT01058824|Bioequivalence|bioequivalence
5138206|NCT01058824|Lincomycin Hydrocloride|lincomycin hydrocloride
5138207|NCT01058811|lung cancer|lung cancer
5138208|NCT01058798|Neuroblastoma|neuroblastoma
5138209|NCT01058798|B4GALNT3|b4galnt3
5138210|NCT01058798|Prognosis|prognosis
5138211|NCT01058785|Gene therapy|gene therapy
5138212|NCT01058785|Flow cytometry|flow cytometry
5138213|NCT01058785|Immunoenzyme technique|immunoenzyme technique
5138214|NCT01058785|Laboratory biomarker analysis|laboratory biomarker analysis
5138215|NCT01058785|Tumor cell-derivative vaccine therapy|tumor cell-derivative vaccine therapy
5138216|NCT01058772|Induced Labour|induced labour
5138217|NCT01058772|Expectant Management|expectant management
5138218|NCT01058772|C-section rate|c-section rate
5138219|NCT01058772|Maternal Outcomes|maternal outcomes
5138220|NCT01058772|Neonatal Outcomes|neonatal outcomes
5138221|NCT01058759|non-small cell lung cancer|non-small cell lung cancer
5138222|NCT01058759|NSCLC|nsclc
5138223|NCT01058759|Enoxaparin|enoxaparin
5138224|NCT01058759|Locally Advanced or Metastatic Non-small Cell Lung Cancer stadium IIIb/IV|locally advanced or metastatic non-small cell lung cancer stadium iiib/iv
5138225|NCT01058746|pancreas|pancreas
5138226|NCT01058746|surgery|surgery
5138227|NCT01058746|Pancreaticoduodenectomy|pancreaticoduodenectomy
5138228|NCT01058746|Central Pancreatectomy|central pancreatectomy
5138229|NCT01058746|Distal Pancreatectomy|distal pancreatectomy
5138230|NCT01058746|resection|resection
5138231|NCT01058746|IV fluids|iv fluids
5138232|NCT01058746|09-185|09-185
5138233|NCT01058733|semi-automatic response system (SARS)|semi-automatic response system (sars)
5138234|NCT01058733|Diabetes Mellitus|diabetes mellitus
5138235|NCT01058733|Internet|internet
5138236|NCT01058733|ubiquitous health care system|ubiquitous health care system
5138237|NCT01058720|Vitamin D|vitamin d
5138238|NCT01058720|Supplementation|supplementation
5138239|NCT01058720|Adolescence|adolescence
5138240|NCT01058707|Solid tumors, MLN0128, TORC1/2 inhibitors|solid tumors, mln0128, torc1/2 inhibitors
5138241|NCT01058694|Mobile phones,|mobile phones,
5138242|NCT01058694|Medication Adherence|medication adherence
5138243|NCT01058694|Micro-Electrical-Mechanical Systems|micro-electrical-mechanical systems
5138244|NCT01058694|HIV Infections|hiv infections
5138245|NCT01058681|LH pulsatility|lh pulsatility
5138246|NCT01058681|GnRH regulation|gnrh regulation
5138247|NCT01058681|isocaloric nutrition|isocaloric nutrition
5138248|NCT01058681|hypercaloric nutrition|hypercaloric nutrition
5138249|NCT01058681|euglycemic clamps|euglycemic clamps
5138250|NCT01058681|hyperinsulinemic clamps|hyperinsulinemic clamps
5138251|NCT01058681|testosterone|testosterone
5138252|NCT01058681|LH|lh
5138253|NCT01058681|leptine|leptine
5138254|NCT01058681|ghrelin|ghrelin
5138255|NCT01058681|PYY|pyy
5138256|NCT01058681|CCK|cck
5138257|NCT01058681|GLP-1|glp-1
5138258|NCT01058681|GIP|gip
5138259|NCT01058681|cortisol|cortisol
5138260|NCT01058668|Acute Mania|acute mania
5138261|NCT01058668|Bipolar I Disorder|bipolar i disorder
5138262|NCT01058655|Colorectal Cancer|colorectal cancer
5138263|NCT01058642|pain|pain
5138264|NCT01058642|delta opioid receptor agonist|delta opioid receptor agonist
5138265|NCT01058629|Hybrid|hybrid
5138266|NCT01058629|contact lens|contact lens
5138267|NCT01058629|myopia|myopia
5138268|NCT01058629|hyperopia|hyperopia
5138269|NCT01058629|near sighted|near sighted
5138270|NCT01058629|astigmatism|astigmatism
5138271|NCT01058629|far sighted|far sighted
5138272|NCT01058603|Infertility|infertility
5138273|NCT01058603|Cell Culture|cell culture
5138274|NCT01058603|AECC|aecc
5138275|NCT01058603|Endocell|endocell
5138276|NCT01058603|IVF|ivf
5138277|NCT01058590|Inflammation|inflammation
5138278|NCT01058590|Adenotonsillectomy|adenotonsillectomy
5138279|NCT01058577|diabetes|diabetes
5138280|NCT01058564|GERD|gerd
5138281|NCT01058551|Sleep Apnea|sleep apnea
5138282|NCT01058551|Atrial Fibrillation|atrial fibrillation
5138283|NCT01058538|Interleukin, IL2, monoclonal, antibody, cytokine, tumour targeting, solid tumours, dose finding, renal cell carcinoma, fusion protein, RCC,|interleukin, il2, monoclonal, antibody, cytokine, tumour targeting, solid tumours, dose finding, renal cell carcinoma, fusion protein, rcc,
5138284|NCT01058538|L19|l19
5138285|NCT01058512|hepatitis C|hepatitis c
5138286|NCT01058512|chronic HCV|chronic hcv
5138287|NCT01058512|viral HCV|viral hcv
5138288|NCT01058512|genotype 1|genotype 1
5138289|NCT01058512|failed treatment with pegylated interferon plus ribavirin|failed treatment with pegylated interferon plus ribavirin
5138290|NCT01058499|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5138291|NCT01058499|COPD|copd
5138292|NCT01058486|Chronic Disease Management|chronic disease management
5138293|NCT01058486|Physical Activity|physical activity
5138294|NCT01058486|Self-efficacy|self-efficacy
5138295|NCT01058486|Self management|self management
5138296|NCT01058473|Sickle Cell Disease|sickle cell disease
5138297|NCT01058473|Pain|pain
5138298|NCT01058473|Assessment|assessment
5138299|NCT01058460|Cervical Intraepithelial Neoplasia, Grade III|cervical intraepithelial neoplasia, grade iii
5138300|NCT01058460|Cervical Intraepithelial Neoplasia, Grade II|cervical intraepithelial neoplasia, grade ii
5138301|NCT01058447|ADME|adme
5138302|NCT01058447|Healthy volunteers|healthy volunteers
5138303|NCT01058434|Multiple myeloma|multiple myeloma
5138304|NCT01058434|relapsed|relapsed
5138305|NCT01058434|refractory|refractory
5138306|NCT01058434|t(4;14)|t(4;14)
5138307|NCT01058434|FGFR3|fgfr3
5138308|NCT01058421|mechanical ventilation|mechanical ventilation
5138309|NCT01058421|acute respiratory failure|acute respiratory failure
5138310|NCT01058421|physical therapy|physical therapy
5138311|NCT01058421|critical illness neuropathy|critical illness neuropathy
5138312|NCT01058421|critical illness myopathy|critical illness myopathy
5138313|NCT01058408|advanced head and neck cancer|advanced head and neck cancer
5138314|NCT01058408|cisplatin|cisplatin
5138315|NCT01058408|RAD001|rad001
5138316|NCT01058408|radiation|radiation
5138317|NCT01058408|HNSCC|hnscc
5138318|NCT01058395|Traumatic Brain Injury|traumatic brain injury
5138319|NCT01058395|Minocycline|minocycline
5138320|NCT01058395|Outcome|outcome
5138321|NCT01058382|FET|fet
5138322|NCT01058382|Progesterone Support|progesterone support
5138323|NCT01058382|Frozen Embryo Transfer|frozen embryo transfer
5138324|NCT01058356|antibiotics associated colitis|antibiotics associated colitis
5138325|NCT01058356|lactobacilli|lactobacilli
5138326|NCT01058356|probiotics|probiotics
5138327|NCT01058356|prevention|prevention
5138328|NCT01058356|pulmonary infection|pulmonary infection
5138329|NCT01058356|Prevention of antibiotics associated colitis|prevention of antibiotics associated colitis
5138330|NCT01058356|the role of probiotics for prevention of antibiotics associated colitis|the role of probiotics for prevention of antibiotics associated colitis
5138331|NCT01058356|the lactobacilli effect for antibiotics associated colitis|the lactobacilli effect for antibiotics associated colitis
5138429|NCT01057784|quality of life|quality of life
5138430|NCT01057784|body composition|body composition
5138332|NCT01058356|antibiotic associated colitis on pulmonary infectious disease|antibiotic associated colitis on pulmonary infectious disease
5138333|NCT01058343|SLE|sle
5138334|NCT01058330|Neurofibromatosis type 1|neurofibromatosis type 1
5138335|NCT01058330|NF1|nf1
5138336|NCT01058317|respiratory, papilloma, pediatric, juvenile|respiratory, papilloma, pediatric, juvenile
5138337|NCT01058304|osteoarthritis|osteoarthritis
5138338|NCT01058304|knee|knee
5138339|NCT01058304|physical therapy (specialty)|physical therapy (specialty)
5138340|NCT01058304|veterans|veterans
5138341|NCT01058278|Glaucoma|glaucoma
5138342|NCT01058278|Ocular Hypertension|ocular hypertension
5138343|NCT01058278|Intraocular Pressure|intraocular pressure
5138344|NCT01058278|Trabeculectomy|trabeculectomy
5138345|NCT01058239|bortezomib|bortezomib
5138346|NCT01058239|rituximab|rituximab
5138348|NCT01058239|EBV|ebv
5138349|NCT01058239|transplantation|transplantation
5138350|NCT01058226|Experimental malaria challenge|experimental malaria challenge
5138351|NCT01058213|COPD|copd
5138352|NCT01058213|Pulmonary rehabilitation|pulmonary rehabilitation
5138353|NCT01058213|Resistance Training|resistance training
5138354|NCT01058213|Aerobic Training|aerobic training
5138355|NCT01058213|Dyspnea|dyspnea
5138356|NCT01058174|Prophylaxis|prophylaxis
5138357|NCT01058174|Liver transplantation|liver transplantation
5138358|NCT01058174|Invasive Fungal Infection|invasive fungal infection
5138359|NCT01058174|Micafungin|micafungin
5138360|NCT01058174|Prevention|prevention
5138361|NCT01058174|Mycoses|mycoses
5138362|NCT01058161|wrist and hand cartilage abnormalities in inflammatory and chronic rheumatisms|wrist and hand cartilage abnormalities in inflammatory and chronic rheumatisms
5138363|NCT01058148|Cervical Cancer Screening|cervical cancer screening
5138364|NCT01058148|Cervical Precancer|cervical precancer
5138365|NCT01058148|Self-Collection|self-collection
5138366|NCT01058148|Cytology|cytology
5138367|NCT01058148|Human Papilloma Virus (HPV)|human papilloma virus (hpv)
5138368|NCT01058135|insulin resistance|insulin resistance
5138369|NCT01058135|dietary fiber|dietary fiber
5138370|NCT01058135|resistant starch|resistant starch
5138371|NCT01058122|Adverse drug reactions in patients on the oncology ward|adverse drug reactions in patients on the oncology ward
5138372|NCT01058109|bone health, bone density, bone mass|bone health, bone density, bone mass
5138373|NCT01058096|Acute Mania|acute mania
5138374|NCT01058096|Bipolar I Disorder|bipolar i disorder
5138375|NCT01058070|GERD|gerd
5138376|NCT01058057|atorvastatin|atorvastatin
5138377|NCT01058057|percutaneous coronary intervention|percutaneous coronary intervention
5138378|NCT01058057|periprocedural myocardial infarction|periprocedural myocardial infarction
5138379|NCT01058057|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors
5138380|NCT01058044|Cancer, Sunitinib, capecitabine, anastrozole, letrozole|cancer, sunitinib, capecitabine, anastrozole, letrozole
5138381|NCT01058044|adherence, anticancer treatment|adherence, anticancer treatment
5138382|NCT01058018|Cholesterol|cholesterol
5138383|NCT01058018|High density lipoprotein|high density lipoprotein
5138384|NCT01058018|Atherosclerosis|atherosclerosis
5138385|NCT01058018|ApolipoproteinA1|apolipoproteina1
5138386|NCT01058018|Stable angina artery disease|stable angina artery disease
5138387|NCT01058005|MS|ms
5138388|NCT01057979|exercise|exercise
5138389|NCT01057979|college students|college students
5138390|NCT01057979|Sedentary college students|sedentary college students
5138391|NCT01057966|Bioavailability|bioavailability
5138392|NCT01057966|Ocular Vitamins|ocular vitamins
5138393|NCT01057953|Colo-Rectal Cancer|colo-rectal cancer
5138394|NCT01057914|Randomized controlled trial|randomized controlled trial
5138395|NCT01057914|Malnutrition|malnutrition
5138396|NCT01057914|Aged|aged
5138397|NCT01057914|Aged 80 and over|aged 80 and over
5138398|NCT01057914|Nutrition therapy|nutrition therapy
5138399|NCT01057888|Immunization status for:|immunization status for:
5138400|NCT01057888|Tdap|tdap
5138401|NCT01057888|Menactra|menactra
5138402|NCT01057888|HPV (if female)|hpv (if female)
5138403|NCT01057888|Well child care visit|well child care visit
5138404|NCT01057862|Naltrexone|naltrexone
5138405|NCT01057862|Pathological Gambling|pathological gambling
5138406|NCT01057862|Opioid Antagonist|opioid antagonist
5138407|NCT01057849|schizophrenia|schizophrenia
5138408|NCT01057849|first episode|first episode
5138409|NCT01057849|atypical antipsychotics|atypical antipsychotics
5138410|NCT01057849|psychosocial intervention|psychosocial intervention
5138411|NCT01057849|outcome|outcome
5138412|NCT01057849|effectiveness|effectiveness
5138413|NCT01057823|aged|aged
5138414|NCT01057823|sleep deprivation|sleep deprivation
5138415|NCT01057823|actigraphy|actigraphy
5138416|NCT01057823|ambulatory monitoring|ambulatory monitoring
5138417|NCT01057797|COPD|copd
5138418|NCT01057797|Pulmonary rehabilitation|pulmonary rehabilitation
5138419|NCT01057797|Self-efficacy|self-efficacy
5138420|NCT01057797|Muscle strength|muscle strength
5138421|NCT01057797|Dyspnea|dyspnea
5138422|NCT01057797|Exercise adherence|exercise adherence
5138423|NCT01057784|obesity|obesity
5138424|NCT01057784|bariatric|bariatric
5138425|NCT01057784|surgery|surgery
5138426|NCT01057784|sleeve|sleeve
5138427|NCT01057784|gastric bypass|gastric bypass
5138428|NCT01057784|vitamin D|vitamin d
5138903|NCT01055821|Hepatitis C|hepatitis c
5138431|NCT01057784|bone density|bone density
5138432|NCT01057784|adolescent|adolescent
5138433|NCT01057784|child|child
5138434|NCT01057784|teenager|teenager
5138435|NCT01057784|fertility|fertility
5138436|NCT01057784|offspring|offspring
5138437|NCT01057784|biomarker|biomarker
5138438|NCT01057784|epigenome|epigenome
5138439|NCT01057784|gene expression|gene expression
5138440|NCT01057771|meditation|meditation
5138441|NCT01057771|exercise|exercise
5138442|NCT01057771|immunity|immunity
5138443|NCT01057771|respiratory infection|respiratory infection
5138444|NCT01057771|influenza|influenza
5138445|NCT01057771|flu shot|flu shot
5138446|NCT01057771|immunomodulation|immunomodulation
5138447|NCT01057758|Suspicion of ventilator-associated pneumonia|suspicion of ventilator-associated pneumonia
5138448|NCT01057745|woman|woman
5138449|NCT01057745|chemotherapy|chemotherapy
5138450|NCT01057745|radiation|radiation
5138451|NCT01057745|fertility preservation|fertility preservation
5138452|NCT01057745|cryobank|cryobank
5138453|NCT01057719|cross-over design|cross-over design
5138454|NCT01057719|mixed model|mixed model
5138455|NCT01057719|multiple sclerosis|multiple sclerosis
5138456|NCT01057719|physical performance measures|physical performance measures
5138457|NCT01057719|physical therapy|physical therapy
5138458|NCT01057719|the Bobath concept|the bobath concept
5138459|NCT01057719|warm climate|warm climate
5138460|NCT01057719|6-minute walk test|6-minute walk test
5138461|NCT01057706|chiropractic|chiropractic
5138462|NCT01057706|exercise|exercise
5138463|NCT01057706|seniors|seniors
5138464|NCT01057693|Diabetic peripheral neuropathy|diabetic peripheral neuropathy
5138465|NCT01057693|Lyrica|lyrica
5138466|NCT01057693|pregabalin|pregabalin
5138467|NCT01057693|pain|pain
5138468|NCT01057680|Bone|bone
5138469|NCT01057680|Muscle|muscle
5138470|NCT01057680|Strength|strength
5138471|NCT01057680|Kidney|kidney
5138472|NCT01057680|Liver|liver
5138473|NCT01057680|Creatine|creatine
5138474|NCT01057654|Cholesterol|cholesterol
5138475|NCT01057641|PIDLSS, Spacer|pidlss, spacer
5138476|NCT01057628|ASP1941|asp1941
5138477|NCT01057628|Diabetes mellitus|diabetes mellitus
5138478|NCT01057628|Blood glucose|blood glucose
5138479|NCT01057615|Asthma|asthma
5138480|NCT01057615|Exercise-Induced Bronchoconstriction|exercise-induced bronchoconstriction
5138481|NCT01057615|Inflammation|inflammation
5138482|NCT01057615|Airway|airway
5138483|NCT01057615|Fish Oil|fish oil
5138484|NCT01057615|Ascorbic Acid|ascorbic acid
5138485|NCT01057602|Dementia|dementia
5138486|NCT01057602|Screening Tests|screening tests
5138487|NCT01057602|Cognition|cognition
5138488|NCT01057602|Memory|memory
5138489|NCT01057602|MOST|most
5138490|NCT01057589|Pharynx|pharynx
5138491|NCT01057589|Larynx|larynx
5138492|NCT01057589|Cervical esophagus|cervical esophagus
5138493|NCT01057589|Nose|nose
5138494|NCT01057589|Thyroid Gland|thyroid gland
5138495|NCT01057589|Parathyroid Gland|parathyroid gland
5138496|NCT01057576|bioactives|bioactives
5138497|NCT01057576|insulin|insulin
5138498|NCT01057576|botanicals|botanicals
5138499|NCT01057563|Coronary artery disease|coronary artery disease
5138500|NCT01057563|Neointimal hyperplasia|neointimal hyperplasia
5138501|NCT01057563|Drug-eluting balloon|drug-eluting balloon
5138502|NCT01057563|Optical coherence tomography|optical coherence tomography
5138503|NCT01057550|Stress urinary Incontinence|stress urinary incontinence
5138504|NCT01057550|autologous slings|autologous slings
5138505|NCT01057550|slings|slings
5138506|NCT01057550|tvt|tvt
5138507|NCT01057550|grafts|grafts
5138508|NCT01057550|surgery|surgery
5138509|NCT01057537|Polypill|polypill
5138510|NCT01057537|Red Heart Pill|red heart pill
5138511|NCT01057537|Cardiovascular disease|cardiovascular disease
5138512|NCT01057537|Adherence|adherence
5138513|NCT01057537|Secondary prevention|secondary prevention
5138514|NCT01057524|Airway clearance|airway clearance
5138515|NCT01057524|Cystic fibrosis|cystic fibrosis
5138516|NCT01057524|High frequency chest wall oscillation|high frequency chest wall oscillation
5138517|NCT01057511|Crinone|crinone
5138518|NCT01057511|progesterone|progesterone
5138519|NCT01057511|endometrial progesterone concentration|endometrial progesterone concentration
5138520|NCT01057485|Atrial Fibrillation|atrial fibrillation
5138521|NCT01057485|Ablation|ablation
5138522|NCT01057472|Repeatability of measurements|repeatability of measurements
5138523|NCT01057459|Stage II Grade 1 Contiguous Follicular Lymphoma|stage ii grade 1 contiguous follicular lymphoma
5138524|NCT01057459|Stage II Grade 1 Non-Contiguous Follicular Lymphoma|stage ii grade 1 non-contiguous follicular lymphoma
5138525|NCT01057459|Stage II Grade 2 Contiguous Follicular Lymphoma|stage ii grade 2 contiguous follicular lymphoma
5138526|NCT01057459|Stage II Grade 2 Non-Contiguous Follicular Lymphoma|stage ii grade 2 non-contiguous follicular lymphoma
5138527|NCT01057459|Stage II Grade 3 Contiguous Follicular Lymphoma|stage ii grade 3 contiguous follicular lymphoma
5138528|NCT01057459|Stage II Grade 3 Non-Contiguous Follicular Lymphoma|stage ii grade 3 non-contiguous follicular lymphoma
5138529|NCT01057459|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5138530|NCT01057459|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5138904|NCT01055821|Vaccine|vaccine
5138531|NCT01057459|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5138532|NCT01057459|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5138533|NCT01057459|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5138534|NCT01057459|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5138535|NCT01057446|Colonoscopy preparation|colonoscopy preparation
5138536|NCT01057446|sennoside|sennoside
5138537|NCT01057446|sodium phosphate|sodium phosphate
5138538|NCT01057446|the aim is to assess the bowel cleansing effects of two different agents|the aim is to assess the bowel cleansing effects of two different agents
5138539|NCT01057433|Healthy Volunteers|healthy volunteers
5138540|NCT01057407|Hyperphosphatemia|hyperphosphatemia
5138541|NCT01057407|hemodialysis|hemodialysis
5138542|NCT01057407|CKD|ckd
5138543|NCT01057407|ASP1585|asp1585
5138544|NCT01057394|Atrial Fibrillation|atrial fibrillation
5138545|NCT01057381|Adenotonsillectomy|adenotonsillectomy
5138546|NCT01057381|Postoperative analgesia|postoperative analgesia
5138547|NCT01057381|Pediatrics|pediatrics
5138548|NCT01057355|Intraductal papillary mucinous neoplasm|intraductal papillary mucinous neoplasm
5138549|NCT01057355|Mucinous cystic neoplasm|mucinous cystic neoplasm
5138550|NCT01057355|Endoscopic ultrasound|endoscopic ultrasound
5138551|NCT01057355|Endoscopic retrograde cholangiopancreatography|endoscopic retrograde cholangiopancreatography
5138552|NCT01057355|Pancreatic cyst|pancreatic cyst
5138553|NCT01057355|Pancreas cyst|pancreas cyst
5138554|NCT01057355|Alcohol|alcohol
5138555|NCT01057342|extensive stage small cell lung cancer|extensive stage small cell lung cancer
5138556|NCT01057329|TDM|tdm
5138557|NCT01057329|Drug|drug
5138558|NCT01057329|Psychopharmacology|psychopharmacology
5138559|NCT01057329|children|children
5138560|NCT01057329|adolescents|adolescents
5138561|NCT01057303|childhood acute myeloid leukemia/other myeloid malignancies|childhood acute myeloid leukemia/other myeloid malignancies
5138562|NCT01057290|childhood acute myeloid leukemia/other myeloid malignancies|childhood acute myeloid leukemia/other myeloid malignancies
5138563|NCT01057277|Head and Neck Cancer|head and neck cancer
5138564|NCT01057277|Advanced Inoperable Head & Neck Cancer|advanced inoperable head & neck cancer
5138565|NCT01057264|Liver|liver
5138566|NCT01057264|Cancer|cancer
5138567|NCT01057264|Hepatic arterial infusion|hepatic arterial infusion
5138568|NCT01057264|HAI|hai
5138569|NCT01057264|Abraxane|abraxane
5138570|NCT01057264|Nab-Paclitaxel|nab-paclitaxel
5138571|NCT01057264|Paclitaxel|paclitaxel
5138572|NCT01057264|ABI-007|abi-007
5138573|NCT01057264|Gemcitabine|gemcitabine
5138574|NCT01057264|Gemcitabine Hydrochloride|gemcitabine hydrochloride
5138575|NCT01057264|Gemzar|gemzar
5138576|NCT01057264|Bevacizumab|bevacizumab
5138577|NCT01057264|Avastin|avastin
5138578|NCT01057264|Anti-VEGF monoclonal antibody|anti-vegf monoclonal antibody
5138579|NCT01057264|rhuMAb-VEGF|rhumab-vegf
5138580|NCT01057264|Filgrastim|filgrastim
5138581|NCT01057264|G-CSF|g-csf
5138582|NCT01057264|Neupogen|neupogen
5138583|NCT01057251|Nebivolol|nebivolol
5138584|NCT01057251|Bystolic TM|bystolic tm
5138585|NCT01057251|Hypertension|hypertension
5138586|NCT01057251|Stage 2 Hypertension|stage 2 hypertension
5138587|NCT01057238|mechanical ventilation|mechanical ventilation
5138588|NCT01057238|critical care|critical care
5138589|NCT01057212|advanced or metastatic non-squamous non-small cell lung cancer (NSCLC)|advanced or metastatic non-squamous non-small cell lung cancer (nsclc)
5138590|NCT01057199|adult acute myeloid leukemia|adult acute myeloid leukemia
5138591|NCT01057199|childhood acute myeloid leukemia/other myeloid malignancies|childhood acute myeloid leukemia/other myeloid malignancies
5138592|NCT01057173|Heart Valve Disease|heart valve disease
5138593|NCT01057173|Heart Valve Prosthesis|heart valve prosthesis
5138594|NCT01057173|Heart Valve Prosthesis Implantation|heart valve prosthesis implantation
5138595|NCT01057173|Randomized Controlled Trial|randomized controlled trial
5138596|NCT01057121|HIV Infections|hiv infections
5138597|NCT01057108|Hyperphosphatemia|hyperphosphatemia
5138598|NCT01057108|chronic kidney disease|chronic kidney disease
5138599|NCT01057108|salivary phosphorus|salivary phosphorus
5138600|NCT01057095|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5138601|NCT01057095|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5138602|NCT01057095|adult acute myeloid leukemia with del(5q)|adult acute myeloid leukemia with del(5q)
5138603|NCT01057095|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5138604|NCT01057095|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5138605|NCT01057095|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5138606|NCT01057095|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
5138607|NCT01057095|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
5138608|NCT01057095|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5138609|NCT01057095|untreated childhood acute myeloid leukemia and other myeloid malignancies|untreated childhood acute myeloid leukemia and other myeloid malignancies
5138610|NCT01057082|Sarcopenia|sarcopenia
5138611|NCT01057082|Aging|aging
5138612|NCT01057082|Muscle|muscle
5138613|NCT01057082|Dietary Supplement|dietary supplement
5138614|NCT01057082|HMB|hmb
5138615|NCT01057082|Arginine|arginine
5138616|NCT01057082|Glutamine|glutamine
5138617|NCT01057069|Neo adjuvant|neo adjuvant
5138618|NCT01057069|Triple negative|triple negative
5138619|NCT01057069|primary tumor over 2 cm and/or positive lymphnodes|primary tumor over 2 cm and/or positive lymphnodes
5138620|NCT01057056|patients in a sub-acute geriatric rehabilitation department|patients in a sub-acute geriatric rehabilitation department
5138621|NCT01057043|Osteoarthritis|osteoarthritis
5138622|NCT01057017|colorectal cancer|colorectal cancer
5138623|NCT01057004|heart failure|heart failure
5138624|NCT01056978|palliative care unit|palliative care unit
5138625|NCT01056978|bleeding|bleeding
5138626|NCT01056978|thromboembolic|thromboembolic
5138627|NCT01056978|hemorrhagic risk|hemorrhagic risk
5138628|NCT01056978|antithrombotic prophylaxis|antithrombotic prophylaxis
5138629|NCT01056965|Frontotemporal Dementia|frontotemporal dementia
5138630|NCT01056965|Corticobasal Degeneration|corticobasal degeneration
5138631|NCT01056965|Progressive Nonfluent Aphasia|progressive nonfluent aphasia
5138632|NCT01056965|Progressive Supranuclear Palsy|progressive supranuclear palsy
5138633|NCT01056965|FTLD|ftld
5138634|NCT01056965|FTD|ftd
5138635|NCT01056965|PNFA|pnfa
5138636|NCT01056965|CBD|cbd
5138637|NCT01056965|PSP|psp
5138638|NCT01056965|Predicted tauopathies, including:|predicted tauopathies, including:
5138639|NCT01056965|Progressive Supranuclear Palsy (PSP)|progressive supranuclear palsy (psp)
5138640|NCT01056965|(CBS)|(cbs)
5138641|NCT01056965|Progressive Nonfluent Aphasia (PNFA)|progressive nonfluent aphasia (pnfa)
5138642|NCT01056939|Ventilatory care, children, intensive care, NAVA|ventilatory care, children, intensive care, nava
5138643|NCT01056939|Children needing ventilatory care|children needing ventilatory care
5138644|NCT01056926|smoking|smoking
5138645|NCT01056926|nicotine|nicotine
5138646|NCT01056926|Effects of nicotine and non-nicotine factors on continuous working memory.|effects of nicotine and non-nicotine factors on continuous working memory.
5138647|NCT01056926|Effects of nicotine and non-nicotine factors on cue reactivity.|effects of nicotine and non-nicotine factors on cue reactivity.
5138648|NCT01056926|Use of nicotine patches, placebo patches, and denicotinized cigarettes.|use of nicotine patches, placebo patches, and denicotinized cigarettes.
5138649|NCT01056926|memory|memory
5138650|NCT01056913|anastomotic leakage|anastomotic leakage
5138651|NCT01056913|bleeding from the anastomotic region|bleeding from the anastomotic region
5138652|NCT01056913|anastomotic stenosis|anastomotic stenosis
5138653|NCT01056900|articular cartilage defects|articular cartilage defects
5138654|NCT01056900|ACI|aci
5138655|NCT01056900|Autologous Chondrocyte Implantation|autologous chondrocyte implantation
5138656|NCT01056900|Knee joint|knee joint
5138657|NCT01056900|chondron|chondron
5138658|NCT01056887|diabetes insipidus|diabetes insipidus
5138659|NCT01056887|primary polydipsia|primary polydipsia
5138660|NCT01056887|copeptin|copeptin
5138661|NCT01056887|Utility of plasma copeptin in differential diagnosis of polyuria/ polydipsia while performing a traditional deprivation test|utility of plasma copeptin in differential diagnosis of polyuria/ polydipsia while performing a traditional deprivation test
5138662|NCT01056874|Maraviroc|maraviroc
5138663|NCT01056874|Digoxin|digoxin
5138664|NCT01056874|P-glycoprotein|p-glycoprotein
5138665|NCT01056874|Pharmacokinetics|pharmacokinetics
5138666|NCT01056874|Drug Interaction|drug interaction
5138667|NCT01056874|HIV|hiv
5138668|NCT01056861|cervical dystonia|cervical dystonia
5138669|NCT01056861|torticollis|torticollis
5138670|NCT01056861|Botulinum toxin|botulinum toxin
5138671|NCT01056861|magnetoencephalography|magnetoencephalography
5138672|NCT01056861|MEG|meg
5138673|NCT01056861|cortical organizational changes detected by MEG after botulinum toxin in patients with torticollis, correlating with improvement in the symptoms|cortical organizational changes detected by meg after botulinum toxin in patients with torticollis, correlating with improvement in the symptoms
5138674|NCT01056848|Euvolemic Hyponatremia|euvolemic hyponatremia
5138675|NCT01056848|Hypervolemic Hyponatremia|hypervolemic hyponatremia
5138676|NCT01056848|SIADH|siadh
5138677|NCT01056848|Serum Sodium|serum sodium
5138678|NCT01056809|Colorectal cancer|colorectal cancer
5138679|NCT01056809|Metastases|metastases
5138680|NCT01056809|Treatment strategies|treatment strategies
5138681|NCT01056809|Colorectal cancer with synchronous metastases|colorectal cancer with synchronous metastases
5138682|NCT01056796|compression anastomosis|compression anastomosis
5138683|NCT01056796|Colorectal cancer|colorectal cancer
5138684|NCT01056796|Low anterior resection|low anterior resection
5138685|NCT01056796|Radiated to the pelvic area|radiated to the pelvic area
5138686|NCT01056796|Radiotherapy|radiotherapy
5138687|NCT01056783|EoE|eoe
5138688|NCT01056770|Smallpox vaccine efficacy|smallpox vaccine efficacy
5138689|NCT01056757|metastatic breast cancer|metastatic breast cancer
5138690|NCT01056757|ribavirin|ribavirin
5138691|NCT01056757|eIF4E|eif4e
5138692|NCT01056744|coronary stent|coronary stent
5138693|NCT01056744|optical coherence tomography|optical coherence tomography
5138694|NCT01056744|drug-eluting|drug-eluting
5138695|NCT01056744|neointimal proliferation|neointimal proliferation
5138696|NCT01056731|high blood pressure|high blood pressure
5138697|NCT01056731|aliskiren|aliskiren
5138698|NCT01056731|hydrochlorothiazide|hydrochlorothiazide
5138699|NCT01056731|control rate|control rate
5138700|NCT01056718|Diastolic Function|diastolic function
5138701|NCT01056718|Nebivolol|nebivolol
5138702|NCT01056705|Inactivated Poliomyelitis Vaccine|inactivated poliomyelitis vaccine
5138703|NCT01056705|Sabin Strains|sabin strains
5138704|NCT01056705|poliomyelitis|poliomyelitis
5138705|NCT01056692|Asthma|asthma
5138706|NCT01056692|bronchial allergen challenge|bronchial allergen challenge
5138707|NCT01056692|sputum eosinophiilia|sputum eosinophiilia
5138708|NCT01056653|father-child relations|father-child relations
5138709|NCT01056653|paternal behaviour|paternal behaviour
5138710|NCT01056653|early intervention|early intervention
5138711|NCT01056653|child-rearing|child-rearing
5138712|NCT01056640|telemonitoring|telemonitoring
5138713|NCT01056640|usual care|usual care
5138714|NCT01056640|elderly|elderly
5138715|NCT01056640|hospitalization|hospitalization
5138716|NCT01056640|Emergency room visits|emergency room visits
5138717|NCT01056601|insulinoma|insulinoma
5138718|NCT01056601|cancer of pancreas|cancer of pancreas
5138719|NCT01056601|neoplasms, pancreas|neoplasms, pancreas
5138720|NCT01056601|alpha-cell tumor|alpha-cell tumor
5138721|NCT01056601|glucagonoma|glucagonoma
5138722|NCT01056601|beta-cell tumor|beta-cell tumor
5138723|NCT01056601|somatostatinoma|somatostatinoma
5138724|NCT01056588|adolescent smoking|adolescent smoking
5138725|NCT01056588|Contingency management|contingency management
5138726|NCT01056588|Quit smoking|quit smoking
5138727|NCT01056562|Prostate|prostate
5138728|NCT01056562|GU|gu
5138729|NCT01056562|Urological Oncology|urological oncology
5138730|NCT01056549|Intestinal lipoprotein|intestinal lipoprotein
5138731|NCT01056549|Apo B48 and apoB100|apo b48 and apob100
5138732|NCT01056549|Pancreatic clamp|pancreatic clamp
5138733|NCT01056549|GLP-1 agonist|glp-1 agonist
5138734|NCT01056536|Travel|travel
5138735|NCT01056536|casual sexual relationships|casual sexual relationships
5138736|NCT01056536|condoms|condoms
5138737|NCT01056536|Structured intervention|structured intervention
5138738|NCT01056523|AML|aml
5138739|NCT01056497|diabetes|diabetes
5138740|NCT01056497|alpha lipoic acid|alpha lipoic acid
5138741|NCT01056497|endoplasmic reticulum (ER) stress|endoplasmic reticulum (er) stress
5138742|NCT01056497|insulin secretion|insulin secretion
5138743|NCT01056497|insulin sensitivity|insulin sensitivity
5138744|NCT01056484|Alcohol Dependence|alcohol dependence
5138745|NCT01056484|Alcoholism|alcoholism
5138746|NCT01056484|Substance Use Disorders|substance use disorders
5138747|NCT01056484|Substance Abuse|substance abuse
5138748|NCT01056471|Multiple Sclerosis|multiple sclerosis
5138749|NCT01056471|Mesenchymal Stem Cells|mesenchymal stem cells
5138750|NCT01056471|Autologous|autologous
5138751|NCT01056458|acupressure|acupressure
5138752|NCT01056458|perimenopause|perimenopause
5138753|NCT01056458|menopause|menopause
5138754|NCT01056458|anxiety|anxiety
5138755|NCT01056458|life quality|life quality
5138756|NCT01056458|insomnia|insomnia
5138757|NCT01056445|Carotid artery stenting|carotid artery stenting
5138758|NCT01056445|Hemodynamic Instability|hemodynamic instability
5138759|NCT01056445|Valsalva Ratio|valsalva ratio
5138760|NCT01056432|osteoporosis, bone fracture risk, bone ultrasonometry|osteoporosis, bone fracture risk, bone ultrasonometry
5138761|NCT01056419|Graves' ophthalmopathy|graves' ophthalmopathy
5138762|NCT01056419|Total thyroidectomy|total thyroidectomy
5138763|NCT01056419|Anti-thyroid drug treatment|anti-thyroid drug treatment
5138764|NCT01056419|Clinical activity score|clinical activity score
5138765|NCT01056406|Pregnancy|pregnancy
5138766|NCT01056406|Overweight|overweight
5138767|NCT01056406|Obese|obese
5138768|NCT01056406|Nutrition intervention|nutrition intervention
5138769|NCT01056393|HIV|hiv
5138770|NCT01056380|influenza|influenza
5138771|NCT01056380|influenza like illness|influenza like illness
5138772|NCT01056367|Resistant hypertension|resistant hypertension
5138773|NCT01056367|Type-II-Diabetes Mellitus|type-ii-diabetes mellitus
5138774|NCT01056367|Arterial stiffness|arterial stiffness
5138775|NCT01056367|Ventricular function|ventricular function
5138776|NCT01056354|Influenza|influenza
5138777|NCT01056354|respiratory virus|respiratory virus
5138778|NCT01056354|pandemic|pandemic
5138779|NCT01056354|swine flu|swine flu
5138780|NCT01056354|infection|infection
5138781|NCT01056354|MERS-CoV|mers-cov
5138782|NCT01056354|SARS-CoV|sars-cov
5138783|NCT01056341|Infantile Hemangioma|infantile hemangioma
5138784|NCT01056341|Propranolol|propranolol
5138785|NCT01056315|Analgesia|analgesia
5138786|NCT01056315|Diabetic Neuropathy|diabetic neuropathy
5138787|NCT01056315|Neuropathic pain|neuropathic pain
5138788|NCT01056315|Painful|painful
5138789|NCT01056315|Chronic pain|chronic pain
5138790|NCT01056302|Reconstructive surgical procedures|reconstructive surgical procedures
5138791|NCT01056302|visuohaptic|visuohaptic
5138792|NCT01056276|Multiple Myeloma|multiple myeloma
5138793|NCT01056276|Bendamustine|bendamustine
5138794|NCT01056276|Bortezomib|bortezomib
5138795|NCT01056276|Dexamethasone|dexamethasone
5138796|NCT01056263|retrospective trial|retrospective trial
5138797|NCT01056263|5-year survival|5-year survival
5138798|NCT01056263|metastatic renal cancer cell|metastatic renal cancer cell
5138799|NCT01056250|cholelithiasis|cholelithiasis
5138800|NCT01056224|skull pin insertion|skull pin insertion
5138801|NCT01056224|remifentanil|remifentanil
5138802|NCT01056224|short acting opioid|short acting opioid
5138803|NCT01056224|craniotomy|craniotomy
5138804|NCT01056224|cervical spine surgery|cervical spine surgery
5138805|NCT01056224|hemodynamic changes|hemodynamic changes
5138806|NCT01056224|dose requirement|dose requirement
5138807|NCT01056224|age related|age related
5138808|NCT01056198|Diabetic Foot Ulcers|diabetic foot ulcers
5138809|NCT01056198|Diabetic Foot Wounds|diabetic foot wounds
5138810|NCT01056185|influenza|influenza
5138811|NCT01056185|flu|flu
5138812|NCT01056185|swine flu|swine flu
5138813|NCT01056185|respiratory virus|respiratory virus
5138814|NCT01056185|hospitalization|hospitalization
5138815|NCT01056185|MERS-CoV|mers-cov
5138816|NCT01056185|SARS-CoV|sars-cov
5138817|NCT01056172|Chronic hepatitis C|chronic hepatitis c
5138818|NCT01056172|Genotype 2|genotype 2
5138819|NCT01056172|Rapid virologic response|rapid virologic response
5138820|NCT01056172|Sustained virologic response|sustained virologic response
5138821|NCT01056172|Peginterferon alfa-2a|peginterferon alfa-2a
5138822|NCT01056172|Ribavirin|ribavirin
5138823|NCT01056159|asthma|asthma
5138824|NCT01056159|dry powder inhaler|dry powder inhaler
5138825|NCT01056159|short-acting beta2-agonist|short-acting beta2-agonist
5138826|NCT01056159|SABA|saba
5138827|NCT01056159|bronchoconstriction|bronchoconstriction
5138828|NCT01056159|bronchodilation|bronchodilation
5138829|NCT01056159|bronchodilator|bronchodilator
5138830|NCT01056159|metered dose inhaler|metered dose inhaler
5138831|NCT01056146|TBI|tbi
5138832|NCT01056146|intracranial edema|intracranial edema
5138833|NCT01056146|brain edema|brain edema
5138834|NCT01056146|craniocerebral trauma|craniocerebral trauma
5138835|NCT01056146|head injury|head injury
5138836|NCT01056146|brain hemorrhage, traumatic|brain hemorrhage, traumatic
5138837|NCT01056146|subdural hematoma|subdural hematoma
5138838|NCT01056146|brain concussion|brain concussion
5138839|NCT01056146|head injuries, closed|head injuries, closed
5138840|NCT01056146|epidural hematoma|epidural hematoma
5138841|NCT01056146|extra-axial hemorrhage|extra-axial hemorrhage
5138842|NCT01056146|cortical contusion|cortical contusion
5138843|NCT01056146|Additional relevant MeSH terms:|additional relevant mesh terms:
5138844|NCT01056146|Nervous System Diseases|nervous system diseases
5138845|NCT01056146|Wounds and Injuries|wounds and injuries
5138846|NCT01056146|Disorders of Environmental Origin|disorders of environmental origin
5138847|NCT01056146|Central Nervous System Diseases|central nervous system diseases
5138848|NCT01056146|Trauma, Nervous System|trauma, nervous system
5138849|NCT01056146|Brain Diseases|brain diseases
5138850|NCT01056146|Brain Injuries|brain injuries
5138851|NCT01056133|non-alcoholic fatty liver disease|non-alcoholic fatty liver disease
5138852|NCT01056133|non-alcoholic steatohepatitis|non-alcoholic steatohepatitis
5138853|NCT01056107|Constipation, Irritable Bowel Syndrome (IBS), Glucagon Like Peptide analogue|constipation, irritable bowel syndrome (ibs), glucagon like peptide analogue
5138854|NCT01056081|COPD|copd
5138855|NCT01056081|inspiratory muscles|inspiratory muscles
5138856|NCT01056081|diaphragm|diaphragm
5138857|NCT01056055|Ankle|ankle
5138858|NCT01056055|Chronic lateral instability|chronic lateral instability
5138859|NCT01056055|Modified Brostrom procedure|modified brostrom procedure
5138860|NCT01056055|Suture anchor|suture anchor
5138861|NCT01056055|Bone tunnel|bone tunnel
5138862|NCT01056042|pelvic pain|pelvic pain
5138863|NCT01056042|postoperative|postoperative
5138864|NCT01056042|medical therapy|medical therapy
5138865|NCT01056029|Solid Tumors|solid tumors
5138866|NCT01056016|ADHD|adhd
5138867|NCT01056003|gastric inlet patch|gastric inlet patch
5138868|NCT01056003|prevalence|prevalence
5138869|NCT01056003|globus sensations|globus sensations
5138870|NCT01055990|pandemic influenza A (H1N1) 2009|pandemic influenza a (h1n1) 2009
5138871|NCT01055990|blood fix treatment|blood fix treatment
5138872|NCT01055990|influenza A (H1N1) 2009 monovalent vaccine|influenza a (h1n1) 2009 monovalent vaccine
5138873|NCT01055990|effectiveness|effectiveness
5138874|NCT01055990|immunogenicity|immunogenicity
5138875|NCT01055990|safety|safety
5138876|NCT01055977|statin therapy|statin therapy
5138877|NCT01055977|treatment goal|treatment goal
5138878|NCT01055977|dyslipidaemia|dyslipidaemia
5138879|NCT01055951|Insulin pumps|insulin pumps
5138880|NCT01055951|Diabetes|diabetes
5138881|NCT01055912|Congestive Heart Failure|congestive heart failure
5138882|NCT01055912|Volume Overload|volume overload
5138883|NCT01055899|RA|ra
5138884|NCT01055886|PTSD|ptsd
5138885|NCT01055886|smoking cessation|smoking cessation
5138886|NCT01055886|nicotine patch|nicotine patch
5138887|NCT01055873|immune status|immune status
5138888|NCT01055873|adolescents or young adults infected|adolescents or young adults infected
5138889|NCT01055873|impact of viral replication|impact of viral replication
5138890|NCT01055860|uterine Prolapse|uterine prolapse
5138891|NCT01055860|vaginal prolapse|vaginal prolapse
5138892|NCT01055860|mesh erosion|mesh erosion
5138893|NCT01055860|urinary incontinence|urinary incontinence
5138894|NCT01055860|bowel symptoms|bowel symptoms
5138895|NCT01055847|cystic fibrosis|cystic fibrosis
5138896|NCT01055847|CF|cf
5138897|NCT01055847|aztreonam|aztreonam
5138898|NCT01055847|lung infection|lung infection
5138899|NCT01055847|Pseudomonas aeruginosa|pseudomonas aeruginosa
5138900|NCT01055834|Insomnia|insomnia
5138901|NCT01055834|primary insomnia|primary insomnia
5138902|NCT01055834|insomnia associated with psychiatric or physical disorder(s)|insomnia associated with psychiatric or physical disorder(s)
5138905|NCT01055821|HCVac|hcvac
5138906|NCT01055821|MVA-HCV|mva-hcv
5138907|NCT01055808|Insulin|insulin
5138908|NCT01055808|ITR-QOL|itr-qol
5138909|NCT01055808|DTSQ|dtsq
5138910|NCT01055808|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
5138911|NCT01055782|Colonoscopy|colonoscopy
5138912|NCT01055782|Endoguide|endoguide
5138913|NCT01055782|Pain perception|pain perception
5138914|NCT01055782|Colonoscopy to the coecum (success rate)|colonoscopy to the coecum (success rate)
5138915|NCT01055782|Patient's perception of pain|patient's perception of pain
5138916|NCT01055782|Duration of successful colonoscopies|duration of successful colonoscopies
5138917|NCT01055769|Bio-equivalence|bio-equivalence
5138918|NCT01055769|Linezolid OS|linezolid os
5138919|NCT01055769|Linezolid tablet|linezolid tablet
5138920|NCT01055756|Reduction of signs and symptoms and enhanced nasal flow|reduction of signs and symptoms and enhanced nasal flow
5138921|NCT01055756|Nasal Flow|nasal flow
5138922|NCT01055743|Fluorouracil Implants|fluorouracil implants
5138923|NCT01055743|Hepatocellular carcinoma|hepatocellular carcinoma
5138924|NCT01055743|Radical resection|radical resection
5138925|NCT01055730|Pulmonary rehabilitation|pulmonary rehabilitation
5138926|NCT01055730|Exercise therapy|exercise therapy
5138927|NCT01055730|Interstitial lung disease|interstitial lung disease
5138928|NCT01055730|Pulmonary fibrosis|pulmonary fibrosis
5138929|NCT01055730|Mobility limitation|mobility limitation
5138930|NCT01055730|Dyspnea|dyspnea
5138931|NCT01055730|Mental health|mental health
5138932|NCT01055717|avenanthramide|avenanthramide
5138933|NCT01055717|enriched|enriched
5138934|NCT01055717|oat|oat
5138935|NCT01055717|phytochemical|phytochemical
5138936|NCT01055717|bioavailability|bioavailability
5138937|NCT01055704|Methylnaltrexone|methylnaltrexone
5138938|NCT01055704|Codeine|codeine
5138939|NCT01055704|Gastrointestinal motility|gastrointestinal motility
5138940|NCT01055704|Colonic transit|colonic transit
5138941|NCT01055691|healthy volunteers|healthy volunteers
5138942|NCT01055691|bioequivalence|bioequivalence
5138943|NCT01055691|dapagliflozin|dapagliflozin
5138944|NCT01055691|metformin|metformin
5138945|NCT01055678|breast cancer|breast cancer
5138946|NCT01055678|ductal breast carcinoma in situ|ductal breast carcinoma in situ
5138947|NCT01055678|breast cancer in situ|breast cancer in situ
5138948|NCT01055678|invasive carcinoma|invasive carcinoma
5138949|NCT01055678|invasive ductal carcinoma|invasive ductal carcinoma
5138950|NCT01055678|invasive lobular carcinoma|invasive lobular carcinoma
5138951|NCT01055652|Type 2 diabetes mellitus|type 2 diabetes mellitus
5138952|NCT01055652|Japanese|japanese
5138953|NCT01055652|phase 1|phase 1
5138954|NCT01055652|safety|safety
5138955|NCT01055652|dapagliflozin|dapagliflozin
5138956|NCT01055652|Pharmacokinetics|pharmacokinetics
5138957|NCT01055652|Drug-drug Interaction|drug-drug interaction
5138958|NCT01055652|voglibose|voglibose
5138959|NCT01055639|Chronic Pain|chronic pain
5138960|NCT01055639|Acceptance and Commitment Therapy (ACT)|acceptance and commitment therapy (act)
5138961|NCT01055626|Body mass index|body mass index
5138962|NCT01055626|Body fat|body fat
5138963|NCT01055626|Obesity|obesity
5138964|NCT01055626|Overweight|overweight
5138965|NCT01055626|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
5138966|NCT01055626|Air displacement plethysmography|air displacement plethysmography
5138967|NCT01055600|eltrombopag|eltrombopag
5138968|NCT01055600|pharmacokinetics|pharmacokinetics
5138969|NCT01055600|PROMACTA|promacta
5138970|NCT01055600|lactation|lactation
5138971|NCT01055600|milk-only study|milk-only study
5138972|NCT01055587|major abdominal surgery|major abdominal surgery
5138973|NCT01055587|severe burn injury|severe burn injury
5138974|NCT01055587|infection|infection
5138975|NCT01055587|diagnostic|diagnostic
5138976|NCT01055574|lumbar disc arthroplasty|lumbar disc arthroplasty
5138977|NCT01055574|total disc replacement|total disc replacement
5138978|NCT01055574|ProDisc L|prodisc l
5138979|NCT01055574|anterior lumbar interbody fusion|anterior lumbar interbody fusion
5138980|NCT01055574|lumbar spine surgery outcomes|lumbar spine surgery outcomes
5138981|NCT01055561|Acupuncture|acupuncture
5138982|NCT01055561|Behavioral and Psychological Symptoms of Dementia|behavioral and psychological symptoms of dementia
5138983|NCT01055561|BPSD|bpsd
5138984|NCT01055561|MMSE|mmse
5138985|NCT01055561|BEHAVE-AD|behave-ad
5138986|NCT01055561|The Questionnaire of Acupuncture Events|the questionnaire of acupuncture events
5138987|NCT01055561|healthy volunteers|healthy volunteers
5138988|NCT01055548|Preterm|preterm
5138989|NCT01055548|Perinatal|perinatal
5138990|NCT01055548|Ultrasound|ultrasound
5138991|NCT01055548|Cerebral palsy|cerebral palsy
5138992|NCT01055548|Anxiety|anxiety
5138993|NCT01055548|Parents|parents
5138994|NCT01055522|Interleukin, IL2, monoclonal, antibody, cytokine, Dacarbazine, metastatic, melanoma, tumor targeting, Dose definition|interleukin, il2, monoclonal, antibody, cytokine, dacarbazine, metastatic, melanoma, tumor targeting, dose definition
5138995|NCT01055522|, L19|, l19
5138996|NCT01055509|Social Adjustment|social adjustment
5138997|NCT01055509|Quality of life|quality of life
5138998|NCT01055509|Recurrence|recurrence
5138999|NCT01055509|Hospitalization|hospitalization
5139000|NCT01055496|Non-Hodgkin's lymphoma|non-hodgkin's lymphoma
5139001|NCT01055483|Acute myeloid leukemia|acute myeloid leukemia
5139003|NCT01055483|relapsed acute myeloid leukemia|relapsed acute myeloid leukemia
5139004|NCT01055483|refractory acute myeloid leukemia|refractory acute myeloid leukemia
5139005|NCT01055431|iron|iron
5139006|NCT01055431|bioavailability|bioavailability
5139007|NCT01055431|status|status
5139008|NCT01055431|deficiency|deficiency
5139009|NCT01055431|anaemia|anaemia
5139010|NCT01055431|functional foods|functional foods
5139011|NCT01055431|child bearing|child bearing
5139012|NCT01055418|Vitamin C|vitamin c
5139013|NCT01055418|Cognitive performance|cognitive performance
5139014|NCT01055418|Cerebral blood flow|cerebral blood flow
5139015|NCT01055418|Trans cranial doppler|trans cranial doppler
5139016|NCT01055418|Near infrared spectroscopy|near infrared spectroscopy
5139017|NCT01055405|Exercise tolerance|exercise tolerance
5139018|NCT01055405|COPD|copd
5139019|NCT01055405|Pulmonary hypertension|pulmonary hypertension
5139020|NCT01055405|Sildenafil|sildenafil
5139021|NCT01055392|mild cognitive impairment|mild cognitive impairment
5139022|NCT01055392|Alzheimer's disease|alzheimer's disease
5139023|NCT01055392|Lithium|lithium
5139024|NCT01055392|disease-modification|disease-modification
5139025|NCT01055392|cognition|cognition
5139026|NCT01055392|early Alzheimer`s disease|early alzheimer`s disease
5139027|NCT01055379|Rasagiline|rasagiline
5139028|NCT01055379|Depressive Symptoms|depressive symptoms
5139029|NCT01055379|Cognition|cognition
5139030|NCT01055366|Open angle glaucoma|open angle glaucoma
5139031|NCT01055366|OAG|oag
5139032|NCT01055366|Elazop|elazop
5139033|NCT01055366|Azarga|azarga
5139034|NCT01055366|Brinzolamide/Timolol combination|brinzolamide/timolol combination
5139035|NCT01055353|Target organs damage|target organs damage
5139036|NCT01055353|hypertensive patients|hypertensive patients
5139037|NCT01055340|Ketogenesis|ketogenesis
5139038|NCT01055340|Glucose-Dependent Insulin Secretion|glucose-dependent insulin secretion
5139039|NCT01055340|Graded Glucose Infusion|graded glucose infusion
5139040|NCT01055340|Oxyntomodulin|oxyntomodulin
5139041|NCT01055327|Isolated oral clefts|isolated oral clefts
5139042|NCT01055327|lamotrigine|lamotrigine
5139043|NCT01055327|EUROCAT|eurocat
5139044|NCT01055327|congenital malformations|congenital malformations
5139045|NCT01055327|anti-epileptic drugs|anti-epileptic drugs
5139046|NCT01055301|stage I multiple myeloma|stage i multiple myeloma
5139047|NCT01055301|stage II multiple myeloma|stage ii multiple myeloma
5139048|NCT01055301|stage III multiple myeloma|stage iii multiple myeloma
5139049|NCT01055275|iliac aneurysm|iliac aneurysm
5139050|NCT01055275|aortic aneurysm|aortic aneurysm
5139051|NCT01055275|endovascular grafts|endovascular grafts
5139052|NCT01055262|Safety|safety
5139053|NCT01055262|tolerability|tolerability
5139054|NCT01055262|heatwrap|heatwrap
5139055|NCT01055262|lower back|lower back
5139056|NCT01055262|healthy subjects|healthy subjects
5139057|NCT01055249|UVB|uvb
5139058|NCT01055249|pain|pain
5139059|NCT01055249|inflammation|inflammation
5139060|NCT01055249|model|model
5139061|NCT01055249|healthy volunteers|healthy volunteers
5139062|NCT01055249|Ultraviolet radiation (UVR) induced pain and inflammation in healthy volunteers|ultraviolet radiation (uvr) induced pain and inflammation in healthy volunteers
5139063|NCT01055236|sedation|sedation
5139064|NCT01055223|thiazolidinediones|thiazolidinediones
5139065|NCT01055223|rosiglitazone|rosiglitazone
5139066|NCT01055223|amiloride|amiloride
5139067|NCT01055223|pioglitazone|pioglitazone
5139068|NCT01055223|fracture|fracture
5139069|NCT01055223|Spironolactone|spironolactone
5139070|NCT01055210|Heart Failure|heart failure
5139071|NCT01055210|Pacemakers|pacemakers
5139072|NCT01055197|extensive stage small cell lung cancer|extensive stage small cell lung cancer
5139073|NCT01055184|Influenza|influenza
5139074|NCT01055184|H1N1|h1n1
5139075|NCT01055171|alcohol dependence|alcohol dependence
5139076|NCT01055171|PTSD|ptsd
5139077|NCT01055171|propanolol|propanolol
5139078|NCT01055171|craving|craving
5139079|NCT01055171|beta-block|beta-block
5139080|NCT01055171|cue exposure|cue exposure
5139081|NCT01055171|addiction|addiction
5139082|NCT01055171|memory|memory
5139083|NCT01055171|trauma|trauma
5139084|NCT01055171|addictive behavior|addictive behavior
5139085|NCT01055158|HIV|hiv
5139086|NCT01055145|Multidrug-resistant TB, sensitive to levofloxacin and moxifloxacin|multidrug-resistant tb, sensitive to levofloxacin and moxifloxacin
5139087|NCT01055106|bacterial vaginosis|bacterial vaginosis
5139088|NCT01055106|vaginal infection|vaginal infection
5139089|NCT01055106|vaginal discharge|vaginal discharge
5139090|NCT01055106|vaginal disease|vaginal disease
5139091|NCT01055093|diabetes mellitus|diabetes mellitus
5139092|NCT01055093|prospective observational study|prospective observational study
5139093|NCT01055093|diabetic complications|diabetic complications
5139094|NCT01055080|type 1 diabetes|type 1 diabetes
5139095|NCT01055080|beta-cell autoantibodies|beta-cell autoantibodies
5139096|NCT01055080|cow's milk formula|cow's milk formula
5139097|NCT01055080|bovine insulin|bovine insulin
5139098|NCT01055054|bariatrics|bariatrics
5139099|NCT01055015|total knee arthroplasty|total knee arthroplasty
5139100|NCT01055002|Health male volunteers|health male volunteers
5139101|NCT01055002|Male volunteers aged 18-45 years|male volunteers aged 18-45 years
5139203|NCT01054560|SOLITAIRE™|solitaire™
5139102|NCT01055002|Non-smokers and in good health|non-smokers and in good health
5139103|NCT01054989|Healthy adults|healthy adults
5139104|NCT01054989|Insulin sensitivity|insulin sensitivity
5139105|NCT01054976|Alzheimer's disease|alzheimer's disease
5139106|NCT01054976|Galantamine|galantamine
5139107|NCT01054976|Dementia|dementia
5139108|NCT01054963|early inflammatory arthritis|early inflammatory arthritis
5139109|NCT01054963|chronic disease|chronic disease
5139110|NCT01054963|peer support|peer support
5139111|NCT01054963|peer mentor|peer mentor
5139112|NCT01054963|peer counselling|peer counselling
5139113|NCT01054937|4SC-203|4sc-203
5139114|NCT01054937|Phase I|phase i
5139115|NCT01054937|single dose|single dose
5139116|NCT01054937|healthy volunteers|healthy volunteers
5139117|NCT01054911|GIST|gist
5139118|NCT01054911|gastrointestinal stromal tumor|gastrointestinal stromal tumor
5139119|NCT01054911|gastrointestinal stomach tumor|gastrointestinal stomach tumor
5139120|NCT01054911|Sunitinib|sunitinib
5139121|NCT01054898|depression|depression
5139122|NCT01054898|spouse abuse|spouse abuse
5139123|NCT01054898|intervention studies|intervention studies
5139124|NCT01054885|COPD|copd
5139125|NCT01054885|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5139126|NCT01054885|Efficacy|efficacy
5139127|NCT01054885|FEV1|fev1
5139128|NCT01054885|Safety|safety
5139129|NCT01054872|HIV Seronegativity|hiv seronegativity
5139130|NCT01054872|HIV Preventive Vaccine|hiv preventive vaccine
5139131|NCT01054846|Bicycle helmet|bicycle helmet
5139132|NCT01054820|FLECTORÂ® Patch|flectorâ® patch
5139133|NCT01054820|acute back strain|acute back strain
5139134|NCT01054794|Gastroparesis|gastroparesis
5139135|NCT01054794|Gastric Electrical Stimulation|gastric electrical stimulation
5139136|NCT01054781|Diffuse Large B-Cell Lymphoma (DLBCL)|diffuse large b-cell lymphoma (dlbcl)
5139137|NCT01054781|rituximab|rituximab
5139138|NCT01054781|CHOP|chop
5139139|NCT01054768|Antioxidant|antioxidant
5139140|NCT01054768|Inflammation|inflammation
5139141|NCT01054768|Sickle Cell Disease|sickle cell disease
5139142|NCT01054768|Oxidative Stress|oxidative stress
5139143|NCT01054768|Cytokines|cytokines
5139144|NCT01054768|anti-inflammatory|anti-inflammatory
5139145|NCT01054768|Acetylcarnitine|acetylcarnitine
5139146|NCT01054729|Chronic Hepatitis C infection Genotype 1|chronic hepatitis c infection genotype 1
5139147|NCT01054729|HCV|hcv
5139148|NCT01054729|GT1|gt1
5139149|NCT01054729|GT 1|gt 1
5139150|NCT01054716|RhD negative|rhd negative
5139151|NCT01054716|RhD disease|rhd disease
5139152|NCT01054716|fetal nucleic acid|fetal nucleic acid
5139153|NCT01054716|fetal DNA|fetal dna
5139154|NCT01054716|cell free fetal DNA|cell free fetal dna
5139155|NCT01054716|Fetal RHD genotype|fetal rhd genotype
5139156|NCT01054690|Catheterization|catheterization
5139157|NCT01054690|Urinary Tract Infection|urinary tract infection
5139158|NCT01054690|Elective Surgery|elective surgery
5139159|NCT01054677|Infections in nursing homes|infections in nursing homes
5139160|NCT01054677|especially urinary tract infections|especially urinary tract infections
5139161|NCT01054664|liver enzymes|liver enzymes
5139162|NCT01054664|peripheral mononuclear blood cells|peripheral mononuclear blood cells
5139163|NCT01054664|hemodialysis|hemodialysis
5139164|NCT01054664|hepatitis C|hepatitis c
5139165|NCT01054664|RNA|rna
5139166|NCT01054651|Schistosoma mansoni|schistosoma mansoni
5139167|NCT01054651|Praziquantel|praziquantel
5139168|NCT01054651|Artesunate + Sulfamethoxypyrazine/pyrimethamine|artesunate + sulfamethoxypyrazine/pyrimethamine
5139169|NCT01054651|Randomized open-label controlled clinical trial|randomized open-label controlled clinical trial
5139170|NCT01054638|amprenavir|amprenavir
5139171|NCT01054638|fosamprenavir|fosamprenavir
5139172|NCT01054638|HIV|hiv
5139173|NCT01054638|HAART treatment|haart treatment
5139174|NCT01054638|Epzicom|epzicom
5139175|NCT01054638|Trizivir|trizivir
5139176|NCT01054638|Combivir|combivir
5139177|NCT01054638|zidovudine|zidovudine
5139178|NCT01054638|lamivudine|lamivudine
5139179|NCT01054638|cardiovascular disease|cardiovascular disease
5139180|NCT01054638|HIV Infections|hiv infections
5139181|NCT01054625|Squamous Cell Carcinoma of the Head and Neck|squamous cell carcinoma of the head and neck
5139182|NCT01054625|Head and Neck Cancer|head and neck cancer
5139183|NCT01054625|Head and Neck Neoplasms|head and neck neoplasms
5139184|NCT01054625|anti-EGFr monoclonal antibody|anti-egfr monoclonal antibody
5139185|NCT01054625|Zalutumumab|zalutumumab
5139186|NCT01054612|Histology|histology
5139187|NCT01054612|Immunohistochemical|immunohistochemical
5139188|NCT01054612|Gene Expression|gene expression
5139189|NCT01054612|Tissue Sectioning|tissue sectioning
5139190|NCT01054599|epilepsy|epilepsy
5139191|NCT01054599|memory|memory
5139192|NCT01054599|memantine|memantine
5139193|NCT01054599|localization related epilepsy|localization related epilepsy
5139194|NCT01054599|focal epilepsy|focal epilepsy
5139195|NCT01054586|antiretroviral therapy|antiretroviral therapy
5139196|NCT01054586|hepatic impairment|hepatic impairment
5139197|NCT01054586|HIV|hiv
5139198|NCT01054573|Hepatitis C, Chronic|hepatitis c, chronic
5139199|NCT01054573|Telaprevir|telaprevir
5139200|NCT01054573|Roll-over study|roll-over study
5139201|NCT01054560|Ischemic Stroke|ischemic stroke
5139202|NCT01054560|SOLITAIRE™ Device|solitaire™ device
5139204|NCT01054560|MERCI® Device|merci® device
5139205|NCT01054560|MERCI®|merci®
5139206|NCT01054560|Stroke|stroke
5139207|NCT01054560|Ischemic|ischemic
5139208|NCT01054560|Mechanical Thrombectomy|mechanical thrombectomy
5139209|NCT01054560|Brain|brain
5139210|NCT01054560|Brain Clot|brain clot
5139211|NCT01054560|Brain Artery Revascularization|brain artery revascularization
5139212|NCT01054560|Recanalization|recanalization
5139213|NCT01054560|Brain Stroke|brain stroke
5139214|NCT01054560|Clot Retriever|clot retriever
5139215|NCT01054560|Device|device
5139216|NCT01054560|Neurosurgery|neurosurgery
5139217|NCT01054560|Neurovascular Intervention|neurovascular intervention
5139218|NCT01054560|Interventional Neuroradiology|interventional neuroradiology
5139219|NCT01054560|Brain study|brain study
5139220|NCT01054560|neurovascular clinical trial|neurovascular clinical trial
5139221|NCT01054547|topical anesthetic|topical anesthetic
5139222|NCT01054547|liposomal ropivacaine|liposomal ropivacaine
5139223|NCT01054547|dentistry|dentistry
5139224|NCT01054534|urinary incontinence|urinary incontinence
5139225|NCT01054521|radiofrequency turbinate reduction|radiofrequency turbinate reduction
5139226|NCT01054521|nasal obstruction|nasal obstruction
5139227|NCT01054521|Temperature-controlled radiofrequency|temperature-controlled radiofrequency
5139228|NCT01054521|Bipolar radiofrequency|bipolar radiofrequency
5139229|NCT01054521|chronic rhinitis.|chronic rhinitis.
5139230|NCT01054495|Acupuncture|acupuncture
5139231|NCT01054495|Sham acupuncture|sham acupuncture
5139232|NCT01054495|Laser|laser
5139233|NCT01054495|Methodology|methodology
5139234|NCT01054495|Control intervention|control intervention
5139235|NCT01054495|Pilot|pilot
5139236|NCT01054495|Nausea and vomiting in early pregnancy|nausea and vomiting in early pregnancy
5139237|NCT01054495|Patient's experience of different acu-stimulation|patient's experience of different acu-stimulation
5139238|NCT01054495|Blinding in acupuncture research|blinding in acupuncture research
5139239|NCT01054482|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
5139240|NCT01054482|neoadjuvant chemoradiotherapy|neoadjuvant chemoradiotherapy
5139241|NCT01054469|nephrectomy|nephrectomy
5139243|NCT01054456|Low Emetogenic Chemotherapy|low emetogenic chemotherapy
5139244|NCT01054456|Nausea and Vomiting|nausea and vomiting
5139245|NCT01054456|Nausea|nausea
5139246|NCT01054456|Vomiting|vomiting
5139247|NCT01054456|Anti- emetic|anti- emetic
5139248|NCT01054443|Blood Platelet Disorders|blood platelet disorders
5139249|NCT01054443|Immune Thrombocytopenia (ITP)|immune thrombocytopenia (itp)
5139250|NCT01054443|Low Platelet Count|low platelet count
5139251|NCT01054443|Thrombocytopaenia|thrombocytopaenia
5139252|NCT01054443|S-888711|s-888711
5139253|NCT01054443|Splenectomy|splenectomy
5139254|NCT01054443|Thrombopoiesis|thrombopoiesis
5139255|NCT01054443|Hematologic Disease|hematologic disease
5139256|NCT01054443|Auto-immune thrombocytopenic Purpura|auto-immune thrombocytopenic purpura
5139257|NCT01054443|Relapsed Persistent or Chronic ITP|relapsed persistent or chronic itp
5139258|NCT01054443|Idiopathic Thrombocytopenic Purpura|idiopathic thrombocytopenic purpura
5139259|NCT01054443|Thrombotic Thrombocytopenic Purpura (TTP)|thrombotic thrombocytopenic purpura (ttp)
5139260|NCT01054430|Avanafil|avanafil
5139261|NCT01054430|Hepatic|hepatic
5139262|NCT01054430|Erectile Dysfunction|erectile dysfunction
5139263|NCT01054430|Impairment|impairment
5139264|NCT01054417|Appendicitis|appendicitis
5139265|NCT01054417|Laparoscopy|laparoscopy
5139266|NCT01054417|Appendectomy|appendectomy
5139267|NCT01054404|Brain Swelling|brain swelling
5139268|NCT01054404|Brain Edema|brain edema
5139269|NCT01054404|Dehydration|dehydration
5139270|NCT01054352|Seasonal allergies|seasonal allergies
5139271|NCT01054352|Allergic rhinitis|allergic rhinitis
5139272|NCT01054339|Alpha-1 antitrypsin deficiency|alpha-1 antitrypsin deficiency
5139273|NCT01054339|Adeno-associated virus vector|adeno-associated virus vector
5139274|NCT01054339|AAV|aav
5139275|NCT01054339|Gene therapy|gene therapy
5139276|NCT01054339|Human gene transfer|human gene transfer
5139277|NCT01054326|arthroscopic subacromial decompression|arthroscopic subacromial decompression
5139278|NCT01054326|exercise|exercise
5139279|NCT01054326|physical therapy|physical therapy
5139280|NCT01054326|rotator cuff|rotator cuff
5139281|NCT01054326|shoulder impingement syndrome|shoulder impingement syndrome
5139282|NCT01054326|Subacromial impingement after arthroscopic subacromial decompression|subacromial impingement after arthroscopic subacromial decompression
5139283|NCT01054313|Advanced Malignancies|advanced malignancies
5139284|NCT01054313|Taxotere|taxotere
5139285|NCT01054313|Docetaxel|docetaxel
5139286|NCT01054313|Rapamycin|rapamycin
5139287|NCT01054313|Sirolimus|sirolimus
5139288|NCT01054313|Rapamune|rapamune
5139289|NCT01054313|Prednisone|prednisone
5139290|NCT01054313|Resistant to standard therapy|resistant to standard therapy
5139291|NCT01054274|esophageal cancer|esophageal cancer
5139292|NCT01054274|dysphagia|dysphagia
5139293|NCT01054274|stent|stent
5139294|NCT01054274|brachytherapy|brachytherapy
5139295|NCT01054261|avanafil, renal, impairment, TA-1790|avanafil, renal, impairment, ta-1790
5139296|NCT01054248|pregnancy, malaria, artemisinin, vivax, falciparum|pregnancy, malaria, artemisinin, vivax, falciparum
5139297|NCT01054235|prenatal care|prenatal care
5139298|NCT01054235|community-based randomized controlled trial|community-based randomized controlled trial
5139299|NCT01054235|perinatal mortality|perinatal mortality
5139300|NCT01054235|China|china
5139301|NCT01054222|overactive bladder idiopathic|overactive bladder idiopathic
5139302|NCT01054222|elderly fesoterodine SOFIA Portugal extension study|elderly fesoterodine sofia portugal extension study
5139303|NCT01054209|Inadvertent Peri-operative Hypothermia|inadvertent peri-operative hypothermia
5139304|NCT01054209|Shivering|shivering
5139305|NCT01054209|Caesarean Section|caesarean section
5139306|NCT01054209|Elective|elective
5139307|NCT01054209|Warming Mattress|warming mattress
5139308|NCT01054209|Regional Anaesthesia|regional anaesthesia
5139309|NCT01054183|respiratory failure, intubation, GlideScope, pediatric|respiratory failure, intubation, glidescope, pediatric
5139310|NCT01054170|Chronic|chronic
5139311|NCT01054170|obstructive|obstructive
5139312|NCT01054170|pulmonary|pulmonary
5139313|NCT01054170|lung|lung
5139314|NCT01054170|respiratory disease|respiratory disease
5139315|NCT01054170|efficacy|efficacy
5139316|NCT01054170|placebo-controlled|placebo-controlled
5139317|NCT01054170|COPD|copd
5139318|NCT01054170|FEV1|fev1
5139319|NCT01054170|St Georges Respiratory Questionnaire|st georges respiratory questionnaire
5139320|NCT01054170|Computed Tomography|computed tomography
5139321|NCT01054170|MSCT|msct
5139322|NCT01054144|Newly Diagnosed Standard Risk Multiple Myeloma|newly diagnosed standard risk multiple myeloma
5139323|NCT01054144|Senior Adults|senior adults
5139324|NCT01054131|peer support|peer support
5139325|NCT01054131|peer mentor|peer mentor
5139326|NCT01054131|self-management|self-management
5139327|NCT01054131|early inflammatory arthritis|early inflammatory arthritis
5139328|NCT01054131|chronic disease|chronic disease
5139329|NCT01054118|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
5139330|NCT01054105|Pulmonary hypertension|pulmonary hypertension
5139331|NCT01054105|genes|genes
5139332|NCT01054105|mutation|mutation
5139333|NCT01054105|drug therapy|drug therapy
5139334|NCT01054092|ASP1941|asp1941
5139335|NCT01054092|Diabetes mellitus|diabetes mellitus
5139336|NCT01054092|Blood glucose|blood glucose
5139337|NCT01054092|Food effect|food effect
5139338|NCT01054066|Chronic Kidney Disease|chronic kidney disease
5139339|NCT01054066|Cardiovascular Disease|cardiovascular disease
5139340|NCT01054066|Hypertension|hypertension
5139341|NCT01054066|Anemia|anemia
5139342|NCT01054053|Neisseria meningitidis B:14, P1-7, 16|neisseria meningitidis b:14, p1-7, 16
5139343|NCT01054053|Serum bactericidal activity|serum bactericidal activity
5139344|NCT01054053|Menbvac|menbvac
5139345|NCT01054040|cardiovascular disease, portion plate|cardiovascular disease, portion plate
5139346|NCT01054027|Retinopathy of Prematurity (ROP)|retinopathy of prematurity (rop)
5139347|NCT01054027|Eye exams|eye exams
5139348|NCT01054027|Premature infants|premature infants
5139349|NCT01054027|cyclomydril|cyclomydril
5139350|NCT01054014|CR016795|cr016795
5139351|NCT01054001|prostate cancer|prostate cancer
5139352|NCT01054001|prostatectomy|prostatectomy
5139353|NCT01054001|erectile dysfunction|erectile dysfunction
5139354|NCT01053988|Safety|safety
5139355|NCT01053988|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5139356|NCT01053988|Efficacy|efficacy
5139357|NCT01053988|FEV1|fev1
5139358|NCT01053988|COPD|copd
5139359|NCT01053975|RSR|rsr
5139360|NCT01053975|SECG|secg
5139361|NCT01053975|SPECT|spect
5139362|NCT01053975|QCA|qca
5139363|NCT01053975|SCAD|scad
5139364|NCT01053962|Chronic Idiopathic Constipation|chronic idiopathic constipation
5139365|NCT01053962|Constipation|constipation
5139366|NCT01053962|Irritable Bowel Syndrome|irritable bowel syndrome
5139367|NCT01053949|Multiple myeloma|multiple myeloma
5139368|NCT01053949|dexamethasone|dexamethasone
5139369|NCT01053949|pomalidomide|pomalidomide
5139370|NCT01053949|response|response
5139371|NCT01053949|safety|safety
5139372|NCT01053936|Chronic Kidney Disease|chronic kidney disease
5139373|NCT01053936|Type 2 diabetes|type 2 diabetes
5139374|NCT01053936|Diabetic Nephropathy|diabetic nephropathy
5139375|NCT01053923|Perianal Cancer|perianal cancer
5139376|NCT01053923|Anal Cancer|anal cancer
5139377|NCT01053923|MRI scan|mri scan
5139378|NCT01053897|GBT009|gbt009
5139379|NCT01053897|incisional scar|incisional scar
5139380|NCT01053897|breast reconstruction|breast reconstruction
5139381|NCT01053884|Invasive Candidiasis|invasive candidiasis
5139382|NCT01053884|invasive fungal disease|invasive fungal disease
5139383|NCT01053884|Anidulafungin|anidulafungin
5139384|NCT01053871|normal|normal
5139385|NCT01053858|bevacizumab,triamcinolone, intravitreal injection|bevacizumab,triamcinolone, intravitreal injection
5139386|NCT01053845|Neuropathic pain|neuropathic pain
5139387|NCT01053832|ventricular pace suppression|ventricular pace suppression
5139388|NCT01053832|pacemaker|pacemaker
5139389|NCT01053832|efficacy|efficacy
5139390|NCT01053832|safety|safety
5139391|NCT01053832|support of intrinsic heart rhythm|support of intrinsic heart rhythm
5139392|NCT01053819|psoriasis|psoriasis
5139393|NCT01053819|melanoma|melanoma
5139394|NCT01053819|non-melanoma skin cancer|non-melanoma skin cancer
5139395|NCT01053819|etanercept|etanercept
5139396|NCT01053819|Enbrel|enbrel
5139397|NCT01053806|MDS|mds
5139398|NCT01053806|Lenalidomide|lenalidomide
5139399|NCT01053806|5-Azacytidine.|5-azacytidine.
5139400|NCT01053806|ORR|orr
5139401|NCT01053806|PFS|pfs
5139402|NCT01053806|myelodysplastic syndrome.High risk.|myelodysplastic syndrome.high risk.
5139403|NCT01053793|Glycemic index|glycemic index
5139404|NCT01053793|Anthocyanin|anthocyanin
5139405|NCT01053793|Potato|potato
5139406|NCT01053793|Polyphenol|polyphenol
5139407|NCT01053780|Intercessory Prayer, pregnants|intercessory prayer, pregnants
5139408|NCT01053767|Group B streptococcus|group b streptococcus
5139409|NCT01053767|GBS|gbs
5139410|NCT01053767|Vaccine|vaccine
5139411|NCT01053754|adrenocortical insufficiency|adrenocortical insufficiency
5139412|NCT01053754|prolonged corticotherapy|prolonged corticotherapy
5139413|NCT01053715|Hemophilia|hemophilia
5139414|NCT01053715|Quality of Life|quality of life
5139415|NCT01053689|Bioequivalence, Glimepiride, Crossover|bioequivalence, glimepiride, crossover
5139416|NCT01053676|Hyperphosphatemia|hyperphosphatemia
5139417|NCT01053676|BE|be
5139418|NCT01053676|Granule|granule
5139419|NCT01053676|Healthy volunteers|healthy volunteers
5139420|NCT01053650|Healthy volunteers|healthy volunteers
5139421|NCT01053650|Open / hidden|open / hidden
5139422|NCT01053650|Placebo effect|placebo effect
5139423|NCT01053637|lacerations|lacerations
5139424|NCT01053637|sutures|sutures
5139425|NCT01053637|pediatrics|pediatrics
5139426|NCT01053637|child|child
5139427|NCT01053637|pain|pain
5139428|NCT01053637|Anxiety|anxiety
5139429|NCT01053624|Tracheostomy and thoracic surgery|tracheostomy and thoracic surgery
5139430|NCT01053624|postoperative complications|postoperative complications
5139431|NCT01053624|pulmonary surgical procedures|pulmonary surgical procedures
5139432|NCT01053624|respiratory failure|respiratory failure
5139433|NCT01053611|composite variability index|composite variability index
5139434|NCT01053611|bispectral index|bispectral index
5139435|NCT01053611|pain|pain
5139436|NCT01053598|Mycobacterium tuberculosis|mycobacterium tuberculosis
5139437|NCT01053598|Nitrate Reductase Assay|nitrate reductase assay
5139438|NCT01053598|NRA|nra
5139439|NCT01053598|REMA|rema
5139440|NCT01053598|RETA|reta
5139441|NCT01053598|Rezazurine|rezazurine
5139442|NCT01053585|Gastro-esophageal junction, reflux, insertion angle, magnetic resonance imaging, manometry|gastro-esophageal junction, reflux, insertion angle, magnetic resonance imaging, manometry
5139443|NCT01053572|Chronic low back pain|chronic low back pain
5139444|NCT01053572|Post lumbar laminectomy syndrome|post lumbar laminectomy syndrome
5139445|NCT01053572|Lower extremity pain|lower extremity pain
5139446|NCT01053572|Local anesthetic|local anesthetic
5139447|NCT01053572|Steroid|steroid
5139448|NCT01053572|Percutaneous lumbar adhesiolysis|percutaneous lumbar adhesiolysis
5139449|NCT01053559|Crohn's|crohn's
5139450|NCT01053559|Inflammatory Bowel Disease|inflammatory bowel disease
5139451|NCT01053533|Chinese herbal medicines|chinese herbal medicines
5139452|NCT01053533|pandemic H1N1 influenza|pandemic h1n1 influenza
5139453|NCT01053533|effectiveness|effectiveness
5139454|NCT01053533|safety|safety
5139455|NCT01053507|Headache|headache
5139456|NCT01053507|Post-traumatic headache|post-traumatic headache
5139457|NCT01053507|Brain injury|brain injury
5139458|NCT01053507|Cognitive impairment|cognitive impairment
5139459|NCT01053468|breast cancer|breast cancer
5139460|NCT01053468|physical activity|physical activity
5139461|NCT01053468|quality of life|quality of life
5139462|NCT01053468|theory of planned behavior|theory of planned behavior
5139463|NCT01053468|behavior change|behavior change
5139464|NCT01053468|health promotion|health promotion
5139465|NCT01053455|Non-invasive ventilation|non-invasive ventilation
5139466|NCT01053455|SiPAP|sipap
5139467|NCT01053455|CPAP|cpap
5139468|NCT01053455|low birth weight infants|low birth weight infants
5139469|NCT01053455|respiratory distress syndrome|respiratory distress syndrome
5139470|NCT01053442|iron absorption|iron absorption
5139471|NCT01053442|stable isotopes|stable isotopes
5139472|NCT01053442|NaFeEDTA|nafeedta
5139473|NCT01053442|Non-transferrin-bound iron (NTBI)|non-transferrin-bound iron (ntbi)
5139474|NCT01053442|Hepcidin|hepcidin
5139475|NCT01053429|Regulatory Post-Marketing Surveillance|regulatory post-marketing surveillance
5139476|NCT01053429|Regulatory Pharmacovigilance|regulatory pharmacovigilance
5139477|NCT01053429|ziprasidone|ziprasidone
5139478|NCT01053416|glaucoma|glaucoma
5139479|NCT01053416|pigmentary glaucoma|pigmentary glaucoma
5139480|NCT01053416|laser iridotomy|laser iridotomy
5139481|NCT01053403|MDMA|mdma
5139482|NCT01053403|Ecstasy|ecstasy
5139483|NCT01053403|MDMA effect on sleep|mdma effect on sleep
5139484|NCT01053403|MDMA effect on water homeostasis|mdma effect on water homeostasis
5139485|NCT01053403|MDMA effect on neurocognitive function|mdma effect on neurocognitive function
5139486|NCT01053403|Recreational Drug Use|recreational drug use
5139487|NCT01053403|Drug Abuse|drug abuse
5139488|NCT01053390|gallbladder neoplasmas|gallbladder neoplasmas
5139489|NCT01053390|Gallbladder Neoplasms,Advanced Stage,Chemotherapy,Somatostatin|gallbladder neoplasms,advanced stage,chemotherapy,somatostatin
5139490|NCT01053377|Influenza|influenza
5139491|NCT01053377|Tamiflu|tamiflu
5139492|NCT01053377|Osteltamivir|osteltamivir
5139493|NCT01053377|Transmission|transmission
5139494|NCT01053377|Prevention|prevention
5139495|NCT01053377|Resistance|resistance
5140180|NCT01050751|UK-453|uk-453
5139496|NCT01053377|Post-Exposure Profylaxe|post-exposure profylaxe
5139497|NCT01053338|Bioequivalence,Ibuprofen Diphenhydramine Citrate,Crossover|bioequivalence,ibuprofen diphenhydramine citrate,crossover
5139498|NCT01053325|Malaria|malaria
5139499|NCT01053325|Pregnancy|pregnancy
5139500|NCT01053325|Prevention|prevention
5139501|NCT01053325|HIV|hiv
5139502|NCT01053325|Sub-Sahara Africa|sub-sahara africa
5139503|NCT01053312|Amyloid|amyloid
5139504|NCT01053312|NPH Normal pressure hydrocephalus|nph normal pressure hydrocephalus
5139505|NCT01053312|PET Positron Emission Tomography|pet positron emission tomography
5139506|NCT01053312|SUVR Standard uptake value ratios|suvr standard uptake value ratios
5139507|NCT01053299|Developmental dysplasia of the hip (DDH)|developmental dysplasia of the hip (ddh)
5139508|NCT01053299|newborn|newborn
5139509|NCT01053299|universal screening|universal screening
5139510|NCT01053299|Universal ultrasound-screening for DDH in newborns|universal ultrasound-screening for ddh in newborns
5139511|NCT01053299|The accuracy of ultrasound-recording of the hip in newborns|the accuracy of ultrasound-recording of the hip in newborns
5139512|NCT01053286|Dysphagia|dysphagia
5139513|NCT01053286|Globus|globus
5139514|NCT01053286|Gastroesophageal reflux|gastroesophageal reflux
5139515|NCT01053273|Low back pain|low back pain
5139516|NCT01053273|Post lumbar laminectomy syndrome|post lumbar laminectomy syndrome
5139517|NCT01053273|Lumbar spinal stenosis|lumbar spinal stenosis
5139518|NCT01053273|Local anesthetic steroid|local anesthetic steroid
5139519|NCT01053273|Lumbar transforaminal epidural injection|lumbar transforaminal epidural injection
5139520|NCT01053273|Percutaneous epidural adhesiolysis|percutaneous epidural adhesiolysis
5139521|NCT01053273|Caudal epidural injection|caudal epidural injection
5139522|NCT01053260|Contingency Management|contingency management
5139523|NCT01053260|Weight Loss|weight loss
5139524|NCT01053247|Atopic Dermatitis|atopic dermatitis
5139525|NCT01053234|Hyperglycaemia|hyperglycaemia
5139526|NCT01053234|Postprandial|postprandial
5139527|NCT01053234|Type 2 diabetes|type 2 diabetes
5139528|NCT01053234|Cardiovascular risk markers|cardiovascular risk markers
5139529|NCT01053221|mycophenolate|mycophenolate
5139530|NCT01053221|living donor|living donor
5139531|NCT01053208|Bioequivalence,Ibuprofen Diphenhydramine Citrate,Crossover|bioequivalence,ibuprofen diphenhydramine citrate,crossover
5139532|NCT01053195|Diabetes|diabetes
5139533|NCT01053195|prevention|prevention
5139534|NCT01053195|intervention|intervention
5139535|NCT01053182|esophageal cancer|esophageal cancer
5139536|NCT01053182|postoperative complications|postoperative complications
5139537|NCT01053182|diaphragm|diaphragm
5139538|NCT01053182|pulmonary function|pulmonary function
5139539|NCT01053169|Coagulopathy|coagulopathy
5139540|NCT01053169|Perioperative bleeding|perioperative bleeding
5139541|NCT01053169|Prothrombin complex|prothrombin complex
5139542|NCT01053169|Liver disease|liver disease
5139543|NCT01053156|Fragile X syndrome|fragile x syndrome
5139544|NCT01053156|minocycline|minocycline
5139545|NCT01053156|targeted treatment|targeted treatment
5139546|NCT01053143|Influenza|influenza
5139547|NCT01053143|Pandemic Influenza|pandemic influenza
5139548|NCT01053143|Swine-Origin Influenza A/H1N1 Non-adjuvanted Vaccine|swine-origin influenza a/h1n1 non-adjuvanted vaccine
5139549|NCT01053143|Influenza A Virus, H1N1 subtype|influenza a virus, h1n1 subtype
5139550|NCT01053143|Adults|adults
5139551|NCT01053130|obesity|obesity
5139552|NCT01053130|bariatric surgery|bariatric surgery
5139553|NCT01053130|chronic kidney disease|chronic kidney disease
5139554|NCT01053130|weight loss|weight loss
5139555|NCT01053130|exercise|exercise
5139556|NCT01053117|central venous catheter|central venous catheter
5139557|NCT01053117|arteriovenous fistula|arteriovenous fistula
5139558|NCT01053117|hemodialysis|hemodialysis
5139559|NCT01053117|vascular access|vascular access
5139560|NCT01053117|dialysis|dialysis
5139561|NCT01053104|Colorectal cancer|colorectal cancer
5139562|NCT01053104|Breast cancer|breast cancer
5139563|NCT01053104|Capecitabine|capecitabine
5139564|NCT01053104|Docetaxel|docetaxel
5139565|NCT01053104|Mobile phone|mobile phone
5139566|NCT01053104|Toxicity|toxicity
5139567|NCT01053104|Metastatic|metastatic
5139568|NCT01053091|exercise-base rehabilitation|exercise-base rehabilitation
5139569|NCT01053091|diastolic heart failure|diastolic heart failure
5139570|NCT01053091|cardiovascular function|cardiovascular function
5139571|NCT01053091|aerobic fitness|aerobic fitness
5139572|NCT01053078|Type 1 diabetes|type 1 diabetes
5139573|NCT01053078|Hypoglycemia unawareness|hypoglycemia unawareness
5139574|NCT01053078|low blood sugar|low blood sugar
5139575|NCT01053065|Atherosclerosis|atherosclerosis
5139576|NCT01053065|Macrophages|macrophages
5139577|NCT01053065|Carotid arteries|carotid arteries
5139578|NCT01053065|Statin|statin
5139579|NCT01053052|Patency Tests, Fallopian Tubes|patency tests, fallopian tubes
5139580|NCT01053052|Hysterosalpingography|hysterosalpingography
5139581|NCT01053052|Sonography, Medical|sonography, medical
5139582|NCT01053026|Angiotensin receptor II antagonist|angiotensin receptor ii antagonist
5139583|NCT01053013|macrobead|macrobead
5139584|NCT01053013|biological|biological
5139585|NCT01053013|mouse cells|mouse cells
5139586|NCT01053000|ACTINIC KERATOSES|actinic keratoses
5139587|NCT01053000|HAND|hand
5139588|NCT01053000|FOREARM|forearm
5139589|NCT01052987|Gout|gout
5139590|NCT01052987|Hyperuricemia|hyperuricemia
5139591|NCT01052974|femoral neck fracture|femoral neck fracture
5139592|NCT01052974|analgesia|analgesia
5139593|NCT01052961|severe influenza|severe influenza
5139594|NCT01052961|hospitalized adults|hospitalized adults
5139595|NCT01052961|oseltamivir treatment|oseltamivir treatment
5139596|NCT01052948|dopamine agonists|dopamine agonists
5139597|NCT01052948|cabergoline|cabergoline
5139598|NCT01052948|Parkinson's disease|parkinson's disease
5139599|NCT01052948|hyperprolactinemia|hyperprolactinemia
5139600|NCT01052948|epidemiology|epidemiology
5139601|NCT01052948|cardiac valvulopathy|cardiac valvulopathy
5139602|NCT01052935|Group B streptococcus|group b streptococcus
5139603|NCT01052935|GBS|gbs
5139604|NCT01052935|Vaccine|vaccine
5139605|NCT01052922|Colorectal Neoplasms|colorectal neoplasms
5139606|NCT01052922|Mass Screening|mass screening
5139607|NCT01052922|Population Surveillance|population surveillance
5139608|NCT01052922|Randomized controlled trial|randomized controlled trial
5139609|NCT01052922|Occult Blood|occult blood
5139610|NCT01052922|Colonoscopy|colonoscopy
5139611|NCT01052922|Sigmoidoscopy|sigmoidoscopy
5139612|NCT01052922|Health Behavior|health behavior
5139613|NCT01052909|Bioequivalence, Glimepiride, Crossover|bioequivalence, glimepiride, crossover
5139614|NCT01052896|Dyspepsia|dyspepsia
5139615|NCT01052896|Functional|functional
5139616|NCT01052883|TMC114-TiDP3-C182|tmc114-tidp3-c182
5139617|NCT01052883|TMC114-C182|tmc114-c182
5139618|NCT01052883|TMC114|tmc114
5139619|NCT01052883|HIV|hiv
5139620|NCT01052883|HIV Infections|hiv infections
5139621|NCT01052870|pharmacogenomics, androgen receptor gene, androgen sensitivity, CAG repeats, androgenetic alopecia|pharmacogenomics, androgen receptor gene, androgen sensitivity, cag repeats, androgenetic alopecia
5139622|NCT01052870|Pharmacogenomics in treatment for androgenetic alopecia in women|pharmacogenomics in treatment for androgenetic alopecia in women
5139623|NCT01052857|to evaluate acupuncture as possible alternative treatment for induction of labor|to evaluate acupuncture as possible alternative treatment for induction of labor
5139624|NCT01052857|Induction|induction
5139625|NCT01052857|treatment|treatment
5139626|NCT01052857|posterm|posterm
5139627|NCT01052844|Vomiting|vomiting
5139628|NCT01052844|Antiemetics|antiemetics
5139629|NCT01052844|Dexamethasone|dexamethasone
5139630|NCT01052844|Cisplatin|cisplatin
5139631|NCT01052844|Antineoplastic combined chemotherapy protocols|antineoplastic combined chemotherapy protocols
5139632|NCT01052831|Compulsive Gambling|compulsive gambling
5139633|NCT01052831|Compulsive Buying|compulsive buying
5139634|NCT01052831|Compulsive Shopping|compulsive shopping
5139635|NCT01052831|Compulsive Eating|compulsive eating
5139636|NCT01052831|Hypersexuality|hypersexuality
5139637|NCT01052831|Dopamine Agonists|dopamine agonists
5139638|NCT01052831|Mirapex|mirapex
5139639|NCT01052831|Pramipexole|pramipexole
5139640|NCT01052831|Requip|requip
5139641|NCT01052831|Ropinirole|ropinirole
5139642|NCT01052831|Impulse Control Disorders|impulse control disorders
5139643|NCT01052818|Non small-cell lung cancer|non small-cell lung cancer
5139644|NCT01052818|Circulating tumor cells|circulating tumor cells
5139645|NCT01052818|Carcinoembryonic antigen|carcinoembryonic antigen
5139646|NCT01052818|Cytokeratin|cytokeratin
5139647|NCT01052805|nerve|nerve
5139648|NCT01052805|myelinated nerve|myelinated nerve
5139649|NCT01052805|unmyelinated nerve|unmyelinated nerve
5139650|NCT01052792|Bioequivalence|bioequivalence
5139651|NCT01052792|Naproxen|naproxen
5139652|NCT01052792|crossover|crossover
5139653|NCT01052779|Iron deficiency anemia|iron deficiency anemia
5139654|NCT01052779|Chronic kidney disease|chronic kidney disease
5139655|NCT01052779|Feraheme|feraheme
5139656|NCT01052779|Ferumoxytol|ferumoxytol
5139657|NCT01052779|Iron sucrose|iron sucrose
5139658|NCT01052779|IDA|ida
5139659|NCT01052779|CKD|ckd
5139660|NCT01052779|Venofer|venofer
5139661|NCT01052766|lung cancer|lung cancer
5139662|NCT01052766|PET Scan|pet scan
5139663|NCT01052766|CT Scan|ct scan
5139664|NCT01052766|BH-PET scan|bh-pet scan
5139665|NCT01052766|09-134|09-134
5139666|NCT01052753|Attention-deficit/hyperactivity disorder|attention-deficit/hyperactivity disorder
5139667|NCT01052753|executive function|executive function
5139668|NCT01052753|endophenotype|endophenotype
5139669|NCT01052753|dopaminergic system|dopaminergic system
5139670|NCT01052753|noradrenergic system|noradrenergic system
5139671|NCT01052753|candidate gene|candidate gene
5139672|NCT01052753|Family-based association study|family-based association study
5139673|NCT01052740|Breast Cancer|breast cancer
5139674|NCT01052740|Mammography|mammography
5139675|NCT01052740|Screening|screening
5139676|NCT01052727|Laparoscopic Cholecystectomy|laparoscopic cholecystectomy
5139677|NCT01052727|quality of life|quality of life
5139678|NCT01052714|Antipsychotic|antipsychotic
5139679|NCT01052714|Bipolar|bipolar
5139680|NCT01052714|Diabetes|diabetes
5139681|NCT01052714|Mental Illness|mental illness
5139682|NCT01052714|Nutrition|nutrition
5139683|NCT01052714|Obesity|obesity
5139684|NCT01052714|Schizoaffective|schizoaffective
5139685|NCT01052714|Schizophrenia|schizophrenia
5139686|NCT01052714|Weight Gain|weight gain
5139687|NCT01052714|Weight Loss|weight loss
5139688|NCT01052688|Down syndrome, aneuploidy, amniocentesis, chorionic villus sampling, Trisomy|down syndrome, aneuploidy, amniocentesis, chorionic villus sampling, trisomy
5139689|NCT01052675|Drug and substance problematic use, abuse or dependence|drug and substance problematic use, abuse or dependence
5139690|NCT01052662|Drug Abuse|drug abuse
5139691|NCT01052649|MNC subpopulations|mnc subpopulations
5139692|NCT01052649|Gene Expression|gene expression
5139693|NCT01052649|Metabolomics|metabolomics
5139694|NCT01052649|Immunological Status|immunological status
5139695|NCT01052636|Hip fracture|hip fracture
5139696|NCT01052636|Intervention program|intervention program
5139697|NCT01052636|Elderly|elderly
5139698|NCT01052623|GH/IGF-1|gh/igf-1
5139699|NCT01052623|Ataxia telangiectasia (AT)|ataxia telangiectasia (at)
5139700|NCT01052623|IGF-1 Generation Test|igf-1 generation test
5139701|NCT01052623|Growth hormone|growth hormone
5139702|NCT01052610|SLIT|slit
5139703|NCT01052610|bronchial asthma|bronchial asthma
5139704|NCT01052610|allergic rhinitis|allergic rhinitis
5139705|NCT01052597|Type 2 diabetes|type 2 diabetes
5139706|NCT01052597|Metabolic syndrome|metabolic syndrome
5139707|NCT01052597|cardiovascular risk|cardiovascular risk
5139708|NCT01052584|malaria|malaria
5139709|NCT01052584|therapeutic efficacy|therapeutic efficacy
5139710|NCT01052584|in vivo|in vivo
5139711|NCT01052584|artemether lumefantrine|artemether lumefantrine
5139712|NCT01052584|coartem|coartem
5139713|NCT01052584|chloroquine|chloroquine
5139714|NCT01052584|Plasmodium falciparum|plasmodium falciparum
5139715|NCT01052584|Plasmodium vivax|plasmodium vivax
5139716|NCT01052571|Chronic low back pain|chronic low back pain
5139717|NCT01052571|Lumbar disc herniation|lumbar disc herniation
5139718|NCT01052571|Lower extremity pain|lower extremity pain
5139719|NCT01052571|Lumbar radiculitis|lumbar radiculitis
5139720|NCT01052571|Local anesthetic|local anesthetic
5139721|NCT01052571|Steroid|steroid
5139722|NCT01052571|Lumbar transforaminal epidural injection|lumbar transforaminal epidural injection
5139723|NCT01052558|Open angle|open angle
5139724|NCT01052558|Glaucoma|glaucoma
5139725|NCT01052558|Cataract|cataract
5139726|NCT01052558|Surgery|surgery
5139727|NCT01052558|Intraocular Pressure|intraocular pressure
5139728|NCT01052545|urinary tract infection|urinary tract infection
5139729|NCT01052545|urinary catheter|urinary catheter
5139730|NCT01052545|bacteriuria|bacteriuria
5139731|NCT01052545|clinical guidelines|clinical guidelines
5139732|NCT01052545|audit-feedback|audit-feedback
5139733|NCT01052545|guidelines implementation|guidelines implementation
5139734|NCT01052532|Mitral Regurgitation|mitral regurgitation
5139735|NCT01052532|LV remodeling|lv remodeling
5139736|NCT01052532|Reactive nitrogen species|reactive nitrogen species
5139737|NCT01052532|Cardiac MRI|cardiac mri
5139738|NCT01052532|Adrenergic overdrive|adrenergic overdrive
5139739|NCT01052519|Obesity|obesity
5139740|NCT01052519|Esophageal Doppler monitoring|esophageal doppler monitoring
5139741|NCT01052519|tissue oxygen tension|tissue oxygen tension
5139742|NCT01052506|Human volunteers|human volunteers
5139743|NCT01052493|obesity|obesity
5139744|NCT01052493|pancreatic polypeptide|pancreatic polypeptide
5139745|NCT01052493|gut hormones|gut hormones
5139746|NCT01052480|Antiviral|antiviral
5139747|NCT01052480|Anti-Influenza Immune Plasma|anti-influenza immune plasma
5139748|NCT01052480|Emerging Infectious Disease|emerging infectious disease
5139749|NCT01052480|Swine Flu|swine flu
5139750|NCT01052454|hot flashes|hot flashes
5139751|NCT01052454|mindfulness|mindfulness
5139752|NCT01052454|stress|stress
5139753|NCT01052441|CCTA|ccta
5139754|NCT01052441|Coronary Artery Stenosis|coronary artery stenosis
5139755|NCT01052441|Iodinated Contrast|iodinated contrast
5139756|NCT01052441|Invasive Coronary Angiography|invasive coronary angiography
5139757|NCT01052428|Chronic MR|chronic mr
5139758|NCT01052428|Volume Overload|volume overload
5139759|NCT01052428|Beta-1 receptor blocker|beta-1 receptor blocker
5139760|NCT01052428|LV remodelling, LV dimensions|lv remodelling, lv dimensions
5139761|NCT01052428|LV systolic function|lv systolic function
5139762|NCT01052428|LV diastolic dysfunction|lv diastolic dysfunction
5139763|NCT01052428|Cardiac MRI|cardiac mri
5139764|NCT01052415|HIV|hiv
5139765|NCT01052415|Stigma|stigma
5139766|NCT01052415|POL|pol
5139767|NCT01052415|Service providers|service providers
5139768|NCT01052415|China|china
5139769|NCT01052415|Universal precaution|universal precaution
5139770|NCT01052389|Schizophrenia|schizophrenia
5139771|NCT01052389|Pragmatic RCT|pragmatic rct
5139772|NCT01052389|Aripiprazole|aripiprazole
5139773|NCT01052389|Olanzapine|olanzapine
5139774|NCT01052389|Haloperidol|haloperidol
5139775|NCT01052389|Metabolic syndrome|metabolic syndrome
5139776|NCT01052389|Drug discontinuation|drug discontinuation
5139777|NCT01052376|nflammatory bowel diseases (IBD)|nflammatory bowel diseases (ibd)
5139778|NCT01052376|Familial adenomatous polyposis (FAP)|familial adenomatous polyposis (fap)
5139779|NCT01052363|CNS tumors|cns tumors
5139780|NCT01052350|Parkinson disease|parkinson disease
5139781|NCT01052350|PET imaging|pet imaging
5139782|NCT01052350|PIB|pib
5139783|NCT01052350|dementia|dementia
5139784|NCT01052311|Coronary artery disease|coronary artery disease
5139785|NCT01052311|Endothelial function|endothelial function
5139786|NCT01052311|Platelet function|platelet function
5139787|NCT01052311|Statins|statins
5139788|NCT01052311|Niacin|niacin
5140181|NCT01050751|061|061
5139789|NCT01052298|Ciprofloxacin|ciprofloxacin
5139790|NCT01052298|Inhalation|inhalation
5139791|NCT01052298|Pharmacokinetics|pharmacokinetics
5139792|NCT01052298|Safety|safety
5139793|NCT01052298|Tolerability|tolerability
5139794|NCT01052298|COPD|copd
5139795|NCT01052285|Transversus abdominis plane block|transversus abdominis plane block
5139796|NCT01052272|Diabetes|diabetes
5139797|NCT01052272|Acute MI|acute mi
5139798|NCT01052272|Ang II type-1 receptor blockade (AT1RB)|ang ii type-1 receptor blockade (at1rb)
5139799|NCT01052272|LV remodeling|lv remodeling
5139800|NCT01052272|ACE inhibitor therapy|ace inhibitor therapy
5139801|NCT01052272|XO inhibitor, Allopurinol|xo inhibitor, allopurinol
5139802|NCT01052272|Systolic dysfunction|systolic dysfunction
5139803|NCT01052272|Diastolic dysfunction|diastolic dysfunction
5139804|NCT01052272|LV dimensions|lv dimensions
5139805|NCT01052272|Cardiac MRI|cardiac mri
5139806|NCT01052259|Chronic rejection|chronic rejection
5139807|NCT01052259|Kidney|kidney
5139808|NCT01052259|Transplantation|transplantation
5139809|NCT01052259|Immunosuppressive|immunosuppressive
5139810|NCT01052246|acne vulgaris|acne vulgaris
5139811|NCT01052246|laser surgery|laser surgery
5139812|NCT01052246|pulsed dye lasers|pulsed dye lasers
5139813|NCT01052246|benzoyl peroxidase|benzoyl peroxidase
5139814|NCT01052246|clindamycin|clindamycin
5139815|NCT01052246|randomized controlled trial|randomized controlled trial
5139816|NCT01052233|Sham-surgery|sham-surgery
5139817|NCT01052233|Development of osteoarthritis|development of osteoarthritis
5139945|NCT01051713|smartphone|smartphone
5139818|NCT01052233|Randomized, double-blinded, placebo-controlled|randomized, double-blinded, placebo-controlled
5139819|NCT01052220|Hypertension|hypertension
5139820|NCT01052220|Blood Pressure|blood pressure
5139821|NCT01052220|End Stage Renal Disease|end stage renal disease
5139822|NCT01052220|Hemodialysis|hemodialysis
5139823|NCT01052220|Interdialytic Weight Gain|interdialytic weight gain
5139824|NCT01052220|Self-Regulation|self-regulation
5139825|NCT01052207|Biological Response Modifiers|biological response modifiers
5139826|NCT01052207|Endocrinology|endocrinology
5139827|NCT01052207|Hormone Dysfunction|hormone dysfunction
5139828|NCT01052207|Hormones|hormones
5139829|NCT01052207|Neuroendocrinology|neuroendocrinology
5139830|NCT01052194|Rheumatoid Arthritis|rheumatoid arthritis
5139831|NCT01052181|Vitamin D|vitamin d
5139832|NCT01052181|Insulin sensitivity|insulin sensitivity
5139833|NCT01052181|Centrally obese|centrally obese
5139834|NCT01052168|simulation|simulation
5139835|NCT01052168|simulators|simulators
5139836|NCT01052168|motion metrics|motion metrics
5139837|NCT01052168|performance metrics|performance metrics
5139838|NCT01052168|skills training|skills training
5139839|NCT01052168|proficiency|proficiency
5139840|NCT01052168|laparoscopic|laparoscopic
5139841|NCT01052155|Controlled substances|controlled substances
5139842|NCT01052155|Opioids|opioids
5139843|NCT01052155|Benzodiazepines|benzodiazepines
5139844|NCT01052155|Illicit drugs|illicit drugs
5139845|NCT01052155|Immunoassay drug testing|immunoassay drug testing
5139846|NCT01052155|Point of care (POC) testing|point of care (poc) testing
5139847|NCT01052155|Liquid Chromatography Tandem Mass Spectometry|liquid chromatography tandem mass spectometry
5139848|NCT01052142|Melanoma|melanoma
5139849|NCT01052142|Cancer vaccines|cancer vaccines
5139850|NCT01052129|Bioequivalence|bioequivalence
5139851|NCT01052129|Naproxen|naproxen
5139852|NCT01052129|crossover|crossover
5139853|NCT01052116|Asthma|asthma
5139854|NCT01052116|Soy|soy
5139855|NCT01052116|Supplement|supplement
5139856|NCT01052116|ACRC|acrc
5139857|NCT01052116|SOYA|soya
5139858|NCT01052090|HCV|hcv
5139859|NCT01052077|OPC-34712|opc-34712
5139860|NCT01052077|Major Depressive Disorder|major depressive disorder
5139861|NCT01052077|Adjunctive Treatment|adjunctive treatment
5139862|NCT01052064|Children|children
5139863|NCT01052064|ADHD|adhd
5139864|NCT01052064|rTMS|rtms
5139865|NCT01052064|Safety|safety
5139866|NCT01052038|Sore throat|sore throat
5139867|NCT01052038|Dexamethasone|dexamethasone
5139868|NCT01052038|Pain|pain
5139869|NCT01052012|Postoperative pain|postoperative pain
5139870|NCT01052012|Post-operative pain|post-operative pain
5139871|NCT01052012|Opioid|opioid
5139872|NCT01052012|Laparoscopic surgery|laparoscopic surgery
5139873|NCT01052012|Bupivacaine|bupivacaine
5139874|NCT01052012|Local anesthetic|local anesthetic
5139875|NCT01051999|Glutamine|glutamine
5139876|NCT01051986|coronary artery bypass|coronary artery bypass
5139877|NCT01051986|off-pump surgery|off-pump surgery
5139878|NCT01051986|composite graft|composite graft
5139879|NCT01051986|saphenous vein|saphenous vein
5139880|NCT01051986|internal thoracic artery|internal thoracic artery
5139881|NCT01051973|Cognitive behavior therapy|cognitive behavior therapy
5139882|NCT01051973|exposure|exposure
5139883|NCT01051973|stress management|stress management
5139884|NCT01051960|Systemic Sclerosis|systemic sclerosis
5139885|NCT01051960|connective tissue disease|connective tissue disease
5139886|NCT01051960|Shortness of breath|shortness of breath
5139887|NCT01051960|Pulmonary Hypertension|pulmonary hypertension
5139888|NCT01051947|Nebivolol|nebivolol
5139889|NCT01051947|Metoprolol|metoprolol
5139890|NCT01051947|central aortic pressure|central aortic pressure
5139891|NCT01051947|hypertension|hypertension
5139892|NCT01051934|Recombinant Immunotoxin|recombinant immunotoxin
5139893|NCT01051934|Monoclonal Antibody|monoclonal antibody
5139894|NCT01051934|Pseudomonas Exotoxin|pseudomonas exotoxin
5139895|NCT01051934|Targeted Therapy|targeted therapy
5139896|NCT01051934|Lung Cancer|lung cancer
5139897|NCT01051934|Non-Small Cell Lung Cancer|non-small cell lung cancer
5139898|NCT01051921|HCV|hcv
5139899|NCT01051921|Null Responder|null responder
5139900|NCT01051895|Cervical intra-epithelial neoplasia|cervical intra-epithelial neoplasia
5139901|NCT01051895|Colposcopy|colposcopy
5139902|NCT01051895|HPV DNA testing|hpv dna testing
5139903|NCT01051895|treatment failure|treatment failure
5139904|NCT01051882|Mesenchymal Stromal Cells (MSC)|mesenchymal stromal cells (msc)
5139905|NCT01051882|Amyotrophic Lateral Sclerosis (ALS)|amyotrophic lateral sclerosis (als)
5139906|NCT01051882|Neuroprotection|neuroprotection
5139907|NCT01051882|Neurodegeneration|neurodegeneration
5139908|NCT01051882|Stem cells|stem cells
5139909|NCT01051882|ALS|als
5139910|NCT01051869|distal humerus|distal humerus
5139911|NCT01051869|fractures|fractures
5139912|NCT01051869|ulnar nerve|ulnar nerve
5139913|NCT01051869|simple decompression|simple decompression
5139914|NCT01051869|anterior transposition|anterior transposition
5139915|NCT01051843|Maternal Breastfeeding|maternal breastfeeding
5139916|NCT01051843|Orofacial Difficulties|orofacial difficulties
5139917|NCT01051843|Rooming-in|rooming-in
5139918|NCT01051843|Speech and Language Therapy|speech and language therapy
5139919|NCT01051817|relapsing-remitting multiple sclerosis|relapsing-remitting multiple sclerosis
5139920|NCT01051817|RRMS|rrms
5139921|NCT01051804|Dry eye|dry eye
5139922|NCT01051804|Visual Performance|visual performance
5139923|NCT01051791|RAD001|rad001
5139924|NCT01051791|Everolimus|everolimus
5139925|NCT01051778|Recurrent abortion|recurrent abortion
5139926|NCT01051778|Antiphospholipid syndrome|antiphospholipid syndrome
5139927|NCT01051778|unfractionated heparin|unfractionated heparin
5139928|NCT01051778|Low Molecular Weight Heparin|low molecular weight heparin
5139929|NCT01051752|Nontuberculous mycobacterial diseases|nontuberculous mycobacterial diseases
5139930|NCT01051752|pharmacokinetics|pharmacokinetics
5139931|NCT01051752|pharmacodynamics|pharmacodynamics
5139932|NCT01051739|vision testing|vision testing
5139933|NCT01051739|perimetry|perimetry
5139934|NCT01051739|glaucoma|glaucoma
5139935|NCT01051739|test variability|test variability
5139936|NCT01051726|aromatherapy|aromatherapy
5139937|NCT01051726|childbirth|childbirth
5139938|NCT01051726|Obstetrics|obstetrics
5139939|NCT01051726|Labour|labour
5139940|NCT01051726|Complementary Medicine|complementary medicine
5139941|NCT01051726|delivery, obstetric|delivery, obstetric
5139942|NCT01051713|obesity|obesity
5139943|NCT01051713|behavioraladherence|behavioraladherence
5139944|NCT01051713|weight loss|weight loss
5139946|NCT01051700|repeat-dose|repeat-dose
5139947|NCT01051700|pharmacokinetics|pharmacokinetics
5139948|NCT01051700|choroidal neovascularization|choroidal neovascularization
5139949|NCT01051700|safety|safety
5139950|NCT01051700|GW786034|gw786034
5139951|NCT01051700|tolerability|tolerability
5139952|NCT01051700|age-related macular degeneration|age-related macular degeneration
5139953|NCT01051700|stem cell growth factor|stem cell growth factor
5139954|NCT01051700|pazopanib|pazopanib
5139955|NCT01051700|platelet derived growth factor|platelet derived growth factor
5139956|NCT01051700|vascular endothelial growth factor|vascular endothelial growth factor
5139957|NCT01051687|vitiligo|vitiligo
5139958|NCT01051674|Obesity|obesity
5139959|NCT01051674|Type 2 diabetes|type 2 diabetes
5139960|NCT01051674|Fiber|fiber
5139961|NCT01051674|Dietary fiber|dietary fiber
5139962|NCT01051674|Low-carbohydrate diet|low-carbohydrate diet
5139963|NCT01051674|High protein diet|high protein diet
5139964|NCT01051661|Influenza|influenza
5139965|NCT01051661|H1N1|h1n1
5139966|NCT01051661|Pandemic|pandemic
5139967|NCT01051648|Triamcinolone acetenoide|triamcinolone acetenoide
5139968|NCT01051648|anterior vitrectomy|anterior vitrectomy
5139969|NCT01051648|presence of vitreous in the anterior chamber.|presence of vitreous in the anterior chamber.
5139970|NCT01051648|effect of triamcinolone injection on IOP,intraocular infection|effect of triamcinolone injection on iop,intraocular infection
5139971|NCT01051635|DNA Repair|dna repair
5139972|NCT01051635|DNA Damage|dna damage
5139973|NCT01051635|Advanced Cancer|advanced cancer
5139974|NCT01051635|Advanced Malignancies|advanced malignancies
5139975|NCT01051635|Topoisomerase Inhibitor|topoisomerase inhibitor
5139976|NCT01051622|PBMC (Peripheral Blood Mononuclear Cells)|pbmc (peripheral blood mononuclear cells)
5139977|NCT01051622|Crohn's Disease|crohn's disease
5139978|NCT01051622|SPECT (Single Photon Emission Computerized Tomography)|spect (single photon emission computerized tomography)
5139979|NCT01051609|Post Menopausal|post menopausal
5139980|NCT01051609|Breast Cancer|breast cancer
5139981|NCT01051596|metastatic|metastatic
5139982|NCT01051596|colorectal cancer|colorectal cancer
5139983|NCT01051583|Neovascular glaucoma|neovascular glaucoma
5139984|NCT01051583|diode laser|diode laser
5139985|NCT01051583|cyclophotocoagulation|cyclophotocoagulation
5139986|NCT01051583|Avastin|avastin
5139987|NCT01051570|hormone-resistant prostate cancer|hormone-resistant prostate cancer
5139988|NCT01051570|recurrent prostate cancer|recurrent prostate cancer
5139989|NCT01051570|stage IV prostate cancer|stage iv prostate cancer
5139990|NCT01051570|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5139991|NCT01051544|ITI|iti
5139992|NCT01051544|HAEMOPHILIA A|haemophilia a
5139993|NCT01051544|INHIBITORS|inhibitors
5139994|NCT01051544|VWF/FVIII Concentrates|vwf/fviii concentrates
5139995|NCT01051531|Schizophrenia|schizophrenia
5139996|NCT01051531|R092670|r092670
5139997|NCT01051531|Paliperidone palmitate|paliperidone palmitate
5139998|NCT01051531|Diagnostic and Statistical Manual of Mental Disorders, 4th Edition|diagnostic and statistical manual of mental disorders, 4th edition
5139999|NCT01051531|Intramuscular injection|intramuscular injection
5140000|NCT01051505|Phase I|phase i
5140001|NCT01051505|multiple ascending dose|multiple ascending dose
5140002|NCT01051505|Safety|safety
5140003|NCT01051505|Tolerability|tolerability
5140004|NCT01051505|Healthy Volunteer|healthy volunteer
5140005|NCT01051479|PET Positron emission tomography|pet positron emission tomography
5140006|NCT01051479|CT X-ray computed tomography|ct x-ray computed tomography
5140007|NCT01051479|Patients with Locally Advanced Esophageal Cancer|patients with locally advanced esophageal cancer
5140008|NCT01051440|lisdexamfetamine|lisdexamfetamine
5140009|NCT01051440|vyvanse|vyvanse
5140010|NCT01051440|bipolar disorder|bipolar disorder
5140011|NCT01051440|depression|depression
5140012|NCT01051440|stimulant|stimulant
5140013|NCT01051440|magnetic resonance spectroscopy|magnetic resonance spectroscopy
5140014|NCT01051440|functional magnetic resonance imaging|functional magnetic resonance imaging
5140015|NCT01051440|neuropsychological testing|neuropsychological testing
5140016|NCT01051427|Nasal packing|nasal packing
5140017|NCT01051427|Haemostatic matrix|haemostatic matrix
5140018|NCT01051427|Epistaxis control|epistaxis control
5140019|NCT01051388|The efficacy of PPI|the efficacy of ppi
5140020|NCT01051388|Patients receiving low-dose aspirin for vascular protection|patients receiving low-dose aspirin for vascular protection
5140021|NCT01051375|anorexia nervosa|anorexia nervosa
5140022|NCT01051375|bulimia nervosa|bulimia nervosa
5140023|NCT01051375|EDNOS|ednos
5140024|NCT01051362|Advanced Non-small Cell Lung Cancer|advanced non-small cell lung cancer
5140025|NCT01051362|Pegylated liposomal doxorubicin|pegylated liposomal doxorubicin
5140026|NCT01051362|Carboplatin|carboplatin
5140027|NCT01051362|Chemotherapy|chemotherapy
5140028|NCT01051349|MS|ms
5140029|NCT01051349|Multiple Sclerosis|multiple sclerosis
5140030|NCT01051336|TARIS Placebo|taris placebo
5140031|NCT01051336|Bladder|bladder
5140032|NCT01051336|Interstitial Cystitis|interstitial cystitis
5140033|NCT01051336|Normal Healthy Volunteers|normal healthy volunteers
5140034|NCT01051297|Obstructive sleep apnea|obstructive sleep apnea
5140035|NCT01051297|venous thrombosis|venous thrombosis
5140036|NCT01051297|pulmonary embolism|pulmonary embolism
5140037|NCT01051297|venous thromboembolism|venous thromboembolism
5140038|NCT01051284|Pancreas|pancreas
5140039|NCT01051284|Newly diagnosed|newly diagnosed
5140040|NCT01051284|Cyberknife|cyberknife
5140041|NCT01051284|Gemcitabine|gemcitabine
5140042|NCT01051271|metoclopramide|metoclopramide
5140043|NCT01051271|akathisia|akathisia
5140044|NCT01051271|midazolam|midazolam
5140045|NCT01051271|diphenhydramine|diphenhydramine
5140046|NCT01051271|metoclopramide induced akathisia|metoclopramide induced akathisia
5140047|NCT01051258|Polymeric Lung Volume Reduction (PLVR)|polymeric lung volume reduction (plvr)
5140048|NCT01051258|Biologic Lung Volume Reduction (BLVR)|biologic lung volume reduction (blvr)
5140049|NCT01051258|AeriSeal|aeriseal
5140050|NCT01051258|treatment|treatment
5140051|NCT01051258|device|device
5140052|NCT01051258|breathing|breathing
5140053|NCT01051258|COPD|copd
5140054|NCT01051258|emphysema|emphysema
5140055|NCT01051258|heterogeneous|heterogeneous
5140056|NCT01051258|homogeneous|homogeneous
5140057|NCT01051258|Pathologic Processes|pathologic processes
5140058|NCT01051258|Respiratory Tract Diseases|respiratory tract diseases
5140059|NCT01051258|Lung Diseases|lung diseases
5140060|NCT01051258|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
5140061|NCT01051245|Diabetes Mellitus, Type 2 [C18.452.394.750.149]|diabetes mellitus, type 2 [c18.452.394.750.149]
5140062|NCT01051245|Case Management [N04.590.233.624.250]|case management [n04.590.233.624.250]
5140063|NCT01051245|Disease Management [N04.590.607]|disease management [n04.590.607]
5140064|NCT01051245|Diabetes Complications [C19.246.099]|diabetes complications [c19.246.099]
5140065|NCT01051232|filibuvir|filibuvir
5140066|NCT01051232|pharmacokinetics|pharmacokinetics
5140067|NCT01051232|Japanese|japanese
5140068|NCT01051232|Asian|asian
5140069|NCT01051219|Losartan|losartan
5140070|NCT01051219|Liver fibrosis|liver fibrosis
5140071|NCT01051219|Nonalcoholic steatohepatitis|nonalcoholic steatohepatitis
5140072|NCT01051193|Seizures|seizures
5140073|NCT01051193|oxcarbazepine|oxcarbazepine
5140074|NCT01051193|child|child
5140075|NCT01051180|HEMORRHOIDS|hemorrhoids
5140076|NCT01051180|TREATMENT|treatment
5140077|NCT01051180|PILES|piles
5140078|NCT01051180|BLEEDING|bleeding
5140079|NCT01051180|HALO|halo
5140080|NCT01051154|Docosahexaenoic acid|docosahexaenoic acid
5140081|NCT01051154|Nutritional status|nutritional status
5140082|NCT01051154|Acute lymphoblastic leukemia|acute lymphoblastic leukemia
5140083|NCT01051154|Long chain polyunsaturated fatty acids|long chain polyunsaturated fatty acids
5140084|NCT01051154|n-3 fatty acids|n-3 fatty acids
5140085|NCT01051154|Remission-induction phase|remission-induction phase
5140086|NCT01051141|alcohol use|alcohol use
5140087|NCT01051141|brief intervention|brief intervention
5140088|NCT01051141|risk behaviors|risk behaviors
5140089|NCT01051128|neurological disorders|neurological disorders
5140090|NCT01051128|multiple sclerosis|multiple sclerosis
5140091|NCT01051128|stroke|stroke
5140092|NCT01051128|cerebral palsy|cerebral palsy
5140093|NCT01051128|spinal cord|spinal cord
5140094|NCT01051128|brain injuries|brain injuries
5140095|NCT01051128|neurodegenerative diseases|neurodegenerative diseases
5140096|NCT01051115|CLL|cll
5140097|NCT01051115|refractory|refractory
5140098|NCT01051115|dasatinib|dasatinib
5140099|NCT01051115|fludarabine|fludarabine
5140100|NCT01051089|type 2 diabetes mellitus|type 2 diabetes mellitus
5140101|NCT01051089|lifestyle modification|lifestyle modification
5140102|NCT01051076|ITI|iti
5140103|NCT01051076|Haemophilia A|haemophilia a
5140104|NCT01051076|Inhibitors|inhibitors
5140105|NCT01051076|Failed ITI|failed iti
5140106|NCT01051076|VWF/FVIII concentrates|vwf/fviii concentrates
5140107|NCT01051063|adult|adult
5140108|NCT01051063|WT1|wt1
5140109|NCT01051063|ASCI|asci
5140110|NCT01051063|complete remission with incomplete blood count recovery|complete remission with incomplete blood count recovery
5140111|NCT01051063|partial remission|partial remission
5140112|NCT01051063|post-induction therapy|post-induction therapy
5140113|NCT01051063|tumor antigen|tumor antigen
5140114|NCT01051063|Acute Myeloid Leukemia|acute myeloid leukemia
5140115|NCT01051063|Immunotherapy|immunotherapy
5140116|NCT01051050|Evidence based medicine|evidence based medicine
5140117|NCT01051050|Improving surgical residents skills and application of EBM in surgical practice|improving surgical residents skills and application of ebm in surgical practice
5140118|NCT01051037|lung tumors|lung tumors
5140119|NCT01051037|central airways|central airways
5140120|NCT01051024|Dietary supplement|dietary supplement
5140121|NCT01051024|Diamel|diamel
5140122|NCT01051024|Polycystic Ovary Syndrome|polycystic ovary syndrome
5140123|NCT01051024|Female Infertility|female infertility
5140124|NCT01050998|Rheumatoid Arthritis|rheumatoid arthritis
5140125|NCT01050998|Mavrilimumab|mavrilimumab
5140126|NCT01050998|CAM-3001|cam-3001
5140127|NCT01050985|advanced cancer|advanced cancer
5140128|NCT01050985|temsirolimus|temsirolimus
5140129|NCT01050985|capecitabine|capecitabine
5140130|NCT01050972|Headache|headache
5140131|NCT01050972|Cervical Pain|cervical pain
5140132|NCT01050972|Cognitive treatment|cognitive treatment
5140133|NCT01050972|Relaxation|relaxation
5140134|NCT01050972|Exercise|exercise
5140135|NCT01050946|Unrelated Umbilical Cord Blood Transplant(UCB)|unrelated umbilical cord blood transplant(ucb)
5140136|NCT01050946|CD34+ Selected mismatched related donor|cd34+ selected mismatched related donor
5140137|NCT01050946|Haploidentical donor|haploidentical donor
5140138|NCT01050946|hematopoietic stem cell transplantation(HSCT)|hematopoietic stem cell transplantation(hsct)
5140139|NCT01050946|ALL|all
5140140|NCT01050946|Leukemia, Lymphocytic, Acute|leukemia, lymphocytic, acute
5140141|NCT01050946|AML|aml
5140142|NCT01050946|Leukemia, Myelocytic, Acute|leukemia, myelocytic, acute
5140143|NCT01050946|CML|cml
5140144|NCT01050946|Leukemia, Myeloid, Chronic|leukemia, myeloid, chronic
5140145|NCT01050946|NHL|nhl
5140146|NCT01050946|Lymphoma, Non-Hodgkin|lymphoma, non-hodgkin
5140147|NCT01050946|HL|hl
5140148|NCT01050946|Lymphoma, Hodgkins|lymphoma, hodgkins
5140149|NCT01050933|Healthy volunteer|healthy volunteer
5140150|NCT01050907|leishmaniasis|leishmaniasis
5140151|NCT01050907|cutaneous disease|cutaneous disease
5140152|NCT01050907|mucosal disease|mucosal disease
5140153|NCT01050907|miltefosine|miltefosine
5140154|NCT01050894|osteoarthritis|osteoarthritis
5140155|NCT01050881|blood donor notification|blood donor notification
5140156|NCT01050881|emotional response|emotional response
5140157|NCT01050881|variant Creutzfeldt-Jacob Disease|variant creutzfeldt-jacob disease
5140158|NCT01050855|Non-malignant diseases|non-malignant diseases
5140159|NCT01050855|Immune deficiencies|immune deficiencies
5140160|NCT01050855|Hemoglobinopathies|hemoglobinopathies
5140161|NCT01050855|Reduced Intensity Conditioning(RIC)|reduced intensity conditioning(ric)
5140162|NCT01050829|Magnetic resonance imaging|magnetic resonance imaging
5140163|NCT01050829|Tumor|tumor
5140164|NCT01050829|Contrast media|contrast media
5140165|NCT01050829|Gadobutrol|gadobutrol
5140166|NCT01050816|articular cartilage defects|articular cartilage defects
5140167|NCT01050816|ACI|aci
5140168|NCT01050816|ankle joint|ankle joint
5140169|NCT01050816|chondron|chondron
5140170|NCT01050803|Diabetes Mellitus|diabetes mellitus
5140171|NCT01050803|Intervention studies|intervention studies
5140172|NCT01050803|Program effectiveness|program effectiveness
5140173|NCT01050790|stage I multiple myeloma|stage i multiple myeloma
5140174|NCT01050790|stage II multiple myeloma|stage ii multiple myeloma
5140175|NCT01050790|stage III multiple myeloma|stage iii multiple myeloma
5140176|NCT01050777|Cutaneous Leishmaniasis caused by l. tropica|cutaneous leishmaniasis caused by l. tropica
5140177|NCT01050751|Bioavailability|bioavailability
5140178|NCT01050751|Bioequivalence|bioequivalence
5140179|NCT01050751|Lersivirine|lersivirine
5140182|NCT01050751|Pharmacokinetics|pharmacokinetics
5140183|NCT01050725|proteome|proteome
5140184|NCT01050725|biomarkers|biomarkers
5140185|NCT01050725|radiotherapy|radiotherapy
5140186|NCT01050725|cancer|cancer
5140187|NCT01050699|critical illness|critical illness
5140188|NCT01050699|sleep|sleep
5140189|NCT01050699|polysomnography|polysomnography
5140190|NCT01050699|inflammatory cytokines|inflammatory cytokines
5140191|NCT01050699|dexmedetomidine|dexmedetomidine
5140192|NCT01050699|acute lung injury|acute lung injury
5140193|NCT01050699|acute respiratory distress syndrome|acute respiratory distress syndrome
5140194|NCT01050699|midazolam|midazolam
5140195|NCT01050699|fentanyl|fentanyl
5140196|NCT01050699|cytokines|cytokines
5140197|NCT01050686|ileostomy reversal|ileostomy reversal
5140198|NCT01050686|subcutaneous drain|subcutaneous drain
5140199|NCT01050686|hospital stay|hospital stay
5140200|NCT01050686|postoperative wound infection|postoperative wound infection
5140201|NCT01050686|patients with elective ileostomy reversal|patients with elective ileostomy reversal
5140202|NCT01050673|VERSAJET hydro-surgical debridement|versajet hydro-surgical debridement
5140203|NCT01050673|traumatic wound|traumatic wound
5140204|NCT01050660|Parenteral nutrition associated liver disease|parenteral nutrition associated liver disease
5140205|NCT01050660|Direct bilirubin|direct bilirubin
5140206|NCT01050660|Intravenous fat emulsion|intravenous fat emulsion
5140207|NCT01050660|Very low birth weight infants|very low birth weight infants
5140208|NCT01050660|PNAC|pnac
5140209|NCT01050634|Aromatase inhibitor|aromatase inhibitor
5140210|NCT01050634|Switch after Tamoxifen|switch after tamoxifen
5140211|NCT01050634|Quality of Life|quality of life
5140212|NCT01050634|Safety|safety
5140213|NCT01050621|ascorbic acid|ascorbic acid
5140214|NCT01050621|vitamin C|vitamin c
5140215|NCT01050621|antioxidants|antioxidants
5140216|NCT01050621|redox therapy|redox therapy
5140217|NCT01050621|cytotoxic chemotherapy|cytotoxic chemotherapy
5140218|NCT01050608|Alcohol Rub|alcohol rub
5140219|NCT01050608|Hand Hygiene|hand hygiene
5140220|NCT01050608|Provider Feedback|provider feedback
5140221|NCT01050608|Health Care Associated Infections|health care associated infections
5140222|NCT01050595|Intensive Care Unit|intensive care unit
5140223|NCT01050595|Constipation|constipation
5140224|NCT01050595|Bowel Management|bowel management
5140225|NCT01050582|Schizophrenia|schizophrenia
5140226|NCT01050582|Bipolar Disorder|bipolar disorder
5140227|NCT01050582|Autistic Disorder|autistic disorder
5140228|NCT01050582|Conduct and Other Disruptive Behavior Disorders|conduct and other disruptive behavior disorders
5140229|NCT01050582|Risperidone|risperidone
5140230|NCT01050582|RISPERDAL|risperdal
5140231|NCT01050582|Antipsychotic Agents|antipsychotic agents
5140232|NCT01050582|Prolactin|prolactin
5140233|NCT01050582|Pediatrics|pediatrics
5140234|NCT01050569|Smoking Cessation|smoking cessation
5140235|NCT01050569|Nicotine Free Cigarettes|nicotine free cigarettes
5140236|NCT01050556|arsenic|arsenic
5140237|NCT01050556|folate|folate
5140238|NCT01050556|folic acid|folic acid
5140239|NCT01050556|creatine|creatine
5140240|NCT01050556|arsenicosis|arsenicosis
5140241|NCT01050556|nutrition|nutrition
5140242|NCT01050530|Cirrhosis|cirrhosis
5140243|NCT01050530|ascites|ascites
5140244|NCT01050530|Tolvaptan|tolvaptan
5140245|NCT01050530|OPC-41061|opc-41061
5140246|NCT01050491|asthma|asthma
5140247|NCT01050491|airway remodeling|airway remodeling
5140248|NCT01050491|airway obstruction|airway obstruction
5140249|NCT01050478|acute agitation|acute agitation
5140250|NCT01050478|aggression|aggression
5140251|NCT01050478|psychosis|psychosis
5140252|NCT01050478|paliperidone extended release|paliperidone extended release
5140253|NCT01050465|HIV|hiv
5140254|NCT01050465|Knee pain|knee pain
5140255|NCT01050465|Colonoscopy|colonoscopy
5140256|NCT01050465|Mammography|mammography
5140257|NCT01050465|Vaccination|vaccination
5140258|NCT01050439|Allogeneic Stem Cell Transplant|allogeneic stem cell transplant
5140259|NCT01050439|Unrelated donor|unrelated donor
5140260|NCT01050439|Cord blood donor|cord blood donor
5140261|NCT01050413|Thymidine Kinase 1 activity|thymidine kinase 1 activity
5140262|NCT01050413|diagnosis|diagnosis
5140263|NCT01050413|prognosis|prognosis
5140264|NCT01050413|follow-up|follow-up
5140265|NCT01050400|CYP2D6|cyp2d6
5140266|NCT01050400|Genetic Polymorphism|genetic polymorphism
5140267|NCT01050400|codeine|codeine
5140268|NCT01050400|breastfeeding|breastfeeding
5140269|NCT01050387|Vitamin D Deficiency|vitamin d deficiency
5140270|NCT01050387|VDD|vdd
5140271|NCT01050387|Vitamin D Supplementation|vitamin d supplementation
5140272|NCT01050387|Vitamin D Binding Protein|vitamin d binding protein
5140273|NCT01050387|DBP|dbp
5140274|NCT01050387|Nutritional rickets|nutritional rickets
5140275|NCT01050387|rickets|rickets
5140276|NCT01050387|25hydroxyvitamin D|25hydroxyvitamin d
5140277|NCT01050387|25OHD|25ohd
5140278|NCT01050387|1,25OH2D|1,25oh2d
5140279|NCT01050387|vitamin D metabolites|vitamin d metabolites
5140280|NCT01050387|PTH|pth
5140281|NCT01050387|vitamin D homeostasis|vitamin d homeostasis
5140375|NCT01049958|asynchrony|asynchrony
5140376|NCT01049958|mechanical ventilation|mechanical ventilation
5140377|NCT01049958|blunt trauma|blunt trauma
5140282|NCT01050361|To reduce perioperative morbidity and mortality associated with congestive heart failure for non-cardiac surgeries|to reduce perioperative morbidity and mortality associated with congestive heart failure for non-cardiac surgeries
5140283|NCT01050322|receptor HER two positive|receptor her two positive
5140284|NCT01050322|lapatinib|lapatinib
5140285|NCT01050322|metastatic breast cancer|metastatic breast cancer
5140286|NCT01050296|Neuroblastoma|neuroblastoma
5140287|NCT01050296|Retinoblastoma|retinoblastoma
5140288|NCT01050296|Osteosarcoma|osteosarcoma
5140289|NCT01050296|Rhabdomyosarcoma|rhabdomyosarcoma
5140290|NCT01050296|Ewing sarcoma|ewing sarcoma
5140291|NCT01050296|Non-rhabdomyosarcoma soft tissue sarcoma|non-rhabdomyosarcoma soft tissue sarcoma
5140292|NCT01050296|Adrenocortical tumors|adrenocortical tumors
5140293|NCT01050296|Liver malignancies|liver malignancies
5140294|NCT01050283|Advanced pancreatic adenocarcinoma|advanced pancreatic adenocarcinoma
5140295|NCT01050244|Soy protein|soy protein
5140296|NCT01050244|Milk protein|milk protein
5140297|NCT01050244|Neuropathic pain|neuropathic pain
5140298|NCT01050231|stroke|stroke
5140299|NCT01050231|cerebrovascular accident|cerebrovascular accident
5140300|NCT01050231|robot|robot
5140301|NCT01050218|Diabetic Peripheral Neuropathy|diabetic peripheral neuropathy
5140302|NCT01050205|Diabetes Prevention|diabetes prevention
5140303|NCT01050205|Cardiovascular Risk Reduction|cardiovascular risk reduction
5140304|NCT01050205|Lifestyle Intervention|lifestyle intervention
5140305|NCT01050205|Group Lifestyle Balance|group lifestyle balance
5140306|NCT01050192|Prematurity|prematurity
5140307|NCT01050192|Nutrition|nutrition
5140308|NCT01050192|Breast Feeding|breast feeding
5140309|NCT01050179|chemosensitivity|chemosensitivity
5140310|NCT01050166|islet transplantation|islet transplantation
5140311|NCT01050166|magnetic resonance|magnetic resonance
5140312|NCT01050166|Type 1 DM|type 1 dm
5140313|NCT01050153|Prevention of venous thromboembolism|prevention of venous thromboembolism
5140314|NCT01050140|fructose|fructose
5140315|NCT01050140|fatty liver disease|fatty liver disease
5140316|NCT01050140|diet|diet
5140317|NCT01050127|Pharmacokinetics|pharmacokinetics
5140318|NCT01050127|Pharmacodynamics|pharmacodynamics
5140319|NCT01050127|Drug Safety|drug safety
5140320|NCT01050127|Phase 1 Clinical Trial|phase 1 clinical trial
5140321|NCT01050114|Botulinum Toxin|botulinum toxin
5140322|NCT01050114|Oxybutynin|oxybutynin
5140323|NCT01050114|Overactive Bladder|overactive bladder
5140324|NCT01050114|Spinal Cord Injury|spinal cord injury
5140325|NCT01050114|Urinary Incontinence|urinary incontinence
5140326|NCT01050114|Nerve Growth Factor|nerve growth factor
5140327|NCT01050114|Urine Biomarkers|urine biomarkers
5140328|NCT01050101|Satiety|satiety
5140329|NCT01050101|Fiber|fiber
5140330|NCT01050101|Nutrition|nutrition
5140331|NCT01050101|Pre- and post-menopausal women|pre- and post-menopausal women
5140332|NCT01050101|overweight|overweight
5140333|NCT01050088|clubfoot|clubfoot
5140334|NCT01050088|casting|casting
5140335|NCT01050088|ponseti|ponseti
5140336|NCT01050088|discomfort|discomfort
5140337|NCT01050075|male breast cancer|male breast cancer
5140338|NCT01050075|neurotoxicity|neurotoxicity
5140339|NCT01050075|recurrent breast cancer|recurrent breast cancer
5140340|NCT01050036|Leukemia, Myeloid|leukemia, myeloid
5140341|NCT01050036|Primary complete remission|primary complete remission
5140342|NCT01050036|Favorable karyotype|favorable karyotype
5140343|NCT01050036|Autologous hematopoietic cell transplantation|autologous hematopoietic cell transplantation
5140344|NCT01050036|Hematopoietic cell transplantation|hematopoietic cell transplantation
5140345|NCT01050023|venous stasis ulcer|venous stasis ulcer
5140346|NCT01050023|wound healing|wound healing
5140347|NCT01050023|Provant Wound Closure System|provant wound closure system
5140348|NCT01050023|radiofrequency|radiofrequency
5140349|NCT01050023|Provant|provant
5140350|NCT01050023|pain relief|pain relief
5140351|NCT01050010|rheumatoid arthritis|rheumatoid arthritis
5140352|NCT01050010|clinical remission|clinical remission
5140353|NCT01050010|synovitis|synovitis
5140354|NCT01050010|dedicated extremity MRI|dedicated extremity mri
5140355|NCT01049997|Non ST Elevation Myocardial Infarction (NSTEMI)|non st elevation myocardial infarction (nstemi)
5140356|NCT01049997|Elderly|elderly
5140357|NCT01049997|Frailty|frailty
5140358|NCT01049984|Parkinson's Disease|parkinson's disease
5140359|NCT01049984|UPDRS|updrs
5140360|NCT01049984|Clinical Global Evaluation Illness Severity score|clinical global evaluation illness severity score
5140361|NCT01049984|Clinical Global Evaluation Improvement|clinical global evaluation improvement
5140362|NCT01049984|B-SIT|b-sit
5140363|NCT01049984|SCOPA - Sleep Daytime Sleepiness|scopa - sleep daytime sleepiness
5140364|NCT01049984|PDQ -39|pdq -39
5140365|NCT01049984|SCOPA - Cognition|scopa - cognition
5140366|NCT01049984|Levodopa|levodopa
5140367|NCT01049984|rasagiline|rasagiline
5140368|NCT01049984|Dopamine Agonist Therapy|dopamine agonist therapy
5140369|NCT01049984|monoamine oxidase type B inhibitor|monoamine oxidase type b inhibitor
5140370|NCT01049971|colorectal surgery|colorectal surgery
5140371|NCT01049971|wound infection|wound infection
5140372|NCT01049971|wound protector|wound protector
5140373|NCT01049971|laparoscopy|laparoscopy
5140374|NCT01049971|surgical site infection after laparoscopic colorectal surgery with minilaparotomy|surgical site infection after laparoscopic colorectal surgery with minilaparotomy
5140378|NCT01049932|HIV|hiv
5140379|NCT01049932|Human Immunodeficiency Virus (HIV)|human immunodeficiency virus (hiv)
5140380|NCT01049932|HIV Seronegativity|hiv seronegativity
5140381|NCT01049919|Critical Limb Ischemia|critical limb ischemia
5140382|NCT01049919|Peripheral Arterial Disease|peripheral arterial disease
5140383|NCT01049919|Peripheral Vascular Disease|peripheral vascular disease
5140384|NCT01049919|CLI|cli
5140385|NCT01049919|PAD|pad
5140386|NCT01049919|PVD|pvd
5140387|NCT01049919|Angiogenesis|angiogenesis
5140388|NCT01049919|Stem Cells|stem cells
5140389|NCT01049919|Cell Therapy|cell therapy
5140390|NCT01049919|Limb Salvage|limb salvage
5140391|NCT01049919|Amputation|amputation
5140392|NCT01049919|Leg Pain|leg pain
5140393|NCT01049906|foot surgery|foot surgery
5140394|NCT01049906|ankle surgery|ankle surgery
5140395|NCT01049906|Patients scheduled for foot and ankle surgery|patients scheduled for foot and ankle surgery
5140396|NCT01049880|Ascorbic Acid|ascorbic acid
5140397|NCT01049880|Gemcitabine|gemcitabine
5140398|NCT01049854|unrelated donor transplant|unrelated donor transplant
5140399|NCT01049854|CD34 selection|cd34 selection
5140400|NCT01049841|pediatric|pediatric
5140401|NCT01049841|children|children
5140402|NCT01049841|perifosine|perifosine
5140403|NCT01049841|temsirolimus|temsirolimus
5140404|NCT01049841|recurrent|recurrent
5140405|NCT01049841|progressive|progressive
5140406|NCT01049841|09-124|09-124
5140407|NCT01049828|Tinnitus|tinnitus
5140408|NCT01049828|fcMRI|fcmri
5140409|NCT01049828|Neural Connectivity|neural connectivity
5140410|NCT01049828|Bother|bother
5140411|NCT01049815|hemodialysis|hemodialysis
5140412|NCT01049815|intimal media thickness|intimal media thickness
5140413|NCT01049802|stroke|stroke
5140414|NCT01049802|hemiplegia|hemiplegia
5140415|NCT01049802|TMS|tms
5140416|NCT01049789|youth|youth
5140417|NCT01049789|HIV|hiv
5140418|NCT01049789|Depression|depression
5140419|NCT01049789|Cognitive Behavioral Therapy|cognitive behavioral therapy
5140420|NCT01049789|Medication management|medication management
5140421|NCT01049776|Lung Cancer Non Small Cell|lung cancer non small cell
5140422|NCT01049763|obese adult|obese adult
5140423|NCT01049763|non obese healthy volunteers|non obese healthy volunteers
5140424|NCT01049763|oseltamivir carboxylate|oseltamivir carboxylate
5140425|NCT01049763|pharmacokinetics|pharmacokinetics
5140426|NCT01049763|healthy volunteers|healthy volunteers
5140427|NCT01049750|type 2 diabetes mellitus|type 2 diabetes mellitus
5140428|NCT01049750|male|male
5140429|NCT01049750|erectile dysfunction|erectile dysfunction
5140430|NCT01049724|Myopia|myopia
5140431|NCT01049724|refractive surgery|refractive surgery
5140432|NCT01049724|LASIK|lasik
5140433|NCT01049724|PRK|prk
5140434|NCT01049724|Lacritin|lacritin
5140435|NCT01049724|Heparanase|heparanase
5140436|NCT01049711|erythropoietin|erythropoietin
5140437|NCT01049711|hemodialysis|hemodialysis
5140438|NCT01049711|cost utility|cost utility
5140439|NCT01049711|incremental cost-effectiveness ratio|incremental cost-effectiveness ratio
5140440|NCT01049711|Quality adjusted life year|quality adjusted life year
5140441|NCT01049711|quality of life|quality of life
5140442|NCT01049698|Obesity|obesity
5140443|NCT01049698|Overweight|overweight
5140444|NCT01049698|Older adults|older adults
5140445|NCT01049698|resistance training|resistance training
5140446|NCT01049698|exercise|exercise
5140447|NCT01049685|HIV|hiv
5140448|NCT01049685|Antiretroviral Therapy, Highly Active|antiretroviral therapy, highly active
5140449|NCT01049685|Efavirenz|efavirenz
5140450|NCT01049685|Lopinavir|lopinavir
5140451|NCT01049685|Comparative Effectiveness Research|comparative effectiveness research
5140452|NCT01049685|Treatment Naive|treatment naive
5140453|NCT01049659|pregnancy|pregnancy
5140454|NCT01049659|iodine deficiency|iodine deficiency
5140455|NCT01049659|neuropsychological development|neuropsychological development
5140456|NCT01049646|renin-angiotensin system|renin-angiotensin system
5140457|NCT01049646|apelin|apelin
5140458|NCT01049646|systemic haemodynamics|systemic haemodynamics
5140459|NCT01049633|Insulin dependence|insulin dependence
5140460|NCT01049633|Hypoglycemia|hypoglycemia
5140461|NCT01049633|Hypoglycemia unawareness|hypoglycemia unawareness
5140462|NCT01049633|Islet transplantation|islet transplantation
5140463|NCT01049620|XELOX|xelox
5140464|NCT01049620|RAD001|rad001
5140465|NCT01049620|phase 1|phase 1
5140466|NCT01049607|Patients undergoing hepatic resection|patients undergoing hepatic resection
5140467|NCT01049581|Gross motor function performance|gross motor function performance
5140468|NCT01049581|pediatric aquatic therapy|pediatric aquatic therapy
5140469|NCT01049581|spastic cerebral palsy|spastic cerebral palsy
5140470|NCT01049568|HIV|hiv
5140471|NCT01049568|Cell phone|cell phone
5140472|NCT01049568|HAART|haart
5140473|NCT01049555|alzheimer|alzheimer
5140474|NCT01049555|apathy|apathy
5140475|NCT01049555|actigraphy|actigraphy
5140476|NCT01049542|Astressin 2B|astressin 2b
5140477|NCT01049542|Forearm blood flow|forearm blood flow
5140478|NCT01049542|vascular|vascular
5140479|NCT01049542|plethysmography|plethysmography
5140480|NCT01049542|heart failure|heart failure
5140481|NCT01049529|Docosahexaenoic acid|docosahexaenoic acid
5140482|NCT01049529|n-3 Long Chain Polyunsaturated Fatty Acids|n-3 long chain polyunsaturated fatty acids
5140483|NCT01049529|omega 3 fatty acids|omega 3 fatty acids
5140484|NCT01049529|neonates|neonates
5140485|NCT01049529|clinical outcomes|clinical outcomes
5140486|NCT01049529|critically ill patients|critically ill patients
5140487|NCT01049529|Inflammatory and antiinflammatory cytokines|inflammatory and antiinflammatory cytokines
5140488|NCT01049529|Length of intensive care stay|length of intensive care stay
5140489|NCT01049516|Military|military
5140490|NCT01049516|Combat|combat
5140491|NCT01049516|Psychological Treatment|psychological treatment
5140492|NCT01049516|Psychotherapy|psychotherapy
5140493|NCT01049516|Trauma|trauma
5140494|NCT01049516|Posttraumatic Stress|posttraumatic stress
5140495|NCT01049516|Posttraumatic Stress Disorder|posttraumatic stress disorder
5140496|NCT01049516|PTSD|ptsd
5140497|NCT01049516|Prolonged Exposure|prolonged exposure
5140498|NCT01049516|Exposure therapy|exposure therapy
5140499|NCT01049516|Behavior Therapy|behavior therapy
5140500|NCT01049516|Cognitive Behavior Therapy|cognitive behavior therapy
5140501|NCT01049516|Post-Traumatic Stress Disorders|post-traumatic stress disorders
5140502|NCT01049516|Stress Disorders, Post-traumatic|stress disorders, post-traumatic
5140503|NCT01049503|Dentifrices|dentifrices
5140504|NCT01049503|Fluoride|fluoride
5140505|NCT01049503|Nails|nails
5140506|NCT01049503|Plaque|plaque
5140507|NCT01049490|Intradermal vaccination, H1N1, microneedle|intradermal vaccination, h1n1, microneedle
5140508|NCT01049477|Pregnancy|pregnancy
5140509|NCT01049477|Cesarean Section|cesarean section
5140510|NCT01049464|Atrial fibrillation|atrial fibrillation
5140511|NCT01049464|Hemodynamically unstable patients|hemodynamically unstable patients
5140512|NCT01049464|Magnesium sulfate|magnesium sulfate
5140513|NCT01049464|Septic shock|septic shock
5140514|NCT01049464|Medical intensive care unit|medical intensive care unit
5140515|NCT01049464|New onset atrial fibrillation|new onset atrial fibrillation
5140516|NCT01049464|Critically ill patients|critically ill patients
5140517|NCT01049451|Multiple Sclerosis|multiple sclerosis
5140518|NCT01049451|ACTH|acth
5140519|NCT01049451|Steroids|steroids
5140520|NCT01049438|MRSA|mrsa
5140521|NCT01049438|Methicillin Resistant Staphylococcus aureus|methicillin resistant staphylococcus aureus
5140522|NCT01049438|Staphylococcus aureus|staphylococcus aureus
5140523|NCT01049438|Skin Infections|skin infections
5140524|NCT01049438|Body Decolonization|body decolonization
5140525|NCT01049425|anthracycline-free|anthracycline-free
5140526|NCT01049425|OncotypDX|oncotypdx
5140527|NCT01049425|taxane|taxane
5140528|NCT01049425|Her2 negative breast cancer|her2 negative breast cancer
5140529|NCT01049386|intestinal permeability|intestinal permeability
5140530|NCT01049386|health|health
5140531|NCT01049386|sugar absorption|sugar absorption
5140532|NCT01049386|intestinal permeability examined in different men (lean vs obese) and different conditions (no breakfast and high-fat breakfast)|intestinal permeability examined in different men (lean vs obese) and different conditions (no breakfast and high-fat breakfast)
5140533|NCT01049373|low-back|low-back
5140534|NCT01049373|pain|pain
5140535|NCT01049373|chronic|chronic
5140536|NCT01049373|constitution|constitution
5140537|NCT01049373|diathesism|diathesism
5140538|NCT01049373|homoeopathy|homoeopathy
5140539|NCT01049373|fixed combination|fixed combination
5140540|NCT01049373|herbal preparation|herbal preparation
5140541|NCT01049373|chronic low back pain lasting more than 6 months|chronic low back pain lasting more than 6 months
5140542|NCT01049360|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5140543|NCT01049360|COPD|copd
5140544|NCT01049360|Chronic Bronchitis|chronic bronchitis
5140545|NCT01049360|Emphysema|emphysema
5140546|NCT01049360|Airflow Obstruction, Chronic|airflow obstruction, chronic
5140547|NCT01049360|Chronic Airflow Obstruction|chronic airflow obstruction
5140548|NCT01049360|Chronic Obstructive Airway Disease|chronic obstructive airway disease
5140549|NCT01049360|Chronic Obstructive Lung Disease|chronic obstructive lung disease
5140550|NCT01049347|depression|depression
5140551|NCT01049321|Dietary Approach to Stop Hypertension|dietary approach to stop hypertension
5140552|NCT01049321|weight|weight
5140553|NCT01049321|coagulation|coagulation
5140554|NCT01049321|DASH eating pattern.|dash eating pattern.
5140555|NCT01049308|heart failure|heart failure
5140556|NCT01049308|cognitive disorders|cognitive disorders
5140557|NCT01049308|medication adherence|medication adherence
5140558|NCT01049308|patient readmissions|patient readmissions
5140559|NCT01049295|taxanes|taxanes
5140560|NCT01049295|breast cancer|breast cancer
5140561|NCT01049295|n3 fatty acids|n3 fatty acids
5140562|NCT01049295|inflammation|inflammation
5140563|NCT01049282|safety|safety
5140564|NCT01049282|immunogenicity|immunogenicity
5140565|NCT01049282|adjuvanted TB subunit vaccine|adjuvanted tb subunit vaccine
5140566|NCT01049269|Body Scanning|body scanning
5140567|NCT01049269|Body Fat|body fat
5140568|NCT01049269|Body Volume|body volume
5140569|NCT01049269|Obesity|obesity
5140570|NCT01049269|No Conditions|no conditions
5140571|NCT01049256|Periodic breathing|periodic breathing
5140572|NCT01049256|Heart Failure|heart failure
5140573|NCT01049256|Chemoreflex|chemoreflex
5140574|NCT01049256|Chemosensitivity|chemosensitivity
5140575|NCT01049243|Atopic Dermatitis|atopic dermatitis
5140576|NCT01049243|Open-Label|open-label
5140577|NCT01049243|Topical|topical
5140578|NCT01049243|Cream|cream
5140579|NCT01049243|Eczema|eczema
5140580|NCT01049243|Vanos|vanos
5140581|NCT01049230|proton beam radiation|proton beam radiation
5140582|NCT01049230|CNS germ cell tumor|cns germ cell tumor
5140583|NCT01049217|neuropathy|neuropathy
5140584|NCT01049217|pain|pain
5140585|NCT01049217|HIV-1|hiv-1
5140586|NCT01049217|HIV Infections|hiv infections
5140587|NCT01049204|HIV|hiv
5140588|NCT01049204|HIV-1 Infections|hiv-1 infections
5140589|NCT01049191|Osteoporosis|osteoporosis
5140590|NCT01049191|Fracture|fracture
5140591|NCT01049191|microMRI|micromri
5140592|NCT01049191|Bone architecture|bone architecture
5140593|NCT01049191|Bone matrix|bone matrix
5140594|NCT01049191|Bone and Bones|bone and bones
5140595|NCT01049191|Magnetic Resonance Imaging|magnetic resonance imaging
5140596|NCT01049178|antioxidant enzymes|antioxidant enzymes
5140597|NCT01049178|asthma|asthma
5140598|NCT01049178|silymarin|silymarin
5140599|NCT01049178|RCT|rct
5140600|NCT01049152|Diabetes mellitus|diabetes mellitus
5140601|NCT01049152|ESRD|esrd
5140602|NCT01049152|CGM|cgm
5140603|NCT01049152|Inflammation markers|inflammation markers
5140604|NCT01049152|Hemodialysis|hemodialysis
5140605|NCT01049152|Diabetic patients|diabetic patients
5140606|NCT01049152|Nondiabetic patients|nondiabetic patients
5140607|NCT01049152|All with ESRD|all with esrd
5140608|NCT01049152|All undergone hemodialysis|all undergone hemodialysis
5140609|NCT01049139|vaccination|vaccination
5140610|NCT01049139|HIV prevention|hiv prevention
5140611|NCT01049139|YMSM|ymsm
5140612|NCT01049139|youth|youth
5140613|NCT01049139|HIV Preventative Vaccine|hiv preventative vaccine
5140614|NCT01049126|Late Stage|late stage
5140615|NCT01049113|Lymphoma|lymphoma
5140616|NCT01049113|B-cell Acute Lymphocytic Leukemia|b-cell acute lymphocytic leukemia
5140617|NCT01049113|ALL|all
5140618|NCT01049100|Surgical Staging|surgical staging
5140619|NCT01049100|Cervical Cancer|cervical cancer
5140620|NCT01049100|Chemoradiation|chemoradiation
5140621|NCT01049100|Outcome|outcome
5140622|NCT01049100|Toxicity|toxicity
5140623|NCT01049087|plasma volume|plasma volume
5140624|NCT01049087|technetium-labeled albumin|technetium-labeled albumin
5140625|NCT01049087|radioiodine-labeled albumin|radioiodine-labeled albumin
5140626|NCT01049087|Healthy volunteers|healthy volunteers
5140627|NCT01049074|Low Back Pain|low back pain
5140628|NCT01049074|Acupuncture|acupuncture
5140629|NCT01049074|RCT|rct
5140630|NCT01049061|Cancer|cancer
5140631|NCT01049061|FRα|frα
5140632|NCT01049048|Endothelial Function|endothelial function
5140633|NCT01049048|Arterial stiffness|arterial stiffness
5140634|NCT01049048|Vitamin D|vitamin d
5140635|NCT01049035|Meningitis|meningitis
5140636|NCT01049035|Meningococcal Infection|meningococcal infection
5140637|NCT01049035|Neisseria meningitidis|neisseria meningitidis
5140638|NCT01049035|Tetravalent Meningococcal Vaccine|tetravalent meningococcal vaccine
5140639|NCT01049022|Pharmacokinetics|pharmacokinetics
5140640|NCT01049009|Nitric Oxide|nitric oxide
5140641|NCT01049009|Adrenergic beta-Antagonists|adrenergic beta-antagonists
5140642|NCT01049009|Antihypertensive Agents|antihypertensive agents
5140643|NCT01049009|Vasodilator Agents|vasodilator agents
5140644|NCT01049009|Anti-Arrhythmia Agents|anti-arrhythmia agents
5140645|NCT01049009|Sympatholytics|sympatholytics
5140646|NCT01049009|Vascular Resistance|vascular resistance
5140647|NCT01049009|Neurotransmitter Agents|neurotransmitter agents
5140648|NCT01049009|Cardiovascular Diseases|cardiovascular diseases
5140649|NCT01049009|Metoprolol succinate|metoprolol succinate
5140650|NCT01049009|Therapeutic Uses|therapeutic uses
5140651|NCT01049009|Metoprolol|metoprolol
5140652|NCT01049009|Vascular Diseases|vascular diseases
5140653|NCT01049009|Nebivolol|nebivolol
5140654|NCT01049009|Cardiovascular Agents|cardiovascular agents
5140655|NCT01049009|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors
5140656|NCT01048996|Acute Lung Injury|acute lung injury
5140657|NCT01048996|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
5140658|NCT01048996|Genetic Variability|genetic variability
5140659|NCT01048996|Plasma Biomarkers|plasma biomarkers
5140660|NCT01048996|Pediatrics|pediatrics
5140661|NCT01048983|Lung Cancer|lung cancer
5140662|NCT01048983|NSCLC|nsclc
5140663|NCT01048983|Concurrent Chemoradiation Therapy|concurrent chemoradiation therapy
5140664|NCT01048983|Side Effects|side effects
5140665|NCT01048983|Armodafinil|armodafinil
5140666|NCT01048983|Nuvigil|nuvigil
5140667|NCT01048983|Bupropion|bupropion
5140668|NCT01048983|Wellbutrin|wellbutrin
5140669|NCT01048983|Wellbutrin SR|wellbutrin sr
5140670|NCT01048983|Zyban|zyban
5140671|NCT01048983|Curcumin|curcumin
5140672|NCT01048983|Minocycline|minocycline
5140673|NCT01048983|Dynacin|dynacin
5140674|NCT01048983|Minocin|minocin
5140675|NCT01048983|Minocin PAC|minocin pac
5140676|NCT01048983|Myrac|myrac
5140677|NCT01048983|Solodyn|solodyn
5140678|NCT01048970|Lung cancer|lung cancer
5140679|NCT01048970|Eicosapentaenoic acid oral supplementation|eicosapentaenoic acid oral supplementation
5140680|NCT01048970|Weight loss|weight loss
5140681|NCT01048970|Toxicity|toxicity
5140682|NCT01048970|Body composition|body composition
5140683|NCT01048970|Inflammatory response|inflammatory response
5140684|NCT01048957|Nicotine|nicotine
5140685|NCT01048957|Craving|craving
5140686|NCT01048957|fMRI|fmri
5140687|NCT01048957|EEG|eeg
5140688|NCT01048957|Real Time fMRI Feedback|real time fmri feedback
5140689|NCT01048944|Electroencephalography|electroencephalography
5140690|NCT01048944|nicotine|nicotine
5140691|NCT01048944|bupropion|bupropion
5140692|NCT01048944|attention|attention
5140693|NCT01048944|drug withdrawal symptoms|drug withdrawal symptoms
5140694|NCT01048931|Single-port, laparoscopic-assisted, vaginal hysterectomy|single-port, laparoscopic-assisted, vaginal hysterectomy
5140695|NCT01048918|Circulating tumor cells in breast cancer|circulating tumor cells in breast cancer
5140696|NCT01048905|Pulmonary Hypertension|pulmonary hypertension
5140697|NCT01048905|Sickle Cell Disease|sickle cell disease
5140698|NCT01048905|Thalassemia|thalassemia
5140699|NCT01048892|recurrent neuroblastoma|recurrent neuroblastoma
5140700|NCT01048892|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
5140701|NCT01048892|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
5140702|NCT01048892|recurrent Wilms tumor and other childhood kidney tumors|recurrent wilms tumor and other childhood kidney tumors
5140703|NCT01048892|recurrent retinoblastoma|recurrent retinoblastoma
5140704|NCT01048892|recurrent adrenocortical carcinoma|recurrent adrenocortical carcinoma
5140705|NCT01048892|recurrent gastrointestinal carcinoid tumor|recurrent gastrointestinal carcinoid tumor
5140706|NCT01048879|oseltamivir|oseltamivir
5140707|NCT01048879|influenza|influenza
5140708|NCT01048879|continuous renal replacement therapy|continuous renal replacement therapy
5140709|NCT01048879|extracorporeal membrane oxygenation|extracorporeal membrane oxygenation
5140710|NCT01048879|pharmacokinetics|pharmacokinetics
5140711|NCT01048866|pharyngitis|pharyngitis
5140712|NCT01048866|swollen throat|swollen throat
5140713|NCT01048866|difficulty swallowing|difficulty swallowing
5140714|NCT01048853|Cervix|cervix
5140715|NCT01048853|Stage IA2 or IB1 Carcinoma|stage ia2 or ib1 carcinoma
5140716|NCT01048853|Conservative Surgery|conservative surgery
5140717|NCT01048853|Cervix Cancer recurrence|cervix cancer recurrence
5140718|NCT01048853|Quality of Life Factors|quality of life factors
5140719|NCT01048853|Pelvic lymph nodes|pelvic lymph nodes
5140720|NCT01048853|Pelvic Lymphadenectomy|pelvic lymphadenectomy
5140721|NCT01048853|parametrium|parametrium
5140722|NCT01048853|Cervical cone biopsy|cervical cone biopsy
5140723|NCT01048853|Endocervical curettage|endocervical curettage
5140724|NCT01048853|ECC|ecc
5140725|NCT01048840|Gastroesophageal Reflux|gastroesophageal reflux
5140726|NCT01048827|AML|aml
5140727|NCT01048827|autologous transplant|autologous transplant
5140728|NCT01048801|History of fever|history of fever
5140729|NCT01048801|measured fever|measured fever
5140730|NCT01048788|Cirrhosis|cirrhosis
5140731|NCT01048788|ascites|ascites
5140732|NCT01048788|Tolvaptan|tolvaptan
5140733|NCT01048788|OPC-41061|opc-41061
5140734|NCT01048775|bispectral index|bispectral index
5140735|NCT01048775|cardiac surgery|cardiac surgery
5140736|NCT01048775|asymmetry|asymmetry
5140737|NCT01048762|pulmonary cancer|pulmonary cancer
5140738|NCT01048762|radically operated|radically operated
5140739|NCT01048762|exercise training|exercise training
5140740|NCT01048762|dyspnea counseling|dyspnea counseling
5140741|NCT01048762|quality of life|quality of life
5140742|NCT01048762|physical therapy|physical therapy
5140743|NCT01048749|Low back pain|low back pain
5140744|NCT01048749|nerve root compression|nerve root compression
5140745|NCT01048749|spinal height|spinal height
5140746|NCT01048736|obesity|obesity
5140747|NCT01048736|exercise|exercise
5140748|NCT01048736|intensity|intensity
5140749|NCT01048736|weight loss|weight loss
5140750|NCT01048736|diet|diet
5140751|NCT01048723|Soft Tissue|soft tissue
5140752|NCT01048723|Retroperitoneal|retroperitoneal
5140753|NCT01048723|resectable|resectable
5140754|NCT01048710|Knee osteoarthritis|knee osteoarthritis
5140755|NCT01048710|knee osteonecrosis|knee osteonecrosis
5140756|NCT01048710|osteotomy|osteotomy
5140757|NCT01048697|Obesity|obesity
5140758|NCT01048697|Pharmacokinetics|pharmacokinetics
5140759|NCT01048697|Pharmacodynamics|pharmacodynamics
5140760|NCT01048697|Dose individualization|dose individualization
5140761|NCT01048697|Tuberculosis|tuberculosis
5140762|NCT01048684|Brain tumor|brain tumor
5140763|NCT01048684|Intracranial pressure|intracranial pressure
5140764|NCT01048671|HIV|hiv
5140765|NCT01048658|Sevoflurane|sevoflurane
5140766|NCT01048658|anesthesia|anesthesia
5140767|NCT01048658|abortion|abortion
5140768|NCT01048658|blood loss|blood loss
5140769|NCT01048645|All-trans retinoic acid|all-trans retinoic acid
5140770|NCT01048645|non-small cell lung cancer|non-small cell lung cancer
5140771|NCT01048645|retinoic acid receptor beta|retinoic acid receptor beta
5140772|NCT01048645|chemotherapy|chemotherapy
5140773|NCT01048632|Neonates with HLHS or variant with plan to undergo Norwood Procedure|neonates with hlhs or variant with plan to undergo norwood procedure
5140774|NCT01048619|Myelodysplastic Syndrome|myelodysplastic syndrome
5140775|NCT01048619|MDS|mds
5140776|NCT01048606|Postmenopause|postmenopause
5140777|NCT01048606|Overweight|overweight
5140778|NCT01048606|Women|women
5140779|NCT01048606|Phytoestrogens|phytoestrogens
5140780|NCT01048606|Exercise|exercise
5140781|NCT01048606|Cardiovascular Diseases|cardiovascular diseases
5140782|NCT01048606|Risk Factors|risk factors
5140783|NCT01048606|Aging|aging
5140784|NCT01048593|ocular inflammation cataract surgery|ocular inflammation cataract surgery
5140785|NCT01048593|post cataract surgery inflammation|post cataract surgery inflammation
5140786|NCT01048580|Perifosine|perifosine
5140787|NCT01048580|Capecitabine|capecitabine
5140788|NCT01048580|Colon Cancer|colon cancer
5140789|NCT01048567|Antibiotics|antibiotics
5140790|NCT01048567|Diarrhea|diarrhea
5140791|NCT01048567|Clostridium difficile|clostridium difficile
5140792|NCT01048567|Probiotics|probiotics
5140793|NCT01048567|Prevention & control|prevention & control
5140794|NCT01048554|Melanoma|melanoma
5140795|NCT01048554|Brain mets|brain mets
5140796|NCT01048554|Bevacizumab|bevacizumab
5140797|NCT01048554|Temozolomide|temozolomide
5140798|NCT01048554|Avastin|avastin
5140799|NCT01048554|Temodar|temodar
5140800|NCT01048554|Melanoma with brain mets|melanoma with brain mets
5140801|NCT01048528|immune response to vaccines|immune response to vaccines
5140802|NCT01048528|stress management|stress management
5140803|NCT01048528|perceived risk for breast cancer|perceived risk for breast cancer
5140804|NCT01048515|Caffeine|caffeine
5140805|NCT01048515|Physiological Effects of Drugs|physiological effects of drugs
5140806|NCT01048515|Central Nervous System Agents|central nervous system agents
5140807|NCT01048502|healthy volunteer|healthy volunteer
5140808|NCT01048476|AMD|amd
5140809|NCT01048463|gastric cancer|gastric cancer
5140810|NCT01048463|colorectal cancer|colorectal cancer
5140811|NCT01048463|chemotherapy|chemotherapy
5140812|NCT01048463|eicosapentaenoic acid|eicosapentaenoic acid
5140813|NCT01048463|enteral nutrition|enteral nutrition
5140814|NCT01048450|arthritis|arthritis
5140815|NCT01048450|degeneration|degeneration
5140816|NCT01048424|Urinary incontinence|urinary incontinence
5140817|NCT01048424|Paced respiration|paced respiration
5140818|NCT01048411|stroke rehabilitation|stroke rehabilitation
5140819|NCT01048411|outcome|outcome
5140820|NCT01048411|barthel-index|barthel-index
5140821|NCT01048411|geriatrics|geriatrics
5140822|NCT01048411|elderly|elderly
5140823|NCT01048398|ceophalic version|ceophalic version
5140824|NCT01048398|breech presentation|breech presentation
5140825|NCT01048398|pregnancy|pregnancy
5140826|NCT01048398|remifentanil|remifentanil
5140827|NCT01048398|paracetamol|paracetamol
5140828|NCT01048385|Mitochondrial dysfunction|mitochondrial dysfunction
5140829|NCT01048385|Mitochondrial nutrients|mitochondrial nutrients
5140830|NCT01048385|Aneuploidy|aneuploidy
5140831|NCT01048385|Meiotic Spindle|meiotic spindle
5140832|NCT01048385|Coenzyme Q10|coenzyme q10
5140833|NCT01048385|Electron transfer chain|electron transfer chain
5140834|NCT01048372|HIV|hiv
5140835|NCT01048372|monoclonal antibody|monoclonal antibody
5140836|NCT01048372|immune therapy|immune therapy
5140837|NCT01048372|pathogenesis|pathogenesis
5140838|NCT01048372|cytotoxic T lymphocyte|cytotoxic t lymphocyte
5140839|NCT01048372|anti-CD4|anti-cd4
5140840|NCT01048372|anti-self|anti-self
5140841|NCT01048372|viral replication|viral replication
5140842|NCT01048372|Acute Infection|acute infection
5140843|NCT01048359|Drug abuse, injury, trauma, screening, brief intervention.|drug abuse, injury, trauma, screening, brief intervention.
5140844|NCT01048346|employment, disabilities|employment, disabilities
5140845|NCT01048333|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5140846|NCT01048333|Onset of effect|onset of effect
5140847|NCT01048333|COPD|copd
5140848|NCT01048333|Oxis Turbuhaler|oxis turbuhaler
5140849|NCT01048320|pancreatic cancer|pancreatic cancer
5140850|NCT01048320|toxicity|toxicity
5140851|NCT01048320|chemotherapy|chemotherapy
5140852|NCT01048320|dose finding|dose finding
5140853|NCT01048307|prontosan|prontosan
5140854|NCT01048307|wound cleansing|wound cleansing
5140855|NCT01048307|wound irrigation|wound irrigation
5140856|NCT01048307|phmb|phmb
5140857|NCT01048307|polihexanide|polihexanide
5140858|NCT01048307|betaine|betaine
5140859|NCT01048294|Seasonal affective disorder|seasonal affective disorder
5140860|NCT01048294|phototherapy|phototherapy
5140861|NCT01048294|circadian rhythms|circadian rhythms
5140862|NCT01048294|blue enriched light|blue enriched light
5140863|NCT01048294|melanopsin|melanopsin
5140864|NCT01048294|Primary disease: Seasonal Affective Disorder, winter type|primary disease: seasonal affective disorder, winter type
5140865|NCT01048268|T1DM|t1dm
5140866|NCT01048268|T2DM|t2dm
5140867|NCT01048268|GIP|gip
5140868|NCT01048268|Glucose-dependent insulinotropic polypeptide|glucose-dependent insulinotropic polypeptide
5140869|NCT01048268|Incretin|incretin
5140870|NCT01048216|colorectal liver cancer|colorectal liver cancer
5140871|NCT01048216|metastatic|metastatic
5140872|NCT01048216|radiation therapy|radiation therapy
5140873|NCT01048203|14C ABR 215050 Metabolism and Mass Balance Study|14c abr 215050 metabolism and mass balance study
5140874|NCT01048203|tasquinimod|tasquinimod
5140875|NCT01048203|Metabolic pattern of 14C ABR-215050|metabolic pattern of 14c abr-215050
5140876|NCT01048190|Inactivated Poliomyelitis Vaccine|inactivated poliomyelitis vaccine
5140877|NCT01048190|Sabin Strains|sabin strains
5140878|NCT01048190|poliomyelitis|poliomyelitis
5140879|NCT01048177|vulvodynia|vulvodynia
5140880|NCT01048177|interstitial cystitis|interstitial cystitis
5140881|NCT01048177|pelvic pain|pelvic pain
5140882|NCT01048164|Massage|massage
5140883|NCT01048164|Relaxation|relaxation
5140884|NCT01048151|Prostate|prostate
5140885|NCT01048151|TNFerade Biologic|tnferade biologic
5140886|NCT01048138|Biperiden|biperiden
5140887|NCT01048138|Post-traumatic Epilepsy|post-traumatic epilepsy
5140888|NCT01048138|Traumatic Brain Injury|traumatic brain injury
5140889|NCT01048125|Stress-induced cardiomyopathy|stress-induced cardiomyopathy
5140890|NCT01048125|Takotsubo cardiomyopathy|takotsubo cardiomyopathy
5140891|NCT01048112|campylobacter|campylobacter
5140892|NCT01048112|gastroenteritis|gastroenteritis
5140893|NCT01048112|challenge models|challenge models
5140894|NCT01048099|Breast Cancer|breast cancer
5140895|NCT01048099|Metastatic|metastatic
5140896|NCT01048099|PRO Onc Assay|pro onc assay
5140897|NCT01048099|FISH Testing|fish testing
5140898|NCT01048099|HER Negative|her negative
5140899|NCT01048099|HER Overexpression|her overexpression
5140900|NCT01048099|HER Activation|her activation
5140901|NCT01048086|neuroblastoma|neuroblastoma
5140902|NCT01048086|neuroendocrine tumor|neuroendocrine tumor
5140903|NCT01048086|NET|net
5140904|NCT01048086|retinoic acid|retinoic acid
5140905|NCT01048073|lower respiratory tract infection|lower respiratory tract infection
5140906|NCT01048073|non influenza|non influenza
5140907|NCT01048073|PCR assay|pcr assay
5140908|NCT01048047|aliskiren|aliskiren
5140909|NCT01048047|amlodipine|amlodipine
5140910|NCT01048047|hypertension|hypertension
5140911|NCT01048047|ankle-foot volume|ankle-foot volume
5140912|NCT01048047|mild and moderate hypertension|mild and moderate hypertension
5140913|NCT01048034|Myelodysplastic syndrome|myelodysplastic syndrome
5140914|NCT01048034|Chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5140915|NCT01048034|Transfusion therapy|transfusion therapy
5140916|NCT01048034|Transfusion dependency|transfusion dependency
5140917|NCT01048034|Hypomethylating therapy|hypomethylating therapy
5140918|NCT01048034|Azacitidine|azacitidine
5140919|NCT01048034|DNA-methylation|dna-methylation
5140920|NCT01048034|Epigenetic modifications|epigenetic modifications
5140921|NCT01048021|Measurement of lung mechanics (FEV1, FVC and PEF)|measurement of lung mechanics (fev1, fvc and pef)
5140922|NCT01048008|Glioblastoma multiforme|glioblastoma multiforme
5140923|NCT01048008|Advanced cancers|advanced cancers
5140924|NCT01048008|Brain Neoplasms, Malignant, Primary|brain neoplasms, malignant, primary
5140925|NCT01048008|Brain Tumor, Recurrent|brain tumor, recurrent
5140926|NCT01048008|Advanced cancer|advanced cancer
5140927|NCT01047982|gestational diabetes|gestational diabetes
5140928|NCT01047982|macrosomia|macrosomia
5140929|NCT01047982|hypertension in pregnancy|hypertension in pregnancy
5140930|NCT01047982|HOMA-IR|homa-ir
5140931|NCT01047982|obesity|obesity
5140932|NCT01047969|locally invasive high-risk rectal adenocarcinoma|locally invasive high-risk rectal adenocarcinoma
5140933|NCT01047956|Methadone|methadone
5140934|NCT01047956|NAC|nac
5140935|NCT01047956|opioids|opioids
5140936|NCT01047930|Insomnia|insomnia
5140937|NCT01047930|Smoking|smoking
5140938|NCT01047930|Cue reactivity|cue reactivity
5140939|NCT01047930|Exercise timing|exercise timing
5140940|NCT01047930|Acute nicotine withdrawal|acute nicotine withdrawal
5140941|NCT01047930|Mood disturbances|mood disturbances
5140942|NCT01047930|Smoking abstinence|smoking abstinence
5140943|NCT01047930|Exercise intensity|exercise intensity
5140944|NCT01047930|Altered sleep|altered sleep
5140945|NCT01047930|Exercise duration|exercise duration
5140946|NCT01047930|Nonpharmacologic behavioral treatment|nonpharmacologic behavioral treatment
5140947|NCT01047930|Smoking cessation|smoking cessation
5140948|NCT01047930|Exercise Test|exercise test
5140949|NCT01047930|Polysomnography|polysomnography
5140950|NCT01047917|Meditation|meditation
5140951|NCT01047917|Relaxation Therapy|relaxation therapy
5140952|NCT01047917|Quality of Life|quality of life
5140953|NCT01047865|Type 1 Diabetes (T1D)|type 1 diabetes (t1d)
5140954|NCT01047865|Autoimmunity|autoimmunity
5140955|NCT01047852|chronic respiratory disorders|chronic respiratory disorders
5140956|NCT01047852|hypercapnic respiratory failure|hypercapnic respiratory failure
5140957|NCT01047852|noninvasive ventilation|noninvasive ventilation
5140958|NCT01047839|Pediatric|pediatric
5140959|NCT01047839|Japanese Encephalitis Vaccine|japanese encephalitis vaccine
5140960|NCT01047839|non-endemic countries|non-endemic countries
5140961|NCT01047839|to assess immunogenicity of purified inactivated Japanese Encephalitis (JE) vaccine IC51|to assess immunogenicity of purified inactivated japanese encephalitis (je) vaccine ic51
5140962|NCT01047826|Fractured Tibia|fractured tibia
5140963|NCT01047826|Expert Tibial Nail|expert tibial nail
5140964|NCT01047826|Minimally Invasive Plate Osteosynthesis (M.I.P.O)|minimally invasive plate osteosynthesis (m.i.p.o)
5140965|NCT01047826|Intramedullary Nailing|intramedullary nailing
5140966|NCT01047826|Locked Plate|locked plate
5140967|NCT01047826|distal third|distal third
5140968|NCT01047826|43-A|43-a
5140969|NCT01047813|Cognitive performance|cognitive performance
5140970|NCT01047813|Type 2 diabetes|type 2 diabetes
5140971|NCT01047813|Blood glucose|blood glucose
5140972|NCT01047800|Functional gastrointestinal disorder|functional gastrointestinal disorder
5140973|NCT01047800|GERD|gerd
5140974|NCT01047800|reflux|reflux
5140975|NCT01047800|irritable bowel syndrome|irritable bowel syndrome
5140976|NCT01047800|Functional dyspepsia|functional dyspepsia
5140977|NCT01047800|postprandial fullness|postprandial fullness
5140978|NCT01047800|counseling|counseling
5140979|NCT01047800|service|service
5140980|NCT01047787|Sleep apnea|sleep apnea
5140981|NCT01047787|Cheyne-Stokes Respiration|cheyne-stokes respiration
5140982|NCT01047787|Congestive Heart Failure|congestive heart failure
5140983|NCT01047774|soy protein|soy protein
5140984|NCT01047774|diet|diet
5140985|NCT01047761|Myasthenia Gravis|myasthenia gravis
5140986|NCT01047761|Exercise|exercise
5140987|NCT01047761|Fitness|fitness
5140988|NCT01047761|Body Composition|body composition
5140989|NCT01047761|Physical Activity|physical activity
5140990|NCT01047761|Pulmonary Function|pulmonary function
5140991|NCT01047761|Balance|balance
5140992|NCT01047748|abortion|abortion
5140993|NCT01047735|21+ years old|21+ years old
5140994|NCT01047735|Address|address
5140995|NCT01047735|Adult|adult
5140996|NCT01047735|Amputation|amputation
5140997|NCT01047735|Area|area
5140998|NCT01047735|Arm|arm
5140999|NCT01047735|Atheroscleroses|atheroscleroses
5141000|NCT01047735|Atherosclerosis|atherosclerosis
5141001|NCT01047735|Atherosclerotic|atherosclerotic
5141002|NCT01047735|Cardiovascular Disease|cardiovascular disease
5141003|NCT01047735|Bariatrics|bariatrics
5141004|NCT01047735|Behavior Conditioning Therapy|behavior conditioning therapy
5141005|NCT01047735|Behavior Modification|behavior modification
5141006|NCT01047735|Behavior Therapy|behavior therapy
5141007|NCT01047735|Behavior Treatment|behavior treatment
5141008|NCT01047735|Behavior or Life Style Modifications|behavior or life style modifications
5141009|NCT01047735|Behavioral|behavioral
5141010|NCT01047735|Behavioral Conditioning Therapy|behavioral conditioning therapy
5141011|NCT01047735|Behavioral Modification|behavioral modification
5141012|NCT01047735|Behavioral Therapy|behavioral therapy
5141013|NCT01047735|Behavioral Treatment|behavioral treatment
5141014|NCT01047735|Beta Cell|beta cell
5141015|NCT01047735|Blindness|blindness
5141016|NCT01047735|Blood Pressure, High|blood pressure, high
5141017|NCT01047735|Blood Vessels|blood vessels
5141018|NCT01047735|Body Composition|body composition
5141019|NCT01047735|Body Weight decreased|body weight decreased
5141020|NCT01047735|Cancers|cancers
5141021|NCT01047735|Cardiac infarction|cardiac infarction
5141022|NCT01047735|Cardiovascular Diseases|cardiovascular diseases
5141023|NCT01047735|Care, Health|care, health
5141024|NCT01047735|Cause of Death|cause of death
5141025|NCT01047735|Cell Function|cell function
5141026|NCT01047735|Cell Process|cell process
5141027|NCT01047735|Cell physiology|cell physiology
5141028|NCT01047735|Cellular Function|cellular function
5141029|NCT01047735|Cellular Physiology|cellular physiology
5141030|NCT01047735|Cellular Process|cellular process
5141031|NCT01047735|Cessation of life|cessation of life
5141032|NCT01047735|Clinical|clinical
5141033|NCT01047735|Clinical Trials Design|clinical trials design
5141034|NCT01047735|Communities|communities
5141035|NCT01047735|Conditioning Therapy|conditioning therapy
5141036|NCT01047735|Controlled Clinical Trials, Randomized|controlled clinical trials, randomized
5141037|NCT01047735|Controlled Study|controlled study
5141038|NCT01047735|Country|country
5141039|NCT01047735|D-Glucose|d-glucose
5141040|NCT01047735|Death|death
5141041|NCT01047735|Decision Making|decision making
5141042|NCT01047735|Dextrose|dextrose
5141043|NCT01047735|Diabetes Mellitus|diabetes mellitus
5141044|NCT01047735|Diabetes Mellitus, Adult-Onset|diabetes mellitus, adult-onset
5141045|NCT01047735|Diabetes Mellitus, Ketosis-Resistant|diabetes mellitus, ketosis-resistant
5141046|NCT01047735|Diabetes Mellitus, Non-Insulin-Dependent|diabetes mellitus, non-insulin-dependent
5141047|NCT01047735|Diabetes Mellitus, Noninsulin Dependent|diabetes mellitus, noninsulin dependent
5141048|NCT01047735|Diabetes Mellitus, Slow-Onset|diabetes mellitus, slow-onset
5141049|NCT01047735|Diabetes Mellitus, Stable|diabetes mellitus, stable
5141050|NCT01047735|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
5141051|NCT01047735|Diabetes Mellitus, Type II|diabetes mellitus, type ii
5141052|NCT01047735|Diet|diet
5141053|NCT01047735|Disease|disease
5141054|NCT01047735|Disease remission|disease remission
5141055|NCT01047735|Disorder|disorder
5141056|NCT01047735|Drugs|drugs
5141057|NCT01047735|Dysfunction|dysfunction
5141058|NCT01047735|Effectiveness|effectiveness
5141059|NCT01047735|Epidemic|epidemic
5141060|NCT01047735|Functional disorder|functional disorder
5141061|NCT01047735|Future|future
5141062|NCT01047735|Gastric Bypass|gastric bypass
5141063|NCT01047735|Glucose|glucose
5141064|NCT01047735|Health|health
5141065|NCT01047735|Healthcare|healthcare
5141066|NCT01047735|Hepatic Disorder|hepatic disorder
5141067|NCT01047735|Human, Adult|human, adult
5141068|NCT01047735|Hypertension|hypertension
5141069|NCT01047735|INFLM|inflm
5141070|NCT01047735|Incidence|incidence
5141071|NCT01047735|Inflammation|inflammation
5141072|NCT01047735|Insulin Cell|insulin cell
5141073|NCT01047735|Insulin Resistance|insulin resistance
5141074|NCT01047735|Insulin Secreting Cell|insulin secreting cell
5141075|NCT01047735|Intestinal|intestinal
5141076|NCT01047735|Intestines|intestines
5141077|NCT01047735|Intravenous Glucose Tolerance|intravenous glucose tolerance
5141078|NCT01047735|Intravenous Glucose Tolerance Test|intravenous glucose tolerance test
5141079|NCT01047735|Kidney Failure|kidney failure
5141080|NCT01047735|Kidney Insufficiency|kidney insufficiency
5141081|NCT01047735|Learning|learning
5141082|NCT01047735|Life Style|life style
5141083|NCT01047735|Life Style Modification|life style modification
5141084|NCT01047735|Lifestyle|lifestyle
5141085|NCT01047735|Link|link
5141086|NCT01047735|Liver diseases|liver diseases
5141087|NCT01047735|Longitudinal Studies|longitudinal studies
5141088|NCT01047735|MODY|mody
5141089|NCT01047735|Malignant Neoplasms|malignant neoplasms
5141090|NCT01047735|Malignant Tumor|malignant tumor
5141091|NCT01047735|Maturity-Onset Diabetes Mellitus|maturity-onset diabetes mellitus
5141092|NCT01047735|Measures|measures
5141093|NCT01047735|Medical|medical
5141094|NCT01047735|Medication|medication
5141095|NCT01047735|Metabolic|metabolic
5141096|NCT01047735|Methods|methods
5141097|NCT01047735|Modification|modification
5141098|NCT01047735|Morbid Obesity|morbid obesity
5141099|NCT01047735|Morbidity|morbidity
5141100|NCT01047735|Morbidity - disease rate|morbidity - disease rate
5141101|NCT01047735|Mortality|mortality
5141102|NCT01047735|Mortality Vital Statistics|mortality vital statistics
5141103|NCT01047735|Myocardial Infarct|myocardial infarct
5141104|NCT01047735|Myocardial Infarction|myocardial infarction
5141105|NCT01047735|NAFLD|nafld
5141106|NCT01047735|NASH|nash
5141107|NCT01047735|NIDDM|niddm
5141108|NCT01047735|Non-Insulin Dependent Diabetes|non-insulin dependent diabetes
5141109|NCT01047735|Non-Insulin-Dependent Diabetes Mellitus|non-insulin-dependent diabetes mellitus
5141110|NCT01047735|Non-alcoholic steatohepatitis|non-alcoholic steatohepatitis
5141111|NCT01047735|Obesity|obesity
5141112|NCT01047735|Obesity, Morbid|obesity, morbid
5141113|NCT01047735|Operation|operation
5141114|NCT01047735|Operative Procedures|operative procedures
5141115|NCT01047735|Operative Surgical Procedures|operative surgical procedures
5141116|NCT01047735|Outcome|outcome
5141117|NCT01047735|Outcome Measure|outcome measure
5141118|NCT01047735|PROV|prov
5141119|NCT01047735|Participant|participant
5141120|NCT01047735|Patients|patients
5141121|NCT01047735|Pharmaceutic Preparations|pharmaceutic preparations
5141122|NCT01047735|Pharmaceutical Preparations|pharmaceutical preparations
5141123|NCT01047735|Physical activity|physical activity
5141124|NCT01047735|Physiopathology|physiopathology
5141125|NCT01047735|Pilot Projects|pilot projects
5141126|NCT01047735|Population|population
5141127|NCT01047735|Procedures|procedures
5141128|NCT01047735|Programs (PT)|programs (pt)
5141129|NCT01047735|Programs [Publication Type]|programs [publication type]
5141130|NCT01047735|Provider|provider
5141131|NCT01047735|Psychosocial Factor|psychosocial factor
5141132|NCT01047735|Public Health|public health
5141133|NCT01047735|RMSN|rmsn
5141134|NCT01047735|Randomized|randomized
5141135|NCT01047735|Randomized Controlled Clinical Trials|randomized controlled clinical trials
5141136|NCT01047735|Randomized Controlled Trials|randomized controlled trials
5141137|NCT01047735|Remission|remission
5141138|NCT01047735|Renal Failure|renal failure
5141139|NCT01047735|Renal Insufficiency|renal insufficiency
5141140|NCT01047735|Reporting|reporting
5141141|NCT01047735|Resolution|resolution
5141142|NCT01047735|Science|science
5141143|NCT01047735|Severe obesity|severe obesity
5141144|NCT01047735|Structure|structure
5141145|NCT01047735|Subcellular Process|subcellular process
5141146|NCT01047735|Surgical|surgical
5141147|NCT01047735|Surgical Interventions|surgical interventions
5141148|NCT01047735|Surgical Procedure|surgical procedure
5141149|NCT01047735|T2D|t2d
5141150|NCT01047735|T2DM|t2dm
5141151|NCT01047735|Testing|testing
5141152|NCT01047735|Type 2 diabetes|type 2 diabetes
5141153|NCT01047735|Type II diabetes|type ii diabetes
5141154|NCT01047735|United States|united states
5141155|NCT01047735|Upper arm|upper arm
5141156|NCT01047735|Vascular Hypertensive Disease|vascular hypertensive disease
5141157|NCT01047735|Vascular Hypertensive Disorder|vascular hypertensive disorder
5141158|NCT01047735|Weight|weight
5141159|NCT01047735|Weight Loss|weight loss
5141160|NCT01047735|Weight Reduction|weight reduction
5141161|NCT01047735|Work|work
5141162|NCT01047735|adiposity|adiposity
5141163|NCT01047735|adult human (21+)|adult human (21+)
5141164|NCT01047735|adult onset diabetes|adult onset diabetes
5141165|NCT01047735|atheromatosis|atheromatosis
5141166|NCT01047735|atherosclerotic vascular disease|atherosclerotic vascular disease
5141167|NCT01047735|bariatric surgery|bariatric surgery
5141168|NCT01047735|behavior intervention|behavior intervention
5141169|NCT01047735|behavioral intervention|behavioral intervention
5141170|NCT01047735|blood glucose regulation|blood glucose regulation
5141171|NCT01047735|body weight loss|body weight loss
5141172|NCT01047735|bowel|bowel
5141173|NCT01047735|cardiac infarct|cardiac infarct
5141174|NCT01047735|cardiovascular disorder|cardiovascular disorder
5141175|NCT01047735|cardiovascular risk|cardiovascular risk
5141176|NCT01047735|cardiovascular risk factor|cardiovascular risk factor
5141177|NCT01047735|clinical practice|clinical practice
5141178|NCT01047735|comparative effectiveness|comparative effectiveness
5141179|NCT01047735|coronary attack|coronary attack
5141180|NCT01047735|coronary infarct|coronary infarct
5141181|NCT01047735|coronary infarction|coronary infarction
5141182|NCT01047735|corpulence|corpulence
5141183|NCT01047735|corpulency|corpulency
5141184|NCT01047735|corpulentia|corpulentia
5141185|NCT01047735|design|design
5141186|NCT01047735|designing|designing
5141187|NCT01047735|diabetes|diabetes
5141188|NCT01047735|diabetic patient|diabetic patient
5141189|NCT01047735|disease/disorder|disease/disorder
5141190|NCT01047735|drug/agent|drug/agent
5141191|NCT01047735|effective therapy|effective therapy
5141192|NCT01047735|effectiveness research|effectiveness research
5141193|NCT01047735|fitness|fitness
5141194|NCT01047735|gastric banding|gastric banding
5141195|NCT01047735|gastric bypass surgery|gastric bypass surgery
5141196|NCT01047735|glucose control|glucose control
5141197|NCT01047735|glucose homeostasis|glucose homeostasis
5141198|NCT01047735|glucose metabolism|glucose metabolism
5141199|NCT01047735|glucose regulation|glucose regulation
5141200|NCT01047735|heart attack|heart attack
5141201|NCT01047735|heart infarct|heart infarct
5141202|NCT01047735|heart infarction|heart infarction
5141203|NCT01047735|hepatopathy|hepatopathy
5141204|NCT01047735|hyperpiesia|hyperpiesia
5141205|NCT01047735|hyperpiesis|hyperpiesis
5141206|NCT01047735|hypertensive disease|hypertensive disease
5141207|NCT01047735|implantable gastric stimulation banding|implantable gastric stimulation banding
5141208|NCT01047735|insulin resistant|insulin resistant
5141209|NCT01047735|interest|interest
5141210|NCT01047735|ketosis resistant diabetes|ketosis resistant diabetes
5141211|NCT01047735|life style intervention|life style intervention
5141212|NCT01047735|lifestyle intervention|lifestyle intervention
5141213|NCT01047735|liver disorder|liver disorder
5141214|NCT01047735|long-term study|long-term study
5141215|NCT01047735|malignancy|malignancy
5141216|NCT01047735|maturity onset diabetes|maturity onset diabetes
5141217|NCT01047735|moderate obesity|moderate obesity
5141218|NCT01047735|neoplasm/cancer|neoplasm/cancer
5141219|NCT01047735|non-alcohol fatty liver|non-alcohol fatty liver
5141220|NCT01047735|non-alcohol induced steatohepatitis|non-alcohol induced steatohepatitis
5141221|NCT01047735|non-alcoholic fatty liver|non-alcoholic fatty liver
5141222|NCT01047735|non-alcoholic steato-hepatitis|non-alcoholic steato-hepatitis
5141223|NCT01047735|nonalcohol fatty liver|nonalcohol fatty liver
5141224|NCT01047735|nonalcoholic fatty liver|nonalcoholic fatty liver
5141225|NCT01047735|nonalcoholic steato-hepatitis|nonalcoholic steato-hepatitis
5141226|NCT01047735|nonalcoholic steatohepatitis|nonalcoholic steatohepatitis
5141227|NCT01047735|obese|obese
5141228|NCT01047735|obese people|obese people
5141229|NCT01047735|obese person|obese person
5141230|NCT01047735|obese population|obese population
5141231|NCT01047735|obesity surgery|obesity surgery
5141232|NCT01047735|obesity, extreme|obesity, extreme
5141233|NCT01047735|pathophysiology|pathophysiology
5141234|NCT01047735|pilot study|pilot study
5141235|NCT01047735|programs|programs
5141236|NCT01047735|psychosocial|psychosocial
5141237|NCT01047735|psychosocial variables|psychosocial variables
5141238|NCT01047735|public health medicine (field)|public health medicine (field)
5141239|NCT01047735|public health relevance|public health relevance
5141240|NCT01047735|randomisation|randomisation
5141241|NCT01047735|randomization|randomization
5141242|NCT01047735|randomized controlled study|randomized controlled study
5141243|NCT01047735|randomized trial|randomized trial
5141244|NCT01047735|randomly assigned|randomly assigned
5141245|NCT01047735|respiratory|respiratory
5141246|NCT01047735|response|response
5141247|NCT01047735|stomach bypass|stomach bypass
5141248|NCT01047735|stomach stapling|stomach stapling
5141249|NCT01047735|surgery|surgery
5141250|NCT01047735|trial comparing|trial comparing
5141251|NCT01047735|vascular|vascular
5141252|NCT01047735|weight loss intervention|weight loss intervention
5141253|NCT01047735|weight loss surgery|weight loss surgery
5141254|NCT01047735|wt-loss|wt-loss
5141255|NCT01047722|platelet function test|platelet function test
5141256|NCT01047722|platelets|platelets
5141257|NCT01047722|in vivo test|in vivo test
5141258|NCT01047722|aspirin|aspirin
5141259|NCT01047722|aspirin resistance|aspirin resistance
5141260|NCT01047722|aspirin non-responsiveness|aspirin non-responsiveness
5141261|NCT01047722|in-vivo|in-vivo
5141262|NCT01047722|To assess the specificity and sensitivity of a novel in-vivo diagnostic test of platelet function|to assess the specificity and sensitivity of a novel in-vivo diagnostic test of platelet function
5141263|NCT01047722|"To use this test to define and assess aspirin resistance"|"to use this test to define and assess aspirin resistance"
5141264|NCT01047683|hypertriglyceridemia|hypertriglyceridemia
5141265|NCT01047683|omega-3 fatty acids|omega-3 fatty acids
5141266|NCT01047683|statin|statin
5141267|NCT01047683|triglycerides|triglycerides
5141268|NCT01047683|lipids|lipids
5141269|NCT01047683|EPA|epa
5141270|NCT01047683|docosahexaenoic acid|docosahexaenoic acid
5141271|NCT01047683|fish|fish
5141272|NCT01047683|fatty acids|fatty acids
5141273|NCT01047683|fibrates|fibrates
5141274|NCT01047683|niacin|niacin
5141275|NCT01047683|lipid|lipid
5141276|NCT01047683|atorvastatin|atorvastatin
5141277|NCT01047683|Lovaza|lovaza
5141278|NCT01047683|simvastatin|simvastatin
5141279|NCT01047683|lovastatin|lovastatin
5141280|NCT01047683|pravastatin|pravastatin
5141281|NCT01047683|fluvastatin|fluvastatin
5141282|NCT01047683|rosuvastatin|rosuvastatin
5141283|NCT01047683|Trilipix|trilipix
5141284|NCT01047683|Vytorin|vytorin
5141285|NCT01047683|Simcor|simcor
5141286|NCT01047683|Niaspan|niaspan
5141287|NCT01047683|ezetimibe|ezetimibe
5141288|NCT01047683|Zetia|zetia
5141289|NCT01047683|ethyl-EPA|ethyl-epa
5141290|NCT01047683|ethyl icosapentate|ethyl icosapentate
5141291|NCT01047683|Crestor|crestor
5141292|NCT01047683|Zocor|zocor
5141293|NCT01047683|Lipitor|lipitor
5141294|NCT01047683|LDL|ldl
5141295|NCT01047683|HDL|hdl
5141296|NCT01047683|cholesterol|cholesterol
5141297|NCT01047683|dyslipidemia|dyslipidemia
5141298|NCT01047683|VASCEPA|vascepa
5141299|NCT01047683|icosapent ethyl|icosapent ethyl
5141300|NCT01047670|sepsis, shock, adrenal insufficiency, hydrocortisone, children, paediatric intensive care.|sepsis, shock, adrenal insufficiency, hydrocortisone, children, paediatric intensive care.
5141301|NCT01047670|number of days free of vasoactive support in 7 days|number of days free of vasoactive support in 7 days
5141302|NCT01047670|days free of mechanical ventilation|days free of mechanical ventilation
5141303|NCT01047670|PICU mortality|picu mortality
5141304|NCT01047670|mortality among patient with inappropriate response to the ACTH test|mortality among patient with inappropriate response to the acth test
5141305|NCT01047670|baseline cortisol/ PIM2 correlation|baseline cortisol/ pim2 correlation
5141306|NCT01047657|Asthma|asthma
5141307|NCT01047657|Obesity|obesity
5141308|NCT01047657|weight loss|weight loss
5141309|NCT01047644|port|port
5141310|NCT01047644|catheter|catheter
5141311|NCT01047644|infusion|infusion
5141312|NCT01047644|flush|flush
5141313|NCT01047644|cleanse|cleanse
5141314|NCT01047644|chemotherapy|chemotherapy
5141315|NCT01047618|venous thromboembolism|venous thromboembolism
5141316|NCT01047605|qEEG|qeeg
5141317|NCT01047605|herbal medicine|herbal medicine
5141318|NCT01047605|cognitive function|cognitive function
5141319|NCT01047605|Neurapas balance|neurapas balance
5141320|NCT01047605|Pascoflair|pascoflair
5141321|NCT01047605|hypericum|hypericum
5141322|NCT01047605|passionflower|passionflower
5141323|NCT01047605|valerian|valerian
5141324|NCT01047605|Healthy volunteers|healthy volunteers
5141325|NCT01047605|Influence on quantitative electro-encephalogram (qEEG).|influence on quantitative electro-encephalogram (qeeg).
5141326|NCT01047592|Schizophrenia|schizophrenia
5141327|NCT01047592|cognitive function|cognitive function
5141328|NCT01047592|N-methyl-D-aspartate receptor|n-methyl-d-aspartate receptor
5141329|NCT01047579|Alzheimer's Disease|alzheimer's disease
5141330|NCT01047579|Rivastigmine transdermal|rivastigmine transdermal
5141331|NCT01047579|caregiver preference|caregiver preference
5141332|NCT01047553|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5141334|NCT01047553|Japanese|japanese
5141335|NCT01047553|Phase 3|phase 3
5141336|NCT01047553|Safety|safety
5141337|NCT01047553|OT|ot
5141338|NCT01047553|Oxis|oxis
5141339|NCT01047527|nicotine replacement therapy, smoking cessation, transdermal nicotine|nicotine replacement therapy, smoking cessation, transdermal nicotine
5141340|NCT01047501|hypertriglyceridemia|hypertriglyceridemia
5141341|NCT01047501|omega-3 fatty acids|omega-3 fatty acids
5141342|NCT01047501|statin|statin
5141343|NCT01047501|triglycerides|triglycerides
5141344|NCT01047501|lipids|lipids
5141345|NCT01047501|EPA|epa
5141346|NCT01047501|docosahexaenoic acid|docosahexaenoic acid
5141347|NCT01047501|fish|fish
5141348|NCT01047501|fatty acids|fatty acids
5141349|NCT01047501|fibrates|fibrates
5141350|NCT01047501|niacin|niacin
5141351|NCT01047501|lipid|lipid
5141352|NCT01047501|atorvastatin|atorvastatin
5141353|NCT01047501|Lovaza|lovaza
5141354|NCT01047501|simvastatin|simvastatin
5141355|NCT01047501|lovastatin|lovastatin
5141356|NCT01047501|pravastatin|pravastatin
5141357|NCT01047501|fluvastatin|fluvastatin
5141358|NCT01047501|rosuvastatin|rosuvastatin
5141359|NCT01047501|Trilipix|trilipix
5141360|NCT01047501|Vytorin|vytorin
5141361|NCT01047501|Simcor|simcor
5141362|NCT01047501|Niaspan|niaspan
5141363|NCT01047501|ezetimibe|ezetimibe
5141364|NCT01047501|Zetia|zetia
5141365|NCT01047501|ethyl-EPA|ethyl-epa
5141366|NCT01047501|ethyl icosapentate|ethyl icosapentate
5141367|NCT01047501|Crestor|crestor
5141368|NCT01047501|Zocor|zocor
5141369|NCT01047501|Lipitor|lipitor
5141370|NCT01047501|LDL|ldl
5141371|NCT01047501|HDL|hdl
5141372|NCT01047501|cholesterol|cholesterol
5141373|NCT01047501|dyslipidemia|dyslipidemia
5141374|NCT01047501|VASCEPA|vascepa
5141375|NCT01047501|icosapent ethyl|icosapent ethyl
5141376|NCT01047488|polyneuropathy|polyneuropathy
5141377|NCT01047488|neuropathic pain|neuropathic pain
5141378|NCT01047488|treatment|treatment
5141379|NCT01047475|MB-6|mb-6
5141380|NCT01047475|FOLFOX4|folfox4
5141381|NCT01047475|Metastatic Colorectal Cancer|metastatic colorectal cancer
5141382|NCT01047449|saphenous vein graft patency|saphenous vein graft patency
5141679|NCT01046435|diabetes|diabetes
5141383|NCT01047449|fish oil supplementation|fish oil supplementation
5141384|NCT01047449|coronary artery bypass surgery|coronary artery bypass surgery
5141385|NCT01047449|coronary artery disease|coronary artery disease
5141386|NCT01047436|Plasmodium infections|plasmodium infections
5141387|NCT01047436|Remittent fever|remittent fever
5141388|NCT01047436|Artemether|artemether
5141389|NCT01047436|Artemisinins|artemisinins
5141390|NCT01047436|quinine|quinine
5141391|NCT01047436|Malaria|malaria
5141392|NCT01047436|Protozoan Infections|protozoan infections
5141393|NCT01047436|Anti-Infective Agents|anti-infective agents
5141394|NCT01047436|Antiprotozoal Agents|antiprotozoal agents
5141395|NCT01047436|Schistosomicides|schistosomicides
5141396|NCT01047436|Pharmacologic Actions|pharmacologic actions
5141397|NCT01047436|Malaria, Falciparum|malaria, falciparum
5141398|NCT01047436|Antimalarials|antimalarials
5141399|NCT01047436|Antiparasitic Agents|antiparasitic agents
5141400|NCT01047436|Parasitic Diseases|parasitic diseases
5141401|NCT01047436|sublingual|sublingual
5141402|NCT01047423|Hypertension endothelial dysfunction statin prevention|hypertension endothelial dysfunction statin prevention
5141403|NCT01047410|physical exercise training|physical exercise training
5141404|NCT01047410|quality of life|quality of life
5141405|NCT01047410|exercise capacity|exercise capacity
5141406|NCT01047410|skeletal muscle strength|skeletal muscle strength
5141407|NCT01047410|physical activity level|physical activity level
5141408|NCT01047410|costeffectiveness|costeffectiveness
5141409|NCT01047410|renal transplantation|renal transplantation
5141410|NCT01047410|hemodialysis|hemodialysis
5141411|NCT01047410|peritoneal dialysis|peritoneal dialysis
5141412|NCT01047410|diet|diet
5141413|NCT01047397|hemodialysis|hemodialysis
5141414|NCT01047397|tolerability|tolerability
5141415|NCT01047397|pharmacokinetics|pharmacokinetics
5141416|NCT01047397|safety|safety
5141417|NCT01047397|anemia|anemia
5141418|NCT01047397|renal impairment|renal impairment
5141419|NCT01047397|repeat dose|repeat dose
5141420|NCT01047345|Cervical cancer|cervical cancer
5141421|NCT01047345|Genital warts|genital warts
5141422|NCT01047345|Human papillomavirus vaccine|human papillomavirus vaccine
5141423|NCT01047345|GARDASIL™|gardasil™
5141424|NCT01047319|Relapsing Multiple Sclerosis|relapsing multiple sclerosis
5141425|NCT01047293|colorectal cancer|colorectal cancer
5141426|NCT01047280|Conjugated linoleic acid|conjugated linoleic acid
5141427|NCT01047280|Body weight|body weight
5141428|NCT01047280|Body composition|body composition
5141429|NCT01047280|Blood lipid profile|blood lipid profile
5141430|NCT01047280|Body inflammatory and oxidative status|body inflammatory and oxidative status
5141431|NCT01047267|candidiasis|candidiasis
5141432|NCT01047267|invasive fungal disease|invasive fungal disease
5141433|NCT01047267|critically ill|critically ill
5141434|NCT01047267|anidulafungin|anidulafungin
5141435|NCT01047267|pharmacokinetics|pharmacokinetics
5141436|NCT01047241|Painful medical procedures|painful medical procedures
5141437|NCT01047215|schizophrenia|schizophrenia
5141438|NCT01047215|bipolar|bipolar
5141439|NCT01047215|aripiprazole|aripiprazole
5141440|NCT01047215|quetiapine|quetiapine
5141441|NCT01047189|Mild to moderate acne vulgaris|mild to moderate acne vulgaris
5141442|NCT01047176|Statins|statins
5141443|NCT01047176|Coronary Heart Disease|coronary heart disease
5141444|NCT01047176|Percutaneous coronary intervention (PCI)|percutaneous coronary intervention (pci)
5141445|NCT01047163|Muscle soreness|muscle soreness
5141446|NCT01047163|Simvastatin|simvastatin
5141447|NCT01047163|Men|men
5141448|NCT01047163|Muscle Atrophy|muscle atrophy
5141449|NCT01047150|Myocardial Perfusion Imaging|myocardial perfusion imaging
5141450|NCT01047150|Repeat studies|repeat studies
5141451|NCT01047150|Tetrofosmin|tetrofosmin
5141452|NCT01047150|Sestamibi|sestamibi
5141453|NCT01047137|Urticaria|urticaria
5141454|NCT01047137|Hives|hives
5141455|NCT01047137|Stress|stress
5141456|NCT01047137|Immune dysregulation|immune dysregulation
5141457|NCT01047124|Depression|depression
5141458|NCT01047124|Collaborative Care|collaborative care
5141459|NCT01047124|Cognitive Behaviour Therapy|cognitive behaviour therapy
5141460|NCT01047124|Mental Health Services|mental health services
5141461|NCT01047124|Antidepressants|antidepressants
5141462|NCT01047111|Esophageal Neoplasms|esophageal neoplasms
5141463|NCT01047111|Esophagectomy|esophagectomy
5141464|NCT01047098|Lactation|lactation
5141465|NCT01047098|Breastfeeding|breastfeeding
5141466|NCT01047098|Iron|iron
5141467|NCT01047098|Oxidative stress|oxidative stress
5141468|NCT01047098|Iron status and oxidative stress during lactation|iron status and oxidative stress during lactation
5141469|NCT01047085|cholecystolithiasis|cholecystolithiasis
5141470|NCT01047085|cholecystectomy|cholecystectomy
5141471|NCT01047085|gastroesophageal reflux|gastroesophageal reflux
5141472|NCT01047085|impedance pH|impedance ph
5141473|NCT01047085|The relationship between cholecystolithiasis, cholecystectomy and gastroesophageal reflux by impedance pH-method.|the relationship between cholecystolithiasis, cholecystectomy and gastroesophageal reflux by impedance ph-method.
5141474|NCT01047072|Scleroderma, systemic sclerosis, allogeneic hematopoietic stem cell transplantation|scleroderma, systemic sclerosis, allogeneic hematopoietic stem cell transplantation
5141475|NCT01047059|NSCLC|nsclc
5141476|NCT01047059|Lung Cancer|lung cancer
5141477|NCT01047046|SNM device|snm device
5141478|NCT01047046|Chart review of patients with surgical placed SNM device|chart review of patients with surgical placed snm device
5141479|NCT01047033|Poverty|poverty
5141480|NCT01047033|Global health|global health
5141481|NCT01047033|International health|international health
5141482|NCT01047033|Latin America|latin america
5141483|NCT01047033|Peru|peru
5141484|NCT01047033|Child health|child health
5141485|NCT01047033|Microcredit|microcredit
5141486|NCT01047033|Microenterprise|microenterprise
5141487|NCT01047033|Microfinance|microfinance
5141488|NCT01047020|Impairments of musculoskeletal Health;|impairments of musculoskeletal health;
5141489|NCT01047020|Physical activity;|physical activity;
5141490|NCT01047020|Motor Proficiency;|motor proficiency;
5141491|NCT01047007|Head and Neck Cancer|head and neck cancer
5141492|NCT01047007|Esophageal Cancer|esophageal cancer
5141493|NCT01047007|Gastric Cancer|gastric cancer
5141494|NCT01046981|Surgical site infections|surgical site infections
5141495|NCT01046981|Prevention|prevention
5141496|NCT01046981|Prophylaxis|prophylaxis
5141497|NCT01046981|Tumescent|tumescent
5141498|NCT01046981|Intravenous|intravenous
5141499|NCT01046981|Antibiotic|antibiotic
5141500|NCT01046981|Absorption|absorption
5141501|NCT01046981|Pharmacokinetics|pharmacokinetics
5141502|NCT01046981|Bioavailability|bioavailability
5141503|NCT01046968|Obesity|obesity
5141504|NCT01046968|metabolic syndrome|metabolic syndrome
5141505|NCT01046968|C-reactive protein|c-reactive protein
5141506|NCT01046968|Leptin|leptin
5141507|NCT01046955|ESRD|esrd
5141508|NCT01046942|Saphenous vein|saphenous vein
5141509|NCT01046942|Antiplatelet therapy|antiplatelet therapy
5141510|NCT01046942|Hypercoagulable|hypercoagulable
5141511|NCT01046942|Clopidogrel resistance|clopidogrel resistance
5141512|NCT01046942|Aspirin resistance|aspirin resistance
5141513|NCT01046942|Clopidogrel|clopidogrel
5141514|NCT01046942|Aspirin|aspirin
5141515|NCT01046942|Saphenous vein graft disease|saphenous vein graft disease
5141516|NCT01046942|TEG|teg
5141517|NCT01046942|Thrombelastography|thrombelastography
5141518|NCT01046942|Multiplate aggregometry|multiplate aggregometry
5141519|NCT01046942|Multislice CT|multislice ct
5141520|NCT01046942|Coronary artery bypass graft surgery|coronary artery bypass graft surgery
5141521|NCT01046942|coagulation status|coagulation status
5141522|NCT01046942|graft patency|graft patency
5141523|NCT01046942|CABG|cabg
5141524|NCT01046929|limonene|limonene
5141525|NCT01046929|breast cancer|breast cancer
5141526|NCT01046929|cancer prevention|cancer prevention
5141527|NCT01046903|observational prolonged thromboprophylaxis|observational prolonged thromboprophylaxis
5141528|NCT01046890|Darunavir|darunavir
5141529|NCT01046890|Echinacea purpurea|echinacea purpurea
5141530|NCT01046890|Interaction|interaction
5141531|NCT01046890|Complementary Therapies|complementary therapies
5141532|NCT01046864|Gastro-Intestinal Cancer, NOS|gastro-intestinal cancer, nos
5141533|NCT01046838|Diastolic Heart Failure|diastolic heart failure
5141534|NCT01046825|Lymphoma|lymphoma
5141535|NCT01046825|Leukemia|leukemia
5141536|NCT01046825|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
5141537|NCT01046812|questionnaire|questionnaire
5141538|NCT01046812|halitosis|halitosis
5141539|NCT01046812|caphosol|caphosol
5141540|NCT01046812|Quality of life questionnaire assessing halitosis|quality of life questionnaire assessing halitosis
5141541|NCT01046799|hepatitis B|hepatitis b
5141542|NCT01046799|liver transplantation|liver transplantation
5141543|NCT01046799|shortterm HBIg|shortterm hbig
5141544|NCT01046799|lamivudine resistance|lamivudine resistance
5141545|NCT01046786|spinal cord injury|spinal cord injury
5141546|NCT01046786|cord blood mononuclear cell|cord blood mononuclear cell
5141547|NCT01046786|Methylprednisolone|methylprednisolone
5141548|NCT01046786|Lithium Carbonate|lithium carbonate
5141549|NCT01046773|Children|children
5141550|NCT01046773|Crohn's disease|crohn's disease
5141551|NCT01046773|Vitamin D|vitamin d
5141552|NCT01046760|epilepsy|epilepsy
5141553|NCT01046760|language|language
5141554|NCT01046760|childhood|childhood
5141555|NCT01046760|praxis|praxis
5141556|NCT01046747|external fixation|external fixation
5141557|NCT01046747|pin tract infection|pin tract infection
5141558|NCT01046747|self drilling|self drilling
5141559|NCT01046734|Influenza|influenza
5141560|NCT01046734|virus shedding|virus shedding
5141561|NCT01046734|infection control|infection control
5141562|NCT01046734|swine flu|swine flu
5141563|NCT01046721|blood pressure|blood pressure
5141564|NCT01046721|superior mesenteric artery blood flow|superior mesenteric artery blood flow
5141565|NCT01046721|cardiovascular effects|cardiovascular effects
5141566|NCT01046721|Exenatide|exenatide
5141567|NCT01046708|IUI|iui
5141568|NCT01046708|clomiphene citrate|clomiphene citrate
5141569|NCT01046708|utrogestan|utrogestan
5141570|NCT01046695|VATS|vats
5141571|NCT01046695|Video-Assisted Thoracotomy|video-assisted thoracotomy
5141572|NCT01046695|Thoracic Surgery, Video-Assisted|thoracic surgery, video-assisted
5141573|NCT01046682|HIV|hiv
5141574|NCT01046682|Endothelial dysfunction|endothelial dysfunction
5141575|NCT01046682|Inflammation|inflammation
5141576|NCT01046682|Insulin resistance|insulin resistance
5141577|NCT01046656|nosocomial infection|nosocomial infection
5141578|NCT01046656|diarrhea|diarrhea
5141579|NCT01046656|Lactobacillus reuteri|lactobacillus reuteri
5141580|NCT01046656|gastroenteritis|gastroenteritis
5141581|NCT01046656|rotavirus|rotavirus
5141582|NCT01046643|Women|women
5141583|NCT01046643|Healthy|healthy
5141584|NCT01046643|Menopausal|menopausal
5141585|NCT01046643|Hormone treatment|hormone treatment
5141586|NCT01046630|Phase I|phase i
5141587|NCT01046630|BOLD signal|bold signal
5141588|NCT01046630|fMRI|fmri
5141589|NCT01046630|AZD6765|azd6765
5141590|NCT01046630|BOLD signal measured by fMRI|bold signal measured by fmri
5141591|NCT01046617|infantile colic|infantile colic
5141592|NCT01046617|Lactobacillus reuteri|lactobacillus reuteri
5141593|NCT01046617|duration of crying|duration of crying
5141594|NCT01046604|mitral valve regurgitation|mitral valve regurgitation
5141595|NCT01046604|omega 3 fatty acids|omega 3 fatty acids
5141596|NCT01046604|fish oil|fish oil
5141597|NCT01046604|cardiac|cardiac
5141598|NCT01046604|mitochondria|mitochondria
5141599|NCT01046604|apoptosis|apoptosis
5141600|NCT01046604|human heart|human heart
5141601|NCT01046591|Cleft Palate|cleft palate
5141602|NCT01046591|Cleft Lip|cleft lip
5141603|NCT01046591|Obstructive Sleep Apnea|obstructive sleep apnea
5141604|NCT01046591|Sleep-Disordered Breathing|sleep-disordered breathing
5141605|NCT01046591|Behavior|behavior
5141606|NCT01046591|Learning|learning
5141607|NCT01046578|Folliculogenesis|folliculogenesis
5141608|NCT01046578|Letrozole|letrozole
5141609|NCT01046578|Aromatase Inhibitor|aromatase inhibitor
5141610|NCT01046578|Estrogen|estrogen
5141611|NCT01046552|Choledocholithias|choledocholithias
5141612|NCT01046552|Common bile duct stones|common bile duct stones
5141613|NCT01046552|Endoscopic retrograde cholangiopancreatography|endoscopic retrograde cholangiopancreatography
5141614|NCT01046552|endoscopic sphincterotomy|endoscopic sphincterotomy
5141615|NCT01046552|Preoperative|preoperative
5141616|NCT01046552|intraoperative|intraoperative
5141617|NCT01046552|Laparoscopic common bile duct exploration|laparoscopic common bile duct exploration
5141618|NCT01046526|Psychopathology|psychopathology
5141619|NCT01046526|Nicotine Patch|nicotine patch
5141620|NCT01046526|Eye Tracking|eye tracking
5141621|NCT01046526|Attention|attention
5141622|NCT01046526|Schizophrenic Participants|schizophrenic participants
5141623|NCT01046513|Nicotinic Acetylcholine Receptors|nicotinic acetylcholine receptors
5141624|NCT01046513|Neuroimaging|neuroimaging
5141625|NCT01046513|Positron Emission Tomography (PET)|positron emission tomography (pet)
5141626|NCT01046513|Alpha4beta2|alpha4beta2
5141627|NCT01046513|Nicotine|nicotine
5141628|NCT01046513|Receptor Upregulation|receptor upregulation
5141629|NCT01046500|insulin resistance|insulin resistance
5141630|NCT01046500|body mass index|body mass index
5141631|NCT01046500|myo-inositol|myo-inositol
5141632|NCT01046500|serum triglycerides and cholesterol|serum triglycerides and cholesterol
5141633|NCT01046500|blood pressure|blood pressure
5141634|NCT01046500|metformin|metformin
5141635|NCT01046487|dermatofibrosarcoma|dermatofibrosarcoma
5141636|NCT01046487|cylindroma|cylindroma
5141637|NCT01046487|choroid melanoma|choroid melanoma
5141638|NCT01046487|gastrointestinal stroma tumor|gastrointestinal stroma tumor
5141639|NCT01046487|chordoma|chordoma
5141640|NCT01046487|ocular melanoma|ocular melanoma
5141641|NCT01046487|conjunctival melanoma|conjunctival melanoma
5141642|NCT01046487|malignant melanoma of the anus|malignant melanoma of the anus
5141643|NCT01046487|gastric melanoma|gastric melanoma
5141644|NCT01046487|desmoid tumor|desmoid tumor
5141645|NCT01046474|school children|school children
5141646|NCT01046474|body mass index|body mass index
5141647|NCT01046474|sugar intake|sugar intake
5141648|NCT01046474|beverage intake|beverage intake
5141649|NCT01046461|Ramosetron|ramosetron
5141650|NCT01046461|aprepitant|aprepitant
5141651|NCT01046461|dexamethasone|dexamethasone
5141652|NCT01046461|cancer|cancer
5141653|NCT01046461|chemotherapy|chemotherapy
5141654|NCT01046461|antiemetics|antiemetics
5141655|NCT01046461|cisplatin|cisplatin
5141656|NCT01046461|nausea|nausea
5141657|NCT01046461|vomiting|vomiting
5141658|NCT01046461|high dose cisplatin|high dose cisplatin
5141659|NCT01046448|Children|children
5141660|NCT01046448|chronic renal failure|chronic renal failure
5141661|NCT01046448|chronic kidney disease|chronic kidney disease
5141662|NCT01046448|cardiovascular disease|cardiovascular disease
5141663|NCT01046448|cardiovascular morbidity|cardiovascular morbidity
5141664|NCT01046448|left ventricular hypertrophy|left ventricular hypertrophy
5141665|NCT01046448|carotid intima media thickness|carotid intima media thickness
5141666|NCT01046448|arterial stiffness|arterial stiffness
5141667|NCT01046448|pulse wave velocity|pulse wave velocity
5141668|NCT01046448|augmentation index|augmentation index
5141669|NCT01046448|left ventricular cardiac function|left ventricular cardiac function
5141670|NCT01046448|progression|progression
5141671|NCT01046448|genetic risk factors|genetic risk factors
5141672|NCT01046448|vasculopathy|vasculopathy
5141673|NCT01046448|cardiopathy|cardiopathy
5141674|NCT01046448|whole genome analysis|whole genome analysis
5141675|NCT01046448|haplotype analysis|haplotype analysis
5141676|NCT01046448|SNP-screening|snp-screening
5141677|NCT01046435|periodontitis|periodontitis
5141678|NCT01046435|cardiovascular disease|cardiovascular disease
5141680|NCT01046409|Coronary artery disease|coronary artery disease
5141681|NCT01046409|Bifurcation|bifurcation
5141682|NCT01046409|Myocardial infarction|myocardial infarction
5141683|NCT01046409|Myocardial ischemia|myocardial ischemia
5141684|NCT01046409|Collateral|collateral
5141685|NCT01046383|NON-SMALL CELL LUNG CANCER PATIENTS|non-small cell lung cancer patients
5141686|NCT01046383|WEIGHT LOSS|weight loss
5141687|NCT01046383|QUALITY OF LIFE|quality of life
5141688|NCT01046383|SURVIVAL|survival
5141689|NCT01046383|CHEMOTHERAPY|chemotherapy
5141690|NCT01046383|RADIOTHERAPY|radiotherapy
5141691|NCT01046383|SURGERY|surgery
5141692|NCT01046383|CYSTEINE-RICH WHEY PROTEIN ISOLATE|cysteine-rich whey protein isolate
5141693|NCT01046383|IMN1207|imn1207
5141694|NCT01046383|CANCER-RELATED WASTING (CACHEXIA)|cancer-related wasting (cachexia)
5141695|NCT01046383|BODY WEIGHT|body weight
5141696|NCT01046383|NUTRITIONAL PROTEIN SUPPLEMENT|nutritional protein supplement
5141697|NCT01046357|First in human|first in human
5141698|NCT01046357|Safety|safety
5141699|NCT01046305|Chronic Myeloid Leukemia|chronic myeloid leukemia
5141700|NCT01046305|CML|cml
5141701|NCT01046305|Symptom Burden|symptom burden
5141702|NCT01046305|M. D. Anderson Symptom Inventory|m. d. anderson symptom inventory
5141703|NCT01046305|MDASI-CML|mdasi-cml
5141704|NCT01046305|Severity|severity
5141705|NCT01046305|Interference|interference
5141706|NCT01046305|Questionnaire|questionnaire
5141707|NCT01046305|Interview|interview
5141708|NCT01046292|Gait, Ginkgo biloba, mild cognitive impairment|gait, ginkgo biloba, mild cognitive impairment
5141709|NCT01046253|Bioequivalence|bioequivalence
5141710|NCT01046253|Healthy Subjects|healthy subjects
5141711|NCT01046240|chemotherapy|chemotherapy
5141712|NCT01046240|emesis|emesis
5141713|NCT01046240|palonosetron|palonosetron
5141714|NCT01046227|Serology|serology
5141715|NCT01046227|Monovalent inactivated H1N1 vaccine|monovalent inactivated h1n1 vaccine
5141716|NCT01046227|Pediatric haemato-oncology patients|pediatric haemato-oncology patients
5141717|NCT01046188|Education|education
5141718|NCT01046188|Internet|internet
5141719|NCT01046188|In vitro fertilization|in vitro fertilization
5141720|NCT01046175|Respiratory complications|respiratory complications
5141721|NCT01046175|respiratory insufficiency|respiratory insufficiency
5141722|NCT01046175|respiratory therapy|respiratory therapy
5141723|NCT01046162|Alprazolam|alprazolam
5141724|NCT01046162|Tafil|tafil
5141725|NCT01046162|Xanax|xanax
5141726|NCT01046162|Bioequivalence|bioequivalence
5141727|NCT01046162|Drug Kinetics|drug kinetics
5141728|NCT01046149|Depression|depression
5141729|NCT01046149|Depressive Symptoms|depressive symptoms
5141730|NCT01046149|postmenopause|postmenopause
5141731|NCT01046149|RSA biofeedback|rsa biofeedback
5141732|NCT01046136|common cold|common cold
5141733|NCT01046097|Pneumococcal vaccine|pneumococcal vaccine
5141734|NCT01046084|Bioequivalence|bioequivalence
5141735|NCT01046084|Healthy Subjects|healthy subjects
5141736|NCT01046071|Transversus abdominis plane block, postoperative pain.|transversus abdominis plane block, postoperative pain.
5141737|NCT01046058|TMC435-TiDP16-C113|tmc435-tidp16-c113
5141738|NCT01046058|TMC435-C113|tmc435-c113
5141739|NCT01046058|TMC435|tmc435
5141740|NCT01046058|HCV|hcv
5141741|NCT01046058|Protease Inhibitor|protease inhibitor
5141742|NCT01046058|Hepatitis C|hepatitis c
5141743|NCT01046045|mammalian target-of-rapamycin inhibitors|mammalian target-of-rapamycin inhibitors
5141744|NCT01046045|chronic allograft dysfunction|chronic allograft dysfunction
5141745|NCT01046045|everolimus|everolimus
5141746|NCT01046045|calcineurin inhibitors|calcineurin inhibitors
5141747|NCT01046032|Polycystic ovaries|polycystic ovaries
5141748|NCT01046032|Ovarian stimulation|ovarian stimulation
5141749|NCT01046032|IVF|ivf
5141750|NCT01046032|Ovarian hyperstimulation|ovarian hyperstimulation
5141751|NCT01046032|Metformin|metformin
5141752|NCT01046019|DXA|dxa
5141753|NCT01046019|Hip|hip
5141754|NCT01046019|Arthroplasty|arthroplasty
5141755|NCT01046006|lymphoma|lymphoma
5141756|NCT01046006|Bortezomib|bortezomib
5141757|NCT01046006|Rituximab|rituximab
5141758|NCT01045993|Pilot Study to Assess Methodologies|pilot study to assess methodologies
5141759|NCT01045980|Peritoneal dialysis|peritoneal dialysis
5141760|NCT01045980|Impedance, bioelectric|impedance, bioelectric
5141761|NCT01045980|Hypertrophy, left ventricular|hypertrophy, left ventricular
5141762|NCT01045980|Fluid status|fluid status
5141763|NCT01045980|Volume overload|volume overload
5141764|NCT01045980|Congestive heart failure|congestive heart failure
5141765|NCT01045980|Cardiovascular outcomes|cardiovascular outcomes
5141766|NCT01045980|Randomized controlled trial|randomized controlled trial
5141767|NCT01045967|Bioequivalence|bioequivalence
5141768|NCT01045967|Healthy Subjects|healthy subjects
5141769|NCT01045954|diabetes mellitus type 1|diabetes mellitus type 1
5141770|NCT01045954|continuous glucose monitoring|continuous glucose monitoring
5141771|NCT01045941|Distal Pancreas|distal pancreas
5141772|NCT01045941|Adenocarcinoma|adenocarcinoma
5141773|NCT01045941|Laparoscopic|laparoscopic
5141774|NCT01045941|Gemcitabine|gemcitabine
5141775|NCT01045915|Stage IIIB, stage IIIC or stage IV melanoma|stage iiib, stage iiic or stage iv melanoma
5141776|NCT01045915|Progressive melanoma not responding to previous treatments|progressive melanoma not responding to previous treatments
5141777|NCT01045902|Pulmonary Abscess|pulmonary abscess
5141778|NCT01045902|Aspiration Pneumonia|aspiration pneumonia
5141779|NCT01045889|HIV|hiv
5141780|NCT01045889|non hodgkin lymphoma|non hodgkin lymphoma
5141781|NCT01045889|peripheral blood stem cell transplantation|peripheral blood stem cell transplantation
5141782|NCT01045876|Randomized controlled trial|randomized controlled trial
5141783|NCT01045876|Dexamethasone|dexamethasone
5141784|NCT01045876|Single dose|single dose
5141785|NCT01045876|Preoperative|preoperative
5141786|NCT01045876|Plasma Cortisol level|plasma cortisol level
5141787|NCT01045863|volunteer|volunteer
5141788|NCT01045850|coronary stents|coronary stents
5141789|NCT01045850|non cardiac surgery|non cardiac surgery
5141790|NCT01045850|cardiovascular complications|cardiovascular complications
5141791|NCT01045850|hemorrhagic complications|hemorrhagic complications
5141792|NCT01045850|antiplatelet agents|antiplatelet agents
5141793|NCT01045850|bare metal stent|bare metal stent
5141794|NCT01045850|drug eluting stent|drug eluting stent
5141795|NCT01045850|surgery|surgery
5141796|NCT01045837|Celiac disease, steroids, immunohistochemistry|celiac disease, steroids, immunohistochemistry
5141797|NCT01045824|Schizophrenia|schizophrenia
5141798|NCT01045824|DNA|dna
5141799|NCT01045824|MRI|mri
5141800|NCT01045811|Depression|depression
5141801|NCT01045811|Depressive Symptoms|depressive symptoms
5141802|NCT01045811|postmenopause|postmenopause
5141803|NCT01045811|RSA biofeedback|rsa biofeedback
5141804|NCT01045798|Candidiasis|candidiasis
5141805|NCT01045798|Invasive Candidiasis|invasive candidiasis
5141806|NCT01045798|Fungal Infection|fungal infection
5141807|NCT01045798|Empirical Therapy|empirical therapy
5141808|NCT01045785|aspirin resistance, platelet function assay, dialysis, end stage renal disease|aspirin resistance, platelet function assay, dialysis, end stage renal disease
5141809|NCT01045772|Schnitler syndrome, Muckle-Wells syndrome, anti-IL-1|schnitler syndrome, muckle-wells syndrome, anti-il-1
5141810|NCT01045759|VENOUS THROMBOSIS|venous thrombosis
5141811|NCT01045759|ultrasonography|ultrasonography
5141812|NCT01045759|intensive care unit|intensive care unit
5141813|NCT01045746|whole-body vibration|whole-body vibration
5141814|NCT01045746|stochastic resonance Therapy|stochastic resonance therapy
5141815|NCT01045746|static balance|static balance
5141816|NCT01045746|balance, mobility|balance, mobility
5141817|NCT01045746|elderly, reaction time|elderly, reaction time
5141818|NCT01045746|The focus of the study is effect of SRT on postural balance|the focus of the study is effect of srt on postural balance
5141819|NCT01045733|Cataract|cataract
5141820|NCT01045733|Toric|toric
5141821|NCT01045733|IOL|iol
5141822|NCT01045733|AcrySof|acrysof
5141823|NCT01045733|LRI|lri
5141824|NCT01045733|Astigmatism|astigmatism
5141825|NCT01045720|Schizophrenia|schizophrenia
5141826|NCT01045720|clozapine|clozapine
5141827|NCT01045720|hypersalivation|hypersalivation
5141828|NCT01045720|Suo Quan Wan|suo quan wan
5141829|NCT01045720|Wu Lin San|wu lin san
5141830|NCT01045694|Carpometacarpal Joints|carpometacarpal joints
5141831|NCT01045694|Osteoarthritis|osteoarthritis
5141832|NCT01045694|Basal thumb joint arthritis|basal thumb joint arthritis
5141833|NCT01045694|Trapeziometacarpal arthritis|trapeziometacarpal arthritis
5141834|NCT01045681|Multiple Myeloma|multiple myeloma
5141835|NCT01045681|Elderly patients|elderly patients
5141836|NCT01045681|first relapse|first relapse
5141837|NCT01045681|refractory to first line therapy|refractory to first line therapy
5141838|NCT01045681|Bendamustine Velcade Dexamethasone Association|bendamustine velcade dexamethasone association
5141839|NCT01045655|Depression|depression
5141840|NCT01045655|Perinatal care|perinatal care
5141841|NCT01045655|Postpartum period|postpartum period
5141842|NCT01045655|Pregnancy|pregnancy
5141843|NCT01045655|Female|female
5141844|NCT01045655|Low-income population|low-income population
5141845|NCT01045642|Bioequivalence|bioequivalence
5141846|NCT01045642|Omeprazole|omeprazole
5141847|NCT01045642|Crossover|crossover
5141848|NCT01045629|schizophrenia|schizophrenia
5141849|NCT01045629|PANSS|panss
5141850|NCT01045603|Instanyl|instanyl
5141851|NCT01045603|non-interventional|non-interventional
5141852|NCT01045603|breakthrough cancer pain|breakthrough cancer pain
5141853|NCT01045603|BTP|btp
5141854|NCT01045603|BTCP|btcp
5141855|NCT01045603|Intranasal fentanyl spray|intranasal fentanyl spray
5141856|NCT01045577|Severe Psoriasis|severe psoriasis
5141857|NCT01045577|Kinase Inhibitor|kinase inhibitor
5141858|NCT01045577|Masitinib|masitinib
5141859|NCT01045564|Immunogenicity|immunogenicity
5141860|NCT01045564|Vaccines|vaccines
5141861|NCT01045564|H5N1|h5n1
5141862|NCT01045564|Influenza|influenza
5141863|NCT01045564|Pandemic|pandemic
5141864|NCT01045564|Human|human
5141865|NCT01045564|Avian|avian
5141866|NCT01045564|Safety|safety
5141867|NCT01045551|Inflammatory rosacea|inflammatory rosacea
5141868|NCT01045551|Papules and pustules|papules and pustules
5141869|NCT01045551|Moderate to severe erythema|moderate to severe erythema
5141870|NCT01045551|Telangiectasia|telangiectasia
5141871|NCT01045538|gastric cancer|gastric cancer
5141872|NCT01045538|histone deacetylase inhibitor|histone deacetylase inhibitor
5141873|NCT01045538|1st line chemotherapy|1st line chemotherapy
5141874|NCT01045525|Phlebotomy|phlebotomy
5141875|NCT01045525|Dysmetabolic liversiderosis|dysmetabolic liversiderosis
5141876|NCT01045525|Hepatic Iron overload|hepatic iron overload
5141877|NCT01045512|immunosenescence|immunosenescence
5141878|NCT01045512|heart rate variability|heart rate variability
5141879|NCT01045512|autonomic nervous system|autonomic nervous system
5141880|NCT01045512|ageing|ageing
5141881|NCT01045512|inflammatory/pathogen burden|inflammatory/pathogen burden
5141882|NCT01045512|physical activity|physical activity
5141883|NCT01045499|adolescent obesity surgery|adolescent obesity surgery
5141884|NCT01045499|bariatric surgery|bariatric surgery
5141885|NCT01045499|adjustable gastric banding|adjustable gastric banding
5141886|NCT01045486|Atopic dermatitis|atopic dermatitis
5141887|NCT01045486|Food allergy|food allergy
5141888|NCT01045486|Probiotics|probiotics
5141889|NCT01045473|MIS|mis
5141890|NCT01045473|Minimally Invasive Spine Surgery|minimally invasive spine surgery
5141891|NCT01045473|Fusion|fusion
5141892|NCT01045473|Spine|spine
5141893|NCT01045473|SMISS|smiss
5141894|NCT01045460|Patients with active myeloma (Stage II/III) that have completed induction therapy and are eligible for an autologous stem cell transplant|patients with active myeloma (stage ii/iii) that have completed induction therapy and are eligible for an autologous stem cell transplant
5141895|NCT01045434|Bioequivalence|bioequivalence
5141896|NCT01045434|omeprazole|omeprazole
5141897|NCT01045434|crossover|crossover
5141898|NCT01045421|NSCLC|nsclc
5141899|NCT01045421|SCLC|sclc
5141900|NCT01045421|HNSCC|hnscc
5141901|NCT01045408|Helicobacter pylori|helicobacter pylori
5141902|NCT01045408|Berry extract|berry extract
5141903|NCT01045408|Triple therapy|triple therapy
5141904|NCT01045395|Algae|algae
5141905|NCT01045395|Psoriasis|psoriasis
5141906|NCT01045395|Lipid metabolism|lipid metabolism
5141907|NCT01045395|Inflammation|inflammation
5141908|NCT01045395|Oxidative stress|oxidative stress
5141909|NCT01045382|HSC transplantation|hsc transplantation
5141910|NCT01045382|HLA-mismatched|hla-mismatched
5141911|NCT01045382|Mesenchymal stem cells|mesenchymal stem cells
5141912|NCT01045382|GVHD|gvhd
5141913|NCT01045382|co-infusion|co-infusion
5141914|NCT01045369|HIV|hiv
5141915|NCT01045369|Treatment Naive|treatment naive
5141916|NCT01045343|heart failure|heart failure
5141917|NCT01045343|home monitoring|home monitoring
5141918|NCT01045343|integrated diagnostics|integrated diagnostics
5141919|NCT01045343|Cardiac Resynchronization Therapy with Defibrillator (CRT D)|cardiac resynchronization therapy with defibrillator (crt d)
5141920|NCT01045317|micro-dose|micro-dose
5141921|NCT01045317|pharmacokinetics|pharmacokinetics
5141922|NCT01045317|open label|open label
5141923|NCT01045317|PF-04776548|pf-04776548
5141924|NCT01045278|Hepatitis C patients|hepatitis c patients
5141925|NCT01045278|Hepacivirus|hepacivirus
5141926|NCT01045252|hemodynamics|hemodynamics
5141927|NCT01045252|neonatal|neonatal
5141928|NCT01045239|Diabetic macular edema|diabetic macular edema
5141929|NCT01045239|Diabetic macular oedema|diabetic macular oedema
5141930|NCT01045239|micropulse laser|micropulse laser
5141931|NCT01045239|laser treatment|laser treatment
5141932|NCT01045239|macular thickness|macular thickness
5141933|NCT01045213|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
5141934|NCT01045213|COPD|copd
5141935|NCT01045200|rectal cancer|rectal cancer
5141936|NCT01045200|follow-up|follow-up
5141937|NCT01045200|specialist nurse|specialist nurse
5141938|NCT01045187|endometrial cancer|endometrial cancer
5141939|NCT01045187|Uterine cancer|uterine cancer
5141940|NCT01045187|electronic brachytherapy|electronic brachytherapy
5141941|NCT01045187|Xoft|xoft
5141942|NCT01045174|Asthma|asthma
5141943|NCT01045174|Pediatric|pediatric
5141944|NCT01045174|Emergency department|emergency department
5141945|NCT01045174|Nebulizer|nebulizer
5141946|NCT01045161|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5141947|NCT01045161|COPD|copd
5141948|NCT01045161|Chronic Bronchitis|chronic bronchitis
5141949|NCT01045161|Emphysema|emphysema
5141950|NCT01045161|Airflow Obstruction, Chronic|airflow obstruction, chronic
5141951|NCT01045161|Chronic Airflow Obstruction|chronic airflow obstruction
5141952|NCT01045161|Chronic Obstructive Airway Disease|chronic obstructive airway disease
5141953|NCT01045161|Chronic Obstructive Lung Disease|chronic obstructive lung disease
5141954|NCT01045148|Prostatic Cancer|prostatic cancer
5141955|NCT01045148|Prostatic Neoplasms|prostatic neoplasms
5141956|NCT01045148|Prostate Neoplasms|prostate neoplasms
5141957|NCT01045148|Cancer of the Prostate|cancer of the prostate
5141958|NCT01045135|Pelvic organ prolapse|pelvic organ prolapse
5141959|NCT01045135|Levator hiatus|levator hiatus
5141960|NCT01045135|3 and 4 dimensional ultrasound|3 and 4 dimensional ultrasound
5141961|NCT01045122|Obstructive Sleep Apnea|obstructive sleep apnea
5141962|NCT01045109|prostate|prostate
5141963|NCT01045109|cancer|cancer
5141964|NCT01045109|vitamin D3|vitamin d3
5141965|NCT01045109|early stage|early stage
5141966|NCT01045109|active surveillance|active surveillance
5141967|NCT01045096|Gastroesophageal Reflux|gastroesophageal reflux
5141968|NCT01045096|Erosive Esophagitis|erosive esophagitis
5141969|NCT01045096|Pharmacokinetics|pharmacokinetics
5141970|NCT01045096|Pediatrics|pediatrics
5141971|NCT01045096|Drug Therapy|drug therapy
5141972|NCT01045070|periodontitis and coronary heart disease|periodontitis and coronary heart disease
5141973|NCT01045057|voice prosthesis, larynx cancer, laryngectomy|voice prosthesis, larynx cancer, laryngectomy
5141974|NCT01045044|Breast cancer|breast cancer
5141975|NCT01045044|Magnetic Resonance Imaging|magnetic resonance imaging
5141976|NCT01045044|Anthracycline based systemic chemotherapy|anthracycline based systemic chemotherapy
5141977|NCT01045044|Tumor response|tumor response
5141978|NCT01045044|Cognitive Impairment|cognitive impairment
5141979|NCT01045044|Chemo Brain|chemo brain
5141980|NCT01045031|cognitive function, aging, brain-derived neurotrophic factor|cognitive function, aging, brain-derived neurotrophic factor
5141981|NCT01045018|colitis|colitis
5141982|NCT01045018|ulcerative|ulcerative
5141983|NCT01045018|ulcerative colitis|ulcerative colitis
5141984|NCT01045005|Type 1 diabetes|type 1 diabetes
5141985|NCT01045005|Endothelial dysfunction|endothelial dysfunction
5141986|NCT01045005|Doppler Ultrasound Velocity Waveforms|doppler ultrasound velocity waveforms
5141987|NCT01044992|Multi systemic atrophy|multi systemic atrophy
5141988|NCT01044992|Parkinson Disease|parkinson disease
5141989|NCT01044992|PET investigation|pet investigation
5141990|NCT01044992|Motor control|motor control
5141991|NCT01044992|levodopa|levodopa
5141992|NCT01044992|MSA|msa
5141993|NCT01044992|Comparison with Parkinson disease and dopaminergic challenge.|comparison with parkinson disease and dopaminergic challenge.
5141994|NCT01044979|Colloid osmotic pressure in interstitial fluid|colloid osmotic pressure in interstitial fluid
5141995|NCT01044979|Colloid osmotic pressure in plasma|colloid osmotic pressure in plasma
5141996|NCT01044979|Protein fractions in interstitial fluid|protein fractions in interstitial fluid
5141997|NCT01044966|Glioblastoma|glioblastoma
5141998|NCT01044966|Subventricular|subventricular
5141999|NCT01044966|gliomagenesis|gliomagenesis
5142000|NCT01044966|temozolomide|temozolomide
5142001|NCT01044966|depocyt|depocyt
5142002|NCT01044953|injury incidence|injury incidence
5142003|NCT01044953|male professional soccer|male professional soccer
5142004|NCT01044953|Change of injury incidence in professional soccer|change of injury incidence in professional soccer
5142005|NCT01044940|Colloid Osmotic pressure in interstitial fluid|colloid osmotic pressure in interstitial fluid
5142006|NCT01044940|Colloid Osmotic pressure in plasma|colloid osmotic pressure in plasma
5142007|NCT01044940|Protein fractions in interstitial fluid|protein fractions in interstitial fluid
5142008|NCT01044927|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
5142009|NCT01044927|telemedicine|telemedicine
5142010|NCT01044927|COPD|copd
5142011|NCT01044901|Sickle Cell Disease|sickle cell disease
5142012|NCT01044901|Cardiac magnetic resonance imaging|cardiac magnetic resonance imaging
5142013|NCT01044901|Coronary Disease|coronary disease
5142014|NCT01044901|Pulmonary Hypertension|pulmonary hypertension
5142015|NCT01044888|Heparin responsiveness|heparin responsiveness
5142016|NCT01044888|Off-pump coronary artery bypass graft surgery|off-pump coronary artery bypass graft surgery
5142017|NCT01044888|Risk factors|risk factors
5142018|NCT01044888|Myocardial infarction|myocardial infarction
5142019|NCT01044875|Diabetic retinopathy|diabetic retinopathy
5142020|NCT01044875|Laser treatment|laser treatment
5142021|NCT01044875|Complications|complications
5142022|NCT01044875|Laser wavelength|laser wavelength
5142023|NCT01044862|Pregnancy|pregnancy
5142024|NCT01044862|Infertility|infertility
5142025|NCT01044862|Ovarian stimulation|ovarian stimulation
5142026|NCT01044862|Aromatase inhibitors|aromatase inhibitors
5142027|NCT01044862|Follicle Stimulating Hormone|follicle stimulating hormone
5142028|NCT01044849|Blood Pressure|blood pressure
5142029|NCT01044836|Healthy volunteer|healthy volunteer
5142030|NCT01044823|RA|ra
5142031|NCT01044823|JRA|jra
5142032|NCT01044810|HIV|hiv
5142033|NCT01044810|efavirenz|efavirenz
5142034|NCT01044810|nevirapine|nevirapine
5142035|NCT01044810|allergy|allergy
5142036|NCT01044810|rash|rash
5142037|NCT01044810|Cohort Studies, Historical|cohort studies, historical
5142038|NCT01044810|Retrospective Study|retrospective study
5142039|NCT01044810|exanthem|exanthem
5142040|NCT01044810|Antiretroviral Agents|antiretroviral agents
5142041|NCT01044810|Highly Active Antiretroviral Therapy|highly active antiretroviral therapy
5142042|NCT01044810|HAART|haart
5142043|NCT01044810|treatment failure|treatment failure
5142044|NCT01044797|Healthy Volunteer|healthy volunteer
5142045|NCT01044797|Given Capsule Manipulation|given capsule manipulation
5142046|NCT01044784|CRT|crt
5142047|NCT01044771|HIV|hiv
5142048|NCT01044771|Human immunodeficiency virus|human immunodeficiency virus
5142049|NCT01044771|tenofovir|tenofovir
5142050|NCT01044771|viread|viread
5142051|NCT01044771|truvada|truvada
5142052|NCT01044771|proteinuria|proteinuria
5142053|NCT01044758|Mild Cognitive Impairment|mild cognitive impairment
5142054|NCT01044758|Amnestic Mild Cognitive Impairment|amnestic mild cognitive impairment
5142055|NCT01044758|Functional Magnetic Resonance Imaging|functional magnetic resonance imaging
5142056|NCT01044758|Levetiracetam|levetiracetam
5142057|NCT01044758|Keppra|keppra
5142058|NCT01044758|Medial Temporal Lobe|medial temporal lobe
5142059|NCT01044758|Memory Impairment|memory impairment
5142060|NCT01044758|Alzheimer's Disease|alzheimer's disease
5142061|NCT01044758|AD|ad
5142062|NCT01044732|Colorectal|colorectal
5142063|NCT01044732|Neoplasms|neoplasms
5142064|NCT01044732|Adenomas|adenomas
5142065|NCT01044732|Polyps|polyps
5142066|NCT01044732|Miss rates|miss rates
5142067|NCT01044732|Detection rates|detection rates
5142068|NCT01044732|Colonoscope|colonoscope
5142069|NCT01044732|Third Eye Retroscope|third eye retroscope
5142070|NCT01044706|Bioequivalency|bioequivalency
5142071|NCT01044693|supine Hypertension|supine hypertension
5142072|NCT01044693|autonomic failure|autonomic failure
5142073|NCT01044693|nitric oxide|nitric oxide
5142074|NCT01044693|nebivolol|nebivolol
5142075|NCT01044680|fiber|fiber
5142076|NCT01044680|metabolic syndrome|metabolic syndrome
5142077|NCT01044680|overweight|overweight
5142078|NCT01044680|satiety|satiety
5142079|NCT01044654|HIV|hiv
5142080|NCT01044654|Treatment Experienced|treatment experienced
5142081|NCT01044641|Colloid Osmotic pressure in interstitial fluid|colloid osmotic pressure in interstitial fluid
5142082|NCT01044641|Colloid Osmotic pressure in plasma|colloid osmotic pressure in plasma
5142083|NCT01044641|Protein fractions in interstitial fluid|protein fractions in interstitial fluid
5142084|NCT01044628|COPD|copd
5142085|NCT01044628|Oxygen therapy|oxygen therapy
5142086|NCT01044628|Nocturnal|nocturnal
5142087|NCT01044628|Desaturation|desaturation
5142088|NCT01044628|INOX|inox
5142089|NCT01044615|Mild Traumatic Brain Injury|mild traumatic brain injury
5142090|NCT01044615|Concussion|concussion
5142091|NCT01044615|Magnetic Resonance Imaging (MRI)|magnetic resonance imaging (mri)
5142092|NCT01044615|Positron Emission Tomography(PET)|positron emission tomography(pet)
5142093|NCT01044615|Computed Tomography (CT)|computed tomography (ct)
5142094|NCT01044602|Obesity|obesity
5142095|NCT01044602|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
5142096|NCT01044602|Roux-en-Y Gastric Bypass Surgery|roux-en-y gastric bypass surgery
5142097|NCT01044576|Multiple Sclerosis|multiple sclerosis
5142098|NCT01044563|Depression|depression
5142099|NCT01044563|Depressive Symptoms|depressive symptoms
5142100|NCT01044563|postmenopause|postmenopause
5142101|NCT01044563|RSA biofeedback|rsa biofeedback
5142102|NCT01044550|Diaphragm injury|diaphragm injury
5142103|NCT01044550|Herniation|herniation
5142104|NCT01044537|phase 1|phase 1
5142105|NCT01044537|safety and tolerability|safety and tolerability
5142106|NCT01044537|PK|pk
5142107|NCT01044537|PD|pd
5142108|NCT01044537|type 2 diabetes mellitus|type 2 diabetes mellitus
5142109|NCT01044537|T2DM|t2dm
5142110|NCT01044524|14C labeled ADME (Aborption Distribution Metabolism and Elimination) study|14c labeled adme (aborption distribution metabolism and elimination) study
5142111|NCT01044524|Phase I|phase i
5142112|NCT01044511|Esophageal cancer|esophageal cancer
5142113|NCT01044511|Cardia cancer|cardia cancer
5142114|NCT01044511|Health Related quality of Life|health related quality of life
5142115|NCT01044511|SEMS|sems
5142116|NCT01044511|Home visits|home visits
5142117|NCT01044485|HER-2 positive advanced or metastatic breast cancer|her-2 positive advanced or metastatic breast cancer
5142118|NCT01044485|dose escalation study|dose escalation study
5142119|NCT01044485|lapatinib|lapatinib
5142120|NCT01044485|docetaxel|docetaxel
5142121|NCT01044472|CRT-D|crt-d
5142122|NCT01044459|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5142123|NCT01044459|COPD|copd
5142124|NCT01044459|Chronic Bronchitis|chronic bronchitis
5142125|NCT01044459|Emphysema|emphysema
5142126|NCT01044459|Airflow Obstruction, Chronic|airflow obstruction, chronic
5142127|NCT01044459|Chronic Airflow Obstruction|chronic airflow obstruction
5142128|NCT01044459|Chronic Obstructive Airway Disease|chronic obstructive airway disease
5142129|NCT01044459|Chronic Obstructive Lung Disease|chronic obstructive lung disease
5142130|NCT01044446|peritoneal dialysis|peritoneal dialysis
5142131|NCT01044446|peritonitis|peritonitis
5142132|NCT01044446|CAPD|capd
5142133|NCT01044446|end-stage renal disease|end-stage renal disease
5142134|NCT01044446|peritonitis outcome and ultrafiltration|peritonitis outcome and ultrafiltration
5142135|NCT01044407|respiration|respiration
5142136|NCT01044407|sleep apnea|sleep apnea
5142137|NCT01044407|pacemaker|pacemaker
5142138|NCT01044394|colonoscopy|colonoscopy
5142139|NCT01044394|bowel preparation|bowel preparation
5142140|NCT01044394|polyethylene glycol|polyethylene glycol
5142141|NCT01044394|Quality in endoscopy|quality in endoscopy
5142142|NCT01044394|Bowel Preparation for colonoscopy|bowel preparation for colonoscopy
5142143|NCT01044381|Toenail|toenail
5142144|NCT01044381|Fungal Infections|fungal infections
5142145|NCT01044381|DSO|dso
5142146|NCT01044368|Remote Blood Glucose Monitoring System, Type 2 Diabetes|remote blood glucose monitoring system, type 2 diabetes
5142147|NCT01044355|Resistant Hypertension|resistant hypertension
5142148|NCT01044355|Obstructive Sleep Apnea|obstructive sleep apnea
5142149|NCT01044355|24 Hour Blood Pressure|24 hour blood pressure
5142150|NCT01044355|Arterial Stiffness|arterial stiffness
5142151|NCT01044355|Insulin Resistance|insulin resistance
5142152|NCT01044355|CPAP|cpap
5142153|NCT01044355|APAP|apap
5142154|NCT01044342|Healthy Volunteers|healthy volunteers
5142155|NCT01044342|EEG|eeg
5142156|NCT01044316|Haemophilus influenzae type b (Hib)|haemophilus influenzae type b (hib)
5142157|NCT01044316|Vaccine|vaccine
5142158|NCT01044316|Booster|booster
5142159|NCT01044303|Kidney Transplantation|kidney transplantation
5142160|NCT01044303|Mycophenolic Acid|mycophenolic acid
5142161|NCT01044303|Donor-Specific Antibodies|donor-specific antibodies
5142162|NCT01044303|Kidney Rejection|kidney rejection
5142163|NCT01044290|quality of life|quality of life
5142164|NCT01044290|end of life|end of life
5142165|NCT01044290|self-disclosure|self-disclosure
5142166|NCT01044290|palliative care|palliative care
5142167|NCT01044277|glutathione|glutathione
5142168|NCT01044277|gluthathione peroxidases|gluthathione peroxidases
5142169|NCT01044277|GSH|gsh
5142170|NCT01044264|Acne Vulgaris|acne vulgaris
5142171|NCT01044264|bioequivalency|bioequivalency
5142172|NCT01044264|clindamycin|clindamycin
5142173|NCT01044264|benzoyl peroxide|benzoyl peroxide
5142174|NCT01044251|Medication overuse headache|medication overuse headache
5142175|NCT01044251|Rebound headache|rebound headache
5142176|NCT01044251|Analgesic overuse headache|analgesic overuse headache
5142177|NCT01044251|Transitional therapy|transitional therapy
5142178|NCT01044251|Frovatriptan|frovatriptan
5142179|NCT01044251|Migraine|migraine
5142180|NCT01044238|methamphetamine|methamphetamine
5142181|NCT01044238|methylphenidate|methylphenidate
5142182|NCT01044238|clinical trial|clinical trial
5142183|NCT01044238|random assignment|random assignment
5142184|NCT01044238|double blind|double blind
5142185|NCT01044238|abstinence|abstinence
5142186|NCT01044238|reduction in methamphetamine use|reduction in methamphetamine use
5142187|NCT01044225|newly diagnosed glioblastoma|newly diagnosed glioblastoma
5142188|NCT01044212|Urogynecology|urogynecology
5142189|NCT01044199|rabies|rabies
5142190|NCT01044199|rabies vaccine|rabies vaccine
5142318|NCT01043744|presumptive treatment|presumptive treatment
5142191|NCT01044199|purified cultured embryo chicken rabies vaccine|purified cultured embryo chicken rabies vaccine
5142192|NCT01044186|Deferasirox|deferasirox
5142194|NCT01044186|Iron chelators|iron chelators
5142195|NCT01044186|Deferiprone|deferiprone
5142196|NCT01044186|Transfusional hemosiderosis|transfusional hemosiderosis
5142197|NCT01044186|Congenital aplastic anemia (Diamond Blackfan anemia)|congenital aplastic anemia (diamond blackfan anemia)
5142198|NCT01044186|Red cell aplasia|red cell aplasia
5142199|NCT01044186|Thalassemia|thalassemia
5142200|NCT01044186|β thalassemia|β thalassemia
5142201|NCT01044173|acute abdomen|acute abdomen
5142202|NCT01044173|CT|ct
5142203|NCT01044173|MRI|mri
5142204|NCT01044173|fast imaging|fast imaging
5142205|NCT01044160|cancer as trauma in children|cancer as trauma in children
5142206|NCT01044160|PTG/PTSS/ PTSD in children with cancer vs healthy children|ptg/ptss/ ptsd in children with cancer vs healthy children
5142207|NCT01044147|Obesity|obesity
5142208|NCT01044147|Internet|internet
5142209|NCT01044121|mattress|mattress
5142210|NCT01044121|pain|pain
5142211|NCT01044121|sleep|sleep
5142212|NCT01044121|low back pain|low back pain
5142213|NCT01044121|back|back
5142214|NCT01044121|neck|neck
5142215|NCT01044121|arousal|arousal
5142216|NCT01044121|pillow|pillow
5142217|NCT01044121|kingsdown|kingsdown
5142218|NCT01044121|sleep to live|sleep to live
5142219|NCT01044121|duke university|duke university
5142220|NCT01044121|sleep to live institute|sleep to live institute
5142221|NCT01044121|missouri|missouri
5142222|NCT01044121|springfield|springfield
5142223|NCT01044121|joplin|joplin
5142224|NCT01044121|body diagnostic|body diagnostic
5142225|NCT01044121|dormo diagnostic|dormo diagnostic
5142226|NCT01044121|morning pain|morning pain
5142227|NCT01044095|seasonal influenza vaccine|seasonal influenza vaccine
5142228|NCT01044095|avian influenza H5N1|avian influenza h5n1
5142229|NCT01044095|cross reactivity|cross reactivity
5142230|NCT01044095|prime boost|prime boost
5142231|NCT01044082|Postpartum haemorrhage|postpartum haemorrhage
5142232|NCT01044082|Third stage of labour|third stage of labour
5142233|NCT01044082|Controlled cord traction|controlled cord traction
5142234|NCT01044082|Randomized controlled trial|randomized controlled trial
5142235|NCT01044082|Prevention|prevention
5142236|NCT01044069|Cyclophosphamide|cyclophosphamide
5142237|NCT01044069|T cell|t cell
5142238|NCT01044069|leukapheresis|leukapheresis
5142239|NCT01044069|stem cell transplant|stem cell transplant
5142240|NCT01044069|bone marrow transplant|bone marrow transplant
5142241|NCT01044069|09-114|09-114
5142242|NCT01044030|otitis media|otitis media
5142243|NCT01044030|ear infection|ear infection
5142244|NCT01043991|STEMI|stemi
5142245|NCT01043991|AMI,|ami,
5142246|NCT01043991|acute myocardial infarct|acute myocardial infarct
5142247|NCT01043991|Epo|epo
5142248|NCT01043991|Erythropoietin|erythropoietin
5142249|NCT01043991|ischemia-reperfusion|ischemia-reperfusion
5142250|NCT01043991|apoptosis|apoptosis
5142251|NCT01043965|Diabetes Mellitus|diabetes mellitus
5142252|NCT01043965|Myocardial perfusion imaging|myocardial perfusion imaging
5142253|NCT01043965|Heart diseases|heart diseases
5142254|NCT01043965|Echocardiography|echocardiography
5142255|NCT01043965|Endothelium|endothelium
5142256|NCT01043952|Propofol|propofol
5142257|NCT01043952|Remifentanil|remifentanil
5142258|NCT01043952|Bispectral Index Monitor|bispectral index monitor
5142259|NCT01043939|childhood cancers|childhood cancers
5142260|NCT01043939|cardiovascular disease|cardiovascular disease
5142261|NCT01043939|childhood cancer survivor|childhood cancer survivor
5142262|NCT01043926|Hepatic Insufficiency|hepatic insufficiency
5142263|NCT01043913|Fatigue|fatigue
5142264|NCT01043913|Breast Neoplasms|breast neoplasms
5142265|NCT01043913|Quality of Life|quality of life
5142266|NCT01043913|Paullinia|paullinia
5142267|NCT01043900|Obsessive-Compulsive Disorder|obsessive-compulsive disorder
5142268|NCT01043900|rTMS|rtms
5142269|NCT01043900|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
5142270|NCT01043900|treatment|treatment
5142271|NCT01043900|randomized controlled trials|randomized controlled trials
5142272|NCT01043887|Healthy Volunteers|healthy volunteers
5142273|NCT01043887|Hepatic Insufficiency|hepatic insufficiency
5142274|NCT01043874|Chronic phase|chronic phase
5142275|NCT01043874|Chronic myelogenous leukemia|chronic myelogenous leukemia
5142276|NCT01043874|CML|cml
5142277|NCT01043874|Philadelphia chromosome positive|philadelphia chromosome positive
5142278|NCT01043874|Ph+|ph+
5142279|NCT01043874|Nilotinib|nilotinib
5142280|NCT01043874|CML-CP|cml-cp
5142281|NCT01043874|Suboptimal molecular response|suboptimal molecular response
5142282|NCT01043848|neurogenic detrusor overactivity|neurogenic detrusor overactivity
5142283|NCT01043848|neuromodulation|neuromodulation
5142284|NCT01043848|spinal cord injury|spinal cord injury
5142285|NCT01043848|pudendal nerve stimulation|pudendal nerve stimulation
5142286|NCT01043848|videocystometry|videocystometry
5142287|NCT01043848|neurophysiology|neurophysiology
5142288|NCT01043848|neuroplasticity|neuroplasticity
5142289|NCT01043835|Stomach Neoplasm|stomach neoplasm
5142290|NCT01043835|Laparoscopy|laparoscopy
5142291|NCT01043835|gastrectomy|gastrectomy
5142292|NCT01043822|Autism|autism
5142293|NCT01043822|mental retardation|mental retardation
5142294|NCT01043822|pain|pain
5142295|NCT01043822|emotion|emotion
5142296|NCT01043822|sensory profile|sensory profile
5142297|NCT01043822|children|children
5142298|NCT01043809|schools|schools
5142299|NCT01043809|handwashing|handwashing
5142300|NCT01043809|prevention and control|prevention and control
5142301|NCT01043809|communicable diseases|communicable diseases
5142302|NCT01043809|absenteeism|absenteeism
5142303|NCT01043796|Insecticide treated wall liners|insecticide treated wall liners
5142304|NCT01043796|Insecticide treated nets|insecticide treated nets
5142305|NCT01043796|Incidence cohort|incidence cohort
5142306|NCT01043783|Obesity|obesity
5142307|NCT01043770|Metabolic syndrome|metabolic syndrome
5142308|NCT01043770|Primary prevention|primary prevention
5142309|NCT01043770|Diabetes|diabetes
5142310|NCT01043770|Cardiovascular disease|cardiovascular disease
5142311|NCT01043770|Patient education|patient education
5142312|NCT01043757|Sedentary lifestyle|sedentary lifestyle
5142313|NCT01043757|physical exercise|physical exercise
5142314|NCT01043757|behavioral economics|behavioral economics
5142315|NCT01043757|financial incentives|financial incentives
5142316|NCT01043757|obesity|obesity
5142317|NCT01043744|malaria|malaria
5142319|NCT01043744|Integrated Management of Childhood Illness|integrated management of childhood illness
5142320|NCT01043744|fever|fever
5142321|NCT01043718|Obesity|obesity
5142322|NCT01043718|Internet|internet
5142323|NCT01043705|Pacemaker infection|pacemaker infection
5142324|NCT01043705|Defibrillator infection|defibrillator infection
5142325|NCT01043705|ICD infection|icd infection
5142326|NCT01043705|CRT infection|crt infection
5142327|NCT01043705|Cardiovascular implantable electronic device infection|cardiovascular implantable electronic device infection
5142328|NCT01043705|Infection|infection
5142329|NCT01043705|Pacemaker, Artificial|pacemaker, artificial
5142330|NCT01043705|Defibrillators|defibrillators
5142331|NCT01043692|Chronic Pain > 3 months|chronic pain > 3 months
5142332|NCT01043692|Acupuncture|acupuncture
5142333|NCT01043692|Acceptability|acceptability
5142334|NCT01043692|Geriatrics|geriatrics
5142335|NCT01043679|Bipolar, Mania|bipolar, mania
5142336|NCT01043679|Utapine|utapine
5142337|NCT01043679|Seroquel|seroquel
5142338|NCT01043666|Micturition|micturition
5142339|NCT01043666|YM178|ym178
5142340|NCT01043666|Urinary incontinence|urinary incontinence
5142341|NCT01043666|Frequency|frequency
5142342|NCT01043666|Overactive Bladder|overactive bladder
5142343|NCT01043666|Urgency|urgency
5142344|NCT01043666|Urinary urge incontinence|urinary urge incontinence
5142345|NCT01043653|recovery|recovery
5142346|NCT01043653|serious mental illness|serious mental illness
5142347|NCT01043640|inherited metabolic disorders|inherited metabolic disorders
5142348|NCT01043614|Obesity|obesity
5142349|NCT01043614|Obesity Prevention|obesity prevention
5142350|NCT01043614|Freshman women|freshman women
5142351|NCT01043614|Freshman 15 weight gain|freshman 15 weight gain
5142352|NCT01043614|Self efficacy|self efficacy
5142353|NCT01043614|Activity and nutrition intervention|activity and nutrition intervention
5142354|NCT01043614|Peer education|peer education
5142355|NCT01043588|Surgery|surgery
5142356|NCT01043588|Prostate|prostate
5142357|NCT01043588|Laser 532 nm|laser 532 nm
5142358|NCT01043588|Photo selective Vaporization of the Prostate (PVP)|photo selective vaporization of the prostate (pvp)
5142359|NCT01043588|TransUrethral Resection of the Prostate (TURP)|transurethral resection of the prostate (turp)
5142360|NCT01043588|Men health|men health
5142361|NCT01043575|rifapentine, pharmacokinetics, pharmacodynamics, tuberculosis|rifapentine, pharmacokinetics, pharmacodynamics, tuberculosis
5142362|NCT01043549|Gilles de la Tourette syndrome|gilles de la tourette syndrome
5142363|NCT01043549|Tics|tics
5143041|NCT01040936|outcome|outcome
5142364|NCT01043549|Transcranial magnetic stimulation|transcranial magnetic stimulation
5142365|NCT01043536|IMRT|imrt
5142366|NCT01043536|Radiotherapy escalation dose|radiotherapy escalation dose
5142367|NCT01043536|glioblastoma|glioblastoma
5142368|NCT01043536|escalation radiotherapy dose|escalation radiotherapy dose
5142369|NCT01043523|Liver neoplasms|liver neoplasms
5142370|NCT01043523|Adenoma|adenoma
5142371|NCT01043523|Liver cell carcinoma|liver cell carcinoma
5142372|NCT01043523|Hepatocellular|hepatocellular
5142373|NCT01043523|Liver abscess|liver abscess
5142374|NCT01043484|Resectable rectal cancer|resectable rectal cancer
5142375|NCT01043484|Radiotherapy|radiotherapy
5142376|NCT01043484|Bevacizumab|bevacizumab
5142377|NCT01043484|Capecitabine|capecitabine
5142378|NCT01043471|Obesity|obesity
5142379|NCT01043458|Pharmacokinetics|pharmacokinetics
5142380|NCT01043445|GPR 119|gpr 119
5142381|NCT01043445|GLP-1 secretion|glp-1 secretion
5142382|NCT01043445|2-oleoyl-glycerol|2-oleoyl-glycerol
5142383|NCT01043445|Dietary supplementation|dietary supplementation
5142384|NCT01043432|Traumatic Brain Injury|traumatic brain injury
5142385|NCT01043432|Suicide|suicide
5142386|NCT01043432|Executive Function|executive function
5142387|NCT01043419|Xenon Anesthesia|xenon anesthesia
5142388|NCT01043419|LENOXe™ (xénon 100 % v/v) anesthesia|lenoxe™ (xénon 100 % v/v) anesthesia
5142389|NCT01043419|Muscle Sympathetic Activity|muscle sympathetic activity
5142390|NCT01043419|Baroreflex reagibility|baroreflex reagibility
5142391|NCT01043406|Epilepsy|epilepsy
5142392|NCT01043406|Seizures|seizures
5142393|NCT01043406|Advisory|advisory
5142394|NCT01043406|Prediction|prediction
5142395|NCT01043393|Plaque psoriasis|plaque psoriasis
5142396|NCT01043380|Heart Diseases|heart diseases
5142397|NCT01043380|Hyperlipidemia|hyperlipidemia
5142398|NCT01043380|Atorvastatin|atorvastatin
5142399|NCT01043380|Ezetimibe|ezetimibe
5142400|NCT01043380|Cardiovascular Diseases|cardiovascular diseases
5142401|NCT01043380|Hypercholesterolemia|hypercholesterolemia
5142402|NCT01043380|Coronary Artery Disease|coronary artery disease
5142403|NCT01043380|Dyslipidemias|dyslipidemias
5142404|NCT01043380|Intravascular Ultrasound|intravascular ultrasound
5142405|NCT01043367|Depression|depression
5142406|NCT01043367|Dietary supplement|dietary supplement
5142407|NCT01043367|Deprexil|deprexil
5142408|NCT01043354|cholesterol|cholesterol
5142409|NCT01043354|diabetes|diabetes
5142410|NCT01043354|adherence|adherence
5142411|NCT01043341|HPV|hpv
5142412|NCT01043341|vaccines|vaccines
5142413|NCT01043341|knowledge|knowledge
5142414|NCT01043341|attitude|attitude
5142415|NCT01043328|human papillomavirus|human papillomavirus
5142416|NCT01043328|nested PCR|nested pcr
5142417|NCT01043328|saliva|saliva
5142418|NCT01043328|serum|serum
5142419|NCT01043328|oral tissues|oral tissues
5142420|NCT01043315|Cognitive Function|cognitive function
5142421|NCT01043315|Cognitive Impairment|cognitive impairment
5142422|NCT01043315|Hospitalization|hospitalization
5142423|NCT01043315|Cardiac Disease|cardiac disease
5142424|NCT01043302|lymphoma, intestine, outcome, quality of life|lymphoma, intestine, outcome, quality of life
5142425|NCT01043289|light therapy|light therapy
5142426|NCT01043289|antepartum depression|antepartum depression
5142427|NCT01043289|controlled trial|controlled trial
5142428|NCT01043276|Healthy|healthy
5142429|NCT01043250|schizophrenia|schizophrenia
5142430|NCT01043250|atypical antipsychotics|atypical antipsychotics
5142431|NCT01043250|appetite|appetite
5142432|NCT01043250|eating behavior|eating behavior
5142433|NCT01043237|acoustic|acoustic
5142434|NCT01043237|digital|digital
5142435|NCT01043237|sound|sound
5142436|NCT01043237|vibration|vibration
5142437|NCT01043237|coronary|coronary
5142438|NCT01043237|auscultation|auscultation
5142439|NCT01043237|artery|artery
5142440|NCT01043237|diagnosis|diagnosis
5142441|NCT01043211|Back Pain|back pain
5142442|NCT01043211|Lidocaine|lidocaine
5142443|NCT01043198|CGH array technology|cgh array technology
5142444|NCT01043198|mental retardation|mental retardation
5142445|NCT01043198|chromosomal abnormalities|chromosomal abnormalities
5142446|NCT01043198|syndromic obesity|syndromic obesity
5142447|NCT01043198|obesity|obesity
5142448|NCT01043185|GERD|gerd
5142449|NCT01043185|lesogaberan|lesogaberan
5142450|NCT01043185|impedance|impedance
5142451|NCT01043185|pH|ph
5142452|NCT01043185|pharmacokinetics|pharmacokinetics
5142453|NCT01043185|safety|safety
5142454|NCT01043185|tolerability|tolerability
5142455|NCT01043146|anti-beta1 adrenergic receptor|anti-beta1 adrenergic receptor
5142456|NCT01043146|autoantibody|autoantibody
5142457|NCT01043146|cyclic peptide|cyclic peptide
5142458|NCT01043146|heart failure|heart failure
5142459|NCT01043133|electronic medical records|electronic medical records
5142460|NCT01043133|documentation templates|documentation templates
5142461|NCT01043133|clinical encounter notes|clinical encounter notes
5142462|NCT01043081|African American women who have sex with women|african american women who have sex with women
5142463|NCT01043081|Sexually transmitted infections|sexually transmitted infections
5142464|NCT01043081|Homosexuality|homosexuality
5142465|NCT01043081|Human papillomavirus|human papillomavirus
5143229|NCT01040143|Pneumococci|pneumococci
5142466|NCT01043081|Cervical intraepithelial neoplasia|cervical intraepithelial neoplasia
5142467|NCT01043081|Herpes simplex virus types 1 and 2|herpes simplex virus types 1 and 2
5142468|NCT01043081|Chlamydia|chlamydia
5142469|NCT01043081|Gonorrhea|gonorrhea
5142470|NCT01043081|Trichomoniasis|trichomoniasis
5142471|NCT01043081|Bacterial vaginosis|bacterial vaginosis
5142472|NCT01043081|Syphilis|syphilis
5142473|NCT01043081|Human immunodeficiency virus|human immunodeficiency virus
5142474|NCT01043068|cancer pain|cancer pain
5142475|NCT01043068|opioid|opioid
5142476|NCT01043068|guideline|guideline
5142477|NCT01043055|Breast Cancer Screening|breast cancer screening
5142478|NCT01043042|hypoglycemia among inpatients|hypoglycemia among inpatients
5142479|NCT01043042|hyperglycemia among inpatients|hyperglycemia among inpatients
5142480|NCT01043016|skin cancer|skin cancer
5142481|NCT01043016|esophageal cancer|esophageal cancer
5142482|NCT01043016|photodynamic therapy|photodynamic therapy
5142483|NCT01042990|Stroke|stroke
5142484|NCT01042990|Exercise|exercise
5142485|NCT01042990|Balance|balance
5142486|NCT01042990|Dynamic Gait|dynamic gait
5142487|NCT01042990|Cardiovascular Fitness|cardiovascular fitness
5142488|NCT01042977|dapagliflozin|dapagliflozin
5142489|NCT01042977|diabetes|diabetes
5142490|NCT01042977|cardiovascular disease|cardiovascular disease
5142491|NCT01042964|platelet adhesion and aggregation|platelet adhesion and aggregation
5142492|NCT01042964|acute coronary syndrome|acute coronary syndrome
5142493|NCT01042964|myocardial infarction|myocardial infarction
5142494|NCT01042964|stroke|stroke
5142495|NCT01042964|inhibition of platelet adhesion to plaques|inhibition of platelet adhesion to plaques
5142496|NCT01042964|collagen-induced platelet aggregation|collagen-induced platelet aggregation
5142497|NCT01042951|safety|safety
5142498|NCT01042951|immunogenicity|immunogenicity
5142499|NCT01042951|Healthy Participants|healthy participants
5142500|NCT01042938|Radiation dermatitis in breast cancer patients|radiation dermatitis in breast cancer patients
5142501|NCT01042925|HER2 positive breast cancer|her2 positive breast cancer
5142502|NCT01042925|breast cancer|breast cancer
5142503|NCT01042925|breast tumors|breast tumors
5142504|NCT01042925|human mammary carcinoma|human mammary carcinoma
5142505|NCT01042912|diagnosis|diagnosis
5142506|NCT01042912|carotid|carotid
5142507|NCT01042912|artery|artery
5142508|NCT01042912|disease|disease
5142509|NCT01042912|auscultation|auscultation
5142510|NCT01042912|sound|sound
5142511|NCT01042899|TBI|tbi
5142512|NCT01042899|intracranial edema|intracranial edema
5142513|NCT01042899|brain edema|brain edema
5142514|NCT01042899|craniocerebral trauma|craniocerebral trauma
5142515|NCT01042899|head injury|head injury
5142516|NCT01042899|brain hemorrhage, traumatic|brain hemorrhage, traumatic
5142517|NCT01042899|subdural hematoma|subdural hematoma
5142518|NCT01042899|brain concussion|brain concussion
5142519|NCT01042899|head injuries, closed|head injuries, closed
5142520|NCT01042899|epidural hematoma|epidural hematoma
5142521|NCT01042899|extra-axial hemorrhage|extra-axial hemorrhage
5142522|NCT01042899|cortical contusion|cortical contusion
5142523|NCT01042899|wounds and injuries|wounds and injuries
5142524|NCT01042899|disorders of environmental origin|disorders of environmental origin
5142525|NCT01042899|trauma, nervous system|trauma, nervous system
5142526|NCT01042899|brain injuries|brain injuries
5142527|NCT01042886|Non-blind, randomized controlled trial|non-blind, randomized controlled trial
5142528|NCT01042886|Pilot study|pilot study
5142529|NCT01042873|Desensitization|desensitization
5142530|NCT01042873|beta adrenergic receptors|beta adrenergic receptors
5142531|NCT01042873|Healthy subjects|healthy subjects
5142532|NCT01042860|macular pigment|macular pigment
5142533|NCT01042860|lutein|lutein
5142534|NCT01042860|age-related macular degeneration|age-related macular degeneration
5142535|NCT01042860|AMD|amd
5142536|NCT01042847|ovarian|ovarian
5142537|NCT01042834|air pollution|air pollution
5142538|NCT01042834|autonomic nervous system|autonomic nervous system
5142539|NCT01042834|sleep apnea|sleep apnea
5142540|NCT01042834|Heart rate variability|heart rate variability
5142541|NCT01042834|Healthy volunteers|healthy volunteers
5142542|NCT01042821|anal fistula|anal fistula
5142543|NCT01042821|advancement flap|advancement flap
5142544|NCT01042821|incontinence|incontinence
5142545|NCT01042795|sunitinib|sunitinib
5142546|NCT01042795|bladder neoplasm|bladder neoplasm
5142547|NCT01042795|adjuvant treatment|adjuvant treatment
5142548|NCT01042795|disease free survival|disease free survival
5142549|NCT01042795|cystectomy|cystectomy
5142550|NCT01042782|gastric cancer|gastric cancer
5142551|NCT01042782|RAD001|rad001
5142552|NCT01042782|Mitomycin C|mitomycin c
5142553|NCT01042782|MTD|mtd
5142554|NCT01042743|colon cancer|colon cancer
5142555|NCT01042743|robot|robot
5142556|NCT01042743|laparoscopy|laparoscopy
5142557|NCT01042743|primary, right-side colon cancer|primary, right-side colon cancer
5142558|NCT01042743|robot-assisted surgery|robot-assisted surgery
5142559|NCT01042730|Pitavastatin|pitavastatin
5142560|NCT01042730|Coronary Artery Disease|coronary artery disease
5142561|NCT01042730|Cardiovascular Disease|cardiovascular disease
5142562|NCT01042717|plerixafor|plerixafor
5142563|NCT01042717|autologous transplantation|autologous transplantation
5143421|NCT01039454|fMRI|fmri
5142564|NCT01042717|hematopoietic stem cell mobilization|hematopoietic stem cell mobilization
5142565|NCT01042717|multiple myeloma|multiple myeloma
5142566|NCT01042717|non-Hodgkins lymphoma|non-hodgkins lymphoma
5142567|NCT01042704|Relapsed Myeloma|relapsed myeloma
5142568|NCT01042704|Refractory Myeloma|refractory myeloma
5142569|NCT01042665|Glaucoma|glaucoma
5142570|NCT01042665|intraocular pressure|intraocular pressure
5142571|NCT01042665|latanoprost|latanoprost
5142572|NCT01042665|retinal ganglion cell|retinal ganglion cell
5142573|NCT01042665|pattern electroretinogram|pattern electroretinogram
5142574|NCT01042652|Methadone|methadone
5142575|NCT01042652|HIV|hiv
5142576|NCT01042652|Raltegravir|raltegravir
5142577|NCT01042652|Antiretroviral|antiretroviral
5142578|NCT01042652|Intravenous Drug User|intravenous drug user
5142579|NCT01042652|Methadone Maintenance|methadone maintenance
5142580|NCT01042652|Treatment Naive|treatment naive
5142581|NCT01042639|osteopenia|osteopenia
5142582|NCT01042639|very low birthweight infants|very low birthweight infants
5142583|NCT01042639|bone speed of sound|bone speed of sound
5142584|NCT01042639|quantitative ultrasound|quantitative ultrasound
5142585|NCT01042626|Receptors, Calcium sensing|receptors, calcium sensing
5142586|NCT01042626|Parathyroid Hormone|parathyroid hormone
5142587|NCT01042613|AccuVein AV300 device;|accuvein av300 device;
5142588|NCT01042613|Intravenous cannulation|intravenous cannulation
5142589|NCT01042600|Respiratory distress syndrome|respiratory distress syndrome
5142590|NCT01042600|Surfactant|surfactant
5142591|NCT01042600|Tracheal intubation|tracheal intubation
5142592|NCT01042600|Laryngeal mask airway|laryngeal mask airway
5142593|NCT01042600|Newborn|newborn
5142594|NCT01042587|bright light therapy|bright light therapy
5142595|NCT01042587|circadian rhythm,|circadian rhythm,
5142596|NCT01042587|entrainment|entrainment
5142597|NCT01042574|intracranial hemorrhage (ICH)|intracranial hemorrhage (ich)
5142598|NCT01042574|subarachnoid hemorrhage (SAH)|subarachnoid hemorrhage (sah)
5142599|NCT01042574|intracranial monitoring|intracranial monitoring
5142600|NCT01042574|external ventricular drain (ventriculostomy)|external ventricular drain (ventriculostomy)
5142601|NCT01042574|hypertension|hypertension
5142602|NCT01042561|vitamin d|vitamin d
5142603|NCT01042561|prematurity|prematurity
5142604|NCT01042561|25(OH)D|25(oh)d
5142605|NCT01042561|infant|infant
5142606|NCT01042561|CRP|crp
5142607|NCT01042561|PTH|pth
5142608|NCT01042548|Proteomics|proteomics
5142609|NCT01042548|Breast Cancer Markers|breast cancer markers
5142610|NCT01042548|Tissue Interstitial Fluid|tissue interstitial fluid
5142611|NCT01042509|Chronic Graft vs Host Disease|chronic graft vs host disease
5142612|NCT01042509|Alemtuzumab|alemtuzumab
5142613|NCT01042509|Rituximab|rituximab
5142614|NCT01042509|Low-dose|low-dose
5142615|NCT01042509|Alemtuzumab and rituximab combination|alemtuzumab and rituximab combination
5142616|NCT01042496|Bipolar|bipolar
5142617|NCT01042496|depression|depression
5142618|NCT01042483|active stage|active stage
5142619|NCT01042483|labor|labor
5142620|NCT01042483|progression|progression
5142621|NCT01042483|pregnant women during active phases of labor|pregnant women during active phases of labor
5142622|NCT01042470|pelvic organ prolapse|pelvic organ prolapse
5142623|NCT01042470|pelvic floor dysfunction|pelvic floor dysfunction
5142624|NCT01042470|biomechanics|biomechanics
5142625|NCT01042470|aspiration device|aspiration device
5142626|NCT01042470|connective tissue|connective tissue
5142627|NCT01042457|trough level|trough level
5142628|NCT01042457|therapeutic drug monitoring|therapeutic drug monitoring
5142629|NCT01042457|Mycophenolate mofetil|mycophenolate mofetil
5142630|NCT01042457|Mycophenolic acid|mycophenolic acid
5142631|NCT01042457|lupus nephritis|lupus nephritis
5142632|NCT01042444|Heart disease|heart disease
5142633|NCT01042444|Embolic Protection Device|embolic protection device
5142634|NCT01042444|PCI|pci
5142635|NCT01042444|SVG|svg
5142636|NCT01042431|Nutritional status of ward patients and hospitalization outcome|nutritional status of ward patients and hospitalization outcome
5142637|NCT01042418|satiety|satiety
5142638|NCT01042418|grain structure|grain structure
5142639|NCT01042418|rye|rye
5142640|NCT01042392|Moderate systolic hypertension - adults - aliskiren -ramipril|moderate systolic hypertension - adults - aliskiren -ramipril
5142641|NCT01042379|I-SPY 2|i-spy 2
5142642|NCT01042379|Neoadjuvant|neoadjuvant
5142643|NCT01042379|Breast|breast
5142644|NCT01042379|Cancer|cancer
5142645|NCT01042379|Neoplasm|neoplasm
5142646|NCT01042379|Adaptive|adaptive
5142647|NCT01042379|pCR|pcr
5142648|NCT01042379|Pathologic Complete Response|pathologic complete response
5142649|NCT01042379|Biomarkers signature|biomarkers signature
5142650|NCT01042379|MRI Volume|mri volume
5142651|NCT01042366|Melanoma|melanoma
5142652|NCT01042340|nutrition|nutrition
5142653|NCT01042340|geriatric|geriatric
5142654|NCT01042340|supplement|supplement
5142655|NCT01042340|energy|energy
5142656|NCT01042327|solute clearances|solute clearances
5142657|NCT01042288|Non-Small-Cell Lung Cancer|non-small-cell lung cancer
5142658|NCT01042288|NSCLC|nsclc
5142659|NCT01042288|Panitumumab|panitumumab
5142660|NCT01042288|Vectibix|vectibix
5142661|NCT01042288|Pemetrexed|pemetrexed
5142662|NCT01042288|Alimta|alimta
5142663|NCT01042288|Carboplatin|carboplatin
5142664|NCT01042275|stress urinary incontinence|stress urinary incontinence
5142665|NCT01042275|retropubic sling|retropubic sling
5142666|NCT01042275|transobturator sling|transobturator sling
5142667|NCT01042275|tension-free vaginal tape|tension-free vaginal tape
5142668|NCT01042275|transobturator tape|transobturator tape
5142669|NCT01042275|TVT|tvt
5142670|NCT01042275|TVT-O|tvt-o
5142671|NCT01042275|TOT|tot
5142672|NCT01042275|REMEEX|remeex
5142673|NCT01042275|IVS|ivs
5142674|NCT01042262|Superoxide dismutase|superoxide dismutase
5142675|NCT01042262|Oxygen|oxygen
5142676|NCT01042262|Oxygen free radicals|oxygen free radicals
5142677|NCT01042262|Labor and delivery|labor and delivery
5142678|NCT01042249|PFMT|pfmt
5142679|NCT01042249|Stroke|stroke
5142680|NCT01042249|LUTS|luts
5142681|NCT01042249|Men|men
5142682|NCT01042236|Phase 2 stress urinary incontinence Fesoterodine|phase 2 stress urinary incontinence fesoterodine
5142683|NCT01042223|Factors Predisposing or Causing|factors predisposing or causing
5142684|NCT01042210|preeclampsia|preeclampsia
5142685|NCT01042210|agouti-related peptide|agouti-related peptide
5142686|NCT01042210|intrauterine growth|intrauterine growth
5142687|NCT01042210|birth weight|birth weight
5142688|NCT01042210|Intrauterine growth restriction due to preeclampsia|intrauterine growth restriction due to preeclampsia
5142689|NCT01042197|Vitamin D|vitamin d
5142690|NCT01042197|UVB|uvb
5142691|NCT01042197|Dose-Response|dose-response
5142692|NCT01042197|Body surface area|body surface area
5142693|NCT01042184|H. pylori infected patients without prior eradication therapy|h. pylori infected patients without prior eradication therapy
5142694|NCT01042158|Tadalafil|tadalafil
5142695|NCT01042158|Ambrisentan|ambrisentan
5142696|NCT01042158|Quality of Life|quality of life
5142697|NCT01042145|Primary Care|primary care
5142698|NCT01042145|Treatment|treatment
5142699|NCT01042145|Croup|croup
5142700|NCT01042145|Corticosteroids|corticosteroids
5142701|NCT01042145|Prednisone|prednisone
5142702|NCT01042145|Dexamethasone|dexamethasone
5142703|NCT01042145|Randomized trial|randomized trial
5142704|NCT01042132|intramedullary reaming|intramedullary reaming
5142705|NCT01042132|inflammatory response|inflammatory response
5142706|NCT01042132|human|human
5142707|NCT01042132|femoral shaft fracture|femoral shaft fracture
5142708|NCT01042132|Reamer-irrigator-aspirator|reamer-irrigator-aspirator
5142709|NCT01042119|botulinum neurotoxin type A|botulinum neurotoxin type a
5142710|NCT01042119|BoNT/A|bont/a
5142711|NCT01042119|Botox|botox
5142712|NCT01042119|overactive bladder syndrome|overactive bladder syndrome
5142713|NCT01042106|diabetes|diabetes
5142714|NCT01042093|Analgesia|analgesia
5142715|NCT01042093|postoperative pain|postoperative pain
5142716|NCT01042093|periarticular|periarticular
5142717|NCT01042093|arthroplasty|arthroplasty
5142718|NCT01042093|pain management|pain management
5142719|NCT01042080|Mechanical ventilation|mechanical ventilation
5142720|NCT01042080|Neurally adjusted ventilatory assist (NAVA)|neurally adjusted ventilatory assist (nava)
5142721|NCT01042080|Acute respiratory failure|acute respiratory failure
5142722|NCT01042080|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
5142723|NCT01042080|Weaning|weaning
5142724|NCT01042080|Invasive mechanical ventilation|invasive mechanical ventilation
5142725|NCT01042080|Positive Pressure support Ventilation|positive pressure support ventilation
5142726|NCT01042067|warfarin|warfarin
5142727|NCT01042067|genotyping|genotyping
5142728|NCT01042067|vitamin K|vitamin k
5142729|NCT01042067|dosing|dosing
5142730|NCT01042067|adverse events|adverse events
5142731|NCT01042067|initial phase of treatment|initial phase of treatment
5142732|NCT01042067|algorithm|algorithm
5142733|NCT01042054|Postoperative Care|postoperative care
5142734|NCT01042054|Enhanced|enhanced
5142735|NCT01042054|Recovery|recovery
5142736|NCT01042054|Hepatectomy|hepatectomy
5142737|NCT01042054|Analgesia|analgesia
5142738|NCT01042028|Pancreas cancer|pancreas cancer
5142739|NCT01042028|Everolimus|everolimus
5142740|NCT01042028|Irinotecan|irinotecan
5142741|NCT01042028|Cetuximab|cetuximab
5142742|NCT01042028|Capecitabine|capecitabine
5142743|NCT01042028|Oxaliplatin|oxaliplatin
5142744|NCT01042028|Gemcitabine resistant pancreascancer|gemcitabine resistant pancreascancer
5142745|NCT01042015|trauma|trauma
5142746|NCT01042015|cardiac arrest|cardiac arrest
5142747|NCT01042015|hemorrhagic shock|hemorrhagic shock
5142748|NCT01042002|High intensity exercise|high intensity exercise
5142749|NCT01042002|morbid obesity|morbid obesity
5142750|NCT01042002|gastric bypass|gastric bypass
5142751|NCT01041989|dementia|dementia
5142752|NCT01041989|cognitive impairment|cognitive impairment
5142753|NCT01041989|disability|disability
5142754|NCT01041989|intervention|intervention
5142755|NCT01041989|elderly|elderly
5142756|NCT01041989|lifestyle counseling|lifestyle counseling
5142757|NCT01041976|Veterans|veterans
5142758|NCT01041976|Vocational Rehabilitation|vocational rehabilitation
5142759|NCT01041963|ACEI|acei
5142760|NCT01041963|ARB|arb
5142761|NCT01041963|CAPD|capd
5142762|NCT01041963|Peritoneal membrane transport|peritoneal membrane transport
5142763|NCT01041950|intracerebral hemorrhage|intracerebral hemorrhage
5142764|NCT01041950|intraventricular hemorrhage|intraventricular hemorrhage
5142765|NCT01041950|hydrocephalus|hydrocephalus
5142766|NCT01041950|Intracerebral hemorrhage with severe ventricular involvement and obstructive hydrocephalus|intracerebral hemorrhage with severe ventricular involvement and obstructive hydrocephalus
5142767|NCT01041924|Sleep apnea|sleep apnea
5142768|NCT01041924|Periodic breathing|periodic breathing
5142769|NCT01041924|Heart Failure|heart failure
5142770|NCT01041911|Hemorrhoids|hemorrhoids
5142771|NCT01041898|osteocalcin|osteocalcin
5142772|NCT01041898|insulin|insulin
5142773|NCT01041898|body composition|body composition
5142774|NCT01041898|bone mineral density|bone mineral density
5142775|NCT01041898|Evaluate the effect of osteocalcin on bone mineral density|evaluate the effect of osteocalcin on bone mineral density
5142776|NCT01041898|Evaluate the effect of osteocalcin on body fat distribution|evaluate the effect of osteocalcin on body fat distribution
5142777|NCT01041898|Evaluate the effect of osteocalcin on insulin homeostasis|evaluate the effect of osteocalcin on insulin homeostasis
5142778|NCT01041885|knee cartilage defect repair|knee cartilage defect repair
5142779|NCT01041885|cartilage lesion|cartilage lesion
5142780|NCT01041885|autologous chondrocyte|autologous chondrocyte
5142781|NCT01041885|scaffold|scaffold
5142782|NCT01041885|INSTRUCT|instruct
5142783|NCT01041859|Diabetic Peripheral Neuropathy|diabetic peripheral neuropathy
5142784|NCT01041859|Painful|painful
5142785|NCT01041859|Polyneuropathy|polyneuropathy
5142786|NCT01041859|Peripheral neuropathy|peripheral neuropathy
5142787|NCT01041846|Myelodysplastic Syndrome|myelodysplastic syndrome
5142788|NCT01041846|Dacogen|dacogen
5142789|NCT01041846|Decitabine|decitabine
5142790|NCT01041846|Epigenetic therapy|epigenetic therapy
5142791|NCT01041846|Hypomethylating agent|hypomethylating agent
5142792|NCT01041833|All-trans retinoic acid|all-trans retinoic acid
5142793|NCT01041833|non-small cell lung cancer|non-small cell lung cancer
5142794|NCT01041833|retinoic acid receptor beta|retinoic acid receptor beta
5142795|NCT01041820|exercise|exercise
5142796|NCT01041820|bone marrow adipose tissue|bone marrow adipose tissue
5142797|NCT01041820|bone mineral density|bone mineral density
5142798|NCT01041820|Children in the intervention condition will complete a supervised physical activity program 3 days/wk for 10 weeks|children in the intervention condition will complete a supervised physical activity program 3 days/wk for 10 weeks
5142799|NCT01041820|Control treatment will be provided no intervention|control treatment will be provided no intervention
5142800|NCT01041820|All participants will be instructed not to change their current dietary habits during the study period.|all participants will be instructed not to change their current dietary habits during the study period.
5142801|NCT01041807|Hypertension|hypertension
5142802|NCT01041794|body composition|body composition
5142803|NCT01041794|fat distribution|fat distribution
5142804|NCT01041794|exercise|exercise
5142805|NCT01041794|diet|diet
5142806|NCT01041781|adenocarcinoma of the lung|adenocarcinoma of the lung
5142807|NCT01041781|adenosquamous cell lung cancer|adenosquamous cell lung cancer
5142808|NCT01041781|large cell lung cancer|large cell lung cancer
5142809|NCT01041781|squamous cell lung cancer|squamous cell lung cancer
5142810|NCT01041781|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5142811|NCT01041781|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5142812|NCT01041781|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5142813|NCT01041768|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
5142814|NCT01041755|Encephalopathy|encephalopathy
5142815|NCT01041755|Cirrhosis|cirrhosis
5142816|NCT01041716|Carbapenem|carbapenem
5142817|NCT01041716|Klebsiella pneumoniae carbapenemase|klebsiella pneumoniae carbapenemase
5142818|NCT01041716|Acinetobacter baumannii|acinetobacter baumannii
5142819|NCT01041716|Pseudomonas aeruginosa|pseudomonas aeruginosa
5142820|NCT01041690|Proliferative Diabetic Retinopathy|proliferative diabetic retinopathy
5142821|NCT01041690|Vitrectomy|vitrectomy
5142822|NCT01041690|Bevacizumab|bevacizumab
5142823|NCT01041677|Obesity|obesity
5142824|NCT01041677|Overweight|overweight
5142825|NCT01041677|Body Weight|body weight
5142826|NCT01041677|Body Size|body size
5142827|NCT01041677|Nutritional and Metabolic Diseases|nutritional and metabolic diseases
5142828|NCT01041664|nutrigenomics|nutrigenomics
5142829|NCT01041664|admixture|admixture
5142830|NCT01041664|Hispanic American|hispanic american
5142831|NCT01041664|body composition|body composition
5142832|NCT01041664|Association of diet and body composition|association of diet and body composition
5142833|NCT01041664|Association between genes and body composition|association between genes and body composition
5142834|NCT01041664|Association between gen by diet interaction and body composition|association between gen by diet interaction and body composition
5142835|NCT01041625|Lichen Planus|lichen planus
5142836|NCT01041612|CBD|cbd
5142837|NCT01041612|HBD|hbd
5142838|NCT01041612|cancer of bile duct|cancer of bile duct
5142839|NCT01041612|pancreatic cancer|pancreatic cancer
5142840|NCT01041599|Diabetes Mellitus|diabetes mellitus
5142841|NCT01041599|Hypertension|hypertension
5142842|NCT01041599|Albuminuria|albuminuria
5142843|NCT01041599|vascular stiffness|vascular stiffness
5142844|NCT01041586|Emphysema|emphysema
5142845|NCT01041586|COPD|copd
5142846|NCT01041586|Lung Volume Reduction|lung volume reduction
5142847|NCT01041586|BTVA|btva
5142848|NCT01041573|Pediatric|pediatric
5142849|NCT01041573|Japanese Encephalitis Vaccine|japanese encephalitis vaccine
5142850|NCT01041573|endemic countries|endemic countries
5142851|NCT01041573|to assess the systemic and local safety profile of purified inactivated Japanese Encephalitis Virus (JEV) vaccine IC51|to assess the systemic and local safety profile of purified inactivated japanese encephalitis virus (jev) vaccine ic51
5142852|NCT01041560|Stroke|stroke
5142853|NCT01041560|Tone|tone
5142854|NCT01041560|Strength|strength
5142855|NCT01041547|Insulin sensitivity|insulin sensitivity
5142856|NCT01041547|Vascular function|vascular function
5142857|NCT01041547|Flow-mediated dilation|flow-mediated dilation
5142858|NCT01041547|Arterial stiffness|arterial stiffness
5142859|NCT01041547|Glucose tolerance|glucose tolerance
5142860|NCT01041547|Hypertension|hypertension
5142861|NCT01041534|Adjustable gastric band, morbid obesity, bariatric surgery|adjustable gastric band, morbid obesity, bariatric surgery
5142862|NCT01041521|HIV infection|hiv infection
5142863|NCT01041521|Dyslipidemia|dyslipidemia
5142864|NCT01041521|Elevated Triglyceride level|elevated triglyceride level
5142865|NCT01041521|vascular function (BART)|vascular function (bart)
5142866|NCT01041521|arterial stiffness|arterial stiffness
5142867|NCT01041521|omega three fatty acids|omega three fatty acids
5142868|NCT01041521|complementary therapies|complementary therapies
5142869|NCT01041508|ALL|all
5142870|NCT01041508|AML|aml
5142871|NCT01041508|Recurrence|recurrence
5142872|NCT01041508|Relapsed|relapsed
5142873|NCT01041508|Stem Cell Transplant|stem cell transplant
5142874|NCT01041508|Non-myeloablastive|non-myeloablastive
5142875|NCT01041495|fibromyalgia|fibromyalgia
5142876|NCT01041495|Pain|pain
5142877|NCT01041495|Sleep|sleep
5142878|NCT01041495|Fatigue|fatigue
5142879|NCT01041482|sorafenib|sorafenib
5142880|NCT01041482|renal cell carcinoma|renal cell carcinoma
5142881|NCT01041482|disease free survival|disease free survival
5142882|NCT01041482|Hand food skin reaction|hand food skin reaction
5142883|NCT01041469|Down syndrome, Humans,Clinical study,Immunity, Autoimmunity,|down syndrome, humans,clinical study,immunity, autoimmunity,
5142884|NCT01041456|complicated biliopancreatic diversion|complicated biliopancreatic diversion
5142885|NCT01041456|failed biliopancreatic diversion|failed biliopancreatic diversion
5142886|NCT01041456|revision gastric bypass|revision gastric bypass
5142887|NCT01041456|conversion bariatric surgery|conversion bariatric surgery
5142888|NCT01041456|revision bariatric surgery|revision bariatric surgery
5142889|NCT01041456|re-operative bariatric surgery|re-operative bariatric surgery
5142890|NCT01041456|malabsorptive syndrome|malabsorptive syndrome
5142891|NCT01041456|protein malnutrition|protein malnutrition
5142892|NCT01041456|metabolic bone disease|metabolic bone disease
5142893|NCT01041430|Ambulatory Surgery|ambulatory surgery
5142894|NCT01041430|Aged|aged
5142895|NCT01041417|claudication|claudication
5142896|NCT01041391|Surgical intervention vs Non-Surgical intervention|surgical intervention vs non-surgical intervention
5142897|NCT01041378|Pediatric patients (6 months-5 years) scheduled elective day-case orchiopexy|pediatric patients (6 months-5 years) scheduled elective day-case orchiopexy
5142898|NCT01041365|insulin sensitivity|insulin sensitivity
5142899|NCT01041365|vascular function|vascular function
5142900|NCT01041365|flow-mediated dilation|flow-mediated dilation
5142901|NCT01041365|arterial stiffness|arterial stiffness
5142902|NCT01041365|ethnicity|ethnicity
5142903|NCT01041365|adolescents|adolescents
5142904|NCT01041365|females|females
5142905|NCT01041365|glucose tolerance|glucose tolerance
5142906|NCT01041365|diabetes|diabetes
5142907|NCT01041365|hypertension|hypertension
5142908|NCT01041365|cardiovascular|cardiovascular
5142909|NCT01041352|anaesthesia|anaesthesia
5142910|NCT01041352|laryngeal mask|laryngeal mask
5142911|NCT01041352|prone position|prone position
5142912|NCT01041339|LpPLA2|lppla2
5142913|NCT01041339|ST elevation|st elevation
5142914|NCT01041339|acute pericarditis|acute pericarditis
5142915|NCT01041326|prostatectomy|prostatectomy
5142916|NCT01041326|radiation|radiation
5142917|NCT01041326|neoadjuvant|neoadjuvant
5142918|NCT01041313|Adjuvants, pharmaceuticals|adjuvants, pharmaceuticals
5142919|NCT01041313|Receptors, N-Methyl-D-Aspartate|receptors, n-methyl-d-aspartate
5142920|NCT01041313|Drug tolerance|drug tolerance
5142921|NCT01041313|Pain Measurement|pain measurement
5142922|NCT01041300|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
5142923|NCT01041300|TMS|tms
5142924|NCT01041300|Motor Threashold|motor threashold
5142925|NCT01041300|Multiway|multiway
5142926|NCT01041300|Magstim Rapid 2|magstim rapid 2
5142927|NCT01041300|Abductor policis brevis|abductor policis brevis
5142928|NCT01041300|Figure 8 coil|figure 8 coil
5142929|NCT01041300|Double cone coil|double cone coil
5142930|NCT01041300|Circular coil|circular coil
5142931|NCT01041300|Brainsway|brainsway
5142932|NCT01041300|Healthy participants.|healthy participants.
5142933|NCT01041274|Schizophrenia|schizophrenia
5142934|NCT01041274|Citalopram|citalopram
5142935|NCT01041274|First episode|first episode
5142936|NCT01041274|fMRI|fmri
5142937|NCT01041274|Cognitive behavioral therapy|cognitive behavioral therapy
5142938|NCT01041274|Psychoeducation|psychoeducation
5142939|NCT01041261|Laparoscopic gastric bypass surgery|laparoscopic gastric bypass surgery
5142940|NCT01041261|Medical food|medical food
5142941|NCT01041261|Body composition|body composition
5142942|NCT01041261|Dietary intervention|dietary intervention
5142943|NCT01041248|Relapsing Polychondritis|relapsing polychondritis
5142944|NCT01041248|Single Patient Study|single patient study
5142945|NCT01041248|Tocilizumab|tocilizumab
5142946|NCT01041235|Solid Neoplasms|solid neoplasms
5142947|NCT01041235|Carcinoma|carcinoma
5142949|NCT01041235|Ovarian|ovarian
5142950|NCT01041235|Ovary|ovary
5142951|NCT01041235|Pancreas|pancreas
5142952|NCT01041235|Pancreatic|pancreatic
5142953|NCT01041235|Lung|lung
5142954|NCT01041235|NSCLC|nsclc
5142955|NCT01041235|Non Small Cell Lung|non small cell lung
5142956|NCT01041235|Prostate|prostate
5142957|NCT01041235|Gastric|gastric
5142958|NCT01041235|Head and Neck|head and neck
5142959|NCT01041222|Familial ALS|familial als
5142960|NCT01041222|ALS|als
5142961|NCT01041222|SOD1 Protein|sod1 protein
5142962|NCT01041222|ISIS 333611|isis 333611
5142963|NCT01041222|SOD1Rx|sod1rx
5142964|NCT01041209|Pneumonia|pneumonia
5142965|NCT01041209|Children|children
5142966|NCT01041196|obesity|obesity
5142967|NCT01041196|ulcer disease|ulcer disease
5142968|NCT01041196|marginal ulcer|marginal ulcer
5142969|NCT01041196|perforation|perforation
5142970|NCT01041196|abdominal pain|abdominal pain
5142971|NCT01041196|bariatric surgery|bariatric surgery
5142972|NCT01041196|weight loss surgery|weight loss surgery
5142973|NCT01041183|Oral plus IV ramosetron may be more effective than|oral plus iv ramosetron may be more effective than
5142974|NCT01041183|IV ramosetron and oral ramosetron for the prophylaxis of|iv ramosetron and oral ramosetron for the prophylaxis of
5142975|NCT01041183|PONV after laparoscopic cholecystectomy|ponv after laparoscopic cholecystectomy
5142976|NCT01041170|Rimonabant|rimonabant
5142977|NCT01041170|fMRI|fmri
5142978|NCT01041170|Alternative Matrices|alternative matrices
5142979|NCT01041170|Brain Imaging|brain imaging
5142980|NCT01041170|THC|thc
5142981|NCT01041157|Torticollis|torticollis
5142982|NCT01041157|Botulinum Toxins|botulinum toxins
5142983|NCT01041144|Diabetes|diabetes
5142984|NCT01041144|PDA|pda
5142985|NCT01041144|Internet|internet
5142986|NCT01041144|HbA1c|hba1c
5142987|NCT01041131|Obesity|obesity
5142988|NCT01041131|Obesity recidivism|obesity recidivism
5142989|NCT01041131|Inadequate Initial Weight Loss|inadequate initial weight loss
5142990|NCT01041131|Technical bariatric complications|technical bariatric complications
5142991|NCT01041131|Complicated gastroplasty|complicated gastroplasty
5142992|NCT01041131|Failed gastroplasty|failed gastroplasty
5142993|NCT01041131|Gastroesophageal reflux disease|gastroesophageal reflux disease
5142994|NCT01041131|Revisional gastric bypass|revisional gastric bypass
5142995|NCT01041131|Conversion bariatric surgery|conversion bariatric surgery
5142996|NCT01041131|Re-operative bariatric surgery|re-operative bariatric surgery
5142997|NCT01041131|Technical complications of vertical gastroplasty|technical complications of vertical gastroplasty
5142998|NCT01041131|Complicated vertical gastroplasty|complicated vertical gastroplasty
5142999|NCT01041105|Obesity|obesity
5143000|NCT01041105|Gastroesophageal Reflux Disease|gastroesophageal reflux disease
5143001|NCT01041105|Nissen funduplication|nissen funduplication
5143002|NCT01041105|Antireflux surgery|antireflux surgery
5143003|NCT01041105|Revisional Gastric Bypass|revisional gastric bypass
5143004|NCT01041105|Re-operative bariatric surgery|re-operative bariatric surgery
5143005|NCT01041105|Bariatric surgery|bariatric surgery
5143006|NCT01041105|Nissen|nissen
5143007|NCT01041105|Conversion of Nissen to Gastric Bypass|conversion of nissen to gastric bypass
5143008|NCT01041079|ulcer disease|ulcer disease
5143009|NCT01041079|marginal ulcer|marginal ulcer
5143010|NCT01041079|morbidity of gastric bypass|morbidity of gastric bypass
5143011|NCT01041079|late morbidity of gastric bypass|late morbidity of gastric bypass
5143012|NCT01041079|chronic abdominal pain|chronic abdominal pain
5143013|NCT01041079|GI hemorrhage|gi hemorrhage
5143014|NCT01041079|Perforation|perforation
5143015|NCT01041079|Penetration|penetration
5143016|NCT01041079|Obstruction|obstruction
5143017|NCT01041066|patients who are intubated for general anesthesia|patients who are intubated for general anesthesia
5143018|NCT01041040|Acute Myeloblastic Leukemia|acute myeloblastic leukemia
5143019|NCT01041014|Limited English proficiency|limited english proficiency
5143020|NCT01041014|Cost-effectiveness|cost-effectiveness
5143021|NCT01041014|Emergency Departments|emergency departments
5143022|NCT01041014|Language Discordance|language discordance
5143023|NCT01041014|Satisfaction|satisfaction
5143024|NCT01041014|Limited English proficient patients|limited english proficient patients
5143025|NCT01041014|Spanish-speaking patients|spanish-speaking patients
5143026|NCT01041001|Umbilical Cord Blood|umbilical cord blood
5143027|NCT01041001|Mesenchymal Stem Cells|mesenchymal stem cells
5143028|NCT01041001|cartilage injury|cartilage injury
5143029|NCT01041001|osteoarthritis|osteoarthritis
5143030|NCT01040988|Pacemaker|pacemaker
5143031|NCT01040988|Implantable cardioverter-defibrillator|implantable cardioverter-defibrillator
5143032|NCT01040962|neuropathy|neuropathy
5143033|NCT01040962|diabetes|diabetes
5143034|NCT01040949|smoking cessation|smoking cessation
5143035|NCT01040949|pregnant Latinas|pregnant latinas
5143036|NCT01040949|couples communication|couples communication
5143037|NCT01040949|Latino community|latino community
5143038|NCT01040949|couples communication in Latino couples|couples communication in latino couples
5143039|NCT01040936|acute coronary syndrome|acute coronary syndrome
5143040|NCT01040936|intervention|intervention
5143042|NCT01040936|patients diagnosed ad Non-ST elevation ACS|patients diagnosed ad non-st elevation acs
5143043|NCT01040936|patients received PCI therapy|patients received pci therapy
5143044|NCT01040923|CAD|cad
5143045|NCT01040923|Diagnostic|diagnostic
5143046|NCT01040910|cannabis|cannabis
5143047|NCT01040910|Crohn's disease|crohn's disease
5143048|NCT01040910|Ulcerative colitis|ulcerative colitis
5143049|NCT01040910|IBD|ibd
5143050|NCT01040897|Obesity prevention|obesity prevention
5143051|NCT01040897|Health Literacy|health literacy
5143052|NCT01040897|Health Communication|health communication
5143053|NCT01040858|cognitive strategy intervention|cognitive strategy intervention
5143054|NCT01040858|cognitive disorders|cognitive disorders
5143055|NCT01040845|healthy|healthy
5143056|NCT01040845|pharmacokinetics|pharmacokinetics
5143057|NCT01040845|drug-interaction|drug-interaction
5143058|NCT01040832|Head and Neck Cancer|head and neck cancer
5143059|NCT01040832|Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck Cancer|recurrent or metastatic squamous cell carcinoma of the head and neck cancer
5143060|NCT01040832|Cetuximab|cetuximab
5143061|NCT01040832|EMD 1201081|emd 1201081
5143062|NCT01040819|Diabetes Mellitus|diabetes mellitus
5143063|NCT01040819|6-Ketoprostaglandin F1 alpha|6-ketoprostaglandin f1 alpha
5143064|NCT01040819|15-epi-lipoxin A4|15-epi-lipoxin a4
5143065|NCT01040819|Thiazolidinediones|thiazolidinediones
5143066|NCT01040819|Pioglitazone|pioglitazone
5143067|NCT01040806|Diabetes|diabetes
5143068|NCT01040780|Efficacy|efficacy
5143069|NCT01040780|Safety|safety
5143070|NCT01040780|EGFR-TKI|egfr-tki
5143071|NCT01040780|phase III|phase iii
5143072|NCT01040780|NSCLC|nsclc
5143073|NCT01040767|Ultrasound education|ultrasound education
5143074|NCT01040767|Blended learning|blended learning
5143075|NCT01040767|Distance education|distance education
5143076|NCT01040767|Trauma ultrasound|trauma ultrasound
5143077|NCT01040767|FAST|fast
5143078|NCT01040741|Pandemic influenza A (H1N1) vaccine|pandemic influenza a (h1n1) vaccine
5143079|NCT01040741|Adjuvanted|adjuvanted
5143080|NCT01040715|Rheumatoid arthritis|rheumatoid arthritis
5143081|NCT01040715|anti-drug antibodies|anti-drug antibodies
5143082|NCT01040715|Rheumatoid arthritis with secondary loss of efficacy to anti-TNFa antagonists and anti-drug antibodies|rheumatoid arthritis with secondary loss of efficacy to anti-tnfa antagonists and anti-drug antibodies
5143083|NCT01040676|Diabetes Mellitus|diabetes mellitus
5143084|NCT01040676|Telephone|telephone
5143085|NCT01040676|Nutrition Support|nutrition support
5143086|NCT01040676|Automated|automated
5143087|NCT01040676|Low English Proficiency|low english proficiency
5143088|NCT01040676|Hispanic|hispanic
5143089|NCT01040676|Latino|latino
5143090|NCT01040637|Healthy subjects|healthy subjects
5143091|NCT01040624|Prostate Cancer, Proton Radiation|prostate cancer, proton radiation
5143092|NCT01040611|music therapy|music therapy
5143093|NCT01040611|Tuberculosis|tuberculosis
5143094|NCT01040611|anxiety|anxiety
5143095|NCT01040611|physiological response|physiological response
5143096|NCT01040598|Eosinophilic Esophagitis|eosinophilic esophagitis
5143097|NCT01040598|Xolair|xolair
5143098|NCT01040598|Omalizumab|omalizumab
5143099|NCT01040598|Esophagitis|esophagitis
5143100|NCT01040598|Eosinophils|eosinophils
5143101|NCT01040598|monoclonal antibody|monoclonal antibody
5143102|NCT01040585|cost effectiveness|cost effectiveness
5143103|NCT01040585|linezolid|linezolid
5143104|NCT01040585|ventilator acquired pneumonia|ventilator acquired pneumonia
5143105|NCT01040585|central america|central america
5143106|NCT01040572|Obesity recidivism|obesity recidivism
5143107|NCT01040572|Weight Regain|weight regain
5143108|NCT01040572|Weight recidivism|weight recidivism
5143109|NCT01040572|Morbidity|morbidity
5143110|NCT01040572|Complication|complication
5143111|NCT01040572|Late complications|late complications
5143112|NCT01040572|Revisional gastric bypass|revisional gastric bypass
5143113|NCT01040572|Re-operative gastric bypass|re-operative gastric bypass
5143114|NCT01040572|Revisional bariatric surgery|revisional bariatric surgery
5143115|NCT01040572|Re-operative bariatric surgery|re-operative bariatric surgery
5143116|NCT01040546|Obesity|obesity
5143117|NCT01040546|Metabolic syndrome|metabolic syndrome
5143118|NCT01040546|Weight control educational intervention|weight control educational intervention
5143119|NCT01040546|Food intake|food intake
5143120|NCT01040533|Failed jejunoileal bypass|failed jejunoileal bypass
5143121|NCT01040533|Complicated jejunoileal bypass|complicated jejunoileal bypass
5143122|NCT01040533|Revision gastric bypass|revision gastric bypass
5143123|NCT01040533|Revisional surgery|revisional surgery
5143124|NCT01040533|Reoperations|reoperations
5143125|NCT01040533|Metabolic and nutritional complications|metabolic and nutritional complications
5143126|NCT01040520|CT-based autopsy|ct-based autopsy
5143127|NCT01040520|virtual autopsy|virtual autopsy
5143128|NCT01040520|medical autopsy|medical autopsy
5143129|NCT01040520|quality control|quality control
5143130|NCT01040507|severe obesity|severe obesity
5143131|NCT01040507|morbid obesity|morbid obesity
5143132|NCT01040507|gastric bypass|gastric bypass
5143133|NCT01040507|efficacy of gastric bypass|efficacy of gastric bypass
5143134|NCT01040494|Aliskiren|aliskiren
5143135|NCT01040494|Congestive heart failure|congestive heart failure
5143136|NCT01040494|Central hemodynamics|central hemodynamics
5143137|NCT01040481|Failed gastric bypass|failed gastric bypass
5143138|NCT01040481|Malabsorptive distal gastric bypass|malabsorptive distal gastric bypass
5143139|NCT01040481|Distal gastric bypass|distal gastric bypass
5143140|NCT01040481|Malabsorptive gastric bypass|malabsorptive gastric bypass
5143141|NCT01040481|Adding malabsorption|adding malabsorption
5143142|NCT01040481|Increasing malabsorption|increasing malabsorption
5143143|NCT01040481|Re-operative bariatric surgery|re-operative bariatric surgery
5143144|NCT01040481|Revisional bariatric surgery|revisional bariatric surgery
5143145|NCT01040481|Revisional gastric bypass|revisional gastric bypass
5143146|NCT01040481|Reoperations|reoperations
5143147|NCT01040481|Conversions|conversions
5143148|NCT01040468|Type 2 Diabetes|type 2 diabetes
5143149|NCT01040468|Bariatric Surgery|bariatric surgery
5143150|NCT01040468|Roux-en-Y Gastric Bypass|roux-en-y gastric bypass
5143151|NCT01040468|Gastric Banding|gastric banding
5143152|NCT01040468|Obesity|obesity
5143153|NCT01040468|Weight loss|weight loss
5143154|NCT01040468|Insulin sensitivity|insulin sensitivity
5143155|NCT01040468|GLP-1|glp-1
5143156|NCT01040468|Meal Challenge|meal challenge
5143157|NCT01040468|Euglycemic Clamp|euglycemic clamp
5143158|NCT01040455|functional dyspepsia|functional dyspepsia
5143159|NCT01040455|lansoprazole|lansoprazole
5143160|NCT01040455|placebo effect|placebo effect
5143161|NCT01040442|Postural Balance|postural balance
5143162|NCT01040442|Aging|aging
5143163|NCT01040442|Accidental Falls|accidental falls
5143164|NCT01040442|Vibration|vibration
5143165|NCT01040429|Adolescent|adolescent
5143166|NCT01040429|Clonidine|clonidine
5143167|NCT01040429|Autonomic nervous system|autonomic nervous system
5143168|NCT01040429|Stress|stress
5143169|NCT01040416|complicated marginal ulcer|complicated marginal ulcer
5143170|NCT01040416|complex marginal ulcer|complex marginal ulcer
5143171|NCT01040416|complication after gastric bypass|complication after gastric bypass
5143172|NCT01040416|gastrointestinal hemorrhage|gastrointestinal hemorrhage
5143173|NCT01040390|Acne Vulgaris|acne vulgaris
5143174|NCT01040390|Homoeopathy|homoeopathy
5143175|NCT01040390|Lappa Arctium|lappa arctium
5143176|NCT01040377|Inadequate Initial Weight Loss|inadequate initial weight loss
5143177|NCT01040377|Inadequate weight loss|inadequate weight loss
5143178|NCT01040377|Poor weight loss|poor weight loss
5143179|NCT01040377|Failed gastric bypass|failed gastric bypass
5143180|NCT01040377|Revision gastric bypass|revision gastric bypass
5143181|NCT01040364|Internal hernia|internal hernia
5143182|NCT01040364|Mesocolic hernia|mesocolic hernia
5143183|NCT01040364|Petersen´s hernia|petersen´s hernia
5143184|NCT01040364|Jejunojejunostomy hernia|jejunojejunostomy hernia
5143185|NCT01040364|Bowel obstruction|bowel obstruction
5143186|NCT01040364|Ischemic bowel|ischemic bowel
5143187|NCT01040364|Complication after gastric bypass|complication after gastric bypass
5143188|NCT01040364|Re-operative bariatric surgery|re-operative bariatric surgery
5143189|NCT01040364|Chronic pain after gastric bypass|chronic pain after gastric bypass
5143190|NCT01040351|Infertility|infertility
5143191|NCT01040351|Hydrosalpinx|hydrosalpinx
5143192|NCT01040351|IVF-ET|ivf-et
5143193|NCT01040338|Smoking|smoking
5143194|NCT01040338|Tobacco|tobacco
5143195|NCT01040338|Nicotine|nicotine
5143196|NCT01040338|Dependence|dependence
5143197|NCT01040338|Genetics|genetics
5143198|NCT01040312|UGT1A1, irinotecan|ugt1a1, irinotecan
5143199|NCT01040299|GangTrainer|gangtrainer
5143200|NCT01040299|Gait Rehabilitation|gait rehabilitation
5143201|NCT01040299|Cerebrovascular Disorders|cerebrovascular disorders
5143202|NCT01040299|Robot assisted|robot assisted
5143203|NCT01040299|Transcranial direct current stimulation|transcranial direct current stimulation
5143204|NCT01040286|Subjects, age>21, with Chronic periodontal disease on natural teeth characterized by the presence of at least 2 teeth with periodontal|subjects, age>21, with chronic periodontal disease on natural teeth characterized by the presence of at least 2 teeth with periodontal
5143205|NCT01040286|pockets of 5-9 mm in depth demonstrating bleeding on probing without involving the|pockets of 5-9 mm in depth demonstrating bleeding on probing without involving the
5143206|NCT01040286|apex of the tooth and confirmed by dental X-ray.|apex of the tooth and confirmed by dental x-ray.
5143207|NCT01040260|tobacco use disorder|tobacco use disorder
5143208|NCT01040247|Infertility|infertility
5143209|NCT01040247|Low Responder|low responder
5143210|NCT01040247|IVF|ivf
5143211|NCT01040247|Embryo Transfer|embryo transfer
5143212|NCT01040234|postoperative pain|postoperative pain
5143213|NCT01040234|abdominal surgery|abdominal surgery
5143214|NCT01040234|bilateral dual TAP block|bilateral dual tap block
5143215|NCT01040221|Autism, Autism Spectrum Disorder|autism, autism spectrum disorder
5143216|NCT01040221|ASD|asd
5143217|NCT01040221|Trichuris Suis Ova|trichuris suis ova
5143218|NCT01040221|TSO|tso
5143219|NCT01040221|Treatment|treatment
5143220|NCT01040221|Clinical Trial|clinical trial
5143221|NCT01040195|ankylosing spondylitis|ankylosing spondylitis
5143222|NCT01040195|undifferentiated spondyloarthropathy|undifferentiated spondyloarthropathy
5143223|NCT01040195|spondyloarthropathy|spondyloarthropathy
5143224|NCT01040195|inflammatory back pain|inflammatory back pain
5143225|NCT01040195|methotrexate|methotrexate
5143226|NCT01040195|sulfasalazine|sulfasalazine
5143227|NCT01040195|hydroxychloroquine|hydroxychloroquine
5143228|NCT01040182|ischemic stroke patients|ischemic stroke patients
5143230|NCT01040143|Streptococcus pneumoniae|streptococcus pneumoniae
5143231|NCT01040117|Equilibrium|equilibrium
5143232|NCT01040117|Rehabilitation|rehabilitation
5143233|NCT01040117|Randomized Controlled Trial|randomized controlled trial
5143234|NCT01040117|Postural instability|postural instability
5143235|NCT01040117|Sensory-motor integration|sensory-motor integration
5143236|NCT01040104|wound healing|wound healing
5143237|NCT01040104|hypertrophic scar|hypertrophic scar
5143238|NCT01040104|skin transplantation|skin transplantation
5143239|NCT01040104|diabetes mellitus|diabetes mellitus
5143240|NCT01040091|HIV Seronegativity|hiv seronegativity
5143241|NCT01040091|Treatment Experienced|treatment experienced
5143242|NCT01040065|Acromioclavicular joint arthritis|acromioclavicular joint arthritis
5143243|NCT01040065|distal clavicle resection|distal clavicle resection
5143244|NCT01040065|Mumford procedure|mumford procedure
5143245|NCT01040052|Diphtheria|diphtheria
5143246|NCT01040052|Tetanus|tetanus
5143247|NCT01040052|Pertussis|pertussis
5143248|NCT01040052|Adacel®|adacel®
5143249|NCT01040039|HCV|hcv
5143250|NCT01040039|HIV|hiv
5143251|NCT01040013|LAPAROSCOPY,|laparoscopy,
5143252|NCT01040013|LAPAROTOMY,|laparotomy,
5143253|NCT01040013|OXYGENATION,|oxygenation,
5143254|NCT01040013|ISCHEMIA-REPERFUSION INJURY|ischemia-reperfusion injury
5143255|NCT01040000|NPC-1C|npc-1c
5143256|NCT01040000|Monoclonal antibody|monoclonal antibody
5143257|NCT01040000|Pancreatic Cancer|pancreatic cancer
5143258|NCT01040000|Adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
5143259|NCT01040000|Ductal carcinoma of the pancreas|ductal carcinoma of the pancreas
5143260|NCT01040000|Duct cell carcinomas, pancreas|duct cell carcinomas, pancreas
5143261|NCT01040000|Carcinomas, pancreas duct cell|carcinomas, pancreas duct cell
5143262|NCT01040000|Pancreas duct cell carcinoma|pancreas duct cell carcinoma
5143263|NCT01040000|Pancreatic duct cell carcinoma|pancreatic duct cell carcinoma
5143264|NCT01040000|Adenocarcinoma of the colon|adenocarcinoma of the colon
5143265|NCT01040000|Adenocarcinoma of the rectum|adenocarcinoma of the rectum
5143266|NCT01040000|Colorectal cancer|colorectal cancer
5143267|NCT01040000|Colorectal tumor|colorectal tumor
5143268|NCT01040000|Colorectal neoplasm|colorectal neoplasm
5143269|NCT01039987|Autosomal dominant polycystic kidney disease|autosomal dominant polycystic kidney disease
5143270|NCT01039987|ADPKD|adpkd
5143271|NCT01039987|kidney|kidney
5143272|NCT01039987|Biomarker|biomarker
5143273|NCT01039987|MRI|mri
5143274|NCT01039974|ketoconazole|ketoconazole
5143275|NCT01039974|GSK962040|gsk962040
5143276|NCT01039974|Drug-Drug Interaction|drug-drug interaction
5143277|NCT01039974|Phase I|phase i
5143278|NCT01039961|healthy volunteers|healthy volunteers
5143279|NCT01039961|IV formulation study|iv formulation study
5143280|NCT01039948|Neoplasms|neoplasms
5143281|NCT01039948|Carcinoma|carcinoma
5143282|NCT01039948|Carcinoma, Non-Small-Cell Lung|carcinoma, non-small-cell lung
5143283|NCT01039948|Lung Neoplasms|lung neoplasms
5143284|NCT01039948|Respiratory Tract Neoplasms|respiratory tract neoplasms
5143285|NCT01039948|Neoplasms, Glandular and Epithelial|neoplasms, glandular and epithelial
5143286|NCT01039948|Neoplasms by Histological Type|neoplasms by histological type
5143287|NCT01039948|Thoracic Neoplasms|thoracic neoplasms
5143288|NCT01039948|Neoplasms by Site|neoplasms by site
5143289|NCT01039948|Lung Diseases|lung diseases
5143290|NCT01039948|Respiratory Tract Diseases|respiratory tract diseases
5143291|NCT01039948|Gefitinib|gefitinib
5143292|NCT01039948|Antineoplastic Agents|antineoplastic agents
5143293|NCT01039948|Therapeutic Uses|therapeutic uses
5143294|NCT01039948|Pharmacologic Actions|pharmacologic actions
5143295|NCT01039948|Protein Kinase Inhibitors|protein kinase inhibitors
5143296|NCT01039948|Enzyme Inhibitors|enzyme inhibitors
5143297|NCT01039948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
5143298|NCT01039935|Odor Discrimination|odor discrimination
5143299|NCT01039922|Neuroendocrine Tumors|neuroendocrine tumors
5143300|NCT01039922|Registries|registries
5143301|NCT01039883|Healthy Volunteers|healthy volunteers
5143302|NCT01039870|postthoracotomy pain|postthoracotomy pain
5143303|NCT01039857|Psychotherapy|psychotherapy
5143304|NCT01039857|Depression|depression
5143305|NCT01039857|Adjustment Disorders|adjustment disorders
5143306|NCT01039857|Neuropsychology|neuropsychology
5143307|NCT01039857|Rehabilitation|rehabilitation
5143308|NCT01039857|Coping Skills|coping skills
5143309|NCT01039857|Stroke|stroke
5143310|NCT01039857|Caregivers|caregivers
5143311|NCT01039844|LOC-paclitaxel Injection|loc-paclitaxel injection
5143312|NCT01039844|metastatic Melanoma|metastatic melanoma
5143313|NCT01039831|PIGD|pigd
5143314|NCT01039831|tremor|tremor
5143315|NCT01039831|falls|falls
5143316|NCT01039831|white matter|white matter
5143317|NCT01039818|Graves Disease|graves disease
5143318|NCT01039818|Hyperthyroidism|hyperthyroidism
5143319|NCT01039818|Radioiodine|radioiodine
5143320|NCT01039818|Clinical trial|clinical trial
5143321|NCT01039805|GSK962040|gsk962040
5143322|NCT01039805|13C octanoic acid breath test|13c octanoic acid breath test
5143323|NCT01039805|pharmacokinetics|pharmacokinetics
5143324|NCT01039805|critically ill patients|critically ill patients
5143325|NCT01039805|gut motility|gut motility
5143326|NCT01039805|pharmacodynamics|pharmacodynamics
5143327|NCT01039805|tolerability|tolerability
5143328|NCT01039805|single dose|single dose
5143329|NCT01039805|gastric emtpying|gastric emtpying
5143330|NCT01039792|Autism|autism
5143331|NCT01039792|Pervasive Developmental Disorders|pervasive developmental disorders
5143332|NCT01039779|older fallers|older fallers
5143333|NCT01039779|tai chi|tai chi
5143334|NCT01039766|post traumatic stress disorder|post traumatic stress disorder
5143335|NCT01039766|prevention|prevention
5143336|NCT01039766|oxytocin|oxytocin
5143337|NCT01039753|acute kidney injury|acute kidney injury
5143338|NCT01039753|renal replacement therapy|renal replacement therapy
5143339|NCT01039753|biomarkers|biomarkers
5143340|NCT01039740|Pharmacogenomics|pharmacogenomics
5143341|NCT01039740|Prediction of Mirtazapine response|prediction of mirtazapine response
5143342|NCT01039740|Depressed patients|depressed patients
5143343|NCT01039740|Mirtazapine response|mirtazapine response
5143344|NCT01039740|Adverse event|adverse event
5143345|NCT01039727|Pain [C10.597.617]|pain [c10.597.617]
5143346|NCT01039714|Hypocalcemia|hypocalcemia
5143347|NCT01039714|Hypoparathyroidism|hypoparathyroidism
5143348|NCT01039714|Vitamin D deficiency|vitamin d deficiency
5143349|NCT01039714|Total thyroidectomy|total thyroidectomy
5143350|NCT01039714|calcium|calcium
5143351|NCT01039714|PTH|pth
5143352|NCT01039701|safety|safety
5143353|NCT01039701|tolerability|tolerability
5143354|NCT01039701|mild to moderate Alzheimer's disease|mild to moderate alzheimer's disease
5143355|NCT01039701|To determine the safety and tolerability of AZD1446 vs Placebo given as an add-on treatment to Donepezil in patients with mild to moderate Alzheimer's disease|to determine the safety and tolerability of azd1446 vs placebo given as an add-on treatment to donepezil in patients with mild to moderate alzheimer's disease
5143356|NCT01039688|oral JAK inhibitor|oral jak inhibitor
5143357|NCT01039688|MTX|mtx
5143358|NCT01039688|DMARD|dmard
5143359|NCT01039688|clinical trial|clinical trial
5143360|NCT01039688|joint diseases|joint diseases
5143361|NCT01039688|autoimmune diseases|autoimmune diseases
5143362|NCT01039688|anti-Inflammatory agents|anti-inflammatory agents
5143363|NCT01039688|rheumatic diseases|rheumatic diseases
5143364|NCT01039675|long-acting beta2-receptor agonist|long-acting beta2-receptor agonist
5143365|NCT01039675|Safety and tolerability|safety and tolerability
5143366|NCT01039675|pharmacodynamics|pharmacodynamics
5143367|NCT01039675|pharmacokinetics|pharmacokinetics
5143368|NCT01039675|long-acting muscarinic receptor antagonist|long-acting muscarinic receptor antagonist
5143369|NCT01039675|COPD|copd
5143370|NCT01039649|radiation|radiation
5143371|NCT01039649|Tomography, Spiral Computed|tomography, spiral computed
5143372|NCT01039649|Four-Dimensional Computed Tomography|four-dimensional computed tomography
5143373|NCT01039649|Respiratory Function Tests|respiratory function tests
5143374|NCT01039636|Beta-thalassemia|beta-thalassemia
5143375|NCT01039636|Sickle cell anemia|sickle cell anemia
5143376|NCT01039636|Transfusional iron overload|transfusional iron overload
5143377|NCT01039636|Iron overload|iron overload
5143378|NCT01039636|Iron chelation|iron chelation
5143379|NCT01039623|Healthy volunteers|healthy volunteers
5143380|NCT01039610|single dose|single dose
5143381|NCT01039610|pharmacokinetics|pharmacokinetics
5143382|NCT01039610|GSK945237|gsk945237
5143383|NCT01039610|tolerability|tolerability
5143384|NCT01039610|safety|safety
5143385|NCT01039610|antibiotics|antibiotics
5143386|NCT01039610|linezolid|linezolid
5143387|NCT01039610|QTc|qtc
5143388|NCT01039610|bacterial type II topoisomerase Inhibitors (BTI)|bacterial type ii topoisomerase inhibitors (bti)
5143389|NCT01039610|moxifloxacin|moxifloxacin
5143390|NCT01039610|repeat dose|repeat dose
5143391|NCT01039597|IBD|ibd
5143392|NCT01039597|Ulcerative colitis|ulcerative colitis
5143393|NCT01039584|bioequivalence|bioequivalence
5143394|NCT01039584|butoconazole|butoconazole
5143395|NCT01039584|vulvovaginal|vulvovaginal
5143396|NCT01039584|candidiasis|candidiasis
5143397|NCT01039571|rotator cuff tear|rotator cuff tear
5143398|NCT01039571|arthroscopic repair|arthroscopic repair
5143399|NCT01039571|single row repair|single row repair
5143400|NCT01039571|double row repair|double row repair
5143401|NCT01039571|retear rate|retear rate
5143402|NCT01039558|gastroesophageal reflux disease|gastroesophageal reflux disease
5143403|NCT01039558|lansoprazole|lansoprazole
5143404|NCT01039558|ecabet sodium|ecabet sodium
5143405|NCT01039545|Urinary tract infections|urinary tract infections
5143406|NCT01039545|Anti-bacterial agents|anti-bacterial agents
5143407|NCT01039532|Type 2 diabetes mellitus|type 2 diabetes mellitus
5143408|NCT01039532|Biphasic human insulin thrice a day|biphasic human insulin thrice a day
5143409|NCT01039532|Basal bolus insulin|basal bolus insulin
5143410|NCT01039519|G.I. Stromal Tumor|g.i. stromal tumor
5143411|NCT01039519|GIST|gist
5143412|NCT01039506|UGT1A1, irinotecan|ugt1a1, irinotecan
5143413|NCT01039480|pharmacological biomarker|pharmacological biomarker
5143414|NCT01039480|compliance monitoring|compliance monitoring
5143415|NCT01039480|platelet aggregometry|platelet aggregometry
5143416|NCT01039480|resistance|resistance
5143417|NCT01039480|Platelet Aggregation Inhibitors|platelet aggregation inhibitors
5143418|NCT01039480|Medication Non-Compliance|medication non-compliance
5143419|NCT01039467|Managed Ventricular Pacing|managed ventricular pacing
5143420|NCT01039454|Food Reward|food reward
5143422|NCT01039454|Obese|obese
5143423|NCT01039454|Cognition|cognition
5143424|NCT01039454|Food Addiction|food addiction
5143425|NCT01039454|Behaviour|behaviour
5143426|NCT01039454|Overweight|overweight
5143427|NCT01039454|Food Reinforcement|food reinforcement
5143428|NCT01039454|Metabolic endpoints|metabolic endpoints
5143429|NCT01039428|hyperphosphatemia|hyperphosphatemia
5143430|NCT01039428|hemodialysis|hemodialysis
5143431|NCT01039428|chitosan|chitosan
5143432|NCT01039415|marijuana|marijuana
5143433|NCT01039415|marijuana abuse|marijuana abuse
5143434|NCT01039415|marijuana dependence|marijuana dependence
5143435|NCT01039415|cannabis|cannabis
5143436|NCT01039415|substance-related disorder|substance-related disorder
5143437|NCT01039415|abstinence|abstinence
5143438|NCT01039402|cardiovascular risk|cardiovascular risk
5143440|NCT01039402|Observational, descriptive study|observational, descriptive study
5143441|NCT01039389|Coronary Artery Disease|coronary artery disease
5143442|NCT01039389|Stable|stable
5143443|NCT01039389|Coronary Collaterals|coronary collaterals
5143444|NCT01039389|Therapeutic Collateral Promotion|therapeutic collateral promotion
5143445|NCT01039389|Arteriogenesis|arteriogenesis
5143446|NCT01039389|Bradycardia|bradycardia
5143447|NCT01039376|maintenance therapy|maintenance therapy
5143448|NCT01039376|anti-CD20 monoclonal antibody|anti-cd20 monoclonal antibody
5143449|NCT01039376|ofatumumab|ofatumumab
5143450|NCT01039363|Relapse or refractory acute myeloid leukemia|relapse or refractory acute myeloid leukemia
5143451|NCT01039350|Myelodysplastic syndrome|myelodysplastic syndrome
5143452|NCT01039337|osteoarthritis|osteoarthritis
5143453|NCT01039337|manual therapy|manual therapy
5143454|NCT01039337|manipulation|manipulation
5143455|NCT01039337|hip school|hip school
5143456|NCT01039337|chiropractic|chiropractic
5143457|NCT01039337|patient education|patient education
5143458|NCT01039324|Complex patients|complex patients
5143459|NCT01039324|Care transitions|care transitions
5143460|NCT01039324|Patient safety|patient safety
5143461|NCT01039324|Patient care|patient care
5143462|NCT01039324|Health Information Technology|health information technology
5143463|NCT01039324|Health Information Exchange|health information exchange
5143464|NCT01039324|Clinical Decision Support|clinical decision support
5143465|NCT01039324|Care coordination|care coordination
5143466|NCT01039324|Data sharing|data sharing
5143467|NCT01039311|Lung|lung
5143468|NCT01039311|cancer|cancer
5143469|NCT01039311|bronchoscopy|bronchoscopy
5143470|NCT01039311|optical|optical
5143471|NCT01039311|coherence|coherence
5143472|NCT01039311|tomography|tomography
5143473|NCT01039298|Oral cancer|oral cancer
5143474|NCT01039298|fluorescence visualization|fluorescence visualization
5143475|NCT01039298|surgical margin|surgical margin
5143476|NCT01039298|recurrence|recurrence
5143477|NCT01039285|Very premature infant|very premature infant
5143478|NCT01039285|Surfactant|surfactant
5143479|NCT01039285|Respiratory Distress|respiratory distress
5143480|NCT01039285|Bronchopulmonary Dysplasia|bronchopulmonary dysplasia
5143481|NCT01039272|oral cancer|oral cancer
5143482|NCT01039272|EBV|ebv
5143483|NCT01039272|PCR|pcr
5143484|NCT01039259|adolescent|adolescent
5143485|NCT01039259|body piercing/adverse effects|body piercing/adverse effects
5143486|NCT01039259|tongue piercing|tongue piercing
5143487|NCT01039259|tongue/microbiology|tongue/microbiology
5143488|NCT01039181|Vitamin D|vitamin d
5143489|NCT01039181|Calcitriol|calcitriol
5143490|NCT01039181|cholangiocarcinoma|cholangiocarcinoma
5143491|NCT01039181|Clinical trial|clinical trial
5143492|NCT01039168|Burnout|burnout
5143493|NCT01039168|Sick leave|sick leave
5143494|NCT01039168|Intervention study|intervention study
5143495|NCT01039168|Prospective study|prospective study
5143496|NCT01039168|Work|work
5143497|NCT01039142|Psoriasis|psoriasis
5143498|NCT01039129|Gallstones|gallstones
5143499|NCT01039129|Appendicitis|appendicitis
5143500|NCT01039129|Pelvic pain|pelvic pain
5143501|NCT01039129|Peritoneal mass|peritoneal mass
5143502|NCT01039116|obesity|obesity
5143503|NCT01039116|nutrition|nutrition
5143504|NCT01039116|type 2 diabetes|type 2 diabetes
5143505|NCT01039116|community-based.|community-based.
5143506|NCT01039103|PEG-liposomal prednisolone sodium phosphate|peg-liposomal prednisolone sodium phosphate
5143507|NCT01039090|Not eligible for deep brain stimulation|not eligible for deep brain stimulation
5143508|NCT01039090|Parkinsons's patients|parkinsons's patients
5143509|NCT01039038|prostate|prostate
5143510|NCT01039038|curietherapy|curietherapy
5143511|NCT01039038|radiotherapy|radiotherapy
5143512|NCT01039038|intermediate risk|intermediate risk
5143513|NCT01039025|Myeloma|myeloma
5143514|NCT01039025|Topotecan|topotecan
5143515|NCT01039025|Hycamtin|hycamtin
5143516|NCT01039025|Melphalan|melphalan
5143517|NCT01039025|Alkeran|alkeran
5143518|NCT01039025|Cyclophosphamide|cyclophosphamide
5143519|NCT01039025|Cytoxan|cytoxan
5143520|NCT01039025|Neosar|neosar
5143521|NCT01039025|Stem Cell Harvest|stem cell harvest
5143522|NCT01039025|Peripheral Blood Stem Cells|peripheral blood stem cells
5143523|NCT01039012|bone mineral density|bone mineral density
5143524|NCT01039012|osteoporosis|osteoporosis
5143525|NCT01039012|exercise|exercise
5143526|NCT01039012|bone remodeling|bone remodeling
5143527|NCT01039012|biomotion analysis|biomotion analysis
5143528|NCT01038999|Complementary Therapies|complementary therapies
5143529|NCT01038986|chronic wound|chronic wound
5143530|NCT01038986|refractory wound|refractory wound
5143531|NCT01038986|CureXcell|curexcell
5143532|NCT01038986|activated cell suspension|activated cell suspension
5143533|NCT01038960|ICD, training|icd, training
5143534|NCT01038934|Buccal Mucosa|buccal mucosa
5143535|NCT01038934|DNA|dna
5143536|NCT01038934|Polymerase Chain Reaction|polymerase chain reaction
5143537|NCT01038921|Blood Pressure|blood pressure
5143538|NCT01038921|Glucose levels|glucose levels
5143539|NCT01038921|HDL levels|hdl levels
5143540|NCT01038921|Triglyceride levels|triglyceride levels
5143541|NCT01038921|Waist Circumference|waist circumference
5143542|NCT01038908|sentinel lymph node biopsy (SLNB)|sentinel lymph node biopsy (slnb)
5143543|NCT01038908|axillary lymph node dissection (ALND)|axillary lymph node dissection (alnd)
5143544|NCT01038908|lymphatics|lymphatics
5143545|NCT01038908|blue dye|blue dye
5143546|NCT01038895|Hypertension|hypertension
5143547|NCT01038895|type 2 diabetes|type 2 diabetes
5143548|NCT01038895|aliskiren|aliskiren
5143549|NCT01038895|ramipril|ramipril
5143550|NCT01038895|microalbuminuria|microalbuminuria
5143551|NCT01038895|blood pressure> 130/80 <180/105 mmHg at the end of the wash−out|blood pressure> 130/80 <180/105 mmhg at the end of the wash−out
5143552|NCT01038895|type 2 diabetes mellitus well controlled by medication and / or|type 2 diabetes mellitus well controlled by medication and / or
5143553|NCT01038895|compliance with diet (HbA1c <7%)|compliance with diet (hba1c <7%)
5143554|NCT01038895|Microalbuminuria in the upper range of normal (> 200 <300 mg/24 h)|microalbuminuria in the upper range of normal (> 200 <300 mg/24 h)
5143555|NCT01038882|sedation|sedation
5143556|NCT01038882|midazolam|midazolam
5143557|NCT01038882|flexible bronchoscopy|flexible bronchoscopy
5143558|NCT01038882|tolerance|tolerance
5143559|NCT01038843|VA106483|va106483
5143560|NCT01038843|Nocturia|nocturia
5143561|NCT01038843|males|males
5143562|NCT01038843|nocturnal voids|nocturnal voids
5143563|NCT01038843|anti-diuretic|anti-diuretic
5143564|NCT01038843|hyponatraemia|hyponatraemia
5143565|NCT01038817|tooth-decay|tooth-decay
5143566|NCT01038817|prevention|prevention
5143567|NCT01038817|fluoride-varnish|fluoride-varnish
5143568|NCT01038817|institutionalised elderly people|institutionalised elderly people
5143569|NCT01038804|Breast Cancer|breast cancer
5143570|NCT01038804|Metastatic|metastatic
5143571|NCT01038804|HER2 Negative|her2 negative
5143572|NCT01038804|YM155|ym155
5143573|NCT01038791|chronic hypercapnic respiratory failure|chronic hypercapnic respiratory failure
5143574|NCT01038791|COPD|copd
5143575|NCT01038791|RTD|rtd
5143576|NCT01038791|sleep architecture|sleep architecture
5143577|NCT01038791|humidification|humidification
5143578|NCT01038765|Recurrent Major Depressive Disorder|recurrent major depressive disorder
5143579|NCT01038765|Mindfulness Based Cognitive Therapy|mindfulness based cognitive therapy
5143580|NCT01038765|Randomized Controlled Trial|randomized controlled trial
5143581|NCT01038752|NSCLC|nsclc
5143582|NCT01038752|suramin|suramin
5143583|NCT01038752|lung cancer|lung cancer
5143584|NCT01038752|chemotherapy|chemotherapy
5143585|NCT01038726|Healthy Aging|healthy aging
5143586|NCT01038700|Circulating endothelial compartment|circulating endothelial compartment
5143587|NCT01038700|microparticles|microparticles
5143588|NCT01038700|endothelial progenitors cells|endothelial progenitors cells
5143589|NCT01038700|circulating endothelial cells|circulating endothelial cells
5143590|NCT01038700|transcriptome|transcriptome
5143591|NCT01038700|aging|aging
5143592|NCT01038700|Healthy volunteers|healthy volunteers
5143593|NCT01038687|functional constipation|functional constipation
5143594|NCT01038687|bile acid|bile acid
5143595|NCT01038648|Sitagliptin|sitagliptin
5143596|NCT01038648|Type 2 diabetes|type 2 diabetes
5143597|NCT01038648|Prevention of type 2 diabetes|prevention of type 2 diabetes
5143598|NCT01038635|5-Azacytidine|5-azacytidine
5143599|NCT01038635|5-Aza|5-aza
5143600|NCT01038635|Lenalidomide|lenalidomide
5143601|NCT01038635|Revlimid|revlimid
5143602|NCT01038635|CC-5103|cc-5103
5143603|NCT01038635|Myelodysplastic Syndrome|myelodysplastic syndrome
5143604|NCT01038635|MDS|mds
5143605|NCT01038635|Acute Myelogenous Leukemia|acute myelogenous leukemia
5143606|NCT01038635|AML|aml
5143607|NCT01038622|L-arginine|l-arginine
5143608|NCT01038622|Nasal NO|nasal no
5143609|NCT01038622|Nosocomial infection|nosocomial infection
5143610|NCT01038622|Immune function|immune function
5143611|NCT01038622|HLA-DR expression|hla-dr expression
5143612|NCT01038622|Critically ill|critically ill
5143613|NCT01038622|Medical ICU patients|medical icu patients
5143614|NCT01038609|Postoperative Pain|postoperative pain
5143615|NCT01038596|osteoarthritis, mesenchymal stromal cells, proliferation|osteoarthritis, mesenchymal stromal cells, proliferation
5143616|NCT01038583|Aspirin|aspirin
5143617|NCT01038583|Prevention|prevention
5143618|NCT01038583|Healthy|healthy
5143619|NCT01038583|Over 65 years old|over 65 years old
5143620|NCT01038583|ASPREE|aspree
5143621|NCT01038583|Aspirin in Reducing Events in the Elderly|aspirin in reducing events in the elderly
5143622|NCT01038583|Australia|australia
5143827|NCT01037868|depression|depression
5143623|NCT01038583|Functional disability|functional disability
5143624|NCT01038583|Dementia|dementia
5143625|NCT01038583|Heart Disease/ Stroke|heart disease/ stroke
5143626|NCT01038583|Cancer|cancer
5143627|NCT01038583|Bleeding|bleeding
5143628|NCT01038570|Prader Willi syndrome|prader willi syndrome
5143629|NCT01038570|adults|adults
5143630|NCT01038570|social behaviour|social behaviour
5143631|NCT01038570|stress|stress
5143632|NCT01038570|anxiety|anxiety
5143633|NCT01038570|psychological tests|psychological tests
5143634|NCT01038557|frozen|frozen
5143635|NCT01038557|red blood cells|red blood cells
5143636|NCT01038557|transfusion|transfusion
5143637|NCT01038557|trauma|trauma
5143638|NCT01038544|Esophageal Cancer|esophageal cancer
5143639|NCT01038544|Mediastinal lymph nodes|mediastinal lymph nodes
5143640|NCT01038544|Staging|staging
5143641|NCT01038544|EBUS|ebus
5143642|NCT01038544|EUS|eus
5143643|NCT01038544|Endobronchial Ultrasound|endobronchial ultrasound
5143644|NCT01038544|Endoscopic Ultrasound|endoscopic ultrasound
5143645|NCT01038531|Acute lung injury (ALI)|acute lung injury (ali)
5143646|NCT01038531|Adult respiratory distress syndrome (ARDS)|adult respiratory distress syndrome (ards)
5143647|NCT01038531|Low-tidal-volume strategy|low-tidal-volume strategy
5143648|NCT01038531|ARDS Net|ards net
5143649|NCT01038531|airway pressure release ventilation (APRV)|airway pressure release ventilation (aprv)
5143650|NCT01038531|biomarkers of lung injury|biomarkers of lung injury
5143651|NCT01038518|epidemiology|epidemiology
5143652|NCT01038518|risk factors|risk factors
5143653|NCT01038518|micronutrients|micronutrients
5143654|NCT01038479|Xylitol|xylitol
5143655|NCT01038479|Mutans streptococci|mutans streptococci
5143656|NCT01038479|Maternal consumption|maternal consumption
5143657|NCT01038479|Early childhood tooth decay|early childhood tooth decay
5143658|NCT01038479|Early childhood caries|early childhood caries
5143659|NCT01038479|Childsmile|childsmile
5143660|NCT01038466|CHAT|chat
5143661|NCT01038466|breast cancer|breast cancer
5143662|NCT01038466|non interventional observational study|non interventional observational study
5143663|NCT01038440|Omega 3 fatty acids|omega 3 fatty acids
5143664|NCT01038440|Omega 3 Index|omega 3 index
5143665|NCT01038440|Stearidonic acid (SDA)|stearidonic acid (sda)
5143666|NCT01038440|Eicosapentaenoic acid (EPA)|eicosapentaenoic acid (epa)
5143667|NCT01038440|Red blood cells|red blood cells
5143668|NCT01038440|Lipids|lipids
5143669|NCT01038440|Inflammation markers|inflammation markers
5143670|NCT01038427|Rhinitis|rhinitis
5143671|NCT01038427|Allergic|allergic
5143672|NCT01038427|Seasonal|seasonal
5143673|NCT01038427|Mometasone Furoate|mometasone furoate
5143674|NCT01038427|Equivalence|equivalence
5143675|NCT01038401|HIV infection|hiv infection
5143676|NCT01038401|HAART|haart
5143677|NCT01038401|Viral DNA test positive-10063306|viral dna test positive-10063306
5143678|NCT01038401|Blood HIV RNA 10049826|blood hiv rna 10049826
5143679|NCT01038401|Treatment Experienced|treatment experienced
5143680|NCT01038388|Multiple Myeloma|multiple myeloma
5143681|NCT01038375|hypertension|hypertension
5143682|NCT01038375|stroke|stroke
5143683|NCT01038375|adherence|adherence
5143684|NCT01038362|endothelium|endothelium
5143685|NCT01038362|almonds|almonds
5143686|NCT01038362|dietary interventions|dietary interventions
5143687|NCT01038362|coronary artery disease|coronary artery disease
5143688|NCT01038336|Hearing Loss - Noise-Induced|hearing loss - noise-induced
5143689|NCT01038336|Prevention|prevention
5143690|NCT01038336|Computer-assisted instruction|computer-assisted instruction
5143691|NCT01038323|Fibromyalgia|fibromyalgia
5143692|NCT01038323|FMS|fms
5143693|NCT01038310|Parkinson´s disease|parkinson´s disease
5143694|NCT01038310|FP-CIT-SPECT|fp-cit-spect
5143695|NCT01038297|Scarring|scarring
5143696|NCT01038284|Patient Education|patient education
5143697|NCT01038284|Drug Toxicity|drug toxicity
5143698|NCT01038271|palliative care|palliative care
5143699|NCT01038258|neoadjuvant chemotherapy|neoadjuvant chemotherapy
5143700|NCT01038245|Receptor Up-Regulation|receptor up-regulation
5143701|NCT01038245|Smoking|smoking
5143702|NCT01038245|Nicotine|nicotine
5143703|NCT01038245|Neuroimaging|neuroimaging
5143704|NCT01038232|Distress Tolerance|distress tolerance
5143705|NCT01038232|Cocaine Dependence|cocaine dependence
5143706|NCT01038232|Relapse|relapse
5143707|NCT01038232|Limbic System|limbic system
5143708|NCT01038232|Prefrontal Cortex|prefrontal cortex
5143709|NCT01038232|Healthy Volunteer|healthy volunteer
5143710|NCT01038232|HV|hv
5143711|NCT01038219|fever|fever
5143712|NCT01038219|children|children
5143713|NCT01038219|SUBJECTIVE ASSESSMENT|subjective assessment
5143714|NCT01038206|prevention|prevention
5143715|NCT01038206|HIV|hiv
5143716|NCT01038206|drugs|drugs
5143717|NCT01038206|smoking|smoking
5143718|NCT01038206|Hispanic|hispanic
5143719|NCT01038206|Adolescent|adolescent
5143720|NCT01038206|Familias Unidas|familias unidas
5143721|NCT01038206|Parent-Preadolescent Training|parent-preadolescent training
5143722|NCT01038206|parent-centered|parent-centered
5143723|NCT01038206|unsafe sexual behavior|unsafe sexual behavior
5143724|NCT01038206|efficacy|efficacy
5143725|NCT01038206|intervention|intervention
5144019|NCT01037049|Pathology|pathology
5143726|NCT01038193|Cognition, subarachnoid hemorrhage.|cognition, subarachnoid hemorrhage.
5143727|NCT01038180|pacemaker|pacemaker
5143728|NCT01038180|adverse effects|adverse effects
5143729|NCT01038167|VX-950|vx-950
5143730|NCT01038154|advanced esophageal cancer and stomach cancer|advanced esophageal cancer and stomach cancer
5143731|NCT01038154|Pravastatin|pravastatin
5143732|NCT01038154|Survival|survival
5143733|NCT01038154|adverse effects|adverse effects
5143734|NCT01038128|Bulimia nervosa|bulimia nervosa
5143735|NCT01038128|Bulimia|bulimia
5143736|NCT01038128|Body dysmorphic disorder|body dysmorphic disorder
5143737|NCT01038128|Eating disorders|eating disorders
5143738|NCT01038128|Body image|body image
5143739|NCT01038128|Binge eating|binge eating
5143740|NCT01038128|purging|purging
5143741|NCT01038115|Catheter Ablation|catheter ablation
5143742|NCT01038102|Obesity|obesity
5143743|NCT01038102|Diabetes|diabetes
5143744|NCT01038102|Insulin resistance|insulin resistance
5143745|NCT01038102|Fatty liver|fatty liver
5143746|NCT01038102|NAFLD|nafld
5143747|NCT01038102|Steatosis|steatosis
5143748|NCT01038102|Dietary fatty acids|dietary fatty acids
5143749|NCT01038089|endothelium|endothelium
5143750|NCT01038089|resveratrol|resveratrol
5143751|NCT01038089|diabetes mellitus|diabetes mellitus
5143752|NCT01038076|HIV|hiv
5143753|NCT01038076|AIDS|aids
5143754|NCT01038076|adherence|adherence
5143755|NCT01038076|antiretroviral|antiretroviral
5143756|NCT01038076|aCASI|acasi
5143757|NCT01038076|HAART|haart
5143758|NCT01038076|Complementary Therapies|complementary therapies
5143759|NCT01038076|Adherence Care Manager|adherence care manager
5143760|NCT01038050|Endothelial progenitor cell|endothelial progenitor cell
5143761|NCT01038050|endothelial function(FMD)|endothelial function(fmd)
5143762|NCT01038050|Gingko Biloba Extract|gingko biloba extract
5143763|NCT01038050|Type 2 Diabetes mellitus|type 2 diabetes mellitus
5143764|NCT01038050|Stable coronary artery disease|stable coronary artery disease
5143765|NCT01038050|Endothelial progenitor cells Numbers|endothelial progenitor cells numbers
5143766|NCT01038037|Lung Cancer|lung cancer
5143767|NCT01038037|Non small cell lung cancer|non small cell lung cancer
5143768|NCT01038037|Triple mutational status|triple mutational status
5143769|NCT01038037|KRAS|kras
5143770|NCT01038037|BRAF|braf
5143771|NCT01038037|PI3K|pi3k
5143772|NCT01038024|antioxidant supplement|antioxidant supplement
5143773|NCT01037998|adenocarcinoma|adenocarcinoma
5143774|NCT01037998|non-small-cell lung cancer|non-small-cell lung cancer
5143775|NCT01037998|gefitinib|gefitinib
5143776|NCT01037998|UFUR|ufur
5143777|NCT01037985|Scarring|scarring
5143778|NCT01037972|Galileo|galileo
5143779|NCT01037972|Whole body vibration|whole body vibration
5143780|NCT01037972|Osteoarthritis|osteoarthritis
5143781|NCT01037972|Knee|knee
5143782|NCT01037972|Physiotherapy|physiotherapy
5143783|NCT01037959|severe cirrhosis|severe cirrhosis
5143784|NCT01037959|Patients with severe cirrhosis|patients with severe cirrhosis
5143785|NCT01037946|HIV|hiv
5143786|NCT01037946|Family interventions|family interventions
5143787|NCT01037946|Thailand|thailand
5143788|NCT01037933|Cancer|cancer
5143789|NCT01037933|Humor|humor
5143790|NCT01037933|Distraction|distraction
5143791|NCT01037933|Comedy|comedy
5143792|NCT01037933|Chemotherapy|chemotherapy
5143793|NCT01037907|Oral treatment for MS|oral treatment for ms
5143794|NCT01037907|Oral drug for multiple sclerosis|oral drug for multiple sclerosis
5143795|NCT01037907|Oral RRMS|oral rrms
5143796|NCT01037907|Oral relapsing remitting multiple sclerosis|oral relapsing remitting multiple sclerosis
5143797|NCT01037907|Gamma Linolenic Acid|gamma linolenic acid
5143798|NCT01037907|GLA|gla
5143799|NCT01037907|Fatty acid|fatty acid
5143800|NCT01037907|Triglyceride|triglyceride
5143801|NCT01037907|Structured lipid|structured lipid
5143802|NCT01037907|MRI|mri
5143803|NCT01037907|Magnetic resonance imaging|magnetic resonance imaging
5144048|NCT01036711|Working Memory|working memory
5143804|NCT01037907|gadolinium enhancing lesions|gadolinium enhancing lesions
5143805|NCT01037907|expanded disability status scale|expanded disability status scale
5143806|NCT01037907|EDSS|edss
5143807|NCT01037907|Demyelination|demyelination
5143808|NCT01037907|Remyelination|remyelination
5143809|NCT01037907|TGFB1|tgfb1
5143810|NCT01037907|Transforming growth factor beta 1|transforming growth factor beta 1
5143811|NCT01037907|cytokines|cytokines
5143812|NCT01037907|disease modifying therapy|disease modifying therapy
5143813|NCT01037907|immunomodulator|immunomodulator
5143814|NCT01037907|Anti inflammatory|anti inflammatory
5143815|NCT01037907|Pro inflammatory|pro inflammatory
5143816|NCT01037907|TNF alpha|tnf alpha
5143817|NCT01037907|interleukin 1 beta|interleukin 1 beta
5143818|NCT01037907|interferon gamma|interferon gamma
5143819|NCT01037907|Fayaz Master|fayaz master
5143820|NCT01037907|Omega 6|omega 6
5143821|NCT01037907|Polyunsaturated fatty acid|polyunsaturated fatty acid
5143822|NCT01037907|Cytokine balance|cytokine balance
5143823|NCT01037907|Pleneva TM|pleneva tm
5143824|NCT01037907|BGC20-0134|bgc20-0134
5143825|NCT01037907|RRMS|rrms
5143826|NCT01037894|Acupuncture,Intracerebral hemorrhage, Stroke|acupuncture,intracerebral hemorrhage, stroke
5143828|NCT01037868|alcohol dependency syndrome|alcohol dependency syndrome
5143829|NCT01037868|dual diagnosis|dual diagnosis
5143830|NCT01037868|SMS text messages|sms text messages
5143831|NCT01037855|Swine Flu H1N1 vaccine|swine flu h1n1 vaccine
5143832|NCT01037855|Adjuvanted flu cell culture derived|adjuvanted flu cell culture derived
5143833|NCT01037816|Ankle Sprain|ankle sprain
5143834|NCT01037803|perioperative sublingual microcirculation SDF|perioperative sublingual microcirculation sdf
5143835|NCT01037777|individuals at risk for SCA1, SCA2, SCA3, SCA6 and SCA7|individuals at risk for sca1, sca2, sca3, sca6 and sca7
5143836|NCT01037764|acute lymphoid leukemia|acute lymphoid leukemia
5143837|NCT01037764|primary complete remission|primary complete remission
5143838|NCT01037764|secondary complete remission|secondary complete remission
5143839|NCT01037764|postremission therapy|postremission therapy
5143840|NCT01037764|allogeneic hematopoietic cell transplantation|allogeneic hematopoietic cell transplantation
5143841|NCT01037751|Cancer|cancer
5143842|NCT01037751|Symptom burden|symptom burden
5143843|NCT01037751|M. D. Anderson Symptom Inventory|m. d. anderson symptom inventory
5143844|NCT01037751|MDASI-Ovarian Cancer|mdasi-ovarian cancer
5143845|NCT01037751|Symptoms|symptoms
5143846|NCT01037751|Daily functioning|daily functioning
5143847|NCT01037751|Symptom severity|symptom severity
5143848|NCT01037751|Questionnaire|questionnaire
5143849|NCT01037751|Interview|interview
5143850|NCT01037738|ACL reconstruction|acl reconstruction
5143851|NCT01037738|autologous conditioned serum|autologous conditioned serum
5143852|NCT01037738|Orthokine|orthokine
5143853|NCT01037738|osteoarthritis|osteoarthritis
5143854|NCT01037738|interleukin receptor antagonist|interleukin receptor antagonist
5143855|NCT01037738|growth factors|growth factors
5143856|NCT01037738|WOMAC|womac
5143857|NCT01037738|IKDC|ikdc
5143858|NCT01037725|Healthy volunteer|healthy volunteer
5143859|NCT01037725|first time in human|first time in human
5143860|NCT01037725|food effect|food effect
5143861|NCT01037712|Foetuses infection with CMV|foetuses infection with cmv
5143862|NCT01037712|neurological handicap of infectious origin.|neurological handicap of infectious origin.
5143863|NCT01037699|Ovarian stimulation|ovarian stimulation
5143864|NCT01037699|In Vitro Fertilization|in vitro fertilization
5143865|NCT01037699|Luteinizing Hormone|luteinizing hormone
5143866|NCT01037699|GnRH antagonist|gnrh antagonist
5143867|NCT01037699|Implantation rate in infertile patients undergoing In vitro fertilization and embryo transfer.|implantation rate in infertile patients undergoing in vitro fertilization and embryo transfer.
5143868|NCT01037686|PD|pd
5143869|NCT01037686|DBS|dbs
5143870|NCT01037660|endothelium|endothelium
5143871|NCT01037660|cardiovascular disease|cardiovascular disease
5143872|NCT01037660|dietary fat|dietary fat
5143873|NCT01037660|insulin resistance|insulin resistance
5143874|NCT01037647|Type 2 diabetes|type 2 diabetes
5143875|NCT01037647|Diabetic dyslipidemia|diabetic dyslipidemia
5143876|NCT01037647|VLDL-TG kinetics|vldl-tg kinetics
5143877|NCT01037647|VLDL-TG metabolism|vldl-tg metabolism
5143878|NCT01037634|Avian Influenza|avian influenza
5143879|NCT01037634|H1N1 Influenza|h1n1 influenza
5143880|NCT01037634|Seasonal Influenza|seasonal influenza
5143881|NCT01037621|Herpes simplex type 2|herpes simplex type 2
5143882|NCT01037621|Hepatitis C virus|hepatitis c virus
5143883|NCT01037621|Valacyclovir|valacyclovir
5143884|NCT01037621|Herpes Simplex virus type 2 infection|herpes simplex virus type 2 infection
5143885|NCT01037608|Sativex|sativex
5143886|NCT01037608|fMRI|fmri
5143887|NCT01037608|Alternative Matrices|alternative matrices
5143888|NCT01037608|Brain Imaging|brain imaging
5143889|NCT01037608|THC|thc
5143890|NCT01037595|hemodialysis|hemodialysis
5143891|NCT01037595|turmeric|turmeric
5143892|NCT01037595|pruritus|pruritus
5143893|NCT01037569|Toxicological Screening|toxicological screening
5143894|NCT01037569|Drugs|drugs
5143895|NCT01037569|Alternative Matrices|alternative matrices
5143896|NCT01037569|Urine|urine
5143897|NCT01037569|Children|children
5143898|NCT01037556|AML|aml
5143899|NCT01037556|Acute Myeloid Leukemia|acute myeloid leukemia
5143900|NCT01037556|Acute Myelogenous Leukemia|acute myelogenous leukemia
5143901|NCT01037556|Refractory AML|refractory aml
5143902|NCT01037556|Relapsed AML|relapsed aml
5143903|NCT01037556|Refractory Acute Myeloid Leukemia|refractory acute myeloid leukemia
5143904|NCT01037556|Relapsed Acute Myeloid Leukemia|relapsed acute myeloid leukemia
5143905|NCT01037556|Refractory Acute Myelogenous Leukemia|refractory acute myelogenous leukemia
5143906|NCT01037556|Relapsed Acute Myelogenous Leukemia|relapsed acute myelogenous leukemia
5143907|NCT01037556|ALL|all
5143908|NCT01037556|Acute Lymphocytic Leukemia|acute lymphocytic leukemia
5143909|NCT01037556|Relapsed Acute Lymphocytic Leukemia|relapsed acute lymphocytic leukemia
5143910|NCT01037556|Refractory Acute Lymphocytic Leukemia|refractory acute lymphocytic leukemia
5143911|NCT01037556|Relapsed ALL|relapsed all
5143912|NCT01037556|Refractory ALL|refractory all
5143913|NCT01037530|ACE inhibitors|ace inhibitors
5143914|NCT01037530|Intermittent claudication|intermittent claudication
5143915|NCT01037530|Ramipril|ramipril
5143916|NCT01037517|Myeloma|myeloma
5143917|NCT01037517|Multiple Myeloma or Lymphoma Patients undergoing|multiple myeloma or lymphoma patients undergoing
5143918|NCT01037517|mobilization for the purpose of autologous stem cell collection|mobilization for the purpose of autologous stem cell collection
5143919|NCT01037504|safety|safety
5143920|NCT01037504|tolerability|tolerability
5143921|NCT01037504|healthy|healthy
5143922|NCT01037504|inhalation|inhalation
5143923|NCT01037504|Healthy volunteers|healthy volunteers
5144178|NCT01035996|Incentive Salience|incentive salience
5143924|NCT01037491|aspirin, clopidogrel, peptic ulcer, proton pump inhibitor, rabeprazole, ulcer bleeding|aspirin, clopidogrel, peptic ulcer, proton pump inhibitor, rabeprazole, ulcer bleeding
5143925|NCT01037478|Hodgkin's Lymphoma|hodgkin's lymphoma
5143926|NCT01037478|HDAC|hdac
5143927|NCT01037478|4SC-201|4sc-201
5143928|NCT01037478|Resminostat|resminostat
5143929|NCT01037478|Phase II|phase ii
5143930|NCT01037465|endothelium|endothelium
5143931|NCT01037465|cell signaling|cell signaling
5143932|NCT01037465|N-acetylcysteine|n-acetylcysteine
5143933|NCT01037465|reactive oxygen species|reactive oxygen species
5143934|NCT01037452|Heartburn|heartburn
5143935|NCT01037452|antacid|antacid
5143937|NCT01037452|Lansoprazole|lansoprazole
5143938|NCT01037452|calcium carbonate|calcium carbonate
5143939|NCT01037452|magnesium hydroxide|magnesium hydroxide
5143940|NCT01037452|Relief of heartburn following ingestion of a heartburn-inducing meal|relief of heartburn following ingestion of a heartburn-inducing meal
5143941|NCT01037426|SND Sinus Node Disease|snd sinus node disease
5143942|NCT01037426|Falls|falls
5143943|NCT01037426|Fractures|fractures
5143944|NCT01037413|Scarring|scarring
5143945|NCT01037400|Knee Replacement|knee replacement
5143946|NCT01037400|Arthroplasty|arthroplasty
5143947|NCT01037374|risk|risk
5143948|NCT01037374|assessment|assessment
5143949|NCT01037374|difficult|difficult
5143950|NCT01037374|endotracheal|endotracheal
5143951|NCT01037374|intubation|intubation
5143952|NCT01037361|Children and Adolescents|children and adolescents
5143953|NCT01037361|Motor Control|motor control
5143954|NCT01037361|Movement-Related Potential|movement-related potential
5143955|NCT01037361|Stereotypic Movement Disorder|stereotypic movement disorder
5143956|NCT01037361|Electroencephalogram (EEG)|electroencephalogram (eeg)
5143957|NCT01037348|Choroidal Neovascularisation|choroidal neovascularisation
5143958|NCT01037348|Pathological Myopia|pathological myopia
5143959|NCT01037335|bone graft|bone graft
5143960|NCT01037335|pain|pain
5143961|NCT01037335|chronic|chronic
5143962|NCT01037322|crohn's disease|crohn's disease
5143963|NCT01037322|ulcerative colitis|ulcerative colitis
5143964|NCT01037322|cannabis|cannabis
5143965|NCT01037322|cannabidiol|cannabidiol
5143966|NCT01037296|catheter ablation|catheter ablation
5143967|NCT01037296|robotic navigation|robotic navigation
5143968|NCT01037283|Bipolar|bipolar
5143969|NCT01037283|Depressed|depressed
5143970|NCT01037270|Patients with conditions (PE, Afib, DVT) requiring ongoing INR measurements.|patients with conditions (pe, afib, dvt) requiring ongoing inr measurements.
5143971|NCT01037231|hyperoxaluria|hyperoxaluria
5143972|NCT01037231|oxalate|oxalate
5143973|NCT01037231|PH|ph
5143974|NCT01037192|outpatient|outpatient
5143975|NCT01037192|skin and soft tissue infections|skin and soft tissue infections
5143976|NCT01037192|vancomycin intravenous|vancomycin intravenous
5143977|NCT01037153|Intravenous|intravenous
5143978|NCT01037153|Rate of Delivery|rate of delivery
5143979|NCT01037153|Dose Responses|dose responses
5143980|NCT01037153|Variable Intervals|variable intervals
5143981|NCT01037153|Multiple Rapid Injections|multiple rapid injections
5143982|NCT01037127|GSK1120212|gsk1120212
5143983|NCT01037127|BRAF Inhibitor|braf inhibitor
5143984|NCT01037127|melanoma|melanoma
5143985|NCT01037127|MEK Inhibitor|mek inhibitor
5143986|NCT01037114|Hepatitis A and hepatitis B|hepatitis a and hepatitis b
5143987|NCT01037101|acrophobia|acrophobia
5143988|NCT01037101|virtual reality|virtual reality
5143989|NCT01037101|exposure therapy|exposure therapy
5143990|NCT01037101|In Vivo Exposure Therapy plus D-Cycloserine|in vivo exposure therapy plus d-cycloserine
5143991|NCT01037101|In Vivo Exposure Therapy plus Placebo|in vivo exposure therapy plus placebo
5143992|NCT01037101|Virtual Reality Exposure Therapy plus D-Cycloserine|virtual reality exposure therapy plus d-cycloserine
5143993|NCT01037101|Virtual Reality Exposure Therapy plus Placebo|virtual reality exposure therapy plus placebo
5143994|NCT01037101|Wait-List|wait-list
5143995|NCT01037088|cannabis|cannabis
5143996|NCT01037088|marijuana|marijuana
5143997|NCT01037088|neuropathy|neuropathy
5143998|NCT01037088|antinociception|antinociception
5143999|NCT01037088|mood|mood
5144000|NCT01037088|cognition|cognition
5144001|NCT01037088|neuropathic pain|neuropathic pain
5144002|NCT01037075|Schizophrenia|schizophrenia
5144003|NCT01037075|Dual Diagnosis|dual diagnosis
5144004|NCT01037075|Nicotine Nasal Spray|nicotine nasal spray
5144005|NCT01037075|Drug Abuse/Dependence|drug abuse/dependence
5144006|NCT01037075|Cognitive Processes|cognitive processes
5144007|NCT01037049|Rectal Cancer|rectal cancer
5144008|NCT01037049|6vs12|6vs12
5144009|NCT01037049|6 vs 12|6 vs 12
5144010|NCT01037049|Cancer|cancer
5144011|NCT01037049|CRM|crm
5144012|NCT01037049|Circumferential Resection Margin|circumferential resection margin
5144013|NCT01037049|Quality of Life|quality of life
5144014|NCT01037049|MRI|mri
5144015|NCT01037049|Radiology|radiology
5144016|NCT01037049|Abdominoperineal Excision|abdominoperineal excision
5144017|NCT01037049|Anterior Resection|anterior resection
5144018|NCT01037049|Surgery|surgery
5144020|NCT01037049|Radiotherapy|radiotherapy
5144021|NCT01037036|Ocular Hypertension|ocular hypertension
5144022|NCT01037036|Open-Angle Glaucoma|open-angle glaucoma
5144023|NCT01037036|Xalatan|xalatan
5144024|NCT01037036|IOP|iop
5144025|NCT01037023|PMS (post-marketing surveillance)|pms (post-marketing surveillance)
5144026|NCT01037023|Topotecan|topotecan
5144027|NCT01036971|Physical Examination|physical examination
5144028|NCT01036971|Medical Information|medical information
5144029|NCT01036971|Assessment|assessment
5144030|NCT01036971|Blood Work|blood work
5144031|NCT01036971|Screening|screening
5144032|NCT01036958|Pediatric cGVHD|pediatric cgvhd
5144033|NCT01036958|Response Criteria|response criteria
5144034|NCT01036958|Symptoms|symptoms
5144035|NCT01036958|Quality of Life|quality of life
5144036|NCT01036958|Graft-Versus-Host Disease|graft-versus-host disease
5144037|NCT01036958|GVHD|gvhd
5144038|NCT01036958|Pediatric GVHD|pediatric gvhd
5144039|NCT01036854|Ondansetron, EUR-1025|ondansetron, eur-1025
5144040|NCT01036841|MNE with nocturnal polyuria|mne with nocturnal polyuria
5144041|NCT01036841|monosymptomatic nocturnal enuresis with nocturnal polyuria|monosymptomatic nocturnal enuresis with nocturnal polyuria
5144042|NCT01036802|sickle cell disease|sickle cell disease
5144043|NCT01036802|pulmonary hypertension|pulmonary hypertension
5144044|NCT01036802|coagulation activation|coagulation activation
5144045|NCT01036802|platelet activation|platelet activation
5144046|NCT01036802|endothelial activation|endothelial activation
5144047|NCT01036711|Attention|attention
5144049|NCT01036711|Central Executive Processes|central executive processes
5144050|NCT01036711|Response Preparation|response preparation
5144051|NCT01036711|Cigarettes|cigarettes
5144052|NCT01036685|Children|children
5144053|NCT01036685|fMRI|fmri
5144054|NCT01036685|Task Development|task development
5144055|NCT01036685|Cognition|cognition
5144056|NCT01036659|acute angiotensin converting enzyme inhibitor angioedema|acute angiotensin converting enzyme inhibitor angioedema
5144057|NCT01036646|Patients on stable OAT therapy for at least 3 months.|patients on stable oat therapy for at least 3 months.
5144058|NCT01036633|mucositis|mucositis
5144059|NCT01036594|Ketoconazole|ketoconazole
5144060|NCT01036594|Dexamethasone|dexamethasone
5144061|NCT01036581|Magnetic Resonance Imaging (MRI)|magnetic resonance imaging (mri)
5144062|NCT01036581|Functional Brain Imaging|functional brain imaging
5144063|NCT01036581|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
5144064|NCT01036581|Diffusion Tensor Imaging|diffusion tensor imaging
5144065|NCT01036581|Drug Abuse|drug abuse
5144066|NCT01036568|Psychosis|psychosis
5144067|NCT01036568|Smooth Pursuit|smooth pursuit
5144068|NCT01036568|Motion Perception|motion perception
5144069|NCT01036568|Neurophysiology|neurophysiology
5144070|NCT01036568|fMRI|fmri
5144071|NCT01036529|Spinal Cord Stimulation|spinal cord stimulation
5144072|NCT01036529|Decompression|decompression
5144073|NCT01036529|Fusion with or without instrumentation|fusion with or without instrumentation
5144074|NCT01036529|Discectomy|discectomy
5144075|NCT01036529|Laminectomy|laminectomy
5144076|NCT01036529|Laminotomy|laminotomy
5144077|NCT01036529|Foraminotomy|foraminotomy
5144078|NCT01036516|Drug Cues|drug cues
5144079|NCT01036516|Dopamine Release|dopamine release
5144080|NCT01036516|Psychomotor Stimulants|psychomotor stimulants
5144081|NCT01036516|D2 Dopamine Receptor Subtype|d2 dopamine receptor subtype
5144082|NCT01036516|Neuroimaging|neuroimaging
5144083|NCT01036412|Chlorhexidine|chlorhexidine
5144084|NCT01036412|Chlorhexidine Gel Therapy|chlorhexidine gel therapy
5144085|NCT01036412|1% chlorhexidine gluconate gel|1% chlorhexidine gluconate gel
5144086|NCT01036412|Cariogenic Oral Microflora|cariogenic oral microflora
5144087|NCT01036412|Irradiated Head and Neck Cancer Patients|irradiated head and neck cancer patients
5144088|NCT01036412|caries-forming organisms|caries-forming organisms
5144089|NCT01036412|Radiation treatment|radiation treatment
5144090|NCT01036412|Mouth Cancer|mouth cancer
5144091|NCT01036412|Throat Cancer|throat cancer
5144092|NCT01036412|Tooth decay|tooth decay
5144093|NCT01036399|PTCL|ptcl
5144094|NCT01036360|Obesity|obesity
5144095|NCT01036360|Acute exercise|acute exercise
5144096|NCT01036360|Intensity of exercise|intensity of exercise
5144097|NCT01036360|Energy balance regulation|energy balance regulation
5144098|NCT01036360|Appetite|appetite
5144099|NCT01036308|dietary fibre|dietary fibre
5144100|NCT01036308|legumes|legumes
5144101|NCT01036308|lupin kernel fibre|lupin kernel fibre
5144102|NCT01036308|soy fibre|soy fibre
5144103|NCT01036308|bile acids|bile acids
5144104|NCT01036308|short-chain fatty acids|short-chain fatty acids
5144105|NCT01036308|cholesterol metabolism|cholesterol metabolism
5144106|NCT01036308|Subjects|subjects
5144107|NCT01036243|digestive tolerance|digestive tolerance
5144108|NCT01036243|night sleep|night sleep
5144109|NCT01036243|crying|crying
5144110|NCT01036243|growth|growth
5144111|NCT01036230|fMRI|fmri
5144112|NCT01036230|Methylphenidate|methylphenidate
5144113|NCT01036230|Taste|taste
5144114|NCT01036230|Olfaction|olfaction
5144115|NCT01036230|Addiction|addiction
5144116|NCT01036217|Recruitment|recruitment
5144117|NCT01036217|Adult|adult
5144118|NCT01036217|Telephone|telephone
5144119|NCT01036217|Selection|selection
5144120|NCT01036217|Testing|testing
5144121|NCT01036139|EDS in Parkinson's Disease|eds in parkinson's disease
5144122|NCT01036126|Nicotine|nicotine
5144123|NCT01036126|Cocaine|cocaine
5144124|NCT01036126|N-Back|n-back
5144125|NCT01036126|Craving|craving
5144126|NCT01036126|Dependence|dependence
5144127|NCT01036113|EZN-2208 (PEG-SN38)|ezn-2208 (peg-sn38)
5144128|NCT01036087|Inflammatory Breast Cancer|inflammatory breast cancer
5144130|NCT01036087|Primary breast carcinoma|primary breast carcinoma
5144131|NCT01036087|HER2 negative overexpression|her2 negative overexpression
5144132|NCT01036087|Panitumumab|panitumumab
5144133|NCT01036087|Vectibix|vectibix
5144134|NCT01036087|Nab-paclitaxel|nab-paclitaxel
5144135|NCT01036087|Paclitaxel|paclitaxel
5144136|NCT01036087|Abraxane|abraxane
5144137|NCT01036087|Carboplatin|carboplatin
5144138|NCT01036087|Paraplatin|paraplatin
5144139|NCT01036087|PNC|pnc
5144140|NCT01036087|5-fluorouracil|5-fluorouracil
5144141|NCT01036087|5-FU|5-fu
5144142|NCT01036087|Adrucil|adrucil
5144143|NCT01036087|Efudex|efudex
5144144|NCT01036087|Epirubicin|epirubicin
5144145|NCT01036087|Ellence|ellence
5144146|NCT01036087|Cyclophosphamide|cyclophosphamide
5144147|NCT01036087|Cytoxan|cytoxan
5144148|NCT01036087|Neosar|neosar
5144149|NCT01036087|FEC|fec
5144150|NCT01036074|Drug Abuse|drug abuse
5144151|NCT01036074|Cocaine|cocaine
5144152|NCT01036074|Cocaine Dependence|cocaine dependence
5144153|NCT01036074|Functional MRI|functional mri
5144154|NCT01036074|Pharmalogical MRI|pharmalogical mri
5144155|NCT01036074|Conditioning|conditioning
5144156|NCT01036061|compulsive discorders|compulsive discorders
5144157|NCT01036061|addiction|addiction
5144158|NCT01036048|saphenous vein graft|saphenous vein graft
5144159|NCT01036048|stent|stent
5144160|NCT01036035|Tolterodine|tolterodine
5144161|NCT01036035|Over active Bladder (OAB)|over active bladder (oab)
5144162|NCT01036035|Incontinence|incontinence
5144163|NCT01036022|mesalazine|mesalazine
5144164|NCT01036022|ulcerative colitis|ulcerative colitis
5144165|NCT01036022|pharmacokinetics/dynamics|pharmacokinetics/dynamics
5144166|NCT01036022|GSK1399686|gsk1399686
5144167|NCT01036009|Hematologic|hematologic
5144168|NCT01036009|Malignancy|malignancy
5144169|NCT01036009|Leukemia|leukemia
5144170|NCT01036009|Pre-leukemic|pre-leukemic
5144171|NCT01036009|Allogeneic|allogeneic
5144172|NCT01036009|Transplant|transplant
5144173|NCT01036009|Pediatric|pediatric
5144174|NCT01035996|Classical Conditioning|classical conditioning
5144175|NCT01035996|fMRI|fmri
5144176|NCT01035996|Schizophrenia|schizophrenia
5144177|NCT01035996|TD Model|td model
5144179|NCT01035983|menstrually associated migraine (MAM), Migraines,Menstrual Migraines, menstrually related migraines|menstrually associated migraine (mam), migraines,menstrual migraines, menstrually related migraines
5144180|NCT01035944|Chronic wounds|chronic wounds
5144181|NCT01035944|Chronic wound debridement|chronic wound debridement
5144182|NCT01035944|Debridement|debridement
5144183|NCT01035944|Bedside debridement|bedside debridement
5144184|NCT01035944|Surgical debridement|surgical debridement
5144185|NCT01035944|Wound debridement|wound debridement
5144186|NCT01035944|Minimize bacterial re-colonization of wounds|minimize bacterial re-colonization of wounds
5144187|NCT01035944|HemCon ChitoGauze Dressings|hemcon chitogauze dressings
5144188|NCT01035944|HemCon Dressings|hemcon dressings
5144189|NCT01035944|Chitosan-based dressings|chitosan-based dressings
5144190|NCT01035788|PTSD|ptsd
5144191|NCT01035788|mindfulness meditation|mindfulness meditation
5144192|NCT01035788|cognitive behavior therapy|cognitive behavior therapy
5144193|NCT01035788|relationship function|relationship function
5144194|NCT01035788|couple therapy|couple therapy
5144195|NCT01035775|Colonoscopy|colonoscopy
5144196|NCT01035775|Adenoma detection|adenoma detection
5144197|NCT01035775|Colorectal polyps|colorectal polyps
5144198|NCT01035749|pandemic influenza|pandemic influenza
5144199|NCT01035749|Clinical trial|clinical trial
5144200|NCT01035749|H1N1|h1n1
5144201|NCT01035749|children|children
5144202|NCT01035723|Prefrontal Cortex|prefrontal cortex
5144203|NCT01035723|Hippocampus|hippocampus
5144204|NCT01035723|Amygdala|amygdala
5144205|NCT01035723|MRI|mri
5144206|NCT01035723|Cognitive Tasks|cognitive tasks
5144207|NCT01035697|NICHD Neonatal Research Network|nichd neonatal research network
5144208|NCT01035697|Very Low Birth Weight (VLBW)|very low birth weight (vlbw)
5144209|NCT01035697|Extremely Low Birth Weight (ELBW)|extremely low birth weight (elbw)
5144210|NCT01035697|Prematurity|prematurity
5144211|NCT01035697|Pro-inflammatory cytokines|pro-inflammatory cytokines
5144212|NCT01035697|Anti-inflammatory cytokines|anti-inflammatory cytokines
5144213|NCT01035697|Interleukin-1 (IL-1β)|interleukin-1 (il-1β)
5144214|NCT01035697|Interleukin-2 (IL-2)|interleukin-2 (il-2)
5144215|NCT01035697|Interleukin-3 (IL-3)|interleukin-3 (il-3)
5144216|NCT01035697|Interleukin-8 (IL-8)|interleukin-8 (il-8)
5144217|NCT01035697|Interleukin-9 (IL-9)|interleukin-9 (il-9)
5144218|NCT01035697|Tumor necrosis factor-α (TNF-α)|tumor necrosis factor-α (tnf-α)
5144219|NCT01035697|Regulated upon Activation, Normal T-cell Expressed and Secreted (RANTES)|regulated upon activation, normal t-cell expressed and secreted (rantes)
5144220|NCT01035658|Pazopanib|pazopanib
5144221|NCT01035658|Doxil|doxil
5144222|NCT01035658|Liposomal doxorubicin|liposomal doxorubicin
5144223|NCT01035658|Advanced relapsed|advanced relapsed
5144224|NCT01035658|platinum-sensitive|platinum-sensitive
5144225|NCT01035658|platinum-resistant|platinum-resistant
5144226|NCT01035645|First time in human|first time in human
5144227|NCT01035645|Interleukin-18|interleukin-18
5144228|NCT01035645|Healthy male subjects|healthy male subjects
5144229|NCT01035645|Obese male subjects|obese male subjects
5144230|NCT01035645|Monoclonal antibody|monoclonal antibody
5144231|NCT01035645|Pharmacokinetics|pharmacokinetics
5144232|NCT01035645|Tolerability|tolerability
5144233|NCT01035645|Safety|safety
5144234|NCT01035645|Pharmacodynamics|pharmacodynamics
5144235|NCT01035632|Craving|craving
5144236|NCT01035632|Incubation|incubation
5144237|NCT01035632|Relapse|relapse
5144238|NCT01035632|Smoking Cues|smoking cues
5144239|NCT01035632|Cortisol|cortisol
5144240|NCT01035619|onchocerciasis; river blindness; moxidectin; pediatric|onchocerciasis; river blindness; moxidectin; pediatric
5144241|NCT01035606|attention|attention
5144242|NCT01035606|rehabilitation|rehabilitation
5144243|NCT01035606|training|training
5144244|NCT01035606|functional MRI|functional mri
5144245|NCT01035606|executive function|executive function
5144246|NCT01035606|brain injury|brain injury
5144247|NCT01035580|chemoprevention|chemoprevention
5144248|NCT01035580|curcumin|curcumin
5144249|NCT01035580|pharmacokinetics|pharmacokinetics
5144250|NCT01035580|safety|safety
5144251|NCT01035567|Multivessel coronary artery disease|multivessel coronary artery disease
5144252|NCT01035567|Hybrid revascularization|hybrid revascularization
5144253|NCT01035567|Coronary Artery Bypass Grafting|coronary artery bypass grafting
5144254|NCT01035567|Percutaneous Coronary Interventions|percutaneous coronary interventions
5144255|NCT01035567|Drug eluting stents|drug eluting stents
5144256|NCT01035554|high blood pressure|high blood pressure
5144257|NCT01035541|Major non-cardiac surgery,|major non-cardiac surgery,
5144258|NCT01035541|hemodynamic management,|hemodynamic management,
5144259|NCT01035541|PiCCO,|picco,
5144260|NCT01035541|acute kidney injury,|acute kidney injury,
5144261|NCT01035541|renal outcome|renal outcome
5144262|NCT01035528|diastolic function, postmeal glucose, insulin glargine|diastolic function, postmeal glucose, insulin glargine
5144263|NCT01035515|Healthy subjects|healthy subjects
5144264|NCT01035502|Cancer|cancer
5144265|NCT01035502|CP-4055|cp-4055
5144266|NCT01035502|elacytarabine|elacytarabine
5144267|NCT01035502|combination|combination
5144268|NCT01035502|idarubicin|idarubicin
5144269|NCT01035502|Acute myeloid leukaemia (AML)|acute myeloid leukaemia (aml)
5144270|NCT01035489|Pacemaker treatment in heart failure|pacemaker treatment in heart failure
5144271|NCT01035489|Cardiac resynchronization therapy|cardiac resynchronization therapy
5144272|NCT01035489|DDD pacemakers|ddd pacemakers
5144273|NCT01035476|ALS|als
5144274|NCT01035476|nasal ventilation|nasal ventilation
5144275|NCT01035476|data card recording|data card recording
5144276|NCT01035450|Coronary stent|coronary stent
5144277|NCT01035437|obstructing|obstructing
5144278|NCT01035424|Batten Disease|batten disease
5144279|NCT01035424|Late Infantile Neuronal Lipofuscinosis|late infantile neuronal lipofuscinosis
5144280|NCT01035424|LINCL|lincl
5144281|NCT01035411|COPD|copd
5144282|NCT01035398|stage 0 esophageal cancer|stage 0 esophageal cancer
5144283|NCT01035398|stage I esophageal cancer|stage i esophageal cancer
5144284|NCT01035398|stage II esophageal cancer|stage ii esophageal cancer
5144285|NCT01035398|stage III esophageal cancer|stage iii esophageal cancer
5144286|NCT01035398|stage IV esophageal cancer|stage iv esophageal cancer
5144287|NCT01035385|FOFLOX4|foflox4
5144288|NCT01035385|resectable liver metastasis from colorectal cancer|resectable liver metastasis from colorectal cancer
5144289|NCT01035372|healthy older people|healthy older people
5144290|NCT01035359|radius|radius
5144291|NCT01035359|fracture|fracture
5144292|NCT01035359|wrist|wrist
5144293|NCT01035359|external|external
5144294|NCT01035359|fixation|fixation
5144295|NCT01035359|volar|volar
5144296|NCT01035359|plate|plate
5144297|NCT01035359|DASH|dash
5144298|NCT01035359|PRWE|prwe
5144299|NCT01035346|Fever|fever
5144300|NCT01035346|antipyretic|antipyretic
5144301|NCT01035346|uncomplicated acute viral infection|uncomplicated acute viral infection
5144302|NCT01035346|uncomplicated acute bacterial infections|uncomplicated acute bacterial infections
5144303|NCT01035333|gastric bypass surgery|gastric bypass surgery
5144304|NCT01035307|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
5144305|NCT01035307|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5144306|NCT01035281|Diabetic Neuropathies|diabetic neuropathies
5144307|NCT01035281|Neuropathic Pain|neuropathic pain
5144308|NCT01035281|Cannabinoids|cannabinoids
5144309|NCT01035281|Tree Number C10.668.829.300|tree number c10.668.829.300
5144310|NCT01035268|breast cancer treated by conservative surgery|breast cancer treated by conservative surgery
5144311|NCT01035255|chronic heart failure|chronic heart failure
5144312|NCT01035255|cardiovascular death|cardiovascular death
5144313|NCT01035255|hospitalization|hospitalization
5144314|NCT01035255|outcome study|outcome study
5144315|NCT01035255|BNP|bnp
5144316|NCT01035255|KCCQ|kccq
5144317|NCT01035255|eGFR|egfr
5144318|NCT01035242|OCD|ocd
5144319|NCT01035242|obsessions|obsessions
5144320|NCT01035242|cognitive|cognitive
5144321|NCT01035229|Hepatocellular carcinoma|hepatocellular carcinoma
5144322|NCT01035229|randomized trial|randomized trial
5144323|NCT01035229|medical treatment|medical treatment
5144324|NCT01035229|RAD001|rad001
5144325|NCT01035229|placebo|placebo
5144326|NCT01035229|Advanced Hepatocellular Carcinoma (HCC)|advanced hepatocellular carcinoma (hcc)
5144327|NCT01035216|Relapsed or Refractory B-Cell Chronic Lymphocytic Leukemia (B-CLL)|relapsed or refractory b-cell chronic lymphocytic leukemia (b-cll)
5144328|NCT01035190|Preterm Infants|preterm infants
5144329|NCT01035190|Inhaled Corticosteroids|inhaled corticosteroids
5144330|NCT01035190|Bronchopulmonary Dysplasia|bronchopulmonary dysplasia
5144331|NCT01035177|Bone Mineral Density (BMD);|bone mineral density (bmd);
5144332|NCT01035177|Cortical bone;|cortical bone;
5144333|NCT01035177|Hip fracture;|hip fracture;
5144334|NCT01035177|Osteoporosis;|osteoporosis;
5144335|NCT01035177|Quantitative Computed Tomography (QCT).|quantitative computed tomography (qct).
5144336|NCT01035164|Alzheimer's Disease|alzheimer's disease
5144337|NCT01035164|Diagnostic Imaging|diagnostic imaging
5144338|NCT01035164|Neuroinflammation|neuroinflammation
5144339|NCT01035164|PET Diagnosis|pet diagnosis
5144340|NCT01035164|PET Tracer|pet tracer
5144341|NCT01035151|randomized cluster design|randomized cluster design
5144342|NCT01035151|tobacco cessation|tobacco cessation
5144343|NCT01035151|smoking cessation|smoking cessation
5144344|NCT01035151|African American|african american
5144345|NCT01035125|Self-management|self-management
5144346|NCT01035125|Self-efficacy|self-efficacy
5144347|NCT01035125|Coping|coping
5144348|NCT01035125|Health consumer|health consumer
5144349|NCT01035125|Patient education|patient education
5144350|NCT01035125|Health related quality of life|health related quality of life
5144351|NCT01035099|Letrozole|letrozole
5144352|NCT01035099|IVF (in vitro fertilization)|ivf (in vitro fertilization)
5144353|NCT01035099|Cryopreservation|cryopreservation
5144354|NCT01035099|Fertility Preservation|fertility preservation
5144355|NCT01035099|Breast Cancer|breast cancer
5144356|NCT01035086|dietary fibre|dietary fibre
5144357|NCT01035086|lupin kernel fibre|lupin kernel fibre
5144358|NCT01035086|bile acids|bile acids
5144359|NCT01035086|cholesterol metabolism|cholesterol metabolism
5144360|NCT01035086|blood lipids|blood lipids
5144361|NCT01035086|hypercholesterolemia|hypercholesterolemia
5144362|NCT01035086|fibre-enriched food|fibre-enriched food
5144363|NCT01035086|moderate hypercholesterolemia|moderate hypercholesterolemia
5144364|NCT01035047|Acute Coronary Syndrome|acute coronary syndrome
5144365|NCT01035047|Chest pain|chest pain
5144366|NCT01035047|Cardiac MRI|cardiac mri
5144367|NCT01035047|Risk Stratification|risk stratification
5144368|NCT01035047|Emergency Department|emergency department
5144369|NCT01035008|pancreatic cysts|pancreatic cysts
5144370|NCT01034982|COPD|copd
5144371|NCT01034969|Hereditary angioedema|hereditary angioedema
5144372|NCT01034956|Soft tissue filler|soft tissue filler
5144373|NCT01034956|Dermal filler|dermal filler
5144374|NCT01034956|Complications|complications
5144375|NCT01034956|Patient satisfaction|patient satisfaction
5144376|NCT01034943|radius|radius
5144377|NCT01034943|fracture|fracture
5144378|NCT01034943|wrist|wrist
5144379|NCT01034943|external|external
5144380|NCT01034943|fixation|fixation
5144381|NCT01034943|volar|volar
5144382|NCT01034943|plate|plate
5144383|NCT01034943|DASH|dash
5144384|NCT01034943|PRWE|prwe
5144385|NCT01034930|MANDIBLE|mandible
5144386|NCT01034930|IMPLANTS|implants
5144387|NCT01034930|OVERDENTURE|overdenture
5144388|NCT01034917|Active Comparator|active comparator
5144389|NCT01034917|Placebo Comparator|placebo comparator
5144390|NCT01034917|Sham Comparator|sham comparator
5144391|NCT01034917|No intervention|no intervention
5144392|NCT01034917|Other|other
5144393|NCT01034917|Treatment Experienced|treatment experienced
5144394|NCT01034904|Quality of Life|quality of life
5144395|NCT01034904|HRQoL|hrqol
5144396|NCT01034904|Hemophilia A|hemophilia a
5144397|NCT01034904|Helixate FS|helixate fs
5144398|NCT01034891|BRCA mutation|brca mutation
5144399|NCT01034891|benign breast disease|benign breast disease
5144400|NCT01034891|family history of breast cancer|family history of breast cancer
5144401|NCT01034891|strong family history of breast cancer|strong family history of breast cancer
5144402|NCT01034891|atypical ductal hyperplasia|atypical ductal hyperplasia
5144403|NCT01034891|atypical lobular hyperplasia|atypical lobular hyperplasia
5144404|NCT01034891|high risk for breast cancer|high risk for breast cancer
5144405|NCT01034852|Atrial Fibrillation|atrial fibrillation
5144406|NCT01034852|Maze|maze
5144407|NCT01034852|Ablation|ablation
5144408|NCT01034839|acute myeloid leukemia|acute myeloid leukemia
5144409|NCT01034839|prognosis|prognosis
5144410|NCT01034839|cytarabine|cytarabine
5144411|NCT01034826|NGT, IGT, diabetes|ngt, igt, diabetes
5144412|NCT01034813|contractures, range of motion, scar formation|contractures, range of motion, scar formation
5144413|NCT01034800|HIV Positive|hiv positive
5144414|NCT01034787|CP-675,206|cp-675,206
5144415|NCT01034787|Immunotherapy|immunotherapy
5144416|NCT01034787|AntiCTLA4|antictla4
5144417|NCT01034787|Clinical Trial|clinical trial
5144418|NCT01034787|Unresectable or Metastatic|unresectable or metastatic
5144419|NCT01034774|Human volunteers|human volunteers
5144420|NCT01034761|Electronic prescribing|electronic prescribing
5144421|NCT01034761|Inappropriate medications|inappropriate medications
5144422|NCT01034761|Patient safety|patient safety
5144423|NCT01034761|Elderly patients in the hospital|elderly patients in the hospital
5144424|NCT01034748|Radiolabelled|radiolabelled
5144425|NCT01034748|Mass Balance|mass balance
5144426|NCT01034748|Healthy Volunteers|healthy volunteers
5144427|NCT01034748|Pharmacokinetics|pharmacokinetics
5144428|NCT01034735|Saizen®|saizen®
5144429|NCT01034735|bioequivalence|bioequivalence
5144430|NCT01034735|recombinant human|recombinant human
5144431|NCT01034735|Growth Hormone|growth hormone
5144432|NCT01034735|treatment of growth failure in children|treatment of growth failure in children
5144433|NCT01034735|growth hormone deficiency in adults|growth hormone deficiency in adults
5144434|NCT01034722|Breast Milk|breast milk
5144435|NCT01034722|Fat Globules|fat globules
5144436|NCT01034709|Cytomegalovirus|cytomegalovirus
5144438|NCT01034657|MDS|mds
5144439|NCT01034657|bone marrow|bone marrow
5144440|NCT01034657|anemia|anemia
5144441|NCT01034657|cytopenia|cytopenia
5144442|NCT01034657|transfusion dependance|transfusion dependance
5144443|NCT01034657|EPO|epo
5144444|NCT01034657|ESA|esa
5144445|NCT01034657|erythropoietin|erythropoietin
5144446|NCT01034657|LBH589|lbh589
5144447|NCT01034657|Myelodysplastic Syndromes|myelodysplastic syndromes
5144448|NCT01034657|hematopoietic improvement|hematopoietic improvement
5144449|NCT01034657|IPSS Low|ipss low
5144450|NCT01034657|IPSS Int-1|ipss int-1
5144451|NCT01034657|HI-E|hi-e
5144452|NCT01034657|HDAC Inhibitor|hdac inhibitor
5144453|NCT01034657|HDAC-I|hdac-i
5144454|NCT01034657|DAC-I|dac-i
5144455|NCT01034657|Deacetylase-Inhibitor|deacetylase-inhibitor
5144456|NCT01034657|Histone Deacetylase-Inhibitor|histone deacetylase-inhibitor
5144457|NCT01034657|red blood cell transfusions|red blood cell transfusions
5144458|NCT01034644|Biomarkers|biomarkers
5144459|NCT01034644|Genetic markers|genetic markers
5144460|NCT01034631|Metastatic Kidney Cancer|metastatic kidney cancer
5144461|NCT01034631|BNC105P|bnc105p
5144462|NCT01034618|Diabetes|diabetes
5144463|NCT01034618|protein|protein
5144464|NCT01034618|protein hydrolysate|protein hydrolysate
5144465|NCT01034579|Biomarkers|biomarkers
5144466|NCT01034579|Genetic markers|genetic markers
5144467|NCT01034527|Anterior Cruciate Ligament|anterior cruciate ligament
5144468|NCT01034527|Female Athlete|female athlete
5144469|NCT01034527|Sports Injuries|sports injuries
5144470|NCT01034527|Injury Prevention|injury prevention
5144471|NCT01034501|periodontitis|periodontitis
5144472|NCT01034501|photodynamic therapy|photodynamic therapy
5144473|NCT01034475|acute myeloid leukemia|acute myeloid leukemia
5144474|NCT01034475|acute lymphoblastic leukemia|acute lymphoblastic leukemia
5144475|NCT01034475|multiple myeloma|multiple myeloma
5144476|NCT01034475|chronic myeloid\ leukemia in blast phase|chronic myeloid\ leukemia in blast phase
5144477|NCT01034462|Depression|depression
5144478|NCT01034462|Major Depressive Disorder|major depressive disorder
5144479|NCT01034449|allo graft|allo graft
5144480|NCT01034449|cord blood|cord blood
5144481|NCT01034449|expansion|expansion
5144482|NCT01034449|reduced-intensity conditioning|reduced-intensity conditioning
5144483|NCT01034423|Focus: health effects from omega-3 fatty acids, from fish oil with different quality|focus: health effects from omega-3 fatty acids, from fish oil with different quality
5144484|NCT01034410|AS1411|as1411
5144485|NCT01034410|AML|aml
5144486|NCT01034410|relapsed|relapsed
5144487|NCT01034410|refractory|refractory
5144488|NCT01034410|aptamer|aptamer
5144489|NCT01034410|nucleolin|nucleolin
5144490|NCT01034384|fMRI|fmri
5144491|NCT01034384|Smoking Withdrawal|smoking withdrawal
5144492|NCT01034384|Imaging|imaging
5144493|NCT01034384|Memory|memory
5144494|NCT01034384|Mood|mood
5144495|NCT01034371|Coronary Artery Disease; Hybrid Revascularization;|coronary artery disease; hybrid revascularization;
5144496|NCT01034371|Percutaneous Coronary Intervention; Coronary Artery Bypass|percutaneous coronary intervention; coronary artery bypass
5144497|NCT01034358|inflammatory bowel disease|inflammatory bowel disease
5144498|NCT01034358|Crohn disease|crohn disease
5144499|NCT01034358|ulcerative colitis|ulcerative colitis
5144500|NCT01034358|Papillomavirus vaccines|papillomavirus vaccines
5144501|NCT01034345|Sirolimus|sirolimus
5144502|NCT01034345|Liver Transplantation|liver transplantation
5144503|NCT01034345|Tolerance|tolerance
5144504|NCT01034345|Immune responses|immune responses
5144505|NCT01034345|Allograft tolerance|allograft tolerance
5144506|NCT01034332|Esophageal cancer|esophageal cancer
5144507|NCT01034332|Esophagectomy|esophagectomy
5144508|NCT01034332|Paclitaxel|paclitaxel
5144509|NCT01034332|Induction chemotherapy|induction chemotherapy
5144510|NCT01034319|type 2 diabetes|type 2 diabetes
5144511|NCT01034319|genetics|genetics
5144512|NCT01034319|genetic counseling|genetic counseling
5144513|NCT01034319|diabetes prevention|diabetes prevention
5144514|NCT01034293|feeding frequency|feeding frequency
5144515|NCT01034293|insulin metabolism|insulin metabolism
5144516|NCT01034293|glucose metabolism|glucose metabolism
5144517|NCT01034293|substrate partitioning|substrate partitioning
5144518|NCT01034280|Down Syndrome|down syndrome
5144519|NCT01034280|phenotype|phenotype
5144520|NCT01034280|genotype|genotype
5144521|NCT01034280|patient family|patient family
5144522|NCT01034267|Depression|depression
5144523|NCT01034267|Major Depressive Disorder|major depressive disorder
5144524|NCT01034254|influenza|influenza
5144525|NCT01034254|immunization|immunization
5144526|NCT01034254|pregnancy|pregnancy
5144527|NCT01034254|efficacy|efficacy
5144528|NCT01034254|pertussis|pertussis
5144529|NCT01034254|hepatitis E|hepatitis e
5144530|NCT01034241|milk protein|milk protein
5144531|NCT01034241|overweight|overweight
5144532|NCT01034241|insulin metabolism|insulin metabolism
5144533|NCT01034241|substrate partitioning|substrate partitioning
5144534|NCT01034228|Diarrhoea|diarrhoea
5144535|NCT01034228|L-isoleucine|l-isoleucine
5144536|NCT01034228|children|children
5144537|NCT01034228|ORS|ors
5144538|NCT01034228|Antibacterial peptide|antibacterial peptide
5144539|NCT01034215|Behavioral|behavioral
5144540|NCT01034215|Quality of Life|quality of life
5144541|NCT01034215|Breast Cancer|breast cancer
5144542|NCT01034189|Esophageal cancer|esophageal cancer
5144543|NCT01034189|Chemoradiotherapy|chemoradiotherapy
5144544|NCT01034189|Paclitaxel|paclitaxel
5144545|NCT01034189|Cetuximab|cetuximab
5144546|NCT01034176|BK viremia|bk viremia
5144547|NCT01034176|kidney transplantation|kidney transplantation
5144548|NCT01034176|BK viremia in kidney transplant recipients|bk viremia in kidney transplant recipients
5144549|NCT01034163|Phase III randomized|phase iii randomized
5144550|NCT01034163|double blind|double blind
5144551|NCT01034163|placebo controlled multi-center study|placebo controlled multi-center study
5144552|NCT01034163|panobinostat|panobinostat
5144553|NCT01034163|Hodgkin's lymphoma|hodgkin's lymphoma
5144554|NCT01034163|at risk for relapse|at risk for relapse
5144555|NCT01034163|autologous stem cell transplant|autologous stem cell transplant
5144556|NCT01034137|Treat-to-target, tight control, strategy study, TCZ, MTX|treat-to-target, tight control, strategy study, tcz, mtx
5144557|NCT01034124|warfarin|warfarin
5144558|NCT01034124|midazolam|midazolam
5144559|NCT01034124|cranberry juice|cranberry juice
5144560|NCT01034124|pharmacokinetics|pharmacokinetics
5144561|NCT01034098|Obesity|obesity
5144562|NCT01034098|Postmenopausal women|postmenopausal women
5144563|NCT01034098|Mechanical ventilatory constraints|mechanical ventilatory constraints
5144564|NCT01034098|Dynamic lung volume|dynamic lung volume
5144565|NCT01034098|Expiratory flow limitation|expiratory flow limitation
5144566|NCT01034085|Nicotine|nicotine
5144567|NCT01034085|Schizophrenia|schizophrenia
5144568|NCT01034085|Cognition|cognition
5144569|NCT01034085|Genes|genes
5144570|NCT01034085|Smoking|smoking
5144571|NCT01034085|Cigarette Smoking|cigarette smoking
5144572|NCT01034046|Obesity|obesity
5144573|NCT01034033|quality of life|quality of life
5144574|NCT01034020|Nasal Spray|nasal spray
5144575|NCT01034020|Attention Network Test|attention network test
5144576|NCT01034020|Continuous Performance Test|continuous performance test
5144577|NCT01034020|Attentional Blink Test|attentional blink test
5144578|NCT01034007|tissue engineered vascular graft|tissue engineered vascular graft
5144579|NCT01033994|Knee osteoarthritis|knee osteoarthritis
5144580|NCT01033994|Fibroblast growth factor 18|fibroblast growth factor 18
5144581|NCT01033994|Sprifermin|sprifermin
5144582|NCT01033981|cost effectiveness|cost effectiveness
5144583|NCT01033981|Sunitinib Central America and Caribbean Metastatic Renal Cell Carcinoma|sunitinib central america and caribbean metastatic renal cell carcinoma
5144584|NCT01033968|lasers|lasers
5144585|NCT01033968|pain measurement|pain measurement
5144586|NCT01033968|photocoagulation|photocoagulation
5144587|NCT01033968|retina|retina
5144588|NCT01033955|critical care|critical care
5144589|NCT01033955|H1N1/influenza infection|h1n1/influenza infection
5144590|NCT01033955|respiration|respiration
5144591|NCT01033955|ventilation, artificial|ventilation, artificial
5144592|NCT01033955|critically ill patients|critically ill patients
5144593|NCT01033955|invasive mechanical ventilation|invasive mechanical ventilation
5144594|NCT01033955|H1N1/influenza infection (suspected, probable or confirmed)|h1n1/influenza infection (suspected, probable or confirmed)
5144595|NCT01033942|Pre-exposure prophylaxis|pre-exposure prophylaxis
5144596|NCT01033942|HIV Prevention|hiv prevention
5144597|NCT01033942|Truvada|truvada
5144598|NCT01033942|Many Men, Many Voices|many men, many voices
5144599|NCT01033942|Emtricitabine|emtricitabine
5144600|NCT01033942|Tenofovir disoproxil fumarate|tenofovir disoproxil fumarate
5144601|NCT01033942|Young men who have sex with men|young men who have sex with men
5144602|NCT01033942|HIV Seronegativity|hiv seronegativity
5144603|NCT01033929|tuberculosis|tuberculosis
5144604|NCT01033929|ESAT-6|esat-6
5144605|NCT01033929|CFP-10|cfp-10
5144606|NCT01033929|skin test|skin test
5144607|NCT01033929|diagnostic test|diagnostic test
5144608|NCT01033916|Blood Glucose|blood glucose
5144609|NCT01033916|Insulin/Administration and Dosage|insulin/administration and dosage
5144610|NCT01033916|Coronary Artery Bypass|coronary artery bypass
5144611|NCT01033903|Abortion, Spontaneous|abortion, spontaneous
5144612|NCT01033903|Randomized Controlled Trial|randomized controlled trial
5144613|NCT01033890|local anesthesia|local anesthesia
5144614|NCT01033890|cochlear implant|cochlear implant
5144615|NCT01033890|sedation|sedation
5144616|NCT01033890|3 patients submitted to cochlear implant surgery with local anesthesia with sedation|3 patients submitted to cochlear implant surgery with local anesthesia with sedation
5144617|NCT01033877|Immunisation, active|immunisation, active
5144618|NCT01033812|Networks|networks
5144619|NCT01033812|Index recruiter|index recruiter
5144620|NCT01033799|Probiotic - Lactobacillus casei DN114-001|probiotic - lactobacillus casei dn114-001
5144621|NCT01033799|dairy product - infections - shiftworkers|dairy product - infections - shiftworkers
5144622|NCT01033799|Common infectious diseases,|common infectious diseases,
5144623|NCT01033799|occuring in healthy subjects,|occuring in healthy subjects,
5144624|NCT01033799|including upper respiratory tract infections (defined as rhinopharyngitis, sore throat, sinusitis and otitis),|including upper respiratory tract infections (defined as rhinopharyngitis, sore throat, sinusitis and otitis),
5144625|NCT01033799|lower respiratory tract infections (defined as bronchitis,|lower respiratory tract infections (defined as bronchitis,
5144626|NCT01033799|pneumopathy and flu and flu-like syndromes), and|pneumopathy and flu and flu-like syndromes), and
5144627|NCT01033799|gastrointestinal tract infection defined as gastroenteritis.|gastrointestinal tract infection defined as gastroenteritis.
5144628|NCT01033773|Type 2 diabetes mellitus|type 2 diabetes mellitus
5144629|NCT01033773|Uncontrolled hyperglycemia|uncontrolled hyperglycemia
5144630|NCT01033773|Emergency Department|emergency department
5144631|NCT01033760|Primary HIV-1 infection|primary hiv-1 infection
5144632|NCT01033760|antiretroviral treatment|antiretroviral treatment
5144633|NCT01033760|HIV reservoirs|hiv reservoirs
5144634|NCT01033760|HIV-DNA levels|hiv-dna levels
5144635|NCT01033760|randomized|randomized
5144636|NCT01033760|Treatment Naive|treatment naive
5144637|NCT01033747|iron overload|iron overload
5144638|NCT01033747|iron chelation therapy|iron chelation therapy
5144639|NCT01033747|B-thalassemia|b-thalassemia
5144640|NCT01033708|Psychotherapy|psychotherapy
5144641|NCT01033708|PTSD|ptsd
5144642|NCT01033708|Borderline personality disorders|borderline personality disorders
5144643|NCT01033695|Endoscopy|endoscopy
5144644|NCT01033695|Endoscopic Ultrasound|endoscopic ultrasound
5144645|NCT01033695|Endoscopic Sonoelastography|endoscopic sonoelastography
5144646|NCT01033695|Cancer|cancer
5144647|NCT01033695|Interobserver agreement|interobserver agreement
5144648|NCT01033669|Inhalation profiles|inhalation profiles
5144649|NCT01033669|asthma|asthma
5144650|NCT01033669|COPD|copd
5144651|NCT01033656|adult-onset Still's disease|adult-onset still's disease
5144652|NCT01033656|anakinra|anakinra
5144653|NCT01033656|prednisolone|prednisolone
5144654|NCT01033656|disease-modifying antirheumatic drug|disease-modifying antirheumatic drug
5144655|NCT01033656|methotrexate|methotrexate
5144656|NCT01033656|efficacy|efficacy
5144657|NCT01033656|patients|patients
5144658|NCT01033617|Stem cells|stem cells
5144659|NCT01033617|Cellular therapy|cellular therapy
5144660|NCT01033617|Myocardial repair|myocardial repair
5144661|NCT01033591|Primary Health Care|primary health care
5144662|NCT01033591|Family PractiCe|family practice
5144663|NCT01033591|Hearth Failure|hearth failure
5144664|NCT01033591|Exercise|exercise
5144665|NCT01033591|Randomized Controlled Trials|randomized controlled trials
5144666|NCT01033591|Multicenter Study|multicenter study
5144667|NCT01033591|Quality of life|quality of life
5144668|NCT01033565|Impaired sleep maintenance|impaired sleep maintenance
5144669|NCT01033565|Autism Spectrum Disorders|autism spectrum disorders
5144670|NCT01033565|Pediatric|pediatric
5144671|NCT01033539|Survive|survive
5144672|NCT01033539|safety|safety
5144673|NCT01033539|lactobacillus Reuteri|lactobacillus reuteri
5144674|NCT01033526|Symptomatic treatment of Common Cold symptoms|symptomatic treatment of common cold symptoms
5144675|NCT01033487|Safety|safety
5144676|NCT01033487|Pharmacokinetics|pharmacokinetics
5144677|NCT01033487|Pharmacodynamics|pharmacodynamics
5144678|NCT01033487|PF-03635659|pf-03635659
5144679|NCT01033487|COPD|copd
5144680|NCT01033474|Infertile Patients|infertile patients
5144681|NCT01033461|probiotic|probiotic
5144682|NCT01033461|lactobacillus paracasei|lactobacillus paracasei
5144683|NCT01033461|calcium|calcium
5144684|NCT01033461|faecal microbiota|faecal microbiota
5144685|NCT01033461|cholesterol metabolism|cholesterol metabolism
5144686|NCT01033435|Inflammation|inflammation
5144687|NCT01033435|Oxidative stress|oxidative stress
5144688|NCT01033435|HbA1c|hba1c
5144689|NCT01033435|Hemodialysis|hemodialysis
5144690|NCT01033422|Glaucoma|glaucoma
5144691|NCT01033422|Ocular hypertension|ocular hypertension
5144692|NCT01033422|Intraocular hypertension|intraocular hypertension
5144693|NCT01033409|Salmonella Typhi|salmonella typhi
5144694|NCT01033409|pneumonia|pneumonia
5144695|NCT01033409|oral|oral
5144696|NCT01033409|vaccine|vaccine
5144697|NCT01033396|Allergic rhinitis Environmental exposure unit|allergic rhinitis environmental exposure unit
5144698|NCT01033370|acute|acute
5144699|NCT01033370|aortic|aortic
5144700|NCT01033370|emergencies|emergencies
5144701|NCT01033370|Aortic dissection|aortic dissection
5144702|NCT01033357|dialysis|dialysis
5144703|NCT01033357|hemodialysis|hemodialysis
5144704|NCT01033357|neointimal hyperplasia|neointimal hyperplasia
5144705|NCT01033344|Cat allergy|cat allergy
5144706|NCT01033344|Rhinoconjunctivitis|rhinoconjunctivitis
5144707|NCT01033344|Exposure chamber|exposure chamber
5144708|NCT01033344|Immunotherapy|immunotherapy
5144709|NCT01033344|Cat-PAD|cat-pad
5144710|NCT01033331|Spinal Muscular atrophy|spinal muscular atrophy
5144711|NCT01033331|Valproic acid|valproic acid
5144712|NCT01033331|HMAS|hmas
5144713|NCT01033331|MRC scale|mrc scale
5144714|NCT01033318|Hypertension|hypertension
5144715|NCT01033305|UC|uc
5144716|NCT01033292|ovarian|ovarian
5144717|NCT01033292|cancer|cancer
5144718|NCT01033292|sensitive|sensitive
5144719|NCT01033292|PARP|parp
5144720|NCT01033292|recurrent|recurrent
5144721|NCT01033292|platinum-resistant recurrent ovarian cancer|platinum-resistant recurrent ovarian cancer
5144722|NCT01033279|Coaguchek|coaguchek
5144723|NCT01033279|Portable coagulometer|portable coagulometer
5144724|NCT01033279|Self-monitoring|self-monitoring
5144725|NCT01033279|Coumadin|coumadin
5144726|NCT01033279|Warfarin|warfarin
5144727|NCT01033279|Quality of life|quality of life
5144728|NCT01033279|Pharmacist|pharmacist
5144729|NCT01033227|sickle cell disease|sickle cell disease
5144730|NCT01033227|sickle cell anemia|sickle cell anemia
5144731|NCT01033227|pain crisis|pain crisis
5144732|NCT01033227|nitric oxide|nitric oxide
5144733|NCT01033227|nitrite|nitrite
5144734|NCT01033227|vaso occlusive crisis|vaso occlusive crisis
5144735|NCT01033227|pain medication|pain medication
5144736|NCT01033227|sickled cells|sickled cells
5144737|NCT01033227|blood flow|blood flow
5144738|NCT01033227|microcirculation|microcirculation
5144739|NCT01033214|TAA|taa
5144740|NCT01033214|Thoracic|thoracic
5144741|NCT01033214|Descending Thoracic Aorta|descending thoracic aorta
5144742|NCT01033214|TAArget|taarget
5144743|NCT01033201|Lung rejection|lung rejection
5144744|NCT01033188|double bundle|double bundle
5144745|NCT01033188|hamstring graft|hamstring graft
5144746|NCT01033188|ACL reconstruction|acl reconstruction
5144747|NCT01033188|single bundle|single bundle
5144748|NCT01033175|COPD|copd
5144749|NCT01033175|anemia|anemia
5144750|NCT01033175|exercise|exercise
5144751|NCT01033175|cytokines|cytokines
5144752|NCT01033175|erythropoietin|erythropoietin
5144753|NCT01033123|ovarian|ovarian
5144754|NCT01033123|cancer|cancer
5144755|NCT01033123|sensitive|sensitive
5144756|NCT01033123|PARP|parp
5144757|NCT01033123|recurrent|recurrent
5144758|NCT01033123|platinum-sensitive recurrent ovarian cancer|platinum-sensitive recurrent ovarian cancer
5144759|NCT01033110|inactive|inactive
5144760|NCT01033110|>45 years|>45 years
5144761|NCT01033110|female|female
5144762|NCT01033097|Dermatitis|dermatitis
5144763|NCT01033097|inflammatory skin disease|inflammatory skin disease
5144764|NCT01033097|itch|itch
5144765|NCT01033097|eczema|eczema
5144766|NCT01033084|Depressive Disorder, Major|depressive disorder, major
5144767|NCT01033071|Hypertensive|hypertensive
5144768|NCT01033071|Blood Pressure, High|blood pressure, high
5144769|NCT01033071|Cardiovascular disease|cardiovascular disease
5144770|NCT01033071|Vascular Disease|vascular disease
5144771|NCT01033071|Drug Therapy|drug therapy
5144772|NCT01033058|STEMI|stemi
5144773|NCT01033058|atorvastatin|atorvastatin
5144774|NCT01033058|PCI|pci
5144775|NCT01033045|Hepatitis C|hepatitis c
5144776|NCT01033045|Viral|viral
5144777|NCT01033045|Non-A|non-a
5144778|NCT01033045|Non-B|non-b
5144779|NCT01033045|Parenterally-Transmitted|parenterally-transmitted
5144780|NCT01033032|Metastatic Breast Cancer|metastatic breast cancer
5144781|NCT01033032|Amrubicin|amrubicin
5144782|NCT01033019|Basal cell carcinomas,|basal cell carcinomas,
5144783|NCT01033019|sporadic,|sporadic,
5144784|NCT01033019|superficial and nodular,|superficial and nodular,
5144785|NCT01033019|skin|skin
5144786|NCT01033006|Peripheral Nerves|peripheral nerves
5144787|NCT01033006|Axillary Block|axillary block
5144788|NCT01033006|MRI|mri
5144789|NCT01032993|CoQ10|coq10
5144790|NCT01032993|Statins|statins
5144791|NCT01032993|Myalgia|myalgia
5144792|NCT01032993|Muscle Pain|muscle pain
5144793|NCT01032993|Muscle Weakness|muscle weakness
5144794|NCT01032980|HUMENZA|humenza
5144795|NCT01032980|PANENZA|panenza
5144796|NCT01032980|Influenza|influenza
5144797|NCT01032980|Swine-Origin Influenza A H1N1 Virus|swine-origin influenza a h1n1 virus
5144798|NCT01032980|Influenza virus vaccines|influenza virus vaccines
5144799|NCT01032967|squamous cell carcinoma|squamous cell carcinoma
5144800|NCT01032967|esophagectomy|esophagectomy
5144801|NCT01032967|chemoradiotherapy|chemoradiotherapy
5144802|NCT01032967|chemoradiation|chemoradiation
5144803|NCT01032967|Squamous cell carcinomas of the esophagus|squamous cell carcinomas of the esophagus
5144804|NCT01032954|Botulinum Toxin|botulinum toxin
5144805|NCT01032954|Rejuvenation|rejuvenation
5144806|NCT01032954|Facial dynamic wrinkles|facial dynamic wrinkles
5144807|NCT01032941|Portal Hypertension|portal hypertension
5144808|NCT01032941|Portal Pressure Measurement|portal pressure measurement
5144809|NCT01032941|VSL3|vsl3
5144810|NCT01032941|Cirrhosis|cirrhosis
5144811|NCT01032941|End Stage Liver Disease|end stage liver disease
5144812|NCT01032941|Probiotics|probiotics
5144813|NCT01032928|Swallowing|swallowing
5144814|NCT01032928|Dysphagia|dysphagia
5144815|NCT01032928|Breathing and swallowing|breathing and swallowing
5144816|NCT01032928|Oropharyngeal cancer|oropharyngeal cancer
5144817|NCT01032915|Quiescent uveitis|quiescent uveitis
5144818|NCT01032915|intermediate uveitis|intermediate uveitis
5144819|NCT01032915|panuveitis|panuveitis
5144820|NCT01032915|posterior uveitis|posterior uveitis
5144821|NCT01032915|uveitis|uveitis
5144822|NCT01032902|Human immunodeficiency virus|human immunodeficiency virus
5144823|NCT01032902|Rapid Test|rapid test
5144824|NCT01032902|HIV|hiv
5144825|NCT01032902|HIV Seronegativity|hiv seronegativity
5144826|NCT01032876|Congenital Heart disease|congenital heart disease
5144827|NCT01032876|Cardiopulmonary bypass|cardiopulmonary bypass
5144828|NCT01032876|Neonatal brain injury|neonatal brain injury
5144829|NCT01032876|Deep Hypothermic Circulatory Arrest|deep hypothermic circulatory arrest
5144830|NCT01032876|Antegrade Cerebral Perfusion|antegrade cerebral perfusion
5144831|NCT01032863|Chronic musculoskeletal pain|chronic musculoskeletal pain
5144832|NCT01032863|Benign joint hypermobility syndrome|benign joint hypermobility syndrome
5144833|NCT01032863|Fibromyalgia|fibromyalgia
5144834|NCT01032850|INST 0820|inst 0820
5144835|NCT01032850|sorafenib|sorafenib
5144836|NCT01032850|capecitabine|capecitabine
5144837|NCT01032850|hepatocellular carcinoma|hepatocellular carcinoma
5144838|NCT01032850|lung|lung
5144839|NCT01032850|nexavar|nexavar
5144840|NCT01032850|xeloda|xeloda
5144841|NCT01032850|liver cancer|liver cancer
5144842|NCT01032824|Complementary Therapies|complementary therapies
5144843|NCT01032811|ADHD, childhood cancer|adhd, childhood cancer
5144844|NCT01032811|ADHD/Secondary ADHD Among Survivors of Childhood Cancer|adhd/secondary adhd among survivors of childhood cancer
5144845|NCT01032785|Patent Foramen Ovale|patent foramen ovale
5144846|NCT01032785|Patent Ductus Arteriosus|patent ductus arteriosus
5144847|NCT01032785|PFO|pfo
5144848|NCT01032785|PDA|pda
5144849|NCT01032772|alcohol-exposed pregnancy|alcohol-exposed pregnancy
5144850|NCT01032772|tobacco-exposed pregnancy|tobacco-exposed pregnancy
5144851|NCT01032772|alcohol|alcohol
5144852|NCT01032772|contraception|contraception
5144853|NCT01032772|smoking|smoking
5144854|NCT01032772|pregnancy|pregnancy
5144855|NCT01032746|colon cancer|colon cancer
5144856|NCT01032746|rectal cancer|rectal cancer
5144857|NCT01032733|Weight Loss|weight loss
5144858|NCT01032733|Physical Function|physical function
5144859|NCT01032733|Oxidative Stress|oxidative stress
5144860|NCT01032733|Inflammation|inflammation
5144861|NCT01032720|ultrasound|ultrasound
5144862|NCT01032720|osteoarthritis|osteoarthritis
5144863|NCT01032720|knee|knee
5144864|NCT01032720|corticosteroids|corticosteroids
5144865|NCT01032720|intra-articular|intra-articular
5144866|NCT01032720|injections|injections
5144867|NCT01032694|Community-Acquired Pneumonia|community-acquired pneumonia
5144868|NCT01032694|Azithromycin SR|azithromycin sr
5144869|NCT01032694|Amoxiclav|amoxiclav
5144870|NCT01032681|Solid tumor|solid tumor
5144871|NCT01032681|B-Cell Non-Hodgkin Lymphoma|b-cell non-hodgkin lymphoma
5144872|NCT01032681|Immunocytokine|immunocytokine
5144873|NCT01032681|interleukin-2|interleukin-2
5144874|NCT01032681|immunotherapy|immunotherapy
5144875|NCT01032681|Metastatic or Locally Advanced Solid Tumors or B-Cell Non-Hodgkin Lymphoma|metastatic or locally advanced solid tumors or b-cell non-hodgkin lymphoma
5144876|NCT01032668|percutaneous coronary intervention, clopidogrel resistance, ASA resistance|percutaneous coronary intervention, clopidogrel resistance, asa resistance
5144877|NCT01032655|Helicobacter pylori|helicobacter pylori
5144878|NCT01032655|sequential therapy|sequential therapy
5144879|NCT01032655|susceptibility-driven|susceptibility-driven
5144880|NCT01032655|rescue|rescue
5144881|NCT01032655|levofloxacin|levofloxacin
5144882|NCT01032655|clarithromycin|clarithromycin
5144883|NCT01032655|salvage|salvage
5144884|NCT01032655|treatment failure|treatment failure
5144885|NCT01032655|those who fail from two standard eradication therapies|those who fail from two standard eradication therapies
5144886|NCT01032642|infertility fallopian tubes|infertility fallopian tubes
5144887|NCT01032629|Diabetes|diabetes
5144888|NCT01032629|Type 2 diabetes mellitus|type 2 diabetes mellitus
5144889|NCT01032629|Cardiovascular risk|cardiovascular risk
5144890|NCT01032629|Cardiovascular outcomes|cardiovascular outcomes
5144891|NCT01032629|Canagliflozin (JNJ-28431754)|canagliflozin (jnj-28431754)
5144892|NCT01032629|Placebo|placebo
5144893|NCT01032616|splanchnic bed|splanchnic bed
5144894|NCT01032616|theronine and lysine metabolism uptake|theronine and lysine metabolism uptake
5144895|NCT01032616|isotopes|isotopes
5144896|NCT01032616|metabolism of two indispensable amino acids, threonine and lysine, by the splanchnic bed by Healthy Males|metabolism of two indispensable amino acids, threonine and lysine, by the splanchnic bed by healthy males
5144897|NCT01032603|IXT|ixt
5144898|NCT01032603|Exotropia|exotropia
5144899|NCT01032603|Strabismus|strabismus
5144900|NCT01032603|Intermittent exotropia|intermittent exotropia
5144901|NCT01032590|weight changes|weight changes
5144902|NCT01032590|cancer survivor|cancer survivor
5144903|NCT01032590|stage I colon cancer|stage i colon cancer
5144904|NCT01032590|stage II colon cancer|stage ii colon cancer
5144905|NCT01032590|stage III colon cancer|stage iii colon cancer
5144906|NCT01032590|stage I rectal cancer|stage i rectal cancer
5144907|NCT01032590|stage II rectal cancer|stage ii rectal cancer
5145004|NCT01032265|treatment|treatment
5144908|NCT01032590|stage III rectal cancer|stage iii rectal cancer
5144909|NCT01032577|ischemic cardiomyopathy|ischemic cardiomyopathy
5144910|NCT01032577|nonischemic cardiomyopathy|nonischemic cardiomyopathy
5144911|NCT01032577|implant|implant
5144912|NCT01032577|bipolar sensing|bipolar sensing
5144913|NCT01032577|extended bipolar sensing|extended bipolar sensing
5144914|NCT01032564|estimate the interest of the measure of cervix elasticity degree by elastography in prediction of premature birth within a population of pregnant women|estimate the interest of the measure of cervix elasticity degree by elastography in prediction of premature birth within a population of pregnant women
5144915|NCT01032551|Coronary Angiogram|coronary angiogram
5144916|NCT01032551|Decision Aid|decision aid
5144917|NCT01032551|Vascular Access|vascular access
5144918|NCT01032551|Radial|radial
5144919|NCT01032551|Femoral|femoral
5144920|NCT01032538|Unicondylar Knee Replacement|unicondylar knee replacement
5144921|NCT01032525|Crohn's Disease|crohn's disease
5144922|NCT01032525|Ulcerative Colitis|ulcerative colitis
5144923|NCT01032525|IBD|ibd
5144924|NCT01032525|Inflammatory Bowel Disease in Monroe County, NY|inflammatory bowel disease in monroe county, ny
5144925|NCT01032512|IMMUNE-ENHANCING|immune-enhancing
5144926|NCT01032512|GLUTAMINE|glutamine
5144927|NCT01032512|ARGININE|arginine
5144928|NCT01032512|OMEGA 3 FATTY ACIDS|omega 3 fatty acids
5144929|NCT01032512|ONCOLOGIC SURGERY|oncologic surgery
5144930|NCT01032512|PREOPERATIVE NUTRITION|preoperative nutrition
5144931|NCT01032499|Acne Vulgaris|acne vulgaris
5144932|NCT01032499|Boil|boil
5144933|NCT01032499|Taro Elixir|taro elixir
5144934|NCT01032486|Rasagiline|rasagiline
5144935|NCT01032486|Sleep|sleep
5144936|NCT01032486|Sleepiness|sleepiness
5144937|NCT01032486|Parkinson's Disease Sleep Scale|parkinson's disease sleep scale
5144938|NCT01032486|Epworth Sleepiness Scale|epworth sleepiness scale
5144939|NCT01032460|airway|airway
5144940|NCT01032460|airway device|airway device
5144941|NCT01032460|cervical spine immobilisation|cervical spine immobilisation
5144942|NCT01032434|sertraline|sertraline
5144943|NCT01032434|Polysomnograph|polysomnograph
5144944|NCT01032421|women admitted to the In Vitro Fertilization unit|women admitted to the in vitro fertilization unit
5144945|NCT01032408|Influenza A Virus|influenza a virus
5144946|NCT01032408|Virus Diseases|virus diseases
5144947|NCT01032408|Influenza, Human|influenza, human
5144948|NCT01032408|HIV-1|hiv-1
5144949|NCT01032408|Immunodeficiency Virus|immunodeficiency virus
5144950|NCT01032408|H1N1|h1n1
5144951|NCT01032408|HIV Infection|hiv infection
5144952|NCT01032408|Immunogenicity|immunogenicity
5144953|NCT01032408|safety|safety
5144954|NCT01032408|tolerability|tolerability
5144955|NCT01032395|H1N1|h1n1
5144956|NCT01032395|Pulmonary Disease|pulmonary disease
5144957|NCT01032395|Heart Disease|heart disease
5144958|NCT01032395|Diabetes|diabetes
5144959|NCT01032395|Influenza|influenza
5144960|NCT01032395|immunogenicity|immunogenicity
5144961|NCT01032395|safety|safety
5144962|NCT01032395|tolerability|tolerability
5144963|NCT01032382|leishmaniasis|leishmaniasis
5144964|NCT01032382|cutaneous|cutaneous
5144965|NCT01032382|WR 279,396|wr 279,396
5144966|NCT01032382|paromomycin|paromomycin
5144967|NCT01032382|gentamicin|gentamicin
5144968|NCT01032382|pharmacokinetics|pharmacokinetics
5144969|NCT01032382|safety|safety
5144970|NCT01032382|efficacy|efficacy
5144971|NCT01032369|"Over-weight or obese subjects with learning disability who have completed Nitzan Onim two-year training program and live in housing within the community"|"over-weight or obese subjects with learning disability who have completed nitzan onim two-year training program and live in housing within the community"
5144972|NCT01032356|Distal Radius fracture|distal radius fracture
5144973|NCT01032343|Immunosuppression|immunosuppression
5144974|NCT01032343|Ultraviolet radiation|ultraviolet radiation
5144975|NCT01032343|Nickel|nickel
5144976|NCT01032343|Contact hypersensitivity|contact hypersensitivity
5144977|NCT01032330|intermittent exotropia|intermittent exotropia
5144978|NCT01032330|IXT|ixt
5144979|NCT01032330|natural history|natural history
5144980|NCT01032330|occlusion therapy|occlusion therapy
5144981|NCT01032330|occlusion|occlusion
5144982|NCT01032330|patching|patching
5144983|NCT01032330|strabismus|strabismus
5144984|NCT01032330|strabismus treatment|strabismus treatment
5144985|NCT01032330|stereoacuity|stereoacuity
5144986|NCT01032330|motor alignment|motor alignment
5144987|NCT01032317|Arrhythmia|arrhythmia
5144988|NCT01032317|Electrophysiology|electrophysiology
5144989|NCT01032317|Fibrillation|fibrillation
5144990|NCT01032317|Tachycardia|tachycardia
5144991|NCT01032317|Ablation|ablation
5144992|NCT01032317|Atrial Fibrillation (AF)|atrial fibrillation (af)
5144993|NCT01032317|Ischemic Ventricular Tachycardia (VT)|ischemic ventricular tachycardia (vt)
5144994|NCT01032291|Colorectal cancer|colorectal cancer
5144995|NCT01032291|Revlimid|revlimid
5144996|NCT01032291|Lenalidomide|lenalidomide
5144997|NCT01032291|Cetuximab|cetuximab
5144998|NCT01032291|Erbitux|erbitux
5144999|NCT01032291|KRAS|kras
5145000|NCT01032278|cardiac toxicity|cardiac toxicity
5145001|NCT01032278|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5145002|NCT01032265|female|female
5145003|NCT01032265|stress urinary incontinence|stress urinary incontinence
5145005|NCT01032265|pelvic floor muscle training|pelvic floor muscle training
5145006|NCT01032265|cognitive behavioral therapy|cognitive behavioral therapy
5145007|NCT01032265|internet|internet
5145008|NCT01032265|life style|life style
5145009|NCT01032265|pamphlet|pamphlet
5145010|NCT01032265|eHealth|ehealth
5145011|NCT01032252|fall prevention|fall prevention
5145012|NCT01032252|general practitioners setting|general practitioners setting
5145013|NCT01032252|implementation|implementation
5145014|NCT01032252|network|network
5145015|NCT01032252|community dwelling older adults|community dwelling older adults
5145016|NCT01032252|exercise intervention|exercise intervention
5145017|NCT01032239|Severe spasticity in post-stroke patients|severe spasticity in post-stroke patients
5145018|NCT01032200|fatigue|fatigue
5145019|NCT01032200|cognitive/functional effects|cognitive/functional effects
5145020|NCT01032200|adult giant cell glioblastoma|adult giant cell glioblastoma
5145021|NCT01032200|adult glioblastoma|adult glioblastoma
5145022|NCT01032200|adult gliosarcoma|adult gliosarcoma
5145023|NCT01032200|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5145024|NCT01032200|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
5145025|NCT01032200|adult mixed glioma|adult mixed glioma
5145026|NCT01032200|adult diffuse astrocytoma|adult diffuse astrocytoma
5145027|NCT01032200|adult pilocytic astrocytoma|adult pilocytic astrocytoma
5145028|NCT01032200|adult pineal gland astrocytoma|adult pineal gland astrocytoma
5145029|NCT01032200|adult subependymal giant cell astrocytoma|adult subependymal giant cell astrocytoma
5145030|NCT01032200|adult oligodendroglioma|adult oligodendroglioma
5145031|NCT01032200|adult anaplastic ependymoma|adult anaplastic ependymoma
5145032|NCT01032200|adult ependymoma|adult ependymoma
5145033|NCT01032200|adult myxopapillary ependymoma|adult myxopapillary ependymoma
5145034|NCT01032200|adult subependymoma|adult subependymoma
5145035|NCT01032200|adult anaplastic meningioma|adult anaplastic meningioma
5145036|NCT01032200|adult grade I meningioma|adult grade i meningioma
5145037|NCT01032200|adult grade II meningioma|adult grade ii meningioma
5145038|NCT01032200|adult grade III meningioma|adult grade iii meningioma
5145039|NCT01032200|adult papillary meningioma|adult papillary meningioma
5145040|NCT01032200|adult brain stem glioma|adult brain stem glioma
5145041|NCT01032187|Visceral leishmaniasis|visceral leishmaniasis
5145042|NCT01032187|Amphotericin B deoxycholate|amphotericin b deoxycholate
5145043|NCT01032187|Meglumine antimoniate|meglumine antimoniate
5145044|NCT01032187|Children|children
5145045|NCT01032187|Brazil|brazil
5145046|NCT01032174|Azithromycin SR Amoxiclav 1000 mg Maxillary Sinusitis|azithromycin sr amoxiclav 1000 mg maxillary sinusitis
5145047|NCT01032161|Delirium|delirium
5145048|NCT01032161|Postoperative|postoperative
5145049|NCT01032161|Non-cardiovascular surgery|non-cardiovascular surgery
5145050|NCT01032161|Post-anaesthesia care unit|post-anaesthesia care unit
5145051|NCT01032161|patients between 3 to 12 years old|patients between 3 to 12 years old
5145052|NCT01032161|undergoing selective non-cardiac surgery|undergoing selective non-cardiac surgery
5145053|NCT01032161|under general anesthesia|under general anesthesia
5145054|NCT01032161|surgery|surgery
5145055|NCT01032161|general anesthesia|general anesthesia
5145056|NCT01032148|Recurrent|recurrent
5145057|NCT01032148|Refractory|refractory
5145058|NCT01032122|melanoma|melanoma
5145059|NCT01032122|rituximab|rituximab
5145060|NCT01032122|metastatic|metastatic
5145061|NCT01032122|stage IIIc/IV|stage iiic/iv
5145062|NCT01032122|stem cell|stem cell
5145063|NCT01032122|overall survival|overall survival
5145064|NCT01032122|disease free interval|disease free interval
5145065|NCT01032122|anti-CD20 therapy|anti-cd20 therapy
5145066|NCT01032083|SSRI antidepressant|ssri antidepressant
5145067|NCT01032083|Negative symptoms|negative symptoms
5145068|NCT01032083|Schizophrenia|schizophrenia
5145069|NCT01032070|phase 2|phase 2
5145070|NCT01032070|erlotinib|erlotinib
5145071|NCT01032070|pediatric|pediatric
5145072|NCT01032070|etoposide|etoposide
5145073|NCT01032070|ependymoma|ependymoma
5145074|NCT01032057|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
5145075|NCT01032057|stage II pancreatic cancer|stage ii pancreatic cancer
5145076|NCT01032057|stage III pancreatic cancer|stage iii pancreatic cancer
5145077|NCT01032044|Barrett's esophagus|barrett's esophagus
5145078|NCT01032044|EsoGastroDuodenoscopy|esogastroduodenoscopy
5145079|NCT01032044|Barrett's carcinoma|barrett's carcinoma
5145080|NCT01032044|adenocarcinoma|adenocarcinoma
5145081|NCT01032044|Cellvizio|cellvizio
5145082|NCT01032044|endomicroscopy|endomicroscopy
5145083|NCT01032044|probe-based Confocal Laser Endomicroscopy|probe-based confocal laser endomicroscopy
5145084|NCT01032044|pCLE|pcle
5145085|NCT01032044|Radio-frequency ablation|radio-frequency ablation
5145086|NCT01032044|Endoscopic mucosal resection|endoscopic mucosal resection
5145087|NCT01032044|Photodynamic therapy|photodynamic therapy
5145088|NCT01032031|Green tea|green tea
5145089|NCT01032031|Vitamin C|vitamin c
5145090|NCT01032031|Ultraviolet radiation|ultraviolet radiation
5145091|NCT01032031|Inflammation|inflammation
5145092|NCT01032031|Photoageing|photoageing
5145093|NCT01032018|Acute coronary syndrome|acute coronary syndrome
5145094|NCT01032018|Depression|depression
5145095|NCT01032018|Satisfaction with care|satisfaction with care
5145096|NCT01031992|Hereditary hemorrhagic telangiectasia|hereditary hemorrhagic telangiectasia
5145097|NCT01031992|Rendu-Osler-Weber syndrome|rendu-osler-weber syndrome
5145098|NCT01031992|Epistaxis|epistaxis
5145099|NCT01031992|Nosebleeds|nosebleeds
5145100|NCT01031992|Anemia|anemia
5145101|NCT01031992|Tranexamic acid|tranexamic acid
5145102|NCT01031992|Antifibrinolytics|antifibrinolytics
5145103|NCT01031979|PTSD|ptsd
5145104|NCT01031979|Prolonged Exposure|prolonged exposure
5145105|NCT01031979|extinction|extinction
5145106|NCT01031979|habituation|habituation
5145107|NCT01031979|psychophysiology|psychophysiology
5145108|NCT01031966|ESRD|esrd
5145109|NCT01031953|nausea and vomiting|nausea and vomiting
5145110|NCT01031953|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5145111|NCT01031927|obsessive compulsive disorder|obsessive compulsive disorder
5145112|NCT01031927|sarcosine|sarcosine
5145113|NCT01031927|glycine transporter I|glycine transporter i
5145114|NCT01031927|NMDA receptor|nmda receptor
5145115|NCT01031914|Paced Breathing|paced breathing
5145116|NCT01031914|OSA|osa
5145117|NCT01031914|sleep/wake detection|sleep/wake detection
5145118|NCT01031901|Tuberous Sclerosis|tuberous sclerosis
5145119|NCT01031901|Neurofibromatoses|neurofibromatoses
5145120|NCT01031901|Angiofibroma|angiofibroma
5145121|NCT01031901|Neurofibroma|neurofibroma
5145122|NCT01031901|Sirolimus|sirolimus
5145123|NCT01031888|Corneal re-epithelialization|corneal re-epithelialization
5145124|NCT01031888|Topical insulin application|topical insulin application
5145125|NCT01031888|pars planar vitrectomy|pars planar vitrectomy
5145126|NCT01031888|diabetic retinopathy|diabetic retinopathy
5145127|NCT01031888|penetrating keratoplasty|penetrating keratoplasty
5145128|NCT01031875|recurrent bladder cancer|recurrent bladder cancer
5145129|NCT01031875|stage IV bladder cancer|stage iv bladder cancer
5145130|NCT01031875|recurrent urethral cancer|recurrent urethral cancer
5145131|NCT01031875|distal urethral cancer|distal urethral cancer
5145132|NCT01031875|proximal urethral cancer|proximal urethral cancer
5145133|NCT01031875|urethral cancer associated with invasive bladder cancer|urethral cancer associated with invasive bladder cancer
5145134|NCT01031875|metastatic transitional cell cancer of the renal pelvis and ureter|metastatic transitional cell cancer of the renal pelvis and ureter
5145135|NCT01031875|recurrent transitional cell cancer of the renal pelvis and ureter|recurrent transitional cell cancer of the renal pelvis and ureter
5145136|NCT01031875|stage IV urethral cancer|stage iv urethral cancer
5145137|NCT01031862|healthy volunteer|healthy volunteer
5145138|NCT01031862|reverse cholesterol transport|reverse cholesterol transport
5145139|NCT01031862|RCT|rct
5145140|NCT01031862|3H|3h
5145141|NCT01031849|HIV 1 patients|hiv 1 patients
5145142|NCT01031836|Systemic Lupus Erythematosus|systemic lupus erythematosus
5145143|NCT01031836|Japanese|japanese
5145144|NCT01031836|phase 2|phase 2
5145145|NCT01031836|safety|safety
5145146|NCT01031836|tolerability|tolerability
5145147|NCT01031836|MEDI-545|medi-545
5145148|NCT01031836|Autoimmune Disease|autoimmune disease
5145149|NCT01031836|Immune System Diseases|immune system diseases
5145150|NCT01031823|Autism Spectrum Disorder|autism spectrum disorder
5145151|NCT01031810|Treatment Resistant depression|treatment resistant depression
5145152|NCT01031810|Major Depression|major depression
5145153|NCT01031810|MDD|mdd
5145154|NCT01031810|Depression|depression
5145155|NCT01031797|SLE|sle
5145156|NCT01031797|Disease activity score|disease activity score
5145157|NCT01031797|QT dispersion|qt dispersion
5145158|NCT01031784|liver metastasis|liver metastasis
5145159|NCT01031784|Liver tumors|liver tumors
5145160|NCT01031784|microspheres|microspheres
5145161|NCT01031784|holmium|holmium
5145162|NCT01031784|toxicity|toxicity
5145163|NCT01031771|Cerebral Palsy|cerebral palsy
5145164|NCT01031771|Deglutition|deglutition
5145165|NCT01031771|Deglutition disorders|deglutition disorders
5145166|NCT01031771|Endoscopy|endoscopy
5145167|NCT01031758|Low HDL|low hdl
5145168|NCT01031758|High HDL|high hdl
5145169|NCT01031758|HDL|hdl
5145170|NCT01031758|Reverse Cholesterol Transport|reverse cholesterol transport
5145171|NCT01031758|RCT|rct
5145172|NCT01031758|healthy volunteer|healthy volunteer
5145173|NCT01031758|3H|3h
5145174|NCT01031758|Average HDL|average hdl
5145175|NCT01031745|Complementary Therapies|complementary therapies
5145176|NCT01031745|Drug Users|drug users
5145177|NCT01031732|Minimally invasive|minimally invasive
5145178|NCT01031732|Total hip arthroplasty|total hip arthroplasty
5145179|NCT01031732|Functional outcome|functional outcome
5145180|NCT01031732|To compare the surgical results of 4 MIS THA techniques|to compare the surgical results of 4 mis tha techniques
5145181|NCT01031732|To investigate the functional outcomes of 4 MIS THA techniques|to investigate the functional outcomes of 4 mis tha techniques
5145182|NCT01031732|To study the biochemical parameters after the MIS surgeries.|to study the biochemical parameters after the mis surgeries.
5145183|NCT01031719|Influenza A Virus|influenza a virus
5145184|NCT01031719|Virus Diseases|virus diseases
5145185|NCT01031719|Influenza, Human|influenza, human
5145186|NCT01031719|H1N1|h1n1
5145187|NCT01031719|Immunogenicity|immunogenicity
5145188|NCT01031719|safety|safety
5145189|NCT01031719|tolerability|tolerability
5145190|NCT01031719|tumors|tumors
5145191|NCT01031719|oncology|oncology
5145192|NCT01031706|Hypertonic Saline|hypertonic saline
5145193|NCT01031706|Pediatrics|pediatrics
5145194|NCT01031706|Cystic Fibrosis|cystic fibrosis
5145195|NCT01031706|Mucociliary Clearance|mucociliary clearance
5145196|NCT01031706|Lung Clearance Index|lung clearance index
5145197|NCT01031693|Nicotine|nicotine
5145198|NCT01031693|Cigarettes|cigarettes
5145199|NCT01031693|Tobacco|tobacco
5145200|NCT01031693|Transcranial Magnetic Stimulation (TMS)|transcranial magnetic stimulation (tms)
5145201|NCT01031693|Cue-Induced Craving|cue-induced craving
5145202|NCT01031693|Smoking|smoking
5145203|NCT01031680|dapagliflozin|dapagliflozin
5145204|NCT01031680|diabetes|diabetes
5145205|NCT01031680|cardiovascular disease|cardiovascular disease
5145206|NCT01031680|hypertension|hypertension
5145207|NCT01031667|Patients treated with PCI with stent|patients treated with pci with stent
5145208|NCT01031641|Patient-Reported Outcomes|patient-reported outcomes
5145209|NCT01031641|Symptoms|symptoms
5145210|NCT01031641|Instrument Development|instrument development
5145211|NCT01031641|Adverse Events|adverse events
5145212|NCT01031641|Questionnaire|questionnaire
5145213|NCT01031641|Patient Reported Outcomes|patient reported outcomes
5145214|NCT01031628|GIST|gist
5145215|NCT01031628|Gastrointestinal stromal tumors|gastrointestinal stromal tumors
5145216|NCT01031628|Exon 9|exon 9
5145217|NCT01031628|Gleevec|gleevec
5145218|NCT01031628|Imatinib blood levels|imatinib blood levels
5145219|NCT01031615|School age children and adolescents exposed to a potentially traumatic event|school age children and adolescents exposed to a potentially traumatic event
5145220|NCT01031602|Cancer|cancer
5145221|NCT01031602|Gynecology|gynecology
5145222|NCT01031602|Sexual Dysfunction|sexual dysfunction
5145223|NCT01031602|Depression|depression
5145224|NCT01031602|Anxiety|anxiety
5145225|NCT01031602|Underserved|underserved
5145226|NCT01031602|Minority|minority
5145227|NCT01031602|Psychological distress|psychological distress
5145228|NCT01031589|TMC278-TiDP15-C158|tmc278-tidp15-c158
5145229|NCT01031589|TMC278-C158|tmc278-c158
5145230|NCT01031589|TMC278|tmc278
5145231|NCT01031589|HIV|hiv
5145232|NCT01031589|Non-nucleoside reverse transcriptase inhibitor|non-nucleoside reverse transcriptase inhibitor
5145233|NCT01031589|HIV Seronegativity|hiv seronegativity
5145234|NCT01031576|Osteoarthritis, posture, knee|osteoarthritis, posture, knee
5145235|NCT01031563|Risk Taking|risk taking
5145236|NCT01031563|Schizophrenia|schizophrenia
5145237|NCT01031563|Drug Abuse/Dependence|drug abuse/dependence
5145238|NCT01031563|Comorbidity|comorbidity
5145239|NCT01031563|Impulsivity|impulsivity
5145240|NCT01031563|Drug Abuse|drug abuse
5145241|NCT01031550|liver resection for liver disease|liver resection for liver disease
5145242|NCT01031537|FSME-Immun|fsme-immun
5145243|NCT01031537|TBEV|tbev
5145244|NCT01031537|TBE Researcher|tbe researcher
5145245|NCT01031537|Plavivirus|plavivirus
5145246|NCT01031537|Anti-TBEV Levels|anti-tbev levels
5145247|NCT01031537|Tic-Borne Encephalitis|tic-borne encephalitis
5145248|NCT01031524|Plasmodium falciparum malaria|plasmodium falciparum malaria
5145249|NCT01031511|High-Functioning Autistic Spectrum Disorder|high-functioning autistic spectrum disorder
5145250|NCT01031511|Anxiety|anxiety
5145251|NCT01031511|Cognitive Behavioural Therapy|cognitive behavioural therapy
5145252|NCT01031511|Social Recreational|social recreational
5145253|NCT01031511|Parent Stress|parent stress
5145254|NCT01031498|Nausea|nausea
5145255|NCT01031498|Vomiting|vomiting
5145256|NCT01031498|CINV|cinv
5145257|NCT01031498|Leukemia|leukemia
5145258|NCT01031498|High-risk Myelodysplastic syndrome|high-risk myelodysplastic syndrome
5145259|NCT01031498|AML|aml
5145260|NCT01031498|Hematologic malignancies|hematologic malignancies
5145261|NCT01031498|Hematologic Disorder|hematologic disorder
5145262|NCT01031498|Continuous multi-day chemotherapy|continuous multi-day chemotherapy
5145263|NCT01031498|High-dose cytarabine|high-dose cytarabine
5145264|NCT01031498|Palonosetron|palonosetron
5145265|NCT01031498|Aloxi|aloxi
5145266|NCT01031498|Ondansetron|ondansetron
5145267|NCT01031498|Zofran|zofran
5145268|NCT01031485|hypertension|hypertension
5145269|NCT01031485|blood pressure|blood pressure
5145270|NCT01031485|milk peptides|milk peptides
5145271|NCT01031485|bioactive peptides|bioactive peptides
5145272|NCT01031485|randomized controlled trial|randomized controlled trial
5145273|NCT01031472|HIV, relative bioavailability, food effect, GSK2248761, healthy subjects|hiv, relative bioavailability, food effect, gsk2248761, healthy subjects
5145274|NCT01031472|HIV Seronegativity|hiv seronegativity
5145275|NCT01031446|stage IV breast cancer|stage iv breast cancer
5145276|NCT01031446|Human epidermal growth factor (HER2)-negative breast cancer|human epidermal growth factor (her2)-negative breast cancer
5145277|NCT01031446|triple-negative breast cancer|triple-negative breast cancer
5145278|NCT01031446|hormone-resistant breast cancer|hormone-resistant breast cancer
5145279|NCT01031433|Tobacco Craving|tobacco craving
5145280|NCT01031433|Virtual Reality|virtual reality
5145281|NCT01031433|Schizophrenia|schizophrenia
5145282|NCT01031433|Smoking|smoking
5145283|NCT01031420|bladder|bladder
5145284|NCT01031420|cancer|cancer
5145285|NCT01031420|invasive|invasive
5145286|NCT01031407|Adolescents and Adults|adolescents and adults
5145287|NCT01031407|Autism|autism
5145288|NCT01031407|Functional Magnetic Resonance Imaging (fMRI)|functional magnetic resonance imaging (fmri)
5145289|NCT01031407|MEG|meg
5145290|NCT01031407|Structural MRI|structural mri
5145291|NCT01031407|HV|hv
5145292|NCT01031407|Autism Spectrum Disorder|autism spectrum disorder
5145293|NCT01031407|ASD|asd
5145294|NCT01031407|Autistic Disorder|autistic disorder
5145295|NCT01031407|Asperger Syndrome|asperger syndrome
5145296|NCT01031407|Mental Retardation|mental retardation
5145297|NCT01031407|Healthy Volunteer|healthy volunteer
5145298|NCT01031394|exercise|exercise
5145299|NCT01031394|resistance training|resistance training
5145300|NCT01031381|Recurrent|recurrent
5145301|NCT01031381|ovarian|ovarian
5145302|NCT01031381|fallopian tube|fallopian tube
5145303|NCT01031381|primary peritoneal|primary peritoneal
5145304|NCT01031381|cancer|cancer
5145305|NCT01031381|Recurrent ovarian, fallopian tube, primary peritoneal cancer|recurrent ovarian, fallopian tube, primary peritoneal cancer
5145306|NCT01031355|Female Contraception|female contraception
5145307|NCT01031355|Contraceptives, Oral|contraceptives, oral
5145308|NCT01031342|Colonoscopy|colonoscopy
5145309|NCT01031342|Gastrointestinal bleeding|gastrointestinal bleeding
5145310|NCT01031316|Echocardiography|echocardiography
5145311|NCT01031316|Infant, Premature|infant, premature
5145312|NCT01031316|Infant, Very Low Birth Weight|infant, very low birth weight
5145313|NCT01031303|Diphtheria|diphtheria
5145314|NCT01031303|Tetanus|tetanus
5145315|NCT01031303|Pertussis|pertussis
5145316|NCT01031303|Poliomyelitis|poliomyelitis
5145317|NCT01031303|PENTAXIM™|pentaxim™
5145318|NCT01031303|TETRAXIM™|tetraxim™
5145319|NCT01031290|Cue-Induced Craving|cue-induced craving
5145320|NCT01031290|Cannabis|cannabis
5145321|NCT01031290|Functional Magnetic Resonance Imaging (fMRI)|functional magnetic resonance imaging (fmri)
5145322|NCT01031290|Repetitive TMS (rTMS)|repetitive tms (rtms)
5145323|NCT01031290|Cannabis Craving|cannabis craving
5145324|NCT01031277|Hypercholesterolemia|hypercholesterolemia
5145325|NCT01031277|Update NCEP ATP111|update ncep atp111
5145326|NCT01031277|Survey|survey
5145327|NCT01031264|social drinkers|social drinkers
5145328|NCT01031238|PEM Uptake Value|pem uptake value
5145329|NCT01031238|PUV|puv
5145330|NCT01031238|Standardized Uptake Value|standardized uptake value
5145331|NCT01031238|SUV|suv
5145332|NCT01031238|Malignancies of the Breast|malignancies of the breast
5145333|NCT01031238|[18F]-FDG-PET/CT scanning|[18f]-fdg-pet/ct scanning
5145334|NCT01031238|Tumor|tumor
5145335|NCT01031238|positron emission tomography/computed tomography|positron emission tomography/computed tomography
5145336|NCT01031238|PET/CT scan|pet/ct scan
5145337|NCT01031225|Synta|synta
5145338|NCT01031225|STA 9090|sta 9090
5145339|NCT01031225|ganetespib)|ganetespib)
5145340|NCT01031225|Lung Cancer|lung cancer
5145341|NCT01031225|Non Small Cell Lung Cancer|non small cell lung cancer
5145342|NCT01031225|NSCLC|nsclc
5145343|NCT01031212|cancer|cancer
5145344|NCT01031212|neoplasms|neoplasms
5145345|NCT01031212|adult solid tumor|adult solid tumor
5145346|NCT01031212|antineoplastic agents|antineoplastic agents
5145347|NCT01031199|Multiple sclerosis|multiple sclerosis
5145348|NCT01031199|Diagnostic imaging|diagnostic imaging
5145349|NCT01031199|Neuroinflammation|neuroinflammation
5145350|NCT01031199|PET diagnosis|pet diagnosis
5145351|NCT01031199|PET tracer|pet tracer
5145352|NCT01031186|healthy male volunteers|healthy male volunteers
5145353|NCT01031186|GSK356278|gsk356278
5145354|NCT01031186|first time in man|first time in man
5145355|NCT01031186|major depressive disorder|major depressive disorder
5145356|NCT01031173|α galactosidase A|α galactosidase a
5145357|NCT01031173|glycosphingolipid storage disorder|glycosphingolipid storage disorder
5145358|NCT01031173|agalsidase alfa|agalsidase alfa
5145359|NCT01031173|enzyme replacement therapy|enzyme replacement therapy
5145360|NCT01031173|Replagal|replagal
5145361|NCT01031173|agalsidase beta|agalsidase beta
5145362|NCT01031173|Fabrazyme|fabrazyme
5145363|NCT01031160|Adolescence|adolescence
5145364|NCT01031160|Obesity|obesity
5145365|NCT01031160|Substance Abuse|substance abuse
5145366|NCT01031160|Etiology|etiology
5145367|NCT01031160|Social and Environmental Contexts|social and environmental contexts
5145368|NCT01031160|Health Behaviors|health behaviors
5145369|NCT01031147|Magnetic resonance angiography|magnetic resonance angiography
5145370|NCT01031147|Intracranial aneurysm|intracranial aneurysm
5145371|NCT01031147|Digital subtraction angiography|digital subtraction angiography
5145372|NCT01031147|Volume rendering|volume rendering
5145373|NCT01031121|Cigarette Smoking|cigarette smoking
5145374|NCT01031121|Biomarkers|biomarkers
5145375|NCT01031121|Nicotine|nicotine
5145376|NCT01031121|Cotinine|cotinine
5145377|NCT01031121|Metabolites|metabolites
5145378|NCT01031095|percutaneous coronary intervention|percutaneous coronary intervention
5145379|NCT01031095|low dose intracoronary heparin|low dose intracoronary heparin
5145380|NCT01031069|Cervarix|cervarix
5145381|NCT01031069|Gardasil|gardasil
5145382|NCT01031069|Immunogenicity|immunogenicity
5145383|NCT01031069|Cervical cancer|cervical cancer
5145384|NCT01031069|Safety|safety
5145385|NCT01031069|HPV vaccine|hpv vaccine
5145386|NCT01031043|IEM|iem
5145387|NCT01031030|stage I breast cancer|stage i breast cancer
5145388|NCT01031030|stage II breast cancer|stage ii breast cancer
5145389|NCT01031030|stage IIIA breast cancer|stage iiia breast cancer
5145390|NCT01031030|stage IIIB breast cancer|stage iiib breast cancer
5145391|NCT01031030|stage IIIC breast cancer|stage iiic breast cancer
5145392|NCT01031017|twin pregnancies|twin pregnancies
5145393|NCT01031017|preterm delivery|preterm delivery
5145394|NCT01031017|progesterone|progesterone
5145395|NCT01030991|Heart failure|heart failure
5145396|NCT01030991|Ejection fraction|ejection fraction
5145397|NCT01030991|Diastolic heart failure|diastolic heart failure
5145398|NCT01030991|Diastolic dysfunction|diastolic dysfunction
5145399|NCT01030991|Ventricular-arterial coupling|ventricular-arterial coupling
5145400|NCT01030991|Exercise testing|exercise testing
5145401|NCT01030991|Echocardiography|echocardiography
5145402|NCT01030991|Tissue Doppler imaging|tissue doppler imaging
5145403|NCT01030991|Arterial tonometry|arterial tonometry
5145404|NCT01030991|Genetics|genetics
5145405|NCT01030991|Epidemiology|epidemiology
5145406|NCT01030978|Impaired Glucose Tolerance|impaired glucose tolerance
5145407|NCT01030978|PreDiabetes|prediabetes
5145408|NCT01030978|Diabetes Prevention|diabetes prevention
5145409|NCT01030965|Chronic Bronchitis|chronic bronchitis
5145410|NCT01030965|Anticholinergic|anticholinergic
5145411|NCT01030965|Emphysema|emphysema
5145412|NCT01030965|Long-acting muscarinic antagonist|long-acting muscarinic antagonist
5145413|NCT01030965|COPD|copd
5145414|NCT01030952|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
5145415|NCT01030952|Nateglinide|nateglinide
5145416|NCT01030952|Acarbose|acarbose
5145417|NCT01030952|glucose fluctuation|glucose fluctuation
5145418|NCT01030939|Healthy volunteers|healthy volunteers
5145419|NCT01030939|Men and women|men and women
5145420|NCT01030939|adults and elderly|adults and elderly
5145421|NCT01030939|repeat dose|repeat dose
5145422|NCT01030913|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
5145423|NCT01030900|Immunosuppression|immunosuppression
5145424|NCT01030900|Microenvironment|microenvironment
5145425|NCT01030900|Hodgkin Lymphoma|hodgkin lymphoma
5145426|NCT01030900|B-Cell Lymphoma|b-cell lymphoma
5145427|NCT01030900|Microarray|microarray
5145428|NCT01030900|Diffuse Large B-Cell Lymphoma|diffuse large b-cell lymphoma
5145429|NCT01030887|Cancer|cancer
5145430|NCT01030887|Exercise|exercise
5145431|NCT01030887|Physical Activity|physical activity
5145432|NCT01030887|Randomized controlled trial|randomized controlled trial
5145433|NCT01030874|hypotension, orthostatic|hypotension, orthostatic
5145434|NCT01030874|falls|falls
5145435|NCT01030874|rehabilitation|rehabilitation
5145436|NCT01030874|blood pressure|blood pressure
5145437|NCT01030874|aging|aging
5145438|NCT01030861|type 1 diabetes|type 1 diabetes
5145439|NCT01030861|pre-diabetic|pre-diabetic
5145440|NCT01030861|autoantibody positive|autoantibody positive
5145441|NCT01030861|at risk for type 1 diabetes|at risk for type 1 diabetes
5145442|NCT01030861|glucose intolerance|glucose intolerance
5145443|NCT01030861|relatives of people with type 1 diabetes|relatives of people with type 1 diabetes
5145444|NCT01030835|Screening Protocol|screening protocol
5145445|NCT01030835|Comorbidity|comorbidity
5145446|NCT01030835|Normal Controls|normal controls
5145447|NCT01030835|Substance Use Disorders|substance use disorders
5145448|NCT01030835|Substance Abuse Disorders|substance abuse disorders
5145449|NCT01030822|Catch-up vaccination|catch-up vaccination
5145450|NCT01030822|Safety|safety
5145451|NCT01030822|Pneumococcal vaccine|pneumococcal vaccine
5145452|NCT01030822|Pneumococcal disease|pneumococcal disease
5145453|NCT01030822|Booster vaccination|booster vaccination
5145454|NCT01030822|Immunogenicity|immunogenicity
5145455|NCT01030809|Crohn's disease|crohn's disease
5145456|NCT01030809|community based gastroenterology practices Canada and Belgium|community based gastroenterology practices canada and belgium
5145457|NCT01030809|Cluster randomization controlled trial|cluster randomization controlled trial
5145458|NCT01030809|Remission|remission
5145459|NCT01030809|Corticosteroids|corticosteroids
5145460|NCT01030809|Documented diagnosis of Crohn's disease|documented diagnosis of crohn's disease
5145461|NCT01030770|Diabetes|diabetes
5145462|NCT01030770|Vitreous Haemorrhages|vitreous haemorrhages
5145463|NCT01030757|Liver Cancer|liver cancer
5145464|NCT01030757|Metastatic Liver Cancer|metastatic liver cancer
5145465|NCT01030757|Tomotherapy|tomotherapy
5145466|NCT01030757|Stereotactic Body Radiation Therapy|stereotactic body radiation therapy
5145467|NCT01030744|Gestational Diabetes|gestational diabetes
5145468|NCT01030744|Self-Monitoring of Blood Glucose|self-monitoring of blood glucose
5145469|NCT01030731|Renal Dialysis, Ceftobiprole|renal dialysis, ceftobiprole
5145470|NCT01030731|Skin and soft tissue Infections|skin and soft tissue infections
5145471|NCT01030731|Staphylococcal Skin Infections|staphylococcal skin infections
5145472|NCT01030731|Streptococcal Infection|streptococcal infection
5145473|NCT01030705|Bradycardia|bradycardia
5145474|NCT01030705|pacemaker|pacemaker
5145475|NCT01030692|Cocaine|cocaine
5145476|NCT01030692|Rivastigmine|rivastigmine
5145477|NCT01030692|Huperzine A|huperzine a
5145478|NCT01030679|Diabetes Mellitus, type 2|diabetes mellitus, type 2
5145479|NCT01030679|Glitazone|glitazone
5145480|NCT01030666|periodontal regeneration|periodontal regeneration
5145481|NCT01030666|radiographic bone fill|radiographic bone fill
5145482|NCT01030666|infrabony defects|infrabony defects
5145483|NCT01030666|randomized placebo-controlled clinical trial|randomized placebo-controlled clinical trial
5145484|NCT01030666|guided tissue regeneration, periodontal|guided tissue regeneration, periodontal
5145485|NCT01030653|Voriconazole|voriconazole
5145486|NCT01030653|Pharmacokinetics|pharmacokinetics
5145487|NCT01030653|Obese|obese
5145488|NCT01030653|Healthy Volunteer|healthy volunteer
5145489|NCT01030640|intraepidermal nerve fiber density|intraepidermal nerve fiber density
5145490|NCT01030640|IENF|ienf
5145491|NCT01030640|tanezumab|tanezumab
5145492|NCT01030640|subcutaneous|subcutaneous
5145493|NCT01030640|healthy volunteers|healthy volunteers
5145494|NCT01030627|Eclampsia|eclampsia
5145495|NCT01030627|Preeclampsia|preeclampsia
5145496|NCT01030627|Magnesium sulfate|magnesium sulfate
5145497|NCT01030614|Laparoscopic cholecystectomy,postoperative symptoms|laparoscopic cholecystectomy,postoperative symptoms
5145498|NCT01030601|Diabetic|diabetic
5145499|NCT01030601|Macular Edema|macular edema
5145500|NCT01030601|Pseudophakic|pseudophakic
5145501|NCT01030601|Dexamethasone|dexamethasone
5145502|NCT01030601|Intravitreal|intravitreal
5145503|NCT01030601|Cataract surgery|cataract surgery
5145504|NCT01030575|NICHD Neonatal Research Network|nichd neonatal research network
5145505|NCT01030575|Pharmacokinetics|pharmacokinetics
5145506|NCT01030575|Inositol|inositol
5145507|NCT01030575|Very Low Birth Weight (VLBW)|very low birth weight (vlbw)
5145508|NCT01030575|Extremely Low Birth Weight (ELBW)|extremely low birth weight (elbw)
5145509|NCT01030575|Prematurity|prematurity
5145510|NCT01030562|adolescent, vaccine, human papillomavirus, HPV|adolescent, vaccine, human papillomavirus, hpv
5145511|NCT01030549|cardiovascular magnetic resonance|cardiovascular magnetic resonance
5145512|NCT01030549|ventricular volumes|ventricular volumes
5145513|NCT01030549|ventricular function|ventricular function
5145514|NCT01030549|Healthy normal individuals from 20 to 80 years of age|healthy normal individuals from 20 to 80 years of age
5145516|NCT01030536|CLL|cll
5145517|NCT01030497|Cancer|cancer
5145518|NCT01030497|Cervical Lymph Node Metastases|cervical lymph node metastases
5145519|NCT01030497|High-Resolution PET Imaging System|high-resolution pet imaging system
5145520|NCT01030497|Upper Aerodigestive Tract|upper aerodigestive tract
5145521|NCT01030497|Head|head
5145522|NCT01030497|Neck|neck
5145523|NCT01030497|HR PET Imaging System|hr pet imaging system
5145524|NCT01030497|High-Resolution PET|high-resolution pet
5145525|NCT01030497|PET/CT|pet/ct
5145526|NCT01030497|PEMFlex Solo II|pemflex solo ii
5145527|NCT01030497|positron emission tomography/computed tomography (PET/CT)|positron emission tomography/computed tomography (pet/ct)
5145528|NCT01030484|NAFLD|nafld
5145529|NCT01030484|NASH|nash
5145530|NCT01030484|non-alcoholic steatohepatitis|non-alcoholic steatohepatitis
5145531|NCT01030484|fatty liver disease|fatty liver disease
5145532|NCT01030471|adolescents|adolescents
5145533|NCT01030471|depression|depression
5145534|NCT01030471|adherence|adherence
5145535|NCT01030471|family functioning|family functioning
5145536|NCT01030471|intervention|intervention
5145537|NCT01030458|Blood pressure|blood pressure
5145538|NCT01030458|Hypertension|hypertension
5145539|NCT01030458|Blacks|blacks
5145540|NCT01030458|Africa|africa
5145541|NCT01030458|Blood pressure control|blood pressure control
5145542|NCT01030458|Side-effects|side-effects
5145543|NCT01030445|non-invasive cardiac output monitor|non-invasive cardiac output monitor
5145544|NCT01030445|electrical velocimetry|electrical velocimetry
5145545|NCT01030445|Aesculon|aesculon
5145546|NCT01030445|Icon|icon
5145547|NCT01030445|pediatrics|pediatrics
5145548|NCT01030445|normal reference|normal reference
5145549|NCT01030419|Aging|aging
5145550|NCT01030419|Quality of Life|quality of life
5145551|NCT01030419|Functional fitness|functional fitness
5145552|NCT01030406|Abuse Liability|abuse liability
5145553|NCT01030406|Abuse Prevention|abuse prevention
5145554|NCT01030406|Abuse Resistance|abuse resistance
5145555|NCT01030406|Abuse Deterrence|abuse deterrence
5145556|NCT01030393|hCG|hcg
5145557|NCT01030393|pregnancy|pregnancy
5145558|NCT01030393|implantation|implantation
5145559|NCT01030393|ICSI|icsi
5145560|NCT01030393|IVF|ivf
5145561|NCT01030380|Facial toning|facial toning
5145562|NCT01030380|Facial lift|facial lift
5145563|NCT01030380|Improve facial complexion|improve facial complexion
5145564|NCT01030380|Improve facial tone|improve facial tone
5145565|NCT01030380|Improve radiance of the face|improve radiance of the face
5145566|NCT01030380|Reduce signs of facial aging|reduce signs of facial aging
5145567|NCT01030380|firming, lift, tone face|firming, lift, tone face
5145568|NCT01030367|Coronary artery disease|coronary artery disease
5145569|NCT01030354|Satiety|satiety
5145570|NCT01030354|Meal Replacements|meal replacements
5145571|NCT01030354|High Protein|high protein
5145572|NCT01030354|Standard Protein|standard protein
5145573|NCT01030341|Diabetes|diabetes
5145574|NCT01030341|Gastroparesis|gastroparesis
5145575|NCT01030315|Erythropoietin|erythropoietin
5145576|NCT01030315|Long-acting|long-acting
5145577|NCT01030315|EPO|epo
5145578|NCT01030302|Bortezomib retreatment|bortezomib retreatment
5145579|NCT01030302|Velcade|velcade
5145580|NCT01030302|Proteasome inhibitor|proteasome inhibitor
5145581|NCT01030302|Bortezomib|bortezomib
5145582|NCT01030289|food cravings|food cravings
5145583|NCT01030250|Breast Cancer|breast cancer
5145584|NCT01030250|Adjuvant Chemotherapy|adjuvant chemotherapy
5145585|NCT01030237|Dry eye|dry eye
5145586|NCT01030237|artificial tears|artificial tears
5145587|NCT01030224|Healthy volunteer|healthy volunteer
5145588|NCT01030224|First time in human|first time in human
5145589|NCT01030211|Dengue|dengue
5145590|NCT01030211|Platelet transfusion|platelet transfusion
5145591|NCT01030211|Bleeding|bleeding
5145592|NCT01030211|Prevention|prevention
5145593|NCT01030185|ascites|ascites
5145594|NCT01030185|liver cirrhosis|liver cirrhosis
5145595|NCT01030159|Cancer Anemia Survey|cancer anemia survey
5145596|NCT01030159|Thai National Cancer Institute|thai national cancer institute
5145597|NCT01030133|pain|pain
5145598|NCT01030120|chronic idiopathic urticaria|chronic idiopathic urticaria
5145599|NCT01030120|etanercept|etanercept
5145600|NCT01030107|sleep|sleep
5145601|NCT01030107|obesity|obesity
5145602|NCT01030107|children|children
5145603|NCT01030107|eating behaviors|eating behaviors
5145604|NCT01030107|activity|activity
5145605|NCT01030107|leptin|leptin
5145606|NCT01030107|ghrelin|ghrelin
5145607|NCT01030094|Topiramate|topiramate
5145608|NCT01030094|Carbamazepine|carbamazepine
5145609|NCT01030094|Valproic acid|valproic acid
5145610|NCT01030094|Epilepsy|epilepsy
5145611|NCT01030094|Bone mineral density|bone mineral density
5145612|NCT01030094|Monotherapy|monotherapy
5145613|NCT01030081|24 hour blood pressure|24 hour blood pressure
5145614|NCT01030081|morning blood pressure surge|morning blood pressure surge
5145615|NCT01030081|amlodipine|amlodipine
5145616|NCT01030081|nifedipine GITS|nifedipine gits
5145617|NCT01030068|Smoking Cessation|smoking cessation
5145618|NCT01030068|Yoga|yoga
5145619|NCT01030068|Wellness|wellness
5145620|NCT01030068|Feasibility|feasibility
5145621|NCT01030068|Smoking Cessation Therapy|smoking cessation therapy
5145622|NCT01030055|Neoplasms|neoplasms
5145623|NCT01030055|Cancer|cancer
5145624|NCT01030055|Tumors|tumors
5145625|NCT01030055|Administration, oral|administration, oral
5145626|NCT01030055|Capsules|capsules
5145627|NCT01030055|CHIR258|chir258
5145628|NCT01030055|CHIR-258|chir-258
5145629|NCT01030055|CHIR 258|chir 258
5145630|NCT01030055|TKI258|tki258
5145631|NCT01030055|TKI-258|tki-258
5145632|NCT01030055|TKI 258|tki 258
5145633|NCT01030055|Bioavailability|bioavailability
5145634|NCT01030055|Food|food
5145635|NCT01030042|metastatic|metastatic
5145636|NCT01030042|colorectal cancer|colorectal cancer
5145637|NCT01030042|two sequences therapy|two sequences therapy
5145638|NCT01030029|auricular acupuncture|auricular acupuncture
5145639|NCT01030029|postoperative pain|postoperative pain
5145640|NCT01030029|opioid consumption|opioid consumption
5145641|NCT01030029|laparoscopic surgery|laparoscopic surgery
5145642|NCT01030029|ACUPUNCTURE THERAPY (IM) + EAR, EXTERNAL (IM)|acupuncture therapy (im) + ear, external (im)
5145643|NCT01030016|resistance exercise|resistance exercise
5145644|NCT01030016|beta-blockers|beta-blockers
5145645|NCT01030016|blood pressure|blood pressure
5145646|NCT01030003|Sleep-Disordered Breathing|sleep-disordered breathing
5145647|NCT01030003|Snoring|snoring
5145648|NCT01030003|Pregnancy|pregnancy
5145649|NCT01030003|Fetal Growth Retardation|fetal growth retardation
5145650|NCT01030003|Pre-Eclampsia|pre-eclampsia
5145651|NCT01029990|participation|participation
5145652|NCT01029990|mass screening|mass screening
5145653|NCT01029990|cervical neoplasia|cervical neoplasia
5145654|NCT01029990|health economics|health economics
5145655|NCT01029990|cost-benefit|cost-benefit
5145656|NCT01029964|Childhood obesity|childhood obesity
5145657|NCT01029964|Age-dependent|age-dependent
5145658|NCT01029964|Long-term treatment|long-term treatment
5145659|NCT01029964|BMI SDS|bmi sds
5145660|NCT01029964|Dropouts|dropouts
5145783|NCT01029509|CMS|cms
5145784|NCT01029509|Acute lymphocytic leukemia|acute lymphocytic leukemia
5145661|NCT01029951|Chiropractic; osteopathic physicians; manipulation; neck pain; adverse effects; randomized clinical trial|chiropractic; osteopathic physicians; manipulation; neck pain; adverse effects; randomized clinical trial
5145662|NCT01029951|Subacute non-specific neck pain|subacute non-specific neck pain
5145663|NCT01029938|Intracranial aneurysms;|intracranial aneurysms;
5145664|NCT01029938|Covered stent;|covered stent;
5145665|NCT01029938|Coil embolization|coil embolization
5145666|NCT01029925|metastatic breast cancer|metastatic breast cancer
5145667|NCT01029925|lung cancer|lung cancer
5145668|NCT01029925|Previously treated metastatic breast cancer|previously treated metastatic breast cancer
5145669|NCT01029925|stage IIIb lung cancer|stage iiib lung cancer
5145670|NCT01029925|stage IV lung cancer|stage iv lung cancer
5145671|NCT01029912|Stroke|stroke
5145672|NCT01029912|Hemiplegia|hemiplegia
5145673|NCT01029912|Footdrop|footdrop
5145674|NCT01029912|Electrical Stimulation|electrical stimulation
5145675|NCT01029912|Motor Relearning|motor relearning
5145676|NCT01029912|Neuroplasticity|neuroplasticity
5145677|NCT01029899|Colonoscopy|colonoscopy
5145678|NCT01029899|Force|force
5145679|NCT01029899|Monitor|monitor
5145680|NCT01029899|Endoscopist|endoscopist
5145681|NCT01029899|Trainee|trainee
5145682|NCT01029886|diabetes|diabetes
5145683|NCT01029886|exenatide once weekly|exenatide once weekly
5145684|NCT01029886|Byetta|byetta
5145685|NCT01029886|liraglutide|liraglutide
5145686|NCT01029886|Victoza|victoza
5145687|NCT01029886|Amylin|amylin
5145688|NCT01029886|Lilly|lilly
5145689|NCT01029873|cancer|cancer
5145690|NCT01029873|immunotherapy|immunotherapy
5145691|NCT01029873|targeted|targeted
5145692|NCT01029873|metastatic|metastatic
5145693|NCT01029873|interleukin-2|interleukin-2
5145694|NCT01029873|IL-2|il-2
5145695|NCT01029873|Cisplatin|cisplatin
5145696|NCT01029873|antitumor|antitumor
5145697|NCT01029873|melanoma|melanoma
5145698|NCT01029873|TCR|tcr
5145699|NCT01029873|T-cell receptor|t-cell receptor
5145700|NCT01029873|p53|p53
5145701|NCT01029873|p53 gene|p53 gene
5145702|NCT01029873|p53 tumor suppressor protein|p53 tumor suppressor protein
5145703|NCT01029860|Hypertension|hypertension
5145704|NCT01029860|Ambulatory measurement|ambulatory measurement
5145705|NCT01029847|Patients with axial spondyloarthritis|patients with axial spondyloarthritis
5145706|NCT01029834|BMI >85%for age and gender|bmi >85%for age and gender
5145707|NCT01029821|Low-Molecular-Weight-Heparin|low-molecular-weight-heparin
5145708|NCT01029821|Open Reduction and Internal Fixation|open reduction and internal fixation
5145709|NCT01029821|Thromboprophylaxis|thromboprophylaxis
5145710|NCT01029808|carriers of hemophilia|carriers of hemophilia
5145711|NCT01029782|Cellulitis|cellulitis
5145712|NCT01029782|Emergency Department|emergency department
5145713|NCT01029782|Cefazolin|cefazolin
5145714|NCT01029782|Probenecid|probenecid
5145715|NCT01029782|Cephalexin|cephalexin
5145716|NCT01029756|Pentax Airway Scope AWS S100|pentax airway scope aws s100
5145717|NCT01029756|Pentax AWS|pentax aws
5145718|NCT01029756|Macintosh|macintosh
5145719|NCT01029756|Laryngoscope|laryngoscope
5145720|NCT01029756|Video Laryngoscope|video laryngoscope
5145721|NCT01029743|TKR (Total Knee Replacement)|tkr (total knee replacement)
5145722|NCT01029743|THR (Total Hip Replacement)|thr (total hip replacement)
5145723|NCT01029743|VTE (Venous Thromboembolism)|vte (venous thromboembolism)
5145724|NCT01029743|LMWH (Low Molecular Weight Heparin)|lmwh (low molecular weight heparin)
5145725|NCT01029743|VKA (Vitamin K antagonist)|vka (vitamin k antagonist)
5145726|NCT01029730|Low grade lymphoma|low grade lymphoma
5145727|NCT01029730|Previously untreated lymphoma|previously untreated lymphoma
5145728|NCT01029730|Lymphoma first line|lymphoma first line
5145729|NCT01029730|bendamustine|bendamustine
5145730|NCT01029730|Treanda|treanda
5145731|NCT01029730|bortezomib|bortezomib
5145732|NCT01029730|Velcade|velcade
5145733|NCT01029730|rituximab|rituximab
5145734|NCT01029730|Rituxan|rituxan
5145735|NCT01029717|Central Venous Catheters|central venous catheters
5145736|NCT01029717|blood stream infection|blood stream infection
5145737|NCT01029717|children, intensive care|children, intensive care
5145738|NCT01029717|Heparin bonded|heparin bonded
5145739|NCT01029717|antibiotic coated|antibiotic coated
5145740|NCT01029717|Children in Paediatric Intensive Care Unit|children in paediatric intensive care unit
5145741|NCT01029704|Diabetes Mellitus Type 2|diabetes mellitus type 2
5145742|NCT01029691|Sleep disordered breathing|sleep disordered breathing
5145743|NCT01029691|Preeclampsia|preeclampsia
5145744|NCT01029691|Positive Airway Pressure|positive airway pressure
5145745|NCT01029678|Locally advanced lung cancer|locally advanced lung cancer
5145746|NCT01029678|Elderly patients|elderly patients
5145747|NCT01029678|NSCLC|nsclc
5145748|NCT01029665|Hernia, Diaphragmatic|hernia, diaphragmatic
5145749|NCT01029665|Asthma|asthma
5145750|NCT01029665|Feeding and Eating Disorders of Childhood|feeding and eating disorders of childhood
5145751|NCT01029665|Growth & Development|growth & development
5145752|NCT01029652|frequent flares|frequent flares
5145753|NCT01029652|gout|gout
5145754|NCT01029652|anti-interleukin-1β monoclonal antibody|anti-interleukin-1β monoclonal antibody
5145755|NCT01029639|Pulsatile intravenous insulin|pulsatile intravenous insulin
5145756|NCT01029639|Oral carbohydrate loading|oral carbohydrate loading
5145757|NCT01029639|Respiratory Quotients|respiratory quotients
5145758|NCT01029639|Hypoglycemia|hypoglycemia
5145759|NCT01029639|Diabetes Mellitus, with complications|diabetes mellitus, with complications
5145760|NCT01029600|Randomized study capsulotomy vs distention with steroid|randomized study capsulotomy vs distention with steroid
5145761|NCT01029587|CAPS|caps
5145762|NCT01029587|Kidney transplant|kidney transplant
5145763|NCT01029587|Renal transplant|renal transplant
5145764|NCT01029587|Catastrophic Antiphospholipid Antibody Syndrome|catastrophic antiphospholipid antibody syndrome
5145765|NCT01029574|Rotator cuff lesions|rotator cuff lesions
5145766|NCT01029574|Platelet rich plasma|platelet rich plasma
5145767|NCT01029574|Arthroscopic repair|arthroscopic repair
5145768|NCT01029561|Metabolic syndrome|metabolic syndrome
5145769|NCT01029561|Insulin Resistance|insulin resistance
5145770|NCT01029561|Adipokines|adipokines
5145771|NCT01029561|Proinflammatory markers|proinflammatory markers
5145772|NCT01029561|Obstructive Sleep Apnea Syndrome|obstructive sleep apnea syndrome
5145773|NCT01029561|Continuous Positive Airway Pressure|continuous positive airway pressure
5145774|NCT01029561|Obesity|obesity
5145775|NCT01029561|Bariatric surgery|bariatric surgery
5145776|NCT01029548|HIV|hiv
5145777|NCT01029548|Therapeutic Vaccine|therapeutic vaccine
5145778|NCT01029522|Dyslipidemia|dyslipidemia
5145779|NCT01029509|Advanced Leukemia|advanced leukemia
5145780|NCT01029509|Acute myeloid leukemia|acute myeloid leukemia
5145781|NCT01029509|ALL|all
5145782|NCT01029509|Chronic myeloid leukemia blast crisis|chronic myeloid leukemia blast crisis
5145785|NCT01029509|Chronic lymphocytic leukemia|chronic lymphocytic leukemia
5145786|NCT01029509|Myelodysplastic syndromes|myelodysplastic syndromes
5145787|NCT01029509|MDS|mds
5145788|NCT01029509|OPB 31121|opb 31121
5145789|NCT01029496|umbilical CORD CLAMPING|umbilical cord clamping
5145790|NCT01029496|Neonatal anemia|neonatal anemia
5145791|NCT01029496|Omphalitis|omphalitis
5145792|NCT01029483|Obesity|obesity
5145793|NCT01029483|Weight loss|weight loss
5145794|NCT01029483|low carbohydrate diets|low carbohydrate diets
5145795|NCT01029483|high complex carbohydrate diets|high complex carbohydrate diets
5145796|NCT01029483|Healthy adults|healthy adults
5145797|NCT01029483|Body composition|body composition
5145798|NCT01029483|Energy Expenditure|energy expenditure
5145799|NCT01029470|Luveris|luveris
5145800|NCT01029470|hyporesponse|hyporesponse
5145801|NCT01029470|pituitary downregulation|pituitary downregulation
5145802|NCT01029470|IVF|ivf
5145803|NCT01029470|Infertility women|infertility women
5145804|NCT01029444|Diabetes|diabetes
5145805|NCT01029444|Pulsatile intravenous insulin|pulsatile intravenous insulin
5145806|NCT01029444|Oral carbohydrate loading|oral carbohydrate loading
5145807|NCT01029444|Respiratory Quotients|respiratory quotients
5145808|NCT01029444|Hypoglycemia|hypoglycemia
5145809|NCT01029444|Hyperglycemia|hyperglycemia
5145810|NCT01029444|Diabetes Mellitus, with complications|diabetes mellitus, with complications
5145811|NCT01029431|intubating laryngeal airway|intubating laryngeal airway
5145812|NCT01029431|pediatric|pediatric
5145813|NCT01029418|HCC|hcc
5145814|NCT01029418|hepatocellular carcinoma|hepatocellular carcinoma
5145815|NCT01029418|liver cancer|liver cancer
5145816|NCT01029405|Topical|topical
5145817|NCT01029405|Plaque type psoriasis|plaque type psoriasis
5145818|NCT01029392|Diabetes|diabetes
5145819|NCT01029392|Type I|type i
5145820|NCT01029392|Newly Diagnosis Type I Diabetes Mellitus|newly diagnosis type i diabetes mellitus
5145821|NCT01029379|propofol|propofol
5145822|NCT01029379|depth of anesthesia|depth of anesthesia
5145823|NCT01029379|pharmacogenetics|pharmacogenetics
5145824|NCT01029379|Depth of anesthesia in correlation to plasma concentrations of propofol|depth of anesthesia in correlation to plasma concentrations of propofol
5145825|NCT01029353|NICHD Neonatal Research Network|nichd neonatal research network
5145826|NCT01029353|Very Low Birth Weight (VLBW)|very low birth weight (vlbw)
5145827|NCT01029353|Extremely Low Birth Weight (ELBW)|extremely low birth weight (elbw)
5145828|NCT01029353|Prematurity|prematurity
5145829|NCT01029353|Laparotomy|laparotomy
5145830|NCT01029353|Drainage|drainage
5145831|NCT01029353|Isolated intestinal perforation|isolated intestinal perforation
5145832|NCT01029353|Focal intestinal perforation|focal intestinal perforation
5145833|NCT01029340|Hemophilia A|hemophilia a
5145834|NCT01029340|Factor VIII|factor viii
5145835|NCT01029340|Prophylaxis|prophylaxis
5145836|NCT01029314|Thermometry|thermometry
5145837|NCT01029301|Skin aging|skin aging
5145838|NCT01029301|Skin Wrinkling|skin wrinkling
5145839|NCT01029288|Diabetes|diabetes
5145840|NCT01029288|Decision aid|decision aid
5145841|NCT01029288|Cardiovascular risk|cardiovascular risk
5145842|NCT01029288|Patient education|patient education
5145843|NCT01029275|Acromegaly|acromegaly
5145844|NCT01029275|pituitary adenoma|pituitary adenoma
5145845|NCT01029275|octreotide|octreotide
5145846|NCT01029275|transsphenoïdal surgery|transsphenoïdal surgery
5145847|NCT01029275|GH|gh
5145848|NCT01029275|IGF-1|igf-1
5145849|NCT01029262|Myelodysplastic Syndromes|myelodysplastic syndromes
5145850|NCT01029262|MDS|mds
5145851|NCT01029262|transfusion dependent anemia|transfusion dependent anemia
5145852|NCT01029262|Erythropoiesis stimulating agents|erythropoiesis stimulating agents
5145853|NCT01029262|non-del 5q|non-del 5q
5145854|NCT01029236|obesity|obesity
5145855|NCT01029236|metabolism|metabolism
5145856|NCT01029236|weight loss|weight loss
5145857|NCT01029236|energy expenditure|energy expenditure
5145858|NCT01029236|thermogenesis|thermogenesis
5145859|NCT01029236|Metabolism-Boosting Beverages effect on REE|metabolism-boosting beverages effect on ree
5145860|NCT01029236|Metabolism-Boosting Beverages effect on appetite|metabolism-boosting beverages effect on appetite
5145861|NCT01029210|osteoporosis|osteoporosis
5145862|NCT01029210|temporomandibular disorders|temporomandibular disorders
5145863|NCT01029210|resonance magnetic|resonance magnetic
5145864|NCT01029184|weaning|weaning
5145865|NCT01029184|cereals|cereals
5145866|NCT01029184|allergy|allergy
5145867|NCT01029184|atopy|atopy
5145868|NCT01029184|open allergenic test|open allergenic test
5145869|NCT01029171|falls|falls
5145870|NCT01029171|balance training|balance training
5145871|NCT01029171|strength training|strength training
5145872|NCT01029158|Healthy volunteers|healthy volunteers
5145873|NCT01029158|Comparison of two formulations|comparison of two formulations
5145874|NCT01029158|Improvement of scar appearance|improvement of scar appearance
5145875|NCT01029145|Bipolar disorder|bipolar disorder
5145876|NCT01029145|New occured episode: manic depressive or mixed|new occured episode: manic depressive or mixed
5145877|NCT01029132|Alzheimer's disease|alzheimer's disease
5145878|NCT01029132|Galantamine|galantamine
5145879|NCT01029132|Treatment response|treatment response
5145880|NCT01029132|Efficacy|efficacy
5145881|NCT01029132|Adverse Event|adverse event
5145882|NCT01029119|blood pressure|blood pressure
5145883|NCT01029106|SUI|sui
5145884|NCT01029106|Stress Urinary Incontinence|stress urinary incontinence
5145885|NCT01029106|Patients with Stress Urinary Incontinence|patients with stress urinary incontinence
5145886|NCT01029093|extremity with immobilisation|extremity with immobilisation
5145887|NCT01029093|brain platicity|brain platicity
5145888|NCT01029093|deprivation|deprivation
5145889|NCT01029093|MRI|mri
5145890|NCT01029080|Brain, blood flow|brain, blood flow
5145891|NCT01029080|Measurement techniques, flow velocity waveform analysis|measurement techniques, flow velocity waveform analysis
5145892|NCT01029080|Monitoring, intensive care|monitoring, intensive care
5145893|NCT01029080|Sepsis|sepsis
5145894|NCT01029080|transcranial doppler ultrasound (TCD)|transcranial doppler ultrasound (tcd)
5145895|NCT01029080|Cerebrovascular autoregulation|cerebrovascular autoregulation
5145896|NCT01029080|sepsis-associated delir|sepsis-associated delir
5145897|NCT01029067|schizophrenia|schizophrenia
5145898|NCT01029067|delusion|delusion
5145899|NCT01029067|paranoia|paranoia
5145900|NCT01029067|psychosis|psychosis
5145901|NCT01029054|Multiple Myeloma|multiple myeloma
5145902|NCT01029041|fibromyalgia, exercise, strength, stretch|fibromyalgia, exercise, strength, stretch
5145903|NCT01029015|OAB|oab
5145904|NCT01029015|Insomnia|insomnia
5145905|NCT01029015|Bladder function|bladder function
5145906|NCT01029015|cystometry|cystometry
5145907|NCT01029015|polysomnography|polysomnography
5145908|NCT01029002|Vitamin D|vitamin d
5145910|NCT01029002|proteinuria|proteinuria
5145911|NCT01028989|Polycystic Ovary Syndrome|polycystic ovary syndrome
5145912|NCT01028989|Insulin|insulin
5145913|NCT01028989|Diet|diet
5145914|NCT01028989|Glycemic Load|glycemic load
5145915|NCT01028976|randomized controlled trial|randomized controlled trial
5145916|NCT01028976|primary prevention|primary prevention
5145917|NCT01028976|Vitamin C|vitamin c
5145918|NCT01028976|Antioxidants|antioxidants
5145919|NCT01028976|C-reactive protein|c-reactive protein
5145920|NCT01028976|inflammation|inflammation
5145921|NCT01028976|anti-inflammatory agents|anti-inflammatory agents
5145922|NCT01028976|obesity|obesity
5145923|NCT01028950|YM150|ym150
5145924|NCT01028950|Bleeding|bleeding
5145925|NCT01028950|VTE|vte
5145926|NCT01028950|FXa inhibitor|fxa inhibitor
5145927|NCT01028950|Deep Vein Thrombosis|deep vein thrombosis
5145928|NCT01028950|Venous thromboembolism|venous thromboembolism
5145929|NCT01028937|Hyperopia correction|hyperopia correction
5145930|NCT01028937|Laser vision correction|laser vision correction
5145931|NCT01028937|Optimal keratoplasty|optimal keratoplasty
5145932|NCT01028924|Thorough QTc-Study|thorough qtc-study
5145933|NCT01028924|Short Bowel Syndrome|short bowel syndrome
5145934|NCT01028924|Cardiac safety|cardiac safety
5145935|NCT01028911|Phase 1 Alzheimer's disease Safety Tolerability Pharmacokinetics|phase 1 alzheimer's disease safety tolerability pharmacokinetics
5145936|NCT01028898|IBS|ibs
5145937|NCT01028898|proteomics|proteomics
5145938|NCT01028898|fluorescent quantitation polymerase chain reaction|fluorescent quantitation polymerase chain reaction
5145939|NCT01028898|Western blot|western blot
5145940|NCT01028898|immunohistochemistry staining (IHC)|immunohistochemistry staining (ihc)
5145941|NCT01028898|ATP content|atp content
5145942|NCT01028898|micRNA|micrna
5145943|NCT01028872|higher-order aberrations, contrast sensitivity|higher-order aberrations, contrast sensitivity
5145944|NCT01028859|Tubulin polymerization inhibitor|tubulin polymerization inhibitor
5145945|NCT01028859|CKD-516|ckd-516
5145946|NCT01028859|Phase I|phase i
5145947|NCT01028859|Vascular disrupting agent|vascular disrupting agent
5145948|NCT01028859|DCE MRI|dce mri
5145949|NCT01028846|Type 2 Diabetes|type 2 diabetes
5145950|NCT01028833|power wheelchairs|power wheelchairs
5145951|NCT01028833|power mobility|power mobility
5145952|NCT01028833|young children|young children
5145953|NCT01028820|autism|autism
5145954|NCT01028820|asperger's|asperger's
5145955|NCT01028820|repetitive|repetitive
5145956|NCT01028820|restricted|restricted
5145957|NCT01028820|compulsions|compulsions
5145958|NCT01028807|Early feeding|early feeding
5145959|NCT01028807|Bowel anastomosis|bowel anastomosis
5145960|NCT01028807|Children|children
5145961|NCT01028794|stroke|stroke
5145962|NCT01028794|bone marrow|bone marrow
5145963|NCT01028794|mononuclear cell|mononuclear cell
5145964|NCT01028794|angiogenesis|angiogenesis
5145965|NCT01028794|neurogenesis|neurogenesis
5145966|NCT01028768|Renal impairment|renal impairment
5145967|NCT01028768|Renal impairment study|renal impairment study
5145968|NCT01028755|Maximum Tolerated Dose|maximum tolerated dose
5145969|NCT01028742|Traumatic brain injury|traumatic brain injury
5145970|NCT01028742|Hypopituitarism|hypopituitarism
5145971|NCT01028742|Incidence|incidence
5145972|NCT01028703|Chronic kidney disease|chronic kidney disease
5145973|NCT01028703|left ventricular dysfunction|left ventricular dysfunction
5145974|NCT01028703|diastolic dysfunction|diastolic dysfunction
5145975|NCT01028703|hypertension|hypertension
5145976|NCT01028690|Helicobacter pylori|helicobacter pylori
5145977|NCT01028690|Eradication therapy|eradication therapy
5146261|NCT01027312|Glaucoma|glaucoma
5145978|NCT01028690|Lactobacillus reuteri|lactobacillus reuteri
5145979|NCT01028690|Dyspeptic symptoms|dyspeptic symptoms
5145980|NCT01028677|oxytocin|oxytocin
5145981|NCT01028677|social cognition|social cognition
5145982|NCT01028677|social skill|social skill
5145983|NCT01028677|social functioning|social functioning
5145984|NCT01028677|paranoia|paranoia
5145985|NCT01028677|psychotic symptoms|psychotic symptoms
5145986|NCT01028677|schizophrenia|schizophrenia
5145987|NCT01028677|social deficits|social deficits
5145988|NCT01028677|intranasal administration|intranasal administration
5145989|NCT01028664|Glaucoma and ocular hypertension patients|glaucoma and ocular hypertension patients
5145990|NCT01028651|PAH|pah
5145991|NCT01028651|Pulmonary Hypertension|pulmonary hypertension
5145992|NCT01028651|Remodulin|remodulin
5145993|NCT01028651|Treprostinil|treprostinil
5145994|NCT01028651|Quality of Life|quality of life
5145995|NCT01028638|VEGF imaging|vegf imaging
5145996|NCT01028638|everolimus|everolimus
5145997|NCT01028638|renal cell carcinoma|renal cell carcinoma
5145998|NCT01028638|PET|pet
5145999|NCT01028638|bevacizumab|bevacizumab
5146000|NCT01028625|Heart failure|heart failure
5146001|NCT01028625|Depression|depression
5146002|NCT01028625|Self Care|self care
5146003|NCT01028625|Cognitive behavior therapy|cognitive behavior therapy
5146004|NCT01028599|Heart transplantation|heart transplantation
5146005|NCT01028599|Exercise capacity|exercise capacity
5146006|NCT01028599|Endothelial function|endothelial function
5146007|NCT01028573|bowel preparation|bowel preparation
5146008|NCT01028573|colonoscopy|colonoscopy
5146009|NCT01028560|Wheezing|wheezing
5146010|NCT01028560|Asthma|asthma
5146011|NCT01028560|Allergy|allergy
5146012|NCT01028560|Immunotherapy|immunotherapy
5146013|NCT01028547|PONV|ponv
5146014|NCT01028534|Continuous positive pressure ventilation|continuous positive pressure ventilation
5146015|NCT01028534|Blood pressure|blood pressure
5146016|NCT01028534|Oxygen desaturation index|oxygen desaturation index
5146017|NCT01028534|Endothelial dysfunction|endothelial dysfunction
5146018|NCT01028534|Patient reported measurement|patient reported measurement
5146019|NCT01028521|First time in man, safety study, Cm3.1-AC100|first time in man, safety study, cm3.1-ac100
5146020|NCT01028521|Male volunteer aged 18 to 50 years at Screening|male volunteer aged 18 to 50 years at screening
5146021|NCT01028508|Depression|depression
5146022|NCT01028508|ECT|ect
5146023|NCT01028508|electroconvulsive therapy|electroconvulsive therapy
5146024|NCT01028508|mood disorders|mood disorders
5146025|NCT01028508|continuation ECT|continuation ect
5146026|NCT01028508|continuation pharmacotherapy|continuation pharmacotherapy
5146027|NCT01028508|geriatric|geriatric
5146028|NCT01028508|elderly|elderly
5146029|NCT01028508|lithium|lithium
5146030|NCT01028508|venlafaxine|venlafaxine
5146031|NCT01028482|severity of depression measured by MADRS and CGI|severity of depression measured by madrs and cgi
5146032|NCT01028456|Seizures|seizures
5146033|NCT01028456|Light Therapy|light therapy
5146034|NCT01028430|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
5146035|NCT01028417|subcentimetre nodules|subcentimetre nodules
5146036|NCT01028365|Fertility|fertility
5146037|NCT01028365|Trying to Conceive|trying to conceive
5146038|NCT01028365|Trying to Get Pregnant|trying to get pregnant
5146039|NCT01028365|Pregnancy|pregnancy
5146040|NCT01028339|traumatic brain injury|traumatic brain injury
5146041|NCT01028339|PtiO2|ptio2
5146042|NCT01028339|Cerebral microdialysis|cerebral microdialysis
5146043|NCT01028339|Osmotherapy|osmotherapy
5146044|NCT01028339|hypertonic saline|hypertonic saline
5146045|NCT01028339|mannitol|mannitol
5146046|NCT01028326|Pneumococcal pneumonia vaccine|pneumococcal pneumonia vaccine
5146047|NCT01028313|Chronic Graft-Versus-Host Disease|chronic graft-versus-host disease
5146048|NCT01028313|GVHD|gvhd
5146049|NCT01028313|LBH589|lbh589
5146050|NCT01028313|Panobinostat|panobinostat
5146051|NCT01028300|DDD|ddd
5146052|NCT01028287|Diabetic Nephropathy|diabetic nephropathy
5146053|NCT01028287|Nephrotic syndrome|nephrotic syndrome
5146054|NCT01028274|Hypercholesterolemia|hypercholesterolemia
5146055|NCT01028274|Hypertriglyceridemia|hypertriglyceridemia
5146056|NCT01028274|Fish Oil|fish oil
5146057|NCT01028274|Red Yeast Rice|red yeast rice
5146058|NCT01028261|Obese|obese
5146059|NCT01028261|Obesity|obesity
5146060|NCT01028261|Overweight|overweight
5146061|NCT01028248|Central Retinal Vein Occlusion|central retinal vein occlusion
5146062|NCT01028248|Retinal Vein Occlusive disease|retinal vein occlusive disease
5146063|NCT01028235|Eosinophilic Esophagitis|eosinophilic esophagitis
5146064|NCT01028222|Melanoma|melanoma
5146065|NCT01028222|AMN107|amn107
5146066|NCT01028222|c-Kit|c-kit
5146067|NCT01028222|c-Kit mutated metastatic and/or inoperable melanoma|c-kit mutated metastatic and/or inoperable melanoma
5146068|NCT01028196|schizophrenia|schizophrenia
5146069|NCT01028196|schizoaffective disorder|schizoaffective disorder
5146070|NCT01028196|recurrent depression|recurrent depression
5146071|NCT01028196|Bipolar disorders|bipolar disorders
5146072|NCT01028183|therapeutics|therapeutics
5146073|NCT01028183|safety|safety
5146074|NCT01028183|maternal|maternal
5146075|NCT01028183|neonatal|neonatal
5146076|NCT01028170|Congestive Heart Failure|congestive heart failure
5146077|NCT01028170|Renal Insufficiency|renal insufficiency
5146078|NCT01028170|Cardio-renal Syndrome|cardio-renal syndrome
5146079|NCT01028157|HIV|hiv
5146080|NCT01028157|risk reduction|risk reduction
5146081|NCT01028157|behavioral intervention|behavioral intervention
5146082|NCT01028144|Exercise|exercise
5146083|NCT01028144|Physical Activity|physical activity
5146084|NCT01028144|Adolescent|adolescent
5146085|NCT01028144|Minority Health|minority health
5146086|NCT01028131|cigarette smoking|cigarette smoking
5146087|NCT01028131|pregnancy|pregnancy
5146088|NCT01028131|intervention|intervention
5146089|NCT01028131|efficacy|efficacy
5146090|NCT01028131|Motivational Interviewing|motivational interviewing
5146091|NCT01028131|Contingency Management|contingency management
5146092|NCT01028118|domestic and sexual violence|domestic and sexual violence
5146093|NCT01028118|menopause|menopause
5146094|NCT01028118|professional improvement|professional improvement
5146095|NCT01028118|social support network|social support network
5146096|NCT01028105|Preoperative screening|preoperative screening
5146097|NCT01028105|MRSA|mrsa
5146098|NCT01028105|Incidence|incidence
5146099|NCT01028105|Postoperative infection|postoperative infection
5146100|NCT01028105|Preoperative MRSA Screening Incidence|preoperative mrsa screening incidence
5146101|NCT01028105|Postoperative MRSA Infection Rate|postoperative mrsa infection rate
5146102|NCT01028079|Back Pain|back pain
5146103|NCT01028079|Acute low back pain|acute low back pain
5146104|NCT01028066|nutritional intervention|nutritional intervention
5146105|NCT01028066|nutritional counseling|nutritional counseling
5146106|NCT01028066|feeding behavior|feeding behavior
5146107|NCT01028066|food consumption|food consumption
5146108|NCT01028066|angioplasty|angioplasty
5146109|NCT01028053|Mild Cognitive Impairment|mild cognitive impairment
5146110|NCT01028053|Positron Emission Tomography|positron emission tomography
5146111|NCT01028053|National Institute of Neurological and Communicative Disorders and Stroke|national institute of neurological and communicative disorders and stroke
5146112|NCT01028053|Alzheimer's Disease and Related Disorders Association|alzheimer's disease and related disorders association
5146113|NCT01028053|Assess Prognostic Usefulness of Flutemetamol Injection for Identifying Subjects who will Convert to Clinically Probable Alzheimer's Disease|assess prognostic usefulness of flutemetamol injection for identifying subjects who will convert to clinically probable alzheimer's disease
5146114|NCT01028040|Phase I|phase i
5146115|NCT01028040|AZD3043|azd3043
5146116|NCT01028040|Japanese healthy volunteer|japanese healthy volunteer
5146117|NCT01028027|Blepharokeratoconjunctivitis|blepharokeratoconjunctivitis
5146118|NCT01027988|Retinal Microvascularisation|retinal microvascularisation
5146119|NCT01027988|Fundus|fundus
5146120|NCT01027988|mfERGs|mfergs
5146121|NCT01027988|CHF|chf
5146122|NCT01027988|Cardiovascular Disease|cardiovascular disease
5146123|NCT01027988|Coronarography|coronarography
5146124|NCT01027988|Macrovascularisation|macrovascularisation
5146125|NCT01027988|The objectives are to assess if if any retinal vascular disorder in arterioles and venules can be predictive for cardiovascular morbidity and mortality|the objectives are to assess if if any retinal vascular disorder in arterioles and venules can be predictive for cardiovascular morbidity and mortality
5146126|NCT01027975|laparoscopy|laparoscopy
5146127|NCT01027975|fundoplication|fundoplication
5146128|NCT01027975|Nissen|nissen
5146129|NCT01027975|Thal|thal
5146130|NCT01027975|children|children
5146131|NCT01027975|operative treatment of gastro-oesophageal reflux disease in children|operative treatment of gastro-oesophageal reflux disease in children
5146132|NCT01027962|Early Onset Psychosis|early onset psychosis
5146133|NCT01027962|Laptop Computer|laptop computer
5146134|NCT01027962|Brain Training|brain training
5146135|NCT01027936|Healthy Volunteers|healthy volunteers
5146136|NCT01027910|PCI-24781|pci-24781
5146137|NCT01027910|doxorubicin|doxorubicin
5146138|NCT01027897|Pharmacokinetics|pharmacokinetics
5146139|NCT01027897|Pharmacodynamics|pharmacodynamics
5146140|NCT01027897|Doripenem|doripenem
5146141|NCT01027897|Trauma|trauma
5146142|NCT01027897|sepsis|sepsis
5146143|NCT01027897|Trauma patients with sepsis|trauma patients with sepsis
5146144|NCT01027884|Idebenone|idebenone
5146145|NCT01027884|Duchenne Muscular Dystrophy (DMD)|duchenne muscular dystrophy (dmd)
5146146|NCT01027884|Respiratory function|respiratory function
5146147|NCT01027884|Ambulatory and non-ambulatory patients|ambulatory and non-ambulatory patients
5146148|NCT01027884|Subjects not using glucocorticoids|subjects not using glucocorticoids
5146149|NCT01027858|exercise|exercise
5146150|NCT01027858|aerobic exercise training|aerobic exercise training
5146151|NCT01027858|vascular cognitive impairment|vascular cognitive impairment
5146152|NCT01027858|Mild Sub-cortical Ischaemic Vascular Cognitive Impairment (SIVCI)|mild sub-cortical ischaemic vascular cognitive impairment (sivci)
5146153|NCT01027845|Pneumococcal disease|pneumococcal disease
5146154|NCT01027845|Immunogenicity|immunogenicity
5146155|NCT01027845|Booster vaccination|booster vaccination
5146156|NCT01027845|Pneumococcal vaccine|pneumococcal vaccine
5146157|NCT01027845|Primary vaccination|primary vaccination
5146158|NCT01027845|Safety|safety
5146159|NCT01027832|tracheobronchitis|tracheobronchitis
5146160|NCT01027819|Total knee arthroplasty|total knee arthroplasty
5146161|NCT01027819|Mobile bearing|mobile bearing
5146162|NCT01027819|Fixed bearing|fixed bearing
5146163|NCT01027819|Range of motion|range of motion
5146452|NCT01026545|macrolide|macrolide
5146164|NCT01027819|Knee Society Score|knee society score
5146165|NCT01027806|Children|children
5146166|NCT01027806|Sleep|sleep
5146167|NCT01027806|Obstructive Sleep Apnea|obstructive sleep apnea
5146168|NCT01027793|Stretch marks|stretch marks
5146169|NCT01027793|Striae|striae
5146170|NCT01027793|Tretinoin|tretinoin
5146171|NCT01027793|Superficial dermabrasion|superficial dermabrasion
5146172|NCT01027780|Mindfulness-Based Stress Reduction|mindfulness-based stress reduction
5146173|NCT01027780|MBSR|mbsr
5146174|NCT01027780|Seniors|seniors
5146175|NCT01027780|immune system|immune system
5146176|NCT01027780|keyhole limpet hemocyanin (KLH)|keyhole limpet hemocyanin (klh)
5146177|NCT01027767|Breast|breast
5146178|NCT01027767|MBI|mbi
5146179|NCT01027767|Molecular|molecular
5146180|NCT01027767|Molecular Breast Imaging|molecular breast imaging
5146181|NCT01027767|Dense breast tissue|dense breast tissue
5146182|NCT01027767|Surgery|surgery
5146183|NCT01027767|Radiation|radiation
5146184|NCT01027767|BCT|bct
5146185|NCT01027754|methadone maintenance|methadone maintenance
5146186|NCT01027715|Neonatal Seizures|neonatal seizures
5146187|NCT01027715|Neonatal encephalopathy|neonatal encephalopathy
5146188|NCT01027702|Donor Lymphocyte Infusion|donor lymphocyte infusion
5146189|NCT01027702|Immune Recovery|immune recovery
5146190|NCT01027702|T cell depleted transplant|t cell depleted transplant
5146191|NCT01027702|Mismatched related donor transplants|mismatched related donor transplants
5146192|NCT01027702|Unrelated donor transplants|unrelated donor transplants
5146193|NCT01027689|alprazolam|alprazolam
5146194|NCT01027689|bioequivalence|bioequivalence
5146195|NCT01027689|sublingual|sublingual
5146196|NCT01027676|Gefitinib|gefitinib
5146197|NCT01027676|Vorinostat|vorinostat
5146198|NCT01027663|anemia|anemia
5146199|NCT01027663|malaria|malaria
5146200|NCT01027637|breast reconstruction|breast reconstruction
5146201|NCT01027637|tissue expander|tissue expander
5146202|NCT01027637|Alloderm|alloderm
5146203|NCT01027637|tissue matrix|tissue matrix
5146204|NCT01027624|Pan South African Survey on the Undertreatment of Hypercholesterolaemia|pan south african survey on the undertreatment of hypercholesterolaemia
5146205|NCT01027611|Effectiveness of topical pain medicine for control of pain associated with intravitreal injections|effectiveness of topical pain medicine for control of pain associated with intravitreal injections
5146206|NCT01027611|Eye discomfort|eye discomfort
5146207|NCT01027598|Lung Cancer|lung cancer
5146208|NCT01027598|Previously Treated Advanced Non Small Cell Lung Cancer|previously treated advanced non small cell lung cancer
5146209|NCT01027598|Erlotinib|erlotinib
5146210|NCT01027598|Pazopanib|pazopanib
5146211|NCT01027572|Vegetative state|vegetative state
5146212|NCT01027572|Minimally conscious state|minimally conscious state
5146213|NCT01027572|Thalamic stimulation|thalamic stimulation
5146214|NCT01027559|Major Depression|major depression
5146215|NCT01027559|Functional Magnetic Resonance Imaging|functional magnetic resonance imaging
5146216|NCT01027559|Emotional Circuitry|emotional circuitry
5146217|NCT01027559|Cognitive Behavioral Therapy|cognitive behavioral therapy
5146218|NCT01027546|perioperative blood loss, spinal surgery|perioperative blood loss, spinal surgery
5146219|NCT01027533|multifocal intraocular lens|multifocal intraocular lens
5146220|NCT01027533|visual acuity|visual acuity
5146221|NCT01027533|presbiopia|presbiopia
5146222|NCT01027520|Hand burn|hand burn
5146223|NCT01027520|skin graft|skin graft
5146224|NCT01027520|coban dressing|coban dressing
5146225|NCT01027520|range of motion|range of motion
5146226|NCT01027494|ear tubes|ear tubes
5146227|NCT01027494|ear drainage|ear drainage
5146228|NCT01027494|ear infection|ear infection
5146229|NCT01027494|ear drops|ear drops
5146230|NCT01027494|tympanostomy tubes|tympanostomy tubes
5146231|NCT01027481|lucentis, macular edema, branch retinal vein occlusion|lucentis, macular edema, branch retinal vein occlusion
5146232|NCT01027468|bevacizumab, choroidal neovascularization|bevacizumab, choroidal neovascularization
5146233|NCT01027442|Stereolithography|stereolithography
5146234|NCT01027442|Dental implants,|dental implants,
5146235|NCT01027442|Prosthetics|prosthetics
5146236|NCT01027442|positioning-errors|positioning-errors
5146237|NCT01027442|logistic regression analysis|logistic regression analysis
5146238|NCT01027429|infant|infant
5146239|NCT01027429|newborn|newborn
5146240|NCT01027429|sepsis|sepsis
5146241|NCT01027429|infection|infection
5146242|NCT01027429|community|community
5146243|NCT01027416|ER positive|er positive
5146244|NCT01027416|Tamoxifen|tamoxifen
5146245|NCT01027403|Heart failure|heart failure
5146246|NCT01027403|Adult stem cells|adult stem cells
5146247|NCT01027403|Circulating stem cells|circulating stem cells
5146248|NCT01027403|Acute decompensated heart failure|acute decompensated heart failure
5146249|NCT01027390|neck/shoulder|neck/shoulder
5146250|NCT01027351|Children|children
5146251|NCT01027351|Pre-school|pre-school
5146252|NCT01027351|Meningococcal disease|meningococcal disease
5146253|NCT01027351|Prevention|prevention
5146254|NCT01027351|Vaccination|vaccination
5146255|NCT01027325|Resistant Starch|resistant starch
5146256|NCT01027325|Amylose|amylose
5146257|NCT01027325|Amylopectin|amylopectin
5146258|NCT01027325|LDL subclasses|ldl subclasses
5146259|NCT01027325|Dietary carbohydrate|dietary carbohydrate
5146260|NCT01027325|Postprandial insulinemia|postprandial insulinemia
5146262|NCT01027312|quality of life|quality of life
5146263|NCT01027312|daily living activities|daily living activities
5146264|NCT01027312|visual fields|visual fields
5146265|NCT01027312|contrast sensitivity|contrast sensitivity
5146266|NCT01027299|cardiac failure|cardiac failure
5146267|NCT01027299|thoracic surgery|thoracic surgery
5146268|NCT01027299|cardiac pacing, artificial|cardiac pacing, artificial
5146269|NCT01027273|Stroke|stroke
5146270|NCT01027273|Ischemic Stroke|ischemic stroke
5146271|NCT01027273|Transient Ischemic Attack|transient ischemic attack
5146272|NCT01027273|Stroke Recurrence Prevention|stroke recurrence prevention
5146273|NCT01027273|Cerebrovascular Disorders|cerebrovascular disorders
5146274|NCT01027273|Brain Ischemia|brain ischemia
5146275|NCT01027273|Brain Infraction|brain infraction
5146276|NCT01027273|Brain Diseases|brain diseases
5146277|NCT01027273|Cerebral Infraction|cerebral infraction
5146278|NCT01027273|Self-management|self-management
5146279|NCT01027273|Peer-led|peer-led
5146280|NCT01027273|Community Based|community based
5146281|NCT01027247|Primary Glaucoma|primary glaucoma
5146282|NCT01027234|Healthy volunteers|healthy volunteers
5146283|NCT01027221|Low Dose Radiation|low dose radiation
5146284|NCT01027221|pancreatic cancer|pancreatic cancer
5146285|NCT01027221|Immunostimulation|immunostimulation
5146287|NCT01027169|Hepatic impairment|hepatic impairment
5146288|NCT01027169|Liver diseases|liver diseases
5146289|NCT01027169|Pharmacokinetics|pharmacokinetics
5146290|NCT01027169|To Investigate Pharmacokinetics of Safinamide in Subjects With Mild and Moderate Hepatic Impairment as Compared to Healthy Subjects With Normal Hepatic Function|to investigate pharmacokinetics of safinamide in subjects with mild and moderate hepatic impairment as compared to healthy subjects with normal hepatic function
5146291|NCT01027156|Public Health|public health
5146292|NCT01027156|Biochemistry|biochemistry
5146293|NCT01027156|Ecological|ecological
5146294|NCT01027143|Asthma|asthma
5146295|NCT01027143|Obesity|obesity
5146296|NCT01027143|Pharmacogenetics|pharmacogenetics
5146297|NCT01027143|Nutrigenetics|nutrigenetics
5146298|NCT01027117|Bioavailability|bioavailability
5146299|NCT01027117|Revatio|revatio
5146300|NCT01027117|Healthy Volunteers|healthy volunteers
5146301|NCT01027104|injury prevention|injury prevention
5146302|NCT01027104|firearms|firearms
5146303|NCT01027104|training|training
5146304|NCT01027104|counseling|counseling
5146305|NCT01027104|medical education|medical education
5146306|NCT01027104|safety|safety
5146307|NCT01027104|anticipatory guidance|anticipatory guidance
5146308|NCT01027104|Firearm injury prevention anticipatory guidance|firearm injury prevention anticipatory guidance
5146309|NCT01027091|hypocalcemia|hypocalcemia
5146310|NCT01027091|total thyroidectomy|total thyroidectomy
5146311|NCT01027065|interleukin-7|interleukin-7
5146312|NCT01027065|immune-based therapies|immune-based therapies
5146313|NCT01027065|hepatitis B|hepatitis b
5146314|NCT01027065|HBe negative|hbe negative
5146315|NCT01027065|HBV vaccination|hbv vaccination
5146316|NCT01027065|entecavir|entecavir
5146317|NCT01027065|tenofovir|tenofovir
5146318|NCT01027065|chronic hepatitis|chronic hepatitis
5146319|NCT01027065|immune specific responses to HBV|immune specific responses to hbv
5146320|NCT01027065|phase 1/2a|phase 1/2a
5146321|NCT01027065|viral disease|viral disease
5146322|NCT01027065|liver disease|liver disease
5146323|NCT01027052|MDA|mda
5146324|NCT01027052|Spice|spice
5146325|NCT01027039|primary open angle glaucoma|primary open angle glaucoma
5146326|NCT01027039|pigmentary glaucoma|pigmentary glaucoma
5146327|NCT01027039|exfoliative glaucoma|exfoliative glaucoma
5146328|NCT01027039|angle closure glaucoma|angle closure glaucoma
5146329|NCT01027039|low tension glaucoma|low tension glaucoma
5146330|NCT01027026|Cost analysis|cost analysis
5146331|NCT01027026|Safety|safety
5146332|NCT01027026|Length of stay|length of stay
5146333|NCT01027026|Randomized controlled trials|randomized controlled trials
5146334|NCT01027026|Early discharge|early discharge
5146335|NCT01027000|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5146336|NCT01027000|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
5146337|NCT01027000|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
5146338|NCT01027000|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5146339|NCT01027000|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5146340|NCT01027000|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
5146341|NCT01027000|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
5146342|NCT01027000|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
5146343|NCT01027000|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5146344|NCT01027000|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
5146345|NCT01027000|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5146346|NCT01027000|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5146347|NCT01026974|Children|children
5146348|NCT01026974|Pre-school|pre-school
5146349|NCT01026974|Meningococcal disease|meningococcal disease
5146350|NCT01026974|Prevention|prevention
5146351|NCT01026974|Vaccination|vaccination
5146352|NCT01026961|Safety|safety
5146353|NCT01026961|heart rate|heart rate
5146451|NCT01026545|multiple-dose|multiple-dose
5146354|NCT01026961|systolic and diastolic blood pressure|systolic and diastolic blood pressure
5146355|NCT01026961|arrhythmias|arrhythmias
5146356|NCT01026948|Induction of labour|induction of labour
5146357|NCT01026948|Intraprtum fetal monitoring|intraprtum fetal monitoring
5146358|NCT01026935|open mesh repair|open mesh repair
5146359|NCT01026935|sutured|sutured
5146360|NCT01026935|non-sutured|non-sutured
5146361|NCT01026935|pro-grip|pro-grip
5146362|NCT01026935|postoperative pain|postoperative pain
5146363|NCT01026922|antroduodenal manometry|antroduodenal manometry
5146364|NCT01026922|gastric dysmotility|gastric dysmotility
5146365|NCT01026922|intestinal dysmotility|intestinal dysmotility
5146366|NCT01026896|Mental practice|mental practice
5146367|NCT01026896|motor imagery|motor imagery
5146368|NCT01026896|stroke|stroke
5146369|NCT01026896|hemiplegia|hemiplegia
5146370|NCT01026896|motor recovery|motor recovery
5146371|NCT01026896|neuroplasticity|neuroplasticity
5146372|NCT01026883|hematocrit|hematocrit
5146373|NCT01026883|layered resonant piezoelectric sensors|layered resonant piezoelectric sensors
5146374|NCT01026844|erlotinib|erlotinib
5146375|NCT01026844|tarceva|tarceva
5146376|NCT01026844|hydroxychloroquine|hydroxychloroquine
5146377|NCT01026844|NSCLC|nsclc
5146378|NCT01026818|Erectile Dysfunction|erectile dysfunction
5146379|NCT01026818|Radical Prostatectomy|radical prostatectomy
5146380|NCT01026805|morcellator|morcellator
5146381|NCT01026805|hysteroscope|hysteroscope
5146382|NCT01026805|myomectomy|myomectomy
5146383|NCT01026805|polypectomy|polypectomy
5146384|NCT01026805|uterine fibroids|uterine fibroids
5146385|NCT01026779|rotavirus|rotavirus
5146386|NCT01026779|gastroenteritis|gastroenteritis
5146387|NCT01026779|vaccine|vaccine
5146388|NCT01026779|case-control study|case-control study
5146389|NCT01026779|serotype|serotype
5146390|NCT01026766|Hypothermia|hypothermia
5146391|NCT01026766|Obesity|obesity
5146392|NCT01026766|Heat and moisture exchanger|heat and moisture exchanger
5146393|NCT01026766|Warming blanket|warming blanket
5146394|NCT01026766|Warming fluids|warming fluids
5146395|NCT01026766|Gynecological surgery|gynecological surgery
5146396|NCT01026766|Intravenous anesthesia|intravenous anesthesia
5146397|NCT01026766|Obese patients|obese patients
5146398|NCT01026766|Non obese patients|non obese patients
5146399|NCT01026753|colorectal cancer|colorectal cancer
5146400|NCT01026753|screening|screening
5146401|NCT01026753|fecal occult blood test|fecal occult blood test
5146402|NCT01026753|randomized control trial|randomized control trial
5146403|NCT01026753|primary care oncology|primary care oncology
5146404|NCT01026753|web site|web site
5146405|NCT01026753|provincial health contact center|provincial health contact center
5146406|NCT01026740|Staphylococcal Skin Infections|staphylococcal skin infections
5146407|NCT01026740|Streptococcal Infections|streptococcal infections
5146408|NCT01026727|HIV Infections|hiv infections
5146409|NCT01026727|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5146410|NCT01026727|Virus Diseases|virus diseases
5146411|NCT01026727|Sexually Transmitted Diseases, Viral|sexually transmitted diseases, viral
5146412|NCT01026727|RNA Virus Infections|rna virus infections
5146413|NCT01026727|Slow Virus Diseases|slow virus diseases
5146414|NCT01026727|Immune System Diseases|immune system diseases
5146415|NCT01026727|Sexually Transmitted Diseases|sexually transmitted diseases
5146416|NCT01026727|Lentivirus Infections|lentivirus infections
5146417|NCT01026727|Infection|infection
5146418|NCT01026727|Retroviridae Infections|retroviridae infections
5146419|NCT01026727|Immunologic Deficiency Syndromes|immunologic deficiency syndromes
5146420|NCT01026727|HIV|hiv
5146421|NCT01026727|treatment experienced|treatment experienced
5146422|NCT01026727|bevirimat|bevirimat
5146423|NCT01026701|Osteoblst effect|osteoblst effect
5146424|NCT01026701|Velcade|velcade
5146425|NCT01026701|Proteasome inhibitor|proteasome inhibitor
5146426|NCT01026701|Bortezomib|bortezomib
5146427|NCT01026701|Multjple Myeloma|multjple myeloma
5146428|NCT01026688|Pragmatic randomized controlled trial|pragmatic randomized controlled trial
5146429|NCT01026688|Cardiovascular risk reduction|cardiovascular risk reduction
5146430|NCT01026688|Knowledge translation|knowledge translation
5146431|NCT01026688|Clinical practice guidelines|clinical practice guidelines
5146432|NCT01026662|Aesthetic dermatology|aesthetic dermatology
5146433|NCT01026649|hematoma formation|hematoma formation
5146434|NCT01026649|success rate|success rate
5146435|NCT01026636|Staphylococcal Skin Infections|staphylococcal skin infections
5146436|NCT01026636|Skin Infections|skin infections
5146437|NCT01026636|Streptococcal Infections|streptococcal infections
5146438|NCT01026610|Chronic hepatitis B|chronic hepatitis b
5146439|NCT01026610|LB80380|lb80380
5146440|NCT01026610|treatment-naive|treatment-naive
5146441|NCT01026610|entecavir|entecavir
5146442|NCT01026571|Bicuspid aortic valve|bicuspid aortic valve
5146443|NCT01026558|Obesity, Ceftobiprole|obesity, ceftobiprole
5146444|NCT01026558|Skin Infections|skin infections
5146445|NCT01026558|Staphylococcal Skin Infections|staphylococcal skin infections
5146446|NCT01026558|Bacterial Skin Infections|bacterial skin infections
5146447|NCT01026558|Streptococcal Infection|streptococcal infection
5146448|NCT01026545|safety|safety
5146449|NCT01026545|tolerability|tolerability
5146450|NCT01026545|pharmacokinetics|pharmacokinetics
5146453|NCT01026506|c9,t11-CLA|c9,t11-cla
5146454|NCT01026506|allergic bronchial asthma|allergic bronchial asthma
5146455|NCT01026506|children and adolescents|children and adolescents
5146456|NCT01026493|adult giant cell glioblastoma|adult giant cell glioblastoma
5146457|NCT01026493|adult glioblastoma|adult glioblastoma
5146458|NCT01026493|adult gliosarcoma|adult gliosarcoma
5146459|NCT01026493|recurrent adult brain tumor|recurrent adult brain tumor
5146460|NCT01026493|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5146461|NCT01026493|adult anaplastic ependymoma|adult anaplastic ependymoma
5146462|NCT01026493|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
5146463|NCT01026493|adult brain stem glioma|adult brain stem glioma
5146464|NCT01026493|adult mixed glioma|adult mixed glioma
5146465|NCT01026493|adult pineal gland astrocytoma|adult pineal gland astrocytoma
5146466|NCT01026480|Ileal Pouch Anal Anastomosis|ileal pouch anal anastomosis
5146467|NCT01026480|IPAA|ipaa
5146468|NCT01026480|Pull through|pull through
5146469|NCT01026480|IBD|ibd
5146470|NCT01026480|Ulcerative colitis|ulcerative colitis
5146471|NCT01026480|Familial adenomatous polyposis|familial adenomatous polyposis
5146472|NCT01026480|FAP|fap
5146473|NCT01026480|Hereditary nonpolyposis colorectal cancer|hereditary nonpolyposis colorectal cancer
5146474|NCT01026480|HNPCC|hnpcc
5146475|NCT01026454|HSV|hsv
5146476|NCT01026454|HIV|hiv
5146477|NCT01026441|Aesthetic|aesthetic
5146478|NCT01026428|safinamide|safinamide
5146479|NCT01026428|levodopa|levodopa
5146480|NCT01026428|drug -drug interaction|drug -drug interaction
5146481|NCT01026428|pharmacokinetics|pharmacokinetics
5146482|NCT01026428|Patients diagnosed with idiopathic Parkinson's disease, levodopa-responsive, treated with a stable dose of levodopa/carbidopa|patients diagnosed with idiopathic parkinson's disease, levodopa-responsive, treated with a stable dose of levodopa/carbidopa
5146483|NCT01026415|Antibody-Drug Conjugate|antibody-drug conjugate
5146484|NCT01026415|Antigens, CD30|antigens, cd30
5146485|NCT01026415|Disease, Hodgkin|disease, hodgkin
5146486|NCT01026415|Lymphoma, Large-Cell, Anaplastic|lymphoma, large-cell, anaplastic
5146487|NCT01026415|Lymphoma, Non-Hodgkin|lymphoma, non-hodgkin
5146488|NCT01026415|monomethyl auristatin E|monomethyl auristatin e
5146489|NCT01026415|Drug Therapy|drug therapy
5146490|NCT01026415|Immunotherapy|immunotherapy
5146491|NCT01026415|Hematologic Diseases|hematologic diseases
5146492|NCT01026415|Lymphoma|lymphoma
5146493|NCT01026415|Antibodies, Monoclonal|antibodies, monoclonal
5146494|NCT01026402|Phase I|phase i
5146495|NCT01026402|cancer|cancer
5146496|NCT01026402|advanced solid malignancies|advanced solid malignancies
5146497|NCT01026402|dose escalation|dose escalation
5146498|NCT01026402|AZD2014|azd2014
5146499|NCT01026402|mTor kinase inhibitor|mtor kinase inhibitor
5146500|NCT01026402|safety|safety
5146501|NCT01026402|pharmacokinetics|pharmacokinetics
5146502|NCT01026389|MRA-Contrast agent comparison in peripheral disease|mra-contrast agent comparison in peripheral disease
5146503|NCT01026376|Myelodysplastic Syndromes|myelodysplastic syndromes
5146504|NCT01026376|Decitabine|decitabine
5146505|NCT01026363|Vitamin D|vitamin d
5146506|NCT01026363|Chronic Kidney Disease|chronic kidney disease
5146507|NCT01026350|modulating immune response to flu antigen|modulating immune response to flu antigen
5146508|NCT01026337|recurrent renal cell cancer|recurrent renal cell cancer
5146509|NCT01026311|Coenzyme q10|coenzyme q10
5146510|NCT01026311|statins|statins
5146511|NCT01026311|myalgias|myalgias
5146512|NCT01026311|anaerobic threshold|anaerobic threshold
5146513|NCT01026311|athletic performance|athletic performance
5146514|NCT01026298|asthma|asthma
5146515|NCT01026298|obstructive sleep apnea|obstructive sleep apnea
5146516|NCT01026298|severe asthma|severe asthma
5146517|NCT01026298|OSA|osa
5146518|NCT01026285|Risperdal Consta|risperdal consta
5146519|NCT01026272|Endocannabinoid|endocannabinoid
5146520|NCT01026272|Fish Oil|fish oil
5146521|NCT01026272|Multiple Sclerosis|multiple sclerosis
5146522|NCT01026272|Monocyte Migration|monocyte migration
5146523|NCT01026259|Surgical site infection|surgical site infection
5146524|NCT01026259|wound healing|wound healing
5146525|NCT01026259|tissue oxygen|tissue oxygen
5146526|NCT01026259|angiogenesis|angiogenesis
5146527|NCT01026259|flow cytometry|flow cytometry
5146528|NCT01026259|immunohistochemistry|immunohistochemistry
5146529|NCT01026246|Ghana, malaria, vaccine, Plasmodium falciparum|ghana, malaria, vaccine, plasmodium falciparum
5146530|NCT01026233|Antibodies, Monoclonal|antibodies, monoclonal
5146531|NCT01026233|Antibody-Drug Conjugate|antibody-drug conjugate
5146532|NCT01026233|Antigens, CD30|antigens, cd30
5146533|NCT01026233|Disease, Hodgkin|disease, hodgkin
5146534|NCT01026233|Drug Therapy|drug therapy
5146535|NCT01026233|Hematologic Diseases|hematologic diseases
5146536|NCT01026233|Immunotherapy|immunotherapy
5146537|NCT01026233|Lymphoma|lymphoma
5146538|NCT01026233|monomethylauristatin E|monomethylauristatin e
5146539|NCT01026233|Lymphoma, Large-Cell, Anaplastic|lymphoma, large-cell, anaplastic
5146540|NCT01026207|Diagnostic test|diagnostic test
5146541|NCT01026207|polysomnography|polysomnography
5146542|NCT01026207|Obstructive Sleep Apnea Syndrome|obstructive sleep apnea syndrome
5146543|NCT01026207|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5146544|NCT01026194|insulin resistance|insulin resistance
5146545|NCT01026155|Obese patients (BMI > 30 kg / m²)|obese patients (bmi > 30 kg / m²)
5146546|NCT01026103|gastric bypass|gastric bypass
5146547|NCT01026103|Gastric bypass surgery|gastric bypass surgery
5146548|NCT01026077|Savella pregnant|savella pregnant
5146549|NCT01026077|savella pregnancy|savella pregnancy
5146550|NCT01026077|fibromyalgia pregnant|fibromyalgia pregnant
5146551|NCT01026077|fibromyalgia pregnancy|fibromyalgia pregnancy
5146552|NCT01026077|pregnancy registry savella|pregnancy registry savella
5146553|NCT01026064|Macrolides|macrolides
5146554|NCT01026064|Inflammation|inflammation
5146555|NCT01026064|Azithromycin|azithromycin
5146556|NCT01026064|Cantharidin induced skin blister model|cantharidin induced skin blister model
5146557|NCT01026051|Cancer Vaccine, Immunotherapy, Melanoma|cancer vaccine, immunotherapy, melanoma
5146558|NCT01026038|Pneumococcal vaccine 13-valent|pneumococcal vaccine 13-valent
5146559|NCT01026025|lobectomy|lobectomy
5146560|NCT01026025|segmentectomy|segmentectomy
5146561|NCT01026025|pulmonary resection|pulmonary resection
5146562|NCT01026012|Regadenoson|regadenoson
5146563|NCT01026012|85% predicted heart rate|85% predicted heart rate
5146564|NCT01026012|Myocardial perfusion stress testing|myocardial perfusion stress testing
5146565|NCT01025999|RYGB|rygb
5146566|NCT01025999|Gastrostomy tube|gastrostomy tube
5146567|NCT01025999|DM|dm
5146568|NCT01025999|Gastric Bypass|gastric bypass
5146569|NCT01025960|colonoscopy|colonoscopy
5146570|NCT01025960|adenoma detection|adenoma detection
5146571|NCT01025960|polyps|polyps
5146572|NCT01025947|Atrial fibrillation|atrial fibrillation
5146573|NCT01025947|Cryptogenic stroke|cryptogenic stroke
5146574|NCT01025947|Implantable loop recorder|implantable loop recorder
5146575|NCT01025921|Tracheobronchitis|tracheobronchitis
5146576|NCT01025921|pneumonia|pneumonia
5146577|NCT01025921|inhaled antibiotics|inhaled antibiotics
5146578|NCT01025921|colistin|colistin
5146579|NCT01025921|Ventilator associated tracheobronchitis|ventilator associated tracheobronchitis
5146580|NCT01025921|Ventilator associated pneumonia|ventilator associated pneumonia
5146581|NCT01025908|psychotherapy|psychotherapy
5146582|NCT01025908|panic disorder|panic disorder
5146583|NCT01025908|anxiety|anxiety
5146584|NCT01025908|behavior|behavior
5146585|NCT01025908|cognition|cognition
5146586|NCT01025895|arthroscopic surgical procedure|arthroscopic surgical procedure
5146587|NCT01025882|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
5146588|NCT01025882|stage I pancreatic cancer|stage i pancreatic cancer
5146589|NCT01025882|stage II pancreatic cancer|stage ii pancreatic cancer
5146590|NCT01025882|stage III pancreatic cancer|stage iii pancreatic cancer
5146591|NCT01025856|liver fat|liver fat
5146592|NCT01025856|postprandial lipids metabolism|postprandial lipids metabolism
5146593|NCT01025856|diet|diet
5146594|NCT01025856|exercise|exercise
5146595|NCT01025856|type 2 diabetes|type 2 diabetes
5146596|NCT01025830|HIV;Bioequivalence;Triomune|hiv;bioequivalence;triomune
5146597|NCT01025817|Kidney transplant|kidney transplant
5146598|NCT01025817|renal transplant|renal transplant
5146599|NCT01025817|immunosuppression|immunosuppression
5146600|NCT01025817|mycophenolate mofetil|mycophenolate mofetil
5146601|NCT01025817|tacrolimus|tacrolimus
5146602|NCT01025817|everolimus|everolimus
5146603|NCT01025804|Interfant-06|interfant-06
5146604|NCT01025804|Infant ALL|infant all
5146605|NCT01025804|Asparaginase|asparaginase
5146606|NCT01025804|Pharmacokinetics of asparaginase|pharmacokinetics of asparaginase
5146607|NCT01025804|Antibody formation|antibody formation
5146608|NCT01025778|Haploidentical hematopoietic stem cell transplantation|haploidentical hematopoietic stem cell transplantation
5146609|NCT01025778|Graft versus host disease|graft versus host disease
5146610|NCT01025778|Donor lymphocyte infusion|donor lymphocyte infusion
5146611|NCT01025778|Graft versus leukemia effect|graft versus leukemia effect
5146612|NCT01025778|Immunological recovery|immunological recovery
5146613|NCT01025778|Bridge to transplant approach|bridge to transplant approach
5146614|NCT01025778|Therapy resistant leukemia|therapy resistant leukemia
5146615|NCT01025778|Hematological malignancy|hematological malignancy
5146616|NCT01025752|chronic pain|chronic pain
5146617|NCT01025752|cognitive behavior therapy|cognitive behavior therapy
5146618|NCT01025752|low back pain|low back pain
5146619|NCT01025739|Gastroesophageal Reflux Disease (GERD)|gastroesophageal reflux disease (gerd)
5146620|NCT01025739|EsophyX|esophyx
5146621|NCT01025713|Cystic Fibrosis|cystic fibrosis
5146622|NCT01025713|CF|cf
5146623|NCT01025713|Mucociliary Clearance|mucociliary clearance
5146624|NCT01025713|Epithelial Sodium Channel Inhibitor|epithelial sodium channel inhibitor
5146625|NCT01025713|ENaC Inhibitor|enac inhibitor
5146626|NCT01025713|Airway Hydration|airway hydration
5146627|NCT01025713|Amiloride|amiloride
5146628|NCT01025700|Efficacy|efficacy
5146629|NCT01025700|Marijuana|marijuana
5146630|NCT01025700|Reduction|reduction
5146631|NCT01025700|Craving|craving
5146632|NCT01025687|girls|girls
5146633|NCT01025687|obesity|obesity
5146634|NCT01025687|television viewing|television viewing
5146635|NCT01025687|puberty|puberty
5146636|NCT01025674|School health program|school health program
5146637|NCT01025674|Positive health behavior|positive health behavior
5146638|NCT01025674|School-wide climate|school-wide climate
5146639|NCT01025674|Mental health|mental health
5146640|NCT01025674|Self-esteem|self-esteem
5146641|NCT01025674|Social support|social support
5146642|NCT01025674|Exercise|exercise
5146643|NCT01025674|Nutrition|nutrition
5146644|NCT01025674|Parent involvement|parent involvement
5146645|NCT01025674|Community involvement|community involvement
5146646|NCT01025661|chiropractic|chiropractic
5146647|NCT01025661|hip osteoarthritis|hip osteoarthritis
5146648|NCT01025661|hip arthroplasty|hip arthroplasty
5146649|NCT01025661|pain|pain
5146650|NCT01025661|activities of daily living.|activities of daily living.
5146651|NCT01025648|Mild to Moderate Asthma|mild to moderate asthma
5146652|NCT01025648|Dyspnea|dyspnea
5146653|NCT01025648|Wheezing|wheezing
5146654|NCT01025648|Status Asthmaticus|status asthmaticus
5146655|NCT01025635|rosacea|rosacea
5146656|NCT01025635|papulopustular|papulopustular
5146657|NCT01025635|azelaic acid|azelaic acid
5146658|NCT01025635|foam|foam
5146659|NCT01025622|Stem Cells|stem cells
5146660|NCT01025622|Liver Cirrhosis|liver cirrhosis
5146661|NCT01025622|Cell Therapy|cell therapy
5146662|NCT01025609|spinal cord injury|spinal cord injury
5146663|NCT01025609|cardiovascular disease|cardiovascular disease
5146664|NCT01025609|dietary patterns|dietary patterns
5146665|NCT01025596|interleukin-7|interleukin-7
5146666|NCT01025596|immune-based therapies|immune-based therapies
5146667|NCT01025596|hepatitis C|hepatitis c
5146668|NCT01025596|chronic hepatitis|chronic hepatitis
5146669|NCT01025596|resistance to Peg-interferon and ribavirin bi-therapy|resistance to peg-interferon and ribavirin bi-therapy
5146670|NCT01025596|immune specific responses to HCV|immune specific responses to hcv
5146671|NCT01025596|phase 1|phase 1
5146672|NCT01025596|viral disease|viral disease
5146673|NCT01025596|liver disease|liver disease
5146674|NCT01025583|acute gastroenteritis|acute gastroenteritis
5146675|NCT01025583|intestinal infection|intestinal infection
5146676|NCT01025583|intestinal fluid secretion|intestinal fluid secretion
5146677|NCT01025583|intestinal microflora|intestinal microflora
5146678|NCT01025583|treatment of childhood acute diarrhea|treatment of childhood acute diarrhea
5146679|NCT01025570|pancreas|pancreas
5146680|NCT01025570|pancreatic|pancreatic
5146681|NCT01025570|bosutinib|bosutinib
5146682|NCT01025570|SKI-606|ski-606
5146683|NCT01025570|gemcitabine|gemcitabine
5146684|NCT01025570|gemzar|gemzar
5146685|NCT01025570|Patients with resected pancreatic cancer|patients with resected pancreatic cancer
5146686|NCT01025557|Food intake|food intake
5146687|NCT01025557|Blood glucose|blood glucose
5146688|NCT01025557|Milk|milk
5146689|NCT01025544|Haemophilus influenzae type b (Hib)|haemophilus influenzae type b (hib)
5146690|NCT01025544|Vaccine|vaccine
5146691|NCT01025544|Booster|booster
5146692|NCT01025531|Hepatitis C|hepatitis c
5146693|NCT01025518|Head and Neck Neoplasms|head and neck neoplasms
5146694|NCT01025518|Resistance training|resistance training
5146695|NCT01025518|Muscle mass|muscle mass
5146696|NCT01025518|Functional capacity|functional capacity
5146697|NCT01025505|Untreated Ph+ ALL unfit for intense therapy and allo SCT|untreated ph+ all unfit for intense therapy and allo sct
5146698|NCT01025492|high density lipoprotein|high density lipoprotein
5146699|NCT01025492|arterial compliance|arterial compliance
5146700|NCT01025492|brachial artery flow-mediated dilatation|brachial artery flow-mediated dilatation
5146701|NCT01025479|Osteoporosis|osteoporosis
5146702|NCT01025479|Prostate cancer|prostate cancer
5146703|NCT01025479|LHRH agonist and/or anti-androgen agent|lhrh agonist and/or anti-androgen agent
5146704|NCT01025479|Korean prostate cancer|korean prostate cancer
5146705|NCT01025453|thyroid|thyroid
5146706|NCT01025453|follicular cell|follicular cell
5146707|NCT01025453|papillary cell|papillary cell
5146708|NCT01025453|Hurthle cell|hurthle cell
5146709|NCT01025453|BAY 43-9006|bay 43-9006
5146710|NCT01025453|Temsirolimus|temsirolimus
5146711|NCT01025453|Sorafenib|sorafenib
5146712|NCT01025453|09-148|09-148
5146713|NCT01025427|HIV|hiv
5146714|NCT01025427|HIV persistence|hiv persistence
5146715|NCT01025427|HIV reservoirs|hiv reservoirs
5146716|NCT01025414|pancreatic fistula|pancreatic fistula
5146717|NCT01025401|epilepsy|epilepsy
5146718|NCT01025401|seizures|seizures
5146719|NCT01025401|movement|movement
5146720|NCT01025388|Hypercholesterolemia|hypercholesterolemia
5146721|NCT01025388|The study is focusing on the undertreatment of hypercholesterolemia|the study is focusing on the undertreatment of hypercholesterolemia
5146722|NCT01025375|overweight|overweight
5146723|NCT01025349|bevacizumab|bevacizumab
5146724|NCT01025349|metastatic breast cancer|metastatic breast cancer
5146725|NCT01025349|docetaxel|docetaxel
5146726|NCT01025336|Antibody persistence|antibody persistence
5146727|NCT01025323|Pre hypertension|pre hypertension
5146728|NCT01025323|Lifestyle modification|lifestyle modification
5146729|NCT01025323|DASH diet|dash diet
5146730|NCT01025310|eye movements|eye movements
5146731|NCT01025310|saccades|saccades
5146732|NCT01025310|visual|visual
5146733|NCT01025310|stress|stress
5146734|NCT01025310|search coil|search coil
5146735|NCT01025310|environment|environment
5146736|NCT01025310|Saccadic eye movements|saccadic eye movements
5146737|NCT01025310|Urban environment|urban environment
5146738|NCT01025297|interleukin-7|interleukin-7
5146739|NCT01025297|immune-based therapies|immune-based therapies
5146740|NCT01025297|hepatitis C|hepatitis c
5146741|NCT01025297|chronic hepatitis|chronic hepatitis
5146742|NCT01025297|resistance to Peg-interferon and ribavirin bi-therapy|resistance to peg-interferon and ribavirin bi-therapy
5146743|NCT01025297|immune specific responses to HCV|immune specific responses to hcv
5146744|NCT01025297|phase 1/2a|phase 1/2a
5146745|NCT01025297|viral disease|viral disease
5146746|NCT01025297|liver disease|liver disease
5146747|NCT01025271|meningitis|meningitis
5146748|NCT01025258|Cystic Fibrosis|cystic fibrosis
5146749|NCT01025258|Medication Adherence|medication adherence
5146750|NCT01025258|Multidisciplinary Team|multidisciplinary team
5146751|NCT01025258|Clinical Outcomes|clinical outcomes
5146752|NCT01025245|Remifentanil induced postoperative hyperalgesia|remifentanil induced postoperative hyperalgesia
5146753|NCT01025232|Antibodies, Monoclonal|antibodies, monoclonal
5146754|NCT01025232|Immunologic Factors|immunologic factors
5146755|NCT01025232|Eye Diseases|eye diseases
5146756|NCT01025232|Retinal Degeneration|retinal degeneration
5146757|NCT01025232|Macular Degeneration|macular degeneration
5146758|NCT01025232|Pharmacologic Actions|pharmacologic actions
5146759|NCT01025232|Retinal Diseases|retinal diseases
5146760|NCT01025219|Diagnosis of dependence on cocaine according to DSM-IV-TR criteria|diagnosis of dependence on cocaine according to dsm-iv-tr criteria
5146761|NCT01025206|Multiple Myeloma|multiple myeloma
5146762|NCT01025206|monoclonal antibody|monoclonal antibody
5146764|NCT01025206|pharmacokinetic|pharmacokinetic
5146765|NCT01025193|belimumab|belimumab
5146766|NCT01025193|Benlysta|benlysta
5146767|NCT01025193|LymphoStat B|lymphostat b
5146768|NCT01025193|BLyS specific inhibitors|blys specific inhibitors
5146769|NCT01025180|safety|safety
5146770|NCT01025180|Procalcitonin|procalcitonin
5146771|NCT01025180|PCT|pct
5146772|NCT01025180|SOFA|sofa
5146773|NCT01025180|Sepsis|sepsis
5146774|NCT01025180|Antibiotic|antibiotic
5146775|NCT01025180|Strategy|strategy
5146776|NCT01025180|SIRS|sirs
5146777|NCT01025180|severe sepsis without obvious infection|severe sepsis without obvious infection
5146778|NCT01025167|cancer|cancer
5146779|NCT01025167|enteral nutrition|enteral nutrition
5146780|NCT01025167|omega-3-fatty acids|omega-3-fatty acids
5146781|NCT01025154|Leukemia|leukemia
5146782|NCT01025154|AML|aml
5146783|NCT01025154|chemotherapy-naïve|chemotherapy-naïve
5146784|NCT01025154|Clofarabine|clofarabine
5146785|NCT01025154|Clofarex|clofarex
5146786|NCT01025154|Clolar|clolar
5146787|NCT01025154|Idarubicin|idarubicin
5146788|NCT01025154|Idamycin|idamycin
5146789|NCT01025154|Cytarabine|cytarabine
5146790|NCT01025154|Ara-C|ara-c
5146791|NCT01025154|Cytosar|cytosar
5146792|NCT01025154|DepoCyt|depocyt
5146793|NCT01025154|Cytosine Arabinosine Hydrochloride|cytosine arabinosine hydrochloride
5146794|NCT01025141|MINISCREW|miniscrew
5146795|NCT01025141|space extraction closure|space extraction closure
5146796|NCT01025141|anchorage|anchorage
5146797|NCT01025141|Orthodontic Treatment|orthodontic treatment
5146798|NCT01025141|Extraction of 2 Maxillary Premolar|extraction of 2 maxillary premolar
5146799|NCT01025141|closing of extraction space|closing of extraction space
5146800|NCT01025141|patient aged from 12 to 50 years old|patient aged from 12 to 50 years old
5146801|NCT01025115|Dietary supplement|dietary supplement
5146802|NCT01025115|Diamel|diamel
5146803|NCT01025115|Metabolic Syndrome|metabolic syndrome
5146804|NCT01025089|Cetuximab|cetuximab
5146805|NCT01025089|Cisplatin|cisplatin
5146806|NCT01025089|Cyclophosphamide|cyclophosphamide
5146807|NCT01025089|09-038|09-038
5146808|NCT01025076|Enlarged gastric pouch and stoma|enlarged gastric pouch and stoma
5146809|NCT01025076|Post bariatric surgery|post bariatric surgery
5146810|NCT01025063|Spectral OCT|spectral oct
5146811|NCT01025063|Choroidal Neovascularization|choroidal neovascularization
5146812|NCT01025063|Lucentis|lucentis
5146813|NCT01025063|Visudyne|visudyne
5146814|NCT01025063|PDT|pdt
5146815|NCT01025063|anti-VEGF|anti-vegf
5146816|NCT01025050|Presbyopia|presbyopia
5146817|NCT01025050|Intrastromal|intrastromal
5146818|NCT01025050|Femtosecond Laser|femtosecond laser
5146819|NCT01025050|minimal-invasive|minimal-invasive
5146820|NCT01025050|INTRACOR|intracor
5146821|NCT01025050|Enhance Near Visual Acuity|enhance near visual acuity
5146822|NCT01025037|Rotator Cuff Tear, Large, Massive, Rotator, Cuff. Tear|rotator cuff tear, large, massive, rotator, cuff. tear
5146823|NCT01025024|SNP|snp
5146824|NCT01025024|single-nucleotide polymorphism|single-nucleotide polymorphism
5146825|NCT01025024|glaucoma|glaucoma
5146826|NCT01025024|primary open angle glaucoma|primary open angle glaucoma
5146827|NCT01025011|retinal hemoglobin concentration|retinal hemoglobin concentration
5146828|NCT01025011|non-invasive hemoglobin measurement|non-invasive hemoglobin measurement
5146829|NCT01024998|Age-Related Macular Degeneration|age-related macular degeneration
5146830|NCT01024998|AMD|amd
5146831|NCT01024998|Wet AMD|wet amd
5146832|NCT01024998|Neovascular AMD|neovascular amd
5146833|NCT01024998|Ocular|ocular
5146834|NCT01024998|Ocular gene therapy|ocular gene therapy
5146835|NCT01024998|Subretinal neovascularization|subretinal neovascularization
5146836|NCT01024985|optic neuritis|optic neuritis
5146837|NCT01024985|longitudinally extensive transverse myelitis|longitudinally extensive transverse myelitis
5146838|NCT01024985|retinal nerve fiber layer|retinal nerve fiber layer
5146839|NCT01024985|macular thickness|macular thickness
5146840|NCT01024959|Prostate Cancer|prostate cancer
5146841|NCT01024959|Prostate Biopsy|prostate biopsy
5146842|NCT01024959|PCA3|pca3
5146843|NCT01024946|mesothelioma|mesothelioma
5146844|NCT01024946|pleural|pleural
5146845|NCT01024946|RAD001|rad001
5146846|NCT01024946|Everolimus|everolimus
5146847|NCT01024946|09-142|09-142
5146848|NCT01024946|thoracic|thoracic
5146849|NCT01024946|lung|lung
5146850|NCT01024946|epithelioid|epithelioid
5146851|NCT01024946|sarcomatoid|sarcomatoid
5146852|NCT01024933|Hypertension|hypertension
5146853|NCT01024933|High Blood Pressure|high blood pressure
5146854|NCT01024894|interleukin-7|interleukin-7
5146855|NCT01024894|immune-based therapies|immune-based therapies
5146856|NCT01024894|hepatitis C|hepatitis c
5146857|NCT01024894|chronic hepatitis|chronic hepatitis
5146858|NCT01024894|resistance to Peg-interferon and ribavirin bitherapy|resistance to peg-interferon and ribavirin bitherapy
5146859|NCT01024894|immune specific responses to HCV|immune specific responses to hcv
5146860|NCT01024894|taiwan|taiwan
5146861|NCT01024894|phase 1/2a|phase 1/2a
5146862|NCT01024894|viral disease|viral disease
5146863|NCT01024894|liver disease|liver disease
5146864|NCT01024881|catheterization success rate|catheterization success rate
5146865|NCT01024868|Transversus Abdominis Plane Block|transversus abdominis plane block
5146866|NCT01024829|Non small cell lung cancer|non small cell lung cancer
5146867|NCT01024829|Inoperable|inoperable
5146868|NCT01024829|HX4|hx4
5146869|NCT01024816|Metabolic Syndrome|metabolic syndrome
5146870|NCT01024816|Restorative Yoga|restorative yoga
5146871|NCT01024816|Stretching|stretching
5146872|NCT01024816|Visceral adiposity|visceral adiposity
5146873|NCT01024816|Randomized controlled trial|randomized controlled trial
5146874|NCT01024803|Retina implant, Subretinal|retina implant, subretinal
5146875|NCT01024803|Legal blindness|legal blindness
5146876|NCT01024803|Genetic Diseases, Inborn|genetic diseases, inborn
5146877|NCT01024803|Eye Diseases|eye diseases
5146878|NCT01024803|Retinitis Pigmentosa|retinitis pigmentosa
5146879|NCT01024803|Retinitis|retinitis
5146880|NCT01024803|Retinal Degeneration|retinal degeneration
5146881|NCT01024803|Eye Diseases, Hereditary|eye diseases, hereditary
5146882|NCT01024803|Retinal Diseases|retinal diseases
5146883|NCT01024777|cholecalciferol|cholecalciferol
5146884|NCT01024777|multiple sclerosis|multiple sclerosis
5146885|NCT01024777|vitamin D|vitamin d
5146886|NCT01024777|D3|d3
5146887|NCT01024764|HIV|hiv
5146888|NCT01024764|Tat protein|tat protein
5146889|NCT01024764|Preventive vaccine|preventive vaccine
5146890|NCT01024725|A(H1N1)v influenza|a(h1n1)v influenza
5146891|NCT01024725|vaccination|vaccination
5146892|NCT01024725|pandemic|pandemic
5146893|NCT01024712|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5146894|NCT01024712|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5146895|NCT01024712|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5146896|NCT01024712|adenocarcinoma of the lung|adenocarcinoma of the lung
5146897|NCT01024712|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
5146898|NCT01024712|large cell lung cancer|large cell lung cancer
5146899|NCT01024673|H1N1|h1n1
5146900|NCT01024660|Patients with Mild to Moderate Alzheimer's Disease|patients with mild to moderate alzheimer's disease
5146901|NCT01024634|Arterial stiffness|arterial stiffness
5146902|NCT01024634|Endothelial function|endothelial function
5146903|NCT01024634|Autonomic function|autonomic function
5146904|NCT01024634|Inflammation|inflammation
5146905|NCT01024621|gastric intestinal metaplasia|gastric intestinal metaplasia
5146906|NCT01024621|Confocal laser endomicroscopy|confocal laser endomicroscopy
5146907|NCT01024595|HIV|hiv
5146908|NCT01024595|Tat protein|tat protein
5146909|NCT01024582|breast cancer|breast cancer
5146910|NCT01024582|invasive breast cancer|invasive breast cancer
5146911|NCT01024582|adenocarcinoma of the breast|adenocarcinoma of the breast
5146912|NCT01024569|Severe Mental Illness|severe mental illness
5146913|NCT01024569|Recovery|recovery
5146914|NCT01024569|Psychiatric Disability|psychiatric disability
5146915|NCT01024569|Wellness|wellness
5146916|NCT01024569|Peer Service|peer service
5146917|NCT01024569|WRAP|wrap
5146918|NCT01024556|HIV, HAART|hiv, haart
5146919|NCT01024543|Angiotensin II|angiotensin ii
5146920|NCT01024517|Safety|safety
5146921|NCT01024517|Tolerability|tolerability
5146922|NCT01024517|Pharmacokinetics|pharmacokinetics
5146923|NCT01024504|Cancer|cancer
5146924|NCT01024504|Colorectal cancer|colorectal cancer
5146925|NCT01024504|Elderly|elderly
5146926|NCT01024504|Chemotherapy|chemotherapy
5146927|NCT01024504|Capecitabine|capecitabine
5146928|NCT01024504|Oxaliplatin|oxaliplatin
5146929|NCT01024504|Bevacizumab|bevacizumab
5146930|NCT01024491|premature ejaculation|premature ejaculation
5146931|NCT01024491|paroxetine|paroxetine
5146932|NCT01024491|daily treatment|daily treatment
5146933|NCT01024478|Coronary Artery|coronary artery
5146934|NCT01024478|Magnetic Resonance Angiography|magnetic resonance angiography
5146935|NCT01024478|Coronary Artery disease|coronary artery disease
5146936|NCT01024478|Multicenter Trial|multicenter trial
5146937|NCT01024478|Cardiac MRI|cardiac mri
5146938|NCT01024465|obesity|obesity
5146939|NCT01024465|intragastric balloon|intragastric balloon
5146940|NCT01024452|anticoagulation|anticoagulation
5146941|NCT01024452|warfarin|warfarin
5146942|NCT01024452|computer systems|computer systems
5146943|NCT01024452|international normalized ratio|international normalized ratio
5146944|NCT01024452|nomograms|nomograms
5146945|NCT01024426|Uganda|uganda
5146946|NCT01024426|malaria|malaria
5146947|NCT01024426|enhanced health facility-based care|enhanced health facility-based care
5146948|NCT01024426|febrile illnesses|febrile illnesses
5146949|NCT01024426|health services|health services
5146950|NCT01024413|Thoracic Neoplasms|thoracic neoplasms
5146951|NCT01024413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
5146952|NCT01024413|Protein Kinase Inhibitors|protein kinase inhibitors
5146953|NCT01024413|Respiratory Tract Diseases|respiratory tract diseases
5146954|NCT01024413|Lung Neoplasms|lung neoplasms
5146955|NCT01024413|Erlotinib|erlotinib
5146956|NCT01024413|Gefitinib|gefitinib
5146957|NCT01024413|Epidermal growth factor receptor genes|epidermal growth factor receptor genes
5146958|NCT01024400|Influenza|influenza
5146959|NCT01024400|Vaccine|vaccine
5146960|NCT01024400|Pregnancy|pregnancy
5146961|NCT01024387|AMG 479|amg 479
5146962|NCT01024361|Preterm infants|preterm infants
5146963|NCT01024361|Nasal CPAP|nasal cpap
5146964|NCT01024361|Delivery room|delivery room
5146965|NCT01024361|Newborn|newborn
5146966|NCT01024348|Surgery, knee arthroscopy|surgery, knee arthroscopy
5146967|NCT01024348|Pain, postoperative|pain, postoperative
5146968|NCT01024348|tramadol, extended release|tramadol, extended release
5146969|NCT01024335|opioid dependence|opioid dependence
5146970|NCT01024335|naltrexone|naltrexone
5146971|NCT01024335|vivitrol|vivitrol
5146972|NCT01024335|dronabinol|dronabinol
5146973|NCT01024335|marinol|marinol
5146974|NCT01024322|Diagnosis of keratoconus, post-LASIK ectasia, FFKC, or pellucid marginal degeneration|diagnosis of keratoconus, post-lasik ectasia, ffkc, or pellucid marginal degeneration
5146975|NCT01024309|total hip arthroplasty|total hip arthroplasty
5146976|NCT01024283|Heat Shock Protein 90 Inhibitor (HSP90)|heat shock protein 90 inhibitor (hsp90)
5146977|NCT01024283|Pharmacodynamic|pharmacodynamic
5146978|NCT01024283|Blood|blood
5146979|NCT01024283|Biopsy|biopsy
5146980|NCT01024283|Solid malignancies|solid malignancies
5146981|NCT01024270|endometrial pathology of uterus|endometrial pathology of uterus
5146982|NCT01024270|operative hysteroscopy|operative hysteroscopy
5146983|NCT01024270|efficacy of misoprostol per different routes|efficacy of misoprostol per different routes
5146984|NCT01024257|beta-irradiation;conjunctival autograft;pterygium;recurrence; clinical trial|beta-irradiation;conjunctival autograft;pterygium;recurrence; clinical trial
5146985|NCT01024205|clear cell renal cell carcinoma|clear cell renal cell carcinoma
5146986|NCT01024205|stage IV renal cell cancer|stage iv renal cell cancer
5146987|NCT01024179|Optical Coherence Tomography|optical coherence tomography
5146988|NCT01024179|Coronary artery disease|coronary artery disease
5146989|NCT01024179|Chronic total occlusion|chronic total occlusion
5146990|NCT01024166|Cancer|cancer
5146991|NCT01024166|Patient-Reported Outcomes Computer System|patient-reported outcomes computer system
5146992|NCT01024166|PRO|pro
5146993|NCT01024166|Palliative Care|palliative care
5146994|NCT01024166|Symptoms|symptoms
5146995|NCT01024166|Questionnaire|questionnaire
5146996|NCT01024166|Patients|patients
5146997|NCT01024166|Caregivers|caregivers
5146998|NCT01024166|Palliative Care Physicians|palliative care physicians
5146999|NCT01024166|Palliative Care Nurses|palliative care nurses
5147000|NCT01024153|active video games|active video games
5147001|NCT01024153|children|children
5147002|NCT01024153|physical activity|physical activity
5147003|NCT01024140|Posttraumatic Stress Disorder|posttraumatic stress disorder
5147004|NCT01024140|Escitalopram|escitalopram
5147005|NCT01024140|Efficacy|efficacy
5147006|NCT01024114|MBI|mbi
5147007|NCT01024114|Molecular Breast Imaging|molecular breast imaging
5147008|NCT01024114|Breast Cancer|breast cancer
5147009|NCT01024114|Positive Molecular Breast Imaging scan.|positive molecular breast imaging scan.
5147010|NCT01024088|Guillain Barré syndrome|guillain barré syndrome
5147011|NCT01024088|Swallowing disorders|swallowing disorders
5147012|NCT01024088|Respiratory failure|respiratory failure
5147013|NCT01024075|Chronic Rhinosinusitis|chronic rhinosinusitis
5147014|NCT01024075|Endoscopic sinus surgery|endoscopic sinus surgery
5147015|NCT01024075|Sinufoam|sinufoam
5147016|NCT01024075|Dexamethasone|dexamethasone
5147017|NCT01024075|For patients with Chronic Rhinosinusitis without nasal polyps|for patients with chronic rhinosinusitis without nasal polyps
5147018|NCT01024075|Focus: Define the postoperative sinonasal mucosal healing status of 2 Sinufoam mixtures|focus: define the postoperative sinonasal mucosal healing status of 2 sinufoam mixtures
5147019|NCT01024049|heart failure blood left ventricular dysfunction|heart failure blood left ventricular dysfunction
5147020|NCT01024036|Multicentric Castleman's Disease|multicentric castleman's disease
5147021|NCT01024036|MCD|mcd
5147022|NCT01024036|CNTO 328|cnto 328
5147023|NCT01024036|Best Supportive Care|best supportive care
5147024|NCT01024036|Tumor|tumor
5147025|NCT01024036|Symptomatic response|symptomatic response
5147026|NCT01024036|Pharmacokinetics|pharmacokinetics
5147027|NCT01024036|Interleukin-6|interleukin-6
5147028|NCT01024036|IL6|il6
5147029|NCT01024023|Early Walking Aid|early walking aid
5147030|NCT01024023|Amputee|amputee
5147031|NCT01024023|Trans-tibial|trans-tibial
5147032|NCT01024023|Quality of life|quality of life
5147033|NCT01023997|corneal thickness|corneal thickness
5147034|NCT01023997|exfoliation|exfoliation
5147035|NCT01023984|RECTAL NEOPLASMS|rectal neoplasms
5147036|NCT01023945|ASP1941|asp1941
5147037|NCT01023945|Diabetes mellitus|diabetes mellitus
5147038|NCT01023945|Blood glucose|blood glucose
5147039|NCT01023919|Optical coherence tomography|optical coherence tomography
5147040|NCT01023919|Drug eluting stent|drug eluting stent
5147041|NCT01023919|Coronary Artery Disease|coronary artery disease
5147042|NCT01023919|Diabetes Mellitus|diabetes mellitus
5147043|NCT01023906|Taste|taste
5147044|NCT01023906|general Labeled Magnitude Scale|general labeled magnitude scale
5147045|NCT01023906|Aging|aging
5147046|NCT01023906|Chronic Disease Risk|chronic disease risk
5147047|NCT01023906|Smell|smell
5147048|NCT01023867|Alzheimer's disease|alzheimer's disease
5147049|NCT01023867|Mixed Dementia|mixed dementia
5147050|NCT01023867|Donepezil|donepezil
5147051|NCT01023867|Efficacy|efficacy
5147052|NCT01023867|Adverse Event|adverse event
5147053|NCT01023854|Paravertebral block|paravertebral block
5147054|NCT01023854|loco regional anesthesia|loco regional anesthesia
5147055|NCT01023854|renal surgery|renal surgery
5147056|NCT01023854|PCA morphine|pca morphine
5147057|NCT01023828|K-RAS ONCOGENE MUTATION|k-ras oncogene mutation
5147058|NCT01023828|NON-SMALL CELL LUNG CANCER|non-small cell lung cancer
5147059|NCT01023828|WOOD SMOKE|wood smoke
5147060|NCT01023815|Immunosuppression|immunosuppression
5147061|NCT01023815|renal transplantation|renal transplantation
5147062|NCT01023815|once-a-day regimen|once-a-day regimen
5147063|NCT01023815|steroid withdrawal|steroid withdrawal
5147064|NCT01023815|drug minimization|drug minimization
5147065|NCT01023815|immunosuppression for prevention of acute rejections|immunosuppression for prevention of acute rejections
5147066|NCT01023802|neoadjuvant therapy|neoadjuvant therapy
5147067|NCT01023802|chemotherapy|chemotherapy
5147068|NCT01023802|hormone therapy|hormone therapy
5147069|NCT01023802|breast cancer|breast cancer
5147070|NCT01023802|MBI|mbi
5147071|NCT01023802|Molecular Breast Imaging|molecular breast imaging
5147072|NCT01023789|Drug eluting stent|drug eluting stent
5147073|NCT01023789|Stents|stents
5147074|NCT01023789|Angioplasty|angioplasty
5147075|NCT01023789|Bioabsorbable|bioabsorbable
5147076|NCT01023789|Bioresorbable|bioresorbable
5147077|NCT01023789|Scaffold|scaffold
5147078|NCT01023776|Swine Flu|swine flu
5147079|NCT01023776|H1N1|h1n1
5147080|NCT01023763|Nursing homes|nursing homes
5147081|NCT01023763|Intravenous|intravenous
5147082|NCT01023763|Treatment|treatment
5147083|NCT01023763|Patient trajectory|patient trajectory
5147084|NCT01023763|Hospital admissions|hospital admissions
5147085|NCT01023750|hypertriglyceridemia|hypertriglyceridemia
5147086|NCT01023750|Triglycerides|triglycerides
5147087|NCT01023750|HDL|hdl
5147088|NCT01023750|Insulin resistance|insulin resistance
5147089|NCT01023737|Malignant Solid Tumor|malignant solid tumor
5147090|NCT01023737|Solid Tumor|solid tumor
5147091|NCT01023737|Hydroxychloroquine|hydroxychloroquine
5147092|NCT01023737|Vorinostat|vorinostat
5147093|NCT01023711|Influenza|influenza
5147094|NCT01023698|Diabetic retinopathy|diabetic retinopathy
5147095|NCT01023698|Diabetic macular edema|diabetic macular edema
5147096|NCT01023698|Panretinal photocoagulation|panretinal photocoagulation
5147097|NCT01023685|Active immunization|active immunization
5147098|NCT01023685|Alzheimer disease|alzheimer disease
5147099|NCT01023685|Antibody|antibody
5147100|NCT01023685|Central Nervous System diseases|central nervous system diseases
5147101|NCT01023685|Neurodegenerative diseases|neurodegenerative diseases
5147102|NCT01023685|Vaccine|vaccine
5147103|NCT01023672|Dementia with Lewy Bodies|dementia with lewy bodies
5147104|NCT01023672|hypersomnolence|hypersomnolence
5147105|NCT01023672|cognition|cognition
5147106|NCT01023672|neuropsychiatric morbidity|neuropsychiatric morbidity
5147107|NCT01023672|quality of life|quality of life
5147108|NCT01023659|Smoking cessation|smoking cessation
5147109|NCT01023659|Bupropion|bupropion
5147110|NCT01023659|Varenicline|varenicline
5147111|NCT01023659|Population-level|population-level
5147112|NCT01023659|Mass distribution|mass distribution
5147113|NCT01023659|Drug Therapy|drug therapy
5147114|NCT01023646|Glycemic Index|glycemic index
5147115|NCT01023646|Glycemic Load|glycemic load
5147116|NCT01023646|Glucose|glucose
5147117|NCT01023646|Insulin|insulin
5147118|NCT01023646|Lipoproteins|lipoproteins
5147119|NCT01023646|Free fatty acids|free fatty acids
5147120|NCT01023633|to investigate the efficacy and feasibility of this novel treatment strategy in Chinese mCRC patients|to investigate the efficacy and feasibility of this novel treatment strategy in chinese mcrc patients
5147121|NCT01023633|Primary Endpoint:DDC|primary endpoint:ddc
5147122|NCT01023633|Secondary Endpoint:OS, RR,DCR, PFS,safety|secondary endpoint:os, rr,dcr, pfs,safety
5147123|NCT01023620|HIV|hiv
5147124|NCT01023620|Lipodystrophy|lipodystrophy
5147125|NCT01023620|Lipoatrophy|lipoatrophy
5147126|NCT01023620|Lipohypertrophy|lipohypertrophy
5147127|NCT01023620|Human Immunodeficiency Virus|human immunodeficiency virus
5147128|NCT01023607|optical coherence tomography|optical coherence tomography
5147129|NCT01023607|intravascular ultrasound|intravascular ultrasound
5147130|NCT01023607|Coronary artery disease|coronary artery disease
5147131|NCT01023607|Hyperlipidemia|hyperlipidemia
5147132|NCT01023594|Pancreatic fistula|pancreatic fistula
5147133|NCT01023594|Pancreatic leakage|pancreatic leakage
5147134|NCT01023594|Pancreatoduodenectomy|pancreatoduodenectomy
5147135|NCT01023594|Pancreatic stent|pancreatic stent
5147136|NCT01023581|Type 2 Diabetes mellitus|type 2 diabetes mellitus
5147137|NCT01023581|Non-insulin dependent diabetes mellitus|non-insulin dependent diabetes mellitus
5147138|NCT01023581|Drug Therapy|drug therapy
5147139|NCT01023581|Hypoglycemia,|hypoglycemia,
5147140|NCT01023581|Hyperglycemia|hyperglycemia
5147141|NCT01023568|intubation|intubation
5147142|NCT01023568|pediatric|pediatric
5147143|NCT01023568|videolaryngoscope devices|videolaryngoscope devices
5147144|NCT01023555|Bacteremia|bacteremia
5147145|NCT01023555|Blood Cultures|blood cultures
5147146|NCT01023555|Sepsis|sepsis
5147147|NCT01023542|renal impairment|renal impairment
5147148|NCT01023542|MELD>25|meld>25
5147149|NCT01023542|Liver transplantation|liver transplantation
5147150|NCT01023542|CNI-free|cni-free
5147151|NCT01023542|Bottom-Up|bottom-up
5147152|NCT01023542|Everolimus|everolimus
5147153|NCT01023529|Prostatic Neoplasms|prostatic neoplasms
5147154|NCT01023529|Rectal Neoplasms|rectal neoplasms
5147155|NCT01023529|Palliative treatment|palliative treatment
5147156|NCT01023529|Radiotherapy|radiotherapy
5147157|NCT01023529|Quality of life|quality of life
5147158|NCT01023516|Chronic|chronic
5147159|NCT01023516|obstructive|obstructive
5147160|NCT01023516|pulmonary|pulmonary
5147161|NCT01023516|lung|lung
5147162|NCT01023516|respiratory disease|respiratory disease
5147163|NCT01023516|efficacy|efficacy
5147164|NCT01023516|placebo-controlled|placebo-controlled
5147165|NCT01023516|COPD|copd
5147166|NCT01023516|FEV1|fev1
5147167|NCT01023516|St Georges Respiratory Questionnaire|st georges respiratory questionnaire
5147168|NCT01023503|Statins|statins
5147169|NCT01023503|Dyslipidemia|dyslipidemia
5147170|NCT01023503|Spain|spain
5147171|NCT01023503|Rosuvastatin|rosuvastatin
5147172|NCT01023503|Naive|naive
5147173|NCT01023503|Switching|switching
5147174|NCT01023503|New statins prescriptions in Spain (naive patients and switching)|new statins prescriptions in spain (naive patients and switching)
5147175|NCT01023490|back pain|back pain
5147176|NCT01023490|hypovitaminosis D|hypovitaminosis d
5147177|NCT01023477|Carcinoma, Intraductal, Noninfiltrating|carcinoma, intraductal, noninfiltrating
5147178|NCT01023477|Ductal Carcinoma In Situ|ductal carcinoma in situ
5147179|NCT01023477|DCIS|dcis
5147180|NCT01023477|Carcinoma, Intraductal|carcinoma, intraductal
5147181|NCT01023477|Breast Cancer|breast cancer
5147182|NCT01023477|Breast Tumors|breast tumors
5147183|NCT01023477|chloroquine|chloroquine
5147184|NCT01023477|autophagy|autophagy
5147185|NCT01023477|Autophagic Cell Death|autophagic cell death
5147186|NCT01023477|Autophagocytosis|autophagocytosis
5147187|NCT01023477|Programmed Cell Death, Type II|programmed cell death, type ii
5147188|NCT01023477|Autophagy, Cellular|autophagy, cellular
5147189|NCT01023477|Autophagic Programmed Cell Death|autophagic programmed cell death
5147190|NCT01023464|tear film break-up time|tear film break-up time
5147191|NCT01023451|Pulmonary hypertension|pulmonary hypertension
5147192|NCT01023451|Sickle cell disease|sickle cell disease
5147193|NCT01023451|Pediatric patients|pediatric patients
5147194|NCT01023451|Brain Natriuretic Peptide levels|brain natriuretic peptide levels
5147195|NCT01023425|naive group|naive group
5147196|NCT01023425|switching group|switching group
5147197|NCT01023425|treatment response|treatment response
5147198|NCT01023425|Efficacy|efficacy
5147199|NCT01023425|Adverse event|adverse event
5147200|NCT01023412|Immunonutrition|immunonutrition
5147201|NCT01023412|cancer|cancer
5147202|NCT01023412|GI cancer surgery|gi cancer surgery
5147203|NCT01023386|YM155|ym155
5147204|NCT01023386|Mass-balance|mass-balance
5147205|NCT01023386|Phase I|phase i
5147206|NCT01023386|Pharmacokinetics|pharmacokinetics
5147207|NCT01023373|Angioplasty|angioplasty
5147208|NCT01023373|Atherosclerotic reno vascular disease (ARVD)|atherosclerotic reno vascular disease (arvd)
5147209|NCT01023373|Cardio- and cerebro- vascular comorbidity|cardio- and cerebro- vascular comorbidity
5147210|NCT01023373|End stage renal disease (ERSD)|end stage renal disease (ersd)
5147211|NCT01023373|kidney diseases|kidney diseases
5147212|NCT01023373|High blood pressure|high blood pressure
5147213|NCT01023373|Hypertension|hypertension
5147214|NCT01023373|Ischemic nephropathy|ischemic nephropathy
5147215|NCT01023373|Percutaneous transluminal renal artery stenting (PTRS)|percutaneous transluminal renal artery stenting (ptrs)
5147216|NCT01023373|Randomized controlled trials|randomized controlled trials
5147217|NCT01023373|Renal artery stenosis (RAS)|renal artery stenosis (ras)
5147218|NCT01023373|Renal insufficiency|renal insufficiency
5147219|NCT01023373|Vascular diseases|vascular diseases
5147220|NCT01023347|NSCLC|nsclc
5147221|NCT01023334|Topical analgesia|topical analgesia
5147222|NCT01023334|FlACC Pain Scale|flacc pain scale
5147223|NCT01023334|intracameral lignocaine|intracameral lignocaine
5147224|NCT01023334|Anesthetics|anesthetics
5147225|NCT01023334|Physiological Effects of Drugs|physiological effects of drugs
5147226|NCT01023334|Lidocaine|lidocaine
5147227|NCT01023321|Safety|safety
5147228|NCT01023321|Tolerability|tolerability
5147229|NCT01023321|Pharmacokinetics|pharmacokinetics
5147230|NCT01023308|Myeloma|myeloma
5147231|NCT01023308|DACi|daci
5147232|NCT01023308|Bortezomib|bortezomib
5147233|NCT01023308|Combination|combination
5147234|NCT01023308|Panobinostat|panobinostat
5147235|NCT01023308|LBH589D|lbh589d
5147236|NCT01023308|relapsed|relapsed
5147237|NCT01023308|Velcade®|velcade®
5147238|NCT01023295|Polypoidal Choroidal Vasculopathy|polypoidal choroidal vasculopathy
5147240|NCT01023295|Polypoid|polypoid
5147241|NCT01023295|oxigene|oxigene
5147242|NCT01023295|VDA|vda
5147243|NCT01023295|vascular disrupting agent|vascular disrupting agent
5147244|NCT01023295|combretastatin|combretastatin
5147245|NCT01023295|fosbretabulin|fosbretabulin
5147246|NCT01023282|Parkinson's disease|parkinson's disease
5147247|NCT01023282|Levodopa|levodopa
5147248|NCT01023282|Dyskinesia|dyskinesia
5147249|NCT01023282|ACR325|acr325
5147250|NCT01023269|Neurogenic overactive bladder|neurogenic overactive bladder
5147251|NCT01023269|Urinary incontinence due to incomplete spinal cord injury|urinary incontinence due to incomplete spinal cord injury
5147252|NCT01023269|Neuromodulation|neuromodulation
5147253|NCT01023269|Neuromodulation for treatment of neurogenic overactive bladder|neuromodulation for treatment of neurogenic overactive bladder
5147254|NCT01023269|Patients with Urge urinary incontinence and detrusor overactivity|patients with urge urinary incontinence and detrusor overactivity
5147255|NCT01023256|Rheumatoid arthritis|rheumatoid arthritis
5147256|NCT01023256|GM-CSF|gm-csf
5147257|NCT01023256|MOR103|mor103
5147258|NCT01023243|foot exam|foot exam
5147259|NCT01023243|health services|health services
5147260|NCT01023243|practice improvement|practice improvement
5147261|NCT01023243|quality|quality
5147262|NCT01023243|preventive services|preventive services
5147263|NCT01023243|Natural Language Processing|natural language processing
5147264|NCT01023230|DV-601|dv-601
5147265|NCT01023230|hepatitis B|hepatitis b
5147266|NCT01023230|entecavir|entecavir
5147267|NCT01023230|therapeutic vaccine|therapeutic vaccine
5147268|NCT01023217|Chronic hepatitis B|chronic hepatitis b
5147269|NCT01023217|lamivudine|lamivudine
5147270|NCT01023217|adefovir|adefovir
5147271|NCT01023217|entecavir|entecavir
5147272|NCT01023191|Dialysis|dialysis
5147273|NCT01023191|Peritoneal|peritoneal
5147274|NCT01023191|Catheter|catheter
5147275|NCT01023191|Surgery|surgery
5147276|NCT01023165|Diabetes Mellitus|diabetes mellitus
5147277|NCT01023165|Metabolic Integrity|metabolic integrity
5147278|NCT01023165|Intravenous Bolus Insulin|intravenous bolus insulin
5147279|NCT01023139|Adolescent|adolescent
5147280|NCT01023139|Obesity|obesity
5147281|NCT01023139|Pharmacotherapy|pharmacotherapy
5147282|NCT01023139|Sibutramine|sibutramine
5147283|NCT01023126|Obesity|obesity
5147284|NCT01023126|Exercise|exercise
5147285|NCT01023126|Psychotherapy|psychotherapy
5147286|NCT01023113|Diabetic retinopathy|diabetic retinopathy
5147287|NCT01023113|laser|laser
5147288|NCT01023113|field loss|field loss
5147289|NCT01023113|macular edema|macular edema
5147290|NCT01023113|Visual field loss|visual field loss
5147291|NCT01023100|taste study open label investigational drug oral therapy|taste study open label investigational drug oral therapy
5147292|NCT01023074|MS|ms
5147293|NCT01023074|CAP|cap
5147294|NCT01023048|preimplantation diagnosis|preimplantation diagnosis
5147295|NCT01023022|CareLink|carelink
5147296|NCT01023022|Remote Monitoring|remote monitoring
5147297|NCT01023022|Cardiac Pacemaker, Artificial|cardiac pacemaker, artificial
5147298|NCT01023022|Implantable Cardioverter-Defibrillators|implantable cardioverter-defibrillators
5147299|NCT01023009|Occlusion|occlusion
5147300|NCT01023009|vitrectomy|vitrectomy
5147301|NCT01023009|small gauge vitrectomy|small gauge vitrectomy
5147302|NCT01023009|Postoperative occlusion|postoperative occlusion
5147303|NCT01022996|Hodgkin's Lymphoma|hodgkin's lymphoma
5147304|NCT01022996|Hodgkin Lymphoma|hodgkin lymphoma
5147305|NCT01022996|Hodgkin's Disease|hodgkin's disease
5147306|NCT01022996|Hodgkin Disease|hodgkin disease
5147307|NCT01022996|Lymphoma|lymphoma
5147308|NCT01022996|Lymphoproliferative Disorders|lymphoproliferative disorders
5147309|NCT01022996|Neoplasms by Histological type|neoplasms by histological type
5147310|NCT01022996|Lymphatic Diseases|lymphatic diseases
5147311|NCT01022996|Hemic and Lymphatic Diseases|hemic and lymphatic diseases
5147312|NCT01022996|Recurrent Lymphoma|recurrent lymphoma
5147313|NCT01022996|Refractory Lymphoma|refractory lymphoma
5147314|NCT01022996|Relapsed Lymphoma|relapsed lymphoma
5147315|NCT01022996|Classical Hodgkin Lymphoma|classical hodgkin lymphoma
5147316|NCT01022996|Classical Hodgkin's Disease|classical hodgkin's disease
5147317|NCT01022996|Nodular sclerosing Hodgkin Lymphoma|nodular sclerosing hodgkin lymphoma
5147318|NCT01022996|Mixed-cellularity Hodgkin Lymphoma|mixed-cellularity hodgkin lymphoma
5147319|NCT01022996|Lymphocyte-rich Hodgkin Lymphoma|lymphocyte-rich hodgkin lymphoma
5147320|NCT01022996|Lymphocyte depleted Hodgkin Lymphoma|lymphocyte depleted hodgkin lymphoma
5147321|NCT01022970|Esophagitis|esophagitis
5147322|NCT01022970|Digestive System Diseases|digestive system diseases
5147323|NCT01022970|Esophageal disorder|esophageal disorder
5147324|NCT01022970|Eosinophilic esophagitis|eosinophilic esophagitis
5147325|NCT01022957|extra renal damages|extra renal damages
5147996|NCT01020123|glipizide|glipizide
5147326|NCT01022944|Serous otitis media|serous otitis media
5147327|NCT01022944|Biofilm|biofilm
5147328|NCT01022944|Adenoidectomy|adenoidectomy
5147329|NCT01022944|Chronic otitis media|chronic otitis media
5147330|NCT01022931|Influenza A H1N1|influenza a h1n1
5147331|NCT01022931|Children|children
5147332|NCT01022931|Epidemiology|epidemiology
5147333|NCT01022931|Treatment|treatment
5147334|NCT01022931|Oseltamivir|oseltamivir
5147335|NCT01022931|Genetics|genetics
5147336|NCT01022918|unresectable glioblastoma|unresectable glioblastoma
5147337|NCT01022905|HIV infection|hiv infection
5147338|NCT01022905|transplant|transplant
5147339|NCT01022905|rheumatic disease|rheumatic disease
5147340|NCT01022905|cancer|cancer
5147341|NCT01022905|children|children
5147342|NCT01022892|Endovascular|endovascular
5147343|NCT01022892|Abdominal|abdominal
5147344|NCT01022892|Aortic|aortic
5147345|NCT01022892|Aneurysm|aneurysm
5147346|NCT01022892|Repair|repair
5147347|NCT01022892|Surveillance|surveillance
5147348|NCT01022892|EVAR|evar
5147349|NCT01022892|CT|ct
5147350|NCT01022892|Scan|scan
5147351|NCT01022892|Endoleaks|endoleaks
5147352|NCT01022892|Contrast|contrast
5147353|NCT01022892|Enhanced|enhanced
5147354|NCT01022892|Ultrasound|ultrasound
5147355|NCT01022892|Definity|definity
5147356|NCT01022892|AAA|aaa
5147357|NCT01022892|imaging|imaging
5147358|NCT01022892|No Endoleaks|no endoleaks
5147359|NCT01022879|Pain scale of pain|pain scale of pain
5147360|NCT01022866|falls|falls
5147361|NCT01022866|older adults|older adults
5147362|NCT01022827|stiff shoulder|stiff shoulder
5147363|NCT01022827|massage|massage
5147364|NCT01022827|muscle stiffness|muscle stiffness
5147365|NCT01022775|Degenerative rotator cuff disease|degenerative rotator cuff disease
5147366|NCT01022775|Impingement syndrome|impingement syndrome
5147367|NCT01022775|Dynamic humeral centering|dynamic humeral centering
5147368|NCT01022775|Randomized clinical trial|randomized clinical trial
5147369|NCT01022749|inflammatory bowel disease (IBD)|inflammatory bowel disease (ibd)
5147370|NCT01022749|immunosuppressed or non-immunosuppressed|immunosuppressed or non-immunosuppressed
5147371|NCT01022749|influenza vaccine|influenza vaccine
5147372|NCT01022749|antibody titers|antibody titers
5147373|NCT01022749|seroprotective titers|seroprotective titers
5147374|NCT01022749|vaccine-associated adverse events|vaccine-associated adverse events
5147375|NCT01022736|gabapentin|gabapentin
5147376|NCT01022736|pharmacokinetics|pharmacokinetics
5147377|NCT01022736|visual analogue pain scale|visual analogue pain scale
5147378|NCT01022736|cardiopulmonary bypass|cardiopulmonary bypass
5147379|NCT01022723|Circulating tumor cells|circulating tumor cells
5147380|NCT01022723|metastasis|metastasis
5147381|NCT01022723|cancer|cancer
5147382|NCT01022723|cell isolation|cell isolation
5147383|NCT01022723|mircofludics|mircofludics
5147384|NCT01022723|cell detection|cell detection
5147385|NCT01022710|hearing loss|hearing loss
5147386|NCT01022710|otoacoustic emissions|otoacoustic emissions
5147387|NCT01022684|atherosclerosis|atherosclerosis
5147388|NCT01022684|vascular inflammation|vascular inflammation
5147389|NCT01022684|LpPLA2|lppla2
5147390|NCT01022684|hsCRP|hscrp
5147391|NCT01022684|MCP-1|mcp-1
5147392|NCT01022684|18FDG-PET|18fdg-pet
5147393|NCT01022671|Belotecan|belotecan
5147394|NCT01022671|Camtobell inj|camtobell inj
5147395|NCT01022671|NSCLC|nsclc
5147396|NCT01022658|Insulin Therapy|insulin therapy
5147397|NCT01022658|Vago-sympathetic activity|vago-sympathetic activity
5147398|NCT01022658|arterial stiffness|arterial stiffness
5147399|NCT01022658|endothelial function|endothelial function
5147400|NCT01022645|Intrauterine device|intrauterine device
5147401|NCT01022645|Gestational diabetes|gestational diabetes
5147402|NCT01022645|Postpartum contraception|postpartum contraception
5147403|NCT01022645|Postpartum birth control|postpartum birth control
5147404|NCT01022632|Depression|depression
5147405|NCT01022619|Sleep apnea|sleep apnea
5147406|NCT01022619|high risk pregnancy|high risk pregnancy
5147407|NCT01022619|fetal outcome|fetal outcome
5147408|NCT01022619|cord blood|cord blood
5147409|NCT01022580|nitric oxide|nitric oxide
5147410|NCT01022580|surfactant|surfactant
5147411|NCT01022580|bronchopulmonary dysplasia|bronchopulmonary dysplasia
5147412|NCT01022580|BPD|bpd
5147413|NCT01022580|prematurity|prematurity
5147414|NCT01022580|neonates|neonates
5147415|NCT01022580|iNO|ino
5147416|NCT01022580|pulmonary outcome|pulmonary outcome
5147417|NCT01022580|neurodevelopmental outcome|neurodevelopmental outcome
5147418|NCT01022580|Infasurf|infasurf
5147419|NCT01022580|lung function|lung function
5147420|NCT01022580|Surfactant Dysfunction|surfactant dysfunction
5147421|NCT01022528|Elective total abdominal hysterectomy (with or without salpingo-oophorectomy or minor bladder repair) or myomectomy|elective total abdominal hysterectomy (with or without salpingo-oophorectomy or minor bladder repair) or myomectomy
5147422|NCT01022528|through a lower transverse or low midline incision under general anesthesia|through a lower transverse or low midline incision under general anesthesia
5147423|NCT01022515|pheochromocytoma|pheochromocytoma
5147424|NCT01022515|paraganglioma|paraganglioma
5147425|NCT01022515|hypertension|hypertension
5147426|NCT01022502|psoriasis, indigo naturalis|psoriasis, indigo naturalis
5147427|NCT01022489|Schizophrenia, auditory hallucinations, TMS|schizophrenia, auditory hallucinations, tms
5147428|NCT01022476|Pharmacokinetics|pharmacokinetics
5147429|NCT01022476|Raltegravir|raltegravir
5147430|NCT01022476|Immunosuppressive Agents|immunosuppressive agents
5147431|NCT01022476|Severe hepatic insufficiency|severe hepatic insufficiency
5147432|NCT01022476|Liver Transplantation|liver transplantation
5147433|NCT01022476|Additional Keywords|additional keywords
5147434|NCT01022476|HIV Infection|hiv infection
5147435|NCT01022476|Hepatocarcinoma|hepatocarcinoma
5147436|NCT01022476|Hepatitis C|hepatitis c
5147437|NCT01022476|Hepatitis B|hepatitis b
5147438|NCT01022450|rhabdomyolysis|rhabdomyolysis
5147439|NCT01022450|myopathy|myopathy
5147440|NCT01022450|acute renal failure|acute renal failure
5147441|NCT01022450|neuroleptic malignant syndrome|neuroleptic malignant syndrome
5147442|NCT01022450|Pharmaceutical Preparations|pharmaceutical preparations
5147443|NCT01022450|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors
5147444|NCT01022450|fibrates|fibrates
5147445|NCT01022450|creatine kinase|creatine kinase
5147446|NCT01022424|ADPKD|adpkd
5147447|NCT01022424|Tolvaptan|tolvaptan
5147448|NCT01022424|OPC-41061|opc-41061
5147449|NCT01022411|brown rice|brown rice
5147450|NCT01022411|white rice|white rice
5147451|NCT01022411|diabetes risk|diabetes risk
5147452|NCT01022398|Vitamin D3|vitamin d3
5147453|NCT01022398|HMG-CoA reductase inhibitors (statin)-related myalgias|hmg-coa reductase inhibitors (statin)-related myalgias
5147454|NCT01022359|haemodialysis|haemodialysis
5147455|NCT01022359|vascular access|vascular access
5147456|NCT01022359|central venous catheter|central venous catheter
5147457|NCT01022346|Cervical intraepithelial neoplasia|cervical intraepithelial neoplasia
5147458|NCT01022346|RO5217790|ro5217790
5147459|NCT01022333|BRCA1|brca1
5147460|NCT01022333|breast cancer|breast cancer
5147461|NCT01022333|3,3'-di-indolylmethane|3,3'-di-indolylmethane
5147462|NCT01022333|dietary intervention|dietary intervention
5147463|NCT01022333|estrogen metabolites|estrogen metabolites
5147464|NCT01022333|mRNA expression|mrna expression
5147465|NCT01022333|BRCA1 protein|brca1 protein
5147466|NCT01022333|Estrogen|estrogen
5147467|NCT01022320|OSA|osa
5147468|NCT01022320|Blood pressure|blood pressure
5147469|NCT01022320|Lateral Pharyngoplasty|lateral pharyngoplasty
5147470|NCT01022307|behavioral data acquisition|behavioral data acquisition
5147471|NCT01022307|MRI|mri
5147472|NCT01022294|children|children
5147473|NCT01022294|analgesia|analgesia
5147474|NCT01022294|dental treatment|dental treatment
5147475|NCT01022294|inhalation|inhalation
5147476|NCT01022281|Exfoliation|exfoliation
5147477|NCT01022281|Scanning Laser Polarimetry|scanning laser polarimetry
5147478|NCT01022281|Corneal Thickness|corneal thickness
5147479|NCT01022255|autologous vaccine|autologous vaccine
5147480|NCT01022255|follicular lymphoma|follicular lymphoma
5147481|NCT01022255|magnICON|magnicon
5147482|NCT01022255|plant-made vaccines|plant-made vaccines
5147483|NCT01022255|immune response|immune response
5147484|NCT01022242|Surgical Adhesions|surgical adhesions
5147485|NCT01022242|Post-surgical adhesions|post-surgical adhesions
5147486|NCT01022242|Flexor tendon|flexor tendon
5147487|NCT01022229|Attention Deficit Disorder|attention deficit disorder
5147488|NCT01022229|Pediatrics|pediatrics
5147489|NCT01022229|Attention|attention
5147490|NCT01022229|Impulsivity|impulsivity
5147491|NCT01022229|Complementary Therapies|complementary therapies
5147492|NCT01022216|Wound|wound
5147493|NCT01022216|Skin lesion|skin lesion
5147494|NCT01022216|Antimicrobial|antimicrobial
5147495|NCT01022216|Bioelectric|bioelectric
5147496|NCT01022216|Diabetic foot|diabetic foot
5147497|NCT01022216|Pressure Ulcer|pressure ulcer
5147498|NCT01022203|Couples Therapy|couples therapy
5147499|NCT01022203|PTSD|ptsd
5147500|NCT01022190|Arthroplasty|arthroplasty
5147501|NCT01022190|Hip|hip
5147502|NCT01022190|Cemented|cemented
5147503|NCT01022190|Heterotopic ossification|heterotopic ossification
5147504|NCT01022190|Selective Cyclooxygenase-2 Inhibitors|selective cyclooxygenase-2 inhibitors
5147505|NCT01022190|Arthroplasty, Replacement|arthroplasty, replacement
5147506|NCT01022190|Hip Prosthesis|hip prosthesis
5147507|NCT01022190|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors
5147508|NCT01022164|fibrin glue|fibrin glue
5147509|NCT01022164|vitrectomy|vitrectomy
5147510|NCT01022164|safety and efficacy of fibrin glue|safety and efficacy of fibrin glue
5147511|NCT01022151|Aminophylline|aminophylline
5147512|NCT01022151|sevoflurane|sevoflurane
5147513|NCT01022151|anaesthesia|anaesthesia
5147514|NCT01022151|recovery|recovery
5147515|NCT01022151|cognitive function|cognitive function
5147516|NCT01022151|entropy|entropy
5147517|NCT01022138|HER2-negative breast cancer|her2-negative breast cancer
5147518|NCT01022138|stage IV breast cancer|stage iv breast cancer
5147519|NCT01022138|recurrent breast cancer|recurrent breast cancer
5147520|NCT01022125|TMC435-TiDP16-C121|tmc435-tidp16-c121
5147521|NCT01022125|TMC435-C121|tmc435-c121
5147522|NCT01022125|TMC435|tmc435
5147523|NCT01022125|TMC435350|tmc435350
5147524|NCT01022125|Protease inhibitor|protease inhibitor
5147525|NCT01022125|HCV|hcv
5147526|NCT01022125|Hepatitis C|hepatitis c
5147527|NCT01022112|TA-7284|ta-7284
5147528|NCT01022112|JNJ-28431754|jnj-28431754
5147529|NCT01022112|Canagliflozin|canagliflozin
5147530|NCT01022112|Type 2 diabetes mellitus|type 2 diabetes mellitus
5147531|NCT01022112|Sodium Glucose Co-transporter (SGLT2 inhibitor)|sodium glucose co-transporter (sglt2 inhibitor)
5147532|NCT01022099|Total Knee Arthroplasty|total knee arthroplasty
5147533|NCT01022099|Navigation|navigation
5147534|NCT01022086|Breast Cancer|breast cancer
5147535|NCT01022086|Cardiotoxicity|cardiotoxicity
5147536|NCT01022086|Trastuzumab|trastuzumab
5147537|NCT01022086|Cardiac MRI|cardiac mri
5147538|NCT01022073|Deep Brain Stimulation|deep brain stimulation
5147539|NCT01022073|Subthalamic Nucleus|subthalamic nucleus
5147540|NCT01022073|Globus Pallidus|globus pallidus
5147541|NCT01022073|Parkinson Disease|parkinson disease
5147542|NCT01022060|Dietary supplement|dietary supplement
5147543|NCT01022060|Renalof|renalof
5147544|NCT01022060|Recurrent calcic urolithiasis|recurrent calcic urolithiasis
5147545|NCT01022060|Renal calculi|renal calculi
5147546|NCT01022034|Rectal prolapse|rectal prolapse
5147547|NCT01022034|mesh|mesh
5147548|NCT01022034|recurrence|recurrence
5147549|NCT01022021|non-Hodgkin's lymphoma|non-hodgkin's lymphoma
5147550|NCT01022021|autologous stem cell transplant|autologous stem cell transplant
5147551|NCT01022008|Exorbitism|exorbitism
5147552|NCT01022008|Upper respiratory airways|upper respiratory airways
5147553|NCT01022008|Osteodistraction|osteodistraction
5147554|NCT01022008|Polysomnography|polysomnography
5147555|NCT01021995|Safety of Echinacea in comparison to placebo|safety of echinacea in comparison to placebo
5147556|NCT01021982|Pupillometer|pupillometer
5147557|NCT01021982|Retinitis Pigmentosa|retinitis pigmentosa
5147558|NCT01021982|Glaucoma|glaucoma
5147559|NCT01021982|Objective perimetry|objective perimetry
5147560|NCT01021956|Macular Degeneration|macular degeneration
5147561|NCT01021956|Age Related Macular Degeneration|age related macular degeneration
5147562|NCT01021956|Choroidal Neovascularization|choroidal neovascularization
5147563|NCT01021956|AMD|amd
5147564|NCT01021956|CNV|cnv
5147565|NCT01021956|WST11|wst11
5147566|NCT01021956|Stakel|stakel
5147567|NCT01021956|Photodynamic therapy|photodynamic therapy
5147568|NCT01021956|Vascular Targeted Photodynamic therapy|vascular targeted photodynamic therapy
5147569|NCT01021956|VTP|vtp
5147570|NCT01021943|calcineurin inhibitors|calcineurin inhibitors
5147571|NCT01021943|fibrosis|fibrosis
5147572|NCT01021943|spironolactone|spironolactone
5147573|NCT01021943|Focus of the study is to assess if aldosterone blockade has an effect on interstitial fibrosis amongst kidney transplant recipients|focus of the study is to assess if aldosterone blockade has an effect on interstitial fibrosis amongst kidney transplant recipients
5147574|NCT01021930|Optical coherence tomography|optical coherence tomography
5147575|NCT01021930|Drug eluting stent|drug eluting stent
5147576|NCT01021930|Coronary heart disease|coronary heart disease
5147577|NCT01021930|Diabetes mellitus|diabetes mellitus
5147578|NCT01021917|Obesity|obesity
5147579|NCT01021917|Weight Loss|weight loss
5147580|NCT01021917|Meal Replacements|meal replacements
5147581|NCT01021904|Primary prevention|primary prevention
5147582|NCT01021904|HPV Vaccination|hpv vaccination
5147583|NCT01021904|HPV Infection|hpv infection
5147584|NCT01021904|Cervical Cancer|cervical cancer
5147585|NCT01021904|HPV Related Diseases|hpv related diseases
5147586|NCT01021891|Technosphere® Insulin Inhalation Powder|technosphere® insulin inhalation powder
5147587|NCT01021878|Peritoneal dialysis|peritoneal dialysis
5147588|NCT01021878|Renal replacement therapy|renal replacement therapy
5147589|NCT01021878|Dialysis solutions|dialysis solutions
5147590|NCT01021878|Icodextrin|icodextrin
5147591|NCT01021865|GLP-1|glp-1
5147592|NCT01021865|Myocardial contrast echocardiography|myocardial contrast echocardiography
5147593|NCT01021865|Myocardial perfusion|myocardial perfusion
5147594|NCT01021839|renal dialysis|renal dialysis
5147595|NCT01021839|bioprosthesis|bioprosthesis
5147596|NCT01021839|arteriovenous shunt|arteriovenous shunt
5147597|NCT01021839|surgical|surgical
5147598|NCT01021826|knee replacement|knee replacement
5147599|NCT01021826|hip replacement|hip replacement
5147600|NCT01021826|hyperglycemia|hyperglycemia
5147601|NCT01021826|diabetes|diabetes
5147602|NCT01021826|osteoarthritis|osteoarthritis
5147603|NCT01021800|Pancreatic tubular adenocarcinoma adjuvant setting|pancreatic tubular adenocarcinoma adjuvant setting
5147604|NCT01021787|Sun Protection|sun protection
5147605|NCT01021735|Rheumatoid|rheumatoid
5147606|NCT01021735|Outcome|outcome
5147607|NCT01021735|Cost effectiveness|cost effectiveness
5147608|NCT01021735|Safety|safety
5147609|NCT01021722|sphincter|sphincter
5147610|NCT01021722|obstetric tears|obstetric tears
5147611|NCT01021722|long-term follow-up|long-term follow-up
5147612|NCT01021709|depression|depression
5147613|NCT01021709|direct current stimulation|direct current stimulation
5147614|NCT01021709|extracephalic electrode|extracephalic electrode
5147615|NCT01021696|Dementia|dementia
5147616|NCT01021696|Nursing home|nursing home
5147617|NCT01021696|Pain treatment|pain treatment
5147618|NCT01021696|Pain assessment|pain assessment
5147619|NCT01021696|Agitation|agitation
5147620|NCT01021683|Hematological neoplasms|hematological neoplasms
5147621|NCT01021683|Neutropenia|neutropenia
5147622|NCT01021683|Fever|fever
5147623|NCT01021683|Itraconazole|itraconazole
5147624|NCT01021683|Sporanox|sporanox
5147625|NCT01021683|Antifungal prophylaxis|antifungal prophylaxis
5147626|NCT01021683|Defeverscence|defeverscence
5147627|NCT01021670|Dapoxetine hydrochloride|dapoxetine hydrochloride
5147628|NCT01021670|Priligy|priligy
5147629|NCT01021670|Premature ejaculation|premature ejaculation
5147630|NCT01021670|Non-dapoxetine hydrochloride treatment(s)|non-dapoxetine hydrochloride treatment(s)
5147631|NCT01021657|Glaucoma|glaucoma
5147632|NCT01021657|Tenon's Capsule|tenon's capsule
5147633|NCT01021657|Lipid profile|lipid profile
5147634|NCT01021657|Assessment of lipid profile in Tenon's capsule in patients with Glaucoma|assessment of lipid profile in tenon's capsule in patients with glaucoma
5147635|NCT01021644|APOE|apoe
5147636|NCT01021644|Apolipoprotein E|apolipoprotein e
5147637|NCT01021644|Cognition Disorders|cognition disorders
5147638|NCT01021644|Neurocognition|neurocognition
5147639|NCT01021631|Cardiac surgery|cardiac surgery
5147640|NCT01021631|Strategies of transfusion|strategies of transfusion
5147641|NCT01021631|Red blood cells|red blood cells
5147642|NCT01021631|Liberal|liberal
5147643|NCT01021631|Restrictive|restrictive
5147644|NCT01021631|Anemia|anemia
5147645|NCT01021592|Velcade|velcade
5147646|NCT01021592|QoL|qol
5147647|NCT01021592|Proteasome inhibitor|proteasome inhibitor
5147648|NCT01021592|Bortezomib|bortezomib
5147649|NCT01021592|EORTC QLQ C30|eortc qlq c30
5147650|NCT01021592|EQ 5D|eq 5d
5147651|NCT01021579|Polycystic ovary syndrome|polycystic ovary syndrome
5147652|NCT01021579|Metformin|metformin
5147653|NCT01021579|Simvastatin|simvastatin
5147654|NCT01021566|Opiate addiction|opiate addiction
5147655|NCT01021566|Withdrawal symptoms|withdrawal symptoms
5147656|NCT01021566|hemoperfusion|hemoperfusion
5147657|NCT01021566|hemodialysis|hemodialysis
5147658|NCT01021566|methadone|methadone
5147659|NCT01021553|Proof of Concept|proof of concept
5147660|NCT01021553|Double Blind|double blind
5147661|NCT01021540|Nephritis,Nephropathy|nephritis,nephropathy
5147662|NCT01021514|sRAGE|srage
5147663|NCT01021514|SUV|suv
5147664|NCT01021514|TBR|tbr
5147665|NCT01021514|FDG PET CT|fdg pet ct
5147666|NCT01021514|Type 2 DM|type 2 dm
5147667|NCT01021501|nifedipine controlled release tablets|nifedipine controlled release tablets
5147668|NCT01021501|hypertensive|hypertensive
5147669|NCT01021501|chronic maintenance hemodialysis|chronic maintenance hemodialysis
5147670|NCT01021501|Pharmacokinetics|pharmacokinetics
5147671|NCT01021488|Thrombosis|thrombosis
5147672|NCT01021488|Vein|vein
5147673|NCT01021488|Statin|statin
5147674|NCT01021488|Prevention|prevention
5147675|NCT01021475|Functional Dyspepsia, Visceral Manipulation|functional dyspepsia, visceral manipulation
5147676|NCT01021449|schizophrenia, BDNF, DNA methylation, histone modification|schizophrenia, bdnf, dna methylation, histone modification
5147677|NCT01021436|Pneumonia|pneumonia
5147678|NCT01021436|Gram-negative bacteria|gram-negative bacteria
5147679|NCT01021423|Mantle Cell Lymphoma|mantle cell lymphoma
5147680|NCT01021423|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
5147681|NCT01021423|CC-5013|cc-5013
5147682|NCT01021423|Revlimid|revlimid
5147683|NCT01021423|Lenalidomide|lenalidomide
5147684|NCT01021410|acetaminophen|acetaminophen
5147685|NCT01021410|paracetamol|paracetamol
5147686|NCT01021410|protein adduct|protein adduct
5147687|NCT01021410|healthy volunteer|healthy volunteer
5147688|NCT01021410|acetaminophen-protein adduct formation|acetaminophen-protein adduct formation
5147689|NCT01021397|Respiratory Tract Infection|respiratory tract infection
5147690|NCT01021384|Depression,|depression,
5147691|NCT01021384|Early Intervention,|early intervention,
5147692|NCT01021384|Behavior Disorder,|behavior disorder,
5147693|NCT01021384|Parenting Skills,|parenting skills,
5147694|NCT01021384|Children with Special Health Care Needs,|children with special health care needs,
5147695|NCT01021384|Developmental Disabilities,|developmental disabilities,
5147696|NCT01021384|Family Support Programs|family support programs
5147697|NCT01021371|HRQOL|hrqol
5147698|NCT01021371|Rehabilitation|rehabilitation
5147699|NCT01021371|Cancer Patients|cancer patients
5147700|NCT01021371|General Practice|general practice
5147701|NCT01021332|Vesomni|vesomni
5147702|NCT01021332|Solifenacin succinate|solifenacin succinate
5147703|NCT01021332|EC905|ec905
5147704|NCT01021332|Tamsulosin hydrochloride OCAS|tamsulosin hydrochloride ocas
5147705|NCT01021332|Treatment|treatment
5147706|NCT01021332|Lower Urinary Tract Symptoms|lower urinary tract symptoms
5147707|NCT01021332|Benign Prostatic Hyperplasia|benign prostatic hyperplasia
5147708|NCT01021319|ischemic stroke|ischemic stroke
5147709|NCT01021319|thrombolysis|thrombolysis
5147710|NCT01021319|magnetic resonance imaging|magnetic resonance imaging
5147711|NCT01021319|diffusion weighted imaging|diffusion weighted imaging
5147712|NCT01021319|fluid attenuated inversion recovery|fluid attenuated inversion recovery
5147713|NCT01021319|time window|time window
5147714|NCT01021293|Poliorix|poliorix
5147715|NCT01021293|IPV|ipv
5147716|NCT01021280|Bartter syndrome,|bartter syndrome,
5147717|NCT01021280|parathyroid hormone,|parathyroid hormone,
5147718|NCT01021280|calcium sensing receptor,|calcium sensing receptor,
5147719|NCT01021280|ROMK channel|romk channel
5147720|NCT01021280|Barttin gene|barttin gene
5147721|NCT01021280|PTH response to hypo- and hypercalcemia|pth response to hypo- and hypercalcemia
5147722|NCT01021267|sexual dysfunctions|sexual dysfunctions
5147723|NCT01021267|benign prostatic hyperplasia|benign prostatic hyperplasia
5147724|NCT01021267|saw palmetto|saw palmetto
5147725|NCT01021228|Liver resection|liver resection
5147726|NCT01021228|Continuous volatile anesthesia|continuous volatile anesthesia
5147727|NCT01021228|Continuous intravenous anesthesia|continuous intravenous anesthesia
5147728|NCT01021228|Preconditioning volatile anesthesia|preconditioning volatile anesthesia
5147729|NCT01021228|Comparing three groups of anesthesia during the liver surgery according to their benefit on liver and outcome.|comparing three groups of anesthesia during the liver surgery according to their benefit on liver and outcome.
5147730|NCT01021215|Cancer Prevention|cancer prevention
5147731|NCT01021215|Smoking-related lung disease|smoking-related lung disease
5147732|NCT01021215|Smoking|smoking
5147733|NCT01021215|Celecoxib|celecoxib
5147734|NCT01021215|Celebrex|celebrex
5147735|NCT01021215|Zileuton|zileuton
5147736|NCT01021215|Zyflo CR|zyflo cr
5147737|NCT01021215|Prevention|prevention
5147738|NCT01021202|tracheostomy|tracheostomy
5147739|NCT01021202|tracheotomy|tracheotomy
5147740|NCT01021202|dilational|dilational
5147741|NCT01021202|dilatative|dilatative
5147742|NCT01021202|critical care|critical care
5147743|NCT01021202|intensive care|intensive care
5147744|NCT01021202|COPD|copd
5147745|NCT01021202|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
5147746|NCT01021202|lung disease|lung disease
5147747|NCT01021202|pneumonia|pneumonia
5147748|NCT01021202|prospective study|prospective study
5147749|NCT01021202|questionnaire|questionnaire
5147750|NCT01021202|quality of life|quality of life
5147751|NCT01021202|outcome|outcome
5147752|NCT01021202|mortality|mortality
5147753|NCT01021189|safety|safety
5147754|NCT01021189|tolerability|tolerability
5147755|NCT01021189|AZD1446|azd1446
5147757|NCT01021189|Japanese|japanese
5147758|NCT01021176|Food Intake|food intake
5147759|NCT01021176|Hunger|hunger
5147760|NCT01021176|Lidocaine|lidocaine
5147761|NCT01021176|Nose|nose
5147762|NCT01021176|smell|smell
5147763|NCT01021137|vestibular function tests|vestibular function tests
5147764|NCT01021137|postural balance|postural balance
5147765|NCT01021137|neuroimaging|neuroimaging
5147766|NCT01021124|tuberculosis|tuberculosis
5147767|NCT01021124|bone marrow transplant|bone marrow transplant
5147768|NCT01021124|diagnosis|diagnosis
5147769|NCT01021098|influenza|influenza
5147770|NCT01021098|illness|illness
5147771|NCT01021098|active-duty|active-duty
5147772|NCT01021098|virus|virus
5147773|NCT01021098|flu|flu
5147774|NCT01021098|military|military
5147775|NCT01021098|Influenza-like-illnesses|influenza-like-illnesses
5147776|NCT01021085|Assisted Reproductive Technology|assisted reproductive technology
5147777|NCT01021085|circulating cell free fetal DNA|circulating cell free fetal dna
5147778|NCT01021085|First trimester|first trimester
5147779|NCT01021059|Biological Effects of rhIL-15|biological effects of rhil-15
5147780|NCT01021059|Estimate Antitumor Activity|estimate antitumor activity
5147781|NCT01021059|rhIL-15 Pharmacokinetics|rhil-15 pharmacokinetics
5147782|NCT01021059|Dose and Safety Determination of IL-15|dose and safety determination of il-15
5147783|NCT01021059|Kidney Cancer|kidney cancer
5147784|NCT01021059|Melanoma|melanoma
5147785|NCT01021059|Renal Cell Cancer|renal cell cancer
5147786|NCT01021046|deep anterior lamellar keratoplasty|deep anterior lamellar keratoplasty
5147787|NCT01021046|rejection|rejection
5147788|NCT01021046|high risk patients|high risk patients
5147789|NCT01021046|acellular corneal tissue|acellular corneal tissue
5147790|NCT01021033|Ischemia|ischemia
5147791|NCT01021033|Hemorrhage|hemorrhage
5147792|NCT01021033|Rehabilitation|rehabilitation
5147793|NCT01021033|Stroke|stroke
5147794|NCT01021020|bioequivalence|bioequivalence
5147795|NCT01021020|fasting|fasting
5147796|NCT01021020|fed|fed
5147797|NCT01021020|healthy|healthy
5147798|NCT01020994|Superficial infected eczema|superficial infected eczema
5147799|NCT01020994|Superinfected eczema|superinfected eczema
5147800|NCT01020981|OEF/OIF|oef/oif
5147801|NCT01020981|Peer Group|peer group
5147802|NCT01020981|Veterans|veterans
5147803|NCT01020968|Ischemic Dilated Cardiomyopathy|ischemic dilated cardiomyopathy
5147804|NCT01020968|Non-Ischemic Dilated Cardiomyopathy|non-ischemic dilated cardiomyopathy
5147805|NCT01020968|ixmyelocel-T|ixmyelocel-t
5147806|NCT01020955|GH and IGF-I|gh and igf-i
5147807|NCT01020955|growth hormone deficiency and IGT or diabetes|growth hormone deficiency and igt or diabetes
5147808|NCT01020942|ischemia|ischemia
5147809|NCT01020942|myocardial infarction|myocardial infarction
5147810|NCT01020942|prognosis|prognosis
5147811|NCT01020942|pretreatment|pretreatment
5147812|NCT01020942|electroacupuncture|electroacupuncture
5147813|NCT01020942|stents|stents
5147814|NCT01020942|troponin|troponin
5147815|NCT01020942|percutaneous coronary intervention|percutaneous coronary intervention
5147816|NCT01020916|Induced hypothermia|induced hypothermia
5147817|NCT01020916|Mild induced hypothermia|mild induced hypothermia
5147818|NCT01020916|Therapeutic hypothermia|therapeutic hypothermia
5147819|NCT01020916|Cardiac arrest|cardiac arrest
5147820|NCT01020916|Out-of-hospital cardiac arrest|out-of-hospital cardiac arrest
5147821|NCT01020916|Mortality|mortality
5147822|NCT01020916|Neurological function|neurological function
5147823|NCT01020916|Randomised clinical trial|randomised clinical trial
5147824|NCT01020890|GERD diagnosis|gerd diagnosis
5147825|NCT01020890|GERD-Q|gerd-q
5147826|NCT01020890|GERD patients' characteristics|gerd patients' characteristics
5147827|NCT01020890|GERD|gerd
5147828|NCT01020877|Bioequivalence|bioequivalence
5147829|NCT01020877|Healthy Subjects|healthy subjects
5147830|NCT01020877|Healthy, Normal Subjects|healthy, normal subjects
5147831|NCT01020864|Platinum-resistent head and neck cancer|platinum-resistent head and neck cancer
5147832|NCT01020864|Cetuximab|cetuximab
5147833|NCT01020864|Carboplatin|carboplatin
5147834|NCT01020864|Navelbine|navelbine
5147835|NCT01020864|Phase II trial|phase ii trial
5147836|NCT01020864|Combination chemotherapy|combination chemotherapy
5147837|NCT01020851|hypertension|hypertension
5147838|NCT01020851|stroke|stroke
5147839|NCT01020851|cholesterol|cholesterol
5147840|NCT01020851|adherence|adherence
5147841|NCT01020838|Florbetaben|florbetaben
5147842|NCT01020838|Amyloid beta-protein|amyloid beta-protein
5147843|NCT01020838|Alzheimer's disease|alzheimer's disease
5147844|NCT01020825|Complex perianal fistula|complex perianal fistula
5147845|NCT01020825|Adipose-derived adult stem cells|adipose-derived adult stem cells
5147846|NCT01020825|Fibrin glue|fibrin glue
5147847|NCT01020799|Depression|depression
5147848|NCT01020786|Non-squamous|non-squamous
5147849|NCT01020773|extubation,Respiration, Artificial|extubation,respiration, artificial
5147850|NCT01020760|Macular hole|macular hole
5147851|NCT01020760|Vitrectomy|vitrectomy
5147852|NCT01020760|Prone posturing|prone posturing
5147853|NCT01020734|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5147854|NCT01020734|adult acute myeloid leukemia with del(5q)|adult acute myeloid leukemia with del(5q)
5147855|NCT01020734|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5147856|NCT01020734|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5147857|NCT01020734|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5147858|NCT01020734|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
5147859|NCT01020734|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5147860|NCT01020734|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
5147861|NCT01020734|childhood acute minimally differentiated myeloid leukemia (M0)|childhood acute minimally differentiated myeloid leukemia (m0)
5147862|NCT01020734|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
5147863|NCT01020734|childhood acute myeloblastic leukemia without maturation (M1)|childhood acute myeloblastic leukemia without maturation (m1)
5147864|NCT01020734|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
5147865|NCT01020734|childhood acute myeloblastic leukemia with maturation (M2)|childhood acute myeloblastic leukemia with maturation (m2)
5147866|NCT01020734|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
5147867|NCT01020734|childhood acute myelomonocytic leukemia (M4)|childhood acute myelomonocytic leukemia (m4)
5147868|NCT01020734|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
5147869|NCT01020734|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
5147870|NCT01020734|childhood acute monoblastic leukemia (M5a)|childhood acute monoblastic leukemia (m5a)
5147871|NCT01020734|childhood acute monocytic leukemia (M5b)|childhood acute monocytic leukemia (m5b)
5147872|NCT01020734|adult erythroleukemia (M6a)|adult erythroleukemia (m6a)
5147873|NCT01020734|adult pure erythroid leukemia (M6b)|adult pure erythroid leukemia (m6b)
5147874|NCT01020734|childhood acute erythroleukemia (M6)|childhood acute erythroleukemia (m6)
5147875|NCT01020734|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
5147876|NCT01020734|childhood acute megakaryocytic leukemia (M7)|childhood acute megakaryocytic leukemia (m7)
5147877|NCT01020721|CYP1B1 gene|cyp1b1 gene
5147878|NCT01020695|PTSD|ptsd
5147880|NCT01020695|QEEG|qeeg
5147881|NCT01020695|LORETA|loreta
5147882|NCT01020682|apathy|apathy
5147883|NCT01020682|parkinson|parkinson
5147884|NCT01020682|agonist dopaminergic|agonist dopaminergic
5147885|NCT01020669|fMRI|fmri
5147886|NCT01020669|Prenatal Drug Exposure|prenatal drug exposure
5147887|NCT01020669|Decision Making|decision making
5147888|NCT01020669|Working Memory|working memory
5147889|NCT01020669|Vulnerability|vulnerability
5147890|NCT01020656|anticoagulant agents|anticoagulant agents
5147891|NCT01020656|antiplatelet agents|antiplatelet agents
5147892|NCT01020656|vitreoretinal surgery|vitreoretinal surgery
5147893|NCT01020656|Patients suffered from retinal detachment|patients suffered from retinal detachment
5147894|NCT01020630|adenocarcinoma of stomach|adenocarcinoma of stomach
5147895|NCT01020630|adenocarcinoma of lower oesophagus|adenocarcinoma of lower oesophagus
5147896|NCT01020630|sunitinib|sunitinib
5147897|NCT01020630|FOLFIRI|folfiri
5147898|NCT01020604|BMI|bmi
5147899|NCT01020604|Prostate cancer|prostate cancer
5147900|NCT01020604|Recurrence|recurrence
5147901|NCT01020591|knee osteoarthritis|knee osteoarthritis
5147902|NCT01020591|manual therapy|manual therapy
5147903|NCT01020591|osteopathy|osteopathy
5147904|NCT01020552|APHIA II|aphia ii
5147905|NCT01020552|AIDS, Population, and Health Integrated Assistance project|aids, population, and health integrated assistance project
5147906|NCT01020552|DCF|dcf
5147907|NCT01020552|data collection forms|data collection forms
5147908|NCT01020552|FDA|fda
5147909|NCT01020552|Federal Drug Administration|federal drug administration
5147910|NCT01020552|FP|fp
5147911|NCT01020552|family planning|family planning
5147912|NCT01020552|IRB|irb
5147913|NCT01020552|Institutional Review Board|institutional review board
5147914|NCT01020552|PAC|pac
5147915|NCT01020552|postabortion care|postabortion care
5147916|NCT01020552|To document the ESD PAC svc pkg including the provision of services, client satisfaction with those services and provider attitudes towards PAC services|to document the esd pac svc pkg including the provision of services, client satisfaction with those services and provider attitudes towards pac services
5147917|NCT01020552|To examine any differences in implementation of the ESD PAC services package for youth and adult clients|to examine any differences in implementation of the esd pac services package for youth and adult clients
5147918|NCT01020552|To assess the usefulness of five Youth-Friendly PAC Job Aids developed by ESD|to assess the usefulness of five youth-friendly pac job aids developed by esd
5147919|NCT01020539|Allogeneic Stem Cell Transplantation|allogeneic stem cell transplantation
5147920|NCT01020539|Targeted Immune Therapy|targeted immune therapy
5147921|NCT01020539|Acute Myelogenous Leukemia|acute myelogenous leukemia
5147922|NCT01020539|Myelodysplastic Syndrome|myelodysplastic syndrome
5147923|NCT01020539|Juvenile Myelomonocytic Leukemia|juvenile myelomonocytic leukemia
5147924|NCT01020539|AML|aml
5147925|NCT01020539|MDS|mds
5147926|NCT01020539|JMML|jmml
5147927|NCT01020474|juvenile primary fibromyalgia syndrome|juvenile primary fibromyalgia syndrome
5147928|NCT01020474|pediatric fibromyalgia|pediatric fibromyalgia
5147929|NCT01020474|pregabalin|pregabalin
5147930|NCT01020474|and Lyrica|and lyrica
5147931|NCT01020448|Locally advanced or metastatic Prostate Cancer|locally advanced or metastatic prostate cancer
5147932|NCT01020435|Hypertension|hypertension
5147933|NCT01020422|breast hypertrophy|breast hypertrophy
5147934|NCT01020422|mammaplasty|mammaplasty
5147935|NCT01020422|sexuality|sexuality
5147936|NCT01020422|depression|depression
5147937|NCT01020409|cardiac surgery|cardiac surgery
5147938|NCT01020409|cardiopulmonary bypass|cardiopulmonary bypass
5147939|NCT01020409|acute lung injury|acute lung injury
5147940|NCT01020409|acute respiratory distress syndrome|acute respiratory distress syndrome
5147941|NCT01020409|acute kidney injury|acute kidney injury
5147942|NCT01020409|atrial fibrillation|atrial fibrillation
5147943|NCT01020409|postoperative psychosis|postoperative psychosis
5147944|NCT01020409|myocardial infarct|myocardial infarct
5147945|NCT01020409|sepsis|sepsis
5147946|NCT01020396|Bioequivalence|bioequivalence
5147947|NCT01020396|Metronidazole|metronidazole
5147948|NCT01020396|Vaginosis|vaginosis
5147949|NCT01020370|Patients with RRMS who are participating in the CARE MS I and CARE MS II|patients with rrms who are participating in the care ms i and care ms ii
5147950|NCT01020357|preterm infants|preterm infants
5147951|NCT01020357|very low birthweight|very low birthweight
5147952|NCT01020357|apnea of prematurity|apnea of prematurity
5147953|NCT01020357|methylxanthines|methylxanthines
5147954|NCT01020357|sleep disturbance|sleep disturbance
5147955|NCT01020357|obstructive sleep apnea syndrome|obstructive sleep apnea syndrome
5147956|NCT01020357|polysomnography|polysomnography
5147957|NCT01020357|sleep disruption|sleep disruption
5147958|NCT01020331|ALS|als
5147959|NCT01020318|Traumatic Brain Injury|traumatic brain injury
5147960|NCT01020318|TBI|tbi
5147961|NCT01020318|Brain Injuries|brain injuries
5147962|NCT01020279|muscle pain|muscle pain
5147963|NCT01020279|model|model
5147964|NCT01020266|brain protection|brain protection
5147965|NCT01020266|cardiac surgery|cardiac surgery
5147966|NCT01020266|heart valve replacement|heart valve replacement
5147967|NCT01020266|electroacupuncture|electroacupuncture
5147968|NCT01020266|pretreatment|pretreatment
5147969|NCT01020266|preconditioning|preconditioning
5147970|NCT01020266|Thoracic Surgery|thoracic surgery
5147971|NCT01020253|bisphosphonate, vitamin D3|bisphosphonate, vitamin d3
5147972|NCT01020253|Total Hip arthroplasty|total hip arthroplasty
5147973|NCT01020240|Immediate puerperium|immediate puerperium
5147974|NCT01020240|physiotherapy in postpartum|physiotherapy in postpartum
5147975|NCT01020240|cesarean complications|cesarean complications
5147976|NCT01020227|Postoperative Care|postoperative care
5147977|NCT01020227|Quality of Life|quality of life
5147978|NCT01020227|Integrative Medicine|integrative medicine
5147979|NCT01020227|Coronary Artery Bypass Graft Surgery|coronary artery bypass graft surgery
5147980|NCT01020201|Anesthesia, General|anesthesia, general
5147981|NCT01020201|Elective Gynecological Operation|elective gynecological operation
5147982|NCT01020201|Chinese female patient|chinese female patient
5147983|NCT01020201|Adult|adult
5147984|NCT01020175|allogeneic transplantation|allogeneic transplantation
5147985|NCT01020175|Leukemia|leukemia
5147986|NCT01020175|GvHD|gvhd
5147987|NCT01020175|MDS|mds
5147988|NCT01020162|Chronic pelvic pain|chronic pelvic pain
5147989|NCT01020162|ilioinguinal nerve entrapment|ilioinguinal nerve entrapment
5147990|NCT01020162|randomized study|randomized study
5147991|NCT01020162|Chronic pelvic pain in women|chronic pelvic pain in women
5147992|NCT01020149|Nerve transsection|nerve transsection
5147993|NCT01020136|Bioequivalence Pharmacokinetics|bioequivalence pharmacokinetics
5147994|NCT01020123|Type II Diabetes Mellitus|type ii diabetes mellitus
5147995|NCT01020123|metformin|metformin
5147997|NCT01020110|perfusion chamber|perfusion chamber
5147998|NCT01020110|thrombus D-Dimer|thrombus d-dimer
5147999|NCT01020110|HUVEC|huvec
5148000|NCT01020084|Saliva|saliva
5148001|NCT01020084|Mastication|mastication
5148002|NCT01020084|Communication|communication
5148003|NCT01020071|iridotomy|iridotomy
5148004|NCT01020071|iridoplasty|iridoplasty
5148005|NCT01020071|angle closure glaucoma|angle closure glaucoma
5148006|NCT01020045|HIV|hiv
5148007|NCT01020045|Osteopenia|osteopenia
5148008|NCT01020045|Osteoporosis|osteoporosis
5148009|NCT01020032|Music therapy|music therapy
5148010|NCT01020032|Pain|pain
5148011|NCT01020032|Anxiety|anxiety
5148012|NCT01020032|Depression|depression
5148013|NCT01020032|Controlled randomized trial|controlled randomized trial
5148014|NCT01020019|Cannabis Dependence|cannabis dependence
5148015|NCT01020019|Marijuana Dependence|marijuana dependence
5148016|NCT01020019|Marinol|marinol
5148017|NCT01020019|Lofexidine|lofexidine
5148018|NCT01020006|PCI-27483|pci-27483
5148019|NCT01020006|Factor VIIa|factor viia
5148020|NCT01020006|Gemcitabine|gemcitabine
5148021|NCT01020006|4 months life expectancy|4 months life expectancy
5148022|NCT01020006|Pharmacyclics|pharmacyclics
5148023|NCT01020006|Locally Advanced|locally advanced
5148024|NCT01020006|Metastatic disease|metastatic disease
5148025|NCT01019993|Thoracotomy|thoracotomy
5148026|NCT01019993|one lung ventilation|one lung ventilation
5148027|NCT01019993|HFPPV|hfppv
5148028|NCT01019993|right ventricular function.|right ventricular function.
5148029|NCT01019980|Antipyretics|antipyretics
5148030|NCT01019980|fever|fever
5148031|NCT01019980|diclofenac|diclofenac
5148032|NCT01019980|acetaminophen|acetaminophen
5148033|NCT01019980|children|children
5148034|NCT01019980|acute upper respiratory tract infections|acute upper respiratory tract infections
5148035|NCT01019967|Children and Adolescents|children and adolescents
5148036|NCT01019967|Obsessive-Compulsive Disorder|obsessive-compulsive disorder
5148037|NCT01019967|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
5148038|NCT01019967|Autism|autism
5148039|NCT01019967|OCD|ocd
5148040|NCT01019967|Obsessive Compulsive Disorder|obsessive compulsive disorder
5148041|NCT01019941|Docetaxel|docetaxel
5148042|NCT01019941|CKD-810|ckd-810
5148043|NCT01019941|Taxotere inj.|taxotere inj.
5148044|NCT01019941|Advanced Solid cancer|advanced solid cancer
5148045|NCT01019941|Pharmacokinetic evaluation|pharmacokinetic evaluation
5148046|NCT01019928|GERD|gerd
5148047|NCT01019928|patient|patient
5148048|NCT01019928|esophagus|esophagus
5148049|NCT01019928|pain|pain
5148050|NCT01019915|CRT|crt
5148051|NCT01019915|heart failure|heart failure
5148052|NCT01019915|left bundle branch block|left bundle branch block
5148053|NCT01019915|skeletal muscle|skeletal muscle
5148054|NCT01019915|cytokines|cytokines
5148055|NCT01019915|VO2|vo2
5148056|NCT01019915|pgc1alpha|pgc1alpha
5148057|NCT01019902|iron|iron
5148058|NCT01019902|pregnancy|pregnancy
5148059|NCT01019902|adolescents|adolescents
5148060|NCT01019902|auditory brainstem responses|auditory brainstem responses
5148061|NCT01019902|anemia|anemia
5148062|NCT01019902|neonate|neonate
5148063|NCT01019889|upper respiratory tract infections|upper respiratory tract infections
5148064|NCT01019889|herbal medicine|herbal medicine
5148065|NCT01019876|Bone marrow Failure|bone marrow failure
5148066|NCT01019876|Fanconi|fanconi
5148067|NCT01019876|SCID|scid
5148068|NCT01019850|disseminated neuroblastoma|disseminated neuroblastoma
5148069|NCT01019850|localized unresectable neuroblastoma|localized unresectable neuroblastoma
5148070|NCT01019850|recurrent neuroblastoma|recurrent neuroblastoma
5148071|NCT01019850|regional neuroblastoma|regional neuroblastoma
5148072|NCT01019837|Vaccine|vaccine
5148073|NCT01019824|nerve compression|nerve compression
5148074|NCT01019824|compression radiculopathy|compression radiculopathy
5148075|NCT01019824|post-traumatic/post-surgical lumbar radiculopathy|post-traumatic/post-surgical lumbar radiculopathy
5148076|NCT01019811|Cross-finger flap|cross-finger flap
5148077|NCT01019811|finger injuries|finger injuries
5148078|NCT01019811|fingertip reconstruction|fingertip reconstruction
5148079|NCT01019811|proper digital artery|proper digital artery
5148080|NCT01019811|proper digital nerve.|proper digital nerve.
5148081|NCT01019798|non small cell lung cancer|non small cell lung cancer
5148082|NCT01019798|sunitinib|sunitinib
5148083|NCT01019798|docetaxel|docetaxel
5148084|NCT01019785|Pregnancy rate (pos test, live fetus at 12 weeks, baby home)|pregnancy rate (pos test, live fetus at 12 weeks, baby home)
5148085|NCT01019785|Pregnancy complication (Pregnancy hypertension, SGA, diab)|pregnancy complication (pregnancy hypertension, sga, diab)
5148086|NCT01019785|Thrombin generation|thrombin generation
5148087|NCT01019759|Atrial fibrillation|atrial fibrillation
5148088|NCT01019759|cardiac surgery|cardiac surgery
5148089|NCT01019759|ablation|ablation
5148090|NCT01019759|pulmonary veins|pulmonary veins
5148091|NCT01019746|Hypnosis with propofol|hypnosis with propofol
5148092|NCT01019733|Hypoxia|hypoxia
5148093|NCT01019733|Ischemia|ischemia
5148094|NCT01019733|Brain|brain
5148095|NCT01019733|Children|children
5148096|NCT01019733|Cerebral Palsy|cerebral palsy
5148097|NCT01019707|crystal meth|crystal meth
5148098|NCT01019707|methamphetamine|methamphetamine
5148099|NCT01019707|substance abuse|substance abuse
5148100|NCT01019681|Cord blood injection in peripheral vascular disease|cord blood injection in peripheral vascular disease
5148101|NCT01019668|chorioretinopathy|chorioretinopathy
5148102|NCT01019668|photodynamic therapy|photodynamic therapy
5148103|NCT01019668|reduced fluence|reduced fluence
5148104|NCT01019668|reduced dose|reduced dose
5148105|NCT01019655|thrombophilia|thrombophilia
5148106|NCT01019655|pregnancy|pregnancy
5148107|NCT01019655|heparin|heparin
5148108|NCT01019642|vitamin D|vitamin d
5148109|NCT01019642|diabetes|diabetes
5148110|NCT01019642|C-reactive protein|c-reactive protein
5148111|NCT01019642|insulin resistance|insulin resistance
5148112|NCT01019629|Fabry, Fabry Disease, Alpha-galactosidase A deficiency, GLA gene, mutations|fabry, fabry disease, alpha-galactosidase a deficiency, gla gene, mutations
5148113|NCT01019603|Acne|acne
5148114|NCT01019551|Controlled viremia|controlled viremia
5148115|NCT01019551|Viral reservoirs|viral reservoirs
5148116|NCT01019551|Virus eradication|virus eradication
5148117|NCT01019551|Therapeutic intensification|therapeutic intensification
5148118|NCT01019551|Immunointervention|immunointervention
5148119|NCT01019538|Oxygen|oxygen
5148120|NCT01019538|Hypoxemia|hypoxemia
5148121|NCT01019538|Air travel|air travel
5148122|NCT01019525|respiration|respiration
5148123|NCT01019525|respiratory disorders|respiratory disorders
5148124|NCT01019525|Otolaryngology|otolaryngology
5148125|NCT01019525|Otorhinolaryngology|otorhinolaryngology
5148126|NCT01019525|Posture|posture
5148127|NCT01019499|human|human
5148128|NCT01019499|intervention|intervention
5148129|NCT01019499|blood pressure|blood pressure
5148130|NCT01019499|cardiovascular risk factors|cardiovascular risk factors
5148131|NCT01019499|polyphenols|polyphenols
5148132|NCT01019499|bioavailability|bioavailability
5148133|NCT01019486|Myocardial blood flow|myocardial blood flow
5148134|NCT01019486|Cardiac magnetic resonance imaging|cardiac magnetic resonance imaging
5148135|NCT01019486|Myocardial perfusion imaging|myocardial perfusion imaging
5148136|NCT01019486|Coronary artery flow reserve|coronary artery flow reserve
5148137|NCT01019486|Regadenoson|regadenoson
5148138|NCT01019473|Huntington's disease|huntington's disease
5148139|NCT01019473|Chorea|chorea
5148140|NCT01019473|Dyskinesia|dyskinesia
5148141|NCT01019460|Small intestine|small intestine
5148142|NCT01019460|Magnetic resonance imaging|magnetic resonance imaging
5148143|NCT01019460|Computed tomography scanning|computed tomography scanning
5148144|NCT01019460|Capsule endoscopy|capsule endoscopy
5148145|NCT01019447|Surgical site infection|surgical site infection
5148146|NCT01019447|Antimicrobial triclosan-coated polyglactin 910 suture|antimicrobial triclosan-coated polyglactin 910 suture
5148147|NCT01019447|Length of hospital stay|length of hospital stay
5148148|NCT01019447|SSI|ssi
5148149|NCT01019434|adult glioblastoma|adult glioblastoma
5148150|NCT01019421|Cognition|cognition
5148151|NCT01019408|Clinical Trial|clinical trial
5148152|NCT01019408|Chloroquine|chloroquine
5148153|NCT01019408|Refugees|refugees
5148154|NCT01019408|Afghanistan|afghanistan
5148155|NCT01019408|Pakistan|pakistan
5148156|NCT01019395|Gram Positive Infection|gram positive infection
5148157|NCT01019395|Concurrent Antibiotic Treatment|concurrent antibiotic treatment
5148158|NCT01019382|pancreatic|pancreatic
5148159|NCT01019382|carcinoma|carcinoma
5148160|NCT01019382|cancer|cancer
5148161|NCT01019382|fish|fish
5148162|NCT01019382|alternative|alternative
5148163|NCT01019369|Contraception|contraception
5148164|NCT01019369|Medroxyprogesterone 17-acetate|medroxyprogesterone 17-acetate
5148165|NCT01019369|Self administration|self administration
5148166|NCT01019356|PCOS|pcos
5148167|NCT01019343|Magnetic Resonance Imaging (MRI)|magnetic resonance imaging (mri)
5148168|NCT01019343|Magnetoencephalogram|magnetoencephalogram
5148169|NCT01019343|Electroencephalogram (EEG)|electroencephalogram (eeg)
5148170|NCT01019343|Transcranial Magnetic Stimulation (TMS)|transcranial magnetic stimulation (tms)
5148171|NCT01019343|Motor Deficit|motor deficit
5148172|NCT01019343|Dystonia|dystonia
5148173|NCT01019343|Movement Disorder|movement disorder
5148174|NCT01019343|Parkinson Disease|parkinson disease
5148175|NCT01019343|PD|pd
5148176|NCT01019343|Tourette Syndrome|tourette syndrome
5148177|NCT01019343|TS|ts
5148178|NCT01019343|Tic Disorder|tic disorder
5148179|NCT01019330|radial vs femoral|radial vs femoral
5148180|NCT01019330|radial artery cardiac catheterization|radial artery cardiac catheterization
5148181|NCT01019317|Acute Myelogenous Leukemia|acute myelogenous leukemia
5148182|NCT01019317|High-Risk Myelodysplastic Syndrome|high-risk myelodysplastic syndrome
5148183|NCT01019317|Chronic myeloid leukemia|chronic myeloid leukemia
5148184|NCT01019317|CML|cml
5148185|NCT01019317|Blast crisis|blast crisis
5148186|NCT01019317|Cytarabine|cytarabine
5148187|NCT01019317|Ara-C|ara-c
5148188|NCT01019317|Cytosar|cytosar
5148189|NCT01019317|DepoCyt|depocyt
5148190|NCT01019317|Cytosine arabinosine hydrochloride|cytosine arabinosine hydrochloride
5148191|NCT01019317|Arabinosine Hydrochloride|arabinosine hydrochloride
5148192|NCT01019317|Fludarabine|fludarabine
5148193|NCT01019317|Fludarabine Phosphate|fludarabine phosphate
5148194|NCT01019317|Fludara|fludara
5148195|NCT01019317|Gemtuzumab Ozogamicin|gemtuzumab ozogamicin
5148196|NCT01019317|Mylotarg|mylotarg
5148197|NCT01019291|Indoor pollutants|indoor pollutants
5148198|NCT01019265|Norspan patch|norspan patch
5148199|NCT01019265|Buprenorphine transdermal patch (BTDS)|buprenorphine transdermal patch (btds)
5148200|NCT01019265|efficacy|efficacy
5148201|NCT01019265|buprenorphine|buprenorphine
5148202|NCT01019252|Adolescent|adolescent
5148203|NCT01019252|ADHD|adhd
5148204|NCT01019239|Non-faeculant|non-faeculant
5148205|NCT01019239|Perforated|perforated
5148206|NCT01019239|Diverticulitis|diverticulitis
5148207|NCT01019226|myocardium|myocardium
5148208|NCT01019226|Magnetic resonance imaging|magnetic resonance imaging
5148209|NCT01019213|His-pacing|his-pacing
5148210|NCT01019200|psoriasis|psoriasis
5148211|NCT01019200|heart disease|heart disease
5148212|NCT01019200|cardiovascular disease|cardiovascular disease
5148213|NCT01019200|hyperlipidemia|hyperlipidemia
5148214|NCT01019161|Acute Myeloid Leukaemia (AML)|acute myeloid leukaemia (aml)
5148215|NCT01019161|AML|aml
5148216|NCT01019161|AZD1152|azd1152
5148217|NCT01019161|Pharmacokinetics|pharmacokinetics
5148218|NCT01019135|Women|women
5148219|NCT01019135|Cardiac Care Facilities|cardiac care facilities
5148220|NCT01019135|Patient satisfaction|patient satisfaction
5148221|NCT01019135|Patient participation|patient participation
5148222|NCT01019135|Patient compliance|patient compliance
5148223|NCT01019135|Randomized Control Trial|randomized control trial
5148224|NCT01019135|Coronary artery bypass|coronary artery bypass
5148225|NCT01019135|Angioplasty, transluminal, percutaneous coronary|angioplasty, transluminal, percutaneous coronary
5148226|NCT01019109|scoliosis|scoliosis
5148227|NCT01019096|iron|iron
5148228|NCT01019096|pregnancy|pregnancy
5148229|NCT01019096|heme iron|heme iron
5148230|NCT01019096|non-heme iron|non-heme iron
5148231|NCT01019096|stable isotopes|stable isotopes
5148232|NCT01019096|women/adolescents|women/adolescents
5148233|NCT01019083|Cholera|cholera
5148234|NCT01019083|Typhoid|typhoid
5148235|NCT01019083|Oral Vaccine|oral vaccine
5148236|NCT01019083|Immune response|immune response
5148237|NCT01019083|Vaccine Evaluation|vaccine evaluation
5148238|NCT01019083|Nutrition|nutrition
5148239|NCT01019083|Child Health|child health
5148240|NCT01019057|DDD|ddd
5148241|NCT01019057|decompression|decompression
5148242|NCT01019057|spinous process plate|spinous process plate
5148243|NCT01019044|HIV|hiv
5148244|NCT01019044|Viral reservoirs|viral reservoirs
5148245|NCT01019044|Viral load|viral load
5148246|NCT01019018|subtenon block|subtenon block
5148247|NCT01019005|post-operative analgesia|post-operative analgesia
5148248|NCT01019005|opioid|opioid
5148249|NCT01019005|catheter|catheter
5148250|NCT01019005|tibial nerve block|tibial nerve block
5148251|NCT01018992|PTSD|ptsd
5148252|NCT01018992|Anxiety Disorder|anxiety disorder
5148253|NCT01018992|Corticotropin releasing factor|corticotropin releasing factor
5148254|NCT01018992|Women|women
5148255|NCT01018927|Cardiac MR (CMR)|cardiac mr (cmr)
5148256|NCT01018927|Early Myocardial Infiltration|early myocardial infiltration
5148257|NCT01018927|Amyloid|amyloid
5148258|NCT01018927|Light Chain Deposition Disease|light chain deposition disease
5148259|NCT01018927|Multiple Myeloma|multiple myeloma
5148260|NCT01018914|Prograf|prograf
5148261|NCT01018914|Advagraf|advagraf
5148262|NCT01018914|Myfortic|myfortic
5148263|NCT01018888|Cornea|cornea
5148264|NCT01018888|Transplantation, Cornea|transplantation, cornea
5148265|NCT01018888|Keratoplasty|keratoplasty
5148266|NCT01018888|Grafting, Corneal|grafting, corneal
5148267|NCT01018849|Vitamin D|vitamin d
5148268|NCT01018849|Cardiac Catheterization|cardiac catheterization
5148269|NCT01018849|Cardiovascular event|cardiovascular event
5148270|NCT01018849|Cardiovascular Disease|cardiovascular disease
5148271|NCT01018836|tumors metastatic to brain|tumors metastatic to brain
5148272|NCT01018836|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5148273|NCT01018810|Psoriasis|psoriasis
5148274|NCT01018797|INTRASTROMAL CORNEAL RING|intrastromal corneal ring
5148275|NCT01018797|ASTIGMATISM|astigmatism
5148276|NCT01018797|POSTKERATOPLASTY|postkeratoplasty
5148277|NCT01018797|EYES|eyes
5148278|NCT01018797|To evaluate the clinical outcomes of ICRS implantation to correct high-degree astigmatism on eyes with prior penetrating keratoplasty (PK)|to evaluate the clinical outcomes of icrs implantation to correct high-degree astigmatism on eyes with prior penetrating keratoplasty (pk)
5148279|NCT01018784|Cancer|cancer
5148280|NCT01018784|Mesothelin-positive|mesothelin-positive
5148281|NCT01018771|actifuse|actifuse
5148282|NCT01018771|INFUSE|infuse
5148283|NCT01018771|InductOs|inductos
5148284|NCT01018771|DDD|ddd
5148285|NCT01018771|Degenerative disc disease|degenerative disc disease
5148286|NCT01018771|PLF|plf
5148287|NCT01018771|posterolateral lumbar fusion|posterolateral lumbar fusion
5148288|NCT01018771|bone substitute|bone substitute
5148289|NCT01018771|bone graft|bone graft
5148290|NCT01018771|synthetic bone substitute|synthetic bone substitute
5148291|NCT01018771|spinal surgery|spinal surgery
5148292|NCT01018758|Non-Hodgkin's lymphoma|non-hodgkin's lymphoma
5148293|NCT01018758|Quality of life|quality of life
5148294|NCT01018758|Chemotherapy toxicity|chemotherapy toxicity
5148384|NCT01018394|snuff|snuff
5148385|NCT01018394|moist snuff|moist snuff
5148295|NCT01018758|aggressive Non Hodgkin's Lymphomas treated with moderately emetogenic chemotherapy|aggressive non hodgkin's lymphomas treated with moderately emetogenic chemotherapy
5148296|NCT01018732|Meningococcal|meningococcal
5148297|NCT01018732|ACWY|acwy
5148298|NCT01018732|Conjugate Vaccine|conjugate vaccine
5148299|NCT01018732|Meningitis|meningitis
5148300|NCT01018732|Adolescents|adolescents
5148301|NCT01018732|Persistence|persistence
5148302|NCT01018719|breast cancer radiotherapy cardiotoxicity multidetector CT|breast cancer radiotherapy cardiotoxicity multidetector ct
5148303|NCT01018719|Radiotherapy|radiotherapy
5148304|NCT01018706|Primary pci|primary pci
5148305|NCT01018706|Stent|stent
5148306|NCT01018706|Medical Hystory|medical hystory
5148307|NCT01018706|Antiplatelet therapy|antiplatelet therapy
5148308|NCT01018706|Compliance|compliance
5148309|NCT01018693|Seasonal allergic rhinitis,|seasonal allergic rhinitis,
5148310|NCT01018693|late phase response,|late phase response,
5148311|NCT01018693|alutard avanz,|alutard avanz,
5148312|NCT01018693|immunotherapy,|immunotherapy,
5148313|NCT01018693|visual analogue scale,|visual analogue scale,
5148314|NCT01018693|mini rhinitis quality of life,|mini rhinitis quality of life,
5148315|NCT01018693|immune modulation|immune modulation
5148316|NCT01018667|Heart Failure|heart failure
5148317|NCT01018667|clinical trial|clinical trial
5148318|NCT01018667|biventricular pacing|biventricular pacing
5148319|NCT01018667|cardiac device|cardiac device
5148320|NCT01018654|Substance Abuse|substance abuse
5148321|NCT01018654|Substance Addiction|substance addiction
5148322|NCT01020708|colitis|colitis
5148323|NCT01020708|inflammatory bowel disease|inflammatory bowel disease
5148324|NCT01020708|ulcerative colitis|ulcerative colitis
5148325|NCT01020708|rectal administration|rectal administration
5148326|NCT01020708|enema|enema
5148327|NCT01020708|mesalamine|mesalamine
5148328|NCT01020487|Reduction of parathyroid hormone levels in pediatric patients with Chronic Kidney Disease Stage 3 and 4|reduction of parathyroid hormone levels in pediatric patients with chronic kidney disease stage 3 and 4
5148329|NCT01020292|Adult subjects with a diagnosis of Grade IV Glioma|adult subjects with a diagnosis of grade iv glioma
5148330|NCT01020097|Stage 1 squamous cell carcinoma of the larynx|stage 1 squamous cell carcinoma of the larynx
5148331|NCT01019954|Adults with premalignant head and neck tumors and adults who have Carcinoma in situ of the head and neck in whom standard therapy is not indicated|adults with premalignant head and neck tumors and adults who have carcinoma in situ of the head and neck in whom standard therapy is not indicated
5148332|NCT01019122|cerebral palsy|cerebral palsy
5148333|NCT01019122|DEXA scan|dexa scan
5148334|NCT01019122|bone density|bone density
5148335|NCT01018641|Staphylococcus aureus|staphylococcus aureus
5148336|NCT01018641|Vaccine|vaccine
5148337|NCT01018615|chronic hepatitis C|chronic hepatitis c
5148338|NCT01018615|silymarin|silymarin
5148339|NCT01018615|green tea catechins|green tea catechins
5148340|NCT01018615|green tea extract|green tea extract
5148341|NCT01018615|pharmacokinetics|pharmacokinetics
5148342|NCT01018615|antioxidant activity|antioxidant activity
5148343|NCT01018589|Post surgical scars|post surgical scars
5148344|NCT01018589|Epidermic burn|epidermic burn
5148345|NCT01018589|Cicatrix cream|cicatrix cream
5148346|NCT01018576|delayed cord clamping|delayed cord clamping
5148347|NCT01018576|premature infants|premature infants
5148348|NCT01018576|hypothermia|hypothermia
5148349|NCT01018576|anemia|anemia
5148350|NCT01018576|intraventricular hemorrhage|intraventricular hemorrhage
5148351|NCT01018576|Anemia in premature infants|anemia in premature infants
5148352|NCT01018563|Extension study|extension study
5148353|NCT01018563|Epithelial ovarian cancer|epithelial ovarian cancer
5148354|NCT01018537|Multiple Sclerosis|multiple sclerosis
5148355|NCT01018537|NARCOMS|narcoms
5148356|NCT01018537|Global Patient Registry|global patient registry
5148357|NCT01018524|position of the mesh|position of the mesh
5148358|NCT01018524|recurrence rate|recurrence rate
5148359|NCT01018524|surgical procedure|surgical procedure
5148360|NCT01018524|long time outcome|long time outcome
5148361|NCT01018511|EC905|ec905
5148362|NCT01018511|Solifenacin succinate|solifenacin succinate
5148363|NCT01018511|Tamsulosin hydrochloride OCAS|tamsulosin hydrochloride ocas
5148364|NCT01018511|Treatment|treatment
5148365|NCT01018511|Benign Prostatic Hyperplasia|benign prostatic hyperplasia
5148366|NCT01018511|Vesomni|vesomni
5148367|NCT01018511|Lower Urinary Tract Symptoms|lower urinary tract symptoms
5148368|NCT01018498|Irritable Bowel Syndrome|irritable bowel syndrome
5148369|NCT01018498|Children|children
5148370|NCT01018472|cyanotic heart disease|cyanotic heart disease
5148371|NCT01018472|congenital heart disease|congenital heart disease
5148372|NCT01018472|intestinal microbiota|intestinal microbiota
5148373|NCT01018472|probiotics|probiotics
5148374|NCT01018459|malaria, vaccine, Burkina Faso|malaria, vaccine, burkina faso
5148375|NCT01018446|Hematopoietic stem cell transplantation with busulfan based conditioning|hematopoietic stem cell transplantation with busulfan based conditioning
5148376|NCT01018433|self-injury|self-injury
5148377|NCT01018433|non-suicidal self-injury|non-suicidal self-injury
5148378|NCT01018433|deliberate self-harm|deliberate self-harm
5148379|NCT01018433|self-mutilation|self-mutilation
5148380|NCT01018420|healthy|healthy
5148381|NCT01018394|tobacco dependence|tobacco dependence
5148382|NCT01018394|tobacco reduction|tobacco reduction
5148383|NCT01018394|chewing tobacco|chewing tobacco
5148386|NCT01018381|HCC|hcc
5148387|NCT01018381|HBV|hbv
5148388|NCT01018381|MGN-3|mgn-3
5148389|NCT01018381|BioBran|biobran
5148390|NCT01018381|Alternative Therapy|alternative therapy
5148391|NCT01018355|Patent foramen ovale|patent foramen ovale
5148392|NCT01018355|PFO|pfo
5148393|NCT01018355|Stroke|stroke
5148394|NCT01018355|TIA|tia
5148395|NCT01018355|Percutaneus closure|percutaneus closure
5148396|NCT01018355|Intervention|intervention
5148397|NCT01018329|Adult Brain Tumor|adult brain tumor
5148398|NCT01018316|preoxygenation|preoxygenation
5148399|NCT01018316|UMOX|umox
5148400|NCT01018303|cystic fibrosis|cystic fibrosis
5148401|NCT01018303|vitamins|vitamins
5148402|NCT01018303|antioxidants|antioxidants
5148403|NCT01018303|anthropometric measurements|anthropometric measurements
5148404|NCT01018303|pulmonary function|pulmonary function
5148405|NCT01018264|Overactive bladder|overactive bladder
5148406|NCT01018264|Urinary incontinence|urinary incontinence
5148407|NCT01018264|Urinary frequency|urinary frequency
5148408|NCT01018264|Parkinson's disease|parkinson's disease
5148409|NCT01018212|Cutaneous Groves|cutaneous groves
5148410|NCT01018199|C-reactive protein|c-reactive protein
5148411|NCT01018199|procalcitonin|procalcitonin
5148412|NCT01018199|community-acquired pneumonia|community-acquired pneumonia
5148413|NCT01018199|antibiotic therapy|antibiotic therapy
5148414|NCT01018160|Rabeprazole sodium|rabeprazole sodium
5148415|NCT01018160|Gastroesophageal Reflux|gastroesophageal reflux
5148416|NCT01018160|GERD|gerd
5148417|NCT01018160|Observational|observational
5148418|NCT01018147|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5148419|NCT01018147|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5148420|NCT01018147|stage IA non-small cell lung cancer|stage ia non-small cell lung cancer
5148421|NCT01018147|stage IB non-small cell lung cancer|stage ib non-small cell lung cancer
5148422|NCT01018147|stage IIA non-small cell lung cancer|stage iia non-small cell lung cancer
5148423|NCT01018147|stage IIB non-small cell lung cancer|stage iib non-small cell lung cancer
5148424|NCT01018134|Psoriasis|psoriasis
5148425|NCT01018134|Topical corticosteroids|topical corticosteroids
5148426|NCT01018134|Plaque psoriasis|plaque psoriasis
5148427|NCT01018121|Behavioral Treatment|behavioral treatment
5148428|NCT01018121|Preschool Children|preschool children
5148429|NCT01018121|Obesity Treatment|obesity treatment
5148430|NCT01018069|Acute|acute
5148431|NCT01018069|myeloid|myeloid
5148432|NCT01018069|leukemia|leukemia
5148433|NCT01018069|antisense|antisense
5148434|NCT01018069|chemotherapy|chemotherapy
5148435|NCT01018069|idarubicin|idarubicin
5148436|NCT01018069|cytarabine|cytarabine
5148437|NCT01018069|Patients with AML, except those with APL (acute promyelocytic leukemia), failing a single standard dose cytarabine based frontline induction regimen.|patients with aml, except those with apl (acute promyelocytic leukemia), failing a single standard dose cytarabine based frontline induction regimen.
5148438|NCT01018056|Tourette syndrome|tourette syndrome
5148439|NCT01018056|glutamatergic therapy|glutamatergic therapy
5148440|NCT01018056|D-serine|d-serine
5148441|NCT01018056|riluzole|riluzole
5148442|NCT01018056|glutamate|glutamate
5148443|NCT01018056|glutamate agonist|glutamate agonist
5148444|NCT01018056|glutamate antagonist|glutamate antagonist
5148445|NCT01018056|Tourette syndrome treatment study|tourette syndrome treatment study
5148446|NCT01018056|OCD|ocd
5148447|NCT01018056|tics|tics
5148448|NCT01018043|Cancer Anemia Survey|cancer anemia survey
5148449|NCT01018043|Chulalongkorn hospital|chulalongkorn hospital
5148450|NCT01018030|uncomplicated acute rhinosinusitis|uncomplicated acute rhinosinusitis
5148451|NCT01018030|fluticasone furoate|fluticasone furoate
5148452|NCT01018030|sinusitis|sinusitis
5148453|NCT01018004|stage IB melanoma|stage ib melanoma
5148454|NCT01018004|stage II melanoma|stage ii melanoma
5148455|NCT01017991|infants|infants
5148456|NCT01017991|formula|formula
5148457|NCT01017991|probiotic|probiotic
5148458|NCT01017991|crying|crying
5148459|NCT01017965|Type 1 diabetes|type 1 diabetes
5148460|NCT01017952|Safety|safety
5148461|NCT01017952|COPD|copd
5148462|NCT01017952|FEV1|fev1
5148463|NCT01017952|Efficacy|efficacy
5148464|NCT01017939|Prostate neoplasms|prostate neoplasms
5148465|NCT01017939|Metastatic castration resistant prostate cancer|metastatic castration resistant prostate cancer
5148466|NCT01017939|Metastatic castration refractory prostate cancer|metastatic castration refractory prostate cancer
5148467|NCT01017939|Prostate cancer|prostate cancer
5148468|NCT01017939|Abiraterone acetate|abiraterone acetate
5148469|NCT01017939|CB7630|cb7630
5148470|NCT01017926|Triazolam bioequivalence|triazolam bioequivalence
5148471|NCT01017913|rehabilitation|rehabilitation
5148472|NCT01017913|electrotherapy|electrotherapy
5148473|NCT01017913|back pain|back pain
5148474|NCT01017900|surgery|surgery
5148475|NCT01017900|manual rupture|manual rupture
5148476|NCT01017900|dorsal carpal ganglion|dorsal carpal ganglion
5148477|NCT01017887|laparoscopy|laparoscopy
5148478|NCT01017887|airseal|airseal
5148479|NCT01017887|carbon dioxide|carbon dioxide
5148480|NCT01017887|insufflation|insufflation
5148481|NCT01017887|pneumoperitoneum|pneumoperitoneum
5148482|NCT01017861|Temporal summation|temporal summation
5148483|NCT01017861|Venipuncture pain|venipuncture pain
5148484|NCT01017848|diabetes|diabetes
5148485|NCT01017848|urine pH|urine ph
5148486|NCT01017848|insulin resistance|insulin resistance
5148487|NCT01017848|metabolic syndrome|metabolic syndrome
5148488|NCT01017848|development of diabetes|development of diabetes
5148489|NCT01017835|statins|statins
5148490|NCT01017835|isolated hypertension|isolated hypertension
5148491|NCT01017835|atherosclerosis|atherosclerosis
5148492|NCT01017835|lipid profile|lipid profile
5148493|NCT01017822|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
5148494|NCT01017822|stage III pancreatic cancer|stage iii pancreatic cancer
5148495|NCT01017809|ovarian|ovarian
5148496|NCT01017809|chemotherapy|chemotherapy
5148497|NCT01017809|nausea|nausea
5148498|NCT01017796|Contrast induced nephropathy|contrast induced nephropathy
5148499|NCT01017770|Uncomplicated malaria|uncomplicated malaria
5148500|NCT01017757|Interstitial lung disease|interstitial lung disease
5148501|NCT01017757|Immunosuppressive therapy|immunosuppressive therapy
5148502|NCT01017757|Renal transplant|renal transplant
5148503|NCT01017744|Anesthetic Conserving Device|anesthetic conserving device
5148504|NCT01017744|Anaconda®|anaconda®
5148505|NCT01017744|Sevoflurane|sevoflurane
5148506|NCT01017744|Remifentanil|remifentanil
5148507|NCT01017744|Sedation|sedation
5148508|NCT01017744|Pressure support ventilation|pressure support ventilation
5148509|NCT01017744|Work of breathing|work of breathing
5148510|NCT01017744|Intrinsic positive end expiratory pressure|intrinsic positive end expiratory pressure
5148511|NCT01017744|Ventilatory dead space|ventilatory dead space
5148512|NCT01017744|Intensive care|intensive care
5148513|NCT01017744|Weaning of mechanical ventilation|weaning of mechanical ventilation
5148514|NCT01017744|Ventilated ICU patients in PSV|ventilated icu patients in psv
5148515|NCT01017744|No more in acute state|no more in acute state
5148516|NCT01017744|No respiratory distress|no respiratory distress
5148517|NCT01017744|Sedated by intravenous remifentanil|sedated by intravenous remifentanil
5148518|NCT01017744|In light sedation as define by a Richmond Agitation Sedation Scale (RASS) of - 1 to - 2.|in light sedation as define by a richmond agitation sedation scale (rass) of - 1 to - 2.
5148519|NCT01017731|Advanced Solid tumor|advanced solid tumor
5148520|NCT01017731|Antibodies, Monoclonal|antibodies, monoclonal
5148521|NCT01017731|QTc|qtc
5148522|NCT01017731|Metastatic|metastatic
5148523|NCT01017731|Malignant|malignant
5148524|NCT01017718|Diabetes mellitus type I|diabetes mellitus type i
5148525|NCT01017718|nerve conduction velocity|nerve conduction velocity
5148526|NCT01017718|Young score|young score
5148527|NCT01017718|long term vascular complications|long term vascular complications
5148528|NCT01017666|Healthy Volunteer|healthy volunteer
5148529|NCT01017653|Panitumumab|panitumumab
5148530|NCT01017653|Vectibix|vectibix
5148531|NCT01017653|Irinotecan|irinotecan
5148532|NCT01017653|CPT-11|cpt-11
5148533|NCT01017653|Camptosar|camptosar
5148534|NCT01017653|Malignant glioma|malignant glioma
5148535|NCT01017653|Glioblastoma multiforme|glioblastoma multiforme
5148536|NCT01017653|Gliosarcoma|gliosarcoma
5148537|NCT01017653|Duke|duke
5148538|NCT01017653|Vredenburgh|vredenburgh
5148539|NCT01017653|Pro00015447|pro00015447
5148540|NCT01017627|ESRD|esrd
5148541|NCT01017627|Anemia|anemia
5148542|NCT01017627|Hospitalizations|hospitalizations
5148543|NCT01017627|Mortality|mortality
5148544|NCT01017614|Inflammatory Bowel Disease|inflammatory bowel disease
5148545|NCT01017614|Iron deficiency|iron deficiency
5148546|NCT01017614|Iron deficiency anaemia|iron deficiency anaemia
5148547|NCT01017614|Anaemia|anaemia
5148548|NCT01017601|extensive stage small cell lung cancer|extensive stage small cell lung cancer
5148549|NCT01017588|lumbar support|lumbar support
5148550|NCT01017588|rubber tapper|rubber tapper
5148551|NCT01017562|To clarify the 18F-fluoride uptake patterns associated with aseptic or septic loosening|to clarify the 18f-fluoride uptake patterns associated with aseptic or septic loosening
5148552|NCT01017549|Stage I|stage i
5148553|NCT01017549|Stage II|stage ii
5148554|NCT01017549|Breast|breast
5148555|NCT01017549|Cancer|cancer
5148556|NCT01017536|HIV|hiv
5148557|NCT01017536|Tuberculosis|tuberculosis
5148558|NCT01017536|Vaccine|vaccine
5148559|NCT01017523|diabetes|diabetes
5148560|NCT01017523|relationship|relationship
5148561|NCT01017523|social support|social support
5148562|NCT01017523|telemedicine|telemedicine
5148563|NCT01017497|Brain Metastases|brain metastases
5148564|NCT01017484|blood pressure|blood pressure
5148565|NCT01017484|DASH diet|dash diet
5148566|NCT01017484|hypertension|hypertension
5148567|NCT01017471|carpal tunnel syndrome|carpal tunnel syndrome
5148568|NCT01017471|surgery|surgery
5148569|NCT01017471|PSU retractor|psu retractor
5148570|NCT01017471|carpal tunnel syndrome who failed to conservative treatment|carpal tunnel syndrome who failed to conservative treatment
5148571|NCT01017458|Healthy Adults|healthy adults
5148572|NCT01017445|osteoarthritis, exercise|osteoarthritis, exercise
5148573|NCT01017419|hearing aids|hearing aids
5148574|NCT01017419|counseling|counseling
5148575|NCT01017406|plantar fasciitis|plantar fasciitis
5148576|NCT01017406|heel cushion|heel cushion
5148577|NCT01017406|treatment|treatment
5148578|NCT01017393|preemptive epidural ketamine|preemptive epidural ketamine
5148579|NCT01017393|prevention of chronic post-thoracotomy pain|prevention of chronic post-thoracotomy pain
5148580|NCT01017380|preemptive analgesia|preemptive analgesia
5148581|NCT01017380|cruciate ligament|cruciate ligament
5148582|NCT01017367|RA|ra
5148583|NCT01017367|inflammatory joint disease|inflammatory joint disease
5148584|NCT01017354|vitamin D|vitamin d
5148585|NCT01017354|function|function
5148586|NCT01017354|falls|falls
5148587|NCT01017354|25-hydroxyvitamin D|25-hydroxyvitamin d
5148588|NCT01017354|disability|disability
5148589|NCT01017341|hip fracture|hip fracture
5148590|NCT01017341|back support|back support
5148591|NCT01017328|infants and children undergoing surgery with general anesthesia|infants and children undergoing surgery with general anesthesia
5148592|NCT01017315|baby talcum|baby talcum
5148593|NCT01017315|pruritus|pruritus
5148594|NCT01017315|cast|cast
5148595|NCT01017276|Hyperphosphatemia|hyperphosphatemia
5148596|NCT01017276|Peritoneal dialysis|peritoneal dialysis
5148597|NCT01017276|CKD|ckd
5148598|NCT01017276|ASP1585|asp1585
5148599|NCT01017263|ADHD|adhd
5148600|NCT01017263|Glucose Intolerance|glucose intolerance
5148601|NCT01017263|Obesity|obesity
5148602|NCT01017263|Vyvanse|vyvanse
5148603|NCT01017250|Recurrent|recurrent
5148604|NCT01017237|Dexmedetomidine sedation|dexmedetomidine sedation
5148605|NCT01017237|Oral surgery sedation|oral surgery sedation
5148606|NCT01017237|Dexmedetomidine amnesia|dexmedetomidine amnesia
5148607|NCT01017211|Pain|pain
5148608|NCT01017211|Electromyography|electromyography
5148609|NCT01017211|Acupuncture|acupuncture
5148610|NCT01017211|Randomized controlled trial|randomized controlled trial
5148611|NCT01017211|Rehabilitation|rehabilitation
5148612|NCT01017159|Polyradiculoneuropathy, Chronic Inflammatory Demyelinating|polyradiculoneuropathy, chronic inflammatory demyelinating
5148613|NCT01017159|Subcutaneous immunoglobulin|subcutaneous immunoglobulin
5148614|NCT01017146|Ance|ance
5148615|NCT01017120|Acne|acne
5148616|NCT01017107|acute pancreatitis|acute pancreatitis
5148617|NCT01017107|treatment|treatment
5148618|NCT01017107|organ failure|organ failure
5148619|NCT01017107|activated protein c|activated protein c
5148620|NCT01017094|Pin-site infection|pin-site infection
5148621|NCT01017094|silversulfadiazine|silversulfadiazine
5148622|NCT01017094|open fracture|open fracture
5148623|NCT01017094|open tibial fracture underwent external fixator|open tibial fracture underwent external fixator
5148624|NCT01017081|physiotherapy|physiotherapy
5148625|NCT01017081|children|children
5148626|NCT01017081|clinical trial|clinical trial
5148627|NCT01017068|GLAUCOMA|glaucoma
5148628|NCT01017042|healthy|healthy
5148629|NCT01017042|blood levels|blood levels
5148630|NCT01017003|healthy|healthy
5148631|NCT01017003|pharmacokinetics|pharmacokinetics
5148632|NCT01016990|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5148633|NCT01016990|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5148634|NCT01016990|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5148635|NCT01016990|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5148636|NCT01016990|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5148637|NCT01016990|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5148638|NCT01016990|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5148639|NCT01016990|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5148640|NCT01016990|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5148641|NCT01016990|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5148642|NCT01016990|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5148643|NCT01016990|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5148644|NCT01016990|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5148645|NCT01016990|peripheral T-cell lymphoma|peripheral t-cell lymphoma
5148646|NCT01016990|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
5148647|NCT01016990|AIDS-related diffuse large cell lymphoma|aids-related diffuse large cell lymphoma
5148648|NCT01016990|AIDS-related immunoblastic large cell lymphoma|aids-related immunoblastic large cell lymphoma
5148649|NCT01016990|AIDS-related small noncleaved cell lymphoma|aids-related small noncleaved cell lymphoma
5148650|NCT01016990|AIDS-related diffuse mixed cell lymphoma|aids-related diffuse mixed cell lymphoma
5148651|NCT01016990|AIDS-related diffuse small cleaved cell lymphoma|aids-related diffuse small cleaved cell lymphoma
5148652|NCT01016990|AIDS-related lymphoblastic lymphoma|aids-related lymphoblastic lymphoma
5148653|NCT01016990|Waldenström macroglobulinemia|waldenström macroglobulinemia
5148654|NCT01016964|Androgenetic Alopecia|androgenetic alopecia
5148655|NCT01016964|Hair Loss|hair loss
5148656|NCT01016964|Female Pattern Baldness|female pattern baldness
5148657|NCT01016951|Phase I|phase i
5148658|NCT01016951|Safety study|safety study
5148659|NCT01016951|AZD9164|azd9164
5148660|NCT01016925|femoral perineural catheter|femoral perineural catheter
5148661|NCT01016925|tunnelization|tunnelization
5148662|NCT01016925|complication|complication
5148663|NCT01016925|colonization|colonization
5148664|NCT01016925|infection|infection
5148665|NCT01016899|Electronic|electronic
5148666|NCT01016899|Brachytherapy|brachytherapy
5148667|NCT01016899|Nonmelanoma|nonmelanoma
5148668|NCT01016899|cancer|cancer
5148669|NCT01016886|trastuzumab|trastuzumab
5148670|NCT01016886|cardiac MRI|cardiac mri
5148671|NCT01016886|beta-blocker|beta-blocker
5148672|NCT01016886|biomarkers|biomarkers
5148673|NCT01016886|angiotensin converting enzyme inhibitor|angiotensin converting enzyme inhibitor
5148674|NCT01016886|cardiotoxicity|cardiotoxicity
5148675|NCT01016886|HER2 positive|her2 positive
5148676|NCT01016873|Oraya|oraya
5148677|NCT01016873|Oraya Therapeutics, Inc.|oraya therapeutics, inc.
5148678|NCT01016873|low voltage stereotactic radiotherapy|low voltage stereotactic radiotherapy
5148679|NCT01016873|radiotherapy|radiotherapy
5148680|NCT01016873|IRay|iray
5148681|NCT01016873|Ranibizumab|ranibizumab
5148682|NCT01016873|Lucentis|lucentis
5148683|NCT01016873|AMD|amd
5148684|NCT01016873|Macular Degeneration|macular degeneration
5148685|NCT01016873|xray|xray
5148686|NCT01016873|radiation|radiation
5148687|NCT01016873|x ray|x ray
5148688|NCT01016873|external beam radiation|external beam radiation
5148689|NCT01016873|radiosurgery|radiosurgery
5148690|NCT01016860|OSI-906, irinotecan, colorectal cancer|osi-906, irinotecan, colorectal cancer
5148691|NCT01016834|migraine|migraine
5148692|NCT01016834|treatment satisfaction|treatment satisfaction
5148693|NCT01016821|Oxycodone|oxycodone
5148694|NCT01016821|Labour pain|labour pain
5148695|NCT01016821|Pregnancy|pregnancy
5148696|NCT01016821|Pregnant women|pregnant women
5148697|NCT01016808|Bunionectomy|bunionectomy
5148698|NCT01016808|Opioids|opioids
5148699|NCT01016795|SCF|scf
5148700|NCT01016795|Priming|priming
5148701|NCT01016795|Mobilization|mobilization
5148702|NCT01016795|Lymphoma|lymphoma
5148703|NCT01016795|Clinical Trial|clinical trial
5148704|NCT01016782|Inflammatory Rosacea|inflammatory rosacea
5148705|NCT01016782|Rosacea|rosacea
5148706|NCT01016769|Paclitaxel|paclitaxel
5148707|NCT01016769|Carboplatin|carboplatin
5148708|NCT01016769|Temsirolimus|temsirolimus
5148709|NCT01016769|Head and Neck|head and neck
5148710|NCT01016769|recurrent and/or metastatic|recurrent and/or metastatic
5148711|NCT01016769|09-131|09-131
5148712|NCT01016756|PHACE syndrome|phace syndrome
5148713|NCT01016756|Hemangioma|hemangioma
5148714|NCT01016756|Coarctation of aorta|coarctation of aorta
5148715|NCT01016756|Dandy Walker|dandy walker
5148716|NCT01016756|Brain malformation|brain malformation
5148717|NCT01016756|Eye anomaly|eye anomaly
5148718|NCT01016756|Sternal malformation|sternal malformation
5148719|NCT01016756|Genetic analysis|genetic analysis
5148720|NCT01016756|Cerebral artery anomaly|cerebral artery anomaly
5148721|NCT01016743|parkinson|parkinson
5148722|NCT01016743|rTMS|rtms
5148723|NCT01016717|clopidogrel|clopidogrel
5148724|NCT01016717|platelet function|platelet function
5148725|NCT01016717|omeprazole|omeprazole
5148726|NCT01016717|pantoprazole|pantoprazole
5148727|NCT01016717|coronary disease|coronary disease
5148728|NCT01016665|Breast cancer|breast cancer
5148729|NCT01016665|Short Term|short term
5148730|NCT01016665|Homontherapy|homontherapy
5148731|NCT01016665|aromatase inhibitor|aromatase inhibitor
5148732|NCT01016665|Short term hormonetherapy in breast cancer|short term hormonetherapy in breast cancer
5148733|NCT01016639|Stomach cancer|stomach cancer
5148734|NCT01016639|Gall bladder cancer|gall bladder cancer
5148735|NCT01016639|Bile ductus cancer|bile ductus cancer
5148736|NCT01016639|Pancreas cancer|pancreas cancer
5148737|NCT01016639|Colorectal cancer|colorectal cancer
5148738|NCT01016639|Chemo radiotherapy|chemo radiotherapy
5148739|NCT01016639|Phase I-II|phase i-ii
5148740|NCT01016639|Oxaliplatin|oxaliplatin
5148741|NCT01016639|Capecitabine|capecitabine
5148742|NCT01016639|Response|response
5148743|NCT01016626|Pharmacokinetics|pharmacokinetics
5148744|NCT01016626|Healthy volunteers|healthy volunteers
5148745|NCT01016626|Mycophenolate Mofetil|mycophenolate mofetil
5148746|NCT01016613|chronic kidney disease|chronic kidney disease
5148747|NCT01016613|glomerulonephritis|glomerulonephritis
5148748|NCT01016613|proteinuria|proteinuria
5148749|NCT01016613|nephrotic syndrome|nephrotic syndrome
5148750|NCT01016613|nephropathy|nephropathy
5148751|NCT01016613|biobank|biobank
5148752|NCT01016587|symptoms|symptoms
5148753|NCT01016587|dyspnea|dyspnea
5148754|NCT01016587|pain|pain
5148755|NCT01016587|fatigue|fatigue
5148756|NCT01016587|anxiety|anxiety
5148757|NCT01016587|depression|depression
5148758|NCT01016587|sleeplessness|sleeplessness
5148759|NCT01016587|genetic markers|genetic markers
5148760|NCT01016587|immune markers|immune markers
5148761|NCT01016587|COPD|copd
5148762|NCT01016587|Quality of Life|quality of life
5148763|NCT01016548|Lymphoma|lymphoma
5148764|NCT01016548|Multiple myeloma|multiple myeloma
5148765|NCT01016548|Leukemia, Lymphocytic, Chronic, B-Cell|leukemia, lymphocytic, chronic, b-cell
5148766|NCT01016548|Influenza A Virus, H1N1 Subtype|influenza a virus, h1n1 subtype
5148767|NCT01016548|Influenza Vaccines|influenza vaccines
5148768|NCT01016548|Bone Marrow Transplantation|bone marrow transplantation
5148769|NCT01016535|Family Health Program|family health program
5148770|NCT01016535|Hygiene|hygiene
5148771|NCT01016535|Child Health|child health
5148772|NCT01016522|ALS|als
5148773|NCT01016522|Ketogenic Diet|ketogenic diet
5148774|NCT01016509|restenosis|restenosis
5148775|NCT01016509|insulin|insulin
5148776|NCT01016509|hyperglycemia|hyperglycemia
5148777|NCT01016496|Cerebral Palsy|cerebral palsy
5148778|NCT01016496|Mirror neurons|mirror neurons
5148779|NCT01016496|hemiplegia|hemiplegia
5148780|NCT01016496|action observation therapy|action observation therapy
5148781|NCT01016496|children affected by hemiplegia as a consequence of Cerebral Palsy|children affected by hemiplegia as a consequence of cerebral palsy
5148782|NCT01016483|MEK inhibitor|mek inhibitor
5148783|NCT01016483|cancer|cancer
5148784|NCT01016483|pancreatic Adenocarcinoma|pancreatic adenocarcinoma
5148785|NCT01016483|metastatic|metastatic
5148786|NCT01016483|chemo-naive|chemo-naive
5148787|NCT01016483|phase II|phase ii
5148788|NCT01016457|Diabetes Mellitus|diabetes mellitus
5148789|NCT01016444|asthma|asthma
5148790|NCT01016444|albuterol|albuterol
5148791|NCT01016444|B2AR receptors|b2ar receptors
5148792|NCT01016444|Acute asthma responsive and unresponsive to albuterol|acute asthma responsive and unresponsive to albuterol
5148793|NCT01016431|cardiac pacing|cardiac pacing
5148794|NCT01016431|heart failure|heart failure
5148795|NCT01016431|oxygen consumption|oxygen consumption
5148796|NCT01016431|ventricular dysfunction|ventricular dysfunction
5148797|NCT01016431|left, exercise tolerance|left, exercise tolerance
5148798|NCT01016431|chronotropic incompetence|chronotropic incompetence
5148799|NCT01016431|pacemaker programming|pacemaker programming
5148800|NCT01016418|NASH|nash
5148801|NCT01016418|fatty liver disease|fatty liver disease
5148802|NCT01016418|colostrum|colostrum
5148803|NCT01016405|Dry eye|dry eye
5148804|NCT01016405|incidence and severity|incidence and severity
5148805|NCT01016405|cataract surgery|cataract surgery
5148806|NCT01016392|Observational post-authorization safety study on Kuvan®.|observational post-authorization safety study on kuvan®.
5148807|NCT01016379|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
5148808|NCT01016379|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5148809|NCT01016366|Friedreich's Ataxia|friedreich's ataxia
5148810|NCT01016366|FRDA|frda
5148811|NCT01016366|Neurodegenerative|neurodegenerative
5148812|NCT01016366|Erythropoietin|erythropoietin
5148813|NCT01016366|Carbamylated|carbamylated
5148814|NCT01016366|Neuroprotection|neuroprotection
5148815|NCT01016366|Frataxin|frataxin
5148816|NCT01016353|ABThera|abthera
5148817|NCT01016353|Barker's Vacuum Packing Technique|barker's vacuum packing technique
5148818|NCT01016340|Male Oligoasthenospermia|male oligoasthenospermia
5148819|NCT01016340|MCS|mcs
5148820|NCT01016327|Phase I study|phase i study
5148821|NCT01016327|Advanced Solid Tumors|advanced solid tumors
5148822|NCT01016327|Cdc7 kinase inhibitor|cdc7 kinase inhibitor
5148823|NCT01016288|EUS-FNA|eus-fna
5148824|NCT01016288|22 Gauge Needle|22 gauge needle
5148825|NCT01016288|25 Gauge Needle|25 gauge needle
5148826|NCT01016275|To obtain the first iliac long-term results for a patient cohort treated with nitinol stents only|to obtain the first iliac long-term results for a patient cohort treated with nitinol stents only
5148827|NCT01016262|Ulcerative proctitis|ulcerative proctitis
5148828|NCT01016262|Proctocolitis|proctocolitis
5148829|NCT01016262|Inflammatory Bowel Disease|inflammatory bowel disease
5148830|NCT01016262|Gastrointestinal Diseases|gastrointestinal diseases
5148831|NCT01016262|Colonic Diseases|colonic diseases
5148832|NCT01016262|Mesalamine|mesalamine
5148833|NCT01016262|5-ASA|5-asa
5148834|NCT01016249|Bronchiolitis, Viral|bronchiolitis, viral
5148835|NCT01016249|An acute inflammation of the upper RESPIRATORY TRACT|an acute inflammation of the upper respiratory tract
5148836|NCT01016223|Eosinophilic esophagitis|eosinophilic esophagitis
5148837|NCT01016223|Beclomethasone|beclomethasone
5148838|NCT01016223|Ultrasensitive CRP|ultrasensitive crp
5148839|NCT01016210|pregnancy|pregnancy
5148840|NCT01016210|IVF|ivf
5148841|NCT01016197|Soft tissue mallet finger|soft tissue mallet finger
5148842|NCT01016184|Quality of life|quality of life
5148843|NCT01016158|Umbilical cord serum|umbilical cord serum
5148844|NCT01016158|Recurrent corneal erosion|recurrent corneal erosion
5148845|NCT01016145|Schizophrenia|schizophrenia
5148846|NCT01016145|predictors of response|predictors of response
5148847|NCT01016145|antipsychotics|antipsychotics
5148848|NCT01016145|18-45 years old|18-45 years old
5148849|NCT01016145|non-refractory|non-refractory
5148850|NCT01016106|eczema|eczema
5148851|NCT01016106|atopic dermatitis|atopic dermatitis
5148852|NCT01016106|dry skin|dry skin
5148853|NCT01016106|ichthyosis vulgaris|ichthyosis vulgaris
5148854|NCT01016093|Thalassemia|thalassemia
5148855|NCT01016093|BMT|bmt
5148857|NCT01016080|glutathione|glutathione
5148858|NCT01016080|melanin|melanin
5148859|NCT01016080|whitening|whitening
5148860|NCT01016080|UV spots|uv spots
5148861|NCT01016080|skin pigment|skin pigment
5148862|NCT01016067|Tibia|tibia
5148863|NCT01016067|Tibial|tibial
5148864|NCT01016067|Fracture|fracture
5148865|NCT01016067|Nonunion|nonunion
5148866|NCT01016067|delayed|delayed
5148867|NCT01016067|healing|healing
5148868|NCT01016067|iliac|iliac
5148869|NCT01016067|crest|crest
5148870|NCT01016067|autograft|autograft
5148871|NCT01016067|INFUSE|infuse
5148872|NCT01016067|MASTERGRAFT|mastergraft
5148873|NCT01016067|Fixation|fixation
5148874|NCT01016067|Internal|internal
5148875|NCT01016054|Clinical Trial, Phase1|clinical trial, phase1
5148876|NCT01016054|Combination Drug Therapy|combination drug therapy
5148877|NCT01016054|pharmacokinetics|pharmacokinetics
5148878|NCT01016054|safety|safety
5148879|NCT01016054|Ovarian|ovarian
5148880|NCT01016041|drug-eluting stent|drug-eluting stent
5148881|NCT01016041|stable angina|stable angina
5148882|NCT01016041|ACS|acs
5148883|NCT01016041|MACE|mace
5148884|NCT01016041|safety|safety
5148885|NCT01016041|stent thrombosis|stent thrombosis
5148886|NCT01016028|Cancer|cancer
5148887|NCT01016028|Colorectum Cancer|colorectum cancer
5148888|NCT01016028|Colorectal disease|colorectal disease
5148889|NCT01016028|neuropathic symptom tool|neuropathic symptom tool
5148890|NCT01016028|chemotherapy-induced peripheral neuropathy|chemotherapy-induced peripheral neuropathy
5148891|NCT01016028|CIPN|cipn
5148892|NCT01016028|Pain|pain
5148893|NCT01016028|Quantitative Sensory Testing|quantitative sensory testing
5148894|NCT01016028|QST|qst
5148895|NCT01016028|symptom measurement tools|symptom measurement tools
5148896|NCT01016028|platinum agents|platinum agents
5148897|NCT01016028|cisplatin|cisplatin
5148898|NCT01016028|oxaliplatin|oxaliplatin
5148899|NCT01016028|taxanes|taxanes
5148900|NCT01016028|bortezomib|bortezomib
5148901|NCT01015989|HIV treatment|hiv treatment
5148902|NCT01015989|ART adherence|art adherence
5148903|NCT01015989|Using new technology to improve adherence|using new technology to improve adherence
5148904|NCT01015989|CARE+|care+
5148905|NCT01015989|HIV-1 viral loads|hiv-1 viral loads
5148906|NCT01015976|Gastric Bypass|gastric bypass
5148907|NCT01015976|Sertraline|sertraline
5148908|NCT01015976|Pharmacokinetics|pharmacokinetics
5148909|NCT01015963|recurrent breast cancer|recurrent breast cancer
5148910|NCT01015963|stage IIIA breast cancer|stage iiia breast cancer
5148911|NCT01015963|stage IIIB breast cancer|stage iiib breast cancer
5148912|NCT01015963|stage IIIC breast cancer|stage iiic breast cancer
5148913|NCT01015963|stage IV breast cancer|stage iv breast cancer
5148914|NCT01015963|extensive stage small cell lung cancer|extensive stage small cell lung cancer
5148915|NCT01015963|recurrent small cell lung cancer|recurrent small cell lung cancer
5148916|NCT01015963|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5148917|NCT01015963|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5148918|NCT01015963|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5148919|NCT01015963|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5148920|NCT01015963|stage IV bladder cancer|stage iv bladder cancer
5148921|NCT01015963|recurrent bladder cancer|recurrent bladder cancer
5148922|NCT01015963|stage III bladder cancer|stage iii bladder cancer
5148923|NCT01015963|recurrent lymphoepithelioma of the nasopharynx|recurrent lymphoepithelioma of the nasopharynx
5148924|NCT01015963|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
5148925|NCT01015963|stage III lymphoepithelioma of the nasopharynx|stage iii lymphoepithelioma of the nasopharynx
5148926|NCT01015963|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
5148927|NCT01015963|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
5148928|NCT01015963|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
5148929|NCT01015963|pulmonary carcinoid tumor|pulmonary carcinoid tumor
5148930|NCT01015963|recurrent basal cell carcinoma of the lip|recurrent basal cell carcinoma of the lip
5148931|NCT01015963|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
5148932|NCT01015963|stage III basal cell carcinoma of the lip|stage iii basal cell carcinoma of the lip
5148933|NCT01015963|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
5148934|NCT01015963|stage IV basal cell carcinoma of the lip|stage iv basal cell carcinoma of the lip
5148935|NCT01015963|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5148936|NCT01015963|recurrent adenoid cystic carcinoma of the oral cavity|recurrent adenoid cystic carcinoma of the oral cavity
5148937|NCT01015963|recurrent mucoepidermoid carcinoma of the oral cavity|recurrent mucoepidermoid carcinoma of the oral cavity
5148938|NCT01015963|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
5148939|NCT01015963|stage III adenoid cystic carcinoma of the oral cavity|stage iii adenoid cystic carcinoma of the oral cavity
5148940|NCT01015963|stage III mucoepidermoid carcinoma of the oral cavity|stage iii mucoepidermoid carcinoma of the oral cavity
5148941|NCT01015963|stage III verrucous carcinoma of the oral cavity|stage iii verrucous carcinoma of the oral cavity
5148942|NCT01015963|stage IV adenoid cystic carcinoma of the oral cavity|stage iv adenoid cystic carcinoma of the oral cavity
5148943|NCT01015963|stage IV mucoepidermoid carcinoma of the oral cavity|stage iv mucoepidermoid carcinoma of the oral cavity
5148944|NCT01015963|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
5148945|NCT01015963|recurrent lymphoepithelioma of the oropharynx|recurrent lymphoepithelioma of the oropharynx
5148946|NCT01015963|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
5148947|NCT01015963|stage III lymphoepithelioma of the oropharynx|stage iii lymphoepithelioma of the oropharynx
5148948|NCT01015963|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
5148949|NCT01015963|stage IV lymphoepithelioma of the oropharynx|stage iv lymphoepithelioma of the oropharynx
5149027|NCT01015781|Rehabilitation of hearing impaired|rehabilitation of hearing impaired
5148950|NCT01015963|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5148951|NCT01015963|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
5148952|NCT01015963|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
5148953|NCT01015963|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5148954|NCT01015963|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
5148955|NCT01015963|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
5148956|NCT01015963|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
5148957|NCT01015963|stage III verrucous carcinoma of the larynx|stage iii verrucous carcinoma of the larynx
5148958|NCT01015963|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5148959|NCT01015963|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
5148960|NCT01015963|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity
5148961|NCT01015963|recurrent inverted papilloma of the paranasal sinus and nasal cavity|recurrent inverted papilloma of the paranasal sinus and nasal cavity
5148962|NCT01015963|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity
5148963|NCT01015963|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
5148964|NCT01015963|stage III esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iii esthesioneuroblastoma of the paranasal sinus and nasal cavity
5148965|NCT01015963|stage III inverted papilloma of the paranasal sinus and nasal cavity|stage iii inverted papilloma of the paranasal sinus and nasal cavity
5148966|NCT01015963|stage III midline lethal granuloma of the paranasal sinus and nasal cavity|stage iii midline lethal granuloma of the paranasal sinus and nasal cavity
5148967|NCT01015963|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
5148968|NCT01015963|stage IV esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iv esthesioneuroblastoma of the paranasal sinus and nasal cavity
5148969|NCT01015963|stage IV inverted papilloma of the paranasal sinus and nasal cavity|stage iv inverted papilloma of the paranasal sinus and nasal cavity
5148970|NCT01015963|stage IV midline lethal granuloma of the paranasal sinus and nasal cavity|stage iv midline lethal granuloma of the paranasal sinus and nasal cavity
5148971|NCT01015963|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
5148972|NCT01015963|recurrent salivary gland cancer|recurrent salivary gland cancer
5148973|NCT01015963|stage III salivary gland cancer|stage iii salivary gland cancer
5148974|NCT01015963|stage IV salivary gland cancer|stage iv salivary gland cancer
5148975|NCT01015963|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
5148976|NCT01015963|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5148977|NCT01015963|tongue cancer|tongue cancer
5148978|NCT01015937|diabetes|diabetes
5148979|NCT01015937|nephropathy|nephropathy
5148980|NCT01015937|turmeric|turmeric
5148981|NCT01015937|serum IL8|serum il8
5148982|NCT01015937|serum TGFb|serum tgfb
5148983|NCT01015937|serumINF|seruminf
5148984|NCT01015937|urinary IL8|urinary il8
5148985|NCT01015937|urine TGFb|urine tgfb
5148986|NCT01015924|clavicle|clavicle
5148988|NCT01015924|Plate osteosynthesis|plate osteosynthesis
5148989|NCT01015924|displaced|displaced
5148990|NCT01015924|ESIN|esin
5148991|NCT01015924|displaced midshaft clavicular fractures|displaced midshaft clavicular fractures
5148992|NCT01015911|Antibodies, Monoclonal|antibodies, monoclonal
5148993|NCT01015911|Antibody-Drug Conjugate|antibody-drug conjugate
5148994|NCT01015911|Antigens, CD70|antigens, cd70
5148995|NCT01015911|Lymphoma, Non-Hodgkin|lymphoma, non-hodgkin
5148996|NCT01015911|Carcinoma, Renal Cell|carcinoma, renal cell
5148997|NCT01015911|Immunotherapy|immunotherapy
5148998|NCT01015911|Drug Therapy|drug therapy
5148999|NCT01015911|monomethylauristatin F|monomethylauristatin f
5149000|NCT01015898|basal cell carcinoma|basal cell carcinoma
5149001|NCT01015898|photodynamic therapy|photodynamic therapy
5149002|NCT01015898|photo chemotherapy|photo chemotherapy
5149003|NCT01015898|basal cell epithelioma|basal cell epithelioma
5149004|NCT01015872|sleep apnea syndrome|sleep apnea syndrome
5149005|NCT01015872|CPAP|cpap
5149006|NCT01015872|prostanoids|prostanoids
5149007|NCT01015859|AV conduction|av conduction
5149008|NCT01015859|Atrial fibrillation|atrial fibrillation
5149009|NCT01015846|Core|core
5149010|NCT01015846|Redcord|redcord
5149011|NCT01015846|RUSI|rusi
5149012|NCT01015846|low back|low back
5149013|NCT01015820|Pancreatic Cancer|pancreatic cancer
5149014|NCT01015820|Duodenum|duodenum
5149015|NCT01015820|Spectroscopy|spectroscopy
5149016|NCT01015820|Fiberoptic probe|fiberoptic probe
5149017|NCT01015820|4D-ELF|4d-elf
5149018|NCT01015807|postoperative|postoperative
5149019|NCT01015807|hyperalgesia|hyperalgesia
5149020|NCT01015807|pain|pain
5149021|NCT01015807|transversus abdominis plane block|transversus abdominis plane block
5149022|NCT01015807|TAP block|tap block
5149023|NCT01015807|cesarean section|cesarean section
5149024|NCT01015781|Tinnitus|tinnitus
5149025|NCT01015781|Counseling|counseling
5149026|NCT01015781|Education|education
5149028|NCT01015781|Triage|triage
5149029|NCT01015781|Evaluation studies|evaluation studies
5149030|NCT01015781|Quality of health care|quality of health care
5149031|NCT01015768|corneal staining|corneal staining
5149032|NCT01015768|barrier function|barrier function
5149033|NCT01015768|contact lenses|contact lenses
5149034|NCT01015768|contact lens care solutions|contact lens care solutions
5149035|NCT01015768|contact lens material and care solution bioincompatibility|contact lens material and care solution bioincompatibility
5149036|NCT01015755|thirst palliation and intensive care unit|thirst palliation and intensive care unit
5149037|NCT01015755|thirst intensity and distress|thirst intensity and distress
5149038|NCT01015755|predictors of thirst|predictors of thirst
5149039|NCT01015742|AML|aml
5149040|NCT01015742|ALL|all
5149041|NCT01015742|CML|cml
5149042|NCT01015729|Bioequivalence|bioequivalence
5149043|NCT01015729|ASA|asa
5149044|NCT01015729|Esomeprazole|esomeprazole
5149045|NCT01015729|peptic ulcer disease|peptic ulcer disease
5149046|NCT01015729|pH measurements|ph measurements
5149047|NCT01015716|Weight loss|weight loss
5149048|NCT01015716|Physical activity|physical activity
5149049|NCT01015716|Cognitive Behavioral Training|cognitive behavioral training
5149050|NCT01015703|Vaccine, hypertension|vaccine, hypertension
5149051|NCT01015690|unexplained infertility|unexplained infertility
5149052|NCT01015690|hCG|hcg
5149053|NCT01015690|early pregnancy loss|early pregnancy loss
5149054|NCT01015651|nociception, intraoperative, baroreflex|nociception, intraoperative, baroreflex
5149055|NCT01015638|Healthy volunteers|healthy volunteers
5149056|NCT01015625|breast cancer|breast cancer
5149057|NCT01015625|ABCSG|abcsg
5149058|NCT01015625|POSYTIVE|posytive
5149059|NCT01015625|growth factor|growth factor
5149060|NCT01015625|median survival|median survival
5149061|NCT01015625|surgery on demand|surgery on demand
5149062|NCT01015625|surgical therapy|surgical therapy
5149063|NCT01015625|blood specimen|blood specimen
5149064|NCT01015625|tissue specimen|tissue specimen
5149065|NCT01015625|VEGF|vegf
5149066|NCT01015625|TGF|tgf
5149067|NCT01015625|circulating tumor cells|circulating tumor cells
5149068|NCT01015625|stem cells|stem cells
5149069|NCT01015612|Aortic Valve Stenosis|aortic valve stenosis
5149070|NCT01015612|Aortic Valve Insufficiency|aortic valve insufficiency
5149071|NCT01015599|Obesity prevention|obesity prevention
5149072|NCT01015599|after-school|after-school
5149073|NCT01015599|physical activity|physical activity
5149074|NCT01015599|fruit|fruit
5149075|NCT01015599|vegetable|vegetable
5149076|NCT01015599|children|children
5149077|NCT01015586|Alcohol|alcohol
5149078|NCT01015586|Bipolar Disorder|bipolar disorder
5149079|NCT01015586|Manic depression|manic depression
5149080|NCT01015586|Addiction|addiction
5149081|NCT01015586|Alcoholism|alcoholism
5149082|NCT01015586|Cognitive impairment|cognitive impairment
5149083|NCT01015586|Executive function|executive function
5149084|NCT01015586|Anxiety|anxiety
5149085|NCT01015586|Depression|depression
5149086|NCT01015586|Mania|mania
5149087|NCT01015586|Affective disorder|affective disorder
5149088|NCT01015586|Psychosis|psychosis
5149089|NCT01015586|Carbohydrate deficient transferrin|carbohydrate deficient transferrin
5149090|NCT01015586|Gammaglutamyltransferase|gammaglutamyltransferase
5149091|NCT01015586|California Verbal Learning Test|california verbal learning test
5149092|NCT01015586|Wisconsin Card Sort Test|wisconsin card sort test
5149093|NCT01015586|Stroop Color and Word Test|stroop color and word test
5149094|NCT01015586|Alcohol Stroop Test|alcohol stroop test
5149095|NCT01015586|Emotion Stroop Test|emotion stroop test
5149096|NCT01015586|Point Scoring Reaction Time Test|point scoring reaction time test
5149097|NCT01015586|Rey Osterrieth Complex Figure Test|rey osterrieth complex figure test
5149098|NCT01015586|Trail Making Test|trail making test
5149099|NCT01015586|Montgomery Asberg Depression Rating Scale|montgomery asberg depression rating scale
5149100|NCT01015586|Young Mania Rating Scale|young mania rating scale
5149101|NCT01015586|Timeline Follow Back|timeline follow back
5149102|NCT01015560|bone metastases|bone metastases
5149103|NCT01015560|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5149104|NCT01015547|juvenile idiopathic arthritis|juvenile idiopathic arthritis
5149105|NCT01015547|polyarthritis|polyarthritis
5149106|NCT01015547|combination therapy|combination therapy
5149107|NCT01015547|biologic agents|biologic agents
5149108|NCT01015547|TNF antagonists|tnf antagonists
5149109|NCT01015547|infliximab|infliximab
5149110|NCT01015534|Brain metastases|brain metastases
5149111|NCT01015534|Temozolomide|temozolomide
5149112|NCT01015534|Whole-brain radiotherapy|whole-brain radiotherapy
5149113|NCT01015534|Phase II trial|phase ii trial
5149114|NCT01015521|breast cancer|breast cancer
5149115|NCT01015508|Weight loss and maintenance|weight loss and maintenance
5149116|NCT01015508|body composition|body composition
5149117|NCT01015508|energy expenditure|energy expenditure
5149118|NCT01015508|adipogenic capacity|adipogenic capacity
5149119|NCT01015508|physical activity|physical activity
5149120|NCT01015495|angioid streaks|angioid streaks
5149121|NCT01015495|CNV|cnv
5149122|NCT01015495|intra vitreal ranibizumab|intra vitreal ranibizumab
5149123|NCT01015482|Sunburn|sunburn
5149124|NCT01015482|Remifentanil|remifentanil
5149125|NCT01015482|Hyperalgesia|hyperalgesia
5149126|NCT01015469|bariatric|bariatric
5149127|NCT01015469|surgery|surgery
5149128|NCT01015469|obesity|obesity
5149129|NCT01015469|Roux-en-Y|roux-en-y
5149130|NCT01015469|gastric|gastric
5149131|NCT01015469|medical device|medical device
5149132|NCT01015469|bypass|bypass
5149133|NCT01015469|adiposity|adiposity
5149134|NCT01015469|GaBP-Ring|gabp-ring
5149135|NCT01015469|BMI|bmi
5149136|NCT01015469|banded|banded
5149137|NCT01015469|laparoscopic|laparoscopic
5149138|NCT01015456|lupus nephritis|lupus nephritis
5149139|NCT01015456|mycophenolate sodium|mycophenolate sodium
5149140|NCT01015456|cyclophosphamide|cyclophosphamide
5149141|NCT01015443|Non-Small Cell Lung Carcinoma|non-small cell lung carcinoma
5149142|NCT01015443|Tecemotide|tecemotide
5149143|NCT01015443|L-BLP25|l-blp25
5149144|NCT01015443|Cyclophosphamide|cyclophosphamide
5149145|NCT01015443|placebo controlled|placebo controlled
5149146|NCT01015443|Non-Small Cell Lung Cancer|non-small cell lung cancer
5149147|NCT01015417|Acute lithiasic cholecystitis|acute lithiasic cholecystitis
5149148|NCT01015417|Cholecystectomy|cholecystectomy
5149149|NCT01015417|Postoperative antibiotherapy|postoperative antibiotherapy
5149150|NCT01015417|Surgical site infection|surgical site infection
5149151|NCT01015417|Remote surgical site infection|remote surgical site infection
5149152|NCT01015404|Trafermin|trafermin
5149153|NCT01015404|Periodontitis|periodontitis
5149154|NCT01015391|T2|t2
5149155|NCT01015391|AZA|aza
5149156|NCT01015391|remission|remission
5149157|NCT01015391|Crohn's disease|crohn's disease
5149158|NCT01015378|Recurrent sigmoid diverticulitis|recurrent sigmoid diverticulitis
5149159|NCT01015378|diverticulitis|diverticulitis
5149160|NCT01015378|Colon|colon
5149161|NCT01015378|sigmoid|sigmoid
5149162|NCT01015378|recurrence|recurrence
5149163|NCT01015365|Chronic infected hip arthroplasty|chronic infected hip arthroplasty
5149164|NCT01015365|Fast-track|fast-track
5149165|NCT01015365|One-stage cementless revision|one-stage cementless revision
5149166|NCT01015352|Myelodysplastic Syndromes|myelodysplastic syndromes
5149167|NCT01015326|EGFRI|egfri
5149168|NCT01015326|HRQL|hrql
5149169|NCT01015326|Quality of Life|quality of life
5149170|NCT01015326|Development of a standardized HRQL instrument for anti-EGFR therapy induced|development of a standardized hrql instrument for anti-egfr therapy induced
5149171|NCT01015313|sodium, hypertension, volume overload|sodium, hypertension, volume overload
5149172|NCT01015300|Hemangioblastoma|hemangioblastoma
5149173|NCT01015300|Von Hippel Lindau|von hippel lindau
5149174|NCT01015300|VHL|vhl
5149175|NCT01015300|lesion|lesion
5149176|NCT01015300|EGFR|egfr
5149177|NCT01015287|Acute Coronary Syndromes|acute coronary syndromes
5149178|NCT01015287|Heart Disease|heart disease
5149179|NCT01015287|Percutaneous Coronary Intervention|percutaneous coronary intervention
5149180|NCT01015287|P2Y12|p2y12
5149181|NCT01015287|NSTEMI|nstemi
5149182|NCT01015261|ALL|all
5149183|NCT01015261|BMT|bmt
5149184|NCT01015261|Chemotherapy|chemotherapy
5149185|NCT01015261|Allogenic|allogenic
5149186|NCT01015248|CD 20 positive|cd 20 positive
5149187|NCT01015235|Ketorolac / therapeutic use|ketorolac / therapeutic use
5149188|NCT01015235|Analgesics. Non-narcotic / therapeutic use|analgesics. non-narcotic / therapeutic use
5149189|NCT01015235|Arthroplasty, replacement hip|arthroplasty, replacement hip
5149190|NCT01015235|Arthroplasty, replacement knee|arthroplasty, replacement knee
5149191|NCT01015235|Pain measurement / drug effect|pain measurement / drug effect
5149192|NCT01015235|Pain postoperative / drug therapy|pain postoperative / drug therapy
5149193|NCT01015222|Advanced Malignancies|advanced malignancies
5149194|NCT01015222|Metastatic cancer|metastatic cancer
5149195|NCT01015222|Bevacizumab|bevacizumab
5149196|NCT01015222|Avastin|avastin
5149197|NCT01015222|Dasatinib|dasatinib
5149198|NCT01015222|Sprycel|sprycel
5149199|NCT01015222|Paclitaxel|paclitaxel
5149200|NCT01015222|Taxol|taxol
5149201|NCT01015209|Dry eye syndromes|dry eye syndromes
5149202|NCT01015196|acute myeloid leukemia in first complete remission|acute myeloid leukemia in first complete remission
5149203|NCT01015183|Mucositis|mucositis
5149204|NCT01015183|Bone Marrow Transplantation|bone marrow transplantation
5149205|NCT01015183|BMT|bmt
5149206|NCT01015183|HSCT|hsct
5149207|NCT01015170|smoking cessation|smoking cessation
5149208|NCT01015170|nicotine addiction|nicotine addiction
5149209|NCT01015170|Zyban|zyban
5149210|NCT01015170|bupropion hydrochloride|bupropion hydrochloride
5149211|NCT01015157|Gastric bypass|gastric bypass
5149212|NCT01015157|staple line reinforcement|staple line reinforcement
5149213|NCT01015157|outcomes|outcomes
5149214|NCT01015157|per and postoperative blood loss|per and postoperative blood loss
5149215|NCT01015144|atorvastatin|atorvastatin
5149216|NCT01015144|dilated cardiomyopathy|dilated cardiomyopathy
5149217|NCT01015144|heart failure|heart failure
5149218|NCT01015144|inflammation|inflammation
5149219|NCT01015105|patients with hip fracture|patients with hip fracture
5149220|NCT01015092|HIV|hiv
5149221|NCT01015092|Cardiovascular|cardiovascular
5149222|NCT01015092|Coronary hear disease|coronary hear disease
5149223|NCT01015092|HAART|haart
5149224|NCT01015092|antiretroviral|antiretroviral
5149225|NCT01015079|Pap smear screening|pap smear screening
5149226|NCT01015066|drug dependence|drug dependence
5149227|NCT01015066|substance abuse|substance abuse
5149228|NCT01015066|substance use disorders|substance use disorders
5149229|NCT01015066|buprenorphine|buprenorphine
5149230|NCT01015066|naltrexone|naltrexone
5149231|NCT01015066|adolescents|adolescents
5149232|NCT01015053|postoperative pain|postoperative pain
5149233|NCT01015053|pediatric|pediatric
5149234|NCT01015053|umbilical hernia|umbilical hernia
5149235|NCT01015053|ropivacaine|ropivacaine
5149236|NCT01015053|rectus sheath block|rectus sheath block
5149237|NCT01015053|regional block|regional block
5149238|NCT01015053|ultrasound-guided regional block|ultrasound-guided regional block
5149239|NCT01015053|local infiltration|local infiltration
5149240|NCT01015053|ambulatory surgery|ambulatory surgery
5149241|NCT01015040|solifenacin succinate|solifenacin succinate
5149242|NCT01015040|VESIcare|vesicare
5149243|NCT01015040|Healthy Volunteers|healthy volunteers
5149244|NCT01015014|Gram negative|gram negative
5149245|NCT01015014|bacteria|bacteria
5149246|NCT01015014|infection|infection
5149247|NCT01015001|refractory schizophrenia|refractory schizophrenia
5149248|NCT01015001|rTMS|rtms
5149249|NCT01015001|auditory hallucinations|auditory hallucinations
5149250|NCT01014988|pandemic|pandemic
5149251|NCT01014988|seasonal influenza|seasonal influenza
5149252|NCT01014988|Influenza B virus|influenza b virus
5149253|NCT01014988|H1N1|h1n1
5149254|NCT01014988|zanamivir|zanamivir
5149255|NCT01014988|Influenza A virus, H1N1 Subtype|influenza a virus, h1n1 subtype
5149256|NCT01014988|Relenza|relenza
5149257|NCT01014988|influenza|influenza
5149258|NCT01014988|neuraminidase inhibitor|neuraminidase inhibitor
5149259|NCT01014975|stroke|stroke
5149260|NCT01014975|plasmin|plasmin
5149261|NCT01014975|thrombus|thrombus
5149262|NCT01014975|ischemic|ischemic
5149263|NCT01014975|middle cerebral artery|middle cerebral artery
5149264|NCT01014975|thrombolysis|thrombolysis
5149265|NCT01014975|intra-arterial|intra-arterial
5149266|NCT01014975|fibrin|fibrin
5149267|NCT01014962|Pharmacokinetic|pharmacokinetic
5149268|NCT01014962|tolerability|tolerability
5149269|NCT01014962|multiple escalating doses|multiple escalating doses
5149270|NCT01014936|Phase 1|phase 1
5149271|NCT01014936|advanced solid tumors|advanced solid tumors
5149272|NCT01014936|refractory to standard therapy|refractory to standard therapy
5149273|NCT01014923|motor vehicle|motor vehicle
5149274|NCT01014923|accidents, traffic|accidents, traffic
5149275|NCT01014923|prevention and control|prevention and control
5149276|NCT01014910|Bronchiolitis|bronchiolitis
5149277|NCT01014910|Hypoxia|hypoxia
5149278|NCT01014910|Pulse|pulse
5149279|NCT01014910|Oximetry|oximetry
5149280|NCT01014910|Hospitalized|hospitalized
5149281|NCT01014897|stroke|stroke
5149282|NCT01014897|recovery|recovery
5149283|NCT01014897|tDCS|tdcs
5149284|NCT01014897|direct current|direct current
5149285|NCT01014897|electric stimulation|electric stimulation
5149286|NCT01014871|Forehead Wrinkles Toxin|forehead wrinkles toxin
5149287|NCT01014858|Parkinson's disease|parkinson's disease
5149288|NCT01014858|mild dementia|mild dementia
5149289|NCT01014858|donepezil|donepezil
5149290|NCT01014858|NIHR HTA|nihr hta
5149291|NCT01014845|hepatitis E|hepatitis e
5149292|NCT01014845|vaccine|vaccine
5149293|NCT01014845|efficacy|efficacy
5149294|NCT01014832|Diabetes, insulin.|diabetes, insulin.
5149295|NCT01014819|Dermacorder|dermacorder
5149296|NCT01014819|Electric field|electric field
5149297|NCT01014819|basal cell carcinoma|basal cell carcinoma
5149298|NCT01014819|Gorlin Syndrome|gorlin syndrome
5149299|NCT01014793|Acromegaly resistant|acromegaly resistant
5149300|NCT01014793|combined-treatment|combined-treatment
5149301|NCT01014793|dopamine agonist|dopamine agonist
5149302|NCT01014780|dry eye|dry eye
5149303|NCT01014780|tear film|tear film
5149304|NCT01014780|thickness|thickness
5149305|NCT01014780|artificial tears|artificial tears
5149306|NCT01014767|Choroid Plexus Tumors|choroid plexus tumors
5149307|NCT01014767|Brain Tumor|brain tumor
5149308|NCT01014767|Chemotherapy|chemotherapy
5149309|NCT01014767|Etoposide|etoposide
5149310|NCT01014767|Carboplatin|carboplatin
5149311|NCT01014767|Vincristine|vincristine
5149312|NCT01014767|Cyclophosphamide|cyclophosphamide
5149313|NCT01014767|Methotrexate|methotrexate
5149314|NCT01014767|Doxorubicin|doxorubicin
5149315|NCT01014767|Cisplatin|cisplatin
5149316|NCT01014767|Dactinomycin|dactinomycin
5149317|NCT01014767|temozolomide|temozolomide
5149318|NCT01014767|irinotecan|irinotecan
5149319|NCT01014767|Pediatrics|pediatrics
5149320|NCT01014741|Atrial Fibrillation|atrial fibrillation
5149321|NCT01014741|Catheter Ablation|catheter ablation
5149322|NCT01014741|Complex Fractionate Electrograms|complex fractionate electrograms
5149323|NCT01014715|Breast Cancer|breast cancer
5149324|NCT01014702|Cataract|cataract
5149325|NCT01014702|Capsulotomy|capsulotomy
5149326|NCT01014702|Capsulorrhexis|capsulorrhexis
5149327|NCT01014702|lens fragmentation|lens fragmentation
5149328|NCT01014702|phacoemulsification|phacoemulsification
5149329|NCT01014689|acne vulgaris|acne vulgaris
5149330|NCT01014676|Costs and Cost Analysis|costs and cost analysis
5149331|NCT01014663|Parkinson's disease|parkinson's disease
5149332|NCT01014663|exercise|exercise
5149333|NCT01014663|training program|training program
5149334|NCT01014663|rehabilitation|rehabilitation
5149335|NCT01014663|boxing|boxing
5149336|NCT01014650|glycine site partial agonist|glycine site partial agonist
5149337|NCT01014650|normal volunteers|normal volunteers
5149338|NCT01014650|safety in normal volunteers|safety in normal volunteers
5149339|NCT01014637|Dermatomycoses|dermatomycoses
5149340|NCT01014637|Infection|infection
5149341|NCT01014637|Mycoses|mycoses
5149342|NCT01014637|Nail diseases|nail diseases
5149343|NCT01014637|Ski diseases|ski diseases
5149344|NCT01014637|Skin diseases/infectious|skin diseases/infectious
5149345|NCT01014624|thienopyridine|thienopyridine
5149346|NCT01014624|pharmacologic action|pharmacologic action
5149347|NCT01014624|prasugrel|prasugrel
5149348|NCT01014624|clopidogrel|clopidogrel
5149349|NCT01014611|Heart failure|heart failure
5149350|NCT01014611|Skeletal muscle|skeletal muscle
5149351|NCT01014611|Calcium|calcium
5149352|NCT01014611|Ryanodine receptor|ryanodine receptor
5149353|NCT01014611|Mitochondria|mitochondria
5149354|NCT01014611|Exercise training|exercise training
5149355|NCT01014611|Muscle biopsy|muscle biopsy
5149356|NCT01014611|Healthy volunteers|healthy volunteers
5149357|NCT01014585|Milnacipran|milnacipran
5149358|NCT01014585|Pain|pain
5149359|NCT01014585|Durability of Effect|durability of effect
5149360|NCT01014585|Loss of Therapeutic Response|loss of therapeutic response
5149361|NCT01014585|Fatigue|fatigue
5149362|NCT01014585|Forest Research Institute|forest research institute
5149363|NCT01014585|Savella ®|savella ®
5149364|NCT01014572|Clinical Trials, Phase II|clinical trials, phase ii
5149365|NCT01014572|Exercise|exercise
5149366|NCT01014572|Exercise Tolerance|exercise tolerance
5149367|NCT01014572|Aging|aging
5149368|NCT01014559|Constipation|constipation
5149369|NCT01014559|Oxycodone|oxycodone
5149370|NCT01014559|Oxycodone hydrochloride|oxycodone hydrochloride
5149371|NCT01014559|Naloxone hydrochloride|naloxone hydrochloride
5149372|NCT01014559|Naloxone|naloxone
5149373|NCT01014533|Alcoholism|alcoholism
5149374|NCT01014533|Alcohol dependence|alcohol dependence
5149375|NCT01014533|Insomnia|insomnia
5149376|NCT01014533|Dim light melatonin onset|dim light melatonin onset
5149377|NCT01014533|Gabapentin|gabapentin
5149378|NCT01014520|Lumbar|lumbar
5149379|NCT01014520|Diskectomy|diskectomy
5149380|NCT01014520|Laminectomy|laminectomy
5149381|NCT01014481|HIV|hiv
5149382|NCT01014481|tuberculosis|tuberculosis
5149383|NCT01014481|antiretroviral treatment|antiretroviral treatment
5149384|NCT01014481|timing|timing
5149385|NCT01014468|ranibizumab|ranibizumab
5149386|NCT01014468|bevacizumab|bevacizumab
5149387|NCT01014468|AMD|amd
5149388|NCT01014468|Complications|complications
5149389|NCT01014468|Visual acuity|visual acuity
5149390|NCT01014468|OCt|oct
5149391|NCT01014468|Age Macular Degeneration|age macular degeneration
5149392|NCT01014455|surgery|surgery
5149393|NCT01014429|Phase I dose escalation study|phase i dose escalation study
5149394|NCT01014429|Advanced or metastatic solid tumors|advanced or metastatic solid tumors
5149395|NCT01014429|PLK 1 inhibitor|plk 1 inhibitor
5149396|NCT01014429|Adult patients|adult patients
5149397|NCT01014416|Healthy Korean male|healthy korean male
5149398|NCT01014403|venous thromboembolism|venous thromboembolism
5149399|NCT01014403|enoxaparin|enoxaparin
5149400|NCT01014403|traumatic brain injury|traumatic brain injury
5149401|NCT01014403|Venous thromboembolism prophylaxis after traumatic brain injury|venous thromboembolism prophylaxis after traumatic brain injury
5149402|NCT01014390|benign biliary strictures secondary to chronic pancreatitis/post abdominal surgery/post liver transplant|benign biliary strictures secondary to chronic pancreatitis/post abdominal surgery/post liver transplant
5149403|NCT01014364|Acute lung injury|acute lung injury
5149404|NCT01014364|Acute respiratory distress syndrome|acute respiratory distress syndrome
5149405|NCT01014364|corticosteroids|corticosteroids
5149406|NCT01014364|inflammation|inflammation
5149407|NCT01014351|Metastatic Melanoma|metastatic melanoma
5149408|NCT01014351|Everolimus|everolimus
5149409|NCT01014351|Paclitaxel|paclitaxel
5149410|NCT01014351|Carboplatin|carboplatin
5149411|NCT01014312|Depression|depression
5149412|NCT01014299|Intubation|intubation
5149413|NCT01014299|Hypoxemia|hypoxemia
5149414|NCT01014299|Mechanical ventilation|mechanical ventilation
5149415|NCT01014299|Recruitment maneuver|recruitment maneuver
5149416|NCT01014299|Acute lung injury|acute lung injury
5149417|NCT01014299|Bacterial translocation|bacterial translocation
5149418|NCT01014299|Hypoxemic ICU patients requiring invasive mechanical ventilation|hypoxemic icu patients requiring invasive mechanical ventilation
5149419|NCT01014273|Acute Coronary Syndrome|acute coronary syndrome
5149420|NCT01014273|PCI|pci
5149421|NCT01014273|Percutaneous Coronary Intervention|percutaneous coronary intervention
5149422|NCT01014273|Radial Access|radial access
5149423|NCT01014260|Inflammatory markers of cardiovascular disease|inflammatory markers of cardiovascular disease
5149424|NCT01014247|Moxifloxacin|moxifloxacin
5149425|NCT01014234|Immunosuppressive Agents|immunosuppressive agents
5149426|NCT01014234|Immune system regulation|immune system regulation
5149427|NCT01014234|Regulatory T cells|regulatory t cells
5149428|NCT01014234|Rapamycin|rapamycin
5149429|NCT01014234|Tolerance|tolerance
5149430|NCT01014221|acupuncture|acupuncture
5149431|NCT01014221|carpal tunnel syndrome|carpal tunnel syndrome
5149432|NCT01014221|CTS|cts
5149433|NCT01014221|steroid|steroid
5149434|NCT01014221|global symptom score (GSS)|global symptom score (gss)
5149435|NCT01014208|The All Ireland Cooperative Oncology Research Group|the all ireland cooperative oncology research group
5149436|NCT01014208|GELTAMO|geltamo
5149437|NCT01014208|National Cancer Research Institute Lymphoma Clinical Studies Group|national cancer research institute lymphoma clinical studies group
5149438|NCT01014208|Genmab|genmab
5149439|NCT01014208|ofatumumab|ofatumumab
5149440|NCT01014208|Japan Clinical Oncology Group|japan clinical oncology group
5149441|NCT01014208|Oncology|oncology
5149442|NCT01014208|Polish Lymphoma Research Group|polish lymphoma research group
5149443|NCT01014208|Salvage chemotherapy|salvage chemotherapy
5149444|NCT01014208|refractory|refractory
5149445|NCT01014208|HOVON|hovon
5149446|NCT01014208|DVD|dvd
5149447|NCT01014208|relapsed|relapsed
5149448|NCT01014208|safety|safety
5149449|NCT01014208|efficacy|efficacy
5149450|NCT01014208|DHAP|dhap
5149451|NCT01014208|rituximab|rituximab
5149452|NCT01014208|Autologous Stem Cell Transplant|autologous stem cell transplant
5149453|NCT01014208|Dutch-Belgian Cooperative Trial Group for Hematology-Oncology|dutch-belgian cooperative trial group for hematology-oncology
5149454|NCT01014208|Grupo Espanol de Linfomas|grupo espanol de linfomas
5149455|NCT01014208|Nordic Lymphoma Group|nordic lymphoma group
5149456|NCT01014195|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
5149457|NCT01014195|Neurocognitive function|neurocognitive function
5149458|NCT01014195|ADHD|adhd
5149459|NCT01014195|brain imaging|brain imaging
5149460|NCT01014195|genetic polymorphisms|genetic polymorphisms
5149461|NCT01014195|Psychopathology and neurocognitive Impairment in Leukemia Survivors|psychopathology and neurocognitive impairment in leukemia survivors
5149462|NCT01014182|Early PCI|early pci
5149463|NCT01014182|Myocardial Infarction|myocardial infarction
5149464|NCT01014182|Thrombolysis|thrombolysis
5149465|NCT01014182|Optimal revascularization therapy in STEMI patients|optimal revascularization therapy in stemi patients
5149466|NCT01014169|Health education|health education
5149467|NCT01014169|Sudden Infant Death|sudden infant death
5149468|NCT01014169|Breast Feeding|breast feeding
5149469|NCT01014169|Infant Equipment|infant equipment
5149470|NCT01014156|pulmonary embolism|pulmonary embolism
5149471|NCT01014156|vasoconstriction|vasoconstriction
5149472|NCT01014156|right ventricular dysfunction|right ventricular dysfunction
5149473|NCT01014156|epoprostenol|epoprostenol
5149474|NCT01014156|acute pulmonary embolism with right ventricular dysfunction|acute pulmonary embolism with right ventricular dysfunction
5149475|NCT01014130|Non Small Cell Lung Cancer|non small cell lung cancer
5149476|NCT01014130|Hypofractionated|hypofractionated
5149477|NCT01014130|Stereotactic Radiotherapy|stereotactic radiotherapy
5149478|NCT01014104|Ovarian hyper stimulation syndrome|ovarian hyper stimulation syndrome
5149479|NCT01014104|Methylprednisolone|methylprednisolone
5149480|NCT01014104|IVF|ivf
5149481|NCT01014091|influenza infection|influenza infection
5149482|NCT01014091|GSK Bio's influenza vaccine GSK2340272A|gsk bio's influenza vaccine gsk2340272a
5149483|NCT01014065|sunitinib|sunitinib
5149484|NCT01014065|cardiac MRI|cardiac mri
5149485|NCT01014065|maximal exercise testing|maximal exercise testing
5149486|NCT01014065|biomarkers|biomarkers
5149487|NCT01014065|pharmacokinetics|pharmacokinetics
5149488|NCT01014026|Mass Screening|mass screening
5149489|NCT01014026|Polymerase Chain Reaction|polymerase chain reaction
5149490|NCT01014026|Vaginal Smears|vaginal smears
5149491|NCT01013987|HIV-1|hiv-1
5149492|NCT01013987|triple class failure|triple class failure
5149493|NCT01013987|Maraviroc|maraviroc
5149494|NCT01013987|Raltegravir|raltegravir
5149495|NCT01013987|Darunavir/ritonavir|darunavir/ritonavir
5149496|NCT01013987|Maraviroc with raltegravir and darunavir/ritonavir|maraviroc with raltegravir and darunavir/ritonavir
5149497|NCT01013961|chronic lymphocytic leukemia|chronic lymphocytic leukemia
5149498|NCT01013961|small lymphocytic lymphoma|small lymphocytic lymphoma
5149499|NCT01013961|CLL|cll
5149500|NCT01013961|elderly|elderly
5149501|NCT01013961|low dose rituximab|low dose rituximab
5149502|NCT01013961|alemtuzumab|alemtuzumab
5149503|NCT01013961|monoclonal antibodies|monoclonal antibodies
5149504|NCT01013948|Spirometry|spirometry
5149505|NCT01013948|Bronchitis|bronchitis
5149506|NCT01013948|COPD|copd
5149507|NCT01013948|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
5149508|NCT01013948|Emphysema|emphysema
5149509|NCT01013948|Chronic Bronchitis|chronic bronchitis
5149510|NCT01013935|HIV treatment|hiv treatment
5149511|NCT01013935|ART adherence|art adherence
5149512|NCT01013935|Using new technology to improve adherence|using new technology to improve adherence
5149513|NCT01013935|CARE+|care+
5149514|NCT01013935|HIV-1 viral loads|hiv-1 viral loads
5149515|NCT01013922|COPD|copd
5149516|NCT01013922|COPD-6|copd-6
5149517|NCT01013922|Spirometry|spirometry
5149518|NCT01013922|VC|vc
5149519|NCT01013922|FEV|fev
5149520|NCT01013922|FEV1|fev1
5149521|NCT01013909|Bifonazole|bifonazole
5149522|NCT01013909|Terbinafine|terbinafine
5149523|NCT01013909|Reduced treatment duration|reduced treatment duration
5149524|NCT01013909|Efficacy|efficacy
5149525|NCT01013909|Safety|safety
5149526|NCT01013909|Athlete's foot|athlete's foot
5149527|NCT01013909|Moderate severity|moderate severity
5149528|NCT01013883|systolic dysfunction|systolic dysfunction
5149529|NCT01013883|diastolic dysfunction|diastolic dysfunction
5149530|NCT01013883|mortality|mortality
5149531|NCT01013883|treatment|treatment
5149532|NCT01013883|heart rate|heart rate
5149533|NCT01013870|mild traumatic brain injury|mild traumatic brain injury
5149534|NCT01013870|post-concussion syndrome|post-concussion syndrome
5149535|NCT01013870|acute stress disorder|acute stress disorder
5149536|NCT01013870|post-traumatic stress disorder|post-traumatic stress disorder
5149537|NCT01013870|atorvastatin|atorvastatin
5149538|NCT01013844|skin self-examination|skin self-examination
5149539|NCT01013844|SSE|sse
5149540|NCT01013844|melanoma|melanoma
5149541|NCT01013805|Rectal Cancer|rectal cancer
5149542|NCT01013805|Chemotherapy|chemotherapy
5149543|NCT01013805|Radiotherapy|radiotherapy
5149544|NCT01013792|Diabetic|diabetic
5149545|NCT01013792|Foot|foot
5149546|NCT01013792|Ulcer|ulcer
5149547|NCT01013792|Neuropathic|neuropathic
5149548|NCT01013792|Tegaderm Matrix Dressing|tegaderm matrix dressing
5149549|NCT01013792|DFU|dfu
5149550|NCT01013792|Wound Care|wound care
5149551|NCT01013792|PHI|phi
5149552|NCT01013779|Merkel Cell Cancer|merkel cell cancer
5149553|NCT01013779|PET scanning|pet scanning
5149554|NCT01013766|GSK1362885|gsk1362885
5149555|NCT01013766|Pharmacodynamics|pharmacodynamics
5149556|NCT01013766|Safety|safety
5149557|NCT01013766|Pharmacokinetics|pharmacokinetics
5149558|NCT01013766|T2DM|t2dm
5149559|NCT01013766|Tolerability|tolerability
5149560|NCT01013740|Neoplasms, Breast|neoplasms, breast
5149561|NCT01013727|Volunteers|volunteers
5149562|NCT01013727|healthy subjects|healthy subjects
5149563|NCT01013714|Sudden cardiac death|sudden cardiac death
5149564|NCT01013714|Ventricular tachycardia|ventricular tachycardia
5149565|NCT01013714|Ventricular fibrillation|ventricular fibrillation
5149566|NCT01013714|Cardiomyopathy|cardiomyopathy
5149567|NCT01013714|Internal cardiac defibrillator shocks|internal cardiac defibrillator shocks
5149568|NCT01013714|Internal cardiac defibrillator therapies|internal cardiac defibrillator therapies
5149569|NCT01013701|nasal polyps|nasal polyps
5149570|NCT01013701|nasal steroid|nasal steroid
5149571|NCT01013701|fluticasone furoate|fluticasone furoate
5149572|NCT01013688|Radiofrequency ablation|radiofrequency ablation
5149573|NCT01013688|Maze|maze
5149574|NCT01013688|Atrial fibrillation|atrial fibrillation
5149575|NCT01013675|influenza|influenza
5149576|NCT01013675|active-controlled|active-controlled
5149577|NCT01013675|Phase 2|phase 2
5149578|NCT01013662|septic shock|septic shock
5149579|NCT01013662|glycemic control|glycemic control
5149580|NCT01013662|icu|icu
5149581|NCT01013662|lipid metabolism|lipid metabolism
5149582|NCT01013662|septic patients|septic patients
5149583|NCT01013623|melanoma|melanoma
5149584|NCT01013623|stage IV|stage iv
5149585|NCT01013623|resectable|resectable
5149586|NCT01013623|surgery|surgery
5149587|NCT01013623|medical therapy|medical therapy
5149588|NCT01013610|Healthy Elderly Volunteers|healthy elderly volunteers
5149589|NCT01013597|thyroid|thyroid
5149590|NCT01013597|medullary|medullary
5149591|NCT01013597|differentiated|differentiated
5149592|NCT01013597|radioiodine-resistant|radioiodine-resistant
5149593|NCT01013597|LBH589|lbh589
5149594|NCT01013597|panobinostat|panobinostat
5149595|NCT01013584|vitamin D|vitamin d
5149596|NCT01013558|fetal pain|fetal pain
5149597|NCT01013558|intrauterine|intrauterine
5149598|NCT01013558|needling|needling
5149599|NCT01013545|joint engagement|joint engagement
5149600|NCT01013545|augmentative communication (AAC)|augmentative communication (aac)
5149601|NCT01013545|enhanced milieu training|enhanced milieu training
5149602|NCT01013545|autism spectrum disorder|autism spectrum disorder
5149603|NCT01013545|language|language
5149604|NCT01013532|Ischemic Stroke|ischemic stroke
5149605|NCT01013532|Intracranial Hemorrhage|intracranial hemorrhage
5149606|NCT01013532|Cilostazol|cilostazol
5149607|NCT01013532|Probucol|probucol
5149608|NCT01013506|estrogen receptor-positive breast cancer|estrogen receptor-positive breast cancer
5149609|NCT01013506|progesterone receptor-positive breast cancer|progesterone receptor-positive breast cancer
5149610|NCT01013506|stage IV breast cancer|stage iv breast cancer
5149611|NCT01013506|recurrent breast cancer|recurrent breast cancer
5149612|NCT01013493|breastfeeding|breastfeeding
5149613|NCT01013493|myopia|myopia
5149614|NCT01013493|nearsightedness|nearsightedness
5149615|NCT01013493|children|children
5149616|NCT01013480|Fragile X Syndrome|fragile x syndrome
5149617|NCT01013467|blood pressure|blood pressure
5149618|NCT01013467|control|control
5149619|NCT01013467|adherence|adherence
5149620|NCT01013467|behaviour|behaviour
5149621|NCT01013454|varenicline percutaneous transcutaneous topical transdermal transdermal delivery system patch|varenicline percutaneous transcutaneous topical transdermal transdermal delivery system patch
5149622|NCT01013441|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
5149623|NCT01013428|Traumatic Rupture of Tendon|traumatic rupture of tendon
5149624|NCT01013415|HIV-1|hiv-1
5149625|NCT01013402|Hypoglycemia|hypoglycemia
5149626|NCT01013402|Home Blood Glucose Monitoring|home blood glucose monitoring
5149627|NCT01013402|Subjects are being investigated for the integrity of|subjects are being investigated for the integrity of
5149628|NCT01013402|pituitary-adrenal functions by insulin hypoglycemia test.|pituitary-adrenal functions by insulin hypoglycemia test.
5149629|NCT01013389|actifuse|actifuse
5149630|NCT01013389|INFUSE|infuse
5149631|NCT01013389|InductOs|inductos
5149632|NCT01013389|DDD|ddd
5149633|NCT01013389|degenerative disk disease|degenerative disk disease
5149634|NCT01013389|PLIF|plif
5149635|NCT01013389|PITF|pitf
5149636|NCT01013389|PLF|plf
5149637|NCT01013389|poterolateral lumber fusion|poterolateral lumber fusion
5149638|NCT01013389|Bone substitute|bone substitute
5149639|NCT01013389|bone graft|bone graft
5149640|NCT01013389|synthetic bone substitute|synthetic bone substitute
5149641|NCT01013363|abortion|abortion
5149642|NCT01013363|first trimester|first trimester
5149643|NCT01013363|suction aspiration|suction aspiration
5149644|NCT01013363|vacuum aspiration|vacuum aspiration
5149645|NCT01013363|music|music
5149646|NCT01013363|anesthesia|anesthesia
5149647|NCT01013363|analgesia|analgesia
5149648|NCT01013363|anxiolytic|anxiolytic
5149649|NCT01013363|pain|pain
5149650|NCT01013363|anxiety|anxiety
5149651|NCT01013363|blood pressure|blood pressure
5149652|NCT01013363|heart rate|heart rate
5149653|NCT01013363|satisfaction|satisfaction
5149654|NCT01013350|Multiple Sclerosis|multiple sclerosis
5149655|NCT01013350|Cladribine|cladribine
5149656|NCT01013350|PREMIERE|premiere
5149657|NCT01013350|Observational study|observational study
5149658|NCT01013324|endometrial cancer|endometrial cancer
5149659|NCT01013324|endometrial carcinoma|endometrial carcinoma
5149660|NCT01013324|carcinoma of the endometrium|carcinoma of the endometrium
5149661|NCT01013324|cancer of the endometrium|cancer of the endometrium
5149662|NCT01013311|Implantable Cardioverter-Defibrillator (ICD)- pre-existing|implantable cardioverter-defibrillator (icd)- pre-existing
5149663|NCT01013298|percutaneous tracheostomy|percutaneous tracheostomy
5149664|NCT01013298|paratracheal insertion|paratracheal insertion
5149665|NCT01013298|tracheal injury|tracheal injury
5149666|NCT01013298|transtracheal needle|transtracheal needle
5149667|NCT01013298|ventilatory parameters|ventilatory parameters
5149668|NCT01013285|adult giant cell glioblastoma|adult giant cell glioblastoma
5149669|NCT01013285|adult gliosarcoma|adult gliosarcoma
5149670|NCT01013285|adult glioblastoma|adult glioblastoma
5149671|NCT01013272|entecavir|entecavir
5149672|NCT01013272|lamivudine|lamivudine
5149673|NCT01013272|sequential therapy|sequential therapy
5149674|NCT01013259|E.coli|e.coli
5149675|NCT01013259|Mutaflor|mutaflor
5149676|NCT01013259|grass pollen|grass pollen
5149677|NCT01013259|rhinoconjunctivitis|rhinoconjunctivitis
5149678|NCT01013259|rhinoconjunctivitis caused by grass pollen|rhinoconjunctivitis caused by grass pollen
5149679|NCT01013246|Video games|video games
5149680|NCT01013246|Energy balance|energy balance
5149681|NCT01013246|Metabolism|metabolism
5149682|NCT01013246|Appetite control|appetite control
5149683|NCT01013233|cognitive dysfunction chemotherapy|cognitive dysfunction chemotherapy
5149684|NCT01013220|depression|depression
5149685|NCT01013220|depression care management|depression care management
5149686|NCT01013220|financing|financing
5149687|NCT01013220|absenteeism|absenteeism
5149688|NCT01013220|presenteeism|presenteeism
5149689|NCT01013220|employer decisions to purchase health care benefits|employer decisions to purchase health care benefits
5149690|NCT01013207|CPAP compliance|cpap compliance
5149691|NCT01013194|Liver cirrhosis|liver cirrhosis
5149692|NCT01013194|Fetal stem cells|fetal stem cells
5149693|NCT01013194|Stem cell transplantation|stem cell transplantation
5149694|NCT01013194|Liver transplant candidate|liver transplant candidate
5149695|NCT01013181|Immune Thrombopenia|immune thrombopenia
5149696|NCT01013181|Thrombocytopenia|thrombocytopenia
5149697|NCT01013181|romiplostim|romiplostim
5149698|NCT01013181|compassionate program|compassionate program
5149699|NCT01013168|OncoSorb|oncosorb
5149700|NCT01013168|immune apheresis|immune apheresis
5149701|NCT01013168|sTNF-R1|stnf-r1
5149702|NCT01013168|sTNF-R2|stnf-r2
5149703|NCT01013168|sIL-2R|sil-2r
5149704|NCT01013168|TNF|tnf
5149705|NCT01013142|COPD|copd
5149706|NCT01013129|hereditary prostate cancer|hereditary prostate cancer
5149707|NCT01013129|prostate cancer|prostate cancer
5149708|NCT01013090|Epidural anesthesia|epidural anesthesia
5149709|NCT01013090|Spinal anesthesia|spinal anesthesia
5149710|NCT01013090|Combined spinal-epidural anesthesia|combined spinal-epidural anesthesia
5149711|NCT01013090|Fluid therapy|fluid therapy
5149712|NCT01013090|Crystalloid|crystalloid
5149713|NCT01013090|Colloid|colloid
5149714|NCT01013077|functional vision|functional vision
5149715|NCT01013077|contrast sensitivity|contrast sensitivity
5149716|NCT01013077|aberrometry|aberrometry
5149717|NCT01013077|reading ability|reading ability
5149718|NCT01013064|Erythropoietin|erythropoietin
5149719|NCT01013064|Long acting|long acting
5149720|NCT01013064|EPO|epo
5149721|NCT01013051|obesity|obesity
5149722|NCT01013051|gastric bypass|gastric bypass
5149723|NCT01013051|metformin|metformin
5149724|NCT01013051|pharmacokinetics|pharmacokinetics
5149725|NCT01013051|absorption|absorption
5149726|NCT01013038|myocardial infarction|myocardial infarction
5149727|NCT01013038|percutaneous coronary intervention|percutaneous coronary intervention
5149728|NCT01013038|thrombus aspiration|thrombus aspiration
5149729|NCT01013025|prostate cancer|prostate cancer
5149730|NCT01013025|implant retrieval|implant retrieval
5149731|NCT01013012|highly susceptible patients following spine surgery|highly susceptible patients following spine surgery
5149732|NCT01012999|acute pain, intranasal, sufentanil,|acute pain, intranasal, sufentanil,
5149733|NCT01012999|Acute pain control with an intranasal opiate|acute pain control with an intranasal opiate
5149734|NCT01012973|Macular Edema|macular edema
5149735|NCT01012973|Central Retinal Vein Occlusion|central retinal vein occlusion
5149736|NCT01012973|CRVO|crvo
5149737|NCT01012973|VEGF Trap-Eye|vegf trap-eye
5149738|NCT01012973|best-corrected visual acuity|best-corrected visual acuity
5149739|NCT01012960|methylnaltrexone|methylnaltrexone
5149740|NCT01012960|upper esophageal sphincter|upper esophageal sphincter
5149741|NCT01012960|lower esophageal sphincter|lower esophageal sphincter
5149742|NCT01012960|high resolution solid state manometry|high resolution solid state manometry
5149743|NCT01012960|opioid induced pharyngeal and esophageal dysfunction|opioid induced pharyngeal and esophageal dysfunction
5149744|NCT01012947|MMSE|mmse
5149745|NCT01012947|activity|activity
5149746|NCT01012921|GBR|gbr
5149747|NCT01012921|GTR|gtr
5149748|NCT01012921|Dental Implant surgery|dental implant surgery
5149749|NCT01012869|Coronary chronic total occlusions|coronary chronic total occlusions
5149750|NCT01012856|depressive episode|depressive episode
5149751|NCT01012856|psychotherapy|psychotherapy
5149752|NCT01012856|cognitive therapy|cognitive therapy
5149753|NCT01012856|emotional processing|emotional processing
5149754|NCT01012856|RCT|rct
5149755|NCT01012856|exposure|exposure
5149756|NCT01012856|dual process model|dual process model
5149757|NCT01012856|Implicit Association Test|implicit association test
5149758|NCT01012856|mechanism of change|mechanism of change
5149759|NCT01012843|Perianal|perianal
5149760|NCT01012843|Abscess|abscess
5149761|NCT01012843|Fistulae in ano|fistulae in ano
5149762|NCT01012843|Antibiotic|antibiotic
5149763|NCT01012843|Anorectal|anorectal
5149764|NCT01012830|Schizophrenia|schizophrenia
5149765|NCT01012830|Cognitive Disorders|cognitive disorders
5149766|NCT01012830|Dementia|dementia
5149767|NCT01012830|Huperzine A|huperzine a
5149768|NCT01012830|HupA|hupa
5149769|NCT01012804|stage IV colon cancer|stage iv colon cancer
5149770|NCT01012804|recurrent colon cancer|recurrent colon cancer
5149771|NCT01012791|Zumba exercise|zumba exercise
5149772|NCT01012791|ApoE|apoe
5149773|NCT01012778|Performance impairment|performance impairment
5149774|NCT01012778|Yoga|yoga
5149775|NCT01012778|Meditation|meditation
5149776|NCT01012778|Peer mediated|peer mediated
5149777|NCT01012765|COPD|copd
5149778|NCT01012765|indacaterol|indacaterol
5149779|NCT01012765|QAB149|qab149
5149780|NCT01012765|inspiratory capacity|inspiratory capacity
5149781|NCT01012739|asthma|asthma
5149782|NCT01012739|QAB149|qab149
5149783|NCT01012739|indacaterol|indacaterol
5149784|NCT01012739|pulmonary function|pulmonary function
5149785|NCT01012713|Psoriasis|psoriasis
5149786|NCT01012713|Excimer|excimer
5149787|NCT01012713|Laser|laser
5149788|NCT01012713|Clobex|clobex
5149789|NCT01012713|Vectical|vectical
5149790|NCT01012713|clobetasol spray|clobetasol spray
5149791|NCT01012713|calcitriol|calcitriol
5149792|NCT01012713|Generalized plaque type psoriasis|generalized plaque type psoriasis
5149793|NCT01012674|carotid or vertebral artery disease|carotid or vertebral artery disease
5149794|NCT01012674|Contrast agent|contrast agent
5149795|NCT01012674|MRA|mra
5149796|NCT01012661|Moderate to severe wrinkles and folds such as nasolabial folds|moderate to severe wrinkles and folds such as nasolabial folds
5149797|NCT01012635|spinal cord injury|spinal cord injury
5149798|NCT01012635|chronic pain|chronic pain
5149799|NCT01012622|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
5149800|NCT01012622|Methylphenidate Hydrochloride|methylphenidate hydrochloride
5149801|NCT01012609|high-grade astrocytomas|high-grade astrocytomas
5149802|NCT01012609|newly diagnosed diffuse pontine tumors|newly diagnosed diffuse pontine tumors
5149803|NCT01012609|External beam radiation therapy|external beam radiation therapy
5149804|NCT01012609|cetuximab|cetuximab
5149805|NCT01012609|irinotecan|irinotecan
5149806|NCT01012609|POETIC|poetic
5149807|NCT01012596|Natural Family Planning Methods|natural family planning methods
5149808|NCT01012596|Ovulation Detection|ovulation detection
5149809|NCT01012596|Cervix Mucus|cervix mucus
5149810|NCT01012596|Intention|intention
5149811|NCT01012596|Behavior|behavior
5149812|NCT01012596|Birth Control|birth control
5149813|NCT01012596|Contraception|contraception
5149814|NCT01012596|Pregnancy|pregnancy
5149815|NCT01012596|Fertility|fertility
5149816|NCT01012583|Optical coherence tomography|optical coherence tomography
5149817|NCT01012583|Drug eluting stent|drug eluting stent
5149818|NCT01012583|Biodegradable polymer|biodegradable polymer
5149819|NCT01012583|Intimal|intimal
5149820|NCT01012583|Coverage|coverage
5149821|NCT01012583|assess intimal hyperplasia of drug eluting stent with biodegradable polymer|assess intimal hyperplasia of drug eluting stent with biodegradable polymer
5149822|NCT01012557|H1N1v|h1n1v
5149823|NCT01012557|vaccine|vaccine
5149824|NCT01012557|pregnant|pregnant
5149825|NCT01012557|women|women
5149826|NCT01012557|Assess whether the adjuvanted vaccine offers a meaningful benefit in pregnant women in terms of immune response over the non-adjuvanted vaccine.|assess whether the adjuvanted vaccine offers a meaningful benefit in pregnant women in terms of immune response over the non-adjuvanted vaccine.
5149827|NCT01012557|Assess the persistence of immune response over a 15 month time period after one single vaccination of the pregnant mother.|assess the persistence of immune response over a 15 month time period after one single vaccination of the pregnant mother.
5149828|NCT01012557|Assess whether the immune response to H1N1 in pregnant women is different from that of non-pregnant women of similar age.|assess whether the immune response to h1n1 in pregnant women is different from that of non-pregnant women of similar age.
5149829|NCT01012557|Gain insight on safety of the Novartis egg-based MF59 adjuvanted H1N1 vaccine Focetria in pregnant women and their babies.|gain insight on safety of the novartis egg-based mf59 adjuvanted h1n1 vaccine focetria in pregnant women and their babies.
5149830|NCT01012557|Assess the maternally transferred specific antibodies against H1N1v in the newborn|assess the maternally transferred specific antibodies against h1n1v in the newborn
5149831|NCT01012557|Passive immunity transferred to the infant.|passive immunity transferred to the infant.
5149832|NCT01012544|clopidogrel|clopidogrel
5149833|NCT01012544|pharmacokinetics|pharmacokinetics
5149834|NCT01012544|platelet function tests|platelet function tests
5149835|NCT01012544|platelet reactivity|platelet reactivity
5149836|NCT01012518|percutaneous tracheostomy|percutaneous tracheostomy
5149837|NCT01012518|paratracheal insertion|paratracheal insertion
5149838|NCT01012518|tracheal injury|tracheal injury
5149839|NCT01012518|transtracheal needle|transtracheal needle
5149840|NCT01012518|ventilatory parameters|ventilatory parameters
5149841|NCT01012492|cancer|cancer
5149842|NCT01012492|leukemia|leukemia
5149843|NCT01012492|transplant|transplant
5149844|NCT01012492|bone marrow|bone marrow
5149845|NCT01012479|Blood Pressure|blood pressure
5149846|NCT01012479|Blood Pressure, High|blood pressure, high
5149847|NCT01012479|Drug Therapy|drug therapy
5149848|NCT01012466|pregnancy|pregnancy
5149849|NCT01012466|birth|birth
5149850|NCT01012466|labor|labor
5149851|NCT01012466|labor pain|labor pain
5149852|NCT01012466|catastrophizing|catastrophizing
5149853|NCT01012453|Hand eczema|hand eczema
5149854|NCT01012453|Hand dermatitis|hand dermatitis
5149855|NCT01012453|Occupational skin disease|occupational skin disease
5149856|NCT01012453|skindisease in health care workers|skindisease in health care workers
5149857|NCT01012453|occupational hand dermatitis|occupational hand dermatitis
5149858|NCT01012453|occupational hand eczema|occupational hand eczema
5149859|NCT01012427|Kidney|kidney
5149860|NCT01012427|Cryoablation|cryoablation
5149861|NCT01012427|09-108|09-108
5149862|NCT01012414|Vitamin D|vitamin d
5149863|NCT01012414|Coronary Artery Disease (CAD)|coronary artery disease (cad)
5149864|NCT01012414|Chronic Kidney Disease (CKD)|chronic kidney disease (ckd)
5149865|NCT01012401|Lung cancer|lung cancer
5149866|NCT01012401|Quality of life|quality of life
5149867|NCT01012401|Communication with physician|communication with physician
5149868|NCT01012388|Moderate to severe wrinkles and folds such as nasolabial folds|moderate to severe wrinkles and folds such as nasolabial folds
5149869|NCT01012375|Adult ADHD|adult adhd
5149870|NCT01012362|Solid tumor malignancy|solid tumor malignancy
5149871|NCT01012362|breast cancer|breast cancer
5149872|NCT01012362|lung cancer|lung cancer
5149873|NCT01012362|colon cancer|colon cancer
5149874|NCT01012362|pancreatic cancer|pancreatic cancer
5149875|NCT01012362|head and neck cancer|head and neck cancer
5149876|NCT01012362|kidney cancer|kidney cancer
5149877|NCT01012362|sarcoma|sarcoma
5149878|NCT01012362|hepatocellular cancer|hepatocellular cancer
5149879|NCT01012336|efficacy and safety of Aprepitant/Ramosetron/Dexamethasone in ovary cancer patients with taxol and carboplatin|efficacy and safety of aprepitant/ramosetron/dexamethasone in ovary cancer patients with taxol and carboplatin
5149880|NCT01012323|PID|pid
5149881|NCT01012310|pharmacokinetics safety tolerability multiple dosing|pharmacokinetics safety tolerability multiple dosing
5149882|NCT01012284|Moderate Hepatic Impairment|moderate hepatic impairment
5149883|NCT01012284|Tuberculosis|tuberculosis
5149884|NCT01012284|TMC207|tmc207
5149885|NCT01012284|Mycobacterial adenosine triphosphate (ATP)-synthase|mycobacterial adenosine triphosphate (atp)-synthase
5149886|NCT01012271|Wrist abnormalities|wrist abnormalities
5149887|NCT01012258|antitumor activity|antitumor activity
5149888|NCT01012258|safety|safety
5149889|NCT01012258|cetuximab in combination with radiotherapy|cetuximab in combination with radiotherapy
5149890|NCT01012258|locally advanced squamous cell head & neck carcinoma|locally advanced squamous cell head & neck carcinoma
5149891|NCT01012245|Xchange|xchange
5149892|NCT01012245|Xalatan|xalatan
5149893|NCT01012245|Xalacom|xalacom
5149894|NCT01012245|Betablocker|betablocker
5149895|NCT01012245|observational|observational
5149896|NCT01012245|longterm|longterm
5149897|NCT01012232|total knee arthroplasty|total knee arthroplasty
5149898|NCT01012232|postoperative pain|postoperative pain
5149899|NCT01012206|Children|children
5149900|NCT01012206|Overweight|overweight
5149901|NCT01012206|Obesity|obesity
5149902|NCT01012206|Food habits|food habits
5149903|NCT01012206|Dietary assessment|dietary assessment
5149904|NCT01012206|Physical activity|physical activity
5149905|NCT01012193|adjunctive cilostazol|adjunctive cilostazol
5150211|NCT01010737|Multimeric|multimeric
5149906|NCT01012193|high-MD clopidogrel|high-md clopidogrel
5149907|NCT01012193|CYP 2C19 polymorphism|cyp 2c19 polymorphism
5149908|NCT01012193|high risk patients|high risk patients
5149909|NCT01012180|Bipolar Disorder|bipolar disorder
5149910|NCT01012180|Adaptation|adaptation
5149911|NCT01012180|Parents|parents
5149912|NCT01012180|Risk|risk
5149913|NCT01012180|Coping|coping
5149914|NCT01012180|Survey|survey
5149915|NCT01012167|Schizophrenia, oxytocin, galantamine|schizophrenia, oxytocin, galantamine
5149916|NCT01012128|Temporal Artery Thermometer|temporal artery thermometer
5149917|NCT01012128|Temperature|temperature
5149918|NCT01012128|Preterm Infants|preterm infants
5149919|NCT01012115|Histones|histones
5149920|NCT01012115|organ failure|organ failure
5149921|NCT01012115|sepsis|sepsis
5149922|NCT01012102|EMD 640744|emd 640744
5149923|NCT01012102|Montanide|montanide
5149924|NCT01012102|Advanced solid tumours|advanced solid tumours
5149925|NCT01012089|Hemodialysis|hemodialysis
5149926|NCT01012089|Peritoneal dialysis|peritoneal dialysis
5149927|NCT01012089|Daptomycin|daptomycin
5149928|NCT01012089|Pharmacokinetics|pharmacokinetics
5149929|NCT01012076|maternal synchrony|maternal synchrony
5149930|NCT01012076|parent-child|parent-child
5149931|NCT01012076|parent child play|parent child play
5149932|NCT01012076|social communication|social communication
5149933|NCT01012063|iron|iron
5149934|NCT01012063|erythropoietin|erythropoietin
5149935|NCT01012063|hemoglobin|hemoglobin
5149936|NCT01012063|Total knee replacement arthroplasty|total knee replacement arthroplasty
5149937|NCT01012050|Asthma|asthma
5149938|NCT01012050|status asthmatics|status asthmatics
5149939|NCT01012011|Carcinoma, Hepatocellular|carcinoma, hepatocellular
5149940|NCT01012011|Carcinoma, Renal Cell|carcinoma, renal cell
5149941|NCT01011998|CML|cml
5149942|NCT01011998|Chronic Myelogenous leukemia|chronic myelogenous leukemia
5149943|NCT01011998|INST 0901|inst 0901
5149944|NCT01011998|imatinib|imatinib
5149945|NCT01011998|valproic acid|valproic acid
5149946|NCT01011998|Gleevec|gleevec
5149947|NCT01011985|end stage renal disease|end stage renal disease
5149948|NCT01011985|inflammation|inflammation
5149949|NCT01011985|vascular access|vascular access
5149950|NCT01011985|hemodialysis|hemodialysis
5149951|NCT01011972|Dose escalation|dose escalation
5149952|NCT01011972|XMT-1107|xmt-1107
5149953|NCT01011972|1107|1107
5149954|NCT01011972|Tumor|tumor
5149955|NCT01011972|Phase 1|phase 1
5149956|NCT01011972|Fumagillol|fumagillol
5149957|NCT01011972|PHF|phf
5149958|NCT01011972|Fleximer|fleximer
5149959|NCT01011972|cancer|cancer
5149960|NCT01011972|maximum tolerated dose|maximum tolerated dose
5149961|NCT01011972|MTD|mtd
5149962|NCT01011920|newly diagnosed primary central nervous system lymphoma|newly diagnosed primary central nervous system lymphoma
5149963|NCT01011894|Lenalidomide|lenalidomide
5149964|NCT01011894|CLL|cll
5149965|NCT01011894|09-045|09-045
5149966|NCT01011881|pleuritis|pleuritis
5149967|NCT01011881|empyema|empyema
5149968|NCT01011881|procalcitonin|procalcitonin
5149969|NCT01011829|methamphetamine|methamphetamine
5149970|NCT01011829|crystal meth|crystal meth
5149971|NCT01011829|addiction|addiction
5149972|NCT01011829|los angeles|los angeles
5149973|NCT01011829|medication|medication
5149974|NCT01011829|meth|meth
5149975|NCT01011816|intervertebral disk|intervertebral disk
5149976|NCT01011803|Deglutition|deglutition
5149977|NCT01011803|Phonation|phonation
5149978|NCT01011790|Healing Rhythms™|healing rhythms™
5149979|NCT01011790|Meditation|meditation
5149980|NCT01011790|Biofeedback|biofeedback
5149981|NCT01011790|Stress|stress
5149982|NCT01011777|bladder exstrophy epispadias complex|bladder exstrophy epispadias complex
5149983|NCT01011777|urinary incontinence|urinary incontinence
5149984|NCT01011777|muscle derive cell therapy|muscle derive cell therapy
5149985|NCT01011777|stem cells|stem cells
5149986|NCT01011764|social networks|social networks
5149987|NCT01011764|friendships|friendships
5149988|NCT01011764|autism spectrum disorder|autism spectrum disorder
5149989|NCT01011751|Drug Therapy|drug therapy
5149990|NCT01011712|Genetics|genetics
5149991|NCT01011712|Virus|virus
5149992|NCT01011712|Defense|defense
5149993|NCT01011712|Immune Defects|immune defects
5149994|NCT01011712|Respiratory Viruses|respiratory viruses
5149995|NCT01011712|Herpesvirus|herpesvirus
5149996|NCT01011712|Cytomegalovirus|cytomegalovirus
5149997|NCT01011712|Human Papillomavirus|human papillomavirus
5149998|NCT01011712|Adenovirus|adenovirus
5149999|NCT01011699|nicotinamide|nicotinamide
5150000|NCT01011699|sevelamer hydrochloride|sevelamer hydrochloride
5150001|NCT01011699|phosphatemia|phosphatemia
5150002|NCT01011699|cinacalcet|cinacalcet
5150003|NCT01011699|dyslipidemia|dyslipidemia
5150004|NCT01011699|vascular calcification|vascular calcification
5150005|NCT01011699|bone mass loss|bone mass loss
5150006|NCT01011673|headache|headache
5150007|NCT01011673|tension-type headache|tension-type headache
5150008|NCT01011660|hypertension|hypertension
5150009|NCT01011660|cardiovascular risk factors|cardiovascular risk factors
5150010|NCT01011660|drugs intervention|drugs intervention
5150011|NCT01011660|lipid-lowering therapy|lipid-lowering therapy
5150012|NCT01011660|50-79 years of age|50-79 years of age
5150013|NCT01011660|sign|sign
5150014|NCT01011660|the informed|the informed
5150015|NCT01011660|consent|consent
5150016|NCT01011660|forms|forms
5150017|NCT01011634|abortion|abortion
5150018|NCT01011634|uterine aspiration|uterine aspiration
5150019|NCT01011634|pain control|pain control
5150020|NCT01011621|Prednisolone acetate|prednisolone acetate
5150021|NCT01011621|Betamethasone valerate|betamethasone valerate
5150022|NCT01011595|lung cancer|lung cancer
5150023|NCT01011595|mediastinoscopy|mediastinoscopy
5150024|NCT01011595|mediastinal lymph nodes|mediastinal lymph nodes
5150025|NCT01011595|staging|staging
5150026|NCT01011595|EBUS|ebus
5150027|NCT01011595|EUS|eus
5150028|NCT01011595|Endobronchial Ultrasound|endobronchial ultrasound
5150029|NCT01011595|Endoscopic Ultrasound|endoscopic ultrasound
5150030|NCT01011582|To evaluate biomarkers that cause critical illness in patients with novel H1N1 influenza and with seasonal influenza.|to evaluate biomarkers that cause critical illness in patients with novel h1n1 influenza and with seasonal influenza.
5150031|NCT01011569|difference|difference
5150032|NCT01011556|Age Related Osteoporosis|age related osteoporosis
5150033|NCT01011556|Senile Osteoporosis|senile osteoporosis
5150034|NCT01011543|pulmonary tuberculosis|pulmonary tuberculosis
5150035|NCT01011543|negative sputum exam|negative sputum exam
5150036|NCT01011543|induced sputum|induced sputum
5150037|NCT01011543|endoscopy|endoscopy
5150038|NCT01011530|Melanoma|melanoma
5150039|NCT01011517|muscadine grapes|muscadine grapes
5150040|NCT01011517|endothelial function|endothelial function
5150041|NCT01011491|Obesity|obesity
5150042|NCT01011491|Weight loss|weight loss
5150043|NCT01011491|meal replacements|meal replacements
5150044|NCT01011491|inflammation|inflammation
5150045|NCT01011491|oxidative stress|oxidative stress
5150046|NCT01011491|visceral fat|visceral fat
5150047|NCT01011478|adenomatous polyp|adenomatous polyp
5150048|NCT01011478|stage I colon cancer|stage i colon cancer
5150049|NCT01011478|stage II colon cancer|stage ii colon cancer
5150050|NCT01011478|adenocarcinoma of the colon|adenocarcinoma of the colon
5150051|NCT01011465|Stress|stress
5150052|NCT01011465|Oxytocin|oxytocin
5150053|NCT01011465|Social Support|social support
5150054|NCT01011465|Resilience|resilience
5150055|NCT01011452|Acute Asthma Exacerbation|acute asthma exacerbation
5150056|NCT01011452|Montelukast|montelukast
5150057|NCT01011452|Management of acute asthma exacerbation|management of acute asthma exacerbation
5150058|NCT01011439|B3 and C malignant thymoma|b3 and c malignant thymoma
5150059|NCT01011426|laxative|laxative
5150060|NCT01011426|postoperative care|postoperative care
5150061|NCT01011426|ob-Gyn population|ob-gyn population
5150062|NCT01011426|post-operative patients|post-operative patients
5150063|NCT01011426|obstetrical and gynecological surgery|obstetrical and gynecological surgery
5150064|NCT01011413|HIV|hiv
5150065|NCT01011413|ART|art
5150066|NCT01011413|Efavirenz|efavirenz
5150067|NCT01011413|Dose reduction|dose reduction
5150068|NCT01011400|clitoris|clitoris
5150069|NCT01011387|Diabetic foot ulcers|diabetic foot ulcers
5150070|NCT01011374|Retinal vein occlusion|retinal vein occlusion
5150071|NCT01011374|Ranibizumab|ranibizumab
5150072|NCT01011374|Lucentis|lucentis
5150073|NCT01011374|Depression|depression
5150074|NCT01011348|Gulf War Illness|gulf war illness
5150075|NCT01011348|Coenzyme Q10|coenzyme q10
5150076|NCT01011348|Quality of Life|quality of life
5150077|NCT01011348|Fatigue|fatigue
5150078|NCT01011348|oxidative stress|oxidative stress
5150079|NCT01011335|Staphylococcus aureus|staphylococcus aureus
5150080|NCT01011335|Skin and soft tissue infection|skin and soft tissue infection
5150081|NCT01011335|Methicillin-resistant Staphylococcus aureus|methicillin-resistant staphylococcus aureus
5150082|NCT01011335|Recombinant alpha-toxoid (rAT)|recombinant alpha-toxoid (rat)
5150083|NCT01011335|Recombinant LukS subunit of Panton-Valentine Leukocidin (rLukS-PV)|recombinant luks subunit of panton-valentine leukocidin (rluks-pv)
5150084|NCT01011309|Leishmaniasis|leishmaniasis
5150085|NCT01011309|vaccine|vaccine
5150086|NCT01011309|immunotherapy|immunotherapy
5150087|NCT01011283|MDS|mds
5150088|NCT01011283|Myelodysplastic Syndromes|myelodysplastic syndromes
5150089|NCT01011270|Back pain|back pain
5150090|NCT01011270|postural balance|postural balance
5150091|NCT01011270|RDM|rdm
5150092|NCT01011270|industrial operators|industrial operators
5150093|NCT01011257|CAD|cad
5150094|NCT01011231|Gamma Knife radiosurgery|gamma knife radiosurgery
5150095|NCT01011231|recurrent glioma|recurrent glioma
5150096|NCT01011231|MRI|mri
5150097|NCT01011231|Spectroscopy|spectroscopy
5150098|NCT01011231|Recurrent grade IV glioma (glioblastoma), with two additional exploratory arms for patients with recurrent grade II and grade III gliomas|recurrent grade iv glioma (glioblastoma), with two additional exploratory arms for patients with recurrent grade ii and grade iii gliomas
5150099|NCT01011218|quality of life|quality of life
5150100|NCT01011205|Immunosuppression|immunosuppression
5150101|NCT01011205|Liver|liver
5150102|NCT01011205|Transplant|transplant
5150103|NCT01011205|Advagraf|advagraf
5150104|NCT01011192|Intravenous anesthesia|intravenous anesthesia
5150105|NCT01011192|propofol|propofol
5150106|NCT01011192|pharmacokinetic model|pharmacokinetic model
5150107|NCT01011192|Monitoring|monitoring
5150108|NCT01011192|bispectral index.|bispectral index.
5150109|NCT01011179|Teens Taking Charge|teens taking charge
5150110|NCT01011179|Managing Arthritis Online|managing arthritis online
5150111|NCT01011179|juvenile idiopathic arthritis|juvenile idiopathic arthritis
5150112|NCT01011179|internet|internet
5150113|NCT01011179|self-management|self-management
5150114|NCT01011166|Chronic Hepatitis C|chronic hepatitis c
5150115|NCT01011166|HepC|hepc
5150116|NCT01011166|Hep C|hep c
5150117|NCT01011140|Parenteral Hydration|parenteral hydration
5150118|NCT01011140|Latin American Association for Palliative Care|latin american association for palliative care
5150119|NCT01011140|ALCP|alcp
5150120|NCT01011140|Spanish Society for Palliative Care|spanish society for palliative care
5150121|NCT01011140|SECPAL|secpal
5150122|NCT01011140|Online survey|online survey
5150123|NCT01011140|Palliative care|palliative care
5150124|NCT01011140|Physicians' attitudes|physicians' attitudes
5150125|NCT01011140|End of life|end of life
5150126|NCT01011140|Latin America|latin america
5150127|NCT01011140|Spain|spain
5150128|NCT01011127|Statins|statins
5150129|NCT01011127|Insulin resistance|insulin resistance
5150130|NCT01011114|hypophosphatemia|hypophosphatemia
5150131|NCT01011114|hyperparathyroidism|hyperparathyroidism
5150132|NCT01011114|renal transplant|renal transplant
5150133|NCT01011101|Saccadic Eye Movements|saccadic eye movements
5150134|NCT01011101|Schizophrenia|schizophrenia
5150135|NCT01011101|Healthy Volunteer|healthy volunteer
5150136|NCT01011101|HV|hv
5150137|NCT01011088|Paternity|paternity
5150138|NCT01011088|Psychology|psychology
5150139|NCT01011088|Risk factor|risk factor
5150140|NCT01011075|Lung cancer,|lung cancer,
5150141|NCT01011075|Non-small cell lung cancer|non-small cell lung cancer
5150142|NCT01011075|NSCLC|nsclc
5150143|NCT01011075|Metastatic|metastatic
5150144|NCT01011075|Gleevec|gleevec
5150145|NCT01011075|elderly|elderly
5150146|NCT01011062|Adipose tissue|adipose tissue
5150147|NCT01011062|Adipokines|adipokines
5150148|NCT01011049|Influenza|influenza
5150149|NCT01011049|Fluzone Vaccine|fluzone vaccine
5150150|NCT01011049|Intradermal Injections|intradermal injections
5150151|NCT01011049|Adults|adults
5150152|NCT01011036|healthy study subjects, no disease|healthy study subjects, no disease
5150153|NCT01011023|Bowel anastomosis|bowel anastomosis
5150154|NCT01011023|nasogastric tube|nasogastric tube
5150155|NCT01011023|children|children
5150156|NCT01011010|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
5150157|NCT01011010|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
5150158|NCT01011010|recurrent adult primary liver cancer|recurrent adult primary liver cancer
5150159|NCT01010997|AMD, CNV|amd, cnv
5150160|NCT01010984|metastatic melanoma|metastatic melanoma
5150161|NCT01010984|stage IV melanoma|stage iv melanoma
5150162|NCT01010984|metastatic melanoma to the liver|metastatic melanoma to the liver
5150163|NCT01010971|Mountain Cedar|mountain cedar
5150164|NCT01010945|Advanced Pancreatic Cancer|advanced pancreatic cancer
5150165|NCT01010945|erlotinib|erlotinib
5150166|NCT01010945|gemcitabine|gemcitabine
5150167|NCT01010945|nab-paclitaxel|nab-paclitaxel
5150168|NCT01010945|Adenocarcinoma|adenocarcinoma
5150169|NCT01010945|Phase 1b|phase 1b
5150170|NCT01010932|carotid or vertebral artery disease|carotid or vertebral artery disease
5150171|NCT01010932|Contrast agent|contrast agent
5150172|NCT01010932|MRA|mra
5150173|NCT01010893|pandemic|pandemic
5150174|NCT01010893|prevention|prevention
5150175|NCT01010893|influenza|influenza
5150176|NCT01010893|infection|infection
5150177|NCT01010893|influenza vaccine|influenza vaccine
5150178|NCT01010893|vaccine|vaccine
5150179|NCT01010893|influenza in humans|influenza in humans
5150180|NCT01010880|Multiple Myeloma|multiple myeloma
5150181|NCT01010880|CXCR4|cxcr4
5150182|NCT01010880|Stem Cells|stem cells
5150183|NCT01010880|Mobilization|mobilization
5150184|NCT01010880|Transplantation|transplantation
5150185|NCT01010880|Chemotherapy|chemotherapy
5150186|NCT01010867|Probiotics|probiotics
5150187|NCT01010867|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
5150188|NCT01010867|Pediatrics|pediatrics
5150189|NCT01010854|breast cancer|breast cancer
5150190|NCT01010854|advanced|advanced
5150191|NCT01010854|local|local
5150192|NCT01010841|Metabolic syndrome|metabolic syndrome
5150193|NCT01010841|Serum lipid|serum lipid
5150194|NCT01010841|Dietary intervention|dietary intervention
5150195|NCT01010841|Lifestyle modification|lifestyle modification
5150196|NCT01010841|Glycemic load|glycemic load
5150197|NCT01010841|Phytochemical|phytochemical
5150198|NCT01010841|Hops|hops
5150199|NCT01010841|Acacia|acacia
5150200|NCT01010841|Mediterranean diet|mediterranean diet
5150201|NCT01010841|Kinase modulator|kinase modulator
5150202|NCT01010815|ulcerative colitis|ulcerative colitis
5150203|NCT01010815|gut microbiome|gut microbiome
5150204|NCT01010815|metagenomics|metagenomics
5150205|NCT01010802|Neuroprotection|neuroprotection
5150206|NCT01010802|Parkinson Disease|parkinson disease
5150207|NCT01010802|Erythropoietin|erythropoietin
5150208|NCT01010776|Schizophrenia|schizophrenia
5150209|NCT01010776|Paliperidone|paliperidone
5150210|NCT01010750|ADHD|adhd
5150212|NCT01010737|Vaccine|vaccine
5150213|NCT01010737|Influenza|influenza
5150214|NCT01010737|elderly|elderly
5150215|NCT01010737|phase 1/2|phase 1/2
5150216|NCT01010737|safety|safety
5150217|NCT01010737|efficacy|efficacy
5150218|NCT01010737|tolerability|tolerability
5150219|NCT01010737|reactogenicity|reactogenicity
5150220|NCT01010737|Montanide|montanide
5150221|NCT01010737|hemagglutinin inhibition|hemagglutinin inhibition
5150222|NCT01010737|HAI|hai
5150223|NCT01010737|TIV|tiv
5150224|NCT01010711|migraine|migraine
5150225|NCT01010711|children|children
5150226|NCT01010711|dietary supplement|dietary supplement
5150227|NCT01010711|q10|q10
5150228|NCT01010711|prevention|prevention
5150229|NCT01010698|cimetidine|cimetidine
5150230|NCT01010698|acyclovir|acyclovir
5150231|NCT01010698|pharmacokinetics|pharmacokinetics
5150232|NCT01010698|excipient|excipient
5150233|NCT01010698|formulation|formulation
5150234|NCT01010685|Natural Orifice Transluminal Endoscopic Surgery (NOTES)|natural orifice transluminal endoscopic surgery (notes)
5150235|NCT01010685|Transgastric surgery|transgastric surgery
5150236|NCT01010685|Surgical Procedures, Minimally Invasive|surgical procedures, minimally invasive
5150237|NCT01010659|Dacryocystorhinostomy|dacryocystorhinostomy
5150238|NCT01010646|hepatitis C|hepatitis c
5150239|NCT01010646|viral kinetics|viral kinetics
5150240|NCT01010646|antiviral response|antiviral response
5150241|NCT01010646|Genotype 1 or 4|genotype 1 or 4
5150242|NCT01010620|screening|screening
5150243|NCT01010620|research participation|research participation
5150244|NCT01010620|substance abuse|substance abuse
5150245|NCT01010620|Schizophrenia|schizophrenia
5150246|NCT01010620|nicotine|nicotine
5150247|NCT01010620|Healthy|healthy
5150248|NCT01010620|cigarettes|cigarettes
5150249|NCT01010620|smoking|smoking
5150250|NCT01010620|marijuana|marijuana
5150251|NCT01010620|cocaine|cocaine
5150252|NCT01010581|Rheumatoid Arthritis|rheumatoid arthritis
5150253|NCT01010581|SC12267|sc12267
5150254|NCT01010581|4SC-101|4sc-101
5150255|NCT01010581|Methotrexate|methotrexate
5150256|NCT01010581|Phase II|phase ii
5150257|NCT01010568|CLL|cll
5150258|NCT01010568|SLL|sll
5150259|NCT01010568|Bendamustine|bendamustine
5150260|NCT01010568|Ofatumumab|ofatumumab
5150261|NCT01010542|Single dose psoriasis study|single dose psoriasis study
5150262|NCT01010529|Occupational Therapy|occupational therapy
5150263|NCT01010529|Parkinson's Disease|parkinson's disease
5150264|NCT01010529|Feasibility|feasibility
5150265|NCT01010529|Effectiveness|effectiveness
5150266|NCT01010529|RCT|rct
5150267|NCT01010529|Activities of daily living|activities of daily living
5150268|NCT01010529|Participation|participation
5150269|NCT01010529|Caregiver's Burden|caregiver's burden
5150270|NCT01010490|PACHYMETRY|pachymetry
5150271|NCT01010490|CELL LOSS|cell loss
5150272|NCT01010490|SAFETY|safety
5150273|NCT01010490|EFFICACY|efficacy
5150274|NCT01010490|PHACOEMULSIFICATION|phacoemulsification
5150275|NCT01010490|Intraoperative complications|intraoperative complications
5150276|NCT01010490|CLOCK TIME|clock time
5150277|NCT01010490|FLUID USED|fluid used
5150278|NCT01010490|CORNEAL THICKNESS|corneal thickness
5150279|NCT01010490|ENDOTHELIUM CELL LOSS|endothelium cell loss
5150280|NCT01010477|smoking cessation|smoking cessation
5150281|NCT01010477|schizophrenia|schizophrenia
5150282|NCT01010477|nicotine nasal spray|nicotine nasal spray
5150283|NCT01010477|behavioral counseling|behavioral counseling
5150284|NCT01010464|Adhesions|adhesions
5150285|NCT01010464|Open abdomen|open abdomen
5150286|NCT01010464|Laparotomy|laparotomy
5150287|NCT01010451|pulpotomy|pulpotomy
5150288|NCT01010451|pulpectomy|pulpectomy
5150289|NCT01010451|primary teeth|primary teeth
5150290|NCT01010451|dental care for children|dental care for children
5150291|NCT01010438|sleep studies|sleep studies
5150292|NCT01010438|sleep apnea|sleep apnea
5150293|NCT01010438|OSA|osa
5150294|NCT01010438|Referred for sleep studies by a medical professional|referred for sleep studies by a medical professional
5150295|NCT01010412|Ultrasound|ultrasound
5150296|NCT01010412|Nerve blocks|nerve blocks
5150297|NCT01010412|Upper extremity|upper extremity
5150298|NCT01010399|HIV|hiv
5150299|NCT01010399|triglycerides|triglycerides
5150300|NCT01010399|fosamprenavir|fosamprenavir
5150301|NCT01010386|Pregnancy|pregnancy
5150302|NCT01010386|Infertility|infertility
5150303|NCT01010386|Physiologic Oxygen Tension|physiologic oxygen tension
5150304|NCT01010386|Atmospheric Oxygen Tension|atmospheric oxygen tension
5150305|NCT01010373|Primary Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS) induced AML.|primary acute myeloid leukemia (aml) and myelodysplastic syndrome (mds) induced aml.
5150306|NCT01010360|celiac ganglia|celiac ganglia
5150307|NCT01010347|fractures|fractures
5150308|NCT01010347|casting|casting
5150309|NCT01010347|splinting|splinting
5150310|NCT01010347|pediatrics|pediatrics
5150311|NCT01010334|INST 0813|inst 0813
5150312|NCT01010334|Standard of Care|standard of care
5150313|NCT01010321|skin lesion suspect as BCC or SCC or others|skin lesion suspect as bcc or scc or others
5150314|NCT01010308|infantile hemangioma|infantile hemangioma
5150315|NCT01010308|nadolol|nadolol
5150316|NCT01010295|NHL of the ocular adnexae|nhl of the ocular adnexae
5150317|NCT01010256|To evaluate the phosphate and tension homolog deleted on chromosome ten (PTEN) protein level in leukemia cells from patients with CMML.|to evaluate the phosphate and tension homolog deleted on chromosome ten (pten) protein level in leukemia cells from patients with cmml.
5150318|NCT01010256|To identify the PTEN genetic defect in patients with deficient PTEN protein levels.|to identify the pten genetic defect in patients with deficient pten protein levels.
5150319|NCT01010256|To evaluate the role of PTEN deregulation in CMML pathogenesis.|to evaluate the role of pten deregulation in cmml pathogenesis.
5150320|NCT01010243|multiple myeloma|multiple myeloma
5150321|NCT01010243|anti-inflammatory|anti-inflammatory
5150322|NCT01010243|relapsed|relapsed
5150323|NCT01010243|refractory|refractory
5150324|NCT01010243|progressive|progressive
5150325|NCT01010230|Childhood cancer survivors|childhood cancer survivors
5150326|NCT01010217|Hematologic Neoplasms|hematologic neoplasms
5150327|NCT01010217|Blood Disorders|blood disorders
5150328|NCT01010217|Blood Cancer|blood cancer
5150329|NCT01010217|Transplantation, Blood And Marrow|transplantation, blood and marrow
5150330|NCT01010217|Acute myelogenous leukemia|acute myelogenous leukemia
5150331|NCT01010217|Myelodysplastic syndrome|myelodysplastic syndrome
5150332|NCT01010217|Acute lymphocytic leukemia|acute lymphocytic leukemia
5150333|NCT01010217|Aplastic anemia|aplastic anemia
5150334|NCT01010217|Chronic myelogenous leukemia|chronic myelogenous leukemia
5150335|NCT01010217|Chronic lymphocytic leukemia|chronic lymphocytic leukemia
5150336|NCT01010217|Myeloproliferative disease|myeloproliferative disease
5150337|NCT01010217|Hodgkin's disease|hodgkin's disease
5150338|NCT01010217|Non-Hodgkin's lymphoma|non-hodgkin's lymphoma
5150339|NCT01010217|Multiple myeloma|multiple myeloma
5150340|NCT01010217|Cyclophosphamide|cyclophosphamide
5150341|NCT01010217|Fludarabine|fludarabine
5150342|NCT01010217|Melphalan|melphalan
5150343|NCT01010217|Mesna|mesna
5150344|NCT01010217|Rituximab|rituximab
5150345|NCT01010217|Tacrolimus|tacrolimus
5150346|NCT01010217|Prograf|prograf
5150347|NCT01010217|Mycofenolate mofetil|mycofenolate mofetil
5150348|NCT01010217|MMF|mmf
5150349|NCT01010217|CellCept|cellcept
5150350|NCT01010217|G-CSF|g-csf
5150351|NCT01010217|Filgrastim|filgrastim
5150352|NCT01010217|Neupogen|neupogen
5150353|NCT01010204|Varenicline|varenicline
5150354|NCT01010204|Chantix|chantix
5150355|NCT01010204|Smoking|smoking
5150356|NCT01010204|Bipolar Disorder|bipolar disorder
5150357|NCT01010191|irritable bowel syndrome|irritable bowel syndrome
5150358|NCT01010191|no organic digestive disease|no organic digestive disease
5150359|NCT01010178|COPD|copd
5150360|NCT01010178|Macrolid|macrolid
5150361|NCT01010178|reversibility|reversibility
5150362|NCT01010178|Theophylline|theophylline
5150363|NCT01010178|Corticosteroids|corticosteroids
5150364|NCT01010178|symptoms PFT|symptoms pft
5150365|NCT01010165|acute arthritis|acute arthritis
5150366|NCT01010165|bacteria|bacteria
5150367|NCT01010165|crystal arthritis|crystal arthritis
5150368|NCT01010165|proteomic|proteomic
5150369|NCT01010165|SELDI-TOF|seldi-tof
5150370|NCT01010113|infants|infants
5150371|NCT01010113|prebiotics|prebiotics
5150372|NCT01010113|probiotics|probiotics
5150373|NCT01010113|safety|safety
5150374|NCT01010100|Metabolic Disease|metabolic disease
5150375|NCT01010100|IGT Impaired Glucose Tolerance|igt impaired glucose tolerance
5150376|NCT01010087|patients admitted to ICU|patients admitted to icu
5150377|NCT01010074|retina, Parkinson's disease, ganglion cell, pupillary|retina, parkinson's disease, ganglion cell, pupillary
5150378|NCT01010048|ESWL|eswl
5150379|NCT01010048|urinary calculus|urinary calculus
5150380|NCT01010048|drugs treat|drugs treat
5150381|NCT01010035|type 2 diabetes mellitus|type 2 diabetes mellitus
5150382|NCT01010035|dyslipidemia|dyslipidemia
5150383|NCT01010035|kinetics|kinetics
5150384|NCT01010022|hypovolemia|hypovolemia
5150385|NCT01010022|surgical blood loss|surgical blood loss
5150386|NCT01010022|orthopedic procedures|orthopedic procedures
5150387|NCT01010022|Treatment of reduced circulating blood volume (hypovolemia) including massive hemorrhage|treatment of reduced circulating blood volume (hypovolemia) including massive hemorrhage
5150388|NCT01010009|resveratrol|resveratrol
5150389|NCT01010009|cerebral blood flow|cerebral blood flow
5150390|NCT01010009|NIRS|nirs
5150391|NCT01010009|cognitive performance|cognitive performance
5150392|NCT01009996|Coronary bifurcation lesions|coronary bifurcation lesions
5150393|NCT01009983|triple-negative breast cancer|triple-negative breast cancer
5150394|NCT01009970|Diffuse Large B-Cell Lymphoma|diffuse large b-cell lymphoma
5150395|NCT01009957|ADPKD|adpkd
5150396|NCT01009957|CKD|ckd
5150397|NCT01009957|Renal disease progression|renal disease progression
5150398|NCT01009957|Everolimus|everolimus
5150399|NCT01009944|High blood pressure|high blood pressure
5150400|NCT01009931|Acute Myelogenous Leukemia|acute myelogenous leukemia
5150401|NCT01009931|Relapsed AML|relapsed aml
5150402|NCT01009931|Refractory AML|refractory aml
5150403|NCT01009918|cardiac toxicity|cardiac toxicity
5150404|NCT01009918|HER2-positive breast cancer|her2-positive breast cancer
5150405|NCT01009918|recurrent breast cancer|recurrent breast cancer
5150406|NCT01009918|stage IA breast cancer|stage ia breast cancer
5150407|NCT01009918|stage IB breast cancer|stage ib breast cancer
5150408|NCT01009918|stage II breast cancer|stage ii breast cancer
5150698|NCT01008969|Prostate|prostate
5150409|NCT01009918|stage IIIA breast cancer|stage iiia breast cancer
5150410|NCT01009918|stage IIIB breast cancer|stage iiib breast cancer
5150411|NCT01009918|stage IIIC breast cancer|stage iiic breast cancer
5150412|NCT01009918|male breast cancer|male breast cancer
5150413|NCT01009879|rheumatoid arthritis|rheumatoid arthritis
5150414|NCT01009879|B lymphocytes|b lymphocytes
5150415|NCT01009866|Malignant brain tumor|malignant brain tumor
5150416|NCT01009866|GBM|gbm
5150417|NCT01009866|recurrent brain tumor|recurrent brain tumor
5150418|NCT01009866|Supratentorial malignant brain tumor|supratentorial malignant brain tumor
5150419|NCT01009866|astrocytomas|astrocytomas
5150420|NCT01009866|ependymomas|ependymomas
5150421|NCT01009866|Residual, progressive, or recurrent supratentorial malignant brain tumor based on imaging studies with measurable|residual, progressive, or recurrent supratentorial malignant brain tumor based on imaging studies with measurable
5150422|NCT01009866|disease (>0.5cm).|disease (>0.5cm).
5150423|NCT01009840|Multiple Myeloma|multiple myeloma
5150424|NCT01009840|Bone marrow transplant|bone marrow transplant
5150425|NCT01009840|Stem cell transplant|stem cell transplant
5150426|NCT01009840|Busulfan|busulfan
5150427|NCT01009840|Bortezomib|bortezomib
5150428|NCT01009827|Medication adherence|medication adherence
5150429|NCT01009827|Substance use|substance use
5150430|NCT01009827|Sexual risk behaviors|sexual risk behaviors
5150431|NCT01009814|HIV, HIV attachment inhibitor, attachment inhibitor|hiv, hiv attachment inhibitor, attachment inhibitor
5150432|NCT01009801|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
5150433|NCT01009801|recurrent adult primary liver cancer|recurrent adult primary liver cancer
5150434|NCT01009801|localized resectable adult primary liver cancer|localized resectable adult primary liver cancer
5150435|NCT01009788|ABT-888|abt-888
5150436|NCT01009788|temozolomide|temozolomide
5150437|NCT01009788|TMZ|tmz
5150438|NCT01009775|Melanoma, Stage III|melanoma, stage iii
5150439|NCT01009775|Melanoma, Stage IV|melanoma, stage iv
5150440|NCT01009775|YM 155|ym 155
5150441|NCT01009775|Metastatic Melanoma|metastatic melanoma
5150442|NCT01009762|VACCINE|vaccine
5150443|NCT01009762|THERAPY|therapy
5150444|NCT01009762|CELLULAR IMMUNITY|cellular immunity
5150445|NCT01009762|IMMUNITY|immunity
5150446|NCT01009749|HAART|haart
5150447|NCT01009749|HIV|hiv
5150448|NCT01009749|Adherence|adherence
5150449|NCT01009736|stage I prostate cancer|stage i prostate cancer
5150450|NCT01009736|stage IIB prostate cancer|stage iib prostate cancer
5150451|NCT01009736|stage IIA prostate cancer|stage iia prostate cancer
5150452|NCT01009736|stage III prostate cancer|stage iii prostate cancer
5150453|NCT01009736|stage IV prostate cancer|stage iv prostate cancer
5150454|NCT01009723|Preterm delivery|preterm delivery
5150455|NCT01009723|preterm labor|preterm labor
5150456|NCT01009723|maternal-fetal care|maternal-fetal care
5150457|NCT01009723|maternal serum screening biomarkers|maternal serum screening biomarkers
5150458|NCT01009723|alphafetoprotein|alphafetoprotein
5150459|NCT01009723|AFP|afp
5150460|NCT01009723|human chorionic gonadotropin|human chorionic gonadotropin
5150461|NCT01009723|hCG|hcg
5150462|NCT01009723|unconjugated estriol|unconjugated estriol
5150463|NCT01009723|Inhibin A|inhibin a
5150464|NCT01009723|pregnancy associated plasma protein|pregnancy associated plasma protein
5150465|NCT01009723|PAPP-A|papp-a
5150466|NCT01009723|maternal screening|maternal screening
5150467|NCT01009684|Contraception|contraception
5150468|NCT01009684|Estradiol valerate|estradiol valerate
5150469|NCT01009671|knee osteoarthritis|knee osteoarthritis
5150470|NCT01009658|Gastrointestinal motility|gastrointestinal motility
5150471|NCT01009658|Gastroesophageal reflux|gastroesophageal reflux
5150472|NCT01009658|Gastric emptying|gastric emptying
5150473|NCT01009658|Sodium glutamate|sodium glutamate
5150474|NCT01009658|Lower esophageal sphincter|lower esophageal sphincter
5150475|NCT01009645|education|education
5150476|NCT01009645|vaccination|vaccination
5150477|NCT01009645|preventive service|preventive service
5150478|NCT01009645|Prevention & Control|prevention & control
5150479|NCT01009619|Bronchiolitis Obliterans Syndrome|bronchiolitis obliterans syndrome
5150480|NCT01009619|Acute allograft Rejection|acute allograft rejection
5150481|NCT01009619|Lymphocytic bronchiolitis|lymphocytic bronchiolitis
5150482|NCT01009619|Respiratory infection|respiratory infection
5150483|NCT01009619|Survival|survival
5150484|NCT01009619|Mortality|mortality
5150485|NCT01009619|Pulmonary function|pulmonary function
5150486|NCT01009619|FEV1|fev1
5150487|NCT01009619|Broncho-alveolar lavage|broncho-alveolar lavage
5150488|NCT01009619|Neutrophils|neutrophils
5150489|NCT01009619|Interleukin|interleukin
5150490|NCT01009619|Culture|culture
5150491|NCT01009619|Azithromycin|azithromycin
5150492|NCT01009606|Out-of-hospital|out-of-hospital
5150493|NCT01009606|Emergency|emergency
5150494|NCT01009606|Cardiac arrest|cardiac arrest
5150495|NCT01009606|Post-traumatic stress disorder|post-traumatic stress disorder
5150496|NCT01009593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
5150497|NCT01009593|Antineoplastic Agents|antineoplastic agents
5150498|NCT01009593|Growth Substances|growth substances
5150499|NCT01009593|Physiological Effects of Drugs|physiological effects of drugs
5150500|NCT01009593|Enzyme Inhibitors|enzyme inhibitors
5150501|NCT01009593|Angiogenesis Inhibitors|angiogenesis inhibitors
5150502|NCT01009593|Inhibitors, Angiogenesis|inhibitors, angiogenesis
5150503|NCT01009593|Protein Kinase Inhibitors|protein kinase inhibitors
5150504|NCT01009593|Pharmacologic Actions|pharmacologic actions
5150505|NCT01009593|Growth Inhibitors|growth inhibitors
5150506|NCT01009593|Angiogenesis Modulating Agents|angiogenesis modulating agents
5150507|NCT01009593|Sorafenib|sorafenib
5150508|NCT01009567|OHSS|ohss
5150509|NCT01009554|Mouthwashes|mouthwashes
5150510|NCT01009541|pregabalin pharmacokinetics bioavailability bioequivalence|pregabalin pharmacokinetics bioavailability bioequivalence
5150511|NCT01009528|Quality of care|quality of care
5150512|NCT01009528|General Practice|general practice
5150513|NCT01009528|Electronic Feedback System|electronic feedback system
5150514|NCT01009515|metastatic|metastatic
5150515|NCT01009515|melanoma|melanoma
5150516|NCT01009515|skin cancer|skin cancer
5150517|NCT01009515|paclitaxel|paclitaxel
5150518|NCT01009515|carboplatin|carboplatin
5150519|NCT01009515|temozolomide|temozolomide
5150520|NCT01009476|Dementia|dementia
5150521|NCT01009476|Galantamine|galantamine
5150522|NCT01009476|Cholinesterase inhibitors|cholinesterase inhibitors
5150523|NCT01009476|Nootropic agents|nootropic agents
5150524|NCT01009476|Alzheimer|alzheimer
5150525|NCT01009476|Vascular dementia|vascular dementia
5150526|NCT01009476|Cognitive symptoms|cognitive symptoms
5150527|NCT01009476|Behavioural symptoms|behavioural symptoms
5150528|NCT01009476|Care giving times|care giving times
5150529|NCT01009463|COPD|copd
5150530|NCT01009463|Safety|safety
5150531|NCT01009463|FEV1|fev1
5150532|NCT01009463|Efficacy|efficacy
5150533|NCT01009450|cirrhotic liver, gall bladder stone|cirrhotic liver, gall bladder stone
5150534|NCT01009437|HER2-negative breast cancer|her2-negative breast cancer
5150535|NCT01009437|HER2-positive breast cancer|her2-positive breast cancer
5150536|NCT01009437|estrogen receptor-positive breast cancer|estrogen receptor-positive breast cancer
5150537|NCT01009437|triple-negative breast cancer|triple-negative breast cancer
5150538|NCT01009437|stage I breast cancer|stage i breast cancer
5150539|NCT01009437|stage II breast cancer|stage ii breast cancer
5150540|NCT01009437|stage IIIA breast cancer|stage iiia breast cancer
5150541|NCT01009437|stage IIIB breast cancer|stage iiib breast cancer
5150542|NCT01009437|stage IIIC breast cancer|stage iiic breast cancer
5150543|NCT01009437|stage IV breast cancer|stage iv breast cancer
5150544|NCT01009437|ductal breast carcinoma in situ|ductal breast carcinoma in situ
5150545|NCT01009398|Anesthesia and Analgesia|anesthesia and analgesia
5150546|NCT01009398|Regional anesthesia|regional anesthesia
5150547|NCT01009398|Thoracic Paravertebral block|thoracic paravertebral block
5150548|NCT01009398|Catheter location|catheter location
5150549|NCT01009385|cervical|cervical
5150550|NCT01009385|epidural|epidural
5150551|NCT01009385|epidural pressure|epidural pressure
5150552|NCT01009385|monitoring|monitoring
5150553|NCT01009372|surgeon's physiology|surgeon's physiology
5150554|NCT01009372|stress response|stress response
5150555|NCT01009372|break scheme|break scheme
5150556|NCT01009359|Alzheimers disease|alzheimers disease
5150557|NCT01009359|Diagnostic imaging|diagnostic imaging
5150558|NCT01009359|PET/CT diagnosis|pet/ct diagnosis
5150559|NCT01009359|PET tracer|pet tracer
5150560|NCT01009333|urgency frequency|urgency frequency
5150561|NCT01009333|urinary urge incontinence|urinary urge incontinence
5150562|NCT01009333|InterStim Therapy|interstim therapy
5150563|NCT01009320|Pacemaker|pacemaker
5150564|NCT01009320|Magnets|magnets
5150565|NCT01009320|Drape|drape
5150566|NCT01009320|Ferrite|ferrite
5150567|NCT01009320|Magnetic field|magnetic field
5150568|NCT01009320|Pacemaker interference|pacemaker interference
5150569|NCT01009307|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5150570|NCT01009307|adult diffuse astrocytoma|adult diffuse astrocytoma
5150571|NCT01009307|adult pilocytic astrocytoma|adult pilocytic astrocytoma
5150572|NCT01009307|adult subependymal giant cell astrocytoma|adult subependymal giant cell astrocytoma
5150573|NCT01009307|adult anaplastic ependymoma|adult anaplastic ependymoma
5150574|NCT01009307|adult ependymoma|adult ependymoma
5150575|NCT01009307|adult myxopapillary ependymoma|adult myxopapillary ependymoma
5150576|NCT01009307|adult subependymoma|adult subependymoma
5150577|NCT01009307|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
5150578|NCT01009307|adult oligodendroglioma|adult oligodendroglioma
5150579|NCT01009307|adult brain stem glioma|adult brain stem glioma
5150580|NCT01009307|adult giant cell glioblastoma|adult giant cell glioblastoma
5150581|NCT01009307|adult glioblastoma|adult glioblastoma
5150582|NCT01009307|recurrent adult brain tumor|recurrent adult brain tumor
5150583|NCT01009307|adult gliosarcoma|adult gliosarcoma
5150584|NCT01009307|adult mixed glioma|adult mixed glioma
5150585|NCT01009307|adult pineal gland astrocytoma|adult pineal gland astrocytoma
5150586|NCT01009307|adult ependymoblastoma|adult ependymoblastoma
5150587|NCT01009307|adult medulloblastoma|adult medulloblastoma
5150588|NCT01009307|adult supratentorial primitive neuroectodermal tumor (PNET)|adult supratentorial primitive neuroectodermal tumor (pnet)
5150589|NCT01009307|adult pineoblastoma|adult pineoblastoma
5150590|NCT01009307|adult pineocytoma|adult pineocytoma
5150591|NCT01009294|Duchenne muscular dystrophy|duchenne muscular dystrophy
5150592|NCT01009294|Becker muscular dystrophy|becker muscular dystrophy
5150593|NCT01009294|Nonsense mutation|nonsense mutation
5150594|NCT01009294|Premature stop codon|premature stop codon
5150595|NCT01009294|DMD|dmd
5150596|NCT01009294|BMD|bmd
5150597|NCT01009294|Ataluren|ataluren
5150598|NCT01009294|PTC124|ptc124
5150599|NCT01009281|Crohn's Disease|crohn's disease
5150600|NCT01009281|Crohns|crohns
5150601|NCT01009281|Bowel disease|bowel disease
5150602|NCT01009281|digestive disorders|digestive disorders
5150603|NCT01009281|auto immune|auto immune
5150604|NCT01009281|diarrhea|diarrhea
5150605|NCT01009281|Inflammatory Bowel Disease (IBD)|inflammatory bowel disease (ibd)
5150606|NCT01009281|gastrointestinal diseases|gastrointestinal diseases
5150607|NCT01009281|digestive system diseases|digestive system diseases
5150608|NCT01009281|Antibody|antibody
5150609|NCT01009281|IL 17|il 17
5150610|NCT01009281|anti IL-17|anti il-17
5150611|NCT01009281|monoclonal antibody|monoclonal antibody
5150612|NCT01009281|Crohn's Disease (Chron's, CD)|crohn's disease (chron's, cd)
5150613|NCT01009255|Alzheimer's disease|alzheimer's disease
5150614|NCT01009255|placebo controlled|placebo controlled
5150615|NCT01009255|randomised|randomised
5150616|NCT01009255|Histamine|histamine
5150617|NCT01009255|H3 Antagonist|h3 antagonist
5150618|NCT01009255|double blind|double blind
5150619|NCT01009255|Cognition|cognition
5150620|NCT01009242|CDP6038|cdp6038
5150621|NCT01009216|Pharmacokinetics|pharmacokinetics
5150622|NCT01009216|Pharmacology|pharmacology
5150623|NCT01009216|Drug Safety|drug safety
5150624|NCT01009216|Phase 1 Clinical Trials|phase 1 clinical trials
5150625|NCT01009203|squamous cell carcinoma|squamous cell carcinoma
5150626|NCT01009203|head|head
5150627|NCT01009203|neck|neck
5150628|NCT01009203|aerodigestive|aerodigestive
5150629|NCT01009190|Dose finding PARPi Chemotherapy|dose finding parpi chemotherapy
5150630|NCT01009177|Melanoma|melanoma
5150631|NCT01009177|Metastatic|metastatic
5150632|NCT01009177|DTIC|dtic
5150633|NCT01009177|Bosentan|bosentan
5150634|NCT01009151|telemonitoring|telemonitoring
5150635|NCT01009151|internet|internet
5150636|NCT01009151|home monitoring system|home monitoring system
5150637|NCT01009151|heart failure|heart failure
5150638|NCT01009151|self management plan|self management plan
5150639|NCT01009151|web portal|web portal
5150640|NCT01009138|Subthreshold Depression|subthreshold depression
5150641|NCT01009138|Diabetes-related Distress|diabetes-related distress
5150642|NCT01009138|Minor Depression|minor depression
5150643|NCT01009138|Light affective Disorder|light affective disorder
5150644|NCT01009138|Subclinical depressive Symptoms|subclinical depressive symptoms
5150645|NCT01009138|Diabetes mellitus|diabetes mellitus
5150646|NCT01009138|Late Complications|late complications
5150647|NCT01009138|Markers of Inflammation|markers of inflammation
5150648|NCT01009125|questionnaires|questionnaires
5150649|NCT01009125|health care surveys/methods|health care surveys/methods
5150650|NCT01009125|motivation|motivation
5150651|NCT01009125|living donors|living donors
5150652|NCT01009125|living kidney donation|living kidney donation
5150653|NCT01009112|Sleep|sleep
5150654|NCT01009112|Sleep Disorder|sleep disorder
5150655|NCT01009112|Veterans|veterans
5150656|NCT01009112|Active Duty|active duty
5150657|NCT01009112|OEF|oef
5150658|NCT01009112|OIF|oif
5150659|NCT01009112|PTSD|ptsd
5150660|NCT01009099|pulmonary disease|pulmonary disease
5150661|NCT01009099|COPD|copd
5150662|NCT01009086|Arthritis, Psoriatic|arthritis, psoriatic
5150663|NCT01009086|Ustekinumab|ustekinumab
5150664|NCT01009086|CNTO 1275|cnto 1275
5150665|NCT01009086|Stelara|stelara
5150666|NCT01009086|Psoriasis|psoriasis
5150667|NCT01009060|H3 Antagonist|h3 antagonist
5150668|NCT01009060|Schizophrenia|schizophrenia
5150669|NCT01009060|double blind|double blind
5150670|NCT01009060|Histamine|histamine
5150671|NCT01009060|randomised|randomised
5150672|NCT01009060|placebo controlled|placebo controlled
5150673|NCT01009060|Cognition|cognition
5150674|NCT01009047|Schizophrenia|schizophrenia
5150675|NCT01009047|Paliperidone|paliperidone
5150676|NCT01009047|Aripiprazole|aripiprazole
5150677|NCT01009021|pain|pain
5150678|NCT01009021|retinal photocoagulation|retinal photocoagulation
5150679|NCT01009021|potassium diclofenac|potassium diclofenac
5150680|NCT01009008|cancer|cancer
5150681|NCT01009008|breast cancer|breast cancer
5150682|NCT01009008|mastectomy|mastectomy
5150683|NCT01009008|breast reconstruction|breast reconstruction
5150684|NCT01009008|reconstruction|reconstruction
5150685|NCT01009008|tissue expansion|tissue expansion
5150686|NCT01009008|two-stage breast reconstruction|two-stage breast reconstruction
5150687|NCT01009008|tissue expander|tissue expander
5150688|NCT01009008|AeroForm|aeroform
5150689|NCT01009008|AirXpander|airxpander
5150690|NCT01008995|psoriasis|psoriasis
5150691|NCT01008995|asian patients|asian patients
5150692|NCT01008995|Chinese|chinese
5150693|NCT01008995|ustekinumab|ustekinumab
5150694|NCT01008995|CNTO 1275|cnto 1275
5150695|NCT01008995|Stelara|stelara
5150696|NCT01008982|Belimumab,Sjögren's Syndrome.|belimumab,sjögren's syndrome.
5150697|NCT01008982|Have a diagnosis of primary SS according to the updated American European Consensus Group Criteria|have a diagnosis of primary ss according to the updated american european consensus group criteria
5150699|NCT01008969|SPECT/CT|spect/ct
5150700|NCT01008956|Influenza|influenza
5150701|NCT01008956|H1N1|h1n1
5150702|NCT01008956|Pandemic|pandemic
5150703|NCT01008956|GSK Bio's influenza vaccine GSK2340274A|gsk bio's influenza vaccine gsk2340274a
5150704|NCT01008930|Peripheral Tumors|peripheral tumors
5150705|NCT01008930|Arm|arm
5150706|NCT01008930|Leg|leg
5150707|NCT01008930|Head|head
5150708|NCT01008930|Neck|neck
5150709|NCT01008930|HR PET Imaging System|hr pet imaging system
5150710|NCT01008930|High-Resolution PET|high-resolution pet
5150711|NCT01008930|PET/CT|pet/ct
5150712|NCT01008930|PEMFlex Solo II|pemflex solo ii
5150713|NCT01008930|positron emission tomography/computed tomography (PET/CT)|positron emission tomography/computed tomography (pet/ct)
5150714|NCT01008917|Hepatocellular carcinoma|hepatocellular carcinoma
5150715|NCT01008917|HCC|hcc
5150716|NCT01008917|Liver cancer|liver cancer
5150717|NCT01008917|Hepatoma|hepatoma
5150718|NCT01008904|cancer survivor|cancer survivor
5150719|NCT01008904|hot flashes|hot flashes
5150720|NCT01008904|breast cancer|breast cancer
5150721|NCT01008904|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5150722|NCT01008891|arthritis|arthritis
5150723|NCT01008891|ankle pain|ankle pain
5150724|NCT01008891|foot pain|foot pain
5150725|NCT01008891|hindfoot fracture|hindfoot fracture
5150726|NCT01008891|ankle fracture|ankle fracture
5150727|NCT01008891|rheumatoid arthritis|rheumatoid arthritis
5150728|NCT01008891|arthrosis|arthrosis
5150729|NCT01008891|Foot/Hindfoot Fusion|foot/hindfoot fusion
5150730|NCT01008852|rheumatoid arthritis|rheumatoid arthritis
5150731|NCT01008852|seropositive|seropositive
5150732|NCT01008852|methotrexate|methotrexate
5150733|NCT01008839|study sarcopenia, which muscle becomes weaker with age|study sarcopenia, which muscle becomes weaker with age
5150734|NCT01008826|sulforaphane|sulforaphane
5150735|NCT01008826|pharmacokinetics|pharmacokinetics
5150736|NCT01008813|HIV infection|hiv infection
5150737|NCT01008813|adjuvanted and non-adjuvanted A(H1N1)v influenza vaccine|adjuvanted and non-adjuvanted a(h1n1)v influenza vaccine
5150738|NCT01008813|immunogenicity|immunogenicity
5150739|NCT01008813|safety|safety
5150740|NCT01008800|Autism Spectrum Disorder|autism spectrum disorder
5150741|NCT01008800|language|language
5150742|NCT01008800|social|social
5150743|NCT01008800|toddlers|toddlers
5150744|NCT01008787|Cancer Prevention|cancer prevention
5150745|NCT01008787|Focus Group|focus group
5150746|NCT01008787|Interview|interview
5150747|NCT01008787|Physical Activity|physical activity
5150748|NCT01008787|African American women|african american women
5150749|NCT01008787|Exercise|exercise
5150750|NCT01008787|Exercise habits|exercise habits
5150751|NCT01008787|Health behavior|health behavior
5150752|NCT01008761|Pre-school child|pre-school child
5150753|NCT01008761|Wheezy episode|wheezy episode
5150754|NCT01008748|Smoking|smoking
5150755|NCT01008748|Latinos|latinos
5150756|NCT01008748|Mexican American|mexican american
5150757|NCT01008748|Spanish-speaking smokers|spanish-speaking smokers
5150758|NCT01008748|Ecological momentary assessment|ecological momentary assessment
5150759|NCT01008748|Nicotine patch|nicotine patch
5150760|NCT01008748|Smoking cessation counseling|smoking cessation counseling
5150761|NCT01008748|Questionnaire|questionnaire
5150762|NCT01008748|EMA|ema
5150763|NCT01008722|Atrial Fibrillation|atrial fibrillation
5150764|NCT01008722|Ablation|ablation
5150765|NCT01008696|Reflux esophagitis|reflux esophagitis
5150766|NCT01008696|Rabeprazole|rabeprazole
5150767|NCT01008696|Lansoprazole|lansoprazole
5150768|NCT01008683|Stem cell and and heart transplant patients who will receive pandemic H1N1 influenza vaccinations|stem cell and and heart transplant patients who will receive pandemic h1n1 influenza vaccinations
5150769|NCT01008670|Cardiac resynchronization therapy|cardiac resynchronization therapy
5150770|NCT01008657|Radiofrequency-Extranodular-Multipolar ablation|radiofrequency-extranodular-multipolar ablation
5150771|NCT01008657|Recurrence|recurrence
5150772|NCT01008644|carbon dioxide|carbon dioxide
5150773|NCT01008644|ventilation|ventilation
5150774|NCT01008644|gender|gender
5150775|NCT01008644|osmolality|osmolality
5150776|NCT01008644|menstruation cycle|menstruation cycle
5150777|NCT01008631|renal failure|renal failure
5150778|NCT01008631|sodium Thiosulfate|sodium thiosulfate
5150779|NCT01008631|pharmakokinetic|pharmakokinetic
5150780|NCT01008618|Chronic pain|chronic pain
5150781|NCT01008618|Osteoarthritis|osteoarthritis
5150782|NCT01008618|Low back pain|low back pain
5150783|NCT01008618|Fentanyl|fentanyl
5150784|NCT01008618|JNS020QD|jns020qd
5150785|NCT01008618|Patch, transdermal|patch, transdermal
5150786|NCT01008618|Opioid analgesics|opioid analgesics
5150787|NCT01008605|Erectile Dysfunction|erectile dysfunction
5150788|NCT01008592|dermatographism, levocetirizine (Xyzal)|dermatographism, levocetirizine (xyzal)
5150789|NCT01008592|chronic idiopathic urticaria, dermatographism|chronic idiopathic urticaria, dermatographism
5150790|NCT01008579|Patient Reported Outcome Measures|patient reported outcome measures
5150791|NCT01008579|falls|falls
5150792|NCT01008579|older adults|older adults
5150793|NCT01008553|Postherpetic Neuralgia|postherpetic neuralgia
5150794|NCT01008553|Complex Regional Pain Syndromes (CRPS)|complex regional pain syndromes (crps)
5150795|NCT01008553|Postoperative Pain|postoperative pain
5150796|NCT01008553|Fentanyl|fentanyl
5150797|NCT01008553|Patch, transdermal|patch, transdermal
5150798|NCT01008553|Opioid analgesics|opioid analgesics
5150799|NCT01008540|cytomegalovirus|cytomegalovirus
5150800|NCT01008540|resistance|resistance
5150801|NCT01008540|transplantation|transplantation
5150802|NCT01008540|Patient coming to an French transplantation center for solid organ or bone marrow transplant, with information and signed consent|patient coming to an french transplantation center for solid organ or bone marrow transplant, with information and signed consent
5150803|NCT01008527|skin|skin
5150804|NCT01008527|cutaneous|cutaneous
5150805|NCT01008527|immunotherapy|immunotherapy
5150806|NCT01008527|immunology|immunology
5150807|NCT01008527|dose escalation|dose escalation
5150808|NCT01008514|ductal breast carcinoma in situ|ductal breast carcinoma in situ
5150809|NCT01008514|stage IA breast cancer|stage ia breast cancer
5150810|NCT01008514|stage IB breast cancer|stage ib breast cancer
5150811|NCT01008514|stage II breast cancer|stage ii breast cancer
5150812|NCT01008501|hydatidiform moles|hydatidiform moles
5150813|NCT01008501|complete hydatidiform moles|complete hydatidiform moles
5150814|NCT01008501|partial hydatidiform moles|partial hydatidiform moles
5150815|NCT01008501|Molar pregnancy|molar pregnancy
5150816|NCT01008501|NLRP7|nlrp7
5150817|NCT01008501|pregnancy wastage|pregnancy wastage
5150818|NCT01008501|imprinting|imprinting
5150819|NCT01008501|sporadic hydatidiform moles|sporadic hydatidiform moles
5150820|NCT01008501|recurrent hydatidiform moles|recurrent hydatidiform moles
5150821|NCT01008488|colonic diverticulitis|colonic diverticulitis
5150822|NCT01008488|diverticular disease|diverticular disease
5150823|NCT01008488|antibiotic therapy|antibiotic therapy
5150824|NCT01008475|EMD 525797|emd 525797
5150825|NCT01008475|Cetuximab|cetuximab
5150826|NCT01008475|Irinotecan|irinotecan
5150827|NCT01008475|metastatic colorectal cancer|metastatic colorectal cancer
5150828|NCT01008449|Staples|staples
5150829|NCT01008449|Sutures|sutures
5150830|NCT01008449|Cesarean Delivery|cesarean delivery
5150831|NCT01008449|Wound|wound
5150832|NCT01008449|Skin Closure|skin closure
5150833|NCT01008449|Wound infection|wound infection
5150834|NCT01008449|Wound disruption|wound disruption
5150835|NCT01008436|Ability of topical drug to reduce acute and overall bleeding as well as blood transfusions|ability of topical drug to reduce acute and overall bleeding as well as blood transfusions
5150836|NCT01008423|Proctitis|proctitis
5150837|NCT01008423|Proctosigmoiditis|proctosigmoiditis
5150838|NCT01008423|Ulcerative|ulcerative
5150839|NCT01008423|Salix|salix
5150840|NCT01008423|Budesonide foam|budesonide foam
5150841|NCT01008423|Budesonide|budesonide
5150842|NCT01008423|Rectal|rectal
5150843|NCT01008423|Gastrointestinal|gastrointestinal
5150844|NCT01008423|Colitis|colitis
5150845|NCT01008423|UC|uc
5150846|NCT01008423|UP|up
5150847|NCT01008423|UPS|ups
5150848|NCT01008423|Additional relevant MeSH terms:|additional relevant mesh terms:
5150849|NCT01008423|Proctocolitis|proctocolitis
5150850|NCT01008423|Ulcer|ulcer
5150851|NCT01008423|Colitis, Ulcerative|colitis, ulcerative
5150852|NCT01008423|Gastroenteritis|gastroenteritis
5150853|NCT01008423|Gastrointestinal Diseases|gastrointestinal diseases
5150854|NCT01008423|Digestive System Diseases|digestive system diseases
5150855|NCT01008423|Rectal Diseases|rectal diseases
5150856|NCT01008423|Intestinal Diseases|intestinal diseases
5150857|NCT01008423|Colonic Diseases|colonic diseases
5150858|NCT01008423|Sigmoid Diseases|sigmoid diseases
5150859|NCT01008423|Pathologic Processes|pathologic processes
5150860|NCT01008423|Inflammatory Bowel Diseases|inflammatory bowel diseases
5150861|NCT01008423|Bronchodilator Agents|bronchodilator agents
5150862|NCT01008423|Autonomic Agents|autonomic agents
5150863|NCT01008423|Peripheral Nervous System Agents|peripheral nervous system agents
5150864|NCT01008423|Physiological Effects of Drugs|physiological effects of drugs
5150865|NCT01008423|Pharmacologic Actions|pharmacologic actions
5150866|NCT01008423|Anti-Asthmatic Agents|anti-asthmatic agents
5150867|NCT01008423|Respiratory System Agents|respiratory system agents
5150868|NCT01008423|Therapeutic Uses|therapeutic uses
5150869|NCT01008423|Glucocorticoids|glucocorticoids
5150870|NCT01008423|Hormones|hormones
5150871|NCT01008423|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists
5150872|NCT01008423|Anti-Inflammatory Agents|anti-inflammatory agents
5150873|NCT01008410|Proctitis|proctitis
5150874|NCT01008410|Proctosigmoiditis|proctosigmoiditis
5150875|NCT01008410|Ulcerative|ulcerative
5150876|NCT01008410|Salix|salix
5150877|NCT01008410|Budesonide foam|budesonide foam
5150878|NCT01008410|Budesonide|budesonide
5150879|NCT01008410|Rectal|rectal
5150880|NCT01008410|Gastrointestinal|gastrointestinal
5150881|NCT01008410|Colitis|colitis
5150882|NCT01008410|UC|uc
5150883|NCT01008410|UP|up
5150884|NCT01008410|UPS|ups
5150885|NCT01008410|Additional relevant MeSH terms:|additional relevant mesh terms:
5150886|NCT01008410|Proctocolitis|proctocolitis
5150887|NCT01008410|Ulcer|ulcer
5150888|NCT01008410|Colitis, Ulcerative|colitis, ulcerative
5150889|NCT01008410|Gastroenteritis|gastroenteritis
5150890|NCT01008410|Gastrointestinal Diseases|gastrointestinal diseases
5150891|NCT01008410|Digestive System Diseases|digestive system diseases
5150892|NCT01008410|Rectal Diseases|rectal diseases
5150893|NCT01008410|Intestinal Diseases|intestinal diseases
5150894|NCT01008410|Colonic Diseases|colonic diseases
5150895|NCT01008410|Sigmoid Diseases|sigmoid diseases
5150896|NCT01008410|Pathologic Processes|pathologic processes
5150897|NCT01008410|Inflammatory Bowel Diseases|inflammatory bowel diseases
5150898|NCT01008410|Bronchodilator Agents|bronchodilator agents
5150899|NCT01008410|Autonomic Agents|autonomic agents
5150900|NCT01008410|Peripheral Nervous System Agents|peripheral nervous system agents
5150901|NCT01008410|Physiological Effects of Drugs|physiological effects of drugs
5150902|NCT01008410|Pharmacologic Actions|pharmacologic actions
5150903|NCT01008410|Anti-Asthmatic Agents|anti-asthmatic agents
5150904|NCT01008410|Respiratory System Agents|respiratory system agents
5150905|NCT01008410|Therapeutic Uses|therapeutic uses
5150906|NCT01008410|Glucocorticoids|glucocorticoids
5150907|NCT01008410|Hormones|hormones
5150908|NCT01008410|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists
5150909|NCT01008410|Anti-Inflammatory Agents|anti-inflammatory agents
5150910|NCT01008397|Rhinitis, Allergic, Seasonal|rhinitis, allergic, seasonal
5150911|NCT01008371|Obesity|obesity
5150912|NCT01008371|Cholecystokinin|cholecystokinin
5150913|NCT01008371|Oxytocin|oxytocin
5150914|NCT01008371|Satiety|satiety
5150915|NCT01008371|Gastric emptying|gastric emptying
5150916|NCT01008371|Anxiety|anxiety
5150917|NCT01008371|Depression|depression
5150918|NCT01008371|Panic Disorder|panic disorder
5150919|NCT01008332|House Dust Mite Allergy|house dust mite allergy
5150920|NCT01008332|Immunotherapy|immunotherapy
5150921|NCT01008332|Rhinoconjunctivitis|rhinoconjunctivitis
5150922|NCT01008332|Toleromune HDM|toleromune hdm
5150923|NCT01008319|Anovulation|anovulation
5150924|NCT01008319|Ovulation induction|ovulation induction
5150925|NCT01008306|Cardiorespiratory fitness|cardiorespiratory fitness
5150926|NCT01008306|physical activity|physical activity
5150927|NCT01008306|hypertension|hypertension
5150928|NCT01008306|overweight and obesity|overweight and obesity
5150929|NCT01008306|metabolic syndrome|metabolic syndrome
5150930|NCT01008306|Body composition|body composition
5150931|NCT01008241|Hospice|hospice
5150932|NCT01008241|End of Life|end of life
5150933|NCT01008241|Knowledge|knowledge
5150934|NCT01008241|Attitudes|attitudes
5150935|NCT01008241|Opinions|opinions
5150936|NCT01008241|Advanced Care Planning|advanced care planning
5150937|NCT01008241|Death and Dying|death and dying
5150938|NCT01008241|Communication|communication
5150939|NCT01008241|Knowledge and Attitudes of South Florida Residents on Hospice Care|knowledge and attitudes of south florida residents on hospice care
5150940|NCT01008228|spontaneous|spontaneous
5150941|NCT01008228|primary|primary
5150942|NCT01008228|first episode|first episode
5150943|NCT01008215|INR Control|inr control
5150944|NCT01008215|Warfarin dosing|warfarin dosing
5150945|NCT01008215|Family physicians|family physicians
5150946|NCT01008215|Cluster randomization|cluster randomization
5150947|NCT01008176|Hypertension|hypertension
5150948|NCT01008176|Sleep|sleep
5150949|NCT01008176|Blood Pressure|blood pressure
5150950|NCT01008176|Inflammatory Markers|inflammatory markers
5150951|NCT01008150|breast cancer|breast cancer
5150952|NCT01008150|neoadjuvant|neoadjuvant
5150953|NCT01008150|neratinib|neratinib
5150954|NCT01008150|paclitaxel|paclitaxel
5150955|NCT01008150|trastuzumab|trastuzumab
5150956|NCT01008150|doxorubicin|doxorubicin
5150957|NCT01008150|cyclophosphamide|cyclophosphamide
5150958|NCT01008124|Benign Paroxysmal Positional Vertigo|benign paroxysmal positional vertigo
5150959|NCT01008124|BPPV|bppv
5150960|NCT01008124|PC|pc
5150961|NCT01008124|BPPN|bppn
5150962|NCT01008124|Vertigo|vertigo
5150963|NCT01008111|regeneration|regeneration
5150964|NCT01008111|tissue survival|tissue survival
5150965|NCT01008111|biological processes|biological processes
5150966|NCT01008111|connective tissue|connective tissue
5150967|NCT01008111|tissue|tissue
5150968|NCT01008098|Posttraumatic Stress Disorder|posttraumatic stress disorder
5150969|NCT01008098|Escitalopram|escitalopram
5150970|NCT01008098|Magnetic Resonance Imaging|magnetic resonance imaging
5150971|NCT01008098|BDNF|bdnf
5150972|NCT01008085|STEMI|stemi
5150973|NCT01008085|self-expandable|self-expandable
5150974|NCT01008085|balloon-expandable|balloon-expandable
5150975|NCT01008046|Polycystic ovary syndrome|polycystic ovary syndrome
5150976|NCT01008046|clomiphene resistance|clomiphene resistance
5150977|NCT01008046|metformin|metformin
5150978|NCT01008046|N-acetyl cysteine|n-acetyl cysteine
5150979|NCT01008020|tea catechin extracts|tea catechin extracts
5150980|NCT01008020|influenza infection|influenza infection
5150981|NCT01008020|prophylaxis|prophylaxis
5150982|NCT01008020|supplements|supplements
5150983|NCT01008020|adults over 20 years old|adults over 20 years old
5150984|NCT01008020|both men and women|both men and women
5150985|NCT01008007|Viusid|viusid
5150986|NCT01008007|Dietary supplements|dietary supplements
5150987|NCT01008007|Acute fever|acute fever
5150988|NCT01008007|Viral etiology|viral etiology
5150989|NCT01007994|Nocturnal hypertension|nocturnal hypertension
5150990|NCT01007994|Pediatric|pediatric
5150991|NCT01007994|Renal Transplant|renal transplant
5150992|NCT01007994|Pulse Wave Velocity|pulse wave velocity
5150993|NCT01007994|Echocardiogram|echocardiogram
5150994|NCT01007994|Pediatric Renal Transplant Recipient|pediatric renal transplant recipient
5150995|NCT01007968|solid tumors|solid tumors
5150996|NCT01007968|hepatic function|hepatic function
5150997|NCT01007968|advanced|advanced
5150998|NCT01007968|panobinostat|panobinostat
5150999|NCT01007929|ADME|adme
5151000|NCT01007929|safety|safety
5151001|NCT01007929|oral solution|oral solution
5151002|NCT01007890|ChemoFX|chemofx
5151003|NCT01007890|Operable|operable
5151004|NCT01007890|Breast|breast
5151005|NCT01007890|Cancer|cancer
5151006|NCT01007890|Measurable|measurable
5151007|NCT01007890|Disease|disease
5151008|NCT01008163|diabetes|diabetes
5151009|NCT01007942|Metastatic breast cancer|metastatic breast cancer
5151010|NCT01007942|locally advanced breast cancer|locally advanced breast cancer
5151011|NCT01007942|HER2/neu positive breast cancer|her2/neu positive breast cancer
5151012|NCT01007942|HER2/neu over-expressing|her2/neu over-expressing
5151013|NCT01007942|progressive-free survival (PFS)|progressive-free survival (pfs)
5151014|NCT01007942|over survival (OS)|over survival (os)
5151015|NCT01007942|bolero|bolero
5151016|NCT01007942|bolero 3|bolero 3
5151017|NCT01007942|Breast cancer|breast cancer
5151018|NCT01007942|everolimus|everolimus
5151019|NCT01007942|HER+|her+
5151020|NCT01007942|vinorelbine|vinorelbine
5151021|NCT01007942|herceptin|herceptin
5151022|NCT01007942|trastuzumab|trastuzumab
5151023|NCT01007942|RAD001|rad001
5151024|NCT01007877|sleepiness|sleepiness
5151025|NCT01007877|driving|driving
5151026|NCT01007864|Parkinson|parkinson
5151027|NCT01007864|piribedil|piribedil
5151028|NCT01007864|vigilance|vigilance
5151029|NCT01007864|dopamine agonist|dopamine agonist
5151030|NCT01007864|cognition|cognition
5151031|NCT01007851|GnRH agonist|gnrh agonist
5151032|NCT01007851|GnRH antagonist|gnrh antagonist
5151033|NCT01007851|IVF|ivf
5151034|NCT01007851|ICSI|icsi
5151035|NCT01007851|assisted reproduction|assisted reproduction
5151036|NCT01007851|luteal phase|luteal phase
5151037|NCT01007838|Progressive Resistance Training/Exercise|progressive resistance training/exercise
5151038|NCT01007838|Muscle wasting|muscle wasting
5151039|NCT01007838|Chronic Kidney Disease|chronic kidney disease
5151040|NCT01007786|Pediatric Hydrocephalus|pediatric hydrocephalus
5151041|NCT01007786|Ultrasound Guided Surgery|ultrasound guided surgery
5151042|NCT01007773|Dexmedetomidine|dexmedetomidine
5151043|NCT01007773|Intracranial Pressure|intracranial pressure
5151044|NCT01007773|Traumatic Brain Injury|traumatic brain injury
5151045|NCT01007760|Tobacco smoke|tobacco smoke
5151046|NCT01007760|Oxidative stress|oxidative stress
5151047|NCT01007760|Endothelial Function|endothelial function
5151048|NCT01007760|Atherosclerosis|atherosclerosis
5151049|NCT01007760|Arterial Stiffness|arterial stiffness
5151050|NCT01007760|Microvascular Function|microvascular function
5151051|NCT01007747|Geranium oil|geranium oil
5151052|NCT01007747|Neuropathy|neuropathy
5151053|NCT01007734|Quality of life|quality of life
5151054|NCT01007734|COPD patients|copd patients
5151055|NCT01007734|Evaluation According to Gender the Determining Independent Factors of Quality of Life Related to Respiratory Status of Patient With Moderate to Severe COPD|evaluation according to gender the determining independent factors of quality of life related to respiratory status of patient with moderate to severe copd
5151056|NCT01007695|breast cancer|breast cancer
5151057|NCT01007682|intrusive memories|intrusive memories
5151058|NCT01007669|Physical activity|physical activity
5151059|NCT01007656|healthy adult subjects|healthy adult subjects
5151060|NCT01007656|safety evaluation|safety evaluation
5151061|NCT01007656|GD Antrodia camphorata|gd antrodia camphorata
5151062|NCT01007643|anterior knee pain|anterior knee pain
5151063|NCT01007643|adolescents|adolescents
5151064|NCT01007643|female|female
5151065|NCT01007643|interactive video games|interactive video games
5151066|NCT01007643|patellofemoral syndrome|patellofemoral syndrome
5151067|NCT01007643|treatment|treatment
5151068|NCT01007643|compliance|compliance
5151069|NCT01007643|home exercises|home exercises
5151070|NCT01007630|Parkinson's|parkinson's
5151071|NCT01007630|Parkinsons|parkinsons
5151072|NCT01007630|Parkinson|parkinson
5151073|NCT01007630|Parkinson's Disease|parkinson's disease
5151074|NCT01007630|PD|pd
5151075|NCT01007630|Rasagiline|rasagiline
5151076|NCT01007630|Azilect|azilect
5151077|NCT01007630|Olfactory|olfactory
5151078|NCT01007630|Sense of Smell|sense of smell
5151079|NCT01007630|UPSIT|upsit
5151080|NCT01007617|Children|children
5151081|NCT01007617|Cancer|cancer
5151082|NCT01007617|Mucositis|mucositis
5151083|NCT01007617|Laser|laser
5151084|NCT01007617|Prevention|prevention
5151085|NCT01007617|Chemotherapy|chemotherapy
5151086|NCT01007617|Children with malignancies receiving chemotherapy and/or radiotherapy inducing severe mucositis|children with malignancies receiving chemotherapy and/or radiotherapy inducing severe mucositis
5151087|NCT01007604|claudication|claudication
5151088|NCT01007604|pneumatic compression device|pneumatic compression device
5151089|NCT01007578|Paclitaxel|paclitaxel
5151090|NCT01007578|Paclitaxel-coated balloon catheters|paclitaxel-coated balloon catheters
5151091|NCT01007578|Peripheral arterial occlusive disease (PAOD)|peripheral arterial occlusive disease (paod)
5151092|NCT01007578|Plasma levels|plasma levels
5151093|NCT01007578|Femoral artery|femoral artery
5151094|NCT01007578|Popliteal artery|popliteal artery
5151095|NCT01007578|Peripheral arterial disease (PAD) including stenotic or occluded femoro-popliteal arteries due to atherosclerosis|peripheral arterial disease (pad) including stenotic or occluded femoro-popliteal arteries due to atherosclerosis
5151096|NCT01007565|periarticular injection|periarticular injection
5151097|NCT01007552|Biliary Duct Cancer|biliary duct cancer
5151098|NCT01007552|Cancer of the Gallbladder|cancer of the gallbladder
5151099|NCT01007552|Adenocarcinoma of the Gall Bladder|adenocarcinoma of the gall bladder
5151100|NCT01007552|Adenocarcinoma of the Biliary Ducts|adenocarcinoma of the biliary ducts
5151101|NCT01007552|Cholangiocarcinoma|cholangiocarcinoma
5151102|NCT01007552|Extrahepatic cholangiocarcinoma|extrahepatic cholangiocarcinoma
5151103|NCT01007526|Extranodal Lymphoma|extranodal lymphoma
5151104|NCT01007526|Natural killer cell|natural killer cell
5151105|NCT01007526|T cell|t cell
5151106|NCT01007526|Radiotherapy|radiotherapy
5151107|NCT01007526|Chemotherapy|chemotherapy
5151108|NCT01007513|Prematurity|prematurity
5151109|NCT01007513|Inflammation|inflammation
5151110|NCT01007513|Transvaginal ultrasound|transvaginal ultrasound
5151111|NCT01007513|Vaginal secretion|vaginal secretion
5151112|NCT01007513|Inflammatory process|inflammatory process
5151113|NCT01007513|Neonatal morbidity|neonatal morbidity
5151114|NCT01007500|Postoperative nausea and vomiting after video-assisted thoracoscopic surgery|postoperative nausea and vomiting after video-assisted thoracoscopic surgery
5151115|NCT01007487|Plastic wound protector|plastic wound protector
5151116|NCT01007487|Plastic wound retractor|plastic wound retractor
5151117|NCT01007487|Bacterial translocation|bacterial translocation
5151118|NCT01007487|Surgical site infection|surgical site infection
5151119|NCT01007487|Abdominal surgery|abdominal surgery
5151120|NCT01007487|Wound infection|wound infection
5151121|NCT01007461|Acute Myocardial Infarction (AMI)|acute myocardial infarction (ami)
5151122|NCT01007461|STEMI|stemi
5151123|NCT01007461|Acute ST-Segment Elevation Myocardial Infraction (STEMI)|acute st-segment elevation myocardial infraction (stemi)
5151124|NCT01007448|CTCL|ctcl
5151125|NCT01007448|bexarotene|bexarotene
5151126|NCT01007448|Targretin|targretin
5151127|NCT01007448|Refractory Cutaneous T-cell Lymphoma|refractory cutaneous t-cell lymphoma
5151128|NCT01007448|cutaneous T-cell Lymphoma|cutaneous t-cell lymphoma
5151129|NCT01007448|MF|mf
5151130|NCT01007448|Mycoses fungoides|mycoses fungoides
5151131|NCT01007422|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5151132|NCT01007422|pain|pain
5151133|NCT01007409|To assess food effect on the pharmacokinetics of fimasartan in healthy male volunteers|to assess food effect on the pharmacokinetics of fimasartan in healthy male volunteers
5151134|NCT01007396|Interferon-gamma release assay|interferon-gamma release assay
5151135|NCT01007383|Safety and tolerability of LEO 27847|safety and tolerability of leo 27847
5151136|NCT01007370|tracheal intubation|tracheal intubation
5151137|NCT01007370|supraglottic airway devices|supraglottic airway devices
5151138|NCT01007344|flaxseed|flaxseed
5151139|NCT01007344|hypercholesterolemia|hypercholesterolemia
5151140|NCT01007344|children|children
5151141|NCT01007331|Infants|infants
5151142|NCT01007331|Atopic Dermatitis|atopic dermatitis
5151143|NCT01007331|SCORAD|scorad
5151144|NCT01007331|IgE|ige
5151145|NCT01007331|Eosinophil Cation Protein|eosinophil cation protein
5151146|NCT01007331|Calprotectin|calprotectin
5151147|NCT01007331|Intestinal microflora|intestinal microflora
5151148|NCT01007292|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
5151149|NCT01007292|relapsed|relapsed
5151150|NCT01007292|CD20-Positive|cd20-positive
5151151|NCT01007292|YM155|ym155
5151152|NCT01007279|Percutaneous angioplasty|percutaneous angioplasty
5151153|NCT01007279|Myocardial Infarction|myocardial infarction
5151154|NCT01007266|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
5151155|NCT01007266|Adolescents|adolescents
5151156|NCT01007266|Pediatric|pediatric
5151157|NCT01007266|Patient Partner|patient partner
5151158|NCT01007266|Buddy|buddy
5151159|NCT01007266|Obesity|obesity
5151160|NCT01007266|Type 2 Diabetes|type 2 diabetes
5151161|NCT01007240|head and neck carcinoma|head and neck carcinoma
5151162|NCT01007240|obturators|obturators
5151163|NCT01007240|maxillectomy|maxillectomy
5151164|NCT01007240|soft liner|soft liner
5151165|NCT01007240|nano particles|nano particles
5151166|NCT01007240|antibacterial properties|antibacterial properties
5151167|NCT01007240|patients post maxillectomy|patients post maxillectomy
5151168|NCT01007214|Prostate cancer|prostate cancer
5151169|NCT01007214|Prostatectomy|prostatectomy
5151170|NCT01007201|Influenza|influenza
5151171|NCT01007201|H1N1|h1n1
5151172|NCT01007201|vaccine|vaccine
5151173|NCT01007201|Immunogenicity|immunogenicity
5151174|NCT01007188|almond|almond
5151175|NCT01007188|nuts|nuts
5151176|NCT01007188|energy value|energy value
5151177|NCT01007188|cardiovascular disease|cardiovascular disease
5151178|NCT01007188|phytonutrient|phytonutrient
5151179|NCT01007188|gene expression|gene expression
5151180|NCT01007188|energy value of almonds|energy value of almonds
5151181|NCT01007188|energy|energy
5151182|NCT01007175|TNF inhibitor|tnf inhibitor
5151183|NCT01007175|Multiple ascending dose study|multiple ascending dose study
5151184|NCT01007149|Severe asthma,|severe asthma,
5151185|NCT01007149|non-atopic,|non-atopic,
5151186|NCT01007149|omalizumab|omalizumab
5151187|NCT01007136|tDCS|tdcs
5151188|NCT01007136|stroke|stroke
5151189|NCT01007136|functional MRI|functional mri
5151190|NCT01007136|TMS|tms
5151191|NCT01007123|Chronic idiopathic constipation|chronic idiopathic constipation
5151192|NCT01007123|A3309|a3309
5151193|NCT01007110|DHA|dha
5151194|NCT01007097|Diabetes Mellitus, Non Insulin Dependent|diabetes mellitus, non insulin dependent
5151195|NCT01007097|Diabetes Mellitus, Type II|diabetes mellitus, type ii
5151196|NCT01007097|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
5151197|NCT01007097|Drug Therapy|drug therapy
5151198|NCT01007084|pain|pain
5151199|NCT01007084|trauma|trauma
5151200|NCT01007084|propranolol|propranolol
5151201|NCT01007058|Urinary Bladder|urinary bladder
5151202|NCT01007058|Non-muscle-invasive transitional cell carcinoma|non-muscle-invasive transitional cell carcinoma
5151203|NCT01007058|Intact bladder|intact bladder
5151204|NCT01007058|Intravesical Bladder Cancer Therapy|intravesical bladder cancer therapy
5151205|NCT01007058|Tumor Recurrence|tumor recurrence
5151206|NCT01007058|Surrogate markers of response|surrogate markers of response
5151207|NCT01007058|BCG|bcg
5151208|NCT01007058|Bacillus Calmette Guérin|bacillus calmette guérin
5151209|NCT01007058|Interferon-alfa-2b|interferon-alfa-2b
5151210|NCT01007058|IFN-alfa-2b|ifn-alfa-2b
5151211|NCT01007058|Interferon|interferon
5151212|NCT01007058|Fluorescence in situ hybridization|fluorescence in situ hybridization
5151213|NCT01007058|FISH|fish
5151214|NCT01007045|deep vein thrombosis|deep vein thrombosis
5151215|NCT01007045|venous thromboembolic disorders|venous thromboembolic disorders
5151216|NCT01007045|diagnostic ultrasound|diagnostic ultrasound
5151217|NCT01007032|anti-IGF-IR|anti-igf-ir
5151218|NCT01007032|monoclonal|monoclonal
5151219|NCT01007032|solid tumor|solid tumor
5151220|NCT01007032|insulin-like growth factor|insulin-like growth factor
5151221|NCT01007019|Safety, tolerability and PK/PD|safety, tolerability and pk/pd
5151222|NCT01007006|Telepharmacy Robotic Medicine Delivery Unit|telepharmacy robotic medicine delivery unit
5151223|NCT01007006|Brain Injuries|brain injuries
5151224|NCT01007006|Stress Disorders|stress disorders
5151225|NCT01007006|Combat disorders|combat disorders
5151226|NCT01007006|Polytrauma|polytrauma
5151227|NCT01007006|Adherence|adherence
5151228|NCT01006967|balance|balance
5151229|NCT01006967|accidental falls|accidental falls
5151230|NCT01006967|physical therapy|physical therapy
5151231|NCT01006967|ActiveStep|activestep
5151232|NCT01006967|older adults|older adults
5151233|NCT01006954|Poor responder|poor responder
5151234|NCT01006954|Flare up|flare up
5151235|NCT01006954|Micro dose GnRH agonist flare up|micro dose gnrh agonist flare up
5151236|NCT01006954|IVF/ICSI|ivf/icsi
5151237|NCT01006941|Multiple sclerosis|multiple sclerosis
5151238|NCT01006941|safety|safety
5151239|NCT01006941|MRI|mri
5151240|NCT01006941|immunological|immunological
5151241|NCT01006941|Helminths|helminths
5151242|NCT01006941|Trichuris suis|trichuris suis
5151243|NCT01006928|Subjective health feeling|subjective health feeling
5151244|NCT01006928|NICU|nicu
5151245|NCT01006928|team support|team support
5151246|NCT01006915|Diabetic sensorimotor polyneuropathy|diabetic sensorimotor polyneuropathy
5151247|NCT01006902|Elderly|elderly
5151248|NCT01006902|Function|function
5151249|NCT01006902|Oncologic therapy|oncologic therapy
5151250|NCT01006902|Functional change with chemotherapy|functional change with chemotherapy
5151251|NCT01006876|coumadin|coumadin
5151252|NCT01006876|peri-procedural thromboembolism|peri-procedural thromboembolism
5151253|NCT01006876|RFCA|rfca
5151254|NCT01006876|high risk atrial fibrillation|high risk atrial fibrillation
5151255|NCT01006863|Ephedrine|ephedrine
5151256|NCT01006863|phenylephrine|phenylephrine
5151257|NCT01006863|hypotension|hypotension
5151258|NCT01006863|propofol|propofol
5151259|NCT01006863|anesthesia|anesthesia
5151260|NCT01006863|cardiac valve surgery|cardiac valve surgery
5151261|NCT01006837|trauma patients|trauma patients
5151262|NCT01006837|severe injury|severe injury
5151263|NCT01006837|ISS ≥9|iss ≥9
5151264|NCT01006824|Capsule endoscopy|capsule endoscopy
5151265|NCT01006824|gastrointestinal hemorrhage|gastrointestinal hemorrhage
5151266|NCT01006811|West syndrome|west syndrome
5151267|NCT01006811|Hypsarrhythmia|hypsarrhythmia
5151268|NCT01006798|Virus Diseases|virus diseases
5151269|NCT01006798|Respiratory Tract Diseases|respiratory tract diseases
5151270|NCT01006798|Vaccine|vaccine
5151271|NCT01006785|Breast Cancer|breast cancer
5151272|NCT01006785|DLBS 1425|dlbs 1425
5151273|NCT01006785|Cancer|cancer
5151274|NCT01006785|Advanced/Metastatic (Stage IIIB/IV) Breast Cancer|advanced/metastatic (stage iiib/iv) breast cancer
5151275|NCT01006772|Stroke|stroke
5151276|NCT01006772|Ankle Foot Orthosis|ankle foot orthosis
5151277|NCT01006772|Walking Speed|walking speed
5151278|NCT01006772|Gait|gait
5151279|NCT01006772|Rehabilitation|rehabilitation
5151280|NCT01006772|Hemiplegia|hemiplegia
5151281|NCT01006759|Leprosy|leprosy
5151282|NCT01006759|Disability Evaluation|disability evaluation
5151283|NCT01006759|Quality of Life|quality of life
5151284|NCT01006759|Sensation|sensation
5151285|NCT01006746|Remote monitoring|remote monitoring
5151474|NCT01005927|Girls|girls
5151286|NCT01006746|Defibrillators|defibrillators
5151287|NCT01006746|Survey|survey
5151288|NCT01006746|Indication for ICD (primary and secondary prevention)|indication for icd (primary and secondary prevention)
5151289|NCT01006733|pharmacogenetics|pharmacogenetics
5151290|NCT01006733|arthroplasty|arthroplasty
5151291|NCT01006733|VKORC1|vkorc1
5151292|NCT01006733|thromboembolism|thromboembolism
5151293|NCT01006733|warfarin|warfarin
5151294|NCT01006720|Residual neuromuscular block|residual neuromuscular block
5151295|NCT01006720|post-operative residual curarization|post-operative residual curarization
5151296|NCT01006720|PORC|porc
5151297|NCT01006720|sugammadex|sugammadex
5151298|NCT01006720|neostigmine|neostigmine
5151299|NCT01006694|depression|depression
5151300|NCT01006694|collaborative care|collaborative care
5151301|NCT01006694|Vietnam|vietnam
5151302|NCT01006694|behavioral activation|behavioral activation
5151303|NCT01006681|rheumatoid|rheumatoid
5151304|NCT01006681|SLE|sle
5151305|NCT01006681|Psoriatic arthritis|psoriatic arthritis
5151306|NCT01006681|Ankylosing|ankylosing
5151307|NCT01006681|Influenza H1N1|influenza h1n1
5151308|NCT01006681|Vaccine|vaccine
5151309|NCT01006681|Vaccination against H1N1 in rheumatic diseases|vaccination against h1n1 in rheumatic diseases
5151310|NCT01006668|Neonates|neonates
5151311|NCT01006668|Intensive care|intensive care
5151312|NCT01006668|Endotracheal intubation|endotracheal intubation
5151313|NCT01006668|Neonates in intensive care|neonates in intensive care
5151314|NCT01006655|asthma|asthma
5151315|NCT01006655|preschool children|preschool children
5151316|NCT01006655|bronchial hyperresponsiveness|bronchial hyperresponsiveness
5151317|NCT01006655|beclometasone dipropionate - HFA|beclometasone dipropionate - hfa
5151318|NCT01006655|Qvar|qvar
5151319|NCT01006655|Adenosine Challenge test|adenosine challenge test
5151320|NCT01006629|Efficacy of palivizumab|efficacy of palivizumab
5151321|NCT01006629|Respiratory syncytial virus (RSV) infection|respiratory syncytial virus (rsv) infection
5151322|NCT01006629|Prevention of severe RSV infection|prevention of severe rsv infection
5151323|NCT01006629|Preterm infants|preterm infants
5151324|NCT01006629|Infants with bronchopulmonary dysplasia|infants with bronchopulmonary dysplasia
5151325|NCT01006629|Infants with hemodynamically significant congenital heart disease|infants with hemodynamically significant congenital heart disease
5151326|NCT01006603|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
5151327|NCT01006603|elderly patients|elderly patients
5151328|NCT01006603|saxagliptin|saxagliptin
5151329|NCT01006603|randomised|randomised
5151330|NCT01006603|double-blind|double-blind
5151331|NCT01006590|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
5151332|NCT01006590|Saxagliptin|saxagliptin
5151333|NCT01006590|Randomised|randomised
5151334|NCT01006590|Double-blind|double-blind
5151335|NCT01006577|rectal cancer|rectal cancer
5151336|NCT01006577|side-to-end anastomosis|side-to-end anastomosis
5151337|NCT01006577|colon J pouch|colon j pouch
5151338|NCT01006577|fecal incontinence|fecal incontinence
5151339|NCT01006577|anorectal function|anorectal function
5151340|NCT01006577|Are there differences between side-to-end anastomosis and colon J pouch in|are there differences between side-to-end anastomosis and colon j pouch in
5151341|NCT01006577|bowel function (fecal incontinence, frequency of bowel movements, rectal urgency, incomplete evacuation)|bowel function (fecal incontinence, frequency of bowel movements, rectal urgency, incomplete evacuation)
5151342|NCT01006577|quality of life|quality of life
5151343|NCT01006577|postoperative complications|postoperative complications
5151344|NCT01006577|operation time/ institutional costs|operation time/ institutional costs
5151345|NCT01006564|Magnetic Resonance Imaging|magnetic resonance imaging
5151346|NCT01006564|Prostate Cancer|prostate cancer
5151347|NCT01006564|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
5151348|NCT01006564|Radiotherapy planning|radiotherapy planning
5151349|NCT01006551|Schizophrenia Spectrum Disorders|schizophrenia spectrum disorders
5151350|NCT01006538|Wet Age-related Macular Degeneration|wet age-related macular degeneration
5151351|NCT01006538|Predominantly classic|predominantly classic
5151352|NCT01006538|Minimally classic|minimally classic
5151353|NCT01006538|Occult with no classic|occult with no classic
5151354|NCT01006538|Retinal Angiomatous Proliferation (RAP) lesions|retinal angiomatous proliferation (rap) lesions
5151355|NCT01006499|neonatal sepsis|neonatal sepsis
5151356|NCT01006499|pentoxyfilline|pentoxyfilline
5151357|NCT01006499|pentaglobin|pentaglobin
5151358|NCT01006499|biomarker|biomarker
5151359|NCT01006499|To reduce mortality in neonatal sepsis|to reduce mortality in neonatal sepsis
5151360|NCT01006486|Oral anticoagulants|oral anticoagulants
5151361|NCT01006486|Warfarin|warfarin
5151362|NCT01006486|Anticoagulation clinic|anticoagulation clinic
5151363|NCT01006486|Thrombosis|thrombosis
5151364|NCT01006486|Hemorrhage|hemorrhage
5151365|NCT01006473|Chagas Disease|chagas disease
5151366|NCT01006473|Chagas Cardiomyopathy|chagas cardiomyopathy
5151367|NCT01006473|Exercise Movement Techniques|exercise movement techniques
5151368|NCT01006460|Quality of life and subjective well-being in middle aged women|quality of life and subjective well-being in middle aged women
5151369|NCT01006447|tai chi|tai chi
5151370|NCT01006447|exercise|exercise
5151371|NCT01006447|older adults|older adults
5151372|NCT01006447|exercise persistence|exercise persistence
5151373|NCT01006434|Stroke|stroke
5151374|NCT01006434|Thrombolysis|thrombolysis
5151375|NCT01006421|phototherapy|phototherapy
5151376|NCT01006421|Gingko biloba|gingko biloba
5151377|NCT01006421|repigmentation|repigmentation
5151378|NCT01006408|Neuropathy|neuropathy
5151379|NCT01006395|Prostate Cancer|prostate cancer
5151380|NCT01006395|Androgen deprivation|androgen deprivation
5151381|NCT01006395|Bone Health|bone health
5151382|NCT01006395|Insulin resistance|insulin resistance
5151383|NCT01006395|Men with nonmetastatic prostate cancer receiving androgen deprivation|men with nonmetastatic prostate cancer receiving androgen deprivation
5151384|NCT01006369|stage IV colon cancer|stage iv colon cancer
5151385|NCT01006369|stage IV rectal cancer|stage iv rectal cancer
5151386|NCT01006369|recurrent colon cancer|recurrent colon cancer
5151387|NCT01006369|recurrent rectal cancer|recurrent rectal cancer
5151388|NCT01006356|Hydromorphone hydrochloride Oral Osmotic System|hydromorphone hydrochloride oral osmotic system
5151389|NCT01006356|Jurnista|jurnista
5151390|NCT01006317|Maternal health services|maternal health services
5151391|NCT01006317|utilization|utilization
5151392|NCT01006317|education|education
5151393|NCT01006317|randomized controlled trial|randomized controlled trial
5151394|NCT01006317|cost|cost
5151395|NCT01006317|clinical skills|clinical skills
5151396|NCT01006317|rural China|rural china
5151397|NCT01006304|JNJ-39439335|jnj-39439335
5151398|NCT01006304|Placebo|placebo
5151399|NCT01006304|Pain|pain
5151400|NCT01006304|Pain Measurements|pain measurements
5151401|NCT01006304|Adults|adults
5151402|NCT01006304|Men|men
5151403|NCT01006278|biomarker|biomarker
5151404|NCT01006278|knee arthroscopy|knee arthroscopy
5151405|NCT01006278|pain|pain
5151406|NCT01006252|metastatic|metastatic
5151407|NCT01006252|second-line|second-line
5151408|NCT01006239|Cancer|cancer
5151409|NCT01006213|Motivational Intervention|motivational intervention
5151410|NCT01006200|granulation tissue|granulation tissue
5151411|NCT01006200|benign|benign
5151412|NCT01006200|tracheal stenosis|tracheal stenosis
5151413|NCT01006200|ultraflex|ultraflex
5151414|NCT01006200|COPD|copd
5151415|NCT01006187|Analgesics|analgesics
5151416|NCT01006187|Influenza|influenza
5151417|NCT01006187|Vapocoolant|vapocoolant
5151418|NCT01006187|vaccination|vaccination
5151419|NCT01006187|pain|pain
5151420|NCT01006148|Metopic Craniosynostosis|metopic craniosynostosis
5151421|NCT01006122|Randomized|randomized
5151422|NCT01006122|double-blind|double-blind
5151423|NCT01006122|placebo-controlled|placebo-controlled
5151424|NCT01006122|crossover study of PF-03654746 in Excessive Daytime Sleepiness associated with Narcolepsy|crossover study of pf-03654746 in excessive daytime sleepiness associated with narcolepsy
5151425|NCT01006109|MEG|meg
5151426|NCT01006109|Repetitive TMS (rTMS)|repetitive tms (rtms)
5151427|NCT01006109|Decision-Making|decision-making
5151428|NCT01006109|Healthy Volunteers|healthy volunteers
5151429|NCT01006109|HV|hv
5151430|NCT01006109|Healthy Volunteer|healthy volunteer
5151431|NCT01006096|Psoriasis|psoriasis
5151432|NCT01006096|double-blind|double-blind
5151433|NCT01006096|randomized|randomized
5151434|NCT01006096|placebo-controlled|placebo-controlled
5151435|NCT01006096|erlotinib|erlotinib
5151436|NCT01006096|efficacy|efficacy
5151437|NCT01006083|Aspirin|aspirin
5151438|NCT01006083|Plavix|plavix
5151439|NCT01006083|antiplatelet therapy|antiplatelet therapy
5151440|NCT01006083|Hemorrhage|hemorrhage
5151441|NCT01006083|ischemic events|ischemic events
5151442|NCT01006070|multiple myeloma|multiple myeloma
5151443|NCT01006070|spinal disease|spinal disease
5151444|NCT01006044|Glioblastoma multiforme, vaccine, dendritic cells, glioma|glioblastoma multiforme, vaccine, dendritic cells, glioma
5151445|NCT01006031|Liver cirrhosis|liver cirrhosis
5151446|NCT01006031|Hepatitis C virus|hepatitis c virus
5151447|NCT01006031|HIV infection|hiv infection
5151448|NCT01006031|Pegylated interferon alfa-2a|pegylated interferon alfa-2a
5151449|NCT01006031|Ribavirin|ribavirin
5151450|NCT01006031|Treatment experienced|treatment experienced
5151451|NCT01006018|Prediabetic State|prediabetic state
5151453|NCT01006005|Treatment experienced|treatment experienced
5151454|NCT01005992|Scars secondary to injuries to tissues caused by contact with physical (heat, electricity) o chemical agent.|scars secondary to injuries to tissues caused by contact with physical (heat, electricity) o chemical agent.
5151455|NCT01005979|Leukemia, Lymphocytic, Chronic, B-Cell|leukemia, lymphocytic, chronic, b-cell
5151456|NCT01005979|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
5151457|NCT01005979|Lymphoma, Small Lymphocytic|lymphoma, small lymphocytic
5151458|NCT01005979|Lymphoma|lymphoma
5151459|NCT01005979|Leukemia|leukemia
5151460|NCT01005966|remineralization|remineralization
5151461|NCT01005966|enamel|enamel
5151462|NCT01005966|in situ|in situ
5151463|NCT01005966|fluoride|fluoride
5151464|NCT01005966|caries|caries
5151465|NCT01005953|Autism|autism
5151466|NCT01005953|Behavioral Observations|behavioral observations
5151467|NCT01005953|Electronic diaries|electronic diaries
5151468|NCT01005953|Professionals treating children 3-10 with lower functioning autism|professionals treating children 3-10 with lower functioning autism
5151469|NCT01005940|Sleep Apnea Syndromes|sleep apnea syndromes
5151470|NCT01005940|Insulin Resistance|insulin resistance
5151471|NCT01005940|Mandibular advancement device|mandibular advancement device
5151472|NCT01005927|Calcium|calcium
5151473|NCT01005927|Bone and Bones|bone and bones
5151475|NCT01005927|Bone Mineralization|bone mineralization
5151476|NCT01005927|Fiber|fiber
5151477|NCT01005927|Fructooligosaccharide|fructooligosaccharide
5151478|NCT01005927|Female|female
5151479|NCT01005927|Healthy|healthy
5151480|NCT01005927|Adolescents|adolescents
5151481|NCT01005914|adults|adults
5151482|NCT01005914|Philadelphia chromosome precursor ALL,|philadelphia chromosome precursor all,
5151483|NCT01005914|T-cell ALL|t-cell all
5151484|NCT01005914|untreated ALL|untreated all
5151485|NCT01005901|COPD|copd
5151486|NCT01005901|NVA|nva
5151487|NCT01005901|FEV1|fev1
5151488|NCT01005888|Hereditary angioedema|hereditary angioedema
5151489|NCT01005888|HAE|hae
5151490|NCT01005888|C1 esterase inhibitor (human)|c1 esterase inhibitor (human)
5151491|NCT01005888|C1INH-nf|c1inh-nf
5151492|NCT01005875|Hepatocellular carcinoma|hepatocellular carcinoma
5151493|NCT01005875|HCC|hcc
5151494|NCT01005875|Liver Cancer|liver cancer
5151495|NCT01005875|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
5151496|NCT01005862|Alzheimer's disease antibody leucine ABeta|alzheimer's disease antibody leucine abeta
5151497|NCT01005849|Probiotics|probiotics
5151498|NCT01005849|Traveler's diarrhea|traveler's diarrhea
5151499|NCT01005849|Prevention|prevention
5151500|NCT01005836|Cognitive behavioral therapy|cognitive behavioral therapy
5151501|NCT01005836|Anxiety treatment|anxiety treatment
5151502|NCT01005836|Depression treatment|depression treatment
5151503|NCT01005836|Child treatment|child treatment
5151504|NCT01005836|Usual care|usual care
5151505|NCT01005797|Renal Cancer|renal cancer
5151506|NCT01005797|Non Small Cell Lung Cancer (NSCLC)|non small cell lung cancer (nsclc)
5151507|NCT01005797|Solid Tumor|solid tumor
5151508|NCT01005797|Soft tissue sarcoma|soft tissue sarcoma
5151509|NCT01005797|Sorafenib|sorafenib
5151510|NCT01005797|Panobinostat|panobinostat
5151511|NCT01005784|GnRH antagonists|gnrh antagonists
5151512|NCT01005771|Secondarily infected traumatic lesions|secondarily infected traumatic lesions
5151513|NCT01005758|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
5151514|NCT01005758|Philadelphia chromosome positive adult precursor acute lymphoblastic leukemia|philadelphia chromosome positive adult precursor acute lymphoblastic leukemia
5151515|NCT01005758|L1 adult acute lymphoblastic leukemia|l1 adult acute lymphoblastic leukemia
5151516|NCT01005758|L2 adult acute lymphoblastic leukemia|l2 adult acute lymphoblastic leukemia
5151517|NCT01005758|T-cell adult acute lymphoblastic leukemia|t-cell adult acute lymphoblastic leukemia
5151518|NCT01005745|skin|skin
5151519|NCT01005745|adoptive cell therapy|adoptive cell therapy
5151520|NCT01005745|tumor-infiltrating lymphocytes (TIL)|tumor-infiltrating lymphocytes (til)
5151521|NCT01005745|lymphodepletion|lymphodepletion
5151522|NCT01005732|hypertrophic|hypertrophic
5151523|NCT01005732|scar|scar
5151524|NCT01005732|burn|burn
5151525|NCT01005732|cicatrix|cicatrix
5151526|NCT01005732|pressure|pressure
5151527|NCT01005732|garment|garment
5151528|NCT01005693|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5151529|NCT01005667|Nulliparous women in spontaneous labor|nulliparous women in spontaneous labor
5151530|NCT01005654|Gene Expression|gene expression
5151531|NCT01005654|Epigenetic (methylation)|epigenetic (methylation)
5151532|NCT01005654|Tissues Histological Evaluations|tissues histological evaluations
5151533|NCT01005654|Establishment of Tumor Cell Lines|establishment of tumor cell lines
5151534|NCT01005654|Metabolite and Protein Expression|metabolite and protein expression
5151535|NCT01005654|Adrenal Cancer|adrenal cancer
5151536|NCT01005654|Endocrine Tumor|endocrine tumor
5151537|NCT01005654|Thyroid Cancer|thyroid cancer
5151538|NCT01005641|advanced breast cancer|advanced breast cancer
5151539|NCT01005641|hormone-responsive|hormone-responsive
5151540|NCT01005641|metastatic breast cancer|metastatic breast cancer
5151541|NCT01005628|Bortezomib postmarketing surveillance|bortezomib postmarketing surveillance
5151542|NCT01005628|Korea bortezomib PMS|korea bortezomib pms
5151543|NCT01005602|Digoxin|digoxin
5151544|NCT01005602|Pharmacokinetics|pharmacokinetics
5151545|NCT01005602|Dosing|dosing
5151546|NCT01005602|Heart Failure|heart failure
5151547|NCT01005589|Neonatal sepsis|neonatal sepsis
5151548|NCT01005589|Necrotizing enterocolitis|necrotizing enterocolitis
5151549|NCT01005589|CD64 antigen|cd64 antigen
5151550|NCT01005589|Receptors, IgG|receptors, igg
5151551|NCT01005576|Thalassemia|thalassemia
5151552|NCT01005576|Alemtuzumab|alemtuzumab
5151553|NCT01005576|Hematopoietic cell transplant|hematopoietic cell transplant
5151554|NCT01005576|non-myeloablative|non-myeloablative
5151555|NCT01005550|Unilateral spinal anaesthesia|unilateral spinal anaesthesia
5151556|NCT01005550|Hypobaric anaesthesia|hypobaric anaesthesia
5151557|NCT01005550|Ropivacaine|ropivacaine
5151558|NCT01005550|Traumatic hip surgery|traumatic hip surgery
5151559|NCT01005537|stage IV melanoma|stage iv melanoma
5151560|NCT01005524|brain computer interface|brain computer interface
5151561|NCT01005524|P3Speller|p3speller
5151562|NCT01005524|P300|p300
5151563|NCT01005524|Event Related potential|event related potential
5151564|NCT01005524|tetraplegia|tetraplegia
5151565|NCT01005524|Guillain barre syndrome|guillain barre syndrome
5151566|NCT01005524|Feasibility|feasibility
5151567|NCT01005524|Speed of spelling|speed of spelling
5151568|NCT01005524|Accuracy|accuracy
5151569|NCT01005511|Bruxism|bruxism
5151570|NCT01005498|Low carbohydrate diet. Dietary treatment of diabetes mellitus.|low carbohydrate diet. dietary treatment of diabetes mellitus.
5151571|NCT01005498|Diabetes mellitus type 2 and dietary treatment.|diabetes mellitus type 2 and dietary treatment.
5151572|NCT01005485|Myocardial Infarction (MI)|myocardial infarction (mi)
5151573|NCT01005485|Circulating Endothelial Cells (CEC)|circulating endothelial cells (cec)
5151574|NCT01005485|Control Group A: (Vascular Surgery)|control group a: (vascular surgery)
5151575|NCT01005485|Control Group B: (Healthy controls)|control group b: (healthy controls)
5151576|NCT01005472|stage III melanoma|stage iii melanoma
5151577|NCT01005472|stage IV melanoma|stage iv melanoma
5151578|NCT01005472|recurrent melanoma|recurrent melanoma
5151579|NCT01005472|ciliary body and choroid melanoma, medium/large size|ciliary body and choroid melanoma, medium/large size
5151580|NCT01005472|extraocular extension melanoma|extraocular extension melanoma
5151581|NCT01005472|iris melanoma|iris melanoma
5151582|NCT01005472|metastatic intraocular melanoma|metastatic intraocular melanoma
5151583|NCT01005472|recurrent intraocular melanoma|recurrent intraocular melanoma
5151584|NCT01005459|labor pain|labor pain
5151585|NCT01005459|combined spinal epidural labor analgesia|combined spinal epidural labor analgesia
5151586|NCT01005459|CSE analgesia|cse analgesia
5151587|NCT01005459|labor analgesia|labor analgesia
5151588|NCT01005433|dexmedetomidine|dexmedetomidine
5151589|NCT01005433|stress response|stress response
5151590|NCT01005433|cesarean delivery|cesarean delivery
5151591|NCT01005420|Insulin Sensitivity|insulin sensitivity
5151592|NCT01005420|Pre-diabetes|pre-diabetes
5151593|NCT01005420|Diabetes|diabetes
5151594|NCT01005420|Blueberries|blueberries
5151595|NCT01005420|Anthocyanins|anthocyanins
5151596|NCT01005407|HBV vaccine|hbv vaccine
5151597|NCT01005407|Hepatitis B vaccine|hepatitis b vaccine
5151598|NCT01005407|Hepatitis B|hepatitis b
5151599|NCT01005407|Hepatitis|hepatitis
5151600|NCT01005407|HBV|hbv
5151601|NCT01005407|Prevention & Control|prevention & control
5151602|NCT01005407|Healthy|healthy
5151603|NCT01005407|Healthy volunteers|healthy volunteers
5151604|NCT01005381|Calcium|calcium
5151605|NCT01005381|Vitamin D|vitamin d
5151606|NCT01005381|Particle Size|particle size
5151607|NCT01005381|Adolescents|adolescents
5151608|NCT01005381|Bone|bone
5151609|NCT01005381|Osteoporosis|osteoporosis
5151610|NCT01005368|chronic lymphocytic leukemia|chronic lymphocytic leukemia
5151611|NCT01005355|Solid tumor|solid tumor
5151612|NCT01005355|recombinant human IgG1|recombinant human igg1
5151613|NCT01005355|MAB|mab
5151614|NCT01005355|monoclonal antibody|monoclonal antibody
5151615|NCT01005355|VEGFR 2|vegfr 2
5151616|NCT01005355|human vascular endothelial growth factor receptor 2|human vascular endothelial growth factor receptor 2
5151617|NCT01005342|gene expression|gene expression
5151618|NCT01005342|oats|oats
5151619|NCT01005342|rye|rye
5151620|NCT01005342|sugar beet fiber|sugar beet fiber
5151621|NCT01005342|glucose|glucose
5151622|NCT01005342|insulin|insulin
5151623|NCT01005342|triglyceride|triglyceride
5151624|NCT01005342|decreased postprandial glucose|decreased postprandial glucose
5151625|NCT01005342|decreased postprandial insulin|decreased postprandial insulin
5151626|NCT01005342|glycemic index|glycemic index
5151627|NCT01005316|cohort study|cohort study
5151628|NCT01005316|allo-antibodies|allo-antibodies
5151629|NCT01005316|allosensitization|allosensitization
5151630|NCT01005303|Heart Failure|heart failure
5151631|NCT01005303|Micronutrients|micronutrients
5151632|NCT01005303|Vitamin D|vitamin d
5151633|NCT01005303|Inflammation|inflammation
5151634|NCT01005303|Oxidative Stress|oxidative stress
5151635|NCT01005303|Quality of Life|quality of life
5151636|NCT01005303|Physical Functioning|physical functioning
5151637|NCT01005290|cardiovascular|cardiovascular
5151638|NCT01005290|fixed|fixed
5151639|NCT01005290|dose|dose
5151640|NCT01005290|combination|combination
5151641|NCT01005290|pill|pill
5151642|NCT01005290|hypertension|hypertension
5151643|NCT01005277|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
5151644|NCT01005277|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5151645|NCT01005277|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
5151646|NCT01005277|childhood acute myeloid leukemia/other myeloid malignancies|childhood acute myeloid leukemia/other myeloid malignancies
5151647|NCT01005277|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5151648|NCT01005277|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5151649|NCT01005277|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5151650|NCT01005277|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5151651|NCT01005277|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5151652|NCT01005264|diabetic foot|diabetic foot
5151653|NCT01005264|neuropathic plantar ulcer|neuropathic plantar ulcer
5151654|NCT01005264|ulcer healing|ulcer healing
5151655|NCT01005264|non-removable total contact cast|non-removable total contact cast
5151656|NCT01005264|removable cast walker|removable cast walker
5151657|NCT01005251|GERD treatment|gerd treatment
5151658|NCT01005251|Acid and non-acid Reflux|acid and non-acid reflux
5151659|NCT01005251|Heartburn|heartburn
5151660|NCT01005251|Regurgitation|regurgitation
5151661|NCT01005251|Add-on treatment to PPI|add-on treatment to ppi
5151662|NCT01005225|Solid tumor|solid tumor
5151663|NCT01005225|prostate cancer|prostate cancer
5151664|NCT01005225|colon cancer|colon cancer
5151665|NCT01005212|EVAR|evar
5151666|NCT01005212|Ultrasounds|ultrasounds
5151667|NCT01005212|AAA|aaa
5151668|NCT01005212|endoleaks after endovascular repair of AAA|endoleaks after endovascular repair of aaa
5151669|NCT01005199|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
5151670|NCT01005199|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
5151671|NCT01005173|Acetaminophen|acetaminophen
5151672|NCT01005173|APAP|apap
5151673|NCT01005160|Mellitus, type 2|mellitus, type 2
5151674|NCT01005160|pharmacokinetic evaluation|pharmacokinetic evaluation
5151675|NCT01005160|drug interaction between CKD-501 and metformin|drug interaction between ckd-501 and metformin
5151676|NCT01005147|tranexamic acid|tranexamic acid
5151677|NCT01005147|upper GI bleeding|upper gi bleeding
5151678|NCT01005147|blood transfusion|blood transfusion
5151679|NCT01005147|GI bleeding|gi bleeding
5151680|NCT01005108|Hot Flashes for Breast Cancer Patients|hot flashes for breast cancer patients
5151681|NCT01005082|Low salt diet, idiopathic hypercalciuria, calcium stone formers|low salt diet, idiopathic hypercalciuria, calcium stone formers
5151682|NCT01005082|Calcium stone formers with idiopathic hypercalciuria|calcium stone formers with idiopathic hypercalciuria
5151683|NCT01005069|diabetes mellitus|diabetes mellitus
5151684|NCT01005069|DLBS-32|dlbs-32
5151685|NCT01005069|fasting plasma glucose|fasting plasma glucose
5151686|NCT01005069|insulin resistance|insulin resistance
5151687|NCT01005043|non-resectable osteosarcoma|non-resectable osteosarcoma
5151688|NCT01005043|heavy ion radiotherapy|heavy ion radiotherapy
5151689|NCT01005043|particle therapy|particle therapy
5151690|NCT01005043|safety|safety
5151691|NCT01005043|toxicity|toxicity
5151692|NCT01005043|survival|survival
5151693|NCT01005043|radiotherapy|radiotherapy
5151694|NCT01005030|Parkinson Disease|parkinson disease
5151695|NCT01005030|blood|blood
5151696|NCT01005030|plasma|plasma
5151697|NCT01005030|metabolomics|metabolomics
5151698|NCT01005030|spectroscopy|spectroscopy
5151699|NCT01005030|oxidative stress.|oxidative stress.
5151700|NCT01005017|Radiofrequent ablation|radiofrequent ablation
5151701|NCT01005017|Percutaneous radiofrequent therapy|percutaneous radiofrequent therapy
5151702|NCT01005004|PMD|pmd
5151703|NCT01005004|stem cells|stem cells
5151704|NCT01005004|Pelizaeus-Merzbacher Disease|pelizaeus-merzbacher disease
5151705|NCT01005004|human stem cells|human stem cells
5151706|NCT01005004|central nervous system stem cells|central nervous system stem cells
5151707|NCT01004965|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
5151708|NCT01004965|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
5151709|NCT01004965|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5151710|NCT01004965|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5151711|NCT01004965|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5151712|NCT01004965|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5151713|NCT01004965|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5151714|NCT01004952|Skin|skin
5151715|NCT01004952|Sunscreen|sunscreen
5151716|NCT01004952|UVR Protection|uvr protection
5151717|NCT01004952|09-137|09-137
5151718|NCT01004939|prophylaxis|prophylaxis
5151719|NCT01004939|venous thromboembolism|venous thromboembolism
5151720|NCT01004939|postpartum|postpartum
5151721|NCT01004939|fondaparinux|fondaparinux
5151722|NCT01004939|pregnancy|pregnancy
5151723|NCT01004926|Unilateral trans-tibial amputees|unilateral trans-tibial amputees
5151724|NCT01004913|Benign paroxysmal positional vertigo|benign paroxysmal positional vertigo
5151725|NCT01004913|Vestibular evoked myogenic potentials|vestibular evoked myogenic potentials
5151726|NCT01004913|Sacculo-colic reflex|sacculo-colic reflex
5151727|NCT01004900|Glaucoma, Angle Closure|glaucoma, angle closure
5151728|NCT01004900|Selective laser trabeculoplasty|selective laser trabeculoplasty
5151729|NCT01004900|Primary Angle Closure Disease|primary angle closure disease
5151730|NCT01004887|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5151731|NCT01004887|adult giant cell glioblastoma|adult giant cell glioblastoma
5151732|NCT01004887|adult gliosarcoma|adult gliosarcoma
5151733|NCT01004887|childhood high-grade cerebellar astrocytoma|childhood high-grade cerebellar astrocytoma
5151734|NCT01004887|childhood high-grade cerebral astrocytoma|childhood high-grade cerebral astrocytoma
5151735|NCT01004874|malignant glioma|malignant glioma
5151736|NCT01004874|glioblastoma|glioblastoma
5151737|NCT01004874|gliosarcoma|gliosarcoma
5151738|NCT01004874|Avastin|avastin
5151739|NCT01004874|bevacizumab|bevacizumab
5151740|NCT01004874|Topotecan|topotecan
5151741|NCT01004874|Hycamtin|hycamtin
5151742|NCT01004874|Temozolomide|temozolomide
5151743|NCT01004874|Temodar|temodar
5151744|NCT01004874|Pro00019960|pro00019960
5151745|NCT01004874|Vredenburgh|vredenburgh
5151746|NCT01004874|Duke|duke
5151747|NCT01004874|Desjardins|desjardins
5151748|NCT01004861|PVNS|pvns
5151749|NCT01004848|Pre-diabetes|pre-diabetes
5151750|NCT01004848|pre-diabetic state|pre-diabetic state
5151751|NCT01004848|community-based participatory research|community-based participatory research
5151752|NCT01004848|overweight|overweight
5151753|NCT01004848|weight loss intervention, peer-led lifestyle education|weight loss intervention, peer-led lifestyle education
5151754|NCT01004835|migraine|migraine
5151755|NCT01004822|Treatment Non-Randomized Single Group Assignment Safety Study Neoplasms Carcinoma Cancer Malignancy|treatment non-randomized single group assignment safety study neoplasms carcinoma cancer malignancy
5151756|NCT01004809|Dutasteride|dutasteride
5151757|NCT01004796|breast cancer|breast cancer
5151758|NCT01004783|stage I Wilms tumor|stage i wilms tumor
5151759|NCT01004783|stage II Wilms tumor|stage ii wilms tumor
5151760|NCT01004783|epithelial predominant Wilms tumor|epithelial predominant wilms tumor
5151761|NCT01004770|CECT - Contrast-enhanced computed tomography|cect - contrast-enhanced computed tomography
5151762|NCT01004770|HCG - Human Chorionic Gonadotropin|hcg - human chorionic gonadotropin
5151763|NCT01004770|HU - Hounsfield Units|hu - hounsfield units
5151764|NCT01004770|Patient Safety|patient safety
5151765|NCT01004770|Tolerance|tolerance
5151766|NCT01004770|Pharmacokinetic|pharmacokinetic
5151767|NCT01004757|diastolic function|diastolic function
5151768|NCT01004757|postmeal glucose|postmeal glucose
5151769|NCT01004757|insulin resistance|insulin resistance
5151770|NCT01004757|low carb diet|low carb diet
5151771|NCT01004757|type 2 diabetes|type 2 diabetes
5151772|NCT01004744|Postmenopausal women|postmenopausal women
5151773|NCT01004744|ER+|er+
5151774|NCT01004744|Estrogen positive|estrogen positive
5151775|NCT01004744|PR+|pr+
5151776|NCT01004744|Progesterone positive|progesterone positive
5151777|NCT01004731|EGFr|egfr
5151778|NCT01004731|cetuximab|cetuximab
5151779|NCT01004731|gemcitabine|gemcitabine
5151780|NCT01004731|carboplatin|carboplatin
5151781|NCT01004731|NSCLC|nsclc
5151782|NCT01004705|cardiovascular|cardiovascular
5151783|NCT01004705|fixed|fixed
5151784|NCT01004705|dose|dose
5151785|NCT01004705|combination|combination
5151786|NCT01004705|pill|pill
5151787|NCT01004705|LDL|ldl
5151788|NCT01004705|cholesterol|cholesterol
5151789|NCT01004666|Breast cancer|breast cancer
5151790|NCT01004666|Scintimammography|scintimammography
5151791|NCT01004666|CZT|czt
5151792|NCT01004666|High-risk|high-risk
5151793|NCT01004640|chronic myelogenous leukemia|chronic myelogenous leukemia
5151794|NCT01004627|fistula|fistula
5151795|NCT01004627|ultrasound|ultrasound
5151796|NCT01004627|angioaccess|angioaccess
5151797|NCT01004627|preoperative vein mapping|preoperative vein mapping
5151798|NCT01004627|Haemodialysis|haemodialysis
5151799|NCT01004627|Angioaccess surgery|angioaccess surgery
5151800|NCT01004601|pretreated failure advanced stage IIIb/IV NSCLC|pretreated failure advanced stage iiib/iv nsclc
5151801|NCT01004588|elderly|elderly
5151802|NCT01004588|sarcopenia|sarcopenia
5151803|NCT01004588|protein drink|protein drink
5151804|NCT01004588|resistance training|resistance training
5151805|NCT01004575|stents|stents
5151806|NCT01004575|bare metal stents|bare metal stents
5151807|NCT01004562|breast cancer|breast cancer
5151808|NCT01004549|Patients who have previously undergone bilateral intraocular lens implantation|patients who have previously undergone bilateral intraocular lens implantation
5151809|NCT01004523|childhood low-grade cerebellar astrocytoma|childhood low-grade cerebellar astrocytoma
5151810|NCT01004523|childhood low-grade cerebral astrocytoma|childhood low-grade cerebral astrocytoma
5151811|NCT01004523|childhood mixed glioma|childhood mixed glioma
5151812|NCT01004523|adult mixed glioma|adult mixed glioma
5151813|NCT01004523|adult diffuse astrocytoma|adult diffuse astrocytoma
5151814|NCT01004523|childhood oligodendroglioma|childhood oligodendroglioma
5151815|NCT01004523|adult oligodendroglioma|adult oligodendroglioma
5151816|NCT01004510|malignant pleural effusion|malignant pleural effusion
5151817|NCT01004510|non small cell lung cancer|non small cell lung cancer
5151818|NCT01004497|Acute lymphoblastic leukemia, adult, dasatinib|acute lymphoblastic leukemia, adult, dasatinib
5151819|NCT01004484|non-patients|non-patients
5151820|NCT01004484|non-diarrhea functional bowel symptoms|non-diarrhea functional bowel symptoms
5151821|NCT01004458|fibromyalgia|fibromyalgia
5151822|NCT01004458|cognitive behavioral therapy|cognitive behavioral therapy
5151823|NCT01004458|women|women
5151824|NCT01004458|pain|pain
5151825|NCT01004458|stress|stress
5151826|NCT01004458|type A behavior|type a behavior
5151827|NCT01004445|Pneumonia|pneumonia
5151828|NCT01004445|Adjunctive treatment|adjunctive treatment
5151829|NCT01004445|Gram-negative bacteria|gram-negative bacteria
5151830|NCT01004432|humira, remicade|humira, remicade
5151831|NCT01004432|rheumatoid arthritis|rheumatoid arthritis
5151832|NCT01004432|enbrel failure|enbrel failure
5151833|NCT01004432|humira failure|humira failure
5151834|NCT01004432|arthritis|arthritis
5151835|NCT01004432|enbrel|enbrel
5151836|NCT01004419|non small cell lung cancer|non small cell lung cancer
5151837|NCT01004419|vandetanib|vandetanib
5151838|NCT01004419|ZD6474|zd6474
5151839|NCT01004419|fulvestrant|fulvestrant
5151840|NCT01004419|faslodex|faslodex
5151841|NCT01004419|phase 1|phase 1
5151842|NCT01004406|plaque|plaque
5151843|NCT01004406|LDL|ldl
5151844|NCT01004406|statin|statin
5151845|NCT01004406|endothelial|endothelial
5151846|NCT01004406|apheresis|apheresis
5151847|NCT01004406|acute coronary syndrome|acute coronary syndrome
5151848|NCT01004393|Methylnaltrexone|methylnaltrexone
5151849|NCT01004393|Constipation|constipation
5151850|NCT01004393|Narcotic Antagonists|narcotic antagonists
5151851|NCT01004393|Analgesics, Opioid|analgesics, opioid
5151852|NCT01004393|Neoplasms|neoplasms
5151853|NCT01004380|Epithelial Ovarian Cancer|epithelial ovarian cancer
5151854|NCT01004380|Ovarian Cancer|ovarian cancer
5151855|NCT01004367|Promoting healthy lifestyles in adolescents in Ecuador to prevent overweight|promoting healthy lifestyles in adolescents in ecuador to prevent overweight
5151856|NCT01004354|Psychiatric illnesses|psychiatric illnesses
5151857|NCT01004354|Vitamin D deficiency|vitamin d deficiency
5151858|NCT01004354|Obesity|obesity
5151859|NCT01004341|pediatric obesity|pediatric obesity
5151860|NCT01004341|parenting style|parenting style
5151861|NCT01004341|feeding style|feeding style
5151862|NCT01004341|behavioral skills|behavioral skills
5151863|NCT01004341|parenting skills|parenting skills
5151864|NCT01004341|family meals|family meals
5151865|NCT01004328|patient safety|patient safety
5151866|NCT01004328|care transitions|care transitions
5151867|NCT01004328|therapeutic monitoring|therapeutic monitoring
5151868|NCT01004328|skilled nursing facilities|skilled nursing facilities
5151869|NCT01004328|Adverse outcomes after discharge from a SNF to home|adverse outcomes after discharge from a snf to home
5151870|NCT01004315|Overactive bladder|overactive bladder
5151871|NCT01004315|Frequency|frequency
5151872|NCT01004315|Micturition|micturition
5151873|NCT01004315|Urgency|urgency
5151874|NCT01004315|Urge urinary incontinence|urge urinary incontinence
5151875|NCT01004315|OAB|oab
5151876|NCT01004302|Obsessive-compulsive disorder|obsessive-compulsive disorder
5151877|NCT01004302|Radiosurgery|radiosurgery
5151878|NCT01004302|Psychosurgery|psychosurgery
5151879|NCT01004302|Treatment outcome|treatment outcome
5151880|NCT01004302|Randomized Controlled Trials|randomized controlled trials
5151881|NCT01004289|Acute myocardial infarction|acute myocardial infarction
5151882|NCT01004289|Primary percutaneous coronary intervention|primary percutaneous coronary intervention
5151883|NCT01004289|Postconditioning|postconditioning
5151884|NCT01004276|primary health care|primary health care
5151885|NCT01004276|delivery of health care|delivery of health care
5151886|NCT01004276|smoking cessation|smoking cessation
5151887|NCT01004276|chronic disease|chronic disease
5151888|NCT01004276|disease management|disease management
5151889|NCT01004276|pilot projects|pilot projects
5151890|NCT01004263|acute migraine with or without aura in adolescents|acute migraine with or without aura in adolescents
5151891|NCT01004237|insulin resistance|insulin resistance
5151892|NCT01004237|hypertensive|hypertensive
5151893|NCT01004237|hypercholesterolemic patients|hypercholesterolemic patients
5151894|NCT01004224|advanced solid tumors|advanced solid tumors
5151895|NCT01004224|lung cancer|lung cancer
5151896|NCT01004224|bladder cancer|bladder cancer
5151897|NCT01004224|BGJ398|bgj398
5151898|NCT01004224|FGFR|fgfr
5151899|NCT01004224|kinase inhibitor|kinase inhibitor
5151900|NCT01004224|advanced solid malignancies|advanced solid malignancies
5151901|NCT01004211|bladder cancer|bladder cancer
5151902|NCT01004211|recurrence|recurrence
5151903|NCT01004198|Trauma|trauma
5151904|NCT01004198|Hemorrhage|hemorrhage
5151905|NCT01004198|Hemorrhagic shock|hemorrhagic shock
5151906|NCT01004198|Lactic acidosis|lactic acidosis
5151907|NCT01004198|Oxygen carriers|oxygen carriers
5151908|NCT01004198|Oxygen therapeutics|oxygen therapeutics
5151909|NCT01004198|Hemoglobin solutions|hemoglobin solutions
5151910|NCT01004198|Hemoglobin substitutes|hemoglobin substitutes
5151911|NCT01004198|Red cell substitutes|red cell substitutes
5151912|NCT01004198|PEG-hemoglobin|peg-hemoglobin
5151913|NCT01004172|carboplatin|carboplatin
5151914|NCT01004172|bevacizumab|bevacizumab
5151915|NCT01004159|Colorectal cancer|colorectal cancer
5151916|NCT01004159|KRAS wild type tumors|kras wild type tumors
5151917|NCT01004146|incentive spirometry|incentive spirometry
5151918|NCT01004146|bariatric surgery|bariatric surgery
5151919|NCT01004146|obesity|obesity
5151920|NCT01004133|Age 80 or older|age 80 or older
5151921|NCT01004133|No chronic disease|no chronic disease
5151922|NCT01004094|children|children
5151923|NCT01004094|video games|video games
5151924|NCT01004094|internet|internet
5151925|NCT01004094|parents|parents
5151926|NCT01004094|fruit|fruit
5151927|NCT01004094|vegetable|vegetable
5151928|NCT01004094|implementation intention|implementation intention
5151929|NCT01004094|goal setting|goal setting
5151930|NCT01004094|fruit and vegetable consumption|fruit and vegetable consumption
5151931|NCT01004094|obesity prevention|obesity prevention
5151932|NCT01004094|cancer prevention|cancer prevention
5151933|NCT01004081|Cancer of Breast|cancer of breast
5151934|NCT01004081|Cancer of the Breast|cancer of the breast
5151935|NCT01004068|Clomiphene|clomiphene
5151936|NCT01004068|Diet|diet
5151937|NCT01004068|Exercise|exercise
5151938|NCT01004068|Infertility|infertility
5151939|NCT01004068|PCOS|pcos
5151940|NCT01004068|Physical activity|physical activity
5151941|NCT01004068|Treatment|treatment
5151942|NCT01004055|Wound|wound
5151943|NCT01004055|Skin lesion|skin lesion
5151944|NCT01004055|Antimicrobial|antimicrobial
5151945|NCT01004055|Bioelectric|bioelectric
5151946|NCT01004042|Depression|depression
5151947|NCT01004042|Botulinum toxin|botulinum toxin
5151948|NCT01004042|Glabella|glabella
5151949|NCT01004042|Quality of life|quality of life
5151950|NCT01004042|Self-steem|self-steem
5151951|NCT01004029|17P|17p
5151952|NCT01004029|hydroxyprogesterone caproate|hydroxyprogesterone caproate
5151953|NCT01004029|preterm birth|preterm birth
5151954|NCT01004029|progesterone|progesterone
5151955|NCT01004029|women with a singleton pregnancy aged 18 years or older with a history of a previous singleton spontaneous preterm delivery|women with a singleton pregnancy aged 18 years or older with a history of a previous singleton spontaneous preterm delivery
5151956|NCT01004016|Spinocerebellar degeneration|spinocerebellar degeneration
5151957|NCT01004016|Thyrotropin-Releasing Hormone (TRH)|thyrotropin-releasing hormone (trh)
5151958|NCT01004016|SCD|scd
5151959|NCT01003990|Treatment experienced|treatment experienced
5151960|NCT01003964|NON-SMALL CELL LUNG CANCER|non-small cell lung cancer
5151961|NCT01003964|excision repair cross-complementing 1|excision repair cross-complementing 1
5151962|NCT01003964|Gemcitabine and cisplatin|gemcitabine and cisplatin
5151963|NCT01003964|Irinotecan and cisplatin|irinotecan and cisplatin
5151964|NCT01003964|Pemetrexed|pemetrexed
5151965|NCT01003964|Docetaxel|docetaxel
5151966|NCT01003964|advanced NSCLC|advanced nsclc
5151967|NCT01003951|Lymphedema|lymphedema
5151968|NCT01003951|Acupuncture|acupuncture
5151969|NCT01003951|09-136|09-136
5151970|NCT01003938|chemotherapy|chemotherapy
5151971|NCT01003938|combination therapy|combination therapy
5151972|NCT01003938|targeted therapy|targeted therapy
5151973|NCT01003938|second-line|second-line
5151974|NCT01003925|Knee pain, osteoarthritis, non-surgical treatment, age 65+|knee pain, osteoarthritis, non-surgical treatment, age 65+
5151975|NCT01003912|Lysosomal Storage Diseases|lysosomal storage diseases
5151976|NCT01003912|Inborn Errors of Metabolism|inborn errors of metabolism
5151977|NCT01003912|Krabbe|krabbe
5151978|NCT01003912|Infantile metachromatic leukodystrophy disease|infantile metachromatic leukodystrophy disease
5151979|NCT01003912|MLD|mld
5151980|NCT01003912|Tay Sachs|tay sachs
5151981|NCT01003912|Sandhoff|sandhoff
5151982|NCT01003912|GM2 gangliosidoses|gm2 gangliosidoses
5151983|NCT01003912|Pelizaeus-Merzbacher disease|pelizaeus-merzbacher disease
5151984|NCT01003912|PMD|pmd
5151985|NCT01003886|post marketing surveillance Filipino benign prostatic hyperplasia BPH Doxazosin GITS|post marketing surveillance filipino benign prostatic hyperplasia bph doxazosin gits
5151986|NCT01003873|morbid obesity|morbid obesity
5151987|NCT01003873|bariatric surgery|bariatric surgery
5151988|NCT01003873|lifestyle intervention|lifestyle intervention
5151989|NCT01003873|endocannabinoids system|endocannabinoids system
5151990|NCT01003860|postoperative analgesia|postoperative analgesia
5151991|NCT01003847|Insulin resistance|insulin resistance
5151992|NCT01003834|substance use|substance use
5151993|NCT01003834|drug use|drug use
5151994|NCT01003834|drug abuse|drug abuse
5151995|NCT01003782|cholangitis|cholangitis
5151996|NCT01003782|antibiotic|antibiotic
5151997|NCT01003782|bacteriobilia|bacteriobilia
5151998|NCT01003782|bile|bile
5151999|NCT01003782|ERCP|ercp
5152000|NCT01003756|Preoperative|preoperative
5152001|NCT01003756|Exercise|exercise
5152002|NCT01003756|Joint Replacement|joint replacement
5152003|NCT01003756|Hip|hip
5152004|NCT01003756|Knee|knee
5152005|NCT01003730|Intraoperative protective ventilation strategies|intraoperative protective ventilation strategies
5152006|NCT01003691|Phase 1b Advanced Dry Age-Related Macular Degeneration RN6G|phase 1b advanced dry age-related macular degeneration rn6g
5152007|NCT01003678|Myelodysplastic syndrome|myelodysplastic syndrome
5152008|NCT01003678|Clofarabine|clofarabine
5152009|NCT01003678|low-dose oral clofarabine|low-dose oral clofarabine
5152010|NCT01003678|intermediate risk Myelodysplastic syndrome|intermediate risk myelodysplastic syndrome
5152011|NCT01003678|high risk Myelodysplastic syndrome|high risk myelodysplastic syndrome
5152012|NCT01003652|goiter|goiter
5152013|NCT01003639|papilledema|papilledema
5152014|NCT01003639|vision loss|vision loss
5152015|NCT01003639|headache|headache
5152016|NCT01003639|obesity|obesity
5152017|NCT01003639|women|women
5152018|NCT01003639|diplopia|diplopia
5152019|NCT01003639|tinnitus|tinnitus
5152020|NCT01003626|Advanced cutaneous melanoma|advanced cutaneous melanoma
5152021|NCT01003626|Tumor Pressure|tumor pressure
5152022|NCT01003626|Tumor IFP|tumor ifp
5152023|NCT01003626|Interstitial Fluid Pressure|interstitial fluid pressure
5152024|NCT01003626|IFP|ifp
5152025|NCT01003626|Transducer-tipped catheter Mikro-Tip SPC-320|transducer-tipped catheter mikro-tip spc-320
5152026|NCT01003626|Transducer Millar|transducer millar
5152027|NCT01003626|Power Lab 8/30 amplifier|power lab 8/30 amplifier
5152028|NCT01003613|Tranilast|tranilast
5152029|NCT01003613|fibrin glue|fibrin glue
5152030|NCT01003613|primary pterygium|primary pterygium
5152031|NCT01003613|conjunctival autograft|conjunctival autograft
5152032|NCT01003600|Survivorship|survivorship
5152033|NCT01003600|Quality of Life|quality of life
5152034|NCT01003600|Questionnaire|questionnaire
5152035|NCT01003600|09-133|09-133
5152036|NCT01003587|India|india
5152037|NCT01003587|evidence-based policy|evidence-based policy
5152038|NCT01003587|knowledge translation|knowledge translation
5152140|NCT01003197|Validation|validation
5152039|NCT01003587|disease control priorities|disease control priorities
5152040|NCT01003587|decision-makers|decision-makers
5152041|NCT01003587|health spending|health spending
5152042|NCT01003587|health services delivery|health services delivery
5152043|NCT01003587|maternal and child health|maternal and child health
5152044|NCT01003587|policy making|policy making
5152045|NCT01003587|delivery of health care|delivery of health care
5152046|NCT01003574|cardiovascular health outcomes in cancer survivors|cardiovascular health outcomes in cancer survivors
5152047|NCT01003561|ultrasonographic exam on upper and lower extremities|ultrasonographic exam on upper and lower extremities
5152048|NCT01003548|Embryo culture|embryo culture
5152049|NCT01003548|IVF|ivf
5152050|NCT01003548|Microfluidics|microfluidics
5152051|NCT01003548|infertility|infertility
5152052|NCT01003535|Parkinson´s disease|parkinson´s disease
5152053|NCT01003535|Acetylcholine receptors|acetylcholine receptors
5152054|NCT01003522|Bronchial stents|bronchial stents
5152055|NCT01003522|Airway obstruction|airway obstruction
5152056|NCT01003522|Non-small cell lung cancer|non-small cell lung cancer
5152057|NCT01003509|inguinal|inguinal
5152058|NCT01003509|hernia|hernia
5152059|NCT01003509|new|new
5152060|NCT01003509|repair|repair
5152061|NCT01003509|modified shouldice|modified shouldice
5152062|NCT01003509|double|double
5152063|NCT01003496|Cocaine|cocaine
5152064|NCT01003496|crack|crack
5152065|NCT01003496|heroin|heroin
5152066|NCT01003496|non-prescribed opioids|non-prescribed opioids
5152067|NCT01003496|contingency management|contingency management
5152068|NCT01003496|community reinforcement approach|community reinforcement approach
5152069|NCT01003496|facilitated therapeutic alliance|facilitated therapeutic alliance
5152070|NCT01003496|chronic disease treatment models|chronic disease treatment models
5152071|NCT01003483|metformin|metformin
5152072|NCT01003483|orlistat|orlistat
5152073|NCT01003483|pcos|pcos
5152074|NCT01003483|obese|obese
5152075|NCT01003470|cerebral infarction|cerebral infarction
5152076|NCT01003470|Paralysis|paralysis
5152077|NCT01003470|acupuncture|acupuncture
5152078|NCT01003470|rehabilitation|rehabilitation
5152079|NCT01003470|trial|trial
5152080|NCT01003444|Muscle biopsy Malonyl CoA Biomarker assay|muscle biopsy malonyl coa biomarker assay
5152081|NCT01003418|GSK2340272A|gsk2340272a
5152082|NCT01003418|H1N1 pandemic influenza|h1n1 pandemic influenza
5152083|NCT01003405|Overactive bladder|overactive bladder
5152084|NCT01003405|Frequency|frequency
5152085|NCT01003405|Micturition|micturition
5152086|NCT01003405|Urgency|urgency
5152087|NCT01003405|Urge urinary incontinence|urge urinary incontinence
5152088|NCT01003405|OAB|oab
5152089|NCT01003392|Coronary artery disease|coronary artery disease
5152090|NCT01003392|Coffee|coffee
5152091|NCT01003392|Heart system|heart system
5152092|NCT01003379|cognitive dysfunction|cognitive dysfunction
5152093|NCT01003379|schizophrenia|schizophrenia
5152094|NCT01003379|Phase 2|phase 2
5152095|NCT01003366|safety during central venous catheterization|safety during central venous catheterization
5152096|NCT01003353|Stroke|stroke
5152097|NCT01003353|Strength training|strength training
5152098|NCT01003353|exercise therapy|exercise therapy
5152099|NCT01003340|asthma|asthma
5152100|NCT01003340|children|children
5152101|NCT01003340|community health workers|community health workers
5152102|NCT01003340|home intervention|home intervention
5152103|NCT01003327|laryngeal mask, leak pressure|laryngeal mask, leak pressure
5152104|NCT01003327|leak pressure|leak pressure
5152105|NCT01003314|Vaccine|vaccine
5152106|NCT01003314|Safety|safety
5152107|NCT01003314|Immunogenicity|immunogenicity
5152108|NCT01003314|Protection|protection
5152109|NCT01003314|Sporozoite challenge|sporozoite challenge
5152110|NCT01003301|cat allergy|cat allergy
5152111|NCT01003288|H1N1 pandemic vaccine immunogenicity safety|h1n1 pandemic vaccine immunogenicity safety
5152112|NCT01003288|Health employees|health employees
5152113|NCT01003275|Chronic kidney disease|chronic kidney disease
5152114|NCT01003275|Vitamin D|vitamin d
5152115|NCT01003275|Paricalcitol|paricalcitol
5152116|NCT01003275|Placebo|placebo
5152117|NCT01003275|Kidney|kidney
5152118|NCT01003275|Renal|renal
5152119|NCT01003275|Oxidative Stress|oxidative stress
5152120|NCT01003275|Immune cell function|immune cell function
5152121|NCT01003275|Glucose|glucose
5152122|NCT01003275|Glucose tolerance|glucose tolerance
5152123|NCT01003262|Observation Unit|observation unit
5152124|NCT01003262|Emergency Department|emergency department
5152125|NCT01003249|over distention of bladder|over distention of bladder
5152126|NCT01003249|Dysfunctional voiding|dysfunctional voiding
5152127|NCT01003249|dysfunctional elimination syndrome|dysfunctional elimination syndrome
5152128|NCT01003236|Diabetic nephropathy|diabetic nephropathy
5152129|NCT01003236|Type II Diabetes|type ii diabetes
5152130|NCT01003236|Milk Thistle extract|milk thistle extract
5152131|NCT01003236|Silymarin|silymarin
5152132|NCT01003223|phosphorus|phosphorus
5152133|NCT01003223|dialysis|dialysis
5152134|NCT01003223|PhosLo|phoslo
5152135|NCT01003223|CKD stage V|ckd stage v
5152136|NCT01003210|otitis media|otitis media
5152137|NCT01003210|children|children
5152138|NCT01003210|homeopathy|homeopathy
5152139|NCT01003197|Development|development
5152141|NCT01003197|Prediction Score|prediction score
5152142|NCT01003197|Complication|complication
5152143|NCT01003197|Liver resection|liver resection
5152144|NCT01003197|develop and validate a score to predict serious complications following liver resection using pre-operative risk factors.|develop and validate a score to predict serious complications following liver resection using pre-operative risk factors.
5152145|NCT01003184|diabetes|diabetes
5152146|NCT01003184|exenatide once weekly|exenatide once weekly
5152147|NCT01003184|Byetta|byetta
5152148|NCT01003184|insulin detemir|insulin detemir
5152149|NCT01003184|Levemir|levemir
5152150|NCT01003184|Amylin|amylin
5152151|NCT01003184|Lilly|lilly
5152152|NCT01003171|Pharmacokinetics|pharmacokinetics
5152153|NCT01003171|PK|pk
5152154|NCT01003171|MCS|mcs
5152155|NCT01003171|Benign Prostatic Hyperplasia|benign prostatic hyperplasia
5152156|NCT01003171|Multi-Carotenoids|multi-carotenoids
5152157|NCT01003171|Healthy subjects|healthy subjects
5152158|NCT01003158|Cancer|cancer
5152159|NCT01003158|tumour|tumour
5152160|NCT01003158|metastatic|metastatic
5152161|NCT01003158|breast cancer|breast cancer
5152162|NCT01003145|Influenza|influenza
5152163|NCT01003145|vaccine|vaccine
5152164|NCT01003145|Immunogenicity|immunogenicity
5152165|NCT01003132|Psychosis|psychosis
5152166|NCT01003132|Distress|distress
5152167|NCT01003132|Mindfulness|mindfulness
5152168|NCT01003132|Acceptance|acceptance
5152169|NCT01003132|Values|values
5152170|NCT01003119|Alcohol addiction|alcohol addiction
5152171|NCT01003119|Alcohol treatment|alcohol treatment
5152172|NCT01003119|Alcohol recovery|alcohol recovery
5152173|NCT01003119|Post residential treatment DSM-IV diagnosis of alcohol dependence|post residential treatment dsm-iv diagnosis of alcohol dependence
5152174|NCT01003106|RVO|rvo
5152175|NCT01003106|BRVO|brvo
5152176|NCT01003106|CRVO|crvo
5152177|NCT01003106|Vein occlusion|vein occlusion
5152178|NCT01003093|Tuberculosis|tuberculosis
5152179|NCT01003093|Vaccine|vaccine
5152180|NCT01003093|Ag85B|ag85b
5152181|NCT01003093|ESAT-6|esat-6
5152182|NCT01003093|IC31|ic31
5152183|NCT01003080|The evaluation of hemostasis during total knee arthroplasty using the aquamantys device.|the evaluation of hemostasis during total knee arthroplasty using the aquamantys device.
5152184|NCT01003054|Leukemia|leukemia
5152185|NCT01003054|CML|cml
5152186|NCT01003054|Busulfan|busulfan
5152187|NCT01003054|Busulfex|busulfex
5152188|NCT01003054|Myleran|myleran
5152189|NCT01003054|Cyclophosphamide|cyclophosphamide
5152190|NCT01003054|Cytoxan|cytoxan
5152191|NCT01003054|Neosar|neosar
5152192|NCT01003054|Imatinib Mesylate|imatinib mesylate
5152193|NCT01003054|Gleevec|gleevec
5152194|NCT01003054|Autologous Stem Cell Transplantation|autologous stem cell transplantation
5152195|NCT01003054|Stem Cell Transplant|stem cell transplant
5152196|NCT01003041|healthy normal infants|healthy normal infants
5152197|NCT01003028|Total intravenous anesthesia|total intravenous anesthesia
5152198|NCT01003028|Maximum plasma concentration of remifentanil|maximum plasma concentration of remifentanil
5152199|NCT01003015|HCC|hcc
5152200|NCT01003015|Safety|safety
5152201|NCT01003015|BAY73-4506|bay73-4506
5152202|NCT01003002|Parkinson's disease|parkinson's disease
5152203|NCT01003002|Dyskinesia|dyskinesia
5152204|NCT01003002|Movement Disorders|movement disorders
5152205|NCT01002989|ankle brachial index|ankle brachial index
5152206|NCT01002989|WatchBP Office|watchbp office
5152207|NCT01002989|oscillometric measurement|oscillometric measurement
5152208|NCT01002937|Biomarkers|biomarkers
5152209|NCT01002937|Prognosis response to treatment|prognosis response to treatment
5152210|NCT01002937|Renal cancer|renal cancer
5152211|NCT01002924|Cancer|cancer
5152212|NCT01002924|Adenocarcinoma|adenocarcinoma
5152213|NCT01002924|Phase II|phase ii
5152214|NCT01002924|Lung|lung
5152215|NCT01002924|Non-small cell lung cancer|non-small cell lung cancer
5152216|NCT01002924|NSCLC|nsclc
5152217|NCT01002924|extension|extension
5152218|NCT01002924|EC145|ec145
5152219|NCT01002924|Prior exposure to EC145|prior exposure to ec145
5152220|NCT01002911|Device procedure|device procedure
5152221|NCT01002911|pacemaker|pacemaker
5152222|NCT01002911|ICD|icd
5152223|NCT01002911|antibiotics|antibiotics
5152224|NCT01002898|HIV-1 RNA|hiv-1 rna
5152225|NCT01002898|Treatment experienced|treatment experienced
5152226|NCT01002885|Infertility|infertility
5152227|NCT01002885|FSH Receptor Polymorphisms|fsh receptor polymorphisms
5152228|NCT01002872|FGF23|fgf23
5152229|NCT01002872|CKD|ckd
5152230|NCT01002872|Fosrenol|fosrenol
5152231|NCT01002872|Hyperphosphatemia|hyperphosphatemia
5152232|NCT01002859|Coronary artery bypass graft surgery (CABG)|coronary artery bypass graft surgery (cabg)
5152233|NCT01002859|Cardiopulmonary Bypass (CPB)|cardiopulmonary bypass (cpb)
5152234|NCT01002859|Cyclosporine|cyclosporine
5152235|NCT01002859|ischaemia reperfusion|ischaemia reperfusion
5152236|NCT01002846|Efficacy|efficacy
5152237|NCT01002846|Acupuncture|acupuncture
5152238|NCT01002846|Hypertension|hypertension
5152239|NCT01002833|Plasmodium falciparum|plasmodium falciparum
5152240|NCT01002833|Malaria|malaria
5152241|NCT01002820|Epileptic Seizures|epileptic seizures
5152242|NCT01002820|Seizure Disorder|seizure disorder
5152243|NCT01002820|Seizures|seizures
5152244|NCT01002820|Convulsions|convulsions
5152245|NCT01002820|Anticonvulsant|anticonvulsant
5152246|NCT01002820|Anticonvulsive|anticonvulsive
5152247|NCT01002820|Antiepileptic|antiepileptic
5152248|NCT01002820|Ganaxolone|ganaxolone
5152249|NCT01002794|Degenerative meniscal tear|degenerative meniscal tear
5152250|NCT01002794|Arthroscopy|arthroscopy
5152251|NCT01002794|Exercise therapy|exercise therapy
5152252|NCT01002781|Tocilizumab Still|tocilizumab still
5152253|NCT01002755|Leukemia|leukemia
5152254|NCT01002755|CLL|cll
5152255|NCT01002755|SLL|sll
5152256|NCT01002755|Lenalidomide|lenalidomide
5152257|NCT01002755|Ofatumumab|ofatumumab
5152258|NCT01002742|GVHD|gvhd
5152259|NCT01002729|Oseltamivir Pharmacokinetics Obesity|oseltamivir pharmacokinetics obesity
5152260|NCT01002729|Oseltamivir Pharmacokinetics in Obesity|oseltamivir pharmacokinetics in obesity
5152261|NCT01002716|rheumatoid influenza vaccine cell immunity|rheumatoid influenza vaccine cell immunity
5152262|NCT01002703|Lenalidomide|lenalidomide
5152263|NCT01002703|Bendamustine|bendamustine
5152264|NCT01002703|Multiple Myeloma|multiple myeloma
5152265|NCT01002703|Myeloma|myeloma
5152266|NCT01002703|Revlimid|revlimid
5152267|NCT01002703|Phase I/II|phase i/ii
5152268|NCT01002703|refractory Myeloma|refractory myeloma
5152269|NCT01002703|relapsed Myeloma|relapsed myeloma
5152270|NCT01002690|Asthma|asthma
5152271|NCT01002690|Allergen challenge|allergen challenge
5152272|NCT01002690|Airway responsiveness|airway responsiveness
5152273|NCT01002690|Prostaglandins|prostaglandins
5152274|NCT01002690|Eicosanoids|eicosanoids
5152275|NCT01002677|brain injury|brain injury
5152276|NCT01002677|traumatic brain injury|traumatic brain injury
5152277|NCT01002677|training|training
5152278|NCT01002677|teaching|teaching
5152279|NCT01002677|curriculum|curriculum
5152280|NCT01002664|Benign Prostatic Hyperplasia|benign prostatic hyperplasia
5152281|NCT01002664|Multi-carotenoids|multi-carotenoids
5152282|NCT01002664|MCS-2|mcs-2
5152283|NCT01002664|Lower Urinary Tract Symptoms|lower urinary tract symptoms
5152284|NCT01002664|International prostate symptom scores|international prostate symptom scores
5152285|NCT01002651|gastrointestinal health|gastrointestinal health
5152286|NCT01002651|healthy subjects|healthy subjects
5152287|NCT01002625|Double-Blind Randomized Placebo-Controlled 2-Way Crossover Polysomnographic Endpoints|double-blind randomized placebo-controlled 2-way crossover polysomnographic endpoints
5152288|NCT01002612|Nutritional status|nutritional status
5152289|NCT01002612|Thai HIV-infected children|thai hiv-infected children
5152290|NCT01002599|bariatric surgery|bariatric surgery
5152291|NCT01002599|morbidly obese|morbidly obese
5152292|NCT01002599|BMI >35|bmi >35
5152293|NCT01002599|CPAP|cpap
5152294|NCT01002599|Venturi|venturi
5152295|NCT01002599|Boussignac|boussignac
5152296|NCT01002599|Ventilation|ventilation
5152297|NCT01002599|Pulmonary function|pulmonary function
5152298|NCT01002599|Morbidly Obese Patients undergoing bariatric surgery|morbidly obese patients undergoing bariatric surgery
5152299|NCT01002586|Alzheimer's dementia|alzheimer's dementia
5152300|NCT01002586|Wii-Fit|wii-fit
5152301|NCT01002586|Walking|walking
5152302|NCT01002586|Falls|falls
5152303|NCT01002573|Pediatric|pediatric
5152304|NCT01002573|Fever|fever
5152305|NCT01002560|Melanoma|melanoma
5152306|NCT01002560|Novel Prognostic Markers|novel prognostic markers
5152307|NCT01002547|steatohepatitis|steatohepatitis
5152308|NCT01002547|type 2 diabetes|type 2 diabetes
5152309|NCT01002547|fatty liver|fatty liver
5152310|NCT01002534|Cystic Fibrosis|cystic fibrosis
5152311|NCT01002534|Vardenafil|vardenafil
5152312|NCT01002534|Nasal instillation|nasal instillation
5152313|NCT01002534|Nasal Potential difference|nasal potential difference
5152314|NCT01002521|Diabetes|diabetes
5152315|NCT01002521|vascular|vascular
5152316|NCT01002521|haptoglobin|haptoglobin
5152317|NCT01002521|tumor|tumor
5152318|NCT01002521|necrosis|necrosis
5152319|NCT01002521|factor|factor
5152320|NCT01002521|alpha|alpha
5152321|NCT01002521|traps|traps
5152322|NCT01002521|impaired|impaired
5152323|NCT01002521|wound|wound
5152324|NCT01002521|healing|healing
5152325|NCT01002521|Impaired wound healing in patients with diabetes mellitus|impaired wound healing in patients with diabetes mellitus
5152326|NCT01002508|influenza vaccine scleroderma immunogenicity safety|influenza vaccine scleroderma immunogenicity safety
5152327|NCT01002495|myocardial|myocardial
5152328|NCT01002495|ischemia|ischemia
5152329|NCT01002495|coronary disease|coronary disease
5152330|NCT01002495|angina|angina
5152331|NCT01002482|Hyperglycemia|hyperglycemia
5152332|NCT01002482|Hypoglycemia|hypoglycemia
5152333|NCT01002482|Intensive Care Unit|intensive care unit
5152334|NCT01002482|Glucose Control|glucose control
5152335|NCT01002482|Insulin|insulin
5152336|NCT01002482|Computer Protocol|computer protocol
5152337|NCT01002482|Metabolic Disorders|metabolic disorders
5152338|NCT01002469|isotope ratio measurement|isotope ratio measurement
5152339|NCT01002469|urea cycle|urea cycle
5152340|NCT01002469|13C acetate|13c acetate
5152341|NCT01002469|Healthy adults|healthy adults
5152342|NCT01002456|Adrenergic beta-Antagonists|adrenergic beta-antagonists
5152343|NCT01002456|Guideline Adherence|guideline adherence
5152344|NCT01002456|Drug Prescriptions|drug prescriptions
5152345|NCT01002456|target dose|target dose
5152346|NCT01002443|Helicobacter pylori|helicobacter pylori
5152347|NCT01002443|glandular atrophy|glandular atrophy
5152348|NCT01002443|intestinal metaplasia|intestinal metaplasia
5152349|NCT01002443|subtotal gastrectomy|subtotal gastrectomy
5152350|NCT01002443|gastric cancer|gastric cancer
5152351|NCT01002443|Precancerous lesion of gastric cancer|precancerous lesion of gastric cancer
5152352|NCT01002430|Myocardial ischemia|myocardial ischemia
5152353|NCT01002430|Refractory angina pectoris|refractory angina pectoris
5152354|NCT01002430|Vascular endothelial growth factor|vascular endothelial growth factor
5152355|NCT01002430|Gene therapy|gene therapy
5152356|NCT01002430|Perfusion|perfusion
5152357|NCT01002417|Benign Prostatic Hyperplasia|benign prostatic hyperplasia
5152358|NCT01002417|Multi-carotenoids|multi-carotenoids
5152359|NCT01002417|MCS-2|mcs-2
5152360|NCT01002417|Lower Urinary Tract Symptoms|lower urinary tract symptoms
5152361|NCT01002417|International prostate symptom scores|international prostate symptom scores
5152362|NCT01002404|ERCP|ercp
5152363|NCT01002404|deep biliary cannulation|deep biliary cannulation
5152364|NCT01002404|guide wire cannulation|guide wire cannulation
5152365|NCT01002404|post-ERCP pancreatitis|post-ercp pancreatitis
5152366|NCT01002404|Success of deep biliary cannulation|success of deep biliary cannulation
5152367|NCT01002404|Rate of post-ERCP pancreatitis|rate of post-ercp pancreatitis
5152368|NCT01002404|Time used to deep biliary cannulation|time used to deep biliary cannulation
5152369|NCT01002391|breast hypertrophy|breast hypertrophy
5152370|NCT01002391|mammaplasty|mammaplasty
5152371|NCT01002391|bandages|bandages
5152372|NCT01002391|surgical site infection|surgical site infection
5152373|NCT01002391|skin colonization|skin colonization
5152374|NCT01002352|obesity|obesity
5152375|NCT01002352|bariatric|bariatric
5152376|NCT01002352|BOLD|bold
5152377|NCT01002352|weightloss|weightloss
5152378|NCT01002352|database|database
5152379|NCT01002352|data registry|data registry
5152380|NCT01002326|Pediatric|pediatric
5152381|NCT01002326|Body Dysmorphic Disorder|body dysmorphic disorder
5152382|NCT01002326|BDD|bdd
5152383|NCT01002326|CBT|cbt
5152384|NCT01002326|Cognitive-Behavioral Therapy|cognitive-behavioral therapy
5152385|NCT01002300|Social Cognition|social cognition
5152386|NCT01002300|Oxytocin|oxytocin
5152387|NCT01002274|Benign Prostatic Hyperplasia|benign prostatic hyperplasia
5152388|NCT01002274|BPH|bph
5152389|NCT01002274|MCS-2|mcs-2
5152390|NCT01002274|Multi-Carotenoids|multi-carotenoids
5152391|NCT01002274|Lower Urinary Tract Symptoms|lower urinary tract symptoms
5152392|NCT01002274|International prostate symptom score|international prostate symptom score
5152393|NCT01002261|Galactose|galactose
5152394|NCT01002261|PET/CT|pet/ct
5152395|NCT01002261|Liver physiology|liver physiology
5152396|NCT01002261|Liver pathophysiology|liver pathophysiology
5152397|NCT01002248|Multiple Myeloma|multiple myeloma
5152398|NCT01002248|Relapsed multiple myeloma|relapsed multiple myeloma
5152399|NCT01002248|Refractory multiple myeloma|refractory multiple myeloma
5152400|NCT01002248|Relapsed refractory multiple myeloma|relapsed refractory multiple myeloma
5152401|NCT01002235|Diabetic|diabetic
5152402|NCT01002235|Neuropathy|neuropathy
5152403|NCT01002235|peripheral|peripheral
5152404|NCT01002235|diabetes|diabetes
5152405|NCT01002222|Benign Prostatic Hyperplasia|benign prostatic hyperplasia
5152406|NCT01002222|MCS-2|mcs-2
5152407|NCT01002222|Multi-Carotenoids|multi-carotenoids
5152408|NCT01002222|Lower Urinary Tract Symptoms|lower urinary tract symptoms
5152409|NCT01002222|International prostate symptom score|international prostate symptom score
5152410|NCT01002209|Diabetes|diabetes
5152411|NCT01002209|Vascular Surgery|vascular surgery
5152412|NCT01002209|Hyperbaric oxygen|hyperbaric oxygen
5152413|NCT01002209|Surgical complications|surgical complications
5152414|NCT01002209|Wound complication|wound complication
5152415|NCT01002209|Randomized|randomized
5152416|NCT01002209|Controlled|controlled
5152417|NCT01002196|Selective Mutism|selective mutism
5152418|NCT01002196|Intervention|intervention
5152419|NCT01002183|Malaria|malaria
5152420|NCT01002183|Plasmodium falciparum|plasmodium falciparum
5152421|NCT01002183|acute uncomplicated|acute uncomplicated
5152422|NCT01002170|Tuberculosis|tuberculosis
5152423|NCT01002170|Cycloserine|cycloserine
5152424|NCT01002170|Pharmacokinetics|pharmacokinetics
5152425|NCT01002157|Coronary Artery Calcification|coronary artery calcification
5152426|NCT01002157|Vitamin K|vitamin k
5152427|NCT01002157|Trial|trial
5152428|NCT01002157|Treatment|treatment
5152429|NCT01002131|Digital Volume Tomography|digital volume tomography
5152430|NCT01002131|Cone Beam CT|cone beam ct
5152431|NCT01002131|impacted and supernumerary teeth|impacted and supernumerary teeth
5152432|NCT01002131|dental and maxillofacial radiology|dental and maxillofacial radiology
5152433|NCT01002118|heart rate variability|heart rate variability
5152434|NCT01002118|Dialysis|dialysis
5152435|NCT01002105|Baclofen|baclofen
5152436|NCT01002105|Alcohol|alcohol
5152437|NCT01002105|Baclofen as add-on to standard treatment of alcohol|baclofen as add-on to standard treatment of alcohol
5152438|NCT01002092|Osteosarcoma|osteosarcoma
5152439|NCT01002092|Endostar|endostar
5152440|NCT01002092|Chemotherapy|chemotherapy
5152441|NCT01002066|Fever|fever
5152442|NCT01002066|Malaria|malaria
5152443|NCT01002066|RDT|rdt
5152444|NCT01002066|IMCI|imci
5152445|NCT01002066|Children<5 years of age|children<5 years of age
5152446|NCT01002066|ACT|act
5152447|NCT01002053|diabetes|diabetes
5152448|NCT01002053|neuropathy|neuropathy
5152449|NCT01002053|ankle block|ankle block
5152450|NCT01002053|regional anesthesia|regional anesthesia
5152451|NCT01002053|ultrasound|ultrasound
5152452|NCT01002053|nerve localization|nerve localization
5152453|NCT01002053|Nerve localization in patients undergoing foot surgery and having ankle block|nerve localization in patients undergoing foot surgery and having ankle block
5152454|NCT01002040|HIV|hiv
5152455|NCT01002040|vaccine,|vaccine,
5152456|NCT01002040|H1N1|h1n1
5152457|NCT01002040|influenza|influenza
5152458|NCT01002040|H1N1 Influenza vaccine|h1n1 influenza vaccine
5152459|NCT01002040|Arepanrix|arepanrix
5152460|NCT01002040|Pandemic|pandemic
5152461|NCT01002040|H1N1 2009 Influenza|h1n1 2009 influenza
5152462|NCT01002040|HIV preventive vaccine|hiv preventive vaccine
5152463|NCT01002027|Postnatal Depression|postnatal depression
5152464|NCT01002027|CBT-Counselling|cbt-counselling
5152465|NCT01002027|Primary care|primary care
5152466|NCT01002014|Breast Cancer|breast cancer
5152467|NCT01002014|Skin Sparing Mastectomy|skin sparing mastectomy
5152468|NCT01002014|Breast Cancer Prophylaxis|breast cancer prophylaxis
5152469|NCT01002014|Nipple Sparing Mastectomy|nipple sparing mastectomy
5152470|NCT01002014|Nipple Areolar Complex|nipple areolar complex
5152471|NCT01002014|Mastectomy|mastectomy
5152472|NCT01002014|Breast Reconstruction|breast reconstruction
5152473|NCT01002014|Local recurrence following nipple sparing mastectomy|local recurrence following nipple sparing mastectomy
5152474|NCT01002014|Cosmetic outcomes following nipple sparing mastectomy|cosmetic outcomes following nipple sparing mastectomy
5152475|NCT01002014|Complications following nipple sparing mastectomy|complications following nipple sparing mastectomy
5152476|NCT01001988|Encephalitis|encephalitis
5152477|NCT01001988|Japanese Encephalitis|japanese encephalitis
5152478|NCT01001988|Japanese Encephalitis Chimeric Virus Vaccine|japanese encephalitis chimeric virus vaccine
5152479|NCT01001988|Toddlers|toddlers
5152480|NCT01001975|Sunscreens|sunscreens
5152481|NCT01001962|Hypertension in type II diabetes|hypertension in type ii diabetes
5152482|NCT01001962|Cardiovascular morbidity and mortality|cardiovascular morbidity and mortality
5152483|NCT01001936|PHASE 1 SKI-606 Solid tumor|phase 1 ski-606 solid tumor
5152484|NCT01001897|IUD insertion|iud insertion
5152485|NCT01001897|nulliparous women|nulliparous women
5152486|NCT01001897|contraception|contraception
5152487|NCT01001884|caregiver, psychoeducational, colon|caregiver, psychoeducational, colon
5152488|NCT01001871|Iron deficiency anemia|iron deficiency anemia
5152489|NCT01001871|Sprinkles®|sprinkles®
5152490|NCT01001871|micronutrients|micronutrients
5152491|NCT01001871|malaria incidence|malaria incidence
5152492|NCT01001871|iron supplement|iron supplement
5152493|NCT01001858|OSA|osa
5152494|NCT01001858|CPAP compliance|cpap compliance
5152495|NCT01001858|nurse domiciliary led|nurse domiciliary led
5152496|NCT01001858|sleep disease|sleep disease
5152497|NCT01001845|hemodialysis|hemodialysis
5152498|NCT01001845|oxidative stress|oxidative stress
5152499|NCT01001845|plasma malondialdehyde|plasma malondialdehyde
5152500|NCT01001845|Glutathion peroxidase|glutathion peroxidase
5152501|NCT01001780|Graft versus Host Disease|graft versus host disease
5152502|NCT01001780|Allogeneic Hematopoietic Stem Cell Transplant|allogeneic hematopoietic stem cell transplant
5152503|NCT01001767|Omega-3 Fatty Acids|omega-3 fatty acids
5152504|NCT01001767|HIV|hiv
5152505|NCT01001767|Heart Disease|heart disease
5152506|NCT01001767|Treatment experienced|treatment experienced
5152507|NCT01001754|Hepatitis C|hepatitis c
5152508|NCT01001754|Hepatitis C, Chronic|hepatitis c, chronic
5152509|NCT01001754|PEGylated recombinant interleukin 29|pegylated recombinant interleukin 29
5152510|NCT01001754|PEG-interferon lambda|peg-interferon lambda
5152511|NCT01001754|Interleukin 29|interleukin 29
5152512|NCT01001754|Virus|virus
5152513|NCT01001754|Infection|infection
5152514|NCT01001754|Liver Diseases|liver diseases
5152515|NCT01001741|HIV|hiv
5152516|NCT01001741|Antiretrovirals|antiretrovirals
5152517|NCT01001741|Adherence|adherence
5152518|NCT01001741|Text messaging|text messaging
5152519|NCT01001741|Antiretroviral adherence|antiretroviral adherence
5152520|NCT01001741|Treatment experienced|treatment experienced
5152521|NCT01001728|Breast Cancer|breast cancer
5152522|NCT01001728|Radiotherapy|radiotherapy
5152523|NCT01001728|Prone position|prone position
5152524|NCT01001702|Open Label|open label
5152525|NCT01001702|Aripiprazole|aripiprazole
5152526|NCT01001689|Pregnancy|pregnancy
5152527|NCT01001689|Preventive health care|preventive health care
5152528|NCT01001689|Fitness|fitness
5152529|NCT01001689|Nutrition|nutrition
5152530|NCT01001689|Obesity|obesity
5152531|NCT01001689|Diabetes|diabetes
5152532|NCT01001689|Weight gain|weight gain
5152533|NCT01001676|renal failure|renal failure
5152534|NCT01001676|Restenosis|restenosis
5152535|NCT01001676|Dialysis access|dialysis access
5152536|NCT01001676|Paclitaxel|paclitaxel
5152537|NCT01001676|Angioplasty|angioplasty
5152538|NCT01001676|Intimal hyperplasia|intimal hyperplasia
5152539|NCT01001663|CAG|cag
5152540|NCT01001650|Malaria Vaccine|malaria vaccine
5152541|NCT01001650|Plasmodium falciparum|plasmodium falciparum
5152542|NCT01001637|curcumin|curcumin
5152543|NCT01001637|alzheimer's|alzheimer's
5152544|NCT01001637|longVida|longvida
5152545|NCT01001637|dementia|dementia
5152546|NCT01001624|Cosmetic|cosmetic
5152547|NCT01001624|Facial cream|facial cream
5152548|NCT01001624|Melasma|melasma
5152549|NCT01001624|Melanil|melanil
5152550|NCT01001611|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
5152551|NCT01001611|glitazone|glitazone
5152552|NCT01001611|Type II Diabetes|type ii diabetes
5152553|NCT01001611|Hypolipidemic|hypolipidemic
5152554|NCT01001611|oral hypoglycemic agent|oral hypoglycemic agent
5152555|NCT01001585|mitochondrial disease|mitochondrial disease
5152556|NCT01001585|sevoflurane|sevoflurane
5152557|NCT01001585|mitochondrial disease and sevoflurane sensitivity|mitochondrial disease and sevoflurane sensitivity
5152558|NCT01001572|Blood pressure|blood pressure
5152559|NCT01001572|hypertension|hypertension
5152560|NCT01001572|Exforge|exforge
5152561|NCT01001572|valsartan/amlodipine|valsartan/amlodipine
5152562|NCT01001559|Depression|depression
5152563|NCT01001559|Combination therapy|combination therapy
5152564|NCT01001559|antidepressant|antidepressant
5152565|NCT01001559|Deplin|deplin
5152566|NCT01001559|folate|folate
5152567|NCT01001559|methylfolate|methylfolate
5152568|NCT01001546|Veterans|veterans
5152569|NCT01001546|Smoking cessation|smoking cessation
5152570|NCT01001546|Operation Enduring Freedom|operation enduring freedom
5152571|NCT01001546|Operation Iraqi Freedom|operation iraqi freedom
5152572|NCT01001533|Electrical Cardiometry|electrical cardiometry
5152573|NCT01001533|Dexmedetomidine|dexmedetomidine
5152574|NCT01001533|ICON|icon
5152575|NCT01001533|bio-impedance|bio-impedance
5152576|NCT01001533|cardiac monitor|cardiac monitor
5152577|NCT01001520|Genetics|genetics
5152578|NCT01001520|Nicotine|nicotine
5152579|NCT01001520|Cognition|cognition
5152580|NCT01001520|fMRI|fmri
5152581|NCT01001507|Family planning|family planning
5152582|NCT01001507|HIV|hiv
5152583|NCT01001507|Integrated services|integrated services
5152584|NCT01001507|Unintended pregnancy|unintended pregnancy
5152585|NCT01001507|Kenya|kenya
5152586|NCT01001494|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5152587|NCT01001494|antimuscarinic|antimuscarinic
5152588|NCT01001494|COPD|copd
5152589|NCT01001481|Treatment review|treatment review
5152590|NCT01001481|Schizophrenia|schizophrenia
5152591|NCT01001481|Observational|observational
5152592|NCT01001481|Prospective studies|prospective studies
5152593|NCT01001481|Australia|australia
5152594|NCT01001468|Psoriasis|psoriasis
5152595|NCT01001455|BP|bp
5152596|NCT01001442|Multiple myeloma|multiple myeloma
5152597|NCT01001442|Relapsed|relapsed
5152598|NCT01001442|Refractory|refractory
5152599|NCT01001429|sedation for vitreoretinal surgery|sedation for vitreoretinal surgery
5152600|NCT01001390|Acute Lymphoblastic leukemia|acute lymphoblastic leukemia
5152601|NCT01001377|Panitumumab|panitumumab
5152602|NCT01001377|Vectibix|vectibix
5152603|NCT01001377|Colon Cancer|colon cancer
5152604|NCT01001377|Colorectal Cancer|colorectal cancer
5152605|NCT01001377|Rectal Cancer|rectal cancer
5152606|NCT01001377|Cetuximab|cetuximab
5152607|NCT01001377|Erbitux|erbitux
5152608|NCT01001377|Metastatic|metastatic
5152609|NCT01001351|Chronic Kidney Disease|chronic kidney disease
5152610|NCT01001351|Arteriovenous Grafts (AVG)|arteriovenous grafts (avg)
5152611|NCT01001351|Hemodialysis|hemodialysis
5152612|NCT01001351|Vascular Access|vascular access
5152613|NCT01001351|Dialysis|dialysis
5152614|NCT01001351|Graft|graft
5152615|NCT01001351|Access|access
5152616|NCT01001351|vonapanitase|vonapanitase
5152617|NCT01001351|kidney|kidney
5152618|NCT01001351|renal|renal
5152619|NCT01001325|influenza|influenza
5152620|NCT01001325|vaccine|vaccine
5152621|NCT01001325|observer blind|observer blind
5152622|NCT01001312|Heart Failure|heart failure
5152623|NCT01001312|Therapeutics|therapeutics
5152624|NCT01001312|Blood volume|blood volume
5152625|NCT01001286|dropout youth in low income communities in Amman, Jordan|dropout youth in low income communities in amman, jordan
5152626|NCT01001273|Pancreas Transplantation|pancreas transplantation
5152627|NCT01001273|Kidney Transplantation|kidney transplantation
5152628|NCT01001273|Organ Transplantation|organ transplantation
5152629|NCT01001273|Pancreas and Simultaneous Pancreas/Kidney Transplant Recipients|pancreas and simultaneous pancreas/kidney transplant recipients
5152630|NCT01001260|Prostaglandins|prostaglandins
5152631|NCT01001260|vascular injury|vascular injury
5152632|NCT01001247|TMC278-TiDP6-C154|tmc278-tidp6-c154
5152633|NCT01001247|TMC278-C154|tmc278-c154
5152634|NCT01001247|TMC278|tmc278
5152635|NCT01001247|Healthy volunteers|healthy volunteers
5152636|NCT01001247|omeprazole|omeprazole
5152637|NCT01001247|proton pump inhibitor|proton pump inhibitor
5152638|NCT01001247|HIV|hiv
5152639|NCT01001208|Etanercept|etanercept
5152640|NCT01001208|Methotrexate|methotrexate
5152641|NCT01001208|Psoriasis|psoriasis
5152642|NCT01001182|observational|observational
5152643|NCT01001182|non-interventional|non-interventional
5152644|NCT01001182|prospective|prospective
5152645|NCT01001169|GSK Bio's influenza vaccine GSK2340274A|gsk bio's influenza vaccine gsk2340274a
5152646|NCT01001169|influenza infection|influenza infection
5152647|NCT01001156|Aged|aged
5152648|NCT01001156|Breathing Muscles|breathing muscles
5152649|NCT01001156|Strength Muscles|strength muscles
5152650|NCT01001156|Institution of long Permanence for elderly|institution of long permanence for elderly
5152651|NCT01001130|avamys|avamys
5152652|NCT01001130|Allergic Rhinitis|allergic rhinitis
5152653|NCT01001130|post marketing surveillance|post marketing surveillance
5152654|NCT01001130|Seasonal Allergic Rhinitis|seasonal allergic rhinitis
5152655|NCT01001130|Perennial Allergic Rhinitis (PAR)|perennial allergic rhinitis (par)
5152656|NCT01001117|Cataract|cataract
5152657|NCT01001117|Capsulotomy|capsulotomy
5152658|NCT01001117|Capsulorrhexis|capsulorrhexis
5152659|NCT01001117|Phacoemulsification|phacoemulsification
5152660|NCT01001104|Metabolic Diseases|metabolic diseases
5152661|NCT01001104|Glucose Metabolism Disorders|glucose metabolism disorders
5152662|NCT01001104|Diabetes|diabetes
5152663|NCT01001104|GLP-1|glp-1
5152664|NCT01001104|Lilly|lilly
5152665|NCT01001091|Conjunctivitis|conjunctivitis
5152666|NCT01001091|conjunctival inflammation|conjunctival inflammation
5152667|NCT01001091|ocular allergies|ocular allergies
5152668|NCT01001078|supraglottic airway devices|supraglottic airway devices
5152669|NCT01001078|I-Gel|i-gel
5152670|NCT01001078|Supreme Laryngeal mask airway|supreme laryngeal mask airway
5152671|NCT01001078|Airway leak pressure|airway leak pressure
5152672|NCT01001078|peak airway pressure|peak airway pressure
5152673|NCT01001052|Healthy|healthy
5152674|NCT01001052|bioavailability|bioavailability
5152675|NCT01001039|chronic sinusitis|chronic sinusitis
5152676|NCT01001039|facial pain|facial pain
5152677|NCT01001026|vaccine|vaccine
5152678|NCT01001026|H1N1|h1n1
5152679|NCT01001026|influenza|influenza
5152680|NCT01001026|H1N1 influenza vaccine|h1n1 influenza vaccine
5152681|NCT01001026|pandemic|pandemic
5152682|NCT01000987|alcohol|alcohol
5152683|NCT01000987|reactivity|reactivity
5152684|NCT01000987|smoking cessation medications|smoking cessation medications
5152685|NCT01000974|primary vaccination course|primary vaccination course
5152686|NCT01000974|Haemophilus influenzae type b|haemophilus influenzae type b
5152687|NCT01000974|infants, children|infants, children
5152688|NCT01000974|booster vaccination|booster vaccination
5152689|NCT01000974|immunogenicity|immunogenicity
5152690|NCT01000974|safety|safety
5152691|NCT01000974|Gram-negative bacterial infections|gram-negative bacterial infections
5152692|NCT01000974|vaccines, conjugate|vaccines, conjugate
5152693|NCT01000961|cystinosis|cystinosis
5152694|NCT01000961|cysteamine|cysteamine
5152695|NCT01000961|inheritable disease|inheritable disease
5152696|NCT01000961|orphan disease|orphan disease
5152697|NCT01000961|CTNS protein, human|ctns protein, human
5152698|NCT01000961|metabolic disease|metabolic disease
5152699|NCT01000961|nephropathic cystinosis|nephropathic cystinosis
5152700|NCT01000948|Prostate cancer|prostate cancer
5152701|NCT01000948|Castration resistant|castration resistant
5152702|NCT01000948|Chemotherapy resistant|chemotherapy resistant
5152703|NCT01000948|Endothelial receptor A inhibitor|endothelial receptor a inhibitor
5152704|NCT01000948|ZD4054|zd4054
5152705|NCT01000935|Rotator Cuff Decompression Repair|rotator cuff decompression repair
5152706|NCT01000922|Mealtime Insulin|mealtime insulin
5152707|NCT01000922|Rapid acting insulin|rapid acting insulin
5152708|NCT01000922|Ultra fast VIAject|ultra fast viaject
5152709|NCT01000922|prandial insulin|prandial insulin
5152710|NCT01000896|Phase I|phase i
5152711|NCT01000896|cancer|cancer
5152712|NCT01000896|solid tumors|solid tumors
5152713|NCT01000896|advanced solid malignancies|advanced solid malignancies
5152714|NCT01000896|NSCLC|nsclc
5152715|NCT01000896|epithelial ovarian cancer|epithelial ovarian cancer
5152716|NCT01000896|dose escalation|dose escalation
5152717|NCT01000896|combination treatment|combination treatment
5152718|NCT01000896|src inhibitor|src inhibitor
5152719|NCT01000896|Japanese|japanese
5152720|NCT01000883|stage IIIA breast cancer|stage iiia breast cancer
5152721|NCT01000883|stage IIIB breast cancer|stage iiib breast cancer
5152722|NCT01000883|stage IIIC breast cancer|stage iiic breast cancer
5152723|NCT01000883|stage IV breast cancer|stage iv breast cancer
5152724|NCT01000883|recurrent breast cancer|recurrent breast cancer
5152725|NCT01000857|controlled-release tablet|controlled-release tablet
5152726|NCT01000857|repeat dose|repeat dose
5152727|NCT01000857|immediate-release tablet|immediate-release tablet
5152728|NCT01000857|paroxetine|paroxetine
5152729|NCT01000857|safety|safety
5152730|NCT01000857|crossover|crossover
5152731|NCT01000857|pharmacokinetics|pharmacokinetics
5152732|NCT01000857|steady-state|steady-state
5152733|NCT01000857|Japanese healthy male volunteers|japanese healthy male volunteers
5152734|NCT01000857|tolerance|tolerance
5152735|NCT01000844|Hemophilia|hemophilia
5152736|NCT01000844|Joint|joint
5152737|NCT01000844|Cartilage|cartilage
5152738|NCT01000844|Damage|damage
5152739|NCT01000844|Prophylaxis|prophylaxis
5152740|NCT01000844|Factor VIII|factor viii
5152741|NCT01000844|FVIII|fviii
5152742|NCT01000844|Disease|disease
5152743|NCT01000844|Arthropathy|arthropathy
5152744|NCT01000831|vaccine|vaccine
5152745|NCT01000831|influenza|influenza
5152746|NCT01000831|H1N1 influenza vaccine|h1n1 influenza vaccine
5152747|NCT01000831|influenza vaccine|influenza vaccine
5152748|NCT01000831|Arepanrix|arepanrix
5152749|NCT01000818|Treatment experienced|treatment experienced
5152750|NCT01000779|Non Cirrhotic Portal Hypertension, secondary prophylaxis|non cirrhotic portal hypertension, secondary prophylaxis
5152751|NCT01000740|EAP|eap
5152752|NCT01000740|Long term survival (3 years)|long term survival (3 years)
5152753|NCT01000740|Gefitinib|gefitinib
5152754|NCT01000740|efficacy|efficacy
5152755|NCT01000727|Atherosclerosis|atherosclerosis
5152756|NCT01000727|Heart disease|heart disease
5152757|NCT01000727|Cardiovascular disease|cardiovascular disease
5152758|NCT01000727|Lp-PLA2 inhibitor|lp-pla2 inhibitor
5152759|NCT01000727|The TIMI Study Group|the timi study group
5152760|NCT01000727|Coronary Heart Disease (CHD)|coronary heart disease (chd)
5152761|NCT01000727|Acute Coronary Syndrome (ACS)|acute coronary syndrome (acs)
5152762|NCT01000701|Inflammation|inflammation
5152763|NCT01000701|ACS|acs
5152764|NCT01000701|Prevention|prevention
5152765|NCT01000701|Education|education
5152766|NCT01000701|Clinical management|clinical management
5152767|NCT01000675|aneurysm|aneurysm
5152768|NCT01000675|coils|coils
5152769|NCT01000662|whole breast radiotherapy|whole breast radiotherapy
5152770|NCT01000662|tumor bed boost|tumor bed boost
5152771|NCT01000649|V1a agonist|v1a agonist
5152772|NCT01000636|Renal transplant patients|renal transplant patients
5152773|NCT01000636|Actinic Keratoses|actinic keratoses
5152774|NCT01000636|Metvix PDT|metvix pdt
5152775|NCT01000636|Field cancerisation|field cancerisation
5152776|NCT01000636|Gene expression|gene expression
5152777|NCT01000597|pharmacokinetics|pharmacokinetics
5152778|NCT01000597|serum cortisol|serum cortisol
5152779|NCT01000597|pharmacodynamics|pharmacodynamics
5152780|NCT01000597|fluticasone furoate|fluticasone furoate
5152781|NCT01000597|healthy Caucasian, Japanese, Korean and Chinese subjects|healthy caucasian, japanese, korean and chinese subjects
5152782|NCT01000584|vaccine|vaccine
5152783|NCT01000584|H1N1|h1n1
5152784|NCT01000584|influenza|influenza
5152785|NCT01000584|H1N1 influenza vaccine|h1n1 influenza vaccine
5152786|NCT01000584|influenza vaccine|influenza vaccine
5152787|NCT01000584|seasonal Influenza|seasonal influenza
5152788|NCT01000571|H1N1 pandemic flu|h1n1 pandemic flu
5152789|NCT01000558|non-Hodgkin lymphoma|non-hodgkin lymphoma
5152790|NCT01000545|Diabetes Mellitus|diabetes mellitus
5152791|NCT01000545|Chronic Kidney Disease|chronic kidney disease
5152792|NCT01000545|Glycosaminoglycans|glycosaminoglycans
5152793|NCT01000545|Sulodexide|sulodexide
5152794|NCT01000545|Macroalbuminuria|macroalbuminuria
5152795|NCT01000545|Safety and Efficacy|safety and efficacy
5152796|NCT01000532|steroid, leads, threshold, pacemaker|steroid, leads, threshold, pacemaker
5152797|NCT01000519|Diabetes mellitus|diabetes mellitus
5152798|NCT01000519|Randomized control trial|randomized control trial
5152799|NCT01000519|Exercise|exercise
5152800|NCT01000519|Hemoglobin A, Glycosylated|hemoglobin a, glycosylated
5152801|NCT01000506|Dose-ranging|dose-ranging
5152802|NCT01000506|Safety|safety
5152803|NCT01000506|Pharmacodynamics|pharmacodynamics
5152804|NCT01000506|eosinophils|eosinophils
5152805|NCT01000506|SB-240563|sb-240563
5152806|NCT01000506|Efficacy|efficacy
5152807|NCT01000506|Severe refractory asthma|severe refractory asthma
5152808|NCT01000506|mepolizumab|mepolizumab
5152809|NCT01000506|Placebo|placebo
5152810|NCT01000493|efficacy|efficacy
5152811|NCT01000493|double-blind|double-blind
5152812|NCT01000493|Clinician Administered PTSD Scale|clinician administered ptsd scale
5152813|NCT01000493|placebo|placebo
5152814|NCT01000493|Sleep|sleep
5152815|NCT01000493|safety|safety
5152816|NCT01000493|CAPS|caps
5152817|NCT01000493|neurokinin-1 antagonist|neurokinin-1 antagonist
5152818|NCT01000493|orvepitant|orvepitant
5152819|NCT01000493|PTSD|ptsd
5152820|NCT01000493|randomized|randomized
5152821|NCT01000493|Post traumatic stress disorder|post traumatic stress disorder
5152822|NCT01000493|Phase II|phase ii
5152823|NCT01000467|PK assessment for healthy male volunteer|pk assessment for healthy male volunteer
5152824|NCT01000467|Healthy male subjects aged 20 to 40 years|healthy male subjects aged 20 to 40 years
5152825|NCT01000441|Rheumatoid arthritis with inadequate response to 1 anti-TNF|rheumatoid arthritis with inadequate response to 1 anti-tnf
5152826|NCT01000428|NSCLC|nsclc
5152827|NCT01000428|Tarceva|tarceva
5152828|NCT01000428|Positron emission technology|positron emission technology
5152829|NCT01000428|FLT|flt
5152830|NCT01000428|FDG|fdg
5152831|NCT01000415|Stage Ib2-early IIb of cervical cancer|stage ib2-early iib of cervical cancer
5152832|NCT01000415|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
5152833|NCT01000415|Cisplatin plus gemcitabine|cisplatin plus gemcitabine
5152834|NCT01000415|Radical hysterectomy with pelvic lymphadenectomy|radical hysterectomy with pelvic lymphadenectomy
5152835|NCT01000415|Quality of life|quality of life
5152836|NCT01000415|Stage Ib2-IIb of cervical cancer patients|stage ib2-iib of cervical cancer patients
5152837|NCT01000402|Bipolar Disorder|bipolar disorder
5152838|NCT01000402|Attention-Deficit/Hyperactivity Disorder|attention-deficit/hyperactivity disorder
5152839|NCT01000402|Genetics|genetics
5152840|NCT01000402|Environmental Factors|environmental factors
5152841|NCT01000402|Family Factors|family factors
5152842|NCT01000376|Cancer|cancer
5152843|NCT01000376|solid tumors|solid tumors
5152844|NCT01000350|orthostatic intolerance|orthostatic intolerance
5152845|NCT01000350|exercise capacity|exercise capacity
5152846|NCT01000350|tachycardia|tachycardia
5152847|NCT01000350|POTS|pots
5152848|NCT01000337|Liver Apoptosis|liver apoptosis
5152849|NCT01000324|Hepatitis A|hepatitis a
5152850|NCT01000324|Hepatitis B|hepatitis b
5152851|NCT01000311|MenACWY conjugate vaccine in infants|menacwy conjugate vaccine in infants
5152852|NCT01000311|Meningococcal vaccine in infants|meningococcal vaccine in infants
5152853|NCT01000311|MenACWY|menacwy
5152854|NCT01000246|mammacarcinoma|mammacarcinoma
5152855|NCT01000246|breastcancer|breastcancer
5152856|NCT01000246|chemotherapy|chemotherapy
5152857|NCT01000246|heart failure|heart failure
5152858|NCT01000246|influenza virus vaccine|influenza virus vaccine
5152859|NCT01000233|PATOLOGIC CALCIFICATION|patologic calcification
5152860|NCT01000233|AORTIC VALVE STENOSIS|aortic valve stenosis
5152861|NCT01000233|INOSITOL HEXAPHOSPHATE|inositol hexaphosphate
5152862|NCT01000207|Influenza A|influenza a
5152863|NCT01000207|H1N1 subtype|h1n1 subtype
5152864|NCT01000207|Children/adolescent|children/adolescent
5152865|NCT01000207|Vaccine|vaccine
5152866|NCT01000207|Adjuvant|adjuvant
5152867|NCT01000194|postprandial|postprandial
5152868|NCT01000194|gene expression profiles|gene expression profiles
5152869|NCT01000194|microarray|microarray
5152870|NCT01000168|Brain Injury|brain injury
5152871|NCT01000168|Rehabilitation|rehabilitation
5152872|NCT01000168|Treadmill therapy|treadmill therapy
5152873|NCT01000155|fetal hemoglobin|fetal hemoglobin
5152874|NCT01000155|vorinostat|vorinostat
5152875|NCT01000155|HDAC inhibitor|hdac inhibitor
5152876|NCT01000155|SAHA|saha
5152877|NCT01000142|Osteopathic|osteopathic
5152878|NCT01000142|Manipulation|manipulation
5152879|NCT01000142|Preventative|preventative
5152880|NCT01000142|Elderly|elderly
5152881|NCT01000142|Nursing Home|nursing home
5152882|NCT01000142|Prevention: General Health Status|prevention: general health status
5152883|NCT01000129|Radiotherapy|radiotherapy
5152884|NCT01000129|Bladder cancer|bladder cancer
5152885|NCT01000129|Adaptive planning|adaptive planning
5152886|NCT01000116|Tapp|tapp
5152887|NCT01000116|Early pain|early pain
5152888|NCT01000116|well-being|well-being
5152889|NCT01000116|Seroma|seroma
5152890|NCT01000116|Haematoma|haematoma
5152891|NCT01000116|Fibrin glue|fibrin glue
5152892|NCT01000116|tacks|tacks
5152893|NCT01000103|Stroke|stroke
5152894|NCT01000103|Visuospatial neglect|visuospatial neglect
5152895|NCT01000103|Visuospatial extinction|visuospatial extinction
5152896|NCT01000103|Transcranial Magnetic Stimulation (TMS)|transcranial magnetic stimulation (tms)
5152897|NCT01000103|Non-invasive brain stimulation|non-invasive brain stimulation
5152898|NCT01000103|Neuromodulation|neuromodulation
5152899|NCT01000103|Brain parietal cortex|brain parietal cortex
5152900|NCT01000103|Neurological sequels|neurological sequels
5152901|NCT01000103|Cognitive rehabilitation|cognitive rehabilitation
5152902|NCT01000090|Acromegaly|acromegaly
5152903|NCT01000090|Somatostatin analogues|somatostatin analogues
5152904|NCT01000090|Treatment|treatment
5152905|NCT01000077|Regenerative Medicine|regenerative medicine
5152906|NCT01000077|Tissue Collection|tissue collection
5152907|NCT01000077|Cell Culture Systems|cell culture systems
5152908|NCT01000077|Routine Surgery|routine surgery
5152909|NCT01000064|Traumatic Brain Injury|traumatic brain injury
5152910|NCT01000064|Attention Deficit|attention deficit
5152911|NCT01000064|TBI|tbi
5152912|NCT01000051|Transplant Thrombocytopenia|transplant thrombocytopenia
5152913|NCT01000051|Hematopoietic cell transplantation|hematopoietic cell transplantation
5152914|NCT01000051|HCT|hct
5152915|NCT01000051|Low platelet count|low platelet count
5152916|NCT01000051|Bleeding|bleeding
5152917|NCT01000051|Blood clot|blood clot
5152918|NCT01000051|Stem Cell Transplant|stem cell transplant
5152919|NCT01000051|Blood And Marrow Transplantation|blood and marrow transplantation
5152920|NCT01000051|Eltrombopag|eltrombopag
5152921|NCT01000051|Promacta|promacta
5152922|NCT01000038|Wii-Fit|wii-fit
5152923|NCT01000038|Assisted living|assisted living
5152924|NCT01000038|Alzheimer's dementia|alzheimer's dementia
5152925|NCT01000025|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5152926|NCT01000025|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5152927|NCT01000025|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5152928|NCT00999999|Craniotomy outcome|craniotomy outcome
5152929|NCT00999999|CSF leakage|csf leakage
5152930|NCT00999999|Dural sealant|dural sealant
5152931|NCT00999960|Laparoscopy|laparoscopy
5152932|NCT00999960|Prostate|prostate
5152933|NCT00999960|Cancer|cancer
5152934|NCT00999960|Learning|learning
5152935|NCT00999960|Simulation|simulation
5152936|NCT00999960|Simulator|simulator
5152937|NCT00999947|genetics|genetics
5152938|NCT00999947|mutation screening|mutation screening
5152939|NCT00999947|phenotype-genotype analysis|phenotype-genotype analysis
5152940|NCT00999947|desmosomal genes|desmosomal genes
5153327|NCT00998452|Weight|weight
5152941|NCT00999921|Fibrocystic Breast Disease|fibrocystic breast disease
5152942|NCT00999921|Fibroadenoma|fibroadenoma
5152943|NCT00999921|Mastalgia|mastalgia
5152944|NCT00999908|COPD|copd
5152945|NCT00999908|indacaterol|indacaterol
5152946|NCT00999908|tiotropium|tiotropium
5152947|NCT00999895|Schizophrenia|schizophrenia
5152948|NCT00999895|Switch of antipsychotic treatment|switch of antipsychotic treatment
5152949|NCT00999895|Outcome evaluation|outcome evaluation
5152950|NCT00999895|monotherapy|monotherapy
5152951|NCT00999895|Greece|greece
5152952|NCT00999882|mTor Kinase Inhibitor|mtor kinase inhibitor
5152953|NCT00999882|Phase I/II|phase i/ii
5152954|NCT00999882|Dose escalation|dose escalation
5152955|NCT00999882|Hepatocellular carcinoma (HCC)|hepatocellular carcinoma (hcc)
5152956|NCT00999882|Asia|asia
5152957|NCT00999882|HCC|hcc
5152958|NCT00999882|Safety and pharmacokinetics|safety and pharmacokinetics
5152959|NCT00999869|Newly diagnosed|newly diagnosed
5152960|NCT00999869|Alopecia areata|alopecia areata
5152961|NCT00999869|Botulinum toxin A|botulinum toxin a
5152962|NCT00999869|Corticosteroid|corticosteroid
5152963|NCT00999869|Intralesional injection|intralesional injection
5152964|NCT00999856|medical device,|medical device,
5152965|NCT00999856|sub-conjunctival insert|sub-conjunctival insert
5152966|NCT00999856|photometer|photometer
5152967|NCT00999856|fluorescence|fluorescence
5152968|NCT00999856|subconjunctival interstitial fluid glucose|subconjunctival interstitial fluid glucose
5152969|NCT00999856|non-invasive measurement|non-invasive measurement
5152970|NCT00999843|Sorafenib|sorafenib
5152971|NCT00999843|Three-dimensional conformal radiation therapy|three-dimensional conformal radiation therapy
5152972|NCT00999843|Intensity-modulated radiation therapy|intensity-modulated radiation therapy
5152973|NCT00999843|Transcatheter arterial chemoembolization|transcatheter arterial chemoembolization
5152974|NCT00999817|Drug-Drug interaction Study CYP2D6 inhibition Healthy Subjects|drug-drug interaction study cyp2d6 inhibition healthy subjects
5152975|NCT00999804|Locally Advanced Breast Cancer Neoadjuvant Endocrine|locally advanced breast cancer neoadjuvant endocrine
5152976|NCT00999778|Autism|autism
5152977|NCT00999778|Social and Communication Deficits in Autism|social and communication deficits in autism
5152978|NCT00999778|Parent and Caregiver interventions with children with Autism|parent and caregiver interventions with children with autism
5152979|NCT00999778|Autism Spectrum Disorder|autism spectrum disorder
5152980|NCT00999778|ASD|asd
5152981|NCT00999765|Bipolar Disorder|bipolar disorder
5152982|NCT00999765|Bipolar Depression|bipolar depression
5152983|NCT00999765|Mindfulness-Based Cognitive Therapy|mindfulness-based cognitive therapy
5152984|NCT00999765|MBCT|mbct
5152985|NCT00999765|Maintenance|maintenance
5152986|NCT00999765|Euthymic|euthymic
5152987|NCT00999765|Efficacy|efficacy
5152988|NCT00999765|Feasibility|feasibility
5152989|NCT00999752|Hypertension|hypertension
5152990|NCT00999752|African Americans|african americans
5152991|NCT00999752|Arterial Stiffness|arterial stiffness
5152992|NCT00999752|Vascular Resistance|vascular resistance
5152993|NCT00999739|pneumococcal vaccines|pneumococcal vaccines
5152994|NCT00999739|HIV|hiv
5152995|NCT00999739|antibody response|antibody response
5152996|NCT00999739|antibody affinity|antibody affinity
5152997|NCT00999739|Antibody formation|antibody formation
5152998|NCT00999739|Phagocytosis|phagocytosis
5152999|NCT00999713|Acute Lung Injury|acute lung injury
5153000|NCT00999713|Cancer|cancer
5153001|NCT00999713|Pediatrics|pediatrics
5153002|NCT00999700|Locally advanced HNSCC|locally advanced hnscc
5153003|NCT00999700|Chemo-radiation|chemo-radiation
5153004|NCT00999700|Induction chemotherapy|induction chemotherapy
5153005|NCT00999700|Stage III/IV|stage iii/iv
5153006|NCT00999700|Unresectable disease|unresectable disease
5153007|NCT00999687|Nail psoriasis|nail psoriasis
5153008|NCT00999687|Indigo naturalis|indigo naturalis
5153009|NCT00999674|Exercise|exercise
5153010|NCT00999648|Tinnitus|tinnitus
5153011|NCT00999648|Myofascial Trigger Points|myofascial trigger points
5153012|NCT00999648|Myofascial Pain Syndrome|myofascial pain syndrome
5153013|NCT00999648|Controlled Clinical Trial|controlled clinical trial
5153014|NCT00999635|Insoles|insoles
5153015|NCT00999635|Prevention of Ulceration|prevention of ulceration
5153016|NCT00999635|Diabetic Foot|diabetic foot
5153017|NCT00999635|Neuropathic|neuropathic
5153018|NCT00999622|infection|infection
5153019|NCT00999622|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5153020|NCT00999622|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
5153021|NCT00999622|adult giant cell glioblastoma|adult giant cell glioblastoma
5153022|NCT00999622|adult gliosarcoma|adult gliosarcoma
5153023|NCT00999622|adult oligodendroglioma|adult oligodendroglioma
5153024|NCT00999622|adult glioblastoma|adult glioblastoma
5153025|NCT00999622|adult diffuse astrocytoma|adult diffuse astrocytoma
5153026|NCT00999622|adult pilocytic astrocytoma|adult pilocytic astrocytoma
5153027|NCT00999622|adult pineal gland astrocytoma|adult pineal gland astrocytoma
5153028|NCT00999622|adult subependymal giant cell astrocytoma|adult subependymal giant cell astrocytoma
5153029|NCT00999609|Adeno-associated virus|adeno-associated virus
5153030|NCT00999609|AAV|aav
5153031|NCT00999609|Leber congenital amaurosis|leber congenital amaurosis
5153032|NCT00999609|RPE65|rpe65
5153033|NCT00999609|Gene therapy|gene therapy
5153034|NCT00999609|Gene transfer|gene transfer
5153035|NCT00999609|voretigene neparvovec-rzyl|voretigene neparvovec-rzyl
5153036|NCT00999609|Retinitis pigmentosa|retinitis pigmentosa
5153037|NCT00999596|Breast Cancer|breast cancer
5153038|NCT00999596|Digital Mammography|digital mammography
5153039|NCT00999583|Cardiac arrest|cardiac arrest
5153040|NCT00999583|erythropoietin|erythropoietin
5153041|NCT00999583|post-anoxic encephalopathy|post-anoxic encephalopathy
5153042|NCT00999583|neuroprotective drugs|neuroprotective drugs
5153043|NCT00999570|outcome|outcome
5153044|NCT00999570|quality of life|quality of life
5153045|NCT00999570|total knee arthroplasty|total knee arthroplasty
5153046|NCT00999570|clinical outcome scores post total knee arthroplasty|clinical outcome scores post total knee arthroplasty
5153047|NCT00999570|quality of life scores post total knee arthroplasty|quality of life scores post total knee arthroplasty
5153048|NCT00999557|breast cancer|breast cancer
5153049|NCT00999557|male breast cancer|male breast cancer
5153050|NCT00999557|alopecia|alopecia
5153052|NCT00999544|oxycodone|oxycodone
5153053|NCT00999544|NK1 antagonist|nk1 antagonist
5153054|NCT00999544|aprepitant|aprepitant
5153055|NCT00999544|intranasal|intranasal
5153056|NCT00999544|abuse|abuse
5153057|NCT00999531|Cystic Fibrosis|cystic fibrosis
5153058|NCT00999531|CF|cf
5153059|NCT00999531|Mucociliary Clearance|mucociliary clearance
5153060|NCT00999531|Epithelial Sodium Channel Inhibitor|epithelial sodium channel inhibitor
5153061|NCT00999531|ENaC Inhibitor|enac inhibitor
5153062|NCT00999531|Airway Hydration|airway hydration
5153063|NCT00999531|Amiloride|amiloride
5153064|NCT00999518|Randomized double blind placebo-controlled parallel-group dose-range finding interstitial cystitis efficacy pain urinary symptoms safety|randomized double blind placebo-controlled parallel-group dose-range finding interstitial cystitis efficacy pain urinary symptoms safety
5153065|NCT00999505|Schizophrenia|schizophrenia
5153066|NCT00999505|Amantadine|amantadine
5153067|NCT00999505|Residual symptoms|residual symptoms
5153068|NCT00999492|Tecnis Multifocal|tecnis multifocal
5153069|NCT00999492|Patients scheduled for cataract or lens replacement surgery with implantation of multifocal intraocular lenses|patients scheduled for cataract or lens replacement surgery with implantation of multifocal intraocular lenses
5153070|NCT00999453|LDL-cholesterol|ldl-cholesterol
5153071|NCT00999453|Prevalent peritoneal dialysis patients with hypercholesterolemia|prevalent peritoneal dialysis patients with hypercholesterolemia
5153072|NCT00999440|Chronic Pain|chronic pain
5153073|NCT00999440|Methadone|methadone
5153074|NCT00999440|Perceived Sleep|perceived sleep
5153075|NCT00999440|QTc|qtc
5153076|NCT00999427|Povidone-iodine|povidone-iodine
5153077|NCT00999427|prostate cancer|prostate cancer
5153078|NCT00999427|biopsy|biopsy
5153079|NCT00999427|transrectal ultrasound|transrectal ultrasound
5153080|NCT00999427|urinary tract infection|urinary tract infection
5153081|NCT00999427|fever|fever
5153082|NCT00999427|sepsis|sepsis
5153083|NCT00999427|antisepsis|antisepsis
5153084|NCT00999427|prevention|prevention
5153085|NCT00999427|complications|complications
5153086|NCT00999414|MM|mm
5153087|NCT00999388|Lifestyle|lifestyle
5153088|NCT00999388|Environment|environment
5153089|NCT00999388|Neurodegenerative Diseases|neurodegenerative diseases
5153090|NCT00999388|Elderly|elderly
5153091|NCT00999388|Public Health|public health
5153092|NCT00999388|PD|pd
5153093|NCT00999388|Parkinson Disease|parkinson disease
5153094|NCT00999375|Type 1 Diabetes|type 1 diabetes
5153095|NCT00999375|Diet|diet
5153096|NCT00999375|Behavioral Intervention|behavioral intervention
5153097|NCT00999375|Children|children
5153098|NCT00999375|Adolescents|adolescents
5153099|NCT00999362|calcineurin activity|calcineurin activity
5153100|NCT00999362|real-time PCR|real-time pcr
5153101|NCT00999362|Gene expression of calcineurin|gene expression of calcineurin
5153102|NCT00999362|T-lymphocytes|t-lymphocytes
5153103|NCT00999362|interferon-gamma|interferon-gamma
5153104|NCT00999362|Pharmacodynamics|pharmacodynamics
5153105|NCT00999362|Pharmacokinetics|pharmacokinetics
5153106|NCT00999362|tacrolimus|tacrolimus
5153107|NCT00999362|western blot|western blot
5153108|NCT00999362|Hoechst|hoechst
5153109|NCT00999349|iron overload condition|iron overload condition
5153110|NCT00999349|regular desferrioxamine administration|regular desferrioxamine administration
5153111|NCT00999349|receiving continuous blood transfusions|receiving continuous blood transfusions
5153112|NCT00999336|Betrixaban|betrixaban
5153113|NCT00999336|Renal impairment|renal impairment
5153114|NCT00999336|Healthy|healthy
5153115|NCT00999336|Kidney dysfunction|kidney dysfunction
5153116|NCT00999310|Klinefelter syndrome|klinefelter syndrome
5153117|NCT00999310|Neuropsychology|neuropsychology
5153118|NCT00999310|Neuroradiology|neuroradiology
5153119|NCT00999310|Genetics|genetics
5153120|NCT00999297|thermogenesis|thermogenesis
5153121|NCT00999297|respiratory quotient|respiratory quotient
5153122|NCT00999297|fat oxidation|fat oxidation
5153123|NCT00999284|ZK200775 is tested for its effects on vision on healthy probands.|zk200775 is tested for its effects on vision on healthy probands.
5153124|NCT00999271|Glucose-dependent insulinotropic polypeptide|glucose-dependent insulinotropic polypeptide
5153125|NCT00999271|gastric emptying|gastric emptying
5153126|NCT00999271|appetite|appetite
5153127|NCT00999271|energy intake|energy intake
5153128|NCT00999271|lipid metabolism|lipid metabolism
5153328|NCT00998452|Diet|diet
5153129|NCT00999258|glomerular filtration rate|glomerular filtration rate
5153130|NCT00999258|chronic allograft nephropathy|chronic allograft nephropathy
5153131|NCT00999258|Kidney transplantation|kidney transplantation
5153132|NCT00999258|African American|african american
5153133|NCT00999232|erythromycin|erythromycin
5153134|NCT00999232|prokinetics|prokinetics
5153135|NCT00999232|nasojejunal tubes|nasojejunal tubes
5153136|NCT00999232|Bengmark feeding tube|bengmark feeding tube
5153137|NCT00999232|post-pyloric feeding|post-pyloric feeding
5153138|NCT00999232|pancreatitis|pancreatitis
5153139|NCT00999232|Non-critically ill patients having pancreatitis who require jejunal enteral nutrition|non-critically ill patients having pancreatitis who require jejunal enteral nutrition
5153140|NCT00999219|FK199B|fk199b
5153141|NCT00999219|Zolpidem|zolpidem
5153142|NCT00999206|Influenza|influenza
5153143|NCT00999206|Vaccine|vaccine
5153144|NCT00999206|CHMP criteria|chmp criteria
5153145|NCT00999193|Shoulder|shoulder
5153146|NCT00999193|Fracture|fracture
5153147|NCT00999193|Locking Plate|locking plate
5153148|NCT00999193|Hemiarthroplasty|hemiarthroplasty
5153149|NCT00999193|Conservative|conservative
5153150|NCT00999193|Comminuted Proximal Humerus Fracture|comminuted proximal humerus fracture
5153151|NCT00999180|Botulinum Toxin|botulinum toxin
5153152|NCT00999180|Rehabilitation|rehabilitation
5153153|NCT00999180|Stroke|stroke
5153154|NCT00999167|Cirrhosis|cirrhosis
5153155|NCT00999167|Episodic Hepatic Encephalopathy|episodic hepatic encephalopathy
5153156|NCT00999167|HE|he
5153157|NCT00999167|HPN-100|hpn-100
5153158|NCT00999167|GT4P|gt4p
5153159|NCT00999167|glycerol phenylbutyrate|glycerol phenylbutyrate
5153160|NCT00999154|Energy Expenditure|energy expenditure
5153161|NCT00999154|Dietary Intake|dietary intake
5153162|NCT00999154|Physical Activity|physical activity
5153163|NCT00999154|Body Weight Regulation|body weight regulation
5153164|NCT00999154|Sedentary|sedentary
5153165|NCT00999154|HV|hv
5153166|NCT00999154|Healthy Volunteer|healthy volunteer
5153167|NCT00999128|PI3K inhibitor|pi3k inhibitor
5153168|NCT00999128|PI3 kinase|pi3 kinase
5153169|NCT00999128|PI3 kinase inhibitor|pi3 kinase inhibitor
5153170|NCT00999115|Rectovaginal Fistula|rectovaginal fistula
5153171|NCT00999115|Crohn Disease|crohn disease
5153172|NCT00999115|Allogenic|allogenic
5153173|NCT00999115|Adipose-Derived Stem Cells|adipose-derived stem cells
5153174|NCT00999102|hypertension|hypertension
5153175|NCT00999102|beta blockers|beta blockers
5153176|NCT00999102|Metoprolol|metoprolol
5153177|NCT00999102|blood pressure, high|blood pressure, high
5153178|NCT00999102|antihypertensive agents|antihypertensive agents
5153179|NCT00999102|vascular resistance|vascular resistance
5153180|NCT00999102|adrenergic beta-receptor blockaders|adrenergic beta-receptor blockaders
5153181|NCT00999102|beta-Adrenergic blockers|beta-adrenergic blockers
5153182|NCT00999102|beta-Adrenergic Blocking Agents|beta-adrenergic blocking agents
5153183|NCT00999102|beta-Adrenergic Receptor Blockaders|beta-adrenergic receptor blockaders
5153184|NCT00999102|beta-Blockers, Adrenergic|beta-blockers, adrenergic
5153185|NCT00999102|Bystolic|bystolic
5153186|NCT00999102|Nebivolol|nebivolol
5153187|NCT00999102|Nebivololum|nebivololum
5153188|NCT00999102|Nebivololum [Latin]|nebivololum [latin]
5153189|NCT00999102|R65,824|r65,824
5153190|NCT00999102|Beloc- Zok|beloc- zok
5153191|NCT00999102|H 93/26 succinate|h 93/26 succinate
5153192|NCT00999102|Metoprolol succinate|metoprolol succinate
5153193|NCT00999102|Seloken ZOC|seloken zoc
5153194|NCT00999102|Selozok|selozok
5153195|NCT00999102|Spesicor Dos|spesicor dos
5153196|NCT00999102|Toprol XL|toprol xl
5153197|NCT00999102|Toprol-XL|toprol-xl
5153198|NCT00999102|UNII-TH25PD4CCB|unii-th25pd4ccb
5153199|NCT00999089|Coronary disease|coronary disease
5153200|NCT00999089|Coronary artery bypass grafting|coronary artery bypass grafting
5153201|NCT00999089|Cardiopulmonary bypass|cardiopulmonary bypass
5153202|NCT00999089|Extracorporeal circulation|extracorporeal circulation
5153203|NCT00999089|Cardioplegia|cardioplegia
5153204|NCT00999089|Off pump|off pump
5153205|NCT00999063|GerdQ|gerdq
5153206|NCT00999050|type two diabetes|type two diabetes
5153207|NCT00999050|gastric bypass surgery|gastric bypass surgery
5153208|NCT00999050|overweight or moderately obese|overweight or moderately obese
5153209|NCT00999011|critical care|critical care
5153210|NCT00999011|inflammatory biomarkers|inflammatory biomarkers
5153211|NCT00999011|cytokines|cytokines
5153212|NCT00999011|mechanical ventilation|mechanical ventilation
5153213|NCT00999011|activity|activity
5153214|NCT00999011|mobility therapy|mobility therapy
5153215|NCT00999011|More than 48 hours of mechanical ventilation|more than 48 hours of mechanical ventilation
5153216|NCT00998998|iron deficiency anemia|iron deficiency anemia
5153217|NCT00998998|infant behavior|infant behavior
5153218|NCT00998998|infant development|infant development
5153219|NCT00998972|kidney graft,|kidney graft,
5153220|NCT00998972|delayed graft function|delayed graft function
5153221|NCT00998972|N-acetylcysteine|n-acetylcysteine
5153222|NCT00998959|Depression|depression
5153223|NCT00998959|Major Depression|major depression
5153224|NCT00998946|Relapsed|relapsed
5153225|NCT00998946|Refractory|refractory
5153226|NCT00998946|Non-Hodgkin's|non-hodgkin's
5153723|NCT00996996|Bexxar|bexxar
5153227|NCT00998933|Testosterone replacement therapy|testosterone replacement therapy
5153228|NCT00998920|Healthy volunteers|healthy volunteers
5153229|NCT00998907|Open Abdominal Surgery|open abdominal surgery
5153230|NCT00998907|Fascial Closure|fascial closure
5153231|NCT00998894|BIS|bis
5153232|NCT00998894|MAC|mac
5153233|NCT00998894|MAP|map
5153234|NCT00998881|insulin resistance|insulin resistance
5153235|NCT00998868|Rotator Cuff|rotator cuff
5153236|NCT00998868|Tendinopathy|tendinopathy
5153237|NCT00998868|ultrasonography|ultrasonography
5153238|NCT00998855|Exercise in obesity|exercise in obesity
5153239|NCT00998842|ECG|ecg
5153240|NCT00998842|EKG|ekg
5153241|NCT00998842|healthy subjects|healthy subjects
5153242|NCT00998842|electrocardiography, ambulatory|electrocardiography, ambulatory
5153243|NCT00998829|psoriasis|psoriasis
5153244|NCT00998829|psoriatic arthritis|psoriatic arthritis
5153245|NCT00998829|epidemiology|epidemiology
5153246|NCT00998829|prevalence|prevalence
5153247|NCT00998816|thoracotomy|thoracotomy
5153248|NCT00998816|chronic|chronic
5153249|NCT00998816|pain|pain
5153250|NCT00998816|pregabalin|pregabalin
5153251|NCT00998816|Lyrica|lyrica
5153252|NCT00998803|Influenza virus|influenza virus
5153253|NCT00998790|Urinary Incontinence, Stress|urinary incontinence, stress
5153254|NCT00998790|Intrinsic sphincter deficiency|intrinsic sphincter deficiency
5153255|NCT00998790|Secondary|secondary
5153256|NCT00998790|TUR|tur
5153257|NCT00998790|TURP|turp
5153258|NCT00998790|Radical prostatectomy|radical prostatectomy
5153259|NCT00998790|Open prostatectomy|open prostatectomy
5153260|NCT00998790|Post-suprapubic prostatectomy|post-suprapubic prostatectomy
5153261|NCT00998777|tubing program|tubing program
5153262|NCT00998777|shoulder strengthening|shoulder strengthening
5153263|NCT00998777|injury prevention|injury prevention
5153264|NCT00998764|antibody|antibody
5153265|NCT00998764|immunotherapy|immunotherapy
5153266|NCT00998751|cKIT inhibitor|ckit inhibitor
5153267|NCT00998751|GIST|gist
5153268|NCT00998712|gestational diabetes mellitus|gestational diabetes mellitus
5153269|NCT00998712|pregnancy|pregnancy
5153270|NCT00998712|cardiovascular disease risk|cardiovascular disease risk
5153271|NCT00998699|Diabetes|diabetes
5153272|NCT00998699|Type 1|type 1
5153273|NCT00998686|diabetes|diabetes
5153274|NCT00998686|DPP4 inhibitor|dpp4 inhibitor
5153275|NCT00998686|dutogliptin|dutogliptin
5153276|NCT00998673|Silica gel fiber|silica gel fiber
5153277|NCT00998673|Chronic venous leg ulcers|chronic venous leg ulcers
5153278|NCT00998673|Venous ulcer|venous ulcer
5153279|NCT00998673|Stasis ulcer|stasis ulcer
5153280|NCT00998673|Varicose ulcer|varicose ulcer
5153281|NCT00998660|Parkinson's disease|parkinson's disease
5153282|NCT00998660|Essential Tremor|essential tremor
5153283|NCT00998660|Dystonia (where indication is approved)|dystonia (where indication is approved)
5153284|NCT00998660|Deep brain stimulation|deep brain stimulation
5153285|NCT00998660|Activa RC|activa rc
5153286|NCT00998647|modified ultrafiltration|modified ultrafiltration
5153287|NCT00998647|cardiac surgery|cardiac surgery
5153288|NCT00998647|ROTEM|rotem
5153289|NCT00998647|Multiple Electrode Aggregometry|multiple electrode aggregometry
5153290|NCT00998634|SCA2|sca2
5153291|NCT00998634|Lithium|lithium
5153292|NCT00998621|Hepatitis C, Chronic|hepatitis c, chronic
5153293|NCT00998621|HIV Infection|hiv infection
5153294|NCT00998621|Medication Adherence|medication adherence
5153295|NCT00998621|Questionnaire Design|questionnaire design
5153296|NCT00998621|Treatment experienced|treatment experienced
5153297|NCT00998595|Diabetes, Gestational|diabetes, gestational
5153298|NCT00998595|Postpartum Period|postpartum period
5153299|NCT00998595|Reproductive Health Services|reproductive health services
5153300|NCT00998595|Health Promotion|health promotion
5153301|NCT00998595|Health Personnel|health personnel
5153302|NCT00998582|Cardiovascular Disease|cardiovascular disease
5153303|NCT00998582|HIV Infection|hiv infection
5153304|NCT00998582|Abacavir|abacavir
5153305|NCT00998582|Artery Elasticity|artery elasticity
5153306|NCT00998582|Treatment experienced|treatment experienced
5153307|NCT00998556|Peripartum cardiomyopathy|peripartum cardiomyopathy
5153308|NCT00998556|Bromocriptine|bromocriptine
5153309|NCT00998543|Smallpox Vaccinia Virus Smallpox Vaccine Variola Virus|smallpox vaccinia virus smallpox vaccine variola virus
5153310|NCT00998530|Trichomonas vaginalis|trichomonas vaginalis
5153311|NCT00998530|trichomoniasis|trichomoniasis
5153312|NCT00998530|MLST|mlst
5153313|NCT00998530|Multilocus sequence typing|multilocus sequence typing
5153314|NCT00998517|Malnutrition|malnutrition
5153315|NCT00998517|Supplemental Food|supplemental food
5153316|NCT00998517|CSB++|csb++
5153317|NCT00998517|Supplementary Plumpy|supplementary plumpy
5153318|NCT00998504|impaired fat oxidation|impaired fat oxidation
5153319|NCT00998504|fat accumulation|fat accumulation
5153320|NCT00998504|mitochondrial dysfunction|mitochondrial dysfunction
5153321|NCT00998504|mitochondrial biogenesis|mitochondrial biogenesis
5153322|NCT00998465|Obesity|obesity
5153323|NCT00998465|Hypertension|hypertension
5153324|NCT00998465|Salt sensitivity|salt sensitivity
5153325|NCT00998465|Laparoscopic gastric bypass|laparoscopic gastric bypass
5153326|NCT00998465|Bariatric surgery|bariatric surgery
5153329|NCT00998452|Physical Activity|physical activity
5153330|NCT00998452|Veterans|veterans
5153331|NCT00998452|MOVE! Program|move! program
5153332|NCT00998439|in stent restenosis|in stent restenosis
5153333|NCT00998439|paclitaxel coated balloon catheter|paclitaxel coated balloon catheter
5153334|NCT00998439|pepcad|pepcad
5153335|NCT00998439|drug eluting balloon|drug eluting balloon
5153336|NCT00998426|hepatitis B immune globulin|hepatitis b immune globulin
5153337|NCT00998426|HBIG|hbig
5153338|NCT00998426|HepaGam B|hepagam b
5153339|NCT00998426|orthotopic liver transplant|orthotopic liver transplant
5153340|NCT00998413|asthma|asthma
5153341|NCT00998413|overweight|overweight
5153342|NCT00998413|obesity|obesity
5153343|NCT00998413|children|children
5153344|NCT00998400|Cognitive-behavioral treatment|cognitive-behavioral treatment
5153345|NCT00998400|Well-being therapy|well-being therapy
5153346|NCT00998400|Depression|depression
5153347|NCT00998400|Demoralization|demoralization
5153348|NCT00998400|Acute coronary syndrome|acute coronary syndrome
5153349|NCT00998361|Sarcoma|sarcoma
5153350|NCT00998361|allogeneic|allogeneic
5153351|NCT00998361|Hemopoietic stem cell transplant|hemopoietic stem cell transplant
5153352|NCT00998348|parenting|parenting
5153353|NCT00998348|diet|diet
5153354|NCT00998348|physical activity|physical activity
5153355|NCT00998348|family|family
5153356|NCT00998348|home|home
5153357|NCT00998348|child|child
5153358|NCT00998335|Type 2 diabetes mellitus|type 2 diabetes mellitus
5153359|NCT00998335|Insulin therapy|insulin therapy
5153360|NCT00998335|Detemir (Levemir)|detemir (levemir)
5153361|NCT00998335|Aspart (Novolog)|aspart (novolog)
5153362|NCT00998335|Hepatic steatosis|hepatic steatosis
5153363|NCT00998322|metastatic|metastatic
5153364|NCT00998322|pancreatic|pancreatic
5153365|NCT00998322|adenocarcinoma|adenocarcinoma
5153366|NCT00998322|REOLYSIN|reolysin
5153367|NCT00998322|chemotherapy|chemotherapy
5153368|NCT00998322|gemcitabine|gemcitabine
5153369|NCT00998309|skin infection|skin infection
5153370|NCT00998309|soft tissue infection|soft tissue infection
5153371|NCT00998309|sexually-transmitted infection|sexually-transmitted infection
5153372|NCT00998309|infection oral|infection oral
5153373|NCT00998309|Regulatory Post Marketing Commitment Plan|regulatory post marketing commitment plan
5153374|NCT00998270|MM|mm
5153375|NCT00998257|Contraception|contraception
5153376|NCT00998257|Premenstrual Dysphoric Disorder|premenstrual dysphoric disorder
5153377|NCT00998257|PMDD|pmdd
5153378|NCT00998257|Acne|acne
5153379|NCT00998244|low carbohydrate|low carbohydrate
5153380|NCT00998244|low fat|low fat
5153381|NCT00998244|diet|diet
5153382|NCT00998244|overweight|overweight
5153383|NCT00998244|GERD|gerd
5153384|NCT00998244|gastroesophageal reflux disease|gastroesophageal reflux disease
5153385|NCT00998244|acid reflux|acid reflux
5153386|NCT00998244|heartburn|heartburn
5153387|NCT00998218|Sudden Cardiac Death|sudden cardiac death
5153388|NCT00998218|Arrythmias|arrythmias
5153389|NCT00998218|Triggered activity|triggered activity
5153390|NCT00998218|left ventricular dysfunction|left ventricular dysfunction
5153391|NCT00998192|carcinoma|carcinoma
5153392|NCT00998192|squamous cell|squamous cell
5153393|NCT00998192|lung|lung
5153394|NCT00998192|REOLYSIN|reolysin
5153395|NCT00998192|chemotherapy|chemotherapy
5153396|NCT00998192|carboplatin|carboplatin
5153397|NCT00998192|paclitaxel|paclitaxel
5153398|NCT00998192|Carcinoma, Squamous Cell of the Lung|carcinoma, squamous cell of the lung
5153399|NCT00998179|TENS|tens
5153400|NCT00998179|acupuncture|acupuncture
5153401|NCT00998179|FEV1|fev1
5153402|NCT00998179|Normal Healthy subjects|normal healthy subjects
5153403|NCT00998166|NSCLC|nsclc
5153404|NCT00998153|substance use|substance use
5153405|NCT00998153|PTSD|ptsd
5153406|NCT00998153|risky behaviors|risky behaviors
5153407|NCT00998153|revictimization|revictimization
5153408|NCT00998140|resuscitation|resuscitation
5153409|NCT00998140|sudden death|sudden death
5153410|NCT00998140|cardiopulmonary resuscitation|cardiopulmonary resuscitation
5153411|NCT00998140|emergency medical services|emergency medical services
5153412|NCT00998140|termination of resuscitation|termination of resuscitation
5153413|NCT00998140|ventricular fibrillation|ventricular fibrillation
5153414|NCT00998140|out-of-hospital cardiac arrest|out-of-hospital cardiac arrest
5153415|NCT00998140|asystole|asystole
5153416|NCT00998140|medical futility|medical futility
5153417|NCT00998140|withdrawing treatment|withdrawing treatment
5153418|NCT00998140|transportation of patients|transportation of patients
5153419|NCT00998140|health expenditures|health expenditures
5153420|NCT00998140|healthcare costs|healthcare costs
5153421|NCT00998127|Dual Anti-Platelet Therapy|dual anti-platelet therapy
5153422|NCT00998127|Non-adherence|non-adherence
5153423|NCT00998127|MACE|mace
5153424|NCT00998127|NACE|nace
5153425|NCT00998114|Early Cardiac Diastolic Dysfunction|early cardiac diastolic dysfunction
5153426|NCT00998114|Aerobic Exercise|aerobic exercise
5153427|NCT00998114|Weight Reduction|weight reduction
5153428|NCT00998101|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5153429|NCT00998101|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5153724|NCT00996970|HIV|hiv
5153430|NCT00998101|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5153431|NCT00998088|Blood management|blood management
5153432|NCT00998088|Orthopedic surgery|orthopedic surgery
5153433|NCT00998088|elective|elective
5153434|NCT00998088|randomized study|randomized study
5153435|NCT00998088|adults|adults
5153436|NCT00998088|hip replacement|hip replacement
5153437|NCT00998088|knee replacement|knee replacement
5153438|NCT00998075|Bioequivalence|bioequivalence
5153439|NCT00998075|ASA|asa
5153440|NCT00998075|Esomeprazole|esomeprazole
5153441|NCT00998075|peptic ulcer disease|peptic ulcer disease
5153442|NCT00998075|primary cardiovascular protection|primary cardiovascular protection
5153443|NCT00998075|healthy volunteers|healthy volunteers
5153444|NCT00998062|Dyslipaemia|dyslipaemia
5153445|NCT00998062|atherosclerosis risk|atherosclerosis risk
5153446|NCT00998062|increased hsCRP|increased hscrp
5153447|NCT00998062|inflammatory and oxidative status in the Spanish population|inflammatory and oxidative status in the spanish population
5153448|NCT00998036|TNBC|tnbc
5153449|NCT00998036|Temsirolimus|temsirolimus
5153450|NCT00998036|Erlotinib|erlotinib
5153451|NCT00998036|Cisplatin|cisplatin
5153452|NCT00998036|Breast Cancer|breast cancer
5153453|NCT00998023|Angiogram|angiogram
5153454|NCT00998023|Catheter Angiogram|catheter angiogram
5153455|NCT00998010|adult giant cell glioblastoma|adult giant cell glioblastoma
5153456|NCT00998010|adult glioblastoma|adult glioblastoma
5153457|NCT00998010|adult gliosarcoma|adult gliosarcoma
5153458|NCT00997997|Skin Diseases, Bacterial|skin diseases, bacterial
5153459|NCT00997997|Product Surveillance|product surveillance
5153460|NCT00997997|Postmarketing|postmarketing
5153461|NCT00997984|ADHD|adhd
5153462|NCT00997971|Hydrolysed rice protein formula|hydrolysed rice protein formula
5153463|NCT00997971|Cow's milk protein allergy|cow's milk protein allergy
5153464|NCT00997971|Infant formula|infant formula
5153465|NCT00997971|Gastrointestinal tolerance|gastrointestinal tolerance
5153466|NCT00997945|Phase I, advanced solid malignancies, advance solid tumour|phase i, advanced solid malignancies, advance solid tumour
5153467|NCT00997945|advanced cancer|advanced cancer
5153468|NCT00997945|ZD4054 (Zibotentan)|zd4054 (zibotentan)
5153469|NCT00997945|china|china
5153470|NCT00997945|PK|pk
5153471|NCT00997945|pharmacokinetics|pharmacokinetics
5153472|NCT00997932|levonorgestrel releasing intrauterine device|levonorgestrel releasing intrauterine device
5153473|NCT00997932|levonorgestrel releasing intrauterine contraception|levonorgestrel releasing intrauterine contraception
5153474|NCT00997932|unintended pregnancy prevention|unintended pregnancy prevention
5153475|NCT00997932|postpartum contraception|postpartum contraception
5153476|NCT00997906|stage III lymphoepithelioma of the nasopharynx|stage iii lymphoepithelioma of the nasopharynx
5153477|NCT00997906|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
5153478|NCT00997906|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
5153479|NCT00997906|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
5153480|NCT00997893|menopause|menopause
5153481|NCT00997893|hot flashes|hot flashes
5153482|NCT00997893|soy|soy
5153483|NCT00997893|estrogen|estrogen
5153484|NCT00997893|anxiety|anxiety
5153485|NCT00997880|rosuvastatin|rosuvastatin
5153486|NCT00997867|Pain|pain
5153487|NCT00997867|Surgery|surgery
5153488|NCT00997867|Catheter|catheter
5153489|NCT00997867|Nerve Block|nerve block
5153490|NCT00997867|Popliteal|popliteal
5153491|NCT00997867|Sciatic|sciatic
5153492|NCT00997867|Femoral|femoral
5153493|NCT00997867|Interscalene|interscalene
5153494|NCT00997867|UCSD|ucsd
5153495|NCT00997867|Moderate-to-severe pain|moderate-to-severe pain
5153496|NCT00997867|Perineural Catheter|perineural catheter
5153497|NCT00997867|Orthopedic Surgery|orthopedic surgery
5153498|NCT00997854|Feeding|feeding
5153499|NCT00997854|Intolerance|intolerance
5153500|NCT00997854|Preterm|preterm
5153501|NCT00997854|Bolus|bolus
5153502|NCT00997841|POC|poc
5153503|NCT00997841|ROTEM|rotem
5153504|NCT00997841|Multiplate|multiplate
5153505|NCT00997841|bleeding tendency|bleeding tendency
5153506|NCT00997841|coagulation management|coagulation management
5153507|NCT00997841|amount of transfused red blood cell concentrates,|amount of transfused red blood cell concentrates,
5153508|NCT00997841|FFP|ffp
5153509|NCT00997841|platelet concentrates|platelet concentrates
5153510|NCT00997841|rate of rethoracotomy|rate of rethoracotomy
5153511|NCT00997841|ventilation time|ventilation time
5153512|NCT00997828|Coronary Artery Disease|coronary artery disease
5153513|NCT00997828|stent|stent
5153514|NCT00997828|coronary artery bypass graft surgery|coronary artery bypass graft surgery
5153515|NCT00997828|multivessel coronary artery disease|multivessel coronary artery disease
5153516|NCT00997815|Recalcitrant|recalcitrant
5153517|NCT00997815|Alopecia totalis|alopecia totalis
5153518|NCT00997815|Alopecia universalis|alopecia universalis
5153519|NCT00997815|Botulinum toxin A|botulinum toxin a
5153520|NCT00997802|Computed Tomographic Colonography|computed tomographic colonography
5153521|NCT00997802|Colonic Polyps|colonic polyps
5153522|NCT00997802|Colonic Neoplasms|colonic neoplasms
5153523|NCT00997802|Computer Aided Diagnosis|computer aided diagnosis
5153524|NCT00997789|Rebamipide|rebamipide
5153525|NCT00997789|Bioequivalence|bioequivalence
5153526|NCT00997789|ABCB1 genetic polymorphisms|abcb1 genetic polymorphisms
5153527|NCT00997776|Hip Fracture|hip fracture
5153528|NCT00997776|Exercise|exercise
5153529|NCT00997776|Rehabilitation|rehabilitation
5153530|NCT00997776|Functional Performance|functional performance
5153531|NCT00997763|stenting, XIENCE V, CYPHER|stenting, xience v, cypher
5153532|NCT00997750|ACS|acs
5153533|NCT00997750|Acute Coronary Syndrome|acute coronary syndrome
5153534|NCT00997750|NSAID|nsaid
5153535|NCT00997750|Lornoxicam|lornoxicam
5153536|NCT00997750|Xefocam|xefocam
5153537|NCT00997737|incentive spirometry|incentive spirometry
5153538|NCT00997737|diaphragm mobility|diaphragm mobility
5153539|NCT00997737|ultrasound|ultrasound
5153540|NCT00997737|diaphragmatic breathing|diaphragmatic breathing
5153541|NCT00997724|assisted-VATS (video-assisted thoracoscopic surgery)|assisted-vats (video-assisted thoracoscopic surgery)
5153542|NCT00997724|sleeve lobectomy|sleeve lobectomy
5153543|NCT00997724|bronchoplasty|bronchoplasty
5153544|NCT00997711|Diabetes|diabetes
5153545|NCT00997711|death|death
5153546|NCT00997711|MI|mi
5153547|NCT00997711|TVR|tvr
5153548|NCT00997698|Intracranial aneurysm|intracranial aneurysm
5153549|NCT00997698|Magnetic resonance angiography|magnetic resonance angiography
5153550|NCT00997698|Epidemiology|epidemiology
5153551|NCT00997685|XELOX|xelox
5153552|NCT00997685|potentially resectable liver metastasis from CRC|potentially resectable liver metastasis from crc
5153553|NCT00997672|MSA|msa
5153554|NCT00997672|Lithium|lithium
5153555|NCT00997672|Lithium carbonate|lithium carbonate
5153556|NCT00997672|MSA-P|msa-p
5153557|NCT00997672|MSA-C|msa-c
5153558|NCT00997659|chromium picolinate|chromium picolinate
5153559|NCT00997659|insulin resistance|insulin resistance
5153560|NCT00997659|obesity|obesity
5153561|NCT00997646|Performance|performance
5153562|NCT00997646|hospitalist|hospitalist
5153563|NCT00997646|ward|ward
5153564|NCT00997646|hospitalization|hospitalization
5153565|NCT00997633|Intraperitoneal volume|intraperitoneal volume
5153566|NCT00997633|peritoneal carcinomatosis|peritoneal carcinomatosis
5153567|NCT00997633|cytoreductive surgery|cytoreductive surgery
5153568|NCT00997633|SPECT|spect
5153569|NCT00997633|intraperitoneal chemotherapy|intraperitoneal chemotherapy
5153570|NCT00997620|Hay Fever|hay fever
5153571|NCT00997620|Daytime somnolence|daytime somnolence
5153572|NCT00997620|Cognition|cognition
5153573|NCT00997607|Vaccine|vaccine
5153574|NCT00997594|adrenal gland|adrenal gland
5153575|NCT00997581|Gout|gout
5153576|NCT00997568|transesophageal|transesophageal
5153577|NCT00997568|transducer|transducer
5153578|NCT00997568|TEE|tee
5153579|NCT00997555|inhalation|inhalation
5153580|NCT00997555|bronchoscopy|bronchoscopy
5153581|NCT00997555|burn|burn
5153582|NCT00997555|pneumonia|pneumonia
5153583|NCT00997529|Stem cell transplant|stem cell transplant
5153584|NCT00997529|Non-myeloablative|non-myeloablative
5153585|NCT00997529|Metastatic Solid Tumor|metastatic solid tumor
5153586|NCT00997529|Donor Leukocyte Infusion|donor leukocyte infusion
5153587|NCT00997516|Laparoscopy|laparoscopy
5153588|NCT00997516|Appendicitis|appendicitis
5153589|NCT00997516|Single-incision laparoscopic surgery|single-incision laparoscopic surgery
5153590|NCT00997516|SILS|sils
5153591|NCT00997490|depression|depression
5153592|NCT00997490|HAMD 21|hamd 21
5153593|NCT00997490|anxiety|anxiety
5153594|NCT00997490|HAMA|hama
5153595|NCT00997490|Hypericum|hypericum
5153596|NCT00997490|Valerian|valerian
5153597|NCT00997490|Passionflower|passionflower
5153598|NCT00997490|F32.0|f32.0
5153599|NCT00997490|F33.0|f33.0
5153600|NCT00997477|aerolizer|aerolizer
5153601|NCT00997477|formoterol|formoterol
5153602|NCT00997477|budesonide|budesonide
5153603|NCT00997477|asthma|asthma
5153604|NCT00997451|Medically unexplained chronic fatigue|medically unexplained chronic fatigue
5153605|NCT00997451|Chronic fatigue syndrome|chronic fatigue syndrome
5153606|NCT00997451|Cognitive-behavior therapy|cognitive-behavior therapy
5153607|NCT00997451|Self-management|self-management
5153608|NCT00997451|Primary care|primary care
5153609|NCT00997451|Nurses|nurses
5153610|NCT00997451|Economic analysis|economic analysis
5153611|NCT00997451|Cost effectiveness|cost effectiveness
5153612|NCT00997451|One year follow-up|one year follow-up
5153613|NCT00997425|wandering|wandering
5153614|NCT00997425|subjective exit barriers|subjective exit barriers
5153615|NCT00997399|Ph I|ph i
5153616|NCT00997399|panobinostat (DACi)|panobinostat (daci)
5153617|NCT00997399|PK & safety|pk & safety
5153618|NCT00997399|solid tumors|solid tumors
5153619|NCT00997399|varying renal function|varying renal function
5153620|NCT00997399|advanced|advanced
5153621|NCT00997386|Hematologic malignancies|hematologic malignancies
5153622|NCT00997386|lymphoma, leukemia, MDS (myelodysplastic syndrome)|lymphoma, leukemia, mds (myelodysplastic syndrome)
5153623|NCT00997386|reduced-intensity preparative regimen|reduced-intensity preparative regimen
5153624|NCT00997386|allogeneic peripheral blood stem cell transplant|allogeneic peripheral blood stem cell transplant
5153625|NCT00997386|myelofibrosis or other myeloproliferative syndromes|myelofibrosis or other myeloproliferative syndromes
5153626|NCT00997373|Endometrial Cancer|endometrial cancer
5153627|NCT00997373|Endometrial Carcinoma|endometrial carcinoma
5153628|NCT00997373|Aromatase Inhibitor|aromatase inhibitor
5153629|NCT00997373|Letrozole|letrozole
5153630|NCT00997373|Femara|femara
5153631|NCT00997360|Phase 1|phase 1
5153632|NCT00997360|Maximum tolerated dose|maximum tolerated dose
5153633|NCT00997360|Solid tumors|solid tumors
5153634|NCT00997334|erlotinib|erlotinib
5153635|NCT00997334|EGFR mutation|egfr mutation
5153636|NCT00997334|NSCLC|nsclc
5153637|NCT00997321|ketamine|ketamine
5153638|NCT00997321|propofol|propofol
5153639|NCT00997321|procedural sedation|procedural sedation
5153640|NCT00997321|moderate procedural sedation in the ED|moderate procedural sedation in the ed
5153641|NCT00997308|AZD1446|azd1446
5153642|NCT00997308|to investigate safety and tolerability in Healthy subjects during 4 weeks of administration|to investigate safety and tolerability in healthy subjects during 4 weeks of administration
5153643|NCT00997295|low flow gas|low flow gas
5153644|NCT00997295|Heat and moisture exchanger|heat and moisture exchanger
5153645|NCT00997295|Humidity|humidity
5153646|NCT00997295|Temperature|temperature
5153647|NCT00997295|Core temperature|core temperature
5153648|NCT00997295|Women|women
5153649|NCT00997269|CoQ-10|coq-10
5153650|NCT00997269|statin|statin
5153651|NCT00997269|muscle pain|muscle pain
5153652|NCT00997269|cardiovascular|cardiovascular
5153653|NCT00997256|sleep-EEG|sleep-eeg
5153654|NCT00997256|sleep architecture|sleep architecture
5153655|NCT00997256|sleep duration|sleep duration
5153656|NCT00997256|sleep continuity|sleep continuity
5153657|NCT00997256|REM-sleep|rem-sleep
5153658|NCT00997256|vigilance|vigilance
5153659|NCT00997256|well-being|well-being
5153660|NCT00997256|Healthy volunteers|healthy volunteers
5153661|NCT00997243|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5153662|NCT00997243|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5153663|NCT00997243|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5153664|NCT00997243|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
5153665|NCT00997243|refractory anemia with excess blasts|refractory anemia with excess blasts
5153666|NCT00997243|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
5153667|NCT00997243|refractory anemia|refractory anemia
5153668|NCT00997243|refractory cytopenia with multilineage dysplasia|refractory cytopenia with multilineage dysplasia
5153669|NCT00997230|EGFR mutation ,newly diagnosed NSCLC, locally advanced or metastatic NSCLC|egfr mutation ,newly diagnosed nsclc, locally advanced or metastatic nsclc
5153670|NCT00997217|RIPC|ripc
5153671|NCT00997217|cardiac surgery|cardiac surgery
5153672|NCT00997217|ischemic preconditioning|ischemic preconditioning
5153673|NCT00997217|cardiac surgical procedures|cardiac surgical procedures
5153674|NCT00997204|HAE|hae
5153675|NCT00997204|Type I HAE|type i hae
5153676|NCT00997204|Type II HAE|type ii hae
5153677|NCT00997191|Bevacizumab|bevacizumab
5153678|NCT00997191|Diabetes|diabetes
5153679|NCT00997191|Intravitreal|intravitreal
5153680|NCT00997191|Macular edema|macular edema
5153681|NCT00997191|triamcinolone|triamcinolone
5153682|NCT00997191|VEGF|vegf
5153683|NCT00997178|Diabetes|diabetes
5153684|NCT00997178|Diabetes Mellitus|diabetes mellitus
5153685|NCT00997178|Periodontal Disease|periodontal disease
5153686|NCT00997178|Periodontitis|periodontitis
5153687|NCT00997178|Glycosylated Hemoglobin|glycosylated hemoglobin
5153688|NCT00997178|HbA1c|hba1c
5153689|NCT00997165|fatty liver|fatty liver
5153690|NCT00997165|adipose tissue|adipose tissue
5153691|NCT00997152|Diabetes|diabetes
5153692|NCT00997139|healthcare|healthcare
5153693|NCT00997139|staphylococcus aureus|staphylococcus aureus
5153694|NCT00997139|nasal|nasal
5153695|NCT00997126|propofol|propofol
5153696|NCT00997126|alfentanil|alfentanil
5153697|NCT00997126|nitrous oxide|nitrous oxide
5153698|NCT00997126|moderate procedural sedation|moderate procedural sedation
5153699|NCT00997126|Moderate Procedural Sedation in the Emergency Department|moderate procedural sedation in the emergency department
5153700|NCT00997113|propofol|propofol
5153701|NCT00997113|alfentanil|alfentanil
5153702|NCT00997113|procedural sedation|procedural sedation
5153703|NCT00997113|stress biomarkers|stress biomarkers
5153704|NCT00997113|Deep procedural sedation in the ED|deep procedural sedation in the ed
5153705|NCT00997100|Systemic Lupus Erythematosus (SLE)|systemic lupus erythematosus (sle)
5153706|NCT00997100|ABR-215757|abr-215757
5153707|NCT00997100|Change in Biomarkers|change in biomarkers
5153708|NCT00997087|OCD|ocd
5153709|NCT00997074|pain after abortion|pain after abortion
5153710|NCT00997074|abortion|abortion
5153711|NCT00997035|Fungal Infections|fungal infections
5153712|NCT00997035|Eye Disease|eye disease
5153713|NCT00997035|Fungal Keratitis|fungal keratitis
5153714|NCT00997035|Visual Acuity|visual acuity
5153715|NCT00997022|HCC|hcc
5153716|NCT00997022|High-risk Hepatocellular Cancer|high-risk hepatocellular cancer
5153717|NCT00997009|EGFR|egfr
5153718|NCT00997009|chemotherapy|chemotherapy
5153719|NCT00996996|Radioimmunotherapy|radioimmunotherapy
5153720|NCT00996996|Anti-B1 Antibody and Iodine-131 Anti-B1 Antibody|anti-b1 antibody and iodine-131 anti-b1 antibody
5153721|NCT00996996|Tositumomab and Iodine I 131 Tositumomab|tositumomab and iodine i 131 tositumomab
5153722|NCT00996996|non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
5153725|NCT00996970|H1N1|h1n1
5153726|NCT00996970|Influenza|influenza
5153727|NCT00996970|Vaccination|vaccination
5153728|NCT00996970|Seroresponse|seroresponse
5153729|NCT00996970|Immunogenicity|immunogenicity
5153730|NCT00996970|Vaccine|vaccine
5153731|NCT00996944|ropinirole|ropinirole
5153732|NCT00996944|haemodialysis|haemodialysis
5153733|NCT00996944|restless legs syndrome|restless legs syndrome
5153734|NCT00996931|autistic spectrum disorder|autistic spectrum disorder
5153735|NCT00996931|lenalidomide|lenalidomide
5153736|NCT00996918|antibody|antibody
5153737|NCT00996905|Epidural Analgesia|epidural analgesia
5153738|NCT00996905|Ultrasound|ultrasound
5153739|NCT00996905|Training, Inservice|training, inservice
5153740|NCT00996892|GDC0941|gdc0941
5153741|NCT00996892|GDC0973|gdc0973
5153742|NCT00996892|MEK|mek
5153743|NCT00996892|MEK Inhibitor|mek inhibitor
5153744|NCT00996892|PI3K|pi3k
5153745|NCT00996892|PI3K Inhibitor|pi3k inhibitor
5153746|NCT00996892|PI3 Kinase|pi3 kinase
5153747|NCT00996892|PI3 Kinase Inhibitor|pi3 kinase inhibitor
5153748|NCT00996879|Human Volunteers|human volunteers
5153749|NCT00996853|safety|safety
5153750|NCT00996853|Influenza|influenza
5153751|NCT00996853|vaccine|vaccine
5153752|NCT00996853|reactogenicity|reactogenicity
5153753|NCT00996853|swine flu|swine flu
5153754|NCT00996840|dilmapimod|dilmapimod
5153755|NCT00996840|p38|p38
5153756|NCT00996840|SB-681323|sb-681323
5153757|NCT00996840|Acute Lung Injury (ALI)|acute lung injury (ali)
5153758|NCT00996840|Acute Respiratory Distress Syndrome (ARDS)|acute respiratory distress syndrome (ards)
5153759|NCT00996827|Melanoma|melanoma
5153760|NCT00996827|Skin cancer|skin cancer
5153761|NCT00996827|Vitamin D|vitamin d
5153762|NCT00996827|Vitamin D receptor|vitamin d receptor
5153763|NCT00996827|Sunlight|sunlight
5153764|NCT00996827|Cytokine|cytokine
5153765|NCT00996814|Bioethics|bioethics
5153766|NCT00996788|Patients suffering of dyspepsia due to chronic gastritis|patients suffering of dyspepsia due to chronic gastritis
5153767|NCT00996775|Alcohol Consumption|alcohol consumption
5153768|NCT00996762|bioequivalence, lapatinib, GW572016|bioequivalence, lapatinib, gw572016
5153769|NCT00996736|Fungal Infections|fungal infections
5153770|NCT00996736|Eye Disease|eye disease
5153771|NCT00996736|Fungal Keratitis|fungal keratitis
5153772|NCT00996736|Visual Acuity|visual acuity
5153773|NCT00996710|Genome-wide|genome-wide
5153774|NCT00996710|09-068|09-068
5153775|NCT00996697|COPD (chronic obstructive pulmonary disease)|copd (chronic obstructive pulmonary disease)
5153776|NCT00996684|Wet age related macular degeneration (AMD)|wet age related macular degeneration (amd)
5153777|NCT00996684|Wet AMD|wet amd
5153778|NCT00996684|Vitreomacular adhesion (VMA)|vitreomacular adhesion (vma)
5153779|NCT00996684|Vitreomacular traction (VMT)|vitreomacular traction (vmt)
5153780|NCT00996684|Neovascular age related macular degeneration|neovascular age related macular degeneration
5153781|NCT00996671|focal adhesion kinase inhibitor|focal adhesion kinase inhibitor
5153782|NCT00996671|healthy volunteers|healthy volunteers
5153783|NCT00996671|first time in human|first time in human
5153784|NCT00996645|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
5153785|NCT00996645|Coronary Artery Disease|coronary artery disease
5153786|NCT00996645|Primary Health Care|primary health care
5153787|NCT00996645|Feedback, Psychological|feedback, psychological
5153788|NCT00996645|Quality Assurance, Health Care|quality assurance, health care
5153789|NCT00996632|breast cancer|breast cancer
5153790|NCT00996632|ultrasonic knife|ultrasonic knife
5153791|NCT00996632|volume drainage|volume drainage
5153792|NCT00996593|Tositumomab|tositumomab
5153793|NCT00996593|radioimmunotherapy|radioimmunotherapy
5153794|NCT00996593|rituximab|rituximab
5153795|NCT00996593|anti-B1|anti-b1
5153796|NCT00996593|I 131|i 131
5153797|NCT00996593|Bexxar|bexxar
5153798|NCT00996593|iodine|iodine
5153799|NCT00996593|non-Hodgkin's lymphoma|non-hodgkin's lymphoma
5153800|NCT00996580|Contraception|contraception
5153801|NCT00996580|Oral contraceptives|oral contraceptives
5153802|NCT00996567|Malignant mesothelioma|malignant mesothelioma
5153803|NCT00996554|Hand-sutured colo-colonic and ileo-colonic anastomoses in elective surgery|hand-sutured colo-colonic and ileo-colonic anastomoses in elective surgery
5153804|NCT00996541|Runaway youth|runaway youth
5153805|NCT00996541|Homeless youth|homeless youth
5153806|NCT00996541|Family intervention|family intervention
5153807|NCT00996541|Family functioning|family functioning
5153808|NCT00996541|HIV risk behavior|hiv risk behavior
5153809|NCT00996541|HIV Seronegativity|hiv seronegativity
5153810|NCT00996528|fetal alcohol syndrome|fetal alcohol syndrome
5153811|NCT00996528|alcohol abuse|alcohol abuse
5153812|NCT00996528|HIV|hiv
5153813|NCT00996528|malnutrition|malnutrition
5153814|NCT00996528|children|children
5153815|NCT00996528|mentor mother|mentor mother
5153816|NCT00996528|behavioral intervention|behavioral intervention
5153817|NCT00996528|South Africa|south africa
5153818|NCT00996528|Maternal alcohol use|maternal alcohol use
5153819|NCT00996528|HIV-related transmission behaviors|hiv-related transmission behaviors
5153820|NCT00996528|low birth weight babies and low-weight children|low birth weight babies and low-weight children
5153821|NCT00996528|HIV Seronegativity|hiv seronegativity
5153822|NCT00996515|Advanced Solid Tumor Malignancies|advanced solid tumor malignancies
5153823|NCT00996515|Erlotinib|erlotinib
5153824|NCT00996515|Vidaza|vidaza
5153825|NCT00996515|Tarceva|tarceva
5153826|NCT00996515|5-azacytidine|5-azacytidine
5153827|NCT00996476|Hepatitis C|hepatitis c
5153828|NCT00996476|Hepatitis C virus|hepatitis c virus
5153829|NCT00996476|Interferon Alfa-2a|interferon alfa-2a
5153830|NCT00996476|Ribavirin|ribavirin
5153831|NCT00996476|Viral RNA|viral rna
5153832|NCT00996450|brain tumour|brain tumour
5153833|NCT00996437|vitreous|vitreous
5153834|NCT00996437|hemorrhage|hemorrhage
5153835|NCT00996437|proliferative|proliferative
5153836|NCT00996437|diabetic|diabetic
5153837|NCT00996437|retinopathy|retinopathy
5153838|NCT00996437|intravitreal|intravitreal
5153839|NCT00996437|ranibizumab|ranibizumab
5153840|NCT00996437|Lucentis|lucentis
5153841|NCT00996437|saline|saline
5153842|NCT00996437|vitrectomy|vitrectomy
5153843|NCT00996411|Healthy volunteers are being studied to evaluate the subject-rated, behavioral, and abuse liability effects of salvinorin A|healthy volunteers are being studied to evaluate the subject-rated, behavioral, and abuse liability effects of salvinorin a
5153844|NCT00996398|Cryotherapy|cryotherapy
5153845|NCT00996398|Joint Position Sense|joint position sense
5153846|NCT00996398|Proprioception|proprioception
5153847|NCT00996398|Pre Cooling|pre cooling
5153848|NCT00996398|Knee Injury|knee injury
5153849|NCT00996398|Physical Therapy Modalities|physical therapy modalities
5153850|NCT00996398|Physical Therapy Techniques|physical therapy techniques
5153851|NCT00996398|Weightbearing|weightbearing
5153852|NCT00996398|NonWeightbearing|nonweightbearing
5153853|NCT00996398|Randomised Control Trial|randomised control trial
5153854|NCT00996385|Pleural Mesothelioma|pleural mesothelioma
5153855|NCT00996385|Peritoneal Mesothelioma|peritoneal mesothelioma
5153856|NCT00996359|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5153857|NCT00996359|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5153858|NCT00996359|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5153859|NCT00996359|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5153860|NCT00996359|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5153861|NCT00996359|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5153862|NCT00996359|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5153863|NCT00996359|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5153864|NCT00996359|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5153865|NCT00996359|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5153866|NCT00996359|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5153867|NCT00996359|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5153868|NCT00996359|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5153869|NCT00996359|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5153870|NCT00996359|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5153871|NCT00996359|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5153872|NCT00996359|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5153873|NCT00996359|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5153874|NCT00996359|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5153875|NCT00996359|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5153876|NCT00996359|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5153877|NCT00996359|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5153878|NCT00996359|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5153879|NCT00996359|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5153880|NCT00996359|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5153881|NCT00996359|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5153882|NCT00996359|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5153883|NCT00996359|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5153884|NCT00996359|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5153885|NCT00996359|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5153886|NCT00996359|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
5153887|NCT00996359|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5153888|NCT00996359|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5153889|NCT00996359|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
5153890|NCT00996359|peripheral T-cell lymphoma|peripheral t-cell lymphoma
5153891|NCT00996359|hepatosplenic T-cell lymphoma|hepatosplenic t-cell lymphoma
5153892|NCT00996359|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5153893|NCT00996359|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5153894|NCT00996359|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5153895|NCT00996359|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5153896|NCT00996359|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5153897|NCT00996359|refractory multiple myeloma|refractory multiple myeloma
5153898|NCT00996359|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
5153899|NCT00996359|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5153900|NCT00996359|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
5153901|NCT00996359|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5153902|NCT00996359|childhood diffuse large cell lymphoma|childhood diffuse large cell lymphoma
5153903|NCT00996359|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
5153904|NCT00996359|Burkitt lymphoma|burkitt lymphoma
5153905|NCT00996359|childhood immunoblastic large cell lymphoma|childhood immunoblastic large cell lymphoma
5153906|NCT00996359|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
5153907|NCT00996359|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
5153908|NCT00996359|recurrent childhood anaplastic large cell lymphoma|recurrent childhood anaplastic large cell lymphoma
5153909|NCT00996359|recurrent childhood grade III lymphomatoid granulomatosis|recurrent childhood grade iii lymphomatoid granulomatosis
5153910|NCT00996359|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
5153911|NCT00996359|childhood nasal type extranodal NK/T-cell lymphoma|childhood nasal type extranodal nk/t-cell lymphoma
5153912|NCT00996346|INST 0909|inst 0909
5153913|NCT00996346|Irinotecan|irinotecan
5153914|NCT00996346|Temsirolimus|temsirolimus
5153915|NCT00996346|refractory sarcomas|refractory sarcomas
5153916|NCT00996346|3066K1|3066k1
5153917|NCT00996346|3066K1-1208|3066k1-1208
5153918|NCT00996346|20091334|20091334
5153919|NCT00996333|Stage IVB|stage ivb
5153920|NCT00996320|Internship and Residency|internship and residency
5153921|NCT00996320|Medical Errors|medical errors
5153922|NCT00996320|Burnout, Professional|burnout, professional
5153923|NCT00996320|Burnout|burnout
5153924|NCT00996320|Depression|depression
5153925|NCT00996320|Actigraphy|actigraphy
5153926|NCT00996320|Personnel Staffing and Scheduling|personnel staffing and scheduling
5153927|NCT00996320|Sleep Deprivation|sleep deprivation
5153928|NCT00996320|Workload|workload
5153929|NCT00996320|Humans|humans
5153930|NCT00996320|Adult|adult
5153931|NCT00996320|Male|male
5153932|NCT00996320|Female|female
5153933|NCT00996320|Intensive Care Units|intensive care units
5153934|NCT00996320|Prospective Studies|prospective studies
5153935|NCT00996320|Crossover Studies|crossover studies
5153936|NCT00996320|Work Schedule Tolerance|work schedule tolerance
5153937|NCT00996320|Disorders of Excessive Somnolence|disorders of excessive somnolence
5153938|NCT00996320|Guideline Adherence|guideline adherence
5153939|NCT00996320|Internal Medicine Education|internal medicine education
5153940|NCT00996307|Swine Flu|swine flu
5153941|NCT00996307|Flu|flu
5153942|NCT00996307|Vaccine|vaccine
5153943|NCT00996307|Children|children
5153944|NCT00996307|Adjuvant|adjuvant
5153945|NCT00996307|A/H1N1 2009 Influenza|a/h1n1 2009 influenza
5153946|NCT00996281|Hypertensive|hypertensive
5153947|NCT00996281|Blood Pressure, High|blood pressure, high
5153948|NCT00996281|Cardiovascular disease|cardiovascular disease
5153949|NCT00996281|Vascular Disease|vascular disease
5153950|NCT00996281|Drug Therapy|drug therapy
5153951|NCT00996268|hypertriglyceridemia|hypertriglyceridemia
5153952|NCT00996268|GSK2212836|gsk2212836
5153953|NCT00996268|relative bioavailability|relative bioavailability
5153954|NCT00996242|Schizophrenia|schizophrenia
5153955|NCT00996242|L-lysine|l-lysine
5153956|NCT00996242|PANSS|panss
5153957|NCT00996229|Diet|diet
5153958|NCT00996229|elderly|elderly
5153959|NCT00996229|cognition|cognition
5153960|NCT00996229|prevention|prevention
5153961|NCT00996229|cognitive decline|cognitive decline
5153962|NCT00996229|Lifestyle|lifestyle
5153963|NCT00996216|Peginterferon|peginterferon
5153964|NCT00996216|Platelets|platelets
5153965|NCT00996216|Ribavirin|ribavirin
5153966|NCT00996216|Hepatitis C-related thrombocytopenia|hepatitis c-related thrombocytopenia
5153967|NCT00996216|Thrombocytopenia|thrombocytopenia
5153968|NCT00996216|Hepatitis C|hepatitis c
5153969|NCT00996216|Thrombopoietin|thrombopoietin
5153970|NCT00996190|transthoracic bioreactance|transthoracic bioreactance
5153971|NCT00996190|noninvasive monitoring|noninvasive monitoring
5153972|NCT00996190|vasopressor|vasopressor
5153973|NCT00996190|blood pressure|blood pressure
5153974|NCT00996177|Pain|pain
5153975|NCT00996177|Patient-controlled analgesia|patient-controlled analgesia
5153976|NCT00996177|Postoperative pain|postoperative pain
5153977|NCT00996177|Transdermal fentanyl|transdermal fentanyl
5153978|NCT00996177|Surgical pain|surgical pain
5153979|NCT00996177|Opioid analgesics|opioid analgesics
5153980|NCT00996151|Hypergonadism|hypergonadism
5153981|NCT00996151|Testosterone Transfer|testosterone transfer
5153982|NCT00996138|Influenza A|influenza a
5153983|NCT00996138|H1N1 subtype|h1n1 subtype
5153984|NCT00996138|Adult|adult
5153985|NCT00996138|Vaccine|vaccine
5153986|NCT00996138|Adjuvant|adjuvant
5153987|NCT00996138|Swine-Origin Influenza A H1N1 Virus|swine-origin influenza a h1n1 virus
5153988|NCT00996125|Immunogenicity|immunogenicity
5153989|NCT00996125|Safety|safety
5153990|NCT00996125|Human papillomavirus|human papillomavirus
5153991|NCT00996125|China|china
5153992|NCT00996125|HPV vaccine|hpv vaccine
5153993|NCT00996112|primary health care|primary health care
5153994|NCT00996099|continuous glucose monitoring|continuous glucose monitoring
5153995|NCT00996099|intensive insulin therapy|intensive insulin therapy
5153996|NCT00996099|critically ill|critically ill
5153997|NCT00996099|cardiac surgery|cardiac surgery
5153998|NCT00996099|hyperglycemia of critically ill|hyperglycemia of critically ill
5153999|NCT00996073|Degenerative disc disease|degenerative disc disease
5154000|NCT00996073|Spondylolisthesis|spondylolisthesis
5154001|NCT00996073|Spinal stenosis|spinal stenosis
5154002|NCT00996073|Stem cells|stem cells
5154003|NCT00996073|Adult Stem Cells|adult stem cells
5154004|NCT00996073|Spinal Fusion|spinal fusion
5154005|NCT00996073|Lumbar Spinal Fusion|lumbar spinal fusion
5154006|NCT00996073|TLIF|tlif
5154007|NCT00996073|PLIF|plif
5154008|NCT00996073|Mesoblast|mesoblast
5154009|NCT00996060|Lung Cancer|lung cancer
5154010|NCT00996060|Advanced Lung Cancer|advanced lung cancer
5154011|NCT00996060|Unresectable Lung cancer|unresectable lung cancer
5154012|NCT00996060|Previously treated lung cancer|previously treated lung cancer
5154013|NCT00996047|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
5154014|NCT00996047|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5154015|NCT00996047|acute undifferentiated leukemia|acute undifferentiated leukemia
5154016|NCT00996047|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5154017|NCT00996047|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5154018|NCT00996047|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5154019|NCT00996047|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5154020|NCT00996047|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5154021|NCT00996047|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5154022|NCT00996047|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5154023|NCT00996047|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
5154024|NCT00996047|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5154025|NCT00996047|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
5154026|NCT00996047|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
5154027|NCT00996047|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
5154028|NCT00996047|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5154029|NCT00996047|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5154030|NCT00996047|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
5154031|NCT00996047|mast cell leukemia|mast cell leukemia
5154032|NCT00996047|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
5154033|NCT00996047|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
5154034|NCT00996047|prolymphocytic leukemia|prolymphocytic leukemia
5154035|NCT00996047|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5154036|NCT00996047|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5154037|NCT00996047|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5154038|NCT00996047|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5154039|NCT00996047|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5154040|NCT00996047|refractory hairy cell leukemia|refractory hairy cell leukemia
5154041|NCT00996047|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5154042|NCT00996047|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5154043|NCT00996047|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
5154044|NCT00996047|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
5154045|NCT00996047|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5154046|NCT00996047|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5154047|NCT00996047|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
5154048|NCT00996047|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
5154049|NCT00996047|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
5154050|NCT00996047|untreated childhood acute myeloid leukemia and other myeloid malignancies|untreated childhood acute myeloid leukemia and other myeloid malignancies
5154051|NCT00996047|untreated hairy cell leukemia|untreated hairy cell leukemia
5154052|NCT00996047|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
5154053|NCT00996047|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5154054|NCT00996047|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5154055|NCT00996047|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5154056|NCT00996047|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
5154057|NCT00996047|myelodysplastic/myeloproliferative neoplasms|myelodysplastic/myeloproliferative neoplasms
5154058|NCT00996034|Nicotine, SPECT, vaccine, receptor|nicotine, spect, vaccine, receptor
5154059|NCT00996021|GSK1349572|gsk1349572
5154060|NCT00996021|moxifloxacin|moxifloxacin
5154061|NCT00996021|Avelox|avelox
5154062|NCT00996021|QTc|qtc
5154063|NCT00995982|Influenza|influenza
5154064|NCT00995982|Healthy|healthy
5154065|NCT00995982|Immunity|immunity
5154066|NCT00995982|Preventive|preventive
5154067|NCT00995982|Flu|flu
5154068|NCT00995982|HV|hv
5154069|NCT00995982|Healthy Volunteer|healthy volunteer
5154070|NCT00995969|Mild to moderate psoriasis vulgaris|mild to moderate psoriasis vulgaris
5154071|NCT00995956|Albumin|albumin
5154072|NCT00995956|Mycophenolic acid|mycophenolic acid
5154073|NCT00995956|IMPDH|impdh
5154074|NCT00995956|Free fraction|free fraction
5154075|NCT00995930|Atherosclerosis,|atherosclerosis,
5154076|NCT00995930|Type 2 Diabetes Mellitus, T2DM,|type 2 diabetes mellitus, t2dm,
5154077|NCT00995930|Cardiovascular Diseases, ACZ885, impaired glucose tolerance, IGT, Canakinumab|cardiovascular diseases, acz885, impaired glucose tolerance, igt, canakinumab
5154078|NCT00995917|acupuncture|acupuncture
5154079|NCT00995917|menstrual pain|menstrual pain
5154080|NCT00995917|dysmenorrhea|dysmenorrhea
5154081|NCT00995917|menstrual cramps|menstrual cramps
5154082|NCT00995917|vitamin K1|vitamin k1
5154083|NCT00995904|asthmatic children|asthmatic children
5154084|NCT00995891|Laboratory Research Specimens|laboratory research specimens
5154085|NCT00995891|Biologic Samples|biologic samples
5154086|NCT00995891|Sample Collection|sample collection
5154087|NCT00995891|Tissue Procurement|tissue procurement
5154088|NCT00995891|HV|hv
5154089|NCT00995891|Healthy Volunteer|healthy volunteer
5154090|NCT00995878|Uterine fibroids|uterine fibroids
5154091|NCT00995878|Fibroids|fibroids
5154092|NCT00995878|Uterine leiomyomas|uterine leiomyomas
5154093|NCT00995878|UAE|uae
5154094|NCT00995878|UFE|ufe
5154095|NCT00995878|Magnetic resonance guided focused ultrasound|magnetic resonance guided focused ultrasound
5154096|NCT00995878|MRgFUS|mrgfus
5154097|NCT00995878|Pelvic pain|pelvic pain
5154098|NCT00995865|Prevention of yellow fever virus infection|prevention of yellow fever virus infection
5154099|NCT00995852|Endoscopic lung volume reduction|endoscopic lung volume reduction
5154100|NCT00995852|emphysema|emphysema
5154101|NCT00995852|COPD|copd
5154102|NCT00995852|Patients with bilateral heterogeneous pulmonary emphysema|patients with bilateral heterogeneous pulmonary emphysema
5154103|NCT00995839|terlipressin|terlipressin
5154104|NCT00995839|vasopressin|vasopressin
5154105|NCT00995839|sepsis|sepsis
5154106|NCT00995839|septic shock|septic shock
5154107|NCT00995839|norepinephrine|norepinephrine
5154108|NCT00995813|Intestinal failure|intestinal failure
5154109|NCT00995813|Rotavirus vaccine|rotavirus vaccine
5154110|NCT00995813|Infants|infants
5154111|NCT00995800|Asthma|asthma
5154112|NCT00995787|Type II diabetes mellitus|type ii diabetes mellitus
5154113|NCT00995787|metformin|metformin
5154114|NCT00995787|sulfonylurea|sulfonylurea
5154115|NCT00995774|stroke|stroke
5154116|NCT00995774|function|function
5154117|NCT00995774|arm|arm
5154118|NCT00995774|hand|hand
5154119|NCT00995774|robotic|robotic
5154120|NCT00995774|therapy|therapy
5154121|NCT00995774|motor|motor
5154122|NCT00995774|movement|movement
5154123|NCT00995774|treatment|treatment
5154124|NCT00995761|biweekly|biweekly
5154125|NCT00995761|docetaxel|docetaxel
5154126|NCT00995761|cisplatin|cisplatin
5154127|NCT00995761|non-small cell lung cancer|non-small cell lung cancer
5154128|NCT00995735|NOTES|notes
5154129|NCT00995735|Natural Orifice Translumenal Endoscopic surgery|natural orifice translumenal endoscopic surgery
5154130|NCT00995735|Cholecystectomy|cholecystectomy
5154131|NCT00995735|Appendectomy|appendectomy
5154132|NCT00995735|Endoscopy|endoscopy
5154133|NCT00995735|Laparoscopy|laparoscopy
5154134|NCT00995735|Minimally invasive surgery|minimally invasive surgery
5154135|NCT00995735|clinical trials|clinical trials
5154136|NCT00995722|Ocular myasthenia gravis|ocular myasthenia gravis
5154137|NCT00995722|Prednisone|prednisone
5154138|NCT00995722|Steroids|steroids
5154139|NCT00995709|Behçet's disease,|behçet's disease,
5154140|NCT00995709|intermediate uveitis|intermediate uveitis
5154141|NCT00995709|panuveitis|panuveitis
5154142|NCT00995709|posterior uveitis|posterior uveitis
5154144|NCT00995696|Interactive Voice Response (IVR)|interactive voice response (ivr)
5154145|NCT00995696|Antidepressant|antidepressant
5154146|NCT00995683|intracranial hypertension|intracranial hypertension
5154147|NCT00995683|neurological outcome|neurological outcome
5154148|NCT00995683|osmotherapy|osmotherapy
5154149|NCT00995670|hyperglycemia|hyperglycemia
5154150|NCT00995670|statin|statin
5154151|NCT00995670|blood vessels|blood vessels
5154152|NCT00995670|ischemic preconditioning|ischemic preconditioning
5154153|NCT00995670|Anesthesia, inhalational|anesthesia, inhalational
5154154|NCT00995670|endothelium|endothelium
5154155|NCT00995670|5% dextrose|5% dextrose
5154156|NCT00995644|smoking|smoking
5154157|NCT00995644|smoking cessation|smoking cessation
5154158|NCT00995644|tobacco use cessation|tobacco use cessation
5154159|NCT00995644|tobacco use disorder|tobacco use disorder
5154160|NCT00995631|liposuction|liposuction
5154161|NCT00995631|adipose tissue|adipose tissue
5154162|NCT00995631|dietary fatty acids|dietary fatty acids
5154163|NCT00995631|triglyceride storage|triglyceride storage
5154164|NCT00995631|Normal healthy aging|normal healthy aging
5154165|NCT00995618|Gout|gout
5154166|NCT00995618|Hyperuricemia|hyperuricemia
5154167|NCT00995592|nutrition|nutrition
5154168|NCT00995592|child weight|child weight
5154169|NCT00995592|undernourishment|undernourishment
5154170|NCT00995592|mentor mother|mentor mother
5154171|NCT00995592|South Africa|south africa
5154172|NCT00995579|Physical Activity|physical activity
5154173|NCT00995579|Energy Expenditure|energy expenditure
5154174|NCT00995540|T1DM|t1dm
5154175|NCT00995540|Regeneration|regeneration
5154176|NCT00995540|Islet|islet
5154177|NCT00995540|Beta cell|beta cell
5154178|NCT00995540|INGAP Peptide|ingap peptide
5154179|NCT00995527|Post Swine Flu Blood Samples|post swine flu blood samples
5154180|NCT00995527|Biologic Sample Collection|biologic sample collection
5154181|NCT00995527|Laboratory Research Samples|laboratory research samples
5154182|NCT00995527|H1N1 Vaccine Samples|h1n1 vaccine samples
5154183|NCT00995527|HV|hv
5154184|NCT00995527|Healthy Volunteer|healthy volunteer
5154185|NCT00995514|acute coronary syndrome|acute coronary syndrome
5154186|NCT00995514|cardiovascular death|cardiovascular death
5154187|NCT00995514|non-fatal MI|non-fatal mi
5154188|NCT00995514|non-fatal stroke|non-fatal stroke
5154189|NCT00995514|genetic testing|genetic testing
5154190|NCT00995514|CYP2C19|cyp2c19
5154191|NCT00995514|clopidogrel|clopidogrel
5154192|NCT00995514|prasugrel|prasugrel
5154193|NCT00995514|antiplatelet therapy|antiplatelet therapy
5154194|NCT00995514|genotyping|genotyping
5154195|NCT00995514|bleeding|bleeding
5154196|NCT00995501|steroid administration|steroid administration
5154197|NCT00995501|tight glucose control|tight glucose control
5154198|NCT00995501|light anesthesiReducing inflammatory response to surgical stress|light anesthesireducing inflammatory response to surgical stress
5154199|NCT00995501|a|a
5154200|NCT00995488|Urothelial Cancer|urothelial cancer
5154201|NCT00995488|ABI-007|abi-007
5154202|NCT00995488|Bladder Cancer|bladder cancer
5154203|NCT00995488|front-line|front-line
5154204|NCT00995449|Rheumatoid Arthritis|rheumatoid arthritis
5154205|NCT00995449|Biologics-Inadequate|biologics-inadequate
5154206|NCT00995449|KB003|kb003
5154207|NCT00995449|GM-CSF|gm-csf
5154208|NCT00995436|Extractions|extractions
5154209|NCT00995436|Anchorage supplementation|anchorage supplementation
5154210|NCT00995423|Coronary Artery Disease|coronary artery disease
5154211|NCT00995423|stent|stent
5154212|NCT00995410|Subjects Who are at Risk for Developing Aspirin-ASA|subjects who are at risk for developing aspirin-asa
5154213|NCT00995410|Subject must have a pre-existing condition for which aspirin is already indicated|subject must have a pre-existing condition for which aspirin is already indicated
5154214|NCT00995410|Gastric Ulcers|gastric ulcers
5154215|NCT00995397|Insect bites|insect bites
5154216|NCT00995397|Dexchlorpheniramine|dexchlorpheniramine
5154217|NCT00995397|Lotion|lotion
5154218|NCT00995397|Cream|cream
5154219|NCT00995371|Spinal Stenosis|spinal stenosis
5154220|NCT00995371|Lumbar Spinal Stenosis|lumbar spinal stenosis
5154221|NCT00995371|Laminotomy|laminotomy
5154222|NCT00995371|Laminectomy|laminectomy
5154223|NCT00995371|Spine Surgery|spine surgery
5154224|NCT00995358|Epitope peptide|epitope peptide
5154225|NCT00995358|CTL|ctl
5154226|NCT00995358|Esophageal cancer|esophageal cancer
5154227|NCT00995358|Vaccination|vaccination
5154228|NCT00995345|Type 2 Diabetes|type 2 diabetes
5154229|NCT00995345|Metformin|metformin
5154230|NCT00995332|Acute myelogenous leukemia|acute myelogenous leukemia
5154231|NCT00995332|all-trans retinoic acid|all-trans retinoic acid
5154232|NCT00995332|valproic acid|valproic acid
5154233|NCT00995332|cytarabine|cytarabine
5154234|NCT00995332|Disease stabilization|disease stabilization
5154235|NCT00995332|survival|survival
5154236|NCT00995332|toxicity|toxicity
5154237|NCT00995319|mouth|mouth
5154238|NCT00995319|Mucositis|mucositis
5154239|NCT00995319|Dysphagia|dysphagia
5154240|NCT00995319|malnutrition|malnutrition
5154241|NCT00995319|Xerostomia|xerostomia
5154242|NCT00995319|saliva|saliva
5154243|NCT00995319|tooth injuries|tooth injuries
5154244|NCT00995306|Active comparator|active comparator
5154245|NCT00995306|Active civamide cream, 0.075%|active civamide cream, 0.075%
5154246|NCT00995306|Active civamide cream, 0.01%|active civamide cream, 0.01%
5154247|NCT00995280|follicle flushing|follicle flushing
5154248|NCT00995280|oocyte retrieval|oocyte retrieval
5154249|NCT00995280|needle|needle
5154250|NCT00995267|childhood obesity|childhood obesity
5154251|NCT00995267|nutrition|nutrition
5154252|NCT00995267|exercise|exercise
5154253|NCT00995267|Alfred Adler|alfred adler
5154254|NCT00995267|schoolchildren|schoolchildren
5154255|NCT00995267|intervention study|intervention study
5154256|NCT00995267|community-based trial|community-based trial
5154257|NCT00995267|parent-child interaction|parent-child interaction
5154258|NCT00995267|nutritional behaviors|nutritional behaviors
5154259|NCT00995254|secondhand smoke|secondhand smoke
5154260|NCT00995254|children|children
5154261|NCT00995254|Chinese|chinese
5154262|NCT00995254|respiratory symptoms|respiratory symptoms
5154263|NCT00995254|household smoking policy|household smoking policy
5154264|NCT00995254|Respiratory illnesses among children|respiratory illnesses among children
5154265|NCT00995241|Raltegravir|raltegravir
5154266|NCT00995241|intracellular concentration|intracellular concentration
5154267|NCT00995241|plasmatic concentration|plasmatic concentration
5154268|NCT00995241|HIV|hiv
5154269|NCT00995241|Treatment experienced|treatment experienced
5154270|NCT00995228|overhydration|overhydration
5154271|NCT00995228|fluid restriction|fluid restriction
5154272|NCT00995228|post-anesthesia care unit|post-anesthesia care unit
5154273|NCT00995215|spinal cord injury|spinal cord injury
5154274|NCT00995215|SCI|sci
5154275|NCT00995215|paralysis|paralysis
5154276|NCT00995215|cough|cough
5154277|NCT00995215|cervical spinal cord injury|cervical spinal cord injury
5154278|NCT00995215|thoracic spinal cord injury|thoracic spinal cord injury
5154279|NCT00995202|stage II colon cancer|stage ii colon cancer
5154280|NCT00995202|stage II rectal cancer|stage ii rectal cancer
5154281|NCT00995202|stage III colon cancer|stage iii colon cancer
5154282|NCT00995202|stage III rectal cancer|stage iii rectal cancer
5154283|NCT00995202|adenocarcinoma of the colon|adenocarcinoma of the colon
5154284|NCT00995202|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5154285|NCT00995189|contact lens wear|contact lens wear
5154286|NCT00995189|multi-purpose solution|multi-purpose solution
5154287|NCT00995189|corneal staining|corneal staining
5154288|NCT00995176|Prevention|prevention
5154289|NCT00995176|HIV|hiv
5154290|NCT00995176|HIV seronegativity|hiv seronegativity
5154291|NCT00995163|outcomes study|outcomes study
5154292|NCT00995163|hemodialysis|hemodialysis
5154293|NCT00995163|CKD-MBD|ckd-mbd
5154294|NCT00995150|contraception|contraception
5154295|NCT00995150|intrauterine|intrauterine
5154296|NCT00995150|long-term|long-term
5154297|NCT00995150|reversible|reversible
5154298|NCT00995137|Relapsed or refractory B-Lineage ALL|relapsed or refractory b-lineage all
5154299|NCT00995124|ovicide|ovicide
5154300|NCT00995124|head lice infestation|head lice infestation
5154301|NCT00995098|Acute severe pancreatitis|acute severe pancreatitis
5154302|NCT00995098|nutritional support|nutritional support
5154303|NCT00995098|enteral nutrition|enteral nutrition
5154304|NCT00995098|parenteral nutrition|parenteral nutrition
5154305|NCT00995085|ADHD|adhd
5154306|NCT00995085|ADD|add
5154307|NCT00995085|TOVA|tova
5154308|NCT00995085|METADOXINE|metadoxine
5154309|NCT00995072|sexual dysfunction|sexual dysfunction
5154310|NCT00995072|female|female
5154311|NCT00995072|hypertension|hypertension
5154312|NCT00995072|high blood pressure|high blood pressure
5154313|NCT00995072|beta blockers|beta blockers
5154314|NCT00995072|metoprolol|metoprolol
5154315|NCT00995072|nebivolol|nebivolol
5154316|NCT00995072|Bystolic|bystolic
5154317|NCT00995072|Toprol XL|toprol xl
5154318|NCT00995059|stage I multiple myeloma|stage i multiple myeloma
5154319|NCT00995059|stage II multiple myeloma|stage ii multiple myeloma
5154320|NCT00995059|stage III multiple myeloma|stage iii multiple myeloma
5154321|NCT00995046|Hemophilia A|hemophilia a
5154322|NCT00995046|prophylaxis|prophylaxis
5154323|NCT00995046|thrombin generation test (TGT)|thrombin generation test (tgt)
5154324|NCT00995033|Smoking cessation|smoking cessation
5154325|NCT00995033|Smoking lapse behavior|smoking lapse behavior
5154326|NCT00995033|Smoking Relapse behavior|smoking relapse behavior
5154327|NCT00995033|Varenicline|varenicline
5154328|NCT00995033|Nicotine conjugate vaccine|nicotine conjugate vaccine
5154329|NCT00995033|Medication effect on smoking lapse behavior|medication effect on smoking lapse behavior
5154330|NCT00995020|Cone biopsy|cone biopsy
5154331|NCT00995020|Conization|conization
5154332|NCT00995020|Loop electrosurgical excisional procedures|loop electrosurgical excisional procedures
5154333|NCT00995020|Large Loop Excision of Transformation Zone|large loop excision of transformation zone
5154334|NCT00995020|Needle Excision of Transformation Zone|needle excision of transformation zone
5154335|NCT00995020|Straight Wire Excision of Transformation Zone|straight wire excision of transformation zone
5154336|NCT00995020|Electrosurgery|electrosurgery
5154337|NCT00995007|Brain Tumor|brain tumor
5154338|NCT00995007|Chemotherapy|chemotherapy
5154339|NCT00995007|Antiangiogenesis|antiangiogenesis
5154340|NCT00995007|Radiation|radiation
5154341|NCT00995007|Progression|progression
5154342|NCT00995007|Glioma|glioma
5154343|NCT00995007|Glioblastoma Multiforme|glioblastoma multiforme
5154344|NCT00994994|pediatric cardiac surgery|pediatric cardiac surgery
5154345|NCT00994994|bleeding|bleeding
5154346|NCT00994994|tranexamic acid|tranexamic acid
5154347|NCT00994994|fibrinolysis|fibrinolysis
5154348|NCT00994994|blood loss in pediatric cardiac surgery|blood loss in pediatric cardiac surgery
5154349|NCT00994981|magnesium and reperfusion injury|magnesium and reperfusion injury
5154350|NCT00994968|stage II breast cancer|stage ii breast cancer
5154351|NCT00994968|stage III breast cancer|stage iii breast cancer
5154352|NCT00994955|SRT|srt
5154353|NCT00994955|laser|laser
5154354|NCT00994955|diabetic macular edema|diabetic macular edema
5154355|NCT00994955|diabetes|diabetes
5154356|NCT00994955|Clinically significant diabetic macular edema|clinically significant diabetic macular edema
5154357|NCT00994929|biologic effects|biologic effects
5154358|NCT00994929|von Willebrand disease|von willebrand disease
5154359|NCT00994929|hemophilia|hemophilia
5154360|NCT00994929|interleukin-11|interleukin-11
5154361|NCT00994929|DDAVp|ddavp
5154362|NCT00994916|Lambert-Eaton myasthenic syndrome|lambert-eaton myasthenic syndrome
5154363|NCT00994916|3,4 diaminopyridine|3,4 diaminopyridine
5154364|NCT00994903|Statin|statin
5154365|NCT00994903|Colon|colon
5154366|NCT00994903|Colorectal|colorectal
5154367|NCT00994903|Intestinal Neoplasms|intestinal neoplasms
5154368|NCT00994903|ERAS|eras
5154369|NCT00994903|Perioperative Care|perioperative care
5154370|NCT00994890|Double-blind safety|double-blind safety
5154371|NCT00994825|levosimendan|levosimendan
5154372|NCT00994825|cardiac surgery|cardiac surgery
5154373|NCT00994825|cardiac anesthesia|cardiac anesthesia
5154374|NCT00994825|mortality|mortality
5154375|NCT00994825|survival|survival
5154376|NCT00994825|inotropic drugs|inotropic drugs
5154377|NCT00994812|Polycystic ovary syndrome|polycystic ovary syndrome
5154378|NCT00994812|PCOS|pcos
5154379|NCT00994812|Metformin|metformin
5154380|NCT00994812|Miscarriage|miscarriage
5154381|NCT00994812|Infertility|infertility
5154382|NCT00994812|Complications of pregnancy|complications of pregnancy
5154383|NCT00994786|treatment-resistant|treatment-resistant
5154384|NCT00994786|refractory|refractory
5154385|NCT00994786|obsessive compulsive disorder|obsessive compulsive disorder
5154386|NCT00994786|Lyrica|lyrica
5154387|NCT00994786|pregabalin|pregabalin
5154388|NCT00994786|Serotonin Reuptake Inhibitor-Refractory Obsessive-Compulsive Disorder|serotonin reuptake inhibitor-refractory obsessive-compulsive disorder
5154389|NCT00994773|Hepatitis B|hepatitis b
5154390|NCT00994773|simvastatin|simvastatin
5154391|NCT00994773|HBV DNA|hbv dna
5154392|NCT00994760|intranasal fentanyl spray|intranasal fentanyl spray
5154393|NCT00994747|infancy|infancy
5154394|NCT00994747|nutrition|nutrition
5154395|NCT00994747|protein hydrolysate formula|protein hydrolysate formula
5154396|NCT00994747|flavor preferences|flavor preferences
5154397|NCT00994747|food preferences|food preferences
5154398|NCT00994747|growth|growth
5154399|NCT00994747|emotional development|emotional development
5154400|NCT00994747|mother-infant interaction|mother-infant interaction
5154401|NCT00994747|infant temperament|infant temperament
5154402|NCT00994747|feeding patterning|feeding patterning
5154403|NCT00994747|taste receptor and obesity genotype|taste receptor and obesity genotype
5154404|NCT00994747|sensitive period|sensitive period
5154405|NCT00994721|Pancreatic Cancer|pancreatic cancer
5154406|NCT00994695|Trivalent meningococcal polysaccharide vaccine|trivalent meningococcal polysaccharide vaccine
5154407|NCT00994695|Children|children
5154408|NCT00994695|Safety|safety
5154409|NCT00994695|Immunogenicity|immunogenicity
5154410|NCT00994695|To assess Safety of trivalent meningococcal polysaccharide vaccine in children|to assess safety of trivalent meningococcal polysaccharide vaccine in children
5154411|NCT00994695|To assess the immunogenicity of the trivalent polysaccharide vaccine in children|to assess the immunogenicity of the trivalent polysaccharide vaccine in children
5154412|NCT00994682|Additional relevant MeSH terms:|additional relevant mesh terms:
5154413|NCT00994682|Hypoglycemic Agents|hypoglycemic agents
5154414|NCT00994682|Physiological Effects of Drugs|physiological effects of drugs
5154415|NCT00994682|Pharmacologic Actions|pharmacologic actions
5154416|NCT00994682|Pioglitazone|pioglitazone
5154417|NCT00994656|invasive procedures|invasive procedures
5154418|NCT00994656|hypovolemia|hypovolemia
5154419|NCT00994643|NHL|nhl
5154420|NCT00994643|Non Hodgkin's Lymphoma|non hodgkin's lymphoma
5154421|NCT00994643|Lymphoma|lymphoma
5154422|NCT00994591|Nicotine|nicotine
5154423|NCT00994591|Cotinine|cotinine
5154424|NCT00994591|CYP2A6|cyp2a6
5154425|NCT00994578|Advanced cancer|advanced cancer
5154426|NCT00994565|Physical activity|physical activity
5154427|NCT00994565|health behaviour|health behaviour
5154428|NCT00994565|lifestyle|lifestyle
5154429|NCT00994565|productivity|productivity
5154430|NCT00994565|outcomes|outcomes
5154431|NCT00994526|Colorectal cancer|colorectal cancer
5154432|NCT00994526|Processed meat|processed meat
5154433|NCT00994526|Calcium|calcium
5154434|NCT00994526|Vitamin E|vitamin e
5154435|NCT00994526|Preventive strategies|preventive strategies
5154436|NCT00994513|Antioxidant|antioxidant
5154437|NCT00994513|Obesity|obesity
5154438|NCT00994487|Childhood Obesity|childhood obesity
5154439|NCT00994487|Breastfeeding|breastfeeding
5154440|NCT00994487|Bottle Feeding|bottle feeding
5154441|NCT00994487|Dietary Intake|dietary intake
5154442|NCT00994487|Preload|preload
5154443|NCT00994487|Compensation|compensation
5154444|NCT00994487|Parental Feeding Style|parental feeding style
5154445|NCT00994474|Laser surgery|laser surgery
5154446|NCT00994474|Profilometry|profilometry
5154447|NCT00994474|Fitzpatrick wrinkle score|fitzpatrick wrinkle score
5154448|NCT00994474|Patient Benefit Index|patient benefit index
5154449|NCT00994474|Patient satisfaction|patient satisfaction
5154450|NCT00994461|Endoscopy|endoscopy
5154451|NCT00994448|Adolescents|adolescents
5154452|NCT00994448|Methamphetamine abuse|methamphetamine abuse
5154453|NCT00994448|Bupropion|bupropion
5154454|NCT00994448|Addiction|addiction
5154455|NCT00994448|Pharmacotherapy|pharmacotherapy
5154456|NCT00994448|Cognitive Behavioral Therapy|cognitive behavioral therapy
5154457|NCT00994448|Contingency Management|contingency management
5154458|NCT00994448|Teens|teens
5154459|NCT00994435|obesity|obesity
5154460|NCT00994422|PEDICULUS HUMANUS CAPITIS|pediculus humanus capitis
5154461|NCT00994422|Head Lice|head lice
5154462|NCT00994409|Stroke|stroke
5154463|NCT00994370|Pro-angiogenic markers|pro-angiogenic markers
5154464|NCT00994370|SIRT|sirt
5154465|NCT00994370|hepatic metastases|hepatic metastases
5154466|NCT00994357|Real-time Continuous Glucose Monitoring|real-time continuous glucose monitoring
5154467|NCT00994357|Macrosomia|macrosomia
5154468|NCT00994344|Darunavir|darunavir
5154469|NCT00994344|Lopinavir|lopinavir
5154470|NCT00994344|Monotherapy|monotherapy
5154471|NCT00994344|Antiretroviral simplification strategy|antiretroviral simplification strategy
5154472|NCT00994344|HIV|hiv
5154473|NCT00994344|Treatment experienced|treatment experienced
5154474|NCT00994331|Percutaneous Coronary Intervention|percutaneous coronary intervention
5154475|NCT00994331|Magnetic Navigation|magnetic navigation
5154476|NCT00994331|Computed Tomography|computed tomography
5154477|NCT00994318|Ferinject Iron Deficiency Anaemia Chronic Kidney Disease|ferinject iron deficiency anaemia chronic kidney disease
5154478|NCT00994305|kidney transplantation|kidney transplantation
5154479|NCT00994305|oxidative stress|oxidative stress
5154480|NCT00994305|acetylcysteine|acetylcysteine
5154481|NCT00994305|graft rejection|graft rejection
5154482|NCT00994292|Factor Xa|factor xa
5154483|NCT00994292|Anticoagulant|anticoagulant
5154484|NCT00994292|YM150|ym150
5154485|NCT00994292|Acute Coronary Syndrome|acute coronary syndrome
5154486|NCT00994279|fatigue|fatigue
5154487|NCT00994279|depression|depression
5154488|NCT00994279|sleep disorders|sleep disorders
5154489|NCT00994279|stage IA breast cancer|stage ia breast cancer
5154490|NCT00994279|stage IB breast cancer|stage ib breast cancer
5154491|NCT00994279|stage II breast cancer|stage ii breast cancer
5154492|NCT00994279|stage IIIA breast cancer|stage iiia breast cancer
5154493|NCT00994279|stage IIIB breast cancer|stage iiib breast cancer
5154494|NCT00994279|stage IIIC breast cancer|stage iiic breast cancer
5154495|NCT00994279|recurrent breast cancer|recurrent breast cancer
5154496|NCT00994266|Type 2 diabetes|type 2 diabetes
5154497|NCT00994266|Diamel|diamel
5154498|NCT00994266|Dietary supplement|dietary supplement
5154499|NCT00994227|electron microscopy|electron microscopy
5154500|NCT00994227|internal limiting membrane|internal limiting membrane
5154501|NCT00994227|macular disease|macular disease
5154502|NCT00994227|optical coherence tomography|optical coherence tomography
5154503|NCT00994188|Renal tumor|renal tumor
5154504|NCT00994188|Ureteral tumor|ureteral tumor
5154505|NCT00994188|Ureteral stricture|ureteral stricture
5154506|NCT00994188|Restored kidney|restored kidney
5154507|NCT00994188|Renal transplantation|renal transplantation
5154508|NCT00994188|Family members|family members
5154509|NCT00994175|Pioglitazone|pioglitazone
5154510|NCT00994175|Severe, Refractory Asthma|severe, refractory asthma
5154511|NCT00994175|Peroxisome Proliferator-Activated Receptor Gamma|peroxisome proliferator-activated receptor gamma
5154512|NCT00994175|Airflow Obstruction|airflow obstruction
5154513|NCT00994175|Airway Inflammation|airway inflammation
5154514|NCT00994175|Asthma|asthma
5154515|NCT00994162|NPWT|npwt
5154516|NCT00994162|Gauze-based filler|gauze-based filler
5154517|NCT00994162|Acute or Chronic Wounds|acute or chronic wounds
5154518|NCT00994162|Efficacy|efficacy
5154519|NCT00994149|Infants of Diabetic Mothers|infants of diabetic mothers
5154520|NCT00994149|Hypoglycemia|hypoglycemia
5154521|NCT00994149|Diazoxide|diazoxide
5154522|NCT00994149|Large for Gestation Infants|large for gestation infants
5154523|NCT00994136|Catheters, indwelling|catheters, indwelling
5154524|NCT00994136|Catheterization, Central Venous|catheterization, central venous
5154525|NCT00994136|Withdrawal occlusion|withdrawal occlusion
5154526|NCT00994136|Heparin lock|heparin lock
5154527|NCT00994123|Non-Small Cell Lung Cancer|non-small cell lung cancer
5154528|NCT00994123|NSCLC|nsclc
5154529|NCT00994123|Advanced Non-Small Cell Lung Cancer|advanced non-small cell lung cancer
5154530|NCT00994123|Metastatic Non-Small Cell Lung Cancer|metastatic non-small cell lung cancer
5154531|NCT00994123|Lung Cancer|lung cancer
5154532|NCT00994123|Erlotinib|erlotinib
5154533|NCT00994123|Tarceva|tarceva
5154534|NCT00994123|MM-121|mm-121
5154535|NCT00994123|ErbB3|erbb3
5154536|NCT00994123|Her3|her3
5154537|NCT00994123|Epidermal Growth Factor Receptor|epidermal growth factor receptor
5154538|NCT00994123|anti-ErbB3 human monoclonal antibody|anti-erbb3 human monoclonal antibody
5154539|NCT00994123|ErbB3 antagonist|erbb3 antagonist
5154540|NCT00994110|PANCREAS|pancreas
5154541|NCT00994110|Pasireotide|pasireotide
5154542|NCT00994110|SOM230|som230
5154543|NCT00994110|saline placebo|saline placebo
5154544|NCT00994110|09-039|09-039
5154545|NCT00994097|NGR-hTNF|ngr-htnf
5154546|NCT00994097|Randomized controlled trial|randomized controlled trial
5154547|NCT00994097|Gemcitabine|gemcitabine
5154548|NCT00994097|Cisplatin|cisplatin
5154549|NCT00994097|Pemetrexed|pemetrexed
5154550|NCT00994097|Carcinoma, non-small cell lung|carcinoma, non-small cell lung
5154551|NCT00994084|Obesity|obesity
5154552|NCT00994084|Minority children|minority children
5154553|NCT00994084|Community intervention program|community intervention program
5154554|NCT00994084|Lifestyle changes|lifestyle changes
5154555|NCT00994084|Physical activities|physical activities
5154556|NCT00994084|Nutrition lessons|nutrition lessons
5154557|NCT00994084|Behavior modification|behavior modification
5154558|NCT00994071|Brain Tumor|brain tumor
5154559|NCT00994071|CNC Tumor|cnc tumor
5154560|NCT00994071|Pediatric|pediatric
5154561|NCT00994071|PARP Inhibitor|parp inhibitor
5154562|NCT00994071|Oral Chemotherapy|oral chemotherapy
5154563|NCT00994058|Preterm Labor|preterm labor
5154564|NCT00994058|Uterine Inhibitor|uterine inhibitor
5154565|NCT00994058|Electro-Inhibition|electro-inhibition
5154566|NCT00994045|Thoraco-Abdominal Aneurysm (TAAA)|thoraco-abdominal aneurysm (taaa)
5154567|NCT00994045|Coagulopathy|coagulopathy
5154568|NCT00994045|Fresh Frozen Plasma|fresh frozen plasma
5154569|NCT00994045|Fibrinogen Concentrate|fibrinogen concentrate
5154570|NCT00994032|vertebroplasty|vertebroplasty
5154571|NCT00994032|disability evaluation|disability evaluation
5154572|NCT00994032|outcome assessment|outcome assessment
5154573|NCT00994032|pain measurement|pain measurement
5154574|NCT00994019|HPV|hpv
5154575|NCT00994019|oral cancer|oral cancer
5154576|NCT00994019|young adults|young adults
5154577|NCT00994006|Magnesium|magnesium
5154578|NCT00994006|nutrition|nutrition
5154579|NCT00994006|platelets|platelets
5154580|NCT00994006|aggregation|aggregation
5154581|NCT00993993|cleft palate|cleft palate
5154582|NCT00993980|qigong|qigong
5154583|NCT00993980|traditional chinese medicine|traditional chinese medicine
5154584|NCT00993980|exercise therapy|exercise therapy
5154585|NCT00993980|low back pain|low back pain
5154586|NCT00993967|FRDA|frda
5154587|NCT00993967|idebenone|idebenone
5154588|NCT00993967|FRDA disease|frda disease
5154589|NCT00993954|Nurse Treatment|nurse treatment
5154590|NCT00993954|Pulled Elbow|pulled elbow
5154591|NCT00993941|BMSC|bmsc
5154592|NCT00993941|Stem cells|stem cells
5154593|NCT00993941|Liver cirrhosis|liver cirrhosis
5154594|NCT00993941|Transplantation|transplantation
5154595|NCT00993928|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
5154596|NCT00993928|fatigue|fatigue
5154597|NCT00993928|sleep disorders|sleep disorders
5154598|NCT00993928|cancer survivor|cancer survivor
5154599|NCT00993915|Coronary Artery Disease|coronary artery disease
5154600|NCT00993915|Hyperlipidemia|hyperlipidemia
5154601|NCT00993915|Atorvastatin|atorvastatin
5154602|NCT00993902|Double IUI|double iui
5154603|NCT00993902|Intrauterine insemination|intrauterine insemination
5154604|NCT00993902|Unexplained infertility|unexplained infertility
5154605|NCT00993889|Virtual Reality Peds|virtual reality peds
5154606|NCT00993876|Depression|depression
5154607|NCT00993876|CREB|creb
5154608|NCT00993876|cognitive performance|cognitive performance
5154609|NCT00993876|psychotherapy|psychotherapy
5154610|NCT00993876|SSRI|ssri
5154611|NCT00993876|SNRI|snri
5154612|NCT00993863|delta opioid agonist|delta opioid agonist
5154613|NCT00993863|dental pain|dental pain
5154614|NCT00993850|Bipolar disorder|bipolar disorder
5154615|NCT00993850|Insomnia|insomnia
5154616|NCT00993850|Sleep disturbance|sleep disturbance
5154617|NCT00993850|Cognitive behavioral therapy|cognitive behavioral therapy
5154618|NCT00993837|endoscopic thyroidectomy|endoscopic thyroidectomy
5154619|NCT00993837|thyroid carcinoma|thyroid carcinoma
5154620|NCT00993811|male circumcision|male circumcision
5154621|NCT00993811|HIV|hiv
5154622|NCT00993811|Africa|africa
5154623|NCT00993811|HIV Seronegativity|hiv seronegativity
5154624|NCT00993798|Post operative pain|post operative pain
5154625|NCT00993798|Local anaesthesia|local anaesthesia
5154626|NCT00993798|Postoperative pain after arthroscopic shoulder surgery|postoperative pain after arthroscopic shoulder surgery
5154627|NCT00993759|common cold|common cold
5154628|NCT00993759|rhinovirus|rhinovirus
5154629|NCT00993759|prevention|prevention
5154630|NCT00993746|Ultrasound guided infraclavicular brachial plexus block|ultrasound guided infraclavicular brachial plexus block
5154631|NCT00993746|Bupivacaine|bupivacaine
5154632|NCT00993746|Bupivacaine plus lidocaine|bupivacaine plus lidocaine
5154633|NCT00993746|End stage renal disease|end stage renal disease
5154634|NCT00993746|Arteriovenous fistula|arteriovenous fistula
5154635|NCT00993733|hemodiafiltration|hemodiafiltration
5154637|NCT00993733|dialysis solution|dialysis solution
5154638|NCT00993733|acute renal failure|acute renal failure
5154639|NCT00993733|intensive care unit|intensive care unit
5154640|NCT00993720|patients with type 1 diabetes mellitus|patients with type 1 diabetes mellitus
5154641|NCT00993707|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
5154642|NCT00993694|methemoglobinemia|methemoglobinemia
5154643|NCT00993694|aplastic anemia|aplastic anemia
5154644|NCT00993694|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5154645|NCT00993694|acute undifferentiated leukemia|acute undifferentiated leukemia
5154646|NCT00993694|atypical chronic myeloid leukemia, BCR-ABL negative|atypical chronic myeloid leukemia, bcr-abl negative
5154647|NCT00993694|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5154648|NCT00993694|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
5154649|NCT00993694|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
5154650|NCT00993694|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
5154651|NCT00993694|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5154652|NCT00993694|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5154653|NCT00993694|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
5154654|NCT00993694|mast cell leukemia|mast cell leukemia
5154879|NCT00993265|N-Acetylcysteine|n-acetylcysteine
5154655|NCT00993694|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
5154656|NCT00993694|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
5154657|NCT00993694|prolymphocytic leukemia|prolymphocytic leukemia
5154658|NCT00993694|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5154659|NCT00993694|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5154660|NCT00993694|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5154661|NCT00993694|refractory hairy cell leukemia|refractory hairy cell leukemia
5154662|NCT00993694|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5154663|NCT00993694|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5154664|NCT00993694|stage 0 chronic lymphocytic leukemia|stage 0 chronic lymphocytic leukemia
5154665|NCT00993694|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
5154666|NCT00993694|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
5154667|NCT00993694|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5154668|NCT00993694|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5154669|NCT00993694|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
5154670|NCT00993694|AIDS-related diffuse large cell lymphoma|aids-related diffuse large cell lymphoma
5154671|NCT00993694|AIDS-related diffuse mixed cell lymphoma|aids-related diffuse mixed cell lymphoma
5154672|NCT00993694|AIDS-related diffuse small cleaved cell lymphoma|aids-related diffuse small cleaved cell lymphoma
5154673|NCT00993694|AIDS-related immunoblastic large cell lymphoma|aids-related immunoblastic large cell lymphoma
5154674|NCT00993694|AIDS-related lymphoblastic lymphoma|aids-related lymphoblastic lymphoma
5154675|NCT00993694|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
5154676|NCT00993694|AIDS-related primary CNS lymphoma|aids-related primary cns lymphoma
5154677|NCT00993694|AIDS-related small noncleaved cell lymphoma|aids-related small noncleaved cell lymphoma
5154678|NCT00993694|HIV-associated Hodgkin lymphoma|hiv-associated hodgkin lymphoma
5154679|NCT00993694|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
5154680|NCT00993694|stage I childhood Hodgkin lymphoma|stage i childhood hodgkin lymphoma
5154681|NCT00993694|stage II childhood Hodgkin lymphoma|stage ii childhood hodgkin lymphoma
5154682|NCT00993694|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
5154683|NCT00993694|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5154684|NCT00993694|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
5154685|NCT00993694|cutaneous B-cell non-Hodgkin lymphoma|cutaneous b-cell non-hodgkin lymphoma
5154686|NCT00993694|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5154687|NCT00993694|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
5154688|NCT00993694|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
5154689|NCT00993694|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
5154690|NCT00993694|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
5154691|NCT00993694|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5154692|NCT00993694|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
5154693|NCT00993694|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
5154694|NCT00993694|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
5154695|NCT00993694|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
5154696|NCT00993694|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
5154697|NCT00993694|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5154698|NCT00993694|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5154699|NCT00993694|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5154700|NCT00993694|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
5154701|NCT00993694|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
5154702|NCT00993694|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
5154703|NCT00993694|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
5154704|NCT00993694|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
5154705|NCT00993694|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
5154706|NCT00993694|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
5154707|NCT00993694|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
5154708|NCT00993694|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
5154709|NCT00993694|stage I mantle cell lymphoma|stage i mantle cell lymphoma
5154710|NCT00993694|stage I marginal zone lymphoma|stage i marginal zone lymphoma
5154711|NCT00993694|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
5154712|NCT00993694|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5154713|NCT00993694|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5154714|NCT00993694|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5154715|NCT00993694|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5154716|NCT00993694|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
5154717|NCT00993694|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
5154718|NCT00993694|stage I childhood large cell lymphoma|stage i childhood large cell lymphoma
5154719|NCT00993694|stage I childhood lymphoblastic lymphoma|stage i childhood lymphoblastic lymphoma
5154720|NCT00993694|stage I childhood small noncleaved cell lymphoma|stage i childhood small noncleaved cell lymphoma
5154721|NCT00993694|stage II childhood large cell lymphoma|stage ii childhood large cell lymphoma
5154722|NCT00993694|stage II childhood lymphoblastic lymphoma|stage ii childhood lymphoblastic lymphoma
5154723|NCT00993694|stage II childhood small noncleaved cell lymphoma|stage ii childhood small noncleaved cell lymphoma
5154724|NCT00993694|stage III childhood large cell lymphoma|stage iii childhood large cell lymphoma
5154725|NCT00993694|stage III childhood lymphoblastic lymphoma|stage iii childhood lymphoblastic lymphoma
5154726|NCT00993694|stage III childhood small noncleaved cell lymphoma|stage iii childhood small noncleaved cell lymphoma
5154727|NCT00993694|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5154728|NCT00993694|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5154729|NCT00993694|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5154730|NCT00993694|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5154731|NCT00993694|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5154732|NCT00993694|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5154733|NCT00993694|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
5154734|NCT00993694|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
5154735|NCT00993694|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
5154736|NCT00993694|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5154737|NCT00993694|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5154738|NCT00993694|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5154739|NCT00993694|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5154740|NCT00993694|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5154741|NCT00993694|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5154742|NCT00993694|recurrent childhood grade III lymphomatoid granulomatosis|recurrent childhood grade iii lymphomatoid granulomatosis
5154743|NCT00993694|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
5154744|NCT00993694|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
5154745|NCT00993694|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
5154746|NCT00993694|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5154747|NCT00993694|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5154748|NCT00993694|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5154749|NCT00993694|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5154750|NCT00993694|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5154751|NCT00993694|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5154752|NCT00993694|Burkitt lymphoma|burkitt lymphoma
5154753|NCT00993694|childhood diffuse large cell lymphoma|childhood diffuse large cell lymphoma
5154754|NCT00993694|childhood grade III lymphomatoid granulomatosis|childhood grade iii lymphomatoid granulomatosis
5154755|NCT00993694|childhood immunoblastic large cell lymphoma|childhood immunoblastic large cell lymphoma
5154756|NCT00993694|childhood nasal type extranodal NK/T-cell lymphoma|childhood nasal type extranodal nk/t-cell lymphoma
5154757|NCT00993694|intraocular lymphoma|intraocular lymphoma
5154758|NCT00993694|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
5154759|NCT00993694|post-transplant lymphoproliferative disorder|post-transplant lymphoproliferative disorder
5154760|NCT00993694|chronic eosinophilic leukemia|chronic eosinophilic leukemia
5154761|NCT00993694|chronic neutrophilic leukemia|chronic neutrophilic leukemia
5154762|NCT00993694|primary myelofibrosis|primary myelofibrosis
5154763|NCT00993694|essential thrombocythemia|essential thrombocythemia
5154764|NCT00993694|polycythemia vera|polycythemia vera
5154765|NCT00993694|extramedullary plasmacytoma|extramedullary plasmacytoma
5154766|NCT00993694|isolated plasmacytoma of bone|isolated plasmacytoma of bone
5154767|NCT00993694|stage I multiple myeloma|stage i multiple myeloma
5154768|NCT00993694|stage II multiple myeloma|stage ii multiple myeloma
5154769|NCT00993694|stage III multiple myeloma|stage iii multiple myeloma
5154770|NCT00993694|primary systemic amyloidosis|primary systemic amyloidosis
5154771|NCT00993694|refractory multiple myeloma|refractory multiple myeloma
5154772|NCT00993694|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5154773|NCT00993694|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5154774|NCT00993694|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5154775|NCT00993694|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
5154776|NCT00993694|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
5154777|NCT00993694|recurrent childhood anaplastic large cell lymphoma|recurrent childhood anaplastic large cell lymphoma
5154778|NCT00993694|stage I childhood anaplastic large cell lymphoma|stage i childhood anaplastic large cell lymphoma
5154779|NCT00993694|stage II childhood anaplastic large cell lymphoma|stage ii childhood anaplastic large cell lymphoma
5154780|NCT00993694|stage III childhood anaplastic large cell lymphoma|stage iii childhood anaplastic large cell lymphoma
5154781|NCT00993694|stage IV childhood anaplastic large cell lymphoma|stage iv childhood anaplastic large cell lymphoma
5154782|NCT00993694|stage III childhood Hodgkin lymphoma|stage iii childhood hodgkin lymphoma
5154880|NCT00993265|Children|children
5154783|NCT00993681|Prevention of Travelers' Diarrhea|prevention of travelers' diarrhea
5154784|NCT00993668|influenza|influenza
5154785|NCT00993668|vaccine|vaccine
5154786|NCT00993668|pneumococcal vaccine|pneumococcal vaccine
5154787|NCT00993668|certolizumab pegol|certolizumab pegol
5154788|NCT00993668|Cimzia|cimzia
5154789|NCT00993655|peritoneal cavity cancer|peritoneal cavity cancer
5154790|NCT00993655|fallopian tube cancer|fallopian tube cancer
5154791|NCT00993655|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
5154792|NCT00993655|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5154793|NCT00993655|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5154794|NCT00993655|malignant pleural effusion|malignant pleural effusion
5154795|NCT00993655|ovarian clear cell cystadenocarcinoma|ovarian clear cell cystadenocarcinoma
5154796|NCT00993655|ovarian clear cell tumor with proliferating activity|ovarian clear cell tumor with proliferating activity
5154797|NCT00993642|estrogen receptor positive tamoxifen resistant breast cancer|estrogen receptor positive tamoxifen resistant breast cancer
5154798|NCT00993629|PTSD|ptsd
5154799|NCT00993629|Depression|depression
5154800|NCT00993629|Neurosteroids|neurosteroids
5154801|NCT00993603|Lifestyle|lifestyle
5154802|NCT00993603|Diabetes Mellitus|diabetes mellitus
5154803|NCT00993603|prevention/onset delay.|prevention/onset delay.
5154804|NCT00993590|Persistent asthma|persistent asthma
5154805|NCT00993590|Asthma related emergency room visits|asthma related emergency room visits
5154806|NCT00993590|Asthma control, adolescents|asthma control, adolescents
5154807|NCT00993590|Adherence, asthma control medications|adherence, asthma control medications
5154808|NCT00993577|Stretching|stretching
5154809|NCT00993577|Pain|pain
5154810|NCT00993564|Therapeutic hypothermia|therapeutic hypothermia
5154811|NCT00993564|Head cooling|head cooling
5154812|NCT00993564|Hypoxic ischemic encephalopathy|hypoxic ischemic encephalopathy
5154813|NCT00993564|Newborn|newborn
5154814|NCT00993551|cleft palate|cleft palate
5154815|NCT00993551|paediatric|paediatric
5154816|NCT00993551|pediatric|pediatric
5154817|NCT00993551|surgery|surgery
5154818|NCT00993551|speech|speech
5154819|NCT00993551|velopharyngeal|velopharyngeal
5154820|NCT00993538|Leukaemia|leukaemia
5154821|NCT00993538|Blood and marrow cells culture|blood and marrow cells culture
5154822|NCT00993538|Cell growth|cell growth
5154823|NCT00993538|Cell differentiation|cell differentiation
5154824|NCT00993525|diabetic retinopathy|diabetic retinopathy
5154825|NCT00993525|ranibizumab|ranibizumab
5154826|NCT00993525|new vessels|new vessels
5154827|NCT00993525|intravitreal injection|intravitreal injection
5154828|NCT00993525|Persistent retina new vessels|persistent retina new vessels
5154829|NCT00993512|photochemical internalisation|photochemical internalisation
5154830|NCT00993512|photosensitiser|photosensitiser
5154831|NCT00993512|cutaneous tumour|cutaneous tumour
5154832|NCT00993512|sub-cutaneous tumour|sub-cutaneous tumour
5154833|NCT00993512|dose escalation|dose escalation
5154834|NCT00993486|Haploidentical stem cell transplantation|haploidentical stem cell transplantation
5154835|NCT00993486|Graft-versus-host disease|graft-versus-host disease
5154836|NCT00993486|Immune reconstitution|immune reconstitution
5154837|NCT00993486|Alloreactive T-cells|alloreactive t-cells
5154838|NCT00993486|Photodepletion|photodepletion
5154839|NCT00993486|TH9402|th9402
5154840|NCT00993486|Transplant related mortality|transplant related mortality
5154841|NCT00993486|Hematologic malignancy|hematologic malignancy
5154842|NCT00993460|Obesity|obesity
5154843|NCT00993460|Insulin sensitivity|insulin sensitivity
5154844|NCT00993460|Inflammation|inflammation
5154845|NCT00993447|Dengue|dengue
5154846|NCT00993447|Dengue hemorrhagic fever|dengue hemorrhagic fever
5154847|NCT00993447|Dengue virus|dengue virus
5154848|NCT00993447|Dengue fever|dengue fever
5154849|NCT00993447|Sanofi pasteur's CYD Dengue vaccine|sanofi pasteur's cyd dengue vaccine
5154850|NCT00993434|Child|child
5154851|NCT00993395|addiction|addiction
5154852|NCT00993395|peer mentor|peer mentor
5154853|NCT00993395|adherence|adherence
5154854|NCT00993369|Prediction of neuro developmental delay|prediction of neuro developmental delay
5154855|NCT00993356|Acromegaly|acromegaly
5154856|NCT00993356|Macroadenomas|macroadenomas
5154857|NCT00993356|Lanreotide|lanreotide
5154858|NCT00993356|Transsphenoidal neurosurgery|transsphenoidal neurosurgery
5154859|NCT00993356|Preoperative|preoperative
5154860|NCT00993343|GVHD|gvhd
5154861|NCT00993343|tacrolimus|tacrolimus
5154862|NCT00993343|sirolimus|sirolimus
5154863|NCT00993343|cyclosporine|cyclosporine
5154864|NCT00993343|allogeneic|allogeneic
5154865|NCT00993343|stem cell transplantation|stem cell transplantation
5154866|NCT00993343|Relapse-free survival|relapse-free survival
5154867|NCT00993330|macular pigment|macular pigment
5154868|NCT00993330|to measure macular pigment in the retina|to measure macular pigment in the retina
5154869|NCT00993317|CDP870|cdp870
5154870|NCT00993317|Korea|korea
5154871|NCT00993317|CIMZIA|cimzia
5154872|NCT00993291|Parkinson's Disease|parkinson's disease
5154873|NCT00993291|DBS|dbs
5154874|NCT00993291|Frequency|frequency
5154875|NCT00993291|Deep brain stimulation|deep brain stimulation
5154876|NCT00993265|Trichotillomania|trichotillomania
5154877|NCT00993265|Hair pulling|hair pulling
5154878|NCT00993265|glutamate|glutamate
5154881|NCT00993252|head injury|head injury
5154882|NCT00993252|radiography|radiography
5154883|NCT00993252|clinical impact|clinical impact
5154884|NCT00993252|dissemination|dissemination
5154885|NCT00993226|Postoperative pain|postoperative pain
5154886|NCT00993226|Local anaesthesia|local anaesthesia
5154887|NCT00993226|Postoperative pain after open abdominal hysterectomy surgery|postoperative pain after open abdominal hysterectomy surgery
5154888|NCT00993213|fat mass|fat mass
5154889|NCT00993213|body composition|body composition
5154890|NCT00993200|Warfarin|warfarin
5154891|NCT00993200|Pharmacogenetic|pharmacogenetic
5154892|NCT00993161|Neuromuscular disorders|neuromuscular disorders
5154893|NCT00993161|Evaluation|evaluation
5154894|NCT00993161|Strength|strength
5154895|NCT00993161|Upper limb|upper limb
5154896|NCT00993148|Treatment naive|treatment naive
5154897|NCT00993135|renal toxicity|renal toxicity
5154898|NCT00993135|childhood acute lymphoblastic leukemia|childhood acute lymphoblastic leukemia
5154899|NCT00993135|adult acute lymphoblastic leukemia|adult acute lymphoblastic leukemia
5154900|NCT00993122|pre treatment|pre treatment
5154901|NCT00993122|therapy compliance|therapy compliance
5154902|NCT00993122|SVR|svr
5154903|NCT00993122|sustained virological response|sustained virological response
5154904|NCT00993122|TH1 TH2 ratio|th1 th2 ratio
5154905|NCT00993109|Nifedipine GITS/OROS (Adalat®)|nifedipine gits/oros (adalat®)
5154906|NCT00993109|Valsartan (Diovan®)|valsartan (diovan®)
5154907|NCT00993109|Hypertension|hypertension
5154908|NCT00993083|Influenza|influenza
5154909|NCT00993083|Vaccine|vaccine
5154910|NCT00993070|capsaicin|capsaicin
5154911|NCT00993070|placebo|placebo
5154912|NCT00993070|trial|trial
5154913|NCT00993070|diabetic polyneuropathy|diabetic polyneuropathy
5154914|NCT00993070|neuropathic pain|neuropathic pain
5154915|NCT00993057|Euglycemia|euglycemia
5154916|NCT00993057|craniotomy|craniotomy
5154917|NCT00993057|neurosurgery|neurosurgery
5154918|NCT00993057|hypoglycemia|hypoglycemia
5154919|NCT00993057|insulin|insulin
5154920|NCT00993031|HIV|hiv
5154921|NCT00993031|Placental Malaria|placental malaria
5154922|NCT00993031|Pregnancy|pregnancy
5154923|NCT00993031|Uganda|uganda
5154924|NCT00993031|Protease inhibitors|protease inhibitors
5154925|NCT00993031|Trimethoprim-sulfamethoxazole|trimethoprim-sulfamethoxazole
5154926|NCT00993031|Treatment experienced|treatment experienced
5154927|NCT00993018|Diabetic Neuropathy|diabetic neuropathy
5154928|NCT00993018|Diabetic painful neuropathy|diabetic painful neuropathy
5154929|NCT00993018|JNJ-42160443|jnj-42160443
5154930|NCT00993018|Neuropathic pain|neuropathic pain
5154931|NCT00993018|Pain|pain
5154932|NCT00993018|Pharmacokinetics|pharmacokinetics
5154933|NCT00993005|Hypertrophic scars|hypertrophic scars
5154934|NCT00993005|Keloids|keloids
5154935|NCT00993005|Asian Gotu Kola|asian gotu kola
5154936|NCT00993005|Asian Pennywort|asian pennywort
5154937|NCT00992992|Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (CHOP)|cyclophosphamide, doxorubicin, vincristine, and prednisone (chop)
5154938|NCT00992992|Tositumomab|tositumomab
5154939|NCT00992992|Tositumomab and Iodine I-131 tostumomab|tositumomab and iodine i-131 tostumomab
5154940|NCT00992992|Bexxar|bexxar
5154941|NCT00992992|Iodine-131 Anti-B1 Antibody|iodine-131 anti-b1 antibody
5154942|NCT00992992|Mantle Cell|mantle cell
5154943|NCT00992992|radioimmunotherapy|radioimmunotherapy
5154944|NCT00992979|Addiction|addiction
5154945|NCT00992979|Anxiety|anxiety
5154946|NCT00992979|Withdrawal|withdrawal
5154947|NCT00992979|Psychoactive Drugs|psychoactive drugs
5154948|NCT00992979|Therapeutic Massage|therapeutic massage
5154949|NCT00992966|to acquire database of pneumonia cases in children|to acquire database of pneumonia cases in children
5154950|NCT00992953|Virtual Reality|virtual reality
5154951|NCT00992953|Post Traumatic Stress Disorder|post traumatic stress disorder
5154952|NCT00992953|Combat|combat
5154953|NCT00992953|Military|military
5154954|NCT00992953|Major Depressive Disorder|major depressive disorder
5154955|NCT00992953|Anxiety|anxiety
5154956|NCT00992953|Virtual Reality Exposure with Stimulus Control|virtual reality exposure with stimulus control
5154957|NCT00992953|Treatment as Usual|treatment as usual
5154958|NCT00992940|awake craniotomy|awake craniotomy
5154959|NCT00992940|patient-controlled sedation analgesia|patient-controlled sedation analgesia
5154960|NCT00992940|anesthetist-controlled sedation analgesia|anesthetist-controlled sedation analgesia
5154961|NCT00992940|remifentanil-propofol|remifentanil-propofol
5154962|NCT00992940|tumour surgery|tumour surgery
5154963|NCT00992927|Injections, Intra-Articular|injections, intra-articular
5154964|NCT00992927|Range of Motion, Articular|range of motion, articular
5154965|NCT00992927|Pain|pain
5154966|NCT00992914|Hot flushes (vasomotor symptoms)|hot flushes (vasomotor symptoms)
5154967|NCT00992901|gastric bypass surgery|gastric bypass surgery
5154968|NCT00992901|glucose tolerance|glucose tolerance
5154969|NCT00992901|Insulin response to meal ingestion|insulin response to meal ingestion
5154970|NCT00992901|Gut hormone and neural response to meal ingestion|gut hormone and neural response to meal ingestion
5154971|NCT00992888|Alcoholic Hepatitis|alcoholic hepatitis
5154972|NCT00992888|Alcohol|alcohol
5154973|NCT00992888|Endotoxin|endotoxin
5154974|NCT00992888|LPS|lps
5154975|NCT00992888|Liver dialysis|liver dialysis
5154976|NCT00992888|Innate immunity|innate immunity
5155277|NCT00991627|Atropine|atropine
5154977|NCT00992888|Toll Like receptors|toll like receptors
5154978|NCT00992875|Healthy but stressed individuals|healthy but stressed individuals
5154979|NCT00992849|Corneal neovascularization|corneal neovascularization
5154980|NCT00992849|bevacizumab|bevacizumab
5154981|NCT00992836|Influenza A Virus, H1N1 Subtype|influenza a virus, h1n1 subtype
5154982|NCT00992836|Vaccine|vaccine
5154983|NCT00992836|Children|children
5154984|NCT00992836|Adolescents|adolescents
5154985|NCT00992836|HIV-Infected|hiv-infected
5154986|NCT00992836|Perinatal HIV Infection|perinatal hiv infection
5154987|NCT00992836|Treatment experienced|treatment experienced
5154988|NCT00992823|Iron|iron
5154989|NCT00992823|anemia|anemia
5154990|NCT00992823|supplementation|supplementation
5154991|NCT00992823|preschoolers|preschoolers
5154992|NCT00992823|prevalence|prevalence
5154993|NCT00992823|preschoolers children from public day care centers|preschoolers children from public day care centers
5154994|NCT00992810|upper limb|upper limb
5154995|NCT00992810|hand|hand
5154996|NCT00992810|arm|arm
5154997|NCT00992810|surgery|surgery
5154998|NCT00992810|supraclavicular nerve block|supraclavicular nerve block
5154999|NCT00992810|brachial plexus nerve block|brachial plexus nerve block
5155000|NCT00992810|ultrasound-guided regional anesthesia|ultrasound-guided regional anesthesia
5155001|NCT00992797|Insulin resistance|insulin resistance
5155002|NCT00992797|Insulin secretory dysfunction|insulin secretory dysfunction
5155003|NCT00992797|Inflammation|inflammation
5155004|NCT00992797|Vascular stiffness|vascular stiffness
5155005|NCT00992784|Influenza Vaccines|influenza vaccines
5155006|NCT00992784|GSK Bio's influenza vaccine GSK2186877A|gsk bio's influenza vaccine gsk2186877a
5155007|NCT00992784|influenza infection|influenza infection
5155008|NCT00992758|bone marrow|bone marrow
5155009|NCT00992758|Radioimmunotherapy|radioimmunotherapy
5155010|NCT00992758|non-Hodgkin's lymphoma|non-hodgkin's lymphoma
5155011|NCT00992758|Bexxar|bexxar
5155012|NCT00992758|anti-B1 antibody|anti-b1 antibody
5155013|NCT00992758|tositumomab and iodine I-131 tositumomab|tositumomab and iodine i-131 tositumomab
5155014|NCT00992758|NHL|nhl
5155015|NCT00992758|tositumomab|tositumomab
5155016|NCT00992745|prostate cancer|prostate cancer
5155017|NCT00992745|imaging|imaging
5155018|NCT00992745|metastases|metastases
5155019|NCT00992745|PSMA|psma
5155020|NCT00992745|ProstaScint®|prostascint®
5155021|NCT00992719|H1N1, influenza A viruses, vaccine, pregnant women|h1n1, influenza a viruses, vaccine, pregnant women
5155022|NCT00992706|palmar-plantar erythrodysesthesia|palmar-plantar erythrodysesthesia
5155023|NCT00992706|stage IV breast cancer|stage iv breast cancer
5155024|NCT00992706|male breast cancer|male breast cancer
5155025|NCT00992693|Crimean-Congo Hemorrhagic Fever|crimean-congo hemorrhagic fever
5155026|NCT00992693|Lassa Fever|lassa fever
5155027|NCT00992693|CCHF|cchf
5155028|NCT00992693|LF|lf
5155029|NCT00992693|Viral Hemorrhagic Fever|viral hemorrhagic fever
5155030|NCT00992693|VHF|vhf
5155031|NCT00992693|Ribavirin|ribavirin
5155032|NCT00992680|Lung Disease|lung disease
5155033|NCT00992680|Chronic Airflow Obstruction|chronic airflow obstruction
5155034|NCT00992680|Chronic Bronchitis|chronic bronchitis
5155035|NCT00992680|Pulmonary Emphysema|pulmonary emphysema
5155036|NCT00992680|Walk|walk
5155037|NCT00992667|apocynin|apocynin
5155038|NCT00992667|asthma|asthma
5155039|NCT00992654|Open Label Access Program|open label access program
5155040|NCT00992654|Treatment experienced|treatment experienced
5155041|NCT00992641|Systems biology|systems biology
5155042|NCT00992641|Nutrition|nutrition
5155043|NCT00992641|Nordic diet|nordic diet
5155044|NCT00992641|Dietary recommendations|dietary recommendations
5155045|NCT00992641|Metabolic syndrome|metabolic syndrome
5155046|NCT00992641|Features of metabolic syndrome|features of metabolic syndrome
5155047|NCT00992628|GlideScope Video Laryngoscope|glidescope video laryngoscope
5155048|NCT00992628|Macintosh Direct Laryngoscope|macintosh direct laryngoscope
5155049|NCT00992628|Intubation|intubation
5155050|NCT00992628|Applied Forces|applied forces
5155051|NCT00992628|Elective surgery where endotracheal intubation required|elective surgery where endotracheal intubation required
5155052|NCT00992589|Gastroesophageal Reflux|gastroesophageal reflux
5155053|NCT00992589|Gastroesophageal Reflux Disease|gastroesophageal reflux disease
5155054|NCT00992589|GERD|gerd
5155055|NCT00992589|Proton Pump Inhibitor|proton pump inhibitor
5155056|NCT00992589|PPI|ppi
5155057|NCT00992589|Regurgitation|regurgitation
5155058|NCT00992589|Infants|infants
5155059|NCT00992589|AcipHex, PARIET|aciphex, pariet
5155060|NCT00992589|ALFENCE|alfence
5155061|NCT00992576|Confirmatory|confirmatory
5155062|NCT00992576|Constipation|constipation
5155063|NCT00992576|Pain|pain
5155064|NCT00992576|Hydromorphone|hydromorphone
5155065|NCT00992576|Naloxone|naloxone
5155066|NCT00992563|wet age-related macular degeneration, exudative|wet age-related macular degeneration, exudative
5155067|NCT00992550|hookah|hookah
5155068|NCT00992550|cigarette|cigarette
5155069|NCT00992550|smoking|smoking
5155070|NCT00992524|Misoprostol|misoprostol
5155071|NCT00992524|Labor, Obstetric|labor, obstetric
5155072|NCT00992524|Labor, Induced|labor, induced
5155073|NCT00992511|influenza infection|influenza infection
5155074|NCT00992511|GSK Bio's influenza vaccine GSK2340272A|gsk bio's influenza vaccine gsk2340272a
5155472|NCT00990977|exercise|exercise
5155075|NCT00992498|COPD (Chronic Obstructive Pulmonary Disease)|copd (chronic obstructive pulmonary disease)
5155076|NCT00992498|outpatients|outpatients
5155077|NCT00992498|rehabilitation|rehabilitation
5155078|NCT00992498|comorbidities|comorbidities
5155079|NCT00992498|patient-centered outcome|patient-centered outcome
5155080|NCT00992459|Urea Cycle Disorder (UCD)|urea cycle disorder (ucd)
5155082|NCT00992459|hyperammonemia|hyperammonemia
5155083|NCT00992459|Buphenyl (NaPBA)|buphenyl (napba)
5155084|NCT00992459|glycerol phenylbutyrate (GPB)|glycerol phenylbutyrate (gpb)
5155085|NCT00992459|Sodium Phenylbutyrate (NaPBA)|sodium phenylbutyrate (napba)
5155086|NCT00992446|Autologous stem cell transplant|autologous stem cell transplant
5155087|NCT00992446|NHL|nhl
5155088|NCT00992446|maintenance therapy|maintenance therapy
5155089|NCT00992433|influenza, H1N1, vaccine, human immunodeficiency virus|influenza, h1n1, vaccine, human immunodeficiency virus
5155090|NCT00992420|thienopyridine|thienopyridine
5155091|NCT00992420|platelets|platelets
5155092|NCT00992420|CYP2C19|cyp2c19
5155093|NCT00992420|clopidogrel|clopidogrel
5155094|NCT00992420|platelet function tests|platelet function tests
5155095|NCT00992420|platelet|platelet
5155096|NCT00992420|genes|genes
5155097|NCT00992420|cytochrome P450|cytochrome p450
5155098|NCT00992420|single nucleotide polymorphisms|single nucleotide polymorphisms
5155099|NCT00992420|Platelet Aggregation Inhibitors|platelet aggregation inhibitors
5155100|NCT00992407|Schizophrenia|schizophrenia
5155101|NCT00992407|Risperidone|risperidone
5155102|NCT00992407|Risperdal|risperdal
5155103|NCT00992394|Plaque psoriasis - etanercept - response maintenance|plaque psoriasis - etanercept - response maintenance
5155104|NCT00992381|GI Pain|gi pain
5155105|NCT00992381|healthy participants|healthy participants
5155106|NCT00992381|Safety|safety
5155107|NCT00992381|bioavailability|bioavailability
5155108|NCT00992368|Quality-Adjusted Life Years:A measurement index|quality-adjusted life years:a measurement index
5155109|NCT00992368|Cost-Benefit Analysis:A method of comparing costs|cost-benefit analysis:a method of comparing costs
5155110|NCT00992368|Mammaplasty|mammaplasty
5155111|NCT00992368|QALY|qaly
5155112|NCT00992368|Health-related quality of life|health-related quality of life
5155113|NCT00992368|Cost-effectiveness|cost-effectiveness
5155114|NCT00992368|Breast|breast
5155115|NCT00992355|Cataract|cataract
5155116|NCT00992355|Phacoemulsification|phacoemulsification
5155117|NCT00992355|Treatment duration|treatment duration
5155118|NCT00992329|ciprofloxacin|ciprofloxacin
5155119|NCT00992329|pharmacokinetics|pharmacokinetics
5155120|NCT00992329|formulation|formulation
5155121|NCT00992316|Inflammatory pain|inflammatory pain
5155122|NCT00992303|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5155123|NCT00992290|cirrhosis|cirrhosis
5155124|NCT00992290|hepatic encephalopathy|hepatic encephalopathy
5155125|NCT00992290|complications|complications
5155126|NCT00992290|probiotic|probiotic
5155127|NCT00992290|lactobacillus GG|lactobacillus gg
5155128|NCT00992264|Cigarette Smoking|cigarette smoking
5155129|NCT00992264|Health Behavior|health behavior
5155130|NCT00992264|Intervention Studies|intervention studies
5155131|NCT00992264|Personal Communication|personal communication
5155132|NCT00992251|prostate cancer|prostate cancer
5155133|NCT00992225|Metastatic|metastatic
5155134|NCT00992212|Pandemic influenza|pandemic influenza
5155135|NCT00992212|vaccine|vaccine
5155136|NCT00992199|intraperitoneal chemotherapy|intraperitoneal chemotherapy
5155137|NCT00992199|cisplatin|cisplatin
5155138|NCT00992199|fluorouracil|fluorouracil
5155139|NCT00992199|advanced gastric cancer|advanced gastric cancer
5155140|NCT00992186|Prostate cancer|prostate cancer
5155141|NCT00992186|Infusion|infusion
5155142|NCT00992186|Carlumab|carlumab
5155143|NCT00992186|CNTO 888|cnto 888
5155144|NCT00992173|Neuroblastoma|neuroblastoma
5155145|NCT00992173|MIBG|mibg
5155146|NCT00992173|Iobenguane|iobenguane
5155147|NCT00992160|Polysomnography (PSG)|polysomnography (psg)
5155148|NCT00992160|Adults|adults
5155149|NCT00992160|Primary Insomnia|primary insomnia
5155150|NCT00992134|Lymphoma, Mantle-Cell|lymphoma, mantle-cell
5155151|NCT00992134|Bendamustine|bendamustine
5155152|NCT00992134|Cytarabine|cytarabine
5155153|NCT00992134|Rituximab|rituximab
5155154|NCT00992134|Treatment|treatment
5155155|NCT00992134|Combination chemotherapy|combination chemotherapy
5155156|NCT00992121|pazopanib|pazopanib
5155157|NCT00992121|Renal Cell Carcinoma|renal cell carcinoma
5155158|NCT00992121|Kidney|kidney
5155159|NCT00992121|cancer|cancer
5155160|NCT00992121|bevacizumab|bevacizumab
5155161|NCT00992108|Bruxism|bruxism
5155162|NCT00992108|Myofascial pain|myofascial pain
5155163|NCT00992108|EMG|emg
5155164|NCT00992108|Ultrasound|ultrasound
5155165|NCT00992108|Masticatory myofascial face pain from bruxism and clenching|masticatory myofascial face pain from bruxism and clenching
5155166|NCT00992082|Postoperative pain|postoperative pain
5155167|NCT00992082|Local Infiltration Analgesia|local infiltration analgesia
5155168|NCT00992082|Knee arthroplasty|knee arthroplasty
5155169|NCT00992069|ARV|arv
5155170|NCT00992069|Pharmacokinetics|pharmacokinetics
5155171|NCT00992069|TMC207|tmc207
5155172|NCT00992069|Efavirenz|efavirenz
5155173|NCT00992043|creatine supplementation|creatine supplementation
5155174|NCT00992043|exercise training|exercise training
5155175|NCT00992017|Vaccine|vaccine
5155176|NCT00992017|Pregnant|pregnant
5155177|NCT00992017|Perinatal|perinatal
5155178|NCT00992004|Osteoarthritis, Knee|osteoarthritis, knee
5155179|NCT00992004|Osteoarthritis|osteoarthritis
5155180|NCT00992004|Joint Diseases|joint diseases
5155181|NCT00992004|Arthritis|arthritis
5155182|NCT00992004|Rheumatic Diseases|rheumatic diseases
5155183|NCT00991991|stage I melanoma|stage i melanoma
5155184|NCT00991991|stage II melanoma|stage ii melanoma
5155185|NCT00991991|stage III melanoma|stage iii melanoma
5155186|NCT00991978|breast cancer|breast cancer
5155187|NCT00991978|VEGF|vegf
5155188|NCT00991978|Screening|screening
5155189|NCT00991965|Alveolar Ridge Augmentation|alveolar ridge augmentation
5155190|NCT00991965|Dental Implantation, Endosseous|dental implantation, endosseous
5155191|NCT00991965|Osseointegration|osseointegration
5155192|NCT00991965|Bone Morphogenetic Proteins|bone morphogenetic proteins
5155193|NCT00991939|Immune thrombocytopenic purpura|immune thrombocytopenic purpura
5155194|NCT00991939|ITP|itp
5155195|NCT00991939|Dexamethasone|dexamethasone
5155196|NCT00991939|Prednisone|prednisone
5155197|NCT00991926|obesity|obesity
5155198|NCT00991926|GH/IGF-1 axis|gh/igf-1 axis
5155199|NCT00991926|postprandial NEFA|postprandial nefa
5155200|NCT00991913|Delirium|delirium
5155201|NCT00991913|Postoperative|postoperative
5155202|NCT00991913|Non-cardiovascular surgery|non-cardiovascular surgery
5155203|NCT00991913|Post-anaesthesia care unit|post-anaesthesia care unit
5155204|NCT00991887|Heterotopic Ossification|heterotopic ossification
5155205|NCT00991887|Distal humerus Fracture-dislocations of the elbow|distal humerus fracture-dislocations of the elbow
5155206|NCT00991887|Radiation Therapy|radiation therapy
5155207|NCT00991874|Nitric oxide|nitric oxide
5155208|NCT00991874|Asthma|asthma
5155209|NCT00991874|Longitudinal studies|longitudinal studies
5155210|NCT00991874|Child|child
5155211|NCT00991861|Actinic Keratosis|actinic keratosis
5155212|NCT00991861|AK|ak
5155213|NCT00991861|NMSC|nmsc
5155214|NCT00991848|Lidocaine;|lidocaine;
5155215|NCT00991848|Fibromyalgia|fibromyalgia
5155216|NCT00991848|signs|signs
5155217|NCT00991848|symptoms|symptoms
5155218|NCT00991822|open angle glaucoma|open angle glaucoma
5155219|NCT00991822|timolol|timolol
5155220|NCT00991822|dorzolamide|dorzolamide
5155221|NCT00991809|opioid induced hyperalgesia|opioid induced hyperalgesia
5155222|NCT00991783|Fimasartan|fimasartan
5155223|NCT00991783|Drug interaction|drug interaction
5155224|NCT00991770|Discomfort|discomfort
5155225|NCT00991770|Port-a-Catheters|port-a-catheters
5155226|NCT00991770|Complementary and Alternative Medicine|complementary and alternative medicine
5155227|NCT00991770|Massage|massage
5155228|NCT00991757|RWJ-333369|rwj-333369
5155229|NCT00991757|Anticonvulsants|anticonvulsants
5155230|NCT00991757|Antiepileptic drugs|antiepileptic drugs
5155231|NCT00991757|Epilepsy, Focal|epilepsy, focal
5155232|NCT00991757|Seizure Disorder|seizure disorder
5155233|NCT00991744|Leukemia|leukemia
5155234|NCT00991744|Central nervous system|central nervous system
5155235|NCT00991744|Neurotoxicity|neurotoxicity
5155236|NCT00991744|Liposomal cytarabine|liposomal cytarabine
5155237|NCT00991744|Children|children
5155238|NCT00991744|Acute lymphoblastic leukemia|acute lymphoblastic leukemia
5155239|NCT00991744|Childhood acute lymphoblastic leukemia|childhood acute lymphoblastic leukemia
5155240|NCT00991744|Intrathecal|intrathecal
5155241|NCT00991744|Efficacy|efficacy
5155242|NCT00991744|Safety|safety
5155243|NCT00991731|Physical Activity|physical activity
5155244|NCT00991731|Faith based|faith based
5155245|NCT00991731|Non faith based|non faith based
5155246|NCT00991731|African American|african american
5155247|NCT00991731|Female|female
5155248|NCT00991731|Pedometers|pedometers
5155249|NCT00991718|GDC0449|gdc0449
5155250|NCT00991705|Fimasartan, Atorvastatin|fimasartan, atorvastatin
5155251|NCT00991692|Pediatric CI Therapy|pediatric ci therapy
5155252|NCT00991692|ACQUIREc Therapy|acquirec therapy
5155253|NCT00991692|Dosage|dosage
5155254|NCT00991692|Occupational Therapy|occupational therapy
5155255|NCT00991692|Physical Therapy|physical therapy
5155256|NCT00991692|Cerebral Palsy|cerebral palsy
5155257|NCT00991692|Hemiparesis|hemiparesis
5155258|NCT00991679|Dry eye syndrome|dry eye syndrome
5155259|NCT00991679|CXCL9 chemokine|cxcl9 chemokine
5155260|NCT00991679|CXCL10 chemokine|cxcl10 chemokine
5155261|NCT00991679|CXCL11 chemokine|cxcl11 chemokine
5155262|NCT00991679|CXCR3 receptor|cxcr3 receptor
5155263|NCT00991666|AMD|amd
5155264|NCT00991666|rigidity|rigidity
5155265|NCT00991666|pulsatile ocular blood flow|pulsatile ocular blood flow
5155266|NCT00991666|Physiology of the eye|physiology of the eye
5155267|NCT00991653|Weight|weight
5155268|NCT00991653|Breast|breast
5155269|NCT00991653|Cancer|cancer
5155270|NCT00991627|Ephedrine|ephedrine
5155271|NCT00991627|Adrenergic Agents|adrenergic agents
5155272|NCT00991627|Central Nervous System Stimulants|central nervous system stimulants
5155273|NCT00991627|Sympathomimetics|sympathomimetics
5155274|NCT00991627|Vasoconstrictor Agents|vasoconstrictor agents
5155275|NCT00991627|Bupivacaine|bupivacaine
5155276|NCT00991627|Anesthetics, Local|anesthetics, local
5155278|NCT00991627|Adjuvants, Anesthesia|adjuvants, anesthesia
5155279|NCT00991627|Anti-Arrhythmia Agents|anti-arrhythmia agents
5155280|NCT00991627|Bronchodilator Agents|bronchodilator agents
5155281|NCT00991627|Muscarinic Antagonists|muscarinic antagonists
5155282|NCT00991627|Mydriatics|mydriatics
5155283|NCT00991627|Parasympatholytics|parasympatholytics
5155284|NCT00991627|Morphine|morphine
5155285|NCT00991627|Analgesics, Opioid|analgesics, opioid
5155286|NCT00991627|Narcotics|narcotics
5155287|NCT00991627|Ringer's Lactate|ringer's lactate
5155288|NCT00991627|Isotonic Solutions|isotonic solutions
5155289|NCT00991627|Hypotension|hypotension
5155290|NCT00991627|Blood pressure|blood pressure
5155291|NCT00991627|Signs and Symptoms|signs and symptoms
5155292|NCT00991627|Pregnancy|pregnancy
5155293|NCT00991627|Anesthesia, Obstetrical|anesthesia, obstetrical
5155294|NCT00991627|Inferior Vena Cava|inferior vena cava
5155295|NCT00991601|liver|liver
5155296|NCT00991601|pancreas|pancreas
5155297|NCT00991601|cancer|cancer
5155298|NCT00991601|tumor|tumor
5155299|NCT00991601|FNAC|fnac
5155300|NCT00991588|PCL|pcl
5155301|NCT00991588|Posterolateral|posterolateral
5155302|NCT00991575|Diabetes mellitus, type1|diabetes mellitus, type1
5155303|NCT00991575|cardiovascular disease|cardiovascular disease
5155304|NCT00991575|diabetes complications|diabetes complications
5155305|NCT00991575|Glycation end products, advanced|glycation end products, advanced
5155306|NCT00991562|relapsed or relapsed/refractory multiple myeloma|relapsed or relapsed/refractory multiple myeloma
5155307|NCT00991549|overweight|overweight
5155308|NCT00991549|obesity|obesity
5155309|NCT00991549|glucose intolerance|glucose intolerance
5155310|NCT00991549|pre-diabetes|pre-diabetes
5155311|NCT00991523|resistance|resistance
5155312|NCT00991523|exercise|exercise
5155313|NCT00991523|protein|protein
5155314|NCT00991523|recovery|recovery
5155315|NCT00991510|renal transplantation|renal transplantation
5155316|NCT00991510|mycophenolate mofetil|mycophenolate mofetil
5155317|NCT00991510|pharmacokinetics|pharmacokinetics
5155318|NCT00991510|immunosuppression|immunosuppression
5155319|NCT00991497|varicose veins|varicose veins
5155320|NCT00991497|foam sclerotherapy|foam sclerotherapy
5155321|NCT00991497|compression bandaging|compression bandaging
5155322|NCT00991497|duration|duration
5155323|NCT00991484|ventral|ventral
5155324|NCT00991484|inguinal|inguinal
5155325|NCT00991484|hernia|hernia
5155326|NCT00991484|inheritance|inheritance
5155327|NCT00991484|genetics|genetics
5155328|NCT00991471|Emergency Department Wait Times|emergency department wait times
5155329|NCT00991471|Physician Nurse at Triage|physician nurse at triage
5155330|NCT00991471|Overcrowding|overcrowding
5155331|NCT00991471|CostEffectiveness|costeffectiveness
5155332|NCT00991445|Unicompartmental knee arthroplasty|unicompartmental knee arthroplasty
5155333|NCT00991445|Surgical exposure|surgical exposure
5155334|NCT00991445|Minimal invasive surgery|minimal invasive surgery
5155335|NCT00991445|Local Infiltration Analgesia|local infiltration analgesia
5155336|NCT00991445|Knee Arthroplasty|knee arthroplasty
5155337|NCT00991432|Alveolar Ridge Augmentation|alveolar ridge augmentation
5155338|NCT00991432|Dental Implantation, Endosseous|dental implantation, endosseous
5155339|NCT00991432|Osseointegration|osseointegration
5155340|NCT00991432|Space Maintenance|space maintenance
5155341|NCT00991432|Bone Morphogenetic Proteins|bone morphogenetic proteins
5155342|NCT00991419|PET|pet
5155343|NCT00991419|Alzheimer's disease|alzheimer's disease
5155344|NCT00991419|diagnostic|diagnostic
5155345|NCT00991406|Electric Stimulation|electric stimulation
5155346|NCT00991406|Hemiplegia|hemiplegia
5155347|NCT00991406|walking|walking
5155348|NCT00991393|Maxillary Sinus Augmentation|maxillary sinus augmentation
5155349|NCT00991393|Dental Implantation|dental implantation
5155350|NCT00991393|Osseointegration|osseointegration
5155351|NCT00991393|Bone Morphogenetic Proteins|bone morphogenetic proteins
5155352|NCT00991367|Post-surgical scars|post-surgical scars
5155353|NCT00991367|Asian Gotu Kola|asian gotu kola
5155354|NCT00991367|Asian Pennywort|asian pennywort
5155355|NCT00991354|HIV Seronegativity|hiv seronegativity
5155356|NCT00991354|HIV Preventive Vaccine|hiv preventive vaccine
5155357|NCT00991341|Cardiac surgery|cardiac surgery
5155358|NCT00991341|Red blood cell|red blood cell
5155359|NCT00991341|Transfusion|transfusion
5155360|NCT00991328|PD|pd
5155361|NCT00991328|POCD|pocd
5155362|NCT00991328|Post-op Delirium (PD)|post-op delirium (pd)
5155363|NCT00991328|Post-op Cognitive Dysfunction (POCD)|post-op cognitive dysfunction (pocd)
5155364|NCT00991315|prostate cancer|prostate cancer
5155365|NCT00991302|Adherence|adherence
5155366|NCT00991302|Behavioral Intervention|behavioral intervention
5155367|NCT00991302|Antiretroviral Therapy|antiretroviral therapy
5155368|NCT00991302|ART|art
5155369|NCT00991302|Highly Active Antiretroviral Therapy|highly active antiretroviral therapy
5155370|NCT00991302|HAART|haart
5155371|NCT00991302|Treatment experienced|treatment experienced
5155372|NCT00991289|Hepatitis C genotype 1|hepatitis c genotype 1
5155373|NCT00991289|HCV treatment naive|hcv treatment naive
5155374|NCT00991289|HCV/HIV coinfection|hcv/hiv coinfection
5155375|NCT00991289|Antiretroviral|antiretroviral
5155376|NCT00991289|Ribavirin|ribavirin
5155377|NCT00991289|Pegylated Interferon alfa|pegylated interferon alfa
5155378|NCT00991289|Nitazoxanide|nitazoxanide
5155379|NCT00991276|restless legs syndrome RLS polysomnography PSG sleep disturbance patient reported outcome|restless legs syndrome rls polysomnography psg sleep disturbance patient reported outcome
5155380|NCT00991263|stage II breast cancer|stage ii breast cancer
5155381|NCT00991263|stage IIIA breast cancer|stage iiia breast cancer
5155382|NCT00991250|Malignant melanoma|malignant melanoma
5155383|NCT00991237|NRS|nrs
5155384|NCT00991237|GPE|gpe
5155385|NCT00991237|pain reduction|pain reduction
5155386|NCT00991237|quality of life|quality of life
5155387|NCT00991224|HIV|hiv
5155388|NCT00991224|HIV therapeutic vaccine|hiv therapeutic vaccine
5155389|NCT00991211|Comparison|comparison
5155390|NCT00991211|Bendamustine + Rituximab|bendamustine + rituximab
5155391|NCT00991211|CHOP + Rituximab|chop + rituximab
5155392|NCT00991211|Progression free survival|progression free survival
5155393|NCT00991211|Overall survival|overall survival
5155394|NCT00991211|Toxicity|toxicity
5155395|NCT00991211|Safety|safety
5155396|NCT00991198|Topically dissolved oxygen|topically dissolved oxygen
5155397|NCT00991198|inflammatory cutaneous disease|inflammatory cutaneous disease
5155398|NCT00991198|rosacea|rosacea
5155399|NCT00991198|acne vulgaris|acne vulgaris
5155400|NCT00991198|atopic dermatitis|atopic dermatitis
5155401|NCT00991198|seborrheic dermatitis|seborrheic dermatitis
5155402|NCT00991198|photodamage|photodamage
5155403|NCT00991185|Infections in Children|infections in children
5155404|NCT00991172|sciatica|sciatica
5155405|NCT00991172|sciatic pain|sciatic pain
5155406|NCT00991172|pain|pain
5155407|NCT00991172|back pain|back pain
5155408|NCT00991159|Endocrinology; Hypercholesterolemia; Hyperlipidemia; Lipid Metabolism Disorders RN316 PF-04950615|endocrinology; hypercholesterolemia; hyperlipidemia; lipid metabolism disorders rn316 pf-04950615
5155409|NCT00991146|CAPS|caps
5155410|NCT00991146|FCAS|fcas
5155411|NCT00991146|MWS|mws
5155412|NCT00991146|NOMID|nomid
5155413|NCT00991146|cryopyrin-associated periodic syndromes|cryopyrin-associated periodic syndromes
5155414|NCT00991146|Familial Cold Autoinflammatory Syndrome|familial cold autoinflammatory syndrome
5155415|NCT00991146|Muckle-Wells Syndrome|muckle-wells syndrome
5155416|NCT00991146|Neonatal Onset Multisystem Inflammatory Disease|neonatal onset multisystem inflammatory disease
5155417|NCT00991146|canakinumab|canakinumab
5155418|NCT00991146|ACZ885|acz885
5155419|NCT00991146|children|children
5155420|NCT00991146|systemic autoinflammatory disease|systemic autoinflammatory disease
5155421|NCT00991146|NALP-3|nalp-3
5155422|NCT00991146|human monoclonal anti-human interleukin-1beta (IL-1beta)antibody|human monoclonal anti-human interleukin-1beta (il-1beta)antibody
5155423|NCT00991146|autosomal dominant|autosomal dominant
5155424|NCT00991146|familial autoinflammatory syndrome|familial autoinflammatory syndrome
5155425|NCT00991107|phase I|phase i
5155426|NCT00991107|safety|safety
5155427|NCT00991107|tolerance|tolerance
5155428|NCT00991107|insulin resistance|insulin resistance
5155429|NCT00991107|obese|obese
5155430|NCT00991094|Proton Therapy|proton therapy
5155431|NCT00991094|Proton Therapy Treatment Plan|proton therapy treatment plan
5155432|NCT00991094|Proton Dose Distributions|proton dose distributions
5155433|NCT00991094|Side Effects|side effects
5155434|NCT00991094|Symptoms|symptoms
5155435|NCT00991094|Normal Tissue Toxicity|normal tissue toxicity
5155436|NCT00991094|Dose Response Relationship|dose response relationship
5155437|NCT00991081|pharmacogenetics|pharmacogenetics
5155438|NCT00991081|genetic counseling|genetic counseling
5155439|NCT00991081|genetic feedback|genetic feedback
5155440|NCT00991081|nicotine replacement|nicotine replacement
5155441|NCT00991081|bupropion|bupropion
5155442|NCT00991081|smoking cessation|smoking cessation
5155443|NCT00991081|primary care|primary care
5155444|NCT00991081|telehealth|telehealth
5155445|NCT00991081|motivational interviewing|motivational interviewing
5155446|NCT00991068|Pain|pain
5155447|NCT00991068|Mild to moderate Carpal Tunnel Syndrome|mild to moderate carpal tunnel syndrome
5155448|NCT00991042|Cytokines|cytokines
5155449|NCT00991042|Low back pain|low back pain
5155450|NCT00991042|Intervertebral disk displacement|intervertebral disk displacement
5155451|NCT00991042|Interleukins|interleukins
5155452|NCT00991042|Tumor necrosis factor-alpha|tumor necrosis factor-alpha
5155453|NCT00991029|Transient Ischemic Attack|transient ischemic attack
5155454|NCT00991029|TIA|tia
5155455|NCT00991029|minor stroke|minor stroke
5155456|NCT00991003|Colon Capsule Endoscopy|colon capsule endoscopy
5155457|NCT00991003|Colorectal Cancer|colorectal cancer
5155458|NCT00991003|Colonoscopy|colonoscopy
5155459|NCT00990990|Safety tolerability pharmacokinetics (PK) pharmacodynamics whole blood activity (WBA) PNU-100480 linezolid pyrazinamide multiple dose|safety tolerability pharmacokinetics (pk) pharmacodynamics whole blood activity (wba) pnu-100480 linezolid pyrazinamide multiple dose
5155460|NCT00990977|breast cancer|breast cancer
5155461|NCT00990977|supportive care|supportive care
5155462|NCT00990977|post-treatment|post-treatment
5155463|NCT00990977|intervention|intervention
5155464|NCT00990977|MBSR|mbsr
5155465|NCT00990977|mindfulness|mindfulness
5155466|NCT00990977|anxiety|anxiety
5155467|NCT00990977|depression|depression
5155468|NCT00990977|lifestyle|lifestyle
5155469|NCT00990977|diet|diet
5155470|NCT00990977|alcohol consumption|alcohol consumption
5155471|NCT00990977|smoking|smoking
5155473|NCT00990977|spirituality|spirituality
5155474|NCT00990977|existential well-being|existential well-being
5155475|NCT00990977|physical symptoms|physical symptoms
5155476|NCT00990977|women|women
5155477|NCT00990925|Obesity|obesity
5155478|NCT00990925|Schizophrenia|schizophrenia
5155479|NCT00990925|Schizoaffective disorder|schizoaffective disorder
5155480|NCT00990925|weight loss|weight loss
5155481|NCT00990899|hypertension|hypertension
5155482|NCT00990899|obstructive sleep apnea|obstructive sleep apnea
5155483|NCT00990899|pediatrics|pediatrics
5155484|NCT00990886|Oxybutynin|oxybutynin
5155485|NCT00990886|Ditropan|ditropan
5155486|NCT00990886|Menopause Treatment|menopause treatment
5155487|NCT00990886|Vasomotor symptoms|vasomotor symptoms
5155488|NCT00990886|Hot Flashes|hot flashes
5155489|NCT00990886|Non-hormonal therapy for Vasomotor symptoms|non-hormonal therapy for vasomotor symptoms
5155490|NCT00990873|stage I non-small cell lung cancer|stage i non-small cell lung cancer
5155491|NCT00990860|Combination of TACE With Sorafenib|combination of tace with sorafenib
5155492|NCT00990834|Statin|statin
5155493|NCT00990834|Myopathy|myopathy
5155494|NCT00990834|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors
5155495|NCT00990834|Atrogin-1|atrogin-1
5155496|NCT00990795|open heart surgery|open heart surgery
5155497|NCT00990795|cyclosporine|cyclosporine
5155498|NCT00990795|myocardial protection|myocardial protection
5155499|NCT00990769|Emergence delirium|emergence delirium
5155500|NCT00990769|Bispectral Index|bispectral index
5155501|NCT00990769|Depth of anesthesia|depth of anesthesia
5155502|NCT00990743|Ocular hypertension|ocular hypertension
5155503|NCT00990743|Glaucoma|glaucoma
5155504|NCT00990743|Beta-blocker|beta-blocker
5155505|NCT00990730|rheumatoid arthritis|rheumatoid arthritis
5155506|NCT00990730|endothelial dysfunction|endothelial dysfunction
5155507|NCT00990730|lipoproteins|lipoproteins
5155508|NCT00990730|inflammation|inflammation
5155509|NCT00990730|oxidative stress|oxidative stress
5155510|NCT00990730|arterial stiffness|arterial stiffness
5155511|NCT00990717|natural killer cells|natural killer cells
5155512|NCT00990717|leukemia|leukemia
5155513|NCT00990717|lymphoma|lymphoma
5155514|NCT00990717|myeloma|myeloma
5155515|NCT00990717|Hodgkin's disease|hodgkin's disease
5155516|NCT00990717|cell therapy|cell therapy
5155517|NCT00990704|Secondary hyperparathyroidism|secondary hyperparathyroidism
5155518|NCT00990704|Hemodialysis|hemodialysis
5155519|NCT00990704|paricalcitol|paricalcitol
5155520|NCT00990704|maxacalcitol|maxacalcitol
5155521|NCT00990691|Rett syndrome|rett syndrome
5155522|NCT00990678|HIV-1|hiv-1
5155523|NCT00990678|humans|humans
5155524|NCT00990678|vitamin D|vitamin d
5155525|NCT00990678|1-hydroxy-vitamin D|1-hydroxy-vitamin d
5155526|NCT00990678|Rocaltrol|rocaltrol
5155527|NCT00990678|calcium|calcium
5155528|NCT00990678|complementary therapies|complementary therapies
5155529|NCT00990665|CRT|crt
5155530|NCT00990665|Heart Failure|heart failure
5155531|NCT00990665|LV Leads|lv leads
5155532|NCT00990652|brain tumor|brain tumor
5155533|NCT00990639|hepatic fibrosis|hepatic fibrosis
5155534|NCT00990639|angiotensin II blocking agents|angiotensin ii blocking agents
5155535|NCT00990639|alcoholic liver disease|alcoholic liver disease
5155536|NCT00990626|Seroquel XR|seroquel xr
5155537|NCT00990626|schizophrenia relapse prevention|schizophrenia relapse prevention
5155538|NCT00990613|percutaneous transcutaneous dimebon transdermal pharmacokinetics|percutaneous transcutaneous dimebon transdermal pharmacokinetics
5155539|NCT00990600|adherence|adherence
5155540|NCT00990600|Qol|qol
5155541|NCT00990600|virologic efficacy|virologic efficacy
5155542|NCT00990600|immunologic efficacy|immunologic efficacy
5155543|NCT00990600|patients' preference|patients' preference
5155544|NCT00990600|once-daily|once-daily
5155545|NCT00990600|HAART|haart
5155546|NCT00990600|treatment experienced|treatment experienced
5155547|NCT00990587|relapsed and refractory hematologic malignancy|relapsed and refractory hematologic malignancy
5155548|NCT00990587|ALL (acute lymphoid leukemia)|all (acute lymphoid leukemia)
5155549|NCT00990587|CLL (chronic lymphoid leukemia)|cll (chronic lymphoid leukemia)
5155550|NCT00990587|High risk myelodysplasia (MDS) with an IPSS (International Prognostic Scoring System) score >2.5|high risk myelodysplasia (mds) with an ipss (international prognostic scoring system) score >2.5
5155551|NCT00990587|CML (chronic myelogenous leukemia) blast crisis|cml (chronic myelogenous leukemia) blast crisis
5155552|NCT00990587|Relapsed or refractory acute myeloid leukemia (AML)|relapsed or refractory acute myeloid leukemia (aml)
5155553|NCT00990548|Cardiac Caregivers|cardiac caregivers
5155554|NCT00990548|Cardiac Patient Clinical Outcomes|cardiac patient clinical outcomes
5155555|NCT00990548|Prevention of CVD|prevention of cvd
5155556|NCT00990535|neuroendocrine tumors|neuroendocrine tumors
5155557|NCT00990535|octreotide|octreotide
5155558|NCT00990535|somatostatin analogues|somatostatin analogues
5155559|NCT00990522|sharp debridment|sharp debridment
5155560|NCT00990522|patients with full thickness wounds of greater than 30 days duration|patients with full thickness wounds of greater than 30 days duration
5155561|NCT00990509|Primary ICH|primary ich
5155562|NCT00990509|Albumin|albumin
5155563|NCT00990509|MRI|mri
5155564|NCT00990509|Neuroimaging outcome|neuroimaging outcome
5155565|NCT00990509|Placebo-controlled|placebo-controlled
5155566|NCT00990509|Phase II|phase ii
5155567|NCT00990509|Blinded|blinded
5155568|NCT00990509|Safety|safety
5155569|NCT00990509|Acute ICH|acute ich
5155570|NCT00990509|ICH|ich
5155571|NCT00990509|Primary acute (< 48 hours) supratentorial ICH|primary acute (< 48 hours) supratentorial ich
5155572|NCT00990496|Glioblastoma multiforme|glioblastoma multiforme
5155573|NCT00990496|GBM|gbm
5155574|NCT00990496|Cytomegalovirus|cytomegalovirus
5155575|NCT00990496|CMV|cmv
5155576|NCT00990496|Cytotoxic T lymphocyte|cytotoxic t lymphocyte
5155577|NCT00990496|CTL|ctl
5155578|NCT00990470|Transplantation|transplantation
5155579|NCT00990470|Liver|liver
5155580|NCT00990470|Endoscopy|endoscopy
5155581|NCT00990470|Colonoscopy|colonoscopy
5155582|NCT00990470|Gastroscopy|gastroscopy
5155583|NCT00990457|Exercise|exercise
5155584|NCT00990457|Weight loss diet|weight loss diet
5155585|NCT00990457|Obesity|obesity
5155586|NCT00990457|Overweight|overweight
5155587|NCT00990457|Abdominal obesity|abdominal obesity
5155588|NCT00990457|Cardiovascular function|cardiovascular function
5155589|NCT00990457|Body composition|body composition
5155590|NCT00990444|blood glucose|blood glucose
5155591|NCT00990444|blood insulin|blood insulin
5155592|NCT00990444|dextran|dextran
5155593|NCT00990444|diabetes|diabetes
5155594|NCT00990444|hyperglycemia|hyperglycemia
5155595|NCT00990444|hypoglycemia|hypoglycemia
5155596|NCT00990444|oral delivery|oral delivery
5155597|NCT00990444|portal delivery|portal delivery
5155598|NCT00990431|skin aging|skin aging
5155599|NCT00990431|laser surgery|laser surgery
5155600|NCT00990431|fractional photothermolysis|fractional photothermolysis
5155601|NCT00990431|comparative study|comparative study
5155602|NCT00990431|Ablative fractional treatment of peri-orbital rhytides|ablative fractional treatment of peri-orbital rhytides
5155603|NCT00990418|Postoperative pain|postoperative pain
5155604|NCT00990418|E-TRANS System, fentanyl HCl System|e-trans system, fentanyl hcl system
5155605|NCT00990418|E-TRANSS (fentanyl HCl) System|e-transs (fentanyl hcl) system
5155606|NCT00990418|Acute postoperative pain|acute postoperative pain
5155607|NCT00990405|Rome III criteria|rome iii criteria
5155608|NCT00990392|Blood stream infections|blood stream infections
5155609|NCT00990392|Catheter related infections|catheter related infections
5155610|NCT00990392|Central venous catheter related infections|central venous catheter related infections
5155611|NCT00990392|Line sepsis|line sepsis
5155612|NCT00990392|Topical antibiotics|topical antibiotics
5155613|NCT00990392|Bacitracin|bacitracin
5155614|NCT00990392|Polymixin|polymixin
5155615|NCT00990392|Gramicidin|gramicidin
5155616|NCT00990392|Polysporin Triple Therapy|polysporin triple therapy
5155617|NCT00990392|Intensive care unit|intensive care unit
5155618|NCT00990379|HIV|hiv
5155619|NCT00990379|brain diseases|brain diseases
5155620|NCT00990379|spinal fluid|spinal fluid
5155621|NCT00990379|HIV positive|hiv positive
5155622|NCT00990366|antireflux valve|antireflux valve
5155623|NCT00990366|biliary obstruction|biliary obstruction
5155624|NCT00990366|cholangitis|cholangitis
5155625|NCT00990366|biliary stent|biliary stent
5155626|NCT00990353|Spatial neglect|spatial neglect
5155627|NCT00990353|hemineglect|hemineglect
5155628|NCT00990353|stroke|stroke
5155629|NCT00990353|cognition|cognition
5155630|NCT00990353|prism adaptation|prism adaptation
5155631|NCT00990353|Hierarchical linear modeling|hierarchical linear modeling
5155632|NCT00990353|growth curve modeling|growth curve modeling
5155633|NCT00990327|Coronary artery disease|coronary artery disease
5155634|NCT00990327|Myocardial Perfusion Imaging|myocardial perfusion imaging
5155635|NCT00990301|Healthy Subjects|healthy subjects
5155636|NCT00990301|Bioequivalence|bioequivalence
5155637|NCT00990288|To decrease blood loss during knee surgery|to decrease blood loss during knee surgery
5155638|NCT00990262|acute chest pain|acute chest pain
5155639|NCT00990262|emergency department|emergency department
5155640|NCT00990262|cardiac computed tomography|cardiac computed tomography
5155641|NCT00990249|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
5155642|NCT00990249|ALL|all
5155643|NCT00990249|Acute lymphoblastic lymphoma|acute lymphoblastic lymphoma
5155644|NCT00990249|acute biphenotypic leukemia|acute biphenotypic leukemia
5155645|NCT00990249|Allogeneic hematopoietic cell transplantation|allogeneic hematopoietic cell transplantation
5155646|NCT00990249|HCT|hct
5155647|NCT00990249|Stem Cell Transplant|stem cell transplant
5155648|NCT00990249|Treatment-related mortality|treatment-related mortality
5155649|NCT00990249|Tyrosine kinase inhibitors|tyrosine kinase inhibitors
5155650|NCT00990249|TKI|tki
5155651|NCT00990249|Busulfan|busulfan
5155652|NCT00990249|Busulfex|busulfex
5155653|NCT00990249|Myleran|myleran
5155654|NCT00990249|Clofarabine|clofarabine
5155655|NCT00990249|Clolar|clolar
5155656|NCT00990249|Clofarex|clofarex
5155657|NCT00990249|Gleevec|gleevec
5155658|NCT00990249|Imatinib Mesylate|imatinib mesylate
5155659|NCT00990236|deep vein thrombosis|deep vein thrombosis
5155660|NCT00990236|superficial venous thrombosis|superficial venous thrombosis
5155661|NCT00990236|pulmonary embolus|pulmonary embolus
5155662|NCT00990223|Eplerenone Aldosterone and Plasma Renin Activity responses Pharmacodynamics|eplerenone aldosterone and plasma renin activity responses pharmacodynamics
5155663|NCT00990197|Pilot study|pilot study
5155664|NCT00990197|Randomized clinical trial|randomized clinical trial
5155665|NCT00990197|Smoking cessation|smoking cessation
5155666|NCT00990197|Acute coronary syndrome|acute coronary syndrome
5155667|NCT00990197|Transdermal nicotine patch|transdermal nicotine patch
5155668|NCT00990184|Impaired Fasting Glucose|impaired fasting glucose
5155669|NCT00990184|PreDiabetes|prediabetes
5155670|NCT00990171|peritoneal Dialysis|peritoneal dialysis
5155671|NCT00990171|wasting and malnutrition|wasting and malnutrition
5155672|NCT00990171|nutrition status|nutrition status
5155673|NCT00990171|bioelectrical impedance analysis|bioelectrical impedance analysis
5155674|NCT00990171|body composition|body composition
5155675|NCT00990158|Vitamin K1 (phytonadione)|vitamin k1 (phytonadione)
5155676|NCT00990158|Randomized controlled trial|randomized controlled trial
5155677|NCT00990158|Warfarin|warfarin
5155678|NCT00990158|Coagulopathy|coagulopathy
5155679|NCT00990158|Time in therapeutic range|time in therapeutic range
5155680|NCT00990158|Bleeding|bleeding
5155681|NCT00990158|Thrombosis|thrombosis
5155682|NCT00990158|VKORC1 and CYP2C9 genotypes|vkorc1 and cyp2c9 genotypes
5155683|NCT00990158|Time INR in therapeutic range|time inr in therapeutic range
5155684|NCT00990132|COPD|copd
5155685|NCT00990132|Respiratory failure|respiratory failure
5155686|NCT00990132|Non-invasive ventilation|non-invasive ventilation
5155687|NCT00990132|Home mechanical ventilation|home mechanical ventilation
5155688|NCT00990119|high flow therapy|high flow therapy
5155689|NCT00990119|high flow nasal cannula|high flow nasal cannula
5155690|NCT00990119|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
5155691|NCT00990119|respiratory insufficiency|respiratory insufficiency
5155692|NCT00990106|posttraumatic stress disorder|posttraumatic stress disorder
5155693|NCT00990106|PTSD|ptsd
5155694|NCT00990106|nightmares|nightmares
5155695|NCT00990106|prazosin|prazosin
5155696|NCT00990106|sleep disturbance|sleep disturbance
5155697|NCT00990106|combat trauma|combat trauma
5155698|NCT00990067|MDMA|mdma
5155699|NCT00990067|serotonin|serotonin
5155700|NCT00990067|norepinephrine|norepinephrine
5155701|NCT00990067|Ecstasy|ecstasy
5155702|NCT00990067|stimulant|stimulant
5155703|NCT00990054|Cytarabine,|cytarabine,
5155704|NCT00990054|Daunorubicin,|daunorubicin,
5155705|NCT00990054|De Novo,|de novo,
5155706|NCT00990054|Acute Myeloid Leukemia,|acute myeloid leukemia,
5155707|NCT00990054|AML|aml
5155708|NCT00990041|periodontitis|periodontitis
5155709|NCT00990041|find cytokines in blood of periodontal patients|find cytokines in blood of periodontal patients
5155710|NCT00990028|moderate head injury|moderate head injury
5155711|NCT00990028|rosuvastatin|rosuvastatin
5155712|NCT00990028|statin|statin
5155713|NCT00990028|amnesia|amnesia
5155714|NCT00990028|orientation|orientation
5155715|NCT00990015|Safety; tolerability; pharmacokinetics/pharmacodynamics|safety; tolerability; pharmacokinetics/pharmacodynamics
5155716|NCT00989989|DME|dme
5155717|NCT00989989|Diabetic|diabetic
5155718|NCT00989989|macula|macula
5155719|NCT00989989|edema|edema
5155720|NCT00989989|ranibizumab|ranibizumab
5155721|NCT00989989|REVEAL|reveal
5155722|NCT00989976|Sleep|sleep
5155723|NCT00989976|Diabetes Risk|diabetes risk
5155724|NCT00989963|PAH|pah
5155725|NCT00989950|daytrana|daytrana
5155726|NCT00989950|sleep latency|sleep latency
5155727|NCT00989950|adhd rating scales|adhd rating scales
5155728|NCT00989950|ADHD|adhd
5155729|NCT00989937|oxytocin|oxytocin
5155730|NCT00989924|Diabetes mellitus|diabetes mellitus
5155731|NCT00989924|Coronary heart disease|coronary heart disease
5155732|NCT00989924|Magnetocardiography|magnetocardiography
5155733|NCT00989911|Single ventricle congenital heart disease|single ventricle congenital heart disease
5155734|NCT00989898|T1D, closed-loop systems, overnight hypoglycaemia|t1d, closed-loop systems, overnight hypoglycaemia
5155735|NCT00989885|Evaluation|evaluation
5155736|NCT00989885|Obstructive sleep apnea|obstructive sleep apnea
5155737|NCT00989885|Polysomnography|polysomnography
5155738|NCT00989872|Macrolides|macrolides
5155739|NCT00989872|Antibiotics|antibiotics
5155740|NCT00989872|Safety|safety
5155741|NCT00989872|Tolerability|tolerability
5155742|NCT00989872|Pharmacokinetics|pharmacokinetics
5155743|NCT00989872|Phase I|phase i
5155744|NCT00989872|MRSA/SSTI|mrsa/ssti
5155745|NCT00989859|monitoring|monitoring
5155746|NCT00989846|biomarker|biomarker
5155747|NCT00989846|lung disease|lung disease
5155748|NCT00989833|Exercise induced asthma|exercise induced asthma
5155749|NCT00989833|Mild intermittent asthma|mild intermittent asthma
5155750|NCT00989833|Exercise induced bronchoconstriction|exercise induced bronchoconstriction
5155751|NCT00989820|osteoradionecrosis|osteoradionecrosis
5155752|NCT00989820|mandible|mandible
5155753|NCT00989820|radiotherapy|radiotherapy
5155754|NCT00989820|hyperbaric oxygen therapy|hyperbaric oxygen therapy
5155755|NCT00989807|CF|cf
5155756|NCT00989807|Cystic fibrosis|cystic fibrosis
5155757|NCT00989807|Pseudomonas aeruginosa|pseudomonas aeruginosa
5155758|NCT00989807|EAP|eap
5155759|NCT00989807|Expanded access|expanded access
5155760|NCT00989807|AZLI|azli
5155761|NCT00989807|Aztreonam lysine|aztreonam lysine
5155762|NCT00989794|cartilage|cartilage
5155763|NCT00989794|implantation|implantation
5155764|NCT00989794|chondrocyte|chondrocyte
5155765|NCT00989794|condyle|condyle
5155766|NCT00989781|PCOS, Androgens, ovary, polycystic|pcos, androgens, ovary, polycystic
5155767|NCT00989768|Botulinum toxin type A|botulinum toxin type a
5155768|NCT00989768|field effects|field effects
5155769|NCT00989768|dose-equivalence|dose-equivalence
5155770|NCT00989768|anhydrotic action halos|anhydrotic action halos
5155771|NCT00989755|Tobacco dependence treatment in primary health care setting|tobacco dependence treatment in primary health care setting
5155772|NCT00989755|Fax to Quit|fax to quit
5155773|NCT00989755|Fax to Quit plus Enhanced Academic Detailing|fax to quit plus enhanced academic detailing
5155774|NCT00989755|Fax referral|fax referral
5155775|NCT00989755|Quitline|quitline
5155776|NCT00989742|lymphangioleiomatosis|lymphangioleiomatosis
5155777|NCT00989742|LAM|lam
5155778|NCT00989742|tuberous sclerosis|tuberous sclerosis
5155779|NCT00989742|doxycycline|doxycycline
5155780|NCT00989742|matrix metalloproteinases|matrix metalloproteinases
5155781|NCT00989742|MMP|mmp
5155782|NCT00989729|Endovascular Aortic Repair|endovascular aortic repair
5155783|NCT00989729|Methylprednisolone|methylprednisolone
5155784|NCT00989729|Systemic inflammatory response syndrome|systemic inflammatory response syndrome
5155785|NCT00989703|Safety|safety
5155786|NCT00989703|Tolerability|tolerability
5155787|NCT00989703|Pharmacokinetics|pharmacokinetics
5155788|NCT00989690|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5155789|NCT00989690|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5155790|NCT00989690|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5155791|NCT00989664|non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
5155792|NCT00989664|radioimmunotherapy|radioimmunotherapy
5155793|NCT00989664|NHL|nhl
5155794|NCT00989664|Bexxar|bexxar
5155795|NCT00989664|lymphoma|lymphoma
5155796|NCT00989664|Tositumomab|tositumomab
5155797|NCT00989625|migraine|migraine
5155798|NCT00989625|single dose|single dose
5155799|NCT00989625|healthy volunteer|healthy volunteer
5155800|NCT00989625|adolescence|adolescence
5155801|NCT00989625|pharmacokinetics|pharmacokinetics
5155802|NCT00989612|influenza infection|influenza infection
5155803|NCT00989612|GSK Biologicals' influenza vaccine GSK2340272A|gsk biologicals' influenza vaccine gsk2340272a
5155804|NCT00989599|phlebitis|phlebitis
5155805|NCT00989599|Chamomilla recutita|chamomilla recutita
5155806|NCT00989599|Catheterization peripheral|catheterization peripheral
5155807|NCT00989586|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5155808|NCT00989586|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5155809|NCT00989586|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5155810|NCT00989586|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5155811|NCT00989586|MALT lymphoma|malt lymphoma
5155812|NCT00989586|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5155813|NCT00989586|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5155814|NCT00989586|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5155815|NCT00989586|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
5155816|NCT00989534|shift work|shift work
5155817|NCT00989534|diabetes|diabetes
5155818|NCT00989534|Affects of shift work and sleep loss on health|affects of shift work and sleep loss on health
5155819|NCT00989521|Asthma|asthma
5155820|NCT00989521|bronchial diseases|bronchial diseases
5155821|NCT00989521|lung diseases|lung diseases
5155822|NCT00989521|bronchitis|bronchitis
5155823|NCT00989521|respiratory tract diseases|respiratory tract diseases
5155824|NCT00989508|Perhexiline|perhexiline
5155825|NCT00989508|Aortic Valve Stenosis|aortic valve stenosis
5155826|NCT00989508|Hypertrophy, Left Ventricular|hypertrophy, left ventricular
5155827|NCT00989508|Myocardial Reperfusion Injury|myocardial reperfusion injury
5155828|NCT00989508|Cardiac Output, Low|cardiac output, low
5155829|NCT00989508|Troponin|troponin
5155830|NCT00989495|AIS|ais
5155831|NCT00989456|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
5155832|NCT00989456|Heart failure|heart failure
5155833|NCT00989456|Stroke|stroke
5155834|NCT00989456|quality of life|quality of life
5155835|NCT00989456|self management education|self management education
5155836|NCT00989456|physical exercise|physical exercise
5155837|NCT00989456|primary health care|primary health care
5155838|NCT00989443|Cervix Intraepithelial Neoplasia grades 2 and 3|cervix intraepithelial neoplasia grades 2 and 3
5155839|NCT00989430|stroke|stroke
5155840|NCT00989430|CVA|cva
5155841|NCT00989430|cerebrovascular accident|cerebrovascular accident
5155842|NCT00989430|rehabilitation|rehabilitation
5155843|NCT00989417|Remote monitoring|remote monitoring
5155844|NCT00989417|Defibrillators, Implantable|defibrillators, implantable
5155845|NCT00989417|Home monitoring|home monitoring
5155846|NCT00989417|Shock|shock
5155847|NCT00989417|Implantable cardioverter-defibrillator Therapy|implantable cardioverter-defibrillator therapy
5155848|NCT00989404|pk|pk
5155849|NCT00989404|healthy subjects|healthy subjects
5155850|NCT00989404|influenza virus|influenza virus
5155851|NCT00989404|Safety|safety
5155852|NCT00989404|pandemic|pandemic
5155853|NCT00989391|Phase 1 multiple dose safety toleration pharmacokinetic|phase 1 multiple dose safety toleration pharmacokinetic
5155854|NCT00989378|sleep|sleep
5155855|NCT00989378|insulin|insulin
5155856|NCT00989378|diabetes|diabetes
5155960|NCT00989014|Rosacea|rosacea
5155961|NCT00989001|Atrial Fibrillation|atrial fibrillation
5155857|NCT00989378|determine association between sleep characteristics and diabetes risk|determine association between sleep characteristics and diabetes risk
5155858|NCT00989365|Aerobic Exercise|aerobic exercise
5155859|NCT00989365|Exercise|exercise
5155860|NCT00989352|PCNSL|pcnsl
5155861|NCT00989352|Lymphoma|lymphoma
5155862|NCT00989352|Methotrexate|methotrexate
5155863|NCT00989352|Lomustine|lomustine
5155864|NCT00989352|Procarbazine|procarbazine
5155865|NCT00989352|Rituximab|rituximab
5155866|NCT00989352|Elderly|elderly
5155867|NCT00989352|Chemotherapy|chemotherapy
5155868|NCT00989339|lipid emulsion|lipid emulsion
5155869|NCT00989339|endothelial function|endothelial function
5155870|NCT00989339|inflammatory markers|inflammatory markers
5155871|NCT00989339|oxidative stress|oxidative stress
5155872|NCT00989339|insulin sensitivity|insulin sensitivity
5155873|NCT00989339|carbohydrate metabolism|carbohydrate metabolism
5155874|NCT00989326|Remote monitoring|remote monitoring
5155875|NCT00989326|Pacemaker|pacemaker
5155876|NCT00989326|Follow up|follow up
5155877|NCT00989326|Follow-up studies|follow-up studies
5155878|NCT00989313|Peplin|peplin
5155879|NCT00989313|Actinic keratosis|actinic keratosis
5155880|NCT00989313|PEP005|pep005
5155881|NCT00989300|Drug-Drug interaction|drug-drug interaction
5155882|NCT00989300|Clopidogrel|clopidogrel
5155883|NCT00989300|Rabeprazol|rabeprazol
5155884|NCT00989300|Omeprazol|omeprazol
5155885|NCT00989300|Pharmacodynamic Study|pharmacodynamic study
5155886|NCT00989287|GSK Bio's influenza vaccine GSK2340272A|gsk bio's influenza vaccine gsk2340272a
5155887|NCT00989287|influenza infection|influenza infection
5155888|NCT00989274|Influenza|influenza
5155889|NCT00989274|Vaccination|vaccination
5155890|NCT00989274|Immunology|immunology
5155891|NCT00989274|Immunogenicity|immunogenicity
5155892|NCT00989274|Reactogenicity|reactogenicity
5155893|NCT00989274|Safety|safety
5155894|NCT00989274|Influenza vaccine|influenza vaccine
5155895|NCT00989274|Immune response|immune response
5155896|NCT00989274|Adverse effects|adverse effects
5155897|NCT00989261|AML|aml
5155898|NCT00989261|AC220|ac220
5155899|NCT00989261|acute|acute
5155900|NCT00989261|FLT3|flt3
5155901|NCT00989261|inhibitor|inhibitor
5155902|NCT00989261|kinase|kinase
5155903|NCT00989261|leukemia|leukemia
5155904|NCT00989261|leukaemia|leukaemia
5155905|NCT00989261|myeloid|myeloid
5155906|NCT00989261|relapsed|relapsed
5155907|NCT00989261|refractory|refractory
5155908|NCT00989248|Ergospirometry|ergospirometry
5155909|NCT00989248|Cardiopulmonary Exercise Test|cardiopulmonary exercise test
5155910|NCT00989248|Exercises|exercises
5155911|NCT00989248|Immersion|immersion
5155912|NCT00989235|NOS|nos
5155913|NCT00989222|Distal radius fractures|distal radius fractures
5155914|NCT00989222|Fractures of the distal radius|fractures of the distal radius
5155915|NCT00989222|Volar plate|volar plate
5155916|NCT00989222|External fixation|external fixation
5155917|NCT00989209|facial paralysis|facial paralysis
5155918|NCT00989209|asymmetry|asymmetry
5155919|NCT00989209|myofunctional therapy|myofunctional therapy
5155920|NCT00989209|botulinum toxin|botulinum toxin
5155921|NCT00989209|facial evaluation|facial evaluation
5155922|NCT00989183|Ovaries|ovaries
5155923|NCT00989183|Reproductive Age|reproductive age
5155924|NCT00989183|Oophorectomy|oophorectomy
5155925|NCT00989157|Gastric Bypass|gastric bypass
5155926|NCT00989157|Duloxetine|duloxetine
5155927|NCT00989157|Cymbalta|cymbalta
5155928|NCT00989157|Pharmacokinetics|pharmacokinetics
5155929|NCT00989144|HIV seronegative|hiv seronegative
5155930|NCT00989144|acute infection|acute infection
5155931|NCT00989131|Ovarian Cancer|ovarian cancer
5155932|NCT00989105|stage I prostate cancer|stage i prostate cancer
5155933|NCT00989105|stage IIB prostate cancer|stage iib prostate cancer
5155934|NCT00989105|stage IIA prostate cancer|stage iia prostate cancer
5155935|NCT00989105|stage III prostate cancer|stage iii prostate cancer
5155936|NCT00989105|stage IV prostate cancer|stage iv prostate cancer
5155937|NCT00989105|recurrent prostate cancer|recurrent prostate cancer
5155938|NCT00989092|anemia of cancer|anemia of cancer
5155939|NCT00989092|darbepoetin alfa|darbepoetin alfa
5155940|NCT00989092|Aranesp|aranesp
5155941|NCT00989079|Single Ascending Dose Study in healthy subjects|single ascending dose study in healthy subjects
5155942|NCT00989066|Xience V|xience v
5155943|NCT00989066|stent|stent
5155944|NCT00989066|coronary disease|coronary disease
5155945|NCT00989053|depression|depression
5155946|NCT00989053|anxiety|anxiety
5155947|NCT00989053|stress|stress
5155948|NCT00989053|antidepressant therapy|antidepressant therapy
5155949|NCT00989053|SSRI|ssri
5155950|NCT00989053|infertility|infertility
5155951|NCT00989053|in vitro fertilization (IVF)|in vitro fertilization (ivf)
5155952|NCT00989053|immunological factors|immunological factors
5155953|NCT00989053|depressive and anxiety symptoms in women undergoing IVF treatment|depressive and anxiety symptoms in women undergoing ivf treatment
5155954|NCT00989040|NPZ|npz
5155955|NCT00989040|Pain|pain
5155956|NCT00989027|Uterine contraction|uterine contraction
5155957|NCT00989027|Dose-response|dose-response
5155958|NCT00989027|Oxytocin pre-treatment|oxytocin pre-treatment
5155959|NCT00989014|Erythematotelangiectatic|erythematotelangiectatic
5155962|NCT00989001|RSD1235|rsd1235
5155963|NCT00989001|Vernakalant|vernakalant
5155964|NCT00989001|conversion|conversion
5155965|NCT00988988|Multiple Sclerosis|multiple sclerosis
5155966|NCT00988988|AGEE|agee
5155967|NCT00988988|histamine response|histamine response
5155968|NCT00988962|pain|pain
5155969|NCT00988962|opioids|opioids
5155970|NCT00988949|Proof of mechanism study|proof of mechanism study
5155971|NCT00988936|[F-18]RGD-K5|[f-18]rgd-k5
5155972|NCT00988936|RGD-K5|rgd-k5
5155973|NCT00988936|K5-101|k5-101
5155974|NCT00988936|Avastin|avastin
5155975|NCT00988936|angiogenesis|angiogenesis
5155976|NCT00988936|anti-angiogenesis|anti-angiogenesis
5155977|NCT00988936|chemotherapy|chemotherapy
5155978|NCT00988936|breast cancer|breast cancer
5155979|NCT00988936|colon cancer|colon cancer
5155980|NCT00988936|rectal cancer|rectal cancer
5155981|NCT00988936|lung cancer|lung cancer
5155982|NCT00988936|non-squamous|non-squamous
5155983|NCT00988936|non small cell|non small cell
5155984|NCT00988910|Combined Oral Contraceptives|combined oral contraceptives
5155985|NCT00988910|COC|coc
5155986|NCT00988871|PICC (peripherally inserted central venous catheter)|picc (peripherally inserted central venous catheter)
5155987|NCT00988871|CICC (centrally inserted central venous catheter|cicc (centrally inserted central venous catheter
5155988|NCT00988871|CVP (central venous pressure)|cvp (central venous pressure)
5155989|NCT00988871|LT (liver transplantation)|lt (liver transplantation)
5155990|NCT00988871|agreement|agreement
5155991|NCT00988845|dietary supplement|dietary supplement
5155992|NCT00988845|indole 3 carbinol|indole 3 carbinol
5155993|NCT00988845|estrogen|estrogen
5155994|NCT00988806|Advanced heart failure|advanced heart failure
5155995|NCT00988806|Levosimendan|levosimendan
5155996|NCT00988806|Intermittent long-term infusions|intermittent long-term infusions
5155997|NCT00988780|Immune reconstitution inflammatory syndrome|immune reconstitution inflammatory syndrome
5155998|NCT00988780|CCR5 antagonist|ccr5 antagonist
5155999|NCT00988780|Maraviroc|maraviroc
5156000|NCT00988780|HIV|hiv
5156001|NCT00988780|treatment naive|treatment naive
5156002|NCT00988767|Hepatitis B|hepatitis b
5156003|NCT00988767|DNA vaccine|dna vaccine
5156004|NCT00988767|immunotherapy|immunotherapy
5156005|NCT00988754|Obesity|obesity
5156006|NCT00988754|childhood and adolescence|childhood and adolescence
5156007|NCT00988754|school and family-based lifestyle intervention|school and family-based lifestyle intervention
5156008|NCT00988754|cardiovascular risk|cardiovascular risk
5156009|NCT00988754|Obesity and associated cardiovascular risk in childhood and adolescence,|obesity and associated cardiovascular risk in childhood and adolescence,
5156010|NCT00988754|health behaviour|health behaviour
5156011|NCT00988741|Unresectable|unresectable
5156012|NCT00988741|Hepatocellular|hepatocellular
5156013|NCT00988741|Carcinoma|carcinoma
5156014|NCT00988702|Dan Tian Breathing|dan tian breathing
5156015|NCT00988702|Physiological measurement|physiological measurement
5156016|NCT00988702|progressive muscle relaxation|progressive muscle relaxation
5156017|NCT00988702|Monitoring, Physiologic|monitoring, physiologic
5156018|NCT00988689|starch|starch
5156019|NCT00988689|carbohydrates|carbohydrates
5156020|NCT00988689|blood glucose|blood glucose
5156021|NCT00988689|food intake|food intake
5156022|NCT00988689|satiety|satiety
5156023|NCT00988689|appetite|appetite
5156024|NCT00988663|electroconvulsive therapy|electroconvulsive therapy
5156025|NCT00988663|memantine|memantine
5156026|NCT00988663|cognitive function|cognitive function
5156027|NCT00988663|memory|memory
5156028|NCT00988650|Metabolic syndrome|metabolic syndrome
5156029|NCT00988650|Mediterranean diet|mediterranean diet
5156030|NCT00988650|Blood lipids|blood lipids
5156031|NCT00988650|Coronary heart disease|coronary heart disease
5156032|NCT00988650|Apolipoprotein|apolipoprotein
5156033|NCT00988624|bioavailability pharmacokinetics Alzheimer's Disease Huntington Disease|bioavailability pharmacokinetics alzheimer's disease huntington disease
5156034|NCT00988611|Reproductive aging|reproductive aging
5156035|NCT00988598|phase 1 Alzheimer's disease donepezil|phase 1 alzheimer's disease donepezil
5156036|NCT00988585|Heart Disease Risk Reduction|heart disease risk reduction
5156037|NCT00988572|Wrist fractures|wrist fractures
5156038|NCT00988572|Vestibular asymmetry|vestibular asymmetry
5156039|NCT00988572|Vestibular rehabilitation|vestibular rehabilitation
5156040|NCT00988572|Fall-related wrist fractures|fall-related wrist fractures
5156041|NCT00988572|Patients 50 years or older|patients 50 years or older
5156042|NCT00988559|high grade cervical dysplasia|high grade cervical dysplasia
5156043|NCT00988559|treatment vaccine|treatment vaccine
5156044|NCT00988559|therapeutic|therapeutic
5156045|NCT00988559|HPV|hpv
5156046|NCT00988559|DNA vaccine|dna vaccine
5156047|NCT00988559|gene therapy|gene therapy
5156048|NCT00988559|gene gun|gene gun
5156049|NCT00988559|pre-cancerous|pre-cancerous
5156050|NCT00988546|Disability Evaluation|disability evaluation
5156051|NCT00988546|Joint Diseases|joint diseases
5156052|NCT00988546|Joint Disability|joint disability
5156053|NCT00988533|Head Lice|head lice
5156054|NCT00988533|Pediculus|pediculus
5156055|NCT00988520|Neuromuscular Blocking Agents|neuromuscular blocking agents
5156056|NCT00988481|Bulimia Nervosa|bulimia nervosa
5156057|NCT00988481|Topiramate|topiramate
5156058|NCT00988481|Augmentation|augmentation
5156059|NCT00988468|Knee Osteoarthritis|knee osteoarthritis
5156060|NCT00988468|Manual Therapy|manual therapy
5156061|NCT00988468|Therapeutic Exercise|therapeutic exercise
5156062|NCT00988468|Ultrasound|ultrasound
5156063|NCT00988468|Effusion|effusion
5156064|NCT00988455|basal cell carcinoma|basal cell carcinoma
5156065|NCT00988455|photodynamic therapy|photodynamic therapy
5156066|NCT00988455|photo chemotherapy|photo chemotherapy
5156067|NCT00988455|basal cell epithelioma|basal cell epithelioma
5156068|NCT00988442|Adherence|adherence
5156069|NCT00988442|Treatment|treatment
5156070|NCT00988442|Adherence Intervention|adherence intervention
5156071|NCT00988442|Telephone Intervention|telephone intervention
5156072|NCT00988442|treatment experienced|treatment experienced
5156073|NCT00988429|Refractory|refractory
5156074|NCT00988429|partial|partial
5156075|NCT00988429|epilepsy|epilepsy
5156076|NCT00988429|efficacy|efficacy
5156077|NCT00988429|eslicarbazepine|eslicarbazepine
5156078|NCT00988429|safety|safety
5156079|NCT00988416|IPMN|ipmn
5156080|NCT00988390|mothers living with HIV|mothers living with hiv
5156081|NCT00988390|family intervention|family intervention
5156082|NCT00988390|family functioning|family functioning
5156083|NCT00988390|conflict|conflict
5156084|NCT00988390|Mental health|mental health
5156085|NCT00988390|and physical health|and physical health
5156086|NCT00988390|Family relationships (functioning and conflict)|family relationships (functioning and conflict)
5156087|NCT00988377|whey protein|whey protein
5156088|NCT00988377|subjective appetite|subjective appetite
5156089|NCT00988377|shor-term food intake|shor-term food intake
5156090|NCT00988377|blood glucose|blood glucose
5156091|NCT00988364|Metabolic Syndrome|metabolic syndrome
5156092|NCT00988364|LDL subfraction L5|ldl subfraction l5
5156093|NCT00988364|The reduction of LDL Chol in patients with Metabolic Syndrome|the reduction of ldl chol in patients with metabolic syndrome
5156094|NCT00988364|The prevalence of L5 in patients with Metabolic Syndrome|the prevalence of l5 in patients with metabolic syndrome
5156095|NCT00988364|The reduction of L5 subfraction in patients with Metabolic Syndrome|the reduction of l5 subfraction in patients with metabolic syndrome
5156096|NCT00988351|sleep apnea|sleep apnea
5156097|NCT00988351|positive airway pressure|positive airway pressure
5156098|NCT00988351|portable monitoring|portable monitoring
5156099|NCT00988351|auto positive airway pressure|auto positive airway pressure
5156100|NCT00988338|Trinity Evolution|trinity evolution
5156101|NCT00988338|Arthrodesis|arthrodesis
5156102|NCT00988338|Foot Fusion|foot fusion
5156103|NCT00988338|Ankle Fusion|ankle fusion
5156104|NCT00988338|Allograft|allograft
5156105|NCT00988312|dendritic cells (DC)|dendritic cells (dc)
5156106|NCT00988312|idiotype (Id)|idiotype (id)
5156107|NCT00988312|immunotherapy|immunotherapy
5156108|NCT00988299|older|older
5156109|NCT00988299|NEAT|neat
5156110|NCT00988299|exercise|exercise
5156111|NCT00988299|RMR|rmr
5156112|NCT00988299|energy expenditure|energy expenditure
5156113|NCT00988273|Crohn's disease|crohn's disease
5156114|NCT00988273|Ulcerative colitis|ulcerative colitis
5156115|NCT00988273|dysplasia|dysplasia
5156116|NCT00988247|Rhinitis, Allergic, Perennial|rhinitis, allergic, perennial
5156117|NCT00988247|BDP-HFA|bdp-hfa
5156118|NCT00988247|Hay fever|hay fever
5156119|NCT00988247|Allergic rhinitis|allergic rhinitis
5156120|NCT00988234|Lumbar plexus block|lumbar plexus block
5156121|NCT00988234|sciatic nerve block|sciatic nerve block
5156122|NCT00988234|position|position
5156123|NCT00988234|ultrasound guidance|ultrasound guidance
5156124|NCT00988234|elective lower limb surgery|elective lower limb surgery
5156125|NCT00988208|Castrate-Resistant Prostate Cancer|castrate-resistant prostate cancer
5156126|NCT00988208|Revlimid|revlimid
5156127|NCT00988208|Lenalidomide|lenalidomide
5156128|NCT00988195|Neoplasm|neoplasm
5156129|NCT00988195|Hepatocellular Carcinoma|hepatocellular carcinoma
5156130|NCT00988182|Whey protein|whey protein
5156131|NCT00988182|Hydrolysate whey protein|hydrolysate whey protein
5156132|NCT00988182|Blood glucose|blood glucose
5156133|NCT00988182|Insulin|insulin
5156134|NCT00988169|AT-101|at-101
5156135|NCT00988169|erlotinib|erlotinib
5156136|NCT00988169|Unresectable Stage IIIB|unresectable stage iiib
5156137|NCT00988169|09-026|09-026
5156138|NCT00988156|Epilepsy|epilepsy
5156139|NCT00988156|Partial|partial
5156140|NCT00988156|Refractory|refractory
5156141|NCT00988156|Children|children
5156142|NCT00988156|Adolescents|adolescents
5156143|NCT00988156|Adjunctive|adjunctive
5156144|NCT00988156|Randomised|randomised
5156145|NCT00988156|Double-blind|double-blind
5156146|NCT00988156|Placebo-controlled|placebo-controlled
5156147|NCT00988156|Parallel-group|parallel-group
5156148|NCT00988143|Influenza|influenza
5156149|NCT00988143|Trivalent Influenza Virus Vaccine|trivalent influenza virus vaccine
5156150|NCT00988143|Quadrivalent Influenza Virus Vaccine|quadrivalent influenza virus vaccine
5156151|NCT00988130|sexual dysfunction|sexual dysfunction
5156152|NCT00988130|stage I prostate cancer|stage i prostate cancer
5156153|NCT00988130|stage IIB prostate cancer|stage iib prostate cancer
5156154|NCT00988130|stage IIA prostate cancer|stage iia prostate cancer
5156155|NCT00988130|stage III prostate cancer|stage iii prostate cancer
5156156|NCT00988117|PDD|pdd
5156353|NCT00987428|ERCP|ercp
5156157|NCT00988117|Parkinson's Disease with Dementia|parkinson's disease with dementia
5156158|NCT00988117|rivastigmine|rivastigmine
5156159|NCT00988117|rivastigmine patch|rivastigmine patch
5156160|NCT00988117|open label|open label
5156161|NCT00988117|Parkinson's Disease|parkinson's disease
5156162|NCT00988117|Parkinsons Disease|parkinsons disease
5156163|NCT00988117|memory|memory
5156164|NCT00988117|Exelon|exelon
5156165|NCT00988117|Exelon Patch|exelon patch
5156166|NCT00988104|Behavior Therapy|behavior therapy
5156167|NCT00988104|Randomized Controlled Trial|randomized controlled trial
5156168|NCT00988078|metformin|metformin
5156169|NCT00988078|Hyperandrogenism|hyperandrogenism
5156170|NCT00988078|Metabolic Syndrome X|metabolic syndrome x
5156171|NCT00988078|adolescents|adolescents
5156172|NCT00988078|melatonin|melatonin
5156173|NCT00988078|Polycystic Ovary Syndrome|polycystic ovary syndrome
5156174|NCT00988078|Insulin Resistance|insulin resistance
5156175|NCT00988078|Menstrual Cycle|menstrual cycle
5156176|NCT00988052|Relapsing Multiple Sclerosis|relapsing multiple sclerosis
5156177|NCT00988039|Human Immunodeficiency virus|human immunodeficiency virus
5156178|NCT00988039|second line therapy|second line therapy
5156179|NCT00988039|raltegravir|raltegravir
5156180|NCT00988039|aluvia|aluvia
5156181|NCT00988039|monotherapy|monotherapy
5156182|NCT00988039|integrase inhibitor|integrase inhibitor
5156183|NCT00988039|protease inhibitor|protease inhibitor
5156184|NCT00988039|Randomized Controlled Trial|randomized controlled trial
5156185|NCT00988013|total marrow irradiation|total marrow irradiation
5156186|NCT00988013|intensity modulated radiation|intensity modulated radiation
5156187|NCT00988013|leukemia|leukemia
5156188|NCT00988013|hematologic diseases|hematologic diseases
5156189|NCT00988000|outpatients|outpatients
5156190|NCT00987987|hematological malignancy|hematological malignancy
5156191|NCT00987987|allogeneic hematopoietic stem cell transplantation|allogeneic hematopoietic stem cell transplantation
5156192|NCT00987987|donor lymphocyte infusion|donor lymphocyte infusion
5156193|NCT00987987|antitumor immunotherapy|antitumor immunotherapy
5156194|NCT00987987|graft-versus-tumor effect|graft-versus-tumor effect
5156195|NCT00987987|regulatory T cells|regulatory t cells
5156196|NCT00987987|adult|adult
5156197|NCT00987974|ischemia reperfusion injury|ischemia reperfusion injury
5156198|NCT00987974|endothelial dysfunction|endothelial dysfunction
5156200|NCT00987974|rosuvastatin|rosuvastatin
5156201|NCT00987974|atorvastatin|atorvastatin
5156202|NCT00987974|placebo|placebo
5156203|NCT00987974|ecto-5'-nucleotidase|ecto-5'-nucleotidase
5156204|NCT00987974|flow mediated dilation|flow mediated dilation
5156205|NCT00987961|opioid dependence|opioid dependence
5156206|NCT00987961|suboxone|suboxone
5156207|NCT00987961|HIV risk behavior|hiv risk behavior
5156208|NCT00987948|HIV|hiv
5156209|NCT00987948|dementia|dementia
5156210|NCT00987948|High HIV DNA within CD14+ PBMCs|high hiv dna within cd14+ pbmcs
5156211|NCT00987948|treatment experienced|treatment experienced
5156212|NCT00987922|Stroke|stroke
5156213|NCT00987922|Acute|acute
5156214|NCT00987922|Infarction|infarction
5156215|NCT00987922|Ischemic|ischemic
5156216|NCT00987922|Thrombolysis|thrombolysis
5156217|NCT00987922|Mild|mild
5156218|NCT00987922|Hypothermia|hypothermia
5156219|NCT00987909|Cat|cat
5156220|NCT00987909|Allergy|allergy
5156221|NCT00987909|Immunotherapy|immunotherapy
5156222|NCT00987909|Sublingual|sublingual
5156223|NCT00987909|Exposure chamber|exposure chamber
5156224|NCT00987909|Safety|safety
5156225|NCT00987909|Rhinoconjunctivitis|rhinoconjunctivitis
5156226|NCT00987896|colonoscopy|colonoscopy
5156227|NCT00987896|polypectomy|polypectomy
5156228|NCT00987896|NOTES|notes
5156229|NCT00987883|Nutritional Support|nutritional support
5156230|NCT00987870|Stable plaque Psoriasis|stable plaque psoriasis
5156231|NCT00987870|inflammatory skin|inflammatory skin
5156232|NCT00987870|with or without arthritis|with or without arthritis
5156233|NCT00987857|esophageal cancer|esophageal cancer
5156234|NCT00987857|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
5156235|NCT00987857|Barrett esophagus|barrett esophagus
5156236|NCT00987831|SLE|sle
5156237|NCT00987831|lupus|lupus
5156238|NCT00987831|biomarkers|biomarkers
5156239|NCT00987831|depomedrol|depomedrol
5156240|NCT00987831|flare|flare
5156241|NCT00987831|disease activity|disease activity
5156242|NCT00987818|Biomarkers|biomarkers
5156243|NCT00987818|Antibiotic therapy|antibiotic therapy
5156244|NCT00987805|Functional dyspepsia|functional dyspepsia
5156245|NCT00987805|Banhasasim-tang|banhasasim-tang
5156246|NCT00987805|Gastrointestinal Symptom score|gastrointestinal symptom score
5156247|NCT00987805|Visual Analogue Scale|visual analogue scale
5156248|NCT00987805|Functional Dyspepsia-related Quality of Life|functional dyspepsia-related quality of life
5156249|NCT00987805|Electrogastrography|electrogastrography
5156250|NCT00987792|Community Acquired Pneumonia|community acquired pneumonia
5156251|NCT00987779|Bioequivalence study|bioequivalence study
5156252|NCT00987779|Food effect study|food effect study
5156253|NCT00987779|Pharmacokinetics|pharmacokinetics
5156254|NCT00987779|Gabapentin|gabapentin
5156255|NCT00987766|advanced adult primary liver cancer|advanced adult primary liver cancer
5156256|NCT00987766|stage III pancreatic cancer|stage iii pancreatic cancer
5156257|NCT00987766|stage IV pancreatic cancer|stage iv pancreatic cancer
5156258|NCT00987766|periampullary adenocarcinoma|periampullary adenocarcinoma
5156259|NCT00987766|small intestine adenocarcinoma|small intestine adenocarcinoma
5156260|NCT00987766|adenocarcinoma of the extrahepatic bile duct|adenocarcinoma of the extrahepatic bile duct
5156261|NCT00987766|adenocarcinoma of the gallbladder|adenocarcinoma of the gallbladder
5156262|NCT00987766|unresectable extrahepatic bile duct cancer|unresectable extrahepatic bile duct cancer
5156263|NCT00987766|unresectable gallbladder cancer|unresectable gallbladder cancer
5156264|NCT00987753|L-377202, prostate cancer, PSA|l-377202, prostate cancer, psa
5156265|NCT00987740|hypercapnic respiratory failure, COPD|hypercapnic respiratory failure, copd
5156266|NCT00987714|Organ Donors|organ donors
5156267|NCT00987714|Recipients|recipients
5156268|NCT00987701|Neurobehavior|neurobehavior
5156269|NCT00987701|Development|development
5156270|NCT00987701|Fluid management|fluid management
5156271|NCT00987701|Neuraxial anesthesia|neuraxial anesthesia
5156272|NCT00987688|trauma|trauma
5156273|NCT00987688|Brain injury|brain injury
5156274|NCT00987688|Pre-hospital|pre-hospital
5156275|NCT00987688|cooling|cooling
5156276|NCT00987675|stage I prostate cancer|stage i prostate cancer
5156277|NCT00987675|stage IIB prostate cancer|stage iib prostate cancer
5156278|NCT00987675|stage IIA prostate cancer|stage iia prostate cancer
5156279|NCT00987675|stage III prostate cancer|stage iii prostate cancer
5156280|NCT00987662|irbesartan|irbesartan
5156281|NCT00987662|amlodipine|amlodipine
5156282|NCT00987662|obesity|obesity
5156283|NCT00987662|ambulatory blood pressure monitoring|ambulatory blood pressure monitoring
5156284|NCT00987662|new onset diabetes|new onset diabetes
5156285|NCT00987649|pelvic mass|pelvic mass
5156286|NCT00987649|ovarian cancer|ovarian cancer
5156287|NCT00987649|adnexal mass|adnexal mass
5156288|NCT00987649|CA125|ca125
5156289|NCT00987649|HE4|he4
5156290|NCT00987636|Ewing Sarcoma|ewing sarcoma
5156291|NCT00987636|localized|localized
5156292|NCT00987636|disseminated|disseminated
5156293|NCT00987636|metastases|metastases
5156294|NCT00987636|bone|bone
5156295|NCT00987636|soft tissue|soft tissue
5156296|NCT00987610|Percutaneous coronary intervention|percutaneous coronary intervention
5156297|NCT00987610|chronic total occlusion|chronic total occlusion
5156298|NCT00987610|guidewire|guidewire
5156299|NCT00987610|Angioplasty, Transluminal, Percutaneous Coronary|angioplasty, transluminal, percutaneous coronary
5156300|NCT00987610|Angioplasty|angioplasty
5156301|NCT00987610|Percutaneous Coronary|percutaneous coronary
5156302|NCT00987597|Smoking|smoking
5156303|NCT00987597|nicotine replacement|nicotine replacement
5156304|NCT00987597|psychological behaviour|psychological behaviour
5156305|NCT00987597|Smoking > 5 cigarettes per day|smoking > 5 cigarettes per day
5156306|NCT00987597|Hospitalisation for acute coronary syndrome|hospitalisation for acute coronary syndrome
5156307|NCT00987571|carpal tunnel syndrome|carpal tunnel syndrome
5156308|NCT00987571|median nerve|median nerve
5156309|NCT00987571|ultrasound|ultrasound
5156310|NCT00987571|electrodiagnosis|electrodiagnosis
5156311|NCT00987571|Normal subjects|normal subjects
5156312|NCT00987558|Eslicarbazepine acetate|eslicarbazepine acetate
5156313|NCT00987558|simvastatin|simvastatin
5156314|NCT00987545|Keloids|keloids
5156315|NCT00987545|recurrence|recurrence
5156316|NCT00987532|preschool|preschool
5156317|NCT00987532|participatory intervention|participatory intervention
5156318|NCT00987532|cluster-randomization|cluster-randomization
5156319|NCT00987532|children|children
5156320|NCT00987532|obesity prevention|obesity prevention
5156321|NCT00987519|acute bronchiolitis|acute bronchiolitis
5156322|NCT00987519|acute gastroenteritis|acute gastroenteritis
5156323|NCT00987519|febrile convulsion|febrile convulsion
5156324|NCT00987519|viral agents|viral agents
5156325|NCT00987519|molecular methods|molecular methods
5156326|NCT00987506|drug eluting stents|drug eluting stents
5156327|NCT00987506|Stents|stents
5156328|NCT00987506|Angioplasty|angioplasty
5156329|NCT00987506|Chronic coronary occlusion|chronic coronary occlusion
5156330|NCT00987506|Stent thrombosis|stent thrombosis
5156331|NCT00987506|Vascular disease|vascular disease
5156332|NCT00987506|Myocardial ischemia|myocardial ischemia
5156333|NCT00987506|Coronary artery stenosis|coronary artery stenosis
5156334|NCT00987506|Coronary Disease|coronary disease
5156335|NCT00987506|Coronary Artery Disease|coronary artery disease
5156336|NCT00987506|Coronary Restenosis|coronary restenosis
5156337|NCT00987493|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5156338|NCT00987493|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5156339|NCT00987480|Stem Cell Transplantation|stem cell transplantation
5156340|NCT00987480|Anemia|anemia
5156341|NCT00987480|Busulfan|busulfan
5156342|NCT00987480|Cyclophosphamide|cyclophosphamide
5156343|NCT00987480|Fludarabine|fludarabine
5156344|NCT00987480|08-031|08-031
5156345|NCT00987467|Atopic|atopic
5156346|NCT00987467|Keratoconjunctivitis|keratoconjunctivitis
5156347|NCT00987467|Restasis|restasis
5156348|NCT00987467|Cyclosporine|cyclosporine
5156349|NCT00987441|Neurobehavior|neurobehavior
5156350|NCT00987441|Epidural analgesia|epidural analgesia
5156351|NCT00987441|Local anesthetic|local anesthetic
5156352|NCT00987441|Opioid|opioid
5156354|NCT00987428|EUS|eus
5156355|NCT00987428|Pancreatitis biliary|pancreatitis biliary
5156356|NCT00987428|Severe|severe
5156357|NCT00987428|Interventional endoscopy|interventional endoscopy
5156358|NCT00987428|Choledocolithiasis|choledocolithiasis
5156359|NCT00987402|Surgery|surgery
5156360|NCT00987402|hand scrubbing|hand scrubbing
5156361|NCT00987402|post-operative infection|post-operative infection
5156362|NCT00987402|surgical site infection|surgical site infection
5156363|NCT00987402|surgical hand preparation|surgical hand preparation
5156364|NCT00987402|plain soap and water|plain soap and water
5156365|NCT00987402|alcohol-based hand rub|alcohol-based hand rub
5156366|NCT00987402|Cost of surgical hand preparation agent|cost of surgical hand preparation agent
5156367|NCT00987402|Side effects of use of hand preparation agent|side effects of use of hand preparation agent
5156368|NCT00987389|Vasculitis|vasculitis
5156369|NCT00987389|Granulomatosis with Polyangiitis|granulomatosis with polyangiitis
5156370|NCT00987389|Microscopic Polyangiitis|microscopic polyangiitis
5156371|NCT00987389|Wegener's|wegener's
5156372|NCT00987389|ANCA-Associated Vasculitis|anca-associated vasculitis
5156373|NCT00987389|GPA|gpa
5156374|NCT00987389|MPA|mpa
5156375|NCT00987389|Treatment|treatment
5156376|NCT00987389|Plasma exchange|plasma exchange
5156377|NCT00987389|Glucocorticoids|glucocorticoids
5156378|NCT00987389|ANCA-Positive|anca-positive
5156379|NCT00987363|critical limb ischemia (CLI)|critical limb ischemia (cli)
5156380|NCT00987363|diabetic foot|diabetic foot
5156381|NCT00987363|bone marrow derived mononuclear cells|bone marrow derived mononuclear cells
5156382|NCT00987363|cell therapy|cell therapy
5156383|NCT00987350|Jet Injector|jet injector
5156384|NCT00987350|Vaccine|vaccine
5156385|NCT00987350|Influenza|influenza
5156386|NCT00987337|Hepatitis C Polymerase Inhibitor PF-00868554 Filibuvir|hepatitis c polymerase inhibitor pf-00868554 filibuvir
5156387|NCT00987311|Probiotics|probiotics
5156388|NCT00987311|intestinal immune system|intestinal immune system
5156389|NCT00987311|human|human
5156390|NCT00987311|healthy subjects|healthy subjects
5156391|NCT00987311|dairy drink|dairy drink
5156392|NCT00987311|Healthy adults|healthy adults
5156393|NCT00987298|Abdominal Fat|abdominal fat
5156394|NCT00987298|Visceral Fat|visceral fat
5156395|NCT00987298|Subcutaneous Fat|subcutaneous fat
5156396|NCT00987298|Dual-energy x-ray absorptiometry|dual-energy x-ray absorptiometry
5156397|NCT00987298|DXA|dxa
5156398|NCT00987298|Computed Tomography|computed tomography
5156399|NCT00987298|CT|ct
5156400|NCT00987298|Body Mass Index|body mass index
5156401|NCT00987298|Body composition|body composition
5156402|NCT00987298|Percent fat|percent fat
5156403|NCT00987298|Waist circumference|waist circumference
5156404|NCT00987298|Hip circumference|hip circumference
5156405|NCT00987285|RE AIM model|re aim model
5156406|NCT00987285|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
5156407|NCT00987285|Interactive voice recognition|interactive voice recognition
5156408|NCT00987285|Computer Assisted Self Management|computer assisted self management
5156409|NCT00987272|Allergies|allergies
5156410|NCT00987272|Ocular|ocular
5156411|NCT00987259|Myocardial infarction|myocardial infarction
5156412|NCT00987259|Myocardial oedema|myocardial oedema
5156413|NCT00987259|Magnetic resonance|magnetic resonance
5156414|NCT00987246|Actinic Keratosis|actinic keratosis
5156415|NCT00987246|AK|ak
5156416|NCT00987246|NMSC|nmsc
5156417|NCT00987246|Combination|combination
5156418|NCT00987220|CSF Biomarkers Acetylcholine|csf biomarkers acetylcholine
5156419|NCT00987207|Postconditioning|postconditioning
5156420|NCT00987207|cyclosporine A|cyclosporine a
5156421|NCT00987207|myocardial ischemia|myocardial ischemia
5156422|NCT00987207|cardiac surgery|cardiac surgery
5156423|NCT00987207|aortic valvulopathy|aortic valvulopathy
5156424|NCT00987194|HIV|hiv
5156425|NCT00987194|rapid testing|rapid testing
5156426|NCT00987194|HIV seronegativity|hiv seronegativity
5156427|NCT00987181|Pulse wave velocity|pulse wave velocity
5156428|NCT00987181|Non contact|non contact
5156429|NCT00987181|Non-invasive|non-invasive
5156430|NCT00987181|Photoplethysmography|photoplethysmography
5156431|NCT00987181|Doppler flow velocimetry|doppler flow velocimetry
5156432|NCT00987168|Congenital Hyperinsulinism|congenital hyperinsulinism
5156433|NCT00987168|Hypoglycemia,|hypoglycemia,
5156434|NCT00987168|Sandostatine subcutaneous in 3 daily injections|sandostatine subcutaneous in 3 daily injections
5156435|NCT00987168|Intramuscular injection of Sandostatine® LP per month|intramuscular injection of sandostatine® lp per month
5156436|NCT00987155|Functional electrical stimulation cycling|functional electrical stimulation cycling
5156437|NCT00987155|arm crank|arm crank
5156438|NCT00987155|wheelchair|wheelchair
5156439|NCT00987155|ergometry|ergometry
5156440|NCT00987155|paraplegia|paraplegia
5156441|NCT00987155|spinal cord injury|spinal cord injury
5156442|NCT00987155|exercise testing|exercise testing
5156443|NCT00987129|DHA|dha
5156444|NCT00987129|EPA|epa
5156445|NCT00987129|AMD|amd
5156446|NCT00987129|drusen|drusen
5156447|NCT00987129|omega-3 fatty acids|omega-3 fatty acids
5156448|NCT00987129|omega6:omega3 ratio|omega6:omega3 ratio
5156449|NCT00987116|Myasthenia gravis|myasthenia gravis
5156450|NCT00987116|Steroids side effects|steroids side effects
5156553|NCT00986648|acute liver failure|acute liver failure
5156451|NCT00987116|Comparison of strategies for tapering steroids|comparison of strategies for tapering steroids
5156452|NCT00987116|Generalized MG corresponding to grade III, IV or V of MGFA|generalized mg corresponding to grade iii, iv or v of mgfa
5156453|NCT00987103|renal transplantation|renal transplantation
5156454|NCT00987103|tacrolimus|tacrolimus
5156455|NCT00987103|pharmacokinetics|pharmacokinetics
5156456|NCT00987103|rectal|rectal
5156457|NCT00987103|sublingual|sublingual
5156458|NCT00987103|rectal administration|rectal administration
5156459|NCT00987103|sublingual administration|sublingual administration
5156460|NCT00987090|subjects developing symptoms of Alzheimer Disease|subjects developing symptoms of alzheimer disease
5156461|NCT00987077|CSC|csc
5156462|NCT00987077|SRT|srt
5156463|NCT00987064|Protexo|protexo
5156464|NCT00987064|Asthma|asthma
5156465|NCT00987064|Temperature controlled Laminar Airflow|temperature controlled laminar airflow
5156466|NCT00987064|Perennial allergy|perennial allergy
5156467|NCT00987064|Quality of life|quality of life
5156468|NCT00987064|MiniAQLQ|miniaqlq
5156469|NCT00987064|FeNO|feno
5156470|NCT00987064|FEV1|fev1
5156471|NCT00987064|PEF|pef
5156472|NCT00987051|sentinel node procedure|sentinel node procedure
5156473|NCT00987051|radiocolloid|radiocolloid
5156474|NCT00987051|patent blue|patent blue
5156475|NCT00987038|drug interaction CYP3A4 glucocorticoids midazolam|drug interaction cyp3a4 glucocorticoids midazolam
5156476|NCT00987025|hypertension|hypertension
5156477|NCT00987025|telehealth|telehealth
5156478|NCT00987025|nurse monitor|nurse monitor
5156479|NCT00987025|nutrition center|nutrition center
5156480|NCT00986999|HIV infected|hiv infected
5156481|NCT00986999|treatment experienced|treatment experienced
5156482|NCT00986986|Human immunodeficiency virus|human immunodeficiency virus
5156483|NCT00986986|Low high density lipoprotein|low high density lipoprotein
5156484|NCT00986986|Endothelial function|endothelial function
5156485|NCT00986986|Flow-mediated vasodilation|flow-mediated vasodilation
5156486|NCT00986973|PKU|pku
5156487|NCT00986973|BH4|bh4
5156488|NCT00986973|KUVAN|kuvan
5156489|NCT00986973|PET scan|pet scan
5156490|NCT00986973|Neurodevelopment|neurodevelopment
5156491|NCT00986960|multiple sclerosis|multiple sclerosis
5156492|NCT00986960|relapsing remitting|relapsing remitting
5156493|NCT00986960|RRMS|rrms
5156494|NCT00986921|Length of time for procedure to be completed|length of time for procedure to be completed
5156495|NCT00986921|Need for additional dilation|need for additional dilation
5156496|NCT00986921|Subject satisfaction with procedure|subject satisfaction with procedure
5156497|NCT00986895|HPN-100|hpn-100
5156498|NCT00986895|GT4P|gt4p
5156499|NCT00986895|Glyceryl tri-(4-phenylbutyrate)|glyceryl tri-(4-phenylbutyrate)
5156500|NCT00986882|Postoperative pain|postoperative pain
5156501|NCT00986869|Safety|safety
5156502|NCT00986869|Bronchoscopy|bronchoscopy
5156503|NCT00986869|Pulmonary|pulmonary
5156504|NCT00986869|Hypertension|hypertension
5156505|NCT00986843|HM30181A|hm30181a
5156506|NCT00986843|Irinotecan|irinotecan
5156507|NCT00986843|MTD|mtd
5156508|NCT00986843|DLT|dlt
5156509|NCT00986830|Rhinosinusitis|rhinosinusitis
5156510|NCT00986830|Balloon catheters|balloon catheters
5156511|NCT00986830|Office treatment|office treatment
5156512|NCT00986830|Otorhinolaryngologic Diseases|otorhinolaryngologic diseases
5156513|NCT00986830|Respiratory Tract Infections|respiratory tract infections
5156514|NCT00986830|Respiratory Tract Diseases|respiratory tract diseases
5156515|NCT00986830|FinESS Sinus Treatment|finess sinus treatment
5156516|NCT00986830|endoscopic sinus surgery|endoscopic sinus surgery
5156517|NCT00986817|Refractory ascites|refractory ascites
5156518|NCT00986817|Cirrhosis Terlipressin|cirrhosis terlipressin
5156519|NCT00986817|Paracentesis|paracentesis
5156520|NCT00986791|risk reduction|risk reduction
5156521|NCT00986765|Fetal growth restriction|fetal growth restriction
5156522|NCT00986765|Abruptio placentae|abruptio placentae
5156523|NCT00986765|Perinatal death|perinatal death
5156524|NCT00986752|stent|stent
5156525|NCT00986752|atherectomy|atherectomy
5156526|NCT00986752|paclitaxel-eluting balloon|paclitaxel-eluting balloon
5156527|NCT00986739|Chronic pathologies|chronic pathologies
5156528|NCT00986739|elderly|elderly
5156529|NCT00986739|atmospheric pollution|atmospheric pollution
5156530|NCT00986739|unplanned hospitalization|unplanned hospitalization
5156531|NCT00986739|case-crossover|case-crossover
5156532|NCT00986687|Oocyte cryopreservation|oocyte cryopreservation
5156533|NCT00986687|vitrification|vitrification
5156534|NCT00986674|Advanced Non-small Cell Lung Cancer|advanced non-small cell lung cancer
5156535|NCT00986674|Carboplatin|carboplatin
5156536|NCT00986674|Paclitaxel|paclitaxel
5156537|NCT00986674|Cetuximab|cetuximab
5156538|NCT00986674|IMC-A12|imc-a12
5156539|NCT00986661|melanoma|melanoma
5156540|NCT00986661|uveal|uveal
5156541|NCT00986661|ocular|ocular
5156542|NCT00986661|mUM|mum
5156543|NCT00986661|mOM|mom
5156544|NCT00986661|OM|om
5156545|NCT00986661|UM|um
5156546|NCT00986661|pancreatic|pancreatic
5156547|NCT00986661|colon|colon
5156548|NCT00986661|colorectal|colorectal
5156549|NCT00986661|lung|lung
5156550|NCT00986661|metastatic|metastatic
5156551|NCT00986661|carcinoid|carcinoid
5156552|NCT00986661|neuroendocrine|neuroendocrine
5156554|NCT00986648|hepatic encephalopathy|hepatic encephalopathy
5156555|NCT00986648|acetaminophen toxicity|acetaminophen toxicity
5156556|NCT00986635|Activated partial thromboplastin time|activated partial thromboplastin time
5156557|NCT00986635|Thrombin clotting Time|thrombin clotting time
5156558|NCT00986635|Anti-Xa-activity|anti-xa-activity
5156559|NCT00986635|Factor X-activity|factor x-activity
5156560|NCT00986635|Factor XIII-activity|factor xiii-activity
5156561|NCT00986635|Antithrombin (based on factor II)|antithrombin (based on factor ii)
5156562|NCT00986635|Antithrombin (based on factor X<9|antithrombin (based on factor x<9
5156563|NCT00986596|vitamin D|vitamin d
5156564|NCT00986596|skeletal muscle|skeletal muscle
5156565|NCT00986596|vitamin D receptor|vitamin d receptor
5156566|NCT00986583|Succinylcholine|succinylcholine
5156567|NCT00986583|Statins|statins
5156568|NCT00986583|myalgias|myalgias
5156569|NCT00986583|statins with succinylcholine and pain|statins with succinylcholine and pain
5156570|NCT00986570|Botulinum Toxin A|botulinum toxin a
5156571|NCT00986570|Wrinkles|wrinkles
5156572|NCT00986557|cytomegalovirus infection|cytomegalovirus infection
5156573|NCT00986557|graft versus host disease|graft versus host disease
5156574|NCT00986544|Laparoscopy|laparoscopy
5156575|NCT00986544|cholecystectomy|cholecystectomy
5156576|NCT00986544|drainage|drainage
5156577|NCT00986531|schizophrenia|schizophrenia
5156578|NCT00986531|early phase trials|early phase trials
5156579|NCT00986518|Advanced Colorectal Cancer|advanced colorectal cancer
5156580|NCT00986518|Hepatic and/or lung metastasis|hepatic and/or lung metastasis
5156581|NCT00986518|Adaptive autologous cell immunotherapy|adaptive autologous cell immunotherapy
5156582|NCT00986518|T- regulatory lymphocyte depletion|t- regulatory lymphocyte depletion
5156583|NCT00986518|Neo-adjuvant reduced intensity chemotherapeutic conditioning|neo-adjuvant reduced intensity chemotherapeutic conditioning
5156584|NCT00986505|lidocaine|lidocaine
5156585|NCT00986505|fibromyalgia|fibromyalgia
5156586|NCT00986505|intravenous lidocaine|intravenous lidocaine
5156587|NCT00986505|manifestations|manifestations
5156588|NCT00986492|Sleep deprivation|sleep deprivation
5156589|NCT00986492|Food intake|food intake
5156590|NCT00986492|Motor activity|motor activity
5156591|NCT00986492|Normal, healthy subjects|normal, healthy subjects
5156592|NCT00986479|Patients|patients
5156593|NCT00986466|exercise|exercise
5156594|NCT00986466|falls|falls
5156595|NCT00986466|physical functioning|physical functioning
5156596|NCT00986466|vitamin D|vitamin d
5156597|NCT00986466|mobility function|mobility function
5156598|NCT00986466|neuromuscular functioning¨|neuromuscular functioning¨
5156599|NCT00986466|quality of life|quality of life
5156600|NCT00986466|number of fallers|number of fallers
5156601|NCT00986466|fall-related injuries including bone fractures|fall-related injuries including bone fractures
5156602|NCT00986466|bone mass|bone mass
5156603|NCT00986453|Breast Reduction|breast reduction
5156604|NCT00986453|PlasmaBlade|plasmablade
5156605|NCT00986453|Electrosurgery|electrosurgery
5156606|NCT00986453|PEAK Surgical|peak surgical
5156607|NCT00986453|Medtronic Advanced Energy|medtronic advanced energy
5156608|NCT00986453|Medtronic|medtronic
5156609|NCT00986414|Parkinson Disease|parkinson disease
5156610|NCT00986414|L-dopa|l-dopa
5156611|NCT00986414|Levodopa|levodopa
5156612|NCT00986414|dyskinesia|dyskinesia
5156613|NCT00986401|Adults|adults
5156614|NCT00986375|Randomized Controlled Trial|randomized controlled trial
5156615|NCT00986375|evidence- and theory-based behavioral intervention|evidence- and theory-based behavioral intervention
5156616|NCT00986375|expert system|expert system
5156617|NCT00986375|stages of change|stages of change
5156618|NCT00986375|motivational interviewing|motivational interviewing
5156619|NCT00986375|tailoring|tailoring
5156620|NCT00986375|Self Care|self care
5156621|NCT00986375|Rehabilitation|rehabilitation
5156622|NCT00986375|Expert Systems|expert systems
5156623|NCT00986375|Behavior|behavior
5156624|NCT00986375|Motivation|motivation
5156625|NCT00986362|Safety in pediatrics|safety in pediatrics
5156626|NCT00986349|Diabetes|diabetes
5156627|NCT00986349|Weight Loss|weight loss
5156628|NCT00986349|GI Dynamics|gi dynamics
5156629|NCT00986349|EndoBarrier|endobarrier
5156630|NCT00986336|topiramate|topiramate
5156631|NCT00986336|risperidone, bipolar disorder|risperidone, bipolar disorder
5156632|NCT00986323|Asthma|asthma
5156633|NCT00986323|Temperature controlled Laminar Airflow|temperature controlled laminar airflow
5156634|NCT00986323|TLA|tla
5156635|NCT00986323|Perennial allergy|perennial allergy
5156636|NCT00986323|Quality of life|quality of life
5156637|NCT00986323|Environmental control|environmental control
5156638|NCT00986310|fluoxetine|fluoxetine
5156639|NCT00986310|epilepsy|epilepsy
5156640|NCT00986310|Prozac|prozac
5156641|NCT00986297|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5156642|NCT00986297|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
5156643|NCT00986297|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5156644|NCT00986297|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5156645|NCT00986297|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5156646|NCT00986297|adenocarcinoma of the lung|adenocarcinoma of the lung
5156647|NCT00986297|adenosquamous cell lung cancer|adenosquamous cell lung cancer
5156648|NCT00986297|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
5156649|NCT00986297|large cell lung cancer|large cell lung cancer
5156650|NCT00986297|squamous cell lung cancer|squamous cell lung cancer
5156651|NCT00986284|Non Small Cell Lung Cancer|non small cell lung cancer
5156652|NCT00986284|Gefitinib|gefitinib
5156653|NCT00986284|Neoadjuvant Therapy|neoadjuvant therapy
5156654|NCT00986271|severe sepsis, intensive care units|severe sepsis, intensive care units
5156655|NCT00986258|pain assessment|pain assessment
5156656|NCT00986258|tapentadol|tapentadol
5156657|NCT00986258|centrally acting analgesic|centrally acting analgesic
5156658|NCT00986245|Parkinson disease|parkinson disease
5156659|NCT00986245|Ropinirole|ropinirole
5156660|NCT00986219|Asthma|asthma
5156661|NCT00986219|Language|language
5156662|NCT00986219|Symptoms,|symptoms,
5156663|NCT00986219|Limitation of Daily activities|limitation of daily activities
5156664|NCT00986219|Patients|patients
5156665|NCT00986219|Physicians|physicians
5156666|NCT00986219|Greece|greece
5156667|NCT00986206|ovarian epithelial cancer|ovarian epithelial cancer
5156668|NCT00986206|BRCA1 mutation carrier|brca1 mutation carrier
5156669|NCT00986206|BRCA2 mutation carrier|brca2 mutation carrier
5156670|NCT00986206|stage IA ovarian epithelial cancer|stage ia ovarian epithelial cancer
5156671|NCT00986206|stage IB ovarian epithelial cancer|stage ib ovarian epithelial cancer
5156672|NCT00986206|stage IC ovarian epithelial cancer|stage ic ovarian epithelial cancer
5156673|NCT00986206|stage IIA ovarian epithelial cancer|stage iia ovarian epithelial cancer
5156674|NCT00986206|stage IIB ovarian epithelial cancer|stage iib ovarian epithelial cancer
5156675|NCT00986206|stage IIC ovarian epithelial cancer|stage iic ovarian epithelial cancer
5156676|NCT00986206|stage IIIA ovarian epithelial cancer|stage iiia ovarian epithelial cancer
5156677|NCT00986206|stage IIIB ovarian epithelial cancer|stage iiib ovarian epithelial cancer
5156678|NCT00986206|stage IIIC ovarian epithelial cancer|stage iiic ovarian epithelial cancer
5156679|NCT00986206|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5156680|NCT00986193|Aortic Valve Stenosis|aortic valve stenosis
5156681|NCT00986193|Stent Valve|stent valve
5156682|NCT00986193|Biological Aortic Valve Prosthesis|biological aortic valve prosthesis
5156683|NCT00986180|Acute Low Back Pain|acute low back pain
5156684|NCT00986180|Low Back Pain With Leg Pain Below The Knee|low back pain with leg pain below the knee
5156685|NCT00986180|Radiculopathy, Oxycodone|radiculopathy, oxycodone
5156686|NCT00986180|Tapentadol|tapentadol
5156687|NCT00986180|NUCYNTA|nucynta
5156688|NCT00986167|Psychosis|psychosis
5156689|NCT00986167|Aggression|aggression
5156690|NCT00986167|Acute|acute
5156691|NCT00986167|Quetiapine XR|quetiapine xr
5156692|NCT00986154|Recurrent Thrombosis|recurrent thrombosis
5156693|NCT00986154|Recurrent Pulmonary Embolism|recurrent pulmonary embolism
5156694|NCT00986154|Symptomatic Deep Vein Thrombosis|symptomatic deep vein thrombosis
5156695|NCT00986154|Symptomatic Pulmonary Embolism|symptomatic pulmonary embolism
5156696|NCT00986154|Venous Thromboembolism (VTE)|venous thromboembolism (vte)
5156697|NCT00986128|Topiramate|topiramate
5156698|NCT00986128|Lithium|lithium
5156699|NCT00986128|Bipolar disorder|bipolar disorder
5156700|NCT00986115|epilepsy|epilepsy
5156701|NCT00986115|memory|memory
5156702|NCT00986115|cognition|cognition
5156703|NCT00986115|memantine|memantine
5156704|NCT00986102|Carbapenem|carbapenem
5156705|NCT00986102|Doripenem|doripenem
5156706|NCT00986102|Doribax|doribax
5156707|NCT00986102|Nosocomial pneumonia, Intra-abdominal infections|nosocomial pneumonia, intra-abdominal infections
5156708|NCT00986102|Urinary tract infection|urinary tract infection
5156709|NCT00986089|post-placental|post-placental
5156710|NCT00986089|IUD|iud
5156711|NCT00986089|Copper IUD|copper iud
5156712|NCT00986089|cesarean section|cesarean section
5156713|NCT00986089|immediate post-partum|immediate post-partum
5156714|NCT00986089|continuation|continuation
5156715|NCT00986076|Pediatric Cataract Surgery|pediatric cataract surgery
5156716|NCT00986076|Low-Molecular weight Heparin|low-molecular weight heparin
5156717|NCT00986076|Intraocular infusion|intraocular infusion
5156718|NCT00986076|Anti-inflammatory effect|anti-inflammatory effect
5156719|NCT00986063|Nevirapine induced rash|nevirapine induced rash
5156720|NCT00986063|Hepatitis|hepatitis
5156721|NCT00986063|Pharmacogenomics|pharmacogenomics
5156722|NCT00986063|AIDS|aids
5156723|NCT00986063|HIV|hiv
5156724|NCT00986063|treatment naive|treatment naive
5156725|NCT00986050|STEMI|stemi
5156726|NCT00986050|DES|des
5156727|NCT00986050|BMS|bms
5156728|NCT00986050|abciximab|abciximab
5156729|NCT00986037|Adverse events|adverse events
5156730|NCT00986037|Pharmacokinetics|pharmacokinetics
5156731|NCT00986024|Exercise therapy|exercise therapy
5156732|NCT00986011|obesity|obesity
5156733|NCT00986011|weight changes|weight changes
5156734|NCT00986011|healthy, no evidence of disease|healthy, no evidence of disease
5156735|NCT00985998|nimotuzumab|nimotuzumab
5156736|NCT00985998|non-small cell lung cancer|non-small cell lung cancer
5156737|NCT00985998|chemotherapy|chemotherapy
5156738|NCT00985985|smoking cessation|smoking cessation
5156739|NCT00985985|nicotine lozenge|nicotine lozenge
5156740|NCT00985985|nicotine replacement therapy|nicotine replacement therapy
5156741|NCT00985972|PHYSICAL ACTIVITY|physical activity
5156742|NCT00985972|SCHOOL|school
5156743|NCT00985972|NUTRITION|nutrition
5156744|NCT00985972|EDUCATION|education
5156745|NCT00985972|OVERWEIGHT|overweight
5156746|NCT00985959|Multiple myeloma|multiple myeloma
5156747|NCT00985959|Hematopoietic stem cell transplant|hematopoietic stem cell transplant
5156748|NCT00985959|HSCT|hsct
5156749|NCT00985959|Melphalan|melphalan
5156750|NCT00985959|Prednisolone|prednisolone
5156751|NCT00985959|Bortezomib|bortezomib
5156752|NCT00985959|JNJ-26866138|jnj-26866138
5156753|NCT00985933|Healthy normal volunteers|healthy normal volunteers
5156754|NCT00985920|blood loss|blood loss
5156755|NCT00985920|postoperative|postoperative
5156756|NCT00985907|myeloma|myeloma
5156757|NCT00985907|DMV|dmv
5156758|NCT00985894|Teledermatology|teledermatology
5156759|NCT00985894|Telemedicine|telemedicine
5156760|NCT00985894|Atopic Dermatitis|atopic dermatitis
5156761|NCT00985881|Artificial limbs|artificial limbs
5156762|NCT00985881|Gait|gait
5156763|NCT00985881|Posture|posture
5156764|NCT00985881|Prosthesis|prosthesis
5156765|NCT00985881|Vibration|vibration
5156766|NCT00985868|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
5156767|NCT00985842|Artificial limbs|artificial limbs
5156768|NCT00985842|Gait|gait
5156769|NCT00985842|Oximetry|oximetry
5156770|NCT00985842|Prosthesis|prosthesis
5156771|NCT00985842|Rehabilitation|rehabilitation
5156772|NCT00985829|basal cell carcinoma|basal cell carcinoma
5156773|NCT00985829|photodynamic therapy|photodynamic therapy
5156774|NCT00985829|photo chemotherapy|photo chemotherapy
5156775|NCT00985829|basal cell epithelioma|basal cell epithelioma
5156776|NCT00985816|Preterm|preterm
5156777|NCT00985816|newborns|newborns
5156778|NCT00985816|Gastric|gastric
5156779|NCT00985816|Motility|motility
5156780|NCT00985816|Mucosal|mucosal
5156781|NCT00985816|immunity|immunity
5156782|NCT00985803|Systemic Lupus Erythematosus|systemic lupus erythematosus
5156783|NCT00985803|Activity Physical|activity physical
5156784|NCT00985803|Activity Disease,trials randomized|activity disease,trials randomized
5156785|NCT00985790|vaccine|vaccine
5156786|NCT00985790|Influenza|influenza
5156787|NCT00985777|pancreas|pancreas
5156788|NCT00985777|resectable|resectable
5156789|NCT00985777|pancreatic tumor|pancreatic tumor
5156790|NCT00985777|pancreatic ductal adenocarcinoma|pancreatic ductal adenocarcinoma
5156791|NCT00985777|intraductal papillary mucinous neoplasm of the pancreas|intraductal papillary mucinous neoplasm of the pancreas
5156792|NCT00985777|mucinous cystic neoplasm|mucinous cystic neoplasm
5156793|NCT00985777|pancreatic exocrine neoplasia|pancreatic exocrine neoplasia
5156794|NCT00985751|immunogenicity|immunogenicity
5156795|NCT00985751|toddlers|toddlers
5156796|NCT00985751|Pneumococcal vaccine|pneumococcal vaccine
5156797|NCT00985751|Haemophilus influenzae|haemophilus influenzae
5156798|NCT00985751|safety|safety
5156799|NCT00985751|Streptococcus pneumoniae|streptococcus pneumoniae
5156800|NCT00985751|Streptococcus Pneumoniae Vaccines|streptococcus pneumoniae vaccines
5156801|NCT00985738|Prostate Cancer|prostate cancer
5156802|NCT00985738|Early Stage Prostate Cancer|early stage prostate cancer
5156803|NCT00985725|Major Depressive Disorder|major depressive disorder
5156804|NCT00985699|non-Hodgkin lymphoma|non-hodgkin lymphoma
5156805|NCT00985699|cutaneous B-cell non-Hodgkin lymphoma|cutaneous b-cell non-hodgkin lymphoma
5156806|NCT00985699|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5156807|NCT00985699|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5156808|NCT00985686|e-mental health|e-mental health
5156809|NCT00985686|Adolescent mental health|adolescent mental health
5156810|NCT00985686|Spirituality|spirituality
5156811|NCT00985673|GSK Bio's influenza vaccine GSK2340274A|gsk bio's influenza vaccine gsk2340274a
5156812|NCT00985673|influenza infection|influenza infection
5156813|NCT00985673|GSK Bio's influenza vaccine GSK2340273A|gsk bio's influenza vaccine gsk2340273a
5156815|NCT00985647|HAART|haart
5156816|NCT00985647|ART|art
5156817|NCT00985647|Pharmacokinetic|pharmacokinetic
5156818|NCT00985647|Healthy volunteers|healthy volunteers
5156819|NCT00985647|3TC|3tc
5156820|NCT00985647|Lamivudine|lamivudine
5156821|NCT00985634|off pump bypass OPCAB|off pump bypass opcab
5156822|NCT00985634|OPCAB|opcab
5156823|NCT00985621|monoclonal antibody|monoclonal antibody
5156824|NCT00985621|RN624|rn624
5156825|NCT00985621|PF-04383119|pf-04383119
5156826|NCT00985621|nerve growth factor|nerve growth factor
5156827|NCT00985621|OA|oa
5156828|NCT00985621|pain|pain
5156829|NCT00985621|arthritis|arthritis
5156830|NCT00985608|H pylori|h pylori
5156831|NCT00985608|eradication therapy|eradication therapy
5156832|NCT00985595|Adolescent|adolescent
5156833|NCT00985595|substance abuse|substance abuse
5156834|NCT00985582|Influenza A Virus (H1N1)|influenza a virus (h1n1)
5156835|NCT00985569|Constipation|constipation
5156836|NCT00985569|Nursing Home|nursing home
5156837|NCT00985569|Quality Indicator|quality indicator
5156838|NCT00985556|recurrent gastric cancer|recurrent gastric cancer
5156839|NCT00985556|adenocarcinoma of the stomach|adenocarcinoma of the stomach
5156840|NCT00985556|stage IIIA gastric cancer|stage iiia gastric cancer
5156841|NCT00985556|stage IIIB gastric cancer|stage iiib gastric cancer
5156842|NCT00985556|stage IIIC gastric cancer|stage iiic gastric cancer
5156843|NCT00985556|stage IV gastric cancer|stage iv gastric cancer
5156844|NCT00985543|HIV|hiv
5156845|NCT00985543|ART|art
5156846|NCT00985543|HAART|haart
5156847|NCT00985543|Pharmacokinetics|pharmacokinetics
5156848|NCT00985543|Lopinavir/ritonavir|lopinavir/ritonavir
5156849|NCT00985543|Lower dose selection|lower dose selection
5156850|NCT00985517|Parkinson's disease|parkinson's disease
5156851|NCT00985517|Movement Disorders|movement disorders
5156852|NCT00985517|Gene Therapy|gene therapy
5156853|NCT00985517|Neurotrophic Factors|neurotrophic factors
5156854|NCT00985517|GDNF|gdnf
5156855|NCT00985517|Neurturin|neurturin
5156856|NCT00985517|DBS|dbs
5156857|NCT00985517|Dopamine|dopamine
5156858|NCT00985504|Major Depressive Disorder|major depressive disorder
5156859|NCT00985504|Apathy|apathy
5156860|NCT00985504|Duloxetine Hydrochloride|duloxetine hydrochloride
5156861|NCT00985504|SSRI|ssri
5156862|NCT00985504|Escitalopram|escitalopram
5156863|NCT00985491|obesity|obesity
5156864|NCT00985478|First in Man|first in man
5156865|NCT00985478|SLV342|slv342
5156866|NCT00985478|Atherosclerosis|atherosclerosis
5156867|NCT00985465|Booster vaccination|booster vaccination
5156868|NCT00985465|Pneumococcal vaccine|pneumococcal vaccine
5156869|NCT00985465|Catch-up vaccination|catch-up vaccination
5156870|NCT00985465|Pneumococcal disease|pneumococcal disease
5156871|NCT00985465|Safety|safety
5156872|NCT00985465|Immunogenicity|immunogenicity
5156873|NCT00985452|Medication|medication
5156874|NCT00985452|Adherence|adherence
5156875|NCT00985452|Hypertension|hypertension
5156876|NCT00985426|chronic kidney disease|chronic kidney disease
5156877|NCT00985426|kidney failure|kidney failure
5156878|NCT00985426|kidney failure,chronic|kidney failure,chronic
5156879|NCT00985426|chronic kidney failure|chronic kidney failure
5156880|NCT00985426|hepatitis B virus (HBV) vaccine|hepatitis b virus (hbv) vaccine
5156881|NCT00985426|hepatitis B vaccine|hepatitis b vaccine
5156882|NCT00985426|hepatitis B|hepatitis b
5156883|NCT00985426|hepatitis|hepatitis
5156884|NCT00985426|HBV|hbv
5156885|NCT00985426|prevention and control|prevention and control
5156886|NCT00985426|dialysis|dialysis
5156887|NCT00985413|Cockayne Syndrome|cockayne syndrome
5156888|NCT00985413|pediatrics|pediatrics
5156889|NCT00985413|growth|growth
5156890|NCT00985413|hearing|hearing
5156891|NCT00985413|Ageing|ageing
5156892|NCT00985400|recurrent colon cancer|recurrent colon cancer
5156893|NCT00985400|stage IV colon cancer|stage iv colon cancer
5156894|NCT00985400|Gastrointestinal|gastrointestinal
5156895|NCT00985400|Exercise|exercise
5156896|NCT00985400|Relaxation|relaxation
5156897|NCT00985400|Meditation|meditation
5156898|NCT00985387|Solifenacin|solifenacin
5156899|NCT00985387|Overactive bladder|overactive bladder
5156900|NCT00985387|persistency of the treatment|persistency of the treatment
5156901|NCT00985387|Vesicare|vesicare
5156902|NCT00985348|Levetiracetam|levetiracetam
5156903|NCT00985348|Healthy volunteers|healthy volunteers
5156904|NCT00985348|Healthy Subjects|healthy subjects
5156905|NCT00985322|Hemodialysis|hemodialysis
5156906|NCT00985309|unsatisfactory|unsatisfactory
5156907|NCT00985309|Pap smear|pap smear
5156908|NCT00985296|Allergic rhinitis|allergic rhinitis
5156909|NCT00985296|Allergic conjunctivitis|allergic conjunctivitis
5156910|NCT00985283|prevention|prevention
5156911|NCT00985283|older adults|older adults
5156912|NCT00985283|function|function
5156913|NCT00985283|participation|participation
5156914|NCT00985283|life satisfaction|life satisfaction
5156915|NCT00985283|self-rated health|self-rated health
5156916|NCT00985244|COPD|copd
5156917|NCT00985244|COPD exacerbation|copd exacerbation
5156918|NCT00985244|macrolide|macrolide
5156919|NCT00985244|diseae progression|diseae progression
5156920|NCT00985244|bacterial colonisation|bacterial colonisation
5156921|NCT00985218|infertility|infertility
5156922|NCT00985218|embryo development|embryo development
5156923|NCT00985205|Randomized Clinical Trial|randomized clinical trial
5156924|NCT00985205|Glutamine|glutamine
5156925|NCT00985205|Themal Burn Injuries|themal burn injuries
5156926|NCT00985205|Nutrition|nutrition
5156927|NCT00985205|Outcome Assessment|outcome assessment
5156928|NCT00985205|Critical Care|critical care
5156929|NCT00985205|Total Body Surface Area|total body surface area
5156930|NCT00985192|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
5156931|NCT00985192|adenocarcinoma of the stomach|adenocarcinoma of the stomach
5156932|NCT00985192|recurrent esophageal cancer|recurrent esophageal cancer
5156933|NCT00985192|stage III esophageal cancer|stage iii esophageal cancer
5156934|NCT00985192|stage IV esophageal cancer|stage iv esophageal cancer
5156935|NCT00985192|recurrent gastric cancer|recurrent gastric cancer
5156936|NCT00985192|stage III gastric cancer|stage iii gastric cancer
5156937|NCT00985192|stage IV gastric cancer|stage iv gastric cancer
5156938|NCT00985179|Randomized Controlled Trial|randomized controlled trial
5156939|NCT00985179|evidence- and theory-based behavioral intervention|evidence- and theory-based behavioral intervention
5156940|NCT00985179|expert system|expert system
5156941|NCT00985179|stages of change|stages of change
5156942|NCT00985179|motivational interviewing|motivational interviewing
5156943|NCT00985179|tailoring|tailoring
5156944|NCT00985179|Self Care|self care
5156945|NCT00985179|Expert Systems|expert systems
5156946|NCT00985127|Hyperuricemia|hyperuricemia
5156947|NCT00985127|Gout|gout
5156948|NCT00985114|Type II Diabetes|type ii diabetes
5156949|NCT00985114|Obesity|obesity
5156950|NCT00985088|GSK Bio's influenza vaccine GSK2340274A|gsk bio's influenza vaccine gsk2340274a
5156951|NCT00985088|influenza infection|influenza infection
5156952|NCT00985088|GSK Bio's influenza vaccine GSK2340273A|gsk bio's influenza vaccine gsk2340273a
5156953|NCT00985075|Allergic rhinitis|allergic rhinitis
5156954|NCT00985075|Allergic conjunctivitis|allergic conjunctivitis
5156955|NCT00985062|Folic Acid|folic acid
5156956|NCT00985062|Homocysteine|homocysteine
5156957|NCT00985062|Ovarian response|ovarian response
5156958|NCT00985062|In Vitro Fertilization|in vitro fertilization
5156959|NCT00985036|glioma|glioma
5156960|NCT00985036|meningioma|meningioma
5156961|NCT00985036|VEGF|vegf
5156962|NCT00985023|Unstable|unstable
5156963|NCT00985023|Lisfranc|lisfranc
5156964|NCT00985023|fracture|fracture
5156965|NCT00985023|dislocation|dislocation
5156966|NCT00985023|midfoot|midfoot
5156967|NCT00985010|hepatic encephalopathy|hepatic encephalopathy
5156968|NCT00985010|hepatitis C|hepatitis c
5156969|NCT00985010|manganese|manganese
5156970|NCT00985010|mortality|mortality
5156971|NCT00985010|prognosis.|prognosis.
5156972|NCT00984997|Superior Sulcus Tumor|superior sulcus tumor
5156973|NCT00984997|Lung Cancer|lung cancer
5156974|NCT00984997|Non-Small Cell|non-small cell
5156975|NCT00984997|Multimodality Treatment|multimodality treatment
5156976|NCT00984997|Surgery|surgery
5156977|NCT00984997|Segmentectomy|segmentectomy
5156978|NCT00984997|Lobectomy|lobectomy
5156979|NCT00984997|Cisplatin|cisplatin
5156980|NCT00984997|CDDP|cddp
5156981|NCT00984997|Etoposide|etoposide
5156982|NCT00984997|VP-16|vp-16
5156983|NCT00984997|VePesid|vepesid
5156984|NCT00984997|Radiation Therapy|radiation therapy
5156985|NCT00984997|Radiotherapy|radiotherapy
5156986|NCT00984997|Chest Irradiation|chest irradiation
5156987|NCT00984997|Prophylactic Cranial Irradiation|prophylactic cranial irradiation
5156988|NCT00984997|PCI|pci
5156989|NCT00984971|Microbicides|microbicides
5156990|NCT00984971|Tenofovir|tenofovir
5156991|NCT00984971|HIV seronegativity|hiv seronegativity
5156992|NCT00984945|pandemic vaccine|pandemic vaccine
5156993|NCT00984945|influenza|influenza
5156994|NCT00984945|H5N1|h5n1
5156995|NCT00984945|Virus Like Particle (VLP)|virus like particle (vlp)
5156996|NCT00984932|systemic sclerosis|systemic sclerosis
5156997|NCT00984932|pulmonary hypertension|pulmonary hypertension
5156998|NCT00984932|rosuvastatin|rosuvastatin
5156999|NCT00984919|recurrent prostate cancer|recurrent prostate cancer
5157000|NCT00984919|stage I prostate cancer|stage i prostate cancer
5157001|NCT00984919|stage II prostate cancer|stage ii prostate cancer
5157002|NCT00984919|stage III prostate cancer|stage iii prostate cancer
5157003|NCT00984919|stage IV prostate cancer|stage iv prostate cancer
5157004|NCT00984893|Osteoporosis|osteoporosis
5157005|NCT00984893|Bone Mineral density|bone mineral density
5157006|NCT00984893|fragility fractures|fragility fractures
5157007|NCT00984893|zoledronic acid.|zoledronic acid.
5157008|NCT00984893|Treatment|treatment
5157009|NCT00984880|Sedation|sedation
5157010|NCT00984880|anaesthesia|anaesthesia
5157011|NCT00984880|Safety|safety
5157012|NCT00984880|Tolerability|tolerability
5157013|NCT00984880|Pharmacokinetics|pharmacokinetics
5157014|NCT00984880|Pharmacodynamics|pharmacodynamics
5157015|NCT00984867|Dapagliflozin DPP IV inhibitor add on study|dapagliflozin dpp iv inhibitor add on study
5157016|NCT00984867|Inadequate control|inadequate control
5157017|NCT00984854|Cicatrix|cicatrix
5157018|NCT00984854|Scar|scar
5157019|NCT00984854|Wound-healing|wound-healing
5157020|NCT00984854|Re-epithelialisation|re-epithelialisation
5157021|NCT00984854|RN1004|rn1004
5157022|NCT00984854|Mannose-6-phosphate|mannose-6-phosphate
5157023|NCT00984854|M6P|m6p
5157024|NCT00984854|Juvidex|juvidex
5157025|NCT00984841|Diabetes Mellitus targeted mailing|diabetes mellitus targeted mailing
5157026|NCT00984828|multiple myeloma|multiple myeloma
5157027|NCT00984828|autologous stem cell transplantation|autologous stem cell transplantation
5157028|NCT00984828|velcade|velcade
5157029|NCT00984815|NSAID|nsaid
5157030|NCT00984815|Chronic Pain|chronic pain
5157031|NCT00984815|Osteoarthritis|osteoarthritis
5157032|NCT00984815|Rheumatoid Arthritis|rheumatoid arthritis
5157033|NCT00984789|Transdermal Patch|transdermal patch
5157034|NCT00984789|Bleeding|bleeding
5157035|NCT00984789|Pregnancy|pregnancy
5157036|NCT00984776|coronary artery|coronary artery
5157037|NCT00984776|MRI|mri
5157038|NCT00984776|vessel wall imaging|vessel wall imaging
5157039|NCT00984763|Malaria|malaria
5157040|NCT00984763|Vaccine|vaccine
5157041|NCT00984724|Smoking|smoking
5157042|NCT00984724|Motivation and Problem Solving|motivation and problem solving
5157043|NCT00984724|MAPS|maps
5157044|NCT00984724|Low Income Smokers|low income smokers
5157045|NCT00984724|HCHD community clinics|hchd community clinics
5157046|NCT00984724|Telephone-based counseling|telephone-based counseling
5157047|NCT00984698|Posttraumatic Stress Disorder|posttraumatic stress disorder
5157048|NCT00984698|Depression|depression
5157049|NCT00984698|Sleep Initiation and Maintenance Disorders|sleep initiation and maintenance disorders
5157050|NCT00984698|Insomnia|insomnia
5157051|NCT00984698|Psychotherapy, Group|psychotherapy, group
5157052|NCT00984698|Cognitive Behavioral Therapy|cognitive behavioral therapy
5157053|NCT00984698|Randomized Controlled Trial|randomized controlled trial
5157054|NCT00984698|Veterans|veterans
5157055|NCT00984698|Social Rhythms|social rhythms
5157056|NCT00984672|Lumbar Degenerative Disease|lumbar degenerative disease
5157057|NCT00984672|Bone Morphogenetic Protein|bone morphogenetic protein
5157058|NCT00984672|TLIF|tlif
5157059|NCT00984659|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
5157060|NCT00984659|Dyspnea|dyspnea
5157061|NCT00984646|Cicatrix|cicatrix
5157062|NCT00984646|Scar|scar
5157063|NCT00984646|Wound-healing|wound-healing
5157064|NCT00984646|Prevascar|prevascar
5157065|NCT00984646|Interleukin-10 (IL-10)|interleukin-10 (il-10)
5157066|NCT00984646|Ilodecakin|ilodecakin
5157067|NCT00984646|RN1003|rn1003
5157068|NCT00984633|Neuromuscular Blocking Agents|neuromuscular blocking agents
5157069|NCT00984607|Laparoscopic Gastric Band|laparoscopic gastric band
5157070|NCT00984607|LAP BAND system|lap band system
5157071|NCT00984594|allograft|allograft
5157072|NCT00984594|knee injury|knee injury
5157073|NCT00984594|cartilage injury|cartilage injury
5157074|NCT00984581|Cicatrix|cicatrix
5157075|NCT00984581|Scar|scar
5157076|NCT00984581|Wound healing|wound healing
5157077|NCT00984581|Avotermin|avotermin
5157078|NCT00984581|TGF beta 3|tgf beta 3
5157079|NCT00984581|Juvista|juvista
5157080|NCT00984581|RN1001|rn1001
5157081|NCT00984555|Biomarkers|biomarkers
5157082|NCT00984555|Semen Exposure|semen exposure
5157083|NCT00984542|recurrent small cell lung cancer|recurrent small cell lung cancer
5157084|NCT00984529|Chronic heart failure|chronic heart failure
5157085|NCT00984529|candesartan cilexetil|candesartan cilexetil
5157086|NCT00984529|clinical signs|clinical signs
5157087|NCT00984529|symptoms|symptoms
5157088|NCT00984516|Cicatrix|cicatrix
5157089|NCT00984516|Scar|scar
5157090|NCT00984516|Wound-healing|wound-healing
5157091|NCT00984516|Juvidex|juvidex
5157092|NCT00984516|Mannose-6-phosphate|mannose-6-phosphate
5157093|NCT00984516|M6P|m6p
5157094|NCT00984516|RN1004|rn1004
5157095|NCT00984503|Cicatrix|cicatrix
5157096|NCT00984503|Scar|scar
5157097|NCT00984503|Wound healing|wound healing
5157098|NCT00984503|Avotermin|avotermin
5157099|NCT00984503|TGF beta 3|tgf beta 3
5157100|NCT00984503|Juvista|juvista
5157101|NCT00984503|RN1001|rn1001
5157102|NCT00984490|stage I breast cancer|stage i breast cancer
5157103|NCT00984490|stage II breast cancer|stage ii breast cancer
5157104|NCT00984477|Healthy volunteer|healthy volunteer
5157105|NCT00984477|healthy subjects|healthy subjects
5157106|NCT00984477|AZD5122|azd5122
5157107|NCT00984477|single oral dose|single oral dose
5157108|NCT00984477|phase 1|phase 1
5157109|NCT00984477|Healthy volunteer phase 1 study|healthy volunteer phase 1 study
5157110|NCT00984464|metastatic|metastatic
5157111|NCT00984464|melanoma|melanoma
5157112|NCT00984464|REOLYSIN|reolysin
5157113|NCT00984464|chemotherapy|chemotherapy
5157114|NCT00984464|carboplatin|carboplatin
5157115|NCT00984464|paclitaxel|paclitaxel
5157116|NCT00984451|Antibody Treatment|antibody treatment
5157117|NCT00984451|Immune Therapy|immune therapy
5157118|NCT00984451|Infectious Diseases|infectious diseases
5157119|NCT00984451|IVIG|ivig
5157120|NCT00984451|Plasma Apheresis|plasma apheresis
5157121|NCT00984451|Influenza A|influenza a
5157122|NCT00984451|Swine Flu|swine flu
5157123|NCT00984399|vaginitis|vaginitis
5157124|NCT00984399|Postmenopausal|postmenopausal
5157125|NCT00984399|17-β estradiol|17-β estradiol
5157126|NCT00984399|09-110|09-110
5157127|NCT00984386|Cicatrix|cicatrix
5157128|NCT00984386|Scar|scar
5157129|NCT00984386|Wound-healing|wound-healing
5157130|NCT00984386|Zesteem|zesteem
5157131|NCT00984386|17β-Estradiol|17β-estradiol
5157132|NCT00984386|RN1002|rn1002
5157133|NCT00984373|Schizophrenia epidemiology|schizophrenia epidemiology
5157134|NCT00984373|Schizophrenic patients' social and health characteristics|schizophrenic patients' social and health characteristics
5157135|NCT00984360|Meth|meth
5157136|NCT00984360|Methamphetamine Addiction|methamphetamine addiction
5157137|NCT00984360|Methamphetamine Treatment|methamphetamine treatment
5157138|NCT00984360|Naltrexone|naltrexone
5157139|NCT00984360|Vivitrol|vivitrol
5157140|NCT00984360|A118G|a118g
5157141|NCT00984360|OPRM1|oprm1
5157142|NCT00984347|nipple stimulation|nipple stimulation
5157143|NCT00984347|Oxytocin|oxytocin
5157144|NCT00984347|induction of labor|induction of labor
5157145|NCT00984347|term pregnancies|term pregnancies
5157146|NCT00984347|grandmultipara|grandmultipara
5157147|NCT00984347|VBAC|vbac
5157148|NCT00984347|PROM|prom
5157149|NCT00984347|comparison of two methods for induction of labor|comparison of two methods for induction of labor
5157150|NCT00984334|pain|pain
5157151|NCT00984334|opioid|opioid
5157152|NCT00984334|constipation|constipation
5157153|NCT00984334|Subjects taking opioids for chronic non-cancer pain, who|subjects taking opioids for chronic non-cancer pain, who
5157154|NCT00984334|experience symptoms of opioid induced constipation|experience symptoms of opioid induced constipation
5157155|NCT00984321|Geriatric|geriatric
5157156|NCT00984321|Elderly|elderly
5157157|NCT00984321|Counseling|counseling
5157158|NCT00984321|Depression|depression
5157159|NCT00984321|Anxiety|anxiety
5157160|NCT00984321|Intervention|intervention
5157161|NCT00984321|Psychoeducational|psychoeducational
5157162|NCT00984321|09-116|09-116
5157163|NCT00984308|sleep apnea|sleep apnea
5157164|NCT00984308|hypertension|hypertension
5157165|NCT00984308|brain ischemia|brain ischemia
5157166|NCT00984282|RAI-Refractory|rai-refractory
5157167|NCT00984282|Differentiated|differentiated
5157168|NCT00984282|Follicular|follicular
5157169|NCT00984282|Papillary|papillary
5157170|NCT00984282|Hurthle|hurthle
5157171|NCT00984256|Malaria|malaria
5157172|NCT00984256|Prophylaxis|prophylaxis
5157173|NCT00984256|Atovaquone|atovaquone
5157174|NCT00984256|Malarone|malarone
5157175|NCT00984256|Challenge|challenge
5157176|NCT00984243|lung cancer|lung cancer
5157177|NCT00984230|Infant Formula|infant formula
5157178|NCT00984230|Gut|gut
5157179|NCT00984217|panitumumab|panitumumab
5157180|NCT00984217|salivary gland malignancies|salivary gland malignancies
5157181|NCT00984217|radiotherapy|radiotherapy
5157182|NCT00984204|cavo-tricuspid dependent|cavo-tricuspid dependent
5157183|NCT00984191|Papillary thyroid cancer|papillary thyroid cancer
5157184|NCT00984191|99mTechnetium MIBI SPECT CT|99mtechnetium mibi spect ct
5157185|NCT00984191|preoperative|preoperative
5157186|NCT00984191|cervical lymphadenopathy|cervical lymphadenopathy
5157187|NCT00984191|cervical metastasis|cervical metastasis
5157188|NCT00984178|Reperfusion|reperfusion
5157189|NCT00984178|acute myocardial infarction|acute myocardial infarction
5157190|NCT00984178|stem cell therapy|stem cell therapy
5157191|NCT00984178|GCSF|gcsf
5157192|NCT00984178|bone marrow mononuclear cells|bone marrow mononuclear cells
5157193|NCT00984178|magnetic resonance|magnetic resonance
5157194|NCT00984165|Allotransplant|allotransplant
5157195|NCT00984165|Relapse|relapse
5157196|NCT00984165|Radiation|radiation
5157197|NCT00984165|Donor Lymphocyte Infusion|donor lymphocyte infusion
5157198|NCT00984165|Hematologic Malignancies|hematologic malignancies
5157199|NCT00984165|Multiple Myeloma|multiple myeloma
5157200|NCT00984165|Hodgkin Lymphoma|hodgkin lymphoma
5157201|NCT00984165|Non-Hodgkin Lymphoma|non-hodgkin lymphoma
5157202|NCT00984165|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
5157204|NCT00984152|Raltegravir|raltegravir
5157205|NCT00984152|Women|women
5157206|NCT00984152|Viral Suppression|viral suppression
5157207|NCT00984152|Viral Reservoir|viral reservoir
5157208|NCT00984152|Immune Parameters|immune parameters
5157209|NCT00984152|Gut|gut
5157210|NCT00984152|Genital Tract|genital tract
5157211|NCT00984139|persistence|persistence
5157212|NCT00984139|HBV|hbv
5157213|NCT00984139|Long-term|long-term
5157214|NCT00984139|Engerix™-B Kinder|engerix™-b kinder
5157215|NCT00984139|Hepatitis B|hepatitis b
5157216|NCT00984139|adolescent|adolescent
5157217|NCT00984113|Elinogrel|elinogrel
5157218|NCT00984113|Renal impairment|renal impairment
5157219|NCT00984113|Healthy|healthy
5157220|NCT00984113|Kidney dysfunction|kidney dysfunction
5157221|NCT00984100|Cholelithiasis|cholelithiasis
5157222|NCT00984100|Biliary dyskinesia|biliary dyskinesia
5157223|NCT00984087|depression|depression
5157224|NCT00984087|TMS|tms
5157225|NCT00984087|adolescent|adolescent
5157226|NCT00984087|transcranial magnetic stimulation|transcranial magnetic stimulation
5157227|NCT00984087|MDD|mdd
5157228|NCT00984087|Major depression|major depression
5157229|NCT00984087|mood disorders|mood disorders
5157230|NCT00984074|stage III salivary gland cancer|stage iii salivary gland cancer
5157231|NCT00984074|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
5157232|NCT00984074|stage I squamous cell carcinoma of the hypopharynx|stage i squamous cell carcinoma of the hypopharynx
5157233|NCT00984074|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
5157234|NCT00984074|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
5157235|NCT00984074|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
5157236|NCT00984074|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
5157237|NCT00984074|stage I squamous cell carcinoma of the larynx|stage i squamous cell carcinoma of the larynx
5157238|NCT00984074|stage I verrucous carcinoma of the larynx|stage i verrucous carcinoma of the larynx
5157239|NCT00984074|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
5157240|NCT00984074|stage II verrucous carcinoma of the larynx|stage ii verrucous carcinoma of the larynx
5157241|NCT00984074|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
5157242|NCT00984074|stage III verrucous carcinoma of the larynx|stage iii verrucous carcinoma of the larynx
5157243|NCT00984074|recurrent adenoid cystic carcinoma of the oral cavity|recurrent adenoid cystic carcinoma of the oral cavity
5157244|NCT00984074|recurrent mucoepidermoid carcinoma of the oral cavity|recurrent mucoepidermoid carcinoma of the oral cavity
5157386|NCT00983814|ADHD|adhd
5157387|NCT00983814|Adult ADHD|adult adhd
5157245|NCT00984074|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
5157246|NCT00984074|stage I adenoid cystic carcinoma of the oral cavity|stage i adenoid cystic carcinoma of the oral cavity
5157247|NCT00984074|stage I mucoepidermoid carcinoma of the oral cavity|stage i mucoepidermoid carcinoma of the oral cavity
5157248|NCT00984074|stage I verrucous carcinoma of the oral cavity|stage i verrucous carcinoma of the oral cavity
5157249|NCT00984074|stage II adenoid cystic carcinoma of the oral cavity|stage ii adenoid cystic carcinoma of the oral cavity
5157250|NCT00984074|stage II mucoepidermoid carcinoma of the oral cavity|stage ii mucoepidermoid carcinoma of the oral cavity
5157251|NCT00984074|stage II verrucous carcinoma of the oral cavity|stage ii verrucous carcinoma of the oral cavity
5157252|NCT00984074|stage III adenoid cystic carcinoma of the oral cavity|stage iii adenoid cystic carcinoma of the oral cavity
5157253|NCT00984074|stage III mucoepidermoid carcinoma of the oral cavity|stage iii mucoepidermoid carcinoma of the oral cavity
5157254|NCT00984074|stage III verrucous carcinoma of the oral cavity|stage iii verrucous carcinoma of the oral cavity
5157255|NCT00984074|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
5157256|NCT00984074|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
5157257|NCT00984074|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
5157258|NCT00984074|recurrent basal cell carcinoma of the lip|recurrent basal cell carcinoma of the lip
5157259|NCT00984074|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
5157260|NCT00984074|stage I basal cell carcinoma of the lip|stage i basal cell carcinoma of the lip
5157261|NCT00984074|stage II basal cell carcinoma of the lip|stage ii basal cell carcinoma of the lip
5157262|NCT00984074|stage III basal cell carcinoma of the lip|stage iii basal cell carcinoma of the lip
5157263|NCT00984074|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
5157264|NCT00984074|untreated metastatic squamous neck cancer with occult primary|untreated metastatic squamous neck cancer with occult primary
5157265|NCT00984074|recurrent lymphoepithelioma of the nasopharynx|recurrent lymphoepithelioma of the nasopharynx
5157266|NCT00984074|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
5157267|NCT00984074|stage I lymphoepithelioma of the nasopharynx|stage i lymphoepithelioma of the nasopharynx
5157268|NCT00984074|stage I squamous cell carcinoma of the nasopharynx|stage i squamous cell carcinoma of the nasopharynx
5157269|NCT00984074|stage II lymphoepithelioma of the nasopharynx|stage ii lymphoepithelioma of the nasopharynx
5157270|NCT00984074|stage II squamous cell carcinoma of the nasopharynx|stage ii squamous cell carcinoma of the nasopharynx
5157271|NCT00984074|stage III lymphoepithelioma of the nasopharynx|stage iii lymphoepithelioma of the nasopharynx
5157272|NCT00984074|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
5157273|NCT00984074|recurrent lymphoepithelioma of the oropharynx|recurrent lymphoepithelioma of the oropharynx
5157274|NCT00984074|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
5157275|NCT00984074|stage I lymphoepithelioma of the oropharynx|stage i lymphoepithelioma of the oropharynx
5157276|NCT00984074|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
5157277|NCT00984074|stage II lymphoepithelioma of the oropharynx|stage ii lymphoepithelioma of the oropharynx
5157278|NCT00984074|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
5157279|NCT00984074|stage III lymphoepithelioma of the oropharynx|stage iii lymphoepithelioma of the oropharynx
5157280|NCT00984074|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
5157281|NCT00984074|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity
5157282|NCT00984074|recurrent inverted papilloma of the paranasal sinus and nasal cavity|recurrent inverted papilloma of the paranasal sinus and nasal cavity
5157283|NCT00984074|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity
5157284|NCT00984074|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
5157285|NCT00984074|stage I esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage i esthesioneuroblastoma of the paranasal sinus and nasal cavity
5157286|NCT00984074|stage I inverted papilloma of the paranasal sinus and nasal cavity|stage i inverted papilloma of the paranasal sinus and nasal cavity
5157287|NCT00984074|stage I midline lethal granuloma of the paranasal sinus and nasal cavity|stage i midline lethal granuloma of the paranasal sinus and nasal cavity
5157288|NCT00984074|stage I squamous cell carcinoma of the paranasal sinus and nasal cavity|stage i squamous cell carcinoma of the paranasal sinus and nasal cavity
5157289|NCT00984074|stage II esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage ii esthesioneuroblastoma of the paranasal sinus and nasal cavity
5157290|NCT00984074|stage II inverted papilloma of the paranasal sinus and nasal cavity|stage ii inverted papilloma of the paranasal sinus and nasal cavity
5157406|NCT00983749|Blood Flow Velocity|blood flow velocity
5157291|NCT00984074|stage II midline lethal granuloma of the paranasal sinus and nasal cavity|stage ii midline lethal granuloma of the paranasal sinus and nasal cavity
5157292|NCT00984074|stage II squamous cell carcinoma of the paranasal sinus and nasal cavity|stage ii squamous cell carcinoma of the paranasal sinus and nasal cavity
5157293|NCT00984074|stage III esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iii esthesioneuroblastoma of the paranasal sinus and nasal cavity
5157294|NCT00984074|stage III inverted papilloma of the paranasal sinus and nasal cavity|stage iii inverted papilloma of the paranasal sinus and nasal cavity
5157575|NCT00983047|Docetaxel|docetaxel
5157295|NCT00984074|stage III midline lethal granuloma of the paranasal sinus and nasal cavity|stage iii midline lethal granuloma of the paranasal sinus and nasal cavity
5157296|NCT00984074|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
5157297|NCT00984074|high-grade salivary gland mucoepidermoid carcinoma|high-grade salivary gland mucoepidermoid carcinoma
5157298|NCT00984074|low-grade salivary gland mucoepidermoid carcinoma|low-grade salivary gland mucoepidermoid carcinoma
5157299|NCT00984074|recurrent salivary gland cancer|recurrent salivary gland cancer
5157300|NCT00984074|salivary gland acinic cell tumor|salivary gland acinic cell tumor
5157301|NCT00984074|salivary gland adenocarcinoma|salivary gland adenocarcinoma
5157302|NCT00984074|salivary gland adenoid cystic carcinoma|salivary gland adenoid cystic carcinoma
5157303|NCT00984074|salivary gland anaplastic carcinoma|salivary gland anaplastic carcinoma
5157304|NCT00984074|salivary gland malignant mixed cell type tumor|salivary gland malignant mixed cell type tumor
5157305|NCT00984074|salivary gland poorly differentiated carcinoma|salivary gland poorly differentiated carcinoma
5157306|NCT00984074|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
5157307|NCT00984074|stage I salivary gland cancer|stage i salivary gland cancer
5157308|NCT00984074|stage II salivary gland cancer|stage ii salivary gland cancer
5157309|NCT00984074|tongue cancer|tongue cancer
5157310|NCT00984061|healthy|healthy
5157311|NCT00984061|pharmacokinetics|pharmacokinetics
5157312|NCT00984061|drug-drug interaction|drug-drug interaction
5157313|NCT00984048|Colorectal cancer|colorectal cancer
5157314|NCT00984048|FOLFOX|folfox
5157315|NCT00984048|FOLFIRI|folfiri
5157316|NCT00984048|Avastin|avastin
5157317|NCT00984048|Metastases|metastases
5157318|NCT00984048|Liver|liver
5157319|NCT00984048|Colon cancer|colon cancer
5157320|NCT00984048|Biomarkers|biomarkers
5157321|NCT00984048|Resistance|resistance
5157322|NCT00984048|Biobanking|biobanking
5157323|NCT00984048|Colorectal cancer with unresectable metastases to the liver|colorectal cancer with unresectable metastases to the liver
5157324|NCT00984022|abscess|abscess
5157325|NCT00984022|MRSA|mrsa
5157326|NCT00984022|Aquacel dressing|aquacel dressing
5157327|NCT00984022|Iodoform dressing|iodoform dressing
5157328|NCT00984009|healthy|healthy
5157329|NCT00984009|pharmacokinetics|pharmacokinetics
5157330|NCT00984009|grapefruit juice|grapefruit juice
5157331|NCT00984009|furanocoumarins|furanocoumarins
5157332|NCT00984009|cytochrome p450 3A4|cytochrome p450 3a4
5157333|NCT00983983|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
5157335|NCT00983983|Motor Neuron Disease|motor neuron disease
5157336|NCT00983983|MND|mnd
5157337|NCT00983983|Fat|fat
5157338|NCT00983983|Lipid|lipid
5157339|NCT00983983|Cholesterol|cholesterol
5157340|NCT00983983|Omega-3 fatty acid|omega-3 fatty acid
5157341|NCT00983983|Diet|diet
5157342|NCT00983983|Tube feed|tube feed
5157343|NCT00983983|Gastrostomy|gastrostomy
5157344|NCT00983983|PEG|peg
5157345|NCT00983983|Adults with Amyotrophic Lateral Sclerosis (ALS)|adults with amyotrophic lateral sclerosis (als)
5157346|NCT00983970|Adolescents|adolescents
5157347|NCT00983970|Obesity|obesity
5157348|NCT00983970|Exercise|exercise
5157349|NCT00983970|Music|music
5157350|NCT00983970|Virtual Reality|virtual reality
5157351|NCT00983944|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
5157352|NCT00983944|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5157353|NCT00983944|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
5157354|NCT00983944|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5157355|NCT00983944|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5157356|NCT00983944|childhood diffuse large cell lymphoma|childhood diffuse large cell lymphoma
5157357|NCT00983944|stage I childhood large cell lymphoma|stage i childhood large cell lymphoma
5157358|NCT00983944|stage II childhood large cell lymphoma|stage ii childhood large cell lymphoma
5157359|NCT00983944|stage III childhood large cell lymphoma|stage iii childhood large cell lymphoma
5157360|NCT00983944|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
5157361|NCT00983931|healthy|healthy
5157362|NCT00983931|adult|adult
5157363|NCT00983931|colchicine|colchicine
5157364|NCT00983931|cyclosporine|cyclosporine
5157365|NCT00983931|blood levels over time|blood levels over time
5157366|NCT00983905|healthy;|healthy;
5157367|NCT00983905|adult;|adult;
5157368|NCT00983905|blood levels over time|blood levels over time
5157369|NCT00983892|Cancer|cancer
5157370|NCT00983892|caregiver|caregiver
5157371|NCT00983892|pain|pain
5157372|NCT00983892|symptom|symptom
5157373|NCT00983892|information technology|information technology
5157374|NCT00983892|palliative care|palliative care
5157375|NCT00983879|Infantile globoid cell leukodystrophy|infantile globoid cell leukodystrophy
5157376|NCT00983879|GLD|gld
5157377|NCT00983879|Krabbe disease|krabbe disease
5157378|NCT00983879|Natural History Study|natural history study
5157379|NCT00983853|VX-950|vx-950
5157380|NCT00983853|INCIVEK|incivek
5157381|NCT00983853|INCIVO|incivo
5157382|NCT00983840|diet|diet
5157383|NCT00983840|African-American families|african-american families
5157384|NCT00983840|web-based|web-based
5157385|NCT00983814|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
5157388|NCT00983814|Adult Attention Deficit Hyperactivity Disorder|adult attention deficit hyperactivity disorder
5157389|NCT00983788|CPT II|cpt ii
5157390|NCT00983788|VLCAD|vlcad
5157391|NCT00983775|Pharmacokinetic profile|pharmacokinetic profile
5157392|NCT00983775|Pharmacodynamic profile|pharmacodynamic profile
5157393|NCT00983775|insulin|insulin
5157394|NCT00983775|jet injector|jet injector
5157395|NCT00983762|Knee osteoarthritis|knee osteoarthritis
5157396|NCT00983762|Leg strength|leg strength
5157397|NCT00983762|Functional outcomes|functional outcomes
5157398|NCT00983762|Minimally Invasive Surgery Mini-Incision (MIS) TKA|minimally invasive surgery mini-incision (mis) tka
5157399|NCT00983762|Unicompartmental knee arthroplasty|unicompartmental knee arthroplasty
5157400|NCT00983762|Standard Para-patellar surgery TKA|standard para-patellar surgery tka
5157401|NCT00983762|gait|gait
5157402|NCT00983762|knee arthroplasty|knee arthroplasty
5157403|NCT00983749|External Counterpulsation|external counterpulsation
5157404|NCT00983749|Counterpulsation, Diastolic|counterpulsation, diastolic
5157405|NCT00983749|Ultrasonography, Doppler, Transcranial|ultrasonography, doppler, transcranial
5157407|NCT00983749|Neurologic Deficit|neurologic deficit
5157408|NCT00983723|Patient Foramen Ovale|patient foramen ovale
5157409|NCT00983723|PFO|pfo
5157410|NCT00983723|Stroke|stroke
5157411|NCT00983723|Ischemic Brain Injury|ischemic brain injury
5157412|NCT00983723|Neurovascular Disease|neurovascular disease
5157413|NCT00983710|prostate neoplasms|prostate neoplasms
5157414|NCT00983697|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
5157415|NCT00983697|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
5157416|NCT00983697|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
5157417|NCT00983697|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
5157418|NCT00983697|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
5157419|NCT00983697|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
5157420|NCT00983697|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5157421|NCT00983697|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5157422|NCT00983697|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5157423|NCT00983697|stage II verrucous carcinoma of the oral cavity|stage ii verrucous carcinoma of the oral cavity
5157424|NCT00983697|stage III verrucous carcinoma of the oral cavity|stage iii verrucous carcinoma of the oral cavity
5157425|NCT00983697|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
5157426|NCT00983697|tongue cancer|tongue cancer
5157427|NCT00983684|Neoplasms by Site|neoplasms by site
5157428|NCT00983684|Breast Neoplasms|breast neoplasms
5157429|NCT00983684|Breast Diseases|breast diseases
5157430|NCT00983684|Breast Cancer|breast cancer
5157431|NCT00983684|Cancer of Breast|cancer of breast
5157432|NCT00983684|Cancer of the Breast|cancer of the breast
5157433|NCT00983684|Carcinoma|carcinoma
5157434|NCT00983671|Asthma|asthma
5157435|NCT00983671|cystic fibrosis|cystic fibrosis
5157436|NCT00983671|chronic lung disease|chronic lung disease
5157437|NCT00983671|bronchopulmonary dysplasia|bronchopulmonary dysplasia
5157438|NCT00983671|pneumonia|pneumonia
5157439|NCT00983658|Anti-OX40L|anti-ox40l
5157440|NCT00983658|Mild Allergic Asthma|mild allergic asthma
5157441|NCT00983658|Allergies|allergies
5157442|NCT00983658|Allergic Asthma|allergic asthma
5157443|NCT00983658|Adult Asthma|adult asthma
5157444|NCT00983645|Kidney Transplantation|kidney transplantation
5157445|NCT00983645|Immunosuppression|immunosuppression
5157446|NCT00983632|vagus nerve stimulation|vagus nerve stimulation
5157447|NCT00983632|heart rate|heart rate
5157448|NCT00983632|systolic arterial pressure|systolic arterial pressure
5157449|NCT00983619|Cancer|cancer
5157450|NCT00983593|Mind Body Bridging|mind body bridging
5157451|NCT00983593|Domestic Violence Offender Treatment|domestic violence offender treatment
5157452|NCT00983593|Batterer Treatment|batterer treatment
5157453|NCT00983554|testosterone|testosterone
5157454|NCT00983554|insulin|insulin
5157455|NCT00983554|obesity|obesity
5157456|NCT00983554|aromatase|aromatase
5157457|NCT00983554|5 alpha reductase|5 alpha reductase
5157458|NCT00983541|intra or extrahepatic cholangiocarcinoma|intra or extrahepatic cholangiocarcinoma
5157459|NCT00983541|liver cancer|liver cancer
5157460|NCT00983541|liver|liver
5157461|NCT00983541|HCC|hcc
5157462|NCT00983541|EHCC|ehcc
5157463|NCT00983528|cancer|cancer
5157464|NCT00983528|lymphoblastic|lymphoblastic
5157465|NCT00983528|leukemia|leukemia
5157466|NCT00983502|Idiopathic Chronic Fatigue|idiopathic chronic fatigue
5157467|NCT00983502|Chronic Fatigue Syndrome|chronic fatigue syndrome
5157468|NCT00983502|Myalgic encephalomyelitis|myalgic encephalomyelitis
5157469|NCT00983489|breast feeding|breast feeding
5157470|NCT00983489|counselling|counselling
5157471|NCT00983489|video demonstration|video demonstration
5157472|NCT00983476|Randomized controlled trial|randomized controlled trial
5157473|NCT00983476|Obesity|obesity
5157474|NCT00983476|Comparative Effectiveness|comparative effectiveness
5157475|NCT00983476|Clinical practice guidelines|clinical practice guidelines
5157476|NCT00983476|Medical Informatics Computing|medical informatics computing
5157477|NCT00983476|Services, Mental Health|services, mental health
5157478|NCT00983476|Self-care|self-care
5157479|NCT00983476|Psychotic disorders|psychotic disorders
5157480|NCT00983476|Mental Health Care|mental health care
5157481|NCT00983476|Veterans|veterans
5157482|NCT00983463|Nonalcoholic fatty liver disease (NAFLD)|nonalcoholic fatty liver disease (nafld)
5157483|NCT00983463|Nonalcoholic steatohepatitis (NASH)|nonalcoholic steatohepatitis (nash)
5157484|NCT00983463|Obesity|obesity
5157485|NCT00983463|Lipidomics|lipidomics
5157486|NCT00983463|Proteomics|proteomics
5157487|NCT00983424|Breast Cancer|breast cancer
5157488|NCT00983411|non-invasive intermittent positive-pressure ventilation|non-invasive intermittent positive-pressure ventilation
5157489|NCT00983411|work of breathing|work of breathing
5157490|NCT00983411|Pulse transit time|pulse transit time
5157491|NCT00983385|low back pain|low back pain
5157492|NCT00983385|pain|pain
5157493|NCT00983385|assessment|assessment
5157494|NCT00983385|tapentadol|tapentadol
5157495|NCT00983385|centrally acting analgesic|centrally acting analgesic
5157496|NCT00983372|healthy; adult; volunteer; colchicine; diltiazem; blood levels over time|healthy; adult; volunteer; colchicine; diltiazem; blood levels over time
5157497|NCT00983359|tumors metastatic to brain|tumors metastatic to brain
5157498|NCT00983359|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5157499|NCT00983346|cancer|cancer
5157500|NCT00983346|myeloma|myeloma
5157501|NCT00983346|multiple myeloma|multiple myeloma
5157502|NCT00983346|smoldering myeloma|smoldering myeloma
5157503|NCT00983333|Health communication|health communication
5157504|NCT00983333|Health literacy|health literacy
5157505|NCT00983333|Patient|patient
5157506|NCT00983333|Health Care Professional|health care professional
5157507|NCT00983333|Satisfaction|satisfaction
5157508|NCT00983320|Fibromyalgia|fibromyalgia
5157509|NCT00983320|pain|pain
5157510|NCT00983320|quetiapine|quetiapine
5157511|NCT00983320|randomized placebo controlled trial|randomized placebo controlled trial
5157512|NCT00983307|Radiation|radiation
5157513|NCT00983307|Erlotinib|erlotinib
5157514|NCT00983307|Tarceva|tarceva
5157515|NCT00983294|blood levels over time;|blood levels over time;
5157516|NCT00983294|colchicine;|colchicine;
5157517|NCT00983294|azithromycin;|azithromycin;
5157518|NCT00983294|healthy|healthy
5157519|NCT00983281|Combat casualty care|combat casualty care
5157520|NCT00983281|Hextend|hextend
5157521|NCT00983281|Colloid|colloid
5157522|NCT00983268|periampullary adenocarcinoma|periampullary adenocarcinoma
5157523|NCT00983268|stage I pancreatic cancer|stage i pancreatic cancer
5157524|NCT00983268|stage II pancreatic cancer|stage ii pancreatic cancer
5157525|NCT00983268|stage III pancreatic cancer|stage iii pancreatic cancer
5157526|NCT00983229|difficult airway|difficult airway
5157527|NCT00983229|fibreoptic intubation|fibreoptic intubation
5157528|NCT00983229|supraglottic airways|supraglottic airways
5157529|NCT00983229|laryngeal mask airway|laryngeal mask airway
5157530|NCT00983216|blood levels over time;|blood levels over time;
5157531|NCT00983216|pharmacokinetics;|pharmacokinetics;
5157532|NCT00983216|healthy adult;|healthy adult;
5157533|NCT00983216|cytochrome p450|cytochrome p450
5157534|NCT00983203|Dry eye|dry eye
5157535|NCT00983203|artificial tears|artificial tears
5157536|NCT00983190|HeartMate II|heartmate ii
5157537|NCT00983190|BeneMACS|benemacs
5157538|NCT00983190|LVAD|lvad
5157539|NCT00983190|Thoratec Corporation|thoratec corporation
5157540|NCT00983164|antiviral therapy|antiviral therapy
5157541|NCT00983164|antioxidant therapy|antioxidant therapy
5157542|NCT00983164|hepatitis C virus|hepatitis c virus
5157543|NCT00983164|oxidative stress|oxidative stress
5157544|NCT00983164|vitamin E|vitamin e
5157545|NCT00983125|Labour|labour
5157546|NCT00983125|Epidural analgesia|epidural analgesia
5157547|NCT00983125|Clonidine|clonidine
5157548|NCT00983125|Levobupivacaine|levobupivacaine
5157549|NCT00983125|Opiates|opiates
5157550|NCT00983125|Patient-controlled|patient-controlled
5157551|NCT00983125|Active spontaneous labour requiring epidural analgesia|active spontaneous labour requiring epidural analgesia
5157552|NCT00983112|Gonarthrosis|gonarthrosis
5157553|NCT00983112|Knee prosthesis insertion|knee prosthesis insertion
5157554|NCT00983112|Bleeding|bleeding
5157555|NCT00983112|Undergoing a total knee prothesis surgery|undergoing a total knee prothesis surgery
5157556|NCT00983112|knee prothesis surgery|knee prothesis surgery
5157557|NCT00983112|Knee arthrosis|knee arthrosis
5157558|NCT00983112|Thrombosis|thrombosis
5157559|NCT00983086|Flavanones and vascular function|flavanones and vascular function
5157560|NCT00983073|Osteoarthritis|osteoarthritis
5157561|NCT00983073|Pain|pain
5157562|NCT00983073|Assessment|assessment
5157563|NCT00983073|Tapentadol|tapentadol
5157564|NCT00983073|Centrally acting analgesic|centrally acting analgesic
5157565|NCT00983073|Chronic pain due to osteoarthritis|chronic pain due to osteoarthritis
5157566|NCT00983060|NIM811|nim811
5157567|NCT00983060|chronic hepatitis|chronic hepatitis
5157568|NCT00983060|chronic hepatitis C|chronic hepatitis c
5157569|NCT00983060|chronic hepatitis C genotype-1|chronic hepatitis c genotype-1
5157571|NCT00983060|HCV-1|hcv-1
5157572|NCT00983060|relapser|relapser
5157573|NCT00983047|Nimotuzumab|nimotuzumab
5157574|NCT00983047|NSCLC|nsclc
5157576|NCT00983034|nephrotic syndrome|nephrotic syndrome
5157577|NCT00983034|Helicobacter pylori infection|helicobacter pylori infection
5157578|NCT00983034|proteinuria|proteinuria
5157579|NCT00983034|membranous nephropathy|membranous nephropathy
5157580|NCT00983008|Signs and Symptoms|signs and symptoms
5157581|NCT00983008|Fatigue|fatigue
5157582|NCT00983008|Sleep Deprivation|sleep deprivation
5157583|NCT00983008|Internship and Residency|internship and residency
5157584|NCT00983008|Depression|depression
5157585|NCT00983008|Medical Errors|medical errors
5157586|NCT00983008|Burnout, Professional|burnout, professional
5157587|NCT00983008|Burnout|burnout
5157588|NCT00983008|Actigraphy|actigraphy
5157589|NCT00983008|Personnel Staffing and Scheduling|personnel staffing and scheduling
5157590|NCT00983008|Workload|workload
5157591|NCT00983008|Humans|humans
5157592|NCT00983008|Adult|adult
5157593|NCT00983008|Male|male
5157594|NCT00983008|Female|female
5157595|NCT00983008|Intensive Care Units|intensive care units
5157596|NCT00983008|Prospective Studies|prospective studies
5157597|NCT00983008|Work Schedule Tolerance|work schedule tolerance
5157598|NCT00983008|Disorders of Excessive Somnolence|disorders of excessive somnolence
5157599|NCT00983008|Guideline Adherence|guideline adherence
5157600|NCT00983008|Internal Medicine Education|internal medicine education
5157601|NCT00982982|Schizophrenia|schizophrenia
5157602|NCT00982982|Mental Disorders|mental disorders
5157603|NCT00982982|Psychotic Disorders|psychotic disorders
5157604|NCT00982982|Schizophrenia and Disorders with Psychotic Features|schizophrenia and disorders with psychotic features
5157605|NCT00982982|Cannabis|cannabis
5157606|NCT00982969|tuberculosis|tuberculosis
5157607|NCT00982969|pneumonia|pneumonia
5157608|NCT00982969|QuantiFERON-TB Gold in-tube|quantiferon-tb gold in-tube
5157609|NCT00982969|Tuberculin skin test|tuberculin skin test
5157610|NCT00982930|Tobramycin Inhalation Powder|tobramycin inhalation powder
5157611|NCT00982930|Cystic fibrosis|cystic fibrosis
5157612|NCT00982930|Lung diseases|lung diseases
5157613|NCT00982930|Anti-Bacterial Agents|anti-bacterial agents
5157614|NCT00982917|playground|playground
5157615|NCT00982917|injury prevention|injury prevention
5157616|NCT00982904|neglected disease|neglected disease
5157617|NCT00982904|africa|africa
5157618|NCT00982904|new drug|new drug
5157619|NCT00982904|oral drug|oral drug
5157620|NCT00982904|parasite|parasite
5157621|NCT00982891|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
5157622|NCT00982891|palliation|palliation
5157623|NCT00982891|opioids|opioids
5157624|NCT00982878|treatment experienced|treatment experienced
5157625|NCT00982865|MEK inhibitor|mek inhibitor
5157626|NCT00982865|Cancer|cancer
5157627|NCT00982865|Solid tumors|solid tumors
5157628|NCT00982852|Angioplasty|angioplasty
5157629|NCT00982852|Coronary Vessels|coronary vessels
5157630|NCT00982852|Heart Disease|heart disease
5157631|NCT00982852|Cardiology|cardiology
5157632|NCT00982852|Atherosclerosis|atherosclerosis
5157633|NCT00982852|Catheterization|catheterization
5157634|NCT00982826|Phase 1|phase 1
5157635|NCT00982826|Single and Multiple Ascending Dose|single and multiple ascending dose
5157636|NCT00982826|Food Effect|food effect
5157637|NCT00982813|Periodontal disease|periodontal disease
5157638|NCT00982813|Per-term delivery|per-term delivery
5157639|NCT00982813|Sulcular bleeding index|sulcular bleeding index
5157640|NCT00982813|Bacteriological gingival presence|bacteriological gingival presence
5157641|NCT00982813|Cytokines|cytokines
5157642|NCT00982813|Active periodontal disease with sulcular bleeding index|active periodontal disease with sulcular bleeding index
5157643|NCT00982813|Bacteriological sampling in periodontal pocketing|bacteriological sampling in periodontal pocketing
5157644|NCT00982813|Cytokines in the periodontal pocketing|cytokines in the periodontal pocketing
5157645|NCT00982800|gabapentin|gabapentin
5157646|NCT00982800|opioid consumption|opioid consumption
5157647|NCT00982800|analgesic|analgesic
5157648|NCT00982800|anxiety|anxiety
5157649|NCT00982800|quality of life|quality of life
5157650|NCT00982787|Epilepsy|epilepsy
5157651|NCT00982787|Seizures|seizures
5157652|NCT00982787|Passiflora|passiflora
5157654|NCT00982761|occupational drivers|occupational drivers
5157655|NCT00982761|health status|health status
5157656|NCT00982748|Fatigue|fatigue
5157657|NCT00982748|Chemotherapy|chemotherapy
5157658|NCT00982748|Yoga|yoga
5157659|NCT00982748|Breathing|breathing
5157660|NCT00982748|Cancer|cancer
5157661|NCT00982748|Anxiety|anxiety
5157662|NCT00982748|Pranayama|pranayama
5157663|NCT00982748|Stress|stress
5157664|NCT00982748|Fatigue-associated symptoms in chemotherapy patients|fatigue-associated symptoms in chemotherapy patients
5157665|NCT00982748|Quality of life in chemotherapy patients|quality of life in chemotherapy patients
5157666|NCT00982722|primary hyperparathyroidism|primary hyperparathyroidism
5157667|NCT00982722|postoperative vitamin D supplementation|postoperative vitamin d supplementation
5157668|NCT00982696|head and neck cancer|head and neck cancer
5157669|NCT00982696|opioid growth factor|opioid growth factor
5157670|NCT00982683|Surgery|surgery
5157671|NCT00982683|Moon phases|moon phases
5157672|NCT00982683|hemorrhage|hemorrhage
5157673|NCT00982670|Metabolic syndrome|metabolic syndrome
5157674|NCT00982670|Systemic lupus erythematosus|systemic lupus erythematosus
5157675|NCT00982657|Phase Ib Phase II Advanced solid tumor Clear cell renal cancer Sunitinib plus / minus CVX-060|phase ib phase ii advanced solid tumor clear cell renal cancer sunitinib plus / minus cvx-060
5157676|NCT00982631|temsirolimus (Torisel®)|temsirolimus (torisel®)
5157677|NCT00982631|pegylated liposomal doxorubicin (PLD, Doxil®/ Caelyx®)|pegylated liposomal doxorubicin (pld, doxil®/ caelyx®)
5157678|NCT00982579|HIV preventive vaccine|hiv preventive vaccine
5157679|NCT00982553|Healthy Volunteers|healthy volunteers
5157680|NCT00982540|empiric antifungal therapy|empiric antifungal therapy
5157681|NCT00982540|preemptive antifungal therapy|preemptive antifungal therapy
5157682|NCT00982540|febrile neutropenia|febrile neutropenia
5157683|NCT00982540|risk stratification|risk stratification
5157684|NCT00982540|invasive fungal infection|invasive fungal infection
5157685|NCT00982527|cardiopulmonary bypass|cardiopulmonary bypass
5157686|NCT00982527|pediatric cardiac surgery|pediatric cardiac surgery
5157687|NCT00982527|acute renal failure|acute renal failure
5157688|NCT00982527|renal biomarkers|renal biomarkers
5157689|NCT00982527|fenoldopam|fenoldopam
5157690|NCT00982527|Focus on optimization of perfusion during pediatric CPB|focus on optimization of perfusion during pediatric cpb
5157691|NCT00982514|Asparaginase|asparaginase
5157692|NCT00982514|thrombosis|thrombosis
5157693|NCT00982514|ALL|all
5157694|NCT00982514|central line|central line
5157695|NCT00982501|(BMI 25-29,9 kg/m2)|(bmi 25-29,9 kg/m2)
5157696|NCT00982475|pulmonary vein isolation|pulmonary vein isolation
5157697|NCT00982475|robotic navigation|robotic navigation
5157698|NCT00982475|atrial fibrillation|atrial fibrillation
5157699|NCT00982462|cognition|cognition
5157700|NCT00982462|vision|vision
5157701|NCT00982462|immunology|immunology
5157702|NCT00982462|DHA|dha
5157703|NCT00982462|ARA|ara
5157704|NCT00982462|infant|infant
5157705|NCT00982462|nutrition|nutrition
5157706|NCT00982449|EBV+ malignancies|ebv+ malignancies
5157707|NCT00982449|KSHV+ malignancies|kshv+ malignancies
5157708|NCT00982449|HIV-associated lymphomas|hiv-associated lymphomas
5157709|NCT00982449|Hodgkin Lymphoma|hodgkin lymphoma
5157710|NCT00982449|nonHodgkin Lymphoma or|nonhodgkin lymphoma or
5157711|NCT00982449|nonHodgkins Lymphoproliferative Disease|nonhodgkins lymphoproliferative disease
5157712|NCT00982449|Primary Effusion Lymphoma|primary effusion lymphoma
5157713|NCT00982449|Kaposi's Sarcoma|kaposi's sarcoma
5157714|NCT00982449|Gastric Cancer|gastric cancer
5157715|NCT00982449|Nasopharyngeal Cancer|nasopharyngeal cancer
5157716|NCT00982436|Combined Modality Therapy|combined modality therapy
5157717|NCT00982436|Neoadjuvant Therapy|neoadjuvant therapy
5157718|NCT00982436|Head and neck neoplasms|head and neck neoplasms
5157719|NCT00982423|heart failure|heart failure
5157720|NCT00982423|heart failure with and without kidney dysfunction|heart failure with and without kidney dysfunction
5157721|NCT00982410|pain|pain
5157722|NCT00982410|alcohol|alcohol
5157723|NCT00982410|illicit drugs|illicit drugs
5157724|NCT00982410|pain management|pain management
5157725|NCT00982384|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
5157726|NCT00982384|Disease management|disease management
5157727|NCT00982384|Pulmonary rehabilitation|pulmonary rehabilitation
5157728|NCT00982384|Quality of life|quality of life
5157729|NCT00982371|type 2 diabetes mellitus|type 2 diabetes mellitus
5157730|NCT00982371|osteoporosis|osteoporosis
5157731|NCT00982371|bone quality|bone quality
5157732|NCT00982371|magnetic resonance imaging|magnetic resonance imaging
5157733|NCT00982371|fracture|fracture
5157734|NCT00982371|postmenopausal women >65 years old|postmenopausal women >65 years old
5157735|NCT00982345|Depression|depression
5157736|NCT00982345|Anxiety|anxiety
5157737|NCT00982345|Seroquel|seroquel
5157738|NCT00982345|Quetiapine|quetiapine
5157739|NCT00982345|fMRI|fmri
5157740|NCT00982345|pictures|pictures
5157741|NCT00982332|polymyalgia rheumatica|polymyalgia rheumatica
5157742|NCT00982319|Broccoli Sprout Extract|broccoli sprout extract
5157743|NCT00982319|Breast Cancer|breast cancer
5157744|NCT00982306|alcohol|alcohol
5157745|NCT00982306|brief interventions|brief interventions
5157746|NCT00982306|counseling|counseling
5157747|NCT00982306|harmful/hazardous alcohol drinkers|harmful/hazardous alcohol drinkers
5157748|NCT00982280|Osteoarthritis|osteoarthritis
5157749|NCT00982280|pain assessment|pain assessment
5157750|NCT00982280|tapentadol|tapentadol
5157751|NCT00982280|centrally acting analgesic|centrally acting analgesic
5157752|NCT00982267|cancer|cancer
5157753|NCT00982254|Type 2 Diabetes|type 2 diabetes
5157754|NCT00982254|Oral Insulin|oral insulin
5157755|NCT00982254|Pharmacokinetics|pharmacokinetics
5157756|NCT00982254|Pharmacodynamics|pharmacodynamics
5157757|NCT00982241|OAB|oab
5157758|NCT00982241|urine|urine
5157759|NCT00982241|osmolality|osmolality
5157760|NCT00982241|urge|urge
5157761|NCT00982241|fluid intake|fluid intake
5157762|NCT00982241|PPIUS|ppius
5157763|NCT00982241|urge score|urge score
5157764|NCT00982241|bladder|bladder
5157765|NCT00982215|Paracetamol|paracetamol
5157766|NCT00982215|per-oral mucosa PMB|per-oral mucosa pmb
5157767|NCT00982215|No disease, healthy volunteers|no disease, healthy volunteers
5157768|NCT00982202|PPAR-gamma|ppar-gamma
5157769|NCT00982202|inflammation|inflammation
5157770|NCT00982189|treatment experienced|treatment experienced
5158249|NCT00980317|Third party|third party
5157771|NCT00982176|Anatomo-functional determinants|anatomo-functional determinants
5157772|NCT00982176|cognitive impairment|cognitive impairment
5157773|NCT00982176|coronary syndrome|coronary syndrome
5157774|NCT00982176|brain MRI|brain mri
5157775|NCT00982176|cerebral perfusion scintigraphy|cerebral perfusion scintigraphy
5157776|NCT00982150|Talampanel|talampanel
5157777|NCT00982150|Open-Label Study|open-label study
5157778|NCT00982150|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
5157779|NCT00982137|Japanese Encephalitis|japanese encephalitis
5157780|NCT00982137|Yellow Fever|yellow fever
5157781|NCT00982137|ChimeriVax™-JE|chimerivax™-je
5157782|NCT00982137|STAMARIL®|stamaril®
5157783|NCT00982137|Adult|adult
5157784|NCT00982124|Osteogenesis Imperfecta|osteogenesis imperfecta
5157785|NCT00982124|Infants with moderate to severe Osteogenesis Imperfecta|infants with moderate to severe osteogenesis imperfecta
5157786|NCT00982111|Nonsquamous|nonsquamous
5157787|NCT00982111|Non Small Cell Lung Cancer|non small cell lung cancer
5157788|NCT00982111|First line treatment|first line treatment
5157789|NCT00982111|Monoclonal|monoclonal
5157790|NCT00982111|Antibodies|antibodies
5157791|NCT00982111|Epidermal Growth Factor Receptor (EGFR)|epidermal growth factor receptor (egfr)
5157792|NCT00982098|Prostatectomy|prostatectomy
5157793|NCT00982098|Prostatic cancer|prostatic cancer
5157794|NCT00982098|Urinary incontinence|urinary incontinence
5157795|NCT00982098|Exercise|exercise
5157796|NCT00982098|Electric stimulation therapy|electric stimulation therapy
5157797|NCT00982098|Counseling|counseling
5157798|NCT00982085|Asthma|asthma
5157799|NCT00982085|Allergic rhinitis|allergic rhinitis
5157800|NCT00982085|Military|military
5157801|NCT00982072|nephrotic minimal change tacrolimus prednisolone|nephrotic minimal change tacrolimus prednisolone
5157802|NCT00982059|Colorectal cancer screening|colorectal cancer screening
5157803|NCT00982059|Cancer survivor|cancer survivor
5157804|NCT00982059|Radiation therapy|radiation therapy
5157805|NCT00982046|contact lenses|contact lenses
5157806|NCT00982046|disinfection solutions|disinfection solutions
5157807|NCT00982046|contact lens care|contact lens care
5157808|NCT00982033|Heart failure with normal ejection fraction|heart failure with normal ejection fraction
5157809|NCT00982033|Elderly|elderly
5157810|NCT00982020|safety|safety
5157811|NCT00982020|schizophrenia|schizophrenia
5157812|NCT00982020|bipolar I (manic or mixed)|bipolar i (manic or mixed)
5157813|NCT00982020|adolescents|adolescents
5157814|NCT00982020|weight management|weight management
5157816|NCT00981994|respiratory infection|respiratory infection
5157817|NCT00981994|antimicrobial drugs|antimicrobial drugs
5157818|NCT00981994|decision support|decision support
5157819|NCT00981994|Adult patients|adult patients
5157820|NCT00981981|humans|humans
5157821|NCT00981981|randomized clinical trial|randomized clinical trial
5157822|NCT00981981|dietary fiber|dietary fiber
5157823|NCT00981981|nutrition|nutrition
5157824|NCT00981981|beta-glucan|beta-glucan
5157825|NCT00981981|oats|oats
5157826|NCT00981981|LDL cholesterol|ldl cholesterol
5157827|NCT00981981|coronary heart disease|coronary heart disease
5157828|NCT00981955|Caffeine|caffeine
5157829|NCT00981955|Ltheanine|ltheanine
5157830|NCT00981955|Near Infrared Spectroscopy|near infrared spectroscopy
5157831|NCT00981955|Cerebral Blood Flow|cerebral blood flow
5157832|NCT00981955|Cognitive Function|cognitive function
5157833|NCT00981955|Mood|mood
5157834|NCT00981942|Nephrogenic systemic fibrosis|nephrogenic systemic fibrosis
5157835|NCT00981942|Imatinib mesylate|imatinib mesylate
5157836|NCT00981942|Glivec|glivec
5157837|NCT00981942|Gleevec|gleevec
5157838|NCT00981929|CYP2D6|cyp2d6
5157839|NCT00981929|CYP2C9|cyp2c9
5157840|NCT00981929|CYP2C19|cyp2c19
5157841|NCT00981929|CYP1A2|cyp1a2
5157842|NCT00981916|determination of depth to epidural space using ultrasound|determination of depth to epidural space using ultrasound
5157843|NCT00981903|VTE in cancer patients|vte in cancer patients
5157844|NCT00981890|Brain Metastases|brain metastases
5157845|NCT00981890|Stereotactic radiosurgery|stereotactic radiosurgery
5157846|NCT00981890|Sunitinib|sunitinib
5157847|NCT00981890|Patients with Brain Metastases|patients with brain metastases
5157848|NCT00981877|acute diarrhea|acute diarrhea
5157849|NCT00981877|rotavirus|rotavirus
5157850|NCT00981877|probiotic|probiotic
5157851|NCT00981877|children|children
5157852|NCT00981864|radiation therapy in breast cancer|radiation therapy in breast cancer
5157853|NCT00981864|concurrent radiation|concurrent radiation
5157854|NCT00981864|Breast cancer patients|breast cancer patients
5157855|NCT00981851|intervention study|intervention study
5157856|NCT00981851|interaction|interaction
5157857|NCT00981851|COPD|copd
5157858|NCT00981812|PET|pet
5157859|NCT00981812|PEM|pem
5157860|NCT00981812|Positron Emission Mammography|positron emission mammography
5157861|NCT00981812|Breast Biopsy|breast biopsy
5157862|NCT00981799|Relapse|relapse
5157863|NCT00981799|T cell|t cell
5157864|NCT00981799|Lymphoblastic|lymphoblastic
5157865|NCT00981799|Leukemia|leukemia
5157866|NCT00981799|Lymphoma|lymphoma
5157867|NCT00981799|Nelarabine|nelarabine
5157868|NCT00981799|TACL|tacl
5157869|NCT00981799|NECTAR|nectar
5157870|NCT00981786|24-hour IOP control|24-hour iop control
5157871|NCT00981786|brinzolamide/timolol|brinzolamide/timolol
5157872|NCT00981786|brimonidine/timolol|brimonidine/timolol
5157873|NCT00981786|travoprost|travoprost
5157874|NCT00981773|HIV switch|hiv switch
5157875|NCT00981773|HIV|hiv
5157876|NCT00981773|treatment experienced|treatment experienced
5157877|NCT00981734|Aging|aging
5157878|NCT00981734|functionality|functionality
5157879|NCT00981734|life style|life style
5157880|NCT00981734|To have more than sixty years|to have more than sixty years
5157881|NCT00981721|Phase I|phase i
5157882|NCT00981721|Advanced solid malignancies|advanced solid malignancies
5157883|NCT00981721|Advanced solid tumour|advanced solid tumour
5157884|NCT00981721|Advanced cancer|advanced cancer
5157885|NCT00981721|Cediranib (RECENTIN™, AZD2171)|cediranib (recentin™, azd2171)
5157886|NCT00981721|China|china
5157887|NCT00981721|PK|pk
5157888|NCT00981721|pharmacokinetics|pharmacokinetics
5157889|NCT00981708|Amyloidosis|amyloidosis
5157890|NCT00981708|lenalidomide|lenalidomide
5157891|NCT00981708|newly diagnosed|newly diagnosed
5157892|NCT00981708|relapsed|relapsed
5157893|NCT00981708|primary systemic AL amyloidosis|primary systemic al amyloidosis
5157894|NCT00981695|HIV|hiv
5157895|NCT00981695|Vaccine|vaccine
5157896|NCT00981695|MVA|mva
5157897|NCT00981695|PMTCT|pmtct
5157898|NCT00981695|HIV preventive vaccine|hiv preventive vaccine
5157899|NCT00981695|HIV seronegativity|hiv seronegativity
5157900|NCT00981682|decrease in the number of nocturic episodes for patients with nocturia|decrease in the number of nocturic episodes for patients with nocturia
5157901|NCT00981669|brazilian pentavalent rotavirus vaccine|brazilian pentavalent rotavirus vaccine
5157902|NCT00981669|safety|safety
5157903|NCT00981669|tolerability|tolerability
5157904|NCT00981669|immunogenicity|immunogenicity
5157905|NCT00981656|stage I bladder cancer|stage i bladder cancer
5157906|NCT00981656|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
5157907|NCT00981643|Meditation|meditation
5157908|NCT00981643|Multiple Sclerosis|multiple sclerosis
5157909|NCT00981643|Peripheral Neuropathy|peripheral neuropathy
5157910|NCT00981630|Japanese Encephalitis|japanese encephalitis
5157911|NCT00981630|ChimeriVax™-JE Vaccine|chimerivax™-je vaccine
5157912|NCT00981630|Adult|adult
5157913|NCT00981604|SILS|sils
5157914|NCT00981604|Laparoscopic Cholecystectomy|laparoscopic cholecystectomy
5157915|NCT00981604|Children|children
5157916|NCT00981591|Iloprost|iloprost
5157917|NCT00981591|Nitric oxide|nitric oxide
5157918|NCT00981591|Mechanical ventilator|mechanical ventilator
5157919|NCT00981578|bone cancer|bone cancer
5157920|NCT00981578|pain palliation|pain palliation
5157921|NCT00981578|metastasis|metastasis
5157922|NCT00981578|breast cancer|breast cancer
5157923|NCT00981578|lung cancer|lung cancer
5157924|NCT00981578|prostate cancer|prostate cancer
5157925|NCT00981578|cancer related pain|cancer related pain
5157926|NCT00981578|tumors|tumors
5157927|NCT00981565|Carpal tunnel syndrome|carpal tunnel syndrome
5157928|NCT00981565|CTS|cts
5157929|NCT00981565|medianus impingement|medianus impingement
5157930|NCT00981552|Cervix Cancer|cervix cancer
5157931|NCT00981552|IMRT|imrt
5157932|NCT00981552|Organ Motion|organ motion
5157933|NCT00981552|Target Definition|target definition
5157934|NCT00981539|The focus of this study is to determine whether it is beneficial to administer enemas before surgery|the focus of this study is to determine whether it is beneficial to administer enemas before surgery
5157935|NCT00981526|Schizophrenia|schizophrenia
5157936|NCT00981526|Cognition|cognition
5157937|NCT00981526|Metabolism|metabolism
5157938|NCT00981526|Antipsychotics|antipsychotics
5157939|NCT00981526|Psychopathology|psychopathology
5157940|NCT00981500|obesity|obesity
5157941|NCT00981500|gastric bypass|gastric bypass
5157942|NCT00981500|gastric banding|gastric banding
5157943|NCT00981500|weight loss|weight loss
5157944|NCT00981500|insulin sensitivity|insulin sensitivity
5157945|NCT00981500|sleeve gastrectomy|sleeve gastrectomy
5157946|NCT00981500|fibroblast growth factor 21|fibroblast growth factor 21
5157947|NCT00981500|fibroblast growth factor 19|fibroblast growth factor 19
5157948|NCT00981474|cardiac surgery; brain injury; cerebral autoregulation|cardiac surgery; brain injury; cerebral autoregulation
5157949|NCT00981461|Andregenetic Alopecia|andregenetic alopecia
5157950|NCT00981461|Hair Loss|hair loss
5157951|NCT00981461|Female Pattern Baldness|female pattern baldness
5157952|NCT00981448|zinc|zinc
5157953|NCT00981448|diabetes|diabetes
5157954|NCT00981448|genetics|genetics
5157955|NCT00981435|Glaucoma|glaucoma
5157956|NCT00981435|Trabeculoplasty|trabeculoplasty
5157957|NCT00981435|Selective laser trabeculoplasty|selective laser trabeculoplasty
5157958|NCT00981435|Intraocular pressure|intraocular pressure
5157959|NCT00981422|glaucoma|glaucoma
5157960|NCT00981422|immunology|immunology
5157961|NCT00981422|immunophenotype|immunophenotype
5157962|NCT00981409|Fondaparinux sodium|fondaparinux sodium
5157963|NCT00981409|contrast-enhanced MDCT|contrast-enhanced mdct
5157964|NCT00981409|Deep Vein Thrombosis|deep vein thrombosis
5157965|NCT00981409|Pulmonary thromboembolism|pulmonary thromboembolism
5157966|NCT00981396|smoking|smoking
5157967|NCT00981396|EFT (Emotional Freedom Techniques)|eft (emotional freedom techniques)
5157968|NCT00981396|CBT (cognitive behavior therapy)|cbt (cognitive behavior therapy)
5157969|NCT00981396|cravings|cravings
5157970|NCT00981396|trauma|trauma
5157971|NCT00981383|Fatty Acids, Omega-3|fatty acids, omega-3
5157972|NCT00981370|Sickle Cell Disease|sickle cell disease
5157973|NCT00981370|Sickle Cell Anemia|sickle cell anemia
5157974|NCT00981370|Iron Overload|iron overload
5157975|NCT00981370|Chelation Therapy|chelation therapy
5157976|NCT00981370|Iron overload from blood transfusions|iron overload from blood transfusions
5157977|NCT00981370|Heart rate variability|heart rate variability
5157978|NCT00981370|Autonomic dysfunction|autonomic dysfunction
5157979|NCT00981357|Cross-over evaluate the efficacy of PF-04457845 in relieving pain due to osteoarthritis OA knee osteoarthritis of knee pain due to osteoarthritis|cross-over evaluate the efficacy of pf-04457845 in relieving pain due to osteoarthritis oa knee osteoarthritis of knee pain due to osteoarthritis
5157980|NCT00981344|wheelchair|wheelchair
5157981|NCT00981344|mobility disability|mobility disability
5157982|NCT00981344|evidence based practice|evidence based practice
5157983|NCT00981344|self help devices|self help devices
5157984|NCT00981344|Veterans prescribed mobility aids|veterans prescribed mobility aids
5157985|NCT00981331|Subtalar joint|subtalar joint
5157986|NCT00981331|Musculoskeletal Manipulations|musculoskeletal manipulations
5157987|NCT00981331|Manipulation, Chiropractic|manipulation, chiropractic
5157988|NCT00981331|Ankle sprain|ankle sprain
5157989|NCT00981331|Inversion sprain|inversion sprain
5157990|NCT00981331|Range of motion, Articular|range of motion, articular
5157991|NCT00981331|Quaternion|quaternion
5157992|NCT00981331|Eigen analysis|eigen analysis
5157993|NCT00981318|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5157994|NCT00981318|HIV|hiv
5157995|NCT00981318|AIDS|aids
5157996|NCT00981318|treatment experienced|treatment experienced
5157997|NCT00981305|dyspareunia|dyspareunia
5157998|NCT00981305|breast cancer|breast cancer
5157999|NCT00981305|sexual dysfunction|sexual dysfunction
5158000|NCT00981305|vaginal lubricant|vaginal lubricant
5158001|NCT00981292|Epigallocatechin Gallate|epigallocatechin gallate
5158002|NCT00981292|cerebral blood flow|cerebral blood flow
5158003|NCT00981292|Near Infrared spectroscopy|near infrared spectroscopy
5158004|NCT00981292|Electroencephalography|electroencephalography
5158005|NCT00981292|cognitive function|cognitive function
5158006|NCT00981292|mood|mood
5158007|NCT00981292|cerebro-electrical activity|cerebro-electrical activity
5158008|NCT00981279|Health Profile|health profile
5158009|NCT00981279|AIDS|aids
5158010|NCT00981279|Health Promotion|health promotion
5158011|NCT00981279|HIV|hiv
5158012|NCT00981279|treatment experienced|treatment experienced
5158013|NCT00981266|Augmentation|augmentation
5158014|NCT00981266|Augmentation Revision|augmentation revision
5158015|NCT00981253|Stress Management Training|stress management training
5158016|NCT00981253|Cardiac Rehabilitation|cardiac rehabilitation
5158017|NCT00981253|Stress|stress
5158018|NCT00981253|Depression|depression
5158019|NCT00981227|pain herpetic neuralgia|pain herpetic neuralgia
5158020|NCT00981214|Cystic fibrosis|cystic fibrosis
5158021|NCT00981214|Exocrine Pancreatic Insufficiency|exocrine pancreatic insufficiency
5158022|NCT00981214|Zenpep-1009|zenpep-1009
5158023|NCT00981201|Smoking|smoking
5158024|NCT00981201|Cancer Prevention|cancer prevention
5158025|NCT00981201|Celecoxib|celecoxib
5158026|NCT00981201|Celebrex|celebrex
5158027|NCT00981201|Placebo|placebo
5158028|NCT00981175|Japanese Encephalitis|japanese encephalitis
5158029|NCT00981175|Japanese Encephalitis Vaccines|japanese encephalitis vaccines
5158030|NCT00981175|Adult|adult
5158031|NCT00981136|Appendicitis|appendicitis
5158032|NCT00981136|Appendectomy|appendectomy
5158033|NCT00981136|Children|children
5158034|NCT00981136|Laparoscopic|laparoscopic
5158035|NCT00981136|SILS|sils
5158036|NCT00981110|Surgical site infections (SSI)|surgical site infections (ssi)
5158037|NCT00981110|Advanced antimicrobial dressing and clean surgery|advanced antimicrobial dressing and clean surgery
5158038|NCT00981110|Hydrofibre dressing|hydrofibre dressing
5158039|NCT00981097|HIV infection|hiv infection
5158040|NCT00981097|HIV-associated Hodgkin lymphoma|hiv-associated hodgkin lymphoma
5158041|NCT00981097|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
5158042|NCT00981097|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
5158043|NCT00981097|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5158044|NCT00981097|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5158045|NCT00981097|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
5158046|NCT00981097|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
5158047|NCT00981097|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
5158048|NCT00981097|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5158049|NCT00981097|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5158050|NCT00981097|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
5158051|NCT00981097|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5158052|NCT00981097|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
5158053|NCT00981097|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5158054|NCT00981097|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5158055|NCT00981097|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
5158248|NCT00980317|Renal transplantation|renal transplantation
5158056|NCT00981097|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
5158057|NCT00981097|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
5158058|NCT00981097|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5158059|NCT00981097|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5158060|NCT00981071|Tuberculosis|tuberculosis
5158061|NCT00981071|QuantiFERON|quantiferon
5158062|NCT00981071|Outbreak|outbreak
5158063|NCT00981071|Conversion|conversion
5158064|NCT00981058|Squamous|squamous
5158065|NCT00981058|Non Small Cell Lung Cancer|non small cell lung cancer
5158066|NCT00981058|First line treatment|first line treatment
5158067|NCT00981058|Monoclonal|monoclonal
5158068|NCT00981058|Antibodies|antibodies
5158069|NCT00981058|Epidermal Growth Factor Receptor (EGFR)|epidermal growth factor receptor (egfr)
5158070|NCT00981045|IDA|ida
5158071|NCT00981032|Aspirin|aspirin
5158072|NCT00981032|Behavior|behavior
5158073|NCT00981032|Cardiovascular Disease|cardiovascular disease
5158074|NCT00981019|survival rates|survival rates
5158075|NCT00981019|risk communication|risk communication
5158076|NCT00981019|screening counselling|screening counselling
5158077|NCT00981019|screening recommendation|screening recommendation
5158078|NCT00981019|understanding of medical risk|understanding of medical risk
5158079|NCT00981006|ischemic cardiomyopathy (ICM)|ischemic cardiomyopathy (icm)
5158080|NCT00980993|Prostate|prostate
5158081|NCT00980993|Motion|motion
5158082|NCT00980993|Respiration|respiration
5158083|NCT00980980|MRSA infection|mrsa infection
5158084|NCT00980967|Lung transplantation|lung transplantation
5158085|NCT00980967|Chronic lung rejection|chronic lung rejection
5158086|NCT00980967|Obliterative bronchiolitis|obliterative bronchiolitis
5158087|NCT00980967|Predictive factors|predictive factors
5158088|NCT00980954|cervical adenocarcinoma|cervical adenocarcinoma
5158089|NCT00980954|cervical adenosquamous cell carcinoma|cervical adenosquamous cell carcinoma
5158090|NCT00980954|cervical squamous cell carcinoma|cervical squamous cell carcinoma
5158091|NCT00980954|stage IA cervical cancer|stage ia cervical cancer
5158092|NCT00980954|stage IB cervical cancer|stage ib cervical cancer
5158093|NCT00980954|stage IIA cervical cancer|stage iia cervical cancer
5158094|NCT00980941|starch|starch
5158095|NCT00980941|carbohydrates|carbohydrates
5158096|NCT00980941|blood glucose|blood glucose
5158097|NCT00980941|food intake|food intake
5158098|NCT00980941|satiety|satiety
5158099|NCT00980941|appetite|appetite
5158100|NCT00980915|Acute Lung Injury|acute lung injury
5158101|NCT00980915|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
5158102|NCT00980915|Respiratory Distress|respiratory distress
5158103|NCT00980915|pneumonia|pneumonia
5158104|NCT00980915|sepsis|sepsis
5158105|NCT00980915|aspiration|aspiration
5158106|NCT00980915|pancreatitis|pancreatitis
5158107|NCT00980889|bile duct obstruction|bile duct obstruction
5158108|NCT00980889|jaundice|jaundice
5158109|NCT00980889|metal stent|metal stent
5158110|NCT00980850|Flu vaccine|flu vaccine
5158111|NCT00980850|H1N1 swine flu virus|h1n1 swine flu virus
5158112|NCT00980850|Immunogenicity|immunogenicity
5158113|NCT00980850|Reactogenicity|reactogenicity
5158114|NCT00980824|cognitive behaviour therapy|cognitive behaviour therapy
5158115|NCT00980824|self harm|self harm
5158116|NCT00980824|personality disorder|personality disorder
5158117|NCT00980824|complex comorbidity|complex comorbidity
5158118|NCT00980824|mental health|mental health
5158119|NCT00980798|Osteoarthritis|osteoarthritis
5158120|NCT00980798|Strong pain killer|strong pain killer
5158121|NCT00980798|Strong opioid|strong opioid
5158122|NCT00980798|Low starting dose|low starting dose
5158123|NCT00980798|Fewer side effects|fewer side effects
5158124|NCT00980798|Physical functioning|physical functioning
5158125|NCT00980798|Pain control|pain control
5158126|NCT00980798|Quality of life|quality of life
5158127|NCT00980798|Sleep quality|sleep quality
5158128|NCT00980785|Alzheimer's Disease|alzheimer's disease
5158129|NCT00980785|Hypertension|hypertension
5158130|NCT00980759|Extended-field Irradiation (EFI)|extended-field irradiation (efi)
5158131|NCT00980759|Cervical cancer|cervical cancer
5158132|NCT00980759|Hypoxia|hypoxia
5158133|NCT00980759|Carbonic anhydrase 9 (CA9)|carbonic anhydrase 9 (ca9)
5158134|NCT00980759|locally advanced uterine cervical cancer|locally advanced uterine cervical cancer
5158135|NCT00980746|pain diabetes neuropathy|pain diabetes neuropathy
5158136|NCT00980733|Micronutrients|micronutrients
5158137|NCT00980733|zinc|zinc
5158138|NCT00980733|iron|iron
5158139|NCT00980733|iodine|iodine
5158140|NCT00980733|fortification|fortification
5158141|NCT00980733|school children|school children
5158142|NCT00980707|versican|versican
5158143|NCT00980707|hyaluronan|hyaluronan
5158144|NCT00980707|sputum|sputum
5158145|NCT00980694|ubiquinol|ubiquinol
5158146|NCT00980694|coenzyme Q10|coenzyme q10
5158147|NCT00980694|Huntington disease|huntington disease
5158148|NCT00980681|Renal disease|renal disease
5158149|NCT00980681|Contrast agent|contrast agent
5158150|NCT00980681|MRA|mra
5158151|NCT00980642|surgery|surgery
5158152|NCT00980642|thermometer|thermometer
5158153|NCT00980642|non-invasive|non-invasive
5158154|NCT00980642|interoperative core temperature|interoperative core temperature
5158155|NCT00980642|anesthesia|anesthesia
5158156|NCT00980616|Arthroplasty, hip|arthroplasty, hip
5158157|NCT00980616|blood losses|blood losses
5158158|NCT00980616|pain|pain
5158159|NCT00980616|local analgesia|local analgesia
5158160|NCT00980616|epinephrine|epinephrine
5158161|NCT00980616|Primary total hip arthroplasty|primary total hip arthroplasty
5158162|NCT00980603|gastric cancer|gastric cancer
5158163|NCT00980603|metastatic|metastatic
5158164|NCT00980603|docetaxel|docetaxel
5158165|NCT00980603|cisplatin|cisplatin
5158166|NCT00980603|S-1|s-1
5158167|NCT00980590|supine emergency intubations|supine emergency intubations
5158168|NCT00980590|emergency intubations|emergency intubations
5158169|NCT00980538|TMC125-TiDP35-C239|tmc125-tidp35-c239
5158170|NCT00980538|TMC125-C239|tmc125-c239
5158171|NCT00980538|TMC125|tmc125
5158172|NCT00980538|HIV|hiv
5158173|NCT00980538|Etravirine|etravirine
5158174|NCT00980538|Intelence|intelence
5158175|NCT00980538|IntelenceTM|intelencetm
5158176|NCT00980525|healthy|healthy
5158177|NCT00980512|behavior problems|behavior problems
5158178|NCT00980512|parent training|parent training
5158179|NCT00980512|foster care|foster care
5158180|NCT00980486|Antibiotic Concentration|antibiotic concentration
5158181|NCT00980486|Tissue|tissue
5158182|NCT00980486|Obesity|obesity
5158183|NCT00980486|Cesarean|cesarean
5158184|NCT00980473|Primary Angle Closure Disease|primary angle closure disease
5158185|NCT00980447|H5N1|h5n1
5158186|NCT00980447|Vaccine|vaccine
5158187|NCT00980447|Influenza H5N1|influenza h5n1
5158188|NCT00980447|Avian influenza H5N1|avian influenza h5n1
5158189|NCT00980447|Pandemic|pandemic
5158190|NCT00980434|vertebral fracture|vertebral fracture
5158191|NCT00980434|spinal cord injury|spinal cord injury
5158192|NCT00980421|iron|iron
5158193|NCT00980421|iron toxicity markers|iron toxicity markers
5158194|NCT00980421|oxidative stress markers|oxidative stress markers
5158195|NCT00980421|iron supplementation|iron supplementation
5158196|NCT00980421|NTBI|ntbi
5158197|NCT00980421|iron over load|iron over load
5158198|NCT00980421|interleukin levels|interleukin levels
5158199|NCT00980421|iron status|iron status
5158200|NCT00980421|acut phase reactants|acut phase reactants
5158201|NCT00980421|preschool children|preschool children
5158202|NCT00980395|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5158203|NCT00980395|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5158204|NCT00980395|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5158205|NCT00980395|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5158206|NCT00980395|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5158207|NCT00980395|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5158208|NCT00980395|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
5158209|NCT00980395|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5158210|NCT00980395|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5158211|NCT00980395|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5158212|NCT00980395|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5158213|NCT00980395|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5158214|NCT00980395|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5158215|NCT00980395|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5158216|NCT00980395|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5158217|NCT00980395|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5158218|NCT00980395|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5158219|NCT00980395|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5158220|NCT00980395|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5158221|NCT00980395|extranodal marginal zone BCL mucosa assoc lymphoid tissue|extranodal marginal zone bcl mucosa assoc lymphoid tissue
5158222|NCT00980395|nodal marginal zone B Cell lymphoma|nodal marginal zone b cell lymphoma
5158223|NCT00980395|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5158224|NCT00980382|Stomach Neoplasms|stomach neoplasms
5158225|NCT00980382|phase I/II|phase i/ii
5158226|NCT00980382|Combination chemotherapy|combination chemotherapy
5158227|NCT00980382|S-1|s-1
5158228|NCT00980382|Docetaxel|docetaxel
5158229|NCT00980369|Lateral internal sphincterotomy|lateral internal sphincterotomy
5158230|NCT00980369|Anal fissure|anal fissure
5158231|NCT00980369|Surgical technique|surgical technique
5158232|NCT00980369|Incision|incision
5158233|NCT00980369|Wound healing|wound healing
5158234|NCT00980356|Diabetes Kidney transplantation|diabetes kidney transplantation
5158235|NCT00980356|New onset diabetes mellitus after transplantation|new onset diabetes mellitus after transplantation
5158236|NCT00980330|Hepatitis C|hepatitis c
5158237|NCT00980330|Peginterferon alpha-2a|peginterferon alpha-2a
5158238|NCT00980330|PegIFNalpha-2a|pegifnalpha-2a
5158239|NCT00980330|RBV|rbv
5158240|NCT00980330|Ribavirin|ribavirin
5158241|NCT00980330|Placebo|placebo
5158242|NCT00980330|TMC435-TIDP16-C206|tmc435-tidp16-c206
5158243|NCT00980330|TMC435-C206|tmc435-c206
5158244|NCT00980330|TMC435|tmc435
5158245|NCT00980330|HCV|hcv
5158246|NCT00980317|Renal tumor|renal tumor
5158247|NCT00980317|Restored kidney|restored kidney
5158250|NCT00980304|Diffuse large B cell lymphomas|diffuse large b cell lymphomas
5158251|NCT00980278|sinus lift|sinus lift
5158252|NCT00980278|tooth extraction|tooth extraction
5158253|NCT00980278|dental implant|dental implant
5158254|NCT00980252|Schizophrenia|schizophrenia
5158255|NCT00980252|Cognitive Behavioral Therapy|cognitive behavioral therapy
5158256|NCT00980252|Compliance|compliance
5158257|NCT00980252|Medication Adherence|medication adherence
5158258|NCT00980252|Psychotic Disorders|psychotic disorders
5158259|NCT00980252|Mental Disorders|mental disorders
5158260|NCT00980252|Outcomes|outcomes
5158261|NCT00980252|Psychoeducation|psychoeducation
5158262|NCT00980252|Adherence Attitudes|adherence attitudes
5158263|NCT00980252|Intervention|intervention
5158264|NCT00980252|Nonadherence|nonadherence
5158265|NCT00980252|Schizophrenia and Disorders with Psychotic Features|schizophrenia and disorders with psychotic features
5158266|NCT00980239|Solid Tumors|solid tumors
5158267|NCT00980239|Liver|liver
5158268|NCT00980239|hepatic arterial infusion|hepatic arterial infusion
5158269|NCT00980239|HAI|hai
5158270|NCT00980239|Bevacizumab|bevacizumab
5158271|NCT00980239|Avastin|avastin
5158272|NCT00980239|Cetuximab|cetuximab
5158273|NCT00980239|Erbitux|erbitux
5158274|NCT00980239|Irinotecan|irinotecan
5158275|NCT00980239|Camptosar|camptosar
5158276|NCT00980239|Oxaliplatin|oxaliplatin
5158277|NCT00980239|Eloxatin|eloxatin
5158278|NCT00980213|renal cell cancer|renal cell cancer
5158279|NCT00980213|sunitinib|sunitinib
5158280|NCT00980213|costs|costs
5158281|NCT00980213|quality of life|quality of life
5158282|NCT00980200|GW642444|gw642444
5158283|NCT00980200|once daily dosing|once daily dosing
5158284|NCT00980200|asthma|asthma
5158285|NCT00980200|efficacy|efficacy
5158286|NCT00980200|safety|safety
5158287|NCT00980200|FEV1|fev1
5158288|NCT00980187|blood tests|blood tests
5158289|NCT00980187|cardiac function|cardiac function
5158290|NCT00980187|endothelial function|endothelial function
5158291|NCT00980187|arterial function|arterial function
5158292|NCT00980174|men|men
5158293|NCT00980174|male|male
5158294|NCT00980174|denosumab|denosumab
5158295|NCT00980174|BMD|bmd
5158296|NCT00980174|lumbar spine|lumbar spine
5158297|NCT00980174|ADAMO|adamo
5158298|NCT00980174|The ADAMO Trial|the adamo trial
5158299|NCT00980174|male osteoporosis|male osteoporosis
5158300|NCT00980174|osteoporosis in men|osteoporosis in men
5158301|NCT00980174|males with low bone mineral density|males with low bone mineral density
5158302|NCT00980161|Hepatitis C|hepatitis c
5158303|NCT00980161|Peginterferon|peginterferon
5158304|NCT00980161|Ribavirin|ribavirin
5158305|NCT00980161|MicroRNA|microrna
5158306|NCT00980148|Chlamydia trachomatis, Chlamydia, Doxycycline, Azithromycin|chlamydia trachomatis, chlamydia, doxycycline, azithromycin
5158307|NCT00980135|Sinecort|sinecort
5158308|NCT00980135|Hydrocortison|hydrocortison
5158309|NCT00980135|Mild atopic dermatitis|mild atopic dermatitis
5158310|NCT00980135|Efficacy, safety|efficacy, safety
5158311|NCT00980122|Advanced cancer patients dying in hospital receive aggressive cancer-specific therapy and supportive measures.|advanced cancer patients dying in hospital receive aggressive cancer-specific therapy and supportive measures.
5158312|NCT00980109|Influenza Prophylaxis|influenza prophylaxis
5158313|NCT00980109|Long Term|long term
5158314|NCT00980109|Oral Oseltamivir|oral oseltamivir
5158315|NCT00980109|Inhaled Zanamivir|inhaled zanamivir
5158316|NCT00980083|GLP-1|glp-1
5158317|NCT00980083|exendin(9-39)|exendin(9-39)
5158318|NCT00980083|gastric emptying|gastric emptying
5158319|NCT00980083|incretin|incretin
5158320|NCT00980083|human|human
5158321|NCT00980070|lumbar puncture positioning device|lumbar puncture positioning device
5158322|NCT00980031|Aldosterone Blockade|aldosterone blockade
5158323|NCT00980031|Aldosterone Receptor Blockers|aldosterone receptor blockers
5158324|NCT00980031|cardiac chamber size|cardiac chamber size
5158325|NCT00980031|wall thickness|wall thickness
5158326|NCT00980031|left ventricular ejection fraction|left ventricular ejection fraction
5158327|NCT00980031|left atrial volumes|left atrial volumes
5158328|NCT00980031|diastolic function|diastolic function
5158329|NCT00980018|CML|cml
5158330|NCT00980018|Leukemia|leukemia
5158331|NCT00980018|Tasigna|tasigna
5158332|NCT00980018|nilotinib|nilotinib
5158333|NCT00980018|AMN107|amn107
5158334|NCT00980018|CML-CP|cml-cp
5158335|NCT00980018|Chronic Phase|chronic phase
5158336|NCT00980005|GSK Biologicals influenza vaccine GSK1557482A|gsk biologicals influenza vaccine gsk1557482a
5158337|NCT00980005|influenza infection|influenza infection
5158338|NCT00979979|Hepatitis C|hepatitis c
5158339|NCT00979979|Genotype|genotype
5158340|NCT00979979|Realtime PCR|realtime pcr
5158341|NCT00979966|Locally advanced or metastatic non-clear cell renal cell cancer (ncc-RCC)|locally advanced or metastatic non-clear cell renal cell cancer (ncc-rcc)
5158342|NCT00979953|delta opioid receptor agonist|delta opioid receptor agonist
5158343|NCT00979953|osteoarthritis|osteoarthritis
5158344|NCT00979953|pain|pain
5158345|NCT00979940|atorvastatin|atorvastatin
5158346|NCT00979940|clopidogrel|clopidogrel
5158347|NCT00979940|percutaneous intervention|percutaneous intervention
5158348|NCT00979940|periprocedural myonecrosis|periprocedural myonecrosis
5158349|NCT00979927|Antisense|antisense
5158350|NCT00979927|miR-122 antagonist|mir-122 antagonist
5158351|NCT00979927|safety in healthy Volunteers|safety in healthy volunteers
5158352|NCT00979927|Hepatitis C|hepatitis c
5158353|NCT00979914|osteoarthritis|osteoarthritis
5158354|NCT00979914|patient education|patient education
5158355|NCT00979914|function|function
5158356|NCT00979914|physio therapy|physio therapy
5158357|NCT00979888|dyspnea|dyspnea
5158358|NCT00979888|depression|depression
5158359|NCT00979888|fatigue|fatigue
5158360|NCT00979888|anxiety disorder|anxiety disorder
5158361|NCT00979888|small cell lung cancer|small cell lung cancer
5158362|NCT00979888|non-small cell lung cancer|non-small cell lung cancer
5158363|NCT00979875|insulin|insulin
5158364|NCT00979875|recombinant human hyaluronidase|recombinant human hyaluronidase
5158365|NCT00979875|Healthy volunteers|healthy volunteers
5158366|NCT00979849|safety|safety
5158367|NCT00979849|tolerability|tolerability
5158368|NCT00979849|healthy|healthy
5158369|NCT00979849|inhalation|inhalation
5158370|NCT00979836|venous|venous
5158371|NCT00979836|ulcer|ulcer
5158372|NCT00979836|phlebotonic|phlebotonic
5158373|NCT00979836|calcium dobesilate|calcium dobesilate
5158374|NCT00979836|clinical trial|clinical trial
5158375|NCT00979810|PET scan|pet scan
5158376|NCT00979810|CT scan|ct scan
5158377|NCT00979810|09-060|09-060
5158378|NCT00979810|CNS|cns
5158379|NCT00979797|Community IMCI|community imci
5158380|NCT00979797|C-IMCI|c-imci
5158381|NCT00979797|CHW|chw
5158382|NCT00979797|Children|children
5158383|NCT00979797|Evaluation|evaluation
5158384|NCT00979797|Behaviour|behaviour
5158385|NCT00979797|Counselling|counselling
5158386|NCT00979797|Under 5 mortality|under 5 mortality
5158387|NCT00979797|Under 5 Nutrition|under 5 nutrition
5158388|NCT00979784|obesity|obesity
5158389|NCT00979784|primary care|primary care
5158390|NCT00979771|GSK706769|gsk706769
5158391|NCT00979771|Enbrel|enbrel
5158392|NCT00979771|Rheumatoid Arthritis|rheumatoid arthritis
5158393|NCT00979745|Erythropoietic Protoporphyria|erythropoietic protoporphyria
5158394|NCT00979745|EPP|epp
5158395|NCT00979745|Afamelanotide|afamelanotide
5158396|NCT00979732|high blood pressure|high blood pressure
5158397|NCT00979732|dietary supplements|dietary supplements
5158398|NCT00979732|nutrition|nutrition
5158399|NCT00979719|Randomized Controlled Trial|randomized controlled trial
5158400|NCT00979719|evidence- and theory-based behavioral intervention|evidence- and theory-based behavioral intervention
5158401|NCT00979719|expert system|expert system
5158402|NCT00979719|stages of change|stages of change
5158403|NCT00979719|motivational interviewing|motivational interviewing
5158404|NCT00979719|tailoring|tailoring
5158405|NCT00979719|Self Care|self care
5158406|NCT00979719|Rehabilitation|rehabilitation
5158407|NCT00979719|Expert Systems|expert systems
5158408|NCT00979693|anxiety|anxiety
5158409|NCT00979693|stage IV melanoma|stage iv melanoma
5158410|NCT00979693|depression|depression
5158411|NCT00979693|spirituality|spirituality
5158412|NCT00979693|pain|pain
5158413|NCT00979680|sphincter preservation|sphincter preservation
5158414|NCT00979680|neoadjuvant therapy|neoadjuvant therapy
5158415|NCT00979667|Upper respiratory tract infection|upper respiratory tract infection
5158416|NCT00979667|Influenza A|influenza a
5158417|NCT00979667|Human Swine Influenza|human swine influenza
5158418|NCT00979654|Sifalimumab|sifalimumab
5158419|NCT00979654|MEDI-545|medi-545
5158420|NCT00979641|breast cancer|breast cancer
5158421|NCT00979641|metastatic|metastatic
5158422|NCT00979641|chemotherapy|chemotherapy
5158423|NCT00979641|bevacizumab|bevacizumab
5158424|NCT00979641|docetaxel|docetaxel
5158425|NCT00979641|Phase II|phase ii
5158426|NCT00979641|first line chemotherapy|first line chemotherapy
5158427|NCT00979641|metastatic breast cancer patients|metastatic breast cancer patients
5158428|NCT00979628|Type 2 Diabetes|type 2 diabetes
5158429|NCT00979628|Inpatient Hyperglycemia|inpatient hyperglycemia
5158430|NCT00979615|vasomotor rhinitis|vasomotor rhinitis
5158431|NCT00979615|chronic non-allergic rhinitis|chronic non-allergic rhinitis
5158432|NCT00979615|VMR|vmr
5158433|NCT00979602|GSK Bio's influenza vaccine GSK2340274A|gsk bio's influenza vaccine gsk2340274a
5158434|NCT00979602|Influenza Vaccines|influenza vaccines
5158435|NCT00979602|GSK Bio's influenza vaccine GSK2340273A|gsk bio's influenza vaccine gsk2340273a
5158436|NCT00979602|influenza infection|influenza infection
5158437|NCT00979589|stroke|stroke
5158438|NCT00979589|transient ischemic attack|transient ischemic attack
5158439|NCT00979589|acute treatment|acute treatment
5158440|NCT00979589|acute non-disabling cerebrovascular event|acute non-disabling cerebrovascular event
5158441|NCT00979589|clopidogrel|clopidogrel
5158442|NCT00979589|clopidogrel combined with ASA|clopidogrel combined with asa
5158443|NCT00979589|recurrence of stroke and other vascular events|recurrence of stroke and other vascular events
5158444|NCT00979563|HM30181AK|hm30181ak
5158445|NCT00979563|Irinotecan tablet|irinotecan tablet
5158446|NCT00979563|MTD|mtd
5158447|NCT00979563|DLT|dlt
5158448|NCT00979550|laser|laser
5158449|NCT00979550|pediatric|pediatric
5158450|NCT00979550|skin pigmentation|skin pigmentation
5158451|NCT00979524|Depressive symptoms|depressive symptoms
5158452|NCT00979524|Mental health services|mental health services
5158453|NCT00979524|Adolescents|adolescents
5158454|NCT00979524|Young adults|young adults
5158455|NCT00979524|African-American|african-american
5158456|NCT00979511|osteoporosis|osteoporosis
5158457|NCT00979511|calcium|calcium
5158458|NCT00979511|weight-bearing exercise|weight-bearing exercise
5158459|NCT00979511|bone mass|bone mass
5158460|NCT00979511|prepubertal girls|prepubertal girls
5158461|NCT00979485|Pediatric IBD|pediatric ibd
5158462|NCT00979485|Microparticles|microparticles
5158463|NCT00979472|Solifenacin|solifenacin
5158464|NCT00979472|Overactive bladder|overactive bladder
5158465|NCT00979472|Micturition|micturition
5158466|NCT00979472|Urinary urgency|urinary urgency
5158467|NCT00979472|Vesicare|vesicare
5158468|NCT00979446|Interactive phone-based intervention with written materials|interactive phone-based intervention with written materials
5158469|NCT00979446|Older adults|older adults
5158470|NCT00979446|Physical activity|physical activity
5158471|NCT00979446|Cognitive stimulation|cognitive stimulation
5158472|NCT00979446|Social engagement|social engagement
5158473|NCT00979433|Extubation failure|extubation failure
5158474|NCT00979433|Continuous positive airway pressure|continuous positive airway pressure
5158475|NCT00979433|Bubble CPAP|bubble cpap
5158476|NCT00979420|treatment experienced|treatment experienced
5158477|NCT00979407|influenza infection|influenza infection
5158478|NCT00979407|GSK Biologicals' influenza vaccine GSK2340272A and GSK2340274A|gsk biologicals' influenza vaccine gsk2340272a and gsk2340274a
5158479|NCT00979394|Diabetes Care at GPs in Austria|diabetes care at gps in austria
5158480|NCT00979394|Characteristic of diabetes patients at GPs in Austria|characteristic of diabetes patients at gps in austria
5158481|NCT00979381|sunitinib|sunitinib
5158482|NCT00979381|sorafenib|sorafenib
5158483|NCT00979381|immune response|immune response
5158484|NCT00979355|Whole body|whole body
5158485|NCT00979355|SPECT|spect
5158486|NCT00979342|morcellator|morcellator
5158487|NCT00979342|hysteroscope|hysteroscope
5158488|NCT00979342|myomectomy|myomectomy
5158489|NCT00979342|polypectomy|polypectomy
5158490|NCT00979342|uterine fibroids|uterine fibroids
5158491|NCT00979342|uterine polyps|uterine polyps
5158492|NCT00979342|local anesthetic|local anesthetic
5158493|NCT00979342|cervical block|cervical block
5158494|NCT00979342|pain management|pain management
5158495|NCT00979329|sunitinib|sunitinib
5158496|NCT00979329|sorafenib|sorafenib
5158497|NCT00979329|fatigue|fatigue
5158498|NCT00979329|depression|depression
5158499|NCT00979329|quality of life|quality of life
5158500|NCT00979329|metastatic RCC|metastatic rcc
5158501|NCT00979329|colorectal cancer|colorectal cancer
5158502|NCT00979329|GIST|gist
5158503|NCT00979303|Pediatric|pediatric
5158504|NCT00979303|Electrophysiology|electrophysiology
5158505|NCT00979303|Ablation|ablation
5158506|NCT00979303|Radiation|radiation
5158507|NCT00979303|Devices|devices
5158508|NCT00979303|SVT|svt
5158509|NCT00979290|Fix-dose combination anti-TB drug|fix-dose combination anti-tb drug
5158510|NCT00979290|adverse effect|adverse effect
5158511|NCT00979290|efficiency|efficiency
5158512|NCT00979264|Quality Improvement|quality improvement
5158513|NCT00979251|Influenza|influenza
5158514|NCT00979251|Immunocompromised|immunocompromised
5158515|NCT00979251|HIV|hiv
5158516|NCT00979251|History of transplant|history of transplant
5158517|NCT00979238|Hemophilia B|hemophilia b
5158518|NCT00979238|Factor IX Gene|factor ix gene
5158519|NCT00979238|Factor IX Protein|factor ix protein
5158520|NCT00979238|Vector|vector
5158521|NCT00979225|health information technology|health information technology
5158522|NCT00979225|clinical decision support|clinical decision support
5158523|NCT00979225|medication management|medication management
5158524|NCT00979225|medication adherence|medication adherence
5158525|NCT00979212|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5158526|NCT00979212|adenocarcinoma of the lung|adenocarcinoma of the lung
5158527|NCT00979212|adenosquamous cell lung cancer|adenosquamous cell lung cancer
5158528|NCT00979212|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
5158529|NCT00979212|large cell lung cancer|large cell lung cancer
5158530|NCT00979212|squamous cell lung cancer|squamous cell lung cancer
5158531|NCT00979199|IHD|ihd
5158532|NCT00979199|CAD|cad
5158533|NCT00979199|Non invasive imaging|non invasive imaging
5158534|NCT00979199|SPECT|spect
5158535|NCT00979199|PET|pet
5158536|NCT00979199|CMR|cmr
5158537|NCT00979199|Echocardiography|echocardiography
5158538|NCT00979186|transgastric cholecystectomy|transgastric cholecystectomy
5158539|NCT00979173|malignant glioma|malignant glioma
5158540|NCT00979173|glioblastoma multiforme|glioblastoma multiforme
5158541|NCT00979173|gliosarcoma|gliosarcoma
5158542|NCT00979173|anaplastic astrocytoma|anaplastic astrocytoma
5158543|NCT00979173|anaplastic oligodendroglioma|anaplastic oligodendroglioma
5158544|NCT00979173|anaplastic mixed glioma|anaplastic mixed glioma
5158545|NCT00979173|Pro00018751|pro00018751
5158546|NCT00979173|Duke|duke
5158547|NCT00979173|Ambit|ambit
5158548|NCT00979173|AC480|ac480
5158549|NCT00979147|knee arthritis|knee arthritis
5158550|NCT00979147|total knee arthroplasty|total knee arthroplasty
5158551|NCT00979147|total knee replacement|total knee replacement
5158552|NCT00979147|metal backed tibial component|metal backed tibial component
5158553|NCT00979147|all-polyethylene tibia|all-polyethylene tibia
5158554|NCT00979147|modular polished tibial baseplate|modular polished tibial baseplate
5158555|NCT00979134|Cancer|cancer
5158556|NCT00979134|Tumour|tumour
5158557|NCT00979134|Advanced Solid Malignancies|advanced solid malignancies
5158558|NCT00979134|FGFR|fgfr
5158559|NCT00979134|Squamous NSCLC|squamous nsclc
5158560|NCT00979134|Gastric adenocarcinoma|gastric adenocarcinoma
5158561|NCT00979121|ALI|ali
5158562|NCT00979121|Sepsis|sepsis
5158563|NCT00979121|statin|statin
5158564|NCT00979108|Radiculopathy|radiculopathy
5158565|NCT00979108|Neck pain|neck pain
5158566|NCT00979108|Physical therapy modalities|physical therapy modalities
5158567|NCT00979108|Rehabilitation|rehabilitation
5158568|NCT00979095|multiple hernia|multiple hernia
5158569|NCT00979056|Traveller's diarrhoea|traveller's diarrhoea
5158570|NCT00979056|Prevention|prevention
5158571|NCT00979043|knee osteoarthritis|knee osteoarthritis
5158572|NCT00979043|weight-loss|weight-loss
5158573|NCT00979043|exercise|exercise
5158574|NCT00979043|obesity|obesity
5158575|NCT00979043|physical function|physical function
5158576|NCT00979043|total mortality|total mortality
5158577|NCT00979017|malignant glioma|malignant glioma
5158578|NCT00979017|glioblastoma multiforme|glioblastoma multiforme
5158579|NCT00979017|gliosarcoma|gliosarcoma
5158580|NCT00979017|Avastin|avastin
5158581|NCT00979017|bevacizumab|bevacizumab
5158582|NCT00979017|Temodar|temodar
5158583|NCT00979017|temozolomide|temozolomide
5158584|NCT00979017|Irinotecan|irinotecan
5158585|NCT00979017|CPT-11|cpt-11
5158586|NCT00979017|Pro00019065|pro00019065
5158587|NCT00979017|Vredenburgh|vredenburgh
5158588|NCT00979017|Duke|duke
5158589|NCT00979004|Photosensitivity|photosensitivity
5158590|NCT00979004|Epilepsy|epilepsy
5158591|NCT00979004|Seizures|seizures
5158592|NCT00978991|Benign prostate hyperplasia|benign prostate hyperplasia
5158593|NCT00978991|Erectile dysfunction|erectile dysfunction
5158594|NCT00978965|kidney transplantation|kidney transplantation
5158595|NCT00978965|immunosuppression|immunosuppression
5158596|NCT00978965|single nucleotide polymorphism|single nucleotide polymorphism
5158597|NCT00978965|IMPDH|impdh
5158598|NCT00978926|Anti-Vascular Endothelial growth factor|anti-vascular endothelial growth factor
5158599|NCT00978913|dendritic cell|dendritic cell
5158600|NCT00978913|cancervaccine|cancervaccine
5158601|NCT00978913|breast cancer|breast cancer
5158602|NCT00978913|malignant melanoma|malignant melanoma
5158603|NCT00978913|Cyclophosphamide|cyclophosphamide
5158604|NCT00978900|satiety peptides|satiety peptides
5158605|NCT00978900|GLP-1|glp-1
5158606|NCT00978900|PYY|pyy
5158607|NCT00978900|ghrelin|ghrelin
5158608|NCT00978900|appetite profile|appetite profile
5158609|NCT00978900|Sweetening Agents|sweetening agents
5158610|NCT00978887|Facial cream|facial cream
5158611|NCT00978887|natural product|natural product
5158612|NCT00978887|facial wrinkles|facial wrinkles
5158613|NCT00978874|recurrent cervical cancer|recurrent cervical cancer
5158614|NCT00978874|stage IB cervical cancer|stage ib cervical cancer
5158615|NCT00978874|stage IIA cervical cancer|stage iia cervical cancer
5158616|NCT00978874|stage IIB cervical cancer|stage iib cervical cancer
5158617|NCT00978874|stage III cervical cancer|stage iii cervical cancer
5158618|NCT00978874|stage IVA cervical cancer|stage iva cervical cancer
5158619|NCT00978874|stage IVB cervical cancer|stage ivb cervical cancer
5158620|NCT00978848|trichomonas|trichomonas
5158621|NCT00978848|chlamydia|chlamydia
5158622|NCT00978848|gonorrhea|gonorrhea
5158623|NCT00978848|emergency contraception|emergency contraception
5158624|NCT00978848|emergency contraception use|emergency contraception use
5158625|NCT00978835|Diabetes|diabetes
5158626|NCT00978835|Hypertension|hypertension
5158627|NCT00978835|Physical Activity|physical activity
5158628|NCT00978835|Diet|diet
5158629|NCT00978835|Medication Adherence|medication adherence
5158630|NCT00978822|Subarachnoid hemorrhage|subarachnoid hemorrhage
5158631|NCT00978822|Hypertension|hypertension
5158632|NCT00978822|brain Aneurysm|brain aneurysm
5158633|NCT00978822|intracerebral hemorrhage|intracerebral hemorrhage
5158634|NCT00978822|antihypertensive|antihypertensive
5158635|NCT00978822|calcium channel blockers|calcium channel blockers
5158636|NCT00978822|infusion|infusion
5158637|NCT00978822|neurocritical care|neurocritical care
5158638|NCT00978809|BPPV|bppv
5158639|NCT00978809|postural stability|postural stability
5158640|NCT00978809|Epley|epley
5158641|NCT00978809|Semont|semont
5158642|NCT00978796|Diabetes Mellitus|diabetes mellitus
5158643|NCT00978796|Type 1 diabetes|type 1 diabetes
5158644|NCT00978796|glucose variability|glucose variability
5158645|NCT00978783|Phonation|phonation
5158646|NCT00978783|Tracheostomy|tracheostomy
5158647|NCT00978783|phonation valve|phonation valve
5158648|NCT00978783|positive end expiratory pressure|positive end expiratory pressure
5158649|NCT00978770|stage II breast cancer|stage ii breast cancer
5158650|NCT00978770|stage IIIA breast cancer|stage iiia breast cancer
5158651|NCT00978770|stage IIIB breast cancer|stage iiib breast cancer
5158652|NCT00978770|stage IIIC breast cancer|stage iiic breast cancer
5158653|NCT00978757|hepatectomy|hepatectomy
5158654|NCT00978757|IL 6|il 6
5158655|NCT00978757|organ failure|organ failure
5158656|NCT00978757|ketamine|ketamine
5158657|NCT00978757|Pringle|pringle
5158658|NCT00978744|Clinical Health Record|clinical health record
5158659|NCT00978744|Computerized Decision Support|computerized decision support
5158660|NCT00978744|Patient Safety|patient safety
5158661|NCT00978744|Resource Utilization|resource utilization
5158662|NCT00978718|prostate cancer|prostate cancer
5158663|NCT00978705|Keratinocyte Cell|keratinocyte cell
5158664|NCT00978705|severe burn wound|severe burn wound
5158665|NCT00978692|Myopia|myopia
5158666|NCT00978692|Astigmatism|astigmatism
5158667|NCT00978692|Orthokeratology|orthokeratology
5158668|NCT00978692|Corneal thickness|corneal thickness
5158669|NCT00978692|Corneal curvatures|corneal curvatures
5158670|NCT00978692|Corneal biomechanics|corneal biomechanics
5158671|NCT00978679|Children|children
5158672|NCT00978679|Peripheral refraction|peripheral refraction
5158673|NCT00978679|Aberration|aberration
5158674|NCT00978679|Eyeball length|eyeball length
5158675|NCT00978679|Myopic control|myopic control
5158676|NCT00978679|Myopia|myopia
5158677|NCT00978679|Corneal reshaping|corneal reshaping
5158678|NCT00978679|Orthokeratology|orthokeratology
5158679|NCT00978653|allopurinol|allopurinol
5158680|NCT00978653|chronic kidney disease|chronic kidney disease
5158681|NCT00978653|endothelial dysfunction|endothelial dysfunction
5158682|NCT00978653|hyperuricemia|hyperuricemia
5158683|NCT00978653|uric acid|uric acid
5158684|NCT00978653|vascular endothelium|vascular endothelium
5158685|NCT00978653|xanthine oxidase inhibitor|xanthine oxidase inhibitor
5158686|NCT00978640|Sirt1 activity|sirt1 activity
5158687|NCT00978601|post-operative analgesia|post-operative analgesia
5158688|NCT00978601|early discharge,|early discharge,
5158689|NCT00978601|fast recovery,|fast recovery,
5158690|NCT00978601|minimally invasive myomectomy,|minimally invasive myomectomy,
5158691|NCT00978601|laparoscopy,|laparoscopy,
5158692|NCT00978601|laparoscopically assisted myomectomy|laparoscopically assisted myomectomy
5158693|NCT00978601|patient discharge|patient discharge
5158694|NCT00978601|Anesthesia Recovery Period|anesthesia recovery period
5158695|NCT00978575|Iron treatment|iron treatment
5158696|NCT00978575|Upper gastrointestinal bleeding|upper gastrointestinal bleeding
5158697|NCT00978549|pain|pain
5158698|NCT00978549|nausea and vomiting|nausea and vomiting
5158699|NCT00978549|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
5158700|NCT00978549|adenocarcinoma of the stomach|adenocarcinoma of the stomach
5158701|NCT00978549|adenocarcinoma of the gastroesophageal junction|adenocarcinoma of the gastroesophageal junction
5158702|NCT00978549|recurrent gastric cancer|recurrent gastric cancer
5158703|NCT00978549|stage IIIA gastric cancer|stage iiia gastric cancer
5158704|NCT00978549|stage IIIB gastric cancer|stage iiib gastric cancer
5158705|NCT00978549|stage IIIC gastric cancer|stage iiic gastric cancer
5158706|NCT00978549|stage IV gastric cancer|stage iv gastric cancer
5158707|NCT00978549|recurrent esophageal cancer|recurrent esophageal cancer
5158708|NCT00978549|stage IIIA esophageal cancer|stage iiia esophageal cancer
5158709|NCT00978549|stage IIIB esophageal cancer|stage iiib esophageal cancer
5158710|NCT00978549|stage IIIC esophageal cancer|stage iiic esophageal cancer
5158711|NCT00978549|stage IV esophageal cancer|stage iv esophageal cancer
5158712|NCT00978536|Multiple sclerosis|multiple sclerosis
5158713|NCT00978536|cognitive deterioration|cognitive deterioration
5158714|NCT00978536|biomarkers|biomarkers
5158715|NCT00978536|cerebrospinal fluid|cerebrospinal fluid
5158716|NCT00978536|Alzheimer disease|alzheimer disease
5158717|NCT00978510|Tuberculosis|tuberculosis
5158718|NCT00978510|Disease transmission|disease transmission
5158719|NCT00978510|Exposure to biological agents|exposure to biological agents
5158720|NCT00978510|Health personnel|health personnel
5158721|NCT00978484|PTSD|ptsd
5158722|NCT00978484|Depression|depression
5158723|NCT00978484|Anxiety|anxiety
5158724|NCT00978484|Virtual Reality|virtual reality
5158725|NCT00978484|Computer Therapy|computer therapy
5158726|NCT00978484|Exposure Therapy|exposure therapy
5158727|NCT00978484|Prolonged Exposure|prolonged exposure
5158728|NCT00978484|Military Medicine|military medicine
5158729|NCT00978484|Combat|combat
5158730|NCT00978484|Iraq|iraq
5158731|NCT00978484|Afghanistan|afghanistan
5158732|NCT00978484|Air Force Personnel|air force personnel
5158733|NCT00978484|Armed Forces Personnel|armed forces personnel
5158734|NCT00978484|Army Personnel|army personnel
5158735|NCT00978484|Coast Guard|coast guard
5158736|NCT00978484|psychology|psychology
5158737|NCT00978484|military psychiatry|military psychiatry
5158738|NCT00978484|combat disorders|combat disorders
5158739|NCT00978484|combat neurosis|combat neurosis
5158740|NCT00978484|Marines|marines
5158741|NCT00978484|Military|military
5158742|NCT00978484|Navy Personnel|navy personnel
5158743|NCT00978484|Sailors|sailors
5158744|NCT00978484|Soldiers|soldiers
5158745|NCT00978471|Conventional chemotherapy|conventional chemotherapy
5158746|NCT00978471|cytapheresis|cytapheresis
5158747|NCT00978471|Peripheral stem cell autograft|peripheral stem cell autograft
5158748|NCT00978471|Surgical resection|surgical resection
5158749|NCT00978471|Thiotepa|thiotepa
5158750|NCT00978458|neurotoxicity|neurotoxicity
5158751|NCT00978458|adult diffuse astrocytoma|adult diffuse astrocytoma
5158752|NCT00978458|adult oligodendroglioma|adult oligodendroglioma
5158753|NCT00978458|recurrent adult brain tumor|recurrent adult brain tumor
5158754|NCT00978458|adult mixed glioma|adult mixed glioma
5158755|NCT00978445|Systemic embolic events|systemic embolic events
5158756|NCT00978445|Thromboembolic Complications with Atrial Fibrillation|thromboembolic complications with atrial fibrillation
5158757|NCT00978445|Prophylaxis with Atrial Fibrillation|prophylaxis with atrial fibrillation
5158758|NCT00978445|Mechanical Cardiac Valve Replacement|mechanical cardiac valve replacement
5158759|NCT00978432|NHL|nhl
5158760|NCT00978432|DLBCL|dlbcl
5158761|NCT00978432|recurrent|recurrent
5158762|NCT00978432|refractory|refractory
5158763|NCT00978432|de novo|de novo
5158764|NCT00978419|Statins|statins
5158765|NCT00978419|Burns|burns
5158766|NCT00978419|Sedatives|sedatives
5158767|NCT00978419|Neurocognitive|neurocognitive
5158768|NCT00978419|Septic|septic
5158769|NCT00978419|Mortality|mortality
5158770|NCT00978419|C Reactive Protein|c reactive protein
5158771|NCT00978419|Septic shock|septic shock
5158772|NCT00978419|Sedation|sedation
5158773|NCT00978419|Neurocognitive function|neurocognitive function
5158774|NCT00978406|Dietary Assessment Methods|dietary assessment methods
5158775|NCT00978406|Measurement of Diet|measurement of diet
5158776|NCT00978406|24-Hour Diet Recall|24-hour diet recall
5158777|NCT00978406|Validation|validation
5158778|NCT00978406|Feeding Study|feeding study
5158779|NCT00978367|Cicatrix|cicatrix
5158780|NCT00978367|Scar|scar
5158781|NCT00978367|Avotermin|avotermin
5158782|NCT00978367|Juvista|juvista
5158783|NCT00978367|RN1001|rn1001
5158784|NCT00978367|TGF beta 3|tgf beta 3
5158785|NCT00978354|acute kidney injury|acute kidney injury
5158786|NCT00978354|acute renal failure|acute renal failure
5158787|NCT00978354|loop diuretic|loop diuretic
5158788|NCT00978354|critical illness|critical illness
5158789|NCT00978354|sepsis|sepsis
5158790|NCT00978354|renal replacement therapy|renal replacement therapy
5158791|NCT00978354|dialysis|dialysis
5158792|NCT00978354|renal recovery|renal recovery
5158793|NCT00978354|survival|survival
5158794|NCT00978341|Clinical Trial Methodology study Neuropathic pain in Spinal cord injury patients Pain endpoints Crossover design|clinical trial methodology study neuropathic pain in spinal cord injury patients pain endpoints crossover design
5158795|NCT00978328|Pain conditions|pain conditions
5158796|NCT00978328|Oxycodone immediate release|oxycodone immediate release
5158797|NCT00978328|Percocet®, Tylox®|percocet®, tylox®
5158798|NCT00978328|Roxicodone®|roxicodone®
5158799|NCT00978328|Registry|registry
5158800|NCT00978328|Side effects|side effects
5158801|NCT00978328|Observational|observational
5158802|NCT00978328|Pain management|pain management
5158803|NCT00978302|Cicatrix|cicatrix
5158804|NCT00978302|Scar|scar
5158805|NCT00978302|Wound healing|wound healing
5158806|NCT00978302|Avotermin|avotermin
5158807|NCT00978302|TGF beta 3|tgf beta 3
5158808|NCT00978302|Juvista|juvista
5158809|NCT00978302|RN1001|rn1001
5158810|NCT00978289|obesity|obesity
5158811|NCT00978289|gastric bypass surgery|gastric bypass surgery
5158812|NCT00978276|Receptors|receptors
5158813|NCT00978276|Immunohistochemistry|immunohistochemistry
5158814|NCT00978276|Breast|breast
5158815|NCT00978276|Over expression of Hormone receptors in carcinoma of the breast sues|over expression of hormone receptors in carcinoma of the breast sues
5158816|NCT00978250|DNA Methylation|dna methylation
5158817|NCT00978250|Advanced Cancer|advanced cancer
5158818|NCT00978250|Methyltransferase Inhibitor|methyltransferase inhibitor
5158819|NCT00978250|Epigenetics|epigenetics
5158820|NCT00978250|Gene Re-Expression|gene re-expression
5158821|NCT00978250|Breast Cancer|breast cancer
5158822|NCT00978250|Head and Neck Cancer|head and neck cancer
5158823|NCT00978250|Lung Cancer|lung cancer
5158824|NCT00978250|Non-Small Cell Lung Cancer|non-small cell lung cancer
5158825|NCT00978250|Bladder Cancer|bladder cancer
5158826|NCT00978237|HIV - Lipoatrophy|hiv - lipoatrophy
5158827|NCT00978237|treatment experienced|treatment experienced
5158828|NCT00978224|dietary supplement|dietary supplement
5158829|NCT00978224|hemodialysis|hemodialysis
5158830|NCT00978224|Chronic Inflammatory Syndrome|chronic inflammatory syndrome
5158831|NCT00978224|Viusid|viusid
5158832|NCT00978211|DOTATOC|dotatoc
5158833|NCT00978211|somatostatin|somatostatin
5158834|NCT00978211|radiopeptide|radiopeptide
5158835|NCT00978211|Yttrium|yttrium
5158836|NCT00978211|Lutetium|lutetium
5158837|NCT00978211|neuroendocrine|neuroendocrine
5158838|NCT00978211|cancer|cancer
5158839|NCT00978198|Pharmacokinetics|pharmacokinetics
5158840|NCT00978198|Safety and tolerability|safety and tolerability
5158841|NCT00978198|Plasma concentration|plasma concentration
5158842|NCT00978198|ASP1517|asp1517
5158843|NCT00978198|FG-4592|fg-4592
5158844|NCT00978185|nausea and vomiting|nausea and vomiting
5158845|NCT00978185|anxiety disorder|anxiety disorder
5158846|NCT00978185|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5158847|NCT00978159|esomeprazole|esomeprazole
5158848|NCT00978159|famotidine|famotidine
5158849|NCT00978159|aspirin|aspirin
5158850|NCT00978159|dyspepsia|dyspepsia
5158851|NCT00978133|Colectomy|colectomy
5158852|NCT00978133|Closure|closure
5158853|NCT00978133|Wound|wound
5158854|NCT00978133|Dermabond|dermabond
5158855|NCT00978133|Propen|propen
5158856|NCT00978120|Influenza A Virus, H1N1 Subtype|influenza a virus, h1n1 subtype
5158857|NCT00978120|Vaccine|vaccine
5158858|NCT00978107|Hepatic tumors|hepatic tumors
5158859|NCT00978107|Metastatic colorectal cancer|metastatic colorectal cancer
5158860|NCT00978081|precancerous condition|precancerous condition
5158861|NCT00978081|stage 0 hypopharyngeal cancer|stage 0 hypopharyngeal cancer
5158862|NCT00978081|stage 0 laryngeal cancer|stage 0 laryngeal cancer
5158863|NCT00978081|stage 0 lip and oral cavity cancer|stage 0 lip and oral cavity cancer
5158864|NCT00978081|stage 0 nasopharyngeal cancer|stage 0 nasopharyngeal cancer
5158865|NCT00978081|stage 0 oropharyngeal cancer|stage 0 oropharyngeal cancer
5158866|NCT00978081|stage 0 paranasal sinus and nasal cavity cancer|stage 0 paranasal sinus and nasal cavity cancer
5158867|NCT00978068|Pediatric HIV|pediatric hiv
5158868|NCT00978068|Malaria|malaria
5158869|NCT00978068|Uganda|uganda
5158870|NCT00978068|Nevirapine|nevirapine
5158871|NCT00978068|Zidovudine|zidovudine
5158872|NCT00978068|Lamivudine|lamivudine
5158873|NCT00978068|Lopinavir/ritonavir|lopinavir/ritonavir
5158874|NCT00978068|Stavudine|stavudine
5158875|NCT00978068|Efavirenz|efavirenz
5158876|NCT00978068|HIV|hiv
5158877|NCT00978029|immunotherapy|immunotherapy
5158878|NCT00978016|GERD|gerd
5158879|NCT00978003|Vasti Medialis|vasti medialis
5158880|NCT00978003|Knee|knee
5158881|NCT00978003|MR Imaging|mr imaging
5158882|NCT00978003|Vasti Lateralis|vasti lateralis
5158883|NCT00978003|HV|hv
5158884|NCT00978003|Healthy Volunteer|healthy volunteer
5158885|NCT00977990|Skin Swab|skin swab
5158886|NCT00977990|Self-Sample|self-sample
5158887|NCT00977977|Nephrotic Syndrome|nephrotic syndrome
5158888|NCT00977977|Renal Disease|renal disease
5158889|NCT00977977|Autoimmune Diseases|autoimmune diseases
5158890|NCT00977977|Clinical Trial|clinical trial
5158891|NCT00977977|Proteinuria|proteinuria
5158892|NCT00977964|Infant|infant
5158893|NCT00977951|Cicatrix|cicatrix
5158894|NCT00977951|Scar|scar
5158895|NCT00977951|Avotermin|avotermin
5158896|NCT00977951|Juvista|juvista
5158897|NCT00977951|RN1001|rn1001
5158898|NCT00977951|TGF beta 3|tgf beta 3
5158899|NCT00977938|Acute Coronary Syndrome|acute coronary syndrome
5158900|NCT00977938|Adverse event|adverse event
5158901|NCT00977938|Antiplatelet therapy|antiplatelet therapy
5158902|NCT00977938|Sirolimus|sirolimus
5158903|NCT00977938|Everolimus|everolimus
5158904|NCT00977938|Paclitaxel|paclitaxel
5158905|NCT00977938|Zotarolimus|zotarolimus
5158906|NCT00977938|Bare Metal Stent|bare metal stent
5158907|NCT00977938|Drug Eluting Stent|drug eluting stent
5158908|NCT00977938|Clinical Events Committee|clinical events committee
5158909|NCT00977938|Dual antiplatelet therapy|dual antiplatelet therapy
5158910|NCT00977938|Harvard Clinical Research Institute|harvard clinical research institute
5158911|NCT00977938|Major Adverse Cardiac and Cerebral Event|major adverse cardiac and cerebral event
5158912|NCT00977938|Major Bleeding|major bleeding
5158913|NCT00977938|Myocardial infarction|myocardial infarction
5158914|NCT00977938|Myocardial ischemia|myocardial ischemia
5158915|NCT00977938|Percutaneous coronary intervention|percutaneous coronary intervention
5158916|NCT00977938|Stent placement|stent placement
5158917|NCT00977938|Stent Thrombosis|stent thrombosis
5158918|NCT00977938|Thienopyridine|thienopyridine
5158919|NCT00977938|Clopidogrel|clopidogrel
5158920|NCT00977938|Prasugrel|prasugrel
5158921|NCT00977925|Hemostasis|hemostasis
5158922|NCT00977912|B. lactis|b. lactis
5158923|NCT00977912|Preterm|preterm
5158924|NCT00977912|Necrotizing Enterocolitis (NEC)|necrotizing enterocolitis (nec)
5158925|NCT00977899|Plasmodium Falciparum|plasmodium falciparum
5158926|NCT00977899|Alum Adsorbed|alum adsorbed
5158927|NCT00977899|Ookinete Surface Protein|ookinete surface protein
5158928|NCT00977899|Malaria Vaccine|malaria vaccine
5158929|NCT00977899|Healthy Volunteer|healthy volunteer
5158930|NCT00977899|HV|hv
5158931|NCT00977860|Prostate|prostate
5158932|NCT00977860|Stereotactic|stereotactic
5158933|NCT00977860|Radiosurgery|radiosurgery
5158934|NCT00977847|Family History|family history
5158935|NCT00977847|Electronic Health Record|electronic health record
5158936|NCT00977834|Geriatric Assessment|geriatric assessment
5158937|NCT00977808|Artificial pancreas|artificial pancreas
5158938|NCT00977808|Closed-Loop control|closed-loop control
5158939|NCT00977795|Brain Neoplasms|brain neoplasms
5158940|NCT00977795|5-ALA|5-ala
5158941|NCT00977795|Aminolevulinic acid|aminolevulinic acid
5158942|NCT00977795|Fluorescence|fluorescence
5158943|NCT00977795|Gliomas|gliomas
5158944|NCT00977795|Glioblastoma|glioblastoma
5158945|NCT00977795|Surgery|surgery
5158946|NCT00977769|cesarean delivery|cesarean delivery
5158947|NCT00977769|blood pressure|blood pressure
5158948|NCT00977769|cardiac output|cardiac output
5158949|NCT00977756|Treatment|treatment
5158950|NCT00977756|Children|children
5158951|NCT00977756|Integrase Inhibitors|integrase inhibitors
5158952|NCT00977756|Entry Inhibitors|entry inhibitors
5158953|NCT00977756|Treatment Experienced|treatment experienced
5158954|NCT00977730|Hepatitis|hepatitis
5158955|NCT00977730|Fatty Liver|fatty liver
5159247|NCT00976443|Obesity|obesity
5158956|NCT00977730|Non Alcoholic Steatohepatitis|non alcoholic steatohepatitis
5158957|NCT00977730|Protandim|protandim
5158958|NCT00977717|oxaliplatin|oxaliplatin
5158959|NCT00977717|neuropathy|neuropathy
5158960|NCT00977717|SNPs|snps
5158961|NCT00977704|Correction of peri-oral wrinkles|correction of peri-oral wrinkles
5158962|NCT00977691|Peripheral Blood Stem Cell Transplantation|peripheral blood stem cell transplantation
5158963|NCT00977691|Anemia, Sickle Cell|anemia, sickle cell
5158964|NCT00977691|Graft-Versus-Host Disease|graft-versus-host disease
5158965|NCT00977691|Sirolimus (Rapamune )|sirolimus (rapamune )
5158966|NCT00977691|Alemtuzumab (Campath )|alemtuzumab (campath )
5158967|NCT00977691|Thalassemia|thalassemia
5158968|NCT00977691|Sickle Cell Disease|sickle cell disease
5158969|NCT00977678|open access gastroscopy|open access gastroscopy
5158970|NCT00977652|fecal incontinence|fecal incontinence
5158971|NCT00977626|Safety|safety
5158972|NCT00977626|Tolerability|tolerability
5158973|NCT00977626|Healthy|healthy
5158974|NCT00977626|Pharmacokinetics|pharmacokinetics
5158975|NCT00977626|Healthy volunteers|healthy volunteers
5158976|NCT00977613|Treated Stage 2 and Stage 3 colorectal cancer|treated stage 2 and stage 3 colorectal cancer
5158977|NCT00977600|Ammonul|ammonul
5158978|NCT00977600|Sodium phenylacetate|sodium phenylacetate
5158979|NCT00977600|sodium benzoate|sodium benzoate
5158980|NCT00977600|Buphenyl|buphenyl
5158981|NCT00977600|sodium phenylbutyrate|sodium phenylbutyrate
5158982|NCT00977600|HPN-100|hpn-100
5158983|NCT00977600|GT4P|gt4p
5158984|NCT00977600|Glyceryl tri-(4-phenylbutyrate)|glyceryl tri-(4-phenylbutyrate)
5158985|NCT00977600|Healthy Volunteers|healthy volunteers
5158986|NCT00977587|irritable bowel syndrome|irritable bowel syndrome
5158987|NCT00977587|faecal serine proteases|faecal serine proteases
5158988|NCT00977561|Small Cell Lung Cancer|small cell lung cancer
5158989|NCT00977561|Extensive stage disease|extensive stage disease
5158990|NCT00977561|SCLC|sclc
5158991|NCT00977561|IGF-1R inhibitor|igf-1r inhibitor
5158992|NCT00977548|MDS|mds
5158993|NCT00977548|blood diseases|blood diseases
5158994|NCT00977548|bone marrow|bone marrow
5158995|NCT00977548|hematopoietic|hematopoietic
5158996|NCT00977548|leukemia|leukemia
5158997|NCT00977522|schizophrenia negative symptoms adjunctive|schizophrenia negative symptoms adjunctive
5158998|NCT00977509|genes|genes
5158999|NCT00977509|mutation|mutation
5159000|NCT00977509|non-small cell lung cancer|non-small cell lung cancer
5159001|NCT00977509|cancer cells|cancer cells
5159002|NCT00977496|hemodialysis|hemodialysis
5159003|NCT00977496|microbiota|microbiota
5159004|NCT00977496|Staphylococcus aureus|staphylococcus aureus
5159005|NCT00977470|NSCLC|nsclc
5159006|NCT00977470|HCQ|hcq
5159007|NCT00977470|erlotinib|erlotinib
5159008|NCT00977470|Tarceva|tarceva
5159009|NCT00977457|stage I prostate cancer|stage i prostate cancer
5159010|NCT00977457|stage II prostate cancer|stage ii prostate cancer
5159011|NCT00977457|stage III prostate cancer|stage iii prostate cancer
5159012|NCT00977457|stage IV prostate cancer|stage iv prostate cancer
5159013|NCT00977444|knee|knee
5159014|NCT00977444|osteoarthritis|osteoarthritis
5159015|NCT00977418|Healthy Aging|healthy aging
5159016|NCT00977418|Exercise|exercise
5159017|NCT00977418|Cognition|cognition
5159018|NCT00977418|Cognitive Training|cognitive training
5159266|NCT00976352|Gene Therapy|gene therapy
5159019|NCT00977418|Keeping healthy seniors as mentally efficient as possible|keeping healthy seniors as mentally efficient as possible
5159020|NCT00977405|Wound infection|wound infection
5159021|NCT00977405|Gentamicin|gentamicin
5159022|NCT00977405|Contaminated wounds|contaminated wounds
5159023|NCT00977392|human papilloma virus infection|human papilloma virus infection
5159024|NCT00977392|health status unknown|health status unknown
5159025|NCT00977353|Major depressive disorder|major depressive disorder
5159026|NCT00977353|Depression|depression
5159027|NCT00977353|Sarcosine|sarcosine
5159028|NCT00977353|N-methylglycine|n-methylglycine
5159029|NCT00977353|NMDA|nmda
5159030|NCT00977340|Chronic nightmare sufferers|chronic nightmare sufferers
5159031|NCT00977340|nightmares|nightmares
5159032|NCT00977340|Imagery Rehearsal Therapy IRT|imagery rehearsal therapy irt
5159033|NCT00977340|sleep disturbance|sleep disturbance
5159034|NCT00977340|treatment of nightmares|treatment of nightmares
5159035|NCT00977340|confrontation|confrontation
5159036|NCT00977340|People who suffer of chronic nightmares|people who suffer of chronic nightmares
5159037|NCT00977327|Glioma|glioma
5159038|NCT00977327|Intraoperative MR|intraoperative mr
5159039|NCT00977327|Intraoperative Ultrasound|intraoperative ultrasound
5159040|NCT00977327|resection|resection
5159041|NCT00977327|Intraoperative navigation|intraoperative navigation
5159042|NCT00977327|Extent of resection|extent of resection
5159043|NCT00977314|Unilateral Hearing Loss|unilateral hearing loss
5159044|NCT00977301|HIV infection|hiv infection
5159045|NCT00977301|interaction|interaction
5159046|NCT00977301|pharmacokinetics|pharmacokinetics
5159047|NCT00977275|early stage invasive breast cancer|early stage invasive breast cancer
5159048|NCT00977275|Partial breast irradiation|partial breast irradiation
5159049|NCT00977275|interstitial implant|interstitial implant
5159050|NCT00977262|fatty acids|fatty acids
5159051|NCT00977262|peripheral blood mononuclear cells|peripheral blood mononuclear cells
5159052|NCT00977262|inflammation|inflammation
5159053|NCT00977262|nutrigenomics|nutrigenomics
5159054|NCT00977249|long term nicotine gum use|long term nicotine gum use
5159055|NCT00977249|varenicline|varenicline
5159056|NCT00977249|adverse effects|adverse effects
5159057|NCT00977236|children|children
5159058|NCT00977236|corneal reshaping|corneal reshaping
5159059|NCT00977236|myopia|myopia
5159060|NCT00977236|myopia control|myopia control
5159061|NCT00977236|orthokeratology|orthokeratology
5159062|NCT00977223|Aldosterone|aldosterone
5159063|NCT00977223|Substance P|substance p
5159064|NCT00977223|Cortisol|cortisol
5159065|NCT00977223|Aprepitant|aprepitant
5159066|NCT00977223|Adrenal glands|adrenal glands
5159067|NCT00977210|Phase 1|phase 1
5159068|NCT00977210|oxi4503|oxi4503
5159069|NCT00977210|oxigene|oxigene
5159070|NCT00977210|cruk|cruk
5159071|NCT00977210|solid tumors|solid tumors
5159072|NCT00977210|VDA|vda
5159073|NCT00977210|vascular disrupting agent|vascular disrupting agent
5159074|NCT00977184|Parkinson's Disease|parkinson's disease
5159075|NCT00977184|Transcranial Magnetic Stimulation (TMS)|transcranial magnetic stimulation (tms)
5159076|NCT00977184|Treatment Study|treatment study
5159077|NCT00977184|PD|pd
5159078|NCT00977184|Parkinson Disease|parkinson disease
5159079|NCT00977171|chronic fatigue syndrome|chronic fatigue syndrome
5159080|NCT00977171|CFS|cfs
5159081|NCT00977171|neurally mediated hypotension|neurally mediated hypotension
5159082|NCT00977171|NMH|nmh
5159083|NCT00977171|neurogenic orthostatic hypotension|neurogenic orthostatic hypotension
5159084|NCT00977171|NOH|noh
5159085|NCT00977171|orthostatic hypotension|orthostatic hypotension
5159086|NCT00977171|droxidopa|droxidopa
5159087|NCT00977158|Cystic Fibrosis|cystic fibrosis
5159088|NCT00977158|Microbiota|microbiota
5159089|NCT00977158|upper respiratory tract|upper respiratory tract
5159090|NCT00977158|16S rRNA sequence analysis|16s rrna sequence analysis
5159091|NCT00977158|Staphylococcus aureus|staphylococcus aureus
5159092|NCT00977158|Pseudomonas aeruginosa|pseudomonas aeruginosa
5159093|NCT00977158|Burkholderia cepacia|burkholderia cepacia
5159094|NCT00977158|Haemophilus influenzae|haemophilus influenzae
5159095|NCT00977158|Streptococcus pneumoniae|streptococcus pneumoniae
5159096|NCT00977145|melanoma|melanoma
5159097|NCT00977145|peptide vaccine|peptide vaccine
5159098|NCT00977145|interferon gamma|interferon gamma
5159099|NCT00977145|immunotherapy|immunotherapy
5159100|NCT00977132|Myelodysplastic Syndromes|myelodysplastic syndromes
5159101|NCT00977132|Valproic acid|valproic acid
5159102|NCT00977132|Lenalidomide|lenalidomide
5159103|NCT00977119|breast cancer|breast cancer
5159104|NCT00977119|capecitabine|capecitabine
5159105|NCT00977093|Coronary artery disease|coronary artery disease
5159106|NCT00977093|Cardiac magnetic resonance imaging|cardiac magnetic resonance imaging
5159107|NCT00977093|single photon emission computed tomography|single photon emission computed tomography
5159108|NCT00977093|invasive coronary angiography|invasive coronary angiography
5159109|NCT00977080|Zemplar|zemplar
5159110|NCT00977080|paricalcitol|paricalcitol
5159111|NCT00977080|IMPACT SHPT|impact shpt
5159112|NCT00977080|Hemodialysis|hemodialysis
5159113|NCT00977080|Chronic Kidney Disease Stage 5|chronic kidney disease stage 5
5159114|NCT00977067|GDC0152|gdc0152
5159115|NCT00977067|IAP|iap
5159116|NCT00977067|IAP Antagonist|iap antagonist
5159117|NCT00977054|Hepatitis C|hepatitis c
5159118|NCT00977054|Peginterferon alfa-2a|peginterferon alfa-2a
5159119|NCT00977054|Ribavirin|ribavirin
5159120|NCT00977054|Plasmapheresis|plasmapheresis
5159121|NCT00977054|Genotype 1|genotype 1
5159122|NCT00977041|Neurofeedback|neurofeedback
5159123|NCT00977028|Tumescent|tumescent
5159124|NCT00977028|Local Anesthesia|local anesthesia
5159125|NCT00977028|Lidocaine|lidocaine
5159126|NCT00977028|Dosage Maximum|dosage maximum
5159127|NCT00977028|Subcutaneous infiltration|subcutaneous infiltration
5159128|NCT00977028|maximum Safe mg per kg dosage of lidocaine|maximum safe mg per kg dosage of lidocaine
5159129|NCT00977028|Tumescent Local Anesthesia|tumescent local anesthesia
5159130|NCT00977002|noninvasive ventilation|noninvasive ventilation
5159131|NCT00977002|extubation|extubation
5159132|NCT00977002|Respiratory failure|respiratory failure
5159133|NCT00977002|reintubation|reintubation
5159134|NCT00976976|Resected advanced gastric cancer stage IIIB and IV|resected advanced gastric cancer stage iiib and iv
5159135|NCT00976963|UTI|uti
5159136|NCT00976924|blood glucose|blood glucose
5159137|NCT00976898|proton beam radiation|proton beam radiation
5159138|NCT00976872|omega 3|omega 3
5159139|NCT00976872|inflammation|inflammation
5159140|NCT00976872|augmentation index|augmentation index
5159141|NCT00976872|endothelial function|endothelial function
5159142|NCT00976859|childhood sexual abuse|childhood sexual abuse
5159143|NCT00976859|CSA|csa
5159144|NCT00976859|posttraumatic stress disorder|posttraumatic stress disorder
5159145|NCT00976859|PTSD, feeling of being polluted|ptsd, feeling of being polluted
5159146|NCT00976859|mental pollution, mental contamination|mental pollution, mental contamination
5159147|NCT00976859|feeling of being contaminated|feeling of being contaminated
5159148|NCT00976859|sexual assault|sexual assault
5159149|NCT00976859|disgust, shame|disgust, shame
5159150|NCT00976846|hemodialysis|hemodialysis
5159151|NCT00976846|on line|on line
5159152|NCT00976846|postdilution|postdilution
5159153|NCT00976846|high-flux dialyzer|high-flux dialyzer
5159154|NCT00976846|hemodiafiltration|hemodiafiltration
5159155|NCT00976833|Acute Respiratory Failure|acute respiratory failure
5159156|NCT00976833|Early ICU Mobility|early icu mobility
5159157|NCT00976833|Early Physical Therapy|early physical therapy
5159158|NCT00976833|Critical Care|critical care
5159159|NCT00976833|Intensive Care|intensive care
5159160|NCT00976833|ICU|icu
5159161|NCT00976820|influenza infection|influenza infection
5159162|NCT00976820|Influenza Vaccines|influenza vaccines
5159163|NCT00976820|GSK Bio's influenza vaccine GSK2340273A|gsk bio's influenza vaccine gsk2340273a
5159164|NCT00976820|GSK Bio's influenza vaccine GSK2340274A|gsk bio's influenza vaccine gsk2340274a
5159165|NCT00976807|critical care|critical care
5159166|NCT00976807|intensive care|intensive care
5159167|NCT00976807|weakness|weakness
5159168|NCT00976807|myopathy|myopathy
5159169|NCT00976807|paresis|paresis
5159170|NCT00976807|rehabilitation|rehabilitation
5159171|NCT00976794|BD I|bd i
5159172|NCT00976768|Advanced gastric cancer|advanced gastric cancer
5159173|NCT00976768|FOLFIRI|folfiri
5159174|NCT00976755|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5159175|NCT00976755|hormone-resistant prostate cancer|hormone-resistant prostate cancer
5159176|NCT00976755|stage III prostate cancer|stage iii prostate cancer
5159177|NCT00976755|stage IV prostate cancer|stage iv prostate cancer
5159178|NCT00976742|plasma lipoprotein lipids|plasma lipoprotein lipids
5159179|NCT00976742|body composition|body composition
5159180|NCT00976742|glucose tolerance|glucose tolerance
5159181|NCT00976742|inflammation markers|inflammation markers
5159182|NCT00976742|insulin sensitivity|insulin sensitivity
5159183|NCT00976742|coagulation markers|coagulation markers
5159184|NCT00976729|monocyte chemoattractant protein-1 (MCP-1)|monocyte chemoattractant protein-1 (mcp-1)
5159185|NCT00976729|L-oligonucleotide aptamer|l-oligonucleotide aptamer
5159186|NCT00976729|Spiegelmer|spiegelmer
5159187|NCT00976716|posttraumatic pain|posttraumatic pain
5159188|NCT00976703|cervical foley catheter|cervical foley catheter
5159189|NCT00976690|Crohn's Disease|crohn's disease
5159190|NCT00976690|Ileocolic resection|ileocolic resection
5159191|NCT00976690|Endoscopic recurrence|endoscopic recurrence
5159192|NCT00976690|Ileocolic or colon resection (>50cm)|ileocolic or colon resection (>50cm)
5159193|NCT00976651|infertility|infertility
5159194|NCT00976651|ICSI|icsi
5159195|NCT00976651|hCG|hcg
5159196|NCT00976651|infertility treatment|infertility treatment
5159197|NCT00976638|Antimicrobial Resistant Bacteria|antimicrobial resistant bacteria
5159198|NCT00976638|Hospital acquired infections|hospital acquired infections
5159199|NCT00976638|Colonization|colonization
5159200|NCT00976638|Bacteremia|bacteremia
5159201|NCT00976638|MRSA|mrsa
5159202|NCT00976638|VRE|vre
5159203|NCT00976638|ESBL|esbl
5159204|NCT00976638|Intensive Care|intensive care
5159205|NCT00976638|ICU|icu
5159206|NCT00976625|diastolic function|diastolic function
5159207|NCT00976625|aortic regurgitation|aortic regurgitation
5159208|NCT00976625|aortic valve replacement|aortic valve replacement
5159209|NCT00976625|left ventricular hypertrophy|left ventricular hypertrophy
5159210|NCT00976625|myocardial structure|myocardial structure
5159211|NCT00976625|LV remodeling|lv remodeling
5159212|NCT00976625|Muscular regression|muscular regression
5159213|NCT00976625|LV fibrous tissue|lv fibrous tissue
5159214|NCT00976612|Gastrointestinal stromal tumor|gastrointestinal stromal tumor
5159215|NCT00976612|pharmacokinetics|pharmacokinetics
5159216|NCT00976612|nilotinib|nilotinib
5159217|NCT00976586|Incontinentia pigmenti|incontinentia pigmenti
5159218|NCT00976586|recombination|recombination
5159219|NCT00976586|IKBKG|ikbkg
5159220|NCT00976586|IKBKGP|ikbkgp
5159221|NCT00976573|Stage IV Skin Melanoma|stage iv skin melanoma
5159222|NCT00976573|recurrent melanoma|recurrent melanoma
5159223|NCT00976560|Lack of interest and energy|lack of interest and energy
5159224|NCT00976560|Psychomotor retardation|psychomotor retardation
5159225|NCT00976560|Cytokines|cytokines
5159226|NCT00976560|Major Depressive disorder|major depressive disorder
5159227|NCT00976547|tinnitus|tinnitus
5159228|NCT00976547|depression|depression
5159229|NCT00976547|audiometry|audiometry
5159230|NCT00976547|measurement|measurement
5159231|NCT00976534|Analgesic effect|analgesic effect
5159232|NCT00976534|Peripheral Neuropathic pain|peripheral neuropathic pain
5159233|NCT00976534|Posttraumatic Neuralgia (PTN)|posttraumatic neuralgia (ptn)
5159234|NCT00976534|Postherpetic Neuralgia (PHN)|postherpetic neuralgia (phn)
5159235|NCT00976508|advanced solid tumors cancer refractory cancer figitumumab pegvisomant|advanced solid tumors cancer refractory cancer figitumumab pegvisomant
5159236|NCT00976482|Cardiovascular|cardiovascular
5159237|NCT00976482|Pacemaker|pacemaker
5159238|NCT00976482|Mortality|mortality
5159239|NCT00976482|Physiologic pacing|physiologic pacing
5159240|NCT00976456|lung cancer|lung cancer
5159241|NCT00976456|NSCLC|nsclc
5159242|NCT00976456|elderly|elderly
5159243|NCT00976456|non-squamous|non-squamous
5159244|NCT00976456|Elderly patients at least 65 years old|elderly patients at least 65 years old
5159245|NCT00976456|first line therapy|first line therapy
5159246|NCT00976456|non-squamous non-small cell lung cancer stage IIIb or IV|non-squamous non-small cell lung cancer stage iiib or iv
5159248|NCT00976443|Gastric Emptying|gastric emptying
5159249|NCT00976443|Satiation|satiation
5159250|NCT00976443|Endosonography|endosonography
5159251|NCT00976443|Endoscopy|endoscopy
5159252|NCT00976443|Feeding Behavior|feeding behavior
5159253|NCT00976430|Autologous Stem Cells.|autologous stem cells.
5159254|NCT00976404|HIV-1 infection|hiv-1 infection
5159255|NCT00976404|Treatment intensification|treatment intensification
5159256|NCT00976404|Immunomodulation|immunomodulation
5159257|NCT00976404|HIV-rAd5 vaccine|hiv-rad5 vaccine
5159258|NCT00976391|open-label|open-label
5159259|NCT00976391|albiglutide|albiglutide
5159260|NCT00976391|insulin glargine|insulin glargine
5159261|NCT00976391|preprandial insulin|preprandial insulin
5159262|NCT00976378|stromal cell-derived factor-1 (SDF-1)|stromal cell-derived factor-1 (sdf-1)
5159263|NCT00976378|L-oligonucleotide aptamer|l-oligonucleotide aptamer
5159264|NCT00976378|Spiegelmer|spiegelmer
5159265|NCT00976365|Breast Cancer|breast cancer
5159267|NCT00976352|Pompe Disease|pompe disease
5159268|NCT00976352|Glycogen Storage Disease|glycogen storage disease
5159269|NCT00976339|Breast cancer|breast cancer
5159270|NCT00976339|Vitamin D|vitamin d
5159271|NCT00976339|Premenopausal|premenopausal
5159272|NCT00976313|thoracic epidural analgesia|thoracic epidural analgesia
5159273|NCT00976313|urinary micturition|urinary micturition
5159274|NCT00976313|thoracotomy|thoracotomy
5159275|NCT00976300|SLE|sle
5159276|NCT00976300|lupus nephritis|lupus nephritis
5159277|NCT00976300|cyclosporine A|cyclosporine a
5159278|NCT00976300|cyclophosphamide|cyclophosphamide
5159279|NCT00976300|active proliferative lupus nephritis (class III or IV according to WHO)|active proliferative lupus nephritis (class iii or iv according to who)
5159280|NCT00976287|Stem cells|stem cells
5159281|NCT00976287|Liver cirrhosis|liver cirrhosis
5159282|NCT00976287|Radiology|radiology
5159283|NCT00976287|Interventional|interventional
5159284|NCT00976287|Transplantation|transplantation
5159285|NCT00976274|Korean red ginseng|korean red ginseng
5159286|NCT00976274|metabolic syndrome|metabolic syndrome
5159287|NCT00976274|blood pressure|blood pressure
5159288|NCT00976274|arterial stiffness|arterial stiffness
5159289|NCT00976274|inflammation|inflammation
5159290|NCT00976274|oxidative stress|oxidative stress
5159291|NCT00976261|type 2 diabetes|type 2 diabetes
5159292|NCT00976261|single dose|single dose
5159293|NCT00976261|3-O-methylglucose|3-o-methylglucose
5159294|NCT00976261|healthy volunteer|healthy volunteer
5159295|NCT00976261|repeat dose|repeat dose
5159296|NCT00976248|everolimus|everolimus
5159297|NCT00976248|RAD001|rad001
5159298|NCT00976248|WM|wm
5159299|NCT00976235|Macular Degeneration|macular degeneration
5159300|NCT00976235|Visual Impairment|visual impairment
5159301|NCT00976235|Quality of Life|quality of life
5159302|NCT00976235|Telescope Prosthesis|telescope prosthesis
5159303|NCT00976196|Aspirin|aspirin
5159304|NCT00976196|Blood platelets|blood platelets
5159305|NCT00976196|proteomics|proteomics
5159306|NCT00976196|Platelet reactivity|platelet reactivity
5159307|NCT00976183|ovarian cancer|ovarian cancer
5159308|NCT00976183|gynecologic oncology|gynecologic oncology
5159309|NCT00976183|vorinostat|vorinostat
5159310|NCT00976183|treatment|treatment
5159311|NCT00976170|Advanced or metastatic HCC|advanced or metastatic hcc
5159312|NCT00976157|STREM-1|strem-1
5159313|NCT00976157|BAL|bal
5159314|NCT00976157|VAP|vap
5159315|NCT00976144|safety|safety
5159316|NCT00976144|LAMA|lama
5159317|NCT00976144|pharmacodynamics|pharmacodynamics
5159318|NCT00976144|tolerability|tolerability
5159319|NCT00976144|Muscarinic receptor antagonist,|muscarinic receptor antagonist,
5159320|NCT00976144|anticholinergic,|anticholinergic,
5159321|NCT00976144|beta-2 agonist|beta-2 agonist
5159322|NCT00976144|healthy Japanese subjects|healthy japanese subjects
5159323|NCT00976144|LABA|laba
5159324|NCT00976144|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
5159325|NCT00976144|pharmacokinetics|pharmacokinetics
5159326|NCT00976131|Breast Cancer|breast cancer
5159327|NCT00976131|Early Stage Breast Cancer|early stage breast cancer
5159328|NCT00976131|Complementary and Alternative Medicine|complementary and alternative medicine
5159329|NCT00976131|CAM|cam
5159330|NCT00976118|Dementia of Alzheimer's type|dementia of alzheimer's type
5159331|NCT00976118|mild to moderate Alzheimer's Disease|mild to moderate alzheimer's disease
5159332|NCT00976105|Pharmacokinetics|pharmacokinetics
5159333|NCT00976105|Pharmacodynamics|pharmacodynamics
5159334|NCT00976105|Safety and tolerability|safety and tolerability
5159335|NCT00976105|Repeat dose|repeat dose
5159336|NCT00976105|Personality traits|personality traits
5159337|NCT00976105|Fat mass|fat mass
5159338|NCT00976105|Healthy volunteers|healthy volunteers
5159339|NCT00976092|myocardial infarction|myocardial infarction
5159340|NCT00976092|clopidogrel|clopidogrel
5159341|NCT00976092|prasugrel|prasugrel
5159342|NCT00976092|bivalirudin|bivalirudin
5159343|NCT00976092|primary PCI|primary pci
5159344|NCT00976079|Tibial femoral knee osteoarthritis|tibial femoral knee osteoarthritis
5159345|NCT00976079|Osteoarthritis|osteoarthritis
5159346|NCT00976066|Obesity|obesity
5159347|NCT00976066|Naltrexone|naltrexone
5159348|NCT00976066|Carfentanil|carfentanil
5159349|NCT00976066|Receptor Occupancy|receptor occupancy
5159350|NCT00976066|mu-opioid Receptor|mu-opioid receptor
5159351|NCT00976066|PET (Positron Emission Tomography)|pet (positron emission tomography)
5159352|NCT00976066|BOLD-fMRI|bold-fmri
5159353|NCT00976053|Myocardial perfusion imaging|myocardial perfusion imaging
5159354|NCT00976053|Single photon emission computed tomography|single photon emission computed tomography
5159355|NCT00976053|Positron emission tomography|positron emission tomography
5159356|NCT00976040|HIV-1|hiv-1
5159357|NCT00976040|Africa|africa
5159358|NCT00976040|Botswana|botswana
5159359|NCT00976040|Highly active antiretroviral therapy|highly active antiretroviral therapy
5159360|NCT00976040|treatment naive|treatment naive
5159361|NCT00976027|Influenza|influenza
5159362|NCT00976027|Respiratory Tract Infections|respiratory tract infections
5159363|NCT00976027|Influenza-like illness|influenza-like illness
5159364|NCT00976027|Elderly|elderly
5159365|NCT00976027|Fluzone®|fluzone®
5159366|NCT00976027|Efficacy|efficacy
5159367|NCT00976001|Follow-up after stroke|follow-up after stroke
5159368|NCT00975988|PMS (post-marketing surveillance)|pms (post-marketing surveillance)
5159369|NCT00975988|TYKERB® tablets|tykerb® tablets
5159370|NCT00975975|Paroxysmal nocturnal hemoglobinuria|paroxysmal nocturnal hemoglobinuria
5159371|NCT00975975|severe aplastic anemia|severe aplastic anemia
5159372|NCT00975975|Mantle cell|mantle cell
5159373|NCT00975962|Stroke|stroke
5159374|NCT00975962|Neuroprotection|neuroprotection
5159375|NCT00975962|remote preconditioning|remote preconditioning
5159376|NCT00975962|Salvage index (%): Difference in infarct growth (PWI-DWI)|salvage index (%): difference in infarct growth (pwi-dwi)
5159377|NCT00975949|fluconazole prophylaxis|fluconazole prophylaxis
5159378|NCT00975949|fungal colonization|fungal colonization
5159379|NCT00975949|fungal infection|fungal infection
5159380|NCT00975949|preterm infants|preterm infants
5159381|NCT00975949|long term outcomes|long term outcomes
5159382|NCT00975949|quality of life|quality of life
5159383|NCT00975936|Microdose|microdose
5159384|NCT00975936|Drug-Drug Interaction|drug-drug interaction
5159385|NCT00975936|Ketoconazole|ketoconazole
5159386|NCT00975936|Phase 0|phase 0
5159387|NCT00975923|Quality Improvement|quality improvement
5159388|NCT00975923|Critical Care|critical care
5159389|NCT00975923|Collaboratives|collaboratives
5159390|NCT00975923|Patient Safety|patient safety
5159391|NCT00975923|Tool Kit|tool kit
5159392|NCT00975910|Supratentorial Craniotomy|supratentorial craniotomy
5159393|NCT00975897|adenocarcinoma of the colon|adenocarcinoma of the colon
5159394|NCT00975897|recurrent colon cancer|recurrent colon cancer
5159395|NCT00975897|stage III colon cancer|stage iii colon cancer
5159396|NCT00975897|stage IV colon cancer|stage iv colon cancer
5159397|NCT00975897|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5159398|NCT00975897|recurrent rectal cancer|recurrent rectal cancer
5159399|NCT00975897|stage III rectal cancer|stage iii rectal cancer
5159400|NCT00975897|stage IV rectal cancer|stage iv rectal cancer
5159401|NCT00975884|GSK Bio's influenza vaccine GSK2340272A|gsk bio's influenza vaccine gsk2340272a
5159402|NCT00975884|influenza infection|influenza infection
5159403|NCT00975884|Influenza vaccine|influenza vaccine
5159404|NCT00975871|Livedo vasculitis|livedo vasculitis
5159405|NCT00975871|Genetic pleomorphism|genetic pleomorphism
5159406|NCT00975858|Symptomatic Coronary Artery Disease Patients|symptomatic coronary artery disease patients
5159408|NCT00975845|Anterior Cruciate Ligament|anterior cruciate ligament
5159409|NCT00975845|Torn tendon|torn tendon
5159410|NCT00975845|ACL Repair|acl repair
5159411|NCT00975845|ACL reconstruction|acl reconstruction
5159412|NCT00975832|The independent effect of PCOS and obesity on adipose expression and plasma levels of adipocytokines|the independent effect of pcos and obesity on adipose expression and plasma levels of adipocytokines
5159413|NCT00975793|Sepsis|sepsis
5159414|NCT00975793|Severe sepsis|severe sepsis
5159415|NCT00975793|Septic shock|septic shock
5159416|NCT00975780|Pneumonia|pneumonia
5159417|NCT00975780|Lower respiratory tract infection|lower respiratory tract infection
5159418|NCT00975780|Lower respiratory tract infection other than pneumonia|lower respiratory tract infection other than pneumonia
5159419|NCT00975754|Inhalation|inhalation
5159420|NCT00975754|lung deposition|lung deposition
5159421|NCT00975741|Asthma|asthma
5159422|NCT00975741|Mometasone furoate|mometasone furoate
5159423|NCT00975741|Inhalation devices|inhalation devices
5159424|NCT00975741|Forced expiratory volume|forced expiratory volume
5159425|NCT00975728|Anti-oxidant|anti-oxidant
5159426|NCT00975728|Açai|açai
5159427|NCT00975728|Food supplement|food supplement
5159428|NCT00975728|Sun protection|sun protection
5159429|NCT00975728|Skin erythema prevention|skin erythema prevention
5159430|NCT00975728|Anti-oxidant efficacy|anti-oxidant efficacy
5159431|NCT00975728|Anti-age efficacy|anti-age efficacy
5159432|NCT00975728|Skin photo-induced damage protection|skin photo-induced damage protection
5159433|NCT00975715|Seizures|seizures
5159434|NCT00975715|oxcarbazepine|oxcarbazepine
5159435|NCT00975715|child|child
5159436|NCT00975702|Remote ischemic preconditioning|remote ischemic preconditioning
5159437|NCT00975702|deceased organ donors|deceased organ donors
5159438|NCT00975702|ischemia reperfusion injury|ischemia reperfusion injury
5159439|NCT00975702|Delayed graft function|delayed graft function
5159440|NCT00975702|Clinical outcomes in kidney transplant recipients|clinical outcomes in kidney transplant recipients
5159734|NCT00974532|balance|balance
5159441|NCT00975702|Clinical outcomes in liver transplant recipients|clinical outcomes in liver transplant recipients
5159442|NCT00975702|Clinical outcomes in pancreas transplant recipients|clinical outcomes in pancreas transplant recipients
5159443|NCT00975689|Niemann-Pick Disease, Type C|niemann-pick disease, type c
5159444|NCT00975689|Biomarkers|biomarkers
5159445|NCT00975689|N-Acetyl Cysteine|n-acetyl cysteine
5159446|NCT00975689|Oxidized Cholesterol|oxidized cholesterol
5159447|NCT00975689|Neurodegeneration|neurodegeneration
5159448|NCT00975689|NPC|npc
5159449|NCT00975676|estrogen receptor-positive breast cancer|estrogen receptor-positive breast cancer
5159450|NCT00975676|progesterone receptor-positive breast cancer|progesterone receptor-positive breast cancer
5159451|NCT00975676|stage IA breast cancer|stage ia breast cancer
5159452|NCT00975676|stage IB breast cancer|stage ib breast cancer
5159453|NCT00975676|stage II breast cancer|stage ii breast cancer
5159454|NCT00975676|stage IIIA breast cancer|stage iiia breast cancer
5159455|NCT00975663|Lung transplantation|lung transplantation
5159456|NCT00975663|heart-lung transplantation|heart-lung transplantation
5159457|NCT00975663|therapeutic drug monitoring|therapeutic drug monitoring
5159458|NCT00975663|tacrolimus|tacrolimus
5159459|NCT00975663|mycophenolate|mycophenolate
5159460|NCT00975663|immunosuppressant|immunosuppressant
5159461|NCT00975663|pharmacokinetics|pharmacokinetics
5159462|NCT00975650|Primary Hypogonadism|primary hypogonadism
5159463|NCT00975650|Secondary Hypogonadism|secondary hypogonadism
5159464|NCT00975611|schizophrenia|schizophrenia
5159465|NCT00975611|schizoaffective disorder|schizoaffective disorder
5159466|NCT00975611|paliperidone ER|paliperidone er
5159467|NCT00975611|risperidone Consta|risperidone consta
5159468|NCT00975611|prolactin|prolactin
5159469|NCT00975611|hyperprolactinemia|hyperprolactinemia
5159470|NCT00975572|Flu|flu
5159471|NCT00975572|adjuvanted H1N1 vaccine|adjuvanted h1n1 vaccine
5159472|NCT00975572|non-adjuvanted H1N1 vaccine|non-adjuvanted h1n1 vaccine
5159473|NCT00975572|Immunogenictiy|immunogenictiy
5159474|NCT00975572|Safety|safety
5159475|NCT00975546|fertility|fertility
5159476|NCT00975546|HIV discordant|hiv discordant
5159477|NCT00975546|HIV|hiv
5159478|NCT00975546|Infertility in HIV-discordant couples|infertility in hiv-discordant couples
5159479|NCT00975546|HIV seronegativity|hiv seronegativity
5159480|NCT00975533|type 2 diabetes mellitus|type 2 diabetes mellitus
5159481|NCT00975533|obesity|obesity
5159482|NCT00975520|Neurotropic|neurotropic
5159483|NCT00975520|Melanoma|melanoma
5159484|NCT00975520|Observation|observation
5159485|NCT00975520|Radiation Therapy|radiation therapy
5159486|NCT00975520|Relapse|relapse
5159487|NCT00975494|pde5-inhibition|pde5-inhibition
5159488|NCT00975494|sildenafil|sildenafil
5159489|NCT00975494|LV diastolic function|lv diastolic function
5159490|NCT00975494|heart failure patients|heart failure patients
5159491|NCT00975481|oral single-dose 6-way crossover recreational drug users abuse potential pharmacodynamics safety|oral single-dose 6-way crossover recreational drug users abuse potential pharmacodynamics safety
5159492|NCT00975468|pressure-controlled|pressure-controlled
5159493|NCT00975468|volume-controlled|volume-controlled
5159494|NCT00975468|one lung|one lung
5159495|NCT00975468|ventilation|ventilation
5159496|NCT00975468|lung injury|lung injury
5159497|NCT00975468|thoracotomy|thoracotomy
5159498|NCT00975442|Elbow|elbow
5159499|NCT00975442|Tendinitis|tendinitis
5159500|NCT00975442|Sports Medicine|sports medicine
5159501|NCT00975442|Athletic injuries|athletic injuries
5159502|NCT00975429|Prostatic Disease|prostatic disease
5159503|NCT00975429|Genital neoplasm, male|genital neoplasm, male
5159504|NCT00975429|Urogenital neoplasm|urogenital neoplasm
5159505|NCT00975429|Genital disease,male|genital disease,male
5159506|NCT00975429|Male urogenital disease|male urogenital disease
5159507|NCT00975429|Neoplasms|neoplasms
5159508|NCT00975429|Neoplasm by site|neoplasm by site
5159509|NCT00975429|Prostatic neoplasm|prostatic neoplasm
5159510|NCT00975429|Carcinoma|carcinoma
5159511|NCT00975416|Drug Dependence|drug dependence
5159512|NCT00975416|Cognitive Behavior|cognitive behavior
5159513|NCT00975416|Oxytocin|oxytocin
5159514|NCT00975416|Cocaine|cocaine
5159515|NCT00975416|Heroin|heroin
5159516|NCT00975416|fMRI|fmri
5159517|NCT00975403|mild COPD|mild copd
5159518|NCT00975403|dyspnea|dyspnea
5159519|NCT00975403|exercise|exercise
5159520|NCT00975403|respiratory mechanics|respiratory mechanics
5159521|NCT00975403|COPD|copd
5159522|NCT00975390|Glycogen|glycogen
5159523|NCT00975390|Carbohydrate|carbohydrate
5159524|NCT00975390|Protein|protein
5159525|NCT00975390|Caffeine|caffeine
5159526|NCT00975390|Post exercise muscle glycogen synthesis|post exercise muscle glycogen synthesis
5159527|NCT00975390|Sports nutrition|sports nutrition
5159528|NCT00975377|hair removal|hair removal
5159529|NCT00975377|hair clipping|hair clipping
5159530|NCT00975377|surgical site infection|surgical site infection
5159531|NCT00975377|incisional infection|incisional infection
5159532|NCT00975377|wound infection|wound infection
5159533|NCT00975364|Folate|folate
5159534|NCT00975364|Methylenetetrahydrofolate reductase|methylenetetrahydrofolate reductase
5159535|NCT00975364|Speciation|speciation
5159536|NCT00975364|Nutrient status|nutrient status
5159537|NCT00975364|Bioavailability|bioavailability
5160066|NCT00973648|Tinnitus|tinnitus
5159538|NCT00975364|Polymorphism, single nucleotide|polymorphism, single nucleotide
5159539|NCT00975351|folates|folates
5159540|NCT00975351|5-methyltetrahydrofolic acid|5-methyltetrahydrofolic acid
5159541|NCT00975351|pharmacokinetics|pharmacokinetics
5159542|NCT00975351|bioavailability|bioavailability
5159543|NCT00975351|biotransformation|biotransformation
5159544|NCT00975338|health care transition, young adults, rehabilitation|health care transition, young adults, rehabilitation
5159545|NCT00975325|Bioequivalency|bioequivalency
5159546|NCT00975312|lentigo|lentigo
5159547|NCT00975312|hydroquinone|hydroquinone
5159548|NCT00975312|tretinoin|tretinoin
5159549|NCT00975312|fluocinolone acetonide|fluocinolone acetonide
5159550|NCT00975299|Neoplasm|neoplasm
5159551|NCT00975299|PET/CT diagnosis|pet/ct diagnosis
5159552|NCT00975299|PET tracer|pet tracer
5159553|NCT00975273|Asthma|asthma
5159554|NCT00975273|Dyspnea|dyspnea
5159555|NCT00975273|Paroxysmal|paroxysmal
5159556|NCT00975273|Pulmonary|pulmonary
5159557|NCT00975273|Respiratory hypersensitivity|respiratory hypersensitivity
5159558|NCT00975273|Airway inflammation|airway inflammation
5159559|NCT00975273|Airway obstruction|airway obstruction
5159560|NCT00975273|Wheezing|wheezing
5159561|NCT00975247|Quality Improvement|quality improvement
5159562|NCT00975247|Colonoscopy|colonoscopy
5159563|NCT00975247|Screening|screening
5159564|NCT00975247|Colon Cancer|colon cancer
5159565|NCT00975247|Polyp detection rates|polyp detection rates
5159566|NCT00975247|Colonoscopy completion rates|colonoscopy completion rates
5159567|NCT00975247|Scope Withdrawal time|scope withdrawal time
5159568|NCT00975247|Reduce costs through improving bowel prep quality|reduce costs through improving bowel prep quality
5159569|NCT00975234|Intra-lesion injection of autologous myoblasts|intra-lesion injection of autologous myoblasts
5159570|NCT00975221|Primary hyperparathyroidism|primary hyperparathyroidism
5159571|NCT00975221|Parathyroidectomy|parathyroidectomy
5159572|NCT00975221|Hypercalcemia|hypercalcemia
5159573|NCT00975208|Osteogenesis [G07.700.320.500.325.377.625.100.729]|osteogenesis [g07.700.320.500.325.377.625.100.729]
5159574|NCT00975208|Tooth Eruption [G10.549.235.726]|tooth eruption [g10.549.235.726]
5159575|NCT00975182|PI3K|pi3k
5159576|NCT00975182|NSCLC|nsclc
5159577|NCT00975182|Tarceva|tarceva
5159578|NCT00975143|isotretinoin|isotretinoin
5159579|NCT00975143|dermatology|dermatology
5159580|NCT00975143|skin|skin
5159581|NCT00975117|Dietary supplement|dietary supplement
5159582|NCT00975117|male infertility|male infertility
5159583|NCT00975117|spermatogenesis|spermatogenesis
5159584|NCT00975104|Aging|aging
5159585|NCT00975104|Frailty|frailty
5159586|NCT00975104|Sedentary|sedentary
5159587|NCT00975104|Immobilization|immobilization
5159588|NCT00975104|Atrophy|atrophy
5159589|NCT00975104|Muscle Wasting|muscle wasting
5159590|NCT00975104|Physical Activity|physical activity
5159591|NCT00975078|dexamethasone-suppression-test|dexamethasone-suppression-test
5159592|NCT00975078|high dose glucocorticoid treatment|high dose glucocorticoid treatment
5159593|NCT00975078|Population at Risk|population at risk
5159594|NCT00975065|Galvus|galvus
5159595|NCT00975039|Inoperable|inoperable
5159596|NCT00975039|Inoperable Cholangiocarcinoma|inoperable cholangiocarcinoma
5159597|NCT00975039|Non-resectable|non-resectable
5159598|NCT00975039|Non-resectable Cholangiocarcinoma|non-resectable cholangiocarcinoma
5159599|NCT00975039|Carcinoma|carcinoma
5159600|NCT00975026|Massage|massage
5159601|NCT00975026|Chair Massage|chair massage
5159602|NCT00975026|Pain|pain
5159603|NCT00975026|Discomfort|discomfort
5159604|NCT00975026|Stretching|stretching
5159605|NCT00975026|Stretching Exercises|stretching exercises
5159606|NCT00975026|Sonographer|sonographer
5159607|NCT00975026|Cardiac Sonographer|cardiac sonographer
5159608|NCT00975013|Laparoscopic Gastric Bypass|laparoscopic gastric bypass
5159609|NCT00975013|Morbid Obesity|morbid obesity
5159610|NCT00975013|Bone Mineral Density|bone mineral density
5159611|NCT00975000|Intervention|intervention
5159612|NCT00975000|Cinacalcet|cinacalcet
5159613|NCT00975000|Sensipar|sensipar
5159614|NCT00975000|Mimpara|mimpara
5159615|NCT00975000|hyperparathyroidism|hyperparathyroidism
5159616|NCT00975000|calcium|calcium
5159617|NCT00975000|osteodystrophy|osteodystrophy
5159618|NCT00975000|hypercalcemia|hypercalcemia
5159619|NCT00975000|renal|renal
5159620|NCT00975000|transplant|transplant
5159621|NCT00975000|acute rejection|acute rejection
5159622|NCT00975000|kidney transplant failure|kidney transplant failure
5159623|NCT00975000|hypophosphatemia|hypophosphatemia
5159624|NCT00974987|adult giant cell glioblastoma|adult giant cell glioblastoma
5159625|NCT00974987|adult glioblastoma|adult glioblastoma
5159626|NCT00974987|adult gliosarcoma|adult gliosarcoma
5159627|NCT00974974|Parkinson's Disease|parkinson's disease
5159628|NCT00974961|Levobupivacaine|levobupivacaine
5159630|NCT00974961|Spinal Anesthesia|spinal anesthesia
5159631|NCT00974961|Responses of ANS to these two drugs|responses of ans to these two drugs
5159632|NCT00974948|Pancreatic cancer|pancreatic cancer
5159633|NCT00974948|Therapy|therapy
5159634|NCT00974948|Neurolysis|neurolysis
5159635|NCT00974935|Staphylococcal enterotoxin B, vaccine, Staphylococcus aureus, toxic shock syndrome|staphylococcal enterotoxin b, vaccine, staphylococcus aureus, toxic shock syndrome
5159636|NCT00974922|Vitamin D|vitamin d
5159637|NCT00974922|Hypertension|hypertension
5159638|NCT00974909|Fecal incontinence|fecal incontinence
5159639|NCT00974896|Advanced Solid Tumors|advanced solid tumors
5159640|NCT00974896|AMG 479|amg 479
5159641|NCT00974896|Amgen|amgen
5159642|NCT00974896|Oncology|oncology
5159643|NCT00974896|Phase 1b|phase 1b
5159644|NCT00974883|ultrasound|ultrasound
5159645|NCT00974883|GCA|gca
5159646|NCT00974883|temporal arteritis|temporal arteritis
5159647|NCT00974883|biopsy|biopsy
5159648|NCT00974857|Hemodialysis|hemodialysis
5159649|NCT00974857|Left Ventricular Hypertrophy|left ventricular hypertrophy
5159650|NCT00974857|Body Composition Monitor|body composition monitor
5159651|NCT00974844|posterior assisted levitation|posterior assisted levitation
5159652|NCT00974844|Pars Plana|pars plana
5159653|NCT00974844|Dropped nucleus|dropped nucleus
5159654|NCT00974844|cataract|cataract
5159655|NCT00974844|complication of|complication of
5159656|NCT00974844|surgery|surgery
5159657|NCT00974818|Bladder|bladder
5159658|NCT00974818|Mitomycin C|mitomycin c
5159659|NCT00974818|MMC|mmc
5159660|NCT00974818|TheracysR Bacillus Calmette-Guerin|theracysr bacillus calmette-guerin
5159661|NCT00974818|BCG|bcg
5159662|NCT00974818|intravesical|intravesical
5159663|NCT00974818|09-118|09-118
5159664|NCT00974805|COPD|copd
5159665|NCT00974805|Emphysema|emphysema
5159666|NCT00974805|Bronchitis|bronchitis
5159667|NCT00974792|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5159668|NCT00974792|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5159669|NCT00974779|kidney failure chronic|kidney failure chronic
5159670|NCT00974779|renal dialysis|renal dialysis
5159671|NCT00974779|inflammation|inflammation
5159672|NCT00974779|monocytes|monocytes
5159673|NCT00974779|end stage renal disease on regular thrice weekly hemodialysis|end stage renal disease on regular thrice weekly hemodialysis
5159674|NCT00974766|bronchial asthma|bronchial asthma
5159675|NCT00974766|allergic bronchopulmonary aspergillosis|allergic bronchopulmonary aspergillosis
5159676|NCT00974753|epiretinal membrane|epiretinal membrane
5159677|NCT00974740|type 1 diabetes|type 1 diabetes
5159678|NCT00974727|Childhood overweight|childhood overweight
5159679|NCT00974727|Gardening|gardening
5159680|NCT00974727|Summer weight gain|summer weight gain
5159681|NCT00974714|chronic hypertension in pregnancy|chronic hypertension in pregnancy
5159682|NCT00974701|symptoms of acute overt upper gastrointestinal hemorrhage|symptoms of acute overt upper gastrointestinal hemorrhage
5159683|NCT00974688|Congenital|congenital
5159684|NCT00974688|physical activity participation|physical activity participation
5159685|NCT00974688|Moderate-to-vigorous physical activity|moderate-to-vigorous physical activity
5159686|NCT00974675|Asthma|asthma
5159687|NCT00974675|CAT-354|cat-354
5159688|NCT00974675|Tralokinumab|tralokinumab
5159689|NCT00974662|Non-Small Cell Lung Cancer|non-small cell lung cancer
5159690|NCT00974662|Lung Cancer|lung cancer
5159691|NCT00974662|NSCLC|nsclc
5159692|NCT00974649|drop-out|drop-out
5159693|NCT00974649|predictors of treatment continuation/discontinuation|predictors of treatment continuation/discontinuation
5159694|NCT00974649|IVF/ICSI|ivf/icsi
5159695|NCT00974649|infertility|infertility
5159696|NCT00974649|counseling|counseling
5159697|NCT00974649|psychology|psychology
5159698|NCT00974649|Assisted Reproduction|assisted reproduction
5159699|NCT00974649|Counselling|counselling
5159700|NCT00974636|Kidney Disease|kidney disease
5159701|NCT00974636|Albuminuria|albuminuria
5159702|NCT00974636|Glomerular filtration rate|glomerular filtration rate
5159703|NCT00974636|Volume status|volume status
5159704|NCT00974636|Bioimpedance analysis|bioimpedance analysis
5159705|NCT00974623|Bone growth substitute|bone growth substitute
5159706|NCT00974623|Autograft|autograft
5159707|NCT00974623|Allograft|allograft
5159708|NCT00974623|Spine fusion|spine fusion
5159709|NCT00974610|stage IV melanoma|stage iv melanoma
5159710|NCT00974610|recurrent melanoma|recurrent melanoma
5159711|NCT00974610|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5159712|NCT00974610|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5159713|NCT00974610|extensive stage small cell lung cancer|extensive stage small cell lung cancer
5159714|NCT00974610|recurrent small cell lung cancer|recurrent small cell lung cancer
5159715|NCT00974610|stage IV breast cancer|stage iv breast cancer
5159716|NCT00974610|recurrent breast cancer|recurrent breast cancer
5159717|NCT00974610|male breast cancer|male breast cancer
5159718|NCT00974610|stage III pancreatic cancer|stage iii pancreatic cancer
5159719|NCT00974610|stage IV pancreatic cancer|stage iv pancreatic cancer
5159720|NCT00974610|recurrent pancreatic cancer|recurrent pancreatic cancer
5159721|NCT00974610|stage IV colon cancer|stage iv colon cancer
5159722|NCT00974610|recurrent colon cancer|recurrent colon cancer
5159723|NCT00974610|stage IV rectal cancer|stage iv rectal cancer
5159724|NCT00974610|recurrent rectal cancer|recurrent rectal cancer
5159725|NCT00974597|burn|burn
5159726|NCT00974597|donor site|donor site
5159727|NCT00974597|treatment of burns|treatment of burns
5159728|NCT00974597|Treatment of Donor Sites|treatment of donor sites
5159729|NCT00974584|NSCLC|nsclc
5159730|NCT00974584|PI3K|pi3k
5159731|NCT00974584|Avastin|avastin
5159732|NCT00974558|dyspnea|dyspnea
5159733|NCT00974558|fan|fan
5159735|NCT00974532|chronic kidney disease|chronic kidney disease
5159736|NCT00974532|calcium|calcium
5159737|NCT00974532|phosphorus|phosphorus
5159738|NCT00974519|ADIS|adis
5159739|NCT00974519|complementary therapies|complementary therapies
5159740|NCT00974506|geriatric patients living in residential community (shared flats), multiple disease-conditions|geriatric patients living in residential community (shared flats), multiple disease-conditions
5159741|NCT00974493|oral|oral
5159742|NCT00974493|intravenous|intravenous
5159743|NCT00974493|antibiotics|antibiotics
5159744|NCT00974493|bone|bone
5159745|NCT00974493|joint|joint
5159746|NCT00974493|infection|infection
5159747|NCT00974480|Skin|skin
5159748|NCT00974480|Aging|aging
5159749|NCT00974480|Rejuva-a|rejuva-a
5159750|NCT00974480|Redermic|redermic
5159751|NCT00974454|AIDS|aids
5159752|NCT00974454|complementary therapies|complementary therapies
5159753|NCT00974454|treatment experienced|treatment experienced
5159754|NCT00974441|Bioequivalence|bioequivalence
5159755|NCT00974428|Osteoarthritis|osteoarthritis
5159756|NCT00974428|Disease of joints|disease of joints
5159757|NCT00974428|Wobenzym® N|wobenzym® n
5159758|NCT00974428|WOMAC pain score|womac pain score
5159759|NCT00974428|Subject reported pain (VAS)|subject reported pain (vas)
5159760|NCT00974415|BMI classification-overweight|bmi classification-overweight
5159761|NCT00974402|Active duty|active duty
5159762|NCT00974402|Afghanistan|afghanistan
5159763|NCT00974402|Anger|anger
5159764|NCT00974402|Anxiety|anxiety
5159765|NCT00974402|Avoidance|avoidance
5159766|NCT00974402|BAMC|bamc
5159767|NCT00974402|Brooke Army Medical Center|brooke army medical center
5159768|NCT00974402|Cognitive Behavioral Therapy|cognitive behavioral therapy
5159769|NCT00974402|Combat|combat
5159770|NCT00974402|Combat Disorder|combat disorder
5159771|NCT00974402|Coping|coping
5159772|NCT00974402|Counseling|counseling
5159773|NCT00974402|Counselor|counselor
5159774|NCT00974402|Deployment|deployment
5159775|NCT00974402|Depression|depression
5159776|NCT00974402|Exposure|exposure
5159777|NCT00974402|Fear|fear
5159778|NCT00974402|Feeling alone|feeling alone
5159779|NCT00974402|Flashbacks|flashbacks
5159780|NCT00974402|Guard|guard
5159781|NCT00974402|Guilt|guilt
5159782|NCT00974402|Hospitalization|hospitalization
5159783|NCT00974402|Iraq|iraq
5159784|NCT00974402|Mental Health|mental health
5159785|NCT00974402|Military|military
5159786|NCT00974402|Military member|military member
5159787|NCT00974402|Military personnel|military personnel
5159788|NCT00974402|Neuroses|neuroses
5159789|NCT00974402|Nightmares|nightmares
5159791|NCT00974402|OIF|oif
5159792|NCT00974402|Prolonged Exposure Therapy|prolonged exposure therapy
5159793|NCT00974402|Psychiatric|psychiatric
5159794|NCT00974402|Psychiatric medication|psychiatric medication
5159795|NCT00974402|Psychological distress|psychological distress
5159796|NCT00974402|Psychotherapy|psychotherapy
5159797|NCT00974402|Reserve|reserve
5159798|NCT00974402|Retired|retired
5159799|NCT00974402|Sadness|sadness
5159800|NCT00974402|Separated|separated
5159801|NCT00974402|Sleeplessness|sleeplessness
5159802|NCT00974402|Soldier|soldier
5159803|NCT00974402|Stress|stress
5159804|NCT00974402|Stress disorder|stress disorder
5159805|NCT00974402|Stress management|stress management
5159806|NCT00974402|STRONG STAR|strong star
5159807|NCT00974402|Suicidal|suicidal
5159808|NCT00974402|Suicide|suicide
5159809|NCT00974402|Therapy|therapy
5159810|NCT00974402|Trauma|trauma
5159811|NCT00974402|Traumatic Event|traumatic event
5159812|NCT00974402|Trouble Sleeping|trouble sleeping
5159813|NCT00974402|Veteran|veteran
5159814|NCT00974402|Veterans|veterans
5159815|NCT00974402|War|war
5159816|NCT00974402|WHMC|whmc
5159817|NCT00974402|Wilford Hall Medical Center|wilford hall medical center
5159818|NCT00974402|PTSD|ptsd
5159819|NCT00974402|Posttraumatic Stress Disorders|posttraumatic stress disorders
5159820|NCT00974389|stage III colon cancer|stage iii colon cancer
5159821|NCT00974389|stage III rectal cancer|stage iii rectal cancer
5159822|NCT00974389|stage IV colon cancer|stage iv colon cancer
5159823|NCT00974389|stage IV rectal cancer|stage iv rectal cancer
5159824|NCT00974389|recurrent colon cancer|recurrent colon cancer
5159825|NCT00974389|recurrent rectal cancer|recurrent rectal cancer
5159826|NCT00974376|Cannabis Treatment|cannabis treatment
5159827|NCT00974376|Cannabis Use|cannabis use
5159828|NCT00974376|Cannabis Dependence|cannabis dependence
5159829|NCT00974376|Executive Functioning|executive functioning
5159830|NCT00974376|Cognitive Deficits|cognitive deficits
5159831|NCT00974363|meningococcal vaccine GSK 134612|meningococcal vaccine gsk 134612
5159832|NCT00974350|Post-operative pain|post-operative pain
5159833|NCT00974350|hernia surgery|hernia surgery
5159834|NCT00974350|opioid|opioid
5159835|NCT00974337|Adrenal insufficiency|adrenal insufficiency
5159836|NCT00974337|cortisol|cortisol
5159837|NCT00974337|preterm|preterm
5159838|NCT00974337|shock|shock
5159839|NCT00974337|neonate|neonate
5159840|NCT00974324|peripheral T cell lymphoma|peripheral t cell lymphoma
5159841|NCT00974324|chemotherapy|chemotherapy
5159842|NCT00974324|anti-angiogeneses|anti-angiogeneses
5160260|NCT00972959|bone pain|bone pain
5159843|NCT00974311|Prostate Cancer|prostate cancer
5159844|NCT00974311|Castration-resistant|castration-resistant
5159845|NCT00974285|AIDS|aids
5159846|NCT00974285|complementary therapies|complementary therapies
5159847|NCT00974259|Hypoxia|hypoxia
5159848|NCT00974259|Ischemia|ischemia
5159849|NCT00974259|Intracranial hypertension|intracranial hypertension
5159850|NCT00974259|Neurocritical care|neurocritical care
5159851|NCT00974246|COPD|copd
5159852|NCT00974246|Depression|depression
5159853|NCT00974246|Nursing Home|nursing home
5159854|NCT00974233|CLL|cll
5159855|NCT00974233|SLL|sll
5159856|NCT00974220|inhaled fentanyl|inhaled fentanyl
5159857|NCT00974220|dyspnea|dyspnea
5159858|NCT00974220|exercise|exercise
5159859|NCT00974220|COPD|copd
5159860|NCT00974194|Cholecystolithiasis|cholecystolithiasis
5159861|NCT00974194|Cholecystectomy|cholecystectomy
5159862|NCT00974194|Laparoscopic surgery|laparoscopic surgery
5159863|NCT00974194|Single port|single port
5159864|NCT00974168|pain|pain
5159865|NCT00974168|radiation toxicity|radiation toxicity
5159866|NCT00974168|spinal cord compression|spinal cord compression
5159867|NCT00974168|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5159868|NCT00974155|Major|major
5159869|NCT00974155|Depression|depression
5159870|NCT00974155|Disorder|disorder
5159871|NCT00974142|COPD|copd
5159872|NCT00974142|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5159873|NCT00974142|Cyclosporine|cyclosporine
5159874|NCT00974142|Oral Immunotherapy|oral immunotherapy
5159875|NCT00974142|Advanced stage|advanced stage
5159876|NCT00974103|low back pain|low back pain
5159877|NCT00974103|pelvic pain|pelvic pain
5159878|NCT00974103|pelvic girdle pain|pelvic girdle pain
5159879|NCT00974103|post partum|post partum
5159880|NCT00974090|insulin resistance|insulin resistance
5159881|NCT00974077|recurrent depression,|recurrent depression,
5159882|NCT00974077|mindfulness training|mindfulness training
5159883|NCT00974077|attention|attention
5159884|NCT00974077|Evoked EEG potentials|evoked eeg potentials
5159885|NCT00974077|Relapse prevention in recurrent depression|relapse prevention in recurrent depression
5159886|NCT00974064|COPD|copd
5159887|NCT00974064|Lung disease|lung disease
5159888|NCT00974064|Chronic bronchitis|chronic bronchitis
5159889|NCT00974064|Emphysema|emphysema
5159890|NCT00974064|Smoking|smoking
5159891|NCT00974064|Smoking cessation|smoking cessation
5159892|NCT00974064|Quit smoking|quit smoking
5159893|NCT00974064|Healthy smoker|healthy smoker
5159895|NCT00974064|Non-smoker|non-smoker
5159896|NCT00974051|Children|children
5159897|NCT00974051|Exercise|exercise
5159898|NCT00974051|Hypoglycemia|hypoglycemia
5159899|NCT00974038|Bulimia Nervosa, EDNOS, Adolescents|bulimia nervosa, ednos, adolescents
5159900|NCT00974012|Bioequivalence|bioequivalence
5159901|NCT00973999|Botulinum Toxin|botulinum toxin
5159902|NCT00973999|Saliva|saliva
5159903|NCT00973999|Tracheostomy tube|tracheostomy tube
5159904|NCT00973986|atorvastatin|atorvastatin
5159905|NCT00973986|genetic polymorphisms|genetic polymorphisms
5159906|NCT00973986|coronary heart disease|coronary heart disease
5159907|NCT00973986|pharmacokinetics|pharmacokinetics
5159908|NCT00973986|CYP3A|cyp3a
5159909|NCT00973973|Pelvic Pain|pelvic pain
5159910|NCT00973973|NBI-56418|nbi-56418
5159911|NCT00973973|Endometriosis|endometriosis
5159912|NCT00973947|stage I squamous cell carcinoma of the hypopharynx|stage i squamous cell carcinoma of the hypopharynx
5159913|NCT00973947|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
5159914|NCT00973947|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
5159915|NCT00973947|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5159916|NCT00973947|stage I squamous cell carcinoma of the larynx|stage i squamous cell carcinoma of the larynx
5159917|NCT00973947|stage I verrucous carcinoma of the larynx|stage i verrucous carcinoma of the larynx
5159918|NCT00973947|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
5159919|NCT00973947|stage II verrucous carcinoma of the larynx|stage ii verrucous carcinoma of the larynx
5159920|NCT00973947|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
5159921|NCT00973947|stage III verrucous carcinoma of the larynx|stage iii verrucous carcinoma of the larynx
5159922|NCT00973947|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5159923|NCT00973947|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
5159924|NCT00973947|stage I adenoid cystic carcinoma of the oral cavity|stage i adenoid cystic carcinoma of the oral cavity
5159925|NCT00973947|stage I mucoepidermoid carcinoma of the oral cavity|stage i mucoepidermoid carcinoma of the oral cavity
5159926|NCT00973947|stage I verrucous carcinoma of the oral cavity|stage i verrucous carcinoma of the oral cavity
5159927|NCT00973947|stage II adenoid cystic carcinoma of the oral cavity|stage ii adenoid cystic carcinoma of the oral cavity
5159928|NCT00973947|stage II mucoepidermoid carcinoma of the oral cavity|stage ii mucoepidermoid carcinoma of the oral cavity
5159929|NCT00973947|stage II verrucous carcinoma of the oral cavity|stage ii verrucous carcinoma of the oral cavity
5159930|NCT00973947|stage III adenoid cystic carcinoma of the oral cavity|stage iii adenoid cystic carcinoma of the oral cavity
5159931|NCT00973947|stage III mucoepidermoid carcinoma of the oral cavity|stage iii mucoepidermoid carcinoma of the oral cavity
5159932|NCT00973947|stage III verrucous carcinoma of the oral cavity|stage iii verrucous carcinoma of the oral cavity
5159933|NCT00973947|stage IV adenoid cystic carcinoma of the oral cavity|stage iv adenoid cystic carcinoma of the oral cavity
5159934|NCT00973947|stage IV mucoepidermoid carcinoma of the oral cavity|stage iv mucoepidermoid carcinoma of the oral cavity
5159935|NCT00973947|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
5159936|NCT00973947|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
5159937|NCT00973947|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
5159938|NCT00973947|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
5159939|NCT00973947|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5159940|NCT00973947|stage I basal cell carcinoma of the lip|stage i basal cell carcinoma of the lip
5159941|NCT00973947|stage II basal cell carcinoma of the lip|stage ii basal cell carcinoma of the lip
5159942|NCT00973947|stage III basal cell carcinoma of the lip|stage iii basal cell carcinoma of the lip
5159943|NCT00973947|stage IV basal cell carcinoma of the lip|stage iv basal cell carcinoma of the lip
5159944|NCT00973947|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
5159945|NCT00973947|untreated metastatic squamous neck cancer with occult primary|untreated metastatic squamous neck cancer with occult primary
5159946|NCT00973947|stage I lymphoepithelioma of the nasopharynx|stage i lymphoepithelioma of the nasopharynx
5159947|NCT00973947|stage I squamous cell carcinoma of the nasopharynx|stage i squamous cell carcinoma of the nasopharynx
5159948|NCT00973947|stage II lymphoepithelioma of the nasopharynx|stage ii lymphoepithelioma of the nasopharynx
5159949|NCT00973947|stage II squamous cell carcinoma of the nasopharynx|stage ii squamous cell carcinoma of the nasopharynx
5159950|NCT00973947|stage III lymphoepithelioma of the nasopharynx|stage iii lymphoepithelioma of the nasopharynx
5159951|NCT00973947|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
5159952|NCT00973947|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
5159953|NCT00973947|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
5159954|NCT00973947|stage I lymphoepithelioma of the oropharynx|stage i lymphoepithelioma of the oropharynx
5159955|NCT00973947|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
5159956|NCT00973947|stage II lymphoepithelioma of the oropharynx|stage ii lymphoepithelioma of the oropharynx
5159957|NCT00973947|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
5159958|NCT00973947|stage III lymphoepithelioma of the oropharynx|stage iii lymphoepithelioma of the oropharynx
5159959|NCT00973947|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
5159960|NCT00973947|stage IV lymphoepithelioma of the oropharynx|stage iv lymphoepithelioma of the oropharynx
5159961|NCT00973947|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5159962|NCT00973947|stage I esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage i esthesioneuroblastoma of the paranasal sinus and nasal cavity
5159963|NCT00973947|stage I inverted papilloma of the paranasal sinus and nasal cavity|stage i inverted papilloma of the paranasal sinus and nasal cavity
5159964|NCT00973947|stage I midline lethal granuloma of the paranasal sinus and nasal cavity|stage i midline lethal granuloma of the paranasal sinus and nasal cavity
5159965|NCT00973947|stage I squamous cell carcinoma of the paranasal sinus and nasal cavity|stage i squamous cell carcinoma of the paranasal sinus and nasal cavity
5159966|NCT00973947|stage II esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage ii esthesioneuroblastoma of the paranasal sinus and nasal cavity
5159967|NCT00973947|stage II inverted papilloma of the paranasal sinus and nasal cavity|stage ii inverted papilloma of the paranasal sinus and nasal cavity
5159968|NCT00973947|stage II midline lethal granuloma of the paranasal sinus and nasal cavity|stage ii midline lethal granuloma of the paranasal sinus and nasal cavity
5159969|NCT00973947|stage II squamous cell carcinoma of the paranasal sinus and nasal cavity|stage ii squamous cell carcinoma of the paranasal sinus and nasal cavity
5159970|NCT00973947|stage III esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iii esthesioneuroblastoma of the paranasal sinus and nasal cavity
5159971|NCT00973947|stage III inverted papilloma of the paranasal sinus and nasal cavity|stage iii inverted papilloma of the paranasal sinus and nasal cavity
5159972|NCT00973947|stage III midline lethal granuloma of the paranasal sinus and nasal cavity|stage iii midline lethal granuloma of the paranasal sinus and nasal cavity
5159973|NCT00973947|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
5159974|NCT00973947|stage IV esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iv esthesioneuroblastoma of the paranasal sinus and nasal cavity
5159975|NCT00973947|stage IV inverted papilloma of the paranasal sinus and nasal cavity|stage iv inverted papilloma of the paranasal sinus and nasal cavity
5159976|NCT00973947|stage IV midline lethal granuloma of the paranasal sinus and nasal cavity|stage iv midline lethal granuloma of the paranasal sinus and nasal cavity
5159977|NCT00973947|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
5159978|NCT00973947|stage I salivary gland cancer|stage i salivary gland cancer
5159979|NCT00973947|stage II salivary gland cancer|stage ii salivary gland cancer
5159980|NCT00973947|stage III salivary gland cancer|stage iii salivary gland cancer
5159981|NCT00973947|stage IV salivary gland cancer|stage iv salivary gland cancer
5159982|NCT00973947|recurrent lymphoepithelioma of the nasopharynx|recurrent lymphoepithelioma of the nasopharynx
5160067|NCT00973648|Ringing in ears|ringing in ears
5159983|NCT00973947|recurrent lymphoepithelioma of the oropharynx|recurrent lymphoepithelioma of the oropharynx
5159984|NCT00973947|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
5159985|NCT00973947|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
5159986|NCT00973947|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
5159987|NCT00973947|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
5159988|NCT00973947|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
5159989|NCT00973947|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
5159990|NCT00973947|recurrent basal cell carcinoma of the lip|recurrent basal cell carcinoma of the lip
5159991|NCT00973947|recurrent adenoid cystic carcinoma of the oral cavity|recurrent adenoid cystic carcinoma of the oral cavity
5159992|NCT00973947|recurrent mucoepidermoid carcinoma of the oral cavity|recurrent mucoepidermoid carcinoma of the oral cavity
5159993|NCT00973947|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
5159994|NCT00973947|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
5159995|NCT00973947|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity
5159996|NCT00973947|recurrent inverted papilloma of the paranasal sinus and nasal cavity|recurrent inverted papilloma of the paranasal sinus and nasal cavity
5159997|NCT00973947|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity
5159998|NCT00973947|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
5159999|NCT00973947|recurrent salivary gland cancer|recurrent salivary gland cancer
5160000|NCT00973921|Stent|stent
5160001|NCT00973921|under-expansion|under-expansion
5160002|NCT00973921|StentOp|stentop
5160003|NCT00973921|StentOptimizer|stentoptimizer
5160004|NCT00973921|IVUS|ivus
5160005|NCT00973921|IC-PRO|ic-pro
5160006|NCT00973921|image enhancement|image enhancement
5160007|NCT00973908|Clostridium difficile associated diarrhoea|clostridium difficile associated diarrhoea
5160008|NCT00973908|antibiotic associated diarrhoea|antibiotic associated diarrhoea
5160009|NCT00973895|Influenza|influenza
5160010|NCT00973895|Healthy|healthy
5160011|NCT00973895|Immunity|immunity
5160012|NCT00973895|Preventive|preventive
5160013|NCT00973895|Pandemic|pandemic
5160014|NCT00973882|Hormone resistant prostate cancer|hormone resistant prostate cancer
5160015|NCT00973882|Neuro-endocrine marker|neuro-endocrine marker
5160016|NCT00973882|Carboplatin-Etoposide combination|carboplatin-etoposide combination
5160017|NCT00973882|Neuro-endocrine differentiation|neuro-endocrine differentiation
5160018|NCT00973869|colon cancer|colon cancer
5160019|NCT00973869|rectal cancer|rectal cancer
5160020|NCT00973830|Changes in HbA1c|changes in hba1c
5160021|NCT00973817|Hepatitis|hepatitis
5160022|NCT00973817|AOCH|aoch
5160023|NCT00973804|Reduced Intensity Conditioning|reduced intensity conditioning
5160024|NCT00973804|Umbilical Cord Blood Transplant|umbilical cord blood transplant
5160025|NCT00973804|Targeted Immune Depletion|targeted immune depletion
5160026|NCT00973804|Leukemia|leukemia
5160027|NCT00973804|Lymphoma|lymphoma
5160028|NCT00973804|Multiple Myeloma|multiple myeloma
5160029|NCT00973804|Non-Hodgkins Lymphoma|non-hodgkins lymphoma
5160030|NCT00973804|Hodgkins Lymphoma|hodgkins lymphoma
5160031|NCT00973791|Spinal anesthesia|spinal anesthesia
5160032|NCT00973791|Fluid therapy|fluid therapy
5160033|NCT00973778|Intensity Modulated Radiation Therapy|intensity modulated radiation therapy
5160034|NCT00973778|Capecitabine|capecitabine
5160035|NCT00973778|Resectable Rectal Carcinoma|resectable rectal carcinoma
5160036|NCT00973765|abcess|abcess
5160037|NCT00973765|MRSA|mrsa
5160038|NCT00973765|cellulitis|cellulitis
5160039|NCT00973765|antibiotics|antibiotics
5160040|NCT00973765|uncomplicated abscesses|uncomplicated abscesses
5160041|NCT00973752|ALL|all
5160042|NCT00973739|NF-2|nf-2
5160043|NCT00973739|NF-2 related tumors|nf-2 related tumors
5160044|NCT00973739|Schwannoma, Acoustic, Bilateral|schwannoma, acoustic, bilateral
5160045|NCT00973739|schwannomas|schwannomas
5160046|NCT00973739|Neurilemmoma of other cranial and peripheral nerves|neurilemmoma of other cranial and peripheral nerves
5160047|NCT00973739|NF2 related benign intracranial tumors including|nf2 related benign intracranial tumors including
5160048|NCT00973739|NF2 related meningiomas|nf2 related meningiomas
5160049|NCT00973739|NF2 related ependymomas|nf2 related ependymomas
5160050|NCT00973739|NF2 related spinal neurofibromas|nf2 related spinal neurofibromas
5160051|NCT00973739|NF2 related gliomas|nf2 related gliomas
5160052|NCT00973713|Advanced cholangiocarcinoma|advanced cholangiocarcinoma
5160053|NCT00973700|Swine Flu|swine flu
5160054|NCT00973700|Flu|flu
5160055|NCT00973700|Vaccine|vaccine
5160056|NCT00973700|Adjuvant|adjuvant
5160057|NCT00973687|pediatric|pediatric
5160058|NCT00973687|dexamethasone|dexamethasone
5160059|NCT00973687|management|management
5160060|NCT00973687|corticosteroids|corticosteroids
5160061|NCT00973687|asthma|asthma
5160062|NCT00973661|Overweight|overweight
5160063|NCT00973661|Diagnosis|diagnosis
5160064|NCT00973661|Counseling|counseling
5160065|NCT00973661|Medical Records Systems, Computerized|medical records systems, computerized
5160068|NCT00973648|Functional connectivity MRI|functional connectivity mri
5160069|NCT00973648|Voluntary control of tinnitus|voluntary control of tinnitus
5160070|NCT00973635|education|education
5160071|NCT00973635|web-based intervention|web-based intervention
5160072|NCT00973635|patient care|patient care
5160073|NCT00973622|Tobacco cessation|tobacco cessation
5160074|NCT00973622|Tobacco dependence|tobacco dependence
5160075|NCT00973622|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
5160076|NCT00973622|Nicotine Dependence|nicotine dependence
5160077|NCT00973622|Delayed Discounting|delayed discounting
5160078|NCT00973609|metastatic colorectal cancer|metastatic colorectal cancer
5160079|NCT00973609|Bevacizumab|bevacizumab
5160080|NCT00973609|Avastin®|avastin®
5160081|NCT00973609|phase 3|phase 3
5160082|NCT00973609|maintenance treatment|maintenance treatment
5160083|NCT00973609|treatment pause|treatment pause
5160084|NCT00973609|drug holiday|drug holiday
5160085|NCT00973609|stage IV|stage iv
5160086|NCT00973583|vitamin D|vitamin d
5160087|NCT00973583|infection|infection
5160088|NCT00973583|Vitamin D for the prevention of respiratory tract infections|vitamin d for the prevention of respiratory tract infections
5160089|NCT00973570|tobacco cessation|tobacco cessation
5160090|NCT00973570|evaluation|evaluation
5160091|NCT00973570|epidémiology|epidémiology
5160092|NCT00973570|adolescent|adolescent
5160093|NCT00973570|apprentices|apprentices
5160094|NCT00973557|bevacizumab|bevacizumab
5160095|NCT00973544|breast reconstruction complications|breast reconstruction complications
5160096|NCT00973544|drains|drains
5160097|NCT00973544|silicone implant|silicone implant
5160098|NCT00973531|Sleep Disordered Breathing|sleep disordered breathing
5160099|NCT00973531|Sleep Apnea|sleep apnea
5160100|NCT00973531|Hypertension|hypertension
5160101|NCT00973531|Continuous Positive Airway Pressure|continuous positive airway pressure
5160102|NCT00973518|Alzheimer's Disease|alzheimer's disease
5160103|NCT00973518|AD|ad
5160104|NCT00973518|Healthy Control|healthy control
5160105|NCT00973505|Breast neoplasms|breast neoplasms
5160106|NCT00973505|Aromatase inhibitors|aromatase inhibitors
5160107|NCT00973505|Genetic polymorphisms|genetic polymorphisms
5160108|NCT00973505|Arthralgia|arthralgia
5160109|NCT00973505|Arthritis|arthritis
5160110|NCT00973492|type 1 diabetes|type 1 diabetes
5160111|NCT00973492|functional insulinotherapy|functional insulinotherapy
5160112|NCT00973479|Arthritis, Rheumatoid|arthritis, rheumatoid
5160113|NCT00973479|Active rheumatoid arthritis|active rheumatoid arthritis
5160114|NCT00973479|Golimumab|golimumab
5160115|NCT00973479|CNTO148|cnto148
5160116|NCT00973479|Anti-TNFalpha monoclonal antibody|anti-tnfalpha monoclonal antibody
5160117|NCT00973479|Methotrexate|methotrexate
5160118|NCT00973479|Intravenous|intravenous
5160119|NCT00973466|HIV-infection|hiv-infection
5160120|NCT00973466|Neisseria gonorrhea|neisseria gonorrhea
5160121|NCT00973466|Chlamydia trachomatis|chlamydia trachomatis
5160122|NCT00973466|Herpes simplex virus|herpes simplex virus
5160123|NCT00973466|prevalence|prevalence
5160124|NCT00973453|non-seasonal allergy|non-seasonal allergy
5160125|NCT00973453|house dust mite|house dust mite
5160126|NCT00973453|immunotherapy|immunotherapy
5160127|NCT00973453|dose tolerability|dose tolerability
5160128|NCT00973440|geriatric assessment|geriatric assessment
5160129|NCT00973427|NSCLC|nsclc
5160130|NCT00973414|Combined epidural spinal anesthesia|combined epidural spinal anesthesia
5160131|NCT00973414|Fluid therapy|fluid therapy
5160132|NCT00973388|VX-950-TiDP24-C136|vx-950-tidp24-c136
5160133|NCT00973388|VX-950-C136|vx-950-c136
5160134|NCT00973388|VX-950|vx-950
5160135|NCT00973388|HEPATITIS|hepatitis
5160136|NCT00973388|Telaprevir|telaprevir
5160137|NCT00973388|Moxifloxacin|moxifloxacin
5160138|NCT00973388|ECG|ecg
5160139|NCT00973388|QT|qt
5160140|NCT00973388|QTc|qtc
5160141|NCT00973375|Drug-eluting stent|drug-eluting stent
5160142|NCT00973375|coronary restenosis|coronary restenosis
5160143|NCT00973375|coronary thrombosis|coronary thrombosis
5160144|NCT00973362|Cervix Cancer|cervix cancer
5160145|NCT00973362|Cervical Intraepithelial Neoplasia (CIN)|cervical intraepithelial neoplasia (cin)
5160146|NCT00973362|Human Papillomavirus Virus (HPV)|human papillomavirus virus (hpv)
5160147|NCT00973362|APTIMA HPV Assay|aptima hpv assay
5160148|NCT00973362|FDA-Approved HPV DNA Test|fda-approved hpv dna test
5160149|NCT00973362|TIGRIS DTS (direct tube sampling) System|tigris dts (direct tube sampling) system
5160150|NCT00973362|Clinical Sensitivity (%)|clinical sensitivity (%)
5160151|NCT00973362|Clinical Specificity (%)|clinical specificity (%)
5160152|NCT00973362|Positive Predictive Value [PPV] (%)|positive predictive value [ppv] (%)
5160153|NCT00973362|Negative Predictive Value [NPV] (%)|negative predictive value [npv] (%)
5160154|NCT00973362|Atypical Squamous Cells Undetermined Significance (ASC-US)|atypical squamous cells undetermined significance (asc-us)
5160155|NCT00973362|Relative Risk|relative risk
5160156|NCT00973349|Swine Flu|swine flu
5160157|NCT00973349|Flu|flu
5160158|NCT00973349|Vaccine|vaccine
5160159|NCT00973349|Adults|adults
5160160|NCT00973349|Elderly|elderly
5160161|NCT00973349|Non-Elderly|non-elderly
5160162|NCT00973349|Adjuvant|adjuvant
5160163|NCT00973336|postoperative follow-up|postoperative follow-up
5160164|NCT00973323|BAY59-7939|bay59-7939
5160165|NCT00973323|Rivaroxaban|rivaroxaban
5160166|NCT00973323|Non-valvular atrial fibrillation|non-valvular atrial fibrillation
5160167|NCT00973323|Japanese Patients|japanese patients
5160168|NCT00973323|Phase II|phase ii
5160169|NCT00973310|Non-small-cell lung cancer|non-small-cell lung cancer
5160170|NCT00973310|Radiation therapy|radiation therapy
5160171|NCT00973310|Epidermal growth factor receptor|epidermal growth factor receptor
5160172|NCT00973310|Tyrosine kinase inhibitor|tyrosine kinase inhibitor
5160173|NCT00973297|Falls|falls
5160174|NCT00973284|Prevention of acute gastroenteritis due to infection with and experimental Norwalk Virus|prevention of acute gastroenteritis due to infection with and experimental norwalk virus
5160175|NCT00973271|hypertriglyceridemia|hypertriglyceridemia
5160176|NCT00973245|BAY59-7939|bay59-7939
5160177|NCT00973245|Rivaroxaban|rivaroxaban
5160178|NCT00973245|Non-valvular atrial fibrillation|non-valvular atrial fibrillation
5160179|NCT00973245|Japanese Patients|japanese patients
5160180|NCT00973245|Phase II|phase ii
5160181|NCT00973232|Tramadol|tramadol
5160182|NCT00973232|Acetaminophen|acetaminophen
5160183|NCT00973232|combination|combination
5160184|NCT00973232|pharmacokinetics|pharmacokinetics
5160185|NCT00973232|bioavailability|bioavailability
5160186|NCT00973232|Zaldiar|zaldiar
5160187|NCT00973232|Ultracet|ultracet
5160188|NCT00973232|fed|fed
5160189|NCT00973232|fasted|fasted
5160190|NCT00973232|single-dose|single-dose
5160191|NCT00973232|multiple-dose|multiple-dose
5160192|NCT00973232|healthy|healthy
5160193|NCT00973232|volunteers|volunteers
5160194|NCT00973232|Healthy volunteers|healthy volunteers
5160195|NCT00973219|HBsAg loss|hbsag loss
5160196|NCT00973219|HBsAg seroconversion|hbsag seroconversion
5160197|NCT00973219|chronic hepatitis B|chronic hepatitis b
5160198|NCT00973219|low viral load|low viral load
5160199|NCT00973219|inactive carrier hepatitis B|inactive carrier hepatitis b
5160200|NCT00973206|cardiovascular morbidity|cardiovascular morbidity
5160201|NCT00973206|mortality community study|mortality community study
5160202|NCT00973193|rectum|rectum
5160203|NCT00973193|colorectal|colorectal
5160204|NCT00973193|cancer|cancer
5160205|NCT00973193|adenocarcinoma|adenocarcinoma
5160206|NCT00973193|anti-EGFR|anti-egfr
5160207|NCT00973193|monoclonal antibodies|monoclonal antibodies
5160208|NCT00973193|neoadjuvant therapy|neoadjuvant therapy
5160209|NCT00973193|preoperative radiotherapy|preoperative radiotherapy
5160210|NCT00973180|Prescription medication understanding among diabetic and hypertension patients.|prescription medication understanding among diabetic and hypertension patients.
5160211|NCT00973180|Prescription medication use among diabetic and hypertension patients.|prescription medication use among diabetic and hypertension patients.
5160212|NCT00973180|Hemoglobin A1c changes among diabetic patients.|hemoglobin a1c changes among diabetic patients.
5160213|NCT00973180|Blood pressure changes among hypertension patients.|blood pressure changes among hypertension patients.
5160214|NCT00973167|Fracture rate|fracture rate
5160215|NCT00973167|Fracture risks|fracture risks
5160216|NCT00973154|Pneumonia|pneumonia
5160217|NCT00973154|Corticosteroids|corticosteroids
5160218|NCT00973154|clinical stability|clinical stability
5160219|NCT00973141|Moderate to severe, osteoarthritis-related pain|moderate to severe, osteoarthritis-related pain
5160220|NCT00973141|Osteoarthritis-related pain|osteoarthritis-related pain
5160221|NCT00973141|Moderate to severe chronic pain|moderate to severe chronic pain
5160222|NCT00973141|JNJ-42160443|jnj-42160443
5160223|NCT00973089|Primary tooth|primary tooth
5160224|NCT00973089|Caries, Dental|caries, dental
5160225|NCT00973089|Alternative treatment|alternative treatment
5160226|NCT00973076|Phase I, cancer|phase i, cancer
5160227|NCT00973076|solid tumors|solid tumors
5160228|NCT00973076|advanced solid malignancies|advanced solid malignancies
5160229|NCT00973076|dose escalation|dose escalation
5160230|NCT00973076|mTOR Kinase Inhibitor|mtor kinase inhibitor
5160231|NCT00973076|Japanese|japanese
5160232|NCT00973063|bacteremia|bacteremia
5160233|NCT00973063|blood culture|blood culture
5160234|NCT00973063|contamination|contamination
5160235|NCT00973050|Bioequivalence|bioequivalence
5160236|NCT00973037|Breast neoplasms|breast neoplasms
5160237|NCT00973037|Tamoxifen|tamoxifen
5160238|NCT00973037|Genotype|genotype
5160239|NCT00973037|CYP2D6|cyp2d6
5160240|NCT00973024|JNJ-42160443|jnj-42160443
5160241|NCT00973024|Low back pain-related pain|low back pain-related pain
5160242|NCT00973024|moderate to severe, chronic pain|moderate to severe, chronic pain
5160243|NCT00973011|GA|ga
5160244|NCT00972998|anal sphincter pressure|anal sphincter pressure
5160245|NCT00972998|phenyephrine|phenyephrine
5160246|NCT00972985|Healthy Control subjects|healthy control subjects
5160247|NCT00972972|fruit polyphenols|fruit polyphenols
5160248|NCT00972972|phytochemicals|phytochemicals
5160249|NCT00972972|neurocognition|neurocognition
5160250|NCT00972972|neuropsychology|neuropsychology
5160251|NCT00972972|psychopharmacology|psychopharmacology
5160252|NCT00972972|gene expression|gene expression
5160253|NCT00972972|biochemistry|biochemistry
5160254|NCT00972959|multiple myeloma|multiple myeloma
5160255|NCT00972959|1-3 Prior Lines of Therapy|1-3 prior lines of therapy
5160256|NCT00972959|bortezomib (Velcade)|bortezomib (velcade)
5160257|NCT00972959|zoledronic acid (Zometa)|zoledronic acid (zometa)
5160258|NCT00972959|Dexamethasone|dexamethasone
5160259|NCT00972959|bone mineral density|bone mineral density
5160261|NCT00972959|bone metabolism|bone metabolism
5160262|NCT00972959|osteolytic lesions|osteolytic lesions
5160263|NCT00972959|DEXA-scans|dexa-scans
5160264|NCT00972959|X-ray radiography|x-ray radiography
5160265|NCT00972946|MRI|mri
5160266|NCT00972946|SPIO|spio
5160267|NCT00972933|Immunogenicity Analysis|immunogenicity analysis
5160268|NCT00972933|Biomarker Analysis|biomarker analysis
5160269|NCT00972933|experimental|experimental
5160270|NCT00972920|Transversus abdominis plane|transversus abdominis plane
5160271|NCT00972920|Acute pain service|acute pain service
5160272|NCT00972920|Ultrasound|ultrasound
5160273|NCT00972907|anal fissure|anal fissure
5160274|NCT00972907|pain|pain
5160275|NCT00972907|nifedipine|nifedipine
5160276|NCT00972894|Group B streptococcus|group b streptococcus
5160277|NCT00972894|Polymerase chain reaction|polymerase chain reaction
5160278|NCT00972894|PCR|pcr
5160279|NCT00972894|Intrapartum screening|intrapartum screening
5160280|NCT00972894|Risk factors|risk factors
5160281|NCT00972894|arly onset Group B streptococcus infection|arly onset group b streptococcus infection
5160282|NCT00972881|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5160283|NCT00972881|Locally advanced rectal cancer|locally advanced rectal cancer
5160284|NCT00972868|Unidirectional mask|unidirectional mask
5160285|NCT00972868|NPPV|nppv
5160286|NCT00972868|COPD|copd
5160287|NCT00972868|respiratory physiology|respiratory physiology
5160288|NCT00972855|Bioequivalence|bioequivalence
5160289|NCT00972842|PTCL|ptcl
5160290|NCT00972842|Peripheral T-Cell Non-Hodgkin's Lymphoma|peripheral t-cell non-hodgkin's lymphoma
5160291|NCT00972842|Vorinostat|vorinostat
5160292|NCT00972842|Lenalidomid|lenalidomid
5160293|NCT00972829|Hypercholesterolemia|hypercholesterolemia
5160294|NCT00972816|Swine Flu|swine flu
5160295|NCT00972816|Flu|flu
5160296|NCT00972816|Vaccine|vaccine
5160297|NCT00972816|Children|children
5160298|NCT00972816|Adjuvant|adjuvant
5160299|NCT00972803|gingivitis|gingivitis
5160300|NCT00972803|dental plaque|dental plaque
5160301|NCT00972803|mouthrinse|mouthrinse
5160302|NCT00972790|brain tumor|brain tumor
5160303|NCT00972790|un-ruptured aneurysm|un-ruptured aneurysm
5160304|NCT00972790|arteriovenous malformation|arteriovenous malformation
5160305|NCT00972790|epileptic focus|epileptic focus
5160306|NCT00972790|supratentorial|supratentorial
5160307|NCT00972764|Laryngomalacia|laryngomalacia
5160308|NCT00972764|Factors Associated or Predisposing|factors associated or predisposing
5160309|NCT00972751|stage II rectal cancer|stage ii rectal cancer
5160310|NCT00972751|stage III rectal cancer|stage iii rectal cancer
5160311|NCT00972751|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5160312|NCT00972725|Chloroquine|chloroquine
5160313|NCT00972725|Human Immunodeficiency Virus|human immunodeficiency virus
5160314|NCT00972712|Multiple Myeloma|multiple myeloma
5160315|NCT00972699|Human Immunodeficiency Virus|human immunodeficiency virus
5160316|NCT00972699|Acquired Immune Deficiency Syndrome|acquired immune deficiency syndrome
5160317|NCT00972699|Tuberculosis|tuberculosis
5160318|NCT00972699|Women|women
5160319|NCT00972699|Pregnancy|pregnancy
5160320|NCT00972699|Vertical Transmission of Human Immunodeficiency Virus|vertical transmission of human immunodeficiency virus
5160321|NCT00972699|South Africa|south africa
5160322|NCT00972699|Low Birth Weight|low birth weight
5160323|NCT00972686|solid tumors|solid tumors
5160324|NCT00972686|lymphoma|lymphoma
5160325|NCT00972686|Phosphoinositide 3-kinase inhibitor|phosphoinositide 3-kinase inhibitor
5160326|NCT00972660|Mesenchymal stem cell|mesenchymal stem cell
5160327|NCT00972660|Efficacy|efficacy
5160328|NCT00972660|Safety|safety
5160329|NCT00972647|fracture|fracture
5160330|NCT00972647|fixation|fixation
5160331|NCT00972647|fluoroscopy|fluoroscopy
5160332|NCT00972647|laser|laser
5160333|NCT00972647|radiation|radiation
5160334|NCT00972634|depression|depression
5160335|NCT00972634|cachexia|cachexia
5160336|NCT00972634|pain|pain
5160337|NCT00972634|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5160338|NCT00972608|congenital heart disease|congenital heart disease
5160339|NCT00972608|surgical planning|surgical planning
5160340|NCT00972582|leucine intake|leucine intake
5160341|NCT00972582|tolerable upper limit|tolerable upper limit
5160342|NCT00972582|adults|adults
5160343|NCT00972582|amino acid supplements|amino acid supplements
5160344|NCT00972582|Excessive Leucine Intake|excessive leucine intake
5160345|NCT00972569|BNP with or without PDE-V in heart failure|bnp with or without pde-v in heart failure
5160346|NCT00972556|Mineral Trioxide Aggregate|mineral trioxide aggregate
5160347|NCT00972556|Formocresol|formocresol
5160348|NCT00972556|pulpotomy|pulpotomy
5160349|NCT00972556|primary molar|primary molar
5160350|NCT00972556|treatment outcome|treatment outcome
5160351|NCT00972543|Moderate to severe chronic plaque psoriasis|moderate to severe chronic plaque psoriasis
5160352|NCT00972543|palms and/or soles|palms and/or soles
5160353|NCT00972543|with or without pustules|with or without pustules
5160354|NCT00972530|rheumatoid arthritis|rheumatoid arthritis
5160355|NCT00972530|treatment|treatment
5160356|NCT00972517|GSK Bio's influenza vaccine GSK2340272A|gsk bio's influenza vaccine gsk2340272a
5160357|NCT00972517|influenza infection|influenza infection
5160358|NCT00972504|Proof of concept|proof of concept
5160359|NCT00972465|nimotuzumab colorectal cancer chemotherapy|nimotuzumab colorectal cancer chemotherapy
5160360|NCT00972452|Type II Diabetes|type ii diabetes
5160361|NCT00972452|Insulin Resistance|insulin resistance
5160362|NCT00972452|Exercise|exercise
5160363|NCT00972452|Continuous Glucose Monitoring|continuous glucose monitoring
5160364|NCT00972439|Oral Contraceptives|oral contraceptives
5160365|NCT00972439|Breast Tissue|breast tissue
5160366|NCT00972413|breast cancer|breast cancer
5160367|NCT00972413|cone beam computed tomography|cone beam computed tomography
5160368|NCT00972400|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
5160369|NCT00972400|fatigue|fatigue
5160370|NCT00972400|cancer survivor|cancer survivor
5160371|NCT00972400|breast cancer|breast cancer
5160372|NCT00972387|carbohydrate-protein|carbohydrate-protein
5160373|NCT00972387|endurance exercise|endurance exercise
5160374|NCT00972387|supplement|supplement
5160375|NCT00972361|Adenoidectomy|adenoidectomy
5160376|NCT00972361|Tonsillectomy|tonsillectomy
5160377|NCT00972361|Ventilation Tubes|ventilation tubes
5160378|NCT00972361|Preoperational screening|preoperational screening
5160379|NCT00972361|Coagulation Profile|coagulation profile
5160380|NCT00972361|Lupus anticoagulant|lupus anticoagulant
5160381|NCT00972348|HIV|hiv
5160382|NCT00972348|Personal Health Record|personal health record
5160383|NCT00972348|Laboratory values: CD4 cells and HIV Viral load|laboratory values: cd4 cells and hiv viral load
5160384|NCT00972348|Medication Reconciliation|medication reconciliation
5160385|NCT00972335|Avastin|avastin
5160386|NCT00972335|RAD001|rad001
5160387|NCT00972335|Meningioma|meningioma
5160388|NCT00972335|Bevacizumab|bevacizumab
5160389|NCT00972335|Everolimus|everolimus
5160390|NCT00972335|Brain|brain
5160391|NCT00972309|Epotope-Enhanced TARP Peptide|epotope-enhanced tarp peptide
5160392|NCT00972309|Prostate Cancer|prostate cancer
5160393|NCT00972309|TARP Peptide-Pulsed Dendritic Cells|tarp peptide-pulsed dendritic cells
5160394|NCT00972309|PSADT|psadt
5160395|NCT00972309|HLA-A*0201|hla-a*0201
5160396|NCT00972270|Arterial Occlusive Disease|arterial occlusive disease
5160397|NCT00972270|Heart Diseases|heart diseases
5160398|NCT00972270|Myocardial Ischemia|myocardial ischemia
5160399|NCT00972270|Vascular Disease|vascular disease
5160400|NCT00972270|Arteriosclerosis|arteriosclerosis
5160401|NCT00972270|Ischemia|ischemia
5160402|NCT00972257|24-hour IOP control|24-hour iop control
5160403|NCT00972257|primary open-angle glaucoma|primary open-angle glaucoma
5160404|NCT00972257|brimonidine/timolol|brimonidine/timolol
5160405|NCT00972257|dorzolamide/timolol|dorzolamide/timolol
5160406|NCT00972244|Type 2 diabetes mellitus|type 2 diabetes mellitus
5160407|NCT00972244|Japanese|japanese
5160408|NCT00972244|phase 2|phase 2
5160409|NCT00972244|efficacy|efficacy
5160410|NCT00972244|safety|safety
5160411|NCT00972244|dapagliflozin|dapagliflozin
5160412|NCT00972231|Thalassemia Major|thalassemia major
5160413|NCT00972231|Thalassemia Intermedia|thalassemia intermedia
5160414|NCT00972231|Sickle Cell Anemia|sickle cell anemia
5160415|NCT00972231|Sickle Cell Thalassemia|sickle cell thalassemia
5160416|NCT00972231|Iron Overload|iron overload
5160417|NCT00972231|Growth Velocity|growth velocity
5160418|NCT00972218|Spondyloarthritis|spondyloarthritis
5160419|NCT00972218|Ankylosing Spondylitis|ankylosing spondylitis
5160420|NCT00972218|Crohn's disease|crohn's disease
5160421|NCT00972218|adalimumab|adalimumab
5160422|NCT00972218|treatment|treatment
5160423|NCT00972205|Pgp|pgp
5160424|NCT00972205|Solid Tumors|solid tumors
5160425|NCT00972205|Drug Resistance|drug resistance
5160426|NCT00972205|Sestamibi|sestamibi
5160427|NCT00972205|Cancer|cancer
5160428|NCT00972205|Solid Tumor|solid tumor
5160429|NCT00972192|HIV testing|hiv testing
5160430|NCT00972192|HIV risk behavior|hiv risk behavior
5160431|NCT00972192|access to care|access to care
5160432|NCT00972179|healthy volunteers|healthy volunteers
5160433|NCT00972153|Decrease in CFU density at surgery site|decrease in cfu density at surgery site
5160434|NCT00972153|Decrease in airborne particulate at surgery site|decrease in airborne particulate at surgery site
5160435|NCT00972140|Patients with stable COPD|patients with stable copd
5160436|NCT00972101|Blood And Marrow Transplantation|blood and marrow transplantation
5160437|NCT00972101|Leukemia|leukemia
5160438|NCT00972101|Lymphoma|lymphoma
5160439|NCT00972101|Pediatrics|pediatrics
5160440|NCT00972101|Etoposide|etoposide
5160441|NCT00972101|Expanded Cord Blood T Cells|expanded cord blood t cells
5160442|NCT00972101|Filgrastim|filgrastim
5160443|NCT00972101|Fludarabine|fludarabine
5160444|NCT00972101|Melphalan|melphalan
5160445|NCT00972101|Mycophenolate Mofetil|mycophenolate mofetil
5160446|NCT00972101|Rituximab|rituximab
5160447|NCT00972101|Tacrolimus|tacrolimus
5160448|NCT00972101|Thiotepa|thiotepa
5160449|NCT00972101|Thymoglobulin|thymoglobulin
5160450|NCT00972101|Total Body Irradiation|total body irradiation
5160451|NCT00972088|inflammation of the small bowel|inflammation of the small bowel
5160452|NCT00972075|totally blind subjects|totally blind subjects
5160453|NCT00972062|Subcutaneous injections|subcutaneous injections
5160454|NCT00972062|Skin abnormalities|skin abnormalities
5160455|NCT00972049|safety|safety
5160456|NCT00972049|tolerability|tolerability
5160457|NCT00972049|AZD2516|azd2516
5160458|NCT00972049|pain|pain
5160459|NCT00972049|Japanese|japanese
5160460|NCT00972036|COLON|colon
5160461|NCT00972036|LIVER|liver
5160462|NCT00972036|RECTUM|rectum
5160463|NCT00972036|SIR-Spheres|sir-spheres
5160464|NCT00972036|09-030|09-030
5160465|NCT00972023|triple-negative breast cancer|triple-negative breast cancer
5160466|NCT00972023|stage I breast cancer|stage i breast cancer
5160467|NCT00972023|stage II breast cancer|stage ii breast cancer
5160468|NCT00972023|stage IIIA breast cancer|stage iiia breast cancer
5160469|NCT00972023|stage IIIB breast cancer|stage iiib breast cancer
5160470|NCT00972023|stage IIIC breast cancer|stage iiic breast cancer
5160471|NCT00972010|Breast|breast
5160472|NCT00972010|Cancer|cancer
5160473|NCT00972010|Lumpectomies|lumpectomies
5160474|NCT00972010|PlasmaBlade|plasmablade
5160475|NCT00972010|Breast conservation therapy|breast conservation therapy
5160476|NCT00971971|Hypotension|hypotension
5160477|NCT00971971|Acute renal failure|acute renal failure
5160478|NCT00971971|acute kidney injury|acute kidney injury
5160479|NCT00971971|dialysis|dialysis
5160480|NCT00971971|ICU|icu
5160481|NCT00971958|HIV prevention|hiv prevention
5160482|NCT00971958|infant, neonatal, male circumcision|infant, neonatal, male circumcision
5160483|NCT00971932|Recurrent and/or metastatic|recurrent and/or metastatic
5160484|NCT00971932|SCCHN|scchn
5160485|NCT00971919|pain|pain
5160486|NCT00971919|perioperative/postoperative complications|perioperative/postoperative complications
5160487|NCT00971919|breast cancer in situ|breast cancer in situ
5160488|NCT00971919|stage IA breast cancer|stage ia breast cancer
5160489|NCT00971919|stage IB breast cancer|stage ib breast cancer
5160490|NCT00971919|stage II breast cancer|stage ii breast cancer
5160491|NCT00971919|stage IIIA breast cancer|stage iiia breast cancer
5160492|NCT00971919|stage IIIB breast cancer|stage iiib breast cancer
5160493|NCT00971919|stage IIIC breast cancer|stage iiic breast cancer
5160494|NCT00971906|Pandemic influenza|pandemic influenza
5160495|NCT00971906|Vaccine|vaccine
5160496|NCT00971893|Acute Exacerbation of Bronchial Asthma Acute Asthma|acute exacerbation of bronchial asthma acute asthma
5160497|NCT00971880|Blood transfusions|blood transfusions
5160498|NCT00971880|Adverse events|adverse events
5160499|NCT00971880|Hepatitis C|hepatitis c
5160500|NCT00971880|HIV|hiv
5160501|NCT00971854|Dystonia|dystonia
5160502|NCT00971828|Myositis|myositis
5160503|NCT00971828|polymyositis|polymyositis
5160504|NCT00971828|dermatomyositis|dermatomyositis
5160505|NCT00971815|HPA-axis|hpa-axis
5160506|NCT00971815|fetal programming|fetal programming
5160507|NCT00971789|Sirolimus|sirolimus
5160508|NCT00971789|Cowden Syndrome|cowden syndrome
5160509|NCT00971789|PTEN Mutation|pten mutation
5160510|NCT00971789|Hamartoma Syndrome|hamartoma syndrome
5160511|NCT00971776|Patient receiving AB5000 ventricle potentially recoverable|patient receiving ab5000 ventricle potentially recoverable
5160512|NCT00971763|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
5160513|NCT00971763|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
5160514|NCT00971763|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5160515|NCT00971763|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5160516|NCT00971763|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5160517|NCT00971750|ultrasonography|ultrasonography
5160518|NCT00971750|gallbladder|gallbladder
5160519|NCT00971750|cholelithiasis|cholelithiasis
5160520|NCT00971750|laparoscopic|laparoscopic
5160521|NCT00971750|gastric bypass|gastric bypass
5160522|NCT00971750|obesity|obesity
5160523|NCT00971750|bariatric surgery|bariatric surgery
5160524|NCT00971737|stage IV breast cancer|stage iv breast cancer
5160525|NCT00971737|male breast cancer|male breast cancer
5160526|NCT00971724|Prednisolone|prednisolone
5160527|NCT00971724|Glucocorticoids|glucocorticoids
5160528|NCT00971711|IBS|ibs
5160529|NCT00971711|irritable bowel syndrome|irritable bowel syndrome
5160530|NCT00971711|abdominal pain|abdominal pain
5160531|NCT00971711|urgency|urgency
5160532|NCT00971711|bloating|bloating
5160533|NCT00971711|diarrhea|diarrhea
5160534|NCT00971698|Splenectomy|splenectomy
5160535|NCT00971698|Thrombocytosis|thrombocytosis
5160536|NCT00971698|Infections|infections
5160537|NCT00971698|Spleen|spleen
5160538|NCT00971698|Sickle Cell Thalassemia|sickle cell thalassemia
5160539|NCT00971672|Infants|infants
5160540|NCT00971672|Iron Deficiency|iron deficiency
5160541|NCT00971672|Anemia|anemia
5160542|NCT00971672|Healthy infants that attend the pediatric community clinics|healthy infants that attend the pediatric community clinics
5160543|NCT00971659|type 2 diabetes|type 2 diabetes
5160544|NCT00971646|overactive bladder|overactive bladder
5160545|NCT00971646|self-consciousness|self-consciousness
5160546|NCT00971646|perceptual urge sensation|perceptual urge sensation
5160547|NCT00971620|Cutaneous Leiomyomas|cutaneous leiomyomas
5160548|NCT00971620|Skin Pain|skin pain
5160549|NCT00971620|Botox Therapy|botox therapy
5160550|NCT00971620|Hereditary Leiomyomatosis|hereditary leiomyomatosis
5160551|NCT00971620|Renal Cell Cancer|renal cell cancer
5160552|NCT00971620|Cutaneous Leiomyoma|cutaneous leiomyoma
5160553|NCT00971607|Acute myocardial infarction|acute myocardial infarction
5160554|NCT00971607|Postconditioning|postconditioning
5160555|NCT00971607|Sevoflurane|sevoflurane
5160556|NCT00971594|weight loss|weight loss
5160557|NCT00971594|glucose metabolism|glucose metabolism
5160558|NCT00971568|Interstitial cystitis|interstitial cystitis
5160559|NCT00971568|Painful bladder syndrome|painful bladder syndrome
5160560|NCT00971555|Transient Hypothyroxinemia|transient hypothyroxinemia
5160561|NCT00971555|Late Preterm Infants|late preterm infants
5160562|NCT00971555|Total T4|total t4
5160563|NCT00971555|TSH|tsh
5160564|NCT00971555|Illness severity|illness severity
5160565|NCT00971555|NICU|nicu
5160566|NCT00971542|Pandemic influenza|pandemic influenza
5160567|NCT00971542|Vaccine|vaccine
5160568|NCT00971529|Smoking cessation|smoking cessation
5160569|NCT00971529|tea filter|tea filter
5160570|NCT00971516|diabetes|diabetes
5160571|NCT00971516|implants|implants
5160572|NCT00971516|cytokines|cytokines
5160573|NCT00971503|Diabetes type 1|diabetes type 1
5160574|NCT00971503|Adult Stem cells|adult stem cells
5160575|NCT00971503|Local injection|local injection
5160576|NCT00971503|Catheter delivery|catheter delivery
5160577|NCT00971503|Bone marrow|bone marrow
5160578|NCT00971490|COPD|copd
5160579|NCT00971490|FEV1|fev1
5160580|NCT00971490|beta endorphin|beta endorphin
5160581|NCT00971490|SGRQ|sgrq
5160582|NCT00971490|Acu-TENS|acu-tens
5160583|NCT00971477|Teledermatology|teledermatology
5160584|NCT00971477|Telemedicine|telemedicine
5160585|NCT00971477|Psoriasis|psoriasis
5160586|NCT00971464|AMD|amd
5160587|NCT00971464|EV|ev
5160588|NCT00971464|CCTV|cctv
5160589|NCT00971464|Reading|reading
5160590|NCT00971464|vision|vision
5160591|NCT00971451|Anterior cruciate ligament|anterior cruciate ligament
5160592|NCT00971451|ACL|acl
5160593|NCT00971438|appendicitis|appendicitis
5160594|NCT00971438|diagnosis|diagnosis
5160595|NCT00971438|diagnostic imaging|diagnostic imaging
5160596|NCT00971438|clinical scoring system|clinical scoring system
5160597|NCT00971425|influenza infection|influenza infection
5160598|NCT00971425|GSK Bio's influenza vaccine GSK2340272A|gsk bio's influenza vaccine gsk2340272a
5160599|NCT00971386|Heart Failure|heart failure
5160600|NCT00971373|antimicrobial|antimicrobial
5160601|NCT00971373|epidemiology|epidemiology
5160602|NCT00971373|bacteriology|bacteriology
5160603|NCT00971373|CFU|cfu
5160604|NCT00971360|conversion|conversion
5160605|NCT00971360|cytokine|cytokine
5160606|NCT00971360|inflammation|inflammation
5160607|NCT00971347|obesity|obesity
5160608|NCT00971347|overweight|overweight
5160609|NCT00971347|weight loss|weight loss
5160610|NCT00971347|randomized controlled trial|randomized controlled trial
5160611|NCT00971347|chewing gum|chewing gum
5160612|NCT00971334|Down Syndrome|down syndrome
5160613|NCT00971334|Aneuploidy|aneuploidy
5160614|NCT00971334|Amniocentesis|amniocentesis
5160615|NCT00971334|CVS|cvs
5160616|NCT00971321|influenza infection|influenza infection
5160617|NCT00971321|GSK Bio's influenza vaccine GSK2340272A|gsk bio's influenza vaccine gsk2340272a
5160618|NCT00971295|eslicarbazepine acetate|eslicarbazepine acetate
5160619|NCT00971295|zebinix|zebinix
5160620|NCT00971295|metformin|metformin
5160621|NCT00971256|Bladder|bladder
5160622|NCT00971256|Cancer|cancer
5160623|NCT00971256|Cytology|cytology
5160624|NCT00971243|Insulin resistance|insulin resistance
5160625|NCT00971230|HIV|hiv
5160626|NCT00971230|Human Immunodeficiency Virus|human immunodeficiency virus
5160627|NCT00971217|Internet based Cognitive-Behavioural Intervention|internet based cognitive-behavioural intervention
5160628|NCT00971217|Exercise Intervention|exercise intervention
5160629|NCT00971217|Depression|depression
5160630|NCT00971217|Perceived Social Support|perceived social support
5160631|NCT00971217|Physical Self-Concept|physical self-concept
5160632|NCT00971204|atrial fibrillation|atrial fibrillation
5160633|NCT00971204|PAF|paf
5160634|NCT00971191|Stage I - III surgical resection molecular change brief pre-operative exposure|stage i - iii surgical resection molecular change brief pre-operative exposure
5160635|NCT00971178|Analgesia|analgesia
5160636|NCT00971178|Dental pain|dental pain
5160637|NCT00971178|Dexmedetomidine|dexmedetomidine
5160638|NCT00971178|Pain|pain
5160639|NCT00971178|Peripheral effects|peripheral effects
5160640|NCT00971165|Hypertension|hypertension
5160641|NCT00971165|Chlorthalidone|chlorthalidone
5160642|NCT00971165|Amiloride|amiloride
5160643|NCT00971165|Losartan|losartan
5160644|NCT00971165|treatment|treatment
5160645|NCT00971152|IVF|ivf
5160646|NCT00971152|dose comparison of gonadotrophins|dose comparison of gonadotrophins
5160647|NCT00971152|poor responder to ovarian stimulation|poor responder to ovarian stimulation
5160648|NCT00971139|Online patient-provider communication|online patient-provider communication
5160649|NCT00971139|Organizational change|organizational change
5160650|NCT00971139|Symptom management|symptom management
5160651|NCT00971126|hepatocellular carcinoma|hepatocellular carcinoma
5160652|NCT00971100|Pandemic influenza|pandemic influenza
5160653|NCT00971100|Vaccine|vaccine
5160654|NCT00971087|Breast cancer|breast cancer
5160655|NCT00971087|breast cancer screening|breast cancer screening
5160656|NCT00971074|Arthralgia|arthralgia
5160657|NCT00971074|Viscosupplementation|viscosupplementation
5160658|NCT00971074|Knee|knee
5160659|NCT00971074|Menisci, Tibial|menisci, tibial
5160660|NCT00971074|Surgery, Outpatient|surgery, outpatient
5160661|NCT00971061|Ahmed valve|ahmed valve
5160662|NCT00971061|single-plate Molteno implant|single-plate molteno implant
5160663|NCT00971061|refractory glaucoma|refractory glaucoma
5160664|NCT00971061|surgical treatment|surgical treatment
5160665|NCT00971048|pressure ulcers|pressure ulcers
5160666|NCT00971048|PU|pu
5160667|NCT00971048|diabetic foot ulcers|diabetic foot ulcers
5160668|NCT00971048|DFU|dfu
5160669|NCT00971048|Bates-Jensen Wound Assessment|bates-jensen wound assessment
5160670|NCT00971035|MILR1444A|milr1444a
5160671|NCT00971022|Low-income populations|low-income populations
5160672|NCT00971022|Chronic health condition|chronic health condition
5160673|NCT00971022|Prescription medication|prescription medication
5160674|NCT00971022|Prescription drugs|prescription drugs
5160675|NCT00971022|Discount generic prescription programs|discount generic prescription programs
5160676|NCT00971022|Survey|survey
5160677|NCT00971022|Awareness|awareness
5160678|NCT00971022|Focus Group|focus group
5160679|NCT00971022|Houston|houston
5160680|NCT00971009|Symptom management|symptom management
5160681|NCT00971009|Interactive Health Communication Application|interactive health communication application
5160682|NCT00971009|Patient-provider communication|patient-provider communication
5160683|NCT00971009|Health care costs|health care costs
5160684|NCT00970996|Melanoma|melanoma
5160685|NCT00970996|Abraxane|abraxane
5160686|NCT00970996|Nab-paclitaxel|nab-paclitaxel
5160687|NCT00970996|Paclitaxel (protein-bound)|paclitaxel (protein-bound)
5160688|NCT00970996|ABI-007|abi-007
5160689|NCT00970996|Cisplatin|cisplatin
5160690|NCT00970996|Platinol-AQ|platinol-aq
5160691|NCT00970996|Platinol|platinol
5160692|NCT00970996|CDDP|cddp
5160693|NCT00970996|Interleukin 2|interleukin 2
5160694|NCT00970996|IL-2|il-2
5160695|NCT00970996|Proleukin|proleukin
5160696|NCT00970996|Intron A|intron a
5160697|NCT00970996|Interferon alpha 2b|interferon alpha 2b
5160698|NCT00970996|Interferon alfa-2b|interferon alfa-2b
5160699|NCT00970996|Temodar|temodar
5160700|NCT00970996|Temozolomide|temozolomide
5160701|NCT00970970|Vascular endothelial growth factor|vascular endothelial growth factor
5160702|NCT00970970|von Hippel Lindau disease|von hippel lindau disease
5160703|NCT00970970|molecular imaging|molecular imaging
5160704|NCT00970970|biomarker|biomarker
5160705|NCT00970957|Macular edema|macular edema
5160706|NCT00970957|Retinal Vein Occlusion|retinal vein occlusion
5160707|NCT00970957|Bevacizumab|bevacizumab
5160708|NCT00970944|Traumatic Brain Injury|traumatic brain injury
5160709|NCT00970944|Rehabilitation|rehabilitation
5160710|NCT00970944|Disorders of Consciousness|disorders of consciousness
5160711|NCT00970944|Functional Outcome|functional outcome
5160712|NCT00970944|Amantadine Hydrochloride|amantadine hydrochloride
5160713|NCT00970931|hypertension|hypertension
5160714|NCT00970931|diuretics|diuretics
5160715|NCT00970918|Cardiovascular disease|cardiovascular disease
5160716|NCT00970918|Carotid Intima Media Thickness|carotid intima media thickness
5160717|NCT00970905|Radiation|radiation
5160718|NCT00970905|Nausea|nausea
5160719|NCT00970905|Vomiting|vomiting
5160720|NCT00970905|Ondansetron|ondansetron
5160721|NCT00970905|Aprepitant|aprepitant
5160722|NCT00970892|Anticoagulation|anticoagulation
5160723|NCT00970892|warfarin|warfarin
5160724|NCT00970892|VKORC1|vkorc1
5160725|NCT00970892|CYP2C9|cyp2c9
5160726|NCT00970892|thromboembolism|thromboembolism
5160727|NCT00970892|pharmacogenetics|pharmacogenetics
5160728|NCT00970879|malaria|malaria
5160729|NCT00970879|pregnancy|pregnancy
5160730|NCT00970879|HIV|hiv
5160731|NCT00970879|prevention|prevention
5160732|NCT00970879|cotrimoxazole|cotrimoxazole
5160733|NCT00970879|mefloquine|mefloquine
5160734|NCT00970866|multiple micronutrients|multiple micronutrients
5160735|NCT00970866|home fortification|home fortification
5160736|NCT00970866|complementary foods|complementary foods
5160737|NCT00970866|infant feeding|infant feeding
5160738|NCT00970866|lipid-based nutrient supplements|lipid-based nutrient supplements
5160739|NCT00970853|Evaluate developmental outcomes|evaluate developmental outcomes
5160740|NCT00970853|Evaluate child cognitive, academic, and behavioral outcomes|evaluate child cognitive, academic, and behavioral outcomes
5160741|NCT00970840|Acceptability|acceptability
5160742|NCT00970840|Supplements|supplements
5160743|NCT00970840|Home-fortification|home-fortification
5160744|NCT00970827|Coronary artery disease|coronary artery disease
5160745|NCT00970827|PCI|pci
5160746|NCT00970827|Postconditioning|postconditioning
5160747|NCT00970827|Elective or urgent PCI|elective or urgent pci
5160748|NCT00970814|Alcoholism|alcoholism
5160749|NCT00970814|Alcohol Drinking|alcohol drinking
5160750|NCT00970814|Alcoholic Intoxication|alcoholic intoxication
5160751|NCT00970814|Alcohol Abuse|alcohol abuse
5160752|NCT00970801|Atypical mycobacteria|atypical mycobacteria
5160753|NCT00970775|Phase I|phase i
5160754|NCT00970775|Japanese healthy volunteer|japanese healthy volunteer
5160755|NCT00970775|AZD2423|azd2423
5160756|NCT00970749|chlamydia|chlamydia
5160757|NCT00970749|healthy women|healthy women
5160758|NCT00970749|history of endocervical chlamydia|history of endocervical chlamydia
5160759|NCT00970749|no history of endocervical chlamydia|no history of endocervical chlamydia
5160760|NCT00970736|Motor cortex|motor cortex
5160761|NCT00970736|Motor control|motor control
5160762|NCT00970736|Neuroplasticity|neuroplasticity
5160763|NCT00970736|Aging|aging
5160764|NCT00970736|Swallowing|swallowing
5160765|NCT00970723|Diabetic retinopathy|diabetic retinopathy
5160766|NCT00970723|Macula edema|macula edema
5160767|NCT00970723|Sleep apnea|sleep apnea
5160768|NCT00970723|High blood pressure|high blood pressure
5160769|NCT00970697|MARTORELL'S ULCER|martorell's ulcer
5160770|NCT00970697|hydrogel|hydrogel
5160771|NCT00970697|Hypertensive leg ulcer|hypertensive leg ulcer
5160772|NCT00970684|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5160773|NCT00970684|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5160774|NCT00970684|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5160775|NCT00970684|adenocarcinoma of the lung|adenocarcinoma of the lung
5160776|NCT00970684|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
5160777|NCT00970684|large cell lung cancer|large cell lung cancer
5160778|NCT00970671|scar|scar
5160779|NCT00970671|laser therapy|laser therapy
5160780|NCT00970671|lasers, pulsed dye|lasers, pulsed dye
5160781|NCT00970658|Plaster|plaster
5160782|NCT00970658|injuries|injuries
5160783|NCT00970658|regions miofasciais articulated|regions miofasciais articulated
5160784|NCT00970658|Reducing signs, symptoms|reducing signs, symptoms
5160785|NCT00970645|Non small cell lung cancer|non small cell lung cancer
5160786|NCT00970645|mediastinum|mediastinum
5160787|NCT00970645|endobronchial ultrasound fine needle aspiration|endobronchial ultrasound fine needle aspiration
5160788|NCT00970645|endoscopic ultrasound|endoscopic ultrasound
5160789|NCT00970645|mediastinoscopy|mediastinoscopy
5160790|NCT00970645|surgical or minimally invasive evaluation of mediastinum|surgical or minimally invasive evaluation of mediastinum
5160791|NCT00970645|NSCLC|nsclc
5160792|NCT00970606|ARDS|ards
5160793|NCT00970606|H1N1|h1n1
5160794|NCT00970606|Influenza|influenza
5160795|NCT00970606|Statin|statin
5160796|NCT00970580|BIIB022|biib022
5160797|NCT00970580|Stage IV|stage iv
5160798|NCT00970580|Taxol|taxol
5160799|NCT00970580|Stage IIIB|stage iiib
5160800|NCT00970580|Carboplatin|carboplatin
5160801|NCT00970580|Paclitaxel|paclitaxel
5160802|NCT00970580|Non Small Cell Lung Cancer|non small cell lung cancer
5160803|NCT00970580|Treatment Naive|treatment naive
5160804|NCT00970580|Anti IGF1R|anti igf1r
5160805|NCT00970580|NSCLC|nsclc
5160806|NCT00970580|Open Label|open label
5160807|NCT00970580|IGF1R|igf1r
5160808|NCT00970580|Paraplatin|paraplatin
5160809|NCT00970580|Cytotoxic|cytotoxic
5160810|NCT00970580|Mitotic Inhibitor|mitotic inhibitor
5160811|NCT00970580|Taxane|taxane
5160812|NCT00970580|Alkylating agent|alkylating agent
5160813|NCT00970567|therapy after positive ketone bodies in the blood|therapy after positive ketone bodies in the blood
5160814|NCT00970567|timepoint of diagnosis|timepoint of diagnosis
5160815|NCT00970567|timepoint of metabolic normalisation|timepoint of metabolic normalisation
5160816|NCT00970554|Amblyopia|amblyopia
5160817|NCT00970554|Telescopic magnification|telescopic magnification
5160818|NCT00970554|Patching|patching
5160819|NCT00970541|Cinnamon|cinnamon
5160820|NCT00970541|PCOS|pcos
5160821|NCT00970541|low blood sugar|low blood sugar
5160822|NCT00970541|Insulin|insulin
5160823|NCT00970541|Glucose|glucose
5160824|NCT00970528|Oral Hypoglycemic Agent|oral hypoglycemic agent
5160825|NCT00970515|Laparoscopy|laparoscopy
5160826|NCT00970515|Incisional hernia|incisional hernia
5160827|NCT00970515|Umbilical hernia|umbilical hernia
5160828|NCT00970515|Mesh repair|mesh repair
5160829|NCT00970515|Postoperative complications|postoperative complications
5160830|NCT00970502|celecoxib|celecoxib
5160831|NCT00970502|erlotinib|erlotinib
5160832|NCT00970502|epidermal growth factor receptor|epidermal growth factor receptor
5160833|NCT00970502|intensity-modulated radiotherapy|intensity-modulated radiotherapy
5160834|NCT00970502|cyclooxygenase-2|cyclooxygenase-2
5160835|NCT00970502|reirradiation|reirradiation
5160836|NCT00970489|atrial fibrillation|atrial fibrillation
5160837|NCT00970489|fish oil|fish oil
5160838|NCT00970463|The GH-system and cardiac function|the gh-system and cardiac function
5160839|NCT00970450|Paracetamol|paracetamol
5160840|NCT00970450|Tropisetron|tropisetron
5160841|NCT00970450|Central analgesic effect|central analgesic effect
5160842|NCT00970450|Area of allodynia|area of allodynia
5160843|NCT00970450|Secondary hyperalgesia|secondary hyperalgesia
5160844|NCT00970398|Infant formula|infant formula
5160845|NCT00970398|Bovine milk Osteopontin|bovine milk osteopontin
5160846|NCT00970398|growth|growth
5160847|NCT00970398|health|health
5160848|NCT00970398|immune functions|immune functions
5160849|NCT00970372|Coercion|coercion
5160850|NCT00970359|thyroid|thyroid
5160851|NCT00970359|metastases|metastases
5160852|NCT00970359|AZD6244|azd6244
5160853|NCT00970359|09-048|09-048
5160854|NCT00970346|Digestive System Diseases|digestive system diseases
5160855|NCT00970346|Genetic Diseases|genetic diseases
5160856|NCT00970346|Inborn|inborn
5160857|NCT00970346|Respiratory Tract Diseases|respiratory tract diseases
5160858|NCT00970346|Cystic Fibrosis|cystic fibrosis
5160859|NCT00970346|Lung Disease|lung disease
5160960|NCT00969774|Photography|photography
5160860|NCT00970346|Pancreatic Diseases|pancreatic diseases
5160861|NCT00970333|Alzheimer disease|alzheimer disease
5160862|NCT00970333|Parkinson disease|parkinson disease
5160863|NCT00970333|Multiple Sclerosis|multiple sclerosis
5160864|NCT00970320|Anal Incontinence|anal incontinence
5160865|NCT00970320|urinary incontinence|urinary incontinence
5160866|NCT00970320|primiparas|primiparas
5160867|NCT00970320|prevalence|prevalence
5160868|NCT00970320|pelvic floor exercise treatment|pelvic floor exercise treatment
5160869|NCT00970320|Quality of Life (QoL)|quality of life (qol)
5160870|NCT00970294|diabetes|diabetes
5160871|NCT00970268|COPD|copd
5160872|NCT00970268|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5160873|NCT00970268|Chronic Bronchitis|chronic bronchitis
5160874|NCT00970268|Emphysema|emphysema
5160875|NCT00970268|Airflow Obstruction, Chronic|airflow obstruction, chronic
5160876|NCT00970268|Chronic Airflow Obstruction|chronic airflow obstruction
5160877|NCT00970268|Chronic Obstructive Airway Disease|chronic obstructive airway disease
5160878|NCT00970268|Chronic Obstructive Lung Disease|chronic obstructive lung disease
5160879|NCT00970255|Breastfeeding difficulties|breastfeeding difficulties
5160880|NCT00970255|lingual frenulum|lingual frenulum
5160881|NCT00970255|labial frenulum|labial frenulum
5160882|NCT00970255|frenotomy|frenotomy
5160883|NCT00970216|HBV DNA non-detectability|hbv dna non-detectability
5160884|NCT00970203|Vaccine|vaccine
5160885|NCT00970203|Androgen Ablation|androgen ablation
5160886|NCT00970203|PSA Progression|psa progression
5160887|NCT00970190|sinusitis|sinusitis
5160888|NCT00970177|Pandemic influenza vaccine|pandemic influenza vaccine
5160889|NCT00970151|Fetal Inflammation|fetal inflammation
5160890|NCT00970151|Birth Outcome|birth outcome
5160891|NCT00970151|Pregnancy|pregnancy
5160892|NCT00970138|Progress free survival|progress free survival
5160893|NCT00970138|Toxicity|toxicity
5160894|NCT00970138|Response rate|response rate
5160895|NCT00970138|Overall survival|overall survival
5160896|NCT00970138|Quality of live|quality of live
5160897|NCT00970125|advance care planning|advance care planning
5160898|NCT00970125|cancer|cancer
5160899|NCT00970112|pain|pain
5160900|NCT00970112|pain assessment|pain assessment
5160901|NCT00970086|measure of postoperative pain|measure of postoperative pain
5160902|NCT00970086|children undergoing groin surgery|children undergoing groin surgery
5160903|NCT00970073|calcineurin inhibitor delay|calcineurin inhibitor delay
5160904|NCT00970073|Kidney|kidney
5160905|NCT00970060|neuropathy|neuropathy
5160906|NCT00970060|diabetes|diabetes
5160907|NCT00970047|pregnant|pregnant
5160908|NCT00970047|fetal sex determination|fetal sex determination
5160909|NCT00970047|gender determination|gender determination
5160910|NCT00970047|noninvasive test|noninvasive test
5160911|NCT00970047|fetal DNA|fetal dna
5160912|NCT00970034|Atrial fibrillation, apoptosis, oligonucleotide microarray|atrial fibrillation, apoptosis, oligonucleotide microarray
5160913|NCT00970008|Osteoarthritis|osteoarthritis
5160914|NCT00970008|Knee|knee
5160915|NCT00969995|inflammation|inflammation
5160916|NCT00969995|migraine|migraine
5160917|NCT00969995|headache|headache
5160918|NCT00969982|Pregnancy termination|pregnancy termination
5160919|NCT00969982|abortion|abortion
5160920|NCT00969982|medical abortion|medical abortion
5160921|NCT00969982|2nd trimester|2nd trimester
5160922|NCT00969982|mifepristone|mifepristone
5160923|NCT00969982|misoprostol|misoprostol
5160924|NCT00969969|First MTP Joint|first mtp joint
5160925|NCT00969969|Hallux Rigidus|hallux rigidus
5160926|NCT00969969|Hallux Limitus|hallux limitus
5160927|NCT00969969|Cartilage Replacement|cartilage replacement
5160928|NCT00969969|Osteoarthritis|osteoarthritis
5160929|NCT00969969|First MTP Joint Osteoarthritis|first mtp joint osteoarthritis
5160930|NCT00969969|Big Toe Pain|big toe pain
5160931|NCT00969956|Diabetes, Complication, Cardio-vascular disease|diabetes, complication, cardio-vascular disease
5160932|NCT00969943|HPA axis|hpa axis
5160933|NCT00969930|COMT|comt
5160934|NCT00969930|ApoE|apoe
5160935|NCT00969930|BDNF|bdnf
5160936|NCT00969930|executive function|executive function
5160937|NCT00969930|bipolar|bipolar
5160938|NCT00969930|cognition|cognition
5160939|NCT00969930|Cognitive deficits and Bipolar disease type I|cognitive deficits and bipolar disease type i
5160940|NCT00969878|Cocaine Vaccine, TA-CD 09|cocaine vaccine, ta-cd 09
5160941|NCT00969865|Atherosclerosis|atherosclerosis
5160942|NCT00969852|Sertraline|sertraline
5160943|NCT00969852|PET|pet
5160944|NCT00969852|Serotonin receptor occupancy|serotonin receptor occupancy
5160945|NCT00969852|PK-PD Model|pk-pd model
5160946|NCT00969839|Fracture|fracture
5160947|NCT00969839|Humerus|humerus
5160948|NCT00969839|Intramedullary|intramedullary
5160949|NCT00969839|Fixation|fixation
5160950|NCT00969826|GCPGC|gcpgc
5160951|NCT00969826|Pharmacokinetics|pharmacokinetics
5160952|NCT00969826|Pharmacodynamics|pharmacodynamics
5160953|NCT00969813|Hepatic impairment|hepatic impairment
5160954|NCT00969800|Common cold|common cold
5160955|NCT00969800|Influenza|influenza
5160956|NCT00969800|Pneumonia|pneumonia
5160957|NCT00969774|Face|face
5160958|NCT00969774|Cephalometry|cephalometry
5160959|NCT00969774|Anthropometry|anthropometry
5160961|NCT00969774|Diagnosis|diagnosis
5160962|NCT00969774|Adult|adult
5160963|NCT00969774|Morphology|morphology
5160964|NCT00969774|Comparative Study|comparative study
5160965|NCT00969735|Atrial fibrillation|atrial fibrillation
5160966|NCT00969735|Catheter ablation|catheter ablation
5160967|NCT00969735|Cryoenergy|cryoenergy
5160968|NCT00969735|Implantable loop recorder|implantable loop recorder
5160969|NCT00969735|Pulmonary vein|pulmonary vein
5160970|NCT00969722|Neuroblastoma|neuroblastoma
5160971|NCT00969722|3F8|3f8
5160972|NCT00969722|Primary refractory|primary refractory
5160973|NCT00969709|Depression|depression
5160974|NCT00969709|Major Depressive Disorder|major depressive disorder
5160975|NCT00969696|ability to learn, working memory|ability to learn, working memory
5160976|NCT00969657|rectal cancer stage I-III|rectal cancer stage i-iii
5160977|NCT00969657|concurrent chemoradiotherapie|concurrent chemoradiotherapie
5160978|NCT00969657|response prediction|response prediction
5160979|NCT00969631|Polycystic ovary syndrome|polycystic ovary syndrome
5160980|NCT00969631|clomiphene resistance|clomiphene resistance
5160981|NCT00969631|metformin|metformin
5160982|NCT00969631|laparoscopic ovarian diathermy|laparoscopic ovarian diathermy
5160983|NCT00969618|ADHD|adhd
5160984|NCT00969605|weaning|weaning
5160985|NCT00969605|adaptive support ventilation|adaptive support ventilation
5160986|NCT00969605|COPD|copd
5160987|NCT00969592|diabetes|diabetes
5160988|NCT00969579|Cancer|cancer
5160989|NCT00969579|Psychosocial Stress|psychosocial stress
5160990|NCT00969579|Parenting|parenting
5160991|NCT00969566|Diabetes|diabetes
5160992|NCT00969566|Sitagliptin|sitagliptin
5160993|NCT00969566|C-peptide|c-peptide
5160994|NCT00969566|Glucagon|glucagon
5160995|NCT00969540|Back Pain|back pain
5160996|NCT00969540|Sleep|sleep
5160997|NCT00969527|Oncoxin|oncoxin
5160998|NCT00969527|Viusid|viusid
5160999|NCT00969527|dietary supplements|dietary supplements
5161000|NCT00969527|rheumatoid arthritis|rheumatoid arthritis
5161001|NCT00969514|Robotic cystectomy|robotic cystectomy
5161002|NCT00969514|Bladder|bladder
5161003|NCT00969488|matern diet|matern diet
5161004|NCT00969488|obese|obese
5161005|NCT00969488|postpartum|postpartum
5161006|NCT00969488|body weight change|body weight change
5161007|NCT00969488|Women with overweight|women with overweight
5161008|NCT00969475|scar revision|scar revision
5161009|NCT00969475|intraoperative|intraoperative
5161010|NCT00969475|fractional carbon dioxide laser|fractional carbon dioxide laser
5161011|NCT00969462|Doxorubicin|doxorubicin
5161012|NCT00969462|pharmacokinetics|pharmacokinetics
5161013|NCT00969462|non-Hodgkin's lymphoma|non-hodgkin's lymphoma
5161014|NCT00969462|response|response
5161015|NCT00969462|association between response to chemotherapy|association between response to chemotherapy
5161016|NCT00969462|myelosuppression degree|myelosuppression degree
5161017|NCT00969462|doxorubicin pharmacokinetics|doxorubicin pharmacokinetics
5161018|NCT00969449|Naproxen Sodium|naproxen sodium
5161019|NCT00969436|Mumps|mumps
5161020|NCT00969436|Immunogenicity|immunogenicity
5161021|NCT00969436|Vaccines|vaccines
5161022|NCT00969436|Safety|safety
5161023|NCT00969436|Rubella|rubella
5161024|NCT00969436|Combined Vaccine|combined vaccine
5161025|NCT00969436|Varicella Vaccine|varicella vaccine
5161026|NCT00969436|Children|children
5161027|NCT00969436|Measles|measles
5161028|NCT00969436|Humans|humans
5161029|NCT00969423|persistent pain|persistent pain
5161030|NCT00969423|neuropathic pain|neuropathic pain
5161031|NCT00969423|Chronic Pain|chronic pain
5161032|NCT00969423|VATS|vats
5161033|NCT00969423|Primary spontaneous pneumothorax patients|primary spontaneous pneumothorax patients
5161034|NCT00969410|Neoplasms|neoplasms
5161035|NCT00969410|Neoplasm metastasis|neoplasm metastasis
5161036|NCT00969410|Liver neoplasms|liver neoplasms
5161037|NCT00969410|Neoplastic processes|neoplastic processes
5161038|NCT00969410|Pathologic processes|pathologic processes
5161039|NCT00969410|Digestive system neoplasms|digestive system neoplasms
5161040|NCT00969410|Neoplasms by site|neoplasms by site
5161041|NCT00969410|Digestive system diseases|digestive system diseases
5161042|NCT00969410|Liver diseases|liver diseases
5161043|NCT00969397|Birthmark|birthmark
5161044|NCT00969397|PWS|pws
5161045|NCT00969384|Physical health|physical health
5161046|NCT00969384|Mental illness|mental illness
5161047|NCT00969384|prevention|prevention
5161048|NCT00969384|Waist circumference|waist circumference
5161049|NCT00969371|posterior chamber intraocular lens|posterior chamber intraocular lens
5161050|NCT00969371|PCIOL|pciol
5161051|NCT00969371|IOL|iol
5161052|NCT00969345|Healthy Elderly Subjects|healthy elderly subjects
5161053|NCT00969345|Respiratory Yoga Exercises|respiratory yoga exercises
5161054|NCT00969345|Heart Rate Variability|heart rate variability
5161055|NCT00969345|Baroreflex|baroreflex
5161056|NCT00969345|Quality of Life|quality of life
5161057|NCT00969332|liver|liver
5161058|NCT00969332|Parenteral Nutrition|parenteral nutrition
5161059|NCT00969332|fish oil|fish oil
5161060|NCT00969332|Omegaven|omegaven
5161061|NCT00969332|children|children
5161062|NCT00969319|Octocog alfa|octocog alfa
5161063|NCT00969319|Hemophilia A|hemophilia a
5161064|NCT00969293|Macular Edema|macular edema
5161065|NCT00969293|Occlusive retinal vascular disease|occlusive retinal vascular disease
5161066|NCT00969293|Central Retinal Vein Occlusion|central retinal vein occlusion
5161067|NCT00969293|CRVO|crvo
5161068|NCT00969280|Acupuncture|acupuncture
5161069|NCT00969280|Dry eye syndrome|dry eye syndrome
5161070|NCT00969280|Ocular Surface Disease Index|ocular surface disease index
5161071|NCT00969280|Schirmer test|schirmer test
5161072|NCT00969280|Tear film Break-up time|tear film break-up time
5161073|NCT00969267|ear acupuncture|ear acupuncture
5161074|NCT00969267|obese|obese
5161075|NCT00969267|obese women|obese women
5161076|NCT00969267|women|women
5161077|NCT00969254|Pílulas de Lussen|pílulas de lussen
5161078|NCT00969254|Efficacy|efficacy
5161079|NCT00969254|Safety|safety
5161080|NCT00969254|Dysuria|dysuria
5161081|NCT00969254|Symptomatic control|symptomatic control
5161082|NCT00969241|saliva|saliva
5161083|NCT00969241|free-radicals|free-radicals
5161084|NCT00969241|periodontitis|periodontitis
5161085|NCT00969228|Gastroenteritis|gastroenteritis
5161086|NCT00969215|burn scar|burn scar
5161087|NCT00969215|fractional carbon dioxide laser|fractional carbon dioxide laser
5161088|NCT00969215|scar revision|scar revision
5161089|NCT00969202|Prostate Cancer|prostate cancer
5161090|NCT00969202|Cancer of the Prostate|cancer of the prostate
5161091|NCT00969202|Prostate Tumor|prostate tumor
5161092|NCT00969202|Novalis Tx|novalis tx
5161093|NCT00969202|Novalis|novalis
5161094|NCT00969202|Stereotactic Radiosurgery|stereotactic radiosurgery
5161095|NCT00969202|Radiosurgery|radiosurgery
5161096|NCT00969202|Radiation|radiation
5161097|NCT00969189|anesthesia|anesthesia
5161098|NCT00969189|child|child
5161099|NCT00969189|infant|infant
5161100|NCT00969189|laryngeal mask|laryngeal mask
5161101|NCT00969176|pain|pain
5161102|NCT00969176|fever|fever
5161103|NCT00969176|neonate|neonate
5161104|NCT00969176|preterm|preterm
5161105|NCT00969176|term|term
5161106|NCT00969176|newborn|newborn
5161107|NCT00969163|Biomarkers of Skin Androgenization|biomarkers of skin androgenization
5161108|NCT00969150|Major Depressive Disorder|major depressive disorder
5161109|NCT00969150|Depression|depression
5161110|NCT00969137|smoking, nicotine, cigarettes|smoking, nicotine, cigarettes
5161111|NCT00969124|colonoscopy|colonoscopy
5161112|NCT00969124|polyps|polyps
5161113|NCT00969124|adenomas|adenomas
5161114|NCT00969124|miss rates|miss rates
5161115|NCT00969111|Proton Radiation, Prostate Cancer|proton radiation, prostate cancer
5161116|NCT00969098|Histologically proven of Malignant pleural mesothelioma;|histologically proven of malignant pleural mesothelioma;
5161117|NCT00969098|Patients not candidate to radical surgery;|patients not candidate to radical surgery;
5161118|NCT00969098|Candidate to first-line pemetrexed-based chemotherapy;|candidate to first-line pemetrexed-based chemotherapy;
5161119|NCT00969085|Cutaneous T-cell lymphoma|cutaneous t-cell lymphoma
5161120|NCT00969085|Skin|skin
5161121|NCT00969085|Mycosis fungoides|mycosis fungoides
5161122|NCT00969085|MF|mf
5161123|NCT00969085|Sézary syndrome|sézary syndrome
5161124|NCT00969085|SS|ss
5161125|NCT00969085|Curcumin|curcumin
5161126|NCT00969085|Turmeric|turmeric
5161127|NCT00969072|GI198745|gi198745
5161128|NCT00969072|Long term extension study|long term extension study
5161129|NCT00969072|BPH|bph
5161130|NCT00969059|peripheral nerve injury|peripheral nerve injury
5161131|NCT00969059|p38 kinase inhibitor|p38 kinase inhibitor
5161132|NCT00969059|neuropathic pain|neuropathic pain
5161133|NCT00969046|Colon cancer|colon cancer
5161134|NCT00969046|MTD|mtd
5161135|NCT00969046|DLT|dlt
5161136|NCT00969046|EPO906|epo906
5161137|NCT00969046|patupilone|patupilone
5161138|NCT00969020|Length of stay|length of stay
5161139|NCT00969020|Timed up and go|timed up and go
5161140|NCT00968994|Wound Healing|wound healing
5161141|NCT00968994|Wound Infection|wound infection
5161142|NCT00968981|Hedgehog|hedgehog
5161143|NCT00968981|BCC|bcc
5161144|NCT00968981|basal cell carcinoma|basal cell carcinoma
5161145|NCT00968955|Postoperative acute pain|postoperative acute pain
5161146|NCT00968955|Total hip arthroplasty|total hip arthroplasty
5161147|NCT00968955|Local infiltration analgesia|local infiltration analgesia
5161148|NCT00968942|Lateral Canthal Lines|lateral canthal lines
5161149|NCT00968942|Crow's Feet|crow's feet
5161150|NCT00968942|Facial Wrinkles|facial wrinkles
5161151|NCT00968929|pulmonary embolism|pulmonary embolism
5161152|NCT00968929|thrombolysis|thrombolysis
5161153|NCT00968929|massive|massive
5161154|NCT00968929|submassive|submassive
5161155|NCT00968929|recombinant streptokinase|recombinant streptokinase
5161156|NCT00968929|urokinase|urokinase
5161157|NCT00968903|Hip arthroplasty|hip arthroplasty
5161158|NCT00968903|Methylprednisolone|methylprednisolone
5161159|NCT00968903|Post-operative pain|post-operative pain
5161160|NCT00968890|GSK Bio's influenza vaccine GSK2340272A|gsk bio's influenza vaccine gsk2340272a
5161161|NCT00968890|Influenza infection|influenza infection
5161162|NCT00968877|Renal Insufficiency|renal insufficiency
5161163|NCT00968877|Cholecalciferol|cholecalciferol
5161164|NCT00968877|Kidney Disease|kidney disease
5161165|NCT00968877|Kidney Failure|kidney failure
5161166|NCT00968877|Vitamin D|vitamin d
5161167|NCT00968877|Vitamin D Deficiency|vitamin d deficiency
5161168|NCT00968877|Vitamin D3|vitamin d3
5161169|NCT00968864|T cell depleted|t cell depleted
5161170|NCT00968864|Matched unrelated donors|matched unrelated donors
5161171|NCT00968864|Haplocompatible donors|haplocompatible donors
5161172|NCT00968851|Schizophrenia|schizophrenia
5161173|NCT00968851|Central nervous System Diseases|central nervous system diseases
5161174|NCT00968851|Cognition|cognition
5161175|NCT00968838|White Blood Cell Transfusion|white blood cell transfusion
5161176|NCT00968838|Radiated Cells|radiated cells
5161177|NCT00968838|Unradiated Cells|unradiated cells
5161178|NCT00968838|Leukocyte Transfusions|leukocyte transfusions
5161179|NCT00968838|Life-threatening Infections|life-threatening infections
5161180|NCT00968825|Lateral Canthal Lines|lateral canthal lines
5161181|NCT00968825|Crow's Feet|crow's feet
5161182|NCT00968825|Facial Wrinkles|facial wrinkles
5161183|NCT00968812|Diabetes|diabetes
5161184|NCT00968812|Metformin|metformin
5161185|NCT00968812|Glimepiride|glimepiride
5161186|NCT00968812|Hemoglobin A1c|hemoglobin a1c
5161187|NCT00968812|Type 2 diabetes mellitus|type 2 diabetes mellitus
5161188|NCT00968812|Canagliflozin|canagliflozin
5161189|NCT00968799|Ovarian Neoplasms|ovarian neoplasms
5161190|NCT00968799|Recurrence|recurrence
5161191|NCT00968799|Hyperthermia, Induced|hyperthermia, induced
5161192|NCT00968799|Peritoneal Neoplasms|peritoneal neoplasms
5161193|NCT00968799|recurrent epithelial ovarian cancer|recurrent epithelial ovarian cancer
5161194|NCT00968799|recurrent fallopian tube carcinoma|recurrent fallopian tube carcinoma
5161195|NCT00968786|hypertension|hypertension
5161196|NCT00968786|type 2 diabetes|type 2 diabetes
5161197|NCT00968786|home monitoring|home monitoring
5161198|NCT00968773|inguinal hernia|inguinal hernia
5161199|NCT00968773|mesh|mesh
5161200|NCT00968773|hernia repair device|hernia repair device
5161201|NCT00968760|CD19+ lymphoid malignancies|cd19+ lymphoid malignancies
5161202|NCT00968760|non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
5161203|NCT00968760|NHL|nhl
5161204|NCT00968760|small lymphocytic lymphoma|small lymphocytic lymphoma
5161205|NCT00968760|SLL|sll
5161206|NCT00968760|follicular lymphoma|follicular lymphoma
5161207|NCT00968760|mantle cell lymphoma|mantle cell lymphoma
5161208|NCT00968760|gene cell transfer|gene cell transfer
5161209|NCT00968760|CD19-specific T cells|cd19-specific t cells
5161210|NCT00968760|Stem Cell Transplant|stem cell transplant
5161211|NCT00968760|T Cell Infusion|t cell infusion
5161212|NCT00968760|Chemotherapy|chemotherapy
5161213|NCT00968760|Leukapheresis|leukapheresis
5161214|NCT00968760|BCNU|bcnu
5161215|NCT00968760|carmustine|carmustine
5161216|NCT00968760|Cytarabine|cytarabine
5161217|NCT00968760|Etoposide|etoposide
5161218|NCT00968760|Interleukin-2|interleukin-2
5161219|NCT00968760|Proleukin|proleukin
5161220|NCT00968760|Melphalan|melphalan
5161221|NCT00968760|Rituximab|rituximab
5161222|NCT00968760|T cell therapy|t cell therapy
5161224|NCT00968747|Fast|fast
5161225|NCT00968747|healthy|healthy
5161226|NCT00968747|diet|diet
5161227|NCT00968747|study|study
5161228|NCT00968747|manipulation|manipulation
5161229|NCT00968747|dietary|dietary
5161230|NCT00968747|FGF21|fgf21
5161231|NCT00968747|Fibroblast growth factor|fibroblast growth factor
5161232|NCT00968747|PTRF|ptrf
5161233|NCT00968747|Polymerase 1 and transcript release factor|polymerase 1 and transcript release factor
5161234|NCT00968747|adipose|adipose
5161235|NCT00968747|fat|fat
5161236|NCT00968747|blood|blood
5161237|NCT00968747|inpatient|inpatient
5161238|NCT00968747|outpatient|outpatient
5161239|NCT00968747|NAFLD|nafld
5161240|NCT00968747|metabolism|metabolism
5161241|NCT00968734|Vitamin D|vitamin d
5161242|NCT00968734|colecalciferol|colecalciferol
5161243|NCT00968734|absorption by Vitamin D|absorption by vitamin d
5161244|NCT00968721|Inflammatory bowel disease|inflammatory bowel disease
5161245|NCT00968721|Crohn's disease|crohn's disease
5161246|NCT00968721|Ulcerative colitis|ulcerative colitis
5161247|NCT00968721|medication adherence|medication adherence
5161248|NCT00968721|Decisional influences|decisional influences
5161249|NCT00968708|Diabetes Mellitus - Type 2|diabetes mellitus - type 2
5161250|NCT00968708|Diabetes Mellitus|diabetes mellitus
5161251|NCT00968708|cardiovascular outcomes|cardiovascular outcomes
5161252|NCT00968708|heart attack|heart attack
5161253|NCT00968708|stroke|stroke
5161254|NCT00968708|dipeptidyl-peptidase IV inhibitors|dipeptidyl-peptidase iv inhibitors
5161255|NCT00968708|metabolic disorders|metabolic disorders
5161256|NCT00968708|metabolic diseases|metabolic diseases
5161257|NCT00968708|glucose metabolism disorders|glucose metabolism disorders
5161258|NCT00968682|cardiac toxicity|cardiac toxicity
5161259|NCT00968682|HER2-positive breast cancer|her2-positive breast cancer
5161260|NCT00968682|stage IA breast cancer|stage ia breast cancer
5161261|NCT00968682|stage IB breast cancer|stage ib breast cancer
5161262|NCT00968682|stage II breast cancer|stage ii breast cancer
5161263|NCT00968682|stage IIIA breast cancer|stage iiia breast cancer
5161264|NCT00968682|stage IIIB breast cancer|stage iiib breast cancer
5161265|NCT00968682|stage IIIC breast cancer|stage iiic breast cancer
5161266|NCT00968656|Breast cancer|breast cancer
5161267|NCT00968656|Head and Neck Cancer|head and neck cancer
5161268|NCT00968656|Diffuse Large B-cell lymphoma|diffuse large b-cell lymphoma
5161269|NCT00968656|Cellular proliferation|cellular proliferation
5161270|NCT00968643|spinal cord compression|spinal cord compression
5161271|NCT00968643|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5161272|NCT00968617|Anemia|anemia
5161273|NCT00968604|Pancreatic Cancer|pancreatic cancer
5161274|NCT00968604|Pancreas|pancreas
5161275|NCT00968604|Liver|liver
5161276|NCT00968604|Liver Tumor Biopsy|liver tumor biopsy
5161277|NCT00968604|BikDD Nanoparticle|bikdd nanoparticle
5161278|NCT00968604|C-VISA BikDD|c-visa bikdd
5161279|NCT00968591|Hepatic insufficiency|hepatic insufficiency
5161280|NCT00968591|liver disease|liver disease
5161281|NCT00968591|cirrhosis|cirrhosis
5161282|NCT00968591|pharmacokinetics|pharmacokinetics
5161283|NCT00968578|Knee arthroplasty|knee arthroplasty
5161284|NCT00968578|Methylprednisolone|methylprednisolone
5161285|NCT00968578|Post-operative pain|post-operative pain
5161286|NCT00968565|Heart Defects, Congenital|heart defects, congenital
5161287|NCT00968565|Extracorporeal Membrane Oxygenation|extracorporeal membrane oxygenation
5161288|NCT00968565|Citric Acid|citric acid
5161289|NCT00968565|Heparin|heparin
5161290|NCT00968565|Respiratory Insufficiency|respiratory insufficiency
5161291|NCT00968552|Any Gastrointestinal problem that would require an endoscopically placed stent|any gastrointestinal problem that would require an endoscopically placed stent
5161292|NCT00968539|GSK Bio's influenza vaccine GSK2340272A|gsk bio's influenza vaccine gsk2340272a
5161293|NCT00968539|influenza infection|influenza infection
5161294|NCT00968526|influenza infection|influenza infection
5161295|NCT00968526|GSK Bio's influenza vaccine GSK2340272A|gsk bio's influenza vaccine gsk2340272a
5161296|NCT00968513|Smoking Cessation, Inpatient Psychiatry, Stages of Change|smoking cessation, inpatient psychiatry, stages of change
5161297|NCT00968500|Grief|grief
5161298|NCT00968500|bereavement|bereavement
5161299|NCT00968500|questionnaires|questionnaires
5161300|NCT00968500|09-107|09-107
5161301|NCT00968487|Lyophilized Plasma|lyophilized plasma
5161302|NCT00968487|Fresh Frozen Plasma|fresh frozen plasma
5161303|NCT00968487|Hemorrhage|hemorrhage
5161304|NCT00968487|Coagulopathy|coagulopathy
5161305|NCT00968487|Autologous|autologous
5161306|NCT00968487|HemCon|hemcon
5161307|NCT00968487|Plasmapheresis|plasmapheresis
5161308|NCT00968487|Freeze Drying|freeze drying
5161309|NCT00968487|Transfusion|transfusion
5161310|NCT00968487|Resuscitation|resuscitation
5161311|NCT00968487|Safety of Lyophilized Plasma in Normal, Healthy Volunteers|safety of lyophilized plasma in normal, healthy volunteers
5161312|NCT00968461|Chronic lymphocytic leukemia|chronic lymphocytic leukemia
5161313|NCT00968461|CLL|cll
5161314|NCT00968461|PEITC|peitc
5161315|NCT00968461|Phenethyl Isothiocyanate|phenethyl isothiocyanate
5161316|NCT00968461|Fludarabine|fludarabine
5161317|NCT00968448|respiratory muscle|respiratory muscle
5161318|NCT00968448|breathing pattern|breathing pattern
5161319|NCT00968448|exercise performance|exercise performance
5161320|NCT00968435|bevacizumab|bevacizumab
5161321|NCT00968435|cisplatin|cisplatin
5161322|NCT00968435|cetuximab|cetuximab
5161323|NCT00968435|radiation therapy|radiation therapy
5161324|NCT00968435|Phase II|phase ii
5161325|NCT00968435|09-083|09-083
5161326|NCT00968422|Pharmacology|pharmacology
5161327|NCT00968422|Drug Safety|drug safety
5161328|NCT00968422|Phase 1 Clinical Trials|phase 1 clinical trials
5161329|NCT00968422|Pharmacokinetics|pharmacokinetics
5161330|NCT00968409|Breast Cancer|breast cancer
5161331|NCT00968409|Hormone Receptor|hormone receptor
5161332|NCT00968396|Myeloma|myeloma
5161333|NCT00968396|Ex-Vivo Depletion of Myeloma Cells|ex-vivo depletion of myeloma cells
5161334|NCT00968396|Peripheral Blood Progenitor Cell Grafts|peripheral blood progenitor cell grafts
5161335|NCT00968396|PBPC|pbpc
5161336|NCT00968396|Stem Cell Transplant|stem cell transplant
5161337|NCT00968396|Bone marrow stem cells|bone marrow stem cells
5161338|NCT00968396|Melphalan|melphalan
5161339|NCT00968396|Alkeran|alkeran
5161340|NCT00968396|Apheresis|apheresis
5161341|NCT00968383|Acute Coronary Syndrome|acute coronary syndrome
5161342|NCT00968383|Myocardial infarction|myocardial infarction
5161343|NCT00968383|Infarct Related Artery|infarct related artery
5161344|NCT00968383|Percutaneous Coronary Intervention|percutaneous coronary intervention
5161345|NCT00968383|Medical treatment|medical treatment
5161346|NCT00968383|Tissue Viability|tissue viability
5161347|NCT00968383|Magnetic Resonance|magnetic resonance
5161348|NCT00968370|Severe and very severe pneumonia|severe and very severe pneumonia
5161349|NCT00968370|severe malnutrition|severe malnutrition
5161350|NCT00968370|children|children
5161351|NCT00968370|day-care management|day-care management
5161352|NCT00968370|hospital management|hospital management
5161353|NCT00968357|SCV-07|scv-07
5161354|NCT00968357|relapsers|relapsers
5161355|NCT00968357|Hepatitis C|hepatitis c
5161356|NCT00968331|relapsed and refractory DLBCL|relapsed and refractory dlbcl
5161357|NCT00968318|Tissue expander|tissue expander
5161358|NCT00968318|seroma|seroma
5161359|NCT00968318|extrusion|extrusion
5161360|NCT00968318|lymphatics|lymphatics
5161361|NCT00968318|deep fascia|deep fascia
5161362|NCT00968318|Rate of seroma formation after excision of strip of deep fascia|rate of seroma formation after excision of strip of deep fascia
5161363|NCT00968305|African American children with stable asthma|african american children with stable asthma
5161364|NCT00968305|Asthma severity|asthma severity
5161365|NCT00968305|Interleukin 13 from PHA stimulated PBMC|interleukin 13 from pha stimulated pbmc
5161366|NCT00968305|Lung function (FEV1%)|lung function (fev1%)
5161367|NCT00968305|Total serum IgE|total serum ige
5161368|NCT00968305|Pediatrics|pediatrics
5161369|NCT00968292|K3 Promoter prosthetic foot Tensegrity Prosthetics Jerome Rifkin|k3 promoter prosthetic foot tensegrity prosthetics jerome rifkin
5161370|NCT00968279|Patients with atrial fibrillation|patients with atrial fibrillation
5161371|NCT00968266|Adherence|adherence
5161372|NCT00968266|Compliance|compliance
5161373|NCT00968266|Rheumatoid Arthritis|rheumatoid arthritis
5161374|NCT00968266|Intervention|intervention
5161375|NCT00968266|Beliefs about medication|beliefs about medication
5161376|NCT00968266|Motivational Interviewing|motivational interviewing
5161377|NCT00968266|Medication adherence|medication adherence
5161378|NCT00968266|Patient compliance|patient compliance
5161379|NCT00968266|Intervention studies|intervention studies
5161380|NCT00968253|Acute Lymphocytic Leukemia|acute lymphocytic leukemia
5161381|NCT00968253|ALL|all
5161382|NCT00968253|Hyper-CVAD|hyper-cvad
5161383|NCT00968253|Everolimus|everolimus
5161384|NCT00968253|6-mercaptopurine|6-mercaptopurine
5161385|NCT00968253|Citrovorum|citrovorum
5161386|NCT00968253|Cyclophosphamide|cyclophosphamide
5161387|NCT00968253|Cytarabine|cytarabine
5161388|NCT00968253|Dexamethasone|dexamethasone
5161389|NCT00968253|Doxorubicin|doxorubicin
5161390|NCT00968253|G-CSF|g-csf
5161391|NCT00968253|Methotrexate|methotrexate
5161392|NCT00968253|MESNA|mesna
5161393|NCT00968253|Pegfilgrastim|pegfilgrastim
5161394|NCT00968253|Prednisone|prednisone
5161395|NCT00968253|RAD001|rad001
5161396|NCT00968253|Solumedrol|solumedrol
5161397|NCT00968253|Vincristine Sulfate|vincristine sulfate
5161398|NCT00968240|GBM|gbm
5161399|NCT00968240|AA|aa
5161400|NCT00968240|AO|ao
5161401|NCT00968240|Brain|brain
5161402|NCT00968240|Tumors|tumors
5161403|NCT00968240|Malignant|malignant
5161404|NCT00968240|Glioblastoma|glioblastoma
5161405|NCT00968240|Multiforme|multiforme
5161406|NCT00968240|Anaplastic|anaplastic
5161407|NCT00968240|Astrocytoma|astrocytoma
5161408|NCT00968227|subarachnoid hemorrhage|subarachnoid hemorrhage
5161409|NCT00968227|vasospasm|vasospasm
5161410|NCT00968227|transfusion|transfusion
5161411|NCT00968227|cerebral oxygen delivery|cerebral oxygen delivery
5161412|NCT00968227|hemoglobin|hemoglobin
5161413|NCT00968214|stage IA breast cancer|stage ia breast cancer
5161414|NCT00968214|stage IB breast cancer|stage ib breast cancer
5161415|NCT00968214|stage II breast cancer|stage ii breast cancer
5161416|NCT00968214|stage IIIA breast cancer|stage iiia breast cancer
5161417|NCT00968214|stage IIIB breast cancer|stage iiib breast cancer
5161418|NCT00968214|stage IIIC breast cancer|stage iiic breast cancer
5161419|NCT00968214|estrogen receptor-positive breast cancer|estrogen receptor-positive breast cancer
5161420|NCT00968214|progesterone receptor-positive breast cancer|progesterone receptor-positive breast cancer
5161421|NCT00968188|HIV Risk|hiv risk
5161422|NCT00968188|Internet Intervention|internet intervention
5161423|NCT00968188|Homosexuality, Male|homosexuality, male
5161424|NCT00968188|HIV Seronegativity|hiv seronegativity
5161425|NCT00968175|Ultrasound guided celiac plexus neurolysis|ultrasound guided celiac plexus neurolysis
5161426|NCT00968175|CPN|cpn
5161427|NCT00968175|Pancreatic Cancer|pancreatic cancer
5161428|NCT00968175|Pain Management|pain management
5161429|NCT00968162|Bone Marrow Transplant|bone marrow transplant
5161430|NCT00968162|Sickle Cell Disease|sickle cell disease
5161431|NCT00968136|refractory infantile spasms|refractory infantile spasms
5161432|NCT00968110|Milk Allergy|milk allergy
5161433|NCT00968097|Alzheimer' disease|alzheimer' disease
5161434|NCT00968097|SPECT imaging|spect imaging
5161435|NCT00968084|Diagnostic Work Up|diagnostic work up
5161436|NCT00968084|Normal Volunteers|normal volunteers
5161437|NCT00968084|HV|hv
5161438|NCT00968084|Inflammatory Disease|inflammatory disease
5161439|NCT00968084|Autoimmune Disease|autoimmune disease
5161440|NCT00968084|Immunologic Disease|immunologic disease
5161441|NCT00968084|Healthy Volunteer|healthy volunteer
5161442|NCT00968071|Leukemia|leukemia
5161443|NCT00968071|AML|aml
5161444|NCT00968071|MDS|mds
5161445|NCT00968071|High-Risk Myelodysplastic Syndrome|high-risk myelodysplastic syndrome
5161446|NCT00968071|Decitabine|decitabine
5161447|NCT00968071|5-aza-2 deoxycytidine|5-aza-2 deoxycytidine
5161448|NCT00968071|Dacogen|dacogen
5161449|NCT00968071|Gemtuzumab Ozogamicin|gemtuzumab ozogamicin
5161450|NCT00968071|Mylotarg|mylotarg
5161451|NCT00968058|Leak Pressure|leak pressure
5161452|NCT00968058|Intubation, Endotracheal|intubation, endotracheal
5161453|NCT00968058|Pediatric|pediatric
5161454|NCT00968058|Temporal Variation|temporal variation
5161455|NCT00968045|Fibrinogen|fibrinogen
5161456|NCT00968045|Postoperative bleeding|postoperative bleeding
5161457|NCT00968045|Transfusions|transfusions
5161458|NCT00968045|CABG|cabg
5161459|NCT00968032|PFO|pfo
5161460|NCT00968032|Patent Foramen Ovale|patent foramen ovale
5161461|NCT00968006|diabetes|diabetes
5161462|NCT00968006|endothelium|endothelium
5161463|NCT00968006|stem cells|stem cells
5161464|NCT00967993|hyperphosphatemia|hyperphosphatemia
5161465|NCT00967993|end-stage renal disease|end-stage renal disease
5161466|NCT00967993|ESRD|esrd
5161467|NCT00967993|hemodialysis|hemodialysis
5161468|NCT00967993|diabetes|diabetes
5161469|NCT00967993|dialysis|dialysis
5161470|NCT00967980|pain|pain
5161471|NCT00967980|Hip Resurfacing|hip resurfacing
5161472|NCT00967980|catheter|catheter
5161473|NCT00967980|nerve block|nerve block
5161474|NCT00967980|UCSD|ucsd
5161475|NCT00967980|hip surgery|hip surgery
5161476|NCT00967980|psoas|psoas
5161477|NCT00967980|femoral|femoral
5161478|NCT00967980|ambulation|ambulation
5161479|NCT00967980|hip flexion|hip flexion
5161480|NCT00967980|infusion|infusion
5161481|NCT00967967|control|control
5161482|NCT00967967|symptoms|symptoms
5161483|NCT00967954|stage IIB prostate cancer|stage iib prostate cancer
5161484|NCT00967954|stage IIA prostate cancer|stage iia prostate cancer
5161485|NCT00967954|stage III prostate cancer|stage iii prostate cancer
5161486|NCT00967954|stage IV prostate cancer|stage iv prostate cancer
5161487|NCT00967941|Vascular Surgery|vascular surgery
5161488|NCT00967928|Stage IV or Recurrent Cervical cancer|stage iv or recurrent cervical cancer
5161489|NCT00967915|Ankyloglossia|ankyloglossia
5161490|NCT00967915|Tongue tie|tongue tie
5161491|NCT00967915|Frenotomy|frenotomy
5161492|NCT00967915|Frenulectomy|frenulectomy
5161493|NCT00967915|Breast feeding|breast feeding
5161494|NCT00967915|HATLFF|hatlff
5161495|NCT00967915|IBFAT|ibfat
5161496|NCT00967902|intracoronary stent|intracoronary stent
5161497|NCT00967902|drug eluting stent|drug eluting stent
5161498|NCT00967902|sirolimus|sirolimus
5161499|NCT00967902|endothelial progenitor cells|endothelial progenitor cells
5161500|NCT00967889|stage III prostate cancer|stage iii prostate cancer
5161501|NCT00967889|stage IV prostate cancer|stage iv prostate cancer
5161502|NCT00967889|recurrent prostate cancer|recurrent prostate cancer
5161503|NCT00967876|Men or women of any ethnic group scheduled to undergo conventional coronary angiography for suspected coronary artery stent stenosis|men or women of any ethnic group scheduled to undergo conventional coronary angiography for suspected coronary artery stent stenosis
5161504|NCT00967863|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5161505|NCT00967863|stage III prostate cancer|stage iii prostate cancer
5161506|NCT00967863|stage IV prostate cancer|stage iv prostate cancer
5161507|NCT00967850|High Myopia|high myopia
5161508|NCT00967850|Bevacizumab|bevacizumab
5161509|NCT00967850|Photodynamic therapy|photodynamic therapy
5161510|NCT00967837|Diabetes with complications|diabetes with complications
5161511|NCT00967837|Wound healing|wound healing
5161512|NCT00967824|breast cancer|breast cancer
5161513|NCT00967798|cystic fibrosis|cystic fibrosis
5161514|NCT00967798|diabetes|diabetes
5161515|NCT00967798|inflammation|inflammation
5161516|NCT00967798|oxidative stress|oxidative stress
5161517|NCT00967798|redox balance|redox balance
5161518|NCT00967798|lung disease|lung disease
5161519|NCT00967785|WHIM|whim
5161520|NCT00967785|Mozobil (TM)|mozobil (tm)
5161521|NCT00967785|Neutrophil Disorder|neutrophil disorder
5161522|NCT00967785|Plerixafor|plerixafor
5161523|NCT00967772|Pharmacokinetics|pharmacokinetics
5161524|NCT00967772|Safety|safety
5161525|NCT00967772|tolerability|tolerability
5161526|NCT00967759|common cold|common cold
5161527|NCT00967759|treatment|treatment
5161528|NCT00967759|inflammatory symptoms of superior air passages affection|inflammatory symptoms of superior air passages affection
5161529|NCT00967694|Glaucoma|glaucoma
5161530|NCT00967694|Nitrous oxide|nitrous oxide
5161531|NCT00967668|Counseling|counseling
5161532|NCT00967668|Veterans|veterans
5161533|NCT00967668|Weight loss|weight loss
5161534|NCT00967668|Physical activity|physical activity
5161535|NCT00967668|Diet|diet
5161536|NCT00967655|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5161537|NCT00967655|stage I rectal cancer|stage i rectal cancer
5161538|NCT00967655|stage II rectal cancer|stage ii rectal cancer
5161539|NCT00967655|stage III rectal cancer|stage iii rectal cancer
5161540|NCT00967642|Patients with Diabetes Mellitus Submitted to Percutaneous Coronary Intervention with Stent|patients with diabetes mellitus submitted to percutaneous coronary intervention with stent
5161541|NCT00967629|Diabetic nephropathy|diabetic nephropathy
5161542|NCT00967629|CKD progression|ckd progression
5161543|NCT00967629|AGEs|ages
5161544|NCT00967629|oxidative stress|oxidative stress
5161545|NCT00967629|dietary AGEs|dietary ages
5161546|NCT00967616|metastatic|metastatic
5161547|NCT00967616|colon|colon
5161548|NCT00967616|rectum|rectum
5161549|NCT00967616|combination|combination
5161550|NCT00967616|chemotherapy|chemotherapy
5161551|NCT00967603|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
5161552|NCT00967603|stage IV pancreatic cancer|stage iv pancreatic cancer
5161553|NCT00967564|Myelodysplastic Syndrome|myelodysplastic syndrome
5161554|NCT00967564|Quality of Life|quality of life
5161555|NCT00967564|Anemia|anemia
5161556|NCT00967564|Epoetin alfa|epoetin alfa
5161557|NCT00967564|Eprex|eprex
5161558|NCT00967551|Diarrhea|diarrhea
5161559|NCT00967551|Pneumonia|pneumonia
5161560|NCT00967551|Upper respiratory infections|upper respiratory infections
5161561|NCT00967551|Acute gastroenteritis|acute gastroenteritis
5161562|NCT00967538|psoriasis|psoriasis
5161563|NCT00967538|etanercept|etanercept
5161564|NCT00967538|efficacy|efficacy
5161565|NCT00967538|response|response
5161566|NCT00967538|anti-TNF alpha|anti-tnf alpha
5161567|NCT00967538|treatment efficacy|treatment efficacy
5161568|NCT00967525|AML|aml
5161569|NCT00967525|ALL|all
5161570|NCT00967525|leukemia|leukemia
5161571|NCT00967525|CML|cml
5161572|NCT00967525|Myelodysplastic Syndrome|myelodysplastic syndrome
5161573|NCT00967525|malignancies|malignancies
5161574|NCT00967525|Undifferentiated leukemia|undifferentiated leukemia
5161575|NCT00967525|High risk malignancies|high risk malignancies
5161576|NCT00967512|Oligonucleotides, Antisense|oligonucleotides, antisense
5161577|NCT00967512|Tumor Suppressor Protein p53|tumor suppressor protein p53
5161578|NCT00967512|idarubicin|idarubicin
5161579|NCT00967512|cytarabine|cytarabine
5161580|NCT00967499|PONV|ponv
5161581|NCT00967499|rescue|rescue
5161582|NCT00967473|Astigmatism|astigmatism
5161583|NCT00967473|cataract|cataract
5161584|NCT00967473|corneal astigmatism|corneal astigmatism
5161585|NCT00967473|IOL|iol
5161586|NCT00967473|AcrySof|acrysof
5161587|NCT00967460|Childhood obesity|childhood obesity
5161588|NCT00967460|Children|children
5161589|NCT00967460|Inactivity|inactivity
5161590|NCT00967460|Physical activity|physical activity
5161591|NCT00967460|Motor skills|motor skills
5161592|NCT00967460|Motor fitness|motor fitness
5161593|NCT00967460|Quality of life|quality of life
5161594|NCT00967460|Nutrition|nutrition
5161595|NCT00967460|Family|family
5161596|NCT00967434|infarction|infarction
5161597|NCT00967434|ischemia|ischemia
5161598|NCT00967434|surgery|surgery
5161599|NCT00967434|perioperative|perioperative
5161600|NCT00967434|statins|statins
5161601|NCT00967421|Driving|driving
5161603|NCT00967421|Driving simulation|driving simulation
5161604|NCT00967421|Drugs|drugs
5161605|NCT00967421|Ethanol|ethanol
5161606|NCT00967408|Stroke|stroke
5161607|NCT00967408|Antidepressive Agents,Second-Generation|antidepressive agents,second-generation
5161608|NCT00967408|Treatment Outcome|treatment outcome
5161609|NCT00967408|Rehabilitation|rehabilitation
5161610|NCT00967382|Pregnancy|pregnancy
5161611|NCT00967382|Thrombophilia|thrombophilia
5161612|NCT00967382|High-risk pregnancy|high-risk pregnancy
5161613|NCT00967382|LMWH prophylaxis|lmwh prophylaxis
5161614|NCT00967382|Placenta mediated pregnancy complications|placenta mediated pregnancy complications
5161615|NCT00967369|Lymphoma|lymphoma
5161616|NCT00967369|Classical Hodgkin Lymphoma|classical hodgkin lymphoma
5161617|NCT00967369|Cancer|cancer
5161618|NCT00967369|Bortezomib|bortezomib
5161619|NCT00967369|Velcade|velcade
5161620|NCT00967369|Chemotherapy|chemotherapy
5161621|NCT00967369|ICE|ice
5161622|NCT00967369|Ifosfamide|ifosfamide
5161623|NCT00967369|Ifex|ifex
5161624|NCT00967369|Mesna|mesna
5161625|NCT00967369|Mesnex|mesnex
5161626|NCT00967369|Carboplatin|carboplatin
5161627|NCT00967369|Paraplatin|paraplatin
5161628|NCT00967369|Etoposide|etoposide
5161629|NCT00967369|VePesid|vepesid
5161630|NCT00967369|BICE|bice
5161631|NCT00967369|Pegfilgrastim|pegfilgrastim
5161632|NCT00967369|Neulasta|neulasta
5161633|NCT00967356|Healthy volunteers|healthy volunteers
5161634|NCT00967343|Haploidentical stem cell transplantation|haploidentical stem cell transplantation
5161635|NCT00967343|Graft-versus-host disease|graft-versus-host disease
5161636|NCT00967343|Immune reconstitution|immune reconstitution
5161637|NCT00967343|Alloreactive T-cells|alloreactive t-cells
5161638|NCT00967343|Photodepletion|photodepletion
5161639|NCT00967343|TH9402|th9402
5161640|NCT00967343|Transplant related mortality|transplant related mortality
5161641|NCT00967343|Hematologic malignancy|hematologic malignancy
5161642|NCT00967317|Auris-Sedina|auris-sedina
5161643|NCT00967317|Otitis|otitis
5161644|NCT00967317|Efficacy|efficacy
5161645|NCT00967317|Tolerability|tolerability
5161646|NCT00967304|Unprovoked Venous thromboembolism|unprovoked venous thromboembolism
5161647|NCT00967304|Clinical decision rule|clinical decision rule
5161648|NCT00967304|Anticoagulants|anticoagulants
5161649|NCT00967304|Recurrence|recurrence
5161650|NCT00967304|Prognostic|prognostic
5161651|NCT00967304|Risk stratification|risk stratification
5161652|NCT00967291|acinar cell adenocarcinoma of the pancreas|acinar cell adenocarcinoma of the pancreas
5161653|NCT00967291|duct cell adenocarcinoma of the pancreas|duct cell adenocarcinoma of the pancreas
5161654|NCT00967291|stage IV pancreatic cancer|stage iv pancreatic cancer
5161655|NCT00967291|recurrent pancreatic cancer|recurrent pancreatic cancer
5161656|NCT00967278|OPCAB|opcab
5161657|NCT00967278|pulmonary artery catheter|pulmonary artery catheter
5161658|NCT00967278|esophageal doppler|esophageal doppler
5161659|NCT00967278|hemodynamics|hemodynamics
5161660|NCT00967265|Introduction seminar|introduction seminar
5161661|NCT00967265|Psychoeducation|psychoeducation
5161662|NCT00967265|Waiting list|waiting list
5161663|NCT00967265|Patient participation|patient participation
5161664|NCT00967265|Mental disorders|mental disorders
5161665|NCT00967252|surgery|surgery
5161666|NCT00967252|inflammation|inflammation
5161667|NCT00967252|infection|infection
5161668|NCT00967252|statins|statins
5161953|NCT00965991|Metformin|metformin
5161669|NCT00967239|ductal breast carcinoma in situ|ductal breast carcinoma in situ
5161670|NCT00967239|invasive ductal breast carcinoma|invasive ductal breast carcinoma
5161671|NCT00967239|invasive lobular breast carcinoma|invasive lobular breast carcinoma
5161672|NCT00967239|invasive lobular breast carcinoma with predominant in situ component|invasive lobular breast carcinoma with predominant in situ component
5161673|NCT00967226|hemangioma|hemangioma
5161674|NCT00967200|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5161675|NCT00967200|adult diffuse astrocytoma|adult diffuse astrocytoma
5161676|NCT00967200|adult glioblastoma|adult glioblastoma
5161677|NCT00967200|adult giant cell glioblastoma|adult giant cell glioblastoma
5161678|NCT00967200|adult gliosarcoma|adult gliosarcoma
5161679|NCT00967200|adult pilocytic astrocytoma|adult pilocytic astrocytoma
5161680|NCT00967200|adult pineal gland astrocytoma|adult pineal gland astrocytoma
5161681|NCT00967200|adult subependymal giant cell astrocytoma|adult subependymal giant cell astrocytoma
5161682|NCT00967200|adult brain stem glioma|adult brain stem glioma
5161683|NCT00967200|adult choroid plexus tumor|adult choroid plexus tumor
5161684|NCT00967200|adult craniopharyngioma|adult craniopharyngioma
5161685|NCT00967200|adult ependymoblastoma|adult ependymoblastoma
5161686|NCT00967200|adult medulloblastoma|adult medulloblastoma
5161687|NCT00967200|adult supratentorial primitive neuroectodermal tumor (PNET)|adult supratentorial primitive neuroectodermal tumor (pnet)
5161688|NCT00967200|adult anaplastic ependymoma|adult anaplastic ependymoma
5161689|NCT00967200|adult ependymoma|adult ependymoma
5161690|NCT00967200|adult myxopapillary ependymoma|adult myxopapillary ependymoma
5161691|NCT00967200|adult subependymoma|adult subependymoma
5161692|NCT00967200|meningeal melanocytoma|meningeal melanocytoma
5161693|NCT00967200|adult meningeal hemangiopericytoma|adult meningeal hemangiopericytoma
5161694|NCT00967200|adult grade I meningioma|adult grade i meningioma
5161695|NCT00967200|adult grade II meningioma|adult grade ii meningioma
5161696|NCT00967200|adult anaplastic meningioma|adult anaplastic meningioma
5161697|NCT00967200|adult papillary meningioma|adult papillary meningioma
5161698|NCT00967200|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
5161699|NCT00967200|adult oligodendroglioma|adult oligodendroglioma
5161700|NCT00967200|adult pineoblastoma|adult pineoblastoma
5161701|NCT00967200|adult pineocytoma|adult pineocytoma
5161702|NCT00967200|adult mixed glioma|adult mixed glioma
5161703|NCT00967200|recurrent adult brain tumor|recurrent adult brain tumor
5161704|NCT00967161|knee replacement motion analysis|knee replacement motion analysis
5161705|NCT00967135|Thoracotomy|thoracotomy
5161706|NCT00967135|Neuropathic pain|neuropathic pain
5161707|NCT00967122|adjustment, hunger|adjustment, hunger
5161708|NCT00967122|Hunger/satiety changes before and after gastric band adjustment|hunger/satiety changes before and after gastric band adjustment
5161709|NCT00967109|Anemia|anemia
5161710|NCT00967109|Tissue oxygenation|tissue oxygenation
5161711|NCT00967109|Spine surgery|spine surgery
5161712|NCT00967096|rifaximin|rifaximin
5161713|NCT00967096|acute graft versus host disease|acute graft versus host disease
5161714|NCT00967096|bone marrow transplant|bone marrow transplant
5161715|NCT00967096|non-malignancy requiring BMT|non-malignancy requiring bmt
5161716|NCT00967083|Quality of Life|quality of life
5161717|NCT00967083|Questionnaires|questionnaires
5161718|NCT00967083|Interviews|interviews
5161719|NCT00967083|family members|family members
5161720|NCT00967083|care givers|care givers
5161721|NCT00967083|09-104|09-104
5161722|NCT00967057|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5161723|NCT00967057|T-cell childhood acute lymphoblastic leukemia|t-cell childhood acute lymphoblastic leukemia
5161724|NCT00967044|Relapsed or Refractory Lymphoma|relapsed or refractory lymphoma
5161725|NCT00967044|Hodgkin's lymphoma|hodgkin's lymphoma
5161726|NCT00967044|Non Hodgkin's Lymphoma|non hodgkin's lymphoma
5161728|NCT00967044|LBH589|lbh589
5161729|NCT00967044|Panobinostat|panobinostat
5161730|NCT00967044|RAD001|rad001
5161731|NCT00967044|Everolimus|everolimus
5161732|NCT00967031|HER2-positive breast cancer|her2-positive breast cancer
5161733|NCT00967031|male breast cancer|male breast cancer
5161734|NCT00967031|stage IV breast cancer|stage iv breast cancer
5161735|NCT00967031|tumors metastatic to brain|tumors metastatic to brain
5161736|NCT00967018|Safety parameters|safety parameters
5161737|NCT00967018|ECG, blood and urine samples|ecg, blood and urine samples
5161738|NCT00967018|general health state|general health state
5161739|NCT00967005|N acetyl cysteine|n acetyl cysteine
5161740|NCT00967005|Pathological gambling|pathological gambling
5161741|NCT00967005|Nicotine dependence|nicotine dependence
5161742|NCT00966992|Uterine Cervical Cancer|uterine cervical cancer
5161743|NCT00966992|Cancer of Cervix|cancer of cervix
5161744|NCT00966992|Cervix Cancer|cervix cancer
5161745|NCT00966979|Osteoarthritis, Post-traumatic arthritis|osteoarthritis, post-traumatic arthritis
5161746|NCT00966966|Alzheimer Disease|alzheimer disease
5161747|NCT00966940|Glaucoma|glaucoma
5161748|NCT00966940|IOP|iop
5161749|NCT00966940|Travoprost|travoprost
5161750|NCT00966927|quality of life|quality of life
5161751|NCT00966927|functional independence|functional independence
5161752|NCT00966927|spina bifid|spina bifid
5161753|NCT00966888|stage II breast cancer|stage ii breast cancer
5161754|NCT00966875|rheumatoid arthritis|rheumatoid arthritis
5161755|NCT00966875|RA|ra
5161756|NCT00966849|Randomized Controlled Trial|randomized controlled trial
5161757|NCT00966849|Financial Support|financial support
5161758|NCT00966849|Poverty|poverty
5161759|NCT00966849|Child, Orphaned|child, orphaned
5161760|NCT00966849|HIV|hiv
5161761|NCT00966836|Heart Transplantation|heart transplantation
5161762|NCT00966836|Cardiac Allograft Vasculopathy|cardiac allograft vasculopathy
5161763|NCT00966836|Cytomegalovirus Infection|cytomegalovirus infection
5161764|NCT00966836|Everolimus|everolimus
5161765|NCT00966836|Valganciclovir|valganciclovir
5161766|NCT00966836|Mycophenolate|mycophenolate
5161767|NCT00966823|Diaphragm|diaphragm
5161768|NCT00966823|Trachea|trachea
5161769|NCT00966823|Lung development|lung development
5161770|NCT00966823|Lung growth|lung growth
5161771|NCT00966823|Tracheal occlusion|tracheal occlusion
5161772|NCT00966823|ECMO|ecmo
5161773|NCT00966823|Neonatal death|neonatal death
5161774|NCT00966810|chronic myelocytic leukemia|chronic myelocytic leukemia
5161775|NCT00966810|allogeneic stem cell transplantation|allogeneic stem cell transplantation
5161776|NCT00966810|T cell depletion|t cell depletion
5161777|NCT00966810|donor lymphocyte infusion|donor lymphocyte infusion
5161778|NCT00966810|GvHD|gvhd
5161779|NCT00966810|transplant related mortality|transplant related mortality
5161780|NCT00966771|contraception|contraception
5161781|NCT00966771|emergency contraception|emergency contraception
5161782|NCT00966771|pregnancy prevention after unprotected intercourse|pregnancy prevention after unprotected intercourse
5161783|NCT00966745|surgical field condition|surgical field condition
5161784|NCT00966719|Jaundice|jaundice
5161785|NCT00966719|Breastfeeding|breastfeeding
5161786|NCT00966719|Infants|infants
5161787|NCT00966706|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
5161788|NCT00966706|stage III pancreatic cancer|stage iii pancreatic cancer
5161789|NCT00966706|stage IV pancreatic cancer|stage iv pancreatic cancer
5161790|NCT00966693|Relapsed/Refractory Multiple Myeloma|relapsed/refractory multiple myeloma
5161791|NCT00966693|RRMM|rrmm
5161792|NCT00966693|Lenalidomide|lenalidomide
5161793|NCT00966693|Revlimid|revlimid
5161794|NCT00966693|CC-5013|cc-5013
5161795|NCT00966693|Thalidomide|thalidomide
5161796|NCT00966693|Thalomid|thalomid
5161797|NCT00966693|Dexamethasone|dexamethasone
5161798|NCT00966693|Decadron|decadron
5161799|NCT00966680|general anesthesia|general anesthesia
5161800|NCT00966680|spinal anesthesia|spinal anesthesia
5161801|NCT00966680|emergency cesarean delivery|emergency cesarean delivery
5161802|NCT00966667|cancer survivor|cancer survivor
5161803|NCT00966667|stage I colon cancer|stage i colon cancer
5161804|NCT00966667|stage II colon cancer|stage ii colon cancer
5161805|NCT00966667|stage III colon cancer|stage iii colon cancer
5161806|NCT00966667|stage I rectal cancer|stage i rectal cancer
5161807|NCT00966667|stage II rectal cancer|stage ii rectal cancer
5161808|NCT00966667|stage III rectal cancer|stage iii rectal cancer
5161809|NCT00966654|CABG|cabg
5161810|NCT00966654|Cardiac Surgical Patient|cardiac surgical patient
5161811|NCT00966628|pediatric|pediatric
5161812|NCT00966628|dengue|dengue
5161813|NCT00966628|hypertonic sodium lactate|hypertonic sodium lactate
5161814|NCT00966628|fluid resuscitation|fluid resuscitation
5161815|NCT00966628|Ringer's lactate|ringer's lactate
5161816|NCT00966615|malnutrition|malnutrition
5161817|NCT00966615|fluid status|fluid status
5161818|NCT00966615|survival|survival
5161819|NCT00966589|groin pain|groin pain
5161820|NCT00966589|sportsman hernia|sportsman hernia
5161821|NCT00966589|osteitis pubis|osteitis pubis
5161822|NCT00966589|laparoscopic surgery|laparoscopic surgery
5161823|NCT00966576|Glaucoma|glaucoma
5161824|NCT00966576|IOP|iop
5161825|NCT00966576|AZARGA|azarga
5161826|NCT00966563|Mangafodipir|mangafodipir
5161827|NCT00966563|Primary Percutaneous Coronary Intervention|primary percutaneous coronary intervention
5161828|NCT00966563|Myocardial infarction|myocardial infarction
5161829|NCT00966563|Troponin|troponin
5161830|NCT00966563|CK-MB|ck-mb
5161831|NCT00966563|Magnetic Resonance Imaging|magnetic resonance imaging
5161832|NCT00966550|Tomato|tomato
5161833|NCT00966550|Nutrition|nutrition
5161834|NCT00966537|to study the clinical application of 3D/4D ultrasound for fetal scanning|to study the clinical application of 3d/4d ultrasound for fetal scanning
5161835|NCT00966537|to study the clinical application of 3D/4D ultrasound for pelvic scanning;|to study the clinical application of 3d/4d ultrasound for pelvic scanning;
5161836|NCT00966537|to demonstrate how to optimally display the different organs.|to demonstrate how to optimally display the different organs.
5161837|NCT00966537|to correlate our findings with other diagnostic tools like MRI, CT;|to correlate our findings with other diagnostic tools like mri, ct;
5161838|NCT00966537|to correlate our findings with clinical outcome.|to correlate our findings with clinical outcome.
5161839|NCT00966524|Endotracheal intubation|endotracheal intubation
5161840|NCT00966511|lung cancer|lung cancer
5161841|NCT00966511|lung resection|lung resection
5161842|NCT00966511|lobectomy|lobectomy
5161843|NCT00966511|pneumonectomy|pneumonectomy
5161844|NCT00966511|lung function|lung function
5161845|NCT00966511|perfusion|perfusion
5161846|NCT00966498|malignancy|malignancy
5161847|NCT00966498|solid tumor|solid tumor
5161848|NCT00966498|recurrent|recurrent
5161849|NCT00966498|high risk|high risk
5161850|NCT00966485|ASA resistance|asa resistance
5161851|NCT00966485|coronary stenting|coronary stenting
5161852|NCT00966485|platelet function|platelet function
5161853|NCT00966485|laboratory ASA resistance|laboratory asa resistance
5161854|NCT00966485|MACE|mace
5161855|NCT00966485|Positive SPECT|positive spect
5161856|NCT00966472|Rosuvastatin|rosuvastatin
5161857|NCT00966472|Erlotinib|erlotinib
5161858|NCT00966472|Squamous Cell Carcinoma|squamous cell carcinoma
5161859|NCT00966472|Nom-Small Cell Lung Cancer|nom-small cell lung cancer
5161860|NCT00966459|COPD|copd
5161861|NCT00966446|MRSA; household; infection; colonization|mrsa; household; infection; colonization
5161862|NCT00966433|Proseal™ LMA|proseal™ lma
5161863|NCT00966433|children|children
5161864|NCT00966433|ventilation|ventilation
5161865|NCT00966433|general anesthesia|general anesthesia
5161866|NCT00966433|Children under general anesthesia for outpatient surgery|children under general anesthesia for outpatient surgery
5161867|NCT00966407|Metabolic Syndrome|metabolic syndrome
5161868|NCT00966407|Obesity|obesity
5161869|NCT00966407|Genetic risk markers|genetic risk markers
5161870|NCT00966407|Single Nucleotide Polymorphisms|single nucleotide polymorphisms
5161871|NCT00966407|Young adults|young adults
5161872|NCT00966407|Fitness testing|fitness testing
5161873|NCT00966394|ADHD, saliva, caries|adhd, saliva, caries
5161874|NCT00966381|breastfeeding|breastfeeding
5161875|NCT00966381|bone mineral density|bone mineral density
5161876|NCT00966381|exercise|exercise
5161877|NCT00966381|diet|diet
5161878|NCT00966355|Cirrhosis, Esophagus Disorders, Varicose Veins|cirrhosis, esophagus disorders, varicose veins
5161879|NCT00966342|vaccine|vaccine
5161880|NCT00966342|influenza|influenza
5161881|NCT00966342|influenza vaccine|influenza vaccine
5161882|NCT00966342|pandemic preparedness|pandemic preparedness
5161883|NCT00966329|Switching|switching
5161884|NCT00966329|Maraviroc|maraviroc
5161885|NCT00966329|Virological efficacy|virological efficacy
5161886|NCT00966329|Lipid profile|lipid profile
5161887|NCT00966329|Tropism|tropism
5161888|NCT00966316|Acute Ischemic Stroke；clinical pathway;TCM；|acute ischemic stroke；clinical pathway;tcm；
5161889|NCT00966303|rehabilitation|rehabilitation
5161890|NCT00966303|dyspnea|dyspnea
5161891|NCT00966303|strength|strength
5161892|NCT00966290|anticoagulants|anticoagulants
5161893|NCT00966290|management|management
5161894|NCT00966290|anticoagulation clinics|anticoagulation clinics
5161895|NCT00966290|randomized comparison|randomized comparison
5161896|NCT00966277|Pancreas|pancreas
5161897|NCT00966277|Primary venous thromboembolism|primary venous thromboembolism
5161898|NCT00966277|VTE|vte
5161899|NCT00966277|Chemotherapy|chemotherapy
5161900|NCT00966277|Deep venous thrombosis|deep venous thrombosis
5161901|NCT00966277|Pulmonary embolism|pulmonary embolism
5161902|NCT00966277|Dalteparin|dalteparin
5161903|NCT00966277|Fragmin|fragmin
5161904|NCT00966277|Thromboprophylaxis|thromboprophylaxis
5161905|NCT00966264|randomized controlled trial|randomized controlled trial
5161906|NCT00966264|menorrhagia|menorrhagia
5161907|NCT00966264|LNG-IUS|lng-ius
5161908|NCT00966264|hysterectomy|hysterectomy
5161909|NCT00966251|Primary Hepatocellular Carcinoma|primary hepatocellular carcinoma
5161910|NCT00966238|influenza|influenza
5161911|NCT00966238|vaccine|vaccine
5161912|NCT00966199|blood pressure|blood pressure
5161913|NCT00966199|aging|aging
5161914|NCT00966199|cerebrovascular circulation|cerebrovascular circulation
5161915|NCT00966199|hypertension|hypertension
5161916|NCT00966186|ProSeal Laryngeal Mask Airway|proseal laryngeal mask airway
5161917|NCT00966186|Rotational technique|rotational technique
5161918|NCT00966186|Success rate|success rate
5161919|NCT00966186|Postoperative complications|postoperative complications
5161920|NCT00966160|treatment naive|treatment naive
5161921|NCT00966134|mountain medicine|mountain medicine
5161922|NCT00966134|ghrelin|ghrelin
5161923|NCT00966134|growth hormone|growth hormone
5161924|NCT00966134|hypoxia|hypoxia
5161925|NCT00966134|physiology of hormonal adaptation to high altitude|physiology of hormonal adaptation to high altitude
5161926|NCT00966121|Cirrhosis|cirrhosis
5161927|NCT00966121|Esophagus Disorders|esophagus disorders
5161928|NCT00966121|Varicose Veins|varicose veins
5161929|NCT00966095|prostate cancer|prostate cancer
5161930|NCT00966082|Cirrhosis|cirrhosis
5161931|NCT00966082|Esophagus Disorders|esophagus disorders
5161932|NCT00966082|Varicose Veins|varicose veins
5161933|NCT00966069|Respiratory tract infections|respiratory tract infections
5161934|NCT00966069|Viral infections|viral infections
5161935|NCT00966069|Pediatrics|pediatrics
5161936|NCT00966069|Specimen collection|specimen collection
5161937|NCT00966056|Nasal adhesions|nasal adhesions
5161938|NCT00966056|Nasal synechiae|nasal synechiae
5161939|NCT00966056|Mitomycin|mitomycin
5161940|NCT00966056|Mitomycin c|mitomycin c
5161941|NCT00966056|Teflon|teflon
5161942|NCT00966056|Splints|splints
5161943|NCT00966056|Septal splints|septal splints
5161944|NCT00966017|PET Scan|pet scan
5161945|NCT00966004|Urge incontinence|urge incontinence
5161946|NCT00966004|YM178|ym178
5161947|NCT00966004|Overactive Bladder|overactive bladder
5161948|NCT00966004|Urgency|urgency
5161949|NCT00966004|Urinary incontinence|urinary incontinence
5161950|NCT00966004|mirabegron|mirabegron
5161951|NCT00966004|Micturition|micturition
5161952|NCT00965991|Gestational diabetes|gestational diabetes
5161954|NCT00965991|Glyburide|glyburide
5161955|NCT00965991|oral agents|oral agents
5161956|NCT00965978|ONO-5920|ono-5920
5161957|NCT00965978|YM529|ym529
5161958|NCT00965978|Minodronic Acid|minodronic acid
5161959|NCT00965978|Food Effect|food effect
5161960|NCT00965965|health behavior|health behavior
5161961|NCT00965965|randomized controlled trials|randomized controlled trials
5161962|NCT00965965|self-efficacy|self-efficacy
5161963|NCT00965965|patient education|patient education
5161964|NCT00965965|comprehension|comprehension
5161965|NCT00965965|mass screening|mass screening
5161966|NCT00965965|prevention and control|prevention and control
5161967|NCT00965926|Overactive Bladder|overactive bladder
5161968|NCT00965926|Urinary incontinence|urinary incontinence
5161969|NCT00965926|YM178|ym178
5161970|NCT00965926|mirabegron|mirabegron
5161971|NCT00965900|Cirrhosis|cirrhosis
5161972|NCT00965900|Esophagus Disorders|esophagus disorders
5161973|NCT00965900|Varicose Veins|varicose veins
5161974|NCT00965874|Rapid Atrial Fibrillation|rapid atrial fibrillation
5161975|NCT00965874|Magnesium Sulfate|magnesium sulfate
5161976|NCT00965874|Cardiac arrhythmia|cardiac arrhythmia
5161977|NCT00965861|Tissue Registry|tissue registry
5161978|NCT00965861|Tissue Collection|tissue collection
5161979|NCT00965861|Unknown Primary|unknown primary
5161980|NCT00965861|Breast|breast
5161981|NCT00965861|Lung|lung
5161982|NCT00965861|Gastrointestinal|gastrointestinal
5161983|NCT00965861|Bone Marrow Transplant|bone marrow transplant
5161984|NCT00965861|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
5161985|NCT00965861|Central Nervous System|central nervous system
5161986|NCT00965861|Head and Neck|head and neck
5161987|NCT00965861|Melanoma|melanoma
5161988|NCT00965861|Myelodysplastic syndrome|myelodysplastic syndrome
5161989|NCT00965861|Multiple Myeloma|multiple myeloma
5161990|NCT00965861|Lymphoma|lymphoma
5161991|NCT00965861|Gynecologic|gynecologic
5161992|NCT00965861|Genitourinary|genitourinary
5161993|NCT00965861|Refractory Malignancy|refractory malignancy
5161994|NCT00965848|Pneumonia, Ventilator-Associated|pneumonia, ventilator-associated
5161995|NCT00965848|Intra-abdominal Infections|intra-abdominal infections
5161996|NCT00965848|Urinary tract Infections|urinary tract infections
5161997|NCT00965848|Doripenem|doripenem
5161998|NCT00965848|Doribax|doribax
5161999|NCT00965835|PET Scan|pet scan
5162000|NCT00965822|URTI|urti
5162001|NCT00965822|Natural Health Products|natural health products
5162002|NCT00965796|Intravenous lidocaine|intravenous lidocaine
5162003|NCT00965796|postoperative analgesia|postoperative analgesia
5162004|NCT00965783|Sleep, Apnea, OSA, obese, middle-aged|sleep, apnea, osa, obese, middle-aged
5162005|NCT00965770|abortion|abortion
5162006|NCT00965770|intrauterine device|intrauterine device
5162007|NCT00965770|cost-effectiveness|cost-effectiveness
5162008|NCT00965744|Ligasure vessel sealing system|ligasure vessel sealing system
5162009|NCT00965744|Azygoportal Disconnection|azygoportal disconnection
5162010|NCT00965744|Splenectomy|splenectomy
5162011|NCT00965744|Portal hypertension|portal hypertension
5162012|NCT00965731|Lung Neoplasms|lung neoplasms
5162013|NCT00965731|Crizotinib|crizotinib
5162014|NCT00965718|advanced pancreatic cancer|advanced pancreatic cancer
5162015|NCT00965705|Binge Eating Disorder|binge eating disorder
5162016|NCT00965705|overeating|overeating
5162017|NCT00965705|binge eating|binge eating
5162018|NCT00965705|women|women
5162019|NCT00965705|overweight|overweight
5162020|NCT00965705|compulsive overeating|compulsive overeating
5162021|NCT00965679|Cardiac CT|cardiac ct
5162022|NCT00965679|Iodinated Radiocontrast|iodinated radiocontrast
5162023|NCT00965679|Ionizing Radiation|ionizing radiation
5162024|NCT00965679|Aortic Valve Stenosis|aortic valve stenosis
5162025|NCT00965679|Percutaneous Aortic Valve Replacement|percutaneous aortic valve replacement
5162026|NCT00965679|Heart Valve|heart valve
5162027|NCT00965666|Fanconi Anemia|fanconi anemia
5162028|NCT00965666|Hemic and Lymphatic Diseases|hemic and lymphatic diseases
5162029|NCT00965666|Anti-Rheumatic Agents|anti-rheumatic agents
5162030|NCT00965666|Anemia, Hypoplastic, Congenital|anemia, hypoplastic, congenital
5162031|NCT00965666|DNA Repair-Deficiency Disorders|dna repair-deficiency disorders
5162032|NCT00965666|Congenital, Hereditary, and|congenital, hereditary, and
5162033|NCT00965666|Neonatal Diseases and Abnormalities|neonatal diseases and abnormalities
5162034|NCT00965640|male pattern baldness|male pattern baldness
5162035|NCT00965640|androgenetic alopecia|androgenetic alopecia
5162036|NCT00965640|hair loss|hair loss
5162037|NCT00965614|diagnose cardiac arrhythmia and CAD.|diagnose cardiac arrhythmia and cad.
5162038|NCT00965614|we'll try to establish the specific model to detect and diagnose cardiac arrhythmia and CAD.|we'll try to establish the specific model to detect and diagnose cardiac arrhythmia and cad.
5162039|NCT00965601|Fibromyalgia|fibromyalgia
5162040|NCT00965588|Alzheimer's disease|alzheimer's disease
5162041|NCT00965588|amyloid beta|amyloid beta
5162042|NCT00965588|vaccine|vaccine
5162043|NCT00965575|epilepsy|epilepsy
5162044|NCT00965575|sleep|sleep
5162045|NCT00965575|seizures|seizures
5162046|NCT00965575|cognition|cognition
5162047|NCT00965562|Premenstrual syndrome|premenstrual syndrome
5162048|NCT00965562|PMS|pms
5162049|NCT00965562|calcium|calcium
5162050|NCT00965536|Schizophrenia|schizophrenia
5162051|NCT00965536|Bipolar Disorder|bipolar disorder
5162052|NCT00965536|Manic Disorder|manic disorder
5162053|NCT00965536|Register study|register study
5162054|NCT00965536|Quetiapine|quetiapine
5162055|NCT00965536|Quetiapine Prolong|quetiapine prolong
5162056|NCT00965536|Seroquel|seroquel
5162057|NCT00965536|Seroquel Prolong|seroquel prolong
5162058|NCT00965536|Seroquel XR|seroquel xr
5162059|NCT00965536|In-patient|in-patient
5162060|NCT00965523|Cancer|cancer
5162061|NCT00965523|breast cancer|breast cancer
5162062|NCT00965523|neoplasm|neoplasm
5162063|NCT00965523|E7389|e7389
5162064|NCT00965523|Eribulin|eribulin
5162065|NCT00965510|diabetes|diabetes
5162066|NCT00965497|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
5162067|NCT00965497|ALS|als
5162068|NCT00965497|Multiple Sclerosis|multiple sclerosis
5162069|NCT00965497|MS|ms
5162070|NCT00965497|Major Depression|major depression
5162071|NCT00965497|Depression|depression
5162072|NCT00965497|Major Depressive Disorder|major depressive disorder
5162073|NCT00965497|antidepressants|antidepressants
5162074|NCT00965497|Escitalopram|escitalopram
5162075|NCT00965497|Lexapro|lexapro
5162076|NCT00965484|Genotropin Medical device Patient reported outcome|genotropin medical device patient reported outcome
5162077|NCT00965471|percutaneous coronary artery intervention|percutaneous coronary artery intervention
5162078|NCT00965471|coronary artery bypass graft|coronary artery bypass graft
5162079|NCT00965471|acute coronary syndrome|acute coronary syndrome
5162080|NCT00965458|New-onset Type 1 Diabetes Mellitus|new-onset type 1 diabetes mellitus
5162081|NCT00965458|New-onset T1DM|new-onset t1dm
5162082|NCT00965458|New-onset T1D|new-onset t1d
5162083|NCT00965458|Alefacept|alefacept
5162084|NCT00965458|Amevive®|amevive®
5162085|NCT00965445|isoprostanes|isoprostanes
5162086|NCT00965445|mass spectrometry|mass spectrometry
5162087|NCT00965406|acute coronary syndrome|acute coronary syndrome
5162088|NCT00965406|glucose insulin potassium|glucose insulin potassium
5162089|NCT00965393|Ischaemia reperfusion|ischaemia reperfusion
5162090|NCT00965393|Platelet activation|platelet activation
5162091|NCT00965393|Endothelial function|endothelial function
5162092|NCT00965393|Remote ischaemic preconditioning|remote ischaemic preconditioning
5162093|NCT00965393|Bradykinin|bradykinin
5162094|NCT00965380|Trinity Evolution|trinity evolution
5162095|NCT00965380|Symptomatic lumbar degenerative disc disease|symptomatic lumbar degenerative disc disease
5162096|NCT00965380|Posterior lumbar interbody fusion|posterior lumbar interbody fusion
5162097|NCT00965380|Transforaminal lumbar interbody fusion|transforaminal lumbar interbody fusion
5162098|NCT00965367|POV tonsillectomy adenoidectomy acupuncture acupressure child|pov tonsillectomy adenoidectomy acupuncture acupressure child
5162099|NCT00965367|Effectiveness of acupuncture on|effectiveness of acupuncture on
5162100|NCT00965354|severe|severe
5162101|NCT00965354|acute|acute
5162102|NCT00965354|influenza|influenza
5162103|NCT00965354|consortium|consortium
5162104|NCT00965354|swine|swine
5162105|NCT00965354|flu|flu
5162106|NCT00965354|influenza A|influenza a
5162107|NCT00965354|H1N1|h1n1
5162108|NCT00965354|hospital|hospital
5162109|NCT00965354|admission|admission
5162110|NCT00965341|Cancer|cancer
5162111|NCT00965341|Fatigue|fatigue
5162112|NCT00965341|Testosterone Replacement Therapy|testosterone replacement therapy
5162113|NCT00965341|Depo-Testosterone|depo-testosterone
5162114|NCT00965341|Testosterone cypionate|testosterone cypionate
5162115|NCT00965341|Testosterone enanthate|testosterone enanthate
5162116|NCT00965341|Hypogonadic|hypogonadic
5162117|NCT00965341|Functional Assessment of Cancer Therapy-Fatigue subscale|functional assessment of cancer therapy-fatigue subscale
5162118|NCT00965341|FACIT-F|facit-f
5162119|NCT00965328|anticoagulation|anticoagulation
5162120|NCT00965328|hemofiltration|hemofiltration
5162121|NCT00965328|acute kidney injury|acute kidney injury
5162122|NCT00965328|heparin|heparin
5162123|NCT00965328|hemostasis|hemostasis
5162124|NCT00965328|nadroparin|nadroparin
5162125|NCT00965328|anti-Xa|anti-xa
5162126|NCT00965328|endogenous thrombin potential|endogenous thrombin potential
5162127|NCT00965315|CV (cardiovascular)|cv (cardiovascular)
5162128|NCT00965315|MI (myocardial infarction)|mi (myocardial infarction)
5162129|NCT00965315|fenofibrate|fenofibrate
5162130|NCT00965315|rosuvastatin|rosuvastatin
5162131|NCT00965315|this trial is to test the hypothesis that the addition of fenofibrate on rosuvastatin would provide a further reduction in the time|this trial is to test the hypothesis that the addition of fenofibrate on rosuvastatin would provide a further reduction in the time
5162132|NCT00965302|Obesity|obesity
5162133|NCT00965302|Diabetes mellitus, Type 2|diabetes mellitus, type 2
5162134|NCT00965302|Sleeve gastrectomy|sleeve gastrectomy
5162135|NCT00965302|Metabolic surgery|metabolic surgery
5162136|NCT00965289|Aggressive large B-cell lymphoma (DLBCL)|aggressive large b-cell lymphoma (dlbcl)
5162137|NCT00965289|Intensive chemotherapy|intensive chemotherapy
5162138|NCT00965289|Rituximab|rituximab
5162139|NCT00965289|ASCT|asct
5162140|NCT00965276|Adjuvant Therapy|adjuvant therapy
5162141|NCT00965276|Paclitaxel|paclitaxel
5162142|NCT00965276|Chemoresistance|chemoresistance
5162143|NCT00965276|Serine/Threonine Kinase|serine/threonine kinase
5162144|NCT00965276|Cell Survival|cell survival
5162145|NCT00965276|Breast Cancer|breast cancer
5162146|NCT00965263|Cocaine|cocaine
5162147|NCT00965263|immunotherapy|immunotherapy
5162148|NCT00965263|vaccination|vaccination
5162149|NCT00965263|antibody|antibody
5162150|NCT00965263|addiction|addiction
5162151|NCT00965263|dependence|dependence
5162152|NCT00965250|Thymic Malignancies|thymic malignancies
5162153|NCT00965250|IMC-A12|imc-a12
5162154|NCT00965250|Insulin-Like Growth Factor|insulin-like growth factor
5162155|NCT00965224|AML (acute myeloid leukemia)|aml (acute myeloid leukemia)
5162156|NCT00965224|CML (chronic myeloid leukemia)|cml (chronic myeloid leukemia)
5162157|NCT00965224|MM (multiple myeloma)|mm (multiple myeloma)
5162158|NCT00965211|Tourette's, OCD, dTMS, YGTSS, YBOCS, supplementary motor cortex|tourette's, ocd, dtms, ygtss, ybocs, supplementary motor cortex
5162159|NCT00965211|Tourette's syndrome and Obsessive compulsive disorder|tourette's syndrome and obsessive compulsive disorder
5162160|NCT00965198|Catheters, Indwelling|catheters, indwelling
5162161|NCT00965198|Biofilms|biofilms
5162162|NCT00965185|Cardiovascular Disease|cardiovascular disease
5162163|NCT00965185|HIV|hiv
5162164|NCT00965185|Atherosclerosis|atherosclerosis
5162165|NCT00965185|Inflammation|inflammation
5162166|NCT00965185|Statins|statins
5162167|NCT00965185|treatment experienced|treatment experienced
5162168|NCT00965172|Cancer|cancer
5162169|NCT00965172|Mucositis|mucositis
5162170|NCT00965172|Chemotherapy|chemotherapy
5162171|NCT00965172|Caphosol|caphosol
5162172|NCT00965172|Calcium phosphate|calcium phosphate
5162173|NCT00965172|Sodium Bicarbonate|sodium bicarbonate
5162174|NCT00965172|Baking Soda Solution|baking soda solution
5162175|NCT00965172|Multi-cycle chemotherapy|multi-cycle chemotherapy
5162176|NCT00965146|Osteoarthritis, traumatic arthritis, avascular necrosis|osteoarthritis, traumatic arthritis, avascular necrosis
5162177|NCT00965120|Ischaemia reperfusion|ischaemia reperfusion
5162178|NCT00965120|Bradykinin|bradykinin
5162179|NCT00965120|Platelet activation|platelet activation
5162180|NCT00965120|Endothelial function|endothelial function
5162181|NCT00965068|Autism|autism
5162182|NCT00965068|Autism Spectrum Disorder|autism spectrum disorder
5162183|NCT00965068|Cholesterol|cholesterol
5162184|NCT00965068|Smith-Lemli-Opitz Syndrome|smith-lemli-opitz syndrome
5162185|NCT00965068|ASD|asd
5162186|NCT00965068|Pervasive Developmental Disorder|pervasive developmental disorder
5162187|NCT00965068|PPD-NOS|ppd-nos
5162188|NCT00965042|Ceftobiprole|ceftobiprole
5162189|NCT00965042|ZEVTERA|zevtera
5162190|NCT00965042|ZEFTERA|zeftera
5162191|NCT00965042|Intestinal Microflora|intestinal microflora
5162192|NCT00965029|COPD|copd
5162193|NCT00965029|Spirometry|spirometry
5162194|NCT00965029|Weaning|weaning
5162195|NCT00965016|Extracorporeal membrane oxygenation，induced hypothermia|extracorporeal membrane oxygenation，induced hypothermia
5162196|NCT00964990|Moderate to severe chronic peripheral neuropathic pain|moderate to severe chronic peripheral neuropathic pain
5162197|NCT00964990|Postherpetic neuralgia|postherpetic neuralgia
5162198|NCT00964990|Post-traumatic neuralgia|post-traumatic neuralgia
5162199|NCT00964990|Moderate to severe chronic pain|moderate to severe chronic pain
5162200|NCT00964990|JNJ-42160443|jnj-42160443
5162201|NCT00964977|pN1|pn1
5162202|NCT00964977|head and neck cancer|head and neck cancer
5162203|NCT00964977|radiation|radiation
5162204|NCT00964977|prognosis|prognosis
5162205|NCT00964977|comprehensive cohort design|comprehensive cohort design
5162206|NCT00964951|H1N1, influenza A viruses, vaccine, elderly|h1n1, influenza a viruses, vaccine, elderly
5162207|NCT00964938|Hemodynamic response|hemodynamic response
5162208|NCT00964938|Cardiac resynchronization therapy|cardiac resynchronization therapy
5162209|NCT00964886|chronic pain|chronic pain
5162210|NCT00964886|back pain|back pain
5162211|NCT00964886|antidepressants|antidepressants
5162213|NCT00964873|STA-9090|sta-9090
5162214|NCT00964873|ganetespib|ganetespib
5162215|NCT00964873|Hematologic Cancers|hematologic cancers
5162216|NCT00964873|Acute Myeloid Leukemia|acute myeloid leukemia
5162217|NCT00964873|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
5162218|NCT00964873|Blast-phase Chronic Myelogenous Leukemia|blast-phase chronic myelogenous leukemia
5162219|NCT00964873|AML|aml
5162220|NCT00964873|ALL|all
5162221|NCT00964873|CML|cml
5162222|NCT00964873|HSP90 Inhibitor|hsp90 inhibitor
5162223|NCT00964847|hypertension|hypertension
5162224|NCT00964847|cardiovascular disease|cardiovascular disease
5162225|NCT00964847|yoga|yoga
5162226|NCT00964821|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5162227|NCT00964821|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5162228|NCT00964821|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5162229|NCT00964821|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5162230|NCT00964821|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5162231|NCT00964821|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5162232|NCT00964821|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5162233|NCT00964821|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5162234|NCT00964821|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5162235|NCT00964821|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5162236|NCT00964821|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5162237|NCT00964821|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5162238|NCT00964821|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5162239|NCT00964821|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5162240|NCT00964821|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5162241|NCT00964821|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5162242|NCT00964821|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5162243|NCT00964821|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5162244|NCT00964821|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5162245|NCT00964821|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5162246|NCT00964821|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5162247|NCT00964821|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5162248|NCT00964821|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5162249|NCT00964821|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5162250|NCT00964821|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5162251|NCT00964821|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5162252|NCT00964821|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5162253|NCT00964821|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5162254|NCT00964821|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5162255|NCT00964821|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5162256|NCT00964821|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5162257|NCT00964821|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5162258|NCT00964821|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5162259|NCT00964821|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
5162260|NCT00964821|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5162261|NCT00964821|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5162262|NCT00964821|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5162263|NCT00964821|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5162264|NCT00964821|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5162265|NCT00964821|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5162266|NCT00964821|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5162267|NCT00964821|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5162268|NCT00964821|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5162269|NCT00964821|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5162270|NCT00964821|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5162271|NCT00964821|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
5162272|NCT00964821|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5162273|NCT00964821|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
5162274|NCT00964821|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
5162275|NCT00964821|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
5162276|NCT00964821|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
5162277|NCT00964821|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5162278|NCT00964821|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5162279|NCT00964821|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5162280|NCT00964821|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5162281|NCT00964821|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
5162282|NCT00964821|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
5162283|NCT00964821|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5162284|NCT00964821|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5162285|NCT00964821|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5162286|NCT00964821|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5162287|NCT00964821|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5162288|NCT00964821|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5162289|NCT00964821|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5162290|NCT00964821|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5162291|NCT00964821|atypical chronic myeloid leukemia, BCR-ABL negative|atypical chronic myeloid leukemia, bcr-abl negative
5162292|NCT00964821|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5162293|NCT00964821|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5162294|NCT00964821|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5162295|NCT00964821|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5162296|NCT00964821|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5162297|NCT00964821|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5162490|NCT00964054|depression|depression
5162298|NCT00964821|refractory hairy cell leukemia|refractory hairy cell leukemia
5162299|NCT00964821|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5162300|NCT00964821|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5162301|NCT00964821|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5162302|NCT00964821|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5162303|NCT00964821|chronic eosinophilic leukemia|chronic eosinophilic leukemia
5162304|NCT00964821|primary myelofibrosis|primary myelofibrosis
5162305|NCT00964821|chronic neutrophilic leukemia|chronic neutrophilic leukemia
5162306|NCT00964821|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5162307|NCT00964821|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
5162308|NCT00964821|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5162309|NCT00964821|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5162310|NCT00964821|stage I multiple myeloma|stage i multiple myeloma
5162311|NCT00964821|stage II multiple myeloma|stage ii multiple myeloma
5162312|NCT00964821|stage III multiple myeloma|stage iii multiple myeloma
5162313|NCT00964821|refractory multiple myeloma|refractory multiple myeloma
5162314|NCT00964821|aplastic anemia|aplastic anemia
5162315|NCT00964808|Hip fractures|hip fractures
5162316|NCT00964808|Treatment Outcome|treatment outcome
5162317|NCT00964808|Painkiller|painkiller
5162318|NCT00964795|Eyes|eyes
5162319|NCT00964795|Neovascular|neovascular
5162320|NCT00964795|Macular Degeneration|macular degeneration
5162321|NCT00964795|Retina|retina
5162322|NCT00964795|AMD|amd
5162323|NCT00964795|VEGF Trap-Eye|vegf trap-eye
5162324|NCT00964795|Best Corrected Visual Acuity|best corrected visual acuity
5162325|NCT00964782|Fontan|fontan
5162326|NCT00964782|sildenafil|sildenafil
5162327|NCT00964782|exercise capacity|exercise capacity
5162328|NCT00964782|Patients with Fontan Circulation|patients with fontan circulation
5162329|NCT00964769|Pneumococcal Vaccine|pneumococcal vaccine
5162330|NCT00964769|Aged|aged
5162331|NCT00964756|ovarian cancer|ovarian cancer
5162332|NCT00964756|Recurrent ovarian cancer and other gynecologic cancers|recurrent ovarian cancer and other gynecologic cancers
5162333|NCT00964743|Neurologic Oncology|neurologic oncology
5162334|NCT00964743|Neoplastic Meningitis from solid tumors|neoplastic meningitis from solid tumors
5162335|NCT00964743|Brain and Nervous System|brain and nervous system
5162336|NCT00964743|Breast Cancer|breast cancer
5162337|NCT00964730|Thorough QT Study|thorough qt study
5162338|NCT00964730|Talampanel|talampanel
5162339|NCT00964730|Cardiac Repolarizatiom|cardiac repolarizatiom
5162340|NCT00964730|Healthy Volunteers|healthy volunteers
5162341|NCT00964717|back pain|back pain
5162342|NCT00964717|neck pain|neck pain
5162343|NCT00964717|anxiety|anxiety
5162344|NCT00964717|range of motion|range of motion
5162345|NCT00964691|malaria|malaria
5162346|NCT00964691|IPTp|iptp
5162347|NCT00964691|Fansidar|fansidar
5162348|NCT00964691|Intermittent Preventive Treatment in pregnancy|intermittent preventive treatment in pregnancy
5162349|NCT00964691|pregnancy|pregnancy
5162350|NCT00964691|prophylaxis|prophylaxis
5162351|NCT00964691|Chloroquine|chloroquine
5162352|NCT00964691|Anemia|anemia
5162353|NCT00964691|Prevention|prevention
5162354|NCT00964691|Placental malaria|placental malaria
5162355|NCT00964691|Solomon Islands|solomon islands
5162356|NCT00964691|Low birth weight|low birth weight
5162357|NCT00964665|Hepatitis B,|hepatitis b,
5162358|NCT00964665|Chronic,|chronic,
5162359|NCT00964665|Hepatitis B e Antigens positive|hepatitis b e antigens positive
5162360|NCT00964652|treadmill|treadmill
5162361|NCT00964652|body load|body load
5162362|NCT00964652|Parkinson's disease|parkinson's disease
5162363|NCT00964652|gait|gait
5162364|NCT00964639|Pain|pain
5162365|NCT00964639|Postoperative|postoperative
5162366|NCT00964639|Local infiltration analgesia|local infiltration analgesia
5162367|NCT00964639|Cerebral palsy|cerebral palsy
5162368|NCT00964639|r-FLACC|r-flacc
5162369|NCT00964626|stage IA ovarian epithelial cancer|stage ia ovarian epithelial cancer
5162370|NCT00964626|stage IB ovarian epithelial cancer|stage ib ovarian epithelial cancer
5162371|NCT00964626|stage IC ovarian epithelial cancer|stage ic ovarian epithelial cancer
5162372|NCT00964626|stage IIA ovarian epithelial cancer|stage iia ovarian epithelial cancer
5162373|NCT00964626|stage IIB ovarian epithelial cancer|stage iib ovarian epithelial cancer
5162374|NCT00964626|stage IIC ovarian epithelial cancer|stage iic ovarian epithelial cancer
5162375|NCT00964626|stage IIIA ovarian epithelial cancer|stage iiia ovarian epithelial cancer
5162376|NCT00964626|stage IIIB ovarian epithelial cancer|stage iiib ovarian epithelial cancer
5162377|NCT00964626|stage IIIC ovarian epithelial cancer|stage iiic ovarian epithelial cancer
5162378|NCT00964626|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5162379|NCT00964613|Pars Plana|pars plana
5162380|NCT00964613|Surgical Capsulotomy|surgical capsulotomy
5162381|NCT00964613|Posterior capsule opacification|posterior capsule opacification
5162382|NCT00964613|visual outcome|visual outcome
5162383|NCT00964613|Complications|complications
5162384|NCT00964600|transversus abdominis block|transversus abdominis block
5162385|NCT00964600|postoperative pain|postoperative pain
5162386|NCT00964600|cesarean|cesarean
5162387|NCT00964587|diabetes self management education|diabetes self management education
5162388|NCT00964587|problem-solving training|problem-solving training
5162389|NCT00964587|health behavior change|health behavior change
5162390|NCT00964587|health literacy|health literacy
5162391|NCT00964548|vasospasm|vasospasm
5162392|NCT00964548|subarachnoid hemorrhage|subarachnoid hemorrhage
5162393|NCT00964548|neurocritical care|neurocritical care
5162394|NCT00964548|dantrolene|dantrolene
5162395|NCT00964548|vasorelaxation|vasorelaxation
5162396|NCT00964522|Quality of life|quality of life
5162397|NCT00964522|Breast Cancer|breast cancer
5162398|NCT00964522|Nursing Care|nursing care
5162399|NCT00964522|Education|education
5162400|NCT00964522|Chemotherapy|chemotherapy
5162401|NCT00964496|vascular malformation|vascular malformation
5162402|NCT00964496|gastrointestinal bleeding|gastrointestinal bleeding
5162403|NCT00964496|thalidomide|thalidomide
5162404|NCT00964483|Hypertension|hypertension
5162405|NCT00964470|Burn, donor site, skin graft, dressing, AWBAT™-D, XEROFORM™, GLUCAN II™|burn, donor site, skin graft, dressing, awbat™-d, xeroform™, glucan ii™
5162406|NCT00964457|cetuximab|cetuximab
5162407|NCT00964457|rectum cancer|rectum cancer
5162408|NCT00964457|radiation|radiation
5162409|NCT00964457|MRI|mri
5162410|NCT00964444|Labor and delivery|labor and delivery
5162411|NCT00964444|Vaginal delivery|vaginal delivery
5162412|NCT00964379|Intra versus extraperitoneal colostomy|intra versus extraperitoneal colostomy
5162413|NCT00964353|coumadine|coumadine
5162414|NCT00964353|genotype|genotype
5162415|NCT00964353|genes|genes
5162416|NCT00964353|Warfarin|warfarin
5162417|NCT00964327|TMC114-C201|tmc114-c201
5162418|NCT00964327|TMC114|tmc114
5162419|NCT00964327|HIV|hiv
5162420|NCT00964327|darunavir|darunavir
5162421|NCT00964314|advanced cancer|advanced cancer
5162422|NCT00964314|TCM five elements music therapy|tcm five elements music therapy
5162423|NCT00964314|quality of life (QOL)|quality of life (qol)
5162424|NCT00964301|Asthma|asthma
5162425|NCT00964301|Low-income|low-income
5162426|NCT00964301|Quality of life|quality of life
5162427|NCT00964301|Children|children
5162428|NCT00964288|electrical hyperalgesia|electrical hyperalgesia
5162429|NCT00964288|threshold tracking|threshold tracking
5162430|NCT00964288|pain|pain
5162431|NCT00964275|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5162432|NCT00964275|thromboembolism|thromboembolism
5162433|NCT00964262|diabetes|diabetes
5162434|NCT00964262|exenatide|exenatide
5162435|NCT00964262|SR exenatide|sr exenatide
5162436|NCT00964262|Peptron|peptron
5162437|NCT00964236|sapropterin|sapropterin
5162438|NCT00964236|Kuvan|kuvan
5162439|NCT00964236|cognition|cognition
5162440|NCT00964236|brain|brain
5162441|NCT00964223|Acne vulgaris|acne vulgaris
5162442|NCT00964210|Juvenile Idiopathic Arthritis|juvenile idiopathic arthritis
5162443|NCT00964210|Inflammatory Bowel Disease|inflammatory bowel disease
5162444|NCT00964210|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
5162445|NCT00964210|Chronic Renal Disease|chronic renal disease
5162446|NCT00964210|Solid Organ Transplant|solid organ transplant
5162447|NCT00964197|FemmeJock|femmejock
5162448|NCT00964197|Pelvic Organ Prolapse|pelvic organ prolapse
5162449|NCT00964184|Maturity onset diabetes of the young 3 protein, human|maturity onset diabetes of the young 3 protein, human
5162450|NCT00964171|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
5162451|NCT00964171|recurrent pancreatic cancer|recurrent pancreatic cancer
5162452|NCT00964171|stage IV pancreatic cancer|stage iv pancreatic cancer
5162453|NCT00964158|influenza infection|influenza infection
5162454|NCT00964158|GSK Bio's influenza vaccine GSK2340272A|gsk bio's influenza vaccine gsk2340272a
5162455|NCT00964145|Nulliparous women|nulliparous women
5162456|NCT00964145|ultrasound|ultrasound
5162457|NCT00964132|Non-Small Cell Lung Cancer|non-small cell lung cancer
5162458|NCT00964132|NSCLC|nsclc
5162459|NCT00964132|Rexinoid|rexinoid
5162460|NCT00964132|NRX194204|nrx194204
5162461|NCT00964132|Lung Cancer|lung cancer
5162462|NCT00964132|RXR|rxr
5162463|NCT00964106|inducer|inducer
5162464|NCT00964106|midazolam|midazolam
5162465|NCT00964106|inhibitor|inhibitor
5162466|NCT00964106|rosiglitazone|rosiglitazone
5162467|NCT00964106|dextromethorphan|dextromethorphan
5162468|NCT00964106|caffeine|caffeine
5162469|NCT00964106|cocktail|cocktail
5162470|NCT00964106|pioglitazone|pioglitazone
5162471|NCT00964106|omeprazole|omeprazole
5162472|NCT00964106|CYP|cyp
5162473|NCT00964106|rosuvastatin|rosuvastatin
5162474|NCT00964106|probe drug|probe drug
5162475|NCT00964106|drug interaction|drug interaction
5162476|NCT00964106|flurbiprofen|flurbiprofen
5162477|NCT00964093|premature|premature
5162478|NCT00964093|infection|infection
5162479|NCT00964093|central line|central line
5162480|NCT00964093|very low birth weight|very low birth weight
5162481|NCT00964093|silver alginate|silver alginate
5162482|NCT00964093|Algidex|algidex
5162483|NCT00964093|neonatal|neonatal
5162484|NCT00964093|NICU|nicu
5162485|NCT00964067|rehabilitation outcome|rehabilitation outcome
5162486|NCT00964067|cardiac patients|cardiac patients
5162487|NCT00964067|exercise intensity|exercise intensity
5162488|NCT00964054|adolescents|adolescents
5162489|NCT00964054|exercise|exercise
5162491|NCT00964054|dose response|dose response
5162492|NCT00964054|pilot study|pilot study
5162493|NCT00964041|Cognitive Impairment|cognitive impairment
5162494|NCT00964041|Neuroplasticity|neuroplasticity
5162495|NCT00964041|D-cycloserine|d-cycloserine
5162496|NCT00964041|N-methyl-D-aspartate (NMDA)|n-methyl-d-aspartate (nmda)
5162497|NCT00964041|Anti-Bacterial Agents|anti-bacterial agents
5162498|NCT00964041|Mental Disorders|mental disorders
5162499|NCT00964041|Psychotic Disorders|psychotic disorders
5162500|NCT00964041|Antitubercular Agents|antitubercular agents
5162501|NCT00964041|Schizophrenia and Disorders with Psychotic Features|schizophrenia and disorders with psychotic features
5162502|NCT00964041|Schizoaffective Disorder|schizoaffective disorder
5162503|NCT00964028|Combined vaccine|combined vaccine
5162504|NCT00964015|colloid fluid|colloid fluid
5162505|NCT00964015|crystalloid fluid|crystalloid fluid
5162506|NCT00964015|surgery|surgery
5162507|NCT00964015|coronary artery bypass grafting|coronary artery bypass grafting
5162508|NCT00964015|renal function|renal function
5162509|NCT00964015|Patients undergoing coronary artery bypass surgery|patients undergoing coronary artery bypass surgery
5162510|NCT00964002|recurrent prostate cancer|recurrent prostate cancer
5162511|NCT00964002|stage IV prostate cancer|stage iv prostate cancer
5162512|NCT00963989|Acute stroke|acute stroke
5162513|NCT00963989|Large cerebral vessel occlusion|large cerebral vessel occlusion
5162514|NCT00963989|Core infarct volume|core infarct volume
5162515|NCT00963989|Penumbra System|penumbra system
5162516|NCT00963989|Revascularization|revascularization
5162517|NCT00963989|Intracerebral hemorrhage|intracerebral hemorrhage
5162518|NCT00963989|mRS|mrs
5162519|NCT00963989|NIHSS|nihss
5162520|NCT00963989|Procedural serious adverse events|procedural serious adverse events
5162521|NCT00963989|All cause mortality|all cause mortality
5162522|NCT00963976|Stroke|stroke
5162523|NCT00963976|Hypertension|hypertension
5162524|NCT00963976|Cerebral Blood Flow|cerebral blood flow
5162525|NCT00963976|CT Perfusion|ct perfusion
5162526|NCT00963963|sexual health|sexual health
5162527|NCT00963963|adolescent health|adolescent health
5162528|NCT00963963|parent education|parent education
5162529|NCT00963963|HIV Seronegativity|hiv seronegativity
5162530|NCT00963963|treatment experienced|treatment experienced
5162531|NCT00963950|cholecystectomy|cholecystectomy
5162532|NCT00963937|adolescent|adolescent
5162533|NCT00963937|sumatriptan|sumatriptan
5162534|NCT00963937|children|children
5162535|NCT00963937|migraine|migraine
5162536|NCT00963924|Cognitive Impairment|cognitive impairment
5162537|NCT00963924|Neuroplasticity|neuroplasticity
5162538|NCT00963924|D-cycloserine|d-cycloserine
5162539|NCT00963924|NMDA|nmda
5162540|NCT00963924|Anti-Bacterial Agents|anti-bacterial agents
5162541|NCT00963924|Mental Disorders|mental disorders
5162542|NCT00963924|Psychotic Disorders|psychotic disorders
5162543|NCT00963924|Antitubercular Agents|antitubercular agents
5162544|NCT00963924|Schizophrenia and Disorders with Psychotic Features|schizophrenia and disorders with psychotic features
5162545|NCT00963924|Schizoaffective Disorder|schizoaffective disorder
5162546|NCT00963911|colon cancer|colon cancer
5162547|NCT00963911|rectal cancer|rectal cancer
5162548|NCT00963911|non-small cell lung cancer|non-small cell lung cancer
5162549|NCT00963911|small cell lung cancer|small cell lung cancer
5162550|NCT00963911|hypopharyngeal squamous cell carcinoma|hypopharyngeal squamous cell carcinoma
5162551|NCT00963911|laryngeal squamous cell carcinoma|laryngeal squamous cell carcinoma
5162552|NCT00963911|laryngeal verrucous carcinoma|laryngeal verrucous carcinoma
5162553|NCT00963911|lip and oral cavity squamous cell carcinoma|lip and oral cavity squamous cell carcinoma
5162554|NCT00963911|oral cavity verrucous carcinoma|oral cavity verrucous carcinoma
5162555|NCT00963911|nasopharyngeal squamous cell carcinoma|nasopharyngeal squamous cell carcinoma
5162556|NCT00963911|oropharyngeal squamous cell carcinoma|oropharyngeal squamous cell carcinoma
5162557|NCT00963911|paranasal sinus and nasal cavity squamous cell carcinoma|paranasal sinus and nasal cavity squamous cell carcinoma
5162558|NCT00963911|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
5162559|NCT00963911|prostate cancer|prostate cancer
5162560|NCT00963911|breast cancer|breast cancer
5162561|NCT00963911|adult non-Hodgkin lymphoma|adult non-hodgkin lymphoma
5162562|NCT00963898|Intravenous sedation|intravenous sedation
5162563|NCT00963898|Target controlled infusion|target controlled infusion
5162564|NCT00963898|Bispectral index|bispectral index
5162565|NCT00963898|Dental treatment|dental treatment
5162566|NCT00963898|Mental Retardation|mental retardation
5162567|NCT00963898|Deep sedation|deep sedation
5162568|NCT00963859|Robotic-assisted laparoscopic surgery|robotic-assisted laparoscopic surgery
5162569|NCT00963859|Extended pelvic lymph node dissection|extended pelvic lymph node dissection
5162570|NCT00963859|RA-PLND|ra-plnd
5162571|NCT00963859|Second-look open lymph node dissection|second-look open lymph node dissection
5162572|NCT00963859|O-PLND|o-plnd
5162573|NCT00963859|Radical Cystectomy|radical cystectomy
5162574|NCT00963859|Urinary diversion|urinary diversion
5162575|NCT00963859|Bladder|bladder
5162576|NCT00963846|schizophrenia|schizophrenia
5162577|NCT00963846|cognition|cognition
5162578|NCT00963846|functioning|functioning
5162579|NCT00963833|Multiple Sclerosis|multiple sclerosis
5162580|NCT00963833|MS|ms
5162581|NCT00963833|Non-interventional|non-interventional
5162582|NCT00963820|Relapsed multiple myeloma|relapsed multiple myeloma
5162583|NCT00963820|Refractory multiple myeloma|refractory multiple myeloma
5162584|NCT00963820|Drug therapy|drug therapy
5162585|NCT00963794|Rectal cancer|rectal cancer
5162586|NCT00963794|Population screening|population screening
5162587|NCT00963794|Early detection|early detection
5162588|NCT00963781|Coronary Artery Disease|coronary artery disease
5162589|NCT00963781|Drug-Eluting Stents|drug-eluting stents
5162590|NCT00963781|Coronary Thrombosis|coronary thrombosis
5162591|NCT00963781|Platelet Aggregation Inhibitors|platelet aggregation inhibitors
5162592|NCT00963781|Coronary Restenosis|coronary restenosis
5162593|NCT00963768|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
5162594|NCT00963768|JNJ-28431754|jnj-28431754
5162595|NCT00963768|Canagliflozin|canagliflozin
5162596|NCT00963768|Sodium Glucose Co-transporter (SGLT2 inhibitor)|sodium glucose co-transporter (sglt2 inhibitor)
5162597|NCT00963768|Pharmacokinetics|pharmacokinetics
5162598|NCT00963768|Pharmacodynamics|pharmacodynamics
5162599|NCT00963755|Imaging|imaging
5162600|NCT00963755|Positron emission tomography|positron emission tomography
5162601|NCT00963755|F-18-FCH|f-18-fch
5162602|NCT00963755|Magnetic resonance imaging|magnetic resonance imaging
5162603|NCT00963755|Magnetic resonance spectroscopy|magnetic resonance spectroscopy
5162604|NCT00963742|cataract surgery|cataract surgery
5162605|NCT00963742|IOL|iol
5162606|NCT00963742|Intraocular lens|intraocular lens
5162607|NCT00963729|estrogen receptor-positive breast cancer|estrogen receptor-positive breast cancer
5162608|NCT00963729|recurrent breast cancer|recurrent breast cancer
5162609|NCT00963729|stage II breast cancer|stage ii breast cancer
5162610|NCT00963729|stage IIIA breast cancer|stage iiia breast cancer
5162611|NCT00963729|stage IIIB breast cancer|stage iiib breast cancer
5162612|NCT00963729|stage IIIC breast cancer|stage iiic breast cancer
5162613|NCT00963716|endobronchial biopsy|endobronchial biopsy
5162614|NCT00963716|bronchoscopy|bronchoscopy
5162615|NCT00963716|interventional pulmonology|interventional pulmonology
5162616|NCT00963677|Shikani optical stylet(SOS)|shikani optical stylet(sos)
5162617|NCT00963677|difficult airways|difficult airways
5162618|NCT00963677|intubation|intubation
5162619|NCT00963664|melanoma|melanoma
5162620|NCT00963664|malignant melanoma|malignant melanoma
5162621|NCT00963664|interferon|interferon
5162622|NCT00963664|interferon alfa-2b|interferon alfa-2b
5162623|NCT00963664|Intron-A|intron-a
5162624|NCT00963664|Intron A|intron a
5162625|NCT00963664|Intron|intron
5162626|NCT00963664|lovastatin|lovastatin
5162627|NCT00963664|mevinolin|mevinolin
5162628|NCT00963664|Mevacor|mevacor
5162629|NCT00963664|statin|statin
5162630|NCT00963664|HRI|hri
5162631|NCT00963651|Pulmonary nodule, solitary|pulmonary nodule, solitary
5162632|NCT00963651|Multiple pulmonary nodules|multiple pulmonary nodules
5162633|NCT00963625|Blastocyst transfer|blastocyst transfer
5162634|NCT00963625|endometrial receptivity|endometrial receptivity
5162635|NCT00963625|IVF|ivf
5162636|NCT00963625|in vitro fertilization|in vitro fertilization
5162637|NCT00963625|embryo cryopreservation|embryo cryopreservation
5162638|NCT00963612|Microvascular Invasion|microvascular invasion
5162639|NCT00963612|Blood-Oxygen-Level Dependent Magnetic Resonance Imaging (BOLD MRI)|blood-oxygen-level dependent magnetic resonance imaging (bold mri)
5162640|NCT00963560|ReSTOR +3|restor +3
5162641|NCT00963547|Documented to be HER2+|documented to be her2+
5162642|NCT00963534|Mantle cell lymphoma|mantle cell lymphoma
5162643|NCT00963534|Lenalidomide|lenalidomide
5162644|NCT00963534|Bendamustine|bendamustine
5162645|NCT00963534|Rituximab|rituximab
5162646|NCT00963534|Nordic Lymphoma Group|nordic lymphoma group
5162647|NCT00963534|MTD for lenalidomide|mtd for lenalidomide
5162648|NCT00963534|Untreated patients|untreated patients
5162649|NCT00963534|Patients with mantle cell lymphoma, age over 65 years|patients with mantle cell lymphoma, age over 65 years
5162650|NCT00963521|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
5162651|NCT00963521|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
5162652|NCT00963521|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
5162653|NCT00963521|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5162654|NCT00963521|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5162655|NCT00963521|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5162656|NCT00963521|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5162657|NCT00963508|Head Lice|head lice
5162658|NCT00963495|clioquinol|clioquinol
5162659|NCT00963495|relapsed and refractory hematologic malignancy|relapsed and refractory hematologic malignancy
5162660|NCT00963495|ALL|all
5162661|NCT00963495|HD|hd
5162662|NCT00963495|CLL|cll
5162663|NCT00963495|High risk myelodysplasia (MDS) with an IPSS score >2.5|high risk myelodysplasia (mds) with an ipss score >2.5
5162664|NCT00963495|CML blast crisis|cml blast crisis
5162665|NCT00963495|Relapsed or refractory acute myeloid leukemia (AML)|relapsed or refractory acute myeloid leukemia (aml)
5162666|NCT00963482|Smoking|smoking
5162667|NCT00963482|Alcohol|alcohol
5162668|NCT00963482|Outcome|outcome
5162669|NCT00963482|Harm reduction|harm reduction
5162670|NCT00963482|Alcohol drinking|alcohol drinking
5162671|NCT00963482|Treatment outcome|treatment outcome
5162672|NCT00963482|Treatment effectiveness|treatment effectiveness
5162673|NCT00963443|Aspirin Complex|aspirin complex
5162674|NCT00963443|Acetylsalicylic Acid|acetylsalicylic acid
5162675|NCT00963443|Pseudoephedrine|pseudoephedrine
5162676|NCT00963443|Common Cold|common cold
5162677|NCT00963430|H1N1, influenza A viruses, pregnant women|h1n1, influenza a viruses, pregnant women
5162678|NCT00963417|osteoporosis|osteoporosis
5162679|NCT00963417|estrogen receptor-positive breast cancer|estrogen receptor-positive breast cancer
5162680|NCT00963417|progesterone receptor-positive breast cancer|progesterone receptor-positive breast cancer
5162681|NCT00963417|stage IA breast cancer|stage ia breast cancer
5162682|NCT00963417|stage IB breast cancer|stage ib breast cancer
5162683|NCT00963417|stage II breast cancer|stage ii breast cancer
5162684|NCT00963417|stage IIIA breast cancer|stage iiia breast cancer
5162685|NCT00963404|Image-guided Radiotherapy|image-guided radiotherapy
5162686|NCT00963404|Fiducial marker|fiducial marker
5162687|NCT00963404|Adverse effects|adverse effects
5162688|NCT00963391|Health Production|health production
5162689|NCT00963391|Government Policy; Regulation; Public Health|government policy; regulation; public health
5162690|NCT00963391|Government Policy; Provision and Effects of Welfare Programs|government policy; provision and effects of welfare programs
5162691|NCT00963391|Gastrointestinal diseases|gastrointestinal diseases
5162692|NCT00963391|Respiratory Tract Infections|respiratory tract infections
5162693|NCT00963391|Diarrhea|diarrhea
5162694|NCT00963391|Ethanol|ethanol
5162695|NCT00963391|Child, Preschool|child, preschool
5162696|NCT00963391|Handwashing|handwashing
5162697|NCT00963365|Phase 1|phase 1
5162698|NCT00963365|Healthy volunteers|healthy volunteers
5162699|NCT00963352|Colon cancer|colon cancer
5162700|NCT00963352|Open surgery resection|open surgery resection
5162701|NCT00963352|Laparoscopic surgery resection|laparoscopic surgery resection
5162702|NCT00963352|Morbidity|morbidity
5162703|NCT00963352|Mortality|mortality
5162704|NCT00963352|Metastases|metastases
5162705|NCT00963352|Oncology|oncology
5162706|NCT00963352|Freedom of malignant disease recurrence|freedom of malignant disease recurrence
5162707|NCT00963352|Safety of intervention open and laparoscopic|safety of intervention open and laparoscopic
5162708|NCT00963352|Examination of adverse markers|examination of adverse markers
5162709|NCT00963352|Development of metastases in lungs and other organs|development of metastases in lungs and other organs
5162710|NCT00963339|AMD|amd
5162711|NCT00963326|stage I squamous cell carcinoma of the hypopharynx|stage i squamous cell carcinoma of the hypopharynx
5162712|NCT00963326|stage I squamous cell carcinoma of the larynx|stage i squamous cell carcinoma of the larynx
5162713|NCT00963326|stage I squamous cell carcinoma of the nasopharynx|stage i squamous cell carcinoma of the nasopharynx
5162714|NCT00963326|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
5162715|NCT00963326|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
5162716|NCT00963326|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
5162717|NCT00963326|stage II squamous cell carcinoma of the nasopharynx|stage ii squamous cell carcinoma of the nasopharynx
5162718|NCT00963326|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
5162719|NCT00963326|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
5162720|NCT00963326|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
5162721|NCT00963326|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
5162722|NCT00963326|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
5162723|NCT00963326|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5162724|NCT00963326|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5162725|NCT00963326|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
5162726|NCT00963326|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5162727|NCT00963326|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
5162728|NCT00963326|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
5162729|NCT00963326|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
5162730|NCT00963326|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
5162731|NCT00963326|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
5162732|NCT00963326|stage I verrucous carcinoma of the oral cavity|stage i verrucous carcinoma of the oral cavity
5162733|NCT00963326|stage II verrucous carcinoma of the oral cavity|stage ii verrucous carcinoma of the oral cavity
5162734|NCT00963326|stage III verrucous carcinoma of the oral cavity|stage iii verrucous carcinoma of the oral cavity
5162735|NCT00963326|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
5162736|NCT00963326|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
5162737|NCT00963326|stage I verrucous carcinoma of the larynx|stage i verrucous carcinoma of the larynx
5162738|NCT00963326|stage II verrucous carcinoma of the larynx|stage ii verrucous carcinoma of the larynx
5162739|NCT00963326|stage III verrucous carcinoma of the larynx|stage iii verrucous carcinoma of the larynx
5162740|NCT00963326|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
5162741|NCT00963326|tongue cancer|tongue cancer
5162742|NCT00963313|Axial psoriatic arthritis|axial psoriatic arthritis
5162743|NCT00963313|Adalimumab|adalimumab
5162744|NCT00963313|Humira|humira
5162745|NCT00963313|anti-TNF|anti-tnf
5162746|NCT00963300|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5162747|NCT00963300|stage I prostate cancer|stage i prostate cancer
5162748|NCT00963300|stage IIB prostate cancer|stage iib prostate cancer
5162749|NCT00963300|stage IIA prostate cancer|stage iia prostate cancer
5162750|NCT00963300|stage III prostate cancer|stage iii prostate cancer
5162751|NCT00963300|stage IV prostate cancer|stage iv prostate cancer
5162752|NCT00963287|alternative medicine|alternative medicine
5162753|NCT00963287|traditional Chinese medicine|traditional chinese medicine
5162754|NCT00963274|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5162755|NCT00963274|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
5162756|NCT00963274|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
5162757|NCT00963274|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5162758|NCT00963274|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5162759|NCT00963274|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5162760|NCT00963274|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
5162761|NCT00963274|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
5162762|NCT00963274|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
5162763|NCT00963274|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5162764|NCT00963274|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5162765|NCT00963274|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
5162766|NCT00963274|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5162767|NCT00963274|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
5162768|NCT00963274|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5162769|NCT00963274|hepatosplenic T-cell lymphoma|hepatosplenic t-cell lymphoma
5162770|NCT00963274|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5162771|NCT00963274|peripheral T-cell lymphoma|peripheral t-cell lymphoma
5162772|NCT00963261|melanoma|melanoma
5162773|NCT00963261|interferon-a|interferon-a
5162774|NCT00963261|quality of life|quality of life
5162775|NCT00963261|psychological distress|psychological distress
5162776|NCT00963261|depressive symptoms|depressive symptoms
5162777|NCT00963261|side effects|side effects
5162778|NCT00963248|EBV|ebv
5162779|NCT00963248|PTLD|ptld
5162780|NCT00963248|RTx|rtx
5162781|NCT00963248|pediatric|pediatric
5162782|NCT00963235|vaccine|vaccine
5162783|NCT00963235|13-valent pneumococcal conjugate vaccine|13-valent pneumococcal conjugate vaccine
5162784|NCT00963235|human immunodeficiency virus|human immunodeficiency virus
5162785|NCT00963222|Atherosclerosis|atherosclerosis
5162786|NCT00963222|Coronary Artery Disease|coronary artery disease
5162787|NCT00963222|Vitamin A|vitamin a
5162788|NCT00963222|CD4-Positive T-Lymphocytes|cd4-positive t-lymphocytes
5162789|NCT00963222|Th1 Cells|th1 cells
5162790|NCT00963222|Th2 Cells|th2 cells
5162791|NCT00963209|endocrine sensitive|endocrine sensitive
5162792|NCT00963209|breast cancer|breast cancer
5162793|NCT00963209|tamoxifen|tamoxifen
5162794|NCT00963209|genotyping|genotyping
5162795|NCT00963209|phenotyping|phenotyping
5162796|NCT00963209|Pharmacokinetics|pharmacokinetics
5162797|NCT00963209|Endoxifen|endoxifen
5162798|NCT00963183|Safety|safety
5162799|NCT00963183|Tolerability|tolerability
5162800|NCT00963183|Healthy|healthy
5162801|NCT00963183|Inhalation|inhalation
5162802|NCT00963157|H1N1, influenza A viruses, vaccine, elderly|h1n1, influenza a viruses, vaccine, elderly
5162803|NCT00963144|Gerd Questionnaire|gerd questionnaire
5162804|NCT00963131|Central serous chorioretinopathy,antioxidants|central serous chorioretinopathy,antioxidants
5162805|NCT00963118|Angelica keiskei|angelica keiskei
5162806|NCT00963118|Glycine max|glycine max
5162807|NCT00963118|metabolic syndrome|metabolic syndrome
5162808|NCT00963092|adenocarcinoma of the gastroesophageal junction|adenocarcinoma of the gastroesophageal junction
5162809|NCT00963092|recurrent gastric cancer|recurrent gastric cancer
5162810|NCT00963092|stage IV gastric cancer|stage iv gastric cancer
5162811|NCT00963092|adenocarcinoma of the stomach|adenocarcinoma of the stomach
5162812|NCT00963092|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
5162813|NCT00963092|recurrent esophageal cancer|recurrent esophageal cancer
5162814|NCT00963092|stage I esophageal cancer|stage i esophageal cancer
5162815|NCT00963092|stage II esophageal cancer|stage ii esophageal cancer
5162816|NCT00963092|stage III esophageal cancer|stage iii esophageal cancer
5162817|NCT00963092|stage IV esophageal cancer|stage iv esophageal cancer
5162818|NCT00963092|stage IA gastric cancer|stage ia gastric cancer
5162819|NCT00963092|stage IB gastric cancer|stage ib gastric cancer
5162820|NCT00963092|stage IIA gastric cancer|stage iia gastric cancer
5162821|NCT00963092|stage IIB gastric cancer|stage iib gastric cancer
5162822|NCT00963092|stage IIIA gastric cancer|stage iiia gastric cancer
5162823|NCT00963092|stage IIIB gastric cancer|stage iiib gastric cancer
5162824|NCT00963092|stage IIIC gastric cancer|stage iiic gastric cancer
5162825|NCT00963079|IVF|ivf
5162826|NCT00963079|in vitro fertilization|in vitro fertilization
5162827|NCT00963079|blastocyst transfer|blastocyst transfer
5162929|NCT00962689|diagnosis|diagnosis
5162828|NCT00963079|endometrial receptivity|endometrial receptivity
5162829|NCT00963079|embryo cryopreservation|embryo cryopreservation
5162830|NCT00963066|NAVA|nava
5162831|NCT00963066|Acute Lung Injury|acute lung injury
5162832|NCT00963066|Pressure Support Ventilation|pressure support ventilation
5162833|NCT00963066|Intubation|intubation
5162834|NCT00963066|Tracheostomy|tracheostomy
5162835|NCT00963066|Mechanical ventilation|mechanical ventilation
5162836|NCT00963053|dysmenorrhoea|dysmenorrhoea
5162837|NCT00963053|dysmenorrhea|dysmenorrhea
5162838|NCT00963053|pain|pain
5162839|NCT00963053|pre-emptive|pre-emptive
5162840|NCT00963040|intranasal oxytocin|intranasal oxytocin
5162841|NCT00963040|acute headache treatment|acute headache treatment
5162842|NCT00963040|chronic daily headache|chronic daily headache
5162843|NCT00963027|Hypertension, Pulmonary|hypertension, pulmonary
5162844|NCT00963027|Treprostinil|treprostinil
5162845|NCT00963027|Pharmacokinetics|pharmacokinetics
5162846|NCT00963027|Treprostinil Diethanolamine|treprostinil diethanolamine
5162847|NCT00963027|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
5162848|NCT00963027|Esomeprazole|esomeprazole
5162849|NCT00963001|Hypertension, Pulmonary|hypertension, pulmonary
5162850|NCT00963001|Treprostinil|treprostinil
5162851|NCT00963001|Pharmacokinetics|pharmacokinetics
5162852|NCT00963001|Treprostinil Diethanolamine|treprostinil diethanolamine
5162853|NCT00963001|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
5162854|NCT00962988|Cerebrovascular disease|cerebrovascular disease
5162855|NCT00962988|stroke|stroke
5162856|NCT00962988|Transient Ischemic Attack|transient ischemic attack
5162857|NCT00962988|smoking cessation|smoking cessation
5162858|NCT00962988|Pharmacotherapy|pharmacotherapy
5162859|NCT00962962|Abnormal fasting glucose|abnormal fasting glucose
5162860|NCT00962949|POTS|pots
5162861|NCT00962949|Orthostatic intolerance|orthostatic intolerance
5162862|NCT00962936|Chronic Hepatitis C|chronic hepatitis c
5162863|NCT00962936|HCV Genotype I infection|hcv genotype i infection
5162864|NCT00962936|Liver disease|liver disease
5162865|NCT00962923|Systemic sclerosis|systemic sclerosis
5162866|NCT00962923|Mesenchymal Stem Cells|mesenchymal stem cells
5162867|NCT00962923|Transplantation|transplantation
5162868|NCT00962910|Femoral Fractures|femoral fractures
5162869|NCT00962910|Critical Pathway|critical pathway
5162870|NCT00962910|Cluster Randomized Controlled Trial|cluster randomized controlled trial
5162871|NCT00962910|Safety|safety
5162872|NCT00962910|Efficiency|efficiency
5162873|NCT00962897|atherosclerosis|atherosclerosis
5162874|NCT00962897|covered stent|covered stent
5162875|NCT00962897|percutaneous intervention|percutaneous intervention
5162876|NCT00962897|stent|stent
5162877|NCT00962897|angioplasty|angioplasty
5162878|NCT00962884|Orthostatic hypotension|orthostatic hypotension
5162879|NCT00962884|Breathing|breathing
5162880|NCT00962884|Blood pressure|blood pressure
5162881|NCT00962884|standing|standing
5162882|NCT00962845|stage III melanoma|stage iii melanoma
5162883|NCT00962845|stage IV melanoma|stage iv melanoma
5162884|NCT00962832|rhuMAb IFNalpha|rhumab ifnalpha
5162885|NCT00962832|SLE|sle
5162886|NCT00962819|Mumps|mumps
5162887|NCT00962819|Immunity|immunity
5162888|NCT00962819|Vaccine|vaccine
5162889|NCT00962819|Mumps antibodies|mumps antibodies
5162890|NCT00962819|Mumps immunity|mumps immunity
5162891|NCT00962806|Pediatric obesity|pediatric obesity
5162892|NCT00962806|Insulin resistance|insulin resistance
5162893|NCT00962806|Diabetes|diabetes
5162894|NCT00962806|Mitochondria|mitochondria
5162895|NCT00962793|latent tuberculosis prevalence of health care workers|latent tuberculosis prevalence of health care workers
5162896|NCT00962780|vaccine|vaccine
5162897|NCT00962780|13-valent pneumococcal conjugate vaccine|13-valent pneumococcal conjugate vaccine
5162898|NCT00962780|23-valent pneumococcal polysaccharide vaccine|23-valent pneumococcal polysaccharide vaccine
5162899|NCT00962780|human immunodeficiency virus|human immunodeficiency virus
5162900|NCT00962767|Oncology comparison study|oncology comparison study
5162901|NCT00962754|recording fluid balance|recording fluid balance
5162902|NCT00962754|reliability|reliability
5162903|NCT00962754|utility|utility
5162904|NCT00962754|sick neonate|sick neonate
5162905|NCT00962754|fluid balance|fluid balance
5162906|NCT00962754|inpatient|inpatient
5162907|NCT00962754|sick|sick
5162908|NCT00962728|heart rate|heart rate
5162909|NCT00962728|tachycardia|tachycardia
5162910|NCT00962728|orthostatic intolerance|orthostatic intolerance
5162911|NCT00962715|Leukemia|leukemia
5162913|NCT00962715|Influenza Vaccine Trivalent Inactivated|influenza vaccine trivalent inactivated
5162914|NCT00962715|TIV|tiv
5162915|NCT00962715|Flu|flu
5162916|NCT00962715|Pegasys|pegasys
5162917|NCT00962715|Pegylated interferon|pegylated interferon
5162918|NCT00962715|Roferon|roferon
5162919|NCT00962715|Interferon|interferon
5162920|NCT00962702|Exclusion|exclusion
5162921|NCT00962702|Left Atrial Appendage|left atrial appendage
5162922|NCT00962702|Surgical|surgical
5162923|NCT00962702|Open chest|open chest
5162924|NCT00962689|chronic rhinosinusitis|chronic rhinosinusitis
5162925|NCT00962689|biofilm|biofilm
5162926|NCT00962689|sinus tissue|sinus tissue
5162927|NCT00962689|nasal secretions|nasal secretions
5162928|NCT00962689|proteomics|proteomics
5162930|NCT00962689|decreased antibiotics|decreased antibiotics
5162931|NCT00962689|Develop a test to identify patients with sinusitis subtypes|develop a test to identify patients with sinusitis subtypes
5162932|NCT00962676|suspicious of tuberculosis|suspicious of tuberculosis
5162933|NCT00962676|immunocompromised patients|immunocompromised patients
5162934|NCT00962650|abdominal adhesions|abdominal adhesions
5162935|NCT00962650|diagnostic peritoneoscopy|diagnostic peritoneoscopy
5162936|NCT00962650|Natural Orifice Transluminal Endoscopic Surgery|natural orifice transluminal endoscopic surgery
5162937|NCT00962650|NOTES|notes
5162938|NCT00962637|Secondary Hypogonadism|secondary hypogonadism
5162939|NCT00962624|Meningococcal|meningococcal
5162940|NCT00962624|Vaccine|vaccine
5162941|NCT00962624|Meningitis|meningitis
5162942|NCT00962611|Solid tumors|solid tumors
5162943|NCT00962611|Advanced cancer|advanced cancer
5162944|NCT00962598|Adolescents|adolescents
5162945|NCT00962598|Major Depressive Disorder|major depressive disorder
5162946|NCT00962598|Proton Magnetic Resonance Spectroscopy|proton magnetic resonance spectroscopy
5162947|NCT00962598|Immune System Activation|immune system activation
5162948|NCT00962598|Omega-3 Fatty Acids|omega-3 fatty acids
5162949|NCT00962572|Outcomes|outcomes
5162950|NCT00962572|Cancer|cancer
5162951|NCT00962572|Radiotherapy|radiotherapy
5162952|NCT00962572|Socio-economic|socio-economic
5162953|NCT00962546|cerebral aneurysm|cerebral aneurysm
5162954|NCT00962546|subarachnoid hemorrhage|subarachnoid hemorrhage
5162955|NCT00962546|cerebral vasospasm|cerebral vasospasm
5162956|NCT00962546|computed tomographic perfusion|computed tomographic perfusion
5162957|NCT00962546|computed tomographic angiography|computed tomographic angiography
5162958|NCT00962533|Chronic Hepatitis B|chronic hepatitis b
5162959|NCT00962520|pancreatic cancer|pancreatic cancer
5162960|NCT00962520|resectable|resectable
5162961|NCT00962520|Tarceva|tarceva
5162962|NCT00962507|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
5162963|NCT00962507|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
5162964|NCT00962507|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5162965|NCT00962507|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
5162966|NCT00962507|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5162967|NCT00962507|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5162968|NCT00962507|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5162969|NCT00962507|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5162970|NCT00962507|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5162971|NCT00962507|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5162972|NCT00962507|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5162973|NCT00962507|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5162974|NCT00962507|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
5162975|NCT00962507|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5162976|NCT00962507|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5162977|NCT00962507|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5162978|NCT00962507|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5162979|NCT00962507|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5162980|NCT00962507|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5162981|NCT00962507|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5162982|NCT00962507|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5162983|NCT00962507|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5162984|NCT00962507|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5162985|NCT00962507|cutaneous B-cell non-Hodgkin lymphoma|cutaneous b-cell non-hodgkin lymphoma
5162986|NCT00962507|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
5162987|NCT00962507|refractory multiple myeloma|refractory multiple myeloma
5162988|NCT00962468|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
5162989|NCT00962468|Critical Pathway|critical pathway
5162990|NCT00962468|Cluster Randomized Controlled Trial|cluster randomized controlled trial
5162991|NCT00962468|Safety|safety
5162992|NCT00962468|Efficiency|efficiency
5162993|NCT00962455|Spirometry|spirometry
5162994|NCT00962455|Family Practice|family practice
5162995|NCT00962455|Randomized Controlled Trial|randomized controlled trial
5162996|NCT00962455|Feedback|feedback
5162997|NCT00962455|Intervention Studies|intervention studies
5162998|NCT00962442|alcoholic hepatitis|alcoholic hepatitis
5162999|NCT00962442|N-Acetylcysteine|n-acetylcysteine
5163000|NCT00962442|enteral nutrition|enteral nutrition
5163001|NCT00962442|oxidative stress|oxidative stress
5163002|NCT00962442|severe acute alcoholic hepatitis|severe acute alcoholic hepatitis
5163003|NCT00962429|neuropathy, lipoic acid|neuropathy, lipoic acid
5163004|NCT00962416|Drug eluting stent|drug eluting stent
5163005|NCT00962416|Biolimus|biolimus
5163006|NCT00962416|Biodegradable stent|biodegradable stent
5163007|NCT00962416|ST-elevation myocardial infarction|st-elevation myocardial infarction
5163008|NCT00962416|Coronary artery disease|coronary artery disease
5163009|NCT00962403|post traumatic stress disorder|post traumatic stress disorder
5163010|NCT00962403|yoga|yoga
5163011|NCT00962403|meditation|meditation
5163012|NCT00962403|military|military
5163013|NCT00962403|veteran|veteran
5163014|NCT00962403|trauma|trauma
5163015|NCT00962403|stress|stress
5163016|NCT00962403|depression|depression
5163017|NCT00962403|anxiety|anxiety
5163018|NCT00962403|insomnia|insomnia
5163019|NCT00962403|autonomic|autonomic
5163020|NCT00962377|molecular expression testing|molecular expression testing
5163021|NCT00962377|right ventricular endomyocardial biopsy|right ventricular endomyocardial biopsy
5163022|NCT00962351|total hip replacement|total hip replacement
5163023|NCT00962351|primary cementless total hip arthroplasty|primary cementless total hip arthroplasty
5163024|NCT00962351|metal ion|metal ion
5163025|NCT00962351|metal-on-metal|metal-on-metal
5163026|NCT00962338|convalescence|convalescence
5163027|NCT00962338|pain|pain
5163028|NCT00962338|nausea|nausea
5163029|NCT00962338|vomiting|vomiting
5163030|NCT00962338|sexual dysfunction|sexual dysfunction
5163031|NCT00962325|Physical activity|physical activity
5163032|NCT00962325|Obesity|obesity
5163033|NCT00962325|Bariatric surgery|bariatric surgery
5163034|NCT00962325|Weight Loss|weight loss
5163035|NCT00962312|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
5163036|NCT00962312|recurrent pancreatic cancer|recurrent pancreatic cancer
5163037|NCT00962312|stage IV pancreatic cancer|stage iv pancreatic cancer
5163038|NCT00962299|Child|child
5163039|NCT00962299|Wheezing|wheezing
5163040|NCT00962299|Dyspnea|dyspnea
5163041|NCT00962299|Inhaled corticosteroids|inhaled corticosteroids
5163042|NCT00962286|Furosemide|furosemide
5163043|NCT00962286|obesity|obesity
5163044|NCT00962273|health personnel|health personnel
5163045|NCT00962273|communicable diseases|communicable diseases
5163046|NCT00962273|stress, psychological|stress, psychological
5163047|NCT00962273|resilience, psychological|resilience, psychological
5163048|NCT00962273|disaster planning|disaster planning
5163049|NCT00962273|education|education
5163050|NCT00962273|online|online
5163051|NCT00962260|glucocerebrosidase|glucocerebrosidase
5163052|NCT00962260|enzyme replacement therapy|enzyme replacement therapy
5163053|NCT00962260|Gaucher disease|gaucher disease
5163054|NCT00962260|plant cell culture|plant cell culture
5163055|NCT00962260|splenomegaly|splenomegaly
5163056|NCT00962260|hepatomegaly|hepatomegaly
5163057|NCT00962260|anemia|anemia
5163058|NCT00962260|thrombocytopenia|thrombocytopenia
5163059|NCT00962247|physical activity|physical activity
5163060|NCT00962247|relative reinforcing value|relative reinforcing value
5163061|NCT00962247|sedentary behavior|sedentary behavior
5163062|NCT00962247|obesity|obesity
5163063|NCT00962234|Lipogenesis|lipogenesis
5163064|NCT00962234|Lipolysis|lipolysis
5163065|NCT00962234|Phospholipids|phospholipids
5163066|NCT00962234|Body Composition|body composition
5163067|NCT00962234|Nutritional Status|nutritional status
5163068|NCT00962234|Lipid Metabolism|lipid metabolism
5163069|NCT00962221|LDL lipoprotein subclasses in subclinical hypothyroidism|ldl lipoprotein subclasses in subclinical hypothyroidism
5163070|NCT00962208|children|children
5163071|NCT00962208|corneal reshaping|corneal reshaping
5163072|NCT00962208|myopia|myopia
5163073|NCT00962208|myopia control|myopia control
5163074|NCT00962208|orthokeratology|orthokeratology
5163075|NCT00962195|health|health
5163076|NCT00962195|blood pressure|blood pressure
5163077|NCT00962195|liver enzymes|liver enzymes
5163078|NCT00962195|insulin resistance|insulin resistance
5163079|NCT00962182|celiac disease|celiac disease
5163080|NCT00962182|transglutaminase antibody|transglutaminase antibody
5163081|NCT00962169|Guideline adherence|guideline adherence
5163082|NCT00962169|Implementation|implementation
5163083|NCT00962169|Physical therapy|physical therapy
5163084|NCT00962169|Low back pain|low back pain
5163085|NCT00962169|Health plan implementation|health plan implementation
5163086|NCT00962156|Sepsis|sepsis
5163087|NCT00962156|Shock|shock
5163088|NCT00962156|Fluid therapy|fluid therapy
5163089|NCT00962156|Plasma expanders|plasma expanders
5163090|NCT00962143|Acute Achilles Tendon Tear|acute achilles tendon tear
5163091|NCT00962143|Acute Achilles Tendon Repair|acute achilles tendon repair
5163092|NCT00962130|tissue perfusion|tissue perfusion
5163093|NCT00962130|reconstructive surgery|reconstructive surgery
5163094|NCT00962130|continuous glucose monitoring|continuous glucose monitoring
5163095|NCT00962117|Food Reinforcement|food reinforcement
5163096|NCT00962117|Energy Intake|energy intake
5163097|NCT00962117|Obesity|obesity
5163098|NCT00962117|Dopamine|dopamine
5163099|NCT00962104|ADHD|adhd
5163100|NCT00962091|Area under the plasma concentration versus time curve (AUC)|area under the plasma concentration versus time curve (auc)
5163101|NCT00962091|Maximum plasma concentration (Cmax)|maximum plasma concentration (cmax)
5163102|NCT00962091|Area under the plasma concentration versus time curve zero to the time of the last quantifiable concentration (AUC0-tlast)|area under the plasma concentration versus time curve zero to the time of the last quantifiable concentration (auc0-tlast)
5163103|NCT00962091|Confidence intervals (CI)|confidence intervals (ci)
5163104|NCT00962091|Time of first observed maximum plasma concentration (Tmax)|time of first observed maximum plasma concentration (tmax)
5163105|NCT00962078|COPD|copd
5163106|NCT00962078|Pre-Lung-Transplantation|pre-lung-transplantation
5163308|NCT00961090|Brain tumor|brain tumor
5163107|NCT00962078|Intervall versus continuous training|intervall versus continuous training
5163108|NCT00962078|6 MWD|6 mwd
5163109|NCT00962039|Abdominal Pain|abdominal pain
5163110|NCT00962039|Anxiety|anxiety
5163111|NCT00962026|Interleukin 1|interleukin 1
5163112|NCT00962026|Type 1 diabetes mellitus|type 1 diabetes mellitus
5163113|NCT00962026|Rilonacept|rilonacept
5163114|NCT00962026|Arcalyst|arcalyst
5163115|NCT00962000|Hemodialysis|hemodialysis
5163116|NCT00962000|Dialysis, Renal|dialysis, renal
5163117|NCT00961987|Maternity care|maternity care
5163118|NCT00961987|Interprofessional collaboration|interprofessional collaboration
5163119|NCT00961987|Continuity of Care|continuity of care
5163120|NCT00961987|Integration|integration
5163121|NCT00961974|type 1 diabetes|type 1 diabetes
5163122|NCT00961974|hemoglobin A1c|hemoglobin a1c
5163123|NCT00961974|family|family
5163124|NCT00961974|involvement|involvement
5163125|NCT00961974|responsibility|responsibility
5163126|NCT00961974|conflict|conflict
5163127|NCT00961974|quality of life|quality of life
5163128|NCT00961974|children|children
5163129|NCT00961961|Bipolar Disorder|bipolar disorder
5163130|NCT00961961|Manic Depression|manic depression
5163131|NCT00961961|Major Depressive Episode|major depressive episode
5163132|NCT00961961|Mania|mania
5163133|NCT00961961|Hypomania|hypomania
5163134|NCT00961961|Long Term Treatment|long term treatment
5163135|NCT00961948|Indigo carmine dye spraying|indigo carmine dye spraying
5163136|NCT00961948|Narrow band imaging (NBI)|narrow band imaging (nbi)
5163137|NCT00961948|Confocal Microscopy|confocal microscopy
5163138|NCT00961935|bipolar disorder|bipolar disorder
5163139|NCT00961935|child bipolar disorder|child bipolar disorder
5163140|NCT00961935|adolescent bipolar disorder|adolescent bipolar disorder
5163141|NCT00961935|pediatric bipolar disorder|pediatric bipolar disorder
5163142|NCT00961935|fMRI|fmri
5163143|NCT00961935|MRI|mri
5163144|NCT00961935|EEG|eeg
5163145|NCT00961935|neurocognitive tasks|neurocognitive tasks
5163146|NCT00961922|childhood brain tumour survivors|childhood brain tumour survivors
5163147|NCT00961896|Basal Cell Carcinoma|basal cell carcinoma
5163148|NCT00961896|Gorlin Syndrome,|gorlin syndrome,
5163149|NCT00961896|Gorlin-Goltz Syndrome,|gorlin-goltz syndrome,
5163150|NCT00961896|Basal Cell Nevus Syndrome,|basal cell nevus syndrome,
5163151|NCT00961896|Nevoid Basal Cell Carcinoma Syndrome,|nevoid basal cell carcinoma syndrome,
5163152|NCT00961896|Basal Cell Carcinoma Nevus Syndrome|basal cell carcinoma nevus syndrome
5163153|NCT00961883|HIV|hiv
5163154|NCT00961883|Vaccine|vaccine
5163155|NCT00961883|HIV Seronegativity|hiv seronegativity
5163156|NCT00961883|Preventive Vaccine|preventive vaccine
5163157|NCT00961870|bone|bone
5163158|NCT00961870|motor neuron excitability|motor neuron excitability
5163159|NCT00961870|forearm vibration|forearm vibration
5163160|NCT00961870|Mechanical Loading|mechanical loading
5163161|NCT00961831|Neoplasm|neoplasm
5163162|NCT00961831|PET/CT diagnosis|pet/ct diagnosis
5163163|NCT00961831|PET tracer|pet tracer
5163164|NCT00961818|Voice|voice
5163165|NCT00961818|Voice Quality|voice quality
5163166|NCT00961818|Voice Training|voice training
5163167|NCT00961818|Evaluation|evaluation
5163168|NCT00961805|Fibromyalgia|fibromyalgia
5163169|NCT00961805|Treatment|treatment
5163170|NCT00961805|Dance|dance
5163171|NCT00961805|Randomized controlled study|randomized controlled study
5163172|NCT00961805|Exercise|exercise
5163173|NCT00961753|PDA|pda
5163174|NCT00961753|Ibuprofen|ibuprofen
5163175|NCT00961753|Preterm|preterm
5163176|NCT00961753|Neonate|neonate
5163177|NCT00961740|Childhood Obesity|childhood obesity
5163178|NCT00961740|CBT|cbt
5163179|NCT00961740|Family|family
5163180|NCT00961740|Lifestyle change|lifestyle change
5163181|NCT00961727|Bedside Pews|bedside pews
5163182|NCT00961727|Credit Valley Hospital|credit valley hospital
5163183|NCT00961727|The Bedside Paediatric Early Warning System|the bedside paediatric early warning system
5163184|NCT00961727|clinically deteriorating|clinically deteriorating
5163185|NCT00961714|VCF|vcf
5163186|NCT00961688|PCOS|pcos
5163187|NCT00961688|polycystic ovary syndrome|polycystic ovary syndrome
5163188|NCT00961688|Polycystic ovarian syndrome|polycystic ovarian syndrome
5163189|NCT00961688|infertility|infertility
5163190|NCT00961688|ovulation|ovulation
5163191|NCT00961675|otitis|otitis
5163192|NCT00961675|acute|acute
5163193|NCT00961675|externa|externa
5163194|NCT00961675|ear|ear
5163195|NCT00961649|Open-Angle Glaucoma|open-angle glaucoma
5163196|NCT00961649|Ocular Hypertension|ocular hypertension
5163197|NCT00961649|Brinzolamide|brinzolamide
5163198|NCT00961649|Brimonidine|brimonidine
5163199|NCT00961649|Intraocular Pressure|intraocular pressure
5163200|NCT00961610|internet support|internet support
5163201|NCT00961610|cancer|cancer
5163202|NCT00961610|rehabilitation|rehabilitation
5163203|NCT00961597|Meniscus|meniscus
5163204|NCT00961597|Avascular region|avascular region
5163205|NCT00961597|Platelet rich plasma|platelet rich plasma
5163206|NCT00961571|colorectal cancer|colorectal cancer
5163207|NCT00961571|sunitinib|sunitinib
5163208|NCT00961571|capecitabine|capecitabine
5163209|NCT00961558|varicocelectomy|varicocelectomy
5163210|NCT00961558|male infertility|male infertility
5163211|NCT00961558|clinical varicoceles|clinical varicoceles
5163212|NCT00961558|randomized control trial|randomized control trial
5163213|NCT00961532|intracerebral hemorrhage|intracerebral hemorrhage
5163214|NCT00961532|platelets|platelets
5163215|NCT00961506|cholecystectomy|cholecystectomy
5163216|NCT00961506|gallbladder|gallbladder
5163217|NCT00961506|laparoscopy|laparoscopy
5163218|NCT00961506|laparoendoscopic|laparoendoscopic
5163219|NCT00961467|Relapsed/ refractory Multiple Myeloma|relapsed/ refractory multiple myeloma
5163220|NCT00961454|Major depressive disorder, anxiety disorders, treatments, photobiomodulation, near infra-red phototherapy, cerebral blood flow|major depressive disorder, anxiety disorders, treatments, photobiomodulation, near infra-red phototherapy, cerebral blood flow
5163221|NCT00961441|Levetiracetam|levetiracetam
5163222|NCT00961441|Epilepsy|epilepsy
5163223|NCT00961441|Children|children
5163224|NCT00961441|Adults|adults
5163225|NCT00961428|Anorexia Nervosa|anorexia nervosa
5163226|NCT00961428|Eating Disorders|eating disorders
5163227|NCT00961428|Exercise|exercise
5163228|NCT00961428|Physical Activity|physical activity
5163229|NCT00961402|Exercise|exercise
5163230|NCT00961402|PostParum Depression|postparum depression
5163231|NCT00961389|delirium|delirium
5163232|NCT00961389|critical care|critical care
5163233|NCT00961389|risk factors|risk factors
5163234|NCT00961389|prediction|prediction
5163235|NCT00961389|inflammation|inflammation
5163236|NCT00961376|melanoma|melanoma
5163237|NCT00961376|unresectable stage III or IV melanoma|unresectable stage iii or iv melanoma
5163238|NCT00961350|PA32540 is proposed for the secondary prevention of cardio- and cerebrovascular events in patients at risk for developing aspirin-associated gastric ulcers.|pa32540 is proposed for the secondary prevention of cardio- and cerebrovascular events in patients at risk for developing aspirin-associated gastric ulcers.
5163239|NCT00961337|school children|school children
5163240|NCT00961337|influenza vaccination|influenza vaccination
5163241|NCT00961337|vaccine effectiveness|vaccine effectiveness
5163242|NCT00961337|influenza attack rate|influenza attack rate
5163243|NCT00961337|absenteeism|absenteeism
5163244|NCT00961337|Influenza vaccine|influenza vaccine
5163245|NCT00961311|Balloon|balloon
5163246|NCT00961311|Angioplasty|angioplasty
5163247|NCT00961311|Coronary Artery|coronary artery
5163248|NCT00961311|PCI|pci
5163249|NCT00961311|PTCA|ptca
5163250|NCT00961311|Heart Disease|heart disease
5163251|NCT00961311|Myocardial Ischemia|myocardial ischemia
5163252|NCT00961298|IBS|ibs
5163253|NCT00961298|Irritable Bowel Syndrome|irritable bowel syndrome
5163254|NCT00961298|GAD|gad
5163255|NCT00961298|Generalized Anxiety Disorder|generalized anxiety disorder
5163256|NCT00961285|pharmacogenomics|pharmacogenomics
5163257|NCT00961285|genotyping|genotyping
5163258|NCT00961272|Pre-menopausal|pre-menopausal
5163259|NCT00961272|Pharmacokinetics|pharmacokinetics
5163260|NCT00961272|Raltegravir|raltegravir
5163261|NCT00961272|Women|women
5163262|NCT00961272|HIV-infected|hiv-infected
5163263|NCT00961259|healthy|healthy
5163264|NCT00961259|pharmacokinetics|pharmacokinetics
5163265|NCT00961259|therapeutic equivalency|therapeutic equivalency
5163266|NCT00961259|fenofibric acid|fenofibric acid
5163267|NCT00961246|web based intervention|web based intervention
5163268|NCT00961246|individually-tailored|individually-tailored
5163269|NCT00961246|Chinese-American children|chinese-american children
5163270|NCT00961246|compared the changes in physical activity level|compared the changes in physical activity level
5163271|NCT00961246|changes in dietary intake|changes in dietary intake
5163272|NCT00961246|changes in coping strategy used|changes in coping strategy used
5163273|NCT00961246|changes in BMI|changes in bmi
5163274|NCT00961233|eosinophilic esophagitis|eosinophilic esophagitis
5163275|NCT00961194|Ketamine|ketamine
5163276|NCT00961194|pain|pain
5163277|NCT00961194|neuropathic pain|neuropathic pain
5163278|NCT00961194|chronic|chronic
5163279|NCT00961181|paclitaxel|paclitaxel
5163280|NCT00961181|in-stent restenosis|in-stent restenosis
5163281|NCT00961181|BMS-ISR|bms-isr
5163282|NCT00961181|DES-ISR|des-isr
5163283|NCT00961181|drug eluting balloon|drug eluting balloon
5163284|NCT00961168|Mechanical Ventilation|mechanical ventilation
5163285|NCT00961155|asthma|asthma
5163286|NCT00961155|children|children
5163287|NCT00961155|EBC|ebc
5163288|NCT00961155|exposure to tabacco|exposure to tabacco
5163289|NCT00961155|antiasthma treatment|antiasthma treatment
5163290|NCT00961142|Haploidentical Transplantation|haploidentical transplantation
5163291|NCT00961142|CD3/CD19 Depletion|cd3/cd19 depletion
5163292|NCT00961142|AML|aml
5163293|NCT00961142|ALL|all
5163294|NCT00961142|Reduced Intensity Conditioning|reduced intensity conditioning
5163295|NCT00961129|colorectal cancer|colorectal cancer
5163296|NCT00961129|needs|needs
5163297|NCT00961129|survivors|survivors
5163298|NCT00961129|any stage|any stage
5163299|NCT00961116|healthy|healthy
5163300|NCT00961116|pharmacokinetics|pharmacokinetics
5163301|NCT00961116|therapeutic equivalency|therapeutic equivalency
5163302|NCT00961116|fasting|fasting
5163303|NCT00961116|procetofen|procetofen
5163304|NCT00961116|fenofibric acid|fenofibric acid
5163305|NCT00961103|spinal muscular atrophy|spinal muscular atrophy
5163306|NCT00961103|motor development|motor development
5163307|NCT00961103|orthoses|orthoses
5163309|NCT00961090|glioma|glioma
5163310|NCT00961090|surgical resection|surgical resection
5163311|NCT00961090|ALA|ala
5163312|NCT00961090|ultraviolet light|ultraviolet light
5163313|NCT00961077|elderly|elderly
5163314|NCT00961077|S-1|s-1
5163315|NCT00961077|Oxaliplatin|oxaliplatin
5163316|NCT00961077|relapsed or metastatic gastric cancer|relapsed or metastatic gastric cancer
5163317|NCT00961064|Promacta|promacta
5163318|NCT00961064|Thrombocytopenia|thrombocytopenia
5163319|NCT00961064|Myelodysplastic Syndrome|myelodysplastic syndrome
5163320|NCT00961064|MDS|mds
5163321|NCT00961051|adapted contact lens wearers|adapted contact lens wearers
5163322|NCT00961038|Ciprofloxacin|ciprofloxacin
5163323|NCT00961038|Inhalation|inhalation
5163324|NCT00961038|Pharmacokinetics|pharmacokinetics
5163325|NCT00961038|Safety|safety
5163326|NCT00961038|Tolerability|tolerability
5163327|NCT00961038|COPD|copd
5163328|NCT00961012|Randomized control trial|randomized control trial
5163329|NCT00961012|pressure mapping|pressure mapping
5163330|NCT00961012|High Fowler's position|high fowler's position
5163331|NCT00961012|bed|bed
5163332|NCT00961012|ventilation|ventilation
5163333|NCT00961012|slow vital capacity|slow vital capacity
5163334|NCT00961012|older adult population|older adult population
5163335|NCT00961012|65 years and older|65 years and older
5163336|NCT00960999|stage I non-small cell lung cancer|stage i non-small cell lung cancer
5163337|NCT00960999|squamous cell lung cancer|squamous cell lung cancer
5163338|NCT00960999|adenocarcinoma of the lung|adenocarcinoma of the lung
5163339|NCT00960999|large cell lung cancer|large cell lung cancer
5163340|NCT00960973|vitamin K|vitamin k
5163341|NCT00960973|beta cell|beta cell
5163342|NCT00960973|glucose metabolism|glucose metabolism
5163343|NCT00960973|insulin resistance|insulin resistance
5163344|NCT00960960|MBC|mbc
5163345|NCT00960960|PI3K|pi3k
5163346|NCT00960960|Avastin|avastin
5163347|NCT00960960|Herceptin|herceptin
5163348|NCT00960934|Osteoporosis|osteoporosis
5163349|NCT00960934|Postmenopausal|postmenopausal
5163350|NCT00960934|MK-5442|mk-5442
5163351|NCT00960921|Pulmonary artery pressure|pulmonary artery pressure
5163352|NCT00960921|Hypoxia|hypoxia
5163353|NCT00960921|Iron|iron
5163354|NCT00960921|Hypoxia-inducible factor|hypoxia-inducible factor
5163355|NCT00960921|High altitude|high altitude
5163356|NCT00960908|Zotarolimus|zotarolimus
5163357|NCT00960908|Drug eluting stent|drug eluting stent
5163358|NCT00960908|Endeavor Resolute|endeavor resolute
5163359|NCT00960895|Lymphangioleiomyomatosis|lymphangioleiomyomatosis
5163360|NCT00960895|Pulmonary hypertension|pulmonary hypertension
5163361|NCT00960882|Pharmacokinetics|pharmacokinetics
5163362|NCT00960882|Diabetes|diabetes
5163363|NCT00960882|gastric tolerability|gastric tolerability
5163364|NCT00960869|PA32540 is proposed for the secondary prevention of cardio- and cerebrovascular events in patients at risk for developing aspirin-associated gastric ulcers.|pa32540 is proposed for the secondary prevention of cardio- and cerebrovascular events in patients at risk for developing aspirin-associated gastric ulcers.
5163365|NCT00960856|pharmacokinetics|pharmacokinetics
5163366|NCT00960843|Morbid Obesity|morbid obesity
5163367|NCT00960843|Gastric Banding|gastric banding
5163368|NCT00960843|Bariatric Banding|bariatric banding
5163369|NCT00960843|Swedish Adjustable Gastric Band|swedish adjustable gastric band
5163370|NCT00960817|Normal coronary artery with slow blood flow|normal coronary artery with slow blood flow
5163371|NCT00960804|OA|oa
5163372|NCT00960791|Type II diabetes mellitus|type ii diabetes mellitus
5163373|NCT00960791|absorption|absorption
5163374|NCT00960791|distribution|distribution
5163375|NCT00960791|metabolism|metabolism
5163376|NCT00960791|excretion|excretion
5163377|NCT00960791|14C-labelled|14c-labelled
5163378|NCT00960778|gender|gender
5163379|NCT00960778|nicotine dependence|nicotine dependence
5163380|NCT00960778|nicotine replacement therapy|nicotine replacement therapy
5163381|NCT00960778|extinction|extinction
5163382|NCT00960778|denicotinized cigarettes|denicotinized cigarettes
5163383|NCT00960765|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
5163384|NCT00960765|Gastric Bypass|gastric bypass
5163385|NCT00960765|Gastric Banding|gastric banding
5163386|NCT00960765|Endotoxin|endotoxin
5163387|NCT00960752|gp100 peptide|gp100 peptide
5163388|NCT00960752|MAGE-3 peptide|mage-3 peptide
5163389|NCT00960752|R848|r848
5163390|NCT00960752|Resiquimod|resiquimod
5163391|NCT00960752|Toll Like Receptor|toll like receptor
5163392|NCT00960752|TLR|tlr
5163393|NCT00960752|T-cells|t-cells
5163394|NCT00960752|Tumor|tumor
5163395|NCT00960752|Metastatic|metastatic
5163396|NCT00960752|Lesions|lesions
5163397|NCT00960752|Injection Site|injection site
5163398|NCT00960739|disseminated neuroblastoma|disseminated neuroblastoma
5163399|NCT00960739|localized unresectable neuroblastoma|localized unresectable neuroblastoma
5163400|NCT00960739|recurrent neuroblastoma|recurrent neuroblastoma
5163401|NCT00960739|stage 4S neuroblastoma|stage 4s neuroblastoma
5163402|NCT00960726|Leukemia|leukemia
5163403|NCT00960726|NOV-002|nov-002
5163404|NCT00960726|Myelodysplastic Syndrome|myelodysplastic syndrome
5163405|NCT00960726|MDS|mds
5163406|NCT00960713|observational cohort|observational cohort
5163407|NCT00960713|rituximab|rituximab
5163408|NCT00960713|off-label use|off-label use
5163409|NCT00960713|auto-immunity|auto-immunity
5163410|NCT00960713|cytopenia|cytopenia
5163411|NCT00960700|MFlex|mflex
5163412|NCT00960700|Multifocal|multifocal
5163413|NCT00960700|630F|630f
5163414|NCT00960687|healthy|healthy
5163415|NCT00960687|pharmacokinetics|pharmacokinetics
5163416|NCT00960687|therapeutic equivalency|therapeutic equivalency
5163417|NCT00960661|diabetes|diabetes
5163418|NCT00960661|exenatide|exenatide
5163419|NCT00960661|Byetta|byetta
5163420|NCT00960661|insulin lispro|insulin lispro
5163421|NCT00960661|Humalog|humalog
5163422|NCT00960661|insulin glargine|insulin glargine
5163423|NCT00960661|Lantus|lantus
5163424|NCT00960661|Amylin|amylin
5163425|NCT00960661|Lilly|lilly
5163426|NCT00960648|Everolimus|everolimus
5163427|NCT00960648|Sirolimus|sirolimus
5163428|NCT00960648|Drug eluting stent|drug eluting stent
5163429|NCT00960635|new-onset|new-onset
5163430|NCT00960622|treatment experienced|treatment experienced
5163431|NCT00960609|Communicating veins|communicating veins
5163432|NCT00960609|hepatic venous anastomosis|hepatic venous anastomosis
5163433|NCT00960609|intra-operative ultrasonography|intra-operative ultrasonography
5163434|NCT00960609|hepatic resection|hepatic resection
5163435|NCT00960609|hepatic neoplasm|hepatic neoplasm
5163436|NCT00960609|Primary and metastatic liver tumors|primary and metastatic liver tumors
5163437|NCT00960596|educational intervention|educational intervention
5163438|NCT00960596|asthma|asthma
5163439|NCT00960596|Environmental Tobacco Smoke(ETS)|environmental tobacco smoke(ets)
5163440|NCT00960596|children|children
5163441|NCT00960583|Chronic low back pain|chronic low back pain
5163442|NCT00960583|Multidisciplinary rehabilitation|multidisciplinary rehabilitation
5163443|NCT00960583|Exercise|exercise
5163444|NCT00960583|Cost-effectiveness|cost-effectiveness
5163445|NCT00960570|healthy|healthy
5163446|NCT00960570|adult|adult
5163447|NCT00960570|efavirenz|efavirenz
5163448|NCT00960570|fenofibric acid|fenofibric acid
5163449|NCT00960570|blood levels|blood levels
5163450|NCT00960557|hepatic tumor burden|hepatic tumor burden
5163451|NCT00960557|liver cancer|liver cancer
5163452|NCT00960557|liver carcinoma|liver carcinoma
5163453|NCT00960557|carcinoma|carcinoma
5163454|NCT00960557|hepatic cancer|hepatic cancer
5163455|NCT00960557|hepatic carcinoma|hepatic carcinoma
5163456|NCT00960557|VDA|vda
5163457|NCT00960557|Vascular Disrupting Agent|vascular disrupting agent
5163458|NCT00960544|Capecitabine|capecitabine
5163459|NCT00960544|Xeloda|xeloda
5163460|NCT00960544|Gene expression|gene expression
5163461|NCT00960544|Pharmacokinetic testing|pharmacokinetic testing
5163462|NCT00960544|PK sampling|pk sampling
5163463|NCT00960544|DNA analysis|dna analysis
5163464|NCT00960518|HBV-related unresectable HCC|hbv-related unresectable hcc
5163465|NCT00960518|TACE|tace
5163466|NCT00960518|adefovir|adefovir
5163467|NCT00960518|recurrence rate|recurrence rate
5163468|NCT00960505|Diet|diet
5163469|NCT00960505|Coronary heart disease|coronary heart disease
5163470|NCT00960505|Obesity|obesity
5163471|NCT00960505|Weight loss|weight loss
5163472|NCT00960505|Weight maintenance|weight maintenance
5163473|NCT00960492|Astrocytic tumor|astrocytic tumor
5163474|NCT00960492|Glioblastoma with oligodendroglial components|glioblastoma with oligodendroglial components
5163475|NCT00960466|Stress, Psychological|stress, psychological
5163476|NCT00960466|Neoplasms/psychology|neoplasms/psychology
5163477|NCT00960466|Psychology|psychology
5163478|NCT00960440|randomized double-blind placebo-controlled investigational drug oral therapy safety and efficacy|randomized double-blind placebo-controlled investigational drug oral therapy safety and efficacy
5163479|NCT00960427|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5163480|NCT00960427|stage II rectal cancer|stage ii rectal cancer
5163481|NCT00960427|stage III rectal cancer|stage iii rectal cancer
5163482|NCT00960414|obesity|obesity
5163483|NCT00960414|randomized controlled trial|randomized controlled trial
5163484|NCT00960414|weight loss|weight loss
5163485|NCT00960414|metabolic syndrome|metabolic syndrome
5163486|NCT00960401|coronary calcium scoring|coronary calcium scoring
5163487|NCT00960401|breast cancer patients|breast cancer patients
5163488|NCT00960401|radiation treatment|radiation treatment
5163489|NCT00960375|smoking cessation|smoking cessation
5163490|NCT00960375|serious mental illness|serious mental illness
5163491|NCT00960349|Gastric cancer|gastric cancer
5163492|NCT00960349|Japanese|japanese
5163493|NCT00960349|PhI|phi
5163494|NCT00960349|Safety and tolerability|safety and tolerability
5163495|NCT00960349|Cediranib in combination with cisplatin plus a fluoropyrimidine|cediranib in combination with cisplatin plus a fluoropyrimidine
5163496|NCT00960349|Cediranib|cediranib
5163497|NCT00960349|Capecitabine|capecitabine
5163498|NCT00960349|S-1|s-1
5163499|NCT00960349|Cisplatin|cisplatin
5163500|NCT00960349|Untreated locally advanced or metastatic unresectable gastric cancer (GC)|untreated locally advanced or metastatic unresectable gastric cancer (gc)
5163501|NCT00960336|HER2-negative breast cancer|her2-negative breast cancer
5163502|NCT00960336|recurrent breast cancer|recurrent breast cancer
5163503|NCT00960336|stage IV breast cancer|stage iv breast cancer
5163504|NCT00960336|invasive ductal breast carcinoma|invasive ductal breast carcinoma
5163505|NCT00960336|invasive lobular breast carcinoma|invasive lobular breast carcinoma
5163506|NCT00960323|pharmacokinetics|pharmacokinetics
5163507|NCT00960310|Treatment|treatment
5163508|NCT00960297|Non-Small Cell Lung Cancer|non-small cell lung cancer
5163509|NCT00960297|NSCLC|nsclc
5163510|NCT00960297|Preoperative chemotherapy|preoperative chemotherapy
5163511|NCT00960297|Bevacizumab|bevacizumab
5163512|NCT00960297|Avastin|avastin
5163513|NCT00960284|stage IB pancreatic cancer|stage ib pancreatic cancer
5163514|NCT00960284|stage II pancreatic cancer|stage ii pancreatic cancer
5163515|NCT00960284|stage III pancreatic cancer|stage iii pancreatic cancer
5163516|NCT00960284|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
5163517|NCT00960271|Non-small cell lung cancer|non-small cell lung cancer
5163518|NCT00960271|mediastinal lymph node|mediastinal lymph node
5163519|NCT00960271|resectable|resectable
5163520|NCT00960271|EBUS|ebus
5163521|NCT00960271|stage IIIA|stage iiia
5163522|NCT00960271|significant mediastinal lymph node at thoracic CT Scan|significant mediastinal lymph node at thoracic ct scan
5163523|NCT00960258|Solid Tumors|solid tumors
5163524|NCT00960232|vitamin D|vitamin d
5163525|NCT00960232|blood pressure|blood pressure
5163526|NCT00960232|lipids|lipids
5163527|NCT00960232|infection|infection
5163528|NCT00960232|depression|depression
5163529|NCT00960193|blood levels over time|blood levels over time
5163530|NCT00960193|colchicine|colchicine
5163531|NCT00960193|seville orange juice|seville orange juice
5163532|NCT00960193|pharmacokinetics|pharmacokinetics
5163534|NCT00960167|radiotherapy|radiotherapy
5163535|NCT00960167|dose escalation|dose escalation
5163536|NCT00960167|Toxicity|toxicity
5163537|NCT00960167|Local control|local control
5163538|NCT00960154|Lumpectomy|lumpectomy
5163539|NCT00960154|PlasmaBlade|plasmablade
5163540|NCT00960154|Electrosurgery|electrosurgery
5163541|NCT00960154|PEAK Surgical|peak surgical
5163542|NCT00960154|Medtronic Advanced Energy|medtronic advanced energy
5163543|NCT00960154|Medtronic|medtronic
5163544|NCT00960115|NSCLC|nsclc
5163545|NCT00960115|Stage III|stage iii
5163546|NCT00960115|EMD531444|emd531444
5163547|NCT00960115|L-BLP25|l-blp25
5163548|NCT00960115|Cyclophosphamide|cyclophosphamide
5163549|NCT00960115|Immunotherapy|immunotherapy
5163550|NCT00960115|Tecemotide|tecemotide
5163551|NCT00960102|cochlear implantation|cochlear implantation
5163552|NCT00960089|Toenail|toenail
5163553|NCT00960089|Fungus|fungus
5163554|NCT00960089|Onychomycosis|onychomycosis
5163555|NCT00960089|Dermatophyte|dermatophyte
5163556|NCT00960076|T2DM|t2dm
5163557|NCT00960076|Metformin|metformin
5163558|NCT00960076|A1c|a1c
5163559|NCT00960037|Vitamin D3|vitamin d3
5163560|NCT00960037|obesity|obesity
5163561|NCT00960037|cholecalciferol|cholecalciferol
5163562|NCT00960024|Vocational rehabilitation|vocational rehabilitation
5163563|NCT00960024|Severe mental illness|severe mental illness
5163564|NCT00960024|Psychosis|psychosis
5163565|NCT00960024|Mental Health|mental health
5163566|NCT00960011|Inguinal hernia|inguinal hernia
5163567|NCT00960011|mesh|mesh
5163568|NCT00960011|progrip|progrip
5163569|NCT00959998|Persistent Cancer-Related Fatigue|persistent cancer-related fatigue
5163570|NCT00959985|compression sleeve|compression sleeve
5163571|NCT00959985|compression bandage|compression bandage
5163572|NCT00959972|Varenicline|varenicline
5163573|NCT00959972|transdermal nicotine patch|transdermal nicotine patch
5163574|NCT00959972|cardiovascular disease|cardiovascular disease
5163575|NCT00959972|prevention|prevention
5163576|NCT00959972|coronary heart disease|coronary heart disease
5163577|NCT00959972|Smoking cessation|smoking cessation
5163578|NCT00959959|CRPC|crpc
5163579|NCT00959959|HRPC|hrpc
5163580|NCT00959959|TOK-001|tok-001
5163581|NCT00959959|ARMOR|armor
5163582|NCT00959959|ARMOR1|armor1
5163583|NCT00959946|Phase 1/2|phase 1/2
5163584|NCT00959946|2-part study|2-part study
5163585|NCT00959946|bosutinib and capecitabine|bosutinib and capecitabine
5163586|NCT00959920|Indwelling bladder catheter|indwelling bladder catheter
5163587|NCT00959920|Intermittent straight catheterization|intermittent straight catheterization
5163588|NCT00959920|Labor and Delivery|labor and delivery
5163589|NCT00959920|Time to delivery during labor|time to delivery during labor
5163590|NCT00959907|Muscular activity|muscular activity
5163591|NCT00959907|wrinkles in frontal area|wrinkles in frontal area
5163592|NCT00959907|action halos|action halos
5163593|NCT00959894|HIV|hiv
5163594|NCT00959894|Infection|infection
5163595|NCT00959894|Treatment Naive|treatment naive
5163596|NCT00959894|Adults|adults
5163597|NCT00959894|Once|once
5163598|NCT00959894|Daily|daily
5163599|NCT00959894|Etravirine|etravirine
5163600|NCT00959894|HIV-1 Infection|hiv-1 infection
5163601|NCT00959881|Alzheimer Disease|alzheimer disease
5163602|NCT00959868|Bladder cancer|bladder cancer
5163603|NCT00959868|Superficial bladder cancer (Ta or T1)|superficial bladder cancer (ta or t1)
5163604|NCT00959868|Muscle invasive bladder cancer (T2)|muscle invasive bladder cancer (t2)
5163605|NCT00959868|Transurethral resection|transurethral resection
5163606|NCT00959868|Radical cystectomy|radical cystectomy
5163607|NCT00959868|OGX-427|ogx-427
5163608|NCT00959868|Antisense oligonucleotide|antisense oligonucleotide
5163609|NCT00959868|Heat shock protein 27|heat shock protein 27
5163610|NCT00959868|superficial bladder tumour (Ta or T1) or CIS prior to a transurethral resection|superficial bladder tumour (ta or t1) or cis prior to a transurethral resection
5163611|NCT00959868|Muscle invasive (T2) bladder cancer prior to radical cystectomy|muscle invasive (t2) bladder cancer prior to radical cystectomy
5163612|NCT00959855|COPD|copd
5163613|NCT00959855|Pulmonary Rehabilitation|pulmonary rehabilitation
5163614|NCT00959855|Inflammation|inflammation
5163615|NCT00959855|Oxidative Stress|oxidative stress
5163616|NCT00959855|Steps|steps
5163617|NCT00959855|Free Living Activities|free living activities
5163618|NCT00959855|Exacerbation|exacerbation
5163619|NCT00959842|hypertriglyceridemia|hypertriglyceridemia
5163620|NCT00959842|Omega-3 Fatty Acids|omega-3 fatty acids
5163621|NCT00959842|Lipoprotein|lipoprotein
5163622|NCT00959842|Statin|statin
5163623|NCT00959842|Lovaza|lovaza
5163624|NCT00959829|Communication|communication
5163625|NCT00959829|Complementary Therapies|complementary therapies
5163626|NCT00959829|Intensive Care|intensive care
5163627|NCT00959829|Ethics|ethics
5163628|NCT00959816|Volunteers|volunteers
5163629|NCT00959803|Phase 1|phase 1
5163630|NCT00959803|Pharmacokinetics|pharmacokinetics
5163631|NCT00959803|Healthy Young Adult|healthy young adult
5163632|NCT00959803|Japanese|japanese
5163633|NCT00959803|Healthy Elderly|healthy elderly
5163634|NCT00959803|Alzheimer disease|alzheimer disease
5163635|NCT00959790|Health|health
5163636|NCT00959790|Obesity|obesity
5163637|NCT00959790|Oxidative stress|oxidative stress
5163638|NCT00959790|Challenge concept|challenge concept
5163639|NCT00959790|Vegetables|vegetables
5163640|NCT00959751|migraine|migraine
5163641|NCT00959738|loop ileostomy|loop ileostomy
5163642|NCT00959738|quality of life|quality of life
5163643|NCT00959738|morbidity|morbidity
5163644|NCT00959738|Rectal Neoplasms|rectal neoplasms
5163645|NCT00959725|Infliximab|infliximab
5163646|NCT00959725|Diabetes|diabetes
5163647|NCT00959725|Macular Edema|macular edema
5163648|NCT00959699|coinfection|coinfection
5163649|NCT00959699|protease inhibitor|protease inhibitor
5163650|NCT00959699|HIV|hiv
5163651|NCT00959686|Bendamustine refractory or relapsed T-cell lymphoma.|bendamustine refractory or relapsed t-cell lymphoma.
5163652|NCT00959660|Diastolic heart failure|diastolic heart failure
5163653|NCT00959660|Heart Failure|heart failure
5163654|NCT00959660|Elderly|elderly
5163655|NCT00959660|Obesity|obesity
5163656|NCT00959647|Hedgehog pathway inhibitor|hedgehog pathway inhibitor
5163657|NCT00959621|Habitual abortion|habitual abortion
5163658|NCT00959621|recurrent abortion|recurrent abortion
5163659|NCT00959621|hereditary and acquired|hereditary and acquired
5163660|NCT00959621|thrombophilia|thrombophilia
5163661|NCT00959621|preeclampsia|preeclampsia
5163662|NCT00959621|premature birth|premature birth
5163663|NCT00959621|miscarriage|miscarriage
5163664|NCT00959621|stillbirth|stillbirth
5163665|NCT00959621|LMWH (low molecular weigh heparin)|lmwh (low molecular weigh heparin)
5163666|NCT00959621|ASA|asa
5163667|NCT00959621|aspirin|aspirin
5163668|NCT00959608|Weight Management in adults|weight management in adults
5163669|NCT00959608|Reducing Health Disparities|reducing health disparities
5163670|NCT00959595|Diabetes mellitus|diabetes mellitus
5163671|NCT00959595|neuropathy|neuropathy
5163672|NCT00959595|foot|foot
5163673|NCT00959595|sensibility|sensibility
5163674|NCT00959595|brain plasticity|brain plasticity
5163675|NCT00959582|Relapsed ovarian cancer|relapsed ovarian cancer
5163676|NCT00959569|esmolol|esmolol
5163677|NCT00959569|cardiac surgery|cardiac surgery
5163678|NCT00959569|cardiac anesthesia|cardiac anesthesia
5163679|NCT00959569|mortality|mortality
5163680|NCT00959569|beta blockers|beta blockers
5163681|NCT00959569|beta-blockers|beta-blockers
5163682|NCT00959569|cardiac protection|cardiac protection
5163683|NCT00959556|recurrent breast cancer|recurrent breast cancer
5163684|NCT00959556|stage IA breast cancer|stage ia breast cancer
5163685|NCT00959556|stage IB breast cancer|stage ib breast cancer
5163686|NCT00959556|stage II breast cancer|stage ii breast cancer
5163687|NCT00959556|stage IIIA breast cancer|stage iiia breast cancer
5163688|NCT00959556|stage IIIB breast cancer|stage iiib breast cancer
5163689|NCT00959556|stage IIIC breast cancer|stage iiic breast cancer
5163690|NCT00959556|stage IV breast cancer|stage iv breast cancer
5163691|NCT00959530|complete dentures|complete dentures
5163692|NCT00959530|patient satisfaction|patient satisfaction
5163693|NCT00959530|treatment cost|treatment cost
5163694|NCT00959517|Placebo controlled|placebo controlled
5163695|NCT00959517|Efficacy|efficacy
5163696|NCT00959517|Artemisinin-based combination therapy|artemisinin-based combination therapy
5163697|NCT00959517|Primaquine|primaquine
5163698|NCT00959517|Gametocytes|gametocytes
5163699|NCT00959491|Colonoscopy|colonoscopy
5163700|NCT00959491|Occult Blood|occult blood
5163701|NCT00959491|Fecal|fecal
5163702|NCT00959478|Carbon Monoxide (CO)|carbon monoxide (co)
5163703|NCT00959478|Carbon Monoxide Poisoning|carbon monoxide poisoning
5163704|NCT00959478|Carbon Monoxide Alarm/Detector|carbon monoxide alarm/detector
5163705|NCT00959478|Precaution Adoption Process Model (PAPM)|precaution adoption process model (papm)
5163706|NCT00959478|Injury Prevention|injury prevention
5163707|NCT00959478|Emergency Department|emergency department
5163708|NCT00959452|Hypochondria|hypochondria
5163709|NCT00959452|Cognitive behavioural therapy|cognitive behavioural therapy
5163710|NCT00959452|Long term follow-up|long term follow-up
5163711|NCT00959452|Psychosomatics|psychosomatics
5163712|NCT00959452|Psychotherapy|psychotherapy
5163713|NCT00959426|- Mutliple Ascending Dose Study in Overweight Subjects - Body Weight - Signs and Symptoms|- mutliple ascending dose study in overweight subjects - body weight - signs and symptoms
5163714|NCT00959400|Fentanyl Transdermal|fentanyl transdermal
5163715|NCT00959400|Pain|pain
5163716|NCT00959400|Cancer|cancer
5163717|NCT00959387|head and neck cancer|head and neck cancer
5163718|NCT00959387|induction chemotherapy|induction chemotherapy
5163719|NCT00959374|Abdominoplasty|abdominoplasty
5163720|NCT00959374|Reduction Mammaplasty|reduction mammaplasty
5163721|NCT00959374|Mastopexy|mastopexy
5163722|NCT00959361|patient compliance|patient compliance
5163723|NCT00959361|guidelines adherence|guidelines adherence
5163724|NCT00959361|advance directive adherence|advance directive adherence
5163725|NCT00959361|treatment refusal|treatment refusal
5163726|NCT00959361|directly observed therapy|directly observed therapy
5163727|NCT00959361|anti-retroviral agents|anti-retroviral agents
5163728|NCT00959361|HIV seropositivity|hiv seropositivity
5163729|NCT00959361|HIV infections|hiv infections
5163730|NCT00959361|HIV|hiv
5163731|NCT00959361|pharmaceutical services|pharmaceutical services
5163732|NCT00959361|HIV-positives patients|hiv-positives patients
5163733|NCT00959361|treatment experienced|treatment experienced
5163734|NCT00959348|Asthma|asthma
5163735|NCT00959348|Diabetes|diabetes
5163736|NCT00959348|Impaired glucose tolerance|impaired glucose tolerance
5163737|NCT00959348|Insulin resistance|insulin resistance
5163738|NCT00959335|treatment|treatment
5163739|NCT00959322|Capsulotomy|capsulotomy
5163740|NCT00959309|pediatrics|pediatrics
5163741|NCT00959309|media|media
5163742|NCT00959309|MUPS|mups
5163743|NCT00959296|Registry|registry
5163744|NCT00959296|Pain|pain
5163745|NCT00959296|Chronic Pain|chronic pain
5163746|NCT00959296|Back Pain|back pain
5163747|NCT00959296|Intractable Spasticity|intractable spasticity
5163748|NCT00959296|Parkinson's Disease|parkinson's disease
5163749|NCT00959296|Essential Tremor|essential tremor
5163750|NCT00959296|Dystonia|dystonia
5163751|NCT00959296|Implantable Pumps|implantable pumps
5163752|NCT00959296|Incontinence|incontinence
5163753|NCT00959257|Asthma|asthma
5163754|NCT00959257|Inhaled corticosteroids|inhaled corticosteroids
5163755|NCT00959257|Cardiovascular morbidities|cardiovascular morbidities
5163756|NCT00959257|Systemic inflammation|systemic inflammation
5163757|NCT00959244|ductal breast carcinoma in situ|ductal breast carcinoma in situ
5163758|NCT00959244|stage I breast cancer|stage i breast cancer
5163759|NCT00959244|stage II breast cancer|stage ii breast cancer
5163760|NCT00959244|stage IIIA breast cancer|stage iiia breast cancer
5163761|NCT00959244|stage IIIB breast cancer|stage iiib breast cancer
5163762|NCT00959244|stage IIIC breast cancer|stage iiic breast cancer
5163763|NCT00959244|stage IV breast cancer|stage iv breast cancer
5163764|NCT00959231|hematopoietic/lymphoid cancer|hematopoietic/lymphoid cancer
5163765|NCT00959218|Dronabinol|dronabinol
5163766|NCT00959218|(-)trans-delta9-tetrahydrocannabinol|(-)trans-delta9-tetrahydrocannabinol
5163767|NCT00959218|central neuropathic pain|central neuropathic pain
5163768|NCT00959218|multiple sclerosis|multiple sclerosis
5163769|NCT00959218|analgesic|analgesic
5163770|NCT00959218|Central neuropathic pain related to multiple sclerosis|central neuropathic pain related to multiple sclerosis
5163771|NCT00959179|CHF|chf
5163772|NCT00959166|Acute hepatitis C|acute hepatitis c
5163773|NCT00959166|HIV|hiv
5163774|NCT00959166|Neurocognitive function|neurocognitive function
5163775|NCT00959166|Neuroinflammation|neuroinflammation
5163776|NCT00959153|Fragmenting of kidney stones|fragmenting of kidney stones
5163777|NCT00959153|extracorporeal shockwave lithotripsy|extracorporeal shockwave lithotripsy
5163778|NCT00959140|Allo PBSC|allo pbsc
5163779|NCT00959140|HSCT|hsct
5163780|NCT00959140|Bone Marrow Transplant|bone marrow transplant
5163781|NCT00959140|Allogeneic Bone Marrow Transplant|allogeneic bone marrow transplant
5163782|NCT00959140|Matched Related Donor Transplant|matched related donor transplant
5163783|NCT00959140|MRD HSCT|mrd hsct
5163784|NCT00959127|Colorectal Adenocarcinoma|colorectal adenocarcinoma
5163785|NCT00959127|Colon Cancer|colon cancer
5163786|NCT00959127|Rectal Cancer|rectal cancer
5163787|NCT00959114|Celiac Disease|celiac disease
5163788|NCT00959114|Coeliac Disease|coeliac disease
5163789|NCT00959114|Celiac Sprue|celiac sprue
5163790|NCT00959114|Keliakia|keliakia
5163791|NCT00959075|Thiamin supplementation|thiamin supplementation
5163792|NCT00959075|Thiamin deficiency|thiamin deficiency
5163793|NCT00959075|Heart failure|heart failure
5163794|NCT00959075|Improve heart function|improve heart function
5163795|NCT00959075|Vitamin B1 supplementation|vitamin b1 supplementation
5163796|NCT00959062|Pilot Study|pilot study
5163797|NCT00959062|Randomized Controlled Trial|randomized controlled trial
5163798|NCT00959062|Critically Ill|critically ill
5163799|NCT00959062|Child|child
5163800|NCT00959062|Pediatric|pediatric
5163801|NCT00959062|Clonidine|clonidine
5163802|NCT00959062|Sedation|sedation
5163803|NCT00959023|stage I prostate cancer|stage i prostate cancer
5164009|NCT00958152|VX-222|vx-222
5163804|NCT00959023|stage IIB prostate cancer|stage iib prostate cancer
5163805|NCT00959023|stage IIA prostate cancer|stage iia prostate cancer
5163806|NCT00959023|stage III prostate cancer|stage iii prostate cancer
5163807|NCT00959023|stage IV prostate cancer|stage iv prostate cancer
5163808|NCT00959023|recurrent prostate cancer|recurrent prostate cancer
5163809|NCT00959010|Omega 3|omega 3
5163810|NCT00959010|Cystic Fibrosis|cystic fibrosis
5163811|NCT00959010|Inflammatory markers|inflammatory markers
5163812|NCT00958997|diabetes|diabetes
5163813|NCT00958997|islet|islet
5163814|NCT00958997|pancreas|pancreas
5163815|NCT00958997|beta cell mass|beta cell mass
5163816|NCT00958997|PET imaging|pet imaging
5163817|NCT00958997|FPDTBZ|fpdtbz
5163818|NCT00958997|arginine stimulus test|arginine stimulus test
5163819|NCT00958984|pediatric|pediatric
5163820|NCT00958984|solid organ transplant|solid organ transplant
5163821|NCT00958984|hemoglobin|hemoglobin
5163822|NCT00958971|Breast cancer|breast cancer
5163823|NCT00958971|HER2 negative|her2 negative
5163824|NCT00958971|FGFR1|fgfr1
5163825|NCT00958958|Acute Coronary Syndrome|acute coronary syndrome
5163826|NCT00958958|randomized cluster trial|randomized cluster trial
5163827|NCT00958958|quality improvement|quality improvement
5163828|NCT00958945|Postoperative Hematocrit|postoperative hematocrit
5163829|NCT00958945|Postoperative Hemoglobin|postoperative hemoglobin
5163830|NCT00958919|breathlessness intensity|breathlessness intensity
5163831|NCT00958919|breathlessness unpleasantness|breathlessness unpleasantness
5163832|NCT00958919|endorphins|endorphins
5163833|NCT00958919|resistive breathing loads|resistive breathing loads
5163834|NCT00958906|Infliximab|infliximab
5163835|NCT00958906|Uveitis|uveitis
5163836|NCT00958906|Macular Edema|macular edema
5163837|NCT00958906|Intraocular Inflammation|intraocular inflammation
5163838|NCT00958893|Uterine fibroids|uterine fibroids
5163839|NCT00958867|Resistance exercise training|resistance exercise training
5163840|NCT00958867|aerobic exercise training|aerobic exercise training
5163841|NCT00958854|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
5163842|NCT00958841|Rare tumors of neuroendocrine origin|rare tumors of neuroendocrine origin
5163843|NCT00958841|NETs of the pancreatic|nets of the pancreatic
5163844|NCT00958841|Pituitary NETs|pituitary nets
5163845|NCT00958841|EAS Tumors|eas tumors
5163846|NCT00958841|Nelson's Syndrome|nelson's syndrome
5163847|NCT00958841|Pancreatic neoplasm|pancreatic neoplasm
5163848|NCT00958841|pituitary neoplasm|pituitary neoplasm
5163849|NCT00958841|Nelson Syndrome|nelson syndrome
5163850|NCT00958841|ectopic ACTH syndrome|ectopic acth syndrome
5163851|NCT00958841|pasireotide LAR|pasireotide lar
5163852|NCT00958841|PNETs|pnets
5163853|NCT00958841|PiNETS|pinets
5163854|NCT00958815|vascular imaging|vascular imaging
5163855|NCT00958815|diabetes|diabetes
5163856|NCT00958815|rupture prone plaques|rupture prone plaques
5163857|NCT00958815|HIV|hiv
5163858|NCT00958815|treatment experienced|treatment experienced
5163859|NCT00958802|tissue engineering|tissue engineering
5163860|NCT00958776|Influenza|influenza
5163861|NCT00958776|Hospitalized|hospitalized
5163862|NCT00958776|Antiviral|antiviral
5163863|NCT00958776|Flu|flu
5163864|NCT00958763|HCV|hcv
5163865|NCT00958763|Alcohol|alcohol
5163866|NCT00958763|Methadone Maintained|methadone maintained
5163867|NCT00958750|Androgenetic alopecia|androgenetic alopecia
5163868|NCT00958750|female pattern hair loss|female pattern hair loss
5163869|NCT00958737|stage III colon cancer|stage iii colon cancer
5163870|NCT00958737|adenocarcinoma of the colon|adenocarcinoma of the colon
5163871|NCT00958724|HKI-272|hki-272
5163872|NCT00958724|Vinorelbine|vinorelbine
5163873|NCT00958724|Combination|combination
5163874|NCT00958724|Solid Tumor|solid tumor
5163875|NCT00958724|Neratinib|neratinib
5163876|NCT00958724|Nerlynx|nerlynx
5163877|NCT00958724|PB-272|pb-272
5163878|NCT00958685|ginger extract|ginger extract
5163879|NCT00958685|ARDS|ards
5163880|NCT00958685|enteral feeding|enteral feeding
5163881|NCT00958685|mechanical ventilation|mechanical ventilation
5163882|NCT00958685|ICU|icu
5163883|NCT00958646|OMT|omt
5163884|NCT00958646|biomarker|biomarker
5163885|NCT00958646|Manipulation, osteopathic|manipulation, osteopathic
5163886|NCT00958633|Bipolar I disorder|bipolar i disorder
5163887|NCT00958633|Depression|depression
5163888|NCT00958633|Antidepressant|antidepressant
5163889|NCT00958620|Chronic Achilles Tendinopathy|chronic achilles tendinopathy
5163890|NCT00958607|Caregivers|caregivers
5163891|NCT00958607|Stroke|stroke
5163892|NCT00958607|Social support|social support
5163893|NCT00958607|Phase specific care|phase specific care
5163894|NCT00958581|antifibrinolytics|antifibrinolytics
5163895|NCT00958542|cerebral palsy|cerebral palsy
5163896|NCT00958542|scoliosis|scoliosis
5163897|NCT00958542|children|children
5163898|NCT00958529|fiber|fiber
5163899|NCT00958529|inulin|inulin
5163900|NCT00958529|gastrointestinal tolerance|gastrointestinal tolerance
5163901|NCT00958516|volunteers|volunteers
5163902|NCT00958503|safety|safety
5163903|NCT00958503|biomarker|biomarker
5163904|NCT00958503|thiamphenicol|thiamphenicol
5163905|NCT00958503|EAAT2|eaat2
5163906|NCT00958477|Safety|safety
5163907|NCT00958477|tolerability|tolerability
5163908|NCT00958477|pharmacokinetics|pharmacokinetics
5163909|NCT00958477|pharmacodynamics of EMD 525797|pharmacodynamics of emd 525797
5163910|NCT00958477|prostate cancer patients|prostate cancer patients
5163911|NCT00958464|MRI|mri
5163912|NCT00958464|Perthes'disease|perthes'disease
5163913|NCT00958464|hip|hip
5163914|NCT00958464|cartilage|cartilage
5163915|NCT00958451|Calcium|calcium
5163916|NCT00958451|Vitamin D deficiency|vitamin d deficiency
5163917|NCT00958451|Chronic Kidney disease|chronic kidney disease
5163918|NCT00958438|Intercritical Gout|intercritical gout
5163919|NCT00958438|Metabolism, Inborn Errors|metabolism, inborn errors
5163920|NCT00958438|Allopurinol|allopurinol
5163921|NCT00958438|Metabolic Diseases|metabolic diseases
5163922|NCT00958438|Genetic Diseases, Inborn|genetic diseases, inborn
5163923|NCT00958438|Musculoskeletal Diseases|musculoskeletal diseases
5163924|NCT00958438|Joint Diseases|joint diseases
5163925|NCT00958438|Arthritis|arthritis
5163926|NCT00958438|Rheumatic Diseases|rheumatic diseases
5163927|NCT00958438|Metabolic disorder|metabolic disorder
5163928|NCT00958438|Purine-Pyrimidine Metabolism, Inborn Errors|purine-pyrimidine metabolism, inborn errors
5163929|NCT00958438|Gout|gout
5163930|NCT00958412|Endometriosis|endometriosis
5163931|NCT00958412|Pelvic pain|pelvic pain
5163932|NCT00958412|Oral progesterone blocker|oral progesterone blocker
5163933|NCT00958399|satiety|satiety
5163934|NCT00958399|fiber|fiber
5163935|NCT00958399|food intake|food intake
5163936|NCT00958399|gut hormones|gut hormones
5163937|NCT00958399|visual analog scales|visual analog scales
5163938|NCT00958399|microflora|microflora
5163939|NCT00958386|colorectal cancer|colorectal cancer
5163940|NCT00958386|Panitumumab|panitumumab
5163941|NCT00958386|irinotecan|irinotecan
5163942|NCT00958373|Scoliosis|scoliosis
5163943|NCT00958373|adolescent idiopathic scoliosis|adolescent idiopathic scoliosis
5163944|NCT00958373|spine curve|spine curve
5163945|NCT00958373|pediatric|pediatric
5163946|NCT00958373|mental health|mental health
5163947|NCT00958373|screening|screening
5163948|NCT00958360|vision, low|vision, low
5163949|NCT00958334|Uterine fibroids|uterine fibroids
5163950|NCT00958321|adenocarcinoma of the lung|adenocarcinoma of the lung
5163951|NCT00958321|large cell lung cancer|large cell lung cancer
5163952|NCT00958321|squamous cell lung cancer|squamous cell lung cancer
5163953|NCT00958321|malignant pleural effusion|malignant pleural effusion
5163954|NCT00958321|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5163955|NCT00958321|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5163956|NCT00958321|stage IA non-small cell lung cancer|stage ia non-small cell lung cancer
5163957|NCT00958321|stage IB non-small cell lung cancer|stage ib non-small cell lung cancer
5163958|NCT00958321|stage IIA non-small cell lung cancer|stage iia non-small cell lung cancer
5163959|NCT00958321|stage IIB non-small cell lung cancer|stage iib non-small cell lung cancer
5163960|NCT00958308|Probiotic|probiotic
5163961|NCT00958308|Antibiotic-Associated Diarrhea (AAD) Prevention|antibiotic-associated diarrhea (aad) prevention
5163962|NCT00958308|Clostridium Difficile-Associated Diarrhea (CDAD)Prevention|clostridium difficile-associated diarrhea (cdad)prevention
5163963|NCT00958295|urinary tract infection|urinary tract infection
5163964|NCT00958295|cystitis|cystitis
5163965|NCT00958282|cocaine|cocaine
5163966|NCT00958282|treatment|treatment
5163967|NCT00958282|lisdexamfetamine|lisdexamfetamine
5163968|NCT00958282|dependence|dependence
5163969|NCT00958282|addiction|addiction
5163970|NCT00958282|crack|crack
5163971|NCT00958269|diabetes|diabetes
5163972|NCT00958269|DPP4 inhibitor|dpp4 inhibitor
5163973|NCT00958269|dutogliptin|dutogliptin
5163974|NCT00958269|PHX1149|phx1149
5163975|NCT00958256|Mantle Cell Lymphoma|mantle cell lymphoma
5163976|NCT00958256|Lymphoma|lymphoma
5163977|NCT00958256|Bortezomib|bortezomib
5163978|NCT00958256|Velcade|velcade
5163979|NCT00958256|Rituximab|rituximab
5163980|NCT00958256|Rituxan|rituxan
5163981|NCT00958256|Cyclophosphamide|cyclophosphamide
5163982|NCT00958256|Cytoxan|cytoxan
5163983|NCT00958256|Neosar|neosar
5163984|NCT00958256|Mesna|mesna
5163985|NCT00958256|Mesnex|mesnex
5163986|NCT00958256|G-CSF|g-csf
5163987|NCT00958256|Filgrastim|filgrastim
5163988|NCT00958256|Neupogen|neupogen
5163989|NCT00958230|endarterectomy|endarterectomy
5163990|NCT00958230|dCell|dcell
5163991|NCT00958230|Tissue Regenix Ltd|tissue regenix ltd
5163992|NCT00958230|TRL|trl
5163993|NCT00958230|Vascular Patch|vascular patch
5163994|NCT00958230|Treatment|treatment
5163995|NCT00958217|Depressive symptoms|depressive symptoms
5163996|NCT00958217|Substance-related disorders|substance-related disorders
5163997|NCT00958217|Posttraumatic stress disorders|posttraumatic stress disorders
5163998|NCT00958217|Psychotherapy|psychotherapy
5163999|NCT00958204|Depression|depression
5164000|NCT00958204|rating scales|rating scales
5164001|NCT00958204|RCT|rct
5164002|NCT00958204|combination treatment|combination treatment
5164003|NCT00958204|light therapy|light therapy
5164004|NCT00958204|negative ion therapy|negative ion therapy
5164005|NCT00958204|fluoxetine|fluoxetine
5164006|NCT00958204|antidepressants|antidepressants
5164007|NCT00958165|Treatment of PAF using EAS-AC|treatment of paf using eas-ac
5164008|NCT00958152|VX-950|vx-950
5164010|NCT00958152|STAT-C|stat-c
5164011|NCT00958139|Lyme disease|lyme disease
5164012|NCT00958139|tick|tick
5164013|NCT00958100|raltegravir switch toxicity|raltegravir switch toxicity
5164014|NCT00958100|treatment experienced|treatment experienced
5164015|NCT00958061|CVD|cvd
5164016|NCT00958048|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
5164017|NCT00958048|hypoventilation|hypoventilation
5164018|NCT00957996|influenza|influenza
5164019|NCT00957996|hospitalized|hospitalized
5164020|NCT00957996|flu|flu
5164021|NCT00957996|antiviral|antiviral
5164022|NCT00957970|Stress shielding|stress shielding
5164023|NCT00957970|Bone mineral density|bone mineral density
5164024|NCT00957970|stemless femoral component|stemless femoral component
5164025|NCT00957944|Rotigotine|rotigotine
5164026|NCT00957944|Neupro®|neupro®
5164027|NCT00957918|levodopa-induced dyskinesia|levodopa-induced dyskinesia
5164028|NCT00957918|Parkinson's disease|parkinson's disease
5164029|NCT00957918|parkinsonian|parkinsonian
5164030|NCT00957918|levodopa-induced dyskinesias in Parkinson's disease|levodopa-induced dyskinesias in parkinson's disease
5164031|NCT00957892|Healthy Infants|healthy infants
5164032|NCT00957892|Satiation|satiation
5164033|NCT00957892|Satiety|satiety
5164034|NCT00957892|Intake Regulation|intake regulation
5164035|NCT00957892|Infant Feeding|infant feeding
5164036|NCT00957892|Infant Formula Feeding|infant formula feeding
5164037|NCT00957879|Vitamin D|vitamin d
5164038|NCT00957879|FGF23|fgf23
5164039|NCT00957879|FGF-23|fgf-23
5164040|NCT00957879|Phosphate|phosphate
5164041|NCT00957866|The number of cases in the database thus far (4,477) is clearly sufficient to achieve meaningful results|the number of cases in the database thus far (4,477) is clearly sufficient to achieve meaningful results
5164042|NCT00957853|Head and Neck Cancer|head and neck cancer
5164043|NCT00957853|Squamous cell carcinoma of the head and neck|squamous cell carcinoma of the head and neck
5164044|NCT00957853|HNSCC|hnscc
5164045|NCT00957853|Cetuximab|cetuximab
5164046|NCT00957853|IMC-A12|imc-a12
5164047|NCT00957853|Tumor|tumor
5164048|NCT00957853|Biomarkers|biomarkers
5164049|NCT00957853|Phospho-AKT|phospho-akt
5164050|NCT00957853|Surgical resection|surgical resection
5164051|NCT00957840|Omaya reservoirs|omaya reservoirs
5164052|NCT00957840|cerebral oxygenation|cerebral oxygenation
5164053|NCT00957840|VP shunt|vp shunt
5164054|NCT00957840|IVH|ivh
5164055|NCT00957840|post hemorrhagic ventricular dilation (PVHD)|post hemorrhagic ventricular dilation (pvhd)
5164056|NCT00957814|nutritional education|nutritional education
5164057|NCT00957814|diet adherence|diet adherence
5164058|NCT00957814|nutritional knowledge|nutritional knowledge
5164059|NCT00957814|life quality|life quality
5164060|NCT00957814|nutritional status|nutritional status
5164061|NCT00957814|impact of nutritional orientations by a systematic education program applied to outpatients with HF, in comparison to patients in a conventional treatment.|impact of nutritional orientations by a systematic education program applied to outpatients with hf, in comparison to patients in a conventional treatment.
5164062|NCT00957801|Sarcopenia|sarcopenia
5164063|NCT00957801|Aging muscle|aging muscle
5164064|NCT00957801|Androgen|androgen
5164065|NCT00957801|Cytokines|cytokines
5164066|NCT00957801|Muscle metabolism|muscle metabolism
5164067|NCT00957788|tinnitus|tinnitus
5164068|NCT00957788|acouphenes|acouphenes
5164069|NCT00957788|ear|ear
5164070|NCT00957788|ringing|ringing
5164071|NCT00957788|buzzing|buzzing
5164072|NCT00957788|roaring|roaring
5164073|NCT00957788|hissing|hissing
5164074|NCT00957788|clicking|clicking
5164075|NCT00957775|Substance Abuse Treatment|substance abuse treatment
5164076|NCT00957775|Adolescents|adolescents
5164077|NCT00957775|Substance-Related Disorders|substance-related disorders
5164078|NCT00957775|Alcohol-Related Disorders|alcohol-related disorders
5164079|NCT00957775|Marijuana Abuse|marijuana abuse
5164080|NCT00957762|Body Composition|body composition
5164081|NCT00957762|Glucose Tolerance|glucose tolerance
5164082|NCT00957762|Insulin Sensitivity|insulin sensitivity
5164083|NCT00957762|Metabolic Syndrome|metabolic syndrome
5164084|NCT00957736|graft versus host disease|graft versus host disease
5164085|NCT00957736|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5164086|NCT00957736|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5164087|NCT00957736|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5164088|NCT00957736|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5164089|NCT00957736|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5164090|NCT00957736|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5164091|NCT00957736|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5164092|NCT00957736|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5164093|NCT00957736|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5164094|NCT00957736|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5164095|NCT00957736|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5164096|NCT00957736|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5164097|NCT00957736|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5164098|NCT00957736|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5164428|NCT00956579|sensory|sensory
5164099|NCT00957736|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5164100|NCT00957736|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5164101|NCT00957736|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5164102|NCT00957736|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5164103|NCT00957736|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5164104|NCT00957736|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5164105|NCT00957736|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5164106|NCT00957736|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5164107|NCT00957736|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5164108|NCT00957736|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5164109|NCT00957736|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5164110|NCT00957736|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5164111|NCT00957736|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5164112|NCT00957736|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5164113|NCT00957736|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5164114|NCT00957736|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5164115|NCT00957736|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5164116|NCT00957736|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5164117|NCT00957736|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5164118|NCT00957736|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
5164119|NCT00957736|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
5164340|NCT00957112|stage IA breast cancer|stage ia breast cancer
5164120|NCT00957736|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
5164121|NCT00957736|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5164122|NCT00957736|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5164123|NCT00957736|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5164124|NCT00957736|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5164125|NCT00957736|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5164126|NCT00957736|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5164127|NCT00957736|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5164128|NCT00957736|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
5164129|NCT00957736|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5164130|NCT00957736|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5164131|NCT00957736|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5164132|NCT00957736|noncontiguous (NC) stage II adult Burkitt lymphoma|noncontiguous (nc) stage ii adult burkitt lymphoma
5164133|NCT00957736|NC stage II adult diffuse large cell lymphoma|nc stage ii adult diffuse large cell lymphoma
5164134|NCT00957736|NC stage II adult diffuse mixed cell lymphoma|nc stage ii adult diffuse mixed cell lymphoma
5164135|NCT00957736|NC stage II adult diffuse small cleaved cell lymphoma|nc stage ii adult diffuse small cleaved cell lymphoma
5164136|NCT00957736|NC stage II adult immunoblastic large cell lymphoma|nc stage ii adult immunoblastic large cell lymphoma
5164137|NCT00957736|NC stage II adult lymphoblastic lymphoma|nc stage ii adult lymphoblastic lymphoma
5164138|NCT00957736|NC stage II grade 1 follicular lymphoma|nc stage ii grade 1 follicular lymphoma
5164139|NCT00957736|NC stage II grade 2 follicular lymphoma|nc stage ii grade 2 follicular lymphoma
5164140|NCT00957736|NC stage II grade 3 follicular lymphoma|nc stage ii grade 3 follicular lymphoma
5164141|NCT00957736|NC stage II mantle cell lymphoma|nc stage ii mantle cell lymphoma
5164142|NCT00957736|NC stage II marginal zone lymphoma|nc stage ii marginal zone lymphoma
5164143|NCT00957736|NC stage II small lymphocytic lymphoma|nc stage ii small lymphocytic lymphoma
5164144|NCT00957736|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5164145|NCT00957736|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5164146|NCT00957736|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5164147|NCT00957736|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5164148|NCT00957736|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5164149|NCT00957736|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5164150|NCT00957736|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5164151|NCT00957736|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5164152|NCT00957736|atypical chronic myeloid leukemia, BCR-ABL negative|atypical chronic myeloid leukemia, bcr-abl negative
5164153|NCT00957736|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5164154|NCT00957736|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
5164155|NCT00957736|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
5164156|NCT00957736|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
5164157|NCT00957736|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5164158|NCT00957736|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5164159|NCT00957736|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
5164429|NCT00956579|MEG|meg
5164160|NCT00957736|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5164161|NCT00957736|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5164162|NCT00957736|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5164163|NCT00957736|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5164164|NCT00957736|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5164165|NCT00957736|refractory hairy cell leukemia|refractory hairy cell leukemia
5164166|NCT00957736|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5164167|NCT00957736|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5164168|NCT00957736|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5164169|NCT00957736|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5164170|NCT00957736|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
5164171|NCT00957736|chronic eosinophilic leukemia|chronic eosinophilic leukemia
5164172|NCT00957736|primary myelofibrosis|primary myelofibrosis
5164173|NCT00957736|chronic neutrophilic leukemia|chronic neutrophilic leukemia
5164174|NCT00957736|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5164175|NCT00957736|disseminated neuroblastoma|disseminated neuroblastoma
5164176|NCT00957736|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
5164177|NCT00957736|poor prognosis metastatic gestational trophoblastic tumor|poor prognosis metastatic gestational trophoblastic tumor
5164178|NCT00957736|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
5164179|NCT00957736|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5164180|NCT00957736|recurrent Wilms tumor and other childhood kidney tumors|recurrent wilms tumor and other childhood kidney tumors
5164181|NCT00957736|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
5164182|NCT00957736|recurrent neuroblastoma|recurrent neuroblastoma
5164183|NCT00957736|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5164184|NCT00957736|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
5164185|NCT00957736|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
5164186|NCT00957736|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5164187|NCT00957736|stage I multiple myeloma|stage i multiple myeloma
5164188|NCT00957736|stage II multiple myeloma|stage ii multiple myeloma
5164189|NCT00957736|stage III multiple myeloma|stage iii multiple myeloma
5164190|NCT00957736|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
5164191|NCT00957736|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5164192|NCT00957736|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5164193|NCT00957736|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
5164194|NCT00957736|stage IIIA breast cancer|stage iiia breast cancer
5164195|NCT00957736|stage IIIB breast cancer|stage iiib breast cancer
5164196|NCT00957736|stage IIIC breast cancer|stage iiic breast cancer
5164197|NCT00957736|stage IV breast cancer|stage iv breast cancer
5164198|NCT00957736|refractory multiple myeloma|refractory multiple myeloma
5164199|NCT00957710|progressive aphasia|progressive aphasia
5164200|NCT00957710|semantic dementia|semantic dementia
5164201|NCT00957710|neuroimaging|neuroimaging
5164202|NCT00957710|treatment|treatment
5164203|NCT00957710|errorless learning|errorless learning
5164204|NCT00957697|Central Neuropathic Pain|central neuropathic pain
5164205|NCT00957697|Central Post-Stroke Pain|central post-stroke pain
5164206|NCT00957697|Stroke|stroke
5164207|NCT00957697|Pain|pain
5164208|NCT00957684|refractory|refractory
5164209|NCT00957684|partial|partial
5164210|NCT00957684|epilepsy|epilepsy
5164212|NCT00957671|Traumatic Brain injury|traumatic brain injury
5164213|NCT00957671|Growth hormone deficiency|growth hormone deficiency
5164214|NCT00957671|Anterior pituitary hormone|anterior pituitary hormone
5164215|NCT00957671|Recombinant human growth Hormone|recombinant human growth hormone
5164216|NCT00957671|Genotropin|genotropin
5164217|NCT00957658|Osteoarthritis|osteoarthritis
5164218|NCT00957645|Central post-stroke pain|central post-stroke pain
5164219|NCT00957645|post-stroke pain|post-stroke pain
5164220|NCT00957645|shoulder pain|shoulder pain
5164221|NCT00957619|pentoxyfilline|pentoxyfilline
5164222|NCT00957619|liver regeneration|liver regeneration
5164223|NCT00957619|major liver resection|major liver resection
5164224|NCT00957619|reduction of the I/R injury|reduction of the i/r injury
5164225|NCT00957606|Prostate cancer|prostate cancer
5164226|NCT00957606|androgen deprivation therapy|androgen deprivation therapy
5164227|NCT00957606|osteoporosis|osteoporosis
5164228|NCT00957593|Induction of labor in term pregnancies|induction of labor in term pregnancies
5164229|NCT00957593|Term pregnancy|term pregnancy
5164230|NCT00957593|Cesarean delivery|cesarean delivery
5164231|NCT00957580|MEK Inhibitor|mek inhibitor
5164232|NCT00957580|Pimasertib|pimasertib
5164233|NCT00957580|Acute Myeloid Leukemia|acute myeloid leukemia
5164234|NCT00957580|Hematological Malignancies|hematological malignancies
5164235|NCT00957580|Elderly Patients|elderly patients
5164236|NCT00957580|Phase II|phase ii
5164237|NCT00957541|NYHA Class III or IV|nyha class iii or iv
5164238|NCT00957541|Implantable Cardiac Defibrillator|implantable cardiac defibrillator
5164239|NCT00957541|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
5165524|NCT00952354|MLU|mlu
5164240|NCT00957528|Low Normal Testosterone|low normal testosterone
5164241|NCT00957528|Male|male
5164242|NCT00957528|Aging|aging
5164243|NCT00957489|Orthodontic treatment of Class II division 1 malocclusion|orthodontic treatment of class ii division 1 malocclusion
5164244|NCT00957476|Pregnancy|pregnancy
5164245|NCT00957476|Metabolic Diseases|metabolic diseases
5164246|NCT00957476|Obesity|obesity
5164247|NCT00957476|Fetal adiposity|fetal adiposity
5164248|NCT00957476|Omega-3|omega-3
5164249|NCT00957476|Inflammation|inflammation
5164250|NCT00957476|Insulin Resistance|insulin resistance
5164251|NCT00957463|endothelial function|endothelial function
5164252|NCT00957450|cervix cancer|cervix cancer
5164253|NCT00957450|intra-pelvic organ motion|intra-pelvic organ motion
5164254|NCT00957450|cervical cancer and CBCT|cervical cancer and cbct
5164255|NCT00957437|Phase 1|phase 1
5164256|NCT00957437|healthy volunteer|healthy volunteer
5164257|NCT00957437|male|male
5164258|NCT00957437|pharmacokinetics|pharmacokinetics
5164259|NCT00957437|AZD1305|azd1305
5164260|NCT00957424|tobacco use disorder|tobacco use disorder
5164261|NCT00957424|bladder cancer|bladder cancer
5164262|NCT00957424|cervical cancer|cervical cancer
5164263|NCT00957424|esophageal cancer|esophageal cancer
5164264|NCT00957424|gastric cancer|gastric cancer
5164265|NCT00957424|renal cell carcinoma|renal cell carcinoma
5164266|NCT00957424|adult primary liver cancer|adult primary liver cancer
5164267|NCT00957424|non-small cell lung cancer|non-small cell lung cancer
5164268|NCT00957424|small cell lung cancer|small cell lung cancer
5164269|NCT00957424|pancreatic cancer|pancreatic cancer
5164270|NCT00957424|hypopharyngeal cancer|hypopharyngeal cancer
5164271|NCT00957424|laryngeal cancer|laryngeal cancer
5164272|NCT00957424|lip and oral cavity cancer|lip and oral cavity cancer
5164273|NCT00957424|nasopharyngeal cancer|nasopharyngeal cancer
5164274|NCT00957424|oropharyngeal cancer|oropharyngeal cancer
5164275|NCT00957424|paranasal sinus and nasal cavity cancer|paranasal sinus and nasal cavity cancer
5164276|NCT00957424|adult acute myeloid leukemia|adult acute myeloid leukemia
5164277|NCT00957411|stage IB cervical cancer|stage ib cervical cancer
5164278|NCT00957411|stage IIA cervical cancer|stage iia cervical cancer
5164279|NCT00957411|stage IIB cervical cancer|stage iib cervical cancer
5164280|NCT00957411|stage III cervical cancer|stage iii cervical cancer
5164281|NCT00957411|cervical adenocarcinoma|cervical adenocarcinoma
5164282|NCT00957411|cervical squamous cell carcinoma|cervical squamous cell carcinoma
5164283|NCT00957398|Irritable Bowel Syndrome|irritable bowel syndrome
5164284|NCT00957398|Irritable Bowel Syndrome subgroups|irritable bowel syndrome subgroups
5164285|NCT00957398|Motility|motility
5164286|NCT00957385|Leukemia|leukemia
5164287|NCT00957385|Remission|remission
5164288|NCT00957372|epilepsy|epilepsy
5164289|NCT00957359|Cancer|cancer
5164290|NCT00957359|Anxiety|anxiety
5164291|NCT00957359|Depression|depression
5164292|NCT00957359|Hallucinogens|hallucinogens
5164293|NCT00957346|Pregnancy termination|pregnancy termination
5164294|NCT00957346|abortion|abortion
5164295|NCT00957346|medical abortion|medical abortion
5164296|NCT00957346|2nd trimester|2nd trimester
5164297|NCT00957346|mifepristone|mifepristone
5164298|NCT00957346|misoprostol|misoprostol
5164299|NCT00957333|ketamine|ketamine
5164300|NCT00957333|bladder dysfunction|bladder dysfunction
5164301|NCT00957333|bladder mucosa|bladder mucosa
5164302|NCT00957333|mechanisms|mechanisms
5164303|NCT00957320|leukemia|leukemia
5164304|NCT00957320|cancer|cancer
5164305|NCT00957320|oncology|oncology
5164306|NCT00957320|sirolimus|sirolimus
5164307|NCT00957320|ALL|all
5164308|NCT00957281|Asthma|asthma
5164309|NCT00957281|Systemic inflammation|systemic inflammation
5164310|NCT00957281|Oxidative stress|oxidative stress
5164311|NCT00957281|Cardiovascular morbidity|cardiovascular morbidity
5164312|NCT00957281|Airway inflammation|airway inflammation
5164313|NCT00957268|Type 2 diabetes mellitus|type 2 diabetes mellitus
5164314|NCT00957268|Non-insulin dependent diabetes mellitus|non-insulin dependent diabetes mellitus
5164315|NCT00957268|Drug therapy|drug therapy
5164316|NCT00957268|Pediatrics|pediatrics
5164317|NCT00957255|rotator cuff tear|rotator cuff tear
5164318|NCT00957255|rotator cuff repair|rotator cuff repair
5164319|NCT00957242|IPF|ipf
5164320|NCT00957242|Warfarin|warfarin
5164321|NCT00957216|adult onset ataxia|adult onset ataxia
5164322|NCT00957203|Parkinson's disease|parkinson's disease
5164323|NCT00957203|levodopa|levodopa
5164324|NCT00957203|end of dose wearing off|end of dose wearing off
5164325|NCT00957203|OFF time|off time
5164326|NCT00957190|Ocular Hypertension|ocular hypertension
5164327|NCT00957190|Open Angle Glaucoma|open angle glaucoma
5164328|NCT00957164|Chronic pain|chronic pain
5164329|NCT00957164|PTSD|ptsd
5164330|NCT00957151|chronic pancreatitis|chronic pancreatitis
5164331|NCT00957151|exocrine pancreatic insufficiency|exocrine pancreatic insufficiency
5164332|NCT00957151|enzyme therapy|enzyme therapy
5164333|NCT00957151|patients with chronic pancreatitis and exocrine pancreatic insufficiency|patients with chronic pancreatitis and exocrine pancreatic insufficiency
5164334|NCT00957151|taking enzyme replacement therapy|taking enzyme replacement therapy
5164335|NCT00957125|Localized primary breast cancer|localized primary breast cancer
5166183|NCT00950716|empowerment|empowerment
5164336|NCT00957125|Inflammatory breast cancer|inflammatory breast cancer
5164337|NCT00957112|anxiety disorder|anxiety disorder
5164338|NCT00957112|depression|depression
5164339|NCT00957112|fatigue|fatigue
5164341|NCT00957112|stage IB breast cancer|stage ib breast cancer
5164342|NCT00957112|stage II breast cancer|stage ii breast cancer
5164343|NCT00957112|stage IIIA breast cancer|stage iiia breast cancer
5164344|NCT00957086|Phase III Adjuvant Concurrent Chemo-RT +/- nimotuzumab|phase iii adjuvant concurrent chemo-rt +/- nimotuzumab
5164345|NCT00957073|Heart Failure|heart failure
5164346|NCT00957073|Diastolic dysfunction|diastolic dysfunction
5164347|NCT00957047|refractory|refractory
5164348|NCT00957047|partial|partial
5164349|NCT00957047|epilepsy|epilepsy
5164350|NCT00957021|Knee|knee
5164351|NCT00956982|Hepatitis C Virus Pegylated Interferon Ribavirin Older|hepatitis c virus pegylated interferon ribavirin older
5164352|NCT00956969|headaches|headaches
5164353|NCT00956969|stress management|stress management
5164354|NCT00956969|assertiveness training|assertiveness training
5164355|NCT00956969|relaxation training|relaxation training
5164356|NCT00956969|emotional expression|emotional expression
5164357|NCT00956956|An investigator and subject blinded (sponsor open)|an investigator and subject blinded (sponsor open)
5164358|NCT00956956|multiple dose|multiple dose
5164359|NCT00956956|dose escalation design with PF 04455242 and matching placebo.|dose escalation design with pf 04455242 and matching placebo.
5164360|NCT00956943|nicotine dependence|nicotine dependence
5164361|NCT00956943|nicotine replacement therapy|nicotine replacement therapy
5164362|NCT00956943|transdermal nicotine|transdermal nicotine
5164363|NCT00956943|nicotine metabolism|nicotine metabolism
5164364|NCT00956943|high dose|high dose
5164365|NCT00956930|advanced adult primary liver cancer|advanced adult primary liver cancer
5164366|NCT00956930|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
5164367|NCT00956930|recurrent adult primary liver cancer|recurrent adult primary liver cancer
5164368|NCT00956930|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
5164369|NCT00956904|Prostate Cancer|prostate cancer
5164370|NCT00956904|Prostatectomy|prostatectomy
5164371|NCT00956904|Transrectal Ultrasound|transrectal ultrasound
5164372|NCT00956904|Tandem RALP|tandem ralp
5164373|NCT00956891|short-term effects|short-term effects
5164374|NCT00956891|long-term follow-up|long-term follow-up
5164375|NCT00956891|liver failure patients|liver failure patients
5164376|NCT00956891|autologous MSCs transplantation|autologous mscs transplantation
5164377|NCT00956878|Cancer|cancer
5164378|NCT00956878|Pain|pain
5164379|NCT00956878|SNP|snp
5164380|NCT00956865|Glaucoma|glaucoma
5164381|NCT00956865|Intervention|intervention
5164382|NCT00956865|Follow up|follow up
5164383|NCT00956839|Tropical calcific pancreatitis|tropical calcific pancreatitis
5164384|NCT00956839|Tropical chronic pancreatitis|tropical chronic pancreatitis
5164385|NCT00956839|Chronic pancreatitis|chronic pancreatitis
5164386|NCT00956839|Vitamin D|vitamin d
5164387|NCT00956839|Vitamin D deficiency|vitamin d deficiency
5164388|NCT00956839|Cholecalciferol|cholecalciferol
5164389|NCT00956839|Intramuscular vitamin D3|intramuscular vitamin d3
5164390|NCT00956826|electrode vacuum delivery|electrode vacuum delivery
5164391|NCT00956813|menopausal symptoms|menopausal symptoms
5164392|NCT00956813|hot flashes|hot flashes
5164393|NCT00956813|breast cancer|breast cancer
5164394|NCT00956813|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5164395|NCT00956787|Myelodysplastic Syndrome|myelodysplastic syndrome
5164396|NCT00956774|HSG|hsg
5164397|NCT00956774|Cannula|cannula
5164398|NCT00956774|HSG procedure|hsg procedure
5164399|NCT00956774|infertility evaluation|infertility evaluation
5164400|NCT00956761|Influenza vaccine|influenza vaccine
5164401|NCT00956748|chronic suppurative otitis media with persistent otorrhea|chronic suppurative otitis media with persistent otorrhea
5164402|NCT00956735|Cardiovascular Disease|cardiovascular disease
5164403|NCT00956735|Type II Diabetes|type ii diabetes
5164404|NCT00956735|Nutrition|nutrition
5164405|NCT00956735|Pistachios|pistachios
5164406|NCT00956735|Cardiovascular disease risk factors in adults with Type II diabetes|cardiovascular disease risk factors in adults with type ii diabetes
5164407|NCT00956696|Epilepsy|epilepsy
5164408|NCT00956696|mental retardation|mental retardation
5164409|NCT00956683|infraclavicular nerve block ultrasound dual endpoint stimulation|infraclavicular nerve block ultrasound dual endpoint stimulation
5164410|NCT00956657|Randomised Controlled Trial|randomised controlled trial
5164411|NCT00956657|Adherence|adherence
5164412|NCT00956657|Patient Participation|patient participation
5164413|NCT00956631|Spinal Stenosis|spinal stenosis
5164414|NCT00956631|Lumbar Spinal Stenosis|lumbar spinal stenosis
5164415|NCT00956605|EEG-biofeedback|eeg-biofeedback
5164416|NCT00956605|neurofeedback|neurofeedback
5164417|NCT00956605|computer attention training systems|computer attention training systems
5164418|NCT00956605|ADHD|adhd
5164419|NCT00956605|ADD|add
5164420|NCT00956605|child|child
5164421|NCT00956605|children|children
5164422|NCT00956592|Video laryngoscopy|video laryngoscopy
5164423|NCT00956592|Intubation success|intubation success
5164424|NCT00956592|Difficult airway|difficult airway
5164425|NCT00956592|CMAC laryngoscope|cmac laryngoscope
5164426|NCT00956579|autism|autism
5164427|NCT00956579|autistic|autistic
5164430|NCT00956579|connectivity|connectivity
5164431|NCT00956579|brain|brain
5164432|NCT00956579|MRI|mri
5164433|NCT00956579|language|language
5164434|NCT00956579|developmental|developmental
5164435|NCT00956579|neurodevelopmental|neurodevelopmental
5164436|NCT00956579|aspergers|aspergers
5164437|NCT00956579|asperger's|asperger's
5164438|NCT00956579|dyslexia|dyslexia
5164439|NCT00956579|coherence|coherence
5164440|NCT00956553|HPV|hpv
5164441|NCT00956553|Human Papilloma Virus|human papilloma virus
5164442|NCT00956553|Cervical cancer vaccine|cervical cancer vaccine
5164443|NCT00956540|Tracheostomy|tracheostomy
5164444|NCT00956540|decannulation|decannulation
5164445|NCT00956540|weaning|weaning
5164446|NCT00956540|Tracheostomy Weaning|tracheostomy weaning
5164447|NCT00956527|Adolescent|adolescent
5164448|NCT00956527|Substance Use|substance use
5164449|NCT00956527|Early Intervention|early intervention
5164450|NCT00956527|Martial Arts|martial arts
5164451|NCT00956527|Karate|karate
5164452|NCT00956514|depression|depression
5164453|NCT00956514|major depressive disorder|major depressive disorder
5164454|NCT00956514|transcranial magnetic stimulation|transcranial magnetic stimulation
5164455|NCT00956514|TMS|tms
5164456|NCT00956514|EEG|eeg
5164457|NCT00956514|electroencephalography|electroencephalography
5164458|NCT00956514|Major Depression,|major depression,
5164459|NCT00956501|fall|fall
5164460|NCT00956501|balance|balance
5164461|NCT00956488|Exercise for Amyotrophic lateral sclerosis|exercise for amyotrophic lateral sclerosis
5164462|NCT00956475|anxiety disorder|anxiety disorder
5164463|NCT00956475|long-term effects secondary to cancer therapy in adults|long-term effects secondary to cancer therapy in adults
5164464|NCT00956475|fatigue|fatigue
5164465|NCT00956475|pain|pain
5164466|NCT00956475|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
5164467|NCT00956475|cancer survivor|cancer survivor
5164468|NCT00956475|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5164469|NCT00956475|acute undifferentiated leukemia|acute undifferentiated leukemia
5164470|NCT00956475|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5164471|NCT00956475|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5164472|NCT00956475|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5164473|NCT00956475|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5164474|NCT00956475|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5164475|NCT00956475|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5164476|NCT00956475|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5164477|NCT00956475|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
5164478|NCT00956475|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5164479|NCT00956475|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5164480|NCT00956475|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5164481|NCT00956475|mast cell leukemia|mast cell leukemia
5164482|NCT00956475|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
5164483|NCT00956475|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
5164484|NCT00956475|prolymphocytic leukemia|prolymphocytic leukemia
5164485|NCT00956475|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5164486|NCT00956475|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5164487|NCT00956475|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5164488|NCT00956475|refractory hairy cell leukemia|refractory hairy cell leukemia
5164489|NCT00956475|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5164490|NCT00956475|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5164491|NCT00956475|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
5164492|NCT00956475|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
5164493|NCT00956475|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5164494|NCT00956475|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5164495|NCT00956475|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
5164496|NCT00956475|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
5164497|NCT00956475|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
5164498|NCT00956475|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
5164499|NCT00956475|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
5164500|NCT00956475|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
5164501|NCT00956475|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
5164502|NCT00956475|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
5164503|NCT00956475|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
5164504|NCT00956475|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
5164505|NCT00956475|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
5164506|NCT00956475|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
5164507|NCT00956475|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
5167903|NCT00944827|steatosis|steatosis
5164508|NCT00956475|stage I mantle cell lymphoma|stage i mantle cell lymphoma
5164509|NCT00956475|stage I marginal zone lymphoma|stage i marginal zone lymphoma
5164510|NCT00956475|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
5164511|NCT00956475|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
5164512|NCT00956475|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
5164513|NCT00956475|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
5164514|NCT00956475|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5164515|NCT00956475|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5164516|NCT00956475|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5164517|NCT00956475|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5164518|NCT00956475|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5164519|NCT00956475|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5164520|NCT00956475|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5164521|NCT00956475|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
5164522|NCT00956475|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
5164523|NCT00956475|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5164524|NCT00956475|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5164525|NCT00956475|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5164526|NCT00956475|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5164527|NCT00956475|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5164528|NCT00956475|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5164529|NCT00956475|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5164530|NCT00956475|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5164531|NCT00956475|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5164532|NCT00956475|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5164533|NCT00956475|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5164534|NCT00956475|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5164535|NCT00956475|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5164536|NCT00956475|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
5164537|NCT00956475|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
5164538|NCT00956475|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5164539|NCT00956475|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5164540|NCT00956475|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5164541|NCT00956475|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5164542|NCT00956475|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5164543|NCT00956475|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5164544|NCT00956475|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5164545|NCT00956475|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5164546|NCT00956475|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5164547|NCT00956475|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5164548|NCT00956475|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
5164549|NCT00956475|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5164550|NCT00956475|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5164551|NCT00956475|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5164552|NCT00956475|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
5164553|NCT00956475|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5164554|NCT00956475|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5164555|NCT00956475|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5164556|NCT00956475|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5164557|NCT00956475|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5164558|NCT00956475|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5164559|NCT00956475|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5164560|NCT00956475|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5164561|NCT00956475|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
5164562|NCT00956475|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5164563|NCT00956475|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
5164564|NCT00956475|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
5164565|NCT00956475|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
5164566|NCT00956475|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
5164567|NCT00956475|adult grade III lymphomatoid granulomatosis|adult grade iii lymphomatoid granulomatosis
5164568|NCT00956475|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
5164569|NCT00956475|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
5164570|NCT00956475|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5164571|NCT00956475|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5164572|NCT00956475|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5164573|NCT00956475|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
5164574|NCT00956475|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
5164575|NCT00956475|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
5164576|NCT00956475|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
5164577|NCT00956475|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
5164578|NCT00956475|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
5164579|NCT00956475|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
5164580|NCT00956475|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
5164581|NCT00956475|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
5164582|NCT00956475|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
5164583|NCT00956475|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
5164584|NCT00956475|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
5164585|NCT00956475|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
5164586|NCT00956475|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5164587|NCT00956475|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
5164588|NCT00956475|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
5164589|NCT00956475|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
5164590|NCT00956475|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
5164591|NCT00956475|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5164592|NCT00956475|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5164593|NCT00956475|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5164594|NCT00956475|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5164595|NCT00956475|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
5164596|NCT00956475|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
5164597|NCT00956475|intraocular lymphoma|intraocular lymphoma
5164598|NCT00956475|primary central nervous system lymphoma|primary central nervous system lymphoma
5164599|NCT00956475|post-transplant lymphoproliferative disorder|post-transplant lymphoproliferative disorder
5164600|NCT00956475|cutaneous B-cell non-Hodgkin lymphoma|cutaneous b-cell non-hodgkin lymphoma
5164601|NCT00956475|small intestine lymphoma|small intestine lymphoma
5164602|NCT00956462|intraocular pressure|intraocular pressure
5164603|NCT00956462|Ahmed valve|ahmed valve
5164604|NCT00956462|NSAIDS|nsaids
5164605|NCT00956462|steroids|steroids
5164606|NCT00956449|flu|flu
5164607|NCT00956449|influenza|influenza
5164608|NCT00956449|seasonal influenza|seasonal influenza
5164609|NCT00956449|influenza vaccine antigen|influenza vaccine antigen
5164610|NCT00956449|immunogenicity|immunogenicity
5164611|NCT00956449|safety|safety
5164612|NCT00956449|tolerability|tolerability
5164613|NCT00956449|antibody response|antibody response
5164614|NCT00956449|intra muscular|intra muscular
5164615|NCT00956449|elderly|elderly
5164616|NCT00956449|non-elderly|non-elderly
5164617|NCT00956436|Liver Cancer|liver cancer
5164618|NCT00956436|Hepatocellular Carcinoma|hepatocellular carcinoma
5164619|NCT00956436|Sorafenib|sorafenib
5164620|NCT00956436|HCC|hcc
5164621|NCT00956436|BIIB022|biib022
5164622|NCT00956436|Open-Label|open-label
5164623|NCT00956436|IGF-1R|igf-1r
5164624|NCT00956436|Nexavar|nexavar
5164625|NCT00956423|obstructive sleep apnea|obstructive sleep apnea
5164626|NCT00956423|exercise training|exercise training
5164627|NCT00956423|aerobic exercise|aerobic exercise
5164628|NCT00956423|resistance exercise|resistance exercise
5164629|NCT00956410|Active immunization|active immunization
5164630|NCT00956410|Alzheimer disease|alzheimer disease
5164631|NCT00956410|Antibody|antibody
5164632|NCT00956410|Central Nervous System Diseases|central nervous system diseases
5164633|NCT00956410|Neurodegenerative diseases|neurodegenerative diseases
5164634|NCT00956410|Vaccine|vaccine
5164635|NCT00956397|Functional Dyspepsia|functional dyspepsia
5164636|NCT00956397|Small Intestinal Bacterial Overgrowth|small intestinal bacterial overgrowth
5164637|NCT00956397|chronic abdominal discomfort|chronic abdominal discomfort
5164638|NCT00956384|Breast reconstruction|breast reconstruction
5164639|NCT00956384|Early stage|early stage
5164640|NCT00956384|Skin-saving mastectomy|skin-saving mastectomy
5164641|NCT00956384|Prophylactic mastectomy|prophylactic mastectomy
5164642|NCT00956384|Acellular dermal matrix|acellular dermal matrix
5164643|NCT00956384|BRCA Mutation Carriers|brca mutation carriers
5164644|NCT00956371|ONO-7746|ono-7746
5164645|NCT00956371|Healthy adult subjects|healthy adult subjects
5164646|NCT00956358|bronchiolitis obliterans syndrome|bronchiolitis obliterans syndrome
5164647|NCT00956332|Peripheral arterial disease (PAD)|peripheral arterial disease (pad)
5164648|NCT00956332|Peripheral vascular disease (PVD)|peripheral vascular disease (pvd)
5164649|NCT00956332|Critical limb ischemia (CLI)|critical limb ischemia (cli)
5164650|NCT00956332|Cell therapy|cell therapy
5164651|NCT00956332|Gene therapy|gene therapy
5164652|NCT00956332|Endothelial cells|endothelial cells
5164653|NCT00956332|Smooth muscle cells|smooth muscle cells
5164654|NCT00956332|Angiogenesis|angiogenesis
5164655|NCT00956332|Arteriogenesis|arteriogenesis
5164656|NCT00956332|amputation|amputation
5164657|NCT00956332|diabetic foot|diabetic foot
5164658|NCT00956319|Insomnia|insomnia
5164659|NCT00956319|Zolpidem|zolpidem
5164660|NCT00956319|Estazolam|estazolam
5164661|NCT00956306|Udenafil,DA-8159,hepatic impairment,healthy volunteers|udenafil,da-8159,hepatic impairment,healthy volunteers
5164783|NCT00955864|Polarized Light|polarized light
5164662|NCT00956280|The frequency and type of KRAS mutation in a sample of the Brazilian population with advanced NSCLC|the frequency and type of kras mutation in a sample of the brazilian population with advanced nsclc
5164663|NCT00956280|KRAS mutation in population with advanced NSCLC|kras mutation in population with advanced nsclc
5164664|NCT00956267|Polycystic ovary syndrome|polycystic ovary syndrome
5164665|NCT00956267|clomiphene resistance|clomiphene resistance
5164666|NCT00956267|letrozole|letrozole
5164667|NCT00956267|Laparoscopic ovarian diathermy|laparoscopic ovarian diathermy
5164668|NCT00956254|mucositis|mucositis
5164669|NCT00956254|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5164670|NCT00956254|pain|pain
5164671|NCT00956241|rectal cancer|rectal cancer
5164672|NCT00956241|colonic pouch|colonic pouch
5164673|NCT00956241|side-to-end anastomosis|side-to-end anastomosis
5164674|NCT00956241|preoperative radiotherapy|preoperative radiotherapy
5164675|NCT00956215|post operative|post operative
5164676|NCT00956215|obese|obese
5164677|NCT00956202|Influenza|influenza
5164678|NCT00956202|Pandemic Flu|pandemic flu
5164679|NCT00956202|Swine-origin A/H1N1 Influenza|swine-origin a/h1n1 influenza
5164680|NCT00956202|Inactivated split-virion vaccine|inactivated split-virion vaccine
5164681|NCT00956202|Adjuvant|adjuvant
5164682|NCT00956189|Antipsychotic Agents|antipsychotic agents
5164683|NCT00956189|Metabolic Syndrome X|metabolic syndrome x
5164684|NCT00956189|Identification|identification
5164685|NCT00956189|Prediction|prediction
5164686|NCT00956176|Cidofovir|cidofovir
5164687|NCT00956176|Vistide|vistide
5164688|NCT00956176|Adenovirus|adenovirus
5164689|NCT00956176|BK virus infections|bk virus infections
5164690|NCT00956176|HSCT|hsct
5164691|NCT00956176|Hemorrhagic Cystitis|hemorrhagic cystitis
5164692|NCT00956176|Foley catheter|foley catheter
5164693|NCT00956176|Viral infection|viral infection
5164694|NCT00956176|Bladder instillation|bladder instillation
5164695|NCT00956176|Intravesical|intravesical
5164696|NCT00956176|Transurethral catheter|transurethral catheter
5164697|NCT00956176|Transplantation|transplantation
5164698|NCT00956150|Chronic Multisymptom Complex|chronic multisymptom complex
5164699|NCT00956150|Small Intestinal Bacterial Overgrowth|small intestinal bacterial overgrowth
5164700|NCT00956150|Gulf War Syndrome|gulf war syndrome
5164701|NCT00956150|Chronic Multisymptom Illness Complex|chronic multisymptom illness complex
5164702|NCT00956137|spinal anesthesia|spinal anesthesia
5164703|NCT00956137|ultrasound|ultrasound
5164704|NCT00956137|palpation|palpation
5164705|NCT00956137|knee|knee
5164706|NCT00956137|hip|hip
5164707|NCT00956137|surgery|surgery
5164708|NCT00956137|intervertebral space|intervertebral space
5164709|NCT00956111|Novel Influenza A/H1N1 Vaccine|novel influenza a/h1n1 vaccine
5164710|NCT00956111|Immunogenictiy|immunogenictiy
5164711|NCT00956111|Safety|safety
5164712|NCT00956085|OCD|ocd
5164713|NCT00956072|gastrointestinal stromal tumor|gastrointestinal stromal tumor
5164714|NCT00956059|focal segmental glomerulosclerosis|focal segmental glomerulosclerosis
5164715|NCT00956059|prednisone|prednisone
5164716|NCT00956059|mycophenolate mofetil|mycophenolate mofetil
5164717|NCT00956059|FK506|fk506
5164718|NCT00956046|Influenza|influenza
5164719|NCT00956046|Pandemic Flu|pandemic flu
5164720|NCT00956046|Swine-origin A/H1N1 Influenza|swine-origin a/h1n1 influenza
5164721|NCT00956046|Swine-origin Influenza Virus|swine-origin influenza virus
5164722|NCT00956046|Infants|infants
5164723|NCT00956033|Cancer|cancer
5164724|NCT00956033|Peripheral Neuropathy|peripheral neuropathy
5164725|NCT00956033|Bortezomib|bortezomib
5164726|NCT00956020|platelet rich plasma|platelet rich plasma
5164727|NCT00956020|fibrin matrix|fibrin matrix
5164728|NCT00956020|dermal filler|dermal filler
5164729|NCT00956007|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
5164730|NCT00956007|stage III verrucous carcinoma of the larynx|stage iii verrucous carcinoma of the larynx
5164731|NCT00956007|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5164732|NCT00956007|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
5164733|NCT00956007|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
5164734|NCT00956007|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5164735|NCT00956007|stage III verrucous carcinoma of the oral cavity|stage iii verrucous carcinoma of the oral cavity
5164736|NCT00956007|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
5164833|NCT00955604|Parkinson's Disease|parkinson's disease
5164737|NCT00956007|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
5164738|NCT00956007|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5164739|NCT00956007|tongue cancer|tongue cancer
5164740|NCT00955968|HIV Infection|hiv infection
5164741|NCT00955968|HAART|haart
5164742|NCT00955968|Maternal Health|maternal health
5164743|NCT00955955|Depression|depression
5164744|NCT00955955|Medical food|medical food
5164745|NCT00955942|radiation toxicity|radiation toxicity
5164746|NCT00955942|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5164747|NCT00955942|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5164748|NCT00955942|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5164749|NCT00955942|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5164750|NCT00955929|Penis|penis
5164751|NCT00955929|PLACEBO|placebo
5164752|NCT00955929|SILDENAFIL CITRATE|sildenafil citrate
5164753|NCT00955929|TRIMIX|trimix
5164754|NCT00955929|Bimix|bimix
5164755|NCT00955929|Viagra|viagra
5164756|NCT00955929|09-005|09-005
5164757|NCT00955929|Erectile Dysfunction following Bilateral Nerve-Sparing|erectile dysfunction following bilateral nerve-sparing
5164758|NCT00955916|relapsed|relapsed
5164759|NCT00955916|refractory|refractory
5164760|NCT00955916|acute|acute
5164761|NCT00955916|myeloid|myeloid
5164762|NCT00955916|AML|aml
5164763|NCT00955916|CML|cml
5164764|NCT00955916|blast crisis|blast crisis
5164765|NCT00955903|glucose|glucose
5164766|NCT00955903|insulin|insulin
5164767|NCT00955903|lipids|lipids
5164768|NCT00955903|C-reactive protein|c-reactive protein
5164769|NCT00955903|adiponectin|adiponectin
5164770|NCT00955903|leptin|leptin
5164771|NCT00955903|TNF alpha|tnf alpha
5164772|NCT00955903|IL-6|il-6
5164773|NCT00955903|Quality of Life|quality of life
5164774|NCT00955903|functional status|functional status
5164775|NCT00955890|cardioprotection|cardioprotection
5164776|NCT00955890|anthracycline chemotherapy|anthracycline chemotherapy
5164777|NCT00955890|breast cancer|breast cancer
5164778|NCT00955877|extended-release epidural morphine|extended-release epidural morphine
5164779|NCT00955877|DepoDur|depodur
5164780|NCT00955877|Spastic Cerebral Palsy|spastic cerebral palsy
5164781|NCT00955864|Cervix|cervix
5164782|NCT00955864|Colposcope|colposcope
5164784|NCT00955864|Cervix Structure|cervix structure
5164785|NCT00955864|Collagen|collagen
5164786|NCT00955864|HV|hv
5164787|NCT00955864|Healthy Volunteer|healthy volunteer
5164788|NCT00955864|Healthy Women|healthy women
5164789|NCT00955825|allergic rhinoconjunctivitis|allergic rhinoconjunctivitis
5164790|NCT00955812|OPB-31121|opb-31121
5164791|NCT00955812|Advanced Solid Tumor|advanced solid tumor
5164792|NCT00955812|STAT3|stat3
5164793|NCT00955812|IL-6-induced STAT3 phosphorylation|il-6-induced stat3 phosphorylation
5164794|NCT00955799|Subjective, Tinnitus|subjective, tinnitus
5164795|NCT00955786|Solid Tumors|solid tumors
5164796|NCT00955786|Lymphoma|lymphoma
5164797|NCT00955786|G-Quadruplex|g-quadruplex
5164798|NCT00955773|GSK1120212, everolimus, solid tumors, pancreatic cancer, non-small lung cancer, KRAS-mutant|gsk1120212, everolimus, solid tumors, pancreatic cancer, non-small lung cancer, kras-mutant
5164799|NCT00955773|cancer|cancer
5164800|NCT00955760|Healthy subjects|healthy subjects
5164801|NCT00955734|wrist|wrist
5164802|NCT00955734|fracture|fracture
5164803|NCT00955734|motion|motion
5164804|NCT00955734|surgery|surgery
5164805|NCT00955721|Cholangiocarcinoma|cholangiocarcinoma
5164806|NCT00955721|Biliary Tract Cancer|biliary tract cancer
5164807|NCT00955721|Gallbladder Cancer|gallbladder cancer
5164808|NCT00955695|adenocarcinoma of the lung|adenocarcinoma of the lung
5164809|NCT00955695|adenosquamous cell lung cancer|adenosquamous cell lung cancer
5164810|NCT00955695|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
5164811|NCT00955695|large cell lung cancer|large cell lung cancer
5164812|NCT00955695|squamous cell lung cancer|squamous cell lung cancer
5164813|NCT00955695|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5164814|NCT00955695|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5164815|NCT00955682|Meningococcal vaccine GSK134612|meningococcal vaccine gsk134612
5164816|NCT00955669|mesenchymal stem cells|mesenchymal stem cells
5164817|NCT00955669|mononuclear cells|mononuclear cells
5164818|NCT00955656|Characteristics of medical practices|characteristics of medical practices
5164819|NCT00955656|Practitioners providing care to children with asthma|practitioners providing care to children with asthma
5164820|NCT00955656|Medically underserved and impoverished Arkansas Delta region|medically underserved and impoverished arkansas delta region
5164821|NCT00955656|Characteristics of medical practices and practitioners|characteristics of medical practices and practitioners
5164822|NCT00955656|Disadvantaged populations|disadvantaged populations
5164823|NCT00955643|periodontitis|periodontitis
5164824|NCT00955643|hyperbaric oxygen therapy|hyperbaric oxygen therapy
5164825|NCT00955630|Histoplasmosis|histoplasmosis
5164826|NCT00955630|Lucentis|lucentis
5164827|NCT00955630|Ranibizumab|ranibizumab
5164828|NCT00955630|OHS|ohs
5164829|NCT00955617|Dotarem|dotarem
5164830|NCT00955617|Gadovist|gadovist
5164831|NCT00955617|Peripheral arterial disease|peripheral arterial disease
5164832|NCT00955617|MRA|mra
5164834|NCT00955604|Serotonin Toxicity|serotonin toxicity
5164835|NCT00955604|Rasagiline|rasagiline
5164836|NCT00955604|Antidepressants|antidepressants
5164837|NCT00955604|Chart Review|chart review
5164838|NCT00955604|Retrospective|retrospective
5164839|NCT00955591|human papilloma virus infection|human papilloma virus infection
5164840|NCT00955591|anal cancer|anal cancer
5164841|NCT00955591|HIV infection|hiv infection
5164842|NCT00955552|osteoarthritis (OA)|osteoarthritis (oa)
5164843|NCT00955552|knee|knee
5164844|NCT00955539|Heart Failure|heart failure
5164845|NCT00955539|Cardiac resynchronization therapy|cardiac resynchronization therapy
5164846|NCT00955539|Optimization|optimization
5164847|NCT00955539|Viability|viability
5164848|NCT00955539|Mechanical dyssynchrony|mechanical dyssynchrony
5164849|NCT00955526|Parkinson's disease|parkinson's disease
5164850|NCT00955526|levodopa|levodopa
5164851|NCT00955526|end of dose wearing off|end of dose wearing off
5164852|NCT00955526|OFF time|off time
5164853|NCT00955513|Ankle sprain|ankle sprain
5164854|NCT00955513|soft tissue injury|soft tissue injury
5164855|NCT00955500|Hepatic encephalopathy|hepatic encephalopathy
5164856|NCT00955500|Cirrhosis|cirrhosis
5164857|NCT00955500|Proteins of the diet|proteins of the diet
5164858|NCT00955500|Branched-chain amino acids|branched-chain amino acids
5164859|NCT00955487|Premature Newborns|premature newborns
5164860|NCT00955487|Inhaled Nitric Oxide|inhaled nitric oxide
5164861|NCT00955448|Anterior pelvic organ prolapse|anterior pelvic organ prolapse
5164862|NCT00955448|Surgical repair|surgical repair
5164863|NCT00955448|Pelvic floor surgery|pelvic floor surgery
5164864|NCT00955448|Randomized clinical trial|randomized clinical trial
5164865|NCT00955435|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5164866|NCT00955435|stage I prostate cancer|stage i prostate cancer
5164867|NCT00955435|stage IIB prostate cancer|stage iib prostate cancer
5164868|NCT00955435|stage IIA prostate cancer|stage iia prostate cancer
5164869|NCT00955435|stage III prostate cancer|stage iii prostate cancer
5164870|NCT00955422|Diagnosis|diagnosis
5164871|NCT00955422|Alzheimer's Disease|alzheimer's disease
5164872|NCT00955422|Memory Disorder|memory disorder
5164873|NCT00955422|Dementia|dementia
5164874|NCT00955422|Alzheimer Disease|alzheimer disease
5164875|NCT00955422|Memory Loss|memory loss
5164876|NCT00955396|sodium channel blocker|sodium channel blocker
5164877|NCT00955396|ambulatory blood pressure|ambulatory blood pressure
5164878|NCT00955383|Japanese|japanese
5164879|NCT00955370|Uncertainty|uncertainty
5164880|NCT00955370|Undiagnosed|undiagnosed
5164881|NCT00955370|Rare Diseases|rare diseases
5164882|NCT00955370|Parents|parents
5164883|NCT00955370|Multiple Abnormalities|multiple abnormalities
5164884|NCT00955357|Epilepsy Treatment|epilepsy treatment
5164885|NCT00955357|Anti-epileptic drugs|anti-epileptic drugs
5164886|NCT00955357|Seizures|seizures
5164887|NCT00955357|Vimpat|vimpat
5164888|NCT00955344|colorectal cancer screening|colorectal cancer screening
5164889|NCT00955344|American Board of Internal Medicine Maintenance of Certification program|american board of internal medicine maintenance of certification program
5164890|NCT00955344|Currently enrolled in or plan to enroll in the American Board of Internal Medicine Maintenance of Certification program|currently enrolled in or plan to enroll in the american board of internal medicine maintenance of certification program
5164891|NCT00955305|Non-Small Cell Lung Cancer|non-small cell lung cancer
5164892|NCT00955305|cixutumumab|cixutumumab
5164893|NCT00955292|Solid Tumors|solid tumors
5164894|NCT00955292|Lymphoma|lymphoma
5164895|NCT00955292|G-Quadruplex|g-quadruplex
5164896|NCT00955279|Ustekinumab|ustekinumab
5164897|NCT00955279|CNTO 1275|cnto 1275
5164898|NCT00955279|Stelara|stelara
5164899|NCT00955279|Golimumab|golimumab
5164900|NCT00955279|CNTO 148|cnto 148
5164901|NCT00955279|Simponi|simponi
5164902|NCT00955279|Sarcoidosis|sarcoidosis
5164903|NCT00955279|Sarcoid|sarcoid
5164904|NCT00955279|Pulmonary Sarcoidosis|pulmonary sarcoidosis
5164905|NCT00955279|Skin Sarcoidosis|skin sarcoidosis
5164906|NCT00955266|Separation|separation
5164907|NCT00955266|Cardiopulmonary bypass|cardiopulmonary bypass
5164908|NCT00955266|Calcium chloride|calcium chloride
5164909|NCT00955253|Neglect|neglect
5164910|NCT00955253|Attention|attention
5164911|NCT00955253|Vigilance|vigilance
5164912|NCT00955253|Stroke|stroke
5164913|NCT00955253|Hemineglect|hemineglect
5164914|NCT00955253|Unilateral Neglect|unilateral neglect
5164915|NCT00955253|Spatial Neglect|spatial neglect
5164916|NCT00955240|stage II anal cancer|stage ii anal cancer
5164917|NCT00955240|stage IIIA anal cancer|stage iiia anal cancer
5164918|NCT00955240|stage IIIB anal cancer|stage iiib anal cancer
5164919|NCT00955240|squamous cell carcinoma of the anus|squamous cell carcinoma of the anus
5164920|NCT00955227|Omega-3 Fatty acid|omega-3 fatty acid
5164921|NCT00955227|ALA (alpha linolenic acid)|ala (alpha linolenic acid)
5164922|NCT00955227|Ezetimibe|ezetimibe
5164923|NCT00955227|Flaxseed oil capsules|flaxseed oil capsules
5164924|NCT00955214|TAXUS Liberté|taxus liberté
5164925|NCT00955214|Small coronary artery disease|small coronary artery disease
5164926|NCT00955214|Paclitaxel-eluting stent|paclitaxel-eluting stent
5164927|NCT00955201|diabetes mellitus|diabetes mellitus
5164928|NCT00955201|diabetic neuropathies|diabetic neuropathies
5164929|NCT00955201|Aerobic Exercise|aerobic exercise
5164930|NCT00955201|Exercise Therapy|exercise therapy
5164931|NCT00955201|electromyography|electromyography
5164932|NCT00955201|United States Veterans|united states veterans
5164933|NCT00955188|colon cancer|colon cancer
5164934|NCT00955188|rectal cancer|rectal cancer
5164935|NCT00955175|stage I non-small cell lung cancer|stage i non-small cell lung cancer
5164936|NCT00955175|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
5164937|NCT00955175|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5164938|NCT00955175|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5164939|NCT00955162|Substance Abuse, Intravenous|substance abuse, intravenous
5164940|NCT00955162|Buprenorphine|buprenorphine
5164941|NCT00955149|Primary sclerosing cholangitis|primary sclerosing cholangitis
5164942|NCT00955149|Trisomy 7|trisomy 7
5164943|NCT00955149|Cholangiocarcinoma|cholangiocarcinoma
5164944|NCT00955149|Chemoprevention|chemoprevention
5164945|NCT00955149|Erlotinib|erlotinib
5164946|NCT00955136|ST elevated myocardial infarction|st elevated myocardial infarction
5164947|NCT00955136|Acute coronary syndrome|acute coronary syndrome
5164948|NCT00955136|MRX 801|mrx 801
5164949|NCT00955136|Echocardiography|echocardiography
5164950|NCT00955123|Inflammation|inflammation
5164951|NCT00955123|Urea synthesis|urea synthesis
5164952|NCT00955123|Catabolism|catabolism
5164953|NCT00955123|Nitrogen balance|nitrogen balance
5164954|NCT00955110|Opioid|opioid
5164955|NCT00955110|Recreational|recreational
5164956|NCT00955110|Oxymorphone|oxymorphone
5164957|NCT00955110|Oxycodone|oxycodone
5164958|NCT00955110|Extended Release|extended release
5164959|NCT00955110|Healthy NonDependent Recreational Opioid Users|healthy nondependent recreational opioid users
5164960|NCT00955097|Definity|definity
5164961|NCT00955097|liver tumors|liver tumors
5164962|NCT00955097|intra operative contrast|intra operative contrast
5164963|NCT00955097|liver cancer|liver cancer
5164964|NCT00955097|hepatic tumors|hepatic tumors
5164965|NCT00955097|identify liver tumors|identify liver tumors
5164966|NCT00955097|surgery liver tumors|surgery liver tumors
5164967|NCT00955097|Patients with known hepatic tumors|patients with known hepatic tumors
5164968|NCT00955071|exercise|exercise
5164969|NCT00955071|physical activity|physical activity
5164970|NCT00955071|diet|diet
5164971|NCT00955071|metabolic risk|metabolic risk
5164972|NCT00955071|visceral fat|visceral fat
5164973|NCT00955071|Insulin Resistance|insulin resistance
5164974|NCT00955058|PSA|psa
5164975|NCT00955058|PCO|pco
5164976|NCT00955058|PCOS|pcos
5164977|NCT00955045|long-term tolerability and safety|long-term tolerability and safety
5164978|NCT00955045|istradefylline treatment|istradefylline treatment
5164979|NCT00955045|levodopa/carbidopa|levodopa/carbidopa
5164980|NCT00955032|Parkinson's disease|parkinson's disease
5164981|NCT00955032|Apathy|apathy
5164982|NCT00955032|rTMS|rtms
5164983|NCT00955032|Repetitive transcranial magnetic stimulation|repetitive transcranial magnetic stimulation
5164984|NCT00955032|Depression|depression
5164985|NCT00955019|Barrett's|barrett's
5164986|NCT00955019|Esophagus|esophagus
5164987|NCT00955019|Reflux|reflux
5164988|NCT00955019|dysplasia|dysplasia
5164989|NCT00955019|adenocarcinoma|adenocarcinoma
5164990|NCT00955006|HIV Seronegativity|hiv seronegativity
5164991|NCT00955006|HIV Preventive Vaccine|hiv preventive vaccine
5164992|NCT00954993|Hepatitis C Virus (HCV)|hepatitis c virus (hcv)
5164993|NCT00954993|Vaniprevir|vaniprevir
5164994|NCT00954993|MK-7009|mk-7009
5164995|NCT00954980|Varicose Veins|varicose veins
5164996|NCT00954980|Superficial Thrombophlebitis|superficial thrombophlebitis
5164997|NCT00954980|Deep Vein Thrombosis|deep vein thrombosis
5164998|NCT00954980|Ulceration|ulceration
5164999|NCT00954980|leg pain|leg pain
5165000|NCT00954980|leg swelling|leg swelling
5165001|NCT00954967|Diabetes Mellitus|diabetes mellitus
5165002|NCT00954967|Smoking Cessation|smoking cessation
5165003|NCT00954967|Primary Health Care|primary health care
5165004|NCT00954967|Motivational Interview|motivational interview
5165005|NCT00954954|Arthroplasty|arthroplasty
5165006|NCT00954954|Replacement|replacement
5165007|NCT00954954|Knee|knee
5165008|NCT00954954|Range of Motion|range of motion
5165009|NCT00954941|Hematologic Disorder|hematologic disorder
5165010|NCT00954941|Acute myelogenous leukemia|acute myelogenous leukemia
5165011|NCT00954941|AML|aml
5165012|NCT00954941|High-risk myelodysplastic syndrome|high-risk myelodysplastic syndrome
5165013|NCT00954941|HR-MDS|hr-mds
5165014|NCT00954941|Chronic Myelogenous Leukemia|chronic myelogenous leukemia
5165015|NCT00954941|CML|cml
5165016|NCT00954941|Ondansetron|ondansetron
5165017|NCT00954941|Zofran|zofran
5165018|NCT00954941|Aprepitant|aprepitant
5165019|NCT00954941|Emend|emend
5165020|NCT00954941|L 754030|l 754030
5165021|NCT00954941|MK 869|mk 869
5165022|NCT00954941|Emesis|emesis
5165023|NCT00954941|Nausea|nausea
5165024|NCT00954941|Vomiting|vomiting
5165025|NCT00954928|hand|hand
5165026|NCT00954928|wrist|wrist
5165027|NCT00954928|anticoagulation|anticoagulation
5165028|NCT00954928|surgery|surgery
5165029|NCT00954928|patients on anticoagulant medication|patients on anticoagulant medication
5165030|NCT00954915|chronic plaque psoriasis|chronic plaque psoriasis
5165031|NCT00954915|psoriatic arthritis|psoriatic arthritis
5165032|NCT00954902|Spice|spice
5165033|NCT00954902|responses to stress|responses to stress
5165034|NCT00954902|Inflammatory|inflammatory
5165035|NCT00954837|Thyroid cancer|thyroid cancer
5165036|NCT00954837|thyroid FNA|thyroid fna
5165037|NCT00954837|repeat FNA|repeat fna
5165038|NCT00954837|thyroid screening|thyroid screening
5165039|NCT00954837|thyroid ultrasonography|thyroid ultrasonography
5165040|NCT00954837|FNA screening|fna screening
5165041|NCT00954811|pregnancy|pregnancy
5165042|NCT00954798|Influenza|influenza
5165043|NCT00954798|Pandemic Flu|pandemic flu
5165044|NCT00954798|Swine-origin Influenza|swine-origin influenza
5165045|NCT00954798|Inactivated split-virion vaccine|inactivated split-virion vaccine
5165046|NCT00954798|Adjuvant|adjuvant
5165047|NCT00954798|Adult|adult
5165048|NCT00954785|ankle|ankle
5165049|NCT00954785|ligament|ligament
5165050|NCT00954785|sprain|sprain
5165051|NCT00954785|non-steroidal anti-inflammatory drugs|non-steroidal anti-inflammatory drugs
5165052|NCT00954785|treatment|treatment
5165053|NCT00954785|Acute ankle ligament sprain|acute ankle ligament sprain
5165054|NCT00954772|Staged versus Simultaneous Bilateral DBS|staged versus simultaneous bilateral dbs
5165055|NCT00954759|Infantile colic|infantile colic
5165056|NCT00954759|Chiropractic|chiropractic
5165057|NCT00954759|Manipulation|manipulation
5165058|NCT00954759|Randomized controlled trial|randomized controlled trial
5165059|NCT00954746|Advanced Dupuytren's Disease|advanced dupuytren's disease
5165060|NCT00954746|Muscular Diseases|muscular diseases
5165061|NCT00954746|Musculoskeletal Diseases|musculoskeletal diseases
5165062|NCT00954746|Contracture Joint Diseases|contracture joint diseases
5165063|NCT00954746|Connective Tissue Diseases|connective tissue diseases
5165064|NCT00954746|Dupuytren's Contracture|dupuytren's contracture
5165065|NCT00954733|Hysteroscopic surgery|hysteroscopic surgery
5165066|NCT00954733|Hypoventilation|hypoventilation
5165068|NCT00954733|Transcutaneous Co2 Monitor|transcutaneous co2 monitor
5165069|NCT00954720|AML|aml
5165070|NCT00954720|ALL|all
5165071|NCT00954720|MDS|mds
5165072|NCT00954720|iron overload|iron overload
5165073|NCT00954707|Atherosclerosis|atherosclerosis
5165074|NCT00954681|Cannabis|cannabis
5165075|NCT00954681|quetiapine|quetiapine
5165076|NCT00954668|Non-ST-elevation myocardial infarction|non-st-elevation myocardial infarction
5165077|NCT00954668|angiography|angiography
5165078|NCT00954668|percutaneous coronary intervention|percutaneous coronary intervention
5165079|NCT00954668|timing|timing
5165080|NCT00954655|gastrointestinal stromal tumor|gastrointestinal stromal tumor
5165081|NCT00954642|Solid Tumor|solid tumor
5165082|NCT00954642|Locally Advanced Solid Tumor|locally advanced solid tumor
5165083|NCT00954642|Avastin|avastin
5165084|NCT00954629|Osteoarthritis|osteoarthritis
5165085|NCT00954629|Pain|pain
5165086|NCT00954629|Knee|knee
5165087|NCT00954616|Inappropriate Medications Associated|inappropriate medications associated
5165088|NCT00954616|Alzheimer's disease|alzheimer's disease
5165089|NCT00954603|delirium rating scale|delirium rating scale
5165090|NCT00954603|clinical global improvement|clinical global improvement
5165091|NCT00954603|extrapyramidal side effect|extrapyramidal side effect
5165092|NCT00954577|obesity|obesity
5165093|NCT00954577|diabetes|diabetes
5165094|NCT00954577|exercise|exercise
5165095|NCT00954577|education|education
5165096|NCT00954577|child|child
5165097|NCT00954564|arthralgia|arthralgia
5165098|NCT00954564|stage I breast cancer|stage i breast cancer
5165099|NCT00954564|stage II breast cancer|stage ii breast cancer
5165100|NCT00954564|stage IIIA breast cancer|stage iiia breast cancer
5165101|NCT00954525|Pancreatic Cancer|pancreatic cancer
5165102|NCT00954512|Antibodies, neoplasm|antibodies, neoplasm
5165103|NCT00954499|tactile stimulation|tactile stimulation
5165104|NCT00954499|pain|pain
5165105|NCT00954499|immunization|immunization
5165106|NCT00954499|infant|infant
5165107|NCT00954460|VPRIV|vpriv
5165108|NCT00954460|Enzyme Replacement Therapy|enzyme replacement therapy
5165109|NCT00954460|Gaucher disease|gaucher disease
5165110|NCT00954460|glucocerebrosidase|glucocerebrosidase
5165111|NCT00954460|beta-glucocerebrosidase|beta-glucocerebrosidase
5165112|NCT00954460|Acid beta-glucocerebrosidase|acid beta-glucocerebrosidase
5165113|NCT00954460|glucosylceramidase|glucosylceramidase
5165114|NCT00954460|D-glucosyl-N-acylsphingosine glucohydrolase|d-glucosyl-n-acylsphingosine glucohydrolase
5165115|NCT00954460|gene activation|gene activation
5165116|NCT00954460|human|human
5165117|NCT00954395|vitamin K antagonists, D-dimer,|vitamin k antagonists, d-dimer,
5165118|NCT00954395|deep vein thrombosis, pulmonary embolism,|deep vein thrombosis, pulmonary embolism,
5165119|NCT00954382|Down syndrome|down syndrome
5165120|NCT00954382|IQ|iq
5165121|NCT00954382|mental age|mental age
5165122|NCT00954382|neuropsychological function|neuropsychological function
5165123|NCT00954369|Alzheimer's disease|alzheimer's disease
5165124|NCT00954369|AD|ad
5165125|NCT00954369|W372|w372
5165126|NCT00954369|W372000|w372000
5165127|NCT00954369|[F-18]W372|[f-18]w372
5165128|NCT00954369|exploratory|exploratory
5165129|NCT00954369|imaging|imaging
5165130|NCT00954356|Pain following 3rd molar/wisdom tooth extraction|pain following 3rd molar/wisdom tooth extraction
5165131|NCT00954343|Foot Ulcers|foot ulcers
5165132|NCT00954343|Extracorporeal Shockwave|extracorporeal shockwave
5165133|NCT00954343|Chronic wound|chronic wound
5165134|NCT00954330|rct, intervention, surgery, lateral ligament injury of the ankle|rct, intervention, surgery, lateral ligament injury of the ankle
5165135|NCT00954330|REturn to pre-injury level|return to pre-injury level
5165136|NCT00954317|epidural|epidural
5165137|NCT00954317|labour analgesia|labour analgesia
5165138|NCT00954304|Pgp inhibitor|pgp inhibitor
5165139|NCT00954304|P-glycoprotein inhibitor|p-glycoprotein inhibitor
5165140|NCT00954291|antinauseant and antiemetic|antinauseant and antiemetic
5165141|NCT00954278|non small cell lung cancer|non small cell lung cancer
5165142|NCT00954278|phase 1|phase 1
5165143|NCT00954278|sorafenib|sorafenib
5165144|NCT00954278|intrapatient dose escalation|intrapatient dose escalation
5165145|NCT00954265|pregnancy occurence|pregnancy occurence
5165146|NCT00954265|OHSS|ohss
5165147|NCT00954226|Head & Neck squamous cell carcinoma|head & neck squamous cell carcinoma
5165148|NCT00954226|HN cancer|hn cancer
5165149|NCT00954226|Surgery|surgery
5165150|NCT00954226|Erlotinib|erlotinib
5165151|NCT00954226|Biomarkers|biomarkers
5165152|NCT00954226|Phosphorylation of AKT|phosphorylation of akt
5165153|NCT00954161|First aid|first aid
5165154|NCT00954161|Helping behaviour|helping behaviour
5165155|NCT00954161|Health education|health education
5165156|NCT00954161|Myocardial infarction|myocardial infarction
5165157|NCT00954161|Emergencies|emergencies
5165159|NCT00954148|colorectal|colorectal
5165160|NCT00954148|head/neck|head/neck
5165161|NCT00954148|lung|lung
5165162|NCT00954148|PET/CT|pet/ct
5165163|NCT00954135|neoadjuvant therapy, sorafenib, letrozolo, cyclophosphamide|neoadjuvant therapy, sorafenib, letrozolo, cyclophosphamide
5165164|NCT00954122|Acute schizophrenia|acute schizophrenia
5165165|NCT00954109|Insulin Resistance|insulin resistance
5165166|NCT00954109|Type 2 Diabetes|type 2 diabetes
5165167|NCT00954070|gastroesophageal reflux disease|gastroesophageal reflux disease
5165168|NCT00954057|TED|ted
5165169|NCT00954044|randomized clinical trial|randomized clinical trial
5165170|NCT00954044|prostate cancer|prostate cancer
5165171|NCT00954044|partnered exercise|partnered exercise
5165172|NCT00954005|relapsed indolent lymphoma|relapsed indolent lymphoma
5165173|NCT00954005|gemcitabine|gemcitabine
5165174|NCT00954005|oxaliplatin|oxaliplatin
5165175|NCT00954005|rituximab|rituximab
5165176|NCT00953992|acute kidney disease|acute kidney disease
5165177|NCT00953992|prognosis|prognosis
5165178|NCT00953992|oxidative stress|oxidative stress
5165179|NCT00953992|inflammation|inflammation
5165180|NCT00953992|gene polymorphism|gene polymorphism
5165181|NCT00953979|ankylosing spondylitis|ankylosing spondylitis
5165182|NCT00953979|treatment|treatment
5165183|NCT00953979|Sulfasalazine|sulfasalazine
5165184|NCT00953979|kunxian capsule|kunxian capsule
5165185|NCT00953914|pyridostigmine|pyridostigmine
5165186|NCT00953914|autonomic modulation|autonomic modulation
5165187|NCT00953914|diabetes mellitus|diabetes mellitus
5165188|NCT00953914|heart rate variability|heart rate variability
5165189|NCT00953888|Healthy volunteer|healthy volunteer
5165190|NCT00953888|Single ascending dose|single ascending dose
5165191|NCT00953888|Safety|safety
5165192|NCT00953888|Tolerability|tolerability
5165193|NCT00953888|Healthy volunteer study|healthy volunteer study
5165194|NCT00953862|ADHD|adhd
5165195|NCT00953862|Substance Use Disorder|substance use disorder
5165196|NCT00953862|Residential Treatment Facility|residential treatment facility
5165197|NCT00953849|Calcitriol|calcitriol
5165198|NCT00953849|Celecoxib|celecoxib
5165199|NCT00953849|Immunotherapy|immunotherapy
5165200|NCT00953836|kinetics|kinetics
5165201|NCT00953836|alkylresorcinol metabolites|alkylresorcinol metabolites
5165202|NCT00953836|rye fiber|rye fiber
5165203|NCT00953823|Thiamin supplementation|thiamin supplementation
5165204|NCT00953823|Thiamin deficiency|thiamin deficiency
5165205|NCT00953823|Heart failure|heart failure
5165206|NCT00953823|Heart function|heart function
5165207|NCT00953823|Vitamin B1 supplementation|vitamin b1 supplementation
5165208|NCT00953810|heart failure|heart failure
5165209|NCT00953810|education|education
5165210|NCT00953810|non-pharmacological management|non-pharmacological management
5165211|NCT00953810|prognosis|prognosis
5165212|NCT00953797|Resistant Hypertension|resistant hypertension
5165213|NCT00953797|Endothelial dysfunction|endothelial dysfunction
5165214|NCT00953797|Enhanced External Counterpulsation|enhanced external counterpulsation
5165215|NCT00953784|surgery|surgery
5165216|NCT00953784|wound infections|wound infections
5165217|NCT00953784|colorectal|colorectal
5165218|NCT00953771|TTP|ttp
5165219|NCT00953771|Thrombotic Thrombocytopenic Purpura|thrombotic thrombocytopenic purpura
5165220|NCT00953758|Chronic Myeloid Leukemia Myelofibrosis Myelodysplastic Syndrome Acute myeloid Leukemia Hedgehog inhibitor|chronic myeloid leukemia myelofibrosis myelodysplastic syndrome acute myeloid leukemia hedgehog inhibitor
5165221|NCT00953745|Depression|depression
5165222|NCT00953745|Neuroimaging|neuroimaging
5165223|NCT00953745|Aripiprazole|aripiprazole
5165224|NCT00953745|Mood disorder|mood disorder
5165225|NCT00953745|PET Scan|pet scan
5165226|NCT00953745|fMRI|fmri
5165227|NCT00953732|Peplin|peplin
5165228|NCT00953732|Actinic keratosis|actinic keratosis
5165229|NCT00953732|PEP005|pep005
5165230|NCT00953719|Hip arthroplasty|hip arthroplasty
5165231|NCT00953719|Acetabular cup|acetabular cup
5165232|NCT00953719|Ceramic-on-polyethylene|ceramic-on-polyethylene
5165233|NCT00953706|Fibrosis|fibrosis
5165234|NCT00953706|Pancreatic Diseases|pancreatic diseases
5165235|NCT00953706|Digestive System Diseases|digestive system diseases
5165236|NCT00953706|Lung Diseases|lung diseases
5165237|NCT00953706|Respiratory Tract Diseases|respiratory tract diseases
5165238|NCT00953706|Genetic Diseases, Inborn|genetic diseases, inborn
5165239|NCT00953706|Infant, Newborn, Diseases|infant, newborn, diseases
5165240|NCT00953706|Pathologic Processes|pathologic processes
5165241|NCT00953693|Induced pluripotent stem cells|induced pluripotent stem cells
5165242|NCT00953693|Hepatic disorders|hepatic disorders
5165243|NCT00953693|Eye disorders|eye disorders
5165244|NCT00953693|Blood groups|blood groups
5165245|NCT00953654|Generalized Anxiety Disorder|generalized anxiety disorder
5165246|NCT00953654|Exercise Training|exercise training
5165247|NCT00953654|Strength Training|strength training
5165248|NCT00953654|Mental Health|mental health
5165249|NCT00953641|Vaginal Misoprostol|vaginal misoprostol
5165250|NCT00953641|Cervical ripening|cervical ripening
5165251|NCT00953641|Endometrial biopsy|endometrial biopsy
5165252|NCT00953628|endometrium|endometrium
5165253|NCT00953628|histology|histology
5165254|NCT00953628|pregnancy|pregnancy
5165255|NCT00953615|PSC|psc
5165256|NCT00953615|Thalidomide|thalidomide
5165257|NCT00953589|treatment naive|treatment naive
5165258|NCT00953576|castration resistant prostate cancer|castration resistant prostate cancer
5165259|NCT00953576|KHAD|khad
5165260|NCT00953563|Venous Leg Ulcers|venous leg ulcers
5165261|NCT00953537|stage IV breast cancer|stage iv breast cancer
5165262|NCT00953524|Influenza|influenza
5165263|NCT00953524|Pandemic Flu|pandemic flu
5165264|NCT00953524|Swine-origin A/H1N1 Influenza|swine-origin a/h1n1 influenza
5165265|NCT00953524|Adult|adult
5165266|NCT00953511|esophagus|esophagus
5165267|NCT00953511|chemoradiation|chemoradiation
5165268|NCT00953511|excision repair cross-complementing gene|excision repair cross-complementing gene
5165269|NCT00953511|polymorphism|polymorphism
5165270|NCT00953511|response prediction|response prediction
5165271|NCT00953498|diabetes|diabetes
5165272|NCT00953498|glitazones|glitazones
5165273|NCT00953498|HDL|hdl
5165274|NCT00953485|Sjogren's Syndrome|sjogren's syndrome
5165275|NCT00953485|Mesenchymal Stem Cells|mesenchymal stem cells
5165276|NCT00953485|Transplantation|transplantation
5165277|NCT00953472|hypertension treatment|hypertension treatment
5165278|NCT00953459|extensive stage small cell lung cancer|extensive stage small cell lung cancer
5165279|NCT00953459|recurrent small cell lung cancer|recurrent small cell lung cancer
5165280|NCT00953446|metastatic renal cell carcinoma|metastatic renal cell carcinoma
5165281|NCT00953446|ASL MRI|asl mri
5165282|NCT00953446|sunitinib|sunitinib
5165283|NCT00953446|AMG386|amg386
5165284|NCT00953433|Intratracheal|intratracheal
5165285|NCT00953420|nasopharyngeal carcinoma|nasopharyngeal carcinoma
5165286|NCT00953420|Carboplatin|carboplatin
5165287|NCT00953420|Docetaxel|docetaxel
5165288|NCT00953420|Epstein-Barr Virus|epstein-barr virus
5165289|NCT00953420|T Lymphocytes|t lymphocytes
5165290|NCT00953420|EBV-CTLs|ebv-ctls
5165291|NCT00953394|octreotide LAR|octreotide lar
5165292|NCT00953394|neuroendocrine carcinoma|neuroendocrine carcinoma
5165293|NCT00953394|metronomic 5fluorouracil|metronomic 5fluorouracil
5165294|NCT00953381|Ilaprazole|ilaprazole
5165295|NCT00953381|Proton pump inhibitor|proton pump inhibitor
5165296|NCT00953381|Duodenal ulcer|duodenal ulcer
5165297|NCT00953381|Acid suppression|acid suppression
5165298|NCT00953381|Randomized trial|randomized trial
5165299|NCT00953368|remote ischemic preconditioning|remote ischemic preconditioning
5165300|NCT00953368|cognitive function|cognitive function
5165301|NCT00953368|off-pump coronary artery bypass graft|off-pump coronary artery bypass graft
5165302|NCT00953342|AEROBIC EXERCISE|aerobic exercise
5165303|NCT00953342|ASTHMA CONTROL|asthma control
5165304|NCT00953342|ASTHMA QUALITY OF LIFE|asthma quality of life
5165305|NCT00953342|INFLAMMATION|inflammation
5165306|NCT00953342|TREATMENT|treatment
5165307|NCT00953303|heart failure|heart failure
5165308|NCT00953303|prednisone|prednisone
5165309|NCT00953303|cardiovascular mortality|cardiovascular mortality
5165310|NCT00953303|renal function|renal function
5165311|NCT00953290|Cellulite|cellulite
5165312|NCT00953290|Adipose tissue|adipose tissue
5165313|NCT00953290|Circumference|circumference
5165314|NCT00953290|Reduction|reduction
5165315|NCT00953290|Thigh|thigh
5165316|NCT00953277|Nerve Repair|nerve repair
5165317|NCT00953277|Erectile Function|erectile function
5165318|NCT00953277|Prostate Cancer|prostate cancer
5165319|NCT00953277|Robot Assisted Laparoscopic Prostatectomy|robot assisted laparoscopic prostatectomy
5165320|NCT00953277|Continence|continence
5165321|NCT00953251|high sensitive troponin T; non-STEMI; early detection.|high sensitive troponin t; non-stemi; early detection.
5165322|NCT00953251|To detect non-STEMI in a cohort of patients with acute coronary syndrome|to detect non-stemi in a cohort of patients with acute coronary syndrome
5165323|NCT00953225|prostate cancer|prostate cancer
5165324|NCT00953225|vitamin D|vitamin d
5165325|NCT00953212|atrial fibrillation|atrial fibrillation
5165326|NCT00953212|cardiac surgery|cardiac surgery
5165327|NCT00953212|open heart surgery|open heart surgery
5165328|NCT00953199|endoscopic retrograde cholangiopancreatography|endoscopic retrograde cholangiopancreatography
5165329|NCT00953199|ERCP|ercp
5165330|NCT00953199|pancreatitis|pancreatitis
5165331|NCT00953199|lidocaine|lidocaine
5165332|NCT00953199|post-ERCP pancreatitis|post-ercp pancreatitis
5165333|NCT00953186|Diabetes|diabetes
5165334|NCT00953186|Foot ulcer|foot ulcer
5165335|NCT00953186|Neuropathy|neuropathy
5165336|NCT00953186|Ischemia|ischemia
5165337|NCT00953160|Cellulite|cellulite
5165338|NCT00953160|Adipose tissue|adipose tissue
5165339|NCT00953160|Circumference|circumference
5165340|NCT00953160|Reduction|reduction
5165341|NCT00953160|Thigh|thigh
5165342|NCT00953160|Abdomen|abdomen
5165343|NCT00953160|Flank|flank
5165344|NCT00953134|periconceptional|periconceptional
5165345|NCT00953134|iron|iron
5165346|NCT00953134|folic acid|folic acid
5165347|NCT00953134|supplementation|supplementation
5165348|NCT00953121|irinotecan|irinotecan
5165349|NCT00953121|carboplatin|carboplatin
5165350|NCT00953121|bevacizumab|bevacizumab
5165351|NCT00953121|Avastin|avastin
5165352|NCT00953095|Autism Spectrum Disorder|autism spectrum disorder
5165353|NCT00953095|treatment|treatment
5165354|NCT00953095|joint attention|joint attention
5165355|NCT00953095|communication|communication
5165356|NCT00953095|language|language
5165357|NCT00953043|lubiprostone|lubiprostone
5165358|NCT00953043|colon|colon
5165359|NCT00953043|motility|motility
5165360|NCT00953043|sensation|sensation
5165361|NCT00953017|Efficacy of bowel cleansing|efficacy of bowel cleansing
5165362|NCT00953017|Patient tolerability|patient tolerability
5165363|NCT00953017|Amitiza|amitiza
5165364|NCT00953017|Dulcolax|dulcolax
5165365|NCT00953017|Miralax|miralax
5165366|NCT00953017|Colonoscopy preparation|colonoscopy preparation
5165367|NCT00953017|Bowel preparation|bowel preparation
5165368|NCT00953017|Screening colonoscopy|screening colonoscopy
5165369|NCT00953004|dietary fiber|dietary fiber
5165370|NCT00953004|obesity|obesity
5165371|NCT00953004|apparent energy digestibility|apparent energy digestibility
5165372|NCT00952978|Ilaprazole|ilaprazole
5165373|NCT00952978|Proton pump inhibitor|proton pump inhibitor
5165374|NCT00952978|Duodenal ulcer|duodenal ulcer
5165375|NCT00952978|Acid suppression|acid suppression
5165376|NCT00952978|Randomized trial|randomized trial
5165377|NCT00952965|BP|bp
5165378|NCT00952939|ciliary body and choroid melanoma, small size|ciliary body and choroid melanoma, small size
5165379|NCT00952939|iris melanoma|iris melanoma
5165380|NCT00952939|intraocular melanoma|intraocular melanoma
5165381|NCT00952939|ciliary body and choroid melanoma, medium/large size|ciliary body and choroid melanoma, medium/large size
5165382|NCT00952926|Watchful Waiting|watchful waiting
5165383|NCT00952926|Rectal cancer|rectal cancer
5165384|NCT00952926|Observation|observation
5165385|NCT00952926|Avoid operation|avoid operation
5165386|NCT00952900|TMJMD|tmjmd
5165387|NCT00952900|Acute Pain|acute pain
5165388|NCT00952900|RDC/TMD|rdc/tmd
5165389|NCT00952900|Community Treatment Clinics|community treatment clinics
5165390|NCT00952900|RCT|rct
5165391|NCT00952900|Evidence-Based Outcomes|evidence-based outcomes
5165392|NCT00952900|Short- and long-term follow-up|short- and long-term follow-up
5165393|NCT00952900|Biopsychosocial|biopsychosocial
5165394|NCT00952900|Assessment and Treatment|assessment and treatment
5165395|NCT00952900|Ability to read and write English|ability to read and write english
5165396|NCT00952900|6 months' or less duration of TMD|6 months' or less duration of tmd
5165397|NCT00952900|No other pain-related conditions|no other pain-related conditions
5165398|NCT00952874|anal cancer|anal cancer
5165399|NCT00952874|Molecular biology|molecular biology
5165400|NCT00952874|HIV status|hiv status
5165401|NCT00952874|HPV infection|hpv infection
5165402|NCT00952874|Microsatellite instability|microsatellite instability
5165403|NCT00952874|Biopsy proven Squamous Cell carcinoma of the Anus|biopsy proven squamous cell carcinoma of the anus
5165404|NCT00952874|Squamous Cell carcinoma of the Anus|squamous cell carcinoma of the anus
5165405|NCT00952861|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
5165406|NCT00952861|Infection|infection
5165407|NCT00952861|Antibiotics|antibiotics
5165408|NCT00952848|pain|pain
5165409|NCT00952848|neurotoxicity|neurotoxicity
5165410|NCT00952848|chemotherapeutic agent toxicity|chemotherapeutic agent toxicity
5165411|NCT00952848|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5165412|NCT00952848|peripheral neuropathy|peripheral neuropathy
5165413|NCT00952835|Asthma|asthma
5165414|NCT00952835|rhinitis|rhinitis
5165415|NCT00952835|EIB|eib
5165416|NCT00952835|Exhaled Nitric oxide|exhaled nitric oxide
5165417|NCT00952835|lung function|lung function
5165418|NCT00952835|vitamin d|vitamin d
5165419|NCT00952796|intra-abdominal infection|intra-abdominal infection
5165420|NCT00952796|moxifloxacin|moxifloxacin
5165421|NCT00952796|ampicillin/sulbactam|ampicillin/sulbactam
5165422|NCT00952783|Peplin|peplin
5165423|NCT00952783|Actinic keratosis|actinic keratosis
5165424|NCT00952783|PEP005|pep005
5165425|NCT00952770|Coronary artery disease|coronary artery disease
5165426|NCT00952770|Coronary intervention|coronary intervention
5165427|NCT00952770|intima-media thickness|intima-media thickness
5165428|NCT00952757|APS-related hyperprolactinaemia|aps-related hyperprolactinaemia
5165429|NCT00952757|Quetiapine|quetiapine
5165430|NCT00952757|Schizophrenia|schizophrenia
5165431|NCT00952757|Bipolar|bipolar
5165432|NCT00952744|acute myocardial infarction|acute myocardial infarction
5165433|NCT00952744|ST-segment elevation myocardial infarction|st-segment elevation myocardial infarction
5165434|NCT00952744|STEMI|stemi
5165435|NCT00952744|non-ST-segment elevation myocardial infarction|non-st-segment elevation myocardial infarction
5165436|NCT00952744|NSTEMI|nstemi
5165437|NCT00952744|unstable angina|unstable angina
5165438|NCT00952744|unstable angina pectoris|unstable angina pectoris
5165439|NCT00952744|UA|ua
5165440|NCT00952744|UAP|uap
5165441|NCT00952692|breast cancer|breast cancer
5165442|NCT00952692|HER2|her2
5165443|NCT00952692|Lapatinib|lapatinib
5165444|NCT00952692|dHER2 ASCI|dher2 asci
5165445|NCT00952692|overexpressing HER2|overexpressing her2
5165446|NCT00952692|refractory to trastuzumab|refractory to trastuzumab
5165447|NCT00952679|The investigators evaluated the new method by comparing lymph nodes defined by CT and traditional ways.|the investigators evaluated the new method by comparing lymph nodes defined by ct and traditional ways.
5165448|NCT00952666|Prostate Cancer|prostate cancer
5165449|NCT00952666|Transrectal Ultrasound Imaging of Prostate|transrectal ultrasound imaging of prostate
5165450|NCT00952666|Neurovascular Bundles|neurovascular bundles
5165451|NCT00952666|Robot Assisted Laparoscopic Radical Prostatectomy|robot assisted laparoscopic radical prostatectomy
5165452|NCT00952653|depression|depression
5165453|NCT00952640|vitamin A|vitamin a
5165454|NCT00952640|post-partum|post-partum
5165455|NCT00952640|infant|infant
5165456|NCT00952640|acute phase response|acute phase response
5165457|NCT00952627|Cardiac fibrosis|cardiac fibrosis
5165458|NCT00952627|Diastolic dysfunction|diastolic dysfunction
5165459|NCT00952627|Hypertension|hypertension
5165460|NCT00952614|retinal vein occlusion|retinal vein occlusion
5165461|NCT00952614|sustained drug delivery implant|sustained drug delivery implant
5165462|NCT00952614|steroid|steroid
5165463|NCT00952614|macular edema|macular edema
5165464|NCT00952601|Tourette|tourette
5165465|NCT00952601|Atkins|atkins
5165466|NCT00952601|Ketosis|ketosis
5165467|NCT00952601|Tic|tic
5165468|NCT00952588|Acute Myeloid Leukaemia,|acute myeloid leukaemia,
5165469|NCT00952588|AML|aml
5165470|NCT00952575|Prevention of foeto-maternal allo-immunisation|prevention of foeto-maternal allo-immunisation
5165471|NCT00952562|vitamin d|vitamin d
5165472|NCT00952562|calcium|calcium
5165473|NCT00952562|blood pressure|blood pressure
5165474|NCT00952536|Randomised controlled trial|randomised controlled trial
5165475|NCT00952536|Double blind fully masked|double blind fully masked
5165476|NCT00952536|Dietary supplement|dietary supplement
5165477|NCT00952523|acne|acne
5165478|NCT00952523|irritation|irritation
5165479|NCT00952523|objective sensory methods|objective sensory methods
5165480|NCT00952510|Range of motion, articular|range of motion, articular
5165481|NCT00952510|Cervical spine|cervical spine
5165482|NCT00952497|Gastric Cancer|gastric cancer
5165483|NCT00952497|Gastro-Esophageal Cancer|gastro-esophageal cancer
5165484|NCT00952497|GE-Junction|ge-junction
5165485|NCT00952497|Advanced Gastric Cancer|advanced gastric cancer
5165486|NCT00952484|Hypophosphatasia|hypophosphatasia
5165487|NCT00952484|HPP|hpp
5165488|NCT00952484|Bone Disease|bone disease
5165489|NCT00952484|Soft Bones|soft bones
5165490|NCT00952484|Low Alkaline Phosphatase|low alkaline phosphatase
5165491|NCT00952484|genetic metabolic disorder|genetic metabolic disorder
5165492|NCT00952484|alkaline phosphatase|alkaline phosphatase
5165493|NCT00952484|tissue non-specific alkaline phosphatase|tissue non-specific alkaline phosphatase
5165494|NCT00952484|rickets|rickets
5165495|NCT00952484|osteomalacia|osteomalacia
5165496|NCT00952471|Asthma|asthma
5165497|NCT00952471|Children|children
5165498|NCT00952471|CPOE|cpoe
5165499|NCT00952471|Decision Support|decision support
5165500|NCT00952471|Framing|framing
5165501|NCT00952471|Heuristic|heuristic
5165502|NCT00952471|Order Sets|order sets
5165503|NCT00952458|Safety|safety
5165504|NCT00952458|Midazolam and propofol sedation|midazolam and propofol sedation
5165505|NCT00952458|ERCP|ercp
5165506|NCT00952458|Bispectral Index monitoring|bispectral index monitoring
5165507|NCT00952432|Carpal Tunnel Syndrome|carpal tunnel syndrome
5165508|NCT00952432|Multiple Excitability Test|multiple excitability test
5165509|NCT00952432|Nerve Conduction Study|nerve conduction study
5165510|NCT00952432|QtracW|qtracw
5165511|NCT00952432|carbamazepine|carbamazepine
5165512|NCT00952432|Acupuncture|acupuncture
5165513|NCT00952419|Influenza|influenza
5165514|NCT00952419|Pandemic Flu|pandemic flu
5165515|NCT00952419|Swine-origin A/H1N1 Influenza|swine-origin a/h1n1 influenza
5165516|NCT00952419|Children|children
5165517|NCT00952406|Pelvic Floor Disorders|pelvic floor disorders
5165518|NCT00952406|Sexual Function|sexual function
5165519|NCT00952406|Incontinence|incontinence
5165520|NCT00952406|Pelvic Organ Prolapse|pelvic organ prolapse
5165521|NCT00952393|receptors nicotinic|receptors nicotinic
5165522|NCT00952380|VTE|vte
5165523|NCT00952354|Down syndrome|down syndrome
5165525|NCT00952354|language development|language development
5165526|NCT00952354|language assessment|language assessment
5165527|NCT00952341|CINV|cinv
5165528|NCT00952328|breastfeeding outcomes|breastfeeding outcomes
5165529|NCT00952328|breastfeeding self-efficacy|breastfeeding self-efficacy
5165530|NCT00952328|infant weight loss|infant weight loss
5165531|NCT00952315|kidney stones|kidney stones
5165532|NCT00952315|intracorporeal lithotriptors|intracorporeal lithotriptors
5165533|NCT00952315|kidney stone removal|kidney stone removal
5165534|NCT00952302|Hypoxia|hypoxia
5165535|NCT00952302|Iron|iron
5165536|NCT00952302|Hypoxia-Inducible Factor 1|hypoxia-inducible factor 1
5165537|NCT00952302|Chronic mountain sickness|chronic mountain sickness
5165538|NCT00952289|Myelofibrosis|myelofibrosis
5165539|NCT00952289|Post-Polycythemia Vera Myelofibrosis|post-polycythemia vera myelofibrosis
5165540|NCT00952289|Post-Essential Thrombocythemia Myelofibrosis|post-essential thrombocythemia myelofibrosis
5165541|NCT00952276|Influenza Pandemic Flu Swine-origin A/H1N1 Influenza Adults|influenza pandemic flu swine-origin a/h1n1 influenza adults
5165542|NCT00952263|Hepatitis C|hepatitis c
5165543|NCT00952263|Phase I|phase i
5165544|NCT00952263|Infusion|infusion
5165545|NCT00952263|Pharmacokinetics|pharmacokinetics
5165546|NCT00952263|MBL-HCV1|mbl-hcv1
5165547|NCT00952263|Monoclonal antibody|monoclonal antibody
5165548|NCT00952263|Safety Assessment|safety assessment
5165549|NCT00952250|quality improvement|quality improvement
5165550|NCT00952237|Autologous Peripheral Blood Stem Cell Transplant|autologous peripheral blood stem cell transplant
5165551|NCT00952237|IL-2|il-2
5165552|NCT00952237|GM-CSF|gm-csf
5165553|NCT00952224|myocardial salvage|myocardial salvage
5165554|NCT00952224|cardiovascular magnetic resonance|cardiovascular magnetic resonance
5165555|NCT00952224|magnetic resonance imaging|magnetic resonance imaging
5165556|NCT00952224|myocardial infarction|myocardial infarction
5165557|NCT00952224|prognosis|prognosis
5165558|NCT00952211|stroke|stroke
5165559|NCT00952211|obstructive sleep apnea|obstructive sleep apnea
5165560|NCT00952211|fatigue|fatigue
5165561|NCT00952211|quality of life|quality of life
5165562|NCT00952185|viral infection|viral infection
5165563|NCT00952185|aplastic anemia|aplastic anemia
5165564|NCT00952185|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5165565|NCT00952185|acute undifferentiated leukemia|acute undifferentiated leukemia
5165566|NCT00952185|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5165567|NCT00952185|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5165568|NCT00952185|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5165569|NCT00952185|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5165570|NCT00952185|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5165571|NCT00952185|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5165572|NCT00952185|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5165573|NCT00952185|atypical chronic myeloid leukemia, BCR-ABL negative|atypical chronic myeloid leukemia, bcr-abl negative
5165574|NCT00952185|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5165575|NCT00952185|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5165576|NCT00952185|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5165577|NCT00952185|mast cell leukemia|mast cell leukemia
5165578|NCT00952185|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
5165579|NCT00952185|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
5165580|NCT00952185|prolymphocytic leukemia|prolymphocytic leukemia
5165581|NCT00952185|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5165582|NCT00952185|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5165583|NCT00952185|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
5165584|NCT00952185|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5165585|NCT00952185|refractory hairy cell leukemia|refractory hairy cell leukemia
5165586|NCT00952185|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5165587|NCT00952185|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5165588|NCT00952185|stage 0 chronic lymphocytic leukemia|stage 0 chronic lymphocytic leukemia
5165589|NCT00952185|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
5165590|NCT00952185|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
5165591|NCT00952185|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
5165592|NCT00952185|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
5165593|NCT00952185|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
5165594|NCT00952185|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5165595|NCT00952185|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
5165596|NCT00952185|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5165597|NCT00952185|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
5165598|NCT00952185|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5165599|NCT00952185|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
5165600|NCT00952185|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
5168390|NCT00942825|Lung|lung
5165601|NCT00952185|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5165602|NCT00952185|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5165603|NCT00952185|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5165604|NCT00952185|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
5165605|NCT00952185|cutaneous B-cell non-Hodgkin lymphoma|cutaneous b-cell non-hodgkin lymphoma
5165606|NCT00952185|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5165607|NCT00952185|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
5165608|NCT00952185|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
5165609|NCT00952185|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
5165610|NCT00952185|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
5165611|NCT00952185|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5165612|NCT00952185|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
5165613|NCT00952185|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
5165614|NCT00952185|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
5165615|NCT00952185|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
5165616|NCT00952185|adult grade III lymphomatoid granulomatosis|adult grade iii lymphomatoid granulomatosis
5165617|NCT00952185|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
5165618|NCT00952185|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
5165619|NCT00952185|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5165620|NCT00952185|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5165621|NCT00952185|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5165622|NCT00952185|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
5165623|NCT00952185|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
5165624|NCT00952185|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
5165625|NCT00952185|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
5165626|NCT00952185|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
5165722|NCT00952159|O-demethyl-tramadol|o-demethyl-tramadol
5165627|NCT00952185|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
5165628|NCT00952185|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
5165629|NCT00952185|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
5165630|NCT00952185|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
5165631|NCT00952185|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
5165632|NCT00952185|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
5165633|NCT00952185|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
5165634|NCT00952185|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
5165635|NCT00952185|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
5165636|NCT00952185|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
5165637|NCT00952185|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
5165638|NCT00952185|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
5165639|NCT00952185|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
5165640|NCT00952185|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
5165641|NCT00952185|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
5165642|NCT00952185|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
5165643|NCT00952185|stage I mantle cell lymphoma|stage i mantle cell lymphoma
5165644|NCT00952185|stage I marginal zone lymphoma|stage i marginal zone lymphoma
5165645|NCT00952185|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
5165646|NCT00952185|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
5165647|NCT00952185|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5165648|NCT00952185|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
5165649|NCT00952185|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
5165650|NCT00952185|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
5165651|NCT00952185|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
5165652|NCT00952185|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5165653|NCT00952185|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5165654|NCT00952185|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5165655|NCT00952185|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5165656|NCT00952185|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
5165657|NCT00952185|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
5165658|NCT00952185|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5165659|NCT00952185|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5165660|NCT00952185|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5165661|NCT00952185|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5165662|NCT00952185|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5165663|NCT00952185|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5165664|NCT00952185|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5165665|NCT00952185|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5165666|NCT00952185|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5165667|NCT00952185|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5165668|NCT00952185|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5165669|NCT00952185|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5165670|NCT00952185|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5165671|NCT00952185|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5165672|NCT00952185|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5165673|NCT00952185|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5165674|NCT00952185|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5165675|NCT00952185|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5165676|NCT00952185|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5165677|NCT00952185|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5165678|NCT00952185|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5165679|NCT00952185|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5165680|NCT00952185|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5165681|NCT00952185|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5165682|NCT00952185|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5165683|NCT00952185|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5165684|NCT00952185|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5165685|NCT00952185|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5165686|NCT00952185|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
5165687|NCT00952185|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5165688|NCT00952185|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5165689|NCT00952185|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5165690|NCT00952185|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5165691|NCT00952185|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5165692|NCT00952185|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5165693|NCT00952185|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5165694|NCT00952185|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5165695|NCT00952185|intraocular lymphoma|intraocular lymphoma
5165696|NCT00952185|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
5165697|NCT00952185|primary central nervous system Hodgkin lymphoma|primary central nervous system hodgkin lymphoma
5165698|NCT00952185|post-transplant lymphoproliferative disorder|post-transplant lymphoproliferative disorder
5165699|NCT00952185|chronic eosinophilic leukemia|chronic eosinophilic leukemia
5165700|NCT00952185|chronic neutrophilic leukemia|chronic neutrophilic leukemia
5165701|NCT00952185|primary myelofibrosis|primary myelofibrosis
5165702|NCT00952185|essential thrombocythemia|essential thrombocythemia
5165703|NCT00952185|polycythemia vera|polycythemia vera
5165704|NCT00952185|extramedullary plasmacytoma|extramedullary plasmacytoma
5165705|NCT00952185|isolated plasmacytoma of bone|isolated plasmacytoma of bone
5165706|NCT00952185|stage I multiple myeloma|stage i multiple myeloma
5165707|NCT00952185|stage II multiple myeloma|stage ii multiple myeloma
5165708|NCT00952185|stage III multiple myeloma|stage iii multiple myeloma
5165709|NCT00952185|primary systemic amyloidosis|primary systemic amyloidosis
5165710|NCT00952185|refractory multiple myeloma|refractory multiple myeloma
5165711|NCT00952185|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5165712|NCT00952185|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5165713|NCT00952185|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5165714|NCT00952185|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
5165715|NCT00952172|Stair stepping training|stair stepping training
5165716|NCT00952172|OSAS|osas
5165717|NCT00952172|cardiopulmonary fitness|cardiopulmonary fitness
5165718|NCT00952172|sleep disturbance|sleep disturbance
5165719|NCT00952172|Actigraphy|actigraphy
5165720|NCT00952159|tramadol|tramadol
5165721|NCT00952159|CYP2D6|cyp2d6
5165723|NCT00952159|poor metabolizer|poor metabolizer
5165724|NCT00952159|genotyping|genotyping
5165725|NCT00952159|phenotyping|phenotyping
5165726|NCT00952146|NOTES|notes
5165727|NCT00952146|Transgastric|transgastric
5165728|NCT00952146|Appendectomy|appendectomy
5165729|NCT00952146|Safety|safety
5165730|NCT00952146|Feasibility|feasibility
5165731|NCT00952133|PONV|ponv
5165732|NCT00952133|Outpatient surgery|outpatient surgery
5165733|NCT00952133|Laparoscopic abdominal surgery|laparoscopic abdominal surgery
5165734|NCT00952133|Laparoscopic gynecologic surgery|laparoscopic gynecologic surgery
5165735|NCT00952120|Wound healing|wound healing
5165736|NCT00952120|Negative pressure wound therapy|negative pressure wound therapy
5165737|NCT00952120|Skin graft|skin graft
5165738|NCT00952107|breast cancer|breast cancer
5165739|NCT00952107|breast reconstructive surgery|breast reconstructive surgery
5165740|NCT00952107|flap assessment|flap assessment
5165741|NCT00952094|Healthy volunteer|healthy volunteer
5165742|NCT00952081|Hypertension|hypertension
5165743|NCT00952081|Neurosurgery|neurosurgery
5165744|NCT00952081|bloodpressure control|bloodpressure control
5165745|NCT00952081|brain tumor resection|brain tumor resection
5165746|NCT00952081|epilepsy focus resection|epilepsy focus resection
5165747|NCT00952068|Back Pain|back pain
5165748|NCT00952055|neopterin|neopterin
5165749|NCT00952055|macrophage|macrophage
5165750|NCT00952055|inflammation|inflammation
5165751|NCT00952042|Tendinopathy, Achilles, Eccentric training, Heavy slow resistance training|tendinopathy, achilles, eccentric training, heavy slow resistance training
5165752|NCT00952029|stage IV colon cancer|stage iv colon cancer
5165753|NCT00952029|stage IV rectal cancer|stage iv rectal cancer
5165754|NCT00952016|colorectal cancer|colorectal cancer
5165755|NCT00952016|MSH2|msh2
5165756|NCT00952016|metastatic|metastatic
5165757|NCT00952003|Avastin|avastin
5165758|NCT00952003|Campto|campto
5165759|NCT00952003|Oxaliplatin|oxaliplatin
5165760|NCT00952003|Taxotere|taxotere
5165761|NCT00951977|End Stage Renal Disease (ESRD)|end stage renal disease (esrd)
5165762|NCT00951977|Transplantation|transplantation
5165763|NCT00951977|Living Kidney Donation|living kidney donation
5165764|NCT00951977|Kidney Transplant|kidney transplant
5165765|NCT00951938|Trinity Evolution|trinity evolution
5165766|NCT00951938|Anterior Cervical Discectomy and Fusion|anterior cervical discectomy and fusion
5165767|NCT00951938|Allograft|allograft
5165768|NCT00951925|diagnostic bone marrow biopsies|diagnostic bone marrow biopsies
5165769|NCT00951925|bone marrow harvesting for autologous BMT|bone marrow harvesting for autologous bmt
5165770|NCT00951912|genistein|genistein
5165771|NCT00951912|daidzein|daidzein
5165772|NCT00951912|impaired glucose regulation|impaired glucose regulation
5165773|NCT00951912|glucose metabolism|glucose metabolism
5165774|NCT00951912|lipids metabolism|lipids metabolism
5165775|NCT00951912|inflammation|inflammation
5165776|NCT00951912|women|women
5165777|NCT00951899|Incretins|incretins
5165778|NCT00951899|colesevelam|colesevelam
5165779|NCT00951899|hepatobiliary circulation|hepatobiliary circulation
5165780|NCT00951886|Ataxia Teleangiectasia|ataxia teleangiectasia
5165781|NCT00951886|Spirometry|spirometry
5165782|NCT00951886|Respiratory rare diseases|respiratory rare diseases
5165783|NCT00951860|Fullterm Birth|fullterm birth
5165784|NCT00951860|Neonate|neonate
5165785|NCT00951860|Prematurity|prematurity
5165786|NCT00951860|Neurodevelopment|neurodevelopment
5165787|NCT00951860|Autonomic Nervous System activity|autonomic nervous system activity
5165788|NCT00951847|Oxcarbazepine oral suspension fed study|oxcarbazepine oral suspension fed study
5165789|NCT00951834|Alzheimer´s Disease|alzheimer´s disease
5165790|NCT00951834|Epigallocatechin-Gallate|epigallocatechin-gallate
5165791|NCT00951834|Neuroprotection|neuroprotection
5165792|NCT00951834|ADAS-COG|adas-cog
5165793|NCT00951834|early stage of Alzheimer's Disease|early stage of alzheimer's disease
5165794|NCT00951821|Suicidal Ideation|suicidal ideation
5165795|NCT00951821|Suicide Attempts|suicide attempts
5165796|NCT00951808|Anemia, Sickle Cell|anemia, sickle cell
5165797|NCT00951808|Acute Chest Syndrome|acute chest syndrome
5165798|NCT00951808|Secretory phospholipase A2(sPLA2)|secretory phospholipase a2(spla2)
5165799|NCT00951795|HIV|hiv
5165800|NCT00951795|AIDS|aids
5165801|NCT00951795|CD4|cd4
5165802|NCT00951782|COPD|copd
5165803|NCT00951756|Dietary fat|dietary fat
5165804|NCT00951756|Microbiome composition|microbiome composition
5165805|NCT00951756|Controlled feeding experiment|controlled feeding experiment
5165806|NCT00951743|AIDS|aids
5165807|NCT00951743|HIV|hiv
5165808|NCT00951743|mDAPTA|mdapta
5165809|NCT00951730|Down Syndrome|down syndrome
5165810|NCT00951730|Adult|adult
5165811|NCT00951730|Children|children
5165812|NCT00951730|Sleep apnea|sleep apnea
5165813|NCT00951730|Sleep hypopnea|sleep hypopnea
5165814|NCT00951730|Polysomnography|polysomnography
5165815|NCT00951717|Postpartum Depressive Symptoms|postpartum depressive symptoms
5165816|NCT00951717|Physical Symptoms|physical symptoms
5165817|NCT00951717|Emotional Symptoms|emotional symptoms
5165818|NCT00951717|Infant Colic|infant colic
5165819|NCT00951717|Social Support|social support
5165820|NCT00951717|Breastfeeding|breastfeeding
5165821|NCT00951704|CPR|cpr
5165822|NCT00951704|Tissue Perfusion|tissue perfusion
5165823|NCT00951704|invasive arterial pressure|invasive arterial pressure
5165824|NCT00951704|exhaled carbon dioxide|exhaled carbon dioxide
5165825|NCT00951704|Quality of life|quality of life
5165826|NCT00951704|Quality of chest compressions|quality of chest compressions
5165827|NCT00951704|Epidemiology of sudden cardiac arrest(OHCA)|epidemiology of sudden cardiac arrest(ohca)
5165828|NCT00951691|Elderly|elderly
5165829|NCT00951691|Acute Medical Rehabilitation|acute medical rehabilitation
5165830|NCT00951678|ultrasound|ultrasound
5165831|NCT00951678|femoral vein|femoral vein
5165832|NCT00951678|internal jugular vein|internal jugular vein
5165833|NCT00951665|Trastuzumab DM1 (T-DM1)|trastuzumab dm1 (t-dm1)
5165834|NCT00951665|Trastuzumab emtansine|trastuzumab emtansine
5165835|NCT00951665|Armed Herceptin|armed herceptin
5165836|NCT00951665|HER2|her2
5165837|NCT00951665|HER2+|her2+
5165838|NCT00951665|HER2 Positive Breast Cancer|her2 positive breast cancer
5165839|NCT00951652|CBT|cbt
5165840|NCT00951652|GAD|gad
5165841|NCT00951652|Interpersonal Therapy|interpersonal therapy
5165842|NCT00951652|Emotion-Focused Therapy|emotion-focused therapy
5165843|NCT00951639|Cassia|cassia
5165844|NCT00951639|Cinnamon|cinnamon
5165845|NCT00951639|Blood Glucose|blood glucose
5165846|NCT00951639|Endurance exercise|endurance exercise
5165847|NCT00951639|Acute exercise|acute exercise
5165848|NCT00951639|Overweight|overweight
5165849|NCT00951639|Obesity|obesity
5165850|NCT00951639|Women|women
5165851|NCT00951626|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
5165852|NCT00951626|therapy-related toxicity|therapy-related toxicity
5165853|NCT00951626|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5165854|NCT00951626|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5165855|NCT00951626|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5165856|NCT00951626|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5165857|NCT00951626|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5165858|NCT00951626|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5165859|NCT00951626|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5165860|NCT00951626|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5165861|NCT00951626|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5165862|NCT00951626|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5165863|NCT00951626|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5165864|NCT00951626|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5165865|NCT00951626|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5165866|NCT00951626|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5165867|NCT00951626|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5165868|NCT00951626|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5165869|NCT00951626|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5165870|NCT00951626|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5165871|NCT00951626|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5165872|NCT00951626|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5165873|NCT00951626|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5165874|NCT00951626|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5165875|NCT00951626|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5165876|NCT00951626|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5165877|NCT00951626|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5165878|NCT00951626|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5165879|NCT00951626|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5165880|NCT00951626|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5165881|NCT00951626|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5165882|NCT00951626|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5165883|NCT00951626|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5165884|NCT00951626|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5165885|NCT00951626|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5165886|NCT00951626|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5165887|NCT00951626|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5165888|NCT00951626|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5165889|NCT00951626|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5165890|NCT00951626|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5165891|NCT00951626|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5165892|NCT00951626|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5165893|NCT00951626|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5165894|NCT00951626|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5165895|NCT00951626|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5165896|NCT00951626|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5165897|NCT00951626|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
5165898|NCT00951626|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5165899|NCT00951626|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
5165900|NCT00951626|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
5165901|NCT00951626|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
5165902|NCT00951626|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
5165903|NCT00951626|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5165904|NCT00951626|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5165905|NCT00951626|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5165906|NCT00951626|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5165907|NCT00951626|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
5165908|NCT00951626|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
5165909|NCT00951626|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5165910|NCT00951626|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5165911|NCT00951626|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5165912|NCT00951626|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5165913|NCT00951626|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5165914|NCT00951626|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5165915|NCT00951626|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5165916|NCT00951626|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5165917|NCT00951626|atypical chronic myeloid leukemia, BCR-ABL negative|atypical chronic myeloid leukemia, bcr-abl negative
5165918|NCT00951626|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5165919|NCT00951626|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5165920|NCT00951626|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5165921|NCT00951626|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5165922|NCT00951626|refractory hairy cell leukemia|refractory hairy cell leukemia
5165923|NCT00951626|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5165924|NCT00951626|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5165925|NCT00951626|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5165926|NCT00951626|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5165927|NCT00951626|chronic eosinophilic leukemia|chronic eosinophilic leukemia
5165928|NCT00951626|primary myelofibrosis|primary myelofibrosis
5165929|NCT00951626|chronic neutrophilic leukemia|chronic neutrophilic leukemia
5165930|NCT00951626|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5165931|NCT00951626|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
5165932|NCT00951626|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5165933|NCT00951626|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5165934|NCT00951626|refractory multiple myeloma|refractory multiple myeloma
5165935|NCT00951613|small cell lung cancer|small cell lung cancer
5165936|NCT00951613|carcinoma, lung|carcinoma, lung
5165937|NCT00951613|Sensitive-relapsed or refractory-relapsed small cell lung cancer|sensitive-relapsed or refractory-relapsed small cell lung cancer
5165938|NCT00951600|Oxcarbazepine oral suspension fasting study|oxcarbazepine oral suspension fasting study
5165939|NCT00951587|Colonic Diseases|colonic diseases
5165940|NCT00951574|thromboembolism|thromboembolism
5165941|NCT00951574|cancer|cancer
5165942|NCT00951574|chemotherapy|chemotherapy
5165943|NCT00951574|low-molecular-weight-heparin|low-molecular-weight-heparin
5165944|NCT00951574|nadroparin|nadroparin
5165945|NCT00951561|Dysmenorrhea|dysmenorrhea
5165946|NCT00951548|Probiotics|probiotics
5165947|NCT00951548|VSL#3|vsl#3
5165948|NCT00951548|Double-blind|double-blind
5165949|NCT00951548|Placebo controlled|placebo controlled
5165950|NCT00951535|stage I prostate cancer|stage i prostate cancer
5165951|NCT00951535|stage IIB prostate cancer|stage iib prostate cancer
5165952|NCT00951535|stage IIA prostate cancer|stage iia prostate cancer
5165953|NCT00951535|stage III prostate cancer|stage iii prostate cancer
5165954|NCT00951522|Cystic Fibrosis|cystic fibrosis
5165955|NCT00951522|CF|cf
5165956|NCT00951522|Mucociliary Clearance|mucociliary clearance
5165957|NCT00951522|Epithelial Sodium Channel Inhibitor|epithelial sodium channel inhibitor
5165958|NCT00951522|ENaC Inhibitor|enac inhibitor
5165959|NCT00951522|Airway Hydration|airway hydration
5165960|NCT00951522|Amiloride|amiloride
5165961|NCT00951509|Electric power wheelchair driving|electric power wheelchair driving
5165962|NCT00951509|rehabilitation|rehabilitation
5165963|NCT00951509|driving assessments|driving assessments
5165964|NCT00951483|Cardiovascular Biomarkers|cardiovascular biomarkers
5165965|NCT00951483|Depression|depression
5165966|NCT00951483|Quetiapine|quetiapine
5165967|NCT00951470|Head and neck lymphedema|head and neck lymphedema
5165968|NCT00951470|Complete Decongestive Therapy|complete decongestive therapy
5165969|NCT00951470|CDT|cdt
5165970|NCT00951470|Oral cavity cancer|oral cavity cancer
5165971|NCT00951470|Oropharyngeal cancer|oropharyngeal cancer
5165972|NCT00951457|CLL|cll
5165973|NCT00951457|pretreated|pretreated
5165974|NCT00951457|immune therapy|immune therapy
5165975|NCT00951457|dose escalation|dose escalation
5165976|NCT00951457|maintenance therapy|maintenance therapy
5165977|NCT00951457|Bendamustine|bendamustine
5165978|NCT00951457|Alemtuzumab|alemtuzumab
5165979|NCT00951444|adenosquamous cell lung cancer|adenosquamous cell lung cancer
5165980|NCT00951444|squamous cell lung cancer|squamous cell lung cancer
5165981|NCT00951444|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5165982|NCT00951444|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5165983|NCT00951444|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5165984|NCT00951431|Functional dyspepsia|functional dyspepsia
5165985|NCT00951431|PPI|ppi
5165986|NCT00951431|postprandial fullness|postprandial fullness
5165987|NCT00951431|delayed gastric emptying|delayed gastric emptying
5165988|NCT00951418|clozapine|clozapine
5165989|NCT00951418|schizophrenia|schizophrenia
5165990|NCT00951418|cognition|cognition
5165991|NCT00951418|t-wave morphology|t-wave morphology
5165992|NCT00951392|Insulin sensitivity|insulin sensitivity
5165993|NCT00951392|aging|aging
5165994|NCT00951392|lipid metabolism|lipid metabolism
5165995|NCT00951392|hyperinsulinemic clamp|hyperinsulinemic clamp
5165996|NCT00951392|gene expression|gene expression
5165997|NCT00951392|sirtuins|sirtuins
5165998|NCT00951366|premature birth|premature birth
5165999|NCT00951366|neonatal respiratory distress|neonatal respiratory distress
5166000|NCT00951366|chronic lung disease|chronic lung disease
5166001|NCT00951366|epidemiologicfactors|epidemiologicfactors
5166002|NCT00951366|genetic factors|genetic factors
5166003|NCT00951353|Transplantation|transplantation
5166004|NCT00951353|Kidney Failure|kidney failure
5166005|NCT00951353|End Stage Renal Disease|end stage renal disease
5166006|NCT00951353|Pediatric|pediatric
5166007|NCT00951340|CBT|cbt
5166008|NCT00951340|Emotional-Focused Therapy|emotional-focused therapy
5166009|NCT00951340|Interpersonal Therapy|interpersonal therapy
5166010|NCT00951327|Primary sclerosing cholangitis|primary sclerosing cholangitis
5166011|NCT00951314|Genetic Polymorphisms|genetic polymorphisms
5166012|NCT00951314|Metabotropic Glutamate Receptors|metabotropic glutamate receptors
5166013|NCT00951314|Positron Emission Tomograhy (PET)|positron emission tomograhy (pet)
5166014|NCT00951314|Cocaine Dependence|cocaine dependence
5166015|NCT00951314|Cue-Induced Craving|cue-induced craving
5166016|NCT00951314|Drug Abuse|drug abuse
5166017|NCT00951288|AMD|amd
5166018|NCT00951288|Retinal Function|retinal function
5166019|NCT00951288|Neuroprotection|neuroprotection
5166020|NCT00951262|life review|life review
5166021|NCT00951262|quality of life|quality of life
5166022|NCT00951262|advanced cancer patients|advanced cancer patients
5166023|NCT00951249|MSM|msm
5166024|NCT00951249|HIV infections|hiv infections
5166025|NCT00951249|HIV Seronegativity|hiv seronegativity
5166026|NCT00951236|Trigger Finger|trigger finger
5166027|NCT00951236|Trigger Thumb|trigger thumb
5166028|NCT00951210|Peripheral Artery Disease|peripheral artery disease
5166029|NCT00951210|Peripheral Vascular Disease|peripheral vascular disease
5166030|NCT00951210|Critical limb ischemia|critical limb ischemia
5166031|NCT00951210|PAD|pad
5166032|NCT00951210|CLI|cli
5166033|NCT00951197|dementia|dementia
5166034|NCT00951197|Alzheimer's Disease|alzheimer's disease
5166035|NCT00951197|diagnostic|diagnostic
5166036|NCT00951197|biomarkers|biomarkers
5166037|NCT00951197|neuroimaging|neuroimaging
5166038|NCT00951197|PET|pet
5166039|NCT00951197|MRI|mri
5166040|NCT00951197|mild cognitive impairment|mild cognitive impairment
5166041|NCT00951184|depression|depression
5166042|NCT00951184|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5166043|NCT00951158|Conjugated Linoleic Acid|conjugated linoleic acid
5166044|NCT00951158|Clarinol|clarinol
5166045|NCT00951158|S14 Expression|s14 expression
5166046|NCT00951132|Inflammation|inflammation
5166047|NCT00951132|Atherosclerosis|atherosclerosis
5166048|NCT00951132|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors
5166049|NCT00951119|type 2 diabetes|type 2 diabetes
5166050|NCT00951119|hypertension|hypertension
5166051|NCT00951119|treatment|treatment
5166052|NCT00951119|non-medical|non-medical
5166053|NCT00951106|Peru|peru
5166054|NCT00951106|Sulfadoxine-pyrimethamine|sulfadoxine-pyrimethamine
5166055|NCT00951106|Drug resistance|drug resistance
5166056|NCT00951093|GERD|gerd
5166057|NCT00951093|Gastric bypass|gastric bypass
5166058|NCT00951080|ulcer|ulcer
5166059|NCT00951080|venous|venous
5166060|NCT00951080|diabetic|diabetic
5166061|NCT00951080|wounds and injuries|wounds and injuries
5166062|NCT00951067|Lymphedema|lymphedema
5166063|NCT00951067|Breast Cancer|breast cancer
5166064|NCT00951067|Upper Extremity|upper extremity
5166065|NCT00951067|Arm|arm
5166066|NCT00951054|breast cancer|breast cancer
5166067|NCT00951054|triple negative|triple negative
5166068|NCT00951054|ER-negative|er-negative
5166069|NCT00951054|PR-negative|pr-negative
5166070|NCT00951054|HER2-negative|her2-negative
5166071|NCT00951054|ER-, PR-, HER2- (Triple Negative) breast cancer|er-, pr-, her2- (triple negative) breast cancer
5166072|NCT00951041|influenza infection|influenza infection
5166073|NCT00951041|GSK Bio's influenza vaccine GSK2340272A|gsk bio's influenza vaccine gsk2340272a
5166074|NCT00951028|Adherence|adherence
5166075|NCT00951015|GSK1349572|gsk1349572
5166076|NCT00951015|emtricitabine|emtricitabine
5166077|NCT00951015|tenofovir|tenofovir
5166078|NCT00951015|efavirenz|efavirenz
5166079|NCT00951015|abacavir|abacavir
5166080|NCT00951015|antiretroviral therapy naive|antiretroviral therapy naive
5166081|NCT00951015|dose selection|dose selection
5166082|NCT00951015|HIV-1 Infection|hiv-1 infection
5166083|NCT00951015|integrase inhibitor|integrase inhibitor
5166084|NCT00951015|HIV infection|hiv infection
5166085|NCT00951015|once daily|once daily
5166086|NCT00951015|lamivudine|lamivudine
5166087|NCT00951002|anal fistula|anal fistula
5166088|NCT00951002|acellular dermal matrix|acellular dermal matrix
5166089|NCT00951002|treatment|treatment
5166090|NCT00951002|postoperative complications|postoperative complications
5166091|NCT00951002|recurrence|recurrence
5166092|NCT00950989|Autoimmune Diseases|autoimmune diseases
5166093|NCT00950989|Musculoskeletal Diseases|musculoskeletal diseases
5166094|NCT00950989|Joint Diseases|joint diseases
5166095|NCT00950989|Arthritis|arthritis
5166096|NCT00950989|Connective Tissue Diseases|connective tissue diseases
5166097|NCT00950989|Arthritis, Rheumatoid|arthritis, rheumatoid
5166098|NCT00950989|Rheumatic Diseases|rheumatic diseases
5166099|NCT00950963|Diabetes, Nurse phone intervention, lipid control|diabetes, nurse phone intervention, lipid control
5166100|NCT00950950|Amgen|amgen
5166101|NCT00950950|Postmenopausal|postmenopausal
5166102|NCT00950950|Bone Density|bone density
5166103|NCT00950924|Hyperopia|hyperopia
5166104|NCT00950924|Refractive Error|refractive error
5166105|NCT00950924|Ocular Biometrics|ocular biometrics
5166106|NCT00950924|Axial Length|axial length
5166107|NCT00950924|Contact Lenses|contact lenses
5166108|NCT00950924|Bifocal Contact Lenses|bifocal contact lenses
5166109|NCT00950911|Bone metastases|bone metastases
5166110|NCT00950911|Hormone-refractory prostate cancer|hormone-refractory prostate cancer
5166111|NCT00950911|Multiple myeloma|multiple myeloma
5166112|NCT00950911|Denosumab|denosumab
5166113|NCT00950911|Breast cancer|breast cancer
5166114|NCT00950911|20050103|20050103
5166115|NCT00950911|20050136|20050136
5166116|NCT00950911|20050244|20050244
5166117|NCT00950911|Advanced cancer|advanced cancer
5166118|NCT00950911|Tumor|tumor
5166119|NCT00950911|Prostate cancer|prostate cancer
5166120|NCT00950911|Zoledronic acid|zoledronic acid
5166121|NCT00950898|coffee|coffee
5166122|NCT00950898|caffeine|caffeine
5166123|NCT00950898|glucose metabolism|glucose metabolism
5166124|NCT00950898|insulin sensitivity|insulin sensitivity
5166125|NCT00950898|diabetes|diabetes
5166126|NCT00950885|sleep|sleep
5166127|NCT00950885|alertness|alertness
5166128|NCT00950885|performance|performance
5166129|NCT00950885|vigilance|vigilance
5166130|NCT00950885|circadian|circadian
5166131|NCT00950859|treatment experienced|treatment experienced
5166132|NCT00950859|HIV Infection|hiv infection
5166133|NCT00950859|raltegravir resistance|raltegravir resistance
5166134|NCT00950859|GSK1349572|gsk1349572
5166135|NCT00950859|optimized background regimen|optimized background regimen
5166136|NCT00950859|integrase inhibitor|integrase inhibitor
5166137|NCT00950846|Congenital Pediatric Disorders|congenital pediatric disorders
5166138|NCT00950846|Umbilical Cord Blood Transplant|umbilical cord blood transplant
5166139|NCT00950846|Congenital Abnormalities|congenital abnormalities
5166140|NCT00950846|Cord Blood Stem Cell Transplantation|cord blood stem cell transplantation
5166141|NCT00950846|Busulfan|busulfan
5166142|NCT00950846|Cytoxan|cytoxan
5166143|NCT00950846|Cyclophosphamide|cyclophosphamide
5166144|NCT00950846|Fludarabine|fludarabine
5166145|NCT00950833|Catch-up vaccination|catch-up vaccination
5166146|NCT00950833|Pneumococcal vaccine|pneumococcal vaccine
5166147|NCT00950833|Immune memory|immune memory
5166148|NCT00950833|Nasopharyngeal carriage|nasopharyngeal carriage
5166149|NCT00950833|Immunogenicity|immunogenicity
5166150|NCT00950833|Pneumococcal disease|pneumococcal disease
5166151|NCT00950833|Safety|safety
5166152|NCT00950820|Open-label|open-label
5166153|NCT00950820|Phase-II-Study|phase-ii-study
5166154|NCT00950820|Randomized|randomized
5166155|NCT00950820|Metastatic|metastatic
5166156|NCT00950820|Colorectal|colorectal
5166157|NCT00950820|Cancer|cancer
5166158|NCT00950820|Panitumumab|panitumumab
5166159|NCT00950820|Vectibix®|vectibix®
5166160|NCT00950820|second-line-treatment|second-line-treatment
5166161|NCT00950820|KRAS|kras
5166162|NCT00950807|Dose ranging|dose ranging
5166163|NCT00950807|Chronic Bronchitis|chronic bronchitis
5166164|NCT00950807|Long-acting muscarinic antagonist|long-acting muscarinic antagonist
5166165|NCT00950807|cross-over|cross-over
5166166|NCT00950807|COPD|copd
5166167|NCT00950807|Emphysema|emphysema
5166168|NCT00950807|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
5166169|NCT00950807|anticholinergic|anticholinergic
5166170|NCT00950794|Long acting beta2-agonist|long acting beta2-agonist
5166171|NCT00950781|Menopause|menopause
5166172|NCT00950781|Cortisol|cortisol
5166173|NCT00950781|ACTH|acth
5166174|NCT00950768|Myeloma|myeloma
5166175|NCT00950768|Melphalan|melphalan
5166176|NCT00950768|Autologous transplantation|autologous transplantation
5166177|NCT00950729|car driving simulator|car driving simulator
5166178|NCT00950729|orthopedic leg immobilisation|orthopedic leg immobilisation
5166179|NCT00950729|braking time|braking time
5166180|NCT00950729|braking force|braking force
5166181|NCT00950716|type II diabetes|type ii diabetes
5166182|NCT00950716|peer support|peer support
5166184|NCT00950703|Assessing the perceptions of Canadian Primary care physicians towards global Cardiovascular risk assessment.|assessing the perceptions of canadian primary care physicians towards global cardiovascular risk assessment.
5166185|NCT00950690|observational safety study|observational safety study
5166186|NCT00950677|Diabetes|diabetes
5166187|NCT00950677|pramlintide|pramlintide
5166188|NCT00950677|Symlin|symlin
5166189|NCT00950677|exenatide|exenatide
5166190|NCT00950677|byetta|byetta
5166191|NCT00950677|glucagon|glucagon
5166192|NCT00950677|gastric emptying|gastric emptying
5166193|NCT00950664|cervical dystonia|cervical dystonia
5166194|NCT00950664|botulinum toxin|botulinum toxin
5166195|NCT00950638|AMD|amd
5166196|NCT00950625|intraperitoneal analgesia|intraperitoneal analgesia
5166197|NCT00950625|laparoscopic cholecystectomy|laparoscopic cholecystectomy
5166198|NCT00950625|lignocaine|lignocaine
5166199|NCT00950625|bupevacaine|bupevacaine
5166200|NCT00950612|Tuberculosis vaccine|tuberculosis vaccine
5166201|NCT00950586|Drug interaction|drug interaction
5166202|NCT00950586|Saftey|saftey
5166203|NCT00950586|Pharmacokinetics|pharmacokinetics
5166204|NCT00950586|Cognition|cognition
5166205|NCT00950573|cardiovascular disease|cardiovascular disease
5166206|NCT00950573|endstage renal disease|endstage renal disease
5166207|NCT00950547|Blood Transfusion|blood transfusion
5166208|NCT00950547|Cell Saver|cell saver
5166209|NCT00950547|Cardiac Surgery|cardiac surgery
5166210|NCT00950547|Evaluate the efficacy of cell salvage CardioPAT routinely used in cardiac surgery in reducing blood transfusions.|evaluate the efficacy of cell salvage cardiopat routinely used in cardiac surgery in reducing blood transfusions.
5166211|NCT00950521|Stroke|stroke
5166212|NCT00950521|Stem Cell|stem cell
5166213|NCT00950521|Cell Therapy|cell therapy
5166214|NCT00950521|CD34 Stem cell|cd34 stem cell
5166215|NCT00950521|Peripheral blood Stem cell|peripheral blood stem cell
5166216|NCT00950495|Parallel design|parallel design
5166217|NCT00950495|Oral appliance|oral appliance
5166218|NCT00950495|Mandibular advancement device|mandibular advancement device
5166219|NCT00950495|Continuous positive airway pressure|continuous positive airway pressure
5166220|NCT00950495|Placebo|placebo
5166221|NCT00950495|Therapy|therapy
5166222|NCT00950495|Side-effects|side-effects
5166223|NCT00950495|Compliance|compliance
5166224|NCT00950482|Menopause|menopause
5166225|NCT00950482|Acupuncture|acupuncture
5166226|NCT00950482|Hotflash|hotflash
5166227|NCT00950469|high sensitive troponin T; cardiac necrosis; early detection; myoglobin; h-FABP|high sensitive troponin t; cardiac necrosis; early detection; myoglobin; h-fabp
5166228|NCT00950469|early identification and risk stratification of patients with suspicious acute coronary syndrome|early identification and risk stratification of patients with suspicious acute coronary syndrome
5166229|NCT00950443|Upper airway obstruction|upper airway obstruction
5166230|NCT00950443|child|child
5166231|NCT00950443|acoustic reflection method|acoustic reflection method
5166232|NCT00950443|endoscopy|endoscopy
5166233|NCT00950443|work of breathing|work of breathing
5166234|NCT00950443|sleep study|sleep study
5166235|NCT00950443|CT scan|ct scan
5166236|NCT00950430|Imaging|imaging
5166237|NCT00950430|PET|pet
5166238|NCT00950430|PiB|pib
5166239|NCT00950430|FDG|fdg
5166240|NCT00950430|MCI|mci
5166241|NCT00950430|Dementia|dementia
5166242|NCT00950430|Alzheimer's Disease|alzheimer's disease
5166243|NCT00950430|Brain Amyloid|brain amyloid
5166244|NCT00950417|nimotuzumab esophageal chemo-radiotherapy|nimotuzumab esophageal chemo-radiotherapy
5166245|NCT00950404|Bioavailability Pharmacokinetic Formulation|bioavailability pharmacokinetic formulation
5166246|NCT00950391|peripheral nerve injury|peripheral nerve injury
5166247|NCT00950391|peripheral nerve surgery|peripheral nerve surgery
5166248|NCT00950391|nerve repair|nerve repair
5166249|NCT00950391|nerve graft|nerve graft
5166250|NCT00950378|edema|edema
5166251|NCT00950378|blood supply|blood supply
5166252|NCT00950378|lower legs|lower legs
5166253|NCT00950378|venous stasis|venous stasis
5166254|NCT00950365|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5166255|NCT00950365|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5166256|NCT00950365|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5166257|NCT00950365|progressive or recurrent stage III or stage IV non-small cell lung cancer|progressive or recurrent stage iii or stage iv non-small cell lung cancer
5166258|NCT00950352|methamphetamine|methamphetamine
5166259|NCT00950352|Citicoline|citicoline
5166260|NCT00950352|CDP-Choline|cdp-choline
5166261|NCT00950352|Neuroimaging|neuroimaging
5166262|NCT00950352|MRI|mri
5166263|NCT00950352|Brain|brain
5166264|NCT00950352|MRS|mrs
5166265|NCT00950352|DTI|dti
5166266|NCT00950339|GI bleeding|gi bleeding
5166267|NCT00950339|clopidogrel|clopidogrel
5166268|NCT00950339|aspirin|aspirin
5166269|NCT00950339|prevention|prevention
5166270|NCT00950339|angiography|angiography
5166271|NCT00950326|osteoarthritis|osteoarthritis
5166272|NCT00950326|hydrotherapy|hydrotherapy
5166273|NCT00950326|affusion|affusion
5166274|NCT00950326|conventional physiotherapy|conventional physiotherapy
5166275|NCT00950326|comparison|comparison
5166276|NCT00950313|Diabetes|diabetes
5166277|NCT00950313|Screening|screening
5166278|NCT00950313|Risk|risk
5166279|NCT00950313|Self assessment|self assessment
5166280|NCT00950287|apnea-bradycardias|apnea-bradycardias
5166281|NCT00950287|preterm infants|preterm infants
5166282|NCT00950274|Cell therapy|cell therapy
5166283|NCT00950274|Bone marrow|bone marrow
5166284|NCT00950274|CD133|cd133
5166285|NCT00950274|Bypass surgery|bypass surgery
5166286|NCT00950274|Stem cells|stem cells
5166287|NCT00950274|Myocardial infarction|myocardial infarction
5166288|NCT00950274|Myocardial ischemia|myocardial ischemia
5166289|NCT00950261|Cervical neoplasms|cervical neoplasms
5166290|NCT00950261|Cisplatin|cisplatin
5166291|NCT00950261|Concurrent Chemoradiation|concurrent chemoradiation
5166292|NCT00950248|Idebenone|idebenone
5166293|NCT00950248|Magnetic Resonance Imaging (MRI)|magnetic resonance imaging (mri)
5166294|NCT00950248|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
5166295|NCT00950248|Mitochondrial Enhancer|mitochondrial enhancer
5166296|NCT00950248|Multiple Sclerosis|multiple sclerosis
5166297|NCT00950248|MS|ms
5166298|NCT00950248|Primary Progressive Multiple Sclerosis|primary progressive multiple sclerosis
5166299|NCT00950235|obese|obese
5166300|NCT00950235|pregnant|pregnant
5166301|NCT00950235|large for gestational age|large for gestational age
5166302|NCT00950235|large for gestational age baby|large for gestational age baby
5166303|NCT00950222|Intensive care unit|intensive care unit
5166304|NCT00950222|Ventilator associated pneumonia|ventilator associated pneumonia
5166305|NCT00950222|Gram negative bacilli infection|gram negative bacilli infection
5166306|NCT00950222|Empirical antibiotic therapy|empirical antibiotic therapy
5166307|NCT00950222|Pharmacokinetic / pharmacodynamic|pharmacokinetic / pharmacodynamic
5166308|NCT00950222|Imipenem|imipenem
5166309|NCT00950222|Amikacin|amikacin
5166310|NCT00950222|Gram negative bacilli|gram negative bacilli
5166311|NCT00950209|type 2 diabetic patients in the fed state|type 2 diabetic patients in the fed state
5166312|NCT00950183|cryotherapy|cryotherapy
5166313|NCT00950183|postoperative pain|postoperative pain
5166314|NCT00950183|Iceman|iceman
5166315|NCT00950183|primary first metatarsal osteotomy (PMO)|primary first metatarsal osteotomy (pmo)
5166316|NCT00950183|lateral ankle ligament reconstruction (LAR)|lateral ankle ligament reconstruction (lar)
5166317|NCT00950170|ReFacto AF|refacto af
5166318|NCT00950170|factor VIII|factor viii
5166319|NCT00950170|inhibitors|inhibitors
5166320|NCT00950170|antibodies|antibodies
5166321|NCT00950144|pain|pain
5166322|NCT00950144|depression|depression
5166323|NCT00950144|fatigue|fatigue
5166324|NCT00950144|stage III colon cancer|stage iii colon cancer
5166325|NCT00950144|stage IV colon cancer|stage iv colon cancer
5166326|NCT00950144|recurrent colon cancer|recurrent colon cancer
5166327|NCT00950144|stage III rectal cancer|stage iii rectal cancer
5166328|NCT00950144|stage IV rectal cancer|stage iv rectal cancer
5166329|NCT00950144|recurrent rectal cancer|recurrent rectal cancer
5166330|NCT00950144|stage III pancreatic cancer|stage iii pancreatic cancer
5166331|NCT00950144|stage IV pancreatic cancer|stage iv pancreatic cancer
5166332|NCT00950144|recurrent pancreatic cancer|recurrent pancreatic cancer
5166333|NCT00950144|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
5166334|NCT00950144|advanced adult primary liver cancer|advanced adult primary liver cancer
5166335|NCT00950144|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
5166336|NCT00950144|recurrent adult primary liver cancer|recurrent adult primary liver cancer
5166337|NCT00950118|Congenital Diaphragmatic Hernia (CDH)|congenital diaphragmatic hernia (cdh)
5166338|NCT00950118|Genes|genes
5166339|NCT00950118|Genetic|genetic
5166340|NCT00950118|Genetic testing|genetic testing
5166341|NCT00950118|exome sequencing|exome sequencing
5166342|NCT00950118|genome sequencing|genome sequencing
5166343|NCT00950118|RNAseq|rnaseq
5166344|NCT00950105|CPSI2364|cpsi2364
5166345|NCT00950105|Semapimod|semapimod
5166346|NCT00950105|Anti TNF alpha|anti tnf alpha
5166347|NCT00950105|Crohn's Disease|crohn's disease
5166348|NCT00950105|Safety|safety
5166349|NCT00950105|Tolerability|tolerability
5166350|NCT00950105|Pharmacokinetics|pharmacokinetics
5166352|NCT00950092|atrial fibrillation|atrial fibrillation
5166353|NCT00950092|ablation|ablation
5166354|NCT00950092|surgical ablation|surgical ablation
5166355|NCT00950092|afib|afib
5166356|NCT00950092|coagulation|coagulation
5166357|NCT00950092|RF|rf
5166358|NCT00950092|epicardial|epicardial
5166359|NCT00950092|Arrhythmias|arrhythmias
5166360|NCT00950079|sodium bicarbonate|sodium bicarbonate
5166361|NCT00950079|diabetes mellitus|diabetes mellitus
5166362|NCT00950079|coronary angiography or intervention|coronary angiography or intervention
5166363|NCT00950040|At-risk drinking|at-risk drinking
5166364|NCT00950040|Type 2 diabetes|type 2 diabetes
5166365|NCT00950040|Treatment adherence|treatment adherence
5166366|NCT00950040|At-risk drinking among Type 2 diabetic patients|at-risk drinking among type 2 diabetic patients
5166367|NCT00950014|Numeracy|numeracy
5166368|NCT00950001|Brain tumors|brain tumors
5166369|NCT00950001|Metastatic brain disease|metastatic brain disease
5166370|NCT00950001|Post-surgical|post-surgical
5166371|NCT00950001|Stereotactic radiosurgery|stereotactic radiosurgery
5166372|NCT00950001|SRS|srs
5166373|NCT00950001|Whole brain radiotherapy|whole brain radiotherapy
5166374|NCT00950001|MRI|mri
5166375|NCT00950001|Magnetic Resonance Imaging|magnetic resonance imaging
5166376|NCT00950001|Outpatient radiation procedure|outpatient radiation procedure
5166377|NCT00949988|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
5166378|NCT00949988|CLL|cll
5166379|NCT00949988|Dasatinib|dasatinib
5166380|NCT00949988|Rituximab|rituximab
5166381|NCT00949988|Relapsed|relapsed
5166382|NCT00949988|Refractory|refractory
5166383|NCT00949975|Chronic|chronic
5166384|NCT00949975|Obstructive|obstructive
5166385|NCT00949975|Pulmonary|pulmonary
5166386|NCT00949975|Lung|lung
5166387|NCT00949975|Respiratory disease|respiratory disease
5166388|NCT00949975|Efficacy|efficacy
5166389|NCT00949975|Safety and tolerability|safety and tolerability
5166390|NCT00949975|Placebo-controlled|placebo-controlled
5166391|NCT00949975|Pharmacokinetics|pharmacokinetics
5166392|NCT00949975|COPD|copd
5166393|NCT00949962|stage I prostate cancer|stage i prostate cancer
5166394|NCT00949962|stage IIB prostate cancer|stage iib prostate cancer
5166395|NCT00949962|stage IIA prostate cancer|stage iia prostate cancer
5166396|NCT00949962|stage III prostate cancer|stage iii prostate cancer
5166397|NCT00949936|Spine surgery|spine surgery
5166398|NCT00949923|Postmenopausal women|postmenopausal women
5166399|NCT00949923|Suspicious for breast ca|suspicious for breast ca
5166400|NCT00949897|Adult Acquired Flatfoot|adult acquired flatfoot
5166401|NCT00949897|Biofoam Porous Metal Implant|biofoam porous metal implant
5166402|NCT00949897|Allograft Bone Wedge|allograft bone wedge
5166403|NCT00949871|stage I breast cancer|stage i breast cancer
5166404|NCT00949871|stage II breast cancer|stage ii breast cancer
5166405|NCT00949871|stage IIIA breast cancer|stage iiia breast cancer
5166406|NCT00949871|stage IIIB breast cancer|stage iiib breast cancer
5166407|NCT00949871|stage IIIC breast cancer|stage iiic breast cancer
5166408|NCT00949871|stage IV breast cancer|stage iv breast cancer
5166409|NCT00949871|cancer survivor|cancer survivor
5166410|NCT00949858|Sleep Disorders|sleep disorders
5166411|NCT00949858|Obstructive Sleep Apnea|obstructive sleep apnea
5166412|NCT00949858|Restless Leg Syndrome|restless leg syndrome
5166413|NCT00949858|Insomnia|insomnia
5166414|NCT00949858|Actigraphy|actigraphy
5166415|NCT00949845|Effect of Inflammatory challenge on depressed mood|effect of inflammatory challenge on depressed mood
5166416|NCT00949845|Effect of inflammatory challenge on social pain|effect of inflammatory challenge on social pain
5166417|NCT00949832|rickets|rickets
5166418|NCT00949832|calcium|calcium
5166419|NCT00949832|vitamin D|vitamin d
5166420|NCT00949832|nutrition|nutrition
5166421|NCT00949832|child|child
5166422|NCT00949819|Prostate Cancer|prostate cancer
5166423|NCT00949819|Low risk|low risk
5166424|NCT00949819|Gleason 6|gleason 6
5166425|NCT00949819|Active surveillance|active surveillance
5166426|NCT00949806|Botulinum toxin|botulinum toxin
5166427|NCT00949793|Pathology|pathology
5166428|NCT00949793|Microscopy, Confocal|microscopy, confocal
5166429|NCT00949793|Microscopy, Fluorescence|microscopy, fluorescence
5166430|NCT00949793|Intraoperative Procedures|intraoperative procedures
5166431|NCT00949780|ABR|abr
5166432|NCT00949780|Chloral Hydrate|chloral hydrate
5166433|NCT00949780|Sedation|sedation
5166434|NCT00949780|Children|children
5166435|NCT00949754|honeybee venom|honeybee venom
5166436|NCT00949754|osteoarthritis|osteoarthritis
5166437|NCT00949754|pain|pain
5166438|NCT00949754|knees|knees
5166439|NCT00949728|Pterygium|pterygium
5166440|NCT00949728|Autologous Transplantation|autologous transplantation
5166441|NCT00949728|Conjunctiva|conjunctiva
5166442|NCT00949728|Fibrin Tissue Adhesive|fibrin tissue adhesive
5166443|NCT00949728|Recurrence|recurrence
5166444|NCT00949715|Pacemaker|pacemaker
5166445|NCT00949715|Implantable Pulse Generator (IPG)|implantable pulse generator (ipg)
5166446|NCT00949715|AV Conduction Disturbance|av conduction disturbance
5166447|NCT00949715|Selective Site Pacing|selective site pacing
5166448|NCT00949689|adolescence|adolescence
5166449|NCT00949689|insomnia|insomnia
5166450|NCT00949689|depression|depression
5166451|NCT00949689|sleep problems|sleep problems
5166452|NCT00949689|cognitive therapy|cognitive therapy
5166453|NCT00949663|Diabetes|diabetes
5166454|NCT00949663|Blood Sugar|blood sugar
5166455|NCT00949663|Xenin-25|xenin-25
5166456|NCT00949663|GIP|gip
5166457|NCT00949663|Insulin|insulin
5166458|NCT00949637|obesity prevention|obesity prevention
5166459|NCT00949637|girl scouts|girl scouts
5166460|NCT00949637|physical activity|physical activity
5166461|NCT00949637|family meals|family meals
5166462|NCT00949637|fruits and vegetables|fruits and vegetables
5166463|NCT00949637|health promotion|health promotion
5166464|NCT00949624|PDGFr Inhibition;|pdgfr inhibition;
5166465|NCT00949624|VEGFr inhibition;|vegfr inhibition;
5166466|NCT00949624|targeted therapy|targeted therapy
5166467|NCT00949611|Decision Aid|decision aid
5166468|NCT00949611|Shared Decision Making|shared decision making
5166469|NCT00949611|Shared Medical Decision Making|shared medical decision making
5166470|NCT00949598|estrogen receptor-positive breast cancer|estrogen receptor-positive breast cancer
5166471|NCT00949598|stage IA breast cancer|stage ia breast cancer
5166472|NCT00949598|stage IB breast cancer|stage ib breast cancer
5166473|NCT00949598|stage II breast cancer|stage ii breast cancer
5166474|NCT00949598|stage IIIA breast cancer|stage iiia breast cancer
5166475|NCT00949585|randomized, controlled feeding study;|randomized, controlled feeding study;
5166476|NCT00949585|crossover design|crossover design
5166477|NCT00949585|potassium intake|potassium intake
5166478|NCT00949572|mucosal immunity|mucosal immunity
5166479|NCT00949572|immunization|immunization
5166480|NCT00949572|sublingual|sublingual
5166481|NCT00949520|patients|patients
5166482|NCT00949520|functional evaluation|functional evaluation
5166483|NCT00949520|known coronary artery lesion|known coronary artery lesion
5166484|NCT00949494|knee osteoarthritis, synvisc, hyaluronan, dGEMRIC,cartilage|knee osteoarthritis, synvisc, hyaluronan, dgemric,cartilage
5166485|NCT00949481|postpartum|postpartum
5166486|NCT00949481|family planning|family planning
5166487|NCT00949481|job aid|job aid
5166488|NCT00949481|immunization|immunization
5166489|NCT00949481|pregnancy test|pregnancy test
5166490|NCT00949468|Keratitis|keratitis
5166491|NCT00949455|stage IV bladder cancer|stage iv bladder cancer
5166492|NCT00949455|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
5166493|NCT00949429|postoperative pain|postoperative pain
5166494|NCT00949429|cardiac surgery|cardiac surgery
5166495|NCT00949429|risk factors|risk factors
5166496|NCT00949416|genetic|genetic
5166497|NCT00949403|Non-Alcoholic Fatty Liver disease|non-alcoholic fatty liver disease
5166498|NCT00949390|Advanced Cancer|advanced cancer
5166499|NCT00949390|Advanced Malignancy|advanced malignancy
5166500|NCT00949390|Complementary and Alternative Medicine|complementary and alternative medicine
5166501|NCT00949390|CAM|cam
5166502|NCT00949390|Investigational Cancer Therapeutics|investigational cancer therapeutics
5166503|NCT00949390|Phase I Clinical Trials|phase i clinical trials
5166504|NCT00949377|Constipation|constipation
5166505|NCT00949377|opioid|opioid
5166506|NCT00949364|Myeloproliferative Neoplasms|myeloproliferative neoplasms
5166507|NCT00949364|Pomalidomide|pomalidomide
5166508|NCT00949364|Fibrotic Stage|fibrotic stage
5166509|NCT00949364|Patients with Myeloproliferative Neoplasms in Fibrotic Stage|patients with myeloproliferative neoplasms in fibrotic stage
5166510|NCT00949351|ACEI, ARB, DN, aliskiren, proteinuria|acei, arb, dn, aliskiren, proteinuria
5166511|NCT00949338|stage I prostate cancer|stage i prostate cancer
5166512|NCT00949338|stage IIB prostate cancer|stage iib prostate cancer
5166513|NCT00949338|stage IIA prostate cancer|stage iia prostate cancer
5166514|NCT00949338|stage III prostate cancer|stage iii prostate cancer
5166515|NCT00949338|stage IV prostate cancer|stage iv prostate cancer
5166516|NCT00949338|recurrent prostate cancer|recurrent prostate cancer
5166517|NCT00949325|osteosarcoma|osteosarcoma
5166518|NCT00949325|soft tissue sarcoma|soft tissue sarcoma
5166519|NCT00949325|rhabdomyosarcoma|rhabdomyosarcoma
5166520|NCT00949325|leiomyosarcoma|leiomyosarcoma
5166521|NCT00949325|Ewing's sarcoma|ewing's sarcoma
5166522|NCT00949325|chondrosarcoma|chondrosarcoma
5166523|NCT00949325|liposarcoma|liposarcoma
5166524|NCT00949325|malignant fibrous histiocytoma|malignant fibrous histiocytoma
5166525|NCT00949325|malignant peripheral nerve sheath tumor|malignant peripheral nerve sheath tumor
5166526|NCT00949325|pleiomorphic sarcoma|pleiomorphic sarcoma
5166527|NCT00949325|spindle cell sarcoma|spindle cell sarcoma
5166528|NCT00949325|synovial sarcoma|synovial sarcoma
5166529|NCT00949325|cancer stem cell|cancer stem cell
5166530|NCT00949312|stage II colon cancer|stage ii colon cancer
5166531|NCT00949286|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
5166532|NCT00949273|cylindrical abdominoperineal resection|cylindrical abdominoperineal resection
5166533|NCT00949273|rectal cancer|rectal cancer
5166534|NCT00949273|acellular dermal matrix|acellular dermal matrix
5166535|NCT00949273|pelvic reconstruction|pelvic reconstruction
5166536|NCT00949273|circumferential resection margin|circumferential resection margin
5166537|NCT00949273|overall survival|overall survival
5166538|NCT00949260|PIH|pih
5166539|NCT00949260|pregnancy induced hypertension|pregnancy induced hypertension
5166540|NCT00949260|pregnancy|pregnancy
5166541|NCT00949260|bioimpedance|bioimpedance
5166542|NCT00949260|noninvasive monitoring|noninvasive monitoring
5166543|NCT00949260|Cardiac Output|cardiac output
5166544|NCT00949260|Blood Pressure|blood pressure
5166545|NCT00949247|stage I breast cancer|stage i breast cancer
5166546|NCT00949247|stage II breast cancer|stage ii breast cancer
5166547|NCT00949247|stage IIIA breast cancer|stage iiia breast cancer
5166548|NCT00949247|stage IIIB breast cancer|stage iiib breast cancer
5166549|NCT00949247|stage IIIC breast cancer|stage iiic breast cancer
5166550|NCT00949247|HER2-positive breast cancer|her2-positive breast cancer
5166551|NCT00949234|post exposure prophylaxis|post exposure prophylaxis
5166552|NCT00949234|biomedical prevention|biomedical prevention
5166553|NCT00949234|HIV seronegativity|hiv seronegativity
5166554|NCT00949221|Type 1 diabetes|type 1 diabetes
5166555|NCT00949221|Paediatric|paediatric
5166556|NCT00949221|Real Time Continuous Glucose Monitoring|real time continuous glucose monitoring
5166557|NCT00949221|Glycemic control|glycemic control
5166558|NCT00949221|Therapeutic education|therapeutic education
5166559|NCT00949208|Healthy people|healthy people
5166560|NCT00949195|COPD|copd
5166561|NCT00949195|healthy patients|healthy patients
5166562|NCT00949195|PAP|pap
5166563|NCT00949195|CPX|cpx
5166564|NCT00949195|SSE|sse
5166565|NCT00949195|hsCRP|hscrp
5166566|NCT00949195|FMD|fmd
5168485|NCT00942461|a-defensins|a-defensins
5166567|NCT00949182|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
5166568|NCT00949182|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
5166569|NCT00949169|Atherosclerosis|atherosclerosis
5166570|NCT00949169|Carotid IMT|carotid imt
5166571|NCT00949169|Multidetector CT|multidetector ct
5166572|NCT00949169|Type 2 diabetes|type 2 diabetes
5166573|NCT00949156|Craniopharyngiomas|craniopharyngiomas
5166574|NCT00949156|Classification|classification
5166575|NCT00949156|Membranous structure|membranous structure
5166576|NCT00949156|Pituitary stalk|pituitary stalk
5166577|NCT00949156|Obesity|obesity
5166578|NCT00949156|panhypopituitarism|panhypopituitarism
5166579|NCT00949143|wheelchair user|wheelchair user
5166580|NCT00949117|malnutrition|malnutrition
5166581|NCT00949117|weight changes|weight changes
5166582|NCT00949117|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
5166583|NCT00949117|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5166584|NCT00949117|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
5166585|NCT00949117|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
5166586|NCT00949117|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5166587|NCT00949117|untreated childhood acute myeloid leukemia|untreated childhood acute myeloid leukemia
5166588|NCT00949117|other myeloid malignancies|other myeloid malignancies
5166589|NCT00949117|stage I childhood Hodgkin lymphoma|stage i childhood hodgkin lymphoma
5166590|NCT00949117|stage II childhood Hodgkin lymphoma|stage ii childhood hodgkin lymphoma
5166591|NCT00949117|stage III childhood Hodgkin lymphoma|stage iii childhood hodgkin lymphoma
5166592|NCT00949117|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
5166593|NCT00949117|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
5166594|NCT00949117|recurrent childhood anaplastic large cell lymphoma|recurrent childhood anaplastic large cell lymphoma
5166595|NCT00949117|stage I childhood anaplastic large cell lymphoma|stage i childhood anaplastic large cell lymphoma
5166596|NCT00949117|stage II childhood anaplastic large cell lymphoma|stage ii childhood anaplastic large cell lymphoma
5166597|NCT00949117|stage III childhood anaplastic large cell lymphoma|stage iii childhood anaplastic large cell lymphoma
5166598|NCT00949117|stage IV childhood anaplastic large cell lymphoma|stage iv childhood anaplastic large cell lymphoma
5166599|NCT00949117|recurrent childhood grade III lymphomatoid granulomatosis|recurrent childhood grade iii lymphomatoid granulomatosis
5166600|NCT00949117|childhood diffuse large cell lymphoma|childhood diffuse large cell lymphoma
5166601|NCT00949117|childhood immunoblastic large cell lymphoma|childhood immunoblastic large cell lymphoma
5166602|NCT00949117|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
5166603|NCT00949117|stage I childhood large cell lymphoma|stage i childhood large cell lymphoma
5166604|NCT00949117|stage II childhood large cell lymphoma|stage ii childhood large cell lymphoma
5166605|NCT00949117|stage III childhood large cell lymphoma|stage iii childhood large cell lymphoma
5166606|NCT00949117|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
5166607|NCT00949117|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
5166608|NCT00949117|stage I childhood lymphoblastic lymphoma|stage i childhood lymphoblastic lymphoma
5166609|NCT00949117|stage II childhood lymphoblastic lymphoma|stage ii childhood lymphoblastic lymphoma
5166610|NCT00949117|stage III childhood lymphoblastic lymphoma|stage iii childhood lymphoblastic lymphoma
5166611|NCT00949117|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
5166612|NCT00949117|childhood nasal type extranodal NK/T-cell lymphoma|childhood nasal type extranodal nk/t-cell lymphoma
5166613|NCT00949117|childhood Burkitt lymphoma|childhood burkitt lymphoma
5166614|NCT00949117|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
5166615|NCT00949117|stage I childhood small noncleaved cell lymphoma|stage i childhood small noncleaved cell lymphoma
5166616|NCT00949117|stage II childhood small noncleaved cell lymphoma|stage ii childhood small noncleaved cell lymphoma
5166617|NCT00949117|stage III childhood small noncleaved cell lymphoma|stage iii childhood small noncleaved cell lymphoma
5166618|NCT00949117|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
5166619|NCT00949117|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
5166620|NCT00949117|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5166621|NCT00949117|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5166622|NCT00949117|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5166623|NCT00949117|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
5166624|NCT00949104|Sucrose|sucrose
5166625|NCT00949104|pain|pain
5166626|NCT00949104|neonate|neonate
5166627|NCT00949104|preterm|preterm
5166628|NCT00949104|orogastric tube|orogastric tube
5166629|NCT00949091|Diabetes Mellitus, Non Insulin Dependent|diabetes mellitus, non insulin dependent
5166630|NCT00949091|Diabetes Mellitus, Type II|diabetes mellitus, type ii
5166631|NCT00949091|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
5166632|NCT00949091|Drug Therapy|drug therapy
5166633|NCT00949078|peanut|peanut
5166634|NCT00949078|allergy|allergy
5166635|NCT00949065|complex regional pain syndrome|complex regional pain syndrome
5166636|NCT00949065|sympathetic reflex dystrophy|sympathetic reflex dystrophy
5166637|NCT00949065|intravenous immunoglobulins|intravenous immunoglobulins
5166638|NCT00949065|autoimmune disease|autoimmune disease
5166639|NCT00949052|cancer survivor|cancer survivor
5166640|NCT00949052|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5166641|NCT00949052|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5166642|NCT00949052|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5166643|NCT00949052|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5166644|NCT00949052|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5166645|NCT00949052|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5166646|NCT00949052|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5166647|NCT00949052|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5166648|NCT00949052|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5166649|NCT00949052|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5166650|NCT00949052|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5166651|NCT00949052|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5166652|NCT00949052|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5166653|NCT00949052|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5166654|NCT00949052|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5166655|NCT00949052|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5166656|NCT00949052|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5166657|NCT00949052|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5166658|NCT00949052|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5166659|NCT00949052|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5166660|NCT00949052|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5166876|NCT00948558|citrate anticoagulation|citrate anticoagulation
5166661|NCT00949052|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5166662|NCT00949052|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5166663|NCT00949052|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5166664|NCT00949052|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5166665|NCT00949052|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5166666|NCT00949052|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5166667|NCT00949052|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5166668|NCT00949052|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5166669|NCT00949052|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5166670|NCT00949052|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5166671|NCT00949052|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5166672|NCT00949052|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5166673|NCT00949052|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
5166674|NCT00949052|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
5166675|NCT00949052|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
5166676|NCT00949052|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5166677|NCT00949052|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5166678|NCT00949052|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5166679|NCT00949052|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5166680|NCT00949052|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5166681|NCT00949052|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5166682|NCT00949052|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5166683|NCT00949052|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
5166684|NCT00949052|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5166685|NCT00949052|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5166686|NCT00949052|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5166687|NCT00949052|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5166688|NCT00949052|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
5166689|NCT00949052|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5166690|NCT00949052|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
5166691|NCT00949052|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
5166692|NCT00949052|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
5166693|NCT00949052|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
5166694|NCT00949052|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5166695|NCT00949052|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5166696|NCT00949052|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5166697|NCT00949052|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5166698|NCT00949052|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
5166699|NCT00949052|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
5166700|NCT00949052|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5166701|NCT00949052|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5166702|NCT00949052|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5166703|NCT00949052|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5166704|NCT00949052|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5166705|NCT00949052|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5166706|NCT00949052|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5166707|NCT00949052|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5166708|NCT00949052|atypical chronic myeloid leukemia, BCR-ABL negative|atypical chronic myeloid leukemia, bcr-abl negative
5166709|NCT00949052|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5166710|NCT00949052|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
5166711|NCT00949052|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
5166712|NCT00949052|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
5166713|NCT00949052|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5166714|NCT00949052|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5166715|NCT00949052|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
5166716|NCT00949052|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5166717|NCT00949052|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5166718|NCT00949052|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5166719|NCT00949052|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5166720|NCT00949052|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5166721|NCT00949052|refractory hairy cell leukemia|refractory hairy cell leukemia
5166722|NCT00949052|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5166723|NCT00949052|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5166724|NCT00949052|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5166725|NCT00949052|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5166726|NCT00949052|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
5166727|NCT00949052|chronic eosinophilic leukemia|chronic eosinophilic leukemia
5166728|NCT00949052|primary myelofibrosis|primary myelofibrosis
5166729|NCT00949052|chronic neutrophilic leukemia|chronic neutrophilic leukemia
5166730|NCT00949052|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5166731|NCT00949052|disseminated neuroblastoma|disseminated neuroblastoma
5166732|NCT00949052|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
5166733|NCT00949052|poor prognosis metastatic gestational trophoblastic tumor|poor prognosis metastatic gestational trophoblastic tumor
5166734|NCT00949052|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
5166735|NCT00949052|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5166736|NCT00949052|recurrent Wilms tumor and other childhood kidney tumors|recurrent wilms tumor and other childhood kidney tumors
5166737|NCT00949052|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
5166738|NCT00949052|recurrent neuroblastoma|recurrent neuroblastoma
5166739|NCT00949052|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5166740|NCT00949052|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
5166741|NCT00949052|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
5166742|NCT00949052|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5166743|NCT00949052|stage I multiple myeloma|stage i multiple myeloma
5166744|NCT00949052|stage II multiple myeloma|stage ii multiple myeloma
5166745|NCT00949052|stage III multiple myeloma|stage iii multiple myeloma
5166746|NCT00949052|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
5166747|NCT00949052|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5166748|NCT00949052|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5166749|NCT00949052|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
5166750|NCT00949052|stage IIIA breast cancer|stage iiia breast cancer
5166751|NCT00949052|stage IIIB breast cancer|stage iiib breast cancer
5166752|NCT00949052|stage IIIC breast cancer|stage iiic breast cancer
5166753|NCT00949052|stage IV breast cancer|stage iv breast cancer
5166754|NCT00949052|refractory multiple myeloma|refractory multiple myeloma
5166755|NCT00949026|Brain Cancer|brain cancer
5166756|NCT00949026|Brain Neoplasms, Malignant|brain neoplasms, malignant
5166757|NCT00949013|stage IA breast cancer|stage ia breast cancer
5166758|NCT00949013|stage IB breast cancer|stage ib breast cancer
5166759|NCT00949013|stage II breast cancer|stage ii breast cancer
5166760|NCT00949013|stage IIIA breast cancer|stage iiia breast cancer
5166761|NCT00949013|stage IIIB breast cancer|stage iiib breast cancer
5166762|NCT00949013|stage IIIC breast cancer|stage iiic breast cancer
5166763|NCT00948987|aspirin resistance|aspirin resistance
5166764|NCT00948987|cardiovascular risk|cardiovascular risk
5166765|NCT00948987|prostaglandins|prostaglandins
5166766|NCT00948987|platelet inhibition|platelet inhibition
5166767|NCT00948974|social anxiety|social anxiety
5166768|NCT00948974|treatment|treatment
5168486|NCT00942461|TLRs|tlrs
5166769|NCT00948974|Cognitive Behavioral Therapy|cognitive behavioral therapy
5166770|NCT00948974|Acceptance and Commitment Therapy|acceptance and commitment therapy
5166771|NCT00948974|Cognitive Therapy|cognitive therapy
5166772|NCT00948961|NYESO1|nyeso1
5166773|NCT00948961|cancer vaccine|cancer vaccine
5166774|NCT00948961|immunotherapy|immunotherapy
5166775|NCT00948961|breast cancer|breast cancer
5166776|NCT00948961|ovarian cancer|ovarian cancer
5166777|NCT00948961|non-small cell lung cancer|non-small cell lung cancer
5166778|NCT00948961|myeloma|myeloma
5166779|NCT00948961|sarcoma|sarcoma
5166780|NCT00948961|melanoma|melanoma
5166781|NCT00948961|Resiquimod|resiquimod
5166782|NCT00948961|Poly-ICLC|poly-iclc
5166783|NCT00948961|Hiltonol|hiltonol
5166784|NCT00948961|esophageal cancer|esophageal cancer
5166785|NCT00948961|bladder cancer|bladder cancer
5166786|NCT00948961|chondrosarcoma|chondrosarcoma
5166787|NCT00948961|adenocarcinoma|adenocarcinoma
5166788|NCT00948935|Biliary Cancer|biliary cancer
5166789|NCT00948935|Cholangiocarcinoma|cholangiocarcinoma
5166790|NCT00948935|Panitumumab|panitumumab
5166791|NCT00948922|multiple myeloma|multiple myeloma
5166792|NCT00948922|myeloma|myeloma
5166793|NCT00948922|myeloma proteins|myeloma proteins
5166794|NCT00948922|autologous|autologous
5166795|NCT00948922|allogeneic|allogeneic
5166796|NCT00948896|Chemoprevention|chemoprevention
5166797|NCT00948896|Uganda|uganda
5166798|NCT00948896|Malaria|malaria
5166799|NCT00948896|Trimethoprim-sulfamethoxazole|trimethoprim-sulfamethoxazole
5166800|NCT00948896|Sulfadoxine-pyrimethamine|sulfadoxine-pyrimethamine
5166801|NCT00948896|Dihydroartemisinin-piperaquine|dihydroartemisinin-piperaquine
5166802|NCT00948883|organ transplant|organ transplant
5166803|NCT00948883|cancer|cancer
5166804|NCT00948883|biobank|biobank
5166805|NCT00948883|immunosuppressive drugs|immunosuppressive drugs
5166806|NCT00948883|lymphoma|lymphoma
5166807|NCT00948870|alternative medicine|alternative medicine
5166808|NCT00948857|DHEA|dhea
5166809|NCT00948857|POF|pof
5166810|NCT00948857|Pregnancy|pregnancy
5166811|NCT00948857|Ovarian Failure|ovarian failure
5166812|NCT00948857|Otherwise Unexplained infertility|otherwise unexplained infertility
5166813|NCT00948857|Ovarian aging|ovarian aging
5166814|NCT00948844|falls|falls
5166815|NCT00948844|Missteps|missteps
5166816|NCT00948831|biologics|biologics
5166817|NCT00948831|fusion rates|fusion rates
5166818|NCT00948831|lumbar fusion|lumbar fusion
5166819|NCT00948831|ALIF|alif
5166820|NCT00948818|Irritable Bowel Syndrome|irritable bowel syndrome
5166821|NCT00948818|Constipation|constipation
5166822|NCT00948818|Linaclotide|linaclotide
5166823|NCT00948805|corpus luteum rescue|corpus luteum rescue
5166824|NCT00948805|Gonadotropin Releasing Hormone (GnRH agonist)|gonadotropin releasing hormone (gnrh agonist)
5166825|NCT00948805|human Chorionic Gonadotropin (hCG)|human chorionic gonadotropin (hcg)
5166826|NCT00948805|infertility|infertility
5166827|NCT00948805|pregnancy rate|pregnancy rate
5166828|NCT00948792|platelets|platelets
5166829|NCT00948792|transfusion|transfusion
5166830|NCT00948792|thrombocytopenia|thrombocytopenia
5166831|NCT00948779|Patient education|patient education
5166832|NCT00948779|Antibiotic|antibiotic
5166833|NCT00948779|Child|child
5166834|NCT00948779|Respiratory tract infection|respiratory tract infection
5166835|NCT00948779|Patient satisfaction|patient satisfaction
5166836|NCT00948779|Parental knowledge|parental knowledge
5166837|NCT00948779|Adherence|adherence
5166838|NCT00948766|Alzheimer's disease|alzheimer's disease
5166839|NCT00948766|dementia|dementia
5166840|NCT00948766|Alzheimer's type|alzheimer's type
5166841|NCT00948753|Graft-versus-host disease|graft-versus-host disease
5166842|NCT00948753|GVHD|gvhd
5166843|NCT00948753|Maraviroc|maraviroc
5166844|NCT00948753|non-myeloablative allogeneic stem-cell transplantation|non-myeloablative allogeneic stem-cell transplantation
5166845|NCT00948753|Hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
5166846|NCT00948740|vitamin D|vitamin d
5166847|NCT00948701|Breast cancer|breast cancer
5166848|NCT00948701|Exercise|exercise
5166849|NCT00948701|Physical activity|physical activity
5166850|NCT00948701|Community volunteers|community volunteers
5166851|NCT00948701|Peer mentors|peer mentors
5166852|NCT00948701|Peer coaches|peer coaches
5166853|NCT00948701|Social support|social support
5166854|NCT00948688|Zolinza|zolinza
5166855|NCT00948675|Advanced Non-Small Cell Lung Cancer of Nonsquamous Histology|advanced non-small cell lung cancer of nonsquamous histology
5166856|NCT00948675|Advanced Lung Cancer|advanced lung cancer
5166857|NCT00948675|Non-Small Cell Lung Cancer|non-small cell lung cancer
5166858|NCT00948675|Lung Cancer|lung cancer
5166859|NCT00948662|Safety|safety
5166860|NCT00948662|tolerability|tolerability
5166861|NCT00948662|ascending single doses|ascending single doses
5166862|NCT00948662|healthy subjects|healthy subjects
5166863|NCT00948649|Varenicline, Working memory|varenicline, working memory
5166864|NCT00948623|COPD|copd
5166865|NCT00948623|physical activity|physical activity
5166866|NCT00948623|pulmonary rehabilitation|pulmonary rehabilitation
5166867|NCT00948623|counseling|counseling
5166868|NCT00948610|Rheumatoid Arthritis|rheumatoid arthritis
5166869|NCT00948597|propofol|propofol
5166870|NCT00948597|elective surgical procedure|elective surgical procedure
5166871|NCT00948597|Obese subjects|obese subjects
5166872|NCT00948584|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
5166873|NCT00948584|Insulin dose titration system|insulin dose titration system
5166874|NCT00948571|Vital capacity, FEV1, airway resistance|vital capacity, fev1, airway resistance
5166875|NCT00948571|perioperative changes in lung function|perioperative changes in lung function
5166877|NCT00948558|pharmacokinetic|pharmacokinetic
5166878|NCT00948558|critically ill|critically ill
5166879|NCT00948558|acute kidney failure|acute kidney failure
5166880|NCT00948545|Autonomic nervous system|autonomic nervous system
5166881|NCT00948545|Bariatric surgery|bariatric surgery
5166882|NCT00948545|Observational study for individuals having bariatric surgery|observational study for individuals having bariatric surgery
5166883|NCT00948532|degenerative disc disease|degenerative disc disease
5166884|NCT00948532|lumbar spine|lumbar spine
5166885|NCT00948532|XLIF|xlif
5166886|NCT00948532|Degenerative conditions|degenerative conditions
5166887|NCT00948519|Rhinosinusitis, sinusitis, chronic, nasal polyps, phototherapy, laser,laser therapy, antibiotic, safety laser, ICG, indocyanine green|rhinosinusitis, sinusitis, chronic, nasal polyps, phototherapy, laser,laser therapy, antibiotic, safety laser, icg, indocyanine green
5166888|NCT00948519|Chronic Rhinosinusitis with or without nasal polyposis|chronic rhinosinusitis with or without nasal polyposis
5166889|NCT00948493|diabetes|diabetes
5166890|NCT00948493|insulin therapy|insulin therapy
5166891|NCT00948480|autologous tumor cell vaccine|autologous tumor cell vaccine
5166892|NCT00948480|metastatic melanoma|metastatic melanoma
5166893|NCT00948480|sargramostim (GM-CSF)|sargramostim (gm-csf)
5166894|NCT00948467|Advanced nonhematologic malignancies|advanced nonhematologic malignancies
5166895|NCT00948467|Advanced metastatic melanoma|advanced metastatic melanoma
5166896|NCT00948467|BRAF gene|braf gene
5166897|NCT00948454|smoking|smoking
5166898|NCT00948441|intestinal insufficiency|intestinal insufficiency
5166899|NCT00948441|central venous catheter|central venous catheter
5166900|NCT00948441|Catheter-Related Infections|catheter-related infections
5166901|NCT00948441|pediatrics|pediatrics
5166902|NCT00948441|ethanol|ethanol
5166903|NCT00948428|actinic keratoses|actinic keratoses
5166904|NCT00948428|imiquimod|imiquimod
5166905|NCT00948428|therapeutic equivalence|therapeutic equivalence
5166906|NCT00948428|bioequivalence|bioequivalence
5166907|NCT00948415|Obesity|obesity
5166908|NCT00948415|Weight loss|weight loss
5166909|NCT00948415|Internet|internet
5166910|NCT00948402|PED/PEA-15 protein|ped/pea-15 protein
5166911|NCT00948402|PCOS|pcos
5166912|NCT00948402|IR|ir
5166913|NCT00948402|metformin|metformin
5166914|NCT00948402|OCP|ocp
5166915|NCT00948402|Oral Contraceptive|oral contraceptive
5166916|NCT00948376|Natural history|natural history
5166917|NCT00948376|IFT80|ift80
5166918|NCT00948376|short ribs|short ribs
5166919|NCT00948376|multivisceral involvement|multivisceral involvement
5166920|NCT00948363|Kiwi fruits|kiwi fruits
5166921|NCT00948363|Blood pressure|blood pressure
5166922|NCT00948363|Endothelial function|endothelial function
5166923|NCT00948363|Antioxidant capacity|antioxidant capacity
5166924|NCT00948350|cervical instability|cervical instability
5166925|NCT00948350|awake intubation|awake intubation
5166926|NCT00948350|laryngeal anesthesia|laryngeal anesthesia
5166927|NCT00948324|ype 2 diabetes mellitus, continuous subcutaneous insulin infusion,|ype 2 diabetes mellitus, continuous subcutaneous insulin infusion,
5166928|NCT00948324|α-lipoic acid ,rosiglitazone ,metformin，therapy|α-lipoic acid ,rosiglitazone ,metformin，therapy
5166929|NCT00948298|cardiovascular disease|cardiovascular disease
5166930|NCT00948298|vitamin D|vitamin d
5166931|NCT00948298|african american|african american
5166932|NCT00948298|low vitamin D levels|low vitamin d levels
5166933|NCT00948285|breast cancer|breast cancer
5166934|NCT00948285|magnetic resonance imaging|magnetic resonance imaging
5166935|NCT00948272|Rabies|rabies
5166936|NCT00948272|Rabies virus|rabies virus
5166937|NCT00948272|Purified Vero Rabies Vaccine|purified vero rabies vaccine
5166938|NCT00948272|Serum Free|serum free
5166939|NCT00948259|safety|safety
5166940|NCT00948259|GSK inhibitor|gsk inhibitor
5166941|NCT00948259|Alzheimer|alzheimer
5166942|NCT00948233|Tobacco|tobacco
5166943|NCT00948233|Smoking Cessation|smoking cessation
5166944|NCT00948233|Prevention|prevention
5166945|NCT00948233|Smokeless tobacco|smokeless tobacco
5166946|NCT00948233|Habit|habit
5166947|NCT00948220|HCV|hcv
5166948|NCT00948220|hepatitis C virus|hepatitis c virus
5166949|NCT00948220|CHC|chc
5166950|NCT00948220|chronic hepatitis c|chronic hepatitis c
5166951|NCT00948220|interferon|interferon
5166952|NCT00948220|ribavirin|ribavirin
5166953|NCT00948220|DEXA|dexa
5166954|NCT00948220|BMD|bmd
5166955|NCT00948220|bone mineral density|bone mineral density
5166956|NCT00948220|osteoporosis|osteoporosis
5166957|NCT00948220|osteopenia|osteopenia
5166958|NCT00948220|osteodystrophy|osteodystrophy
5166959|NCT00948220|osteodensitometry|osteodensitometry
5166960|NCT00948220|Bone Density|bone density
5166961|NCT00948220|Hepatitis, Viral, Human|hepatitis, viral, human
5166962|NCT00948220|Anti-Infective Agents|anti-infective agents
5166963|NCT00948220|peginterferon alfa-2a|peginterferon alfa-2a
5166964|NCT00948207|Metastatic Cancer|metastatic cancer
5166965|NCT00948207|Recurrent Cancer|recurrent cancer
5166966|NCT00948207|Distributed Hematological Cancer|distributed hematological cancer
5166967|NCT00948207|Advanced Cancer|advanced cancer
5166968|NCT00948207|Terminal Cancer|terminal cancer
5166969|NCT00948207|Stage III Cancer|stage iii cancer
5166970|NCT00948207|Stage IV Cancer|stage iv cancer
5166971|NCT00948194|Extended Donor Criteria|extended donor criteria
5166972|NCT00948181|Epinephrine, Norepinephrine, normetanephrine|epinephrine, norepinephrine, normetanephrine
5166973|NCT00948181|Catecholamine concentrations during surgery|catecholamine concentrations during surgery
5166974|NCT00948168|T2DM|t2dm
5166975|NCT00948168|exenatide|exenatide
5166976|NCT00948168|HbA1c|hba1c
5166977|NCT00948168|weight|weight
5166978|NCT00948168|waist circumference|waist circumference
5166979|NCT00948168|insulin sensitivity|insulin sensitivity
5166980|NCT00948168|beta-cell function|beta-cell function
5166981|NCT00948155|smoking|smoking
5166982|NCT00948155|nicotine|nicotine
5166983|NCT00948155|varenicline|varenicline
5166984|NCT00948142|Acute Bacterial Skin and Skin Struction Infections; Bacterial Skin Diseases; Staphylococcal Skin Infections; MRSA|acute bacterial skin and skin struction infections; bacterial skin diseases; staphylococcal skin infections; mrsa
5166985|NCT00948129|Smoking Cessation|smoking cessation
5166986|NCT00948129|Low-Income|low-income
5166987|NCT00948129|Cigarette smoking|cigarette smoking
5166988|NCT00948129|Uninsured and underinsured|uninsured and underinsured
5166989|NCT00948129|NRT|nrt
5166990|NCT00948129|Nicoderm CQ|nicoderm cq
5166991|NCT00948129|Habits|habits
5166992|NCT00948116|Diabetes mellitus|diabetes mellitus
5166993|NCT00948116|Renal Impairment|renal impairment
5166994|NCT00948116|Acute Kidney Injury|acute kidney injury
5166995|NCT00948116|Coronary revascularisation|coronary revascularisation
5166996|NCT00948116|eGFR <60ml/min|egfr <60ml/min
5166997|NCT00948103|Nitrous Oxide|nitrous oxide
5167124|NCT00947635|Immunosuppression|immunosuppression
5166998|NCT00948103|Administration, Intravesical Drug|administration, intravesical drug
5166999|NCT00948103|Botulinum toxin|botulinum toxin
5167000|NCT00948090|Hodgkin Lymphoma|hodgkin lymphoma
5167001|NCT00948090|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
5167002|NCT00948090|Bone marrow transplant|bone marrow transplant
5167003|NCT00948090|stem cell transplant|stem cell transplant
5167004|NCT00948090|busulfan|busulfan
5167005|NCT00948090|cyclophosphamide|cyclophosphamide
5167006|NCT00948090|etoposide|etoposide
5167007|NCT00948077|tuberculosis|tuberculosis
5167008|NCT00948077|pharmacokinetic|pharmacokinetic
5167009|NCT00948077|first-line drugs|first-line drugs
5167010|NCT00948064|Leukemia|leukemia
5167011|NCT00948064|Acute Myelogenous Leukemia|acute myelogenous leukemia
5167012|NCT00948064|AML|aml
5167013|NCT00948064|Myelodysplastic Syndrome|myelodysplastic syndrome
5167014|NCT00948064|MDS|mds
5167015|NCT00948064|Vorinostat|vorinostat
5167016|NCT00948064|SAHA|saha
5167017|NCT00948064|Suberoylanilide Hydroxamic Acid|suberoylanilide hydroxamic acid
5167018|NCT00948064|MSK-390|msk-390
5167019|NCT00948064|Zolinza|zolinza
5167020|NCT00948064|Azacitidine|azacitidine
5167021|NCT00948064|5-Azacitidine|5-azacitidine
5167022|NCT00948064|5-Aza|5-aza
5167023|NCT00948064|Vidaza|vidaza
5167024|NCT00948064|5-AZC|5-azc
5167025|NCT00948064|AZA-CR|aza-cr
5167026|NCT00948064|Ladakamycin|ladakamycin
5167027|NCT00948064|NSC-102816|nsc-102816
5167028|NCT00948038|Inflammation|inflammation
5167029|NCT00948038|Oxidative stress|oxidative stress
5167030|NCT00948025|Peripheral Nerve Repair|peripheral nerve repair
5167031|NCT00948025|Conduit|conduit
5167032|NCT00948025|AVANCE|avance
5167033|NCT00948025|Neuroma Resection|neuroma resection
5167034|NCT00948025|Nerve Gap Repair|nerve gap repair
5167035|NCT00948025|Digital Nerve Repair|digital nerve repair
5167036|NCT00948012|Sickle Cell Anemia|sickle cell anemia
5167037|NCT00948012|Pulmonary Hypertension|pulmonary hypertension
5167038|NCT00948012|Exercise echocardiography|exercise echocardiography
5167039|NCT00948012|Echocardiography|echocardiography
5167040|NCT00947973|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
5167041|NCT00947973|ADHD|adhd
5167042|NCT00947973|School Based|school based
5167043|NCT00947973|Intervention|intervention
5167044|NCT00947973|Psychosocial|psychosocial
5167045|NCT00947973|Academic Intervention|academic intervention
5167046|NCT00947973|Behavioral|behavioral
5167047|NCT00947960|Adult Polyglucosan Body Disease (APBD)|adult polyglucosan body disease (apbd)
5167048|NCT00947960|Glycogen Brancher Enzyme (GBE1) Deficiency|glycogen brancher enzyme (gbe1) deficiency
5167049|NCT00947947|condom use|condom use
5167050|NCT00947947|HIV prevention|hiv prevention
5167051|NCT00947947|African American|african american
5167052|NCT00947947|Behavioral intervention|behavioral intervention
5167053|NCT00947947|HIV Seronegativity|hiv seronegativity
5167054|NCT00947934|Alzheimer disease,hypothalamus,Deep Brain Stimulation|alzheimer disease,hypothalamus,deep brain stimulation
5167055|NCT00947921|Functional MItral regurgitation|functional mitral regurgitation
5167056|NCT00947908|Hymenoptera venom allergy|hymenoptera venom allergy
5167057|NCT00947908|Dendritic cells (DC)|dendritic cells (dc)
5167058|NCT00947895|ACTH|acth
5167059|NCT00947895|Acthar gel|acthar gel
5167060|NCT00947895|adrenocorticotropin|adrenocorticotropin
5167061|NCT00947895|methylprednisolone|methylprednisolone
5167062|NCT00947895|solumedrol|solumedrol
5167063|NCT00947895|MS|ms
5167064|NCT00947895|multiple|multiple
5167065|NCT00947895|sclerosis|sclerosis
5167066|NCT00947895|relapse|relapse
5167067|NCT00947895|exacerbation|exacerbation
5167068|NCT00947895|sub-responsive|sub-responsive
5167069|NCT00947895|IV|iv
5167070|NCT00947856|Antibodies, Monoclonal|antibodies, monoclonal
5167071|NCT00947856|Antibody-Drug Conjugate|antibody-drug conjugate
5167072|NCT00947856|Antigens, CD30|antigens, cd30
5167073|NCT00947856|Drug Therapy|drug therapy
5167074|NCT00947856|Hematologic Diseases|hematologic diseases
5167075|NCT00947856|Immunotherapy|immunotherapy
5167076|NCT00947856|Monomethylauristatin E|monomethylauristatin e
5167077|NCT00947843|CHD|chd
5167078|NCT00947843|CHD equivalents|chd equivalents
5167079|NCT00947830|CML|cml
5167080|NCT00947830|intracellular imatinib level|intracellular imatinib level
5167081|NCT00947830|OCT-1|oct-1
5167082|NCT00947804|Acute Coronary Artery Syndrome Risk Stratification Score|acute coronary artery syndrome risk stratification score
5167083|NCT00947791|Bipolar Disorder|bipolar disorder
5167084|NCT00947791|Depression|depression
5167085|NCT00947791|Treatment-Resistant|treatment-resistant
5167086|NCT00947791|ketamine|ketamine
5167087|NCT00947791|antidepressant|antidepressant
5167088|NCT00947791|glutamate|glutamate
5167089|NCT00947765|Tennis Elbow|tennis elbow
5167090|NCT00947765|Epicondylitis, Lateral Humeral|epicondylitis, lateral humeral
5167091|NCT00947752|Multiple Sclerosis|multiple sclerosis
5167092|NCT00947752|Relapsing Remitting Multiple Sclerosis (RRMS)|relapsing remitting multiple sclerosis (rrms)
5167093|NCT00947752|Glatiramer Acetate (GA)|glatiramer acetate (ga)
5167094|NCT00947739|CZ|cz
5167095|NCT00947739|Stehlin|stehlin
5167096|NCT00947739|Lymphomas|lymphomas
5167097|NCT00947713|Human chorionic gonadotropin|human chorionic gonadotropin
5167098|NCT00947713|Clomiphene citrate|clomiphene citrate
5167099|NCT00947713|chronic anovulation|chronic anovulation
5167100|NCT00947713|Polycystic Ovary Syndrome|polycystic ovary syndrome
5167101|NCT00947713|Follicolugenesis|follicolugenesis
5167102|NCT00947700|Infants|infants
5167103|NCT00947700|Risk markers|risk markers
5167104|NCT00947700|ERP|erp
5167105|NCT00947700|Parent child interaction|parent child interaction
5167106|NCT00947700|Promoting First Relations|promoting first relations
5167107|NCT00947700|Social Communication|social communication
5167108|NCT00947687|influenza|influenza
5167109|NCT00947687|healthy subject|healthy subject
5167110|NCT00947687|virus inoculation|virus inoculation
5167111|NCT00947687|symptom scores|symptom scores
5167112|NCT00947687|viral shedding|viral shedding
5167113|NCT00947687|bioaerosol output|bioaerosol output
5167114|NCT00947674|Cellsorba EX|cellsorba ex
5167115|NCT00947661|glaucoma latanoprost|glaucoma latanoprost
5167116|NCT00947648|acute myelogenous leukemia|acute myelogenous leukemia
5167117|NCT00947648|AML|aml
5167118|NCT00947648|myelodysplastic syndrome|myelodysplastic syndrome
5167119|NCT00947648|MDS|mds
5167120|NCT00947648|Neutropenia|neutropenia
5167121|NCT00947648|raw fruits and vegetables|raw fruits and vegetables
5167122|NCT00947635|Type 1 diabetes|type 1 diabetes
5167123|NCT00947635|Transplants|transplants
5167125|NCT00947635|Hyperlipidemia|hyperlipidemia
5167126|NCT00947635|Nutrition Therapy|nutrition therapy
5167127|NCT00947622|Fibromyalgia|fibromyalgia
5167128|NCT00947622|Neuromodulation|neuromodulation
5167129|NCT00947622|Transcranial Direct Current Stimulation|transcranial direct current stimulation
5167130|NCT00947622|Occipital|occipital
5167131|NCT00947609|Latent tuberculosis|latent tuberculosis
5167132|NCT00947609|HIV|hiv
5167133|NCT00947609|Children|children
5167134|NCT00947609|Interferon gamma release assays|interferon gamma release assays
5167135|NCT00947609|Thailand|thailand
5167136|NCT00947609|QuantiFERON TB Gold In-tube|quantiferon tb gold in-tube
5167137|NCT00947609|T-Spot.TB|t-spot.tb
5167138|NCT00947596|Atropine|atropine
5167139|NCT00947596|Aerosol|aerosol
5167140|NCT00947596|Inhaler|inhaler
5167141|NCT00947596|Dry Powder|dry powder
5167142|NCT00947583|fusion rates|fusion rates
5167143|NCT00947583|TLIF|tlif
5167144|NCT00947583|Osteocel Plus|osteocel plus
5167145|NCT00947583|biologics|biologics
5167146|NCT00947583|lumbar fusion|lumbar fusion
5167147|NCT00947570|Cognitive Behavioral Therapy|cognitive behavioral therapy
5167148|NCT00947570|Functional Brain Imaging|functional brain imaging
5167149|NCT00947570|Psychotherapy|psychotherapy
5167150|NCT00947570|Treatment|treatment
5167151|NCT00947570|Brain Imaging|brain imaging
5167152|NCT00947544|Urea Cycle Disorder|urea cycle disorder
5167153|NCT00947544|UCD|ucd
5167154|NCT00947544|GT4P|gt4p
5167155|NCT00947544|Buphenyl|buphenyl
5167156|NCT00947544|hyperammonemia|hyperammonemia
5167157|NCT00947544|sodium phenylbutyrate|sodium phenylbutyrate
5167158|NCT00947518|chlorhexidine|chlorhexidine
5167159|NCT00947518|preterm|preterm
5167160|NCT00947518|newborn|newborn
5167161|NCT00947518|skin condition|skin condition
5167162|NCT00947518|temperature|temperature
5167163|NCT00947518|skin flora|skin flora
5167164|NCT00947505|Androgenetic alopecia|androgenetic alopecia
5167165|NCT00947505|Hair loss|hair loss
5167166|NCT00947505|Male Pattern baldness|male pattern baldness
5167167|NCT00947492|Rheumatoid Arthritis patients|rheumatoid arthritis patients
5167168|NCT00947492|treated with new immunosuppressive drugs : Orencia* (abatacept) and RoActemra* (tocilizumab).|treated with new immunosuppressive drugs : orencia* (abatacept) and roactemra* (tocilizumab).
5167169|NCT00947479|obstructive sleep apnea|obstructive sleep apnea
5167170|NCT00947479|pulse-wave velocity,|pulse-wave velocity,
5167171|NCT00947479|acute kidney injury|acute kidney injury
5167172|NCT00947479|biomarkers of acute kidney injury|biomarkers of acute kidney injury
5167173|NCT00947466|Buprenorphine transdermal patch (BTDS)|buprenorphine transdermal patch (btds)
5167174|NCT00947466|Moderate to severe mouth pain|moderate to severe mouth pain
5167175|NCT00947466|Chemotherapy induced mucositis|chemotherapy induced mucositis
5167176|NCT00947466|Pharmacokinetic|pharmacokinetic
5167177|NCT00947453|asthma|asthma
5167178|NCT00947453|montelukast|montelukast
5167179|NCT00947440|Phase 1|phase 1
5167180|NCT00947440|Bioavailability|bioavailability
5167181|NCT00947427|type 1 diabetes|type 1 diabetes
5167182|NCT00947427|newly diagnosed T1D|newly diagnosed t1d
5167183|NCT00947427|T1D|t1d
5167184|NCT00947427|canakinumab|canakinumab
5167185|NCT00947427|anti IL-1|anti il-1
5167186|NCT00947414|cellulite; shockwave; microcirculation; skin|cellulite; shockwave; microcirculation; skin
5167187|NCT00947401|Surgery, elective|surgery, elective
5167188|NCT00947401|Fluids|fluids
5167189|NCT00947401|Post Anesthesia Care Unit|post anesthesia care unit
5167190|NCT00947401|PACU|pacu
5167191|NCT00947401|Fluid management|fluid management
5167192|NCT00947388|Refractory Chronic Lymphocytic Leukemia|refractory chronic lymphocytic leukemia
5167193|NCT00947388|Bendamustine|bendamustine
5167194|NCT00947388|Alemtuzumab|alemtuzumab
5167195|NCT00947388|Phase I|phase i
5167196|NCT00947388|CLL|cll
5167197|NCT00947375|schizophrenia|schizophrenia
5167198|NCT00947375|lamictal TM|lamictal tm
5167199|NCT00947375|haloperidol decanoate|haloperidol decanoate
5167200|NCT00947323|simvastatin|simvastatin
5167201|NCT00947323|endothelial dysfunction|endothelial dysfunction
5167202|NCT00947323|erectile dysfunction|erectile dysfunction
5167203|NCT00947310|Inappropriate therapy|inappropriate therapy
5167204|NCT00947310|ICD therapy|icd therapy
5167205|NCT00947310|Primary prevention|primary prevention
5167206|NCT00947297|Urea Cycle Disorder|urea cycle disorder
5167207|NCT00947297|UCD|ucd
5167208|NCT00947297|hyperammonemia|hyperammonemia
5167209|NCT00947297|Buphenyl|buphenyl
5167210|NCT00947297|Sodium Phenylbutyrate|sodium phenylbutyrate
5167211|NCT00947271|STD|std
5167212|NCT00947271|STI|sti
5167213|NCT00947271|Sexual Behavior|sexual behavior
5167214|NCT00947271|Prevention|prevention
5167215|NCT00947271|HIV seronegativity|hiv seronegativity
5167216|NCT00947258|Muscle Strength|muscle strength
5167217|NCT00947258|Torque|torque
5167218|NCT00947258|Muscle Stretching Exercises|muscle stretching exercises
5167219|NCT00947258|Range of Motion|range of motion
5167220|NCT00947232|major depressive disorder|major depressive disorder
5167221|NCT00947232|physical activity|physical activity
5167222|NCT00947232|aging with physical disability|aging with physical disability
5167223|NCT00947232|motivational interviewing|motivational interviewing
5167224|NCT00947219|Androgenetic Alopecia|androgenetic alopecia
5167225|NCT00947219|Hair Loss|hair loss
5167226|NCT00947219|Male Pattern Baldness|male pattern baldness
5167227|NCT00947206|Chinese Americans|chinese americans
5167228|NCT00947206|lay health worker outreach|lay health worker outreach
5167229|NCT00947206|colorectal cancer screening|colorectal cancer screening
5167230|NCT00947193|Hemophilia A|hemophilia a
5167231|NCT00947193|Hemophilia B|hemophilia b
5167232|NCT00947193|Factor VIII|factor viii
5167233|NCT00947193|Factor IX|factor ix
5167234|NCT00947193|FVIII|fviii
5167235|NCT00947193|FIX|fix
5167236|NCT00947193|Nonsense mutation|nonsense mutation
5167237|NCT00947193|Premature stop codon|premature stop codon
5167238|NCT00947193|HA|ha
5167239|NCT00947193|HB|hb
5167240|NCT00947193|PTC124|ptc124
5167241|NCT00947193|Ataluren|ataluren
5167242|NCT00947180|Biofeedback|biofeedback
5167243|NCT00947180|Pelvic floor|pelvic floor
5167244|NCT00947180|Levator ani syndrome|levator ani syndrome
5167245|NCT00947180|Chronic proctalgia|chronic proctalgia
5167246|NCT00947180|Electrogalvanic stimulation|electrogalvanic stimulation
5167247|NCT00947180|Massage|massage
5167248|NCT00947154|trichotillomania|trichotillomania
5167249|NCT00947154|aripiprazole|aripiprazole
5167250|NCT00947154|treatment|treatment
5167251|NCT00947141|Optimising treatment of cytomegalovirus infection|optimising treatment of cytomegalovirus infection
5167252|NCT00947128|Antiemetic|antiemetic
5167253|NCT00947115|Cervical cancer|cervical cancer
5167254|NCT00947115|HPV vaccine|hpv vaccine
5167255|NCT00947102|pancreatic tubular adenocarcinoma|pancreatic tubular adenocarcinoma
5167256|NCT00947102|gemcitabine|gemcitabine
5167257|NCT00947102|gene expression|gene expression
5167258|NCT00947102|immunological status|immunological status
5167259|NCT00947102|serological status|serological status
5167260|NCT00947102|pancreatic tubular adenocarcinoma adjuvant setting|pancreatic tubular adenocarcinoma adjuvant setting
5167261|NCT00947089|ORC (oxidized regenerated cellulose)|orc (oxidized regenerated cellulose)
5167262|NCT00947089|SSI (Surgical site infections)|ssi (surgical site infections)
5167263|NCT00947076|Antidepressant|antidepressant
5167264|NCT00947063|Antihistamine|antihistamine
5167265|NCT00947050|CAD|cad
5167266|NCT00947050|prompt physical exercise|prompt physical exercise
5167267|NCT00947050|collateral function|collateral function
5167268|NCT00947011|Healthy volunteers|healthy volunteers
5167269|NCT00947011|GLP-1|glp-1
5167270|NCT00947011|Januvia|januvia
5167271|NCT00947011|Sitagliptin|sitagliptin
5167272|NCT00946998|Chronic Kidney Disease|chronic kidney disease
5167273|NCT00946998|Depression|depression
5167274|NCT00946998|Antidepressants|antidepressants
5167275|NCT00946998|randomized controlled trial|randomized controlled trial
5167276|NCT00946998|treatment|treatment
5167277|NCT00946998|Sertraline|sertraline
5167278|NCT00946985|Schizophrenia|schizophrenia
5167279|NCT00946985|Risperidone|risperidone
5167280|NCT00946985|Risperdal|risperdal
5167281|NCT00946985|Paliperidone Palmitate|paliperidone palmitate
5167282|NCT00946985|Invega Sustenna|invega sustenna
5167283|NCT00946972|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
5167284|NCT00946959|cardiac surgery|cardiac surgery
5167285|NCT00946959|angioplasty|angioplasty
5167286|NCT00946959|cognitive decline|cognitive decline
5167287|NCT00946946|Randomized|randomized
5167288|NCT00946946|Crohn's Disease|crohn's disease
5167289|NCT00946946|Prevention|prevention
5167290|NCT00946946|Azathioprine|azathioprine
5167291|NCT00946946|mesalazine|mesalazine
5167292|NCT00946946|mesalamine|mesalamine
5167293|NCT00946946|TPMT|tpmt
5167294|NCT00946933|acid-base balance|acid-base balance
5167295|NCT00946933|ventilatory control|ventilatory control
5167296|NCT00946933|dyspnea|dyspnea
5167297|NCT00946933|exercise|exercise
5167298|NCT00946933|modified rebreathing procedure|modified rebreathing procedure
5167299|NCT00946933|Normal|normal
5167300|NCT00946933|older|older
5167301|NCT00946907|acute pericarditis|acute pericarditis
5167302|NCT00946907|treatment|treatment
5167303|NCT00946907|recurrence|recurrence
5167304|NCT00946894|Total thyroidectomy|total thyroidectomy
5167305|NCT00946894|Subtotal thyroidectomy|subtotal thyroidectomy
5167306|NCT00946894|Dunhill operation|dunhill operation
5167307|NCT00946894|Recurrent nodular goiter|recurrent nodular goiter
5167308|NCT00946894|Completion thyroidectomy|completion thyroidectomy
5167309|NCT00946894|Recurrent laryngeal nerve palsy|recurrent laryngeal nerve palsy
5167310|NCT00946894|Hypoparathyroidism following thyroidectomy|hypoparathyroidism following thyroidectomy
5167311|NCT00946894|Recurrent goiter|recurrent goiter
5167312|NCT00946881|Prostatic disease|prostatic disease
5167313|NCT00946881|genital neoplasm, male|genital neoplasm, male
5167314|NCT00946881|Urogenital neoplasm|urogenital neoplasm
5167315|NCT00946881|Genital disease|genital disease
5167316|NCT00946881|male|male
5167317|NCT00946881|Male urogenital disease|male urogenital disease
5167318|NCT00946881|Neoplasms|neoplasms
5167319|NCT00946881|Neoplasm by site|neoplasm by site
5167320|NCT00946881|prostatic neoplasm|prostatic neoplasm
5167321|NCT00946881|Carcinoma|carcinoma
5167322|NCT00946868|intermittent claudication|intermittent claudication
5167323|NCT00946868|metabolic syndrome|metabolic syndrome
5167324|NCT00946855|soccer|soccer
5167325|NCT00946855|laboratory|laboratory
5167326|NCT00946855|reference|reference
5167327|NCT00946855|exercise|exercise
5167328|NCT00946855|variability|variability
5167329|NCT00946855|season|season
5167330|NCT00946855|elite athletes|elite athletes
5167331|NCT00946855|Define reference blood parameters in elite athletes|define reference blood parameters in elite athletes
5167332|NCT00946842|Healthy|healthy
5167333|NCT00946842|Bioavailability|bioavailability
5167334|NCT00946842|Relative bioavailability|relative bioavailability
5167335|NCT00946842|TMC207|tmc207
5167336|NCT00946842|Fed condition|fed condition
5167337|NCT00946842|Fasted condition|fasted condition
5167338|NCT00946803|Pain|pain
5167339|NCT00946803|Fatigue|fatigue
5167340|NCT00946803|Sleep|sleep
5167341|NCT00946803|Cancer|cancer
5167342|NCT00946803|Complementary therapies|complementary therapies
5167343|NCT00946790|Immunosuppressant and Antirheumatic|immunosuppressant and antirheumatic
5167344|NCT00946777|Dry Eye Signs|dry eye signs
5167345|NCT00946777|barrier function|barrier function
5167346|NCT00946764|Antidepressant|antidepressant
5167347|NCT00946751|Anticonvulsant|anticonvulsant
5167348|NCT00946738|Raynaud's phenomenon|raynaud's phenomenon
5167349|NCT00946738|biofeedback|biofeedback
5167350|NCT00946738|deep oscillation|deep oscillation
5167351|NCT00946738|systemic sclerosis|systemic sclerosis
5167352|NCT00946738|physiotherapy|physiotherapy
5167353|NCT00946725|Angina (Chest Pain)|angina (chest pain)
5167354|NCT00946725|Hypertension|hypertension
5167355|NCT00946660|Contingency Management|contingency management
5167356|NCT00946660|Drug Self-Administration|drug self-administration
5167357|NCT00946647|Myelodysplastic Syndromes|myelodysplastic syndromes
5167358|NCT00946647|Chronic Myelomonocytic Leukemia|chronic myelomonocytic leukemia
5167359|NCT00946647|Acute Myeloid Leukemia|acute myeloid leukemia
5167360|NCT00946647|hypomethylating therapy|hypomethylating therapy
5167361|NCT00946647|deacetylase inhibitor|deacetylase inhibitor
5167362|NCT00946647|MDS|mds
5167363|NCT00946647|CMML|cmml
5167364|NCT00946647|AML|aml
5167365|NCT00946608|Antihistamine|antihistamine
5167366|NCT00946595|Undetectable|undetectable
5167367|NCT00946595|HIV infections|hiv infections
5167368|NCT00946595|Monotherapy|monotherapy
5167369|NCT00946595|Lopinavir/ritonavir|lopinavir/ritonavir
5167370|NCT00946595|Protease inhibitor|protease inhibitor
5167371|NCT00946595|Treatment experienced|treatment experienced
5167372|NCT00946582|parenting management program|parenting management program
5167373|NCT00946582|ADHD|adhd
5167374|NCT00946569|Asthma|asthma
5167375|NCT00946569|Persistent asthma|persistent asthma
5167376|NCT00946569|Adults with persistent asthma|adults with persistent asthma
5167377|NCT00946569|Chronic asthma|chronic asthma
5167378|NCT00946569|JNJ-39758979|jnj-39758979
5167379|NCT00946569|Placebo|placebo
5167380|NCT00946556|herpes simplex virus type 2|herpes simplex virus type 2
5167381|NCT00946556|HIV|hiv
5167382|NCT00946556|genital immunology|genital immunology
5167383|NCT00946556|CD4+ T cell|cd4+ t cell
5167384|NCT00946556|valacyclovir|valacyclovir
5167385|NCT00946556|HIV seronegativity|hiv seronegativity
5167386|NCT00946543|stage IIB prostate cancer|stage iib prostate cancer
5167387|NCT00946543|stage IIA prostate cancer|stage iia prostate cancer
5167388|NCT00946543|stage III prostate cancer|stage iii prostate cancer
5167389|NCT00946543|stage IV prostate cancer|stage iv prostate cancer
5167390|NCT00946491|Typical Antipsychotic|typical antipsychotic
5167391|NCT00946478|atopic dermatitis|atopic dermatitis
5167392|NCT00946478|elidel|elidel
5167393|NCT00946478|pimecrolimus|pimecrolimus
5167394|NCT00946478|CASM981|casm981
5167395|NCT00946478|immunity|immunity
5167396|NCT00946478|cathelicidin|cathelicidin
5167397|NCT00946478|antimicrobial peptide|antimicrobial peptide
5167398|NCT00946478|eczema|eczema
5167399|NCT00946452|Control|control
5167400|NCT00946452|Satisfaction|satisfaction
5167401|NCT00946439|training exercise gait|training exercise gait
5167402|NCT00946413|CBT, Depressed and suicidal adolescents|cbt, depressed and suicidal adolescents
5167403|NCT00946400|Heparin-induced thrombocytopenia|heparin-induced thrombocytopenia
5167404|NCT00946400|HIT|hit
5167405|NCT00946400|4Ts|4ts
5167406|NCT00946400|Chong scale|chong scale
5167407|NCT00946400|interobserver variability|interobserver variability
5167408|NCT00946387|Antiemetic|antiemetic
5167409|NCT00946374|Mantle-Cell-Lymphoma|mantle-cell-lymphoma
5167410|NCT00946374|MCL|mcl
5167411|NCT00946374|Non Hodgkin´s Lymphoma|non hodgkin´s lymphoma
5167412|NCT00946374|NHL|nhl
5167413|NCT00946374|Immunochemotherapy|immunochemotherapy
5167414|NCT00946374|R-CHOP|r-chop
5167415|NCT00946374|CHOP|chop
5167416|NCT00946374|High-dose chemotherapy|high-dose chemotherapy
5167417|NCT00946374|BEAM|beam
5167418|NCT00946374|HD-BEAM|hd-beam
5167419|NCT00946374|Autologous stem cell transplantation|autologous stem cell transplantation
5167420|NCT00946374|Reduced conditioning regimen|reduced conditioning regimen
5167421|NCT00946374|Unrelated donor|unrelated donor
5167422|NCT00946374|Sibling donor|sibling donor
5167423|NCT00946374|Total Body Irradiation|total body irradiation
5167424|NCT00946374|TBI|tbi
5167425|NCT00946374|Allogenic stem cell transplantation|allogenic stem cell transplantation
5167426|NCT00946374|ABSCT|absct
5167427|NCT00946374|ASCT|asct
5167428|NCT00946374|Fludarabine+TBI|fludarabine+tbi
5167429|NCT00946348|Dronabinol|dronabinol
5167430|NCT00946348|Schizophrenia|schizophrenia
5167431|NCT00946348|Dual Diagnosis|dual diagnosis
5167432|NCT00946348|Substance Abuse|substance abuse
5167433|NCT00946348|Cannabis Use Disorder|cannabis use disorder
5167434|NCT00946322|post-traumatic stress disorder|post-traumatic stress disorder
5167435|NCT00946322|alcohol-related disorders|alcohol-related disorders
5167436|NCT00946322|substance use disorders|substance use disorders
5167437|NCT00946322|couple therapy|couple therapy
5167438|NCT00946296|Graves Disease|graves disease
5167439|NCT00946283|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5167440|NCT00946283|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5167441|NCT00946283|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5167442|NCT00946283|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5167443|NCT00946283|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5167444|NCT00946283|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5167445|NCT00946283|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5167446|NCT00946283|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5167447|NCT00946283|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5167448|NCT00946283|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5167449|NCT00946283|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5167450|NCT00946283|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5167451|NCT00946283|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5167452|NCT00946283|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5167453|NCT00946283|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5167454|NCT00946283|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5167455|NCT00946283|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5167456|NCT00946283|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5168588|NCT00942084|Sepsis|sepsis
5167457|NCT00946283|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5167458|NCT00946283|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5167459|NCT00946283|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5167460|NCT00946283|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5167461|NCT00946283|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5167462|NCT00946283|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5167463|NCT00946283|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5167464|NCT00946283|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5167465|NCT00946283|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5167466|NCT00946283|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5167467|NCT00946283|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5167468|NCT00946283|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5167469|NCT00946283|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5167470|NCT00946283|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5167471|NCT00946283|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5167472|NCT00946283|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5167473|NCT00946283|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5167474|NCT00946283|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5167475|NCT00946283|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5167476|NCT00946283|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5167477|NCT00946283|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5167478|NCT00946283|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5167479|NCT00946283|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5167480|NCT00946283|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5167481|NCT00946283|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5167482|NCT00946283|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5167483|NCT00946283|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
5167484|NCT00946283|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5167485|NCT00946283|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
5167486|NCT00946283|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
5167595|NCT00946023|nonmyeloablative|nonmyeloablative
5167487|NCT00946283|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
5167488|NCT00946283|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
5167489|NCT00946283|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5167490|NCT00946283|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5167491|NCT00946283|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5167492|NCT00946283|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5167493|NCT00946283|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
5167494|NCT00946283|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
5167495|NCT00946283|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5167496|NCT00946283|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5167497|NCT00946283|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5167498|NCT00946283|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5167499|NCT00946283|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5167500|NCT00946283|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5167501|NCT00946283|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5167502|NCT00946283|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5167503|NCT00946283|atypical chronic myeloid leukemia, BCR-ABL negative|atypical chronic myeloid leukemia, bcr-abl negative
5167504|NCT00946283|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5167505|NCT00946283|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5167506|NCT00946283|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5167507|NCT00946283|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5167508|NCT00946283|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5167509|NCT00946283|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5167510|NCT00946283|refractory hairy cell leukemia|refractory hairy cell leukemia
5167511|NCT00946283|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5167512|NCT00946283|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5167513|NCT00946283|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5167514|NCT00946283|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5167515|NCT00946283|chronic eosinophilic leukemia|chronic eosinophilic leukemia
5167516|NCT00946283|primary myelofibrosis|primary myelofibrosis
5168589|NCT00942071|Influenza|influenza
5167517|NCT00946283|chronic neutrophilic leukemia|chronic neutrophilic leukemia
5167518|NCT00946283|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5167519|NCT00946283|disseminated neuroblastoma|disseminated neuroblastoma
5167520|NCT00946283|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
5167521|NCT00946283|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5167522|NCT00946283|recurrent neuroblastoma|recurrent neuroblastoma
5167523|NCT00946283|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5167524|NCT00946283|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
5167525|NCT00946283|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
5167526|NCT00946283|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5167527|NCT00946283|stage II multiple myeloma|stage ii multiple myeloma
5167528|NCT00946283|stage III multiple myeloma|stage iii multiple myeloma
5167529|NCT00946283|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
5167530|NCT00946283|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5167531|NCT00946283|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5167532|NCT00946283|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
5167533|NCT00946283|stage IIIA breast cancer|stage iiia breast cancer
5167534|NCT00946283|stage IIIB breast cancer|stage iiib breast cancer
5167535|NCT00946283|stage IIIC breast cancer|stage iiic breast cancer
5167536|NCT00946283|stage IV breast cancer|stage iv breast cancer
5167537|NCT00946283|refractory multiple myeloma|refractory multiple myeloma
5167538|NCT00946270|CC-4047|cc-4047
5167539|NCT00946270|Pomalidomide|pomalidomide
5167540|NCT00946270|polycythemia vera|polycythemia vera
5167541|NCT00946270|essential thrombocythemia myelofibrosis|essential thrombocythemia myelofibrosis
5167542|NCT00946257|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
5167543|NCT00946244|Early intervention|early intervention
5167544|NCT00946244|Mother-child interaction|mother-child interaction
5167545|NCT00946244|Neurodevelopment|neurodevelopment
5167546|NCT00946244|Parenting|parenting
5167547|NCT00946244|Prematurity|prematurity
5167548|NCT00946244|Preschool age|preschool age
5167549|NCT00946231|Heart Failure|heart failure
5167550|NCT00946231|BNP|bnp
5167551|NCT00946231|B-type natriuretic peptide|b-type natriuretic peptide
5167552|NCT00946231|home testing|home testing
5167553|NCT00946205|rectal prolapse|rectal prolapse
5167554|NCT00946205|laparoscopic rectopexy|laparoscopic rectopexy
5167555|NCT00946205|obstructed defecation|obstructed defecation
5167556|NCT00946192|Amenorrhea|amenorrhea
5167557|NCT00946192|Adolescent|adolescent
5167558|NCT00946192|Endurance|endurance
5167559|NCT00946192|Athletes|athletes
5167560|NCT00946192|Females|females
5167561|NCT00946192|Osteopenia|osteopenia
5167562|NCT00946192|Osteoporosis|osteoporosis
5167563|NCT00946192|Estrogen|estrogen
5167564|NCT00946179|Influenza|influenza
5167565|NCT00946179|Influenza virus vaccine|influenza virus vaccine
5167566|NCT00946179|Split virion|split virion
5167567|NCT00946166|pneumonia|pneumonia
5167568|NCT00946166|statins|statins
5167569|NCT00946166|cytokines|cytokines
5167570|NCT00946153|Carcinoma|carcinoma
5167571|NCT00946153|Hepatocellular|hepatocellular
5167572|NCT00946140|Ovary|ovary
5167573|NCT00946140|MRI|mri
5167574|NCT00946140|08-132|08-132
5167575|NCT00946127|Normal Pressure Hydrocephalus|normal pressure hydrocephalus
5167576|NCT00946127|Communicating Hydrocephalus|communicating hydrocephalus
5167577|NCT00946127|Gait disorder|gait disorder
5167578|NCT00946127|Cognition|cognition
5167579|NCT00946127|Shunt|shunt
5167580|NCT00946127|Endoscopic Third Ventriculostomy.|endoscopic third ventriculostomy.
5167581|NCT00946101|randomized, double-blind, placebo-controlled|randomized, double-blind, placebo-controlled
5167582|NCT00946062|low vision|low vision
5167583|NCT00946062|ophthalmology|ophthalmology
5167584|NCT00946062|randomised controlled trial|randomised controlled trial
5167585|NCT00946062|mobility|mobility
5167586|NCT00946062|orientation|orientation
5167587|NCT00946062|cane|cane
5167588|NCT00946062|aged|aged
5167589|NCT00946049|Checking clinical antibacterial effect of Vicryl Plus compared to conventional Vicryl in intraoral surgery|checking clinical antibacterial effect of vicryl plus compared to conventional vicryl in intraoral surgery
5167590|NCT00946049|Bacteria|bacteria
5167591|NCT00946023|lymphoma|lymphoma
5167592|NCT00946023|non hodgkin lymphoma|non hodgkin lymphoma
5167593|NCT00946023|allogeneic|allogeneic
5167594|NCT00946023|bone marrow transplantation|bone marrow transplantation
5167596|NCT00946023|cyclophosphamide|cyclophosphamide
5167597|NCT00946023|rituximab|rituximab
5167598|NCT00946010|Hepatitis B|hepatitis b
5167599|NCT00946010|Hepatitis C|hepatitis c
5167600|NCT00946010|genotype|genotype
5167601|NCT00946010|DNA level|dna level
5167602|NCT00946010|RNA level|rna level
5167603|NCT00946010|Taiwan|taiwan
5167604|NCT00945997|misoprostol|misoprostol
5167605|NCT00945997|mifepristone|mifepristone
5167606|NCT00945997|medical abortion|medical abortion
5167607|NCT00945997|randomised controlled trial|randomised controlled trial
5167608|NCT00945984|Localized renal cell carcinoma|localized renal cell carcinoma
5167609|NCT00945971|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
5167610|NCT00945971|Catecholamine|catecholamine
5167611|NCT00945971|Children|children
5167612|NCT00945971|Physical Activity|physical activity
5167613|NCT00945958|Glaucoma|glaucoma
5167614|NCT00945958|Ocular hypertension|ocular hypertension
5167615|NCT00945945|Osteoarthritis, Knee|osteoarthritis, knee
5167616|NCT00945945|Pain|pain
5167617|NCT00945932|asthma|asthma
5167618|NCT00945932|GW870086X|gw870086x
5167619|NCT00945932|Efficacy|efficacy
5167620|NCT00945932|FEV1|fev1
5167621|NCT00945932|repeat-dose|repeat-dose
5167622|NCT00945919|Oral morphine|oral morphine
5167623|NCT00945919|oxycodone|oxycodone
5167624|NCT00945919|OPANA|opana
5167625|NCT00945919|Oxymorphone|oxymorphone
5167626|NCT00945919|pain|pain
5167627|NCT00945919|nociceptive|nociceptive
5167628|NCT00945919|neuropathic|neuropathic
5167629|NCT00945919|rotation|rotation
5167630|NCT00945919|titration|titration
5167631|NCT00945919|mixed origin non-cancer pain|mixed origin non-cancer pain
5167632|NCT00945906|Hereditary Factor XIII deficiency|hereditary factor xiii deficiency
5167633|NCT00945906|Factor XIII|factor xiii
5167634|NCT00945880|HCV|hcv
5167635|NCT00945880|Hepatitis C|hepatitis c
5167636|NCT00945880|Hepatitis|hepatitis
5167637|NCT00945867|flecainide|flecainide
5167638|NCT00945867|pharmacogenetics|pharmacogenetics
5167639|NCT00945854|wholegrain cereals|wholegrain cereals
5167640|NCT00945854|glycemic index|glycemic index
5167641|NCT00945854|metabolic syndrome|metabolic syndrome
5167642|NCT00945854|insulin sensitivity|insulin sensitivity
5167643|NCT00945841|influenza vaccine|influenza vaccine
5167644|NCT00945841|vaccine|vaccine
5167645|NCT00945828|pediatric cancer, neurocognitive outcomes for pediatric cancer|pediatric cancer, neurocognitive outcomes for pediatric cancer
5167646|NCT00945828|acute lymphoblastic leukemia|acute lymphoblastic leukemia
5167647|NCT00945828|central nervous system tumors|central nervous system tumors
5167648|NCT00945828|lymphoma|lymphoma
5167649|NCT00945815|B-cell adult acute lymphoblastic leukemia|b-cell adult acute lymphoblastic leukemia
5167650|NCT00945815|L1 adult acute lymphoblastic leukemia|l1 adult acute lymphoblastic leukemia
5167651|NCT00945815|L2 adult acute lymphoblastic leukemia|l2 adult acute lymphoblastic leukemia
5167652|NCT00945815|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5167653|NCT00945789|Asphyxia neonatorum|asphyxia neonatorum
5167654|NCT00945789|Infants|infants
5167655|NCT00945789|EEG|eeg
5167656|NCT00945789|Brain MRI|brain mri
5167657|NCT00945789|Nitric oxide|nitric oxide
5167658|NCT00945776|OSA|osa
5167659|NCT00945776|CPAP|cpap
5167660|NCT00945763|Dental Pain|dental pain
5167661|NCT00945737|hypercholesterolemia|hypercholesterolemia
5167662|NCT00945737|cholesterol|cholesterol
5167663|NCT00945737|soy|soy
5167664|NCT00945711|dual diagnosis|dual diagnosis
5167665|NCT00945698|Stunting|stunting
5167666|NCT00945698|Growth failure|growth failure
5167667|NCT00945698|Malnutrition|malnutrition
5167668|NCT00945698|Lipid based nutrient supplement|lipid based nutrient supplement
5167669|NCT00945698|LNS|lns
5167670|NCT00945698|Prevention|prevention
5167671|NCT00945698|Malawi|malawi
5167672|NCT00945698|Sub-Saharan Africa|sub-saharan africa
5167673|NCT00945698|Dietary supplementation|dietary supplementation
5167674|NCT00945698|Efficacy|efficacy
5167675|NCT00945685|Skin Aging|skin aging
5167676|NCT00945685|Skin Wrinkling|skin wrinkling
5167677|NCT00945672|Alzheimer's disease amyloid imaging antibody|alzheimer's disease amyloid imaging antibody
5167678|NCT00945633|Obesity|obesity
5167679|NCT00945633|unhealthy weight gain|unhealthy weight gain
5167680|NCT00945620|Trans-abdominis block|trans-abdominis block
5167681|NCT00945620|post-cesarean|post-cesarean
5167682|NCT00945607|Complementary Medicine|complementary medicine
5167683|NCT00945607|Alternative Medicine|alternative medicine
5167684|NCT00945607|Breast Cancer|breast cancer
5167685|NCT00945594|flexible cystoscopy|flexible cystoscopy
5167686|NCT00945594|rigid cystoscopy|rigid cystoscopy
5167687|NCT00945594|bladder|bladder
5167688|NCT00945594|outcome assessment|outcome assessment
5167689|NCT00945594|pain measurement|pain measurement
5167690|NCT00945581|Healthy Elderly volunteers|healthy elderly volunteers
5167691|NCT00945568|QOL|qol
5167692|NCT00945568|liver|liver
5167693|NCT00945555|Antibacterials|antibacterials
5167694|NCT00945555|Classification of antibacterial agent|classification of antibacterial agent
5167695|NCT00945555|Febrile neutropenia|febrile neutropenia
5167696|NCT00945555|Turkey|turkey
5167697|NCT00945542|Trauma|trauma
5167698|NCT00945542|Coagulopathy|coagulopathy
5167699|NCT00945542|Transfusion|transfusion
5167700|NCT00945542|Plasma|plasma
5167701|NCT00945542|Massive Transfusion|massive transfusion
5167702|NCT00945529|Fontan|fontan
5167703|NCT00945516|Metal stent|metal stent
5167704|NCT00945516|Bile duct stricture|bile duct stricture
5167705|NCT00945516|Stent migration|stent migration
5167706|NCT00945516|Feasibility|feasibility
5167707|NCT00945516|Safety|safety
5167708|NCT00945516|Removability|removability
5167709|NCT00945503|Glycine Tranporter|glycine tranporter
5167710|NCT00945503|MRI|mri
5167711|NCT00945503|PET|pet
5167712|NCT00945490|Benign prostatic hyperplasia|benign prostatic hyperplasia
5167713|NCT00945490|BPH|bph
5167714|NCT00945490|Enlarged prostate|enlarged prostate
5167715|NCT00945451|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5167716|NCT00945451|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5167717|NCT00945451|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
5167718|NCT00945438|Influenza|influenza
5167719|NCT00945438|Influenza virus vaccine|influenza virus vaccine
5167720|NCT00945438|Split virion|split virion
5167721|NCT00945438|Intradermal|intradermal
5167722|NCT00945425|Phase I|phase i
5167723|NCT00945425|Volunteer|volunteer
5167724|NCT00945412|microdebrider tonsillotomy|microdebrider tonsillotomy
5167725|NCT00945412|Post-tonsillectomy hemorrhage|post-tonsillectomy hemorrhage
5167726|NCT00945386|children|children
5167727|NCT00945386|critically ill|critically ill
5167728|NCT00945386|furosemide|furosemide
5167729|NCT00945386|acoustic emission|acoustic emission
5167730|NCT00945373|rosacea|rosacea
5167731|NCT00945373|telangiectasias|telangiectasias
5167732|NCT00945373|topical treatment|topical treatment
5167733|NCT00945373|pulsed dye laser|pulsed dye laser
5167734|NCT00945360|Leiomyoma|leiomyoma
5167735|NCT00945360|perimenopause|perimenopause
5167736|NCT00945360|aromatase inhibitor|aromatase inhibitor
5167737|NCT00945347|Cystic fibrosis|cystic fibrosis
5167738|NCT00945347|miglustat|miglustat
5167739|NCT00945347|nasal instillation|nasal instillation
5167740|NCT00945347|nasal potential difference|nasal potential difference
5167741|NCT00945334|Constipation predominant Irritable Bowel Syndrome|constipation predominant irritable bowel syndrome
5167742|NCT00945308|Primary PCI|primary pci
5167743|NCT00945308|Acute myocardial infarction|acute myocardial infarction
5167744|NCT00945308|Myocardial blush|myocardial blush
5167745|NCT00945308|Primary coronary intervention in acute myocardial infarction|primary coronary intervention in acute myocardial infarction
5167746|NCT00945308|focusing on the effect of the study drug on the immediate TIMI|focusing on the effect of the study drug on the immediate timi
5167747|NCT00945308|flow at the infarct related artery and on the myocardial|flow at the infarct related artery and on the myocardial
5167748|NCT00945308|perfusion evaluated by the TIMI myocardial perfusion grade or|perfusion evaluated by the timi myocardial perfusion grade or
5167749|NCT00945308|blush|blush
5167750|NCT00945295|Cerebrovascular Accident/Rehabilitation|cerebrovascular accident/rehabilitation
5167751|NCT00945295|Muscle Spasticity|muscle spasticity
5167752|NCT00945295|Botulinum Neurotoxin Type A|botulinum neurotoxin type a
5167753|NCT00945295|Post-stroke focal upper limb spasticity|post-stroke focal upper limb spasticity
5167754|NCT00945282|IDX12899|idx12899
5167755|NCT00945282|adaptive|adaptive
5167756|NCT00945282|monotherapy|monotherapy
5167757|NCT00945282|pharmacokinetics|pharmacokinetics
5167758|NCT00945282|Treatment-naive|treatment-naive
5167759|NCT00945282|HIV-1|hiv-1
5167760|NCT00945282|GSK2248761|gsk2248761
5167761|NCT00945282|NNRTI|nnrti
5167762|NCT00945282|HIV Infections|hiv infections
5167763|NCT00945282|treatment naive|treatment naive
5167764|NCT00945256|metabolism|metabolism
5167765|NCT00945256|exercise|exercise
5167766|NCT00945256|sodium nitroprusside|sodium nitroprusside
5167767|NCT00945243|SCDD|scdd
5167768|NCT00945230|Neurosurgical outcome|neurosurgical outcome
5167769|NCT00945230|Actigraphy|actigraphy
5167770|NCT00945230|Treatment Response Measurement|treatment response measurement
5167771|NCT00945217|Atherogenic dyslipidemia|atherogenic dyslipidemia
5167772|NCT00945217|Non-HDL-C|non-hdl-c
5167773|NCT00945217|Postmenopausal women|postmenopausal women
5167774|NCT00945217|SAH gene family|sah gene family
5167775|NCT00945204|type 2 diabetes|type 2 diabetes
5167776|NCT00945204|intermediate care|intermediate care
5167777|NCT00945204|primary care|primary care
5167778|NCT00945204|randomised controlled trial|randomised controlled trial
5167779|NCT00945191|ovarian|ovarian
5167780|NCT00945191|cancer|cancer
5167781|NCT00945191|metastatic|metastatic
5167782|NCT00945191|locally|locally
5167783|NCT00945191|advanced|advanced
5167784|NCT00945191|chemotherapy|chemotherapy
5167785|NCT00945191|neoplasm|neoplasm
5167786|NCT00945178|Safety|safety
5167787|NCT00945178|Tolerability|tolerability
5167788|NCT00945178|Healthy|healthy
5167789|NCT00945178|Pharmacokinetics|pharmacokinetics
5167790|NCT00945165|Continuous Glucose Monitoring System|continuous glucose monitoring system
5167791|NCT00945165|Exercise|exercise
5167792|NCT00945152|Elimination of MRSA in open wounds|elimination of mrsa in open wounds
5167793|NCT00945152|MRSA infected open wounds|mrsa infected open wounds
5167794|NCT00945126|Allogeneic stem cell transplantation in pediatric patients|allogeneic stem cell transplantation in pediatric patients
5167795|NCT00945126|CD3/CD19 depleted stem cells|cd3/cd19 depleted stem cells
5167796|NCT00945126|malignant and non-malignant high risk diseases|malignant and non-malignant high risk diseases
5167797|NCT00945113|pilot|pilot
5167798|NCT00945113|stammer|stammer
5167799|NCT00945113|stutter|stutter
5167800|NCT00945113|children|children
5167801|NCT00945113|randomised controlled trial|randomised controlled trial
5167802|NCT00945113|RCT|rct
5167803|NCT00945113|Speech and Language Therapy|speech and language therapy
5167804|NCT00945113|Stuttering|stuttering
5167805|NCT00945100|Amblyopia|amblyopia
5167806|NCT00945100|patching|patching
5167807|NCT00945100|occlusion|occlusion
5167808|NCT00945087|bacteriophage|bacteriophage
5167809|NCT00945087|bacteriophage preparation|bacteriophage preparation
5167810|NCT00945087|bacterial infection|bacterial infection
5167811|NCT00945087|antibiotic-resistant infection|antibiotic-resistant infection
5167812|NCT00945087|multidrug-resistant bacteria|multidrug-resistant bacteria
5167813|NCT00945087|MRSA|mrsa
5167814|NCT00945074|Acupuncture|acupuncture
5167815|NCT00945074|Moxibustion|moxibustion
5167816|NCT00945074|Traditional Chinese Medicine|traditional chinese medicine
5167817|NCT00945074|Complementary Medicine|complementary medicine
5167818|NCT00945074|Irritable Bowel Syndrome|irritable bowel syndrome
5167819|NCT00945074|IBS|ibs
5167820|NCT00945061|ductal breast carcinoma in situ|ductal breast carcinoma in situ
5167821|NCT00945061|recurrent breast cancer|recurrent breast cancer
5167822|NCT00945061|invasive ductal breast carcinoma|invasive ductal breast carcinoma
5167823|NCT00945061|medullary ductal breast carcinoma with lymphocytic infiltrate|medullary ductal breast carcinoma with lymphocytic infiltrate
5167824|NCT00945061|mucinous ductal breast carcinoma|mucinous ductal breast carcinoma
5167825|NCT00945061|papillary ductal breast carcinoma|papillary ductal breast carcinoma
5167826|NCT00945061|tubular ductal breast carcinoma|tubular ductal breast carcinoma
5167827|NCT00945061|male breast cancer|male breast cancer
5167828|NCT00945022|General Surgery|general surgery
5167829|NCT00944996|PACAP (Pituitary Adenylate Cyclase Activating Polypeptide)|pacap (pituitary adenylate cyclase activating polypeptide)
5167830|NCT00944996|Major Depression|major depression
5167831|NCT00944996|Receptors|receptors
5167832|NCT00944996|Gene polymorphism|gene polymorphism
5167833|NCT00944996|PACAP signaling system|pacap signaling system
5167834|NCT00944996|Etiology of major depression|etiology of major depression
5167835|NCT00944996|Mechanism of antidepressants action|mechanism of antidepressants action
5167836|NCT00944996|PACAP receptors gene polymorphism|pacap receptors gene polymorphism
5167837|NCT00944996|Pathogenesis of major depression|pathogenesis of major depression
5167838|NCT00944996|Responsiveness to the antidepressant drugs|responsiveness to the antidepressant drugs
5167839|NCT00944983|Hypertension|hypertension
5167840|NCT00944983|Hypotension|hypotension
5167841|NCT00944983|Clinical Validation|clinical validation
5167842|NCT00944983|Blood Pressure Accuracy|blood pressure accuracy
5167843|NCT00944983|ISO 81600 Standard|iso 81600 standard
5167844|NCT00944983|British Hypertension Society|british hypertension society
5167845|NCT00944983|European Society of Hypertension|european society of hypertension
5167846|NCT00944983|International Protocol|international protocol
5167847|NCT00944970|Coronary artery disease|coronary artery disease
5167848|NCT00944970|Angina|angina
5167849|NCT00944970|Anginal symptoms|anginal symptoms
5167850|NCT00944970|Ischemic heart disease|ischemic heart disease
5167851|NCT00944970|Ischemia|ischemia
5167852|NCT00944970|Single photon emission computed tomography|single photon emission computed tomography
5167853|NCT00944970|Pharmacologic stress|pharmacologic stress
5167854|NCT00944970|Myocardial perfusion imaging|myocardial perfusion imaging
5167855|NCT00944970|Suspected coronary artery disease|suspected coronary artery disease
5167856|NCT00944970|known coronary artery disease|known coronary artery disease
5167857|NCT00944970|typical or atypical anginal symptoms|typical or atypical anginal symptoms
5167858|NCT00944957|Raltegravir|raltegravir
5167859|NCT00944957|efavirenz|efavirenz
5167860|NCT00944957|anxiety|anxiety
5167861|NCT00944957|depression|depression
5167862|NCT00944957|sleep quality|sleep quality
5167863|NCT00944957|HIV|hiv
5167864|NCT00944957|NNRTI|nnrti
5167865|NCT00944957|Tritherapy|tritherapy
5167866|NCT00944957|compliance|compliance
5167867|NCT00944957|stocrin|stocrin
5167868|NCT00944957|treatment experienced|treatment experienced
5167869|NCT00944944|CORPUS UTERI,|corpus uteri,
5167870|NCT00944944|ENDOMETRIUM|endometrium
5167871|NCT00944944|FALLOPIAN TUBE|fallopian tube
5167872|NCT00944944|OVARY|ovary
5167873|NCT00944944|VAGINA|vagina
5167874|NCT00944944|Lymphedema|lymphedema
5167875|NCT00944944|Questionnaire|questionnaire
5167876|NCT00944944|Quality of Life|quality of life
5167877|NCT00944944|09-077|09-077
5167878|NCT00944944|Fallopian Tubes|fallopian tubes
5167879|NCT00944931|Cerebral Cortex|cerebral cortex
5167880|NCT00944931|Cognition|cognition
5167881|NCT00944931|Motor Cortex|motor cortex
5167882|NCT00944931|Cognitive Enhancement|cognitive enhancement
5167883|NCT00944931|Prefrontal Cortex|prefrontal cortex
5167884|NCT00944931|Healthy Volunteer|healthy volunteer
5167885|NCT00944918|Breast Cancer|breast cancer
5167886|NCT00944879|HIV|hiv
5167887|NCT00944879|vaccine|vaccine
5167888|NCT00944879|prevention|prevention
5167889|NCT00944879|HPV|hpv
5167890|NCT00944879|adolescents|adolescents
5167891|NCT00944853|zinc supplement|zinc supplement
5167892|NCT00944853|prevention|prevention
5167893|NCT00944853|zinc deficiency|zinc deficiency
5167894|NCT00944853|plasma zinc concentration|plasma zinc concentration
5167895|NCT00944840|Intermittent Preventive Treatment|intermittent preventive treatment
5167896|NCT00944840|Home based management of malaria|home based management of malaria
5167897|NCT00944827|Green Tea Extract|green tea extract
5167898|NCT00944827|Catechins|catechins
5167899|NCT00944827|Statin|statin
5167900|NCT00944827|atorvastatin|atorvastatin
5167901|NCT00944827|body composition|body composition
5167902|NCT00944827|visceral fat|visceral fat
5167904|NCT00944827|oxidative stress|oxidative stress
5167905|NCT00944827|quality of life|quality of life
5167906|NCT00944827|OGTT|ogtt
5167907|NCT00944827|OGIS|ogis
5167908|NCT00944827|ISI matsuda|isi matsuda
5167909|NCT00944814|Lipid-based nutrient supplement|lipid-based nutrient supplement
5167910|NCT00944814|Prevention of malnutrition|prevention of malnutrition
5167911|NCT00944814|Prevention of micronutrient deficiencies|prevention of micronutrient deficiencies
5167912|NCT00944814|Zinc|zinc
5167913|NCT00944801|glioblastoma|glioblastoma
5167914|NCT00944801|first-line|first-line
5167915|NCT00944801|clinical trial|clinical trial
5167916|NCT00944801|PEG-liposomal doxorubicin|peg-liposomal doxorubicin
5167917|NCT00944801|temozolomide|temozolomide
5167918|NCT00944801|radiotherapy|radiotherapy
5167919|NCT00944801|phase 1|phase 1
5167920|NCT00944801|phase 2|phase 2
5167921|NCT00944788|physical activity|physical activity
5167922|NCT00944788|aging|aging
5167923|NCT00944788|inpatients|inpatients
5167924|NCT00944788|quality of life|quality of life
5167925|NCT00944788|depression|depression
5167926|NCT00944775|Exercise|exercise
5167927|NCT00944775|Dialysis|dialysis
5167928|NCT00944775|Non-invasive cardiac measures|non-invasive cardiac measures
5167929|NCT00944775|Exercise trained patients|exercise trained patients
5167930|NCT00944775|Controls|controls
5167931|NCT00944762|Stroke|stroke
5167932|NCT00944749|H- ATG|h- atg
5167933|NCT00944749|Anti -Thymocyte Globulin|anti -thymocyte globulin
5167934|NCT00944749|Lymphocyte Immune Globulin|lymphocyte immune globulin
5167935|NCT00944749|Aplastic Anemia|aplastic anemia
5167936|NCT00944736|Crohn's Disease|crohn's disease
5167937|NCT00944736|Pediatric|pediatric
5167938|NCT00944736|VSL#3|vsl#3
5167939|NCT00944736|Permeability|permeability
5167940|NCT00944736|Probiotic|probiotic
5167941|NCT00944736|Zonulin|zonulin
5167942|NCT00944723|zinc fortification|zinc fortification
5167943|NCT00944723|zinc supplementation|zinc supplementation
5167944|NCT00944723|plasma zinc concentration|plasma zinc concentration
5167945|NCT00944710|Amblyopia|amblyopia
5167946|NCT00944710|atropine|atropine
5167947|NCT00944710|Plano lens|plano lens
5167948|NCT00944684|Chronic hepatitis C|chronic hepatitis c
5167949|NCT00944684|Antiviral treatment|antiviral treatment
5167950|NCT00944684|Ribavirin|ribavirin
5167951|NCT00944684|Sustained virological response|sustained virological response
5167952|NCT00944684|Hemolytic anemia|hemolytic anemia
5167953|NCT00944684|Erythropoetin|erythropoetin
5167954|NCT00944658|Ankylosing spondylitis|ankylosing spondylitis
5167955|NCT00944658|Imaging|imaging
5167956|NCT00944580|MAGE-A1|mage-a1
5167957|NCT00944580|MAGE-A3|mage-a3
5167958|NCT00944580|NY-ESO-1|ny-eso-1
5167959|NCT00944580|antigen|antigen
5167960|NCT00944580|vaccine|vaccine
5167961|NCT00944580|dendritic cells|dendritic cells
5167962|NCT00944580|immunohistochemistry|immunohistochemistry
5167963|NCT00944580|immunology|immunology
5167964|NCT00944567|Primary Mediastinal B-Cell Lymphoma|primary mediastinal b-cell lymphoma
5167965|NCT00944567|Positron emission tomography|positron emission tomography
5167966|NCT00944554|Relapse|relapse
5167967|NCT00944554|Smoking Cessation|smoking cessation
5167968|NCT00944554|Substance Abuse|substance abuse
5167969|NCT00944541|maraviroc|maraviroc
5167970|NCT00944541|immune restoration|immune restoration
5167971|NCT00944541|treatment intensification|treatment intensification
5167972|NCT00944528|Cancer of Breast|cancer of breast
5167973|NCT00944528|Cancer of the Breast|cancer of the breast
5167974|NCT00944528|Neoplasms, Breast|neoplasms, breast
5167975|NCT00944528|Single dose radiation|single dose radiation
5167976|NCT00944528|Radiotherapy|radiotherapy
5167977|NCT00944528|Preoperative|preoperative
5167978|NCT00944515|sinusitis|sinusitis
5167979|NCT00944515|azithromycin|azithromycin
5167980|NCT00944502|Neuralgy|neuralgy
5167981|NCT00944502|Dexamethasone|dexamethasone
5167982|NCT00944502|Complex Vitamins|complex vitamins
5167983|NCT00944502|Injection|injection
5167984|NCT00944502|Symptoms of neuralgy of various origins|symptoms of neuralgy of various origins
5167985|NCT00944489|Hypertension|hypertension
5167986|NCT00944489|Health-Related Quality of Life Adherence to the antihypertension treatment|health-related quality of life adherence to the antihypertension treatment
5167987|NCT00944489|Ambulatory Patients|ambulatory patients
5167988|NCT00944489|MINICHAL score|minichal score
5167989|NCT00944489|Treatment Adherence Scale (MMAS)|treatment adherence scale (mmas)
5167990|NCT00944489|Quality of life|quality of life
5167991|NCT00944489|Adherence to treatment|adherence to treatment
5167992|NCT00944476|Sarcoma|sarcoma
5167993|NCT00944476|soft tissue|soft tissue
5167994|NCT00944476|MRI|mri
5167995|NCT00944476|Questionnaire|questionnaire
5167996|NCT00944476|09-078|09-078
5167997|NCT00944463|advanced pancreatic cancer|advanced pancreatic cancer
5167998|NCT00944463|gemcitabine|gemcitabine
5167999|NCT00944463|simvastatin|simvastatin
5168000|NCT00944463|placebo|placebo
5168001|NCT00944437|Ventilation, Mechanical|ventilation, mechanical
5168002|NCT00944437|Positive-Pressure Respiration|positive-pressure respiration
5168003|NCT00944437|Continuous Positive Airway Pressure|continuous positive airway pressure
5168004|NCT00944424|Vitamin D in patients with metastatic breast cancer|vitamin d in patients with metastatic breast cancer
5168005|NCT00944398|Zinc fortification|zinc fortification
5168006|NCT00944398|Plasma zinc concentration|plasma zinc concentration
5168007|NCT00944398|Assessment of zinc status|assessment of zinc status
5168008|NCT00944372|Tumor|tumor
5168009|NCT00944372|somatostatin receptor|somatostatin receptor
5168010|NCT00944359|zinc supplementation|zinc supplementation
5168011|NCT00944359|diarrhea management|diarrhea management
5168012|NCT00944359|zinc deficiency|zinc deficiency
5168013|NCT00944359|malaria|malaria
5168014|NCT00944333|second generation DES|second generation des
5168015|NCT00944333|clopidogrel|clopidogrel
5168016|NCT00944333|dual platelet therapy|dual platelet therapy
5168017|NCT00944333|patients with documented silent ischemia|patients with documented silent ischemia
5168018|NCT00944333|unstable angina pectoris (Braunwald Classification)|unstable angina pectoris (braunwald classification)
5168019|NCT00944333|Diagnosis of angina pectoris (CCS)|diagnosis of angina pectoris (ccs)
5168020|NCT00944307|HIV|hiv
5168021|NCT00944307|antiretroviral|antiretroviral
5168022|NCT00944307|drug interaction|drug interaction
5168023|NCT00944307|human immunodeficiency virus|human immunodeficiency virus
5168024|NCT00944294|Coronary artery disease|coronary artery disease
5168025|NCT00944294|Angina|angina
5168026|NCT00944294|Anginal symptoms|anginal symptoms
5168027|NCT00944294|Ischemic heart disease|ischemic heart disease
5168028|NCT00944294|Ischemia|ischemia
5168029|NCT00944294|Single photon emission computed tomography|single photon emission computed tomography
5168030|NCT00944294|Pharmacologic stress|pharmacologic stress
5168031|NCT00944294|Myocardial perfusion imaging|myocardial perfusion imaging
5168032|NCT00944294|typical or atypical anginal symptoms|typical or atypical anginal symptoms
5168033|NCT00944294|Suspected coronary artery disease|suspected coronary artery disease
5168034|NCT00944294|known coronary artery disease|known coronary artery disease
5168035|NCT00944281|point-of-use fortification|point-of-use fortification
5168036|NCT00944281|zinc supplement|zinc supplement
5168037|NCT00944281|lipid-based nutrient supplement|lipid-based nutrient supplement
5168038|NCT00944281|zinc deficiency|zinc deficiency
5168039|NCT00944281|micronutrient deficiency|micronutrient deficiency
5168040|NCT00944281|anemia|anemia
5168041|NCT00944268|Passiflora, Crataegus and Salix|passiflora, crataegus and salix
5168042|NCT00944268|Mild and Moderate anxiety|mild and moderate anxiety
5168043|NCT00944268|Tablet|tablet
5168044|NCT00944268|To evaluate the efficacy and tolerability of the combination|to evaluate the efficacy and tolerability of the combination
5168045|NCT00944229|Heart Failure|heart failure
5168046|NCT00944229|omega 3|omega 3
5168047|NCT00944229|lovaza|lovaza
5168048|NCT00944229|VO2 max|vo2 max
5168049|NCT00944216|keratosis pilaris|keratosis pilaris
5168050|NCT00944203|jellyfish|jellyfish
5168051|NCT00944203|jellyfish venom|jellyfish venom
5168052|NCT00944203|jellyfish dermatitis|jellyfish dermatitis
5168053|NCT00944203|jellyfish stings|jellyfish stings
5168054|NCT00944203|Ipomea pes-caprae|ipomea pes-caprae
5168055|NCT00944190|pain|pain
5168056|NCT00944190|fatigue|fatigue
5168057|NCT00944190|depression|depression
5168058|NCT00944190|cognitive difficulties|cognitive difficulties
5168059|NCT00944190|self-management|self-management
5168060|NCT00944151|pain|pain
5168061|NCT00944151|UCSD|ucsd
5168062|NCT00944151|catheter|catheter
5168063|NCT00944151|nerve block|nerve block
5168064|NCT00944151|hernia|hernia
5168065|NCT00944151|post-surgery pain|post-surgery pain
5168066|NCT00944151|abdominal pain|abdominal pain
5168067|NCT00944151|pelvic pain|pelvic pain
5168068|NCT00944151|Transversus abdominal plane|transversus abdominal plane
5168069|NCT00944151|Hernia Repair|hernia repair
5168070|NCT00944151|Transversus Abdominal Plane Block|transversus abdominal plane block
5168071|NCT00944138|Obesity|obesity
5168072|NCT00944138|meditation|meditation
5168073|NCT00944138|chronic kidney disease|chronic kidney disease
5168074|NCT00944112|Intensive care|intensive care
5168075|NCT00944112|Blood Transfusion|blood transfusion
5168076|NCT00944112|Anemia|anemia
5168077|NCT00944099|intervention studies|intervention studies
5168078|NCT00944099|feeding behavior|feeding behavior
5168079|NCT00944099|eating frequency|eating frequency
5168080|NCT00944099|weight loss|weight loss
5168081|NCT00944099|dietary intake|dietary intake
5168082|NCT00944086|Recruitment|recruitment
5168083|NCT00944086|Oxygen Concentration|oxygen concentration
5168084|NCT00944086|pneumoperitoneum|pneumoperitoneum
5168085|NCT00944086|laparoscopy|laparoscopy
5168086|NCT00944073|H1N1, influenza A viruses, vaccine, infants, children|h1n1, influenza a viruses, vaccine, infants, children
5168087|NCT00944047|invasive breast cancer|invasive breast cancer
5168088|NCT00944047|HER2|her2
5168089|NCT00944047|primary breast cancer|primary breast cancer
5168090|NCT00944047|neo-adjuvant therapy|neo-adjuvant therapy
5168091|NCT00944047|Trastuzumab|trastuzumab
5168092|NCT00944047|Nab-paclitaxel|nab-paclitaxel
5168093|NCT00944034|Meningococcal meningitis|meningococcal meningitis
5168094|NCT00944034|prevention|prevention
5168095|NCT00944034|vaccination|vaccination
5168096|NCT00944034|toddler|toddler
5168097|NCT00944021|Early Bactericidal Activity|early bactericidal activity
5168098|NCT00944021|EBA|eba
5168099|NCT00944021|Pulmonary Tuberculosis|pulmonary tuberculosis
5168100|NCT00944021|PA-824|pa-824
5168101|NCT00944021|pretomanid|pretomanid
5168102|NCT00944008|Acute Lymphoblastic Leukemia (ALL)|acute lymphoblastic leukemia (all)
5168103|NCT00944008|Depocyte®|depocyte®
5168104|NCT00944008|Neuromeningeal relapse|neuromeningeal relapse
5168105|NCT00944008|Between 16 and 30 years old|between 16 and 30 years old
5168106|NCT00944008|Standard risk|standard risk
5168107|NCT00943995|End Stage Kidney Disease|end stage kidney disease
5168108|NCT00943995|Kidney Failure|kidney failure
5168109|NCT00943995|Short stature|short stature
5168110|NCT00943995|Growth Hormone therapy|growth hormone therapy
5168111|NCT00943982|Cystoid Macular Edema|cystoid macular edema
5168112|NCT00943982|Intermediate Uveitis|intermediate uveitis
5168113|NCT00943982|Uveitis|uveitis
5168114|NCT00943982|OCT|oct
5168115|NCT00943982|Interferon-Gamma (IFN-Gamma)|interferon-gamma (ifn-gamma)
5168116|NCT00943969|obesity|obesity
5168117|NCT00943969|gastric bypass|gastric bypass
5168118|NCT00943969|morphine|morphine
5168119|NCT00943969|pharmacokinetic|pharmacokinetic
5168120|NCT00943969|absorption|absorption
5168121|NCT00943956|stage III prostate cancer|stage iii prostate cancer
5168122|NCT00943956|stage IV prostate cancer|stage iv prostate cancer
5168123|NCT00943943|acute myelogenous leukemia|acute myelogenous leukemia
5168124|NCT00943943|AML|aml
5168125|NCT00943943|Leukemia|leukemia
5168126|NCT00943943|myeloid leukemias|myeloid leukemias
5168127|NCT00943943|mutated fms-like tyrosine kinase receptor-3|mutated fms-like tyrosine kinase receptor-3
5168128|NCT00943943|FLT3 Mutations|flt3 mutations
5168129|NCT00943943|G-CSF|g-csf
5168130|NCT00943943|Granulocyte Colony Stimulating Factor|granulocyte colony stimulating factor
5168131|NCT00943943|Filgrastim|filgrastim
5168132|NCT00943943|Neupogen|neupogen
5168133|NCT00943943|Plerixafor|plerixafor
5168134|NCT00943943|Mobozil|mobozil
5168135|NCT00943943|Sorafenib|sorafenib
5168136|NCT00943943|BAY 43-9006|bay 43-9006
5168137|NCT00943904|urinary leakage associated with urinary urgency|urinary leakage associated with urinary urgency
5168138|NCT00943904|unable to fully empty bladder|unable to fully empty bladder
5168139|NCT00943904|Comparison: Motor&Sensory Response to Interstim Stimulation|comparison: motor&sensory response to interstim stimulation
5168140|NCT00943878|H1N1, influenza A viruses, vaccine, elderly, TIV|h1n1, influenza a viruses, vaccine, elderly, tiv
5168141|NCT00943865|metabolic syndrome|metabolic syndrome
5168142|NCT00943865|lifestyle|lifestyle
5168143|NCT00943865|exercise|exercise
5168144|NCT00943865|endothelial dysfunction|endothelial dysfunction
5168145|NCT00943865|insulin sensitivity|insulin sensitivity
5168146|NCT00943865|lipids|lipids
5168147|NCT00943839|stage IV renal cell cancer|stage iv renal cell cancer
5168148|NCT00943813|communication|communication
5168149|NCT00943813|survey|survey
5168150|NCT00943813|video|video
5168151|NCT00943813|09-043|09-043
5168152|NCT00943800|Appropriate candidate for transplantation|appropriate candidate for transplantation
5168153|NCT00943800|An HLA-identical related or unrelated donor cannot be identified within an appropriate time frame.|an hla-identical related or unrelated donor cannot be identified within an appropriate time frame.
5168154|NCT00943774|Physiology|physiology
5168155|NCT00943774|Phenotype|phenotype
5168156|NCT00943774|Genetics|genetics
5168157|NCT00943774|Genomics|genomics
5168158|NCT00943774|Stress|stress
5168159|NCT00943774|Baroreflex|baroreflex
5168160|NCT00943774|Blood Pressure|blood pressure
5168161|NCT00943774|Arterial stiffness|arterial stiffness
5168162|NCT00943761|hepatitis C|hepatitis c
5168163|NCT00943735|Overactive Bladder Incontinence Adherence Behavioral interventions|overactive bladder incontinence adherence behavioral interventions
5168164|NCT00943709|hyperglycemia|hyperglycemia
5168165|NCT00943709|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5168166|NCT00943709|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
5168167|NCT00943709|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5168168|NCT00943709|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5168169|NCT00943709|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5168170|NCT00943709|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5168171|NCT00943709|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5168172|NCT00943709|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5168173|NCT00943709|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
5168174|NCT00943670|MBC|mbc
5168175|NCT00943670|TDM1|tdm1
5168176|NCT00943670|Armed Herceptin|armed herceptin
5168177|NCT00943670|Herceptin|herceptin
5168178|NCT00943670|Trastuzumab emtansine|trastuzumab emtansine
5168179|NCT00943644|MBI|mbi
5168180|NCT00943644|Breast|breast
5168181|NCT00943644|Breast Cancer|breast cancer
5168182|NCT00943631|H1N1, influenza A viruses, vaccine, elderly|h1n1, influenza a viruses, vaccine, elderly
5168183|NCT00943618|Smoking Cessation|smoking cessation
5168184|NCT00943618|Nicotine Withdrawal|nicotine withdrawal
5168185|NCT00943618|Smoking Reduction|smoking reduction
5168186|NCT00943618|Varenicline|varenicline
5168187|NCT00943618|Chantix|chantix
5168188|NCT00943618|Bupropion|bupropion
5168189|NCT00943618|Zyban|zyban
5168190|NCT00943605|Mastectomy|mastectomy
5168191|NCT00943605|PlasmaBlade|plasmablade
5168192|NCT00943605|Electrosurgery|electrosurgery
5168193|NCT00943605|PEAK Surgical|peak surgical
5168194|NCT00943605|Medtronic Advanced Energy|medtronic advanced energy
5168195|NCT00943605|Medtronic|medtronic
5168196|NCT00943592|Melphalan|melphalan
5168197|NCT00943592|Alemtuzumab|alemtuzumab
5168198|NCT00943592|Clofarabine|clofarabine
5168199|NCT00943579|autism|autism
5168200|NCT00943579|autistic disorder|autistic disorder
5168201|NCT00943579|tetrahydrobiopterin|tetrahydrobiopterin
5168202|NCT00943579|sapropterin|sapropterin
5168203|NCT00943579|treatment|treatment
5168204|NCT00943566|Pain|pain
5168205|NCT00943566|Cancer|cancer
5168206|NCT00943566|Morphine|morphine
5168207|NCT00943553|AML|aml
5168208|NCT00943540|pharmacokinetics|pharmacokinetics
5168209|NCT00943540|single dose|single dose
5168210|NCT00943540|raltegravir|raltegravir
5168211|NCT00943540|Treatment experienced|treatment experienced
5168212|NCT00943527|Breast|breast
5168213|NCT00943527|Menstrual Cycle|menstrual cycle
5168214|NCT00943527|Breast Cancer|breast cancer
5168215|NCT00943527|Hormone|hormone
5168216|NCT00943527|MBI|mbi
5168217|NCT00943527|Molecular Breast Imaging|molecular breast imaging
5168218|NCT00943527|Breast Imaging|breast imaging
5168219|NCT00943514|Primary Ciliary Dyskinesia|primary ciliary dyskinesia
5168220|NCT00943514|Variant Cystic Fibrosis|variant cystic fibrosis
5168221|NCT00943514|Bronchopulmonary Mycosis|bronchopulmonary mycosis
5168222|NCT00943514|Airway Infection Susceptibility|airway infection susceptibility
5168223|NCT00943514|Chronic Respiratory Infection|chronic respiratory infection
5168224|NCT00943514|Bronchiectasis|bronchiectasis
5168225|NCT00943488|influenza A viruses, H1N1, elderly|influenza a viruses, h1n1, elderly
5168226|NCT00943475|DPNB, pain, hemodynamics effects, circumcision|dpnb, pain, hemodynamics effects, circumcision
5168227|NCT00943449|Hepatocellular Carcinoma|hepatocellular carcinoma
5168228|NCT00943449|Sorafenib|sorafenib
5168229|NCT00943449|HDAC|hdac
5168230|NCT00943449|4SC-201|4sc-201
5168231|NCT00943449|Phase II|phase ii
5168232|NCT00943449|Resminostat|resminostat
5168233|NCT00943436|Exercise|exercise
5168234|NCT00943436|Sedentary|sedentary
5168235|NCT00943436|Energy Expenditure|energy expenditure
5168236|NCT00943436|Energy Balance|energy balance
5168237|NCT00943436|Macronutrient Intake|macronutrient intake
5168238|NCT00943436|Energy and Macronutrient intake|energy and macronutrient intake
5168239|NCT00943436|Exercise and Energy Balance|exercise and energy balance
5168240|NCT00943423|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
5168241|NCT00943423|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
5168242|NCT00943410|HER2-positive breast cancer|her2-positive breast cancer
5168243|NCT00943410|inflammatory breast cancer|inflammatory breast cancer
5168244|NCT00943410|recurrent breast cancer|recurrent breast cancer
5168245|NCT00943410|stage IIIA breast cancer|stage iiia breast cancer
5168246|NCT00943410|stage IIIB breast cancer|stage iiib breast cancer
5168247|NCT00943410|stage IIIC breast cancer|stage iiic breast cancer
5168248|NCT00943410|stage IV breast cancer|stage iv breast cancer
5168249|NCT00943358|influenza|influenza
5168250|NCT00943358|immunogenicity|immunogenicity
5168251|NCT00943358|vaccine|vaccine
5168252|NCT00943345|GI|gi
5168253|NCT00943345|gastrointestinal|gastrointestinal
5168254|NCT00943345|permeability|permeability
5168255|NCT00943345|indometacin|indometacin
5168256|NCT00943345|indomethacin|indomethacin
5168257|NCT00943345|coeliac|coeliac
5168258|NCT00943332|Orthopedic Procedures|orthopedic procedures
5168259|NCT00943332|Fracture Fixation, Internal|fracture fixation, internal
5168260|NCT00943332|Fracture Fixation, External|fracture fixation, external
5168261|NCT00943332|femur fracture|femur fracture
5168262|NCT00943332|pediatrics|pediatrics
5168263|NCT00943319|Cancers of the blood|cancers of the blood
5168264|NCT00943306|Homozygous|homozygous
5168265|NCT00943306|Familial|familial
5168266|NCT00943306|Hypercholesterolemia|hypercholesterolemia
5168267|NCT00943306|MTP|mtp
5168268|NCT00943306|Apheresis|apheresis
5168269|NCT00943306|lomitapide|lomitapide
5168270|NCT00943306|Homozygous Familial Hypercholesterolemia (HoFH)|homozygous familial hypercholesterolemia (hofh)
5168271|NCT00943293|GVHD|gvhd
5168272|NCT00943280|probability of patient participation in each of the Groups 1, 2 and 3.|probability of patient participation in each of the groups 1, 2 and 3.
5168273|NCT00943280|Identification of factors predicting poor participation in screening for Barrett's esophagus.|identification of factors predicting poor participation in screening for barrett's esophagus.
5168274|NCT00943267|Activated Protein C|activated protein c
5168275|NCT00943267|Lipopolysaccharides|lipopolysaccharides
5168276|NCT00943267|Inflammation, Pulmonary|inflammation, pulmonary
5168277|NCT00943254|Metabolic Cardiovascular Syndrome|metabolic cardiovascular syndrome
5168278|NCT00943241|Breast|breast
5168279|NCT00943241|Breast Cancer|breast cancer
5168280|NCT00943241|MBI|mbi
5168281|NCT00943241|Molecular Breast Imaging|molecular breast imaging
5168282|NCT00943241|Molecular Imaging|molecular imaging
5168283|NCT00943228|Renal transplantation|renal transplantation
5168284|NCT00943228|Adequate exposure|adequate exposure
5168285|NCT00943228|Acute rejection|acute rejection
5168286|NCT00943228|mycophenolate mofetil|mycophenolate mofetil
5168287|NCT00943228|immunosuppression|immunosuppression
5168288|NCT00943215|CALERIE II Follow-up|calerie ii follow-up
5168590|NCT00942071|Vaccine|vaccine
5168289|NCT00943202|H1N1, influenza A viruses, TIV, vaccine, infants, children|h1n1, influenza a viruses, tiv, vaccine, infants, children
5168290|NCT00943189|Fetal anomalies scan at the time of NT study|fetal anomalies scan at the time of nt study
5168291|NCT00943176|Fatigue|fatigue
5168292|NCT00943163|cyclorotation|cyclorotation
5168293|NCT00943163|pupil|pupil
5168294|NCT00943163|laser refractive surgery|laser refractive surgery
5168295|NCT00943150|Abdominoplasty|abdominoplasty
5168296|NCT00943150|PlasmaBlade|plasmablade
5168297|NCT00943150|Electrosurgery|electrosurgery
5168298|NCT00943150|PEAK Surgical|peak surgical
5168299|NCT00943150|Medtronic Advanced Energy|medtronic advanced energy
5168300|NCT00943150|Medtronic|medtronic
5168301|NCT00943111|Gaucher disease,|gaucher disease,
5168302|NCT00943111|Genz-112638,|genz-112638,
5168303|NCT00943111|beta-glucosidase,|beta-glucosidase,
5168304|NCT00943111|acid ß-glucosidase,|acid ß-glucosidase,
5168305|NCT00943111|glucocerebrosidase,|glucocerebrosidase,
5168306|NCT00943111|glucosylceramide,|glucosylceramide,
5168307|NCT00943111|D-glucosyl-N-acylsphingosine glucohydrolase,|d-glucosyl-n-acylsphingosine glucohydrolase,
5168308|NCT00943111|substrate reduction therapy|substrate reduction therapy
5168309|NCT00943085|Early Signs of Bipolar Disorder|early signs of bipolar disorder
5168310|NCT00943085|High Risk Youth|high risk youth
5168311|NCT00943085|Adolescence|adolescence
5168312|NCT00943085|Childhood|childhood
5168313|NCT00943072|Macular edema|macular edema
5168314|NCT00943072|Retinal vein occlusion|retinal vein occlusion
5168315|NCT00943072|CRVO|crvo
5168316|NCT00943072|VEGF Trap-Eye|vegf trap-eye
5168317|NCT00943072|best-corrected visual acuity|best-corrected visual acuity
5168318|NCT00943072|Regeneron|regeneron
5168319|NCT00943072|COPERNICUS|copernicus
5168320|NCT00943059|Mitochondrial function|mitochondrial function
5168321|NCT00943059|Diabetes|diabetes
5168322|NCT00943059|Cardiomyopathy|cardiomyopathy
5168323|NCT00943059|insulin resistance|insulin resistance
5168324|NCT00943059|lipid lowering|lipid lowering
5168325|NCT00943059|triglycerides|triglycerides
5168326|NCT00943059|Acipimox|acipimox
5168327|NCT00943046|leads|leads
5168328|NCT00943046|pacemaker|pacemaker
5168329|NCT00943046|efficacy|efficacy
5168330|NCT00943046|safety|safety
5168331|NCT00943033|MBCT|mbct
5168332|NCT00943033|Mindfulness-Based Cognitive Therapy|mindfulness-based cognitive therapy
5168333|NCT00943033|Mindfulness|mindfulness
5168334|NCT00943033|Meditation|meditation
5168335|NCT00943033|Relapse Prevention|relapse prevention
5168336|NCT00943033|Recurrent Depression|recurrent depression
5168337|NCT00943033|Depression|depression
5168338|NCT00943033|Major Depressive Disorder|major depressive disorder
5168339|NCT00943020|Dietary supplement|dietary supplement
5168340|NCT00943020|Carbohydrate loading|carbohydrate loading
5168341|NCT00943020|Healthy volunteers|healthy volunteers
5168342|NCT00943020|Anaesthesia|anaesthesia
5168343|NCT00943020|Surgery|surgery
5168344|NCT00943020|Glutamine|glutamine
5168345|NCT00942994|Hypertension|hypertension
5168346|NCT00942994|Aliskiren|aliskiren
5168347|NCT00942994|Amlodipine|amlodipine
5168348|NCT00942994|HCTZ|hctz
5168349|NCT00942994|Systolic blood pressure|systolic blood pressure
5168350|NCT00942994|Diastolic blood pressure|diastolic blood pressure
5168351|NCT00942994|Stage II|stage ii
5168352|NCT00942994|Combination|combination
5168353|NCT00942981|PET Study|pet study
5168354|NCT00942981|(18F) Fallypride|(18f) fallypride
5168355|NCT00942981|(11C)NNC-112|(11c)nnc-112
5168356|NCT00942981|Schizoaffective Disorder|schizoaffective disorder
5168357|NCT00942981|Schizophrenia|schizophrenia
5168358|NCT00942981|Healthy Volunteer|healthy volunteer
5168359|NCT00942981|HV|hv
5168360|NCT00942929|anorexia nervosa|anorexia nervosa
5168361|NCT00942929|adolescents|adolescents
5168362|NCT00942929|lung function tests|lung function tests
5168363|NCT00942929|refeeding|refeeding
5168364|NCT00942916|Make sure the difference of the serum inflammatory marker between the two groups|make sure the difference of the serum inflammatory marker between the two groups
5168365|NCT00942903|HME|hme
5168366|NCT00942903|Provox|provox
5168367|NCT00942903|voice prosthesis|voice prosthesis
5168368|NCT00942903|laryngectomy|laryngectomy
5168369|NCT00942890|Case Management|case management
5168370|NCT00942890|Amputation|amputation
5168371|NCT00942890|Muscle strength|muscle strength
5168372|NCT00942890|phantom limb pain|phantom limb pain
5168373|NCT00942877|VEGF|vegf
5168374|NCT00942877|Antiangiogenesis|antiangiogenesis
5168375|NCT00942877|Tyrosine Kinase Inhibitor|tyrosine kinase inhibitor
5168376|NCT00942877|Advanced Cancer|advanced cancer
5168377|NCT00942877|Alveolar Soft Part Sarcoma|alveolar soft part sarcoma
5168378|NCT00942877|Sarcoma|sarcoma
5168379|NCT00942851|Dystonia|dystonia
5168380|NCT00942851|Blepharospasm|blepharospasm
5168381|NCT00942851|Botulinum Toxin|botulinum toxin
5168382|NCT00942851|Treatment|treatment
5168383|NCT00942851|Clinical Trial|clinical trial
5168384|NCT00942851|Focal Dystonia|focal dystonia
5168385|NCT00942838|Recurrent Ovarian Carcinoma|recurrent ovarian carcinoma
5168386|NCT00942838|Cancer|cancer
5168387|NCT00942825|NSCL|nscl
5168388|NCT00942825|non-squamous non small cell lung cancer|non-squamous non small cell lung cancer
5168389|NCT00942825|Lung Cancer|lung cancer
5168391|NCT00942825|non-squamous|non-squamous
5168392|NCT00942825|metastatic|metastatic
5168393|NCT00942825|pleural effusion|pleural effusion
5168394|NCT00942825|Stage IIIb|stage iiib
5168395|NCT00942825|Stage IV|stage iv
5168396|NCT00942825|NSCLC|nsclc
5168397|NCT00942812|Children|children
5168398|NCT00942812|Recovery|recovery
5168399|NCT00942812|Diarrhea Pack|diarrhea pack
5168400|NCT00942812|Social Marketing|social marketing
5168401|NCT00942799|Genz-644282|genz-644282
5168402|NCT00942799|Topoisomerase I inhibitors|topoisomerase i inhibitors
5168403|NCT00942799|Top1|top1
5168404|NCT00942799|solid tumors|solid tumors
5168405|NCT00942799|dose-escalation|dose-escalation
5168406|NCT00942799|pharmacokinetic (PK)|pharmacokinetic (pk)
5168407|NCT00942799|MTD (Maximum Tolerated Dose)|mtd (maximum tolerated dose)
5168408|NCT00942799|oncology|oncology
5168409|NCT00942799|cancer|cancer
5168410|NCT00942786|natriuretic peptides|natriuretic peptides
5168411|NCT00942786|emergency non-cardiac surgery|emergency non-cardiac surgery
5168412|NCT00942773|Healthy volunteer|healthy volunteer
5168413|NCT00942747|temsirolimus, primary CNS lymphoma, PCNSL, salvage treatment|temsirolimus, primary cns lymphoma, pcnsl, salvage treatment
5168414|NCT00942734|Head and Neck|head and neck
5168415|NCT00942734|Squamous Cell Carcinoma|squamous cell carcinoma
5168416|NCT00942734|RAD001|rad001
5168417|NCT00942734|Erlotinib|erlotinib
5168418|NCT00942734|Everolimus|everolimus
5168419|NCT00942734|OSI-774|osi-774
5168420|NCT00942734|Tarceva|tarceva
5168421|NCT00942721|Web-based Intervention|web-based intervention
5168422|NCT00942721|CBT Treatment|cbt treatment
5168423|NCT00942708|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
5168424|NCT00942708|Pulmonary Hypertension|pulmonary hypertension
5168425|NCT00942695|pistachio|pistachio
5168426|NCT00942695|nuts|nuts
5168427|NCT00942695|energy value|energy value
5168428|NCT00942695|cardiovascular disease|cardiovascular disease
5168429|NCT00942695|phytonutrient|phytonutrient
5168430|NCT00942695|gene expression|gene expression
5168431|NCT00942695|energy value of pistachio nuts|energy value of pistachio nuts
5168432|NCT00942682|sorafenib|sorafenib
5168433|NCT00942682|RAD001|rad001
5168434|NCT00942669|Sleep Apnea Syndrome|sleep apnea syndrome
5168435|NCT00942669|SAS|sas
5168436|NCT00942669|SleepStrip OTC|sleepstrip otc
5168437|NCT00942656|trans fatty acids|trans fatty acids
5168438|NCT00942656|ruminant|ruminant
5168439|NCT00942656|cardiovascular disease|cardiovascular disease
5168440|NCT00942630|percutaneous|percutaneous
5168441|NCT00942630|transhepatic|transhepatic
5168442|NCT00942630|biliary|biliary
5168443|NCT00942630|drainage|drainage
5168444|NCT00942630|cholangioscopy|cholangioscopy
5168445|NCT00942617|platelet aggregation|platelet aggregation
5168446|NCT00942617|granule secretion|granule secretion
5168447|NCT00942617|thromboxane production|thromboxane production
5168448|NCT00942617|cyclooxygenase-1|cyclooxygenase-1
5168449|NCT00942617|ATP release|atp release
5168450|NCT00942617|aspirin resistance|aspirin resistance
5168451|NCT00942617|platelet activation|platelet activation
5168452|NCT00942617|flow cytometry|flow cytometry
5168453|NCT00942617|Platelet aggregation in healthy volunteers|platelet aggregation in healthy volunteers
5168454|NCT00942604|Peplin|peplin
5168455|NCT00942604|Actinic keratosis|actinic keratosis
5168456|NCT00942604|PEP005|pep005
5168457|NCT00942591|multiple sclerosis|multiple sclerosis
5168458|NCT00942591|interferon beta|interferon beta
5168459|NCT00942591|atorvastatin|atorvastatin
5168460|NCT00942578|Dual Antiangiogenic Combination Therapy for mCRPC|dual antiangiogenic combination therapy for mcrpc
5168461|NCT00942578|Efficacy and Toxicity Profile|efficacy and toxicity profile
5168462|NCT00942578|Single Stage Phase 2 With Early Stopping, Run In Phase For Toxicity|single stage phase 2 with early stopping, run in phase for toxicity
5168585|NCT00942084|Pharmacokinetics|pharmacokinetics
5168463|NCT00942578|Correlative Measurements|correlative measurements
5168464|NCT00942578|Overall Survival Assessment|overall survival assessment
5168465|NCT00942578|Metastatic Prostate Cancer|metastatic prostate cancer
5168466|NCT00942578|Prostate Cancer|prostate cancer
5168467|NCT00942565|Open gynecological surgery|open gynecological surgery
5168468|NCT00942539|Neonates|neonates
5168469|NCT00942526|esophageal cancer|esophageal cancer
5168470|NCT00942526|anastomotic leakage|anastomotic leakage
5168471|NCT00942526|Prevention of anastomotic leakage after esophageal surgery|prevention of anastomotic leakage after esophageal surgery
5168472|NCT00942513|substrate absorption|substrate absorption
5168473|NCT00942513|substrate oxidation|substrate oxidation
5168474|NCT00942513|glucose regulation|glucose regulation
5168475|NCT00942513|whey protein|whey protein
5168476|NCT00942513|soy protein|soy protein
5168477|NCT00942513|sucrose|sucrose
5168478|NCT00942513|fructose|fructose
5168479|NCT00942513|lactose|lactose
5168480|NCT00942500|Post-conditioning|post-conditioning
5168481|NCT00942500|ST-elevation myocardial infarction|st-elevation myocardial infarction
5168482|NCT00942500|Angioplasty, Transluminal, Percutaneous Coronary|angioplasty, transluminal, percutaneous coronary
5168483|NCT00942487|arterial hypertension|arterial hypertension
5168484|NCT00942474|The focus of the study is to assess the ability of the nerve access tool to facilitate nerve lead placement|the focus of the study is to assess the ability of the nerve access tool to facilitate nerve lead placement
5168487|NCT00942461|Inflammatory Cytokines|inflammatory cytokines
5168488|NCT00942461|CRP|crp
5168489|NCT00942461|No metastases|no metastases
5168490|NCT00942461|No other obvious inflammation|no other obvious inflammation
5168491|NCT00942461|No chronic diseases|no chronic diseases
5168492|NCT00942435|YM150|ym150
5168493|NCT00942435|Bleeding|bleeding
5168494|NCT00942435|VTE|vte
5168495|NCT00942435|FXa inhibitor|fxa inhibitor
5168496|NCT00942435|Deep Vein Thrombosis|deep vein thrombosis
5168497|NCT00942435|Venous thromboembolism|venous thromboembolism
5168498|NCT00942422|monoclonal gammopathy of undetermined significance|monoclonal gammopathy of undetermined significance
5168499|NCT00942422|smoldering multiple myeloma|smoldering multiple myeloma
5168500|NCT00942396|Mammography|mammography
5168501|NCT00942383|liver tumor|liver tumor
5168502|NCT00942383|liver tumors|liver tumors
5168503|NCT00942383|liver cancer|liver cancer
5168504|NCT00942383|hepatocellular carcinoma|hepatocellular carcinoma
5168505|NCT00942383|metastatic colorectal cancer|metastatic colorectal cancer
5168506|NCT00942383|metastatic cancer to the liver|metastatic cancer to the liver
5168507|NCT00942383|metastatic cancer|metastatic cancer
5168508|NCT00942383|metastatic neuroendocrine cancer|metastatic neuroendocrine cancer
5168509|NCT00942383|liver|liver
5168510|NCT00942383|liver surgery|liver surgery
5168511|NCT00942383|radiofrequency ablation|radiofrequency ablation
5168512|NCT00942383|microwave ablation|microwave ablation
5168513|NCT00942370|mechanography|mechanography
5168514|NCT00942370|electromyography|electromyography
5168515|NCT00942370|effort cough|effort cough
5168516|NCT00942344|Amlodipine|amlodipine
5168517|NCT00942344|Losartan|losartan
5168518|NCT00942344|Hypertension|hypertension
5168519|NCT00942318|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
5168520|NCT00942318|Continuous subcutaneous insulin infusion|continuous subcutaneous insulin infusion
5168521|NCT00942318|Insulin external pump|insulin external pump
5168522|NCT00942318|Multiple daily injections|multiple daily injections
5168523|NCT00942318|Basal-bolus regimen|basal-bolus regimen
5168524|NCT00942318|Education|education
5168525|NCT00942305|Allogeneic stem cell transplant|allogeneic stem cell transplant
5168526|NCT00942305|CMV seropositive (R+)|cmv seropositive (r+)
5168527|NCT00942305|transplant|transplant
5168528|NCT00942305|Allogeneic stem cell transplant recipients who were CMV seropositive (R+) at the time of transplant will be eligible for enrollment|allogeneic stem cell transplant recipients who were cmv seropositive (r+) at the time of transplant will be eligible for enrollment
5168529|NCT00942292|Hepatic|hepatic
5168530|NCT00942292|colorectal|colorectal
5168531|NCT00942292|metastases|metastases
5168532|NCT00942292|TPN|tpn
5168533|NCT00942292|Fish oil|fish oil
5168534|NCT00942253|RLS|rls
5168535|NCT00942253|Muscle|muscle
5168536|NCT00942253|Dialysis|dialysis
5168537|NCT00942253|exercise|exercise
5168538|NCT00942253|dopamine agonist|dopamine agonist
5168539|NCT00942253|Sleep|sleep
5168540|NCT00942227|Sciatica|sciatica
5168541|NCT00942227|Radiculopathy|radiculopathy
5168542|NCT00942227|Physical therapy modalities|physical therapy modalities
5168543|NCT00942227|Rehabilitation|rehabilitation
5168544|NCT00942214|Multiple sclerosis|multiple sclerosis
5168545|NCT00942214|natalizumab|natalizumab
5168546|NCT00942214|pharmacogenomics|pharmacogenomics
5168547|NCT00942201|Asthma|asthma
5168548|NCT00942201|Dexamethasone|dexamethasone
5168549|NCT00942201|Emergency Department|emergency department
5168550|NCT00942188|Diabetes|diabetes
5168551|NCT00942188|Type 2 Diabetes|type 2 diabetes
5168552|NCT00942175|Pharmacology|pharmacology
5168553|NCT00942175|Stomach Ulcer|stomach ulcer
5168554|NCT00942175|Esophagitis, Peptic|esophagitis, peptic
5168555|NCT00942175|Zollinger-Ellison Syndrome|zollinger-ellison syndrome
5168556|NCT00942175|Platelet function|platelet function
5168557|NCT00942175|PPI|ppi
5168558|NCT00942175|clopidogrel|clopidogrel
5168559|NCT00942175|Pharmacokinetics and Pharmacodynamics|pharmacokinetics and pharmacodynamics
5168560|NCT00942162|PREDICT|predict
5168561|NCT00942162|ASCI|asci
5168562|NCT00942162|Tumor antigen|tumor antigen
5168563|NCT00942162|Melanoma|melanoma
5168564|NCT00942162|Immunotherapeutic|immunotherapeutic
5168565|NCT00942149|Infants|infants
5168566|NCT00942149|Daptomycin|daptomycin
5168567|NCT00942136|HIV|hiv
5168568|NCT00942136|GSK1349572|gsk1349572
5168569|NCT00942136|omeprazole|omeprazole
5168570|NCT00942136|Prilosec|prilosec
5168571|NCT00942136|supratherapeutic dose|supratherapeutic dose
5168572|NCT00942136|pharmacokinetics|pharmacokinetics
5168573|NCT00942136|drug interaction|drug interaction
5168574|NCT00942136|HIV Infections|hiv infections
5168575|NCT00942110|Postprandial glucose, lipid metabolism|postprandial glucose, lipid metabolism
5168576|NCT00942110|humoral factors|humoral factors
5168577|NCT00942097|Homeopathy|homeopathy
5168578|NCT00942097|overweight|overweight
5168579|NCT00942097|obesity|obesity
5168580|NCT00942097|mental disorder|mental disorder
5168581|NCT00942097|pregnancy|pregnancy
5168582|NCT00942097|Overweight pregnant women with suspicious mental disorder|overweight pregnant women with suspicious mental disorder
5168583|NCT00942084|HSV|hsv
5168584|NCT00942084|Acyclovir|acyclovir
5168586|NCT00942084|Neonate|neonate
5168587|NCT00942084|Premature|premature
5168591|NCT00942058|biological markers|biological markers
5168592|NCT00942058|CA9 protein|ca9 protein
5168593|NCT00942058|metastatic conventional renal cell cancer|metastatic conventional renal cell cancer
5168594|NCT00942058|kidney cancer|kidney cancer
5168595|NCT00942045|cervical spine|cervical spine
5168596|NCT00942045|ACDF|acdf
5168597|NCT00942045|biologics|biologics
5168598|NCT00942045|fusion rates|fusion rates
5168599|NCT00942019|BMI|bmi
5168600|NCT00942019|obesity|obesity
5168601|NCT00942019|CO|co
5168602|NCT00942019|tobacco smoking|tobacco smoking
5168603|NCT00942019|adolescents|adolescents
5168604|NCT00942006|Lyme neuroborreliosis|lyme neuroborreliosis
5168605|NCT00942006|Lyme borreliosis|lyme borreliosis
5168606|NCT00942006|erythema migrans|erythema migrans
5168607|NCT00942006|doxycycline treatment|doxycycline treatment
5168608|NCT00942006|ceftriaxone treatment|ceftriaxone treatment
5168609|NCT00942006|outcome|outcome
5168610|NCT00942006|subjective symptoms|subjective symptoms
5168611|NCT00941980|biologics|biologics
5168612|NCT00941980|fusion rates|fusion rates
5168613|NCT00941980|PLIF|plif
5168614|NCT00941980|lumbar fusion|lumbar fusion
5168615|NCT00941967|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
5168616|NCT00941967|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
5168617|NCT00941967|recurrent adult primary liver cancer|recurrent adult primary liver cancer
5168618|NCT00941967|advanced adult primary liver cancer|advanced adult primary liver cancer
5168619|NCT00941954|Physical activity|physical activity
5168620|NCT00941954|Diabetes|diabetes
5168621|NCT00941954|Prevention|prevention
5168622|NCT00941954|Pedometer|pedometer
5168623|NCT00941954|Walking|walking
5168624|NCT00941954|Structured education|structured education
5168625|NCT00941954|Randomized|randomized
5168626|NCT00941954|Risk score|risk score
5168627|NCT00941954|Impaired glucose regulation|impaired glucose regulation
5168628|NCT00941941|Inguinal|inguinal
5168629|NCT00941941|Hernia|hernia
5168630|NCT00941941|Hernia-repair|hernia-repair
5168631|NCT00941941|Non-mesh|non-mesh
5168632|NCT00941941|Mesh|mesh
5168633|NCT00941941|Desarda|desarda
5168634|NCT00941941|Lichtenstein|lichtenstein
5168635|NCT00941928|Blood And Marrow Transplantation|blood and marrow transplantation
5168636|NCT00941928|Relapsed Acute Lymphoblastic Leukemia|relapsed acute lymphoblastic leukemia
5168637|NCT00941928|ALL|all
5168638|NCT00941928|Leukemia|leukemia
5168639|NCT00941928|Pediatrics|pediatrics
5168640|NCT00941928|Haploidentical NK cells|haploidentical nk cells
5168641|NCT00941928|Cyclophosphamide|cyclophosphamide
5168642|NCT00941928|Cytoxan|cytoxan
5168643|NCT00941928|Neosar|neosar
5168644|NCT00941928|Epratuzumab|epratuzumab
5168645|NCT00941928|Fludarabine|fludarabine
5168646|NCT00941928|Fludarabine Phosphate|fludarabine phosphate
5168647|NCT00941928|Fludara|fludara
5168648|NCT00941928|Interleukin-2|interleukin-2
5168649|NCT00941928|IL-2|il-2
5168650|NCT00941928|Proleukin|proleukin
5168651|NCT00941928|Low-dose interleukin|low-dose interleukin
5168652|NCT00941928|Mesna|mesna
5168653|NCT00941928|Mesnex|mesnex
5168654|NCT00941928|Natural Killer Cells|natural killer cells
5168655|NCT00941928|NK Cells Transplant|nk cells transplant
5168656|NCT00941915|CaP|cap
5168657|NCT00941915|SBRT|sbrt
5168658|NCT00941915|Prostate|prostate
5168659|NCT00941915|ExacTrac|exactrac
5168660|NCT00941915|Calypso|calypso
5168661|NCT00941915|IMRT|imrt
5168662|NCT00941915|Radiation|radiation
5168663|NCT00941915|Cancer of Prostate|cancer of prostate
5168664|NCT00941915|Prostatic Neoplasms|prostatic neoplasms
5168665|NCT00941902|human asialoglycoprotein receptor (ASGPR)|human asialoglycoprotein receptor (asgpr)
5168666|NCT00941902|hepatocytes|hepatocytes
5168667|NCT00941902|bariatric surgery|bariatric surgery
5168668|NCT00941889|HIV|hiv
5168669|NCT00941889|HPV|hpv
5168670|NCT00941889|Anal condylomata|anal condylomata
5168671|NCT00941889|Vaccine|vaccine
5168672|NCT00941889|HIV positive patients|hiv positive patients
5168673|NCT00941889|Anal condylomata or anal warts|anal condylomata or anal warts
5168674|NCT00941876|AE|ae
5168675|NCT00941876|adverse event|adverse event
5168676|NCT00941876|AIDS|aids
5168677|NCT00941876|acquired immunodeficiency syndrome|acquired immunodeficiency syndrome
5168678|NCT00941876|ALT (SGPT)|alt (sgpt)
5168679|NCT00941876|alanine aminotransferase|alanine aminotransferase
5168680|NCT00941876|ART|art
5168681|NCT00941876|antiretroviral therapy|antiretroviral therapy
5168682|NCT00941876|AST (SGOT)|ast (sgot)
5168683|NCT00941876|aspartate aminotransferase|aspartate aminotransferase
5168684|NCT00941876|DCF|dcf
5168685|NCT00941876|data collection forms|data collection forms
5168686|NCT00941876|DMC|dmc
5168687|NCT00941876|Data Monitoring Committee|data monitoring committee
5168688|NCT00941876|FDA|fda
5168689|NCT00941876|(U.S.) Food and Drug Administration|(u.s.) food and drug administration
5168690|NCT00941876|GCP|gcp
5168691|NCT00941876|Good Clinical Practice guidelines|good clinical practice guidelines
5168692|NCT00941876|HB sAg|hb sag
5168693|NCT00941876|Hepatitis B surface antigen|hepatitis b surface antigen
5168694|NCT00941876|ICH|ich
5168794|NCT00941577|Bronchial Diseases|bronchial diseases
5168695|NCT00941876|International Conference of Harmonisation|international conference of harmonisation
5168696|NCT00941876|IND|ind
5168697|NCT00941876|Investigational New Drug Application|investigational new drug application
5168698|NCT00941876|IRB|irb
5168699|NCT00941876|Institutional Review Board|institutional review board
5168700|NCT00941876|IU|iu
5168701|NCT00941876|International units|international units
5168702|NCT00941876|mg|mg
5168703|NCT00941876|milligram(s)|milligram(s)
5168704|NCT00941876|mm3|mm3
5168705|NCT00941876|cubic millimeter(s)|cubic millimeter(s)
5168706|NCT00941876|PCR|pcr
5168707|NCT00941876|polymerase chain reaction|polymerase chain reaction
5168708|NCT00941876|SAE|sae
5168709|NCT00941876|serious adverse event|serious adverse event
5168710|NCT00941876|µg|µg
5168711|NCT00941876|microgram|microgram
5168712|NCT00941876|ULN|uln
5168713|NCT00941876|upper limit of the normal range|upper limit of the normal range
5168714|NCT00941876|WB|wb
5168715|NCT00941876|Western Blot|western blot
5168716|NCT00941876|To inform the Ministry of Health strategy for integrating FP and HIV/AIDS Care and Treatment Services in Tanzania|to inform the ministry of health strategy for integrating fp and hiv/aids care and treatment services in tanzania
5168717|NCT00941876|HIV seronegativity|hiv seronegativity
5168718|NCT00941863|Sorafenib|sorafenib
5168719|NCT00941863|Advanced Solid Tumors|advanced solid tumors
5168720|NCT00941863|Maximum tolerated dose|maximum tolerated dose
5168721|NCT00941863|Carboplatin and paclitaxel chemotherapy combination|carboplatin and paclitaxel chemotherapy combination
5168722|NCT00941850|Cardiac resynchronizton therapy|cardiac resynchronizton therapy
5168723|NCT00941850|CRT|crt
5168724|NCT00941850|Heart failure|heart failure
5168725|NCT00941850|Dyssynchrony|dyssynchrony
5168726|NCT00941850|Echocardiography|echocardiography
5168727|NCT00941850|Pacemakers|pacemakers
5168728|NCT00941850|Nonresponders|nonresponders
5168729|NCT00941837|Palm olein|palm olein
5168730|NCT00941837|homocsyteine|homocsyteine
5168731|NCT00941837|Cholesterol|cholesterol
5168732|NCT00941837|lipoproteins|lipoproteins
5168733|NCT00941837|Interleukins|interleukins
5168734|NCT00941837|CRP|crp
5168735|NCT00941837|Blood Pressure|blood pressure
5168736|NCT00941837|Total homocystein|total homocystein
5168737|NCT00941837|Serum lipid profile|serum lipid profile
5168738|NCT00941837|Serum apolipoproteins|serum apolipoproteins
5168739|NCT00941837|Inflammatory markers|inflammatory markers
5168740|NCT00941824|pharmacokinetic|pharmacokinetic
5168741|NCT00941824|mycophénolate acid|mycophénolate acid
5168742|NCT00941824|kidney transplantation|kidney transplantation
5168743|NCT00941798|Asthma|asthma
5168744|NCT00941798|LABA|laba
5168745|NCT00941798|Safety|safety
5168746|NCT00941785|Malaria|malaria
5168747|NCT00941785|Intermittent Preventive Treatment|intermittent preventive treatment
5168748|NCT00941785|IPTc|iptc
5168749|NCT00941785|sIPTc|siptc
5168750|NCT00941785|Burkina Faso|burkina faso
5168751|NCT00941772|Nasogastric tube verification with ultrasonography|nasogastric tube verification with ultrasonography
5168752|NCT00941772|ultrasonography|ultrasonography
5168753|NCT00941759|Breast|breast
5168754|NCT00941759|Blood and tissue collection|blood and tissue collection
5168755|NCT00941759|Epidemiologic|epidemiologic
5168756|NCT00941759|Questionnaire|questionnaire
5168757|NCT00941759|TBCRC (Translational Breast Cancer Research Consortium)|tbcrc (translational breast cancer research consortium)
5168758|NCT00941759|09-056|09-056
5168759|NCT00941733|BTK|btk
5168760|NCT00941733|CLI|cli
5168761|NCT00941733|PTA|pta
5168762|NCT00941720|stage I multiple myeloma|stage i multiple myeloma
5168763|NCT00941720|stage II multiple myeloma|stage ii multiple myeloma
5168764|NCT00941720|stage III multiple myeloma|stage iii multiple myeloma
5168765|NCT00941707|Rheumatoid Arthritis|rheumatoid arthritis
5168766|NCT00941707|JNJ-38518168|jnj-38518168
5168767|NCT00941694|asthma|asthma
5168768|NCT00941694|aged|aged
5168769|NCT00941694|self care|self care
5168770|NCT00941681|omecamtiv mecarbil|omecamtiv mecarbil
5168771|NCT00941655|Gastric Carcinoma|gastric carcinoma
5168772|NCT00941655|Chemotherapy|chemotherapy
5168773|NCT00941655|Liver Tumors|liver tumors
5168774|NCT00941655|Peritoneal Tumors|peritoneal tumors
5168775|NCT00941655|Metastatic Gastric Cancer|metastatic gastric cancer
5168776|NCT00941655|Stomach Cancer|stomach cancer
5168777|NCT00941655|Gastric Cancer|gastric cancer
5168778|NCT00941642|Nonalcoholic Fatty Liver Disease (NAFLD)|nonalcoholic fatty liver disease (nafld)
5168779|NCT00941642|Lovaza|lovaza
5168780|NCT00941642|Steatosis|steatosis
5168781|NCT00941642|Non-Alcoholic steatohepatitis (NASH)|non-alcoholic steatohepatitis (nash)
5168782|NCT00941629|PTSD|ptsd
5168783|NCT00941629|Telemedicine|telemedicine
5168784|NCT00941629|Clinical Trial|clinical trial
5168785|NCT00941629|Psychotherapy|psychotherapy
5168786|NCT00941616|Von Willebrand Disease|von willebrand disease
5168787|NCT00941590|tick borne encephalitis|tick borne encephalitis
5168788|NCT00941590|clinical outcome|clinical outcome
5168789|NCT00941590|postencephalitic symptoms|postencephalitic symptoms
5168790|NCT00941577|Hypersensitivity|hypersensitivity
5168791|NCT00941577|Lung Diseases, Obstructive|lung diseases, obstructive
5168792|NCT00941577|Immune System Diseases|immune system diseases
5168793|NCT00941577|Respiratory Tract Diseases|respiratory tract diseases
5168795|NCT00941577|Lung Diseases|lung diseases
5168796|NCT00941577|Hypersensitivity, Immediate|hypersensitivity, immediate
5168797|NCT00941577|Asthma|asthma
5168798|NCT00941577|Respiratory Hypersensitivity|respiratory hypersensitivity
5168799|NCT00941551|Thyroid lobectomy,|thyroid lobectomy,
5168800|NCT00941551|prophylactic levothyroxine treatment,|prophylactic levothyroxine treatment,
5168801|NCT00941551|recurrent nodular goiter,|recurrent nodular goiter,
5168802|NCT00941551|iodine deficiency,|iodine deficiency,
5168803|NCT00941551|long-term follow-up,|long-term follow-up,
5168804|NCT00941551|completion thyroidectomy|completion thyroidectomy
5168805|NCT00941538|nasopharyngeal cancer|nasopharyngeal cancer
5168806|NCT00941538|screening|screening
5168807|NCT00941538|biomarker|biomarker
5168808|NCT00941538|early detection|early detection
5168809|NCT00941538|epidemiological survey|epidemiological survey
5168810|NCT00941525|Central corneal thickness|central corneal thickness
5168811|NCT00941525|24hour fluctuation of intraocular pressure|24hour fluctuation of intraocular pressure
5168812|NCT00941525|Open angle glaucoma|open angle glaucoma
5168813|NCT00941525|Ocular hypertension|ocular hypertension
5168814|NCT00941512|Colposcopy|colposcopy
5168815|NCT00941499|Advanced Cancers|advanced cancers
5168816|NCT00941499|Liver|liver
5168817|NCT00941499|Oxaliplatin|oxaliplatin
5168818|NCT00941499|Eloxatin|eloxatin
5168819|NCT00941499|Bevacizumab|bevacizumab
5168820|NCT00941499|Avastin|avastin
5168821|NCT00941499|Anit-VEGF monoclonal antibody|anit-vegf monoclonal antibody
5168822|NCT00941499|rhuMAb-VEGF|rhumab-vegf
5168823|NCT00941499|5-fluorouracil|5-fluorouracil
5168824|NCT00941499|5-FU|5-fu
5168825|NCT00941499|Adrucil|adrucil
5168826|NCT00941499|Efudex|efudex
5168827|NCT00941499|Leucovorin|leucovorin
5168828|NCT00941499|Citrovorum|citrovorum
5168829|NCT00941499|Wellcovorin|wellcovorin
5168830|NCT00941499|Cetuximab|cetuximab
5168831|NCT00941499|C225|c225
5168832|NCT00941499|Erbitux|erbitux
5168833|NCT00941499|IMC-C225|imc-c225
5168834|NCT00941473|Epidural Injection|epidural injection
5168835|NCT00941473|Bone Density|bone density
5168836|NCT00941460|progressive or recurrent glioblastoma|progressive or recurrent glioblastoma
5168837|NCT00941460|temozolomide|temozolomide
5168838|NCT00941460|dose intensification|dose intensification
5168839|NCT00941460|comparison of two dosing regimens|comparison of two dosing regimens
5168840|NCT00941447|Type 2 Diabetes|type 2 diabetes
5168841|NCT00941447|Obesity|obesity
5168842|NCT00941447|Self-Regulation|self-regulation
5168843|NCT00941447|Self-Efficacy|self-efficacy
5168844|NCT00941434|RUTF|rutf
5168845|NCT00941434|SAM|sam
5168846|NCT00941434|Nutributter|nutributter
5168847|NCT00941395|Cancer Prevention|cancer prevention
5168848|NCT00941395|College students|college students
5168849|NCT00941395|Prevention intervention|prevention intervention
5168850|NCT00941395|Smoking|smoking
5168851|NCT00941395|Tobacco|tobacco
5168852|NCT00941395|Internet-based|internet-based
5168853|NCT00941395|Cognitive Behavioral Therapy|cognitive behavioral therapy
5168854|NCT00941395|Nicotine lozenges|nicotine lozenges
5168855|NCT00941382|sibutramine|sibutramine
5168856|NCT00941382|metformin|metformin
5168857|NCT00941382|obesity|obesity
5168858|NCT00941356|MRSA nasal colonisation|mrsa nasal colonisation
5168859|NCT00941356|Probiotics|probiotics
5168860|NCT00941330|Breast, Male|breast, male
5168861|NCT00941330|Breast, Female|breast, female
5168862|NCT00941317|onychomycosis|onychomycosis
5168863|NCT00941317|micro-drilling|micro-drilling
5168864|NCT00941291|idiopathic macular hole|idiopathic macular hole
5168865|NCT00941291|cataract|cataract
5168866|NCT00941291|edema|edema
5168867|NCT00941291|Reopening|reopening
5168868|NCT00941265|treatment of anomia|treatment of anomia
5168869|NCT00941265|levodopa|levodopa
5168870|NCT00941265|"patient with aphasia hospitalised at the Service de neurorehabilitation with presence of anomia"|"patient with aphasia hospitalised at the service de neurorehabilitation with presence of anomia"
5168871|NCT00941239|Metformin ER|metformin er
5168872|NCT00941239|Pharmacokinetics|pharmacokinetics
5168873|NCT00941239|Tolerability|tolerability
5168874|NCT00941239|Healthy volunteers|healthy volunteers
5168875|NCT00941226|Cerebral Palsy|cerebral palsy
5168876|NCT00941226|Caregivers|caregivers
5168877|NCT00941226|Quality of Life|quality of life
5168878|NCT00941213|fractures of vertebral bodies Th10-L2|fractures of vertebral bodies th10-l2
5168879|NCT00941213|(AO A1 with kyphosis, A2.3, B or C-type)|(ao a1 with kyphosis, a2.3, b or c-type)
5168880|NCT00941187|pulmonary embolism|pulmonary embolism
5168881|NCT00941187|pulmonary capillary blood volume|pulmonary capillary blood volume
5168882|NCT00941187|double diffusion NO/CO method|double diffusion no/co method
5168883|NCT00941174|(13C5) Calcium Leucovorin|(13c5) calcium leucovorin
5168884|NCT00941174|Folate absorption across the large intestine|folate absorption across the large intestine
5168885|NCT00941174|Folate Bioavailability|folate bioavailability
5168886|NCT00941122|MRSA, VRE|mrsa, vre
5168887|NCT00941109|MDS|mds
5168888|NCT00941096|Glaucoma|glaucoma
5168889|NCT00941096|Ocular Hypertension|ocular hypertension
5168890|NCT00941096|Lumigan|lumigan
5168891|NCT00941096|Ganfort|ganfort
5168892|NCT00941083|Simplification from protease inhibitors to raltegravir|simplification from protease inhibitors to raltegravir
5168893|NCT00941083|Treatment Experienced|treatment experienced
5168894|NCT00941083|HIV-1 Infections|hiv-1 infections
5168895|NCT00941044|non-invasive ventilation|non-invasive ventilation
5168896|NCT00941044|diaphragm|diaphragm
5168897|NCT00941044|electrical activity|electrical activity
5168898|NCT00941044|neurally adjusted ventilatory assist|neurally adjusted ventilatory assist
5168899|NCT00941044|volunteers|volunteers
5168900|NCT00941031|Moderate to severe chronic plaque-type psoriasis|moderate to severe chronic plaque-type psoriasis
5168901|NCT00941031|AIN457|ain457
5168902|NCT00941031|dermatology|dermatology
5168903|NCT00941018|Resolvins|resolvins
5168904|NCT00941018|RvE1|rve1
5168905|NCT00941018|Healthy volunteers|healthy volunteers
5168906|NCT00940979|Integuseal microbial sealant|integuseal microbial sealant
5168907|NCT00940979|Infection prophylaxis|infection prophylaxis
5168908|NCT00940979|Postoperative wound infection|postoperative wound infection
5168909|NCT00940979|Arterial bypass surgery|arterial bypass surgery
5168910|NCT00940966|ADA diet|ada diet
5168911|NCT00940966|low carbohydrate diet|low carbohydrate diet
5168912|NCT00940966|Metabolic syndrome|metabolic syndrome
5168913|NCT00940927|Albuterol|albuterol
5168914|NCT00940927|Forced expiratory volume in one second|forced expiratory volume in one second
5168915|NCT00940927|Dose at fifty percent of maximum effect|dose at fifty percent of maximum effect
5168916|NCT00940927|Maximum effective dose|maximum effective dose
5168917|NCT00940927|Metered dose inhaler|metered dose inhaler
5168918|NCT00940927|Nebulizer|nebulizer
5168919|NCT00940914|Parkinson's disease|parkinson's disease
5168920|NCT00940914|pain|pain
5168921|NCT00940914|dopamine transporters imaging|dopamine transporters imaging
5168922|NCT00940901|priapism|priapism
5168923|NCT00940901|sickle cell disease|sickle cell disease
5168924|NCT00940901|sildenafil|sildenafil
5168925|NCT00940901|phosphodiesterase type 5 inhibitor|phosphodiesterase type 5 inhibitor
5168926|NCT00940888|ICD|icd
5168927|NCT00940888|CRTD|crtd
5168928|NCT00940888|Heart Failure|heart failure
5168929|NCT00940888|DF4|df4
5168930|NCT00940862|psoriasis|psoriasis
5168931|NCT00940862|vascular inflammation|vascular inflammation
5168932|NCT00940862|coronary atherosclerosis|coronary atherosclerosis
5168933|NCT00940836|Anti-cold|anti-cold
5168934|NCT00940836|Cold preparation|cold preparation
5168935|NCT00940836|RCT|rct
5168936|NCT00940823|Glaucoma Drainage Device|glaucoma drainage device
5168937|NCT00940823|Aqueous Shunt Implant|aqueous shunt implant
5168938|NCT00940823|Ahmed Valve|ahmed valve
5168939|NCT00940823|Baerveldt Tube|baerveldt tube
5168940|NCT00940823|Refractory Glaucoma|refractory glaucoma
5168941|NCT00940797|diabetes|diabetes
5168942|NCT00940797|Type 2|type 2
5168943|NCT00940797|monotherapy|monotherapy
5168944|NCT00940797|antidiabetics|antidiabetics
5168945|NCT00940797|metformin|metformin
5168946|NCT00940771|HIV|hiv
5168947|NCT00940771|Lipids|lipids
5168948|NCT00940771|Atazanavir|atazanavir
5168949|NCT00940771|Pediatric|pediatric
5168950|NCT00940771|treatment experienced|treatment experienced
5168951|NCT00940745|HICH|hich
5168952|NCT00940745|Suction drainages|suction drainages
5168953|NCT00940745|TTAC|ttac
5168954|NCT00940732|Help-seeking|help-seeking
5168955|NCT00940732|Mental Health|mental health
5168956|NCT00940732|Athletes|athletes
5168957|NCT00940719|Multiple Sclerosis|multiple sclerosis
5168958|NCT00940719|Regulatory T cell function|regulatory t cell function
5168959|NCT00940719|Vitamin D|vitamin d
5168960|NCT00940719|Vitamin D3|vitamin d3
5168961|NCT00940719|25-hydroxyvitamin D|25-hydroxyvitamin d
5168962|NCT00940706|Cerebral Palsy|cerebral palsy
5168963|NCT00940706|Activity monitoring|activity monitoring
5168964|NCT00940706|Treadmill|treadmill
5168965|NCT00940706|Group training|group training
5168966|NCT00940706|Physical active life style|physical active life style
5168967|NCT00940693|Attention Deficit Disorder with Hyperactivity|attention deficit disorder with hyperactivity
5168968|NCT00940693|Duloxetine|duloxetine
5168969|NCT00940693|Adult|adult
5168970|NCT00940693|ADDH|addh
5168971|NCT00940693|ADHD|adhd
5168972|NCT00940680|Amlodipine|amlodipine
5168973|NCT00940680|Losartan|losartan
5168974|NCT00940680|hypertension|hypertension
5168975|NCT00940667|Amlodipine|amlodipine
5168976|NCT00940667|Losartan|losartan
5168977|NCT00940667|hypertension|hypertension
5168978|NCT00940654|Fever|fever
5168979|NCT00940654|Antipyretic|antipyretic
5168980|NCT00940654|Infection|infection
5168981|NCT00940654|Mortality|mortality
5168982|NCT00940654|Cooling|cooling
5168983|NCT00940654|Non steroid anti inflammatory drugs|non steroid anti inflammatory drugs
5168984|NCT00940654|Acetaminophen|acetaminophen
5168985|NCT00940654|Steroid|steroid
5168986|NCT00940654|ICU|icu
5168987|NCT00940654|Intensive care|intensive care
5168988|NCT00940654|Critically ill|critically ill
5168989|NCT00940641|Healthy Volunteer|healthy volunteer
5168990|NCT00940615|traumatic brain injury|traumatic brain injury
5168991|NCT00940615|aerobic exercise|aerobic exercise
5168992|NCT00940615|Diffusion Tensor Imaging|diffusion tensor imaging
5168993|NCT00940615|Neuropsychology|neuropsychology
5168994|NCT00940615|Rehabilitation|rehabilitation
5168995|NCT00940602|TELESTO|telesto
5168996|NCT00940602|MDS Study|mds study
5168997|NCT00940602|Myelodysplastic Syndromes|myelodysplastic syndromes
5168998|NCT00940602|Myelodysplastic Syndromes (low-int-1 risk)|myelodysplastic syndromes (low-int-1 risk)
5168999|NCT00940589|Alzheimer's Disease|alzheimer's disease
5169000|NCT00940589|Acetylcholinesterase inhibitor|acetylcholinesterase inhibitor
5169001|NCT00940589|cognitive function|cognitive function
5169002|NCT00940589|Circadin|circadin
5169003|NCT00940589|Sleep disturbances|sleep disturbances
5169004|NCT00940576|mare's milk, Crohn's disease, ulcerative colitis, clinical|mare's milk, crohn's disease, ulcerative colitis, clinical
5169005|NCT00940563|GIST|gist
5169006|NCT00940563|imatinib|imatinib
5169007|NCT00940563|advanced GIST|advanced gist
5169008|NCT00940537|Obese|obese
5169009|NCT00940537|MRS|mrs
5169010|NCT00940537|hepatic triglyceride content|hepatic triglyceride content
5169011|NCT00940537|MR spectroscopy|mr spectroscopy
5169012|NCT00940524|Leukemia|leukemia
5169013|NCT00940524|ALL|all
5169014|NCT00940524|ALLOPURINOL|allopurinol
5169015|NCT00940524|CARMUSTINE (BCNU)|carmustine (bcnu)
5169016|NCT00940524|CYCLOPHOSPHAMIDE (CYTOXAN)|cyclophosphamide (cytoxan)
5169017|NCT00940524|CYTARABINE (ARA-C)|cytarabine (ara-c)
5169018|NCT00940524|DACTINOMYCIN|dactinomycin
5169019|NCT00940524|DASATINIB|dasatinib
5169020|NCT00940524|DEXAMETHASONE|dexamethasone
5169021|NCT00940524|DOXORUBICIN/ADRIAMYCIN|doxorubicin/adriamycin
5169022|NCT00940524|ETOPOSIDE (VP-16)|etoposide (vp-16)
5169023|NCT00940524|MERCAPTOPURINE|mercaptopurine
5169024|NCT00940524|METHOTREXATE|methotrexate
5169025|NCT00940524|MITOXANTRONE|mitoxantrone
5169026|NCT00940524|PEGASPERGASE|pegaspergase
5169027|NCT00940524|VINCRISTINE|vincristine
5169028|NCT00940511|All conditions faced by disabled Medicaid recipients|all conditions faced by disabled medicaid recipients
5169029|NCT00940498|Phase 1|phase 1
5169030|NCT00940498|Dose Finding|dose finding
5169031|NCT00940498|Solid Tumors|solid tumors
5169032|NCT00940498|Tumors|tumors
5169033|NCT00940498|PF-05212384|pf-05212384
5169034|NCT00940472|type 2 diabetes|type 2 diabetes
5169035|NCT00940472|monotherapy|monotherapy
5169036|NCT00940472|antidiabetics|antidiabetics
5169037|NCT00940472|metformin|metformin
5169038|NCT00940459|contact lenses|contact lenses
5169039|NCT00940459|conjunctival staining|conjunctival staining
5169040|NCT00940459|contact lens wear|contact lens wear
5169041|NCT00940446|Insorb staples|insorb staples
5169042|NCT00940446|Metal Staples|metal staples
5169043|NCT00940433|Minimally invasive|minimally invasive
5169044|NCT00940433|Inguinal hernia|inguinal hernia
5169045|NCT00940433|Pro-peritoneal repair|pro-peritoneal repair
5169046|NCT00940407|dry AMD|dry amd
5169047|NCT00940407|light treatment|light treatment
5169048|NCT00940407|ARMD|armd
5169049|NCT00940407|photobiomodulation|photobiomodulation
5169050|NCT00940407|macular|macular
5169051|NCT00940407|eye disease|eye disease
5169052|NCT00940407|ageing eye disease|ageing eye disease
5169053|NCT00940394|mutual support group|mutual support group
5169054|NCT00940394|psychoeducation group|psychoeducation group
5169055|NCT00940394|family caregivers|family caregivers
5169056|NCT00940394|schizophrenia|schizophrenia
5169057|NCT00940381|Advanced Malignancies|advanced malignancies
5169058|NCT00940381|Sirolimus|sirolimus
5169059|NCT00940381|Rapamune|rapamune
5169060|NCT00940381|Cetuximab|cetuximab
5169061|NCT00940381|C225|c225
5169062|NCT00940381|Erbitux|erbitux
5169063|NCT00940381|IMC-225|imc-225
5169064|NCT00940368|Nausea|nausea
5169065|NCT00940368|Vomiting|vomiting
5169066|NCT00940368|Chemotherapy|chemotherapy
5169067|NCT00940355|COPD|copd
5169068|NCT00940355|Health Status|health status
5169069|NCT00940355|Intervention|intervention
5169070|NCT00940355|Secondary prevention|secondary prevention
5169071|NCT00940355|patient-tailored treatment|patient-tailored treatment
5169072|NCT00940342|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
5169073|NCT00940342|Rituximab|rituximab
5169074|NCT00940342|Leukemia|leukemia
5169075|NCT00940342|Sargramostim|sargramostim
5169076|NCT00940342|GM-CSF|gm-csf
5169077|NCT00940329|Drug interactions|drug interactions
5169078|NCT00940329|Pharmacodynamic interactions|pharmacodynamic interactions
5169079|NCT00940329|Pharmacokinetic interactions|pharmacokinetic interactions
5169080|NCT00940329|Formoterol|formoterol
5169081|NCT00940329|Healthy subjects|healthy subjects
5169082|NCT00940329|Phase I study|phase i study
5169083|NCT00940329|Roflumilast|roflumilast
5169084|NCT00940316|recurrent colon cancer|recurrent colon cancer
5169085|NCT00940316|stage IV colon cancer|stage iv colon cancer
5169086|NCT00940316|recurrent rectal cancer|recurrent rectal cancer
5169087|NCT00940316|stage IV rectal cancer|stage iv rectal cancer
5169088|NCT00940290|practice guideline as topic|practice guideline as topic
5169089|NCT00940290|decision making|decision making
5169090|NCT00940290|evidence based medicine|evidence based medicine
5169091|NCT00940277|women couples counseling groups support intervention marriage|women couples counseling groups support intervention marriage
5169092|NCT00940264|symptomatic cholecystolithiasis|symptomatic cholecystolithiasis
5169093|NCT00940251|Ayurvedic formulation|ayurvedic formulation
5169094|NCT00940251|type 2 diabetes mellitus|type 2 diabetes mellitus
5169360|NCT00939133|Retin A micro|retin a micro
5169095|NCT00940251|secondary failure to oral hypoglycemic agents|secondary failure to oral hypoglycemic agents
5169096|NCT00940251|antidiabetic|antidiabetic
5169097|NCT00940225|Breast Cancer|breast cancer
5169098|NCT00940225|Melanoma|melanoma
5169099|NCT00940225|Stomach or Gastroesophageal Junction Carcinoma|stomach or gastroesophageal junction carcinoma
5169100|NCT00940225|Hepatocellular Carcinoma (HCC)|hepatocellular carcinoma (hcc)
5169101|NCT00940225|Small Cell Lung Cancer (SCLC)|small cell lung cancer (sclc)
5169102|NCT00940225|Non-Small Cell Lung Cancer (NSCLC)|non-small cell lung cancer (nsclc)
5169103|NCT00940225|Ovarian Cancer|ovarian cancer
5169104|NCT00940225|Pancreatic Cancer|pancreatic cancer
5169105|NCT00940225|Prostate Cancer|prostate cancer
5169106|NCT00940212|Safety|safety
5169107|NCT00940212|tolerability|tolerability
5169108|NCT00940212|healthy|healthy
5169109|NCT00940212|pharmacokinetics|pharmacokinetics
5169110|NCT00940199|Breast cancer, sentinel lymph node mapping, biopsy|breast cancer, sentinel lymph node mapping, biopsy
5169111|NCT00940173|xenotransplantation|xenotransplantation
5169112|NCT00940173|type I diabetes|type i diabetes
5169113|NCT00940173|porcine islets|porcine islets
5169114|NCT00940160|Asthma|asthma
5169115|NCT00940134|obesity|obesity
5169116|NCT00940134|energy expenditure|energy expenditure
5169117|NCT00940134|incretins|incretins
5169118|NCT00940134|appetite regulation|appetite regulation
5169119|NCT00940134|GLP-1|glp-1
5169120|NCT00940134|PYY|pyy
5169121|NCT00940134|ad libitum energy intake|ad libitum energy intake
5169122|NCT00940121|Healthy volunteer subjects|healthy volunteer subjects
5169123|NCT00940121|pharmacokinetics|pharmacokinetics
5169124|NCT00940121|YM178|ym178
5169125|NCT00940121|mirabegron|mirabegron
5169126|NCT00940121|IV infusion|iv infusion
5169127|NCT00940121|oral administration|oral administration
5169128|NCT00940095|Subarachnoid|subarachnoid
5169129|NCT00940095|Aneurysmal|aneurysmal
5169130|NCT00940095|surgical clipping|surgical clipping
5169131|NCT00940095|PIVLAZ|pivlaz
5169132|NCT00940095|vasospasm|vasospasm
5169133|NCT00940095|cerebral vasospasm|cerebral vasospasm
5169134|NCT00940095|clazosentan|clazosentan
5169135|NCT00940095|Actelion|actelion
5169136|NCT00940095|Hemorrhage|hemorrhage
5169137|NCT00940082|Diabetes;|diabetes;
5169138|NCT00940082|Echocardiography;|echocardiography;
5169139|NCT00940082|High-sensitive C-reactive protein;|high-sensitive c-reactive protein;
5169140|NCT00940082|homocysteine;|homocysteine;
5169141|NCT00940082|TNF-α|tnf-α
5169142|NCT00940069|TS|ts
5169143|NCT00940069|polymorphism|polymorphism
5169144|NCT00940069|lung cancer|lung cancer
5169145|NCT00940069|adenocarcinoma|adenocarcinoma
5169146|NCT00940069|pemetrexed|pemetrexed
5169147|NCT00940056|Atrial fibrillation|atrial fibrillation
5169148|NCT00940056|Ablation|ablation
5169149|NCT00940056|Thoracoscopy|thoracoscopy
5169150|NCT00940056|Atrial function|atrial function
5169151|NCT00940043|bedside test|bedside test
5169152|NCT00940043|interleukins|interleukins
5169153|NCT00940043|inflammation|inflammation
5169154|NCT00940043|vaginal secretions|vaginal secretions
5169155|NCT00940030|Mechanical Bowel Preparation (MBP)|mechanical bowel preparation (mbp)
5169156|NCT00940030|enema|enema
5169157|NCT00940017|PK|pk
5169158|NCT00940017|fungal infection|fungal infection
5169159|NCT00940004|dendritic cell vaccination|dendritic cell vaccination
5169160|NCT00940004|melanoma|melanoma
5169161|NCT00940004|toll like receptor ligands|toll like receptor ligands
5169162|NCT00940004|vaccines|vaccines
5169163|NCT00939991|GBM|gbm
5169164|NCT00939965|localized unresectable neuroblastoma|localized unresectable neuroblastoma
5169165|NCT00939965|recurrent neuroblastoma|recurrent neuroblastoma
5169166|NCT00939965|stage 4S neuroblastoma|stage 4s neuroblastoma
5169167|NCT00939952|ertapenem|ertapenem
5169168|NCT00939952|CAPD|capd
5169169|NCT00939952|dialysis|dialysis
5169170|NCT00939913|contrast nephropathy|contrast nephropathy
5169171|NCT00939913|intravenous n-acetlycysteine|intravenous n-acetlycysteine
5169172|NCT00939900|avascular necrosis of femoral head|avascular necrosis of femoral head
5169173|NCT00939900|bisphosphonate|bisphosphonate
5169174|NCT00939900|collapse|collapse
5169175|NCT00939874|HIV+|hiv+
5169176|NCT00939874|Raltegravir|raltegravir
5169177|NCT00939874|Tenofovir|tenofovir
5169178|NCT00939874|osteopenia|osteopenia
5169179|NCT00939874|osteoporosis|osteoporosis
5169180|NCT00939874|bone markers|bone markers
5169181|NCT00939874|treatment experienced|treatment experienced
5169182|NCT00939861|colorectal endometriosis, laparoscopy, laparotomy|colorectal endometriosis, laparoscopy, laparotomy
5169183|NCT00939861|gynecologic and digestive symptoms|gynecologic and digestive symptoms
5169184|NCT00939861|quality of life (SF-36 questionnaire)|quality of life (sf-36 questionnaire)
5169185|NCT00939861|morbidity|morbidity
5169186|NCT00939861|fertility|fertility
5169187|NCT00939848|Disease-Free Survival|disease-free survival
5169188|NCT00939770|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
5169189|NCT00939770|recurrent neuroblastoma|recurrent neuroblastoma
5169190|NCT00939770|recurrent childhood anaplastic large cell lymphoma|recurrent childhood anaplastic large cell lymphoma
5169191|NCT00939770|recurrent childhood brain stem glioma|recurrent childhood brain stem glioma
5169461|NCT00938730|Warfarin|warfarin
5169192|NCT00939770|recurrent childhood cerebellar astrocytoma|recurrent childhood cerebellar astrocytoma
5169193|NCT00939770|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
5169194|NCT00939770|recurrent childhood anaplastic astrocytoma|recurrent childhood anaplastic astrocytoma
5169195|NCT00939770|recurrent childhood anaplastic oligoastrocytoma|recurrent childhood anaplastic oligoastrocytoma
5169196|NCT00939770|recurrent childhood anaplastic oligodendroglioma|recurrent childhood anaplastic oligodendroglioma
5169197|NCT00939770|recurrent childhood fibrillary astrocytoma|recurrent childhood fibrillary astrocytoma
5169198|NCT00939770|recurrent childhood gemistocytic astrocytoma|recurrent childhood gemistocytic astrocytoma
5169199|NCT00939770|recurrent childhood giant cell glioblastoma|recurrent childhood giant cell glioblastoma
5169200|NCT00939770|recurrent childhood glioblastoma|recurrent childhood glioblastoma
5169201|NCT00939770|recurrent childhood gliomatosis cerebri|recurrent childhood gliomatosis cerebri
5169202|NCT00939770|recurrent childhood gliosarcoma|recurrent childhood gliosarcoma
5169203|NCT00939770|recurrent childhood oligoastrocytoma|recurrent childhood oligoastrocytoma
5169204|NCT00939770|recurrent childhood oligodendroglioma|recurrent childhood oligodendroglioma
5169205|NCT00939770|recurrent childhood pilocytic astrocytoma|recurrent childhood pilocytic astrocytoma
5169206|NCT00939770|recurrent childhood pilomyxoid astrocytoma|recurrent childhood pilomyxoid astrocytoma
5169207|NCT00939770|recurrent childhood pleomorphic xanthoastrocytoma|recurrent childhood pleomorphic xanthoastrocytoma
5169208|NCT00939770|recurrent childhood protoplasmic astrocytoma|recurrent childhood protoplasmic astrocytoma
5169209|NCT00939770|recurrent childhood subependymal giant cell astrocytoma|recurrent childhood subependymal giant cell astrocytoma
5169210|NCT00939770|recurrent childhood visual pathway and hypothalamic glioma|recurrent childhood visual pathway and hypothalamic glioma
5169211|NCT00939770|recurrent childhood visual pathway glioma|recurrent childhood visual pathway glioma
5169212|NCT00939770|recurrent childhood medulloblastoma|recurrent childhood medulloblastoma
5169213|NCT00939770|recurrent childhood ependymoma|recurrent childhood ependymoma
5169214|NCT00939770|recurrent childhood pineoblastoma|recurrent childhood pineoblastoma
5169215|NCT00939770|recurrent childhood supratentorial primitive neuroectodermal tumor|recurrent childhood supratentorial primitive neuroectodermal tumor
5169216|NCT00939770|childhood choroid plexus tumor|childhood choroid plexus tumor
5169217|NCT00939770|childhood craniopharyngioma|childhood craniopharyngioma
5169218|NCT00939770|childhood ependymoblastoma|childhood ependymoblastoma
5169219|NCT00939770|childhood medulloepithelioma|childhood medulloepithelioma
5169220|NCT00939770|childhood grade I meningioma|childhood grade i meningioma
5169221|NCT00939770|childhood grade II meningioma|childhood grade ii meningioma
5169222|NCT00939770|childhood grade III meningioma|childhood grade iii meningioma
5169223|NCT00939770|childhood central nervous system germ cell tumor|childhood central nervous system germ cell tumor
5169224|NCT00939770|recurrent childhood spinal cord neoplasm|recurrent childhood spinal cord neoplasm
5169225|NCT00939770|childhood infratentorial ependymoma|childhood infratentorial ependymoma
5169226|NCT00939770|childhood supratentorial ependymoma|childhood supratentorial ependymoma
5169227|NCT00939770|childhood high-grade cerebellar astrocytoma|childhood high-grade cerebellar astrocytoma
5169228|NCT00939770|childhood high-grade cerebral astrocytoma|childhood high-grade cerebral astrocytoma
5169229|NCT00939770|childhood low-grade cerebellar astrocytoma|childhood low-grade cerebellar astrocytoma
5169230|NCT00939770|childhood low-grade cerebral astrocytoma|childhood low-grade cerebral astrocytoma
5169231|NCT00939770|childhood atypical teratoid/rhabdoid tumor|childhood atypical teratoid/rhabdoid tumor
5169232|NCT00939757|Healthy volunteer subjects|healthy volunteer subjects
5169233|NCT00939757|pharmacokinetics|pharmacokinetics
5169234|NCT00939757|YM178|ym178
5169235|NCT00939757|mirabegron|mirabegron
5169236|NCT00939757|food|food
5169237|NCT00939744|contractile activity|contractile activity
5169238|NCT00939744|eicosanoids|eicosanoids
5169239|NCT00939744|pregnant women|pregnant women
5169240|NCT00939744|obstetrics complications|obstetrics complications
5169241|NCT00939731|bioavailability, capsule, tablet, healthy volunteer|bioavailability, capsule, tablet, healthy volunteer
5169242|NCT00939718|depression;vitamin B12;randomized control trial|depression;vitamin b12;randomized control trial
5169243|NCT00939679|obesity|obesity
5169244|NCT00939679|bariatric surgery|bariatric surgery
5169245|NCT00939679|energy expenditure|energy expenditure
5169246|NCT00939679|incretins|incretins
5169247|NCT00939679|appetite regulation|appetite regulation
5169248|NCT00939679|body composition|body composition
5169249|NCT00939679|GLP-1|glp-1
5169250|NCT00939666|Rectal cancer|rectal cancer
5169251|NCT00939666|Chemoradiation|chemoradiation
5169252|NCT00939666|Response|response
5169253|NCT00939666|Wait-and-see policy|wait-and-see policy
5169254|NCT00939666|Transanal endoscopic microsurgery|transanal endoscopic microsurgery
5169255|NCT00939653|relapsed|relapsed
5169256|NCT00939653|relapse|relapse
5169257|NCT00939653|refractory|refractory
5169258|NCT00939653|AML|aml
5169259|NCT00939653|Acute myelogenous leukemia|acute myelogenous leukemia
5169260|NCT00939653|Relapsed AML|relapsed aml
5169261|NCT00939640|Diet|diet
5169262|NCT00939640|Sodium|sodium
5169263|NCT00939640|Hypertension|hypertension
5169264|NCT00939640|Potassium|potassium
5169265|NCT00939640|Antioxidants|antioxidants
5169266|NCT00939640|congestive heart failure|congestive heart failure
5169267|NCT00939640|Heart failure with normal ejection fraction|heart failure with normal ejection fraction
5169462|NCT00938717|IBS|ibs
5169463|NCT00938691|Scar|scar
5169268|NCT00939640|Heart failure with preserved systolic function|heart failure with preserved systolic function
5169269|NCT00939601|Obstructive Sleep Apnea|obstructive sleep apnea
5169270|NCT00939601|OSA|osa
5169271|NCT00939601|Adherence|adherence
5169272|NCT00939601|CPAP|cpap
5169273|NCT00939601|Cognition|cognition
5169274|NCT00939588|Aliskiren,|aliskiren,
5169275|NCT00939588|hypertension,|hypertension,
5169276|NCT00939588|renin-angiotensin-aldosterone system|renin-angiotensin-aldosterone system
5169277|NCT00939575|preeclampsia, metabolomics, blood, urine|preeclampsia, metabolomics, blood, urine
5169278|NCT00939562|Bioequivalence|bioequivalence
5169279|NCT00939549|High dose cyclophosphamide|high dose cyclophosphamide
5169280|NCT00939523|recurrent nonfunctioning adenoma|recurrent nonfunctioning adenoma
5169281|NCT00939523|prolactinomas|prolactinomas
5169282|NCT00939523|resistant pituitary tumors|resistant pituitary tumors
5169283|NCT00939523|aggressive pituitary tumors|aggressive pituitary tumors
5169284|NCT00939523|malignant pituitary adenomas|malignant pituitary adenomas
5169285|NCT00939510|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5169286|NCT00939510|hormone-resistant prostate cancer|hormone-resistant prostate cancer
5169287|NCT00939510|recurrent prostate cancer|recurrent prostate cancer
5169288|NCT00939510|stage IV prostate cancer|stage iv prostate cancer
5169289|NCT00939432|incontinence|incontinence
5169290|NCT00939432|urinary|urinary
5169291|NCT00939432|taboo|taboo
5169292|NCT00939432|shame|shame
5169293|NCT00939432|embarrassment|embarrassment
5169294|NCT00939432|treatment|treatment
5169295|NCT00939432|depression|depression
5169296|NCT00939432|cancer|cancer
5169297|NCT00939419|Tuberculosis care|tuberculosis care
5169298|NCT00939419|community tuberculosis care|community tuberculosis care
5169299|NCT00939419|Health facility based tuberculosis care|health facility based tuberculosis care
5169300|NCT00939380|hematopoietic stem cell transplant|hematopoietic stem cell transplant
5169301|NCT00939380|bone marrow transplant|bone marrow transplant
5169302|NCT00939380|children|children
5169303|NCT00939380|parents|parents
5169304|NCT00939380|counseling|counseling
5169305|NCT00939380|depression|depression
5169306|NCT00939354|Asthma in subjects over the age of 65|asthma in subjects over the age of 65
5169307|NCT00939341|Symbicort SMART|symbicort smart
5169308|NCT00939328|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
5169309|NCT00939328|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5169310|NCT00939315|Glioma, diagnosis|glioma, diagnosis
5169311|NCT00939315|Imaging|imaging
5169312|NCT00939315|Positron emission tomography|positron emission tomography
5169313|NCT00939315|Magnetic resonance imaging|magnetic resonance imaging
5169314|NCT00939315|Magnetic resonance spectroscopy|magnetic resonance spectroscopy
5169315|NCT00939289|Continuous glucose monitoring|continuous glucose monitoring
5169316|NCT00939276|cataract surgery|cataract surgery
5169317|NCT00939276|macular edema|macular edema
5169318|NCT00939276|prevention|prevention
5169319|NCT00939263|deglutition disorders|deglutition disorders
5169320|NCT00939263|esophageal diseases|esophageal diseases
5169321|NCT00939263|eosinophilia|eosinophilia
5169322|NCT00939250|Diabetes|diabetes
5169323|NCT00939250|Depression|depression
5169324|NCT00939250|Disease Self Management|disease self management
5169325|NCT00939250|Measurement Based Care|measurement based care
5169326|NCT00939237|Coronary heart disease|coronary heart disease
5169327|NCT00939237|Carotid intima-media thickness|carotid intima-media thickness
5169328|NCT00939237|Biomarkers|biomarkers
5169329|NCT00939224|Near-infrared spectroscopy (NIRS)|near-infrared spectroscopy (nirs)
5169330|NCT00939224|Regional oxygen saturation|regional oxygen saturation
5169331|NCT00939224|Pediatrics|pediatrics
5169332|NCT00939224|Cardiac catheterization|cardiac catheterization
5169333|NCT00939224|Congenital heart disease|congenital heart disease
5169334|NCT00939211|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
5169335|NCT00939211|efficacy|efficacy
5169336|NCT00939211|safety|safety
5169337|NCT00939211|inhalation|inhalation
5169338|NCT00939211|long-acting muscarinic receptor antagonist (LAMA)|long-acting muscarinic receptor antagonist (lama)
5169339|NCT00939198|Hookworm|hookworm
5169340|NCT00939198|Allergy|allergy
5169341|NCT00939198|Vaccine|vaccine
5169342|NCT00939198|Skin Test|skin test
5169343|NCT00939198|Immediate-type hypersensitivity to Na-ASP-2 hookworm antigen|immediate-type hypersensitivity to na-asp-2 hookworm antigen
5169344|NCT00939185|Compliance and Safety Study in Children with Upper and Lower Respiratory Tract Infections|compliance and safety study in children with upper and lower respiratory tract infections
5169345|NCT00939172|Advanced Refractory Solid Malignancies|advanced refractory solid malignancies
5169346|NCT00939172|Solid tumor|solid tumor
5169347|NCT00939172|Lymphoma|lymphoma
5169348|NCT00939172|TTP607|ttp607
5169349|NCT00939159|Low or Intermediate-1 Risk Myelodysplastic Syndrome|low or intermediate-1 risk myelodysplastic syndrome
5169350|NCT00939159|MDS|mds
5169351|NCT00939159|Cancer|cancer
5169352|NCT00939159|LBH589|lbh589
5169353|NCT00939146|self management|self management
5169354|NCT00939146|quality of life|quality of life
5169355|NCT00939146|end of life|end of life
5169356|NCT00939133|acne|acne
5169357|NCT00939133|tretinoin|tretinoin
5169358|NCT00939133|isotretinoin|isotretinoin
5169359|NCT00939133|recurrence|recurrence
5169361|NCT00939120|Benign prostatic hyperplasia (BPH)|benign prostatic hyperplasia (bph)
5169362|NCT00939120|dutasteride|dutasteride
5169363|NCT00939120|tolterodine ER|tolterodine er
5169364|NCT00939107|low back pain|low back pain
5169365|NCT00939107|Intervertebral disc|intervertebral disc
5169366|NCT00939107|McKenzie|mckenzie
5169367|NCT00939107|Physical Therapy|physical therapy
5169368|NCT00939107|Spinal manipulation|spinal manipulation
5169369|NCT00939107|Chiropractics|chiropractics
5169370|NCT00939107|Patient education|patient education
5169371|NCT00939107|Exercise therapy|exercise therapy
5169372|NCT00939107|Random allocation|random allocation
5169373|NCT00939094|Pain, Mechanical Hypersensitivity|pain, mechanical hypersensitivity
5169374|NCT00939094|Allodynia|allodynia
5169375|NCT00939094|Efficacy|efficacy
5169376|NCT00939094|analgesia|analgesia
5169377|NCT00939094|Neuropathic|neuropathic
5169378|NCT00939081|Obesity|obesity
5169379|NCT00939081|Women's health|women's health
5169380|NCT00939081|Minority health|minority health
5169381|NCT00939081|Obesity prevention|obesity prevention
5169382|NCT00939068|Chronic hepatitis B, Telbivudine, Intrauterine transmission|chronic hepatitis b, telbivudine, intrauterine transmission
5169383|NCT00939029|tobacco use|tobacco use
5169384|NCT00939029|smokeless tobacco|smokeless tobacco
5169385|NCT00939029|chewing tobacco|chewing tobacco
5169386|NCT00939029|snuff|snuff
5169387|NCT00939029|nicotine replacement|nicotine replacement
5169388|NCT00939029|tobacco dependence|tobacco dependence
5169389|NCT00939029|tobacco cessation|tobacco cessation
5169390|NCT00939029|tobacco abstinence|tobacco abstinence
5169391|NCT00939016|Dietary Assessment|dietary assessment
5169392|NCT00939016|24-hour dietary recall|24-hour dietary recall
5169393|NCT00939016|Dietary Restraint|dietary restraint
5169394|NCT00939016|Social Desirability|social desirability
5169395|NCT00939016|Portion estimation|portion estimation
5169396|NCT00939016|Underreporting|underreporting
5169397|NCT00938977|Obesity Hypoventilation syndrome|obesity hypoventilation syndrome
5169398|NCT00938977|cytokines|cytokines
5169399|NCT00938977|Adipokines|adipokines
5169400|NCT00938977|continuous positive airway pressure|continuous positive airway pressure
5169401|NCT00938977|bilevel support ventilation|bilevel support ventilation
5169402|NCT00938977|Response to continuous positive airway pressure|response to continuous positive airway pressure
5169403|NCT00938964|Cognition|cognition
5169404|NCT00938951|Dry Eye|dry eye
5169405|NCT00938951|Visual Performance|visual performance
5169406|NCT00938938|risk communication|risk communication
5169407|NCT00938938|medical reporting|medical reporting
5169408|NCT00938938|Mass media|mass media
5169409|NCT00938925|aggressive debridement|aggressive debridement
5169410|NCT00938925|nail lacquer|nail lacquer
5169411|NCT00938925|onychomycosis|onychomycosis
5169412|NCT00938925|podiatry|podiatry
5169413|NCT00938925|chiropody|chiropody
5169414|NCT00938925|podiatry care|podiatry care
5169415|NCT00938912|Lacosamide (VIMPAT)|lacosamide (vimpat)
5169416|NCT00938899|TMC435350-TiDP16-C101|tmc435350-tidp16-c101
5169417|NCT00938899|TMC435350-C101|tmc435350-c101
5169418|NCT00938899|TMC435350|tmc435350
5169419|NCT00938899|HCV|hcv
5169420|NCT00938873|MBCT|mbct
5169421|NCT00938873|identity|identity
5169422|NCT00938873|depression|depression
5169423|NCT00938873|recurrent|recurrent
5169424|NCT00938873|homework|homework
5169425|NCT00938860|Hepatitis C|hepatitis c
5169426|NCT00938860|liver transplantation|liver transplantation
5169427|NCT00938860|anti-viral therapy|anti-viral therapy
5169428|NCT00938847|left ventricular dysfunction|left ventricular dysfunction
5169429|NCT00938847|myocardial infarction|myocardial infarction
5169430|NCT00938847|left ventricular dysfunction (LVDF) after acute myocardial infarction|left ventricular dysfunction (lvdf) after acute myocardial infarction
5169431|NCT00938808|Osteoarthritis|osteoarthritis
5169432|NCT00938808|Obesity|obesity
5169433|NCT00938808|Weight loss|weight loss
5169434|NCT00938808|Dietary instruction|dietary instruction
5169435|NCT00938808|Formula diet|formula diet
5169436|NCT00938808|Attention|attention
5169437|NCT00938795|liver disease|liver disease
5169438|NCT00938795|uncertainty|uncertainty
5169439|NCT00938795|self management|self management
5169440|NCT00938769|cancer|cancer
5169441|NCT00938769|caregiver|caregiver
5169442|NCT00938769|symptom|symptom
5169443|NCT00938769|self management|self management
5169444|NCT00938756|leptomeningeal metastases|leptomeningeal metastases
5169445|NCT00938756|male breast cancer|male breast cancer
5169446|NCT00938756|stage IV breast cancer|stage iv breast cancer
5169447|NCT00938756|tumors metastatic to brain|tumors metastatic to brain
5169448|NCT00938756|adult meningioma|adult meningioma
5169449|NCT00938743|ADHD|adhd
5169450|NCT00938743|adults|adults
5169451|NCT00938743|driving performance|driving performance
5169452|NCT00938743|atomoxetine|atomoxetine
5169453|NCT00938730|Nonvalvular Atrial Fibrillation (NVAF)|nonvalvular atrial fibrillation (nvaf)
5169454|NCT00938730|Factor Xa Inhibitor|factor xa inhibitor
5169455|NCT00938730|Stroke|stroke
5169456|NCT00938730|Thromboembolism|thromboembolism
5169457|NCT00938730|Transient Ischemic attack|transient ischemic attack
5169458|NCT00938730|Anticoagulants|anticoagulants
5169459|NCT00938730|Prevention|prevention
5169460|NCT00938730|YM150|ym150
5169464|NCT00938691|Appearance|appearance
5169465|NCT00938691|Spread|spread
5169466|NCT00938678|Healthy volunteers|healthy volunteers
5169467|NCT00938665|Alzheimer|alzheimer
5169468|NCT00938665|Memory disorder|memory disorder
5169469|NCT00938665|dementia|dementia
5169470|NCT00938665|cognitive behavioral decline|cognitive behavioral decline
5169471|NCT00938665|vascular dementia|vascular dementia
5169472|NCT00938665|front temporal dementia|front temporal dementia
5169473|NCT00938652|triple negative breast cancer|triple negative breast cancer
5169474|NCT00938652|metastatic breast cancer|metastatic breast cancer
5169475|NCT00938652|Triple negative metastatic breast cancer|triple negative metastatic breast cancer
5169476|NCT00938626|refractory multiple myeloma|refractory multiple myeloma
5169477|NCT00938626|stage I multiple myeloma|stage i multiple myeloma
5169478|NCT00938626|stage II multiple myeloma|stage ii multiple myeloma
5169479|NCT00938626|stage III multiple myeloma|stage iii multiple myeloma
5169480|NCT00938613|SAR|sar
5169481|NCT00938600|pharmacokinetics|pharmacokinetics
5169482|NCT00938600|safety|safety
5169483|NCT00938587|Rheumatoid Arthritis Glucocorticoids Prednisone|rheumatoid arthritis glucocorticoids prednisone
5169484|NCT00938561|Chronic Kidney Disease|chronic kidney disease
5169485|NCT00938561|Glomerular Filtration Rate|glomerular filtration rate
5169486|NCT00938561|Kidney function|kidney function
5169487|NCT00938561|Markers|markers
5169488|NCT00938548|mastectomy|mastectomy
5169489|NCT00938548|pain, postoperative|pain, postoperative
5169490|NCT00938548|pregabalin|pregabalin
5169491|NCT00938535|Obesity|obesity
5169492|NCT00938535|Women's health|women's health
5169493|NCT00938535|Minority health|minority health
5169494|NCT00938535|Obesity prevention|obesity prevention
5169495|NCT00938522|Cilostazol loading|cilostazol loading
5169496|NCT00938522|Angioplasty, Transluminal, Percutaneous Coronary|angioplasty, transluminal, percutaneous coronary
5169497|NCT00938509|IBUPROFEN|ibuprofen
5169498|NCT00938509|CHILDREN|children
5169499|NCT00938509|FEVER|fever
5169500|NCT00938483|infant formula|infant formula
5169501|NCT00938483|cow's milk allergy|cow's milk allergy
5169502|NCT00938470|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
5169503|NCT00938470|adenocarcinoma of the gastroesophageal junction|adenocarcinoma of the gastroesophageal junction
5169504|NCT00938470|stage IIIA gastric cancer|stage iiia gastric cancer
5169505|NCT00938470|stage IIIB gastric cancer|stage iiib gastric cancer
5169506|NCT00938470|stage IIIC gastric cancer|stage iiic gastric cancer
5169507|NCT00938470|stage IIIA esophageal cancer|stage iiia esophageal cancer
5169508|NCT00938470|stage IIIB esophageal cancer|stage iiib esophageal cancer
5169509|NCT00938470|stage IIIC esophageal cancer|stage iiic esophageal cancer
5169510|NCT00938457|protocol specific|protocol specific
5169511|NCT00938444|Patients with moderate to severe RA|patients with moderate to severe ra
5169512|NCT00938431|Lacosamide|lacosamide
5169513|NCT00938431|Vimpat|vimpat
5169514|NCT00938431|Children|children
5169515|NCT00938431|Epilepsy|epilepsy
5169516|NCT00938431|Seizures|seizures
5169517|NCT00938431|Anti-epileptic|anti-epileptic
5169518|NCT00938405|type 1 diabetes mellitus|type 1 diabetes mellitus
5169519|NCT00938405|colesevelam|colesevelam
5169520|NCT00938405|LDL|ldl
5169521|NCT00938405|cholesterol|cholesterol
5169522|NCT00938405|A1c|a1c
5169523|NCT00938405|target range glucose values|target range glucose values
5169524|NCT00938392|influenza infection|influenza infection
5169525|NCT00938392|GSK Bio's influenza vaccine GSK2186877A|gsk bio's influenza vaccine gsk2186877a
5169526|NCT00938379|mosquito|mosquito
5169527|NCT00938379|repellent|repellent
5169528|NCT00938379|vector control|vector control
5169529|NCT00938379|malaria|malaria
5169530|NCT00938353|Moderate croup (Westley score 3-8)|moderate croup (westley score 3-8)
5169531|NCT00938340|Cardiovascular Disease|cardiovascular disease
5169532|NCT00938327|Gastroenteritis|gastroenteritis
5169533|NCT00938301|healthy volunteer, first in human, safety and tolerability|healthy volunteer, first in human, safety and tolerability
5169534|NCT00938288|Antithrombin|antithrombin
5169535|NCT00938288|Thrombosis|thrombosis
5169536|NCT00938288|Pharmacokinetics|pharmacokinetics
5169537|NCT00938288|Hereditary Antithrombin Deficiency|hereditary antithrombin deficiency
5169538|NCT00938288|Congenital Antithrombin Deficiency|congenital antithrombin deficiency
5169539|NCT00938249|Moderately Elevated Serum Triglyceride|moderately elevated serum triglyceride
5169540|NCT00938236|lung transplant|lung transplant
5169541|NCT00938236|lung transplant recipient|lung transplant recipient
5169542|NCT00938236|bronchiolitis obliterans syndrome|bronchiolitis obliterans syndrome
5169543|NCT00938236|bronchiolitis obliterans|bronchiolitis obliterans
5169544|NCT00938236|single lung transplant|single lung transplant
5169545|NCT00938236|double lung transplant|double lung transplant
5169546|NCT00938236|heart-lung transplant|heart-lung transplant
5169547|NCT00938236|Aerosol|aerosol
5169548|NCT00938223|melanoma|melanoma
5169549|NCT00938223|peptide|peptide
5169550|NCT00938223|vaccine|vaccine
5169551|NCT00938223|adjuvant|adjuvant
5169552|NCT00938223|advanced|advanced
5169553|NCT00938210|Colonic surgery|colonic surgery
5169554|NCT00938210|Postoperative care|postoperative care
5169555|NCT00938210|Fatigue|fatigue
5169556|NCT00938210|Physical function|physical function
5169557|NCT00938210|Quality of life|quality of life
5169558|NCT00938197|Fimasartan|fimasartan
5169559|NCT00938197|Drug interaction|drug interaction
5169560|NCT00938184|tolerance|tolerance
5169561|NCT00938184|single dose|single dose
5169562|NCT00938184|paroxetine|paroxetine
5169563|NCT00938184|controlled-release tablet|controlled-release tablet
5169564|NCT00938184|safety|safety
5169565|NCT00938184|pharmacokinetics|pharmacokinetics
5169566|NCT00938184|Japanese healthy male subjects|japanese healthy male subjects
5169567|NCT00938171|Cytokine|cytokine
5169568|NCT00938171|Anesthesia|anesthesia
5169569|NCT00938171|Local anesthesia|local anesthesia
5169570|NCT00938171|surgery|surgery
5169571|NCT00938171|breast cancer|breast cancer
5169572|NCT00938158|albiglutide|albiglutide
5169573|NCT00938158|hemodialysis|hemodialysis
5169574|NCT00938158|pharmacokinetics|pharmacokinetics
5169575|NCT00938158|renal|renal
5169576|NCT00938145|recurrent bladder cancer|recurrent bladder cancer
5169577|NCT00938145|stage II bladder cancer|stage ii bladder cancer
5169578|NCT00938145|stage III bladder cancer|stage iii bladder cancer
5169579|NCT00938145|stage IV bladder cancer|stage iv bladder cancer
5169580|NCT00938132|fimasartan|fimasartan
5169581|NCT00938132|drug interaction|drug interaction
5169582|NCT00938119|Cardiovascular disease|cardiovascular disease
5169583|NCT00938119|Diabetes|diabetes
5169584|NCT00938106|Intra-uterine Brachytherapy|intra-uterine brachytherapy
5169585|NCT00938106|cervix cancer|cervix cancer
5169586|NCT00938106|Patients suitable for intra-uterine brachytherapy for invasive carcinoma of the cervix.|patients suitable for intra-uterine brachytherapy for invasive carcinoma of the cervix.
5169587|NCT00938067|Injuries, Trauma|injuries, trauma
5169588|NCT00938054|Outcome|outcome
5169589|NCT00938054|Autism|autism
5169590|NCT00938054|Pervasive Developmental Disorder|pervasive developmental disorder
5169591|NCT00938028|microbiome|microbiome
5169592|NCT00938028|metabolome|metabolome
5169593|NCT00938028|stool|stool
5169594|NCT00938028|fecal samples|fecal samples
5169595|NCT00938028|handling|handling
5169596|NCT00938028|toddler|toddler
5169597|NCT00938015|postmarketing surveillance|postmarketing surveillance
5169598|NCT00938015|Enbrel|enbrel
5169599|NCT00938015|psoriatic arthritis|psoriatic arthritis
5169600|NCT00937989|ductal breast carcinoma in situ|ductal breast carcinoma in situ
5169601|NCT00937989|lobular breast carcinoma in situ|lobular breast carcinoma in situ
5169602|NCT00937989|male breast cancer|male breast cancer
5169603|NCT00937989|stage I breast cancer|stage i breast cancer
5169604|NCT00937989|stage II breast cancer|stage ii breast cancer
5169605|NCT00937989|stage IIIA breast cancer|stage iiia breast cancer
5169606|NCT00937989|stage IIIB breast cancer|stage iiib breast cancer
5169607|NCT00937989|stage IIIC breast cancer|stage iiic breast cancer
5169608|NCT00937976|Hemodialysis and peritoneal dialysis|hemodialysis and peritoneal dialysis
5169609|NCT00937963|cholesterol|cholesterol
5169610|NCT00937963|cardiovascular|cardiovascular
5169611|NCT00937963|CVD|cvd
5169612|NCT00937963|Triglycerides|triglycerides
5169613|NCT00937963|Heart|heart
5169614|NCT00937950|HPV|hpv
5169615|NCT00937950|Papillomavirus|papillomavirus
5169616|NCT00937950|Human papillomavirus|human papillomavirus
5169617|NCT00937950|Cervical cancer|cervical cancer
5169618|NCT00937950|HPV vaccine|hpv vaccine
5169619|NCT00937924|EUS|eus
5169620|NCT00937924|ERCP|ercp
5169621|NCT00937924|Sedation Level|sedation level
5169622|NCT00937924|Adverse Symptoms|adverse symptoms
5169623|NCT00937924|Recovery time|recovery time
5169624|NCT00937911|YM150|ym150
5169625|NCT00937911|Bleeding|bleeding
5169626|NCT00937911|Anticoagulant|anticoagulant
5169627|NCT00937911|Venous thromboembolism|venous thromboembolism
5169628|NCT00937911|FXa inhibitor|fxa inhibitor
5169629|NCT00937898|lean beef|lean beef
5169630|NCT00937898|cholesterol|cholesterol
5169631|NCT00937898|lipids|lipids
5169632|NCT00937898|diet intervention|diet intervention
5169633|NCT00937885|Reminiscence|reminiscence
5169634|NCT00937885|Nursing home staff|nursing home staff
5169635|NCT00937885|Nursing home residents|nursing home residents
5169636|NCT00937885|Elderly|elderly
5169637|NCT00937846|Cognitive impairment|cognitive impairment
5169638|NCT00937846|Schizophrenia|schizophrenia
5169639|NCT00937846|Alzheimer's Disease|alzheimer's disease
5169640|NCT00937846|PET|pet
5169641|NCT00937833|prostate cancer|prostate cancer
5169642|NCT00937833|prostatectomy|prostatectomy
5169643|NCT00937833|incontinence|incontinence
5169644|NCT00937820|YM150|ym150
5169645|NCT00937820|Bleeding|bleeding
5169646|NCT00937820|VTE|vte
5169647|NCT00937820|FXa inhibitor|fxa inhibitor
5169648|NCT00937820|Venous thromboembolism|venous thromboembolism
5169649|NCT00937807|hemodynamic stability|hemodynamic stability
5169650|NCT00937807|xenon|xenon
5169651|NCT00937807|carotid surgery|carotid surgery
5169652|NCT00937807|general anesthesia|general anesthesia
5169653|NCT00937781|stage III melanoma|stage iii melanoma
5169654|NCT00937781|recurrent melanoma|recurrent melanoma
5169655|NCT00937755|schizophrenia|schizophrenia
5169656|NCT00937755|antipsychotics|antipsychotics
5169657|NCT00937755|glucose homeostasis|glucose homeostasis
5169658|NCT00937755|metabolic disturbance|metabolic disturbance
5169659|NCT00937742|cardiovascular disease|cardiovascular disease
5169660|NCT00937742|Lycopene|lycopene
5169661|NCT00937742|Tomato|tomato
5169662|NCT00937729|uncompliant patients with virological failure|uncompliant patients with virological failure
5169663|NCT00937729|Treatment experienced|treatment experienced
5169664|NCT00937716|schizophrenia|schizophrenia
5169665|NCT00937716|treatment response|treatment response
5169666|NCT00937716|risperidone|risperidone
5169667|NCT00937716|functional magnetic resonance|functional magnetic resonance
5169668|NCT00937716|functional magnetic spectroscopy|functional magnetic spectroscopy
5169669|NCT00937690|melanoma|melanoma
5169670|NCT00937690|cutaneous|cutaneous
5169671|NCT00937690|imaging|imaging
5169672|NCT00937677|Tysabri|tysabri
5169673|NCT00937677|VWMTR|vwmtr
5169674|NCT00937664|Phase I|phase i
5169675|NCT00937664|cancer|cancer
5169676|NCT00937664|solid tumors|solid tumors
5169677|NCT00937664|advanced solid malignancies|advanced solid malignancies
5169678|NCT00937664|dose escalation|dose escalation
5169679|NCT00937664|combination treatment|combination treatment
5169680|NCT00937664|CHK inhibitor|chk inhibitor
5169681|NCT00937664|Japanese|japanese
5169682|NCT00937651|Fimasartan|fimasartan
5169683|NCT00937651|Essential Hypertension|essential hypertension
5169684|NCT00937638|Metabolic syndrome|metabolic syndrome
5169685|NCT00937638|Lean Beef|lean beef
5169686|NCT00937638|CVD|cvd
5169687|NCT00937612|Head and Neck Neoplasms|head and neck neoplasms
5169688|NCT00937612|Chemotherapy|chemotherapy
5169689|NCT00937612|Radiotherapy, Adjuvant|radiotherapy, adjuvant
5169690|NCT00937612|Surgery|surgery
5169691|NCT00937599|obese|obese
5169692|NCT00937599|brazil nuts|brazil nuts
5169693|NCT00937599|oxidative stress|oxidative stress
5169694|NCT00937599|microcirculatory|microcirculatory
5169695|NCT00937599|metabolic profile|metabolic profile
5169696|NCT00937586|Metastatic Prostate Cancer|metastatic prostate cancer
5169697|NCT00937586|Prostate Cancer Risk Assessment|prostate cancer risk assessment
5169698|NCT00937573|stents|stents
5169699|NCT00937573|mortality|mortality
5169700|NCT00937573|revascularization|revascularization
5169701|NCT00937573|stent thrombosis|stent thrombosis
5169702|NCT00937573|Drug-Eluting Stents|drug-eluting stents
5169703|NCT00937547|cervical cancer|cervical cancer
5169704|NCT00937547|Human Papillomavirus Infection|human papillomavirus infection
5169705|NCT00937534|Fimasartan|fimasartan
5169706|NCT00937534|healthy elderly and young male volunteer|healthy elderly and young male volunteer
5169707|NCT00937534|pharmacokinetic|pharmacokinetic
5169708|NCT00937521|Immunogenicity|immunogenicity
5169709|NCT00937521|Meningitis|meningitis
5169710|NCT00937521|Antibody|antibody
5169711|NCT00937521|Infants|infants
5169712|NCT00937508|smoking|smoking
5169713|NCT00937508|quitting|quitting
5169714|NCT00937508|varenicline|varenicline
5169715|NCT00937508|preoperative|preoperative
5169716|NCT00937508|long term abstinence|long term abstinence
5169717|NCT00937469|Social skills training for children with ADHD|social skills training for children with adhd
5169718|NCT00937469|Children with ADHD|children with adhd
5169719|NCT00937456|Esophagus|esophagus
5169720|NCT00937456|Cancer|cancer
5169721|NCT00937456|Surgery|surgery
5169722|NCT00937456|Laparoscopy|laparoscopy
5169723|NCT00937456|Randomized trial|randomized trial
5169724|NCT00937456|Esophageal cancer deemed to be resectable|esophageal cancer deemed to be resectable
5169725|NCT00937443|Physical Activity|physical activity
5169726|NCT00937443|Cardiac Heart Failure|cardiac heart failure
5169727|NCT00937443|Exercise Regimen|exercise regimen
5169728|NCT00937443|Cardioreparative Factors|cardioreparative factors
5169729|NCT00937430|Pelvic organ prolapse|pelvic organ prolapse
5169730|NCT00937430|Bowel preparation|bowel preparation
5169731|NCT00937417|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5169732|NCT00937417|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5169733|NCT00937417|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5169734|NCT00937417|stage IV breast cancer|stage iv breast cancer
5169735|NCT00937417|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
5169736|NCT00937417|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5169737|NCT00937417|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
5169738|NCT00937417|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
5169739|NCT00937417|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5169740|NCT00937417|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
5169741|NCT00937417|recurrent adenoid cystic carcinoma of the oral cavity|recurrent adenoid cystic carcinoma of the oral cavity
5169742|NCT00937417|recurrent mucoepidermoid carcinoma of the oral cavity|recurrent mucoepidermoid carcinoma of the oral cavity
5169743|NCT00937417|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
5169744|NCT00937417|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
5169745|NCT00937417|recurrent basal cell carcinoma of the lip|recurrent basal cell carcinoma of the lip
5169746|NCT00937417|stage IV adenoid cystic carcinoma of the oral cavity|stage iv adenoid cystic carcinoma of the oral cavity
5169747|NCT00937417|stage IV basal cell carcinoma of the lip|stage iv basal cell carcinoma of the lip
5169824|NCT00937222|peanuts|peanuts
5169825|NCT00937222|peanut butter|peanut butter
5169748|NCT00937417|stage IV mucoepidermoid carcinoma of the oral cavity|stage iv mucoepidermoid carcinoma of the oral cavity
5169749|NCT00937417|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5169750|NCT00937417|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
5169751|NCT00937417|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
5169752|NCT00937417|recurrent lymphoepithelioma of the nasopharynx|recurrent lymphoepithelioma of the nasopharynx
5169753|NCT00937417|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
5169754|NCT00937417|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
5169755|NCT00937417|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
5169756|NCT00937417|recurrent lymphoepithelioma of the oropharynx|recurrent lymphoepithelioma of the oropharynx
5169757|NCT00937417|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
5169758|NCT00937417|stage IV lymphoepithelioma of the oropharynx|stage iv lymphoepithelioma of the oropharynx
5169759|NCT00937417|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5169760|NCT00937417|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity
5169761|NCT00937417|recurrent inverted papilloma of the paranasal sinus and nasal cavity|recurrent inverted papilloma of the paranasal sinus and nasal cavity
5169762|NCT00937417|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity
5169763|NCT00937417|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
5169764|NCT00937417|stage IV esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iv esthesioneuroblastoma of the paranasal sinus and nasal cavity
5169765|NCT00937417|stage IV inverted papilloma of the paranasal sinus and nasal cavity|stage iv inverted papilloma of the paranasal sinus and nasal cavity
5169766|NCT00937417|stage IV midline lethal granuloma of the paranasal sinus and nasal cavity|stage iv midline lethal granuloma of the paranasal sinus and nasal cavity
5169767|NCT00937417|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
5169768|NCT00937417|recurrent salivary gland cancer|recurrent salivary gland cancer
5169769|NCT00937417|stage IV salivary gland cancer|stage iv salivary gland cancer
5169770|NCT00937417|anaplastic thyroid cancer|anaplastic thyroid cancer
5169771|NCT00937417|stage IV follicular thyroid cancer|stage iv follicular thyroid cancer
5169772|NCT00937417|insular thyroid cancer|insular thyroid cancer
5169773|NCT00937417|stage IV papillary thyroid cancer|stage iv papillary thyroid cancer
5169774|NCT00937417|recurrent thyroid cancer|recurrent thyroid cancer
5169775|NCT00937417|thyroid gland medullary carcinoma|thyroid gland medullary carcinoma
5169776|NCT00937417|recurrent prostate cancer|recurrent prostate cancer
5169777|NCT00937417|hormone-resistant prostate cancer|hormone-resistant prostate cancer
5169778|NCT00937417|recurrent breast cancer|recurrent breast cancer
5169779|NCT00937417|stage IV prostate cancer|stage iv prostate cancer
5169780|NCT00937417|male breast cancer|male breast cancer
5169781|NCT00937404|IPV|ipv
5169782|NCT00937391|MRI agents|mri agents
5169783|NCT00937391|Magnevist|magnevist
5169784|NCT00937365|Pregnancy|pregnancy
5169785|NCT00937365|Pain|pain
5169786|NCT00937365|Low back pain|low back pain
5169787|NCT00937365|Pubic symphysis pain|pubic symphysis pain
5169788|NCT00937365|CAM|cam
5169789|NCT00937365|Complementary & Alternative Medicine|complementary & alternative medicine
5169790|NCT00937365|Exercise|exercise
5169791|NCT00937365|Chiropractic|chiropractic
5169792|NCT00937365|Spinal manipulation|spinal manipulation
5169793|NCT00937365|Adjustments|adjustments
5169794|NCT00937365|Neuroemotional technique|neuroemotional technique
5169795|NCT00937365|Mind body|mind body
5169796|NCT00937365|Mind body therapy|mind body therapy
5169797|NCT00937365|Attachment|attachment
5169798|NCT00937365|Maternal Fetal relationship|maternal fetal relationship
5169799|NCT00937365|Intrauterine attachment|intrauterine attachment
5169800|NCT00937365|Heart rate variability|heart rate variability
5169801|NCT00937365|VAS|vas
5169802|NCT00937365|Visual analog scale|visual analog scale
5169803|NCT00937365|Roland Morris Disability Index|roland morris disability index
5169804|NCT00937352|Mild to moderate Alzheimer's disease|mild to moderate alzheimer's disease
5169805|NCT00937339|cerebrovascular accident|cerebrovascular accident
5169806|NCT00937339|bone|bone
5169807|NCT00937339|muscle|muscle
5169808|NCT00937339|vibration|vibration
5169809|NCT00937287|HPV|hpv
5169810|NCT00937287|African American|african american
5169811|NCT00937287|Rural|rural
5169812|NCT00937274|ETEC EPEC diarrhoea|etec epec diarrhoea
5169813|NCT00937274|phage therapy|phage therapy
5169814|NCT00937274|ORS|ors
5169815|NCT00937248|Cone Beam CT in rectal cancer patients|cone beam ct in rectal cancer patients
5169816|NCT00937248|Immobilizing rectal cancer patients|immobilizing rectal cancer patients
5169817|NCT00937248|Image guided radiotherapy in rectal cancer patients|image guided radiotherapy in rectal cancer patients
5169818|NCT00937235|Smoking Cessation|smoking cessation
5169819|NCT00937235|Anxiety|anxiety
5169820|NCT00937235|Behavior Therapy|behavior therapy
5169821|NCT00937235|Varenicline|varenicline
5169822|NCT00937222|diabetes|diabetes
5169823|NCT00937222|cholesterol|cholesterol
5169826|NCT00937222|dietary intervention|dietary intervention
5169827|NCT00937222|HDL cholesterol|hdl cholesterol
5169828|NCT00937183|Waldenström macroglobulinemia|waldenström macroglobulinemia
5169829|NCT00937183|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5169830|NCT00937183|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
5169831|NCT00937183|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
5169832|NCT00937183|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
5169833|NCT00937183|stage II grade 1 follicular lymphoma|stage ii grade 1 follicular lymphoma
5169834|NCT00937183|stage II grade 2 follicular lymphoma|stage ii grade 2 follicular lymphoma
5169835|NCT00937183|stage II grade 3 follicular lymphoma|stage ii grade 3 follicular lymphoma
5169836|NCT00937183|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5169837|NCT00937183|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5169838|NCT00937183|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5169839|NCT00937183|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
5169840|NCT00937183|stage II small lymphocytic lymphoma|stage ii small lymphocytic lymphoma
5169841|NCT00937183|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5169842|NCT00937183|stage I marginal zone lymphoma|stage i marginal zone lymphoma
5169843|NCT00937183|stage II marginal zone lymphoma|stage ii marginal zone lymphoma
5169844|NCT00937183|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5169845|NCT00937183|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
5169846|NCT00937183|stage II adult diffuse large cell lymphoma|stage ii adult diffuse large cell lymphoma
5169847|NCT00937183|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5169848|NCT00937183|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5169849|NCT00937183|stage I mantle cell lymphoma|stage i mantle cell lymphoma
5169850|NCT00937183|stage II mantle cell lymphoma|stage ii mantle cell lymphoma
5169851|NCT00937183|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5169852|NCT00937183|stage I multiple myeloma|stage i multiple myeloma
5169853|NCT00937183|stage II multiple myeloma|stage ii multiple myeloma
5169854|NCT00937183|stage III multiple myeloma|stage iii multiple myeloma
5169855|NCT00937183|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
5169856|NCT00937183|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
5169857|NCT00937183|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
5169858|NCT00937183|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5169859|NCT00937170|Total Knee Replacement|total knee replacement
5169860|NCT00937170|Gender Specific Design|gender specific design
5169861|NCT00937157|Inflammation|inflammation
5169862|NCT00937157|Multiple Sclerosis|multiple sclerosis
5169863|NCT00937157|Glatiramer Acetate|glatiramer acetate
5169864|NCT00937157|Gd enhancing lesions|gd enhancing lesions
5169865|NCT00937157|1.5T protocol|1.5t protocol
5169866|NCT00937157|3T protocol|3t protocol
5169867|NCT00937157|Magnetization transfer imaging (MTI)|magnetization transfer imaging (mti)
5169868|NCT00937157|Lesion activity analysis|lesion activity analysis
5169869|NCT00937157|Copaxone|copaxone
5169870|NCT00937144|endothelial function|endothelial function
5169871|NCT00937144|endothelial progenitor stem cells|endothelial progenitor stem cells
5169872|NCT00937118|laparotomy|laparotomy
5169873|NCT00937118|duodenal injury|duodenal injury
5169874|NCT00937118|pancreatic injury|pancreatic injury
5169875|NCT00937118|trauma|trauma
5169876|NCT00937092|Heart Failure|heart failure
5169877|NCT00937092|Dopamine|dopamine
5169878|NCT00937092|Furosemide|furosemide
5169879|NCT00937092|Worsening Renal Function|worsening renal function
5169880|NCT00937092|Hypokalemia|hypokalemia
5169881|NCT00937092|Outcomes|outcomes
5169882|NCT00937092|Prognosis|prognosis
5169883|NCT00937079|Glucagon-like peptide-1 receptor targeting|glucagon-like peptide-1 receptor targeting
5169884|NCT00937079|Insulinoma imaging|insulinoma imaging
5169885|NCT00937079|Exendin-4|exendin-4
5169886|NCT00937079|molecular imaging|molecular imaging
5169887|NCT00937066|Cost-effectiveness analysis|cost-effectiveness analysis
5169888|NCT00937066|Symbicort|symbicort
5169889|NCT00937053|Neutropenia|neutropenia
5169890|NCT00937053|Transfusions|transfusions
5169891|NCT00937053|Hemoglobin|hemoglobin
5169892|NCT00937053|Bone marrow transplant|bone marrow transplant
5169893|NCT00937053|Hematopoietic stem cell transplant|hematopoietic stem cell transplant
5169894|NCT00937040|Osmotic Release Oral System (OROS®) Extended Release Methylphenidate HCl|osmotic release oral system (oros®) extended release methylphenidate hcl
5169895|NCT00937040|CONCERTA® (OROS MPH)|concerta® (oros mph)
5169896|NCT00937027|Antifolate|antifolate
5169897|NCT00937027|Psoriasis|psoriasis
5169898|NCT00937027|Antiinflammatory drug|antiinflammatory drug
5169899|NCT00937027|Autoimmune disease|autoimmune disease
5169900|NCT00937027|Treatment|treatment
5169901|NCT00937014|infant formula|infant formula
5169902|NCT00937014|growth|growth
5169903|NCT00937014|weight|weight
5169904|NCT00937001|myopathy|myopathy
5169905|NCT00937001|respiratory failure|respiratory failure
5169906|NCT00937001|cognitive impairment|cognitive impairment
5169907|NCT00937001|delirium|delirium
5169908|NCT00936988|Hyperparathyroidism, Primary|hyperparathyroidism, primary
5169909|NCT00936988|cinacalcet|cinacalcet
5169910|NCT00936962|Meningococcal C vaccine|meningococcal c vaccine
5169911|NCT00936962|Meningitis study|meningitis study
5169912|NCT00936962|Canadian vaccine schedule|canadian vaccine schedule
5169913|NCT00936962|Prevention of Meningococcal C disease|prevention of meningococcal c disease
5169914|NCT00936949|total hip arthroplasty|total hip arthroplasty
5169915|NCT00936949|posterolateral|posterolateral
5169916|NCT00936949|modified lateral|modified lateral
5169917|NCT00936936|Testis|testis
5169918|NCT00936936|Relapsed Testicular Cancer|relapsed testicular cancer
5169919|NCT00936936|Bevacizumab|bevacizumab
5169920|NCT00936936|Avastin|avastin
5169921|NCT00936936|Anti-VEGF monoclonal antibody|anti-vegf monoclonal antibody
5169922|NCT00936936|rhuMAb-VEGF|rhumab-vegf
5169923|NCT00936936|Carboplatin|carboplatin
5169924|NCT00936936|Paraplatin|paraplatin
5169925|NCT00936936|Docetaxel|docetaxel
5169926|NCT00936936|Taxotere|taxotere
5169927|NCT00936936|Etoposide|etoposide
5169928|NCT00936936|VePesid|vepesid
5169929|NCT00936936|Gemcitabine|gemcitabine
5169930|NCT00936936|Gemcitabine Hydrochloride|gemcitabine hydrochloride
5169931|NCT00936936|Gemzar|gemzar
5169932|NCT00936936|Ifosfamide|ifosfamide
5169933|NCT00936936|Ifex|ifex
5169934|NCT00936936|Melphalan|melphalan
5169935|NCT00936936|Alkeran|alkeran
5169936|NCT00936923|CAPD|capd
5169937|NCT00936923|Diuretics|diuretics
5169938|NCT00936923|Residual Renal Function|residual renal function
5169939|NCT00936923|furosemide|furosemide
5169940|NCT00936910|central line fungal infections|central line fungal infections
5169941|NCT00936910|antifungal lock therapy|antifungal lock therapy
5169942|NCT00936910|Ambisome lock therapy|ambisome lock therapy
5169943|NCT00936884|Opioid Induced Constipation|opioid induced constipation
5169944|NCT00936871|lersivirine QT QTc ECG HIV NNRTI|lersivirine qt qtc ecg hiv nnrti
5169945|NCT00936858|radioiodine refractory thyroid cancer|radioiodine refractory thyroid cancer
5169946|NCT00936858|RAD001|rad001
5169947|NCT00936832|stage IV rectal cancer|stage iv rectal cancer
5169948|NCT00936832|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5169949|NCT00936832|liver metastases|liver metastases
5169950|NCT00936832|lung metastases|lung metastases
5169951|NCT00936819|Stent|stent
5169952|NCT00936819|endothelial progenitor cells|endothelial progenitor cells
5169953|NCT00936819|nitric oxide|nitric oxide
5169954|NCT00936819|myocardial infarction|myocardial infarction
5169955|NCT00936819|MRI|mri
5169956|NCT00936806|Intracranial tumor patients|intracranial tumor patients
5169957|NCT00936793|Drug Interaction|drug interaction
5169958|NCT00936793|Asthma|asthma
5169959|NCT00936793|HIV|hiv
5169960|NCT00936793|Beclomethasone|beclomethasone
5169961|NCT00936793|Protease Inhibitors|protease inhibitors
5169962|NCT00936793|HV|hv
5169963|NCT00936793|Healthy Volunteer|healthy volunteer
5169964|NCT00936793|HIV Infections|hiv infections
5169965|NCT00936780|Coronary Artery Disease|coronary artery disease
5169966|NCT00936780|Restenosis|restenosis
5169967|NCT00936780|Stent thrombosis|stent thrombosis
5169968|NCT00936780|Coronary stents|coronary stents
5169969|NCT00936780|Angioplasty|angioplasty
5169970|NCT00936780|Drug Eluting Stents (DES)|drug eluting stents (des)
5169971|NCT00936767|falciparum malaria|falciparum malaria
5169972|NCT00936767|artemisone|artemisone
5169973|NCT00936767|artesunate|artesunate
5169974|NCT00936767|resistance|resistance
5169975|NCT00936754|Glycemic index|glycemic index
5169976|NCT00936754|Reduction of glycemic index of ingested foods|reduction of glycemic index of ingested foods
5169977|NCT00936741|Cushing's Disease|cushing's disease
5169978|NCT00936741|Cushing's Syndrome|cushing's syndrome
5169979|NCT00936741|Cushings|cushings
5169980|NCT00936741|Pituitary|pituitary
5169981|NCT00936741|ACTH|acth
5169982|NCT00936741|Adrenocorticotropic hormone|adrenocorticotropic hormone
5169983|NCT00936741|Ectopic|ectopic
5169984|NCT00936741|Adrenal adenoma|adrenal adenoma
5169985|NCT00936741|Adrenal carcinoma|adrenal carcinoma
5169986|NCT00936741|Adrenal autonomy|adrenal autonomy
5169987|NCT00936741|Cortisol|cortisol
5169988|NCT00936741|Hypercortisolemia|hypercortisolemia
5169989|NCT00936741|Cushingoid|cushingoid
5169990|NCT00936741|Moon facies|moon facies
5169991|NCT00936741|Dorsocervical fat|dorsocervical fat
5169992|NCT00936741|Plethora|plethora
5169993|NCT00936741|Hirsutism|hirsutism
5169994|NCT00936741|Violaceous striae|violaceous striae
5169995|NCT00936741|Hormone|hormone
5169996|NCT00936741|Contraceptive|contraceptive
5169997|NCT00936741|Endocrine|endocrine
5169998|NCT00936741|Cushing Syndrome|cushing syndrome
5169999|NCT00936741|Ectopic ACTH Secretion|ectopic acth secretion
5170000|NCT00936715|prevention of chronic hepatitis B recurrence|prevention of chronic hepatitis b recurrence
5170001|NCT00936715|post orthotopic liver transplant|post orthotopic liver transplant
5170002|NCT00936715|prevention of chronic hepatitis B recurrence in patients who have undergone orthotopic liver transplant|prevention of chronic hepatitis b recurrence in patients who have undergone orthotopic liver transplant
5170003|NCT00936702|Newly Diagnosed Carcinoma of Unknown Primary Origin|newly diagnosed carcinoma of unknown primary origin
5170004|NCT00936702|Squamous Cell Carcinoma of Unknown Primary Origin|squamous cell carcinoma of unknown primary origin
5170005|NCT00936702|Undifferentiated Carcinoma of Unknown Primary|undifferentiated carcinoma of unknown primary
5170205|NCT00935818|nicotine|nicotine
5170006|NCT00936702|newly diagnosed carcinoma of unknown primary|newly diagnosed carcinoma of unknown primary
5170007|NCT00936689|Hepatocellular carcinoma;|hepatocellular carcinoma;
5170008|NCT00936689|Chemoembolization;|chemoembolization;
5170009|NCT00936689|DC-Beads.|dc-beads.
5170010|NCT00936676|parkinson's|parkinson's
5170011|NCT00936676|long-term effects|long-term effects
5170012|NCT00936676|adagio|adagio
5170013|NCT00936676|rasagiline|rasagiline
5170014|NCT00936676|delayed start|delayed start
5170015|NCT00936663|Diabetes|diabetes
5170016|NCT00936663|Kidney Transplant|kidney transplant
5170017|NCT00936663|Sitagliptin|sitagliptin
5170018|NCT00936650|Hyperparathyroidism, Primary|hyperparathyroidism, primary
5170019|NCT00936650|cinacalcet|cinacalcet
5170020|NCT00936624|Persistent asthma|persistent asthma
5170021|NCT00936611|LBH589|lbh589
5170022|NCT00936611|WM|wm
5170023|NCT00936611|panobinostat|panobinostat
5170024|NCT00936611|relapsed|relapsed
5170025|NCT00936611|waldenstrom|waldenstrom
5170026|NCT00936611|macroglobulinemia|macroglobulinemia
5170027|NCT00936598|Sleep|sleep
5170028|NCT00936598|Endometrial Neoplasms|endometrial neoplasms
5170029|NCT00936598|Pain|pain
5170030|NCT00936585|Crohn's Disease|crohn's disease
5170031|NCT00936585|Infusion|infusion
5170032|NCT00936585|Anti IL-17 Monoclonal Antibody|anti il-17 monoclonal antibody
5170033|NCT00936585|Placebo|placebo
5170034|NCT00936585|Crohn Disease|crohn disease
5170035|NCT00936585|Inflammatory Bowel Disease|inflammatory bowel disease
5170036|NCT00936572|Probiotics|probiotics
5170037|NCT00936572|La1|la1
5170038|NCT00936572|BB536|bb536
5170039|NCT00936572|Colorectal surgery|colorectal surgery
5170040|NCT00936572|Intestinal immunity|intestinal immunity
5170041|NCT00936572|Dendritic cells|dendritic cells
5170042|NCT00936572|Lymphocyte|lymphocyte
5170043|NCT00936572|Microbiota|microbiota
5170044|NCT00936559|rotator cuff tear repair|rotator cuff tear repair
5170045|NCT00936559|open surgical technique|open surgical technique
5170046|NCT00936559|safety|safety
5170047|NCT00936520|Diabetic Macular Edema|diabetic macular edema
5170048|NCT00936520|DME|dme
5170049|NCT00936520|Pars Plana Vitrectomy|pars plana vitrectomy
5170050|NCT00936520|Ocular Inflammation|ocular inflammation
5170051|NCT00936507|energy density|energy density
5170052|NCT00936507|portion size|portion size
5170053|NCT00936507|child feeding|child feeding
5170054|NCT00936494|obstructive sleep apnea|obstructive sleep apnea
5170055|NCT00936494|sleep related breathing disorder|sleep related breathing disorder
5170056|NCT00936494|snoring|snoring
5170057|NCT00936494|disturbed sleeping|disturbed sleeping
5170058|NCT00936494|open mouth breathing|open mouth breathing
5170059|NCT00936494|upper airway resistance syndrome|upper airway resistance syndrome
5170060|NCT00936481|OSA|osa
5170061|NCT00936468|Elderly influenza vaccine|elderly influenza vaccine
5170062|NCT00936455|telemedicine|telemedicine
5170063|NCT00936455|telephone|telephone
5170064|NCT00936455|outcomes|outcomes
5170065|NCT00936442|Compliance|compliance
5170066|NCT00936442|Early Breast Cancer|early breast cancer
5170067|NCT00936429|Dengue fever|dengue fever
5170068|NCT00936429|Dengue hemorrhagic fever|dengue hemorrhagic fever
5170069|NCT00936429|Dengue shock syndrome|dengue shock syndrome
5170070|NCT00936429|Vaccine|vaccine
5170071|NCT00936429|Hawaii Biotech|hawaii biotech
5170072|NCT00936416|Glomerular Filtration Rate|glomerular filtration rate
5170073|NCT00936416|Renal Blood Flow|renal blood flow
5170074|NCT00936416|MRI|mri
5170075|NCT00936416|Inulin|inulin
5170076|NCT00936416|Para-Aminohippuric Acid|para-aminohippuric acid
5170077|NCT00936390|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5170078|NCT00936390|stage IIB prostate cancer|stage iib prostate cancer
5170079|NCT00936390|stage IIA prostate cancer|stage iia prostate cancer
5170080|NCT00936351|schizophrenia|schizophrenia
5170081|NCT00936351|intervention studies|intervention studies
5170082|NCT00936351|mindfulness meditation|mindfulness meditation
5170083|NCT00936351|vocational rehabilitation|vocational rehabilitation
5170084|NCT00936351|schizoaffective disorder|schizoaffective disorder
5170085|NCT00936351|psychotic disorders|psychotic disorders
5170086|NCT00936338|anterior disc displacement without reduction of temporomandibular disorders|anterior disc displacement without reduction of temporomandibular disorders
5170087|NCT00936325|SCLS|scls
5170088|NCT00936325|Systemic Capillary Leak Syndrome|systemic capillary leak syndrome
5170089|NCT00936299|Adolescents|adolescents
5170090|NCT00936299|Substance Use Disorder|substance use disorder
5170091|NCT00936299|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
5170092|NCT00936299|Cognitive Behavioral Therapy|cognitive behavioral therapy
5170093|NCT00936286|Obstructive Sleep Apnea Syndrome|obstructive sleep apnea syndrome
5170094|NCT00936286|Respiratory Muscle Training|respiratory muscle training
5170095|NCT00936286|Normocapnic Hyperpnea|normocapnic hyperpnea
5170096|NCT00936286|SpiroTiger|spirotiger
5170097|NCT00936286|Polysomnography|polysomnography
5170098|NCT00936273|Sleep apnea syndrome|sleep apnea syndrome
5170099|NCT00936273|SAS|sas
5170100|NCT00936273|double loop gain|double loop gain
5170101|NCT00936273|DLI|dli
5170102|NCT00936273|double loop index|double loop index
5170103|NCT00936273|periodic breathing|periodic breathing
5170104|NCT00936273|polysomnography|polysomnography
5170105|NCT00936260|osteoporosis|osteoporosis
5170106|NCT00936260|postmenopausal|postmenopausal
5170107|NCT00936260|alendronate|alendronate
5170108|NCT00936234|CAD|cad
5170109|NCT00936234|diabetes|diabetes
5170110|NCT00936234|SDF-1|sdf-1
5170111|NCT00936234|endothelial function|endothelial function
5170112|NCT00936221|BRAF mutation positive|braf mutation positive
5170113|NCT00936221|advanced melanoma|advanced melanoma
5170114|NCT00936221|Advanced cutaneous melanoma|advanced cutaneous melanoma
5170115|NCT00936221|Unknown primary melanoma|unknown primary melanoma
5170116|NCT00936195|HIV|hiv
5170117|NCT00936195|pregnancy|pregnancy
5170118|NCT00936195|breastfeeding|breastfeeding
5170119|NCT00936195|PMTCT|pmtct
5170120|NCT00936195|ARV treatment|arv treatment
5170121|NCT00936195|treatment naive|treatment naive
5170122|NCT00936169|Patients with at least one complex lesion suitable for implantation of a drug-eluting stent|patients with at least one complex lesion suitable for implantation of a drug-eluting stent
5170123|NCT00936143|Spondylitis, Ankylosing|spondylitis, ankylosing
5170124|NCT00936143|infliximab|infliximab
5170125|NCT00936143|Antibodies, Monoclonal|antibodies, monoclonal
5170126|NCT00936130|Roux-en-Y gastric bypass surgery|roux-en-y gastric bypass surgery
5170127|NCT00936130|Sleeve gastrectomy (SGx) surgery|sleeve gastrectomy (sgx) surgery
5170128|NCT00936130|Gastric banding (GBx) surgery|gastric banding (gbx) surgery
5170129|NCT00936130|Low calorie diet program|low calorie diet program
5170130|NCT00936117|Cancer of the Blood|cancer of the blood
5170131|NCT00936117|Cancer of Bone Marrow|cancer of bone marrow
5170132|NCT00936117|Acute Leukemia|acute leukemia
5170133|NCT00936117|AML|aml
5170134|NCT00936117|Fungal infection|fungal infection
5170135|NCT00936117|Prophylaxis|prophylaxis
5170136|NCT00936117|Posaconazole|posaconazole
5170137|NCT00936117|SCH 56592|sch 56592
5170138|NCT00936117|Noxafil|noxafil
5170139|NCT00936117|Chemotherapy|chemotherapy
5170140|NCT00936104|pancreas|pancreas
5170141|NCT00936104|cancer|cancer
5170142|NCT00936104|stem cell|stem cell
5170143|NCT00936091|intestinal parasitic infections|intestinal parasitic infections
5170144|NCT00936091|malnutrition|malnutrition
5170145|NCT00936091|Anemia|anemia
5170146|NCT00936078|kidney transplantation|kidney transplantation
5170147|NCT00936078|cohort study|cohort study
5170148|NCT00936078|qualitative research|qualitative research
5170149|NCT00936078|health services research|health services research
5170150|NCT00936078|hypertension|hypertension
5170151|NCT00936065|Etanercept|etanercept
5170152|NCT00936065|Acitretin|acitretin
5170153|NCT00936065|Psoriasis|psoriasis
5170154|NCT00936052|glioblastomas|glioblastomas
5170155|NCT00936052|GBM|gbm
5170156|NCT00936052|gliosarcoma|gliosarcoma
5170157|NCT00936052|blastoma|blastoma
5170158|NCT00936052|sarcoma|sarcoma
5170159|NCT00936013|novel influenza A(H1N1)|novel influenza a(h1n1)
5170160|NCT00936013|chinese medicinal herbs|chinese medicinal herbs
5170161|NCT00936000|alcohol abuse|alcohol abuse
5170162|NCT00936000|alveolar capillary permeability|alveolar capillary permeability
5170163|NCT00935987|Primary Myelofibrosis|primary myelofibrosis
5170164|NCT00935987|Post-Polycythemia Vera|post-polycythemia vera
5170287|NCT00935493|aging|aging
5170165|NCT00935987|Post-Essential Thrombocythemia|post-essential thrombocythemia
5170166|NCT00935987|CYT387|cyt387
5170167|NCT00935961|CISPLATIN|cisplatin
5170168|NCT00935961|RAD001|rad001
5170169|NCT00935961|TAXOTERE (DOCETAXEL)|taxotere (docetaxel)
5170170|NCT00935961|09-028|09-028
5170171|NCT00935961|Squamous Cell Carcinoma|squamous cell carcinoma
5170172|NCT00935961|Local-Regional Advanced Head and Neck|local-regional advanced head and neck
5170173|NCT00935948|hemorrhoids|hemorrhoids
5170174|NCT00935948|hemorrhoidal disease|hemorrhoidal disease
5170175|NCT00935948|water smartweed|water smartweed
5170176|NCT00935948|hamamelis|hamamelis
5170177|NCT00935948|RCT|rct
5170178|NCT00935935|Treatment experienced|treatment experienced
5170179|NCT00935922|Flaxseed|flaxseed
5170180|NCT00935922|Weight loss|weight loss
5170181|NCT00935922|Heart health|heart health
5170182|NCT00935922|Diabetes|diabetes
5170183|NCT00935909|IV cannulation|iv cannulation
5170184|NCT00935896|Ventilator-associated lung injury|ventilator-associated lung injury
5170185|NCT00935896|Tumor necrosis factor-alpha|tumor necrosis factor-alpha
5170186|NCT00935896|Interleukin-8|interleukin-8
5170187|NCT00935896|Mechanical ventilation|mechanical ventilation
5170188|NCT00935896|Low tidal volume ventilation|low tidal volume ventilation
5170189|NCT00935896|Normal lungs|normal lungs
5170190|NCT00935883|Age Related macular Degeneration|age related macular degeneration
5170191|NCT00935883|Macular Degeneration|macular degeneration
5170192|NCT00935883|Drusen|drusen
5170193|NCT00935883|Geographic atrophy|geographic atrophy
5170194|NCT00935883|Eculizumab|eculizumab
5170195|NCT00935883|Soliris|soliris
5170196|NCT00935857|Balloon Enteroscopy|balloon enteroscopy
5170197|NCT00935857|Looping|looping
5170198|NCT00935844|Advanced solid tumors|advanced solid tumors
5170199|NCT00935844|Lymphoma|lymphoma
5170200|NCT00935831|Tolerability|tolerability
5170201|NCT00935831|Safety|safety
5170202|NCT00935831|Pharmacokinetics|pharmacokinetics
5170203|NCT00935831|Pharmacodynamics|pharmacodynamics
5170204|NCT00935818|smoking|smoking
5170206|NCT00935818|tobacco|tobacco
5170207|NCT00935818|dependence|dependence
5170208|NCT00935818|cessation|cessation
5170209|NCT00935818|abstinence|abstinence
5170210|NCT00935805|Diabetes Mellitus|diabetes mellitus
5170211|NCT00935805|Arterial Hypertension|arterial hypertension
5170212|NCT00935805|Treatment|treatment
5170213|NCT00935805|Primary Care|primary care
5170214|NCT00935792|hematopoietic cancer|hematopoietic cancer
5170215|NCT00935792|lymphoid cancer|lymphoid cancer
5170216|NCT00935779|Stomach Neoplasms|stomach neoplasms
5170217|NCT00935779|Peritoneum|peritoneum
5170218|NCT00935766|Latinos Using Cardio Health Actions to Reduce Risk|latinos using cardio health actions to reduce risk
5170219|NCT00935766|Omega three Fatty Acids|omega three fatty acids
5170220|NCT00935766|Vascular Function and Inflammation|vascular function and inflammation
5170221|NCT00935753|Lesch-Nyhan Disease|lesch-nyhan disease
5170222|NCT00935753|self-mutilating behavior|self-mutilating behavior
5170223|NCT00935740|thromboembolic disease|thromboembolic disease
5170224|NCT00935740|thromboplastin|thromboplastin
5170225|NCT00935740|hypercoagulability|hypercoagulability
5170226|NCT00935740|congestive heart failure|congestive heart failure
5170227|NCT00935727|renal transplant|renal transplant
5170228|NCT00935727|ultrasound|ultrasound
5170229|NCT00935727|elastography|elastography
5170230|NCT00935714|Arm|arm
5170231|NCT00935714|Lymphedema|lymphedema
5170232|NCT00935714|Breast Cancer|breast cancer
5170233|NCT00935714|Exercise|exercise
5170234|NCT00935714|Breast Cancer related Lymphedema|breast cancer related lymphedema
5170235|NCT00935701|Autism Spectrum Disorder|autism spectrum disorder
5170236|NCT00935701|Acupressure|acupressure
5170237|NCT00935701|Acupuncture|acupuncture
5170238|NCT00935688|malaria|malaria
5170239|NCT00935688|rapid diagnostic tests|rapid diagnostic tests
5170240|NCT00935688|afghanistan|afghanistan
5170241|NCT00935688|Non-specific fever|non-specific fever
5170242|NCT00935675|Patients with head and neck squamous cell carcinomas|patients with head and neck squamous cell carcinomas
5170243|NCT00935675|head and neck squamous cell carcinomas|head and neck squamous cell carcinomas
5170244|NCT00935662|First time in man|first time in man
5170245|NCT00935662|Safety study|safety study
5170246|NCT00935662|AZD8329|azd8329
5170247|NCT00935649|Toenail Fungus|toenail fungus
5170248|NCT00935649|PinPointe|pinpointe
5170249|NCT00935649|FootLaser|footlaser
5170250|NCT00935649|Onychomycosis|onychomycosis
5170251|NCT00935649|Fungal nails|fungal nails
5170252|NCT00935636|Intubation|intubation
5170253|NCT00935623|Malaria, Plasmodium vivax|malaria, plasmodium vivax
5170254|NCT00935610|Elderly persons|elderly persons
5170255|NCT00935610|Muscle function and strength|muscle function and strength
5170256|NCT00935610|Body composition|body composition
5170257|NCT00935610|Inflammatory cytokine levels|inflammatory cytokine levels
5170258|NCT00935610|Cognitive functions|cognitive functions
5170259|NCT00935610|Cysteine-rich whey protein isolate|cysteine-rich whey protein isolate
5170260|NCT00935610|Immunocal|immunocal
5170261|NCT00935610|Resistance training|resistance training
5170262|NCT00935610|Improved muscle function|improved muscle function
5170263|NCT00935610|Improved quality of life|improved quality of life
5170264|NCT00935610|Aging processes|aging processes
5170265|NCT00935610|Quality of life|quality of life
5170266|NCT00935597|Relapsed Non-Hodgkin's Lymphoma|relapsed non-hodgkin's lymphoma
5170267|NCT00935597|Hodgkin's Disease|hodgkin's disease
5170268|NCT00935597|Multiple Myeloma|multiple myeloma
5170269|NCT00935597|Chronic Lymphocytic Lymphoma|chronic lymphocytic lymphoma
5170270|NCT00935597|Relapsed Non-Hodgkin's lymphoma (excluding follicular lymphoma and marginal zone lymphoma)|relapsed non-hodgkin's lymphoma (excluding follicular lymphoma and marginal zone lymphoma)
5170271|NCT00935584|Communication|communication
5170272|NCT00935584|Doctor-patient relations|doctor-patient relations
5170273|NCT00935584|medical informatics|medical informatics
5170274|NCT00935584|patient-centered care|patient-centered care
5170275|NCT00935584|medical records systems, computerized|medical records systems, computerized
5170276|NCT00935558|dendritic cell|dendritic cell
5170277|NCT00935558|cancer vaccine|cancer vaccine
5170278|NCT00935558|breast cancer|breast cancer
5170279|NCT00935558|aromatase inhibitor|aromatase inhibitor
5170280|NCT00935558|Zadaxin|zadaxin
5170281|NCT00935545|Brain Tumors|brain tumors
5170282|NCT00935545|High Grade|high grade
5170283|NCT00935545|CNS|cns
5170284|NCT00935532|diabetes; exenatide once weekly; Byetta; glargine; Lantus; Amylin; Lilly|diabetes; exenatide once weekly; byetta; glargine; lantus; amylin; lilly
5170285|NCT00935519|total hip arthroplasty, ceramic, survival|total hip arthroplasty, ceramic, survival
5170286|NCT00935493|guanfacine|guanfacine
5170288|NCT00935493|cognitive aging|cognitive aging
5170289|NCT00935493|prefrontal cognitive function|prefrontal cognitive function
5170290|NCT00935493|executive function|executive function
5170291|NCT00935493|prefrontal cortex|prefrontal cortex
5170292|NCT00935480|HIV|hiv
5170293|NCT00935480|INTEGRASE INHIBITOR|integrase inhibitor
5170294|NCT00935480|Inhibitor on the lymphoid reservoir|inhibitor on the lymphoid reservoir
5170295|NCT00935480|Residual HIV replication|residual hiv replication
5170296|NCT00935480|treatment experienced|treatment experienced
5170297|NCT00935454|hepatocyte matrix implantation|hepatocyte matrix implantation
5170298|NCT00935454|endstage liver disease|endstage liver disease
5170299|NCT00935454|liver cirrhosis|liver cirrhosis
5170300|NCT00935454|impaired liver parenchyma|impaired liver parenchyma
5170301|NCT00935454|improvement of liver function|improvement of liver function
5170302|NCT00935441|Diabetes mellitus|diabetes mellitus
5170303|NCT00935441|chronic care|chronic care
5170304|NCT00935441|case management|case management
5170305|NCT00935441|telemedicine|telemedicine
5170306|NCT00935428|Equestrian injury|equestrian injury
5170307|NCT00935428|Horse injury|horse injury
5170308|NCT00935428|Trauma|trauma
5170309|NCT00935428|Horse|horse
5170310|NCT00935428|Equestrian|equestrian
5170311|NCT00935415|asthma|asthma
5170312|NCT00935415|exercise-induced bronchoconstriction|exercise-induced bronchoconstriction
5170313|NCT00935415|montelukast|montelukast
5170314|NCT00935415|clinical protection|clinical protection
5170315|NCT00935415|children|children
5170316|NCT00935415|time effect|time effect
5170317|NCT00935402|Energy balance|energy balance
5170318|NCT00935402|Weight management|weight management
5170319|NCT00935402|Food intake|food intake
5170320|NCT00935402|Energy expenditure|energy expenditure
5170321|NCT00935376|Sleep Management|sleep management
5170322|NCT00935376|Awareness Training Programs|awareness training programs
5170323|NCT00935376|Mindfulness Meditation|mindfulness meditation
5170324|NCT00935376|Mind Body Bridging|mind body bridging
5170325|NCT00935363|glyburide|glyburide
5170326|NCT00935363|pharmacokinetics|pharmacokinetics
5170327|NCT00935363|pharmacodynamics|pharmacodynamics
5170328|NCT00935363|drug interaction|drug interaction
5170329|NCT00935363|Healthy Volunteers|healthy volunteers
5170330|NCT00935350|viscous|viscous
5170331|NCT00935350|fibre|fibre
5170332|NCT00935350|polysaccharide|polysaccharide
5170333|NCT00935350|blood glucose|blood glucose
5170334|NCT00935350|postprandial|postprandial
5170335|NCT00935337|Sleep problems|sleep problems
5170336|NCT00935337|Awareness training program|awareness training program
5170337|NCT00935337|Mind body bridging|mind body bridging
5170338|NCT00935324|allo-SCT, GvHD, CK18-F|allo-sct, gvhd, ck18-f
5170339|NCT00935298|Renal Transplantation|renal transplantation
5170340|NCT00935298|Tacrolimus|tacrolimus
5170341|NCT00935298|CYP3A5|cyp3a5
5170342|NCT00935298|Genotyping|genotyping
5170343|NCT00935285|Ventilator-associated pneumonia (VAP)|ventilator-associated pneumonia (vap)
5170344|NCT00935285|Intensive care unit (ICU)|intensive care unit (icu)
5170345|NCT00935285|Toll-like receptors|toll-like receptors
5170346|NCT00935259|Hypercholesterolemia, Dyslipidemia, simvastatin, Zocor|hypercholesterolemia, dyslipidemia, simvastatin, zocor
5170347|NCT00935246|Genomic devices|genomic devices
5170348|NCT00935246|Prediction of Escitalopram Response|prediction of escitalopram response
5170349|NCT00935246|Depressed Patients|depressed patients
5170350|NCT00935233|ductal breast carcinoma in situ|ductal breast carcinoma in situ
5170351|NCT00935207|Pain|pain
5170352|NCT00935207|Pediatric Pain|pediatric pain
5170353|NCT00935207|Pain Diary|pain diary
5170354|NCT00935207|Pediatric Pain Measurement|pediatric pain measurement
5170355|NCT00935207|Pain Measurement|pain measurement
5170356|NCT00935194|Novel Influenza A(H1N1)|novel influenza a(h1n1)
5170357|NCT00935194|Oseltamivir|oseltamivir
5170358|NCT00935194|Chinese Medicinal Herbs|chinese medicinal herbs
5170359|NCT00935181|COPD|copd
5170360|NCT00935181|diaphragm|diaphragm
5170361|NCT00935181|muscle|muscle
5170362|NCT00935181|stretching|stretching
5170363|NCT00935181|exercises|exercises
5170364|NCT00935181|dyspnea|dyspnea
5170365|NCT00935181|respiratory muscle stretching|respiratory muscle stretching
5170366|NCT00935181|pulmonary rehabilitation|pulmonary rehabilitation
5170367|NCT00935181|exercise training|exercise training
5170368|NCT00935181|improved exercise capacity, dyspnea, quality of life|improved exercise capacity, dyspnea, quality of life
5170369|NCT00935168|Intensive Care|intensive care
5170370|NCT00935168|Fluid Resuscitation|fluid resuscitation
5170371|NCT00935168|Saline|saline
5170372|NCT00935168|Hydroxy-ethyl starch|hydroxy-ethyl starch
5170373|NCT00935155|exercise therapy|exercise therapy
5170374|NCT00935155|Knee arthroplasty|knee arthroplasty
5170375|NCT00935155|Acupuncture Analgesia|acupuncture analgesia
5170376|NCT00935155|Arthroplasty, Replacement, Knee|arthroplasty, replacement, knee
5170377|NCT00935155|rehabilitation|rehabilitation
5170378|NCT00935142|stage IV cancer with no treatment options|stage iv cancer with no treatment options
5170379|NCT00935142|non-curative|non-curative
5170380|NCT00935129|Treatment satisfaction|treatment satisfaction
5170381|NCT00935129|OmniPod|omnipod
5170382|NCT00935129|Insulin pump|insulin pump
5170383|NCT00935129|diabetes|diabetes
5170384|NCT00935103|Addiction|addiction
5170385|NCT00935103|Psychoeducation|psychoeducation
5170386|NCT00935103|Risk reduction behaviour|risk reduction behaviour
5170387|NCT00935103|Drop in center (DIC)|drop in center (dic)
5170388|NCT00935090|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5170389|NCT00935090|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5170390|NCT00935090|acute undifferentiated leukemia|acute undifferentiated leukemia
5170391|NCT00935090|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5170392|NCT00935090|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5170602|NCT00934752|de novo stenotic lesions|de novo stenotic lesions
5170393|NCT00935090|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5170394|NCT00935090|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5170395|NCT00935090|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5170396|NCT00935090|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5170397|NCT00935090|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5170398|NCT00935090|atypical chronic myeloid leukemia, BCR-ABL negative|atypical chronic myeloid leukemia, bcr-abl negative
5170399|NCT00935090|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5170400|NCT00935090|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5170401|NCT00935090|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5170402|NCT00935090|mast cell leukemia|mast cell leukemia
5170403|NCT00935090|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
5170404|NCT00935090|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
5170405|NCT00935090|prolymphocytic leukemia|prolymphocytic leukemia
5170406|NCT00935090|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5170407|NCT00935090|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5170408|NCT00935090|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
5170409|NCT00935090|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5170410|NCT00935090|refractory hairy cell leukemia|refractory hairy cell leukemia
5170411|NCT00935090|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5170412|NCT00935090|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5170413|NCT00935090|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
5170414|NCT00935090|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
5170415|NCT00935090|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
5170416|NCT00935090|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
5170417|NCT00935090|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
5170418|NCT00935090|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5170419|NCT00935090|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
5170420|NCT00935090|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5170421|NCT00935090|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
5170422|NCT00935090|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
5170423|NCT00935090|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
5170424|NCT00935090|untreated hairy cell leukemia|untreated hairy cell leukemia
5170425|NCT00935090|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5170426|NCT00935090|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
5170427|NCT00935090|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
5170428|NCT00935090|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5170429|NCT00935090|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5170430|NCT00935090|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5170431|NCT00935090|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
5170432|NCT00935090|cutaneous B-cell non-Hodgkin lymphoma|cutaneous b-cell non-hodgkin lymphoma
5170433|NCT00935090|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5170434|NCT00935090|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
5170435|NCT00935090|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
5170436|NCT00935090|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
5170437|NCT00935090|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
5170438|NCT00935090|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5170439|NCT00935090|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
5170440|NCT00935090|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
5170441|NCT00935090|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
5170442|NCT00935090|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
5170443|NCT00935090|adult grade III lymphomatoid granulomatosis|adult grade iii lymphomatoid granulomatosis
5170444|NCT00935090|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
5170445|NCT00935090|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
5170446|NCT00935090|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5170447|NCT00935090|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5170448|NCT00935090|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5170449|NCT00935090|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
5170450|NCT00935090|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
5170451|NCT00935090|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
5170452|NCT00935090|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
5170453|NCT00935090|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
5170454|NCT00935090|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
5170792|NCT00933816|cisplatin|cisplatin
5170455|NCT00935090|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
5170456|NCT00935090|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
5170457|NCT00935090|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
5170458|NCT00935090|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
5170459|NCT00935090|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
5170460|NCT00935090|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
5170461|NCT00935090|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
5170462|NCT00935090|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
5170463|NCT00935090|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
5170464|NCT00935090|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
5170465|NCT00935090|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
5170466|NCT00935090|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
5170467|NCT00935090|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
5170468|NCT00935090|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
5170469|NCT00935090|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
5170470|NCT00935090|stage I mantle cell lymphoma|stage i mantle cell lymphoma
5170471|NCT00935090|stage I marginal zone lymphoma|stage i marginal zone lymphoma
5170472|NCT00935090|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
5170473|NCT00935090|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
5170474|NCT00935090|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5170475|NCT00935090|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
5170476|NCT00935090|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
5170477|NCT00935090|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
5170478|NCT00935090|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
5170479|NCT00935090|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5170480|NCT00935090|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5170481|NCT00935090|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5170482|NCT00935090|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5170483|NCT00935090|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
5170484|NCT00935090|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
5170485|NCT00935090|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5170486|NCT00935090|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5170487|NCT00935090|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5170488|NCT00935090|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5170489|NCT00935090|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5170490|NCT00935090|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5170491|NCT00935090|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5170492|NCT00935090|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5170493|NCT00935090|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5170494|NCT00935090|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5170495|NCT00935090|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5170496|NCT00935090|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5170497|NCT00935090|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5170498|NCT00935090|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5170499|NCT00935090|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5170500|NCT00935090|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5170501|NCT00935090|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5170502|NCT00935090|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5170503|NCT00935090|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5170504|NCT00935090|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5170505|NCT00935090|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5170506|NCT00935090|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5170507|NCT00935090|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5170508|NCT00935090|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5170509|NCT00935090|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5170510|NCT00935090|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5170511|NCT00935090|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5170512|NCT00935090|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5170513|NCT00935090|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
5170514|NCT00935090|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5170515|NCT00935090|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5170795|NCT00933790|HIV|hiv
5170516|NCT00935090|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5170517|NCT00935090|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5170518|NCT00935090|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5170519|NCT00935090|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5170520|NCT00935090|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5170521|NCT00935090|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5170522|NCT00935090|intraocular lymphoma|intraocular lymphoma
5170523|NCT00935090|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
5170524|NCT00935090|primary central nervous system Hodgkin lymphoma|primary central nervous system hodgkin lymphoma
5170525|NCT00935090|post-transplant lymphoproliferative disorder|post-transplant lymphoproliferative disorder
5170526|NCT00935090|chronic eosinophilic leukemia|chronic eosinophilic leukemia
5170527|NCT00935090|chronic neutrophilic leukemia|chronic neutrophilic leukemia
5170528|NCT00935090|primary myelofibrosis|primary myelofibrosis
5170529|NCT00935090|essential thrombocythemia|essential thrombocythemia
5170530|NCT00935090|polycythemia vera|polycythemia vera
5170531|NCT00935090|extramedullary plasmacytoma|extramedullary plasmacytoma
5170532|NCT00935090|isolated plasmacytoma of bone|isolated plasmacytoma of bone
5170533|NCT00935090|stage I multiple myeloma|stage i multiple myeloma
5170534|NCT00935090|stage II multiple myeloma|stage ii multiple myeloma
5170535|NCT00935090|stage III multiple myeloma|stage iii multiple myeloma
5170536|NCT00935090|primary systemic amyloidosis|primary systemic amyloidosis
5170537|NCT00935090|refractory multiple myeloma|refractory multiple myeloma
5170538|NCT00935090|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5170539|NCT00935090|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5170540|NCT00935090|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5170541|NCT00935090|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
5170542|NCT00935077|Hypertension|hypertension
5170543|NCT00935077|Pharmacist Physician Collaborative Management of Hypertension|pharmacist physician collaborative management of hypertension
5170544|NCT00935064|Diabetes|diabetes
5170545|NCT00935051|type 1 diabetes|type 1 diabetes
5170546|NCT00935051|type 2 diabetes|type 2 diabetes
5170547|NCT00935051|Diabetic foot ulcer|diabetic foot ulcer
5170548|NCT00935025|Phase I|phase i
5170549|NCT00935025|Japanese healthy volunteer|japanese healthy volunteer
5170550|NCT00935025|AZD1305|azd1305
5170551|NCT00935025|Japanese and Caucasian|japanese and caucasian
5170552|NCT00934986|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
5170553|NCT00934986|NK Cells|nk cells
5170554|NCT00934973|irritable bowel syndrome|irritable bowel syndrome
5170555|NCT00934973|treatment|treatment
5170556|NCT00934960|vision|vision
5170557|NCT00934960|Intraocular lenses|intraocular lenses
5170558|NCT00934947|Burns|burns
5170559|NCT00934947|Pain|pain
5170560|NCT00934934|Candida|candida
5170561|NCT00934934|ventilator associated pneumonia|ventilator associated pneumonia
5170562|NCT00934934|respiratory tract infection|respiratory tract infection
5170563|NCT00934934|antifungal|antifungal
5170564|NCT00934934|biomarker|biomarker
5170565|NCT00934921|Bioequivalence|bioequivalence
5170566|NCT00934908|Zyprexa®|zyprexa®
5170567|NCT00934908|Green Tea|green tea
5170568|NCT00934908|ALL|all
5170569|NCT00934895|stage IIIA breast cancer|stage iiia breast cancer
5170570|NCT00934895|stage IIIB breast cancer|stage iiib breast cancer
5170571|NCT00934895|stage IIIC breast cancer|stage iiic breast cancer
5170572|NCT00934895|stage IV breast cancer|stage iv breast cancer
5170573|NCT00934895|HER2-negative breast cancer|her2-negative breast cancer
5170574|NCT00934895|recurrent breast cancer|recurrent breast cancer
5170575|NCT00934882|Colorectal cancer|colorectal cancer
5170576|NCT00934882|Targeted therapy|targeted therapy
5170577|NCT00934882|Multi-kinase inhibitor|multi-kinase inhibitor
5170578|NCT00934882|FOLFOX|folfox
5170579|NCT00934882|FOLFIRI|folfiri
5170580|NCT00934843|Cardiopulmonary Bypass (CPB)|cardiopulmonary bypass (cpb)
5170581|NCT00934843|System Inflammatory Response|system inflammatory response
5170582|NCT00934843|Low Cardiac Output Syndrome (LCOS) in Neonates|low cardiac output syndrome (lcos) in neonates
5170583|NCT00934843|Methylprednisolone|methylprednisolone
5170584|NCT00934843|Cardiopulmonary Bypass (CPB) in Neonates|cardiopulmonary bypass (cpb) in neonates
5170585|NCT00934843|Glucocorticoid Use in Neonatal Cardiac Surgery|glucocorticoid use in neonatal cardiac surgery
5170586|NCT00934843|Steroid|steroid
5170587|NCT00934830|Antibiotic|antibiotic
5170588|NCT00934830|Ultrasound|ultrasound
5170589|NCT00934830|Efficacy|efficacy
5170590|NCT00934830|Treatment|treatment
5170591|NCT00934817|Volunteer|volunteer
5170592|NCT00934804|refractive surgery|refractive surgery
5170593|NCT00934791|Kidney Transplant|kidney transplant
5170594|NCT00934791|Autosomal dominant polycystic kidney disease|autosomal dominant polycystic kidney disease
5170595|NCT00934791|Polycystic liver disease|polycystic liver disease
5170596|NCT00934778|Confocal microscopy|confocal microscopy
5170597|NCT00934778|Endocytoscopy|endocytoscopy
5170598|NCT00934778|Diffuse lung disease|diffuse lung disease
5170599|NCT00934778|Minimally invasive|minimally invasive
5170600|NCT00934778|Lung cancer and dysplasia|lung cancer and dysplasia
5170601|NCT00934765|overweight, obesity, male, fertility|overweight, obesity, male, fertility
5170603|NCT00934739|High-Risk Oral Cavity Cancer,|high-risk oral cavity cancer,
5170604|NCT00934739|Anti-Angiogenesis|anti-angiogenesis
5170605|NCT00934726|Quality of Life|quality of life
5170606|NCT00934726|Patient satisfaction|patient satisfaction
5170607|NCT00934726|Schizophrenia|schizophrenia
5170608|NCT00934726|Investigate quality of life in schizophrenia|investigate quality of life in schizophrenia
5170609|NCT00934713|montelukast, very young children, lung function tests|montelukast, very young children, lung function tests
5170610|NCT00934700|perinatal asphyxia|perinatal asphyxia
5170611|NCT00934700|encephalopathy|encephalopathy
5170612|NCT00934700|neuroprotection|neuroprotection
5170613|NCT00934687|depression|depression
5170614|NCT00934687|depressive|depressive
5170615|NCT00934687|botulinum|botulinum
5170616|NCT00934687|botox|botox
5170617|NCT00934674|Healthy Subjects|healthy subjects
5170618|NCT00934661|hip resurfacing|hip resurfacing
5170619|NCT00934661|hip arthroplasty|hip arthroplasty
5170620|NCT00934635|D2-receptor occupancy|d2-receptor occupancy
5170621|NCT00934635|Antipsychotic drugs|antipsychotic drugs
5170622|NCT00934635|Paliperidone ER, Oral risperidone|paliperidone er, oral risperidone
5170623|NCT00934635|Dopamine|dopamine
5170624|NCT00934635|Fallypride|fallypride
5170625|NCT00934635|Plasma concentration|plasma concentration
5170626|NCT00934635|Therapeutic window, Healthy controls|therapeutic window, healthy controls
5170627|NCT00934622|AcrySof|acrysof
5170628|NCT00934622|ReSTOR|restor
5170629|NCT00934622|Aspheric IOL|aspheric iol
5170630|NCT00934622|Cataract|cataract
5170631|NCT00934609|Exercise|exercise
5170632|NCT00934609|heart failure|heart failure
5170633|NCT00934609|dilated cardiomyopathy|dilated cardiomyopathy
5170634|NCT00934609|Endurance training|endurance training
5170635|NCT00934596|Cardiac de-airing|cardiac de-airing
5170636|NCT00934596|CO2 insufflation|co2 insufflation
5170637|NCT00934596|Air emboli|air emboli
5170638|NCT00934596|Trans cranial doppler|trans cranial doppler
5170639|NCT00934596|Intraoperative echocardiography|intraoperative echocardiography
5170640|NCT00934583|Bulimia Nervosa|bulimia nervosa
5170641|NCT00934583|Binge Eating|binge eating
5170642|NCT00934583|Binge-Eating Disorder|binge-eating disorder
5170643|NCT00934570|Obesity|obesity
5170644|NCT00934570|Metformin|metformin
5170645|NCT00934570|Physical activity|physical activity
5170646|NCT00934570|Cardiovascular health|cardiovascular health
5170647|NCT00934544|Myelofibrosis|myelofibrosis
5170648|NCT00934544|Post-Polycythemia Vera Myelofibrosis|post-polycythemia vera myelofibrosis
5170649|NCT00934544|Post-Essential Thrombocythemia Myelofibrosis|post-essential thrombocythemia myelofibrosis
5170650|NCT00934531|Mild Cognitive Impairment (MCI)|mild cognitive impairment (mci)
5170651|NCT00934531|Falls|falls
5170652|NCT00934531|donepezil|donepezil
5170653|NCT00934531|gait variability|gait variability
5170654|NCT00934518|Squamous cell carcinoma, Head and Neck cancer|squamous cell carcinoma, head and neck cancer
5170655|NCT00934505|Positron-Emission Tomography|positron-emission tomography
5170656|NCT00934505|PET Scan|pet scan
5170658|NCT00934505|oesophageal cancer|oesophageal cancer
5170659|NCT00934505|chemo-Radiation Oncology|chemo-radiation oncology
5170660|NCT00934505|SUV|suv
5170661|NCT00934492|Malnutrition|malnutrition
5170662|NCT00934492|Wasting|wasting
5170663|NCT00934492|Kwashiorkor|kwashiorkor
5170664|NCT00934492|Immune deficiency|immune deficiency
5170665|NCT00934492|Infection|infection
5170666|NCT00934492|Prophylaxis|prophylaxis
5170667|NCT00934492|Mortality|mortality
5170668|NCT00934492|Kenya|kenya
5170669|NCT00934479|Chronic Constipation|chronic constipation
5170670|NCT00934479|Constipation Predominant Irritable Bowel Syndrome|constipation predominant irritable bowel syndrome
5170671|NCT00934479|Intestinal Microecology|intestinal microecology
5170672|NCT00934453|Healthy adult volunteers|healthy adult volunteers
5170673|NCT00934453|Lactobacillus rhamnosus GG|lactobacillus rhamnosus gg
5170674|NCT00934453|probiotic|probiotic
5170675|NCT00934453|dietary supplement|dietary supplement
5170676|NCT00934453|safety|safety
5170677|NCT00934453|Safety Assessment|safety assessment
5170678|NCT00934440|kidney cancer|kidney cancer
5170679|NCT00934440|renal cell|renal cell
5170680|NCT00934427|Raynaud's|raynaud's
5170681|NCT00934427|scleroderma|scleroderma
5170682|NCT00934427|nitroglycerin|nitroglycerin
5170683|NCT00934427|MQX-503|mqx-503
5170684|NCT00934427|treatment|treatment
5170685|NCT00934401|FLT|flt
5170686|NCT00934401|fluorolabeled thymidine|fluorolabeled thymidine
5170687|NCT00934401|breast cancer|breast cancer
5170688|NCT00934401|Positron-Emission Mammography|positron-emission mammography
5170689|NCT00934388|Sportsmans groin, Gilmores groin|sportsmans groin, gilmores groin
5170690|NCT00934375|Mild Cognitive Impairment|mild cognitive impairment
5170691|NCT00934349|Comoro Island|comoro island
5170692|NCT00934349|vit B1 intake|vit b1 intake
5170693|NCT00934349|Thiamine status|thiamine status
5170694|NCT00934349|Genetic factor|genetic factor
5170695|NCT00934323|volunteer|volunteer
5170696|NCT00934310|Patient Safety|patient safety
5170697|NCT00934310|Team work|team work
5170698|NCT00934310|Communication|communication
5170699|NCT00934310|Ambulatory surgical patients|ambulatory surgical patients
5170793|NCT00933816|fluorouracil|fluorouracil
5170794|NCT00933790|TB|tb
5170700|NCT00934297|MRI visible breast lesions that are occult under ultrasound|mri visible breast lesions that are occult under ultrasound
5170701|NCT00934284|sciatic neuropathy|sciatic neuropathy
5170702|NCT00934284|physical therapy|physical therapy
5170703|NCT00934284|spinal injections|spinal injections
5170704|NCT00934271|acromegaly|acromegaly
5170705|NCT00934271|irradiation|irradiation
5170706|NCT00934271|remission|remission
5170707|NCT00934271|pituitary function|pituitary function
5170708|NCT00934258|genes|genes
5170709|NCT00934258|rosuvastatin|rosuvastatin
5170710|NCT00934258|fenofibrate|fenofibrate
5170711|NCT00934258|Cardiovascular (CV) diseases|cardiovascular (cv) diseases
5170712|NCT00934258|dyslipidemia|dyslipidemia
5170713|NCT00934258|metabolic syndrome|metabolic syndrome
5170714|NCT00934258|identify genetic determinants of the wide range of interindividual variability in phenotypic and clinical response to the lipid-lowering drug classes|identify genetic determinants of the wide range of interindividual variability in phenotypic and clinical response to the lipid-lowering drug classes
5170715|NCT00934258|identify genetic susceptibility to drug-related side effects.|identify genetic susceptibility to drug-related side effects.
5170716|NCT00934245|Influenza|influenza
5170717|NCT00934245|India|india
5170718|NCT00934245|Children|children
5170719|NCT00934245|Trivalent Influenza Vaccine (TIV)|trivalent influenza vaccine (tiv)
5170720|NCT00934245|Inactivated poliovirus vaccine (IPV)|inactivated poliovirus vaccine (ipv)
5170721|NCT00934245|Direct vaccine effectiveness|direct vaccine effectiveness
5170722|NCT00934245|Indirect vaccine effectiveness|indirect vaccine effectiveness
5170723|NCT00934232|cancer|cancer
5170724|NCT00934232|myeloma|myeloma
5170725|NCT00934219|hypertriglyceridemia|hypertriglyceridemia
5170726|NCT00934219|triglycerides|triglycerides
5170727|NCT00934219|familial hypertriglyceridemia|familial hypertriglyceridemia
5170728|NCT00934206|Exercise|exercise
5170729|NCT00934206|healthy subjects|healthy subjects
5170730|NCT00934180|Bioequivalence|bioequivalence
5170731|NCT00934154|multiple myeloma|multiple myeloma
5170732|NCT00934154|thalidomide|thalidomide
5170733|NCT00934154|melphalan|melphalan
5170734|NCT00934154|prednisolone|prednisolone
5170735|NCT00934154|newly diagnosed|newly diagnosed
5170736|NCT00934154|elderly|elderly
5170737|NCT00934154|not eligible for transplantation|not eligible for transplantation
5170738|NCT00934141|Organizational change|organizational change
5170739|NCT00934141|process improvement|process improvement
5170740|NCT00934141|addiction treatment|addiction treatment
5170741|NCT00934141|cost effectiveness study|cost effectiveness study
5170742|NCT00934128|Advanced Cancer|advanced cancer
5170743|NCT00934128|Persistent Dyspnea|persistent dyspnea
5170744|NCT00934128|Shortness of breath|shortness of breath
5170745|NCT00934128|Specialized breathing devices|specialized breathing devices
5170746|NCT00934128|Bilevel positive airway pressure device|bilevel positive airway pressure device
5170747|NCT00934128|BIPAP|bipap
5170748|NCT00934128|High flow oxygen delivery device|high flow oxygen delivery device
5170749|NCT00934128|VapoTherm|vapotherm
5170750|NCT00934128|Edmonton Symptom Assessment Scale|edmonton symptom assessment scale
5170751|NCT00934128|ESAS|esas
5170752|NCT00934115|To define the incidence, categories of infections by organ systems, etiologic agents and risk|to define the incidence, categories of infections by organ systems, etiologic agents and risk
5170753|NCT00934037|Coronary Artery Disease|coronary artery disease
5170754|NCT00934037|Computed Tomography|computed tomography
5170755|NCT00934037|Myoperfusion|myoperfusion
5170756|NCT00934037|Angiography|angiography
5170757|NCT00934037|SPECT|spect
5170758|NCT00934024|nicotine dependence|nicotine dependence
5170759|NCT00934024|tobacco|tobacco
5170760|NCT00934024|smoking|smoking
5170761|NCT00934011|C-reactive protein|c-reactive protein
5170762|NCT00934011|procalcitonin|procalcitonin
5170763|NCT00934011|sepsis|sepsis
5170764|NCT00934011|antibiotic therapy|antibiotic therapy
5170765|NCT00933998|DPN|dpn
5170766|NCT00933959|Sleep problems|sleep problems
5170767|NCT00933959|Awareness training program|awareness training program
5170768|NCT00933959|Mind body bridging|mind body bridging
5170769|NCT00933920|Aliskiren,|aliskiren,
5170770|NCT00933920|hypertension,|hypertension,
5170771|NCT00933920|renin-angiotensin-aldosterone system,|renin-angiotensin-aldosterone system,
5170772|NCT00933920|pharmacokinetics,|pharmacokinetics,
5170773|NCT00933920|pharmacodynamics|pharmacodynamics
5170774|NCT00933894|VX-950-TiDP24-C133|vx-950-tidp24-c133
5170775|NCT00933894|VX-950-C133|vx-950-c133
5170776|NCT00933894|VX950|vx950
5170777|NCT00933894|HCV|hcv
5170778|NCT00933894|telaprevir|telaprevir
5170779|NCT00933894|escitalopram|escitalopram
5170780|NCT00933881|GDM|gdm
5170781|NCT00933868|A stroke that occurred three months to four years ago|a stroke that occurred three months to four years ago
5170782|NCT00933855|Training Workshop|training workshop
5170783|NCT00933855|Communication|communication
5170784|NCT00933855|Questionnaires|questionnaires
5170785|NCT00933855|Multiple Diseases|multiple diseases
5170786|NCT00933829|absorbable sutures|absorbable sutures
5170787|NCT00933829|non-absorbable sutures|non-absorbable sutures
5170788|NCT00933829|wound management|wound management
5170789|NCT00933816|sorafenib|sorafenib
5170790|NCT00933816|intraarterial infusion chemotherapy|intraarterial infusion chemotherapy
5170791|NCT00933816|Low dose FP|low dose fp
5170796|NCT00933790|ARR|arr
5170797|NCT00933790|Short course chemotherapy|short course chemotherapy
5170798|NCT00933790|Drug resistance|drug resistance
5170799|NCT00933751|central venous oxygen saturation|central venous oxygen saturation
5170800|NCT00933751|oxygen transport|oxygen transport
5170801|NCT00933751|physiologic monitoring|physiologic monitoring
5170802|NCT00933751|tissue oxygenation|tissue oxygenation
5170803|NCT00933751|Patients before high risk abdominal surgery|patients before high risk abdominal surgery
5170804|NCT00933738|Patients needing OAT (Oral Anticoagulation Therapy)|patients needing oat (oral anticoagulation therapy)
5170805|NCT00933725|menopausal syndrome|menopausal syndrome
5170806|NCT00933725|TCM intervention|tcm intervention
5170807|NCT00933673|NK/T cell lymphoma|nk/t cell lymphoma
5170808|NCT00933673|DICE|dice
5170809|NCT00933673|L-asparaginase|l-asparaginase
5170810|NCT00933660|Education|education
5170811|NCT00933660|Retention|retention
5170812|NCT00933660|Retrieval|retrieval
5170813|NCT00933647|Camellia sinensis|camellia sinensis
5170814|NCT00933647|Ilex paraguariensis|ilex paraguariensis
5170815|NCT00933647|Green tea|green tea
5170816|NCT00933647|Yerba mate tea|yerba mate tea
5170817|NCT00933647|Maté|maté
5170818|NCT00933647|Dyslipidemia|dyslipidemia
5170819|NCT00933647|Inflammation|inflammation
5170820|NCT00933647|Obesity|obesity
5170821|NCT00933634|atrial fibrillation|atrial fibrillation
5170822|NCT00933634|electrical cardioversion|electrical cardioversion
5170823|NCT00933634|pharmacological cardioversion|pharmacological cardioversion
5170824|NCT00933608|subjective memory complaints|subjective memory complaints
5170825|NCT00933608|cognitively healthy|cognitively healthy
5170826|NCT00933608|family history|family history
5170827|NCT00933608|AD|ad
5170828|NCT00933595|HIV|hiv
5170829|NCT00933595|Lung|lung
5170830|NCT00933582|Osteoarthritis, Knee|osteoarthritis, knee
5170831|NCT00933582|Knee Pain|knee pain
5170832|NCT00933582|Pain Measurement|pain measurement
5170833|NCT00933582|Naproxen|naproxen
5170834|NCT00933582|Placebo|placebo
5170835|NCT00933582|Treatment Outcome|treatment outcome
5170836|NCT00933556|infection|infection
5170837|NCT00933556|probiotics|probiotics
5170838|NCT00933543|Acne Vulgaris|acne vulgaris
5170839|NCT00933543|Moderate to severe|moderate to severe
5170840|NCT00933517|breast cancer, neoadjuvant therapies, chemotherapy, targeted therapy|breast cancer, neoadjuvant therapies, chemotherapy, targeted therapy
5170841|NCT00933491|healthy|healthy
5170842|NCT00933478|Patulous Eustachian Tube Dysfunction|patulous eustachian tube dysfunction
5170843|NCT00933465|Fecal incontinence|fecal incontinence
5170844|NCT00933452|duloxetine|duloxetine
5170845|NCT00933452|pharmacokinetics|pharmacokinetics
5170846|NCT00933452|antidepressant|antidepressant
5170847|NCT00933452|antidepressive agents|antidepressive agents
5170848|NCT00933452|depression|depression
5170849|NCT00933452|psychotropic drugs|psychotropic drugs
5170850|NCT00933452|safety|safety
5170851|NCT00933452|Chinese|chinese
5170852|NCT00933452|HAN|han
5170853|NCT00933452|BDNF|bdnf
5170854|NCT00933439|Depression|depression
5170855|NCT00933439|Major Depressive Disorder|major depressive disorder
5170856|NCT00933439|Cognitive Function|cognitive function
5170857|NCT00933439|Psychosocial Function|psychosocial function
5170858|NCT00933426|Castration-Resistant Prostate Cancer|castration-resistant prostate cancer
5170859|NCT00933426|CRPC|crpc
5170860|NCT00933426|Prostate|prostate
5170861|NCT00933426|Lenalidomide|lenalidomide
5170862|NCT00933426|Revlimid|revlimid
5170863|NCT00933426|CC-5103|cc-5103
5170864|NCT00933426|Paclitaxel|paclitaxel
5170865|NCT00933426|Taxol|taxol
5170866|NCT00933426|Taxanes|taxanes
5170867|NCT00933400|Computed Tomography|computed tomography
5170868|NCT00933400|CTA|cta
5170869|NCT00933400|Cardiac CT|cardiac ct
5170870|NCT00933400|CT|ct
5170871|NCT00933400|Cardiac CTA|cardiac cta
5170872|NCT00933400|Chest Pain|chest pain
5170873|NCT00933400|Heart Attack|heart attack
5170874|NCT00933400|Emergency Department|emergency department
5170875|NCT00933400|Myocardial Infarction|myocardial infarction
5170876|NCT00933400|Cost Effectiveness|cost effectiveness
5170877|NCT00933400|Acute Coronary Event|acute coronary event
5170878|NCT00933400|Heart Imaging|heart imaging
5170879|NCT00933387|oral squamous cell carcinoma|oral squamous cell carcinoma
5170880|NCT00933387|neoadjuvant bio-chemotherapy|neoadjuvant bio-chemotherapy
5170881|NCT00933387|concurrent bio-radiotherapy|concurrent bio-radiotherapy
5170882|NCT00933387|biomarker|biomarker
5170883|NCT00933374|bladder cancer|bladder cancer
5170884|NCT00933374|RAD001|rad001
5170885|NCT00933374|Paclitaxel|paclitaxel
5170886|NCT00933361|Adult|adult
5170887|NCT00933348|ulcer|ulcer
5170888|NCT00933348|venous|venous
5170889|NCT00933348|pressure|pressure
5170890|NCT00933348|wound|wound
5170891|NCT00933348|treatment|treatment
5170892|NCT00933322|ruminant|ruminant
5170893|NCT00933322|industrial|industrial
5170894|NCT00933322|endothelial function|endothelial function
5170895|NCT00933322|flow-mediated dilation|flow-mediated dilation
5170896|NCT00933322|blood lipids|blood lipids
5170897|NCT00933322|nutrition|nutrition
5170898|NCT00933322|trans fatty acids|trans fatty acids
5171190|NCT00931983|Walking|walking
5170899|NCT00933322|coronary disease|coronary disease
5170900|NCT00933322|endothelial function of the brachial artery|endothelial function of the brachial artery
5170901|NCT00933322|inflammation|inflammation
5170902|NCT00933322|insulin resistancy|insulin resistancy
5170903|NCT00933322|coagulation|coagulation
5170904|NCT00933309|Breast|breast
5170905|NCT00933309|Obese|obese
5170906|NCT00933309|Obesity Treatment|obesity treatment
5170907|NCT00933309|Exemestane|exemestane
5170908|NCT00933309|Aromasin|aromasin
5170909|NCT00933309|Metformin and Rosiglitazone|metformin and rosiglitazone
5170910|NCT00933309|Avandamet|avandamet
5170911|NCT00933309|Postmenopausal|postmenopausal
5170912|NCT00933309|Hormone-sensitive|hormone-sensitive
5170913|NCT00933309|Hormone-receptive-positive breast cancer|hormone-receptive-positive breast cancer
5170914|NCT00933296|Schnitzler syndrome|schnitzler syndrome
5170915|NCT00933296|Waldentsröm's disease|waldentsröm's disease
5170916|NCT00933296|anakinra|anakinra
5170917|NCT00933283|Healthy participants|healthy participants
5170918|NCT00933283|Pharmacokinetics|pharmacokinetics
5170919|NCT00933283|Pharmacodynamic|pharmacodynamic
5170920|NCT00933283|Potential interaction|potential interaction
5170921|NCT00933283|VX-950-TiDP24-C135|vx-950-tidp24-c135
5170922|NCT00933283|VX-950|vx-950
5170923|NCT00933283|Methadone|methadone
5170924|NCT00933283|Telaprevir|telaprevir
5170925|NCT00933283|Steady-state|steady-state
5170926|NCT00933270|Superficial Femoral Artery or SFA|superficial femoral artery or sfa
5170927|NCT00933244|Vitamin D|vitamin d
5170928|NCT00933244|Cholecalciferol|cholecalciferol
5170929|NCT00933244|Parathyroid Hormone|parathyroid hormone
5170930|NCT00933244|Calcium Absorption|calcium absorption
5170931|NCT00933244|Bone Mineral Density|bone mineral density
5170932|NCT00933244|Muscle Function|muscle function
5170933|NCT00933231|Tacrolimus|tacrolimus
5170934|NCT00933231|Kidney Transplantation|kidney transplantation
5170935|NCT00933231|Advagraf|advagraf
5170936|NCT00933231|Immunosuppression|immunosuppression
5170937|NCT00933231|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors
5170938|NCT00933179|Prevention of pregnancy|prevention of pregnancy
5170939|NCT00933153|Elderly|elderly
5170940|NCT00933153|Malnutrition|malnutrition
5170941|NCT00933153|Oral Nutrition Supplement|oral nutrition supplement
5170942|NCT00933153|Meals on Wheels|meals on wheels
5170943|NCT00933140|HIV|hiv
5170944|NCT00933140|women|women
5170945|NCT00933140|anal cytology|anal cytology
5170946|NCT00933127|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
5170947|NCT00933127|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
5170948|NCT00933127|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
5170949|NCT00933127|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5170950|NCT00933127|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5170951|NCT00933127|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5170952|NCT00933127|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5170953|NCT00933127|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5170954|NCT00933127|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5170955|NCT00933127|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5170956|NCT00933127|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5170957|NCT00933127|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5170958|NCT00933114|DCE MRI|dce mri
5170959|NCT00933114|PET|pet
5170960|NCT00933114|Perfusion|perfusion
5170961|NCT00933114|Permeability|permeability
5170962|NCT00933114|Cancer of the head and neck|cancer of the head and neck
5170963|NCT00933114|Head, Neck neoplasms|head, neck neoplasms
5170964|NCT00933088|adolescent coping strategies|adolescent coping strategies
5170965|NCT00933088|stress response|stress response
5170966|NCT00933088|breast cancer|breast cancer
5170967|NCT00933049|Efficacy|efficacy
5170968|NCT00933049|children|children
5170969|NCT00933049|pneumonia|pneumonia
5170970|NCT00933049|cotrimoxazole|cotrimoxazole
5170971|NCT00933049|amoxicillin|amoxicillin
5170972|NCT00933036|Osteoporosis|osteoporosis
5170973|NCT00933036|VCF|vcf
5170974|NCT00933036|PVA|pva
5170975|NCT00933036|Vertebroplasty|vertebroplasty
5170976|NCT00933036|Kyphoplasty|kyphoplasty
5170977|NCT00933036|Vertebral fracture|vertebral fracture
5170978|NCT00933036|Pathologic fracture|pathologic fracture
5170979|NCT00933036|Vertebral augmentation|vertebral augmentation
5170980|NCT00933010|metabolic syndrome|metabolic syndrome
5170981|NCT00933010|lipids|lipids
5170982|NCT00933010|waist circumference|waist circumference
5170983|NCT00933010|HDL|hdl
5170984|NCT00933010|hypertension|hypertension
5170985|NCT00932997|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
5170986|NCT00932997|stage I breast cancer|stage i breast cancer
5170987|NCT00932997|stage II breast cancer|stage ii breast cancer
5170988|NCT00932997|stage IIIA breast cancer|stage iiia breast cancer
5170989|NCT00932997|cancer survivor|cancer survivor
5170990|NCT00932958|Myocardial Infarction|myocardial infarction
5170991|NCT00932919|Agoraphobia|agoraphobia
5171191|NCT00931983|Treadmill|treadmill
5170992|NCT00932919|Cognitive therapy|cognitive therapy
5170993|NCT00932919|Thought field therapy|thought field therapy
5170994|NCT00932919|Psychotherapy research|psychotherapy research
5170995|NCT00932906|Education|education
5170996|NCT00932906|Retention|retention
5170997|NCT00932906|Retrieval|retrieval
5170998|NCT00932906|Self training|self training
5170999|NCT00932893|Lung Neoplasms ALK gene crizotinib|lung neoplasms alk gene crizotinib
5171000|NCT00932867|Arterial Hypertension|arterial hypertension
5171001|NCT00932854|Mediastinal lymphadenopathy|mediastinal lymphadenopathy
5171002|NCT00932854|EBUS|ebus
5171003|NCT00932854|Bronchoscopy|bronchoscopy
5171004|NCT00932854|Sarcoidosis|sarcoidosis
5171005|NCT00932828|Peanut allergy|peanut allergy
5171006|NCT00932802|Non-Interventional|non-interventional
5171007|NCT00932802|Observational|observational
5171008|NCT00932802|NIS|nis
5171009|NCT00932802|Moxifloxacin|moxifloxacin
5171010|NCT00932802|MXF|mxf
5171011|NCT00932802|Avelox|avelox
5171012|NCT00932802|AECB|aecb
5171013|NCT00932750|Body composition|body composition
5171014|NCT00932750|Weight loss|weight loss
5171015|NCT00932750|Weight management|weight management
5171016|NCT00932750|Beverages|beverages
5171017|NCT00932750|Diet|diet
5171018|NCT00932724|Metastatic|metastatic
5171019|NCT00932724|Colorectal|colorectal
5171020|NCT00932724|Cancer|cancer
5171021|NCT00932724|refractory|refractory
5171022|NCT00932724|Phase II|phase ii
5171023|NCT00932724|randomised|randomised
5171024|NCT00932724|double-blind|double-blind
5171025|NCT00932724|controlled|controlled
5171026|NCT00932724|multicenter|multicenter
5171027|NCT00932724|CY-503|cy-503
5171028|NCT00932724|Cytavis|cytavis
5171029|NCT00932711|COPD|copd
5171030|NCT00932698|Relapsed multiple myeloma|relapsed multiple myeloma
5171031|NCT00932698|Refractory multiple myeloma|refractory multiple myeloma
5171032|NCT00932698|IXAZOMIB Proteasome inhibitor|ixazomib proteasome inhibitor
5171033|NCT00932685|pediatric emergence agitation and pain|pediatric emergence agitation and pain
5171034|NCT00932672|Prostate Cancer|prostate cancer
5171035|NCT00932672|Atkins|atkins
5171036|NCT00932659|End-Stage Renal Disease|end-stage renal disease
5171037|NCT00932659|Hemodialysis|hemodialysis
5171038|NCT00932659|Cardiac Arrhythmias|cardiac arrhythmias
5171039|NCT00932633|neonatal brain injury|neonatal brain injury
5171040|NCT00932633|congenital heart disease|congenital heart disease
5171041|NCT00932633|magnetic resonance imaging|magnetic resonance imaging
5171042|NCT00932633|cardiopulmonary bypass|cardiopulmonary bypass
5171043|NCT00932633|neurodevelopmental outcome|neurodevelopmental outcome
5171044|NCT00932620|hypercholesterolemia|hypercholesterolemia
5171045|NCT00932620|statins|statins
5171046|NCT00932620|simvastatin|simvastatin
5171047|NCT00932620|ezetimibe|ezetimibe
5171048|NCT00932620|LDL particles|ldl particles
5171049|NCT00932607|seasonal|seasonal
5171050|NCT00932607|rhinitis|rhinitis
5171051|NCT00932607|rhinoconjunctivitis|rhinoconjunctivitis
5171052|NCT00932607|birch pollen|birch pollen
5171053|NCT00932607|immunotherapy|immunotherapy
5171054|NCT00932607|sublingual|sublingual
5171055|NCT00932594|Create the New Serial Treatment of TMD|create the new serial treatment of tmd
5171056|NCT00932594|Promote the Classification of Biodynamics in the TMD|promote the classification of biodynamics in the tmd
5171057|NCT00932594|Evaluate the Effect of Adjusting TMJ Treatment|evaluate the effect of adjusting tmj treatment
5171058|NCT00932594|Establish the New Standard of the TMJ Treatment|establish the new standard of the tmj treatment
5171059|NCT00932594|Invent New Device to Measure Pressure without Trauma|invent new device to measure pressure without trauma
5171060|NCT00932581|Parkinson's Disease|parkinson's disease
5171061|NCT00932581|Movement Disorders|movement disorders
5171062|NCT00932581|Unified Parkinson's Disease Rating Scale|unified parkinson's disease rating scale
5171063|NCT00932581|Short Parkinson's Evaluation Scale|short parkinson's evaluation scale
5171064|NCT00932581|Scales for Outcomes in Parkinson's Disease|scales for outcomes in parkinson's disease
5171065|NCT00932581|Motor Evaluation|motor evaluation
5171066|NCT00932581|Schwab and England activities of daily living|schwab and england activities of daily living
5171067|NCT00932581|Bradykinesia|bradykinesia
5171068|NCT00932581|psychometrics|psychometrics
5171069|NCT00932581|order effects|order effects
5171070|NCT00932581|hoehn yahr aging|hoehn yahr aging
5171071|NCT00932581|assessments|assessments
5171072|NCT00932555|Octocog alfa|octocog alfa
5171073|NCT00932555|Hemophilia A|hemophilia a
5171074|NCT00932542|Hemorrhoidectomy|hemorrhoidectomy
5171075|NCT00932529|Antipsychotic drugs|antipsychotic drugs
5171076|NCT00932529|Treatment effectiveness|treatment effectiveness
5171077|NCT00932529|Randomized controlled trial|randomized controlled trial
5171078|NCT00932516|South Beach Diet™|south beach diet™
5171079|NCT00932516|overweight|overweight
5171080|NCT00932516|obesity|obesity
5171081|NCT00932516|satiety|satiety
5171082|NCT00932516|weight loss|weight loss
5171083|NCT00932503|Vicryl plus|vicryl plus
5171084|NCT00932503|wound infection|wound infection
5171085|NCT00932503|coated suture material|coated suture material
5171086|NCT00932503|open abdominal surgery|open abdominal surgery
5171087|NCT00932503|transverse laparotomy|transverse laparotomy
5171088|NCT00932451|Lung Neoplasms ALK gene Crizotinib|lung neoplasms alk gene crizotinib
5171089|NCT00932438|colon cancer|colon cancer
5171090|NCT00932438|liver metastases|liver metastases
5171091|NCT00932425|Stroke|stroke
5171092|NCT00932425|Cryptogenic|cryptogenic
5171093|NCT00932425|Cardioembolic|cardioembolic
5171094|NCT00932425|Atrial Fibrillation|atrial fibrillation
5171095|NCT00932412|Younger Patients with Newly-Diagnosed Acute Myeloid Leukemia (AML).|younger patients with newly-diagnosed acute myeloid leukemia (aml).
5171096|NCT00932386|Lower extremity surgery with tourniquet use|lower extremity surgery with tourniquet use
5171097|NCT00932373|HER2-positive breast cancer|her2-positive breast cancer
5171098|NCT00932373|MBC|mbc
5171099|NCT00932373|Trastuzumab emtansine|trastuzumab emtansine
5171100|NCT00932373|Herceptin|herceptin
5171101|NCT00932373|T-DM1|t-dm1
5171102|NCT00932360|Fibromyalgia|fibromyalgia
5171103|NCT00932360|Transcutaneous Electrical Nerve Stimulation (TENS)|transcutaneous electrical nerve stimulation (tens)
5171104|NCT00932347|Camellia sinensis|camellia sinensis
5171105|NCT00932347|volatile sulfur compounds|volatile sulfur compounds
5171106|NCT00932334|kidney|kidney
5171107|NCT00932334|transplant|transplant
5171108|NCT00932334|donation|donation
5171109|NCT00932321|Contraception|contraception
5171110|NCT00932295|tobacco|tobacco
5171111|NCT00932295|cigarette|cigarette
5171112|NCT00932295|nicotine|nicotine
5171113|NCT00932282|Peanut|peanut
5171114|NCT00932282|Allergy|allergy
5171115|NCT00932282|Hypersensitivity|hypersensitivity
5171116|NCT00932269|Diphtheria|diphtheria
5171117|NCT00932269|Tetanus|tetanus
5171118|NCT00932269|Pertussis|pertussis
5171119|NCT00932269|Polio|polio
5171120|NCT00932269|Haemophilus influenzae type B|haemophilus influenzae type b
5171121|NCT00932269|Hib|hib
5171122|NCT00932269|Measles|measles
5171123|NCT00932269|Mumps|mumps
5171124|NCT00932269|Rubella|rubella
5171125|NCT00932269|Hepatitis B|hepatitis b
5171126|NCT00932269|Vaccine|vaccine
5171127|NCT00932269|Vaccination|vaccination
5171128|NCT00932269|Immunity|immunity
5171129|NCT00932269|Vaccination program|vaccination program
5171130|NCT00932269|Sweden|sweden
5171131|NCT00932269|ELISA|elisa
5171132|NCT00932256|Rhinitis, Allergic, Seasonal|rhinitis, allergic, seasonal
5171133|NCT00932243|bacteremia|bacteremia
5171134|NCT00932243|sepsis|sepsis
5171135|NCT00932243|Toll-Like-Receptors (TLRs)|toll-like-receptors (tlrs)
5171136|NCT00932204|obsessive-compulsive disorder|obsessive-compulsive disorder
5171137|NCT00932204|repetitive transcranial magnetic stimulation|repetitive transcranial magnetic stimulation
5171138|NCT00932204|right dorsolateral prefrontal cortex|right dorsolateral prefrontal cortex
5171139|NCT00932204|supplementary motor area (SMA)|supplementary motor area (sma)
5171140|NCT00932191|Cataract|cataract
5171141|NCT00932191|Corneal endothelial cell loss|corneal endothelial cell loss
5171142|NCT00932191|Ultrasound power|ultrasound power
5171143|NCT00932191|Corneal endothelium|corneal endothelium
5171144|NCT00932178|Anxiety|anxiety
5171145|NCT00932178|Worry|worry
5171146|NCT00932178|nervousness|nervousness
5171147|NCT00932178|Older Adult|older adult
5171148|NCT00932152|advanced non-small cell lung cancer|advanced non-small cell lung cancer
5171149|NCT00932152|postmenopausal|postmenopausal
5171150|NCT00932152|bevacizumab|bevacizumab
5171151|NCT00932152|fulvestrant|fulvestrant
5171152|NCT00932152|anastrozole|anastrozole
5171153|NCT00932139|Hypertension|hypertension
5171154|NCT00932139|blood pressure|blood pressure
5171155|NCT00932139|arrhythmias|arrhythmias
5171156|NCT00932139|mild to moderate hypertension|mild to moderate hypertension
5171157|NCT00932126|Phase 1 dose escalation dose finding pharmacokinetic and pharmacodynamic study|phase 1 dose escalation dose finding pharmacokinetic and pharmacodynamic study
5171158|NCT00932113|tumor necrosis factor (TNF) inhibitor|tumor necrosis factor (tnf) inhibitor
5171159|NCT00932113|tumor necrosis factor (TNF) blockade|tumor necrosis factor (tnf) blockade
5171160|NCT00932113|Methotrexate|methotrexate
5171161|NCT00932113|treatment|treatment
5171162|NCT00932113|mechanism|mechanism
5171163|NCT00932113|psoriasis|psoriasis
5171164|NCT00932100|ACS|acs
5171165|NCT00932100|Acute Coronary Syndrome|acute coronary syndrome
5171166|NCT00932100|Catheterization|catheterization
5171167|NCT00932087|Platelet function|platelet function
5171168|NCT00932087|diabetes|diabetes
5171169|NCT00932087|metabolic syndrome|metabolic syndrome
5171170|NCT00932074|Atopic Dermatitis|atopic dermatitis
5171171|NCT00932061|Fibromyalgia|fibromyalgia
5171172|NCT00932061|Healthy controls|healthy controls
5171173|NCT00932061|Acupuncture|acupuncture
5171174|NCT00932061|Sham Acupuncture|sham acupuncture
5171175|NCT00932061|fMRI|fmri
5171176|NCT00932061|Biological marker|biological marker
5171177|NCT00932048|Diabetes Mellitus|diabetes mellitus
5171178|NCT00932048|Statins|statins
5171179|NCT00932048|PET|pet
5171180|NCT00932035|breast cancer|breast cancer
5171181|NCT00932035|axillary mapping|axillary mapping
5171182|NCT00932035|lymphedema|lymphedema
5171183|NCT00932009|Human papillomavirus infection|human papillomavirus infection
5171184|NCT00932009|Tanzanian men|tanzanian men
5171185|NCT00932009|Prevalence|prevalence
5171186|NCT00931996|schizophrenia|schizophrenia
5171187|NCT00931996|antipsychotic|antipsychotic
5171188|NCT00931996|risperidone|risperidone
5171189|NCT00931983|Incomplete spinal cord injuries|incomplete spinal cord injuries
5171192|NCT00931983|Training|training
5171193|NCT00931970|Hemodialysis|hemodialysis
5171194|NCT00931970|Peritoneal dialysis|peritoneal dialysis
5171195|NCT00931970|Mortality|mortality
5171196|NCT00931970|Prospective cohort|prospective cohort
5171197|NCT00931970|Clinical study|clinical study
5171198|NCT00931957|Etanercept|etanercept
5171199|NCT00931957|Behcet's syndrome|behcet's syndrome
5171200|NCT00931957|Behcet's Disease|behcet's disease
5171201|NCT00931957|Ocular Lesions|ocular lesions
5171202|NCT00931957|Uveitis|uveitis
5171203|NCT00931957|Retinal Vasculitis|retinal vasculitis
5171204|NCT00931944|ALS|als
5171205|NCT00931944|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
5171206|NCT00931944|Lou Gehrig|lou gehrig
5171207|NCT00931944|Lou Gehrig's|lou gehrig's
5171208|NCT00931944|Lou Gehrig's disease|lou gehrig's disease
5171209|NCT00931944|Motor Neuron Disease|motor neuron disease
5171210|NCT00931944|Nervous System Diseases|nervous system diseases
5171211|NCT00931944|KNS-760704|kns-760704
5171212|NCT00931944|RTPB|rtpb
5171213|NCT00931905|This study included workers exposed to lead.|this study included workers exposed to lead.
5171214|NCT00931892|celiac disease|celiac disease
5171215|NCT00931892|gluten challenge|gluten challenge
5171216|NCT00931866|diclofenac|diclofenac
5171217|NCT00931866|acute pain|acute pain
5171218|NCT00931866|topical|topical
5171219|NCT00931866|patch|patch
5171220|NCT00931866|Acute Pain due to Mild to Moderate Soft Tissue Injury|acute pain due to mild to moderate soft tissue injury
5171221|NCT00931840|EZN-2208 (PEG-SN38)|ezn-2208 (peg-sn38)
5171222|NCT00931827|Contraception|contraception
5171223|NCT00931814|Depression|depression
5171224|NCT00931814|physical function|physical function
5171225|NCT00931814|Quality of life|quality of life
5171226|NCT00931801|AIDS|aids
5171227|NCT00931801|HIV|hiv
5171228|NCT00931801|Atazanavir|atazanavir
5171229|NCT00931801|Raltegravir|raltegravir
5171230|NCT00931801|Tenofovir|tenofovir
5171231|NCT00931801|protease inhibitors|protease inhibitors
5171232|NCT00931788|Management of hypertension and cholesterol|management of hypertension and cholesterol
5171233|NCT00931788|stroke|stroke
5171234|NCT00931788|TIA|tia
5171235|NCT00931775|Major depressive disorder, citalopram, pindolol, HDRS|major depressive disorder, citalopram, pindolol, hdrs
5171236|NCT00931762|Bone marrow|bone marrow
5171237|NCT00931762|Myelofibrosis|myelofibrosis
5171238|NCT00931762|JAK2mutation|jak2mutation
5171239|NCT00931762|Post-Polycythemia Vera|post-polycythemia vera
5171240|NCT00931762|Post-Essential Thrombocytopenia|post-essential thrombocytopenia
5171241|NCT00931749|ultrasound therapy|ultrasound therapy
5171242|NCT00931749|knee cartilage thickness|knee cartilage thickness
5171243|NCT00931749|knee cartilage volume|knee cartilage volume
5171244|NCT00931749|mild knee osteoarthritis|mild knee osteoarthritis
5171245|NCT00931749|moderate knee osteoarthritis|moderate knee osteoarthritis
5171246|NCT00931736|Tuberculosis|tuberculosis
5171247|NCT00931723|Acute Mania|acute mania
5171248|NCT00931723|Mania, Adults|mania, adults
5171249|NCT00931723|Seroquel|seroquel
5171250|NCT00931723|Acute Mania in Adult Patients|acute mania in adult patients
5171251|NCT00931710|Hypertension|hypertension
5171252|NCT00931710|combination therapy|combination therapy
5171253|NCT00931710|valsartan|valsartan
5171254|NCT00931710|cardiovascular diseases|cardiovascular diseases
5171255|NCT00931697|Mefloquine|mefloquine
5171256|NCT00931697|Malaria|malaria
5171257|NCT00931697|(+) Mefloquine|(+) mefloquine
5171258|NCT00931697|Pharmacokinetics|pharmacokinetics
5171259|NCT00931671|Physical fitness|physical fitness
5171260|NCT00931671|Cerebral circulation|cerebral circulation
5171261|NCT00931671|Walking|walking
5171262|NCT00931645|Chronic lymphocytic leukemia,|chronic lymphocytic leukemia,
5171263|NCT00931645|autologous stem cell transplantation|autologous stem cell transplantation
5171264|NCT00931632|Bronchopulmonary Dysplasia, BPD|bronchopulmonary dysplasia, bpd
5171265|NCT00931619|Fluorine-18 Fluorodeoxyglucose|fluorine-18 fluorodeoxyglucose
5171266|NCT00931619|Epilepsy|epilepsy
5171267|NCT00931619|Epileptic Focus|epileptic focus
5171268|NCT00931619|Temporal Lobe Epilepsy|temporal lobe epilepsy
5171269|NCT00931619|Depression|depression
5171270|NCT00931619|Major Depressive Disorder|major depressive disorder
5171271|NCT00931619|Healthy Volunteer|healthy volunteer
5171272|NCT00931619|HV|hv
5171273|NCT00931606|anemia|anemia
5171274|NCT00931606|metastatic|metastatic
5171275|NCT00931606|breast|breast
5171276|NCT00931606|cancer|cancer
5171277|NCT00931593|Transient lower esophageal sphincter relaxation|transient lower esophageal sphincter relaxation
5171278|NCT00931593|high resolution manometry|high resolution manometry
5171279|NCT00931593|dentsleeve probe|dentsleeve probe
5171280|NCT00931593|healthy volunteers|healthy volunteers
5171281|NCT00931580|Vitamin D|vitamin d
5171282|NCT00931580|Adolescent|adolescent
5171283|NCT00931580|African American|african american
5171284|NCT00931580|White|white
5171285|NCT00931541|Safety|safety
5171286|NCT00931541|Tolerability|tolerability
5171287|NCT00931541|Healthy|healthy
5171288|NCT00931528|sexual dysfunction|sexual dysfunction
5171289|NCT00931528|stage IIB prostate cancer|stage iib prostate cancer
5171290|NCT00931528|stage IIA prostate cancer|stage iia prostate cancer
5171387|NCT00931073|ketoconazole|ketoconazole
5171291|NCT00931528|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5171292|NCT00931515|DDD|ddd
5171293|NCT00931502|Stent thrombosis|stent thrombosis
5171294|NCT00931502|Acute Coronary Syndrome|acute coronary syndrome
5171295|NCT00931502|ACS|acs
5171296|NCT00931502|Stenting|stenting
5171297|NCT00931502|Interventional Cardiology|interventional cardiology
5171298|NCT00931502|Cardiology|cardiology
5171299|NCT00931502|Cardiovascular Research|cardiovascular research
5171300|NCT00931502|Registry|registry
5171301|NCT00931489|Age Related Macular Degeneration|age related macular degeneration
5171302|NCT00931489|Lucentis|lucentis
5171303|NCT00931489|Ranibizumab|ranibizumab
5171304|NCT00931489|Antibodies|antibodies
5171305|NCT00931489|Retinal and RPE Autoimmunity|retinal and rpe autoimmunity
5171306|NCT00931463|second line therapy|second line therapy
5171307|NCT00931463|combination antiretroviral therapy|combination antiretroviral therapy
5171308|NCT00931463|first-line failure|first-line failure
5171309|NCT00931463|AIDS|aids
5171310|NCT00931463|treatment experienced|treatment experienced
5171311|NCT00931450|estrogen receptor-positive breast cancer|estrogen receptor-positive breast cancer
5171312|NCT00931450|HER2-negative breast cancer|her2-negative breast cancer
5171313|NCT00931450|stage IA breast cancer|stage ia breast cancer
5171314|NCT00931450|stage IB breast cancer|stage ib breast cancer
5171315|NCT00931450|stage II breast cancer|stage ii breast cancer
5171316|NCT00931450|stage IIIA breast cancer|stage iiia breast cancer
5171317|NCT00931450|stage IIIB breast cancer|stage iiib breast cancer
5171318|NCT00931437|vitamin K|vitamin k
5171319|NCT00931437|Bio-availability|bio-availability
5171320|NCT00931424|Primary Chronic Venous Insufficiency|primary chronic venous insufficiency
5171321|NCT00931424|surgery|surgery
5171322|NCT00931424|reconstruction|reconstruction
5171323|NCT00931424|valve|valve
5171324|NCT00931411|Atopic Dermatitis|atopic dermatitis
5171325|NCT00931411|Vitamin B3|vitamin b3
5171326|NCT00931372|Insulin release|insulin release
5171327|NCT00931372|Diabetes mellitus type 2|diabetes mellitus type 2
5171328|NCT00931372|GLP-1 agonist|glp-1 agonist
5171329|NCT00931359|axillary|axillary
5171330|NCT00931359|hyperhidrosis|hyperhidrosis
5171331|NCT00931359|primary focal|primary focal
5171332|NCT00931346|HIV|hiv
5171333|NCT00931346|Human Immunodeficiency Virus|human immunodeficiency virus
5171334|NCT00931333|Vertebroplasty|vertebroplasty
5171335|NCT00931333|spine|spine
5171336|NCT00931333|vertebra height|vertebra height
5171337|NCT00931333|adverse events|adverse events
5171338|NCT00931333|calcium phosphate bone cement|calcium phosphate bone cement
5171339|NCT00931320|Ratio improvement|ratio improvement
5171340|NCT00931320|LDL-C|ldl-c
5171341|NCT00931320|HDL-C|hdl-c
5171342|NCT00931320|Ratio of Low Density Lipoprotein Cholesterol to High Density Lipoprotein Cholesterol Improvement|ratio of low density lipoprotein cholesterol to high density lipoprotein cholesterol improvement
5171343|NCT00931320|High Density Lipoprotein Cholesterol|high density lipoprotein cholesterol
5171344|NCT00931281|Multiple Ascending Doses|multiple ascending doses
5171345|NCT00931268|Lipoatrophy|lipoatrophy
5171346|NCT00931268|Buttock treatment|buttock treatment
5171347|NCT00931255|kidney transplant|kidney transplant
5171348|NCT00931255|tacrolimus|tacrolimus
5171349|NCT00931255|sirolimus|sirolimus
5171350|NCT00931255|delayed graft function|delayed graft function
5171351|NCT00931255|Graft survival|graft survival
5171352|NCT00931255|Acute rejection|acute rejection
5171353|NCT00931255|Chronic allograft nephropathy|chronic allograft nephropathy
5171355|NCT00931242|dermatitis|dermatitis
5171356|NCT00931242|TNF blockade|tnf blockade
5171357|NCT00931242|PDE4 inhibitor|pde4 inhibitor
5171358|NCT00931242|T cell inhibitor|t cell inhibitor
5171359|NCT00931229|hepatitis B reactivation|hepatitis b reactivation
5171360|NCT00931216|PMTCT|pmtct
5171361|NCT00931216|Vertical transmission of HIV|vertical transmission of hiv
5171362|NCT00931216|Pregnant women|pregnant women
5171363|NCT00931216|Infant HIV testing|infant hiv testing
5171364|NCT00931216|Kenya|kenya
5171365|NCT00931216|AIDS|aids
5171366|NCT00931164|phase I/II study|phase i/ii study
5171367|NCT00931164|effects of sodium oxybate|effects of sodium oxybate
5171368|NCT00931164|cohort of 6 children and young adults|cohort of 6 children and young adults
5171369|NCT00931164|AHC|ahc
5171370|NCT00931138|Acute Myeloid Leukemia in adults|acute myeloid leukemia in adults
5171371|NCT00931138|Newly-diagnosed untreated AML|newly-diagnosed untreated aml
5171372|NCT00931138|Patient aged 50 to 70 years|patient aged 50 to 70 years
5171373|NCT00931125|Severe proliferative diabetic retinopathy|severe proliferative diabetic retinopathy
5171374|NCT00931112|Peripheral Arterial Disease|peripheral arterial disease
5171375|NCT00931112|Walking ability|walking ability
5171376|NCT00931112|Quality of life|quality of life
5171377|NCT00931112|Exercise training|exercise training
5171378|NCT00931099|pregnancy|pregnancy
5171379|NCT00931099|sleep disordered breathing|sleep disordered breathing
5171380|NCT00931099|obstructive sleep apnea|obstructive sleep apnea
5171381|NCT00931086|Rheumatoid Arthritis|rheumatoid arthritis
5171382|NCT00931086|RA|ra
5171383|NCT00931073|Drug Interactions|drug interactions
5171384|NCT00931073|pharmacokinetics|pharmacokinetics
5171385|NCT00931073|CYP2D6|cyp2d6
5171386|NCT00931073|CYP2C19|cyp2c19
5171388|NCT00931073|omeprazole|omeprazole
5171389|NCT00931060|Ammonia|ammonia
5171390|NCT00931060|Citric acid cycle|citric acid cycle
5171391|NCT00931060|Branched Chain Amino Acids|branched chain amino acids
5171392|NCT00931034|South Beach Diet™|south beach diet™
5171393|NCT00931034|overweight|overweight
5171394|NCT00931034|obesity|obesity
5171395|NCT00931034|satiety|satiety
5171396|NCT00931034|weight loss|weight loss
5171397|NCT00931034|diabetes|diabetes
5171398|NCT00931008|Locally Advanced or Metastatic Non-Small Cell Lung Cancer|locally advanced or metastatic non-small cell lung cancer
5171399|NCT00930982|Ciprofloxacin|ciprofloxacin
5171400|NCT00930982|Airway infection|airway infection
5171401|NCT00930982|Bronchiectasis|bronchiectasis
5171402|NCT00930969|Cardiac Ischemia|cardiac ischemia
5171403|NCT00930969|ST segment elevated Myocardial Infarction (STEMI)|st segment elevated myocardial infarction (stemi)
5171404|NCT00930969|Non-ST Segment elevated Myocardial Infarction (NSTEMI)|non-st segment elevated myocardial infarction (nstemi)
5171405|NCT00930969|Implantable Cardioverter Defibrillator (ICD)|implantable cardioverter defibrillator (icd)
5171406|NCT00930969|Cardiac Electrogram (EGM)|cardiac electrogram (egm)
5171407|NCT00930969|Coronary Artery Disease (CAD)|coronary artery disease (cad)
5171408|NCT00930956|Diabetes|diabetes
5171409|NCT00930956|Obesity|obesity
5171410|NCT00930956|Hyperglycemia|hyperglycemia
5171411|NCT00930956|Dietary Fiber|dietary fiber
5171412|NCT00930956|Wheat|wheat
5171413|NCT00930956|Grain|grain
5171414|NCT00930943|opioid tolerant|opioid tolerant
5171415|NCT00930943|chronic pain|chronic pain
5171416|NCT00930930|triple-negative breast cancer|triple-negative breast cancer
5171417|NCT00930930|stage II breast cancer|stage ii breast cancer
5171418|NCT00930930|stage IIIA breast cancer|stage iiia breast cancer
5171419|NCT00930930|stage IIIB breast cancer|stage iiib breast cancer
5171420|NCT00930930|stage IIIC breast cancer|stage iiic breast cancer
5171421|NCT00930930|male breast cancer|male breast cancer
5171422|NCT00930917|delivery room, polyethylene cap, preterm infant, temperature|delivery room, polyethylene cap, preterm infant, temperature
5171423|NCT00930891|Extensive-Disease Small-Cell Lung Cancer|extensive-disease small-cell lung cancer
5171424|NCT00930878|registry|registry
5171425|NCT00930878|drug eluting coronary stent system|drug eluting coronary stent system
5171426|NCT00930878|observational|observational
5171427|NCT00930878|prospective|prospective
5171428|NCT00930878|open-label|open-label
5171429|NCT00930852|Migraine|migraine
5171430|NCT00930852|Children|children
5171431|NCT00930852|Primary headache disorders|primary headache disorders
5171432|NCT00930852|Appetite|appetite
5171433|NCT00930852|Obesity|obesity
5171434|NCT00930852|Feeding Behavior|feeding behavior
5171435|NCT00930839|Niacin|niacin
5171436|NCT00930839|Prostaglandin D2|prostaglandin d2
5171437|NCT00930839|Flushing|flushing
5171438|NCT00930839|Nicotinic acid stimulated release of prostaglandin D2|nicotinic acid stimulated release of prostaglandin d2
5171439|NCT00930826|The effect of bronchial asthma on school performance|the effect of bronchial asthma on school performance
5171440|NCT00930813|Drug coated balloon|drug coated balloon
5171441|NCT00930813|SFA disease|sfa disease
5171442|NCT00930813|Femoropopliteal disease|femoropopliteal disease
5171443|NCT00930813|Angioplasty|angioplasty
5171444|NCT00930813|PAD|pad
5171445|NCT00930813|Paclitaxel|paclitaxel
5171446|NCT00930813|Tubulin modulators|tubulin modulators
5171447|NCT00930813|Antineoplastic Agents|antineoplastic agents
5171448|NCT00930813|Mitosis Modulators|mitosis modulators
5171449|NCT00930813|Balloon angioplasty|balloon angioplasty
5171450|NCT00930813|Local drug delivery|local drug delivery
5171451|NCT00930813|Restenosis|restenosis
5171452|NCT00930813|Drug-coated balloon|drug-coated balloon
5171453|NCT00930800|Exercise capacity|exercise capacity
5171454|NCT00930800|Physical activity|physical activity
5171455|NCT00930800|Quality of life|quality of life
5171456|NCT00930787|hernia repair, surgical mesh, co-morbidities|hernia repair, surgical mesh, co-morbidities
5171457|NCT00930774|traumatic brain injury|traumatic brain injury
5171458|NCT00930774|rehabilitation|rehabilitation
5171459|NCT00930774|auditory processing disorder|auditory processing disorder
5171460|NCT00930761|breast feeding|breast feeding
5171461|NCT00930761|music therapy|music therapy
5171462|NCT00930761|maternal welfare|maternal welfare
5171463|NCT00930761|infant, newborn|infant, newborn
5171464|NCT00930722|Quinapril non-interventional/observational study safety|quinapril non-interventional/observational study safety
5171465|NCT00930709|Botulinum Toxin Type A|botulinum toxin type a
5171466|NCT00930709|Exercise|exercise
5171467|NCT00930709|Randomized Controlled Trial|randomized controlled trial
5171468|NCT00930709|Muscle Stretching Exercises|muscle stretching exercises
5171469|NCT00930709|Strength Training|strength training
5171470|NCT00930709|Treatment Outcome|treatment outcome
5171471|NCT00930696|endometriosis|endometriosis
5171472|NCT00930696|abdominal lavage|abdominal lavage
5171473|NCT00930696|bowel perforation|bowel perforation
5171474|NCT00930696|discoid resection|discoid resection
5171475|NCT00930696|laparoscopy|laparoscopy
5171476|NCT00930670|ranitidine|ranitidine
5171477|NCT00930670|pantoprazole|pantoprazole
5171478|NCT00930670|esomeprazole|esomeprazole
5171479|NCT00930670|omeprazole|omeprazole
5171480|NCT00930670|atorvastatin|atorvastatin
5171481|NCT00930670|rosuvastatin|rosuvastatin
5171482|NCT00930670|statin|statin
5171483|NCT00930670|clopidogrel resistance|clopidogrel resistance
5171484|NCT00930670|antiplatelet therapy|antiplatelet therapy
5171485|NCT00930670|coronary artery disease|coronary artery disease
5171486|NCT00930670|percutaneous coronary intervention|percutaneous coronary intervention
5171487|NCT00930670|stent|stent
5171488|NCT00930670|clopidogrel|clopidogrel
5171489|NCT00930670|proton pump inhibitors|proton pump inhibitors
5171490|NCT00930670|drug interactions|drug interactions
5171491|NCT00930670|drug resistance|drug resistance
5171492|NCT00930670|genetic polymorphism|genetic polymorphism
5171493|NCT00930657|Panic Disorder|panic disorder
5171494|NCT00930657|Separation Anxiety|separation anxiety
5171495|NCT00930657|Familial|familial
5171496|NCT00930657|Risk|risk
5171497|NCT00930657|Respiratory Physiology|respiratory physiology
5171498|NCT00930644|short bowel syndrome|short bowel syndrome
5171499|NCT00930644|parenteral nutrition|parenteral nutrition
5171500|NCT00930644|PN|pn
5171501|NCT00930644|HPN|hpn
5171502|NCT00930644|TPN|tpn
5171503|NCT00930644|SBS|sbs
5171504|NCT00930631|CAD|cad
5171505|NCT00930631|Pharmacokinetics|pharmacokinetics
5171506|NCT00930631|BMS747158|bms747158
5171507|NCT00930618|Prolonged pregnancy|prolonged pregnancy
5171508|NCT00930618|Nulliparity|nulliparity
5171509|NCT00930618|Cervical ripening|cervical ripening
5171510|NCT00930618|Induced labor|induced labor
5171511|NCT00930618|Cesarean section|cesarean section
5171512|NCT00930592|Psoriasis|psoriasis
5171513|NCT00930592|Metabolic Syndrome|metabolic syndrome
5171514|NCT00930592|Cardiovascular Risk|cardiovascular risk
5171515|NCT00930566|Allogeneic Hematopoietic Stem Cell Transplantation|allogeneic hematopoietic stem cell transplantation
5171516|NCT00930566|Extracorporeal Photopheresis|extracorporeal photopheresis
5171517|NCT00930553|Multiple Sclerosis|multiple sclerosis
5171518|NCT00930501|chemotherapy|chemotherapy
5171519|NCT00930501|cancer|cancer
5171520|NCT00930501|AMH|amh
5171521|NCT00930501|gonadotoxicity|gonadotoxicity
5171522|NCT00930501|ovarian reserve|ovarian reserve
5171523|NCT00930501|patients exposed to chemotherapy|patients exposed to chemotherapy
5171524|NCT00930488|Moxifloxacin|moxifloxacin
5171525|NCT00930488|MXF|mxf
5171526|NCT00930488|Avelox|avelox
5171527|NCT00930488|Sinusitis|sinusitis
5171528|NCT00930488|Acute bacterial sinusitis, ABS|acute bacterial sinusitis, abs
5171529|NCT00930462|colonoscopy|colonoscopy
5171530|NCT00930462|cap|cap
5171531|NCT00930462|hood|hood
5171532|NCT00930462|cecal intubation time|cecal intubation time
5171533|NCT00930462|polyp detection rate|polyp detection rate
5171534|NCT00930462|performance|performance
5171535|NCT00930449|Pediatrics|pediatrics
5171536|NCT00930449|Attention-Deficit Hyperactivity Disorder|attention-deficit hyperactivity disorder
5171537|NCT00930449|Learning Disorder|learning disorder
5171538|NCT00930449|Computerized Working Memory Training Program|computerized working memory training program
5171539|NCT00930436|chronic kidney disease|chronic kidney disease
5171540|NCT00930410|pancreas neoplasms|pancreas neoplasms
5171541|NCT00930410|bile duct diseases|bile duct diseases
5171542|NCT00930410|Cholangiopancreatography, Endoscopic Retrograde|cholangiopancreatography, endoscopic retrograde
5171543|NCT00930410|ERCP|ercp
5171544|NCT00930397|Pre-eclampsia|pre-eclampsia
5171545|NCT00930397|UTERO-placental unit vascularization|utero-placental unit vascularization
5171546|NCT00930397|Hypertension, pregnancy- induced|hypertension, pregnancy- induced
5171547|NCT00930397|IUGR|iugr
5171548|NCT00930397|Screening|screening
5171549|NCT00930397|3D Doppler Ultrasound|3d doppler ultrasound
5171550|NCT00930384|psoriasis|psoriasis
5171551|NCT00930384|fatty liver|fatty liver
5171552|NCT00930384|metabolic syndrome|metabolic syndrome
5171553|NCT00930371|fatty liver|fatty liver
5171554|NCT00930371|insulin resistance|insulin resistance
5171555|NCT00930371|diet|diet
5171556|NCT00930371|inflammation|inflammation
5171557|NCT00930371|oxidative stress|oxidative stress
5171558|NCT00930358|Sedation|sedation
5171559|NCT00930358|Colonoscopy|colonoscopy
5171560|NCT00930358|General anesthesia|general anesthesia
5171561|NCT00930345|Renal cell carcinoma|renal cell carcinoma
5171562|NCT00930345|Antiangiogenics|antiangiogenics
5171563|NCT00930345|Biomarkers|biomarkers
5171564|NCT00930345|Imagery|imagery
5171565|NCT00930332|sleep disorders|sleep disorders
5171566|NCT00930332|nausea and vomiting|nausea and vomiting
5171567|NCT00930332|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5171568|NCT00930332|pain|pain
5171569|NCT00930306|Chronic Pain|chronic pain
5171570|NCT00930306|AZD2066|azd2066
5171571|NCT00930293|Interpersonal Psychotherapy|interpersonal psychotherapy
5171572|NCT00930280|stroke|stroke
5171573|NCT00930280|brain attack|brain attack
5171574|NCT00930280|hemorrhagic stroke|hemorrhagic stroke
5171575|NCT00930280|risk factors|risk factors
5171576|NCT00930267|fever|fever
5171577|NCT00930267|children|children
5171578|NCT00930267|cancer|cancer
5171579|NCT00930267|leukemia|leukemia
5171580|NCT00930267|stem cell transplantation|stem cell transplantation
5171581|NCT00930267|infections in pediatric cancer patients presenting with fever during or following chemotherapy.|infections in pediatric cancer patients presenting with fever during or following chemotherapy.
5171582|NCT00930254|pediatric nursing|pediatric nursing
5171583|NCT00930254|peripheral catheterization|peripheral catheterization
5171584|NCT00930254|ultrasonics|ultrasonics
5171585|NCT00930254|intravenous infusions|intravenous infusions
5171586|NCT00930241|Lung Transplantation|lung transplantation
5171587|NCT00930241|Tacrolimus|tacrolimus
5171588|NCT00930241|Deterioration of graft function|deterioration of graft function
5171589|NCT00930228|Luteinizing hormone|luteinizing hormone
5171590|NCT00930228|Testosterone|testosterone
5171591|NCT00930215|Healthy volunteer|healthy volunteer
5171592|NCT00930215|Japanese males|japanese males
5171593|NCT00930215|homo-EM|homo-em
5171594|NCT00930215|Bioequivalence study|bioequivalence study
5171595|NCT00930202|Traumatic Brain Injury|traumatic brain injury
5171596|NCT00930202|Conivaptan|conivaptan
5171597|NCT00930202|Vaprisol|vaprisol
5171598|NCT00930202|Sodium|sodium
5171599|NCT00930189|age related macular degeneration|age related macular degeneration
5171600|NCT00930163|Adult Asthma|adult asthma
5171601|NCT00930150|Schizoaffective Disorder|schizoaffective disorder
5171602|NCT00930137|Cardiovascular disease|cardiovascular disease
5171603|NCT00930137|Trans fatty acids|trans fatty acids
5171604|NCT00930137|Ruminant|ruminant
5171605|NCT00930137|Blood lipids|blood lipids
5171606|NCT00930137|Lipoproteins|lipoproteins
5171607|NCT00930137|Women|women
5171608|NCT00930124|cleft lip and palate|cleft lip and palate
5171609|NCT00930124|distraction osteogenesis|distraction osteogenesis
5171610|NCT00930124|conventional orthognathic surgery|conventional orthognathic surgery
5171611|NCT00930124|stability|stability
5171612|NCT00930124|morbidity|morbidity
5171613|NCT00930124|soft tissue changes|soft tissue changes
5171614|NCT00930124|psychological adjustment|psychological adjustment
5171615|NCT00930124|speech changes|speech changes
5171616|NCT00930124|velopharyngeal function|velopharyngeal function
5171617|NCT00930111|inpatient|inpatient
5171618|NCT00930111|hospitalists|hospitalists
5171619|NCT00930111|residency|residency
5171620|NCT00930111|job satisfaction|job satisfaction
5171621|NCT00930111|burnout, professional|burnout, professional
5171622|NCT00930111|professional practice|professional practice
5171623|NCT00930111|medical education|medical education
5171624|NCT00930098|acute lymphoblastic leukemia|acute lymphoblastic leukemia
5171625|NCT00930098|clolar|clolar
5171626|NCT00930098|evoltra|evoltra
5171627|NCT00930098|clofarabine|clofarabine
5171628|NCT00930098|refractory/relapsed acute leukemia|refractory/relapsed acute leukemia
5171629|NCT00930098|pediatric acute leukemia|pediatric acute leukemia
5171630|NCT00930085|sepsis|sepsis
5171631|NCT00930085|septic shock|septic shock
5171632|NCT00930059|Alzheimer's disease|alzheimer's disease
5171633|NCT00930059|PF-04447943|pf-04447943
5171634|NCT00930059|efficacy|efficacy
5171635|NCT00930059|safety|safety
5171636|NCT00930059|plasma concentrations|plasma concentrations
5171637|NCT00930046|ropivacaine|ropivacaine
5171638|NCT00930046|pediatric|pediatric
5171639|NCT00930046|children|children
5171640|NCT00930046|continuous|continuous
5171641|NCT00930046|wound|wound
5171642|NCT00930046|catheter|catheter
5171643|NCT00930046|infusion|infusion
5171644|NCT00930046|pyeloplasty|pyeloplasty
5171645|NCT00930033|Nephrectomy,|nephrectomy,
5171646|NCT00930033|metastatic renal cell carcinoma,|metastatic renal cell carcinoma,
5171647|NCT00930033|sunitinib|sunitinib
5171648|NCT00930020|ischemic stroke recovery|ischemic stroke recovery
5171649|NCT00930020|minocycline|minocycline
5171650|NCT00930020|neuroprotection|neuroprotection
5171651|NCT00930020|acute stroke|acute stroke
5171652|NCT00930007|Luteinizing hormone|luteinizing hormone
5171653|NCT00930007|Puberty|puberty
5171654|NCT00929994|cardiac rehab|cardiac rehab
5171655|NCT00929981|Contact Dermatitis|contact dermatitis
5171656|NCT00929981|Allergic Dermatitis|allergic dermatitis
5171657|NCT00929968|Allergic rhinitis,|allergic rhinitis,
5171658|NCT00929968|atopic patients,|atopic patients,
5171659|NCT00929968|seasonal allergy,|seasonal allergy,
5171660|NCT00929968|ragweed allergy|ragweed allergy
5171661|NCT00929955|Anti inflammatory|anti inflammatory
5171662|NCT00929955|Schizophrenia|schizophrenia
5171663|NCT00929955|Simvastatin|simvastatin
5171664|NCT00929955|ondansetron|ondansetron
5171665|NCT00929942|lung transplantation|lung transplantation
5171666|NCT00929942|bronchial stenosis|bronchial stenosis
5171667|NCT00929942|biodegradable stent|biodegradable stent
5171668|NCT00929929|Aging|aging
5171669|NCT00929929|Functionality|functionality
5171670|NCT00929929|Sarcopenia|sarcopenia
5171671|NCT00929929|Leucine|leucine
5171672|NCT00929929|Progressive resistance exercise|progressive resistance exercise
5171673|NCT00929916|colonoscopy|colonoscopy
5171674|NCT00929916|MoviPrep|moviprep
5171675|NCT00929890|Obesity|obesity
5171676|NCT00929890|Exercise|exercise
5171677|NCT00929890|Diet|diet
5171678|NCT00929890|Lifestyle|lifestyle
5171679|NCT00929890|Vascular reactivity|vascular reactivity
5171680|NCT00929890|Body composition|body composition
5171681|NCT00929890|Lipids|lipids
5171682|NCT00929890|Glucose|glucose
5171683|NCT00929890|Insulin resistance|insulin resistance
5171684|NCT00929838|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
5171685|NCT00929838|Diabetes Mellitus, Adult-Onset|diabetes mellitus, adult-onset
5171686|NCT00929838|Diabetes Mellitus, Non-Insulin-Dependent|diabetes mellitus, non-insulin-dependent
5171687|NCT00929838|African Americans|african americans
5171688|NCT00929838|Blacks|blacks
5171689|NCT00929838|Randomized Controlled Trial|randomized controlled trial
5171690|NCT00929838|Controlled Clinical Trial|controlled clinical trial
5171691|NCT00929838|Behavioral Research|behavioral research
5171692|NCT00929838|Behavioral Medicine|behavioral medicine
5171693|NCT00929825|Salivary stimulation|salivary stimulation
5171694|NCT00929825|Transplantation of hematopoietic stem cells|transplantation of hematopoietic stem cells
5171695|NCT00929825|Hyperboloid|hyperboloid
5171696|NCT00929825|Transcutaneous Electrical Stimulation|transcutaneous electrical stimulation
5171697|NCT00929812|obesity|obesity
5171698|NCT00929812|food intake|food intake
5171699|NCT00929812|glucagon|glucagon
5171700|NCT00929812|ghrelin|ghrelin
5171701|NCT00929812|glucose|glucose
5171702|NCT00929812|insulin|insulin
5171703|NCT00929786|Plasma levels isoniazid rifampicin pyrazinamide|plasma levels isoniazid rifampicin pyrazinamide
5171704|NCT00929760|Chronic Kidney disease|chronic kidney disease
5171705|NCT00929760|Nephrologists|nephrologists
5171706|NCT00929760|Primary Care|primary care
5171707|NCT00929760|Death|death
5171708|NCT00929760|Renal Replacement Therapy|renal replacement therapy
5171709|NCT00929760|Specialised renal care|specialised renal care
5171710|NCT00929747|Cataract|cataract
5171711|NCT00929747|Toric|toric
5171712|NCT00929747|IOL|iol
5171713|NCT00929747|AcrySof, LRI|acrysof, lri
5171714|NCT00929734|Inflammation|inflammation
5171715|NCT00929734|Atherosclerosis|atherosclerosis
5171716|NCT00929734|Hydroxymethylglutaryl-coenzyme A Reductase Inhibitors|hydroxymethylglutaryl-coenzyme a reductase inhibitors
5171717|NCT00929721|CAP|cap
5171718|NCT00929708|COPD|copd
5171719|NCT00929708|Efficacy|efficacy
5171720|NCT00929708|Safety|safety
5171721|NCT00929708|Inhalation|inhalation
5171722|NCT00929682|Labor|labor
5171723|NCT00929682|Epidural analgesia|epidural analgesia
5171724|NCT00929682|Local anesthetics|local anesthetics
5171725|NCT00929682|Levobupivacaine|levobupivacaine
5171727|NCT00929682|Patient-controlled|patient-controlled
5171728|NCT00929682|Active spontaneous labor requiring epidural analgesia|active spontaneous labor requiring epidural analgesia
5171729|NCT00929669|pituitary tumor|pituitary tumor
5171730|NCT00929669|endocrine|endocrine
5171731|NCT00929656|Rehabilitation|rehabilitation
5171732|NCT00929656|Neurophysiology|neurophysiology
5171733|NCT00929656|Upper Extremity|upper extremity
5171734|NCT00929643|health care costs|health care costs
5171735|NCT00929643|Intra-Abdominal Infection|intra-abdominal infection
5171736|NCT00929630|fibrin glue|fibrin glue
5171737|NCT00929630|transsphincteric anal fistulas|transsphincteric anal fistulas
5171738|NCT00929630|seton|seton
5171739|NCT00929630|incontinence|incontinence
5171740|NCT00929630|prospective randomised trial|prospective randomised trial
5171741|NCT00929617|breast cancer|breast cancer
5171742|NCT00929617|physical activity|physical activity
5171743|NCT00929617|exercise|exercise
5171744|NCT00929617|quality of life|quality of life
5171745|NCT00929617|doubly labeled water|doubly labeled water
5171746|NCT00929604|HIV|hiv
5171747|NCT00929604|AIDS|aids
5171748|NCT00929604|Zambia|zambia
5171749|NCT00929604|viral load|viral load
5171750|NCT00929604|antiretroviral therapy|antiretroviral therapy
5171751|NCT00929604|cluster randomization|cluster randomization
5171752|NCT00929604|ART monitoring|art monitoring
5171753|NCT00929604|treatment failure|treatment failure
5171754|NCT00929604|randomized clinical trial|randomized clinical trial
5171755|NCT00929604|treatment naive|treatment naive
5171756|NCT00929591|stage II breast cancer|stage ii breast cancer
5171757|NCT00929591|stage IIIA breast cancer|stage iiia breast cancer
5171758|NCT00929578|Psoriasis|psoriasis
5171759|NCT00929578|T-lymphocytes|t-lymphocytes
5171760|NCT00929578|Fluphenazine|fluphenazine
5171761|NCT00929565|hemoptysis|hemoptysis
5171762|NCT00929552|Blood pressure|blood pressure
5171763|NCT00929552|Insulin sensitivity|insulin sensitivity
5171764|NCT00929552|Blood lipid profile|blood lipid profile
5171765|NCT00929539|Diabetes|diabetes
5171766|NCT00929526|HPV vaccine|hpv vaccine
5171767|NCT00929526|cervical intraepithelial neoplasia (CIN)|cervical intraepithelial neoplasia (cin)
5171768|NCT00929526|including new onset of autoimmune disease [NOAD])|including new onset of autoimmune disease [noad])
5171769|NCT00929526|new onset of chronic disease (NOCD)|new onset of chronic disease (nocd)
5171770|NCT00929526|medically significant condition (MSC)|medically significant condition (msc)
5171771|NCT00929487|contact lens wear|contact lens wear
5171772|NCT00929487|contact lens solution|contact lens solution
5171773|NCT00929487|corneal staining|corneal staining
5171774|NCT00929461|omega-3 fatty acids|omega-3 fatty acids
5171775|NCT00929461|lactate|lactate
5171776|NCT00929461|surgery|surgery
5171777|NCT00929461|gastric cancer|gastric cancer
5171778|NCT00929461|address the effect of postoperative administration of omega-3 fatty acids on cellular hypoperfusion associated with major gastric surgery.|address the effect of postoperative administration of omega-3 fatty acids on cellular hypoperfusion associated with major gastric surgery.
5171779|NCT00929448|Traumatic brain injury|traumatic brain injury
5171780|NCT00929435|MRSA|mrsa
5171781|NCT00929435|Contact isolation|contact isolation
5171782|NCT00929435|Incidence|incidence
5171783|NCT00929422|spinal cord injury|spinal cord injury
5171784|NCT00929422|PET|pet
5171785|NCT00929422|cerebral function|cerebral function
5171786|NCT00929422|cortical reorganization|cortical reorganization
5171787|NCT00929409|Postpartum anemia, iron-deficiency|postpartum anemia, iron-deficiency
5171788|NCT00929396|Tuberculosis|tuberculosis
5171789|NCT00929396|Vaccine|vaccine
5171790|NCT00929396|Ag85B|ag85b
5171791|NCT00929396|ESAT-6|esat-6
5171792|NCT00929396|IC31|ic31
5171793|NCT00929383|Intracranial Atherosclerosis|intracranial atherosclerosis
5171794|NCT00929383|Stenosis|stenosis
5171795|NCT00929383|ICAD|icad
5171796|NCT00929383|atherosclerotic lesions|atherosclerotic lesions
5171797|NCT00929383|stenting|stenting
5171798|NCT00929370|Schizophrenia|schizophrenia
5171799|NCT00929370|GSK1018921|gsk1018921
5171800|NCT00929370|GlyT-1 inhibitor|glyt-1 inhibitor
5171801|NCT00929370|Healthy Volunteers|healthy volunteers
5171802|NCT00929370|CSF|csf
5171803|NCT00929370|Patient|patient
5171804|NCT00929370|Midazolam|midazolam
5171805|NCT00929344|Alcohol|alcohol
5171806|NCT00929344|Alcohol treatment|alcohol treatment
5171807|NCT00929344|Alcoholism|alcoholism
5171808|NCT00929344|Alcohol Abuse|alcohol abuse
5171809|NCT00929344|Alcohol Dependence|alcohol dependence
5171810|NCT00929331|Influenza|influenza
5171811|NCT00929331|Fluviral®|fluviral®
5171812|NCT00929305|chronic pain|chronic pain
5171813|NCT00929305|neck|neck
5171814|NCT00929305|shoulder|shoulder
5171815|NCT00929305|musculoskeletal origin|musculoskeletal origin
5171816|NCT00929292|Infant formula|infant formula
5171817|NCT00929292|Alpha-lactalbumin|alpha-lactalbumin
5171818|NCT00929292|Protein composition|protein composition
5171819|NCT00929292|Colic|colic
5171820|NCT00929292|Probiotics|probiotics
5171821|NCT00929279|Acute coronary syndrome|acute coronary syndrome
5171822|NCT00929279|Abciximab|abciximab
5171823|NCT00929279|Bolus|bolus
5171824|NCT00929279|Infusion|infusion
5171825|NCT00929279|platelet inhibition|platelet inhibition
5171826|NCT00929279|Non ST segment elevation acute coronary syndrome|non st segment elevation acute coronary syndrome
5171827|NCT00929266|peripheral stem cells (PSC) donors|peripheral stem cells (psc) donors
5171828|NCT00929266|cultured red blood cells|cultured red blood cells
5171829|NCT00929266|In vivo half life|in vivo half life
5171830|NCT00929253|Opioid Dependence|opioid dependence
5171831|NCT00929253|Opiates|opiates
5171832|NCT00929253|Hydrocodone|hydrocodone
5171833|NCT00929253|Oxycodone|oxycodone
5171834|NCT00929253|Oxycontin|oxycontin
5171835|NCT00929253|Narcotic Abuse|narcotic abuse
5171836|NCT00929227|Atherosclerosis|atherosclerosis
5171837|NCT00929227|Myocardial Ischemia|myocardial ischemia
5171838|NCT00929227|Diagnostic Testing|diagnostic testing
5171839|NCT00929227|Cardiac Commuted Tomography|cardiac commuted tomography
5171840|NCT00929227|Cardiac Magnetic Resonance Imaging|cardiac magnetic resonance imaging
5171841|NCT00929227|Coronary Artery Disease|coronary artery disease
5171842|NCT00929214|Breast Cancer|breast cancer
5171843|NCT00929214|Metastasized|metastasized
5171844|NCT00929214|Limited bone-only metastasis|limited bone-only metastasis
5171845|NCT00929214|Local Therapy|local therapy
5171846|NCT00929214|Radiation|radiation
5171847|NCT00929214|Radiation Therapy|radiation therapy
5171848|NCT00929214|RT|rt
5171849|NCT00929214|Surgery|surgery
5171850|NCT00929214|Standard Therapy|standard therapy
5171851|NCT00929214|Chemotherapy|chemotherapy
5171852|NCT00929214|Endocrine Therapy|endocrine therapy
5171853|NCT00929188|Moderate to severe chronic, cancer-related pain related to an active cancer|moderate to severe chronic, cancer-related pain related to an active cancer
5171854|NCT00929188|Cancer-related pain|cancer-related pain
5171855|NCT00929188|Moderate to severe chronic pain|moderate to severe chronic pain
5171856|NCT00929188|JNJ-42160443|jnj-42160443
5171857|NCT00929175|Hypertension|hypertension
5171858|NCT00929175|Resistant Hypertension|resistant hypertension
5171859|NCT00929175|Sleep apnea syndrome|sleep apnea syndrome
5171860|NCT00929175|Treatment|treatment
5171861|NCT00929162|ovarian|ovarian
5171862|NCT00929162|cancer|cancer
5171863|NCT00929162|chemotherapy|chemotherapy
5171864|NCT00929162|sensitive|sensitive
5171865|NCT00929162|ZD4054|zd4054
5171866|NCT00929136|Endotoxin|endotoxin
5171867|NCT00929136|Insulin resistance|insulin resistance
5171868|NCT00929136|Lipolysis|lipolysis
5171869|NCT00929136|Proteolysis|proteolysis
5171870|NCT00929136|Intracellular Insulin Signaling|intracellular insulin signaling
5171871|NCT00929136|Regional effects of inflammation/endotoxin|regional effects of inflammation/endotoxin
5171872|NCT00929123|manual therapy|manual therapy
5171873|NCT00929123|carpal tunnel syndrome|carpal tunnel syndrome
5171874|NCT00929123|central sensitization|central sensitization
5171875|NCT00929110|COPD|copd
5171876|NCT00929110|NVA237|nva237
5171877|NCT00929110|glycopyrronium bromide|glycopyrronium bromide
5171878|NCT00929097|Colorectal Neoplasms, (Hereditary Nonpolyposis)|colorectal neoplasms, (hereditary nonpolyposis)
5171879|NCT00929097|Guideline|guideline
5171880|NCT00929097|Health Plan Implementation|health plan implementation
5171881|NCT00929097|Decision Support Techniques|decision support techniques
5171882|NCT00929097|Risk assessment|risk assessment
5171883|NCT00929097|Familial colorectal cancer risk|familial colorectal cancer risk
5171884|NCT00929097|Risk assessment tool|risk assessment tool
5171885|NCT00929084|Race Disparities|race disparities
5171886|NCT00929084|Breast Cancer|breast cancer
5171887|NCT00929084|Quality of Life|quality of life
5171888|NCT00929084|Treatment Adherence|treatment adherence
5171889|NCT00929071|wrinkles|wrinkles
5171890|NCT00929071|dermal filler|dermal filler
5171891|NCT00929071|collagen|collagen
5171892|NCT00929071|soft tissue augmentation|soft tissue augmentation
5171893|NCT00929071|lidocaine|lidocaine
5171894|NCT00929071|aesthetic|aesthetic
5171895|NCT00929045|Growth Hormone replacement|growth hormone replacement
5171896|NCT00929045|subject 8 to 21|subject 8 to 21
5171897|NCT00929045|moderate to severe traumatic brain injury|moderate to severe traumatic brain injury
5171898|NCT00929045|growth hormone deficient|growth hormone deficient
5171899|NCT00929032|Liver Transplantation|liver transplantation
5171900|NCT00929032|Immunosystem of the Liver|immunosystem of the liver
5171901|NCT00929032|Marginal and Non-marginal grafts|marginal and non-marginal grafts
5171902|NCT00929019|uveal melanoma|uveal melanoma
5171903|NCT00929019|chromosome 3|chromosome 3
5171904|NCT00929019|high risk|high risk
5171905|NCT00929019|immunotherapy|immunotherapy
5171906|NCT00929019|adjuvant|adjuvant
5171907|NCT00929019|high risk genetic profile|high risk genetic profile
5171908|NCT00929019|loss of chromosome 3|loss of chromosome 3
5171909|NCT00929006|hyperandrogenemia|hyperandrogenemia
5171910|NCT00929006|pubertal|pubertal
5171911|NCT00929006|polycystic ovary syndrome|polycystic ovary syndrome
5171912|NCT00928993|actigraphy|actigraphy
5171913|NCT00928993|polysomnography|polysomnography
5171914|NCT00928993|pediatrics|pediatrics
5171915|NCT00928993|sleep|sleep
5171916|NCT00928993|To validate Actigraphy against polysomnography|to validate actigraphy against polysomnography
5171917|NCT00928980|Recurrent Major Depressive Disorder|recurrent major depressive disorder
5171918|NCT00928980|Mindfulness Based Cognitive Therapy|mindfulness based cognitive therapy
5171919|NCT00928980|Cost-effectiveness|cost-effectiveness
5171920|NCT00928980|Antidepressant medication|antidepressant medication
5171921|NCT00928980|Randomized Controlled Trial|randomized controlled trial
5171922|NCT00928967|Multiple Sclerosis|multiple sclerosis
5171923|NCT00928967|Quality of life|quality of life
5171924|NCT00928954|gabapentin|gabapentin
5171925|NCT00928954|memantine|memantine
5171926|NCT00928954|nystagmus|nystagmus
5171927|NCT00928954|Drug treatment|drug treatment
5171928|NCT00928941|PTSD|ptsd
5171929|NCT00928941|rehabilitation|rehabilitation
5171930|NCT00928928|Lipid peroxidation|lipid peroxidation
5171931|NCT00928928|Protein peroxidation|protein peroxidation
5171932|NCT00928928|DNA peroxidation|dna peroxidation
5171933|NCT00928928|RNA peroxidation|rna peroxidation
5171934|NCT00928928|Cytokines|cytokines
5171935|NCT00928928|hsCRP|hscrp
5171936|NCT00928928|Oxidative stress markers|oxidative stress markers
5171937|NCT00928928|Open surgery|open surgery
5171938|NCT00928928|Laparoscopic surgery|laparoscopic surgery
5171939|NCT00928915|Intracranial Hemorrhages|intracranial hemorrhages
5171940|NCT00928915|Vitamin-K antagonist|vitamin-k antagonist
5171941|NCT00928915|Hemostatic treatment|hemostatic treatment
5171942|NCT00928915|Prothrombin complex|prothrombin complex
5171943|NCT00928915|Fresh frozen plasma|fresh frozen plasma
5171944|NCT00928915|Intracranial Hemorrhages related to vitamin-K antagonist|intracranial hemorrhages related to vitamin-k antagonist
5171945|NCT00928902|melanoma|melanoma
5171946|NCT00928902|vaccine|vaccine
5171947|NCT00928902|peptides|peptides
5171948|NCT00928902|adjuvant|adjuvant
5171949|NCT00928902|immunogenicity|immunogenicity
5171950|NCT00928902|stage IIB, stage III or resected stage IV|stage iib, stage iii or resected stage iv
5171951|NCT00928889|diabetes mellitus, type 2|diabetes mellitus, type 2
5171952|NCT00928889|nateglinide|nateglinide
5171953|NCT00928889|acarbose|acarbose
5171954|NCT00928889|hyperglycemia|hyperglycemia
5171955|NCT00928889|dyslipidemias|dyslipidemias
5171956|NCT00928889|C-reactive protein|c-reactive protein
5171957|NCT00928876|anakinra|anakinra
5171958|NCT00928876|Diabetes mellitus, type 2|diabetes mellitus, type 2
5171959|NCT00928876|Insulin resistance|insulin resistance
5171960|NCT00928876|Interleukin-1beta|interleukin-1beta
5171961|NCT00928863|haemorrhagia postpartum|haemorrhagia postpartum
5171962|NCT00928863|implementation guidelines|implementation guidelines
5171963|NCT00928863|maternal morbidity|maternal morbidity
5171964|NCT00928863|management of obstetrics and trauma|management of obstetrics and trauma
5171965|NCT00928850|Prostate|prostate
5171966|NCT00928850|Radical Prostatectomy|radical prostatectomy
5171967|NCT00928850|urethral irrigation|urethral irrigation
5171968|NCT00928850|fascial suturing|fascial suturing
5171969|NCT00928850|09-051|09-051
5171970|NCT00928811|Simulect|simulect
5171971|NCT00928811|de novo kidney transplant subjects|de novo kidney transplant subjects
5171972|NCT00928811|calcineurin inhibitors|calcineurin inhibitors
5171973|NCT00928811|Prograf|prograf
5171974|NCT00928785|Tetanus Vaccine|tetanus vaccine
5171975|NCT00928785|Tdap-IPV vaccine|tdap-ipv vaccine
5171976|NCT00928772|Cranial Electro Stimulation|cranial electro stimulation
5171977|NCT00928772|First Eye Cataract Surgery|first eye cataract surgery
5171978|NCT00928772|Preoperative sedation|preoperative sedation
5171979|NCT00928772|Perioperative sedation|perioperative sedation
5171980|NCT00928759|Obesity|obesity
5171981|NCT00928759|Polycystic Ovary Syndrome|polycystic ovary syndrome
5171982|NCT00928733|Permeability|permeability
5171983|NCT00928733|tight junctions|tight junctions
5171984|NCT00928733|cytokines|cytokines
5171985|NCT00928733|inflammatory bowel diseases|inflammatory bowel diseases
5171986|NCT00928733|The effect of alcohol on the intestinal permeability may have major consequences on health.|the effect of alcohol on the intestinal permeability may have major consequences on health.
5171987|NCT00928733|It's generally accepted that an increased intestinal permeability in alcoholic subjects lead|it's generally accepted that an increased intestinal permeability in alcoholic subjects lead
5171988|NCT00928733|to translocation of bacterial endotoxins from the gut lumen into the portal vein and then to the liver.|to translocation of bacterial endotoxins from the gut lumen into the portal vein and then to the liver.
5171989|NCT00928733|In the liver, endotoxins trigger the immune system and activate the resident macrophages, Kupffer cells.|in the liver, endotoxins trigger the immune system and activate the resident macrophages, kupffer cells.
5171990|NCT00928733|Activation of Kupffer cells leads to production of chemokines (IL-8) and|activation of kupffer cells leads to production of chemokines (il-8) and
5171991|NCT00928733|proinflammatory cytokines (IL-1, TNFα),resulting in hepatocytes damage, inflammation, fibrosis and finally cirrhosis.|proinflammatory cytokines (il-1, tnfα),resulting in hepatocytes damage, inflammation, fibrosis and finally cirrhosis.
5171992|NCT00928720|fibromyalgia|fibromyalgia
5171993|NCT00928720|pain|pain
5171994|NCT00928720|sleep disturbance|sleep disturbance
5171995|NCT00928720|fatigue|fatigue
5171996|NCT00928720|depression|depression
5171997|NCT00928720|functional magnetic resonance imaging|functional magnetic resonance imaging
5171998|NCT00928707|Polycythemia Vera|polycythemia vera
5171999|NCT00928707|GIVINOSTAT|givinostat
5172000|NCT00928707|ITF2357|itf2357
5172001|NCT00928655|apnea|apnea
5172002|NCT00928655|sleep|sleep
5172003|NCT00928655|altitude|altitude
5172004|NCT00928655|hypoxia|hypoxia
5172005|NCT00928655|treatment|treatment
5172006|NCT00928655|CPAP|cpap
5172007|NCT00928642|ovarian|ovarian
5172008|NCT00928642|cancer|cancer
5172009|NCT00928642|peritoneal|peritoneal
5172010|NCT00928642|endometrioid|endometrioid
5172011|NCT00928642|mucinous|mucinous
5172012|NCT00928642|serous|serous
5172013|NCT00928642|clear cell|clear cell
5172014|NCT00928629|Peripheral Arterial Disease|peripheral arterial disease
5172015|NCT00928629|Cardiovascular Disease|cardiovascular disease
5172016|NCT00928629|Vascular Disease|vascular disease
5172017|NCT00928616|hyperlipidemia|hyperlipidemia
5172018|NCT00928616|plant sterols|plant sterols
5172019|NCT00928616|monocytes|monocytes
5172020|NCT00928603|prostate cancer|prostate cancer
5172021|NCT00928603|therapy|therapy
5172022|NCT00928590|open-angle glaucoma|open-angle glaucoma
5172023|NCT00928590|ocular hypertension|ocular hypertension
5172024|NCT00928590|pseudoexfoliation|pseudoexfoliation
5172025|NCT00928590|pigment dispersion|pigment dispersion
5172026|NCT00928577|Smallpox|smallpox
5172027|NCT00928577|Smallpox Vaccine|smallpox vaccine
5172028|NCT00928577|Vaccinia virus|vaccinia virus
5172029|NCT00928577|Military|military
5172030|NCT00928564|Pelvic floor muscle spasm|pelvic floor muscle spasm
5172031|NCT00928564|Pelvic pain|pelvic pain
5172032|NCT00928564|physical therapy|physical therapy
5172033|NCT00928564|pudendal block|pudendal block
5172034|NCT00928538|Female Contraception|female contraception
5172035|NCT00928538|Home Visits|home visits
5172036|NCT00928538|CONTRACEPTIVE AGENTS|contraceptive agents
5172037|NCT00928538|CONTRACEPTIVE DEVICES|contraceptive devices
5172038|NCT00928525|PDGFr alpha|pdgfr alpha
5172039|NCT00928525|PDGFr beta|pdgfr beta
5172040|NCT00928525|KIT|kit
5172041|NCT00928512|Rheumatoid Arthritis, RA, ACR, inflammatory joints|rheumatoid arthritis, ra, acr, inflammatory joints
5172042|NCT00928499|urge/frequency|urge/frequency
5172043|NCT00928499|urge incontinence|urge incontinence
5172044|NCT00928499|Interstim|interstim
5172045|NCT00928499|after success Interstim planning IPG placement|after success interstim planning ipg placement
5172046|NCT00928460|Electrocardiogram|electrocardiogram
5172047|NCT00928460|Electrocardiography|electrocardiography
5172048|NCT00928460|Perioperative care|perioperative care
5172049|NCT00928460|Preoperative care|preoperative care
5172050|NCT00928460|Preanesthesia Evaluation|preanesthesia evaluation
5172051|NCT00928460|Acute Coronary Syndrome|acute coronary syndrome
5172052|NCT00928460|Postoperative Myocardial Infarction|postoperative myocardial infarction
5172053|NCT00928460|Myocardial ischaemia|myocardial ischaemia
5172054|NCT00928460|Postoperative Cardiac Death|postoperative cardiac death
5172055|NCT00928460|Intraoperative complications|intraoperative complications
5172056|NCT00928460|Postoperative complications|postoperative complications
5172057|NCT00928460|Cost-effectiveness analysis|cost-effectiveness analysis
5172058|NCT00928447|rHuPH20|rhuph20
5172059|NCT00928447|Recombinant Human hyaluronidase|recombinant human hyaluronidase
5172060|NCT00928421|Varicose Veins|varicose veins
5172061|NCT00928395|Urgent PC|urgent pc
5172062|NCT00928395|Overactive Bladder|overactive bladder
5172063|NCT00928395|SUmiT Trial|sumit trial
5172064|NCT00928395|Overactive Urinary Bladder|overactive urinary bladder
5172065|NCT00928382|Spinal Cord|spinal cord
5172066|NCT00928382|Healthy Volunteer|healthy volunteer
5172067|NCT00928382|Metastasis|metastasis
5172068|NCT00928382|Samples|samples
5172069|NCT00928382|Spinal Cord Vertebrae|spinal cord vertebrae
5172070|NCT00928382|Cancer|cancer
5172071|NCT00928382|HV|hv
5172072|NCT00928356|Coronary Artery Disease|coronary artery disease
5172073|NCT00928356|Robotic Coronary Artery Bypass Surgery|robotic coronary artery bypass surgery
5172074|NCT00928356|Percutaneous Coronary Intervention|percutaneous coronary intervention
5172075|NCT00928356|Hybrid Coronary Revascularization|hybrid coronary revascularization
5172076|NCT00928343|Safety|safety
5172077|NCT00928343|Tolerability|tolerability
5172078|NCT00928343|Pharmacokinetics|pharmacokinetics
5172079|NCT00928330|TDM-1|tdm-1
5172080|NCT00928330|HER2|her2
5172081|NCT00928330|HER2+|her2+
5172082|NCT00928330|HER2+ Breast Cancer|her2+ breast cancer
5172083|NCT00928330|HER-2|her-2
5172084|NCT00928330|MBC|mbc
5172085|NCT00928330|Trastuzumab emtansine|trastuzumab emtansine
5172086|NCT00928304|Amyloid beta-protein|amyloid beta-protein
5172087|NCT00928304|Down Syndrome|down syndrome
5172088|NCT00928291|procalcitonin|procalcitonin
5172089|NCT00928291|neutropenia|neutropenia
5172090|NCT00928291|febrile neutropenia|febrile neutropenia
5172091|NCT00928291|antibiotic therapy|antibiotic therapy
5172092|NCT00928291|neutropenic patients|neutropenic patients
5172093|NCT00928265|intracranial|intracranial
5172094|NCT00928265|stenting|stenting
5172095|NCT00928265|endovascular treatment|endovascular treatment
5172096|NCT00928265|stent-assisted coiling|stent-assisted coiling
5172097|NCT00928265|cerebrovascular disease|cerebrovascular disease
5172098|NCT00928252|Hormone Refractory Prostate Cancer|hormone refractory prostate cancer
5172099|NCT00928252|Castrate Resistant Prostate Cancer|castrate resistant prostate cancer
5172100|NCT00928239|vaginal vault prolapse|vaginal vault prolapse
5172101|NCT00928239|laparoscopic sacropexy|laparoscopic sacropexy
5172102|NCT00928213|Preeclampsia|preeclampsia
5172104|NCT00928213|GH|gh
5172105|NCT00928213|PP13|pp13
5172106|NCT00928213|Doppler|doppler
5172107|NCT00928213|placenta|placenta
5172108|NCT00928213|PTD|ptd
5172109|NCT00928213|Preterm delivery|preterm delivery
5172110|NCT00928200|Relapsed|relapsed
5172111|NCT00928200|Allergy|allergy
5172112|NCT00928200|Erwinia|erwinia
5172113|NCT00928200|Acute|acute
5172114|NCT00928200|Lymphoblastic|lymphoblastic
5172115|NCT00928200|Leukemia|leukemia
5172116|NCT00928187|HIV|hiv
5172117|NCT00928187|Second line treatment|second line treatment
5172118|NCT00928187|WHO recommendations|who recommendations
5172119|NCT00928187|Africa|africa
5172120|NCT00928187|Treatment strategies|treatment strategies
5172121|NCT00928187|treatment experienced|treatment experienced
5172122|NCT00928174|Androgen insensitive prostate cancer|androgen insensitive prostate cancer
5172123|NCT00928161|Reflux Disease|reflux disease
5172124|NCT00928161|Acid-reflux|acid-reflux
5172125|NCT00928161|Head and Neck Cancer|head and neck cancer
5172126|NCT00928161|HNC|hnc
5172127|NCT00928161|Radiation Therapy|radiation therapy
5172128|NCT00928161|Mucositis|mucositis
5172129|NCT00928161|Radiation-induced xerostomia|radiation-induced xerostomia
5172130|NCT00928161|RIX|rix
5172131|NCT00928161|Dry Mouth|dry mouth
5172132|NCT00928161|Heartburn|heartburn
5172133|NCT00928161|Dexlansoprazole|dexlansoprazole
5172134|NCT00928161|Prevacid|prevacid
5172135|NCT00928161|Prevacid Solu-Tab|prevacid solu-tab
5172136|NCT00928161|GERD|gerd
5172137|NCT00928109|eating disorders|eating disorders
5172138|NCT00928109|couples therapy|couples therapy
5172139|NCT00928096|Lymphoma|lymphoma
5172140|NCT00928096|Radiotherapy|radiotherapy
5172141|NCT00928096|Positron-Emission Tomography|positron-emission tomography
5172142|NCT00928096|CT scan|ct scan
5172143|NCT00928083|Phase I|phase i
5172144|NCT00928083|Safety and tolerability|safety and tolerability
5172145|NCT00928083|Pharmacokinetic|pharmacokinetic
5172146|NCT00928083|synthetic peroxide|synthetic peroxide
5172147|NCT00928083|trioxolane|trioxolane
5172148|NCT00928083|treatment of erythrocytic stages of malaria|treatment of erythrocytic stages of malaria
5172149|NCT00928070|Urgency Urinary Incontinence OAB|urgency urinary incontinence oab
5172150|NCT00928057|Pen Needle|pen needle
5172151|NCT00928057|Diabetes|diabetes
5172152|NCT00928057|Insulin|insulin
5172153|NCT00928057|Glycemic|glycemic
5172154|NCT00928057|Pain|pain
5172155|NCT00928057|Fructosamine|fructosamine
5172156|NCT00928057|Leakage|leakage
5172157|NCT00928057|Hypoglycemia|hypoglycemia
5172158|NCT00928057|Hyperglycemia|hyperglycemia
5172159|NCT00928018|allogeneic stem cell transplant|allogeneic stem cell transplant
5172160|NCT00928018|reduced intensity conditioning|reduced intensity conditioning
5172161|NCT00928018|graft versus host disease|graft versus host disease
5172162|NCT00928018|GVHD|gvhd
5172163|NCT00928018|RIC transplantation|ric transplantation
5172164|NCT00928005|Weight loss diet|weight loss diet
5172165|NCT00928005|Exercise training|exercise training
5172166|NCT00928005|Type 2 diabetes|type 2 diabetes
5172167|NCT00928005|Prediabetes|prediabetes
5172168|NCT00928005|Cardiovascular health|cardiovascular health
5172169|NCT00927966|RAD001|rad001
5172170|NCT00927966|CP-751,871|cp-751,871
5172171|NCT00927966|advanced sarcoma|advanced sarcoma
5172172|NCT00927966|advanced malignant solid tumor|advanced malignant solid tumor
5172173|NCT00927953|West Nile virus|west nile virus
5172174|NCT00927953|WNV|wnv
5172175|NCT00927953|Encephalitis|encephalitis
5172176|NCT00927953|Meningitis|meningitis
5172177|NCT00927953|Acute Flaccid Paralysis|acute flaccid paralysis
5172178|NCT00927953|Monoclonal Antibody|monoclonal antibody
5172179|NCT00927953|WNND|wnnd
5172180|NCT00927953|West Nile Fever|west nile fever
5172181|NCT00927953|WNF|wnf
5172182|NCT00927940|TARGET VESSEL REVASCULARIZATION (TVR)|target vessel revascularization (tvr)
5172183|NCT00927940|MYOCARDIAL INFARCTION (MI)|myocardial infarction (mi)
5172184|NCT00927940|TARGET VESSEL FAILURE (TVF)|target vessel failure (tvf)
5172185|NCT00927940|TARGET LESION REVASCULARIZATION (TLR)|target lesion revascularization (tlr)
5172186|NCT00927940|TARGET LESION FAILURE (TLF)|target lesion failure (tlf)
5172187|NCT00927940|STENT THROMBOSIS|stent thrombosis
5172188|NCT00927940|RESTENOTIC LESION|restenotic lesion
5172189|NCT00927940|PERCUTANEOUS CORONARY INTERVENTION (PCI)|percutaneous coronary intervention (pci)
5172190|NCT00927901|QAB149|qab149
5172191|NCT00927901|asthma|asthma
5172192|NCT00927901|indacaterol salts (acetate, maleate, and xinafoate)|indacaterol salts (acetate, maleate, and xinafoate)
5172193|NCT00927901|orally inhaled indacaterol salts|orally inhaled indacaterol salts
5172194|NCT00927901|persistent asthma|persistent asthma
5172195|NCT00927862|warfarin metabolism|warfarin metabolism
5172196|NCT00927862|CYP2C9|cyp2c9
5172197|NCT00927862|genotyping|genotyping
5172198|NCT00927862|VKORC1|vkorc1
5172199|NCT00927862|anticoagulation|anticoagulation
5172200|NCT00927862|atrial fibrillation|atrial fibrillation
5172201|NCT00927862|deep vein thrombosis|deep vein thrombosis
5172202|NCT00927862|pulmonary embolism|pulmonary embolism
5172203|NCT00927862|Patients initiating warfarin for thromboembolic conditions|patients initiating warfarin for thromboembolic conditions
5172204|NCT00927849|anal hypertonia|anal hypertonia
5172205|NCT00927849|sphincterotomy|sphincterotomy
5172206|NCT00927849|incontinence|incontinence
5172207|NCT00927849|manometry|manometry
5172208|NCT00927810|Gout|gout
5172209|NCT00927810|Gouty arthritis|gouty arthritis
5172210|NCT00927810|Gout flares|gout flares
5172211|NCT00927810|Anti-interleukin-1β monoclonal antibody|anti-interleukin-1β monoclonal antibody
5172212|NCT00927797|immunochemotherapy|immunochemotherapy
5172213|NCT00927797|Pentostatin|pentostatin
5172214|NCT00927797|Cyclophosphamide|cyclophosphamide
5172215|NCT00927797|Rituximab|rituximab
5172216|NCT00927797|Maintenance|maintenance
5172217|NCT00927797|indolent B-NHL|indolent b-nhl
5172218|NCT00927797|B-CLL|b-cll
5172219|NCT00927797|B-NHL|b-nhl
5172220|NCT00927784|Mesenchymal Precursor Cells|mesenchymal precursor cells
5172221|NCT00927784|Left Ventricular Assist Device|left ventricular assist device
5172222|NCT00927784|LVAD|lvad
5172223|NCT00927784|Congestive Heart Failure|congestive heart failure
5172224|NCT00927784|Stem Cells|stem cells
5172225|NCT00927771|melanosis|melanosis
5172226|NCT00927771|melasma|melasma
5172227|NCT00927771|azelaic acid|azelaic acid
5172228|NCT00927771|hydroquinone|hydroquinone
5172229|NCT00927745|Respiration Artificial|respiration artificial
5172230|NCT00927745|Positive-Pressure Respiration|positive-pressure respiration
5172231|NCT00927745|Critical Care|critical care
5172232|NCT00927745|Intensive Care Units|intensive care units
5172233|NCT00927732|Brugada|brugada
5172234|NCT00927732|hydroquinidine|hydroquinidine
5172235|NCT00927732|ventricular arrhythmia|ventricular arrhythmia
5172236|NCT00927732|patients with Brugada syndrome, high cardiac arrhythmic risk and implanted with an implantable cardioverter defibrillator|patients with brugada syndrome, high cardiac arrhythmic risk and implanted with an implantable cardioverter defibrillator
5172237|NCT00927719|Smallpox|smallpox
5172238|NCT00927719|Smallpox Vaccine|smallpox vaccine
5172239|NCT00927719|Vaccinia virus|vaccinia virus
5172240|NCT00927719|Military|military
5172241|NCT00927706|Assistive Technology|assistive technology
5172242|NCT00927706|Mobility Limitation|mobility limitation
5172243|NCT00927706|Physical Disability|physical disability
5172244|NCT00927706|Caregiver|caregiver
5172245|NCT00927706|Participation|participation
5172246|NCT00927693|Atherosclerosis|atherosclerosis
5172247|NCT00927693|Coronary Artery Disease|coronary artery disease
5172248|NCT00927693|Cardiac Risk Factors|cardiac risk factors
5172249|NCT00927693|Coronary Calcium Scan|coronary calcium scan
5172250|NCT00927693|Prevention|prevention
5172251|NCT00927680|Colorectal Cancer|colorectal cancer
5172252|NCT00927680|Familial Colorectal Cancer|familial colorectal cancer
5172253|NCT00927680|Genetics|genetics
5172254|NCT00927680|Hispanics|hispanics
5172255|NCT00927667|Hemophilia A|hemophilia a
5172256|NCT00927667|Joint Status|joint status
5172257|NCT00927667|Bleeds|bleeds
5172258|NCT00927667|Magnetic Resonce Imaging|magnetic resonce imaging
5172259|NCT00927654|Iloprost|iloprost
5172260|NCT00927654|pulmonary hypertension|pulmonary hypertension
5172261|NCT00927654|cardio pulmonary morbidity|cardio pulmonary morbidity
5172262|NCT00927654|high risk cardiac surgical patients|high risk cardiac surgical patients
5172263|NCT00927641|Ankle Sprain|ankle sprain
5172264|NCT00927628|vitrectomy|vitrectomy
5172265|NCT00927628|macular hole|macular hole
5172266|NCT00927628|ILM peeling|ilm peeling
5172267|NCT00927615|myocardial infarction|myocardial infarction
5172268|NCT00927615|glycoprotein IIb/IIIa|glycoprotein iib/iiia
5172269|NCT00927615|percutaneous coronary intervention|percutaneous coronary intervention
5172270|NCT00927615|thrombus aspiration|thrombus aspiration
5172271|NCT00927615|myocardial perfusion|myocardial perfusion
5172272|NCT00927602|renal failure|renal failure
5172273|NCT00927602|medical patient|medical patient
5172274|NCT00927602|venous thromboembolism|venous thromboembolism
5172275|NCT00927602|prophylaxis|prophylaxis
5172276|NCT00927602|fondaparinux|fondaparinux
5172277|NCT00927589|HER2+ Metastatic Cancer|her2+ metastatic cancer
5172278|NCT00927589|HER2+ Locally Advanced Inoperable Cancer|her2+ locally advanced inoperable cancer
5172279|NCT00927589|HER2+ Solid Malignancy|her2+ solid malignancy
5172280|NCT00927576|cognitive training|cognitive training
5172281|NCT00927576|neuroplasticity|neuroplasticity
5172282|NCT00927576|cognitive impairment|cognitive impairment
5172283|NCT00927576|recovery of function|recovery of function
5172284|NCT00927576|memory|memory
5172285|NCT00927576|attention|attention
5172286|NCT00927563|Gambling|gambling
5172287|NCT00927563|Addiction|addiction
5172288|NCT00927550|resistant depression|resistant depression
5172289|NCT00927550|lithium|lithium
5172290|NCT00927550|RCT|rct
5172291|NCT00927550|lithium therapy|lithium therapy
5172292|NCT00927550|standard therapy|standard therapy
5172293|NCT00927537|Hypertension|hypertension
5172294|NCT00927524|Insulin analogs|insulin analogs
5172295|NCT00927524|diabetes|diabetes
5172296|NCT00927511|metastatic hormone-responsive breast cancer menopausal women|metastatic hormone-responsive breast cancer menopausal women
5172297|NCT00927498|Acute myeloid Leukemia|acute myeloid leukemia
5172298|NCT00927498|patient aged 50 to 70 years|patient aged 50 to 70 years
5172299|NCT00927485|Familial Adenomatous Polyposis (FAP)|familial adenomatous polyposis (fap)
5172300|NCT00927485|Curcumin|curcumin
5172301|NCT00927485|Colorectal polyps|colorectal polyps
5172302|NCT00927485|Duodenal polyps|duodenal polyps
5172303|NCT00927472|Head Lice|head lice
5172304|NCT00927459|cholesterol|cholesterol
5172305|NCT00927459|coronary artery disease|coronary artery disease
5172306|NCT00927446|esophageal cancer|esophageal cancer
5172307|NCT00927446|head and neck cancer|head and neck cancer
5172308|NCT00927446|narrow band imaging|narrow band imaging
5172309|NCT00927446|endoscopy|endoscopy
5172310|NCT00927446|screening|screening
5172311|NCT00927433|Fatigue|fatigue
5172312|NCT00927433|Cancer|cancer
5172313|NCT00927433|Radiation therapy|radiation therapy
5172314|NCT00927433|Chemotherapy|chemotherapy
5172315|NCT00927433|Hormones|hormones
5172316|NCT00927433|Surgery|surgery
5172317|NCT00927433|Breast cancer|breast cancer
5172318|NCT00927420|Bipolar disorder|bipolar disorder
5172319|NCT00927420|adherence|adherence
5172320|NCT00927420|treatment|treatment
5172321|NCT00927420|real life practice|real life practice
5172322|NCT00927407|Head Lice|head lice
5172323|NCT00927394|Hypertension, Type II Diabetes, Aliskiren, Valsartan,|hypertension, type ii diabetes, aliskiren, valsartan,
5172324|NCT00927394|Systolic blood pressure, Diastolic blood pressure,|systolic blood pressure, diastolic blood pressure,
5172325|NCT00927394|Stage II, Combination|stage ii, combination
5172326|NCT00927368|TKA|tka
5172327|NCT00927368|total knee replacement|total knee replacement
5172328|NCT00927355|pioglitazone|pioglitazone
5172329|NCT00927355|human bone marrow stem cells|human bone marrow stem cells
5172330|NCT00927355|adipocytes|adipocytes
5172331|NCT00927355|osteoblasts|osteoblasts
5172332|NCT00927355|bone mineral density|bone mineral density
5172333|NCT00927355|adiponectin|adiponectin
5172334|NCT00927355|leptin|leptin
5172335|NCT00927355|CTX|ctx
5172336|NCT00927355|P1NP|p1np
5172337|NCT00927355|Osteocalcin|osteocalcin
5172338|NCT00927342|Air leak|air leak
5172339|NCT00927342|Thoracic Surgery|thoracic surgery
5172340|NCT00927342|Sealants|sealants
5172341|NCT00927329|Dermatophagoides|dermatophagoides
5172342|NCT00927329|farinae|farinae
5172343|NCT00927329|allergen|allergen
5172344|NCT00927329|dust|dust
5172345|NCT00927329|allergic|allergic
5172346|NCT00927329|mite|mite
5172347|NCT00927329|allergy|allergy
5172348|NCT00927316|Report of Urinary Tract Infection episode|report of urinary tract infection episode
5172349|NCT00927303|retinal thickness|retinal thickness
5172350|NCT00927303|threshold algorithm|threshold algorithm
5172351|NCT00927303|optical coherence tomography|optical coherence tomography
5172352|NCT00927290|hepatitis C; insulin resistance; glitazones; pioglitazone; steatosis; viral kinetics; antiviral response|hepatitis c; insulin resistance; glitazones; pioglitazone; steatosis; viral kinetics; antiviral response
5172353|NCT00927264|tobacco smoke exposure smoking|tobacco smoke exposure smoking
5172354|NCT00927251|heart failure|heart failure
5172355|NCT00927251|cardiac pacing|cardiac pacing
5172356|NCT00927251|cardiac resynchronization therapy|cardiac resynchronization therapy
5172357|NCT00927251|left ventricular lead|left ventricular lead
5172358|NCT00927238|Single Level|single level
5172359|NCT00927238|Lumbar Disc Disease|lumbar disc disease
5172360|NCT00927238|DDD|ddd
5172361|NCT00927199|High-Oleic Canola Oil|high-oleic canola oil
5172362|NCT00927199|Flaxseed Oil|flaxseed oil
5172363|NCT00927199|Monounsaturated Fatty Acids|monounsaturated fatty acids
5172364|NCT00927199|Polyunsaturated Fatty Acids|polyunsaturated fatty acids
5172365|NCT00927199|Alpha Linolenic Acid|alpha linolenic acid
5172366|NCT00927199|Cardiovascular|cardiovascular
5172367|NCT00927199|Hypercholesterolemia|hypercholesterolemia
5172368|NCT00927199|Lipids|lipids
5172369|NCT00927199|Inflammation|inflammation
5172370|NCT00927199|Metabolism|metabolism
5172371|NCT00927186|osteoporosis|osteoporosis
5172372|NCT00927186|teriparatide|teriparatide
5172373|NCT00927186|zoledronic acid|zoledronic acid
5172374|NCT00927186|histomorphometry|histomorphometry
5172375|NCT00927186|bone biopsy|bone biopsy
5172376|NCT00927186|postmenopausal|postmenopausal
5172377|NCT00927173|TMS|tms
5172378|NCT00927173|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
5172379|NCT00927173|MDD|mdd
5172380|NCT00927173|Major Depressive Disorder|major depressive disorder
5172381|NCT00927160|Mobile Acute Care of the Elderly Unit|mobile acute care of the elderly unit
5172382|NCT00927160|Geriatric Models of Care|geriatric models of care
5172383|NCT00927147|head and neck cancer|head and neck cancer
5172384|NCT00927147|boron neutron capture therapy|boron neutron capture therapy
5172385|NCT00927147|cetuximab|cetuximab
5172386|NCT00927147|epidermal growth factor receptor|epidermal growth factor receptor
5172387|NCT00927147|safety|safety
5172388|NCT00927147|efficacy|efficacy
5172389|NCT00927147|survival|survival
5172390|NCT00927134|Chronic Granulomatous Disease in children (=or< 18 years)|chronic granulomatous disease in children (=or< 18 years)
5172391|NCT00927108|Adult Progenitor Stem cells|adult progenitor stem cells
5172392|NCT00927108|Alzheimer's disease|alzheimer's disease
5172393|NCT00927108|Parkinson's disease|parkinson's disease
5172394|NCT00927108|Multiple sclerosis|multiple sclerosis
5172395|NCT00927095|PMDD|pmdd
5172396|NCT00927095|Oral contraceptives|oral contraceptives
5172397|NCT00927095|steroid hormones|steroid hormones
5172398|NCT00927095|neurosteroids|neurosteroids
5172399|NCT00927069|Adalimumab|adalimumab
5172400|NCT00927030|Autism|autism
5172401|NCT00927030|children|children
5172402|NCT00927030|sleep|sleep
5172403|NCT00927030|insomnia|insomnia
5172404|NCT00927017|Healthy volunteers|healthy volunteers
5172405|NCT00927004|mechanical hyperalgesia|mechanical hyperalgesia
5172406|NCT00927004|cold hyperalgesia|cold hyperalgesia
5172407|NCT00927004|chronic pain|chronic pain
5172408|NCT00926978|Thyroid|thyroid
5172409|NCT00926978|I-124|i-124
5172410|NCT00926965|tardive dyskinesia|tardive dyskinesia
5172411|NCT00926965|neurocognitive function|neurocognitive function
5172412|NCT00926952|Actinic keratoses|actinic keratoses
5172413|NCT00926952|actinic keratosis|actinic keratosis
5172414|NCT00926952|methylamonolevulinate|methylamonolevulinate
5172415|NCT00926952|photodynamic therapy|photodynamic therapy
5172416|NCT00926952|without occlusion|without occlusion
5172417|NCT00926952|short incubation|short incubation
5172418|NCT00926939|Cigarette|cigarette
5172419|NCT00926939|Nicotine|nicotine
5172420|NCT00926939|Smoking|smoking
5172421|NCT00926939|Contingency Management|contingency management
5172422|NCT00926939|Voucher reinforcement|voucher reinforcement
5172423|NCT00926939|Smoking Abstinence|smoking abstinence
5172424|NCT00926939|Internet-based treatment|internet-based treatment
5172425|NCT00926926|Healthy volunteer|healthy volunteer
5172426|NCT00926913|Macular Degeneration|macular degeneration
5172427|NCT00926900|Alcoholism|alcoholism
5172428|NCT00926900|D-cycloserine|d-cycloserine
5172429|NCT00926900|extinction|extinction
5172430|NCT00926900|cue-exposure|cue-exposure
5172431|NCT00926874|ischaemic stroke|ischaemic stroke
5172432|NCT00926874|acute coronary syndrome|acute coronary syndrome
5172433|NCT00926874|obstructive sleep apnea syndrome|obstructive sleep apnea syndrome
5172434|NCT00926874|brachial endothelial function|brachial endothelial function
5172435|NCT00926874|blood pressure|blood pressure
5172436|NCT00926874|aortic stiffness|aortic stiffness
5172437|NCT00926861|age-related macular degeneration|age-related macular degeneration
5172438|NCT00926861|detachment of the posterior hyaloid|detachment of the posterior hyaloid
5172439|NCT00926861|AMD|amd
5172440|NCT00926848|coronary heart disease|coronary heart disease
5172441|NCT00926848|cardiac rehabilitation|cardiac rehabilitation
5172442|NCT00926848|lifestyle change|lifestyle change
5172443|NCT00926848|coronary artery bypass graft|coronary artery bypass graft
5172444|NCT00926848|social support|social support
5172445|NCT00926848|social cognitive learning theory|social cognitive learning theory
5172446|NCT00926809|endoscopic mucosal resection|endoscopic mucosal resection
5172447|NCT00926809|iatrogenic|iatrogenic
5172448|NCT00926796|gonorrhea, gonococcal infections, Neisseria gonorrhoeae|gonorrhea, gonococcal infections, neisseria gonorrhoeae
5172449|NCT00926783|paroxysmal|paroxysmal
5172450|NCT00926783|persistent|persistent
5172451|NCT00926783|targeted|targeted
5172452|NCT00926783|generalized|generalized
5172453|NCT00926783|CFAE|cfae
5172454|NCT00926757|lymphoma|lymphoma
5172455|NCT00926757|CD20|cd20
5172456|NCT00926757|Hepatitis B virus|hepatitis b virus
5172457|NCT00926757|reactivation|reactivation
5172458|NCT00926757|Rituximab|rituximab
5172459|NCT00926744|physical activity|physical activity
5172460|NCT00926744|nutrition|nutrition
5172461|NCT00926744|cardiovascular diseases|cardiovascular diseases
5172462|NCT00926744|musculo-skeletal problems|musculo-skeletal problems
5172463|NCT00926731|Acute Myeloid Leukaemia (AML)|acute myeloid leukaemia (aml)
5172464|NCT00926718|BIS monitor|bis monitor
5172465|NCT00926718|rocuronium|rocuronium
5172466|NCT00926718|The effect of the neuromuscular blocking drug rocuronium on the response of the Composite Variability Index to laryngoscopy|the effect of the neuromuscular blocking drug rocuronium on the response of the composite variability index to laryngoscopy
5172467|NCT00926705|Dexmedetomidine|dexmedetomidine
5172468|NCT00926705|Fentanyl|fentanyl
5172469|NCT00926705|Pain|pain
5172470|NCT00926705|Pediatrics|pediatrics
5172471|NCT00926692|B-cells|b-cells
5172472|NCT00926692|CD5+|cd5+
5172473|NCT00926692|B1 Cells|b1 cells
5172474|NCT00926692|Healthy Controls|healthy controls
5172475|NCT00926666|Ageing|ageing
5172476|NCT00926666|Pain|pain
5172477|NCT00926666|Pharmacology|pharmacology
5172478|NCT00926666|Imaging|imaging
5172479|NCT00926666|Anaesthesiology|anaesthesiology
5172480|NCT00926666|Musculoskeletal disease|musculoskeletal disease
5172481|NCT00926653|Geriatric Depression|geriatric depression
5172482|NCT00926640|Solid Tumors|solid tumors
5172483|NCT00926640|Histone deacetylase inhibitors|histone deacetylase inhibitors
5172484|NCT00926640|EP &amp; Belinostat|ep &amp; belinostat
5172485|NCT00926640|Phase I|phase i
5172486|NCT00926640|SCLC|sclc
5172487|NCT00926640|Small Cell Lung Cancer|small cell lung cancer
5172488|NCT00926627|endothelin receptor antagonist|endothelin receptor antagonist
5172489|NCT00926627|bosentan|bosentan
5172490|NCT00926614|GT1|gt1
5172491|NCT00926614|HCV|hcv
5172492|NCT00926614|non responder|non responder
5172493|NCT00926614|relapser|relapser
5172494|NCT00926588|Pain|pain
5172495|NCT00926588|Telecare|telecare
5172496|NCT00926588|Collaborative care|collaborative care
5172497|NCT00926575|BDP|bdp
5172498|NCT00926575|orBec|orbec
5172499|NCT00926575|GVHD|gvhd
5172500|NCT00926575|beclomethasone dipropionate|beclomethasone dipropionate
5172501|NCT00926575|bone marrow transplant|bone marrow transplant
5172502|NCT00926575|hematopoietic cell transplant|hematopoietic cell transplant
5172503|NCT00926575|HCT|hct
5172504|NCT00926575|stem cell transplant|stem cell transplant
5172505|NCT00926575|marrow transplant|marrow transplant
5172506|NCT00926575|SCT|sct
5172507|NCT00926575|beclomethasone 17,21-dipropionate|beclomethasone 17,21-dipropionate
5172508|NCT00926562|Contrast Induced Nephropathy|contrast induced nephropathy
5172509|NCT00926562|CIN|cin
5172510|NCT00926562|Cardiac Catheterization|cardiac catheterization
5172511|NCT00926549|spectral domain-OCT|spectral domain-oct
5172512|NCT00926549|macular thickness|macular thickness
5172513|NCT00926549|myopia|myopia
5172514|NCT00926549|hypermetropia|hypermetropia
5172515|NCT00926549|normal|normal
5172516|NCT00926523|Pulmonary Hypertension|pulmonary hypertension
5172517|NCT00926523|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
5172518|NCT00926523|Interstitial Lung Disease|interstitial lung disease
5172519|NCT00926523|MIF|mif
5172520|NCT00926497|antibiotic therapy|antibiotic therapy
5172521|NCT00926497|early-onset sepsis|early-onset sepsis
5172522|NCT00926497|interventions study|interventions study
5172523|NCT00926497|procalcitonin|procalcitonin
5172524|NCT00926497|term and near-term neonates|term and near-term neonates
5172525|NCT00926484|Dentin hypersensitivity|dentin hypersensitivity
5172526|NCT00926484|Tooth Mousse|tooth mousse
5172527|NCT00926484|fluoride varnish|fluoride varnish
5172528|NCT00926471|Autism|autism
5172529|NCT00926471|Anxiety|anxiety
5172530|NCT00926471|Autism Spectrum Disorders with Comorbid Anxiety|autism spectrum disorders with comorbid anxiety
5172531|NCT00926458|stress echocardiography|stress echocardiography
5172532|NCT00926458|coronary angiography|coronary angiography
5172533|NCT00926458|coronary artery disease|coronary artery disease
5172534|NCT00926445|Pain behavior|pain behavior
5172535|NCT00926432|Balance|balance
5172536|NCT00926432|Spine disorders|spine disorders
5172537|NCT00926432|equilibrium|equilibrium
5172538|NCT00926419|Varicella|varicella
5172539|NCT00926419|Hepatitis A|hepatitis a
5172540|NCT00926419|Vaccine|vaccine
5172541|NCT00926419|Injector|injector
5172542|NCT00926419|Fractional dose|fractional dose
5172543|NCT00926419|Intradermal|intradermal
5172544|NCT00926419|Children|children
5172545|NCT00926406|Environmental lead exposure, maintenance hemodialysis; blood lead levels, EDTA chelating agents, malnutrition, anemia, inflammation, mortality.|environmental lead exposure, maintenance hemodialysis; blood lead levels, edta chelating agents, malnutrition, anemia, inflammation, mortality.
5172546|NCT00926406|To determine whether lead chelation therapy improves the anemia, malnutrition, inflammation, morbidity or mortality in hemodialysis patients.|to determine whether lead chelation therapy improves the anemia, malnutrition, inflammation, morbidity or mortality in hemodialysis patients.
5172547|NCT00926393|inpatient|inpatient
5172548|NCT00926393|bipolar depression|bipolar depression
5172549|NCT00926393|quetiapine|quetiapine
5172550|NCT00926393|Seroquel IR|seroquel ir
5172551|NCT00926393|Seroquel XR|seroquel xr
5172552|NCT00926393|safety|safety
5172553|NCT00926393|tolerability|tolerability
5172554|NCT00926380|osteoporosis|osteoporosis
5172555|NCT00926380|postmenopausal|postmenopausal
5172556|NCT00926380|denosumab|denosumab
5172557|NCT00926380|teriparatide|teriparatide
5172558|NCT00926380|Forteo®|forteo®
5172559|NCT00926380|DXA|dxa
5172560|NCT00926380|Bone Mineral Density|bone mineral density
5172561|NCT00926380|pQCT|pqct
5172562|NCT00926367|Acne|acne
5172563|NCT00926341|Metabolic syndrome|metabolic syndrome
5172564|NCT00926341|inflammatory markers|inflammatory markers
5172565|NCT00926341|Thiazolidinediones|thiazolidinediones
5172566|NCT00926341|Angiotensin receptor blockers|angiotensin receptor blockers
5172567|NCT00926328|Gingivitis and Plaque|gingivitis and plaque
5172568|NCT00926315|Breast Neoplasms|breast neoplasms
5172569|NCT00926315|Calcitriol|calcitriol
5172570|NCT00926315|Postmenopausal|postmenopausal
5172571|NCT00926315|Cell Proliferation|cell proliferation
5172572|NCT00926315|Gene Expression Profiling|gene expression profiling
5172573|NCT00926302|The bioequivalence of Levetiracetam vs. Keppra|the bioequivalence of levetiracetam vs. keppra
5172574|NCT00926302|volunteer|volunteer
5172575|NCT00926276|Gastroesophageal Reflux Disease (GERD)|gastroesophageal reflux disease (gerd)
5172576|NCT00926276|Bronchopulmonary Dysplasia (BPD)|bronchopulmonary dysplasia (bpd)
5172577|NCT00926276|Fundoplication|fundoplication
5172578|NCT00926263|Pharmacokinetics|pharmacokinetics
5172579|NCT00926263|Pharmacodynamics|pharmacodynamics
5172580|NCT00926263|QTc interval prolongation|qtc interval prolongation
5172581|NCT00926250|Sarcopenia|sarcopenia
5172582|NCT00926237|Tinnitus|tinnitus
5172583|NCT00926237|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
5172584|NCT00926237|TMS|tms
5172585|NCT00926237|rTMS|rtms
5172586|NCT00926224|Adult patients with chronic liver disease scheduled for a liver biopsy and a BMI superior or equal to 28 kg/m²|adult patients with chronic liver disease scheduled for a liver biopsy and a bmi superior or equal to 28 kg/m²
5172587|NCT00926198|Upper airway infections|upper airway infections
5172588|NCT00926198|pharyngotonsillitis|pharyngotonsillitis
5172589|NCT00926198|GABHS|gabhs
5172590|NCT00926185|Dry Eye|dry eye
5172591|NCT00926185|ophthalmic delivery|ophthalmic delivery
5172592|NCT00926172|Magnetic resonance angiography|magnetic resonance angiography
5172593|NCT00926172|Intracranial aneurysm|intracranial aneurysm
5172594|NCT00926172|cerebral aneurysm|cerebral aneurysm
5172595|NCT00926172|unruptured aneurysm|unruptured aneurysm
5172596|NCT00926172|Epidemiology|epidemiology
5172597|NCT00926172|Magnetic Resonance Imaging|magnetic resonance imaging
5172598|NCT00926159|Cardiomyopathies|cardiomyopathies
5172599|NCT00926146|Hepatitis B and C|hepatitis b and c
5172600|NCT00926146|HIV|hiv
5172601|NCT00926146|nurse case management|nurse case management
5172602|NCT00926146|HIV seronegativity|hiv seronegativity
5172603|NCT00926120|Chronic Hepatitis C|chronic hepatitis c
5172604|NCT00926081|Peripheral Artery Disease|peripheral artery disease
5172605|NCT00926081|Quality of Life|quality of life
5172606|NCT00926081|Outcome|outcome
5172607|NCT00926081|Endothelial Progenitor Cells|endothelial progenitor cells
5172608|NCT00926081|Microcirculation|microcirculation
5172609|NCT00926068|Diabetes Mellitus|diabetes mellitus
5172610|NCT00926068|Foot Ulcer|foot ulcer
5172611|NCT00926068|DFU|dfu
5172612|NCT00926068|Wound healing|wound healing
5172613|NCT00926055|high risk patients in atherosclerosis|high risk patients in atherosclerosis
5172614|NCT00926042|Healthy|healthy
5172615|NCT00926042|volunteer|volunteer
5172616|NCT00926042|Healthy controls|healthy controls
5172617|NCT00926042|Normal controls|normal controls
5172618|NCT00926016|Hepatitis C|hepatitis c
5172619|NCT00926003|HIV|hiv
5172620|NCT00926003|Children|children
5172621|NCT00926003|Africa|africa
5172622|NCT00926003|Neuropsychology|neuropsychology
5172623|NCT00926003|cognitive rehabilitation|cognitive rehabilitation
5172624|NCT00926003|computers|computers
5172625|NCT00925990|HCV|hcv
5172626|NCT00925990|interferon-naive|interferon-naive
5172627|NCT00925977|treatment satisfaction|treatment satisfaction
5172628|NCT00925977|insulin Glargine|insulin glargine
5172629|NCT00925977|insulin Apidra|insulin apidra
5172630|NCT00925977|NPH insulin|nph insulin
5172631|NCT00925951|Persistent Non-specific Low Back Pain|persistent non-specific low back pain
5172632|NCT00925951|wet cupping|wet cupping
5172633|NCT00925951|cupping|cupping
5172634|NCT00925951|Numerical Rating Scale|numerical rating scale
5172635|NCT00925938|Hysteroscopy|hysteroscopy
5172636|NCT00925938|Cervical priming|cervical priming
5172637|NCT00925938|Cervical dilatation|cervical dilatation
5172638|NCT00925938|Misoprostol|misoprostol
5172639|NCT00925938|Endoscopy, uterine|endoscopy, uterine
5172640|NCT00925925|Low birth weight|low birth weight
5172641|NCT00925925|small for gestational age|small for gestational age
5172642|NCT00925925|B-cell function|b-cell function
5172643|NCT00925925|epigenetics|epigenetics
5172644|NCT00925925|B1a|b1a
5172645|NCT00925925|B1b|b1b
5172646|NCT00925925|CD19|cd19
5172647|NCT00925925|CD5|cd5
5172648|NCT00925912|Hemorrhoidectomy|hemorrhoidectomy
5172649|NCT00925912|perianal block|perianal block
5172650|NCT00925912|local anesthesia|local anesthesia
5172651|NCT00925912|spinal anesthesia|spinal anesthesia
5172652|NCT00925899|Melatonin|melatonin
5172653|NCT00925899|Palliative care|palliative care
5172654|NCT00925899|Advanced cancer|advanced cancer
5172655|NCT00925899|Symptoms|symptoms
5172656|NCT00925899|Quality of life|quality of life
5172657|NCT00925899|Randomized controlled trial|randomized controlled trial
5172658|NCT00925886|Astigmatism|astigmatism
5172659|NCT00925886|Cataract|cataract
5172660|NCT00925873|Fludarabine|fludarabine
5172661|NCT00925873|AML|aml
5172662|NCT00925873|elderly patients|elderly patients
5172663|NCT00925847|Amyotrophic lateral sclerosis|amyotrophic lateral sclerosis
5172664|NCT00925847|Lithium|lithium
5172665|NCT00925847|Survival|survival
5172666|NCT00925834|Coronary angiography|coronary angiography
5172667|NCT00925834|Placebo effect|placebo effect
5172668|NCT00925834|Suggestion|suggestion
5172669|NCT00925821|Allogeneic stem cell transplantation|allogeneic stem cell transplantation
5172670|NCT00925821|Lenalidomide|lenalidomide
5172671|NCT00925821|IMiD|imid
5172672|NCT00925808|Unsuspected Venous Thromboembolism|unsuspected venous thromboembolism
5172673|NCT00925808|VTE|vte
5172674|NCT00925808|Routine Computed Tomography|routine computed tomography
5172675|NCT00925808|CT Scans|ct scans
5172676|NCT00925795|HIV|hiv
5172677|NCT00925795|atherosclerosis|atherosclerosis
5172678|NCT00925795|extra virgin olive oil|extra virgin olive oil
5172679|NCT00925795|Alternative therapies|alternative therapies
5172680|NCT00925795|Treatment experienced+|treatment experienced+
5172681|NCT00925782|autologous stem cell transplantation|autologous stem cell transplantation
5172682|NCT00925756|HIV|hiv
5172683|NCT00925756|low CD4 recovery|low cd4 recovery
5172684|NCT00925756|Low CD4 recovery despite HIV control|low cd4 recovery despite hiv control
5172685|NCT00925756|Treatment experienced|treatment experienced
5172686|NCT00925743|Phase 1|phase 1
5172687|NCT00925743|XRP6258|xrp6258
5172688|NCT00925743|cisplatin|cisplatin
5172689|NCT00925743|Antineoplastic Combined Chemotherapy Protocols|antineoplastic combined chemotherapy protocols
5172690|NCT00925730|Atopic dermatitis|atopic dermatitis
5172691|NCT00925730|AD|ad
5172692|NCT00925730|pimecrolimus|pimecrolimus
5172693|NCT00925730|blood|blood
5172694|NCT00925730|absorption|absorption
5172695|NCT00925730|systemic|systemic
5172696|NCT00925717|ADA recommendation|ada recommendation
5172697|NCT00925665|Intubation|intubation
5172698|NCT00925665|Glidescope|glidescope
5172699|NCT00925665|Macintosh|macintosh
5172700|NCT00925665|Abscess|abscess
5172701|NCT00925665|Difficult intubations in patients with odontogenic abscesses|difficult intubations in patients with odontogenic abscesses
5172702|NCT00925652|CM|cm
5172703|NCT00925652|bevacizumab|bevacizumab
5172704|NCT00925652|cyclophosphamide|cyclophosphamide
5172705|NCT00925652|methotrexate|methotrexate
5172706|NCT00925652|exercise intervention|exercise intervention
5172707|NCT00925652|diet intervention|diet intervention
5172708|NCT00925639|phytoestrogen|phytoestrogen
5172709|NCT00925639|coagulation|coagulation
5172710|NCT00925639|menopause|menopause
5172711|NCT00925639|ddimer|ddimer
5172712|NCT00925639|antithrombin|antithrombin
5172713|NCT00925639|hypercoagulation|hypercoagulation
5172714|NCT00925613|Exchanging double lumen tube with laryngeal mask Proseal|exchanging double lumen tube with laryngeal mask proseal
5172715|NCT00925613|Exchange double lumen tube with tracheal tube|exchange double lumen tube with tracheal tube
5172716|NCT00925613|Exchange double lumen tube before emergence decrease cough|exchange double lumen tube before emergence decrease cough
5172717|NCT00925613|thoracoscopy and postoperative respiratory complications|thoracoscopy and postoperative respiratory complications
5172718|NCT00925613|thoracostomy and postoperative respiratory complications|thoracostomy and postoperative respiratory complications
5172719|NCT00925613|postoperative cough|postoperative cough
5172720|NCT00925613|postoperative respiratory complications|postoperative respiratory complications
5172721|NCT00925613|laryngeal mask and postoperative respiratory complications|laryngeal mask and postoperative respiratory complications
5172722|NCT00925600|Lens Opacification|lens opacification
5172723|NCT00925600|Bone Loss|bone loss
5172724|NCT00925600|Androgen Deprivation Therapy|androgen deprivation therapy
5172725|NCT00925600|Non-metastatic prostate cancer|non-metastatic prostate cancer
5172727|NCT00925587|Anemia|anemia
5172728|NCT00925587|correction|correction
5172729|NCT00925587|darbepoetin alfa|darbepoetin alfa
5172730|NCT00925574|CNTO 1959|cnto 1959
5172731|NCT00925574|Healthy Volunteers|healthy volunteers
5172732|NCT00925574|Psoriasis|psoriasis
5172733|NCT00925561|Coronary Artery Calcification|coronary artery calcification
5172734|NCT00925548|Phase III trial|phase iii trial
5172735|NCT00925548|randomized|randomized
5172736|NCT00925548|cancer vaccine|cancer vaccine
5172737|NCT00925548|MUC1|muc1
5172738|NCT00925548|BLP25|blp25
5172739|NCT00925548|advanced breast cancer|advanced breast cancer
5172740|NCT00925548|postmenopausal breast cancer|postmenopausal breast cancer
5172741|NCT00925548|immunotherapy of breast cancer|immunotherapy of breast cancer
5172742|NCT00925548|Inoperable locally advanced, recurrent, or metastatic endocrine-sensitive Breast Cancer|inoperable locally advanced, recurrent, or metastatic endocrine-sensitive breast cancer
5172743|NCT00925535|Pharmacokinetics HIV Tuberculosis Lersivirine UK-453|pharmacokinetics hiv tuberculosis lersivirine uk-453
5172744|NCT00925535|061 Rifabutin|061 rifabutin
5172745|NCT00925535|HIV Infections|hiv infections
5172746|NCT00925509|upper digestive tract cancer|upper digestive tract cancer
5172747|NCT00925509|implants|implants
5172748|NCT00925509|implants insertion|implants insertion
5172749|NCT00925509|radio-surgical guidance|radio-surgical guidance
5172750|NCT00925509|accuracy of implants insertion|accuracy of implants insertion
5173043|NCT00924469|Prednisone|prednisone
5172751|NCT00925509|cranial/facial radiotherapy or brachytherapy and/or microvascular fibula transfer.|cranial/facial radiotherapy or brachytherapy and/or microvascular fibula transfer.
5172752|NCT00925509|Bone volume sufficient to support an implant|bone volume sufficient to support an implant
5172753|NCT00925496|Omarthrosis shoulder joint|omarthrosis shoulder joint
5172754|NCT00925483|left ventricular mass|left ventricular mass
5172755|NCT00925483|cardiac MRI|cardiac mri
5172756|NCT00925483|long dialysis|long dialysis
5172757|NCT00925483|daily dialysis|daily dialysis
5172758|NCT00925470|Target organs impairment|target organs impairment
5172759|NCT00925470|High blood pressure|high blood pressure
5172760|NCT00925470|Evaluation of target organs impairment on patients suffering from high blood pressure without known cardiovascular or renal disease|evaluation of target organs impairment on patients suffering from high blood pressure without known cardiovascular or renal disease
5172761|NCT00925457|Serious ventricular arrhythmia|serious ventricular arrhythmia
5172762|NCT00925457|Sudden cardiac death|sudden cardiac death
5172763|NCT00925457|Domperidone|domperidone
5172764|NCT00925457|Case-control study|case-control study
5172765|NCT00925457|Saskatchewan residents|saskatchewan residents
5172766|NCT00925457|Observational Study|observational study
5172767|NCT00925444|Absorbable implants|absorbable implants
5172768|NCT00925444|Humans|humans
5172769|NCT00925444|Alginates|alginates
5172770|NCT00925444|Pneumonectomy/methods|pneumonectomy/methods
5172771|NCT00925444|Pneumonectomy/instrumentation|pneumonectomy/instrumentation
5172772|NCT00925444|Surgical Stapling|surgical stapling
5172773|NCT00925444|Thoracic surgery|thoracic surgery
5172774|NCT00925444|Tissue Adhesives|tissue adhesives
5172775|NCT00925444|Prospective studies|prospective studies
5172776|NCT00925418|Neoplasm|neoplasm
5172777|NCT00925418|breast Neoplasm|breast neoplasm
5172778|NCT00925418|docetaxel|docetaxel
5172779|NCT00925418|Glove|glove
5172780|NCT00925405|Breast Cancer|breast cancer
5172781|NCT00925405|Hodgkin's lymphoma|hodgkin's lymphoma
5172782|NCT00925405|Mantle-field Irradiation|mantle-field irradiation
5172783|NCT00925405|Mammogram|mammogram
5172784|NCT00925405|Magnetic resonance imaging|magnetic resonance imaging
5172785|NCT00925405|MRI Breast Cancer Screening|mri breast cancer screening
5172786|NCT00925392|doripenem|doripenem
5172787|NCT00925392|epithelial lining fluid|epithelial lining fluid
5172788|NCT00925392|alveolar macrophages|alveolar macrophages
5172789|NCT00925392|pharmacokinetics|pharmacokinetics
5172790|NCT00925392|Healthy adult subjects|healthy adult subjects
5172791|NCT00925366|Shoulder|shoulder
5172792|NCT00925366|MRI|mri
5172793|NCT00925366|MR arthrography|mr arthrography
5172794|NCT00925366|CT arthrography|ct arthrography
5172795|NCT00925366|Rotator cuff tear|rotator cuff tear
5172796|NCT00925366|Arthroscopy|arthroscopy
5172797|NCT00925353|lidocaine|lidocaine
5172798|NCT00925353|pre-medication|pre-medication
5172799|NCT00925353|mammography|mammography
5172800|NCT00925353|pain|pain
5172801|NCT00925353|safety|safety
5172802|NCT00925340|Alcohol|alcohol
5172803|NCT00925340|Substance Abuse|substance abuse
5172804|NCT00925340|Adolescent|adolescent
5172805|NCT00925340|Family functioning|family functioning
5172806|NCT00925314|Stage III Melanoma|stage iii melanoma
5172807|NCT00925314|Melanoma|melanoma
5172808|NCT00925314|TLI|tli
5172809|NCT00925314|Transgenic Lymphocyte Immunization|transgenic lymphocyte immunization
5172810|NCT00925314|CB-10-01-02|cb-10-01-02
5172811|NCT00925301|AmicusTherapeutics|amicustherapeutics
5172812|NCT00925301|AT1001|at1001
5172813|NCT00925301|Migalastat|migalastat
5172814|NCT00925301|Pharmacokinetics|pharmacokinetics
5172815|NCT00925301|Substrate|substrate
5172816|NCT00925288|Female sex worker|female sex worker
5172817|NCT00925288|Peru|peru
5172818|NCT00925288|Cervical infection|cervical infection
5172819|NCT00925288|Cervical abnormality|cervical abnormality
5172820|NCT00925288|Serum antibody|serum antibody
5172821|NCT00925288|Vaccine acceptance|vaccine acceptance
5172822|NCT00925288|Alternative schedule|alternative schedule
5172823|NCT00925288|Viral infections|viral infections
5172824|NCT00925288|Human papillomavirus vaccine|human papillomavirus vaccine
5172825|NCT00925288|Human papillomavirus (HPV)|human papillomavirus (hpv)
5172826|NCT00925288|non inferiority|non inferiority
5172827|NCT00925275|Solid tumors|solid tumors
5172828|NCT00925275|Refractory|refractory
5172829|NCT00925275|Relapsed|relapsed
5172830|NCT00925275|Radiation|radiation
5172831|NCT00925275|Dosimetry|dosimetry
5172832|NCT00925275|Radiopharmaceutical|radiopharmaceutical
5172833|NCT00925275|Biodistribution|biodistribution
5172834|NCT00925275|Pharmacokinetics|pharmacokinetics
5172835|NCT00925275|Cancer|cancer
5172836|NCT00925275|Phase I|phase i
5172837|NCT00925262|mental health|mental health
5172838|NCT00925262|randomized controlled trial|randomized controlled trial
5172839|NCT00925262|torture|torture
5172840|NCT00925249|rheumatoid arthritis|rheumatoid arthritis
5172841|NCT00925249|RA|ra
5172842|NCT00925249|TB|tb
5172843|NCT00925249|tuberculosis|tuberculosis
5172844|NCT00925249|anti-TNF therapy|anti-tnf therapy
5172845|NCT00925249|biologic therapy|biologic therapy
5172846|NCT00925249|quantiferon|quantiferon
5172847|NCT00925249|IGRA|igra
5172940|NCT00924885|Local anaesthesia|local anaesthesia
5172848|NCT00925249|Newly diagnosed rheumatoid arthritis (RA) in the Tricare system|newly diagnosed rheumatoid arthritis (ra) in the tricare system
5172849|NCT00925236|MYH9 gene|myh9 gene
5172850|NCT00925236|macrothrombocytopenia|macrothrombocytopenia
5172851|NCT00925236|leukocyte inclusions|leukocyte inclusions
5172852|NCT00925236|cataracts deafness|cataracts deafness
5172853|NCT00925236|nephritis|nephritis
5172854|NCT00925236|MYH9 Related Disorders|myh9 related disorders
5172855|NCT00925223|IBS|ibs
5172856|NCT00925223|BDNf|bdnf
5172857|NCT00925223|visceral hypersensitivity|visceral hypersensitivity
5172858|NCT00925210|Endobronchial ultrasound|endobronchial ultrasound
5172859|NCT00925210|Electromagnetic Navigation Bronchoscopy|electromagnetic navigation bronchoscopy
5172860|NCT00925210|Bronchoscopy|bronchoscopy
5172861|NCT00925210|Ultrasonography|ultrasonography
5172862|NCT00925197|anticoagulation|anticoagulation
5172863|NCT00925197|fluindione|fluindione
5172864|NCT00925197|patient self-testing|patient self-testing
5172865|NCT00925197|coaguchek|coaguchek
5172866|NCT00925197|inratio|inratio
5172867|NCT00925197|Post operative antivitamin K therapy|post operative antivitamin k therapy
5172868|NCT00925184|questionnaire, medical education, medical students.|questionnaire, medical education, medical students.
5172869|NCT00925171|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
5172870|NCT00925171|Pulmonary rehabilitation|pulmonary rehabilitation
5172871|NCT00925171|Chronic Respiratory Questionnaire|chronic respiratory questionnaire
5172872|NCT00925158|Rhytidoplasty|rhytidoplasty
5172873|NCT00925158|Video-Assisted Surgery|video-assisted surgery
5172874|NCT00925158|Surgical instruments|surgical instruments
5172875|NCT00925158|Dissection|dissection
5172876|NCT00925158|Innovative therapies|innovative therapies
5172877|NCT00925158|Face|face
5172878|NCT00925158|Aging|aging
5172879|NCT00925158|Premature aging|premature aging
5172880|NCT00925158|Rejuvenation|rejuvenation
5172881|NCT00925132|Metastatic|metastatic
5172882|NCT00925132|Melanoma|melanoma
5172883|NCT00925132|Epigenetic|epigenetic
5172884|NCT00925132|Temozolomide|temozolomide
5172885|NCT00925132|Decitabine|decitabine
5172886|NCT00925132|Panobinostat|panobinostat
5172887|NCT00925132|LBH589|lbh589
5172888|NCT00925119|Diabetes|diabetes
5172889|NCT00925119|Atenolol|atenolol
5172890|NCT00925119|Genetic|genetic
5172891|NCT00925106|Bioavailability, pharmacokinetics, celecoxib|bioavailability, pharmacokinetics, celecoxib
5172892|NCT00925093|vancomycin|vancomycin
5172893|NCT00925093|teicoplanin|teicoplanin
5172894|NCT00925093|linezolid|linezolid
5172895|NCT00925093|intravenous|intravenous
5172896|NCT00925093|cerebrospinal fluid|cerebrospinal fluid
5172897|NCT00925093|CSF|csf
5172898|NCT00925093|pharmacokinetics|pharmacokinetics
5172899|NCT00925093|penetration|penetration
5172900|NCT00925093|blood-brain barrier|blood-brain barrier
5172901|NCT00925093|Pharmacokinetics of three antibiotics in relation to cerebrospinal fluid|pharmacokinetics of three antibiotics in relation to cerebrospinal fluid
5172902|NCT00925067|Inguinal hernia|inguinal hernia
5172903|NCT00925067|Laparoscopic repair|laparoscopic repair
5172904|NCT00925067|Prostheses|prostheses
5172905|NCT00925067|Male fertility|male fertility
5172906|NCT00925054|PKU|pku
5172907|NCT00925054|PEG PAL|peg pal
5172908|NCT00925054|BioMarin|biomarin
5172909|NCT00924989|ACC|acc
5172910|NCT00924989|Adrenocortical carcinoma|adrenocortical carcinoma
5172911|NCT00924989|OSI-906|osi-906
5172912|NCT00924989|Insulin-like growth factor-1 receptor (IGF-1R)|insulin-like growth factor-1 receptor (igf-1r)
5172913|NCT00924989|GALACCTIC|galacctic
5172914|NCT00924963|Pain of venipuncture or IV insertion|pain of venipuncture or iv insertion
5172915|NCT00924950|Psoriasis|psoriasis
5172916|NCT00924950|Plaque psoriasis, with bilateral symmetrical lesions.|plaque psoriasis, with bilateral symmetrical lesions.
5172917|NCT00924950|A diagnosis of stable plaque-type psoriasis vulgaris|a diagnosis of stable plaque-type psoriasis vulgaris
5172918|NCT00924950|with at least one pair of symmetric lesions on either|with at least one pair of symmetric lesions on either
5172919|NCT00924950|the trunk, arms, or legs that would serve as target lesions.|the trunk, arms, or legs that would serve as target lesions.
5172920|NCT00924937|Cardiovascular events|cardiovascular events
5172921|NCT00924937|Blood pressure|blood pressure
5172922|NCT00924937|Incidence of Cancer|incidence of cancer
5172923|NCT00924937|Cognitive decline|cognitive decline
5172924|NCT00924937|Mediterranean Diet|mediterranean diet
5172925|NCT00924937|Secondary Prevention|secondary prevention
5172926|NCT00924937|Low fat diet|low fat diet
5172927|NCT00924924|health promotion|health promotion
5172928|NCT00924924|prevention|prevention
5172929|NCT00924924|worksite wellness|worksite wellness
5172930|NCT00924924|behavior change|behavior change
5172931|NCT00924924|healthy volunteers|healthy volunteers
5172932|NCT00924911|GSK1322322, relative bioavailability, single dose, food effect, H2 blocker, healthy subjects, open label, PIB, tablet|gsk1322322, relative bioavailability, single dose, food effect, h2 blocker, healthy subjects, open label, pib, tablet
5172933|NCT00924898|Acute HIV|acute hiv
5172934|NCT00924898|HIV|hiv
5172935|NCT00924898|Acute Infections|acute infections
5172936|NCT00924898|Acute Infection|acute infection
5172937|NCT00924885|Reproductive Medicine|reproductive medicine
5172938|NCT00924885|Fertilization in Vitro|fertilization in vitro
5172939|NCT00924885|Oocyte retrieval|oocyte retrieval
5172941|NCT00924885|Aspiration needle|aspiration needle
5172942|NCT00924872|stroke|stroke
5172943|NCT00924872|power wheelchair skills|power wheelchair skills
5172944|NCT00924872|training|training
5172945|NCT00924872|safety|safety
5172946|NCT00924859|cerebral venous thrombosis|cerebral venous thrombosis
5172947|NCT00924859|stroke|stroke
5172948|NCT00924859|coagulation|coagulation
5172949|NCT00924846|high frequency oscillatory ventilation|high frequency oscillatory ventilation
5172950|NCT00924846|respiratory failure|respiratory failure
5172951|NCT00924846|children|children
5172952|NCT00924846|inhaled nitric oxide|inhaled nitric oxide
5172953|NCT00924833|hypoxia|hypoxia
5172954|NCT00924833|autonomic nervous system|autonomic nervous system
5172955|NCT00924833|blood pressure|blood pressure
5172956|NCT00924833|heart rate|heart rate
5172957|NCT00924833|exercise|exercise
5172958|NCT00924833|heart failure|heart failure
5172959|NCT00924833|receptors, adrenergic, beta.|receptors, adrenergic, beta.
5172960|NCT00924820|Neoplastic Meningitis|neoplastic meningitis
5172961|NCT00924820|NM|nm
5172962|NCT00924820|Advanced Cancers|advanced cancers
5172963|NCT00924820|Brain Cancer|brain cancer
5172964|NCT00924820|Advanced Cancer|advanced cancer
5172965|NCT00924820|Brain Diseases|brain diseases
5172966|NCT00924820|Central Nervous System Disorders|central nervous system disorders
5172967|NCT00924820|CNS|cns
5172968|NCT00924820|Bevacizumab|bevacizumab
5172969|NCT00924820|Avastin|avastin
5172970|NCT00924820|Anti-VEGF monoclonal antibody|anti-vegf monoclonal antibody
5172971|NCT00924820|rhuMAb-VEGF|rhumab-vegf
5172972|NCT00924820|Spinal Cord|spinal cord
5172973|NCT00924820|meninges|meninges
5172974|NCT00924820|cerebrospinal fluid|cerebrospinal fluid
5172975|NCT00924820|CSF|csf
5172976|NCT00924807|Prostate Cancer|prostate cancer
5172977|NCT00924807|Combined Androgen Blockade|combined androgen blockade
5172978|NCT00924807|Radiotherapy|radiotherapy
5172979|NCT00924807|Sorafenib|sorafenib
5172980|NCT00924781|Anemia associated with chronic kidney disease (CKD)|anemia associated with chronic kidney disease (ckd)
5172981|NCT00924781|Hemodialysis|hemodialysis
5172982|NCT00924768|Otherwise healthy current cigarette smokers|otherwise healthy current cigarette smokers
5172983|NCT00924768|current cigarette smokers|current cigarette smokers
5172984|NCT00924755|Surgical mesh|surgical mesh
5172985|NCT00924742|The PK of Tapimycin|the pk of tapimycin
5172986|NCT00924742|volunteer|volunteer
5172987|NCT00924690|Colon|colon
5172988|NCT00924690|Cancer|cancer
5172989|NCT00924690|Screening|screening
5172990|NCT00924690|Prevention|prevention
5172991|NCT00924690|Information|information
5172992|NCT00924677|genicular nerve|genicular nerve
5172993|NCT00924677|osteoarthritis|osteoarthritis
5172994|NCT00924677|knee|knee
5172995|NCT00924677|neurotomy|neurotomy
5172996|NCT00924664|low back pain monoclonal antibody nerve growth factor|low back pain monoclonal antibody nerve growth factor
5172997|NCT00924651|fatigue|fatigue
5172998|NCT00924651|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5172999|NCT00924638|atrial fibrillation|atrial fibrillation
5173000|NCT00924638|cryptogenic stroke|cryptogenic stroke
5173001|NCT00924638|continuous monitoring|continuous monitoring
5173002|NCT00924638|implantable loop recorder|implantable loop recorder
5173003|NCT00924638|insertable cardiac monitor|insertable cardiac monitor
5173004|NCT00924612|Primary hypogonadism|primary hypogonadism
5173005|NCT00924612|Secondary hypogonadism|secondary hypogonadism
5173006|NCT00924599|Recurring Gestational Diabetes|recurring gestational diabetes
5173007|NCT00924599|Prevention|prevention
5173008|NCT00924573|Glimepiride|glimepiride
5173009|NCT00924573|Metformin|metformin
5173010|NCT00924573|Combination Drug Therapy|combination drug therapy
5173011|NCT00924560|Adolescents|adolescents
5173012|NCT00924560|Bone Mineral Density|bone mineral density
5173013|NCT00924560|Oral Contraceptive|oral contraceptive
5173014|NCT00924547|Cystic Fibrosis|cystic fibrosis
5173015|NCT00924547|Docosahexanoic Acid|docosahexanoic acid
5173016|NCT00924547|DHA|dha
5173017|NCT00924547|isoprostanes|isoprostanes
5173018|NCT00924547|fatty acid|fatty acid
5173019|NCT00924534|type 2 diabetes|type 2 diabetes
5173020|NCT00924534|interventional|interventional
5173021|NCT00924534|placebo|placebo
5173022|NCT00924534|controlled|controlled
5173023|NCT00924534|PK|pk
5173024|NCT00924534|PD|pd
5173025|NCT00924534|safety|safety
5173026|NCT00924521|grains|grains
5173027|NCT00924521|fiber|fiber
5173028|NCT00924521|metabolic syndrome|metabolic syndrome
5173029|NCT00924521|insulin|insulin
5173030|NCT00924508|eczema|eczema
5173031|NCT00924508|at least 3 patches of eczema|at least 3 patches of eczema
5173032|NCT00924495|low back pain|low back pain
5173033|NCT00924495|motor control|motor control
5173034|NCT00924495|cortical regulation|cortical regulation
5173035|NCT00924495|transcranial magnetic stimulation|transcranial magnetic stimulation
5173036|NCT00924482|cardiac output|cardiac output
5173037|NCT00924482|ECOM|ecom
5173038|NCT00924482|Endotracheal Cardiac Output Monitor|endotracheal cardiac output monitor
5173039|NCT00924482|Perioperative medical care|perioperative medical care
5173040|NCT00924469|Prostate cancer|prostate cancer
5173041|NCT00924469|Abiraterone acetate|abiraterone acetate
5173042|NCT00924469|Leuprolide acetate|leuprolide acetate
5173044|NCT00924469|CB7630|cb7630
5173045|NCT00924469|Testosterone|testosterone
5173046|NCT00924456|Transcendental Meditation|transcendental meditation
5173047|NCT00924456|blood pressure|blood pressure
5173048|NCT00924456|psychological distress|psychological distress
5173049|NCT00924456|high psychological distress|high psychological distress
5173050|NCT00924443|acute myelogenous leukemia|acute myelogenous leukemia
5173051|NCT00924443|acute myeloid leukemia|acute myeloid leukemia
5173052|NCT00924443|clolar|clolar
5173053|NCT00924443|evoltra|evoltra
5173054|NCT00924443|clofarabine|clofarabine
5173055|NCT00924443|untreated acute leukemia|untreated acute leukemia
5173056|NCT00924443|adult acute leukemia|adult acute leukemia
5173057|NCT00924430|Interaction SLV337 and simvastatin|interaction slv337 and simvastatin
5173058|NCT00924430|Type 2 diabetes mellitus|type 2 diabetes mellitus
5173059|NCT00924417|Pain associated with peripheral intravenous line placement|pain associated with peripheral intravenous line placement
5173060|NCT00924404|Xylitol vs. Saline|xylitol vs. saline
5173061|NCT00924404|nasal washes|nasal washes
5173062|NCT00924404|sinusitis|sinusitis
5173063|NCT00924391|cholesterol|cholesterol
5173064|NCT00924391|plant sterols|plant sterols
5173065|NCT00924391|cholesterol absorption|cholesterol absorption
5173066|NCT00924365|Children|children
5173067|NCT00924365|AIDS|aids
5173068|NCT00924365|Toxicity|toxicity
5173069|NCT00924365|Development|development
5173070|NCT00924365|Puberty|puberty
5173071|NCT00924365|HIV|hiv
5173072|NCT00924365|Pediatrics|pediatrics
5173073|NCT00924365|HIV Infections|hiv infections
5173074|NCT00924352|Metastatic Breast Cancer|metastatic breast cancer
5173075|NCT00924339|soy protein|soy protein
5173076|NCT00924339|familial hypercholesterolaemia|familial hypercholesterolaemia
5173077|NCT00924339|children and adolescents|children and adolescents
5173078|NCT00924339|isoflavones|isoflavones
5173079|NCT00924339|FH|fh
5173080|NCT00924326|B Cell Malignancies|b cell malignancies
5173081|NCT00924326|T Cell Persistence|t cell persistence
5173082|NCT00924326|Immunotherapy|immunotherapy
5173083|NCT00924326|Cell Transfer|cell transfer
5173084|NCT00924326|Leukemia|leukemia
5173085|NCT00924326|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
5173086|NCT00924326|CLL|cll
5173087|NCT00924326|Lymphoma|lymphoma
5173088|NCT00924313|Prostate Cancer|prostate cancer
5173089|NCT00924313|MRI|mri
5173090|NCT00924313|C-11 Acetate|c-11 acetate
5173091|NCT00924313|PET|pet
5173092|NCT00924300|feasibility of MEG in pediatric populations|feasibility of meg in pediatric populations
5173093|NCT00924287|Metastatic Cancer|metastatic cancer
5173094|NCT00924287|Tumor Regression|tumor regression
5173095|NCT00924287|Immunotherapy|immunotherapy
5173096|NCT00924287|Safety|safety
5173097|NCT00924287|Cancer|cancer
5173098|NCT00924261|hip|hip
5173099|NCT00924261|gait|gait
5173100|NCT00924261|walking|walking
5173101|NCT00924261|falls|falls
5173102|NCT00924261|stretching|stretching
5173103|NCT00924261|Flexibility|flexibility
5173104|NCT00924261|Aged|aged
5173105|NCT00924248|Liver MRI|liver mri
5173106|NCT00924209|Neoadjuvant|neoadjuvant
5173107|NCT00924209|Stage IIIA (N2)|stage iiia (n2)
5173108|NCT00924209|Cisplatin|cisplatin
5173109|NCT00924209|Gemcitabine|gemcitabine
5173110|NCT00924209|Bevacizumab|bevacizumab
5173111|NCT00924209|Non-Small Cell Lung Cancer|non-small cell lung cancer
5173112|NCT00924209|NSCLC|nsclc
5173113|NCT00924196|Plexiform Neurofibroma|plexiform neurofibroma
5173114|NCT00924196|Optic Pathway Tumor|optic pathway tumor
5173115|NCT00924196|Neurofibroma|neurofibroma
5173116|NCT00924196|Malignant Peripheral Nerve Sheath Tumor|malignant peripheral nerve sheath tumor
5173117|NCT00924196|Volumetric MRI|volumetric mri
5173118|NCT00924196|Neurofibromatosis Type 1|neurofibromatosis type 1
5173119|NCT00924196|NF1|nf1
5173120|NCT00924196|Optic Glioma|optic glioma
5173121|NCT00924183|Depression|depression
5173122|NCT00924183|Symptom scales|symptom scales
5173123|NCT00924183|Symptom measures|symptom measures
5173124|NCT00924183|Vancouver Semi-Structured Interview for Depression|vancouver semi-structured interview for depression
5173125|NCT00924183|V-SID|v-sid
5173126|NCT00924183|VSID|vsid
5173127|NCT00924183|treatment-as-usual|treatment-as-usual
5173128|NCT00924183|treatment as usual|treatment as usual
5173129|NCT00924183|open-label|open-label
5173130|NCT00924183|open label|open label
5173131|NCT00924183|Major Depressive Episode|major depressive episode
5173132|NCT00924183|MDE|mde
5173133|NCT00924170|Immunotoxin|immunotoxin
5173134|NCT00924170|CD25|cd25
5173135|NCT00924170|Immunogenicity|immunogenicity
5173136|NCT00924170|Neutralization|neutralization
5173137|NCT00924170|Neutralizing Antibodies|neutralizing antibodies
5173138|NCT00924170|Adult T-Cell Leukemia|adult t-cell leukemia
5173139|NCT00924170|Leukemia|leukemia
5173140|NCT00924170|ATL|atl
5173141|NCT00924131|Late Effects|late effects
5173142|NCT00924131|Radiation|radiation
5173143|NCT00924131|Chemotherapy|chemotherapy
5173144|NCT00924131|Hodgkin's Disease|hodgkin's disease
5173145|NCT00924131|Lymphoma|lymphoma
5173146|NCT00924131|Hodgkin Disease|hodgkin disease
5173147|NCT00924118|Acute myocardial infarction|acute myocardial infarction
5173148|NCT00924118|Reperfusion injury|reperfusion injury
5173149|NCT00924118|Nitric oxide|nitric oxide
5173150|NCT00924092|Immunotherapy|immunotherapy
5173151|NCT00924092|Lung Cancer|lung cancer
5173152|NCT00924092|Colorectal Cancer|colorectal cancer
5173153|NCT00924092|Head and Neck Cancer|head and neck cancer
5173154|NCT00924092|Prostate|prostate
5173155|NCT00924092|Breast Cancer|breast cancer
5173156|NCT00924079|Analysis of plasma concentration of nalbuphine|analysis of plasma concentration of nalbuphine
5173157|NCT00924066|Ixabepilone|ixabepilone
5173158|NCT00924066|BMS-247550|bms-247550
5173159|NCT00924066|Ixempra|ixempra
5173160|NCT00924066|Cervical Cancer|cervical cancer
5173161|NCT00924066|Epothilone|epothilone
5173162|NCT00924053|Diabetes Mellitus Type 2|diabetes mellitus type 2
5173163|NCT00924040|BL22 in HCL after Immunotoxin|bl22 in hcl after immunotoxin
5173164|NCT00924040|Hairy Cell Leukemia|hairy cell leukemia
5173165|NCT00924040|Leukemia|leukemia
5173166|NCT00924027|Radiation|radiation
5173167|NCT00924027|Cancer|cancer
5173168|NCT00924027|HDR|hdr
5173169|NCT00924027|Brachytherapy|brachytherapy
5173170|NCT00924027|Training|training
5173171|NCT00924014|heart failure|heart failure
5173172|NCT00924001|Clinical Response|clinical response
5173173|NCT00924001|Immunotherapy|immunotherapy
5173174|NCT00924001|Cancer|cancer
5173175|NCT00924001|Cytokines|cytokines
5173176|NCT00924001|Adoptive Cell Therapy|adoptive cell therapy
5173177|NCT00924001|Melanoma|melanoma
5173178|NCT00924001|Metastatic Melanoma|metastatic melanoma
5173179|NCT00923988|Secondhand smoke|secondhand smoke
5173180|NCT00923988|passive smoking|passive smoking
5173181|NCT00923988|platelet function|platelet function
5173182|NCT00923988|endothelial function|endothelial function
5173183|NCT00923962|Basic science|basic science
5173184|NCT00923962|Type 2 Diabetes mellitus|type 2 diabetes mellitus
5173185|NCT00923962|Glucagon like peptid-1|glucagon like peptid-1
5173186|NCT00923962|Coronary Bloodflow|coronary bloodflow
5173187|NCT00923962|Metabolite uptake|metabolite uptake
5173188|NCT00923949|NSCLC Stage Ia-IIb|nsclc stage ia-iib
5173189|NCT00923949|Resectable NSCLC|resectable nsclc
5173190|NCT00923949|Non-Small Cell Lung Cancer|non-small cell lung cancer
5173191|NCT00923949|NSCLC|nsclc
5173192|NCT00923936|Kaposi's Sarcoma|kaposi's sarcoma
5173193|NCT00923936|HIV|hiv
5173194|NCT00923936|Doxil|doxil
5173195|NCT00923936|VEGF|vegf
5173196|NCT00923936|Bevacizumab|bevacizumab
5173197|NCT00923923|stress reactivity|stress reactivity
5173198|NCT00923923|PTSD|ptsd
5173199|NCT00923923|alcohol dependence|alcohol dependence
5173200|NCT00923923|drinking|drinking
5173201|NCT00923923|craving|craving
5173202|NCT00923910|WT1 Peptide Dendritic Cell Vaccine|wt1 peptide dendritic cell vaccine
5173203|NCT00923910|Hematologic Malignancies|hematologic malignancies
5173204|NCT00923910|Relapse After Allogeneic Stem Cell Transplantation|relapse after allogeneic stem cell transplantation
5173205|NCT00923910|Donor Lymphocyte Infusions|donor lymphocyte infusions
5173206|NCT00923910|WT1-Positive|wt1-positive
5173207|NCT00923910|Dendritic Cell Vaccine|dendritic cell vaccine
5173208|NCT00923910|Tumor Immunotherapy|tumor immunotherapy
5173209|NCT00923910|Allogeneic Adoptive Immunotherapy|allogeneic adoptive immunotherapy
5173210|NCT00923910|Hodgkins Lymphoma|hodgkins lymphoma
5173211|NCT00923910|Leukemia|leukemia
5173212|NCT00923910|Acute Myelogenous Leukemia|acute myelogenous leukemia
5173213|NCT00923910|AML|aml
5173214|NCT00923910|Acute Lymphocytic Leukemia|acute lymphocytic leukemia
5173215|NCT00923910|ALL|all
5173216|NCT00923910|Chronic Myelogenous Leukemia|chronic myelogenous leukemia
5173217|NCT00923910|CML|cml
5173218|NCT00923910|Myelodysplasia Syndrome|myelodysplasia syndrome
5173219|NCT00923910|Non-Hodgkin Lymphoma|non-hodgkin lymphoma
5173220|NCT00923897|Hepatocellular Carcinoma|hepatocellular carcinoma
5173221|NCT00923897|Hepatic Metastasis|hepatic metastasis
5173222|NCT00923897|Palliative Radiation Therapy|palliative radiation therapy
5173223|NCT00923897|Locally advanced HCC and Hepatic Metastasis|locally advanced hcc and hepatic metastasis
5173224|NCT00923884|NSCLC|nsclc
5173225|NCT00923884|Genotype|genotype
5173226|NCT00923884|SCLC|sclc
5173227|NCT00923884|Lung Cancer|lung cancer
5173228|NCT00923884|Non-Small Cell Lung Cancer|non-small cell lung cancer
5173229|NCT00923884|Small Cell Lung Cancer|small cell lung cancer
5173230|NCT00923871|CBCT|cbct
5173231|NCT00923871|Breast Cancer|breast cancer
5173232|NCT00923858|Rotator Cuff|rotator cuff
5173233|NCT00923858|Ultrasound|ultrasound
5173234|NCT00923858|Pain|pain
5173235|NCT00923858|Tear Progression|tear progression
5173236|NCT00923845|Metastatic Renal Cell Carcinoma|metastatic renal cell carcinoma
5173237|NCT00923845|Allogeneic Hematopoietic Stem Cell Transplant|allogeneic hematopoietic stem cell transplant
5173238|NCT00923845|Th2 Cells|th2 cells
5173239|NCT00923845|Sirolimus|sirolimus
5173240|NCT00923845|Pentostatin|pentostatin
5173241|NCT00923845|Kidney Cancer|kidney cancer
5173242|NCT00923845|Renal Cell Carcinoma|renal cell carcinoma
5173243|NCT00923845|Metastatic Renal Cell Cancer|metastatic renal cell cancer
5173244|NCT00923832|Fungal Infections|fungal infections
5173245|NCT00923832|PCR Assays|pcr assays
5173246|NCT00923832|Cell Wall Derived Biomarkers|cell wall derived biomarkers
5173247|NCT00923832|EORTC/MSG Definitions|eortc/msg definitions
5173554|NCT00922753|Inspiratory|inspiratory
5173248|NCT00923832|Molecular Assays|molecular assays
5173249|NCT00923832|Lung Fungal Infection|lung fungal infection
5173250|NCT00923832|Invasive Pulmonary Fungal Infection|invasive pulmonary fungal infection
5173251|NCT00923832|Invasive Pulmonary Aspegillosis|invasive pulmonary aspegillosis
5173252|NCT00923832|Invasive Pulmonary Zycomycosis|invasive pulmonary zycomycosis
5173253|NCT00923819|Adolescents|adolescents
5173254|NCT00923819|Gastric Bypass|gastric bypass
5173255|NCT00923819|Quality of Life|quality of life
5173256|NCT00923819|Mental Health|mental health
5173257|NCT00923819|Lifestyle|lifestyle
5173258|NCT00923806|Metastatic Cancer|metastatic cancer
5173259|NCT00923806|Tumor Regression|tumor regression
5173260|NCT00923806|Safety|safety
5173261|NCT00923806|Immunotherapy|immunotherapy
5173262|NCT00923793|skull defects|skull defects
5173263|NCT00923793|Hydroxylapatite implant|hydroxylapatite implant
5173264|NCT00923793|Titanium implant|titanium implant
5173265|NCT00923793|calotte defects without the possibility to be covered with the missing own bone|calotte defects without the possibility to be covered with the missing own bone
5173266|NCT00923780|Tissue Acquisition|tissue acquisition
5173267|NCT00923780|Gene Expression|gene expression
5173268|NCT00923780|Class Predictor Model|class predictor model
5173269|NCT00923780|Endocrine Tumor|endocrine tumor
5173270|NCT00923741|Lung Cancer|lung cancer
5173271|NCT00923741|Immunity|immunity
5173272|NCT00923741|Clinical Response|clinical response
5173273|NCT00923741|Cytokines|cytokines
5173274|NCT00923741|Elispot Assay|elispot assay
5173275|NCT00923741|Non-Small Cell Lung Cancer|non-small cell lung cancer
5173276|NCT00923741|NSCLC|nsclc
5173277|NCT00923728|AVN - 944|avn - 944
5173278|NCT00923728|Phase I|phase i
5173279|NCT00923728|Adult Solid Tumors|adult solid tumors
5173280|NCT00923728|Cancer|cancer
5173281|NCT00923728|Solid Tumor|solid tumor
5173282|NCT00923676|Hyperlipidemia|hyperlipidemia
5173283|NCT00923676|LDL-cholesterol|ldl-cholesterol
5173284|NCT00923676|HDL-cholesterol|hdl-cholesterol
5173285|NCT00923676|triglycerides|triglycerides
5173286|NCT00923676|IIEF|iief
5173287|NCT00923676|FSFI|fsfi
5173288|NCT00923676|Male and female sexual dysfunctions|male and female sexual dysfunctions
5173289|NCT00923663|MALT lymphoma|malt lymphoma
5173290|NCT00923663|Advanced or Helicobacter pylori-refractory MALT lymphoma|advanced or helicobacter pylori-refractory malt lymphoma
5173291|NCT00923650|Informed Consent|informed consent
5173292|NCT00923650|Pediatric Phase I Clinical Trials|pediatric phase i clinical trials
5173293|NCT00923650|Assent|assent
5173294|NCT00923650|Questionnaires|questionnaires
5173295|NCT00923650|Osteosarcoma|osteosarcoma
5173296|NCT00923650|Ewing's Sarcoma|ewing's sarcoma
5173297|NCT00923650|Neuroblastoma|neuroblastoma
5173298|NCT00923650|Brain Tumors|brain tumors
5173299|NCT00923650|Leukemia|leukemia
5173300|NCT00923637|Non small cell lung cancer|non small cell lung cancer
5173301|NCT00923637|video assisted thoracic surgery|video assisted thoracic surgery
5173302|NCT00923637|Adjuvant chemotherapy|adjuvant chemotherapy
5173303|NCT00923637|Pemetrexed|pemetrexed
5173304|NCT00923637|Oxaliplatin|oxaliplatin
5173305|NCT00923624|electronic medical record|electronic medical record
5173306|NCT00923624|antiretroviral medication adherence|antiretroviral medication adherence
5173307|NCT00923611|Hypertension|hypertension
5173308|NCT00923611|Fimasartan|fimasartan
5173309|NCT00923598|TKA|tka
5173310|NCT00923598|Bilateral|bilateral
5173311|NCT00923598|Cleveland Clinic|cleveland clinic
5173312|NCT00923598|UCSD|ucsd
5173313|NCT00923598|Catheter|catheter
5173314|NCT00923598|Nerve block|nerve block
5173315|NCT00923598|Postoperative pain|postoperative pain
5173316|NCT00923598|Femoral Catheter|femoral catheter
5173317|NCT00923598|Bilateral Total Knee Arthroplasty|bilateral total knee arthroplasty
5173318|NCT00923598|Bilateral Femoral Catheter|bilateral femoral catheter
5173319|NCT00923572|Oral contraceptive|oral contraceptive
5173320|NCT00923533|Fimasartan|fimasartan
5173321|NCT00923533|Drug interaction|drug interaction
5173322|NCT00923520|Solid Tumors|solid tumors
5173323|NCT00923520|Phase I|phase i
5173324|NCT00923520|Lymphoma|lymphoma
5173325|NCT00923520|Dimethane Sulfonate (DMS612, NSC 281612)|dimethane sulfonate (dms612, nsc 281612)
5173326|NCT00923520|Cancer|cancer
5173327|NCT00923520|Solid Tumor|solid tumor
5173328|NCT00923520|Renal Cell Cancer|renal cell cancer
5173329|NCT00923520|Kidney Cancer|kidney cancer
5173330|NCT00923520|Breast Cancer|breast cancer
5173331|NCT00923520|Colon Cancer|colon cancer
5173332|NCT00923520|Lung Disease|lung disease
5173333|NCT00923520|Non-Hodgkin Lymphoma|non-hodgkin lymphoma
5173334|NCT00923520|NHL|nhl
5173335|NCT00923507|Chronic Lymphocytic Leukemia (CLL)|chronic lymphocytic leukemia (cll)
5173336|NCT00923507|Monoclonal B Cell Lymphocytosis|monoclonal b cell lymphocytosis
5173337|NCT00923507|Small Lymphocytic Lymphoma (SLL)|small lymphocytic lymphoma (sll)
5173338|NCT00923507|Leukemia|leukemia
5173339|NCT00923507|Lymphoma|lymphoma
5173340|NCT00923494|Anesthesia|anesthesia
5173341|NCT00923481|Multi-Kinase Inhibitor|multi-kinase inhibitor
5173342|NCT00923481|Neoplasms|neoplasms
5173343|NCT00923481|Advanced Cancer|advanced cancer
5173344|NCT00923481|Kidney Cancer|kidney cancer
5173345|NCT00923481|Liver Cancer|liver cancer
5173346|NCT00923481|Pheochromocytoma|pheochromocytoma
5173347|NCT00923481|Non-Small Cell Lung Cancer|non-small cell lung cancer
5173348|NCT00923481|Colorectal Cancer|colorectal cancer
5173349|NCT00923481|Head and Neck Cancer|head and neck cancer
5173350|NCT00923468|Pharmacokinetics|pharmacokinetics
5173351|NCT00923468|Phase I Trials|phase i trials
5173352|NCT00923468|Children|children
5173353|NCT00923468|Relaspsed Solid Tumors|relaspsed solid tumors
5173354|NCT00923468|Relapsed Leukemia|relapsed leukemia
5173355|NCT00923468|Relapsed Brain Tumors|relapsed brain tumors
5173356|NCT00923442|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
5173357|NCT00923442|Acute Lymphocytic Leukemia|acute lymphocytic leukemia
5173358|NCT00923442|Pediatric Blood Disorders|pediatric blood disorders
5173359|NCT00923442|Hodgkins and non-Hodgkins lymphoma|hodgkins and non-hodgkins lymphoma
5173360|NCT00923442|MDS|mds
5173361|NCT00923429|Manual therapy|manual therapy
5173362|NCT00923429|Low back pain|low back pain
5173363|NCT00923429|Pain|pain
5173364|NCT00923429|Return to work|return to work
5173365|NCT00923416|Intra-Prostate Markers|intra-prostate markers
5173366|NCT00923416|Transrectal Ultrasound|transrectal ultrasound
5173367|NCT00923416|Prostate Cancer Patients|prostate cancer patients
5173368|NCT00923403|plant sterols|plant sterols
5173369|NCT00923403|diet|diet
5173370|NCT00923403|soymilk|soymilk
5173371|NCT00923403|cholesterol|cholesterol
5173372|NCT00923390|Renal Cancer|renal cancer
5173373|NCT00923390|Immunotherapy|immunotherapy
5173374|NCT00923390|Clinical Response|clinical response
5173375|NCT00923390|Toxicity|toxicity
5173376|NCT00923390|Gene Therapy|gene therapy
5173377|NCT00923390|Kidney Cancer|kidney cancer
5173378|NCT00923377|Breast Cancer|breast cancer
5173379|NCT00923377|Breast Cancer Prevention|breast cancer prevention
5173380|NCT00923377|High Risk|high risk
5173381|NCT00923377|Breast Stem Cells|breast stem cells
5173382|NCT00923377|Mammographic Density|mammographic density
5173383|NCT00923377|Breast Cancer Risk|breast cancer risk
5173384|NCT00923364|GATA2|gata2
5173385|NCT00923364|Transplant|transplant
5173386|NCT00923364|Immunodeficiency|immunodeficiency
5173387|NCT00923364|Myelodysplasia|myelodysplasia
5173388|NCT00923364|MonoMAC|monomac
5173389|NCT00923351|Vaccine|vaccine
5173390|NCT00923351|Immunotherapy|immunotherapy
5173391|NCT00923351|Cancer|cancer
5173392|NCT00923351|Chemotherapy|chemotherapy
5173393|NCT00923351|Tumor Lysate/KLH Pulsed Dendritic Cell Vaccine|tumor lysate/klh pulsed dendritic cell vaccine
5173394|NCT00923351|Neuroblastoma|neuroblastoma
5173395|NCT00923351|Autologous Lymphocyte Infusion|autologous lymphocyte infusion
5173396|NCT00923351|Ewing's Sarcoma|ewing's sarcoma
5173397|NCT00923351|Rhabdomyosarcoma|rhabdomyosarcoma
5173398|NCT00923338|fistula|fistula
5173399|NCT00923338|vesico-vaginal fistula|vesico-vaginal fistula
5173400|NCT00923325|Biomarker Analysis|biomarker analysis
5173401|NCT00923325|Sarcomas|sarcomas
5173402|NCT00923325|Ewing's Sarcoma|ewing's sarcoma
5173403|NCT00923325|Osteosarcoma|osteosarcoma
5173404|NCT00923325|Rhabdomyosarcoma|rhabdomyosarcoma
5173405|NCT00923325|Synovial Sarcoma|synovial sarcoma
5173406|NCT00923325|Other Sarcoma|other sarcoma
5173407|NCT00923299|stage IV pancreatic cancer|stage iv pancreatic cancer
5173408|NCT00923299|recurrent pancreatic cancer|recurrent pancreatic cancer
5173409|NCT00923299|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
5173410|NCT00923273|Pemetrexed|pemetrexed
5173411|NCT00923273|Sirolimus|sirolimus
5173412|NCT00923273|Non-Small Cell Lung Cancer|non-small cell lung cancer
5173413|NCT00923273|Phase I/II|phase i/ii
5173414|NCT00923273|mTOR Inhibitor|mtor inhibitor
5173415|NCT00923273|NSCLC|nsclc
5173416|NCT00923273|Lung Cancer|lung cancer
5173417|NCT00923260|Omentectomy|omentectomy
5173418|NCT00923260|metabolic syndrome|metabolic syndrome
5173419|NCT00923260|acute phase reactants|acute phase reactants
5173420|NCT00923247|Vandetanib|vandetanib
5173421|NCT00923247|Bortezomib|bortezomib
5173422|NCT00923247|Medullary Thyroid|medullary thyroid
5173423|NCT00923247|Proteasome Inhibitor|proteasome inhibitor
5173424|NCT00923247|Cancer|cancer
5173425|NCT00923247|Solid Tumor|solid tumor
5173426|NCT00923247|Thyroid Cancer|thyroid cancer
5173427|NCT00923247|Medullary Thyroid Cancer|medullary thyroid cancer
5173428|NCT00923234|monosomy 5|monosomy 5
5173429|NCT00923234|del5q|del5q
5173430|NCT00923234|lenalidomide|lenalidomide
5173431|NCT00923234|azacitidine|azacitidine
5173432|NCT00923221|Blood|blood
5173433|NCT00923221|Prostate Cancer|prostate cancer
5173434|NCT00923221|Genotyping|genotyping
5173435|NCT00923195|Metastatic Melanoma|metastatic melanoma
5173436|NCT00923195|Tumor Regression|tumor regression
5173437|NCT00923195|Safety|safety
5173438|NCT00923195|Immunotherapy|immunotherapy
5173439|NCT00923182|Relapsed or Refractory Chronic Lymphocytic Leukemia,|relapsed or refractory chronic lymphocytic leukemia,
5173440|NCT00923182|CLL|cll
5173441|NCT00923169|Renal Cell|renal cell
5173442|NCT00923169|Melanoma|melanoma
5173443|NCT00923169|Monoclonal Antibodies|monoclonal antibodies
5173444|NCT00923169|Phase I|phase i
5173445|NCT00923169|TGF-B|tgf-b
5173446|NCT00923156|Heart failure|heart failure
5173447|NCT00923156|Systolic|systolic
5173448|NCT00923156|Aliskiren|aliskiren
5173449|NCT00923156|Ramipril|ramipril
5173450|NCT00923156|Angiotensin II|angiotensin ii
5173451|NCT00923156|Ang II|ang ii
5173452|NCT00923156|Plasma Renin Activity|plasma renin activity
5173453|NCT00923156|PRA|pra
5173454|NCT00923156|Plasma Renin Concentration|plasma renin concentration
5173455|NCT00923156|PR,|pr,
5173456|NCT00923156|brain natriuretic peptide|brain natriuretic peptide
5173457|NCT00923156|BNP|bnp
5173458|NCT00923156|urinary aldosterone|urinary aldosterone
5173459|NCT00923156|Escape|escape
5173460|NCT00923156|Pharmacokinetic|pharmacokinetic
5173461|NCT00923156|PK|pk
5173462|NCT00923130|Renal Cell Carcinoma|renal cell carcinoma
5173463|NCT00923130|Bevacizumab|bevacizumab
5173464|NCT00923130|Ixabepilone|ixabepilone
5173465|NCT00923130|Phase II|phase ii
5173466|NCT00923117|Glioblastoma|glioblastoma
5173467|NCT00923117|Chemotherapy|chemotherapy
5173468|NCT00923117|Anti-Angiogenesis|anti-angiogenesis
5173469|NCT00923117|Radiation|radiation
5173470|NCT00923117|Brain Tumor|brain tumor
5173471|NCT00923117|Malignant Glioma|malignant glioma
5173472|NCT00923117|Glioblastoma Multiforme|glioblastoma multiforme
5173473|NCT00923104|Radiation|radiation
5173474|NCT00923104|Blister|blister
5173475|NCT00923104|Healthy Volunteer|healthy volunteer
5173476|NCT00923104|Samples|samples
5173477|NCT00923104|Prostate Cancer|prostate cancer
5173478|NCT00923104|Breast Cancer|breast cancer
5173479|NCT00923104|HV|hv
5173480|NCT00923091|triple combination|triple combination
5173481|NCT00923091|parallel group|parallel group
5173482|NCT00923091|dual combination|dual combination
5173483|NCT00923078|schizophrenia|schizophrenia
5173484|NCT00923078|cognitive remediation|cognitive remediation
5173485|NCT00923078|rehabilitation|rehabilitation
5173486|NCT00923078|electrophysiology|electrophysiology
5173487|NCT00923078|neuropsychology|neuropsychology
5173488|NCT00923065|Cancer|cancer
5173489|NCT00923065|Oncology|oncology
5173490|NCT00923065|Standard Care|standard care
5173491|NCT00923052|Cancer Stem Cells|cancer stem cells
5173492|NCT00923052|Biomarkers|biomarkers
5173493|NCT00923052|Surgery|surgery
5173494|NCT00923052|Solid Organ Cancers|solid organ cancers
5173495|NCT00923052|Natural History|natural history
5173496|NCT00923052|Cancer|cancer
5173497|NCT00923052|Solid Organ Cancer|solid organ cancer
5173498|NCT00923052|Liver Cancer|liver cancer
5173499|NCT00923052|Colorectal Cancer|colorectal cancer
5173500|NCT00923052|Breast Cancer|breast cancer
5173501|NCT00923052|Gastric Cancer|gastric cancer
5173502|NCT00923052|Pancreatic Ductal Cancer|pancreatic ductal cancer
5173503|NCT00923039|The early origin of cardiovascular disease|the early origin of cardiovascular disease
5173504|NCT00923026|Gene Therapy|gene therapy
5173505|NCT00923026|Follow-Up|follow-up
5173506|NCT00923026|Delayed Toxicity|delayed toxicity
5173507|NCT00923026|Adenocarcinoma|adenocarcinoma
5173508|NCT00923026|Melanoma|melanoma
5173509|NCT00923026|Neuroendocrine Tumors|neuroendocrine tumors
5173510|NCT00923026|Carcinoma|carcinoma
5173511|NCT00923013|Hairy Cell Leukemia|hairy cell leukemia
5173512|NCT00923013|Cladribine|cladribine
5173513|NCT00923013|Rituximab|rituximab
5173514|NCT00923013|Minimal Residual Disease|minimal residual disease
5173515|NCT00923013|Leukemia|leukemia
5173516|NCT00923000|Herb Drug|herb drug
5173517|NCT00923000|volunteers|volunteers
5173518|NCT00922987|lyrica pregabalin epilepsy partial seizures|lyrica pregabalin epilepsy partial seizures
5173519|NCT00922974|spinal bone metastases|spinal bone metastases
5173520|NCT00922974|pain|pain
5173521|NCT00922961|brachytherapy, late cutaneous toxicity|brachytherapy, late cutaneous toxicity
5173522|NCT00922948|Radiofrequency ablation|radiofrequency ablation
5173523|NCT00922948|Cryosurgery|cryosurgery
5173524|NCT00922948|Renal cancers|renal cancers
5173525|NCT00922896|Gemcitabine|gemcitabine
5173526|NCT00922896|Cisplatin|cisplatin
5173527|NCT00922896|Erlotinib|erlotinib
5173528|NCT00922883|Promacta|promacta
5173529|NCT00922883|SAA|saa
5173530|NCT00922883|Aplastic Anemia|aplastic anemia
5173531|NCT00922883|Thrombocytopenia|thrombocytopenia
5173532|NCT00922857|Respiratory Insufficiency|respiratory insufficiency
5173533|NCT00922857|Muscular Atrophy|muscular atrophy
5173534|NCT00922857|Respiratory rehabilitation|respiratory rehabilitation
5173535|NCT00922844|hypotension|hypotension
5173536|NCT00922844|low blood pressure|low blood pressure
5173537|NCT00922844|vasopressor need|vasopressor need
5173538|NCT00922831|Cognition, Affective MS symptoms|cognition, affective ms symptoms
5173539|NCT00922818|Perineal|perineal
5173540|NCT00922818|Prostatectomy|prostatectomy
5173541|NCT00922818|Nerve|nerve
5173542|NCT00922818|Anatomic|anatomic
5173543|NCT00922818|Surgery|surgery
5173544|NCT00922818|Neoplasms, Prostatic|neoplasms, prostatic
5173545|NCT00922818|Prostate Cancer|prostate cancer
5173546|NCT00922818|Prostate Neoplasms|prostate neoplasms
5173547|NCT00922818|Prostatic Cancer|prostatic cancer
5173548|NCT00922818|Prostate|prostate
5173549|NCT00922818|Cancer|cancer
5173550|NCT00922818|Recurrent|recurrent
5173551|NCT00922805|Pediatrics, short bowel syndrome, soluble fiber|pediatrics, short bowel syndrome, soluble fiber
5173552|NCT00922766|dalteparin non-ST segment elevated acute coronary syndromes|dalteparin non-st segment elevated acute coronary syndromes
5173553|NCT00922753|Preoxygenation|preoxygenation
5173555|NCT00922753|Support|support
5173556|NCT00922753|Healthy|healthy
5173557|NCT00922753|EndtidalO2|endtidalo2
5173558|NCT00922740|Nocturia|nocturia
5173559|NCT00922740|Pharmacokinetics|pharmacokinetics
5173560|NCT00922740|Pharmacodynamics|pharmacodynamics
5173561|NCT00922740|Water-loading|water-loading
5173562|NCT00922740|Elderly|elderly
5173563|NCT00922740|Males|males
5173564|NCT00922727|L. reuteri|l. reuteri
5173565|NCT00922727|Cytokines|cytokines
5173566|NCT00922727|Toll like receptors|toll like receptors
5173567|NCT00922727|Healthy Adults|healthy adults
5173568|NCT00922727|Probiotics|probiotics
5173569|NCT00922714|Glutamine|glutamine
5173570|NCT00922714|ICU patients|icu patients
5173571|NCT00922714|Critically ill|critically ill
5173572|NCT00922714|Nutrition|nutrition
5173573|NCT00922701|Peritoneal dialysis|peritoneal dialysis
5173574|NCT00922701|L-carnitine|l-carnitine
5173575|NCT00922688|Dipeptide Alanyl-Glutamine|dipeptide alanyl-glutamine
5173576|NCT00922688|Insulin sensitivity|insulin sensitivity
5173577|NCT00922688|Intracellular signaling|intracellular signaling
5173578|NCT00922688|Antioxidant/oxidant parameters|antioxidant/oxidant parameters
5173579|NCT00922688|Lipolysis|lipolysis
5173580|NCT00922688|Inflammatory response in the liver|inflammatory response in the liver
5173581|NCT00922675|ST-elevation myocardial infarction|st-elevation myocardial infarction
5173582|NCT00922662|coronary artery disease|coronary artery disease
5173583|NCT00922662|chest pain|chest pain
5173584|NCT00922662|CCTA|ccta
5173585|NCT00922623|Nasolabial folds|nasolabial folds
5173586|NCT00922597|Continuous infusion|continuous infusion
5173587|NCT00922597|Surgery|surgery
5173588|NCT00922597|Severe haemophilia A|severe haemophilia a
5173589|NCT00922584|non-small cell lung cancer|non-small cell lung cancer
5173590|NCT00922584|Sorafenib|sorafenib
5173591|NCT00922584|targeted therapy|targeted therapy
5173592|NCT00922571|Cataract|cataract
5173593|NCT00922571|Femtosecond laser|femtosecond laser
5173594|NCT00922558|tetra-axiametric posturography|tetra-axiametric posturography
5173595|NCT00922558|postural control|postural control
5173596|NCT00922558|tetrax|tetrax
5173597|NCT00922558|children|children
5173598|NCT00922545|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
5173599|NCT00922545|Quality of life|quality of life
5173600|NCT00922545|Primary health care|primary health care
5173601|NCT00922532|Hypoxic Respiratory Failure (HRF), Pulmonary Hypertension|hypoxic respiratory failure (hrf), pulmonary hypertension
5173602|NCT00922519|Positron Emission Tomography|positron emission tomography
5173603|NCT00922519|Sodium 18F-Fluoride|sodium 18f-fluoride
5173604|NCT00922519|99mTc-MDP|99mtc-mdp
5173605|NCT00922519|Bone Scan|bone scan
5173606|NCT00922506|Overactive bladder|overactive bladder
5173607|NCT00922506|Benign prostate hyperplasia|benign prostate hyperplasia
5173608|NCT00922506|Doxazosin|doxazosin
5173609|NCT00922506|Tolterodine|tolterodine
5173610|NCT00922493|weaning|weaning
5173611|NCT00922493|inspiratory muscle training|inspiratory muscle training
5173612|NCT00922493|maximum inspiratory pressure (MIP)|maximum inspiratory pressure (mip)
5173613|NCT00922493|index of Tobin (IT)|index of tobin (it)
5173614|NCT00922493|intubated|intubated
5173615|NCT00922493|intensive care unit|intensive care unit
5173616|NCT00922493|elderly|elderly
5173617|NCT00922480|Hypertension|hypertension
5173618|NCT00922480|Losartan|losartan
5173619|NCT00922454|patients will be matched based on AAA neck length and neck and iliac angulation|patients will be matched based on aaa neck length and neck and iliac angulation
5173620|NCT00922441|Fimasartan|fimasartan
5173621|NCT00922441|Essential Hypertension|essential hypertension
5173622|NCT00922441|24hour ABPM|24hour abpm
5173623|NCT00922441|Population PK|population pk
5173624|NCT00922428|rheumatism|rheumatism
5173625|NCT00922428|arthralgia|arthralgia
5173626|NCT00922428|myalgia|myalgia
5173627|NCT00922428|lumbago|lumbago
5173628|NCT00922428|homoeopathy|homoeopathy
5173629|NCT00922428|injection|injection
5173630|NCT00922428|PASCOE-Agil HOM Injektopas|pascoe-agil hom injektopas
5173631|NCT00922428|efficacy|efficacy
5173632|NCT00922428|tolerability|tolerability
5173633|NCT00922428|acceptance|acceptance
5173634|NCT00922428|safety|safety
5173635|NCT00922415|Crohn's disease|crohn's disease
5173636|NCT00922415|calprotectin|calprotectin
5173637|NCT00922402|Acute|acute
5173638|NCT00922402|heart failure|heart failure
5173639|NCT00922402|hyperglycemia|hyperglycemia
5173640|NCT00922402|Acute heart failure with high levels of glycemia|acute heart failure with high levels of glycemia
5173641|NCT00922389|Diabetes Complications|diabetes complications
5173642|NCT00922389|Lower limb ischemia|lower limb ischemia
5173643|NCT00922389|Adult stem cells|adult stem cells
5173644|NCT00922389|peripheral blood stem cells|peripheral blood stem cells
5173645|NCT00922376|Diabetes|diabetes
5173646|NCT00922376|self- management|self- management
5173647|NCT00922376|glycemic control|glycemic control
5173648|NCT00922376|telehealth|telehealth
5173649|NCT00922376|mhealth|mhealth
5173650|NCT00922363|safety|safety
5173651|NCT00922363|vaccine|vaccine
5173652|NCT00922363|tuberculosis|tuberculosis
5173653|NCT00922363|CAF01|caf01
5173654|NCT00922363|Ag85B-ESAT-6|ag85b-esat-6
5173655|NCT00922363|prevention|prevention
5173656|NCT00922350|asthma|asthma
5173657|NCT00922350|heliox|heliox
5173658|NCT00922350|bronchodilators|bronchodilators
5173659|NCT00922350|posture|posture
5173660|NCT00922337|distal embolization|distal embolization
5173661|NCT00922337|thrombotic lesions|thrombotic lesions
5173662|NCT00922337|AMI|ami
5173663|NCT00922337|ACS|acs
5173664|NCT00922337|SVG|svg
5173665|NCT00922324|Healthy volunteers|healthy volunteers
5173666|NCT00922311|Proteinuria|proteinuria
5173667|NCT00922285|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
5173668|NCT00922285|health status unknown|health status unknown
5173669|NCT00922272|Schizophrenia|schizophrenia
5173670|NCT00922259|Flu|flu
5173671|NCT00922259|Influenza|influenza
5173672|NCT00922259|Vaccine|vaccine
5173673|NCT00922259|Prevention|prevention
5173674|NCT00922246|overuse injuries|overuse injuries
5173675|NCT00922246|conscript|conscript
5173676|NCT00922246|prevention|prevention
5173677|NCT00922233|Contraception|contraception
5173678|NCT00922220|low back pain|low back pain
5173679|NCT00922220|spinal manipulation|spinal manipulation
5173680|NCT00922220|central sensitization|central sensitization
5173681|NCT00922220|manual therapy|manual therapy
5173682|NCT00922194|Type 2 diabetes|type 2 diabetes
5173683|NCT00922194|Obesity|obesity
5173684|NCT00922194|Extended Release Metformin|extended release metformin
5173685|NCT00922181|malignancy|malignancy
5173686|NCT00922181|liver|liver
5173687|NCT00922181|microwave|microwave
5173688|NCT00922181|surgery|surgery
5173689|NCT00922168|Sleep|sleep
5173690|NCT00922168|apnea|apnea
5173691|NCT00922168|obstructive|obstructive
5173692|NCT00922168|central|central
5173693|NCT00922155|endobronchial ultrasound|endobronchial ultrasound
5173694|NCT00922155|guide sheath|guide sheath
5173695|NCT00922155|peripheral pulmonary lesions|peripheral pulmonary lesions
5173696|NCT00922129|Sirolimus|sirolimus
5173697|NCT00922129|Calcineurin inhibitor|calcineurin inhibitor
5173698|NCT00922129|prostate cancer|prostate cancer
5173699|NCT00922103|Colitis, Ulcerative|colitis, ulcerative
5173700|NCT00922103|Ileo Neo Rectal Anastomosis|ileo neo rectal anastomosis
5173701|NCT00922103|Ileal Pouch Anal Anastomosis|ileal pouch anal anastomosis
5173702|NCT00922103|Quality of Life|quality of life
5173703|NCT00922103|functional results|functional results
5173704|NCT00922103|reconstructive surgery|reconstructive surgery
5173705|NCT00922103|surgery|surgery
5173706|NCT00922090|Schizophrenia|schizophrenia
5173707|NCT00922090|Seroquel XR|seroquel xr
5173708|NCT00922090|CGI-CB|cgi-cb
5173709|NCT00922090|SWN-K|swn-k
5173710|NCT00922051|COPD|copd
5173711|NCT00922051|FEV1|fev1
5173712|NCT00922051|beta endorphin|beta endorphin
5173713|NCT00922051|TENS|tens
5173714|NCT00922051|acupuncture|acupuncture
5173715|NCT00922025|NSCLC|nsclc
5173716|NCT00922025|Male|male
5173717|NCT00922025|Smoking Pattern|smoking pattern
5173718|NCT00922025|Efficacy|efficacy
5173719|NCT00922012|Electromagnetic Stimulation Therapy|electromagnetic stimulation therapy
5173720|NCT00922012|Chronic Prostatitis|chronic prostatitis
5173721|NCT00922012|Chronic Pelvic Pain Syndrome|chronic pelvic pain syndrome
5173722|NCT00921999|Chickenpox|chickenpox
5173723|NCT00921999|Shingles|shingles
5173724|NCT00921999|Varicella|varicella
5173725|NCT00921999|Zoster|zoster
5173726|NCT00921999|Vaccine|vaccine
5173727|NCT00921986|genetics|genetics
5173728|NCT00921986|biorepository|biorepository
5173729|NCT00921986|cardiac death|cardiac death
5173730|NCT00921986|atrial fibrillation|atrial fibrillation
5173731|NCT00921986|ventricular fibrillation|ventricular fibrillation
5173732|NCT00921986|ventricular tachycardia|ventricular tachycardia
5173733|NCT00921986|supraventricular tachycardias|supraventricular tachycardias
5173734|NCT00921986|premature ventricular complexes|premature ventricular complexes
5173735|NCT00921986|premature atrial complexes|premature atrial complexes
5173736|NCT00921986|atrioventricular and intraventricular blocks|atrioventricular and intraventricular blocks
5173737|NCT00921986|sinus node dysfunction|sinus node dysfunction
5173738|NCT00921986|syncope|syncope
5173739|NCT00921986|vasovagal reactivity|vasovagal reactivity
5173740|NCT00921986|postural orthostatic tachycardia syndrome|postural orthostatic tachycardia syndrome
5173741|NCT00921973|influenza|influenza
5173742|NCT00921973|universal influenza vaccine|universal influenza vaccine
5173743|NCT00921960|Left ventricular dysfunction|left ventricular dysfunction
5173744|NCT00921960|Left ventricular systolic dysfunction|left ventricular systolic dysfunction
5173745|NCT00921960|Left ventricular diastolic dysfunction|left ventricular diastolic dysfunction
5173746|NCT00921960|Myocardial Infarction|myocardial infarction
5173747|NCT00921960|Hypertension|hypertension
5173748|NCT00921960|Diabetes|diabetes
5173749|NCT00921960|Obesity|obesity
5173750|NCT00921960|Dyslipidaemia|dyslipidaemia
5173751|NCT00921960|Heart Failure|heart failure
5173752|NCT00921960|Prevention|prevention
5173753|NCT00921960|Screening|screening
5173754|NCT00921960|Cardiovascular Risk Factors|cardiovascular risk factors
5173755|NCT00921960|Echocardiography|echocardiography
5173756|NCT00921960|Natriuretic Peptides|natriuretic peptides
5173757|NCT00921947|influenza vaccine|influenza vaccine
5173758|NCT00921947|M2e|m2e
5173759|NCT00921947|Universal influenza vaccine|universal influenza vaccine
5173760|NCT00921934|Herpes|herpes
5173761|NCT00921934|Shingles|shingles
5173762|NCT00921934|virus disease|virus disease
5173763|NCT00921934|vitamin C|vitamin c
5173764|NCT00921934|ascorbic acid|ascorbic acid
5173765|NCT00921934|antioxidant|antioxidant
5173766|NCT00921934|oxidative stress|oxidative stress
5173767|NCT00921908|total hip arthroplasty|total hip arthroplasty
5173768|NCT00921895|Pink Eye,|pink eye,
5173769|NCT00921895|Viral conjunctivitis|viral conjunctivitis
5173770|NCT00921895|Adenoviral conjunctivitis|adenoviral conjunctivitis
5173771|NCT00921895|Keratoconjunctivitis|keratoconjunctivitis
5173772|NCT00921882|Type 2 diabetes|type 2 diabetes
5173773|NCT00921882|Post-partum screening|post-partum screening
5173774|NCT00921869|Cancer|cancer
5173775|NCT00921869|Gastrointestinal Cancer|gastrointestinal cancer
5173776|NCT00921856|Acetylcholine|acetylcholine
5173777|NCT00921843|Pediatric patients undergoing surgery|pediatric patients undergoing surgery
5173778|NCT00921830|ibuprofen|ibuprofen
5173779|NCT00921830|healthy volunteers|healthy volunteers
5173780|NCT00921830|bioavailability|bioavailability
5173781|NCT00921830|pharmacokinetics|pharmacokinetics
5173782|NCT00921830|suppository|suppository
5173783|NCT00921817|healthy children|healthy children
5173784|NCT00921804|Schizophrenia|schizophrenia
5173785|NCT00921804|Hallucinations|hallucinations
5173786|NCT00921804|Paranoia|paranoia
5173787|NCT00921804|Inpatient schizophrenia clinical trial|inpatient schizophrenia clinical trial
5173788|NCT00921791|Hypertension|hypertension
5173789|NCT00921791|Blood pressure|blood pressure
5173790|NCT00921791|Home Blood Pressure Monitoring|home blood pressure monitoring
5173791|NCT00921791|Ambulatory Blood Pressure Monitoring|ambulatory blood pressure monitoring
5173792|NCT00921791|Pharmaceutical care|pharmaceutical care
5173793|NCT00921778|Laparoscopic supracervical hysterectomy|laparoscopic supracervical hysterectomy
5173794|NCT00921778|Vaginal bleeding|vaginal bleeding
5173795|NCT00921778|Patient satisfaction|patient satisfaction
5173796|NCT00921778|vaginal bleeding after laparoscopic hysterectomy|vaginal bleeding after laparoscopic hysterectomy
5173797|NCT00921765|Pain|pain
5173798|NCT00921765|Naloxone|naloxone
5173799|NCT00921765|Ketamine|ketamine
5173800|NCT00921765|Third Molar|third molar
5173801|NCT00921765|Surgery|surgery
5173802|NCT00921752|Lipid therapy|lipid therapy
5173803|NCT00921752|high CV risk|high cv risk
5173804|NCT00921752|lipid goal attainment|lipid goal attainment
5173805|NCT00921752|High cardiovascular risk patients|high cardiovascular risk patients
5173806|NCT00921739|Non small cell lung cancer|non small cell lung cancer
5173807|NCT00921739|Small cell lung cancer|small cell lung cancer
5173808|NCT00921739|Thymoma unresectable|thymoma unresectable
5173809|NCT00921739|Thymic carcinoma unresectable|thymic carcinoma unresectable
5173810|NCT00921726|Drug Interaction|drug interaction
5173811|NCT00921713|Early cancer care|early cancer care
5173812|NCT00921700|Paracetamol|paracetamol
5173813|NCT00921700|Acetaminophen|acetaminophen
5173814|NCT00921700|Ibuprofen|ibuprofen
5173815|NCT00921700|Pain|pain
5173816|NCT00921700|Postoperative pain|postoperative pain
5173817|NCT00921700|third molar|third molar
5173818|NCT00921674|therapeutic equivalency|therapeutic equivalency
5173819|NCT00921674|pharmacokinetics|pharmacokinetics
5173820|NCT00921674|food|food
5173821|NCT00921674|Healthy Volunteers|healthy volunteers
5173822|NCT00921661|oxaliplatin|oxaliplatin
5173823|NCT00921661|5-FU|5-fu
5173824|NCT00921661|Folinic Acid|folinic acid
5173825|NCT00921648|EEG|eeg
5173826|NCT00921648|general paresis|general paresis
5173827|NCT00921648|MRI|mri
5173828|NCT00921648|neurosyphilis|neurosyphilis
5173829|NCT00921635|Haemoglobin|haemoglobin
5173830|NCT00921622|Blood pressure|blood pressure
5173831|NCT00921622|Vitamin C|vitamin c
5173832|NCT00921622|Vitamin D|vitamin d
5173833|NCT00921609|Acromegaly|acromegaly
5173834|NCT00921609|OGTT|ogtt
5173835|NCT00921609|post-op|post-op
5173836|NCT00921596|Surgical Procedures, Cardiac|surgical procedures, cardiac
5173837|NCT00921596|Minimally Invasive Surgical Procedures|minimally invasive surgical procedures
5173838|NCT00921596|Thoracoscopes|thoracoscopes
5173839|NCT00921596|Cardiopulmonary Bypass|cardiopulmonary bypass
5173840|NCT00921583|survival rate|survival rate
5173841|NCT00921583|success rate|success rate
5173842|NCT00921570|TWEAK|tweak
5173843|NCT00921570|FMD|fmd
5173844|NCT00921570|PTX3|ptx3
5173845|NCT00921570|Valsartan|valsartan
5173846|NCT00921570|Amlodipine|amlodipine
5173847|NCT00921570|Renin Angiotensin System|renin angiotensin system
5173848|NCT00921557|Bone mineral density|bone mineral density
5173849|NCT00921544|ROP|rop
5173850|NCT00921544|sucrose|sucrose
5173851|NCT00921544|pain|pain
5173852|NCT00921531|Hepatocellular carcinoma|hepatocellular carcinoma
5173853|NCT00921531|thalidomide|thalidomide
5173854|NCT00921531|TACE|tace
5173855|NCT00921531|Child-Pugh Class A or B|child-pugh class a or b
5173856|NCT00921518|Cardiac surgery|cardiac surgery
5173857|NCT00921518|Sodium bicarbonate|sodium bicarbonate
5173858|NCT00921518|Acute kidney injury|acute kidney injury
5173859|NCT00921518|Saline|saline
5173860|NCT00921505|Acetaminophen|acetaminophen
5173861|NCT00921505|Ibuprofen|ibuprofen
5173862|NCT00921505|Platelets|platelets
5173863|NCT00921505|Leukocytes|leukocytes
5173864|NCT00921505|Oxygen species|oxygen species
5173865|NCT00921505|Humans|humans
5173866|NCT00921505|Blood Platelets|blood platelets
5173867|NCT00921505|Reactive Oxygen Species|reactive oxygen species
5173868|NCT00921505|Platelet Activation|platelet activation
5173869|NCT00921492|Luteinizing hormone|luteinizing hormone
5173870|NCT00921492|Cortisol|cortisol
5173871|NCT00921492|HPA axis|hpa axis
5173872|NCT00921492|HPO axis|hpo axis
5173873|NCT00921492|Ovulation|ovulation
5173874|NCT00921492|Heart rate variability|heart rate variability
5173875|NCT00921492|Psychological distress and quality of life|psychological distress and quality of life
5173876|NCT00921479|third molar|third molar
5173877|NCT00921479|quality of life|quality of life
5173878|NCT00921479|postoperative swelling|postoperative swelling
5173879|NCT00921479|postoperative pain|postoperative pain
5173880|NCT00921479|Surgical Procedures, Operative|surgical procedures, operative
5173881|NCT00921479|Postoperative Period|postoperative period
5173882|NCT00921466|Evaluate the clinical content of the e-SSRS-IVR|evaluate the clinical content of the e-ssrs-ivr
5173883|NCT00921453|Internet|internet
5173884|NCT00921453|Information supply|information supply
5173885|NCT00921453|Tailoring|tailoring
5173886|NCT00921453|Patient empowerment|patient empowerment
5173887|NCT00921453|Headaches|headaches
5173888|NCT00921453|Meta-search|meta-search
5173889|NCT00921453|Consumer Health Information|consumer health information
5173890|NCT00921453|Information Services|information services
5173891|NCT00921453|Information Storage and Retrieval|information storage and retrieval
5173892|NCT00921453|Information Systems|information systems
5173893|NCT00921440|coronary artery|coronary artery
5173894|NCT00921440|stenosis|stenosis
5173895|NCT00921427|Hemianopia|hemianopia
5173896|NCT00921427|Rehabilitation|rehabilitation
5173897|NCT00921427|Transcranial direct current stimulation|transcranial direct current stimulation
5173898|NCT00921427|Visual field|visual field
5173899|NCT00921414|Mantle cell lymphoma|mantle cell lymphoma
5173900|NCT00921414|R DHAP|r dhap
5173901|NCT00921414|ASCT|asct
5173902|NCT00921414|Rituximab Maintenance|rituximab maintenance
5173903|NCT00921388|Smoking Cessation|smoking cessation
5173904|NCT00921388|Exercise|exercise
5173905|NCT00921388|Postmenopausal women|postmenopausal women
5173906|NCT00921388|CHANTIX|chantix
5173907|NCT00921388|varenicline|varenicline
5173908|NCT00921362|Schizophrenia|schizophrenia
5173909|NCT00921349|Prophylaxis|prophylaxis
5173910|NCT00921349|ligation|ligation
5173911|NCT00921349|beta blockers|beta blockers
5173912|NCT00921349|First bleeding rate|first bleeding rate
5173913|NCT00921336|subjects with advanced Solid tumor who have not responded to standard therapy or for whom no standard therapy is available|subjects with advanced solid tumor who have not responded to standard therapy or for whom no standard therapy is available
5173914|NCT00921323|Obesity|obesity
5173915|NCT00921323|Physical activity|physical activity
5173916|NCT00921323|pedometers|pedometers
5173917|NCT00921323|children|children
5173918|NCT00921310|Temsirolimus and pemetrexed for recurrent or refractory NSCLC|temsirolimus and pemetrexed for recurrent or refractory nsclc
5173919|NCT00921297|Alzheimer's Disease|alzheimer's disease
5173920|NCT00921297|vision impairment|vision impairment
5173921|NCT00921297|cataract|cataract
5173922|NCT00921297|quality of life|quality of life
5173923|NCT00921297|retinal nerve fiber layer|retinal nerve fiber layer
5173924|NCT00921271|Compartment syndrome|compartment syndrome
5173925|NCT00921258|latent prostate cancer|latent prostate cancer
5173926|NCT00921258|Patient with latent prostate cancer|patient with latent prostate cancer
5173927|NCT00921258|PSA ≤ 10 ng/ml|psa ≤ 10 ng/ml
5173928|NCT00921258|Clinical stage T1c or T2a|clinical stage t1c or t2a
5173929|NCT00921258|Patient who accept just be control|patient who accept just be control
5173930|NCT00921245|Overactive Bladder|overactive bladder
5173931|NCT00921232|Life-ending patient|life-ending patient
5173932|NCT00921232|caregiver|caregiver
5173933|NCT00921219|therapeutic equivalency|therapeutic equivalency
5173934|NCT00921219|pharmacokinetics|pharmacokinetics
5173935|NCT00921219|food|food
5173936|NCT00921219|Healthy volunteers|healthy volunteers
5173937|NCT00921206|influenza|influenza
5173938|NCT00921206|influenza vaccine|influenza vaccine
5173939|NCT00921206|universal influenza vaccine|universal influenza vaccine
5173940|NCT00921206|Matrix 2e protein|matrix 2e protein
5173941|NCT00921206|M2e|m2e
5173942|NCT00921206|Immune response|immune response
5173943|NCT00921193|Prostate|prostate
5173944|NCT00921193|fiducials|fiducials
5173945|NCT00921193|radiation Therapy|radiation therapy
5173946|NCT00921193|Tracking|tracking
5173947|NCT00921193|Localization|localization
5173948|NCT00921180|Hepatitis B, chronic|hepatitis b, chronic
5173949|NCT00921180|Peginterferon alfa-2a|peginterferon alfa-2a
5173950|NCT00921180|Entecavir|entecavir
5173951|NCT00921167|Glioblastoma|glioblastoma
5173952|NCT00921167|Astrocytoma|astrocytoma
5173953|NCT00921167|Chemotherapy|chemotherapy
5173954|NCT00921154|therapeutic equivalency|therapeutic equivalency
5173955|NCT00921154|pharmacokinetics|pharmacokinetics
5173956|NCT00921154|fasting|fasting
5173957|NCT00921154|Healthy Volunteers|healthy volunteers
5173958|NCT00921141|Implantable central venous access ports, cancer|implantable central venous access ports, cancer
5173959|NCT00921128|Muscimol|muscimol
5173960|NCT00921128|Convection-Enhanced Delivery|convection-enhanced delivery
5173961|NCT00921128|Parkinson's Disease|parkinson's disease
5173962|NCT00921128|Deep Brain Stimulation|deep brain stimulation
5173963|NCT00921128|Parkinson Disease|parkinson disease
5173964|NCT00921128|PD|pd
5173965|NCT00921115|hormone receptor positive|hormone receptor positive
5173966|NCT00921115|invasive breast cancer|invasive breast cancer
5173967|NCT00921115|endocrine therapy|endocrine therapy
5173968|NCT00921115|Anastrazole|anastrazole
5173969|NCT00921115|Fulvestrant|fulvestrant
5173970|NCT00921115|breast tumors|breast tumors
5173971|NCT00921115|postmenopausal|postmenopausal
5173972|NCT00921102|Atropine|atropine
5173973|NCT00921102|Morphine|morphine
5173974|NCT00921102|Analgesics, Opioid|analgesics, opioid
5173975|NCT00921102|Antiemetics|antiemetics
5173976|NCT00921089|Atherosclerosis|atherosclerosis
5173977|NCT00921089|Cardiovascular disease|cardiovascular disease
5173978|NCT00921089|Hemodialysis|hemodialysis
5173979|NCT00921089|Inflammation|inflammation
5173980|NCT00921089|Vascular calcification|vascular calcification
5173981|NCT00921050|subclinical hypothyroidism|subclinical hypothyroidism
5173982|NCT00921050|elderly|elderly
5173983|NCT00921050|mild cognitive impairment|mild cognitive impairment
5173984|NCT00921050|neuropsychological test|neuropsychological test
5173985|NCT00921050|NEUROPSI|neuropsi
5173986|NCT00921037|Neurofibromatosis Type 1|neurofibromatosis type 1
5173987|NCT00921037|Morbus Recklinghausen|morbus recklinghausen
5173988|NCT00921037|cutaneous neurofibromas|cutaneous neurofibromas
5173989|NCT00921037|Erbium-YAG-Laser|erbium-yag-laser
5173990|NCT00921037|Vaporisation|vaporisation
5173991|NCT00921037|Thermal Necrosis|thermal necrosis
5173992|NCT00921024|Complicated Urinary Tract Infection|complicated urinary tract infection
5173993|NCT00921024|Pyelonephritis|pyelonephritis
5173994|NCT00921024|Antimicrobial|antimicrobial
5173995|NCT00921024|Cephalosporin|cephalosporin
5173996|NCT00921024|Intravenous|intravenous
5173997|NCT00921011|hypertension|hypertension
5173998|NCT00921011|diabetes|diabetes
5173999|NCT00921011|smoking|smoking
5174000|NCT00921011|hyperlipidemia|hyperlipidemia
5174001|NCT00921011|atherosclerosis risk|atherosclerosis risk
5174002|NCT00920998|Z-338|z-338
5174003|NCT00920998|YM443|ym443
5174004|NCT00920998|healthy volunteers|healthy volunteers
5174005|NCT00920985|Pregnancy prevention|pregnancy prevention
5174006|NCT00920985|Female contraception|female contraception
5174007|NCT00920985|Patch|patch
5174008|NCT00920972|Bone marrow|bone marrow
5174009|NCT00920972|Transplant|transplant
5174010|NCT00920972|Transplantation|transplantation
5174011|NCT00920972|Hematopoietic|hematopoietic
5174012|NCT00920972|Umbilical cord|umbilical cord
5174013|NCT00920972|Related|related
5174014|NCT00920972|Unrelated|unrelated
5174015|NCT00920972|Reduced|reduced
5174016|NCT00920972|Non-myeloablative|non-myeloablative
5174017|NCT00920972|Nonmyeloablative|nonmyeloablative
5174018|NCT00920972|Non-malignant|non-malignant
5174019|NCT00920972|Nonmalignant|nonmalignant
5174020|NCT00920946|Huntington|huntington
5174021|NCT00920946|Dimebon|dimebon
5174022|NCT00920946|HD|hd
5174023|NCT00920946|Huntingtin|huntingtin
5174024|NCT00920933|Ozone challenge|ozone challenge
5174025|NCT00920933|airway neutrophilia|airway neutrophilia
5174026|NCT00920933|induced sputum|induced sputum
5174027|NCT00920933|Healthy volunteers|healthy volunteers
5174028|NCT00920920|3D-4D MRI-based Brachytherapy|3d-4d mri-based brachytherapy
5174029|NCT00920920|Cervical Cancer|cervical cancer
5174030|NCT00920920|Multicenter Clinical Study|multicenter clinical study
5174031|NCT00920920|Locally advanced cervical cancer|locally advanced cervical cancer
5174032|NCT00920881|Continuous glucose monitoring|continuous glucose monitoring
5174033|NCT00920881|Accuracy|accuracy
5174034|NCT00920881|Continuous glucose-error grid analysis|continuous glucose-error grid analysis
5174035|NCT00920868|Phase I|phase i
5174036|NCT00920868|Solid Tumor|solid tumor
5174037|NCT00920868|Colorectal|colorectal
5174038|NCT00920868|Dasatinib|dasatinib
5174039|NCT00920868|Sprycel|sprycel
5174040|NCT00920868|Bevacizumab|bevacizumab
5174041|NCT00920868|Avastin|avastin
5174042|NCT00920868|Oxaliplatin|oxaliplatin
5174043|NCT00920868|Eloxatin|eloxatin
5174044|NCT00920868|Capecitabine|capecitabine
5174045|NCT00920868|Xeloda|xeloda
5174046|NCT00920868|Duke|duke
5174047|NCT00920868|Any Solid Tumor (Phase I)|any solid tumor (phase i)
5174048|NCT00920868|Metastatic Colorectal Cancer (Expanded Cohort)|metastatic colorectal cancer (expanded cohort)
5174049|NCT00920842|metabolic syndrome|metabolic syndrome
5174050|NCT00920842|long-term effects secondary to cancer therapy in children|long-term effects secondary to cancer therapy in children
5174051|NCT00920842|cardiovascular complications|cardiovascular complications
5174052|NCT00920842|cancer survivor|cancer survivor
5174053|NCT00920842|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
5174054|NCT00920842|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
5174055|NCT00920842|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
5174056|NCT00920842|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
5174145|NCT00920582|MGA031|mga031
5174057|NCT00920842|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
5174058|NCT00920842|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
5174059|NCT00920842|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5174060|NCT00920842|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5174061|NCT00920829|Alcohol Dependence|alcohol dependence
5174062|NCT00920829|Alcoholism|alcoholism
5174063|NCT00920829|Naltrexone|naltrexone
5174064|NCT00920829|Substance Abuse|substance abuse
5174065|NCT00920829|Genetics|genetics
5174066|NCT00920816|Axitinib in First & Second Line Treatment of Patients With Metastatic Renal Cell Cancer|axitinib in first & second line treatment of patients with metastatic renal cell cancer
5174067|NCT00920777|CBT|cbt
5174068|NCT00920777|Fukuda criteria|fukuda criteria
5174069|NCT00920777|Mental functioning|mental functioning
5174070|NCT00920777|Physical functioning|physical functioning
5174071|NCT00920764|CKD Stages 3&4|ckd stages 3&4
5174072|NCT00920764|Endothelin antagonist|endothelin antagonist
5174073|NCT00920764|Proteinuria|proteinuria
5174074|NCT00920751|water infusion|water infusion
5174075|NCT00920751|air insufflation|air insufflation
5174076|NCT00920751|colonoscopy|colonoscopy
5174077|NCT00920751|colorectal cancer screening|colorectal cancer screening
5174078|NCT00920738|metabolic syndrome|metabolic syndrome
5174079|NCT00920738|cancer survivor|cancer survivor
5174080|NCT00920738|childhood soft tissue sarcoma|childhood soft tissue sarcoma
5174081|NCT00920738|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
5174082|NCT00920738|childhood acute lymphoblastic leukemia|childhood acute lymphoblastic leukemia
5174083|NCT00920738|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
5174084|NCT00920738|childhood Hodgkin lymphoma|childhood hodgkin lymphoma
5174085|NCT00920738|childhood non-Hodgkin lymphoma|childhood non-hodgkin lymphoma
5174086|NCT00920738|childhood acute myeloid leukemia/other myeloid malignancies|childhood acute myeloid leukemia/other myeloid malignancies
5174087|NCT00920738|chronic lymphocytic leukemia|chronic lymphocytic leukemia
5174088|NCT00920738|childhood brain stem glioma|childhood brain stem glioma
5174089|NCT00920738|childhood cerebellar astrocytoma|childhood cerebellar astrocytoma
5174090|NCT00920738|childhood cerebral astrocytoma/malignant glioma|childhood cerebral astrocytoma/malignant glioma
5174091|NCT00920738|childhood choroid plexus tumor|childhood choroid plexus tumor
5174092|NCT00920738|childhood craniopharyngioma|childhood craniopharyngioma
5174093|NCT00920738|childhood embryonal tumor|childhood embryonal tumor
5174094|NCT00920738|childhood ependymoma|childhood ependymoma
5174095|NCT00920738|childhood oligodendroglioma|childhood oligodendroglioma
5174096|NCT00920738|childhood pineal parenchymal tumor|childhood pineal parenchymal tumor
5174097|NCT00920738|childhood mixed glioma|childhood mixed glioma
5174098|NCT00920738|childhood subependymal giant cell astrocytoma|childhood subependymal giant cell astrocytoma
5174099|NCT00920738|childhood visual pathway and hypothalamic glioma|childhood visual pathway and hypothalamic glioma
5174100|NCT00920725|DKA|dka
5174101|NCT00920712|chronic atrophic gastritis|chronic atrophic gastritis
5174102|NCT00920712|Traditional Chinese Medicine|traditional chinese medicine
5174103|NCT00920686|Migraine|migraine
5174104|NCT00920686|aura|aura
5174105|NCT00920673|child|child
5174106|NCT00920647|hunters syndrome|hunters syndrome
5174107|NCT00920647|hunter's syndrome|hunter's syndrome
5174108|NCT00920647|hunter disease|hunter disease
5174109|NCT00920647|hunters disease|hunters disease
5174110|NCT00920647|hunter's disease|hunter's disease
5174111|NCT00920647|Mucopolysaccharidosis(MPS) II|mucopolysaccharidosis(mps) ii
5174112|NCT00920647|Mucopolysaccharidosis(MPS)2|mucopolysaccharidosis(mps)2
5174113|NCT00920647|Mucopolysaccharidosis (MPS) 2|mucopolysaccharidosis (mps) 2
5174114|NCT00920647|Mucopolysaccharidosis (mps) ii|mucopolysaccharidosis (mps) ii
5174115|NCT00920647|mucopolysaccharides|mucopolysaccharides
5174116|NCT00920647|lysosomal storage disease|lysosomal storage disease
5174117|NCT00920647|lysosomal storage disorder|lysosomal storage disorder
5174118|NCT00920647|chronic ear infection|chronic ear infection
5174119|NCT00920647|enlarged adenoids|enlarged adenoids
5174120|NCT00920647|mps symptoms|mps symptoms
5174121|NCT00920647|mps diagnosis|mps diagnosis
5174122|NCT00920647|ert treatment|ert treatment
5174123|NCT00920647|elaprase|elaprase
5174124|NCT00920647|idursulfase|idursulfase
5174125|NCT00920647|iduronate sulfatase|iduronate sulfatase
5174126|NCT00920647|iduronate 2 sulfatase|iduronate 2 sulfatase
5174127|NCT00920647|enzyme replacement therapy|enzyme replacement therapy
5174128|NCT00920647|hunter syndrome treatment|hunter syndrome treatment
5174129|NCT00920647|hunter's syndrome treatment|hunter's syndrome treatment
5174130|NCT00920647|hunter syndrome therapy|hunter syndrome therapy
5174131|NCT00920647|hunter's disease treatment|hunter's disease treatment
5174132|NCT00920647|mps society|mps society
5174133|NCT00920621|Asthma|asthma
5174134|NCT00920621|Vitamin D|vitamin d
5174135|NCT00920621|Randomized Control Trial|randomized control trial
5174136|NCT00920608|AZD9056|azd9056
5174137|NCT00920608|Pharmacokinetics|pharmacokinetics
5174138|NCT00920608|interaction|interaction
5174139|NCT00920608|Methotrexate|methotrexate
5174140|NCT00920608|Rheumatoid Arthritis|rheumatoid arthritis
5174141|NCT00920595|Cancer|cancer
5174142|NCT00920582|Teplizumab|teplizumab
5174143|NCT00920582|Protege|protege
5174144|NCT00920582|Protege Encore|protege encore
5174146|NCT00920582|Monoclonal antibody|monoclonal antibody
5174147|NCT00920582|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
5174148|NCT00920582|T1DM|t1dm
5174149|NCT00920582|MacroGenics|macrogenics
5174150|NCT00920582|Recent Onset Diabetes|recent onset diabetes
5174151|NCT00920582|hOKT3γ1 (Ala-Ala)|hokt3γ1 (ala-ala)
5174152|NCT00920582|Encore|encore
5174153|NCT00920569|cardiac output|cardiac output
5174154|NCT00920569|recirculation|recirculation
5174155|NCT00920569|oxygenator blood volume|oxygenator blood volume
5174156|NCT00920569|venoarterial extracorporeal membrane oxygenation|venoarterial extracorporeal membrane oxygenation
5174157|NCT00920569|venovenous extracorporeal membrane oxygenation|venovenous extracorporeal membrane oxygenation
5174158|NCT00920530|Screening|screening
5174159|NCT00920530|real time PCR|real time pcr
5174160|NCT00920530|Streptococcus agalactiae|streptococcus agalactiae
5174161|NCT00920530|Pregnant women|pregnant women
5174162|NCT00920504|Mesh: patient education as topic|mesh: patient education as topic
5174163|NCT00920504|Mesh: neoplasms|mesh: neoplasms
5174164|NCT00920504|Mesh: medication therapy management|mesh: medication therapy management
5174165|NCT00920504|pain self management|pain self management
5174166|NCT00920504|symptom management|symptom management
5174167|NCT00920504|education of patients with pain from neoplasm metastases|education of patients with pain from neoplasm metastases
5174168|NCT00920491|Chief complaint|chief complaint
5174169|NCT00920491|non-specific symptoms|non-specific symptoms
5174170|NCT00920491|general weakness / general deterioration|general weakness / general deterioration
5174171|NCT00920491|risk assessment in ED patients with non-specific symptoms|risk assessment in ed patients with non-specific symptoms
5174172|NCT00920478|Rheumatoid arthritis|rheumatoid arthritis
5174173|NCT00920478|Musculoskeletal Ultrasound|musculoskeletal ultrasound
5174174|NCT00920478|Synovitis|synovitis
5174175|NCT00920478|DMARD|dmard
5174176|NCT00920478|Etanercept|etanercept
5174177|NCT00920478|Biomarkers|biomarkers
5174178|NCT00920478|Undifferentiated Inflammatory Polyarthritis|undifferentiated inflammatory polyarthritis
5174179|NCT00920452|implantable cardioverter defibrillator (ICD)|implantable cardioverter defibrillator (icd)
5174180|NCT00920452|defibrillation leads, cardiac resynchronization therapy (CRT)|defibrillation leads, cardiac resynchronization therapy (crt)
5174181|NCT00920439|Poliomyelitis Vaccines|poliomyelitis vaccines
5174182|NCT00920439|IPV|ipv
5174183|NCT00920426|HIV|hiv
5174184|NCT00920426|naive|naive
5174185|NCT00920426|Phase II|phase ii
5174186|NCT00920426|integrase inhibitor|integrase inhibitor
5174187|NCT00920426|GSK1265744|gsk1265744
5174188|NCT00920426|newly diagnosed|newly diagnosed
5174189|NCT00920426|pharmacokinetics|pharmacokinetics
5174190|NCT00920426|AIDS|aids
5174191|NCT00920426|integrase|integrase
5174192|NCT00920426|HIV Infections|hiv infections
5174193|NCT00920426|Treatment naive|treatment naive
5174194|NCT00920387|Anxiety|anxiety
5174195|NCT00920387|quality of life|quality of life
5174196|NCT00920387|psychotherapy|psychotherapy
5174197|NCT00920387|potentially fatal illness|potentially fatal illness
5174198|NCT00920387|lysergic acid diethylamide|lysergic acid diethylamide
5174199|NCT00920374|Influenza|influenza
5174200|NCT00920348|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
5174201|NCT00920348|COPD|copd
5174202|NCT00920348|Cohort study|cohort study
5174203|NCT00920348|prospective longitudinal study|prospective longitudinal study
5174204|NCT00920348|tissue bank|tissue bank
5174205|NCT00920335|Adult intracranial ependymoma|adult intracranial ependymoma
5174206|NCT00920322|Depression|depression
5174207|NCT00920322|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
5174208|NCT00920309|Autosomal Dominant Polycystic Kidney Disease|autosomal dominant polycystic kidney disease
5174209|NCT00920309|rapamycin|rapamycin
5174210|NCT00920309|ADPKD|adpkd
5174211|NCT00920296|drug interaction|drug interaction
5174212|NCT00920296|integrase inhibitor|integrase inhibitor
5174213|NCT00920283|Stents|stents
5174214|NCT00920283|Bare Metal Stents|bare metal stents
5174215|NCT00920283|PCI|pci
5174216|NCT00920283|Coronary Artery Disease|coronary artery disease
5174217|NCT00920283|Coronary Artery Stenosis|coronary artery stenosis
5174218|NCT00920283|Stent Thrombosis|stent thrombosis
5174219|NCT00920283|Vascular Disease|vascular disease
5174220|NCT00920283|Myocardial Ischemia|myocardial ischemia
5174221|NCT00920270|Hospital-Acquired Pneumonia|hospital-acquired pneumonia
5174222|NCT00920270|Gram Negative Bacteria|gram negative bacteria
5174223|NCT00920257|oncology|oncology
5174224|NCT00920257|breast cancer|breast cancer
5174225|NCT00920257|AKT inhibitor|akt inhibitor
5174226|NCT00920257|first time in human|first time in human
5174227|NCT00920257|lymphoma|lymphoma
5174228|NCT00920257|endometrial cancer|endometrial cancer
5174229|NCT00920257|GSK2141795|gsk2141795
5174230|NCT00920257|solid tumors|solid tumors
5174231|NCT00920244|Resuscitation|resuscitation
5174232|NCT00920244|Cardiac arrest|cardiac arrest
5174233|NCT00920244|State-transitions|state-transitions
5174234|NCT00920244|Markov|markov
5174235|NCT00920218|Vaccine|vaccine
5174236|NCT00920218|Safety|safety
5174237|NCT00920218|Herpes Zoster|herpes zoster
5174238|NCT00920218|Immunogenicity|immunogenicity
5174239|NCT00920218|Stem cell transplantation|stem cell transplantation
5174240|NCT00920205|MPC-3100|mpc-3100
5174241|NCT00920205|HSP90 inhibitor|hsp90 inhibitor
5174242|NCT00920205|oral drug|oral drug
5174243|NCT00920205|cancer|cancer
5174244|NCT00920192|c-MET|c-met
5174245|NCT00920192|VEGFR2|vegfr2
5174246|NCT00920192|Advanced hepatocellular carcinoma|advanced hepatocellular carcinoma
5174247|NCT00920179|dry eye, in vivo confocal microscopy, inflammation, acinar unit density, lacrimal gland|dry eye, in vivo confocal microscopy, inflammation, acinar unit density, lacrimal gland
5174248|NCT00920166|Infant formula|infant formula
5174249|NCT00920166|Alpha-lactalbumin|alpha-lactalbumin
5174250|NCT00920166|Symbiotic|symbiotic
5174251|NCT00920166|Allergy|allergy
5174252|NCT00920166|Gastrointestinal tolerance|gastrointestinal tolerance
5174253|NCT00920166|Bacterial colonization|bacterial colonization
5174254|NCT00920166|Faecal IgA analysis|faecal iga analysis
5174255|NCT00920153|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
5174256|NCT00920153|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
5174257|NCT00920153|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5174258|NCT00920153|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5174259|NCT00920140|Oncology, GSK1120212, MEK inhibitor, hematological malignancies, AML|oncology, gsk1120212, mek inhibitor, hematological malignancies, aml
5174260|NCT00920140|CMML|cmml
5174261|NCT00920140|MDS|mds
5174262|NCT00920127|AKL1|akl1
5174263|NCT00920127|COPD|copd
5174264|NCT00920101|atherosclerotic plaques|atherosclerotic plaques
5174265|NCT00920101|hypercholesterolemia|hypercholesterolemia
5174266|NCT00920101|HMG-CoA reductase inhibitor|hmg-coa reductase inhibitor
5174267|NCT00920101|statin|statin
5174268|NCT00920101|lipid-lowering therapy|lipid-lowering therapy
5174269|NCT00920088|probes|probes
5174270|NCT00920088|NNRTI|nnrti
5174271|NCT00920088|drug interaction|drug interaction
5174272|NCT00920088|protease inhitibor|protease inhitibor
5174273|NCT00920075|Juvenile Osteoporosis|juvenile osteoporosis
5174274|NCT00920075|Bone Mineral Density|bone mineral density
5174275|NCT00920075|Fosamax|fosamax
5174276|NCT00920075|Dual Energy X-Ray Absorptiometry|dual energy x-ray absorptiometry
5174277|NCT00920075|Fracture|fracture
5174278|NCT00920062|recirculation|recirculation
5174279|NCT00920062|ultrasound dilution|ultrasound dilution
5174280|NCT00920062|venovenous extracorporeal membrane oxygenation|venovenous extracorporeal membrane oxygenation
5174281|NCT00920049|Driving|driving
5174282|NCT00920049|Injury|injury
5174283|NCT00920049|Prevention|prevention
5174284|NCT00920049|Intervention|intervention
5174285|NCT00920049|Parents|parents
5174286|NCT00920036|PTSD|ptsd
5174287|NCT00920036|Combat|combat
5174288|NCT00920036|Biofeedback|biofeedback
5174289|NCT00920036|Psychophysiology|psychophysiology
5174290|NCT00920023|SPIO MRI|spio mri
5174291|NCT00920023|Feridex|feridex
5174292|NCT00920010|non-small cell lung cancer|non-small cell lung cancer
5174293|NCT00920010|small cell lung cancer|small cell lung cancer
5174294|NCT00919997|human papilloma virus infection|human papilloma virus infection
5174295|NCT00919997|HIV infection|hiv infection
5174296|NCT00919997|HIV Infections|hiv infections
5174297|NCT00919984|OVARIAN NEOPLASMS|ovarian neoplasms
5174298|NCT00919984|ADJUVANT CHEMOTHERAPY|adjuvant chemotherapy
5174299|NCT00919984|INTRAPERITONEAL CHEMOTHERAPY|intraperitoneal chemotherapy
5174300|NCT00919971|Bi spectral Index|bi spectral index
5174301|NCT00919971|Sedation depth monitoring|sedation depth monitoring
5174302|NCT00919971|Out of hospital ventilated patients|out of hospital ventilated patients
5174303|NCT00919958|Peripheral Artery Disease|peripheral artery disease
5174304|NCT00919958|Peripheral Vascular Disease|peripheral vascular disease
5174305|NCT00919958|Critical limb ischemia|critical limb ischemia
5174306|NCT00919945|Neonates|neonates
5174307|NCT00919945|Congenital Heart Disease|congenital heart disease
5174308|NCT00919945|Postoperative Feeding|postoperative feeding
5174309|NCT00919945|Splanchnic Blood Flow|splanchnic blood flow
5174310|NCT00919932|Depression|depression
5174311|NCT00919932|CBT|cbt
5174312|NCT00919932|Texting|texting
5174313|NCT00919932|SMS|sms
5174314|NCT00919919|menopause|menopause
5174315|NCT00919919|Endometrial Thickness|endometrial thickness
5174316|NCT00919919|progesterone|progesterone
5174317|NCT00919906|haptic|haptic
5174318|NCT00919906|rehabilitation|rehabilitation
5174319|NCT00919906|fine-motor skill|fine-motor skill
5174320|NCT00919906|handwriting|handwriting
5174321|NCT00919893|chronic prostatitis symptom index|chronic prostatitis symptom index
5174322|NCT00919893|male|male
5174323|NCT00919893|inflammatory|inflammatory
5174324|NCT00919893|CP-CPPS|cp-cpps
5174325|NCT00919893|Cernilton|cernilton
5174326|NCT00919893|pelvic pain|pelvic pain
5174327|NCT00919893|symptoms|symptoms
5174328|NCT00919867|Normal, healthy volunteers (for this Phase 1 study)|normal, healthy volunteers (for this phase 1 study)
5174329|NCT00919854|Human immunodeficiency virus 1|human immunodeficiency virus 1
5174330|NCT00919854|HIV-1|hiv-1
5174331|NCT00919854|Darunavir|darunavir
5174332|NCT00919854|Ritonavir|ritonavir
5174333|NCT00919854|Norvir|norvir
5174334|NCT00919841|postpartum|postpartum
5174335|NCT00919841|involution|involution
5174336|NCT00919841|three-dimension sonography|three-dimension sonography
5174337|NCT00919841|size of the uterus|size of the uterus
5174338|NCT00919815|Leprosy|leprosy
5174339|NCT00919815|Type 1 Reactions|type 1 reactions
5174340|NCT00919815|Prednisolone|prednisolone
5174341|NCT00919815|Ciclosporin|ciclosporin
5174342|NCT00919802|Interstitial cystitis (IC)|interstitial cystitis (ic)
5174343|NCT00919802|Oxytocin|oxytocin
5174344|NCT00919802|Bladder|bladder
5174345|NCT00919802|Void|void
5174346|NCT00919776|Leprosy|leprosy
5174347|NCT00919776|ENL|enl
5174348|NCT00919776|Erythema Nodosum Leprosum|erythema nodosum leprosum
5174349|NCT00919776|Prednisolone|prednisolone
5174350|NCT00919776|Ciclosporin|ciclosporin
5174351|NCT00919763|Atopic Dermatitis|atopic dermatitis
5174352|NCT00919737|NPC-08|npc-08
5174353|NCT00919737|carmustine|carmustine
5174354|NCT00919737|nitrosourea|nitrosourea
5174355|NCT00919737|safety|safety
5174356|NCT00919724|AIDS|aids
5174357|NCT00919724|Endothelial Function|endothelial function
5174358|NCT00919724|Inflammation|inflammation
5174359|NCT00919724|Immune Activation|immune activation
5174360|NCT00919724|treatment naive|treatment naive
5174361|NCT00919711|Menopausal Osteoporosis|menopausal osteoporosis
5174362|NCT00919698|Hypnotics and Sedatives|hypnotics and sedatives
5174363|NCT00919698|Respiration, Artificial|respiration, artificial
5174364|NCT00919698|Ventilators, Mechanical|ventilators, mechanical
5174365|NCT00919698|Critical care|critical care
5174366|NCT00919698|Intensive care|intensive care
5174367|NCT00919672|Irritable bowel syndrome|irritable bowel syndrome
5174368|NCT00919672|Sacral nerve stimulation|sacral nerve stimulation
5174369|NCT00919672|Motility|motility
5174370|NCT00919672|Pain perception|pain perception
5174371|NCT00919672|GSRS-IBS|gsrs-ibs
5174372|NCT00919672|IBS-IS|ibs-is
5174373|NCT00919659|parenteral nutrition|parenteral nutrition
5174374|NCT00919659|cancer cachexia|cancer cachexia
5174375|NCT00919659|pancreatic cancer|pancreatic cancer
5174376|NCT00919633|hepatitis C|hepatitis c
5174377|NCT00919633|HCV|hcv
5174378|NCT00919633|genotype|genotype
5174379|NCT00919633|sustained virological response|sustained virological response
5174380|NCT00919633|rapid virological response|rapid virological response
5174381|NCT00919633|interferon|interferon
5174382|NCT00919620|Psychotic disorders|psychotic disorders
5174383|NCT00919620|Psychoses|psychoses
5174384|NCT00919607|quetiapine fumarate(SEROQUEL) extended-release(XR) China PK Study|quetiapine fumarate(seroquel) extended-release(xr) china pk study
5174385|NCT00919607|pharmacokinetics parameters|pharmacokinetics parameters
5174386|NCT00919594|Interpersonal Psychotherapy|interpersonal psychotherapy
5174387|NCT00919594|Depression|depression
5174388|NCT00919594|Mothers|mothers
5174389|NCT00919581|Spinal cord injury|spinal cord injury
5174390|NCT00919555|ALS Treatment|als treatment
5174391|NCT00919555|Tretinoin|tretinoin
5174392|NCT00919555|Pioglitazone HCL|pioglitazone hcl
5174393|NCT00919555|Actos|actos
5174394|NCT00919555|Tau levels|tau levels
5174395|NCT00919555|ALS|als
5174396|NCT00919542|Leprosy|leprosy
5174397|NCT00919542|ENL|enl
5174398|NCT00919542|Erythema Nodosum Leprosum|erythema nodosum leprosum
5174399|NCT00919542|Prednisolone|prednisolone
5174400|NCT00919542|Ciclosporin|ciclosporin
5174401|NCT00919516|Bone marrow transplantation|bone marrow transplantation
5174402|NCT00919516|Ischemia|ischemia
5174403|NCT00919516|Neoangiogenesis|neoangiogenesis
5174404|NCT00919516|Peripheral arterial disease|peripheral arterial disease
5174405|NCT00919516|Stem cell therapy|stem cell therapy
5174406|NCT00919503|nonmalignant diseases|nonmalignant diseases
5174407|NCT00919503|nonmalignant inherited disorders|nonmalignant inherited disorders
5174408|NCT00919503|primary immunodeficiency diseases|primary immunodeficiency diseases
5174409|NCT00919503|primary immune deficiency disorders|primary immune deficiency disorders
5174410|NCT00919503|chronic granulomatous|chronic granulomatous
5174411|NCT00919503|disease|disease
5174412|NCT00919503|IPEX syndrome|ipex syndrome
5174413|NCT00919503|hemophagocytic lymphohistiocytosis|hemophagocytic lymphohistiocytosis
5174414|NCT00919503|Wiskott Aldrich Syndrome|wiskott aldrich syndrome
5174415|NCT00919503|bone marrow failure syndromes|bone marrow failure syndromes
5174416|NCT00919503|Shwachman Diamond Syndrome|shwachman diamond syndrome
5174417|NCT00919503|Dyskeratosis Congenita|dyskeratosis congenita
5174418|NCT00919503|Diamond Blackfan Anemia|diamond blackfan anemia
5174419|NCT00919503|inborn errors of metabolism|inborn errors of metabolism
5174420|NCT00919503|metabolic diseases|metabolic diseases
5174421|NCT00919503|hemoglobinopathies|hemoglobinopathies
5174422|NCT00919503|sickle cell disease|sickle cell disease
5174423|NCT00919503|thalassemia|thalassemia
5174424|NCT00919503|reduced intensity transplantation|reduced intensity transplantation
5174425|NCT00919503|hematopoietic cell transplantation|hematopoietic cell transplantation
5174426|NCT00919503|bone marrow transplantation|bone marrow transplantation
5174427|NCT00919503|umbilical cord blood transplantation|umbilical cord blood transplantation
5174428|NCT00919490|Healthy Volunteers|healthy volunteers
5174429|NCT00919477|Prostate cancer|prostate cancer
5174430|NCT00919477|Casodex|casodex
5174431|NCT00919477|Monotherapy|monotherapy
5174432|NCT00919464|Compartment pressure|compartment pressure
5174433|NCT00919464|compartment syndrome|compartment syndrome
5174434|NCT00919464|femur fracture|femur fracture
5174435|NCT00919451|Leprosy|leprosy
5174436|NCT00919451|Type 1 Reaction|type 1 reaction
5174437|NCT00919451|Prednisolone|prednisolone
5174438|NCT00919451|Ciclosporin|ciclosporin
5174439|NCT00919425|stage 0 chronic lymphocytic leukemia|stage 0 chronic lymphocytic leukemia
5174440|NCT00919425|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
5174441|NCT00919425|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
5174442|NCT00919425|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5174443|NCT00919425|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5174444|NCT00919425|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5174445|NCT00919425|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5174446|NCT00919425|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5174447|NCT00919425|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5174448|NCT00919425|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5174449|NCT00919425|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5174561|NCT00919009|TACE|tace
5174450|NCT00919425|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5174451|NCT00919425|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
5174452|NCT00919425|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
5174453|NCT00919425|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
5174454|NCT00919425|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5174455|NCT00919425|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5174456|NCT00919425|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5174457|NCT00919425|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5174458|NCT00919425|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5174459|NCT00919425|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5174460|NCT00919425|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
5174461|NCT00919425|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5174462|NCT00919425|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
5174463|NCT00919425|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5174464|NCT00919425|untreated childhood acute myeloid leukemia and other myeloid malignancies|untreated childhood acute myeloid leukemia and other myeloid malignancies
5174465|NCT00919425|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5174466|NCT00919425|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
5174467|NCT00919425|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
5174468|NCT00919425|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5174469|NCT00919425|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5174470|NCT00919425|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5174471|NCT00919425|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5174472|NCT00919425|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
5174473|NCT00919425|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5174474|NCT00919425|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
5174475|NCT00919425|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
5174476|NCT00919425|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
5174477|NCT00919412|Non Invasive Biomarkers Preterm Delivery|non invasive biomarkers preterm delivery
5174478|NCT00919399|breast cancer|breast cancer
5174479|NCT00919399|locally advanced|locally advanced
5174480|NCT00919399|Menopausal patient|menopausal patient
5174481|NCT00919399|aromasin|aromasin
5174482|NCT00919399|tamoxifen|tamoxifen
5174483|NCT00919399|efficacy|efficacy
5174484|NCT00919386|Ureteric Measurement|ureteric measurement
5174485|NCT00919373|Catheter Ablation|catheter ablation
5174486|NCT00919373|Defibrillators, Implantable|defibrillators, implantable
5174487|NCT00919347|Cardiovascular Autonomic Neuropathy|cardiovascular autonomic neuropathy
5174488|NCT00919347|Diabetic Autonomic Neuropathy|diabetic autonomic neuropathy
5174489|NCT00919347|Autonomic Dysfunction|autonomic dysfunction
5174490|NCT00919334|Myopia progression|myopia progression
5174491|NCT00919334|Myopia control|myopia control
5174492|NCT00919334|Simultaneous vision|simultaneous vision
5174493|NCT00919334|Myopic defocus|myopic defocus
5174494|NCT00919321|CLL|cll
5174495|NCT00919321|PPV|ppv
5174496|NCT00919321|PCV|pcv
5174497|NCT00919308|Simulation|simulation
5174498|NCT00919308|Invasive procedures|invasive procedures
5174499|NCT00919295|Fibromyalgia syndrome|fibromyalgia syndrome
5174500|NCT00919295|mirtazapine|mirtazapine
5174501|NCT00919295|randomized controlled trial|randomized controlled trial
5174502|NCT00919295|pilot study|pilot study
5174503|NCT00919282|pancreatic cancer|pancreatic cancer
5174504|NCT00919282|gemcitabine|gemcitabine
5174505|NCT00919282|combination|combination
5174506|NCT00919243|prednisone|prednisone
5174507|NCT00919243|allopurinol|allopurinol
5174508|NCT00919243|heart failure|heart failure
5174509|NCT00919243|hyperuricemia|hyperuricemia
5174510|NCT00919230|Hip fracture|hip fracture
5174511|NCT00919230|iron therapy|iron therapy
5174512|NCT00919230|anaemia|anaemia
5174513|NCT00919217|Multiple Sclerosis|multiple sclerosis
5174514|NCT00919217|MS|ms
5174515|NCT00919217|Relapsing-remitting multiple sclerosis|relapsing-remitting multiple sclerosis
5174516|NCT00919217|RR-MS|rr-ms
5174517|NCT00919217|Women|women
5174518|NCT00919204|AG-013736, axitinib, pharmacokinetics, healthy, Chinese|ag-013736, axitinib, pharmacokinetics, healthy, chinese
5174519|NCT00919191|acne|acne
5174520|NCT00919191|irritation|irritation
5174521|NCT00919191|objective sensory methods|objective sensory methods
5174522|NCT00919178|Dengue virus|dengue virus
5174523|NCT00919178|Vaccine|vaccine
5174524|NCT00919178|DEN4|den4
5174525|NCT00919178|Dengue|dengue
5174526|NCT00919165|carotid stenting|carotid stenting
5174527|NCT00919165|cognitive function|cognitive function
5174528|NCT00919165|pre and post stent|pre and post stent
5174529|NCT00919165|severe carotid artery stenosis|severe carotid artery stenosis
5174530|NCT00919152|stress ulcer prophylaxis|stress ulcer prophylaxis
5174531|NCT00919152|intensive care|intensive care
5174532|NCT00919152|Critically ill|critically ill
5174533|NCT00919152|proton pump inhibitors|proton pump inhibitors
5174534|NCT00919152|pharmacoeconomics|pharmacoeconomics
5174535|NCT00919139|multiple myeloma|multiple myeloma
5174536|NCT00919139|Waldenström macroglobulinemia|waldenström macroglobulinemia
5174537|NCT00919139|monoclonal gammopathy of undetermined significance|monoclonal gammopathy of undetermined significance
5174538|NCT00919139|primary systemic amyloidosis|primary systemic amyloidosis
5174539|NCT00919126|Xenon in Anaesthesia|xenon in anaesthesia
5174540|NCT00919113|Bladder Pain|bladder pain
5174541|NCT00919113|GAG replacement therapy|gag replacement therapy
5174542|NCT00919113|IC/PBS|ic/pbs
5174543|NCT00919100|pediatric|pediatric
5174544|NCT00919100|venipuncture|venipuncture
5174545|NCT00919100|pain|pain
5174546|NCT00919100|vibration|vibration
5174547|NCT00919100|vapocoolant|vapocoolant
5174548|NCT00919074|Patients undergoing endoscopic retrograde cholangiopancreatography for the first time|patients undergoing endoscopic retrograde cholangiopancreatography for the first time
5174549|NCT00919074|Particular focus on patients who meet predefined criteria for a difficult bile duct cannulation|particular focus on patients who meet predefined criteria for a difficult bile duct cannulation
5174550|NCT00919061|GALL BLADDER|gall bladder
5174551|NCT00919061|BILE DUCTS|bile ducts
5174552|NCT00919061|BAY 43-9006|bay 43-9006
5174553|NCT00919061|SORAFENIB|sorafenib
5174554|NCT00919061|CISPLATIN|cisplatin
5174555|NCT00919061|GEMCITABINE|gemcitabine
5174556|NCT00919061|09-029|09-029
5174557|NCT00919035|prostate cancer|prostate cancer
5174558|NCT00919035|androgen-independent prostate cancer (AIPC) Prostate Cancer|androgen-independent prostate cancer (aipc) prostate cancer
5174559|NCT00919022|Inoperable Prostate Cancer|inoperable prostate cancer
5174560|NCT00919022|Erectile Dysfunction|erectile dysfunction
5174562|NCT00919009|Sorafenib|sorafenib
5174563|NCT00918996|Cesarean Section|cesarean section
5174564|NCT00918996|Bladder Flap|bladder flap
5174565|NCT00918996|Operating time|operating time
5174566|NCT00918983|Benign prostatic hyperplasia|benign prostatic hyperplasia
5174568|NCT00918983|Enlarged prostate|enlarged prostate
5174569|NCT00918970|autonomous nervous system|autonomous nervous system
5174570|NCT00918970|brain death|brain death
5174571|NCT00918970|organs transplantation|organs transplantation
5174572|NCT00918957|Tobramycin Inhalation Powder|tobramycin inhalation powder
5174573|NCT00918957|Cystic fibrosis|cystic fibrosis
5174574|NCT00918957|Lung diseases|lung diseases
5174575|NCT00918957|Anti-Bacterial Agents|anti-bacterial agents
5174576|NCT00918957|Treatment of infections with P. aeruginosa in cystic fibrosis subjects|treatment of infections with p. aeruginosa in cystic fibrosis subjects
5174577|NCT00918944|clinical decision support tool|clinical decision support tool
5174578|NCT00918944|electronic health record|electronic health record
5174579|NCT00918944|control tool|control tool
5174580|NCT00918944|spirometry|spirometry
5174581|NCT00918944|quality of life survey|quality of life survey
5174582|NCT00918944|provider survey|provider survey
5174583|NCT00918931|Leukemia|leukemia
5174584|NCT00918931|Systemic Mastocytosis|systemic mastocytosis
5174585|NCT00918931|SM|sm
5174586|NCT00918931|Obatoclax mesylate|obatoclax mesylate
5174587|NCT00918931|GX15-070MS|gx15-070ms
5174588|NCT00918918|Alcohol Consumption|alcohol consumption
5174589|NCT00918918|High Density Lipoprotein (HDL)|high density lipoprotein (hdl)
5174590|NCT00918918|lipopolysaccharides (LPS)|lipopolysaccharides (lps)
5174591|NCT00918918|Apolipoproteins|apolipoproteins
5174592|NCT00918918|Inflammation|inflammation
5174593|NCT00918905|pervasive healthcare|pervasive healthcare
5174594|NCT00918905|telecare|telecare
5174595|NCT00918905|telemedicine|telemedicine
5174596|NCT00918905|COPD|copd
5174597|NCT00918892|breast cancer|breast cancer
5174598|NCT00918892|estrogen receptor-negative breast cancer|estrogen receptor-negative breast cancer
5174599|NCT00918892|estrogen receptor-positive breast cancer|estrogen receptor-positive breast cancer
5174600|NCT00918892|progesterone receptor-negative breast cancer|progesterone receptor-negative breast cancer
5174601|NCT00918892|progesterone receptor-positive breast cancer|progesterone receptor-positive breast cancer
5174602|NCT00918892|triple-negative breast cancer|triple-negative breast cancer
5174603|NCT00918892|HER2-negative breast cancer|her2-negative breast cancer
5174604|NCT00918892|HER2-positive breast cancer|her2-positive breast cancer
5174605|NCT00918879|DPP-4 inhibitors|dpp-4 inhibitors
5174606|NCT00918879|HbA1c|hba1c
5174607|NCT00918879|Incretins|incretins
5174608|NCT00918866|Phase 4|phase 4
5174609|NCT00918866|DEFINITY®|definity®
5174610|NCT00918866|hemodynamics|hemodynamics
5174611|NCT00918866|pulmonary artery pressure|pulmonary artery pressure
5174612|NCT00918853|pancreas|pancreas
5174613|NCT00918853|adenocarcinoma|adenocarcinoma
5174614|NCT00918840|HIV|hiv
5174615|NCT00918840|Vaccine|vaccine
5174616|NCT00918840|Immune Therapy|immune therapy
5174617|NCT00918840|DermaVir|dermavir
5174618|NCT00918840|Treatment experienced|treatment experienced
5174619|NCT00918827|adenocarcinoma of the colon|adenocarcinoma of the colon
5174620|NCT00918827|stage III colon cancer|stage iii colon cancer
5174621|NCT00918801|T1DM|t1dm
5174622|NCT00918801|MRI|mri
5174623|NCT00918788|breast cancer|breast cancer
5174624|NCT00918775|Renal Cell Carcinoma|renal cell carcinoma
5174625|NCT00918775|RCC|rcc
5174626|NCT00918775|Kidney|kidney
5174627|NCT00918775|Metastasectomy|metastasectomy
5174628|NCT00918775|Surgery|surgery
5174629|NCT00918775|Tumor Removal|tumor removal
5174630|NCT00918762|perioperative/postoperative complications|perioperative/postoperative complications
5174631|NCT00918762|precancerous condition|precancerous condition
5174632|NCT00918762|stage I squamous cell carcinoma of the hypopharynx|stage i squamous cell carcinoma of the hypopharynx
5174633|NCT00918762|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
5174634|NCT00918762|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
5174635|NCT00918762|stage I squamous cell carcinoma of the larynx|stage i squamous cell carcinoma of the larynx
5174636|NCT00918762|stage I verrucous carcinoma of the larynx|stage i verrucous carcinoma of the larynx
5174637|NCT00918762|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
5174638|NCT00918762|stage II verrucous carcinoma of the larynx|stage ii verrucous carcinoma of the larynx
5174639|NCT00918762|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
5174640|NCT00918762|stage III verrucous carcinoma of the larynx|stage iii verrucous carcinoma of the larynx
5174641|NCT00918762|stage I lymphoepithelioma of the nasopharynx|stage i lymphoepithelioma of the nasopharynx
5174642|NCT00918762|stage I squamous cell carcinoma of the nasopharynx|stage i squamous cell carcinoma of the nasopharynx
5174643|NCT00918762|stage II lymphoepithelioma of the nasopharynx|stage ii lymphoepithelioma of the nasopharynx
5174644|NCT00918762|stage II squamous cell carcinoma of the nasopharynx|stage ii squamous cell carcinoma of the nasopharynx
5174645|NCT00918762|stage III lymphoepithelioma of the nasopharynx|stage iii lymphoepithelioma of the nasopharynx
5174646|NCT00918762|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
5174647|NCT00918762|stage I lymphoepithelioma of the oropharynx|stage i lymphoepithelioma of the oropharynx
5174648|NCT00918762|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
5174649|NCT00918762|stage II lymphoepithelioma of the oropharynx|stage ii lymphoepithelioma of the oropharynx
5174650|NCT00918762|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
5174651|NCT00918762|stage III lymphoepithelioma of the oropharynx|stage iii lymphoepithelioma of the oropharynx
5174652|NCT00918762|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
5174653|NCT00918736|Ankle joint|ankle joint
5174654|NCT00918736|Balance|balance
5174655|NCT00918736|Hyaluronic acid|hyaluronic acid
5174656|NCT00918736|Osteoarthritis|osteoarthritis
5174657|NCT00918710|Squamous cell carcinoma of Oropharynx|squamous cell carcinoma of oropharynx
5174658|NCT00918710|Human papillomavirus.|human papillomavirus.
5174659|NCT00918710|Biological prognostic markers.|biological prognostic markers.
5174660|NCT00918697|photorefractive keratectomy|photorefractive keratectomy
5174661|NCT00918697|PRK|prk
5174662|NCT00918697|alcohol-assisted debridement|alcohol-assisted debridement
5174663|NCT00918697|mechanical debridement|mechanical debridement
5174664|NCT00918697|confocal scan|confocal scan
5174665|NCT00918697|confocal microscopy|confocal microscopy
5174666|NCT00918684|Depression|depression
5174667|NCT00918671|Headache|headache
5174668|NCT00918671|Medication overuse|medication overuse
5174669|NCT00918671|chronic|chronic
5174670|NCT00918671|relapse|relapse
5174671|NCT00918658|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
5174672|NCT00918658|chronic myelogenous leukemia|chronic myelogenous leukemia
5174673|NCT00918658|adult acute lymphoblastic leukemia|adult acute lymphoblastic leukemia
5174674|NCT00918658|childhood acute lymphoblastic leukemia|childhood acute lymphoblastic leukemia
5174675|NCT00918658|adult acute myeloid leukemia|adult acute myeloid leukemia
5174676|NCT00918658|childhood acute myeloid leukemia/other myeloid malignancies|childhood acute myeloid leukemia/other myeloid malignancies
5174677|NCT00918658|multiple myeloma|multiple myeloma
5174678|NCT00918645|stage IV prostate cancer|stage iv prostate cancer
5174679|NCT00918645|recurrent prostate cancer|recurrent prostate cancer
5174680|NCT00918645|bone metastases|bone metastases
5174681|NCT00918632|food-effect pharmacokinetics AG-013736 food fasting|food-effect pharmacokinetics ag-013736 food fasting
5174682|NCT00918619|randomized,|randomized,
5174683|NCT00918619|controlled,|controlled,
5174684|NCT00918619|haemostatic agents,|haemostatic agents,
5174685|NCT00918619|Sangustop,|sangustop,
5174686|NCT00918619|Tachosil,|tachosil,
5174889|NCT00917618|knee|knee
5174687|NCT00918619|liver resection,|liver resection,
5174688|NCT00918619|haemostasis|haemostasis
5174689|NCT00918593|Metastases|metastases
5174690|NCT00918593|Cutaneous|cutaneous
5174691|NCT00918593|Ulcerating|ulcerating
5174692|NCT00918593|Palliative|palliative
5174693|NCT00918593|ulcerating metastases|ulcerating metastases
5174694|NCT00918567|ADHD|adhd
5174695|NCT00918567|impact of atomoxetine with and and without behavior therapy at school and home|impact of atomoxetine with and and without behavior therapy at school and home
5174696|NCT00918554|Sarcoid-associated uveitis|sarcoid-associated uveitis
5174697|NCT00918554|Macular oedema|macular oedema
5174698|NCT00918554|Methotrexate|methotrexate
5174699|NCT00918554|Conventional corticosteroids sparing agent.|conventional corticosteroids sparing agent.
5174700|NCT00918541|atherosclerotic disease|atherosclerotic disease
5174701|NCT00918541|progression|progression
5174702|NCT00918541|natural progression of atherosclerotic disease|natural progression of atherosclerotic disease
5174703|NCT00918541|natural history of atherosclerosis at the level of the carotid artery as evaluated by MRI|natural history of atherosclerosis at the level of the carotid artery as evaluated by mri
5174704|NCT00918528|Urethral stricture|urethral stricture
5174705|NCT00918528|Mitomycin C|mitomycin c
5174706|NCT00918528|Internal Urethrotomy|internal urethrotomy
5174707|NCT00918515|Sedation|sedation
5174708|NCT00918515|Anaesthesia|anaesthesia
5174709|NCT00918515|Safety|safety
5174710|NCT00918515|tolerability|tolerability
5174711|NCT00918515|pharmacokinetics|pharmacokinetics
5174712|NCT00918515|pharmacodynamics|pharmacodynamics
5174713|NCT00918515|healthy male volunteers|healthy male volunteers
5174714|NCT00918489|soft tissue sarcoma|soft tissue sarcoma
5174715|NCT00918489|metastatic|metastatic
5174716|NCT00918489|vorinostat|vorinostat
5174717|NCT00918463|lymphoma|lymphoma
5174718|NCT00918463|diffuse|diffuse
5174719|NCT00918463|refractory|refractory
5174720|NCT00918437|uvulopalatoplasty|uvulopalatoplasty
5174721|NCT00918437|postoperative pain|postoperative pain
5174722|NCT00918437|quality of life|quality of life
5174723|NCT00918411|diarrhea|diarrhea
5174724|NCT00918411|IBS|ibs
5174725|NCT00918411|Colonic diseases|colonic diseases
5174726|NCT00918411|YM060|ym060
5174727|NCT00918385|hormone resistant prostate cancer|hormone resistant prostate cancer
5174728|NCT00918385|castration resistant prostate cancer|castration resistant prostate cancer
5174729|NCT00918385|hormone refractory prostate cancer|hormone refractory prostate cancer
5174730|NCT00918385|metastatic prostate cancer|metastatic prostate cancer
5174731|NCT00918385|hormonal therapy|hormonal therapy
5174732|NCT00918385|antiandrogen therapy|antiandrogen therapy
5174733|NCT00918385|androgen receptor|androgen receptor
5174734|NCT00918385|nilutamide|nilutamide
5174735|NCT00918385|dasatinib|dasatinib
5174736|NCT00918385|genomics|genomics
5174737|NCT00918385|genomic signature|genomic signature
5174738|NCT00918385|genomic predictor|genomic predictor
5174739|NCT00918385|genomic analysis|genomic analysis
5174740|NCT00918385|genomic expression profile|genomic expression profile
5174741|NCT00918372|MSCTA|mscta
5174742|NCT00918372|Marathon runners|marathon runners
5174743|NCT00918346|Ocular hypertension|ocular hypertension
5174744|NCT00918320|Temozolomide|temozolomide
5174745|NCT00918320|Topotecan|topotecan
5174746|NCT00918320|paediatric solid tumours|paediatric solid tumours
5174747|NCT00918320|Miscellaneous other solid tumours|miscellaneous other solid tumours
5174748|NCT00918307|Tobacco Dependence|tobacco dependence
5174749|NCT00918307|HIV infection|hiv infection
5174750|NCT00918307|varenicline|varenicline
5174751|NCT00918294|CRT|crt
5174752|NCT00918294|heart failure|heart failure
5174753|NCT00918294|optimization|optimization
5174754|NCT00918294|Timing cycle optimization methods|timing cycle optimization methods
5174755|NCT00918268|Influenza vaccine|influenza vaccine
5174756|NCT00918255|Hidradenitis Suppurativa|hidradenitis suppurativa
5174757|NCT00918255|Adalimumab|adalimumab
5174758|NCT00918255|Nodule|nodule
5174759|NCT00918255|Abscess|abscess
5174760|NCT00918255|Fistula|fistula
5174761|NCT00918255|Physicians Global Assessment|physicians global assessment
5174762|NCT00918255|Hurley Stage|hurley stage
5174763|NCT00918255|Sartorius Scale|sartorius scale
5174764|NCT00918242|Coronary Heart Disease|coronary heart disease
5174765|NCT00918242|computed tomography|computed tomography
5174766|NCT00918242|prevalence of coronary artery disease|prevalence of coronary artery disease
5174767|NCT00918229|Prostate|prostate
5174768|NCT00918229|cancer|cancer
5174769|NCT00918229|radiation|radiation
5174770|NCT00918229|biodegradable implantable balloon|biodegradable implantable balloon
5174771|NCT00918229|intrarectal balloon|intrarectal balloon
5174772|NCT00918216|breast cancer|breast cancer
5174773|NCT00918203|Lung neoplasms|lung neoplasms
5174774|NCT00918203|IMC-3G3|imc-3g3
5174775|NCT00918203|carboplatin|carboplatin
5174776|NCT00918203|paclitaxel|paclitaxel
5174777|NCT00918203|PDGFr|pdgfr
5174778|NCT00918190|Postoperative nausea and vomiting|postoperative nausea and vomiting
5174779|NCT00918190|Pediatric|pediatric
5174780|NCT00918190|Strabismus|strabismus
5174781|NCT00918190|Late onset postoperative nausea and vomiting|late onset postoperative nausea and vomiting
5174782|NCT00918112|Parkinson's Disease|parkinson's disease
5174783|NCT00918099|Mesh|mesh
5174784|NCT00918099|vaginal prolapse|vaginal prolapse
5174785|NCT00918099|Recurrence rate|recurrence rate
5174786|NCT00918086|Vitamin D|vitamin d
5174787|NCT00918086|Tuberculosis|tuberculosis
5174788|NCT00918073|HIV infected smokers|hiv infected smokers
5174789|NCT00918073|HIV|hiv
5174790|NCT00918034|BPH|bph
5174791|NCT00918034|LUTS|luts
5174792|NCT00918034|talaporfin sodium|talaporfin sodium
5174793|NCT00918008|URINARY BLADDER|urinary bladder
5174794|NCT00918008|Bladder|bladder
5174795|NCT00918008|Blood sample|blood sample
5174796|NCT00918008|Lymph Nodes|lymph nodes
5174797|NCT00917995|parastomal hernia|parastomal hernia
5174798|NCT00917995|prophylactic mesh|prophylactic mesh
5174799|NCT00917995|colostomy|colostomy
5174800|NCT00917995|hernia|hernia
5174801|NCT00917956|Lithium|lithium
5174803|NCT00917956|InclusionIBM|inclusionibm
5174804|NCT00917956|Myositis|myositis
5174805|NCT00917943|smoking|smoking
5174806|NCT00917943|pregnancy|pregnancy
5174807|NCT00917943|counseling|counseling
5174808|NCT00917943|prevention|prevention
5174809|NCT00917943|tailored intervention|tailored intervention
5174810|NCT00917943|postpartum|postpartum
5174811|NCT00917943|women|women
5174812|NCT00917943|cessation|cessation
5174813|NCT00917930|exercise training|exercise training
5174814|NCT00917930|functional recovery|functional recovery
5174815|NCT00917930|heart diseases|heart diseases
5174816|NCT00917930|altered glucose metabolism early after an acute cardiac event|altered glucose metabolism early after an acute cardiac event
5174817|NCT00917930|non diabetes CAD patients|non diabetes cad patients
5174818|NCT00917930|glycometabolic state|glycometabolic state
5174819|NCT00917917|Metabolic syndrome|metabolic syndrome
5174820|NCT00917917|exercise training|exercise training
5174821|NCT00917917|abdominal fat mass|abdominal fat mass
5174822|NCT00917917|endothelial function|endothelial function
5174823|NCT00917917|diastolic function|diastolic function
5174824|NCT00917904|HIV Infections|hiv infections
5174825|NCT00917904|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5174826|NCT00917904|Healthy|healthy
5174827|NCT00917904|HIV seronegativity|hiv seronegativity
5174828|NCT00917891|HIV Infections|hiv infections
5174829|NCT00917891|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5174830|NCT00917891|Healthy|healthy
5174831|NCT00917891|HIV seronegativity|hiv seronegativity
5174832|NCT00917878|Milk|milk
5174833|NCT00917878|Postprandial hyperlipidemia|postprandial hyperlipidemia
5174834|NCT00917878|Postprandial inflammation|postprandial inflammation
5174835|NCT00917878|Overweight|overweight
5174836|NCT00917852|aorta|aorta
5174837|NCT00917852|trauma|trauma
5174838|NCT00917852|transection|transection
5174839|NCT00917839|neuroprotection|neuroprotection
5174840|NCT00917839|multiple sclerosis|multiple sclerosis
5174841|NCT00917839|brain atrophy|brain atrophy
5174842|NCT00917839|mr-spectroscopy|mr-spectroscopy
5174843|NCT00917813|HIV|hiv
5174844|NCT00917813|monoclonal antibody|monoclonal antibody
5174845|NCT00917813|KD-247|kd-247
5174846|NCT00917813|treatment naive|treatment naive
5174847|NCT00917800|angiography|angiography
5174848|NCT00917800|exercise testing|exercise testing
5174849|NCT00917800|high frequency ECG|high frequency ecg
5174850|NCT00917800|coronary artery disease|coronary artery disease
5174851|NCT00917787|Asthma|asthma
5174852|NCT00917774|gender specific knee|gender specific knee
5174853|NCT00917774|osteoarthritis|osteoarthritis
5174854|NCT00917774|total knee arthroplasty|total knee arthroplasty
5174855|NCT00917761|Hepatitis B, chronic|hepatitis b, chronic
5174856|NCT00917761|Peginterferon alfa-2a|peginterferon alfa-2a
5174857|NCT00917761|Entecavir|entecavir
5174858|NCT00917735|Green tea|green tea
5174859|NCT00917735|Breast cancer|breast cancer
5174860|NCT00917735|Prevention|prevention
5174861|NCT00917735|COMT genotype|comt genotype
5174862|NCT00917735|EGCG (Epigallocatechin gallate)|egcg (epigallocatechin gallate)
5174863|NCT00917735|Mammographic density|mammographic density
5174864|NCT00917735|Reproductive hormones|reproductive hormones
5174865|NCT00917735|IGF axis proteins|igf axis proteins
5174866|NCT00917735|Oxidative stress|oxidative stress
5174867|NCT00917722|Parkinson's Disease|parkinson's disease
5174868|NCT00917722|STN DBS|stn dbs
5174869|NCT00917722|Deep Brain Stimulation|deep brain stimulation
5174870|NCT00917709|dementia with Lewy bodies|dementia with lewy bodies
5174871|NCT00917709|imaging|imaging
5174872|NCT00917709|acetylcholine|acetylcholine
5174873|NCT00917709|dopamine|dopamine
5174874|NCT00917709|IBVM|ibvm
5174875|NCT00917709|DATSCAN|datscan
5174876|NCT00917670|trabecular meshwork|trabecular meshwork
5174877|NCT00917670|electron microscopy|electron microscopy
5174878|NCT00917657|photorefractive keratectomy|photorefractive keratectomy
5174879|NCT00917657|hyperopia|hyperopia
5174880|NCT00917657|radial keratotomy|radial keratotomy
5174881|NCT00917657|refractive surgery|refractive surgery
5174882|NCT00917644|Bioqeuivalence, Pharmacokinetics, Atorvastatin|bioqeuivalence, pharmacokinetics, atorvastatin
5174883|NCT00917631|Co-bedding|co-bedding
5174884|NCT00917631|Procedural pain|procedural pain
5174885|NCT00917631|Twin|twin
5174886|NCT00917631|Comfort|comfort
5174887|NCT00917631|RCT|rct
5174888|NCT00917618|osteoarthritis|osteoarthritis
5174890|NCT00917618|exercise|exercise
5174891|NCT00917618|cycling|cycling
5174892|NCT00917592|Diverticulitis|diverticulitis
5174893|NCT00917579|Bioequivalence, pharmacokinetics, atorvastatin|bioequivalence, pharmacokinetics, atorvastatin
5174894|NCT00917566|Airtraq|airtraq
5174895|NCT00917566|Pediatric|pediatric
5174896|NCT00917553|diabetic retinopathy|diabetic retinopathy
5174897|NCT00917553|diabetes|diabetes
5174898|NCT00917553|diabetic eye studies|diabetic eye studies
5174899|NCT00917527|Subjects with family history of coronary heart disease|subjects with family history of coronary heart disease
5174900|NCT00917514|Dosing Tool|dosing tool
5174901|NCT00917514|Compliance|compliance
5174902|NCT00917514|User Friendly|user friendly
5174903|NCT00917514|Crohn's Disease|crohn's disease
5174904|NCT00917514|Ulcerative Colitis|ulcerative colitis
5174905|NCT00917501|Mania|mania
5174906|NCT00917501|Adolescents at risk for Mania|adolescents at risk for mania
5174907|NCT00917488|Allergen extract Standardization|allergen extract standardization
5174908|NCT00917475|preterm infants|preterm infants
5174909|NCT00917462|ESOPHAGUS|esophagus
5174910|NCT00917462|BAY 43-9006 (SORAFENIB)|bay 43-9006 (sorafenib)
5174911|NCT00917462|09-016|09-016
5174912|NCT00917462|Nexavar®.|nexavar®.
5174913|NCT00917449|Metabolic Syndrome|metabolic syndrome
5174914|NCT00917449|Impaired glucose tolerance|impaired glucose tolerance
5174915|NCT00917449|Type 2 diabetes mellitus|type 2 diabetes mellitus
5174916|NCT00917449|Endothelial dysfunction|endothelial dysfunction
5174917|NCT00917449|L-arginine|l-arginine
5174918|NCT00917449|Insulin resistance|insulin resistance
5174919|NCT00917423|Anorexia Nervosa|anorexia nervosa
5174920|NCT00917423|Exercise|exercise
5174921|NCT00917423|Physical Activity|physical activity
5174922|NCT00917397|Traumatized refugee|traumatized refugee
5174923|NCT00917397|treatment|treatment
5174924|NCT00917397|antidepressants|antidepressants
5174925|NCT00917397|psychotherapy|psychotherapy
5174926|NCT00917397|PTSD in traumatized refugees|ptsd in traumatized refugees
5174927|NCT00917384|IMC-1121B|imc-1121b
5174928|NCT00917384|Monoclonal antibody (MAb)|monoclonal antibody (mab)
5174929|NCT00917384|Vascular endothelial growth factor (VEGF)|vascular endothelial growth factor (vegf)
5174930|NCT00917384|Human vascular endothelial growth factor receptor-2 (VEGFR-2)|human vascular endothelial growth factor receptor-2 (vegfr-2)
5174931|NCT00917384|Platinum resistant|platinum resistant
5174932|NCT00917384|platinum refractory|platinum refractory
5174933|NCT00917384|Gastric|gastric
5174934|NCT00917384|Gastroesophageal Junction Adenocarcinoma|gastroesophageal junction adenocarcinoma
5174935|NCT00917384|metastatic|metastatic
5174936|NCT00917384|Angiogenesis|angiogenesis
5174937|NCT00917371|adults with attention-deficit hyperactivity disorder|adults with attention-deficit hyperactivity disorder
5174938|NCT00917371|atomoxetine|atomoxetine
5174939|NCT00917371|neuropsychological functioning|neuropsychological functioning
5174940|NCT00917371|brain imaging studies|brain imaging studies
5174941|NCT00917358|Hepatitis C|hepatitis c
5174942|NCT00917358|Dialysis|dialysis
5174943|NCT00917358|Interferon|interferon
5174944|NCT00917345|ARC|arc
5174945|NCT00917345|PRA|pra
5174946|NCT00917345|primary aldosteronism|primary aldosteronism
5174947|NCT00917345|captopril test|captopril test
5174948|NCT00917345|aldosterone-renin ratio|aldosterone-renin ratio
5174949|NCT00917345|Primary aldosteronism (PA) than PRA and establish thresholds for the diagnosis using ARC.|primary aldosteronism (pa) than pra and establish thresholds for the diagnosis using arc.
5174950|NCT00917332|pain|pain
5174951|NCT00917332|childbirth|childbirth
5174952|NCT00917332|relaxation|relaxation
5174953|NCT00917332|guided imagery|guided imagery
5174954|NCT00917332|VAS|vas
5174955|NCT00917332|epidural|epidural
5174956|NCT00917306|Peplin|peplin
5174957|NCT00917306|Actinic keratosis|actinic keratosis
5174958|NCT00917306|PEP005|pep005
5174959|NCT00917293|Tardive Dyskinesia|tardive dyskinesia
5174960|NCT00917293|Schizophrenia|schizophrenia
5174961|NCT00917293|Pyridoxal 5'-phosphate|pyridoxal 5'-phosphate
5174962|NCT00917280|Parkinson's Disease|parkinson's disease
5174963|NCT00917267|diabetes|diabetes
5174964|NCT00917267|exenatide|exenatide
5174965|NCT00917267|once weekly|once weekly
5174966|NCT00917267|Byetta|byetta
5174967|NCT00917267|Amylin|amylin
5174968|NCT00917267|Lilly|lilly
5174969|NCT00917254|YM150|ym150
5174970|NCT00917254|Thrombosis|thrombosis
5174971|NCT00917254|VTE|vte
5174972|NCT00917254|Knee Replacement|knee replacement
5174973|NCT00917254|Anticoagulant|anticoagulant
5174974|NCT00917254|FXa inhibitor|fxa inhibitor
5174975|NCT00917241|Graves' disease|graves' disease
5174976|NCT00917241|dexamethasone|dexamethasone
5174977|NCT00917241|relapse|relapse
5174978|NCT00917241|methimazole|methimazole
5174979|NCT00917215|Asthma|asthma
5174980|NCT00917215|Acupuncture|acupuncture
5174981|NCT00917215|Pulmonary function|pulmonary function
5174982|NCT00917215|Quality of life|quality of life
5174983|NCT00917189|VCFS|vcfs
5174984|NCT00917189|Chromosome 22q Deletion Syndrome|chromosome 22q deletion syndrome
5174985|NCT00917189|Learning Disorders|learning disorders
5174986|NCT00917163|coronary artery disease|coronary artery disease
5174987|NCT00917163|restenosis|restenosis
5174988|NCT00917163|stent thrombosis|stent thrombosis
5174989|NCT00917163|coronary stents|coronary stents
5174990|NCT00917163|angioplasty|angioplasty
5174991|NCT00917163|drug eluting stents|drug eluting stents
5174992|NCT00917150|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
5174993|NCT00917150|COPD|copd
5174994|NCT00917150|emphysema|emphysema
5174995|NCT00917137|Lung cancer|lung cancer
5174996|NCT00917137|Lung nodule|lung nodule
5174997|NCT00917137|Transbronchial needle aspiration|transbronchial needle aspiration
5174998|NCT00917137|Transbronchial lung biopsy|transbronchial lung biopsy
5174999|NCT00917137|Bronchoscopy|bronchoscopy
5175000|NCT00917124|cerebral oximetry|cerebral oximetry
5175001|NCT00917124|NIRS|nirs
5175002|NCT00917124|INVOS|invos
5175003|NCT00917111|Randomized|randomized
5175004|NCT00917111|Double-Blind|double-blind
5175005|NCT00917111|Multi-Center|multi-center
5175006|NCT00917111|Placebo-Controlled|placebo-controlled
5175007|NCT00917111|Phase II|phase ii
5175008|NCT00917111|Nasal Carbon Dioxide|nasal carbon dioxide
5175009|NCT00917111|Carbon Dioxide|carbon dioxide
5175010|NCT00917111|Efficacy|efficacy
5175011|NCT00917111|Safety|safety
5175012|NCT00917111|Total Nasal Symptom Score|total nasal symptom score
5175013|NCT00917098|Behavior Therapy|behavior therapy
5175014|NCT00917098|Supportive Counseling|supportive counseling
5175015|NCT00917098|Child|child
5175016|NCT00917098|Adolescent|adolescent
5175017|NCT00917098|Hair Pulling|hair pulling
5175018|NCT00917098|CBT|cbt
5175019|NCT00917085|Preterm infant|preterm infant
5175020|NCT00917085|Skin-to-skin contact|skin-to-skin contact
5175021|NCT00917085|kangaroo care|kangaroo care
5175022|NCT00917085|temperature|temperature
5175023|NCT00917085|behavioral state|behavioral state
5175024|NCT00917072|Clinical Handoff|clinical handoff
5175025|NCT00917072|Medical Education|medical education
5175026|NCT00917072|Simulation|simulation
5175027|NCT00917072|Residency and Internship|residency and internship
5175028|NCT00917059|Major Depressive Disorder|major depressive disorder
5175029|NCT00917059|SSRI|ssri
5175030|NCT00917059|EEG|eeg
5175031|NCT00917046|All-cause heart failure patients|all-cause heart failure patients
5175032|NCT00917046|coronary artery disease etiology|coronary artery disease etiology
5175033|NCT00917046|dilated cardiomyopathy etiology|dilated cardiomyopathy etiology
5175034|NCT00917020|Randomized|randomized
5175035|NCT00917020|Double-Blind|double-blind
5175036|NCT00917020|Multi-Center|multi-center
5175037|NCT00917020|Phase II|phase ii
5175038|NCT00917020|Nasal Carbon Dioxide|nasal carbon dioxide
5175039|NCT00917020|Carbon Dioxide|carbon dioxide
5175040|NCT00917020|Efficacy|efficacy
5175041|NCT00917020|Safety|safety
5175042|NCT00917020|Total Nasal Symptom Score|total nasal symptom score
5175043|NCT00917007|ABO incompatibility|abo incompatibility
5175044|NCT00917007|hemolysis|hemolysis
5175045|NCT00917007|jaundice|jaundice
5175046|NCT00917007|hyperbilirubinemia|hyperbilirubinemia
5175047|NCT00917007|newborn|newborn
5175048|NCT00916994|Rotator Cuff Tear|rotator cuff tear
5175049|NCT00916981|pseudarthrosis|pseudarthrosis
5175050|NCT00916981|Treatment|treatment
5175051|NCT00916981|osteoblast grafting|osteoblast grafting
5175052|NCT00916981|cell therapy|cell therapy
5175053|NCT00916981|nonunion|nonunion
5175054|NCT00916968|Gender specific|gender specific
5175055|NCT00916968|cruciate retaining|cruciate retaining
5175056|NCT00916968|total knee arthroplasty|total knee arthroplasty
5175057|NCT00916968|Bilateral Osteoarthritis of the knee joint|bilateral osteoarthritis of the knee joint
5175058|NCT00916955|22q11.2 deletion syndrome|22q11.2 deletion syndrome
5175059|NCT00916955|velo-cardio-facial syndrome|velo-cardio-facial syndrome
5175060|NCT00916955|congenital anomalies|congenital anomalies
5175061|NCT00916955|mental illness|mental illness
5175062|NCT00916955|congenital heart disease|congenital heart disease
5175063|NCT00916942|Tolerability study|tolerability study
5175064|NCT00916916|Acromegaly|acromegaly
5175065|NCT00916916|Lanreotide|lanreotide
5175066|NCT00916903|Talus|talus
5175067|NCT00916903|Neuroserpin|neuroserpin
5175068|NCT00916903|mental retardation|mental retardation
5175069|NCT00916903|epilepsy|epilepsy
5175070|NCT00916903|FENIB|fenib
5175071|NCT00916903|XLMR|xlmr
5175072|NCT00916890|Opioid pharmacogenetics|opioid pharmacogenetics
5175073|NCT00916890|Opioid pharmacokinetic|opioid pharmacokinetic
5175074|NCT00916890|Long-term opioid treatment|long-term opioid treatment
5175075|NCT00916890|Cancer pain|cancer pain
5175076|NCT00916877|Prophylactic Cranial Irradiation|prophylactic cranial irradiation
5175077|NCT00916877|Her-2-positive met breast cancer|her-2-positive met breast cancer
5175078|NCT00916851|attention-deficit hyperactivity disorder|attention-deficit hyperactivity disorder
5175079|NCT00916851|autism spectrum disorders|autism spectrum disorders
5175080|NCT00916851|normally developing children and adolescents|normally developing children and adolescents
5175081|NCT00916851|cognitive functions|cognitive functions
5175082|NCT00916851|emotion/behaviors|emotion/behaviors
5175083|NCT00916851|brain imaging|brain imaging
5175084|NCT00916851|genotypes|genotypes
5175085|NCT00916838|Type 1 Diabetes Mellitis|type 1 diabetes mellitis
5175087|NCT00916825|breast cancer|breast cancer
5175088|NCT00916825|quality of life|quality of life
5175089|NCT00916825|children of somatically ill parents|children of somatically ill parents
5175090|NCT00916825|psychological adaptation|psychological adaptation
5175091|NCT00916812|Difficult intubation|difficult intubation
5175092|NCT00916812|Hyomental distance|hyomental distance
5175093|NCT00916812|Obstetric|obstetric
5175094|NCT00916812|Mallampati classification|mallampati classification
5175095|NCT00916812|Thyromental distance|thyromental distance
5175096|NCT00916812|Sternomental distance|sternomental distance
5175097|NCT00916799|telehealth|telehealth
5175098|NCT00916799|oximetry|oximetry
5175099|NCT00916799|copd|copd
5175100|NCT00916786|Attention-deficit/hyperactivity disorder|attention-deficit/hyperactivity disorder
5175101|NCT00916786|pharmacogenetics|pharmacogenetics
5175102|NCT00916786|molecular genetics|molecular genetics
5175103|NCT00916786|medication response|medication response
5175104|NCT00916773|Obstructive sleep apnea|obstructive sleep apnea
5175105|NCT00916773|Airway inflammation|airway inflammation
5175106|NCT00916773|Exercise-induced bronchoconstriction|exercise-induced bronchoconstriction
5175107|NCT00916773|Continuous positive airway pressure|continuous positive airway pressure
5175108|NCT00916760|allergic, rhinoconjunctivitis, Immunotherapy|allergic, rhinoconjunctivitis, immunotherapy
5175109|NCT00916747|Progeria|progeria
5175110|NCT00916734|McKenzie|mckenzie
5175111|NCT00916734|thrust manipulation|thrust manipulation
5175112|NCT00916734|clinical prediction rule|clinical prediction rule
5175113|NCT00916721|Smoking cessation|smoking cessation
5175114|NCT00916721|propranolol|propranolol
5175115|NCT00916721|memory reconsolidation blockade|memory reconsolidation blockade
5175116|NCT00916721|craving|craving
5175117|NCT00916708|endometrial cancer|endometrial cancer
5175118|NCT00916708|follow up|follow up
5175119|NCT00916708|relapse|relapse
5175120|NCT00916695|Stents|stents
5175121|NCT00916695|Angioplasty|angioplasty
5175122|NCT00916695|Coronary Artery Disease|coronary artery disease
5175123|NCT00916695|Bifurcation Coronary Lesions|bifurcation coronary lesions
5175124|NCT00916669|SCLC|sclc
5175125|NCT00916669|enoxaparin sodium|enoxaparin sodium
5175126|NCT00916669|cisplatin|cisplatin
5175127|NCT00916669|etoposide|etoposide
5175128|NCT00916656|Congenital fibrinogen deficiency|congenital fibrinogen deficiency
5175129|NCT00916643|Hypercholesterolemia|hypercholesterolemia
5175130|NCT00916643|FH|fh
5175131|NCT00916643|LDL-C|ldl-c
5175132|NCT00916643|CHD|chd
5175133|NCT00916630|recurrent|recurrent
5175134|NCT00916630|alimta|alimta
5175135|NCT00916630|pemetrexed|pemetrexed
5175136|NCT00916630|CNS lymphoma|cns lymphoma
5175137|NCT00916630|Primary CNS lymphoma|primary cns lymphoma
5175138|NCT00916630|Metastatic lymphoma to brain|metastatic lymphoma to brain
5175139|NCT00916617|open-label|open-label
5175140|NCT00916617|safety|safety
5175141|NCT00916617|antibody|antibody
5175142|NCT00916604|AZD1656|azd1656
5175143|NCT00916604|Safety|safety
5175144|NCT00916604|Pharmacokinetics|pharmacokinetics
5175145|NCT00916604|Pharmacodynamic|pharmacodynamic
5175146|NCT00916604|Multiple ascending doses|multiple ascending doses
5175147|NCT00916604|Japanese|japanese
5175148|NCT00916604|T2DM|t2dm
5175149|NCT00916591|gastroesophageal reflux|gastroesophageal reflux
5175150|NCT00916591|respiratory aspiration|respiratory aspiration
5175151|NCT00916578|Advanced Inflammatory Breast Cancer|advanced inflammatory breast cancer
5175152|NCT00916578|Non-Inflammatory Breast Cancer|non-inflammatory breast cancer
5175153|NCT00916578|Capecitabine|capecitabine
5175154|NCT00916578|Xeloda|xeloda
5175155|NCT00916578|Concomitant Radiation|concomitant radiation
5175156|NCT00916578|Radiation Therapy|radiation therapy
5175157|NCT00916578|Radiotherapy|radiotherapy
5175158|NCT00916578|Women|women
5175159|NCT00916565|optimize nutritional content of infant formula|optimize nutritional content of infant formula
5175160|NCT00916565|Infant|infant
5175161|NCT00916552|Erythropoietin|erythropoietin
5175162|NCT00916552|Epo|epo
5175163|NCT00916552|depression|depression
5175164|NCT00916552|bipolar disorder|bipolar disorder
5175165|NCT00916552|cognition|cognition
5175166|NCT00916552|cognitive function|cognitive function
5175167|NCT00916552|antidepressant|antidepressant
5175168|NCT00916526|Chronic cough|chronic cough
5175169|NCT00916526|Inhaled corticosteroid treatment|inhaled corticosteroid treatment
5175170|NCT00916526|Bronchial provocation test with mannitol|bronchial provocation test with mannitol
5175171|NCT00916526|Methacholine|methacholine
5175172|NCT00916513|Diabetes|diabetes
5175173|NCT00916513|Treatment Satisfaction|treatment satisfaction
5175174|NCT00916513|Quality of Life|quality of life
5175175|NCT00916513|HbA1c levels and goals|hba1c levels and goals
5175176|NCT00916513|Healthcare resources consumption|healthcare resources consumption
5175177|NCT00916500|CERVICAL CANCER, CONCURRENT CHEMORADIATION, CISPLATIN|cervical cancer, concurrent chemoradiation, cisplatin
5175178|NCT00916461|First episode psychosis|first episode psychosis
5175179|NCT00916461|Schizophrenia|schizophrenia
5175180|NCT00916461|Minocycline|minocycline
5175181|NCT00916461|neuroprotection|neuroprotection
5175182|NCT00916461|First episode non affective psychosis|first episode non affective psychosis
5175183|NCT00916461|With in first five years of illness|with in first five years of illness
5175184|NCT00916448|Endotoxin|endotoxin
5175185|NCT00916448|Bilirubin|bilirubin
5175186|NCT00916448|Inflammation|inflammation
5175187|NCT00916448|Sepsis|sepsis
5175188|NCT00916448|Multi organ dysfunction syndrome|multi organ dysfunction syndrome
5175189|NCT00916448|Oxidative Stress|oxidative stress
5175190|NCT00916448|Heme oxygenase|heme oxygenase
5175191|NCT00916435|Arrhythmia|arrhythmia
5175192|NCT00916435|Cardiac Arrest|cardiac arrest
5175193|NCT00916435|Cardiomyopathy|cardiomyopathy
5175194|NCT00916435|Heart Failure|heart failure
5175195|NCT00916422|Immunotherapy|immunotherapy
5175196|NCT00916422|Allergoid|allergoid
5175197|NCT00916422|Depigmented|depigmented
5175198|NCT00916422|Polymerized|polymerized
5175199|NCT00916422|Allergen-extract|allergen-extract
5175200|NCT00916422|Rhinoconjunctivitis|rhinoconjunctivitis
5175201|NCT00916409|Glioblastoma Multiforme|glioblastoma multiforme
5175202|NCT00916409|Glioblastoma|glioblastoma
5175204|NCT00916409|Brain tumor|brain tumor
5175205|NCT00916409|Treatment|treatment
5175206|NCT00916409|Minimal toxicity|minimal toxicity
5175207|NCT00916409|Newly Diagnosed|newly diagnosed
5175208|NCT00916409|TTFields|ttfields
5175209|NCT00916409|Tumor Treating Fields|tumor treating fields
5175210|NCT00916409|NovoCure|novocure
5175211|NCT00916383|Skin Irritation|skin irritation
5175212|NCT00916383|Donepezil Transdermal Patch System|donepezil transdermal patch system
5175213|NCT00916383|Elderly|elderly
5175214|NCT00916383|Alzheimer's subjects|alzheimer's subjects
5175215|NCT00916383|Skin Irritation in elderly Alzheimer's subjects|skin irritation in elderly alzheimer's subjects
5175216|NCT00916370|drug eluting stents|drug eluting stents
5175217|NCT00916370|stents|stents
5175218|NCT00916370|Angioplasty|angioplasty
5175219|NCT00916370|myocardial ischemia|myocardial ischemia
5175220|NCT00916370|coronary artery stenosis|coronary artery stenosis
5175221|NCT00916370|Coronary Disease|coronary disease
5175222|NCT00916370|Coronary Artery Disease|coronary artery disease
5175223|NCT00916370|Coronary Restenosis|coronary restenosis
5175224|NCT00916370|Long lesion|long lesion
5175225|NCT00916357|recombinant human hyaluronidase PH20 (rHuPH20)|recombinant human hyaluronidase ph20 (rhuph20)
5175226|NCT00916357|Insulin lispro|insulin lispro
5175227|NCT00916357|Regular human insulin|regular human insulin
5175228|NCT00916331|total knee replacement arthroplasty|total knee replacement arthroplasty
5175229|NCT00916331|subcutaneous indwelling|subcutaneous indwelling
5175230|NCT00916331|blood loss|blood loss
5175231|NCT00916331|complications|complications
5175232|NCT00916331|functional status|functional status
5175233|NCT00916305|deafness noise tinnitus hearingloss|deafness noise tinnitus hearingloss
5175234|NCT00916292|Diabetes|diabetes
5175235|NCT00916292|dermal ulcers|dermal ulcers
5175236|NCT00916279|Bare Metal In-Stent Restenosis|bare metal in-stent restenosis
5175237|NCT00916279|Paclitaxel Coated Balloon Catheter|paclitaxel coated balloon catheter
5175238|NCT00916279|Drug Coated Balloon|drug coated balloon
5175239|NCT00916279|Coronary Artery Disease|coronary artery disease
5175240|NCT00916266|Seizure frequency|seizure frequency
5175241|NCT00916266|Hippocampal volume|hippocampal volume
5175242|NCT00916266|Adverse effects|adverse effects
5175243|NCT00916253|Sleep|sleep
5175244|NCT00916253|real driving|real driving
5175245|NCT00916253|simulated driving|simulated driving
5175246|NCT00916253|MWT|mwt
5175247|NCT00916240|Adolescents|adolescents
5175248|NCT00916240|African American|african american
5175249|NCT00916227|Low or Intermediate-1 Risk Myelodysplastic Syndrome|low or intermediate-1 risk myelodysplastic syndrome
5175250|NCT00916201|schizophrenia|schizophrenia
5175251|NCT00916188|Black Tea|black tea
5175252|NCT00916188|Oxidative Stress|oxidative stress
5175253|NCT00916188|Blood Lipids|blood lipids
5175254|NCT00916188|Insulin Sensitivity|insulin sensitivity
5175255|NCT00916175|hyperglycemia|hyperglycemia
5175256|NCT00916175|overweight|overweight
5175257|NCT00916175|functional food|functional food
5175258|NCT00916175|aloe vera|aloe vera
5175259|NCT00916175|cnidoscolus chayamansa|cnidoscolus chayamansa
5175260|NCT00916162|aromatase inhibitor|aromatase inhibitor
5175261|NCT00916149|Epilepsy|epilepsy
5175262|NCT00916149|Cognition|cognition
5175263|NCT00916149|Lamictal|lamictal
5175264|NCT00916149|Lamotrigine|lamotrigine
5175265|NCT00916149|Keppra|keppra
5175266|NCT00916149|Levetiracetam|levetiracetam
5175267|NCT00916136|Pre-operative Traction|pre-operative traction
5175268|NCT00916136|Traction|traction
5175269|NCT00916136|Proximal Femur Fracture|proximal femur fracture
5175270|NCT00916136|Femoral Fractures|femoral fractures
5175271|NCT00916136|Femoral Fracture|femoral fracture
5175272|NCT00916136|Skeletal Traction|skeletal traction
5175273|NCT00916136|Cutaneous Traction|cutaneous traction
5175274|NCT00916123|castrate-resistant prostate cancer|castrate-resistant prostate cancer
5175275|NCT00916123|CRPC|crpc
5175276|NCT00916110|healthy subjects|healthy subjects
5175277|NCT00916071|Bulimia Nervosa|bulimia nervosa
5175278|NCT00916071|Eating Disorder NOS|eating disorder nos
5175279|NCT00916071|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
5175280|NCT00916071|ADHD|adhd
5175281|NCT00916058|Multiple Myeloma|multiple myeloma
5175282|NCT00916058|Autologous Stem Cell Transplant|autologous stem cell transplant
5175283|NCT00916058|ASCT|asct
5175284|NCT00916058|MM|mm
5175285|NCT00916019|gene expression|gene expression
5175286|NCT00916019|skeletal muscle|skeletal muscle
5175287|NCT00916019|Healthy men|healthy men
5175288|NCT00916006|Peplin|peplin
5175289|NCT00916006|Actinic keratosis|actinic keratosis
5175290|NCT00916006|PEP005|pep005
5175291|NCT00915993|stage IV renal cell cancer|stage iv renal cell cancer
5175292|NCT00915993|recurrent renal cell cancer|recurrent renal cell cancer
5175293|NCT00915980|Meal-test|meal-test
5175294|NCT00915980|reduced OGTT|reduced ogtt
5175295|NCT00915980|gastric bypass surgery and glucose metabolism|gastric bypass surgery and glucose metabolism
5175296|NCT00915980|Glucose metabolism before and after gastric bypass|glucose metabolism before and after gastric bypass
5175297|NCT00915980|Different OGTT|different ogtt
5175298|NCT00915980|New meal- test|new meal- test
5175299|NCT00915967|Infection|infection
5175300|NCT00915967|Vancomycin|vancomycin
5175301|NCT00915967|Neurosurgery|neurosurgery
5175302|NCT00915967|Stimulator|stimulator
5175303|NCT00915967|Pump|pump
5175304|NCT00915967|Deep Brain Stimulation|deep brain stimulation
5175305|NCT00915967|Intrathecal Pump|intrathecal pump
5175306|NCT00915954|Acromegaly|acromegaly
5175307|NCT00915954|Type 2 diabetes mellitus|type 2 diabetes mellitus
5175308|NCT00915954|recombinant human IGF1|recombinant human igf1
5175309|NCT00915954|oral glucose tolerance test|oral glucose tolerance test
5175310|NCT00915915|Female contraception|female contraception
5175311|NCT00915915|Ovulation inhibition|ovulation inhibition
5175312|NCT00915889|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
5175313|NCT00915889|stage IA cervical cancer|stage ia cervical cancer
5175314|NCT00915889|stage IB cervical cancer|stage ib cervical cancer
5175315|NCT00915889|stage IIA cervical cancer|stage iia cervical cancer
5175316|NCT00915889|stage IIB cervical cancer|stage iib cervical cancer
5175317|NCT00915889|stage III cervical cancer|stage iii cervical cancer
5175318|NCT00915889|cancer survivor|cancer survivor
5175319|NCT00915876|chronic kidney disease|chronic kidney disease
5175320|NCT00915876|Vitamin D|vitamin d
5175321|NCT00915863|pancreaticoduodenectomy|pancreaticoduodenectomy
5175322|NCT00915863|pancreatic fistula|pancreatic fistula
5175323|NCT00915863|reconstruction|reconstruction
5175324|NCT00915863|isolated Roux-en-Y|isolated roux-en-y
5175325|NCT00915837|DME|dme
5175326|NCT00915824|Drug therapy|drug therapy
5175327|NCT00915824|Prescribing|prescribing
5175328|NCT00915824|Appropriateness|appropriateness
5175329|NCT00915824|Randomized controlled trial|randomized controlled trial
5175330|NCT00915824|STOPP/START criteria|stopp/start criteria
5175331|NCT00915824|Appropriateness of prescribing in older patients|appropriateness of prescribing in older patients
5175332|NCT00915824|Prescription Drugs|prescription drugs
5175333|NCT00915811|Myelodysplastic Syndromes|myelodysplastic syndromes
5175334|NCT00915811|Leukemia, Myeloid, Acute|leukemia, myeloid, acute
5175335|NCT00915811|Haematopoietic stem cell transplantation|haematopoietic stem cell transplantation
5175336|NCT00915811|Fludarabine|fludarabine
5175337|NCT00915811|Busulphan|busulphan
5175338|NCT00915811|Thymoglobuline|thymoglobuline
5175339|NCT00915759|ProKera|prokera
5175340|NCT00915759|Amniotic membrane|amniotic membrane
5175341|NCT00915759|Photorefractive Keratectomy|photorefractive keratectomy
5175342|NCT00915759|PRK|prk
5175343|NCT00915759|time to re-epithelialization|time to re-epithelialization
5175344|NCT00915746|Phase I|phase i
5175345|NCT00915746|ketoconazole|ketoconazole
5175346|NCT00915746|CYP3A4 inhibitor|cyp3a4 inhibitor
5175347|NCT00915746|drug interaction|drug interaction
5175348|NCT00915746|metabolism|metabolism
5175349|NCT00915746|Healthly Volunteer|healthly volunteer
5175350|NCT00915746|JNJ-31001074|jnj-31001074
5175351|NCT00915733|acute myocardial infarction|acute myocardial infarction
5175352|NCT00915733|inhibition of platelet aggregation|inhibition of platelet aggregation
5175353|NCT00915733|triple antiplatelet therapy|triple antiplatelet therapy
5175354|NCT00915733|high maintenance-dose clopidogrel.|high maintenance-dose clopidogrel.
5175355|NCT00915733|CYP2C19 polymorphism|cyp2c19 polymorphism
5175356|NCT00915733|High posttreatment platelet reactivity|high posttreatment platelet reactivity
5175357|NCT00915733|Platelet Aggregation Inhibitors|platelet aggregation inhibitors
5175358|NCT00915733|CYP2C19, human|cyp2c19, human
5175359|NCT00915720|Atrial Fibrillation|atrial fibrillation
5175360|NCT00915720|Surgical Ablation|surgical ablation
5175361|NCT00915720|Implanted loop recorder|implanted loop recorder
5175362|NCT00915720|Atrial Fibrillation Ablation|atrial fibrillation ablation
5175363|NCT00915707|obesity|obesity
5175364|NCT00915707|diabetes, risk|diabetes, risk
5175365|NCT00915707|obesity, diabetes risk related to sleep|obesity, diabetes risk related to sleep
5175366|NCT00915694|adult giant cell glioblastoma|adult giant cell glioblastoma
5175367|NCT00915694|adult gliosarcoma|adult gliosarcoma
5175368|NCT00915694|adult glioblastoma|adult glioblastoma
5175369|NCT00915681|amatoxin|amatoxin
5175370|NCT00915681|amanita|amanita
5175371|NCT00915681|mushroom poisoning|mushroom poisoning
5175372|NCT00915681|hepatic failure|hepatic failure
5175373|NCT00915681|milk thistle|milk thistle
5175374|NCT00915681|Silibinin|silibinin
5175375|NCT00915681|Legalon|legalon
5175376|NCT00915668|Healthy women|healthy women
5175377|NCT00915668|Non-childbearing potential|non-childbearing potential
5175378|NCT00915668|Drug-drug interaction|drug-drug interaction
5175379|NCT00915668|Oral contraceptive|oral contraceptive
5175380|NCT00915668|OC|oc
5175381|NCT00915668|Ovral-L|ovral-l
5175382|NCT00915668|ethinyl estradiol|ethinyl estradiol
5175383|NCT00915668|EE|ee
5175384|NCT00915668|levonorgestrel|levonorgestrel
5175385|NCT00915668|JNJ-31001074|jnj-31001074
5175386|NCT00915655|HIV Infections|hiv infections
5175387|NCT00915655|TMC114-TiDP29-C230|tmc114-tidp29-c230
5175388|NCT00915655|TMC114-C230|tmc114-c230
5175389|NCT00915655|TMC114|tmc114
5175390|NCT00915655|HIV-1|hiv-1
5175391|NCT00915655|Darunavir|darunavir
5175392|NCT00915655|Ritonavir|ritonavir
5175393|NCT00915655|NRTI|nrti
5175394|NCT00915655|Treatment Naive|treatment naive
5175395|NCT00915642|Obesity|obesity
5175396|NCT00915642|Weight loss rate|weight loss rate
5175397|NCT00915642|Sleep|sleep
5175398|NCT00915642|Vigil|vigil
5175399|NCT00915642|Metabolism|metabolism
5175400|NCT00915642|Actigraphy|actigraphy
5175401|NCT00915642|Normal|normal
5175402|NCT00915603|Metastatic Breast Cancer|metastatic breast cancer
5175403|NCT00915603|Paclitaxel|paclitaxel
5175404|NCT00915603|Bevacizumab|bevacizumab
5175405|NCT00915603|Everolimus|everolimus
5175406|NCT00915577|Multiple Sclerosis|multiple sclerosis
5175407|NCT00915577|interferon beta-1a|interferon beta-1a
5175408|NCT00915577|Avonex|avonex
5175409|NCT00915577|liquid Avonex|liquid avonex
5175410|NCT00915564|Hepatitis C|hepatitis c
5175411|NCT00915564|HCV|hcv
5175412|NCT00915564|Hepatitis C Virus|hepatitis c virus
5175413|NCT00915564|HCV negative|hcv negative
5175414|NCT00915564|Protease inhibitor|protease inhibitor
5175415|NCT00915564|Methadone|methadone
5175416|NCT00915564|TMC435|tmc435
5175417|NCT00915551|Peplin|peplin
5175418|NCT00915551|Actinic keratosis|actinic keratosis
5175419|NCT00915551|PEP005|pep005
5175420|NCT00915538|Asthma|asthma
5175421|NCT00915538|Formoterol|formoterol
5175422|NCT00915538|LABA|laba
5175423|NCT00915538|Symbicort|symbicort
5175424|NCT00915538|Aerochamber|aerochamber
5175425|NCT00915512|Schizophrenia|schizophrenia
5175426|NCT00915512|Paliperidone|paliperidone
5175428|NCT00915486|Diabetic|diabetic
5175429|NCT00915486|ulcer|ulcer
5175430|NCT00915486|topical|topical
5175431|NCT00915486|PDGF|pdgf
5175432|NCT00915486|GSoC|gsoc
5175433|NCT00915460|Multiple Sclerosis|multiple sclerosis
5175434|NCT00915460|Avonex|avonex
5175435|NCT00915460|Interferon beta-1a|interferon beta-1a
5175436|NCT00915460|patients at high risk to develop multiple sclerosis|patients at high risk to develop multiple sclerosis
5175437|NCT00915447|Cat Allergic Rhinitis|cat allergic rhinitis
5175438|NCT00915434|Healthy volunteer|healthy volunteer
5175439|NCT00915434|Phase I|phase i
5175440|NCT00915434|Non-childbearing potential|non-childbearing potential
5175441|NCT00915434|JNJ-31001074|jnj-31001074
5175442|NCT00915434|Food|food
5175443|NCT00915434|Pharmacokinetics|pharmacokinetics
5175444|NCT00915421|cardiac arrest|cardiac arrest
5175445|NCT00915421|therapeutic hypothermia|therapeutic hypothermia
5175446|NCT00915421|Postresuscitative disease|postresuscitative disease
5175447|NCT00915408|Multiple Myeloma|multiple myeloma
5175448|NCT00915408|Cyclophosphamide|cyclophosphamide
5175449|NCT00915408|Dexamethasone|dexamethasone
5175450|NCT00915408|Lenalidomide|lenalidomide
5175451|NCT00915356|AZD1305|azd1305
5175452|NCT00915356|intravenous cardioversion of Atrial Fibrillation|intravenous cardioversion of atrial fibrillation
5175453|NCT00915343|Adrenal insufficiency|adrenal insufficiency
5175454|NCT00915343|Primary adrenal insufficiency|primary adrenal insufficiency
5175455|NCT00915343|Addison's disease|addison's disease
5175456|NCT00915343|Hydrocortisone|hydrocortisone
5175457|NCT00915343|Modified release|modified release
5175458|NCT00915330|Transbronchial needle aspiration|transbronchial needle aspiration
5175459|NCT00915330|Bronchoscopy|bronchoscopy
5175460|NCT00915330|Rapid on-site cytopathologic evaluation|rapid on-site cytopathologic evaluation
5175461|NCT00915330|Mediastinal lymphadenopathy|mediastinal lymphadenopathy
5175462|NCT00915330|Hilar Lymphadenopathy|hilar lymphadenopathy
5175463|NCT00915304|Clinical Decision Support System|clinical decision support system
5175464|NCT00915304|Automatic reminder|automatic reminder
5175465|NCT00915304|Primary care|primary care
5175466|NCT00915304|Evidence-Based Medicine|evidence-based medicine
5175467|NCT00915291|medical education|medical education
5175468|NCT00915291|clinical decisionmaking|clinical decisionmaking
5175469|NCT00915291|pharmaceutical marketing|pharmaceutical marketing
5175470|NCT00915278|Neoplasms|neoplasms
5175471|NCT00915278|monoclonal antibody|monoclonal antibody
5175472|NCT00915278|PF-04605412|pf-04605412
5175473|NCT00915278|advanced metastatic solid tumors|advanced metastatic solid tumors
5175474|NCT00915265|Epidural analgesia|epidural analgesia
5175475|NCT00915265|Continuous preperitoneal analgesia|continuous preperitoneal analgesia
5175476|NCT00915265|Surgery|surgery
5175477|NCT00915265|Open colorectal surgery|open colorectal surgery
5175478|NCT00915265|Fast-track surgery|fast-track surgery
5175479|NCT00915265|ERAS|eras
5175480|NCT00915252|Acute Myeloid Leukemia|acute myeloid leukemia
5175481|NCT00915252|azacitidine|azacitidine
5175482|NCT00915252|elderly|elderly
5175483|NCT00915252|demethylating agent|demethylating agent
5175484|NCT00915252|flt3|flt3
5175485|NCT00915252|AML|aml
5175486|NCT00915239|volunteers|volunteers
5175487|NCT00915226|Optic disk|optic disk
5175488|NCT00915226|Regional blood flow|regional blood flow
5175489|NCT00915226|Autoregulation|autoregulation
5175490|NCT00915213|E. Coli|e. coli
5175491|NCT00915213|Prostate Biopsy|prostate biopsy
5175492|NCT00915200|Diabetic Nephropathies|diabetic nephropathies
5175493|NCT00915200|Proteinuria|proteinuria
5175494|NCT00915200|Renal Insufficiency, Chronic|renal insufficiency, chronic
5175495|NCT00915200|Monocytes|monocytes
5175496|NCT00915200|Oxidative stress|oxidative stress
5175497|NCT00915200|Inflammation|inflammation
5175498|NCT00915200|Antioxidants|antioxidants
5175499|NCT00915200|Glutathione|glutathione
5175500|NCT00915200|Silymarin|silymarin
5175501|NCT00915200|Acetylcysteine|acetylcysteine
5175502|NCT00915200|Dietary Supplements|dietary supplements
5175503|NCT00915200|Complementary Therapies|complementary therapies
5175504|NCT00915187|Vaccination, influenza prevention|vaccination, influenza prevention
5175505|NCT00915174|drug-drug interaction study|drug-drug interaction study
5175506|NCT00915161|ventilation|ventilation
5175507|NCT00915161|oxygenation|oxygenation
5175508|NCT00915148|Prolonged labor|prolonged labor
5175509|NCT00915148|Ultrasound|ultrasound
5175510|NCT00915148|Caeserian section|caeserian section
5175511|NCT00915135|Insomnia|insomnia
5175512|NCT00915135|Sleep Initiation and Maintenance Disorders|sleep initiation and maintenance disorders
5175513|NCT00915135|Drug Therapy|drug therapy
5175514|NCT00915122|IMRT treatment for Prostate cancer patients|imrt treatment for prostate cancer patients
5175515|NCT00915122|Radiation treatment for prostate cancer|radiation treatment for prostate cancer
5175516|NCT00915122|cancer of the prostate|cancer of the prostate
5175517|NCT00915122|Patients with high risk adenocarcinoma of the prostate|patients with high risk adenocarcinoma of the prostate
5175518|NCT00915109|amputees|amputees
5175519|NCT00915109|lower limb|lower limb
5175520|NCT00915096|Follicular Lymphoma|follicular lymphoma
5175521|NCT00915096|PET|pet
5175522|NCT00915096|GELA|gela
5175523|NCT00915070|BQ-123|bq-123
5175524|NCT00915070|Optic Nerve Head Blood Flow|optic nerve head blood flow
5175525|NCT00915070|Intraocular Pressure|intraocular pressure
5175526|NCT00915070|Regional Blood Flow|regional blood flow
5175527|NCT00915070|Ocular Physiology|ocular physiology
5175528|NCT00915070|Optic Disk|optic disk
5175529|NCT00915044|IBD|ibd
5175530|NCT00915031|Robotic prostatectomy|robotic prostatectomy
5175531|NCT00915031|Hypothermia|hypothermia
5175532|NCT00915031|Potency|potency
5175533|NCT00915018|ErbB-2 positive advanced breast cancer|erbb-2 positive advanced breast cancer
5175534|NCT00915018|HKI-272|hki-272
5175535|NCT00915018|Neratinib|neratinib
5175536|NCT00915018|Nerlynx|nerlynx
5175537|NCT00915018|HER2|her2
5175538|NCT00915018|PB-272|pb-272
5175539|NCT00915018|metastatic breast cancer|metastatic breast cancer
5175540|NCT00915005|Locally-advanced non-small-cell lung carcinoma|locally-advanced non-small-cell lung carcinoma
5175541|NCT00915005|NSCLC|nsclc
5175542|NCT00915005|Lung Cancer|lung cancer
5175543|NCT00915005|Image-Guided Adaptive Conformal Photon|image-guided adaptive conformal photon
5175544|NCT00915005|Proton Therapy|proton therapy
5175545|NCT00915005|Chemotherapy|chemotherapy
5175546|NCT00915005|Treatment Related Pneumonitis|treatment related pneumonitis
5175547|NCT00914992|optic disk|optic disk
5175548|NCT00914992|regional blood flow|regional blood flow
5175549|NCT00914992|autoregulation|autoregulation
5175550|NCT00914979|Angiosculpt|angiosculpt
5175551|NCT00914979|Bifurcation Lesion|bifurcation lesion
5175552|NCT00914979|Side branch|side branch
5175553|NCT00914979|IVUS|ivus
5175554|NCT00914953|social isolation|social isolation
5175555|NCT00914953|cooperative behavior|cooperative behavior
5175556|NCT00914953|depression|depression
5175557|NCT00914953|loneliness|loneliness
5175558|NCT00914953|happiness|happiness
5175559|NCT00914953|empathy|empathy
5175560|NCT00914940|graft versus host disease|graft versus host disease
5175561|NCT00914940|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5175562|NCT00914940|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5175563|NCT00914940|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
5175564|NCT00914940|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5175565|NCT00914940|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5175566|NCT00914940|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5175567|NCT00914940|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5175568|NCT00914940|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5175569|NCT00914940|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5175570|NCT00914940|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5175571|NCT00914940|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5175572|NCT00914940|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
5175573|NCT00914940|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5175574|NCT00914940|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
5175575|NCT00914940|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5175675|NCT00914511|Elderly|elderly
5175576|NCT00914940|refractory anemia with excess blasts|refractory anemia with excess blasts
5175577|NCT00914940|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5175578|NCT00914940|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5175579|NCT00914927|Thrombocytopenia|thrombocytopenia
5175580|NCT00914927|chronic liver disease|chronic liver disease
5175581|NCT00914901|Asthma|asthma
5175582|NCT00914901|Doping|doping
5175583|NCT00914901|Salmeterol|salmeterol
5175584|NCT00914901|Beta-agonist|beta-agonist
5175585|NCT00914901|Urine concentrations|urine concentrations
5175586|NCT00914888|children|children
5175587|NCT00914888|pediatry|pediatry
5175588|NCT00914888|pneumonia|pneumonia
5175589|NCT00914888|intra-abdominal|intra-abdominal
5175590|NCT00914888|infection|infection
5175591|NCT00914875|kidney function tests|kidney function tests
5175592|NCT00914875|anti-inflammatory agents, non-steroidal|anti-inflammatory agents, non-steroidal
5175593|NCT00914875|laparoscopic cholecystectomy|laparoscopic cholecystectomy
5175594|NCT00914875|adult|adult
5175595|NCT00914862|Sleep Initiation and Maintenance Disorders|sleep initiation and maintenance disorders
5175596|NCT00914862|Drug Therapy|drug therapy
5175597|NCT00914836|shoulder|shoulder
5175598|NCT00914836|subacromion|subacromion
5175599|NCT00914836|corticosteroid|corticosteroid
5175600|NCT00914836|bursitis|bursitis
5175601|NCT00914836|tendinitis|tendinitis
5175602|NCT00914836|calcific tendonitis|calcific tendonitis
5175603|NCT00914836|subacromial bursitis|subacromial bursitis
5175604|NCT00914836|rotator cuff tendinitis|rotator cuff tendinitis
5175605|NCT00914810|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
5175606|NCT00914810|Vitamin D|vitamin d
5175607|NCT00914810|Cholecalciferol|cholecalciferol
5175608|NCT00914810|Skeletal muscle|skeletal muscle
5175609|NCT00914797|Asthma|asthma
5175610|NCT00914797|Doping|doping
5175611|NCT00914797|Beta agonist|beta agonist
5175612|NCT00914797|Terbutaline|terbutaline
5175613|NCT00914797|Pharmacokinetics|pharmacokinetics
5175614|NCT00914784|TRALI|trali
5175615|NCT00914784|Transfusion|transfusion
5175616|NCT00914784|dyspnea|dyspnea
5175617|NCT00914784|pulmonary infiltrates|pulmonary infiltrates
5175618|NCT00914771|Pandemic Influenza|pandemic influenza
5175619|NCT00914771|H5N1|h5n1
5175620|NCT00914771|Adults and Elderly|adults and elderly
5175621|NCT00914771|antigen dose|antigen dose
5175622|NCT00914758|multiple sclerosis|multiple sclerosis
5175623|NCT00914758|cognition|cognition
5175624|NCT00914758|cognitive functioning|cognitive functioning
5175625|NCT00914758|Campath|campath
5175626|NCT00914758|Rebif|rebif
5175627|NCT00914758|alemtuzumab|alemtuzumab
5175628|NCT00914758|interferon|interferon
5175629|NCT00914732|IMVAMUNE®, smallpox, vaccine|imvamune®, smallpox, vaccine
5175630|NCT00914719|sexual risk behavior among adolescents|sexual risk behavior among adolescents
5175631|NCT00914719|alcohol and drug use among adolescents|alcohol and drug use among adolescents
5175632|NCT00914706|Diabetes|diabetes
5175633|NCT00914693|Fertility control|fertility control
5175634|NCT00914693|Contraception|contraception
5175635|NCT00914667|Overactive Bladder Urgency Frequency|overactive bladder urgency frequency
5175636|NCT00914654|Asthma|asthma
5175637|NCT00914654|Doping|doping
5175638|NCT00914654|Formoterol|formoterol
5175639|NCT00914654|Urinary concentrations|urinary concentrations
5175640|NCT00914654|Beta-agonists|beta-agonists
5175641|NCT00914641|formulation; sustained release; modified release; extended release|formulation; sustained release; modified release; extended release
5175642|NCT00914628|high risk acute leukemia|high risk acute leukemia
5175643|NCT00914628|HSV-TK|hsv-tk
5175644|NCT00914628|Haploidentical HCT|haploidentical hct
5175645|NCT00914628|GvHD|gvhd
5175647|NCT00914628|Immunoreconstitution|immunoreconstitution
5175648|NCT00914615|Stereotactic Body Radiation Therapy|stereotactic body radiation therapy
5175649|NCT00914615|Liver Metastasis from colorectal cancer|liver metastasis from colorectal cancer
5175650|NCT00914615|Patients with Liver Metastasis|patients with liver metastasis
5175651|NCT00914576|Endotoxin, Escherichia Coli|endotoxin, escherichia coli
5175652|NCT00914576|Retina|retina
5175653|NCT00914576|Regional Blood Flow|regional blood flow
5175654|NCT00914563|Burned shock|burned shock
5175655|NCT00914563|Volume resuscitative patterns|volume resuscitative patterns
5175656|NCT00914563|Non-invasive hemodynamic monitoring|non-invasive hemodynamic monitoring
5175657|NCT00914550|Pneumonia|pneumonia
5175658|NCT00914550|Lung Infiltrates|lung infiltrates
5175659|NCT00914550|Antibiotic discontinuation|antibiotic discontinuation
5175660|NCT00914550|De-escalation therapy|de-escalation therapy
5175661|NCT00914537|Anal Cancer|anal cancer
5175662|NCT00914537|AIN|ain
5175663|NCT00914537|HPV|hpv
5175664|NCT00914537|Cytology|cytology
5175665|NCT00914537|HIV|hiv
5175666|NCT00914537|HIV Positive|hiv positive
5175667|NCT00914524|Chronic Glomerulonephritis|chronic glomerulonephritis
5175668|NCT00914524|Diabetic Nephropathy|diabetic nephropathy
5175669|NCT00914524|Angiotensin II Receptor Blocker|angiotensin ii receptor blocker
5175670|NCT00914524|Urinary Protein|urinary protein
5175671|NCT00914511|Semen|semen
5175672|NCT00914511|Sperm|sperm
5175673|NCT00914511|Avanafil|avanafil
5175674|NCT00914511|Pharmacokinetics|pharmacokinetics
5175676|NCT00914498|Xylocaine|xylocaine
5175677|NCT00914498|Casarean section|casarean section
5175678|NCT00914498|Post operative pain|post operative pain
5175679|NCT00914498|Scar quality|scar quality
5175680|NCT00914472|Preventing the thrombi formation|preventing the thrombi formation
5175681|NCT00914459|hemophilia A|hemophilia a
5175682|NCT00914446|Steatohepatitis|steatohepatitis
5175683|NCT00914433|COPD|copd
5175684|NCT00914420|OCT|oct
5175685|NCT00914420|Reendothelialisation|reendothelialisation
5175686|NCT00914420|Intrepide|intrepide
5175687|NCT00914420|Trapidil|trapidil
5175688|NCT00914420|Taxus|taxus
5175689|NCT00914407|Ocular physiology|ocular physiology
5175690|NCT00914394|L-NG-Monomethyl Arginine|l-ng-monomethyl arginine
5175691|NCT00914394|Optic Nerve Head Blood Flow|optic nerve head blood flow
5175692|NCT00914394|Intraocular Pressure|intraocular pressure
5175693|NCT00914394|Regional Blood Flow|regional blood flow
5175694|NCT00914394|Ocular Physiology|ocular physiology
5175695|NCT00914394|Optic Disk|optic disk
5175696|NCT00914381|Community reinforcement approach|community reinforcement approach
5175697|NCT00914381|Contingency management|contingency management
5175698|NCT00914381|12-step facilitation counseling|12-step facilitation counseling
5175699|NCT00914381|Cocaine dependence|cocaine dependence
5175700|NCT00914381|Women|women
5175701|NCT00914368|Platelet Aggregation Inhibitors|platelet aggregation inhibitors
5175702|NCT00914368|Aspirin|aspirin
5175703|NCT00914368|Clopidogrel|clopidogrel
5175704|NCT00914368|Pathologic Processes|pathologic processes
5175705|NCT00914368|Disease|disease
5175706|NCT00914368|Therapeutic Uses|therapeutic uses
5175707|NCT00914368|Syndrome|syndrome
5175708|NCT00914368|Hematologic Agents|hematologic agents
5175709|NCT00914368|Cardiovascular Diseases|cardiovascular diseases
5175710|NCT00914368|Pharmacologic Actions|pharmacologic actions
5175711|NCT00914355|Hepatocellular Carcinoma|hepatocellular carcinoma
5175712|NCT00914355|Stereotactic Body Radiation|stereotactic body radiation
5175713|NCT00914355|Unresectable liver cancer|unresectable liver cancer
5175714|NCT00914355|Patients with Hepatocellular Carcinoma|patients with hepatocellular carcinoma
5175715|NCT00914342|Gerd|gerd
5175716|NCT00914342|GerdQ questionnaire|gerdq questionnaire
5175717|NCT00914342|work productivity|work productivity
5175718|NCT00914342|Greece|greece
5175719|NCT00914329|stress provoked|stress provoked
5175720|NCT00914329|healthy volunteers|healthy volunteers
5175721|NCT00914329|gelsemium|gelsemium
5175722|NCT00914329|homeopathy|homeopathy
5175723|NCT00914316|Lower leg claudication|lower leg claudication
5175724|NCT00914316|Poor circulation of the leg muscles|poor circulation of the leg muscles
5175725|NCT00914316|Cramping or discomfort in the lower legs|cramping or discomfort in the lower legs
5175726|NCT00914316|Lower leg pain|lower leg pain
5175727|NCT00914316|PAD (Peripheral arterial disease)|pad (peripheral arterial disease)
5175728|NCT00914303|Safety|safety
5175729|NCT00914303|tolerability|tolerability
5175730|NCT00914303|healthy|healthy
5175731|NCT00914303|Healthy volunteer study|healthy volunteer study
5175732|NCT00914277|Rho-kinase inhibitor|rho-kinase inhibitor
5175733|NCT00914277|male impotence|male impotence
5175734|NCT00914264|chronic obstructive airway disease|chronic obstructive airway disease
5175735|NCT00914264|obstructive sleep apnea|obstructive sleep apnea
5175736|NCT00914264|continuous positive airway pressure|continuous positive airway pressure
5175737|NCT00914251|endothelial|endothelial
5175738|NCT00914251|metabolic syndrome|metabolic syndrome
5175739|NCT00914251|hesperidin|hesperidin
5175740|NCT00914238|Randomized clinical trial|randomized clinical trial
5175741|NCT00914238|first episode psychosis of schizophrenia and schizotypal disorder|first episode psychosis of schizophrenia and schizotypal disorder
5175742|NCT00914238|rehabilitation|rehabilitation
5175743|NCT00914238|psychosocial|psychosocial
5175744|NCT00914238|health service research|health service research
5175745|NCT00914238|schizotypal Disorder|schizotypal disorder
5175746|NCT00914225|Human immunodeficiency virus|human immunodeficiency virus
5175747|NCT00914225|malaria|malaria
5175748|NCT00914225|plasmodium falciparum|plasmodium falciparum
5175749|NCT00914225|diarrhea|diarrhea
5175750|NCT00914225|helminth|helminth
5175751|NCT00914225|HIV|hiv
5175752|NCT00914225|Treatment naive|treatment naive
5175753|NCT00914199|PCI|pci
5175754|NCT00914199|Bifurcation lesion|bifurcation lesion
5175755|NCT00914186|Atopic Dermatitis|atopic dermatitis
5175756|NCT00914186|Pruritus|pruritus
5175757|NCT00914160|Anti-inflammatory|anti-inflammatory
5175758|NCT00914147|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5175759|NCT00914134|Parkinson's disease|parkinson's disease
5175760|NCT00914134|Autonomic nervous system|autonomic nervous system
5175761|NCT00914134|Levodopa infusion|levodopa infusion
5175762|NCT00914108|Preterm Infants|preterm infants
5175763|NCT00914108|Developmental Care|developmental care
5175764|NCT00914108|NIDCAP|nidcap
5175765|NCT00914108|Intrauterine Growth Restriction|intrauterine growth restriction
5175766|NCT00914108|APIB|apib
5175767|NCT00914108|EEG|eeg
5175768|NCT00914108|Neurobehavior|neurobehavior
5175769|NCT00914095|Parkinson's disease|parkinson's disease
5175770|NCT00914095|Freezing of Gait|freezing of gait
5175771|NCT00914095|Methylphenidate|methylphenidate
5175969|NCT00913107|Tegretol®|tegretol®
5175772|NCT00914095|Dopamine transporter inhibitor|dopamine transporter inhibitor
5175773|NCT00914095|Noradrenaline|noradrenaline
5175774|NCT00914082|Self hypnosis|self hypnosis
5175775|NCT00914082|Hypnosis|hypnosis
5175776|NCT00914082|mental training|mental training
5175777|NCT00914082|antenatal training|antenatal training
5175778|NCT00914082|pregnancy|pregnancy
5175779|NCT00914082|pain control|pain control
5175780|NCT00914082|Childbirth|childbirth
5175781|NCT00914082|Analgesia|analgesia
5175782|NCT00914043|fatigue|fatigue
5175783|NCT00914043|HER2-negative breast cancer|her2-negative breast cancer
5175784|NCT00914043|stage II breast cancer|stage ii breast cancer
5175785|NCT00914043|stage IIIA breast cancer|stage iiia breast cancer
5175786|NCT00914043|stage IIIB breast cancer|stage iiib breast cancer
5175787|NCT00914030|Visual perception|visual perception
5175788|NCT00914030|Local/global processing|local/global processing
5175789|NCT00914030|Attention|attention
5175790|NCT00914030|Visual priming|visual priming
5175791|NCT00914030|Collinearity|collinearity
5175792|NCT00914030|Grouping|grouping
5175793|NCT00914017|Breast Cancer|breast cancer
5175794|NCT00914017|Breast Cancer Prevention|breast cancer prevention
5175795|NCT00914017|Mammographic Density|mammographic density
5175796|NCT00914017|Breast Density|breast density
5175797|NCT00914017|Breast Cancer Biomarkers|breast cancer biomarkers
5175798|NCT00914004|Antidepressant|antidepressant
5175799|NCT00913991|Nitric Oxide|nitric oxide
5175800|NCT00913978|Normothermia|normothermia
5175801|NCT00913978|Colorectal Surgery|colorectal surgery
5175802|NCT00913978|Bair Huggers|bair huggers
5175803|NCT00913978|VitaHeat|vitaheat
5175804|NCT00913952|Antidepressant|antidepressant
5175805|NCT00913939|Prostate Cancer|prostate cancer
5175806|NCT00913939|HDR Brachytherapy|hdr brachytherapy
5175807|NCT00913939|Prostate Brachytherapy|prostate brachytherapy
5175808|NCT00913926|Climacteric symptoms|climacteric symptoms
5175809|NCT00913913|Renal Cell Carcinoma|renal cell carcinoma
5175810|NCT00913900|Arterial Occlusive Diseases|arterial occlusive diseases
5175811|NCT00913900|Vascular Disease|vascular disease
5175812|NCT00913887|Anti-Inflammatory|anti-inflammatory
5175813|NCT00913861|endoscopy|endoscopy
5175814|NCT00913861|comfort|comfort
5175815|NCT00913861|non-pharmacological|non-pharmacological
5175816|NCT00913848|Treatment of Epilepsy and Bipolar Disorder|treatment of epilepsy and bipolar disorder
5175817|NCT00913835|Liposomal Doxorubicin|liposomal doxorubicin
5175818|NCT00913835|IMC-3G3|imc-3g3
5175819|NCT00913835|3G3|3g3
5175820|NCT00913835|Platinum resistant|platinum resistant
5175821|NCT00913835|Platinum refractory|platinum refractory
5175822|NCT00913835|Ovary|ovary
5175823|NCT00913835|Neoplasm|neoplasm
5175824|NCT00913835|PDGFr|pdgfr
5175825|NCT00913822|Antidepressant|antidepressant
5175826|NCT00913809|Antidepressant|antidepressant
5175827|NCT00913796|Renal transplantation|renal transplantation
5175828|NCT00913796|Metabolic acidosis|metabolic acidosis
5175829|NCT00913796|Physical capacity|physical capacity
5175830|NCT00913796|Bone histology|bone histology
5175831|NCT00913796|Bone histomorphometry|bone histomorphometry
5175832|NCT00913796|Parathyroid function|parathyroid function
5175833|NCT00913796|Calcium and phosphate metabolism|calcium and phosphate metabolism
5175834|NCT00913783|Antidepressant|antidepressant
5175835|NCT00913770|opioid dependence|opioid dependence
5175836|NCT00913770|buprenorphine|buprenorphine
5175837|NCT00913770|brief intervention|brief intervention
5175838|NCT00913757|Hepatocellular Carcinoma|hepatocellular carcinoma
5175839|NCT00913757|Liver Cancer|liver cancer
5175840|NCT00913757|Chronic Liver Disease|chronic liver disease
5175841|NCT00913757|Genome Wide Association Study|genome wide association study
5175842|NCT00913757|Gene Expression Profiling|gene expression profiling
5175843|NCT00913744|AMD|amd
5175844|NCT00913731|Psychotic symptom assessments|psychotic symptom assessments
5175845|NCT00913731|Observational assessments of patients with acute psychotic symptoms|observational assessments of patients with acute psychotic symptoms
5175846|NCT00913705|NATCH|natch
5175847|NCT00913705|LUNG|lung
5175848|NCT00913705|OPERABLE NSCLC|operable nsclc
5175849|NCT00913705|SURGERY PLUS ADJUVANT THERAPY|surgery plus adjuvant therapy
5175850|NCT00913705|SURGERY PLUS NEOADJUVANT THERAPY|surgery plus neoadjuvant therapy
5175851|NCT00913692|Glutamine|glutamine
5175852|NCT00913692|Herpes Labialis|herpes labialis
5175853|NCT00913692|Herpes Simplex Virus|herpes simplex virus
5175854|NCT00913692|Cold Sore|cold sore
5175855|NCT00913679|osteonecrosis|osteonecrosis
5175856|NCT00913679|femoral neck fracture|femoral neck fracture
5175857|NCT00913679|implant fixation|implant fixation
5175858|NCT00913679|implant failure|implant failure
5175859|NCT00913679|periprosthetic bone mineral density|periprosthetic bone mineral density
5175860|NCT00913679|gait function|gait function
5175861|NCT00913679|gait analysis|gait analysis
5175862|NCT00913679|patient recovery|patient recovery
5175863|NCT00913666|Multiple Sclerosis|multiple sclerosis
5175864|NCT00913653|Heart failure|heart failure
5175865|NCT00913653|LCZ696|lcz696
5175866|NCT00913640|Prospective Memory Performance|prospective memory performance
5175867|NCT00913640|Prospective Memory Outcome|prospective memory outcome
5175868|NCT00913640|Parkinson's Disease|parkinson's disease
5175869|NCT00913627|Extended-release|extended-release
5175870|NCT00913627|ibuprofen|ibuprofen
5175871|NCT00913614|insomnia pediatric safety|insomnia pediatric safety
5175872|NCT00913601|Idiopathic Fecal Incontinence|idiopathic fecal incontinence
5175873|NCT00913601|Fecal Incontinence|fecal incontinence
5175874|NCT00913601|Sacral Nerve Stimulation|sacral nerve stimulation
5175875|NCT00913601|Sacral Nerve Neuromodulation|sacral nerve neuromodulation
5175876|NCT00913575|neuromuscular training|neuromuscular training
5175877|NCT00913575|preoperative exercise|preoperative exercise
5175878|NCT00913575|physiotherapy|physiotherapy
5175879|NCT00913575|total knee replacement|total knee replacement
5175880|NCT00913575|knee osteoarthritis|knee osteoarthritis
5175881|NCT00913562|Ocular Physiology|ocular physiology
5175882|NCT00913562|Regional Blood Flow|regional blood flow
5175883|NCT00913549|Antihistamine|antihistamine
5175884|NCT00913536|Bladder Cancer|bladder cancer
5175885|NCT00913536|Cone Beam CT|cone beam ct
5175886|NCT00913536|On-line image guidance|on-line image guidance
5175887|NCT00913536|Radiation therapy in bladder cancer patients|radiation therapy in bladder cancer patients
5175888|NCT00913523|tampons|tampons
5175889|NCT00913523|Glycerol Monolaurate|glycerol monolaurate
5175890|NCT00913523|vaginal microflora|vaginal microflora
5175891|NCT00913523|microbes|microbes
5175892|NCT00913523|Vaginal Tampon|vaginal tampon
5175893|NCT00913497|Type 1 diabetes mellitus in children|type 1 diabetes mellitus in children
5175894|NCT00913497|insulin glulisine|insulin glulisine
5175895|NCT00913497|insulin aspart|insulin aspart
5175896|NCT00913497|post prandial|post prandial
5175897|NCT00913484|Disulfiram|disulfiram
5175898|NCT00913484|Buprenorphine|buprenorphine
5175899|NCT00913484|Cocaine dependence|cocaine dependence
5175900|NCT00913484|Opioid dependence|opioid dependence
5175901|NCT00913484|Dopamine-Beta-Hydroxylase|dopamine-beta-hydroxylase
5175902|NCT00913471|Spinal cord injury|spinal cord injury
5175903|NCT00913471|SCI|sci
5175904|NCT00913471|Neuropathic pain|neuropathic pain
5175905|NCT00913471|Pain|pain
5175906|NCT00913445|Appendicitis|appendicitis
5175907|NCT00913445|appendicectomy|appendicectomy
5175908|NCT00913445|stitches|stitches
5175909|NCT00913445|wound healing|wound healing
5175910|NCT00913445|cosmetic results|cosmetic results
5175911|NCT00913432|rheumatoid arthritis|rheumatoid arthritis
5175912|NCT00913432|methotrexate|methotrexate
5175913|NCT00913432|DMARD|dmard
5175914|NCT00913432|c-kit inhibitor|c-kit inhibitor
5175915|NCT00913419|Antidepressant|antidepressant
5175916|NCT00913406|Effect of lutein fortification growth healthy term infants|effect of lutein fortification growth healthy term infants
5175917|NCT00913367|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
5175918|NCT00913354|infertility|infertility
5175919|NCT00913354|ivf|ivf
5175920|NCT00913354|acupuncture|acupuncture
5175921|NCT00913328|Asthma|asthma
5175922|NCT00913328|Airway responsiveness|airway responsiveness
5175923|NCT00913328|Dose-response plateau|dose-response plateau
5175924|NCT00913328|Montelukast|montelukast
5175925|NCT00913328|Add-on to inhaled corticosteroids|add-on to inhaled corticosteroids
5175926|NCT00913315|prostatitis|prostatitis
5175927|NCT00913315|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists
5175928|NCT00913315|tolterodine|tolterodine
5175929|NCT00913302|Ankylosing Spondylitis|ankylosing spondylitis
5175930|NCT00913302|Education|education
5175931|NCT00913302|Physical fitness|physical fitness
5175932|NCT00913289|Liver Cirrhosis|liver cirrhosis
5175933|NCT00913263|Prostate cancer|prostate cancer
5175934|NCT00913250|Multiple Sclerosis|multiple sclerosis
5175935|NCT00913250|Interferon beta-1a|interferon beta-1a
5175936|NCT00913237|Antidepressant|antidepressant
5175937|NCT00913224|Anti-inflammatory|anti-inflammatory
5175938|NCT00913198|Pancreas|pancreas
5175939|NCT00913198|Advanced adenocarcinoma|advanced adenocarcinoma
5175940|NCT00913198|CP-4126|cp-4126
5175941|NCT00913185|Acne|acne
5175942|NCT00913172|TB|tb
5175943|NCT00913172|cost|cost
5175944|NCT00913172|HEWs|hews
5175945|NCT00913172|Cost-effectiveness|cost-effectiveness
5175946|NCT00913172|treatment success rate|treatment success rate
5175947|NCT00913159|Renal stones|renal stones
5175948|NCT00913159|lithotripsy|lithotripsy
5175949|NCT00913159|stone free rate|stone free rate
5175950|NCT00913146|Management of fever|management of fever
5175951|NCT00913146|Malaria|malaria
5175952|NCT00913146|Malaria rapid diagnostic test|malaria rapid diagnostic test
5175953|NCT00913146|Clinical trial|clinical trial
5175954|NCT00913133|Anticoagulation|anticoagulation
5175955|NCT00913133|Prophylaxis|prophylaxis
5175956|NCT00913133|Desirudin|desirudin
5175957|NCT00913133|Direct thrombin inhibitor|direct thrombin inhibitor
5175958|NCT00913133|Heparin-induced thrombocytopenia|heparin-induced thrombocytopenia
5175959|NCT00913120|YM150|ym150
5175960|NCT00913120|FXa inhibitor|fxa inhibitor
5175961|NCT00913120|Thrombosis|thrombosis
5175962|NCT00913120|Anticoagulant|anticoagulant
5175963|NCT00913120|Venous thromboembolism|venous thromboembolism
5175964|NCT00913120|Arthroplasty, replacement, hip|arthroplasty, replacement, hip
5175965|NCT00913107|Trigeminal Neuralgia|trigeminal neuralgia
5175966|NCT00913107|Lamotrigine|lamotrigine
5175967|NCT00913107|Carbamazepine|carbamazepine
5175968|NCT00913107|Lamictal®|lamictal®
5175970|NCT00913094|Hypertension|hypertension
5175971|NCT00913081|Skin|skin
5175972|NCT00913081|pharmacology|pharmacology
5175973|NCT00913081|metabolism|metabolism
5175974|NCT00913081|lipid|lipid
5175975|NCT00913068|radical prostatectomy|radical prostatectomy
5175976|NCT00913055|S-LAR|s-lar
5175977|NCT00913055|Octreotide|octreotide
5175978|NCT00913055|Implant|implant
5175979|NCT00913042|Febrile neutropenia|febrile neutropenia
5175980|NCT00913042|Blood culture|blood culture
5175981|NCT00913042|Bacteremia|bacteremia
5175982|NCT00913042|Bacterial DNA testing|bacterial dna testing
5175983|NCT00913029|primary open angle glaucoma (POAG)|primary open angle glaucoma (poag)
5175984|NCT00913029|OAG|oag
5175985|NCT00913029|glaucoma|glaucoma
5175986|NCT00913016|hormonal therapy(letrozole)|hormonal therapy(letrozole)
5175987|NCT00913016|postmenopausal breast cancer|postmenopausal breast cancer
5175988|NCT00913016|quality of life|quality of life
5175989|NCT00913003|Lidocaine|lidocaine
5175990|NCT00913003|Mastectomy|mastectomy
5175991|NCT00913003|Pain|pain
5175992|NCT00912990|Pediatric|pediatric
5175993|NCT00912977|Parkinsons disease|parkinsons disease
5175994|NCT00912977|dyskinesia|dyskinesia
5175995|NCT00912977|measurement|measurement
5175996|NCT00912964|Urgency|urgency
5175997|NCT00912964|YM178|ym178
5175998|NCT00912964|Urinary incontinence|urinary incontinence
5175999|NCT00912964|Mirabegron|mirabegron
5176000|NCT00912964|Micturition|micturition
5176001|NCT00912964|Frequency|frequency
5176002|NCT00912964|Urinary urgency incontinence|urinary urgency incontinence
5176003|NCT00912964|Overactive Bladder|overactive bladder
5176004|NCT00912938|metastatic breast cancer|metastatic breast cancer
5176005|NCT00912938|bone remodeling markers|bone remodeling markers
5176006|NCT00912938|zoledronic acid|zoledronic acid
5176007|NCT00912912|Genitourinary|genitourinary
5176008|NCT00912912|Testis|testis
5176009|NCT00912912|Refractory Germ Cell Tumors|refractory germ cell tumors
5176010|NCT00912912|Advanced germ cell tumors|advanced germ cell tumors
5176011|NCT00912912|GCTs|gcts
5176012|NCT00912912|Sunitinib Malate|sunitinib malate
5176013|NCT00912912|Sutent|sutent
5176014|NCT00912912|SU011248|su011248
5176015|NCT00912899|Refractory Multiple Myeloma|refractory multiple myeloma
5176016|NCT00912899|CB3304|cb3304
5176017|NCT00912899|Noscapine HCl|noscapine hcl
5176018|NCT00912899|Multiple Myeloma|multiple myeloma
5176019|NCT00912886|alzheimer|alzheimer
5176020|NCT00912886|memory|memory
5176021|NCT00912886|neurosteroids|neurosteroids
5176022|NCT00912873|pain|pain
5176023|NCT00912873|catheter|catheter
5176024|NCT00912873|nerve block|nerve block
5176025|NCT00912873|UCSD|ucsd
5176026|NCT00912873|range of motion|range of motion
5176027|NCT00912873|hip surgery|hip surgery
5176028|NCT00912873|psoas compartment|psoas compartment
5176029|NCT00912860|multiple sclerosis|multiple sclerosis
5176030|NCT00912860|interferon beta-1a|interferon beta-1a
5176031|NCT00912860|avonex|avonex
5176032|NCT00912847|HBV carriers|hbv carriers
5176033|NCT00912834|hematuria|hematuria
5176034|NCT00912834|urinary tract infection|urinary tract infection
5176035|NCT00912821|Renal Replacement Therapy|renal replacement therapy
5176036|NCT00912821|Peritoneal dialysis|peritoneal dialysis
5176037|NCT00912808|parkinsons disease|parkinsons disease
5176038|NCT00912808|falling|falling
5176039|NCT00912795|Smoking Cessation|smoking cessation
5176040|NCT00912795|technology|technology
5176041|NCT00912795|developing countries|developing countries
5176042|NCT00912782|ESRD|esrd
5176043|NCT00912782|Vitamin D|vitamin d
5176044|NCT00912782|Arteriovenous Fistulae|arteriovenous fistulae
5176045|NCT00912782|Dialysis Vascular Access|dialysis vascular access
5176046|NCT00912769|Total knee replacement|total knee replacement
5176047|NCT00912769|Subvastus|subvastus
5176048|NCT00912769|Midvastus|midvastus
5176049|NCT00912769|Isokinetic|isokinetic
5176050|NCT00912769|Quadriceps|quadriceps
5176051|NCT00912756|endovascular therapy|endovascular therapy
5176052|NCT00912756|restenosis|restenosis
5176053|NCT00912756|cilostazol|cilostazol
5176054|NCT00912756|femoropopliteal artery lesions|femoropopliteal artery lesions
5176055|NCT00912756|Chronic arteriosclerosis obliterans afflicting the femoropopliteal artery area|chronic arteriosclerosis obliterans afflicting the femoropopliteal artery area
5176056|NCT00912743|Colorectal cancer|colorectal cancer
5176057|NCT00912743|Olaparib|olaparib
5176058|NCT00912743|MSI status|msi status
5176059|NCT00912743|Stage IV|stage iv
5176060|NCT00912743|Measurable Colorectal Cancer|measurable colorectal cancer
5176061|NCT00912743|Stratified by MSI Status|stratified by msi status
5176062|NCT00912730|melanoma|melanoma
5176063|NCT00912730|imaging|imaging
5176064|NCT00912730|sentinel node|sentinel node
5176065|NCT00912730|biopsy|biopsy
5176066|NCT00912704|Hemodialysis patients|hemodialysis patients
5176067|NCT00912704|Kidney|kidney
5176068|NCT00912704|Physician attitudes|physician attitudes
5176069|NCT00912704|Family wishes|family wishes
5176070|NCT00912704|30 numbers require maximum|30 numbers require maximum
5176071|NCT00912691|Autism|autism
5176072|NCT00912678|Kidney transplantation|kidney transplantation
5176073|NCT00912678|Old for old kidney transplantation|old for old kidney transplantation
5176074|NCT00912678|European senior program|european senior program
5176075|NCT00912678|Calcineurin inhibitor free immunosuppression|calcineurin inhibitor free immunosuppression
5176076|NCT00912665|Optic Nerve Head Blood Flow|optic nerve head blood flow
5176077|NCT00912665|Intraocular Pressure|intraocular pressure
5176078|NCT00912665|Regional Blood Flow|regional blood flow
5176079|NCT00912665|Ocular Physiology|ocular physiology
5176080|NCT00912665|Optic Disk|optic disk
5176081|NCT00912652|obesity|obesity
5176082|NCT00912652|rural health|rural health
5176083|NCT00912652|exercise|exercise
5176084|NCT00912639|recurrent breast cancer|recurrent breast cancer
5176085|NCT00912639|Genexol-PM|genexol-pm
5176086|NCT00912626|siblings|siblings
5176087|NCT00912626|family|family
5176088|NCT00912626|child behavior|child behavior
5176089|NCT00912626|critical illness|critical illness
5176090|NCT00912626|social support|social support
5176091|NCT00912613|Critical illness|critical illness
5176092|NCT00912613|ICU Diaries|icu diaries
5176093|NCT00912613|Post Traumatic Stress Disorder|post traumatic stress disorder
5176094|NCT00912613|Incidence|incidence
5176095|NCT00912600|Intensive Care Units|intensive care units
5176096|NCT00912600|Triage|triage
5176097|NCT00912600|Aged, 80 and over|aged, 80 and over
5176098|NCT00912600|Death|death
5176099|NCT00912600|Activities of Daily Living|activities of daily living
5176100|NCT00912600|Health Services Research|health services research
5176101|NCT00912600|Health Care Quality, Access, and Evaluation|health care quality, access, and evaluation
5176102|NCT00912574|Melanoma|melanoma
5176103|NCT00912574|adjuvant|adjuvant
5176104|NCT00912574|dendritic cells|dendritic cells
5176105|NCT00912574|vaccine|vaccine
5176106|NCT00912561|chronic brain ischaemia|chronic brain ischaemia
5176107|NCT00912561|stroke prevention|stroke prevention
5176108|NCT00912561|exercise|exercise
5176109|NCT00912561|physical training|physical training
5176110|NCT00912561|Chronic, extra- or intracranial stenoses of brain supplying arteries|chronic, extra- or intracranial stenoses of brain supplying arteries
5176111|NCT00912548|premenopause|premenopause
5176112|NCT00912548|ovarian function suppression|ovarian function suppression
5176113|NCT00912548|tamoxifen|tamoxifen
5176114|NCT00912535|Primary Anxiety Disorders|primary anxiety disorders
5176115|NCT00912535|Mood Disorders with Comorbid Anxiety Symptoms|mood disorders with comorbid anxiety symptoms
5176116|NCT00912522|reward|reward
5176117|NCT00912522|TMS|tms
5176118|NCT00912522|cognition|cognition
5176119|NCT00912522|Motivation|motivation
5176120|NCT00912522|Perception|perception
5176121|NCT00912522|Decision making|decision making
5176122|NCT00912509|infectious keratitis|infectious keratitis
5176123|NCT00912509|cross linking|cross linking
5176124|NCT00912509|corneal ulcer|corneal ulcer
5176125|NCT00912509|corneal infection|corneal infection
5176126|NCT00912509|collagen cross linking|collagen cross linking
5176127|NCT00912496|Influenza, H5N1, vaccine, avian influenza|influenza, h5n1, vaccine, avian influenza
5176128|NCT00912483|VTE|vte
5176129|NCT00912470|genetic vascular risc factors|genetic vascular risc factors
5176130|NCT00912470|ocular blood flow|ocular blood flow
5176131|NCT00912470|progressive glaucoma|progressive glaucoma
5176132|NCT00912457|sleep apnea|sleep apnea
5176133|NCT00912457|donepezil|donepezil
5176134|NCT00912457|pharmacological|pharmacological
5176135|NCT00912457|cholinergic|cholinergic
5176136|NCT00912444|Breast Neoplasms|breast neoplasms
5176137|NCT00912444|Neoadjuvant|neoadjuvant
5176138|NCT00912444|Chemotherapy|chemotherapy
5176139|NCT00912444|Docetaxel|docetaxel
5176140|NCT00912444|Cyclophosphamide|cyclophosphamide
5176141|NCT00912444|Anthracycline|anthracycline
5176142|NCT00912431|Healthy Volunteers|healthy volunteers
5176143|NCT00912418|melanoma|melanoma
5176144|NCT00912418|vaccine|vaccine
5176145|NCT00912418|IL2 low dose|il2 low dose
5176146|NCT00912405|Patients diagnosed with Chronic Sinusitis undergoing functional endoscopic surgery (FESS)|patients diagnosed with chronic sinusitis undergoing functional endoscopic surgery (fess)
5176147|NCT00912366|VATS|vats
5176148|NCT00912366|Lung cancer|lung cancer
5176149|NCT00912366|NSCLC|nsclc
5176150|NCT00912353|Phase I|phase i
5176151|NCT00912353|Japanese healthy volunteer|japanese healthy volunteer
5176152|NCT00912353|AZD7268|azd7268
5176153|NCT00912340|Breast Cancer|breast cancer
5176154|NCT00912327|Colorectal|colorectal
5176155|NCT00912327|KRAS mutation|kras mutation
5176156|NCT00912327|Stage IV|stage iv
5176157|NCT00912327|Imprime PGG|imprime pgg
5176158|NCT00912327|Cetuximab|cetuximab
5176159|NCT00912327|Immunotherapy|immunotherapy
5176160|NCT00912314|OAB|oab
5176161|NCT00912314|overactive bladder|overactive bladder
5176162|NCT00912314|ptns|ptns
5176163|NCT00912314|posterior tibial nerve stimulation|posterior tibial nerve stimulation
5176164|NCT00912314|percutaneous tibial nerve stimulation|percutaneous tibial nerve stimulation
5176165|NCT00912301|chenodeoxycholate, IBS, transit, colon, constipation|chenodeoxycholate, ibs, transit, colon, constipation
5176166|NCT00912288|Alzheimer disease moderate-to-severe memantine safety and efficacy|alzheimer disease moderate-to-severe memantine safety and efficacy
5176167|NCT00912262|Analgesics|analgesics
5176168|NCT00912262|Capsaicin|capsaicin
5176169|NCT00912249|Horticulture Therapy|horticulture therapy
5176170|NCT00912249|Psychiatric Rehabilitation|psychiatric rehabilitation
5176171|NCT00912249|Nature-assisted psychotherapy|nature-assisted psychotherapy
5176172|NCT00912249|Day Care|day care
5176173|NCT00912236|Obesity|obesity
5176174|NCT00912236|HDL|hdl
5176175|NCT00912236|HDL functionality|hdl functionality
5176176|NCT00912223|Follicular Non-Hodgkin's Lymphoma|follicular non-hodgkin's lymphoma
5176177|NCT00912223|Hematopoietic Stem Cell Transplant (HSCT)|hematopoietic stem cell transplant (hsct)
5176178|NCT00912223|Non-Myeloablative Transplant (NST)|non-myeloablative transplant (nst)
5176179|NCT00912184|Kidney failure, acute|kidney failure, acute
5176180|NCT00912184|Shock|shock
5176181|NCT00912184|Toxins, biological|toxins, biological
5176182|NCT00912184|Hemofiltration|hemofiltration
5176183|NCT00912184|High cut off/super high flux membranes|high cut off/super high flux membranes
5176184|NCT00912171|obstructive sleep apnea syndrome|obstructive sleep apnea syndrome
5176185|NCT00912171|snoring|snoring
5176186|NCT00912171|adenotonsillar hypertrophy|adenotonsillar hypertrophy
5176187|NCT00912171|polysomnography|polysomnography
5176188|NCT00912171|intranasal steroids|intranasal steroids
5176189|NCT00912171|Anti-leukotrienes|anti-leukotrienes
5176190|NCT00912158|CPE|cpe
5176191|NCT00912158|CPAP|cpap
5176192|NCT00912158|BiPAP|bipap
5176193|NCT00912158|non invasive mechanical ventilation|non invasive mechanical ventilation
5176194|NCT00912132|Fetal Growth|fetal growth
5176195|NCT00912132|Pregnancy|pregnancy
5176196|NCT00912119|craniofacial surgery|craniofacial surgery
5176197|NCT00912119|pharmacokinetics|pharmacokinetics
5176198|NCT00912119|cranial vault abnormalities|cranial vault abnormalities
5176199|NCT00912119|homologous blood products|homologous blood products
5176200|NCT00912119|wide scalp dissections|wide scalp dissections
5176201|NCT00912119|transfusion requirements|transfusion requirements
5176202|NCT00912106|osteoarthritis|osteoarthritis
5176203|NCT00912106|HA|ha
5176204|NCT00912106|synovial fluid|synovial fluid
5176205|NCT00912106|lubrication|lubrication
5176206|NCT00912093|HAE|hae
5176207|NCT00912093|Type I HAE|type i hae
5176208|NCT00912093|Type II HAE|type ii hae
5176209|NCT00912080|genomic signature|genomic signature
5176210|NCT00912080|lymph nodes|lymph nodes
5176211|NCT00912080|no metastases|no metastases
5176212|NCT00912054|OAG|oag
5176213|NCT00912054|OH|oh
5176214|NCT00912041|Brain computer interface|brain computer interface
5176215|NCT00912041|Assistive device|assistive device
5176216|NCT00912041|Environmental control|environmental control
5176217|NCT00912041|Communication device|communication device
5176218|NCT00912041|quadriplegia|quadriplegia
5176219|NCT00912041|tetraplegia|tetraplegia
5176220|NCT00911989|Obesity|obesity
5176221|NCT00911989|Weight Loss|weight loss
5176222|NCT00911976|Coronary artery bypass|coronary artery bypass
5176223|NCT00911976|Stents|stents
5176224|NCT00911976|Angioplasty, Transluminal, Percutaneous Coronary|angioplasty, transluminal, percutaneous coronary
5176225|NCT00911976|Coronary Restenosis|coronary restenosis
5176226|NCT00911976|Everolimus|everolimus
5176227|NCT00911976|Saphenous vein grafts|saphenous vein grafts
5176228|NCT00911963|VX-222|vx-222
5176229|NCT00911937|incontinence OAB urgency nocturia|incontinence oab urgency nocturia
5176230|NCT00911924|primary open angle glaucoma (POAG)|primary open angle glaucoma (poag)
5176231|NCT00911924|OAG|oag
5176232|NCT00911924|glaucoma|glaucoma
5176233|NCT00911911|Breast cancer|breast cancer
5176234|NCT00911911|Neo-adjuvant chemotherapy|neo-adjuvant chemotherapy
5176235|NCT00911911|Proteomic|proteomic
5176236|NCT00911911|Histological response|histological response
5176237|NCT00911898|Her2 amplified solid tumors|her2 amplified solid tumors
5176238|NCT00911898|Breast Cancer|breast cancer
5176239|NCT00911898|Her3/ErbB3|her3/erbb3
5176240|NCT00911898|Bispecific Antibody|bispecific antibody
5176241|NCT00911885|Weight|weight
5176242|NCT00911885|Diet|diet
5176243|NCT00911885|Lipids|lipids
5176244|NCT00911872|wrinkles|wrinkles
5176245|NCT00911872|dermal filler|dermal filler
5176246|NCT00911872|collagen|collagen
5176247|NCT00911872|soft tissue augmentation|soft tissue augmentation
5176248|NCT00911872|aesthetic|aesthetic
5176249|NCT00911859|Multiple Myeloma|multiple myeloma
5176250|NCT00911859|CNTO328|cnto328
5176251|NCT00911859|Interleukin-6 (IL-6)|interleukin-6 (il-6)
5176252|NCT00911859|Monoclonal antibody|monoclonal antibody
5176253|NCT00911859|Anti-IL-6 monoclonal antibody|anti-il-6 monoclonal antibody
5176254|NCT00911859|Bortezomib|bortezomib
5176255|NCT00911859|Velcade|velcade
5176256|NCT00911859|Melphalan|melphalan
5176257|NCT00911859|Prednisone|prednisone
5176258|NCT00911846|opioid dependence substitution buprenorphine methadone|opioid dependence substitution buprenorphine methadone
5176259|NCT00911846|"substitution"|"substitution"
5176260|NCT00911833|Trust|trust
5176261|NCT00911807|Clinical Trial, Phase II|clinical trial, phase ii
5176262|NCT00911807|Randomized Controlled Trial|randomized controlled trial
5176263|NCT00911807|Multicenter Study|multicenter study
5176264|NCT00911807|Cerebrolysin|cerebrolysin
5176265|NCT00911807|Donepezil|donepezil
5176266|NCT00911794|Dyspnea|dyspnea
5176267|NCT00911794|Written Disclosure Therapy|written disclosure therapy
5176268|NCT00911794|COPD|copd
5176269|NCT00911794|Pulmonary Fibrosis|pulmonary fibrosis
5176270|NCT00911794|Chronic Lung Diseases|chronic lung diseases
5176271|NCT00911794|Pulmonary Rehabilitation|pulmonary rehabilitation
5176272|NCT00911781|Infantile hemangioma|infantile hemangioma
5176273|NCT00911768|Xerostomia|xerostomia
5176274|NCT00911768|Panax ginseng(Korean Red Ginseng)|panax ginseng(korean red ginseng)
5176275|NCT00911768|Visual Analogue Scale|visual analogue scale
5176276|NCT00911768|Salivary Flow Rates|salivary flow rates
5176277|NCT00911755|Laryngoscopy|laryngoscopy
5176278|NCT00911755|Glidescope|glidescope
5176279|NCT00911729|paraganglioma|paraganglioma
5176280|NCT00911729|pheochromocytoma|pheochromocytoma
5176281|NCT00911716|estrogen receptor-negative breast cancer|estrogen receptor-negative breast cancer
5176282|NCT00911716|estrogen receptor-positive breast cancer|estrogen receptor-positive breast cancer
5176283|NCT00911716|HER2-negative breast cancer|her2-negative breast cancer
5176284|NCT00911716|stage IA breast cancer|stage ia breast cancer
5176285|NCT00911716|stage IB breast cancer|stage ib breast cancer
5176286|NCT00911716|stage II breast cancer|stage ii breast cancer
5176287|NCT00911716|stage IIIA breast cancer|stage iiia breast cancer
5176288|NCT00911716|male breast cancer|male breast cancer
5176289|NCT00911690|Dementia|dementia
5176290|NCT00911690|Alzheimers Disease|alzheimers disease
5176291|NCT00911690|Cognitive Disorders|cognitive disorders
5176292|NCT00911690|Tissue Banking|tissue banking
5176293|NCT00911677|Delirium (MeSH Unique ID D003693)|delirium (mesh unique id d003693)
5176294|NCT00911677|Cognition Disorders (MeSH Unique ID D003072)|cognition disorders (mesh unique id d003072)
5176295|NCT00911677|Postoperative Complications (MeSH Unique ID D011183)|postoperative complications (mesh unique id d011183)
5176296|NCT00911677|Apolipoproteins E (MeSH Unique ID D001057)|apolipoproteins e (mesh unique id d001057)
5176297|NCT00911664|Vitamin D|vitamin d
5176298|NCT00911664|HIV-Infected children|hiv-infected children
5176299|NCT00911664|CD4 count|cd4 count
5176300|NCT00911651|COPD|copd
5176301|NCT00911651|salbutamol|salbutamol
5176302|NCT00911651|ipratropium bromide|ipratropium bromide
5176303|NCT00911651|computational fluid dynamics|computational fluid dynamics
5176304|NCT00911651|functional imaging|functional imaging
5176305|NCT00911651|central and peripheral airways|central and peripheral airways
5176306|NCT00911638|Patient decision aids|patient decision aids
5176307|NCT00911638|Patient preferences|patient preferences
5176308|NCT00911638|Osteoarthritis|osteoarthritis
5176309|NCT00911638|Joint replacement|joint replacement
5176310|NCT00911638|Waiting times|waiting times
5176311|NCT00911625|glargine|glargine
5176312|NCT00911625|glulisine|glulisine
5176313|NCT00911625|type 2 diabetes|type 2 diabetes
5176314|NCT00911625|renal insufficiency|renal insufficiency
5176315|NCT00911612|bile acid|bile acid
5176316|NCT00911612|malabsorption|malabsorption
5176317|NCT00911612|permeability|permeability
5176318|NCT00911612|diarrhea|diarrhea
5176319|NCT00911612|IBS|ibs
5176320|NCT00911612|stool|stool
5176321|NCT00911599|Individuals undergoing unilateral total hip replacement.|individuals undergoing unilateral total hip replacement.
5176322|NCT00911573|pediatry|pediatry
5176323|NCT00911573|children|children
5176324|NCT00911573|skin|skin
5176325|NCT00911573|bacteria|bacteria
5176326|NCT00911573|MRSA|mrsa
5176327|NCT00911560|BETA-D-GLUCAN|beta-d-glucan
5176328|NCT00911560|OPT-821|opt-821
5176329|NCT00911560|GD2-KLH|gd2-klh
5176330|NCT00911560|GD3-KLH|gd3-klh
5176331|NCT00911560|QS 21|qs 21
5176332|NCT00911560|Vaccine|vaccine
5176333|NCT00911560|05-075|05-075
5176334|NCT00911547|chronic asthma|chronic asthma
5176335|NCT00911534|Gastroesophageal Reflux Disease|gastroesophageal reflux disease
5176336|NCT00911534|GERD|gerd
5176337|NCT00911521|human papillomavirus|human papillomavirus
5176338|NCT00911521|vaccine|vaccine
5176339|NCT00911521|lupus|lupus
5176340|NCT00911508|Atrial Fibrillation|atrial fibrillation
5176341|NCT00911508|Left Atrial Ablation|left atrial ablation
5176342|NCT00911508|Pulmonary Vein Isolation|pulmonary vein isolation
5176343|NCT00911508|Catheter Ablation|catheter ablation
5176344|NCT00911508|Antiarrhythmic Drug Therapy|antiarrhythmic drug therapy
5176345|NCT00911495|Sickle Cell Disease|sickle cell disease
5176346|NCT00911482|Type 2 Diabetes|type 2 diabetes
5176347|NCT00911482|Dyslipidemia|dyslipidemia
5176348|NCT00911482|FFA|ffa
5176349|NCT00911482|Triglycerides|triglycerides
5176350|NCT00911482|Tracers|tracers
5176351|NCT00911469|Knee osteoarthritis|knee osteoarthritis
5176352|NCT00911469|fibroblast growth factor 18|fibroblast growth factor 18
5176353|NCT00911430|Staphylococcus Aureus (S. Areus)|staphylococcus aureus (s. areus)
5176354|NCT00911430|Recurrent Staphylococcal Infection|recurrent staphylococcal infection
5176355|NCT00911430|Atopic Dermatitis|atopic dermatitis
5176356|NCT00911430|Immunodeficiency|immunodeficiency
5176357|NCT00911430|Community Associated Staphylococcal Infection|community associated staphylococcal infection
5176358|NCT00911430|Staphylococcal Infection|staphylococcal infection
5176359|NCT00911430|Invasive Staphylococcal Infection|invasive staphylococcal infection
5176360|NCT00911430|Staph Infection|staph infection
5176361|NCT00911417|peripheral arterial disease|peripheral arterial disease
5176362|NCT00911417|peripheral vascular disease|peripheral vascular disease
5176363|NCT00911404|Gestational diabetes|gestational diabetes
5176364|NCT00911404|Carbohydrate|carbohydrate
5176365|NCT00911404|Diet|diet
5176366|NCT00911404|Insulin|insulin
5176367|NCT00911391|Doppler|doppler
5176368|NCT00911391|Colectomy|colectomy
5176369|NCT00911391|ERAS|eras
5176370|NCT00911391|Fluid|fluid
5176371|NCT00911391|Perioperative Care|perioperative care
5176372|NCT00911378|weaning|weaning
5176373|NCT00911378|mechanical ventilation|mechanical ventilation
5176374|NCT00911365|voluntary participants|voluntary participants
5176375|NCT00911365|75 years old or less|75 years old or less
5176376|NCT00911352|Cryotherapy|cryotherapy
5176377|NCT00911352|Hand toxicity|hand toxicity
5176378|NCT00911352|Nail toxicity|nail toxicity
5176379|NCT00911352|Infection control|infection control
5176380|NCT00911326|HNSCC|hnscc
5176381|NCT00911313|Polycystic ovary syndrome|polycystic ovary syndrome
5176382|NCT00911313|clomiphene resistance|clomiphene resistance
5176383|NCT00911313|letrozole|letrozole
5176384|NCT00911300|Cardioversion, Electric|cardioversion, electric
5176385|NCT00911300|Pathological Conditions, Sings and Symptoms|pathological conditions, sings and symptoms
5176386|NCT00911300|Cardiovascular Diseases|cardiovascular diseases
5176387|NCT00911300|Heart Diseases|heart diseases
5176388|NCT00911300|Atrial Fibrillation|atrial fibrillation
5176389|NCT00911300|Arrhythmias, Cardiac|arrhythmias, cardiac
5176390|NCT00911300|Pathologic Processes|pathologic processes
5176391|NCT00911300|Anticoagulants|anticoagulants
5176392|NCT00911287|Chronic pain|chronic pain
5176393|NCT00911287|Extended Release|extended release
5176394|NCT00911287|Long-Acting Opioid|long-acting opioid
5176395|NCT00911287|Opioid|opioid
5176396|NCT00911287|Opioid-Naive|opioid-naive
5176397|NCT00911287|Oxymorphone|oxymorphone
5176398|NCT00911274|Bioequivalence|bioequivalence
5176399|NCT00911274|Healthy Subjects|healthy subjects
5176400|NCT00911261|Cancer Pain|cancer pain
5176401|NCT00911261|Neuropathic Pain|neuropathic pain
5176402|NCT00911261|Extended Release|extended release
5176403|NCT00911261|Long-Acting Opioid|long-acting opioid
5176404|NCT00911261|Oxymorphone|oxymorphone
5176405|NCT00911248|Angiogenesis|angiogenesis
5176406|NCT00911248|Neurofibromatosis|neurofibromatosis
5176407|NCT00911248|Post-transcriptional control|post-transcriptional control
5176408|NCT00911248|PTC299|ptc299
5176409|NCT00911248|VEGF|vegf
5176410|NCT00911235|The Effect Of Fluconazole On Pharmacokinetics Of Fesoterodine In Healthy Subjects|the effect of fluconazole on pharmacokinetics of fesoterodine in healthy subjects
5176411|NCT00911222|antiemetic therapy|antiemetic therapy
5176412|NCT00911222|emesis|emesis
5176413|NCT00911222|vomiting|vomiting
5176414|NCT00911222|nausea|nausea
5176415|NCT00911222|moderately and highly emetogenic chemotherapy|moderately and highly emetogenic chemotherapy
5176416|NCT00911222|cisplatin|cisplatin
5176417|NCT00911222|carboplatin|carboplatin
5176418|NCT00911222|oxaliplatin|oxaliplatin
5176419|NCT00911222|anthracycline|anthracycline
5176420|NCT00911222|cyclophosphamid|cyclophosphamid
5176421|NCT00911209|Heart Disease|heart disease
5176422|NCT00911209|Obesity|obesity
5176423|NCT00911196|Prognosis|prognosis
5176424|NCT00911196|Markers|markers
5176425|NCT00911196|Expression analysis|expression analysis
5176426|NCT00911196|Hepatocellular carcinoma|hepatocellular carcinoma
5176427|NCT00911183|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
5176428|NCT00911183|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5176429|NCT00911183|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5176430|NCT00911183|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5176431|NCT00911170|adenocarcinoma of the colon or rectum|adenocarcinoma of the colon or rectum
5176432|NCT00911170|febrile neutropenia|febrile neutropenia
5176433|NCT00911170|Bevacizumab|bevacizumab
5176434|NCT00911170|Avastin|avastin
5176435|NCT00911170|5-fluorouracil, Oxaliplatin, Leucovorin (FOLFOX)|5-fluorouracil, oxaliplatin, leucovorin (folfox)
5176436|NCT00911170|5-fluorouracil, Irinotecan, Leucovorin (FOLFIRI)|5-fluorouracil, irinotecan, leucovorin (folfiri)
5176437|NCT00911157|Pulmonary thromboembolism|pulmonary thromboembolism
5176438|NCT00911157|contrast-enhanced MDCT|contrast-enhanced mdct
5176439|NCT00911157|Deep Vein Thrombosis|deep vein thrombosis
5176440|NCT00911157|Fondaparinux sodium|fondaparinux sodium
5176441|NCT00911144|Safety|safety
5176442|NCT00911144|Pneumococcal vaccine|pneumococcal vaccine
5176443|NCT00911144|Immunogenicity|immunogenicity
5176444|NCT00911144|Pneumococcal disease|pneumococcal disease
5176445|NCT00911144|Booster vaccination|booster vaccination
5176446|NCT00911131|Small grade esophageal varices|small grade esophageal varices
5176447|NCT00911131|capsule endoscopy|capsule endoscopy
5176448|NCT00911131|PillCam ESO|pillcam eso
5176449|NCT00911131|abdominal binder|abdominal binder
5176450|NCT00911118|prostate|prostate
5176451|NCT00911118|radiation|radiation
5176452|NCT00911118|09-035|09-035
5176453|NCT00911105|Multiple Myeloma|multiple myeloma
5176454|NCT00911105|Non-interventional study|non-interventional study
5176455|NCT00911105|Lenalidomide|lenalidomide
5176456|NCT00911105|Dexamethasone|dexamethasone
5176457|NCT00911105|Observational|observational
5176458|NCT00911105|Time to progression|time to progression
5176459|NCT00911105|Clinical routine|clinical routine
5176460|NCT00911105|Germany|germany
5176461|NCT00911105|Plasmacytoma|plasmacytoma
5176462|NCT00911092|Oesophageal cancer|oesophageal cancer
5176463|NCT00911092|exclusive concomitant radiochemotherapy|exclusive concomitant radiochemotherapy
5176464|NCT00911079|Stage III, IV cervical cancer|stage iii, iv cervical cancer
5176465|NCT00911079|Rising prostate specific antigen (PSA) after local therapy|rising prostate specific antigen (psa) after local therapy
5176466|NCT00911053|melatonin|melatonin
5176467|NCT00911053|sleep|sleep
5176468|NCT00911053|blindness|blindness
5176469|NCT00911053|blind individuals|blind individuals
5176470|NCT00911027|Prostate|prostate
5176471|NCT00911027|Cancer|cancer
5176472|NCT00911027|Biopsy|biopsy
5176473|NCT00911027|Guided|guided
5176474|NCT00911027|Contrast|contrast
5176475|NCT00911027|Enhanced|enhanced
5176476|NCT00911027|SonoVue|sonovue
5176477|NCT00911027|Suspicion of prostate cancer|suspicion of prostate cancer
5176478|NCT00911001|Arthroplasty|arthroplasty
5176479|NCT00911001|Antithrombotic prophylaxis treatment|antithrombotic prophylaxis treatment
5176480|NCT00911001|Replacement|replacement
5176481|NCT00911001|Knee|knee
5176482|NCT00910988|healthy|healthy
5176483|NCT00910988|sedentary|sedentary
5176484|NCT00910988|men|men
5176485|NCT00910988|acute effects of antipsychotic|acute effects of antipsychotic
5176486|NCT00910988|blood sugar|blood sugar
5176487|NCT00910988|insulin sensitivity|insulin sensitivity
5176488|NCT00910975|Hepatitis C virus|hepatitis c virus
5176489|NCT00910975|Real-time PCR|real-time pcr
5176490|NCT00910975|Treatment|treatment
5176491|NCT00910962|NSTEMI, acute coronary syndrome, p38 MAPK inhibitor, GW856553, percutaneous coronary intervention|nstemi, acute coronary syndrome, p38 mapk inhibitor, gw856553, percutaneous coronary intervention
5176492|NCT00910949|persistent pain|persistent pain
5176493|NCT00910949|neuropathic pain|neuropathic pain
5176494|NCT00910949|Thoracotomy|thoracotomy
5176495|NCT00910949|Chronic Pain|chronic pain
5176496|NCT00910936|HIV|hiv
5176497|NCT00910936|Exercise|exercise
5176498|NCT00910936|Inflammation|inflammation
5176499|NCT00910936|Quality of life|quality of life
5176500|NCT00910936|Lipodystrophia|lipodystrophia
5176501|NCT00910923|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
5176502|NCT00910897|Newly Diagnosed|newly diagnosed
5176503|NCT00910897|multiple myeloma|multiple myeloma
5176504|NCT00910897|induction|induction
5176505|NCT00910897|Thalidomide|thalidomide
5176506|NCT00910884|stage I breast cancer|stage i breast cancer
5176507|NCT00910884|stage II breast cancer|stage ii breast cancer
5176508|NCT00910884|stage IIIA breast cancer|stage iiia breast cancer
5176509|NCT00910884|male breast cancer|male breast cancer
5176510|NCT00910871|Tuberculosis|tuberculosis
5176511|NCT00910871|TMC207-TiDP13-C209|tmc207-tidp13-c209
5176512|NCT00910871|TMC207-C209|tmc207-c209
5176513|NCT00910871|TMC207|tmc207
5176514|NCT00910871|TB|tb
5176515|NCT00910871|MDR-TB|mdr-tb
5176516|NCT00910832|Dyschesia treatment|dyschesia treatment
5176517|NCT00910832|Rehabilitation|rehabilitation
5176518|NCT00910832|Dyschesia|dyschesia
5176519|NCT00910819|Colorectal Cancer|colorectal cancer
5176520|NCT00910819|Advanced Colorectal Cancer|advanced colorectal cancer
5176521|NCT00910819|Epidemiology|epidemiology
5176522|NCT00910819|Health Services Research|health services research
5176523|NCT00910819|Germany|germany
5176524|NCT00910819|Registry|registry
5176525|NCT00910819|Palliative Care|palliative care
5176526|NCT00910819|Palliative Treatment|palliative treatment
5176527|NCT00910819|Adjuvant Drug Therapy|adjuvant drug therapy
5176528|NCT00910819|Nutrition Assessment|nutrition assessment
5176529|NCT00910819|Physical Activity|physical activity
5176530|NCT00910806|TMC207-TiDP13-C117|tmc207-tidp13-c117
5176531|NCT00910806|TMC207-C110|tmc207-c110
5176532|NCT00910806|TMC207|tmc207
5176533|NCT00910806|drug-drug interaction|drug-drug interaction
5176534|NCT00910806|Tuberculosis|tuberculosis
5176535|NCT00910806|HIV|hiv
5176536|NCT00910806|nevirapine|nevirapine
5176537|NCT00910806|open-label|open-label
5176538|NCT00910806|Pharmacokinetics|pharmacokinetics
5176539|NCT00910793|Asthma|asthma
5176540|NCT00910793|Formoterol|formoterol
5176541|NCT00910793|Beclomethasone Dipropionate|beclomethasone dipropionate
5176542|NCT00910793|Computational Fluid Dynamics|computational fluid dynamics
5176543|NCT00910793|Functional Imaging|functional imaging
5176544|NCT00910793|Central and Peripheral Airways|central and peripheral airways
5176545|NCT00910754|Prostate neoplasms|prostate neoplasms
5176546|NCT00910754|Metastatic castration resistant prostate cancer|metastatic castration resistant prostate cancer
5176547|NCT00910754|Abiraterone acetate|abiraterone acetate
5176548|NCT00910754|CB7630|cb7630
5176549|NCT00910741|pancreatic cancer|pancreatic cancer
5176550|NCT00910741|Gemcitabine|gemcitabine
5176551|NCT00910728|Primary Myelofibrosis (PMF)|primary myelofibrosis (pmf)
5176552|NCT00910728|Post-Polycythaemia Vera/Essential Thrombocythaemia Myelofibrosis (Post-PV/ET MF)|post-polycythaemia vera/essential thrombocythaemia myelofibrosis (post-pv/et mf)
5176553|NCT00910728|Myeloproliferative diseases|myeloproliferative diseases
5176554|NCT00910728|Phase I|phase i
5176555|NCT00910728|Phase II|phase ii
5176556|NCT00910728|Bone marrow|bone marrow
5176557|NCT00910715|erythema migrans|erythema migrans
5176558|NCT00910715|Lyme borreliosis|lyme borreliosis
5176559|NCT00910715|doxycycline treatment|doxycycline treatment
5176560|NCT00910715|outcome|outcome
5176561|NCT00910715|subjective symptoms|subjective symptoms
5176562|NCT00910702|retinal detachment, vitreous body substitute|retinal detachment, vitreous body substitute
5176563|NCT00910689|Migraine Headache|migraine headache
5176564|NCT00910689|Preventive Therapy|preventive therapy
5176565|NCT00910689|Beta Blocker Medication|beta blocker medication
5176566|NCT00910689|Behavior Therapy|behavior therapy
5176567|NCT00910689|Clinical Trial|clinical trial
5176568|NCT00910676|EGF-R inhibitors|egf-r inhibitors
5176569|NCT00910663|Bioequivalence|bioequivalence
5176570|NCT00910663|Healthy Subjects|healthy subjects
5176571|NCT00910650|Adoptive transfer therapy|adoptive transfer therapy
5176572|NCT00910650|Dendritic cell vaccines|dendritic cell vaccines
5176573|NCT00910637|Pregnancy prevention|pregnancy prevention
5176574|NCT00910637|Female contraception|female contraception
5176575|NCT00910637|Patch|patch
5176576|NCT00910611|pediatric|pediatric
5176577|NCT00910611|immunization|immunization
5176578|NCT00910611|pain|pain
5176579|NCT00910611|analgesia|analgesia
5176580|NCT00910611|Immunization pain|immunization pain
5176581|NCT00910598|clinically isolated syndrome|clinically isolated syndrome
5176582|NCT00910598|relapsing remitting multiple sclerosis|relapsing remitting multiple sclerosis
5176583|NCT00910598|glatiramer acetate|glatiramer acetate
5176584|NCT00910598|Optical Coherence Tomography|optical coherence tomography
5176585|NCT00910585|childhood|childhood
5176586|NCT00910585|asthma|asthma
5176587|NCT00910572|Yttrium-90|yttrium-90
5176588|NCT00910572|Radiation|radiation
5176589|NCT00910572|Radioembolization|radioembolization
5176590|NCT00910572|Hepatoma|hepatoma
5176591|NCT00910572|BCLC classification|bclc classification
5176592|NCT00910572|Hepatic loco-regional treatments|hepatic loco-regional treatments
5176593|NCT00910572|Yttrium|yttrium
5176594|NCT00910572|Microspheres|microspheres
5176595|NCT00910559|Autism Spectrum Disorder|autism spectrum disorder
5176596|NCT00910559|Autism|autism
5176597|NCT00910559|Asperger Syndrome|asperger syndrome
5176598|NCT00910559|Pervasive Developmental Disorders- Not Otherwise Specified|pervasive developmental disorders- not otherwise specified
5176599|NCT00910546|Lung Cancer|lung cancer
5176600|NCT00910546|Stereotactic radiotherapy|stereotactic radiotherapy
5176601|NCT00910546|Image guidance|image guidance
5176602|NCT00910546|breathing adaption|breathing adaption
5176603|NCT00910546|tumor motion|tumor motion
5176604|NCT00910546|implanted marker|implanted marker
5176605|NCT00910533|Lyme neuroborreliosis|lyme neuroborreliosis
5176606|NCT00910507|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
5176607|NCT00910507|Exercise|exercise
5176608|NCT00910507|Counseling|counseling
5176609|NCT00910507|Behavior|behavior
5176610|NCT00910494|Rectal neoplasm C04.588.274.476.411.307.790|rectal neoplasm c04.588.274.476.411.307.790
5176611|NCT00910494|Intraoperative Radiotherapy|intraoperative radiotherapy
5176612|NCT00910481|Coronary Artery Disease|coronary artery disease
5176613|NCT00910481|Percutaneous Transluminal Coronary Angioplasty|percutaneous transluminal coronary angioplasty
5176614|NCT00910481|Intraaortic Balloon Pumping|intraaortic balloon pumping
5176615|NCT00910481|Left Ventricular Dysfunction|left ventricular dysfunction
5176616|NCT00910481|High Risk|high risk
5176617|NCT00910455|Phase 1|phase 1
5176618|NCT00910455|Safety|safety
5176619|NCT00910455|Tolerability|tolerability
5176620|NCT00910455|Pharmacokinetics|pharmacokinetics
5176621|NCT00910429|Chronic thromboembolic Hypertension|chronic thromboembolic hypertension
5176622|NCT00910429|PH|ph
5176623|NCT00910429|soluble Guanylate Cyclase Stimulator|soluble guanylate cyclase stimulator
5176624|NCT00910429|sGC|sgc
5176625|NCT00910416|Anesthesia|anesthesia
5176626|NCT00910416|Monitoring, Intraoperative|monitoring, intraoperative
5176627|NCT00910416|Electroencephalography/*drug effects|electroencephalography/*drug effects
5176628|NCT00910403|Presbyopia|presbyopia
5176629|NCT00910403|LASIK|lasik
5176630|NCT00910403|Hyperopes|hyperopes
5176631|NCT00910390|IVF|ivf
5176632|NCT00910390|embryo cryopreservation|embryo cryopreservation
5176633|NCT00910390|vitrification|vitrification
5176634|NCT00910390|Human Embryo|human embryo
5176635|NCT00910390|Embryonic development|embryonic development
5176636|NCT00910390|Pregnancy rate|pregnancy rate
5176637|NCT00910377|breastfeeding|breastfeeding
5176638|NCT00910377|exclusive breastfeeding|exclusive breastfeeding
5176639|NCT00910377|lactation counseling|lactation counseling
5176640|NCT00910377|teenagers|teenagers
5176641|NCT00910377|complementary food|complementary food
5176642|NCT00910377|adolescent|adolescent
5176643|NCT00910377|caregivers|caregivers
5176644|NCT00910364|Lower extremity DVT|lower extremity dvt
5176645|NCT00910364|Clot|clot
5176646|NCT00910364|leg clot|leg clot
5176647|NCT00910364|Deep vein thrombosis|deep vein thrombosis
5176648|NCT00910364|Thrombosis|thrombosis
5176649|NCT00910364|Warfarin|warfarin
5176650|NCT00910351|Cystic Fibrosis|cystic fibrosis
5176651|NCT00910351|Pharmacokinetics|pharmacokinetics
5176652|NCT00910351|Pediatrics|pediatrics
5176653|NCT00910351|Inhalation|inhalation
5176654|NCT00910351|Sputum|sputum
5176655|NCT00910338|Pelvic Floor Muscle Training|pelvic floor muscle training
5176656|NCT00910338|Extracorporeal Biofeedback|extracorporeal biofeedback
5176657|NCT00910325|Female|female
5176658|NCT00910325|Cholelithiasis|cholelithiasis
5176659|NCT00910325|Natural Orifice Surgery|natural orifice surgery
5176660|NCT00910325|Laparoscopic- Assisted|laparoscopic- assisted
5176661|NCT00910325|Transvaginal|transvaginal
5176662|NCT00910299|Clopidogrel|clopidogrel
5176663|NCT00910299|VerifyNow|verifynow
5176664|NCT00910299|PRU Measurements|pru measurements
5176665|NCT00910299|Drug Eluting Stents (DES)|drug eluting stents (des)
5176666|NCT00910299|Heart Disease|heart disease
5176667|NCT00910299|Percutaneous Coronary Intervention (PCI)|percutaneous coronary intervention (pci)
5176668|NCT00910299|P2Y12|p2y12
5176669|NCT00910299|Platelets|platelets
5176670|NCT00910299|Platelet Reactivity|platelet reactivity
5176671|NCT00910286|Pressure support ventilation|pressure support ventilation
5176672|NCT00910286|cycling off criteria|cycling off criteria
5176673|NCT00910286|expiratory trigger|expiratory trigger
5176674|NCT00910286|patient-ventilator interaction|patient-ventilator interaction
5176675|NCT00910286|patient comfort|patient comfort
5176676|NCT00910273|IMT evaluation in AS patients treated with etanercept|imt evaluation in as patients treated with etanercept
5176677|NCT00910260|vitamin D level under phototherapy|vitamin d level under phototherapy
5176678|NCT00910247|Seizures|seizures
5176679|NCT00910247|Epilepsy|epilepsy
5176680|NCT00910247|Anticonvulsant|anticonvulsant
5176681|NCT00910247|Monotherapy|monotherapy
5176682|NCT00910247|Epilepsy with simple or complete partial onset seizures|epilepsy with simple or complete partial onset seizures
5176683|NCT00910234|Periventricular leukomalacia (PVL)|periventricular leukomalacia (pvl)
5176684|NCT00910234|Erythropoietin (EPO)|erythropoietin (epo)
5176685|NCT00910234|Retinopathy of prematurity (ROP)|retinopathy of prematurity (rop)
5176686|NCT00910234|Hypoxia-ischemia|hypoxia-ischemia
5176687|NCT00910221|Cardiac surgery|cardiac surgery
5176688|NCT00910221|Cardiopulmonary bypass|cardiopulmonary bypass
5176689|NCT00910221|Oxidative stress|oxidative stress
5176690|NCT00910221|Acute renal dysfunction|acute renal dysfunction
5176691|NCT00910221|Atorvastatin|atorvastatin
5176692|NCT00910208|Pain|pain
5176693|NCT00910208|Analgesia|analgesia
5176694|NCT00910208|Analgesia, Patient-controlled|analgesia, patient-controlled
5176695|NCT00910208|Emergency Medicine|emergency medicine
5176696|NCT00910195|Obstructive sleep apnea|obstructive sleep apnea
5176697|NCT00910195|CPAP|cpap
5176698|NCT00910195|Bi-Level|bi-level
5176699|NCT00910182|Splenic rupture|splenic rupture
5176700|NCT00910182|abdominal injuries|abdominal injuries
5176701|NCT00910182|Surgery|surgery
5176702|NCT00910182|Angiography|angiography
5176703|NCT00910182|Embolisation|embolisation
5176704|NCT00910182|Computed tomography|computed tomography
5176705|NCT00910182|Classification|classification
5176706|NCT00910169|Anorexia nervosa|anorexia nervosa
5176707|NCT00910169|treatment|treatment
5176708|NCT00910169|inpatient|inpatient
5176709|NCT00910169|efficacy|efficacy
5176710|NCT00910169|outcome|outcome
5176711|NCT00910143|Rectal cancer|rectal cancer
5176712|NCT00910143|Colorectal Surgery|colorectal surgery
5176713|NCT00910143|Surgery|surgery
5176714|NCT00910143|Local neoplasm recurrence|local neoplasm recurrence
5176715|NCT00910143|survival|survival
5176716|NCT00910143|Follow-up Study|follow-up study
5176717|NCT00910130|Retinol Binding Protein 4|retinol binding protein 4
5176718|NCT00910130|Insulin Resistance|insulin resistance
5176719|NCT00910130|Diabetes|diabetes
5176720|NCT00910130|End Stage Renal Disease|end stage renal disease
5176721|NCT00910130|Dialysis|dialysis
5176722|NCT00910130|Nutrition|nutrition
5176723|NCT00910117|HNSCC|hnscc
5176724|NCT00910117|induction chemotherapy|induction chemotherapy
5176725|NCT00910117|nimotuzumab|nimotuzumab
5176726|NCT00910104|PNALD|pnald
5176727|NCT00910104|Omegaven|omegaven
5176728|NCT00910104|Parenteral Nutrition Associated Liver Disease|parenteral nutrition associated liver disease
5176729|NCT00910104|Cholestasis|cholestasis
5176730|NCT00910104|Short Bowel Syndrome|short bowel syndrome
5176731|NCT00910091|Endometrial cancer|endometrial cancer
5176732|NCT00910091|Antitumour efficacy in women with advanced endometrial cancer|antitumour efficacy in women with advanced endometrial cancer
5176733|NCT00910078|Total kappa and lambda ratio|total kappa and lambda ratio
5176734|NCT00910078|Stem cell transplantation|stem cell transplantation
5176735|NCT00910078|Serum immunofixation|serum immunofixation
5176736|NCT00910065|Acute Coronary Syndrome|acute coronary syndrome
5176737|NCT00910065|ACS|acs
5176738|NCT00910065|Aspirin|aspirin
5176739|NCT00910052|randomised|randomised
5176740|NCT00910052|controlled|controlled
5176741|NCT00910052|double blinded|double blinded
5176742|NCT00910039|cognitive/functional effects|cognitive/functional effects
5176743|NCT00910039|tumors metastatic to brain|tumors metastatic to brain
5176744|NCT00910039|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5176745|NCT00910026|EBC and mechanical ventilation|ebc and mechanical ventilation
5176746|NCT00910026|low tidal volume ventilation|low tidal volume ventilation
5176747|NCT00910026|high tidal volume ventilation|high tidal volume ventilation
5176748|NCT00910026|inflammatory and oxidative stress EBC biomarkers|inflammatory and oxidative stress ebc biomarkers
5176749|NCT00910026|Ventilator induced lung injury|ventilator induced lung injury
5176750|NCT00910013|TKR|tkr
5176751|NCT00910013|Femoral block|femoral block
5176752|NCT00910013|Ropivacaïne|ropivacaïne
5176753|NCT00910013|intra-articular ropivacaïne|intra-articular ropivacaïne
5176754|NCT00910013|post-operative analgesia|post-operative analgesia
5176755|NCT00910000|carboplatin|carboplatin
5176756|NCT00910000|gemcitabine|gemcitabine
5176757|NCT00910000|vorinostat|vorinostat
5176758|NCT00909987|rectum|rectum
5176759|NCT00909987|intermediate risk cancer rectum|intermediate risk cancer rectum
5176760|NCT00909987|neoadjuvant|neoadjuvant
5176761|NCT00909974|multiple micronutrients|multiple micronutrients
5176762|NCT00909974|energy deficiency|energy deficiency
5176763|NCT00909961|Osteoporosis|osteoporosis
5176764|NCT00909961|Bone Mineral Density|bone mineral density
5176765|NCT00909961|Biomarkers|biomarkers
5176766|NCT00909948|Related stem cell transplant,|related stem cell transplant,
5176767|NCT00909948|TBI,|tbi,
5176768|NCT00909948|Mismatched stem cell transplant|mismatched stem cell transplant
5176769|NCT00909948|Fludarabine|fludarabine
5176770|NCT00909948|Non-myeloablative|non-myeloablative
5176771|NCT00909948|Lymphoma|lymphoma
5176772|NCT00909948|Multiple myeloma|multiple myeloma
5176773|NCT00909935|To determine pharmacokinetics of dexmedetomidine in children|to determine pharmacokinetics of dexmedetomidine in children
5176774|NCT00909922|Amputation|amputation
5176775|NCT00909922|Amputees|amputees
5176776|NCT00909922|Artificial Limbs|artificial limbs
5176777|NCT00909922|Leg Length Inequality|leg length inequality
5176778|NCT00909922|Lower Extremity|lower extremity
5176779|NCT00909922|Pelvis|pelvis
5176780|NCT00909922|Posture|posture
5176781|NCT00909922|Prostheses|prostheses
5176782|NCT00909922|Range of Motion|range of motion
5176783|NCT00909922|Trunk Muscles|trunk muscles
5176784|NCT00909909|ductal breast carcinoma in situ|ductal breast carcinoma in situ
5176785|NCT00909909|invasive ductal breast carcinoma|invasive ductal breast carcinoma
5176786|NCT00909909|invasive lobular breast carcinoma|invasive lobular breast carcinoma
5176787|NCT00909909|medullary ductal breast carcinoma with lymphocytic infiltrate|medullary ductal breast carcinoma with lymphocytic infiltrate
5176788|NCT00909909|mucinous ductal breast carcinoma|mucinous ductal breast carcinoma
5176789|NCT00909909|papillary ductal breast carcinoma|papillary ductal breast carcinoma
5176790|NCT00909909|tubular ductal breast carcinoma|tubular ductal breast carcinoma
5176791|NCT00909909|stage I breast cancer|stage i breast cancer
5176792|NCT00909909|stage II breast cancer|stage ii breast cancer
5176793|NCT00909909|stage IIIA breast cancer|stage iiia breast cancer
5176794|NCT00909896|endometrial|endometrial
5176795|NCT00909896|pain|pain
5176796|NCT00909883|Idiopathic Parkinson's disease|idiopathic parkinson's disease
5176797|NCT00909883|Foot (Tiptoe) dystonia|foot (tiptoe) dystonia
5176798|NCT00909883|Botulinum Toxin|botulinum toxin
5176799|NCT00909883|Muscles : Flexor digitorum longus/ Flexor digitorum brevis/ quadratus plantae|muscles : flexor digitorum longus/ flexor digitorum brevis/ quadratus plantae
5176800|NCT00909870|Venous leg ulcer|venous leg ulcer
5176801|NCT00909870|randomized trial|randomized trial
5176802|NCT00909870|clinical trial|clinical trial
5176803|NCT00909870|Dermagraft|dermagraft
5176804|NCT00909870|compression therapy|compression therapy
5176805|NCT00909870|surgical debridement|surgical debridement
5176806|NCT00909870|venous stasis|venous stasis
5176807|NCT00909870|chronic ulcer|chronic ulcer
5176808|NCT00909870|chronic wound|chronic wound
5176809|NCT00909870|fibroblasts|fibroblasts
5176810|NCT00909857|Primary Dysmenorrhea|primary dysmenorrhea
5176811|NCT00909857|Oral Contraception|oral contraception
5176812|NCT00909831|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5176813|NCT00909805|dermabond glue|dermabond glue
5176814|NCT00909805|suture|suture
5176815|NCT00909805|children|children
5176816|NCT00909779|Chronic obstructive pulmonary disease (COPD)|chronic obstructive pulmonary disease (copd)
5176817|NCT00909779|respiratory|respiratory
5176818|NCT00909779|long-acting beta agonist (LABA)|long-acting beta agonist (laba)
5176819|NCT00909753|Bioequivalence|bioequivalence
5176820|NCT00909753|Healthy Subjects|healthy subjects
5176821|NCT00909740|Solid Tumor|solid tumor
5176822|NCT00909740|Cancer|cancer
5176823|NCT00909727|Fibrosis|fibrosis
5176824|NCT00909727|Pancreatic Diseases|pancreatic diseases
5176825|NCT00909727|Digestive System Diseases|digestive system diseases
5176826|NCT00909727|Lung Diseases|lung diseases
5176827|NCT00909727|Respiratory Tract Diseases|respiratory tract diseases
5176828|NCT00909727|Genetic Diseases, Inborn|genetic diseases, inborn
5176829|NCT00909727|Infant, Newborn, Diseases|infant, newborn, diseases
5176830|NCT00909727|Pathologic Processes|pathologic processes
5176831|NCT00909714|stroke|stroke
5176832|NCT00909714|non-invasive cortical stimulation|non-invasive cortical stimulation
5176833|NCT00909714|motor recovery|motor recovery
5176834|NCT00909714|cortical plasticity|cortical plasticity
5176835|NCT00909714|TDCS|tdcs
5176836|NCT00909701|Dietary supplement|dietary supplement
5176837|NCT00909701|healthy volunteers|healthy volunteers
5176838|NCT00909701|Anaesthesia for surgery|anaesthesia for surgery
5176839|NCT00909688|Healthy Subjects|healthy subjects
5176840|NCT00909662|cognitive/functional effects|cognitive/functional effects
5176841|NCT00909662|long-term effects secondary to cancer therapy in adults|long-term effects secondary to cancer therapy in adults
5176842|NCT00909662|fatigue|fatigue
5176843|NCT00909662|stage I breast cancer|stage i breast cancer
5176844|NCT00909662|stage II breast cancer|stage ii breast cancer
5176845|NCT00909662|stage IIIA breast cancer|stage iiia breast cancer
5176846|NCT00909662|stage IIIB breast cancer|stage iiib breast cancer
5176847|NCT00909662|stage IIIC breast cancer|stage iiic breast cancer
5176848|NCT00909649|fibrin glue|fibrin glue
5176849|NCT00909649|seroma|seroma
5176850|NCT00909649|mastectomy|mastectomy
5176851|NCT00909636|multiple ascending doses (MAD)|multiple ascending doses (mad)
5176852|NCT00909610|Bioequivalence|bioequivalence
5176853|NCT00909610|Healthy Subjects|healthy subjects
5176854|NCT00909584|Hematology|hematology
5176855|NCT00909584|Neutropenia|neutropenia
5176857|NCT00909584|Severe Chronic Neutropenia|severe chronic neutropenia
5176858|NCT00909584|Idiopathic|idiopathic
5176859|NCT00909584|Telintra|telintra
5176860|NCT00909584|ezatiostat hydrochloride|ezatiostat hydrochloride
5176861|NCT00909584|ezatiostat|ezatiostat
5176862|NCT00909584|TLK199|tlk199
5176863|NCT00909584|Glutathione|glutathione
5176864|NCT00909584|Glutathione analog|glutathione analog
5176865|NCT00909584|Glutathione Transferase|glutathione transferase
5176866|NCT00909584|Glutathione Transferase inhibitor|glutathione transferase inhibitor
5176867|NCT00909584|Glutathione Transferase P1-1 inhibitor|glutathione transferase p1-1 inhibitor
5176868|NCT00909584|GSTp1-1 inhibitor|gstp1-1 inhibitor
5176869|NCT00909584|Apoptosis|apoptosis
5176870|NCT00909584|Differentiation|differentiation
5176871|NCT00909584|Enzyme inhibitor|enzyme inhibitor
5176872|NCT00909571|FK506E|fk506e
5176873|NCT00909571|MR4|mr4
5176874|NCT00909571|Prograf|prograf
5176875|NCT00909571|Tacrolimus|tacrolimus
5176876|NCT00909571|Living Liver Transplantation|living liver transplantation
5176877|NCT00909558|metastatic malignancies|metastatic malignancies
5176878|NCT00909558|tumor markers|tumor markers
5176879|NCT00909558|chemotherapy|chemotherapy
5176880|NCT00909558|cancer|cancer
5176881|NCT00909558|breast cancer|breast cancer
5176882|NCT00909558|glioma|glioma
5176883|NCT00909558|hepatocellular cancer|hepatocellular cancer
5176884|NCT00909558|squamous cell lung cancer|squamous cell lung cancer
5176885|NCT00909558|pancreatic cancer|pancreatic cancer
5176886|NCT00909558|colon cancer|colon cancer
5176887|NCT00909558|prostate cancer|prostate cancer
5176888|NCT00909545|Early Parkinson disease|early parkinson disease
5176889|NCT00909532|Fibrosis|fibrosis
5176890|NCT00909532|Pancreatic Diseases|pancreatic diseases
5176891|NCT00909532|Lung Diseases|lung diseases
5176892|NCT00909532|Respiratory Tract Diseases|respiratory tract diseases
5176893|NCT00909532|Genetic Diseases, Inborn|genetic diseases, inborn
5176894|NCT00909532|Infant, Newborn, Diseases|infant, newborn, diseases
5176895|NCT00909532|Pathologic Processes|pathologic processes
5176896|NCT00909493|Improvement of patient care as measured by self-rated health and improve physician satisfaction with chronic pain management|improvement of patient care as measured by self-rated health and improve physician satisfaction with chronic pain management
5176897|NCT00909454|Vitamin D deficiency|vitamin d deficiency
5176898|NCT00909454|Adolescents|adolescents
5176899|NCT00909454|African Americans|african americans
5176900|NCT00909454|Overweight|overweight
5176901|NCT00909454|Obesity|obesity
5176902|NCT00909441|Breast Cancer|breast cancer
5176903|NCT00909441|Node Positive Breast Cancer|node positive breast cancer
5176904|NCT00909441|Sentinel Lymph Node Biopsy|sentinel lymph node biopsy
5176905|NCT00909441|Breast Surgery|breast surgery
5176906|NCT00909441|Axillary Lymph Node Dissection|axillary lymph node dissection
5176907|NCT00909441|Neoadjuvant Chemotherapy|neoadjuvant chemotherapy
5176908|NCT00909428|Bladder|bladder
5176909|NCT00909428|Urinary Urgency|urinary urgency
5176910|NCT00909428|Solifenacin|solifenacin
5176911|NCT00909428|Vesicare(R)|vesicare(r)
5176912|NCT00909415|patients with anorectal malformation|patients with anorectal malformation
5176913|NCT00909376|Pregnancy|pregnancy
5176914|NCT00909376|Ultrasonography|ultrasonography
5176915|NCT00909376|outcome|outcome
5176916|NCT00909376|adverse|adverse
5176917|NCT00909350|Barrett's esophagus|barrett's esophagus
5176918|NCT00909350|BE|be
5176919|NCT00909350|esophageal adenocarcinoma|esophageal adenocarcinoma
5176920|NCT00909350|Micro-RNA|micro-rna
5176921|NCT00909350|miR expression|mir expression
5176922|NCT00909324|Post LASIK dry eye|post lasik dry eye
5176923|NCT00909324|Pre LASIK dry eye|pre lasik dry eye
5176924|NCT00909324|Hypromellose|hypromellose
5176925|NCT00909311|Food effect|food effect
5176926|NCT00909298|Left ventricular assist devices|left ventricular assist devices
5176927|NCT00909298|Cardiac Disease|cardiac disease
5176928|NCT00909298|Heart Failure|heart failure
5176929|NCT00909298|Anticoagulant for Left Ventricular Assist Devices|anticoagulant for left ventricular assist devices
5176930|NCT00909285|Alzheimer|alzheimer
5176931|NCT00909285|TMS|tms
5176932|NCT00909285|cognitive training|cognitive training
5176933|NCT00909272|ultrasound|ultrasound
5176934|NCT00909272|diagnostic|diagnostic
5176935|NCT00909272|lumbar|lumbar
5176936|NCT00909272|median branch|median branch
5176937|NCT00909272|block|block
5176938|NCT00909272|Lumbar facet joint pain|lumbar facet joint pain
5176939|NCT00909259|Sleep Disordered Breathing|sleep disordered breathing
5176940|NCT00909259|Periodic Breathing|periodic breathing
5176941|NCT00909259|Cheyne-Stokes Respiration|cheyne-stokes respiration
5176942|NCT00909259|Sleep Apnea|sleep apnea
5176943|NCT00909233|Erectile dysfunction,|erectile dysfunction,
5176944|NCT00909233|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors
5176945|NCT00909220|Major Depressive Disorder, EEG, Negativity bias|major depressive disorder, eeg, negativity bias
5176946|NCT00909207|Advanced Cancers|advanced cancers
5176947|NCT00909207|Hematologic Disorders|hematologic disorders
5176948|NCT00909207|Solid Tumors|solid tumors
5176949|NCT00909207|Cognitive Interview|cognitive interview
5176950|NCT00909207|Patient-Reported Outcomes|patient-reported outcomes
5176951|NCT00909207|PRO|pro
5176952|NCT00909207|Common Terminology Criteria for Adverse Events|common terminology criteria for adverse events
5176953|NCT00909207|CTCAE|ctcae
5176954|NCT00909207|PRO-CTCAE|pro-ctcae
5176955|NCT00909207|Cancer Symptoms|cancer symptoms
5176956|NCT00909207|Interview|interview
5176957|NCT00909194|Juvenile Primary Fibromyalgia|juvenile primary fibromyalgia
5176958|NCT00909194|Adolescents|adolescents
5176959|NCT00909194|Psychiatry|psychiatry
5176960|NCT00909168|Induction chemotherapy|induction chemotherapy
5176961|NCT00909168|Fludarabine|fludarabine
5176962|NCT00909168|Gemtuzumab Ozogamicin|gemtuzumab ozogamicin
5176963|NCT00909155|Major Depressive Disorder|major depressive disorder
5176964|NCT00909142|Breast cancer|breast cancer
5176965|NCT00909142|Prostate cancer|prostate cancer
5176966|NCT00909142|Multiple myeloma|multiple myeloma
5176967|NCT00909129|HIV-1|hiv-1
5176968|NCT00909129|Chronic hepatitis C|chronic hepatitis c
5176969|NCT00909129|Immune activation|immune activation
5176970|NCT00909129|HCV kinetics|hcv kinetics
5176971|NCT00909129|IP-10|ip-10
5176972|NCT00909116|ODS|ods
5176973|NCT00909116|chronic constipation|chronic constipation
5176974|NCT00909116|internal rectal prolapse|internal rectal prolapse
5176975|NCT00909116|rectocele|rectocele
5176976|NCT00909116|Stapled Transanal Rectal Resection|stapled transanal rectal resection
5176977|NCT00909116|Contour Transtar|contour transtar
5176978|NCT00909116|STARR|starr
5176979|NCT00909103|Endoscopic Ultrasound Elastography|endoscopic ultrasound elastography
5176980|NCT00909103|Pancreatic adenocarcinoma|pancreatic adenocarcinoma
5176981|NCT00909103|Chronic Pancreatitis|chronic pancreatitis
5176982|NCT00909090|macular pigment|macular pigment
5176983|NCT00909090|glare disability|glare disability
5176984|NCT00909090|lutein|lutein
5176985|NCT00909090|photostress|photostress
5176986|NCT00909077|ITP-Rituximab-dexamethasone|itp-rituximab-dexamethasone
5176987|NCT00909051|Diabetes Mellitus|diabetes mellitus
5176988|NCT00909012|phenylketonuria|phenylketonuria
5176989|NCT00909012|docosahexaenoic acid|docosahexaenoic acid
5176990|NCT00909012|visually evoked potential|visually evoked potential
5176991|NCT00909012|choice-reaction time|choice-reaction time
5176992|NCT00908999|anosognosia fMRI amnestic MCI Alzheimer|anosognosia fmri amnestic mci alzheimer
5176993|NCT00908999|anosognosia in AD and MCI|anosognosia in ad and mci
5176994|NCT00908986|Lupus Membranous Nephritis|lupus membranous nephritis
5176995|NCT00908973|Obesity|obesity
5176996|NCT00908973|Gastric bypass|gastric bypass
5176997|NCT00908973|Gut hormone|gut hormone
5176998|NCT00908973|Intestinal transit time|intestinal transit time
5176999|NCT00908960|enoxaparin|enoxaparin
5177000|NCT00908947|SFA|sfa
5177001|NCT00908947|Stent|stent
5177002|NCT00908947|Popliteal|popliteal
5177003|NCT00908947|infrainguinal|infrainguinal
5177004|NCT00908947|LifeStent|lifestent
5177005|NCT00908947|Peripheral|peripheral
5177006|NCT00908947|Arterial|arterial
5177007|NCT00908934|Relative Bioavailability|relative bioavailability
5177008|NCT00908934|AZD9056|azd9056
5177009|NCT00908908|Advanced Solid Tumors|advanced solid tumors
5177010|NCT00908908|Failure of Multiple Prior Chemotherapy Regimens|failure of multiple prior chemotherapy regimens
5177011|NCT00908895|Radius fractures|radius fractures
5177012|NCT00908895|Radio-radial fixator|radio-radial fixator
5177013|NCT00908895|Percutaneous pinning|percutaneous pinning
5177014|NCT00908895|Grip strength|grip strength
5177015|NCT00908882|Nursing Care|nursing care
5177016|NCT00908882|Veterans|veterans
5177017|NCT00908869|advanced neoplasm|advanced neoplasm
5177018|NCT00908869|adult advanced neoplasm|adult advanced neoplasm
5177019|NCT00908856|stroke cell therapy repair autologous|stroke cell therapy repair autologous
5177020|NCT00908843|Contrast nephropathy|contrast nephropathy
5177021|NCT00908843|Renal failure|renal failure
5177022|NCT00908817|postoperative sore throat|postoperative sore throat
5177023|NCT00908817|tracheal intubation|tracheal intubation
5177024|NCT00908817|lubrication|lubrication
5177025|NCT00908817|triamcinolone|triamcinolone
5177026|NCT00908804|acute appendicitis|acute appendicitis
5177027|NCT00908791|Conjugated Linoleic Acid|conjugated linoleic acid
5177028|NCT00908791|Proof of Principle|proof of principle
5177029|NCT00908791|Lipogenic Pathway|lipogenic pathway
5177030|NCT00908791|Clarinol|clarinol
5177031|NCT00908778|Diabetic Retinopathy|diabetic retinopathy
5177032|NCT00908765|Exercise Training COPD|exercise training copd
5177033|NCT00908752|HCC|hcc
5177034|NCT00908739|stage I renal cell cancer|stage i renal cell cancer
5177035|NCT00908739|stage III renal cell cancer|stage iii renal cell cancer
5177036|NCT00908739|recurrent renal cell cancer|recurrent renal cell cancer
5177037|NCT00908739|clear cell renal cell carcinoma|clear cell renal cell carcinoma
5177038|NCT00908739|childhood renal cell carcinoma|childhood renal cell carcinoma
5177039|NCT00908713|Severe CAP|severe cap
5177040|NCT00908713|Adjuvant therapy|adjuvant therapy
5178251|NCT00904072|CPOE|cpoe
5177041|NCT00908713|Glucocorticoids|glucocorticoids
5177042|NCT00908713|CAP Fine V with C-reactive protein >= 15 mg/100 mL|cap fine v with c-reactive protein >= 15 mg/100 ml
5177043|NCT00908700|Atrial fibrillation|atrial fibrillation
5177044|NCT00908700|Stroke|stroke
5177045|NCT00908700|left atrial appendage|left atrial appendage
5177046|NCT00908700|Re-exploration for bleeding|re-exploration for bleeding
5177047|NCT00908661|Parastomal, hernia|parastomal, hernia
5177048|NCT00908648|screening colonoscopy|screening colonoscopy
5177049|NCT00908648|narrow band imaging|narrow band imaging
5177050|NCT00908635|sepsis|sepsis
5177051|NCT00908635|organ failure|organ failure
5177052|NCT00908622|Percutaneous implantation of autologous myoblasts|percutaneous implantation of autologous myoblasts
5177053|NCT00908609|Breast Cancer Diagnosis|breast cancer diagnosis
5177054|NCT00908609|Optical Imaging|optical imaging
5177055|NCT00908609|Ultrasound Imaging|ultrasound imaging
5177056|NCT00908609|Monitoring Neoadjuvant Chemotherapy Response|monitoring neoadjuvant chemotherapy response
5177057|NCT00908596|Nephrogenic Systemic Fibrosis (NSF)|nephrogenic systemic fibrosis (nsf)
5177058|NCT00908596|Primovist / Eovist|primovist / eovist
5177059|NCT00908583|Alloantibody|alloantibody
5177060|NCT00908583|Desensitization|desensitization
5177061|NCT00908583|Kidney Transplantation|kidney transplantation
5177062|NCT00908583|Nephrology|nephrology
5177063|NCT00908583|Plasma Cells|plasma cells
5177064|NCT00908583|Translational Research/Science|translational research/science
5177065|NCT00908570|estrogen|estrogen
5177066|NCT00908570|estriol|estriol
5177067|NCT00908570|cream|cream
5177068|NCT00908570|vagina|vagina
5177069|NCT00908570|infection prevention|infection prevention
5177070|NCT00908557|Lexicosyntactic readability improvement|lexicosyntactic readability improvement
5177071|NCT00908557|phase II/III trials|phase ii/iii trials
5177072|NCT00908557|ethic|ethic
5177073|NCT00908557|Informed consent|informed consent
5177074|NCT00908544|HIV-infection|hiv-infection
5177075|NCT00908544|Primary HIV-infection|primary hiv-infection
5177076|NCT00908544|Proviral DNA|proviral dna
5177077|NCT00908544|Eradication|eradication
5177078|NCT00908544|Multi drug class HAART|multi drug class haart
5177079|NCT00908531|Breast neoplasms|breast neoplasms
5177080|NCT00908531|Randomised trial|randomised trial
5177081|NCT00908531|Aromatase Inhibitors|aromatase inhibitors
5177082|NCT00908531|Preoperative care|preoperative care
5177083|NCT00908531|Age 60 or older|age 60 or older
5177084|NCT00908531|Hormone receptor positive tumor|hormone receptor positive tumor
5177085|NCT00908531|Tumor lager than 2 cm|tumor lager than 2 cm
5177086|NCT00908531|No distant metastasis|no distant metastasis
5177087|NCT00908518|Cognitive dysfunction|cognitive dysfunction
5177088|NCT00908518|Cardiac morbidity|cardiac morbidity
5177089|NCT00908518|anesthesia|anesthesia
5177090|NCT00908505|Cystic fibrosis|cystic fibrosis
5177091|NCT00908505|physiotherapy|physiotherapy
5177092|NCT00908505|pulmonary function test|pulmonary function test
5177093|NCT00908492|Randomized control trial|randomized control trial
5177094|NCT00908492|Dementia caregivers|dementia caregivers
5177095|NCT00908492|Occupational Therapy|occupational therapy
5177096|NCT00908492|Caregivers|caregivers
5177097|NCT00908479|Exercise|exercise
5177098|NCT00908479|Rehabilitation|rehabilitation
5177099|NCT00908479|leg function|leg function
5177100|NCT00908479|in patient|in patient
5177101|NCT00908479|RCT|rct
5177102|NCT00908466|Non-infectious|non-infectious
5177103|NCT00908466|Uveitis|uveitis
5177104|NCT00908466|Panuveitis|panuveitis
5177105|NCT00908453|NPC-06|npc-06
5177106|NCT00908453|fosphenytoin|fosphenytoin
5177107|NCT00908453|phenytoin|phenytoin
5177108|NCT00908453|pharmacokinetics|pharmacokinetics
5177109|NCT00908453|safety|safety
5177110|NCT00908440|Decision Aid|decision aid
5177111|NCT00908440|Posttraumatic Stress Disorder|posttraumatic stress disorder
5177112|NCT00908440|evidence-based treatments|evidence-based treatments
5177113|NCT00908427|benign prostatic hyperplasia|benign prostatic hyperplasia
5177114|NCT00908427|KTP laser|ktp laser
5177115|NCT00908427|transurethral resection of prostate|transurethral resection of prostate
5177116|NCT00908427|urinary bladder neck obstruction|urinary bladder neck obstruction
5177117|NCT00908414|PEPI-TiDP23-C104|pepi-tidp23-c104
5177118|NCT00908414|PEPI-C104|pepi-c104
5177119|NCT00908414|PEPI|pepi
5177120|NCT00908414|TMC589337|tmc589337
5177121|NCT00908414|TMC589354|tmc589354
5177122|NCT00908414|TMC310911|tmc310911
5177123|NCT00908414|Healthy Volunteers|healthy volunteers
5177124|NCT00908401|breastmilk|breastmilk
5177125|NCT00908401|oral sucrose|oral sucrose
5177126|NCT00908401|analgesia|analgesia
5177127|NCT00908401|preterm neonates|preterm neonates
5177128|NCT00908401|Neonates|neonates
5177129|NCT00908388|Acute, Complicated Type B Dissection|acute, complicated type b dissection
5177130|NCT00908375|Pregabalin|pregabalin
5177131|NCT00908375|Radicular pain|radicular pain
5177132|NCT00908375|Failed back surgery|failed back surgery
5177133|NCT00908375|Of greater than 3 months duration|of greater than 3 months duration
5177134|NCT00908362|Dendritic cells|dendritic cells
5177135|NCT00908362|Airway|airway
5177136|NCT00908362|Smoker|smoker
5177137|NCT00908362|COPD|copd
5177138|NCT00908336|Adenocarcinoma|adenocarcinoma
5178252|NCT00904046|Uric acid|uric acid
5177139|NCT00908336|Carcinoma, Non-Small Cell|carcinoma, non-small cell
5177140|NCT00908336|Lung Neoplasms|lung neoplasms
5177141|NCT00908336|Docetaxel|docetaxel
5177142|NCT00908336|Erlotinib|erlotinib
5177143|NCT00908336|Chemotherapy|chemotherapy
5177144|NCT00908323|HIV Seronegativity|hiv seronegativity
5177145|NCT00908323|HIV Preventive Vaccine|hiv preventive vaccine
5177146|NCT00908310|CKD - Chronic Kidney Disease|ckd - chronic kidney disease
5177147|NCT00908310|GBCA - Gadolinium-based contrast agent|gbca - gadolinium-based contrast agent
5177148|NCT00908310|GFR - Glomerular Filtration Rate|gfr - glomerular filtration rate
5177149|NCT00908310|MRI - Magnetic Resonance Imaging|mri - magnetic resonance imaging
5177150|NCT00908310|NSF - Nephrogenic Systemic Fibrosis|nsf - nephrogenic systemic fibrosis
5177151|NCT00908310|Known or suspected CKD with an eGFR greater than or equal to 30mL & less than 60 mL/min/1.73m2 as measured within 30 days prior to the OMNISCAN.|known or suspected ckd with an egfr greater than or equal to 30ml & less than 60 ml/min/1.73m2 as measured within 30 days prior to the omniscan.
5177152|NCT00908297|Cardiovascular disease|cardiovascular disease
5177153|NCT00908297|End stage renal disease|end stage renal disease
5177154|NCT00908297|Atherosclerosis|atherosclerosis
5177155|NCT00908297|Oxidative stress|oxidative stress
5177156|NCT00908297|Antioxidants|antioxidants
5177157|NCT00908284|AIDS|aids
5177158|NCT00908284|Acquired Immune Deficiency Syndrome Virus|acquired immune deficiency syndrome virus
5177159|NCT00908284|Human Immunodeficiency Virus|human immunodeficiency virus
5177160|NCT00908284|Exercise Physiology|exercise physiology
5177161|NCT00908284|Endothelial Dysfunction|endothelial dysfunction
5177162|NCT00908245|Preconditioning|preconditioning
5177163|NCT00908245|Hepatectomy|hepatectomy
5177164|NCT00908245|Clamping|clamping
5177165|NCT00908232|multiple myeloma|multiple myeloma
5177166|NCT00908232|bortezomib|bortezomib
5177167|NCT00908232|hematology|hematology
5177168|NCT00908232|bone marrow cancer|bone marrow cancer
5177169|NCT00908232|immunoglobulin|immunoglobulin
5177170|NCT00908232|refractory|refractory
5177171|NCT00908232|progression|progression
5177172|NCT00908232|dexamethasone|dexamethasone
5177173|NCT00908232|lenalidomide|lenalidomide
5177174|NCT00908232|cyclophosphamide|cyclophosphamide
5177175|NCT00908219|malignant ascites|malignant ascites
5177176|NCT00908219|bevacizumab|bevacizumab
5177177|NCT00908219|vascular endothelial growth factor (VEGF)|vascular endothelial growth factor (vegf)
5177178|NCT00908219|paracentesis|paracentesis
5177179|NCT00908206|Alcoholism|alcoholism
5177180|NCT00908206|Craving|craving
5177181|NCT00908206|Dependence|dependence
5177182|NCT00908206|Alcohol|alcohol
5177183|NCT00908193|Treatment of abdominal ruptured|treatment of abdominal ruptured
5177184|NCT00908193|Digestive system disease|digestive system disease
5177185|NCT00908193|Coelioscopy|coelioscopy
5177186|NCT00908193|Assistance robotics|assistance robotics
5177187|NCT00908193|Medical device|medical device
5177188|NCT00908193|DA VINCI Robot|da vinci robot
5177189|NCT00908193|Pain patient|pain patient
5177190|NCT00908193|Morphine consumption|morphine consumption
5177191|NCT00908193|Comparative Randomized study|comparative randomized study
5177192|NCT00908193|patient over 18 years|patient over 18 years
5177193|NCT00908193|with ruptured abdominal|with ruptured abdominal
5177194|NCT00908193|with an indication of treatment of ruptured|with an indication of treatment of ruptured
5177195|NCT00908180|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5177196|NCT00908167|sorafenib|sorafenib
5177197|NCT00908167|cytarabine|cytarabine
5177198|NCT00908167|clofarabine|clofarabine
5177199|NCT00908167|acute myeloid leukemia|acute myeloid leukemia
5177200|NCT00908167|acute promyelocytic leukemia|acute promyelocytic leukemia
5177201|NCT00908167|acute lymphoblastic leukemia|acute lymphoblastic leukemia
5177202|NCT00908154|sodium channel blocker|sodium channel blocker
5177203|NCT00908154|bipolar disorder|bipolar disorder
5177204|NCT00908154|repeat dose|repeat dose
5177205|NCT00908141|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5177206|NCT00908141|recurrent prostate cancer|recurrent prostate cancer
5177207|NCT00908128|Bioequivalence|bioequivalence
5177208|NCT00908128|Healthy Subjects|healthy subjects
5177209|NCT00908102|low back pain|low back pain
5177210|NCT00908102|recurrent|recurrent
5177211|NCT00908102|subacute|subacute
5177212|NCT00908102|secondary prevention|secondary prevention
5177213|NCT00908102|primary care|primary care
5177214|NCT00908102|occupational health|occupational health
5177215|NCT00908102|back book|back book
5177216|NCT00908102|rehabilitation|rehabilitation
5177217|NCT00908089|rheumatoid arthritis|rheumatoid arthritis
5177218|NCT00908089|methotrexate|methotrexate
5177219|NCT00908089|sulfasalazine|sulfasalazine
5177220|NCT00908089|hydroxychloroquine|hydroxychloroquine
5177221|NCT00908089|infliximab|infliximab
5177222|NCT00908076|constipation|constipation
5177223|NCT00908076|Parkinson's disease|parkinson's disease
5177224|NCT00908063|TBI|tbi
5177225|NCT00908063|Traumatic Brain Injury|traumatic brain injury
5177226|NCT00908050|bruxism, botulinum toxin, sleep study|bruxism, botulinum toxin, sleep study
5177227|NCT00908037|idiopathic thrombocytopenic purpura|idiopathic thrombocytopenic purpura
5177228|NCT00908037|ITP|itp
5177229|NCT00908037|pharmacokinetics|pharmacokinetics
5177230|NCT00908037|chronic ITP|chronic itp
5177231|NCT00908037|eltrombopag|eltrombopag
5177232|NCT00908037|thrombocytopenia|thrombocytopenia
5177233|NCT00908037|pharmacodynamics|pharmacodynamics
5177234|NCT00908037|pediatrics|pediatrics
5177235|NCT00908011|Hypercholesterolemia|hypercholesterolemia
5177236|NCT00908011|HIV|hiv
5177237|NCT00908011|Ezetimibe|ezetimibe
5177238|NCT00908011|Statin|statin
5177239|NCT00908011|Apolipoprotein B100/Apolipoprotein A1 ratio|apolipoprotein b100/apolipoprotein a1 ratio
5177240|NCT00907998|Coronary heart disease|coronary heart disease
5177241|NCT00907998|APL180|apl180
5177242|NCT00907985|Healthy Volunteer|healthy volunteer
5177243|NCT00907985|Resting motor threshold (rMT)|resting motor threshold (rmt)
5177244|NCT00907985|Transcranial magnetic stimulation (TMS)|transcranial magnetic stimulation (tms)
5177245|NCT00907972|Parkinson's Disease|parkinson's disease
5177246|NCT00907972|Parkinson Disease|parkinson disease
5177247|NCT00907972|PD|pd
5177248|NCT00907972|Movement Disorder|movement disorder
5177249|NCT00907946|Renal stones|renal stones
5177250|NCT00907907|Bioequivalence|bioequivalence
5177251|NCT00907907|Subjects|subjects
5177252|NCT00907894|Chronic hepatitis B,|chronic hepatitis b,
5177253|NCT00907894|telbivudine,|telbivudine,
5177254|NCT00907894|pharmacokinetics,|pharmacokinetics,
5177255|NCT00907894|safety,|safety,
5177256|NCT00907894|tolerability,|tolerability,
5177257|NCT00907894|pediatric|pediatric
5177258|NCT00907868|ductal breast carcinoma in situ|ductal breast carcinoma in situ
5177259|NCT00907855|Ischemic Heart Disease|ischemic heart disease
5177260|NCT00907855|Duke Activity Status Index|duke activity status index
5177261|NCT00907855|Stress Myocardial Perfusion Imaging|stress myocardial perfusion imaging
5177262|NCT00907842|stoma|stoma
5177263|NCT00907829|stroke|stroke
5177264|NCT00907829|fingertip force|fingertip force
5177265|NCT00907829|muscle coordination|muscle coordination
5177266|NCT00907816|this study does not look at patient conditions|this study does not look at patient conditions
5177267|NCT00907803|Orthopoxvirus|orthopoxvirus
5177268|NCT00907803|Smallpox|smallpox
5177269|NCT00907803|This is a safety study only|this is a safety study only
5177270|NCT00907803|ST-246 is being studied for treatment of Orthopoxviruses|st-246 is being studied for treatment of orthopoxviruses
5177271|NCT00907790|Irritable Bowel Syndrome|irritable bowel syndrome
5177272|NCT00907790|Cognitive Therapy|cognitive therapy
5177273|NCT00907790|Abdominal Pain|abdominal pain
5177274|NCT00907790|Quality of Life|quality of life
5177275|NCT00907777|Haemophilus influenzae|haemophilus influenzae
5177276|NCT00907777|Streptococcus pneumoniae|streptococcus pneumoniae
5177277|NCT00907777|safety|safety
5177278|NCT00907777|Pneumococcal conjugate vaccine|pneumococcal conjugate vaccine
5177279|NCT00907777|immunogenicity|immunogenicity
5177280|NCT00907725|medical abortion|medical abortion
5177281|NCT00907725|serum BhCG follow-up|serum bhcg follow-up
5177282|NCT00907725|ultrasonographic follow-up|ultrasonographic follow-up
5177283|NCT00907725|follow-up methods|follow-up methods
5177284|NCT00907712|amputation|amputation
5177285|NCT00907712|vascular|vascular
5177286|NCT00907712|below knee|below knee
5177287|NCT00907712|above knee|above knee
5177288|NCT00907712|cardiovascular|cardiovascular
5177289|NCT00907712|echo|echo
5177290|NCT00907712|cardiovascular assessment|cardiovascular assessment
5177291|NCT00907699|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5177292|NCT00907699|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5177293|NCT00907699|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5177294|NCT00907686|Transfusion Transmitted Cytomegalovirus (TT-CMV)|transfusion transmitted cytomegalovirus (tt-cmv)
5177295|NCT00907686|Low birthweight infants (LBWIs)|low birthweight infants (lbwis)
5177296|NCT00907686|Leukoreduction and filter failure|leukoreduction and filter failure
5177297|NCT00907686|CMV Seronegative blood products|cmv seronegative blood products
5177298|NCT00907660|Obesity|obesity
5177299|NCT00907660|Weight loss|weight loss
5177300|NCT00907660|Meal replacements|meal replacements
5177301|NCT00907660|Health services research|health services research
5177302|NCT00907634|cervix|cervix
5177303|NCT00907634|cervical|cervical
5177304|NCT00907634|radiation|radiation
5177305|NCT00907621|Infant Colic|infant colic
5177306|NCT00907621|Acupuncture|acupuncture
5177307|NCT00907621|General Practice|general practice
5177308|NCT00907595|Huntington's chorea|huntington's chorea
5177309|NCT00907595|Huntington's Disease|huntington's disease
5177310|NCT00907595|Parkinson's Disease|parkinson's disease
5177311|NCT00907595|Parkinsonism|parkinsonism
5177312|NCT00907595|Dementia|dementia
5177313|NCT00907595|Dementia with Lewy Bodies|dementia with lewy bodies
5177314|NCT00907595|Actigraphy|actigraphy
5177315|NCT00907595|Circadian dysregulation|circadian dysregulation
5177316|NCT00907595|Sleep Disorders|sleep disorders
5177317|NCT00907595|Circadian rhythm|circadian rhythm
5177318|NCT00907582|PCR negative|pcr negative
5177319|NCT00907569|Small cell lung cancer|small cell lung cancer
5177320|NCT00907569|radiotherapy dose escalation|radiotherapy dose escalation
5177321|NCT00907543|esophageal carcinoma|esophageal carcinoma
5177322|NCT00907543|chemotherapy|chemotherapy
5177323|NCT00907543|radiation|radiation
5177324|NCT00907543|surgery|surgery
5177325|NCT00907543|randomized clinical trial|randomized clinical trial
5177326|NCT00907543|Clinical Trial|clinical trial
5177327|NCT00907543|Radiotherapy|radiotherapy
5177328|NCT00907491|Cough|cough
5177329|NCT00907491|Wheeze Rate|wheeze rate
5177330|NCT00907491|Respiratory Function Tests|respiratory function tests
5177331|NCT00907478|Idiopathic Thrombocytopenic Purpura|idiopathic thrombocytopenic purpura
5177332|NCT00907478|Idiopathic Thrombocytopenia Purpura|idiopathic thrombocytopenia purpura
5177333|NCT00907478|Immune Thrombocytopenic Purpura|immune thrombocytopenic purpura
5177334|NCT00907478|Immune Thrombocytopenia|immune thrombocytopenia
5177335|NCT00907478|ITP|itp
5177336|NCT00907452|Pharmacogenomics|pharmacogenomics
5177337|NCT00907452|prediction response|prediction response
5177338|NCT00907452|prediction adverse event|prediction adverse event
5177339|NCT00907439|Diastole, physiopathology|diastole, physiopathology
5177340|NCT00907439|coronary artery disease|coronary artery disease
5177341|NCT00907439|volatile anesthetic|volatile anesthetic
5177342|NCT00907439|sevoflurane|sevoflurane
5177343|NCT00907426|eyelashes|eyelashes
5177344|NCT00907413|cancer|cancer
5177345|NCT00907413|bile duct|bile duct
5177346|NCT00907400|Phase 1|phase 1
5177347|NCT00907400|Healthy Volunteer|healthy volunteer
5177348|NCT00907400|Healthy Volunteer Study|healthy volunteer study
5177349|NCT00907387|Lateral Canthal Lines|lateral canthal lines
5177350|NCT00907387|Crow's Feet|crow's feet
5177351|NCT00907387|Facial Wrinkles|facial wrinkles
5177352|NCT00907374|Microalbuminuria|microalbuminuria
5177353|NCT00907374|Carotid intima media thickness|carotid intima media thickness
5177354|NCT00907374|Endothelial dysfunction|endothelial dysfunction
5177355|NCT00907374|Renin angiotensin system|renin angiotensin system
5177356|NCT00907374|Diabetic nephropathy|diabetic nephropathy
5177357|NCT00907361|pacemaker|pacemaker
5177358|NCT00907361|ICD|icd
5177359|NCT00907361|Implantable Cardioverter Defibrillator|implantable cardioverter defibrillator
5177360|NCT00907361|MRI|mri
5177361|NCT00907361|Magnetic Resonance Imaging|magnetic resonance imaging
5177362|NCT00907348|NHL|nhl
5177363|NCT00907348|Non Hodgkin Lymphoma|non hodgkin lymphoma
5177364|NCT00907348|Follicular Lymphoma|follicular lymphoma
5177365|NCT00907335|acne|acne
5177366|NCT00907335|irritation|irritation
5177367|NCT00907335|objective sensory methods|objective sensory methods
5177368|NCT00907322|oral, single ascending doses; CYP2D6 metabolizer status; healthy subjects; safety, tolerability, pharmacokinetics|oral, single ascending doses; cyp2d6 metabolizer status; healthy subjects; safety, tolerability, pharmacokinetics
5177369|NCT00907309|alcohol abuse|alcohol abuse
5177370|NCT00907309|marijuana abuse|marijuana abuse
5177371|NCT00907309|drug abuse|drug abuse
5177372|NCT00907309|tobacco use|tobacco use
5177373|NCT00907309|tobacco dependence|tobacco dependence
5177374|NCT00907296|Fracture Healing|fracture healing
5177375|NCT00907296|Tibial Diaphyseal Fracture|tibial diaphyseal fracture
5177376|NCT00907283|NBIA|nbia
5177377|NCT00907283|Iron overload AND brain|iron overload and brain
5177378|NCT00907283|Iron chelation AND neurodegeneration|iron chelation and neurodegeneration
5177379|NCT00907283|Brain iron Overload|brain iron overload
5177380|NCT00907283|Neurodegeneration|neurodegeneration
5177381|NCT00907283|Brain iron Accumulation|brain iron accumulation
5177382|NCT00907257|acne|acne
5177383|NCT00907257|irritation|irritation
5177384|NCT00907257|objective sensory methods|objective sensory methods
5177385|NCT00907218|ADHD|adhd
5177386|NCT00907218|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
5177387|NCT00907218|ADHD medication|adhd medication
5177388|NCT00907218|Chantix|chantix
5177389|NCT00907218|varenicline|varenicline
5177390|NCT00907218|smoking|smoking
5177391|NCT00907218|smoking cessation|smoking cessation
5177392|NCT00907218|quit smoking|quit smoking
5177393|NCT00907205|Advanced Solid Tumors|advanced solid tumors
5177394|NCT00907205|Metastatic Solid Tumors|metastatic solid tumors
5177395|NCT00907205|PI3K|pi3k
5177396|NCT00907205|PI3K Inhibitors|pi3k inhibitors
5177397|NCT00907205|PI3 Kinase Inhibitors|pi3 kinase inhibitors
5177398|NCT00907205|mTORC inhibitor|mtorc inhibitor
5177399|NCT00907205|mTORC1 inhibitor|mtorc1 inhibitor
5177400|NCT00907205|mTORC2 inhibitor|mtorc2 inhibitor
5177401|NCT00907205|vascular targeted|vascular targeted
5177402|NCT00907205|conjugate|conjugate
5177403|NCT00907192|Cancer|cancer
5177404|NCT00907192|Opioid analgesic prescriptions|opioid analgesic prescriptions
5177405|NCT00907192|Narcotic pain drugs|narcotic pain drugs
5177406|NCT00907192|Self-report|self-report
5177407|NCT00907192|Questionnaire|questionnaire
5177408|NCT00907192|Interview|interview
5177409|NCT00907192|Actual use|actual use
5177410|NCT00907192|Doctor-prescribed use|doctor-prescribed use
5177411|NCT00907192|Frequency of deviation|frequency of deviation
5177412|NCT00907166|Cornerstone Pharmaceuticals, Inc.|cornerstone pharmaceuticals, inc.
5177413|NCT00907166|CPI-613|cpi-613
5177414|NCT00907166|Altered Energy Metabolism Directed Compound|altered energy metabolism directed compound
5177415|NCT00907166|Phase I|phase i
5177416|NCT00907166|Phase II|phase ii
5177417|NCT00907166|Cancer|cancer
5177418|NCT00907166|Carcinoma of the Pancreas|carcinoma of the pancreas
5177419|NCT00907166|Pancreatic Cancer|pancreatic cancer
5177420|NCT00907166|Pancreatic Carcinoma|pancreatic carcinoma
5177421|NCT00907153|Polycystic Ovary Syndrome|polycystic ovary syndrome
5177422|NCT00907153|Vitamin D|vitamin d
5177423|NCT00907153|Insulin resistance|insulin resistance
5177424|NCT00907153|Inflammation|inflammation
5177425|NCT00907140|Cervical Cancer|cervical cancer
5177426|NCT00907140|Positron Emission Tomography|positron emission tomography
5177427|NCT00907140|Fluorodeoxyglucose|fluorodeoxyglucose
5177428|NCT00907127|Metabolic|metabolic
5177429|NCT00907127|Syndrome|syndrome
5177430|NCT00907127|CAN|can
5177431|NCT00907114|proliferative diabetic retinopathy|proliferative diabetic retinopathy
5177432|NCT00907114|macular edema|macular edema
5177433|NCT00907114|panphotocoagulation|panphotocoagulation
5177434|NCT00907114|topic ketorolac|topic ketorolac
5177435|NCT00907114|efficacy|efficacy
5177436|NCT00907114|treatment|treatment
5177437|NCT00907088|Iron depletion|iron depletion
5177438|NCT00907088|Children|children
5177439|NCT00907088|Educational intervention|educational intervention
5177440|NCT00907088|Office-based|office-based
5177441|NCT00907075|diabetes|diabetes
5177442|NCT00907075|nutrition|nutrition
5177443|NCT00907075|diet|diet
5177444|NCT00907075|foods|foods
5177445|NCT00907062|vitiligo|vitiligo
5177446|NCT00907062|leucoderma|leucoderma
5177447|NCT00907049|quality of sleep|quality of sleep
5177448|NCT00907049|neck pain|neck pain
5177449|NCT00907049|disability|disability
5177450|NCT00907049|catastrophizing|catastrophizing
5177451|NCT00907049|depression|depression
5177452|NCT00907036|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5177453|NCT00907023|solid organ transplant|solid organ transplant
5177454|NCT00907023|hospital discharge|hospital discharge
5177455|NCT00907010|Ageing|ageing
5177456|NCT00907010|Sarcopenia|sarcopenia
5177457|NCT00907010|Muscular contraction|muscular contraction
5177458|NCT00906997|Colorectal cancer|colorectal cancer
5177459|NCT00906997|Screening|screening
5177460|NCT00906997|Prevention|prevention
5177461|NCT00906997|Fecal occult blood test|fecal occult blood test
5177462|NCT00906997|Colonoscopy|colonoscopy
5177463|NCT00906997|Colorectal neoplasm|colorectal neoplasm
5177464|NCT00906997|Randomized clinical trial|randomized clinical trial
5177465|NCT00906984|Hepatocellular carcinoma|hepatocellular carcinoma
5177466|NCT00906984|Liver cancer|liver cancer
5177467|NCT00906984|Primary liver cancer|primary liver cancer
5177468|NCT00906984|Unresectable liver cancer|unresectable liver cancer
5177469|NCT00906984|Unresectable hepatocellular carcinoma|unresectable hepatocellular carcinoma
5177470|NCT00906984|TheraSphere|therasphere
5177471|NCT00906971|Physical Therapy|physical therapy
5177472|NCT00906971|Chronic Functional Constipation|chronic functional constipation
5177473|NCT00906971|Children|children
5177474|NCT00906945|stem cell mobilization|stem cell mobilization
5177475|NCT00906945|chemosensitization|chemosensitization
5177476|NCT00906945|CXCR4|cxcr4
5177477|NCT00906945|SDF-1|sdf-1
5177478|NCT00906945|CXCL-12|cxcl-12
5177479|NCT00906932|Fiberoptic intubation|fiberoptic intubation
5177480|NCT00906932|direct laryngoscopy|direct laryngoscopy
5177481|NCT00906932|Trachview|trachview
5177482|NCT00906932|Comparison of a fiberoptic intubating videoscope to direct laryngoscopy.|comparison of a fiberoptic intubating videoscope to direct laryngoscopy.
5177483|NCT00906919|self-efficacy|self-efficacy
5177484|NCT00906919|health behavior|health behavior
5177485|NCT00906919|patient education|patient education
5177486|NCT00906919|health education|health education
5177487|NCT00906893|[18F]-FMISO uptake|[18f]-fmiso uptake
5177488|NCT00906893|Glioblastoma|glioblastoma
5177489|NCT00906893|Hypoxia|hypoxia
5177490|NCT00906893|tumours|tumours
5177491|NCT00906880|Human African Trypanosomiasis|human african trypanosomiasis
5177492|NCT00906880|HAT|hat
5177493|NCT00906880|sleeping sickness|sleeping sickness
5177494|NCT00906880|combination treatment|combination treatment
5177495|NCT00906880|nifurtimox|nifurtimox
5177496|NCT00906880|eflornithine|eflornithine
5177497|NCT00906880|Human African Trypanosomiasis in the meningo-encephalitic phase (stage 2 HAT)|human african trypanosomiasis in the meningo-encephalitic phase (stage 2 hat)
5177498|NCT00906867|Vocal cord dysfunction|vocal cord dysfunction
5177499|NCT00906867|Laryngoscopy|laryngoscopy
5177500|NCT00906867|Methacholine challenge|methacholine challenge
5177501|NCT00906867|Pulmonary function testing|pulmonary function testing
5177502|NCT00906854|urinary incontinence|urinary incontinence
5177503|NCT00906854|physical exercise|physical exercise
5177504|NCT00906841|Disseminated diffuse large B-cell lymphoma|disseminated diffuse large b-cell lymphoma
5177505|NCT00906841|first line treatment|first line treatment
5177506|NCT00906841|R CHOP|r chop
5177507|NCT00906841|90Y-DOTA-hLL2|90y-dota-hll2
5177508|NCT00906841|Patients older than 60 years|patients older than 60 years
5177509|NCT00906828|Levodopa/carbidopa infusion|levodopa/carbidopa infusion
5177510|NCT00906828|entacapone|entacapone
5177511|NCT00906828|tolcapone|tolcapone
5177512|NCT00906828|efficacy|efficacy
5177513|NCT00906828|pharmacokinetic|pharmacokinetic
5177514|NCT00906828|pharmacodynamics|pharmacodynamics
5177515|NCT00906802|pancreaticoduodenectomy|pancreaticoduodenectomy
5177516|NCT00906802|reconstruction|reconstruction
5177517|NCT00906789|Lung Cancer|lung cancer
5177518|NCT00906789|Chest Radiograph|chest radiograph
5177519|NCT00906789|Computer-aided Detection|computer-aided detection
5177520|NCT00906789|Image processing|image processing
5177521|NCT00906763|Parkinson's disease|parkinson's disease
5177522|NCT00906763|Neurodegenerative Disorders|neurodegenerative disorders
5177523|NCT00906763|Biogenic amines|biogenic amines
5177524|NCT00906763|Chocolate|chocolate
5177525|NCT00906763|Cocoa|cocoa
5177526|NCT00906750|FLuMIST|flumist
5177527|NCT00906750|Inactivated influenza vaccine|inactivated influenza vaccine
5177528|NCT00906750|Study of FluMist versus inactivated influenza vaccine in children with cancer|study of flumist versus inactivated influenza vaccine in children with cancer
5177529|NCT00906737|Multiple Sclerosis|multiple sclerosis
5177530|NCT00906737|Gait|gait
5177531|NCT00906737|foot-drop|foot-drop
5177532|NCT00906737|Ankle-Bot|ankle-bot
5177533|NCT00906737|Physical Therapy|physical therapy
5177534|NCT00906737|Gait Abnormalities|gait abnormalities
5177535|NCT00906711|Aging|aging
5177536|NCT00906711|Postural Balance|postural balance
5177537|NCT00906685|CRVO|crvo
5177538|NCT00906685|anti-VEGF|anti-vegf
5177539|NCT00906685|Macular edema|macular edema
5177540|NCT00906672|Dermal substitute Integra®|dermal substitute integra®
5177541|NCT00906672|Flap|flap
5177542|NCT00906672|graft|graft
5177543|NCT00906672|traumatic wound|traumatic wound
5177544|NCT00906672|medico economic costs|medico economic costs
5177545|NCT00906672|esthetical and functional scar results|esthetical and functional scar results
5177546|NCT00906659|center point thickness|center point thickness
5177547|NCT00906659|diabetic retinopathy|diabetic retinopathy
5177548|NCT00906659|diabetic macular edema|diabetic macular edema
5177549|NCT00906659|macular volume|macular volume
5177550|NCT00906659|visual capacity|visual capacity
5177551|NCT00906659|visual function|visual function
5177552|NCT00906646|cardiac|cardiac
5177553|NCT00906646|surgery|surgery
5177554|NCT00906646|metabolic|metabolic
5177555|NCT00906646|supplements|supplements
5177556|NCT00906646|antioxidant|antioxidant
5177557|NCT00906633|antifungal therapies|antifungal therapies
5177558|NCT00906620|Data on student's healthy and at-risk lifestyles and their relation with health measured by well-being, depression and suicidality|data on student's healthy and at-risk lifestyles and their relation with health measured by well-being, depression and suicidality
5177559|NCT00906607|Urinary Incontinence|urinary incontinence
5177560|NCT00906581|Depression|depression
5177561|NCT00906568|Cystic fibrosis|cystic fibrosis
5177562|NCT00906568|Sensitization to Aspergillus|sensitization to aspergillus
5177563|NCT00906568|Bronchial allergen challenge|bronchial allergen challenge
5177564|NCT00906568|Induced Sputum|induced sputum
5177565|NCT00906568|Bronchial inflammation|bronchial inflammation
5177566|NCT00906568|Small airways disease (SAD)|small airways disease (sad)
5177567|NCT00906542|acute stroke|acute stroke
5177568|NCT00906542|ischemic stroke|ischemic stroke
5177569|NCT00906542|pneumonia|pneumonia
5177570|NCT00906542|chest infection|chest infection
5177571|NCT00906542|brain lesion|brain lesion
5177572|NCT00906542|lesion topology|lesion topology
5177573|NCT00906542|dysphagia|dysphagia
5177574|NCT00906542|sympathetic activation|sympathetic activation
5177575|NCT00906542|immunosuppression|immunosuppression
5177576|NCT00906529|Type 2 Diabetes|type 2 diabetes
5177577|NCT00906529|Inpatient|inpatient
5177578|NCT00906529|Length of Stay|length of stay
5177579|NCT00906529|Blood Glucose Control|blood glucose control
5177580|NCT00906516|Recurrent Glioblastoma multiforme (GBM)|recurrent glioblastoma multiforme (gbm)
5177581|NCT00906516|Recurrent Brain Tumor|recurrent brain tumor
5177582|NCT00906516|Recurrent Brain Disease|recurrent brain disease
5177583|NCT00906516|Neuradiab|neuradiab
5177584|NCT00906516|Avastin|avastin
5177585|NCT00906516|Bevacizumab|bevacizumab
5177586|NCT00906503|pulmonary nodule|pulmonary nodule
5177587|NCT00906490|Glucose Monitoring|glucose monitoring
5177588|NCT00906490|Accurate Blood Glucose Monitoring in critical care setting|accurate blood glucose monitoring in critical care setting
5177589|NCT00906451|myocardial infarction|myocardial infarction
5177590|NCT00906451|inflammation|inflammation
5177591|NCT00906451|endothelial dysfunction|endothelial dysfunction
5177592|NCT00906425|Dental Implant|dental implant
5177593|NCT00906412|Essential Tremor|essential tremor
5177594|NCT00906399|interferon|interferon
5177595|NCT00906399|injectable|injectable
5177597|NCT00906399|SC|sc
5177598|NCT00906399|PEGylated|pegylated
5177599|NCT00906399|Interferon beta-1a|interferon beta-1a
5177600|NCT00906399|relapsing|relapsing
5177601|NCT00906399|PEG|peg
5177602|NCT00906399|multiple sclerosis|multiple sclerosis
5177603|NCT00906399|subcutaneous|subcutaneous
5177604|NCT00906386|Varenicline|varenicline
5177605|NCT00906373|Hepatocellular Carcinoma|hepatocellular carcinoma
5177606|NCT00906373|Liver Neoplasms|liver neoplasms
5177607|NCT00906373|Antibodies, Monoclonal|antibodies, monoclonal
5177608|NCT00906347|Labor augmentation|labor augmentation
5177609|NCT00906347|Oral misoprostol|oral misoprostol
5177610|NCT00906334|Myelodysplastic Syndrome|myelodysplastic syndrome
5177611|NCT00906334|Trisomy 8|trisomy 8
5177612|NCT00906334|Intermediate-2 Risk Group|intermediate-2 risk group
5177613|NCT00906334|High-Risk Group|high-risk group
5177614|NCT00906334|azacitidine|azacitidine
5177615|NCT00906334|azacytidine|azacytidine
5177616|NCT00906334|Vidaza|vidaza
5177617|NCT00906334|decitabine|decitabine
5177618|NCT00906334|Dacogen|dacogen
5177619|NCT00906321|Web-Based Decision Support|web-based decision support
5178359|NCT00903565|ColoPrint|coloprint
5177620|NCT00906321|Breast Cancer Risk|breast cancer risk
5177621|NCT00906295|Hemoglobin|hemoglobin
5177622|NCT00906295|Ambulation|ambulation
5177623|NCT00906282|neoadjuvant NSCLC|neoadjuvant nsclc
5177624|NCT00906282|NSCLC|nsclc
5177625|NCT00906282|pemetrexed|pemetrexed
5177626|NCT00906269|impotence|impotence
5177627|NCT00906269|prostatic neoplasms|prostatic neoplasms
5177628|NCT00906269|hyperbaric oxygenation|hyperbaric oxygenation
5177629|NCT00906269|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors
5177630|NCT00906256|Hepatitis C|hepatitis c
5177631|NCT00906256|Pharmacokinetics|pharmacokinetics
5177632|NCT00906256|AZD7295|azd7295
5177633|NCT00906256|Healthy volunteers|healthy volunteers
5177634|NCT00906217|colonoscopy|colonoscopy
5177635|NCT00906217|preparation|preparation
5177636|NCT00906217|safety|safety
5177637|NCT00906217|elderly|elderly
5177638|NCT00906204|Renal transplantation|renal transplantation
5177639|NCT00906204|Kidney transplantation|kidney transplantation
5177640|NCT00906178|HIV prevention|hiv prevention
5177641|NCT00906178|technology|technology
5177642|NCT00906178|adolescent|adolescent
5177643|NCT00906178|developing countries|developing countries
5177644|NCT00906152|quality of sleep|quality of sleep
5177645|NCT00906152|low back pain|low back pain
5177646|NCT00906152|disability|disability
5177647|NCT00906152|catastrophizing|catastrophizing
5177648|NCT00906152|depression|depression
5177649|NCT00906139|Propofol|propofol
5177650|NCT00906139|Midazolam|midazolam
5177651|NCT00906139|Cirrhosis|cirrhosis
5177652|NCT00906139|Gastrointestinal endoscopy|gastrointestinal endoscopy
5177653|NCT00906139|Complications|complications
5177654|NCT00906139|Sedation|sedation
5177655|NCT00906126|oral misoprostol|oral misoprostol
5177656|NCT00906126|labor augmentation|labor augmentation
5177657|NCT00906126|arrest of dilation|arrest of dilation
5177658|NCT00906126|nulliparous|nulliparous
5177659|NCT00906113|Retinoblastoma|retinoblastoma
5177660|NCT00906100|Biventricular ICD|biventricular icd
5177661|NCT00906100|AV delay|av delay
5177662|NCT00906087|Myocilin gene|myocilin gene
5177663|NCT00906087|Glaucoma|glaucoma
5177664|NCT00906087|dorzolamide and timolol combination eyedrop|dorzolamide and timolol combination eyedrop
5177665|NCT00906074|Surgical Wound Infection|surgical wound infection
5177666|NCT00906074|Surgical Site Infection|surgical site infection
5177667|NCT00906074|Abdominal Surgery|abdominal surgery
5177668|NCT00906061|Carcinoma, Small Cell|carcinoma, small cell
5177669|NCT00906061|Lung Neoplasms|lung neoplasms
5177670|NCT00906061|Docetaxel|docetaxel
5177671|NCT00906061|Gemcitabine|gemcitabine
5177673|NCT00906035|Peripheral Arterial Disease|peripheral arterial disease
5177674|NCT00906035|PAD|pad
5177675|NCT00906035|Claudication|claudication
5177676|NCT00906035|Peripheral Vascular Disease|peripheral vascular disease
5177677|NCT00906022|Below the Knee|below the knee
5177678|NCT00906022|Infrapopliteal arteries|infrapopliteal arteries
5177679|NCT00906022|nitinol|nitinol
5177680|NCT00906022|limb ischemia|limb ischemia
5177681|NCT00906022|claudication|claudication
5177682|NCT00906022|self-expanding stent|self-expanding stent
5177683|NCT00906022|duplex|duplex
5177684|NCT00906022|angiography|angiography
5177685|NCT00905983|Carcinoma, Non-Small-Cell|carcinoma, non-small-cell
5177686|NCT00905983|Elderly patients|elderly patients
5177687|NCT00905983|Docetaxel|docetaxel
5177688|NCT00905983|Gemcitabine|gemcitabine
5177689|NCT00905957|transversus abdominis plane block|transversus abdominis plane block
5177690|NCT00905957|relief|relief
5177691|NCT00905944|Left ventricular failure|left ventricular failure
5177692|NCT00905944|chronic heart failure|chronic heart failure
5177693|NCT00905944|Pacemaker|pacemaker
5177694|NCT00905944|Resynchronisation therapy|resynchronisation therapy
5177695|NCT00905944|Exercise|exercise
5177696|NCT00905944|Endurance exercise|endurance exercise
5177697|NCT00905931|Aneurysmal subarachnoid hemorrhage (aSAH)|aneurysmal subarachnoid hemorrhage (asah)
5177698|NCT00905931|Cerebral vasospasm|cerebral vasospasm
5177699|NCT00905931|impaired cerebral autoregulation|impaired cerebral autoregulation
5177700|NCT00905931|transient hyperaemic response test|transient hyperaemic response test
5177701|NCT00905931|delayed ischaemic neurological deficits|delayed ischaemic neurological deficits
5177702|NCT00905918|colon cancer|colon cancer
5177703|NCT00905918|rectal cancer|rectal cancer
5177704|NCT00905905|myocardial infarction|myocardial infarction
5177705|NCT00905905|systemic inflammatory activity|systemic inflammatory activity
5177706|NCT00905905|endothelial function|endothelial function
5177707|NCT00905892|overfeeding|overfeeding
5177708|NCT00905892|stable isotopes|stable isotopes
5177709|NCT00905892|lipoprotein metabolism|lipoprotein metabolism
5177710|NCT00905892|lipid oxidation|lipid oxidation
5177711|NCT00905892|fat distribution|fat distribution
5177712|NCT00905892|gene expression|gene expression
5177713|NCT00905892|endotoxemia|endotoxemia
5177714|NCT00905892|mass spectrometry/gas chromatography|mass spectrometry/gas chromatography
5177715|NCT00905879|Magnetic Resonance Imaging (MRI)|magnetic resonance imaging (mri)
5177716|NCT00905879|Observational study|observational study
5177717|NCT00905879|Gadobutrol|gadobutrol
5177718|NCT00905866|Quality of life|quality of life
5177719|NCT00905866|Hyperparathyroidism|hyperparathyroidism
5178553|NCT00902863|mindfulness|mindfulness
5177720|NCT00905853|Ventricular Tachycardia|ventricular tachycardia
5177721|NCT00905853|Catheter Ablation|catheter ablation
5177722|NCT00905853|ICD therapy|icd therapy
5177723|NCT00905853|Antiarrhythmic Drug Therapy|antiarrhythmic drug therapy
5177724|NCT00905853|Ischemic Heart Disease|ischemic heart disease
5177725|NCT00905827|suicide|suicide
5177726|NCT00905827|assessment|assessment
5177727|NCT00905827|management|management
5177728|NCT00905827|Provider Training|provider training
5177729|NCT00905827|health services|health services
5177730|NCT00905814|Bioequivalence|bioequivalence
5177731|NCT00905801|Non small cell lung cancer|non small cell lung cancer
5177732|NCT00905801|NSCLC|nsclc
5177733|NCT00905801|CTP|ctp
5177734|NCT00905801|Perfusion|perfusion
5177735|NCT00905801|Imaging|imaging
5177736|NCT00905788|Embryo transfer|embryo transfer
5177737|NCT00905788|IVF/ICSI|ivf/icsi
5177738|NCT00905788|Embryo expulsion|embryo expulsion
5177739|NCT00905775|Isoflurane;|isoflurane;
5177740|NCT00905775|Propofol|propofol
5177741|NCT00905775|Renal functions tests|renal functions tests
5177742|NCT00905775|Cardiovascular tests|cardiovascular tests
5177743|NCT00905775|revascularization surgery of the myocardium|revascularization surgery of the myocardium
5177744|NCT00905775|extracorporeal circulation|extracorporeal circulation
5177745|NCT00905762|pharmacokinetics|pharmacokinetics
5177746|NCT00905736|tendon|tendon
5177747|NCT00905736|healing|healing
5177748|NCT00905736|microcurrent|microcurrent
5177749|NCT00905736|chronic tennis elbow|chronic tennis elbow
5177750|NCT00905723|climacterium|climacterium
5177751|NCT00905723|sexual life|sexual life
5177752|NCT00905723|isoflavone|isoflavone
5177753|NCT00905723|estrogen|estrogen
5177754|NCT00905723|McCoy's sexual questionnaire|mccoy's sexual questionnaire
5177755|NCT00905723|Kupperman index|kupperman index
5177756|NCT00905710|colorectal adenomas|colorectal adenomas
5177757|NCT00905710|colorectal cancer|colorectal cancer
5177758|NCT00905710|Lynch syndrome|lynch syndrome
5177759|NCT00905710|chromoendoscopy|chromoendoscopy
5177760|NCT00905697|Living donor lung transplantation|living donor lung transplantation
5177761|NCT00905697|Health-related quality of life|health-related quality of life
5177762|NCT00905697|Prognosis|prognosis
5177763|NCT00905697|Patient reported outcome|patient reported outcome
5177764|NCT00905684|Compliance|compliance
5177765|NCT00905684|Hormonal Contraception|hormonal contraception
5177766|NCT00905671|Lipid Core Plaque|lipid core plaque
5177767|NCT00905671|LCP|lcp
5177768|NCT00905671|Bifurcation|bifurcation
5177769|NCT00905671|Stenosis|stenosis
5177770|NCT00905671|Lesion|lesion
5177771|NCT00905671|Angioplasty|angioplasty
5177772|NCT00905658|stage IVA cervical cancer|stage iva cervical cancer
5177773|NCT00905658|stage IVB cervical cancer|stage ivb cervical cancer
5177774|NCT00905658|fallopian tube cancer|fallopian tube cancer
5177775|NCT00905658|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5177776|NCT00905658|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
5177777|NCT00905658|ovarian sarcoma|ovarian sarcoma
5177778|NCT00905658|ovarian stromal cancer|ovarian stromal cancer
5177779|NCT00905658|stage IV endometrial carcinoma|stage iv endometrial carcinoma
5177780|NCT00905658|stage IV uterine sarcoma|stage iv uterine sarcoma
5177781|NCT00905658|stage IVA vaginal cancer|stage iva vaginal cancer
5177782|NCT00905658|stage IVB vaginal cancer|stage ivb vaginal cancer
5177783|NCT00905658|stage IV vulvar cancer|stage iv vulvar cancer
5177784|NCT00905645|Breast Augmentation|breast augmentation
5177785|NCT00905645|Breast Reconstruction|breast reconstruction
5177786|NCT00905645|Breast Revision|breast revision
5177787|NCT00905645|Silicone breast implants|silicone breast implants
5177788|NCT00905606|Bioequivalence|bioequivalence
5177789|NCT00905606|Healthy Subjects|healthy subjects
5177790|NCT00905593|chronic myeloid leukemia,|chronic myeloid leukemia,
5177791|NCT00905593|blast crisis,|blast crisis,
5177792|NCT00905593|accelerated phase,|accelerated phase,
5177793|NCT00905593|nilotinib,|nilotinib,
5177794|NCT00905593|imatinib,|imatinib,
5177795|NCT00905593|resistant,|resistant,
5177796|NCT00905593|intolerant,|intolerant,
5177797|NCT00905593|chronic phase|chronic phase
5177798|NCT00905580|thyroidectomy|thyroidectomy
5177799|NCT00905580|pain, postoperative|pain, postoperative
5177800|NCT00905580|pregabalin|pregabalin
5177801|NCT00905567|Bioequivalence|bioequivalence
5177802|NCT00905567|Healthy Subjects|healthy subjects
5177803|NCT00905554|sedation|sedation
5177804|NCT00905554|warm water|warm water
5177805|NCT00905528|type 2 diabetes mellitus|type 2 diabetes mellitus
5177806|NCT00905528|endothelial function|endothelial function
5177807|NCT00905528|renal hemodynamics|renal hemodynamics
5177808|NCT00905515|Kidney Transplantation|kidney transplantation
5177809|NCT00905515|Immunosuppressive Agents|immunosuppressive agents
5177810|NCT00905502|Obesity|obesity
5177811|NCT00905502|fluid management|fluid management
5177812|NCT00905502|postoperative complications|postoperative complications
5177813|NCT00905502|bariatric surgery|bariatric surgery
5177814|NCT00905502|hemostasis|hemostasis
5177815|NCT00905476|NPPV|nppv
5177816|NCT00905476|Prognosis|prognosis
5177817|NCT00905476|Health-related quality of life|health-related quality of life
5177818|NCT00905476|Patient reported outcomes|patient reported outcomes
5177819|NCT00905463|Lung transplant candidates|lung transplant candidates
5177820|NCT00905463|Health-related quality of life|health-related quality of life
5177821|NCT00905463|patient reported outcome|patient reported outcome
5177822|NCT00905463|Prognosis|prognosis
5177823|NCT00905450|Surgery|surgery
5177824|NCT00905437|perioperative|perioperative
5177825|NCT00905437|pregabalin|pregabalin
5177826|NCT00905437|total hip replacement|total hip replacement
5177827|NCT00905437|post-operative pain|post-operative pain
5177828|NCT00905411|Overweight|overweight
5177829|NCT00905411|blood pressure|blood pressure
5177830|NCT00905411|DASH diet|dash diet
5177831|NCT00905411|Pacific|pacific
5177832|NCT00905411|children|children
5177833|NCT00905398|Leukemia|leukemia
5177834|NCT00905398|Lymphoblastic|lymphoblastic
5177835|NCT00905398|Acute|acute
5177836|NCT00905398|Philadelphia|philadelphia
5177837|NCT00905398|BCR-ABL|bcr-abl
5177838|NCT00905398|Nilotinib|nilotinib
5177839|NCT00905398|Treatment|treatment
5177840|NCT00905385|nontypeable Haemophilus influenzae, NTHi|nontypeable haemophilus influenzae, nthi
5177841|NCT00905346|Bioequivalence|bioequivalence
5177842|NCT00905346|Healthy Subjects|healthy subjects
5177843|NCT00905333|pharmacokinetics|pharmacokinetics
5177844|NCT00905333|candesartan|candesartan
5177845|NCT00905333|felodipine|felodipine
5177846|NCT00905333|test formulations|test formulations
5177847|NCT00905333|Atacand®|atacand®
5177848|NCT00905333|Splendil®|splendil®
5177849|NCT00905333|healthy volunteers|healthy volunteers
5177850|NCT00905333|blood samples|blood samples
5177851|NCT00905333|after meal intake interaction|after meal intake interaction
5177852|NCT00905333|Kinetic interaction amongst test formulations of Candesartan and Felodipine and the brands Atacand® and Splendil® in healthy volunteers after a fasting period.|kinetic interaction amongst test formulations of candesartan and felodipine and the brands atacand® and splendil® in healthy volunteers after a fasting period.
5177853|NCT00905320|Hernia repair|hernia repair
5177854|NCT00905307|Schizophrenia|schizophrenia
5177855|NCT00905307|Relapsed|relapsed
5177856|NCT00905281|Metastatic breast cancer|metastatic breast cancer
5177857|NCT00905281|Supportive care|supportive care
5177858|NCT00905281|Third or fourth line of chemotherapy|third or fourth line of chemotherapy
5177859|NCT00905281|Quality of life|quality of life
5177860|NCT00905281|Treatment preferences|treatment preferences
5177861|NCT00905268|FRDA|frda
5177862|NCT00905268|idebenone|idebenone
5177863|NCT00905268|FRDA disease|frda disease
5177864|NCT00905255|hyperglycemia|hyperglycemia
5177865|NCT00905255|GLP-1|glp-1
5177866|NCT00905242|Kidney Transplantation|kidney transplantation
5177867|NCT00905242|Gastrointestinal Agents|gastrointestinal agents
5177868|NCT00905229|hip fracture|hip fracture
5177869|NCT00905229|warfarin|warfarin
5177870|NCT00905229|vitamin k|vitamin k
5177871|NCT00905229|Phytonadione|phytonadione
5177872|NCT00905229|INR level|inr level
5177873|NCT00905216|heparin|heparin
5177874|NCT00905203|Postmenopausal women|postmenopausal women
5177875|NCT00905203|Diabetes|diabetes
5177876|NCT00905203|Skin microcirculation|skin microcirculation
5177877|NCT00905203|Exercise capacity|exercise capacity
5177878|NCT00905203|Skeletal muscle oxygenation|skeletal muscle oxygenation
5177879|NCT00905203|Dose-response relationship|dose-response relationship
5177880|NCT00905203|postmenopausal diabetic women|postmenopausal diabetic women
5177881|NCT00905177|Atrial Fibrillation|atrial fibrillation
5177882|NCT00905177|deep vein thrombosis|deep vein thrombosis
5177883|NCT00905177|anticoagulation|anticoagulation
5177884|NCT00905177|warfarin|warfarin
5177885|NCT00905177|coumadin|coumadin
5177886|NCT00905164|Bioequivalence|bioequivalence
5177887|NCT00905164|Healthy Subjects|healthy subjects
5177888|NCT00905151|HIV positive|hiv positive
5177889|NCT00905151|AIDS|aids
5177890|NCT00905151|antiretroviral|antiretroviral
5177891|NCT00905151|Kidney disease|kidney disease
5177892|NCT00905151|Antiretroviral Therapy|antiretroviral therapy
5177893|NCT00905138|Safety|safety
5177894|NCT00905138|Tolerability|tolerability
5177895|NCT00905138|Pharmacokinetics|pharmacokinetics
5177896|NCT00905125|influenza, trivalent, vaccine, pregnant women|influenza, trivalent, vaccine, pregnant women
5177897|NCT00905112|Pregnancy|pregnancy
5177898|NCT00905112|Pain|pain
5177899|NCT00905112|Musculoskeletal manipulations|musculoskeletal manipulations
5177900|NCT00905112|Exercise|exercise
5177901|NCT00905086|cognitive/functional effects|cognitive/functional effects
5177902|NCT00905086|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
5177903|NCT00905086|stage I breast cancer|stage i breast cancer
5177904|NCT00905086|stage II breast cancer|stage ii breast cancer
5177905|NCT00905086|stage IIIA breast cancer|stage iiia breast cancer
5177906|NCT00905086|stage IIIB breast cancer|stage iiib breast cancer
5177907|NCT00905086|stage IIIC breast cancer|stage iiic breast cancer
5177908|NCT00905086|stage I colon cancer|stage i colon cancer
5177909|NCT00905086|stage II colon cancer|stage ii colon cancer
5177910|NCT00905086|stage III colon cancer|stage iii colon cancer
5177911|NCT00905086|stage I rectal cancer|stage i rectal cancer
5177912|NCT00905086|stage II rectal cancer|stage ii rectal cancer
5177913|NCT00905086|stage III rectal cancer|stage iii rectal cancer
5177914|NCT00905086|stage I non-small cell lung cancer|stage i non-small cell lung cancer
5177915|NCT00905086|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
5177916|NCT00905086|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5177917|NCT00905086|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5177918|NCT00905086|stage I prostate cancer|stage i prostate cancer
5177919|NCT00905086|stage II prostate cancer|stage ii prostate cancer
5177920|NCT00905086|stage III prostate cancer|stage iii prostate cancer
5177921|NCT00905086|extensive stage small cell lung cancer|extensive stage small cell lung cancer
5177922|NCT00905086|limited stage small cell lung cancer|limited stage small cell lung cancer
5177923|NCT00905073|type 1 diabetes mellitus|type 1 diabetes mellitus
5177924|NCT00905073|cyclosporin|cyclosporin
5177925|NCT00905073|methotrexate|methotrexate
5177926|NCT00905073|renal function|renal function
5177927|NCT00905060|Newly Diagnosed Glioblastoma Multiforme, vaccine|newly diagnosed glioblastoma multiforme, vaccine
5177928|NCT00905047|colo-rectal cancer|colo-rectal cancer
5177929|NCT00905047|advanced|advanced
5177930|NCT00905047|metastatic|metastatic
5177931|NCT00905047|locally advanced or metastatic colo-rectal cancer|locally advanced or metastatic colo-rectal cancer
5177932|NCT00905034|Acute lymphoblastic leukemia|acute lymphoblastic leukemia
5177933|NCT00905034|ALL|all
5177934|NCT00905034|Leukemia|leukemia
5177935|NCT00905034|Methotrexate|methotrexate
5177936|NCT00905034|Vincristine|vincristine
5177937|NCT00905034|PEG-l-asparaginase|peg-l-asparaginase
5177938|NCT00905034|PEG asparaginase|peg asparaginase
5177939|NCT00905034|Pegaspargase|pegaspargase
5177940|NCT00905034|Oncaspar|oncaspar
5177941|NCT00905034|Polyethylene Glycol Conjugated Lasparaginase-H|polyethylene glycol conjugated lasparaginase-h
5177942|NCT00905034|Dexamethasone|dexamethasone
5177943|NCT00905034|Decadron|decadron
5177944|NCT00905034|Rituximab|rituximab
5177945|NCT00905034|Rituxan|rituxan
5177946|NCT00905021|Breast Cancer|breast cancer
5177947|NCT00905021|Metastatic|metastatic
5177948|NCT00905021|Hormone Receptor Positive|hormone receptor positive
5177949|NCT00905008|drug-eluting stent|drug-eluting stent
5177950|NCT00905008|bare-metal stent|bare-metal stent
5177951|NCT00905008|long-term safety|long-term safety
5177952|NCT00905008|mortality|mortality
5177953|NCT00905008|stent thrombosis|stent thrombosis
5177954|NCT00905008|Angioplasty|angioplasty
5177955|NCT00905008|Transluminal|transluminal
5177956|NCT00905008|Percutaneous Coronary|percutaneous coronary
5177957|NCT00904995|Leukemia|leukemia
5177958|NCT00904995|Cancer of the blood|cancer of the blood
5177959|NCT00904995|Cancer of the bone marrow|cancer of the bone marrow
5177960|NCT00904995|Hematologic malignancy|hematologic malignancy
5177961|NCT00904995|Invasive fungal infection|invasive fungal infection
5177962|NCT00904995|Voriconazole|voriconazole
5177963|NCT00904995|Vfend|vfend
5177964|NCT00904995|antifungal prophylaxis|antifungal prophylaxis
5177965|NCT00904982|warfarin|warfarin
5177966|NCT00904982|coumadin|coumadin
5177967|NCT00904982|adherence|adherence
5177968|NCT00904982|mechanical heart valves|mechanical heart valves
5177969|NCT00904969|Urinary Incontinence, Stress|urinary incontinence, stress
5177970|NCT00904969|Intrinsic sphincter deficiency|intrinsic sphincter deficiency
5177971|NCT00904969|Secondary|secondary
5177972|NCT00904969|Transurethral Resection (TUR)|transurethral resection (tur)
5177973|NCT00904969|Transurethral Resection of the Prostate (TURP)|transurethral resection of the prostate (turp)
5177974|NCT00904969|Radical prostatectomy|radical prostatectomy
5177975|NCT00904969|Open prostatectomy|open prostatectomy
5177976|NCT00904969|Post-suprapubic prostatectomy|post-suprapubic prostatectomy
5177977|NCT00904956|Latent Tuberculosis Infection|latent tuberculosis infection
5177978|NCT00904956|High Resolution Scanners|high resolution scanners
5177979|NCT00904956|Dynamic Hypothesis of Latent Tuberculosis Infection|dynamic hypothesis of latent tuberculosis infection
5177980|NCT00904943|Bioequivalence|bioequivalence
5177981|NCT00904943|Healthy Subjects|healthy subjects
5177982|NCT00904930|Tooth mobility assessment|tooth mobility assessment
5177983|NCT00904930|Splinting|splinting
5177984|NCT00904930|Splint Rigidity|splint rigidity
5177985|NCT00904917|African American Mothers|african american mothers
5177986|NCT00904917|Children|children
5177987|NCT00904917|African American Families|african american families
5177988|NCT00904917|Parental Depression|parental depression
5177989|NCT00904917|Preventive Intervention|preventive intervention
5177990|NCT00904891|Adolescents|adolescents
5177991|NCT00904891|Prevention|prevention
5177992|NCT00904891|Bibliotherapy|bibliotherapy
5177993|NCT00904878|pregnant IBD patients|pregnant ibd patients
5177994|NCT00904865|Single port access|single port access
5177995|NCT00904865|Laparoscopy|laparoscopy
5177996|NCT00904865|cholecystectomy|cholecystectomy
5177997|NCT00904865|cholangiography|cholangiography
5177998|NCT00904865|cosmesis|cosmesis
5177999|NCT00904826|NMO|nmo
5178000|NCT00904826|Devic's disease|devic's disease
5178001|NCT00904826|Neuromyelitis optica|neuromyelitis optica
5178002|NCT00904826|NMO-IgG|nmo-igg
5178003|NCT00904826|Aquaporin-4 antibody|aquaporin-4 antibody
5178004|NCT00904826|Eculizumab|eculizumab
5178005|NCT00904826|Complement|complement
5178006|NCT00904813|Rectal cancer|rectal cancer
5178554|NCT00902863|yoga|yoga
5178007|NCT00904813|Preoperative radiotherapy|preoperative radiotherapy
5178008|NCT00904813|Timing of Surgery|timing of surgery
5178009|NCT00904813|Prognosis|prognosis
5178010|NCT00904800|Phase I|phase i
5178011|NCT00904800|Healthy volunteers|healthy volunteers
5178012|NCT00904787|Leukemia|leukemia
5178013|NCT00904787|Hematologic neoplasms|hematologic neoplasms
5178014|NCT00904774|bronchopulmonary dysplasia|bronchopulmonary dysplasia
5178015|NCT00904774|neonates|neonates
5178016|NCT00904774|lung development|lung development
5178017|NCT00904774|prematurity|prematurity
5178018|NCT00904761|diabetes mellitus|diabetes mellitus
5178019|NCT00904761|autonomic neuropathy|autonomic neuropathy
5178020|NCT00904761|exercise training|exercise training
5178021|NCT00904761|exercise capacity|exercise capacity
5178022|NCT00904761|heart rate variability|heart rate variability
5178023|NCT00904748|Sildenafil|sildenafil
5178024|NCT00904748|Bio-equivalence|bio-equivalence
5178025|NCT00904735|adult grade I meningioma|adult grade i meningioma
5178026|NCT00904735|adult grade II meningioma|adult grade ii meningioma
5178027|NCT00904735|adult anaplastic meningioma|adult anaplastic meningioma
5178028|NCT00904735|adult papillary meningioma|adult papillary meningioma
5178029|NCT00904735|recurrent adult brain tumor|recurrent adult brain tumor
5178030|NCT00904722|Follicular lymphoma|follicular lymphoma
5178031|NCT00904722|Immunotherapy|immunotherapy
5178032|NCT00904722|CT-011|ct-011
5178033|NCT00904722|Monoclonal Antibody CT-011|monoclonal antibody ct-011
5178034|NCT00904722|Rituximab|rituximab
5178035|NCT00904722|Rituxan|rituxan
5178036|NCT00904696|Irritable bowel syndrome|irritable bowel syndrome
5178037|NCT00904696|probiotics|probiotics
5178038|NCT00904670|Hyperactivity Attention Deficit Disorder|hyperactivity attention deficit disorder
5178039|NCT00904670|ADHD|adhd
5178040|NCT00904670|Pediatric Patients|pediatric patients
5178041|NCT00904670|Quillivant|quillivant
5178042|NCT00904670|methylphenidate|methylphenidate
5178043|NCT00904657|pharmacokinetic/pharmacodynamic modeling|pharmacokinetic/pharmacodynamic modeling
5178044|NCT00904657|biomarkers (growth factors) as a possible tool of drug effect|biomarkers (growth factors) as a possible tool of drug effect
5178045|NCT00904644|HIV|hiv
5178046|NCT00904644|antiretroviral treatment|antiretroviral treatment
5178047|NCT00904644|Swiss HIV Cohort Study|swiss hiv cohort study
5178048|NCT00904644|drug resistance|drug resistance
5178049|NCT00904644|integrase inhibitor|integrase inhibitor
5178050|NCT00904644|Treatment|treatment
5178051|NCT00904618|Suburethral slings|suburethral slings
5178052|NCT00904618|Urethra|urethra
5178053|NCT00904618|Urinary incontinence|urinary incontinence
5178054|NCT00904618|Urinary stress incontinence|urinary stress incontinence
5178055|NCT00904592|diabetic retinopathy|diabetic retinopathy
5178056|NCT00904592|traditional chinese medicine|traditional chinese medicine
5178057|NCT00904579|Organ Transplants|organ transplants
5178058|NCT00904579|Immunosuppression|immunosuppression
5178059|NCT00904579|Cancer|cancer
5178060|NCT00904579|End Stage Renal Disease|end stage renal disease
5178061|NCT00904579|ESRD|esrd
5178062|NCT00904579|Cancer Risk|cancer risk
5178063|NCT00904566|microarray|microarray
5178064|NCT00904566|gene expression profiling|gene expression profiling
5178065|NCT00904566|MammaPrint|mammaprint
5178066|NCT00904566|breast cancer|breast cancer
5178067|NCT00904553|Brain|brain
5178068|NCT00904553|metastases|metastases
5178069|NCT00904527|Relaxation (Schultz)|relaxation (schultz)
5178070|NCT00904527|Migraine|migraine
5178071|NCT00904527|antipain center|antipain center
5178072|NCT00904514|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5178073|NCT00904514|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
5178074|NCT00904514|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5178075|NCT00904514|Waldenström macroglobulinemia|waldenström macroglobulinemia
5178076|NCT00904514|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5178077|NCT00904514|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5178078|NCT00904514|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5178079|NCT00904514|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5178080|NCT00904514|refractory hairy cell leukemia|refractory hairy cell leukemia
5178081|NCT00904514|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5178082|NCT00904514|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5178083|NCT00904514|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5178084|NCT00904514|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5178085|NCT00904514|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5178086|NCT00904514|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5178087|NCT00904514|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5178088|NCT00904514|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5178089|NCT00904514|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5178090|NCT00904514|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5178091|NCT00904514|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
5178092|NCT00904514|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
5178753|NCT00901966|Melanoma|melanoma
5178093|NCT00904514|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
5178094|NCT00904514|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
5178095|NCT00904514|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
5178096|NCT00904514|prolymphocytic leukemia|prolymphocytic leukemia
5178097|NCT00904514|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5178098|NCT00904514|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
5178099|NCT00904514|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5178100|NCT00904514|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5178101|NCT00904514|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5178102|NCT00904514|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5178103|NCT00904514|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5178104|NCT00904514|stage IV colon cancer|stage iv colon cancer
5178105|NCT00904514|stage IV breast cancer|stage iv breast cancer
5178106|NCT00904514|recurrent breast cancer|recurrent breast cancer
5178107|NCT00904514|stage IV gastric cancer|stage iv gastric cancer
5178108|NCT00904514|recurrent gastric cancer|recurrent gastric cancer
5178109|NCT00904514|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5178110|NCT00904514|recurrent pancreatic cancer|recurrent pancreatic cancer
5178111|NCT00904514|recurrent colon cancer|recurrent colon cancer
5178112|NCT00904514|stage IV esophageal cancer|stage iv esophageal cancer
5178113|NCT00904514|recurrent esophageal cancer|recurrent esophageal cancer
5178114|NCT00904514|recurrent bladder cancer|recurrent bladder cancer
5178115|NCT00904514|stage IV bladder cancer|stage iv bladder cancer
5178116|NCT00904514|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5178117|NCT00904514|epithelial mesothelioma|epithelial mesothelioma
5178118|NCT00904514|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
5178223|NCT00904254|Antibodies, Monoclonal|antibodies, monoclonal
5178119|NCT00904514|recurrent salivary gland cancer|recurrent salivary gland cancer
5178120|NCT00904514|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
5178121|NCT00904514|stage III cervical cancer|stage iii cervical cancer
5178122|NCT00904514|recurrent cervical cancer|recurrent cervical cancer
5178123|NCT00904514|stage IVB cervical cancer|stage ivb cervical cancer
5178124|NCT00904514|stage IVA cervical cancer|stage iva cervical cancer
5178125|NCT00904514|squamous cell lung cancer|squamous cell lung cancer
5178126|NCT00904514|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5178127|NCT00904514|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5178128|NCT00904514|advanced malignant mesothelioma|advanced malignant mesothelioma
5178129|NCT00904514|recurrent malignant mesothelioma|recurrent malignant mesothelioma
5178130|NCT00904514|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5178131|NCT00904514|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5178132|NCT00904514|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5178133|NCT00904514|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
5178134|NCT00904514|ovarian undifferentiated adenocarcinoma|ovarian undifferentiated adenocarcinoma
5178135|NCT00904514|ovarian mixed epithelial carcinoma|ovarian mixed epithelial carcinoma
5178136|NCT00904514|ovarian serous cystadenocarcinoma|ovarian serous cystadenocarcinoma
5178137|NCT00904514|ovarian endometrioid adenocarcinoma|ovarian endometrioid adenocarcinoma
5178138|NCT00904514|ovarian clear cell cystadenocarcinoma|ovarian clear cell cystadenocarcinoma
5178139|NCT00904514|cervical squamous cell carcinoma|cervical squamous cell carcinoma
5178140|NCT00904514|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
5178141|NCT00904514|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
5178142|NCT00904514|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5178143|NCT00904514|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
5178144|NCT00904514|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
5178145|NCT00904514|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5178146|NCT00904514|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
5178147|NCT00904514|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
5178148|NCT00904514|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
5178149|NCT00904514|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
5178150|NCT00904514|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5178151|NCT00904514|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
5178152|NCT00904514|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
5178153|NCT00904514|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5178154|NCT00904514|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
5178155|NCT00904514|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
5178156|NCT00904514|fallopian tube cancer|fallopian tube cancer
5178157|NCT00904514|primary peritoneal cavity cancer|primary peritoneal cavity cancer
5178158|NCT00904514|ovarian carcinosarcoma|ovarian carcinosarcoma
5178159|NCT00904514|Brenner tumor|brenner tumor
5178160|NCT00904514|untreated metastatic squamous neck cancer with occult primary|untreated metastatic squamous neck cancer with occult primary
5178161|NCT00904514|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
5178162|NCT00904514|stage III salivary gland cancer|stage iii salivary gland cancer
5178163|NCT00904514|stage IV salivary gland cancer|stage iv salivary gland cancer
5178164|NCT00904514|stage II pancreatic cancer|stage ii pancreatic cancer
5178165|NCT00904514|stage III pancreatic cancer|stage iii pancreatic cancer
5178166|NCT00904514|ovarian mucinous cystadenocarcinoma|ovarian mucinous cystadenocarcinoma
5178167|NCT00904514|stage IV pancreatic cancer|stage iv pancreatic cancer
5178168|NCT00904514|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
5178169|NCT00904514|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5178170|NCT00904514|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5178171|NCT00904514|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5178172|NCT00904514|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5178173|NCT00904514|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5178174|NCT00904501|Limb ischemia|limb ischemia
5178175|NCT00904501|Cell Therapy|cell therapy
5178176|NCT00904488|Acute Decompensated Heart Failure|acute decompensated heart failure
5178177|NCT00904488|Diuretics|diuretics
5178178|NCT00904436|Tetraplegia|tetraplegia
5178179|NCT00904436|Breathing Patterns|breathing patterns
5178180|NCT00904436|Dyspnea|dyspnea
5178181|NCT00904410|adenocarcinoma|adenocarcinoma
5178182|NCT00904410|breast|breast
5178183|NCT00904384|HIV+|hiv+
5178184|NCT00904384|COPD|copd
5178185|NCT00904384|emphysema|emphysema
5178186|NCT00904358|internal jugular vein|internal jugular vein
5178187|NCT00904358|cross sectional area|cross sectional area
5178188|NCT00904358|ultrasound|ultrasound
5178189|NCT00904358|central venous pressure|central venous pressure
5178190|NCT00904345|SCC Head and Neck Cancer|scc head and neck cancer
5178191|NCT00904332|Transcranial Magnetic Stimulation (TMS)|transcranial magnetic stimulation (tms)
5178192|NCT00904332|Electroencephalogram (EEG)|electroencephalogram (eeg)
5178193|NCT00904332|Motor Learning|motor learning
5178194|NCT00904332|Health Volunteer|health volunteer
5178196|NCT00904319|osteoarthritis|osteoarthritis
5178197|NCT00904319|knee pain|knee pain
5178198|NCT00904319|power training|power training
5178199|NCT00904319|rehabilitation|rehabilitation
5178200|NCT00904306|binge eating|binge eating
5178201|NCT00904306|chromium|chromium
5178202|NCT00904306|mood|mood
5178203|NCT00904306|glucose|glucose
5178204|NCT00904306|appetite|appetite
5178205|NCT00904293|warfarin|warfarin
5178206|NCT00904293|CYP2C9|cyp2c9
5178207|NCT00904293|VKOR|vkor
5178208|NCT00904293|Coumadin|coumadin
5178209|NCT00904293|pharmacogenetics|pharmacogenetics
5178210|NCT00904293|pharmacogenomics|pharmacogenomics
5178211|NCT00904293|anticoagulation|anticoagulation
5178212|NCT00904293|genotype-guided therapy|genotype-guided therapy
5178213|NCT00904254|cerebrovascular disorders|cerebrovascular disorders
5178214|NCT00904254|symptomatic carotid artery stenosis|symptomatic carotid artery stenosis
5178215|NCT00904254|asymptomatic carotid artery stenosis|asymptomatic carotid artery stenosis
5178216|NCT00904254|monoclonal antibody|monoclonal antibody
5178217|NCT00904254|diagnostics|diagnostics
5178218|NCT00904254|molecular target|molecular target
5178219|NCT00904254|immunoglobulin Fab fragments|immunoglobulin fab fragments
5178220|NCT00904254|physiological effects of drugs|physiological effects of drugs
5178221|NCT00904254|Tc99m-pertechnetate|tc99m-pertechnetate
5178222|NCT00904254|Fab-fragment of Anti-human CD4|fab-fragment of anti-human cd4
5178224|NCT00904254|Antibodies|antibodies
5178225|NCT00904228|hypothermia|hypothermia
5178226|NCT00904228|euthermia|euthermia
5178227|NCT00904228|hyperthermia|hyperthermia
5178228|NCT00904228|mortality|mortality
5178229|NCT00904228|morbidity|morbidity
5178230|NCT00904228|sepsis|sepsis
5178231|NCT00904228|bronchopulmonary dysplasia|bronchopulmonary dysplasia
5178232|NCT00904228|intraventricular hemorrhage|intraventricular hemorrhage
5178233|NCT00904228|ventilator days|ventilator days
5178234|NCT00904150|menstruation|menstruation
5178235|NCT00904150|migraine|migraine
5178236|NCT00904150|menstrual migraine|menstrual migraine
5178237|NCT00904150|genetics|genetics
5178238|NCT00904137|Supracondylar fracture|supracondylar fracture
5178239|NCT00904137|humerus|humerus
5178240|NCT00904137|elbow|elbow
5178241|NCT00904124|Dietary fiber|dietary fiber
5178242|NCT00904124|guar gum|guar gum
5178243|NCT00904124|alginate|alginate
5178244|NCT00904124|cellulose|cellulose
5178245|NCT00904124|food intake|food intake
5178246|NCT00904124|eating behaviour|eating behaviour
5178247|NCT00904098|migraine|migraine
5178248|NCT00904072|CDSS|cdss
5178249|NCT00904072|prescribing error|prescribing error
5178250|NCT00904072|prescribing errors influenced by CDSS|prescribing errors influenced by cdss
5178253|NCT00904046|Nephrolithiasis|nephrolithiasis
5178254|NCT00904007|Educational Technology|educational technology
5178255|NCT00904007|Hypertension|hypertension
5178256|NCT00904007|Education, Professional|education, professional
5178257|NCT00903994|Acute Pain|acute pain
5178258|NCT00903968|refractory|refractory
5178259|NCT00903968|relapsed|relapsed
5178260|NCT00903968|bortezomib|bortezomib
5178261|NCT00903968|AMD3100|amd3100
5178262|NCT00903968|plerixafor|plerixafor
5178263|NCT00903955|Mucus|mucus
5178264|NCT00903955|COPD|copd
5178265|NCT00903955|Chronic Bronchitis|chronic bronchitis
5178266|NCT00903916|antipsychotic|antipsychotic
5178267|NCT00903916|ghrelin|ghrelin
5178268|NCT00903916|PYY|pyy
5178269|NCT00903916|appetite|appetite
5178270|NCT00903916|weight gain|weight gain
5178271|NCT00903903|active synovitis|active synovitis
5178272|NCT00903838|Parkinson's disease|parkinson's disease
5178273|NCT00903825|femoral artery puncture|femoral artery puncture
5178274|NCT00903825|local anesthesia|local anesthesia
5178275|NCT00903825|ultrasound guided|ultrasound guided
5178276|NCT00903799|Drug-refractory gastroparesis|drug-refractory gastroparesis
5178277|NCT00903799|diabetes mellitus induced gastroparesis|diabetes mellitus induced gastroparesis
5178278|NCT00903799|Gastric electrical stimulation|gastric electrical stimulation
5178279|NCT00903799|Long-term multicenter study|long-term multicenter study
5178280|NCT00903786|Seizure|seizure
5178281|NCT00903786|epilepsy|epilepsy
5178282|NCT00903773|VX-950-TiDP24-C132|vx-950-tidp24-c132
5178283|NCT00903773|VX-950-C132|vx-950-c132
5178284|NCT00903773|VX-950|vx-950
5178285|NCT00903773|HCV|hcv
5178286|NCT00903760|Myelodysplastic Syndrome|myelodysplastic syndrome
5178287|NCT00903760|MDS|mds
5178288|NCT00903760|Leukemia|leukemia
5178289|NCT00903760|Decitabine|decitabine
5178290|NCT00903760|clofarabine|clofarabine
5178291|NCT00903760|Dacogen®|dacogen®
5178292|NCT00903760|Clolar®|clolar®
5178293|NCT00903747|Prucalopride|prucalopride
5178294|NCT00903747|safety study|safety study
5178295|NCT00903734|Metastatic Cancer|metastatic cancer
5178296|NCT00903734|Histology-independent|histology-independent
5178297|NCT00903734|EGFR Mutation|egfr mutation
5178298|NCT00903734|EGFR inhibitor-sensitive mutation|egfr inhibitor-sensitive mutation
5178299|NCT00903734|Erlotinib Hydrochloride|erlotinib hydrochloride
5178300|NCT00903734|Tarceva|tarceva
5178301|NCT00903734|OSI-774|osi-774
5178302|NCT00903734|Cetuximab|cetuximab
5178303|NCT00903734|Bortezomib|bortezomib
5178304|NCT00903734|Dasatinib|dasatinib
5178305|NCT00903708|Advanced Cancers|advanced cancers
5178306|NCT00903708|LY2275796|ly2275796
5178307|NCT00903708|Eukaryotic initiation factor 4E|eukaryotic initiation factor 4e
5178308|NCT00903708|eIF-4E|eif-4e
5178309|NCT00903695|Memory XL|memory xl
5178310|NCT00903695|Mild Cognitive Impairment|mild cognitive impairment
5178311|NCT00903695|cognitive status|cognitive status
5178312|NCT00903682|HIV|hiv
5178313|NCT00903682|Intelence|intelence
5178314|NCT00903682|etravirine|etravirine
5178315|NCT00903682|ETR|etr
5178316|NCT00903682|TMC125|tmc125
5178317|NCT00903682|Sustiva|sustiva
5178318|NCT00903682|efavirenz|efavirenz
5178319|NCT00903682|EFV|efv
5178320|NCT00903682|Non-nucleoside Reverse Transcriptase Inhibitor|non-nucleoside reverse transcriptase inhibitor
5178321|NCT00903682|NNRTI|nnrti
5178322|NCT00903682|treatment-naive|treatment-naive
5178323|NCT00903669|Facial paralysis|facial paralysis
5178324|NCT00903669|Muscle tonus|muscle tonus
5178325|NCT00903669|Rehabilitation|rehabilitation
5178326|NCT00903669|Myofunctional|myofunctional
5178327|NCT00903669|Stomatognathic system|stomatognathic system
5178328|NCT00903656|metastatic breast cancer|metastatic breast cancer
5178329|NCT00903656|Her2|her2
5178330|NCT00903656|Lapatinib|lapatinib
5178331|NCT00903656|Caelyx|caelyx
5178332|NCT00903656|cardiotoxic|cardiotoxic
5178333|NCT00903643|Painful Bladder Syndrome|painful bladder syndrome
5178334|NCT00903643|Urinary Bladder|urinary bladder
5178335|NCT00903630|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5178336|NCT00903630|fallopian tube cancer|fallopian tube cancer
5178337|NCT00903630|peritoneal cavity cancer|peritoneal cavity cancer
5178338|NCT00903617|lipids|lipids
5178339|NCT00903617|HM74A|hm74a
5178340|NCT00903604|Cardiac surgery|cardiac surgery
5178341|NCT00903604|coronary artery bypass grafting|coronary artery bypass grafting
5178342|NCT00903604|valve surgery|valve surgery
5178343|NCT00903604|aortic root or ascending aortic aneurysm repair surgery|aortic root or ascending aortic aneurysm repair surgery
5178344|NCT00903604|Acute kidney injury|acute kidney injury
5178345|NCT00903591|Breast|breast
5178346|NCT00903591|cancer|cancer
5178347|NCT00903591|09-040|09-040
5178348|NCT00903591|blood sample|blood sample
5178349|NCT00903591|saliva sample|saliva sample
5178350|NCT00903591|WECARE|wecare
5178351|NCT00903591|GWA|gwa
5178352|NCT00903578|FGF-23|fgf-23
5178353|NCT00903578|vitamin D|vitamin d
5178354|NCT00903578|phosphate|phosphate
5178355|NCT00903578|allograft dysfunction|allograft dysfunction
5178356|NCT00903578|mortality|mortality
5178357|NCT00903565|genomic profiling|genomic profiling
5178358|NCT00903565|gene expression|gene expression
5178360|NCT00903565|adenocarcinoma colon|adenocarcinoma colon
5178361|NCT00903565|recurrence risk assessment|recurrence risk assessment
5178362|NCT00903565|prospective|prospective
5178363|NCT00903539|Peripherally Inserted Central Catheter|peripherally inserted central catheter
5178364|NCT00903539|Central Venous Catheter|central venous catheter
5178365|NCT00903539|Intravenous Catheter|intravenous catheter
5178366|NCT00903539|StatLock|statlock
5178367|NCT00903539|Patients indicated to have an intravenous catheter placed|patients indicated to have an intravenous catheter placed
5178368|NCT00903526|fungal susceptibility|fungal susceptibility
5178369|NCT00903474|anxiety disorder|anxiety disorder
5178370|NCT00903474|depression|depression
5178371|NCT00903474|cognitive/functional effects|cognitive/functional effects
5178372|NCT00903474|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
5178373|NCT00903474|cancer survivor|cancer survivor
5178374|NCT00903474|breast cancer|breast cancer
5178375|NCT00903448|Normal Healthy Subject Population|normal healthy subject population
5178376|NCT00903435|Cystitis|cystitis
5178377|NCT00903435|Urinary|urinary
5178378|NCT00903435|Bladder|bladder
5178379|NCT00903422|Advanced Myelodysplastic Syndrome|advanced myelodysplastic syndrome
5178380|NCT00903422|Thrombocytopenia|thrombocytopenia
5178381|NCT00903422|sAML/MDS|saml/mds
5178382|NCT00903422|Eltrombopag|eltrombopag
5178383|NCT00903422|TPO-R agonist|tpo-r agonist
5178384|NCT00903422|de novo AML|de novo aml
5178385|NCT00903422|Thrombopoietin|thrombopoietin
5178386|NCT00903422|MDS|mds
5178387|NCT00903422|Thrombopoietin receptor agonist|thrombopoietin receptor agonist
5178388|NCT00903422|secondary Acute Myeloid Leukemia after MDS|secondary acute myeloid leukemia after mds
5178389|NCT00903422|Platelets|platelets
5178390|NCT00903409|High triglycerides|high triglycerides
5178391|NCT00903409|Lovaza|lovaza
5178392|NCT00903409|simvastatin|simvastatin
5178393|NCT00903409|omega-3-acid ethyl esters|omega-3-acid ethyl esters
5178394|NCT00903396|nausea and vomiting|nausea and vomiting
5178395|NCT00903396|gastrointestinal carcinoid tumor|gastrointestinal carcinoid tumor
5178396|NCT00903396|anal cancer|anal cancer
5178397|NCT00903396|carcinoma of the appendix|carcinoma of the appendix
5178398|NCT00903396|colon cancer|colon cancer
5178399|NCT00903396|rectal cancer|rectal cancer
5178400|NCT00903396|extrahepatic bile duct cancer|extrahepatic bile duct cancer
5178401|NCT00903396|gallbladder cancer|gallbladder cancer
5178402|NCT00903396|gastric cancer|gastric cancer
5178403|NCT00903396|liver and intrahepatic biliary tract cancer|liver and intrahepatic biliary tract cancer
5178404|NCT00903396|pancreatic cancer|pancreatic cancer
5178405|NCT00903396|small intestine cancer|small intestine cancer
5178406|NCT00903396|primary peritoneal cavity cancer|primary peritoneal cavity cancer
5178407|NCT00903370|Mitral Valve Regurgitation|mitral valve regurgitation
5178408|NCT00903370|Mitral Valve Surgery|mitral valve surgery
5178409|NCT00903370|Mitral Valve Disease|mitral valve disease
5178410|NCT00903370|Ablation, Catheter|ablation, catheter
5178411|NCT00903370|Catheter Ablation, Radiofrequency|catheter ablation, radiofrequency
5178412|NCT00903357|Atopic dermatitis|atopic dermatitis
5178413|NCT00903357|Montelukast|montelukast
5178414|NCT00903331|idiopathic pulmonary fibrosis|idiopathic pulmonary fibrosis
5178415|NCT00903331|MUSIC|music
5178416|NCT00903318|Endocrine|endocrine
5178417|NCT00903318|Environmental Chemicals|environmental chemicals
5178418|NCT00903318|Male:Female Birth Ratio|male:female birth ratio
5178419|NCT00903318|Phthalate Exposure|phthalate exposure
5178420|NCT00903318|Generational sex ratio trends|generational sex ratio trends
5178421|NCT00903318|Mexican American|mexican american
5178422|NCT00903318|Baytown|baytown
5178423|NCT00903318|Rio Grande Valley|rio grande valley
5178424|NCT00903318|Hidalgo County|hidalgo county
5178425|NCT00903318|Texas|texas
5178426|NCT00903305|pain|pain
5178427|NCT00903305|fatigue|fatigue
5178428|NCT00903305|nausea and vomiting|nausea and vomiting
5178429|NCT00903305|stage I breast cancer|stage i breast cancer
5178430|NCT00903305|stage II breast cancer|stage ii breast cancer
5178431|NCT00903305|stage IIIA breast cancer|stage iiia breast cancer
5178432|NCT00903305|stage IIIB breast cancer|stage iiib breast cancer
5178433|NCT00903305|stage IIIC breast cancer|stage iiic breast cancer
5178434|NCT00903292|EGFR|egfr
5178435|NCT00903292|NSCLC|nsclc
5178436|NCT00903292|EGFR mutation rate|egfr mutation rate
5178437|NCT00903279|MRSA colonization|mrsa colonization
5178438|NCT00903279|Orthopedic Surgery|orthopedic surgery
5178439|NCT00903279|Altabax|altabax
5178440|NCT00903279|Placebo|placebo
5178441|NCT00903266|Aphasia|aphasia
5178442|NCT00903266|Speech Impairment|speech impairment
5178443|NCT00903266|Stroke|stroke
5178444|NCT00903266|Cerebrovascular Accident|cerebrovascular accident
5178445|NCT00903266|Cerebral Infarction|cerebral infarction
5178446|NCT00903266|Brain Ischemia|brain ischemia
5178447|NCT00903266|Brain Infarction|brain infarction
5178448|NCT00903266|Cerebrovascular Disorder|cerebrovascular disorder
5178449|NCT00903227|Asthma|asthma
5178450|NCT00903227|Allergic rhinitis|allergic rhinitis
5178451|NCT00903227|fluticasone|fluticasone
5178452|NCT00903227|methacholine|methacholine
5178453|NCT00903214|stage I breast cancer|stage i breast cancer
5178454|NCT00903214|stage II breast cancer|stage ii breast cancer
5178455|NCT00903214|stage IIIA breast cancer|stage iiia breast cancer
5178456|NCT00903201|cystic fibrosis|cystic fibrosis
5178457|NCT00903188|Renal Transplantation|renal transplantation
5178458|NCT00903188|graft function|graft function
5178459|NCT00903188|cardiovascular events|cardiovascular events
5178460|NCT00903188|malignancy|malignancy
5178461|NCT00903188|cyclosporin|cyclosporin
5178462|NCT00903188|steroids|steroids
5178463|NCT00903188|mycophenolate|mycophenolate
5178464|NCT00903188|everolimus|everolimus
5178465|NCT00903188|renal biopsies|renal biopsies
5178466|NCT00903188|pharmacokinetics|pharmacokinetics
5178467|NCT00903175|RAD001|rad001
5178468|NCT00903175|everolimus|everolimus
5178469|NCT00903175|sunitinib|sunitinib
5178470|NCT00903175|renal cell carcinoma|renal cell carcinoma
5178471|NCT00903175|kidney cancer|kidney cancer
5178472|NCT00903175|metastatic renal cell cancer|metastatic renal cell cancer
5178473|NCT00903175|advanced kidney cancer|advanced kidney cancer
5178474|NCT00903162|hormone-receptor positive|hormone-receptor positive
5178475|NCT00903162|tamoxifen|tamoxifen
5178476|NCT00903162|letrozole|letrozole
5178477|NCT00903162|zoledronic acid|zoledronic acid
5178478|NCT00903162|leuprolide|leuprolide
5178479|NCT00903149|Premature babies|premature babies
5178480|NCT00903149|Social interaction|social interaction
5178481|NCT00903149|Psychoeducative intervention|psychoeducative intervention
5178482|NCT00903149|Mother Infant Transaction Program|mother infant transaction program
5178483|NCT00903149|Three years follow-up|three years follow-up
5178484|NCT00903149|Late preterm|late preterm
5178485|NCT00903149|Cognitive development|cognitive development
5178486|NCT00903149|Social development|social development
5178487|NCT00903149|Emotional development|emotional development
5178488|NCT00903149|Motor development|motor development
5178489|NCT00903149|Children born preterm and their parents|children born preterm and their parents
5178490|NCT00903136|Barrett esophagus|barrett esophagus
5178491|NCT00903136|esophageal cancer|esophageal cancer
5178492|NCT00903136|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
5178493|NCT00903084|Pharmacokinetics in Hair|pharmacokinetics in hair
5178494|NCT00903084|Tenofovir|tenofovir
5178495|NCT00903084|Pharmacokinetics|pharmacokinetics
5178496|NCT00903084|Concentrations|concentrations
5178497|NCT00903084|Hair|hair
5178498|NCT00903071|Hypertension|hypertension
5178499|NCT00903071|Primary Care|primary care
5178500|NCT00903071|Physician Learning|physician learning
5178501|NCT00903045|Overactive bladder|overactive bladder
5178502|NCT00903045|Propiverin|propiverin
5178503|NCT00903032|compliance/adherence|compliance/adherence
5178504|NCT00903019|Homebound|homebound
5178505|NCT00903019|Older Adults|older adults
5178506|NCT00903019|Disability|disability
5178507|NCT00903019|Videoconferencing|videoconferencing
5178508|NCT00903006|Breast|breast
5178509|NCT00903006|Hormone receptor-positive metastatic breast cancer|hormone receptor-positive metastatic breast cancer
5178510|NCT00903006|Fulvestrant|fulvestrant
5178511|NCT00903006|Faslodex|faslodex
5178512|NCT00903006|MK-0646|mk-0646
5178513|NCT00903006|Dasatinib|dasatinib
5178514|NCT00903006|BMS-354825|bms-354825
5178515|NCT00903006|Sprycel|sprycel
5178516|NCT00903006|Adjuvant hormonal therapy|adjuvant hormonal therapy
5178517|NCT00902993|MAD|mad
5178518|NCT00902993|NNR|nnr
5178519|NCT00902993|to investigate safety and tolerability in a multiple ascending dose study in Healthy subjects|to investigate safety and tolerability in a multiple ascending dose study in healthy subjects
5178520|NCT00902993|AZD1446|azd1446
5178521|NCT00902980|Kidney transplantation|kidney transplantation
5178522|NCT00902980|Tacrolimus|tacrolimus
5178523|NCT00902980|Immunosuppression|immunosuppression
5178524|NCT00902967|Postoperative pain|postoperative pain
5178525|NCT00902967|atorvastatin|atorvastatin
5178526|NCT00902967|analgesic|analgesic
5178527|NCT00902967|antiinflammatory|antiinflammatory
5178528|NCT00902954|Disease free survival|disease free survival
5178529|NCT00902954|Distant disease free survival|distant disease free survival
5178530|NCT00902954|Toxicity|toxicity
5178531|NCT00902954|Overall survival|overall survival
5178532|NCT00902941|Parkinson´s disease|parkinson´s disease
5178533|NCT00902941|olfaction|olfaction
5178534|NCT00902941|rasagiline|rasagiline
5178535|NCT00902941|smell testing|smell testing
5178536|NCT00902928|Elective hip replacement surgery|elective hip replacement surgery
5178537|NCT00902928|Factor Xa|factor xa
5178538|NCT00902928|Venous Thromboembolism|venous thromboembolism
5178539|NCT00902928|Thrombosis|thrombosis
5178540|NCT00902928|Anticoagulants|anticoagulants
5178541|NCT00902928|Prevention|prevention
5178542|NCT00902928|YM150|ym150
5178543|NCT00902915|multiple myeloma renal insufficiency|multiple myeloma renal insufficiency
5178544|NCT00902902|Hepatocellular carcinoma|hepatocellular carcinoma
5178545|NCT00902889|Globus pallidus|globus pallidus
5178546|NCT00902889|Huntington's Disease|huntington's disease
5178547|NCT00902889|Deep Brain Stimulation|deep brain stimulation
5178548|NCT00902889|Movement Disorders|movement disorders
5178549|NCT00902876|root coverage|root coverage
5178550|NCT00902876|gingival recession|gingival recession
5178551|NCT00902876|keratinized gingiva|keratinized gingiva
5178552|NCT00902863|chronic pain|chronic pain
5178555|NCT00902863|quality of life|quality of life
5178556|NCT00902863|stress|stress
5178557|NCT00902837|randomised|randomised
5178558|NCT00902837|double-blind|double-blind
5178559|NCT00902837|double-dummy|double-dummy
5178560|NCT00902837|parallel-group|parallel-group
5178561|NCT00902837|non-inferiority|non-inferiority
5178562|NCT00902837|pain locomotor function|pain locomotor function
5178563|NCT00902837|improvement in symptoms of constipation|improvement in symptoms of constipation
5178564|NCT00902837|moderate to severe pain due to osteoarthritis (OA)|moderate to severe pain due to osteoarthritis (oa)
5178565|NCT00902837|OXN PR|oxn pr
5178566|NCT00902837|OxyPR|oxypr
5178567|NCT00902837|Moderate to severe chronic nonmalignant OA|moderate to severe chronic nonmalignant oa
5178568|NCT00902824|HIV|hiv
5178569|NCT00902811|uncomplicated falciparum malaria|uncomplicated falciparum malaria
5178570|NCT00902811|artemisinin combination therapy|artemisinin combination therapy
5178571|NCT00902798|Autism|autism
5178572|NCT00902798|Autism Spectrum Disorders|autism spectrum disorders
5178573|NCT00902798|Asperger's Syndrome|asperger's syndrome
5178574|NCT00902798|Pervasive Developmental Disorder|pervasive developmental disorder
5178575|NCT00902798|Cognition|cognition
5178576|NCT00902798|Social Cognition|social cognition
5178577|NCT00902798|Psychosocial Treatment|psychosocial treatment
5178578|NCT00902798|Cognitive Enhancement Therapy|cognitive enhancement therapy
5178579|NCT00902798|Enriched Supportive Therapy|enriched supportive therapy
5178580|NCT00902798|Therapy|therapy
5178581|NCT00902798|Psychotherapy|psychotherapy
5178582|NCT00902785|exploratory|exploratory
5178583|NCT00902785|observational|observational
5178584|NCT00902785|non-interventional study age-related macular degeneration (AMD) choroidal neovascularization (CNV)|non-interventional study age-related macular degeneration (amd) choroidal neovascularization (cnv)
5178585|NCT00902772|Recreational CNS depressant|recreational cns depressant
5178586|NCT00902772|Abuse liability|abuse liability
5178587|NCT00902772|Abuse potential|abuse potential
5178588|NCT00902772|Healthy Recreational CNS Depressant Users|healthy recreational cns depressant users
5178589|NCT00902759|Surgery|surgery
5178590|NCT00902759|Chemotherapy|chemotherapy
5178591|NCT00902759|Radiation Therapy|radiation therapy
5178592|NCT00902759|Pancreatic cancer|pancreatic cancer
5178593|NCT00902759|Fatigue|fatigue
5178594|NCT00902733|pain|pain
5178595|NCT00902733|fatigue|fatigue
5178596|NCT00902733|nausea and vomiting|nausea and vomiting
5178597|NCT00902733|recurrent pancreatic cancer|recurrent pancreatic cancer
5178598|NCT00902733|stage I pancreatic cancer|stage i pancreatic cancer
5178599|NCT00902733|stage II pancreatic cancer|stage ii pancreatic cancer
5178600|NCT00902733|stage III pancreatic cancer|stage iii pancreatic cancer
5178601|NCT00902733|stage IV pancreatic cancer|stage iv pancreatic cancer
5178602|NCT00902720|Ovarian|ovarian
5178603|NCT00902720|Tissue|tissue
5178604|NCT00902720|Cryopreservation|cryopreservation
5178605|NCT00902707|healthy nonsmokers|healthy nonsmokers
5178606|NCT00902694|Serious Mental Illness|serious mental illness
5178607|NCT00902694|Weight Loss|weight loss
5178608|NCT00902681|Bioequivalence, Pharmacokinetics|bioequivalence, pharmacokinetics
5178609|NCT00902668|radiation toxicity|radiation toxicity
5178610|NCT00902668|stage IA breast cancer|stage ia breast cancer
5178611|NCT00902668|stage IB breast cancer|stage ib breast cancer
5178612|NCT00902668|stage II breast cancer|stage ii breast cancer
5178613|NCT00902668|breast cancer in situ|breast cancer in situ
5178614|NCT00902655|Nocturnal polyuria|nocturnal polyuria
5178615|NCT00902655|Nocturnal bladder capacity|nocturnal bladder capacity
5178616|NCT00902642|Physical therapy,|physical therapy,
5178617|NCT00902642|musculoskeletal pain,|musculoskeletal pain,
5178618|NCT00902642|psychosocial factors,|psychosocial factors,
5178619|NCT00902642|dissimilation,|dissimilation,
5178620|NCT00902642|evidence based,|evidence based,
5178621|NCT00902642|education|education
5178622|NCT00902629|Epiretinal Fibrosis|epiretinal fibrosis
5178623|NCT00902629|Macular Pucker|macular pucker
5178624|NCT00902616|Type 2 diabetes|type 2 diabetes
5178625|NCT00902616|Peripheral neuropathy|peripheral neuropathy
5178626|NCT00902616|Microcirculation|microcirculation
5178627|NCT00902603|pulmonary arterial hypertension|pulmonary arterial hypertension
5178628|NCT00902603|Ventavis®|ventavis®
5178629|NCT00902603|iloprost|iloprost
5178630|NCT00902590|renal pelvis|renal pelvis
5178631|NCT00902590|ureter|ureter
5178632|NCT00902590|bladder|bladder
5178633|NCT00902590|09-025|09-025
5178634|NCT00902590|Renal Pelvis, Ureter, Bladder Cancer|renal pelvis, ureter, bladder cancer
5178635|NCT00902564|Generalized Anxiety Disorder|generalized anxiety disorder
5178636|NCT00902564|GAD|gad
5178637|NCT00902564|Antidepressant|antidepressant
5178638|NCT00902564|Anxiolytic|anxiolytic
5178639|NCT00902551|DNA cytometry|dna cytometry
5178640|NCT00902551|Cytology|cytology
5178641|NCT00902551|Diagnosis accuracy|diagnosis accuracy
5178642|NCT00902538|Add on treatment|add on treatment
5178643|NCT00902538|essential hypertension|essential hypertension
5178644|NCT00902525|two sequential doses of 90Y-Ibritumomab Tiuxetan|two sequential doses of 90y-ibritumomab tiuxetan
5178645|NCT00902499|functional magnetic resonance imaging|functional magnetic resonance imaging
5178646|NCT00902486|Rheumatoid arthritis|rheumatoid arthritis
5178647|NCT00902473|Topiramate fed study|topiramate fed study
5178861|NCT00901680|Tissue Bank|tissue bank
5178648|NCT00902460|drug interactions CYP3A4 CYP3A5 midazolam anti-rheumatic agents|drug interactions cyp3a4 cyp3a5 midazolam anti-rheumatic agents
5178649|NCT00902447|Human Blood Cell Disorders|human blood cell disorders
5178650|NCT00902447|lymphoid, myeloid and erythroid proliferative disease|lymphoid, myeloid and erythroid proliferative disease
5178651|NCT00902434|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
5178652|NCT00902421|Overactive bladder|overactive bladder
5178653|NCT00902421|SSRI|ssri
5178654|NCT00902421|Antimuscarinics|antimuscarinics
5178655|NCT00902395|Preschool children|preschool children
5178656|NCT00902382|Infertility|infertility
5178657|NCT00902382|Ovulation stimulation|ovulation stimulation
5178658|NCT00902382|Pregnancy|pregnancy
5178659|NCT00902369|AK106-001616|ak106-001616
5178660|NCT00902356|Amgen|amgen
5178661|NCT00902356|Phase 1|phase 1
5178662|NCT00902356|First in Human|first in human
5178663|NCT00902356|Postmenopausal|postmenopausal
5178664|NCT00902343|Liver|liver
5178665|NCT00902343|Cancer|cancer
5178666|NCT00902343|Primary|primary
5178667|NCT00902343|Metastatic|metastatic
5178668|NCT00902343|transfusions|transfusions
5178669|NCT00902343|08-158|08-158
5178670|NCT00902330|depression|depression
5178671|NCT00902330|anxiety disorder|anxiety disorder
5178672|NCT00902330|fatigue|fatigue
5178673|NCT00902330|pain|pain
5178674|NCT00902330|sleep disorders|sleep disorders
5178675|NCT00902330|stage IA breast cancer|stage ia breast cancer
5178676|NCT00902330|stage IB breast cancer|stage ib breast cancer
5178677|NCT00902330|stage II breast cancer|stage ii breast cancer
5178678|NCT00902330|stage IIIA breast cancer|stage iiia breast cancer
5178679|NCT00902304|Hypertension|hypertension
5178680|NCT00902304|valsartan|valsartan
5178681|NCT00902291|Clinical Trial, Phase II|clinical trial, phase ii
5178682|NCT00902291|Combination Drug Therapy|combination drug therapy
5178683|NCT00902291|Gemcitabine|gemcitabine
5178684|NCT00902291|AGS-1C4D4|ags-1c4d4
5178685|NCT00902291|Pancreatic Cancer|pancreatic cancer
5178686|NCT00902278|influenzavirus A|influenzavirus a
5178687|NCT00902278|influenzavirus B|influenzavirus b
5178688|NCT00902278|human influenza|human influenza
5178689|NCT00902278|T lymphocytes|t lymphocytes
5178690|NCT00902278|influenza vaccines|influenza vaccines
5178691|NCT00902226|Social Anxiety Disorder|social anxiety disorder
5178692|NCT00902226|SAD|sad
5178693|NCT00902226|Antidepressant|antidepressant
5178694|NCT00902226|Anxiolytic|anxiolytic
5178695|NCT00902200|Glaucoma|glaucoma
5178696|NCT00902200|Intraocular pressure|intraocular pressure
5178697|NCT00902187|Bioequivalence|bioequivalence
5178698|NCT00902174|Pulmonary arterial hypertension|pulmonary arterial hypertension
5178699|NCT00902174|Imatinib|imatinib
5178700|NCT00902174|6MWD|6mwd
5178701|NCT00902174|Borg scale|borg scale
5178702|NCT00902174|Pulmonary hypertension|pulmonary hypertension
5178703|NCT00902148|Surgery|surgery
5178704|NCT00902148|Colectomy|colectomy
5178705|NCT00902148|Proctocolectomy|proctocolectomy
5178706|NCT00902148|Adhesions|adhesions
5178707|NCT00902135|Multiple Sclerosis|multiple sclerosis
5178708|NCT00902135|Interferon beta-1b|interferon beta-1b
5178709|NCT00902122|p53 gene|p53 gene
5178710|NCT00902122|thyroid|thyroid
5178711|NCT00902122|gene therapy|gene therapy
5178712|NCT00902122|malignant tumors|malignant tumors
5178713|NCT00902109|visual field|visual field
5178714|NCT00902109|perimetry|perimetry
5178715|NCT00902109|progression|progression
5178716|NCT00902109|POAG|poag
5178717|NCT00902109|glaucoma|glaucoma
5178718|NCT00902096|cord blood|cord blood
5178719|NCT00902096|IgE|ige
5178720|NCT00902096|prenatal|prenatal
5178721|NCT00902096|predictor|predictor
5178722|NCT00902083|p53 gene|p53 gene
5178723|NCT00902083|Oral and Maxillofacial|oral and maxillofacial
5178724|NCT00902083|gene therapy|gene therapy
5178725|NCT00902083|malignant tumors|malignant tumors
5178726|NCT00902044|Refractory Sarcoma|refractory sarcoma
5178727|NCT00902044|Metastatic Sarcoma|metastatic sarcoma
5178728|NCT00902044|Sarcoma|sarcoma
5178729|NCT00902044|HER2-positive|her2-positive
5178730|NCT00902044|Gene Therapy|gene therapy
5178731|NCT00902044|HER2-specific T cells|her2-specific t cells
5178732|NCT00902031|Docusate|docusate
5178733|NCT00902031|Constipation|constipation
5178734|NCT00902031|Colace|colace
5178735|NCT00902031|Palliative Care|palliative care
5178736|NCT00902031|Sennoside|sennoside
5178737|NCT00902031|Senokot|senokot
5178738|NCT00902031|Terminally Ill|terminally ill
5178739|NCT00902031|Stool|stool
5178740|NCT00902031|Randomized Trial|randomized trial
5178741|NCT00902018|ITP|itp
5178742|NCT00902005|Endothelial dysfunction|endothelial dysfunction
5178743|NCT00902005|Bone and cartilage markers|bone and cartilage markers
5178744|NCT00902005|Inflammatory disease activity|inflammatory disease activity
5178745|NCT00902005|Rheumatoid arthritis|rheumatoid arthritis
5178746|NCT00902005|Psoriatic arthritis|psoriatic arthritis
5178747|NCT00902005|Ankylosing Spondylitis|ankylosing spondylitis
5178748|NCT00901992|type 2 diabetes|type 2 diabetes
5178749|NCT00901992|education|education
5178750|NCT00901992|self-management|self-management
5178751|NCT00901992|insulin therapy|insulin therapy
5178752|NCT00901979|Type 2 Diabetes|type 2 diabetes
5178754|NCT00901966|Sun Exposure History|sun exposure history
5178755|NCT00901966|Sun Exposure|sun exposure
5178756|NCT00901953|migraine|migraine
5178757|NCT00901953|migrainous vertigo|migrainous vertigo
5178758|NCT00901953|vestibular evoked myogenic potentials|vestibular evoked myogenic potentials
5178759|NCT00901953|vestibular function test|vestibular function test
5178760|NCT00901953|vestibular disorders|vestibular disorders
5178761|NCT00901927|Lymphoma|lymphoma
5178762|NCT00901927|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
5178763|NCT00901927|Untreated High Risk Follicular Lymphoma|untreated high risk follicular lymphoma
5178764|NCT00901927|Bendamustine hydrochloride|bendamustine hydrochloride
5178765|NCT00901927|Bendamustine HCI|bendamustine hci
5178766|NCT00901927|Bendamustine|bendamustine
5178767|NCT00901927|CEP-18083|cep-18083
5178768|NCT00901927|SDX-105|sdx-105
5178769|NCT00901927|Treanda|treanda
5178770|NCT00901927|Mitoxantrone|mitoxantrone
5178771|NCT00901927|Novantrone|novantrone
5178772|NCT00901927|Rituximab|rituximab
5178773|NCT00901927|Rituxan|rituxan
5178774|NCT00901914|Hypersensitivity|hypersensitivity
5178775|NCT00901914|Allergy|allergy
5178776|NCT00901914|Birch, allergy, Sublingual Immunotherapy|birch, allergy, sublingual immunotherapy
5178777|NCT00901901|Sorafenib (Nexavar)|sorafenib (nexavar)
5178778|NCT00901901|Erlotinib (Tarceva)|erlotinib (tarceva)
5178779|NCT00901901|First Line|first line
5178780|NCT00901901|HCC|hcc
5178781|NCT00901888|Renin Angiotensin System|renin angiotensin system
5178782|NCT00901875|Buprenorphine|buprenorphine
5178783|NCT00901875|Naloxone|naloxone
5178784|NCT00901875|Suboxone|suboxone
5178785|NCT00901862|Migraine|migraine
5178786|NCT00901862|therapy|therapy
5178787|NCT00901862|magnetic therapy|magnetic therapy
5178788|NCT00901862|prophylaxis|prophylaxis
5178789|NCT00901862|prevention|prevention
5178790|NCT00901836|Sarcoma|sarcoma
5178791|NCT00901810|Length Determination|length determination
5178792|NCT00901810|Working Length|working length
5178793|NCT00901810|Electronic Apex Locator|electronic apex locator
5178794|NCT00901810|Root Canal Therapy|root canal therapy
5178795|NCT00901810|Endodontics|endodontics
5178796|NCT00901797|ABD|abd
5178797|NCT00901797|ABDuction|abduction
5178798|NCT00901797|ABR|abr
5178799|NCT00901797|Arthroscopic Bankart Repair|arthroscopic bankart repair
5178800|NCT00901797|ACJ|acj
5178801|NCT00901797|AcromioClavicular Joint|acromioclavicular joint
5178802|NCT00901797|AD|ad
5178803|NCT00901797|Anterior Drawer|anterior drawer
5178804|NCT00901797|ARIC|aric
5178805|NCT00901797|Arthroscopic Rotator Interval Closure|arthroscopic rotator interval closure
5178806|NCT00901797|BL|bl
5178807|NCT00901797|Bankart Lesion|bankart lesion
5178808|NCT00901797|CHL|chl
5178809|NCT00901797|CoracoHumeral Ligament|coracohumeral ligament
5178810|NCT00901797|ER|er
5178811|NCT00901797|External Rotation|external rotation
5178812|NCT00901797|FF|ff
5178813|NCT00901797|Forward Flexion|forward flexion
5178814|NCT00901797|GHJ|ghj
5178815|NCT00901797|GlenoHumeral Joint|glenohumeral joint
5178816|NCT00901797|HSL|hsl
5178817|NCT00901797|HillSacs Lesion|hillsacs lesion
5178818|NCT00901797|IR|ir
5178819|NCT00901797|Internal Rotation|internal rotation
5178820|NCT00901797|ISP|isp
5178821|NCT00901797|InfraSPinatus|infraspinatus
5178822|NCT00901797|PD|pd
5178823|NCT00901797|Posterior Drawer|posterior drawer
5178824|NCT00901797|RI|ri
5178825|NCT00901797|Rotator Interval|rotator interval
5178826|NCT00901797|ROM|rom
5178827|NCT00901797|Range Of Motion|range of motion
5178828|NCT00901797|SGHL|sghl
5178829|NCT00901797|Superior GlenoHumeral Ligament|superior glenohumeral ligament
5178830|NCT00901797|SSC|ssc
5178831|NCT00901797|SubSCapularis|subscapularis
5178832|NCT00901797|SSP|ssp
5178833|NCT00901797|SupraSPinatus|supraspinatus
5178834|NCT00901784|Topiramate fasting study|topiramate fasting study
5178835|NCT00901771|Sleep|sleep
5178836|NCT00901771|Sleep Apnea, Obstructive|sleep apnea, obstructive
5178837|NCT00901771|OSA|osa
5178838|NCT00901771|OSAH|osah
5178839|NCT00901745|Renin angiotensin system|renin angiotensin system
5178840|NCT00901745|Apelin|apelin
5178841|NCT00901745|Vasodilatation|vasodilatation
5178842|NCT00901745|Heart disease|heart disease
5178843|NCT00901745|Vascular biology|vascular biology
5178844|NCT00901732|Caphosol|caphosol
5178845|NCT00901732|Oral Mucositis|oral mucositis
5178846|NCT00901732|Eusa Pharma|eusa pharma
5178847|NCT00901732|Moffitt Cancer Center|moffitt cancer center
5178848|NCT00901719|Renin angiotensin system|renin angiotensin system
5178849|NCT00901719|Apelin|apelin
5178850|NCT00901719|Cardiac output|cardiac output
5178851|NCT00901719|Vasodilatation|vasodilatation
5178852|NCT00901706|Self-Neglect|self-neglect
5178853|NCT00901706|Comprehensive Geriatric Assessment (CGA)|comprehensive geriatric assessment (cga)
5178854|NCT00901706|Geriatric Syndromes|geriatric syndromes
5178855|NCT00901706|Quality of Life|quality of life
5178856|NCT00901706|Basic Activities of Daily Living|basic activities of daily living
5178857|NCT00901706|Instrumental Activities of Daily Living|instrumental activities of daily living
5178858|NCT00901693|pink eye|pink eye
5178859|NCT00901693|eye infection|eye infection
5178860|NCT00901693|conjunctivitis|conjunctivitis
5178862|NCT00901654|Vaccination|vaccination
5178863|NCT00901654|Diarrhea|diarrhea
5178864|NCT00901654|Traveler's Diarrhea|traveler's diarrhea
5178865|NCT00901654|ETEC|etec
5178866|NCT00901654|Enterotoxigenic E. coli|enterotoxigenic e. coli
5178867|NCT00901641|cognitive training|cognitive training
5178868|NCT00901641|insomnia|insomnia
5178869|NCT00901628|periarticular multimodal drug injection|periarticular multimodal drug injection
5178870|NCT00901615|lymphoma|lymphoma
5178871|NCT00901615|lenalidomide|lenalidomide
5178872|NCT00901615|gela|gela
5178873|NCT00901602|streptococcus pneumoniae|streptococcus pneumoniae
5178874|NCT00901602|pneumococcus|pneumococcus
5178875|NCT00901602|pneumonia|pneumonia
5178876|NCT00901602|meningitis|meningitis
5178877|NCT00901602|serotypes|serotypes
5178878|NCT00901602|bacteremia|bacteremia
5178879|NCT00901602|sepsis|sepsis
5178880|NCT00901589|n-3 PUFAs|n-3 pufas
5178881|NCT00901589|menopause|menopause
5178882|NCT00901589|adipose tissue|adipose tissue
5178883|NCT00901589|estrogens|estrogens
5178884|NCT00901589|Incorporation of fishoil in pre- and postmenopausal women|incorporation of fishoil in pre- and postmenopausal women
5178885|NCT00901589|Marine n-3 PUFAs influence on female hormones in blood|marine n-3 pufas influence on female hormones in blood
5178886|NCT00901576|Healthy volunteers|healthy volunteers
5178887|NCT00901563|Gap Junctions|gap junctions
5178888|NCT00901563|Rotigaptide|rotigaptide
5178889|NCT00901563|Ischaemia reperfusion|ischaemia reperfusion
5178890|NCT00901563|t-PA|t-pa
5178891|NCT00901563|Fibrinolysis|fibrinolysis
5178892|NCT00901563|Endothelial function|endothelial function
5178893|NCT00901563|Venous occlusion plethysmography|venous occlusion plethysmography
5178895|NCT00901550|anti-TNF|anti-tnf
5178896|NCT00901550|Early RA|early ra
5178897|NCT00901537|Non-small Cell Lung Cancer|non-small cell lung cancer
5178898|NCT00901537|Head and Neck Cancer|head and neck cancer
5178899|NCT00901537|Azacitidine|azacitidine
5178900|NCT00901537|Vidaza|vidaza
5178901|NCT00901537|Cisplatin|cisplatin
5178902|NCT00901524|HCV Genotype 1, 4|hcv genotype 1, 4
5178903|NCT00901524|Virological response|virological response
5178904|NCT00901524|Ribavirin|ribavirin
5178905|NCT00901524|PegPegIFN- alpha 2a|pegpegifn- alpha 2a
5178906|NCT00901524|Viral Hepatitis (HCV)|viral hepatitis (hcv)
5178907|NCT00901511|Whole lung lavage|whole lung lavage
5178908|NCT00901511|Pulmonary surfactant|pulmonary surfactant
5178909|NCT00901511|GM-CSF|gm-csf
5178910|NCT00901511|Autoantibodies anti GM-CSF|autoantibodies anti gm-csf
5178911|NCT00901485|Respiratory insufficiency|respiratory insufficiency
5178912|NCT00901485|Hypercapnia|hypercapnia
5178913|NCT00901485|Hypoventilation|hypoventilation
5178914|NCT00901485|Sleep|sleep
5178915|NCT00901485|Polysomnography|polysomnography
5178916|NCT00901485|Hypoxia|hypoxia
5178917|NCT00901485|Titration|titration
5178918|NCT00901485|Non Invasive Ventilation|non invasive ventilation
5178919|NCT00901472|Type 2 diabetes,|type 2 diabetes,
5178920|NCT00901472|obstructive sleep apnea|obstructive sleep apnea
5178921|NCT00901459|Repetitive Transcranial Magnetic Stimulation|repetitive transcranial magnetic stimulation
5178922|NCT00901459|Cigarette Smoker|cigarette smoker
5178923|NCT00901459|Cigarette Dependence|cigarette dependence
5178924|NCT00901459|To block cue-elicited craving in dependent cigarette smokers|to block cue-elicited craving in dependent cigarette smokers
5178925|NCT00901433|Asthma|asthma
5178926|NCT00901433|Wheeze Rate|wheeze rate
5178927|NCT00901433|Respiratory Function Tests|respiratory function tests
5178928|NCT00901420|Prostate|prostate
5178929|NCT00901420|Urodynamic Evaluation|urodynamic evaluation
5178930|NCT00901420|Prostatectomy|prostatectomy
5178931|NCT00901420|Salvage prostatectomy|salvage prostatectomy
5178932|NCT00901420|Bladder compliance|bladder compliance
5178933|NCT00901420|Radiation Therapy|radiation therapy
5178934|NCT00901420|External beam radiation therapy|external beam radiation therapy
5178935|NCT00901420|Quality-of-life|quality-of-life
5178936|NCT00901407|augmentation|augmentation
5178937|NCT00901407|depression|depression
5178938|NCT00901407|resistance|resistance
5178939|NCT00901394|Nitrous oxide|nitrous oxide
5178940|NCT00901394|cobalamin|cobalamin
5178941|NCT00901394|homocysteine|homocysteine
5178942|NCT00901394|vitamin B12|vitamin b12
5178943|NCT00901394|folate|folate
5178944|NCT00901394|No specific diseases targeted|no specific diseases targeted
5178945|NCT00901381|Ischemic stroke|ischemic stroke
5178946|NCT00901381|Stem cells|stem cells
5178947|NCT00901381|Colony-stimulating factors|colony-stimulating factors
5178948|NCT00901381|Filgrastim|filgrastim
5178949|NCT00901381|Randomized controlled trial|randomized controlled trial
5178950|NCT00901355|Blood pressure|blood pressure
5178951|NCT00901355|Arterial stiffness|arterial stiffness
5178952|NCT00901355|Morbidity|morbidity
5178953|NCT00901355|Mortality|mortality
5178954|NCT00901355|Elderly|elderly
5178955|NCT00901342|Androgen independent prostate cancer (AIPC)|androgen independent prostate cancer (aipc)
5178956|NCT00901342|CRPC|crpc
5178957|NCT00901342|prostate cancer|prostate cancer
5178958|NCT00901342|prostate|prostate
5178959|NCT00901342|immune therapy|immune therapy
5178960|NCT00901342|immunotherapy|immunotherapy
5178961|NCT00901342|vaccine|vaccine
5178962|NCT00901342|dendritic cells|dendritic cells
5178963|NCT00901342|antigen-presenting cells|antigen-presenting cells
5178964|NCT00901342|antigen presenting cells|antigen presenting cells
5178965|NCT00901342|cancer vaccine|cancer vaccine
5178966|NCT00901342|prostate specific antigen (PSA)|prostate specific antigen (psa)
5178967|NCT00901342|prostatic adenocarcinoma|prostatic adenocarcinoma
5178968|NCT00901329|TKA|tka
5178969|NCT00901329|functional outcome|functional outcome
5178970|NCT00901329|pain|pain
5178971|NCT00901329|ROM|rom
5178972|NCT00901329|gait|gait
5178973|NCT00901316|Skin and Soft Tissue Infections|skin and soft tissue infections
5178974|NCT00901316|Abscesses|abscesses
5178975|NCT00901316|Boils|boils
5178976|NCT00901316|Clorox Baths|clorox baths
5178977|NCT00901316|Colonization|colonization
5178978|NCT00901316|Staph|staph
5178979|NCT00901316|MRSA|mrsa
5178980|NCT00901316|MSSA|mssa
5178981|NCT00901316|Recurrent Infections|recurrent infections
5178982|NCT00901316|Prevention CA-SA Infections|prevention ca-sa infections
5178983|NCT00901316|Community-Acquired Staphylococcus in Children|community-acquired staphylococcus in children
5178984|NCT00901290|oral contraceptive|oral contraceptive
5178985|NCT00901277|Post MI|post mi
5178986|NCT00901264|Chemosensitivity, chemotherapy, all cancers, personalized chemotherapy, personalized cancer treatment|chemosensitivity, chemotherapy, all cancers, personalized chemotherapy, personalized cancer treatment
5178987|NCT00901264|Cancer Patients for whom chemotherapy is planned.|cancer patients for whom chemotherapy is planned.
5178988|NCT00901251|OABSS|oabss
5178989|NCT00901238|retinoblastoma|retinoblastoma
5178990|NCT00901238|intra-arterial chemotherapy|intra-arterial chemotherapy
5178991|NCT00901238|chemosurgery|chemosurgery
5178992|NCT00901238|melphalan|melphalan
5178993|NCT00901238|topotecan|topotecan
5178994|NCT00901225|NHL|nhl
5178995|NCT00901212|Heart Failure|heart failure
5178996|NCT00901212|resynchronisation|resynchronisation
5178997|NCT00901212|ICD|icd
5178998|NCT00901199|Thalassemia|thalassemia
5178999|NCT00901199|Chelation|chelation
5179000|NCT00901199|Iron Overload|iron overload
5179001|NCT00901199|Thalassemia patients with Iron overload|thalassemia patients with iron overload
5179002|NCT00901186|Diabetic Macular Edema|diabetic macular edema
5179003|NCT00901186|Ranibizumab|ranibizumab
5179004|NCT00901186|Laser Treatment|laser treatment
5179005|NCT00901186|Visual impairment|visual impairment
5179006|NCT00901173|Case-Control Study|case-control study
5179007|NCT00901173|Esophageal Squamous Cell Carcinoma|esophageal squamous cell carcinoma
5179008|NCT00901173|Risk Factors|risk factors
5179009|NCT00901160|thromboelastography|thromboelastography
5179010|NCT00901160|post-operative complications|post-operative complications
5179011|NCT00901160|anti-platelet agents|anti-platelet agents
5179012|NCT00901160|prospective|prospective
5179013|NCT00901160|pilot|pilot
5179014|NCT00901160|patients taking anti-platelet agents|patients taking anti-platelet agents
5179015|NCT00901147|t-cell lymphoma|t-cell lymphoma
5179016|NCT00901147|peripheral t-cell lymphoma|peripheral t-cell lymphoma
5179017|NCT00901147|nk/t-cell lymphoma, nasal type|nk/t-cell lymphoma, nasal type
5179018|NCT00901147|bortezomib|bortezomib
5179019|NCT00901147|velcade|velcade
5179020|NCT00901147|panobinostat|panobinostat
5179021|NCT00901147|LBH589b|lbh589b
5179022|NCT00901147|histone deacetylase inhibitor|histone deacetylase inhibitor
5179023|NCT00901147|proteasome inhibitor|proteasome inhibitor
5179024|NCT00901134|therapeutic hypothermia after cardiac arrest|therapeutic hypothermia after cardiac arrest
5179025|NCT00901121|maxillary sinus lift|maxillary sinus lift
5179026|NCT00901121|Histomorphometric evaluation|histomorphometric evaluation
5179027|NCT00901121|bone graft|bone graft
5179028|NCT00901121|bone augmentation|bone augmentation
5179029|NCT00901108|open angle glaucoma|open angle glaucoma
5179030|NCT00901108|trabectome|trabectome
5179031|NCT00901108|trabeculectomy|trabeculectomy
5179032|NCT00901108|cataract|cataract
5179033|NCT00901082|chronic pain|chronic pain
5179034|NCT00901082|anxiety|anxiety
5179035|NCT00901082|intervention|intervention
5179036|NCT00901082|information|information
5179037|NCT00901082|relaxation|relaxation
5179038|NCT00901056|ED|ed
5179039|NCT00901056|Erectile Dysfunction|erectile dysfunction
5179040|NCT00901056|Erectile dysfunction treated with PDE-5 inhibitors|erectile dysfunction treated with pde-5 inhibitors
5179041|NCT00901030|platelet function|platelet function
5179042|NCT00901030|perioperative complications|perioperative complications
5179043|NCT00901030|thromboelastography|thromboelastography
5179044|NCT00901030|coronary stents|coronary stents
5179045|NCT00901030|non-cardiac surgery|non-cardiac surgery
5179046|NCT00901004|Minimal Change|minimal change
5179047|NCT00901004|GERD|gerd
5179048|NCT00901004|GERDQ|gerdq
5179049|NCT00900991|Pandemic Influenza A Vaccine|pandemic influenza a vaccine
5179050|NCT00900991|Immunogenictiy|immunogenictiy
5179051|NCT00900991|Safety|safety
5179052|NCT00900978|Streptococcus pneumoniae|streptococcus pneumoniae
5179053|NCT00900978|carriage|carriage
5179054|NCT00900978|Resistance|resistance
5179055|NCT00900978|Serotype|serotype
5179056|NCT00900978|vaccination|vaccination
5179057|NCT00900978|Colonization of S. pneumoniae|colonization of s. pneumoniae
5179058|NCT00900965|irritable bowel syndrome|irritable bowel syndrome
5179059|NCT00900965|IBS|ibs
5179060|NCT00900965|fMRI|fmri
5179061|NCT00900965|acupuncture|acupuncture
5179062|NCT00900965|functional|functional
5179063|NCT00900965|brain|brain
5179064|NCT00900900|Cigarette Smokers|cigarette smokers
5179065|NCT00900900|DHEA|dhea
5179066|NCT00900900|dehydroepiandrosterone|dehydroepiandrosterone
5179067|NCT00900900|pregnenolone|pregnenolone
5179068|NCT00900900|Nicotine withdrawal symptoms|nicotine withdrawal symptoms
5179069|NCT00900887|diabetic retinopathy|diabetic retinopathy
5179070|NCT00900887|clinically significant macular edema|clinically significant macular edema
5179071|NCT00900887|selective photocoagulation|selective photocoagulation
5179072|NCT00900887|topic ketorolac|topic ketorolac
5179073|NCT00900887|topic nepafenac|topic nepafenac
5179074|NCT00900887|efficacy|efficacy
5179075|NCT00900887|treatment|treatment
5179076|NCT00900874|Formoterol|formoterol
5179077|NCT00900874|Rapid bronchodilation|rapid bronchodilation
5179078|NCT00900861|asthma control level|asthma control level
5179079|NCT00900861|visual analogue scale|visual analogue scale
5179080|NCT00900848|Posterior tibial artery bypass|posterior tibial artery bypass
5179081|NCT00900848|Iliofemoral artery injury|iliofemoral artery injury
5179082|NCT00900848|Shock|shock
5179083|NCT00900848|Reconstruction|reconstruction
5179084|NCT00900835|fatigue|fatigue
5179085|NCT00900835|pain|pain
5179086|NCT00900835|recurrent breast cancer|recurrent breast cancer
5179087|NCT00900835|stage I breast cancer|stage i breast cancer
5179088|NCT00900835|stage II breast cancer|stage ii breast cancer
5179089|NCT00900835|stage IIIA breast cancer|stage iiia breast cancer
5179090|NCT00900835|stage IIIB breast cancer|stage iiib breast cancer
5179091|NCT00900835|stage IIIC breast cancer|stage iiic breast cancer
5179092|NCT00900835|stage IV breast cancer|stage iv breast cancer
5179093|NCT00900835|recurrent prostate cancer|recurrent prostate cancer
5179094|NCT00900835|stage I prostate cancer|stage i prostate cancer
5179095|NCT00900835|stage II prostate cancer|stage ii prostate cancer
5179096|NCT00900835|stage III prostate cancer|stage iii prostate cancer
5179097|NCT00900835|stage IV prostate cancer|stage iv prostate cancer
5179098|NCT00900835|recurrent colon cancer|recurrent colon cancer
5179099|NCT00900835|stage I colon cancer|stage i colon cancer
5179100|NCT00900835|stage II colon cancer|stage ii colon cancer
5179101|NCT00900835|stage III colon cancer|stage iii colon cancer
5179102|NCT00900835|stage IV colon cancer|stage iv colon cancer
5179103|NCT00900835|extensive stage small cell lung cancer|extensive stage small cell lung cancer
5179104|NCT00900835|limited stage small cell lung cancer|limited stage small cell lung cancer
5179105|NCT00900835|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5179106|NCT00900835|recurrent small cell lung cancer|recurrent small cell lung cancer
5179107|NCT00900835|stage I non-small cell lung cancer|stage i non-small cell lung cancer
5179108|NCT00900835|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
5179109|NCT00900835|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5179110|NCT00900835|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5179111|NCT00900835|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5179112|NCT00900822|bone grafting|bone grafting
5179113|NCT00900822|sinus elevation|sinus elevation
5179114|NCT00900822|sinus augmentation|sinus augmentation
5179115|NCT00900809|Acute Myeloid Leukemia|acute myeloid leukemia
5179116|NCT00900809|Neukoplast™|neukoplast™
5179117|NCT00900809|NK-92|nk-92
5179118|NCT00900809|Refractory|refractory
5179119|NCT00900809|Refractory or Relapsed Acute Myeloid Leukemia|refractory or relapsed acute myeloid leukemia
5179120|NCT00900796|Ankylosing spondylitis;predictive factors|ankylosing spondylitis;predictive factors
5179121|NCT00900783|herpes zoster|herpes zoster
5179122|NCT00900783|shingles|shingles
5179123|NCT00900783|Phase II|phase ii
5179124|NCT00900783|FV-100|fv-100
5179125|NCT00900783|Inhibitex|inhibitex
5179126|NCT00900770|dementia|dementia
5179127|NCT00900770|mild cognitive impairment|mild cognitive impairment
5179128|NCT00900770|beta amyloid|beta amyloid
5179129|NCT00900757|Primary Glioma|primary glioma
5179130|NCT00900757|Palonosetron|palonosetron
5179131|NCT00900757|Standard Radiotherapy|standard radiotherapy
5179132|NCT00900757|Temozolomide|temozolomide
5179133|NCT00900744|Tamoxifen|tamoxifen
5179134|NCT00900744|Breast Cancer|breast cancer
5179135|NCT00900731|COPD|copd
5179136|NCT00900731|indacaterol|indacaterol
5179137|NCT00900731|beta 2 agonist|beta 2 agonist
5179138|NCT00900731|tiotropium|tiotropium
5179139|NCT00900692|Excessive pronation|excessive pronation
5179140|NCT00900692|CVA|cva
5179141|NCT00900692|Forearm|forearm
5179142|NCT00900692|Excessive pronation following CVA|excessive pronation following cva
5179143|NCT00900679|transitional care planning|transitional care planning
5179144|NCT00900679|stage I ovarian epithelial cancer|stage i ovarian epithelial cancer
5179145|NCT00900679|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
5179146|NCT00900679|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5179147|NCT00900679|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5179148|NCT00900666|Stiff knee gait|stiff knee gait
5179149|NCT00900666|Gait analysis|gait analysis
5179150|NCT00900666|Traumatic Brain Injury|traumatic brain injury
5179151|NCT00900666|Acquired Brain Injury|acquired brain injury
5179152|NCT00900653|urinary tract infections|urinary tract infections
5179153|NCT00900653|postmenopause|postmenopause
5179154|NCT00900653|lactobacillus|lactobacillus
5179155|NCT00900653|estriol|estriol
5179156|NCT00900627|Cancer|cancer
5179157|NCT00900627|Tumour|tumour
5179158|NCT00900627|Breast cancer|breast cancer
5179159|NCT00900627|Metastatic|metastatic
5179160|NCT00900627|Secondary|secondary
5179161|NCT00900614|Hematologic malignancy|hematologic malignancy
5179162|NCT00900614|Prostate carcinoma|prostate carcinoma
5179163|NCT00900614|Hematologic cancer|hematologic cancer
5179164|NCT00900614|Prostate cancer|prostate cancer
5179165|NCT00900601|Sacroiliac pain|sacroiliac pain
5179166|NCT00900601|Sacroiliac instability|sacroiliac instability
5179167|NCT00900601|Pelvic girdle pain|pelvic girdle pain
5179168|NCT00900601|Sacroiliac arthrodesis|sacroiliac arthrodesis
5179169|NCT00900601|Arthrodesis|arthrodesis
5179170|NCT00900601|Surgery|surgery
5179171|NCT00900588|immunogenictiy|immunogenictiy
5179172|NCT00900588|safety|safety
5179173|NCT00900588|pandemic influenza A vaccine|pandemic influenza a vaccine
5179174|NCT00900575|cervical cancer|cervical cancer
5179175|NCT00900575|LEEP|leep
5179176|NCT00900575|colposcopy|colposcopy
5179177|NCT00900562|Zalypsis|zalypsis
5179178|NCT00900562|Cancer|cancer
5179179|NCT00900562|Endometrial|endometrial
5179180|NCT00900562|Uterine Cervical|uterine cervical
5179181|NCT00900562|PharmaMar|pharmamar
5179182|NCT00900549|Heart failure|heart failure
5179183|NCT00900549|Cardiac resynchronization therapy|cardiac resynchronization therapy
5179184|NCT00900549|ICD|icd
5179185|NCT00900536|clear cell renal cell carcinoma|clear cell renal cell carcinoma
5179186|NCT00900536|stage I renal cell cancer|stage i renal cell cancer
5179187|NCT00900536|stage II renal cell cancer|stage ii renal cell cancer
5179188|NCT00900536|stage III renal cell cancer|stage iii renal cell cancer
5179189|NCT00900536|stage IV renal cell cancer|stage iv renal cell cancer
5179190|NCT00900536|papillary renal cell carcinoma|papillary renal cell carcinoma
5179191|NCT00900523|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5179192|NCT00900523|stage I ovarian epithelial cancer|stage i ovarian epithelial cancer
5179193|NCT00900523|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
5179194|NCT00900523|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5179195|NCT00900523|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5179196|NCT00900510|subcutaneous abscess|subcutaneous abscess
5179197|NCT00900510|Incision and drainage|incision and drainage
5179198|NCT00900510|Methicillin-resistant staphylococcus aureus|methicillin-resistant staphylococcus aureus
5179199|NCT00900497|granulocytes|granulocytes
5179200|NCT00900497|Graft-vs-Host-Disease|graft-vs-host-disease
5179201|NCT00900484|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
5179202|NCT00900484|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
5179203|NCT00900484|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
5179204|NCT00900484|stage II adult diffuse large cell lymphoma|stage ii adult diffuse large cell lymphoma
5179205|NCT00900484|stage II adult diffuse mixed cell lymphoma|stage ii adult diffuse mixed cell lymphoma
5179206|NCT00900484|stage II adult diffuse small cleaved cell lymphoma|stage ii adult diffuse small cleaved cell lymphoma
5179207|NCT00900484|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5179208|NCT00900484|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5179209|NCT00900484|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5179210|NCT00900484|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5179211|NCT00900484|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5179212|NCT00900484|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5179213|NCT00900484|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
5179214|NCT00900484|stage II grade 3 follicular lymphoma|stage ii grade 3 follicular lymphoma
5179215|NCT00900484|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5179216|NCT00900484|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5179217|NCT00900484|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
5179218|NCT00900484|stage II adult immunoblastic large cell lymphoma|stage ii adult immunoblastic large cell lymphoma
5179219|NCT00900484|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5179220|NCT00900484|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5179221|NCT00900484|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
5179222|NCT00900484|stage II adult lymphoblastic lymphoma|stage ii adult lymphoblastic lymphoma
5179223|NCT00900484|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5179224|NCT00900484|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5179225|NCT00900484|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
5179226|NCT00900484|stage II adult Burkitt lymphoma|stage ii adult burkitt lymphoma
5179227|NCT00900484|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5179228|NCT00900484|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5179229|NCT00900471|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5179230|NCT00900471|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
5179231|NCT00900458|preeclampsia|preeclampsia
5179232|NCT00900458|low vs high plasma volume|low vs high plasma volume
5179233|NCT00900432|recurrent colon cancer|recurrent colon cancer
5179234|NCT00900432|stage I colon cancer|stage i colon cancer
5179235|NCT00900432|stage II colon cancer|stage ii colon cancer
5179236|NCT00900432|stage III colon cancer|stage iii colon cancer
5179237|NCT00900432|stage IV colon cancer|stage iv colon cancer
5179238|NCT00900419|non-small cell lung cancer|non-small cell lung cancer
5179239|NCT00900419|small cell lung cancer|small cell lung cancer
5179240|NCT00900419|squamous lung dysplasia|squamous lung dysplasia
5179241|NCT00900419|hypopharyngeal cancer|hypopharyngeal cancer
5179242|NCT00900419|laryngeal cancer|laryngeal cancer
5179243|NCT00900419|lip and oral cavity cancer|lip and oral cavity cancer
5179244|NCT00900419|metastatic squamous neck cancer with occult primary|metastatic squamous neck cancer with occult primary
5179245|NCT00900419|nasopharyngeal cancer|nasopharyngeal cancer
5179246|NCT00900419|oropharyngeal cancer|oropharyngeal cancer
5179247|NCT00900419|paranasal sinus and nasal cavity cancer|paranasal sinus and nasal cavity cancer
5179248|NCT00900419|salivary gland cancer|salivary gland cancer
5179249|NCT00900419|esophageal cancer|esophageal cancer
5179250|NCT00900419|pulmonary carcinoid tumor|pulmonary carcinoid tumor
5179251|NCT00900419|tongue cancer|tongue cancer
5179252|NCT00900380|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
5179253|NCT00900380|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
5179254|NCT00900380|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
5179255|NCT00900380|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
5179256|NCT00900380|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
5179257|NCT00900380|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
5179258|NCT00900380|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5179259|NCT00900380|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
5179260|NCT00900380|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
5179261|NCT00900380|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5179262|NCT00900380|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5179263|NCT00900380|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5179264|NCT00900380|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5179265|NCT00900380|adult erythroleukemia (M6a)|adult erythroleukemia (m6a)
5179266|NCT00900380|adult pure erythroid leukemia (M6b)|adult pure erythroid leukemia (m6b)
5179267|NCT00900367|breast cancer|breast cancer
5179268|NCT00900354|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
5179269|NCT00900341|adult soft tissue sarcoma|adult soft tissue sarcoma
5179270|NCT00900341|childhood soft tissue sarcoma|childhood soft tissue sarcoma
5179271|NCT00900328|adenocarcinoma of the lung|adenocarcinoma of the lung
5179272|NCT00900328|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5179273|NCT00900328|stage 0 non-small cell lung cancer|stage 0 non-small cell lung cancer
5179274|NCT00900328|stage I non-small cell lung cancer|stage i non-small cell lung cancer
5179275|NCT00900328|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
5179276|NCT00900328|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5179277|NCT00900328|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5179278|NCT00900328|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5179279|NCT00900302|male breast cancer|male breast cancer
5179280|NCT00900302|recurrent breast cancer|recurrent breast cancer
5179281|NCT00900302|stage IA breast cancer|stage ia breast cancer
5179282|NCT00900302|stage IB breast cancer|stage ib breast cancer
5179283|NCT00900302|stage II breast cancer|stage ii breast cancer
5179284|NCT00900302|stage IIIA breast cancer|stage iiia breast cancer
5179285|NCT00900302|stage IIIB breast cancer|stage iiib breast cancer
5179286|NCT00900302|stage IIIC breast cancer|stage iiic breast cancer
5179287|NCT00900302|stage IV breast cancer|stage iv breast cancer
5179288|NCT00900302|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5179289|NCT00900302|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
5179290|NCT00900302|squamous cell carcinoma of the anus|squamous cell carcinoma of the anus
5179291|NCT00900302|squamous cell carcinoma of the bladder|squamous cell carcinoma of the bladder
5179292|NCT00900302|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
5179293|NCT00900302|squamous cell carcinoma of the gallbladder|squamous cell carcinoma of the gallbladder
5179294|NCT00900302|squamous cell carcinoma of the skin|squamous cell carcinoma of the skin
5179295|NCT00900302|squamous cell carcinoma of the vulva|squamous cell carcinoma of the vulva
5179296|NCT00900302|squamous cell lung cancer|squamous cell lung cancer
5179297|NCT00900302|vaginal squamous cell carcinoma|vaginal squamous cell carcinoma
5179298|NCT00900302|stage I squamous cell carcinoma of the hypopharynx|stage i squamous cell carcinoma of the hypopharynx
5179299|NCT00900302|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
5179300|NCT00900302|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
5179301|NCT00900302|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5179360|NCT00900302|stage IV bladder cancer|stage iv bladder cancer
5179302|NCT00900302|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
5179303|NCT00900302|stage I squamous cell carcinoma of the larynx|stage i squamous cell carcinoma of the larynx
5179304|NCT00900302|stage I verrucous carcinoma of the larynx|stage i verrucous carcinoma of the larynx
5179305|NCT00900302|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
5179306|NCT00900302|stage II verrucous carcinoma of the larynx|stage ii verrucous carcinoma of the larynx
5179307|NCT00900302|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
5179308|NCT00900302|stage III verrucous carcinoma of the larynx|stage iii verrucous carcinoma of the larynx
5179309|NCT00900302|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5179310|NCT00900302|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
5179311|NCT00900302|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
5179312|NCT00900302|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
5179313|NCT00900302|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
5179314|NCT00900302|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
5179315|NCT00900302|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
5179697|NCT00900094|stage II breast cancer|stage ii breast cancer
5179316|NCT00900302|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5179317|NCT00900302|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
5179318|NCT00900302|stage I verrucous carcinoma of the oral cavity|stage i verrucous carcinoma of the oral cavity
5179319|NCT00900302|stage II verrucous carcinoma of the oral cavity|stage ii verrucous carcinoma of the oral cavity
5179320|NCT00900302|stage III verrucous carcinoma of the oral cavity|stage iii verrucous carcinoma of the oral cavity
5179321|NCT00900302|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
5179322|NCT00900302|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
5179323|NCT00900302|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
5179324|NCT00900302|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
5179325|NCT00900302|untreated metastatic squamous neck cancer with occult primary|untreated metastatic squamous neck cancer with occult primary
5179326|NCT00900302|stage I squamous cell carcinoma of the nasopharynx|stage i squamous cell carcinoma of the nasopharynx
5179327|NCT00900302|stage II squamous cell carcinoma of the nasopharynx|stage ii squamous cell carcinoma of the nasopharynx
5179328|NCT00900302|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
5179329|NCT00900302|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
5179330|NCT00900302|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
5179331|NCT00900302|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
5179332|NCT00900302|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
5179333|NCT00900302|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
5179334|NCT00900302|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5179335|NCT00900302|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
5179336|NCT00900302|stage I squamous cell carcinoma of the paranasal sinus and nasal cavity|stage i squamous cell carcinoma of the paranasal sinus and nasal cavity
5179337|NCT00900302|stage II squamous cell carcinoma of the paranasal sinus and nasal cavity|stage ii squamous cell carcinoma of the paranasal sinus and nasal cavity
5179338|NCT00900302|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
5179339|NCT00900302|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
5179340|NCT00900302|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
5179341|NCT00900302|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
5179342|NCT00900302|stage I salivary gland cancer|stage i salivary gland cancer
5179343|NCT00900302|stage II salivary gland cancer|stage ii salivary gland cancer
5179344|NCT00900302|stage III salivary gland cancer|stage iii salivary gland cancer
5179345|NCT00900302|stage IV salivary gland cancer|stage iv salivary gland cancer
5179346|NCT00900302|recurrent salivary gland cancer|recurrent salivary gland cancer
5179347|NCT00900302|squamous cell carcinoma of unknown primary|squamous cell carcinoma of unknown primary
5179348|NCT00900302|cervical squamous cell carcinoma|cervical squamous cell carcinoma
5179349|NCT00900302|penile squamous cell carcinoma|penile squamous cell carcinoma
5179350|NCT00900302|recurrent anal cancer|recurrent anal cancer
5179351|NCT00900302|stage I anal cancer|stage i anal cancer
5179352|NCT00900302|stage II anal cancer|stage ii anal cancer
5179353|NCT00900302|stage IIIA anal cancer|stage iiia anal cancer
5179354|NCT00900302|stage IIIB anal cancer|stage iiib anal cancer
5179355|NCT00900302|stage IV anal cancer|stage iv anal cancer
5179356|NCT00900302|recurrent bladder cancer|recurrent bladder cancer
5179357|NCT00900302|stage I bladder cancer|stage i bladder cancer
5179358|NCT00900302|stage II bladder cancer|stage ii bladder cancer
5179359|NCT00900302|stage III bladder cancer|stage iii bladder cancer
5179361|NCT00900302|recurrent esophageal cancer|recurrent esophageal cancer
5179362|NCT00900302|stage I esophageal cancer|stage i esophageal cancer
5179363|NCT00900302|stage II esophageal cancer|stage ii esophageal cancer
5179364|NCT00900302|stage III esophageal cancer|stage iii esophageal cancer
5179365|NCT00900302|stage IV esophageal cancer|stage iv esophageal cancer
5179366|NCT00900302|localized gallbladder cancer|localized gallbladder cancer
5179367|NCT00900302|recurrent gallbladder cancer|recurrent gallbladder cancer
5179368|NCT00900302|unresectable gallbladder cancer|unresectable gallbladder cancer
5179369|NCT00900302|recurrent vulvar cancer|recurrent vulvar cancer
5179370|NCT00900302|stage I vulvar cancer|stage i vulvar cancer
5179371|NCT00900302|stage II vulvar cancer|stage ii vulvar cancer
5179372|NCT00900302|stage III vulvar cancer|stage iii vulvar cancer
5179373|NCT00900302|stage IV vulvar cancer|stage iv vulvar cancer
5179374|NCT00900302|recurrent cervical cancer|recurrent cervical cancer
5179375|NCT00900302|stage IA cervical cancer|stage ia cervical cancer
5179376|NCT00900302|stage IB cervical cancer|stage ib cervical cancer
5179377|NCT00900302|stage IIA cervical cancer|stage iia cervical cancer
5179378|NCT00900302|stage IIB cervical cancer|stage iib cervical cancer
5179379|NCT00900302|stage III cervical cancer|stage iii cervical cancer
5179380|NCT00900302|stage IVA cervical cancer|stage iva cervical cancer
5179381|NCT00900302|stage IVB cervical cancer|stage ivb cervical cancer
5179382|NCT00900302|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5179383|NCT00900302|stage I non-small cell lung cancer|stage i non-small cell lung cancer
5179384|NCT00900302|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
5179385|NCT00900302|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5179386|NCT00900302|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5179387|NCT00900302|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5179388|NCT00900302|recurrent skin cancer|recurrent skin cancer
5179389|NCT00900302|newly diagnosed carcinoma of unknown primary|newly diagnosed carcinoma of unknown primary
5179390|NCT00900302|recurrent carcinoma of unknown primary|recurrent carcinoma of unknown primary
5179391|NCT00900302|recurrent penile cancer|recurrent penile cancer
5179392|NCT00900302|stage I penile cancer|stage i penile cancer
5179393|NCT00900302|stage II penile cancer|stage ii penile cancer
5179394|NCT00900302|stage III penile cancer|stage iii penile cancer
5179395|NCT00900302|stage IV penile cancer|stage iv penile cancer
5179396|NCT00900302|recurrent melanoma|recurrent melanoma
5179397|NCT00900302|stage IA melanoma|stage ia melanoma
5179398|NCT00900302|stage IB melanoma|stage ib melanoma
5179399|NCT00900302|stage IIA melanoma|stage iia melanoma
5179400|NCT00900302|stage IIB melanoma|stage iib melanoma
5179401|NCT00900302|stage IIC melanoma|stage iic melanoma
5179402|NCT00900302|stage IIIA melanoma|stage iiia melanoma
5179403|NCT00900302|stage IIIB melanoma|stage iiib melanoma
5179404|NCT00900302|stage IIIC melanoma|stage iiic melanoma
5179405|NCT00900302|stage IV melanoma|stage iv melanoma
5179406|NCT00900289|stage IC ovarian epithelial cancer|stage ic ovarian epithelial cancer
5179407|NCT00900289|stage IIA ovarian epithelial cancer|stage iia ovarian epithelial cancer
5179408|NCT00900289|stage IIB ovarian epithelial cancer|stage iib ovarian epithelial cancer
5179409|NCT00900289|stage IIC ovarian epithelial cancer|stage iic ovarian epithelial cancer
5179410|NCT00900289|stage IIIA ovarian epithelial cancer|stage iiia ovarian epithelial cancer
5179411|NCT00900289|stage IIIB ovarian epithelial cancer|stage iiib ovarian epithelial cancer
5179412|NCT00900289|stage IIIC ovarian epithelial cancer|stage iiic ovarian epithelial cancer
5179413|NCT00900289|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5179414|NCT00900276|localized transitional cell cancer of the renal pelvis and ureter|localized transitional cell cancer of the renal pelvis and ureter
5179415|NCT00900276|metastatic transitional cell cancer of the renal pelvis and ureter|metastatic transitional cell cancer of the renal pelvis and ureter
5179416|NCT00900276|recurrent transitional cell cancer of the renal pelvis and ureter|recurrent transitional cell cancer of the renal pelvis and ureter
5179417|NCT00900276|regional transitional cell cancer of the renal pelvis and ureter|regional transitional cell cancer of the renal pelvis and ureter
5179418|NCT00900276|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
5179419|NCT00900276|stage I renal cell cancer|stage i renal cell cancer
5179420|NCT00900276|stage II renal cell cancer|stage ii renal cell cancer
5179421|NCT00900276|recurrent renal cell cancer|recurrent renal cell cancer
5179422|NCT00900276|recurrent bladder cancer|recurrent bladder cancer
5179423|NCT00900276|stage I bladder cancer|stage i bladder cancer
5179424|NCT00900276|stage II bladder cancer|stage ii bladder cancer
5179425|NCT00900276|stage III bladder cancer|stage iii bladder cancer
5179426|NCT00900276|stage IV bladder cancer|stage iv bladder cancer
5179427|NCT00900276|anterior urethral cancer|anterior urethral cancer
5179428|NCT00900276|posterior urethral cancer|posterior urethral cancer
5179429|NCT00900276|recurrent urethral cancer|recurrent urethral cancer
5179430|NCT00900276|urethral cancer associated with invasive bladder cancer|urethral cancer associated with invasive bladder cancer
5179431|NCT00900263|stage I multiple myeloma|stage i multiple myeloma
5179432|NCT00900263|isolated plasmacytoma of bone|isolated plasmacytoma of bone
5179433|NCT00900263|monoclonal gammopathy of undetermined significance|monoclonal gammopathy of undetermined significance
5179434|NCT00900237|Partial|partial
5179435|NCT00900237|Epilepsy|epilepsy
5179436|NCT00900237|Eslicarbazepine acetate|eslicarbazepine acetate
5179437|NCT00900237|Pharmacokinetics|pharmacokinetics
5179438|NCT00900237|Tolerability|tolerability
5179439|NCT00900224|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5179440|NCT00900224|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5179441|NCT00900224|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5179442|NCT00900224|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5179443|NCT00900224|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5179444|NCT00900224|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
5179445|NCT00900224|untreated childhood acute myeloid leukemia and other myeloid malignancies|untreated childhood acute myeloid leukemia and other myeloid malignancies
5179446|NCT00900224|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5179447|NCT00900211|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
5179448|NCT00900211|stage I adult soft tissue sarcoma|stage i adult soft tissue sarcoma
5179449|NCT00900211|stage II adult soft tissue sarcoma|stage ii adult soft tissue sarcoma
5179450|NCT00900211|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
5179451|NCT00900211|adult synovial sarcoma|adult synovial sarcoma
5179452|NCT00900211|adult angiosarcoma|adult angiosarcoma
5179453|NCT00900211|adult epithelioid sarcoma|adult epithelioid sarcoma
5179454|NCT00900211|adult extraskeletal chondrosarcoma|adult extraskeletal chondrosarcoma
5179455|NCT00900211|adult leiomyosarcoma|adult leiomyosarcoma
5179456|NCT00900211|adult liposarcoma|adult liposarcoma
5179457|NCT00900211|adult malignant fibrous histiocytoma|adult malignant fibrous histiocytoma
5179458|NCT00900211|adult malignant hemangiopericytoma|adult malignant hemangiopericytoma
5179459|NCT00900211|adult malignant mesenchymoma|adult malignant mesenchymoma
5179460|NCT00900211|adult fibrosarcoma|adult fibrosarcoma
5179461|NCT00900211|adult neurofibrosarcoma|adult neurofibrosarcoma
5179462|NCT00900198|Tissue Collection|tissue collection
5179463|NCT00900198|Biospecimen|biospecimen
5179464|NCT00900198|Assay Development|assay development
5179465|NCT00900198|Tissue Acquisition|tissue acquisition
5179466|NCT00900198|Tissue Biopsies|tissue biopsies
5179467|NCT00900185|recurrent prostate cancer|recurrent prostate cancer
5179468|NCT00900185|stage I prostate cancer|stage i prostate cancer
5179469|NCT00900185|stage IIB prostate cancer|stage iib prostate cancer
5179470|NCT00900185|stage IIA prostate cancer|stage iia prostate cancer
5179471|NCT00900185|stage III prostate cancer|stage iii prostate cancer
5179472|NCT00900185|stage IV prostate cancer|stage iv prostate cancer
5179473|NCT00900172|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5179474|NCT00900172|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5179475|NCT00900172|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5179476|NCT00900172|adenocarcinoma of the lung|adenocarcinoma of the lung
5179477|NCT00900172|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
5179478|NCT00900159|Shift-work|shift-work
5179479|NCT00900159|SWSD|swsd
5179480|NCT00900159|eszopiclone|eszopiclone
5179482|NCT00900159|shiftworkers|shiftworkers
5179483|NCT00900146|type 2 diabetes|type 2 diabetes
5179484|NCT00900146|canakinumab|canakinumab
5179485|NCT00900133|stage I breast cancer|stage i breast cancer
5179486|NCT00900133|stage II breast cancer|stage ii breast cancer
5179487|NCT00900133|stage IIIA breast cancer|stage iiia breast cancer
5179488|NCT00900133|stage IIIB breast cancer|stage iiib breast cancer
5179489|NCT00900133|stage IIIC breast cancer|stage iiic breast cancer
5179490|NCT00900120|aplastic anemia|aplastic anemia
5179491|NCT00900120|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
5179492|NCT00900120|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5179493|NCT00900120|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
5179494|NCT00900120|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5179495|NCT00900120|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5179496|NCT00900120|acute undifferentiated leukemia|acute undifferentiated leukemia
5179497|NCT00900120|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5179498|NCT00900120|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5179499|NCT00900120|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5179500|NCT00900120|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5179501|NCT00900120|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5179502|NCT00900120|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5179503|NCT00900120|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5179504|NCT00900120|atypical chronic myeloid leukemia, BCR-ABL negative|atypical chronic myeloid leukemia, bcr-abl negative
5179505|NCT00900120|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5179506|NCT00900120|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
5179507|NCT00900120|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
5179508|NCT00900120|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
5179509|NCT00900120|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5179510|NCT00900120|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5179511|NCT00900120|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
5179512|NCT00900120|mast cell leukemia|mast cell leukemia
5179513|NCT00900120|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
5179514|NCT00900120|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
5179515|NCT00900120|prolymphocytic leukemia|prolymphocytic leukemia
5179516|NCT00900120|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5179517|NCT00900120|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5179518|NCT00900120|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
5179519|NCT00900120|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5179520|NCT00900120|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5179521|NCT00900120|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5179522|NCT00900120|refractory hairy cell leukemia|refractory hairy cell leukemia
5179523|NCT00900120|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5179524|NCT00900120|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5179525|NCT00900120|stage 0 chronic lymphocytic leukemia|stage 0 chronic lymphocytic leukemia
5179526|NCT00900120|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
5179527|NCT00900120|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
5179528|NCT00900120|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
5179529|NCT00900120|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
5179530|NCT00900120|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
5179531|NCT00900120|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5179532|NCT00900120|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
5179533|NCT00900120|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5179534|NCT00900120|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
5179535|NCT00900120|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
5179536|NCT00900120|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
5179537|NCT00900120|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
5179538|NCT00900120|untreated childhood acute myeloid leukemia and other myeloid malignancies|untreated childhood acute myeloid leukemia and other myeloid malignancies
5179539|NCT00900120|untreated hairy cell leukemia|untreated hairy cell leukemia
5179540|NCT00900120|AIDS-related diffuse large cell lymphoma|aids-related diffuse large cell lymphoma
5179541|NCT00900120|AIDS-related diffuse mixed cell lymphoma|aids-related diffuse mixed cell lymphoma
5179542|NCT00900120|AIDS-related diffuse small cleaved cell lymphoma|aids-related diffuse small cleaved cell lymphoma
5179543|NCT00900120|AIDS-related immunoblastic large cell lymphoma|aids-related immunoblastic large cell lymphoma
5179544|NCT00900120|AIDS-related lymphoblastic lymphoma|aids-related lymphoblastic lymphoma
5179545|NCT00900120|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
5179546|NCT00900120|AIDS-related primary CNS lymphoma|aids-related primary cns lymphoma
5179547|NCT00900120|AIDS-related small noncleaved cell lymphoma|aids-related small noncleaved cell lymphoma
5179548|NCT00900120|HIV-associated Hodgkin lymphoma|hiv-associated hodgkin lymphoma
5179549|NCT00900120|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5179550|NCT00900120|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
5179551|NCT00900120|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
5179552|NCT00900120|stage I childhood Hodgkin lymphoma|stage i childhood hodgkin lymphoma
5179553|NCT00900120|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
5179554|NCT00900120|stage II childhood Hodgkin lymphoma|stage ii childhood hodgkin lymphoma
5179555|NCT00900120|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5179556|NCT00900120|stage III childhood Hodgkin lymphoma|stage iii childhood hodgkin lymphoma
5179557|NCT00900120|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5179558|NCT00900120|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
5179559|NCT00900120|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5179560|NCT00900120|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
5179561|NCT00900120|cutaneous B-cell non-Hodgkin lymphoma|cutaneous b-cell non-hodgkin lymphoma
5179562|NCT00900120|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5179563|NCT00900120|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
5179564|NCT00900120|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
5179565|NCT00900120|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
5179566|NCT00900120|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
5179567|NCT00900120|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5179568|NCT00900120|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
5179569|NCT00900120|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
5179570|NCT00900120|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
5179571|NCT00900120|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
5179572|NCT00900120|adult grade III lymphomatoid granulomatosis|adult grade iii lymphomatoid granulomatosis
5179573|NCT00900120|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
5179574|NCT00900120|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
5180294|NCT00899431|Rituximab|rituximab
5179575|NCT00900120|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5179576|NCT00900120|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5179577|NCT00900120|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5179578|NCT00900120|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
5179579|NCT00900120|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
5179580|NCT00900120|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
5179581|NCT00900120|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
5179582|NCT00900120|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
5179583|NCT00900120|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
5179584|NCT00900120|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
5179585|NCT00900120|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
5179586|NCT00900120|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
5179587|NCT00900120|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
5179588|NCT00900120|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
5179589|NCT00900120|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
5179590|NCT00900120|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
5179591|NCT00900120|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
5179592|NCT00900120|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
5179593|NCT00900120|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
5179594|NCT00900120|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
5179595|NCT00900120|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
5179596|NCT00900120|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
5179597|NCT00900120|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
5179598|NCT00900120|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
5179599|NCT00900120|stage I mantle cell lymphoma|stage i mantle cell lymphoma
5179600|NCT00900120|stage I marginal zone lymphoma|stage i marginal zone lymphoma
5179601|NCT00900120|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
5179602|NCT00900120|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
5179603|NCT00900120|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5179604|NCT00900120|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
5179605|NCT00900120|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
5179606|NCT00900120|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
5179607|NCT00900120|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
5179608|NCT00900120|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5179609|NCT00900120|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5179610|NCT00900120|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5179611|NCT00900120|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5179612|NCT00900120|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
5179613|NCT00900120|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
5179614|NCT00900120|stage I childhood large cell lymphoma|stage i childhood large cell lymphoma
5179615|NCT00900120|stage I childhood lymphoblastic lymphoma|stage i childhood lymphoblastic lymphoma
5179616|NCT00900120|stage I childhood small noncleaved cell lymphoma|stage i childhood small noncleaved cell lymphoma
5179617|NCT00900120|stage II childhood large cell lymphoma|stage ii childhood large cell lymphoma
5179618|NCT00900120|stage II childhood lymphoblastic lymphoma|stage ii childhood lymphoblastic lymphoma
5179619|NCT00900120|stage II childhood small noncleaved cell lymphoma|stage ii childhood small noncleaved cell lymphoma
5179620|NCT00900120|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5179621|NCT00900120|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5179622|NCT00900120|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5179623|NCT00900120|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5179624|NCT00900120|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5179625|NCT00900120|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5179626|NCT00900120|stage III childhood large cell lymphoma|stage iii childhood large cell lymphoma
5179627|NCT00900120|stage III childhood lymphoblastic lymphoma|stage iii childhood lymphoblastic lymphoma
5179628|NCT00900120|stage III childhood small noncleaved cell lymphoma|stage iii childhood small noncleaved cell lymphoma
5179629|NCT00900120|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5179630|NCT00900120|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5179631|NCT00900120|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5179632|NCT00900120|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5179633|NCT00900120|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5180510|NCT00898807|aggression|aggression
5179634|NCT00900120|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5179635|NCT00900120|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5179636|NCT00900120|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5179637|NCT00900120|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5179638|NCT00900120|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5179639|NCT00900120|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5179640|NCT00900120|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5179641|NCT00900120|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
5179642|NCT00900120|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
5179643|NCT00900120|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
5179644|NCT00900120|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5179645|NCT00900120|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5179646|NCT00900120|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5179647|NCT00900120|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5179648|NCT00900120|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5179649|NCT00900120|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5179650|NCT00900120|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5179651|NCT00900120|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5179652|NCT00900120|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5179653|NCT00900120|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5179654|NCT00900120|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
5179655|NCT00900120|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5179656|NCT00900120|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5179657|NCT00900120|recurrent childhood grade III lymphomatoid granulomatosis|recurrent childhood grade iii lymphomatoid granulomatosis
5179658|NCT00900120|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
5179659|NCT00900120|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
5179660|NCT00900120|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
5179661|NCT00900120|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5179662|NCT00900120|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5179663|NCT00900120|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5179664|NCT00900120|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5179665|NCT00900120|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5179666|NCT00900120|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5179667|NCT00900120|Burkitt lymphoma|burkitt lymphoma
5179668|NCT00900120|childhood diffuse large cell lymphoma|childhood diffuse large cell lymphoma
5179669|NCT00900120|childhood grade III lymphomatoid granulomatosis|childhood grade iii lymphomatoid granulomatosis
5179670|NCT00900120|childhood immunoblastic large cell lymphoma|childhood immunoblastic large cell lymphoma
5179671|NCT00900120|childhood nasal type extranodal NK/T-cell lymphoma|childhood nasal type extranodal nk/t-cell lymphoma
5179672|NCT00900120|intraocular lymphoma|intraocular lymphoma
5179673|NCT00900120|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
5179674|NCT00900120|primary central nervous system Hodgkin lymphoma|primary central nervous system hodgkin lymphoma
5179675|NCT00900120|post-transplant lymphoproliferative disorder|post-transplant lymphoproliferative disorder
5179676|NCT00900120|chronic eosinophilic leukemia|chronic eosinophilic leukemia
5179677|NCT00900120|chronic neutrophilic leukemia|chronic neutrophilic leukemia
5179678|NCT00900120|primary myelofibrosis|primary myelofibrosis
5179679|NCT00900120|essential thrombocythemia|essential thrombocythemia
5179680|NCT00900120|polycythemia vera|polycythemia vera
5179681|NCT00900120|extramedullary plasmacytoma|extramedullary plasmacytoma
5179682|NCT00900120|isolated plasmacytoma of bone|isolated plasmacytoma of bone
5179683|NCT00900120|stage I multiple myeloma|stage i multiple myeloma
5179684|NCT00900120|stage II multiple myeloma|stage ii multiple myeloma
5179685|NCT00900120|stage III multiple myeloma|stage iii multiple myeloma
5179686|NCT00900120|primary systemic amyloidosis|primary systemic amyloidosis
5179687|NCT00900120|refractory multiple myeloma|refractory multiple myeloma
5179688|NCT00900120|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5179689|NCT00900120|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5179690|NCT00900120|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
5179691|NCT00900120|recurrent childhood anaplastic large cell lymphoma|recurrent childhood anaplastic large cell lymphoma
5179692|NCT00900120|stage I childhood anaplastic large cell lymphoma|stage i childhood anaplastic large cell lymphoma
5179693|NCT00900120|stage II childhood anaplastic large cell lymphoma|stage ii childhood anaplastic large cell lymphoma
5179694|NCT00900120|stage III childhood anaplastic large cell lymphoma|stage iii childhood anaplastic large cell lymphoma
5179695|NCT00900120|stage IV childhood anaplastic large cell lymphoma|stage iv childhood anaplastic large cell lymphoma
5179696|NCT00900094|stage I breast cancer|stage i breast cancer
5179698|NCT00900094|stage IIIA breast cancer|stage iiia breast cancer
5179699|NCT00900094|stage IIIB breast cancer|stage iiib breast cancer
5179700|NCT00900094|stage IV breast cancer|stage iv breast cancer
5179701|NCT00900094|adenocarcinoma of the colon|adenocarcinoma of the colon
5179702|NCT00900094|stage I colon cancer|stage i colon cancer
5179703|NCT00900094|stage II colon cancer|stage ii colon cancer
5179704|NCT00900094|stage III colon cancer|stage iii colon cancer
5179705|NCT00900094|stage IV colon cancer|stage iv colon cancer
5179706|NCT00900094|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
5179707|NCT00900094|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
5179708|NCT00900094|stage I esophageal cancer|stage i esophageal cancer
5179709|NCT00900094|stage II esophageal cancer|stage ii esophageal cancer
5179710|NCT00900094|stage III esophageal cancer|stage iii esophageal cancer
5179711|NCT00900094|stage IV esophageal cancer|stage iv esophageal cancer
5179712|NCT00900094|stage I non-small cell lung cancer|stage i non-small cell lung cancer
5179713|NCT00900094|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
5179714|NCT00900094|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5179715|NCT00900094|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5179716|NCT00900094|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5179717|NCT00900094|stage I ovarian epithelial cancer|stage i ovarian epithelial cancer
5179718|NCT00900094|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
5179719|NCT00900094|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5179720|NCT00900094|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5179721|NCT00900094|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
5179722|NCT00900094|advanced adult primary liver cancer|advanced adult primary liver cancer
5179723|NCT00900094|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
5179724|NCT00900094|stage II pancreatic cancer|stage ii pancreatic cancer
5179725|NCT00900094|stage III pancreatic cancer|stage iii pancreatic cancer
5179726|NCT00900094|extensive stage small cell lung cancer|extensive stage small cell lung cancer
5179727|NCT00900094|stage IIIC breast cancer|stage iiic breast cancer
5179728|NCT00900094|stage IV pancreatic cancer|stage iv pancreatic cancer
5179729|NCT00900094|recurrent breast cancer|recurrent breast cancer
5179730|NCT00900094|recurrent colon cancer|recurrent colon cancer
5179731|NCT00900094|recurrent esophageal cancer|recurrent esophageal cancer
5179732|NCT00900094|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5179733|NCT00900094|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5179734|NCT00900094|recurrent adult primary liver cancer|recurrent adult primary liver cancer
5179735|NCT00900094|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
5179736|NCT00900094|recurrent small cell lung cancer|recurrent small cell lung cancer
5179737|NCT00900081|cervical squamous cell carcinoma|cervical squamous cell carcinoma
5179738|NCT00900081|stage IA cervical cancer|stage ia cervical cancer
5179739|NCT00900081|stage 0 cervical cancer|stage 0 cervical cancer
5179740|NCT00900081|cervical intraepithelial neoplasia grade 1|cervical intraepithelial neoplasia grade 1
5179741|NCT00900081|cervical intraepithelial neoplasia grade 2|cervical intraepithelial neoplasia grade 2
5179742|NCT00900081|cervical intraepithelial neoplasia grade 3|cervical intraepithelial neoplasia grade 3
5179743|NCT00900068|nausea and vomiting|nausea and vomiting
5179744|NCT00900068|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5179745|NCT00900068|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5179746|NCT00900068|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5179747|NCT00900068|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5179748|NCT00900068|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5179749|NCT00900068|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5179750|NCT00900068|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5179751|NCT00900068|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5179752|NCT00900068|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5179753|NCT00900068|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5179754|NCT00900068|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5179755|NCT00900068|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5179756|NCT00900068|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5179757|NCT00900068|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5179758|NCT00900068|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5179759|NCT00900068|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5179760|NCT00900068|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5179761|NCT00900068|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5179762|NCT00900068|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5179763|NCT00900068|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5179764|NCT00900068|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5179765|NCT00900068|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5179766|NCT00900068|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5179767|NCT00900068|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5179768|NCT00900068|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5179769|NCT00900068|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5179770|NCT00900068|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5181920|NCT00896285|pleurodesis|pleurodesis
5179771|NCT00900068|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5179772|NCT00900068|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5179773|NCT00900068|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5179774|NCT00900068|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5179775|NCT00900068|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5179776|NCT00900068|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5179777|NCT00900068|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5179778|NCT00900068|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5179779|NCT00900068|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5179780|NCT00900068|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5179781|NCT00900068|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5179782|NCT00900068|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5179783|NCT00900068|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5179784|NCT00900068|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5179785|NCT00900068|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5179786|NCT00900068|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5179787|NCT00900068|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5179788|NCT00900068|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
5179789|NCT00900068|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5179790|NCT00900068|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
5179791|NCT00900068|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
5179792|NCT00900068|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
5179793|NCT00900068|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
5179794|NCT00900068|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5179795|NCT00900068|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5179796|NCT00900068|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5179797|NCT00900068|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5179798|NCT00900068|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
5179799|NCT00900068|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
5179800|NCT00900068|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5179801|NCT00900068|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5179802|NCT00900068|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5179803|NCT00900068|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5179804|NCT00900068|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5179805|NCT00900068|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5179806|NCT00900068|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5179807|NCT00900068|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5179808|NCT00900068|atypical chronic myeloid leukemia, BCR-ABL negative|atypical chronic myeloid leukemia, bcr-abl negative
5179809|NCT00900068|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5179810|NCT00900068|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5179811|NCT00900068|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5179812|NCT00900068|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5179813|NCT00900068|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5179814|NCT00900068|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5179815|NCT00900068|refractory hairy cell leukemia|refractory hairy cell leukemia
5179816|NCT00900068|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5179817|NCT00900068|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5179818|NCT00900068|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5179819|NCT00900068|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5179820|NCT00900068|chronic eosinophilic leukemia|chronic eosinophilic leukemia
5179821|NCT00900068|primary myelofibrosis|primary myelofibrosis
5179822|NCT00900068|chronic neutrophilic leukemia|chronic neutrophilic leukemia
5179823|NCT00900068|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5179824|NCT00900068|disseminated neuroblastoma|disseminated neuroblastoma
5179825|NCT00900068|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
5179826|NCT00900068|poor prognosis metastatic gestational trophoblastic tumor|poor prognosis metastatic gestational trophoblastic tumor
5179827|NCT00900068|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5179828|NCT00900068|recurrent neuroblastoma|recurrent neuroblastoma
5179829|NCT00900068|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5179830|NCT00900068|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
5180029|NCT00899860|stage I renal cell cancer|stage i renal cell cancer
5179831|NCT00900068|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
5179832|NCT00900068|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5179833|NCT00900068|stage I multiple myeloma|stage i multiple myeloma
5179834|NCT00900068|stage II multiple myeloma|stage ii multiple myeloma
5179835|NCT00900068|stage III multiple myeloma|stage iii multiple myeloma
5179836|NCT00900068|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
5179837|NCT00900068|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5179838|NCT00900068|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5179839|NCT00900068|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
5179840|NCT00900068|stage IIIA breast cancer|stage iiia breast cancer
5179841|NCT00900068|stage IIIB breast cancer|stage iiib breast cancer
5179842|NCT00900068|stage IIIC breast cancer|stage iiic breast cancer
5179843|NCT00900068|stage IV breast cancer|stage iv breast cancer
5179844|NCT00900068|refractory multiple myeloma|refractory multiple myeloma
5179845|NCT00900055|Fanconi anemia|fanconi anemia
5179846|NCT00900055|multiple myeloma and other plasma cell neoplasms|multiple myeloma and other plasma cell neoplasms
5179847|NCT00900055|chronic myeloproliferative disorders|chronic myeloproliferative disorders
5179848|NCT00900055|myelodysplastic/myeloproliferative neoplasms|myelodysplastic/myeloproliferative neoplasms
5179849|NCT00900042|stage IV renal cell cancer|stage iv renal cell cancer
5179850|NCT00900029|Venous Leg Ulcer|venous leg ulcer
5179851|NCT00900029|Venous Stasis Ulcer|venous stasis ulcer
5179853|NCT00900029|VSU|vsu
5179854|NCT00900029|Leg Ulcer|leg ulcer
5179855|NCT00900029|Leg Wound|leg wound
5179856|NCT00900016|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
5179857|NCT00900016|recurrent pancreatic cancer|recurrent pancreatic cancer
5179858|NCT00900016|stage I pancreatic cancer|stage i pancreatic cancer
5179859|NCT00900016|stage II pancreatic cancer|stage ii pancreatic cancer
5179860|NCT00900003|stage I pancreatic cancer|stage i pancreatic cancer
5179861|NCT00900003|stage II pancreatic cancer|stage ii pancreatic cancer
5179862|NCT00900003|stage III pancreatic cancer|stage iii pancreatic cancer
5179863|NCT00900003|stage IV pancreatic cancer|stage iv pancreatic cancer
5179864|NCT00899977|refractory hypertension|refractory hypertension
5179865|NCT00899977|hypertension|hypertension
5179866|NCT00899951|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5179867|NCT00899951|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5179868|NCT00899951|acute undifferentiated leukemia|acute undifferentiated leukemia
5179869|NCT00899951|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5179870|NCT00899951|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5179871|NCT00899951|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5179872|NCT00899951|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5179873|NCT00899951|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5179874|NCT00899951|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5179875|NCT00899951|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5179876|NCT00899951|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
5179877|NCT00899951|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5179878|NCT00899951|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5179879|NCT00899951|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5179880|NCT00899951|mast cell leukemia|mast cell leukemia
5179881|NCT00899951|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
5179882|NCT00899951|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
5179883|NCT00899951|prolymphocytic leukemia|prolymphocytic leukemia
5179884|NCT00899951|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5179885|NCT00899951|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5179886|NCT00899951|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
5179887|NCT00899951|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5179888|NCT00899951|refractory hairy cell leukemia|refractory hairy cell leukemia
5179889|NCT00899951|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5179890|NCT00899951|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5179891|NCT00899951|stage 0 chronic lymphocytic leukemia|stage 0 chronic lymphocytic leukemia
5179892|NCT00899951|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
5179893|NCT00899951|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
5179894|NCT00899951|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
5179895|NCT00899951|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
5179896|NCT00899951|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
5179897|NCT00899951|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5179898|NCT00899951|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
5179899|NCT00899951|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5179900|NCT00899951|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
5179901|NCT00899951|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5180292|NCT00899431|Fludarabine|fludarabine
5179902|NCT00899951|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
5179903|NCT00899951|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
5179904|NCT00899951|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5179905|NCT00899951|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5179906|NCT00899951|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5179907|NCT00899951|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
5179908|NCT00899951|cutaneous B-cell non-Hodgkin lymphoma|cutaneous b-cell non-hodgkin lymphoma
5179909|NCT00899951|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5179910|NCT00899951|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
5179911|NCT00899951|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
5179912|NCT00899951|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
5179913|NCT00899951|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
5179914|NCT00899951|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5179915|NCT00899951|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
5179916|NCT00899951|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
5179917|NCT00899951|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
5179918|NCT00899951|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
5179919|NCT00899951|adult grade III lymphomatoid granulomatosis|adult grade iii lymphomatoid granulomatosis
5179920|NCT00899951|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
5179921|NCT00899951|Waldenström macroglobulinemia|waldenström macroglobulinemia
5179922|NCT00899951|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5179923|NCT00899951|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5179924|NCT00899951|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5179925|NCT00899951|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
5179926|NCT00899951|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
5179927|NCT00899951|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
5179928|NCT00899951|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
5179929|NCT00899951|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
5179930|NCT00899951|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
5179931|NCT00899951|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
5179932|NCT00899951|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
5179933|NCT00899951|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
5179934|NCT00899951|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
5179935|NCT00899951|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
5179936|NCT00899951|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
5179937|NCT00899951|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
5179938|NCT00899951|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
5179939|NCT00899951|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
5179940|NCT00899951|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
5179941|NCT00899951|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
5179942|NCT00899951|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
5179943|NCT00899951|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
5179944|NCT00899951|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
5179945|NCT00899951|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
5179946|NCT00899951|stage I mantle cell lymphoma|stage i mantle cell lymphoma
5179947|NCT00899951|stage I marginal zone lymphoma|stage i marginal zone lymphoma
5179948|NCT00899951|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
5179949|NCT00899951|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
5179950|NCT00899951|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5179951|NCT00899951|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
5179952|NCT00899951|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
5179953|NCT00899951|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
5179954|NCT00899951|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
5179955|NCT00899951|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5179956|NCT00899951|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5179957|NCT00899951|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5179958|NCT00899951|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5179959|NCT00899951|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
5179960|NCT00899951|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
5179961|NCT00899951|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5179962|NCT00899951|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5179963|NCT00899951|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5179964|NCT00899951|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5179965|NCT00899951|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5179966|NCT00899951|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5179967|NCT00899951|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5179968|NCT00899951|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5179969|NCT00899951|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5179970|NCT00899951|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5179971|NCT00899951|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5179972|NCT00899951|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5179973|NCT00899951|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5179974|NCT00899951|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5179975|NCT00899951|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5179976|NCT00899951|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5179977|NCT00899951|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5179978|NCT00899951|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5179979|NCT00899951|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5179980|NCT00899951|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5179981|NCT00899951|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5179982|NCT00899951|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5179983|NCT00899951|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5179984|NCT00899951|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5179985|NCT00899951|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5179986|NCT00899951|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5179987|NCT00899951|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5179988|NCT00899951|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5179989|NCT00899951|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
5179990|NCT00899951|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5179991|NCT00899951|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5179992|NCT00899951|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5179993|NCT00899951|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5179994|NCT00899951|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5179995|NCT00899951|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5179996|NCT00899951|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5179997|NCT00899951|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5179998|NCT00899951|intraocular lymphoma|intraocular lymphoma
5179999|NCT00899951|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
5180000|NCT00899951|primary central nervous system Hodgkin lymphoma|primary central nervous system hodgkin lymphoma
5180001|NCT00899951|post-transplant lymphoproliferative disorder|post-transplant lymphoproliferative disorder
5180002|NCT00899951|chronic eosinophilic leukemia|chronic eosinophilic leukemia
5180003|NCT00899951|chronic neutrophilic leukemia|chronic neutrophilic leukemia
5180004|NCT00899951|primary myelofibrosis|primary myelofibrosis
5180005|NCT00899951|essential thrombocythemia|essential thrombocythemia
5180006|NCT00899951|polycythemia vera|polycythemia vera
5180007|NCT00899951|extramedullary plasmacytoma|extramedullary plasmacytoma
5180008|NCT00899951|isolated plasmacytoma of bone|isolated plasmacytoma of bone
5180009|NCT00899951|monoclonal gammopathy of undetermined significance|monoclonal gammopathy of undetermined significance
5180010|NCT00899951|stage I multiple myeloma|stage i multiple myeloma
5180011|NCT00899951|stage II multiple myeloma|stage ii multiple myeloma
5180012|NCT00899951|stage III multiple myeloma|stage iii multiple myeloma
5180013|NCT00899951|primary systemic amyloidosis|primary systemic amyloidosis
5180014|NCT00899951|refractory multiple myeloma|refractory multiple myeloma
5180015|NCT00899951|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5180016|NCT00899951|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5180017|NCT00899951|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5180018|NCT00899951|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
5180019|NCT00899951|pain|pain
5180020|NCT00899912|stage IIB prostate cancer|stage iib prostate cancer
5180021|NCT00899912|stage IIA prostate cancer|stage iia prostate cancer
5180022|NCT00899912|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5180023|NCT00899899|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5180024|NCT00899899|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
5180025|NCT00899899|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5180026|NCT00899899|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5180027|NCT00899873|chronic lymphocytic leukemia|chronic lymphocytic leukemia
5180028|NCT00899860|recurrent renal cell cancer|recurrent renal cell cancer
5180030|NCT00899860|stage II renal cell cancer|stage ii renal cell cancer
5180031|NCT00899860|stage III renal cell cancer|stage iii renal cell cancer
5180032|NCT00899860|stage IV renal cell cancer|stage iv renal cell cancer
5180033|NCT00899834|adult brain stem glioma|adult brain stem glioma
5180034|NCT00899834|childhood brain stem glioma|childhood brain stem glioma
5180035|NCT00899821|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
5180036|NCT00899821|untreated metastatic squamous neck cancer with occult primary|untreated metastatic squamous neck cancer with occult primary
5180037|NCT00899821|stage I squamous cell carcinoma of the hypopharynx|stage i squamous cell carcinoma of the hypopharynx
5180038|NCT00899821|stage I squamous cell carcinoma of the larynx|stage i squamous cell carcinoma of the larynx
5180039|NCT00899821|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
5180040|NCT00899821|stage I squamous cell carcinoma of the nasopharynx|stage i squamous cell carcinoma of the nasopharynx
5180041|NCT00899821|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
5180042|NCT00899821|stage I squamous cell carcinoma of the paranasal sinus and nasal cavity|stage i squamous cell carcinoma of the paranasal sinus and nasal cavity
5180043|NCT00899821|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
5180044|NCT00899821|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
5180045|NCT00899821|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
5180046|NCT00899821|stage II squamous cell carcinoma of the nasopharynx|stage ii squamous cell carcinoma of the nasopharynx
5180047|NCT00899821|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
5180048|NCT00899821|stage II squamous cell carcinoma of the paranasal sinus and nasal cavity|stage ii squamous cell carcinoma of the paranasal sinus and nasal cavity
5180049|NCT00899821|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
5180050|NCT00899821|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
5180051|NCT00899821|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
5180052|NCT00899821|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
5180053|NCT00899821|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
5180054|NCT00899821|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
5180055|NCT00899821|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5180056|NCT00899821|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5180057|NCT00899821|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5180058|NCT00899821|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
5180059|NCT00899821|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5180060|NCT00899821|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
5180061|NCT00899821|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
5180062|NCT00899821|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
5180063|NCT00899821|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
5180064|NCT00899821|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
5180065|NCT00899821|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
5180066|NCT00899821|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
5180067|NCT00899821|recurrent salivary gland cancer|recurrent salivary gland cancer
5180068|NCT00899821|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
5180069|NCT00899821|stage I salivary gland cancer|stage i salivary gland cancer
5180160|NCT00899717|Pain|pain
5180070|NCT00899821|stage II salivary gland cancer|stage ii salivary gland cancer
5180071|NCT00899821|stage III salivary gland cancer|stage iii salivary gland cancer
5180072|NCT00899821|stage IV salivary gland cancer|stage iv salivary gland cancer
5180073|NCT00899808|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5180074|NCT00899808|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
5180075|NCT00899808|hematopoietic/lymphoid cancer|hematopoietic/lymphoid cancer
5180076|NCT00899795|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5180077|NCT00899795|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5180078|NCT00899795|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5180079|NCT00899795|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5180080|NCT00899795|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5180081|NCT00899795|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5180082|NCT00899795|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5180083|NCT00899795|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5180084|NCT00899795|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5180085|NCT00899795|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5181921|NCT00896285|chest tube|chest tube
5180086|NCT00899795|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
5180087|NCT00899795|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
5180088|NCT00899769|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
5180089|NCT00899769|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
5180090|NCT00899769|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
5180091|NCT00899769|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
5180092|NCT00899769|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
5180093|NCT00899769|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
5180094|NCT00899769|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
5180095|NCT00899769|stage I squamous cell carcinoma of the hypopharynx|stage i squamous cell carcinoma of the hypopharynx
5180096|NCT00899769|stage I squamous cell carcinoma of the larynx|stage i squamous cell carcinoma of the larynx
5180097|NCT00899769|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
5180098|NCT00899769|stage I squamous cell carcinoma of the nasopharynx|stage i squamous cell carcinoma of the nasopharynx
5180099|NCT00899769|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
5180100|NCT00899769|stage I squamous cell carcinoma of the paranasal sinus and nasal cavity|stage i squamous cell carcinoma of the paranasal sinus and nasal cavity
5180101|NCT00899769|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
5180102|NCT00899769|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
5180103|NCT00899769|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
5180104|NCT00899769|stage II squamous cell carcinoma of the nasopharynx|stage ii squamous cell carcinoma of the nasopharynx
5180105|NCT00899769|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
5180106|NCT00899769|stage II squamous cell carcinoma of the paranasal sinus and nasal cavity|stage ii squamous cell carcinoma of the paranasal sinus and nasal cavity
5180107|NCT00899769|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
5180108|NCT00899769|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
5180109|NCT00899769|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
5180110|NCT00899769|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
5180111|NCT00899769|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
5180112|NCT00899769|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
5180113|NCT00899769|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5180114|NCT00899769|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5180115|NCT00899769|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5180116|NCT00899769|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
5180117|NCT00899769|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5180118|NCT00899769|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
5180119|NCT00899769|untreated metastatic squamous neck cancer with occult primary|untreated metastatic squamous neck cancer with occult primary
5180120|NCT00899769|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
5180121|NCT00899769|recurrent salivary gland cancer|recurrent salivary gland cancer
5180122|NCT00899769|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
5180123|NCT00899769|stage I salivary gland cancer|stage i salivary gland cancer
5180124|NCT00899769|stage II salivary gland cancer|stage ii salivary gland cancer
5180125|NCT00899769|stage III salivary gland cancer|stage iii salivary gland cancer
5180126|NCT00899769|stage IV salivary gland cancer|stage iv salivary gland cancer
5180127|NCT00899756|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5180128|NCT00899756|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5180129|NCT00899756|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5180130|NCT00899756|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5180131|NCT00899743|adult erythroleukemia (M6a)|adult erythroleukemia (m6a)
5180132|NCT00899743|adult pure erythroid leukemia (M6b)|adult pure erythroid leukemia (m6b)
5180133|NCT00899743|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
5180134|NCT00899743|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
5180135|NCT00899743|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
5180136|NCT00899743|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
5180137|NCT00899743|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
5180138|NCT00899743|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
5180139|NCT00899743|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
5180140|NCT00899743|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5180293|NCT00899431|Lenalidomide|lenalidomide
5180141|NCT00899743|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5180142|NCT00899743|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5180143|NCT00899743|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5180144|NCT00899743|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
5180145|NCT00899717|Temporomandibular Joint Disorders (TMD)|temporomandibular joint disorders (tmd)
5180146|NCT00899717|Orofacial pain|orofacial pain
5180147|NCT00899717|Limited mouth opening|limited mouth opening
5180148|NCT00899717|Craniomandibular dysfunction syndrome|craniomandibular dysfunction syndrome
5180149|NCT00899717|Axiography|axiography
5180150|NCT00899717|Gnatography|gnatography
5180151|NCT00899717|Preferred chewing side|preferred chewing side
5180152|NCT00899717|Occlusal adjustment|occlusal adjustment
5180153|NCT00899717|Selective grinding|selective grinding
5180154|NCT00899717|Handedness|handedness
5180155|NCT00899717|Bruxism|bruxism
5180156|NCT00899717|TMD|tmd
5180157|NCT00899717|Costen's Syndrome|costen's syndrome
5180158|NCT00899717|Myofascial pain|myofascial pain
5180159|NCT00899717|TMD treatment|tmd treatment
5180161|NCT00899704|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
5180162|NCT00899704|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
5180163|NCT00899704|tongue cancer|tongue cancer
5180164|NCT00899691|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5180165|NCT00899678|Certolizumab Pegol|certolizumab pegol
5180166|NCT00899678|Cimzia ®|cimzia ®
5180167|NCT00899678|Crohn's Disease|crohn's disease
5180168|NCT00899665|stage IV prostate cancer|stage iv prostate cancer
5180169|NCT00899665|bone metastases|bone metastases
5180170|NCT00899665|anemia|anemia
5180171|NCT00899665|monoclonal gammopathy of undetermined significance|monoclonal gammopathy of undetermined significance
5180172|NCT00899665|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5180173|NCT00899665|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5180174|NCT00899665|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5180175|NCT00899652|childhood acute myelomonocytic leukemia (M4)|childhood acute myelomonocytic leukemia (m4)
5180176|NCT00899652|childhood acute monocytic leukemia (M5b)|childhood acute monocytic leukemia (m5b)
5180177|NCT00899652|childhood acute monoblastic leukemia (M5a)|childhood acute monoblastic leukemia (m5a)
5180178|NCT00899652|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5180179|NCT00899652|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
5180180|NCT00899652|untreated childhood acute myeloid leukemia and other myeloid malignancies|untreated childhood acute myeloid leukemia and other myeloid malignancies
5180181|NCT00899652|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5180182|NCT00899652|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5180183|NCT00899639|stage I breast cancer|stage i breast cancer
5180184|NCT00899639|stage II breast cancer|stage ii breast cancer
5180185|NCT00899639|stage IIIA breast cancer|stage iiia breast cancer
5180186|NCT00899639|estrogen receptor-positive breast cancer|estrogen receptor-positive breast cancer
5180187|NCT00899639|male breast cancer|male breast cancer
5180188|NCT00899626|colon cancer|colon cancer
5180189|NCT00899626|esophageal cancer|esophageal cancer
5180190|NCT00899626|gastric cancer|gastric cancer
5180191|NCT00899626|pancreatic cancer|pancreatic cancer
5180192|NCT00899626|adenomatous polyp|adenomatous polyp
5180193|NCT00899613|localized malignant mesothelioma|localized malignant mesothelioma
5180194|NCT00899613|lung metastases|lung metastases
5180195|NCT00899613|malignant pleural effusion|malignant pleural effusion
5180196|NCT00899600|chronic pain|chronic pain
5180197|NCT00899600|back surgery|back surgery
5180198|NCT00899600|opioid dependent|opioid dependent
5180199|NCT00899600|NMDA receptor antagonism|nmda receptor antagonism
5180200|NCT00899600|Ketamine|ketamine
5180201|NCT00899600|Central sensitization|central sensitization
5180202|NCT00899574|toll-like receptor|toll-like receptor
5180203|NCT00899574|toll-like receptor agonist|toll-like receptor agonist
5180204|NCT00899574|recurrent breast cancer|recurrent breast cancer
5180205|NCT00899574|breast cancer metastasized to skin and/or chestwall|breast cancer metastasized to skin and/or chestwall
5180206|NCT00899574|immunomodulator|immunomodulator
5180207|NCT00899561|Chronic rhinosinusitis|chronic rhinosinusitis
5180208|NCT00899561|Computed tomography|computed tomography
5180209|NCT00899561|Histology|histology
5180210|NCT00899561|Middle turbinate|middle turbinate
5180211|NCT00899561|Morphometry|morphometry
5180212|NCT00899561|osteomyelitis|osteomyelitis
5180213|NCT00899561|polyps|polyps
5180214|NCT00899548|stage IV breast cancer|stage iv breast cancer
5180215|NCT00899548|recurrent breast cancer|recurrent breast cancer
5180216|NCT00899535|adenocarcinoma of the lung|adenocarcinoma of the lung
5180217|NCT00899535|large cell lung cancer|large cell lung cancer
5180218|NCT00899535|squamous cell lung cancer|squamous cell lung cancer
5180219|NCT00899535|stage I non-small cell lung cancer|stage i non-small cell lung cancer
5180220|NCT00899535|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
5180221|NCT00899522|Fanconi anemia|fanconi anemia
5180222|NCT00899522|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5180223|NCT00899522|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
5180224|NCT00899509|stage II breast cancer|stage ii breast cancer
5180225|NCT00899509|stage IIIA breast cancer|stage iiia breast cancer
5180226|NCT00899496|stage IV bladder cancer|stage iv bladder cancer
5180227|NCT00899496|stage IV colon cancer|stage iv colon cancer
5180228|NCT00899496|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5180229|NCT00899496|stage IV pancreatic cancer|stage iv pancreatic cancer
5180230|NCT00899496|stage IV rectal cancer|stage iv rectal cancer
5180231|NCT00899496|stage IV renal cell cancer|stage iv renal cell cancer
5180232|NCT00899496|stage IV melanoma|stage iv melanoma
5180233|NCT00899496|stage III multiple myeloma|stage iii multiple myeloma
5180234|NCT00899496|extensive stage small cell lung cancer|extensive stage small cell lung cancer
5180235|NCT00899496|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
5180236|NCT00899496|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
5180237|NCT00899496|stage IV breast cancer|stage iv breast cancer
5180238|NCT00899496|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5180239|NCT00899496|stage IV prostate cancer|stage iv prostate cancer
5180240|NCT00899496|stage IV endometrial carcinoma|stage iv endometrial carcinoma
5180241|NCT00899496|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5180242|NCT00899496|metastatic osteosarcoma|metastatic osteosarcoma
5180243|NCT00899496|stage IV uterine sarcoma|stage iv uterine sarcoma
5180244|NCT00899496|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5180245|NCT00899496|ovarian sarcoma|ovarian sarcoma
5180246|NCT00899496|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5180247|NCT00899496|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5180248|NCT00899496|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5180249|NCT00899496|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5180250|NCT00899496|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5180251|NCT00899496|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5180252|NCT00899496|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5180253|NCT00899496|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5180254|NCT00899496|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5180255|NCT00899496|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5180256|NCT00899496|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5180257|NCT00899496|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5180258|NCT00899496|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5180259|NCT00899496|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5180260|NCT00899496|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5180261|NCT00899496|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5180262|NCT00899496|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5180263|NCT00899496|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5180466|NCT00898885|oral manifestations|oral manifestations
5180264|NCT00899496|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5180265|NCT00899496|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5180266|NCT00899496|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5180267|NCT00899496|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5180268|NCT00899496|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5180269|NCT00899496|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5180270|NCT00899496|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
5180271|NCT00899496|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
5180272|NCT00899496|cutaneous B-cell non-Hodgkin lymphoma|cutaneous b-cell non-hodgkin lymphoma
5180273|NCT00899496|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
5180274|NCT00899496|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
5180275|NCT00899496|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
5180276|NCT00899496|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
5180277|NCT00899496|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5180278|NCT00899496|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
5180279|NCT00899496|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
5180280|NCT00899496|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
5180281|NCT00899496|adult grade III lymphomatoid granulomatosis|adult grade iii lymphomatoid granulomatosis
5180282|NCT00899496|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
5180283|NCT00899496|intraocular lymphoma|intraocular lymphoma
5180284|NCT00899457|squamous cell lung cancer|squamous cell lung cancer
5180285|NCT00899457|non-small cell lung cancer|non-small cell lung cancer
5180286|NCT00899457|small cell lung cancer|small cell lung cancer
5180287|NCT00899457|healthy, no evidence of disease|healthy, no evidence of disease
5180288|NCT00899431|Nonmyeloablative Stem Cell Transplantation|nonmyeloablative stem cell transplantation
5180289|NCT00899431|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
5180290|NCT00899431|CLL|cll
5180291|NCT00899431|Immunomanipulation|immunomanipulation
5180295|NCT00899431|Thymoglobulin|thymoglobulin
5180296|NCT00899431|Stem Cell Transplantation|stem cell transplantation
5180297|NCT00899418|recurrent breast cancer|recurrent breast cancer
5180298|NCT00899418|stage IV breast cancer|stage iv breast cancer
5180299|NCT00899405|lung cancer|lung cancer
5180300|NCT00899392|consent|consent
5180301|NCT00899392|Anxiety|anxiety
5180302|NCT00899392|Satisfaction|satisfaction
5180303|NCT00899392|Efficiency|efficiency
5180304|NCT00899392|Questions|questions
5180305|NCT00899392|Attainment of Informed Consent (Consent-20)|attainment of informed consent (consent-20)
5180306|NCT00899392|Procedural State Anxiety (STAI)|procedural state anxiety (stai)
5180307|NCT00899392|Subject Satisfaction (mGHAA-9)|subject satisfaction (mghaa-9)
5180308|NCT00899392|Duration in Endoscopy Suite|duration in endoscopy suite
5180309|NCT00899392|Number of questions asked|number of questions asked
5180310|NCT00899366|T-cell adult acute lymphoblastic leukemia|t-cell adult acute lymphoblastic leukemia
5180311|NCT00899366|T-cell childhood acute lymphoblastic leukemia|t-cell childhood acute lymphoblastic leukemia
5180312|NCT00899366|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
5180313|NCT00899366|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
5180314|NCT00899366|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5180315|NCT00899366|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5180316|NCT00899366|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5180317|NCT00899366|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
5180318|NCT00899353|ES-CLL|es-cll
5180319|NCT00899353|MGUS|mgus
5180320|NCT00899353|SMM|smm
5180321|NCT00899353|Early Stage - Chronic Lymphocytic Leukemia|early stage - chronic lymphocytic leukemia
5180322|NCT00899340|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
5180323|NCT00899340|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
5180324|NCT00899340|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
5180325|NCT00899340|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
5180326|NCT00899340|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5180327|NCT00899327|myelodysplastic syndromes|myelodysplastic syndromes
5180328|NCT00899327|acute myeloid leukemia|acute myeloid leukemia
5180329|NCT00899301|breast cancer|breast cancer
5180330|NCT00899301|stage IA breast cancer|stage ia breast cancer
5180331|NCT00899301|stage IB breast cancer|stage ib breast cancer
5180332|NCT00899301|stage II breast cancer|stage ii breast cancer
5180333|NCT00899301|stage IIIA breast cancer|stage iiia breast cancer
5180334|NCT00899301|stage IIIB breast cancer|stage iiib breast cancer
5180335|NCT00899301|stage IIIC breast cancer|stage iiic breast cancer
5180336|NCT00899301|stage IV breast cancer|stage iv breast cancer
5180337|NCT00899288|osteoporosis|osteoporosis
5180338|NCT00899288|stage I breast cancer|stage i breast cancer
5180339|NCT00899288|stage II breast cancer|stage ii breast cancer
5180340|NCT00899288|stage IIIA breast cancer|stage iiia breast cancer
5180341|NCT00899262|lung cancer|lung cancer
5180342|NCT00899262|tobacco use disorder|tobacco use disorder
5180343|NCT00899210|liver metastases|liver metastases
5180344|NCT00899210|adenocarcinoma of the colon|adenocarcinoma of the colon
5180345|NCT00899210|stage IV colon cancer|stage iv colon cancer
5180346|NCT00899210|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5180347|NCT00899210|stage IV rectal cancer|stage iv rectal cancer
5180348|NCT00899210|recurrent colon cancer|recurrent colon cancer
5180349|NCT00899210|recurrent rectal cancer|recurrent rectal cancer
5180350|NCT00899197|stage I breast cancer|stage i breast cancer
5180351|NCT00899197|stage II breast cancer|stage ii breast cancer
5180352|NCT00899197|stage IIIA breast cancer|stage iiia breast cancer
5180353|NCT00899197|stage IIIB breast cancer|stage iiib breast cancer
5180354|NCT00899184|recurrent prostate cancer|recurrent prostate cancer
5180355|NCT00899184|stage IV prostate cancer|stage iv prostate cancer
5180356|NCT00899184|stage I prostate cancer|stage i prostate cancer
5180357|NCT00899184|stage IIB prostate cancer|stage iib prostate cancer
5180358|NCT00899184|stage IIA prostate cancer|stage iia prostate cancer
5180359|NCT00899184|stage III prostate cancer|stage iii prostate cancer
5180360|NCT00899171|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5180361|NCT00899171|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5180362|NCT00899171|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5180363|NCT00899171|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5180364|NCT00899171|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5180365|NCT00899171|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5180366|NCT00899171|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5180367|NCT00899171|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
5181759|NCT00896688|fluoroscopic guidance|fluoroscopic guidance
5180368|NCT00899171|adult acute erythroid leukemia (M6)|adult acute erythroid leukemia (m6)
5180369|NCT00899171|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
5180509|NCT00898807|neuropsychiatric symptoms|neuropsychiatric symptoms
5180370|NCT00899171|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
5180371|NCT00899171|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
5180372|NCT00899171|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
5180373|NCT00899171|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
5180374|NCT00899171|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
5180375|NCT00899171|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
5180376|NCT00899171|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5180377|NCT00899158|recurrent pancreatic cancer|recurrent pancreatic cancer
5180378|NCT00899158|stage I pancreatic cancer|stage i pancreatic cancer
5180379|NCT00899158|stage II pancreatic cancer|stage ii pancreatic cancer
5180380|NCT00899158|stage III pancreatic cancer|stage iii pancreatic cancer
5180381|NCT00899158|stage IV pancreatic cancer|stage iv pancreatic cancer
5180382|NCT00899158|cachexia|cachexia
5180383|NCT00899132|skin cancer|skin cancer
5180384|NCT00899132|small intestine cancer|small intestine cancer
5180385|NCT00899132|pancreatic cancer|pancreatic cancer
5180386|NCT00899132|malignant testicular germ cell tumor|malignant testicular germ cell tumor
5180387|NCT00899132|testicular teratoma|testicular teratoma
5180388|NCT00899119|Waldenström macroglobulinemia|waldenström macroglobulinemia
5180389|NCT00899080|stage I multiple myeloma|stage i multiple myeloma
5180390|NCT00899080|stage II multiple myeloma|stage ii multiple myeloma
5180391|NCT00899080|stage III multiple myeloma|stage iii multiple myeloma
5180392|NCT00899041|Prosthesis|prosthesis
5180393|NCT00899028|stage 0 non-small cell lung cancer|stage 0 non-small cell lung cancer
5180394|NCT00899028|stage I non-small cell lung cancer|stage i non-small cell lung cancer
5180395|NCT00899028|extensive stage small cell lung cancer|extensive stage small cell lung cancer
5180396|NCT00899028|limited stage small cell lung cancer|limited stage small cell lung cancer
5180397|NCT00899028|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
5180398|NCT00899028|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5180399|NCT00899028|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5180400|NCT00899028|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5180401|NCT00899015|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5180402|NCT00899015|childhood acute promyelocytic leukemia (M3)|childhood acute promyelocytic leukemia (m3)
5180403|NCT00899015|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5180404|NCT00899015|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
5180405|NCT00899015|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
5180406|NCT00899015|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
5180407|NCT00899015|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
5180408|NCT00899015|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
5180409|NCT00899015|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
5180410|NCT00899002|childhood hepatocellular carcinoma|childhood hepatocellular carcinoma
5180411|NCT00899002|childhood liver cancer|childhood liver cancer
5180412|NCT00899002|adult primary liver cancer|adult primary liver cancer
5180413|NCT00899002|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
5180414|NCT00898976|stage I breast cancer|stage i breast cancer
5180415|NCT00898976|stage II breast cancer|stage ii breast cancer
5180416|NCT00898976|stage IV breast cancer|stage iv breast cancer
5180417|NCT00898976|stage IIIA breast cancer|stage iiia breast cancer
5180418|NCT00898976|breast cancer in situ|breast cancer in situ
5180419|NCT00898976|recurrent breast cancer|recurrent breast cancer
5180420|NCT00898976|stage IIIB breast cancer|stage iiib breast cancer
5180421|NCT00898976|inflammatory breast cancer|inflammatory breast cancer
5180422|NCT00898976|stage IIIC breast cancer|stage iiic breast cancer
5180423|NCT00898963|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5180424|NCT00898963|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5180425|NCT00898963|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5180426|NCT00898963|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5180427|NCT00898963|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5180428|NCT00898963|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5180429|NCT00898950|diabetes|diabetes
5180430|NCT00898950|aspirin|aspirin
5180431|NCT00898950|oxidative stress|oxidative stress
5180432|NCT00898950|insulin resistance|insulin resistance
5180433|NCT00898950|endothelial function|endothelial function
5180434|NCT00898950|inflammation|inflammation
5180435|NCT00898950|photoplethysmography|photoplethysmography
5180436|NCT00898950|dysglycaemia|dysglycaemia
5180437|NCT00898937|breast cancer|breast cancer
5180438|NCT00898924|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5180439|NCT00898924|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5180440|NCT00898911|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
5180441|NCT00898911|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5180442|NCT00898911|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5180443|NCT00898911|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
5180444|NCT00898911|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
5180445|NCT00898911|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
5180446|NCT00898911|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
5180447|NCT00898911|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5180448|NCT00898911|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
5180449|NCT00898911|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
5180450|NCT00898911|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
5180451|NCT00898911|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
5180452|NCT00898911|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
5180453|NCT00898911|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
5180454|NCT00898911|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
5180455|NCT00898911|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5180456|NCT00898911|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
5180457|NCT00898911|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
5180458|NCT00898911|recurrent salivary gland cancer|recurrent salivary gland cancer
5180459|NCT00898911|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
5180460|NCT00898911|stage IV salivary gland cancer|stage iv salivary gland cancer
5180461|NCT00898898|stage IA breast cancer|stage ia breast cancer
5180462|NCT00898898|stage IB breast cancer|stage ib breast cancer
5180463|NCT00898898|stage II breast cancer|stage ii breast cancer
5180464|NCT00898898|stage IIIA breast cancer|stage iiia breast cancer
5180465|NCT00898898|HER2-positive breast cancer|her2-positive breast cancer
5180467|NCT00898885|bone marrow transplantation|bone marrow transplantation
5180468|NCT00898885|adverse effects|adverse effects
5180469|NCT00898872|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5180470|NCT00898872|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5180471|NCT00898872|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5180472|NCT00898872|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5180473|NCT00898872|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5180474|NCT00898872|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5180475|NCT00898872|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5180476|NCT00898872|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
5180477|NCT00898872|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5180478|NCT00898872|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5180479|NCT00898872|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5180480|NCT00898872|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5180481|NCT00898872|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5180482|NCT00898872|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5180483|NCT00898872|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5180484|NCT00898872|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5180485|NCT00898872|Waldenström macroglobulinemia|waldenström macroglobulinemia
5180486|NCT00898872|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
5180487|NCT00898872|recurrent childhood grade III lymphomatoid granulomatosis|recurrent childhood grade iii lymphomatoid granulomatosis
5180488|NCT00898872|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
5180489|NCT00898872|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
5180490|NCT00898872|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
5180491|NCT00898872|childhood diffuse large cell lymphoma|childhood diffuse large cell lymphoma
5180492|NCT00898872|childhood immunoblastic large cell lymphoma|childhood immunoblastic large cell lymphoma
5180493|NCT00898872|childhood Burkitt lymphoma|childhood burkitt lymphoma
5180494|NCT00898872|childhood nasal type extranodal NK/T-cell lymphoma|childhood nasal type extranodal nk/t-cell lymphoma
5180495|NCT00898859|ADAM|adam
5180496|NCT00898859|epithelial|epithelial
5180497|NCT00898859|COPD|copd
5180498|NCT00898846|stage II colon cancer|stage ii colon cancer
5180499|NCT00898846|stage II rectal cancer|stage ii rectal cancer
5180500|NCT00898846|adenocarcinoma of the colon|adenocarcinoma of the colon
5180501|NCT00898846|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5180502|NCT00898833|recurrent prostate cancer|recurrent prostate cancer
5180503|NCT00898833|stage III prostate cancer|stage iii prostate cancer
5180504|NCT00898833|stage IV prostate cancer|stage iv prostate cancer
5180505|NCT00898833|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5180506|NCT00898820|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5180507|NCT00898820|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5180508|NCT00898820|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5180511|NCT00898807|mood lability|mood lability
5180512|NCT00898794|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5180513|NCT00898794|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
5180514|NCT00898781|male breast cancer|male breast cancer
5180515|NCT00898781|stage IV breast cancer|stage iv breast cancer
5180516|NCT00898781|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5180517|NCT00898781|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
5180518|NCT00898781|stage IV pancreatic cancer|stage iv pancreatic cancer
5180519|NCT00898781|stage IV colon cancer|stage iv colon cancer
5180520|NCT00898781|ovarian sarcoma|ovarian sarcoma
5180521|NCT00898768|Lynch syndrome|lynch syndrome
5180522|NCT00898768|HNPCC|hnpcc
5180523|NCT00898768|Capsule endoscopy|capsule endoscopy
5180524|NCT00898768|Small bowel cancer|small bowel cancer
5180525|NCT00898768|Double balloon endoscopy|double balloon endoscopy
5180526|NCT00898742|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
5180527|NCT00898742|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5180528|NCT00898742|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5180529|NCT00898742|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
5180530|NCT00898742|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
5180531|NCT00898742|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
5180532|NCT00898742|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
5180533|NCT00898742|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5180534|NCT00898742|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
5180535|NCT00898742|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
5180536|NCT00898742|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
5180537|NCT00898742|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
5180538|NCT00898742|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
5180539|NCT00898742|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
5180540|NCT00898742|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
5180541|NCT00898742|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5180542|NCT00898742|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
5180543|NCT00898742|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
5180544|NCT00898742|recurrent salivary gland cancer|recurrent salivary gland cancer
5180545|NCT00898742|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
5180546|NCT00898742|stage IV salivary gland cancer|stage iv salivary gland cancer
5180547|NCT00898703|breast cancer|breast cancer
5180548|NCT00898690|stage I breast cancer|stage i breast cancer
5180549|NCT00898690|stage II breast cancer|stage ii breast cancer
5180550|NCT00898690|stage IIIA breast cancer|stage iiia breast cancer
5180551|NCT00898690|stage IIIB breast cancer|stage iiib breast cancer
5180552|NCT00898690|stage IIIC breast cancer|stage iiic breast cancer
5180553|NCT00898690|stage IV breast cancer|stage iv breast cancer
5180554|NCT00898690|recurrent breast cancer|recurrent breast cancer
5180555|NCT00898664|stage I squamous cell carcinoma of the hypopharynx|stage i squamous cell carcinoma of the hypopharynx
5180556|NCT00898664|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
5180557|NCT00898664|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
5180558|NCT00898664|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5180559|NCT00898664|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
5180560|NCT00898664|stage I squamous cell carcinoma of the larynx|stage i squamous cell carcinoma of the larynx
5180561|NCT00898664|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
5180562|NCT00898664|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
5180563|NCT00898664|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5180564|NCT00898664|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
5180565|NCT00898664|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
5180566|NCT00898664|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
5180567|NCT00898664|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
5180568|NCT00898664|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5180569|NCT00898664|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
5180570|NCT00898664|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
5180571|NCT00898664|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
5180676|NCT00898638|stage I salivary gland cancer|stage i salivary gland cancer
5180572|NCT00898664|untreated metastatic squamous neck cancer with occult primary|untreated metastatic squamous neck cancer with occult primary
5180573|NCT00898664|stage I squamous cell carcinoma of the nasopharynx|stage i squamous cell carcinoma of the nasopharynx
5180574|NCT00898664|stage II squamous cell carcinoma of the nasopharynx|stage ii squamous cell carcinoma of the nasopharynx
5180575|NCT00898664|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
5180576|NCT00898664|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
5180577|NCT00898664|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
5180578|NCT00898664|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
5180579|NCT00898664|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
5180580|NCT00898664|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
5180581|NCT00898664|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5180582|NCT00898664|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
5180583|NCT00898664|stage I squamous cell carcinoma of the paranasal sinus and nasal cavity|stage i squamous cell carcinoma of the paranasal sinus and nasal cavity
5180584|NCT00898664|stage II squamous cell carcinoma of the paranasal sinus and nasal cavity|stage ii squamous cell carcinoma of the paranasal sinus and nasal cavity
5180585|NCT00898664|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
5180586|NCT00898664|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
5180587|NCT00898664|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
5180588|NCT00898664|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
5180589|NCT00898664|stage I salivary gland cancer|stage i salivary gland cancer
5180590|NCT00898664|stage II salivary gland cancer|stage ii salivary gland cancer
5180591|NCT00898664|stage III salivary gland cancer|stage iii salivary gland cancer
5180592|NCT00898664|stage IV salivary gland cancer|stage iv salivary gland cancer
5180593|NCT00898664|recurrent salivary gland cancer|recurrent salivary gland cancer
5180594|NCT00898638|stage I squamous cell carcinoma of the hypopharynx|stage i squamous cell carcinoma of the hypopharynx
5180595|NCT00898638|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
5180596|NCT00898638|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
5180597|NCT00898638|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5180598|NCT00898638|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
5180599|NCT00898638|stage I squamous cell carcinoma of the larynx|stage i squamous cell carcinoma of the larynx
5180600|NCT00898638|stage I verrucous carcinoma of the larynx|stage i verrucous carcinoma of the larynx
5180601|NCT00898638|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
5180602|NCT00898638|stage II verrucous carcinoma of the larynx|stage ii verrucous carcinoma of the larynx
5180603|NCT00898638|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
5180604|NCT00898638|stage III verrucous carcinoma of the larynx|stage iii verrucous carcinoma of the larynx
5180605|NCT00898638|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5180606|NCT00898638|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
5180607|NCT00898638|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
5180608|NCT00898638|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
5180609|NCT00898638|stage I adenoid cystic carcinoma of the oral cavity|stage i adenoid cystic carcinoma of the oral cavity
5180610|NCT00898638|stage I basal cell carcinoma of the lip|stage i basal cell carcinoma of the lip
5180611|NCT00898638|stage I mucoepidermoid carcinoma of the oral cavity|stage i mucoepidermoid carcinoma of the oral cavity
5180612|NCT00898638|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
5180613|NCT00898638|stage I verrucous carcinoma of the oral cavity|stage i verrucous carcinoma of the oral cavity
5180614|NCT00898638|stage II adenoid cystic carcinoma of the oral cavity|stage ii adenoid cystic carcinoma of the oral cavity
5180615|NCT00898638|stage II basal cell carcinoma of the lip|stage ii basal cell carcinoma of the lip
5180616|NCT00898638|stage II mucoepidermoid carcinoma of the oral cavity|stage ii mucoepidermoid carcinoma of the oral cavity
5180617|NCT00898638|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
5180618|NCT00898638|stage II verrucous carcinoma of the oral cavity|stage ii verrucous carcinoma of the oral cavity
5180619|NCT00898638|stage III adenoid cystic carcinoma of the oral cavity|stage iii adenoid cystic carcinoma of the oral cavity
5180620|NCT00898638|stage III basal cell carcinoma of the lip|stage iii basal cell carcinoma of the lip
5180621|NCT00898638|stage III mucoepidermoid carcinoma of the oral cavity|stage iii mucoepidermoid carcinoma of the oral cavity
5180622|NCT00898638|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
5180623|NCT00898638|stage III verrucous carcinoma of the oral cavity|stage iii verrucous carcinoma of the oral cavity
5180624|NCT00898638|stage IV adenoid cystic carcinoma of the oral cavity|stage iv adenoid cystic carcinoma of the oral cavity
5180625|NCT00898638|stage IV basal cell carcinoma of the lip|stage iv basal cell carcinoma of the lip
5180626|NCT00898638|stage IV mucoepidermoid carcinoma of the oral cavity|stage iv mucoepidermoid carcinoma of the oral cavity
5180986|NCT00898222|aspirin|aspirin
5180627|NCT00898638|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5180628|NCT00898638|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
5180629|NCT00898638|recurrent adenoid cystic carcinoma of the oral cavity|recurrent adenoid cystic carcinoma of the oral cavity
5180630|NCT00898638|recurrent basal cell carcinoma of the lip|recurrent basal cell carcinoma of the lip
5180631|NCT00898638|recurrent mucoepidermoid carcinoma of the oral cavity|recurrent mucoepidermoid carcinoma of the oral cavity
5180632|NCT00898638|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
5180633|NCT00898638|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
5180634|NCT00898638|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
5180635|NCT00898638|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
5180636|NCT00898638|untreated metastatic squamous neck cancer with occult primary|untreated metastatic squamous neck cancer with occult primary
5180637|NCT00898638|stage I lymphoepithelioma of the nasopharynx|stage i lymphoepithelioma of the nasopharynx
5180638|NCT00898638|stage I squamous cell carcinoma of the nasopharynx|stage i squamous cell carcinoma of the nasopharynx
5180639|NCT00898638|stage II lymphoepithelioma of the nasopharynx|stage ii lymphoepithelioma of the nasopharynx
5180640|NCT00898638|stage II squamous cell carcinoma of the nasopharynx|stage ii squamous cell carcinoma of the nasopharynx
5180641|NCT00898638|stage III lymphoepithelioma of the nasopharynx|stage iii lymphoepithelioma of the nasopharynx
5180642|NCT00898638|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
5180643|NCT00898638|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
5180644|NCT00898638|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
5180645|NCT00898638|recurrent lymphoepithelioma of the nasopharynx|recurrent lymphoepithelioma of the nasopharynx
5180646|NCT00898638|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
5180647|NCT00898638|stage I lymphoepithelioma of the oropharynx|stage i lymphoepithelioma of the oropharynx
5180648|NCT00898638|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
5180649|NCT00898638|stage II lymphoepithelioma of the oropharynx|stage ii lymphoepithelioma of the oropharynx
5180650|NCT00898638|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
5180651|NCT00898638|stage III lymphoepithelioma of the oropharynx|stage iii lymphoepithelioma of the oropharynx
5180652|NCT00898638|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
5180653|NCT00898638|stage IV lymphoepithelioma of the oropharynx|stage iv lymphoepithelioma of the oropharynx
5180654|NCT00898638|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5180655|NCT00898638|recurrent lymphoepithelioma of the oropharynx|recurrent lymphoepithelioma of the oropharynx
5180656|NCT00898638|stage I esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage i esthesioneuroblastoma of the paranasal sinus and nasal cavity
5180657|NCT00898638|stage I inverted papilloma of the paranasal sinus and nasal cavity|stage i inverted papilloma of the paranasal sinus and nasal cavity
5180658|NCT00898638|stage I midline lethal granuloma of the paranasal sinus and nasal cavity|stage i midline lethal granuloma of the paranasal sinus and nasal cavity
5180659|NCT00898638|stage I squamous cell carcinoma of the paranasal sinus and nasal cavity|stage i squamous cell carcinoma of the paranasal sinus and nasal cavity
5180660|NCT00898638|stage II esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage ii esthesioneuroblastoma of the paranasal sinus and nasal cavity
5180661|NCT00898638|stage II inverted papilloma of the paranasal sinus and nasal cavity|stage ii inverted papilloma of the paranasal sinus and nasal cavity
5180662|NCT00898638|stage II midline lethal granuloma of the paranasal sinus and nasal cavity|stage ii midline lethal granuloma of the paranasal sinus and nasal cavity
5180663|NCT00898638|stage II squamous cell carcinoma of the paranasal sinus and nasal cavity|stage ii squamous cell carcinoma of the paranasal sinus and nasal cavity
5180664|NCT00898638|stage III esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iii esthesioneuroblastoma of the paranasal sinus and nasal cavity
5180665|NCT00898638|stage III inverted papilloma of the paranasal sinus and nasal cavity|stage iii inverted papilloma of the paranasal sinus and nasal cavity
5180666|NCT00898638|stage III midline lethal granuloma of the paranasal sinus and nasal cavity|stage iii midline lethal granuloma of the paranasal sinus and nasal cavity
5180667|NCT00898638|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
5180668|NCT00898638|stage IV esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iv esthesioneuroblastoma of the paranasal sinus and nasal cavity
5180669|NCT00898638|stage IV inverted papilloma of the paranasal sinus and nasal cavity|stage iv inverted papilloma of the paranasal sinus and nasal cavity
5180670|NCT00898638|stage IV midline lethal granuloma of the paranasal sinus and nasal cavity|stage iv midline lethal granuloma of the paranasal sinus and nasal cavity
5180671|NCT00898638|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
5180672|NCT00898638|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity
5180673|NCT00898638|recurrent inverted papilloma of the paranasal sinus and nasal cavity|recurrent inverted papilloma of the paranasal sinus and nasal cavity
5180674|NCT00898638|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity
5180675|NCT00898638|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
5180677|NCT00898638|stage II salivary gland cancer|stage ii salivary gland cancer
5180678|NCT00898638|stage III salivary gland cancer|stage iii salivary gland cancer
5180679|NCT00898638|stage IV salivary gland cancer|stage iv salivary gland cancer
5180680|NCT00898638|recurrent salivary gland cancer|recurrent salivary gland cancer
5180681|NCT00898638|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
5180682|NCT00898612|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5180683|NCT00898612|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5180684|NCT00898612|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5180685|NCT00898612|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5180686|NCT00898612|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5180687|NCT00898612|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5180688|NCT00898612|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5180689|NCT00898612|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5180690|NCT00898612|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5180691|NCT00898612|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5180692|NCT00898612|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5180693|NCT00898612|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5180694|NCT00898612|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5180695|NCT00898612|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5180696|NCT00898612|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5180697|NCT00898612|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5180698|NCT00898612|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5180699|NCT00898612|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5180700|NCT00898612|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5180701|NCT00898612|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5180702|NCT00898612|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5180703|NCT00898612|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5180704|NCT00898612|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5180705|NCT00898612|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5180706|NCT00898612|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5180707|NCT00898612|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5180708|NCT00898612|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5180709|NCT00898612|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5180710|NCT00898612|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5180711|NCT00898612|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5180712|NCT00898612|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5180713|NCT00898612|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5180714|NCT00898612|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5180715|NCT00898612|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
5180716|NCT00898612|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
5180717|NCT00898612|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
5180718|NCT00898612|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5180719|NCT00898612|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5180720|NCT00898612|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5180721|NCT00898612|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5180722|NCT00898612|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5180723|NCT00898612|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5180724|NCT00898612|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5180725|NCT00898612|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
5180726|NCT00898612|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5180727|NCT00898612|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5180728|NCT00898612|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5180729|NCT00898612|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5180730|NCT00898612|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
5180731|NCT00898612|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5180732|NCT00898612|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
5180733|NCT00898612|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
5180734|NCT00898612|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
5180735|NCT00898612|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
5180736|NCT00898612|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5180737|NCT00898612|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5180738|NCT00898612|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5180739|NCT00898612|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5180740|NCT00898612|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
5180741|NCT00898612|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
5180742|NCT00898612|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5180743|NCT00898612|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5180744|NCT00898612|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5180745|NCT00898612|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5180746|NCT00898612|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5180747|NCT00898612|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5180748|NCT00898612|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5180749|NCT00898612|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5180750|NCT00898612|atypical chronic myeloid leukemia, BCR-ABL negative|atypical chronic myeloid leukemia, bcr-abl negative
5180751|NCT00898612|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5180752|NCT00898612|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
5180753|NCT00898612|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
5180754|NCT00898612|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
5180755|NCT00898612|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5180756|NCT00898612|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5180757|NCT00898612|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
5180758|NCT00898612|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5180759|NCT00898612|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5180760|NCT00898612|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5180761|NCT00898612|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5180762|NCT00898612|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5180763|NCT00898612|refractory hairy cell leukemia|refractory hairy cell leukemia
5180764|NCT00898612|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5180765|NCT00898612|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5180766|NCT00898612|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5180767|NCT00898612|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5180768|NCT00898612|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
5180769|NCT00898612|chronic eosinophilic leukemia|chronic eosinophilic leukemia
5180770|NCT00898612|primary myelofibrosis|primary myelofibrosis
5180771|NCT00898612|chronic neutrophilic leukemia|chronic neutrophilic leukemia
5180772|NCT00898612|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5180773|NCT00898612|disseminated neuroblastoma|disseminated neuroblastoma
5180774|NCT00898612|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
5180775|NCT00898612|poor prognosis metastatic gestational trophoblastic tumor|poor prognosis metastatic gestational trophoblastic tumor
5180776|NCT00898612|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
5180777|NCT00898612|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5180778|NCT00898612|recurrent Wilms tumor and other childhood kidney tumors|recurrent wilms tumor and other childhood kidney tumors
5180779|NCT00898612|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
5180780|NCT00898612|recurrent neuroblastoma|recurrent neuroblastoma
5180781|NCT00898612|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5180782|NCT00898612|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
5180783|NCT00898612|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
5180784|NCT00898612|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5180785|NCT00898612|stage I multiple myeloma|stage i multiple myeloma
5180786|NCT00898612|stage II multiple myeloma|stage ii multiple myeloma
5180787|NCT00898612|stage III multiple myeloma|stage iii multiple myeloma
5180788|NCT00898612|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
5180789|NCT00898612|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5180790|NCT00898612|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5180791|NCT00898612|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
5180792|NCT00898612|stage IIIA breast cancer|stage iiia breast cancer
5180793|NCT00898612|stage IIIB breast cancer|stage iiib breast cancer
5180794|NCT00898612|stage IIIC breast cancer|stage iiic breast cancer
5180795|NCT00898612|stage IV breast cancer|stage iv breast cancer
5180796|NCT00898612|refractory multiple myeloma|refractory multiple myeloma
5180797|NCT00898573|breast cancer|breast cancer
5180798|NCT00898560|Partial|partial
5180799|NCT00898560|Epilepsy|epilepsy
5180800|NCT00898560|Eslicarbazepine acetate|eslicarbazepine acetate
5180801|NCT00898560|Combined oral contraceptive|combined oral contraceptive
5180802|NCT00898560|Pharmacokinetics|pharmacokinetics
5180803|NCT00898560|Tolerability|tolerability
5180804|NCT00898547|advanced malignant mesothelioma|advanced malignant mesothelioma
5180805|NCT00898547|recurrent malignant mesothelioma|recurrent malignant mesothelioma
5180806|NCT00898547|epithelial mesothelioma|epithelial mesothelioma
5180807|NCT00898547|sarcomatous mesothelioma|sarcomatous mesothelioma
5180808|NCT00898534|Pediatrics|pediatrics
5180809|NCT00898534|Hemoglobin A1c|hemoglobin a1c
5180810|NCT00898534|Point of Care testing|point of care testing
5180811|NCT00898508|invasive ductal breast carcinoma|invasive ductal breast carcinoma
5180812|NCT00898508|invasive lobular breast carcinoma|invasive lobular breast carcinoma
5180813|NCT00898508|ductal breast carcinoma in situ|ductal breast carcinoma in situ
5180814|NCT00898508|lobular breast carcinoma in situ|lobular breast carcinoma in situ
5180815|NCT00898508|stage I breast cancer|stage i breast cancer
5180816|NCT00898508|stage II breast cancer|stage ii breast cancer
5180817|NCT00898508|stage IIIA breast cancer|stage iiia breast cancer
5180818|NCT00898508|stage IIIB breast cancer|stage iiib breast cancer
5180819|NCT00898508|stage IIIC breast cancer|stage iiic breast cancer
5180820|NCT00898508|stage IV breast cancer|stage iv breast cancer
5180821|NCT00898495|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
5180822|NCT00898495|stage II esophageal cancer|stage ii esophageal cancer
5180823|NCT00898495|stage III esophageal cancer|stage iii esophageal cancer
5180824|NCT00898495|stage IV esophageal cancer|stage iv esophageal cancer
5180825|NCT00898495|stage I esophageal cancer|stage i esophageal cancer
5180826|NCT00898482|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
5180827|NCT00898482|recurrent pancreatic cancer|recurrent pancreatic cancer
5180828|NCT00898482|stage I pancreatic cancer|stage i pancreatic cancer
5180829|NCT00898482|stage II pancreatic cancer|stage ii pancreatic cancer
5180830|NCT00898482|stage III pancreatic cancer|stage iii pancreatic cancer
5180831|NCT00898482|stage IV pancreatic cancer|stage iv pancreatic cancer
5180832|NCT00898469|childhood acute lymphoblastic leukemia|childhood acute lymphoblastic leukemia
5180833|NCT00898456|adult acute myeloid leukemia|adult acute myeloid leukemia
5180834|NCT00898456|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5180835|NCT00898456|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5180836|NCT00898456|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5180837|NCT00898456|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5180838|NCT00898456|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
5180839|NCT00898456|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
5180840|NCT00898456|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
5180841|NCT00898456|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
5180842|NCT00898456|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
5180843|NCT00898456|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
5180844|NCT00898456|adult erythroleukemia (M6a)|adult erythroleukemia (m6a)
5180845|NCT00898456|adult pure erythroid leukemia (M6b)|adult pure erythroid leukemia (m6b)
5180846|NCT00898456|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
5180847|NCT00898456|adult acute basophilic leukemia|adult acute basophilic leukemia
5180848|NCT00898456|adult acute eosinophilic leukemia|adult acute eosinophilic leukemia
5180849|NCT00898430|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
5180850|NCT00898430|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5180851|NCT00898430|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
5180852|NCT00898430|stage III verrucous carcinoma of the larynx|stage iii verrucous carcinoma of the larynx
5180853|NCT00898430|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5180854|NCT00898430|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
5180855|NCT00898430|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
5180856|NCT00898430|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5180857|NCT00898430|stage III verrucous carcinoma of the oral cavity|stage iii verrucous carcinoma of the oral cavity
5180858|NCT00898430|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
5180859|NCT00898430|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
5180860|NCT00898430|untreated metastatic squamous neck cancer with occult primary|untreated metastatic squamous neck cancer with occult primary
5180861|NCT00898430|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
5180862|NCT00898430|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
5180863|NCT00898430|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
5180864|NCT00898430|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5180865|NCT00898430|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
5180866|NCT00898430|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
5180867|NCT00898430|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
5180868|NCT00898430|stage III salivary gland cancer|stage iii salivary gland cancer
5180869|NCT00898430|stage IV salivary gland cancer|stage iv salivary gland cancer
5180870|NCT00898417|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5180987|NCT00898222|Normal healthy subjects|normal healthy subjects
5180871|NCT00898417|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5180872|NCT00898417|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5180873|NCT00898417|adenocarcinoma of the lung|adenocarcinoma of the lung
5180874|NCT00898417|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
5180875|NCT00898378|healthy, no evidence of disease|healthy, no evidence of disease
5180876|NCT00898378|stage I colon cancer|stage i colon cancer
5180877|NCT00898378|stage II colon cancer|stage ii colon cancer
5180878|NCT00898378|stage III colon cancer|stage iii colon cancer
5180879|NCT00898378|stage IV colon cancer|stage iv colon cancer
5180880|NCT00898378|stage I rectal cancer|stage i rectal cancer
5180881|NCT00898378|stage II rectal cancer|stage ii rectal cancer
5180882|NCT00898378|stage III rectal cancer|stage iii rectal cancer
5180883|NCT00898378|stage IV rectal cancer|stage iv rectal cancer
5180884|NCT00898378|recurrent rectal cancer|recurrent rectal cancer
5180885|NCT00898378|recurrent colon cancer|recurrent colon cancer
5180886|NCT00898378|adenomatous polyp|adenomatous polyp
5180887|NCT00898352|stage III vulvar cancer|stage iii vulvar cancer
5180888|NCT00898352|squamous cell carcinoma of the vulva|squamous cell carcinoma of the vulva
5180889|NCT00898326|stage I prostate cancer|stage i prostate cancer
5180890|NCT00898326|stage IIB prostate cancer|stage iib prostate cancer
5180891|NCT00898326|stage IIA prostate cancer|stage iia prostate cancer
5180892|NCT00898313|lung cancer|lung cancer
5180893|NCT00898300|stage I squamous cell carcinoma of the hypopharynx|stage i squamous cell carcinoma of the hypopharynx
5180894|NCT00898300|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
5180895|NCT00898300|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
5180896|NCT00898300|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5180897|NCT00898300|stage I squamous cell carcinoma of the larynx|stage i squamous cell carcinoma of the larynx
5180898|NCT00898300|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
5180899|NCT00898300|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
5180900|NCT00898300|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5180901|NCT00898300|stage I verrucous carcinoma of the larynx|stage i verrucous carcinoma of the larynx
5180902|NCT00898300|stage II verrucous carcinoma of the larynx|stage ii verrucous carcinoma of the larynx
5180903|NCT00898300|stage III verrucous carcinoma of the larynx|stage iii verrucous carcinoma of the larynx
5180904|NCT00898300|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
5180905|NCT00898300|stage I basal cell carcinoma of the lip|stage i basal cell carcinoma of the lip
5180906|NCT00898300|stage II basal cell carcinoma of the lip|stage ii basal cell carcinoma of the lip
5180907|NCT00898300|stage III basal cell carcinoma of the lip|stage iii basal cell carcinoma of the lip
5180908|NCT00898300|stage IV basal cell carcinoma of the lip|stage iv basal cell carcinoma of the lip
5180909|NCT00898300|stage I mucoepidermoid carcinoma of the oral cavity|stage i mucoepidermoid carcinoma of the oral cavity
5180910|NCT00898300|stage II mucoepidermoid carcinoma of the oral cavity|stage ii mucoepidermoid carcinoma of the oral cavity
5180911|NCT00898300|stage III mucoepidermoid carcinoma of the oral cavity|stage iii mucoepidermoid carcinoma of the oral cavity
5180912|NCT00898300|stage IV mucoepidermoid carcinoma of the oral cavity|stage iv mucoepidermoid carcinoma of the oral cavity
5180913|NCT00898300|stage I verrucous carcinoma of the oral cavity|stage i verrucous carcinoma of the oral cavity
5180914|NCT00898300|stage II verrucous carcinoma of the oral cavity|stage ii verrucous carcinoma of the oral cavity
5180915|NCT00898300|stage III verrucous carcinoma of the oral cavity|stage iii verrucous carcinoma of the oral cavity
5180916|NCT00898300|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
5180917|NCT00898300|stage I adenoid cystic carcinoma of the oral cavity|stage i adenoid cystic carcinoma of the oral cavity
5180918|NCT00898300|stage II adenoid cystic carcinoma of the oral cavity|stage ii adenoid cystic carcinoma of the oral cavity
5180919|NCT00898300|stage III adenoid cystic carcinoma of the oral cavity|stage iii adenoid cystic carcinoma of the oral cavity
5180920|NCT00898300|stage IV adenoid cystic carcinoma of the oral cavity|stage iv adenoid cystic carcinoma of the oral cavity
5180921|NCT00898300|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
5180922|NCT00898300|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
5180923|NCT00898300|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
5180924|NCT00898300|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5180925|NCT00898300|metastatic squamous neck cancer with occult primary|metastatic squamous neck cancer with occult primary
5180926|NCT00898300|stage I lymphoepithelioma of the nasopharynx|stage i lymphoepithelioma of the nasopharynx
5180927|NCT00898300|stage II lymphoepithelioma of the nasopharynx|stage ii lymphoepithelioma of the nasopharynx
5180928|NCT00898300|stage III lymphoepithelioma of the nasopharynx|stage iii lymphoepithelioma of the nasopharynx
5180929|NCT00898300|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
5180930|NCT00898300|stage I squamous cell carcinoma of the nasopharynx|stage i squamous cell carcinoma of the nasopharynx
5180931|NCT00898300|stage II squamous cell carcinoma of the nasopharynx|stage ii squamous cell carcinoma of the nasopharynx
5180932|NCT00898300|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
5180933|NCT00898300|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
5180934|NCT00898300|stage I lymphoepithelioma of the oropharynx|stage i lymphoepithelioma of the oropharynx
5180935|NCT00898300|stage II lymphoepithelioma of the oropharynx|stage ii lymphoepithelioma of the oropharynx
5180936|NCT00898300|stage III lymphoepithelioma of the oropharynx|stage iii lymphoepithelioma of the oropharynx
5180937|NCT00898300|stage IV lymphoepithelioma of the oropharynx|stage iv lymphoepithelioma of the oropharynx
5180938|NCT00898300|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
5180939|NCT00898300|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
5180940|NCT00898300|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
5180941|NCT00898300|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5180942|NCT00898300|stage I esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage i esthesioneuroblastoma of the paranasal sinus and nasal cavity
5180943|NCT00898300|stage II esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage ii esthesioneuroblastoma of the paranasal sinus and nasal cavity
5180944|NCT00898300|stage III esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iii esthesioneuroblastoma of the paranasal sinus and nasal cavity
5180945|NCT00898300|stage IV esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iv esthesioneuroblastoma of the paranasal sinus and nasal cavity
5180946|NCT00898300|stage I inverted papilloma of the paranasal sinus and nasal cavity|stage i inverted papilloma of the paranasal sinus and nasal cavity
5180947|NCT00898300|stage II inverted papilloma of the paranasal sinus and nasal cavity|stage ii inverted papilloma of the paranasal sinus and nasal cavity
5180948|NCT00898300|stage III inverted papilloma of the paranasal sinus and nasal cavity|stage iii inverted papilloma of the paranasal sinus and nasal cavity
5180949|NCT00898300|stage IV inverted papilloma of the paranasal sinus and nasal cavity|stage iv inverted papilloma of the paranasal sinus and nasal cavity
5180950|NCT00898300|stage I midline lethal granuloma of the paranasal sinus and nasal cavity|stage i midline lethal granuloma of the paranasal sinus and nasal cavity
5180951|NCT00898300|stage II midline lethal granuloma of the paranasal sinus and nasal cavity|stage ii midline lethal granuloma of the paranasal sinus and nasal cavity
5180952|NCT00898300|stage III midline lethal granuloma of the paranasal sinus and nasal cavity|stage iii midline lethal granuloma of the paranasal sinus and nasal cavity
5180953|NCT00898300|stage IV midline lethal granuloma of the paranasal sinus and nasal cavity|stage iv midline lethal granuloma of the paranasal sinus and nasal cavity
5180954|NCT00898300|stage I squamous cell carcinoma of the paranasal sinus and nasal cavity|stage i squamous cell carcinoma of the paranasal sinus and nasal cavity
5180955|NCT00898300|stage II squamous cell carcinoma of the paranasal sinus and nasal cavity|stage ii squamous cell carcinoma of the paranasal sinus and nasal cavity
5180956|NCT00898300|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
5180957|NCT00898300|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
5180958|NCT00898300|stage I salivary gland cancer|stage i salivary gland cancer
5180959|NCT00898300|stage II salivary gland cancer|stage ii salivary gland cancer
5180960|NCT00898300|stage III salivary gland cancer|stage iii salivary gland cancer
5180961|NCT00898300|stage IV salivary gland cancer|stage iv salivary gland cancer
5180962|NCT00898300|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
5180963|NCT00898300|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
5180964|NCT00898300|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
5180965|NCT00898300|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
5180966|NCT00898300|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
5180967|NCT00898300|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
5180968|NCT00898300|recurrent adenoid cystic carcinoma of the oral cavity|recurrent adenoid cystic carcinoma of the oral cavity
5180969|NCT00898300|recurrent basal cell carcinoma of the lip|recurrent basal cell carcinoma of the lip
5180970|NCT00898300|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity
5180971|NCT00898300|recurrent inverted papilloma of the paranasal sinus and nasal cavity|recurrent inverted papilloma of the paranasal sinus and nasal cavity
5180972|NCT00898300|recurrent lymphoepithelioma of the nasopharynx|recurrent lymphoepithelioma of the nasopharynx
5180973|NCT00898300|recurrent lymphoepithelioma of the oropharynx|recurrent lymphoepithelioma of the oropharynx
5180974|NCT00898300|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity
5180975|NCT00898300|recurrent mucoepidermoid carcinoma of the oral cavity|recurrent mucoepidermoid carcinoma of the oral cavity
5180976|NCT00898300|recurrent salivary gland cancer|recurrent salivary gland cancer
5180977|NCT00898300|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
5180978|NCT00898300|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
5180979|NCT00898300|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
5180980|NCT00898287|Locally advanced or metastatic adenocarcinoma of pancreas|locally advanced or metastatic adenocarcinoma of pancreas
5180981|NCT00898274|prostate cancer|prostate cancer
5180982|NCT00898274|high grade prostatic intraepithelial neoplasia|high grade prostatic intraepithelial neoplasia
5180983|NCT00898261|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5180984|NCT00898235|primary systemic amyloidosis|primary systemic amyloidosis
5180985|NCT00898222|healthy volunteers|healthy volunteers
5180988|NCT00898209|stage I non-small cell lung cancer|stage i non-small cell lung cancer
5180989|NCT00898209|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
5180990|NCT00898209|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5180991|NCT00898209|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5180992|NCT00898209|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5180993|NCT00898183|stage III melanoma|stage iii melanoma
5180994|NCT00898183|stage IV melanoma|stage iv melanoma
5180995|NCT00898183|recurrent melanoma|recurrent melanoma
5180996|NCT00898170|myoma|myoma
5180997|NCT00898170|hypertension|hypertension
5180998|NCT00898170|erythropoetin|erythropoetin
5180999|NCT00898170|blood pressure|blood pressure
5181000|NCT00898170|erythropoetin level|erythropoetin level
5181001|NCT00898157|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
5181002|NCT00898157|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5181003|NCT00898157|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5181004|NCT00898157|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
5181005|NCT00898157|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5181006|NCT00898157|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5181007|NCT00898144|cervical cancer|cervical cancer
5181008|NCT00898144|cervical intraepithelial neoplasia grade 2|cervical intraepithelial neoplasia grade 2
5181009|NCT00898144|cervical intraepithelial neoplasia grade 3|cervical intraepithelial neoplasia grade 3
5181010|NCT00898144|cervical adenocarcinoma|cervical adenocarcinoma
5181011|NCT00898144|atypical squamous cells of undetermined significance|atypical squamous cells of undetermined significance
5181012|NCT00898131|breast cancer|breast cancer
5181013|NCT00898118|refractory cytopenia with multilineage dysplasia|refractory cytopenia with multilineage dysplasia
5181014|NCT00898118|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
5181015|NCT00898118|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5181016|NCT00898118|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5181017|NCT00898092|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
5181018|NCT00898092|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
5181019|NCT00898092|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
5181020|NCT00898092|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
5181021|NCT00898092|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
5181022|NCT00898092|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
5181023|NCT00898092|adult erythroleukemia (M6a)|adult erythroleukemia (m6a)
5181024|NCT00898092|adult pure erythroid leukemia (M6b)|adult pure erythroid leukemia (m6b)
5181025|NCT00898092|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
5181026|NCT00898092|adult acute eosinophilic leukemia|adult acute eosinophilic leukemia
5181027|NCT00898092|adult acute basophilic leukemia|adult acute basophilic leukemia
5181028|NCT00898092|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
5181029|NCT00898066|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
5181030|NCT00898066|monoclonal gammopathy of undetermined significance|monoclonal gammopathy of undetermined significance
5181031|NCT00898066|primary systemic amyloidosis|primary systemic amyloidosis
5181032|NCT00898066|stage I multiple myeloma|stage i multiple myeloma
5181033|NCT00898066|stage II multiple myeloma|stage ii multiple myeloma
5181034|NCT00898066|stage III multiple myeloma|stage iii multiple myeloma
5181035|NCT00898040|stage I multiple myeloma|stage i multiple myeloma
5181036|NCT00898040|stage II multiple myeloma|stage ii multiple myeloma
5181037|NCT00898040|stage III multiple myeloma|stage iii multiple myeloma
5181038|NCT00898040|refractory multiple myeloma|refractory multiple myeloma
5181039|NCT00898027|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5181040|NCT00898014|stage IV breast cancer|stage iv breast cancer
5181041|NCT00897988|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
5181042|NCT00897988|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
5181043|NCT00897988|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
5181044|NCT00897988|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
5181045|NCT00897988|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5181046|NCT00897975|statin associated myalgias|statin associated myalgias
5181047|NCT00897975|hyperlipidemia|hyperlipidemia
5181048|NCT00897975|red yeast rice|red yeast rice
5181049|NCT00897975|phytosterols|phytosterols
5181050|NCT00897975|therapeutic lifestyle changes|therapeutic lifestyle changes
5181051|NCT00897975|compliance|compliance
5181052|NCT00897962|stage IV breast cancer|stage iv breast cancer
5181053|NCT00897936|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5181054|NCT00897936|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5181055|NCT00897936|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
5181056|NCT00897936|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5181057|NCT00897936|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5181058|NCT00897936|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5181059|NCT00897936|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5181060|NCT00897936|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5181061|NCT00897923|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
5181062|NCT00897923|AIDS-related primary CNS lymphoma|aids-related primary cns lymphoma
5181063|NCT00897923|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5181064|NCT00897923|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
5181065|NCT00897923|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5181066|NCT00897923|intraocular lymphoma|intraocular lymphoma
5181067|NCT00897923|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5181068|NCT00897923|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
5181069|NCT00897923|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5181070|NCT00897923|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5181071|NCT00897923|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5181072|NCT00897923|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5181073|NCT00897923|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5181074|NCT00897923|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5181075|NCT00897923|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
5181076|NCT00897923|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5181077|NCT00897923|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5181078|NCT00897923|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5181079|NCT00897923|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5181080|NCT00897923|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5181081|NCT00897923|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5181082|NCT00897923|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5181083|NCT00897923|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5181084|NCT00897923|small intestine lymphoma|small intestine lymphoma
5181085|NCT00897923|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5181086|NCT00897923|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5181087|NCT00897923|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5181088|NCT00897923|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5181089|NCT00897923|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5181090|NCT00897923|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5181091|NCT00897923|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5181092|NCT00897923|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
5181093|NCT00897923|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
5181094|NCT00897923|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5181095|NCT00897923|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5181096|NCT00897923|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5181097|NCT00897923|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5181098|NCT00897923|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5181099|NCT00897923|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
5181100|NCT00897923|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5181101|NCT00897923|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5181102|NCT00897923|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5181103|NCT00897923|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5181104|NCT00897923|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5181105|NCT00897923|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5181106|NCT00897923|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5181107|NCT00897923|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
5181108|NCT00897923|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
5181109|NCT00897923|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5181110|NCT00897923|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5181111|NCT00897923|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5181112|NCT00897923|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5181113|NCT00897923|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5181114|NCT00897923|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
5181115|NCT00897923|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5181116|NCT00897923|Waldenström macroglobulinemia|waldenström macroglobulinemia
5181117|NCT00897923|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
5181118|NCT00897923|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
5181119|NCT00897923|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
5181120|NCT00897923|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
5181185|NCT00897858|childhood craniopharyngioma|childhood craniopharyngioma
5181121|NCT00897923|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
5181122|NCT00897923|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
5181123|NCT00897923|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
5181124|NCT00897923|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
5181125|NCT00897923|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
5181126|NCT00897923|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
5181127|NCT00897923|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
5181128|NCT00897923|stage I mantle cell lymphoma|stage i mantle cell lymphoma
5181129|NCT00897923|stage I marginal zone lymphoma|stage i marginal zone lymphoma
5181130|NCT00897923|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
5181131|NCT00897923|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
5181132|NCT00897923|adult grade III lymphomatoid granulomatosis|adult grade iii lymphomatoid granulomatosis
5181133|NCT00897923|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
5181134|NCT00897923|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
5181135|NCT00897923|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
5181136|NCT00897923|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
5181137|NCT00897923|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
5181138|NCT00897923|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
5181139|NCT00897923|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
5181140|NCT00897923|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
5181141|NCT00897923|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
5181142|NCT00897923|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
5181143|NCT00897923|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
5181144|NCT00897923|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
5181145|NCT00897923|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
5181146|NCT00897923|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
5181147|NCT00897923|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
5181148|NCT00897923|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5181149|NCT00897923|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
5181150|NCT00897923|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
5181151|NCT00897923|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
5181152|NCT00897923|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
5181153|NCT00897923|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5181154|NCT00897923|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5181155|NCT00897923|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5181156|NCT00897923|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5181157|NCT00897923|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
5181158|NCT00897923|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
5181159|NCT00897923|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
5181160|NCT00897923|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
5181161|NCT00897923|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
5181162|NCT00897910|stage I multiple myeloma|stage i multiple myeloma
5181163|NCT00897910|stage II multiple myeloma|stage ii multiple myeloma
5181164|NCT00897910|stage III multiple myeloma|stage iii multiple myeloma
5181165|NCT00897910|refractory multiple myeloma|refractory multiple myeloma
5181166|NCT00897897|Uterine Leiomyomas|uterine leiomyomas
5181167|NCT00897897|Fibroids|fibroids
5181168|NCT00897897|HIFU|hifu
5181169|NCT00897897|Ablation|ablation
5181170|NCT00897897|High Intensity Focused Ultrasound|high intensity focused ultrasound
5181171|NCT00897884|breast cancer|breast cancer
5181172|NCT00897884|metformin|metformin
5181173|NCT00897884|breast surgery|breast surgery
5181174|NCT00897871|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
5181175|NCT00897858|childhood central nervous system germ cell tumor|childhood central nervous system germ cell tumor
5181176|NCT00897858|childhood choroid plexus tumor|childhood choroid plexus tumor
5181177|NCT00897858|childhood grade I meningioma|childhood grade i meningioma
5181178|NCT00897858|childhood grade II meningioma|childhood grade ii meningioma
5181179|NCT00897858|childhood grade III meningioma|childhood grade iii meningioma
5181180|NCT00897858|childhood atypical teratoid/rhabdoid tumor|childhood atypical teratoid/rhabdoid tumor
5181181|NCT00897858|untreated childhood visual pathway glioma|untreated childhood visual pathway glioma
5181182|NCT00897858|childhood infratentorial ependymoma|childhood infratentorial ependymoma
5181183|NCT00897858|childhood supratentorial ependymoma|childhood supratentorial ependymoma
5181184|NCT00897858|newly diagnosed childhood ependymoma|newly diagnosed childhood ependymoma
5181186|NCT00897858|untreated childhood medulloblastoma|untreated childhood medulloblastoma
5181187|NCT00897858|untreated childhood cerebellar astrocytoma|untreated childhood cerebellar astrocytoma
5181188|NCT00897858|untreated childhood supratentorial primitive neuroectodermal tumor|untreated childhood supratentorial primitive neuroectodermal tumor
5181189|NCT00897858|untreated childhood brain stem glioma|untreated childhood brain stem glioma
5181190|NCT00897858|untreated childhood visual pathway and hypothalamic glioma|untreated childhood visual pathway and hypothalamic glioma
5181191|NCT00897858|childhood high-grade cerebral astrocytoma|childhood high-grade cerebral astrocytoma
5181192|NCT00897858|childhood low-grade cerebral astrocytoma|childhood low-grade cerebral astrocytoma
5181193|NCT00897858|childhood central nervous system choriocarcinoma|childhood central nervous system choriocarcinoma
5181194|NCT00897858|childhood central nervous system embryonal tumor|childhood central nervous system embryonal tumor
5181195|NCT00897858|childhood central nervous system germinoma|childhood central nervous system germinoma
5181196|NCT00897858|childhood central nervous system mixed germ cell tumor|childhood central nervous system mixed germ cell tumor
5181197|NCT00897858|childhood central nervous system teratoma|childhood central nervous system teratoma
5181198|NCT00897858|childhood central nervous system yolk sac tumor|childhood central nervous system yolk sac tumor
5181199|NCT00897845|stage II breast cancer|stage ii breast cancer
5181200|NCT00897845|stage IIIA breast cancer|stage iiia breast cancer
5181201|NCT00897845|stage IIIB breast cancer|stage iiib breast cancer
5181202|NCT00897832|pancreatic cancer|pancreatic cancer
5181203|NCT00897819|recurrent colon cancer|recurrent colon cancer
5181204|NCT00897819|recurrent rectal cancer|recurrent rectal cancer
5181205|NCT00897819|stage III colon cancer|stage iii colon cancer
5181206|NCT00897819|stage III rectal cancer|stage iii rectal cancer
5181207|NCT00897819|stage IV colon cancer|stage iv colon cancer
5181208|NCT00897819|stage IV rectal cancer|stage iv rectal cancer
5181209|NCT00897819|adenocarcinoma of the colon|adenocarcinoma of the colon
5181210|NCT00897819|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5181211|NCT00897806|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5181212|NCT00897806|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5181213|NCT00897806|peritoneal cavity cancer|peritoneal cavity cancer
5181214|NCT00897793|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
5181215|NCT00897793|stage I squamous cell carcinoma of the hypopharynx|stage i squamous cell carcinoma of the hypopharynx
5181216|NCT00897793|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
5181217|NCT00897793|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
5181218|NCT00897793|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5181219|NCT00897793|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
5181220|NCT00897793|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
5181221|NCT00897793|stage I squamous cell carcinoma of the larynx|stage i squamous cell carcinoma of the larynx
5181222|NCT00897793|stage I verrucous carcinoma of the larynx|stage i verrucous carcinoma of the larynx
5181223|NCT00897793|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
5181224|NCT00897793|stage II verrucous carcinoma of the larynx|stage ii verrucous carcinoma of the larynx
5181225|NCT00897793|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
5181226|NCT00897793|stage III verrucous carcinoma of the larynx|stage iii verrucous carcinoma of the larynx
5181227|NCT00897793|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5181228|NCT00897793|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
5181229|NCT00897793|recurrent adenoid cystic carcinoma of the oral cavity|recurrent adenoid cystic carcinoma of the oral cavity
5181230|NCT00897793|recurrent mucoepidermoid carcinoma of the oral cavity|recurrent mucoepidermoid carcinoma of the oral cavity
5181231|NCT00897793|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
5181232|NCT00897793|stage I adenoid cystic carcinoma of the oral cavity|stage i adenoid cystic carcinoma of the oral cavity
5181233|NCT00897793|stage I mucoepidermoid carcinoma of the oral cavity|stage i mucoepidermoid carcinoma of the oral cavity
5181234|NCT00897793|stage I verrucous carcinoma of the oral cavity|stage i verrucous carcinoma of the oral cavity
5181235|NCT00897793|stage II adenoid cystic carcinoma of the oral cavity|stage ii adenoid cystic carcinoma of the oral cavity
5181236|NCT00897793|stage II mucoepidermoid carcinoma of the oral cavity|stage ii mucoepidermoid carcinoma of the oral cavity
5181237|NCT00897793|stage II verrucous carcinoma of the oral cavity|stage ii verrucous carcinoma of the oral cavity
5181238|NCT00897793|stage III adenoid cystic carcinoma of the oral cavity|stage iii adenoid cystic carcinoma of the oral cavity
5181239|NCT00897793|stage III mucoepidermoid carcinoma of the oral cavity|stage iii mucoepidermoid carcinoma of the oral cavity
5181240|NCT00897793|stage III verrucous carcinoma of the oral cavity|stage iii verrucous carcinoma of the oral cavity
5181241|NCT00897793|stage IV adenoid cystic carcinoma of the oral cavity|stage iv adenoid cystic carcinoma of the oral cavity
5181242|NCT00897793|stage IV mucoepidermoid carcinoma of the oral cavity|stage iv mucoepidermoid carcinoma of the oral cavity
5181243|NCT00897793|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
5181244|NCT00897793|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
5181245|NCT00897793|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
5181366|NCT00897767|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
5181246|NCT00897793|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
5181247|NCT00897793|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5181248|NCT00897793|recurrent basal cell carcinoma of the lip|recurrent basal cell carcinoma of the lip
5181249|NCT00897793|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
5181250|NCT00897793|stage I basal cell carcinoma of the lip|stage i basal cell carcinoma of the lip
5181251|NCT00897793|stage II basal cell carcinoma of the lip|stage ii basal cell carcinoma of the lip
5181252|NCT00897793|stage III basal cell carcinoma of the lip|stage iii basal cell carcinoma of the lip
5181253|NCT00897793|stage IV basal cell carcinoma of the lip|stage iv basal cell carcinoma of the lip
5181254|NCT00897793|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
5181255|NCT00897793|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
5181256|NCT00897793|untreated metastatic squamous neck cancer with occult primary|untreated metastatic squamous neck cancer with occult primary
5181257|NCT00897793|recurrent lymphoepithelioma of the nasopharynx|recurrent lymphoepithelioma of the nasopharynx
5181258|NCT00897793|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
5181259|NCT00897793|stage I lymphoepithelioma of the nasopharynx|stage i lymphoepithelioma of the nasopharynx
5181260|NCT00897793|stage I squamous cell carcinoma of the nasopharynx|stage i squamous cell carcinoma of the nasopharynx
5181261|NCT00897793|stage II lymphoepithelioma of the nasopharynx|stage ii lymphoepithelioma of the nasopharynx
5181262|NCT00897793|stage II squamous cell carcinoma of the nasopharynx|stage ii squamous cell carcinoma of the nasopharynx
5181263|NCT00897793|stage III lymphoepithelioma of the nasopharynx|stage iii lymphoepithelioma of the nasopharynx
5181264|NCT00897793|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
5181265|NCT00897793|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
5181266|NCT00897793|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
5181267|NCT00897793|recurrent lymphoepithelioma of the oropharynx|recurrent lymphoepithelioma of the oropharynx
5181268|NCT00897793|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
5181269|NCT00897793|stage I lymphoepithelioma of the oropharynx|stage i lymphoepithelioma of the oropharynx
5181270|NCT00897793|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
5181271|NCT00897793|stage II lymphoepithelioma of the oropharynx|stage ii lymphoepithelioma of the oropharynx
5181272|NCT00897793|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
5181273|NCT00897793|stage III lymphoepithelioma of the oropharynx|stage iii lymphoepithelioma of the oropharynx
5181274|NCT00897793|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
5181275|NCT00897793|stage IV lymphoepithelioma of the oropharynx|stage iv lymphoepithelioma of the oropharynx
5181276|NCT00897793|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5181277|NCT00897793|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity
5181278|NCT00897793|recurrent inverted papilloma of the paranasal sinus and nasal cavity|recurrent inverted papilloma of the paranasal sinus and nasal cavity
5181279|NCT00897793|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity
5181280|NCT00897793|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
5181281|NCT00897793|stage I esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage i esthesioneuroblastoma of the paranasal sinus and nasal cavity
5181282|NCT00897793|stage I inverted papilloma of the paranasal sinus and nasal cavity|stage i inverted papilloma of the paranasal sinus and nasal cavity
5181283|NCT00897793|stage I midline lethal granuloma of the paranasal sinus and nasal cavity|stage i midline lethal granuloma of the paranasal sinus and nasal cavity
5181284|NCT00897793|stage I squamous cell carcinoma of the paranasal sinus and nasal cavity|stage i squamous cell carcinoma of the paranasal sinus and nasal cavity
5181285|NCT00897793|stage II esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage ii esthesioneuroblastoma of the paranasal sinus and nasal cavity
5181286|NCT00897793|stage II inverted papilloma of the paranasal sinus and nasal cavity|stage ii inverted papilloma of the paranasal sinus and nasal cavity
5181287|NCT00897793|stage II midline lethal granuloma of the paranasal sinus and nasal cavity|stage ii midline lethal granuloma of the paranasal sinus and nasal cavity
5181288|NCT00897793|stage II squamous cell carcinoma of the paranasal sinus and nasal cavity|stage ii squamous cell carcinoma of the paranasal sinus and nasal cavity
5181289|NCT00897793|stage III esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iii esthesioneuroblastoma of the paranasal sinus and nasal cavity
5181290|NCT00897793|stage III inverted papilloma of the paranasal sinus and nasal cavity|stage iii inverted papilloma of the paranasal sinus and nasal cavity
5181291|NCT00897793|stage III midline lethal granuloma of the paranasal sinus and nasal cavity|stage iii midline lethal granuloma of the paranasal sinus and nasal cavity
5181292|NCT00897793|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
5181293|NCT00897793|stage IV esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iv esthesioneuroblastoma of the paranasal sinus and nasal cavity
5181294|NCT00897793|stage IV inverted papilloma of the paranasal sinus and nasal cavity|stage iv inverted papilloma of the paranasal sinus and nasal cavity
5181367|NCT00897767|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
5181295|NCT00897793|stage IV midline lethal granuloma of the paranasal sinus and nasal cavity|stage iv midline lethal granuloma of the paranasal sinus and nasal cavity
5181296|NCT00897793|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
5181297|NCT00897793|high-grade salivary gland mucoepidermoid carcinoma|high-grade salivary gland mucoepidermoid carcinoma
5181298|NCT00897793|low-grade salivary gland mucoepidermoid carcinoma|low-grade salivary gland mucoepidermoid carcinoma
5181299|NCT00897793|recurrent salivary gland cancer|recurrent salivary gland cancer
5181300|NCT00897793|salivary gland acinic cell tumor|salivary gland acinic cell tumor
5181301|NCT00897793|salivary gland adenocarcinoma|salivary gland adenocarcinoma
5181302|NCT00897793|salivary gland adenoid cystic carcinoma|salivary gland adenoid cystic carcinoma
5181303|NCT00897793|salivary gland anaplastic carcinoma|salivary gland anaplastic carcinoma
5181304|NCT00897793|salivary gland malignant mixed cell type tumor|salivary gland malignant mixed cell type tumor
5181305|NCT00897793|salivary gland poorly differentiated carcinoma|salivary gland poorly differentiated carcinoma
5181306|NCT00897793|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
5181307|NCT00897793|stage I salivary gland cancer|stage i salivary gland cancer
5181308|NCT00897793|stage II salivary gland cancer|stage ii salivary gland cancer
5181309|NCT00897793|stage III salivary gland cancer|stage iii salivary gland cancer
5181310|NCT00897793|stage IV salivary gland cancer|stage iv salivary gland cancer
5181311|NCT00897793|limited stage small cell lung cancer|limited stage small cell lung cancer
5181312|NCT00897793|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5181313|NCT00897793|recurrent small cell lung cancer|recurrent small cell lung cancer
5181314|NCT00897793|stage I non-small cell lung cancer|stage i non-small cell lung cancer
5181315|NCT00897793|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
5181316|NCT00897793|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5181317|NCT00897793|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5181318|NCT00897793|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5181319|NCT00897793|extensive stage small cell lung cancer|extensive stage small cell lung cancer
5181320|NCT00897793|male breast cancer|male breast cancer
5181321|NCT00897793|recurrent breast cancer|recurrent breast cancer
5181322|NCT00897793|stage I breast cancer|stage i breast cancer
5181323|NCT00897793|stage II breast cancer|stage ii breast cancer
5181324|NCT00897793|stage IIIA breast cancer|stage iiia breast cancer
5181325|NCT00897793|stage IIIB breast cancer|stage iiib breast cancer
5181326|NCT00897793|stage IIIC breast cancer|stage iiic breast cancer
5181327|NCT00897793|stage IV breast cancer|stage iv breast cancer
5181328|NCT00897793|recurrent colon cancer|recurrent colon cancer
5181329|NCT00897793|stage I colon cancer|stage i colon cancer
5181330|NCT00897793|stage II colon cancer|stage ii colon cancer
5181331|NCT00897793|stage III colon cancer|stage iii colon cancer
5181332|NCT00897793|stage IV colon cancer|stage iv colon cancer
5181333|NCT00897793|recurrent rectal cancer|recurrent rectal cancer
5181334|NCT00897793|stage I rectal cancer|stage i rectal cancer
5181335|NCT00897793|stage II rectal cancer|stage ii rectal cancer
5181336|NCT00897793|stage III rectal cancer|stage iii rectal cancer
5181337|NCT00897793|stage IV rectal cancer|stage iv rectal cancer
5181338|NCT00897793|recurrent prostate cancer|recurrent prostate cancer
5181339|NCT00897793|stage I prostate cancer|stage i prostate cancer
5181340|NCT00897793|stage II prostate cancer|stage ii prostate cancer
5181341|NCT00897793|stage III prostate cancer|stage iii prostate cancer
5181342|NCT00897793|stage IV prostate cancer|stage iv prostate cancer
5181343|NCT00897780|Headache|headache
5181344|NCT00897780|Pediatric|pediatric
5181345|NCT00897780|Virtual Reality|virtual reality
5181346|NCT00897780|Biofeedback|biofeedback
5181347|NCT00897767|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5181348|NCT00897767|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
5181349|NCT00897767|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5181350|NCT00897767|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
5181351|NCT00897767|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5181352|NCT00897767|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5181353|NCT00897767|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
5181354|NCT00897767|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
5181355|NCT00897767|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
5181356|NCT00897767|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5181357|NCT00897767|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5181358|NCT00897767|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
5181359|NCT00897767|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5181360|NCT00897767|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5181361|NCT00897767|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5181362|NCT00897767|refractory hairy cell leukemia|refractory hairy cell leukemia
5181363|NCT00897767|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5181364|NCT00897767|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
5181365|NCT00897767|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
5181922|NCT00896285|cancer|cancer
5181368|NCT00897767|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
5181369|NCT00897767|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5181760|NCT00896688|ultrasound guidance|ultrasound guidance
5181370|NCT00897767|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
5181371|NCT00897767|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5181372|NCT00897767|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
5181373|NCT00897767|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
5181374|NCT00897767|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
5181375|NCT00897767|untreated childhood acute myeloid leukemia and other myeloid malignancies|untreated childhood acute myeloid leukemia and other myeloid malignancies
5181376|NCT00897767|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
5181377|NCT00897767|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5181378|NCT00897767|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5181379|NCT00897767|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5181380|NCT00897767|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5181381|NCT00897767|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5181382|NCT00897767|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5181383|NCT00897767|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5181384|NCT00897767|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
5181385|NCT00897767|acute undifferentiated leukemia|acute undifferentiated leukemia
5181386|NCT00897767|mast cell leukemia|mast cell leukemia
5181387|NCT00897767|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5181388|NCT00897767|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
5181389|NCT00897767|prolymphocytic leukemia|prolymphocytic leukemia
5181390|NCT00897767|untreated hairy cell leukemia|untreated hairy cell leukemia
5181391|NCT00897754|adenocarcinoma of the colon|adenocarcinoma of the colon
5181392|NCT00897754|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5181393|NCT00897754|recurrent rectal cancer|recurrent rectal cancer
5181394|NCT00897754|stage III rectal cancer|stage iii rectal cancer
5181395|NCT00897754|stage IV rectal cancer|stage iv rectal cancer
5181396|NCT00897754|recurrent colon cancer|recurrent colon cancer
5181397|NCT00897754|stage III colon cancer|stage iii colon cancer
5181398|NCT00897754|stage IV colon cancer|stage iv colon cancer
5181399|NCT00897741|recurrent pancreatic cancer|recurrent pancreatic cancer
5181400|NCT00897741|stage IV pancreatic cancer|stage iv pancreatic cancer
5181401|NCT00897728|stage IA breast cancer|stage ia breast cancer
5181402|NCT00897728|stage IB breast cancer|stage ib breast cancer
5181403|NCT00897728|stage II breast cancer|stage ii breast cancer
5181404|NCT00897728|stage IIIA breast cancer|stage iiia breast cancer
5181405|NCT00897728|stage IIIB breast cancer|stage iiib breast cancer
5181406|NCT00897728|stage IIIC breast cancer|stage iiic breast cancer
5181407|NCT00897728|HER2-positive breast cancer|her2-positive breast cancer
5181408|NCT00897728|triple-negative breast cancer|triple-negative breast cancer
5181409|NCT00897728|estrogen receptor-negative breast cancer|estrogen receptor-negative breast cancer
5181410|NCT00897715|CKD|ckd
5181411|NCT00897715|inflammation|inflammation
5181412|NCT00897715|CVD|cvd
5181413|NCT00897702|recurrent breast cancer|recurrent breast cancer
5181414|NCT00897702|male breast cancer|male breast cancer
5181415|NCT00897702|stage IV breast cancer|stage iv breast cancer
5181416|NCT00897676|Hyperinsulinism|hyperinsulinism
5181417|NCT00897676|Hypoglycemia|hypoglycemia
5181418|NCT00897676|KATP channel|katp channel
5181419|NCT00897663|adult giant cell glioblastoma|adult giant cell glioblastoma
5181420|NCT00897663|adult gliosarcoma|adult gliosarcoma
5181421|NCT00897663|adult glioblastoma|adult glioblastoma
5181422|NCT00897650|lung cancer|lung cancer
5181423|NCT00897624|metastatic intraocular melanoma|metastatic intraocular melanoma
5181424|NCT00897624|ciliary body and choroid melanoma, medium/large size|ciliary body and choroid melanoma, medium/large size
5181425|NCT00897624|ciliary body and choroid melanoma, small size|ciliary body and choroid melanoma, small size
5181426|NCT00897611|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5181427|NCT00897611|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
5181428|NCT00897611|adult giant cell glioblastoma|adult giant cell glioblastoma
5181429|NCT00897611|recurrent adult brain tumor|recurrent adult brain tumor
5181430|NCT00897611|adult glioblastoma|adult glioblastoma
5181431|NCT00897611|adult gliosarcoma|adult gliosarcoma
5181432|NCT00897559|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
5181433|NCT00897546|recurrent melanoma|recurrent melanoma
5181434|NCT00897546|stage IV melanoma|stage iv melanoma
5181435|NCT00897546|stage IA melanoma|stage ia melanoma
5181436|NCT00897546|stage IB melanoma|stage ib melanoma
5181437|NCT00897546|stage IIA melanoma|stage iia melanoma
5181438|NCT00897546|stage IIB melanoma|stage iib melanoma
5181439|NCT00897546|stage IIC melanoma|stage iic melanoma
5181440|NCT00897546|stage IIIA melanoma|stage iiia melanoma
5181441|NCT00897546|stage IIIB melanoma|stage iiib melanoma
5181442|NCT00897546|stage IIIC melanoma|stage iiic melanoma
5181443|NCT00897533|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5181444|NCT00897533|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5181445|NCT00897533|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5181446|NCT00897533|adenocarcinoma of the lung|adenocarcinoma of the lung
5181447|NCT00897533|squamous cell lung cancer|squamous cell lung cancer
5181448|NCT00897533|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
5181449|NCT00897520|stage II melanoma|stage ii melanoma
5181450|NCT00897520|stage III melanoma|stage iii melanoma
5181451|NCT00897520|stage IV melanoma|stage iv melanoma
5181452|NCT00897507|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
5181453|NCT00897507|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5181454|NCT00897494|stage I pancreatic cancer|stage i pancreatic cancer
5181455|NCT00897494|stage II pancreatic cancer|stage ii pancreatic cancer
5181456|NCT00897494|stage III pancreatic cancer|stage iii pancreatic cancer
5181457|NCT00897494|stage IV pancreatic cancer|stage iv pancreatic cancer
5181458|NCT00897481|stage IV melanoma|stage iv melanoma
5181459|NCT00897481|recurrent melanoma|recurrent melanoma
5181460|NCT00897481|stage IA melanoma|stage ia melanoma
5181461|NCT00897481|stage IB melanoma|stage ib melanoma
5181462|NCT00897481|stage IIA melanoma|stage iia melanoma
5181463|NCT00897481|stage IIB melanoma|stage iib melanoma
5181464|NCT00897481|stage IIC melanoma|stage iic melanoma
5181465|NCT00897481|stage IIIA melanoma|stage iiia melanoma
5181466|NCT00897481|stage IIIB melanoma|stage iiib melanoma
5181467|NCT00897481|stage IIIC melanoma|stage iiic melanoma
5181468|NCT00897468|breast cancer|breast cancer
5181469|NCT00897455|breast cancer|breast cancer
5181470|NCT00897455|BRCA1 mutation carrier|brca1 mutation carrier
5181471|NCT00897455|BRCA2 mutation carrier|brca2 mutation carrier
5181472|NCT00897429|stage IIA colon cancer|stage iia colon cancer
5181473|NCT00897429|stage IIB colon cancer|stage iib colon cancer
5181474|NCT00897429|stage IIC colon cancer|stage iic colon cancer
5181475|NCT00897416|breast cancer|breast cancer
5181476|NCT00897416|stage I breast cancer|stage i breast cancer
5181477|NCT00897416|stage II breast cancer|stage ii breast cancer
5181478|NCT00897416|stage IIIA breast cancer|stage iiia breast cancer
5181479|NCT00897416|stage IIIB breast cancer|stage iiib breast cancer
5181480|NCT00897416|stage IIIC breast cancer|stage iiic breast cancer
5181481|NCT00897416|stage IV breast cancer|stage iv breast cancer
5181482|NCT00897403|colon cancer|colon cancer
5181483|NCT00897403|health status unknown|health status unknown
5181484|NCT00897364|non-small cell lung cancer|non-small cell lung cancer
5181485|NCT00897364|small cell lung cancer|small cell lung cancer
5181486|NCT00897364|squamous lung dysplasia|squamous lung dysplasia
5181487|NCT00897351|recurrent prostate cancer|recurrent prostate cancer
5181488|NCT00897338|stage IV breast cancer|stage iv breast cancer
5181489|NCT00897312|stage IV melanoma|stage iv melanoma
5181490|NCT00897312|hepatitis C infection|hepatitis c infection
5181491|NCT00897312|melanoma (skin)|melanoma (skin)
5181492|NCT00897312|precancerous/nonmalignant condition|precancerous/nonmalignant condition
5181493|NCT00897299|estrogen receptor|estrogen receptor
5181494|NCT00897299|HER-2|her-2
5181495|NCT00897299|PgR|pgr
5181496|NCT00897299|stage II breast cancer|stage ii breast cancer
5181497|NCT00897299|stage IIIA breast cancer|stage iiia breast cancer
5181498|NCT00897299|stage IIIB breast cancer|stage iiib breast cancer
5181499|NCT00897286|childhood atypical teratoid/rhabdoid tumor|childhood atypical teratoid/rhabdoid tumor
5181500|NCT00897286|childhood choroid plexus tumor|childhood choroid plexus tumor
5181501|NCT00897286|childhood medulloblastoma|childhood medulloblastoma
5181502|NCT00897286|recurrent childhood medulloblastoma|recurrent childhood medulloblastoma
5181503|NCT00897286|childhood infratentorial ependymoma|childhood infratentorial ependymoma
5181504|NCT00897286|childhood supratentorial ependymoma|childhood supratentorial ependymoma
5181505|NCT00897286|recurrent childhood ependymoma|recurrent childhood ependymoma
5181506|NCT00897286|recurrent childhood supratentorial primitive neuroectodermal tumor|recurrent childhood supratentorial primitive neuroectodermal tumor
5181507|NCT00897286|untreated childhood supratentorial primitive neuroectodermal tumor|untreated childhood supratentorial primitive neuroectodermal tumor
5181508|NCT00897286|gliomas|gliomas
5181509|NCT00897273|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
5181510|NCT00897273|oropharyngeal cancer|oropharyngeal cancer
5181511|NCT00897273|oropharyngeal squamous cell carcinoma|oropharyngeal squamous cell carcinoma
5181512|NCT00897273|infection|infection
5181513|NCT00897273|precancerous condition|precancerous condition
5181514|NCT00897273|human papilloma virus infection|human papilloma virus infection
5181515|NCT00897260|Unrelated Umbilical Cord Blood Transplant|unrelated umbilical cord blood transplant
5181516|NCT00897260|Multiple cord blood|multiple cord blood
5181517|NCT00897247|malignant mesothelioma|malignant mesothelioma
5181518|NCT00897247|pulmonary complications|pulmonary complications
5181519|NCT00897234|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5181520|NCT00897234|stage I non-small cell lung cancer|stage i non-small cell lung cancer
5181521|NCT00897234|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
5181522|NCT00897234|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5181523|NCT00897234|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5181524|NCT00897234|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5181525|NCT00897221|Friedreich's ataxia|friedreich's ataxia
5181526|NCT00897208|breast cancer|breast cancer
5181527|NCT00897208|ductal breast carcinoma in situ|ductal breast carcinoma in situ
5181528|NCT00897208|breast cancer in situ|breast cancer in situ
5181529|NCT00897208|stage IA breast cancer|stage ia breast cancer
5181530|NCT00897208|stage IB breast cancer|stage ib breast cancer
5181531|NCT00897208|stage II breast cancer|stage ii breast cancer
5181532|NCT00897182|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5181533|NCT00897182|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5181534|NCT00897182|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5181535|NCT00897182|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5181536|NCT00897182|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
5181537|NCT00897182|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5181538|NCT00897182|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5181539|NCT00897182|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5181540|NCT00897182|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
5181541|NCT00897182|untreated childhood acute myeloid leukemia and other myeloid malignancies|untreated childhood acute myeloid leukemia and other myeloid malignancies
5181542|NCT00897143|non-small cell lung cancer|non-small cell lung cancer
5181543|NCT00897143|malignant pleural effusion|malignant pleural effusion
5181544|NCT00897143|small cell lung cancer|small cell lung cancer
5181545|NCT00897130|low-risk (IPSS 0-INT1) MDS according to WHO classification|low-risk (ipss 0-int1) mds according to who classification
5181546|NCT00897117|stage I non-small cell lung cancer|stage i non-small cell lung cancer
5181547|NCT00897117|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
5181548|NCT00897091|stage II breast cancer|stage ii breast cancer
5181549|NCT00897091|stage IIIA breast cancer|stage iiia breast cancer
5181550|NCT00897078|cancer survivor|cancer survivor
5181551|NCT00897078|healthy, no evidence of disease|healthy, no evidence of disease
5181552|NCT00897078|long-term effects secondary to cancer therapy in children|long-term effects secondary to cancer therapy in children
5181553|NCT00897078|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
5181554|NCT00897065|stage IA breast cancer|stage ia breast cancer
5181555|NCT00897065|stage IB breast cancer|stage ib breast cancer
5181556|NCT00897065|stage II breast cancer|stage ii breast cancer
5181557|NCT00897065|stage IIIA breast cancer|stage iiia breast cancer
5181558|NCT00897065|estrogen receptor-positive breast cancer|estrogen receptor-positive breast cancer
5181559|NCT00897065|progesterone receptor-positive breast cancer|progesterone receptor-positive breast cancer
5181560|NCT00897052|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
5181561|NCT00897052|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
5181562|NCT00897052|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5181563|NCT00897052|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
5181564|NCT00897052|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
5181565|NCT00897052|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5181566|NCT00897052|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
5181567|NCT00897052|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
5181568|NCT00897052|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5181569|NCT00897052|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
5181570|NCT00897052|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
5181571|NCT00897052|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5181572|NCT00897039|ovarian serous cystadenocarcinoma|ovarian serous cystadenocarcinoma
5181573|NCT00897039|ovarian undifferentiated adenocarcinoma|ovarian undifferentiated adenocarcinoma
5181574|NCT00897039|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5181575|NCT00897039|ovarian clear cell cystadenocarcinoma|ovarian clear cell cystadenocarcinoma
5181576|NCT00897039|ovarian endometrioid adenocarcinoma|ovarian endometrioid adenocarcinoma
5181577|NCT00897039|ovarian mucinous cystadenocarcinoma|ovarian mucinous cystadenocarcinoma
5181578|NCT00897039|stage IA ovarian epithelial cancer|stage ia ovarian epithelial cancer
5181579|NCT00897039|stage IB ovarian epithelial cancer|stage ib ovarian epithelial cancer
5181580|NCT00897039|stage IC ovarian epithelial cancer|stage ic ovarian epithelial cancer
5181581|NCT00897039|stage IIA ovarian epithelial cancer|stage iia ovarian epithelial cancer
5181582|NCT00897039|stage IIB ovarian epithelial cancer|stage iib ovarian epithelial cancer
5181583|NCT00897039|stage IIC ovarian epithelial cancer|stage iic ovarian epithelial cancer
5181584|NCT00897039|stage IIIA ovarian epithelial cancer|stage iiia ovarian epithelial cancer
5181585|NCT00897039|stage IIIB ovarian epithelial cancer|stage iiib ovarian epithelial cancer
5181586|NCT00897039|stage IIIC ovarian epithelial cancer|stage iiic ovarian epithelial cancer
5181587|NCT00897039|recurrent primary peritoneal cavity cancer|recurrent primary peritoneal cavity cancer
5181588|NCT00897039|stage IA primary peritoneal cavity cancer|stage ia primary peritoneal cavity cancer
5181589|NCT00897039|stage IB primary peritoneal cavity cancer|stage ib primary peritoneal cavity cancer
5181590|NCT00897039|stage IC primary peritoneal cavity cancer|stage ic primary peritoneal cavity cancer
5181591|NCT00897039|stage IIA primary peritoneal cavity cancer|stage iia primary peritoneal cavity cancer
5181592|NCT00897039|stage IIB primary peritoneal cavity cancer|stage iib primary peritoneal cavity cancer
5181593|NCT00897039|stage IIC primary peritoneal cavity cancer|stage iic primary peritoneal cavity cancer
5181594|NCT00897039|stage IIIA primary peritoneal cavity cancer|stage iiia primary peritoneal cavity cancer
5181595|NCT00897039|stage IIIB primary peritoneal cavity cancer|stage iiib primary peritoneal cavity cancer
5181596|NCT00897039|stage IIIC primary peritoneal cavity cancer|stage iiic primary peritoneal cavity cancer
5181597|NCT00897039|recurrent fallopian tube cancer|recurrent fallopian tube cancer
5181598|NCT00897039|stage IA fallopian tube cancer|stage ia fallopian tube cancer
5181599|NCT00897039|stage IB fallopian tube cancer|stage ib fallopian tube cancer
5181600|NCT00897039|stage IC fallopian tube cancer|stage ic fallopian tube cancer
5181601|NCT00897039|stage IIA fallopian tube cancer|stage iia fallopian tube cancer
5181602|NCT00897039|stage IIB fallopian tube cancer|stage iib fallopian tube cancer
5181603|NCT00897039|stage IIC fallopian tube cancer|stage iic fallopian tube cancer
5181604|NCT00897039|stage IIIA fallopian tube cancer|stage iiia fallopian tube cancer
5181605|NCT00897039|stage IIIB fallopian tube cancer|stage iiib fallopian tube cancer
5181606|NCT00897039|stage IIIC fallopian tube cancer|stage iiic fallopian tube cancer
5181607|NCT00897026|stage II breast cancer|stage ii breast cancer
5181608|NCT00897026|stage IIIA breast cancer|stage iiia breast cancer
5181609|NCT00896987|Epilepsy|epilepsy
5181610|NCT00896987|lamotrigine|lamotrigine
5181611|NCT00896987|cognitive function|cognitive function
5181612|NCT00896948|head and neck cancer|head and neck cancer
5181613|NCT00896935|cancer|cancer
5181614|NCT00896922|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
5181615|NCT00896922|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
5181616|NCT00896922|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
5181617|NCT00896922|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5181618|NCT00896922|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5181619|NCT00896922|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5181620|NCT00896922|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5181621|NCT00896922|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5181622|NCT00896922|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5181623|NCT00896922|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5181624|NCT00896922|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5181625|NCT00896922|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5181626|NCT00896909|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5181627|NCT00896909|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5181628|NCT00896909|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5181629|NCT00896896|stage I squamous cell carcinoma of the hypopharynx|stage i squamous cell carcinoma of the hypopharynx
5181630|NCT00896896|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
5181631|NCT00896896|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
5181632|NCT00896896|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5181633|NCT00896896|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
5181634|NCT00896896|stage I squamous cell carcinoma of the larynx|stage i squamous cell carcinoma of the larynx
5181635|NCT00896896|stage I verrucous carcinoma of the larynx|stage i verrucous carcinoma of the larynx
5181636|NCT00896896|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
5181637|NCT00896896|stage II verrucous carcinoma of the larynx|stage ii verrucous carcinoma of the larynx
5181638|NCT00896896|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
5181639|NCT00896896|stage III verrucous carcinoma of the larynx|stage iii verrucous carcinoma of the larynx
5181640|NCT00896896|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5181641|NCT00896896|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
5181642|NCT00896896|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
5181643|NCT00896896|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
5181644|NCT00896896|stage I adenoid cystic carcinoma of the oral cavity|stage i adenoid cystic carcinoma of the oral cavity
5181645|NCT00896896|stage I basal cell carcinoma of the lip|stage i basal cell carcinoma of the lip
5181646|NCT00896896|stage I mucoepidermoid carcinoma of the oral cavity|stage i mucoepidermoid carcinoma of the oral cavity
5181647|NCT00896896|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
5181648|NCT00896896|stage I verrucous carcinoma of the oral cavity|stage i verrucous carcinoma of the oral cavity
5181649|NCT00896896|stage II adenoid cystic carcinoma of the oral cavity|stage ii adenoid cystic carcinoma of the oral cavity
5181650|NCT00896896|stage II basal cell carcinoma of the lip|stage ii basal cell carcinoma of the lip
5181651|NCT00896896|stage II mucoepidermoid carcinoma of the oral cavity|stage ii mucoepidermoid carcinoma of the oral cavity
5181652|NCT00896896|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
5181653|NCT00896896|stage II verrucous carcinoma of the oral cavity|stage ii verrucous carcinoma of the oral cavity
5181845|NCT00896467|extensive stage small cell lung cancer|extensive stage small cell lung cancer
5181654|NCT00896896|stage III adenoid cystic carcinoma of the oral cavity|stage iii adenoid cystic carcinoma of the oral cavity
5181655|NCT00896896|stage III basal cell carcinoma of the lip|stage iii basal cell carcinoma of the lip
5181656|NCT00896896|stage III mucoepidermoid carcinoma of the oral cavity|stage iii mucoepidermoid carcinoma of the oral cavity
5181657|NCT00896896|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
5181658|NCT00896896|stage III verrucous carcinoma of the oral cavity|stage iii verrucous carcinoma of the oral cavity
5181659|NCT00896896|stage IV adenoid cystic carcinoma of the oral cavity|stage iv adenoid cystic carcinoma of the oral cavity
5181660|NCT00896896|stage IV basal cell carcinoma of the lip|stage iv basal cell carcinoma of the lip
5181661|NCT00896896|stage IV mucoepidermoid carcinoma of the oral cavity|stage iv mucoepidermoid carcinoma of the oral cavity
5181662|NCT00896896|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5181663|NCT00896896|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
5181664|NCT00896896|recurrent adenoid cystic carcinoma of the oral cavity|recurrent adenoid cystic carcinoma of the oral cavity
5181665|NCT00896896|recurrent basal cell carcinoma of the lip|recurrent basal cell carcinoma of the lip
5181666|NCT00896896|recurrent mucoepidermoid carcinoma of the oral cavity|recurrent mucoepidermoid carcinoma of the oral cavity
5181667|NCT00896896|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
5181668|NCT00896896|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
5181669|NCT00896896|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
5181670|NCT00896896|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
5181671|NCT00896896|stage I lymphoepithelioma of the nasopharynx|stage i lymphoepithelioma of the nasopharynx
5181672|NCT00896896|stage I squamous cell carcinoma of the nasopharynx|stage i squamous cell carcinoma of the nasopharynx
5181673|NCT00896896|stage II lymphoepithelioma of the nasopharynx|stage ii lymphoepithelioma of the nasopharynx
5181674|NCT00896896|stage II squamous cell carcinoma of the nasopharynx|stage ii squamous cell carcinoma of the nasopharynx
5181675|NCT00896896|stage III lymphoepithelioma of the nasopharynx|stage iii lymphoepithelioma of the nasopharynx
5181676|NCT00896896|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
5181677|NCT00896896|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
5181678|NCT00896896|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
5181679|NCT00896896|recurrent lymphoepithelioma of the nasopharynx|recurrent lymphoepithelioma of the nasopharynx
5181680|NCT00896896|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
5181681|NCT00896896|stage I lymphoepithelioma of the oropharynx|stage i lymphoepithelioma of the oropharynx
5181682|NCT00896896|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
5181683|NCT00896896|stage II lymphoepithelioma of the oropharynx|stage ii lymphoepithelioma of the oropharynx
5181684|NCT00896896|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
5181685|NCT00896896|stage III lymphoepithelioma of the oropharynx|stage iii lymphoepithelioma of the oropharynx
5181686|NCT00896896|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
5181687|NCT00896896|stage IV lymphoepithelioma of the oropharynx|stage iv lymphoepithelioma of the oropharynx
5181688|NCT00896896|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5181689|NCT00896896|recurrent lymphoepithelioma of the oropharynx|recurrent lymphoepithelioma of the oropharynx
5181690|NCT00896896|stage I esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage i esthesioneuroblastoma of the paranasal sinus and nasal cavity
5181691|NCT00896896|stage I inverted papilloma of the paranasal sinus and nasal cavity|stage i inverted papilloma of the paranasal sinus and nasal cavity
5181692|NCT00896896|stage I midline lethal granuloma of the paranasal sinus and nasal cavity|stage i midline lethal granuloma of the paranasal sinus and nasal cavity
5181693|NCT00896896|stage I squamous cell carcinoma of the paranasal sinus and nasal cavity|stage i squamous cell carcinoma of the paranasal sinus and nasal cavity
5181694|NCT00896896|stage II esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage ii esthesioneuroblastoma of the paranasal sinus and nasal cavity
5181695|NCT00896896|stage II inverted papilloma of the paranasal sinus and nasal cavity|stage ii inverted papilloma of the paranasal sinus and nasal cavity
5181696|NCT00896896|stage II midline lethal granuloma of the paranasal sinus and nasal cavity|stage ii midline lethal granuloma of the paranasal sinus and nasal cavity
5181697|NCT00896896|stage II squamous cell carcinoma of the paranasal sinus and nasal cavity|stage ii squamous cell carcinoma of the paranasal sinus and nasal cavity
5181698|NCT00896896|stage III esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iii esthesioneuroblastoma of the paranasal sinus and nasal cavity
5181699|NCT00896896|stage III inverted papilloma of the paranasal sinus and nasal cavity|stage iii inverted papilloma of the paranasal sinus and nasal cavity
5181700|NCT00896896|stage III midline lethal granuloma of the paranasal sinus and nasal cavity|stage iii midline lethal granuloma of the paranasal sinus and nasal cavity
5181701|NCT00896896|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
5181702|NCT00896896|stage IV esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iv esthesioneuroblastoma of the paranasal sinus and nasal cavity
5181703|NCT00896896|stage IV inverted papilloma of the paranasal sinus and nasal cavity|stage iv inverted papilloma of the paranasal sinus and nasal cavity
5181846|NCT00896467|stage IV gastric cancer|stage iv gastric cancer
5181704|NCT00896896|stage IV midline lethal granuloma of the paranasal sinus and nasal cavity|stage iv midline lethal granuloma of the paranasal sinus and nasal cavity
5181705|NCT00896896|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
5181706|NCT00896896|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity
5181707|NCT00896896|recurrent inverted papilloma of the paranasal sinus and nasal cavity|recurrent inverted papilloma of the paranasal sinus and nasal cavity
5181708|NCT00896896|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity
5181709|NCT00896896|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
5181710|NCT00896896|stage I salivary gland cancer|stage i salivary gland cancer
5181711|NCT00896896|stage II salivary gland cancer|stage ii salivary gland cancer
5181712|NCT00896896|stage III salivary gland cancer|stage iii salivary gland cancer
5181713|NCT00896896|stage IV salivary gland cancer|stage iv salivary gland cancer
5181714|NCT00896896|recurrent salivary gland cancer|recurrent salivary gland cancer
5181715|NCT00896896|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
5181716|NCT00896896|recurrent colon cancer|recurrent colon cancer
5181717|NCT00896896|stage IV colon cancer|stage iv colon cancer
5181718|NCT00896896|recurrent rectal cancer|recurrent rectal cancer
5181719|NCT00896896|stage IV rectal cancer|stage iv rectal cancer
5181720|NCT00896896|adenocarcinoma of the colon|adenocarcinoma of the colon
5181721|NCT00896883|turbinate|turbinate
5181723|NCT00896883|sinus surgery|sinus surgery
5181724|NCT00896883|Turbinates|turbinates
5181725|NCT00896857|breast cancer|breast cancer
5181726|NCT00896857|ductal breast carcinoma in situ|ductal breast carcinoma in situ
5181727|NCT00896844|emotional disclosure|emotional disclosure
5181728|NCT00896844|expressive writing|expressive writing
5181729|NCT00896844|students|students
5181730|NCT00896831|minimal hepatic encephalopathy|minimal hepatic encephalopathy
5181731|NCT00896831|L-ornithine-L-aspartate|l-ornithine-l-aspartate
5181732|NCT00896831|psychometric test|psychometric test
5181733|NCT00896831|critical flicker frequency|critical flicker frequency
5181734|NCT00896831|quality of life|quality of life
5181735|NCT00896831|Treatment|treatment
5181736|NCT00896831|Health-related quality of life|health-related quality of life
5181737|NCT00896818|breast cancer|breast cancer
5181738|NCT00896792|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5181739|NCT00896792|hematopoietic/lymphoid cancer|hematopoietic/lymphoid cancer
5181740|NCT00896766|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
5181741|NCT00896766|B-cell childhood acute lymphoblastic leukemia|b-cell childhood acute lymphoblastic leukemia
5181742|NCT00896753|stage IV colon cancer|stage iv colon cancer
5181743|NCT00896753|liver metastases|liver metastases
5181744|NCT00896753|lung metastases|lung metastases
5181745|NCT00896753|recurrent colon cancer|recurrent colon cancer
5181746|NCT00896740|Fanconi anemia|fanconi anemia
5181747|NCT00896727|stage IA breast cancer|stage ia breast cancer
5181748|NCT00896727|stage IB breast cancer|stage ib breast cancer
5181749|NCT00896727|stage II breast cancer|stage ii breast cancer
5181750|NCT00896727|stage IIIA breast cancer|stage iiia breast cancer
5181751|NCT00896701|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5181752|NCT00896701|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5181753|NCT00896701|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5181754|NCT00896701|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5181755|NCT00896701|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5181756|NCT00896701|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5181757|NCT00896701|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5181758|NCT00896688|cervical branch block|cervical branch block
5181761|NCT00896675|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
5181762|NCT00896675|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5181763|NCT00896675|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
5181764|NCT00896675|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5181765|NCT00896675|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5181766|NCT00896675|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
5181767|NCT00896675|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
5181768|NCT00896675|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
5181769|NCT00896675|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
5181770|NCT00896675|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
5181771|NCT00896675|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
5181772|NCT00896675|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5181847|NCT00896467|stage IV anal cancer|stage iv anal cancer
5181773|NCT00896675|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
5181774|NCT00896675|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
5181775|NCT00896675|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
5181776|NCT00896675|stage IV salivary gland cancer|stage iv salivary gland cancer
5181777|NCT00896675|recurrent salivary gland cancer|recurrent salivary gland cancer
5181778|NCT00896662|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5181779|NCT00896662|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5181780|NCT00896662|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5181781|NCT00896662|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5181782|NCT00896662|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5181783|NCT00896662|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5181784|NCT00896662|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5181785|NCT00896662|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5181786|NCT00896662|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5181787|NCT00896662|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5181788|NCT00896662|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5181789|NCT00896662|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5181790|NCT00896662|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5181791|NCT00896662|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5181792|NCT00896662|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5181793|NCT00896662|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5181794|NCT00896662|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5181795|NCT00896662|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5181796|NCT00896662|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5181797|NCT00896662|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5181798|NCT00896662|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5181799|NCT00896662|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5181800|NCT00896662|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5181801|NCT00896662|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5181802|NCT00896662|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5181803|NCT00896662|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5181804|NCT00896662|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5181805|NCT00896662|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5181806|NCT00896649|breast cancer|breast cancer
5181807|NCT00896636|breast cancer|breast cancer
5181808|NCT00896636|healthy, no evidence of disease|healthy, no evidence of disease
5181809|NCT00896623|stage I breast cancer|stage i breast cancer
5181810|NCT00896623|stage II breast cancer|stage ii breast cancer
5181811|NCT00896610|Diabetes Mellitus|diabetes mellitus
5181812|NCT00896610|Type 1 Diabetes|type 1 diabetes
5181813|NCT00896610|Complications|complications
5181814|NCT00896610|Anti Beta-Cell Autoantibodies|anti beta-cell autoantibodies
5181815|NCT00896610|T-Lymphocyte Assays|t-lymphocyte assays
5181816|NCT00896610|Type 2 Diabetes|type 2 diabetes
5181817|NCT00896610|Autoimmune Diabetes|autoimmune diabetes
5181818|NCT00896610|At Risk Diabetes|at risk diabetes
5181819|NCT00896584|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
5181820|NCT00896584|Hypoxemia|hypoxemia
5181821|NCT00896584|Pre-flight evaluation|pre-flight evaluation
5181822|NCT00896584|Hypobaria|hypobaria
5181823|NCT00896584|COPD|copd
5181824|NCT00896584|Pulseoximetry|pulseoximetry
5181825|NCT00896584|Air travel|air travel
5181826|NCT00896584|Exercise desaturation|exercise desaturation
5181827|NCT00896571|Fertility control|fertility control
5181828|NCT00896571|Contraception|contraception
5181829|NCT00896558|GSK1322322, repeat dose, healthy subjects, elderly, drug-drug interaction, probe, midazolam, double-blind|gsk1322322, repeat dose, healthy subjects, elderly, drug-drug interaction, probe, midazolam, double-blind
5181830|NCT00896519|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5181831|NCT00896519|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5181832|NCT00896519|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5181833|NCT00896519|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5181834|NCT00896519|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5181835|NCT00896519|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5181836|NCT00896480|ASCI (Antigen-Specific Cancer Immunotherapeutic)|asci (antigen-specific cancer immunotherapeutic)
5181837|NCT00896480|Cancer immunotherapeutic|cancer immunotherapeutic
5181838|NCT00896480|Malignant melanoma|malignant melanoma
5181839|NCT00896480|MAGE-A3|mage-a3
5181840|NCT00896467|anxiety disorder|anxiety disorder
5181841|NCT00896467|depression|depression
5181842|NCT00896467|stage IV breast cancer|stage iv breast cancer
5181843|NCT00896467|stage IV renal cell cancer|stage iv renal cell cancer
5181844|NCT00896467|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5181848|NCT00896467|stage IV pancreatic cancer|stage iv pancreatic cancer
5181849|NCT00896467|stage IV esophageal cancer|stage iv esophageal cancer
5181850|NCT00896467|advanced adult primary liver cancer|advanced adult primary liver cancer
5181851|NCT00896467|unresectable gallbladder cancer|unresectable gallbladder cancer
5181852|NCT00896467|small intestine cancer|small intestine cancer
5181853|NCT00896454|hypercalcemia|hypercalcemia
5181854|NCT00896454|calcium|calcium
5181855|NCT00896454|bisphosphonates|bisphosphonates
5181856|NCT00896454|denosumab|denosumab
5181857|NCT00896454|amgen|amgen
5181858|NCT00896454|malignancy|malignancy
5181859|NCT00896454|20070315|20070315
5181860|NCT00896454|HMC|hmc
5181861|NCT00896454|oncology|oncology
5181862|NCT00896454|hematology|hematology
5181863|NCT00896428|Asthma|asthma
5181864|NCT00896428|gallopamil|gallopamil
5181865|NCT00896428|airway remodelling|airway remodelling
5181866|NCT00896428|smooth muscle|smooth muscle
5181867|NCT00896415|on two models of CT scanner acquire CT images of the abdomen pelvis and midthigh in 20 Postmenopausal female volunteers|on two models of ct scanner acquire ct images of the abdomen pelvis and midthigh in 20 postmenopausal female volunteers
5181868|NCT00896402|chloraprep|chloraprep
5181869|NCT00896402|betadine|betadine
5181870|NCT00896402|colonization|colonization
5181871|NCT00896402|femoral catheter|femoral catheter
5181872|NCT00896389|hypertension|hypertension
5181873|NCT00896389|hydrochlorothiazide|hydrochlorothiazide
5181874|NCT00896389|HCTZ|hctz
5181875|NCT00896389|Salt sensitivity|salt sensitivity
5181876|NCT00896389|Hydrochlorothiazide induced hyperglycemia|hydrochlorothiazide induced hyperglycemia
5181877|NCT00896376|stage IV breast cancer|stage iv breast cancer
5181878|NCT00896376|HER2-positive breast cancer|her2-positive breast cancer
5181879|NCT00896363|anti-depressant|anti-depressant
5181880|NCT00896363|Severe Depression|severe depression
5181881|NCT00896363|Efficacy|efficacy
5181882|NCT00896363|Major Depressive Disorder|major depressive disorder
5181883|NCT00896363|Major Depressive Episode|major depressive episode
5181884|NCT00896350|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
5181885|NCT00896350|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
5181886|NCT00896350|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
5181887|NCT00896350|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
5181888|NCT00896350|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
5181889|NCT00896350|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
5181890|NCT00896350|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5181891|NCT00896350|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5181892|NCT00896350|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5181893|NCT00896350|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
5181894|NCT00896350|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5181895|NCT00896350|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
5181896|NCT00896350|stage III lymphoepithelioma of the nasopharynx|stage iii lymphoepithelioma of the nasopharynx
5181897|NCT00896350|stage III lymphoepithelioma of the oropharynx|stage iii lymphoepithelioma of the oropharynx
5181898|NCT00896350|stage III verrucous carcinoma of the larynx|stage iii verrucous carcinoma of the larynx
5181899|NCT00896350|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
5181900|NCT00896350|stage IV lymphoepithelioma of the oropharynx|stage iv lymphoepithelioma of the oropharynx
5181901|NCT00896350|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
5181902|NCT00896350|stage III basal cell carcinoma of the lip|stage iii basal cell carcinoma of the lip
5181903|NCT00896350|stage IV basal cell carcinoma of the lip|stage iv basal cell carcinoma of the lip
5181904|NCT00896350|stage III esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iii esthesioneuroblastoma of the paranasal sinus and nasal cavity
5181905|NCT00896350|stage III inverted papilloma of the paranasal sinus and nasal cavity|stage iii inverted papilloma of the paranasal sinus and nasal cavity
5181906|NCT00896350|stage III midline lethal granuloma of the paranasal sinus and nasal cavity|stage iii midline lethal granuloma of the paranasal sinus and nasal cavity
5181907|NCT00896350|stage IV esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iv esthesioneuroblastoma of the paranasal sinus and nasal cavity
5181908|NCT00896350|stage IV inverted papilloma of the paranasal sinus and nasal cavity|stage iv inverted papilloma of the paranasal sinus and nasal cavity
5181909|NCT00896350|stage IV midline lethal granuloma of the paranasal sinus and nasal cavity|stage iv midline lethal granuloma of the paranasal sinus and nasal cavity
5181910|NCT00896350|tongue cancer|tongue cancer
5181911|NCT00896337|iliac artery stenosis|iliac artery stenosis
5181912|NCT00896337|claudication|claudication
5181913|NCT00896337|atherosclerotic iliac disease|atherosclerotic iliac disease
5181914|NCT00896337|peripheral vascular disease|peripheral vascular disease
5181915|NCT00896324|Quality of life|quality of life
5181916|NCT00896298|Lipodystrophy|lipodystrophy
5181917|NCT00896298|Insulin secretory response|insulin secretory response
5181918|NCT00896285|Pleural malignancy|pleural malignancy
5181919|NCT00896285|pleural effusion|pleural effusion
5181923|NCT00896285|cancer pain management|cancer pain management
5181924|NCT00896272|Klinefelter Syndrome|klinefelter syndrome
5181925|NCT00896272|47,XXY|47,xxy
5181926|NCT00896272|XXY|xxy
5181927|NCT00896259|Unilateral total hip arthroplasty|unilateral total hip arthroplasty
5181928|NCT00896233|Staging of liver fibrosis prior to clinical trials for treatment of Hepatitis C Virus|staging of liver fibrosis prior to clinical trials for treatment of hepatitis c virus
5181929|NCT00896220|chronic critical illness|chronic critical illness
5181930|NCT00896220|mechanical ventilation|mechanical ventilation
5181931|NCT00896220|outcomes|outcomes
5181932|NCT00896220|weakness|weakness
5181933|NCT00896220|quality of life|quality of life
5181934|NCT00896220|Critically Ill patients and their family caregiver|critically ill patients and their family caregiver
5181935|NCT00896194|Overweight|overweight
5181936|NCT00896194|Obesity|obesity
5181937|NCT00896194|Self-Efficacy|self-efficacy
5181938|NCT00896194|Treatment Adherence|treatment adherence
5181939|NCT00896168|Arthritis, Rheumatoid|arthritis, rheumatoid
5181940|NCT00896168|Infliximab|infliximab
5181941|NCT00896168|Methotrexate|methotrexate
5181942|NCT00896155|Breast cancer|breast cancer
5181943|NCT00896155|Pulmonary fibrosis|pulmonary fibrosis
5181944|NCT00896155|tamoxifen|tamoxifen
5181945|NCT00896155|radiotherapy|radiotherapy
5181946|NCT00896142|ischemic cardiomyopathy|ischemic cardiomyopathy
5181947|NCT00896142|cardiac resynchronization therapy|cardiac resynchronization therapy
5181948|NCT00896142|LV structure and function|lv structure and function
5181949|NCT00896129|Health Outcomes Research|health outcomes research
5181950|NCT00896129|CML|cml
5181951|NCT00896077|healthy subjects|healthy subjects
5181952|NCT00896064|Pneumococcal vaccine|pneumococcal vaccine
5181953|NCT00896064|Streptococcus pneumoniae|streptococcus pneumoniae
5181954|NCT00896064|Young adults|young adults
5181955|NCT00896051|HIV Infections|hiv infections
5181956|NCT00896051|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5181957|NCT00896051|TMC125-TiDP2-C238|tmc125-tidp2-c238
5181958|NCT00896051|TMC125-C238|tmc125-c238
5181959|NCT00896051|Etravirine|etravirine
5181960|NCT00896051|Intelence|intelence
5181961|NCT00896051|HIV|hiv
5181962|NCT00896051|HIV-1|hiv-1
5181963|NCT00896051|Pharmacokinetics|pharmacokinetics
5181964|NCT00896038|Alcohol Dependence|alcohol dependence
5181965|NCT00896038|Alcohol Treatment|alcohol treatment
5181966|NCT00896038|Alcoholics|alcoholics
5181967|NCT00896038|Alcoholism|alcoholism
5181968|NCT00896038|Posttraumatic Stress Disorder|posttraumatic stress disorder
5181969|NCT00896038|PTSD|ptsd
5181970|NCT00896025|Liver disease|liver disease
5181971|NCT00896012|Kidney Transplant|kidney transplant
5181972|NCT00896012|Immunosuppression drugs|immunosuppression drugs
5181973|NCT00896012|Rapamune|rapamune
5181974|NCT00896012|tacrolimus|tacrolimus
5181975|NCT00896012|calcineurin inhibitor|calcineurin inhibitor
5181976|NCT00896012|Kidney Biopsy, Needle|kidney biopsy, needle
5181977|NCT00895986|Diabetes|diabetes
5181978|NCT00895986|Education|education
5181979|NCT00895960|Brain|brain
5181980|NCT00895960|CNS Disease|cns disease
5181981|NCT00895960|CNS|cns
5181982|NCT00895960|Intracranial Supratentorial GBM|intracranial supratentorial gbm
5181983|NCT00895960|Gliosarcoma|gliosarcoma
5181984|NCT00895960|GS|gs
5181985|NCT00895960|Glioblastoma|glioblastoma
5181986|NCT00895960|GBM|gbm
5181987|NCT00895960|Dasatinib|dasatinib
5181988|NCT00895960|Sprycel|sprycel
5181989|NCT00895960|Temozolomide|temozolomide
5181990|NCT00895960|TMZ|tmz
5181991|NCT00895960|Temodar|temodar
5181992|NCT00895960|Radiation Therapy|radiation therapy
5181993|NCT00895960|Radiotherapy|radiotherapy
5181994|NCT00895960|RT|rt
5181995|NCT00895947|Prophylaxis|prophylaxis
5181996|NCT00895947|Treatment|treatment
5181997|NCT00895947|Symptoms|symptoms
5181998|NCT00895947|Winter Colds and Flu|winter colds and flu
5181999|NCT00895921|Insulin Resistance|insulin resistance
5182000|NCT00895921|Antipsychotic Medications|antipsychotic medications
5182001|NCT00895908|ADHD|adhd
5182002|NCT00895908|Psychosocial Intervention|psychosocial intervention
5182003|NCT00895908|Social Skills Training|social skills training
5182004|NCT00895869|Screening|screening
5182005|NCT00895869|Retinopathy|retinopathy
5182006|NCT00895869|Prematurity|prematurity
5182007|NCT00895869|Pain|pain
5182008|NCT00895856|Physiotherapy|physiotherapy
5182009|NCT00895856|Aged|aged
5182010|NCT00895856|Functionality|functionality
5182011|NCT00895856|Physiotherapic assistance|physiotherapic assistance
5182012|NCT00895856|Functional capacity|functional capacity
5182013|NCT00895843|Third molar|third molar
5182014|NCT00895817|Eosinophilic esophagitis|eosinophilic esophagitis
5182015|NCT00895817|acid reflux|acid reflux
5182016|NCT00895804|MDMA|mdma
5182017|NCT00895804|beta adrenergic|beta adrenergic
5182018|NCT00895804|Ecstasy|ecstasy
5182019|NCT00895791|coronary bifurcation|coronary bifurcation
5182020|NCT00895791|stent implantation|stent implantation
5182021|NCT00895791|PCI|pci
5182022|NCT00895791|Optical Coherence Tomography|optical coherence tomography
5182023|NCT00895778|Neuromuscular blockade|neuromuscular blockade
5182024|NCT00895778|post-operative pain|post-operative pain
5182025|NCT00895778|post-operative pulmonary function|post-operative pulmonary function
5182026|NCT00895765|Melamine|melamine
5182027|NCT00895765|Calculus|calculus
5182028|NCT00895765|Kidney|kidney
5182029|NCT00895765|Child|child
5182030|NCT00895739|aplastic anemia|aplastic anemia
5182031|NCT00895726|cachexia|cachexia
5182032|NCT00895726|neoplasms|neoplasms
5182033|NCT00895713|Hepatitis B|hepatitis b
5182034|NCT00895713|HBV|hbv
5182035|NCT00895713|Anti-hepatitis B antibodies|anti-hepatitis b antibodies
5182036|NCT00895713|Immunoglobulins|immunoglobulins
5182037|NCT00895713|liver transplantation|liver transplantation
5182038|NCT00895713|Protective levels|protective levels
5182039|NCT00895713|Recurrence|recurrence
5182040|NCT00895713|Intramuscular|intramuscular
5182041|NCT00895700|Anxiety|anxiety
5182042|NCT00895700|ICD concerns|icd concerns
5182043|NCT00895700|Quality of life|quality of life
5182044|NCT00895687|Metastatic Cancer|metastatic cancer
5182045|NCT00895687|Bortezomib|bortezomib
5182046|NCT00895687|Velcade|velcade
5182047|NCT00895687|Erlotinib|erlotinib
5182048|NCT00895687|Erlotinib Hydrochloride|erlotinib hydrochloride
5182049|NCT00895687|Tarceva|tarceva
5182050|NCT00895687|EGFR|egfr
5182051|NCT00895687|EGFR mutations|egfr mutations
5182052|NCT00895674|Advanced Renal Cell Carcinoma|advanced renal cell carcinoma
5182053|NCT00895661|rituximab|rituximab
5182054|NCT00895648|Meso|meso
5182055|NCT00895648|mesothelioma|mesothelioma
5182056|NCT00895648|pleura|pleura
5182057|NCT00895648|pleural|pleural
5182058|NCT00895635|Claudication|claudication
5182059|NCT00895635|Peripheral Arterial Disease|peripheral arterial disease
5182060|NCT00895635|Exercise Rehabilitation|exercise rehabilitation
5182061|NCT00895635|Cardiovascular Function|cardiovascular function
5182062|NCT00895622|adult grade I meningioma|adult grade i meningioma
5182063|NCT00895622|adult grade II meningioma|adult grade ii meningioma
5182064|NCT00895622|adult grade III meningioma|adult grade iii meningioma
5182065|NCT00895622|adult anaplastic meningioma|adult anaplastic meningioma
5182066|NCT00895622|adult papillary meningioma|adult papillary meningioma
5182067|NCT00895622|recurrent adult brain tumor|recurrent adult brain tumor
5182068|NCT00895609|Residual neuromuscular block|residual neuromuscular block
5182069|NCT00895609|post-operative residual curarization|post-operative residual curarization
5182070|NCT00895609|PORC|porc
5182071|NCT00895609|sugammadex|sugammadex
5182072|NCT00895609|neostigmine|neostigmine
5182073|NCT00895609|Shallow neuromuscular block (TOF-ratio of 0.5)|shallow neuromuscular block (tof-ratio of 0.5)
5182074|NCT00895596|Chronic hepatitis B|chronic hepatitis b
5182075|NCT00895596|Lamivudine resistant|lamivudine resistant
5182076|NCT00895596|YMDD mutant type|ymdd mutant type
5182077|NCT00895583|renal transplant|renal transplant
5182078|NCT00895583|immunosuppression|immunosuppression
5182079|NCT00895583|sirolimus/rapamune|sirolimus/rapamune
5182080|NCT00895583|planned transition|planned transition
5182081|NCT00895570|sleep restriction|sleep restriction
5182082|NCT00895570|glucose metabolism|glucose metabolism
5182083|NCT00895570|modafinil|modafinil
5182084|NCT00895570|euglycemic clamp|euglycemic clamp
5182085|NCT00895570|insulin sensitivity|insulin sensitivity
5182086|NCT00895570|insulin release|insulin release
5182087|NCT00895557|varenicline|varenicline
5182088|NCT00895557|cocaine|cocaine
5182089|NCT00895557|brain imaging|brain imaging
5182090|NCT00895531|Knee Replacement, Total|knee replacement, total
5182091|NCT00895531|Morphine|morphine
5182092|NCT00895518|PTSD|ptsd
5182093|NCT00895505|DVT|dvt
5182094|NCT00895505|Venous thromboembolism|venous thromboembolism
5182095|NCT00895505|D-Dimer|d-dimer
5182096|NCT00895505|thrombophilia|thrombophilia
5182097|NCT00895505|secondary prophylaxis|secondary prophylaxis
5182098|NCT00895505|secondary prophylaxis using oral anticoagulant treatment (OAT)|secondary prophylaxis using oral anticoagulant treatment (oat)
5182099|NCT00895505|higher risk of recurrence in patients showing increased levels|higher risk of recurrence in patients showing increased levels
5182100|NCT00895505|of D-Dimer after withdrawal of OAT|of d-dimer after withdrawal of oat
5182101|NCT00895505|D-Dimer-based treatment|d-dimer-based treatment
5182102|NCT00895492|diarrhea|diarrhea
5182103|NCT00895492|rotavirus|rotavirus
5182104|NCT00895492|genotype|genotype
5182105|NCT00895492|VP4|vp4
5182106|NCT00895492|VP7|vp7
5182107|NCT00895479|End Stage Renal Disease|end stage renal disease
5182108|NCT00895479|ESRD|esrd
5182109|NCT00895479|Hemodialysis|hemodialysis
5182110|NCT00895479|Access Graft|access graft
5182111|NCT00895466|prostatic diseases|prostatic diseases
5182112|NCT00895466|neoplasms|neoplasms
5182113|NCT00895466|prostatic neoplasms|prostatic neoplasms
5182114|NCT00895466|hormones|hormones
5182115|NCT00895466|androgen antagonists|androgen antagonists
5182116|NCT00895466|vaccines|vaccines
5182117|NCT00895466|peptide vaccines|peptide vaccines
5182118|NCT00895466|adjuvants, immunological|adjuvants, immunological
5182119|NCT00895453|recurrent vulvovaginal candidiasis|recurrent vulvovaginal candidiasis
5182120|NCT00895453|itraconazole|itraconazole
5182121|NCT00895453|classic homeopathy|classic homeopathy
5182122|NCT00895440|Diabetes|diabetes
5182123|NCT00895440|Diabetic neuropathy|diabetic neuropathy
5182124|NCT00895440|neuropad|neuropad
5182125|NCT00895440|Painless peripheral diabetic neuropathy|painless peripheral diabetic neuropathy
5182126|NCT00895440|Painful peripheral diabetic neuropathy|painful peripheral diabetic neuropathy
5182127|NCT00895440|Autonomic peripheral neuropathy|autonomic peripheral neuropathy
5182128|NCT00895440|Charcot neuroarthropathy|charcot neuroarthropathy
5182129|NCT00895427|Coronary artery calcification|coronary artery calcification
5182130|NCT00895414|stage I breast cancer|stage i breast cancer
5182131|NCT00895414|stage II breast cancer|stage ii breast cancer
5182132|NCT00895414|stage IIIA breast cancer|stage iiia breast cancer
5182133|NCT00895414|stage IIIB breast cancer|stage iiib breast cancer
5182134|NCT00895414|stage IIIC breast cancer|stage iiic breast cancer
5182135|NCT00895414|stage IV breast cancer|stage iv breast cancer
5182136|NCT00895401|Nutritional supplement|nutritional supplement
5182137|NCT00895401|Malnutrition|malnutrition
5182138|NCT00895401|Hemodialysis|hemodialysis
5182139|NCT00895401|Nepro with Carb Steady|nepro with carb steady
5182140|NCT00895388|Urinary function|urinary function
5182141|NCT00895388|Anal function|anal function
5182142|NCT00895375|Dermatology|dermatology
5182143|NCT00895375|Skin|skin
5182144|NCT00895375|Psoriasis|psoriasis
5182145|NCT00895375|Sleep|sleep
5182146|NCT00895375|Wake Forest|wake forest
5182147|NCT00895375|Insomnia|insomnia
5182148|NCT00895362|Advanced Cancer|advanced cancer
5182149|NCT00895362|EGFR mutation|egfr mutation
5182150|NCT00895362|Erlotinib|erlotinib
5182151|NCT00895362|Erlotinib Hydrochloride|erlotinib hydrochloride
5182152|NCT00895362|Tarceva|tarceva
5182153|NCT00895362|OSI-774|osi-774
5182154|NCT00895362|Cetuximab|cetuximab
5182155|NCT00895362|C225|c225
5182156|NCT00895362|Erbitux|erbitux
5182157|NCT00895362|IMC-C225|imc-c225
5182158|NCT00895349|Positron Emission Tomography (PET)|positron emission tomography (pet)
5182159|NCT00895349|Diagnostic Intervention|diagnostic intervention
5182160|NCT00895349|Locally Advanced Cervical Cancer|locally advanced cervical cancer
5182161|NCT00895336|Pediatric Ulcerative Colitis|pediatric ulcerative colitis
5182162|NCT00895323|stage I colon cancer|stage i colon cancer
5182163|NCT00895323|stage II colon cancer|stage ii colon cancer
5182164|NCT00895323|stage III colon cancer|stage iii colon cancer
5182165|NCT00895323|stage IV colon cancer|stage iv colon cancer
5182166|NCT00895323|stage I rectal cancer|stage i rectal cancer
5182167|NCT00895323|stage II rectal cancer|stage ii rectal cancer
5182168|NCT00895323|stage III rectal cancer|stage iii rectal cancer
5182169|NCT00895323|stage IV rectal cancer|stage iv rectal cancer
5182170|NCT00895323|recurrent colon cancer|recurrent colon cancer
5182171|NCT00895323|recurrent rectal cancer|recurrent rectal cancer
5182172|NCT00895310|PSA|psa
5182173|NCT00895310|Ketoconazole|ketoconazole
5182174|NCT00895310|Prostate Cancer|prostate cancer
5182175|NCT00895310|Hormone Refractory|hormone refractory
5182176|NCT00895310|Chemotherapy Regimen|chemotherapy regimen
5182177|NCT00895297|Relapsing after allogeneic transplantation|relapsing after allogeneic transplantation
5182178|NCT00895297|Dasatinib|dasatinib
5182179|NCT00895297|Sprycel|sprycel
5182180|NCT00895297|Philadelphia Chromosomes|philadelphia chromosomes
5182181|NCT00895284|robotic|robotic
5182182|NCT00895284|laparoscopic surgical procedures|laparoscopic surgical procedures
5182183|NCT00895271|Primary Immunodeficiency|primary immunodeficiency
5182184|NCT00895271|Immunodysregulation|immunodysregulation
5182185|NCT00895271|Skin Biopsy|skin biopsy
5182186|NCT00895271|Induced Pluripotent Stem Cell (iPS)|induced pluripotent stem cell (ips)
5182187|NCT00895271|Lymphocyte|lymphocyte
5182188|NCT00895271|Common Variable Immunodeficiency|common variable immunodeficiency
5182189|NCT00895271|Severe Combined Immunodeficiency|severe combined immunodeficiency
5182190|NCT00895271|Healthy Volunteer|healthy volunteer
5182191|NCT00895271|HV|hv
5182192|NCT00895258|Schizoaffective Disorder|schizoaffective disorder
5182193|NCT00895258|Major Depressive Disorder|major depressive disorder
5182194|NCT00895258|Supported Employment|supported employment
5182195|NCT00895258|Work|work
5182196|NCT00895258|Rehabilitation|rehabilitation
5182197|NCT00895258|Severe Mental Illness|severe mental illness
5182198|NCT00895258|Cognitive Training|cognitive training
5182199|NCT00895258|Cognitive Rehabilitation|cognitive rehabilitation
5182200|NCT00895258|Cognitive Remediation|cognitive remediation
5182201|NCT00895219|Hyperventilation|hyperventilation
5182202|NCT00895219|Dysfunctional breathing|dysfunctional breathing
5182203|NCT00895219|Physiotherapy|physiotherapy
5182204|NCT00895219|Musculoskeletal techniques|musculoskeletal techniques
5182205|NCT00895193|Niacin|niacin
5182206|NCT00895193|Hypercholesterolemia|hypercholesterolemia
5182207|NCT00895193|Flushing|flushing
5182208|NCT00895180|recurrent adult brain tumor|recurrent adult brain tumor
5182209|NCT00895180|adult glioblastoma|adult glioblastoma
5182210|NCT00895180|adult giant cell glioblastoma|adult giant cell glioblastoma
5182211|NCT00895180|adult gliosarcoma|adult gliosarcoma
5182212|NCT00895167|Heme Oxygenase|heme oxygenase
5182213|NCT00895167|Genetic Polymorphism|genetic polymorphism
5182214|NCT00895167|Healthy Subjects|healthy subjects
5182215|NCT00895154|Sickle Cell Disease|sickle cell disease
5182216|NCT00895154|Sickle Cell|sickle cell
5182217|NCT00895154|Memory|memory
5182218|NCT00895154|Learning|learning
5182219|NCT00895154|Achievement|achievement
5182220|NCT00895141|Saturated fat|saturated fat
5182221|NCT00895141|LDL size|ldl size
5182222|NCT00895141|Large LDL|large ldl
5182223|NCT00895141|Large HDL|large hdl
5182224|NCT00895128|Advanced Cancer|advanced cancer
5182225|NCT00895128|EGFR mutations|egfr mutations
5182226|NCT00895128|Dasatinib|dasatinib
5182227|NCT00895128|Sprycel|sprycel
5182228|NCT00895128|Erlotinib|erlotinib
5182229|NCT00895128|Erlotinib Hydrochloride|erlotinib hydrochloride
5182230|NCT00895128|Tarceva|tarceva
5182231|NCT00895115|prostate cancer|prostate cancer
5182232|NCT00895102|Bioavailability (BA)|bioavailability (ba)
5182233|NCT00895102|Single Ascending Dose (SAD)|single ascending dose (sad)
5182234|NCT00895089|liver abscess|liver abscess
5182235|NCT00895089|moxifloxacin|moxifloxacin
5182236|NCT00895089|ceftriaxone|ceftriaxone
5182237|NCT00895089|treatment|treatment
5182238|NCT00895063|Spasmodic Dysphonia|spasmodic dysphonia
5182239|NCT00895063|Botulinum Toxin|botulinum toxin
5182240|NCT00895063|Vocal Exercise|vocal exercise
5182241|NCT00895024|Caregiver|caregiver
5182242|NCT00895024|Questionnaire|questionnaire
5182243|NCT00895024|Home Hospice Care|home hospice care
5182244|NCT00895024|Family Evaluation of Hospice Care|family evaluation of hospice care
5182245|NCT00895024|FEHC|fehc
5182246|NCT00895024|The Texas Revised Inventory of Grief|the texas revised inventory of grief
5182247|NCT00895024|TRIG|trig
5182248|NCT00895024|Cross-ethnic differences|cross-ethnic differences
5182249|NCT00895024|Parenteral Hydration|parenteral hydration
5182250|NCT00895024|Grief|grief
5182251|NCT00895011|Erectile Dysfunction|erectile dysfunction
5182252|NCT00895011|E.D.|e.d.
5182253|NCT00894998|heparin cardiac surgery|heparin cardiac surgery
5182254|NCT00894985|heparin cardiac surgery|heparin cardiac surgery
5182255|NCT00894959|heparin cardiac surgery|heparin cardiac surgery
5182256|NCT00894946|recurrent IVF implantation failure|recurrent ivf implantation failure
5182257|NCT00894933|Prostate Cancer|prostate cancer
5182258|NCT00894933|Radical Prostatectomy|radical prostatectomy
5182259|NCT00894933|Vesico-Urethral Anastomosis|vesico-urethral anastomosis
5182260|NCT00894920|biotin|biotin
5182261|NCT00894920|deficiency|deficiency
5182262|NCT00894920|pregnancy|pregnancy
5182263|NCT00894920|lymphocyte propionyl-CoA carboxylase|lymphocyte propionyl-coa carboxylase
5182264|NCT00894907|Severe pancreatitis|severe pancreatitis
5182265|NCT00894907|acute pancreatitis|acute pancreatitis
5182266|NCT00894907|haemodynamic monitoring|haemodynamic monitoring
5182267|NCT00894907|PiCCO|picco
5182268|NCT00894894|MP470|mp470
5182269|NCT00894894|MP-470|mp-470
5182270|NCT00894894|SuperGen|supergen
5182271|NCT00894894|Tyrosine|tyrosine
5182272|NCT00894894|Kinase|kinase
5182273|NCT00894894|Inhibitor|inhibitor
5182274|NCT00894894|Solid Malignancies|solid malignancies
5182275|NCT00894894|Oncology|oncology
5182276|NCT00894881|colonoscopy|colonoscopy
5182277|NCT00894881|Healthy individuals before colonoscopy|healthy individuals before colonoscopy
5182278|NCT00894868|Congestive Heart Failure|congestive heart failure
5182279|NCT00894868|CHF, vildagliptin|chf, vildagliptin
5182280|NCT00894868|metabolic disease|metabolic disease
5182281|NCT00894868|cardiovascular disease|cardiovascular disease
5182282|NCT00894868|T2DM|t2dm
5182283|NCT00894855|skin cancer prevention|skin cancer prevention
5182284|NCT00894855|SHADE|shade
5182285|NCT00894855|Beach|beach
5182286|NCT00894842|Schizophrenia|schizophrenia
5182287|NCT00894842|Pregnenolone|pregnenolone
5182288|NCT00894842|Neurocognition|neurocognition
5182289|NCT00894829|heparin cardiac surgery|heparin cardiac surgery
5182290|NCT00894816|Prevention|prevention
5182291|NCT00894816|Probiotics|probiotics
5182292|NCT00894816|Eczema|eczema
5182293|NCT00894816|Allergy|allergy
5182294|NCT00894816|Asthma|asthma
5182295|NCT00894816|Obesity|obesity
5182296|NCT00894816|Caries|caries
5182297|NCT00894816|Gut microbiota|gut microbiota
5182298|NCT00894803|acute ischemic stroke|acute ischemic stroke
5182299|NCT00894803|stroke|stroke
5182300|NCT00894803|rt-PA, thrombolytic|rt-pa, thrombolytic
5182301|NCT00894803|t-PA|t-pa
5182302|NCT00894803|recombinant tissue plasminogen activator|recombinant tissue plasminogen activator
5182303|NCT00894803|Activase|activase
5182304|NCT00894803|eptifibatide|eptifibatide
5182305|NCT00894803|Integrilin|integrilin
5182306|NCT00894803|fibrinolytic agents|fibrinolytic agents
5182307|NCT00894803|clot dissolving|clot dissolving
5182308|NCT00894803|blood clot|blood clot
5182309|NCT00894790|Treatment of the acute pain due to cervical|treatment of the acute pain due to cervical
5182310|NCT00894790|sprain|sprain
5182311|NCT00894790|Celecoxib|celecoxib
5182312|NCT00894790|NSAID|nsaid
5182313|NCT00894790|Diclofenac|diclofenac
5182314|NCT00894777|Psoriasis|psoriasis
5182315|NCT00894764|Childhood|childhood
5182316|NCT00894764|Pneumonia|pneumonia
5182317|NCT00894764|Pneumococcal|pneumococcal
5182318|NCT00894764|pneumococcus|pneumococcus
5182319|NCT00894764|Carriage|carriage
5182320|NCT00894751|dexmedetomidine and propofol for MRI|dexmedetomidine and propofol for mri
5182321|NCT00894751|quality of care between two anesthetic agents for MRI|quality of care between two anesthetic agents for mri
5182322|NCT00894738|pediatric|pediatric
5182323|NCT00894738|mental illness|mental illness
5182324|NCT00894738|antipsychotic|antipsychotic
5182325|NCT00894738|cardiometabolic risk|cardiometabolic risk
5182326|NCT00894738|Antipsychotic agents|antipsychotic agents
5182327|NCT00894738|Mental disorders diagnosed in childhood|mental disorders diagnosed in childhood
5182328|NCT00894725|left colon cancer|left colon cancer
5182329|NCT00894712|Radiation Therapy|radiation therapy
5182330|NCT00894699|procedural sedation|procedural sedation
5182331|NCT00894673|heparin cardiac surgery|heparin cardiac surgery
5182332|NCT00894660|Bioequivalence, Healthy Volunteers|bioequivalence, healthy volunteers
5182333|NCT00894647|actinic keratosis|actinic keratosis
5182334|NCT00894647|skin disease|skin disease
5182335|NCT00894621|Shock|shock
5182336|NCT00894621|Respiration, artificial|respiration, artificial
5182337|NCT00894621|Norepinephrine|norepinephrine
5182338|NCT00894608|letrozole|letrozole
5182339|NCT00894608|ovarian stimulation|ovarian stimulation
5182340|NCT00894608|PCOS|pcos
5182341|NCT00894608|IVF-ET|ivf-et
5182342|NCT00894595|Incidence of ACL injury|incidence of acl injury
5182343|NCT00894595|Risk factors for ACL injury|risk factors for acl injury
5182344|NCT00894595|Prevention of ACL injury or any acute knee injury|prevention of acl injury or any acute knee injury
5182345|NCT00894582|massive ventral hernia|massive ventral hernia
5182346|NCT00894582|abdominal volume|abdominal volume
5182347|NCT00894582|pulmonary function|pulmonary function
5182348|NCT00894582|components separation|components separation
5182349|NCT00894582|abdominal compartments syndrome|abdominal compartments syndrome
5182350|NCT00894569|carcinoma of unknown primary|carcinoma of unknown primary
5182351|NCT00894569|cancer of unknown primary|cancer of unknown primary
5182353|NCT00894569|carboplatin|carboplatin
5182354|NCT00894569|paclitaxel|paclitaxel
5182355|NCT00894569|cetuximab|cetuximab
5182356|NCT00894556|Treatment of acute migraine with or without aura in adults|treatment of acute migraine with or without aura in adults
5182357|NCT00894543|Hot flashes|hot flashes
5182358|NCT00894543|Menopause|menopause
5182359|NCT00894543|Vasomotor symptoms|vasomotor symptoms
5182360|NCT00894504|Metastatic Breast Cancer|metastatic breast cancer
5182361|NCT00894504|Triple Negative|triple negative
5182362|NCT00894504|Panitumumab|panitumumab
5182363|NCT00894504|Vectibix|vectibix
5182364|NCT00894504|Gemcitabine|gemcitabine
5182365|NCT00894504|Gemzar|gemzar
5182366|NCT00894504|Carboplatin|carboplatin
5182367|NCT00894491|alternative medicine|alternative medicine
5182368|NCT00894491|complementary medicine|complementary medicine
5182369|NCT00894491|acupuncture|acupuncture
5182370|NCT00894491|Chinese herbals|chinese herbals
5182371|NCT00894478|MRI-Negative|mri-negative
5182372|NCT00894478|Diffusion tensor imaging|diffusion tensor imaging
5182373|NCT00894478|Localization-related epilepsy|localization-related epilepsy
5182374|NCT00894478|Partial Epilepsy|partial epilepsy
5182375|NCT00894478|Children|children
5182376|NCT00894465|Midazolam|midazolam
5182377|NCT00894465|VCUG|vcug
5182378|NCT00894465|Anxiety|anxiety
5182379|NCT00894452|Methadone|methadone
5182380|NCT00894452|CYP|cyp
5182381|NCT00894452|OPRM1|oprm1
5182382|NCT00894452|MDR1|mdr1
5182383|NCT00894452|COMT|comt
5182384|NCT00894452|Midazolam challenge|midazolam challenge
5182385|NCT00894426|COPD|copd
5182386|NCT00894426|Symptom|symptom
5182387|NCT00894426|Morning activity|morning activity
5182388|NCT00894426|Questionnaire|questionnaire
5182389|NCT00894400|AF|af
5182390|NCT00894400|catheter ablation|catheter ablation
5182391|NCT00894400|fractionated electrogram|fractionated electrogram
5182392|NCT00894400|complex fractionated atrial electrogram (CFAE)|complex fractionated atrial electrogram (cfae)
5182393|NCT00894387|elevated BNP|elevated bnp
5182394|NCT00894387|reduced LVEF|reduced lvef
5182395|NCT00894387|Acute Heart Failure|acute heart failure
5182396|NCT00894387|Cardiovascular death|cardiovascular death
5182397|NCT00894387|CHF|chf
5182398|NCT00894387|hospitalization|hospitalization
5182399|NCT00894387|morbi-mortality trial|morbi-mortality trial
5182400|NCT00894387|outcome study|outcome study
5182401|NCT00894387|endpoint driven|endpoint driven
5182402|NCT00894387|plasma renin activity|plasma renin activity
5182403|NCT00894387|renin angiotensin|renin angiotensin
5182404|NCT00894387|aldosterone system|aldosterone system
5182405|NCT00894387|direct renin inhibitors|direct renin inhibitors
5182406|NCT00894387|BNP|bnp
5182407|NCT00894387|KCCQ|kccq
5182408|NCT00894387|eGFR|egfr
5182409|NCT00894374|Bio-equivalence, Healthy Volunteers|bio-equivalence, healthy volunteers
5182410|NCT00894361|knee arthritis|knee arthritis
5182411|NCT00894361|total knee arthroplasty|total knee arthroplasty
5182412|NCT00894361|total knee replacement|total knee replacement
5182413|NCT00894361|mobile bearing design|mobile bearing design
5182414|NCT00894361|all-polyethylene tibia|all-polyethylene tibia
5182415|NCT00894348|ERCP|ercp
5182416|NCT00894348|Positive Biliary Brush Cytology|positive biliary brush cytology
5182417|NCT00894335|retroperitoneoscopic adrenalectomy|retroperitoneoscopic adrenalectomy
5182418|NCT00894335|intraoperative arterial-alveolar Carbon dioxide Difference|intraoperative arterial-alveolar carbon dioxide difference
5182419|NCT00894322|diabetes|diabetes
5182420|NCT00894322|exenatide once weekly|exenatide once weekly
5182421|NCT00894322|Byetta|byetta
5182422|NCT00894322|Amylin|amylin
5182423|NCT00894322|Lilly|lilly
5182424|NCT00894296|MEG|meg
5182425|NCT00894296|schizophrenia|schizophrenia
5182426|NCT00894296|negative symptoms|negative symptoms
5182427|NCT00894283|DVT|dvt
5182428|NCT00894283|PE|pe
5182429|NCT00894283|MRV|mrv
5182430|NCT00894283|bariatric surgery|bariatric surgery
5182431|NCT00894270|Diabetes|diabetes
5182432|NCT00894270|Injection|injection
5182433|NCT00894270|Needle|needle
5182434|NCT00894257|HCV infected pregnant women|hcv infected pregnant women
5182435|NCT00894244|None- Normal healthy upper arm skin will be used.|none- normal healthy upper arm skin will be used.
5182436|NCT00894205|neuropsychological function|neuropsychological function
5182437|NCT00894205|cognitive function|cognitive function
5182438|NCT00894205|exercise|exercise
5182439|NCT00894205|older adult|older adult
5182440|NCT00894192|This study tests functional ability of patients with refractive error or normal vision while using different types of eyeglasses.|this study tests functional ability of patients with refractive error or normal vision while using different types of eyeglasses.
5182441|NCT00894179|coronary artery disease|coronary artery disease
5182442|NCT00894179|stress echocardiography|stress echocardiography
5182443|NCT00894179|regadenoson|regadenoson
5182444|NCT00894179|atropine|atropine
5182445|NCT00894179|coronary angiogram|coronary angiogram
5182446|NCT00894166|Smoking Cessation|smoking cessation
5182447|NCT00894166|Chantix|chantix
5182448|NCT00894166|varenicline|varenicline
5182449|NCT00894166|Nicotine Replacement Therapy|nicotine replacement therapy
5182450|NCT00894166|Nicotine Patches|nicotine patches
5182451|NCT00894166|Zyban|zyban
5182452|NCT00894166|bupropion|bupropion
5182453|NCT00894166|Quit Smoking|quit smoking
5182454|NCT00894153|p53 gene|p53 gene
5182455|NCT00894153|head and neck malignent tumors|head and neck malignent tumors
5182456|NCT00894153|gene therapy|gene therapy
5182457|NCT00894140|Hip|hip
5182458|NCT00894140|Cementless|cementless
5182459|NCT00894140|Conservative|conservative
5182460|NCT00894127|Lung Cancer|lung cancer
5182461|NCT00894127|Porphyrin|porphyrin
5182462|NCT00894127|Fluorescence|fluorescence
5182463|NCT00894127|Diagnostic|diagnostic
5182464|NCT00894127|Sputum Cytology|sputum cytology
5182465|NCT00894127|Early Detection|early detection
5182466|NCT00894075|genetic metabolic disorder|genetic metabolic disorder
5182467|NCT00894075|alkaline phosphatase|alkaline phosphatase
5182468|NCT00894075|tissue non-specific alkaline phosphatase|tissue non-specific alkaline phosphatase
5182469|NCT00894075|rickets|rickets
5182470|NCT00894075|osteomalacia|osteomalacia
5182471|NCT00894036|esbl children Switzerland|esbl children switzerland
5182472|NCT00894036|Colonization|colonization
5182473|NCT00894036|ESBL-producing gram-negative bacilli|esbl-producing gram-negative bacilli
5182474|NCT00894036|Infection|infection
5182475|NCT00894023|Patients with AMI|patients with ami
5182476|NCT00894010|Photosensitive epilepsy|photosensitive epilepsy
5182477|NCT00894010|Photosensitivity|photosensitivity
5182478|NCT00894010|Seizures|seizures
5182479|NCT00894010|Epilepsy|epilepsy
5182480|NCT00893997|myelodysplastic syndrome|myelodysplastic syndrome
5182481|NCT00893997|MDS|mds
5182482|NCT00893997|PR1 Peptide Vaccine|pr1 peptide vaccine
5182483|NCT00893984|Intolerance|intolerance
5182484|NCT00893984|Beta blocker|beta blocker
5182485|NCT00893971|Healthy Volunteers|healthy volunteers
5182486|NCT00893932|SIRS leptin outcome sepsis|sirs leptin outcome sepsis
5182487|NCT00893906|influenza|influenza
5182488|NCT00893906|influenza vaccine|influenza vaccine
5182489|NCT00893906|vaccine effectiveness|vaccine effectiveness
5182490|NCT00893906|cluster randomized|cluster randomized
5182491|NCT00893906|Africa|africa
5182492|NCT00893893|Obesity|obesity
5182493|NCT00893893|Lipid metabolism|lipid metabolism
5182494|NCT00893893|VLDL|vldl
5182495|NCT00893880|Tinea Pedis|tinea pedis
5182496|NCT00893880|Athletes Foot|athletes foot
5182497|NCT00893880|Nitric Oxide|nitric oxide
5182498|NCT00893867|acute ischemic stroke|acute ischemic stroke
5182499|NCT00893867|neuroprotective agent|neuroprotective agent
5182500|NCT00893841|bipolar|bipolar
5182501|NCT00893841|bipolar depression|bipolar depression
5182502|NCT00893841|bipolar disorder|bipolar disorder
5182503|NCT00893841|depression|depression
5182504|NCT00893841|quetiapine|quetiapine
5182505|NCT00893841|pramipexole|pramipexole
5182506|NCT00893841|Seroquel XR|seroquel xr
5182507|NCT00893841|Mirapex|mirapex
5182508|NCT00893815|HIV|hiv
5182509|NCT00893815|Neurocognitive function|neurocognitive function
5182510|NCT00893802|periodontal disease|periodontal disease
5182511|NCT00893802|pregnancy|pregnancy
5182512|NCT00893802|periodontal treatment|periodontal treatment
5182513|NCT00893763|Nosocomial (Hospital-Acquired) Infections|nosocomial (hospital-acquired) infections
5182514|NCT00893763|Ventilator-Associated Pneumonia|ventilator-associated pneumonia
5182515|NCT00893763|Mechanical ventilation|mechanical ventilation
5182516|NCT00893763|Endotracheal intubation|endotracheal intubation
5182517|NCT00893750|Vulnerable Youths in Northern Uganda|vulnerable youths in northern uganda
5182518|NCT00893750|Formerly Abducted Children|formerly abducted children
5182519|NCT00893750|Reintegration and Reconciliation|reintegration and reconciliation
5182520|NCT00893750|Trauma Treatment|trauma treatment
5182521|NCT00893750|Narrative Exposure Therapy|narrative exposure therapy
5182522|NCT00893750|Reconciliation|reconciliation
5182523|NCT00893750|Revenge Feelings|revenge feelings
5182524|NCT00893737|Migraine|migraine
5182525|NCT00893737|Headache, Migraine|headache, migraine
5182526|NCT00893724|DME|dme
5182527|NCT00893724|NAMD|namd
5182528|NCT00893724|Oxidative damage|oxidative damage
5182529|NCT00893724|Nutritional supplements/vitamins|nutritional supplements/vitamins
5182530|NCT00893724|DNA repair|dna repair
5182531|NCT00893724|NAMD/wet AMD|namd/wet amd
5182532|NCT00893711|infantile colic|infantile colic
5182533|NCT00893711|lactobacillus|lactobacillus
5182534|NCT00893711|gut microflora|gut microflora
5182535|NCT00893711|FISH|fish
5182536|NCT00893711|toll like receptor|toll like receptor
5182537|NCT00893711|T reg|t reg
5182538|NCT00893685|Telemedicine|telemedicine
5182539|NCT00893672|Radiography, Thoracic|radiography, thoracic
5182540|NCT00893672|Intensive Care Units|intensive care units
5182541|NCT00893672|Ventilation, mechanical|ventilation, mechanical
5182542|NCT00893672|Matched-Pair Analysis|matched-pair analysis
5182543|NCT00893659|Beta-glucan|beta-glucan
5182544|NCT00893659|faecal microflora|faecal microflora
5182545|NCT00893659|polypectomized|polypectomized
5182546|NCT00893659|Precancerous Nonmalignant Condition|precancerous nonmalignant condition
5182547|NCT00893646|abdominal obesity|abdominal obesity
5182548|NCT00893646|weight reduction|weight reduction
5182549|NCT00893646|diet|diet
5182550|NCT00893646|exercise training|exercise training
5182551|NCT00893646|lifestyle activity|lifestyle activity
5182552|NCT00893646|health-related fitness|health-related fitness
5182553|NCT00893646|walking|walking
5182554|NCT00893646|actigraphy|actigraphy
5182555|NCT00893646|lifestyle modification|lifestyle modification
5182556|NCT00893646|sleep|sleep
5182557|NCT00893646|sleep hygiene|sleep hygiene
5182558|NCT00893646|alertness|alertness
5182559|NCT00893646|daytime sleepiness|daytime sleepiness
5182560|NCT00893646|metabolic syndrome|metabolic syndrome
5182561|NCT00893646|counselling|counselling
5182562|NCT00893646|health education|health education
5182563|NCT00893646|truck drivers|truck drivers
5182564|NCT00893646|bus drivers|bus drivers
5182565|NCT00893646|randomized controlled trial|randomized controlled trial
5182566|NCT00893633|neuromuscular diseases|neuromuscular diseases
5182567|NCT00893633|critical illness|critical illness
5182568|NCT00893633|mechanical ventilation|mechanical ventilation
5182569|NCT00893633|phrenic nerve|phrenic nerve
5182570|NCT00893633|nerve conduction studies|nerve conduction studies
5182571|NCT00893620|iliac aneurysm|iliac aneurysm
5182572|NCT00893620|endovascular repair|endovascular repair
5182573|NCT00893594|migraine|migraine
5182574|NCT00893594|migraine with aura|migraine with aura
5182575|NCT00893594|headache|headache
5182576|NCT00893581|mania|mania
5182577|NCT00893581|adolescent|adolescent
5182578|NCT00893581|bipolar|bipolar
5182579|NCT00893568|Post traumatic stress disorder PTSD|post traumatic stress disorder ptsd
5182580|NCT00893555|Invasive fungal infection|invasive fungal infection
5182581|NCT00893555|hematological malignancy|hematological malignancy
5182582|NCT00893555|voriconazole|voriconazole
5182583|NCT00893555|therapeutic drug monitoring|therapeutic drug monitoring
5182584|NCT00893529|overweight|overweight
5182585|NCT00893529|children|children
5182586|NCT00893529|intervention|intervention
5182587|NCT00893529|sugar-sweetened beverages|sugar-sweetened beverages
5182588|NCT00893516|non cutaneous peripheral t-cell lymphoma with nodal involvement|non cutaneous peripheral t-cell lymphoma with nodal involvement
5182589|NCT00893477|stage II grade 1 follicular lymphoma|stage ii grade 1 follicular lymphoma
5182590|NCT00893477|stage II grade 2 follicular lymphoma|stage ii grade 2 follicular lymphoma
5182591|NCT00893477|stage II grade 3 follicular lymphoma|stage ii grade 3 follicular lymphoma
5182592|NCT00893477|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5182593|NCT00893477|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5182594|NCT00893477|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5182595|NCT00893477|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5182596|NCT00893477|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5182597|NCT00893477|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5182598|NCT00893451|renal disease|renal disease
5182599|NCT00893451|renal impairment|renal impairment
5182600|NCT00893451|chronic kidney disease stage 3-4|chronic kidney disease stage 3-4
5182601|NCT00893451|25(OH) vitamin D|25(oh) vitamin d
5182602|NCT00893451|cholecalciferol|cholecalciferol
5182603|NCT00893451|vitamin D deficiency|vitamin d deficiency
5182604|NCT00893451|insulin resistance|insulin resistance
5182605|NCT00893451|insulin-glucose clamp|insulin-glucose clamp
5182606|NCT00893451|non-diabetic|non-diabetic
5182607|NCT00893438|Chronic Fatigue Syndrome (CFS)|chronic fatigue syndrome (cfs)
5182608|NCT00893438|Adolescence|adolescence
5182609|NCT00893438|Cognitive behaviour therapy (CBT)|cognitive behaviour therapy (cbt)
5182610|NCT00893438|Web-based|web-based
5182611|NCT00893438|Internet|internet
5182612|NCT00893438|Efficacy|efficacy
5182613|NCT00893425|CD95|cd95
5182614|NCT00893425|ADMA|adma
5182615|NCT00893425|proteinuria|proteinuria
5182616|NCT00893425|diabetic nephropathy|diabetic nephropathy
5182617|NCT00893425|CD95 and ADMA levels|cd95 and adma levels
5182619|NCT00893412|analgesia|analgesia
5182620|NCT00893412|tramadol|tramadol
5182621|NCT00893412|metal cannula|metal cannula
5182622|NCT00893412|balloon catheter|balloon catheter
5182623|NCT00893399|adult patients|adult patients
5182624|NCT00893399|NPM1 mutation|npm1 mutation
5182625|NCT00893386|Extraction|extraction
5182626|NCT00893386|Removal|removal
5182627|NCT00893386|Lead|lead
5182628|NCT00893386|Heart Failure|heart failure
5182629|NCT00893373|AML|aml
5182630|NCT00893373|sorafenib|sorafenib
5182631|NCT00893360|Adult Stem cells|adult stem cells
5182632|NCT00893360|Cardiosphere derived stem cells|cardiosphere derived stem cells
5182633|NCT00893360|Myocardial infarction|myocardial infarction
5182634|NCT00893347|Mild traumatic brain injury|mild traumatic brain injury
5182635|NCT00893347|Concussion|concussion
5182636|NCT00893347|Post-Concussion Syndrome|post-concussion syndrome
5182637|NCT00893347|Cognitive-Behavioural Therapy|cognitive-behavioural therapy
5182638|NCT00893334|Duchenne and Becker muscular dystrophy|duchenne and becker muscular dystrophy
5182639|NCT00893334|muscular dystrophy|muscular dystrophy
5182640|NCT00893295|colon cancer|colon cancer
5182641|NCT00893295|rectal cancer|rectal cancer
5182642|NCT00893282|renal|renal
5182643|NCT00893282|calculi|calculi
5182644|NCT00893282|kidney|kidney
5182645|NCT00893282|stones|stones
5182646|NCT00893269|marijuana|marijuana
5182647|NCT00893269|cannabis|cannabis
5182648|NCT00893269|dependence|dependence
5182649|NCT00893269|withdrawal|withdrawal
5182650|NCT00893256|schizophrenia|schizophrenia
5182651|NCT00893256|risperidone|risperidone
5182652|NCT00893256|citalopram|citalopram
5182653|NCT00893256|secondary negative symptoms|secondary negative symptoms
5182654|NCT00893230|atopic dermatitis|atopic dermatitis
5182655|NCT00893230|chemokines|chemokines
5182656|NCT00893230|probiotics|probiotics
5182657|NCT00893178|eNOS Polymorphism|enos polymorphism
5182658|NCT00893178|TNF alpha polymorphism|tnf alpha polymorphism
5182659|NCT00893178|pulmonary pressure|pulmonary pressure
5182660|NCT00893178|polymorphism of vasoactive substances|polymorphism of vasoactive substances
5182661|NCT00893165|inflammation|inflammation
5182662|NCT00893165|cardiovascular disease|cardiovascular disease
5182663|NCT00893139|Dry Eye|dry eye
5182664|NCT00893126|psoriasis|psoriasis
5182665|NCT00893126|coronary arteriosclerosis|coronary arteriosclerosis
5182666|NCT00893126|coronary events|coronary events
5182667|NCT00893126|rheumatoid arthritis|rheumatoid arthritis
5182668|NCT00893126|arthritis|arthritis
5182669|NCT00893087|Ventilatory care, children, intensive care, asynchrony, triggering|ventilatory care, children, intensive care, asynchrony, triggering
5182670|NCT00893087|Children needing ventilatory care|children needing ventilatory care
5182671|NCT00893074|withdrawal|withdrawal
5182672|NCT00893074|acute effects|acute effects
5182673|NCT00893074|cognitive performance|cognitive performance
5182674|NCT00893074|Marijuana Use|marijuana use
5182675|NCT00893074|Marijuana Abstinence|marijuana abstinence
5182676|NCT00893061|stage IA breast cancer|stage ia breast cancer
5182677|NCT00893061|stage IB breast cancer|stage ib breast cancer
5182678|NCT00893061|stage II breast cancer|stage ii breast cancer
5182679|NCT00893061|stage IIIA breast cancer|stage iiia breast cancer
5182680|NCT00893061|stage IIIB breast cancer|stage iiib breast cancer
5182681|NCT00893061|stage IIIC breast cancer|stage iiic breast cancer
5182682|NCT00893061|estrogen receptor-positive breast cancer|estrogen receptor-positive breast cancer
5182683|NCT00893061|progesterone receptor-positive breast cancer|progesterone receptor-positive breast cancer
5182684|NCT00893048|prednisone|prednisone
5182685|NCT00893048|cellulitis|cellulitis
5182686|NCT00893048|erysipelas|erysipelas
5182687|NCT00893048|steroids|steroids
5182688|NCT00893048|oral|oral
5182689|NCT00893035|Radiotherapy|radiotherapy
5182690|NCT00893035|Late side effects|late side effects
5182691|NCT00893035|Predictive assay|predictive assay
5182692|NCT00893009|Forced expiratory volume in one second|forced expiratory volume in one second
5182693|NCT00893009|Inspiratory capacity|inspiratory capacity
5182694|NCT00893009|endurance time|endurance time
5182695|NCT00893009|residual volume|residual volume
5182696|NCT00892996|Intrathecal morphine|intrathecal morphine
5182697|NCT00892996|Cesarean section|cesarean section
5182698|NCT00892996|Nausea and vomiting|nausea and vomiting
5182699|NCT00892996|Prevention|prevention
5182700|NCT00892983|Obesity|obesity
5182701|NCT00892983|Sleep|sleep
5182702|NCT00892983|Physical activity|physical activity
5182703|NCT00892983|Breast feeding|breast feeding
5182704|NCT00892983|Depression|depression
5182705|NCT00892957|Vascular Surgery|vascular surgery
5182706|NCT00892957|Arterio-arterial bypasses|arterio-arterial bypasses
5182707|NCT00892957|Arterio-venous (AV) shunts|arterio-venous (av) shunts
5182708|NCT00892944|Positron Emission Tomography|positron emission tomography
5182709|NCT00892944|Phase 1|phase 1
5182710|NCT00892944|Healthy volunteers|healthy volunteers
5182711|NCT00892944|AZD2516|azd2516
5182712|NCT00892931|Glioblastoma|glioblastoma
5182713|NCT00892931|Brain Neoplasms|brain neoplasms
5182714|NCT00892931|Recurrence|recurrence
5182715|NCT00892918|pterygium|pterygium
5182716|NCT00892918|gatifloxacin|gatifloxacin
5182717|NCT00892918|moxifloxacin|moxifloxacin
5182718|NCT00892918|corneal epithelial defect|corneal epithelial defect
5182719|NCT00892905|coagulation|coagulation
5182720|NCT00892905|INR|inr
5182721|NCT00892905|aPTT|aptt
5182722|NCT00892905|point of care|point of care
5182723|NCT00892905|laboratory|laboratory
5182724|NCT00892905|CABG|cabg
5182725|NCT00892905|surgery|surgery
5182726|NCT00892892|sympatholytic treatment|sympatholytic treatment
5182727|NCT00892892|sympathetic nerve activity|sympathetic nerve activity
5182728|NCT00892853|calcification|calcification
5182729|NCT00892853|osteoporosis|osteoporosis
5182730|NCT00892827|Rituximab|rituximab
5182731|NCT00892827|Mabthera|mabthera
5182732|NCT00892827|FFP|ffp
5182733|NCT00892827|Fresh Frozen Plasma|fresh frozen plasma
5182734|NCT00892827|CLL|cll
5182735|NCT00892827|Complement|complement
5182736|NCT00892827|Response|response
5182737|NCT00892827|Overall response rate of FFP+Rituximab combined therapy|overall response rate of ffp+rituximab combined therapy
5182738|NCT00892827|Analysis of complement activation pathways prior to, during and|analysis of complement activation pathways prior to, during and
5182739|NCT00892827|after the study treatment.|after the study treatment.
5182740|NCT00892827|Time to disease progression|time to disease progression
5182741|NCT00892827|Time to re-treatment (See Appendix I).|time to re-treatment (see appendix i).
5182742|NCT00892827|Safety of the combination treatment of FFP and RTX.|safety of the combination treatment of ffp and rtx.
5182743|NCT00892801|tumors metastatic to brain|tumors metastatic to brain
5182744|NCT00892801|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5182745|NCT00892801|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5182746|NCT00892788|Overweight|overweight
5182747|NCT00892788|Obesity|obesity
5182748|NCT00892788|Contingency Management|contingency management
5182749|NCT00892775|Working seed virus|working seed virus
5182750|NCT00892775|Rubella|rubella
5182751|NCT00892775|Mumps|mumps
5182752|NCT00892775|Varicella|varicella
5182753|NCT00892775|Combined measles-mumps-rubella-varicella vaccine|combined measles-mumps-rubella-varicella vaccine
5182754|NCT00892775|Pediatric immunization|pediatric immunization
5182755|NCT00892775|Measles|measles
5182756|NCT00892762|Open Angle Glaucoma|open angle glaucoma
5182757|NCT00892762|Ocular hypertension|ocular hypertension
5182758|NCT00892762|OAG|oag
5182759|NCT00892762|OH|oh
5182760|NCT00892749|hyperphosphatemia|hyperphosphatemia
5182761|NCT00892749|hemodialysis|hemodialysis
5182762|NCT00892749|CKD|ckd
5182763|NCT00892749|ASP1585|asp1585
5182764|NCT00892723|AZX100|azx100
5182765|NCT00892723|Patient and Observer Scar Assessment Scale|patient and observer scar assessment scale
5182766|NCT00892723|POSAS|posas
5182767|NCT00892723|Visual Analog Scale|visual analog scale
5182768|NCT00892723|VAS|vas
5182769|NCT00892723|Keloid|keloid
5182770|NCT00892723|Scarring|scarring
5182771|NCT00892723|Scar reduction|scar reduction
5182772|NCT00892723|Scar prevention|scar prevention
5182773|NCT00892710|Non small cell lung cancer|non small cell lung cancer
5182774|NCT00892710|NSCLC|nsclc
5182775|NCT00892710|Pemetrexed|pemetrexed
5182776|NCT00892710|Bevacizumab|bevacizumab
5182777|NCT00892710|Avastin|avastin
5182778|NCT00892710|Carboplatin|carboplatin
5182779|NCT00892710|Stage IIIB/IV|stage iiib/iv
5182780|NCT00892697|hepatitis C|hepatitis c
5182781|NCT00892697|FNA|fna
5182782|NCT00892697|intrahepatic|intrahepatic
5182783|NCT00892684|Randomized|randomized
5182784|NCT00892684|Placebo controlled|placebo controlled
5182785|NCT00892684|Double blind|double blind
5182786|NCT00892684|Omega-3 fatty acids|omega-3 fatty acids
5182787|NCT00892684|Pregnancy|pregnancy
5182788|NCT00892684|Childhood allergy|childhood allergy
5182789|NCT00892684|Cytokines|cytokines
5182790|NCT00892684|Eicosanoids|eicosanoids
5182791|NCT00892684|Polyunsaturated fatty acids|polyunsaturated fatty acids
5182792|NCT00892671|Perceived effectiveness|perceived effectiveness
5182793|NCT00892658|Sorafenib|sorafenib
5182794|NCT00892658|Hepatocellular carcinoma|hepatocellular carcinoma
5182795|NCT00892632|Biliary Strictures|biliary strictures
5182796|NCT00892632|Cholangiocarcinoma|cholangiocarcinoma
5182797|NCT00892632|ERCP|ercp
5182798|NCT00892619|Epiretinal Membrane|epiretinal membrane
5182799|NCT00892619|Vitreomacular traction|vitreomacular traction
5182800|NCT00892619|MVR blade|mvr blade
5182801|NCT00892619|Tano brush|tano brush
5182802|NCT00892619|ILM forceps|ilm forceps
5182803|NCT00892619|surgical technique|surgical technique
5182804|NCT00892606|Surgery, Orthopedic|surgery, orthopedic
5182805|NCT00892606|Pain, Postoperative|pain, postoperative
5182806|NCT00892593|colon|colon
5182807|NCT00892593|neoplasia|neoplasia
5182808|NCT00892593|polyp|polyp
5182809|NCT00892593|adenoma|adenoma
5182810|NCT00892593|FIT|fit
5182811|NCT00892593|cancer|cancer
5182812|NCT00892580|fragile X syndrome|fragile x syndrome
5182813|NCT00892580|biomarkers|biomarkers
5182814|NCT00892567|breast cancer|breast cancer
5182815|NCT00892567|peptide vaccine|peptide vaccine
5182816|NCT00892567|immunotherapy|immunotherapy
5182817|NCT00892554|Phenylketonurias|phenylketonurias
5182818|NCT00892554|Docosahexaenoic Acids|docosahexaenoic acids
5182819|NCT00892554|Neuropsychological Tests|neuropsychological tests
5182820|NCT00892554|Female|female
5182821|NCT00892554|Adolescent|adolescent
5182822|NCT00892554|Adult|adult
5182823|NCT00892541|Schizophrenia|schizophrenia
5182824|NCT00892541|Mood disorders|mood disorders
5182825|NCT00892541|Antipsychotic drugs|antipsychotic drugs
5182826|NCT00892541|Renal secretion|renal secretion
5182827|NCT00892541|ER OROS paliperidone|er oros paliperidone
5182828|NCT00892515|breast cancer|breast cancer
5182829|NCT00892515|healthy, no evidence of disease|healthy, no evidence of disease
5182830|NCT00892502|haematology|haematology
5182831|NCT00892502|haematological|haematological
5182832|NCT00892502|hematology|hematology
5182833|NCT00892502|hematological|hematological
5182834|NCT00892502|malignancy|malignancy
5182835|NCT00892502|lymphoma|lymphoma
5182836|NCT00892502|myeloma|myeloma
5182837|NCT00892502|leukemia|leukemia
5182838|NCT00892502|blood diseases|blood diseases
5182839|NCT00892502|malignant|malignant
5182840|NCT00892502|bismuth|bismuth
5182841|NCT00892489|Schizophrenia, Mood disorders, Antipsychotics|schizophrenia, mood disorders, antipsychotics
5182842|NCT00892489|ER OROS Paliperidone|er oros paliperidone
5182843|NCT00892476|myopia|myopia
5182844|NCT00892476|calcium supplementation|calcium supplementation
5182845|NCT00892476|prematurity|prematurity
5182846|NCT00892463|Major Depressive Disorder|major depressive disorder
5182847|NCT00892463|Seroquel XR|seroquel xr
5182848|NCT00892463|Quetiapine|quetiapine
5182849|NCT00892450|Overactive bladder symptoms|overactive bladder symptoms
5182850|NCT00892450|Parkinson's disease|parkinson's disease
5182851|NCT00892450|darifenacin|darifenacin
5182852|NCT00892450|oxybutynin|oxybutynin
5182853|NCT00892450|cognition|cognition
5182854|NCT00892437|HIV|hiv
5182855|NCT00892437|HIV-1|hiv-1
5182856|NCT00892437|Antiretroviral Treatment-Naive|antiretroviral treatment-naive
5182857|NCT00892424|Liver metastasis|liver metastasis
5182858|NCT00892424|sorafenib|sorafenib
5182859|NCT00892424|Liver metastasis from cancer|liver metastasis from cancer
5182860|NCT00892411|Neuroplasticity|neuroplasticity
5182861|NCT00892411|Prognosis|prognosis
5182862|NCT00892398|Trabeculectomy|trabeculectomy
5182863|NCT00892398|Vascular Endothelial Growth Factor A|vascular endothelial growth factor a
5182864|NCT00892398|Wound Healing|wound healing
5182865|NCT00892398|Angiogenesis Inhibitors|angiogenesis inhibitors
5182866|NCT00892385|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5182867|NCT00892372|body weight|body weight
5182868|NCT00892372|glycohemoglobin|glycohemoglobin
5182869|NCT00892359|pharmacokinetics|pharmacokinetics
5182870|NCT00892359|renal replacement therapy|renal replacement therapy
5182871|NCT00892359|hemofiltration|hemofiltration
5182872|NCT00892359|anidulafungin|anidulafungin
5182873|NCT00892346|autologous hematopoietic stem cell transplantation|autologous hematopoietic stem cell transplantation
5182874|NCT00892346|maintenance|maintenance
5182875|NCT00892333|Repair of a large hernia with SurgiMend 3.0, a biologic mesh|repair of a large hernia with surgimend 3.0, a biologic mesh
5182876|NCT00892320|Schizophrenia, mood stabilizers, antipsychotics|schizophrenia, mood stabilizers, antipsychotics
5182877|NCT00892320|ER OROS paliperidone|er oros paliperidone
5182878|NCT00892307|Diagnostic Imaging|diagnostic imaging
5182879|NCT00892307|Dual Source Multidetector Computed Tomography|dual source multidetector computed tomography
5182880|NCT00892307|Computed Tomography|computed tomography
5182881|NCT00892307|CT|ct
5182882|NCT00892307|Single Photon Emission Computed Tomography|single photon emission computed tomography
5182883|NCT00892307|SPECT|spect
5182884|NCT00892307|Myocardial Perfusion|myocardial perfusion
5182885|NCT00892307|Atherosclerosis|atherosclerosis
5182886|NCT00892268|menopausal symptoms|menopausal symptoms
5182887|NCT00892268|estrogen receptor-positive breast cancer|estrogen receptor-positive breast cancer
5182888|NCT00892268|progesterone receptor-positive breast cancer|progesterone receptor-positive breast cancer
5182889|NCT00892268|breast cancer|breast cancer
5182890|NCT00892268|pain|pain
5182891|NCT00892255|Liver cancer|liver cancer
5182892|NCT00892255|Tumors|tumors
5182893|NCT00892242|Neoadjuvant zoledronic acid in resectable pancreas cancer|neoadjuvant zoledronic acid in resectable pancreas cancer
5182894|NCT00892229|First trimester missed abortion|first trimester missed abortion
5182895|NCT00892229|Misoprostol|misoprostol
5182896|NCT00892229|buccal|buccal
5182897|NCT00892229|vaginal|vaginal
5182898|NCT00892229|cervical ripening|cervical ripening
5182899|NCT00892229|first trimester|first trimester
5182900|NCT00892229|missed abortion|missed abortion
5182901|NCT00892216|PONV|ponv
5182902|NCT00892216|NUSS procedure|nuss procedure
5182903|NCT00892216|Acupressure|acupressure
5182904|NCT00892216|Pectus Excavatum|pectus excavatum
5182905|NCT00892203|Migraine|migraine
5182906|NCT00892203|Headache|headache
5182907|NCT00892190|AML|aml
5182908|NCT00892190|Dasatinib|dasatinib
5182909|NCT00892190|all trans retinoic acid|all trans retinoic acid
5182910|NCT00892190|relapsed AML|relapsed aml
5182911|NCT00892190|refractory AML|refractory aml
5182912|NCT00892190|Relapsed/Refractory Acute myelogenous leukemia|relapsed/refractory acute myelogenous leukemia
5182913|NCT00892190|Elderly subjects (age 65 or older) with acute myelogenous leukemia|elderly subjects (age 65 or older) with acute myelogenous leukemia
5182914|NCT00892190|Myelodysplastic Syndrome|myelodysplastic syndrome
5182915|NCT00892190|MDS|mds
5183352|NCT00890903|Navelbine|navelbine
5182916|NCT00892177|adult giant cell glioblastoma|adult giant cell glioblastoma
5182917|NCT00892177|adult glioblastoma|adult glioblastoma
5182918|NCT00892177|adult gliosarcoma|adult gliosarcoma
5182919|NCT00892177|adult mixed glioma|adult mixed glioma
5182920|NCT00892177|recurrent adult brain tumor|recurrent adult brain tumor
5182921|NCT00892177|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
5182922|NCT00892177|adult oligodendroglioma|adult oligodendroglioma
5182923|NCT00892177|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5182924|NCT00892164|thyroid surgery|thyroid surgery
5182925|NCT00892164|total thyroidectomy|total thyroidectomy
5182926|NCT00892164|harmonic scalpel|harmonic scalpel
5182927|NCT00892164|electrothermal bipolar vessel sealer|electrothermal bipolar vessel sealer
5182928|NCT00892164|hemostatic device|hemostatic device
5182929|NCT00892138|mindfulness training|mindfulness training
5182930|NCT00892138|medical students|medical students
5182931|NCT00892138|psychology students|psychology students
5182932|NCT00892138|stress management|stress management
5182933|NCT00892138|personal development|personal development
5182934|NCT00892138|stress|stress
5182935|NCT00892125|Schizophrenia|schizophrenia
5182936|NCT00892125|Bipolar I disorder|bipolar i disorder
5182937|NCT00892125|mood disorders|mood disorders
5182938|NCT00892125|antipsychotic drugs|antipsychotic drugs
5182939|NCT00892125|enzyme inducer|enzyme inducer
5182940|NCT00892125|Paliperidone ER|paliperidone er
5182941|NCT00892112|Immunoglobulins, Intravenous|immunoglobulins, intravenous
5182942|NCT00892112|Cardiomyopathies|cardiomyopathies
5182943|NCT00892112|Parvo B19, Human|parvo b19, human
5182944|NCT00892099|end stage renal disease|end stage renal disease
5182945|NCT00892099|hemodialysis|hemodialysis
5182946|NCT00892086|geriatric syndrome|geriatric syndrome
5182947|NCT00892086|immobility|immobility
5182948|NCT00892073|Craniopharyngioma surgery|craniopharyngioma surgery
5182949|NCT00892073|Hypothalamic Obesity|hypothalamic obesity
5182950|NCT00892073|Children|children
5182951|NCT00892073|Combined Diazoxide and Metformin|combined diazoxide and metformin
5182952|NCT00892047|Depression|depression
5182953|NCT00892047|Aripiprazole|aripiprazole
5182954|NCT00892047|Venlafaxine|venlafaxine
5182955|NCT00892047|Partial Remission|partial remission
5182956|NCT00892047|Augmentation strategy|augmentation strategy
5182957|NCT00892047|Treatment resistance|treatment resistance
5182958|NCT00892047|Elderly|elderly
5182959|NCT00892047|Late-life|late-life
5182960|NCT00892008|pregabalin|pregabalin
5182961|NCT00892008|neuropathic pain|neuropathic pain
5182962|NCT00892008|safety|safety
5182963|NCT00891995|Type 1 Diabetes|type 1 diabetes
5182964|NCT00891995|Closed Loop Therapy|closed loop therapy
5182965|NCT00891995|Continuous Glucose Monitor|continuous glucose monitor
5182966|NCT00891982|Acne Vulgaris|acne vulgaris
5182967|NCT00891969|stage I breast cancer|stage i breast cancer
5182968|NCT00891969|stage II breast cancer|stage ii breast cancer
5182969|NCT00891969|stage IIIA breast cancer|stage iiia breast cancer
5182970|NCT00891956|Rett Syndrome|rett syndrome
5182971|NCT00891943|Obesity|obesity
5182972|NCT00891943|Overweight|overweight
5182973|NCT00891943|Randomised controlled trial|randomised controlled trial
5182974|NCT00891943|Primary Care|primary care
5182975|NCT00891943|Weight|weight
5182976|NCT00891943|Cardiovascular Risk|cardiovascular risk
5182977|NCT00891943|Diabetes|diabetes
5182978|NCT00891943|Quality of life|quality of life
5182979|NCT00891930|wild-type KRAS|wild-type kras
5182980|NCT00891930|panitumumab|panitumumab
5182981|NCT00891930|biomarker|biomarker
5182982|NCT00891930|mechanisms of acquired resistance|mechanisms of acquired resistance
5182983|NCT00891930|metastatic colorectal cancer|metastatic colorectal cancer
5182984|NCT00891917|Down syndrome|down syndrome
5182985|NCT00891917|coenzyme Q10|coenzyme q10
5182986|NCT00891917|language function|language function
5182987|NCT00891917|behavior|behavior
5182988|NCT00891904|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
5182989|NCT00891904|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
5182990|NCT00891904|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
5182991|NCT00891904|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
5182992|NCT00891904|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
5182993|NCT00891904|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
5182994|NCT00891891|spina bifida, psychosocial adjustment, adolescence, emerging adulthood|spina bifida, psychosocial adjustment, adolescence, emerging adulthood
5182995|NCT00891878|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
5182996|NCT00891878|adenocarcinoma of the gastroesophageal junction|adenocarcinoma of the gastroesophageal junction
5182997|NCT00891878|recurrent esophageal cancer|recurrent esophageal cancer
5182998|NCT00891878|stage IV esophageal cancer|stage iv esophageal cancer
5182999|NCT00891878|stage III esophageal cancer|stage iii esophageal cancer
5183000|NCT00891865|lung transplant|lung transplant
5183001|NCT00891865|BOS|bos
5183002|NCT00891865|OB|ob
5183003|NCT00891865|Respiratory Viral Infection (RVI)|respiratory viral infection (rvi)
5183004|NCT00891865|Lung disease|lung disease
5183797|NCT00889395|caregivers|caregivers
5183005|NCT00891826|Bipolar disorders|bipolar disorders
5183006|NCT00891826|Omega-3 fatty acids|omega-3 fatty acids
5183007|NCT00891826|Heart rate|heart rate
5183008|NCT00891800|Cancer|cancer
5183009|NCT00891800|Breast|breast
5183010|NCT00891800|Liver|liver
5183011|NCT00891787|Probiotics|probiotics
5183012|NCT00891787|Isoagglutinins|isoagglutinins
5183013|NCT00891787|Anti-A|anti-a
5183014|NCT00891787|Anti-B|anti-b
5183015|NCT00891787|Hemolysis|hemolysis
5183016|NCT00891787|Healthy Volunteer|healthy volunteer
5183017|NCT00891787|HV|hv
5183018|NCT00891761|cisplatin|cisplatin
5183019|NCT00891761|nausea|nausea
5183020|NCT00891761|vomiting|vomiting
5183021|NCT00891761|cancer|cancer
5183022|NCT00891761|lung cancer|lung cancer
5183023|NCT00891735|Lucentis|lucentis
5183024|NCT00891735|AMD|amd
5183025|NCT00891735|Age-related macular degeneration|age-related macular degeneration
5183026|NCT00891735|Subfoveal neovascular age-related macular degeneration|subfoveal neovascular age-related macular degeneration
5183027|NCT00891735|Wet AMD|wet amd
5183028|NCT00891735|Macular degeneration|macular degeneration
5183029|NCT00891735|Ranibizumab|ranibizumab
5183030|NCT00891722|recurrent childhood brain stem glioma|recurrent childhood brain stem glioma
5183031|NCT00891722|untreated childhood brain stem glioma|untreated childhood brain stem glioma
5183032|NCT00891722|recurrent childhood cerebellar astrocytoma|recurrent childhood cerebellar astrocytoma
5183033|NCT00891722|untreated childhood cerebellar astrocytoma|untreated childhood cerebellar astrocytoma
5183034|NCT00891722|childhood low-grade cerebral astrocytoma|childhood low-grade cerebral astrocytoma
5183035|NCT00891722|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
5183036|NCT00891722|childhood oligodendroglioma|childhood oligodendroglioma
5183037|NCT00891722|recurrent childhood visual pathway and hypothalamic glioma|recurrent childhood visual pathway and hypothalamic glioma
5183038|NCT00891722|untreated childhood visual pathway and hypothalamic glioma|untreated childhood visual pathway and hypothalamic glioma
5183039|NCT00891722|childhood mixed glioma|childhood mixed glioma
5183040|NCT00891696|Sarcopenia|sarcopenia
5183041|NCT00891696|Aging|aging
5183042|NCT00891696|Metabolism|metabolism
5183043|NCT00891696|Muscle|muscle
5183044|NCT00891696|mTOR|mtor
5183045|NCT00891696|Essential Amino Acids|essential amino acids
5183046|NCT00891696|Exercise|exercise
5183047|NCT00891696|Rapamycin|rapamycin
5183048|NCT00891683|Diabetic|diabetic
5183049|NCT00891683|peripheral|peripheral
5183050|NCT00891683|neuropathy|neuropathy
5183051|NCT00891683|pain|pain
5183052|NCT00891683|hyperalgesia|hyperalgesia
5183053|NCT00891683|allodynia|allodynia
5183054|NCT00891670|CYP2C19 polymorphism|cyp2c19 polymorphism
5183055|NCT00891670|platelet|platelet
5183056|NCT00891670|Adjunctive cilostazol|adjunctive cilostazol
5183057|NCT00891670|high maintenance dose clopidogrel|high maintenance dose clopidogrel
5183058|NCT00891670|P2Y12 Reaction Unit|p2y12 reaction unit
5183059|NCT00891657|Adhesion|adhesion
5183060|NCT00891657|Fibroid|fibroid
5183061|NCT00891657|Myoma|myoma
5183062|NCT00891657|Leiomyoma|leiomyoma
5183063|NCT00891657|Myomectomy|myomectomy
5183064|NCT00891644|HIV|hiv
5183065|NCT00891644|Care-seeking|care-seeking
5183066|NCT00891631|tobacco|tobacco
5183067|NCT00891631|alcohol|alcohol
5183068|NCT00891631|marijuana|marijuana
5183069|NCT00891631|drug use|drug use
5183070|NCT00891631|seat-belt|seat-belt
5183071|NCT00891631|weapons|weapons
5183072|NCT00891631|depression|depression
5183073|NCT00891631|suicidality|suicidality
5183074|NCT00891631|sexual risk behaviors|sexual risk behaviors
5183075|NCT00891618|Lymphoma|lymphoma
5183076|NCT00891618|Myeloma|myeloma
5183077|NCT00891618|Multiple Myeloma|multiple myeloma
5183078|NCT00891618|MM|mm
5183079|NCT00891618|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
5183080|NCT00891618|NHL|nhl
5183081|NCT00891618|Acupuncture|acupuncture
5183082|NCT00891618|Treatment-induced Peripheral Neuropathy|treatment-induced peripheral neuropathy
5183083|NCT00891618|Thalidomide|thalidomide
5183084|NCT00891618|Bortezomib|bortezomib
5183085|NCT00891618|Neuropathy|neuropathy
5183086|NCT00891618|Peripheral Neuropathy|peripheral neuropathy
5183087|NCT00891605|Paclitaxel|paclitaxel
5183088|NCT00891605|Solid Tumors|solid tumors
5183089|NCT00891592|AML|aml
5183090|NCT00891592|MDS|mds
5183091|NCT00891592|ALL|all
5183092|NCT00891592|NHL|nhl
5183093|NCT00891592|Multiple Myeloma|multiple myeloma
5183094|NCT00891592|Hodgkin's|hodgkin's
5183095|NCT00891579|NSCLC|nsclc
5183096|NCT00891579|EGFR|egfr
5183097|NCT00891579|Pemetrexed|pemetrexed
5183098|NCT00891579|Gefitinib|gefitinib
5183099|NCT00891579|without EGFR mutations|without egfr mutations
5183100|NCT00891566|medium to large tear|medium to large tear
5183101|NCT00891566|rotator cuff tear|rotator cuff tear
5183102|NCT00891566|arthroscopic repair|arthroscopic repair
5183103|NCT00891566|repair integrity|repair integrity
5183104|NCT00891566|immobilization|immobilization
5183105|NCT00891553|bone mineral density|bone mineral density
5183106|NCT00891553|calcium-sensing receptor antagonist|calcium-sensing receptor antagonist
5183107|NCT00891553|ronacaleret|ronacaleret
5183108|NCT00891553|postmenopausal osteoporosis|postmenopausal osteoporosis
5183109|NCT00891527|Pulmonary Vein Stenosis,|pulmonary vein stenosis,
5183110|NCT00891527|Avastin and Gleevec,|avastin and gleevec,
5183111|NCT00891527|Targeting VEGF and PDGF|targeting vegf and pdgf
5183112|NCT00891514|Exercise|exercise
5183113|NCT00891514|Inflammation|inflammation
5183114|NCT00891514|Insulin Sensitivity|insulin sensitivity
5183115|NCT00891501|autologous bone marrow mesenchymal stem cells|autologous bone marrow mesenchymal stem cells
5183116|NCT00891501|cartilage repair|cartilage repair
5183117|NCT00891501|osteoarthritis|osteoarthritis
5183118|NCT00891501|osteochondral defects|osteochondral defects
5183119|NCT00891488|VO2 max|vo2 max
5183120|NCT00891488|stress|stress
5183121|NCT00891488|cortisol|cortisol
5183122|NCT00891488|fitness|fitness
5183123|NCT00891475|metastatic renal cell carcinoma|metastatic renal cell carcinoma
5183124|NCT00891475|radiofrequency ablation|radiofrequency ablation
5183125|NCT00891462|COPD|copd
5183126|NCT00891462|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5183127|NCT00891462|Chronic Bronchitis|chronic bronchitis
5183128|NCT00891462|Emphysema|emphysema
5183129|NCT00891462|Airflow Obstruction, Chronic|airflow obstruction, chronic
5183130|NCT00891462|Chronic Airflow Obstruction|chronic airflow obstruction
5183131|NCT00891462|Chronic Obstructive Airway Disease|chronic obstructive airway disease
5183132|NCT00891462|Chronic Obstructive Lung Disease|chronic obstructive lung disease
5183133|NCT00891449|space flight simulation study|space flight simulation study
5183134|NCT00891449|medical research study|medical research study
5183135|NCT00891449|bed rest|bed rest
5183136|NCT00891449|microgravity|microgravity
5183137|NCT00891449|weightlessness|weightlessness
5183138|NCT00891449|The effects of long duration microgravity on humans|the effects of long duration microgravity on humans
5183139|NCT00891423|Meropenem|meropenem
5183140|NCT00891423|extended infusion|extended infusion
5183141|NCT00891423|prolonged infusion|prolonged infusion
5183142|NCT00891423|Time above MIC|time above mic
5183143|NCT00891397|CPRS|cprs
5183144|NCT00891397|stellate ganglion block|stellate ganglion block
5183145|NCT00891397|pregabalin|pregabalin
5183146|NCT00891397|pain|pain
5183147|NCT00891397|Type I|type i
5183148|NCT00891384|Multiple Myeloma|multiple myeloma
5183149|NCT00891384|maintenance therapy|maintenance therapy
5183150|NCT00891384|lenalidomide|lenalidomide
5183151|NCT00891371|symptomatic treatment of patients with refractory diarrhea|symptomatic treatment of patients with refractory diarrhea
5183152|NCT00891358|Adolescent Medicine Trials Network for HIV/AIDS Interventions|adolescent medicine trials network for hiv/aids interventions
5183153|NCT00891358|Human Immunodeficiency Virus|human immunodeficiency virus
5183154|NCT00891358|HIV seronegativity|hiv seronegativity
5183155|NCT00891345|hormone-refractory prostate cancer|hormone-refractory prostate cancer
5183156|NCT00891345|Immunotherapy|immunotherapy
5183157|NCT00891319|hand|hand
5183158|NCT00891319|stroke|stroke
5183159|NCT00891319|hemiplegia|hemiplegia
5183160|NCT00891319|electrical stimulation|electrical stimulation
5183161|NCT00891319|recovery|recovery
5183162|NCT00891306|LPLD, Lipoprotein Lipase Deficiency|lpld, lipoprotein lipase deficiency
5183163|NCT00891306|Chylomicronemia|chylomicronemia
5183164|NCT00891306|Gene therapy|gene therapy
5183165|NCT00891306|AAV|aav
5183166|NCT00891306|Lipoprotein Lipase|lipoprotein lipase
5183167|NCT00891306|Alipogene tiparvovec|alipogene tiparvovec
5183168|NCT00891306|AMT-011|amt-011
5183169|NCT00891293|omega-3-acid ethyl esters|omega-3-acid ethyl esters
5183170|NCT00891293|Very high triglycerides|very high triglycerides
5183171|NCT00891293|Lovaza|lovaza
5183172|NCT00891293|fenofibrate|fenofibrate
5183173|NCT00891280|Inflammatory breast cancer|inflammatory breast cancer
5183174|NCT00891280|Castleman's Disease|castleman's disease
5183175|NCT00891280|Multiple Myeloma|multiple myeloma
5183176|NCT00891280|Breast cancer|breast cancer
5183177|NCT00891280|Solid tumors|solid tumors
5183178|NCT00891280|CK2 inhibitor|ck2 inhibitor
5183179|NCT00891267|Inflammatory markers|inflammatory markers
5183180|NCT00891267|Vascular protection|vascular protection
5183181|NCT00891267|OM Effect|om effect
5183182|NCT00891267|Metabolic syndrome|metabolic syndrome
5183183|NCT00891267|Hypertension|hypertension
5183184|NCT00891254|Incisional hernia|incisional hernia
5183185|NCT00891254|Intraperitoneal mesh repair|intraperitoneal mesh repair
5183186|NCT00891254|On-lay repair|on-lay repair
5183187|NCT00891254|Prosthetic mesh|prosthetic mesh
5183188|NCT00891254|First repair (no recurrent hernia will be included)|first repair (no recurrent hernia will be included)
5183189|NCT00891254|Recurrence|recurrence
5183190|NCT00891254|Complications|complications
5183191|NCT00891241|Heart Failure, PET Imaging, Implantable Cardioverter-Defibrillator, Dosimetry|heart failure, pet imaging, implantable cardioverter-defibrillator, dosimetry
5183192|NCT00891228|Contraception|contraception
5183193|NCT00891228|Male Contraception|male contraception
5183194|NCT00891228|Suppression of Sperm Production|suppression of sperm production
5183195|NCT00891202|Gaucher,|gaucher,
5183196|NCT00891202|beta-glucosidase,|beta-glucosidase,
5183197|NCT00891202|acid ß-glucosidase,|acid ß-glucosidase,
5183198|NCT00891202|glucocerebrosidase,|glucocerebrosidase,
5183199|NCT00891202|glucosylceramide,|glucosylceramide,
5183200|NCT00891202|D-glucosyl-N-acylsphingosine glucohydrolase,|d-glucosyl-n-acylsphingosine glucohydrolase,
5183798|NCT00889395|children|children
5183201|NCT00891202|substrate reduction therapy|substrate reduction therapy
5183202|NCT00891189|Circadian Rhythm|circadian rhythm
5183203|NCT00891176|Conjugate vaccines|conjugate vaccines
5183204|NCT00891176|Meningococcal serogroup C vaccine|meningococcal serogroup c vaccine
5183205|NCT00891176|Antibody persistence|antibody persistence
5183206|NCT00891176|Pneumococcal vaccine|pneumococcal vaccine
5183207|NCT00891176|Haemophilus Influenzae type b vaccine|haemophilus influenzae type b vaccine
5183208|NCT00891163|Topical anesthesia|topical anesthesia
5183209|NCT00891163|Analgesia|analgesia
5183210|NCT00891137|adult acute myeloid leukemia 11q23 (MLL) abnormalities|adult acute myeloid leukemia 11q23 (mll) abnormalities
5183211|NCT00891137|adult acute myeloid leukemia inv(16)(p13;q22)|adult acute myeloid leukemia inv(16)(p13;q22)
5183212|NCT00891137|adult acute myeloid leukemia t(15;17)(q22;q12)|adult acute myeloid leukemia t(15;17)(q22;q12)
5183213|NCT00891137|adult acute myeloid leukemia t(16;16)(p13;q22)|adult acute myeloid leukemia t(16;16)(p13;q22)
5183214|NCT00891137|adult acute myeloid leukemia t(8;21)(q22;q22)|adult acute myeloid leukemia t(8;21)(q22;q22)
5183215|NCT00891137|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5183216|NCT00891137|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5183217|NCT00891137|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5183218|NCT00891137|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
5183219|NCT00891137|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
5183220|NCT00891137|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
5183221|NCT00891137|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5183222|NCT00891137|childhood diffuse large cell lymphoma|childhood diffuse large cell lymphoma
5183223|NCT00891137|childhood immunoblastic large cell lymphoma|childhood immunoblastic large cell lymphoma
5183224|NCT00891137|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5183225|NCT00891137|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5183226|NCT00891137|extranodal marginal zone B-cell lymphoma|extranodal marginal zone b-cell lymphoma
5183227|NCT00891137|mucosa-associated lymphoid tissue|mucosa-associated lymphoid tissue
5183228|NCT00891137|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5183229|NCT00891137|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
5183230|NCT00891137|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
5183231|NCT00891137|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
5183232|NCT00891137|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
5183233|NCT00891137|noncontiguous stage II adult immunoblastic|noncontiguous stage ii adult immunoblastic
5183234|NCT00891137|contiguous stage II adult immunoblastic|contiguous stage ii adult immunoblastic
5183235|NCT00891137|large cell lymphoma|large cell lymphoma
5183236|NCT00891137|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
5183237|NCT00891137|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5183238|NCT00891137|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5183239|NCT00891137|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5183240|NCT00891137|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5183241|NCT00891137|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5183242|NCT00891137|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5183243|NCT00891137|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5183244|NCT00891137|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5183245|NCT00891137|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5183246|NCT00891137|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5183247|NCT00891137|refractory multiple myeloma|refractory multiple myeloma
5183248|NCT00891137|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5183249|NCT00891137|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5183250|NCT00891137|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5183251|NCT00891137|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5183252|NCT00891137|stage I multiple myeloma|stage i multiple myeloma
5183253|NCT00891137|stage II multiple myeloma|stage ii multiple myeloma
5183254|NCT00891137|stage III multiple myeloma|stage iii multiple myeloma
5183255|NCT00891137|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5183256|NCT00891137|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5183257|NCT00891137|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5183258|NCT00891137|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5183259|NCT00891137|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5183260|NCT00891137|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5183261|NCT00891137|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
5183262|NCT00891137|refractory anemia with excess blasts|refractory anemia with excess blasts
5183263|NCT00891137|refractory anemia|refractory anemia
5183264|NCT00891137|prolymphocytic leukemia|prolymphocytic leukemia
5183265|NCT00891137|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
5183266|NCT00891137|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5183351|NCT00890903|advanced breast cancer|advanced breast cancer
5183267|NCT00891137|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5183268|NCT00891137|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5183269|NCT00891137|stage I childhood small noncleaved cell lymphoma|stage i childhood small noncleaved cell lymphoma
5183270|NCT00891137|stage II childhood small noncleaved cell lymphoma|stage ii childhood small noncleaved cell lymphoma
5183271|NCT00891137|stage III childhood small noncleaved cell lymphoma|stage iii childhood small noncleaved cell lymphoma
5183272|NCT00891137|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
5183273|NCT00891137|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
5183274|NCT00891137|stage I childhood large cell lymphoma|stage i childhood large cell lymphoma
5183275|NCT00891137|stage II childhood large cell lymphoma|stage ii childhood large cell lymphoma
5183276|NCT00891137|stage III childhood large cell lymphoma|stage iii childhood large cell lymphoma
5183277|NCT00891137|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
5183278|NCT00891137|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
5183279|NCT00891137|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
5183280|NCT00891137|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
5183281|NCT00891137|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5183282|NCT00891137|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5183283|NCT00891137|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5183284|NCT00891137|stage I mantle cell lymphoma|stage i mantle cell lymphoma
5183285|NCT00891137|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
5183286|NCT00891137|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
5183287|NCT00891137|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5183288|NCT00891137|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
5183289|NCT00891137|stage I childhood lymphoblastic lymphoma|stage i childhood lymphoblastic lymphoma
5183290|NCT00891137|stage II childhood lymphoblastic lymphoma|stage ii childhood lymphoblastic lymphoma
5183291|NCT00891137|stage III childhood lymphoblastic lymphoma|stage iii childhood lymphoblastic lymphoma
5183292|NCT00891137|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
5183293|NCT00891137|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
5183294|NCT00891137|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
5183295|NCT00891137|Burkitt lymphoma|burkitt lymphoma
5183296|NCT00891124|Hypertension|hypertension
5183297|NCT00891124|Type II DM|type ii dm
5183298|NCT00891124|Hyperlipidemia|hyperlipidemia
5183299|NCT00891124|Glycemia|glycemia
5183300|NCT00891124|ADA 2008 guideline|ada 2008 guideline
5183301|NCT00891124|Patient Consultation|patient consultation
5183302|NCT00891111|Health Risk Assessment|health risk assessment
5183303|NCT00891111|Incentives|incentives
5183304|NCT00891111|Preventative Healthcare|preventative healthcare
5183305|NCT00891111|Encouraging Health Risk Assessments|encouraging health risk assessments
5183306|NCT00891085|ventilation|ventilation
5183307|NCT00891085|ards|ards
5183308|NCT00891085|ali|ali
5183309|NCT00891085|trauma|trauma
5183310|NCT00891085|Trauma Patients with ISS > 25|trauma patients with iss > 25
5183311|NCT00891059|Cognitive Impairment|cognitive impairment
5183312|NCT00891059|Diskus Inhaler|diskus inhaler
5183313|NCT00891059|Nursing Home|nursing home
5183314|NCT00891046|Flare|flare
5183315|NCT00891046|arthritis|arthritis
5183316|NCT00891046|IL-1beta antagonist|il-1beta antagonist
5183317|NCT00891046|systemic juvenile idiopathic arthritis|systemic juvenile idiopathic arthritis
5183318|NCT00891046|CHAQ|chaq
5183319|NCT00891046|steroids|steroids
5183320|NCT00891046|ACR pediatric response|acr pediatric response
5183321|NCT00891046|Systemic juvenile idiopathic arthritis with active flare|systemic juvenile idiopathic arthritis with active flare
5183322|NCT00891033|cancer|cancer
5183323|NCT00891007|Measles|measles
5183324|NCT00891007|Virus Disease|virus disease
5183325|NCT00891007|Paediatric Diseases|paediatric diseases
5183326|NCT00891007|Paramyoxyviridae|paramyoxyviridae
5183327|NCT00890994|MBI|mbi
5183328|NCT00890994|Molecular Breast Imaging|molecular breast imaging
5183329|NCT00890994|Breast Cancer|breast cancer
5183330|NCT00890994|DCIS|dcis
5183331|NCT00890994|Breast|breast
5183332|NCT00890994|Calcifications|calcifications
5183333|NCT00890994|Microcalcifications|microcalcifications
5183334|NCT00890968|hand dermatitis|hand dermatitis
5183335|NCT00890968|hand eczema|hand eczema
5183336|NCT00890968|triamcinolone acetonide|triamcinolone acetonide
5183337|NCT00890955|Solid tumors|solid tumors
5183338|NCT00890942|pruritus|pruritus
5183339|NCT00890942|intrathecal morphine|intrathecal morphine
5183340|NCT00890929|Acute myeloid leukemia|acute myeloid leukemia
5183341|NCT00890929|Acute myeloblastic leukemia|acute myeloblastic leukemia
5183342|NCT00890929|AML|aml
5183343|NCT00890916|spinal cord injury|spinal cord injury
5183344|NCT00890916|neuroprosthesis|neuroprosthesis
5183345|NCT00890916|functional electrical stimulation|functional electrical stimulation
5183346|NCT00890916|quadriplegia|quadriplegia
5183347|NCT00890903|NSCLC|nsclc
5183348|NCT00890903|non small cell lung carcinoma|non small cell lung carcinoma
5183349|NCT00890903|metastatic breast cancer|metastatic breast cancer
5183350|NCT00890903|MBC|mbc
5183353|NCT00890903|Navelbine-ORAL|navelbine-oral
5183354|NCT00890903|Vinorelbine|vinorelbine
5183355|NCT00890903|Vinorelbine-ORAL|vinorelbine-oral
5183356|NCT00890903|daily routine|daily routine
5183357|NCT00890903|concomitant antiemetic therapy|concomitant antiemetic therapy
5183358|NCT00890903|patient compliance|patient compliance
5183359|NCT00890903|germany|germany
5183360|NCT00890903|non-interventional study|non-interventional study
5183361|NCT00890903|oral anti cancer therapy|oral anti cancer therapy
5183362|NCT00890903|quality of life|quality of life
5183363|NCT00890877|asthma|asthma
5183364|NCT00890877|treatment|treatment
5183365|NCT00890877|placebo|placebo
5183366|NCT00890877|efficacy|efficacy
5183367|NCT00890877|safety|safety
5183368|NCT00890864|Breast screening|breast screening
5183369|NCT00890864|Mammogram|mammogram
5183370|NCT00890864|Routine screening programme|routine screening programme
5183371|NCT00890851|Radiofrequency|radiofrequency
5183372|NCT00890851|Mini invasin surgery|mini invasin surgery
5183373|NCT00890851|Outpatient treatment|outpatient treatment
5183374|NCT00890851|Men health|men health
5183375|NCT00890838|IVFO|ivfo
5183376|NCT00890838|Inflammation|inflammation
5183377|NCT00890838|Valvular surgery|valvular surgery
5183378|NCT00890838|Inflammatory status|inflammatory status
5183379|NCT00890838|Infectious complications|infectious complications
5183380|NCT00890825|Non small cell lung cancer (NSCLC)|non small cell lung cancer (nsclc)
5183381|NCT00890825|KRAS mutation|kras mutation
5183382|NCT00890812|Acute Ischemic Stroke|acute ischemic stroke
5183383|NCT00890799|transcatheter closure|transcatheter closure
5183384|NCT00890799|ventricular septal defects|ventricular septal defects
5183385|NCT00890760|Malaria|malaria
5183386|NCT00890760|Vaccine|vaccine
5183387|NCT00890747|HIV Infections|hiv infections
5183388|NCT00890747|treatment experienced|treatment experienced
5183389|NCT00890721|Hemorrhoid|hemorrhoid
5183390|NCT00890721|Hemorrhoidectomy|hemorrhoidectomy
5183391|NCT00890721|Postoperative pain|postoperative pain
5183392|NCT00890721|Analgesia|analgesia
5183393|NCT00890695|supplementary feeding|supplementary feeding
5183394|NCT00890695|moderate malnutrition|moderate malnutrition
5183395|NCT00890695|acute infection|acute infection
5183396|NCT00890695|developing country|developing country
5183397|NCT00890695|children|children
5183398|NCT00890682|Bunion|bunion
5183399|NCT00890682|Bunionectomy|bunionectomy
5183400|NCT00890682|Osteotomy|osteotomy
5183401|NCT00890669|treadmill training|treadmill training
5183402|NCT00890669|body load|body load
5183403|NCT00890669|quality of life|quality of life
5183404|NCT00890669|Parkinson's disease|parkinson's disease
5183405|NCT00890669|Motor Symptoms|motor symptoms
5183406|NCT00890656|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
5183407|NCT00890656|ALL|all
5183408|NCT00890656|Leukemia|leukemia
5183409|NCT00890656|Hyper-CVAD|hyper-cvad
5183410|NCT00890643|Stress disorders, post-traumatic|stress disorders, post-traumatic
5183411|NCT00890643|Combat Disorders|combat disorders
5183412|NCT00890643|prazosin|prazosin
5183413|NCT00890643|cognition|cognition
5183414|NCT00890643|neurophysiology|neurophysiology
5183415|NCT00890617|lung metastases|lung metastases
5183416|NCT00890617|stage I non-small cell lung cancer|stage i non-small cell lung cancer
5183417|NCT00890591|hypertension|hypertension
5183418|NCT00890591|angiotensin II type 1 receptor blocker|angiotensin ii type 1 receptor blocker
5183419|NCT00890591|olmesartan|olmesartan
5183420|NCT00890578|Histoacryl|histoacryl
5183421|NCT00890578|closure of surgical incisions|closure of surgical incisions
5183422|NCT00890565|Electrocardiogram|electrocardiogram
5183423|NCT00890565|Effect on electrocardiogram|effect on electrocardiogram
5183424|NCT00890565|Granisetron|granisetron
5183425|NCT00890565|Moxifloxacin|moxifloxacin
5183426|NCT00890565|Pharmacokinetic profile|pharmacokinetic profile
5183427|NCT00890565|Sancuso® patch|sancuso® patch
5183428|NCT00890565|Transdermal|transdermal
5183429|NCT00890526|Tinnitus Retraining Therapy (TRT)|tinnitus retraining therapy (trt)
5183430|NCT00890474|Breech presentation at 34 to 36 weeks of gestation|breech presentation at 34 to 36 weeks of gestation
5183431|NCT00890461|ECG|ecg
5183432|NCT00890461|ICD|icd
5183433|NCT00890448|Alanine Transaminase elevation|alanine transaminase elevation
5183434|NCT00890448|Genetic Markers|genetic markers
5183435|NCT00890448|DNA Markers|dna markers
5183436|NCT00890435|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5183437|NCT00890435|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
5183438|NCT00890435|recurrent childhood brain stem glioma|recurrent childhood brain stem glioma
5183439|NCT00890435|recurrent childhood cerebellar astrocytoma|recurrent childhood cerebellar astrocytoma
5183440|NCT00890435|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
5183441|NCT00890435|recurrent childhood medulloblastoma|recurrent childhood medulloblastoma
5183442|NCT00890435|recurrent childhood supratentorial primitive neuroectodermal tumor|recurrent childhood supratentorial primitive neuroectodermal tumor
5183443|NCT00890435|recurrent childhood ependymoma|recurrent childhood ependymoma
5183444|NCT00890435|recurrent childhood pineoblastoma|recurrent childhood pineoblastoma
5183445|NCT00890435|recurrent childhood subependymal giant cell astrocytoma|recurrent childhood subependymal giant cell astrocytoma
5184747|NCT00885573|sleep apnea|sleep apnea
5183446|NCT00890435|recurrent childhood visual pathway and hypothalamic glioma|recurrent childhood visual pathway and hypothalamic glioma
5183447|NCT00890435|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5183448|NCT00890435|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5183449|NCT00890435|childhood choroid plexus tumor|childhood choroid plexus tumor
5183450|NCT00890435|childhood craniopharyngioma|childhood craniopharyngioma
5183451|NCT00890435|childhood ependymoblastoma|childhood ependymoblastoma
5183452|NCT00890435|childhood medulloepithelioma|childhood medulloepithelioma
5183453|NCT00890435|childhood meningioma|childhood meningioma
5183454|NCT00890435|childhood mixed glioma|childhood mixed glioma
5183455|NCT00890435|childhood oligodendroglioma|childhood oligodendroglioma
5183456|NCT00890435|adult astrocytic tumors|adult astrocytic tumors
5183457|NCT00890435|adult brain stem glioma|adult brain stem glioma
5183458|NCT00890435|adult choroid plexus tumor|adult choroid plexus tumor
5183459|NCT00890435|adult craniopharyngioma|adult craniopharyngioma
5183460|NCT00890435|adult ependymoblastoma|adult ependymoblastoma
5183461|NCT00890435|adult medulloblastoma|adult medulloblastoma
5183462|NCT00890435|adult supratentorial primitive neuroectodermal tumor (PNET)|adult supratentorial primitive neuroectodermal tumor (pnet)
5183463|NCT00890435|adult ependymal tumors|adult ependymal tumors
5183464|NCT00890435|adult meningeal tumor|adult meningeal tumor
5183465|NCT00890435|adult mixed glioma|adult mixed glioma
5183466|NCT00890435|adult oligodendroglial tumors|adult oligodendroglial tumors
5183467|NCT00890435|adult pineal parenchymal tumor|adult pineal parenchymal tumor
5183468|NCT00890435|recurrent adult brain tumor|recurrent adult brain tumor
5183469|NCT00890435|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5183470|NCT00890435|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5183471|NCT00890435|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5183472|NCT00890435|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5183473|NCT00890435|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5183474|NCT00890435|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5183475|NCT00890435|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5183476|NCT00890435|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5183477|NCT00890435|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5183478|NCT00890435|acute undifferentiated leukemia|acute undifferentiated leukemia
5183479|NCT00890435|mast cell leukemia|mast cell leukemia
5183480|NCT00890435|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
5183481|NCT00890435|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
5183482|NCT00890435|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5183483|NCT00890435|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
5183484|NCT00890435|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5183485|NCT00890435|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
5183486|NCT00890435|refractory hairy cell leukemia|refractory hairy cell leukemia
5183487|NCT00890435|prolymphocytic leukemia|prolymphocytic leukemia
5183488|NCT00890422|encephalitis|encephalitis
5183489|NCT00890422|FSME|fsme
5183490|NCT00890422|central european encephalitis|central european encephalitis
5183491|NCT00890409|hypothermia|hypothermia
5183492|NCT00890409|neonate|neonate
5183493|NCT00890409|hypoxic-ischemic encephalopathy|hypoxic-ischemic encephalopathy
5183494|NCT00890409|efficacy|efficacy
5183495|NCT00890409|safety|safety
5183496|NCT00890396|Sickle Cell Anemia|sickle cell anemia
5183497|NCT00890396|Hydroxyurea|hydroxyurea
5183498|NCT00890383|trauma resuscitation|trauma resuscitation
5183499|NCT00890383|abdominal hypertension|abdominal hypertension
5183500|NCT00890383|abdominal compartment syndrome|abdominal compartment syndrome
5183501|NCT00890370|Cystic fibrosis|cystic fibrosis
5183502|NCT00890370|Airway clearance|airway clearance
5183503|NCT00890344|PeaPod|peapod
5183504|NCT00890344|BIA|bia
5183505|NCT00890344|Anthropometry|anthropometry
5183506|NCT00890344|Body Composition|body composition
5183507|NCT00890344|Fat Mass|fat mass
5183508|NCT00890344|Total Body Water|total body water
5183509|NCT00890344|Neonatology|neonatology
5183510|NCT00890305|Metastatic colorectal cancer|metastatic colorectal cancer
5183511|NCT00890305|FOLFOX chemotherapy|folfox chemotherapy
5183512|NCT00890292|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
5183513|NCT00890292|ADHD|adhd
5183514|NCT00890292|JNJ-31001074|jnj-31001074
5183515|NCT00890279|Autosomal Dominant Polycystic Kidney Disease|autosomal dominant polycystic kidney disease
5183516|NCT00890279|Hypertension|hypertension
5183517|NCT00890279|Angiotensin-II Receptor Blocker|angiotensin-ii receptor blocker
5183518|NCT00890279|Calcium Channel Blocker|calcium channel blocker
5183519|NCT00890279|Angiotensin converting enzyme inhibitor|angiotensin converting enzyme inhibitor
5183520|NCT00890279|Kidney Volume|kidney volume
5183521|NCT00890279|eGFR|egfr
5183522|NCT00890266|keratoconus|keratoconus
5183523|NCT00890266|collagen cross-linking|collagen cross-linking
5183524|NCT00890266|riboflavin|riboflavin
5183525|NCT00890266|UV light|uv light
5183526|NCT00890253|Renal impairment|renal impairment
5184846|NCT00885144|Stunting|stunting
5183527|NCT00890253|Liver transplantation|liver transplantation
5183528|NCT00890253|Chronic Renal Insufficiency|chronic renal insufficiency
5183529|NCT00890240|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
5183530|NCT00890240|ADHD|adhd
5183531|NCT00890240|JNJ-31001074|jnj-31001074
5183532|NCT00890227|scoliosis|scoliosis
5183533|NCT00890227|kyphosis|kyphosis
5183534|NCT00890227|Surgical treatment|surgical treatment
5183535|NCT00890214|Anticoagulation|anticoagulation
5183536|NCT00890214|Prostacyclin|prostacyclin
5183537|NCT00890214|Heparin|heparin
5183538|NCT00890214|Renal Replacement Therapy|renal replacement therapy
5183539|NCT00890214|Kidney failure acute|kidney failure acute
5183540|NCT00890214|Platelet aggregation|platelet aggregation
5183541|NCT00890201|Pancreaticobiliary reflux|pancreaticobiliary reflux
5183542|NCT00890201|Normal pancreaticobiliary junction|normal pancreaticobiliary junction
5183543|NCT00890201|Gallstones|gallstones
5183544|NCT00890201|Cholelithiasis|cholelithiasis
5183545|NCT00890201|Cholecystectomy|cholecystectomy
5183546|NCT00890188|THALIDOMIDE|thalidomide
5183547|NCT00890188|UFUR|ufur
5183548|NCT00890188|Colorectal cancer|colorectal cancer
5183549|NCT00890188|Oxaliplatin|oxaliplatin
5183550|NCT00890175|Asthma, Staccato loxapine|asthma, staccato loxapine
5183551|NCT00890162|Omalizumab|omalizumab
5183552|NCT00890162|Idiopathic Anaphylaxis|idiopathic anaphylaxis
5183553|NCT00890162|Serum Tryptase|serum tryptase
5183554|NCT00890162|Placebo-Controlled|placebo-controlled
5183555|NCT00890162|Adult|adult
5183556|NCT00890162|Anaphylaxis|anaphylaxis
5183557|NCT00890162|Allergic Reaction|allergic reaction
5183558|NCT00890149|alcohol abuse|alcohol abuse
5183559|NCT00890149|binge drinking|binge drinking
5183560|NCT00890149|severe drinking|severe drinking
5183561|NCT00890149|alcoholism|alcoholism
5183562|NCT00890149|heavy drinking|heavy drinking
5183563|NCT00890136|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
5183564|NCT00890123|Omega 3 Fatty Acids|omega 3 fatty acids
5183565|NCT00890123|Inflammation|inflammation
5183566|NCT00890123|Hip Surgery|hip surgery
5183567|NCT00890123|Inflammatory status|inflammatory status
5183568|NCT00890123|Infectious complications|infectious complications
5183569|NCT00890110|Renal cell cancer|renal cell cancer
5183570|NCT00890110|sunitinib|sunitinib
5183571|NCT00890110|autologous vaccine|autologous vaccine
5183572|NCT00890110|metastatic RCC|metastatic rcc
5183573|NCT00890097|Geographic Atrophy|geographic atrophy
5183575|NCT00890097|Age-Related Macular Degeneration|age-related macular degeneration
5183576|NCT00890097|AMD|amd
5183577|NCT00890071|Fluid responsiveness|fluid responsiveness
5183578|NCT00890071|Ultrasound|ultrasound
5183579|NCT00890071|Cardiac output|cardiac output
5183580|NCT00890058|Arthritis|arthritis
5183581|NCT00890058|Synovitis|synovitis
5183582|NCT00890058|Aromatase Inhibitor|aromatase inhibitor
5183583|NCT00890058|Arthralgia Syndrome|arthralgia syndrome
5183584|NCT00890045|Vascular access hemodialysis|vascular access hemodialysis
5183585|NCT00890045|ePTFE graft|eptfe graft
5183586|NCT00890045|Graft-eligible|graft-eligible
5183587|NCT00890045|Long-term vascular access for hemodialysis|long-term vascular access for hemodialysis
5183588|NCT00890032|adult giant cell glioblastoma|adult giant cell glioblastoma
5183589|NCT00890032|adult glioblastoma|adult glioblastoma
5183590|NCT00890032|adult gliosarcoma|adult gliosarcoma
5183591|NCT00890032|adult astrocytoma|adult astrocytoma
5183592|NCT00890032|recurrent adult brain tumor|recurrent adult brain tumor
5183593|NCT00890006|Prostate cancer|prostate cancer
5183594|NCT00890006|Magnetic resonance imaging|magnetic resonance imaging
5183595|NCT00889993|Food intake|food intake
5183596|NCT00889993|Gut hormones|gut hormones
5183597|NCT00889993|Fiber|fiber
5183598|NCT00889993|Visual analog scales|visual analog scales
5183599|NCT00889967|Pseudomonas aeruginosa|pseudomonas aeruginosa
5183600|NCT00889967|antimicrobial|antimicrobial
5183601|NCT00889967|inhalation|inhalation
5183602|NCT00889967|ciprofloxacin|ciprofloxacin
5183603|NCT00889967|Non-Cystic Fibrosis Bronchiectasis|non-cystic fibrosis bronchiectasis
5183604|NCT00889954|EBV+|ebv+
5183605|NCT00889954|Her2|her2
5183606|NCT00889954|TGFBeta|tgfbeta
5183607|NCT00889954|EBV positive|ebv positive
5183608|NCT00889954|HER 2 positive malignancy|her 2 positive malignancy
5183609|NCT00889954|cytotoxic T lymphocytes|cytotoxic t lymphocytes
5183610|NCT00889928|gallbladder disease|gallbladder disease
5183611|NCT00889928|cholecystectomy|cholecystectomy
5183612|NCT00889928|gallbladder disease indicated for cholecystectomy|gallbladder disease indicated for cholecystectomy
5183613|NCT00889915|ADHD|adhd
5183614|NCT00889915|Methylphenidate|methylphenidate
5183615|NCT00889915|Amphetamine|amphetamine
5183616|NCT00889902|Molecular Markers|molecular markers
5183617|NCT00889902|Cervical Cancer|cervical cancer
5183618|NCT00889902|Screening|screening
5183619|NCT00889902|Makov|makov
5183620|NCT00889889|Influenza|influenza
5183621|NCT00889889|Phase II|phase ii
5183622|NCT00889889|Placebo-controlled|placebo-controlled
5183623|NCT00889876|Obesity|obesity
5183624|NCT00889876|Adolescents|adolescents
5183625|NCT00889876|Nocturnal blood pressure reduction|nocturnal blood pressure reduction
5183626|NCT00889876|Insulin metabolism|insulin metabolism
5185052|NCT00884403|ultrasound|ultrasound
5183627|NCT00889876|Cardiovascular structure and function|cardiovascular structure and function
5183628|NCT00889876|Treatment|treatment
5183629|NCT00889876|Exercise|exercise
5183630|NCT00889876|Metformin|metformin
5183631|NCT00889876|Insulin|insulin
5183632|NCT00889876|Blood glucose|blood glucose
5183633|NCT00889876|Impaired nocturnal blood pressure reduction|impaired nocturnal blood pressure reduction
5183634|NCT00889863|Flare|flare
5183635|NCT00889863|arthritis|arthritis
5183636|NCT00889863|IL-1beta antagonist|il-1beta antagonist
5183637|NCT00889863|systemic juvenile idiopathic arthritis|systemic juvenile idiopathic arthritis
5183638|NCT00889863|Juvenile rheumatoid|juvenile rheumatoid
5183639|NCT00889850|Healthy|healthy
5183640|NCT00889850|Bioavailability|bioavailability
5183641|NCT00889850|Bioequivalence|bioequivalence
5183642|NCT00889850|Esomeprazole|esomeprazole
5183643|NCT00889850|Bioavailability, Therapeutical Indication Not Studied|bioavailability, therapeutical indication not studied
5183644|NCT00889837|Staccato Loxapine|staccato loxapine
5183645|NCT00889837|COPD|copd
5183646|NCT00889837|pulmonary safety|pulmonary safety
5183647|NCT00889824|Chronic imbalance|chronic imbalance
5183648|NCT00889824|vestibular disorders|vestibular disorders
5183649|NCT00889824|balance prosthesis|balance prosthesis
5183650|NCT00889811|OPCAB|opcab
5183651|NCT00889811|RIPC|ripc
5183652|NCT00889798|Malignant lymphatic disease|malignant lymphatic disease
5183653|NCT00889798|therapy-reality|therapy-reality
5183654|NCT00889798|observation|observation
5183655|NCT00889798|registry|registry
5183656|NCT00889798|therapy sequences|therapy sequences
5183657|NCT00889798|NHL|nhl
5183658|NCT00889798|CLL|cll
5183659|NCT00889798|Germany|germany
5183660|NCT00889798|lenalidomide|lenalidomide
5183661|NCT00889798|alemtuzumab|alemtuzumab
5183662|NCT00889798|rituximab|rituximab
5183663|NCT00889798|bendamustin|bendamustin
5183664|NCT00889798|thalidomide|thalidomide
5183665|NCT00889798|bortezomib|bortezomib
5183666|NCT00889798|ibritumomab-tiuxetan|ibritumomab-tiuxetan
5183667|NCT00889798|G-CSF (Granulocyte-Colony Stimulating Factor)|g-csf (granulocyte-colony stimulating factor)
5183668|NCT00889798|chronic lymphocytic leukaemia|chronic lymphocytic leukaemia
5183669|NCT00889798|follicular lymphoma|follicular lymphoma
5183670|NCT00889798|gastric MALT lymphoma (Mucosa Associated Lymphoid Tissue)|gastric malt lymphoma (mucosa associated lymphoid tissue)
5183671|NCT00889798|nongastric MALT lymphoma (Mucosa Associated Lymphoid Tissue)|nongastric malt lymphoma (mucosa associated lymphoid tissue)
5183672|NCT00889798|nodal marginal zone lymphoma|nodal marginal zone lymphoma
5183673|NCT00889798|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5183674|NCT00889798|mantle cell lymphoma|mantle cell lymphoma
5183675|NCT00889798|diffuse large b-cell lymphoma|diffuse large b-cell lymphoma
5183676|NCT00889785|Adolescents|adolescents
5183677|NCT00889785|Type 2 Diabetes|type 2 diabetes
5183678|NCT00889785|Behavioral Research|behavioral research
5183679|NCT00889772|Respiratory distress, adult|respiratory distress, adult
5183680|NCT00889772|risk|risk
5183681|NCT00889772|emergency room|emergency room
5183682|NCT00889772|high risk surgery|high risk surgery
5183683|NCT00889772|sepsis|sepsis
5183684|NCT00889772|trauma|trauma
5183685|NCT00889772|aspiration|aspiration
5183686|NCT00889772|pneumonia|pneumonia
5183687|NCT00889759|Tuberculosis|tuberculosis
5183688|NCT00889759|Outbreaks|outbreaks
5183689|NCT00889720|smoking cessation|smoking cessation
5183690|NCT00889720|varenicline|varenicline
5183691|NCT00889720|elective surgery|elective surgery
5183692|NCT00889720|wound infections|wound infections
5183693|NCT00889720|post-operative complications|post-operative complications
5183694|NCT00889707|Benign Prostatic Hyperplasia|benign prostatic hyperplasia
5183695|NCT00889707|BPH|bph
5183696|NCT00889707|Enlarged Prostate|enlarged prostate
5183697|NCT00889668|Glucose monitoring|glucose monitoring
5183698|NCT00889668|GlucoTrack|glucotrack
5183699|NCT00889668|Self glucose monitoring|self glucose monitoring
5183700|NCT00889655|efficacy of bowel cleansing|efficacy of bowel cleansing
5183701|NCT00889655|patient tolerability|patient tolerability
5183702|NCT00889655|Golytely|golytely
5183703|NCT00889655|MiraLax|miralax
5183704|NCT00889655|colonoscopy preparation|colonoscopy preparation
5183705|NCT00889655|bowel preparation|bowel preparation
5183706|NCT00889655|screening colonoscopy|screening colonoscopy
5183707|NCT00889629|kidney transplantation|kidney transplantation
5183708|NCT00889629|kidney transplant recipients|kidney transplant recipients
5183709|NCT00889616|Malaria|malaria
5183710|NCT00889616|Asexual Blood Stafe|asexual blood stafe
5183711|NCT00889616|Plasmodium Falciparum|plasmodium falciparum
5183712|NCT00889616|Immunogenicity|immunogenicity
5183713|NCT00889616|Safety|safety
5183714|NCT00889616|Vaccine|vaccine
5183715|NCT00889603|Aricept® Evess|aricept® evess
5183716|NCT00889603|non-interventional study|non-interventional study
5183717|NCT00889603|Alzheimer's Disease|alzheimer's disease
5183718|NCT00889603|Vascular Dementia|vascular dementia
5183719|NCT00889603|efficacy|efficacy
5183720|NCT00889603|tolerability|tolerability
5183721|NCT00889603|safety.|safety.
5183722|NCT00889590|GCT|gct
5183723|NCT00889590|Bisfosfonates|bisfosfonates
5183724|NCT00889564|Vascular access for hemodialysis|vascular access for hemodialysis
5185151|NCT00883961|Cancer|cancer
5183725|NCT00889564|Catheter dependent patients|catheter dependent patients
5183726|NCT00889564|Access challenged patients|access challenged patients
5183727|NCT00889564|Bacteremia|bacteremia
5183728|NCT00889564|HeRO Vascular Access Device|hero vascular access device
5183729|NCT00889538|Autism|autism
5183730|NCT00889538|Severe Behavior Disorder|severe behavior disorder
5183731|NCT00889538|Glutathione|glutathione
5183732|NCT00889538|Antioxidants|antioxidants
5183733|NCT00889525|Cabergoline|cabergoline
5183734|NCT00889486|gastroparesis|gastroparesis
5183735|NCT00889486|diabetes mellitus|diabetes mellitus
5183736|NCT00889486|delayed gastric emptying|delayed gastric emptying
5183737|NCT00889473|larazotide acetate|larazotide acetate
5183738|NCT00889473|gluten|gluten
5183739|NCT00889460|rBet v 1|rbet v 1
5183740|NCT00889460|Birch pollen allergy|birch pollen allergy
5183741|NCT00889460|Sublingual Immunotherapy|sublingual immunotherapy
5183742|NCT00889447|Chronic Obstructive Pulmonary disease (COPD)|chronic obstructive pulmonary disease (copd)
5183743|NCT00889434|Cystic fibrosis|cystic fibrosis
5183744|NCT00889434|splicing mutations|splicing mutations
5183745|NCT00889434|molecular therapy|molecular therapy
5183746|NCT00889434|EGCG|egcg
5183747|NCT00889434|Tocotrienol|tocotrienol
5183748|NCT00889434|Splicing-mutation-mediated Cystic Fibrosis|splicing-mutation-mediated cystic fibrosis
5183749|NCT00889421|uveitis|uveitis
5183750|NCT00889421|apremilast|apremilast
5183751|NCT00889408|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5183752|NCT00889408|childhood diffuse large cell lymphoma|childhood diffuse large cell lymphoma
5183753|NCT00889408|childhood grade III lymphomatoid granulomatosis|childhood grade iii lymphomatoid granulomatosis
5183754|NCT00889408|childhood immunoblastic large cell lymphoma|childhood immunoblastic large cell lymphoma
5183755|NCT00889408|B-cell adult acute lymphoblastic leukemia|b-cell adult acute lymphoblastic leukemia
5183756|NCT00889408|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5183757|NCT00889408|B-cell childhood acute lymphoblastic leukemia|b-cell childhood acute lymphoblastic leukemia
5183758|NCT00889408|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5183759|NCT00889408|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5183760|NCT00889408|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5183761|NCT00889408|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5183762|NCT00889408|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5183763|NCT00889408|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5183764|NCT00889408|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5183765|NCT00889408|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5183766|NCT00889408|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5183767|NCT00889408|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
5183768|NCT00889408|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5183769|NCT00889408|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
5183770|NCT00889408|cutaneous B-cell non-Hodgkin lymphoma|cutaneous b-cell non-hodgkin lymphoma
5183771|NCT00889408|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
5183772|NCT00889408|Waldenström macroglobulinemia|waldenström macroglobulinemia
5183773|NCT00889408|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5183774|NCT00889408|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5183775|NCT00889408|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5183776|NCT00889408|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5183777|NCT00889408|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5183778|NCT00889408|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5183779|NCT00889408|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5183780|NCT00889408|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5183781|NCT00889408|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5183782|NCT00889408|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5183783|NCT00889408|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5183784|NCT00889408|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5183785|NCT00889408|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5183786|NCT00889408|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5183787|NCT00889408|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5183788|NCT00889408|recurrent childhood grade III lymphomatoid granulomatosis|recurrent childhood grade iii lymphomatoid granulomatosis
5183789|NCT00889408|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
5183790|NCT00889408|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
5183791|NCT00889408|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
5183792|NCT00889408|childhood Burkitt lymphoma|childhood burkitt lymphoma
5183793|NCT00889408|intraocular lymphoma|intraocular lymphoma
5183794|NCT00889408|noncutaneous extranodal lymphoma|noncutaneous extranodal lymphoma
5183795|NCT00889408|prolymphocytic leukemia|prolymphocytic leukemia
5183796|NCT00889395|MISC|misc
5183799|NCT00889395|psychosocial gains|psychosocial gains
5183800|NCT00889395|cognitive benefits|cognitive benefits
5183801|NCT00889382|Ovarian Cancer|ovarian cancer
5183802|NCT00889382|Ovarian|ovarian
5183803|NCT00889382|Paclitaxel|paclitaxel
5183804|NCT00889382|OSI-906|osi-906
5183805|NCT00889382|IGF-1R|igf-1r
5183806|NCT00889382|Solid Tumors|solid tumors
5183807|NCT00889369|depression|depression
5183808|NCT00889369|duloxetine|duloxetine
5183809|NCT00889369|menopause|menopause
5183810|NCT00889369|imaging|imaging
5183811|NCT00889369|FMRI|fmri
5183812|NCT00889369|Menopausal staging|menopausal staging
5183813|NCT00889369|vasomotor symptoms|vasomotor symptoms
5183814|NCT00889343|Second-line therapy of metastatic colorectal cancer|second-line therapy of metastatic colorectal cancer
5183815|NCT00889343|Sorafenib|sorafenib
5183816|NCT00889343|Colorectal Neoplasms|colorectal neoplasms
5183817|NCT00889343|palliative therapy|palliative therapy
5183818|NCT00889343|after progression of firstline therapy with an Oxaliplatin- or Irinotecan based Fluoropyrimidine containing regimen ± bevacizumab|after progression of firstline therapy with an oxaliplatin- or irinotecan based fluoropyrimidine containing regimen ± bevacizumab
5183819|NCT00889304|HTO, high tibial osteotomy, open wedge, medial arthritis|hto, high tibial osteotomy, open wedge, medial arthritis
5183820|NCT00889291|End stage renal disease|end stage renal disease
5183821|NCT00889291|Bacteremia|bacteremia
5183822|NCT00889291|HeRO Vascular Access Device|hero vascular access device
5183823|NCT00889291|Access challenged|access challenged
5183824|NCT00889291|Catheter dependent|catheter dependent
5183825|NCT00889291|End stage renal disease requiring vascular access. See HeRO device instructions for use for appropriate patient population|end stage renal disease requiring vascular access. see hero device instructions for use for appropriate patient population
5183826|NCT00889278|Lymphoma|lymphoma
5183827|NCT00889278|Autologous Peripheral Blood Stem Cell Transplant|autologous peripheral blood stem cell transplant
5183828|NCT00889278|APBSCT|apbsct
5183829|NCT00889278|Pneumococcal Conjugate Vaccine|pneumococcal conjugate vaccine
5183830|NCT00889265|Alveolar Bone Augmentation|alveolar bone augmentation
5183831|NCT00889265|Implant Surgery|implant surgery
5183832|NCT00889265|Guided Bone Regeneration (GBR)|guided bone regeneration (gbr)
5183833|NCT00889265|Guided Tissue Regeneration (GTR)|guided tissue regeneration (gtr)
5183834|NCT00889265|Bone Graft|bone graft
5183835|NCT00889265|Periodontal Surgery|periodontal surgery
5183836|NCT00889239|ceramic|ceramic
5183837|NCT00889239|wear rate|wear rate
5183838|NCT00889239|opposing enamel|opposing enamel
5183839|NCT00889226|pitavastatin|pitavastatin
5183840|NCT00889226|PWV|pwv
5183841|NCT00889226|ESPRIT|esprit
5183842|NCT00889226|Pitavastatin and Atorvastatin|pitavastatin and atorvastatin
5183843|NCT00889226|Adiponectin|adiponectin
5183844|NCT00889226|fasting insulin|fasting insulin
5183845|NCT00889226|hs-CRP|hs-crp
5183846|NCT00889226|baPWV|bapwv
5183847|NCT00889213|pancreatectomy|pancreatectomy
5183848|NCT00889213|fistula|fistula
5183849|NCT00889213|fibrin glue|fibrin glue
5183850|NCT00889213|falciform patch|falciform patch
5183851|NCT00889213|surgery|surgery
5183852|NCT00889213|complications|complications
5183853|NCT00889187|radiation therapy|radiation therapy
5183854|NCT00889187|capecitabine|capecitabine
5183855|NCT00889174|Genetic Disorders of the White Matter|genetic disorders of the white matter
5183856|NCT00889174|Leukodystrophies|leukodystrophies
5183857|NCT00889174|Myelin|myelin
5183858|NCT00889174|White Matter Disorder|white matter disorder
5183859|NCT00889174|Genetic Disorder|genetic disorder
5183860|NCT00889161|Crohn's disease|crohn's disease
5183861|NCT00889161|ulcerative colitis|ulcerative colitis
5183862|NCT00889161|curcumin|curcumin
5183863|NCT00889161|pediatric|pediatric
5183864|NCT00889161|inflammatory bowel disease|inflammatory bowel disease
5183865|NCT00889148|hip|hip
5183866|NCT00889148|arthroplasty|arthroplasty
5183867|NCT00889148|postoperative pain|postoperative pain
5183868|NCT00889148|gabapentin|gabapentin
5183869|NCT00889122|Obesity|obesity
5183870|NCT00889122|Exergames|exergames
5183871|NCT00889122|Videogames|videogames
5183872|NCT00889122|Prevention|prevention
5183873|NCT00889122|Family|family
5183874|NCT00889122|Dance Dance Revolution|dance dance revolution
5183875|NCT00889122|Pedometer|pedometer
5183876|NCT00889096|memory|memory
5183877|NCT00889096|heart rate|heart rate
5183878|NCT00889096|skin conductance|skin conductance
5183879|NCT00889096|α-amylase|α-amylase
5183880|NCT00889096|propranolol|propranolol
5183881|NCT00889096|tolerability|tolerability
5183882|NCT00889083|Sepsis|sepsis
5183883|NCT00889083|Peritonitis|peritonitis
5183884|NCT00889083|Mitochondria|mitochondria
5183885|NCT00889083|Liver|liver
5183886|NCT00889057|osteosarcoma|osteosarcoma
5183887|NCT00889057|sorafenib|sorafenib
5183888|NCT00889057|target therapy|target therapy
5183889|NCT00889031|CLL|cll
5183890|NCT00889018|intraocular retinoblastoma|intraocular retinoblastoma
5183891|NCT00889018|chemotherapy|chemotherapy
5183892|NCT00889005|Post-traumatic Stress Disorder|post-traumatic stress disorder
5183893|NCT00889005|Acute Stress Disorder|acute stress disorder
5183894|NCT00889005|Cognitive behavioral therapy|cognitive behavioral therapy
5183895|NCT00889005|Secondary Prevention|secondary prevention
5183896|NCT00889005|Anxiety disorders|anxiety disorders
5183897|NCT00889005|Service Delivery|service delivery
5183898|NCT00888992|Smoking|smoking
5183899|NCT00888992|Cessation|cessation
5183900|NCT00888992|Quitline|quitline
5183901|NCT00888992|Counseling|counseling
5183902|NCT00888979|Smoking Cessation during Pregnancy|smoking cessation during pregnancy
5183903|NCT00888979|Nicotrol Inhaler|nicotrol inhaler
5183904|NCT00888966|heart arrest|heart arrest
5183905|NCT00888966|oxidative stress|oxidative stress
5183906|NCT00888966|lactic acid|lactic acid
5183908|NCT00888953|Falls|falls
5183909|NCT00888953|Nursing Homes|nursing homes
5183910|NCT00888953|Elderly|elderly
5183911|NCT00888953|Prevention|prevention
5183912|NCT00888953|Spain|spain
5183913|NCT00888953|Cluster Randomized Clinical Trial|cluster randomized clinical trial
5183914|NCT00888927|T-Cell Lymphoma|t-cell lymphoma
5183915|NCT00888927|PTCL|ptcl
5183916|NCT00888927|CTCL|ctcl
5183917|NCT00888914|Lateral Canthal Lines|lateral canthal lines
5183918|NCT00888914|Crow's Feet|crow's feet
5183919|NCT00888914|Facial Wrinkles|facial wrinkles
5183920|NCT00888901|ITP|itp
5183921|NCT00888901|eltrombopag|eltrombopag
5183922|NCT00888901|platelet function|platelet function
5183923|NCT00888901|thrombocytopenia|thrombocytopenia
5183924|NCT00888901|Platelet function in patients with cAITP on eltrombopag|platelet function in patients with caitp on eltrombopag
5183925|NCT00888888|Acute appendicitis|acute appendicitis
5183926|NCT00888888|Colonic diverticulitis|colonic diverticulitis
5183927|NCT00888888|Colonic tumors|colonic tumors
5183928|NCT00888888|Colonic resections|colonic resections
5183929|NCT00888875|i-gel|i-gel
5183930|NCT00888875|Fastrach|fastrach
5183931|NCT00888875|intubation|intubation
5183932|NCT00888875|fiberoptic|fiberoptic
5183933|NCT00888875|difficult airway|difficult airway
5183934|NCT00888875|Patients undergoing elective surgery requiring tracheal intubation|patients undergoing elective surgery requiring tracheal intubation
5183935|NCT00888875|Presenting at least one sign of difficult intubation|presenting at least one sign of difficult intubation
5183936|NCT00888862|depression|depression
5183937|NCT00888862|desvenlafaxine|desvenlafaxine
5183938|NCT00888862|menopause|menopause
5183939|NCT00888862|imaging|imaging
5183940|NCT00888862|FMRI|fmri
5183941|NCT00888849|Stapling|stapling
5183942|NCT00888849|hand sutured anastamosis|hand sutured anastamosis
5183943|NCT00888849|colorectal disease|colorectal disease
5183944|NCT00888836|bariatric surgery|bariatric surgery
5183945|NCT00888836|GBP|gbp
5183946|NCT00888836|BPD|bpd
5183947|NCT00888836|type 2 diabetes|type 2 diabetes
5183948|NCT00888823|Fractionated stereotactic radiotherapy|fractionated stereotactic radiotherapy
5183949|NCT00888823|Medically inoperable|medically inoperable
5183950|NCT00888823|Image-guided radiotherapy|image-guided radiotherapy
5183951|NCT00888810|ovarian - cancer - relapse - topotecan - lapatinib|ovarian - cancer - relapse - topotecan - lapatinib
5183952|NCT00888771|Colorectal cancer|colorectal cancer
5183953|NCT00888771|polyps|polyps
5183954|NCT00888771|colonoscopy|colonoscopy
5183955|NCT00888771|advanced imaging|advanced imaging
5183956|NCT00888758|Stents|stents
5183957|NCT00888745|RA|ra
5183958|NCT00888732|Diabetes|diabetes
5183959|NCT00888680|Migraine|migraine
5183960|NCT00888680|Headaches|headaches
5183961|NCT00888680|Migraine headaches|migraine headaches
5183962|NCT00888680|Head pain|head pain
5183963|NCT00888667|ICD patients with PVCs and EGM recordings|icd patients with pvcs and egm recordings
5183964|NCT00888654|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5183965|NCT00888654|stage I prostate cancer|stage i prostate cancer
5183966|NCT00888654|stage II prostate cancer|stage ii prostate cancer
5183967|NCT00888628|Type I diabetes|type i diabetes
5183968|NCT00888628|Islet after Kidney Transplant|islet after kidney transplant
5183969|NCT00888628|Islet transplantation|islet transplantation
5183970|NCT00888589|MBI|mbi
5183971|NCT00888589|Molecular Breast Imaging|molecular breast imaging
5183972|NCT00888589|Breast|breast
5183973|NCT00888589|Breast Cancer|breast cancer
5183974|NCT00888589|Molecular Imaging|molecular imaging
5183975|NCT00888563|Fatigue|fatigue
5183976|NCT00888563|Depression|depression
5183977|NCT00888563|Healthy Volunteer|healthy volunteer
5183978|NCT00888563|HV|hv
5183979|NCT00888537|Decision aid|decision aid
5183980|NCT00888537|Heart attack|heart attack
5183981|NCT00888537|myocardial infarction|myocardial infarction
5183982|NCT00888524|head out water immersion,|head out water immersion,
5183983|NCT00888524|high intensity exercise,|high intensity exercise,
5183984|NCT00888524|evidence-based physiotherapy;|evidence-based physiotherapy;
5183985|NCT00888524|aquatics;|aquatics;
5183986|NCT00888524|hydrotherapy|hydrotherapy
5183987|NCT00888524|aquatics therapy|aquatics therapy
5183988|NCT00888524|exercise therapy|exercise therapy
5183989|NCT00888511|Lung cancer|lung cancer
5183990|NCT00888511|Non-small cell lung cancer|non-small cell lung cancer
5183991|NCT00888511|Tarceva|tarceva
5183992|NCT00888511|Radiotherapy|radiotherapy
5183993|NCT00888511|Local-regionally advanced non-small cell lung cancer|local-regionally advanced non-small cell lung cancer
5183994|NCT00888498|Sprains and Strains|sprains and strains
5183995|NCT00888498|Ankle|ankle
5183996|NCT00888498|Manual Therapies|manual therapies
5183997|NCT00888498|Outcome Studies|outcome studies
5183998|NCT00888472|Extracorporeal leukocytapheresis|extracorporeal leukocytapheresis
5183999|NCT00888459|tobacco|tobacco
5184000|NCT00888459|chew|chew
5184001|NCT00888459|nrt|nrt
5184002|NCT00888459|nicotine lozenges|nicotine lozenges
5184003|NCT00888459|self-help|self-help
5184004|NCT00888446|HIV|hiv
5184005|NCT00888446|HIV seronegativity|hiv seronegativity
5184006|NCT00888446|preventative vaccine|preventative vaccine
5184007|NCT00888433|hypertension|hypertension
5184008|NCT00888433|renal denervation|renal denervation
5184009|NCT00888433|sympathetic nervous system|sympathetic nervous system
5184010|NCT00888433|RDN|rdn
5184011|NCT00888420|Chronic Pain|chronic pain
5184012|NCT00888407|Asian American Health|asian american health
5184013|NCT00888407|Cancer|cancer
5184014|NCT00888407|Hepatitis|hepatitis
5184015|NCT00888407|Hepatitis B|hepatitis b
5184016|NCT00888407|Liver Cancer|liver cancer
5184017|NCT00888394|chiropody|chiropody
5184018|NCT00888394|podiatry|podiatry
5184019|NCT00888394|insoles|insoles
5184020|NCT00888394|foot orthesis|foot orthesis
5184021|NCT00888342|Pulmonary Disease|pulmonary disease
5184022|NCT00888342|Chronic Obstructive|chronic obstructive
5184023|NCT00888342|Hypercapnia|hypercapnia
5184024|NCT00888342|Hypoxemia|hypoxemia
5184025|NCT00888342|Arrhythmias, Cardiac|arrhythmias, cardiac
5184026|NCT00888342|Polysomnography|polysomnography
5184027|NCT00888342|Capnography|capnography
5184028|NCT00888342|Electrocardiography, Holter|electrocardiography, holter
5184029|NCT00888329|Elective hysterectomy|elective hysterectomy
5184030|NCT00888316|iron overload|iron overload
5184031|NCT00888290|metabolic acidosis|metabolic acidosis
5184032|NCT00888290|chronic kidney disease|chronic kidney disease
5184033|NCT00888290|Estimated GFR 15-45|estimated gfr 15-45
5184034|NCT00888264|Antipsychotics|antipsychotics
5184035|NCT00888264|Bipolar Disorder|bipolar disorder
5184036|NCT00888264|Depressive episodes|depressive episodes
5184037|NCT00888264|Bipolar I or II Disorders|bipolar i or ii disorders
5184038|NCT00888251|Obesity|obesity
5184039|NCT00888251|Meal replacement|meal replacement
5184040|NCT00888251|Obesity treatment|obesity treatment
5184041|NCT00888251|Weight management|weight management
5184042|NCT00888225|Tennis elbow|tennis elbow
5184043|NCT00888225|Epicondylitis|epicondylitis
5184044|NCT00888225|Pain|pain
5184045|NCT00888225|Muscle strength|muscle strength
5184046|NCT00888225|Quality of life|quality of life
5184047|NCT00888225|RCT|rct
5184048|NCT00888225|Tendinitis|tendinitis
5184049|NCT00888225|Chronic tennis elbow|chronic tennis elbow
5184050|NCT00888199|amputation|amputation
5184051|NCT00888199|amputee|amputee
5184052|NCT00888199|prosthetic|prosthetic
5184053|NCT00888199|foot|foot
5184054|NCT00888199|prosthesis|prosthesis
5184055|NCT00888199|Tensegrity|tensegrity
5184056|NCT00888199|Prosthetics|prosthetics
5184057|NCT00888199|K3 Promoter|k3 promoter
5184058|NCT00888186|Dyskinesias|dyskinesias
5184059|NCT00888186|Duodenal levodopa infusion|duodenal levodopa infusion
5184060|NCT00888186|Dose optimization|dose optimization
5184061|NCT00888186|Pharmacokinetics|pharmacokinetics
5184062|NCT00888186|Pharmacodynamics|pharmacodynamics
5184063|NCT00888147|Tube feeding|tube feeding
5184064|NCT00888147|Fiber|fiber
5184065|NCT00888147|Constipation|constipation
5184066|NCT00888095|deep brain stimulation|deep brain stimulation
5184067|NCT00888095|caudal Zona incerta|caudal zona incerta
5184068|NCT00888095|Nucleus subthalamicus|nucleus subthalamicus
5184069|NCT00888095|Parkinson's disease|parkinson's disease
5184070|NCT00888095|randomized|randomized
5184071|NCT00888095|blinded|blinded
5184072|NCT00888095|Movement disorder|movement disorder
5184073|NCT00888082|adjuvant chemotherapy|adjuvant chemotherapy
5184074|NCT00888082|breast cancer|breast cancer
5184075|NCT00888082|goserelin acetate|goserelin acetate
5184076|NCT00888082|ovarian function|ovarian function
5184077|NCT00888082|Chemotherapy|chemotherapy
5184078|NCT00888082|Primary invasive breast cancer|primary invasive breast cancer
5184079|NCT00888069|Parathyroid Diseases|parathyroid diseases
5184080|NCT00888069|Renal Insufficiency|renal insufficiency
5184081|NCT00888069|Kidney Failure, Chronic|kidney failure, chronic
5184082|NCT00888069|Hyperparathyroidism, Secondary|hyperparathyroidism, secondary
5184083|NCT00888069|Vitamin D|vitamin d
5184084|NCT00888069|Hyperparathyroidism|hyperparathyroidism
5184085|NCT00888069|Renal Insufficiency, Chronic|renal insufficiency, chronic
5184086|NCT00888069|Kidney Diseases|kidney diseases
5184087|NCT00888069|Kidney Failure|kidney failure
5184088|NCT00888043|solid tumors|solid tumors
5184089|NCT00888043|avastin|avastin
5184090|NCT00888043|Phase I|phase i
5184091|NCT00888043|combination therapy|combination therapy
5184092|NCT00888043|bevacizumab|bevacizumab
5184093|NCT00888030|p-cresol|p-cresol
5184094|NCT00888030|indoxyl sulfate|indoxyl sulfate
5184095|NCT00888030|chronic kidney disease|chronic kidney disease
5184096|NCT00888030|outcome|outcome
5184097|NCT00888017|bone density|bone density
5184098|NCT00888017|proton pump inhibitors|proton pump inhibitors
5184099|NCT00888017|premature infants|premature infants
5184100|NCT00888004|Parkinson's|parkinson's
5184101|NCT00888004|L-dopa|l-dopa
5184102|NCT00888004|dyskinesia|dyskinesia
5184103|NCT00887991|Randomised trial|randomised trial
5184104|NCT00887991|breast pumps|breast pumps
5184105|NCT00887991|efficacy|efficacy
5184106|NCT00887991|preterm|preterm
5184107|NCT00887991|Mothers of preterm infants who plan to express milk for their infants.|mothers of preterm infants who plan to express milk for their infants.
5184108|NCT00887965|Low Bone Mass|low bone mass
5184109|NCT00887965|Low Bone Mineral Density|low bone mineral density
5184110|NCT00887965|Osteoporosis|osteoporosis
5184111|NCT00887965|Postmenopausal Osteoporosis|postmenopausal osteoporosis
5184112|NCT00887965|Bone Biopsy|bone biopsy
5184113|NCT00887965|Transiliac Crest Bone Histology|transiliac crest bone histology
5184114|NCT00887965|Histomorphometry|histomorphometry
5184115|NCT00887952|Deep caries lesion|deep caries lesion
5184116|NCT00887952|dentine caries removal|dentine caries removal
5184117|NCT00887952|dental restoration|dental restoration
5184118|NCT00887952|stepwise excavation|stepwise excavation
5184119|NCT00887939|Physical Urticaria|physical urticaria
5184120|NCT00887939|Pathogenesis|pathogenesis
5184121|NCT00887939|Inflammasome|inflammasome
5184122|NCT00887939|IL-1|il-1
5184123|NCT00887939|Mast Cell|mast cell
5184124|NCT00887939|Urticaria|urticaria
5184125|NCT00887926|AML|aml
5184126|NCT00887926|Leukemia|leukemia
5184127|NCT00887926|Acute Myeloid Leukemia|acute myeloid leukemia
5184128|NCT00887926|Antibodies, Monoclonal|antibodies, monoclonal
5184129|NCT00887900|lamellar keratoplasty|lamellar keratoplasty
5184130|NCT00887900|keratoconus|keratoconus
5184131|NCT00887900|penetrated keratoplasty|penetrated keratoplasty
5184132|NCT00887900|Visual acuity|visual acuity
5184133|NCT00887887|liver surgery|liver surgery
5184134|NCT00887887|gene polymorphisms|gene polymorphisms
5184135|NCT00887887|innate immune response|innate immune response
5184136|NCT00887887|infectious complications|infectious complications
5184137|NCT00887887|post-resectional liver failure|post-resectional liver failure
5184138|NCT00887887|mortality|mortality
5184139|NCT00887861|epilepsy|epilepsy
5184140|NCT00887861|seizure|seizure
5184141|NCT00887861|monotherapy trials|monotherapy trials
5184142|NCT00887861|partial seizure|partial seizure
5184143|NCT00887861|Partial seizures and undergoing evaluation for epilepsy surgery|partial seizures and undergoing evaluation for epilepsy surgery
5184144|NCT00887848|Child|child
5184145|NCT00887848|Robotic-assisted treadmill training|robotic-assisted treadmill training
5184146|NCT00887848|Rehabilitation|rehabilitation
5184147|NCT00887835|PERPOS fusion|perpos fusion
5184148|NCT00887809|Bevacizumab (avastin)|bevacizumab (avastin)
5184149|NCT00887809|Gemcitabine|gemcitabine
5184150|NCT00887809|Taxotere (docetaxel)|taxotere (docetaxel)
5184151|NCT00887809|09-015|09-015
5184152|NCT00887809|Soft tissue|soft tissue
5184153|NCT00887783|Induction chemotherapy|induction chemotherapy
5184154|NCT00887783|Non-small cell lung cancer|non-small cell lung cancer
5184279|NCT00887276|Ampicillin|ampicillin
5184155|NCT00887783|Randomized phase II study|randomized phase ii study
5184156|NCT00887783|Navelbine Oral (R)|navelbine oral (r)
5184157|NCT00887783|3D-conformal radiotherapy|3d-conformal radiotherapy
5184158|NCT00887783|Chemo-radiotherapy|chemo-radiotherapy
5184159|NCT00887783|Local-regionally advanced non-small cell lung cancer|local-regionally advanced non-small cell lung cancer
5184160|NCT00887770|QTcF|qtcf
5184161|NCT00887770|Crossover|crossover
5184162|NCT00887770|ICH E14|ich e14
5184163|NCT00887770|QT/QTc prolongation|qt/qtc prolongation
5184164|NCT00887770|Moxifloxacin|moxifloxacin
5184165|NCT00887770|QT/QTc Interval|qt/qtc interval
5184166|NCT00887744|Degenerative Lumbar Spinal Stenosis|degenerative lumbar spinal stenosis
5184167|NCT00887744|Neurogenic Intermittent Claudication|neurogenic intermittent claudication
5184168|NCT00887744|Interpinous Device|interpinous device
5184169|NCT00887744|Percutaneous|percutaneous
5184170|NCT00887731|closed loop oxygen controller|closed loop oxygen controller
5184171|NCT00887731|premature infants|premature infants
5184172|NCT00887731|oxygen exposure|oxygen exposure
5184173|NCT00887718|PET scan and Hodgkin's Lymphoma|pet scan and hodgkin's lymphoma
5184174|NCT00887718|PET scan and Non Hodgkin's Lymphoma|pet scan and non hodgkin's lymphoma
5184175|NCT00887718|PET scan|pet scan
5184176|NCT00887705|COPD|copd
5184177|NCT00887705|Pulmonary Rehabilitation|pulmonary rehabilitation
5184178|NCT00887705|ADL-Training|adl-training
5184179|NCT00887705|COPD Rehabilitation|copd rehabilitation
5184180|NCT00887679|Escitalopram|escitalopram
5184181|NCT00887679|Anxiety Disorder|anxiety disorder
5184182|NCT00887679|HIV and AIDS|hiv and aids
5184183|NCT00887679|treatment experienced|treatment experienced
5184184|NCT00887640|metastatic|metastatic
5184185|NCT00887640|Temsirolimus|temsirolimus
5184186|NCT00887640|prostate|prostate
5184187|NCT00887640|cancer|cancer
5184188|NCT00887627|Pharmacokinetics|pharmacokinetics
5184189|NCT00887627|Protein Binding|protein binding
5184190|NCT00887627|Conivaptan|conivaptan
5184191|NCT00887627|Vaprisol|vaprisol
5184192|NCT00887627|Kidney Diseases|kidney diseases
5184193|NCT00887614|mindfulness|mindfulness
5184194|NCT00887614|meditation|meditation
5184195|NCT00887614|stress|stress
5184196|NCT00887614|rumination|rumination
5184197|NCT00887614|emotion regulation|emotion regulation
5184198|NCT00887614|sleep quality|sleep quality
5184199|NCT00887614|spirituality|spirituality
5184200|NCT00887614|quality of life|quality of life
5184201|NCT00887588|Chronic heart failure|chronic heart failure
5184202|NCT00887588|preserved ejection fraction|preserved ejection fraction
5184203|NCT00887588|cardiovascular disease|cardiovascular disease
5184204|NCT00887588|NT-proBNP|nt-probnp
5184205|NCT00887588|biomarkers|biomarkers
5184206|NCT00887588|Heart failure with preserved left-ventricular ejection|heart failure with preserved left-ventricular ejection
5184207|NCT00887588|fraction|fraction
5184208|NCT00887575|Breast Cancer|breast cancer
5184209|NCT00887575|Triple-Negative|triple-negative
5184210|NCT00887575|Paclitaxel|paclitaxel
5184211|NCT00887575|Carboplatin|carboplatin
5184212|NCT00887575|Sunitinib|sunitinib
5184213|NCT00887575|Sutent|sutent
5184214|NCT00887575|Neoadjuvant|neoadjuvant
5184215|NCT00887536|National Surgical Adjuvant Breast and Bowel Project (NSABP)|national surgical adjuvant breast and bowel project (nsabp)
5184216|NCT00887536|Taxotere|taxotere
5184217|NCT00887536|Docetaxel|docetaxel
5184218|NCT00887536|Doxorubicin|doxorubicin
5184219|NCT00887536|Cyclophosphamide|cyclophosphamide
5184220|NCT00887536|Bevacizumab|bevacizumab
5184221|NCT00887536|Breast Neoplasms|breast neoplasms
5184222|NCT00887536|Adenocarcinoma|adenocarcinoma
5184223|NCT00887536|Breast Diseases|breast diseases
5184224|NCT00887536|Carcinoma|carcinoma
5184225|NCT00887536|HER2 negative|her2 negative
5184226|NCT00887536|Node negative|node negative
5184227|NCT00887536|High risk node positive|high risk node positive
5184228|NCT00887536|Adjuvant Therapy|adjuvant therapy
5184229|NCT00887510|Metabolic Syndrome|metabolic syndrome
5184230|NCT00887510|High Blood Pressure|high blood pressure
5184231|NCT00887510|Abdominal Obesity|abdominal obesity
5184232|NCT00887510|Impaired Glucose Tolerance|impaired glucose tolerance
5184233|NCT00887484|Acne|acne
5184234|NCT00887484|Acne Vulgaris|acne vulgaris
5184235|NCT00887471|Sleep-disordered breathing|sleep-disordered breathing
5184236|NCT00887471|Obstructive sleep apnea|obstructive sleep apnea
5184237|NCT00887471|Polysomnography|polysomnography
5184238|NCT00887471|Tonsillectomy|tonsillectomy
5184239|NCT00887471|Microdebrider assisted partial intracapsular tonsillectomy|microdebrider assisted partial intracapsular tonsillectomy
5184240|NCT00887458|metastatic prostate cancer|metastatic prostate cancer
5184241|NCT00887458|castration resistant prostate cancer|castration resistant prostate cancer
5184242|NCT00887458|rising PSA|rising psa
5184243|NCT00887445|First in Man|first in man
5184244|NCT00887445|SLV341|slv341
5184245|NCT00887445|diabetes|diabetes
5184246|NCT00887419|chronic back pain|chronic back pain
5184247|NCT00887419|spinal cord stimulator implant|spinal cord stimulator implant
5184248|NCT00887406|first time in human study|first time in human study
5184249|NCT00887406|COPD|copd
5184250|NCT00887406|long-acting bronchodilator|long-acting bronchodilator
5184251|NCT00887393|morbid obesity|morbid obesity
5184252|NCT00887393|non-alcoholic fatty liver disease|non-alcoholic fatty liver disease
5184253|NCT00887393|bariatric surgery|bariatric surgery
5184254|NCT00887393|low fat diet|low fat diet
5184255|NCT00887393|low carbohydrate diet|low carbohydrate diet
5184256|NCT00887380|Breast Cancer|breast cancer
5184257|NCT00887380|Timing of Radiotherapy|timing of radiotherapy
5184258|NCT00887380|Local control|local control
5184259|NCT00887367|Healthy volunteers|healthy volunteers
5184260|NCT00887367|Substance dependence|substance dependence
5184261|NCT00887367|Alcohol dependence|alcohol dependence
5184262|NCT00887354|Low bone mass|low bone mass
5184263|NCT00887354|Recent pertrochanteric hip fracture|recent pertrochanteric hip fracture
5184264|NCT00887328|ischemic stroke|ischemic stroke
5184265|NCT00887328|ischemic penumbra|ischemic penumbra
5184266|NCT00887328|magnetic resonance imaging|magnetic resonance imaging
5184267|NCT00887328|MRI|mri
5184268|NCT00887328|diffusion imaging|diffusion imaging
5184269|NCT00887328|DWI|dwi
5184270|NCT00887328|perfusion imaging|perfusion imaging
5184271|NCT00887328|PWI|pwi
5184272|NCT00887328|thrombolysis|thrombolysis
5184273|NCT00887328|alteplase|alteplase
5184274|NCT00887328|tPA|tpa
5184275|NCT00887328|EPITHET|epithet
5184276|NCT00887315|NSCLC|nsclc
5184277|NCT00887315|Metastatic Stage IV NSCLC|metastatic stage iv nsclc
5184278|NCT00887315|Limited Volume Stage IV Non-small Cell Lung Cancer|limited volume stage iv non-small cell lung cancer
5184280|NCT00887276|Amoxicillin|amoxicillin
5184281|NCT00887276|Moxifloxacin|moxifloxacin
5184282|NCT00887276|Community-Acquired Pneumonia|community-acquired pneumonia
5184283|NCT00887237|Heart failure|heart failure
5184284|NCT00887237|Cardiac resynchronization|cardiac resynchronization
5184285|NCT00887237|Triple site ventricular pacing|triple site ventricular pacing
5184286|NCT00887224|Major Depressive Disorder|major depressive disorder
5184288|NCT00887211|coronary artery disease|coronary artery disease
5184289|NCT00887198|Prostate cancer|prostate cancer
5184290|NCT00887198|Abiraterone acetate|abiraterone acetate
5184291|NCT00887198|CB7630|cb7630
5184292|NCT00887198|CRPC|crpc
5184293|NCT00887198|Metastatic castration-resistant prostate cancer|metastatic castration-resistant prostate cancer
5184294|NCT00887198|hormone refractory prostate cancer|hormone refractory prostate cancer
5184295|NCT00887185|Surgical Simulation|surgical simulation
5184296|NCT00887185|Surgical skills training|surgical skills training
5184297|NCT00887185|Temporal bone surgery|temporal bone surgery
5184298|NCT00887185|Computer simulation|computer simulation
5184299|NCT00887172|Acute upper respiratory tract infections|acute upper respiratory tract infections
5184300|NCT00887146|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5184301|NCT00887146|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
5184302|NCT00887146|adult mixed glioma|adult mixed glioma
5184303|NCT00887120|Second line treatment|second line treatment
5184304|NCT00887120|therapeutic drug monitoring|therapeutic drug monitoring
5184305|NCT00887120|Asia|asia
5184306|NCT00887120|LPV|lpv
5184307|NCT00887120|children|children
5184308|NCT00887120|pharmacokinetic|pharmacokinetic
5184309|NCT00887120|To study the pharmacokinetics of low-dose and standard dose, lopinavir/ritonavir in Protease inhibitor (PI)- naive HIV-1 infected Thai patients.|to study the pharmacokinetics of low-dose and standard dose, lopinavir/ritonavir in protease inhibitor (pi)- naive hiv-1 infected thai patients.
5184310|NCT00887120|To study clinical and immunological efficacy after 48-weeks of lopinavir/ritonavir-based antiretroviral therapy in PI naive HIV-1 infected Thai patients.|to study clinical and immunological efficacy after 48-weeks of lopinavir/ritonavir-based antiretroviral therapy in pi naive hiv-1 infected thai patients.
5184311|NCT00887094|Diabetes mellitus|diabetes mellitus
5184312|NCT00887094|Exercise|exercise
5184313|NCT00887094|Endurance|endurance
5184314|NCT00887094|Resistance|resistance
5184315|NCT00887094|Continuous glucose monitoring system|continuous glucose monitoring system
5184316|NCT00887081|antiviral treatment in hemoglobinopathies|antiviral treatment in hemoglobinopathies
5184317|NCT00887081|management of chronic viral hepatitis C infection|management of chronic viral hepatitis c infection
5184318|NCT00887081|antiviral treatment|antiviral treatment
5184319|NCT00887068|Leukemia|leukemia
5184320|NCT00887068|Acute myelogenous leukemia|acute myelogenous leukemia
5184321|NCT00887068|AML|aml
5184322|NCT00887068|Myelodysplastic syndrome|myelodysplastic syndrome
5184323|NCT00887068|MDS|mds
5184324|NCT00887068|Remission|remission
5184325|NCT00887068|Allogeneic stem cell transplant|allogeneic stem cell transplant
5184326|NCT00887068|Allotx|allotx
5184327|NCT00887068|Azacitidine|azacitidine
5184328|NCT00887068|5-Azacitidine|5-azacitidine
5184329|NCT00887068|5-aza|5-aza
5184330|NCT00887068|Vidaza|vidaza
5184331|NCT00887068|5-AZC|5-azc
5184332|NCT00887068|AZA-CR|aza-cr
5184333|NCT00887068|Ladakamycin|ladakamycin
5184334|NCT00887068|NSC-102816|nsc-102816
5184335|NCT00887042|Acute myeloid leukemia|acute myeloid leukemia
5184336|NCT00887042|Cord blood transplantation|cord blood transplantation
5184337|NCT00887042|Pediatric|pediatric
5184338|NCT00887029|Topical prostaglandin analogue|topical prostaglandin analogue
5184339|NCT00887029|glaucoma|glaucoma
5184340|NCT00887029|POAG|poag
5184341|NCT00887029|OHT|oht
5184342|NCT00887029|OAG|oag
5184343|NCT00887029|ocular hypertension|ocular hypertension
5184344|NCT00887029|fixed combination protaglandin analogue therapy|fixed combination protaglandin analogue therapy
5184345|NCT00887029|DuoTrav|duotrav
5184346|NCT00887029|timolol|timolol
5184347|NCT00887029|travoprost|travoprost
5184348|NCT00887029|24 hour post dose|24 hour post dose
5184349|NCT00887029|IOP|iop
5184350|NCT00887029|dosing preference|dosing preference
5184351|NCT00887003|epidural|epidural
5184352|NCT00887003|volume|volume
5184353|NCT00887003|dose|dose
5184354|NCT00887003|pain relief|pain relief
5184355|NCT00887003|steroid|steroid
5184356|NCT00886990|single- and double-boosted PI|single- and double-boosted pi
5184357|NCT00886990|second line regimen|second line regimen
5184358|NCT00886990|NNRTI failure|nnrti failure
5184359|NCT00886990|HIV-infected children|hiv-infected children
5184360|NCT00886990|Compare virological efficacy and safety of single- or double-boosted PI regimens as second line therapy in children with NNRTI-based treatment failure|compare virological efficacy and safety of single- or double-boosted pi regimens as second line therapy in children with nnrti-based treatment failure
5184361|NCT00886990|treatment experienced|treatment experienced
5184362|NCT00886977|ALS|als
5184363|NCT00886964|HBV vaccine|hbv vaccine
5184364|NCT00886964|HIV children|hiv children
5184365|NCT00886964|immune recovery|immune recovery
5184366|NCT00886964|HBV antibody|hbv antibody
5184367|NCT00886964|Intradermal|intradermal
5184368|NCT00886964|Intramuscular|intramuscular
5184369|NCT00886964|antibody response after HBV vaccine|antibody response after hbv vaccine
5184370|NCT00886964|treatment experienced|treatment experienced
5184371|NCT00886938|tinnitus|tinnitus
5184372|NCT00886925|Hepatic encephalopathy|hepatic encephalopathy
5184373|NCT00886925|Cirrhosis|cirrhosis
5184374|NCT00886925|Albumin|albumin
5184375|NCT00886912|mountain sickness|mountain sickness
5184376|NCT00886899|CTO|cto
5184377|NCT00886899|chronic total occlusion|chronic total occlusion
5184378|NCT00886899|CAD|cad
5184379|NCT00886899|coronary artery disease|coronary artery disease
5184380|NCT00886899|interventional cardiology|interventional cardiology
5184381|NCT00886899|revascularization|revascularization
5184382|NCT00886899|recanalization|recanalization
5184383|NCT00886886|MDMA|mdma
5184384|NCT00886886|norepinephrine|norepinephrine
5184385|NCT00886886|Ecstasy|ecstasy
5184386|NCT00886886|stimulant|stimulant
5184387|NCT00886873|Uterine fibroids|uterine fibroids
5184388|NCT00886873|Mifepristone|mifepristone
5184389|NCT00886873|Antiprogestins|antiprogestins
5184390|NCT00886860|Efficacy|efficacy
5184391|NCT00886860|Cervical ripening/Labor induction|cervical ripening/labor induction
5184392|NCT00886860|Titrated oral misoprostol/Conventional oral misoprostol|titrated oral misoprostol/conventional oral misoprostol
5184393|NCT00886860|Term pregnancy|term pregnancy
5184394|NCT00886847|Lung|lung
5184395|NCT00886847|Lymphadenopathy|lymphadenopathy
5184396|NCT00886847|Enlarged hilar or/and mediastinal lymph adenopathy|enlarged hilar or/and mediastinal lymph adenopathy
5184397|NCT00886847|Benign|benign
5184398|NCT00886847|Malignant|malignant
5184399|NCT00886847|Mediastinal lymph nodes|mediastinal lymph nodes
5184400|NCT00886847|Hilar lymph nodes|hilar lymph nodes
5184401|NCT00886847|Fine Needle Aspiration|fine needle aspiration
5184402|NCT00886847|FNA|fna
5184403|NCT00886847|Fine Needle Capillary Sampling|fine needle capillary sampling
5184404|NCT00886847|FNC|fnc
5184405|NCT00886847|Endobronchial Ultrasound-Guided Biopsy|endobronchial ultrasound-guided biopsy
5184406|NCT00886847|EBUS|ebus
5184407|NCT00886847|Tissue Sample|tissue sample
5184408|NCT00886847|Suction|suction
5184409|NCT00886834|IUD insertion|iud insertion
5184410|NCT00886834|Nulliparous women|nulliparous women
5184411|NCT00886834|Contraception|contraception
5184412|NCT00886834|Family Planning|family planning
5184413|NCT00886834|IUD insertion in nulliparous women|iud insertion in nulliparous women
5184414|NCT00886821|Phase 1 Type 2 diabetes CVX-096 diabetes mellitus|phase 1 type 2 diabetes cvx-096 diabetes mellitus
5184415|NCT00886821|adult-onset diabetes mellitus|adult-onset diabetes mellitus
5184416|NCT00886821|non-insulin dependent|non-insulin dependent
5184417|NCT00886808|DME, Diabetic Retinopathy, Diabetic Macular Edema|dme, diabetic retinopathy, diabetic macular edema
5184418|NCT00886795|hives|hives
5184419|NCT00886795|rash|rash
5184420|NCT00886795|pruritis|pruritis
5184421|NCT00886782|Advanced and/or Metastatic solid cancers|advanced and/or metastatic solid cancers
5184422|NCT00886769|Flare|flare
5184423|NCT00886769|arthritis|arthritis
5184424|NCT00886769|IL-1beta antagonist|il-1beta antagonist
5184425|NCT00886769|systemic juvenile idiopathic arthritis|systemic juvenile idiopathic arthritis
5184426|NCT00886769|Juvenile Rheumatoid|juvenile rheumatoid
5184427|NCT00886769|Systemic juvenile idiopathic arthritis with active flare|systemic juvenile idiopathic arthritis with active flare
5184428|NCT00886756|Phase I|phase i
5184429|NCT00886756|Japanese healthy volunteer|japanese healthy volunteer
5184430|NCT00886756|AZD8529|azd8529
5184431|NCT00886730|Depressive disorder|depressive disorder
5184432|NCT00886730|Primary care|primary care
5184433|NCT00886730|Internet|internet
5184434|NCT00886730|Social support|social support
5184435|NCT00886730|Feasibility|feasibility
5184436|NCT00886717|stage IIIA ovarian epithelial cancer|stage iiia ovarian epithelial cancer
5184437|NCT00886717|stage IIIB ovarian epithelial cancer|stage iiib ovarian epithelial cancer
5184438|NCT00886717|stage IIIC ovarian epithelial cancer|stage iiic ovarian epithelial cancer
5184439|NCT00886717|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5184440|NCT00886717|stage IIIA ovarian germ cell tumor|stage iiia ovarian germ cell tumor
5184441|NCT00886717|stage IIIB ovarian germ cell tumor|stage iiib ovarian germ cell tumor
5184442|NCT00886717|stage IIIC ovarian germ cell tumor|stage iiic ovarian germ cell tumor
5184443|NCT00886717|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
5184444|NCT00886704|Omega-3 fatty acids|omega-3 fatty acids
5184445|NCT00886704|dietary supplementation|dietary supplementation
5184446|NCT00886704|atherosclerosis|atherosclerosis
5184447|NCT00886678|Non-Small Cell Lung Cancer|non-small cell lung cancer
5184448|NCT00886678|pemetrexed|pemetrexed
5184449|NCT00886678|radiation|radiation
5184450|NCT00886665|Diabetic Neuropathy|diabetic neuropathy
5184451|NCT00886665|Nerve Conduction Studies|nerve conduction studies
5184452|NCT00886665|Clinical Trial|clinical trial
5184453|NCT00886652|Scoliosis|scoliosis
5184454|NCT00886652|Muscle Strength|muscle strength
5184455|NCT00886652|Respiratory function tests|respiratory function tests
5184456|NCT00886652|Exercise therapy|exercise therapy
5184457|NCT00886639|COPD III/IV|copd iii/iv
5184458|NCT00886639|Oxygen Supply|oxygen supply
5184459|NCT00886639|Six-Minute-Walking-Test|six-minute-walking-test
5184460|NCT00886639|Oxygen Responder|oxygen responder
5184461|NCT00886626|Obesity|obesity
5184462|NCT00886626|Impaired Glucose Tolerance|impaired glucose tolerance
5184463|NCT00886626|Children|children
5184464|NCT00886587|eczema|eczema
5184465|NCT00886574|Cilostazol versus Aspirin|cilostazol versus aspirin
5184466|NCT00886574|Anti-PLT drug|anti-plt drug
5184467|NCT00886574|Primary Prevention of Atherosclerotic Events|primary prevention of atherosclerotic events
5184468|NCT00886574|Type 2 DM|type 2 dm
5184469|NCT00886574|Intima media thickness (IMT)|intima media thickness (imt)
5184470|NCT00886561|HIV prevention, female sex workers|hiv prevention, female sex workers
5184471|NCT00886561|HIV seronegativity|hiv seronegativity
5184472|NCT00886535|breast cancer|breast cancer
5184473|NCT00886535|hot flashes|hot flashes
5184474|NCT00886535|tamoxifen|tamoxifen
5184475|NCT00886522|Anti-thymocyte globulin Fresenius|anti-thymocyte globulin fresenius
5184476|NCT00886522|Busulfan|busulfan
5184477|NCT00886522|Cord blood|cord blood
5184478|NCT00886522|Cyclophosphamide|cyclophosphamide
5184479|NCT00886522|Fludarabine|fludarabine
5184480|NCT00886522|Human Leucocyte Antigen|human leucocyte antigen
5184481|NCT00886522|Hematopoietic Stem Cell|hematopoietic stem cell
5184482|NCT00886522|Hematopoietic Stem Cell Transplant|hematopoietic stem cell transplant
5184483|NCT00886522|Graft-versus-Host-Disease|graft-versus-host-disease
5184484|NCT00886522|Graft-versus-Host-Disease prophylaxis|graft-versus-host-disease prophylaxis
5184485|NCT00886522|Intrabone infusion|intrabone infusion
5184486|NCT00886522|Thiotepa|thiotepa
5184487|NCT00886509|Coronary Artery Disease|coronary artery disease
5184488|NCT00886509|Stable|stable
5184489|NCT00886509|Coronary Collaterals|coronary collaterals
5184490|NCT00886509|Therapeutic Collateral Promotion (TCP)|therapeutic collateral promotion (tcp)
5184491|NCT00886496|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
5184492|NCT00886496|fever, sweats, and hot flashes|fever, sweats, and hot flashes
5184493|NCT00886496|neutropenia|neutropenia
5184494|NCT00886496|infection|infection
5184495|NCT00886496|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
5184496|NCT00886496|stage I and II childhood small noncleaved cell lymphoma|stage i and ii childhood small noncleaved cell lymphoma
5184497|NCT00886496|stage I childhood small noncleaved cell lymphoma|stage i childhood small noncleaved cell lymphoma
5184498|NCT00886496|stage II childhood small noncleaved cell lymphoma|stage ii childhood small noncleaved cell lymphoma
5184499|NCT00886496|stage III and IV childhood small noncleaved cell lymphoma|stage iii and iv childhood small noncleaved cell lymphoma
5184500|NCT00886496|stage III childhood small noncleaved cell lymphoma|stage iii childhood small noncleaved cell lymphoma
5184501|NCT00886496|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
5184502|NCT00886496|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
5184503|NCT00886496|stage I and II childhood lymphoblastic lymphoma|stage i and ii childhood lymphoblastic lymphoma
5184504|NCT00886496|stage I childhood lymphoblastic lymphoma|stage i childhood lymphoblastic lymphoma
5184505|NCT00886496|stage II childhood lymphoblastic lymphoma|stage ii childhood lymphoblastic lymphoma
5184506|NCT00886496|stage III and IV childhood lymphoblastic lymphoma|stage iii and iv childhood lymphoblastic lymphoma
5184507|NCT00886496|stage III childhood lymphoblastic lymphoma|stage iii childhood lymphoblastic lymphoma
5184508|NCT00886496|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
5184509|NCT00886496|childhood Burkitt lymphoma|childhood burkitt lymphoma
5184510|NCT00886496|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
5184511|NCT00886496|stage I childhood Hodgkin lymphoma|stage i childhood hodgkin lymphoma
5184512|NCT00886496|stage II childhood Hodgkin lymphoma|stage ii childhood hodgkin lymphoma
5184513|NCT00886496|stage III childhood Hodgkin lymphoma|stage iii childhood hodgkin lymphoma
5184514|NCT00886496|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
5184515|NCT00886496|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
5184516|NCT00886496|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5184517|NCT00886496|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
5184518|NCT00886496|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5184519|NCT00886496|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5184520|NCT00886496|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5184521|NCT00886496|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
5184522|NCT00886496|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5184523|NCT00886496|untreated childhood acute myeloid leukemia and other myeloid malignancies|untreated childhood acute myeloid leukemia and other myeloid malignancies
5184524|NCT00886496|childhood grade III lymphomatoid granulomatosis|childhood grade iii lymphomatoid granulomatosis
5184525|NCT00886496|childhood nasal type extranodal NK/T-cell lymphoma|childhood nasal type extranodal nk/t-cell lymphoma
5184526|NCT00886496|recurrent childhood grade III lymphomatoid granulomatosis|recurrent childhood grade iii lymphomatoid granulomatosis
5184527|NCT00886496|childhood diffuse large cell lymphoma|childhood diffuse large cell lymphoma
5184528|NCT00886496|childhood immunoblastic large cell lymphoma|childhood immunoblastic large cell lymphoma
5184529|NCT00886496|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
5184530|NCT00886496|stage I childhood large cell lymphoma|stage i childhood large cell lymphoma
5184531|NCT00886496|stage II childhood large cell lymphoma|stage ii childhood large cell lymphoma
5184532|NCT00886496|stage III and IV childhood large cell lymphoma|stage iii and iv childhood large cell lymphoma
5184533|NCT00886496|stage III childhood large cell lymphoma|stage iii childhood large cell lymphoma
5184534|NCT00886496|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
5184535|NCT00886483|Neurofeedback|neurofeedback
5184536|NCT00886470|cytokines|cytokines
5184537|NCT00886470|pain|pain
5184538|NCT00886470|scarring|scarring
5184539|NCT00886470|vascularity|vascularity
5184540|NCT00886457|Biopsy proven cancer, which is metastatic or unresectable|biopsy proven cancer, which is metastatic or unresectable
5184541|NCT00886431|IVF|ivf
5184542|NCT00886431|embryo cryopreservation|embryo cryopreservation
5184543|NCT00886431|vitrification|vitrification
5184544|NCT00886431|slow cooling|slow cooling
5184545|NCT00886431|slow freezing|slow freezing
5184546|NCT00886431|surplus embryos|surplus embryos
5184547|NCT00886431|Human Reproduction|human reproduction
5184548|NCT00886405|Nitroglycerin|nitroglycerin
5184549|NCT00886405|Locally advanced non small-cell lung cancer|locally advanced non small-cell lung cancer
5184550|NCT00886405|Vascular endothelial growth factor|vascular endothelial growth factor
5185152|NCT00883961|Exercise|exercise
5184551|NCT00886405|Hypoxia Inducible Factor|hypoxia inducible factor
5184552|NCT00886405|Clinical stage IIIA and/or IIIB (without pleural effusion)|clinical stage iiia and/or iiib (without pleural effusion)
5184553|NCT00886392|Clinically Significant Macular Edema|clinically significant macular edema
5184554|NCT00886392|Diabetic Macular Edema|diabetic macular edema
5184555|NCT00886392|Optical Coherence Tomography|optical coherence tomography
5184556|NCT00886392|Diabetic Retinopathy|diabetic retinopathy
5184557|NCT00886392|Severity|severity
5184558|NCT00886379|vitamin d|vitamin d
5184559|NCT00886379|children|children
5184560|NCT00886379|Mongolia|mongolia
5184561|NCT00886366|Type II Diabetes|type ii diabetes
5184562|NCT00886353|RAS|ras
5184563|NCT00886353|ACE2|ace2
5184564|NCT00886353|Cardiovascular|cardiovascular
5184565|NCT00886353|Pulmonary|pulmonary
5184566|NCT00886353|Angiotensin II|angiotensin ii
5184567|NCT00886353|Angiotensin 1-7|angiotensin 1-7
5184568|NCT00886340|diabetes prevention, primary care|diabetes prevention, primary care
5184569|NCT00886327|Colonic capsule endoscopy|colonic capsule endoscopy
5184570|NCT00886327|Crohn's disease|crohn's disease
5184571|NCT00886327|Capsule endoscopy|capsule endoscopy
5184572|NCT00886314|children|children
5184573|NCT00886314|surgery|surgery
5184574|NCT00886314|anxiety|anxiety
5184575|NCT00886301|overweight|overweight
5184576|NCT00886301|obesity|obesity
5184577|NCT00886301|steatohepatitis|steatohepatitis
5184578|NCT00886301|ectopic fat|ectopic fat
5184579|NCT00886275|Postoperative sedation in intensive care|postoperative sedation in intensive care
5184580|NCT00886262|liver transplantation|liver transplantation
5184581|NCT00886262|vasopressin|vasopressin
5184582|NCT00886262|renal function|renal function
5184583|NCT00886262|hypotension|hypotension
5184584|NCT00886262|creatinine|creatinine
5184585|NCT00886262|urine output|urine output
5184586|NCT00886262|diuretics|diuretics
5184587|NCT00886262|vasopressors|vasopressors
5184588|NCT00886262|hemodynamic stability|hemodynamic stability
5184589|NCT00886249|Vision|vision
5184590|NCT00886249|Eye|eye
5184591|NCT00886249|Cataract|cataract
5184592|NCT00886236|Gastric Bypass|gastric bypass
5184593|NCT00886236|Gabapentin|gabapentin
5184594|NCT00886236|Postoperative Nausea and Vomiting|postoperative nausea and vomiting
5184595|NCT00886236|Analgesics, Opioids|analgesics, opioids
5184596|NCT00886236|Sleep Apnea, Obstructive|sleep apnea, obstructive
5184597|NCT00886236|Respiratory Depression|respiratory depression
5184598|NCT00886236|Oximetry|oximetry
5184599|NCT00886223|vaginal vault prolapse repair|vaginal vault prolapse repair
5184600|NCT00886223|robot-assisted laparoscopic sacropexy|robot-assisted laparoscopic sacropexy
5184601|NCT00886223|robot-assisted laparoscopic sacrocolpopexy|robot-assisted laparoscopic sacrocolpopexy
5184602|NCT00886223|robotic laparoscopic sacropexy|robotic laparoscopic sacropexy
5184603|NCT00886210|drain|drain
5184604|NCT00886210|laparoscopic cholecystectomy|laparoscopic cholecystectomy
5184605|NCT00886210|pneumoperitonum|pneumoperitonum
5184606|NCT00886197|reflux|reflux
5184607|NCT00886197|GERD|gerd
5184608|NCT00886184|Hypothermia|hypothermia
5184609|NCT00886184|Cardiac arrest|cardiac arrest
5184610|NCT00886184|Biomarkers|biomarkers
5184611|NCT00886184|Pre hospital cardiac arrest|pre hospital cardiac arrest
5184612|NCT00886171|social skills|social skills
5184613|NCT00886171|physical activity|physical activity
5184614|NCT00886171|peer relationships|peer relationships
5184615|NCT00886171|childhood obesity|childhood obesity
5184616|NCT00886171|changes in physical activity|changes in physical activity
5184617|NCT00886171|changes in social involvement|changes in social involvement
5184618|NCT00886158|Organ Transplants|organ transplants
5184619|NCT00886145|Spinal Cord Injuries|spinal cord injuries
5184620|NCT00886145|Mechanical Stimulation|mechanical stimulation
5184621|NCT00886145|Vibration Plate|vibration plate
5184622|NCT00886132|Phase 2 Study|phase 2 study
5184623|NCT00886132|Sunitinib|sunitinib
5184624|NCT00886132|Recurrent|recurrent
5184625|NCT00886132|Metastatic|metastatic
5184626|NCT00886132|Adenoid Cystic Carcinoma|adenoid cystic carcinoma
5184627|NCT00886132|Salivary Glands|salivary glands
5184628|NCT00886132|Metastasis|metastasis
5184629|NCT00886106|Capsaicin|capsaicin
5184630|NCT00886106|Remifentanil|remifentanil
5184631|NCT00886106|Hyperalgesia|hyperalgesia
5184632|NCT00886093|pharmacokinetics, single dose, crossover, fed vs fasted state|pharmacokinetics, single dose, crossover, fed vs fasted state
5184633|NCT00886080|Atrial fibrillation|atrial fibrillation
5184634|NCT00886080|Health related Quality of Life|health related quality of life
5184635|NCT00886080|Add-on surgery|add-on surgery
5184636|NCT00886080|Ablation|ablation
5184637|NCT00886080|Randomised controlled trial|randomised controlled trial
5184638|NCT00886080|SF-36|sf-36
5184639|NCT00886080|EuroQoL|euroqol
5184640|NCT00886080|MFI-20|mfi-20
5184641|NCT00886067|AZD1446|azd1446
5184642|NCT00886067|PET examination|pet examination
5184643|NCT00886054|Transcranial Doppler|transcranial doppler
5184644|NCT00886054|Transcranial color-coded duplex sonography|transcranial color-coded duplex sonography
5184645|NCT00886054|Neurocritical patients|neurocritical patients
5184646|NCT00886041|laparoscopy|laparoscopy
5184647|NCT00886041|unexplained infertility|unexplained infertility
5184648|NCT00886028|Malignant pleural mesothelioma|malignant pleural mesothelioma
5184649|NCT00886028|Liposomal doxorubicin|liposomal doxorubicin
5184650|NCT00886028|Progression free survival|progression free survival
5184651|NCT00886028|Patients who received LD 60mg/m2 plus cisplatin 80 mg/m2 every 4 weeks for 6 cycles|patients who received ld 60mg/m2 plus cisplatin 80 mg/m2 every 4 weeks for 6 cycles
5184652|NCT00886028|Patients with epithelial, sarcomatoid or biphasic histological confirmed diagnosis of MPM|patients with epithelial, sarcomatoid or biphasic histological confirmed diagnosis of mpm
5184653|NCT00886015|Trachoma|trachoma
5184654|NCT00886015|trichiasis|trichiasis
5184655|NCT00886015|bilamellar tarsal rotation procedure|bilamellar tarsal rotation procedure
5184656|NCT00886002|Healthy volunteers|healthy volunteers
5184657|NCT00885989|SLV338|slv338
5184658|NCT00885989|phase I|phase i
5184659|NCT00885989|healthy volunteers|healthy volunteers
5184660|NCT00885950|colorectal liver metastases|colorectal liver metastases
5184661|NCT00885950|neoadjuvant chemotherapy|neoadjuvant chemotherapy
5184662|NCT00885950|oxaliplatin|oxaliplatin
5184663|NCT00885950|sinusoidal obstruction syndrome|sinusoidal obstruction syndrome
5184664|NCT00885950|anticoagulants|anticoagulants
5184665|NCT00885937|Dexpanthenol|dexpanthenol
5184666|NCT00885937|Safety,|safety,
5184667|NCT00885937|New formulation|new formulation
5184668|NCT00885937|Topical administration|topical administration
5184669|NCT00885924|postoperative Hemorrhage|postoperative hemorrhage
5184670|NCT00885924|Hemorrhage|hemorrhage
5184671|NCT00885924|Vasopressin|vasopressin
5184672|NCT00885924|Blood Loss, Surgical|blood loss, surgical
5184673|NCT00885911|Intubating laryngeal airway|intubating laryngeal airway
5184674|NCT00885911|pediatric|pediatric
5184675|NCT00885911|observational study|observational study
5184676|NCT00885898|Respiratory Insufficiency|respiratory insufficiency
5184677|NCT00885898|Respiratory Failure|respiratory failure
5184678|NCT00885885|Colorectal Cancer|colorectal cancer
5184679|NCT00885885|Panitumumab|panitumumab
5184680|NCT00885885|FOLFOX-4|folfox-4
5184681|NCT00885885|FOLFIRI|folfiri
5184682|NCT00885846|Qigong|qigong
5184683|NCT00885846|Breathing management|breathing management
5184684|NCT00885846|Glucose|glucose
5184685|NCT00885833|Wiskott-Aldrich syndrome|wiskott-aldrich syndrome
5184686|NCT00885833|HSCT|hsct
5184687|NCT00885820|Kidney Transplantation|kidney transplantation
5184688|NCT00885820|Tacrolimus|tacrolimus
5184689|NCT00885820|Immunosuppression|immunosuppression
5184690|NCT00885820|Graft Survival|graft survival
5184691|NCT00885807|ADHD|adhd
5184692|NCT00885807|WFIRS|wfirs
5184693|NCT00885807|WSR|wsr
5184694|NCT00885794|Clinically Significant Diabetic Macular Edema|clinically significant diabetic macular edema
5184695|NCT00885794|Focal Laser|focal laser
5184696|NCT00885794|GRID-Laser|grid-laser
5184697|NCT00885794|Ranibizumab|ranibizumab
5184698|NCT00885794|Lucentis|lucentis
5184699|NCT00885794|Microperimetry|microperimetry
5184700|NCT00885794|High-Definition OCT|high-definition oct
5184701|NCT00885794|Randomized|randomized
5184702|NCT00885794|Observer-Blinded|observer-blinded
5184703|NCT00885794|Ineffective Treatment with Focal Laser or GRID-Laser|ineffective treatment with focal laser or grid-laser
5184704|NCT00885768|RAS(renal Artery Stenosis)|ras(renal artery stenosis)
5184705|NCT00885768|Atherosclerosis|atherosclerosis
5184706|NCT00885768|angiography|angiography
5184707|NCT00885742|Hereditary Factor XIII deficiency|hereditary factor xiii deficiency
5184708|NCT00885742|Factor XIII|factor xiii
5184709|NCT00885729|Cartilage defect|cartilage defect
5184710|NCT00885729|chondrocytes|chondrocytes
5184711|NCT00885729|mesenchymal stem cells (MSC)|mesenchymal stem cells (msc)
5184712|NCT00885729|femoral condyle|femoral condyle
5184713|NCT00885729|knee|knee
5184714|NCT00885703|CM|cm
5184715|NCT00885703|HIV|hiv
5184716|NCT00885703|Meningitis|meningitis
5184717|NCT00885690|Schizophrenia|schizophrenia
5184718|NCT00885690|Antipsychotic|antipsychotic
5184719|NCT00885690|Cognition|cognition
5184720|NCT00885664|HIV|hiv
5184721|NCT00885664|immune reconstitution|immune reconstitution
5184722|NCT00885664|treatment naive|treatment naive
5184723|NCT00885651|SNP|snp
5184724|NCT00885651|catecholamines|catecholamines
5184725|NCT00885651|metoprolole|metoprolole
5184726|NCT00885651|healthy subjects|healthy subjects
5184727|NCT00885651|physiological stress|physiological stress
5184728|NCT00885638|GLP-1|glp-1
5184729|NCT00885638|Insulin secretion|insulin secretion
5184730|NCT00885638|Macronutrients|macronutrients
5184731|NCT00885625|invasive pneumococcal disease|invasive pneumococcal disease
5184732|NCT00885625|pneumococcal conjugated vaccine|pneumococcal conjugated vaccine
5184733|NCT00885612|CHD-Risk|chd-risk
5184734|NCT00885612|Breast Cancer|breast cancer
5184735|NCT00885612|Aromatase Inhibitors|aromatase inhibitors
5184736|NCT00885612|postmenopausal early breast cancer|postmenopausal early breast cancer
5184737|NCT00885599|gingivitis|gingivitis
5184738|NCT00885599|natural remedy|natural remedy
5184739|NCT00885599|inflammation|inflammation
5184740|NCT00885599|C-reactive protein|c-reactive protein
5184741|NCT00885599|mouthwash|mouthwash
5184742|NCT00885586|herpes zoster|herpes zoster
5184743|NCT00885586|neuropathic pain|neuropathic pain
5184744|NCT00885586|acupuncture|acupuncture
5184745|NCT00885586|randomised controlled trial|randomised controlled trial
5184746|NCT00885586|acute herpes zoster|acute herpes zoster
5184748|NCT00885573|pharyngeal sensitivity|pharyngeal sensitivity
5184749|NCT00885573|pharyngeal dilator reflex|pharyngeal dilator reflex
5184750|NCT00885573|diagnosis algorithm|diagnosis algorithm
5184751|NCT00885573|patients with suspected sleep apnea syndrome|patients with suspected sleep apnea syndrome
5184752|NCT00885560|ADHD|adhd
5184753|NCT00885560|SNAP 25|snap 25
5184754|NCT00885560|amphetamine|amphetamine
5184755|NCT00885560|methylphenidate|methylphenidate
5184756|NCT00885534|skin cancer|skin cancer
5184757|NCT00885534|CISPLATIN|cisplatin
5184758|NCT00885534|TEMOZOLOMIDE|temozolomide
5184759|NCT00885534|VINBLASTINE|vinblastine
5184760|NCT00885534|09-017|09-017
5184762|NCT00885508|AML|aml
5184763|NCT00885508|deletion 5q|deletion 5q
5184764|NCT00885508|Documented diagnosis of MDS, or CMML|documented diagnosis of mds, or cmml
5184765|NCT00885508|with WBC < 13,000/mm3 that meets IPSS criteria for intermediate-2|with wbc < 13,000/mm3 that meets ipss criteria for intermediate-2
5184766|NCT00885508|or high-risk disease, or AML with an associated del 5q[31]|or high-risk disease, or aml with an associated del 5q[31]
5184767|NCT00885508|(the deleted chromosomal region must include 5q[31]),|(the deleted chromosomal region must include 5q[31]),
5184768|NCT00885508|with or without additional cytogenetic abnormalities|with or without additional cytogenetic abnormalities
5184769|NCT00885495|HIV|hiv
5184770|NCT00885495|dyslipidemia|dyslipidemia
5184771|NCT00885495|statins|statins
5184772|NCT00885495|protease inhibitors|protease inhibitors
5184773|NCT00885482|HIV/AIDS|hiv/aids
5184774|NCT00885482|HAART|haart
5184775|NCT00885482|Simplification|simplification
5184776|NCT00885482|Atazanavir|atazanavir
5184777|NCT00885482|Lamivudine|lamivudine
5184778|NCT00885482|treatment experienced|treatment experienced
5184779|NCT00885469|known Barrett's Esophagus|known barrett's esophagus
5184780|NCT00885469|Suspected Barrett's Esophagus|suspected barrett's esophagus
5184781|NCT00885469|chronic GERD|chronic gerd
5184782|NCT00885469|known Barrett's Esophagus or chronic GERD|known barrett's esophagus or chronic gerd
5184783|NCT00885456|stroke|stroke
5184784|NCT00885456|secondary prevention|secondary prevention
5184785|NCT00885456|vascular risk|vascular risk
5184786|NCT00885456|behavioral change|behavioral change
5184787|NCT00885456|exercise|exercise
5184788|NCT00885456|lifestyle modification|lifestyle modification
5184789|NCT00885443|propofol|propofol
5184790|NCT00885443|sevoflurane|sevoflurane
5184791|NCT00885443|pediatric|pediatric
5184792|NCT00885443|emergence delirium|emergence delirium
5184793|NCT00885443|Induction of sedation|induction of sedation
5184794|NCT00885430|colonoscopy|colonoscopy
5184795|NCT00885430|preparation|preparation
5184796|NCT00885417|Helicobacter pylori|helicobacter pylori
5184797|NCT00885417|sequential therapy|sequential therapy
5184798|NCT00885417|levofloxacin|levofloxacin
5184799|NCT00885417|clarithromycin|clarithromycin
5184800|NCT00885417|rescue|rescue
5184801|NCT00885417|salvage|salvage
5184802|NCT00885417|treatment failure|treatment failure
5184803|NCT00885417|For those who fail from one standard eradication therapy for H. pylori infection|for those who fail from one standard eradication therapy for h. pylori infection
5184804|NCT00885404|chloride|chloride
5184805|NCT00885404|acidosis|acidosis
5184806|NCT00885391|Atrial Fibrillation|atrial fibrillation
5184807|NCT00885391|Cardioversion|cardioversion
5184808|NCT00885391|Direct Current Cardioversion|direct current cardioversion
5184809|NCT00885391|QT Interval|qt interval
5184810|NCT00885365|cystic fibrosis|cystic fibrosis
5184811|NCT00885365|P. aeruginosa|p. aeruginosa
5184812|NCT00885365|tobramycin|tobramycin
5184813|NCT00885339|Colonic Diseases|colonic diseases
5184814|NCT00885326|recurrent neuroblastoma|recurrent neuroblastoma
5184815|NCT00885313|NAFLD|nafld
5184816|NCT00885313|NASH|nash
5184817|NCT00885313|fibrosis|fibrosis
5184818|NCT00885287|uncomplicated malaria|uncomplicated malaria
5184819|NCT00885287|HIV/AIDS|hiv/aids
5184820|NCT00885287|drug interactions|drug interactions
5184821|NCT00885287|antimalarial drug efficacy|antimalarial drug efficacy
5184822|NCT00885287|antiretrovirals|antiretrovirals
5184823|NCT00885287|pharmacovigilance|pharmacovigilance
5184824|NCT00885287|Tanzania|tanzania
5184825|NCT00885261|chronic pain and metabolic syndrome|chronic pain and metabolic syndrome
5184826|NCT00885248|pancreatic cancer|pancreatic cancer
5184827|NCT00885248|integrated PET-CT|integrated pet-ct
5184828|NCT00885235|Bowel Diseases|bowel diseases
5184829|NCT00885222|Parkinson's disease|parkinson's disease
5184830|NCT00885222|Major depressive disorder|major depressive disorder
5184831|NCT00885222|Deep brain stimulation|deep brain stimulation
5184832|NCT00885209|Colonic Diseases|colonic diseases
5184833|NCT00885196|Psoriasis|psoriasis
5184834|NCT00885196|plaque psoriasis|plaque psoriasis
5184835|NCT00885196|inflammatory skin disease|inflammatory skin disease
5184836|NCT00885196|scaly patches|scaly patches
5184837|NCT00885196|AEB071|aeb071
5184838|NCT00885183|breast cancer|breast cancer
5184839|NCT00885183|chemotherapy|chemotherapy
5184840|NCT00885183|adjuvant therapy|adjuvant therapy
5184841|NCT00885183|acupuncture|acupuncture
5184842|NCT00885183|fatigue|fatigue
5184843|NCT00885183|Early stage breast cancer patients|early stage breast cancer patients
5184844|NCT00885157|Poliomyelitis|poliomyelitis
5184845|NCT00885157|intradermal|intradermal
5184847|NCT00885144|Growth failure|growth failure
5184848|NCT00885144|Malnutrition|malnutrition
5184849|NCT00885144|Lipid based nutrient supplement|lipid based nutrient supplement
5184850|NCT00885144|LNS|lns
5184851|NCT00885144|Prevention|prevention
5184852|NCT00885144|Malawi|malawi
5184853|NCT00885144|Sub-Saharan Africa|sub-saharan africa
5184854|NCT00885144|Dietary supplementation|dietary supplementation
5184855|NCT00885131|Reward Processing|reward processing
5184856|NCT00885131|Motor Cortex|motor cortex
5184857|NCT00885131|HV|hv
5184858|NCT00885131|Healthy Volunteer|healthy volunteer
5184859|NCT00885105|Fluzone® vaccine|fluzone® vaccine
5184860|NCT00885105|Influenza|influenza
5184861|NCT00885092|Contact lenses|contact lenses
5184862|NCT00885092|Disinfecting solutions|disinfecting solutions
5184863|NCT00885066|stage III pancreatic cancer|stage iii pancreatic cancer
5184864|NCT00885066|stage IV pancreatic cancer|stage iv pancreatic cancer
5184865|NCT00885066|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
5184866|NCT00885066|recurrent pancreatic cancer|recurrent pancreatic cancer
5184867|NCT00885053|Inflammation|inflammation
5184868|NCT00885053|Fatty acids, Omega 3|fatty acids, omega 3
5184869|NCT00885053|Leukotrienes|leukotrienes
5184870|NCT00885053|Adiponectin|adiponectin
5184871|NCT00885053|Adipose tissue|adipose tissue
5184872|NCT00885053|RNA, Messenger|rna, messenger
5184873|NCT00885040|Neurofeedback|neurofeedback
5184874|NCT00885040|Tourette Syndrome|tourette syndrome
5184875|NCT00885040|Healthy Volunteer|healthy volunteer
5184876|NCT00885040|Movement Disorder|movement disorder
5184877|NCT00885040|Brain Activity|brain activity
5184878|NCT00885040|fMRI|fmri
5184879|NCT00885040|HV|hv
5184880|NCT00885014|Depressive disorder|depressive disorder
5184881|NCT00885014|Behavior therapy|behavior therapy
5184882|NCT00885014|Workplace|workplace
5184883|NCT00885014|Subthreshold depression|subthreshold depression
5184884|NCT00884988|ankle fracture|ankle fracture
5184885|NCT00884988|edema|edema
5184886|NCT00884988|surgical repair|surgical repair
5184887|NCT00884988|homeopathy|homeopathy
5184888|NCT00884988|lymphomyosot|lymphomyosot
5184889|NCT00884975|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
5184890|NCT00884975|exacerbations|exacerbations
5184891|NCT00884975|quality of life|quality of life
5184892|NCT00884975|emphysema|emphysema
5184893|NCT00884962|emphysema|emphysema
5184894|NCT00884962|aeris|aeris
5184895|NCT00884962|PLVR|plvr
5184896|NCT00884962|BLVR|blvr
5184897|NCT00884962|germany|germany
5184898|NCT00884962|treatment|treatment
5184899|NCT00884962|device|device
5184900|NCT00884962|breathing|breathing
5184901|NCT00884949|Mucopolysaccharidosis IV type A|mucopolysaccharidosis iv type a
5184902|NCT00884949|MPS IV Type A|mps iv type a
5184903|NCT00884949|Mucopolysaccharidosis IVA|mucopolysaccharidosis iva
5184904|NCT00884949|MPS IVA|mps iva
5184905|NCT00884949|Morquio A Syndrome|morquio a syndrome
5184906|NCT00884949|Lysosomal Storage Disorder|lysosomal storage disorder
5184907|NCT00884949|LSD|lsd
5184908|NCT00884949|N-acetylgalactosamine-6-sulfatase|n-acetylgalactosamine-6-sulfatase
5184909|NCT00884949|N-acetylgalactosamine-6-sulfate sulfatase|n-acetylgalactosamine-6-sulfate sulfatase
5184910|NCT00884949|galactose-6-sulfatase|galactose-6-sulfatase
5184911|NCT00884949|GALNS|galns
5184912|NCT00884949|enzyme replacement therapy|enzyme replacement therapy
5184913|NCT00884949|ERT|ert
5184914|NCT00884936|Skin|skin
5184915|NCT00884936|Aging|aging
5184916|NCT00884936|Dermogenomics|dermogenomics
5184917|NCT00884936|Genetic|genetic
5184918|NCT00884936|Biomarker|biomarker
5184919|NCT00884936|Dermatology|dermatology
5184920|NCT00884910|laryngectomy|laryngectomy
5184921|NCT00884910|Provox Vega|provox vega
5184922|NCT00884910|voice prosthesis|voice prosthesis
5184923|NCT00884897|Social Cognition|social cognition
5184924|NCT00884897|Schizophrenia|schizophrenia
5184925|NCT00884897|Oxytocin|oxytocin
5184926|NCT00884884|Alcohol dependence|alcohol dependence
5184927|NCT00884884|alcohol abuse|alcohol abuse
5184928|NCT00884884|topiramate|topiramate
5184929|NCT00884884|aripiprazole|aripiprazole
5184930|NCT00884871|pelvic floor disorders|pelvic floor disorders
5184931|NCT00884871|weight loss|weight loss
5184932|NCT00884858|HIV-1|hiv-1
5184933|NCT00884858|CD4|cd4
5184934|NCT00884858|INR|inr
5184935|NCT00884858|HIV-1 infection|hiv-1 infection
5184936|NCT00884858|extreme immunological compromission|extreme immunological compromission
5184937|NCT00884858|treatment experienced|treatment experienced
5184938|NCT00884845|PM2734|pm2734
5184939|NCT00884845|Tumors|tumors
5184940|NCT00884845|PharmaMar|pharmamar
5184941|NCT00884845|Erlotinib|erlotinib
5184942|NCT00884845|Tarceva|tarceva
5184943|NCT00884832|fecal incontinence|fecal incontinence
5184944|NCT00884832|stool leakage|stool leakage
5184945|NCT00884832|incontinence|incontinence
5184946|NCT00884832|FI|fi
5184947|NCT00884832|Urge predominant fecal incontinence|urge predominant fecal incontinence
5184948|NCT00884819|polycystic ovary syndrome|polycystic ovary syndrome
5184949|NCT00884819|hepatic adiposity|hepatic adiposity
5184950|NCT00884819|diabetes|diabetes
5184951|NCT00884819|hormones|hormones
5185153|NCT00883961|Sport|sport
5184952|NCT00884819|cardiovascular disease|cardiovascular disease
5184953|NCT00884806|Contact lenses|contact lenses
5184954|NCT00884806|Disinfecting solutions|disinfecting solutions
5184955|NCT00884793|HIV|hiv
5184956|NCT00884793|persistence|persistence
5184957|NCT00884793|reservoirs|reservoirs
5184958|NCT00884793|residual replication|residual replication
5184959|NCT00884793|gut|gut
5184960|NCT00884793|gut-associated lymphoid tissue|gut-associated lymphoid tissue
5184961|NCT00884793|treatment experienced|treatment experienced
5184962|NCT00884780|Electronic Diary|electronic diary
5184963|NCT00884780|Body Map|body map
5184964|NCT00884780|Electronic Measure of Pediatric Pain|electronic measure of pediatric pain
5184965|NCT00884767|neurotoxicity|neurotoxicity
5184966|NCT00884767|chemotherapeutic agent toxicity|chemotherapeutic agent toxicity
5184967|NCT00884767|recurrent colon cancer|recurrent colon cancer
5184968|NCT00884767|stage I colon cancer|stage i colon cancer
5184969|NCT00884767|stage II colon cancer|stage ii colon cancer
5184970|NCT00884767|stage III colon cancer|stage iii colon cancer
5184971|NCT00884767|stage IV colon cancer|stage iv colon cancer
5184972|NCT00884767|recurrent rectal cancer|recurrent rectal cancer
5184973|NCT00884767|stage I rectal cancer|stage i rectal cancer
5184974|NCT00884767|stage II rectal cancer|stage ii rectal cancer
5184975|NCT00884767|stage III rectal cancer|stage iii rectal cancer
5184976|NCT00884767|stage IV rectal cancer|stage iv rectal cancer
5184977|NCT00884728|Scabies|scabies
5184978|NCT00884728|Impetigo|impetigo
5184979|NCT00884728|Pyoderma|pyoderma
5184980|NCT00884728|Streptococcal infections|streptococcal infections
5184981|NCT00884702|Sleep|sleep
5184982|NCT00884702|14C-Leucine|14c-leucine
5184983|NCT00884702|Cerebral Protein Synthesis|cerebral protein synthesis
5184984|NCT00884702|Memory|memory
5184985|NCT00884702|Positron Emission Tomography (PET)|positron emission tomography (pet)
5184986|NCT00884702|HV|hv
5184987|NCT00884702|Healthy Volunteer|healthy volunteer
5184988|NCT00884689|Symbicort SMART|symbicort smart
5184989|NCT00884689|Free Combination GCS/LABA treatment|free combination gcs/laba treatment
5184990|NCT00884676|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5184991|NCT00884650|Pain|pain
5184992|NCT00884650|Pain management|pain management
5184993|NCT00884650|Cerebral Palsy|cerebral palsy
5184994|NCT00884637|HMP|hmp
5184995|NCT00884637|CNV|cnv
5184996|NCT00884637|AMD|amd
5184997|NCT00884637|PHP|php
5184998|NCT00884637|HPHP|hphp
5184999|NCT00884637|foresee home|foresee home
5185000|NCT00884624|Bowel Diseases|bowel diseases
5185001|NCT00884598|adult tumors metastatic to brain|adult tumors metastatic to brain
5185002|NCT00884598|extensive stage small cell lung cancer|extensive stage small cell lung cancer
5185003|NCT00884598|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5185004|NCT00884559|Leadership|leadership
5185005|NCT00884559|Team building|team building
5185006|NCT00884559|Resuscitation|resuscitation
5185007|NCT00884533|QTc|qtc
5185008|NCT00884533|pharmacokinetics|pharmacokinetics
5185009|NCT00884533|rosiglitazone XR|rosiglitazone xr
5185010|NCT00884533|cardiac conduction|cardiac conduction
5185011|NCT00884533|healthy volunteers|healthy volunteers
5185012|NCT00884520|[F-18]VM4-037|[f-18]vm4-037
5185013|NCT00884520|VM4-037|vm4-037
5185014|NCT00884520|hypoxia|hypoxia
5185015|NCT00884520|CA-IX|ca-ix
5185016|NCT00884520|CAIX|caix
5185017|NCT00884520|carbonic anhydrase IX|carbonic anhydrase ix
5185018|NCT00884520|hypoxia marker|hypoxia marker
5185019|NCT00884520|lung cancer|lung cancer
5185020|NCT00884520|renal carcinoma|renal carcinoma
5185021|NCT00884520|squamous cell carcinoma|squamous cell carcinoma
5185022|NCT00884520|hepatic carcinoma|hepatic carcinoma
5185023|NCT00884520|head and neck cancer|head and neck cancer
5185024|NCT00884520|advanced stage lung cancer|advanced stage lung cancer
5185025|NCT00884520|exploratory|exploratory
5185026|NCT00884494|Obesity|obesity
5185027|NCT00884494|Insulin resistance|insulin resistance
5185028|NCT00884494|Ghrelin|ghrelin
5185029|NCT00884468|Anxiety and depression in patients with psoriatic arthritis|anxiety and depression in patients with psoriatic arthritis
5185030|NCT00884455|tissue banking, research|tissue banking, research
5185031|NCT00884442|Healthy|healthy
5185032|NCT00884442|Bioavailability|bioavailability
5185033|NCT00884442|Nifedipine|nifedipine
5185034|NCT00884429|Chest physiotherapy|chest physiotherapy
5185035|NCT00884416|high grade glioma|high grade glioma
5185036|NCT00884416|glioblastoma|glioblastoma
5185037|NCT00884416|gliosarcoma|gliosarcoma
5185038|NCT00884416|anaplastic astrocytoma|anaplastic astrocytoma
5185039|NCT00884416|anaplastic oligoastrocytoma|anaplastic oligoastrocytoma
5185040|NCT00884416|anaplastic oligodendroglioma|anaplastic oligodendroglioma
5185041|NCT00884416|phase I|phase i
5185042|NCT00884416|first line treatment|first line treatment
5185043|NCT00884416|sorafenib|sorafenib
5185044|NCT00884416|temozolomide|temozolomide
5185045|NCT00884416|radiation therapy|radiation therapy
5185046|NCT00884416|safety|safety
5185047|NCT00884416|tolerability|tolerability
5185048|NCT00884416|protein kinase inhibitors|protein kinase inhibitors
5185049|NCT00884403|abortion|abortion
5185050|NCT00884403|pregnancy dating|pregnancy dating
5185051|NCT00884403|gestational age|gestational age
5185053|NCT00884390|Hemophilia A|hemophilia a
5185054|NCT00884364|Lymphoma|lymphoma
5185055|NCT00884364|Leukemia|leukemia
5185056|NCT00884364|Multiple myeloma|multiple myeloma
5185057|NCT00884364|Hodgkin´s disease|hodgkin´s disease
5185058|NCT00884364|Exercise|exercise
5185059|NCT00884364|Sport|sport
5185060|NCT00884364|Fatigue|fatigue
5185061|NCT00884364|Hematological neoplastic diseases|hematological neoplastic diseases
5185062|NCT00884351|Epilepsy|epilepsy
5185063|NCT00884351|MEG|meg
5185064|NCT00884351|Seizures|seizures
5185065|NCT00884338|Fatigue|fatigue
5185066|NCT00884338|Cancer|cancer
5185067|NCT00884338|Cognitive impairment|cognitive impairment
5185068|NCT00884338|Exercise|exercise
5185069|NCT00884338|Sport|sport
5185070|NCT00884338|Peripheral blood stem cell transplantation|peripheral blood stem cell transplantation
5185071|NCT00884338|High-dose chemotherapy|high-dose chemotherapy
5185072|NCT00884325|Itching|itching
5185073|NCT00884325|Atopic Dermatitis|atopic dermatitis
5185074|NCT00884312|Multiple myeloma|multiple myeloma
5185075|NCT00884312|proteasome|proteasome
5185076|NCT00884312|Hematological|hematological
5185077|NCT00884312|carfilzomib|carfilzomib
5185078|NCT00884312|PR-171|pr-171
5185079|NCT00884299|Lung function|lung function
5185080|NCT00884299|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
5185081|NCT00884299|Antioxidants|antioxidants
5185082|NCT00884286|Aplidin|aplidin
5185083|NCT00884286|Aggressive Non Hodgkin Lymphoma|aggressive non hodgkin lymphoma
5185084|NCT00884286|Leukemia-Lymphoma, Adult T-Cell and B-cell|leukemia-lymphoma, adult t-cell and b-cell
5185085|NCT00884260|Contraception|contraception
5185086|NCT00884260|Intrauterine contraception system|intrauterine contraception system
5185087|NCT00884247|GERD|gerd
5185088|NCT00884247|Quality of life|quality of life
5185089|NCT00884247|Structured treatment|structured treatment
5185090|NCT00884234|Lateral Canthal Lines|lateral canthal lines
5185091|NCT00884234|Crow's Feet|crow's feet
5185092|NCT00884234|Facial Wrinkles|facial wrinkles
5185093|NCT00884234|Lateral Canthal Area|lateral canthal area
5185094|NCT00884195|Obesity|obesity
5185095|NCT00884182|Influenza|influenza
5185096|NCT00884182|Orthomyxoviruses|orthomyxoviruses
5185097|NCT00884182|Split Virion Pandemic Influenza Vaccine|split virion pandemic influenza vaccine
5185098|NCT00884182|A/H5N1|a/h5n1
5185099|NCT00884143|tamoxifen|tamoxifen
5185100|NCT00884143|arimidex|arimidex
5185101|NCT00884143|adjuvant hormonal therapies|adjuvant hormonal therapies
5185102|NCT00884143|breast cancer|breast cancer
5185103|NCT00884143|post-menopausal|post-menopausal
5185104|NCT00884143|Adjuvant hormonal therapy in patients post menopausal with breast cancer|adjuvant hormonal therapy in patients post menopausal with breast cancer
5185105|NCT00884130|Laparoscopy|laparoscopy
5185106|NCT00884130|Colorectal surgery|colorectal surgery
5185107|NCT00884130|Quality of life|quality of life
5185108|NCT00884130|economic analysis|economic analysis
5185109|NCT00884130|Patients undergoing laparoscopic colorectal surgery|patients undergoing laparoscopic colorectal surgery
5185110|NCT00884104|Solifenacin|solifenacin
5185111|NCT00884104|Tamsulosin|tamsulosin
5185112|NCT00884104|OAB|oab
5185113|NCT00884091|Chinese|chinese
5185114|NCT00884091|Glucagon-like peptide 1|glucagon-like peptide 1
5185115|NCT00884091|Glucagon|glucagon
5185116|NCT00884091|Insulin|insulin
5185117|NCT00884091|Mixed meals|mixed meals
5185118|NCT00884091|Healthy Adults|healthy adults
5185119|NCT00884078|Self harm in south asian women|self harm in south asian women
5185120|NCT00884078|depression|depression
5185121|NCT00884078|suicidal ideations|suicidal ideations
5185122|NCT00884078|problem solving training|problem solving training
5185123|NCT00884065|Physiotherapy|physiotherapy
5185124|NCT00884065|Manual therapy|manual therapy
5185125|NCT00884065|Painful Shoulder|painful shoulder
5185126|NCT00884065|Diacutaneous Fibrolysis|diacutaneous fibrolysis
5185127|NCT00884052|Neonatal seizures|neonatal seizures
5185128|NCT00884039|cornea|cornea
5185129|NCT00884039|transplant|transplant
5185130|NCT00884039|intraocular pressure|intraocular pressure
5185131|NCT00884039|steroid response|steroid response
5185132|NCT00884026|Cesarean delivery|cesarean delivery
5185133|NCT00884026|hypotension|hypotension
5185134|NCT00884026|Augmentation Index|augmentation index
5185135|NCT00884026|Pulse Wave analysis|pulse wave analysis
5185136|NCT00884026|spinal anesthesia|spinal anesthesia
5185137|NCT00884026|Hypotension following spinal anesthesia for cesarean delivery|hypotension following spinal anesthesia for cesarean delivery
5185138|NCT00884013|Pay for Quality|pay for quality
5185139|NCT00884013|Provider|provider
5185140|NCT00884013|Clinical Decision Support|clinical decision support
5185141|NCT00884013|Quality Reporting|quality reporting
5185142|NCT00884013|Quality Measurement|quality measurement
5185143|NCT00883974|preterm bith|preterm bith
5185144|NCT00883974|neurodevelopment|neurodevelopment
5185145|NCT00883974|sensitivity training|sensitivity training
5185146|NCT00883974|magnetic resonance imaging (MRI)|magnetic resonance imaging (mri)
5185147|NCT00883974|Infant neurodevelopment following preterm birth|infant neurodevelopment following preterm birth
5185148|NCT00883961|High-dose chemotherapy|high-dose chemotherapy
5185149|NCT00883961|Hematological neoplasties|hematological neoplasties
5185150|NCT00883961|Fatigue|fatigue
5185154|NCT00883961|Hematologic neoplastic disorders|hematologic neoplastic disorders
5185155|NCT00883948|Acute Lung Injury|acute lung injury
5185156|NCT00883948|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
5185157|NCT00883948|Feeding|feeding
5185158|NCT00883948|Critical Care|critical care
5185159|NCT00883948|Ventilator|ventilator
5185160|NCT00883935|GSK1349572|gsk1349572
5185161|NCT00883935|Atazanavir|atazanavir
5185162|NCT00883935|Ritonavir|ritonavir
5185163|NCT00883935|Reyataz|reyataz
5185164|NCT00883935|Norvir|norvir
5185165|NCT00883935|healthy|healthy
5185166|NCT00883935|pharmacokinetic|pharmacokinetic
5185167|NCT00883909|Prostate Cancer|prostate cancer
5185168|NCT00883909|Benign Prostatic Hyperplasia|benign prostatic hyperplasia
5185169|NCT00883896|Rheumatoid Arthritis|rheumatoid arthritis
5185170|NCT00883896|ACR|acr
5185171|NCT00883896|Methotrexate|methotrexate
5185172|NCT00883896|Interleukin-22|interleukin-22
5185173|NCT00883883|Antibiotic|antibiotic
5185174|NCT00883870|mesenchymal stem cells|mesenchymal stem cells
5185175|NCT00883870|critical limb ischemia|critical limb ischemia
5185176|NCT00883844|Hepatitis B|hepatitis b
5185177|NCT00883844|sustained response|sustained response
5185178|NCT00883844|peginterferon|peginterferon
5185179|NCT00883844|nucleos(t)ide analogues|nucleos(t)ide analogues
5185180|NCT00883831|Acupuncture|acupuncture
5185181|NCT00883831|Hemodialysis|hemodialysis
5185182|NCT00883831|Symptom|symptom
5185183|NCT00883831|end stage renal disease|end stage renal disease
5185184|NCT00883831|chronic kidney disease|chronic kidney disease
5185185|NCT00883831|supportive care|supportive care
5185186|NCT00883818|Overactive bladder|overactive bladder
5185187|NCT00883818|Mycoplasma|mycoplasma
5185188|NCT00883805|Metal Ion Concentration|metal ion concentration
5185189|NCT00883805|Osteolysis|osteolysis
5185190|NCT00883766|Polycystic Ovary Syndrome|polycystic ovary syndrome
5185191|NCT00883766|GnRH Antagonist|gnrh antagonist
5185192|NCT00883766|Long Agonist Protocol|long agonist protocol
5185193|NCT00883766|OHSS|ohss
5185194|NCT00883740|Fibromyalgia sleep maintenance disturbance pregabalin|fibromyalgia sleep maintenance disturbance pregabalin
5185195|NCT00883727|mesenchymal stem cells|mesenchymal stem cells
5185196|NCT00883727|myocardial infarction|myocardial infarction
5185197|NCT00883714|Exercise|exercise
5185198|NCT00883714|sport|sport
5185199|NCT00883714|Allogeneic blood stem cell transplantation|allogeneic blood stem cell transplantation
5185200|NCT00883714|Blood stem cell transplantation|blood stem cell transplantation
5185201|NCT00883714|Fatigue|fatigue
5185202|NCT00883714|Cancer|cancer
5185203|NCT00883714|Physical performance|physical performance
5185204|NCT00883714|Mood|mood
5185205|NCT00883714|Complications|complications
5185206|NCT00883701|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5185207|NCT00883701|exacerbations|exacerbations
5185208|NCT00883701|perforin|perforin
5185209|NCT00883701|granzymes|granzymes
5185210|NCT00883688|Brain Tumor|brain tumor
5185211|NCT00883688|Recurrent Ependymoma|recurrent ependymoma
5185212|NCT00883688|Refractory Ependymoma|refractory ependymoma
5185213|NCT00883688|Intracranial ependymoma|intracranial ependymoma
5185214|NCT00883688|Ependymoblastoma|ependymoblastoma
5185215|NCT00883688|Subependymoma|subependymoma
5185216|NCT00883688|Myxopapillary|myxopapillary
5185217|NCT00883688|Clear cell|clear cell
5185218|NCT00883688|Anaplastic|anaplastic
5185219|NCT00883688|Bevacizumab|bevacizumab
5185220|NCT00883688|Avastin|avastin
5185221|NCT00883688|Anti-VEGF Monoclonal Antibody|anti-vegf monoclonal antibody
5185222|NCT00883688|rhuMAb-VEGF|rhumab-vegf
5185223|NCT00883688|Lapatinib|lapatinib
5185224|NCT00883688|Tykerb|tykerb
5185225|NCT00883688|GW572016|gw572016
5185226|NCT00883675|Lung cancer|lung cancer
5185227|NCT00883675|Adjuvant therapy|adjuvant therapy
5185228|NCT00883649|Keratoconjunctivitis Sicca|keratoconjunctivitis sicca
5185229|NCT00883649|Dry Eyes|dry eyes
5185230|NCT00883649|Post-menopausal|post-menopausal
5185231|NCT00883636|Podocyte Protein|podocyte protein
5185232|NCT00883636|Podocyte Mutation|podocyte mutation
5185233|NCT00883623|AL-Amyloidosis|al-amyloidosis
5185234|NCT00883623|Lenalidomide|lenalidomide
5185235|NCT00883610|QT Interval|qt interval
5185236|NCT00883610|Dual Chamber Pacemaker|dual chamber pacemaker
5185237|NCT00883610|Atrial Fibrillation|atrial fibrillation
5185238|NCT00883584|Proof of Concept|proof of concept
5185239|NCT00883584|Inflammatory Markers|inflammatory markers
5185240|NCT00883584|Lung Function|lung function
5185241|NCT00883584|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5185242|NCT00883584|COPD|copd
5185243|NCT00883571|anal stenosis|anal stenosis
5185244|NCT00883571|flaps|flaps
5185245|NCT00883571|anoplasty|anoplasty
5185246|NCT00883558|recombinant human hyaluronidase (rHuPH20)|recombinant human hyaluronidase (rhuph20)
5185247|NCT00883558|Insulin lispro|insulin lispro
5185248|NCT00883558|regular human insulin|regular human insulin
5185249|NCT00883545|Adherence to screening colonoscopy in women|adherence to screening colonoscopy in women
5185250|NCT00883532|Preterm infant|preterm infant
5185251|NCT00883532|Respiratory distress syndrome|respiratory distress syndrome
5185252|NCT00883532|chronic lung disease|chronic lung disease
5185253|NCT00883532|budesonide|budesonide
5185254|NCT00883532|surfactant|surfactant
5185255|NCT00883493|Acute bipolar depression|acute bipolar depression
5185256|NCT00883493|Lithium carbonate|lithium carbonate
5185257|NCT00883493|quetiapine fumarate|quetiapine fumarate
5185258|NCT00883493|MADRS|madrs
5185259|NCT00883480|NSCLC|nsclc
5185260|NCT00883467|Ischemic Preconditioning|ischemic preconditioning
5185261|NCT00883467|functional MRI|functional mri
5185262|NCT00883467|BOLD|bold
5185263|NCT00883467|Reperfusion|reperfusion
5185264|NCT00883454|hepatocellular carcinoma|hepatocellular carcinoma
5185265|NCT00883454|liver tumor|liver tumor
5185266|NCT00883454|cirrhosis|cirrhosis
5185267|NCT00883454|liver resection|liver resection
5185268|NCT00883454|tumor staging|tumor staging
5185269|NCT00883454|liver disease staging|liver disease staging
5185270|NCT00883441|IMPLEMENTATION RESEARCH|implementation research
5185271|NCT00883441|AEDES|aedes
5185272|NCT00883441|VECTOR CONTROL|vector control
5185273|NCT00883428|low back pain|low back pain
5185274|NCT00883428|pelvic pain|pelvic pain
5185275|NCT00883428|pregnancy|pregnancy
5185276|NCT00883415|metabolism|metabolism
5185277|NCT00883415|myocardium|myocardium
5185278|NCT00883415|chronic kidney disease|chronic kidney disease
5185279|NCT00883402|Carotid stenosis|carotid stenosis
5185280|NCT00883402|CEA|cea
5185281|NCT00883402|CAS|cas
5185282|NCT00883402|Stenting|stenting
5185283|NCT00883389|patient safety|patient safety
5185284|NCT00883389|chronic kidney disease|chronic kidney disease
5185285|NCT00883389|med-alert|med-alert
5185286|NCT00883376|Classification of Stanford for Snoring|classification of stanford for snoring
5185287|NCT00883376|OSAS|osas
5185288|NCT00883376|Apnea-Hipopnea Index|apnea-hipopnea index
5185289|NCT00883363|precondition|precondition
5185290|NCT00883363|ruptured abdominal aortic aneurysm|ruptured abdominal aortic aneurysm
5185291|NCT00883363|myocardial infarction|myocardial infarction
5185292|NCT00883350|Body weight changes|body weight changes
5185293|NCT00883350|Overweight|overweight
5185294|NCT00883350|Obesity|obesity
5185295|NCT00883337|Relapsing-remitting multiple sclerosis|relapsing-remitting multiple sclerosis
5185296|NCT00883324|fFN|ffn
5185297|NCT00883324|fetal fibronectin|fetal fibronectin
5185298|NCT00883324|non-speculum|non-speculum
5185299|NCT00883324|risk of preterm delivery|risk of preterm delivery
5185300|NCT00883311|Efficacy|efficacy
5185301|NCT00883298|temozolomide|temozolomide
5185302|NCT00883298|bevacizumab|bevacizumab
5185303|NCT00883298|Temodar|temodar
5185304|NCT00883298|Avastin|avastin
5185305|NCT00883298|glioblastoma multiforme|glioblastoma multiforme
5185306|NCT00883298|gliosarcoma|gliosarcoma
5185307|NCT00883298|glioma|glioma
5185308|NCT00883298|GBM|gbm
5185309|NCT00883298|brain tumor|brain tumor
5185310|NCT00883272|Menopause|menopause
5185311|NCT00883272|Thrombophilia|thrombophilia
5185312|NCT00883272|factor V Leiden|factor v leiden
5185313|NCT00883272|Estrogen Replacement Therapy|estrogen replacement therapy
5185314|NCT00883272|Hypercoagulability|hypercoagulability
5185315|NCT00883272|Venous Thrombosis|venous thrombosis
5185316|NCT00883259|High-risk patients|high-risk patients
5185317|NCT00883259|Metformin|metformin
5185318|NCT00883259|PCOS|pcos
5185319|NCT00883259|Pregnancy complications|pregnancy complications
5185320|NCT00883259|Previous gestational DM|previous gestational dm
5185321|NCT00883246|PAD|pad
5185322|NCT00883233|Acne|acne
5185323|NCT00883220|self management|self management
5185324|NCT00883220|chronic condition|chronic condition
5185325|NCT00883220|urinary catheter|urinary catheter
5185326|NCT00883207|Depression|depression
5185327|NCT00883207|family therapy|family therapy
5185328|NCT00883207|dialogical processes|dialogical processes
5185329|NCT00883207|Developing couple therapy for depression|developing couple therapy for depression
5185330|NCT00883194|Experimental Pain Model|experimental pain model
5185331|NCT00883155|Antidepressant|antidepressant
5185332|NCT00883142|Lokomat|lokomat
5185333|NCT00883142|Suspended walking|suspended walking
5185334|NCT00883142|Body Weight Supported|body weight supported
5185335|NCT00883142|Treadmill Training|treadmill training
5185336|NCT00883129|Systemic Sclerosis|systemic sclerosis
5185337|NCT00883129|Mycophenolate Mofetil|mycophenolate mofetil
5185338|NCT00883129|Cyclophosphamide|cyclophosphamide
5185339|NCT00883129|High Resolution Computerized Tomography|high resolution computerized tomography
5185340|NCT00883129|Pulmonary Function|pulmonary function
5185341|NCT00883129|Dyspnea|dyspnea
5185342|NCT00883129|Health Related Quality of Life|health related quality of life
5185343|NCT00883103|female urethral catheterization|female urethral catheterization
5185344|NCT00883103|Lidocaine|lidocaine
5185345|NCT00883103|lubricant|lubricant
5185346|NCT00883103|Q-tip test|q-tip test
5185347|NCT00883103|Q tip test|q tip test
5185348|NCT00883103|K-Y jelly|k-y jelly
5185349|NCT00883103|pain perception|pain perception
5185350|NCT00883103|straight catheterization|straight catheterization
5185351|NCT00883090|Factor XIII|factor xiii
5185352|NCT00883077|permeability|permeability
5185353|NCT00883077|inflammatory bowel disease|inflammatory bowel disease
5185354|NCT00883077|confocal laser endomicroscopy|confocal laser endomicroscopy
5185355|NCT00883077|irritable bowel syndrome|irritable bowel syndrome
5185356|NCT00883051|COL-144|col-144
5185357|NCT00883051|acute treatment|acute treatment
5185358|NCT00883051|migraine|migraine
5185359|NCT00883038|insulin resistance|insulin resistance
5185360|NCT00883038|vegetarian diet|vegetarian diet
5185361|NCT00883025|Friedman Classification|friedman classification
5185362|NCT00883025|Apnea-Hypopnea Index|apnea-hypopnea index
5185363|NCT00883025|Obstructive Sleep Apnea Syndrome|obstructive sleep apnea syndrome
5185364|NCT00883012|Viral-confirmed|viral-confirmed
5185365|NCT00882999|Relapsing|relapsing
5185366|NCT00882999|Remitting|remitting
5185367|NCT00882999|Multiple Sclerosis|multiple sclerosis
5185368|NCT00882999|Multiple|multiple
5185369|NCT00882999|Sclerosis|sclerosis
5185370|NCT00882999|MS|ms
5185371|NCT00882999|LY2127399|ly2127399
5185372|NCT00882986|insulin resistance|insulin resistance
5185373|NCT00882960|pre-hospital|pre-hospital
5185374|NCT00882960|intra-nasal fentanyl|intra-nasal fentanyl
5185375|NCT00882960|patients requiring analgesia|patients requiring analgesia
5185376|NCT00882947|Primary Pulmonary Hypertension (PPH)|primary pulmonary hypertension (pph)
5185377|NCT00882934|Placebo|placebo
5185378|NCT00882934|Placebo Effect|placebo effect
5185379|NCT00882934|Sexual Dysfunction|sexual dysfunction
5185380|NCT00882934|Erectile Dysfunction|erectile dysfunction
5185381|NCT00882934|Clinical Trial|clinical trial
5185382|NCT00882921|Hunter syndrome|hunter syndrome
5185383|NCT00882921|hunters syndrome|hunters syndrome
5185384|NCT00882921|hunter's syndrome|hunter's syndrome
5185385|NCT00882921|hunter disease|hunter disease
5185386|NCT00882921|hunters disease|hunters disease
5185387|NCT00882921|hunter's disease|hunter's disease
5185388|NCT00882921|MPS II|mps ii
5185389|NCT00882921|MPSII|mpsii
5185390|NCT00882921|MPS2|mps2
5185391|NCT00882921|MPS 2|mps 2
5185392|NCT00882921|mucopolysaccharides|mucopolysaccharides
5185393|NCT00882921|lysosomal storage disease|lysosomal storage disease
5185394|NCT00882921|lysosomal storage disorder|lysosomal storage disorder
5185395|NCT00882921|chronic ear infection|chronic ear infection
5185396|NCT00882921|enlarged adenoids|enlarged adenoids
5185397|NCT00882921|mps symptoms|mps symptoms
5185398|NCT00882921|mps diagnosis|mps diagnosis
5185399|NCT00882921|mps ii therapy|mps ii therapy
5185400|NCT00882921|MPS II treatment|mps ii treatment
5185401|NCT00882921|ert treatment|ert treatment
5185402|NCT00882921|elaprase|elaprase
5185403|NCT00882921|idursulfase|idursulfase
5185404|NCT00882921|iduronate sulfatase|iduronate sulfatase
5185405|NCT00882921|iduronate 2 sulfatase|iduronate 2 sulfatase
5185406|NCT00882921|enzyme replacement therapy|enzyme replacement therapy
5185407|NCT00882921|hunter syndrome treatment|hunter syndrome treatment
5185408|NCT00882921|hunter's syndrome treatment|hunter's syndrome treatment
5185409|NCT00882921|hunter syndrome therapy|hunter syndrome therapy
5185410|NCT00882921|hunter's disease treatment|hunter's disease treatment
5185411|NCT00882921|mps society|mps society
5185412|NCT00882908|Hepatitis C|hepatitis c
5185413|NCT00882908|TMC435|tmc435
5185414|NCT00882908|Peginterferon alpha-2a|peginterferon alpha-2a
5185415|NCT00882908|PegIFNalpha-2a|pegifnalpha-2a
5185416|NCT00882908|RBV|rbv
5185417|NCT00882908|Ribavirin|ribavirin
5185418|NCT00882908|Placebo|placebo
5185419|NCT00882895|Lymphoma, Non-Hodgkin|lymphoma, non-hodgkin
5185420|NCT00882895|Transplantation, Autologous|transplantation, autologous
5185421|NCT00882895|Transplantation, Homologous|transplantation, homologous
5185422|NCT00882895|Total Lymphoid Irradiation|total lymphoid irradiation
5185423|NCT00882895|Anti-thymocyte globulin|anti-thymocyte globulin
5185424|NCT00882869|Advanced Hepatocellular carcinoma|advanced hepatocellular carcinoma
5185425|NCT00882869|liver|liver
5185426|NCT00882869|cancer|cancer
5185427|NCT00882869|antisense|antisense
5185428|NCT00882869|sorafenib|sorafenib
5185429|NCT00882856|Clozapine|clozapine
5185430|NCT00882856|Sinustachycardia|sinustachycardia
5185431|NCT00882856|Heartrate variability|heartrate variability
5185432|NCT00882856|Cardiomyopathy|cardiomyopathy
5185433|NCT00882843|Vibrating plate|vibrating plate
5185434|NCT00882843|Mechanical Stimulation|mechanical stimulation
5185435|NCT00882843|Osteoporosis|osteoporosis
5185436|NCT00882830|ICU|icu
5185437|NCT00882830|myopathy|myopathy
5185438|NCT00882830|neuropathy|neuropathy
5185439|NCT00882830|EMS|ems
5185440|NCT00882830|critical illness polyneuromyopathy|critical illness polyneuromyopathy
5185441|NCT00882830|NIRS|nirs
5185442|NCT00882830|muscle biopsy|muscle biopsy
5185443|NCT00882830|microdialysis|microdialysis
5185444|NCT00882830|CIPNM|cipnm
5185445|NCT00882817|ILD|ild
5185446|NCT00882804|hemin, heme oxygenase, humans, HO-1|hemin, heme oxygenase, humans, ho-1
5185447|NCT00882791|Skin Cancer|skin cancer
5185448|NCT00882791|Basal Cell|basal cell
5185449|NCT00882791|Mohs surgery|mohs surgery
5185450|NCT00882765|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
5185451|NCT00882765|stage I pancreatic cancer|stage i pancreatic cancer
5185452|NCT00882765|stage II pancreatic cancer|stage ii pancreatic cancer
5185453|NCT00882765|stage III pancreatic cancer|stage iii pancreatic cancer
5185454|NCT00882752|Ulcerative Colitis (UC)|ulcerative colitis (uc)
5185455|NCT00882739|angiography|angiography
5185456|NCT00882739|percutaneous coronary intervention|percutaneous coronary intervention
5185457|NCT00882739|Platelet Aggregation Inhibitors|platelet aggregation inhibitors
5185458|NCT00882739|Platelet Function Tests|platelet function tests
5185459|NCT00882726|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
5185460|NCT00882726|CNTO 3649|cnto 3649
5185461|NCT00882726|safety|safety
5185462|NCT00882726|Phase I|phase i
5185463|NCT00882726|healthy adults|healthy adults
5185464|NCT00882726|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
5185465|NCT00882700|Antibiotic|antibiotic
5185466|NCT00882661|Neck Pain|neck pain
5185467|NCT00882661|Arm Pain|arm pain
5185468|NCT00882648|Drug dependence during pregnancy|drug dependence during pregnancy
5185469|NCT00882635|STEMI|stemi
5185470|NCT00882635|acute coronary syndromes|acute coronary syndromes
5185471|NCT00882635|primary percutaneous coronary intervention|primary percutaneous coronary intervention
5185472|NCT00882622|Ischemic Preconditioning|ischemic preconditioning
5185473|NCT00882622|Cardiac Surgery|cardiac surgery
5185474|NCT00882609|bone metastasis|bone metastasis
5185475|NCT00882609|bone metastases|bone metastases
5185476|NCT00882609|Sodium Fluoride|sodium fluoride
5185477|NCT00882609|F18 Fluoride|f18 fluoride
5185478|NCT00882609|bone scan|bone scan
5185479|NCT00882596|Contura|contura
5185480|NCT00882596|Cancer|cancer
5185481|NCT00882596|Accelerated|accelerated
5185482|NCT00882596|Partial|partial
5185483|NCT00882596|Breast|breast
5185484|NCT00882596|Irradiation|irradiation
5185485|NCT00882583|HNSCC|hnscc
5185486|NCT00882583|Dasatinib|dasatinib
5185487|NCT00882583|Cetuximab|cetuximab
5185488|NCT00882583|Cisplatin|cisplatin
5185489|NCT00882570|Antibiotic|antibiotic
5185490|NCT00882557|End-stage renal disease|end-stage renal disease
5185491|NCT00882557|hemodialysis|hemodialysis
5185492|NCT00882557|chronic renal failure|chronic renal failure
5185493|NCT00882544|hydronephrosis|hydronephrosis
5185494|NCT00882544|robotic pyeloplasty|robotic pyeloplasty
5185495|NCT00882544|pediatric pyeloplasty|pediatric pyeloplasty
5185496|NCT00882518|Quetiapine Fumarate (SEROQUEL) Extended-Release (XR)|quetiapine fumarate (seroquel) extended-release (xr)
5185497|NCT00882518|qualified PANSS assessment|qualified panss assessment
5185498|NCT00882492|Cardiac|cardiac
5185499|NCT00882492|Surgery|surgery
5185500|NCT00882492|Glycemia|glycemia
5185501|NCT00882466|erythropoietin|erythropoietin
5185502|NCT00882453|Physical Activity|physical activity
5185503|NCT00882453|Fatigue|fatigue
5185504|NCT00882453|RRMS|rrms
5185505|NCT00882453|CIS|cis
5185506|NCT00882427|algorithm|algorithm
5185507|NCT00882427|tight glycemic control|tight glycemic control
5185508|NCT00882427|glucose control|glucose control
5185509|NCT00882427|intensive care|intensive care
5185510|NCT00882427|insulin|insulin
5185511|NCT00882427|ICU|icu
5185512|NCT00882414|ferric carboxymaltose|ferric carboxymaltose
5185513|NCT00882414|platelet|platelet
5185514|NCT00882414|thrombocyte|thrombocyte
5185515|NCT00882414|ferritin|ferritin
5185516|NCT00882414|hemoglobin|hemoglobin
5185517|NCT00882414|transferrin|transferrin
5185518|NCT00882388|celecoxib|celecoxib
5185519|NCT00882388|platelet|platelet
5185520|NCT00882388|thrombosis|thrombosis
5185521|NCT00882388|Volunteers|volunteers
5185522|NCT00882375|Smoking Cessation|smoking cessation
5185523|NCT00882336|Cardiovascular risk management|cardiovascular risk management
5185524|NCT00882336|Hyperlipidemia|hyperlipidemia
5185525|NCT00882336|Hypertension|hypertension
5185526|NCT00882336|Diabetes|diabetes
5185527|NCT00882336|Obesity|obesity
5185528|NCT00882310|Pancreatic cancer|pancreatic cancer
5185529|NCT00882310|Gemzar|gemzar
5185530|NCT00882310|Taxotere|taxotere
5185531|NCT00882310|Xeloda|xeloda
5185532|NCT00882310|GTX|gtx
5185533|NCT00882297|Ultrasoundography|ultrasoundography
5185534|NCT00882297|catheterization|catheterization
5185535|NCT00882297|central venous subclavian vein methods|central venous subclavian vein methods
5185536|NCT00882284|NICHD Neonatal Research Network|nichd neonatal research network
5185537|NCT00882284|Blood Pressure Management|blood pressure management
5185538|NCT00882271|Fibromyalgia|fibromyalgia
5185539|NCT00882271|Acupuncture|acupuncture
5185540|NCT00882271|Pain|pain
5185541|NCT00882258|Uterine fibroids|uterine fibroids
5185542|NCT00882232|prostate|prostate
5185543|NCT00882232|cancer|cancer
5185544|NCT00882232|cross-linked|cross-linked
5185545|NCT00882232|hyaluronan|hyaluronan
5185546|NCT00882232|gel|gel
5185547|NCT00882232|Hylaform|hylaform
5185548|NCT00882232|rectal|rectal
5185549|NCT00882232|toxicity|toxicity
5185550|NCT00882219|Drug eluting stent|drug eluting stent
5185551|NCT00882219|Stents|stents
5185552|NCT00882219|Angioplasty|angioplasty
5185553|NCT00882219|Chronic coronary occlusion|chronic coronary occlusion
5185554|NCT00882219|Stent thrombosis|stent thrombosis
5185555|NCT00882219|Vascular disease|vascular disease
5185556|NCT00882219|Myocardial ischemia|myocardial ischemia
5185557|NCT00882219|Coronary artery stenosis|coronary artery stenosis
5185558|NCT00882219|Coronary Disease|coronary disease
5185559|NCT00882219|Coronary Artery Disease|coronary artery disease
5185560|NCT00882219|Coronary Restenosis|coronary restenosis
5185561|NCT00882206|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5185562|NCT00882206|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
5185563|NCT00882206|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5185564|NCT00882206|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5185565|NCT00882193|Chronic hepatitis C|chronic hepatitis c
5185566|NCT00882193|Genotype 1|genotype 1
5185567|NCT00882193|Nonresponder|nonresponder
5185568|NCT00882193|Relapser|relapser
5185569|NCT00882193|Betaine|betaine
5185570|NCT00882193|Antiviral therapy|antiviral therapy
5185571|NCT00882180|Liver|liver
5185572|NCT00882180|Solid Tumors|solid tumors
5185573|NCT00882180|Advanced Solid Tumors with Liver Involvement|advanced solid tumors with liver involvement
5185574|NCT00882154|Antibiotic|antibiotic
5185575|NCT00882141|Exercise|exercise
5185576|NCT00882141|Obesity|obesity
5185577|NCT00882141|Insulin Sensitivity|insulin sensitivity
5185578|NCT00882128|Asthma seasonal respiratory symptoms|asthma seasonal respiratory symptoms
5185579|NCT00882128|Asthmatic patients with increase of respiratory symptoms|asthmatic patients with increase of respiratory symptoms
5185580|NCT00882115|DEP|dep
5185581|NCT00882115|Broccoli Sprout Extract|broccoli sprout extract
5185582|NCT00882115|Allergies|allergies
5185583|NCT00882102|Acute Myelogenous Leukemia|acute myelogenous leukemia
5185584|NCT00882102|High-Risk Myelodysplastic Syndrome|high-risk myelodysplastic syndrome
5185585|NCT00882102|AML|aml
5185586|NCT00882102|MDS|mds
5185587|NCT00882102|Leukemia|leukemia
5185588|NCT00882102|Decitabine|decitabine
5185589|NCT00882102|Gemtuzumab Ozogamicin|gemtuzumab ozogamicin
5185590|NCT00882102|Dacogen|dacogen
5185591|NCT00882102|Mylotarg|mylotarg
5185592|NCT00882089|Contura|contura
5185593|NCT00882089|Cancer|cancer
5185594|NCT00882089|Accelerated|accelerated
5185595|NCT00882089|Partial|partial
5185596|NCT00882089|Breast|breast
5185597|NCT00882089|Irradiation|irradiation
5185598|NCT00882076|acute lymphoblastic leukemia|acute lymphoblastic leukemia
5185599|NCT00882076|chronic lymphocytic leukemia|chronic lymphocytic leukemia
5185600|NCT00882063|Multiple Myeloma|multiple myeloma
5185601|NCT00882037|Methamphetamine Dependence|methamphetamine dependence
5185602|NCT00882037|Substance Abuse Treatment|substance abuse treatment
5185603|NCT00882037|Rural and Urban|rural and urban
5185604|NCT00882037|Latino and Non-Latino|latino and non-latino
5185605|NCT00882024|Rheumatoid arthritis|rheumatoid arthritis
5185606|NCT00882011|T-lymphoblastic lymphoma|t-lymphoblastic lymphoma
5185607|NCT00882011|Intensive chemo/radiotherapy|intensive chemo/radiotherapy
5185608|NCT00882011|Intensive chemotherapy|intensive chemotherapy
5185609|NCT00882011|Transplant|transplant
5185610|NCT00882011|Adult patients|adult patients
5185611|NCT00881998|Evaluate early functional outcomes of two anterior approaches to total hip arthroplasty|evaluate early functional outcomes of two anterior approaches to total hip arthroplasty
5185612|NCT00881985|obstructive sleep apnea|obstructive sleep apnea
5185613|NCT00881985|resistant hypertension|resistant hypertension
5185614|NCT00881985|refractory hypertension|refractory hypertension
5185615|NCT00881985|continuous positive airway pressure|continuous positive airway pressure
5185616|NCT00881985|blood pressure control|blood pressure control
5185617|NCT00881959|exposed Root Surface or Tooth|exposed root surface or tooth
5185618|NCT00881959|Tooth Sensitivity Miller Class I|tooth sensitivity miller class i
5185619|NCT00881959|Miller Class II|miller class ii
5185620|NCT00881959|Gingival Margin|gingival margin
5185621|NCT00881946|chronic lymphocytic leukemia|chronic lymphocytic leukemia
5185622|NCT00881946|aggressive lymphoma|aggressive lymphoma
5185623|NCT00881946|non-Hodgkin's lymphoma|non-hodgkin's lymphoma
5185624|NCT00881946|Hodgkin's lymphoma|hodgkin's lymphoma
5185625|NCT00881946|chronic myelogenous leukemia|chronic myelogenous leukemia
5185626|NCT00881946|multiple myeloma|multiple myeloma
5185627|NCT00881946|acute lymphoblastic leukemia|acute lymphoblastic leukemia
5185628|NCT00881946|acute myeloid leukemia|acute myeloid leukemia
5185629|NCT00881933|Fludarabine, Cyclophosphamide, TBI, severe aplastic anemia,|fludarabine, cyclophosphamide, tbi, severe aplastic anemia,
5185630|NCT00881933|cord blood transplantation, pediatric|cord blood transplantation, pediatric
5185631|NCT00881920|Lymphocytic|lymphocytic
5185632|NCT00881920|Leukemia|leukemia
5185633|NCT00881920|B Cell|b cell
5185634|NCT00881920|Non-Hodgkin|non-hodgkin
5185635|NCT00881920|Multiple Myeloma|multiple myeloma
5185636|NCT00881920|Lymphoma|lymphoma
5185637|NCT00881907|Regeneration (revascularization) of dental pulp|regeneration (revascularization) of dental pulp
5185638|NCT00881907|Immature Permanent Tooth With a Diagnosis of Pulpal Necrosis|immature permanent tooth with a diagnosis of pulpal necrosis
5185639|NCT00881894|Rotigotine|rotigotine
5185640|NCT00881894|Neupro®|neupro®
5185641|NCT00881894|Transdermal Patch|transdermal patch
5185642|NCT00881855|Antibiotics|antibiotics
5185643|NCT00881842|Influenza|influenza
5185644|NCT00881842|Vaccine|vaccine
5185645|NCT00881842|CHMP criteria|chmp criteria
5185646|NCT00881829|Pulse Oximetry|pulse oximetry
5185647|NCT00881829|Temperature|temperature
5185648|NCT00881829|Respiratory Rate|respiratory rate
5185649|NCT00881829|Respiratory Gases|respiratory gases
5185650|NCT00881829|This study determine the measurement accuracy of the physiological parameters|this study determine the measurement accuracy of the physiological parameters
5185651|NCT00881816|Liposomal Paclitaxel|liposomal paclitaxel
5185652|NCT00881816|Capecitabine|capecitabine
5185653|NCT00881816|Maximum tolerated dose|maximum tolerated dose
5185654|NCT00881816|Dose limiting toxicity|dose limiting toxicity
5185655|NCT00881803|Spinal Cord Injuries|spinal cord injuries
5185656|NCT00881803|Ascorbic Acid|ascorbic acid
5185657|NCT00881803|Vitamin C|vitamin c
5185658|NCT00881803|Iron|iron
5185659|NCT00881803|Dietary Supplements|dietary supplements
5185660|NCT00881777|Heart Failure|heart failure
5185661|NCT00881777|Cardiomyopathy|cardiomyopathy
5185662|NCT00881777|Ventricular Dysfunction|ventricular dysfunction
5185663|NCT00881777|Heart Disease|heart disease
5185664|NCT00881764|Anesthesia|anesthesia
5185665|NCT00881764|New York|new york
5185666|NCT00881764|Columbia|columbia
5185667|NCT00881764|Children|children
5185668|NCT00881764|Neurodevelopment|neurodevelopment
5185669|NCT00881764|Child development|child development
5185670|NCT00881764|Pediatric|pediatric
5185671|NCT00881751|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
5185672|NCT00881751|advanced adult primary liver cancer|advanced adult primary liver cancer
5185673|NCT00881751|recurrent adult primary liver cancer|recurrent adult primary liver cancer
5185674|NCT00881738|Antibiotic|antibiotic
5185675|NCT00881725|Metformin|metformin
5185676|NCT00881725|Prostate Cancer|prostate cancer
5185677|NCT00881725|Radical Prostatectomy|radical prostatectomy
5185678|NCT00881725|Neoadjuvant Intervention|neoadjuvant intervention
5185679|NCT00881725|PTEN/AKT Pathway|pten/akt pathway
5185680|NCT00881725|Tumour Expression|tumour expression
5185681|NCT00881725|Ki67 Expression|ki67 expression
5185682|NCT00881712|Non-small cell lung Cancer|non-small cell lung cancer
5185683|NCT00881712|Proton Radiation|proton radiation
5185684|NCT00881712|Stage III|stage iii
5185685|NCT00881699|HIV Information|hiv information
5185686|NCT00881699|HIV Prevention|hiv prevention
5185687|NCT00881699|Severe Mental Illness|severe mental illness
5185688|NCT00881699|HIV seronegativity|hiv seronegativity
5185689|NCT00881686|Ischemic Preconditioning, Myocardial|ischemic preconditioning, myocardial
5185690|NCT00881686|Adenosine|adenosine
5185691|NCT00881673|Conjunctivitis|conjunctivitis
5185692|NCT00881660|Fetal Tracheal Occlusion|fetal tracheal occlusion
5185693|NCT00881660|congenital diaphragmatic hernia|congenital diaphragmatic hernia
5185694|NCT00881660|FETO plug-unplug|feto plug-unplug
5185695|NCT00881660|Goldvalve balloon|goldvalve balloon
5185696|NCT00881660|Severe Congenital Diaphragmatic Hernia|severe congenital diaphragmatic hernia
5185697|NCT00881660|Extremely Severe Congenital Diaphragmatic Hernia|extremely severe congenital diaphragmatic hernia
5185698|NCT00881660|Goldbal balloon|goldbal balloon
5185699|NCT00881660|FETO|feto
5185700|NCT00881647|PTSD|ptsd
5185701|NCT00881647|Insomnia Disorder|insomnia disorder
5185702|NCT00881647|Insomnia|insomnia
5185703|NCT00881647|CBT|cbt
5185704|NCT00881621|Pancreas cancer|pancreas cancer
5185705|NCT00881621|lapatinib|lapatinib
5185706|NCT00881621|capecitabine|capecitabine
5185707|NCT00881608|Menstruation|menstruation
5185708|NCT00881595|Sarcomas|sarcomas
5185709|NCT00881595|High-Risk Soft Tissue Sarcomas|high-risk soft tissue sarcomas
5185710|NCT00881582|Hepatitis c|hepatitis c
5185711|NCT00881582|Renal transplantation|renal transplantation
5185712|NCT00881582|Pegylated interferon|pegylated interferon
5185713|NCT00881556|Allogeneic Stem Cell Transplant|allogeneic stem cell transplant
5185714|NCT00881556|AlloSCT|allosct
5185715|NCT00881556|RDEB|rdeb
5185716|NCT00881556|recessive dystrophic epidermolysis bullosa|recessive dystrophic epidermolysis bullosa
5185717|NCT00881543|Sitagliptin|sitagliptin
5185718|NCT00881543|Diets|diets
5185719|NCT00881543|Diabetes type 2|diabetes type 2
5185720|NCT00881543|Näive patients|näive patients
5185721|NCT00881517|human cytomegalovirus|human cytomegalovirus
5185722|NCT00881517|immune globulin|immune globulin
5185723|NCT00881517|congenital infection|congenital infection
5185724|NCT00881517|prevention|prevention
5185725|NCT00881517|pregnancy|pregnancy
5185726|NCT00881504|Biliary|biliary
5185727|NCT00881504|Oxaliplatin|oxaliplatin
5185728|NCT00881504|Bevacizumab|bevacizumab
5185729|NCT00881491|Regeneration (revascularization) of dental pulp|regeneration (revascularization) of dental pulp
5185730|NCT00881491|Immature permanent tooth with a diagnosis of|immature permanent tooth with a diagnosis of
5185731|NCT00881478|Obesity|obesity
5185732|NCT00881478|Children|children
5185733|NCT00881478|Dyslipidemia|dyslipidemia
5185734|NCT00881478|Hypertension|hypertension
5185735|NCT00881465|Obsessive compulsive disorder|obsessive compulsive disorder
5185736|NCT00881452|Autism|autism
5185737|NCT00881439|Heart failure|heart failure
5185738|NCT00881439|Renal Failure|renal failure
5185739|NCT00881439|Cardiorenal Syndrome|cardiorenal syndrome
5185740|NCT00881439|Renin inhibition|renin inhibition
5185741|NCT00881439|Aliskiren|aliskiren
5185742|NCT00881426|Antibiotic|antibiotic
5185743|NCT00881413|Peptic ulcer bleeding|peptic ulcer bleeding
5185744|NCT00881413|Proton pump inhibitor|proton pump inhibitor
5185745|NCT00881413|Esomeprazole|esomeprazole
5185746|NCT00881413|Pantoprazole|pantoprazole
5185747|NCT00881413|Recurrent bleeding|recurrent bleeding
5185748|NCT00881413|bleeding|bleeding
5185749|NCT00881400|Antibiotic|antibiotic
5185750|NCT00881387|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5185751|NCT00881387|adult lymphocyte depletion Hodgkin lymphoma|adult lymphocyte depletion hodgkin lymphoma
5185752|NCT00881387|adult lymphocyte predominant Hodgkin lymphoma|adult lymphocyte predominant hodgkin lymphoma
5185753|NCT00881387|adult mixed cellularity Hodgkin lymphoma|adult mixed cellularity hodgkin lymphoma
5185754|NCT00881387|adult nodular sclerosis Hodgkin lymphoma|adult nodular sclerosis hodgkin lymphoma
5185755|NCT00881361|stage II breast cancer|stage ii breast cancer
5185756|NCT00881361|stage IIIA breast cancer|stage iiia breast cancer
5185757|NCT00881361|stage IIIB breast cancer|stage iiib breast cancer
5185758|NCT00881335|geriatric|geriatric
5185759|NCT00881335|pulmonary disease|pulmonary disease
5185760|NCT00881335|flutter|flutter
5185761|NCT00881335|sputum|sputum
5185762|NCT00881335|physical therapy techniques|physical therapy techniques
5185763|NCT00881296|Elder Patients|elder patients
5185764|NCT00881296|Non-Small Cell Lung Cancer|non-small cell lung cancer
5185765|NCT00881296|Previously Untreated|previously untreated
5185766|NCT00881296|Advanced|advanced
5185767|NCT00881283|Cushing's disease|cushing's disease
5185768|NCT00881257|Peripheral Vascular Disease|peripheral vascular disease
5185769|NCT00881257|Peripheral Artery Disease|peripheral artery disease
5185770|NCT00881257|Radiofrequency|radiofrequency
5185771|NCT00881218|myocardial ischemia, perfusion imaging, cardiac MRI|myocardial ischemia, perfusion imaging, cardiac mri
5185772|NCT00881205|Multiple Sclerosis|multiple sclerosis
5185773|NCT00881205|Cognition|cognition
5185774|NCT00881205|Rivastigmine|rivastigmine
5185775|NCT00881205|Patch|patch
5185776|NCT00881192|CABG|cabg
5185777|NCT00881192|coronary surgery|coronary surgery
5185778|NCT00881192|intra-aortic balloon pump|intra-aortic balloon pump
5185779|NCT00881192|CABG operation|cabg operation
5185780|NCT00881179|Antibiotic|antibiotic
5185781|NCT00881166|MP-470|mp-470
5185782|NCT00881166|Multi-targeted Tyrosine Kinase Inhibitor|multi-targeted tyrosine kinase inhibitor
5185783|NCT00881166|Malignant disease|malignant disease
5185784|NCT00881153|Antibiotic|antibiotic
5185785|NCT00881140|oral mifepristone|oral mifepristone
5185786|NCT00881140|vaginal tablets|vaginal tablets
5185787|NCT00881114|Head and neck cancer|head and neck cancer
5185788|NCT00881114|pharmacogenetics|pharmacogenetics
5185789|NCT00881114|chemoradiotherapy|chemoradiotherapy
5185790|NCT00881101|Liposomal Paclitaxel|liposomal paclitaxel
5185791|NCT00881101|Maximum tolerated dose|maximum tolerated dose
5185792|NCT00881101|Dose limiting toxicity|dose limiting toxicity
5185793|NCT00881088|Deep vein trombosis|deep vein trombosis
5185794|NCT00881088|Profylaxis|profylaxis
5185795|NCT00881088|Below knee plaster cast|below knee plaster cast
5185796|NCT00881088|Ankle fracture|ankle fracture
5185797|NCT00881075|Magnetic resonance imaging|magnetic resonance imaging
5185798|NCT00881075|Heart diseases|heart diseases
5185799|NCT00881075|myocardial infarction|myocardial infarction
5185800|NCT00881075|contrast agents|contrast agents
5185801|NCT00881075|manganese|manganese
5185802|NCT00881062|ABSORPTION|absorption
5185803|NCT00881062|METABOLISM|metabolism
5185804|NCT00881062|EXCRETION|excretion
5185805|NCT00881049|metastatic acral or mucosal melanoma with c-kit mutation or copy number increase|metastatic acral or mucosal melanoma with c-kit mutation or copy number increase
5185806|NCT00881036|Hepatitis B|hepatitis b
5185807|NCT00881010|Breast Cancer|breast cancer
5185808|NCT00881010|Pain Intervention|pain intervention
5185809|NCT00881010|Underserved minority patients|underserved minority patients
5185810|NCT00881010|African American|african american
5185811|NCT00881010|Hispanic|hispanic
5185812|NCT00881010|Automated Telephone System for measuring symptoms|automated telephone system for measuring symptoms
5185813|NCT00881010|Interactive voice response|interactive voice response
5185814|NCT00881010|IVR|ivr
5185815|NCT00880997|Cocaine Dependence|cocaine dependence
5185816|NCT00880997|Substance Related Disorders|substance related disorders
5185817|NCT00880984|Colon Anastomosis|colon anastomosis
5185818|NCT00880984|Rectum Anastomosis|rectum anastomosis
5185819|NCT00880984|Intestine|intestine
5185820|NCT00880984|Colorectal Surgery|colorectal surgery
5185821|NCT00880984|Colorectal Anastomosis|colorectal anastomosis
5185822|NCT00880971|Lung|lung
5185823|NCT00880971|Carcinoma|carcinoma
5185824|NCT00880971|radiotherapy|radiotherapy
5185825|NCT00880971|Surgery|surgery
5185826|NCT00880945|FBS|fbs
5185827|NCT00880945|coin lesions|coin lesions
5185828|NCT00880945|ENB|enb
5185829|NCT00880945|ROSE|rose
5185830|NCT00880932|warfarin|warfarin
5185831|NCT00880932|NSAID|nsaid
5185832|NCT00880932|The condition is the concomitant prescription of|the condition is the concomitant prescription of
5185833|NCT00880919|Borderline Personality Disorder|borderline personality disorder
5185834|NCT00880919|BPD|bpd
5185835|NCT00880919|Seroquel|seroquel
5185836|NCT00880919|Seroquel XR|seroquel xr
5185837|NCT00880919|quetiapine|quetiapine
5185838|NCT00880919|quetiapine extended-release|quetiapine extended-release
5185839|NCT00880906|eosinophilic esophagitis|eosinophilic esophagitis
5185840|NCT00880906|esophageal food impaction|esophageal food impaction
5185841|NCT00880906|dysphagia|dysphagia
5185842|NCT00880893|Dengue virus|dengue virus
5185843|NCT00880893|Dengue fever|dengue fever
5185844|NCT00880893|Dengue hemorrhagic fever|dengue hemorrhagic fever
5185845|NCT00880893|Dengue diseases|dengue diseases
5185846|NCT00880893|Sanofi Pasteur's CYD Dengue Vaccine|sanofi pasteur's cyd dengue vaccine
5185847|NCT00880880|urinary incontinence|urinary incontinence
5185848|NCT00880880|fecal incontinence|fecal incontinence
5185849|NCT00880880|communication|communication
5185850|NCT00880867|Low Grade Recurrent B and T Cell Lymphoma|low grade recurrent b and t cell lymphoma
5185851|NCT00880854|bladder cancer|bladder cancer
5185852|NCT00880854|BCG-resistant localized transitional cell of the bladder|bcg-resistant localized transitional cell of the bladder
5185853|NCT00880841|healthy normals, phase 1|healthy normals, phase 1
5185854|NCT00880841|phase 1a study for healthy normals|phase 1a study for healthy normals
5185855|NCT00880828|Cervical Radiculopathy|cervical radiculopathy
5185856|NCT00880828|Radicular Pain|radicular pain
5185857|NCT00880828|Acute neck pain|acute neck pain
5185858|NCT00880828|Cervicobrachial pain|cervicobrachial pain
5185859|NCT00880828|Far-infrared ray|far-infrared ray
5185860|NCT00880828|FIR|fir
5185861|NCT00880828|Cervical collar|cervical collar
5185862|NCT00880828|Cervical device|cervical device
5185863|NCT00880828|FIR Device|fir device
5185864|NCT00880815|Leukemia|leukemia
5185865|NCT00880815|Lymphoma|lymphoma
5185866|NCT00880815|Lymphoid Malignancies|lymphoid malignancies
5185867|NCT00880815|Non-myeloablative Allogeneic Conditioning|non-myeloablative allogeneic conditioning
5185868|NCT00880815|Non-myeloablative Allogeneic Hematopoietic Transplantation|non-myeloablative allogeneic hematopoietic transplantation
5185869|NCT00880815|Stem Cell Transplant|stem cell transplant
5185870|NCT00880815|SCT|sct
5185871|NCT00880815|Bendamustine HCI|bendamustine hci
5185872|NCT00880815|Bendamustine|bendamustine
5185873|NCT00880815|Bendamustine Hydrochloride|bendamustine hydrochloride
5185874|NCT00880815|CEP-18083|cep-18083
5185875|NCT00880815|SDX-105|sdx-105
5185876|NCT00880815|Treanda|treanda
5185877|NCT00880815|Fludarabine|fludarabine
5185878|NCT00880815|Fludarabine Phosphate|fludarabine phosphate
5185879|NCT00880815|Fludara|fludara
5185880|NCT00880815|Rituximab|rituximab
5185881|NCT00880815|Rituxan|rituxan
5185882|NCT00880815|FBR|fbr
5185883|NCT00880815|Graft-versus-host disease|graft-versus-host disease
5185884|NCT00880815|GVHD|gvhd
5185885|NCT00880802|Acute Coronary Syndromes|acute coronary syndromes
5185886|NCT00880802|Non ST-Segment Elevation Myocardial Infarction|non st-segment elevation myocardial infarction
5185887|NCT00880802|ST-Segment Elevation Myocardial Infarction|st-segment elevation myocardial infarction
5185888|NCT00880802|Unstable Angina|unstable angina
5185889|NCT00880789|Cord Blood Transplant|cord blood transplant
5185890|NCT00880789|cytomegalovirus|cytomegalovirus
5185891|NCT00880789|CMV|cmv
5185892|NCT00880789|Adenovirus|adenovirus
5185893|NCT00880789|ADV|adv
5185894|NCT00880750|End stage Renal disease|end stage renal disease
5185895|NCT00880724|COPD|copd
5185896|NCT00880724|Emphysema|emphysema
5185897|NCT00880724|Bronchoscopic Treatment|bronchoscopic treatment
5185898|NCT00880724|Interventional Bronchoscopy|interventional bronchoscopy
5185899|NCT00880711|Fiona|fiona
5185900|NCT00880711|Faslodex|faslodex
5185901|NCT00880711|Advanced Breast Cancer|advanced breast cancer
5185902|NCT00880711|Real life data|real life data
5185903|NCT00880711|Collect real life data in clinical practice across Austria|collect real life data in clinical practice across austria
5185904|NCT00880698|Rotavirus|rotavirus
5185905|NCT00880698|Rotavirus vaccine|rotavirus vaccine
5185906|NCT00880685|Compulsive Stealing|compulsive stealing
5185907|NCT00880685|Compulsive Shoplifting|compulsive shoplifting
5185908|NCT00880672|prostate, dutasteride|prostate, dutasteride
5185909|NCT00880672|vascular endothelial growth factor|vascular endothelial growth factor
5185910|NCT00880672|hypoxia inducible factor|hypoxia inducible factor
5185911|NCT00880659|Influenza|influenza
5185912|NCT00880659|secondary transmission|secondary transmission
5185913|NCT00880659|handwashing|handwashing
5185914|NCT00880633|EUS|eus
5185915|NCT00880633|periampullary neoplasms|periampullary neoplasms
5185916|NCT00880620|Parkinson's disease|parkinson's disease
5185917|NCT00880607|Pain|pain
5185918|NCT00880607|Pediatric|pediatric
5185919|NCT00880607|Spinal Fusion|spinal fusion
5185920|NCT00880607|pain management|pain management
5185921|NCT00880555|Magnetic Resonance Imaging|magnetic resonance imaging
5185922|NCT00880555|Alzheimer disease|alzheimer disease
5185923|NCT00880555|Mild cognitive impairment|mild cognitive impairment
5185924|NCT00880555|Continuous arterial spin labeling|continuous arterial spin labeling
5185925|NCT00880555|Semantic memory|semantic memory
5185926|NCT00880542|localized osteosarcoma|localized osteosarcoma
5185927|NCT00880542|stage II adult soft tissue sarcoma|stage ii adult soft tissue sarcoma
5185928|NCT00880542|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
5185929|NCT00880529|rib fractures|rib fractures
5185930|NCT00880529|ventilator|ventilator
5185931|NCT00880529|ON-Q|on-q
5185932|NCT00880529|analgesia|analgesia
5185933|NCT00880503|Multidrug Resistance Molecular Target Analysis|multidrug resistance molecular target analysis
5185934|NCT00880490|COPD|copd
5185935|NCT00880464|autologous vaccination|autologous vaccination
5185936|NCT00880464|GM-CSF|gm-csf
5185937|NCT00880464|adenoviral mediated gene transfer|adenoviral mediated gene transfer
5185938|NCT00880464|Stage IV breast cancer|stage iv breast cancer
5185939|NCT00880451|Children and Adolescents|children and adolescents
5185940|NCT00880451|Aging|aging
5185941|NCT00880451|Brain Imaging|brain imaging
5185942|NCT00880451|MRI (Magnetic Resonance Imaging)|mri (magnetic resonance imaging)
5185943|NCT00880412|safety|safety
5185944|NCT00880412|efficacy|efficacy
5185945|NCT00880412|Alzheimer's disease|alzheimer's disease
5185946|NCT00880412|treatment|treatment
5185947|NCT00880412|phase II|phase ii
5185948|NCT00880412|study|study
5185949|NCT00880412|cholinesterase inhibitor|cholinesterase inhibitor
5185950|NCT00880399|depression|depression
5185951|NCT00880399|QIDS-SR|qids-sr
5185952|NCT00880399|HAMD-17|hamd-17
5185953|NCT00880399|orvepitant|orvepitant
5185954|NCT00880399|MDD|mdd
5185955|NCT00880399|neurokinin-1 antagonist|neurokinin-1 antagonist
5185956|NCT00880399|double-blind|double-blind
5185957|NCT00880399|Phase II|phase ii
5185958|NCT00880399|randomized|randomized
5185959|NCT00880399|efficacy|efficacy
5185960|NCT00880399|placebo|placebo
5185961|NCT00880399|safety|safety
5185962|NCT00880386|dyspnea|dyspnea
5185963|NCT00880386|stage I non-small cell lung cancer|stage i non-small cell lung cancer
5185964|NCT00880386|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
5185965|NCT00880386|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5185966|NCT00880386|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5185967|NCT00880386|pulmonary complications|pulmonary complications
5185968|NCT00880386|radiation fibrosis|radiation fibrosis
5185969|NCT00880373|Sickle Cell Disease|sickle cell disease
5185970|NCT00880373|Pain|pain
5185971|NCT00880373|Ibuprofen|ibuprofen
5185972|NCT00880373|Morphine|morphine
5185973|NCT00880373|Diamorphine|diamorphine
5185974|NCT00880373|Patient Controlled Analgesia|patient controlled analgesia
5185975|NCT00880360|Epithelial Ovarian Cancer|epithelial ovarian cancer
5185976|NCT00880360|FIGO (International Fed of Gyn and Ob)Stage III or Stage IV|figo (international fed of gyn and ob)stage iii or stage iv
5185977|NCT00880360|Extraovarian Peritoneal Cancer|extraovarian peritoneal cancer
5185978|NCT00880360|Fallopian Tube Carcinoma Failing|fallopian tube carcinoma failing
5185979|NCT00880347|Alzheimer's disease|alzheimer's disease
5185980|NCT00880347|Other dementia|other dementia
5185981|NCT00880347|Vascular dementia|vascular dementia
5185982|NCT00880347|Mixed dementia|mixed dementia
5185983|NCT00880347|Parkinson's Disease dementia|parkinson's disease dementia
5185984|NCT00880347|Lewy bodies dementia|lewy bodies dementia
5185985|NCT00880347|Frontotemporal dementia|frontotemporal dementia
5185986|NCT00880347|Blood signature|blood signature
5185987|NCT00880347|Diagnosis|diagnosis
5185988|NCT00880347|SpliceArray (tm)|splicearray (tm)
5185989|NCT00880347|Alzheimer's Disease and other non-AD dementia|alzheimer's disease and other non-ad dementia
5185990|NCT00880334|TCC|tcc
5185991|NCT00880334|Zactima|zactima
5185992|NCT00880334|docetaxel|docetaxel
5185993|NCT00880334|ZD6474|zd6474
5185994|NCT00880334|taxotere|taxotere
5185995|NCT00880321|first time in human|first time in human
5185996|NCT00880321|BRAF inhibitor|braf inhibitor
5185997|NCT00880321|dose escalation|dose escalation
5185998|NCT00880308|Advanced tumors|advanced tumors
5185999|NCT00880308|hedgehog|hedgehog
5186000|NCT00880308|smoothened inhibitor|smoothened inhibitor
5186001|NCT00880269|Acute myeloid leukemia|acute myeloid leukemia
5186003|NCT00880269|relapsed acute myeloid leukemia|relapsed acute myeloid leukemia
5186004|NCT00880269|refractory AML|refractory aml
5186005|NCT00880269|refractory de novo AML|refractory de novo aml
5186006|NCT00880269|refractory secondary AML|refractory secondary aml
5186007|NCT00880269|secondary AML|secondary aml
5186008|NCT00880269|AML following myelodysplastic syndrome (MDS)|aml following myelodysplastic syndrome (mds)
5186009|NCT00880269|AML following antecedent hematological disorder (AHD)|aml following antecedent hematological disorder (ahd)
5186010|NCT00880269|AML resistant to therapy|aml resistant to therapy
5186011|NCT00880256|irritable bowel|irritable bowel
5186012|NCT00880256|mindfulness|mindfulness
5186013|NCT00880256|stress|stress
5186014|NCT00880256|meditation|meditation
5186015|NCT00880243|Acute myeloid leukemia|acute myeloid leukemia
5186016|NCT00880243|Priming|priming
5186017|NCT00880243|GM-CSF|gm-csf
5186018|NCT00880243|Timed-sequential chemotherapy|timed-sequential chemotherapy
5186019|NCT00880243|Prognosis|prognosis
5186020|NCT00880230|Iliac Artery Stenting|iliac artery stenting
5186021|NCT00880230|Peripheral Artery Disease|peripheral artery disease
5186022|NCT00880217|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
5186023|NCT00880217|Attention Deficit Disorders with Hyperactivity|attention deficit disorders with hyperactivity
5186024|NCT00880217|Adult ADHD|adult adhd
5186025|NCT00880217|JNJ-31001074|jnj-31001074
5186026|NCT00880204|Cluster Randomized Trial|cluster randomized trial
5186027|NCT00880204|ESS-EMCH|ess-emch
5186028|NCT00880204|Neonatal|neonatal
5186029|NCT00880204|Maternal|maternal
5186030|NCT00880204|Life threatening emergency event|life threatening emergency event
5186031|NCT00880191|nausea and vomiting|nausea and vomiting
5186032|NCT00880191|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5186033|NCT00880178|Simvastatin|simvastatin
5186034|NCT00880178|Niacin|niacin
5186035|NCT00880178|Vascular Disease|vascular disease
5186036|NCT00880178|Magnetic Resonance Imaging|magnetic resonance imaging
5186037|NCT00880178|High Density Lipoprotein|high density lipoprotein
5186038|NCT00880178|Oxidation|oxidation
5186039|NCT00880178|Proteomics|proteomics
5186040|NCT00880178|Stroke|stroke
5186041|NCT00880178|Cerebrovascular Accident|cerebrovascular accident
5186042|NCT00880165|Polysomnogram|polysomnogram
5186043|NCT00880165|Continuous positive airway pressure|continuous positive airway pressure
5186044|NCT00880152|stress|stress
5186045|NCT00880152|mindfulness|mindfulness
5186046|NCT00880152|trauma|trauma
5186047|NCT00880139|Diabetes mellitus, type 1|diabetes mellitus, type 1
5186048|NCT00880139|Inflammation|inflammation
5186049|NCT00880139|Cytokines|cytokines
5186050|NCT00880139|Vascular reactivity|vascular reactivity
5186051|NCT00880126|Individualized Implementation|individualized implementation
5186052|NCT00880126|Community Development Teams|community development teams
5186053|NCT00880113|CT-perfusion|ct-perfusion
5186054|NCT00880113|CT-angiography|ct-angiography
5186055|NCT00880100|Steatorrhea|steatorrhea
5186056|NCT00880100|Malabsorption of fat|malabsorption of fat
5186057|NCT00880100|Pancreatic enzymes|pancreatic enzymes
5186058|NCT00880100|Abdominal pain|abdominal pain
5186059|NCT00880100|Greasy stools|greasy stools
5186060|NCT00880087|Cardiac Arrest|cardiac arrest
5186061|NCT00880087|Cardiopulmonary Arrest|cardiopulmonary arrest
5186062|NCT00880087|Pediatric Cardiac Arrest|pediatric cardiac arrest
5186063|NCT00880087|VABS|vabs
5186064|NCT00880087|Vineland Adaptive Behavior Scale|vineland adaptive behavior scale
5186065|NCT00880087|POPC/PCPC|popc/pcpc
5186066|NCT00880087|hypoxic-ischemic encephalopathy|hypoxic-ischemic encephalopathy
5186067|NCT00880074|Advanced Cancers|advanced cancers
5186068|NCT00880074|FLT-PET|flt-pet
5186069|NCT00880074|Positron Emission Tomography|positron emission tomography
5186070|NCT00880074|PET|pet
5186071|NCT00880074|[18F] fluorothymidine|[18f] fluorothymidine
5186072|NCT00880074|[F-18]-fluoro-L-thymidine|[f-18]-fluoro-l-thymidine
5186073|NCT00880074|FLT|flt
5186074|NCT00880061|Diffuse Infiltrating Pontine Glioma|diffuse infiltrating pontine glioma
5186075|NCT00880061|Supratentorial High Grade Glioma|supratentorial high grade glioma
5186076|NCT00880061|Convection-Enhanced Delivery|convection-enhanced delivery
5186077|NCT00880061|Pediatric Brain Tumor|pediatric brain tumor
5186078|NCT00880061|Brain Tumor|brain tumor
5186079|NCT00880061|Glioma|glioma
5186080|NCT00880048|depression|depression
5186081|NCT00880048|safety|safety
5186082|NCT00880048|HAMD|hamd
5186083|NCT00880048|QIDS-SR|qids-sr
5186084|NCT00880048|NK-1 antagonist|nk-1 antagonist
5186085|NCT00880048|efficacy|efficacy
5186086|NCT00880048|orvepitant|orvepitant
5186087|NCT00880048|placebo|placebo
5186088|NCT00880048|MDD|mdd
5186089|NCT00880048|video-rating|video-rating
5186090|NCT00880035|sedative drug|sedative drug
5186091|NCT00880035|stress|stress
5186092|NCT00880035|music|music
5186093|NCT00880035|mechanical ventilation|mechanical ventilation
5186094|NCT00880035|IL-6|il-6
5186095|NCT00880035|cortisol|cortisol
5186096|NCT00880035|prolactin|prolactin
5186097|NCT00880035|CRP|crp
5186098|NCT00880035|copeptin|copeptin
5186099|NCT00880022|compression|compression
5186100|NCT00880022|Flexitouch|flexitouch
5186101|NCT00880022|breast cancer|breast cancer
5186102|NCT00880022|lymphedema|lymphedema
5186103|NCT00879996|Opiate Addiction|opiate addiction
5186104|NCT00879996|Narcotic Addiction|narcotic addiction
5186105|NCT00879996|Drug Addiction|drug addiction
5186106|NCT00879996|Pain|pain
5186107|NCT00879983|azithromycin, pharmacokinetics|azithromycin, pharmacokinetics
5186108|NCT00879970|Cardiovascular Outcomes|cardiovascular outcomes
5186109|NCT00879957|Infant, Premature|infant, premature
5186110|NCT00879957|Infant|infant
5186111|NCT00879957|Central venous catheterization|central venous catheterization
5186112|NCT00879957|Anticoagulants|anticoagulants
5186113|NCT00879944|Psoriasis|psoriasis
5186114|NCT00879944|Obesity|obesity
5186115|NCT00879944|BMI|bmi
5186116|NCT00879944|Atopic Dermatitis|atopic dermatitis
5186117|NCT00879918|Cigarette Smoking in African Americans|cigarette smoking in african americans
5186118|NCT00879905|Phase I|phase i
5186119|NCT00879905|Adults|adults
5186120|NCT00879905|HSP990|hsp990
5186121|NCT00879905|Advanced Solid Tumors|advanced solid tumors
5186122|NCT00879905|Hsp90 inhibitor|hsp90 inhibitor
5186123|NCT00879905|Cancer|cancer
5186124|NCT00879892|xenon|xenon
5186125|NCT00879892|hypothermia|hypothermia
5186126|NCT00879892|out-of-hospital cardiac arrest|out-of-hospital cardiac arrest
5186127|NCT00879879|precancerous condition|precancerous condition
5186128|NCT00879866|NSCLC|nsclc
5186129|NCT00879866|immunocytokine|immunocytokine
5186130|NCT00879866|radiation|radiation
5186131|NCT00879866|interleukin-2|interleukin-2
5186132|NCT00879866|immunotherapy|immunotherapy
5186133|NCT00879866|maintenance therapy|maintenance therapy
5186134|NCT00879853|PTSD|ptsd
5186135|NCT00879853|Depression|depression
5186136|NCT00879853|Anger|anger
5186137|NCT00879853|Domestic Violence|domestic violence
5186138|NCT00879853|Refugee|refugee
5186139|NCT00879853|Asylum Seeker|asylum seeker
5186140|NCT00879853|Community Therapist|community therapist
5186141|NCT00879853|Paraprofessional Therapists|paraprofessional therapists
5186142|NCT00879840|Screening|screening
5186143|NCT00879840|Modalities|modalities
5186144|NCT00879840|Gynecological Cancers|gynecological cancers
5186145|NCT00879801|prevention of diabetes|prevention of diabetes
5186146|NCT00879801|susceptibility genes|susceptibility genes
5186147|NCT00879801|type 2 diabetes|type 2 diabetes
5186148|NCT00879801|insulin resistance|insulin resistance
5186149|NCT00879801|beta-cell funtion|beta-cell funtion
5186150|NCT00879788|Ramipril fed condition|ramipril fed condition
5186151|NCT00879775|Pain|pain
5186152|NCT00879775|Cancer patients|cancer patients
5186153|NCT00879775|Caffeine|caffeine
5186154|NCT00879775|Adjuvant analgesics|adjuvant analgesics
5186155|NCT00879775|Sedation|sedation
5186156|NCT00879775|Confusion|confusion
5186157|NCT00879775|Quality of life|quality of life
5186158|NCT00879775|Fatigue|fatigue
5186159|NCT00879762|smallpox, vaccine, IMVAMUNE®|smallpox, vaccine, imvamune®
5186160|NCT00879736|Doctor-patient communication|doctor-patient communication
5186161|NCT00879736|Encounters|encounters
5186162|NCT00879736|Patient education training|patient education training
5186163|NCT00879723|post-burn recovery|post-burn recovery
5186164|NCT00879723|oxidative stress|oxidative stress
5186165|NCT00879723|micronutrient protocol|micronutrient protocol
5186166|NCT00879710|Diabetes Mellitus|diabetes mellitus
5186167|NCT00879710|Hypercholesterolemia|hypercholesterolemia
5186168|NCT00879710|Simvastatin|simvastatin
5186169|NCT00879710|Ezetimibe.|ezetimibe.
5186170|NCT00879697|peripheral arterial disease|peripheral arterial disease
5186171|NCT00879697|exercise|exercise
5186172|NCT00879697|resistance training|resistance training
5186173|NCT00879697|cardiac rehabilitation|cardiac rehabilitation
5186174|NCT00879684|Phase 1|phase 1
5186175|NCT00879684|Tumors|tumors
5186176|NCT00879684|CVX-060|cvx-060
5186177|NCT00879671|lutein|lutein
5186178|NCT00879671|nonexudative AMD|nonexudative amd
5186179|NCT00879671|MPOD|mpod
5186180|NCT00879671|Supplementary Concepts|supplementary concepts
5186181|NCT00879658|Multiple Sclerosis|multiple sclerosis
5186182|NCT00879658|Relapsing-Remitting|relapsing-remitting
5186183|NCT00879658|Demyelinating Autoimmune Diseases|demyelinating autoimmune diseases
5186184|NCT00879645|Renal Impairment|renal impairment
5186185|NCT00879645|Renal Disease|renal disease
5186186|NCT00879645|Sodium Sulfide|sodium sulfide
5186187|NCT00879606|Sepsis|sepsis
5186188|NCT00879606|Acute Lung Injury|acute lung injury
5186189|NCT00879606|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
5186190|NCT00879606|ALI/ARDS|ali/ards
5186191|NCT00879606|Lung Disease|lung disease
5186192|NCT00879580|aneurysm|aneurysm
5186193|NCT00879580|stent|stent
5186194|NCT00879580|intracranial aneurysm|intracranial aneurysm
5186195|NCT00879580|Ruptured Intracranial Aneurysm|ruptured intracranial aneurysm
5186196|NCT00879554|Phase 1|phase 1
5186197|NCT00879554|Solid Tumors|solid tumors
5186198|NCT00879554|CVX-045|cvx-045
5186199|NCT00879541|Hemophilia A|hemophilia a
5186200|NCT00879528|Hodgkin's Lymphoma|hodgkin's lymphoma
5186201|NCT00879528|stem cell reinfusion|stem cell reinfusion
5186202|NCT00879515|Fragile X Premutation|fragile x premutation
5186203|NCT00879515|Fragile X Syndrome|fragile x syndrome
5186204|NCT00879515|Down Syndrome|down syndrome
5186205|NCT00879502|Fragile X Premutation|fragile x premutation
5186206|NCT00879502|FMR1|fmr1
5186207|NCT00879502|Premutation|premutation
5186208|NCT00879502|Fragile X|fragile x
5186209|NCT00879502|Brain Function|brain function
5186210|NCT00879489|Stage IV histologically proven breast cancer|stage iv histologically proven breast cancer
5186211|NCT00879476|Bioequivalence ramipril fasting condition|bioequivalence ramipril fasting condition
5186212|NCT00879463|Blood transfusion in cardiac operations under CPB|blood transfusion in cardiac operations under cpb
5186213|NCT00879463|Infrared spectrophotoscopy|infrared spectrophotoscopy
5186214|NCT00879450|Congenital muscular torticollis|congenital muscular torticollis
5186215|NCT00879437|brain tumor|brain tumor
5186216|NCT00879437|bevacizumab|bevacizumab
5186217|NCT00879437|valproic acid|valproic acid
5186218|NCT00879437|radiation therapy|radiation therapy
5186219|NCT00879424|vitamin D|vitamin d
5186220|NCT00879424|atopic dermatitis|atopic dermatitis
5186221|NCT00879424|eczema|eczema
5186222|NCT00879424|winter|winter
5186223|NCT00879385|KRAS wild-type|kras wild-type
5186224|NCT00879385|Colon|colon
5186225|NCT00879385|Cancer|cancer
5186226|NCT00879385|colorectal|colorectal
5186227|NCT00879385|metastatic colorectal|metastatic colorectal
5186228|NCT00879385|advanced colorectal|advanced colorectal
5186229|NCT00879372|Bipolar Disorder|bipolar disorder
5186230|NCT00879372|cognitive impairment|cognitive impairment
5186231|NCT00879372|depression|depression
5186232|NCT00879346|Healthy Volunteers|healthy volunteers
5186233|NCT00879346|ADME|adme
5186234|NCT00879346|Healthy male volunteers|healthy male volunteers
5186235|NCT00879333|Gastric cancer,|gastric cancer,
5186236|NCT00879333|advanced gastric cancer,|advanced gastric cancer,
5186237|NCT00879333|stomach neoplasm,|stomach neoplasm,
5186238|NCT00879333|stomach disease,|stomach disease,
5186239|NCT00879333|adenocarcinoma of stomach,|adenocarcinoma of stomach,
5186240|NCT00879333|GI neoplasm|gi neoplasm
5186241|NCT00879320|ADHD|adhd
5186242|NCT00879320|health|health
5186243|NCT00879320|healthy lifestyle|healthy lifestyle
5186440|NCT00878579|Spinal|spinal
5186244|NCT00879294|Perforated appendicitis|perforated appendicitis
5186245|NCT00879294|Ruptured appendicitis|ruptured appendicitis
5186246|NCT00879294|Acute appendicitis with perforation|acute appendicitis with perforation
5186247|NCT00879281|COPD|copd
5186248|NCT00879281|emphysema|emphysema
5186249|NCT00879281|chronic bronchitis|chronic bronchitis
5186250|NCT00879268|Liver Transplantation|liver transplantation
5186251|NCT00879268|Organ Preservation|organ preservation
5186252|NCT00879268|Liver Preservation|liver preservation
5186253|NCT00879268|Machine Perfusion|machine perfusion
5186254|NCT00879268|Vasosol|vasosol
5186255|NCT00879268|Machine Preservation|machine preservation
5186256|NCT00879255|cognitive processing therapy|cognitive processing therapy
5186257|NCT00879255|combat|combat
5186258|NCT00879255|veterans|veterans
5186259|NCT00879255|PTSD|ptsd
5186260|NCT00879255|Telemental Health|telemental health
5186261|NCT00879255|Videoteleconference|videoteleconference
5186262|NCT00879255|outcome|outcome
5186263|NCT00879255|Rural|rural
5186264|NCT00879255|Remote|remote
5186265|NCT00879255|CPT|cpt
5186266|NCT00879255|VTC|vtc
5186267|NCT00879242|Thalassemia|thalassemia
5186268|NCT00879242|cardiac MRI T2*|cardiac mri t2*
5186269|NCT00879229|Idiopathic Pulmonary Fibrosis|idiopathic pulmonary fibrosis
5186270|NCT00879229|Pulmonary Hypertension|pulmonary hypertension
5186271|NCT00879229|PH|ph
5186272|NCT00879229|IPF|ipf
5186273|NCT00879229|Ambrisentan|ambrisentan
5186274|NCT00879229|ERA|era
5186275|NCT00879229|Endothelin Receptor Antagonist|endothelin receptor antagonist
5186276|NCT00879229|Cardiovascular|cardiovascular
5186277|NCT00879216|Nocturia|nocturia
5186278|NCT00879216|Hyptotension|hyptotension
5186279|NCT00879216|Elderly|elderly
5186280|NCT00879216|Males|males
5186281|NCT00879203|Type 1 Diabetes Mellitis|type 1 diabetes mellitis
5186282|NCT00879203|Youth|youth
5186283|NCT00879203|Hypoglycemia|hypoglycemia
5186284|NCT00879203|Hyperglycemia|hyperglycemia
5186285|NCT00879203|Cognition|cognition
5186286|NCT00879203|Memory|memory
5186287|NCT00879203|Brain Growth & Development|brain growth & development
5186288|NCT00879203|Magnetic Resonance Imaging|magnetic resonance imaging
5186289|NCT00879177|smoking|smoking
5186290|NCT00879177|varenicline|varenicline
5186291|NCT00879177|behavioral therapy|behavioral therapy
5186292|NCT00879177|ABPM|abpm
5186293|NCT00879177|hypertension|hypertension
5186294|NCT00879164|hot flashes|hot flashes
5186295|NCT00879125|Gastric by-pass on patients with T2DM|gastric by-pass on patients with t2dm
5186296|NCT00879112|Hyperlipidemia|hyperlipidemia
5186297|NCT00879099|Interaction|interaction
5186298|NCT00879099|healthy volunteers|healthy volunteers
5186299|NCT00879099|Interaction study for healthy volunteers|interaction study for healthy volunteers
5186300|NCT00879086|Breast Cancer|breast cancer
5186301|NCT00879086|Oncology|oncology
5186302|NCT00879073|Brain and Nervous System|brain and nervous system
5186303|NCT00879060|Fibrosis|fibrosis
5186304|NCT00879060|Hypertrophic cardiomyopathy|hypertrophic cardiomyopathy
5186305|NCT00879060|MRI|mri
5186306|NCT00879060|To evaluate the efficacy of spironolactone in decreasing myocardial fibrosis in Hypertrophic cardiomyopathy|to evaluate the efficacy of spironolactone in decreasing myocardial fibrosis in hypertrophic cardiomyopathy
5186307|NCT00879047|HIV|hiv
5186308|NCT00879047|Hepatitis C|hepatitis c
5186309|NCT00879034|Hutchinson-Gilford Progeria Syndrome|hutchinson-gilford progeria syndrome
5186310|NCT00879034|HGPS|hgps
5186311|NCT00879034|Progeria|progeria
5186312|NCT00879034|FTI|fti
5186313|NCT00879034|Farnesyltransferase Inhibitor|farnesyltransferase inhibitor
5186314|NCT00879034|Lonafarnib|lonafarnib
5186315|NCT00879034|Zoledronic Acid|zoledronic acid
5186316|NCT00879034|Pravastatin|pravastatin
5186317|NCT00879021|The outcome is to prevent Central Neuropathic Pain|the outcome is to prevent central neuropathic pain
5186318|NCT00879021|participants will have suffered spinal cord trauma|participants will have suffered spinal cord trauma
5186319|NCT00879008|Disease Exacerbation|disease exacerbation
5186320|NCT00879008|Acute Exacerbations of Chronic Bronchitis|acute exacerbations of chronic bronchitis
5186321|NCT00879008|AECB|aecb
5186322|NCT00879008|Avelox|avelox
5186323|NCT00879008|Bronchitis|bronchitis
5186324|NCT00878995|stage IIB cervical cancer|stage iib cervical cancer
5186325|NCT00878995|stage III cervical cancer|stage iii cervical cancer
5186326|NCT00878995|recurrent cervical cancer|recurrent cervical cancer
5186327|NCT00878995|cachexia|cachexia
5186328|NCT00878995|advanced head/neck carcinoma|advanced head/neck carcinoma
5186329|NCT00878995|recurrent head/neck carcinoma|recurrent head/neck carcinoma
5186330|NCT00878969|Hemodialysis|hemodialysis
5186331|NCT00878969|fibrinolysis|fibrinolysis
5186332|NCT00878969|oxidative stress|oxidative stress
5186333|NCT00878969|systemic inflammatory reaction|systemic inflammatory reaction
5186334|NCT00878969|endothelial dysfunction|endothelial dysfunction
5186335|NCT00878969|carotid intima media thickness (IMT|carotid intima media thickness (imt
5186336|NCT00878969|angiotensin receptor blockade|angiotensin receptor blockade
5186337|NCT00878969|angiotensin converting enzyme inhibition|angiotensin converting enzyme inhibition
5186338|NCT00878956|Cardiac surgery|cardiac surgery
5186339|NCT00878956|Cardiopulmonary bypass|cardiopulmonary bypass
5186340|NCT00878956|Oxidative stress|oxidative stress
5186341|NCT00878956|Acute renal dysfunction|acute renal dysfunction
5186342|NCT00878956|Sodium bicarbonate|sodium bicarbonate
5186343|NCT00878943|Open label access|open label access
5186344|NCT00878943|sildenafil|sildenafil
5186345|NCT00878943|pulmonary arterial hypertension|pulmonary arterial hypertension
5186346|NCT00878930|Breast cancer|breast cancer
5186347|NCT00878930|Fulvestrant|fulvestrant
5186348|NCT00878930|Faslodex|faslodex
5186349|NCT00878930|Acceptability|acceptability
5186350|NCT00878930|Compliance|compliance
5186351|NCT00878930|Efficacy|efficacy
5186352|NCT00878917|Equivalence Study|equivalence study
5186353|NCT00878917|Eye Drops Solution|eye drops solution
5186354|NCT00878917|Dorzolamide|dorzolamide
5186355|NCT00878917|Open Angle Glaucoma|open angle glaucoma
5186356|NCT00878917|Ocular Hypertension|ocular hypertension
5186357|NCT00878904|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5186358|NCT00878891|Microdialysis|microdialysis
5186359|NCT00878891|realtime|realtime
5186360|NCT00878891|glucose sensor|glucose sensor
5186361|NCT00878891|coronary artery bypass|coronary artery bypass
5186362|NCT00878878|Pulmonary artery systolic pressure (PASP)|pulmonary artery systolic pressure (pasp)
5186363|NCT00878878|Pulmonary Vascular Resistance (PVR)|pulmonary vascular resistance (pvr)
5186364|NCT00878878|Right Heart Catheterization|right heart catheterization
5186365|NCT00878878|Pulmonary hemodynamics|pulmonary hemodynamics
5186366|NCT00878865|Alprazolam|alprazolam
5186367|NCT00878865|bioequivalence|bioequivalence
5186368|NCT00878839|Cataract|cataract
5186369|NCT00878839|Toric IOL|toric iol
5186370|NCT00878839|Corneal Aberration|corneal aberration
5186371|NCT00878839|Astigmatism|astigmatism
5186372|NCT00878839|AcrySof|acrysof
5186373|NCT00878813|Copeptin|copeptin
5186374|NCT00878813|Vasopressin|vasopressin
5186375|NCT00878813|Stroke|stroke
5186376|NCT00878813|Transient ischemic attack|transient ischemic attack
5186377|NCT00878813|Thrombolytic therapy|thrombolytic therapy
5186378|NCT00878813|Prognosis|prognosis
5186379|NCT00878813|Complications|complications
5186380|NCT00878800|Phase I/II trial|phase i/ii trial
5186381|NCT00878800|Solid tumors|solid tumors
5186382|NCT00878800|Soft tissue sarcoma|soft tissue sarcoma
5186383|NCT00878800|PXD101|pxd101
5186384|NCT00878800|Doxorubicin|doxorubicin
5186385|NCT00878774|Ragweed allergy|ragweed allergy
5186386|NCT00878774|Immunotherapy|immunotherapy
5186387|NCT00878774|Rhinoconjunctivitis|rhinoconjunctivitis
5186388|NCT00878774|Toleromune Ragweed|toleromune ragweed
5186389|NCT00878761|Renal transplant|renal transplant
5186390|NCT00878761|Interstitial fibrosis and tubular atrophy|interstitial fibrosis and tubular atrophy
5186391|NCT00878761|Chronic allograft dysfunction|chronic allograft dysfunction
5186392|NCT00878761|Chronic allograft nephropathy|chronic allograft nephropathy
5186393|NCT00878761|kidney transplant|kidney transplant
5186394|NCT00878735|Meditation|meditation
5186395|NCT00878735|Mindfulness|mindfulness
5186396|NCT00878735|fMRI|fmri
5186397|NCT00878735|cancer|cancer
5186398|NCT00878735|stress|stress
5186399|NCT00878735|anxiety|anxiety
5186400|NCT00878735|depression|depression
5186401|NCT00878735|attention|attention
5186402|NCT00878735|Neuroscience|neuroscience
5186403|NCT00878735|Neuroimaging|neuroimaging
5186404|NCT00878735|Psychobiology|psychobiology
5186405|NCT00878735|Healthy volunteers (regular meditators and non-meditators)|healthy volunteers (regular meditators and non-meditators)
5186406|NCT00878722|Acute Myeloid Leukemia|acute myeloid leukemia
5186407|NCT00878722|PXD101|pxd101
5186408|NCT00878722|Belinostat|belinostat
5186409|NCT00878722|Idarubicin|idarubicin
5186410|NCT00878709|HER-2/erbB-2 positive breast cancer|her-2/erbb-2 positive breast cancer
5186411|NCT00878709|breast cancer|breast cancer
5186412|NCT00878709|adjuvant therapy|adjuvant therapy
5186413|NCT00878709|neratinib|neratinib
5186414|NCT00878709|HKI-272|hki-272
5186415|NCT00878709|Nerlynx|nerlynx
5186416|NCT00878709|PB-272|pb-272
5186417|NCT00878657|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
5186418|NCT00878657|stage III pancreatic cancer|stage iii pancreatic cancer
5186419|NCT00878644|Cardiac Arrest|cardiac arrest
5186420|NCT00878644|Cardiopulmonary Arrest|cardiopulmonary arrest
5186421|NCT00878644|Pediatric Cardiac Arrest|pediatric cardiac arrest
5186422|NCT00878644|VABS|vabs
5186423|NCT00878644|Vineland Adaptive Behavior Survey|vineland adaptive behavior survey
5186424|NCT00878644|POPC/PCPC|popc/pcpc
5186425|NCT00878644|hypoxic-ichemic encephalopathy|hypoxic-ichemic encephalopathy
5186426|NCT00878631|emergency medical services|emergency medical services
5186427|NCT00878631|traumatic brain injury|traumatic brain injury
5186428|NCT00878631|hypertonic saline with dextran|hypertonic saline with dextran
5186429|NCT00878631|fluid resuscitation|fluid resuscitation
5186430|NCT00878618|Healthy volunteers|healthy volunteers
5186431|NCT00878605|Diabetes|diabetes
5186432|NCT00878605|Cyclo-Z|cyclo-z
5186433|NCT00878592|Post liver transplant|post liver transplant
5186434|NCT00878592|weight reduction classes|weight reduction classes
5186435|NCT00878592|obesity|obesity
5186436|NCT00878592|weight management|weight management
5186437|NCT00878592|dietary and lifestyle modification|dietary and lifestyle modification
5186438|NCT00878579|back pain|back pain
5186439|NCT00878579|Spine|spine
5186441|NCT00878579|Lower back pain|lower back pain
5186442|NCT00878579|Lumbar|lumbar
5186443|NCT00878579|Lumbar Pain|lumbar pain
5186445|NCT00878579|Degenerative Disc Disease|degenerative disc disease
5186446|NCT00878566|hypertension|hypertension
5186447|NCT00878566|pharmacists|pharmacists
5186448|NCT00878566|rural health|rural health
5186449|NCT00878566|prescribing|prescribing
5186450|NCT00878553|insomnia|insomnia
5186451|NCT00878553|middle of the night|middle of the night
5186452|NCT00878553|sleep maintenance|sleep maintenance
5186453|NCT00878540|mirtazapine|mirtazapine
5186454|NCT00878540|metabolism|metabolism
5186455|NCT00878540|depression|depression
5186456|NCT00878540|Healthy males|healthy males
5186457|NCT00878527|Heart Failure|heart failure
5186458|NCT00878527|Partial Circulatory Assist|partial circulatory assist
5186459|NCT00878527|NYHA Class IIIb|nyha class iiib
5186460|NCT00878527|NYHA Class IV|nyha class iv
5186461|NCT00878527|Ventricular Assist Device|ventricular assist device
5186462|NCT00878527|VAD|vad
5186463|NCT00878514|Alprazolam|alprazolam
5186464|NCT00878514|Bioequivalence|bioequivalence
5186465|NCT00878501|Phase II|phase ii
5186466|NCT00878501|Pain|pain
5186467|NCT00878475|Quantitative Capnometry|quantitative capnometry
5186468|NCT00878475|N-Terminal Pro-Brain Natriuretic Peptide|n-terminal pro-brain natriuretic peptide
5186469|NCT00878475|Acute Heart Failure|acute heart failure
5186470|NCT00878475|Diagnostic Accuracy|diagnostic accuracy
5186471|NCT00878436|histone deacetylase inhibitor|histone deacetylase inhibitor
5186472|NCT00878436|hormone therapy|hormone therapy
5186473|NCT00878436|androgen-independent|androgen-independent
5186474|NCT00878436|PSA|psa
5186475|NCT00878436|androgen receptor|androgen receptor
5186476|NCT00878423|HSP90|hsp90
5186477|NCT00878423|Metastatic solid tumor including lymphoma which are|metastatic solid tumor including lymphoma which are
5186478|NCT00878423|refractory to standard therapy|refractory to standard therapy
5186479|NCT00878397|malaria|malaria
5186480|NCT00878397|long lasting insecticide nets|long lasting insecticide nets
5186481|NCT00878397|anaemia|anaemia
5186482|NCT00878397|schools|schools
5186483|NCT00878384|Atrial Fibrillation|atrial fibrillation
5186484|NCT00878384|Heart Failure|heart failure
5186485|NCT00878384|Heart Rate Control|heart rate control
5186486|NCT00878384|Catheter Ablation|catheter ablation
5186487|NCT00878371|morphine|morphine
5186488|NCT00878371|blood brain barrier|blood brain barrier
5186489|NCT00878371|surgery induced peripheral inflammatory response|surgery induced peripheral inflammatory response
5186490|NCT00878358|Osteoarthritis|osteoarthritis
5186491|NCT00878358|Total knee replacement|total knee replacement
5186492|NCT00878345|Pediatric sedation|pediatric sedation
5186493|NCT00878345|Pentobarbital|pentobarbital
5186494|NCT00878345|Dexmedetomidine|dexmedetomidine
5186495|NCT00878345|Procedural sedation in children|procedural sedation in children
5186496|NCT00878332|edentulous|edentulous
5186497|NCT00878332|fixed dental rehabilitation|fixed dental rehabilitation
5186498|NCT00878332|insufficient bone height|insufficient bone height
5186499|NCT00878332|Partially edentulous patients|partially edentulous patients
5186500|NCT00878332|Patients interested in fixed non removable dental rehabilitation by dental implants.|patients interested in fixed non removable dental rehabilitation by dental implants.
5186631|NCT00877812|Vitamin B6|vitamin b6
5186501|NCT00878332|The recipient bone with insufficient bone height for dental implant insertion.|the recipient bone with insufficient bone height for dental implant insertion.
5186502|NCT00878332|Adult patients|adult patients
5186503|NCT00878319|Humeral|humeral
5186504|NCT00878319|diaphyseal (mid-shaft)|diaphyseal (mid-shaft)
5186505|NCT00878319|fracture|fracture
5186506|NCT00878319|operative|operative
5186507|NCT00878319|non-operative|non-operative
5186508|NCT00878306|Treatment of drug dependency with HIV medications|treatment of drug dependency with hiv medications
5186509|NCT00878306|HIV|hiv
5186510|NCT00878293|analgesic|analgesic
5186511|NCT00878293|diabetes mellitus|diabetes mellitus
5186512|NCT00878293|chronic neuropathic pain|chronic neuropathic pain
5186513|NCT00878293|painful polyneuropathy caused by diabetes mellitus type I or II|painful polyneuropathy caused by diabetes mellitus type i or ii
5186514|NCT00878267|Cancer|cancer
5186515|NCT00878267|Computer Program|computer program
5186516|NCT00878267|Palliative Care|palliative care
5186517|NCT00878267|Patient-Reported Outcomes|patient-reported outcomes
5186518|NCT00878267|PRO|pro
5186519|NCT00878267|Palliative and Hospice Care Practice|palliative and hospice care practice
5186520|NCT00878267|Electronic Health Record|electronic health record
5186521|NCT00878267|EHR|ehr
5186522|NCT00878267|Interview|interview
5186523|NCT00878254|Mantle Cell Lymphoma|mantle cell lymphoma
5186524|NCT00878254|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
5186525|NCT00878254|MCL|mcl
5186526|NCT00878254|NHL|nhl
5186527|NCT00878241|Colon Anastomosis|colon anastomosis
5186528|NCT00878241|Rectum Anastomosis|rectum anastomosis
5186529|NCT00878241|Intestine|intestine
5186530|NCT00878241|Colorectal Surgery|colorectal surgery
5186531|NCT00878241|Colorectal Anastomosis|colorectal anastomosis
5186532|NCT00878215|Image Guided Liver Surgery|image guided liver surgery
5186533|NCT00878189|Phase 1 dose escalation study in advanced solid tumor malignancy and leukemia|phase 1 dose escalation study in advanced solid tumor malignancy and leukemia
5186534|NCT00878176|sacral neuromodulation therapy|sacral neuromodulation therapy
5186535|NCT00878176|urinary retention|urinary retention
5186536|NCT00878176|screening|screening
5186537|NCT00878176|non obstructive urinary retention|non obstructive urinary retention
5186538|NCT00878150|traumatic brain injury|traumatic brain injury
5186539|NCT00878150|TBI|tbi
5186540|NCT00878150|head injury|head injury
5186541|NCT00878150|brain injury|brain injury
5186542|NCT00878150|depression|depression
5186543|NCT00878150|major depressive disorder|major depressive disorder
5186544|NCT00878150|cognitive behavioral therapy|cognitive behavioral therapy
5186545|NCT00878150|CBT|cbt
5186546|NCT00878150|counseling|counseling
5186547|NCT00878124|Poor ovarian response|poor ovarian response
5186548|NCT00878124|Chromosomal aberrations|chromosomal aberrations
5186549|NCT00878124|poor pregnancy outcome|poor pregnancy outcome
5186550|NCT00878124|Late maternal age|late maternal age
5186551|NCT00878111|NGR-hTNF|ngr-htnf
5186552|NCT00878111|Solid tumours|solid tumours
5186553|NCT00878111|High doses|high doses
5186554|NCT00878098|DDT|ddt
5186555|NCT00878098|Malaria|malaria
5186556|NCT00878098|Pregnancy Outcome|pregnancy outcome
5186557|NCT00878098|Spontaneous Abortion|spontaneous abortion
5186558|NCT00878098|HIV|hiv
5186559|NCT00878098|Pregnancy|pregnancy
5186560|NCT00878085|Robot Therapy|robot therapy
5186561|NCT00878085|Upper Limb|upper limb
5186562|NCT00878085|Stroke|stroke
5186563|NCT00878085|Rehabilitation|rehabilitation
5186564|NCT00878085|fMRI|fmri
5186565|NCT00878085|DTI|dti
5186566|NCT00878072|Herpes labialis|herpes labialis
5186567|NCT00878072|cold sores|cold sores
5186568|NCT00878072|herpes simplex type 1|herpes simplex type 1
5186569|NCT00878046|Hip|hip
5186570|NCT00878046|Cementless|cementless
5186571|NCT00878046|Conservative|conservative
5186572|NCT00878007|Anaemia|anaemia
5186573|NCT00878007|Malaria|malaria
5186574|NCT00878007|Literacy|literacy
5186575|NCT00878007|Kenya|kenya
5186576|NCT00877994|Disordered Eating|disordered eating
5186577|NCT00877994|Parenting|parenting
5186578|NCT00877994|Mothers|mothers
5186579|NCT00877981|hyperparathyroidism|hyperparathyroidism
5186580|NCT00877981|surgery|surgery
5186581|NCT00877981|minimal invasive|minimal invasive
5186582|NCT00877981|videoassited|videoassited
5186583|NCT00877968|Pea flour|pea flour
5186584|NCT00877968|Glycemic response|glycemic response
5186585|NCT00877968|Diabetes|diabetes
5186586|NCT00877968|Sensory|sensory
5186587|NCT00877968|Functional food|functional food
5186588|NCT00877968|Diabetes control and prevention|diabetes control and prevention
5186589|NCT00877955|bioequivalence|bioequivalence
5186590|NCT00877955|pharmacokinetic|pharmacokinetic
5186591|NCT00877955|alprazolam|alprazolam
5186592|NCT00877955|sublingual|sublingual
5186593|NCT00877903|Acute myocardial infarction|acute myocardial infarction
5186594|NCT00877903|AMI|ami
5186595|NCT00877903|Myocardial infarction|myocardial infarction
5186596|NCT00877903|Heart attack|heart attack
5186597|NCT00877903|Mesenchymal stem cells|mesenchymal stem cells
5186598|NCT00877903|MSC|msc
5186599|NCT00877903|Adult human stem cells|adult human stem cells
5186600|NCT00877903|Osiris|osiris
5186601|NCT00877890|diabetes|diabetes
5186602|NCT00877890|exenatide once weekly|exenatide once weekly
5186603|NCT00877890|Byetta|byetta
5186604|NCT00877890|Amylin|amylin
5186605|NCT00877890|Lilly|lilly
5186606|NCT00877890|Bydureon|bydureon
5186607|NCT00877877|HPV vaccine|hpv vaccine
5186608|NCT00877877|cervical cancer|cervical cancer
5186609|NCT00877864|diabetes|diabetes
5186610|NCT00877864|exercise|exercise
5186611|NCT00877864|printed materials|printed materials
5186612|NCT00877851|Diet|diet
5186613|NCT00877851|Physical activity|physical activity
5186614|NCT00877851|Self management|self management
5186615|NCT00877851|Goal setting|goal setting
5186616|NCT00877838|Headache|headache
5186617|NCT00877838|Migraine|migraine
5186618|NCT00877838|Aura|aura
5186619|NCT00877838|Acute|acute
5186620|NCT00877838|Attack|attack
5186621|NCT00877838|Clinical|clinical
5186622|NCT00877838|Trial|trial
5186623|NCT00877838|Intervention|intervention
5186624|NCT00877838|Nitrogen Oxide|nitrogen oxide
5186625|NCT00877838|NOS|nos
5186626|NCT00877838|nNOS|nnos
5186627|NCT00877838|Triptan|triptan
5186628|NCT00877838|5HT|5ht
5186629|NCT00877838|Serotonin|serotonin
5186630|NCT00877825|Diet Therapy|diet therapy
5186632|NCT00877812|Vitamin B6 deficiency|vitamin b6 deficiency
5186633|NCT00877812|Amino acids|amino acids
5186634|NCT00877812|pyridoxine|pyridoxine
5186635|NCT00877799|pain|pain
5186636|NCT00877799|acute pain|acute pain
5186637|NCT00877799|visceral pain|visceral pain
5186638|NCT00877799|kappa agonist|kappa agonist
5186639|NCT00877799|opioid analgesics|opioid analgesics
5186640|NCT00877799|peripheral nervous system agents|peripheral nervous system agents
5186641|NCT00877799|physiological effects of drugs|physiological effects of drugs
5186642|NCT00877799|surgery|surgery
5186643|NCT00877799|hysterectomy|hysterectomy
5186644|NCT00877799|post-operative|post-operative
5186645|NCT00877799|post-operative complications|post-operative complications
5186646|NCT00877773|Advanced cancer|advanced cancer
5186647|NCT00877773|Advanced Cancer with genetic mutation|advanced cancer with genetic mutation
5186648|NCT00877773|Phosphoinositides 3-kinase|phosphoinositides 3-kinase
5186649|NCT00877773|PI3K|pi3k
5186650|NCT00877773|PIK3 mutations|pik3 mutations
5186651|NCT00877773|Temsirolimus|temsirolimus
5186652|NCT00877773|CCI-779|cci-779
5186653|NCT00877773|Torisel|torisel
5186654|NCT00877773|mTOR inhibitor|mtor inhibitor
5186655|NCT00877760|Hepatitis B Entecavir pegylated interferon a-2a|hepatitis b entecavir pegylated interferon a-2a
5186656|NCT00877747|PET|pet
5186657|NCT00877734|alcohol dependence|alcohol dependence
5186658|NCT00877734|baclofen|baclofen
5186659|NCT00877734|pharmacotherapy|pharmacotherapy
5186660|NCT00877734|women|women
5186661|NCT00877721|Postural Control|postural control
5186662|NCT00877721|Gait|gait
5186663|NCT00877721|Falls|falls
5186664|NCT00877721|Elderly|elderly
5186665|NCT00877721|Old adults (65 years old and older) with low risk of falls|old adults (65 years old and older) with low risk of falls
5186666|NCT00877708|E. Coli|e. coli
5186667|NCT00877708|isolates|isolates
5186668|NCT00877695|HIV|hiv
5186669|NCT00877695|HIV Seronegativity|hiv seronegativity
5186670|NCT00877695|prevention|prevention
5186671|NCT00877695|Hispanic|hispanic
5186672|NCT00877695|Latino|latino
5186673|NCT00877695|MSM|msm
5186674|NCT00877695|men|men
5186675|NCT00877682|Prostate Cancer|prostate cancer
5186676|NCT00877682|Prostate Tumor|prostate tumor
5186677|NCT00877682|Adenocarcinoma of the Prostate|adenocarcinoma of the prostate
5186678|NCT00877682|PCA|pca
5186679|NCT00877682|Regional Prostate Cryoablation|regional prostate cryoablation
5186680|NCT00877682|Cryotherapy|cryotherapy
5186681|NCT00877682|Cryoablation|cryoablation
5186682|NCT00877682|Health Related Quality of Life|health related quality of life
5186683|NCT00877682|HRQOL|hrqol
5186684|NCT00877617|Quality of Life|quality of life
5186685|NCT00877617|QOL|qol
5186686|NCT00877617|Questionnaire|questionnaire
5186687|NCT00877617|High Risk localized Prostate Cancer|high risk localized prostate cancer
5186688|NCT00877617|HRLPC|hrlpc
5186689|NCT00877617|Neoadjuvant Investigational Therapy|neoadjuvant investigational therapy
5186690|NCT00877617|Radical Prostatectomy|radical prostatectomy
5186691|NCT00877604|ALS|als
5186692|NCT00877604|Therapy|therapy
5186693|NCT00877604|Tauroursodeoxycholic acid|tauroursodeoxycholic acid
5186694|NCT00877604|TUDCA|tudca
5186695|NCT00877604|antioxidant|antioxidant
5186696|NCT00877604|antiapoptotic drug|antiapoptotic drug
5186697|NCT00877604|neuroprotective drug|neuroprotective drug
5186698|NCT00877591|Interaction of Buprenorphine with HIV and TB Medications|interaction of buprenorphine with hiv and tb medications
5186699|NCT00877578|elderly patient|elderly patient
5186700|NCT00877578|malnutrition|malnutrition
5186701|NCT00877578|new nutritional support|new nutritional support
5186702|NCT00877578|micronutrients|micronutrients
5186703|NCT00877578|elderly patient malnutrition|elderly patient malnutrition
5186704|NCT00877565|LVF|lvf
5186705|NCT00877565|Left ventricular systolic function|left ventricular systolic function
5186706|NCT00877552|Schizophrenia|schizophrenia
5186707|NCT00877552|brain development|brain development
5186708|NCT00877552|MRI|mri
5186709|NCT00877539|Asthma Allergen Challenge|asthma allergen challenge
5186710|NCT00877513|Smoking|smoking
5186711|NCT00877513|Insulin resistance|insulin resistance
5186712|NCT00877513|Metabolic syndrome|metabolic syndrome
5186713|NCT00877513|Body fat distribution|body fat distribution
5186714|NCT00877513|Cigarette smoking|cigarette smoking
5186715|NCT00877500|HER2/neu-negative Breast Cancer|her2/neu-negative breast cancer
5186716|NCT00877500|Residual Breast Cancer|residual breast cancer
5186717|NCT00877500|Surgery|surgery
5186718|NCT00877500|Neoadjuvant Systemic Therapy|neoadjuvant systemic therapy
5186719|NCT00877500|NST|nst
5186720|NCT00877500|Ixabepilone|ixabepilone
5186721|NCT00877500|BMS-247550|bms-247550
5186722|NCT00877500|Epothilone B analogue|epothilone b analogue
5186723|NCT00877487|ADHD|adhd
5186724|NCT00877474|PM01183|pm01183
5186725|NCT00877474|Solid tumors|solid tumors
5186726|NCT00877474|PharmaMar USA|pharmamar usa
5186727|NCT00877448|INFLUENZA|influenza
5186728|NCT00877448|VACCINE|vaccine
5186729|NCT00877448|UNIVERSAL|universal
5186730|NCT00877448|SAFETY|safety
5186731|NCT00877422|vitamin deficiency|vitamin deficiency
5186732|NCT00877409|Acnase|acnase
5186733|NCT00877409|Acne Vulgaris|acne vulgaris
5186734|NCT00877409|Safety|safety
5186735|NCT00877409|Efficacy|efficacy
5186736|NCT00877383|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
5186737|NCT00877383|COPD|copd
5186738|NCT00877383|indacaterol|indacaterol
5186739|NCT00877383|tiotropium|tiotropium
5186740|NCT00877383|bronchodilation|bronchodilation
5186741|NCT00877370|ertapenem|ertapenem
5186742|NCT00877370|continuous hemodialysis|continuous hemodialysis
5186743|NCT00877370|pharmacokinetics|pharmacokinetics
5186744|NCT00877357|Vaccine|vaccine
5186745|NCT00877357|Prevention|prevention
5186746|NCT00877357|Diphtheria|diphtheria
5186747|NCT00877357|Tetanus|tetanus
5186748|NCT00877357|Pertussis|pertussis
5186749|NCT00877357|Hepatitis B|hepatitis b
5186750|NCT00877357|Haemophilus influenzae type b|haemophilus influenzae type b
5186751|NCT00877357|Lot Consistency|lot consistency
5186752|NCT00877357|Long Term Immunogenicity|long term immunogenicity
5186753|NCT00877357|Reactogenicity|reactogenicity
5186754|NCT00877357|Healthy infants|healthy infants
5186755|NCT00877344|Pregnancy|pregnancy
5186756|NCT00877344|IUC|iuc
5186757|NCT00877344|abortion|abortion
5186758|NCT00877344|contraception|contraception
5186759|NCT00877331|Drug Abuse|drug abuse
5186760|NCT00877331|Drug Addiction|drug addiction
5186761|NCT00877331|Drug Dependence|drug dependence
5186762|NCT00877331|Drug Usage|drug usage
5186763|NCT00877331|Drug Use Disorders|drug use disorders
5186764|NCT00877331|Substance Abuse|substance abuse
5186765|NCT00877331|Substance Addiction|substance addiction
5186766|NCT00877331|Substance Dependence|substance dependence
5186767|NCT00877331|Substance Use Disorders|substance use disorders
5186768|NCT00877305|Ischemic Preconditioning|ischemic preconditioning
5186769|NCT00877305|Cognitive function|cognitive function
5186770|NCT00877292|Down Syndrome|down syndrome
5186771|NCT00877292|trisomy 21|trisomy 21
5186772|NCT00877292|prenatal testing|prenatal testing
5186773|NCT00877292|pregnant women|pregnant women
5186774|NCT00877279|Facial wrinkles|facial wrinkles
5186775|NCT00877279|Nasolabial folds|nasolabial folds
5186776|NCT00877266|catheter|catheter
5186777|NCT00877266|ultrasound guidance|ultrasound guidance
5186778|NCT00877266|nerve stimulation|nerve stimulation
5186779|NCT00877266|electrical stimulation|electrical stimulation
5186780|NCT00877266|nerve block|nerve block
5186781|NCT00877266|UCSD|ucsd
5186782|NCT00877266|timed placement|timed placement
5186783|NCT00877266|surgery|surgery
5186784|NCT00877266|Catheter Placement Time|catheter placement time
5186785|NCT00877227|CVA|cva
5186786|NCT00877227|stroke|stroke
5186787|NCT00877227|newborns|newborns
5186788|NCT00877227|homocysteine|homocysteine
5186789|NCT00877227|folinic acid|folinic acid
5186790|NCT00877214|Bendamustine|bendamustine
5186791|NCT00877214|Rituximab|rituximab
5186792|NCT00877214|Significance of maintenance therapy|significance of maintenance therapy
5186793|NCT00877214|Efficacy and safety|efficacy and safety
5186794|NCT00877201|Accommodation|accommodation
5186795|NCT00877201|visual display terminal (VDT)|visual display terminal (vdt)
5186796|NCT00877201|antioxidant|antioxidant
5186797|NCT00877188|breast cancer|breast cancer
5186798|NCT00877188|exercise|exercise
5186799|NCT00877188|upper extremity function|upper extremity function
5186800|NCT00877188|quality of life|quality of life
5186801|NCT00877175|preterm infants|preterm infants
5186802|NCT00877175|mydriasis|mydriasis
5186803|NCT00877175|pupil dilation|pupil dilation
5186804|NCT00877162|Cognitive and behavioural intervention|cognitive and behavioural intervention
5186805|NCT00877162|trial|trial
5186806|NCT00877162|group|group
5186807|NCT00877162|Behavioral sleep problems|behavioral sleep problems
5186808|NCT00877149|Chronic HBV|chronic hbv
5186809|NCT00877136|Liver tumors|liver tumors
5186810|NCT00877136|Liver cancer|liver cancer
5186811|NCT00877136|Adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
5186812|NCT00877136|HCC|hcc
5186813|NCT00877136|Hepatoma|hepatoma
5186814|NCT00877136|Neoplasms|neoplasms
5186815|NCT00877123|fasting glucose|fasting glucose
5186816|NCT00877123|obesity|obesity
5186817|NCT00877123|arab women|arab women
5186818|NCT00877123|interleukin|interleukin
5186819|NCT00877123|diabetes|diabetes
5186820|NCT00877123|impaired fasting glucose (IFG)|impaired fasting glucose (ifg)
5186821|NCT00877110|BETA-D-GLUCAN|beta-d-glucan
5186822|NCT00877110|CYCLOPHOSPHAMIDE (CYTOXAN)|cyclophosphamide (cytoxan)
5186823|NCT00877110|MAB 131 I - 3F8|mab 131 i - 3f8
5186824|NCT00877110|TOPOTECAN|topotecan
5186825|NCT00877110|VINCRISTINE|vincristine
5186826|NCT00877110|Neuroblastoma|neuroblastoma
5186827|NCT00877110|09-011|09-011
5186828|NCT00877097|osteoporosis|osteoporosis
5186829|NCT00877097|Bone mineral density|bone mineral density
5186830|NCT00877097|clodronate|clodronate
5186831|NCT00877097|HRT|hrt
5186832|NCT00877097|postmenopausal|postmenopausal
5186833|NCT00877084|exacerbation|exacerbation
5186834|NCT00877084|COPD|copd
5186835|NCT00877084|Resistance training|resistance training
5186836|NCT00877084|Muscle force|muscle force
5186837|NCT00877058|Frailty|frailty
5186838|NCT00877058|health promotion|health promotion
5186839|NCT00877058|prevention|prevention
5186840|NCT00877058|self management|self management
5186841|NCT00877058|intervention|intervention
5186842|NCT00877045|Gastrointestinal Stromal Tumors|gastrointestinal stromal tumors
5186843|NCT00877045|GIST|gist
5186844|NCT00877045|tyrosine kinase inhibitors|tyrosine kinase inhibitors
5186845|NCT00877045|Imatinib|imatinib
5186846|NCT00877045|Gleevec|gleevec
5186847|NCT00877045|Suntinib|suntinib
5186848|NCT00877045|Sutent|sutent
5186849|NCT00877032|Phase 1|phase 1
5186850|NCT00877032|Dry Age Related Macular Degeneration|dry age related macular degeneration
5186851|NCT00877032|RN6G|rn6g
5186852|NCT00877019|sonic brushes|sonic brushes
5186853|NCT00877019|time effectiveness|time effectiveness
5186854|NCT00877019|brush head design|brush head design
5186855|NCT00877019|ADA-toothbrush|ada-toothbrush
5186856|NCT00877019|professional brushing|professional brushing
5186857|NCT00877019|time dependence|time dependence
5186858|NCT00877019|efficacy|efficacy
5186859|NCT00877019|toothbrush|toothbrush
5186860|NCT00876980|Obstructive sleep apnea|obstructive sleep apnea
5186861|NCT00876980|Type II diabetes mellitus|type ii diabetes mellitus
5186862|NCT00876980|Randomized controlled trial|randomized controlled trial
5186863|NCT00876967|anesthesiology|anesthesiology
5186864|NCT00876967|randomized|randomized
5186865|NCT00876967|laryngoscope|laryngoscope
5186866|NCT00876967|intubation|intubation
5186867|NCT00876967|laryngeal exposition|laryngeal exposition
5186868|NCT00876967|laryngoscope blades|laryngoscope blades
5186869|NCT00876967|plastic single use blade|plastic single use blade
5186870|NCT00876967|metallic single use blade|metallic single use blade
5186871|NCT00876967|metallic reusable blade|metallic reusable blade
5186872|NCT00876967|success to intubation at first attempt|success to intubation at first attempt
5186873|NCT00876967|Cormack and lehanne modify grade|cormack and lehanne modify grade
5186874|NCT00876941|Drug|drug
5186875|NCT00876941|Drug Use|drug use
5186876|NCT00876941|Screening|screening
5186877|NCT00876941|Brief Intervention|brief intervention
5186878|NCT00876941|Primary Care|primary care
5186879|NCT00876941|Utilization|utilization
5186880|NCT00876928|pre-diabetes|pre-diabetes
5186881|NCT00876928|minorities|minorities
5186882|NCT00876928|oral glucose tolerance test|oral glucose tolerance test
5186883|NCT00876928|disposition index|disposition index
5186884|NCT00876928|insulin secretion|insulin secretion
5186885|NCT00876928|insulin sensitivity|insulin sensitivity
5186886|NCT00876928|diabetes|diabetes
5186887|NCT00876915|prevention of VTE and PE in high risk cancer patients|prevention of vte and pe in high risk cancer patients
5186888|NCT00876902|liver transplantation|liver transplantation
5186889|NCT00876902|cadaveric liver transplantation|cadaveric liver transplantation
5186890|NCT00876902|ischemic reperfusion injury|ischemic reperfusion injury
5186891|NCT00876902|primary non-function|primary non-function
5186892|NCT00876902|delayed non-Function|delayed non-function
5186893|NCT00876902|poor early graft function|poor early graft function
5186894|NCT00876902|YSPSL|yspsl
5186895|NCT00876902|recombinant PSGL-Ig|recombinant psgl-ig
5186896|NCT00876889|spinal cord injury|spinal cord injury
5186897|NCT00876889|riluzole|riluzole
5186898|NCT00876889|pharmacokinetics|pharmacokinetics
5186899|NCT00876889|Acute Traumatic Spinal Cord Injury|acute traumatic spinal cord injury
5186900|NCT00876876|hypervolemic hyponatremia|hypervolemic hyponatremia
5186901|NCT00876876|serum sodium|serum sodium
5186902|NCT00876876|fluid overload|fluid overload
5186903|NCT00876876|heartfailure|heartfailure
5186904|NCT00876876|acute heart failure|acute heart failure
5186905|NCT00876876|vasopressin antagonist|vasopressin antagonist
5186906|NCT00876863|Alzheimer's disease|alzheimer's disease
5186907|NCT00876863|Dementia|dementia
5186908|NCT00876863|Memory loss|memory loss
5186909|NCT00876863|Cognitive impairment|cognitive impairment
5186910|NCT00876863|Nerve growth factor|nerve growth factor
5186911|NCT00876863|NGF|ngf
5186912|NCT00876863|Neurotrophic factors|neurotrophic factors
5186913|NCT00876863|Gene therapy|gene therapy
5186914|NCT00876850|cSSI|cssi
5186915|NCT00876850|Abscess|abscess
5186916|NCT00876850|Would|would
5186917|NCT00876850|Cellulitis|cellulitis
5186918|NCT00876850|Complicated Skin and Skin Structure Infections (cSSSI)|complicated skin and skin structure infections (csssi)
5186919|NCT00876824|Black Fever|black fever
5186920|NCT00876824|Kala-Azar|kala-azar
5186921|NCT00876824|Amphotericin B lipid emulsion|amphotericin b lipid emulsion
5186922|NCT00876824|Liposomal Amphotericin B|liposomal amphotericin b
5186923|NCT00876811|raspberry|raspberry
5186924|NCT00876811|fruit|fruit
5186925|NCT00876811|antioxidants|antioxidants
5186926|NCT00876811|polyphenols|polyphenols
5186927|NCT00876811|oxidative stress|oxidative stress
5186928|NCT00876811|dietary intervention|dietary intervention
5186929|NCT00876798|Euvolemic Hyponatremia|euvolemic hyponatremia
5186930|NCT00876798|SIADH|siadh
5186931|NCT00876798|Serum Sodium|serum sodium
5186932|NCT00876785|Rye bread satiety breakfast|rye bread satiety breakfast
5186933|NCT00876772|ALS|als
5186934|NCT00876772|olanazapine|olanazapine
5186935|NCT00876772|Loss of Apptetite|loss of apptetite
5186936|NCT00876772|Appetite Loss|appetite loss
5186937|NCT00876772|Malnutrition|malnutrition
5186938|NCT00876772|Cachexia|cachexia
5186939|NCT00876772|Zyprexa|zyprexa
5186940|NCT00876759|cerebral metastases|cerebral metastases
5186941|NCT00876746|Pain|pain
5186942|NCT00876746|surgery|surgery
5186943|NCT00876746|catheter|catheter
5186944|NCT00876746|nerve block|nerve block
5186945|NCT00876746|supraclavicular|supraclavicular
5186946|NCT00876746|infraclavicular|infraclavicular
5186947|NCT00876746|UCSD|ucsd
5186948|NCT00876746|moderate-to-severe pain|moderate-to-severe pain
5186949|NCT00876746|Supraclavicular catheter|supraclavicular catheter
5186950|NCT00876746|Infraclavicular catheter|infraclavicular catheter
5186951|NCT00876720|Tinnitus|tinnitus
5186952|NCT00876720|chronic subjective tinnitus|chronic subjective tinnitus
5186953|NCT00876720|transcranial magnetic stimulation|transcranial magnetic stimulation
5186954|NCT00876720|sensation disorders|sensation disorders
5186955|NCT00876720|hearing disorders|hearing disorders
5186956|NCT00876707|wavefront|wavefront
5186957|NCT00876707|multifocal IOL|multifocal iol
5186958|NCT00876707|modulation transfer function|modulation transfer function
5186959|NCT00876707|intraocular lenses|intraocular lenses
5186960|NCT00876707|wavefront data|wavefront data
5186961|NCT00876707|Visual performance|visual performance
5186962|NCT00876694|COPD, Chronic Obstructive Pulmonary Disease, Indacaterol, long acting β2-agonist|copd, chronic obstructive pulmonary disease, indacaterol, long acting β2-agonist
5186963|NCT00876681|Catheter|catheter
5186964|NCT00876681|Ultrasound-guidance|ultrasound-guidance
5186965|NCT00876681|Nerve Stimulation|nerve stimulation
5186966|NCT00876681|Electrical stimulation|electrical stimulation
5186967|NCT00876681|nerve block|nerve block
5186968|NCT00876681|UCSD|ucsd
5186969|NCT00876681|Orthopedic surgery|orthopedic surgery
5186970|NCT00876681|Foot/ankle pain|foot/ankle pain
5186971|NCT00876681|Foot/ankle numbness|foot/ankle numbness
5186972|NCT00876681|Popliteal-Sciatic Catheters|popliteal-sciatic catheters
5186973|NCT00876668|Peripheral Vascular diseases|peripheral vascular diseases
5186974|NCT00876668|Microcirculation|microcirculation
5186975|NCT00876668|fluorescence angiography|fluorescence angiography
5186976|NCT00876642|Radiation dermatitis|radiation dermatitis
5186977|NCT00876642|best supportive care|best supportive care
5186978|NCT00876642|Aloe vera gel|aloe vera gel
5186979|NCT00876642|phase III study was to assess the effectiveness of aloe vera and vitamin E.|phase iii study was to assess the effectiveness of aloe vera and vitamin e.
5186980|NCT00876629|MR Elastography|mr elastography
5186981|NCT00876629|kidney|kidney
5186982|NCT00876629|fibrosis|fibrosis
5186983|NCT00876616|lupus nephritis;multi-target therapy; MMF; FK506|lupus nephritis;multi-target therapy; mmf; fk506
5186984|NCT00876603|cervical spondylotic myelopathy|cervical spondylotic myelopathy
5186985|NCT00876603|anterior decompression and fusion|anterior decompression and fusion
5186986|NCT00876603|cervical laminoplasty|cervical laminoplasty
5186987|NCT00876577|Acute Exacerbations of Chronic Bronchitis|acute exacerbations of chronic bronchitis
5186988|NCT00876577|Avelox|avelox
5186989|NCT00876577|Bronchitis|bronchitis
5186990|NCT00876564|Triage precision|triage precision
5186991|NCT00876551|Negative-Pressure Wound Therapy|negative-pressure wound therapy
5186992|NCT00876551|Endoscopic/endoluminal V.A.C. therapy|endoscopic/endoluminal v.a.c. therapy
5186993|NCT00876551|Esophagectomy|esophagectomy
5186994|NCT00876551|Anastomotic leakage|anastomotic leakage
5186995|NCT00876551|Anastomosis, Surgical|anastomosis, surgical
5186996|NCT00876538|Chemotherapy Induced Peripheral Neuropathy|chemotherapy induced peripheral neuropathy
5186997|NCT00876538|TR019622|tr019622
5186998|NCT00876538|Trophos|trophos
5186999|NCT00876525|Heart diseases.|heart diseases.
5187000|NCT00876525|Aortic valve diseases.|aortic valve diseases.
5187001|NCT00876525|Aortic valve insufficiency.|aortic valve insufficiency.
5187002|NCT00876525|Aortic valve stenosis.|aortic valve stenosis.
5187003|NCT00876512|thienopyridine resistance|thienopyridine resistance
5187004|NCT00876512|stable effort angina|stable effort angina
5187005|NCT00876512|platelet activation|platelet activation
5187006|NCT00876512|ADAMTS13|adamts13
5187007|NCT00876512|von Willebrand Factor|von willebrand factor
5187008|NCT00876499|Primary Brain Tumor|primary brain tumor
5187009|NCT00876499|PBT|pbt
5187010|NCT00876499|Brain Cancer|brain cancer
5187011|NCT00876499|Primary glioma|primary glioma
5187012|NCT00876499|Astrocytoma|astrocytoma
5187013|NCT00876499|Oligodendroglioma|oligodendroglioma
5187014|NCT00876499|Oligo-astrocytoma|oligo-astrocytoma
5187015|NCT00876499|Ependymoma|ependymoma
5187016|NCT00876499|Anaplastic astrocytoma|anaplastic astrocytoma
5187017|NCT00876499|Anaplastic oligodendroglioma|anaplastic oligodendroglioma
5187018|NCT00876499|Anaplastic oligo-astrocytoma|anaplastic oligo-astrocytoma
5187019|NCT00876499|Anaplastic ependymoma|anaplastic ependymoma
5187021|NCT00876499|Cytokines|cytokines
5187022|NCT00876499|Questionnaires|questionnaires
5187023|NCT00876499|Actigraphy|actigraphy
5187024|NCT00876499|Sleep Disturbance|sleep disturbance
5187025|NCT00876499|Radiation Therapy|radiation therapy
5187026|NCT00876473|CPAP|cpap
5187027|NCT00876473|Acute Respiratory Failure|acute respiratory failure
5187028|NCT00876434|Sirolimus|sirolimus
5187029|NCT00876434|Anterior Uveitis|anterior uveitis
5187030|NCT00876434|Autoimmune Disease|autoimmune disease
5187031|NCT00876434|Uveitis|uveitis
5187032|NCT00876421|ONO-8539|ono-8539
5187033|NCT00876421|Overactive bladder|overactive bladder
5187034|NCT00876421|OAB|oab
5187035|NCT00876408|RT-PCR molecular profiling assay|rt-pcr molecular profiling assay
5187036|NCT00876408|Molecular Profiling-Real Time Polymerase Chain Reaction|molecular profiling-real time polymerase chain reaction
5187037|NCT00876408|Unknown Primary|unknown primary
5187038|NCT00876408|UPC|upc
5187039|NCT00876408|CUP|cup
5187040|NCT00876395|Breast Cancer|breast cancer
5187041|NCT00876395|HER2+|her2+
5187042|NCT00876395|mTOR|mtor
5187043|NCT00876395|everolimus|everolimus
5187044|NCT00876395|RAD001|rad001
5187045|NCT00876395|first line|first line
5187046|NCT00876395|metastatic|metastatic
5187047|NCT00876395|locally advanced|locally advanced
5187048|NCT00876382|advanced renal cell carcinoma|advanced renal cell carcinoma
5187049|NCT00876382|renal cancer|renal cancer
5187050|NCT00876382|renal cell|renal cell
5187051|NCT00876382|Sorafenib|sorafenib
5187052|NCT00876382|Nexavar|nexavar
5187053|NCT00876382|Bevacizumab|bevacizumab
5187054|NCT00876382|Avastin|avastin
5187055|NCT00876382|Sunitinib|sunitinib
5187056|NCT00876382|Sutent|sutent
5187057|NCT00876369|urticaria|urticaria
5187058|NCT00876369|angioedema|angioedema
5187059|NCT00876369|vitamin D|vitamin d
5187060|NCT00876369|allergy|allergy
5187061|NCT00876356|Asthma|asthma
5187062|NCT00876356|Conjugated Linoleic Acid (CLA)|conjugated linoleic acid (cla)
5187063|NCT00876356|dietary supplement|dietary supplement
5187064|NCT00876330|Clinical Decision Support Systems|clinical decision support systems
5187065|NCT00876330|Hyperlipidemia|hyperlipidemia
5187066|NCT00876330|Hypertension|hypertension
5187067|NCT00876317|Tenosynovitis|tenosynovitis
5187068|NCT00876317|Bursitis|bursitis
5187069|NCT00876304|PF-04802540 multiple dose safety study|pf-04802540 multiple dose safety study
5187070|NCT00876278|Cataract|cataract
5187071|NCT00876278|Intraocular Lens (IOL)|intraocular lens (iol)
5187072|NCT00876278|Mesotest II|mesotest ii
5187073|NCT00876278|Evaluation of usability of Mesotest II for assessment of night driving capacity of pseudo-phakic patients|evaluation of usability of mesotest ii for assessment of night driving capacity of pseudo-phakic patients
5187074|NCT00876265|Facial wrinkles|facial wrinkles
5187075|NCT00876265|Nasolabial fold|nasolabial fold
5187076|NCT00876226|Citalopram|citalopram
5187077|NCT00876226|Pharmacokinetics|pharmacokinetics
5187078|NCT00876226|Short Bowel Syndrome|short bowel syndrome
5187079|NCT00876213|Amylin|amylin
5187080|NCT00876213|GLP-1|glp-1
5187081|NCT00876213|gastric emptying|gastric emptying
5187082|NCT00876213|appetite and food intake|appetite and food intake
5187083|NCT00876200|Williams Beuren syndrome|williams beuren syndrome
5187084|NCT00876200|Cardiovascular abnormalities|cardiovascular abnormalities
5187085|NCT00876200|Cardiovascular structure|cardiovascular structure
5187086|NCT00876187|randomized controlled trial|randomized controlled trial
5187087|NCT00876187|monoclonal antibody|monoclonal antibody
5187088|NCT00876187|nerve growth factor|nerve growth factor
5187089|NCT00876187|naproxen|naproxen
5187090|NCT00876174|Chronic hepatitis C|chronic hepatitis c
5187091|NCT00876174|Genotype 1|genotype 1
5187092|NCT00876161|Healthy Adults|healthy adults
5187093|NCT00876148|Incidence of hepatitis B after allografting|incidence of hepatitis b after allografting
5187094|NCT00876148|Risk of hepatitis B reactivation|risk of hepatitis b reactivation
5187095|NCT00876148|Lamivudine prophylaxis|lamivudine prophylaxis
5187096|NCT00876122|NHL|nhl
5187097|NCT00876122|Metastatic Solid Tumors|metastatic solid tumors
5187098|NCT00876122|PI3K Inhibitors|pi3k inhibitors
5187099|NCT00876122|PI3K|pi3k
5187100|NCT00876109|Metastatic Solid Tumors|metastatic solid tumors
5187101|NCT00876109|PI3K|pi3k
5187102|NCT00876109|PI3K Inhibitors|pi3k inhibitors
5187103|NCT00876096|Diagnosis, Differential|diagnosis, differential
5187104|NCT00876083|Drug utilization review|drug utilization review
5187105|NCT00876070|Metastatic Breast Cancer|metastatic breast cancer
5187106|NCT00876070|Breast Cancer|breast cancer
5187107|NCT00876070|MBC|mbc
5187108|NCT00876070|Abraxane|abraxane
5187109|NCT00876070|Paclitaxel|paclitaxel
5187110|NCT00876070|Taxol|taxol
5187111|NCT00876070|Docetaxel|docetaxel
5187112|NCT00876070|Taxotere|taxotere
5187113|NCT00876057|psychological well-being|psychological well-being
5187114|NCT00876057|recovery|recovery
5187115|NCT00876057|time in hospital|time in hospital
5187116|NCT00876057|sick-leave|sick-leave
5187117|NCT00876057|complications|complications
5187118|NCT00876057|Sexual well-being|sexual well-being
5187119|NCT00876031|pediatric soft tissue sarcoma|pediatric soft tissue sarcoma
5187120|NCT00876031|rhabdomyosarcoma|rhabdomyosarcoma
5187121|NCT00876031|extraosseous Ewing family tumours|extraosseous ewing family tumours
5187122|NCT00876031|synovial sarcoma|synovial sarcoma
5187123|NCT00876031|undifferentiated sarcoma|undifferentiated sarcoma
5187124|NCT00876018|physical performance|physical performance
5187125|NCT00876018|micronutrients|micronutrients
5187126|NCT00876018|physical fitness|physical fitness
5187127|NCT00876018|healthy children|healthy children
5187128|NCT00876005|Wound infection|wound infection
5187129|NCT00875979|MBC|mbc
5187130|NCT00875979|Breast Cancer|breast cancer
5187131|NCT00875979|HER2+|her2+
5187132|NCT00875979|HER2+ breast cancer|her2+ breast cancer
5187133|NCT00875979|HER2 positive breast cancer|her2 positive breast cancer
5187134|NCT00875979|herceptin|herceptin
5187135|NCT00875979|Trastuzumab emtansine|trastuzumab emtansine
5187136|NCT00875953|squamous cell carcinoma|squamous cell carcinoma
5187137|NCT00875953|head and neck cancer|head and neck cancer
5187138|NCT00875953|neck dissection|neck dissection
5187139|NCT00875927|Halitosis|halitosis
5187140|NCT00875914|AV-node reentry tachycardia|av-node reentry tachycardia
5187141|NCT00875914|radiofrequency ablation|radiofrequency ablation
5187142|NCT00875914|magnetic navigation system|magnetic navigation system
5187143|NCT00875901|Lung Cancer|lung cancer
5187144|NCT00875901|Stage I Non-Small Cell Lung Cancer|stage i non-small cell lung cancer
5187145|NCT00875901|Proton Radiation|proton radiation
5187146|NCT00875901|HypoIGRT|hypoigrt
5187147|NCT00875875|Diarrhea, travelers|diarrhea, travelers
5187148|NCT00875875|Acute travelers' diarrhea|acute travelers' diarrhea
5187149|NCT00875862|UCSD|ucsd
5187150|NCT00875862|pain|pain
5187151|NCT00875862|quality-of-life|quality-of-life
5187152|NCT00875862|range-of-motion|range-of-motion
5187153|NCT00875862|interscalene catheter|interscalene catheter
5187154|NCT00875862|nerve block|nerve block
5187155|NCT00875862|shoulder|shoulder
5187156|NCT00875862|Shoulder Manipulation|shoulder manipulation
5187157|NCT00875849|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
5187158|NCT00875849|stage I squamous cell carcinoma of the hypopharynx|stage i squamous cell carcinoma of the hypopharynx
5187159|NCT00875849|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
5187160|NCT00875849|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
5187161|NCT00875849|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
5187162|NCT00875849|stage I squamous cell carcinoma of the larynx|stage i squamous cell carcinoma of the larynx
5187163|NCT00875849|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
5187164|NCT00875849|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
5187165|NCT00875849|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
5187166|NCT00875849|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
5187167|NCT00875849|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
5187168|NCT00875849|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
5187169|NCT00875849|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
5187170|NCT00875849|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
5187171|NCT00875849|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
5187172|NCT00875849|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
5187173|NCT00875849|tongue cancer|tongue cancer
5187174|NCT00875836|Marijuana|marijuana
5187175|NCT00875836|Buspirone|buspirone
5187176|NCT00875836|Contingency management|contingency management
5187177|NCT00875836|Motivational enhancement therapy|motivational enhancement therapy
5187178|NCT00875823|PH|ph
5187179|NCT00875823|Primary Hyperoxaluria|primary hyperoxaluria
5187180|NCT00875823|Type I|type i
5187181|NCT00875823|Type II|type ii
5187182|NCT00875823|NonI-NonII|noni-nonii
5187183|NCT00875823|Kidney stones|kidney stones
5187184|NCT00875823|oxalate|oxalate
5187185|NCT00875823|oxalosis|oxalosis
5187186|NCT00875797|enteral|enteral
5187187|NCT00875797|parenteral|parenteral
5187188|NCT00875797|glutamine|glutamine
5187189|NCT00875797|intestinal permeability|intestinal permeability
5187190|NCT00875797|infection|infection
5187191|NCT00875784|Sumatriptan exposure|sumatriptan exposure
5187192|NCT00875771|metastatic colorectal cancer|metastatic colorectal cancer
5187193|NCT00875771|BEVACIZUMAB|bevacizumab
5187194|NCT00875771|CAPECITABINE|capecitabine
5187195|NCT00875771|IRINOTECAN|irinotecan
5187196|NCT00875758|preterm infants|preterm infants
5187197|NCT00875758|IVH|ivh
5187198|NCT00875758|germinal matrix|germinal matrix
5187199|NCT00875758|intraventricular hemorrhage|intraventricular hemorrhage
5187200|NCT00875758|hydrocephalus|hydrocephalus
5187201|NCT00875732|Resynchronization|resynchronization
5187202|NCT00875732|Device|device
5187203|NCT00875732|Bradycardia|bradycardia
5187204|NCT00875732|atrioventricular block|atrioventricular block
5187205|NCT00875732|Cardiac Resynchronization|cardiac resynchronization
5187206|NCT00875719|COPD patients with respiratory failure|copd patients with respiratory failure
5187207|NCT00875706|Nursing Homes|nursing homes
5187208|NCT00875706|Implementation of innovative programs|implementation of innovative programs
5187209|NCT00875706|Nursing staff|nursing staff
5187210|NCT00875706|Nurses' aides|nurses' aides
5187211|NCT00875706|Educational models|educational models
5187212|NCT00875693|AML|aml
5187213|NCT00875693|leukemia|leukemia
5187214|NCT00875693|MDS|mds
5187215|NCT00875667|Mantle Cell Lymphoma|mantle cell lymphoma
5187216|NCT00875667|Relapsed Mantle Cell Lymphoma|relapsed mantle cell lymphoma
5187217|NCT00875667|Refractory Mantle Cell Lymphoma|refractory mantle cell lymphoma
5187218|NCT00875667|Lymphoma|lymphoma
5187219|NCT00875667|MCL|mcl
5187220|NCT00875654|Cell therapy|cell therapy
5187221|NCT00875654|Stroke|stroke
5187222|NCT00875654|Neuronal Plasticity|neuronal plasticity
5187223|NCT00875654|Recovery|recovery
5187224|NCT00875654|Mesenchymal Stem Cells|mesenchymal stem cells
5187225|NCT00875654|Transplantation|transplantation
5187226|NCT00875628|Japanese Healthy volunteers HCV pharmacokinetics PF-00868554 filibuvir|japanese healthy volunteers hcv pharmacokinetics pf-00868554 filibuvir
5187227|NCT00875615|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
5187228|NCT00875615|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
5187229|NCT00875615|advanced adult primary liver cancer|advanced adult primary liver cancer
5187230|NCT00875602|All hospitalized patients in a general Med/ Surg unit|all hospitalized patients in a general med/ surg unit
5187231|NCT00875589|Traumatic Brain Injury|traumatic brain injury
5187232|NCT00875589|Eye movement recording|eye movement recording
5187233|NCT00875576|social influences|social influences
5187234|NCT00875576|meals|meals
5187235|NCT00875576|obesity|obesity
5187236|NCT00875576|amount of food consumed|amount of food consumed
5187237|NCT00875550|Intubated and mechanically ventilated PICU subjects|intubated and mechanically ventilated picu subjects
5187238|NCT00875537|Burning mouth syndrome|burning mouth syndrome
5187239|NCT00875537|neuropathy|neuropathy
5187240|NCT00875537|inflammation|inflammation
5187241|NCT00875537|tongue mucosa|tongue mucosa
5187242|NCT00875537|tongue innervation|tongue innervation
5187243|NCT00875537|dysgeusia|dysgeusia
5187244|NCT00875524|Dengue virus|dengue virus
5187245|NCT00875524|Dengue fever|dengue fever
5187246|NCT00875524|Dengue hemorrhagic fever|dengue hemorrhagic fever
5187247|NCT00875524|Dengue diseases|dengue diseases
5187248|NCT00875524|Dengue vaccine|dengue vaccine
5187249|NCT00875511|peer rejection|peer rejection
5187250|NCT00875511|obesity|obesity
5187251|NCT00875511|amount of food chosen|amount of food chosen
5187252|NCT00875511|amount of social time chosen|amount of social time chosen
5187253|NCT00875498|iTBS|itbs
5187254|NCT00875498|Negative Symptoms|negative symptoms
5187255|NCT00875485|Monovalent Hepatitis A|monovalent hepatitis a
5187256|NCT00875485|hepatitis B vaccine|hepatitis b vaccine
5187257|NCT00875485|Belgium and Czech Republic|belgium and czech republic
5187258|NCT00875472|social influences|social influences
5187259|NCT00875472|food purchases|food purchases
5187260|NCT00875472|childhood obesity|childhood obesity
5187261|NCT00875472|amount of energy dense food and beverage items purchased|amount of energy dense food and beverage items purchased
5187262|NCT00875472|amount of nutrient dense food and beverage items purchased|amount of nutrient dense food and beverage items purchased
5187263|NCT00875420|hot flashes|hot flashes
5187264|NCT00875420|hot flushes|hot flushes
5187265|NCT00875420|vasomotor symptoms|vasomotor symptoms
5187266|NCT00875420|postmenopausal|postmenopausal
5187267|NCT00875381|Melanocytes|melanocytes
5187268|NCT00875368|HIV-1|hiv-1
5187269|NCT00875368|HAART|haart
5187270|NCT00875368|CD4 cell|cd4 cell
5187271|NCT00875368|Immunologic non-responders|immunologic non-responders
5187272|NCT00875368|Immunology|immunology
5187273|NCT00875368|treatment experienced|treatment experienced
5187274|NCT00875355|tumors metastatic to brain|tumors metastatic to brain
5187275|NCT00875355|stage IV breast cancer|stage iv breast cancer
5187276|NCT00875342|Traumatic Event|traumatic event
5187277|NCT00875342|Trauma Survivor|trauma survivor
5187278|NCT00875342|Exposure Therapy|exposure therapy
5187279|NCT00875342|PTSD DCS|ptsd dcs
5187280|NCT00875342|Telemedicine|telemedicine
5187281|NCT00875342|Telepsychiatry|telepsychiatry
5187282|NCT00875342|Telemental health|telemental health
5187283|NCT00875329|Brain Injury|brain injury
5187284|NCT00875316|Parkinson's disease|parkinson's disease
5187285|NCT00875316|Phase I|phase i
5187286|NCT00875303|Parents' plans to discipline their children|parents' plans to discipline their children
5187287|NCT00875290|Diabetes Mellitus, Type I|diabetes mellitus, type i
5187288|NCT00875290|Children|children
5187289|NCT00875290|Insulin pump therapy|insulin pump therapy
5187290|NCT00875290|Continuous glucose monitor|continuous glucose monitor
5187291|NCT00875264|CEP-11981|cep-11981
5187292|NCT00875264|TIE-2|tie-2
5187293|NCT00875264|VEGF-R|vegf-r
5187294|NCT00875251|body composition|body composition
5187295|NCT00875251|preterm infant|preterm infant
5187296|NCT00875251|anthropometry|anthropometry
5187297|NCT00875238|cardiac toxicity|cardiac toxicity
5187298|NCT00875238|cardiovascular complications|cardiovascular complications
5187299|NCT00875238|stage I breast cancer|stage i breast cancer
5187300|NCT00875238|stage II breast cancer|stage ii breast cancer
5187301|NCT00875238|stage IIIA breast cancer|stage iiia breast cancer
5187302|NCT00875238|stage IIIB breast cancer|stage iiib breast cancer
5187303|NCT00875238|stage IIIC breast cancer|stage iiic breast cancer
5187304|NCT00875225|Hypertension|hypertension
5187305|NCT00875225|Adherence to medications|adherence to medications
5187306|NCT00875212|Calcium glycerophosphate|calcium glycerophosphate
5187307|NCT00875212|Fluoride|fluoride
5187308|NCT00875212|Dentifrice|dentifrice
5187309|NCT00875212|Biofilm|biofilm
5187310|NCT00875212|Dental caries|dental caries
5187311|NCT00875199|Overweight|overweight
5187312|NCT00875199|Obesity|obesity
5187313|NCT00875199|Contingency Management|contingency management
5187314|NCT00875186|bariatric surgery|bariatric surgery
5187315|NCT00875186|co-morbidities|co-morbidities
5187316|NCT00875186|aerobic physical exercise|aerobic physical exercise
5187317|NCT00875173|Selenium|selenium
5187318|NCT00875173|Chagas disease|chagas disease
5187319|NCT00875173|Chagasic cardiopathy|chagasic cardiopathy
5187320|NCT00875147|neoadjuvant chemotherapy|neoadjuvant chemotherapy
5187321|NCT00875147|bevacizumab|bevacizumab
5187322|NCT00875121|Food reinforcement|food reinforcement
5187323|NCT00875121|social reinforcers|social reinforcers
5187324|NCT00875121|overweight|overweight
5187325|NCT00875121|children|children
5187326|NCT00875095|sperm DNA integrity|sperm dna integrity
5187327|NCT00875095|Toluidine blue staining|toluidine blue staining
5187328|NCT00875082|Asthma|asthma
5187329|NCT00875082|Children|children
5187330|NCT00875082|Remodelling|remodelling
5187331|NCT00875082|Metalloproteinases|metalloproteinases
5187332|NCT00875082|Montelukast|montelukast
5187333|NCT00875069|Nosocomial infection|nosocomial infection
5187334|NCT00875069|Catheterization|catheterization
5187335|NCT00875069|Central Venous Ethanol|central venous ethanol
5187336|NCT00875069|lock solution|lock solution
5187337|NCT00875069|intensive care units|intensive care units
5187338|NCT00875069|Renal replacement therapy in ICU|renal replacement therapy in icu
5187339|NCT00875043|ischemic optic neuropathy|ischemic optic neuropathy
5187340|NCT00875043|cortical blindness|cortical blindness
5187341|NCT00875030|Bioequivalence study-artesunate sachets-arsuamoon tablet|bioequivalence study-artesunate sachets-arsuamoon tablet
5187342|NCT00875004|anemia|anemia
5187343|NCT00875004|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5187344|NCT00874991|Cardiac deformation|cardiac deformation
5187345|NCT00874991|Cardiopulmonary bypass|cardiopulmonary bypass
5187346|NCT00874991|TEE|tee
5187347|NCT00874991|Cardiac Surgery|cardiac surgery
5187348|NCT00874991|Left ventricular function|left ventricular function
5187349|NCT00874991|Pulmonary Artery catheter|pulmonary artery catheter
5187350|NCT00874991|Tissue Doppler|tissue doppler
5187351|NCT00874991|Left ventricular function in cardiac surgery|left ventricular function in cardiac surgery
5187352|NCT00874978|Lenalidomide|lenalidomide
5187353|NCT00874978|myelodysplastic syndromes|myelodysplastic syndromes
5187354|NCT00874965|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
5187355|NCT00874965|Electrostimulation|electrostimulation
5187356|NCT00874965|Muscle function|muscle function
5187357|NCT00874965|Exercise ventilation|exercise ventilation
5187358|NCT00874965|Anabolism/catabolism pathway|anabolism/catabolism pathway
5187359|NCT00874952|Metabolic syndrome|metabolic syndrome
5187360|NCT00874952|Lipids|lipids
5187361|NCT00874952|Waist Circumference|waist circumference
5187362|NCT00874952|HDL|hdl
5187363|NCT00874952|hypertension|hypertension
5187364|NCT00874926|Octocog alfa|octocog alfa
5187365|NCT00874926|Haemophilia A|haemophilia a
5187366|NCT00874913|blood flow|blood flow
5187367|NCT00874913|obstructive sleep apnea syndrome|obstructive sleep apnea syndrome
5187368|NCT00874913|normal tension glaucoma|normal tension glaucoma
5187369|NCT00874874|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
5187370|NCT00874874|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
5187371|NCT00874874|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
5187372|NCT00874874|adult angiosarcoma|adult angiosarcoma
5187373|NCT00874861|cancer|cancer
5187374|NCT00874861|brain|brain
5187375|NCT00874861|tumor|tumor
5187376|NCT00874861|vaccine|vaccine
5187377|NCT00874848|Imprime PGG|imprime pgg
5187378|NCT00874848|NSCLC|nsclc
5187379|NCT00874848|Cetuximab|cetuximab
5187380|NCT00874835|Endothelial Keratoplasty|endothelial keratoplasty
5187381|NCT00874835|EK|ek
5187382|NCT00874835|Descemet Stripping Endothelial Keratoplasty|descemet stripping endothelial keratoplasty
5187383|NCT00874835|Corneal Transplantation|corneal transplantation
5187384|NCT00874835|Keratoplasty|keratoplasty
5187385|NCT00874835|DSEK|dsek
5187386|NCT00874835|DSAEK|dsaek
5187387|NCT00874809|insulin pump|insulin pump
5187388|NCT00874809|DM Type 2|dm type 2
5187389|NCT00874809|CGMS|cgms
5187390|NCT00874809|basal rate|basal rate
5187391|NCT00874796|apoptosis|apoptosis
5187392|NCT00874796|liver inflammation|liver inflammation
5187393|NCT00874796|hepatitis C|hepatitis c
5187394|NCT00874783|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
5187395|NCT00874783|Familial Dysautonomia|familial dysautonomia
5187396|NCT00874783|Parkinson's Disease|parkinson's disease
5187397|NCT00874783|Alzheimer's Disease|alzheimer's disease
5187398|NCT00874783|Age Related Macular Degeneration|age related macular degeneration
5187399|NCT00874783|Retinitis Pigmentosa|retinitis pigmentosa
5187400|NCT00874783|Huntington's Disease|huntington's disease
5187401|NCT00874783|Machado - Joseph Disease|machado - joseph disease
5187402|NCT00874783|SMA - Spinal Muscular Atrophy|sma - spinal muscular atrophy
5187403|NCT00874783|Ataxia Telangiectasia|ataxia telangiectasia
5187404|NCT00874770|Antivirals|antivirals
5187405|NCT00874757|Statins, anti-inflammatory|statins, anti-inflammatory
5187406|NCT00874757|Healthy subjects study|healthy subjects study
5187407|NCT00874744|Diabetic macular edema|diabetic macular edema
5187408|NCT00874744|intravitreal injection|intravitreal injection
5187409|NCT00874744|Pharmacological treatment|pharmacological treatment
5187410|NCT00874718|repetitive strain injury|repetitive strain injury
5187411|NCT00874718|quality of life|quality of life
5187412|NCT00874718|functional capacity|functional capacity
5187413|NCT00874718|workers|workers
5187414|NCT00874692|tap water temperature|tap water temperature
5187415|NCT00874692|social housing|social housing
5187416|NCT00874692|scald reduction|scald reduction
5187417|NCT00874692|Temperature (degrees Celsius) of hot tap water at point of delivery.|temperature (degrees celsius) of hot tap water at point of delivery.
5187418|NCT00874666|garlic|garlic
5187419|NCT00874666|allicin|allicin
5187420|NCT00874666|allyl methyl sulfide|allyl methyl sulfide
5187421|NCT00874666|healthy persons|healthy persons
5187422|NCT00874640|Drug utilization review|drug utilization review
5187423|NCT00874627|children > 5 years old|children > 5 years old
5187424|NCT00874627|IgE-mediated|ige-mediated
5187425|NCT00874627|cow milk allergy|cow milk allergy
5187522|NCT00874211|refractory multiple myeloma|refractory multiple myeloma
5187426|NCT00874627|IgE-mediated cow milk allergy persisting after 5 years|ige-mediated cow milk allergy persisting after 5 years
5187427|NCT00874614|radiotherapy|radiotherapy
5187428|NCT00874614|MIBG|mibg
5187429|NCT00874614|Azedra|azedra
5187430|NCT00874614|neuroendocrine tumors|neuroendocrine tumors
5187431|NCT00874614|Iobenguane I 131|iobenguane i 131
5187432|NCT00874614|progenics|progenics
5187433|NCT00874601|acute ischemic stroke|acute ischemic stroke
5187434|NCT00874601|blood pressure|blood pressure
5187435|NCT00874601|valsartan|valsartan
5187436|NCT00874601|death|death
5187437|NCT00874601|dependancy|dependancy
5187438|NCT00874575|HMB|hmb
5187439|NCT00874575|Vitamin D|vitamin d
5187440|NCT00874575|Older Adults|older adults
5187441|NCT00874562|rapamycin|rapamycin
5187442|NCT00874562|corticosteroid|corticosteroid
5187443|NCT00874562|ALL|all
5187444|NCT00874549|Meningococcal Vaccine|meningococcal vaccine
5187445|NCT00874549|Menactra®|menactra®
5187446|NCT00874549|Menomune®|menomune®
5187447|NCT00874536|ADHD|adhd
5187448|NCT00874536|methylphenidate|methylphenidate
5187449|NCT00874536|omega-3|omega-3
5187450|NCT00874523|raltegravir|raltegravir
5187451|NCT00874523|atazanavir|atazanavir
5187452|NCT00874523|HIV infections|hiv infections
5187453|NCT00874523|pharmacokinetics|pharmacokinetics
5187454|NCT00874523|antiretroviral agents|antiretroviral agents
5187455|NCT00874523|treatment experienced|treatment experienced
5187456|NCT00874510|sleep deprivation|sleep deprivation
5187457|NCT00874510|fatigue|fatigue
5187458|NCT00874458|ductal breast carcinoma in situ|ductal breast carcinoma in situ
5187459|NCT00874432|cardiovascular disease|cardiovascular disease
5187460|NCT00874432|angiotensin converting enzyme inhibitors|angiotensin converting enzyme inhibitors
5187461|NCT00874432|chronic kidney disease|chronic kidney disease
5187462|NCT00874432|cardiovascular disease in elderly patients with CKD|cardiovascular disease in elderly patients with ckd
5187463|NCT00874419|EGFR mutation|egfr mutation
5187464|NCT00874419|EGFR-TKI|egfr-tki
5187465|NCT00874419|Chemotherapy|chemotherapy
5187466|NCT00874406|colorectal cancer|colorectal cancer
5187467|NCT00874406|liver metastasis|liver metastasis
5187468|NCT00874406|neoadjuvant chemotherapy|neoadjuvant chemotherapy
5187469|NCT00874393|NICHD Neonatal Research Network|nichd neonatal research network
5187470|NCT00874393|Very Low Birth Weight (VLBW)|very low birth weight (vlbw)
5187471|NCT00874393|Extremely Low Birth Weight (ELBW)|extremely low birth weight (elbw)
5187472|NCT00874393|Prematurity|prematurity
5187473|NCT00874393|Blood Pressure Management|blood pressure management
5187474|NCT00874393|Dopamine|dopamine
5187475|NCT00874393|Hydrocortisone|hydrocortisone
5187476|NCT00874380|Fiber|fiber
5187477|NCT00874380|Dialysis|dialysis
5187478|NCT00874380|Renal Replacement Therapy|renal replacement therapy
5187479|NCT00874380|Food Frequency Questionnaire|food frequency questionnaire
5187480|NCT00874380|FFQ|ffq
5187481|NCT00874380|Dietary counseling|dietary counseling
5187482|NCT00874367|NICHD Neonatal Research Network|nichd neonatal research network
5187483|NCT00874367|Very Low Birth Weight (VLBW)|very low birth weight (vlbw)
5187484|NCT00874367|Extremely Low Birth Weight (ELBW)|extremely low birth weight (elbw)
5187485|NCT00874367|Prematurity|prematurity
5187486|NCT00874367|Early Onset Sepsis|early onset sepsis
5187487|NCT00874354|Myocardial Infarction|myocardial infarction
5187488|NCT00874354|Heart Attack|heart attack
5187489|NCT00874354|Infarct|infarct
5187490|NCT00874354|Stem Cells|stem cells
5187491|NCT00874354|Bone Marrow Derived Mononuclear Cells|bone marrow derived mononuclear cells
5187492|NCT00874354|CHF|chf
5187493|NCT00874354|Congestive Heart Failure|congestive heart failure
5187494|NCT00874354|Stent|stent
5187495|NCT00874354|PCI|pci
5187496|NCT00874354|Percutaneous Coronary Intervention|percutaneous coronary intervention
5187497|NCT00874341|Fruit|fruit
5187498|NCT00874341|Vegetables|vegetables
5187499|NCT00874341|Intervention|intervention
5187500|NCT00874341|Insulin resistance|insulin resistance
5187501|NCT00874341|Cardiovascular disease risk|cardiovascular disease risk
5187502|NCT00874341|Dose response|dose response
5187503|NCT00874341|High risk of cardiovascular disease|high risk of cardiovascular disease
5187504|NCT00874328|Non small cell lung cancer|non small cell lung cancer
5187505|NCT00874328|Irinotecan plus Cisplatin plus S-1|irinotecan plus cisplatin plus s-1
5187506|NCT00874328|Phase I/II trial|phase i/ii trial
5187507|NCT00874315|recurrent or refractory neuroblastoma|recurrent or refractory neuroblastoma
5187508|NCT00874302|Uterine fibroids|uterine fibroids
5187509|NCT00874289|NGAL|ngal
5187510|NCT00874289|Heart failure|heart failure
5187511|NCT00874276|DCA|dca
5187512|NCT00874276|Dichloroacetate|dichloroacetate
5187513|NCT00874276|Trichloroacetate|trichloroacetate
5187514|NCT00874263|Probe-based imaging of GI pre-malignant or malignant lesions|probe-based imaging of gi pre-malignant or malignant lesions
5187515|NCT00874237|Staccato loxapine|staccato loxapine
5187516|NCT00874237|QTc|qtc
5187517|NCT00874237|healthy volunteers|healthy volunteers
5187518|NCT00874224|Colorectal cancer liver metastasis|colorectal cancer liver metastasis
5187519|NCT00874224|Benign liver disease|benign liver disease
5187520|NCT00874211|bone metastases|bone metastases
5187521|NCT00874211|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5187523|NCT00874211|stage I multiple myeloma|stage i multiple myeloma
5187524|NCT00874211|stage II multiple myeloma|stage ii multiple myeloma
5187525|NCT00874211|stage III multiple myeloma|stage iii multiple myeloma
5187526|NCT00874211|male breast cancer|male breast cancer
5187527|NCT00874211|recurrent breast cancer|recurrent breast cancer
5187528|NCT00874211|stage IA breast cancer|stage ia breast cancer
5187529|NCT00874211|stage IB breast cancer|stage ib breast cancer
5187530|NCT00874211|stage II breast cancer|stage ii breast cancer
5187531|NCT00874211|stage IIIA breast cancer|stage iiia breast cancer
5187532|NCT00874211|stage IIIB breast cancer|stage iiib breast cancer
5187533|NCT00874211|stage IIIC breast cancer|stage iiic breast cancer
5187534|NCT00874211|stage IV breast cancer|stage iv breast cancer
5187535|NCT00874211|recurrent prostate cancer|recurrent prostate cancer
5187536|NCT00874211|stage I prostate cancer|stage i prostate cancer
5187537|NCT00874211|stage IIB prostate cancer|stage iib prostate cancer
5187538|NCT00874211|stage IIA prostate cancer|stage iia prostate cancer
5187539|NCT00874211|stage III prostate cancer|stage iii prostate cancer
5187540|NCT00874211|stage IV prostate cancer|stage iv prostate cancer
5187541|NCT00874211|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5187542|NCT00874211|stage I non-small cell lung cancer|stage i non-small cell lung cancer
5187543|NCT00874211|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
5187544|NCT00874211|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5187545|NCT00874211|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5187546|NCT00874211|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5187547|NCT00874211|extensive stage small cell lung cancer|extensive stage small cell lung cancer
5187548|NCT00874211|limited stage small cell lung cancer|limited stage small cell lung cancer
5187549|NCT00874211|recurrent small cell lung cancer|recurrent small cell lung cancer
5187550|NCT00874198|normal pressure hydrocephalus|normal pressure hydrocephalus
5187551|NCT00874198|cerebrospinal fluid dynamic test|cerebrospinal fluid dynamic test
5187552|NCT00874198|cerebrospinal fluid outflow resistance|cerebrospinal fluid outflow resistance
5187553|NCT00874198|cerebrospinal compliance|cerebrospinal compliance
5187554|NCT00874198|outcome|outcome
5187555|NCT00874198|shunt surgery|shunt surgery
5187556|NCT00874198|normal pressure hydrocephalus guidelines|normal pressure hydrocephalus guidelines
5187557|NCT00874198|biomarkers|biomarkers
5187558|NCT00874198|shunt surgery selection|shunt surgery selection
5187559|NCT00874198|Outcome measures|outcome measures
5187560|NCT00874198|Outcomes assessment|outcomes assessment
5187561|NCT00874198|Outcome and process assessment|outcome and process assessment
5187562|NCT00874185|satisfaction|satisfaction
5187563|NCT00874172|Anemia|anemia
5187564|NCT00874172|Sickle Cell|sickle cell
5187565|NCT00874172|Analgesic|analgesic
5187566|NCT00874172|Pain|pain
5187567|NCT00874172|Emergency treatment|emergency treatment
5187568|NCT00874172|Quality of life|quality of life
5187569|NCT00874107|NSCLC|nsclc
5187570|NCT00874107|Phase 2|phase 2
5187571|NCT00874107|Randomized|randomized
5187572|NCT00874107|Efficacy|efficacy
5187573|NCT00874107|Safety|safety
5187574|NCT00874107|Imprime PGG|imprime pgg
5187575|NCT00874107|Bevacizumab|bevacizumab
5187576|NCT00874094|nasolabial folds|nasolabial folds
5187577|NCT00874094|platelet rich plasma|platelet rich plasma
5187578|NCT00874094|fibrin matrix|fibrin matrix
5187579|NCT00874094|facial rhytids|facial rhytids
5187580|NCT00874094|dermal filler|dermal filler
5187581|NCT00874068|term infants|term infants
5187582|NCT00874068|preterm infants|preterm infants
5187583|NCT00874068|bone strength|bone strength
5187584|NCT00874068|Speed of sound (SOS)|speed of sound (sos)
5187585|NCT00874068|Ultrasound|ultrasound
5187586|NCT00874055|social influence|social influence
5187587|NCT00874055|friends|friends
5187588|NCT00874055|eating behavior|eating behavior
5187589|NCT00874055|childhood overweight|childhood overweight
5187590|NCT00874042|dose escalation|dose escalation
5187591|NCT00874042|safety|safety
5187592|NCT00874042|tolerability|tolerability
5187593|NCT00874042|tumor|tumor
5187594|NCT00874042|PK|pk
5187595|NCT00874029|Uterine Fibroids|uterine fibroids
5187596|NCT00874029|Myomas|myomas
5187597|NCT00874016|intubation|intubation
5187598|NCT00874016|Airtraq|airtraq
5187599|NCT00874016|pediatric|pediatric
5187600|NCT00874016|airway|airway
5187601|NCT00874003|alcohol dependence|alcohol dependence
5187602|NCT00874003|anti-depressant|anti-depressant
5187603|NCT00874003|5-HT|5-ht
5187604|NCT00874003|NE|ne
5187605|NCT00873990|fissure sealant|fissure sealant
5187606|NCT00873990|self etch|self etch
5187607|NCT00873990|total etch|total etch
5187608|NCT00873977|Adherence|adherence
5187609|NCT00873977|Continuous Positive Airway Pressure|continuous positive airway pressure
5187610|NCT00873964|Metabolic Syndrome|metabolic syndrome
5187611|NCT00873964|Obesity|obesity
5187612|NCT00873964|Elderly|elderly
5187613|NCT00873964|Insulin Resistance|insulin resistance
5187614|NCT00873938|Artesunate-Amodiaquine|artesunate-amodiaquine
5187615|NCT00873938|Compliance|compliance
5187616|NCT00873938|Malaria|malaria
5187617|NCT00873925|Type 1 Diabetes|type 1 diabetes
5187618|NCT00873912|influenza|influenza
5187619|NCT00873912|FluMist|flumist
5187620|NCT00873899|Heart Failure|heart failure
5187621|NCT00873899|Implantable defibrillator|implantable defibrillator
5187622|NCT00873899|Remote Monitoring|remote monitoring
5187623|NCT00873873|Asthma Progression|asthma progression
5187624|NCT00873873|Airway Wall Thickness|airway wall thickness
5187625|NCT00873873|Corticosteroid Resistance|corticosteroid resistance
5187626|NCT00873873|Biomarkers|biomarkers
5187627|NCT00873873|Pulmonary Physiology|pulmonary physiology
5187629|NCT00873860|Tralokinumab|tralokinumab
5187630|NCT00873860|Asthma|asthma
5187631|NCT00873847|NICHD Neonatal Research Network|nichd neonatal research network
5187632|NCT00873847|Very Low Birth Weight (VLBW)|very low birth weight (vlbw)
5187633|NCT00873847|Extremely Low Birth Weight (ELBW)|extremely low birth weight (elbw)
5187634|NCT00873847|Prematurity|prematurity
5187635|NCT00873847|Amplitude-integrated Electroencephalography (aEEG)|amplitude-integrated electroencephalography (aeeg)
5187636|NCT00873834|autism|autism
5187637|NCT00873834|fluoxetine|fluoxetine
5187638|NCT00873834|Comparative|comparative
5187639|NCT00873834|double blind|double blind
5187640|NCT00873834|placebo|placebo
5187641|NCT00873834|controlled trial|controlled trial
5187642|NCT00873834|anatomy-functional imaging|anatomy-functional imaging
5187643|NCT00873834|children|children
5187644|NCT00873834|DSM-IV-R criteria for autism and CARS score (of 30 or above)|dsm-iv-r criteria for autism and cars score (of 30 or above)
5187645|NCT00873808|breast cancer|breast cancer
5187646|NCT00873795|efficacy|efficacy
5187647|NCT00873795|tolerability|tolerability
5187648|NCT00873795|combination of aripiprazole and SSRI(sertraline)|combination of aripiprazole and ssri(sertraline)
5187649|NCT00873782|Limb Perfusion|limb perfusion
5187650|NCT00873782|Gene Therapy|gene therapy
5187651|NCT00873769|Staccato Loxapine|staccato loxapine
5187652|NCT00873769|pharmacokinetics|pharmacokinetics
5187653|NCT00873769|smokers|smokers
5187654|NCT00873769|non-smokers|non-smokers
5187655|NCT00873756|CRC|crc
5187656|NCT00873756|Colon Cancer|colon cancer
5187657|NCT00873756|Avastin|avastin
5187658|NCT00873756|Apo2L/TRAIL|apo2l/trail
5187659|NCT00873743|lower pain intensity with combination drug after cesarian section in first 48h postoperatively|lower pain intensity with combination drug after cesarian section in first 48h postoperatively
5187660|NCT00873730|Effect of etanercept in subjects with ankylosing spondylitis|effect of etanercept in subjects with ankylosing spondylitis
5187661|NCT00873717|elderly|elderly
5187662|NCT00873717|long-term facilities|long-term facilities
5187663|NCT00873717|nutritional status|nutritional status
5187664|NCT00873691|Patients indicated for an ICD/ CRT-D|patients indicated for an icd/ crt-d
5187665|NCT00873678|Molar tooth|molar tooth
5187666|NCT00873678|AHI1 gene|ahi1 gene
5187667|NCT00873678|CEP290 gene|cep290 gene
5187668|NCT00873678|ciliopathies|ciliopathies
5187669|NCT00873652|Hepatitis B vaccine|hepatitis b vaccine
5187670|NCT00873652|Booster dose|booster dose
5187671|NCT00873652|Persistence|persistence
5187672|NCT00873652|Immune response|immune response
5187673|NCT00873652|Healthy children|healthy children
5187674|NCT00873626|Urinary tract infection|urinary tract infection
5187675|NCT00873626|treatment duration|treatment duration
5187676|NCT00873626|acute pyelonephritis|acute pyelonephritis
5187677|NCT00873626|good use of antibiotics|good use of antibiotics
5187678|NCT00873600|cognitive/functional effects|cognitive/functional effects
5187679|NCT00873600|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
5187680|NCT00873600|stage I breast cancer|stage i breast cancer
5187681|NCT00873600|stage II breast cancer|stage ii breast cancer
5187682|NCT00873600|stage IIIA breast cancer|stage iiia breast cancer
5187683|NCT00873600|stage IIIB breast cancer|stage iiib breast cancer
5187684|NCT00873600|stage IIIC breast cancer|stage iiic breast cancer
5187685|NCT00873600|adenocarcinoma of the colon|adenocarcinoma of the colon
5187686|NCT00873600|stage I colon cancer|stage i colon cancer
5187687|NCT00873600|stage II colon cancer|stage ii colon cancer
5187688|NCT00873600|stage III colon cancer|stage iii colon cancer
5187689|NCT00873587|Thoracotomy|thoracotomy
5187690|NCT00873587|Inspiration|inspiration
5187691|NCT00873587|Expiration|expiration
5187692|NCT00873587|Chest Tube|chest tube
5187693|NCT00873587|pneumothorax|pneumothorax
5187694|NCT00873587|Method of chest tube removal|method of chest tube removal
5187695|NCT00873574|Familial myeloproliferative disorders|familial myeloproliferative disorders
5187696|NCT00873574|JAK-STAT|jak-stat
5187697|NCT00873574|V617|v617
5187698|NCT00873574|JAK2|jak2
5187699|NCT00873561|diabetes|diabetes
5187700|NCT00873561|type 1|type 1
5187701|NCT00873561|adult|adult
5187702|NCT00873561|adolescent|adolescent
5187703|NCT00873561|new onset|new onset
5187704|NCT00873535|Nicotine|nicotine
5187705|NCT00873535|Nicotine dependence|nicotine dependence
5187706|NCT00873535|Smoking cessation|smoking cessation
5187707|NCT00873535|Alcohol|alcohol
5187708|NCT00873535|Alcohol dependence|alcohol dependence
5187709|NCT00873535|Alcohol cessation|alcohol cessation
5187710|NCT00873535|Treatment|treatment
5187711|NCT00873535|Smoking|smoking
5187712|NCT00873535|Cigarette|cigarette
5187713|NCT00873535|Heavy drinkers|heavy drinkers
5187714|NCT00873535|Social drinkers|social drinkers
5187715|NCT00873535|Co-morbidity of alcohol and nicotine dependence|co-morbidity of alcohol and nicotine dependence
5187716|NCT00873535|Nicotine receptor|nicotine receptor
5187717|NCT00873535|Nicotinic receptor|nicotinic receptor
5187718|NCT00873535|Nicotinic acetycholine receptor|nicotinic acetycholine receptor
5187719|NCT00873535|Alpha-4-beta-2 nicotinic acetycholine receptor|alpha-4-beta-2 nicotinic acetycholine receptor
5187720|NCT00873535|Cholinergic receptor|cholinergic receptor
5187721|NCT00873535|Dopamine|dopamine
5187722|NCT00873535|Craving|craving
5187723|NCT00873535|Diary|diary
5187724|NCT00873535|Cue induced|cue induced
5187725|NCT00873535|Pharmacotherapy|pharmacotherapy
5187726|NCT00873535|Varenicline|varenicline
5187727|NCT00873535|Chantix|chantix
5187728|NCT00873535|Champix|champix
5187729|NCT00873522|pneumonia|pneumonia
5187730|NCT00873509|Autism|autism
5187731|NCT00873496|Sjögren's Syndrome|sjögren's syndrome
5187732|NCT00873496|hyposalivation|hyposalivation
5187733|NCT00873496|mouth dryness|mouth dryness
5187734|NCT00873496|complications|complications
5187735|NCT00873483|Pregnancy prevention|pregnancy prevention
5187736|NCT00873483|female contraception|female contraception
5187737|NCT00873483|patch|patch
5187738|NCT00873457|B-Cell Chronic Lymphocytic Leukemia|b-cell chronic lymphocytic leukemia
5187739|NCT00873457|Leukemia|leukemia
5187740|NCT00873444|Hip|hip
5187741|NCT00873444|Cementless|cementless
5187742|NCT00873444|Ceramic-on-Metal|ceramic-on-metal
5187743|NCT00873444|Metal-on-Metal|metal-on-metal
5187744|NCT00873431|Prevention of pneumococcal infections|prevention of pneumococcal infections
5187745|NCT00873418|Heart Failure|heart failure
5187746|NCT00873418|Intervention|intervention
5187747|NCT00873418|Cognitive Behavior Therapy|cognitive behavior therapy
5187748|NCT00873418|Quality of Life|quality of life
5187749|NCT00873405|Type 2 diabetes mellitus|type 2 diabetes mellitus
5187750|NCT00873405|Metabolic control|metabolic control
5187751|NCT00873405|Bariatric Surgery|bariatric surgery
5187752|NCT00873405|Weight Loss|weight loss
5187753|NCT00873405|Sleeve gastrectomy|sleeve gastrectomy
5187754|NCT00873405|BMI reduction|bmi reduction
5187755|NCT00873405|Waist circumference reduction|waist circumference reduction
5187756|NCT00873405|Percentage of excess BMI loss|percentage of excess bmi loss
5187757|NCT00873405|Glucose homeostasis|glucose homeostasis
5187758|NCT00873392|Parkinson's disease|parkinson's disease
5187759|NCT00873392|Motor fluctuation|motor fluctuation
5187760|NCT00873392|Nicotine|nicotine
5187761|NCT00873392|Drug treatment|drug treatment
5187762|NCT00873392|neuroprotection|neuroprotection
5187763|NCT00873366|stage I breast cancer|stage i breast cancer
5187764|NCT00873366|stage II breast cancer|stage ii breast cancer
5187765|NCT00873366|stage IIIA breast cancer|stage iiia breast cancer
5187766|NCT00873366|stage IIIB breast cancer|stage iiib breast cancer
5187767|NCT00873366|stage IIIC breast cancer|stage iiic breast cancer
5187768|NCT00873353|Metastatic Adenocarcinoma of the Pancreas|metastatic adenocarcinoma of the pancreas
5187769|NCT00873340|MS|ms
5187770|NCT00873340|Multiple Sclerosis|multiple sclerosis
5187771|NCT00873340|Betaferon|betaferon
5187772|NCT00873340|Colombia|colombia
5187773|NCT00873327|presumed sepsis|presumed sepsis
5187774|NCT00873301|vulvodynia|vulvodynia
5187775|NCT00873301|vestibulectomy|vestibulectomy
5187776|NCT00873301|surgery|surgery
5187777|NCT00873301|vestibulitis|vestibulitis
5187778|NCT00873288|cervical intraepithelial neoplasia|cervical intraepithelial neoplasia
5187779|NCT00873288|atypical squamous cells of undetermined significance|atypical squamous cells of undetermined significance
5187780|NCT00873288|high-grade squamous intraepithelial lesion|high-grade squamous intraepithelial lesion
5187781|NCT00873288|low-grade squamous intraepithelial lesion|low-grade squamous intraepithelial lesion
5187782|NCT00873275|stage IV colon cancer|stage iv colon cancer
5187783|NCT00873275|stage IV rectal cancer|stage iv rectal cancer
5187784|NCT00873275|recurrent colon cancer|recurrent colon cancer
5187785|NCT00873275|recurrent rectal cancer|recurrent rectal cancer
5187786|NCT00873275|adenocarcinoma of the colon|adenocarcinoma of the colon
5187787|NCT00873275|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5187788|NCT00873262|PreMenstrual Syndrome|premenstrual syndrome
5187789|NCT00873262|Hormones|hormones
5187790|NCT00873262|Skin tests|skin tests
5187791|NCT00873262|Desensitization|desensitization
5187792|NCT00873262|Allergen Immunotherapy|allergen immunotherapy
5187793|NCT00873249|Schizophrenia|schizophrenia
5187794|NCT00873249|Therapeutic adherence|therapeutic adherence
5187795|NCT00873249|Short message system|short message system
5187796|NCT00873249|Mobile phone|mobile phone
5187797|NCT00873236|stage III renal cell cancer|stage iii renal cell cancer
5187798|NCT00873236|stage IV renal cell cancer|stage iv renal cell cancer
5187799|NCT00873210|renal cell carcinoma|renal cell carcinoma
5187800|NCT00873210|sunitinib malate|sunitinib malate
5187801|NCT00873197|Co-administration of transdermal and intravenous granisetron|co-administration of transdermal and intravenous granisetron
5187802|NCT00873197|Granisetron|granisetron
5187803|NCT00873197|Healthy subjects|healthy subjects
5187804|NCT00873197|Intravenous|intravenous
5187805|NCT00873197|Pharmacokinetic profile|pharmacokinetic profile
5187806|NCT00873197|Sancuso® patch|sancuso® patch
5187807|NCT00873197|Transdermal|transdermal
5187808|NCT00873197|Pharmacokinetics|pharmacokinetics
5187809|NCT00873184|massage therapy in patients with brain tumors|massage therapy in patients with brain tumors
5187810|NCT00873171|Osteopathic Manipulation|osteopathic manipulation
5187811|NCT00873158|Adhesive Capsulitis|adhesive capsulitis
5187812|NCT00873158|ROM|rom
5187813|NCT00873158|Dynasplint|dynasplint
5187814|NCT00873145|Survival|survival
5187815|NCT00873145|Function|function
5187816|NCT00873145|Infection|infection
5187817|NCT00873145|Revision|revision
5187818|NCT00873145|Loosening|loosening
5187819|NCT00873119|Belinostat|belinostat
5187820|NCT00873119|PXD101|pxd101
5187821|NCT00873119|Carboplatin|carboplatin
5187822|NCT00873119|Paclitaxel|paclitaxel
5187823|NCT00873119|CUP|cup
5187824|NCT00873119|Carcinoma of unknown primary|carcinoma of unknown primary
5187825|NCT00873119|Occult primary|occult primary
5187826|NCT00873080|reliability|reliability
5187827|NCT00873080|photogrammetry|photogrammetry
5187828|NCT00873067|Atrial fibrillation|atrial fibrillation
5187829|NCT00873067|Complex fractionated electrograms|complex fractionated electrograms
5187830|NCT00873067|CFAE|cfae
5187831|NCT00873041|Thalassemia|thalassemia
5187832|NCT00873041|thalassemia intermedia|thalassemia intermedia
5187833|NCT00873041|alpha-thalassemia|alpha-thalassemia
5187834|NCT00873041|beta-thalassemia|beta-thalassemia
5187835|NCT00873041|deferasirox|deferasirox
5187836|NCT00873041|iron overload|iron overload
5187837|NCT00873041|non-transfusion dependent|non-transfusion dependent
5187838|NCT00873028|Physical therapy|physical therapy
5187839|NCT00873028|Inspiratory muscles|inspiratory muscles
5187840|NCT00873028|Exercise|exercise
5187841|NCT00873015|Cerebral aneurysm|cerebral aneurysm
5187842|NCT00873015|Subarachnoid hemorrhage|subarachnoid hemorrhage
5187843|NCT00873015|Nitrite|nitrite
5187844|NCT00873002|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
5187845|NCT00873002|advanced adult primary liver cancer|advanced adult primary liver cancer
5187846|NCT00873002|recurrent adult primary liver cancer|recurrent adult primary liver cancer
5187847|NCT00873002|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
5187848|NCT00872989|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5187849|NCT00872989|recurrent fallopian tube cancer|recurrent fallopian tube cancer
5187850|NCT00872989|recurrent primary peritoneal cavity cancer|recurrent primary peritoneal cavity cancer
5187851|NCT00872963|malaria vaccine|malaria vaccine
5187852|NCT00872963|RTS,S,|rts,s,
5187853|NCT00872950|LEMS|lems
5187854|NCT00872950|CMS|cms
5187855|NCT00872950|3,4 DIAMINOPYRIDINE|3,4 diaminopyridine
5187856|NCT00872950|3,4 DAP|3,4 dap
5187857|NCT00872924|Bioequivalence|bioequivalence
5187858|NCT00872911|Sarcopenia|sarcopenia
5187859|NCT00872911|nutrition|nutrition
5187860|NCT00872911|aging|aging
5187861|NCT00872911|metabolism|metabolism
5187862|NCT00872911|exercise|exercise
5187863|NCT00872898|autism|autism
5187864|NCT00872898|memantine|memantine
5187865|NCT00872898|pediatric|pediatric
5187866|NCT00872898|Forest Laboratories|forest laboratories
5187867|NCT00872898|Autism in pediatric patients|autism in pediatric patients
5187868|NCT00872885|analgesic|analgesic
5187869|NCT00872885|bunionectomy|bunionectomy
5187870|NCT00872885|surgery|surgery
5187871|NCT00872885|post operative pain|post operative pain
5187872|NCT00872885|single Hallux valgus repair|single hallux valgus repair
5187873|NCT00872872|NVP|nvp
5187874|NCT00872872|PMTCT|pmtct
5187875|NCT00872872|pregnancy|pregnancy
5187876|NCT00872872|resistance|resistance
5187877|NCT00872859|Breast Cancer|breast cancer
5187878|NCT00872859|Cancer of Breast|cancer of breast
5187879|NCT00872859|Reconstructive Surgery|reconstructive surgery
5187880|NCT00872846|Body weight|body weight
5187881|NCT00872846|Signs and symptoms|signs and symptoms
5187882|NCT00872846|Obesity|obesity
5187883|NCT00872846|Metabolic disease|metabolic disease
5187884|NCT00872846|Diabetes mellitus type 2|diabetes mellitus type 2
5187885|NCT00872846|Diabetes mellitus|diabetes mellitus
5187886|NCT00872846|Nutrition disorder|nutrition disorder
5187887|NCT00872846|Endocrine system diseases|endocrine system diseases
5187888|NCT00872846|Overweight|overweight
5187889|NCT00872846|Overnutrition|overnutrition
5187890|NCT00872846|Glucose metabolic disorder|glucose metabolic disorder
5187891|NCT00872833|Transfusion-Dependant Thalassemia|transfusion-dependant thalassemia
5187892|NCT00872833|Pain|pain
5187893|NCT00872833|Mild Pain|mild pain
5187894|NCT00872820|Social Anxiety|social anxiety
5187895|NCT00872820|Social Anxiety Treatment|social anxiety treatment
5187896|NCT00872820|Cognitive Therapy|cognitive therapy
5187897|NCT00872820|Mindfulness|mindfulness
5187898|NCT00872820|Social Phobia|social phobia
5187899|NCT00872820|Social Phobia Treatment|social phobia treatment
5187900|NCT00872807|childhood|childhood
5187901|NCT00872807|therapy|therapy
5187902|NCT00872807|life style|life style
5187903|NCT00872807|motor activity|motor activity
5187904|NCT00872807|obesity|obesity
5187905|NCT00872807|overweight|overweight
5187906|NCT00872807|body mass index|body mass index
5187907|NCT00872807|treatment|treatment
5187908|NCT00872794|Hip|hip
5187909|NCT00872794|Conservative|conservative
5187910|NCT00872794|Metal on Metal|metal on metal
5187911|NCT00872794|Resurfacing|resurfacing
5188011|NCT00872430|phytotherapy|phytotherapy
5188012|NCT00872417|HIV/AIDS|hiv/aids
5187912|NCT00872781|Bioequivalence fixed dose combination of Quinapril HCl 20 mg and Hydrochlorothiazide 25 mg tablets|bioequivalence fixed dose combination of quinapril hcl 20 mg and hydrochlorothiazide 25 mg tablets
5187913|NCT00872742|Impulse Control Disorders|impulse control disorders
5187914|NCT00872742|Behavior Therapy|behavior therapy
5187915|NCT00872742|Acceptance|acceptance
5187916|NCT00872742|Habit Reversal|habit reversal
5187917|NCT00872729|cystinosis|cystinosis
5187918|NCT00872729|cysteamine|cysteamine
5187919|NCT00872729|inheritable disease|inheritable disease
5187920|NCT00872729|orphan disease|orphan disease
5187921|NCT00872729|CTNS protein, human|ctns protein, human
5187922|NCT00872729|nephropathic cystinosis|nephropathic cystinosis
5187923|NCT00872716|specific phobia|specific phobia
5187924|NCT00872716|simple phobia|simple phobia
5187925|NCT00872716|anxiety disorder|anxiety disorder
5187926|NCT00872703|CMV|cmv
5187927|NCT00872703|Prenatal Diagnosis|prenatal diagnosis
5187928|NCT00872703|Ultrasound|ultrasound
5187929|NCT00872703|MRI|mri
5187930|NCT00872690|Multiple Trauma|multiple trauma
5187931|NCT00872690|Blast Injuries|blast injuries
5187932|NCT00872690|Brain Injuries|brain injuries
5187933|NCT00872690|Rehabilitation, Vocational|rehabilitation, vocational
5187934|NCT00872690|Consumer participation|consumer participation
5187935|NCT00872677|weight changes|weight changes
5187936|NCT00872677|obesity|obesity
5187937|NCT00872677|stage I breast cancer|stage i breast cancer
5187938|NCT00872677|stage II breast cancer|stage ii breast cancer
5187939|NCT00872677|stage IIIA breast cancer|stage iiia breast cancer
5187940|NCT00872664|ROP|rop
5187941|NCT00872664|anti-oxidants|anti-oxidants
5187942|NCT00872664|carotenoids|carotenoids
5187943|NCT00872651|Glaucoma|glaucoma
5187944|NCT00872651|intraocular pressure|intraocular pressure
5187945|NCT00872651|travoprost/timolol|travoprost/timolol
5187946|NCT00872651|timolol|timolol
5187947|NCT00872638|wound edge eversion|wound edge eversion
5187948|NCT00872638|cosmetic outcomes|cosmetic outcomes
5187949|NCT00872638|surgical incisions|surgical incisions
5187950|NCT00872625|stage IA breast cancer|stage ia breast cancer
5187951|NCT00872625|stage IB breast cancer|stage ib breast cancer
5187952|NCT00872625|stage II breast cancer|stage ii breast cancer
5187953|NCT00872625|stage IIIA breast cancer|stage iiia breast cancer
5187954|NCT00872625|stage IIIB breast cancer|stage iiib breast cancer
5187955|NCT00872625|stage IIIC breast cancer|stage iiic breast cancer
5187956|NCT00872625|recurrent breast cancer|recurrent breast cancer
5187957|NCT00872612|Sarcoidosis|sarcoidosis
5187958|NCT00872612|Diagnosis|diagnosis
5187959|NCT00872612|Non-caseating granulomas|non-caseating granulomas
5187960|NCT00872612|BAL|bal
5187961|NCT00872612|EUS-FNA|eus-fna
5187962|NCT00872612|EBUS-TBNA|ebus-tbna
5187963|NCT00872612|TBLB|tblb
5187964|NCT00872599|Hypertension|hypertension
5187965|NCT00872599|Phenotyping|phenotyping
5187966|NCT00872599|High Salt intake|high salt intake
5187967|NCT00872599|frequently sampled IV glucose tolerance test(FSIVGTT)|frequently sampled iv glucose tolerance test(fsivgtt)
5187968|NCT00872599|fenofibrate|fenofibrate
5187969|NCT00872599|epoxyeicosatrienoic acids|epoxyeicosatrienoic acids
5187970|NCT00872599|hydroxyeicosatetraenoic acids|hydroxyeicosatetraenoic acids
5187971|NCT00872599|dihydroxyeicosatrienoic acid|dihydroxyeicosatrienoic acid
5187972|NCT00872599|PPAR Alpha Agonist|ppar alpha agonist
5187973|NCT00872599|CYP Monooxygenase Activity|cyp monooxygenase activity
5187974|NCT00872573|Hip|hip
5187975|NCT00872573|Cemented|cemented
5187976|NCT00872547|Hip|hip
5187977|NCT00872547|Resurfacing|resurfacing
5187978|NCT00872547|Metal-on-Metal|metal-on-metal
5187979|NCT00872547|Large Heads|large heads
5187980|NCT00872547|XL Head|xl head
5187981|NCT00872547|ASR - osteoarthritis (primary)|asr - osteoarthritis (primary)
5187982|NCT00872534|To evaluate the acute gastrointestinal safety of PL-2100.|to evaluate the acute gastrointestinal safety of pl-2100.
5187983|NCT00872521|Multiple Myeloma|multiple myeloma
5187984|NCT00872521|transplant eligible|transplant eligible
5187985|NCT00872521|doxorubicin|doxorubicin
5187986|NCT00872521|dexamethasone|dexamethasone
5187987|NCT00872521|bortezomib|bortezomib
5187988|NCT00872521|bortezomib resistance|bortezomib resistance
5187989|NCT00872521|PAD induction|pad induction
5187990|NCT00872521|PIMMS Trial|pimms trial
5187991|NCT00872495|Urothelial Cancer|urothelial cancer
5187992|NCT00872495|Cancer|cancer
5187993|NCT00872495|Bladder Neoplasms|bladder neoplasms
5187994|NCT00872495|Urinary Bladder Cancer|urinary bladder cancer
5187995|NCT00872482|non-small cell lung cancer|non-small cell lung cancer
5187996|NCT00872482|NSCLC|nsclc
5187997|NCT00872482|Brain metastases|brain metastases
5187998|NCT00872482|nimotuzumab|nimotuzumab
5187999|NCT00872482|TheraCIM|theracim
5188000|NCT00872482|h-R3|h-r3
5188001|NCT00872482|Radiation|radiation
5188002|NCT00872469|Postpartum haemorrhage|postpartum haemorrhage
5188003|NCT00872469|randomised controlled trial|randomised controlled trial
5188004|NCT00872469|tranexamic acid|tranexamic acid
5188005|NCT00872469|antifibrinolytic|antifibrinolytic
5188006|NCT00872456|Diabetes Mellitus|diabetes mellitus
5188007|NCT00872456|Cardiovascular Disease|cardiovascular disease
5188008|NCT00872456|Haptoglobin|haptoglobin
5188009|NCT00872430|constipation|constipation
5188010|NCT00872430|RCT|rct
5188013|NCT00872417|antiretroviral therapy|antiretroviral therapy
5188014|NCT00872417|immune reconstitution|immune reconstitution
5188015|NCT00872404|CP-751,871|cp-751,871
5188016|NCT00872404|squamous cell carcinoma|squamous cell carcinoma
5188017|NCT00872404|recurrent or metastatic|recurrent or metastatic
5188018|NCT00872404|after 1st line chemotherapy|after 1st line chemotherapy
5188019|NCT00872378|Morbid Obesity|morbid obesity
5188020|NCT00872378|LAP Band|lap band
5188021|NCT00872378|Adjustable Gastric Band|adjustable gastric band
5188022|NCT00872378|Exenatide|exenatide
5188023|NCT00872378|Byetta|byetta
5188024|NCT00872378|Weight Loss|weight loss
5188025|NCT00872378|Bariatric Surgery|bariatric surgery
5188026|NCT00872365|Pregnancy|pregnancy
5188027|NCT00872365|Exercise|exercise
5188028|NCT00872365|Nutrition|nutrition
5188029|NCT00872365|Micronutrients|micronutrients
5188030|NCT00872365|non-transmissible chronic diseases|non-transmissible chronic diseases
5188031|NCT00872365|Endothelium|endothelium
5188032|NCT00872352|Multiple Myeloma|multiple myeloma
5188033|NCT00872352|Bortezomib|bortezomib
5188034|NCT00872352|Peripheral Neuropathy|peripheral neuropathy
5188035|NCT00872352|evaluation|evaluation
5188036|NCT00872352|evaluation of electrophysiological changes related to the dose and time of bortezomib administration|evaluation of electrophysiological changes related to the dose and time of bortezomib administration
5188037|NCT00872352|investigation of correlation between the incidence of BIPN and the subtype of myeloma|investigation of correlation between the incidence of bipn and the subtype of myeloma
5188038|NCT00872339|Transfusion-Dependent Thalassemia|transfusion-dependent thalassemia
5188039|NCT00872339|Non-Transfusion-Dependent Thalassemia|non-transfusion-dependent thalassemia
5188040|NCT00872326|Diabetes Complications|diabetes complications
5188041|NCT00872326|Lower limb ischemia|lower limb ischemia
5188042|NCT00872326|Adult stem cells|adult stem cells
5188043|NCT00872313|Labor|labor
5188044|NCT00872313|Psychology|psychology
5188045|NCT00872313|Postpartum Psychology|postpartum psychology
5188046|NCT00872287|minimally invasive surgery|minimally invasive surgery
5188047|NCT00872287|scarless cholecystectomy|scarless cholecystectomy
5188048|NCT00872287|new techniques in laparoscopy|new techniques in laparoscopy
5188049|NCT00872287|invisible scar|invisible scar
5188050|NCT00872287|single port access|single port access
5188051|NCT00872287|abdominal pain|abdominal pain
5188052|NCT00872287|shoulder pain|shoulder pain
5188053|NCT00872274|Bioequivalence|bioequivalence
5188054|NCT00872261|Clinical Trials as Topic|clinical trials as topic
5188055|NCT00872261|Adolescent Psychology|adolescent psychology
5188056|NCT00872261|Patient Acceptance of Health Care|patient acceptance of health care
5188057|NCT00872261|HIV Risk Behaviors|hiv risk behaviors
5188058|NCT00872261|Adolescents|adolescents
5188059|NCT00872261|Clinical Trial Recruitment|clinical trial recruitment
5188060|NCT00872261|Microbicide Acceptability|microbicide acceptability
5188061|NCT00872261|Ethics|ethics
5188062|NCT00872261|Mixed Methods|mixed methods
5188063|NCT00872261|HIV|hiv
5188064|NCT00872248|Restless leg syndrome|restless leg syndrome
5188065|NCT00872248|Spinal anesthesia|spinal anesthesia
5188066|NCT00872248|Epidural anesthesia|epidural anesthesia
5188067|NCT00872248|Neuraxial block|neuraxial block
5188068|NCT00872235|Bioequivalence fixed-dose combination of quinapril 20 mg and hydrochlorothiazide 25 mg tablets|bioequivalence fixed-dose combination of quinapril 20 mg and hydrochlorothiazide 25 mg tablets
5188069|NCT00872222|Hip|hip
5188070|NCT00872222|Cementless|cementless
5188071|NCT00872222|Ceramic-on-Ceramic|ceramic-on-ceramic
5188072|NCT00872209|swimmer's ear|swimmer's ear
5188073|NCT00872209|ear drops|ear drops
5188074|NCT00872209|ear foam|ear foam
5188075|NCT00872209|otic foam|otic foam
5188076|NCT00872209|ear infection|ear infection
5188077|NCT00872209|ear pain|ear pain
5188078|NCT00872209|ear inflammation|ear inflammation
5188079|NCT00872183|Motor Learning|motor learning
5188080|NCT00872183|Mirror Neurons|mirror neurons
5188081|NCT00872183|Healthy Volunteer|healthy volunteer
5188082|NCT00872183|HV|hv
5188083|NCT00872170|Pulmonary Hypertension|pulmonary hypertension
5188084|NCT00872157|Castrate-Resistant Prostate Cancer|castrate-resistant prostate cancer
5188085|NCT00872157|Prostate|prostate
5188086|NCT00872157|High-Volume Osseous Metastases|high-volume osseous metastases
5188087|NCT00872157|BMTP-11|bmtp-11
5188088|NCT00872157|Prostate State Antigen|prostate state antigen
5188089|NCT00872157|PSA|psa
5188090|NCT00872131|Anxiety|anxiety
5188091|NCT00872131|Social Phobia|social phobia
5188092|NCT00872131|Generalized Social Anxiety Disorder|generalized social anxiety disorder
5188093|NCT00872118|alcohol consumption|alcohol consumption
5188094|NCT00872118|social anxiety|social anxiety
5188095|NCT00872118|brief intervention|brief intervention
5188096|NCT00872118|motivational interviewing|motivational interviewing
5188097|NCT00872118|cognitive behavioral|cognitive behavioral
5188098|NCT00872105|clavicle|clavicle
5188099|NCT00872105|fractures|fractures
5188100|NCT00872105|distal|distal
5188101|NCT00872092|small bowel|small bowel
5188102|NCT00872092|bacterial overgrowth|bacterial overgrowth
5188103|NCT00872079|warfarin|warfarin
5188104|NCT00872079|pharmacokinetics|pharmacokinetics
5188105|NCT00872079|pharmacodynamics|pharmacodynamics
5188106|NCT00872066|Hip|hip
5188107|NCT00872066|Bone Cement|bone cement
5188108|NCT00872053|robot|robot
5188109|NCT00872053|treadmill|treadmill
5188110|NCT00872053|foot drop|foot drop
5188111|NCT00872053|rehabilitation|rehabilitation
5188112|NCT00872053|gait|gait
5188113|NCT00872040|Sexual function|sexual function
5188114|NCT00872040|Pelvic floor disorders|pelvic floor disorders
5188115|NCT00872040|Delivery mode|delivery mode
5188116|NCT00872027|Critical Illness|critical illness
5188117|NCT00872027|Intensive Care Unit|intensive care unit
5188118|NCT00872027|Acute Respiratory Failure|acute respiratory failure
5188119|NCT00872027|Prolonged Mechanical Ventilation|prolonged mechanical ventilation
5188120|NCT00871975|LUTS|luts
5188121|NCT00871975|OAB|oab
5188122|NCT00871962|long-term oxygen therapy|long-term oxygen therapy
5188123|NCT00871962|COPD patients on necessity of long-term oxygen therapy|copd patients on necessity of long-term oxygen therapy
5188124|NCT00871949|Safety tolerability pharmacokinetics PK first in human FIH|safety tolerability pharmacokinetics pk first in human fih
5188125|NCT00871923|Non-small cell lung cancer|non-small cell lung cancer
5188126|NCT00871923|NSCLC|nsclc
5188127|NCT00871923|Brain Metastases|brain metastases
5188128|NCT00871923|Brain Cancer|brain cancer
5188129|NCT00871923|Lung Cancer|lung cancer
5188130|NCT00871923|Tarceva|tarceva
5188131|NCT00871923|Erlotinib Hydrochloride|erlotinib hydrochloride
5188132|NCT00871923|OSI-774|osi-774
5188133|NCT00871923|Radiation Therapy|radiation therapy
5188134|NCT00871923|Whole Brain Radiation Therapy|whole brain radiation therapy
5188135|NCT00871923|WBRT|wbrt
5188136|NCT00871897|Neuropsychology|neuropsychology
5188137|NCT00871897|Cardiac Rehabilitation|cardiac rehabilitation
5188138|NCT00871884|Post Concussion Syndrome|post concussion syndrome
5188139|NCT00871884|Cognitive Behavioral Therapy|cognitive behavioral therapy
5188140|NCT00871884|Anxiety Sensitivity|anxiety sensitivity
5188141|NCT00871884|Mild Head Injury|mild head injury
5188142|NCT00871884|Psychotherapy|psychotherapy
5188143|NCT00871884|Chronic Post Concussion Symptoms|chronic post concussion symptoms
5188144|NCT00871858|stage II breast cancer|stage ii breast cancer
5188145|NCT00871858|stage IIIA breast cancer|stage iiia breast cancer
5188146|NCT00871858|stage IIIB breast cancer|stage iiib breast cancer
5188147|NCT00871858|estrogen receptor-positive breast cancer|estrogen receptor-positive breast cancer
5188148|NCT00871858|progesterone receptor-positive breast cancer|progesterone receptor-positive breast cancer
5188149|NCT00871845|obesity|obesity
5188150|NCT00871845|hepatitis C|hepatitis c
5188151|NCT00871845|insulin resistance|insulin resistance
5188152|NCT00871845|metabolic syndrome|metabolic syndrome
5188153|NCT00871832|hyperglycemia|hyperglycemia
5188154|NCT00871832|HgA1c|hga1c
5188155|NCT00871832|mortality|mortality
5188156|NCT00871819|Spinal Cord Stimulation|spinal cord stimulation
5188157|NCT00871806|Pharmacokinetics|pharmacokinetics
5188158|NCT00871806|eletriptan|eletriptan
5188159|NCT00871806|bioavailability|bioavailability
5188160|NCT00871806|oral disintegrating tablet|oral disintegrating tablet
5188161|NCT00871780|TYSABRI naive|tysabri naive
5188162|NCT00871780|Relapsing-remitting multiple sclerosis (RRMS)|relapsing-remitting multiple sclerosis (rrms)
5188163|NCT00871767|AZD5672|azd5672
5188164|NCT00871767|relative bioavailability|relative bioavailability
5188165|NCT00871767|rheumatoid arthritis (RA)|rheumatoid arthritis (ra)
5188166|NCT00871754|Bladder Cancer|bladder cancer
5188167|NCT00871754|Cancer, bladder|cancer, bladder
5188168|NCT00871754|Urinary Bladder Cancer|urinary bladder cancer
5188169|NCT00871741|Combined vaccine|combined vaccine
5188170|NCT00871741|Primary vaccination|primary vaccination
5188171|NCT00871728|Onychomycosis, Toe|onychomycosis, toe
5188172|NCT00871728|Itraconazole|itraconazole
5188173|NCT00871728|Sporanox|sporanox
5188174|NCT00871715|stroke|stroke
5188175|NCT00871715|hemiparesis|hemiparesis
5188176|NCT00871715|physical therapy|physical therapy
5188177|NCT00871715|occupational therapy|occupational therapy
5188178|NCT00871715|neurorehabilitation|neurorehabilitation
5188179|NCT00871715|patient focused|patient focused
5188180|NCT00871715|motor learning|motor learning
5188181|NCT00871715|motor control|motor control
5188182|NCT00871715|skill acquisition|skill acquisition
5188183|NCT00871715|skill training|skill training
5188184|NCT00871715|motor recovery|motor recovery
5188185|NCT00871715|task oriented training|task oriented training
5188186|NCT00871715|task specific training|task specific training
5188187|NCT00871715|arm function|arm function
5188188|NCT00871715|hand function|hand function
5188189|NCT00871715|upper extremity|upper extremity
5188190|NCT00871715|arm therapy|arm therapy
5188191|NCT00871715|physical rehabilitation|physical rehabilitation
5188192|NCT00871715|arm rehabilitation|arm rehabilitation
5188193|NCT00871715|motor function|motor function
5188194|NCT00871702|Leukemia|leukemia
5188195|NCT00871702|Lymphoma, Non-Hodgkin|lymphoma, non-hodgkin
5188196|NCT00871702|Hodgkin Disease|hodgkin disease
5188197|NCT00871702|Myelodysplastic Syndromes|myelodysplastic syndromes
5188198|NCT00871702|Multiple Myeloma|multiple myeloma
5188199|NCT00871689|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5188200|NCT00871689|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5188201|NCT00871689|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5188202|NCT00871689|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5188203|NCT00871689|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5188204|NCT00871689|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5188205|NCT00871689|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5188206|NCT00871689|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5188207|NCT00871689|childhood acute myeloid leukemia with 11q23 (MLL) abnormalities|childhood acute myeloid leukemia with 11q23 (mll) abnormalities
5188208|NCT00871689|childhood acute myeloid leukemia with inv(16)(p13;q22)|childhood acute myeloid leukemia with inv(16)(p13;q22)
5188209|NCT00871689|childhood acute myeloid leukemia with t(15;17)(q22;q12)|childhood acute myeloid leukemia with t(15;17)(q22;q12)
5188210|NCT00871689|childhood acute myeloid leukemia with t(16;16)(p13;q22)|childhood acute myeloid leukemia with t(16;16)(p13;q22)
5188211|NCT00871689|childhood acute myeloid leukemia with t(8;21)(q22;q22)|childhood acute myeloid leukemia with t(8;21)(q22;q22)
5188212|NCT00871650|Post Traumatic Stress Disorder|post traumatic stress disorder
5188213|NCT00871650|PTSD|ptsd
5188214|NCT00871650|Brain|brain
5188215|NCT00871650|Imaging|imaging
5188216|NCT00871650|PET|pet
5188217|NCT00871650|Neural|neural
5188218|NCT00871650|Sleep|sleep
5188219|NCT00871650|REM Sleep|rem sleep
5188220|NCT00871637|Pulmonary disease, chronic obstructive|pulmonary disease, chronic obstructive
5188221|NCT00871637|Airway macrophages|airway macrophages
5188222|NCT00871637|Sputum milieu|sputum milieu
5188223|NCT00871637|Airway inflammation|airway inflammation
5188224|NCT00871637|Occupational diseases|occupational diseases
5188225|NCT00871611|Hereditary|hereditary
5188226|NCT00871611|Anderson-Fabry|anderson-fabry
5188227|NCT00871611|prevalence|prevalence
5188228|NCT00871611|heart|heart
5188229|NCT00871611|hypertrophy|hypertrophy
5188230|NCT00871611|urine|urine
5188231|NCT00871611|globotriaosylceramide|globotriaosylceramide
5188232|NCT00871611|isoforms|isoforms
5188233|NCT00871611|α - Galactosidase|α - galactosidase
5188234|NCT00871598|plaque psoriasis|plaque psoriasis
5188235|NCT00871598|BTT1023|btt1023
5188236|NCT00871598|safety|safety
5188237|NCT00871598|pharmacokinetics|pharmacokinetics
5188238|NCT00871585|bicalutamide|bicalutamide
5188239|NCT00871585|PSA|psa
5188240|NCT00871585|advanced prostate cancer|advanced prostate cancer
5188241|NCT00871572|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
5188242|NCT00871533|Biochemical Marker|biochemical marker
5188243|NCT00871533|Biochemical Markers|biochemical markers
5188244|NCT00871533|Biologic Marker|biologic marker
5188245|NCT00871533|Biologic Markers|biologic markers
5188246|NCT00871533|Biomarkers|biomarkers
5188247|NCT00871533|Clinical Marker|clinical marker
5188248|NCT00871533|Clinical Markers|clinical markers
5188249|NCT00871533|Immune Marker|immune marker
5188250|NCT00871533|Immune Markers|immune markers
5188251|NCT00871533|Immunologic Marker|immunologic marker
5188252|NCT00871533|Immunologic Markers|immunologic markers
5188253|NCT00871533|Laboratory Marker|laboratory marker
5188254|NCT00871533|Laboratory Markers|laboratory markers
5188255|NCT00871533|Marker, Biochemical|marker, biochemical
5188256|NCT00871533|Marker, Biological|marker, biological
5188257|NCT00871533|Marker, Clinical|marker, clinical
5188258|NCT00871533|Marker, Immunologic|marker, immunologic
5188259|NCT00871533|Marker, Laboratory|marker, laboratory
5188260|NCT00871533|Marker, Serum|marker, serum
5188261|NCT00871533|Marker, Surrogate|marker, surrogate
5188262|NCT00871533|Markers, Biochemical|markers, biochemical
5188263|NCT00871533|Markers, Biological|markers, biological
5188264|NCT00871533|Markers, Clinical|markers, clinical
5188265|NCT00871533|Markers, Immunologic|markers, immunologic
5188266|NCT00871533|Markers, Laboratory|markers, laboratory
5188267|NCT00871533|Markers, Serum|markers, serum
5188268|NCT00871533|Markers, Surrogate|markers, surrogate
5188269|NCT00871533|Markers, Viral|markers, viral
5188270|NCT00871533|Serum Marker|serum marker
5188271|NCT00871533|Serum Markers|serum markers
5188272|NCT00871533|Surrogate End Point|surrogate end point
5188273|NCT00871533|Surrogate End Points|surrogate end points
5188274|NCT00871533|Surrogate Endpoint|surrogate endpoint
5188275|NCT00871533|Surrogate Endpoints|surrogate endpoints
5188276|NCT00871533|Surrogate Marker|surrogate marker
5188277|NCT00871533|Surrogate Markers|surrogate markers
5188278|NCT00871533|Viral Marker|viral marker
5188279|NCT00871533|Viral Markers|viral markers
5188280|NCT00871520|Palliative Care|palliative care
5188281|NCT00871520|Predictive Value of Tests|predictive value of tests
5188282|NCT00871520|Prospective Studies|prospective studies
5188283|NCT00871520|Survival Analysis|survival analysis
5188284|NCT00871520|Survival prediction|survival prediction
5188285|NCT00871507|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
5188286|NCT00871455|Spinal Cord Injury|spinal cord injury
5188287|NCT00871455|Baclofen|baclofen
5188288|NCT00871455|Growth Hormone, Pituitary|growth hormone, pituitary
5188289|NCT00871455|Insulin-Like Growth Factor I|insulin-like growth factor i
5188290|NCT00871442|PCEA|pcea
5188291|NCT00871442|labor and delivery|labor and delivery
5188292|NCT00871442|pain|pain
5188293|NCT00871442|epidural|epidural
5188294|NCT00871442|anesthesia|anesthesia
5188295|NCT00871442|pregnant women|pregnant women
5188296|NCT00871429|skin toxicity|skin toxicity
5188297|NCT00871429|cancer patients|cancer patients
5188298|NCT00871429|adverse effects|adverse effects
5188299|NCT00871403|GW786034|gw786034
5188300|NCT00871403|pazopanib|pazopanib
5188301|NCT00871403|pemetrexed|pemetrexed
5188302|NCT00871403|cisplatin|cisplatin
5188303|NCT00871403|non-small cell lung cancer|non-small cell lung cancer
5188304|NCT00871403|NSCLC|nsclc
5188305|NCT00871390|Paroxysmal Atrial Fibrillation|paroxysmal atrial fibrillation
5188306|NCT00871390|Permanent/Persistent Atrial Fibrillation|permanent/persistent atrial fibrillation
5188307|NCT00871377|epilepsy|epilepsy
5188308|NCT00871377|cardiac risk factors|cardiac risk factors
5188309|NCT00871377|memory|memory
5188310|NCT00871377|cognition|cognition
5188311|NCT00871377|n-3 fatty acids|n-3 fatty acids
5188312|NCT00871377|fish oil|fish oil
5188313|NCT00871377|EPA|epa
5188314|NCT00871377|DHA|dha
5188315|NCT00871377|seizures|seizures
5188316|NCT00871364|Bioequivalence|bioequivalence
5188317|NCT00871364|venlafaxine|venlafaxine
5188318|NCT00871364|Healthy subjects|healthy subjects
5188319|NCT00871338|combined|combined
5188320|NCT00871338|Vaccines|vaccines
5188321|NCT00871325|Gastric emptying|gastric emptying
5188322|NCT00871325|Small bowel transit|small bowel transit
5188323|NCT00871325|Colonic transit|colonic transit
5188324|NCT00871325|Whole gut transit|whole gut transit
5188325|NCT00871325|Postoperative Ileus|postoperative ileus
5188326|NCT00871312|diabetes|diabetes
5188327|NCT00871312|diabetic|diabetic
5188328|NCT00871312|wound|wound
5188329|NCT00871312|ulcer|ulcer
5188330|NCT00871312|lower extremity|lower extremity
5188331|NCT00871312|foot|foot
5188332|NCT00871312|oxygen|oxygen
5188333|NCT00871312|hyperbaric|hyperbaric
5188334|NCT00871312|topical wound oxygen|topical wound oxygen
5188335|NCT00871299|Treatment-resistant depression, meditation, mindfulness|treatment-resistant depression, meditation, mindfulness
5188336|NCT00871286|Chronic rhinosinusitis|chronic rhinosinusitis
5188337|NCT00871286|Chronic sinusitis|chronic sinusitis
5188338|NCT00871286|CRS|crs
5188339|NCT00871273|capecitabine|capecitabine
5188340|NCT00871273|total gastrectomy|total gastrectomy
5188341|NCT00871273|pharmacokinetic|pharmacokinetic
5188342|NCT00871260|Coronary Disease|coronary disease
5188343|NCT00871260|Stress Testing|stress testing
5188344|NCT00871260|Lexiscan (regadenoson)|lexiscan (regadenoson)
5188345|NCT00871260|Cardiac Magnetic Resonance Imaging|cardiac magnetic resonance imaging
5188346|NCT00871247|Bioequivalence|bioequivalence
5188347|NCT00871247|finasteride|finasteride
5188348|NCT00871247|Healthy subjects|healthy subjects
5188349|NCT00871234|HIV|hiv
5188350|NCT00871234|Endothelial function|endothelial function
5188351|NCT00871234|Etravirine|etravirine
5188352|NCT00871208|Atopic Dermatitis|atopic dermatitis
5188353|NCT00871208|pruritus|pruritus
5188354|NCT00871208|quality of life|quality of life
5188355|NCT00871195|Rhesus D|rhesus d
5188356|NCT00871195|RHD|rhd
5188357|NCT00871195|genotype|genotype
5188358|NCT00871195|phenotype|phenotype
5188359|NCT00871195|neonatal|neonatal
5188360|NCT00871195|noninvasive|noninvasive
5188361|NCT00871195|fetal|fetal
5188362|NCT00871195|MassARRAY|massarray
5188363|NCT00871195|DNA|dna
5188364|NCT00871182|COPD|copd
5188365|NCT00871182|obstructive lung diseases|obstructive lung diseases
5188366|NCT00871182|Tiotropium|tiotropium
5188367|NCT00871169|Irinotecan|irinotecan
5188368|NCT00871169|Oxaliplatin|oxaliplatin
5188369|NCT00871169|Cetuximab|cetuximab
5188370|NCT00871169|Advanced or metastatic pancreatic cancer|advanced or metastatic pancreatic cancer
5188371|NCT00871156|Drug-Drug Interaction|drug-drug interaction
5188372|NCT00871143|CBT|cbt
5188373|NCT00871143|BDD|bdd
5188374|NCT00871130|Thyroid gland|thyroid gland
5188375|NCT00871130|bariatric surgery|bariatric surgery
5188376|NCT00871130|weight loss|weight loss
5188377|NCT00871130|thyroid hormones|thyroid hormones
5188378|NCT00871130|adult|adult
5188379|NCT00871130|morbid obesity|morbid obesity
5188380|NCT00871130|cohort|cohort
5188381|NCT00871117|Co-administration|co-administration
5188382|NCT00871117|Immunization|immunization
5188383|NCT00871117|Preschool|preschool
5188384|NCT00871117|Booster|booster
5188385|NCT00871104|Infective endocarditis|infective endocarditis
5188386|NCT00871091|CAD/CAM|cad/cam
5188387|NCT00871091|orthodontics|orthodontics
5188388|NCT00871091|fixed appliance|fixed appliance
5188389|NCT00871091|tooth movement|tooth movement
5188390|NCT00871065|Cerebral Vasospasm|cerebral vasospasm
5188391|NCT00871065|Vasospasm|vasospasm
5188392|NCT00871065|Subarachnoid Hemorrhage|subarachnoid hemorrhage
5188393|NCT00871065|Sildenafil citrate|sildenafil citrate
5188394|NCT00871065|Aneurysm|aneurysm
5188395|NCT00871065|Intracranial aneurysm|intracranial aneurysm
5188396|NCT00871052|Polymorphic light eruption|polymorphic light eruption
5188397|NCT00871052|UV radiation|uv radiation
5188398|NCT00871052|Vitamin D|vitamin d
5188399|NCT00871052|Immune suppression|immune suppression
5188400|NCT00871052|Prevention|prevention
5188401|NCT00871039|Alcoholism|alcoholism
5188402|NCT00871039|Mechanical ventilation|mechanical ventilation
5188403|NCT00871026|CAD/CAM|cad/cam
5188404|NCT00871026|orthodontics|orthodontics
5188405|NCT00871026|fixed appliance|fixed appliance
5188406|NCT00871026|tooth movement|tooth movement
5188407|NCT00871026|Adverse Effects|adverse effects
5188408|NCT00871026|Time Factors|time factors
5188409|NCT00871026|Treatment Outcome|treatment outcome
5188410|NCT00871013|This study is being done in an attempt to improve the remission rate and the survival time for participants with high-risk myeloma|this study is being done in an attempt to improve the remission rate and the survival time for participants with high-risk myeloma
5188411|NCT00871000|Boostrix Polio|boostrix polio
5188412|NCT00871000|dTpa-IPV|dtpa-ipv
5188413|NCT00870987|Malaria|malaria
5188414|NCT00870987|Vaccine|vaccine
5188415|NCT00870974|Parkinson|parkinson
5188416|NCT00870974|Huntington's|huntington's
5188417|NCT00870974|Fragile X|fragile x
5188418|NCT00870974|Autistic Spectrum|autistic spectrum
5188419|NCT00870974|Alzheimer's|alzheimer's
5188420|NCT00870974|MCI|mci
5188421|NCT00870961|colon cancer|colon cancer
5188422|NCT00870961|rectal cancer|rectal cancer
5188423|NCT00870961|adenomatous polyp|adenomatous polyp
5188424|NCT00870948|Open Label|open label
5188425|NCT00870948|Healthy Volunteers|healthy volunteers
5188426|NCT00870935|Balloon catheter|balloon catheter
5188427|NCT00870935|Cervical vacuum cup|cervical vacuum cup
5188428|NCT00870935|Hysterosalpingography|hysterosalpingography
5188429|NCT00870935|Infertility|infertility
5188430|NCT00870935|Pain|pain
5188431|NCT00870935|Fallopian Tube Patency Tests|fallopian tube patency tests
5188432|NCT00870935|Female Infertility|female infertility
5188433|NCT00870896|capsaicin|capsaicin
5188434|NCT00870896|COPD|copd
5188435|NCT00870896|COPD with chronic bronchitis|copd with chronic bronchitis
5188436|NCT00870870|Tumors|tumors
5188437|NCT00870870|Antibodies, Monoclonal|antibodies, monoclonal
5188438|NCT00870870|Stage IIIb Metastatic Non-Small Cell Lung Cancer|stage iiib metastatic non-small cell lung cancer
5188439|NCT00870870|Stage IV Metastatic Non-Small Cell Lung Cancer|stage iv metastatic non-small cell lung cancer
5188440|NCT00870857|Lungs|lungs
5188441|NCT00870857|antiretrovirals|antiretrovirals
5188442|NCT00870857|HIV|hiv
5188443|NCT00870857|COPD|copd
5188444|NCT00870844|Acute ischemic stroke|acute ischemic stroke
5188445|NCT00870844|Erythropoietin|erythropoietin
5188446|NCT00870844|Carbamylated|carbamylated
5188447|NCT00870844|Neuroprotection|neuroprotection
5188448|NCT00870831|diabetes|diabetes
5188449|NCT00870818|Teplizumab|teplizumab
5188450|NCT00870818|Protege|protege
5188451|NCT00870818|MGA031|mga031
5188452|NCT00870818|Monoclonal antibody|monoclonal antibody
5188453|NCT00870818|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
5188454|NCT00870818|T1DM|t1dm
5188455|NCT00870818|MacroGenics|macrogenics
5188456|NCT00870792|HIV|hiv
5188457|NCT00870792|antiretroviral therapy|antiretroviral therapy
5188458|NCT00870792|medication adherence|medication adherence
5188459|NCT00870792|Treatment Experienced|treatment experienced
5188460|NCT00870779|Fluorescence|fluorescence
5188461|NCT00870779|Brain Tumor|brain tumor
5188462|NCT00870779|Malignant Glioma|malignant glioma
5188463|NCT00870779|Pituitary Tumor|pituitary tumor
5188464|NCT00870779|Skull Base Tumor|skull base tumor
5188465|NCT00870779|Brain Lesions|brain lesions
5188466|NCT00870779|Brain Metastases|brain metastases
5188467|NCT00870779|Meningioma|meningioma
5188468|NCT00870753|Eating disorders|eating disorders
5188469|NCT00870753|yoga|yoga
5188470|NCT00870753|body awareness|body awareness
5188471|NCT00870753|depression|depression
5188472|NCT00870753|anxiety|anxiety
5188473|NCT00870740|MS|ms
5188474|NCT00870740|Multiple Sclerosis|multiple sclerosis
5188475|NCT00870727|PDD NOS|pdd nos
5188476|NCT00870714|Prostate Cancer|prostate cancer
5188477|NCT00870714|Neoadjuvant|neoadjuvant
5188478|NCT00870701|sarcoma|sarcoma
5188479|NCT00870701|soft tissue|soft tissue
5188480|NCT00870701|members|members
5188481|NCT00870701|radiotherapy|radiotherapy
5188482|NCT00870701|absence of radiotherapy|absence of radiotherapy
5188483|NCT00870688|valproate|valproate
5188484|NCT00870688|epilepsy|epilepsy
5188485|NCT00870688|compliance|compliance
5188486|NCT00870688|sustained released minitablet|sustained released minitablet
5188487|NCT00870688|Orfiril long|orfiril long
5188488|NCT00870675|Ventriculomegaly|ventriculomegaly
5188489|NCT00870675|ultrasound|ultrasound
5188490|NCT00870675|MRI|mri
5188491|NCT00870675|fetus|fetus
5188492|NCT00870649|Schistosomiasis vaccine|schistosomiasis vaccine
5188493|NCT00870649|therapeutic vaccine|therapeutic vaccine
5188494|NCT00870649|Bilhvax|bilhvax
5188495|NCT00870636|Pan-Vascular Endothelial Growth Factor Blockade|pan-vascular endothelial growth factor blockade
5188496|NCT00870636|Safety|safety
5188497|NCT00870636|ROP|rop
5188498|NCT00870636|Bevacizumab|bevacizumab
5188499|NCT00870636|Avastin|avastin
5188500|NCT00870610|jugular venous oxygen saturation|jugular venous oxygen saturation
5188501|NCT00870610|hypothermia|hypothermia
5188502|NCT00870597|Floaters|floaters
5188503|NCT00870597|multifocal IOL|multifocal iol
5188504|NCT00870597|visual complaints|visual complaints
5188505|NCT00870597|vitrectomy|vitrectomy
5188506|NCT00870584|Asthma; asthma management; asthma impairment ; Xolair ; omalizumab|asthma; asthma management; asthma impairment ; xolair ; omalizumab
5188507|NCT00870571|Bioequivalence|bioequivalence
5188508|NCT00870571|amlodipine besylate|amlodipine besylate
5188509|NCT00870571|amlodipine|amlodipine
5188510|NCT00870571|Healthy subjects|healthy subjects
5188511|NCT00870558|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
5188512|NCT00870558|advanced adult primary liver cancer|advanced adult primary liver cancer
5188513|NCT00870558|localized resectable adult primary liver cancer|localized resectable adult primary liver cancer
5188514|NCT00870558|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
5188515|NCT00870545|spouses|spouses
5188516|NCT00870545|social support|social support
5188517|NCT00870545|reintegration|reintegration
5188518|NCT00870545|families|families
5188519|NCT00870545|military|military
5188520|NCT00870545|post deployment|post deployment
5188521|NCT00870545|OEF/OIF|oef/oif
5188522|NCT00870532|Phase I|phase i
5188523|NCT00870532|Combination|combination
5188524|NCT00870532|Anti-angiogenic|anti-angiogenic
5188525|NCT00870532|Sorafenib|sorafenib
5188526|NCT00870532|Metronomic oral vinorelbine|metronomic oral vinorelbine
5188527|NCT00870519|Alzheimer disease|alzheimer disease
5188528|NCT00870506|Randomized Controlled Trial|randomized controlled trial
5188529|NCT00870506|Healthcare Disparities|healthcare disparities
5188530|NCT00870493|proteinuria|proteinuria
5188531|NCT00870493|renal failure|renal failure
5188532|NCT00870493|glomerulonephritis|glomerulonephritis
5188533|NCT00870480|Bioequivalence|bioequivalence
5188534|NCT00870480|finasteride|finasteride
5188535|NCT00870480|Healthy subjects|healthy subjects
5188536|NCT00870467|Rheumatoid Arthritis|rheumatoid arthritis
5188537|NCT00870454|Diabetic neuropathies|diabetic neuropathies
5188538|NCT00870454|Diabetic neuropathy, painful|diabetic neuropathy, painful
5188539|NCT00870454|Carisbamate|carisbamate
5188540|NCT00870454|Neurotherapeutic agents|neurotherapeutic agents
5188541|NCT00870441|ASP2151|asp2151
5188542|NCT00870441|Valacyclovir|valacyclovir
5188543|NCT00870441|Healthy Volunteers|healthy volunteers
5188544|NCT00870428|Preeclampsia|preeclampsia
5188545|NCT00870428|proteinuria|proteinuria
5188546|NCT00870415|stage IA breast cancer|stage ia breast cancer
5188547|NCT00870415|stage IB breast cancer|stage ib breast cancer
5188548|NCT00870415|stage II breast cancer|stage ii breast cancer
5188549|NCT00870415|stage IIIA breast cancer|stage iiia breast cancer
5188550|NCT00870415|stage IIIC breast cancer|stage iiic breast cancer
5188551|NCT00870415|ductal breast carcinoma|ductal breast carcinoma
5188552|NCT00870415|invasive ductal breast carcinoma|invasive ductal breast carcinoma
5188553|NCT00870402|aldosterone|aldosterone
5188554|NCT00870402|albuminuria|albuminuria
5188555|NCT00870402|diastolic disfunction|diastolic disfunction
5188556|NCT00870402|hyperkalemia|hyperkalemia
5188557|NCT00870376|lower urinary tract symptoms|lower urinary tract symptoms
5188558|NCT00870376|biomarkers|biomarkers
5188559|NCT00870376|urodynamic studies|urodynamic studies
5188560|NCT00870363|HIV|hiv
5188561|NCT00870363|HIV positive|hiv positive
5188562|NCT00870363|Gastrointestinal Associated Lymphoid Tissue (GALT)|gastrointestinal associated lymphoid tissue (galt)
5188563|NCT00870363|GALT Immune Reconstruction|galt immune reconstruction
5188564|NCT00870363|treatment naive|treatment naive
5188565|NCT00870350|immunogenicity|immunogenicity
5188566|NCT00870350|safety|safety
5188567|NCT00870350|tetanus|tetanus
5188568|NCT00870350|diphtheria|diphtheria
5188569|NCT00870350|acellular|acellular
5188570|NCT00870350|pertussis|pertussis
5188571|NCT00870350|vaccine|vaccine
5188572|NCT00870350|booster|booster
5188573|NCT00870350|adverse event|adverse event
5188574|NCT00870350|adverse reaction|adverse reaction
5188575|NCT00870350|DT1aP|dt1ap
5188576|NCT00870350|DT5ap|dt5ap
5188577|NCT00870350|FHA|fha
5188578|NCT00870350|fimbriae|fimbriae
5188579|NCT00870350|pertactin|pertactin
5188580|NCT00870350|SMI|smi
5188581|NCT00870350|Smittskyddsinstitutet|smittskyddsinstitutet
5188582|NCT00870350|Immune response and safety profile to a Tdap booster|immune response and safety profile to a tdap booster
5188583|NCT00870337|recurrent endometrial carcinoma|recurrent endometrial carcinoma
5188584|NCT00870337|stage IV endometrial carcinoma|stage iv endometrial carcinoma
5188585|NCT00870337|endometrial adenocarcinoma|endometrial adenocarcinoma
5188586|NCT00870324|ICD|icd
5188587|NCT00870324|Tachyarrhythmias|tachyarrhythmias
5188588|NCT00870324|Atrial Fibrillation|atrial fibrillation
5188589|NCT00870324|Patients who meets current ICD or CRT-D implant indications|patients who meets current icd or crt-d implant indications
5188590|NCT00870311|Lithium|lithium
5188591|NCT00870311|Neuroprotection|neuroprotection
5188592|NCT00870311|Neurotrophic|neurotrophic
5188593|NCT00870311|bcl2|bcl2
5188594|NCT00870311|gsk3|gsk3
5188595|NCT00870311|pkc|pkc
5188596|NCT00870311|MRI|mri
5188597|NCT00870311|myoinositol|myoinositol
5188598|NCT00870311|MRS|mrs
5188599|NCT00870311|Alzheimers Disease|alzheimers disease
5188600|NCT00870298|drug orders|drug orders
5188601|NCT00870285|Psoriasis|psoriasis
5188602|NCT00870285|Biologic|biologic
5188603|NCT00870285|Ustekinumab|ustekinumab
5188604|NCT00870285|UVB-311nm narrowband|uvb-311nm narrowband
5188605|NCT00870285|phototherapy|phototherapy
5188606|NCT00870285|half-side comparison|half-side comparison
5188607|NCT00870272|Medical Abortion|medical abortion
5188608|NCT00870272|Mifepristone|mifepristone
5188609|NCT00870272|Misoprostol|misoprostol
5188610|NCT00870272|Sublingual administration|sublingual administration
5188611|NCT00870272|Buccal administration|buccal administration
5188612|NCT00870259|Weight loss|weight loss
5188613|NCT00870259|Weight maintenance|weight maintenance
5188614|NCT00870246|COPD|copd
5188615|NCT00870246|pulmonary emphysema|pulmonary emphysema
5188616|NCT00870233|Gynecologic cancers|gynecologic cancers
5188617|NCT00870233|Quality of Life|quality of life
5188618|NCT00870233|08-155|08-155
5188619|NCT00870233|Surgery|surgery
5188620|NCT00870220|Turner's Syndrome|turner's syndrome
5188621|NCT00870207|Feasibility of implementing TSSC in worksite environment|feasibility of implementing tssc in worksite environment
5188622|NCT00870194|diabetes|diabetes
5188623|NCT00870194|exenatide|exenatide
5188624|NCT00870194|Byetta|byetta
5188625|NCT00870194|sitagliptin|sitagliptin
5188626|NCT00870194|Januvia|januvia
5188627|NCT00870194|Amylin|amylin
5188628|NCT00870194|Lilly|lilly
5188629|NCT00870168|stage IV breast cancer|stage iv breast cancer
5188630|NCT00870168|estrogen receptor-negative breast cancer|estrogen receptor-negative breast cancer
5188631|NCT00870168|progesterone receptor-negative breast cancer|progesterone receptor-negative breast cancer
5188632|NCT00870142|Bioequivalence|bioequivalence
5188633|NCT00870142|amlodipine besylate|amlodipine besylate
5188634|NCT00870142|amlodipine|amlodipine
5188635|NCT00870142|Healthy subjects|healthy subjects
5188636|NCT00870129|brain tumor|brain tumor
5188637|NCT00870129|radiation|radiation
5188638|NCT00870129|MRI|mri
5188639|NCT00870129|09-009|09-009
5188640|NCT00870116|SBRT|sbrt
5188641|NCT00870116|non-operated|non-operated
5188642|NCT00870116|non-metastatic|non-metastatic
5188643|NCT00870116|non-small-cell lung cancer|non-small-cell lung cancer
5188644|NCT00870116|conformational radiotherapy|conformational radiotherapy
5188645|NCT00870116|non-operated non-metastatic non-small-cell lung cancer|non-operated non-metastatic non-small-cell lung cancer
5188646|NCT00870103|Cataract|cataract
5188647|NCT00870077|Intrahepatic fat|intrahepatic fat
5188648|NCT00870077|obesity|obesity
5188649|NCT00870077|body fat|body fat
5188650|NCT00870077|impaired glucose tolerance|impaired glucose tolerance
5188651|NCT00870064|Surgical Procedures, Operative|surgical procedures, operative
5188652|NCT00870064|Fractures, Open|fractures, open
5188653|NCT00870064|Fracture Fixation|fracture fixation
5188654|NCT00870051|Endurant|endurant
5188655|NCT00870051|Stent Graft|stent graft
5188656|NCT00870051|Abdominal Aortic Aneurysm|abdominal aortic aneurysm
5188657|NCT00870038|PCI|pci
5188658|NCT00870038|stent|stent
5188659|NCT00870038|drug eluting stent|drug eluting stent
5188660|NCT00870038|reendothelialization|reendothelialization
5188661|NCT00870038|restenosis|restenosis
5188662|NCT00870038|Percutaneous Coronary Angioplasty|percutaneous coronary angioplasty
5188663|NCT00870025|androgens|androgens
5188664|NCT00870025|hCG|hcg
5188665|NCT00870025|low response|low response
5188666|NCT00870025|IVF|ivf
5188667|NCT00870025|Ovarian response in women with previous low response|ovarian response in women with previous low response
5188668|NCT00869999|rituximab|rituximab
5188669|NCT00869999|everolimus|everolimus
5188670|NCT00869999|DLBCL|dlbcl
5188671|NCT00869999|mTOR|mtor
5188672|NCT00869973|aprepitant|aprepitant
5188673|NCT00869973|delayed emesis|delayed emesis
5188674|NCT00869973|cyclophosphamide plus anthracyclines|cyclophosphamide plus anthracyclines
5188675|NCT00869973|breast cancer|breast cancer
5188676|NCT00869973|antiemetic|antiemetic
5188677|NCT00869960|Healthy Volunteers|healthy volunteers
5188678|NCT00869947|Unilateral below the knee amputation|unilateral below the knee amputation
5188679|NCT00869934|Insomnia|insomnia
5188680|NCT00869934|Sleep disorders|sleep disorders
5188681|NCT00869934|Treatment|treatment
5188682|NCT00869934|Sleep disturbances|sleep disturbances
5188683|NCT00869895|Advanced solid tumors|advanced solid tumors
5188684|NCT00869882|Spondylolisthesis|spondylolisthesis
5188685|NCT00869882|degeneration|degeneration
5188686|NCT00869882|spinal fusion|spinal fusion
5188687|NCT00869869|Heart Failure|heart failure
5188688|NCT00869869|Sleep Disorders|sleep disorders
5188689|NCT00869869|Melatonin|melatonin
5188690|NCT00869869|Antioxidants|antioxidants
5188691|NCT00869869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
5188692|NCT00869869|Nervous System Diseases|nervous system diseases
5188693|NCT00869869|Physiological Effects of Drugs|physiological effects of drugs
5188694|NCT00869869|Vascular Diseases|vascular diseases
5188695|NCT00869869|Central Nervous System Depressants|central nervous system depressants
5188696|NCT00869869|Protective Agents|protective agents
5188697|NCT00869869|Pharmacologic Actions|pharmacologic actions
5188698|NCT00869869|Signs and Symptoms|signs and symptoms
5188699|NCT00869869|Mental Disorders|mental disorders
5188700|NCT00869869|Therapeutic Uses|therapeutic uses
5188701|NCT00869869|Neurologic Manifestations|neurologic manifestations
5188702|NCT00869869|Cardiovascular Diseases|cardiovascular diseases
5188703|NCT00869869|Central Nervous System Agents|central nervous system agents
5188704|NCT00869856|Treatment associated with CRI|treatment associated with cri
5188705|NCT00869843|Metastatic colorectal cancer|metastatic colorectal cancer
5188706|NCT00869830|Biofeedback|biofeedback
5188707|NCT00869830|constipation|constipation
5188708|NCT00869830|Parkinson's disease|parkinson's disease
5188709|NCT00869817|Alzheimer's disease|alzheimer's disease
5188710|NCT00869817|antecedent biomarkers|antecedent biomarkers
5188711|NCT00869817|Amyloid Precursor Protein (APP) mutation|amyloid precursor protein (app) mutation
5188712|NCT00869817|presenilin I (PS1) mutation|presenilin i (ps1) mutation
5188713|NCT00869817|presenilin 2 (PS2) mutation|presenilin 2 (ps2) mutation
5188714|NCT00869817|Autosomal Dominant Alzheimer's Disease|autosomal dominant alzheimer's disease
5188715|NCT00869804|breast cancer|breast cancer
5188716|NCT00869804|chemotherapy-induced peripheral neuropathy|chemotherapy-induced peripheral neuropathy
5188717|NCT00869804|exercise|exercise
5188718|NCT00869791|Parkinson's|parkinson's
5188719|NCT00869778|Chronic Hepatitis B|chronic hepatitis b
5188720|NCT00869778|HBeAg positive|hbeag positive
5188721|NCT00869778|Therapeutic HBV Vaccine|therapeutic hbv vaccine
5188722|NCT00869778|HBV-specific Cytotoxic T Lymphocyte|hbv-specific cytotoxic t lymphocyte
5188723|NCT00869765|Depression|depression
5188724|NCT00869765|Treatment|treatment
5188725|NCT00869765|Transcranial direct current stimulation|transcranial direct current stimulation
5188726|NCT00869765|D-cycloserine|d-cycloserine
5188727|NCT00869752|combined type small cell lung cancer|combined type small cell lung cancer
5188728|NCT00869752|fusiform type small cell lung cancer|fusiform type small cell lung cancer
5188729|NCT00869752|polygonal type small cell lung cancer|polygonal type small cell lung cancer
5188730|NCT00869752|lymphocyte-like type small cell lung cancer|lymphocyte-like type small cell lung cancer
5188731|NCT00869752|extensive stage small cell lung cancer|extensive stage small cell lung cancer
5188732|NCT00869739|cancer survivor|cancer survivor
5188733|NCT00869739|depression|depression
5188734|NCT00869739|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
5188735|NCT00869739|male erectile disorder|male erectile disorder
5188736|NCT00869739|urinary complications|urinary complications
5188737|NCT00869739|gastrointestinal complications|gastrointestinal complications
5188738|NCT00869739|stage I prostate cancer|stage i prostate cancer
5188739|NCT00869739|stage IIB prostate cancer|stage iib prostate cancer
5188740|NCT00869739|stage IIA prostate cancer|stage iia prostate cancer
5188741|NCT00869739|stage III prostate cancer|stage iii prostate cancer
5188742|NCT00869713|Hemorrhagic Fever|hemorrhagic fever
5188743|NCT00869713|Viral Infections|viral infections
5188744|NCT00869713|Neurologic diseases|neurologic diseases
5188745|NCT00869713|Arbovirus Infections|arbovirus infections
5188746|NCT00869713|RVF|rvf
5188747|NCT00869700|HIV|hiv
5188748|NCT00869700|Malaria|malaria
5188749|NCT00869700|Pharmacokinetics|pharmacokinetics
5188750|NCT00869700|Treatment Experienced|treatment experienced
5188751|NCT00869674|GeneSearch|genesearch
5188752|NCT00869674|Breast cancer|breast cancer
5188753|NCT00869648|Airway|airway
5188754|NCT00869648|Anaesthesia|anaesthesia
5188755|NCT00869648|Resuscitation|resuscitation
5188756|NCT00869648|Ventilation|ventilation
5188757|NCT00869635|Cholangiocarcinoma|cholangiocarcinoma
5188758|NCT00869635|Photodynamic therapy|photodynamic therapy
5188759|NCT00869635|S-1|s-1
5188760|NCT00869622|osteoporosis|osteoporosis
5188761|NCT00869622|bone mineral density|bone mineral density
5188762|NCT00869622|fracture|fracture
5188763|NCT00869622|antiepileptic drug|antiepileptic drug
5188764|NCT00869622|seizure|seizure
5188765|NCT00869622|Prevention of bone loss|prevention of bone loss
5188766|NCT00869622|Prevention of osteoporosis|prevention of osteoporosis
5188767|NCT00869622|Prevention of Fractures|prevention of fractures
5188768|NCT00869609|Diabetes Prevention|diabetes prevention
5188769|NCT00869609|CVD Risk Reduction|cvd risk reduction
5188770|NCT00869609|Lifestyle Intervention|lifestyle intervention
5188771|NCT00869596|Sputum inflammatory biomarkers|sputum inflammatory biomarkers
5188772|NCT00869583|Women|women
5188773|NCT00869583|Physical Activity|physical activity
5188774|NCT00869583|Hispanic|hispanic
5188775|NCT00869583|Overweight|overweight
5188776|NCT00869570|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5188777|NCT00869570|stage II rectal cancer|stage ii rectal cancer
5188778|NCT00869570|stage III rectal cancer|stage iii rectal cancer
5188779|NCT00869557|HIV|hiv
5188780|NCT00869557|HIV-1|hiv-1
5188781|NCT00869557|Antiretroviral Treatment-Naive|antiretroviral treatment-naive
5188782|NCT00869557|treatment naive|treatment naive
5188783|NCT00869544|HIV|hiv
5188784|NCT00869544|smoker|smoker
5188785|NCT00869544|emphysema|emphysema
5188786|NCT00869544|antiretrovirals|antiretrovirals
5188787|NCT00869544|COPD|copd
5188788|NCT00869531|Obesity|obesity
5188789|NCT00869531|wholegrain|wholegrain
5188790|NCT00869531|wheat|wheat
5188791|NCT00869531|cardiovascular disease|cardiovascular disease
5188792|NCT00869518|Staphylococcus aureus|staphylococcus aureus
5188793|NCT00869518|colonization|colonization
5188794|NCT00869518|eradication|eradication
5188795|NCT00869518|HIV|hiv
5188796|NCT00869518|rifabutin|rifabutin
5188797|NCT00869505|To evaluate the effectiveness of memantine as an augmenting agent for standard intensive residential treatment of severe obsessive-compulsive disorder (OCD)|to evaluate the effectiveness of memantine as an augmenting agent for standard intensive residential treatment of severe obsessive-compulsive disorder (ocd)
5188798|NCT00869492|Acne|acne
5188799|NCT00869492|Nadifloxacin|nadifloxacin
5188800|NCT00869492|benzoyl peroxide|benzoyl peroxide
5188801|NCT00869479|Nephrogenic Systemic Fibrosis|nephrogenic systemic fibrosis
5188802|NCT00869479|Screening|screening
5188803|NCT00869466|weight changes|weight changes
5188804|NCT00869466|stage IA breast cancer|stage ia breast cancer
5188805|NCT00869466|stage IB breast cancer|stage ib breast cancer
5188806|NCT00869466|stage II breast cancer|stage ii breast cancer
5188807|NCT00869466|stage IIIA breast cancer|stage iiia breast cancer
5188808|NCT00869466|stage IIIB breast cancer|stage iiib breast cancer
5188809|NCT00869466|stage IIIC breast cancer|stage iiic breast cancer
5188810|NCT00869453|Gut hormone|gut hormone
5188811|NCT00869453|hyperglycaemic clamp|hyperglycaemic clamp
5188812|NCT00869453|glucose turnver|glucose turnver
5188813|NCT00869440|CNS 7056|cns 7056
5188814|NCT00869440|Procedural Sedation|procedural sedation
5188815|NCT00869440|Sedation|sedation
5188816|NCT00869440|Endoscopy|endoscopy
5188817|NCT00869427|UVI|uvi
5188818|NCT00869427|Spinal cord injury|spinal cord injury
5188819|NCT00869427|Prevention|prevention
5188820|NCT00869427|Vitamin C|vitamin c
5188821|NCT00869414|hypoglycemia|hypoglycemia
5188822|NCT00869414|type 1 diabetes|type 1 diabetes
5188823|NCT00869414|split dosing insulin glargine|split dosing insulin glargine
5188824|NCT00869414|continuous glucose monitoring|continuous glucose monitoring
5188825|NCT00869401|adult giant cell glioblastoma|adult giant cell glioblastoma
5188826|NCT00869401|adult glioblastoma|adult glioblastoma
5188827|NCT00869401|adult gliosarcoma|adult gliosarcoma
5188828|NCT00869388|malignant|malignant
5188829|NCT00869388|resistant|resistant
5188830|NCT00869388|solid tumor|solid tumor
5188831|NCT00869375|acute or critical limb ischemia with angiographic thrombus|acute or critical limb ischemia with angiographic thrombus
5188832|NCT00869349|Rheumatoid Arthritis|rheumatoid arthritis
5188833|NCT00869349|IFS|ifs
5188834|NCT00869349|psychosocial|psychosocial
5188835|NCT00869349|social support|social support
5188836|NCT00869336|Tinea Pedis|tinea pedis
5188837|NCT00869336|Athlete's Foot|athlete's foot
5188838|NCT00869323|post-transplant lymphoproliferative disorder|post-transplant lymphoproliferative disorder
5188839|NCT00869310|aprepitant|aprepitant
5188840|NCT00869310|delayed emesis|delayed emesis
5188841|NCT00869310|cisplatin|cisplatin
5188842|NCT00869310|antiemetic|antiemetic
5188843|NCT00869284|High-dose chemotherapy|high-dose chemotherapy
5188844|NCT00869284|aggressive NHL|aggressive nhl
5188845|NCT00869284|high-risk|high-risk
5188846|NCT00869284|PBSC|pbsc
5188847|NCT00869271|liver metastasis|liver metastasis
5188848|NCT00869271|colorectal cancer|colorectal cancer
5188849|NCT00869258|Pancreatic cancer|pancreatic cancer
5188850|NCT00869258|Gemcitabine|gemcitabine
5188851|NCT00869258|Docetaxel|docetaxel
5188852|NCT00869258|Capecitabine|capecitabine
5188853|NCT00869245|ACS|acs
5188854|NCT00869245|Acute Coronary Syndrome|acute coronary syndrome
5188855|NCT00869245|Chest pain|chest pain
5188856|NCT00869245|Cardiac MRI|cardiac mri
5188857|NCT00869245|CMR|cmr
5188858|NCT00869245|Risk Stratification|risk stratification
5188859|NCT00869245|Emergency Department|emergency department
5188860|NCT00869232|Multiple Myeloma|multiple myeloma
5188861|NCT00869219|Pain|pain
5188862|NCT00869219|Pain after eyedrops|pain after eyedrops
5188863|NCT00869206|pain|pain
5188864|NCT00869206|Prostate Adenocarcinoma|prostate adenocarcinoma
5188865|NCT00869206|urinary complications|urinary complications
5188866|NCT00869206|stage IV breast cancer|stage iv breast cancer
5188867|NCT00869206|Recurrent Breast Carcinoma|recurrent breast carcinoma
5188868|NCT00869206|stage IV prostate cancer|stage iv prostate cancer
5188869|NCT00869206|recurrent prostate cancer|recurrent prostate cancer
5188870|NCT00869206|Recurrent Prostate Carcinoma|recurrent prostate carcinoma
5188871|NCT00869206|stage I multiple myeloma|stage i multiple myeloma
5188872|NCT00869206|stage II multiple myeloma|stage ii multiple myeloma
5188873|NCT00869206|Refractory Plasma Cell Myeloma|refractory plasma cell myeloma
5188874|NCT00869206|bone metastases|bone metastases
5188875|NCT00869193|Blood pressure|blood pressure
5188876|NCT00869193|Grape seed|grape seed
5188877|NCT00869180|diclofenac|diclofenac
5188878|NCT00869180|ankle sprain|ankle sprain
5188879|NCT00869180|acute pain|acute pain
5188880|NCT00869180|topical|topical
5188881|NCT00869180|patch|patch
5188882|NCT00869180|Acute Pain due to Mild to Moderate Ankle Sprain|acute pain due to mild to moderate ankle sprain
5188883|NCT00869154|Mild TBI|mild tbi
5188884|NCT00869154|TBI (Traumatic Brain Injury)|tbi (traumatic brain injury)
5188885|NCT00869154|Traumatic Brain Injury|traumatic brain injury
5188886|NCT00869154|Injury, Brain, Traumatic|injury, brain, traumatic
5188887|NCT00869154|Injuries, Acute Brain|injuries, acute brain
5188888|NCT00869154|Brain Injuries, Traumatic|brain injuries, traumatic
5188889|NCT00869154|Acute Brain Injuries|acute brain injuries
5188890|NCT00869141|Glaucoma tube shunt procedure|glaucoma tube shunt procedure
5188891|NCT00869128|melatonin|melatonin
5188892|NCT00869128|insomnia|insomnia
5188893|NCT00869128|diabetes|diabetes
5188894|NCT00869128|sleep|sleep
5188895|NCT00869115|Digoxin|digoxin
5188896|NCT00869115|Inotropes|inotropes
5188897|NCT00869115|Lusitropic agents|lusitropic agents
5188898|NCT00869115|Istaroxime|istaroxime
5188899|NCT00869115|Debio 0614|debio 0614
5188900|NCT00869102|IGT|igt
5188901|NCT00869102|IFG|ifg
5188902|NCT00869089|PN|pn
5188903|NCT00869076|Diabetes Mellitus|diabetes mellitus
5188904|NCT00869076|Pharmacist|pharmacist
5188905|NCT00869063|wrist|wrist
5188906|NCT00869063|sprain|sprain
5188907|NCT00869063|strain|strain
5188908|NCT00869063|contusion|contusion
5188909|NCT00869063|diclofenac|diclofenac
5188910|NCT00869063|patch|patch
5188911|NCT00869063|acute pain|acute pain
5188912|NCT00869063|acute pain due to mild to moderate wrist sprain, strain or contusion|acute pain due to mild to moderate wrist sprain, strain or contusion
5188913|NCT00869050|Pancreatic cancer|pancreatic cancer
5188914|NCT00869050|Neuroendocrine tumors|neuroendocrine tumors
5188915|NCT00869050|Carcinoid tumors|carcinoid tumors
5188916|NCT00869050|Pheochromocytomas|pheochromocytomas
5188917|NCT00869050|Gastrinomas|gastrinomas
5188918|NCT00869050|Zollinger-Ellison syndrome|zollinger-ellison syndrome
5188919|NCT00869050|MEN Type I/II|men type i/ii
5188920|NCT00869050|Somatostatinomas|somatostatinomas
5188921|NCT00869050|VIPomas|vipomas
5188922|NCT00869050|Merkel cell tumors|merkel cell tumors
5188923|NCT00869050|medullary thyroid carcinoma|medullary thyroid carcinoma
5188924|NCT00869037|Randomized controlled study|randomized controlled study
5188925|NCT00869037|Total knee arthroplasty|total knee arthroplasty
5188926|NCT00869037|Post operative pain|post operative pain
5188927|NCT00869037|Continuous Femoral Nerve Block|continuous femoral nerve block
5188928|NCT00869037|Posterior Capsular injection|posterior capsular injection
5188929|NCT00869037|Periarticular injection|periarticular injection
5188930|NCT00869024|Heart failure|heart failure
5188931|NCT00869024|Left ventricular assist device|left ventricular assist device
5188932|NCT00869024|Stem cells|stem cells
5188933|NCT00869011|Cancer|cancer
5188934|NCT00869011|renal cell carcinoma|renal cell carcinoma
5188935|NCT00869011|fatigue|fatigue
5188936|NCT00869011|exercise|exercise
5188937|NCT00868998|Biliary Cancer|biliary cancer
5188938|NCT00868972|Renal Artery Obstruction|renal artery obstruction
5188939|NCT00868972|renovascular hypertension|renovascular hypertension
5188940|NCT00868972|stent|stent
5188941|NCT00868972|Kidney Failure|kidney failure
5188942|NCT00868972|embolic protection|embolic protection
5188943|NCT00868959|Bipolar|bipolar
5188944|NCT00868959|Depression|depression
5188945|NCT00868959|Lurasidone|lurasidone
5188946|NCT00868959|Latuda|latuda
5188947|NCT00868946|Ribavirin|ribavirin
5188948|NCT00868946|Hemorrhagic Fever with Renal Syndrome|hemorrhagic fever with renal syndrome
5188949|NCT00868946|Dobrava Virus|dobrava virus
5188950|NCT00868946|Puumala Virus|puumala virus
5188951|NCT00868881|Hypertension|hypertension
5188952|NCT00868881|Therapeutic diagnostic attitude|therapeutic diagnostic attitude
5188953|NCT00868881|Blood pressure|blood pressure
5188954|NCT00868868|Pedometer|pedometer
5188955|NCT00868868|Prostate|prostate
5188956|NCT00868868|Cancer|cancer
5188957|NCT00868868|Hormonotherapy|hormonotherapy
5188958|NCT00868868|Exercise|exercise
5188959|NCT00868855|Coronary Artery Disease|coronary artery disease
5188960|NCT00868842|Penicillin|penicillin
5188961|NCT00868842|Allergy|allergy
5188962|NCT00868842|Prevention|prevention
5188963|NCT00868842|Anaphylaxis|anaphylaxis
5188964|NCT00868842|Clinically proven history of penicillin allergy|clinically proven history of penicillin allergy
5188965|NCT00868842|preventing anaphylaxis|preventing anaphylaxis
5188966|NCT00868829|Stent|stent
5188967|NCT00868829|FireBird2|firebird2
5188968|NCT00868829|Coronary Heart Disease|coronary heart disease
5188969|NCT00868816|oxaliplatine|oxaliplatine
5188970|NCT00868816|colorectal cancer|colorectal cancer
5188971|NCT00868816|chemotherapy|chemotherapy
5188972|NCT00868803|prostate cancer|prostate cancer
5188973|NCT00868777|Implant site development|implant site development
5188974|NCT00868777|Bone grafting|bone grafting
5188975|NCT00868777|Dental implants|dental implants
5188976|NCT00868764|Effect of age|effect of age
5188977|NCT00868764|Effect of body fat|effect of body fat
5188978|NCT00868764|Granisetron|granisetron
5188979|NCT00868764|Pharmacokinetic profile|pharmacokinetic profile
5188980|NCT00868764|Sancuso® patch|sancuso® patch
5188981|NCT00868764|Transdermal|transdermal
5188982|NCT00868751|Antibodies, Monoclonal|antibodies, monoclonal
5188983|NCT00868751|Interleukin 6|interleukin 6
5188984|NCT00868738|Calcium|calcium
5188985|NCT00868738|Vitamin D|vitamin d
5188986|NCT00868738|Magnesium|magnesium
5188987|NCT00868738|Zinc|zinc
5188988|NCT00868725|oral cavity|oral cavity
5188989|NCT00868725|carcinoma|carcinoma
5188990|NCT00868725|thermal imaging|thermal imaging
5188991|NCT00868712|coronary calcification|coronary calcification
5188992|NCT00868712|vitamin K dependent proteins|vitamin k dependent proteins
5188993|NCT00868712|warfarin|warfarin
5188994|NCT00868699|Bipolar I, Depression|bipolar i, depression
5188995|NCT00868673|Role of Fructose in overweight and obesity|role of fructose in overweight and obesity
5188996|NCT00868673|Fructose and metabolic syndrome|fructose and metabolic syndrome
5188997|NCT00868673|Low fructose diet study|low fructose diet study
5189091|NCT00868179|total knee replacement|total knee replacement
5188998|NCT00868673|Effects of fructose in blood pressure and hypertension|effects of fructose in blood pressure and hypertension
5188999|NCT00868673|Somatometry changes observed in fructose diets|somatometry changes observed in fructose diets
5189000|NCT00868673|Fructose induced overweight and obesity|fructose induced overweight and obesity
5189001|NCT00868673|Fructose induced metabolic syndrome|fructose induced metabolic syndrome
5189002|NCT00868673|Fructose induced hyperuricemia|fructose induced hyperuricemia
5189003|NCT00868608|Refractory Indolent NHL|refractory indolent nhl
5189004|NCT00868608|lymphoma|lymphoma
5189005|NCT00868582|Patients with proven or suspected cancer referred for NaF-18 PET to identify bone metastasis|patients with proven or suspected cancer referred for naf-18 pet to identify bone metastasis
5189006|NCT00868569|liver metastasis|liver metastasis
5189007|NCT00868569|colorectal cancer|colorectal cancer
5189008|NCT00868569|oxaliplatine|oxaliplatine
5189009|NCT00868569|transartery chemotherapy|transartery chemotherapy
5189010|NCT00868569|embolision|embolision
5189011|NCT00868569|Unresectable Liver Metastasis of Colorectal Cancer|unresectable liver metastasis of colorectal cancer
5189012|NCT00868556|fMRI scans|fmri scans
5189013|NCT00868556|episodic migraine sufferers|episodic migraine sufferers
5189014|NCT00868556|chronic migraine sufferers|chronic migraine sufferers
5189015|NCT00868556|non migraine sufferers (controls)|non migraine sufferers (controls)
5189016|NCT00868543|Gastric bypass|gastric bypass
5189017|NCT00868543|obesity|obesity
5189018|NCT00868543|superobese|superobese
5189019|NCT00868530|On-demand treatment; Hemostatic Efficacy Assessments; Factor VIII recovery; Factor VIII Inhibitor; Chinese|on-demand treatment; hemostatic efficacy assessments; factor viii recovery; factor viii inhibitor; chinese
5189020|NCT00868517|Veterans|veterans
5189021|NCT00868517|Operation Iraqi Freedom|operation iraqi freedom
5189022|NCT00868517|Operation Enduring Freedom|operation enduring freedom
5189023|NCT00868517|Combat Disorders|combat disorders
5189024|NCT00868517|Acupuncture|acupuncture
5189025|NCT00868517|Complementary Therapies|complementary therapies
5189026|NCT00868504|GI tract|gi tract
5189027|NCT00868504|Tumors|tumors
5189028|NCT00868504|Temperatures|temperatures
5189029|NCT00868491|head and neck cancer|head and neck cancer
5189030|NCT00868491|inoperable|inoperable
5189031|NCT00868491|induction chemotherapy|induction chemotherapy
5189032|NCT00868491|concomitant radiochemotherapy|concomitant radiochemotherapy
5189033|NCT00868491|biological agent|biological agent
5189034|NCT00868491|efficacy|efficacy
5189035|NCT00868491|toxicity|toxicity
5189036|NCT00868478|humanized monoclonal antibody|humanized monoclonal antibody
5189037|NCT00868452|Bipolar I|bipolar i
5189038|NCT00868452|Latuda|latuda
5189039|NCT00868452|Lurasidone|lurasidone
5189040|NCT00868439|HF|hf
5189041|NCT00868439|Heart failure|heart failure
5189042|NCT00868439|hyperkalemia|hyperkalemia
5189043|NCT00868439|chronic kidney disease|chronic kidney disease
5189044|NCT00868439|prevention of hyperkalemia in heart failure participants|prevention of hyperkalemia in heart failure participants
5189045|NCT00868426|Healthy volunteer study|healthy volunteer study
5189046|NCT00868400|Preoperative care|preoperative care
5189047|NCT00868400|colorectal surgery|colorectal surgery
5189048|NCT00868400|carbohydrate|carbohydrate
5189049|NCT00868400|fasting|fasting
5189050|NCT00868387|weight reduction|weight reduction
5189051|NCT00868387|low-carbohydrate|low-carbohydrate
5189052|NCT00868387|body fat|body fat
5189053|NCT00868387|telemedicine|telemedicine
5189054|NCT00868387|cardiovascular risk markers|cardiovascular risk markers
5189055|NCT00868361|Mass Balance|mass balance
5189056|NCT00868361|Talampanel|talampanel
5189057|NCT00868361|Pharmacokinetics|pharmacokinetics
5189058|NCT00868361|Metabolism|metabolism
5189059|NCT00868361|Metabolites|metabolites
5189060|NCT00868361|Healthy Volunteers|healthy volunteers
5189061|NCT00868348|Total Knee Arthroplasty|total knee arthroplasty
5189062|NCT00868335|Cervical degenerative disc disease|cervical degenerative disc disease
5189063|NCT00868335|Anterior cervical discectomy|anterior cervical discectomy
5189064|NCT00868335|Cervical disc prosthesis|cervical disc prosthesis
5189065|NCT00868335|Activ-C|activ-c
5189066|NCT00868335|Mobility|mobility
5189067|NCT00868335|Movement|movement
5189068|NCT00868309|Snake Bite|snake bite
5189069|NCT00868309|Venom and antivenom kinetics|venom and antivenom kinetics
5189070|NCT00868296|Safety|safety
5189071|NCT00868257|AIDS|aids
5189072|NCT00868257|Adherence to Antiretroviral Therapy|adherence to antiretroviral therapy
5189073|NCT00868257|Pediatric|pediatric
5189074|NCT00868257|Resource Limited Setting|resource limited setting
5189075|NCT00868257|Treatment experienced|treatment experienced
5189076|NCT00868244|facial patterns|facial patterns
5189077|NCT00868244|bruxism|bruxism
5189078|NCT00868244|masticatory muscles|masticatory muscles
5189079|NCT00868231|COPD|copd
5189080|NCT00868231|Antimuscarinic|antimuscarinic
5189081|NCT00868218|Influenza A|influenza a
5189082|NCT00868218|pandemic|pandemic
5189083|NCT00868218|vaccine|vaccine
5189084|NCT00868218|immunogenicity|immunogenicity
5189085|NCT00868218|Virus|virus
5189086|NCT00868218|H5N1|h5n1
5189087|NCT00868205|oxidative stress|oxidative stress
5189088|NCT00868205|Comet assay|comet assay
5189089|NCT00868205|antioxidants|antioxidants
5189090|NCT00868179|Thrombosis|thrombosis
5189190|NCT00867776|Depression|depression
5189092|NCT00868166|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
5189093|NCT00868166|TRO19622|tro19622
5189094|NCT00868166|Trophos|trophos
5189095|NCT00868127|Hyperlipidemia|hyperlipidemia
5189096|NCT00868127|Drug Therapy|drug therapy
5189097|NCT00868127|Dyslipidemia|dyslipidemia
5189098|NCT00868114|Inoperable pancreatic cancer|inoperable pancreatic cancer
5189099|NCT00868114|Dendritic Cell Vaccine|dendritic cell vaccine
5189100|NCT00868114|Locally advanced or low volume metatstatic pancreatic cancer|locally advanced or low volume metatstatic pancreatic cancer
5189101|NCT00868101|ischemic|ischemic
5189102|NCT00868101|preconditioning|preconditioning
5189103|NCT00868101|congenital heart disease|congenital heart disease
5189104|NCT00868088|AC|ac
5189105|NCT00868088|SCC|scc
5189106|NCT00868088|SCC-is|scc-is
5189107|NCT00868088|PDT|pdt
5189108|NCT00868088|Mohs|mohs
5189109|NCT00868075|Physiotherapy|physiotherapy
5189110|NCT00868075|Rehabilitation|rehabilitation
5189111|NCT00868075|Bronchiectasis|bronchiectasis
5189112|NCT00868062|The responses of patients to 1L infusions of Gelofusine (succinylated gelatine 40g/L) and Voluven (6% hydroxyethyl starch in 0.9% saline) intraoperatively.|the responses of patients to 1l infusions of gelofusine (succinylated gelatine 40g/l) and voluven (6% hydroxyethyl starch in 0.9% saline) intraoperatively.
5189113|NCT00868049|chewing|chewing
5189114|NCT00868049|deglutition|deglutition
5189115|NCT00868049|orofacial motricity|orofacial motricity
5189116|NCT00868049|obesity|obesity
5189117|NCT00868036|urticaria|urticaria
5189118|NCT00868036|hives|hives
5189119|NCT00868036|dermatitis|dermatitis
5189120|NCT00868036|rash|rash
5189121|NCT00868036|contact dermatitis|contact dermatitis
5189122|NCT00868036|contact|contact
5189123|NCT00868036|contact sensitization|contact sensitization
5189124|NCT00868036|allergy|allergy
5189125|NCT00868036|allergen|allergen
5189126|NCT00868036|patch testing|patch testing
5189127|NCT00868036|IgG|igg
5189128|NCT00868036|delayed-hypersensitivity reaction|delayed-hypersensitivity reaction
5189129|NCT00868036|hypersensitivity|hypersensitivity
5189130|NCT00868010|stroke|stroke
5189131|NCT00868010|donepezil|donepezil
5189132|NCT00868010|recovery|recovery
5189133|NCT00867997|Noncarious Cervical Lesions|noncarious cervical lesions
5189134|NCT00867997|Hypersensitivity|hypersensitivity
5189135|NCT00867997|Teeth|teeth
5189136|NCT00867997|Dentistry|dentistry
5189137|NCT00867997|Practice-based research network|practice-based research network
5189138|NCT00867984|CRT, resynchronization,|crt, resynchronization,
5189139|NCT00867958|Colon Anastomosis|colon anastomosis
5189140|NCT00867958|Rectum Anastomosis|rectum anastomosis
5189141|NCT00867958|Intestine|intestine
5189142|NCT00867958|Colorectal Surgery|colorectal surgery
5189143|NCT00867958|Colorectal Anastomosis|colorectal anastomosis
5189144|NCT00867932|Paroxysmal Nocturnal Hemoglobinuria (PNH)|paroxysmal nocturnal hemoglobinuria (pnh)
5189145|NCT00867906|Cat allergy|cat allergy
5189146|NCT00867906|Immunotherapy|immunotherapy
5189147|NCT00867906|Cat-PAD|cat-pad
5189148|NCT00867880|To evaluate the Pharmacokinetic Profile of IVIb|to evaluate the pharmacokinetic profile of ivib
5189149|NCT00867867|Iron deficiency anemia|iron deficiency anemia
5189150|NCT00867867|Helicobacter pylori|helicobacter pylori
5189151|NCT00867867|Iron absorption|iron absorption
5189152|NCT00867867|Iron fortification|iron fortification
5189153|NCT00867867|ferrous sulphate|ferrous sulphate
5189154|NCT00867867|ferrous fumarate|ferrous fumarate
5189155|NCT00867854|de-intensification|de-intensification
5189156|NCT00867854|HAART|haart
5189157|NCT00867854|monotherapy|monotherapy
5189158|NCT00867854|persistent low-level viremia (LLV)|persistent low-level viremia (llv)
5189159|NCT00867854|treatment experienced|treatment experienced
5189160|NCT00867841|pneumonia, community-acquired|pneumonia, community-acquired
5189161|NCT00867841|polymerase chain reaction|polymerase chain reaction
5189162|NCT00867841|pneumococcus|pneumococcus
5189163|NCT00867841|mycoplasma|mycoplasma
5189164|NCT00867841|chlamydophila|chlamydophila
5189165|NCT00867841|anti-bacterial agents|anti-bacterial agents
5189166|NCT00867828|Decline of global cognitive function|decline of global cognitive function
5189167|NCT00867828|Neuropsychological Test Battery (NTB)|neuropsychological test battery (ntb)
5189168|NCT00867828|Early stage Alzheimer's disease|early stage alzheimer's disease
5189169|NCT00867815|Non-arteritic Anterior Ischemic Optic Neuropathy|non-arteritic anterior ischemic optic neuropathy
5189170|NCT00867815|NAION|naion
5189171|NCT00867815|PDE5 inhibitors|pde5 inhibitors
5189172|NCT00867815|vardenafil|vardenafil
5189173|NCT00867815|Levitra|levitra
5189174|NCT00867815|sildenafil|sildenafil
5189175|NCT00867815|Viagra|viagra
5189176|NCT00867815|Tadalafil|tadalafil
5189177|NCT00867815|Cialis|cialis
5189178|NCT00867815|acute vision loss|acute vision loss
5189179|NCT00867815|vision loss|vision loss
5189180|NCT00867815|blurred vision|blurred vision
5189181|NCT00867815|optic neuropathy|optic neuropathy
5189182|NCT00867815|erectile dysfunction.|erectile dysfunction.
5189183|NCT00867802|MICAS|micas
5189184|NCT00867802|MBSR|mbsr
5189185|NCT00867789|abscess|abscess
5189186|NCT00867789|outcomes|outcomes
5189187|NCT00867789|antibiotics|antibiotics
5189188|NCT00867789|incision and drainage|incision and drainage
5189189|NCT00867789|skin abscess|skin abscess
5189191|NCT00867776|African Americans|african americans
5189192|NCT00867776|Exercise|exercise
5189193|NCT00867776|Culturally tailored intervention|culturally tailored intervention
5189194|NCT00867776|Health disparities|health disparities
5189195|NCT00867763|Polycystic ovaries,|polycystic ovaries,
5189196|NCT00867763|Tubal occlusion|tubal occlusion
5189197|NCT00867763|Unexplained infertility|unexplained infertility
5189198|NCT00867763|Low ovarian reserve|low ovarian reserve
5189199|NCT00867763|Male factor infertility|male factor infertility
5189200|NCT00867750|HCC|hcc
5189201|NCT00867750|RE|re
5189202|NCT00867750|Yttrium-90|yttrium-90
5189203|NCT00867750|SIR-Spheres microspheres|sir-spheres microspheres
5189204|NCT00867750|TACE|tace
5189205|NCT00867750|Radioembolisation|radioembolisation
5189206|NCT00867750|Transarterial Chemoembolisation|transarterial chemoembolisation
5189207|NCT00867737|Asthma|asthma
5189208|NCT00867737|Forced Oscillation|forced oscillation
5189209|NCT00867737|Impulse Oscillometry|impulse oscillometry
5189210|NCT00867737|Electrical-equivalent respiratory system model|electrical-equivalent respiratory system model
5189211|NCT00867724|polyp|polyp
5189212|NCT00867698|Hepatic encephalopathy|hepatic encephalopathy
5189213|NCT00867698|Mild hepatic encephalopathy|mild hepatic encephalopathy
5189214|NCT00867698|HE|he
5189215|NCT00867698|MHE|mhe
5189216|NCT00867698|Cognitive impairment|cognitive impairment
5189217|NCT00867698|Cognitive dysfunction|cognitive dysfunction
5189218|NCT00867698|Liver Disease|liver disease
5189219|NCT00867698|Cirrhosis|cirrhosis
5189220|NCT00867685|Healthy Volunteers|healthy volunteers
5189221|NCT00867672|Acute Myeloid Leukemia|acute myeloid leukemia
5189222|NCT00867672|Low-dose Decitabine|low-dose decitabine
5189223|NCT00867672|Valproic acid|valproic acid
5189224|NCT00867672|All-trans retinoic acid|all-trans retinoic acid
5189225|NCT00867672|Older Patients|older patients
5189226|NCT00867659|ovarian hyperstimulation syndrome|ovarian hyperstimulation syndrome
5189227|NCT00867659|cetrotide acetate|cetrotide acetate
5189228|NCT00867659|GnRH antagonist|gnrh antagonist
5189229|NCT00867659|oocyte donors|oocyte donors
5189230|NCT00867646|PT|pt
5189231|NCT00867646|DVT|dvt
5189232|NCT00867633|urothelial carinoma|urothelial carinoma
5189233|NCT00867633|aristolochic acid|aristolochic acid
5189234|NCT00867633|DNA|dna
5189235|NCT00867633|adduct|adduct
5189236|NCT00867607|Contact dermatitis|contact dermatitis
5189237|NCT00867607|Eczema|eczema
5189238|NCT00867581|middle cerebral artery|middle cerebral artery
5189239|NCT00867581|infarction|infarction
5189240|NCT00867581|chronic stage|chronic stage
5189241|NCT00867581|hippocampal volume|hippocampal volume
5189242|NCT00867581|MRI|mri
5189243|NCT00867581|MRS|mrs
5189244|NCT00867581|neuropsychologic assessment|neuropsychologic assessment
5189245|NCT00867568|Relapsed Neuroblastoma|relapsed neuroblastoma
5189246|NCT00867568|Refractory Neuroblastoma|refractory neuroblastoma
5189247|NCT00867568|Relapsed Medulloblastoma|relapsed medulloblastoma
5189248|NCT00867568|Refractory Medulloblastoma|refractory medulloblastoma
5189249|NCT00867542|past IUGR|past iugr
5189250|NCT00867542|ECC|ecc
5189251|NCT00867542|oral findings in children with past IUGR|oral findings in children with past iugr
5189252|NCT00867503|ovarian cancer|ovarian cancer
5189253|NCT00867503|bendamustine|bendamustine
5189254|NCT00867490|Hypertension|hypertension
5189255|NCT00867490|aliskiren|aliskiren
5189256|NCT00867490|cardiovascular diseases|cardiovascular diseases
5189257|NCT00867477|Cancer of esophagus|cancer of esophagus
5189258|NCT00867477|Gastrointestine|gastrointestine
5189259|NCT00867477|esophagus cancer|esophagus cancer
5189260|NCT00867477|Positron emission tomography|positron emission tomography
5189261|NCT00867477|PET scan|pet scan
5189262|NCT00867477|Nitric oxide|nitric oxide
5189263|NCT00867477|NO|no
5189264|NCT00867477|NO Breathing Test|no breathing test
5189265|NCT00867477|Respiratory symptoms questionnaire|respiratory symptoms questionnaire
5189266|NCT00867464|Vaccine Efficacy|vaccine efficacy
5189267|NCT00867464|Long-Term Protection|long-term protection
5189268|NCT00867464|Immune Response|immune response
5189269|NCT00867464|Human Papillomavirus|human papillomavirus
5189270|NCT00867464|HPV|hpv
5189271|NCT00867464|Vaccine|vaccine
5189272|NCT00867451|Attention Deficit Hyperactivity Disorder (ADHD)|attention deficit hyperactivity disorder (adhd)
5189273|NCT00867438|ulcerative colitis|ulcerative colitis
5189274|NCT00867438|Left-sided, mild to moderate ulcerative colitis|left-sided, mild to moderate ulcerative colitis
5189275|NCT00867425|Diabetes|diabetes
5189276|NCT00867425|Internet|internet
5189277|NCT00867425|Obesity|obesity
5189278|NCT00867425|Obesity with high cardiovascular risks|obesity with high cardiovascular risks
5189279|NCT00867412|NSCLC|nsclc
5189280|NCT00867412|PET/CT|pet/ct
5189281|NCT00867412|Surgery|surgery
5189282|NCT00867412|FDG|fdg
5189283|NCT00867412|staging|staging
5189284|NCT00867373|Obesity|obesity
5189285|NCT00867373|Weight perceptions|weight perceptions
5189286|NCT00867347|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
5189287|NCT00867347|stage II bladder cancer|stage ii bladder cancer
5189288|NCT00867347|stage III bladder cancer|stage iii bladder cancer
5189289|NCT00867334|colorectal neoplasm|colorectal neoplasm
5189290|NCT00867334|colorectal cancer|colorectal cancer
5189291|NCT00867334|imatinib mesylate|imatinib mesylate
5189292|NCT00867334|Gleevec|gleevec
5189293|NCT00867334|Physiological Effects of Drugs|physiological effects of drugs
5189294|NCT00867334|panitumumab|panitumumab
5189295|NCT00867334|Vectibix|vectibix
5189296|NCT00867334|c-kit receptor|c-kit receptor
5189297|NCT00867334|Receptor|receptor
5189298|NCT00867334|Platelet-Derived Growth Factor alpha|platelet-derived growth factor alpha
5189299|NCT00867321|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
5189300|NCT00867321|advanced adult primary liver cancer|advanced adult primary liver cancer
5189301|NCT00867321|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
5189302|NCT00867321|recurrent adult primary liver cancer|recurrent adult primary liver cancer
5189303|NCT00867308|IPSS Int-2|ipss int-2
5189304|NCT00867308|high risk myelodysplastic syndrome|high risk myelodysplastic syndrome
5189305|NCT00867308|MDS)|mds)
5189306|NCT00867308|5q31.1 deletions|5q31.1 deletions
5189307|NCT00867295|implantable catheters|implantable catheters
5189308|NCT00867295|Indwelling Catheters|indwelling catheters
5189309|NCT00867295|infection|infection
5189310|NCT00867295|cefazolin sodium|cefazolin sodium
5189311|NCT00867295|prophylactic|prophylactic
5189312|NCT00867295|antibiotic|antibiotic
5189313|NCT00867295|totally implantable venous access device|totally implantable venous access device
5189314|NCT00867295|cancer patients|cancer patients
5189315|NCT00867269|Idiopathic Lymphocytopenia|idiopathic lymphocytopenia
5189316|NCT00867269|Opportunistic Infection|opportunistic infection
5189317|NCT00867269|Immunodeficiency Syndrome|immunodeficiency syndrome
5189318|NCT00867269|Autoimmune Disease|autoimmune disease
5189319|NCT00867269|CD4+ Lymphocytes|cd4+ lymphocytes
5189320|NCT00867269|Idiopathic CD4 Lymphocytopenia|idiopathic cd4 lymphocytopenia
5189321|NCT00867243|Hepatitis C virus|hepatitis c virus
5189322|NCT00867243|HCV|hcv
5189323|NCT00867243|Hepatitis C (and cirrhosis)|hepatitis c (and cirrhosis)
5189324|NCT00867243|Liver cirrhosis not due to HCV infection|liver cirrhosis not due to hcv infection
5189325|NCT00867230|Myelodysplastic Syndrome|myelodysplastic syndrome
5189326|NCT00867230|Chronic Myelomonocytic Leukemia|chronic myelomonocytic leukemia
5189327|NCT00867230|Acute Myeloid Leukemia|acute myeloid leukemia
5189328|NCT00867230|Acute Lymphocytic Leukemia|acute lymphocytic leukemia
5189329|NCT00867230|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
5189330|NCT00867230|Chronic Myelogenous Leukemia|chronic myelogenous leukemia
5189331|NCT00867230|Agnogenic Myeloid Metaplasia|agnogenic myeloid metaplasia
5189332|NCT00867230|FTS|fts
5189333|NCT00867230|S-Trans, Trans-Farnesylthiosalicylic Acid|s-trans, trans-farnesylthiosalicylic acid
5189334|NCT00867204|ERCP|ercp
5189335|NCT00867204|Study focus was to compare the performance of the ERCP short-wire device versus the Long-wire device.|study focus was to compare the performance of the ercp short-wire device versus the long-wire device.
5189336|NCT00867165|heterozygous familial hypercholesterolemia|heterozygous familial hypercholesterolemia
5189337|NCT00867165|nonfamilial hypercholesterolemia|nonfamilial hypercholesterolemia
5189338|NCT00867152|ritonavir|ritonavir
5189339|NCT00867152|GSK1349572|gsk1349572
5189340|NCT00867152|integrase|integrase
5189341|NCT00867152|lopinavir|lopinavir
5189342|NCT00867152|darunavir|darunavir
5189343|NCT00867152|etravirine|etravirine
5189344|NCT00867139|Influenza|influenza
5189345|NCT00867139|Immunocompromised|immunocompromised
5189346|NCT00867139|Antiviral|antiviral
5189347|NCT00867126|stage IV pancreatic cancer|stage iv pancreatic cancer
5189348|NCT00867126|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
5189349|NCT00867126|recurrent pancreatic cancer|recurrent pancreatic cancer
5189350|NCT00867113|Imatinib|imatinib
5189351|NCT00867113|Protein Kinase Inhibitors|protein kinase inhibitors
5189352|NCT00867113|Gastrointestinal Stromal Tumors|gastrointestinal stromal tumors
5189353|NCT00867113|Digestive System Diseases|digestive system diseases
5189354|NCT00867113|Digestive System Neoplasms|digestive system neoplasms
5189481|NCT00866645|Agitation|agitation
5189355|NCT00867113|Gastrointestinal Diseases|gastrointestinal diseases
5189356|NCT00867113|Gastrointestinal Neoplasms|gastrointestinal neoplasms
5189357|NCT00867113|Adjuvant|adjuvant
5189358|NCT00867113|PERSIST|persist
5189359|NCT00867113|PERSIS-5|persis-5
5189360|NCT00867087|Diffuse large b-cell lymphoma|diffuse large b-cell lymphoma
5189361|NCT00867087|inotuzumab ozogamicin|inotuzumab ozogamicin
5189362|NCT00867087|autologous stem cell transplant|autologous stem cell transplant
5189363|NCT00867061|Myelodysplastic|myelodysplastic
5189364|NCT00867061|IPSS Intermediate 1|ipss intermediate 1
5189365|NCT00867061|IPSS Intermediate 2|ipss intermediate 2
5189366|NCT00867061|IPSS High risk|ipss high risk
5189367|NCT00867048|highly active antiretroviral therapy (HAART)|highly active antiretroviral therapy (haart)
5189368|NCT00867048|CD4 Count|cd4 count
5189369|NCT00867048|Early Intervention|early intervention
5189370|NCT00867048|HIV|hiv
5189371|NCT00867048|HIV Infection|hiv infection
5189372|NCT00867048|HIV Infections|hiv infections
5189373|NCT00867048|treatment naive|treatment naive
5189374|NCT00867022|Inflammatory factors|inflammatory factors
5189375|NCT00867022|Coagulation factors|coagulation factors
5189376|NCT00867022|Sympathetic activity|sympathetic activity
5189377|NCT00866996|Attention deficit hyperactivity disorder|attention deficit hyperactivity disorder
5189378|NCT00866996|Methylphenidate|methylphenidate
5189379|NCT00866996|Atomoxetine|atomoxetine
5189380|NCT00866996|Concerta|concerta
5189381|NCT00866983|Open label|open label
5189382|NCT00866983|sildenafil|sildenafil
5189383|NCT00866983|PAH|pah
5189384|NCT00866983|Brazil|brazil
5189385|NCT00866970|Lung Cancer|lung cancer
5189386|NCT00866970|Fatigue|fatigue
5189387|NCT00866970|Cachexia|cachexia
5189388|NCT00866944|Colorectal carcinoma|colorectal carcinoma
5189389|NCT00866944|Liver metastases (only)|liver metastases (only)
5189390|NCT00866944|R0 resection|r0 resection
5189391|NCT00866944|R0 resection of liver metastases from colorectal cancer|r0 resection of liver metastases from colorectal cancer
5189392|NCT00866905|Breast Cancer|breast cancer
5189393|NCT00866905|Ixabepilone|ixabepilone
5189394|NCT00866905|Ixempra|ixempra
5189395|NCT00866905|Cyclophosphamide|cyclophosphamide
5189396|NCT00866905|Cytoxan|cytoxan
5189397|NCT00866905|Neoadjuvant Therapy|neoadjuvant therapy
5189398|NCT00866879|Sirolimus|sirolimus
5189399|NCT00866879|Rapamune|rapamune
5189400|NCT00866879|Immunosuppression|immunosuppression
5189401|NCT00866879|Renal allograft function|renal allograft function
5189402|NCT00866879|Lymphocytes function|lymphocytes function
5189403|NCT00866853|TMC435350|tmc435350
5189404|NCT00866853|HCV|hcv
5189405|NCT00866853|Hepatitis C|hepatitis c
5189406|NCT00866853|TMC435|tmc435
5189407|NCT00866853|protease inhibitor|protease inhibitor
5189408|NCT00866853|CYP|cyp
5189409|NCT00866853|Cooperstown 5+1 cocktail|cooperstown 5+1 cocktail
5189410|NCT00866840|stage III melanoma|stage iii melanoma
5189411|NCT00866840|stage IV melanoma|stage iv melanoma
5189412|NCT00866840|recurrent melanoma|recurrent melanoma
5189413|NCT00866827|Airway|airway
5189414|NCT00866827|Hemangiomas|hemangiomas
5189415|NCT00866827|Venous Malformations|venous malformations
5189416|NCT00866827|Lymphatic Malformations|lymphatic malformations
5189417|NCT00866814|hernia|hernia
5189418|NCT00866814|open|open
5189419|NCT00866801|coronary blood flow|coronary blood flow
5189420|NCT00866801|coronary flow reserve|coronary flow reserve
5189421|NCT00866801|cardiac sympathetic innervation|cardiac sympathetic innervation
5189422|NCT00866801|general anesthesia|general anesthesia
5189423|NCT00866801|thoracic epidural|thoracic epidural
5189424|NCT00866801|autonomic dysfunction|autonomic dysfunction
5189425|NCT00866801|autonomic neuropathy|autonomic neuropathy
5189426|NCT00866788|Xolair|xolair
5189427|NCT00866788|CIU|ciu
5189428|NCT00866775|Seizure|seizure
5189429|NCT00866775|Epilepsy|epilepsy
5189430|NCT00866775|Anticonvulsant|anticonvulsant
5189431|NCT00866775|Historical Control|historical control
5189432|NCT00866775|Monotherapy|monotherapy
5189433|NCT00866762|Polycythaemia Vera|polycythaemia vera
5189434|NCT00866762|Polycythemia Vera|polycythemia vera
5189435|NCT00866762|Essential Thrombocythaemia|essential thrombocythaemia
5189436|NCT00866762|Essential Thrombocythemia|essential thrombocythemia
5189437|NCT00866762|HDAC-inhibitor|hdac-inhibitor
5189438|NCT00866762|Haematology|haematology
5189439|NCT00866762|Hematology|hematology
5189440|NCT00866762|Haematological disorder|haematological disorder
5189441|NCT00866762|Haematological disease|haematological disease
5189442|NCT00866762|Hematological disorder|hematological disorder
5189443|NCT00866762|Hematological disease|hematological disease
5189444|NCT00866749|acute lymphoblastic leukemia|acute lymphoblastic leukemia
5189445|NCT00866749|acute lymphoblastic lymphoma|acute lymphoblastic lymphoma
5189446|NCT00866749|Leukemia|leukemia
5189447|NCT00866749|ALL|all
5189448|NCT00866749|6-Thioguanine|6-thioguanine
5189449|NCT00866749|Cyclophosphamide|cyclophosphamide
5189450|NCT00866749|Cytarabine|cytarabine
5189451|NCT00866749|Daunorubicin|daunorubicin
5189452|NCT00866749|Doxorubicin|doxorubicin
5189453|NCT00866749|Methotrexate|methotrexate
5189454|NCT00866749|PEG-L-Asparaginase|peg-l-asparaginase
5189455|NCT00866749|Vincristine|vincristine
5189456|NCT00866749|Intrathecal Methotrexate|intrathecal methotrexate
5189457|NCT00866749|Mercaptopurine|mercaptopurine
5189458|NCT00866736|chronic myeloid leukemia|chronic myeloid leukemia
5189459|NCT00866736|dasatinib|dasatinib
5189460|NCT00866736|chronic phase myeloid leukemia|chronic phase myeloid leukemia
5189461|NCT00866723|Avastin|avastin
5189462|NCT00866723|bevacizumab|bevacizumab
5189463|NCT00866697|fallopian tube cancer|fallopian tube cancer
5189464|NCT00866697|pazopanib|pazopanib
5189465|NCT00866697|anti-angiogenesis|anti-angiogenesis
5189466|NCT00866697|ovarian cancer|ovarian cancer
5189467|NCT00866697|primary peritoneal cancer|primary peritoneal cancer
5189468|NCT00866697|tyrosine kinase inhibitors|tyrosine kinase inhibitors
5189469|NCT00866697|gynecologic cancer|gynecologic cancer
5189470|NCT00866684|renal transplant-patients with high-risk for skin cancer|renal transplant-patients with high-risk for skin cancer
5189471|NCT00866671|T-ALL|t-all
5189472|NCT00866671|Safety|safety
5189473|NCT00866671|Post Authorisation Safety Study|post authorisation safety study
5189474|NCT00866671|T-LBL|t-lbl
5189475|NCT00866671|Lymphoblastic Lymphoma|lymphoblastic lymphoma
5189476|NCT00866671|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
5189477|NCT00866658|hyperglycemia|hyperglycemia
5189478|NCT00866658|GLP-1|glp-1
5189479|NCT00866658|sulfonylurea|sulfonylurea
5189480|NCT00866658|insulin|insulin
5189482|NCT00866645|Schizophrenia|schizophrenia
5189483|NCT00866645|Randomized|randomized
5189484|NCT00866645|Blind|blind
5189485|NCT00866645|Parallel|parallel
5189486|NCT00866645|Intramuscular Haloperidol|intramuscular haloperidol
5189487|NCT00866645|Controlled|controlled
5189488|NCT00866645|Multicenter|multicenter
5189489|NCT00866645|Clinical Trial|clinical trial
5189490|NCT00866645|Efficacy|efficacy
5189491|NCT00866645|Safety|safety
5189492|NCT00866645|Intramuscular Levosulpiride|intramuscular levosulpiride
5189493|NCT00866645|Chinese|chinese
5189494|NCT00866645|PANSS-EC|panss-ec
5189495|NCT00866645|ACES|aces
5189496|NCT00866645|CGI|cgi
5189497|NCT00866645|BPRS|bprs
5189498|NCT00866645|PANSS|panss
5189499|NCT00866645|RSESE|rsese
5189500|NCT00866645|BAS|bas
5189501|NCT00866632|Depression|depression
5189502|NCT00866632|Anxiety|anxiety
5189503|NCT00866632|Brain Injury|brain injury
5189504|NCT00866632|Cognitive Therapy|cognitive therapy
5189505|NCT00866632|Coping Skills|coping skills
5189506|NCT00866606|On-demand treatment|on-demand treatment
5189507|NCT00866606|Hemostatic efficacy|hemostatic efficacy
5189508|NCT00866606|Factor IX activity|factor ix activity
5189509|NCT00866606|Factor IX recovery|factor ix recovery
5189510|NCT00866606|Factor IX inhibitor|factor ix inhibitor
5189511|NCT00866606|Chinese|chinese
5189512|NCT00866593|major depressive disorder(MDD)|major depressive disorder(mdd)
5189513|NCT00866593|depression|depression
5189514|NCT00866593|antidepressant|antidepressant
5189515|NCT00866593|escitalpram oxalate|escitalpram oxalate
5189516|NCT00866593|generic|generic
5189517|NCT00866593|innovator|innovator
5189518|NCT00866593|Lexapro|lexapro
5189519|NCT00866593|efficacy|efficacy
5189520|NCT00866593|safety|safety
5189521|NCT00866593|multicenter|multicenter
5189522|NCT00866593|double-blind|double-blind
5189523|NCT00866593|randomized|randomized
5189524|NCT00866593|chinese|chinese
5189525|NCT00866593|HAMD|hamd
5189526|NCT00866593|MADRS|madrs
5189527|NCT00866593|HAMA|hama
5189528|NCT00866593|VAS-PI|vas-pi
5189529|NCT00866593|SDS|sds
5189530|NCT00866593|CGI|cgi
5189531|NCT00866580|Pandemic influenza|pandemic influenza
5189532|NCT00866567|prematurity|prematurity
5189533|NCT00866567|VLBW|vlbw
5189534|NCT00866567|sepsis|sepsis
5189535|NCT00866567|innate immunity|innate immunity
5189536|NCT00866554|Prostate|prostate
5189537|NCT00866554|Brachytherapy|brachytherapy
5189538|NCT00866554|Cytoreduction|cytoreduction
5189539|NCT00866554|Sexual function|sexual function
5189540|NCT00866554|Toxicity|toxicity
5189541|NCT00866541|resistance|resistance
5189542|NCT00866541|flow proportional pressure support|flow proportional pressure support
5189543|NCT00866541|pressure support ventilation|pressure support ventilation
5189544|NCT00866541|volunteers|volunteers
5189545|NCT00866541|assistant breathing|assistant breathing
5189546|NCT00866541|breathing comfort and objective breathing data|breathing comfort and objective breathing data
5189547|NCT00866528|paclitaxel|paclitaxel
5189548|NCT00866528|NSCLC|nsclc
5189549|NCT00866528|pazopanib|pazopanib
5189550|NCT00866528|Advanced Non-Small Cell Lung Cancer|advanced non-small cell lung cancer
5189551|NCT00866528|non-small cell lung cancer|non-small cell lung cancer
5189552|NCT00866528|Advanced Solid Tumor|advanced solid tumor
5189553|NCT00866528|GW786034|gw786034
5189554|NCT00866528|Metastatic Non-Small Cell Lung Cancer|metastatic non-small cell lung cancer
5189555|NCT00866515|Healthy volunteer|healthy volunteer
5189556|NCT00866515|pharmacodynamics|pharmacodynamics
5189557|NCT00866515|Ketoconazole|ketoconazole
5189558|NCT00866515|Drug Interaction|drug interaction
5189559|NCT00866515|pharmacokinetcs|pharmacokinetcs
5189560|NCT00866515|GW642444M|gw642444m
5189561|NCT00866515|pharmacokinetics|pharmacokinetics
5189562|NCT00866502|Parkinson|parkinson
5189563|NCT00866502|Safety|safety
5189564|NCT00866502|PDGF|pdgf
5189565|NCT00866502|Intracerebroventricular|intracerebroventricular
5189566|NCT00866502|Infusion|infusion
5189567|NCT00866502|Device|device
5189568|NCT00866489|Experimental|experimental
5189569|NCT00866476|Shigella|shigella
5189570|NCT00866476|Vaccine|vaccine
5189571|NCT00866476|Mucosal immunity|mucosal immunity
5189572|NCT00866463|Sildenafil, Pharmacokinetics, Healthy Volunteer|sildenafil, pharmacokinetics, healthy volunteer
5189573|NCT00866437|PMS|pms
5189574|NCT00866437|Hormones|hormones
5189575|NCT00866437|Skin tests|skin tests
5189576|NCT00866437|Allergen Immunotherapy|allergen immunotherapy
5189577|NCT00866424|trigeminal neuralgia|trigeminal neuralgia
5189578|NCT00866424|pain|pain
5189579|NCT00866424|HBO|hbo
5189580|NCT00866424|VAS|vas
5189581|NCT00866424|MGPQ|mgpq
5189582|NCT00866411|cranial electrotherapy stimulation|cranial electrotherapy stimulation
5189583|NCT00866411|anxiety|anxiety
5189584|NCT00866411|depression|depression
5189585|NCT00866411|pain|pain
5189586|NCT00866411|sleep disturbance|sleep disturbance
5189587|NCT00866411|combat exposure|combat exposure
5189588|NCT00866411|post traumatic stress|post traumatic stress
5189589|NCT00866411|health status|health status
5189590|NCT00866411|medication use|medication use
5189591|NCT00866411|soldiers|soldiers
5189592|NCT00866398|coronary heart disease|coronary heart disease
5189593|NCT00866398|chd|chd
5189594|NCT00866398|stent|stent
5189595|NCT00866385|Healthy Volunteer|healthy volunteer
5189596|NCT00866385|AZD8566|azd8566
5189597|NCT00866385|Food Effect|food effect
5189598|NCT00866385|Microtracer|microtracer
5189599|NCT00866346|Chronic Myelogenous Leukemia|chronic myelogenous leukemia
5189600|NCT00866346|CML|cml
5189601|NCT00866346|Allogeneic Hematopoietic Transplantation|allogeneic hematopoietic transplantation
5189602|NCT00866346|Bone Marrow Transplant|bone marrow transplant
5189603|NCT00866346|PR1-Specific Cytotoxic T-Lymphocyte Infusion|pr1-specific cytotoxic t-lymphocyte infusion
5189604|NCT00866333|Hodgkin's Lymphoma|hodgkin's lymphoma
5189605|NCT00866333|Relapsed Hodgkin's Lymphoma|relapsed hodgkin's lymphoma
5189606|NCT00866333|Refractory Hodgkin's Lymphoma|refractory hodgkin's lymphoma
5189607|NCT00866320|clear cell renal cell carcinoma|clear cell renal cell carcinoma
5189608|NCT00866320|recurrent renal cell cancer|recurrent renal cell cancer
5189609|NCT00866320|stage IV renal cell cancer|stage iv renal cell cancer
5189610|NCT00866294|Immediate-release formulation of paroxetine (paroxetine IR)|immediate-release formulation of paroxetine (paroxetine ir)
5189611|NCT00866294|HAM-D (17 items)|ham-d (17 items)
5189612|NCT00866294|Controlled-release formulation of paroxetine (paroxetine CR)|controlled-release formulation of paroxetine (paroxetine cr)
5189613|NCT00866281|Acute Myeloid Leukemia|acute myeloid leukemia
5189615|NCT00866281|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
5189616|NCT00866281|ALL|all
5189617|NCT00866281|midostaurin|midostaurin
5189618|NCT00866281|PKC412|pkc412
5189619|NCT00866281|Pediatric relapsed or refractory FLT3 positive Acute Myeloid Leukemia|pediatric relapsed or refractory flt3 positive acute myeloid leukemia
5189620|NCT00866281|Pediatric relapsed or refractory Mixed-lineage leukemia gene rearranged Acute Lymphoblastic leukemia|pediatric relapsed or refractory mixed-lineage leukemia gene rearranged acute lymphoblastic leukemia
5189621|NCT00866268|Blood loss|blood loss
5189622|NCT00866268|Total knee arthroplasty|total knee arthroplasty
5189623|NCT00866268|Adults|adults
5189624|NCT00866268|Drain|drain
5189625|NCT00866268|Drainage system|drainage system
5189626|NCT00866255|endotracheal tube|endotracheal tube
5189627|NCT00866255|endotracheal pressure|endotracheal pressure
5189628|NCT00866255|airway pressure|airway pressure
5189629|NCT00866255|pressure drop|pressure drop
5189630|NCT00866255|calculation|calculation
5189631|NCT00866255|continuous calculation|continuous calculation
5189632|NCT00866242|Shigella|shigella
5189633|NCT00866242|Vaccine|vaccine
5189634|NCT00866242|Mucosal immunity|mucosal immunity
5189635|NCT00866190|Mycobacterium tuberculosis, SQ109|mycobacterium tuberculosis, sq109
5189636|NCT00866164|back pain|back pain
5189637|NCT00866164|intractable pain|intractable pain
5189638|NCT00866164|implantable infusion pump|implantable infusion pump
5189639|NCT00866164|morphine|morphine
5189640|NCT00866151|genetic biomarker|genetic biomarker
5189641|NCT00866151|biomarker|biomarker
5189642|NCT00866151|molecular diagnostics|molecular diagnostics
5189643|NCT00866151|genes|genes
5189644|NCT00866151|genetics|genetics
5189645|NCT00866151|overweight management|overweight management
5189646|NCT00866151|weight management|weight management
5189647|NCT00866151|weight reduction|weight reduction
5189648|NCT00866151|SNPs|snps
5189649|NCT00866151|single nucleotide polymorphisms|single nucleotide polymorphisms
5189650|NCT00866138|multiple myeloma|multiple myeloma
5189651|NCT00866138|t(4/14)|t(4/14)
5189652|NCT00866138|relapsing|relapsing
5189653|NCT00866138|refractory|refractory
5189654|NCT00866125|Polymyositis|polymyositis
5189655|NCT00866125|Dermatomyositis|dermatomyositis
5189656|NCT00866125|Grip force|grip force
5189657|NCT00866125|Quality of life|quality of life
5189658|NCT00866125|Activity performance|activity performance
5189659|NCT00866112|Wheelchair use|wheelchair use
5189660|NCT00866112|Spinal cord injury|spinal cord injury
5189661|NCT00866112|Multiple sclerosis|multiple sclerosis
5189662|NCT00866112|Muscular dystrophy|muscular dystrophy
5189663|NCT00866112|Cerebral palsy|cerebral palsy
5189664|NCT00866112|Spina bifida|spina bifida
5189665|NCT00866112|Amputation|amputation
5189666|NCT00866112|Arthritis|arthritis
5189667|NCT00866112|Stroke|stroke
5189668|NCT00866099|Dementia|dementia
5189669|NCT00866099|primary care|primary care
5189670|NCT00866099|early diagnosis|early diagnosis
5189671|NCT00866099|psychosocial interventions|psychosocial interventions
5189672|NCT00866099|cholinesterase inhibitors|cholinesterase inhibitors
5189673|NCT00866086|stage I non-small cell lung cancer|stage i non-small cell lung cancer
5189674|NCT00866086|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
5189675|NCT00866086|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5189676|NCT00866086|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5189677|NCT00866086|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5189678|NCT00866086|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5189679|NCT00866086|pulmonary carcinoid tumor|pulmonary carcinoid tumor
5189680|NCT00866086|extensive stage small cell lung cancer|extensive stage small cell lung cancer
5189681|NCT00866086|limited stage small cell lung cancer|limited stage small cell lung cancer
5189682|NCT00866086|recurrent small cell lung cancer|recurrent small cell lung cancer
5189683|NCT00866073|AML|aml
5189684|NCT00866073|Acute myeloid leukemia|acute myeloid leukemia
5189685|NCT00866073|Decitabine|decitabine
5189686|NCT00866060|donepezil|donepezil
5189687|NCT00866060|memantine|memantine
5189688|NCT00866060|moderately severe Alzheimer's disease|moderately severe alzheimer's disease
5189689|NCT00866060|severe Alzheimer's disease|severe alzheimer's disease
5189690|NCT00866047|Antigens, CD30|antigens, cd30
5189691|NCT00866047|Antibody-Drug Conjugate|antibody-drug conjugate
5189692|NCT00866047|Antibodies, Monoclonal|antibodies, monoclonal
5189693|NCT00866047|Lymphoma, Non-Hodgkin|lymphoma, non-hodgkin
5189694|NCT00866047|Lymphoma, Large-Cell, Anaplastic|lymphoma, large-cell, anaplastic
5189695|NCT00866047|monomethyl auristatin E|monomethyl auristatin e
5189696|NCT00866047|Drug Therapy|drug therapy
5189697|NCT00866047|Immunotherapy|immunotherapy
5189698|NCT00866047|Hematologic Diseases|hematologic diseases
5189699|NCT00866047|Lymphoma|lymphoma
5189700|NCT00866034|Cetrotide|cetrotide
5189701|NCT00866034|IVF|ivf
5189702|NCT00866034|ICSI|icsi
5189703|NCT00866034|Treatment protocol|treatment protocol
5189704|NCT00866021|HIV infection|hiv infection
5189705|NCT00866021|HCV infection|hcv infection
5189706|NCT00866021|treatment experienced|treatment experienced
5189707|NCT00866008|IVF|ivf
5189708|NCT00866008|In vitro implantation|in vitro implantation
5189709|NCT00866008|Preimplantation genetic screening|preimplantation genetic screening
5189710|NCT00866008|Aneuploidy|aneuploidy
5189711|NCT00865995|pepsin|pepsin
5189712|NCT00865995|aspiration|aspiration
5189713|NCT00865995|GE reflux|ge reflux
5189714|NCT00865982|adenocarcinoma of the stomach, gastro-esophageal junction or distal esophagus|adenocarcinoma of the stomach, gastro-esophageal junction or distal esophagus
5189715|NCT00865982|gastric cancer|gastric cancer
5189716|NCT00865982|esophageal cancer|esophageal cancer
5189717|NCT00865982|gastro-esophageal junction|gastro-esophageal junction
5189718|NCT00865982|docetaxel|docetaxel
5189719|NCT00865982|capecitabine|capecitabine
5189720|NCT00865982|cisplatin|cisplatin
5189721|NCT00865982|perioperative chemotherapy|perioperative chemotherapy
5189722|NCT00865969|Belinostat|belinostat
5189723|NCT00865969|peripheral T-cell lymphoma|peripheral t-cell lymphoma
5189724|NCT00865969|PXD101|pxd101
5189725|NCT00865969|PTCL|ptcl
5189726|NCT00865969|HDAC inhibitor|hdac inhibitor
5189727|NCT00865969|histone deacetylase inhibitor|histone deacetylase inhibitor
5189728|NCT00865956|disease management|disease management
5189729|NCT00865956|substance use disorders|substance use disorders
5189730|NCT00865956|behavioral incentives|behavioral incentives
5189731|NCT00865943|Bioequivalence|bioequivalence
5189732|NCT00865943|Citalopram|citalopram
5189733|NCT00865943|Healthy subjects|healthy subjects
5189734|NCT00865917|POTS|pots
5189735|NCT00865904|∆F508|∆f508
5189736|NCT00865904|F508del|f508del
5189737|NCT00865904|Cystic Fibrosis Transmembrane Conductance Regulator|cystic fibrosis transmembrane conductance regulator
5189738|NCT00865904|CFTR|cftr
5189739|NCT00865904|Pancreatic diseases|pancreatic diseases
5189740|NCT00865904|Lung diseases|lung diseases
5189741|NCT00865904|Genetic disease, inborn|genetic disease, inborn
5189742|NCT00865904|Infant, newborn, diseases|infant, newborn, diseases
5189743|NCT00865891|Bioequivalence|bioequivalence
5189744|NCT00865891|Nifedipine|nifedipine
5189745|NCT00865891|Healthy subjects|healthy subjects
5189746|NCT00865878|Actinic Keratoses|actinic keratoses
5189747|NCT00865878|Skin Neoplasms|skin neoplasms
5189748|NCT00865878|Photodynamic Therapy|photodynamic therapy
5189749|NCT00865878|Transplants|transplants
5189750|NCT00865865|Knee|knee
5189751|NCT00865865|Computer|computer
5189752|NCT00865865|Gap|gap
5189753|NCT00865865|Soft tissue|soft tissue
5189754|NCT00865865|Balancing|balancing
5189755|NCT00865865|Replacement|replacement
5189756|NCT00865865|Arthroplasty|arthroplasty
5189757|NCT00865852|Bioequivalence|bioequivalence
5189758|NCT00865852|Metformin|metformin
5189759|NCT00865852|Healthy subjects|healthy subjects
5189760|NCT00865839|Bioequivalence|bioequivalence
5189761|NCT00865839|Metformin|metformin
5189762|NCT00865839|Healthy subjects|healthy subjects
5189763|NCT00865826|Pulmonary Tuberculosis|pulmonary tuberculosis
5189764|NCT00865826|Myobacterium Infections|myobacterium infections
5189765|NCT00865813|Punch biopsy,|punch biopsy,
5189766|NCT00865813|periocular|periocular
5189767|NCT00865813|tumors.|tumors.
5189768|NCT00865774|Trauma|trauma
5189769|NCT00865774|Alcohol|alcohol
5189770|NCT00865774|Brief Intervention|brief intervention
5189771|NCT00865761|Bioequivalence|bioequivalence
5189772|NCT00865761|Alprazolam|alprazolam
5189773|NCT00865761|Healthy subjects|healthy subjects
5189774|NCT00865748|Bioequivalence|bioequivalence
5189775|NCT00865748|Metformin|metformin
5189776|NCT00865748|Healthy subjects|healthy subjects
5189777|NCT00865722|Remote Postconditioning|remote postconditioning
5189778|NCT00865722|Myocardial reperfusion Injury|myocardial reperfusion injury
5189779|NCT00865722|Myocardial Infarction|myocardial infarction
5189780|NCT00865722|Primary PCI|primary pci
5189781|NCT00865709|Colorectal Cancer|colorectal cancer
5189782|NCT00865709|Metastasis|metastasis
5189783|NCT00865709|Stage IV|stage iv
5189784|NCT00865709|Liver Metastasis|liver metastasis
5189785|NCT00865696|Bioequivalence|bioequivalence
5189786|NCT00865696|Mirtazapine|mirtazapine
5189787|NCT00865696|Healthy subjects|healthy subjects
5189788|NCT00865683|Gestational Diabetes|gestational diabetes
5189789|NCT00865683|Pregnancy|pregnancy
5189790|NCT00865683|Docosahexaenoic Acid|docosahexaenoic acid
5189791|NCT00865683|DHA|dha
5189792|NCT00865683|Maternal-Fetal Exchange|maternal-fetal exchange
5189793|NCT00865657|Bioequivalence|bioequivalence
5189794|NCT00865657|Alprazolam|alprazolam
5189795|NCT00865657|Healthy subjects|healthy subjects
5189796|NCT00865644|imiquimod 5% cream|imiquimod 5% cream
5189797|NCT00865631|Bioequivalence|bioequivalence
5189798|NCT00865631|Gabapentin|gabapentin
5189799|NCT00865631|Healthy subjects|healthy subjects
5189800|NCT00865605|bioequivalence|bioequivalence
5189801|NCT00865605|Vasoconstriction|vasoconstriction
5189802|NCT00865605|Halobetasol|halobetasol
5189803|NCT00865605|Healthy subjects|healthy subjects
5189804|NCT00865592|diabetes|diabetes
5189805|NCT00865592|DPP4 inhibitor|dpp4 inhibitor
5189806|NCT00865592|dutogliptin|dutogliptin
5189807|NCT00865592|PHX1149|phx1149
5189808|NCT00865579|MAO inhibitors|mao inhibitors
5189809|NCT00865579|motor fluctuations|motor fluctuations
5189810|NCT00865579|dyskinesia|dyskinesia
5189811|NCT00865579|Parkinson's Disease|parkinson's disease
5189812|NCT00865566|HIV Seronegativity|hiv seronegativity
5189813|NCT00865566|HIV Preventive Vaccine|hiv preventive vaccine
5189814|NCT00865566|HIV Treatment Vaccine|hiv treatment vaccine
5189815|NCT00865566|Adenovirus|adenovirus
5189816|NCT00865553|tobacco use disorder|tobacco use disorder
5189817|NCT00865540|cataract|cataract
5189818|NCT00865540|pupillary dilation|pupillary dilation
5189819|NCT00865540|anti-inflammatory|anti-inflammatory
5189820|NCT00865540|therapeutic use|therapeutic use
5189821|NCT00865527|Colorectal cancer|colorectal cancer
5189822|NCT00865527|Colon cancer|colon cancer
5189823|NCT00865527|Adenomatous polyps|adenomatous polyps
5189824|NCT00865527|Screening|screening
5189825|NCT00865527|Fecal occult blood test|fecal occult blood test
5189826|NCT00865527|Computed tomographic colonography|computed tomographic colonography
5189827|NCT00865527|Colonoscopy|colonoscopy
5189828|NCT00865514|dichloroacetate|dichloroacetate
5189829|NCT00865514|tyrosine|tyrosine
5189830|NCT00865514|maleylacetoacetate|maleylacetoacetate
5189831|NCT00865514|trichloroethylene|trichloroethylene
5189832|NCT00865514|leucine|leucine
5189833|NCT00865514|haplotype|haplotype
5189834|NCT00865501|primary hypertension|primary hypertension
5189835|NCT00865501|aldosterone|aldosterone
5189836|NCT00865501|left ventricular hypertrophy|left ventricular hypertrophy
5189837|NCT00865475|HIV infection|hiv infection
5189838|NCT00865475|Treatment Experienced|treatment experienced
5189839|NCT00865462|Bioequivalence|bioequivalence
5189840|NCT00865462|Bupropion|bupropion
5189841|NCT00865462|Healthy subjects|healthy subjects
5189842|NCT00865449|spironolactone|spironolactone
5189843|NCT00865449|peritoneal fibrosis|peritoneal fibrosis
5189844|NCT00865449|peritoneal dialysis|peritoneal dialysis
5189845|NCT00865436|Bioequivalence|bioequivalence
5189846|NCT00865436|Metformin|metformin
5189847|NCT00865436|Glyburide|glyburide
5189848|NCT00865436|Healthy subjects|healthy subjects
5189849|NCT00865423|Bioequivalence|bioequivalence
5189850|NCT00865423|Gabapentin|gabapentin
5189851|NCT00865423|Healthy subjects|healthy subjects
5189852|NCT00865410|Bioequivalence|bioequivalence
5189853|NCT00865410|Bupropion|bupropion
5189854|NCT00865410|Healthy subjects|healthy subjects
5189855|NCT00865384|Bioequivalence|bioequivalence
5189856|NCT00865384|Mirtazapine|mirtazapine
5189857|NCT00865384|Healthy subjects|healthy subjects
5189858|NCT00865371|Bioequivalence|bioequivalence
5189859|NCT00865371|Bupropion|bupropion
5189860|NCT00865371|Healthy subjects|healthy subjects
5189861|NCT00865358|yoga|yoga
5189862|NCT00865358|complementary alternative medicine|complementary alternative medicine
5189863|NCT00865358|low back pain|low back pain
5189864|NCT00865358|minority health|minority health
5189865|NCT00865358|health care disparities|health care disparities
5189866|NCT00865358|community health centers|community health centers
5189867|NCT00865345|blood sugar|blood sugar
5189868|NCT00865345|glucose|glucose
5189869|NCT00865345|sensor|sensor
5189870|NCT00865332|PET|pet
5189871|NCT00865332|fMRI|fmri
5189872|NCT00865332|D-Amphetamine|d-amphetamine
5189873|NCT00865332|Cocaine Addiction|cocaine addiction
5189874|NCT00865332|Methylphenidate|methylphenidate
5189875|NCT00865319|Non Small Cell Lung Cancer|non small cell lung cancer
5189876|NCT00865319|Spect CT Imaging|spect ct imaging
5189877|NCT00865319|PET CT Imaging as Comparator|pet ct imaging as comparator
5189878|NCT00865306|Cognitive behavioral therapy|cognitive behavioral therapy
5189879|NCT00865306|Anxiety|anxiety
5189880|NCT00865306|Preschoolers|preschoolers
5189881|NCT00865306|Young Children|young children
5189882|NCT00865306|Parents|parents
5189883|NCT00865306|At-risk|at-risk
5189884|NCT00865306|Behavioral Inhibition|behavioral inhibition
5189885|NCT00865293|Obesity|obesity
5189886|NCT00865293|expiratory flow limitation|expiratory flow limitation
5189887|NCT00865293|EFL|efl
5189888|NCT00865293|posture|posture
5189889|NCT00865293|small airways obstruction|small airways obstruction
5189890|NCT00865293|FOT|fot
5189891|NCT00865280|CSSI|cssi
5189892|NCT00865280|Abscess|abscess
5189893|NCT00865280|Wound|wound
5189894|NCT00865280|Cellulitis|cellulitis
5189895|NCT00865280|Complicated Skin and Skin Structure Infections (cSSSI)|complicated skin and skin structure infections (csssi)
5189896|NCT00865267|Vasoconstriction|vasoconstriction
5189897|NCT00865267|Halobetasol|halobetasol
5189898|NCT00865267|Healthy adult subjects|healthy adult subjects
5189899|NCT00865254|Nicotine Dependence|nicotine dependence
5189900|NCT00865254|Smoking|smoking
5189901|NCT00865254|Smoking Cessation|smoking cessation
5189902|NCT00865254|Contingency Management|contingency management
5189903|NCT00865241|Bioequivalence|bioequivalence
5189904|NCT00865241|Metformin|metformin
5189905|NCT00865241|Glyburide|glyburide
5189906|NCT00865241|Healthy subjects|healthy subjects
5189907|NCT00865228|Hyperlipidemia|hyperlipidemia
5189908|NCT00865228|Dyslipidemia|dyslipidemia
5189909|NCT00865228|High Cholesterol|high cholesterol
5189910|NCT00865228|Drug Therapy|drug therapy
5189911|NCT00865215|Bioequivalence|bioequivalence
5189912|NCT00865215|Propranolol|propranolol
5189913|NCT00865215|Healthy subjects|healthy subjects
5189914|NCT00865202|delirium|delirium
5189915|NCT00865202|surgery|surgery
5189916|NCT00865202|operation|operation
5189917|NCT00865202|geriatric|geriatric
5189918|NCT00865202|complication|complication
5189919|NCT00865163|Percutaneous Coronary Intervention|percutaneous coronary intervention
5189920|NCT00865163|anticoagulation|anticoagulation
5189921|NCT00865163|PCI|pci
5189922|NCT00865150|Prematurity|prematurity
5189923|NCT00865150|Neonatal screening|neonatal screening
5189924|NCT00865150|Parenteral nutrition|parenteral nutrition
5189925|NCT00865150|Amino acids|amino acids
5189926|NCT00865150|Acylcarnitine|acylcarnitine
5189927|NCT00865137|Kidney Transplantation|kidney transplantation
5189928|NCT00865137|Pharmacokinetics|pharmacokinetics
5189929|NCT00865137|Tacrolimus modified release|tacrolimus modified release
5189930|NCT00865137|FK506E|fk506e
5189931|NCT00865111|Bioequivalence|bioequivalence
5189932|NCT00865111|Bupropion|bupropion
5189933|NCT00865111|Healthy subjects|healthy subjects
5189934|NCT00865098|Newly diagnosed locally advanced squamous cell carcinoma of the head and neck (SCCHN)|newly diagnosed locally advanced squamous cell carcinoma of the head and neck (scchn)
5189935|NCT00865085|Bioequivalence|bioequivalence
5189936|NCT00865085|Citalopram|citalopram
5189937|NCT00865085|Healthy subjects|healthy subjects
5189938|NCT00865072|Bioequivalence|bioequivalence
5189939|NCT00865072|Metformin|metformin
5189940|NCT00865072|Healthy subjects|healthy subjects
5189941|NCT00865059|Bioequivalence|bioequivalence
5189942|NCT00865059|Gabapentin|gabapentin
5189943|NCT00865059|Healthy subjects|healthy subjects
5189944|NCT00865046|acupuncture|acupuncture
5189945|NCT00865020|Hypertension|hypertension
5189946|NCT00865020|ABPM|abpm
5189947|NCT00865020|systolic blood pressure|systolic blood pressure
5189948|NCT00865020|diastolic blood pressure|diastolic blood pressure
5189949|NCT00865020|cardiovascular disease|cardiovascular disease
5189950|NCT00865020|aliskiren|aliskiren
5189951|NCT00865020|telmisartan|telmisartan
5189952|NCT00865007|Lipodystrophy|lipodystrophy
5189953|NCT00865007|treatment experienced|treatment experienced
5189954|NCT00864994|COPD|copd
5189955|NCT00864994|Inflammation|inflammation
5189956|NCT00864994|Smoking|smoking
5189957|NCT00864994|Multiorgan pathology|multiorgan pathology
5189958|NCT00864994|Extra pulmonary manifestations|extra pulmonary manifestations
5189959|NCT00864968|Bioequivalence|bioequivalence
5189960|NCT00864968|Nabumetone|nabumetone
5189961|NCT00864968|Healthy subjects|healthy subjects
5189962|NCT00864955|UV-A irradiation|uv-a irradiation
5189963|NCT00864955|Cyclobutane-Pyrimidine Dimer|cyclobutane-pyrimidine dimer
5189964|NCT00864955|Oxidative lesions|oxidative lesions
5189965|NCT00864955|cutaneous phototype|cutaneous phototype
5189966|NCT00864955|UV-B irradiation|uv-b irradiation
5189967|NCT00864955|DNA damages|dna damages
5189968|NCT00864942|CLL|cll
5189969|NCT00864942|NHL|nhl
5189970|NCT00864942|lymphoma|lymphoma
5189971|NCT00864929|Non-interventional study|non-interventional study
5189972|NCT00864929|Vietnam|vietnam
5189973|NCT00864929|inappropriate treatment|inappropriate treatment
5189974|NCT00864929|nosocomial infection|nosocomial infection
5189975|NCT00864916|Endothelial Function|endothelial function
5189976|NCT00864916|Pentoxifylline|pentoxifylline
5189977|NCT00864916|Antiretroviral Therapy|antiretroviral therapy
5189978|NCT00864916|Inflammation|inflammation
5189979|NCT00864903|enterovirus|enterovirus
5189980|NCT00864903|aseptic meningitis|aseptic meningitis
5189981|NCT00864903|real time PCR|real time pcr
5189982|NCT00864903|diagnostics|diagnostics
5189983|NCT00864890|Bioequivalence|bioequivalence
5189984|NCT00864890|Citalopram|citalopram
5189985|NCT00864890|Healthy subjects|healthy subjects
5189986|NCT00864877|retrospective|retrospective
5189987|NCT00864877|comparison|comparison
5189988|NCT00864877|biodegradable|biodegradable
5189989|NCT00864877|implant|implant
5189990|NCT00864877|ankle fracture|ankle fracture
5189991|NCT00864864|sunitinib|sunitinib
5189992|NCT00864838|intraocular pressure|intraocular pressure
5189993|NCT00864838|bevacizumab|bevacizumab
5189994|NCT00864838|acetazolamide|acetazolamide
5189995|NCT00864838|brimonidine|brimonidine
5189996|NCT00864838|anterior chamber paracentesis|anterior chamber paracentesis
5189997|NCT00864825|Schizophrenia|schizophrenia
5189998|NCT00864825|Allopurinol|allopurinol
5189999|NCT00864825|Add-on-treatment|add-on-treatment
5190000|NCT00864799|Abortion|abortion
5190001|NCT00864799|Misoprostol|misoprostol
5190002|NCT00864799|Mifepristone|mifepristone
5190003|NCT00864799|Pregnancy|pregnancy
5190004|NCT00864799|Fetus|fetus
5190005|NCT00864786|Multiple dose safety and pharmacokinetics study|multiple dose safety and pharmacokinetics study
5190006|NCT00864760|Bioequivalence|bioequivalence
5190007|NCT00864760|Gabapentin|gabapentin
5190008|NCT00864760|Healthy subjects|healthy subjects
5190009|NCT00864747|Bioequivalence|bioequivalence
5190010|NCT00864747|Propranolol|propranolol
5190011|NCT00864747|Healthy subjects|healthy subjects
5190012|NCT00864734|Bioequivalence|bioequivalence
5190013|NCT00864734|Metformin|metformin
5190014|NCT00864734|Glyburide|glyburide
5190015|NCT00864734|Healthy subjects|healthy subjects
5190016|NCT00864721|Untreated NSCLC in patients > 70|untreated nsclc in patients > 70
5190017|NCT00864708|Functional Electrical Stimulation|functional electrical stimulation
5190018|NCT00864695|Anesthesia|anesthesia
5190019|NCT00864695|Ethics|ethics
5190020|NCT00864695|Trends|trends
5190021|NCT00864695|Manpower|manpower
5190022|NCT00864695|Perioperative care|perioperative care
5190023|NCT00864682|propofol|propofol
5190024|NCT00864682|lidocaine|lidocaine
5190025|NCT00864682|injection pain|injection pain
5190026|NCT00864669|Bioequivalence|bioequivalence
5190027|NCT00864669|Metformin|metformin
5190028|NCT00864669|Healthy subjects|healthy subjects
5190029|NCT00864656|adrenergic alpha-agonists|adrenergic alpha-agonists
5190030|NCT00864656|phenylephrine|phenylephrine
5190031|NCT00864656|drug effects|drug effects
5190032|NCT00864656|diagnostic use|diagnostic use
5190033|NCT00864643|Hyperlipidemia|hyperlipidemia
5190034|NCT00864643|Drug Therapy|drug therapy
5190035|NCT00864643|Dyslipidemia|dyslipidemia
5190036|NCT00864617|Bioequivalence|bioequivalence
5190037|NCT00864617|Nifedipine|nifedipine
5190038|NCT00864617|Healthy subjects|healthy subjects
5190039|NCT00864604|Bioequivalence|bioequivalence
5190040|NCT00864604|Nabumetone|nabumetone
5190041|NCT00864604|Healthy subjects|healthy subjects
5190042|NCT00864591|SPECT Imaging|spect imaging
5190043|NCT00864591|Stress adenosine CMR|stress adenosine cmr
5190044|NCT00864578|POAG|poag
5190045|NCT00864578|IOP|iop
5190046|NCT00864578|Forskolin|forskolin
5190047|NCT00864578|Food supplement|food supplement
5190048|NCT00864565|Bioequivalence|bioequivalence
5190049|NCT00864565|Fentanyl|fentanyl
5190050|NCT00864565|Healthy subjects|healthy subjects
5190051|NCT00864552|Hemophilia A|hemophilia a
5190052|NCT00864552|Recombinant Factor VIII|recombinant factor viii
5190053|NCT00864539|vitamin D fortification|vitamin d fortification
5190054|NCT00864539|milk|milk
5190055|NCT00864539|orange juice|orange juice
5190056|NCT00864539|supplement|supplement
5190057|NCT00864539|efficacy|efficacy
5190058|NCT00864526|Bioequivalence|bioequivalence
5190059|NCT00864526|Oxycodone|oxycodone
5190060|NCT00864526|Ibuprofen|ibuprofen
5190061|NCT00864526|Healthy subjects|healthy subjects
5190062|NCT00864513|pancreas|pancreas
5190063|NCT00864513|metastatic|metastatic
5190064|NCT00864513|recurrent|recurrent
5190065|NCT00864500|Bio-Equivalence|bio-equivalence
5190066|NCT00864500|Vasoconstriction|vasoconstriction
5190067|NCT00864500|Clobetasol|clobetasol
5190068|NCT00864500|Healthy adult females|healthy adult females
5190069|NCT00864461|Down syndrome|down syndrome
5190070|NCT00864461|Metabolic syndrome X|metabolic syndrome x
5190071|NCT00864461|Insulin resistance|insulin resistance
5190072|NCT00864448|Bioequivalence|bioequivalence
5190073|NCT00864448|Ramipril|ramipril
5190074|NCT00864448|Healthy subjects|healthy subjects
5190075|NCT00864435|Bioequivalence|bioequivalence
5190076|NCT00864435|Carvedilol|carvedilol
5190077|NCT00864435|Healthy subjects|healthy subjects
5190078|NCT00864422|low back pain|low back pain
5190079|NCT00864422|motor training|motor training
5190080|NCT00864422|motor cortex|motor cortex
5190081|NCT00864422|brain plasticity|brain plasticity
5190082|NCT00864409|postoperative pain|postoperative pain
5190083|NCT00864409|total hip arthroplasty|total hip arthroplasty
5190084|NCT00864396|Laryngopharyngeal reflux|laryngopharyngeal reflux
5190085|NCT00864396|Gastroesophageal reflux disease|gastroesophageal reflux disease
5190086|NCT00864396|GERD|gerd
5190087|NCT00864370|Psychiatry|psychiatry
5190088|NCT00864370|Pregnancy|pregnancy
5190089|NCT00864370|Bipolar Disorder|bipolar disorder
5190090|NCT00864357|Bioequivalence|bioequivalence
5190091|NCT00864357|Oxycodone|oxycodone
5190092|NCT00864357|Ibuprofen|ibuprofen
5190093|NCT00864357|Healthy subjects|healthy subjects
5190094|NCT00864344|Bioequivalence|bioequivalence
5190095|NCT00864344|Sertralin|sertralin
5190096|NCT00864344|Healthy subjectse|healthy subjectse
5190097|NCT00864331|lung cancer|lung cancer
5191266|NCT00859209|ETCO2|etco2
5190098|NCT00864331|nonsmall cell lung cancer|nonsmall cell lung cancer
5190099|NCT00864331|radiation therapy|radiation therapy
5190100|NCT00864331|chemotherapy|chemotherapy
5190101|NCT00864331|Locally advanced and metastatic nonsmall cell lung cancer|locally advanced and metastatic nonsmall cell lung cancer
5190102|NCT00864318|refractory|refractory
5190103|NCT00864318|germ cell tumors|germ cell tumors
5190104|NCT00864318|relapse|relapse
5190105|NCT00864318|bad prognosis|bad prognosis
5190106|NCT00864318|Refractory germ cell tumors with relapse and bad prognosis|refractory germ cell tumors with relapse and bad prognosis
5190107|NCT00864305|Bioequivalence|bioequivalence
5190108|NCT00864305|Gabapentin|gabapentin
5190109|NCT00864305|Healthy subjects|healthy subjects
5190110|NCT00864279|Bioequivalence|bioequivalence
5190111|NCT00864279|Cetirizine|cetirizine
5190112|NCT00864279|Healthy subjects|healthy subjects
5190113|NCT00864266|Non small cell lung carcinoma|non small cell lung carcinoma
5190114|NCT00864266|Chemotherapy|chemotherapy
5190115|NCT00864266|Response prediction|response prediction
5190116|NCT00864253|Melanoma|melanoma
5190117|NCT00864253|Malignant|malignant
5190118|NCT00864253|Abraxane|abraxane
5190119|NCT00864253|ABI-007|abi-007
5190120|NCT00864253|Dacarbazine|dacarbazine
5190121|NCT00864253|Dtic-Dome|dtic-dome
5190122|NCT00864240|Vasoconstriction|vasoconstriction
5190123|NCT00864240|Clobetasol|clobetasol
5190124|NCT00864240|Healthy adult females|healthy adult females
5190125|NCT00864227|Acute Lymphoblastic Leukemia/Lymphoma|acute lymphoblastic leukemia/lymphoma
5190126|NCT00864227|Acute Myelogenous Leukemia|acute myelogenous leukemia
5190127|NCT00864227|Mantel-Cell Lymphoma|mantel-cell lymphoma
5190128|NCT00864227|Hematopoietic Transplant|hematopoietic transplant
5190129|NCT00864227|Umbilical Cord Blood (UCB)|umbilical cord blood (ucb)
5190130|NCT00864227|Non-Myeloablative Transplant|non-myeloablative transplant
5190131|NCT00864214|bioidentical hormone|bioidentical hormone
5190132|NCT00864214|menopause|menopause
5190133|NCT00864214|estrogen|estrogen
5190134|NCT00864214|progesterone|progesterone
5190135|NCT00864188|skin health|skin health
5190136|NCT00864188|probiotics|probiotics
5190137|NCT00864188|dairy|dairy
5190138|NCT00864188|oral|oral
5190139|NCT00864162|Bioequivalence|bioequivalence
5190140|NCT00864162|Ramipril|ramipril
5190141|NCT00864162|Healthy subjects|healthy subjects
5190142|NCT00864149|Bioequivalence|bioequivalence
5190143|NCT00864149|Carvedilol|carvedilol
5190144|NCT00864149|Healthy subjects|healthy subjects
5190145|NCT00864123|Obsessive-compulsive disorder|obsessive-compulsive disorder
5190146|NCT00864110|Non small cell lung cancer|non small cell lung cancer
5190147|NCT00864110|SPECT CT imaging|spect ct imaging
5190148|NCT00864110|Pharmacokinetic|pharmacokinetic
5190149|NCT00864110|Radiation Dosimetry|radiation dosimetry
5190150|NCT00864110|PET CT comparison|pet ct comparison
5190151|NCT00864097|Arthritis monoclonal antibody nerve growth factor (NGF) anti-NGF tanezumab PF-04383119 RN-624 OA|arthritis monoclonal antibody nerve growth factor (ngf) anti-ngf tanezumab pf-04383119 rn-624 oa
5190152|NCT00864071|Bioequivalence|bioequivalence
5190153|NCT00864071|Griseofulvin|griseofulvin
5190154|NCT00864071|Healthy subjects|healthy subjects
5190155|NCT00864058|Bioequivalence|bioequivalence
5190156|NCT00864058|Gabapentin|gabapentin
5190157|NCT00864058|Healthy subjects|healthy subjects
5190158|NCT00864032|Soft tissue sarcoma of the extremity and body wall|soft tissue sarcoma of the extremity and body wall
5190159|NCT00864019|Bioequivalence|bioequivalence
5190160|NCT00864019|Sertraline|sertraline
5190161|NCT00864019|Healthy subjects|healthy subjects
5190162|NCT00863980|angiotensin|angiotensin
5190163|NCT00863980|receptor|receptor
5190164|NCT00863980|vulnerable plaque|vulnerable plaque
5190165|NCT00863980|coronary artery|coronary artery
5190166|NCT00863967|physical examination|physical examination
5190167|NCT00863967|diagnostic techniques and procedures|diagnostic techniques and procedures
5190168|NCT00863967|diagnosis|diagnosis
5190169|NCT00863967|immunologic tests|immunologic tests
5190170|NCT00863967|diagnostic tests|diagnostic tests
5190171|NCT00863967|causality|causality
5190172|NCT00863967|genetic test|genetic test
5190173|NCT00863967|biomarker|biomarker
5190174|NCT00863941|Bioequivalence|bioequivalence
5190175|NCT00863941|Bupropion|bupropion
5190176|NCT00863941|Healthy subjects|healthy subjects
5190177|NCT00863915|Bioequivalence|bioequivalence
5190178|NCT00863915|Ramipril|ramipril
5190179|NCT00863915|Healthy subjects|healthy subjects
5190180|NCT00863902|Bioequivalence|bioequivalence
5190181|NCT00863902|Cetirizine|cetirizine
5190182|NCT00863902|Healthy subjects|healthy subjects
5190183|NCT00863876|wavefront measurements of the entire eye|wavefront measurements of the entire eye
5190184|NCT00863863|Bioequivalence|bioequivalence
5190185|NCT00863863|Griseofulvin|griseofulvin
5190186|NCT00863863|Healthy subjects|healthy subjects
5190187|NCT00863837|Acute variceal bleeding|acute variceal bleeding
5190188|NCT00863837|banding ligation|banding ligation
5190189|NCT00863837|vasoconstrictor|vasoconstrictor
5190190|NCT00863837|proton pump inhibitor|proton pump inhibitor
5190191|NCT00863824|NNAL|nnal
5190192|NCT00863824|Cotinine|cotinine
5190193|NCT00863824|Second hand smoke|second hand smoke
5191557|NCT00857883|Obesity|obesity
5190194|NCT00863824|NNAL is a known lung carcinogen. So, we are studying an agent that can potentially cause lung cancer.|nnal is a known lung carcinogen. so, we are studying an agent that can potentially cause lung cancer.
5190195|NCT00863811|POAG|poag
5190196|NCT00863811|IOP|iop
5190197|NCT00863811|Forskolin|forskolin
5190198|NCT00863811|beta-blockers|beta-blockers
5190199|NCT00863811|prostaglandins|prostaglandins
5190200|NCT00863798|Major Depressive Disorder|major depressive disorder
5190201|NCT00863785|Acute Alcoholic Hepatitis|acute alcoholic hepatitis
5190202|NCT00863785|Cirrhosis|cirrhosis
5190203|NCT00863785|Alcohol|alcohol
5190204|NCT00863785|Alcoholic Liver disease|alcoholic liver disease
5190205|NCT00863759|intra-ocular lenses|intra-ocular lenses
5190206|NCT00863759|comparative study|comparative study
5190207|NCT00863759|Ocular aberrations|ocular aberrations
5190208|NCT00863759|Contrast Sensitivity|contrast sensitivity
5190209|NCT00863746|Non-Small Cell Lung Cancer (NSCLC)|non-small cell lung cancer (nsclc)
5190210|NCT00863746|Sorafenib|sorafenib
5190211|NCT00863707|regadenoson|regadenoson
5190212|NCT00863707|chronic kidney disease stage III|chronic kidney disease stage iii
5190213|NCT00863707|chronic kidney disease stage IV|chronic kidney disease stage iv
5190214|NCT00863707|renal impairment|renal impairment
5190215|NCT00863707|coronary artery disease|coronary artery disease
5190216|NCT00863694|cystic fibrosis|cystic fibrosis
5190217|NCT00863694|calprotectin|calprotectin
5190218|NCT00863694|elastase|elastase
5190219|NCT00863681|Pulmonary arterial hypertension|pulmonary arterial hypertension
5190220|NCT00863681|PH|ph
5190221|NCT00863681|Stimulator|stimulator
5190222|NCT00863668|Infection|infection
5190223|NCT00863668|HIV 1|hiv 1
5190224|NCT00863668|HIV|hiv
5190225|NCT00863668|treatment naive|treatment naive
5190226|NCT00863655|Breast Cancer|breast cancer
5190227|NCT00863655|Estrogen Receptor positive|estrogen receptor positive
5190228|NCT00863655|ER+|er+
5190229|NCT00863655|exemestane|exemestane
5190230|NCT00863655|mTOR|mtor
5190231|NCT00863655|everolimus|everolimus
5190232|NCT00863655|refractory|refractory
5190233|NCT00863655|NSAI|nsai
5190234|NCT00863642|Early cholecystectomy|early cholecystectomy
5190235|NCT00863642|gallstone pancreatitis|gallstone pancreatitis
5190236|NCT00863629|myocardial infarction|myocardial infarction
5190237|NCT00863629|oxidative stress|oxidative stress
5190238|NCT00863629|stem cells|stem cells
5190239|NCT00863629|glycemic control|glycemic control
5190240|NCT00863616|COPD|copd
5190241|NCT00863616|Mucus hypersecretion|mucus hypersecretion
5190242|NCT00863616|HRQL|hrql
5190243|NCT00863616|ESWT|eswt
5190244|NCT00863616|HFCWO|hfcwo
5190245|NCT00863603|Supplemental oxygen|supplemental oxygen
5190246|NCT00863603|Intimal hyperplasia|intimal hyperplasia
5190247|NCT00863603|Graft patency|graft patency
5190248|NCT00863577|Healthy volunteers|healthy volunteers
5190249|NCT00863564|Postprandial Period|postprandial period
5190250|NCT00863564|Postprandial Lipaemia|postprandial lipaemia
5190251|NCT00863564|Incretins|incretins
5190252|NCT00863564|Subclinical Inflammation|subclinical inflammation
5190253|NCT00863564|Obesity|obesity
5190254|NCT00863564|Atherosclerosis|atherosclerosis
5190255|NCT00863564|Triglyceride|triglyceride
5190256|NCT00863564|Lipoproteins|lipoproteins
5190257|NCT00863564|Postprandial inflammation|postprandial inflammation
5190258|NCT00863538|Spinocerebellar degeneration|spinocerebellar degeneration
5190259|NCT00863538|Thyrotropin-Releasing Hormone (TRH)|thyrotropin-releasing hormone (trh)
5190260|NCT00863538|SCD|scd
5190261|NCT00863512|stage IA non-small cell lung cancer|stage ia non-small cell lung cancer
5190262|NCT00863512|stage IB non-small cell lung cancer|stage ib non-small cell lung cancer
5190263|NCT00863512|stage IIA non-small cell lung cancer|stage iia non-small cell lung cancer
5190264|NCT00863512|adenocarcinoma of the lung|adenocarcinoma of the lung
5190265|NCT00863512|adenosquamous cell lung cancer|adenosquamous cell lung cancer
5190266|NCT00863512|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
5190267|NCT00863512|large cell lung cancer|large cell lung cancer
5190268|NCT00863512|squamous cell lung cancer|squamous cell lung cancer
5190269|NCT00863499|Attention Deficit/Hyperactivity Disorder|attention deficit/hyperactivity disorder
5190270|NCT00863499|Attention Deficit Disorder|attention deficit disorder
5190271|NCT00863499|ADHD|adhd
5190272|NCT00863499|ADD|add
5190273|NCT00863499|iSPOT|ispot
5190274|NCT00863473|Proximal Humerus Fracture in elderly|proximal humerus fracture in elderly
5190275|NCT00863421|Sleep disordered breathing|sleep disordered breathing
5190276|NCT00863421|Prevalence|prevalence
5190277|NCT00863421|Chronic heart failure|chronic heart failure
5190278|NCT00863421|Incidence|incidence
5190279|NCT00863421|Sleep apnea|sleep apnea
5190280|NCT00863421|Cheyne-Stokes-Breathing|cheyne-stokes-breathing
5190281|NCT00863408|Mosquito|mosquito
5190282|NCT00863408|Human Landing Collection|human landing collection
5190283|NCT00863408|Malaria|malaria
5190284|NCT00863395|pruritis|pruritis
5190285|NCT00863395|itch|itch
5190286|NCT00863395|CTCL|ctcl
5190287|NCT00863382|atrial fibrillation|atrial fibrillation
5190288|NCT00863369|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5190289|NCT00863369|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5191558|NCT00857883|Food Effect|food effect
5190290|NCT00863369|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5190291|NCT00863369|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5190292|NCT00863369|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
5190293|NCT00863369|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5190294|NCT00863369|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5190295|NCT00863369|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5190296|NCT00863369|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5190297|NCT00863369|adult grade III lymphomatoid granulomatosis|adult grade iii lymphomatoid granulomatosis
5190298|NCT00863356|Epistaxis|epistaxis
5190299|NCT00863356|Chitosan|chitosan
5190300|NCT00863356|Hemostatic|hemostatic
5190301|NCT00863356|Nose bleed|nose bleed
5190302|NCT00863356|Nasal bleeding|nasal bleeding
5190303|NCT00863356|Nasal pack|nasal pack
5190304|NCT00863356|Sealant|sealant
5190305|NCT00863356|ChitoFlex®|chitoflex®
5190306|NCT00863356|HemCon|hemcon
5190307|NCT00863356|HemCon® ChitoFlex Surgical Dressing|hemcon® chitoflex surgical dressing
5190308|NCT00863356|HemCon® Nasal Plugs|hemcon® nasal plugs
5190309|NCT00863356|Biocompatible dressing|biocompatible dressing
5190310|NCT00863343|Influenza infections|influenza infections
5190311|NCT00863343|Orthomyxoviridae infections|orthomyxoviridae infections
5190312|NCT00863330|stage IV melanoma|stage iv melanoma
5190313|NCT00863330|recurrent melanoma|recurrent melanoma
5190314|NCT00863317|Bronchiolitis|bronchiolitis
5190315|NCT00863317|montelukast|montelukast
5190316|NCT00863317|leukotriene inhibitor|leukotriene inhibitor
5190317|NCT00863304|monoclonal antibody RN624 PF-04383119 nerve growth factor anti-nerve growth factor OA pain arthritis|monoclonal antibody rn624 pf-04383119 nerve growth factor anti-nerve growth factor oa pain arthritis
5190318|NCT00863291|Depression|depression
5190319|NCT00863291|suicidality|suicidality
5190320|NCT00863291|buprenorphine|buprenorphine
5190321|NCT00863265|Phytosterols|phytosterols
5190322|NCT00863265|Ezetimibe|ezetimibe
5190323|NCT00863265|Cholesterol Excretion|cholesterol excretion
5190324|NCT00863265|Cholesterol Absorption|cholesterol absorption
5190325|NCT00863265|Diet|diet
5190326|NCT00863265|Mass Spectrometry|mass spectrometry
5190327|NCT00863265|Deuterium|deuterium
5190328|NCT00863252|proteinuria|proteinuria
5190329|NCT00863252|creatinine|creatinine
5190330|NCT00863252|kidney survival|kidney survival
5190331|NCT00863252|ESRD|esrd
5190332|NCT00863239|treatment naive|treatment naive
5190333|NCT00863239|genotype 1|genotype 1
5190334|NCT00863226|Quality of Life issues in Parkinson's disease|quality of life issues in parkinson's disease
5190335|NCT00863213|Catheter Ablation, Radiofrequency|catheter ablation, radiofrequency
5190336|NCT00863213|Atrial fibrillation|atrial fibrillation
5190337|NCT00863213|Antiarrhythmic Drugs|antiarrhythmic drugs
5190338|NCT00863200|Depression|depression
5190339|NCT00863200|Cancer|cancer
5190340|NCT00863200|African Americans|african americans
5190341|NCT00863200|Latinos|latinos
5190342|NCT00863200|Hispanics|hispanics
5190343|NCT00863200|Interactive voice response|interactive voice response
5190344|NCT00863200|IVR|ivr
5190345|NCT00863200|Behavioral Intervention|behavioral intervention
5190346|NCT00863174|Multiple myeloma|multiple myeloma
5190347|NCT00863174|Bio-equivalence|bio-equivalence
5190348|NCT00863161|Safety|safety
5190349|NCT00863161|tolerability|tolerability
5190350|NCT00863161|exposure|exposure
5190351|NCT00863161|healthy|healthy
5190352|NCT00863161|renally impaired subjects|renally impaired subjects
5190353|NCT00863148|MDS|mds
5190354|NCT00863148|AML|aml
5190355|NCT00863148|ALL|all
5190356|NCT00863148|RIC|ric
5190357|NCT00863148|clofarabine|clofarabine
5190358|NCT00863148|allo-HSCT|allo-hsct
5190359|NCT00863148|high-risk MDS/AML|high-risk mds/aml
5190360|NCT00863135|obstructive sleep apnea|obstructive sleep apnea
5190361|NCT00863135|refractory arterial hypertension|refractory arterial hypertension
5190362|NCT00863135|continuous positive airways pressure|continuous positive airways pressure
5190363|NCT00863122|Lapatinib|lapatinib
5190364|NCT00863122|Tykerb|tykerb
5190365|NCT00863122|EGFR inhibitor|egfr inhibitor
5190366|NCT00863122|ErbB2 inhibitor|erbb2 inhibitor
5190367|NCT00863122|Pharmacokinetics|pharmacokinetics
5190368|NCT00863096|HPV|hpv
5190369|NCT00863096|acceptability|acceptability
5190370|NCT00863083|pediatric obesity|pediatric obesity
5190371|NCT00863083|pediatric overweight|pediatric overweight
5190372|NCT00863083|multi-family group weight management intervention|multi-family group weight management intervention
5190373|NCT00863083|financial rewards|financial rewards
5190374|NCT00863070|Bladder exstrophy|bladder exstrophy
5190375|NCT00863070|Abnormal gait|abnormal gait
5190376|NCT00863070|anatomy|anatomy
5190377|NCT00863070|urinary bladder disease|urinary bladder disease
5190378|NCT00863070|urogenital abnormalities|urogenital abnormalities
5190379|NCT00863057|HIV Infections|hiv infections
5190380|NCT00863057|Neuropathy|neuropathy
5190381|NCT00863057|Pain|pain
5190382|NCT00863044|off pump coronary bypass|off pump coronary bypass
5190383|NCT00863044|high frequency ventilation|high frequency ventilation
5190384|NCT00863044|cerebral oxygen saturation|cerebral oxygen saturation
5190385|NCT00863044|vasopressors used|vasopressors used
5190386|NCT00863044|right and left ventricular function|right and left ventricular function
5190387|NCT00863044|arterial blood pressure|arterial blood pressure
5190388|NCT00863044|heart rate|heart rate
5190389|NCT00863031|mental health|mental health
5190390|NCT00863031|problem-solving therapy|problem-solving therapy
5190391|NCT00863031|elderly|elderly
5190392|NCT00863031|health-related quality of life|health-related quality of life
5190393|NCT00863031|primary care|primary care
5190394|NCT00863031|Chinese|chinese
5190395|NCT00863018|Corneal endothelial cell|corneal endothelial cell
5190396|NCT00863018|Specular microscopy|specular microscopy
5190397|NCT00863018|Glaucoma implant surgery|glaucoma implant surgery
5190398|NCT00863018|Ahmed glaucoma valve|ahmed glaucoma valve
5190399|NCT00863018|Trabeculectomy|trabeculectomy
5190400|NCT00862992|schizophrenia|schizophrenia
5190401|NCT00862992|antipsychotics|antipsychotics
5190402|NCT00862992|dopamine D3/D2 antagonist|dopamine d3/d2 antagonist
5190403|NCT00862979|Heart Transplantation|heart transplantation
5190404|NCT00862979|Cardiac Transplantation|cardiac transplantation
5190405|NCT00862979|CNI-sparing|cni-sparing
5190406|NCT00862979|renal function|renal function
5190407|NCT00862979|CNI|cni
5190408|NCT00862979|Cyclosporine A|cyclosporine a
5190409|NCT00862979|Everolimus|everolimus
5190410|NCT00862979|mycophenolic acid|mycophenolic acid
5190411|NCT00862953|low carbohydrate|low carbohydrate
5190412|NCT00862953|high protein diet|high protein diet
5190413|NCT00862940|Memantine|memantine
5190414|NCT00862940|Neuroimaging|neuroimaging
5190415|NCT00862940|MRI|mri
5190416|NCT00862940|Brain atrophy|brain atrophy
5190417|NCT00862927|Smoking Cessation|smoking cessation
5190418|NCT00862927|Cigarette Smoking|cigarette smoking
5190419|NCT00862927|Tobacco Smoking|tobacco smoking
5190420|NCT00862927|Cue Reactivity|cue reactivity
5190421|NCT00862927|Virtual Reality|virtual reality
5190422|NCT00862927|VR|vr
5190423|NCT00862927|Contextual Cues|contextual cues
5190424|NCT00862927|Explicit Smoking Cues|explicit smoking cues
5190425|NCT00862927|Craving|craving
5190426|NCT00862927|Physiological Arousal|physiological arousal
5190427|NCT00862927|Nicotine Dependence|nicotine dependence
5190428|NCT00862927|Breath Sample|breath sample
5190429|NCT00862927|Saliva Test|saliva test
5190430|NCT00862927|Questionnaire|questionnaire
5190431|NCT00862914|Skin|skin
5190432|NCT00862914|MicroRNA|microrna
5190433|NCT00862914|miRNA|mirna
5190434|NCT00862914|Dicer|dicer
5190435|NCT00862914|Malignant Melanoma|malignant melanoma
5190436|NCT00862901|cancer|cancer
5190437|NCT00862901|skin metastases|skin metastases
5190438|NCT00862901|chest wall progression of breast cancer|chest wall progression of breast cancer
5190439|NCT00862901|malignant melanoma|malignant melanoma
5190440|NCT00862901|photodynamic therapy|photodynamic therapy
5190441|NCT00862901|photophrin|photophrin
5190442|NCT00862901|satellite and in-transit metastases of malignant melanoma|satellite and in-transit metastases of malignant melanoma
5190443|NCT00862901|skin cancer|skin cancer
5190444|NCT00862875|Insulin initiation|insulin initiation
5190445|NCT00862875|oral therapy failure|oral therapy failure
5190446|NCT00862862|infection|infection
5190447|NCT00862862|staphylococcus aureus|staphylococcus aureus
5190448|NCT00862862|vancomycin|vancomycin
5190449|NCT00862862|pharmacodynammics|pharmacodynammics
5190450|NCT00862849|rHuPH20|rhuph20
5190451|NCT00862849|Recombinant Human Hyaluronidase|recombinant human hyaluronidase
5190452|NCT00862849|Insulin Lispro|insulin lispro
5190453|NCT00862849|Regular Human Insulin|regular human insulin
5190454|NCT00862836|ZD6474|zd6474
5190455|NCT00862836|Vandetanib|vandetanib
5190456|NCT00862836|Zactima|zactima
5190457|NCT00862836|Ovarian Cancer|ovarian cancer
5190458|NCT00862836|Phase I|phase i
5190459|NCT00862836|Phase II|phase ii
5190460|NCT00862836|Randomized|randomized
5190461|NCT00862836|Safety|safety
5190462|NCT00862823|Healthy Volunteers|healthy volunteers
5190463|NCT00862810|Human papillomavirus|human papillomavirus
5190464|NCT00862810|Cervical cancer|cervical cancer
5190465|NCT00862810|Genital warts|genital warts
5190466|NCT00862810|Vaccine|vaccine
5190467|NCT00862810|Immunogenicity|immunogenicity
5190468|NCT00862797|endotracheal tube|endotracheal tube
5190469|NCT00862797|swallowing|swallowing
5190470|NCT00862797|aspiration|aspiration
5190471|NCT00862797|cuff pressure|cuff pressure
5190472|NCT00862797|pneumonia|pneumonia
5190473|NCT00862784|Colorectal carcinoma|colorectal carcinoma
5190474|NCT00862784|CRC|crc
5190475|NCT00862784|Colon Cancer|colon cancer
5190476|NCT00862758|juvenile idiopathic arthritis|juvenile idiopathic arthritis
5190477|NCT00862732|active suicidal ideation|active suicidal ideation
5190478|NCT00862732|cognitive behavioural therapy|cognitive behavioural therapy
5190479|NCT00862732|Sri Lanka|sri lanka
5190480|NCT00862732|RCT|rct
5190481|NCT00862706|Chronic HBV|chronic hbv
5190482|NCT00862693|Immunoglobulin A|immunoglobulin a
5190483|NCT00862693|Antibodies|antibodies
5190484|NCT00862693|treatment|treatment
5190485|NCT00862680|Lung Colorectum|lung colorectum
5190486|NCT00862680|Colorectal cancer|colorectal cancer
5190487|NCT00862680|Lung Cancer|lung cancer
5190488|NCT00862680|Liver Cancer|liver cancer
5190489|NCT00862680|Non-small cell lung cancer|non-small cell lung cancer
5190490|NCT00862680|NSCLC|nsclc
5190491|NCT00862680|4D PET/CT Imaging|4d pet/ct imaging
5190492|NCT00862680|Positron emission tomography/computed tomography|positron emission tomography/computed tomography
5190493|NCT00862680|PET/CT scan|pet/ct scan
5190494|NCT00862680|Breathing motion|breathing motion
5190495|NCT00862667|Pharmacokinetics|pharmacokinetics
5190496|NCT00862641|regadenoson|regadenoson
5190497|NCT00862641|CVT 3146|cvt 3146
5190498|NCT00862641|asthma|asthma
5190499|NCT00862641|coronary artery disease|coronary artery disease
5190500|NCT00862641|pulmonary disease, chronic obstructive|pulmonary disease, chronic obstructive
5190501|NCT00862615|Ageing|ageing
5190502|NCT00862615|Inflammation|inflammation
5190503|NCT00862615|Muscle protein synthesis|muscle protein synthesis
5190504|NCT00862615|Osteopenia|osteopenia
5190505|NCT00862615|Sarcopenia|sarcopenia
5190506|NCT00862602|GDM|gdm
5190507|NCT00862602|gestational diabetes|gestational diabetes
5190508|NCT00862602|pregnancy|pregnancy
5190509|NCT00862602|diabetes|diabetes
5190510|NCT00862602|walking|walking
5190511|NCT00862602|exercise|exercise
5190512|NCT00862602|pedometer|pedometer
5190513|NCT00862602|online|online
5190514|NCT00862589|glucagon|glucagon
5190515|NCT00862589|GLP-1|glp-1
5190516|NCT00862589|hyperglycemia|hyperglycemia
5190517|NCT00862576|Burning Mouth Syndrome|burning mouth syndrome
5190518|NCT00862576|Sleep|sleep
5190519|NCT00862576|Neuropathic pain|neuropathic pain
5190520|NCT00862576|Glossodynia|glossodynia
5190521|NCT00862576|Chronic pain|chronic pain
5190522|NCT00862576|Orofacial pain|orofacial pain
5190523|NCT00862563|Alcoholism|alcoholism
5190524|NCT00862563|Alcohol Dependence|alcohol dependence
5190525|NCT00862563|Alcohol Abuse|alcohol abuse
5190526|NCT00862563|Substance Abuse|substance abuse
5190527|NCT00862563|Alcoholic Intoxication|alcoholic intoxication
5190528|NCT00862550|Head and Neck Cancer|head and neck cancer
5190529|NCT00862550|HNC|hnc
5190530|NCT00862550|Nasopharyngeal carcinoma|nasopharyngeal carcinoma
5190531|NCT00862550|Acupuncture|acupuncture
5190532|NCT00862550|Radiation-Induced Xerostomia|radiation-induced xerostomia
5190533|NCT00862550|Xerostomia|xerostomia
5190534|NCT00862550|Dry Mouth|dry mouth
5190535|NCT00862550|Radiation|radiation
5190536|NCT00862511|metal ion concentration|metal ion concentration
5190537|NCT00862511|total knee arthroplasty|total knee arthroplasty
5190538|NCT00862511|metal hypersensitivity|metal hypersensitivity
5190539|NCT00862498|PTSD|ptsd
5190540|NCT00862498|Written Disclosure|written disclosure
5190541|NCT00862498|Written Emotional Disclosure|written emotional disclosure
5190542|NCT00862498|Narrative Exposure|narrative exposure
5190543|NCT00862498|Narrative Writing|narrative writing
5190544|NCT00862498|Motor Vehicle Accident|motor vehicle accident
5190545|NCT00862472|open-angle glaucoma|open-angle glaucoma
5190546|NCT00862472|ocular hypertension|ocular hypertension
5190547|NCT00862472|open-angle glaucoma (with or without pseudoexfoliation or pigment dispersion component)|open-angle glaucoma (with or without pseudoexfoliation or pigment dispersion component)
5190548|NCT00862459|Contrast Agents|contrast agents
5190549|NCT00862446|Parenteral nutrition associate liver disease|parenteral nutrition associate liver disease
5190550|NCT00862446|TPN cholestasis|tpn cholestasis
5190551|NCT00862446|TPN Associated Liver Disease|tpn associated liver disease
5190552|NCT00862433|Vitamin C|vitamin c
5190553|NCT00862433|Antioxidant|antioxidant
5190554|NCT00862433|Lipid Peroxidation|lipid peroxidation
5190555|NCT00862433|Non-Insulin Requiring Diabetics|non-insulin requiring diabetics
5190556|NCT00862433|Alpha-Tocopherol|alpha-tocopherol
5190557|NCT00862433|Health Volunteer|health volunteer
5190558|NCT00862433|HV|hv
5190559|NCT00862433|Normal Weight|normal weight
5190560|NCT00862433|Overweight|overweight
5190561|NCT00862433|Type 2 Diabetes|type 2 diabetes
5190562|NCT00862420|Platelet aggregation inhibitors|platelet aggregation inhibitors
5190563|NCT00862420|Peripheral arterial disease (PAD)|peripheral arterial disease (pad)
5190564|NCT00862407|Cardiopulmonary bypass|cardiopulmonary bypass
5190565|NCT00862407|Non-pulsatile perfusion|non-pulsatile perfusion
5190566|NCT00862407|Pulsatile perfusion|pulsatile perfusion
5190567|NCT00862407|plasma proteins|plasma proteins
5190568|NCT00862381|shock|shock
5190569|NCT00862381|Tracheal Intubation|tracheal intubation
5190570|NCT00862381|reanimation|reanimation
5190571|NCT00862381|suprarenal insufficiency|suprarenal insufficiency
5190572|NCT00862381|Etomidate|etomidate
5190573|NCT00862381|Adrenocorticotropic Hormone|adrenocorticotropic hormone
5190574|NCT00862381|hydrocortisone|hydrocortisone
5190575|NCT00862368|Motivational Interviewing|motivational interviewing
5190576|NCT00862368|Pediatric Asthma|pediatric asthma
5190577|NCT00862368|Smoking Cessation|smoking cessation
5190578|NCT00862368|Environmental Tobacco Smoke|environmental tobacco smoke
5190579|NCT00862368|Second hand smoke|second hand smoke
5190580|NCT00862368|Biomarker|biomarker
5190581|NCT00862368|Asthma|asthma
5190582|NCT00862368|Asthma Education|asthma education
5190583|NCT00862368|Family Intervention|family intervention
5190584|NCT00862368|Smoking|smoking
5190585|NCT00862368|Nicotine Patch|nicotine patch
5190586|NCT00862368|Parents|parents
5190587|NCT00862368|Caregivers|caregivers
5190588|NCT00862368|Child Wellness|child wellness
5190589|NCT00862355|Carcinoma|carcinoma
5190590|NCT00862355|Ovary|ovary
5190591|NCT00862355|Carcinoma Ovary|carcinoma ovary
5190592|NCT00862342|colorectal cancer|colorectal cancer
5190593|NCT00862342|Bevacizumab|bevacizumab
5190594|NCT00862329|Healthy subjects|healthy subjects
5190595|NCT00862316|Eligible for Unicompartmental Knee Arthritis|eligible for unicompartmental knee arthritis
5190596|NCT00862303|autologous cytokine induced killer cells|autologous cytokine induced killer cells
5190597|NCT00862303|dendritic cell|dendritic cell
5190598|NCT00862303|vaccine|vaccine
5190599|NCT00862303|renal cell carcinoma|renal cell carcinoma
5190600|NCT00862290|sepsis|sepsis
5190601|NCT00862290|microRNA|microrna
5190602|NCT00862277|Menactra®|menactra®
5190603|NCT00862277|Menomune®|menomune®
5190604|NCT00862277|Meningitis|meningitis
5190605|NCT00862277|Meningococcal Infections|meningococcal infections
5190606|NCT00862251|cardiovascular disorder|cardiovascular disorder
5190607|NCT00862225|rhinomanometry|rhinomanometry
5190608|NCT00862225|mode of action|mode of action
5190609|NCT00862225|grass pollen|grass pollen
5190610|NCT00862212|anxiety|anxiety
5190611|NCT00862212|social anxiety|social anxiety
5190612|NCT00862212|social anxiety disorder|social anxiety disorder
5190613|NCT00862212|coping behaviors|coping behaviors
5190614|NCT00862212|alcohol abuse|alcohol abuse
5190615|NCT00862186|Neoplasms|neoplasms
5190616|NCT00862186|Fatigue|fatigue
5190617|NCT00862186|Self Care|self care
5190618|NCT00862173|Gene-expression profile|gene-expression profile
5190619|NCT00862173|Central nervous system metastasis|central nervous system metastasis
5190620|NCT00862173|Non-small-cell lung cancer|non-small-cell lung cancer
5190621|NCT00862160|coronary artery bypass surgery|coronary artery bypass surgery
5190622|NCT00862160|cardiopulmonary bypass|cardiopulmonary bypass
5190623|NCT00862160|heart lung machine|heart lung machine
5190624|NCT00862160|acute cerebrovascular event|acute cerebrovascular event
5190625|NCT00862160|intracranial embolism|intracranial embolism
5190626|NCT00862160|embolism, air|embolism, air
5190627|NCT00862160|outcome assessment (health care)|outcome assessment (health care)
5190628|NCT00862160|neuropsychological tests|neuropsychological tests
5190629|NCT00862160|magnetic resonance imaging|magnetic resonance imaging
5190630|NCT00862160|saccadic eye movement test|saccadic eye movement test
5190631|NCT00862147|Child psychosocial Functioning|child psychosocial functioning
5190632|NCT00862108|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
5190633|NCT00862108|Polymorphism, Single Nucleotide|polymorphism, single nucleotide
5190634|NCT00862108|SLC6A2 protein, human|slc6a2 protein, human
5190635|NCT00862108|ADRA2A protein, human|adra2a protein, human
5190636|NCT00862056|asymptomatic|asymptomatic
5190637|NCT00862056|coronary artery disease|coronary artery disease
5190638|NCT00862043|Secondary Pulmonary Hypertension|secondary pulmonary hypertension
5190639|NCT00862043|Valvular Heart Disease|valvular heart disease
5190640|NCT00862043|Phosphodiesterase-Inhibitors|phosphodiesterase-inhibitors
5190641|NCT00862043|Sildenafil|sildenafil
5190642|NCT00862043|Outcomes Research|outcomes research
5190643|NCT00862030|Palliative radiotherapy|palliative radiotherapy
5190644|NCT00862030|Treatment planning|treatment planning
5190645|NCT00862030|Non-small cell lung cancer|non-small cell lung cancer
5190646|NCT00862017|Physiology|physiology
5190647|NCT00862004|video-assisted thoracoscopic surgery (VATS)|video-assisted thoracoscopic surgery (vats)
5190648|NCT00862004|systematic node dissection (SND)|systematic node dissection (snd)
5190649|NCT00862004|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5190650|NCT00861991|medical communication|medical communication
5190651|NCT00861991|empathy|empathy
5190652|NCT00861991|medical education|medical education
5190653|NCT00861991|standardized patients|standardized patients
5190654|NCT00861991|"enhancing patient satisfaction"|"enhancing patient satisfaction"
5190655|NCT00861978|mild to moderate depression with atypical features according to DSM-IV|mild to moderate depression with atypical features according to dsm-iv
5190656|NCT00861965|Leukemia|leukemia
5190657|NCT00861965|Lymphoma|lymphoma
5190658|NCT00861965|Multiple Myeloma|multiple myeloma
5190659|NCT00861952|Diabetic peripheral neuropathies|diabetic peripheral neuropathies
5190660|NCT00861952|Neuralgia|neuralgia
5190661|NCT00861952|Complementary medicine|complementary medicine
5190662|NCT00861952|Analgesia|analgesia
5190663|NCT00861926|Maintenance and Reliever Treatments|maintenance and reliever treatments
5190664|NCT00861887|Clostridium difficile|clostridium difficile
5190665|NCT00861887|colitis|colitis
5190666|NCT00861887|recurrence|recurrence
5190667|NCT00861887|relapse|relapse
5190668|NCT00861887|Vancomycin|vancomycin
5190669|NCT00861861|Pitavastatin|pitavastatin
5190670|NCT00861861|Atorvastatin|atorvastatin
5190671|NCT00861861|CAD|cad
5190672|NCT00861861|HDL-C|hdl-c
5190673|NCT00861861|Adiponectin|adiponectin
5190674|NCT00861822|Anemia|anemia
5190675|NCT00861822|Cardiac surgery|cardiac surgery
5190676|NCT00861822|RBC transfusion|rbc transfusion
5190677|NCT00861822|Acute Kidney Injury|acute kidney injury
5190678|NCT00861822|Cardiac surgery with cardiopulmonary bypass|cardiac surgery with cardiopulmonary bypass
5190679|NCT00861809|single dose|single dose
5190680|NCT00861809|gut motility|gut motility
5191950|NCT00856401|HEXT|hext
5190681|NCT00861809|Type I Diabetes Mellitus patients|type i diabetes mellitus patients
5190682|NCT00861809|tolerability|tolerability
5190683|NCT00861809|phase II|phase ii
5190684|NCT00861809|13C octanoic acid breath test|13c octanoic acid breath test
5190685|NCT00861809|pharmacodynamics|pharmacodynamics
5190686|NCT00861809|gastric emtpying|gastric emtpying
5190687|NCT00861809|pharmacokinetics|pharmacokinetics
5190688|NCT00861783|oxaliplatin|oxaliplatin
5190689|NCT00861783|diaminocyclohexane oxalatoplatinum|diaminocyclohexane oxalatoplatinum
5190690|NCT00861783|oxalatoplatin|oxalatoplatin
5190691|NCT00861783|oxalatoplatinum|oxalatoplatinum
5190692|NCT00861783|Eloxatin|eloxatin
5190693|NCT00861770|Congestive Heart Failure|congestive heart failure
5190694|NCT00861770|Ultrafiltration|ultrafiltration
5190695|NCT00861770|Blood Volume Measurement|blood volume measurement
5190696|NCT00861744|Measles, Mumps, Rubella, Varicella Vaccine|measles, mumps, rubella, varicella vaccine
5190697|NCT00861744|Children|children
5190698|NCT00861744|Immunogenicity|immunogenicity
5190699|NCT00861744|Safety|safety
5190700|NCT00861744|Humans|humans
5190701|NCT00861744|Combined Vaccine|combined vaccine
5190702|NCT00861744|Vaccines|vaccines
5190703|NCT00861731|chronic renal failure|chronic renal failure
5190704|NCT00861731|proteinuria|proteinuria
5190705|NCT00861731|apolipoprotein|apolipoprotein
5190706|NCT00861731|c reactive protein|c reactive protein
5190707|NCT00861718|Phase 1|phase 1
5190708|NCT00861718|Healthy Volunteer|healthy volunteer
5190709|NCT00861692|Argatroban|argatroban
5190710|NCT00861692|heparin induced thrombocytopenia (HIT)|heparin induced thrombocytopenia (hit)
5190711|NCT00861692|direct thrombin inhibitor (DTI)|direct thrombin inhibitor (dti)
5190712|NCT00861679|HSCT|hsct
5190713|NCT00861679|ALL|all
5190714|NCT00861679|GvHD|gvhd
5190715|NCT00861666|Forgiveness|forgiveness
5190716|NCT00861666|Writing|writing
5190717|NCT00861666|PTSD|ptsd
5190718|NCT00861666|OEF|oef
5190719|NCT00861666|OIF|oif
5190720|NCT00861666|Veterans|veterans
5190721|NCT00861653|Atherosclerosis|atherosclerosis
5190722|NCT00861653|Subjects diagnosed with atherosclerosis|subjects diagnosed with atherosclerosis
5190723|NCT00861640|rabeprazole|rabeprazole
5190724|NCT00861640|omeprazole|omeprazole
5190725|NCT00861640|upper gastrointestinal bleeding|upper gastrointestinal bleeding
5190726|NCT00861627|REOLYSIN|reolysin
5190727|NCT00861627|reovirus|reovirus
5190728|NCT00861627|non-small cell lung cancer|non-small cell lung cancer
5190729|NCT00861627|carcinoma|carcinoma
5190730|NCT00861627|oncolytics virus|oncolytics virus
5190731|NCT00861627|chemotherapy|chemotherapy
5190732|NCT00861627|paclitaxel|paclitaxel
5190733|NCT00861627|carboplatin|carboplatin
5190734|NCT00861588|complementary & alternative medicine|complementary & alternative medicine
5190735|NCT00861588|randomized control trial|randomized control trial
5190736|NCT00861588|uroflowmetry|uroflowmetry
5190737|NCT00861588|quality of life|quality of life
5190738|NCT00861588|benign prostate hyperplasia|benign prostate hyperplasia
5190739|NCT00861575|Cardiovascular|cardiovascular
5190740|NCT00861562|constipation|constipation
5190741|NCT00861562|hemorrhoids|hemorrhoids
5190742|NCT00861562|water smartweed|water smartweed
5190743|NCT00861562|RCT|rct
5190744|NCT00861549|Bioavailability|bioavailability
5190745|NCT00861549|Pharmacokinetics|pharmacokinetics
5190746|NCT00861549|Safety Evaluation|safety evaluation
5190747|NCT00861536|risk factors|risk factors
5190748|NCT00861536|immunology|immunology
5190749|NCT00861523|nausea|nausea
5190750|NCT00861523|vomiting|vomiting
5190751|NCT00861523|pregnancy|pregnancy
5190752|NCT00861523|thiamine|thiamine
5190753|NCT00861523|promethazine|promethazine
5190754|NCT00861523|nausea and vomiting in pregnancy|nausea and vomiting in pregnancy
5190755|NCT00861510|Small Lymphocytic Lymphoma (SLL)|small lymphocytic lymphoma (sll)
5190756|NCT00861510|Prolymphocytic Lymphoma (PLL)|prolymphocytic lymphoma (pll)
5190757|NCT00861510|Hairy Cell Leukemia (HCL)|hairy cell leukemia (hcl)
5190758|NCT00861510|Mantle Cell Lymphoma|mantle cell lymphoma
5190759|NCT00861510|MCL|mcl
5190760|NCT00861510|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
5190761|NCT00861510|CLL|cll
5190762|NCT00861510|Multiple Myeloma|multiple myeloma
5190763|NCT00861510|MM|mm
5190764|NCT00861497|Open-label|open-label
5190765|NCT00861497|Flexible-dose|flexible-dose
5190766|NCT00861497|Extension|extension
5190767|NCT00861497|Safety study|safety study
5190768|NCT00861471|hormone refractory prostate cancer|hormone refractory prostate cancer
5190769|NCT00861471|tyrosine kinase inhibitor|tyrosine kinase inhibitor
5190770|NCT00861471|Gleevec|gleevec
5190771|NCT00861471|PSA|psa
5190772|NCT00861471|prostate specific antigen|prostate specific antigen
5190773|NCT00861471|growth factor receptor inhibitor|growth factor receptor inhibitor
5190774|NCT00861471|androgen independent|androgen independent
5190775|NCT00861445|Lacosamide, Vimpat®|lacosamide, vimpat®
5190776|NCT00861432|Life quality|life quality
5190777|NCT00861432|questionnaire|questionnaire
5190778|NCT00861432|tumor patients|tumor patients
5190779|NCT00861419|AMG 386|amg 386
5190780|NCT00861419|AMG 706|amg 706
5190781|NCT00861419|Bevacizumab|bevacizumab
5190782|NCT00861419|Sorafenib|sorafenib
5190783|NCT00861419|Angiogenesis Inhibitors|angiogenesis inhibitors
5190784|NCT00861419|Combination Therapy|combination therapy
5190785|NCT00861419|Peptibody|peptibody
5190786|NCT00861419|Sunitinib|sunitinib
5190787|NCT00861406|Melanoma|melanoma
5190788|NCT00861406|Stage II melanoma|stage ii melanoma
5190789|NCT00861406|Pegylated Interferon-alfa 2b|pegylated interferon-alfa 2b
5190790|NCT00861406|PEG Interferon alfa-2b|peg interferon alfa-2b
5190791|NCT00861406|PEG Intron|peg intron
5190792|NCT00861406|Melanoma Peptide Vaccine|melanoma peptide vaccine
5190793|NCT00861406|GP100 Vaccine|gp100 vaccine
5190794|NCT00861406|gp100|gp100
5190795|NCT00861406|peptide vaccine|peptide vaccine
5190796|NCT00861406|Leukapheresis|leukapheresis
5190797|NCT00861406|Immune-cell response|immune-cell response
5190798|NCT00861380|Pneumococcal conjugate vaccine|pneumococcal conjugate vaccine
5190799|NCT00861380|Invasive disease|invasive disease
5190800|NCT00861380|Respiratory tract infections|respiratory tract infections
5190801|NCT00861380|Haemophilus influenzae|haemophilus influenzae
5190802|NCT00861380|Streptococcus pneumoniae|streptococcus pneumoniae
5190803|NCT00861380|Acute otitis media|acute otitis media
5190804|NCT00861380|Pneumonia|pneumonia
5190805|NCT00861367|aspirin|aspirin
5190806|NCT00861367|blood loss|blood loss
5190807|NCT00861367|transurethral surgery|transurethral surgery
5190808|NCT00861354|atrial fibrillation|atrial fibrillation
5190809|NCT00861354|home blood pressure monitoring|home blood pressure monitoring
5190810|NCT00861341|Pioglitazone|pioglitazone
5190811|NCT00861341|Thiazolidinediones|thiazolidinediones
5190812|NCT00861341|Platelet Function|platelet function
5190813|NCT00861341|Platelet aggregation|platelet aggregation
5190814|NCT00861341|Diabetic|diabetic
5190815|NCT00861341|Aspirin.|aspirin.
5190816|NCT00861328|Phase 1|phase 1
5190817|NCT00861328|maximum tolerated dose|maximum tolerated dose
5190818|NCT00861328|oxaliplatin|oxaliplatin
5190819|NCT00861328|irinotecan|irinotecan
5190820|NCT00861328|ON 01910.Na|on 01910.na
5190821|NCT00861315|Pneumonia|pneumonia
5190822|NCT00861315|Nebulization|nebulization
5190823|NCT00861315|Amikacin|amikacin
5190824|NCT00861276|Smoking Cessation|smoking cessation
5190825|NCT00861276|Nicotine|nicotine
5190826|NCT00861276|Administration and dosage|administration and dosage
5190827|NCT00861276|Randomized Controlled Trial|randomized controlled trial
5190828|NCT00861250|Bortezomib plus dexamethasone induction therapy|bortezomib plus dexamethasone induction therapy
5190829|NCT00861250|Autologous stem cell transplantation|autologous stem cell transplantation
5190830|NCT00861250|Molecular remission|molecular remission
5190831|NCT00861237|Nux vomica|nux vomica
5190832|NCT00861237|homeopathy|homeopathy
5190833|NCT00861237|heart lung machine|heart lung machine
5190834|NCT00861237|heart surgery|heart surgery
5190835|NCT00861237|postoperatively studied|postoperatively studied
5190836|NCT00861211|asthma|asthma
5190837|NCT00861211|inflammation|inflammation
5190838|NCT00861211|bronchoconstriction|bronchoconstriction
5190839|NCT00861211|allergen challenge|allergen challenge
5190840|NCT00861211|KCa3.1|kca3.1
5190841|NCT00861185|bronchospasm|bronchospasm
5190842|NCT00861185|exercise asthma|exercise asthma
5190843|NCT00861185|inflammation|inflammation
5190844|NCT00861185|KCa3.1|kca3.1
5190845|NCT00861172|Multiple sclerosis|multiple sclerosis
5190846|NCT00861172|Active plaque|active plaque
5190847|NCT00861172|Multimodal analysis|multimodal analysis
5190848|NCT00861172|3T MRI|3t mri
5190849|NCT00861172|Weekly follow-up|weekly follow-up
5190850|NCT00861172|Physiopathology|physiopathology
5190851|NCT00861172|Physiopathology of active lesions formation in Multiple Sclerosis using multimodal MR sequences|physiopathology of active lesions formation in multiple sclerosis using multimodal mr sequences
5190852|NCT00861159|RLIP76 Auto Antibodies|rlip76 auto antibodies
5190853|NCT00861146|nicotine dependence|nicotine dependence
5190854|NCT00861146|tobacco dependence|tobacco dependence
5190855|NCT00861146|smoking cessation|smoking cessation
5190856|NCT00861146|alcoholism|alcoholism
5190857|NCT00861146|self-efficacy|self-efficacy
5190858|NCT00861146|relapse|relapse
5190859|NCT00861133|cardiac monitor|cardiac monitor
5190860|NCT00861133|loop recorder|loop recorder
5190861|NCT00861133|stroke|stroke
5190862|NCT00861133|ECG|ecg
5190863|NCT00861133|Implantable Loop Recorder|implantable loop recorder
5190864|NCT00861133|cryptogenic|cryptogenic
5190865|NCT00861133|ILR|ilr
5190866|NCT00861120|Ovarian cancer|ovarian cancer
5190867|NCT00861120|KRAS wildtype|kras wildtype
5190868|NCT00861120|Platinum resistant|platinum resistant
5190869|NCT00861107|Colorectal cancer|colorectal cancer
5190870|NCT00861107|Breast Cancer|breast cancer
5190871|NCT00861107|Melanoma|melanoma
5190872|NCT00861107|GI cancer|gi cancer
5190873|NCT00861107|Prostate cancer|prostate cancer
5190874|NCT00861107|Kidney cancer|kidney cancer
5190875|NCT00861107|Lung cancer|lung cancer
5190876|NCT00861107|all types metastatic cancer where at least one tumor lesion is accessable for percutaneous cryoablation|all types metastatic cancer where at least one tumor lesion is accessable for percutaneous cryoablation
5190877|NCT00861094|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
5190878|NCT00861094|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
5190879|NCT00861094|stage IIA esophageal cancer|stage iia esophageal cancer
5190880|NCT00861094|stage IIB esophageal cancer|stage iib esophageal cancer
5190881|NCT00861094|stage IIIA esophageal cancer|stage iiia esophageal cancer
5190882|NCT00861094|stage IIIB esophageal cancer|stage iiib esophageal cancer
5190883|NCT00861094|stage IIIC esophageal cancer|stage iiic esophageal cancer
5190884|NCT00861094|stage IV esophageal cancer|stage iv esophageal cancer
5190885|NCT00861081|Group Clinics|group clinics
5190886|NCT00861081|Self Management|self management
5190887|NCT00861068|Lacosamide, Vimpat®|lacosamide, vimpat®
5190888|NCT00861042|Lacosamide, Vimpat®|lacosamide, vimpat®
5190889|NCT00861029|GW786034, pazopanib, moxifloxacin, ECG intervals and morphology, QTc, Holter monitor, pharmacokinetics, safety, cancer|gw786034, pazopanib, moxifloxacin, ecg intervals and morphology, qtc, holter monitor, pharmacokinetics, safety, cancer
5190890|NCT00861016|Post marketing study|post marketing study
5190891|NCT00861003|schizophrenia|schizophrenia
5190892|NCT00861003|adherence|adherence
5190893|NCT00860977|HIV|hiv
5190894|NCT00860977|Herpes simplex virus type II|herpes simplex virus type ii
5190895|NCT00860977|Genital herpes|genital herpes
5190896|NCT00860977|Treatment Naive|treatment naive
5190897|NCT00860964|estradiol valerate|estradiol valerate
5190898|NCT00860964|Medroxyprogesterone|medroxyprogesterone
5190899|NCT00860964|menopause|menopause
5190900|NCT00860964|Lipid|lipid
5190901|NCT00860964|Bone mineral density|bone mineral density
5190902|NCT00860964|Body Composition|body composition
5190903|NCT00860951|Normal|normal
5190904|NCT00860938|Inhaled corticosteroids|inhaled corticosteroids
5190905|NCT00860938|COPD|copd
5190906|NCT00860938|mannitol|mannitol
5190907|NCT00860925|Randomized Controlled Trial|randomized controlled trial
5190908|NCT00860925|Blinded|blinded
5190909|NCT00860925|Clonidine|clonidine
5190910|NCT00860925|acetyl-salicylic acid (ASA)|acetyl-salicylic acid (asa)
5190911|NCT00860925|Perioperative vascular complications|perioperative vascular complications
5190912|NCT00860925|Noncardiac surgery|noncardiac surgery
5190913|NCT00860912|Veritas|veritas
5190914|NCT00860912|Cystocele|cystocele
5190915|NCT00860912|Prolapse|prolapse
5190916|NCT00860899|clonidine|clonidine
5190917|NCT00860899|levobupivacaine|levobupivacaine
5190918|NCT00860899|preoperative analgesia|preoperative analgesia
5190919|NCT00860899|postoperative pain|postoperative pain
5190920|NCT00860899|systemic inflammatory stress response|systemic inflammatory stress response
5190921|NCT00860899|epidural analgesia|epidural analgesia
5190922|NCT00860899|Anesthetics, Local|anesthetics, local
5190923|NCT00860886|Mongolia|mongolia
5190924|NCT00860886|Asia|asia
5190925|NCT00860886|GROWTH FACTORS|growth factors
5190926|NCT00860886|Hormones|hormones
5190927|NCT00860886|Premenopausal|premenopausal
5190928|NCT00860886|Breast Cancer|breast cancer
5190929|NCT00860860|radioimmunotherapy|radioimmunotherapy
5190930|NCT00860860|pretargeting|pretargeting
5190931|NCT00860860|bispecific antibody|bispecific antibody
5190932|NCT00860860|lutetium 177|lutetium 177
5190933|NCT00860860|phase I clinical trial|phase i clinical trial
5190934|NCT00860847|Progression of Atherosclerosis|progression of atherosclerosis
5190935|NCT00860847|Aged garlic extract|aged garlic extract
5190936|NCT00860847|Biomarkers of inflammation|biomarkers of inflammation
5190937|NCT00860847|Coronary Plaque Volume and coronary Stenosis|coronary plaque volume and coronary stenosis
5190938|NCT00860847|Vascular function|vascular function
5190939|NCT00860834|Consumer Participation|consumer participation
5190940|NCT00860834|Telephone Coaching Program|telephone coaching program
5190941|NCT00860821|Healthy subjects|healthy subjects
5190942|NCT00860821|LPS|lps
5190943|NCT00860821|Effect|effect
5190944|NCT00860821|Intranasally|intranasally
5190945|NCT00860808|tinnitus|tinnitus
5190946|NCT00860795|Echinacea|echinacea
5190947|NCT00860795|prevention|prevention
5190948|NCT00860795|immune modulation|immune modulation
5190949|NCT00860782|Sickle Cell Disease|sickle cell disease
5190950|NCT00860782|Educational Outcomes|educational outcomes
5190951|NCT00860782|Neurodevelopmental Functioning|neurodevelopmental functioning
5190952|NCT00860756|sleep|sleep
5190953|NCT00860756|disturbance|disturbance
5190954|NCT00860756|deployment|deployment
5190955|NCT00860756|intervention|intervention
5190956|NCT00860756|actigraph|actigraph
5190957|NCT00860743|intermittent hypoxia|intermittent hypoxia
5190958|NCT00860743|ventilatory long-term facilitation|ventilatory long-term facilitation
5190959|NCT00860743|autonomic nervous system plasticity|autonomic nervous system plasticity
5190960|NCT00860730|Aortic valve replacement|aortic valve replacement
5190961|NCT00860730|Aortic stenosis|aortic stenosis
5190962|NCT00860730|Biological valve|biological valve
5190963|NCT00860730|Sutureless valve|sutureless valve
5190964|NCT00860730|Stented valve|stented valve
5190965|NCT00860730|Aortic Valve Disease|aortic valve disease
5190966|NCT00860717|Leprosy|leprosy
5190967|NCT00860717|Ulcers|ulcers
5190968|NCT00860717|Laser|laser
5190969|NCT00860704|goal directed fluid therapy|goal directed fluid therapy
5190970|NCT00860704|lean patients|lean patients
5190971|NCT00860704|obese patients|obese patients
5190972|NCT00860704|crystalloids|crystalloids
5190973|NCT00860704|Esophageal Doppler|esophageal doppler
5190974|NCT00860704|tissue oxygenation|tissue oxygenation
5190975|NCT00860704|Fluid management during surgery|fluid management during surgery
5190976|NCT00860704|Fluid management|fluid management
5190977|NCT00860691|Curative surgical resection|curative surgical resection
5190978|NCT00860691|Laparoscopic technique|laparoscopic technique
5190979|NCT00860665|colorectal cancer|colorectal cancer
5190980|NCT00860665|prevention|prevention
5190981|NCT00860665|colonoscopy|colonoscopy
5190982|NCT00860665|screening|screening
5190983|NCT00860665|quality assessment|quality assessment
5190984|NCT00860665|colorectal cancer prevention|colorectal cancer prevention
5190985|NCT00860652|Oncology|oncology
5190986|NCT00860652|Prostate Cancer|prostate cancer
5190987|NCT00860652|Radiotherapy|radiotherapy
5190988|NCT00860652|Radical Prostatectomy|radical prostatectomy
5190989|NCT00860652|Prior Radical Prostatectomy (RP)|prior radical prostatectomy (rp)
5190990|NCT00860652|Histological Confirmation of adenocarcinoma of the prostate|histological confirmation of adenocarcinoma of the prostate
5190991|NCT00860652|Positive margins and/or extraprostatic extension (EPE)|positive margins and/or extraprostatic extension (epe)
5190992|NCT00860639|AML|aml
5190993|NCT00860639|gemtuzumab ozogamycin|gemtuzumab ozogamycin
5190994|NCT00860613|gestational diabetes|gestational diabetes
5190995|NCT00860613|medical nutrition therapy program|medical nutrition therapy program
5190996|NCT00860613|glucose monitoring|glucose monitoring
5190997|NCT00860613|metabolic control|metabolic control
5190998|NCT00860613|nutritional status|nutritional status
5190999|NCT00860613|cost effectiveness|cost effectiveness
5191000|NCT00860600|Idiopathic Thrombocytopenic Purpura (ITP)|idiopathic thrombocytopenic purpura (itp)
5191001|NCT00860600|Platelet Response|platelet response
5191002|NCT00860600|PG2 Treatment|pg2 treatment
5191003|NCT00860600|Quality of Life|quality of life
5191004|NCT00860600|Fatigue|fatigue
5191005|NCT00860600|WHO Bleeding score|who bleeding score
5191006|NCT00860587|Antibiotic resistance|antibiotic resistance
5191007|NCT00860587|Antibiotic treatment|antibiotic treatment
5191008|NCT00860561|Efficacy profile|efficacy profile
5191009|NCT00860561|Safety profile|safety profile
5191010|NCT00860561|Faslodex|faslodex
5191011|NCT00860522|relapsed leukemia|relapsed leukemia
5191012|NCT00860522|refractory leukemia|refractory leukemia
5191013|NCT00860509|phytosterols|phytosterols
5191014|NCT00860509|cholesterol excretion|cholesterol excretion
5191015|NCT00860509|cholesterol absorption|cholesterol absorption
5191016|NCT00860509|diet|diet
5191017|NCT00860509|mass spectrometry|mass spectrometry
5191018|NCT00860509|deuterium|deuterium
5191019|NCT00860496|Immunosuppression, JAK3 inhibitor, calcineurin inhibitors, tacrolimus, cyclosporine, pharmacokinetics, safety, tolerability|immunosuppression, jak3 inhibitor, calcineurin inhibitors, tacrolimus, cyclosporine, pharmacokinetics, safety, tolerability
5191020|NCT00860483|Comparison of experienced and novice laparoscopic surgeons|comparison of experienced and novice laparoscopic surgeons
5191021|NCT00860470|micronutrients|micronutrients
5191022|NCT00860470|deficiency|deficiency
5191023|NCT00860470|pregnancy|pregnancy
5191024|NCT00860470|birth outcomes|birth outcomes
5191025|NCT00860470|infant mortality|infant mortality
5191026|NCT00860470|neonatal mortality|neonatal mortality
5191027|NCT00860470|malnutrition|malnutrition
5191028|NCT00860470|antenatal|antenatal
5191029|NCT00860457|Leukemia|leukemia
5191030|NCT00860444|Primary Care|primary care
5191031|NCT00860444|Diet|diet
5191032|NCT00860444|Physical Activity|physical activity
5191033|NCT00860418|asthma|asthma
5191034|NCT00860418|feedback|feedback
5191035|NCT00860418|anti-inflammatory|anti-inflammatory
5191036|NCT00860418|ED visits|ed visits
5191037|NCT00860366|Acute ischemic stroke|acute ischemic stroke
5191038|NCT00860366|thrombolysis|thrombolysis
5191039|NCT00860366|alteplase|alteplase
5191040|NCT00860366|uric acid|uric acid
5191041|NCT00860366|neuroprotection|neuroprotection
5191042|NCT00860366|oxidative stress|oxidative stress
5191043|NCT00860353|Healthy Volunteer|healthy volunteer
5191044|NCT00860353|Single Ascending Dose|single ascending dose
5191045|NCT00860353|Safety|safety
5191046|NCT00860353|Tolerability|tolerability
5191047|NCT00860353|AZD2551|azd2551
5191048|NCT00860353|Healthy Volunteer Study|healthy volunteer study
5191049|NCT00860340|Congestive Heart Failure|congestive heart failure
5191050|NCT00860340|Hemodynamics|hemodynamics
5191051|NCT00860340|Echocardiographs|echocardiographs
5191052|NCT00860327|Pediatric Heart Disease|pediatric heart disease
5191053|NCT00860327|Congenital Heart Disease|congenital heart disease
5191054|NCT00860327|Congenital Heart Defects|congenital heart defects
5191055|NCT00860327|Developmental Biology|developmental biology
5191056|NCT00860327|Contractile Function|contractile function
5191057|NCT00860314|external electrical cardioversion|external electrical cardioversion
5191058|NCT00860314|typical atrial flutter|typical atrial flutter
5191059|NCT00860314|electrode position|electrode position
5191060|NCT00860314|antero-lateral|antero-lateral
5191061|NCT00860314|antero-posterior|antero-posterior
5191062|NCT00860314|biphasic cardioversion|biphasic cardioversion
5191063|NCT00860314|step-up protocol|step-up protocol
5191064|NCT00860301|infantile colic|infantile colic
5191065|NCT00860288|Type 2 Diabetes|type 2 diabetes
5191066|NCT00860288|vildagliptin|vildagliptin
5191067|NCT00860249|education|education
5191068|NCT00860249|preventive service|preventive service
5191069|NCT00860249|screening|screening
5191070|NCT00860249|Colorectal Cancer Screening|colorectal cancer screening
5191071|NCT00860249|Prevention & Control|prevention & control
5191072|NCT00860236|CFS|cfs
5191073|NCT00860236|Giardia|giardia
5191074|NCT00860236|Fatigue|fatigue
5191075|NCT00860236|Cognitive behavioural therapy|cognitive behavioural therapy
5191076|NCT00860236|CBT|cbt
5191077|NCT00860236|Chronic fatigue syndrome|chronic fatigue syndrome
5191078|NCT00860223|Healthy Subjects|healthy subjects
5191079|NCT00860197|Coffee|coffee
5191080|NCT00860197|Elderly|elderly
5191081|NCT00860197|Immune response|immune response
5191082|NCT00860197|Inflammatory status|inflammatory status
5191083|NCT00860184|carotid artery|carotid artery
5191084|NCT00860184|atherosclerosis|atherosclerosis
5191085|NCT00860184|stroke|stroke
5191086|NCT00860184|transient ischemic attack|transient ischemic attack
5191087|NCT00860184|MRI|mri
5191088|NCT00860184|software|software
5191089|NCT00860184|risk|risk
5191090|NCT00860145|epilepsy|epilepsy
5191091|NCT00860145|radiosurgery|radiosurgery
5191092|NCT00860145|temporal lobectomy|temporal lobectomy
5191093|NCT00860132|hip fracture elderly orthogeriatric|hip fracture elderly orthogeriatric
5191094|NCT00860132|cost effectiveness of hip fracture patients|cost effectiveness of hip fracture patients
5191095|NCT00860119|Bioequivalence, Pharmacokinetics, Alprazolam, Sublingual|bioequivalence, pharmacokinetics, alprazolam, sublingual
5191096|NCT00860106|VTE|vte
5191097|NCT00860106|VKA treatment|vka treatment
5191098|NCT00860106|VKA treatment cessation|vka treatment cessation
5191099|NCT00860093|Kidney Calculi|kidney calculi
5191100|NCT00860093|Urolithiasis|urolithiasis
5191101|NCT00860093|Lithotripsy|lithotripsy
5191102|NCT00860093|potassium compounds|potassium compounds
5191103|NCT00860093|magnesium compounds|magnesium compounds
5191104|NCT00860080|post-surgery adhesion formation|post-surgery adhesion formation
5191105|NCT00860067|influenza, FluMist, adults, vaccine|influenza, flumist, adults, vaccine
5191106|NCT00860054|phytosterols|phytosterols
5191107|NCT00860054|cholesterol excretion|cholesterol excretion
5191108|NCT00860054|cholesterol absorption|cholesterol absorption
5191109|NCT00860054|diet|diet
5191110|NCT00860054|mass spectrometry|mass spectrometry
5191111|NCT00860054|deuterium|deuterium
5191112|NCT00860041|pain|pain
5191113|NCT00860041|neurotoxicity|neurotoxicity
5191114|NCT00860041|chemotherapeutic agent toxicity|chemotherapeutic agent toxicity
5191115|NCT00860041|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5191116|NCT00860028|Smoking cessation|smoking cessation
5191117|NCT00860028|Smoking|smoking
5191118|NCT00860028|Tobacco|tobacco
5191119|NCT00860028|Varenicline|varenicline
5191120|NCT00860028|Alcohol|alcohol
5191121|NCT00860002|myomectomy|myomectomy
5191122|NCT00860002|uterine artery occlusion|uterine artery occlusion
5191123|NCT00860002|uterine vessel occlusion|uterine vessel occlusion
5191124|NCT00860002|fibroids|fibroids
5191125|NCT00860002|leiomyomas|leiomyomas
5191126|NCT00860002|Surgical technique, patient suffering and outcomes|surgical technique, patient suffering and outcomes
5191127|NCT00859989|breast cancer|breast cancer
5191128|NCT00859989|weight changes|weight changes
5191129|NCT00859989|obesity|obesity
5191130|NCT00859976|BoneMaster|bonemaster
5191131|NCT00859976|Total Hip Replacement|total hip replacement
5191132|NCT00859976|Bone Density|bone density
5191133|NCT00859976|Patients suitable for Total Hip Replacement|patients suitable for total hip replacement
5191134|NCT00859963|Press fit tibial tray|press fit tibial tray
5191135|NCT00859950|Sleep Apnea|sleep apnea
5191136|NCT00859950|Vascular Occlusion|vascular occlusion
5191137|NCT00859950|Nocturnal Polysomnography|nocturnal polysomnography
5191138|NCT00859950|Continuous Positive Airway Pressure|continuous positive airway pressure
5191139|NCT00859911|micronutrients|micronutrients
5191140|NCT00859898|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
5191141|NCT00859898|Diabetes Mellitus|diabetes mellitus
5191142|NCT00859898|Endocrine System Diseases|endocrine system diseases
5191143|NCT00859898|Glucose Metabolism Disorders|glucose metabolism disorders
5191144|NCT00859898|Metabolic Diseases|metabolic diseases
5191145|NCT00859898|Metformin|metformin
5191146|NCT00859898|Dapagliflozin|dapagliflozin
5191147|NCT00859898|Hypoglycemic Agents|hypoglycemic agents
5191148|NCT00859898|Pharmacologic Actions|pharmacologic actions
5191149|NCT00859898|Physiological Effects of Drugs|physiological effects of drugs
5191150|NCT00859885|patent foramen ovale|patent foramen ovale
5191151|NCT00859885|ischemic stroke|ischemic stroke
5191152|NCT00859885|transient ischemic attack|transient ischemic attack
5191153|NCT00859885|secondary prevention|secondary prevention
5191154|NCT00859885|medical treatment|medical treatment
5191155|NCT00859885|percutaneous device closure|percutaneous device closure
5191156|NCT00859872|acute psychotic agitation|acute psychotic agitation
5191157|NCT00859872|schizophrenia|schizophrenia
5191158|NCT00859872|risperidone oral solution|risperidone oral solution
5191159|NCT00859872|clonazepam|clonazepam
5191160|NCT00859872|haloperidol|haloperidol
5191161|NCT00859846|Arterial line|arterial line
5191162|NCT00859846|Ultrasound|ultrasound
5191163|NCT00859846|Anesthesia|anesthesia
5191164|NCT00859846|Pediatric|pediatric
5191165|NCT00859833|adenosine|adenosine
5191166|NCT00859833|regadenoson|regadenoson
5191951|NCT00856401|c10-007|c10-007
5191167|NCT00859833|adenosine receptor subtypes|adenosine receptor subtypes
5191168|NCT00859807|Amodiaquine suspension|amodiaquine suspension
5191169|NCT00859807|Flavoquine tablets|flavoquine tablets
5191170|NCT00859807|Bioequivalence study|bioequivalence study
5191171|NCT00859794|Epilepsy|epilepsy
5191172|NCT00859794|fMRI|fmri
5191173|NCT00859794|Electrophysiology|electrophysiology
5191174|NCT00859794|Cortical Mapping|cortical mapping
5191175|NCT00859794|Neurosurgery|neurosurgery
5191176|NCT00859781|Prostate|prostate
5191177|NCT00859768|Cancer|cancer
5191178|NCT00859729|DNA|dna
5191179|NCT00859729|Vaccine|vaccine
5191180|NCT00859729|Electroporation|electroporation
5191181|NCT00859729|xenogenic|xenogenic
5191182|NCT00859729|PSA|psa
5191183|NCT00859716|Vaccination|vaccination
5191184|NCT00859716|Diarrhea|diarrhea
5191185|NCT00859716|Traveler's Diarrhea|traveler's diarrhea
5191186|NCT00859716|Campylobacter jejuni|campylobacter jejuni
5191187|NCT00859716|C. jejuni|c. jejuni
5191188|NCT00859716|Campylobacter|campylobacter
5191189|NCT00859716|Campy|campy
5191190|NCT00859703|Aromatase inhibitor treatment|aromatase inhibitor treatment
5191191|NCT00859703|osteoporosis|osteoporosis
5191192|NCT00859703|breast cancer|breast cancer
5191193|NCT00859703|bisphosphonates|bisphosphonates
5191194|NCT00859690|Obstructive Sleep Apnea|obstructive sleep apnea
5191195|NCT00859690|Thrombosis|thrombosis
5191196|NCT00859690|Adenosine Deaminase|adenosine deaminase
5191197|NCT00859690|Sleep Disorder|sleep disorder
5191198|NCT00859677|HIV|hiv
5191199|NCT00859677|Methicillin-resistant Staphylococcus aureus (MRSA)|methicillin-resistant staphylococcus aureus (mrsa)
5191200|NCT00859677|HIV and Staphylococcus aureus infection|hiv and staphylococcus aureus infection
5191201|NCT00859651|breast cancer chemoprevention|breast cancer chemoprevention
5191202|NCT00859651|vitamin D|vitamin d
5191203|NCT00859651|breast density|breast density
5191204|NCT00859625|colonoscopy|colonoscopy
5191205|NCT00859625|adenoma detection rate|adenoma detection rate
5191206|NCT00859599|Monochromatic Phototherapy|monochromatic phototherapy
5191207|NCT00859599|Diabetic Foot Ulcers|diabetic foot ulcers
5191208|NCT00859599|Wound healing|wound healing
5191209|NCT00859599|Bacterial colonisation|bacterial colonisation
5191210|NCT00859586|Acute Myelogenous Leukemia (AML)|acute myelogenous leukemia (aml)
5191211|NCT00859586|Acute Lymphoblastic Leukemia (ALL)|acute lymphoblastic leukemia (all)
5191212|NCT00859586|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
5191213|NCT00859586|Myelodysplastic Syndrome (MDS)|myelodysplastic syndrome (mds)
5191214|NCT00859586|Acute Myelogenous Leukemia|acute myelogenous leukemia
5191215|NCT00859586|AML|aml
5191216|NCT00859586|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
5191217|NCT00859586|ALL|all
5191218|NCT00859586|Myelodysplastic Syndrome|myelodysplastic syndrome
5191219|NCT00859586|MDS|mds
5191220|NCT00859560|Breast cancer|breast cancer
5191221|NCT00859560|post-menopausal women|post-menopausal women
5191222|NCT00859560|Arimidex|arimidex
5191223|NCT00859560|bone fracture|bone fracture
5191224|NCT00859534|Solar Urticaria|solar urticaria
5191225|NCT00859521|Bioequivalence|bioequivalence
5191226|NCT00859521|Healthy Subjects|healthy subjects
5191227|NCT00859508|dura repair following cranial surgery|dura repair following cranial surgery
5191228|NCT00859482|natalizumab|natalizumab
5191229|NCT00859482|multiple sclerosis|multiple sclerosis
5191230|NCT00859469|Mesothelioma|mesothelioma
5191231|NCT00859430|Bioequivalence|bioequivalence
5191232|NCT00859430|Healthy Subjects|healthy subjects
5191233|NCT00859417|correction of anterior prolapse|correction of anterior prolapse
5191234|NCT00859417|prosthetic trans-obturator way kit|prosthetic trans-obturator way kit
5191235|NCT00859417|randomized study|randomized study
5191236|NCT00859404|Mild to moderate persistent asthma|mild to moderate persistent asthma
5191237|NCT00859391|Celiac Disease|celiac disease
5191238|NCT00859378|Hip|hip
5191239|NCT00859378|Hip endoprosthesis|hip endoprosthesis
5191240|NCT00859378|Hip fracture|hip fracture
5191241|NCT00859378|Femoral fracture|femoral fracture
5191242|NCT00859378|Bone cement|bone cement
5191243|NCT00859378|Non-cemented|non-cemented
5191244|NCT00859365|back pain|back pain
5191245|NCT00859365|neck pain|neck pain
5191246|NCT00859365|anxiety|anxiety
5191247|NCT00859365|range of motion|range of motion
5191248|NCT00859339|TCC|tcc
5191249|NCT00859300|myocardial infarction|myocardial infarction
5191250|NCT00859300|ventricular fibrillation|ventricular fibrillation
5191251|NCT00859300|sudden death|sudden death
5191252|NCT00859300|polymorphism|polymorphism
5191253|NCT00859287|Reflux esophagitis|reflux esophagitis
5191254|NCT00859287|Omepral®|omepral®
5191255|NCT00859287|QOLRAD|qolrad
5191256|NCT00859235|Percutaneous endoscopic gastrostomy|percutaneous endoscopic gastrostomy
5191257|NCT00859235|peristomal wound infection|peristomal wound infection
5191258|NCT00859235|antibiotic mouth wash solution|antibiotic mouth wash solution
5191259|NCT00859235|prophylaxis prior Percutaneous endoscopic gastrostomy (PEG)|prophylaxis prior percutaneous endoscopic gastrostomy (peg)
5191260|NCT00859222|LBH589|lbh589
5191261|NCT00859222|bevacizumab|bevacizumab
5191262|NCT00859222|Avastin|avastin
5191263|NCT00859222|Panobinostat|panobinostat
5191264|NCT00859209|HVF|hvf
5191265|NCT00859209|Premature infants|premature infants
5191267|NCT00859196|Wound healing|wound healing
5191268|NCT00859196|Cell proliferation|cell proliferation
5191269|NCT00859196|Gene expression|gene expression
5191270|NCT00859183|in-stent restenosis|in-stent restenosis
5191271|NCT00859183|stents|stents
5191272|NCT00859183|sirolimus|sirolimus
5191273|NCT00859170|kidney stones|kidney stones
5191274|NCT00859170|ureter|ureter
5191275|NCT00859170|laser lithotripsy|laser lithotripsy
5191276|NCT00859157|perioperative/postoperative complications|perioperative/postoperative complications
5191277|NCT00859157|pain|pain
5191278|NCT00859157|ductal breast carcinoma in situ|ductal breast carcinoma in situ
5191279|NCT00859157|invasive ductal breast carcinoma|invasive ductal breast carcinoma
5191280|NCT00859157|invasive lobular breast carcinoma|invasive lobular breast carcinoma
5191281|NCT00859157|stage IA breast cancer|stage ia breast cancer
5191282|NCT00859157|stage IB breast cancer|stage ib breast cancer
5191283|NCT00859157|stage II breast cancer|stage ii breast cancer
5191284|NCT00859157|stage IIIA breast cancer|stage iiia breast cancer
5191285|NCT00859157|stage IIIB breast cancer|stage iiib breast cancer
5191286|NCT00859144|HIV Prevention|hiv prevention
5191287|NCT00859144|Youth|youth
5191288|NCT00859144|Adolescent|adolescent
5191289|NCT00859144|Community Collaboration|community collaboration
5191290|NCT00859144|Community Mentorship|community mentorship
5191291|NCT00859144|Minority|minority
5191292|NCT00859144|Urban|urban
5191293|NCT00859144|Sexual Risk Behaviors|sexual risk behaviors
5191294|NCT00859144|HIV seronegativity|hiv seronegativity
5191295|NCT00859079|diabetes mellitus type 2, GLP-1, insulin infusion|diabetes mellitus type 2, glp-1, insulin infusion
5191296|NCT00859040|recurrent intracranial meningioma(s)|recurrent intracranial meningioma(s)
5191297|NCT00859040|progressive intracranial meningioma(s)|progressive intracranial meningioma(s)
5191298|NCT00859027|Non-metastatic|non-metastatic
5191299|NCT00858975|renal tumor|renal tumor
5191300|NCT00858975|cryotherapy|cryotherapy
5191301|NCT00858975|cytokine|cytokine
5191302|NCT00858962|HIV|hiv
5191303|NCT00858962|Pharmacokinetics|pharmacokinetics
5191304|NCT00858962|Pharmacodynamics|pharmacodynamics
5191305|NCT00858962|Buprenorphine|buprenorphine
5191306|NCT00858962|Raltegravir|raltegravir
5191307|NCT00858962|HIV seronegativity|hiv seronegativity
5191308|NCT00858962|Interaction|interaction
5191309|NCT00858949|Outpatient surgery|outpatient surgery
5191310|NCT00858949|Postoperative nausea and vomiting|postoperative nausea and vomiting
5191311|NCT00858949|Costs|costs
5191312|NCT00858949|Observational|observational
5191313|NCT00858936|CABG(coronary artery bypass graft)|cabg(coronary artery bypass graft)
5191314|NCT00858936|Ischemia|ischemia
5191315|NCT00858936|Heart surgery|heart surgery
5191316|NCT00858936|Heart damage|heart damage
5191317|NCT00858923|Extracorporeal Photophoresis|extracorporeal photophoresis
5191318|NCT00858923|immuno-therapy|immuno-therapy
5191319|NCT00858923|treatment naive|treatment naive
5191320|NCT00858910|Motor imagery|motor imagery
5191321|NCT00858910|Motor skill|motor skill
5191322|NCT00858910|Performance improvement|performance improvement
5191323|NCT00858897|Glutathione|glutathione
5191324|NCT00858884|Systemic lupus erythematosus|systemic lupus erythematosus
5191325|NCT00858884|Libman-Sacks endocarditis|libman-sacks endocarditis
5191326|NCT00858884|Stroke|stroke
5191327|NCT00858884|Transient ischemic attack|transient ischemic attack
5191328|NCT00858884|Neuropsychiatric systemic lupus erythematosus|neuropsychiatric systemic lupus erythematosus
5191329|NCT00858884|Transesophageal echocardiography|transesophageal echocardiography
5191330|NCT00858884|Magnetic resonance imaging|magnetic resonance imaging
5191331|NCT00858845|Leg Weakness|leg weakness
5191332|NCT00858845|Skeletal Myopathy|skeletal myopathy
5191333|NCT00858845|Sympathetic Nerve Activity|sympathetic nerve activity
5191334|NCT00858819|Osteoporosis|osteoporosis
5191335|NCT00858819|Fractures|fractures
5191336|NCT00858819|Bone Mineral Density|bone mineral density
5191337|NCT00858819|Quantitative Computed Tomography|quantitative computed tomography
5191338|NCT00858793|AIDS|aids
5191339|NCT00858793|HIV|hiv
5191340|NCT00858793|Lymphoma|lymphoma
5191341|NCT00858793|Stem Cell Transplantation|stem cell transplantation
5191342|NCT00858793|gene-modified Stem Cells|gene-modified stem cells
5191343|NCT00858793|treatment experienced|treatment experienced
5191344|NCT00858767|vitamin K2|vitamin k2
5191345|NCT00858767|absorption|absorption
5191346|NCT00858767|efficacy|efficacy
5191347|NCT00858754|opioid induced constipation|opioid induced constipation
5191348|NCT00858754|Cancer patients|cancer patients
5191349|NCT00858754|methylnaltrexone|methylnaltrexone
5191350|NCT00858741|bone metastases from any histological subtype.|bone metastases from any histological subtype.
5191351|NCT00858728|Natural killer cell cytotoxicity|natural killer cell cytotoxicity
5191352|NCT00858728|Antibody response|antibody response
5191353|NCT00858728|Tetanus toxoid vaccination|tetanus toxoid vaccination
5191354|NCT00858728|Pneumovax II vaccination|pneumovax ii vaccination
5191355|NCT00858728|Total serum immunoglobulins|total serum immunoglobulins
5191356|NCT00858728|IgG subclasses|igg subclasses
5191357|NCT00858715|Clopidogrel|clopidogrel
5191358|NCT00858715|Aspirin|aspirin
5191359|NCT00858715|Antithrombotic therapy|antithrombotic therapy
5191360|NCT00858715|Platelet function testing|platelet function testing
5191361|NCT00858702|Essential hypertension|essential hypertension
5191362|NCT00858702|Combination therapy|combination therapy
5191363|NCT00858689|Clinical Drug Trial|clinical drug trial
5191364|NCT00858676|acarbose|acarbose
5191365|NCT00858676|diabetes mellitus|diabetes mellitus
5191366|NCT00858676|impaired glucose tolerance|impaired glucose tolerance
5191367|NCT00858676|coronary artery disease|coronary artery disease
5191368|NCT00858663|RAD001(Everolimus)|rad001(everolimus)
5191369|NCT00858663|Cisplatin|cisplatin
5191370|NCT00858663|08-138|08-138
5191371|NCT00858650|registry|registry
5191372|NCT00858650|natural history|natural history
5191373|NCT00858637|Chronic Kidney Disease|chronic kidney disease
5191374|NCT00858637|Dialysis|dialysis
5191375|NCT00858637|Dyslipidemia|dyslipidemia
5191376|NCT00858637|Bile acid sequestrant|bile acid sequestrant
5191377|NCT00858624|Cough|cough
5191378|NCT00858624|Cough reflex|cough reflex
5191379|NCT00858624|NMDA receptor|nmda receptor
5191380|NCT00858624|central sensitisation|central sensitisation
5191381|NCT00858611|Influenza|influenza
5191382|NCT00858611|Healthy|healthy
5191383|NCT00858611|Immunity|immunity
5191384|NCT00858611|Preventive|preventive
5191385|NCT00858611|Flu|flu
5191386|NCT00858611|Healthy Volunteer|healthy volunteer
5191387|NCT00858611|HV|hv
5191388|NCT00858598|Total Knee Arthroplasty|total knee arthroplasty
5191389|NCT00858598|Revision|revision
5191390|NCT00858598|Tibial|tibial
5191391|NCT00858598|Void|void
5191392|NCT00858598|Bone Filler|bone filler
5191393|NCT00858585|Bone metastasis, SNP concordance|bone metastasis, snp concordance
5191394|NCT00858572|Synta|synta
5191395|NCT00858572|STA-9090|sta-9090
5191396|NCT00858572|AML|aml
5191397|NCT00858572|CML|cml
5191398|NCT00858572|MDS|mds
5191399|NCT00858572|myeloproliferative disorder|myeloproliferative disorder
5191400|NCT00858572|hematologic malignancy|hematologic malignancy
5191401|NCT00858572|ganetespib|ganetespib
5191402|NCT00858559|Implantable cardioverter defibrillator|implantable cardioverter defibrillator
5191403|NCT00858559|Remote monitoring|remote monitoring
5191404|NCT00858559|Follow-up|follow-up
5191405|NCT00858533|early intervention|early intervention
5191406|NCT00858533|sickness absence|sickness absence
5191407|NCT00858533|return to work|return to work
5191408|NCT00858533|primary care|primary care
5191409|NCT00858520|COPD|copd
5191410|NCT00858520|Lung cancer|lung cancer
5191411|NCT00858520|genes|genes
5191412|NCT00858520|DNA|dna
5191413|NCT00858494|upper respiratory tract infection|upper respiratory tract infection
5191414|NCT00858494|children|children
5191415|NCT00858494|homeopathic|homeopathic
5191416|NCT00858481|Pediculosis capitis|pediculosis capitis
5191417|NCT00858481|Head Lice|head lice
5191418|NCT00858468|Influenza|influenza
5191419|NCT00858468|Influenza vaccine|influenza vaccine
5191420|NCT00858455|Healthy Volunteers|healthy volunteers
5191421|NCT00858455|Drug interation, Pharmacokinetics|drug interation, pharmacokinetics
5191422|NCT00858442|Burn sequelae|burn sequelae
5191423|NCT00858442|PRP|prp
5191424|NCT00858442|Children|children
5191425|NCT00858429|advanced adult primary liver cancer|advanced adult primary liver cancer
5191426|NCT00858429|liver metastases|liver metastases
5191427|NCT00858429|adult primary cholangiocellular carcinoma|adult primary cholangiocellular carcinoma
5191428|NCT00858403|Advanced Non-small Cell Lung Cancer|advanced non-small cell lung cancer
5191429|NCT00858377|Amgen|amgen
5191430|NCT00858377|Phase 1|phase 1
5191431|NCT00858377|First in Human|first in human
5191432|NCT00858377|Advanced Solid Tumors|advanced solid tumors
5191433|NCT00858377|Clinical Trial|clinical trial
5191434|NCT00858377|Aurora kinase inhibitor|aurora kinase inhibitor
5191435|NCT00858377|Open-label|open-label
5191436|NCT00858377|Oncology|oncology
5191437|NCT00858364|darbepoetin alfa|darbepoetin alfa
5191438|NCT00858364|non-small cell lung cancer|non-small cell lung cancer
5191439|NCT00858364|Aranesp|aranesp
5191440|NCT00858364|chemotherapy|chemotherapy
5191441|NCT00858364|chemotherapy induce anemia|chemotherapy induce anemia
5191442|NCT00858364|advanced lung cancer|advanced lung cancer
5191443|NCT00858364|malignant pleural effusion|malignant pleural effusion
5191444|NCT00858364|metastatic lung cancer|metastatic lung cancer
5191445|NCT00858364|NSCLC|nsclc
5191446|NCT00858364|anemia|anemia
5191447|NCT00858364|lung cancer|lung cancer
5191448|NCT00858364|pleural effusion|pleural effusion
5191449|NCT00858364|Stage IIIB lung cancer|stage iiib lung cancer
5191450|NCT00858364|Stage IV lung cancer|stage iv lung cancer
5191451|NCT00858351|Diabetes|diabetes
5191452|NCT00858351|Neuropathy|neuropathy
5191453|NCT00858351|Peripheral|peripheral
5191454|NCT00858351|Painful|painful
5191455|NCT00858351|Thermal|thermal
5191456|NCT00858351|Temperature|temperature
5191457|NCT00858351|Biofeedback|biofeedback
5191458|NCT00858351|Relaxation|relaxation
5191459|NCT00858351|Diabetic|diabetic
5191460|NCT00858338|stomach cancer|stomach cancer
5191461|NCT00858338|gastroesophageal junction cancer|gastroesophageal junction cancer
5191462|NCT00858338|GEJ cancer|gej cancer
5191463|NCT00858338|intraperitoneal|intraperitoneal
5191464|NCT00858338|adjuvant chemoradiation therapy|adjuvant chemoradiation therapy
5191952|NCT00856401|c10-008|c10-008
5191465|NCT00858338|resection of advanced stomach cancer|resection of advanced stomach cancer
5191466|NCT00858338|locally advanced stomach cancer|locally advanced stomach cancer
5191467|NCT00858325|Cubicin|cubicin
5191468|NCT00858325|PK|pk
5191469|NCT00858325|China Registration|china registration
5191470|NCT00858325|Pharmacokinetics|pharmacokinetics
5191471|NCT00858312|dairy foods|dairy foods
5191472|NCT00858312|weight loss|weight loss
5191473|NCT00858312|fat loss|fat loss
5191474|NCT00858312|metabolic regulation|metabolic regulation
5191475|NCT00858299|proteinuria|proteinuria
5191476|NCT00858299|chronic kidney disease|chronic kidney disease
5191477|NCT00858299|renin-angiotensin system|renin-angiotensin system
5191478|NCT00858299|angiotensinogen|angiotensinogen
5191479|NCT00858273|Glutathione|glutathione
5191480|NCT00858260|Klotho|klotho
5191481|NCT00858260|calcium|calcium
5191482|NCT00858260|phosphate|phosphate
5191483|NCT00858260|parathormone|parathormone
5191484|NCT00858260|survival|survival
5191485|NCT00858260|dialysis|dialysis
5191486|NCT00858260|Adult patients undergoing maintenance dialysis since at leat three months|adult patients undergoing maintenance dialysis since at leat three months
5191487|NCT00858247|vitamin D|vitamin d
5191488|NCT00858247|Obesity|obesity
5191489|NCT00858247|Insulin sensitivity|insulin sensitivity
5191490|NCT00858247|Adolescent Obesity|adolescent obesity
5191491|NCT00858221|obesity|obesity
5191492|NCT00858221|genes|genes
5191493|NCT00858221|polymorphisms|polymorphisms
5191494|NCT00858221|weight loss|weight loss
5191495|NCT00858221|haplotype|haplotype
5191496|NCT00858221|diplotype|diplotype
5191497|NCT00858208|efficacy and safety of Macugen in routine clinical practice|efficacy and safety of macugen in routine clinical practice
5191498|NCT00858195|Anti-inflammatory|anti-inflammatory
5191499|NCT00858182|L-Carnitine|l-carnitine
5191500|NCT00858182|Xylitol|xylitol
5191501|NCT00858182|Peritoneal Dialysis|peritoneal dialysis
5191502|NCT00858169|three-dimensional power Doppler ultrasonography|three-dimensional power doppler ultrasonography
5191503|NCT00858169|wrist|wrist
5191504|NCT00858169|knee|knee
5191505|NCT00858169|rheumatoid arthritis|rheumatoid arthritis
5191506|NCT00858156|Pharmacokinetics|pharmacokinetics
5191507|NCT00858143|Open-label, national, prospective, observational, non-interventional, multi-center, post marketing surveillance study|open-label, national, prospective, observational, non-interventional, multi-center, post marketing surveillance study
5191508|NCT00858130|Veinoplus|veinoplus
5191509|NCT00858130|post thrombotic syndrome|post thrombotic syndrome
5191510|NCT00858130|deep vein thrombosis|deep vein thrombosis
5191511|NCT00858130|electrical muscle stimulator|electrical muscle stimulator
5191512|NCT00858130|Venous stasis syndrome|venous stasis syndrome
5191513|NCT00858130|venous insufficiency syndrome|venous insufficiency syndrome
5191514|NCT00858130|Postphlebitic syndrome|postphlebitic syndrome
5191515|NCT00858130|history of deep vein thrombosis|history of deep vein thrombosis
5191516|NCT00858117|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
5191517|NCT00858117|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
5191518|NCT00858117|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
5191519|NCT00858117|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5191520|NCT00858117|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5191521|NCT00858078|Qualitative Research|qualitative research
5191522|NCT00858078|Semi-Structured Telephone Interview|semi-structured telephone interview
5191523|NCT00858078|BRCA 1/2|brca 1/2
5191524|NCT00858078|Psychosocial/Behavioral Research|psychosocial/behavioral research
5191525|NCT00858078|Hereditary Cancer Risk|hereditary cancer risk
5191526|NCT00858078|BRCA|brca
5191527|NCT00858078|BRCA1 Gene|brca1 gene
5191528|NCT00858078|BRCA2 Gene|brca2 gene
5191529|NCT00858065|Adolescent alcohol and other drug use|adolescent alcohol and other drug use
5191530|NCT00858065|Choice|choice
5191531|NCT00858065|Family-based|family-based
5191532|NCT00858065|Prevention|prevention
5191533|NCT00858052|breast implants|breast implants
5191534|NCT00858052|saline|saline
5191535|NCT00858026|weaning|weaning
5191536|NCT00858026|breastfeeding|breastfeeding
5191537|NCT00858026|infant formula|infant formula
5191538|NCT00858026|fermented formula|fermented formula
5191539|NCT00858013|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
5191540|NCT00858013|Nateglinide|nateglinide
5191541|NCT00858013|Pancreatic beta cell function|pancreatic beta cell function
5191542|NCT00858000|markers|markers
5191543|NCT00858000|expression analysis|expression analysis
5191544|NCT00857987|IRA, Guaifenesin, Etaphedrine, Doxilamine|ira, guaifenesin, etaphedrine, doxilamine
5191545|NCT00857974|Physical Activity|physical activity
5191546|NCT00857974|Renal Transplant Candidate|renal transplant candidate
5191547|NCT00857974|Physical Function|physical function
5191548|NCT00857974|Body Composition|body composition
5191549|NCT00857948|head lice|head lice
5191550|NCT00857948|Pediculus humanus capitis|pediculus humanus capitis
5191551|NCT00857948|ivermectin|ivermectin
5191552|NCT00857935|Pediculosis Capitis|pediculosis capitis
5191553|NCT00857935|Head Lice|head lice
5191554|NCT00857922|Neurological|neurological
5191555|NCT00857922|Neurosurgical|neurosurgical
5191556|NCT00857896|Study of fesoterodine in pediatric overactive bladder patients|study of fesoterodine in pediatric overactive bladder patients
5191559|NCT00857883|Pharmacokinetics|pharmacokinetics
5191560|NCT00857883|First-Time-In-Humans|first-time-in-humans
5191561|NCT00857883|Pharmacodynamics|pharmacodynamics
5191562|NCT00857883|Healthy Volunteers|healthy volunteers
5191563|NCT00857857|asthma|asthma
5191564|NCT00857857|late phase response|late phase response
5191565|NCT00857857|allergen|allergen
5191566|NCT00857857|challenge|challenge
5191567|NCT00857857|GW870086X|gw870086x
5191568|NCT00857844|Chronic Nephrotoxicity|chronic nephrotoxicity
5191569|NCT00857844|Kidney dysfunction post liver transplant|kidney dysfunction post liver transplant
5191570|NCT00857844|Urinary biomarkers of chronic nephrotoxicity from CI|urinary biomarkers of chronic nephrotoxicity from ci
5191571|NCT00857831|spinal cord injury|spinal cord injury
5191572|NCT00857831|Vitamin D deficiency|vitamin d deficiency
5191573|NCT00857831|Functional Electrical Stimulation|functional electrical stimulation
5191574|NCT00857805|Transarterial chemoembolization|transarterial chemoembolization
5191575|NCT00857805|Carcinoma, Hepatocellular|carcinoma, hepatocellular
5191576|NCT00857805|Proton Beam Radiotherapy|proton beam radiotherapy
5191577|NCT00857792|Coronary Disease|coronary disease
5191578|NCT00857792|Cardiac CT Imaging|cardiac ct imaging
5191579|NCT00857792|Stress Testing|stress testing
5191580|NCT00857792|Lexiscan (regadenoson)|lexiscan (regadenoson)
5191581|NCT00857779|allergen immunotherapy|allergen immunotherapy
5191582|NCT00857779|allergy to grass pollen|allergy to grass pollen
5191583|NCT00857766|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5191584|NCT00857766|arterial stiffness|arterial stiffness
5191585|NCT00857766|Computed Tomography|computed tomography
5191586|NCT00857766|pulse wave velocity|pulse wave velocity
5191587|NCT00857766|Pulse wave analysis|pulse wave analysis
5191588|NCT00857727|Dexmedetomidine|dexmedetomidine
5191589|NCT00857727|Emergence Delirium|emergence delirium
5191590|NCT00857727|Agitation|agitation
5191591|NCT00857727|Pediatric|pediatric
5191592|NCT00857727|Anesthesia|anesthesia
5191593|NCT00857714|DCIS|dcis
5191594|NCT00857714|breast|breast
5191595|NCT00857701|total knee arthroplasty|total knee arthroplasty
5191596|NCT00857701|Dynamic Splinting|dynamic splinting
5191597|NCT00857701|Knee extension|knee extension
5191598|NCT00857701|knee|knee
5191599|NCT00857701|Reduced knee flexion after total knee arthroscopy|reduced knee flexion after total knee arthroscopy
5191600|NCT00857688|aphtous|aphtous
5191601|NCT00857688|bismuth|bismuth
5191602|NCT00857688|procain|procain
5191603|NCT00857688|neomycin|neomycin
5191604|NCT00857688|Efficacy of the Association in Treatment of Aphtous|efficacy of the association in treatment of aphtous
5191605|NCT00857675|HBV DNA suppression|hbv dna suppression
5191606|NCT00857675|ALT normalisation|alt normalisation
5191607|NCT00857675|Viral resistance|viral resistance
5191608|NCT00857675|HBeAg seroconversion|hbeag seroconversion
5191609|NCT00857662|US Multicenter|us multicenter
5191610|NCT00857662|Randomized|randomized
5191611|NCT00857662|Onyx|onyx
5191612|NCT00857662|Brain Arteriovenous Malformation (BAVMs)|brain arteriovenous malformation (bavms)
5191613|NCT00857649|Alzheimer's Disease|alzheimer's disease
5191614|NCT00857636|Ethnic minority women|ethnic minority women
5191615|NCT00857636|Cancer screening|cancer screening
5191616|NCT00857636|Health literacy|health literacy
5191617|NCT00857636|Behavioral intervention|behavioral intervention
5191618|NCT00857636|Breast Cancer screening|breast cancer screening
5191619|NCT00857636|Cervical Cancer screening|cervical cancer screening
5191620|NCT00857623|Pain|pain
5191621|NCT00857623|Diabetic Neuropathy|diabetic neuropathy
5191622|NCT00857623|PDN|pdn
5191623|NCT00857623|Analgesia|analgesia
5191624|NCT00857623|Efficacy|efficacy
5191625|NCT00857610|Aged skin|aged skin
5191626|NCT00857610|Photoaged skin|photoaged skin
5191627|NCT00857610|Retinol|retinol
5191628|NCT00857610|Topical retinoids|topical retinoids
5191629|NCT00857597|GERD|gerd
5191630|NCT00857597|endoscopic|endoscopic
5191631|NCT00857597|fundoplication|fundoplication
5191632|NCT00857597|Proton Pump Inhibitors|proton pump inhibitors
5191633|NCT00857597|heartburn|heartburn
5191634|NCT00857597|anti-reflux surgery|anti-reflux surgery
5191635|NCT00857584|Bipolar disorder|bipolar disorder
5191636|NCT00857584|Bipolar depression|bipolar depression
5191637|NCT00857584|quetiapine|quetiapine
5191638|NCT00857584|sertraline|sertraline
5191639|NCT00857571|Dose Response Bioavailability Study|dose response bioavailability study
5191640|NCT00857532|amyloid burden|amyloid burden
5191641|NCT00857532|Parkinson's disease|parkinson's disease
5191642|NCT00857532|florbetapir PET|florbetapir pet
5191643|NCT00857532|amyloid PET imaging|amyloid pet imaging
5191644|NCT00857519|retinoblastoma|retinoblastoma
5191645|NCT00857519|Intraarterial|intraarterial
5191646|NCT00857519|Chemotherapy|chemotherapy
5191647|NCT00857519|Melphalan|melphalan
5191648|NCT00857519|Carboplatin|carboplatin
5191649|NCT00857506|Cognitive outcome|cognitive outcome
5191650|NCT00857506|18F-AV-45 PET scan|18f-av-45 pet scan
5191651|NCT00857506|Amyloid PET scan|amyloid pet scan
5191652|NCT00857506|Florbetapir F 18 amyloid PET scan|florbetapir f 18 amyloid pet scan
5191653|NCT00857506|Normal cognition|normal cognition
5191654|NCT00857506|Change in cognitive status in relation to brain amyloid on PET|change in cognitive status in relation to brain amyloid on pet
5191953|NCT00856401|NPSP558|npsp558
5191655|NCT00857415|florbetapir F 18 PET|florbetapir f 18 pet
5191656|NCT00857415|amyloid imaging|amyloid imaging
5191657|NCT00857415|Amyloid pathology in the brain|amyloid pathology in the brain
5191658|NCT00857402|Arginine|arginine
5191659|NCT00857402|Nitric oxide|nitric oxide
5191660|NCT00857402|Peanuts|peanuts
5191661|NCT00857402|Sedimentation rate|sedimentation rate
5191662|NCT00857389|Cancer|cancer
5191663|NCT00857389|Blood And Marrow Transplantation|blood and marrow transplantation
5191664|NCT00857389|Stem Cell|stem cell
5191665|NCT00857389|Leukemia|leukemia
5191666|NCT00857389|Lymphoma|lymphoma
5191667|NCT00857389|Pediatrics|pediatrics
5191668|NCT00857389|Bone marrow|bone marrow
5191669|NCT00857389|Lymph node system|lymph node system
5191670|NCT00857389|Allogeneic Stem Cell Transplant|allogeneic stem cell transplant
5191671|NCT00857389|ASCT|asct
5191672|NCT00857389|Busulfan|busulfan
5191673|NCT00857389|Busulfex|busulfex
5191674|NCT00857389|Myleran|myleran
5191675|NCT00857389|Clofarabine|clofarabine
5191676|NCT00857389|Clofarex|clofarex
5191677|NCT00857389|Clolar|clolar
5191678|NCT00857389|Thiotepa|thiotepa
5191679|NCT00857389|Antithymocyte globulin|antithymocyte globulin
5191680|NCT00857389|ATG|atg
5191681|NCT00857389|Thymoglobulin|thymoglobulin
5191682|NCT00857389|G-CSF|g-csf
5191683|NCT00857389|Filgrastim|filgrastim
5191684|NCT00857389|Neupogen|neupogen
5191685|NCT00857389|Cyclophosphamide|cyclophosphamide
5191686|NCT00857389|Cytoxan|cytoxan
5191687|NCT00857389|Neosar|neosar
5191688|NCT00857389|Mesna|mesna
5191689|NCT00857389|Mesnex|mesnex
5191690|NCT00857389|Tacrolimus|tacrolimus
5191691|NCT00857389|Prograf|prograf
5191692|NCT00857389|Methotrexate|methotrexate
5191693|NCT00857376|Heart disease risk factors|heart disease risk factors
5191694|NCT00857376|Risk factor management|risk factor management
5191695|NCT00857376|Pre-Diabetes|pre-diabetes
5191696|NCT00857376|Hypertension|hypertension
5191697|NCT00857376|obesity|obesity
5191698|NCT00857376|glucose intolerance|glucose intolerance
5191699|NCT00857376|high cholesterol|high cholesterol
5191700|NCT00857376|abdominal obesity|abdominal obesity
5191701|NCT00857376|enlarged waist|enlarged waist
5191702|NCT00857363|capsule|capsule
5191703|NCT00857363|constipation|constipation
5191704|NCT00857363|whole gut transit|whole gut transit
5191705|NCT00857363|colonic transit|colonic transit
5191706|NCT00857363|gastric emptying|gastric emptying
5191707|NCT00857363|small bowel transit|small bowel transit
5191708|NCT00857350|HIV|hiv
5191709|NCT00857350|resistance|resistance
5191710|NCT00857350|opioid dependence|opioid dependence
5191711|NCT00857324|Refractory or relapsed patients|refractory or relapsed patients
5191712|NCT00857324|dose-finding|dose-finding
5191713|NCT00857324|Vorinostat|vorinostat
5191714|NCT00857298|HIV|hiv
5191715|NCT00857298|Metabolic Syndrome|metabolic syndrome
5191716|NCT00857298|Obesity|obesity
5191717|NCT00857298|Treatment Experienced|treatment experienced
5191718|NCT00857272|colonoscopy|colonoscopy
5191719|NCT00857272|bowel preparation|bowel preparation
5191720|NCT00857259|AMD|amd
5191721|NCT00857259|macular degeneration|macular degeneration
5191722|NCT00857259|Everolimus|everolimus
5191723|NCT00857259|Lucentis|lucentis
5191724|NCT00857259|Ranibizumab|ranibizumab
5191725|NCT00857259|Choroidal Neo-Vascular (CNV) age-onset macular degeneration|choroidal neo-vascular (cnv) age-onset macular degeneration
5191726|NCT00857259|Age-related Macular Degeneration (AMD)|age-related macular degeneration (amd)
5191727|NCT00857246|stomach cancer|stomach cancer
5191728|NCT00857246|biologics|biologics
5191729|NCT00857246|antibody|antibody
5191730|NCT00857246|chemotherapy|chemotherapy
5191731|NCT00857246|chemoradiation|chemoradiation
5191732|NCT00857246|adjuvant therapy|adjuvant therapy
5191733|NCT00857246|neoadjuvant therapy|neoadjuvant therapy
5191734|NCT00857246|epidermal growth factor receptor|epidermal growth factor receptor
5191735|NCT00857246|combination therapy|combination therapy
5191736|NCT00857233|Alzheimer's Disease|alzheimer's disease
5191737|NCT00857220|Hypnotic|hypnotic
5191738|NCT00857220|Eszopiclone|eszopiclone
5191739|NCT00857220|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
5191740|NCT00857220|Insomnia|insomnia
5191741|NCT00857220|Children|children
5191742|NCT00857220|Adolescent|adolescent
5191743|NCT00857207|Cognitive Therapy|cognitive therapy
5191744|NCT00857207|Outcomes Assessment|outcomes assessment
5191745|NCT00857194|Coronary Heart Disease|coronary heart disease
5191746|NCT00857194|spinal cord injury|spinal cord injury
5191747|NCT00857194|risk factor|risk factor
5191748|NCT00857194|postprandial lipemia|postprandial lipemia
5191749|NCT00857181|Liver Cirrhosis|liver cirrhosis
5191750|NCT00857181|Infection|infection
5191751|NCT00857181|Inflammation|inflammation
5191752|NCT00857181|Cytokines|cytokines
5191753|NCT00857155|Coronary Artery Disease|coronary artery disease
5191754|NCT00857155|CABG|cabg
5191755|NCT00857155|Clopidogrel|clopidogrel
5191756|NCT00857155|Aspirin|aspirin
5191757|NCT00857155|Point of Care devices|point of care devices
5191758|NCT00857129|"normal birth"|"normal birth"
5191759|NCT00857129|"birth outcome"|"birth outcome"
5191760|NCT00857129|"low risk birth"|"low risk birth"
5191761|NCT00857129|"low risk units"|"low risk units"
5191762|NCT00857129|If type of birth care unit have effect on birth outcome|if type of birth care unit have effect on birth outcome
5191763|NCT00857129|Apgar score|apgar score
5191764|NCT00857129|breast feeding frequency|breast feeding frequency
5191765|NCT00857129|patient satisfaction|patient satisfaction
5191766|NCT00857116|Deworming|deworming
5191767|NCT00857116|Tuberculosis|tuberculosis
5191768|NCT00857116|TB-score|tb-score
5191769|NCT00857116|Albendazole|albendazole
5191770|NCT00857116|Helminths|helminths
5191771|NCT00857103|computer support|computer support
5191772|NCT00857103|patient-provider communication|patient-provider communication
5191773|NCT00857103|patient-centered care|patient-centered care
5191774|NCT00857103|cancer|cancer
5191775|NCT00857090|Urinary Calculi|urinary calculi
5191776|NCT00857090|Urinary Stones|urinary stones
5191777|NCT00857090|Urinary Tract Stones|urinary tract stones
5191778|NCT00857090|Renal Calculi|renal calculi
5191779|NCT00857090|Kidney Stones|kidney stones
5191780|NCT00857090|Calculi|calculi
5191781|NCT00857090|Urolithotomy|urolithotomy
5191782|NCT00857090|Ureteroscopy|ureteroscopy
5191783|NCT00857077|incidence of anaemia|incidence of anaemia
5191784|NCT00857064|Schizophrenia|schizophrenia
5191785|NCT00857064|antipsychotics|antipsychotics
5191786|NCT00857064|social functioning|social functioning
5191787|NCT00857064|subjective well being|subjective well being
5191788|NCT00857064|Patients suffering from Schizophrenia|patients suffering from schizophrenia
5191789|NCT00857051|Stress|stress
5191790|NCT00857038|COPD|copd
5191791|NCT00857038|Inflammation|inflammation
5191792|NCT00857038|Neutrophilic|neutrophilic
5191793|NCT00857038|Myeloperoxidase|myeloperoxidase
5191794|NCT00857038|Doxycycline|doxycycline
5191795|NCT00857025|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5191796|NCT00857025|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5191797|NCT00857025|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5191798|NCT00857025|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5191799|NCT00857012|Primary early MCa|primary early mca
5191800|NCT00857012|Arimidex|arimidex
5191801|NCT00856999|Glabellar lines of moderate severity at maximum frown|glabellar lines of moderate severity at maximum frown
5191802|NCT00856973|Hypnotic|hypnotic
5191803|NCT00856973|Eszopiclone|eszopiclone
5191804|NCT00856973|Attention Deficit/Hyperactivity Disorder|attention deficit/hyperactivity disorder
5191805|NCT00856973|Insomnia|insomnia
5191806|NCT00856973|Children|children
5191807|NCT00856973|Adolescent|adolescent
5191808|NCT00856973|Polysomnography|polysomnography
5191809|NCT00856973|Actigraphy|actigraphy
5191810|NCT00856947|wheeze|wheeze
5191811|NCT00856947|infections|infections
5191812|NCT00856947|allergy|allergy
5191813|NCT00856947|eczema|eczema
5191814|NCT00856947|vitamin D|vitamin d
5191815|NCT00856934|Skin graft donor site healing|skin graft donor site healing
5191816|NCT00856934|skin|skin
5191817|NCT00856934|wound|wound
5191818|NCT00856934|platelet concentrate|platelet concentrate
5191819|NCT00856934|keratinocytes|keratinocytes
5191820|NCT00856934|burns|burns
5191821|NCT00856921|Relationship between achalasia and AAAS gene|relationship between achalasia and aaas gene
5191822|NCT00856908|Type II Diabetes|type ii diabetes
5191823|NCT00856895|Improved Life Quality|improved life quality
5191824|NCT00856856|Bioabsorbable|bioabsorbable
5191825|NCT00856856|Coronary Stent|coronary stent
5191826|NCT00856856|Everolimus|everolimus
5191827|NCT00856856|drug eluting stents|drug eluting stents
5191828|NCT00856856|stents|stents
5191829|NCT00856856|angioplasty|angioplasty
5191830|NCT00856856|coronary artery disease|coronary artery disease
5191831|NCT00856856|total coronary occlusion|total coronary occlusion
5191832|NCT00856856|coronary artery restenosis|coronary artery restenosis
5191833|NCT00856856|stent thrombosis|stent thrombosis
5191834|NCT00856856|vascular disease|vascular disease
5191835|NCT00856856|myocardial ischemia|myocardial ischemia
5191836|NCT00856856|coronary artery stenosis|coronary artery stenosis
5191837|NCT00856856|CAD|cad
5191838|NCT00856856|CAOD|caod
5191839|NCT00856843|colonoscopy|colonoscopy
5191840|NCT00856843|bowel preparation|bowel preparation
5191841|NCT00856830|Small cell lung cancer|small cell lung cancer
5191842|NCT00856830|Chemonaive|chemonaive
5191843|NCT00856830|Bendamustine|bendamustine
5191844|NCT00856830|Irinotecan|irinotecan
5191845|NCT00856830|Etoposide|etoposide
5191846|NCT00856830|Carboplatin|carboplatin
5191847|NCT00856804|Thalidomide|thalidomide
5191848|NCT00856804|Hepatitis C|hepatitis c
5191849|NCT00856804|Interferon resistance|interferon resistance
5191850|NCT00856804|Immunomodulators|immunomodulators
5191851|NCT00856791|Ovarian|ovarian
5191852|NCT00856791|Cancer|cancer
5191853|NCT00856791|Cisplatin|cisplatin
5191854|NCT00856791|Carboplatin|carboplatin
5191855|NCT00856778|Male sling|male sling
5191856|NCT00856778|stress urinary incontinence|stress urinary incontinence
5191857|NCT00856778|urinary incontinence|urinary incontinence
5191858|NCT00856739|obesity|obesity
5191859|NCT00856739|arthritis|arthritis
5191860|NCT00856700|GLP-1|glp-1
5191861|NCT00856700|Endothelial Function|endothelial function
5191862|NCT00856700|Metabolic Syndrome|metabolic syndrome
5191863|NCT00856687|Asthma Allergen Challenge|asthma allergen challenge
5191864|NCT00856674|IgA nephropathy|iga nephropathy
5191865|NCT00856674|chemokine fusion protein|chemokine fusion protein
5191866|NCT00856674|leukocyte population modulator|leukocyte population modulator
5191867|NCT00856674|phase-1|phase-1
5191868|NCT00856661|Acute ischemic stroke|acute ischemic stroke
5191869|NCT00856661|Angiography|angiography
5191870|NCT00856661|Desmoteplase|desmoteplase
5191871|NCT00856661|Thrombolytic|thrombolytic
5191872|NCT00856622|open-angle glaucoma ocular hypertension glaucoma|open-angle glaucoma ocular hypertension glaucoma
5191873|NCT00856609|Weight Loss|weight loss
5191874|NCT00856609|Byetta (Exenatide)|byetta (exenatide)
5191875|NCT00856609|Energy Expenditure|energy expenditure
5191876|NCT00856609|Food Intake|food intake
5191877|NCT00856609|Obesity|obesity
5191878|NCT00856596|Tinea pedis|tinea pedis
5191879|NCT00856596|Fungus|fungus
5191880|NCT00856596|Pruritus|pruritus
5191881|NCT00856596|Dermatophyte|dermatophyte
5191882|NCT00856596|Athlete's foot|athlete's foot
5191883|NCT00856596|Dermatomycosis|dermatomycosis
5191884|NCT00856596|Skin manifestation|skin manifestation
5191885|NCT00856596|Infectious skin disease|infectious skin disease
5191886|NCT00856596|Foot diseases|foot diseases
5191887|NCT00856570|YM178|ym178
5191888|NCT00856570|Mirabegron|mirabegron
5191889|NCT00856570|DDI|ddi
5191890|NCT00856570|Phase I|phase i
5191891|NCT00856570|Warfarin|warfarin
5191892|NCT00856570|Pharmacokinetics|pharmacokinetics
5191893|NCT00856557|Patients with complex psychosocial needs|patients with complex psychosocial needs
5191894|NCT00856544|Arthritis|arthritis
5191895|NCT00856544|Rheumatoid|rheumatoid
5191896|NCT00856544|Antirheumatic Agents|antirheumatic agents
5191897|NCT00856544|Clinical Trial|clinical trial
5191898|NCT00856531|Möbius syndrome|möbius syndrome
5191899|NCT00856531|Language|language
5191900|NCT00856531|Speech, Language and Hearing Sciences|speech, language and hearing sciences
5191901|NCT00856518|Multiple Sclerosis|multiple sclerosis
5191902|NCT00856518|Parkinson's disease|parkinson's disease
5191903|NCT00856518|Dysphagia|dysphagia
5191904|NCT00856505|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
5191905|NCT00856505|Drug Therapy, Combination|drug therapy, combination
5191906|NCT00856505|Immunosuppression|immunosuppression
5191907|NCT00856492|inflammatory breast cancer|inflammatory breast cancer
5191908|NCT00856492|stage II breast cancer|stage ii breast cancer
5191909|NCT00856492|stage IIIA breast cancer|stage iiia breast cancer
5191910|NCT00856492|stage IIIB breast cancer|stage iiib breast cancer
5191911|NCT00856492|HER2-negative breast cancer|her2-negative breast cancer
5191912|NCT00856492|estrogen receptor-negative breast cancer|estrogen receptor-negative breast cancer
5191913|NCT00856492|estrogen receptor-positive breast cancer|estrogen receptor-positive breast cancer
5191914|NCT00856492|progesterone receptor-negative breast cancer|progesterone receptor-negative breast cancer
5191915|NCT00856492|progesterone receptor-positive breast cancer|progesterone receptor-positive breast cancer
5191916|NCT00856492|stage IIIC breast cancer|stage iiic breast cancer
5191917|NCT00856479|Infuse|infuse
5191918|NCT00856479|cost analysis|cost analysis
5191919|NCT00856479|Non union diaphyseal fracture|non union diaphyseal fracture
5191920|NCT00856479|The efficacy of Infuse BMP 2 in Non union diaphyseal fractures. Also the cost analysis with the amount of time spent in hospital post op.|the efficacy of infuse bmp 2 in non union diaphyseal fractures. also the cost analysis with the amount of time spent in hospital post op.
5191921|NCT00856453|fatigue|fatigue
5191922|NCT00856453|depression|depression
5191923|NCT00856453|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5191924|NCT00856453|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
5191925|NCT00856453|stage I ovarian epithelial cancer|stage i ovarian epithelial cancer
5191926|NCT00856453|stage I ovarian germ cell tumor|stage i ovarian germ cell tumor
5191927|NCT00856453|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
5191928|NCT00856453|stage II ovarian germ cell tumor|stage ii ovarian germ cell tumor
5191929|NCT00856453|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5191930|NCT00856453|stage III ovarian germ cell tumor|stage iii ovarian germ cell tumor
5191931|NCT00856453|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5191932|NCT00856453|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
5191933|NCT00856440|SCI|sci
5191934|NCT00856427|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5191935|NCT00856427|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5191936|NCT00856427|stage IA non-small cell lung cancer|stage ia non-small cell lung cancer
5191937|NCT00856427|stage IB non-small cell lung cancer|stage ib non-small cell lung cancer
5191938|NCT00856427|stage IIA non-small cell lung cancer|stage iia non-small cell lung cancer
5191939|NCT00856427|stage IIB non-small cell lung cancer|stage iib non-small cell lung cancer
5191940|NCT00856401|hypoparathyroidism|hypoparathyroidism
5191941|NCT00856401|hypopara|hypopara
5191942|NCT00856401|PTH|pth
5191943|NCT00856401|parathyroid hormone|parathyroid hormone
5191944|NCT00856401|CL-11-040|cl-11-040
5191945|NCT00856401|CL1-11 Study|cl1-11 study
5191946|NCT00856401|NPSP 558|npsp 558
5191947|NCT00856401|RELAY|relay
5191948|NCT00856401|RACE|race
5191949|NCT00856401|REPLACE|replace
5191954|NCT00856401|Columbia study|columbia study
5191955|NCT00856401|Columbia studies|columbia studies
5191956|NCT00856401|HPTH|hpth
5191957|NCT00856401|PTH1-84|pth1-84
5191958|NCT00856375|colorectal cancer|colorectal cancer
5191959|NCT00856375|Colorectal cancer, second line|colorectal cancer, second line
5191960|NCT00856362|Healthy Subjects|healthy subjects
5191961|NCT00856349|Implantable Cardioverter Defibrillator (ICD)|implantable cardioverter defibrillator (icd)
5191962|NCT00856349|Cardiac Resynchronization Therapy-Defibrillator (CRT-D)|cardiac resynchronization therapy-defibrillator (crt-d)
5191963|NCT00856349|Lead Integrity Alert (LIA)|lead integrity alert (lia)
5191964|NCT00856349|Therapy Programming Report (TPR)|therapy programming report (tpr)
5191965|NCT00856323|Methamphetamine|methamphetamine
5191966|NCT00856323|HIV|hiv
5191967|NCT00856323|Post-exposure prophylaxis|post-exposure prophylaxis
5191968|NCT00856323|HIV seronegativity|hiv seronegativity
5191969|NCT00856310|Healthy volunteers|healthy volunteers
5191970|NCT00856297|Meningococcal|meningococcal
5191971|NCT00856297|ACWY|acwy
5191972|NCT00856297|Conjugate Vaccine|conjugate vaccine
5191973|NCT00856297|Meningitis|meningitis
5191974|NCT00856297|Adolescents|adolescents
5191975|NCT00856297|Persistence|persistence
5191976|NCT00856284|Diabetes Mellitus|diabetes mellitus
5191977|NCT00856284|Drug Therapy|drug therapy
5191978|NCT00856284|Hyperinsulinism|hyperinsulinism
5191979|NCT00856284|Hyperglycemia|hyperglycemia
5191980|NCT00856284|Glucose Intolerance|glucose intolerance
5191981|NCT00856258|Multiple dose in healthy volunteers|multiple dose in healthy volunteers
5191982|NCT00856245|non-Hodgkins|non-hodgkins
5191983|NCT00856245|lymphoma|lymphoma
5191984|NCT00856245|stem cell transplant|stem cell transplant
5191985|NCT00856232|Headache|headache
5191986|NCT00856232|Cephalgia|cephalgia
5191987|NCT00856232|Migraine|migraine
5191988|NCT00856219|Immune System|immune system
5191989|NCT00856206|Metabolism, Inborn Errors|metabolism, inborn errors
5191990|NCT00856206|Allopurinol|allopurinol
5191991|NCT00856206|Metabolic Disease|metabolic disease
5191992|NCT00856206|Genetic Diseases, Inborn|genetic diseases, inborn
5191993|NCT00856206|Musculoskeletal Diseases|musculoskeletal diseases
5191994|NCT00856206|Joint Diseases|joint diseases
5191995|NCT00856206|Arthritis|arthritis
5191996|NCT00856206|Rheumatic Diseases|rheumatic diseases
5191997|NCT00856206|Metabolic disorder|metabolic disorder
5191998|NCT00856206|Purine Pyrimidine Metabolism, Inborn Errors|purine pyrimidine metabolism, inborn errors
5191999|NCT00856206|Gout|gout
5192000|NCT00856206|Intercritical Gout|intercritical gout
5192001|NCT00856193|COPD|copd
5192002|NCT00856193|Bronchodilator|bronchodilator
5192003|NCT00856180|avastin|avastin
5192004|NCT00856180|bevacizumab|bevacizumab
5192005|NCT00856180|cyclophosphamide|cyclophosphamide
5192006|NCT00856180|cytoxan|cytoxan
5192007|NCT00856180|mullerian malignancies|mullerian malignancies
5192008|NCT00856167|temporomandibular dysfunction|temporomandibular dysfunction
5192009|NCT00856167|TMD|tmd
5192010|NCT00856167|TMJ|tmj
5192011|NCT00856167|Traditional Chinese Medicine|traditional chinese medicine
5192012|NCT00856167|TCM|tcm
5192013|NCT00856154|HIV-1|hiv-1
5192014|NCT00856154|HLA-A2|hla-a2
5192015|NCT00856154|Therapeutic|therapeutic
5192016|NCT00856154|Vaccine|vaccine
5192017|NCT00856154|treatment vaccine|treatment vaccine
5192018|NCT00856154|treatment naive|treatment naive
5192019|NCT00856141|IOP measurement|iop measurement
5192020|NCT00856141|IOP fluctuation|iop fluctuation
5192021|NCT00856141|in-vivo IOP measuring device|in-vivo iop measuring device
5192022|NCT00856141|intraocular pressure measurement|intraocular pressure measurement
5192023|NCT00856115|stage I colon cancer|stage i colon cancer
5192024|NCT00856115|stage II colon cancer|stage ii colon cancer
5192025|NCT00856115|stage III colon cancer|stage iii colon cancer
5192026|NCT00856115|stage IV colon cancer|stage iv colon cancer
5192027|NCT00856115|stage I rectal cancer|stage i rectal cancer
5192028|NCT00856115|stage II rectal cancer|stage ii rectal cancer
5192029|NCT00856115|stage III rectal cancer|stage iii rectal cancer
5192030|NCT00856115|stage IV rectal cancer|stage iv rectal cancer
5192031|NCT00856076|Venous thromboembolism|venous thromboembolism
5192032|NCT00856076|Intrauterine fetal death|intrauterine fetal death
5192033|NCT00856076|Risk factor|risk factor
5192034|NCT00856076|Thrombophilia|thrombophilia
5192035|NCT00856076|Venous thromboembolism (in pregnancy)|venous thromboembolism (in pregnancy)
5192036|NCT00856063|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
5192037|NCT00856063|Atomoxetine|atomoxetine
5192038|NCT00856063|Electrodermal Response|electrodermal response
5192039|NCT00856063|Impulsivity|impulsivity
5192040|NCT00856063|Preschool Children|preschool children
5192041|NCT00856050|estrogen receptor positive|estrogen receptor positive
5192042|NCT00856050|progesterone receptor positive|progesterone receptor positive
5192043|NCT00856050|letrozole|letrozole
5192044|NCT00855998|Thymidine Kinase 1|thymidine kinase 1
5192045|NCT00855998|BRCA1 and BRCA2 mutations|brca1 and brca2 mutations
5192046|NCT00855998|hereditary breast/ovarian cancer|hereditary breast/ovarian cancer
5192047|NCT00855985|Pancreatic anastomosis|pancreatic anastomosis
5192048|NCT00855985|Whipple operation|whipple operation
5192049|NCT00855959|Asthma|asthma
5192050|NCT00855959|Pulmicort Respules|pulmicort respules
5192051|NCT00855946|tumor response|tumor response
5192052|NCT00855946|rectal adenocarcinoma|rectal adenocarcinoma
5192053|NCT00855946|preoperative radiochemotherapy|preoperative radiochemotherapy
5192054|NCT00855946|Proteomic analysis|proteomic analysis
5192055|NCT00855946|MALDI-TOF-TOF|maldi-tof-tof
5192056|NCT00855946|rectal adenocarcinoma, tumor response after preoperative radiochemotherapy|rectal adenocarcinoma, tumor response after preoperative radiochemotherapy
5192057|NCT00855920|Metabolism, Inborn Errors|metabolism, inborn errors
5192058|NCT00855920|Allopurinol|allopurinol
5192059|NCT00855920|Metabolic Diseases|metabolic diseases
5192060|NCT00855920|Genetic Diseases, Inborn|genetic diseases, inborn
5192061|NCT00855920|Musculoskeletal Diseases|musculoskeletal diseases
5192062|NCT00855920|Joint Diseases|joint diseases
5192063|NCT00855920|Arthritis|arthritis
5192064|NCT00855920|Rheumatic Diseases|rheumatic diseases
5192065|NCT00855920|Metabolic disorder|metabolic disorder
5192066|NCT00855920|Purine-Pyrimidine Metabolism, Inborn Errors|purine-pyrimidine metabolism, inborn errors
5192067|NCT00855920|Gout|gout
5192068|NCT00855920|Flare|flare
5192069|NCT00855907|IBD|ibd
5192070|NCT00855907|inflammatory bowel disease|inflammatory bowel disease
5192071|NCT00855907|fatty liver|fatty liver
5192072|NCT00855894|Tarceva|tarceva
5192073|NCT00855894|NSCLC|nsclc
5192074|NCT00855881|adjuvant chemotherapy for head and neck cancer|adjuvant chemotherapy for head and neck cancer
5192075|NCT00855868|Amyloid imaging|amyloid imaging
5192076|NCT00855868|Positron Emission Tomography|positron emission tomography
5192077|NCT00855868|18F-AV-45|18f-av-45
5192078|NCT00855868|florbetapir F 18|florbetapir f 18
5192079|NCT00855868|Diagnostic imaging|diagnostic imaging
5192080|NCT00855855|Diphtheria|diphtheria
5192081|NCT00855855|Tetanus|tetanus
5192082|NCT00855855|Pertussis|pertussis
5192083|NCT00855855|Poliovirus types 1-3|poliovirus types 1-3
5192084|NCT00855855|Haemophilus influenzae type b|haemophilus influenzae type b
5192085|NCT00855855|Pentacel®|pentacel®
5192086|NCT00855842|second trimester abortion|second trimester abortion
5192087|NCT00855842|labor induction abortion|labor induction abortion
5192088|NCT00855842|second trimester medical abortion|second trimester medical abortion
5192089|NCT00855842|pregnancy|pregnancy
5192090|NCT00855803|spinal cord metastases|spinal cord metastases
5192091|NCT00855803|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5192092|NCT00855803|pain|pain
5192093|NCT00855790|evaluate the effectiveness of one bite polypectomy with the RJ3 biopsy forcep versus the RJ4 biopsy forcep|evaluate the effectiveness of one bite polypectomy with the rj3 biopsy forcep versus the rj4 biopsy forcep
5192094|NCT00855777|third molar extraction|third molar extraction
5192095|NCT00855777|etoricoxib|etoricoxib
5192096|NCT00855777|ibuprofen|ibuprofen
5192097|NCT00855777|analgesic efficacy|analgesic efficacy
5192098|NCT00855777|pain|pain
5192099|NCT00855738|epilepsy antiepileptic biotherapy|epilepsy antiepileptic biotherapy
5192100|NCT00855725|Epilepsy|epilepsy
5192101|NCT00855725|Depression|depression
5192102|NCT00855725|Neurology|neurology
5192103|NCT00855725|fMRI|fmri
5192104|NCT00855725|Healthy Controls|healthy controls
5192105|NCT00855712|Heart Failure|heart failure
5192106|NCT00855712|Transplant|transplant
5192107|NCT00855712|Warm Perfusion|warm perfusion
5192108|NCT00855712|Organ Care|organ care
5192109|NCT00855712|Resting Mode|resting mode
5192110|NCT00855699|Alcohol detoxification|alcohol detoxification
5192111|NCT00855686|Memantine|memantine
5192112|NCT00855686|Cognition|cognition
5192113|NCT00855686|Parkinson's Disease Dementia|parkinson's disease dementia
5192114|NCT00855686|Dementia With Lewy Bodies|dementia with lewy bodies
5192115|NCT00855673|Claudication|claudication
5192116|NCT00855673|Peripheral Arterial Disease|peripheral arterial disease
5192117|NCT00855673|Intermittent Compression|intermittent compression
5192118|NCT00855673|Mechanical Compression|mechanical compression
5192119|NCT00855673|Flowmedic|flowmedic
5192120|NCT00855660|Bone Metabolism|bone metabolism
5192121|NCT00855634|Pancreatic cancer|pancreatic cancer
5192122|NCT00855634|metastasis|metastasis
5192123|NCT00855634|venous infiltration|venous infiltration
5192124|NCT00855634|Pancreatic cancer with minimal metastatic disease or venous infiltration|pancreatic cancer with minimal metastatic disease or venous infiltration
5192125|NCT00855621|deep brain stimulation|deep brain stimulation
5192126|NCT00855621|subthalamic nucleus|subthalamic nucleus
5192127|NCT00855608|choroidal neovascularization|choroidal neovascularization
5192128|NCT00855608|diabetic retinopathy|diabetic retinopathy
5192129|NCT00855608|uveitis|uveitis
5192130|NCT00855608|refractory cases of uveitis|refractory cases of uveitis
5192131|NCT00855595|Rosacea|rosacea
5192132|NCT00855582|Erectile Dysfunction|erectile dysfunction
5192133|NCT00855582|Benign Prostatic Hyperplasia|benign prostatic hyperplasia
5192134|NCT00855569|allografting|allografting
5192135|NCT00855530|Depression|depression
5192136|NCT00855504|preeclampsia|preeclampsia
5192137|NCT00855504|periodontitis|periodontitis
5192138|NCT00855504|cytokines|cytokines
5192139|NCT00855491|PCO|pco
5192140|NCT00855491|POCO|poco
5192141|NCT00855465|Chronic thromboembolic pulmonary hypertension|chronic thromboembolic pulmonary hypertension
5192142|NCT00855465|PH|ph
5192143|NCT00855465|soluble Guanylate Cyclase Stimulator|soluble guanylate cyclase stimulator
5192144|NCT00855465|sGC|sgc
5192145|NCT00855452|GVL|gvl
5192146|NCT00855452|rIL-2(LAK)|ril-2(lak)
5192147|NCT00855452|GVHD|gvhd
5192148|NCT00855452|MST|mst
5192149|NCT00855452|alloCT|alloct
5192150|NCT00855452|alloBMT|allobmt
5192151|NCT00855439|Diabetes|diabetes
5192152|NCT00855439|Neuropathy|neuropathy
5192153|NCT00855439|Glucose|glucose
5192154|NCT00855439|Control|control
5192155|NCT00855439|Peripheral|peripheral
5192156|NCT00855439|Autonomic|autonomic
5192157|NCT00855413|Acute HIV|acute hiv
5192158|NCT00855413|HIV|hiv
5192159|NCT00855413|Treatment Naive|treatment naive
5192160|NCT00855413|Acute Infections|acute infections
5192161|NCT00855400|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
5192162|NCT00855400|Bone marrow|bone marrow
5192163|NCT00855400|Stem cells|stem cells
5192164|NCT00855400|Autologous|autologous
5192165|NCT00855400|Safety|safety
5192166|NCT00855387|Clinical outcome (complications), in-hospital costs|clinical outcome (complications), in-hospital costs
5192167|NCT00855387|The influence and impact of postoperative complications on in-hospital costs|the influence and impact of postoperative complications on in-hospital costs
5192168|NCT00855361|Gastroesophageal Reflux|gastroesophageal reflux
5192169|NCT00855361|Erosive Gastroesophageal Reflux Disease|erosive gastroesophageal reflux disease
5192170|NCT00855361|Ulcerative Gastroesophageal Reflux Disease|ulcerative gastroesophageal reflux disease
5192171|NCT00855361|Endoscopy|endoscopy
5192172|NCT00855361|Pediatrics|pediatrics
5192173|NCT00855361|GERD|gerd
5192174|NCT00855361|Rabeprazole, Rabeprazole sodium|rabeprazole, rabeprazole sodium
5192175|NCT00855361|AcipHex|aciphex
5192176|NCT00855348|colorectal cancer|colorectal cancer
5192177|NCT00855348|early detection|early detection
5192178|NCT00855348|methylation, biomarker|methylation, biomarker
5192179|NCT00855335|HIV-1|hiv-1
5192180|NCT00855335|HIV|hiv
5192181|NCT00855335|Pregnancy|pregnancy
5192182|NCT00855335|Postpartum|postpartum
5192183|NCT00855335|Human immunodeficiency virus|human immunodeficiency virus
5192184|NCT00855335|PREZISTA|prezista
5192185|NCT00855335|INTELENCE|intelence
5192186|NCT00855335|NORVIR|norvir
5192187|NCT00855335|TMC114|tmc114
5192188|NCT00855335|TMC125|tmc125
5192189|NCT00855335|darunavir|darunavir
5192190|NCT00855335|ritonavir|ritonavir
5192191|NCT00855335|etravirine|etravirine
5192192|NCT00855335|rilpivirine|rilpivirine
5192193|NCT00855335|TMC278|tmc278
5192194|NCT00855335|Cobicistat|cobicistat
5192195|NCT00855335|treatment experienced|treatment experienced
5192196|NCT00855322|Arthritis, Rheumatoid|arthritis, rheumatoid
5192197|NCT00855322|Exercise|exercise
5192198|NCT00855322|Biological Therapy|biological therapy
5192199|NCT00855309|chemotherapeutic agent toxicity|chemotherapeutic agent toxicity
5192200|NCT00855309|renal toxicity|renal toxicity
5192201|NCT00855309|infection|infection
5192202|NCT00855309|neutropenia|neutropenia
5192203|NCT00855270|PTSD|ptsd
5192204|NCT00855257|Acid nicotinique|acid nicotinique
5192205|NCT00855257|FLOW MEDIATED DILATATION (FMD)|flow mediated dilatation (fmd)
5192206|NCT00855257|HDL-C< 0.4 G/L|hdl-c< 0.4 g/l
5192207|NCT00855244|Bone marrow transplantation|bone marrow transplantation
5192208|NCT00855231|Acute coronary syndrome|acute coronary syndrome
5192209|NCT00855231|Coronary artery disease|coronary artery disease
5192210|NCT00855231|cardiac imaging|cardiac imaging
5192211|NCT00855231|computed tomography|computed tomography
5192212|NCT00855218|Sorafenib|sorafenib
5192213|NCT00855218|TACE|tace
5192214|NCT00855218|DC bead|dc bead
5192215|NCT00855218|Combination|combination
5192216|NCT00855205|pulmonary sarcoidosis|pulmonary sarcoidosis
5192217|NCT00855192|anxiety|anxiety
5192218|NCT00855192|depression|depression
5192219|NCT00855192|pregnancy|pregnancy
5192220|NCT00855192|antenatal|antenatal
5192221|NCT00855192|prenatal|prenatal
5192222|NCT00855192|mindfulness-based therapy|mindfulness-based therapy
5192223|NCT00855192|interpersonal therapy|interpersonal therapy
5192224|NCT00855192|support groups|support groups
5192225|NCT00855166|Dapagliflozin|dapagliflozin
5192226|NCT00855166|Metformin|metformin
5192227|NCT00855166|Type 2 diabetes|type 2 diabetes
5192228|NCT00855166|body weight|body weight
5192229|NCT00855153|PTSD|ptsd
5192230|NCT00855153|burns|burns
5192231|NCT00855153|virtual reality exposure|virtual reality exposure
5192232|NCT00855153|D-Cycloserine|d-cycloserine
5192233|NCT00855153|Combat related psychological trauma in burned servicemembers|combat related psychological trauma in burned servicemembers
5192234|NCT00855140|Insomnia|insomnia
5192235|NCT00855140|Primary insomnia|primary insomnia
5192236|NCT00855140|Insomnia disorder|insomnia disorder
5192237|NCT00855140|Acupuncture|acupuncture
5192238|NCT00855127|Biological Markers|biological markers
5192239|NCT00855127|Renal Replacement Therapy|renal replacement therapy
5192240|NCT00855127|Mortality|mortality
5192241|NCT00855114|stage II breast cancer|stage ii breast cancer
5192242|NCT00855114|stage III breast cancer|stage iii breast cancer
5192243|NCT00855114|stage IIIA breast cancer|stage iiia breast cancer
5192244|NCT00855101|Pharmacokinetics and safety of voriconazole intravenous oral adults|pharmacokinetics and safety of voriconazole intravenous oral adults
5192245|NCT00855088|HIV seronegativity|hiv seronegativity
5192246|NCT00855075|Sedation|sedation
5192247|NCT00855075|Analgesia|analgesia
5192248|NCT00855075|Mechanical ventilation|mechanical ventilation
5192249|NCT00855075|Cerebral State Monitor|cerebral state monitor
5192250|NCT00855075|Cerebral State Index|cerebral state index
5192251|NCT00855062|Human immunodeficiency virus (HIV)|human immunodeficiency virus (hiv)
5192252|NCT00855062|HIV associated cognitive impairment|hiv associated cognitive impairment
5192253|NCT00855062|HIV dementia|hiv dementia
5192254|NCT00855062|Uganda|uganda
5192255|NCT00855062|Acquired immune deficiency syndrome (AIDS)|acquired immune deficiency syndrome (aids)
5192256|NCT00855062|Treatment Naive|treatment naive
5192257|NCT00855049|Pharmacokinetics|pharmacokinetics
5192258|NCT00855049|Acetaminophen|acetaminophen
5192259|NCT00855049|Intranasal|intranasal
5192260|NCT00855049|Absorption|absorption
5192261|NCT00855036|blunt renal injury|blunt renal injury
5192262|NCT00855036|kidney laceration|kidney laceration
5192263|NCT00855023|anterior cruciate ligament|anterior cruciate ligament
5192264|NCT00855023|Knee Joint|knee joint
5192265|NCT00855010|Pioglitazone|pioglitazone
5192266|NCT00855010|prediabetes|prediabetes
5192267|NCT00855010|diabetes|diabetes
5192268|NCT00855010|obesity|obesity
5192269|NCT00855010|Pancreatic fat|pancreatic fat
5192270|NCT00854997|Obstructive sleep apnea; myocardial infarction|obstructive sleep apnea; myocardial infarction
5192271|NCT00854984|Depression|depression
5192272|NCT00854984|diabetes|diabetes
5192273|NCT00854984|Coronary heart disease|coronary heart disease
5192275|NCT00854984|Cognitive behavioural therapy|cognitive behavioural therapy
5192276|NCT00854971|NKCell|nkcell
5192277|NCT00854971|FOLFOX-4|folfox-4
5192278|NCT00854971|advanced or unresectable colorectal cancer|advanced or unresectable colorectal cancer
5192279|NCT00854958|Oral|oral
5192280|NCT00854958|Allergy|allergy
5192281|NCT00854958|Syndrome|syndrome
5192282|NCT00854958|Food|food
5192283|NCT00854958|Pollen|pollen
5192284|NCT00854945|Myelodysplastic Syndrome|myelodysplastic syndrome
5192285|NCT00854945|Refractory Cytopenia|refractory cytopenia
5192286|NCT00854945|Refractory Anemia|refractory anemia
5192287|NCT00854945|Dysplasia|dysplasia
5192288|NCT00854945|Acute Myeloid Leukemia|acute myeloid leukemia
5192289|NCT00854932|procalcitonin|procalcitonin
5192290|NCT00854932|sepsis|sepsis
5192291|NCT00854932|newborn|newborn
5192292|NCT00854932|intervention study|intervention study
5192293|NCT00854919|obsessive-compulsive disorder|obsessive-compulsive disorder
5192294|NCT00854919|augmentation treatment|augmentation treatment
5192295|NCT00854919|SSRI-refractory|ssri-refractory
5192296|NCT00854906|dry eye|dry eye
5192297|NCT00854906|keratometer|keratometer
5192298|NCT00854906|fluorescein|fluorescein
5192299|NCT00854893|stroke|stroke
5192300|NCT00854893|aphasia|aphasia
5192301|NCT00854893|aging|aging
5192302|NCT00854893|language learning|language learning
5192303|NCT00854880|Erosive Gastritis|erosive gastritis
5192304|NCT00854867|Solid tumour neoplastic meningitis|solid tumour neoplastic meningitis
5192305|NCT00854867|STNM|stnm
5192306|NCT00854867|leptomeningeal metastases|leptomeningeal metastases
5192307|NCT00854867|DepoCyte|depocyte
5192308|NCT00854867|WBRT|wbrt
5192309|NCT00854867|Whole Brain Radiotherapy|whole brain radiotherapy
5192310|NCT00854867|Liposomal cytarabine intrathecal|liposomal cytarabine intrathecal
5192311|NCT00854867|Solid Tumour Neoplastic Meningitis with or without brain metastasis|solid tumour neoplastic meningitis with or without brain metastasis
5192312|NCT00854854|NKCell|nkcell
5192313|NCT00854854|FOLFOX-4|folfox-4
5192314|NCT00854854|gastric cancer|gastric cancer
5192315|NCT00854841|CML|cml
5192316|NCT00854841|suboptimal response|suboptimal response
5192317|NCT00854841|dasatinib|dasatinib
5192318|NCT00854841|imatinib|imatinib
5192319|NCT00854828|Symptomatic 40-80 y/o w/lumbar Cobb of 30 degrees|symptomatic 40-80 y/o w/lumbar cobb of 30 degrees
5192320|NCT00854828|All Participants must be reasonable surgical candidate at enrollment|all participants must be reasonable surgical candidate at enrollment
5192321|NCT00854815|Perforated appendicitis|perforated appendicitis
5192322|NCT00854815|laparoscopic appendectomy|laparoscopic appendectomy
5192323|NCT00854815|children|children
5192324|NCT00854815|irrigation|irrigation
5192325|NCT00854802|Hepatitis|hepatitis
5192326|NCT00854802|Hepatitis C|hepatitis c
5192327|NCT00854789|Breast cancer|breast cancer
5192328|NCT00854776|aspirin|aspirin
5192329|NCT00854776|clopidogrel|clopidogrel
5192330|NCT00854776|proton pump inhibitor|proton pump inhibitor
5192331|NCT00854776|peptic ulcer|peptic ulcer
5192332|NCT00854776|ulcer complications|ulcer complications
5192333|NCT00854750|Multiple Sclerosis, hx of unilateral ON, evidence of thermal sensitivity, and no evidence of an ocular motor syndrome|multiple sclerosis, hx of unilateral on, evidence of thermal sensitivity, and no evidence of an ocular motor syndrome
5192334|NCT00854750|Multiple Sclerosis, no evidence of ON, and evidence of thermal sensitivity|multiple sclerosis, no evidence of on, and evidence of thermal sensitivity
5192335|NCT00854750|Healthy age/gender matched controls|healthy age/gender matched controls
5192336|NCT00854737|bipolar disorder|bipolar disorder
5192337|NCT00854737|bipolar depression|bipolar depression
5192338|NCT00854737|bipolar mania|bipolar mania
5192339|NCT00854737|manic depression|manic depression
5192340|NCT00854737|depression|depression
5192341|NCT00854737|mania|mania
5192342|NCT00854737|hypomania|hypomania
5192343|NCT00854711|ST elevated Myocardical infraction|st elevated myocardical infraction
5192469|NCT00854152|Tumors|tumors
5192344|NCT00854698|THE LEFT VENTRICULAR REMODELING AFTER MECHANICAL AORTIC VALVE REPLACEMENT|the left ventricular remodeling after mechanical aortic valve replacement
5192345|NCT00854698|exercise training|exercise training
5192346|NCT00854672|Sarcoidosis|sarcoidosis
5192347|NCT00854672|muscle strength|muscle strength
5192348|NCT00854672|exercise intolerance|exercise intolerance
5192349|NCT00854672|QOL|qol
5192350|NCT00854646|ON 01910.Na|on 01910.na
5192351|NCT00854646|refractory|refractory
5192352|NCT00854646|leukemia|leukemia
5192353|NCT00854646|myelodysplastic|myelodysplastic
5192354|NCT00854646|cell cycle|cell cycle
5192355|NCT00854633|Pre-term infants|pre-term infants
5192356|NCT00854633|Pre-term infants 750 to 1500 grams|pre-term infants 750 to 1500 grams
5192357|NCT00854594|Diabetes|diabetes
5192358|NCT00854594|Telemedicine|telemedicine
5192359|NCT00854594|Shared Medical Appointments|shared medical appointments
5192360|NCT00854581|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
5192361|NCT00854581|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
5192362|NCT00854581|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
5192363|NCT00854581|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
5192364|NCT00854581|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
5192365|NCT00854581|HTLV-1 infection|htlv-1 infection
5192366|NCT00854568|B-cell lymphoma|b-cell lymphoma
5192367|NCT00854568|CHOP|chop
5192368|NCT00854568|CEOP|ceop
5192369|NCT00854568|Cardiotoxicity|cardiotoxicity
5192370|NCT00854555|incomplete spinal cord injury|incomplete spinal cord injury
5192371|NCT00854555|locomotor activity|locomotor activity
5192372|NCT00854555|walking function|walking function
5192373|NCT00854555|gait|gait
5192374|NCT00854542|Telepsychiatry|telepsychiatry
5192375|NCT00854542|Culturally Sensitive Collaborative Treatment|culturally sensitive collaborative treatment
5192376|NCT00854542|Chinese Americans|chinese americans
5192377|NCT00854542|Depression|depression
5192378|NCT00854529|bevacizumab|bevacizumab
5192379|NCT00854529|subconjunctival injection|subconjunctival injection
5192380|NCT00854529|trabeculectomy|trabeculectomy
5192381|NCT00854529|bleb|bleb
5192382|NCT00854529|mitomycin c|mitomycin c
5192383|NCT00854516|compression therapy|compression therapy
5192384|NCT00854516|3M|3m
5192385|NCT00854503|Statins administration in diabetic dyslipidemia|statins administration in diabetic dyslipidemia
5192386|NCT00854477|capecitabine|capecitabine
5192387|NCT00854477|Post whipples|post whipples
5192388|NCT00854477|pancreatico-duodenectomy|pancreatico-duodenectomy
5192389|NCT00854477|pancreatic adenocarcinoma|pancreatic adenocarcinoma
5192390|NCT00854477|pharmacokinetic|pharmacokinetic
5192391|NCT00854464|Arsenic Methylation Capability|arsenic methylation capability
5192392|NCT00854464|Arsenic Methylation Enzymes|arsenic methylation enzymes
5192393|NCT00854464|Cigarette Metabolites|cigarette metabolites
5192394|NCT00854464|Cigarette Metabolic Enzymes|cigarette metabolic enzymes
5192395|NCT00854464|DNA Repair Enzymes|dna repair enzymes
5192396|NCT00854464|Inflammatory Factors|inflammatory factors
5192397|NCT00854464|Urothelial Carcinoma|urothelial carcinoma
5192398|NCT00854451|Helicobacter pylori|helicobacter pylori
5192399|NCT00854451|CYP2C19 genotype|cyp2c19 genotype
5192400|NCT00854451|intragastric pH|intragastric ph
5192401|NCT00854451|dual therapy|dual therapy
5192402|NCT00854451|antibiotic resistance|antibiotic resistance
5192403|NCT00854438|anticholinergic drugs|anticholinergic drugs
5192404|NCT00854438|adverse events|adverse events
5192405|NCT00854438|elderly|elderly
5192406|NCT00854438|clinical pharmacist|clinical pharmacist
5192407|NCT00854438|Evaluate the clinical effects of reducing anticholinergic in elderly|evaluate the clinical effects of reducing anticholinergic in elderly
5192408|NCT00854412|Obesity|obesity
5192409|NCT00854412|Weight loss|weight loss
5192410|NCT00854412|Very low-calorie diet|very low-calorie diet
5192411|NCT00854412|Mannose-binding lectin|mannose-binding lectin
5192412|NCT00854412|Insulin resistance|insulin resistance
5192413|NCT00854386|fluid management|fluid management
5192414|NCT00854386|VATS|vats
5192415|NCT00854386|ALI|ali
5192416|NCT00854386|ARDS|ards
5192417|NCT00854373|Infertility|infertility
5192418|NCT00854373|Pregnancy|pregnancy
5192419|NCT00854373|in vitro fertilization|in vitro fertilization
5192420|NCT00854360|Seasonal Allergic Rhinitis|seasonal allergic rhinitis
5192421|NCT00854360|Hayfever|hayfever
5192422|NCT00854347|hyperglycemia|hyperglycemia
5192423|NCT00854347|diabetes|diabetes
5192424|NCT00854347|intensive care|intensive care
5192425|NCT00854347|prevalence|prevalence
5192426|NCT00854334|Sleep|sleep
5192427|NCT00854334|Overweight|overweight
5192428|NCT00854334|Physical activity|physical activity
5192429|NCT00854334|Appetite|appetite
5192430|NCT00854334|NEAT|neat
5192431|NCT00854321|rheumatoid arthritis|rheumatoid arthritis
5192432|NCT00854321|rituximab|rituximab
5192433|NCT00854321|therapy|therapy
5192434|NCT00854308|Tarceva|tarceva
5192435|NCT00854308|Lung Cancer|lung cancer
5192436|NCT00854308|NSCLC|nsclc
5192437|NCT00854295|arthritis|arthritis
5192438|NCT00854295|osteoarthritis|osteoarthritis
5192439|NCT00854295|degenerative knee disease|degenerative knee disease
5192440|NCT00854295|avascular necrosis|avascular necrosis
5192441|NCT00854295|total knee replacement|total knee replacement
5192442|NCT00854295|TKA|tka
5192443|NCT00854256|glaucoma|glaucoma
5192444|NCT00854230|HIV|hiv
5192445|NCT00854230|alcohol|alcohol
5192446|NCT00854230|naltrexone|naltrexone
5192447|NCT00854230|Treatment Experienced|treatment experienced
5192448|NCT00854204|Innovation-TiFP4-C101|innovation-tifp4-c101
5192449|NCT00854204|Innovation-C101|innovation-c101
5192450|NCT00854204|Innovation|innovation
5192451|NCT00854204|TMC114/TMC41629|tmc114/tmc41629
5192452|NCT00854204|controlled-release coformulations|controlled-release coformulations
5192453|NCT00854204|immediate-release coformulation|immediate-release coformulation
5192454|NCT00854204|Pharmacokinetics|pharmacokinetics
5192455|NCT00854191|mechanical simulator|mechanical simulator
5192456|NCT00854191|ERCP|ercp
5192457|NCT00854191|training|training
5192458|NCT00854178|isoflurane|isoflurane
5192459|NCT00854178|propofol|propofol
5192460|NCT00854178|genotoxicity|genotoxicity
5192461|NCT00854178|gene expression|gene expression
5192462|NCT00854178|cytokines|cytokines
5192463|NCT00854178|apoptosis|apoptosis
5192464|NCT00854165|lung transplantation|lung transplantation
5192465|NCT00854165|respiratory failure|respiratory failure
5192466|NCT00854165|ECMO|ecmo
5192467|NCT00854165|Lung transplants in respiratory failure patients|lung transplants in respiratory failure patients
5192468|NCT00854152|NHL|nhl
5192470|NCT00854152|Carcinogenic Tumors|carcinogenic tumors
5192471|NCT00854139|Multiple myeloma|multiple myeloma
5192472|NCT00854139|Renal failure|renal failure
5192473|NCT00854139|Kidney transplant|kidney transplant
5192474|NCT00854126|NHL|nhl
5192475|NCT00854126|Solid Tumors|solid tumors
5192476|NCT00854126|Carcinogenic Tumors|carcinogenic tumors
5192477|NCT00854113|Diabetes Mellitus Type 2|diabetes mellitus type 2
5192478|NCT00854100|Adjunctive|adjunctive
5192479|NCT00854100|Depression|depression
5192480|NCT00854100|Major Depressive Disorder (MDD)|major depressive disorder (mdd)
5192481|NCT00854087|Hepatitis C Virus|hepatitis c virus
5192482|NCT00854087|HCV|hcv
5192483|NCT00854087|Herbal treatment|herbal treatment
5192484|NCT00854087|Herbs|herbs
5192485|NCT00854087|San Diego|san diego
5192486|NCT00854087|Non responder|non responder
5192487|NCT00854087|Relapser|relapser
5192488|NCT00854087|Treatment failure|treatment failure
5192489|NCT00854087|Antifibrotic|antifibrotic
5192490|NCT00854087|Anti-fibrotic|anti-fibrotic
5192491|NCT00854087|Fibrosis|fibrosis
5192492|NCT00854087|Failure of previous Interferon based therapy|failure of previous interferon based therapy
5192493|NCT00854087|Refuse Interferon based therapy|refuse interferon based therapy
5192494|NCT00854087|Intolerance to Interferon|intolerance to interferon
5192495|NCT00854087|Male or female 18-70 years of age|male or female 18-70 years of age
5192496|NCT00854074|Post-operative Paralytic Ileus|post-operative paralytic ileus
5192497|NCT00854074|Neuromodulation|neuromodulation
5192498|NCT00854074|Neurostimulation|neurostimulation
5192499|NCT00854074|Extended loss of functional bowel motility|extended loss of functional bowel motility
5192500|NCT00854048|Pediatric|pediatric
5192501|NCT00854048|Oxygen Saturation|oxygen saturation
5192502|NCT00854048|Cardiopulmonary bypass|cardiopulmonary bypass
5192503|NCT00854035|MK-0431/ONO-5435|mk-0431/ono-5435
5192504|NCT00854035|Type 2 diabetes mellitus|type 2 diabetes mellitus
5192505|NCT00854009|Healthy Subjects|healthy subjects
5192506|NCT00853983|Healthy Volunteers|healthy volunteers
5192507|NCT00853983|ADME|adme
5192508|NCT00853970|Pain and Inflammation as a function of cataract surgery|pain and inflammation as a function of cataract surgery
5192509|NCT00853957|Hypertension|hypertension
5192510|NCT00853957|African Americans|african americans
5192511|NCT00853957|Aliskiren|aliskiren
5192512|NCT00853957|Amlodipine|amlodipine
5192513|NCT00853957|Systolic blood pressure|systolic blood pressure
5192514|NCT00853957|Diastolic blood pressure|diastolic blood pressure
5192515|NCT00853957|Stage II|stage ii
5192516|NCT00853957|Combination|combination
5192517|NCT00853944|islet transplantation|islet transplantation
5192518|NCT00853944|type 1 diabetes|type 1 diabetes
5192519|NCT00853944|incretin|incretin
5192520|NCT00853931|KRAS wild type|kras wild type
5192521|NCT00853931|metastatic colorectal cancer|metastatic colorectal cancer
5192522|NCT00853931|KRAS wild type metastatic colorectal cancer with no prior exposure to EGFR inhibitors|kras wild type metastatic colorectal cancer with no prior exposure to egfr inhibitors
5192523|NCT00853918|Physician survey|physician survey
5192524|NCT00853918|Mail survey|mail survey
5192525|NCT00853918|Response rate|response rate
5192526|NCT00853905|open angle glaucoma (POAG)|open angle glaucoma (poag)
5192527|NCT00853905|angle closure glaucoma (PACG)|angle closure glaucoma (pacg)
5192528|NCT00853905|pigmentary glaucoma|pigmentary glaucoma
5192529|NCT00853905|pseudoexfoliation glaucoma|pseudoexfoliation glaucoma
5192530|NCT00853905|neovascular glaucoma|neovascular glaucoma
5192531|NCT00853905|traumatic glaucoma|traumatic glaucoma
5192532|NCT00853892|Healthy Subjects|healthy subjects
5192533|NCT00853892|Bioequivalence|bioequivalence
5192534|NCT00853866|stroke|stroke
5192535|NCT00853866|reboxetine|reboxetine
5192536|NCT00853866|noradrenaline|noradrenaline
5192537|NCT00853866|motor cortex|motor cortex
5192538|NCT00853866|transcranial direct current stimulation|transcranial direct current stimulation
5192539|NCT00853866|motor function|motor function
5192540|NCT00853866|rehabilitation|rehabilitation
5192541|NCT00853866|Jebsen Taylor test|jebsen taylor test
5192542|NCT00853853|Hemorrhoidectomy|hemorrhoidectomy
5192543|NCT00853853|Hemorrhoids|hemorrhoids
5192544|NCT00853840|pharmacodynamics. maraviroc, vardenafil, blood pressure|pharmacodynamics. maraviroc, vardenafil, blood pressure
5192545|NCT00853827|CAD|cad
5192546|NCT00853827|coronary artery disease|coronary artery disease
5192547|NCT00853827|coronary atherosclerosis|coronary atherosclerosis
5192548|NCT00853827|coronary angiography|coronary angiography
5192549|NCT00853827|IVUS|ivus
5192550|NCT00853827|intravascular ultrasound|intravascular ultrasound
5192551|NCT00853827|plasma renin activity|plasma renin activity
5192552|NCT00853827|renin angiotensin aldosterone system,|renin angiotensin aldosterone system,
5192553|NCT00853827|direct renin inhibitors|direct renin inhibitors
5192554|NCT00853827|coronary atheroma|coronary atheroma
5192555|NCT00853814|adolescence|adolescence
5192556|NCT00853814|obesity|obesity
5192557|NCT00853814|physical activity|physical activity
5192558|NCT00853814|built environment|built environment
5192559|NCT00853814|neighborhood environment|neighborhood environment
5192560|NCT00853814|children|children
5192561|NCT00853814|youth|youth
5192562|NCT00853814|increasing physical activity|increasing physical activity
5192563|NCT00853814|changing dietary intake|changing dietary intake
5192564|NCT00853814|reducing zBMI|reducing zbmi
5192565|NCT00853801|Pre-Diabetes|pre-diabetes
5192566|NCT00853801|Metabolic Syndrome|metabolic syndrome
5192567|NCT00853801|Type 2 Diabetes|type 2 diabetes
5192568|NCT00853801|Diabetes Prevention|diabetes prevention
5192569|NCT00853801|Lifestyle Modification|lifestyle modification
5192570|NCT00853801|Diet Therapy|diet therapy
5192571|NCT00853801|Provider Education|provider education
5192572|NCT00853788|systemic sclerosis|systemic sclerosis
5192573|NCT00853788|biomarkers|biomarkers
5192574|NCT00853788|microarray|microarray
5192575|NCT00853775|heart disease|heart disease
5192576|NCT00853775|cardiovascular disease|cardiovascular disease
5192577|NCT00853775|lipoproteins|lipoproteins
5192578|NCT00853775|lipoprotein(a)|lipoprotein(a)
5192579|NCT00853775|Lp(a)|lp(a)
5192580|NCT00853775|apolipoprotein(a)|apolipoprotein(a)
5192581|NCT00853775|apo(a)|apo(a)
5192582|NCT00853775|fats|fats
5192583|NCT00853775|proteins|proteins
5192584|NCT00853775|metabolism|metabolism
5192585|NCT00853749|Immune response|immune response
5192586|NCT00853749|pneumococcal conjugate vaccine|pneumococcal conjugate vaccine
5192587|NCT00853749|polysaccharide|polysaccharide
5192588|NCT00853736|Healthy Subjects|healthy subjects
5192589|NCT00853736|Bioequivalence|bioequivalence
5192590|NCT00853723|osteoporosis|osteoporosis
5192591|NCT00853723|post-menopausal|post-menopausal
5192592|NCT00853723|bone anabolic agents|bone anabolic agents
5192593|NCT00853710|Prostate-Specific Antigen|prostate-specific antigen
5192594|NCT00853710|Prostate Cancer|prostate cancer
5192595|NCT00853710|Cancer|cancer
5192596|NCT00853710|Assay|assay
5192597|NCT00853697|Prostate|prostate
5192598|NCT00853697|DUTASTERIDE|dutasteride
5192599|NCT00853697|TESTOSTERONE|testosterone
5192600|NCT00853697|09-008|09-008
5192601|NCT00853697|Consortium Protocol LOI# c09-028|consortium protocol loi# c09-028
5192602|NCT00853684|Advanced Colorectal Cancer|advanced colorectal cancer
5192603|NCT00853684|Oxaliplatin|oxaliplatin
5192604|NCT00853684|Capecitabine|capecitabine
5192605|NCT00853684|Endostar|endostar
5192606|NCT00853684|efficacy|efficacy
5192607|NCT00853671|Coronary Artery Disease|coronary artery disease
5192608|NCT00853671|Multidetector Computed Tomography|multidetector computed tomography
5192609|NCT00853671|Myocardial Perfusion Imaging|myocardial perfusion imaging
5192610|NCT00853658|Chronic Heart Failure|chronic heart failure
5192611|NCT00853658|Cardiovascular death|cardiovascular death
5192612|NCT00853658|CHF hospitalization|chf hospitalization
5192613|NCT00853658|morbi-mortality trial|morbi-mortality trial
5192614|NCT00853658|outcome study|outcome study
5192615|NCT00853658|endpoint driven|endpoint driven
5192616|NCT00853658|plasma renin activity|plasma renin activity
5192617|NCT00853658|renin angiotensin aldosterone system|renin angiotensin aldosterone system
5192618|NCT00853658|direct renin inhibitors|direct renin inhibitors
5192619|NCT00853658|BNP|bnp
5192620|NCT00853658|KCCQ|kccq
5192621|NCT00853658|eGFR|egfr
5192622|NCT00853658|(NYHA class II to IV) with elevated|(nyha class ii to iv) with elevated
5192623|NCT00853658|BNP and reduced LVEF|bnp and reduced lvef
5192624|NCT00853632|Mitral valve|mitral valve
5192625|NCT00853632|pericardial bioprostheses|pericardial bioprostheses
5192626|NCT00853632|PERIMOUNT|perimount
5192627|NCT00853632|bovine pericardial leaflets|bovine pericardial leaflets
5192628|NCT00853632|mitral valve replacement|mitral valve replacement
5192629|NCT00853632|mitral valve regurgitation|mitral valve regurgitation
5192630|NCT00853632|Heart valve disease|heart valve disease
5192631|NCT00853619|clinical decision support|clinical decision support
5192632|NCT00853619|knowledge management|knowledge management
5192633|NCT00853619|knowledge representation|knowledge representation
5192634|NCT00853619|clinical guidelines|clinical guidelines
5192635|NCT00853619|coronary artery disease|coronary artery disease
5192636|NCT00853619|myocardial ischemia|myocardial ischemia
5192637|NCT00853619|diabetes mellitus|diabetes mellitus
5192638|NCT00853619|hypertension|hypertension
5192639|NCT00853606|ED|ed
5192640|NCT00853606|Erectile Dysfunction|erectile dysfunction
5192641|NCT00853606|Dysfunction|dysfunction
5192642|NCT00853606|Erectile|erectile
5192643|NCT00853593|heart failure|heart failure
5192644|NCT00853593|cardiac pacing|cardiac pacing
5192645|NCT00853593|cardiac resynchronization therapy|cardiac resynchronization therapy
5192646|NCT00853593|left ventricular lead|left ventricular lead
5192647|NCT00853580|Neurofibromatosis Type 1, Neurocognitive, Phase II|neurofibromatosis type 1, neurocognitive, phase ii
5192648|NCT00853567|Uterine Fibroids|uterine fibroids
5192649|NCT00853554|Healthy Subjects|healthy subjects
5192650|NCT00853554|Bioequivalence|bioequivalence
5192651|NCT00853541|renal impairment|renal impairment
5192652|NCT00853541|heart failure|heart failure
5192653|NCT00853541|hyperphosphatemia|hyperphosphatemia
5192654|NCT00853541|coronary artery calcification|coronary artery calcification
5192655|NCT00853528|spinal cord metastases|spinal cord metastases
5192656|NCT00853502|anorexia nervosa|anorexia nervosa
5192657|NCT00853502|testosterone|testosterone
5192658|NCT00853502|disordered eating|disordered eating
5192659|NCT00853502|hypogonadism|hypogonadism
5192660|NCT00853502|bone|bone
5192661|NCT00853489|Open tibia fractures|open tibia fractures
5192662|NCT00853489|rhBMP-2|rhbmp-2
5192663|NCT00853489|critical size defects|critical size defects
5192664|NCT00853489|bone grafting|bone grafting
5192665|NCT00853463|Pulmonary Embolism|pulmonary embolism
5192666|NCT00853463|Deep Vein Thrombosis|deep vein thrombosis
5192667|NCT00853463|Prophylaxis|prophylaxis
5192668|NCT00853463|Venous thromboembolism|venous thromboembolism
5192669|NCT00853463|Prevention|prevention
5192670|NCT00853463|Medical patients|medical patients
5192671|NCT00853450|Antiplatelet|antiplatelet
5192672|NCT00853437|Comparison of CO by new method to clinician's estimate and implied CO from the measurement of arteriovenous oxygen content difference.|comparison of co by new method to clinician's estimate and implied co from the measurement of arteriovenous oxygen content difference.
5192673|NCT00853424|diabetic retinopathy|diabetic retinopathy
5192674|NCT00853424|diabetic macular edema|diabetic macular edema
5192675|NCT00853424|type 1 diabetes|type 1 diabetes
5192676|NCT00853424|intensive medical therapy|intensive medical therapy
5192677|NCT00853424|islet cell transplantation|islet cell transplantation
5192678|NCT00853424|visual acuity|visual acuity
5192679|NCT00853424|diabetic eye disease|diabetic eye disease
5192680|NCT00853411|Moderate to severe asthma|moderate to severe asthma
5192681|NCT00853398|Primary Osteoarthritis of the knee.|primary osteoarthritis of the knee.
5192682|NCT00853385|oral DMARD|oral dmard
5192683|NCT00853385|JAK inhibitor|jak inhibitor
5192684|NCT00853385|clinical trial|clinical trial
5192685|NCT00853346|Depression|depression
5192686|NCT00853346|Parkinson's Disease|parkinson's disease
5192687|NCT00853346|Major Depression|major depression
5192688|NCT00853346|Cognitive Behavioral Therapy|cognitive behavioral therapy
5192689|NCT00853333|Pain|pain
5192690|NCT00853333|Propofol|propofol
5192691|NCT00853333|Dexmedetomidine|dexmedetomidine
5192692|NCT00853333|Midazolam|midazolam
5192693|NCT00853333|Effects of sedation on pain perception.|effects of sedation on pain perception.
5192694|NCT00853320|Healthy Subjects|healthy subjects
5192695|NCT00853320|Bioequivalence|bioequivalence
5192696|NCT00853307|Drug therapy|drug therapy
5192697|NCT00853294|Healthy Subjects|healthy subjects
5192698|NCT00853294|Bioequivalence|bioequivalence
5192699|NCT00853281|Forest malaria prevention|forest malaria prevention
5192700|NCT00853281|Long-lasting insecticidal hammocks|long-lasting insecticidal hammocks
5192701|NCT00853281|Cluster randomized trial|cluster randomized trial
5192702|NCT00853281|Central Vietnam|central vietnam
5192703|NCT00853268|Healthy Subjects|healthy subjects
5192704|NCT00853268|Bioequivalence|bioequivalence
5192705|NCT00853255|Bird Flu|bird flu
5192706|NCT00853242|Chronic Kidney Disease|chronic kidney disease
5192707|NCT00853242|Phosphate Binder|phosphate binder
5192708|NCT00853242|Phosphate|phosphate
5192709|NCT00853242|Hyperphosphatemia|hyperphosphatemia
5192710|NCT00853229|vulvodynia|vulvodynia
5192711|NCT00853229|vulvar vestibulitis|vulvar vestibulitis
5192712|NCT00853229|chronic vulvar pain|chronic vulvar pain
5192713|NCT00853229|generalized vulvodynia|generalized vulvodynia
5192714|NCT00853229|localized vulvodynia|localized vulvodynia
5192715|NCT00853216|Healthy Subjects|healthy subjects
5192716|NCT00853216|Bioequivalence|bioequivalence
5192717|NCT00853203|Colorectal Cancer|colorectal cancer
5192718|NCT00853203|Rectal Cancer|rectal cancer
5192719|NCT00853203|Psychosocial|psychosocial
5192720|NCT00853203|Expressive Disclosure|expressive disclosure
5192721|NCT00853203|Questionnaires|questionnaires
5192722|NCT00853203|Quality of life|quality of life
5192723|NCT00853203|QOL|qol
5192724|NCT00853203|Electronically Activated Recorder|electronically activated recorder
5192725|NCT00853203|EAR|ear
5192726|NCT00853190|Healthy Subjects|healthy subjects
5192727|NCT00853177|Oocyte retrieval|oocyte retrieval
5192728|NCT00853177|pain|pain
5192729|NCT00853177|surgery|surgery
5192730|NCT00853177|anaesthesiology|anaesthesiology
5192731|NCT00853177|Assisted Reproductive Technologies|assisted reproductive technologies
5192732|NCT00853164|prostate cancer|prostate cancer
5192733|NCT00853164|aerobic exercise|aerobic exercise
5192734|NCT00853164|resistance training|resistance training
5192735|NCT00853138|cognitive-behavioral therapy|cognitive-behavioral therapy
5192736|NCT00853138|chronic pain|chronic pain
5192737|NCT00853138|randomized controlled trial|randomized controlled trial
5192738|NCT00853138|pediatrics|pediatrics
5192739|NCT00853125|clear cell renal cell carcinoma|clear cell renal cell carcinoma
5192740|NCT00853125|stage IV renal cell cancer|stage iv renal cell cancer
5192741|NCT00853112|PAH pulmonary hypertension pulmonary arterial hypertension|pah pulmonary hypertension pulmonary arterial hypertension
5192742|NCT00853099|Ulcerative Colitis|ulcerative colitis
5192743|NCT00853073|failing blebs|failing blebs
5192744|NCT00853073|failing express shunt|failing express shunt
5192745|NCT00853073|avastin|avastin
5192746|NCT00853073|bevacizumab|bevacizumab
5192747|NCT00853073|glaucoma|glaucoma
5192748|NCT00853073|prior trabeculectomy|prior trabeculectomy
5192749|NCT00853073|Express shunt placed under a scleral flap|express shunt placed under a scleral flap
5192750|NCT00853073|subsequent filtration failure|subsequent filtration failure
5192751|NCT00853060|energy expenditure|energy expenditure
5192752|NCT00853060|mechanical ventilation|mechanical ventilation
5192753|NCT00853060|weaning|weaning
5192754|NCT00853060|pressure support ventilation|pressure support ventilation
5192755|NCT00853060|T-tube|t-tube
5192756|NCT00853034|gastrointestinal effects|gastrointestinal effects
5192757|NCT00853034|prebiotic|prebiotic
5192758|NCT00853021|clear cell renal cell carcinoma|clear cell renal cell carcinoma
5192759|NCT00853021|recurrent renal cell cancer|recurrent renal cell cancer
5192760|NCT00853021|stage IV renal cell cancer|stage iv renal cell cancer
5192761|NCT00853008|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
5192762|NCT00853008|High-Risk (HR)|high-risk (hr)
5192763|NCT00853008|Philadelphia Chromosome-Negative|philadelphia chromosome-negative
5192764|NCT00852995|Venous Leg Ulcer (VLU)|venous leg ulcer (vlu)
5192765|NCT00852995|Venous Stasis Ulcer (VSU)|venous stasis ulcer (vsu)
5192766|NCT00852995|VLU|vlu
5192767|NCT00852995|VSU|vsu
5192768|NCT00852995|Leg Ulcer|leg ulcer
5192769|NCT00852995|Leg Wound|leg wound
5192770|NCT00852982|Exercise|exercise
5192771|NCT00852982|Risk factors|risk factors
5192772|NCT00852982|Primary health care|primary health care
5192773|NCT00852969|Chronic Kidney Disease|chronic kidney disease
5192774|NCT00852969|Niacin|niacin
5192775|NCT00852969|HDL|hdl
5192776|NCT00852969|Endothelial Function|endothelial function
5192777|NCT00852956|Betahistine|betahistine
5192778|NCT00852956|Olanzapine|olanzapine
5192779|NCT00852956|Safety of co-administration of Betahistien and Olanzapine|safety of co-administration of betahistien and olanzapine
5192780|NCT00852943|Mast Cells|mast cells
5192781|NCT00852943|Piebaldism|piebaldism
5192782|NCT00852943|Anaphylaxis|anaphylaxis
5192783|NCT00852943|Allergy|allergy
5192784|NCT00852943|Genetics|genetics
5192785|NCT00852930|lymphedema|lymphedema
5192786|NCT00852930|quality of life|quality of life
5192787|NCT00852930|breast cancer|breast cancer
5192788|NCT00852930|symptoms|symptoms
5192789|NCT00852930|lymphedema in breast cancer survivors|lymphedema in breast cancer survivors
5192790|NCT00852917|Pain due to Osteoarthritis of the Knee|pain due to osteoarthritis of the knee
5192791|NCT00852904|Childhood Growth and Development|childhood growth and development
5192792|NCT00852904|Genetics|genetics
5192793|NCT00852904|Children|children
5192794|NCT00852904|Environment|environment
5192795|NCT00852904|Longitudinal Study|longitudinal study
5192796|NCT00852904|National Children's Study|national children's study
5192797|NCT00852891|weaning|weaning
5192798|NCT00852891|echocardiogram|echocardiogram
5192799|NCT00852891|diastolic dysfunction|diastolic dysfunction
5192800|NCT00852891|Mechanical ventilation|mechanical ventilation
5192801|NCT00852878|Recurrent Abdominal Pain|recurrent abdominal pain
5192802|NCT00852878|Biofeedback|biofeedback
5192803|NCT00852878|Heart Rate Variability|heart rate variability
5192804|NCT00852865|Inflammation|inflammation
5192805|NCT00852865|Pain|pain
5192806|NCT00852852|ESRA-C 2|esra-c 2
5192807|NCT00852852|computerized assessment|computerized assessment
5192808|NCT00852839|Dry mouth|dry mouth
5192809|NCT00852839|Sjogren's syndrome|sjogren's syndrome
5192810|NCT00852839|Xerostomia|xerostomia
5192811|NCT00852826|axillary seroma|axillary seroma
5192812|NCT00852826|axillary lymphadenectomy|axillary lymphadenectomy
5192813|NCT00852826|morbidity|morbidity
5192814|NCT00852826|morbidity postlymphadenectomy|morbidity postlymphadenectomy
5192815|NCT00852826|Lymphadenectomy|lymphadenectomy
5192816|NCT00852813|tolerance|tolerance
5192817|NCT00852813|prebiotic|prebiotic
5192818|NCT00852813|gastrointestinal effects|gastrointestinal effects
5192819|NCT00852800|spontaneous bacterial peritonitis|spontaneous bacterial peritonitis
5192820|NCT00852800|albumin|albumin
5192821|NCT00852800|renal impairment|renal impairment
5192822|NCT00852800|mortality|mortality
5192823|NCT00852787|Digoxin like substances|digoxin like substances
5192824|NCT00852787|digibind|digibind
5192825|NCT00852787|digoxin immune fab|digoxin immune fab
5192826|NCT00852787|end-stage-renal-disease|end-stage-renal-disease
5192827|NCT00852787|marinobufagenin|marinobufagenin
5192828|NCT00852761|Psoriasis|psoriasis
5192829|NCT00852748|headache|headache
5192830|NCT00852735|Cardiovascular diseases|cardiovascular diseases
5192831|NCT00852735|Rapeseed oil|rapeseed oil
5192832|NCT00852735|Micronutriments|micronutriments
5192833|NCT00852735|HDL cholesterol|hdl cholesterol
5192834|NCT00852735|Oxidative stress|oxidative stress
5192835|NCT00852735|Tocopherols|tocopherols
5192836|NCT00852735|Sterols|sterols
5192837|NCT00852735|Prevention of cardiovascular diseases|prevention of cardiovascular diseases
5192838|NCT00852722|Multiple sclerosis|multiple sclerosis
5192839|NCT00852722|Diet|diet
5192840|NCT00852709|Myelodysplastic syndrome that has transformed to AML (AML/MDS)|myelodysplastic syndrome that has transformed to aml (aml/mds)
5192841|NCT00852709|Treatment-related AML|treatment-related aml
5192842|NCT00852709|AML evolving from myeloproliferative disorders (MPD)|aml evolving from myeloproliferative disorders (mpd)
5192843|NCT00852709|Acute lymphocytic leukemia (ALL)|acute lymphocytic leukemia (all)
5192844|NCT00852709|Acute promyelocytic leukemia (APL) refractory to arsenic therapy or retinoic acid therapy|acute promyelocytic leukemia (apl) refractory to arsenic therapy or retinoic acid therapy
5192845|NCT00852709|Relapsed and/or refractory acute leukemia with progressive disease since last therapy|relapsed and/or refractory acute leukemia with progressive disease since last therapy
5192846|NCT00852709|Chronic myelogenous leukemia (CML) in accelerated phase or blast crisis refractory to imatinib|chronic myelogenous leukemia (cml) in accelerated phase or blast crisis refractory to imatinib
5192847|NCT00852709|High-risk MPD including myelofibrosis, chronic myelomonocytic leukemia (CMML, and relapsed or refractory juvenile myelomonocytic leukemia (JMML).|high-risk mpd including myelofibrosis, chronic myelomonocytic leukemia (cmml, and relapsed or refractory juvenile myelomonocytic leukemia (jmml).
5192848|NCT00852696|Overactive Bladder|overactive bladder
5192849|NCT00852696|Incontinence|incontinence
5192850|NCT00852696|Solifenacin|solifenacin
5192851|NCT00852696|Women|women
5192852|NCT00852696|Postoperative|postoperative
5192853|NCT00852657|Rotator cuff tear|rotator cuff tear
5192854|NCT00852657|surgical repair|surgical repair
5192855|NCT00852657|Physiotherapy|physiotherapy
5192856|NCT00852657|Treatment benefit|treatment benefit
5192857|NCT00852657|Surgery|surgery
5192858|NCT00852644|stage I non-small cell lung cancer|stage i non-small cell lung cancer
5192859|NCT00852644|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
5192860|NCT00852631|Quetiapine efficacy in schizophrenia|quetiapine efficacy in schizophrenia
5192861|NCT00852618|HIV Integrase Inhibitors|hiv integrase inhibitors
5192862|NCT00852618|HIV Nucleoside Reverse Transcriptase Inhibitors|hiv nucleoside reverse transcriptase inhibitors
5192863|NCT00852618|Treatment Naive|treatment naive
5192864|NCT00852618|Viral Load|viral load
5192865|NCT00852605|Acute Lung Injury after allogeneic transplantation|acute lung injury after allogeneic transplantation
5192866|NCT00852592|Bipolar Disorder Depression Midday Light Therapy|bipolar disorder depression midday light therapy
5192867|NCT00852592|Bipolar Disorder Type I or II|bipolar disorder type i or ii
5192868|NCT00852579|Asthma|asthma
5192869|NCT00852579|Smoker|smoker
5192870|NCT00852579|Macrolide|macrolide
5192871|NCT00852566|Chronic myeloid leukemia|chronic myeloid leukemia
5192872|NCT00852566|tyrosine kinase inhibitor|tyrosine kinase inhibitor
5192873|NCT00852566|stem cell|stem cell
5192874|NCT00852566|Philadelphia chromosome|philadelphia chromosome
5192875|NCT00852566|dasatinib|dasatinib
5192876|NCT00852553|intestinal|intestinal
5192877|NCT00852553|smooth|smooth
5192878|NCT00852553|muscle|muscle
5192879|NCT00852553|GI|gi
5192880|NCT00852553|motility|motility
5192881|NCT00852540|impetigo|impetigo
5192882|NCT00852540|methicillin-resistant Staphylococcus aureus|methicillin-resistant staphylococcus aureus
5192883|NCT00852540|linezolid|linezolid
5192884|NCT00852540|secondarily-infected traumatic lesion|secondarily-infected traumatic lesion
5192885|NCT00852540|uncomplicated skin infection|uncomplicated skin infection
5192886|NCT00852540|retapamulin|retapamulin
5192887|NCT00852527|Traumatic Brain Injury|traumatic brain injury
5192888|NCT00852527|Screening|screening
5192889|NCT00852527|Diagnosis|diagnosis
5192890|NCT00852527|Rehabilitation Outcome|rehabilitation outcome
5192891|NCT00852514|Bioimpedance|bioimpedance
5192892|NCT00852514|ultrafiltration|ultrafiltration
5192893|NCT00852514|blood pressure|blood pressure
5192894|NCT00852514|pulse pressure|pulse pressure
5192895|NCT00852501|Non-functioning pituitary adenoma|non-functioning pituitary adenoma
5192896|NCT00852501|RTPCR|rtpcr
5192897|NCT00852501|Hormonal receptors|hormonal receptors
5192898|NCT00852475|MUFA|mufa
5192899|NCT00852475|PUFA|pufa
5192900|NCT00852475|MOVE! program|move! program
5192901|NCT00852462|SAMI|sami
5192902|NCT00852462|Symptom Assessment and Management Intervention Program|symptom assessment and management intervention program
5192903|NCT00852449|Intraoperative fluid|intraoperative fluid
5192904|NCT00852449|Monitoring|monitoring
5192905|NCT00852449|Oesophageal Doppler|oesophageal doppler
5192906|NCT00852449|Abdominal surgery|abdominal surgery
5192907|NCT00852449|major abdominal surgery|major abdominal surgery
5192908|NCT00852436|neuropathic pain|neuropathic pain
5192909|NCT00852436|orofacial pain|orofacial pain
5192910|NCT00852436|clinical trials|clinical trials
5192911|NCT00852436|pregabalin|pregabalin
5193012|NCT00852137|Peplin|peplin
5192912|NCT00852436|randomized controlled trial|randomized controlled trial
5192913|NCT00852423|Malaria in pregnancy|malaria in pregnancy
5192914|NCT00852423|Sub-saharan Africa|sub-saharan africa
5192915|NCT00852423|Treatment|treatment
5192916|NCT00852423|Artemisinin containing Therapy|artemisinin containing therapy
5192917|NCT00852423|Efficacy|efficacy
5192918|NCT00852423|Safety|safety
5192919|NCT00852410|Endoscopic sinus surgery|endoscopic sinus surgery
5192920|NCT00852384|Anesthesia induction|anesthesia induction
5192921|NCT00852384|Obese patients|obese patients
5192922|NCT00852384|Noninvasive ventilation|noninvasive ventilation
5192923|NCT00852384|Alveolar recruitment|alveolar recruitment
5192924|NCT00852371|Malaria|malaria
5192925|NCT00852371|Intermittent preventive treatment|intermittent preventive treatment
5192926|NCT00852371|Efficacy|efficacy
5192927|NCT00852371|Safety|safety
5192928|NCT00852371|Tolerability|tolerability
5192929|NCT00852371|Schoolchildren|schoolchildren
5192930|NCT00852371|Uganda|uganda
5192931|NCT00852358|mucopolysaccharidosis|mucopolysaccharidosis
5192932|NCT00852358|Hurler-Scheie|hurler-scheie
5192933|NCT00852358|Scheie|scheie
5192934|NCT00852358|laronidase|laronidase
5192935|NCT00852358|cognitive decline|cognitive decline
5192936|NCT00852358|central nervous system|central nervous system
5192937|NCT00852358|enzyme replacement therapy|enzyme replacement therapy
5192938|NCT00852358|intrathecal|intrathecal
5192939|NCT00852358|LA Biomed|la biomed
5192940|NCT00852345|multibacillary leprosy|multibacillary leprosy
5192941|NCT00852345|leprosy|leprosy
5192942|NCT00852345|clofazamine|clofazamine
5192943|NCT00852332|male breast cancer|male breast cancer
5192944|NCT00852332|stage IIIB breast cancer|stage iiib breast cancer
5192945|NCT00852332|stage IIIC breast cancer|stage iiic breast cancer
5192946|NCT00852332|stage IV breast cancer|stage iv breast cancer
5192947|NCT00852332|recurrent breast cancer|recurrent breast cancer
5192948|NCT00852332|stage IIIA breast cancer|stage iiia breast cancer
5192949|NCT00852332|HER2-negative breast cancer|her2-negative breast cancer
5192950|NCT00852319|Interpregnancy Care|interpregnancy care
5192951|NCT00852319|Preconceptual Care|preconceptual care
5192952|NCT00852319|Premature Birth|premature birth
5192953|NCT00852319|Preterm Delivery|preterm delivery
5192954|NCT00852306|oocyte freezing|oocyte freezing
5192955|NCT00852306|vitrification|vitrification
5192956|NCT00852306|slow freeze|slow freeze
5192957|NCT00852306|fertility preservation|fertility preservation
5192958|NCT00852293|liver disease|liver disease
5192959|NCT00852293|Chitinase 3 like-1 protein|chitinase 3 like-1 protein
5192960|NCT00852280|scars|scars
5192961|NCT00852280|late effect of burn|late effect of burn
5192962|NCT00852280|burn|burn
5192963|NCT00852280|pulsed-dye laser|pulsed-dye laser
5192964|NCT00852267|cholesterol|cholesterol
5192965|NCT00852267|diet|diet
5192966|NCT00852267|protein|protein
5192967|NCT00852267|carbohydrate|carbohydrate
5192968|NCT00852267|saturated fat|saturated fat
5192969|NCT00852267|LDL subclass|ldl subclass
5192970|NCT00852267|healthy volunteers|healthy volunteers
5192971|NCT00852254|Cardiac Index|cardiac index
5192972|NCT00852254|Ultrasound Dilution|ultrasound dilution
5192973|NCT00852254|Accuracy of ultrasound dilution cardiac index.|accuracy of ultrasound dilution cardiac index.
5192974|NCT00852228|colorectal cancer|colorectal cancer
5192975|NCT00852228|unresectable metastases|unresectable metastases
5192976|NCT00852228|neo-adjuvant chemotherapy|neo-adjuvant chemotherapy
5192977|NCT00852228|liver metastases|liver metastases
5192978|NCT00852228|chronotherapy|chronotherapy
5192979|NCT00852228|cetuximab|cetuximab
5192980|NCT00852228|irinotecan|irinotecan
5192981|NCT00852228|oxaliplatin|oxaliplatin
5192982|NCT00852228|5-fluorouracil|5-fluorouracil
5192983|NCT00852228|hepatic artery infusion|hepatic artery infusion
5192984|NCT00852228|Unresectable hepatic lesions|unresectable hepatic lesions
5192985|NCT00852228|1 to 3 prior chemotherapy regimens|1 to 3 prior chemotherapy regimens
5192986|NCT00852215|Angioplasty, Transluminal, Percutaneous Coronary|angioplasty, transluminal, percutaneous coronary
5192987|NCT00852215|Paclitaxel-eluting stent|paclitaxel-eluting stent
5192988|NCT00852215|Vision stent|vision stent
5192989|NCT00852202|bipolar|bipolar
5192990|NCT00852202|depression|depression
5192991|NCT00852189|Cancer|cancer
5192992|NCT00852189|Phase 1|phase 1
5192993|NCT00852189|EC0489|ec0489
5192994|NCT00852189|EC20|ec20
5192995|NCT00852189|Refractory|refractory
5192996|NCT00852189|Metastatic|metastatic
5192997|NCT00852189|Experimental|experimental
5192998|NCT00852176|Coronary brachytherapy|coronary brachytherapy
5192999|NCT00852176|Coronary restenosis|coronary restenosis
5193000|NCT00852176|Coronary in stent restenosis|coronary in stent restenosis
5193001|NCT00852163|conditioning, preparative|conditioning, preparative
5193002|NCT00852163|clofarabine; transplant|clofarabine; transplant
5193003|NCT00852163|Busulfan|busulfan
5193004|NCT00852163|leukemia|leukemia
5193005|NCT00852163|myelodysplastic syndrome|myelodysplastic syndrome
5193006|NCT00852150|gastritis|gastritis
5193007|NCT00852150|duodenitis|duodenitis
5193008|NCT00852150|inter-rater reliability|inter-rater reliability
5193009|NCT00852150|intra-rater reliablity|intra-rater reliablity
5193010|NCT00852150|gastroscopy|gastroscopy
5193011|NCT00852150|duodenoscopy|duodenoscopy
5193013|NCT00852137|PEP005|pep005
5193014|NCT00852137|Actinic Keratosis|actinic keratosis
5193015|NCT00852124|Asthma|asthma
5193016|NCT00852124|Probiotic|probiotic
5193017|NCT00852124|VSL#3|vsl#3
5193018|NCT00852111|Fatigue|fatigue
5193019|NCT00852111|Radiotherapy|radiotherapy
5193020|NCT00852111|Cancer Therapy|cancer therapy
5193021|NCT00852111|Cancer|cancer
5193022|NCT00852098|Fundoplication|fundoplication
5193023|NCT00852098|gastroesophageal reflux|gastroesophageal reflux
5193024|NCT00852098|gastric vessels|gastric vessels
5193025|NCT00852098|surgery|surgery
5193026|NCT00852085|Counseling|counseling
5193027|NCT00852085|Crime|crime
5193028|NCT00852085|Adolescent|adolescent
5193029|NCT00852072|common bile duct stones|common bile duct stones
5193030|NCT00852072|mechanical lithotripsy|mechanical lithotripsy
5193031|NCT00852072|balloon sphincteroplasty|balloon sphincteroplasty
5193032|NCT00852059|ADHD|adhd
5193033|NCT00852059|children|children
5193034|NCT00852059|adolescents|adolescents
5193035|NCT00852059|methylphenidate|methylphenidate
5193036|NCT00852059|adherence|adherence
5193037|NCT00852059|immediate release|immediate release
5193038|NCT00852059|extended release|extended release
5193039|NCT00852059|efficacy|efficacy
5193040|NCT00852046|Mechanical ventilation|mechanical ventilation
5193041|NCT00852033|alcoholism|alcoholism
5193042|NCT00852033|alcohol abuse|alcohol abuse
5193043|NCT00852033|prevention|prevention
5193044|NCT00852033|behavior modification|behavior modification
5193045|NCT00852033|parent offspring interaction|parent offspring interaction
5193046|NCT00852033|university student|university student
5193047|NCT00852033|substance abuse related behavior|substance abuse related behavior
5193048|NCT00852033|adolescence|adolescence
5193049|NCT00852007|prostate cancer|prostate cancer
5193050|NCT00852007|dendritic cells|dendritic cells
5193051|NCT00852007|MUC-1|muc-1
5193052|NCT00852007|immune therapy|immune therapy
5193053|NCT00851994|Patients having surgery|patients having surgery
5193054|NCT00851981|Alcohol Liver Disease|alcohol liver disease
5193055|NCT00851968|hepatectomy|hepatectomy
5193056|NCT00851968|Selective HepaticVascular Clamping|selective hepaticvascular clamping
5193057|NCT00851942|Volunteer|volunteer
5193058|NCT00851942|Hypoadrenalism|hypoadrenalism
5193059|NCT00851942|Hypopituitarism|hypopituitarism
5193060|NCT00851942|Healthy volunteers|healthy volunteers
5193061|NCT00851929|sarcoidosis|sarcoidosis
5193062|NCT00851929|pulmonary hypertension|pulmonary hypertension
5193063|NCT00851929|dyspnea|dyspnea
5193064|NCT00851929|sarcoidosis associated pulmonary hypertension|sarcoidosis associated pulmonary hypertension
5193065|NCT00851877|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
5193066|NCT00851877|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5193067|NCT00851877|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
5193068|NCT00851877|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5193069|NCT00851877|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
5193070|NCT00851877|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5193071|NCT00851877|tongue cancer|tongue cancer
5193072|NCT00851864|anticoagulation|anticoagulation
5193073|NCT00851864|pregnancy|pregnancy
5193074|NCT00851851|Surgical patients|surgical patients
5193075|NCT00851838|Peritoneal dialysis|peritoneal dialysis
5193076|NCT00851838|L-carnitine|l-carnitine
5193077|NCT00851825|autonomic modulation|autonomic modulation
5193078|NCT00851825|heart rate|heart rate
5193079|NCT00851825|pressure support ventilation|pressure support ventilation
5193080|NCT00851825|T-tube|t-tube
5193081|NCT00851825|Mechanical ventilation|mechanical ventilation
5193082|NCT00851812|Exercise|exercise
5193083|NCT00851812|Breast cancer|breast cancer
5193084|NCT00851812|fatigue|fatigue
5193085|NCT00851799|ART|art
5193086|NCT00851799|Antiretroviral therapy|antiretroviral therapy
5193087|NCT00851799|Treatment naive|treatment naive
5193088|NCT00851799|Highly active antiretroviral therapy (HAART)|highly active antiretroviral therapy (haart)
5193089|NCT00851786|Herpes Zoster Vaccine|herpes zoster vaccine
5193090|NCT00851786|Herpes Zoster Virus|herpes zoster virus
5193091|NCT00851786|HIV|hiv
5193092|NCT00851721|Hemophilia A|hemophilia a
5193093|NCT00851721|Factor VIII Inhibitor|factor viii inhibitor
5193094|NCT00851721|Factor IX Inhibitor|factor ix inhibitor
5193095|NCT00851721|Hemophilia B|hemophilia b
5193096|NCT00851708|kidney|kidney
5193097|NCT00851708|deceased kidney transplant|deceased kidney transplant
5193098|NCT00851708|oxidative stress|oxidative stress
5193099|NCT00851708|renal function measurements|renal function measurements
5193100|NCT00851695|Lung Function Decline|lung function decline
5193101|NCT00851695|Lung Function|lung function
5193102|NCT00851695|Allergy|allergy
5193103|NCT00851695|COPD|copd
5193104|NCT00851695|Vitamin D|vitamin d
5193105|NCT00851682|Prostate Cancer|prostate cancer
5193106|NCT00851682|Dynamic Contrast Enhanced MRI|dynamic contrast enhanced mri
5193107|NCT00851682|Non-invasive Prostate Cancer Detection|non-invasive prostate cancer detection
5193108|NCT00851669|depression|depression
5193109|NCT00851669|alcohol dependence|alcohol dependence
5193110|NCT00851669|women|women
5193111|NCT00851669|psychotherapy|psychotherapy
5193112|NCT00851669|men|men
5193113|NCT00851630|HIV|hiv
5193114|NCT00851630|Tuberculosis|tuberculosis
5193115|NCT00851630|Treatment Naive|treatment naive
5193116|NCT00851617|Mechanical ventilator weaning|mechanical ventilator weaning
5193117|NCT00851617|Respiratory Muscle Training|respiratory muscle training
5193118|NCT00851617|Ventilator dependent|ventilator dependent
5193119|NCT00851604|ProGRP|progrp
5193120|NCT00851604|CgA|cga
5193121|NCT00851604|NSE|nse
5193122|NCT00851604|TUM2-PK|tum2-pk
5193123|NCT00851604|Neuroendocrine Tumors|neuroendocrine tumors
5193124|NCT00851591|fenugreek|fenugreek
5193125|NCT00851591|galactogogue|galactogogue
5193126|NCT00851591|breastmilk|breastmilk
5193127|NCT00851591|Trigonella foenum-graecum|trigonella foenum-graecum
5193128|NCT00851591|Bird's Foot|bird's foot
5193129|NCT00851591|Greek Clover|greek clover
5193130|NCT00851591|Greek Hay|greek hay
5193131|NCT00851591|Hu Lu Ba|hu lu ba
5193132|NCT00851591|Trigonella|trigonella
5193133|NCT00851578|AF|af
5193134|NCT00851578|atrial fibrillation|atrial fibrillation
5193135|NCT00851578|LAA occlusion|laa occlusion
5193136|NCT00851552|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5193137|NCT00851552|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5193138|NCT00851552|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5193139|NCT00851539|HIV|hiv
5193140|NCT00851539|Teenagers|teenagers
5193141|NCT00851539|Adolescent|adolescent
5193142|NCT00851539|HIV Testing|hiv testing
5193143|NCT00851539|HIV Seronegativity|hiv seronegativity
5193144|NCT00851526|Coronary bifurcation lesion|coronary bifurcation lesion
5193145|NCT00851526|Drug-eluting stent|drug-eluting stent
5193146|NCT00851513|Pudendal neuralgia|pudendal neuralgia
5193147|NCT00851513|pudendal nerve|pudendal nerve
5193148|NCT00851513|Alcock's canal syndrome|alcock's canal syndrome
5193149|NCT00851513|Canal syndrome|canal syndrome
5193150|NCT00851513|neuropathic pain|neuropathic pain
5193151|NCT00851513|infiltration|infiltration
5193152|NCT00851513|randomized protocol|randomized protocol
5193153|NCT00851513|pain scales|pain scales
5193154|NCT00851500|atherosclerosis|atherosclerosis
5193155|NCT00851500|carotid artery disease|carotid artery disease
5193156|NCT00851487|ARI|ari
5193157|NCT00851487|LRTI|lrti
5193158|NCT00851474|COstatus(R)|costatus(r)
5193159|NCT00851474|Ultrasound Dilution|ultrasound dilution
5193160|NCT00851474|Cardiac Output|cardiac output
5193161|NCT00851474|Blood Volumes|blood volumes
5193162|NCT00851474|Comparison of COstatus(R) cardiac output with other methods|comparison of costatus(r) cardiac output with other methods
5193163|NCT00851461|Spinobulbar muscular atrophy|spinobulbar muscular atrophy
5193164|NCT00851461|Kennedy's disease|kennedy's disease
5193165|NCT00851461|Goserelin|goserelin
5193166|NCT00851461|Electrophysiologic study|electrophysiologic study
5193167|NCT00851461|Inclusion body|inclusion body
5193168|NCT00851435|Pneumonia|pneumonia
5193169|NCT00851435|Nosocomial pneumonia|nosocomial pneumonia
5193170|NCT00851435|Pseudomonas aeruginosa|pseudomonas aeruginosa
5193171|NCT00851435|Monoclonal antibody|monoclonal antibody
5193172|NCT00851435|Hospital-Acquired Pneumonia|hospital-acquired pneumonia
5193173|NCT00851422|Ultrasound Dilution|ultrasound dilution
5193174|NCT00851422|Cardiac Output|cardiac output
5193175|NCT00851422|Validation of measured ultrasound dilution cardiac output|validation of measured ultrasound dilution cardiac output
5193176|NCT00851396|Vitamin D deficiency|vitamin d deficiency
5193177|NCT00851396|Insulin resistance|insulin resistance
5193178|NCT00851396|Glucose- Insulin dynamics|glucose- insulin dynamics
5193179|NCT00851396|Obese adolescents|obese adolescents
5193180|NCT00851383|HIV|hiv
5193181|NCT00851383|Human Immunodeficiency Virus|human immunodeficiency virus
5193182|NCT00851383|HIV Seronegativity|hiv seronegativity
5193183|NCT00851383|Preventive Vaccine|preventive vaccine
5193184|NCT00851370|COPD|copd
5193185|NCT00851370|Exacerbation|exacerbation
5193186|NCT00851357|Nicotine Replacement Therapy|nicotine replacement therapy
5193187|NCT00851357|Nicotine Patch|nicotine patch
5193188|NCT00851357|Smoking cessation|smoking cessation
5193189|NCT00851357|Telephone|telephone
5193190|NCT00851357|Tobacco cessation|tobacco cessation
5193191|NCT00851357|Counseling|counseling
5193192|NCT00851357|Nicotine|nicotine
5193193|NCT00851357|Self-Help|self-help
5193194|NCT00851357|Smoking abstinence|smoking abstinence
5193195|NCT00851357|Tobacco Use Disorder|tobacco use disorder
5193196|NCT00851344|Proof-of-Concept|proof-of-concept
5193197|NCT00851344|Allergic Rhinitis|allergic rhinitis
5193198|NCT00851331|Benign childhood epilepsy|benign childhood epilepsy
5193199|NCT00851318|Rheumatoid Arthritis|rheumatoid arthritis
5193200|NCT00851318|Certolizumab Pegol|certolizumab pegol
5193201|NCT00851318|Cimzia|cimzia
5193202|NCT00851305|Stomach|stomach
5193203|NCT00851305|endoscopy|endoscopy
5193204|NCT00851305|neoplasms|neoplasms
5193205|NCT00851292|prostate cancer|prostate cancer
5193207|NCT00851292|TRUS|trus
5193208|NCT00851292|diagnosis|diagnosis
5193209|NCT00851279|arrhythmia|arrhythmia
5193210|NCT00851279|ventricular tachycardia|ventricular tachycardia
5193211|NCT00851279|ablation|ablation
5193212|NCT00851279|mapping|mapping
5193213|NCT00851279|electrophysiology|electrophysiology
5193214|NCT00851253|recurrent adenoid cystic carcinoma of the oral cavity|recurrent adenoid cystic carcinoma of the oral cavity
5193215|NCT00851253|recurrent mucoepidermoid carcinoma of the oral cavity|recurrent mucoepidermoid carcinoma of the oral cavity
5193216|NCT00851253|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
5193217|NCT00851253|stage II adenoid cystic carcinoma of the oral cavity|stage ii adenoid cystic carcinoma of the oral cavity
5193218|NCT00851253|stage II mucoepidermoid carcinoma of the oral cavity|stage ii mucoepidermoid carcinoma of the oral cavity
5193219|NCT00851253|stage II verrucous carcinoma of the oral cavity|stage ii verrucous carcinoma of the oral cavity
5193220|NCT00851253|stage III adenoid cystic carcinoma of the oral cavity|stage iii adenoid cystic carcinoma of the oral cavity
5193221|NCT00851253|stage III mucoepidermoid carcinoma of the oral cavity|stage iii mucoepidermoid carcinoma of the oral cavity
5193222|NCT00851253|stage III verrucous carcinoma of the oral cavity|stage iii verrucous carcinoma of the oral cavity
5193223|NCT00851253|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
5193224|NCT00851253|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
5193225|NCT00851253|recurrent basal cell carcinoma of the lip|recurrent basal cell carcinoma of the lip
5193226|NCT00851253|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
5193227|NCT00851253|stage II basal cell carcinoma of the lip|stage ii basal cell carcinoma of the lip
5193228|NCT00851253|stage III basal cell carcinoma of the lip|stage iii basal cell carcinoma of the lip
5193229|NCT00851253|recurrent lymphoepithelioma of the nasopharynx|recurrent lymphoepithelioma of the nasopharynx
5193230|NCT00851253|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
5193231|NCT00851253|stage II lymphoepithelioma of the nasopharynx|stage ii lymphoepithelioma of the nasopharynx
5193232|NCT00851253|stage II squamous cell carcinoma of the nasopharynx|stage ii squamous cell carcinoma of the nasopharynx
5193233|NCT00851253|stage III lymphoepithelioma of the nasopharynx|stage iii lymphoepithelioma of the nasopharynx
5193234|NCT00851253|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
5193235|NCT00851253|recurrent lymphoepithelioma of the oropharynx|recurrent lymphoepithelioma of the oropharynx
5193236|NCT00851253|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
5193237|NCT00851253|stage II lymphoepithelioma of the oropharynx|stage ii lymphoepithelioma of the oropharynx
5193238|NCT00851253|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
5193239|NCT00851253|stage III lymphoepithelioma of the oropharynx|stage iii lymphoepithelioma of the oropharynx
5193240|NCT00851253|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
5193241|NCT00851253|high-grade salivary gland mucoepidermoid carcinoma|high-grade salivary gland mucoepidermoid carcinoma
5193242|NCT00851253|low-grade salivary gland mucoepidermoid carcinoma|low-grade salivary gland mucoepidermoid carcinoma
5193243|NCT00851253|recurrent salivary gland cancer|recurrent salivary gland cancer
5193244|NCT00851253|salivary gland acinic cell tumor|salivary gland acinic cell tumor
5193245|NCT00851253|salivary gland adenocarcinoma|salivary gland adenocarcinoma
5193246|NCT00851253|salivary gland adenoid cystic carcinoma|salivary gland adenoid cystic carcinoma
5193247|NCT00851253|salivary gland anaplastic carcinoma|salivary gland anaplastic carcinoma
5193248|NCT00851253|salivary gland malignant mixed cell type tumor|salivary gland malignant mixed cell type tumor
5193249|NCT00851253|salivary gland poorly differentiated carcinoma|salivary gland poorly differentiated carcinoma
5193250|NCT00851253|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
5193251|NCT00851253|stage II salivary gland cancer|stage ii salivary gland cancer
5193252|NCT00851253|stage III salivary gland cancer|stage iii salivary gland cancer
5193253|NCT00851253|stage IV adenoid cystic carcinoma of the oral cavity|stage iv adenoid cystic carcinoma of the oral cavity
5193254|NCT00851253|stage IV mucoepidermoid carcinoma of the oral cavity|stage iv mucoepidermoid carcinoma of the oral cavity
5193255|NCT00851253|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5193256|NCT00851253|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
5193257|NCT00851253|stage IV salivary gland cancer|stage iv salivary gland cancer
5193258|NCT00851253|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
5193259|NCT00851253|stage IV lymphoepithelioma of the oropharynx|stage iv lymphoepithelioma of the oropharynx
5193260|NCT00851253|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
5193261|NCT00851253|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5193262|NCT00851253|stage IV basal cell carcinoma of the lip|stage iv basal cell carcinoma of the lip
5193263|NCT00851240|rheumatoid arthritis|rheumatoid arthritis
5193264|NCT00851240|safety|safety
5193265|NCT00851227|Pharmacokinetics|pharmacokinetics
5193266|NCT00851227|Protein Binding|protein binding
5193267|NCT00851227|Conivaptan|conivaptan
5193268|NCT00851227|Vaprisol|vaprisol
5193269|NCT00851227|Liver Disease|liver disease
5193270|NCT00851214|Non-invasive hemodynamic monitoring|non-invasive hemodynamic monitoring
5193271|NCT00851214|Emergency Department patients|emergency department patients
5193272|NCT00851214|trauma with an ISS>15|trauma with an iss>15
5193273|NCT00851214|Non-invasive continuous hemodynamic monitoring|non-invasive continuous hemodynamic monitoring
5193274|NCT00851201|children|children
5193275|NCT00851201|obesity|obesity
5193276|NCT00851201|weight loss|weight loss
5193277|NCT00851201|prevention|prevention
5193278|NCT00851201|diabetes risk|diabetes risk
5193279|NCT00851201|cardiometabolic|cardiometabolic
5193280|NCT00851162|Bone defect|bone defect
5193281|NCT00851162|Benign bone lesions|benign bone lesions
5193282|NCT00851162|Stem cells|stem cells
5193283|NCT00851149|aorta|aorta
5193284|NCT00851149|disease|disease
5193285|NCT00851149|abdominal|abdominal
5193286|NCT00851149|surgery|surgery
5193287|NCT00851149|Osteoarthritis, Hip|osteoarthritis, hip
5193288|NCT00851149|replacement|replacement
5193289|NCT00851149|blood|blood
5193290|NCT00851149|autolog|autolog
5193291|NCT00851149|transfusion|transfusion
5193292|NCT00851149|cytokines|cytokines
5193293|NCT00851136|CRC|crc
5193294|NCT00851136|Colon cancer|colon cancer
5193295|NCT00851136|Avastin|avastin
5193296|NCT00851136|APM4566g|apm4566g
5193297|NCT00851123|Stroke|stroke
5193298|NCT00851123|arm paresis|arm paresis
5193299|NCT00851123|mCIMT|mcimt
5193300|NCT00851123|bimanual training|bimanual training
5193301|NCT00851123|rehabilitation|rehabilitation
5193302|NCT00851110|high dose|high dose
5193303|NCT00851110|breast cancer|breast cancer
5193304|NCT00851110|adjuvant|adjuvant
5193305|NCT00851084|Angiogenesis|angiogenesis
5193306|NCT00851084|Colon cancer|colon cancer
5193307|NCT00851084|Rectal cancer|rectal cancer
5193308|NCT00851084|Oxaliplatin|oxaliplatin
5193309|NCT00851071|Anxiety|anxiety
5193310|NCT00851071|Implantable Cardioverter Defibrillator (ICD)|implantable cardioverter defibrillator (icd)
5193311|NCT00851071|Defibrillators, Implantable|defibrillators, implantable
5193312|NCT00851058|Behavioral research|behavioral research
5193313|NCT00851058|Motivational counseling|motivational counseling
5193314|NCT00851058|Group Counseling|group counseling
5193315|NCT00851058|Motivational Interviewing|motivational interviewing
5193316|NCT00851058|Vicarious Learning|vicarious learning
5193317|NCT00851058|Risky alcohol use|risky alcohol use
5193318|NCT00851058|Recidivism|recidivism
5193319|NCT00851058|Motor Vehicles|motor vehicles
5193320|NCT00851058|Crime|crime
5193321|NCT00851032|Advanced Cancer|advanced cancer
5193322|NCT00851032|Initiative for Molecular Profiling in Advanced Cancer Therapy|initiative for molecular profiling in advanced cancer therapy
5193323|NCT00851032|IMPACT|impact
5193324|NCT00851032|Molecular Profile-Based Study|molecular profile-based study
5193325|NCT00851032|Investigational Cancer Therapeutics Program|investigational cancer therapeutics program
5193326|NCT00851032|Molecular profiling|molecular profiling
5193327|NCT00851032|Phase I Therapies|phase i therapies
5193328|NCT00851032|Tissue Bank|tissue bank
5193329|NCT00851019|Exercise|exercise
5193330|NCT00851019|Video game|video game
5193331|NCT00851019|Type 2 diabetes|type 2 diabetes
5193332|NCT00851019|Dance|dance
5193333|NCT00851006|Depression|depression
5193334|NCT00851006|Females|females
5193335|NCT00851006|Adolescents|adolescents
5193336|NCT00850993|Hemolysis|hemolysis
5193337|NCT00850954|Lung Cancer|lung cancer
5193338|NCT00850954|Cancer|cancer
5193339|NCT00850954|Smoke|smoke
5193340|NCT00850954|Mexican American|mexican american
5193341|NCT00850954|Indoor Air Policy|indoor air policy
5193342|NCT00850954|Secondhand smoke|secondhand smoke
5193343|NCT00850954|SHS|shs
5193344|NCT00850954|Smoking cessation programs|smoking cessation programs
5193345|NCT00850954|Smokers|smokers
5193346|NCT00850954|Tobacco|tobacco
5193347|NCT00850954|Nicotine|nicotine
5193348|NCT00850954|Chronic diseases|chronic diseases
5193349|NCT00850954|Transtheoretical model of change|transtheoretical model of change
5193350|NCT00850954|TTM|ttm
5193351|NCT00850941|Registry|registry
5193352|NCT00850941|Research Database|research database
5193353|NCT00850941|Prostate cancer|prostate cancer
5193354|NCT00850941|Casodex|casodex
5193355|NCT00850941|Flutamide|flutamide
5193356|NCT00850941|Goserelin Acetate|goserelin acetate
5193357|NCT00850941|Leuprolide Acetate|leuprolide acetate
5193358|NCT00850941|Radiation|radiation
5193359|NCT00850941|PSA|psa
5193360|NCT00850941|Post-prostatectomy|post-prostatectomy
5193361|NCT00850941|Radiation Therapy|radiation therapy
5193362|NCT00850941|Prostate Specific Antigen|prostate specific antigen
5193363|NCT00850941|Adenocarcinoma|adenocarcinoma
5193364|NCT00850941|Radical Prostatectomy|radical prostatectomy
5193365|NCT00850941|Bicalutamide|bicalutamide
5193366|NCT00850941|Zoladex|zoladex
5193367|NCT00850941|Lupron Depot|lupron depot
5193368|NCT00850941|Tissue banking|tissue banking
5193369|NCT00850941|Hormones|hormones
5193370|NCT00850928|Postoperative Cognitive Dysfunction|postoperative cognitive dysfunction
5193371|NCT00850928|MCI|mci
5193372|NCT00850928|Mild Cognitive Impairment|mild cognitive impairment
5193373|NCT00850928|Aβ40|aβ40
5193374|NCT00850928|Aβ42|aβ42
5193375|NCT00850928|Apolipoprotein E|apolipoprotein e
5193376|NCT00850928|Inflammatory Markers|inflammatory markers
5193377|NCT00850928|Apolipoprotein E Profile|apolipoprotein e profile
5193378|NCT00850928|Serum Beta Amyloid Profile|serum beta amyloid profile
5193379|NCT00850928|Inflammatory Markers Profile|inflammatory markers profile
5193380|NCT00850915|tuberculosis|tuberculosis
5193381|NCT00850915|community IPT|community ipt
5193382|NCT00850915|isoniazid adverse events|isoniazid adverse events
5193383|NCT00850915|tuberculosis incidence|tuberculosis incidence
5193384|NCT00850902|ELBW|elbw
5193385|NCT00850902|Humidity|humidity
5193386|NCT00850902|BPD|bpd
5193387|NCT00850889|Aesthetic correction of nasolabial folds|aesthetic correction of nasolabial folds
5193388|NCT00850863|COPD|copd
5193389|NCT00850863|Inflammation|inflammation
5193390|NCT00850863|Smoking|smoking
5193391|NCT00850863|Susceptibility|susceptibility
5193392|NCT00850850|PACU|pacu
5193393|NCT00850850|Physostigmine|physostigmine
5193394|NCT00850850|Recovery|recovery
5193395|NCT00850850|Postanesthesia Nursing|postanesthesia nursing
5193396|NCT00850850|Wakefulness|wakefulness
5193397|NCT00850850|General anesthesia|general anesthesia
5193398|NCT00850850|General Anesthetics|general anesthetics
5193399|NCT00850850|Postoperative Period|postoperative period
5193400|NCT00850837|Microbicide|microbicide
5193401|NCT00850837|HIV Seronegativity|hiv seronegativity
5193402|NCT00850824|T2DM|t2dm
5193403|NCT00850811|Peplin|peplin
5193404|NCT00850811|PEP005|pep005
5193405|NCT00850798|Type 2 diabetes|type 2 diabetes
5193406|NCT00850798|Elder patients|elder patients
5193407|NCT00850798|Glycemic control|glycemic control
5193408|NCT00850798|Men or women aged ≥80 years at time of randomization. There is no upper age limit.|men or women aged ≥80 years at time of randomization. there is no upper age limit.
5193409|NCT00850798|Be able to walk by themselves|be able to walk by themselves
5193410|NCT00850798|They had their first diagnosis of type 2 diabetes mellitus at age 30 years or older.|they had their first diagnosis of type 2 diabetes mellitus at age 30 years or older.
5193411|NCT00850772|Enteral nutrition|enteral nutrition
5193412|NCT00850772|Ovarian cancer|ovarian cancer
5193413|NCT00850772|Peritoneal cancer|peritoneal cancer
5193414|NCT00850772|Fallopian tube cancer|fallopian tube cancer
5193415|NCT00850772|Malnutrition|malnutrition
5193416|NCT00850772|Surgery|surgery
5193417|NCT00850772|Gynecological Cancer|gynecological cancer
5193418|NCT00850772|Suspected advanced epithelial ovarian cancer|suspected advanced epithelial ovarian cancer
5193419|NCT00850759|pedestrian safety|pedestrian safety
5193420|NCT00850759|street-crossing ability|street-crossing ability
5193421|NCT00850759|road-crossing|road-crossing
5193422|NCT00850759|children|children
5193423|NCT00850759|injury prevention|injury prevention
5193424|NCT00850746|QT interval|qt interval
5193425|NCT00850746|Cardiac Repolarization|cardiac repolarization
5193426|NCT00850746|Cardiac Conduction|cardiac conduction
5193427|NCT00850746|Healthy Subjects|healthy subjects
5193428|NCT00850746|YM443 (Z-338, acotiamide hydrochloride)|ym443 (z-338, acotiamide hydrochloride)
5193429|NCT00850746|Evaluation of QT Interval|evaluation of qt interval
5193430|NCT00850720|Biological Response Modifiers|biological response modifiers
5193431|NCT00850720|Bypass Surgery|bypass surgery
5193432|NCT00850720|Cardiology|cardiology
5193433|NCT00850720|Congenital Heart Disease|congenital heart disease
5193434|NCT00850720|Endocrinology|endocrinology
5193435|NCT00850720|Hormone Dysfunction|hormone dysfunction
5193436|NCT00850720|Hormones|hormones
5193437|NCT00850720|Neuroendocrinology|neuroendocrinology
5193438|NCT00850720|Pediatric Surgery|pediatric surgery
5193440|NCT00850707|AVG|avg
5193441|NCT00850707|TCC|tcc
5193442|NCT00850707|inflammation|inflammation
5193443|NCT00850707|monocite senescence|monocite senescence
5193444|NCT00850694|Vitamin D deficiency|vitamin d deficiency
5193445|NCT00850694|Obesity|obesity
5193446|NCT00850694|Insulin resistance|insulin resistance
5193447|NCT00850694|Glucose tolerance|glucose tolerance
5193448|NCT00850681|Peplin|peplin
5193449|NCT00850681|PEP005|pep005
5193450|NCT00850668|Food Allergy|food allergy
5193451|NCT00850668|Peanut Allergy|peanut allergy
5193452|NCT00850642|Sputum cell counts|sputum cell counts
5193453|NCT00850642|Neutrophils|neutrophils
5193454|NCT00850642|Severe Asthma|severe asthma
5193455|NCT00850642|ICS|ics
5193456|NCT00850642|Inhaled corticosteroids|inhaled corticosteroids
5193457|NCT00850629|weight regain|weight regain
5193458|NCT00850629|endocrine counterregulation|endocrine counterregulation
5193459|NCT00850616|HIV|hiv
5193460|NCT00850616|HIV Seronegativity|hiv seronegativity
5193461|NCT00850616|Preventive Vaccine|preventive vaccine
5193462|NCT00850603|Menomune® - A/C/Y/W-135|menomune® - a/c/y/w-135
5193463|NCT00850603|Meningococcal Infections|meningococcal infections
5193464|NCT00850603|Meningitis|meningitis
5193465|NCT00850564|growth hormone releasing hormone|growth hormone releasing hormone
5193466|NCT00850551|Early Intervention|early intervention
5193467|NCT00850551|Pulmonary Exacerbation|pulmonary exacerbation
5193468|NCT00850551|Cystic Fibrosis|cystic fibrosis
5193469|NCT00850551|Lung Function|lung function
5193470|NCT00850551|Spirometry|spirometry
5193471|NCT00850551|Phillips Telemonitor|phillips telemonitor
5193472|NCT00850551|Home Spirometry|home spirometry
5193473|NCT00850551|PiKo-6|piko-6
5193474|NCT00850551|Home Monitoring|home monitoring
5193475|NCT00850538|Bone Marrow Lesion|bone marrow lesion
5193476|NCT00850538|BML|bml
5193477|NCT00850538|Arthroplasty|arthroplasty
5193478|NCT00850538|Replacement|replacement
5193479|NCT00850538|Knee|knee
5193480|NCT00850538|Discarded tissue|discarded tissue
5193481|NCT00850486|women|women
5193482|NCT00850486|ischemic heart disease|ischemic heart disease
5193483|NCT00850486|high frequency ECG|high frequency ecg
5193484|NCT00850486|exercise stress testing|exercise stress testing
5193485|NCT00850486|signal processing|signal processing
5193486|NCT00850486|ischemic heart disease in women|ischemic heart disease in women
5193487|NCT00850473|PET|pet
5193488|NCT00850473|CT|ct
5193489|NCT00850473|Heart Attack|heart attack
5193490|NCT00850473|Coronary Artery disease|coronary artery disease
5193491|NCT00850473|Cardiac Catheterization|cardiac catheterization
5193492|NCT00850447|Posttraumatic stress disorder|posttraumatic stress disorder
5193493|NCT00850447|Cognition|cognition
5193494|NCT00850447|Neuropsychological Tests|neuropsychological tests
5193495|NCT00850421|migraine headache|migraine headache
5193496|NCT00850421|Botulinum Toxin Type A|botulinum toxin type a
5193497|NCT00850421|BOTOX|botox
5193498|NCT00850421|BTX-A|btx-a
5193499|NCT00850408|Stroke|stroke
5193500|NCT00850408|rTMS|rtms
5193501|NCT00850408|TMS|tms
5193502|NCT00850408|Rehabilitation|rehabilitation
5193503|NCT00850408|Upper Extremity|upper extremity
5193504|NCT00850395|HIV-1|hiv-1
5193505|NCT00850395|non-interventional|non-interventional
5193506|NCT00850395|CCR-5 tropic virus|ccr-5 tropic virus
5193507|NCT00850395|therapy experienced patients|therapy experienced patients
5193508|NCT00850382|CBF AML|cbf aml
5193509|NCT00850382|Dasatinib|dasatinib
5193510|NCT00850382|Core Binding Factor (CBF)|core binding factor (cbf)
5193511|NCT00850369|Pulmonary hypertension|pulmonary hypertension
5193512|NCT00850369|Sickle cell disease|sickle cell disease
5193513|NCT00850356|Bariatric Surgery|bariatric surgery
5193514|NCT00850356|Body Weight|body weight
5193515|NCT00850356|Health care costs|health care costs
5193516|NCT00850356|Obesity|obesity
5193517|NCT00850356|Obesity Complications|obesity complications
5193518|NCT00850356|Prolonged wait times|prolonged wait times
5193519|NCT00850356|Quality of Life|quality of life
5193520|NCT00850343|Rheumatoid Arthritis|rheumatoid arthritis
5193521|NCT00850343|Certolizumab Pegol|certolizumab pegol
5193522|NCT00850343|Cimzia|cimzia
5193523|NCT00850330|Drug interactions|drug interactions
5193524|NCT00850330|Drug interaction software|drug interaction software
5193525|NCT00850330|Older patients|older patients
5193526|NCT00850330|Hospitalization|hospitalization
5193527|NCT00850304|AML|aml
5193528|NCT00850291|Partial duodenopancreatectomy using electrosurgical vessel sealing device|partial duodenopancreatectomy using electrosurgical vessel sealing device
5193529|NCT00850278|Brain tumor|brain tumor
5193530|NCT00850278|[18F]FLT|[18f]flt
5193531|NCT00850278|[11C]MET|[11c]met
5193532|NCT00850278|TEP-imaging|tep-imaging
5193533|NCT00850278|tumor cell proliferation|tumor cell proliferation
5193534|NCT00850265|Asthma|asthma
5193535|NCT00850265|Formoterol|formoterol
5193536|NCT00850265|Beclomethasone|beclomethasone
5193537|NCT00850265|Extrafine formulation|extrafine formulation
5193538|NCT00850265|Spacer|spacer
5193539|NCT00850265|Moderate|moderate
5193540|NCT00850265|Severe|severe
5193541|NCT00850265|Stable|stable
5193542|NCT00850252|Lifeline|lifeline
5193543|NCT00850252|Tissue engineered blood vessel|tissue engineered blood vessel
5193544|NCT00850252|A-V shunt|a-v shunt
5193545|NCT00850239|diabetes|diabetes
5193546|NCT00850239|DPP4 inhibitor|dpp4 inhibitor
5193547|NCT00850239|dutogliptin|dutogliptin
5193548|NCT00850226|test anxiety|test anxiety
5193549|NCT00850200|Hodgkin Lymphoma, Proton Radiation|hodgkin lymphoma, proton radiation
5193550|NCT00850187|Knee cartilage diseases|knee cartilage diseases
5193551|NCT00850174|Bioequivalence|bioequivalence
5193552|NCT00850174|Healthy Subjects|healthy subjects
5193553|NCT00850161|Type 1 Diabetes|type 1 diabetes
5193554|NCT00850161|Nasal Insulin|nasal insulin
5193555|NCT00850161|Insulin Deficiency|insulin deficiency
5193556|NCT00850161|Insulin-Dependent|insulin-dependent
5193557|NCT00850148|Anwar|anwar
5193558|NCT00850148|Melles|melles
5193559|NCT00850148|Keratoconus|keratoconus
5193560|NCT00850096|Phase 2 Study for novel insulin delivery of type 2 diabetes|phase 2 study for novel insulin delivery of type 2 diabetes
5193561|NCT00850083|Fever|fever
5193562|NCT00850083|Children|children
5193563|NCT00850070|autism|autism
5193564|NCT00850044|FIH|fih
5193565|NCT00850044|SAD|sad
5193566|NCT00850031|Presbyopia|presbyopia
5193567|NCT00850031|Accommodation|accommodation
5193568|NCT00850031|Near visual acuity|near visual acuity
5193569|NCT00850031|LASIK|lasik
5193570|NCT00850018|Sickle Cell Disease|sickle cell disease
5193571|NCT00850018|Sickle Cell Anemia|sickle cell anemia
5193572|NCT00850018|Hemoglobin SS|hemoglobin ss
5193573|NCT00850018|Hemoglobin SB0|hemoglobin sb0
5193574|NCT00850005|neuropathic pain|neuropathic pain
5193575|NCT00850005|resistant|resistant
5193576|NCT00850005|neuroinflammation|neuroinflammation
5193577|NCT00850005|neuroinflammatory markers|neuroinflammatory markers
5193578|NCT00850005|Neuropathic pain that has not responded to standard therapy|neuropathic pain that has not responded to standard therapy
5193579|NCT00849992|Actinic cheilitis|actinic cheilitis
5193580|NCT00849992|Imiquimod 5%|imiquimod 5%
5193581|NCT00849992|Photodynamic therapy|photodynamic therapy
5193582|NCT00849979|Colorectal|colorectal
5193583|NCT00849979|Gastric|gastric
5193584|NCT00849979|Gastrointestinal|gastrointestinal
5193585|NCT00849979|GI|gi
5193586|NCT00849979|Liver|liver
5193587|NCT00849979|Pancreas|pancreas
5193588|NCT00849979|Gastrointestinal Cancers|gastrointestinal cancers
5193589|NCT00849979|Gastro-Intestinal Chemotherapy|gastro-intestinal chemotherapy
5193590|NCT00849979|M.D. Anderson Symptom Inventory|m.d. anderson symptom inventory
5193591|NCT00849979|MDASI-GI|mdasi-gi
5193592|NCT00849979|Medical Oncology|medical oncology
5193593|NCT00849966|Celebrex|celebrex
5193594|NCT00849966|celecoxib|celecoxib
5193595|NCT00849966|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors
5193596|NCT00849966|Anti-Inflammatory Agents Non-Steroidal|anti-inflammatory agents non-steroidal
5193597|NCT00849966|Adverse drug events|adverse drug events
5193598|NCT00849966|quality of life|quality of life
5193599|NCT00849966|Pain Postoperative|pain postoperative
5193600|NCT00849966|Tonsillectomy|tonsillectomy
5193601|NCT00849966|Adenotonsillectomy|adenotonsillectomy
5193602|NCT00849966|Otologic Surgical Procedures|otologic surgical procedures
5193603|NCT00849940|Spectroscopy|spectroscopy
5193604|NCT00849940|Near infrared|near infrared
5193605|NCT00849940|Oximetry|oximetry
5193606|NCT00849940|Hypoxemia|hypoxemia
5193607|NCT00849940|Tissue oxygenation|tissue oxygenation
5193608|NCT00849940|Pediatric|pediatric
5193609|NCT00849927|shoulder instability|shoulder instability
5193610|NCT00849927|labral lesions|labral lesions
5193611|NCT00849927|arthroscopic labral repair|arthroscopic labral repair
5193612|NCT00849927|SLAP|slap
5193613|NCT00849927|triple labrum|triple labrum
5193614|NCT00849927|circumferential labrum|circumferential labrum
5193615|NCT00849927|Pan-labral lesion|pan-labral lesion
5193616|NCT00849888|Thymus Transplantation|thymus transplantation
5193617|NCT00849888|DiGeorge Anomaly|digeorge anomaly
5193618|NCT00849888|Athymia|athymia
5193619|NCT00849888|Low T cell numbers|low t cell numbers
5193620|NCT00849888|Immunoreconstitution|immunoreconstitution
5193621|NCT00849888|Immunodeficiency|immunodeficiency
5193622|NCT00849875|ASCI|asci
5193623|NCT00849875|Dacarbazine|dacarbazine
5193624|NCT00849875|Cancer immunotherapeutic|cancer immunotherapeutic
5193625|NCT00849875|MAGE-A3|mage-a3
5193626|NCT00849875|Malignant melanoma|malignant melanoma
5193627|NCT00849862|Bioequivalence|bioequivalence
5193628|NCT00849862|Healthy Subjects|healthy subjects
5193629|NCT00849849|postgestational diabetes|postgestational diabetes
5193630|NCT00849849|diabetes mellitus|diabetes mellitus
5193631|NCT00849849|OGTT|ogtt
5193632|NCT00849849|insulin sensitivity|insulin sensitivity
5193633|NCT00849849|insulin secretion|insulin secretion
5193634|NCT00849823|African American|african american
5193635|NCT00849823|Men|men
5193636|NCT00849823|Condoms|condoms
5193637|NCT00849823|Randomization|randomization
5193638|NCT00849823|Brief Intervention|brief intervention
5193639|NCT00849823|HIV|hiv
5193640|NCT00849823|HIV Seronegativity|hiv seronegativity
5193641|NCT00849810|Hypertension|hypertension
5193642|NCT00849810|Beta-blockers|beta-blockers
5193643|NCT00849810|Ambulatory blood pressure|ambulatory blood pressure
5193644|NCT00849810|Basal metabolic rate|basal metabolic rate
5193645|NCT00849810|Quality of life|quality of life
5193646|NCT00849797|Bioequivalence|bioequivalence
5193647|NCT00849797|Healthy Subjects|healthy subjects
5193648|NCT00849771|Displaced Scapula Fracture|displaced scapula fracture
5193649|NCT00849771|Scapula Fracture|scapula fracture
5193650|NCT00849771|Extraarticular Scapula Fractures|extraarticular scapula fractures
5193651|NCT00849771|Clavicle|clavicle
5193652|NCT00849758|breast cancer|breast cancer
5193653|NCT00849758|elderly|elderly
5193654|NCT00849758|biomarker|biomarker
5193655|NCT00849745|severe autoimmune diseases|severe autoimmune diseases
5193656|NCT00849745|allogeneic stem cell transplant|allogeneic stem cell transplant
5193657|NCT00849732|HIV Seronegativity|hiv seronegativity
5193658|NCT00849732|Preventive Vaccine|preventive vaccine
5193659|NCT00849719|visual analog scale|visual analog scale
5193660|NCT00849719|patient controlled analgesia|patient controlled analgesia
5193661|NCT00849719|post operative pain|post operative pain
5193662|NCT00849719|rescue drug|rescue drug
5193663|NCT00849706|sleep deprivation|sleep deprivation
5193664|NCT00849706|workload|workload
5193665|NCT00849706|increased workload|increased workload
5193666|NCT00849680|HIV Seronegativity|hiv seronegativity
5193667|NCT00849680|Preventive Vaccine|preventive vaccine
5193668|NCT00849667|ovarian cancer|ovarian cancer
5193669|NCT00849667|relapsed ovarian cancer|relapsed ovarian cancer
5193670|NCT00849667|Platinum-sensitive Ovarian Cancer|platinum-sensitive ovarian cancer
5193671|NCT00849654|PCI-32765|pci-32765
5193672|NCT00849654|Lymphoma|lymphoma
5193673|NCT00849654|Lymphoma, Non-Hodgkin|lymphoma, non-hodgkin
5193674|NCT00849654|Lymphoma, B-Cell|lymphoma, b-cell
5193675|NCT00849654|Burkitt Lymphoma|burkitt lymphoma
5193676|NCT00849654|Lymphoma, B-Cell, Marginal Zone|lymphoma, b-cell, marginal zone
5193677|NCT00849654|Lymphoma, B-Cell, Diffuse|lymphoma, b-cell, diffuse
5193678|NCT00849654|Lymphoma, Follicular|lymphoma, follicular
5193679|NCT00849654|Lymphoma, Mantle Cell|lymphoma, mantle cell
5193680|NCT00849654|Leukemia, Lymphoid|leukemia, lymphoid
5193681|NCT00849654|Leukemia, B-Cell|leukemia, b-cell
5193880|NCT00848796|Heparin Leo|heparin leo
5193682|NCT00849654|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
5193683|NCT00849654|Bruton's Tyrosine Kinase|bruton's tyrosine kinase
5193684|NCT00849641|decompensation|decompensation
5193685|NCT00849641|septic shock|septic shock
5193686|NCT00849641|tissue oxygenation|tissue oxygenation
5193687|NCT00849641|near infrared spectroscopy|near infrared spectroscopy
5193688|NCT00849628|Aged|aged
5193689|NCT00849628|Polypharmacy|polypharmacy
5193690|NCT00849628|Adverse effects|adverse effects
5193691|NCT00849628|Nursing homes|nursing homes
5193692|NCT00849589|Screening|screening
5193693|NCT00849589|Brief intervention|brief intervention
5193694|NCT00849589|Underage drinking|underage drinking
5193695|NCT00849563|predictive genomics|predictive genomics
5193696|NCT00849563|personalized medicine|personalized medicine
5193697|NCT00849563|personal genomics|personal genomics
5193698|NCT00849563|genetic knowledge|genetic knowledge
5193699|NCT00849563|genetic attitudes|genetic attitudes
5193700|NCT00849563|prevention|prevention
5193701|NCT00849563|health outcomes|health outcomes
5193702|NCT00849563|behavioral|behavioral
5193703|NCT00849550|Advanced Solid Tumors|advanced solid tumors
5193704|NCT00849550|Cancer|cancer
5193705|NCT00849550|Capecitabine|capecitabine
5193706|NCT00849550|XELOX|xelox
5193707|NCT00849550|Neoplasms|neoplasms
5193708|NCT00849550|Oxaliplatin|oxaliplatin
5193709|NCT00849550|Bevacizumab|bevacizumab
5193710|NCT00849550|RAD001|rad001
5193711|NCT00849537|Triamcinolon|triamcinolon
5193712|NCT00849537|Cataract|cataract
5193713|NCT00849537|Diabetic retinopathy|diabetic retinopathy
5193714|NCT00849537|non-proliferative retinopathy|non-proliferative retinopathy
5193715|NCT00849511|Migraine prevention|migraine prevention
5193716|NCT00849511|Crossover|crossover
5193717|NCT00849511|Melatonin|melatonin
5193718|NCT00849485|Bioequivalence|bioequivalence
5193719|NCT00849485|Healthy Subjects|healthy subjects
5193720|NCT00849472|Neoadjuvant Breast Cancer|neoadjuvant breast cancer
5193721|NCT00849472|Pazopanib (GW786034)|pazopanib (gw786034)
5193722|NCT00849472|NSABP Foundation, Inc.|nsabp foundation, inc.
5193723|NCT00849472|cyclophosphamide|cyclophosphamide
5193724|NCT00849472|Paclitaxel|paclitaxel
5193725|NCT00849472|Doxorubicin|doxorubicin
5193726|NCT00849459|recurrent breast cancer|recurrent breast cancer
5193727|NCT00849459|stage IV breast cancer|stage iv breast cancer
5193728|NCT00849433|Inflammation|inflammation
5193729|NCT00849433|epithelial|epithelial
5193730|NCT00849433|integrity|integrity
5193731|NCT00849433|ECIS|ecis
5193732|NCT00849394|bevacizumab|bevacizumab
5193733|NCT00849394|proteinuria|proteinuria
5193734|NCT00849381|HPV|hpv
5193735|NCT00849381|HPV vaccine|hpv vaccine
5193736|NCT00849381|papillomavirus|papillomavirus
5193737|NCT00849381|cervical cancer|cervical cancer
5193738|NCT00849381|human papillomavirus|human papillomavirus
5193739|NCT00849329|lapatinib (GW572016), subject, pharmacokinetic, esomeprazole, proton-pump inhibitor, drug interaction, Phase 1|lapatinib (gw572016), subject, pharmacokinetic, esomeprazole, proton-pump inhibitor, drug interaction, phase 1
5193740|NCT00849303|stroke|stroke
5193741|NCT00849303|rehabilitation|rehabilitation
5193742|NCT00849303|gait|gait
5193743|NCT00849303|timing|timing
5193744|NCT00849303|transcranial magnetic stimulation|transcranial magnetic stimulation
5193745|NCT00849277|Respiratory Tract Infections|respiratory tract infections
5193746|NCT00849277|Influenza, Human|influenza, human
5193747|NCT00849277|Probiotics|probiotics
5193748|NCT00849264|hepatocellular carcinoma|hepatocellular carcinoma
5193749|NCT00849264|portal vein tumor thrombus|portal vein tumor thrombus
5193750|NCT00849264|surgical comprehensive treatment|surgical comprehensive treatment
5193751|NCT00849212|Seizures|seizures
5193752|NCT00849212|epilepsy|epilepsy
5193753|NCT00849199|screening|screening
5193754|NCT00849199|early detection|early detection
5193755|NCT00849199|prevention|prevention
5193756|NCT00849199|cancer|cancer
5193757|NCT00849199|high risk|high risk
5193758|NCT00849199|ovarian cancer|ovarian cancer
5193759|NCT00849199|breast cancer|breast cancer
5193760|NCT00849186|stage I renal cell cancer|stage i renal cell cancer
5193761|NCT00849186|stage II renal cell cancer|stage ii renal cell cancer
5193762|NCT00849186|stage III renal cell cancer|stage iii renal cell cancer
5193763|NCT00849186|stage IV renal cell cancer|stage iv renal cell cancer
5193764|NCT00849173|Endometriosis|endometriosis
5193765|NCT00849173|Infertility|infertility
5193766|NCT00849173|Tubal Ligation|tubal ligation
5193767|NCT00849173|Chronic Pelvic Pain|chronic pelvic pain
5193768|NCT00849173|Quality of Life|quality of life
5193769|NCT00849160|Treatment Experienced|treatment experienced
5193770|NCT00849147|Acute Lymphoblastic Leukemia/Lymphoma|acute lymphoblastic leukemia/lymphoma
5193771|NCT00849147|Acute Myelogenous Leukemia|acute myelogenous leukemia
5193772|NCT00849147|Mantel-Cell Lymphoma|mantel-cell lymphoma
5193773|NCT00849147|Hematopoietic Transplant|hematopoietic transplant
5193774|NCT00849147|Haplo-Identical Transplant|haplo-identical transplant
5193775|NCT00849147|Non-Myeloablative Transplant|non-myeloablative transplant
5193776|NCT00849134|First-Time-in-Human|first-time-in-human
5193777|NCT00849134|Tolerability|tolerability
5193778|NCT00849134|Pharmacodynamics|pharmacodynamics
5193779|NCT00849134|Safety|safety
5193780|NCT00849134|Food Effect|food effect
5193781|NCT00849134|Pharmacokinetics|pharmacokinetics
5193782|NCT00849134|Healthy Volunteers|healthy volunteers
5193783|NCT00849121|Vaccine|vaccine
5193784|NCT00849121|pTVG-HP|ptvg-hp
5193785|NCT00849121|Prostate Cancer|prostate cancer
5193786|NCT00849121|Castrate Resistant|castrate resistant
5193787|NCT00849108|Myocardial Perfusion|myocardial perfusion
5193788|NCT00849108|PET imaging|pet imaging
5193789|NCT00849108|SPECT imaging|spect imaging
5193790|NCT00849108|Coronary artery disease|coronary artery disease
5193791|NCT00849108|Subjects that are male and nonpregnant female patients|subjects that are male and nonpregnant female patients
5193792|NCT00849108|presenting with reversible ischemia as characterized by a|presenting with reversible ischemia as characterized by a
5193793|NCT00849108|rest/stress SPECT imaging study using|rest/stress spect imaging study using
5193794|NCT00849108|Technetium(99mTc)-labeled tracers|technetium(99mtc)-labeled tracers
5193795|NCT00849095|Adult|adult
5193796|NCT00849095|Asthma|asthma
5193797|NCT00849095|Bronchodilator Agents|bronchodilator agents
5193798|NCT00849095|Budesonide|budesonide
5193799|NCT00849095|Double-Blind Method|double-blind method
5193800|NCT00849095|Drug Therapy, Combination|drug therapy, combination
5193801|NCT00849095|Ethanolamines|ethanolamines
5193802|NCT00849095|Female|female
5193803|NCT00849095|Forced Expiratory Volume|forced expiratory volume
5193804|NCT00849095|Humans|humans
5193805|NCT00849095|Male|male
5193806|NCT00849095|Terbutaline|terbutaline
5193807|NCT00849082|stage IIB prostate cancer|stage iib prostate cancer
5193808|NCT00849082|stage IIA prostate cancer|stage iia prostate cancer
5193809|NCT00849082|stage III prostate cancer|stage iii prostate cancer
5193810|NCT00849082|stage IV prostate cancer|stage iv prostate cancer
5193811|NCT00849069|Streptococcus pneumoniae|streptococcus pneumoniae
5193812|NCT00849069|Vaccine|vaccine
5193940|NCT00848497|radical prostatectomy|radical prostatectomy
5193813|NCT00849069|Non-typable Haemophilus influenza|non-typable haemophilus influenza
5193814|NCT00849069|Adults and Elderly Adults|adults and elderly adults
5193815|NCT00849056|diabetes|diabetes
5193816|NCT00849043|obstructive sleep apnea hypopnea|obstructive sleep apnea hypopnea
5193817|NCT00849043|OSA|osa
5193818|NCT00849043|OSAH|osah
5193819|NCT00849017|placebo|placebo
5193820|NCT00849017|albiglutide|albiglutide
5193821|NCT00849017|monotherapy|monotherapy
5193822|NCT00849017|diabetes|diabetes
5193823|NCT00849004|keloid|keloid
5193824|NCT00849004|silicone sheet|silicone sheet
5193825|NCT00849004|silicone gel|silicone gel
5193826|NCT00849004|paper tape|paper tape
5193827|NCT00849004|steri-strip|steri-strip
5193828|NCT00848991|precedex|precedex
5193829|NCT00848991|propofol|propofol
5193830|NCT00848978|Functional capacity|functional capacity
5193831|NCT00848978|Quality of life|quality of life
5193832|NCT00848978|Depression|depression
5193833|NCT00848978|Falls|falls
5193834|NCT00848978|Body composition|body composition
5193835|NCT00848978|Physical activity|physical activity
5193836|NCT00848965|fluticasone propionate|fluticasone propionate
5193837|NCT00848965|Vienna Challenge Chamber|vienna challenge chamber
5193838|NCT00848965|glucocorticosteroids|glucocorticosteroids
5193839|NCT00848965|allergic rhinitis|allergic rhinitis
5193840|NCT00848939|systemic sclerosis|systemic sclerosis
5193841|NCT00848939|scleroderma|scleroderma
5193842|NCT00848939|pharmacokinetics|pharmacokinetics
5193843|NCT00848939|treprostinil diethanolamine|treprostinil diethanolamine
5193844|NCT00848926|Antigens, CD30|antigens, cd30
5193845|NCT00848926|Antibody-Drug Conjugate|antibody-drug conjugate
5193846|NCT00848926|Antibodies, Monoclonal|antibodies, monoclonal
5193847|NCT00848926|Disease, Hodgkin|disease, hodgkin
5193848|NCT00848926|Hematologic Diseases|hematologic diseases
5193849|NCT00848926|Lymphoma|lymphoma
5193850|NCT00848926|monomethylauristatin E|monomethylauristatin e
5193851|NCT00848926|Drug Therapy|drug therapy
5193852|NCT00848926|Immunotherapy|immunotherapy
5193853|NCT00848913|strength deficit|strength deficit
5193854|NCT00848913|physical function|physical function
5193855|NCT00848887|Influenza|influenza
5193856|NCT00848887|Flu|flu
5193857|NCT00848887|Vaccine|vaccine
5193858|NCT00848887|Adjuvant|adjuvant
5193859|NCT00848861|propofol sedation|propofol sedation
5193860|NCT00848861|colonoscopy|colonoscopy
5193861|NCT00848861|recovery time|recovery time
5193862|NCT00848861|recovery time after sedation for colonoscopy|recovery time after sedation for colonoscopy
5193863|NCT00848848|Influenza|influenza
5193864|NCT00848848|Flu|flu
5193865|NCT00848848|Vaccine|vaccine
5193866|NCT00848848|Intradermal|intradermal
5193867|NCT00848848|Adjuvant|adjuvant
5193868|NCT00848835|defibrillator|defibrillator
5193869|NCT00848822|Pediatrics|pediatrics
5193870|NCT00848822|Sleep|sleep
5193871|NCT00848822|Glucose regulation|glucose regulation
5193872|NCT00848822|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
5193873|NCT00848809|Acute kidney injury|acute kidney injury
5193874|NCT00848809|Vancomycin therapy|vancomycin therapy
5193875|NCT00848809|Slow-low efficiency daily dialysis|slow-low efficiency daily dialysis
5193876|NCT00848809|Intermittent Hemodialysis|intermittent hemodialysis
5193877|NCT00848809|Kidney|kidney
5193878|NCT00848809|Vancomycin|vancomycin
5193879|NCT00848809|Hemofiltration|hemofiltration
5193881|NCT00848796|Hepalean|hepalean
5193882|NCT00848796|CPB Cardiopuilmonary Bypass|cpb cardiopuilmonary bypass
5193883|NCT00848796|CABG Coronary Artery Bypass Grafting|cabg coronary artery bypass grafting
5193884|NCT00848796|Anticoagulation efficacy|anticoagulation efficacy
5193885|NCT00848783|gastric cancer|gastric cancer
5193886|NCT00848783|gastroesophageal junction|gastroesophageal junction
5193887|NCT00848783|stomach cancer|stomach cancer
5193888|NCT00848783|intraperitoneal infusion|intraperitoneal infusion
5193889|NCT00848783|capecitabine|capecitabine
5193890|NCT00848783|irinotecan|irinotecan
5193891|NCT00848783|cisplatin|cisplatin
5193892|NCT00848783|floxuridine|floxuridine
5193893|NCT00848770|Stroke, Acute|stroke, acute
5193894|NCT00848770|Systolic Pressure of Blood|systolic pressure of blood
5193895|NCT00848757|Diabetes|diabetes
5193896|NCT00848757|Lifestyle Intervention|lifestyle intervention
5193897|NCT00848744|Acne|acne
5193898|NCT00848731|pulmonary hypertension|pulmonary hypertension
5193899|NCT00848731|venous thromboembolism|venous thromboembolism
5193900|NCT00848718|Tumors, cancer|tumors, cancer
5193901|NCT00848705|type 1 diabetes, adolescent, self-management|type 1 diabetes, adolescent, self-management
5193902|NCT00848692|Chronic Fatigue Syndrome|chronic fatigue syndrome
5193903|NCT00848692|CFS|cfs
5193904|NCT00848692|Myalgic Encephalomyelitis|myalgic encephalomyelitis
5193905|NCT00848692|Rituximab|rituximab
5193906|NCT00848692|B-lymphocyte depletion|b-lymphocyte depletion
5193907|NCT00848692|B-cell depletion|b-cell depletion
5193908|NCT00848679|Pre-eclampsia|pre-eclampsia
5193909|NCT00848679|Pregnancy|pregnancy
5193910|NCT00848679|Uteroplacental blood flow|uteroplacental blood flow
5193911|NCT00848679|Epidural|epidural
5193912|NCT00848679|Anesthesia|anesthesia
5193913|NCT00848627|Bladder cancer|bladder cancer
5193914|NCT00848627|Smokers|smokers
5193915|NCT00848627|Hematuria|hematuria
5193916|NCT00848601|SGI-1776|sgi-1776
5193917|NCT00848601|PIM|pim
5193918|NCT00848601|Hormone & Docetaxel refractory Prostate Cancer|hormone & docetaxel refractory prostate cancer
5193919|NCT00848601|Refractory non-Hodgkin's Lymphoma|refractory non-hodgkin's lymphoma
5193920|NCT00848588|agonal breathing|agonal breathing
5193921|NCT00848588|cardiac arrest|cardiac arrest
5193922|NCT00848588|9-1-1 call taker|9-1-1 call taker
5193923|NCT00848588|survey|survey
5193924|NCT00848562|sudden cardiac death|sudden cardiac death
5193925|NCT00848549|Epilepsy|epilepsy
5193926|NCT00848549|Monotherapy|monotherapy
5193927|NCT00848536|OAG|oag
5193928|NCT00848536|OHT|oht
5193929|NCT00848523|LBH859|lbh859
5193930|NCT00848523|Panobinostat|panobinostat
5193931|NCT00848523|GBM|gbm
5193932|NCT00848523|Glioma|glioma
5193933|NCT00848523|Glioblastoma|glioblastoma
5193934|NCT00848523|Astrocytoma|astrocytoma
5193935|NCT00848523|oligodendroglioma|oligodendroglioma
5193936|NCT00848523|oligoastrocytoma|oligoastrocytoma
5193937|NCT00848523|gliosarcoma|gliosarcoma
5193938|NCT00848523|anaplastic|anaplastic
5193939|NCT00848497|hormone replacement therapy|hormone replacement therapy
5193941|NCT00848497|erectile dysfunctions|erectile dysfunctions
5193942|NCT00848497|scheduled for removal of prostate gland|scheduled for removal of prostate gland
5193943|NCT00848471|Indirect calorimeter|indirect calorimeter
5193944|NCT00848471|Validation|validation
5193945|NCT00848471|Energy expenditure|energy expenditure
5193946|NCT00848471|Healthy volunteers|healthy volunteers
5193947|NCT00848458|Azelaic Acid|azelaic acid
5193948|NCT00848458|Iontophoresis|iontophoresis
5193949|NCT00848432|Schizophrenia|schizophrenia
5193950|NCT00848432|Risperidone|risperidone
5193951|NCT00848432|Maintenance treatment|maintenance treatment
5193952|NCT00848432|Relapse|relapse
5193953|NCT00848419|Epidural|epidural
5193954|NCT00848419|Analgesia|analgesia
5193955|NCT00848419|Methadone|methadone
5193956|NCT00848419|Morphine|morphine
5193957|NCT00848419|Pharmacokinetic-pharmacodynamic|pharmacokinetic-pharmacodynamic
5193958|NCT00848419|Experimental pain - analgesic response|experimental pain - analgesic response
5193959|NCT00848406|bronchial|bronchial
5193960|NCT00848406|COPD|copd
5193961|NCT00848406|Asthma|asthma
5193962|NCT00848406|sputum|sputum
5193963|NCT00848406|biopsies|biopsies
5193964|NCT00848393|pediatric cardiac surgery|pediatric cardiac surgery
5193965|NCT00848393|stress response|stress response
5193966|NCT00848393|early extubation|early extubation
5193967|NCT00848393|Dexmedetomidine|dexmedetomidine
5193968|NCT00848393|TOF|tof
5193969|NCT00848393|VSD|vsd
5193970|NCT00848393|AVSD|avsd
5193971|NCT00848380|Hypertension|hypertension
5193972|NCT00848380|hyperlipidemia|hyperlipidemia
5193973|NCT00848354|enbrel|enbrel
5193974|NCT00848354|moderate arthritis|moderate arthritis
5193975|NCT00848354|severe arthritis|severe arthritis
5193976|NCT00848354|rheumatoid arthritis|rheumatoid arthritis
5193977|NCT00848328|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5193978|NCT00848328|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5193979|NCT00848328|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5193980|NCT00848328|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5193981|NCT00848315|cognitive behavioral intervention|cognitive behavioral intervention
5193982|NCT00848315|low literate/illiterate Hispanic patients|low literate/illiterate hispanic patients
5193983|NCT00848302|peripheral vascular disease|peripheral vascular disease
5193984|NCT00848302|endothelial dysfunction|endothelial dysfunction
5193985|NCT00848302|intravascular ultrasound|intravascular ultrasound
5193986|NCT00848302|L-Arginine|l-arginine
5193987|NCT00848289|Bladder cancer|bladder cancer
5193988|NCT00848289|Genetic susceptibility|genetic susceptibility
5193989|NCT00848289|Increased Risk|increased risk
5193990|NCT00848276|PCSK9|pcsk9
5193991|NCT00848276|Lipoprotein metabolism|lipoprotein metabolism
5193992|NCT00848276|testosterone|testosterone
5193993|NCT00848276|estradiol|estradiol
5193994|NCT00848263|Fracture|fracture
5193995|NCT00848263|Radius|radius
5193996|NCT00848263|Surgery|surgery
5193997|NCT00848263|Osteosynthesis|osteosynthesis
5193998|NCT00848250|Cardiopulmonary Bypass|cardiopulmonary bypass
5193999|NCT00848250|ACE inhibitor|ace inhibitor
5194000|NCT00848250|Pediatrics|pediatrics
5194001|NCT00848237|Barrett's Esophagus|barrett's esophagus
5194002|NCT00848237|Dysplasia|dysplasia
5194003|NCT00848237|Intestinal Metaplasia|intestinal metaplasia
5194004|NCT00848224|coronary heart disease|coronary heart disease
5194005|NCT00848224|lipid lowering medication|lipid lowering medication
5194006|NCT00848224|NCEP guidelines|ncep guidelines
5194007|NCT00848211|HIV|hiv
5194008|NCT00848211|vaccine|vaccine
5194009|NCT00848211|lipopeptide|lipopeptide
5194010|NCT00848211|Tat|tat
5194011|NCT00848211|TUTI-16|tuti-16
5194012|NCT00848211|THYMON|thymon
5194013|NCT00848211|Treatment Naive|treatment naive
5194014|NCT00848198|Dry Eye Disease|dry eye disease
5194015|NCT00848198|Dry Eye Syndrome|dry eye syndrome
5194016|NCT00848198|Dry Eye|dry eye
5194017|NCT00848185|VEGF|vegf
5194018|NCT00848185|Trigger|trigger
5194019|NCT00848185|OHSS|ohss
5194020|NCT00848172|Essential Tremor|essential tremor
5194021|NCT00848172|Octanol|octanol
5194022|NCT00848172|Octanoic Acid|octanoic acid
5194023|NCT00848172|Ethanol|ethanol
5194024|NCT00848172|Accelerometry|accelerometry
5194025|NCT00848159|Osteoporosis|osteoporosis
5194026|NCT00848159|kyphosis|kyphosis
5194027|NCT00848159|photogrammetry|photogrammetry
5194028|NCT00848107|systemic sclerosis|systemic sclerosis
5194029|NCT00848107|scleroderma|scleroderma
5194030|NCT00848107|digital ulcers|digital ulcers
5194031|NCT00848107|vasculopathy|vasculopathy
5194032|NCT00848094|hepatocellular carcinoma|hepatocellular carcinoma
5194033|NCT00848094|radiation therapy|radiation therapy
5194034|NCT00848094|3-dimensional conformal radiation therapy (3-DCRT)|3-dimensional conformal radiation therapy (3-dcrt)
5194035|NCT00848094|intensity modulated radiation therapy (IMRT)|intensity modulated radiation therapy (imrt)
5194036|NCT00848094|active breathing control|active breathing control
5194037|NCT00848081|Prostate|prostate
5194038|NCT00848081|BPH|bph
5194039|NCT00848081|Benign Prostatic Hyperplasia|benign prostatic hyperplasia
5194040|NCT00848081|BPH-LUTS|bph-luts
5194041|NCT00848081|LUTS|luts
5194042|NCT00848081|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors
5194043|NCT00848081|tadalafil|tadalafil
5194044|NCT00848081|alpha blockers|alpha blockers
5194045|NCT00848068|lipid layer thickness|lipid layer thickness
5194046|NCT00848042|cancer|cancer
5194047|NCT00848042|head and neck|head and neck
5194048|NCT00848042|laser|laser
5194049|NCT00848042|ablation|ablation
5194050|NCT00848029|Influenza vaccine|influenza vaccine
5194051|NCT00848003|Probiotics|probiotics
5194052|NCT00848003|BB-12|bb-12
5194053|NCT00848003|Yogurt|yogurt
5194054|NCT00848003|Antibiotics|antibiotics
5194055|NCT00847990|Down syndrome|down syndrome
5194056|NCT00847990|aneuploidy|aneuploidy
5194057|NCT00847990|chromosome abnormality|chromosome abnormality
5194058|NCT00847990|amniocentesis|amniocentesis
5194059|NCT00847990|chorionic villus sampling|chorionic villus sampling
5194060|NCT00847990|Laboratory Developed Test (LDT)|laboratory developed test (ldt)
5194061|NCT00847977|Acute head trauma|acute head trauma
5194062|NCT00847964|Heart Failure|heart failure
5194063|NCT00847951|renal|renal
5194064|NCT00847951|neonates|neonates
5194065|NCT00847938|neostigmine|neostigmine
5194066|NCT00847938|neuromuscular blocking agent|neuromuscular blocking agent
5194067|NCT00847938|train of four|train of four
5194068|NCT00847938|anesthesia|anesthesia
5194069|NCT00847912|NMSC|nmsc
5194070|NCT00847912|nonmelanoma skin cancer|nonmelanoma skin cancer
5194071|NCT00847912|topical 5-FU 5% cream|topical 5-fu 5% cream
5194072|NCT00847912|Neoplasms|neoplasms
5194073|NCT00847912|Antineoplastic Agents|antineoplastic agents
5194074|NCT00847912|Therapeutic Uses|therapeutic uses
5194075|NCT00847912|Dermatologic Agents|dermatologic agents
5194076|NCT00847912|Neoplasms by Site|neoplasms by site
5194077|NCT00847912|carcinoma, basal cell|carcinoma, basal cell
5194078|NCT00847912|carcinoma, squamous cell|carcinoma, squamous cell
5194079|NCT00847899|hypertension|hypertension
5194080|NCT00847899|impaired glucose tolerance|impaired glucose tolerance
5194081|NCT00847899|s-EH enzyme inhibition|s-eh enzyme inhibition
5194082|NCT00847899|pre-diabetes|pre-diabetes
5194083|NCT00847873|intimate partner violence|intimate partner violence
5194084|NCT00847873|domestic violence|domestic violence
5194085|NCT00847873|alcohol abuse|alcohol abuse
5194086|NCT00847873|alcohol dependence|alcohol dependence
5194087|NCT00847873|drug abuse|drug abuse
5194088|NCT00847873|drug dependence|drug dependence
5194089|NCT00847873|addiction|addiction
5194090|NCT00847860|cognition|cognition
5194091|NCT00847847|ALS|als
5194092|NCT00847847|Motor neuron|motor neuron
5194093|NCT00847847|Pathophysiology|pathophysiology
5194094|NCT00847847|Neuromuscular junction|neuromuscular junction
5194095|NCT00847847|Neuromuscular transmission|neuromuscular transmission
5194096|NCT00847847|Microelectrodes|microelectrodes
5194097|NCT00847808|Esophageal Reflux|esophageal reflux
5194098|NCT00847808|Gastro-Esophageal Reflux|gastro-esophageal reflux
5194099|NCT00847808|Gastroesophageal Reflux Disease|gastroesophageal reflux disease
5194100|NCT00847808|GERD|gerd
5194101|NCT00847808|Regurgitation, Gastric|regurgitation, gastric
5194102|NCT00847808|Heartburn|heartburn
5194103|NCT00847808|Drug Therapy|drug therapy
5194104|NCT00847769|Ankle Sprain|ankle sprain
5194105|NCT00847756|Otitis media|otitis media
5194106|NCT00847756|demography|demography
5194107|NCT00847756|Streptococcus pneumoniae|streptococcus pneumoniae
5194108|NCT00847756|Haemophilus influenzae|haemophilus influenzae
5194109|NCT00847756|Moraxella catarrhalis|moraxella catarrhalis
5194110|NCT00847756|rhinovirus|rhinovirus
5194111|NCT00847756|children, 0-5 years of age|children, 0-5 years of age
5194112|NCT00847756|diagnosed rAOM, COME or CSOM by an otorhinolaryngologist|diagnosed raom, come or csom by an otorhinolaryngologist
5194113|NCT00847756|primary and secondary hospital Nijmegen, the Netherlands|primary and secondary hospital nijmegen, the netherlands
5194114|NCT00847743|oxidative stress|oxidative stress
5194115|NCT00847743|aging|aging
5194116|NCT00847743|ischemia-reperfusion|ischemia-reperfusion
5194117|NCT00847730|Ease of dressing application, dressing conformability and ease of dressing removal on diabetic foot ulcers using the ActiVAC therapy|ease of dressing application, dressing conformability and ease of dressing removal on diabetic foot ulcers using the activac therapy
5194118|NCT00847717|Oral|oral
5194119|NCT00847717|cancer|cancer
5194120|NCT00847717|surgery|surgery
5194121|NCT00847717|neck dissection|neck dissection
5194122|NCT00847717|spinal accessory nerve|spinal accessory nerve
5194123|NCT00847704|Stroke|stroke
5194124|NCT00847704|Rehabilitation|rehabilitation
5194125|NCT00847704|Robotics|robotics
5194126|NCT00847691|economic evaluation|economic evaluation
5194127|NCT00847691|diagnostics|diagnostics
5194128|NCT00847691|sarcoma|sarcoma
5194129|NCT00847678|Cryptococcal Meningitis|cryptococcal meningitis
5194130|NCT00847665|Pressure ulcers|pressure ulcers
5194131|NCT00847665|Repositioning|repositioning
5194132|NCT00847665|Prevention|prevention
5194133|NCT00847665|Mechanical Ventilation|mechanical ventilation
5194134|NCT00847665|Critical care|critical care
5194135|NCT00847639|Multiple Myeloma|multiple myeloma
5194136|NCT00847639|lenalidomide|lenalidomide
5194137|NCT00847639|Revlimid|revlimid
5194138|NCT00847639|Allogeneic Hematopoietic Cell Transplantation|allogeneic hematopoietic cell transplantation
5194139|NCT00847626|Hypertensive|hypertensive
5194140|NCT00847626|Blood Pressure, High|blood pressure, high
5194141|NCT00847626|Vascular Disease|vascular disease
5194142|NCT00847626|Cardiovascular Disease|cardiovascular disease
5194143|NCT00847626|Drug Therapy|drug therapy
5194144|NCT00847613|double-blind placebo-controlled investigational drug oral therapy safety and efficacy hand and feet x-rays|double-blind placebo-controlled investigational drug oral therapy safety and efficacy hand and feet x-rays
5194145|NCT00847600|Schizophrenia|schizophrenia
5194146|NCT00847600|Neurosteroids|neurosteroids
5194147|NCT00847600|Pregnenolone|pregnenolone
5194148|NCT00847600|Augmentation|augmentation
5194149|NCT00847587|Contraceptive|contraceptive
5194150|NCT00847587|Implant|implant
5194151|NCT00847587|Postpartum period|postpartum period
5194152|NCT00847587|etonogestrel-releasing|etonogestrel-releasing
5194153|NCT00847587|lactogenesis|lactogenesis
5194154|NCT00847587|Breastfeeding|breastfeeding
5194155|NCT00847574|Weight loss|weight loss
5194156|NCT00847574|Weight maintenance|weight maintenance
5194157|NCT00847574|Weight management|weight management
5194158|NCT00847574|Cardiovascular disease risk|cardiovascular disease risk
5194159|NCT00847574|Dietary Guidelines|dietary guidelines
5194160|NCT00847574|Diet and exercise|diet and exercise
5194161|NCT00847574|Prevention|prevention
5194162|NCT00847561|Anxiety|anxiety
5194163|NCT00847548|intimate partner violence|intimate partner violence
5194164|NCT00847548|domestic violence|domestic violence
5194165|NCT00847548|substance abuse|substance abuse
5194166|NCT00847548|alcohol abuse|alcohol abuse
5194167|NCT00847548|drug abuse|drug abuse
5194168|NCT00847548|addiction|addiction
5194169|NCT00847522|melanoma|melanoma
5194170|NCT00847522|skin cancer|skin cancer
5194171|NCT00847522|lymph node|lymph node
5194172|NCT00847522|sentinel lymph node|sentinel lymph node
5194173|NCT00847522|malignant melanoma|malignant melanoma
5194174|NCT00847522|mapping|mapping
5194175|NCT00847509|lung cancer|lung cancer
5194176|NCT00847509|head and neck cancer|head and neck cancer
5194177|NCT00847509|radiotherapy|radiotherapy
5194178|NCT00847509|chemoradiotherapy|chemoradiotherapy
5194179|NCT00847509|radiation|radiation
5194180|NCT00847509|chemoradiation|chemoradiation
5194181|NCT00847509|FLT|flt
5194182|NCT00847509|[F-18]FLT|[f-18]flt
5194183|NCT00847509|FDG|fdg
5194184|NCT00847509|[F-18]FDG|[f-18]fdg
5194185|NCT00847496|Partial Thickness burn|partial thickness burn
5194186|NCT00847496|Biological Dressing|biological dressing
5194187|NCT00847483|glaucoma|glaucoma
5194188|NCT00847483|ocular hypertension|ocular hypertension
5194189|NCT00847483|latanoprost|latanoprost
5194190|NCT00847483|travoprost|travoprost
5194191|NCT00847483|bimatoprost|bimatoprost
5194192|NCT00847470|Dental caries|dental caries
5194193|NCT00847470|Assessments|assessments
5194194|NCT00847470|dental materials|dental materials
5194195|NCT00847457|Exercise|exercise
5194196|NCT00847457|Stretching|stretching
5194197|NCT00847457|Adolescents|adolescents
5194198|NCT00847431|Subthalamic Nucleus|subthalamic nucleus
5194199|NCT00847431|Deep Brain Stimulation|deep brain stimulation
5194200|NCT00847431|Depression|depression
5194201|NCT00847431|Anxiety|anxiety
5194202|NCT00847431|Parkinson's Disease|parkinson's disease
5194203|NCT00847418|pharmacokinetics|pharmacokinetics
5194204|NCT00847418|ketamine|ketamine
5194205|NCT00847418|Anesthetics, Dissociative|anesthetics, dissociative
5194206|NCT00847405|Bioequivalence|bioequivalence
5194207|NCT00847405|Healthy Subjects|healthy subjects
5194208|NCT00847392|Urethral catheterization|urethral catheterization
5194209|NCT00847392|Emergency Department|emergency department
5194210|NCT00847392|Ultrasound|ultrasound
5194211|NCT00847392|Urinary tract infection|urinary tract infection
5194212|NCT00847392|Pediatric|pediatric
5194213|NCT00847379|Duchenne muscular dystrophy|duchenne muscular dystrophy
5194214|NCT00847379|Becker muscular dystrophy|becker muscular dystrophy
5194215|NCT00847379|Nonsense mutation|nonsense mutation
5194216|NCT00847379|Premature stop codon|premature stop codon
5194218|NCT00847379|BMD|bmd
5194219|NCT00847379|Ataluren|ataluren
5194220|NCT00847379|PTC124|ptc124
5194221|NCT00847366|Perifosine|perifosine
5194222|NCT00847353|high frequency ECG|high frequency ecg
5194223|NCT00847353|normal values|normal values
5194224|NCT00847353|asymptomatic|asymptomatic
5194225|NCT00847353|obese|obese
5194226|NCT00847340|Genital warts|genital warts
5194227|NCT00847340|HPV typing|hpv typing
5194228|NCT00847340|HPV infections|hpv infections
5194229|NCT00847340|Condyloma Acuminata|condyloma acuminata
5194230|NCT00847327|Type 1 Diabetes|type 1 diabetes
5194231|NCT00847327|Parenting|parenting
5194232|NCT00847327|Young Children|young children
5194233|NCT00847314|Hypogonadism|hypogonadism
5194234|NCT00847314|Abdominal obesity|abdominal obesity
5194235|NCT00847314|Physical exercise|physical exercise
5194236|NCT00847314|Testosterone|testosterone
5194237|NCT00847288|Heart Failure|heart failure
5194238|NCT00847288|Implantable Cardioverter Defibrillator (ICD)|implantable cardioverter defibrillator (icd)
5194239|NCT00847288|Cardiac Resynchronization Therapy with Defibrillator (CRT D)|cardiac resynchronization therapy with defibrillator (crt d)
5194240|NCT00847288|OptiVol®|optivol®
5194241|NCT00847275|Elderly patients|elderly patients
5194242|NCT00847275|renal insufficiency|renal insufficiency
5194243|NCT00847275|gerontologic evaluation|gerontologic evaluation
5194244|NCT00847262|Hypertension|hypertension
5194245|NCT00847262|Abdominal obesity|abdominal obesity
5194246|NCT00847262|Diabetes|diabetes
5194247|NCT00847262|Treatment|treatment
5194248|NCT00847249|safety|safety
5194249|NCT00847249|tolerability|tolerability
5194250|NCT00847249|healthy|healthy
5194251|NCT00847249|inhalation|inhalation
5194252|NCT00847249|Healthy males|healthy males
5194253|NCT00847236|Polymyalgia Rheumatica|polymyalgia rheumatica
5194254|NCT00847236|Rheumatoid Arthritis|rheumatoid arthritis
5194255|NCT00847236|Rheumatic Disease|rheumatic disease
5194256|NCT00847236|PMR|pmr
5194257|NCT00847223|Mantle cell lymphoma|mantle cell lymphoma
5194258|NCT00847223|Lymphoma|lymphoma
5194259|NCT00847223|relapsed, refractory or progressive MCL|relapsed, refractory or progressive mcl
5194260|NCT00847223|Mantle cell lymphoma (relapsed, refractory or progressive)|mantle cell lymphoma (relapsed, refractory or progressive)
5194261|NCT00847210|Esophageal Reflux|esophageal reflux
5194262|NCT00847210|Gastro-Esophageal Reflux|gastro-esophageal reflux
5194263|NCT00847210|Gastroesophageal Reflux Disease|gastroesophageal reflux disease
5194264|NCT00847210|GERD|gerd
5194265|NCT00847210|Regurgitation, Gastric|regurgitation, gastric
5194266|NCT00847210|Heartburn|heartburn
5194267|NCT00847210|Drug Therapy|drug therapy
5194268|NCT00847210|Adolescent|adolescent
5194269|NCT00847184|nasal intubation|nasal intubation
5194270|NCT00847184|Aitraq|aitraq
5194271|NCT00847184|difficult intubation|difficult intubation
5194272|NCT00847171|male breast cancer|male breast cancer
5194273|NCT00847171|stage II breast cancer|stage ii breast cancer
5194274|NCT00847171|stage IIIA breast cancer|stage iiia breast cancer
5194275|NCT00847171|stage IIIB breast cancer|stage iiib breast cancer
5194276|NCT00847171|stage IIIC breast cancer|stage iiic breast cancer
5194277|NCT00847171|stage IV breast cancer|stage iv breast cancer
5194278|NCT00847171|HER2-positive breast cancer|her2-positive breast cancer
5194279|NCT00847158|POAG|poag
5194280|NCT00847158|Combination glaucoma & cataract procedure|combination glaucoma & cataract procedure
5194281|NCT00847158|trabecular micro-bypass stent|trabecular micro-bypass stent
5194282|NCT00847158|iStent|istent
5194283|NCT00847145|toddler|toddler
5194284|NCT00847145|Meningococcal disease|meningococcal disease
5194285|NCT00847145|prevention|prevention
5194286|NCT00847145|vaccination|vaccination
5194287|NCT00847132|Collaborative Care|collaborative care
5194288|NCT00847119|rectum|rectum
5194289|NCT00847119|adenocarcinoma|adenocarcinoma
5194290|NCT00847119|neoadjuvant|neoadjuvant
5194291|NCT00847119|bevacizumab|bevacizumab
5194292|NCT00847119|capecitabine|capecitabine
5194293|NCT00847119|radiotherapy|radiotherapy
5194294|NCT00847119|locally|locally
5194295|NCT00847119|advanced|advanced
5194296|NCT00847119|resectable|resectable
5194297|NCT00847119|resectable locally advanced adenocarcinoma of the rectum|resectable locally advanced adenocarcinoma of the rectum
5194298|NCT00847119|xeberecto|xeberecto
5194299|NCT00847106|Dendritic Cells|dendritic cells
5194300|NCT00847106|Regulatory T cells|regulatory t cells
5194301|NCT00847106|CD25|cd25
5194302|NCT00847106|Melanoma|melanoma
5194303|NCT00847106|Immunotherapy|immunotherapy
5194304|NCT00847106|Daclizumab|daclizumab
5194305|NCT00847106|Stage IV Melanoma|stage iv melanoma
5194306|NCT00847080|Reactive hypoglycemia|reactive hypoglycemia
5194307|NCT00847080|Sitagliptin|sitagliptin
5194308|NCT00847080|Glucagon-Like Peptide 1|glucagon-like peptide 1
5194309|NCT00847080|Incretins|incretins
5194310|NCT00847080|Prediabetes|prediabetes
5194311|NCT00847054|Solid Tumor|solid tumor
5194312|NCT00847054|Endosialin|endosialin
5194313|NCT00847028|Newborn|newborn
5194314|NCT00847028|Pain|pain
5194315|NCT00847028|glucose solution|glucose solution
5194316|NCT00847028|venipuncture|venipuncture
5194317|NCT00847028|non-pharmacologic pain relief.|non-pharmacologic pain relief.
5194318|NCT00847015|Bladder|bladder
5194319|NCT00847015|Urinary|urinary
5194320|NCT00847015|CISPLATIN|cisplatin
5194321|NCT00847015|GEMCITABINE|gemcitabine
5194322|NCT00847015|SU011248 (Sunitinib Malate)|su011248 (sunitinib malate)
5194323|NCT00847015|08-159|08-159
5194324|NCT00847002|Flexitouch system|flexitouch system
5194325|NCT00847002|FarrowWrap|farrowwrap
5194326|NCT00847002|venous stasis ulcer|venous stasis ulcer
5194327|NCT00846989|glaucoma,|glaucoma,
5194328|NCT00846989|primary open-angle glaucoma (POAG),|primary open-angle glaucoma (poag),
5194329|NCT00846989|ocular hypertension (OH),|ocular hypertension (oh),
5194330|NCT00846989|intraocular pressure (IOP)|intraocular pressure (iop)
5194331|NCT00846976|Safety|safety
5194332|NCT00846963|parenteral nutrition associated cholestasis in neonates|parenteral nutrition associated cholestasis in neonates
5194333|NCT00846963|parenteral nutrition induced cholestasis in preterms|parenteral nutrition induced cholestasis in preterms
5194334|NCT00846963|Bile duct obstruction|bile duct obstruction
5194335|NCT00846963|biliary stasis|biliary stasis
5194336|NCT00846950|H1-antagonist|h1-antagonist
5194337|NCT00846950|Event Related Potentials|event related potentials
5194338|NCT00846950|Memory|memory
5194339|NCT00846950|Information processing|information processing
5194340|NCT00846950|The effects of an H1 antagonist (dexchlorpheniramine) on human cognition|the effects of an h1 antagonist (dexchlorpheniramine) on human cognition
5194341|NCT00846937|Cholesterol|cholesterol
5194342|NCT00846937|Plant stanolester|plant stanolester
5194343|NCT00846937|Beverage|beverage
5194344|NCT00846937|Ileostoma|ileostoma
5194345|NCT00846937|Serum cholesterol level|serum cholesterol level
5194346|NCT00846937|serum LDL-cholesterol level|serum ldl-cholesterol level
5194347|NCT00846937|Intestinal cholesterol absorption efficiency|intestinal cholesterol absorption efficiency
5194348|NCT00846924|Stroke|stroke
5194349|NCT00846924|Transient Ischemic Attack|transient ischemic attack
5194350|NCT00846924|Atrial fibrillation|atrial fibrillation
5194351|NCT00846924|Atrial flutter|atrial flutter
5194352|NCT00846911|Acute Exacerbation of Chronic Bronchitis (AECB) patients|acute exacerbation of chronic bronchitis (aecb) patients
5194353|NCT00846898|blood sugar|blood sugar
5194354|NCT00846898|cholesterol|cholesterol
5194355|NCT00846898|cinnamon|cinnamon
5194356|NCT00846898|HbA1c|hba1c
5194357|NCT00846885|Bioequivalence|bioequivalence
5194358|NCT00846885|Healthy Subjects|healthy subjects
5194359|NCT00846872|GHRP-3|ghrp-3
5194360|NCT00846872|Insulin Resistance|insulin resistance
5194361|NCT00846872|Markers of inflammation|markers of inflammation
5194362|NCT00846872|Endothelial Dysfunction|endothelial dysfunction
5194363|NCT00846872|Flow Mediated Dilation|flow mediated dilation
5194364|NCT00846872|GH/IGF-1 axis|gh/igf-1 axis
5194365|NCT00846872|Post menopausal|post menopausal
5194366|NCT00846859|alcohol dependence|alcohol dependence
5194367|NCT00846859|nicotine dependence|nicotine dependence
5194368|NCT00846859|alcohol abuse|alcohol abuse
5194369|NCT00846859|varenicline|varenicline
5194370|NCT00846859|Champix|champix
5194371|NCT00846859|Chantix|chantix
5194372|NCT00846859|smoking|smoking
5194373|NCT00846859|drinking|drinking
5194374|NCT00846859|snuffing|snuffing
5194375|NCT00846859|diary|diary
5194376|NCT00846859|phosphatidyl ethanol|phosphatidyl ethanol
5194377|NCT00846859|PEth|peth
5194378|NCT00846833|Melanoma, Experimental|melanoma, experimental
5194379|NCT00846755|Thyroid|thyroid
5194380|NCT00846755|Pregnancy|pregnancy
5194381|NCT00846742|Hodgkin Lymphoma|hodgkin lymphoma
5194382|NCT00846716|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
5194383|NCT00846716|Diabetic Nephropathy|diabetic nephropathy
5194384|NCT00846716|Diabetic Retinopathy|diabetic retinopathy
5194385|NCT00846716|pioglitazone|pioglitazone
5194386|NCT00846690|topical anesthetics|topical anesthetics
5194387|NCT00846690|topical anesthesia|topical anesthesia
5194388|NCT00846690|20% benzocaine|20% benzocaine
5194389|NCT00846690|TAC alternate gel|tac alternate gel
5194390|NCT00846690|combination topical anesthetics|combination topical anesthetics
5194391|NCT00846690|dental anesthesia|dental anesthesia
5194392|NCT00846677|Healthy|healthy
5194393|NCT00846677|Infants|infants
5194394|NCT00846677|Vitamin D|vitamin d
5194395|NCT00846651|spinal anesthesia|spinal anesthesia
5194396|NCT00846651|cesarean section|cesarean section
5194397|NCT00846638|Risk drinking|risk drinking
5194398|NCT00846638|Women|women
5194399|NCT00846638|Medical problems|medical problems
5194400|NCT00846625|Biomedical research|biomedical research
5194401|NCT00846625|Macular Edema|macular edema
5194402|NCT00846625|Uveitis|uveitis
5194403|NCT00846625|Ranibizumab|ranibizumab
5194404|NCT00846625|Steroids|steroids
5194405|NCT00846612|refractory|refractory
5194406|NCT00846612|avastin|avastin
5194407|NCT00846612|doxil|doxil
5194408|NCT00846612|relapsed|relapsed
5194409|NCT00846612|ovarian cancer|ovarian cancer
5194410|NCT00846612|platinum-resistant|platinum-resistant
5194411|NCT00846599|brachial artery ultrasound|brachial artery ultrasound
5194412|NCT00846599|brachial artery reactivity|brachial artery reactivity
5194413|NCT00846599|HIV|hiv
5194414|NCT00846599|human immunodeficiency virus|human immunodeficiency virus
5194415|NCT00846599|cardiovascular risk|cardiovascular risk
5194416|NCT00846599|omega three|omega three
5194417|NCT00846599|saturated fat|saturated fat
5194418|NCT00846599|sustiva|sustiva
5194419|NCT00846599|atripla|atripla
5194420|NCT00846599|kaletra|kaletra
5194421|NCT00846599|treatment naive|treatment naive
5194422|NCT00846586|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
5194423|NCT00846586|COPD|copd
5194424|NCT00846586|indacaterol|indacaterol
5194425|NCT00846586|tiotropium|tiotropium
5194426|NCT00846586|bronchodilation|bronchodilation
5194427|NCT00846573|Helium|helium
5194428|NCT00846573|MRI|mri
5194429|NCT00846573|Hyperpolarized Helium|hyperpolarized helium
5194430|NCT00846573|Hyperpolarized Noble Gas|hyperpolarized noble gas
5194431|NCT00846547|Autism|autism
5194432|NCT00846547|Autism Spectrum Disorders|autism spectrum disorders
5194433|NCT00846547|irritability|irritability
5194434|NCT00846547|aberrant behavior|aberrant behavior
5194435|NCT00846534|Oxidative stress markers|oxidative stress markers
5194436|NCT00846534|Cardiac surgery|cardiac surgery
5194437|NCT00846534|Atrial Fibrillation|atrial fibrillation
5194438|NCT00846521|Pediatric Obesity|pediatric obesity
5194439|NCT00846521|Insulin Resistance|insulin resistance
5194440|NCT00846521|Glucose Tolerance|glucose tolerance
5194441|NCT00846521|Adolescents|adolescents
5194442|NCT00846521|Acarbose|acarbose
5194443|NCT00846521|Continuous Glucose Monitoring (CGMS)|continuous glucose monitoring (cgms)
5194444|NCT00846521|Endothelial Dysfunction|endothelial dysfunction
5194445|NCT00846508|cervical cancer|cervical cancer
5194446|NCT00846508|Cisplatin|cisplatin
5194447|NCT00846508|chemoradiation|chemoradiation
5194448|NCT00846495|Migraine|migraine
5194449|NCT00846495|Migraine prevention|migraine prevention
5194450|NCT00846495|Prodrome|prodrome
5194451|NCT00846495|Premonitory phase|premonitory phase
5194452|NCT00846495|Preemptive therapy|preemptive therapy
5194453|NCT00846482|Colorectal cancer|colorectal cancer
5194454|NCT00846482|Oxaliplatin|oxaliplatin
5194455|NCT00846482|ERCC-1|ercc-1
5194456|NCT00846456|Tumor setm cell|tumor setm cell
5194457|NCT00846443|non-small cell lung cancer|non-small cell lung cancer
5194458|NCT00846430|Neurofibromas|neurofibromas
5194459|NCT00846430|Neurofibromatosis 1|neurofibromatosis 1
5194460|NCT00846430|Celecoxib|celecoxib
5194461|NCT00846430|Celebrex|celebrex
5194462|NCT00846430|Peg-Interferon alpha-2b|peg-interferon alpha-2b
5194463|NCT00846430|PEG-Intron|peg-intron
5194464|NCT00846430|Temozolomide|temozolomide
5194465|NCT00846430|Temodar|temodar
5194466|NCT00846430|Vincristine Sulfate|vincristine sulfate
5194467|NCT00846430|Oncovin|oncovin
5194468|NCT00846417|myocardial infarction|myocardial infarction
5194469|NCT00846417|heart failure|heart failure
5194470|NCT00846417|arrhythmia|arrhythmia
5194471|NCT00846404|heart failure|heart failure
5194472|NCT00846404|cardiomyopathy|cardiomyopathy
5194473|NCT00846404|diastolic dysfunction|diastolic dysfunction
5194474|NCT00846378|ST segment elevation myocardial infarction (STEMI)|st segment elevation myocardial infarction (stemi)
5194475|NCT00846378|timed balloon inflations|timed balloon inflations
5194476|NCT00846378|post conditioning|post conditioning
5194477|NCT00846365|Essential Hypertension|essential hypertension
5194478|NCT00846365|Hypertensive|hypertensive
5194479|NCT00846365|Blood Pressure, High|blood pressure, high
5194480|NCT00846365|Vascular Disease|vascular disease
5194481|NCT00846365|Cardiovascular Disease|cardiovascular disease
5194482|NCT00846365|Drug Therapy|drug therapy
5194483|NCT00846352|Bone Marrow Transplantation|bone marrow transplantation
5194484|NCT00846352|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
5194485|NCT00846352|Bronchoscopy|bronchoscopy
5194486|NCT00846339|Smoking cessation|smoking cessation
5194487|NCT00846339|Bupropion|bupropion
5194488|NCT00846326|allergic rhinitis|allergic rhinitis
5194489|NCT00846326|rhinitis medicamentosa|rhinitis medicamentosa
5194490|NCT00846326|imidazolines|imidazolines
5194491|NCT00846326|corticosteroid|corticosteroid
5194492|NCT00846313|Dietary intake|dietary intake
5194493|NCT00846313|Dietary counseling|dietary counseling
5194494|NCT00846313|Weight loss|weight loss
5194495|NCT00846313|Body composition|body composition
5194496|NCT00846313|Resting energy expenditure|resting energy expenditure
5194497|NCT00846313|Quality of life|quality of life
5194498|NCT00846300|Patient compliance|patient compliance
5194499|NCT00846300|Hispanics|hispanics
5194500|NCT00846300|Health Behavior|health behavior
5194501|NCT00846300|Family Physicians|family physicians
5194502|NCT00846300|Primary Healthcare|primary healthcare
5194503|NCT00846287|COPD|copd
5194504|NCT00846287|aformoterol|aformoterol
5194505|NCT00846287|Helium|helium
5194506|NCT00846287|Hyperpolarized helium|hyperpolarized helium
5194507|NCT00846287|Hyperpolarized Noble Gas|hyperpolarized noble gas
5194508|NCT00846287|MRI|mri
5194509|NCT00846274|Healthy Male subjects|healthy male subjects
5194510|NCT00846261|infected|infected
5194511|NCT00846261|Ilizarov|ilizarov
5194512|NCT00846248|diabetes|diabetes
5194513|NCT00846248|insulin resistance|insulin resistance
5194514|NCT00846248|chromium|chromium
5194515|NCT00846248|healthy volunteers|healthy volunteers
5194516|NCT00846235|Dermatitis|dermatitis
5194517|NCT00846235|Atopic|atopic
5194518|NCT00846235|Moisturising cream|moisturising cream
5194519|NCT00846235|Skin|skin
5194520|NCT00846209|prescription drug|prescription drug
5194521|NCT00846209|warnings|warnings
5194522|NCT00846209|health literacy|health literacy
5194523|NCT00846209|enhanced language|enhanced language
5194524|NCT00846183|local injury|local injury
5194525|NCT00846183|implantation rate|implantation rate
5194526|NCT00846183|endometrial receptivity|endometrial receptivity
5194527|NCT00846183|IVF|ivf
5194528|NCT00846170|Irritable bowel syndrome probiotics|irritable bowel syndrome probiotics
5194529|NCT00846157|natural killer cell|natural killer cell
5194530|NCT00846157|DLBCL (Diffuse Large B Cell Lymphoma)|dlbcl (diffuse large b cell lymphoma)
5194531|NCT00846144|Glucose stimulated insulin secretion|glucose stimulated insulin secretion
5194532|NCT00846144|copper|copper
5194533|NCT00846144|cytokines|cytokines
5194534|NCT00846144|diabetes|diabetes
5194535|NCT00846144|Reduction in insulin secretion|reduction in insulin secretion
5194536|NCT00846131|Subjects with primary hepatocellular carcinoma, intended for liver transplantation.|subjects with primary hepatocellular carcinoma, intended for liver transplantation.
5194537|NCT00846118|Pitavastatin|pitavastatin
5194538|NCT00846118|Hemodialysis|hemodialysis
5194539|NCT00846118|Mortality|mortality
5194540|NCT00846118|Cardiovascular disease|cardiovascular disease
5194541|NCT00846105|methicillin resistant Staphylococcus aureus|methicillin resistant staphylococcus aureus
5194542|NCT00846105|MRSA|mrsa
5194543|NCT00846105|cross-infection|cross-infection
5194544|NCT00846105|staphylococcal infection|staphylococcal infection
5194545|NCT00846105|infection control|infection control
5194546|NCT00846092|Diabetic Retinopathy|diabetic retinopathy
5194547|NCT00846092|Diabetic Macular Edema|diabetic macular edema
5194548|NCT00846092|NIR|nir
5194549|NCT00846092|Near-infrared Light Therapy|near-infrared light therapy
5194550|NCT00846079|coronary artery disease|coronary artery disease
5194551|NCT00846079|stress testing|stress testing
5194552|NCT00846066|educational research,|educational research,
5194553|NCT00846066|instructional methods,|instructional methods,
5194554|NCT00846066|Hands on training,|hands on training,
5194555|NCT00846066|Web based training,|web based training,
5194556|NCT00846066|pediatric residents|pediatric residents
5194557|NCT00846066|preventive oral health,|preventive oral health,
5194558|NCT00846066|dental caries,|dental caries,
5194559|NCT00846066|Instructional strategies in Preventive Oral health|instructional strategies in preventive oral health
5194560|NCT00846066|Web-based training on Preventive Oral Health|web-based training on preventive oral health
5194561|NCT00846066|Hands on Training on Preventive Oral Health|hands on training on preventive oral health
5194562|NCT00846040|Obesity|obesity
5194563|NCT00846040|Weight Loss|weight loss
5194564|NCT00846040|Carbohydrate|carbohydrate
5194565|NCT00846040|Fat|fat
5194566|NCT00846040|Macronutrient Balance|macronutrient balance
5194567|NCT00846040|Healthy Volunteer|healthy volunteer
5194568|NCT00846014|asthma|asthma
5194569|NCT00846014|exacerbation|exacerbation
5194570|NCT00846014|Helium|helium
5194572|NCT00846014|Lung imaging|lung imaging
5194573|NCT00846001|Resynchronization Therapy|resynchronization therapy
5194574|NCT00845988|Bipolar disorder|bipolar disorder
5194575|NCT00845988|metabolic complication|metabolic complication
5194576|NCT00845988|Aripiprazole|aripiprazole
5194577|NCT00845988|Weight gain|weight gain
5194578|NCT00845988|Clinical Trial|clinical trial
5194579|NCT00845988|Antipsychotic|antipsychotic
5194580|NCT00845988|Metabolic syndrome|metabolic syndrome
5194581|NCT00845988|Psychopharmacology|psychopharmacology
5194582|NCT00845988|Open Label|open label
5194583|NCT00845962|bupivacaine|bupivacaine
5194584|NCT00845962|chloroprocaine|chloroprocaine
5194585|NCT00845962|spinal|spinal
5194586|NCT00845962|anesthesia|anesthesia
5194587|NCT00845962|elective surgery|elective surgery
5194588|NCT00845962|ambulatory surgery|ambulatory surgery
5194589|NCT00845949|chemokines synovium|chemokines synovium
5194590|NCT00845936|Atypical antipsychotics|atypical antipsychotics
5194591|NCT00845936|Weight|weight
5194592|NCT00845936|adolecsents|adolecsents
5194593|NCT00845936|pediatric|pediatric
5194594|NCT00845936|Metformin|metformin
5194595|NCT00845923|Postherpetic neuralgia of at least 6 months|postherpetic neuralgia of at least 6 months
5194596|NCT00845897|Diabetes mellitus|diabetes mellitus
5194597|NCT00845897|plantar ulcers|plantar ulcers
5194598|NCT00845897|peripheral neuropathy|peripheral neuropathy
5194599|NCT00845884|Gastric|gastric
5194600|NCT00845884|Cancer|cancer
5194601|NCT00845884|Advanced|advanced
5194602|NCT00845884|Docetaxel|docetaxel
5194603|NCT00845884|Cisplatin|cisplatin
5194604|NCT00845884|Capecitabine|capecitabine
5194605|NCT00845884|Bevacizumab|bevacizumab
5194606|NCT00845871|Exjade|exjade
5194607|NCT00845871|deferasirox|deferasirox
5194608|NCT00845871|palatability|palatability
5194609|NCT00845871|tolerability|tolerability
5194610|NCT00845871|food|food
5194611|NCT00845871|iron overload|iron overload
5194612|NCT00845871|Serum Iron overload due to transfusions|serum iron overload due to transfusions
5194613|NCT00845858|Gastroparesis|gastroparesis
5194614|NCT00845858|Diabetic Gastroparesis|diabetic gastroparesis
5194615|NCT00845858|Diabetes|diabetes
5194616|NCT00845858|Diabetes Mellitus|diabetes mellitus
5194617|NCT00845858|Delayed Gastric Emptying|delayed gastric emptying
5194618|NCT00845845|Non-alcoholic steatohepatitis|non-alcoholic steatohepatitis
5194619|NCT00845845|Omega-3 fatty acids|omega-3 fatty acids
5194620|NCT00845845|MRI|mri
5194621|NCT00845845|NASH|nash
5194622|NCT00845819|oral mucositis|oral mucositis
5194623|NCT00845819|intensive chemotherapy|intensive chemotherapy
5194624|NCT00845819|stem cell transplantation|stem cell transplantation
5194625|NCT00845819|epidermal growth factor|epidermal growth factor
5194626|NCT00845806|Diacritics|diacritics
5194627|NCT00845806|Neuronal Processing|neuronal processing
5194628|NCT00845806|fMRI|fmri
5194629|NCT00845806|Arabic|arabic
5194630|NCT00845793|Type 2 diabetes|type 2 diabetes
5194631|NCT00845793|Nutrition|nutrition
5194632|NCT00845793|Lifestyle modifications|lifestyle modifications
5194633|NCT00845780|persistent atrial fibrillation|persistent atrial fibrillation
5194634|NCT00845780|amiodarone|amiodarone
5194635|NCT00845780|late recurrence atrial fibrillation|late recurrence atrial fibrillation
5194636|NCT00845780|adverse events|adverse events
5194637|NCT00845767|Nitric Oxide|nitric oxide
5194638|NCT00845767|Nitric Oxide Synthase|nitric oxide synthase
5194639|NCT00845767|Air Pollution|air pollution
5194640|NCT00845767|Endothelial Dysfunction|endothelial dysfunction
5194641|NCT00845767|Diesel Exhaust|diesel exhaust
5194642|NCT00845754|Post-operative febrile morbidity|post-operative febrile morbidity
5194643|NCT00845754|Post-operative pain management|post-operative pain management
5194644|NCT00845728|Indacaterol|indacaterol
5194645|NCT00845728|Tiotropium|tiotropium
5194646|NCT00845728|COPD|copd
5194647|NCT00845715|rotator cuff|rotator cuff
5194648|NCT00845715|rehabilitation|rehabilitation
5194649|NCT00845715|range of motion|range of motion
5194650|NCT00845702|Renal artery stenosis|renal artery stenosis
5194651|NCT00845702|Contrast agent|contrast agent
5194652|NCT00845702|MRA|mra
5194653|NCT00845689|liver surgery|liver surgery
5194654|NCT00845676|Hepatitis C virus|hepatitis c virus
5194655|NCT00845676|Acute hepatitis C infection|acute hepatitis c infection
5194656|NCT00845676|HIV|hiv
5194657|NCT00845676|HCV|hcv
5194658|NCT00845663|certolizumab pegol|certolizumab pegol
5194659|NCT00845663|Cimzia|cimzia
5194660|NCT00845663|bioequivalence|bioequivalence
5194661|NCT00845663|Comparison Bioequivalence Study|comparison bioequivalence study
5194662|NCT00845650|Anthrax|anthrax
5194663|NCT00845650|Human Anthrax Immune Globulin Intravenous|human anthrax immune globulin intravenous
5194664|NCT00845650|Safety|safety
5194665|NCT00845650|Pharmacokinetics|pharmacokinetics
5194666|NCT00845637|eggplant|eggplant
5194667|NCT00845637|dyslipidemia|dyslipidemia
5194668|NCT00845637|postprandial lipemia|postprandial lipemia
5194669|NCT00845624|oxygen saturation|oxygen saturation
5194670|NCT00845624|retinopathy of prematurity|retinopathy of prematurity
5194671|NCT00845624|long term outcomes|long term outcomes
5194672|NCT00845624|hypoxia|hypoxia
5194673|NCT00845624|hyperoxia|hyperoxia
5194674|NCT00845611|peptide vaccine|peptide vaccine
5194675|NCT00845611|URLC10|urlc10
5194676|NCT00845598|Allergic Rhinitis|allergic rhinitis
5194677|NCT00845585|arterial reconstruction|arterial reconstruction
5194678|NCT00845585|bypass|bypass
5194679|NCT00845585|below knee|below knee
5194680|NCT00845585|PZFE|pzfe
5194681|NCT00845585|Ovine graft|ovine graft
5194682|NCT00845585|Omniflow II|omniflow ii
5194683|NCT00845585|graft patency|graft patency
5194684|NCT00845572|Schizophrenia|schizophrenia
5194685|NCT00845572|Schizoaffective|schizoaffective
5194686|NCT00845572|Risperdal Consta|risperdal consta
5194687|NCT00845572|Medication Adherence|medication adherence
5194688|NCT00845572|Antipsychotic|antipsychotic
5194689|NCT00845559|Childhood Obesity|childhood obesity
5194690|NCT00845559|Insulin resistance|insulin resistance
5194691|NCT00845559|Impaired Glucose Tolerance|impaired glucose tolerance
5194692|NCT00845559|Cardiovascular Disease|cardiovascular disease
5194693|NCT00845559|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
5194694|NCT00845559|Continuous Glucose Monitoring (CGMS)|continuous glucose monitoring (cgms)
5194695|NCT00845559|Exenatide|exenatide
5194696|NCT00845559|Oral Glucose Tolerance Test|oral glucose tolerance test
5194818|NCT00844948|Depression|depression
5194697|NCT00845546|Bioequivalence 10 mg Loratadine 240 mg Pseudoephedrine Sulfate Extended Release Tablets|bioequivalence 10 mg loratadine 240 mg pseudoephedrine sulfate extended release tablets
5194698|NCT00845507|weight gain|weight gain
5194699|NCT00845494|Medication history|medication history
5194700|NCT00845494|medication errors|medication errors
5194701|NCT00845494|Reduction of admission medication history errors|reduction of admission medication history errors
5194702|NCT00845468|coronary flow reserve|coronary flow reserve
5194703|NCT00845468|diabetes mellitus|diabetes mellitus
5194704|NCT00845468|acute myocardial infarction|acute myocardial infarction
5194705|NCT00845468|transthoracic echocardiography|transthoracic echocardiography
5194706|NCT00845442|Bilateral vocal cord paralyses|bilateral vocal cord paralyses
5194707|NCT00845442|Implanted laryngeal stimulator|implanted laryngeal stimulator
5194708|NCT00845442|vocal cord opening|vocal cord opening
5194709|NCT00845442|pulmonary function tests|pulmonary function tests
5194710|NCT00845429|Influenza|influenza
5194711|NCT00845429|Orthomyxoviruses|orthomyxoviruses
5194712|NCT00845429|Split-virion inactivated influenza vaccine|split-virion inactivated influenza vaccine
5194713|NCT00845429|cell-based vaccine|cell-based vaccine
5194714|NCT00845429|Adults|adults
5194715|NCT00845416|TREC|trec
5194716|NCT00845416|T cell|t cell
5194717|NCT00845416|Primary Immunodeficiency|primary immunodeficiency
5194718|NCT00845416|PID|pid
5194719|NCT00845416|Navajo|navajo
5194720|NCT00845416|SCID|scid
5194721|NCT00845403|Hepatitis B carrier|hepatitis b carrier
5194722|NCT00845377|Depression|depression
5194723|NCT00845377|Aging|aging
5194724|NCT00845377|Psychological well-being|psychological well-being
5194725|NCT00845377|Psychosocial intervention|psychosocial intervention
5194726|NCT00845364|Perhexiline|perhexiline
5194727|NCT00845364|Coronary artery bypass|coronary artery bypass
5194728|NCT00845364|Myocardial reperfusion injury|myocardial reperfusion injury
5194729|NCT00845364|Cardiac output, low|cardiac output, low
5194730|NCT00845364|Troponin|troponin
5194731|NCT00845351|Cushing's|cushing's
5194732|NCT00845338|Darifenacin|darifenacin
5194733|NCT00845338|Multiple Sclerosis|multiple sclerosis
5194734|NCT00845338|Open Label Study|open label study
5194735|NCT00845325|Carpal tunnel release|carpal tunnel release
5194736|NCT00845325|Rehabilitation|rehabilitation
5194737|NCT00845325|Early motion|early motion
5194738|NCT00845312|Age|age
5194739|NCT00845312|Mortality|mortality
5194740|NCT00845299|glaucoma|glaucoma
5194741|NCT00845299|ocular hypertension|ocular hypertension
5194742|NCT00845286|exercise, myocardial dysfunction, endothelial dysfunction,|exercise, myocardial dysfunction, endothelial dysfunction,
5194743|NCT00845286|polymorphism|polymorphism
5194744|NCT00845273|Subfoveal choroidal neovascularization secondary to age-related macular degeneration|subfoveal choroidal neovascularization secondary to age-related macular degeneration
5194745|NCT00845247|Case Management|case management
5194746|NCT00845234|behavioral intervention|behavioral intervention
5194747|NCT00845234|implantable cardioverter defibrillator|implantable cardioverter defibrillator
5194748|NCT00845234|psychosocial education|psychosocial education
5194749|NCT00845234|anxiety|anxiety
5194750|NCT00845234|depression|depression
5194751|NCT00845208|Network Support|network support
5194752|NCT00845208|AA|aa
5194753|NCT00845208|Contingency Management|contingency management
5194754|NCT00845195|Rhinitis|rhinitis
5194755|NCT00845195|Allergy|allergy
5194756|NCT00845195|Nasal Spray|nasal spray
5194757|NCT00845195|Antihistamine|antihistamine
5194758|NCT00845195|Intranasal Corticosteroid|intranasal corticosteroid
5194759|NCT00845182|Type 2 diabetes pathogenesis, thiazolidinediones|type 2 diabetes pathogenesis, thiazolidinediones
5194760|NCT00845182|impaired glucose tolerance|impaired glucose tolerance
5194761|NCT00845182|Incretins|incretins
5194762|NCT00845182|Insulin secretion|insulin secretion
5194763|NCT00845169|Air Pollution|air pollution
5194764|NCT00845169|Nitric Oxide|nitric oxide
5194765|NCT00845169|Nitric Oxide Synthase|nitric oxide synthase
5194766|NCT00845169|Diesel exhaust|diesel exhaust
5194767|NCT00845169|endothelial dysfunction|endothelial dysfunction
5194768|NCT00845156|Diabetes|diabetes
5194769|NCT00845156|Insulin resistance|insulin resistance
5194770|NCT00845156|healthy controls|healthy controls
5194771|NCT00845156|anti oxidants|anti oxidants
5194772|NCT00845143|Non-small cell lung cancer|non-small cell lung cancer
5194773|NCT00845143|surgery|surgery
5194774|NCT00845143|lung function|lung function
5194775|NCT00845130|Diabetes|diabetes
5194776|NCT00845130|MR imaging|mr imaging
5194777|NCT00845130|Vitamin C|vitamin c
5194778|NCT00845117|Aniridia,|aniridia,
5194779|NCT00845117|Steven Johnsons Syndrome,|steven johnsons syndrome,
5194780|NCT00845117|Ocular burns,|ocular burns,
5194781|NCT00845117|Pterygium|pterygium
5194782|NCT00845091|Parasympathetic activity|parasympathetic activity
5194783|NCT00845091|Exercise|exercise
5194784|NCT00845091|Education|education
5194785|NCT00845091|Arrhythmias|arrhythmias
5194786|NCT00845091|Defibrillators, Implantable|defibrillators, implantable
5194787|NCT00845078|Breast|breast
5194788|NCT00845078|Radiotherapy|radiotherapy
5194789|NCT00845078|Esthetics|esthetics
5194790|NCT00845078|Treatment Outcome|treatment outcome
5194791|NCT00845078|Reconstructive Surgical Procedures|reconstructive surgical procedures
5194792|NCT00845052|Housestaff|housestaff
5194793|NCT00845052|Patient Safety|patient safety
5194794|NCT00845052|Patient Care|patient care
5194795|NCT00845052|Focus of Study: To assess safety climate amongst housestaff|focus of study: to assess safety climate amongst housestaff
5194796|NCT00845039|Tumors|tumors
5194797|NCT00845039|Antibodies, Monoclonal|antibodies, monoclonal
5194798|NCT00845039|Colorectal Neoplasms|colorectal neoplasms
5194799|NCT00845039|Metastatic K-RAS Wild-Type Carcinoma of the Colon or Rectum|metastatic k-ras wild-type carcinoma of the colon or rectum
5194800|NCT00845013|HIV infection|hiv infection
5194801|NCT00845013|pulmonary hypertension|pulmonary hypertension
5194802|NCT00845013|endothelial function|endothelial function
5194803|NCT00845013|antiretroviral medication|antiretroviral medication
5194804|NCT00845013|Treatment Experienced|treatment experienced
5194805|NCT00844987|PDGF|pdgf
5194806|NCT00844987|HGF|hgf
5194807|NCT00844987|VEGF|vegf
5194808|NCT00844987|ACS|acs
5194809|NCT00844987|markers of myocardial injury|markers of myocardial injury
5194810|NCT00844987|Vascular Endothelial Growth Factor|vascular endothelial growth factor
5194811|NCT00844987|Hepatocyte Growth Factor|hepatocyte growth factor
5194812|NCT00844987|Platelet Derived Growth Factor|platelet derived growth factor
5194813|NCT00844987|Strategies in ACS|strategies in acs
5194814|NCT00844961|IBS|ibs
5194815|NCT00844961|CBT|cbt
5194816|NCT00844961|Internet treatment|internet treatment
5194817|NCT00844961|Cognitive behavior therapy|cognitive behavior therapy
5194819|NCT00844935|Heart rate variability, mechanical ventilation, weaning,|heart rate variability, mechanical ventilation, weaning,
5194820|NCT00844935|spontaneous breathing trial|spontaneous breathing trial
5194821|NCT00844909|CNTO 136|cnto 136
5194822|NCT00844909|safety|safety
5194823|NCT00844909|pharmacokinetics|pharmacokinetics
5194824|NCT00844909|healthy Japanese|healthy japanese
5194825|NCT00844909|healthy Caucasian|healthy caucasian
5194826|NCT00844909|Phase I|phase i
5194827|NCT00844909|antibody|antibody
5194828|NCT00844909|male.|male.
5194829|NCT00844896|Pathological stress & PTSD in preschool children & parents|pathological stress & ptsd in preschool children & parents
5194830|NCT00844896|Child and parent resilience after burn trauma|child and parent resilience after burn trauma
5194831|NCT00844883|primary liver cancer|primary liver cancer
5194832|NCT00844883|sorafenib|sorafenib
5194833|NCT00844883|Nexavar|nexavar
5194834|NCT00844883|doxorubicin|doxorubicin
5194835|NCT00844883|drug eluting beads|drug eluting beads
5194836|NCT00844883|transarterial chemoembolization|transarterial chemoembolization
5194837|NCT00844870|rehabilitation, reaching, stroke|rehabilitation, reaching, stroke
5194838|NCT00844857|Bipolar I Depression|bipolar i depression
5194839|NCT00844844|aHUS|ahus
5194840|NCT00844831|Constipation|constipation
5194841|NCT00844831|small intestinal bacterial overgrowth|small intestinal bacterial overgrowth
5194842|NCT00844831|stool bacteria|stool bacteria
5194843|NCT00844818|smoking cessation|smoking cessation
5194844|NCT00844818|parents|parents
5194845|NCT00844792|Male Urogenital Diseases|male urogenital diseases
5194846|NCT00844792|Antioxidants|antioxidants
5194847|NCT00844792|Vitamin E|vitamin e
5194848|NCT00844792|Vitamin D|vitamin d
5194849|NCT00844792|Lycopene|lycopene
5194850|NCT00844792|Selenium|selenium
5194851|NCT00844779|Metabolic syndrome- hepatic steatosis- steatohepatitis - gene expression|metabolic syndrome- hepatic steatosis- steatohepatitis - gene expression
5194852|NCT00844779|Non alcoholic fatty liver disease (NFALD)|non alcoholic fatty liver disease (nfald)
5194853|NCT00844766|Lactose intolerance|lactose intolerance
5194854|NCT00844766|Lactose|lactose
5194855|NCT00844766|Home-screening test|home-screening test
5194856|NCT00844766|Validate|validate
5194857|NCT00844753|Autism|autism
5194858|NCT00844753|PDD NOS|pdd nos
5194859|NCT00844753|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
5194860|NCT00844753|Parent Management Training|parent management training
5194861|NCT00844740|Familial hypophosphatemic rickets|familial hypophosphatemic rickets
5194862|NCT00844740|Cinacalcet|cinacalcet
5194863|NCT00844740|hyperparathyroidism|hyperparathyroidism
5194864|NCT00844714|endothelial function|endothelial function
5194865|NCT00844714|rheumatoid arthritis|rheumatoid arthritis
5194866|NCT00844714|cardiovascular risk|cardiovascular risk
5194867|NCT00844714|rituxan therapy|rituxan therapy
5194868|NCT00844701|nicotine|nicotine
5194869|NCT00844701|addiction|addiction
5194870|NCT00844701|fMRI|fmri
5194871|NCT00844701|neuroimaging|neuroimaging
5194872|NCT00844701|neurobiology|neurobiology
5194873|NCT00844701|craving|craving
5194874|NCT00844688|Hepatocellular Carcinoma|hepatocellular carcinoma
5194875|NCT00844688|Sorafenib|sorafenib
5194876|NCT00844688|Gemcitabine|gemcitabine
5194877|NCT00844675|endoscopic mucosal resection|endoscopic mucosal resection
5194878|NCT00844675|Proton Pump Inhibitor|proton pump inhibitor
5194879|NCT00844675|gastrointestinal hemorrhage|gastrointestinal hemorrhage
5194880|NCT00844675|rabeprazole|rabeprazole
5194881|NCT00844662|Hyperphosphataemia|hyperphosphataemia
5194882|NCT00844662|phosphate binder|phosphate binder
5194883|NCT00844636|Needlestick injuries|needlestick injuries
5194884|NCT00844636|Glove perforations|glove perforations
5194885|NCT00844636|Blunt Needles|blunt needles
5194886|NCT00844636|Glove perforations of surgeons, assistants|glove perforations of surgeons, assistants
5194887|NCT00844636|Needlestick injuries of same|needlestick injuries of same
5194888|NCT00844623|primary liver cancer, hepatoma|primary liver cancer, hepatoma
5194889|NCT00844584|Atrial fibrillation|atrial fibrillation
5194890|NCT00844584|radiofrequency|radiofrequency
5194891|NCT00844584|totally thoracoscope|totally thoracoscope
5194892|NCT00844584|epicardial|epicardial
5194893|NCT00844571|child abuse and neglect|child abuse and neglect
5194894|NCT00844571|child maltreatment|child maltreatment
5194895|NCT00844571|non accidental injury|non accidental injury
5194896|NCT00844571|training|training
5194897|NCT00844571|educational program|educational program
5194898|NCT00844558|osteoarthritis|osteoarthritis
5194899|NCT00844558|knee pain|knee pain
5194900|NCT00844558|gait training|gait training
5194901|NCT00844558|power training|power training
5194902|NCT00844558|rehabilitation|rehabilitation
5194903|NCT00844558|physical therapy|physical therapy
5194904|NCT00844545|aHUS|ahus
5194905|NCT00844532|Atherosclerosis|atherosclerosis
5194906|NCT00844532|Peripheral artery disease|peripheral artery disease
5194907|NCT00844532|Peripheral vascular disease|peripheral vascular disease
5194908|NCT00844532|PAD|pad
5194909|NCT00844532|Claudication|claudication
5194910|NCT00844532|Peripheral Arterial Occlusive Disease|peripheral arterial occlusive disease
5194911|NCT00844532|Stent|stent
5194912|NCT00844532|PAOD|paod
5194913|NCT00844532|PVD|pvd
5194914|NCT00844519|Treatment Experienced|treatment experienced
5194915|NCT00844519|CCR5 receptor|ccr5 receptor
5194916|NCT00844519|maraviroc|maraviroc
5194917|NCT00844506|Ovarian cancer patients with recurrent disease|ovarian cancer patients with recurrent disease
5194918|NCT00844493|diarrhea|diarrhea
5194919|NCT00844493|vaccine|vaccine
5194920|NCT00844493|enterotoxigenic E coli|enterotoxigenic e coli
5194921|NCT00844493|colonization factor antigen|colonization factor antigen
5194922|NCT00844493|volunteer study|volunteer study
5194923|NCT00844480|spinal cord injury|spinal cord injury
5194924|NCT00844480|osteoporosis|osteoporosis
5194925|NCT00844480|bone loss|bone loss
5194926|NCT00844480|zoledronic acid|zoledronic acid
5194927|NCT00844480|bisphosphonate|bisphosphonate
5194928|NCT00844467|Risk factors|risk factors
5194929|NCT00844467|Case fatality|case fatality
5194930|NCT00844467|disease burden|disease burden
5194931|NCT00844467|Resistance|resistance
5194932|NCT00844467|Benefits of pneumococcal vaccination|benefits of pneumococcal vaccination
5194933|NCT00844454|hepatocellular carcinoma|hepatocellular carcinoma
5194934|NCT00844454|PEI|pei
5194935|NCT00844454|RF ablation|rf ablation
5194936|NCT00844454|tumor ablation|tumor ablation
5194937|NCT00844441|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5194938|NCT00844441|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5194939|NCT00844441|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5194940|NCT00844441|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5194941|NCT00844441|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
5194942|NCT00844441|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5194943|NCT00844441|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5194944|NCT00844441|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5194945|NCT00844441|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5194946|NCT00844441|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
5194947|NCT00844441|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
5194948|NCT00844441|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
5194949|NCT00844441|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
5194950|NCT00844441|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
5194951|NCT00844441|adult acute eosinophilic leukemia|adult acute eosinophilic leukemia
5194952|NCT00844441|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
5194953|NCT00844441|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
5194954|NCT00844441|adult acute basophilic leukemia|adult acute basophilic leukemia
5194955|NCT00844441|acute myeloid leukemia with multilineage dysplasia following myelodysplastic syndrome|acute myeloid leukemia with multilineage dysplasia following myelodysplastic syndrome
5194956|NCT00844441|adult erythroleukemia (M6a)|adult erythroleukemia (m6a)
5194957|NCT00844441|adult pure erythroid leukemia (M6b)|adult pure erythroid leukemia (m6b)
5194958|NCT00844402|Cholestasis|cholestasis
5194959|NCT00844402|Atherosclerosis|atherosclerosis
5194960|NCT00844402|Statins|statins
5194961|NCT00844402|Vascular function|vascular function
5194962|NCT00844389|Open Angle Glaucoma|open angle glaucoma
5194963|NCT00844389|Biophotomodulation|biophotomodulation
5194964|NCT00844389|Near to Infrared light stimulation|near to infrared light stimulation
5194965|NCT00844389|Neuroprotection|neuroprotection
5194966|NCT00844376|Cardiovascular Diseases|cardiovascular diseases
5194967|NCT00844350|Oxytocin|oxytocin
5194968|NCT00844350|Letrozole|letrozole
5194969|NCT00844350|Induction of ovulation|induction of ovulation
5194970|NCT00844337|antibiotic regimens|antibiotic regimens
5194971|NCT00844337|sepsis|sepsis
5194972|NCT00844337|young infants|young infants
5194973|NCT00844337|Bangladeshi|bangladeshi
5194974|NCT00844337|outpatient treatment|outpatient treatment
5194975|NCT00844337|Suspected sepsis in young infants|suspected sepsis in young infants
5194976|NCT00844324|Candesartan|candesartan
5194977|NCT00844324|Bioequivalence|bioequivalence
5194978|NCT00844311|hCG|hcg
5194979|NCT00844311|human chorionic gonadotropin|human chorionic gonadotropin
5194980|NCT00844298|Philadelphia chromosome positive adult precursor acute lymphoblastic leukemia|philadelphia chromosome positive adult precursor acute lymphoblastic leukemia
5194981|NCT00844298|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
5194982|NCT00844285|Certolizumab Pegol, Cimzia ®|certolizumab pegol, cimzia ®
5194983|NCT00844285|Crohn's Disease|crohn's disease
5194984|NCT00844272|Opiate Dependence|opiate dependence
5194985|NCT00844272|Chronic Hepatitis C|chronic hepatitis c
5194986|NCT00844259|Down syndrome|down syndrome
5194987|NCT00844259|Pragmatics|pragmatics
5194988|NCT00844259|Language Development|language development
5194989|NCT00844246|Developmental delays|developmental delays
5194990|NCT00844246|Early intervention services|early intervention services
5194991|NCT00844220|Suspected coronary artery disease|suspected coronary artery disease
5194992|NCT00844207|Bioavailability|bioavailability
5194993|NCT00844155|Prevention or treatment of influenza in ventilated patients|prevention or treatment of influenza in ventilated patients
5194994|NCT00844142|ankylosing spondylitis|ankylosing spondylitis
5194995|NCT00844142|axial spondyloarthritis|axial spondyloarthritis
5194996|NCT00844142|magnetic resonance imaging|magnetic resonance imaging
5194997|NCT00844142|etanercept|etanercept
5194998|NCT00844142|sulfasalazine|sulfasalazine
5194999|NCT00844129|neurofibromatosis type 1|neurofibromatosis type 1
5195000|NCT00844129|spinal abnormalities|spinal abnormalities
5195001|NCT00844129|scoliosis|scoliosis
5195002|NCT00844116|COPD|copd
5195003|NCT00844116|spirometry|spirometry
5195004|NCT00844116|Telematic spirometry|telematic spirometry
5195005|NCT00844103|Volunteer|volunteer
5195006|NCT00844103|Safety|safety
5195007|NCT00844103|Tolerability|tolerability
5195008|NCT00844103|AZD8566|azd8566
5195009|NCT00844090|Apathy|apathy
5195010|NCT00844090|Diabetes|diabetes
5195011|NCT00844090|Self-care behaviors|self-care behaviors
5195012|NCT00844077|Barrett's Intestinal Metaplasia|barrett's intestinal metaplasia
5195013|NCT00844064|Pancreatic cancer|pancreatic cancer
5195014|NCT00844064|Metastatic melanoma|metastatic melanoma
5195015|NCT00844064|Advanced tumor|advanced tumor
5195016|NCT00844064|Targeted therapy|targeted therapy
5195017|NCT00844064|Antisense|antisense
5195018|NCT00844064|Transforming Growth Factor beta 2|transforming growth factor beta 2
5195019|NCT00844064|Dose escalation|dose escalation
5195020|NCT00844051|Influenza|influenza
5195021|NCT00844051|influenza vaccination|influenza vaccination
5195022|NCT00844051|school-based vaccination|school-based vaccination
5195023|NCT00844038|Steven-Johnson syndrome|steven-johnson syndrome
5195024|NCT00844038|erythema multiform|erythema multiform
5195025|NCT00844038|autoimmune disease|autoimmune disease
5195026|NCT00844025|Adverse drug reaction|adverse drug reaction
5195027|NCT00844025|Inappropriate medication|inappropriate medication
5195028|NCT00844025|Pharmacist|pharmacist
5195029|NCT00844025|Pharmaceutical care|pharmaceutical care
5195030|NCT00843986|hyponatremia|hyponatremia
5195031|NCT00843986|euvolemic hyponatremia|euvolemic hyponatremia
5195032|NCT00843986|hypervolemic hyponatremia|hypervolemic hyponatremia
5195033|NCT00843986|acute decompensated heart failure|acute decompensated heart failure
5195034|NCT00843986|conivaptan|conivaptan
5195035|NCT00843986|Vaprisol|vaprisol
5195036|NCT00843973|Iliac Crest Bone Graft|iliac crest bone graft
5195037|NCT00843973|Reamer Irrigator Aspirator|reamer irrigator aspirator
5195038|NCT00843934|Carcinoma, Hepatocellular|carcinoma, hepatocellular
5195039|NCT00843934|Trans arterial chemoembolization|trans arterial chemoembolization
5195040|NCT00843934|Epirubicin|epirubicin
5195041|NCT00843934|Cisplatin|cisplatin
5195042|NCT00843921|Hyperammonemia|hyperammonemia
5195043|NCT00843908|Stress incontinence|stress incontinence
5195044|NCT00843908|Surgical Treatments|surgical treatments
5195045|NCT00843908|Minislings|minislings
5195046|NCT00843895|Laboratory based study|laboratory based study
5195047|NCT00843895|antibiotic susceptibilty|antibiotic susceptibilty
5195048|NCT00843895|invasive strains|invasive strains
5195049|NCT00843843|Circadian Rhythms|circadian rhythms
5195050|NCT00843817|cystic fibrosis|cystic fibrosis
5195051|NCT00843804|nosocomial infection|nosocomial infection
5195052|NCT00843804|bloodstream infection|bloodstream infection
5195053|NCT00843804|central venous catheter|central venous catheter
5195054|NCT00843804|invasive Aspergillosis|invasive aspergillosis
5195523|NCT00842010|Hospital|hospital
5195055|NCT00843804|Clostridium difficile associated disease|clostridium difficile associated disease
5195056|NCT00843791|obesity|obesity
5195057|NCT00843778|Rheumatoid Arthritis|rheumatoid arthritis
5195058|NCT00843778|Moderate to Low Disease Activity|moderate to low disease activity
5195059|NCT00843778|Certolizumab Pegol|certolizumab pegol
5195060|NCT00843765|Stroke|stroke
5195061|NCT00843765|Traditional Chinese Medicine|traditional chinese medicine
5195062|NCT00843765|Rehabilitation|rehabilitation
5195063|NCT00843739|Breathing|breathing
5195064|NCT00843739|Cough|cough
5195065|NCT00843739|Speech|speech
5195066|NCT00843739|Swallow|swallow
5195067|NCT00843739|Parkinson's disease|parkinson's disease
5195068|NCT00843726|stage I non-small cell lung cancer|stage i non-small cell lung cancer
5195069|NCT00843726|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
5195070|NCT00843713|HIV|hiv
5195071|NCT00843713|endothelium|endothelium
5195072|NCT00843713|inflammation|inflammation
5195073|NCT00843713|Treatment Experienced|treatment experienced
5195074|NCT00843687|Schizophrenia|schizophrenia
5195075|NCT00843687|Risperidone|risperidone
5195076|NCT00843687|Long-acting injectable|long-acting injectable
5195077|NCT00843687|Intramuscular injection|intramuscular injection
5195078|NCT00843687|Pharmacokinetics|pharmacokinetics
5195079|NCT00843661|Treatment Experienced|treatment experienced
5195080|NCT00843648|antibody immune profile|antibody immune profile
5195081|NCT00843648|preterm|preterm
5195082|NCT00843648|c-section|c-section
5195083|NCT00843648|breastfeeding|breastfeeding
5195084|NCT00843635|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
5195085|NCT00843635|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
5195086|NCT00843635|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
5195087|NCT00843635|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
5195088|NCT00843635|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
5195089|NCT00843635|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
5195090|NCT00843635|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5195091|NCT00843635|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5195092|NCT00843635|stage I verrucous carcinoma of the oral cavity|stage i verrucous carcinoma of the oral cavity
5195093|NCT00843635|stage II verrucous carcinoma of the oral cavity|stage ii verrucous carcinoma of the oral cavity
5195094|NCT00843635|stage III verrucous carcinoma of the oral cavity|stage iii verrucous carcinoma of the oral cavity
5195095|NCT00843635|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
5195096|NCT00843622|Smoking|smoking
5195097|NCT00843622|Smoking cessation|smoking cessation
5195098|NCT00843622|Smokeless tobacco|smokeless tobacco
5195099|NCT00843622|Snus|snus
5195100|NCT00843609|diabetes mellitus, type 1|diabetes mellitus, type 1
5195101|NCT00843609|hypoglycemia|hypoglycemia
5195102|NCT00843609|continuous glucose monitoring|continuous glucose monitoring
5195103|NCT00843609|HbA1c|hba1c
5195104|NCT00843609|glycemic variability|glycemic variability
5195105|NCT00843596|cardiac surgery requiring ECC|cardiac surgery requiring ecc
5195106|NCT00843583|prevalence|prevalence
5195107|NCT00843583|obstructive sleep apnea|obstructive sleep apnea
5195108|NCT00843583|resistant hypertension|resistant hypertension
5195109|NCT00843570|IVF|ivf
5195110|NCT00843570|Frozen Embryo Replacement|frozen embryo replacement
5195111|NCT00843557|critical illness|critical illness
5195112|NCT00843557|intensive care|intensive care
5195113|NCT00843557|nosocomial infection|nosocomial infection
5195114|NCT00843531|neuroendocrine|neuroendocrine
5195115|NCT00843531|islet cell|islet cell
5195116|NCT00843531|carcinoid|carcinoid
5195117|NCT00843531|pancreatic neuroendocrine|pancreatic neuroendocrine
5195118|NCT00843531|paraganglioma|paraganglioma
5195119|NCT00843531|pheochromocytoma|pheochromocytoma
5195120|NCT00843531|RAD001|rad001
5195121|NCT00843531|everolimus|everolimus
5195122|NCT00843531|erlotinib|erlotinib
5195123|NCT00843531|Tarceva|tarceva
5195124|NCT00843518|Agitation and Aggression|agitation and aggression
5195125|NCT00843505|Smoking Cessation|smoking cessation
5195126|NCT00843505|Motivational Interviewing|motivational interviewing
5195127|NCT00843505|Quitline|quitline
5195128|NCT00843505|Telemedicine|telemedicine
5195129|NCT00843505|Stop Smoking Medication|stop smoking medication
5195130|NCT00843492|deep vein thrombosis|deep vein thrombosis
5195131|NCT00843492|immobilization|immobilization
5195132|NCT00843492|nadroparin|nadroparin
5195133|NCT00843492|isolated lower-extremity injuries distal to the knee|isolated lower-extremity injuries distal to the knee
5195134|NCT00843492|plaster cast|plaster cast
5195135|NCT00843492|non-surgical leg injury|non-surgical leg injury
5195136|NCT00843492|venous thromboembolism|venous thromboembolism
5195137|NCT00843492|bleeding events|bleeding events
5195138|NCT00843492|fondaparinux|fondaparinux
5195139|NCT00843479|diabetes mellitus, type 2|diabetes mellitus, type 2
5195140|NCT00843479|Insulin resistance|insulin resistance
5195141|NCT00843479|Aging|aging
5195142|NCT00843479|Incretins|incretins
5195143|NCT00843479|DPP-IV protein, human|dpp-iv protein, human
5195144|NCT00843479|Glucagon-Like Peptide 1|glucagon-like peptide 1
5195145|NCT00843479|Gastric Inhibitory Polypeptide|gastric inhibitory polypeptide
5195146|NCT00843479|insulin|insulin
5195147|NCT00843479|glucagon|glucagon
5195148|NCT00843479|ghrelin|ghrelin
5195149|NCT00843466|Hand dermatitis|hand dermatitis
5195150|NCT00843453|vitamin B12 deficiency|vitamin b12 deficiency
5195151|NCT00843453|cyanocobalamin deficiency|cyanocobalamin deficiency
5195152|NCT00843453|proton pump inhibitors|proton pump inhibitors
5195153|NCT00843453|omeprazole|omeprazole
5195154|NCT00843440|Antiangiogenic therapies|antiangiogenic therapies
5195155|NCT00843440|Bevacuzimab|bevacuzimab
5195156|NCT00843440|Hemorrhagic Hereditary Telangiectasia (HHT) with severe liver involvement|hemorrhagic hereditary telangiectasia (hht) with severe liver involvement
5195157|NCT00843427|aphasia|aphasia
5195158|NCT00843427|stroke|stroke
5195159|NCT00843427|functional magnetic resonance imaging|functional magnetic resonance imaging
5195160|NCT00843427|fMRI|fmri
5195161|NCT00843427|language recovery after stroke|language recovery after stroke
5195162|NCT00843427|constraint-induced aphasia therapy|constraint-induced aphasia therapy
5195163|NCT00843427|CIAT|ciat
5195164|NCT00843414|Emphysema|emphysema
5195165|NCT00843414|Sarcoidosis|sarcoidosis
5195166|NCT00843414|Interstitial Pulmonary Fibrosis|interstitial pulmonary fibrosis
5195167|NCT00843401|Low oxygen saturation|low oxygen saturation
5195168|NCT00843401|Anticipated need for pulse oximetry monitoring|anticipated need for pulse oximetry monitoring
5195169|NCT00843401|Arterial line in place as indicated per patient's clinical management needs|arterial line in place as indicated per patient's clinical management needs
5195170|NCT00843401|Availability to analyze arterial blood saturation by Co-Oximeter or|availability to analyze arterial blood saturation by co-oximeter or
5195171|NCT00843401|Blood Gas Analyzer|blood gas analyzer
5195172|NCT00843349|Phosphorus|phosphorus
5195173|NCT00843349|Fibroblast Growth Factor-23|fibroblast growth factor-23
5195174|NCT00843349|Kidney Disease|kidney disease
5195175|NCT00843336|fertility monitoring|fertility monitoring
5195176|NCT00843336|contraception|contraception
5195177|NCT00843310|multiple myeloma|multiple myeloma
5195178|NCT00843310|frontline treatment|frontline treatment
5195179|NCT00843310|first-line treatment|first-line treatment
5195180|NCT00843297|Sudden Cardiac Arrest|sudden cardiac arrest
5195181|NCT00843297|Hypothermia|hypothermia
5195182|NCT00843297|Outcome, neurological|outcome, neurological
5195183|NCT00843297|Coolgard|coolgard
5195184|NCT00843297|ArcticSun|arcticsun
5195185|NCT00843284|neuropathic, pain, pregabalin, Lyrica|neuropathic, pain, pregabalin, lyrica
5195186|NCT00843271|COPD MESA LUNG BIOMARKERS|copd mesa lung biomarkers
5195187|NCT00843258|therapy|therapy
5195188|NCT00843258|ultrasound|ultrasound
5195189|NCT00843258|mild dysplasia|mild dysplasia
5195190|NCT00843245|Heart Failure|heart failure
5195191|NCT00843245|Electric bioimpedance|electric bioimpedance
5195192|NCT00843245|Body composition|body composition
5195193|NCT00843245|Diagnosis|diagnosis
5195194|NCT00843245|monitoring|monitoring
5195195|NCT00843245|Prognosis|prognosis
5195196|NCT00843245|Total body water|total body water
5195197|NCT00843232|diabetes mellitus, type 2|diabetes mellitus, type 2
5195198|NCT00843232|Insulin resistance|insulin resistance
5195199|NCT00843232|Aging|aging
5195200|NCT00843232|Incretins|incretins
5195201|NCT00843232|DPP-IV protein, human|dpp-iv protein, human
5195202|NCT00843232|Glucagon-Like Peptide 1|glucagon-like peptide 1
5195203|NCT00843232|Gastric Inhibitory Polypeptide|gastric inhibitory polypeptide
5195204|NCT00843232|insulin|insulin
5195205|NCT00843232|glucagon|glucagon
5195206|NCT00843232|ghrelin|ghrelin
5195207|NCT00843219|Lung|lung
5195208|NCT00843219|Lung Cancer|lung cancer
5195209|NCT00843219|Non-small cell Lung Cancer|non-small cell lung cancer
5195210|NCT00843219|NSCLC|nsclc
5195211|NCT00843219|Motion Correction|motion correction
5195212|NCT00843219|PET/CT Scan|pet/ct scan
5195213|NCT00843219|PET|pet
5195214|NCT00843219|Positron Emission Tomography|positron emission tomography
5195215|NCT00843219|CT|ct
5195216|NCT00843219|Computed Tomography|computed tomography
5195217|NCT00843219|Amplitude Gating|amplitude gating
5195218|NCT00843193|Asthma|asthma
5195219|NCT00843193|Asthma control questionnaire|asthma control questionnaire
5195220|NCT00843180|Bone Marrow Transplant|bone marrow transplant
5195221|NCT00843180|Massage|massage
5195222|NCT00843180|Pediatric Oncology|pediatric oncology
5195223|NCT00843180|children undergoing bone marrow transplantation|children undergoing bone marrow transplantation
5195224|NCT00843167|mammography|mammography
5195225|NCT00843167|biopsy|biopsy
5195226|NCT00843167|ductal breast carcinoma in situ|ductal breast carcinoma in situ
5195227|NCT00843167|atypical ductal breast hyperplasia|atypical ductal breast hyperplasia
5195228|NCT00843154|Natriuretic Peptide, Brain|natriuretic peptide, brain
5195229|NCT00843154|Biological Markers|biological markers
5195230|NCT00843154|Biomarkers|biomarkers
5195231|NCT00843154|Cardiac Failure|cardiac failure
5195232|NCT00843154|Congestive Heart Failure|congestive heart failure
5195233|NCT00843154|Heart Decompensation|heart decompensation
5195234|NCT00843154|Drug Therapy|drug therapy
5195235|NCT00843141|ADHD|adhd
5195236|NCT00843141|Executive functions|executive functions
5195237|NCT00843141|Quality of life|quality of life
5195332|NCT00842738|Cervical cancer|cervical cancer
5195238|NCT00843115|Alzheimer's Disease, naturalistic study|alzheimer's disease, naturalistic study
5195239|NCT00843102|atherosclerosis|atherosclerosis
5195240|NCT00843102|pulmonary hypertension|pulmonary hypertension
5195241|NCT00843089|coronary artery disease|coronary artery disease
5195242|NCT00843089|CABG|cabg
5195243|NCT00843063|pantoprazole|pantoprazole
5195244|NCT00843063|famotidine|famotidine
5195245|NCT00843063|aspirin|aspirin
5195246|NCT00843063|dyspepsia|dyspepsia
5195247|NCT00843063|gastrointestinal bleeding|gastrointestinal bleeding
5195248|NCT00843063|peptic ulcer / erosion|peptic ulcer / erosion
5195249|NCT00843050|CKD inhibitor|ckd inhibitor
5195250|NCT00843050|Mantle Cell Lymphoma|mantle cell lymphoma
5195251|NCT00843037|PARAGANGLIOMA|paraganglioma
5195252|NCT00843037|PHEOCHROMOCYTOMA|pheochromocytoma
5195253|NCT00843037|SUNITINIB|sunitinib
5195254|NCT00843037|PHASE II|phase ii
5195255|NCT00843037|Metastatic or locally advanced malignant paraganglioma|metastatic or locally advanced malignant paraganglioma
5195256|NCT00843037|Metastatic or locally advanced malignant pheochromocytoma|metastatic or locally advanced malignant pheochromocytoma
5195257|NCT00843024|Migraine with or without aura|migraine with or without aura
5195258|NCT00843024|Migraine efficacy|migraine efficacy
5195259|NCT00843024|Migraine|migraine
5195260|NCT00843024|Migraine headache|migraine headache
5195261|NCT00843024|Adolescent migraine|adolescent migraine
5195262|NCT00843024|TREXIMET|treximet
5195263|NCT00843024|Sumatriptan succinate|sumatriptan succinate
5195264|NCT00843024|Naproxen sodium|naproxen sodium
5195265|NCT00843024|Migraine, acute|migraine, acute
5195266|NCT00843011|formulation|formulation
5195267|NCT00843011|safety and tolerability|safety and tolerability
5195268|NCT00843011|pharmacokinetics|pharmacokinetics
5195269|NCT00843011|NK1 antagonist|nk1 antagonist
5195270|NCT00843011|effect of food|effect of food
5195271|NCT00842998|breast cancer|breast cancer
5195272|NCT00842998|HER2|her2
5195273|NCT00842998|Trastuzumab|trastuzumab
5195274|NCT00842998|Lapatinib|lapatinib
5195275|NCT00842998|HER2 gene-amplification|her2 gene-amplification
5195276|NCT00842985|Cannabis Abuse|cannabis abuse
5195277|NCT00842985|Cannabis Dependence|cannabis dependence
5195278|NCT00842985|Cannabis-Related Disorder|cannabis-related disorder
5195279|NCT00842985|Marijuana Dependence|marijuana dependence
5195280|NCT00842985|Marihuana Abuse|marihuana abuse
5195281|NCT00842959|Improvement of adjustment accuracy of intraocular lenses and imaging quality|improvement of adjustment accuracy of intraocular lenses and imaging quality
5195282|NCT00842933|Septic shock|septic shock
5195283|NCT00842933|Acute adrenal insufficiency|acute adrenal insufficiency
5195284|NCT00842920|amnestic MCI|amnestic mci
5195285|NCT00842907|Brazil|brazil
5195286|NCT00842907|isotretinoin|isotretinoin
5195287|NCT00842907|photodamage|photodamage
5195288|NCT00842907|photoaging|photoaging
5195289|NCT00842881|Healingstone|healingstone
5195290|NCT00842868|atherosclerosis|atherosclerosis
5195291|NCT00842868|contrast induced nephropathy|contrast induced nephropathy
5195292|NCT00842868|renal impairment|renal impairment
5195293|NCT00842868|catheterization|catheterization
5195294|NCT00842855|GERD|gerd
5195295|NCT00842855|PPI|ppi
5195296|NCT00842855|partial responders|partial responders
5195297|NCT00842842|surgical fixation devices|surgical fixation devices
5195298|NCT00842842|postoperative pain|postoperative pain
5195299|NCT00842842|ventral hernia|ventral hernia
5195300|NCT00842842|fibrin tissue adhesive|fibrin tissue adhesive
5195301|NCT00842842|laparoscopy|laparoscopy
5195302|NCT00842842|quality of life|quality of life
5195303|NCT00842842|fatigue|fatigue
5195304|NCT00842829|Breakthrough Cancer Pain|breakthrough cancer pain
5195305|NCT00842816|Dementia|dementia
5195306|NCT00842816|Alzheimer Type Senile Dementia|alzheimer type senile dementia
5195307|NCT00842816|Cognitive impairment|cognitive impairment
5195308|NCT00842803|Liver|liver
5195309|NCT00842803|transplant|transplant
5195310|NCT00842803|albumin|albumin
5195311|NCT00842803|outcome|outcome
5195312|NCT00842803|Liver transplant recipients canadian transplant status 1 or 2|liver transplant recipients canadian transplant status 1 or 2
5195313|NCT00842790|Carcinoma, Renal Cell [C04.557.470.200.025.390]|carcinoma, renal cell [c04.557.470.200.025.390]
5195314|NCT00842790|Angiogenesis Inhibitors [D27.505.954.248.025]|angiogenesis inhibitors [d27.505.954.248.025]
5195315|NCT00842790|Tomography Scanners, X-Ray Computed [E07.913]|tomography scanners, x-ray computed [e07.913]
5195316|NCT00842790|Magnetic Resonance Imaging [E01.370.350.825.500]|magnetic resonance imaging [e01.370.350.825.500]
5195317|NCT00842790|Diffusion Magnetic Resonance Imaging [E01.370.350.825.500.150]|diffusion magnetic resonance imaging [e01.370.350.825.500.150]
5195318|NCT00842790|Perfusion [E05.680]|perfusion [e05.680]
5195319|NCT00842777|Childhood obesity|childhood obesity
5195320|NCT00842777|Quality of life|quality of life
5195321|NCT00842777|Self-esteem|self-esteem
5195322|NCT00842777|BMI|bmi
5195323|NCT00842777|parental group treatment|parental group treatment
5195324|NCT00842777|Body image|body image
5195325|NCT00842764|eyelid fat pads|eyelid fat pads
5195326|NCT00842751|5α-reductase|5α-reductase
5195327|NCT00842751|androgen|androgen
5195328|NCT00842751|dihydrotestosterone (DHT)|dihydrotestosterone (dht)
5195329|NCT00842751|drug delivery|drug delivery
5195330|NCT00842751|oestradiol|oestradiol
5195331|NCT00842738|Screening|screening
5195333|NCT00842738|Cervical dysplasia|cervical dysplasia
5195334|NCT00842738|Adverse psychosocial effects|adverse psychosocial effects
5195335|NCT00842738|Alternative treatment|alternative treatment
5195336|NCT00842712|First-line treatment for subjects with advanced NSCLC,|first-line treatment for subjects with advanced nsclc,
5195337|NCT00842712|integrin receptor antagonist, EGFR chimerized monoclonal antibody, chemotherapy|integrin receptor antagonist, egfr chimerized monoclonal antibody, chemotherapy
5195338|NCT00842712|safety run-in + randomization part, MTD, PFS, Overall survival time, best overall response|safety run-in + randomization part, mtd, pfs, overall survival time, best overall response
5195339|NCT00842686|rectal cancer|rectal cancer
5195340|NCT00842686|capecitabine|capecitabine
5195341|NCT00842686|bevacizumab|bevacizumab
5195342|NCT00842686|radiotherapy|radiotherapy
5195343|NCT00842673|Dementia|dementia
5195344|NCT00842673|Alzheimer Type Senile Dementia|alzheimer type senile dementia
5195345|NCT00842673|Cognitive impairment|cognitive impairment
5195346|NCT00842660|Cervical cancer|cervical cancer
5195347|NCT00842660|concurrent chemoradiotherapy|concurrent chemoradiotherapy
5195348|NCT00842660|gemcitabine|gemcitabine
5195349|NCT00842647|Sensitivity|sensitivity
5195350|NCT00842647|specificity|specificity
5195351|NCT00842647|positive rate|positive rate
5195352|NCT00842647|negative rate|negative rate
5195353|NCT00842634|HIV|hiv
5195354|NCT00842634|Treatment Experienced|treatment experienced
5195355|NCT00842621|Sickle Cell Disease, Hemolytic Anemia|sickle cell disease, hemolytic anemia
5195356|NCT00842621|Hemolysis|hemolysis
5195357|NCT00842608|confusion|confusion
5195358|NCT00842608|dementia|dementia
5195359|NCT00842595|relapsed aggressive B-cell lymphoma|relapsed aggressive b-cell lymphoma
5195360|NCT00842595|Chemotherapy|chemotherapy
5195361|NCT00842582|Ovarian cancer|ovarian cancer
5195362|NCT00842582|chemotherapy|chemotherapy
5195363|NCT00842582|azacitidine|azacitidine
5195364|NCT00842569|obesity|obesity
5195365|NCT00842569|cognitive process|cognitive process
5195366|NCT00842569|reward|reward
5195367|NCT00842569|P300|p300
5195368|NCT00842569|ERP|erp
5195369|NCT00842569|Event-related potential during oddball paradigm|event-related potential during oddball paradigm
5195370|NCT00842569|brain electrophysiological patterns|brain electrophysiological patterns
5195371|NCT00842569|externalizing factor|externalizing factor
5195372|NCT00842543|Nutrition|nutrition
5195373|NCT00842543|Oxidative Stress|oxidative stress
5195374|NCT00842543|Insulin Resistance|insulin resistance
5195375|NCT00842543|Whole Food Supplement|whole food supplement
5195376|NCT00842543|Pediatric|pediatric
5195377|NCT00842543|Retinoids|retinoids
5195378|NCT00842543|Antioxidants|antioxidants
5195379|NCT00842543|Dietary Supplements|dietary supplements
5195380|NCT00842530|Dengue virus|dengue virus
5195381|NCT00842530|Dengue fever|dengue fever
5195382|NCT00842530|Dengue hemorrhagic fever|dengue hemorrhagic fever
5195383|NCT00842530|Dengue diseases|dengue diseases
5195384|NCT00842530|Dengue vaccine|dengue vaccine
5195385|NCT00842517|Cocaine Dependence|cocaine dependence
5195386|NCT00842517|Cocaine Abuse|cocaine abuse
5195387|NCT00842517|Substance Abuse|substance abuse
5195388|NCT00842517|Contingency Management|contingency management
5195389|NCT00842517|Drug Treatment|drug treatment
5195390|NCT00842504|Anti-fungal|anti-fungal
5195391|NCT00842504|Immunocompromised|immunocompromised
5195392|NCT00842504|Pharmacokinetic|pharmacokinetic
5195393|NCT00842504|Prophylaxis|prophylaxis
5195394|NCT00842504|Pharmacokinetics|pharmacokinetics
5195395|NCT00842465|Breast diseases,|breast diseases,
5195396|NCT00842465|human mutation,|human mutation,
5195397|NCT00842465|prolactin receptor;|prolactin receptor;
5195398|NCT00842465|breast cancer|breast cancer
5195399|NCT00842452|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5195400|NCT00842452|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5195401|NCT00842452|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5195402|NCT00842452|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
5195403|NCT00842452|stage III ovarian germ cell tumor|stage iii ovarian germ cell tumor
5195404|NCT00842452|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
5195405|NCT00842452|recurrent endometrial carcinoma|recurrent endometrial carcinoma
5195406|NCT00842452|stage III endometrial carcinoma|stage iii endometrial carcinoma
5195407|NCT00842452|stage IV endometrial carcinoma|stage iv endometrial carcinoma
5195408|NCT00842452|recurrent uterine sarcoma|recurrent uterine sarcoma
5195409|NCT00842452|stage III uterine sarcoma|stage iii uterine sarcoma
5195410|NCT00842452|stage IV uterine sarcoma|stage iv uterine sarcoma
5195411|NCT00842452|recurrent vaginal cancer|recurrent vaginal cancer
5195412|NCT00842452|stage III vaginal cancer|stage iii vaginal cancer
5195413|NCT00842452|stage IVA vaginal cancer|stage iva vaginal cancer
5195414|NCT00842452|stage IVB vaginal cancer|stage ivb vaginal cancer
5195415|NCT00842452|recurrent vulvar cancer|recurrent vulvar cancer
5195416|NCT00842452|stage III vulvar cancer|stage iii vulvar cancer
5195417|NCT00842452|stage IV vulvar cancer|stage iv vulvar cancer
5195418|NCT00842452|recurrent cervical cancer|recurrent cervical cancer
5195419|NCT00842452|stage III cervical cancer|stage iii cervical cancer
5195420|NCT00842452|stage IVA cervical cancer|stage iva cervical cancer
5195421|NCT00842452|stage IVB cervical cancer|stage ivb cervical cancer
5195422|NCT00842452|fallopian tube cancer|fallopian tube cancer
5195423|NCT00842452|ovarian sarcoma|ovarian sarcoma
5195424|NCT00842452|ovarian stromal cancer|ovarian stromal cancer
5195425|NCT00842439|aggression|aggression
5195426|NCT00842439|Prevention and treatment of youth aggression|prevention and treatment of youth aggression
5195427|NCT00842426|Diabetes|diabetes
5195428|NCT00842426|Cardiovascular disease|cardiovascular disease
5195429|NCT00842426|Metabolic syndrome|metabolic syndrome
5195430|NCT00842426|Cardiometabolic|cardiometabolic
5195431|NCT00842413|Prefrontal cortex|prefrontal cortex
5195432|NCT00842413|visual consciousness|visual consciousness
5195433|NCT00842413|focal lesions|focal lesions
5195434|NCT00842413|action perception|action perception
5195435|NCT00842400|Obesity|obesity
5195436|NCT00842387|gastroesophageal reflux disease|gastroesophageal reflux disease
5195437|NCT00842387|reflux, heartburn|reflux, heartburn
5195438|NCT00842387|regurgitation|regurgitation
5195439|NCT00842387|acid control|acid control
5195440|NCT00842387|PPI|ppi
5195441|NCT00842387|antiacid|antiacid
5195442|NCT00842387|primary care|primary care
5195443|NCT00842387|esophagitis|esophagitis
5195444|NCT00842348|Lanreotide|lanreotide
5195445|NCT00842348|Somatuline|somatuline
5195446|NCT00842348|Neuroendocrine tumour|neuroendocrine tumour
5195447|NCT00842348|NET|net
5195448|NCT00842335|solid tumors|solid tumors
5195449|NCT00842335|angiogenesis inhibitor|angiogenesis inhibitor
5195450|NCT00842335|dose escalation|dose escalation
5195451|NCT00842335|maximum tolerated dose|maximum tolerated dose
5195452|NCT00842335|JI-101|ji-101
5195453|NCT00842322|chronic kidney disease|chronic kidney disease
5195454|NCT00842322|transplantation|transplantation
5195455|NCT00842322|kidney function|kidney function
5195456|NCT00842322|fluid intake|fluid intake
5195457|NCT00842322|osmolarity|osmolarity
5195458|NCT00842296|GSV|gsv
5195459|NCT00842296|RadioFrequency|radiofrequency
5195460|NCT00842283|dermatologic diseases|dermatologic diseases
5195461|NCT00842270|severe asthma|severe asthma
5195462|NCT00842270|corticosteroids dependent|corticosteroids dependent
5195463|NCT00842270|asthma exacerbation|asthma exacerbation
5195464|NCT00842270|weaning|weaning
5195465|NCT00842270|tyrosine kinase inhibitor|tyrosine kinase inhibitor
5195466|NCT00842270|severe persistent corticosteroid dependent asthma|severe persistent corticosteroid dependent asthma
5195467|NCT00842257|panitumumab|panitumumab
5195468|NCT00842257|cetuximab|cetuximab
5195469|NCT00842257|KRAS wild-type|kras wild-type
5195470|NCT00842231|Corneal astigmatism|corneal astigmatism
5195471|NCT00842231|post-cataract surgery|post-cataract surgery
5195472|NCT00842231|visual performance|visual performance
5195473|NCT00842231|Corneal astigmatism 0.5-0.75 Diopter|corneal astigmatism 0.5-0.75 diopter
5195474|NCT00842218|Gait|gait
5195475|NCT00842218|scoliosis|scoliosis
5195476|NCT00842218|energy|energy
5195477|NCT00842218|mechanics|mechanics
5195478|NCT00842205|hepatitis C|hepatitis c
5195479|NCT00842205|NASH|nash
5195480|NCT00842205|Hem Oxygenase|hem oxygenase
5195481|NCT00842205|Gene polymorphism|gene polymorphism
5195482|NCT00842179|Perclose|perclose
5195483|NCT00842153|Psoriasis|psoriasis
5195484|NCT00842153|Plaque Type Psoriasis|plaque type psoriasis
5195485|NCT00842140|Polycystic ovary syndrome|polycystic ovary syndrome
5195486|NCT00842140|Oral Contraceptives, Hormonal|oral contraceptives, hormonal
5195487|NCT00842140|Cardiovascular Disease|cardiovascular disease
5195488|NCT00842140|Endothelium|endothelium
5195489|NCT00842127|Methylphenidate|methylphenidate
5195490|NCT00842127|ADHD|adhd
5195491|NCT00842127|Multidrug resistance(MDR)polymorphism|multidrug resistance(mdr)polymorphism
5195492|NCT00842127|OROS methylphenidate|oros methylphenidate
5195493|NCT00842114|Intermediate-high FLIPI score|intermediate-high flipi score
5195494|NCT00842114|Follicular Lymphoma|follicular lymphoma
5195495|NCT00842114|Progression free survival|progression free survival
5195496|NCT00842101|Intramedullary nails|intramedullary nails
5195497|NCT00842101|Compartmental syndrome|compartmental syndrome
5195498|NCT00842101|Fractures|fractures
5195499|NCT00842075|type 1 diabetes|type 1 diabetes
5195500|NCT00842075|adolescents|adolescents
5195501|NCT00842075|post prandial glucose|post prandial glucose
5195502|NCT00842049|Subarachnoid haemorrhage|subarachnoid haemorrhage
5195503|NCT00842049|Aneurysm|aneurysm
5195504|NCT00842049|Cerebrospinal fluid drainage|cerebrospinal fluid drainage
5195505|NCT00842036|Family Therapy|family therapy
5195506|NCT00842036|Relationship Dysfunction|relationship dysfunction
5195507|NCT00842036|Family Dysfunction|family dysfunction
5195508|NCT00842036|Family Relations|family relations
5195509|NCT00842036|Stimulant Dependence|stimulant dependence
5195510|NCT00842036|Opiate Dependence|opiate dependence
5195511|NCT00842036|Alcohol Dependence|alcohol dependence
5195512|NCT00842036|Behavior Therapy|behavior therapy
5195513|NCT00842036|Drug Treatment|drug treatment
5195514|NCT00842036|Substance Abuse|substance abuse
5195515|NCT00842036|Drug Addiction|drug addiction
5195516|NCT00842023|Natriuretic peptides|natriuretic peptides
5195517|NCT00842023|BNP|bnp
5195518|NCT00842023|Heart Failure|heart failure
5195519|NCT00842023|Nitoglycerin|nitoglycerin
5195520|NCT00842023|Biomarkers|biomarkers
5195521|NCT00842010|Diabetes|diabetes
5195522|NCT00842010|Inpatient|inpatient
5195524|NCT00842010|Hyperglycemia|hyperglycemia
5195525|NCT00841984|Magnetic resonance spectroscopy|magnetic resonance spectroscopy
5195526|NCT00841984|neurological diseases|neurological diseases
5195527|NCT00841984|metabolic|metabolic
5195528|NCT00841984|inborn errors of metabolism|inborn errors of metabolism
5195529|NCT00841984|Complex neurological diseases of unknown cause|complex neurological diseases of unknown cause
5195530|NCT00841945|Diffuse B larg cell lymphoma|diffuse b larg cell lymphoma
5195531|NCT00841945|Chemotherapy|chemotherapy
5195532|NCT00841945|Radiotherapy|radiotherapy
5195533|NCT00841932|Fractional Flow Reserve|fractional flow reserve
5195534|NCT00841932|Without anticoagulation|without anticoagulation
5195535|NCT00841919|Diabetes|diabetes
5195536|NCT00841919|Inpatient|inpatient
5195537|NCT00841919|Insulin|insulin
5195538|NCT00841919|Insulin pen|insulin pen
5195539|NCT00841893|Thermogenesis|thermogenesis
5195540|NCT00841893|Meal-induced thermogenesis|meal-induced thermogenesis
5195541|NCT00841893|Energy expenditure|energy expenditure
5195542|NCT00841893|Fat oxidation|fat oxidation
5195543|NCT00841893|Carbohydrate oxidation|carbohydrate oxidation
5195544|NCT00841893|Bioactive ingredient|bioactive ingredient
5195545|NCT00841893|Spice|spice
5195546|NCT00841867|Impaired Glucose Tolerance|impaired glucose tolerance
5195547|NCT00841867|Diabetes|diabetes
5195548|NCT00841854|Helicobacter pylori|helicobacter pylori
5195549|NCT00841854|Bismuth|bismuth
5195550|NCT00841854|Salvage treatment|salvage treatment
5195551|NCT00841854|Metronidazole|metronidazole
5195552|NCT00841841|Analgesia|analgesia
5195553|NCT00841841|molar third|molar third
5195554|NCT00841841|acetaminophen|acetaminophen
5195555|NCT00841841|dipyrone|dipyrone
5195556|NCT00841815|Bioequivalence|bioequivalence
5195557|NCT00841815|Healthy Subjects|healthy subjects
5195558|NCT00841802|Chronic sinusitis|chronic sinusitis
5195559|NCT00841802|Chronic rhinosinusitis|chronic rhinosinusitis
5195560|NCT00841802|Nasal polyps|nasal polyps
5195561|NCT00841789|Etanercept|etanercept
5195562|NCT00841776|Acne Vulgaris|acne vulgaris
5195563|NCT00841776|Acne|acne
5195564|NCT00841763|virus|virus
5195565|NCT00841763|pandemic influenza|pandemic influenza
5195566|NCT00841763|vaccine|vaccine
5195567|NCT00841750|Chest Tubes|chest tubes
5195568|NCT00841750|Thoracic Surgery, Video-Assisted|thoracic surgery, video-assisted
5195569|NCT00841750|Lung Diseases, Interstitial|lung diseases, interstitial
5195570|NCT00841750|Pulmonary Nodule, Solitary|pulmonary nodule, solitary
5195571|NCT00841737|Depressive Disorders;|depressive disorders;
5195572|NCT00841737|Primary Health Care;|primary health care;
5195573|NCT00841737|Nurses;|nurses;
5195574|NCT00841737|Health education.|health education.
5195575|NCT00841724|Allogeneic stem cell transplantation|allogeneic stem cell transplantation
5195576|NCT00841724|Reduced-intensity conditioning|reduced-intensity conditioning
5195577|NCT00841724|Reduced-toxicity conditioning|reduced-toxicity conditioning
5195578|NCT00841724|Hematological malignancies|hematological malignancies
5195579|NCT00841724|IV Busulfan|iv busulfan
5195580|NCT00841711|HIV|hiv
5195581|NCT00841711|AIDS|aids
5195582|NCT00841711|Buprenorphine|buprenorphine
5195583|NCT00841711|Intensive Case Management|intensive case management
5195584|NCT00841711|Money Management|money management
5195585|NCT00841711|Rapid Testing|rapid testing
5195586|NCT00841711|Substance Abuse|substance abuse
5195587|NCT00841711|Opioid Dependance|opioid dependance
5195588|NCT00841711|Inmate Population|inmate population
5195589|NCT00841698|Bioequivalence|bioequivalence
5195590|NCT00841698|Healthy Subjects|healthy subjects
5195591|NCT00841672|Hypertension|hypertension
5195592|NCT00841672|systolic blood pressure|systolic blood pressure
5195593|NCT00841672|cardiovascular disease|cardiovascular disease
5195594|NCT00841672|aliskiren|aliskiren
5195595|NCT00841672|amlodipine|amlodipine
5195596|NCT00841659|Bioequivalence|bioequivalence
5195597|NCT00841659|Healthy Subjects|healthy subjects
5195598|NCT00841646|Influenza vaccine|influenza vaccine
5195599|NCT00841633|subarachnoid hemorrhage|subarachnoid hemorrhage
5195600|NCT00841633|ischemia|ischemia
5195601|NCT00841633|vasospasm|vasospasm
5195602|NCT00841633|CT|ct
5195603|NCT00841633|perfusion|perfusion
5195604|NCT00841633|induced hypertension|induced hypertension
5195605|NCT00841633|delayed cerebral ischemia|delayed cerebral ischemia
5195606|NCT00841620|Symptoms|symptoms
5195607|NCT00841620|Postoperative pain|postoperative pain
5195608|NCT00841620|Postoperative complications|postoperative complications
5195609|NCT00841620|Milligan|milligan
5195610|NCT00841620|Anopxy|anopxy
5195611|NCT00841607|whipple|whipple
5195612|NCT00841607|pancreas|pancreas
5195613|NCT00841607|reconstruction|reconstruction
5195614|NCT00841607|leak|leak
5195615|NCT00841607|fistula|fistula
5195616|NCT00841594|healthy volunteers|healthy volunteers
5195617|NCT00841581|Age Related Macular Degeneration|age related macular degeneration
5195618|NCT00841581|Pigment Epithelial Detachment|pigment epithelial detachment
5195619|NCT00841581|Intravitreal Detachment|intravitreal detachment
5195620|NCT00841581|Anti-VEGF|anti-vegf
5195621|NCT00841568|ADPKD|adpkd
5195622|NCT00841568|Tolvaptan|tolvaptan
5195623|NCT00841555|adult giant cell glioblastoma|adult giant cell glioblastoma
5195624|NCT00841555|adult gliosarcoma|adult gliosarcoma
5195625|NCT00841555|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5195626|NCT00841555|adult glioblastoma|adult glioblastoma
5195627|NCT00841555|GBM/AA|gbm/aa
5195628|NCT00841542|Bioequivalence|bioequivalence
5195629|NCT00841542|Healthy Subjects|healthy subjects
5195630|NCT00841529|left atrial appendage|left atrial appendage
5195631|NCT00841529|LAA|laa
5195632|NCT00841529|atrial fibrillation|atrial fibrillation
5195633|NCT00841529|AF|af
5195634|NCT00841516|Specific immunotherapy|specific immunotherapy
5195635|NCT00841516|SIT|sit
5195636|NCT00841516|SCIT|scit
5195637|NCT00841516|recombinant|recombinant
5195638|NCT00841516|Type 1 - Allergy|type 1 - allergy
5195639|NCT00841503|functional food study|functional food study
5195640|NCT00841490|Helicobacter pylori|helicobacter pylori
5195641|NCT00841490|Oral Health|oral health
5195642|NCT00841490|Intellectually & Developmentally Disabled|intellectually & developmentally disabled
5195643|NCT00841477|druguser,HB vaccine adherence, HBV, HCV, HIV incidence|druguser,hb vaccine adherence, hbv, hcv, hiv incidence
5195644|NCT00841464|Parkinson's disease|parkinson's disease
5195645|NCT00841464|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
5195646|NCT00841451|Atrial Fibrillation|atrial fibrillation
5195647|NCT00841451|Persistent|persistent
5195648|NCT00841451|Paroxysmal|paroxysmal
5195649|NCT00841451|Pulmonary Vein isolation|pulmonary vein isolation
5195650|NCT00841451|Omega three fatty acids|omega three fatty acids
5195651|NCT00841451|Fish Oils|fish oils
5195652|NCT00841438|Angioplasty|angioplasty
5195653|NCT00841438|Transluminal|transluminal
5195654|NCT00841438|Percutaneous Coronary|percutaneous coronary
5195655|NCT00841412|Usual Care Control Group|usual care control group
5195656|NCT00841399|Breast cancer|breast cancer
5195657|NCT00841386|Cornea|cornea
5195658|NCT00841386|Keratoconus|keratoconus
5195659|NCT00841386|Ectasia|ectasia
5195660|NCT00841386|Riboflavin|riboflavin
5195661|NCT00841386|Collagen cross-linking|collagen cross-linking
5195662|NCT00841373|Retinal ischemia: Iris/Angle Neovascularization|retinal ischemia: iris/angle neovascularization
5195663|NCT00841360|Social network|social network
5195664|NCT00841360|Asymptomatic HIV|asymptomatic hiv
5195665|NCT00841347|Obesity|obesity
5195666|NCT00841347|Glucose metabolism disorders|glucose metabolism disorders
5195667|NCT00841347|Appetite regulation|appetite regulation
5195668|NCT00841347|Sleep|sleep
5195669|NCT00841347|Adolescent|adolescent
5195670|NCT00841347|Randomized controlled trials|randomized controlled trials
5195671|NCT00841334|Adolescent|adolescent
5195672|NCT00841334|Overweight|overweight
5195673|NCT00841334|Obesity|obesity
5195674|NCT00841334|Weight loss|weight loss
5195675|NCT00841334|Nutrition|nutrition
5195676|NCT00841334|Physical activity|physical activity
5195677|NCT00841334|Community-based participatory research|community-based participatory research
5195678|NCT00841334|School-based|school-based
5195679|NCT00841334|Primary Care|primary care
5195680|NCT00841334|Motivational interviewing|motivational interviewing
5195681|NCT00841321|Ginkgo biloba|ginkgo biloba
5195682|NCT00841321|Multiple Sclerosis|multiple sclerosis
5195683|NCT00841321|Cognition|cognition
5195684|NCT00841321|Neuropsychological Tests|neuropsychological tests
5195685|NCT00841321|Neurobehavioral Manifestations|neurobehavioral manifestations
5195686|NCT00841321|Quality of life|quality of life
5195687|NCT00841321|Randomized Controlled Trials|randomized controlled trials
5195688|NCT00841321|Placebos|placebos
5195689|NCT00841321|Double-Blind Method|double-blind method
5195690|NCT00841282|Colorectal cancer screening|colorectal cancer screening
5195691|NCT00841282|Optical colonoscopy|optical colonoscopy
5195692|NCT00841282|Water method|water method
5195693|NCT00841282|Sedation|sedation
5195694|NCT00841269|Bipolar Manic Depression|bipolar manic depression
5195695|NCT00841256|specific immunotherapy|specific immunotherapy
5195696|NCT00841256|SIT|sit
5195697|NCT00841256|SLIT|slit
5195698|NCT00841256|sublingual|sublingual
5195699|NCT00841243|Hepatitis C|hepatitis c
5195700|NCT00841243|Antiviral therapy|antiviral therapy
5195701|NCT00841243|weight loss|weight loss
5195702|NCT00841243|dietary support|dietary support
5195703|NCT00841243|dietary advise|dietary advise
5195704|NCT00841230|Tinnitus|tinnitus
5195705|NCT00841217|Drug treatment|drug treatment
5195706|NCT00841191|Resistant to anti-EGFR|resistant to anti-egfr
5195707|NCT00841191|Interleukin-6|interleukin-6
5195708|NCT00841191|Neoplasms by Histologic Type|neoplasms by histologic type
5195709|NCT00841191|Immunologic Factors|immunologic factors
5195710|NCT00841191|Mol Physiological Effects of Drugs|mol physiological effects of drugs
5195711|NCT00841191|KRAS protein, human|kras protein, human
5195712|NCT00841191|CNTO 328|cnto 328
5195713|NCT00841178|Randomised controlled trial|randomised controlled trial
5195714|NCT00841178|Venous insufficiency|venous insufficiency
5195715|NCT00841178|Varicose veins|varicose veins
5195716|NCT00841178|Quality of Life|quality of life
5195717|NCT00841178|Clinical effectiveness|clinical effectiveness
5195718|NCT00841178|Cost effectiveness|cost effectiveness
5195719|NCT00841165|Carbon Monoxide Toxicity|carbon monoxide toxicity
5195720|NCT00841165|Carbon|carbon
5195721|NCT00841165|Monoxide|monoxide
5195722|NCT00841165|Poisoning|poisoning
5195723|NCT00841165|Toxicity|toxicity
5195724|NCT00841165|Treatment|treatment
5195725|NCT00841165|CPAP|cpap
5195726|NCT00841165|Hyperbaric|hyperbaric
5195727|NCT00841165|Oxygen|oxygen
5195728|NCT00841152|Bone tumors|bone tumors
5195729|NCT00841152|Surgery|surgery
5195730|NCT00841152|Bone graft substitutes|bone graft substitutes
5195731|NCT00841152|Bioactive glass|bioactive glass
5195732|NCT00841152|Bioceramics|bioceramics
5195733|NCT00841152|Bone autograft|bone autograft
5195734|NCT00841152|Bone allograft|bone allograft
5195735|NCT00841139|perhexiline|perhexiline
5195736|NCT00841139|idiopathic dilated cardiomyopathy|idiopathic dilated cardiomyopathy
5195737|NCT00841139|magnetic resonance spectroscopy|magnetic resonance spectroscopy
5195738|NCT00841139|cardiac energetics|cardiac energetics
5195739|NCT00841126|Hyperphosphatemia|hyperphosphatemia
5195740|NCT00841126|Phosphate binder|phosphate binder
5195741|NCT00841113|Prostate cancer|prostate cancer
5195742|NCT00841113|Advanced|advanced
5195743|NCT00841113|Metastatic|metastatic
5195744|NCT00841100|PKU|pku
5195745|NCT00841100|Kuvan|kuvan
5195746|NCT00841100|BH4|bh4
5195747|NCT00841100|tetrahydrobiopterin|tetrahydrobiopterin
5195748|NCT00841074|Pneumonia|pneumonia
5195749|NCT00841074|Elderly|elderly
5195750|NCT00841074|Chlorhexidine|chlorhexidine
5195751|NCT00841074|Respiratory pathogens|respiratory pathogens
5195752|NCT00841048|Safety and tolerability|safety and tolerability
5195753|NCT00841035|Pancreatic|pancreatic
5195754|NCT00841035|Cancer|cancer
5195755|NCT00841035|Assay|assay
5195756|NCT00841035|Biomarkers|biomarkers
5195757|NCT00841022|anxiety|anxiety
5195758|NCT00841022|anaesthesia|anaesthesia
5195759|NCT00841022|child|child
5195760|NCT00841022|RCT|rct
5195761|NCT00841022|Elective surgery|elective surgery
5195762|NCT00841009|gastric bypass|gastric bypass
5195763|NCT00841009|obesity|obesity
5195764|NCT00840996|Spine Surgery|spine surgery
5195765|NCT00840996|Intraocular pressure|intraocular pressure
5195766|NCT00840996|Lidocaine|lidocaine
5195767|NCT00840996|Epidural Anesthetic|epidural anesthetic
5195768|NCT00840983|delayed cord clamping|delayed cord clamping
5195769|NCT00840983|very low birthweight infant|very low birthweight infant
5195770|NCT00840983|bronchopulmonary dysplasia|bronchopulmonary dysplasia
5195771|NCT00840983|intraventricular hemorrhage|intraventricular hemorrhage
5195772|NCT00840983|motor function|motor function
5195773|NCT00840944|gonadotropin releasing hormone agonist|gonadotropin releasing hormone agonist
5195774|NCT00840944|growth hormone|growth hormone
5195775|NCT00840944|final height|final height
5195776|NCT00840944|bone density|bone density
5195777|NCT00840944|puberty|puberty
5195778|NCT00840931|Myeloid|myeloid
5195779|NCT00840931|Monocytic|monocytic
5195780|NCT00840931|Immunotherapy|immunotherapy
5195781|NCT00840931|Vaccine|vaccine
5195782|NCT00840931|MDS|mds
5195783|NCT00840931|High Risk Myelodysplastic Syndrome|high risk myelodysplastic syndrome
5195784|NCT00840918|Cardiac surgery|cardiac surgery
5195785|NCT00840918|Lidocaine|lidocaine
5195786|NCT00840918|Quality of life|quality of life
5195787|NCT00840905|HPV|hpv
5195788|NCT00840879|Bioequivalence|bioequivalence
5195789|NCT00840879|Healthy Subjects|healthy subjects
5195790|NCT00840866|Bioequivalence|bioequivalence
5195791|NCT00840866|Healthy Subjects|healthy subjects
5195792|NCT00840853|Stem cell transplant|stem cell transplant
5195793|NCT00840853|Acute Lymphoblastic Leukemia (ALL)|acute lymphoblastic leukemia (all)
5195794|NCT00840853|Chronic Lymphocytic Leukemia (CLL)|chronic lymphocytic leukemia (cll)
5195795|NCT00840853|Non Hodgkin's Lymphoma|non hodgkin's lymphoma
5195796|NCT00840853|Cytotoxic T lymphocytes|cytotoxic t lymphocytes
5195797|NCT00840853|CTL|ctl
5195798|NCT00840853|CD-19|cd-19
5195799|NCT00840853|chimeric receptor|chimeric receptor
5195800|NCT00840840|Bioequivalence|bioequivalence
5195801|NCT00840840|Healthy Subjects|healthy subjects
5195802|NCT00840827|stage (IPSS low and INT-1)|stage (ipss low and int-1)
5195803|NCT00840827|RBC transfusion-dependent|rbc transfusion-dependent
5195804|NCT00840827|non-del 5q MDS|non-del 5q mds
5195805|NCT00840814|lymphedema|lymphedema
5195806|NCT00840814|stage I squamous cell carcinoma of the hypopharynx|stage i squamous cell carcinoma of the hypopharynx
5195807|NCT00840814|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
5195808|NCT00840814|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
5195809|NCT00840814|stage I squamous cell carcinoma of the larynx|stage i squamous cell carcinoma of the larynx
5195810|NCT00840814|stage I verrucous carcinoma of the larynx|stage i verrucous carcinoma of the larynx
5195811|NCT00840814|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
5195812|NCT00840814|stage II verrucous carcinoma of the larynx|stage ii verrucous carcinoma of the larynx
5195813|NCT00840814|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
5195814|NCT00840814|stage III verrucous carcinoma of the larynx|stage iii verrucous carcinoma of the larynx
5195815|NCT00840814|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
5195816|NCT00840814|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
5195817|NCT00840814|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
5195818|NCT00840814|stage I verrucous carcinoma of the oral cavity|stage i verrucous carcinoma of the oral cavity
5195819|NCT00840814|stage II verrucous carcinoma of the oral cavity|stage ii verrucous carcinoma of the oral cavity
5195820|NCT00840814|stage III verrucous carcinoma of the oral cavity|stage iii verrucous carcinoma of the oral cavity
5195821|NCT00840814|stage I squamous cell carcinoma of the nasopharynx|stage i squamous cell carcinoma of the nasopharynx
5195822|NCT00840814|stage II squamous cell carcinoma of the nasopharynx|stage ii squamous cell carcinoma of the nasopharynx
5195823|NCT00840814|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
5195824|NCT00840814|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
5195825|NCT00840814|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
5195826|NCT00840814|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
5195827|NCT00840814|stage I squamous cell carcinoma of the paranasal sinus and nasal cavity|stage i squamous cell carcinoma of the paranasal sinus and nasal cavity
5195828|NCT00840814|stage II squamous cell carcinoma of the paranasal sinus and nasal cavity|stage ii squamous cell carcinoma of the paranasal sinus and nasal cavity
5195829|NCT00840814|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
5195830|NCT00840814|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
5195831|NCT00840814|stage I salivary gland cancer|stage i salivary gland cancer
5195832|NCT00840814|stage II salivary gland cancer|stage ii salivary gland cancer
5195833|NCT00840814|stage III salivary gland cancer|stage iii salivary gland cancer
5195834|NCT00840788|skin adhesive|skin adhesive
5195835|NCT00840788|tissue adhesive|tissue adhesive
5195836|NCT00840788|mediolateral episiotomy|mediolateral episiotomy
5195837|NCT00840788|perineal repair|perineal repair
5195838|NCT00840788|labor and delivery|labor and delivery
5195839|NCT00840788|repair|repair
5195840|NCT00840775|Stent|stent
5195841|NCT00840775|interventional cardiology|interventional cardiology
5195842|NCT00840775|catheterization|catheterization
5195843|NCT00840775|symptomatic ischemic heart disease|symptomatic ischemic heart disease
5195844|NCT00840762|HIV-1|hiv-1
5195845|NCT00840762|HIV|hiv
5195846|NCT00840762|HIV Genotypic testing|hiv genotypic testing
5195847|NCT00840762|resistance|resistance
5195848|NCT00840749|STARS|stars
5195849|NCT00840749|Early Stage Non Small Cell Lung Cancer|early stage non small cell lung cancer
5195850|NCT00840749|NSCLC|nsclc
5195851|NCT00840749|CyberKnife|cyberknife
5195852|NCT00840749|Surgery|surgery
5195853|NCT00840749|Accuray|accuray
5195854|NCT00840736|VBG|vbg
5195855|NCT00840736|LAGB|lagb
5195856|NCT00840736|long term results|long term results
5195857|NCT00840736|Weight loss|weight loss
5195858|NCT00840736|Complications|complications
5195859|NCT00840736|Reoperations|reoperations
5195860|NCT00840736|Conversion|conversion
5195861|NCT00840723|Healthy smokers|healthy smokers
5195862|NCT00840723|Current cigarette smokers|current cigarette smokers
5195863|NCT00840723|No lung disease|no lung disease
5195864|NCT00840710|women in active labor|women in active labor
5195865|NCT00840697|low back pain|low back pain
5195866|NCT00840697|neck pain|neck pain
5195867|NCT00840697|return to work|return to work
5195868|NCT00840697|exercises|exercises
5195869|NCT00840697|cognitive intervention|cognitive intervention
5195870|NCT00840684|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5195871|NCT00840684|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
5195872|NCT00840671|Cerebrolysin|cerebrolysin
5195873|NCT00840671|Alteplase|alteplase
5195874|NCT00840671|Ischemic Stroke|ischemic stroke
5195875|NCT00840671|Modified Rankin Scale|modified rankin scale
5195876|NCT00840671|NIH Stroke Scale|nih stroke scale
5195877|NCT00840671|Barthel Index|barthel index
5195878|NCT00840671|Glasgow Outcome Score|glasgow outcome score
5195879|NCT00840658|HIV|hiv
5195880|NCT00840658|Injection drug users|injection drug users
5195881|NCT00840658|Female sex workers|female sex workers
5195882|NCT00840658|STIs|stis
5195883|NCT00840658|HIV Seronegativity|hiv seronegativity
5195884|NCT00840645|YM178|ym178
5195885|NCT00840645|Urinary Bladder, Overactive|urinary bladder, overactive
5195886|NCT00840645|Mirabegron|mirabegron
5195887|NCT00840632|Bioequivalence|bioequivalence
5195888|NCT00840632|Healthy Subjects|healthy subjects
5195889|NCT00840606|Bioequivalence|bioequivalence
5195890|NCT00840606|Healthy Subjects|healthy subjects
5195891|NCT00840593|Acromioclavicular Joint|acromioclavicular joint
5195892|NCT00840593|Dislocation|dislocation
5195893|NCT00840593|Trials, Randomized Clinical|trials, randomized clinical
5195894|NCT00840593|Surgical Procedures, Operative|surgical procedures, operative
5195895|NCT00840580|Cataract, Cornea, Vigamox, Cravit|cataract, cornea, vigamox, cravit
5195896|NCT00840567|Stem cells|stem cells
5195897|NCT00840554|Fatigue|fatigue
5195898|NCT00840554|Cancer-related fatigue|cancer-related fatigue
5195899|NCT00840554|High grade glioma|high grade glioma
5195900|NCT00840554|Quality of life|quality of life
5195901|NCT00840554|Exercise|exercise
5195902|NCT00840554|Physical Therapy|physical therapy
5195903|NCT00840554|HGG|hgg
5195904|NCT00840554|QOL|qol
5195905|NCT00840528|ozone|ozone
5195906|NCT00840502|malaria|malaria
5195907|NCT00840502|ultrasound|ultrasound
5195908|NCT00840502|pregnancy|pregnancy
5195909|NCT00840502|Pregnant women (infected with malaria and without)|pregnant women (infected with malaria and without)
5195910|NCT00840476|Bioequivalence|bioequivalence
5195911|NCT00840476|Healthy Subjects|healthy subjects
5195912|NCT00840463|Pulmonary Hypertension|pulmonary hypertension
5195913|NCT00840463|Diastolic Heart Failure|diastolic heart failure
5195914|NCT00840450|ovarian cancer|ovarian cancer
5195915|NCT00840450|recurrent|recurrent
5195916|NCT00840450|Gleevec|gleevec
5195917|NCT00840450|Paclitaxel|paclitaxel
5195918|NCT00840450|Taxane|taxane
5195919|NCT00840450|mullerian|mullerian
5195920|NCT00840437|angina|angina
5195921|NCT00840437|health related quality of life|health related quality of life
5195922|NCT00840411|Bioequivalence|bioequivalence
5195923|NCT00840411|Healthy Subjects|healthy subjects
5195924|NCT00840398|Bioequivalence|bioequivalence
5195925|NCT00840398|Healthy Subjects|healthy subjects
5195926|NCT00840385|Peripheral T-cell lymphomas (PTCL)|peripheral t-cell lymphomas (ptcl)
5195927|NCT00840385|Fludarabine|fludarabine
5195928|NCT00840372|Blunt needles|blunt needles
5195929|NCT00840372|Semi-blunt needles|semi-blunt needles
5195930|NCT00840372|Buttonhole cannulation method|buttonhole cannulation method
5195931|NCT00840359|Cutaneous leishmaniasis|cutaneous leishmaniasis
5195932|NCT00840359|Photodynamic therapy|photodynamic therapy
5195933|NCT00840346|Acute Myeloblastic Leukaemia (AML)|acute myeloblastic leukaemia (aml)
5195934|NCT00840346|Panobinostat|panobinostat
5195935|NCT00840320|Safety|safety
5195936|NCT00840320|tolerability|tolerability
5195937|NCT00840307|Obesity|obesity
5195938|NCT00840307|Type 2 Diabetes|type 2 diabetes
5195939|NCT00840307|Gastric Banding|gastric banding
5195940|NCT00840294|Men with Elevated PSA|men with elevated psa
5195941|NCT00840281|Bioequivalence|bioequivalence
5195942|NCT00840281|Healthy Subjects|healthy subjects
5195943|NCT00840268|OSDI|osdi
5195944|NCT00840268|corneal staining|corneal staining
5195945|NCT00840268|Dry Eye|dry eye
5195946|NCT00840268|Dry Eye Signs and Symptoms in Dry Eye Patients|dry eye signs and symptoms in dry eye patients
5195947|NCT00840255|Chronic Insomnia lasting more than 1 month|chronic insomnia lasting more than 1 month
5195948|NCT00840229|adhesive capsulitis|adhesive capsulitis
5195949|NCT00840229|corticosteroids|corticosteroids
5195950|NCT00840229|injection|injection
5195951|NCT00840229|pain|pain
5195952|NCT00840216|Bioequivalence|bioequivalence
5195953|NCT00840216|Healthy Subjects|healthy subjects
5195954|NCT00840203|Bioequivalence|bioequivalence
5195955|NCT00840203|Healthy Subjects|healthy subjects
5195956|NCT00840177|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5195957|NCT00840177|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5195958|NCT00840177|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5195959|NCT00840177|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5195960|NCT00840177|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5195961|NCT00840177|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5195962|NCT00840164|small-fiber sensory neuropathy|small-fiber sensory neuropathy
5195963|NCT00840164|nerve pathology|nerve pathology
5195964|NCT00840164|vasculature pathology|vasculature pathology
5195965|NCT00840164|amputation|amputation
5195966|NCT00840164|diabetic foot wound|diabetic foot wound
5195967|NCT00840164|sensory neuropathy|sensory neuropathy
5195968|NCT00840164|below knee amputation|below knee amputation
5195969|NCT00840151|Substance Abuse|substance abuse
5195970|NCT00840151|Contingency Management|contingency management
5195971|NCT00840125|NSCLC|nsclc
5195972|NCT00840125|ERLOTINIB|erlotinib
5195973|NCT00840125|DOCETAXEL|docetaxel
5195974|NCT00840125|first line treatment|first line treatment
5195975|NCT00840125|Stage IIIB /IV|stage iiib /iv
5195976|NCT00840125|not previously treated|not previously treated
5195977|NCT00840125|ECOG PS 2 or age over 65|ecog ps 2 or age over 65
5195978|NCT00840112|Long-chain 3-hydroxyacyl CoA dehydrogenase (LCHAD)|long-chain 3-hydroxyacyl coa dehydrogenase (lchad)
5195979|NCT00840112|Mitochondrial trifunctional protein (TFP)|mitochondrial trifunctional protein (tfp)
5195980|NCT00840112|LCHAD/TFP deficiency with peripheral neuropathy|lchad/tfp deficiency with peripheral neuropathy
5195981|NCT00840099|Bioequivalence|bioequivalence
5195982|NCT00840099|Healthy Subjects|healthy subjects
5195983|NCT00840073|Bioequivalence|bioequivalence
5195984|NCT00840073|Healthy Subjects|healthy subjects
5195985|NCT00840047|Pediatric brain tumor|pediatric brain tumor
5195986|NCT00840047|Pediatric solid tumor|pediatric solid tumor
5195987|NCT00840047|Pediatric solid neoplasms|pediatric solid neoplasms
5195988|NCT00840008|peptic ulcer bleeding|peptic ulcer bleeding
5195989|NCT00840008|upper GI hemorrhage|upper gi hemorrhage
5195990|NCT00840008|adherence to guidelines|adherence to guidelines
5195991|NCT00840008|knowledge transfer|knowledge transfer
5195992|NCT00839995|To determine the efficacy of ROTEM on assessing coagulation profiles.|to determine the efficacy of rotem on assessing coagulation profiles.
5195993|NCT00839969|overactive bladder syndrome|overactive bladder syndrome
5195994|NCT00839969|voiding|voiding
5195995|NCT00839969|pressure flow studies|pressure flow studies
5195996|NCT00839969|urethral dilatation|urethral dilatation
5195997|NCT00839943|ozone|ozone
5195998|NCT00839943|clean air|clean air
5195999|NCT00839930|Bioequivalence|bioequivalence
5196000|NCT00839930|Healthy Subjects|healthy subjects
5196001|NCT00839917|Measles|measles
5196002|NCT00839917|Mumps|mumps
5196003|NCT00839917|Rubella|rubella
5196004|NCT00839917|Varicella|varicella
5196005|NCT00839904|children|children
5196006|NCT00839904|cancer|cancer
5196007|NCT00839904|exercise|exercise
5196008|NCT00839904|fitness|fitness
5196009|NCT00839904|body composition|body composition
5196010|NCT00839891|TQT, QTc|tqt, qtc
5196011|NCT00839865|Evidence-based evaluation|evidence-based evaluation
5196012|NCT00839865|Multi-center randomized controlled clinical trials|multi-center randomized controlled clinical trials
5196013|NCT00839865|Traditional Chinese Medicine|traditional chinese medicine
5196014|NCT00839865|therapy|therapy
5196015|NCT00839865|diabetic foot ulcer|diabetic foot ulcer
5196016|NCT00839865|clinical trails|clinical trails
5196017|NCT00839839|infertility|infertility
5196018|NCT00839839|egg freezing|egg freezing
5196019|NCT00839839|fertility preservation|fertility preservation
5196020|NCT00839826|Prevention of Thromboembolism after total hip replacement|prevention of thromboembolism after total hip replacement
5196021|NCT00839813|Yoga|yoga
5196022|NCT00839813|Posttraumatic Stress Disorder|posttraumatic stress disorder
5196023|NCT00839813|PTSD|ptsd
5196024|NCT00839813|women's health|women's health
5196025|NCT00839800|Asthma|asthma
5196026|NCT00839800|Symbicort Turbuhaler|symbicort turbuhaler
5196027|NCT00839774|Peas|peas
5196028|NCT00839774|Cardiovascular|cardiovascular
5196029|NCT00839774|Diabetes|diabetes
5196030|NCT00839774|Insulin|insulin
5196031|NCT00839774|Insulin resistance|insulin resistance
5196032|NCT00839774|Abdominal fat|abdominal fat
5196033|NCT00839748|asthma|asthma
5196034|NCT00839748|registry for future asthmatic studies|registry for future asthmatic studies
5196035|NCT00839748|questionnaires|questionnaires
5196036|NCT00839748|lung function tests|lung function tests
5196037|NCT00839735|COPD|copd
5196038|NCT00839722|Uterine embolization|uterine embolization
5196039|NCT00839722|leiomyomas|leiomyomas
5196040|NCT00839722|fertility|fertility
5196041|NCT00839722|myomectomies|myomectomies
5196042|NCT00839709|liver disease|liver disease
5196043|NCT00839709|liver transplantation|liver transplantation
5196044|NCT00839709|depletion immunosuppression|depletion immunosuppression
5196045|NCT00839709|non-depletion immunosuppression|non-depletion immunosuppression
5196046|NCT00839696|Breast|breast
5196047|NCT00839696|Estrogens|estrogens
5196048|NCT00839696|Mammography|mammography
5196049|NCT00839670|1- Constraint induced therapy|1- constraint induced therapy
5196050|NCT00839670|2- Stroke|2- stroke
5196051|NCT00839670|3- Upper limb|3- upper limb
5196052|NCT00839670|4- Rehabilitation|4- rehabilitation
5196053|NCT00839670|5- Motor training|5- motor training
5196054|NCT00839670|1- First time clinical ischemic or hemorrhagic stroke|1- first time clinical ischemic or hemorrhagic stroke
5196055|NCT00839670|2- At least 10° of active wrist extension|2- at least 10° of active wrist extension
5196056|NCT00839670|3- At least 10° of thumb abduction/ extension|3- at least 10° of thumb abduction/ extension
5196057|NCT00839670|4- At least 10° of extension in at least 2 additional digits|4- at least 10° of extension in at least 2 additional digits
5196058|NCT00839670|3- Adequate balance while wearing the restraint.|3- adequate balance while wearing the restraint.
5196059|NCT00839657|Embolism|embolism
5196060|NCT00839657|Thrombosis|thrombosis
5196061|NCT00839644|cystic fibrosis|cystic fibrosis
5196062|NCT00839644|Chest Wall Oscillation|chest wall oscillation
5196063|NCT00839644|drainage, postural|drainage, postural
5196064|NCT00839644|Medication Adherence|medication adherence
5196065|NCT00839644|patient dropouts|patient dropouts
5196066|NCT00839631|subjects with advanced solid tumors refractory to standard therapy or for whom no effective therapy is available.|subjects with advanced solid tumors refractory to standard therapy or for whom no effective therapy is available.
5196067|NCT00839605|Thoracic surgery one lung ventilation|thoracic surgery one lung ventilation
5196068|NCT00839605|airway reconstruction|airway reconstruction
5196069|NCT00839592|Insomnia|insomnia
5196070|NCT00839592|Acupuncture|acupuncture
5196071|NCT00839592|Electroacupuncture|electroacupuncture
5196072|NCT00839592|Randomized Clinical Trial|randomized clinical trial
5196073|NCT00839592|Traditional Chinese Medicine|traditional chinese medicine
5196074|NCT00839579|slightly overweight|slightly overweight
5196075|NCT00839579|males 35-45 years|males 35-45 years
5196076|NCT00839566|Atrial Fibrillation|atrial fibrillation
5196077|NCT00839566|Heart Failure|heart failure
5196078|NCT00839540|candidemia|candidemia
5196079|NCT00839540|echinocandin|echinocandin
5196080|NCT00839540|micafungin|micafungin
5196081|NCT00839540|caspofungin|caspofungin
5196082|NCT00839527|diabetes|diabetes
5196083|NCT00839514|Parkinson's disease|parkinson's disease
5196084|NCT00839514|Trichloroethylene|trichloroethylene
5196085|NCT00839488|pantoprazole|pantoprazole
5196086|NCT00839488|famotidine|famotidine
5196087|NCT00839488|stomach ulcer|stomach ulcer
5196088|NCT00839488|digestive system surgical procedure|digestive system surgical procedure
5196089|NCT00839475|colposcopy|colposcopy
5196090|NCT00839475|Cervical intraepithelial neoplasia|cervical intraepithelial neoplasia
5196091|NCT00839475|cervical cancer|cervical cancer
5196092|NCT00839475|cervical precancer|cervical precancer
5196093|NCT00839462|Thermal Erythema|thermal erythema
5196094|NCT00839462|Dexpanthenol|dexpanthenol
5196095|NCT00839462|Erythema|erythema
5196096|NCT00839462|Efficacy|efficacy
5196097|NCT00839449|subarachnoid hemorrhage|subarachnoid hemorrhage
5196098|NCT00839449|cerebral vasospasm|cerebral vasospasm
5196099|NCT00839449|eicosapentaenoic acid|eicosapentaenoic acid
5196100|NCT00839436|Idiopathic CD4+ T-Lymphocytopenia|idiopathic cd4+ t-lymphocytopenia
5196101|NCT00839436|Interleukin-7|interleukin-7
5196102|NCT00839436|Clinical Trial|clinical trial
5196103|NCT00839436|T-Lymphocytes|t-lymphocytes
5196104|NCT00839436|Idiopathic CD4 Lymphocytopenia (ICL)|idiopathic cd4 lymphocytopenia (icl)
5196106|NCT00839423|Major depressive disorder|major depressive disorder
5196107|NCT00839423|Placebo-controlled|placebo-controlled
5196108|NCT00839423|Active reference|active reference
5196109|NCT00839423|Multicenter study|multicenter study
5196110|NCT00839423|Randomised study|randomised study
5196111|NCT00839423|Acute treatment|acute treatment
5196112|NCT00839410|skin cancer|skin cancer
5196113|NCT00839410|melanoma|melanoma
5196114|NCT00839410|sentinel lymph node biopsy|sentinel lymph node biopsy
5196115|NCT00839410|bio bank|bio bank
5196116|NCT00839410|genetic polymorphism|genetic polymorphism
5196117|NCT00839410|prospective cohort|prospective cohort
5196118|NCT00839410|cohort|cohort
5196119|NCT00839410|sentinel lymph nodes|sentinel lymph nodes
5196120|NCT00839410|tissue samples|tissue samples
5196121|NCT00839371|bispectral analysis|bispectral analysis
5196122|NCT00839371|bronchoscopy|bronchoscopy
5196123|NCT00839371|midazolam|midazolam
5196124|NCT00839371|propofol|propofol
5196125|NCT00839371|recovery|recovery
5196126|NCT00839371|sedation|sedation
5196127|NCT00839358|cirrhosis|cirrhosis
5196128|NCT00839358|renal failure|renal failure
5196129|NCT00839358|midodrine|midodrine
5196130|NCT00839358|albumine|albumine
5196131|NCT00839345|platelet|platelet
5196132|NCT00839345|clopidogrel|clopidogrel
5196133|NCT00839345|VerifyNow|verifynow
5196134|NCT00839345|ticlopidine|ticlopidine
5196135|NCT00839345|thrombosis|thrombosis
5196136|NCT00839332|Pancreas|pancreas
5196137|NCT00839332|metastatic cancer|metastatic cancer
5196138|NCT00839332|advanced cancer|advanced cancer
5196139|NCT00839332|Pancreatic cancer|pancreatic cancer
5196140|NCT00839319|hCG|hcg
5196141|NCT00839319|testosterone|testosterone
5196142|NCT00839319|Acyline|acyline
5196143|NCT00839319|Intratesticular hormone|intratesticular hormone
5196144|NCT00839306|Gastroesophageal|gastroesophageal
5196145|NCT00839306|Reflux|reflux
5196146|NCT00839306|Disease|disease
5196147|NCT00839306|GERD|gerd
5196148|NCT00839293|Bioavailability|bioavailability
5196149|NCT00839280|Dry skin|dry skin
5196150|NCT00839280|Dexpanthenol|dexpanthenol
5196151|NCT00839280|Moisturizing effect|moisturizing effect
5196152|NCT00839267|platelet|platelet
5196153|NCT00839267|VASP|vasp
5196154|NCT00839267|clopidogrel|clopidogrel
5196155|NCT00839267|cardiogenic shock|cardiogenic shock
5196156|NCT00839267|myocardial infarction|myocardial infarction
5196157|NCT00839267|percutaneous coronary intervention|percutaneous coronary intervention
5196158|NCT00839254|Streptococcus pneumoniae|streptococcus pneumoniae
5196159|NCT00839254|acute otitis media|acute otitis media
5196160|NCT00839254|Pneumococcal conjugate vaccine|pneumococcal conjugate vaccine
5196161|NCT00839254|nasopharyngeal carriage|nasopharyngeal carriage
5196162|NCT00839254|Haemophilus influenzae|haemophilus influenzae
5196163|NCT00839254|immunogenicity|immunogenicity
5196164|NCT00839254|invasive disease|invasive disease
5196165|NCT00839228|diastolic dysfunction|diastolic dysfunction
5196166|NCT00839228|cardiac energetics|cardiac energetics
5196167|NCT00839228|perhexiline|perhexiline
5196168|NCT00839228|magnetic resonance spectroscopy|magnetic resonance spectroscopy
5196169|NCT00839202|factor VIII|factor viii
5196170|NCT00839202|hemophilia A|hemophilia a
5196171|NCT00839202|assay|assay
5196172|NCT00839189|CCRE|ccre
5196173|NCT00839189|endotoxin|endotoxin
5196174|NCT00839189|LPS|lps
5196175|NCT00839189|asthma|asthma
5196176|NCT00839189|allergies|allergies
5196177|NCT00839189|allergic rhinitis|allergic rhinitis
5196178|NCT00839176|Major Depressive Disorder (MDD)|major depressive disorder (mdd)
5196179|NCT00839176|Serdaxin|serdaxin
5196180|NCT00839176|Rexahn|rexahn
5196181|NCT00839163|Embolism and Thrombosis|embolism and thrombosis
5196182|NCT00839163|Pulmonary embolism|pulmonary embolism
5196183|NCT00839163|Embolism|embolism
5196184|NCT00839163|Thrombosis|thrombosis
5196185|NCT00839150|Diabetic retinopathy|diabetic retinopathy
5196186|NCT00839150|Color vision|color vision
5196187|NCT00839150|Contrast sensitivity|contrast sensitivity
5196188|NCT00839150|Electroretinogram|electroretinogram
5196189|NCT00839150|Flicker-induced vasodilatation|flicker-induced vasodilatation
5196190|NCT00839150|Dynamic Vessel Analyzer|dynamic vessel analyzer
5196191|NCT00839137|asthma|asthma
5196192|NCT00839137|exercise therapy|exercise therapy
5196193|NCT00839124|normal volunteer|normal volunteer
5196194|NCT00839124|healthy control volunteer|healthy control volunteer
5196195|NCT00839124|healthy subjects|healthy subjects
5196196|NCT00839124|asthma|asthma
5196197|NCT00839124|allergy|allergy
5196198|NCT00839124|allergic asthma|allergic asthma
5196199|NCT00839111|Progression free survival|progression free survival
5196200|NCT00839111|Toxicity|toxicity
5196201|NCT00839111|Response rate|response rate
5196202|NCT00839111|overall survival|overall survival
5196203|NCT00839098|power wheelchairs|power wheelchairs
5196204|NCT00839098|assistive technology|assistive technology
5196205|NCT00839098|rehabilitation|rehabilitation
5196206|NCT00839085|CABG|cabg
5196207|NCT00839085|on pump|on pump
5196208|NCT00839085|Grape seed extract|grape seed extract
5196209|NCT00839085|Vit C|vit c
5196210|NCT00839085|Oxidative stress|oxidative stress
5196211|NCT00839072|bioavailability|bioavailability
5196212|NCT00839072|pharmacokinetics|pharmacokinetics
5196213|NCT00839072|healthy|healthy
5196214|NCT00839072|crossover|crossover
5196215|NCT00839072|trazodone|trazodone
5196216|NCT00839059|AML|aml
5196217|NCT00839059|lenalidomide|lenalidomide
5196218|NCT00839046|Pediatric Asthma|pediatric asthma
5196219|NCT00839046|Air Filters|air filters
5196220|NCT00839046|Indoor Particulate Matter|indoor particulate matter
5196221|NCT00839033|Cough assisted device|cough assisted device
5196222|NCT00839033|Neuromuscular disease|neuromuscular disease
5196223|NCT00839033|Respiratory exacerbation|respiratory exacerbation
5196224|NCT00839033|Invasive ventilation,|invasive ventilation,
5196225|NCT00839033|Chest physiotherapy|chest physiotherapy
5196226|NCT00839033|Congenital myopathies|congenital myopathies
5196227|NCT00839020|Surgical Procedures, Minimally Invasive|surgical procedures, minimally invasive
5196228|NCT00839020|Range of Motion|range of motion
5196229|NCT00839020|Articular Arthroplasty, Replacement, Knee|articular arthroplasty, replacement, knee
5196230|NCT00839007|ADHF|adhf
5196231|NCT00839007|AHF|ahf
5196232|NCT00839007|HF|hf
5196233|NCT00838994|Insomnia|insomnia
5196234|NCT00838994|Depression|depression
5196235|NCT00838994|Electroacupuncture|electroacupuncture
5196236|NCT00838994|Acupuncture|acupuncture
5196237|NCT00838994|Randomized Clinical Trial|randomized clinical trial
5196238|NCT00838994|Traditional Chinese Medicine|traditional chinese medicine
5196239|NCT00838981|Treatment for addiction|treatment for addiction
5196240|NCT00838981|Methadone given for opioid dependence|methadone given for opioid dependence
5196241|NCT00838981|Cocaine|cocaine
5196242|NCT00838981|Opiates|opiates
5196243|NCT00838968|hepatocellular carcinoma|hepatocellular carcinoma
5196244|NCT00838968|interferon-alpha|interferon-alpha
5196245|NCT00838968|p48|p48
5196246|NCT00838955|Hodgkin's lymphoma|hodgkin's lymphoma
5196247|NCT00838955|relapsed Hodgkin's lymphoma|relapsed hodgkin's lymphoma
5196248|NCT00838955|refractory Hodgkin's lymphoma|refractory hodgkin's lymphoma
5196249|NCT00838955|Temsirolimus|temsirolimus
5196250|NCT00838942|Eyes disease and dementia.|eyes disease and dementia.
5196251|NCT00838942|Cataract surgery in the patient with dementia.|cataract surgery in the patient with dementia.
5196252|NCT00838942|Visual hallucinations|visual hallucinations
5196253|NCT00838942|Visual acuity,|visual acuity,
5196254|NCT00838942|Specific eye pathologies in Alzheimer's disease.|specific eye pathologies in alzheimer's disease.
5196255|NCT00838942|Improvement of behaviour,|improvement of behaviour,
5196256|NCT00838942|Improvement of autonomy|improvement of autonomy
5196257|NCT00838942|Improvement of mood|improvement of mood
5196258|NCT00838942|Cataract extraction in Alzheimer disease patient|cataract extraction in alzheimer disease patient
5196259|NCT00838929|brain metastases|brain metastases
5196260|NCT00838929|radiation|radiation
5196261|NCT00838929|vorinostat|vorinostat
5196262|NCT00838929|lung cancer|lung cancer
5196263|NCT00838929|breast cancer|breast cancer
5196264|NCT00838916|diabetes|diabetes
5196265|NCT00838903|diabetes|diabetes
5196266|NCT00838877|Alzheimer's Disease|alzheimer's disease
5196267|NCT00838877|PET|pet
5196268|NCT00838877|Phase 1|phase 1
5196269|NCT00838877|Positron Emission Tomography|positron emission tomography
5196270|NCT00838864|variceal bleeding|variceal bleeding
5196271|NCT00838864|antibiotic prophylaxis|antibiotic prophylaxis
5196272|NCT00838864|ceftrioxone|ceftrioxone
5196273|NCT00838851|endotoxin|endotoxin
5196274|NCT00838851|CCRE|ccre
5196275|NCT00838851|LPS|lps
5196276|NCT00838838|Testosterone replacement therapy|testosterone replacement therapy
5196277|NCT00838838|Hypogonadism|hypogonadism
5196278|NCT00838838|Osteoporosis|osteoporosis
5196279|NCT00838838|Immobilisation|immobilisation
5196280|NCT00838838|Paraplegia|paraplegia
5196281|NCT00838838|Testosterone|testosterone
5196282|NCT00838825|diabetes|diabetes
5196283|NCT00838825|chronic care management|chronic care management
5196284|NCT00838825|resource utilization|resource utilization
5196285|NCT00838825|outcome|outcome
5196286|NCT00838825|glycohemoglobin|glycohemoglobin
5196287|NCT00838825|hospitalization|hospitalization
5196288|NCT00838812|clindamycin|clindamycin
5196289|NCT00838812|tretinoin|tretinoin
5196290|NCT00838812|acne vulgaris|acne vulgaris
5196291|NCT00838812|Acne vulgaris mild to moderate|acne vulgaris mild to moderate
5196292|NCT00838799|diabetic|diabetic
5196293|NCT00838799|peripheral|peripheral
5196294|NCT00838799|neuropathic|neuropathic
5196295|NCT00838799|pain|pain
5196296|NCT00838799|chronic|chronic
5196297|NCT00838799|diabetes|diabetes
5196298|NCT00838760|PEPI-TiDP23-C103|pepi-tidp23-c103
5196299|NCT00838760|PEPI-C103|pepi-c103
5196300|NCT00838760|PEPI|pepi
5196301|NCT00838760|TMC558445|tmc558445
5196302|NCT00838760|TMC310911|tmc310911
5196303|NCT00838760|Darunavir, Healthy volunteers|darunavir, healthy volunteers
5196304|NCT00838760|Pharmacokinetics|pharmacokinetics
5196305|NCT00838760|HIV Infections|hiv infections
5196306|NCT00838747|folate receptor|folate receptor
5196307|NCT00838747|blood samples|blood samples
5196308|NCT00838747|ovarian cancer|ovarian cancer
5196309|NCT00838747|development of measure of folate receptor in blood samples|development of measure of folate receptor in blood samples
5196310|NCT00838747|possible selection of patients for treatment with FR targeted agents|possible selection of patients for treatment with fr targeted agents
5196311|NCT00838734|CORNEAL TOPOGRAPHY|corneal topography
5196312|NCT00838734|KERATOPLASTY|keratoplasty
5196313|NCT00838721|Open Angle Glaucoma|open angle glaucoma
5196314|NCT00838721|Ocular Hypertension|ocular hypertension
5196315|NCT00838721|Laser Trabeculoplasty|laser trabeculoplasty
5196316|NCT00838695|Hand vein sensitivity|hand vein sensitivity
5196317|NCT00838695|phenylephrine|phenylephrine
5196318|NCT00838695|nitroglycerin|nitroglycerin
5196319|NCT00838682|peptic ulcer bleeding|peptic ulcer bleeding
5196320|NCT00838682|rabeprazole|rabeprazole
5196321|NCT00838682|proton pump inhibitor|proton pump inhibitor
5196322|NCT00838669|Schizophrenia|schizophrenia
5196323|NCT00838669|Mood disorders|mood disorders
5196324|NCT00838669|Antipsychotic drugs|antipsychotic drugs
5196325|NCT00838669|Extended release OROS paliperidone|extended release oros paliperidone
5196326|NCT00838656|ovarian carcinosarcoma|ovarian carcinosarcoma
5196327|NCT00838656|stage IIIA ovarian epithelial cancer|stage iiia ovarian epithelial cancer
5196328|NCT00838656|stage IIIB ovarian epithelial cancer|stage iiib ovarian epithelial cancer
5196329|NCT00838656|stage IIIC ovarian epithelial cancer|stage iiic ovarian epithelial cancer
5196330|NCT00838656|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5196331|NCT00838656|stage IIIA primary peritoneal cavity cancer|stage iiia primary peritoneal cavity cancer
5196332|NCT00838656|stage IIIB primary peritoneal cavity cancer|stage iiib primary peritoneal cavity cancer
5196333|NCT00838656|stage IIIC primary peritoneal cavity cancer|stage iiic primary peritoneal cavity cancer
5196334|NCT00838656|stage IV primary peritoneal cavity cancer|stage iv primary peritoneal cavity cancer
5196335|NCT00838656|stage IIIA fallopian tube cancer|stage iiia fallopian tube cancer
5196336|NCT00838656|stage IIIB fallopian tube cancer|stage iiib fallopian tube cancer
5196337|NCT00838656|stage IIIC fallopian tube cancer|stage iiic fallopian tube cancer
5196338|NCT00838656|stage IV fallopian tube cancer|stage iv fallopian tube cancer
5196339|NCT00838643|allogeneic transplantation|allogeneic transplantation
5196340|NCT00838643|Invasive aspergillosis|invasive aspergillosis
5196341|NCT00838630|Bioequivalence|bioequivalence
5196342|NCT00838630|Healthy Subjects|healthy subjects
5196343|NCT00838617|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
5196344|NCT00838617|Ultrasonography|ultrasonography
5196345|NCT00838617|Atrophy|atrophy
5196346|NCT00838591|MN-221|mn-221
5196347|NCT00838591|Asthma|asthma
5196348|NCT00838591|Acute|acute
5196349|NCT00838591|Exacerbation|exacerbation
5196350|NCT00838578|KRN330|krn330
5196351|NCT00838578|Colorectal Cancer|colorectal cancer
5196352|NCT00838578|Antimetabolites|antimetabolites
5196353|NCT00838578|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic
5196354|NCT00838578|Digestive System Neoplasms|digestive system neoplasms
5196355|NCT00838578|Immunologic Factors|immunologic factors
5196356|NCT00838578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
5196357|NCT00838578|Antineoplastic Agents|antineoplastic agents
5196358|NCT00838578|Gastrointestinal Diseases|gastrointestinal diseases
5196359|NCT00838578|Physiological Effects of Drugs|physiological effects of drugs
5196360|NCT00838578|Colonic Diseases|colonic diseases
5196361|NCT00838578|Irinotecan|irinotecan
5196362|NCT00838578|Enzyme Inhibitors|enzyme inhibitors
5196363|NCT00838578|Intestinal Diseases|intestinal diseases
5196364|NCT00838578|Immunosuppressive Agents|immunosuppressive agents
5196365|NCT00838578|Rectal Diseases|rectal diseases
5196366|NCT00838578|Pharmacologic Actions|pharmacologic actions
5196367|NCT00838578|Intestinal Neoplasms|intestinal neoplasms
5196368|NCT00838578|Neoplasms by Site|neoplasms by site
5196369|NCT00838578|Digestive System Diseases|digestive system diseases
5196370|NCT00838578|Therapeutic Uses|therapeutic uses
5196371|NCT00838578|Fluorouracil|fluorouracil
5196372|NCT00838578|Neoplasms|neoplasms
5196373|NCT00838578|Gastrointestinal Neoplasms|gastrointestinal neoplasms
5196374|NCT00838578|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic
5196375|NCT00838578|Colorectal Neoplasms|colorectal neoplasms
5196376|NCT00838565|Safety and tolerability Pharmacokinetics Pharmacodynamics PF-04236921|safety and tolerability pharmacokinetics pharmacodynamics pf-04236921
5196377|NCT00838552|asthma inflammation bronchoscopy|asthma inflammation bronchoscopy
5196378|NCT00838539|Neratinib|neratinib
5196379|NCT00838539|solid tumors|solid tumors
5196380|NCT00838539|phase 1|phase 1
5196381|NCT00838539|dose finding study|dose finding study
5196382|NCT00838539|HKI-272|hki-272
5196383|NCT00838539|Nerlynx|nerlynx
5196384|NCT00838539|Temsirolimus|temsirolimus
5196385|NCT00838539|PB-272|pb-272
5196386|NCT00838526|Gastroesophageal|gastroesophageal
5196387|NCT00838526|Reflux|reflux
5196388|NCT00838526|Disease|disease
5196389|NCT00838526|GERD|gerd
5196390|NCT00838513|aHUS|ahus
5196391|NCT00838500|Venous insufficiency|venous insufficiency
5196392|NCT00838500|Leg ulcer|leg ulcer
5196393|NCT00838500|balneology|balneology
5196394|NCT00838500|hydrotherapy|hydrotherapy
5196395|NCT00838500|Modified Rutherford score|modified rutherford score
5196396|NCT00838500|Euroquol EQ 5d scale|euroquol eq 5d scale
5196397|NCT00838500|CIVIQ2 scale|civiq2 scale
5196398|NCT00838500|Visual analogic Scale|visual analogic scale
5196399|NCT00838500|SPA treatment|spa treatment
5196400|NCT00838487|chondroitin|chondroitin
5196401|NCT00838487|glucosamine|glucosamine
5196402|NCT00838487|osteoarthritis|osteoarthritis
5196403|NCT00838474|metabolic rate|metabolic rate
5196404|NCT00838474|music|music
5196405|NCT00838474|preterm infants|preterm infants
5196406|NCT00838474|energy expenditure|energy expenditure
5196407|NCT00838474|NIDCA|nidca
5196408|NCT00838448|exercise|exercise
5196409|NCT00838448|cannabis use|cannabis use
5196410|NCT00838448|visual cues|visual cues
5196411|NCT00838435|Phenylketonuria|phenylketonuria
5196412|NCT00838435|PKU|pku
5196413|NCT00838435|Kuvan|kuvan
5196414|NCT00838435|Phenoptin|phenoptin
5196415|NCT00838435|Biopten|biopten
5196416|NCT00838435|Neurocognitive Function|neurocognitive function
5196417|NCT00838435|Phenylalanine|phenylalanine
5196418|NCT00838383|multi-center, placebo-controlled, randomized study of sitaxsentan administered to subjects post-cross-clamp release and 12 hours post-CPB|multi-center, placebo-controlled, randomized study of sitaxsentan administered to subjects post-cross-clamp release and 12 hours post-cpb
5196419|NCT00838370|Pharmacogenetics|pharmacogenetics
5196420|NCT00838370|cost-benefit analysis|cost-benefit analysis
5196421|NCT00838370|toxicity|toxicity
5196422|NCT00838370|antineoplastic drugs|antineoplastic drugs
5196423|NCT00838370|Dihydropyrimidine Dehydrogenase|dihydropyrimidine dehydrogenase
5196424|NCT00838357|Mobilisation stem cells|mobilisation stem cells
5196425|NCT00838357|G-CSF Mobilisation Regimen|g-csf mobilisation regimen
5196426|NCT00838357|Lymphoma|lymphoma
5196427|NCT00838357|Multiple Myeloma|multiple myeloma
5196428|NCT00838344|medication adherence|medication adherence
5196429|NCT00838344|medication persistence|medication persistence
5196430|NCT00838344|pharmacist interventions|pharmacist interventions
5196431|NCT00838344|diabetes|diabetes
5196432|NCT00838344|persistence|persistence
5196433|NCT00838344|adherence|adherence
5196434|NCT00838331|Blood Transfusions|blood transfusions
5196435|NCT00838318|Colorectal CancerScreening|colorectal cancerscreening
5196436|NCT00838318|CRC|crc
5196437|NCT00838318|Hispanic|hispanic
5196438|NCT00838318|CRC Patients|crc patients
5196439|NCT00838318|First-Degree Relatives|first-degree relatives
5196440|NCT00838318|FDRs|fdrs
5196441|NCT00838318|Interviews|interviews
5196442|NCT00838318|Colorectal cancer screening|colorectal cancer screening
5196443|NCT00838318|CRCS|crcs
5196444|NCT00838318|Key Informants|key informants
5196445|NCT00838305|MDMA|mdma
5196446|NCT00838305|citalopram|citalopram
5196447|NCT00838305|serotonin|serotonin
5196448|NCT00838305|psychedelic|psychedelic
5196449|NCT00838292|food supplementation|food supplementation
5196450|NCT00838292|HIV|hiv
5196451|NCT00838292|malnutrition|malnutrition
5196452|NCT00838279|Bioequivalence|bioequivalence
5196453|NCT00838279|Healthy Subjects|healthy subjects
5196454|NCT00838266|mouthrinse|mouthrinse
5196455|NCT00838266|grape seed extract|grape seed extract
5196456|NCT00838266|fluor|fluor
5196457|NCT00838266|plaque index|plaque index
5196458|NCT00838253|Acute Heart Failure|acute heart failure
5196459|NCT00838253|Inotropes|inotropes
5196460|NCT00838253|Lusitropic agents|lusitropic agents
5196461|NCT00838253|Istaroxime|istaroxime
5196462|NCT00838253|Debio 0614|debio 0614
5196463|NCT00838240|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
5196464|NCT00838240|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
5196465|NCT00838240|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
5196466|NCT00838240|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
5196467|NCT00838240|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
5196468|NCT00838240|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
5196469|NCT00838240|adult erythroleukemia (M6a)|adult erythroleukemia (m6a)
5196470|NCT00838240|adult pure erythroid leukemia (M6b)|adult pure erythroid leukemia (m6b)
5196471|NCT00838240|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
5196472|NCT00838240|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5196473|NCT00838240|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5196474|NCT00838240|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5196475|NCT00838240|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5196476|NCT00838240|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
5196477|NCT00838240|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5196478|NCT00838240|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5196479|NCT00838227|Schizophrenia|schizophrenia
5196480|NCT00838227|Cognition|cognition
5196481|NCT00838227|Obesity|obesity
5196482|NCT00838227|Sedation|sedation
5196483|NCT00838201|Androgen deprivation therapy for non-metastatic prostate cancer|androgen deprivation therapy for non-metastatic prostate cancer
5196484|NCT00838188|Metabolic rate|metabolic rate
5196485|NCT00838188|indirect calorimetry|indirect calorimetry
5196486|NCT00838188|oral feeding|oral feeding
5196487|NCT00838175|Peripheral Venous Catheterization|peripheral venous catheterization
5196488|NCT00838162|Human immunodeficiency virus type 1|human immunodeficiency virus type 1
5196489|NCT00838162|HIV-1|hiv-1
5196490|NCT00838162|HIV-1 treatment-naive|hiv-1 treatment-naive
5196491|NCT00838162|TMC310911|tmc310911
5196492|NCT00838162|Protease inhibitor|protease inhibitor
5196493|NCT00838162|Ritonavir|ritonavir
5196494|NCT00838162|Antiviral Activity|antiviral activity
5196495|NCT00838162|HIV Infections|hiv infections
5196496|NCT00838162|Treatment Naive|treatment naive
5196497|NCT00838136|Bioequivalence|bioequivalence
5196498|NCT00838136|Healthy Subjects|healthy subjects
5196499|NCT00838110|Alzheimer's Disease|alzheimer's disease
5196500|NCT00838110|Dimebon|dimebon
5196501|NCT00838110|Safety|safety
5196502|NCT00838110|Tolerability|tolerability
5196503|NCT00838097|CKD|ckd
5196504|NCT00838097|Paediatric|paediatric
5196505|NCT00838097|Darbepoetin Alfa|darbepoetin alfa
5196506|NCT00838071|Hepatitis B|hepatitis b
5196507|NCT00838071|HBV|hbv
5196508|NCT00838071|Anti-hepatitis B antibodies|anti-hepatitis b antibodies
5196509|NCT00838071|Immunoglobulins|immunoglobulins
5196510|NCT00838071|liver transplantation|liver transplantation
5196511|NCT00838071|Protective levels|protective levels
5196512|NCT00838071|Recurrence|recurrence
5196513|NCT00838071|Intravenous|intravenous
5196514|NCT00838058|pharmacology formulation normal healthy volunteers food effect|pharmacology formulation normal healthy volunteers food effect
5196515|NCT00838032|acute schizophrenic patients|acute schizophrenic patients
5196516|NCT00838006|post-traumatic stress disorder|post-traumatic stress disorder
5196517|NCT00838006|post-deployment|post-deployment
5196518|NCT00838006|prediction|prediction
5196519|NCT00838006|prevention|prevention
5196520|NCT00837993|Advanced Stage Serous Carcinoma of the Ovary|advanced stage serous carcinoma of the ovary
5196521|NCT00837993|serous ovarian carcinoma|serous ovarian carcinoma
5196522|NCT00837993|Ovary|ovary
5196523|NCT00837993|GOG Protocol 158|gog protocol 158
5196524|NCT00837993|Survival Analysis|survival analysis
5196525|NCT00837993|Pathology Slides|pathology slides
5196526|NCT00837993|Two-tier Grading System|two-tier grading system
5196527|NCT00837993|Ancillary Study|ancillary study
5196528|NCT00837980|head and neck cancer|head and neck cancer
5196529|NCT00837980|DW MRI|dw mri
5196530|NCT00837980|PET|pet
5196531|NCT00837980|DCE MRI|dce mri
5196532|NCT00837980|functional imaging|functional imaging
5196533|NCT00837980|IMRT|imrt
5196534|NCT00837967|Asthma|asthma
5196535|NCT00837967|Symbicort Turbuhaler|symbicort turbuhaler
5196536|NCT00837954|PTFE Graft|ptfe graft
5196537|NCT00837954|Suture Hole Bleeding|suture hole bleeding
5196538|NCT00837954|Hemostasis|hemostasis
5196539|NCT00837928|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5196540|NCT00837928|tumors metastatic to brain|tumors metastatic to brain
5196541|NCT00837915|Bioequivaelnce Loratadine 10mg /Pseudoephedrine Sulfate 240 mg Extended Release Tablets|bioequivaelnce loratadine 10mg /pseudoephedrine sulfate 240 mg extended release tablets
5196542|NCT00837902|Atenolol|atenolol
5196543|NCT00837902|Exercise|exercise
5196544|NCT00837902|Genotype|genotype
5196545|NCT00837902|Healthy volunteers|healthy volunteers
5196546|NCT00837889|cognition|cognition
5196547|NCT00837889|decompensation|decompensation
5196548|NCT00837889|heart failure|heart failure
5196549|NCT00837889|recompensation|recompensation
5196550|NCT00837876|recurrent pancreatic cancer|recurrent pancreatic cancer
5196551|NCT00837876|stage III pancreatic cancer|stage iii pancreatic cancer
5196552|NCT00837876|stage IV pancreatic cancer|stage iv pancreatic cancer
5196553|NCT00837876|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
5196554|NCT00837850|total hip arthroplasty|total hip arthroplasty
5196555|NCT00837850|Charnley stem|charnley stem
5196556|NCT00837850|RSA|rsa
5196557|NCT00837850|non-inflammatory arthritis|non-inflammatory arthritis
5196558|NCT00837837|pharmacokinetics|pharmacokinetics
5196559|NCT00837837|children|children
5196560|NCT00837837|adolescents|adolescents
5196561|NCT00837837|antihistamine|antihistamine
5196562|NCT00837824|Fabry Disease patients with Severe Renal Disease|fabry disease patients with severe renal disease
5196563|NCT00837811|Arthritis|arthritis
5196564|NCT00837772|Alignment|alignment
5196565|NCT00837759|Type I Diabetes|type i diabetes
5196566|NCT00837759|Preserve Beta Cell Function|preserve beta cell function
5196567|NCT00837759|Sitagliptin|sitagliptin
5196568|NCT00837759|Lansoprazole|lansoprazole
5196569|NCT00837759|GAD65 (Diamyd)|gad65 (diamyd)
5196570|NCT00837759|Diabetes|diabetes
5196571|NCT00837759|Type 1 Diabetes|type 1 diabetes
5196572|NCT00837759|T1DM|t1dm
5196573|NCT00837733|Endometrial biopsy|endometrial biopsy
5196574|NCT00837733|IVF/ICSI|ivf/icsi
5196575|NCT00837733|Pregnancy outcome|pregnancy outcome
5196576|NCT00837733|Recurrent implantation failure|recurrent implantation failure
5196577|NCT00837720|hypertension|hypertension
5196578|NCT00837720|blood pressure|blood pressure
5196579|NCT00837720|Atacand®|atacand®
5196580|NCT00837720|candesartan|candesartan
5196581|NCT00837707|aripiprazole|aripiprazole
5196582|NCT00837707|Tardive Dyskinesia|tardive dyskinesia
5196583|NCT00837694|BMI|bmi
5196584|NCT00837694|obesity|obesity
5196585|NCT00837694|sensitization|sensitization
5196586|NCT00837694|food reinforcement|food reinforcement
5196587|NCT00837694|snack food|snack food
5196588|NCT00837694|Portion size of daily snacks|portion size of daily snacks
5196589|NCT00837694|Weight status|weight status
5196590|NCT00837681|Bone Marrow Transplant|bone marrow transplant
5196591|NCT00837681|hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
5196592|NCT00837668|sarcoidosis|sarcoidosis
5196593|NCT00837668|stromal gene expression|stromal gene expression
5196594|NCT00837668|pulmonary sarcoidosis|pulmonary sarcoidosis
5196595|NCT00837668|bronchoscopy|bronchoscopy
5196596|NCT00837655|Chronic kidney disease|chronic kidney disease
5196597|NCT00837655|End-stage renal disease|end-stage renal disease
5196598|NCT00837655|phosphate binder|phosphate binder
5196599|NCT00837655|insulin resistance|insulin resistance
5196600|NCT00837655|glucose intolerance|glucose intolerance
5196601|NCT00837655|sevelamer|sevelamer
5196602|NCT00837642|Vascular function in offspring of ART|vascular function in offspring of art
5196603|NCT00837629|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
5196604|NCT00837629|COPD|copd
5196605|NCT00837629|Symbicort Turbuhaler|symbicort turbuhaler
5196606|NCT00837616|Turner Syndrome|turner syndrome
5196607|NCT00837616|Hypogonadism|hypogonadism
5196608|NCT00837616|GH|gh
5196609|NCT00837616|Estrogen|estrogen
5196610|NCT00837616|Estrogen Patches|estrogen patches
5196611|NCT00837616|IGF-I|igf-i
5196612|NCT00837616|Body Composition|body composition
5196613|NCT00837616|Protein Metabolism|protein metabolism
5196614|NCT00837616|Lipid Oxidation|lipid oxidation
5196615|NCT00837616|Estradiol assay by LCMSMS|estradiol assay by lcmsms
5196616|NCT00837616|Recombinant Cell Bioassay|recombinant cell bioassay
5196617|NCT00837603|tga|tga
5196618|NCT00837603|atrial switch|atrial switch
5196619|NCT00837603|training|training
5196620|NCT00837590|Vascular function|vascular function
5196621|NCT00837590|Glucose tolerance|glucose tolerance
5196622|NCT00837590|Obesity|obesity
5196623|NCT00837590|Pre-diabetes|pre-diabetes
5196624|NCT00837564|chronic depression|chronic depression
5196625|NCT00837564|CBASP|cbasp
5196626|NCT00837564|Escitalopram|escitalopram
5196627|NCT00837564|depression|depression
5196628|NCT00837564|trauma|trauma
5196629|NCT00837551|Non-steroid|non-steroid
5196630|NCT00837551|Small molecule|small molecule
5196631|NCT00837551|Topical cream|topical cream
5196632|NCT00837551|Inflammatory disease|inflammatory disease
5196633|NCT00837551|Skin|skin
5196634|NCT00837538|Spinal sagittal range of motion|spinal sagittal range of motion
5196635|NCT00837538|Intersegmental range of motion|intersegmental range of motion
5196636|NCT00837538|Spinal Mouse|spinal mouse
5196637|NCT00837512|microneedle continuous subcutaneous insulin infusion|microneedle continuous subcutaneous insulin infusion
5196638|NCT00837499|Breast|breast
5196639|NCT00837499|Breast Cancer|breast cancer
5196640|NCT00837499|Risk Factors|risk factors
5196641|NCT00837499|Mexican Women|mexican women
5196642|NCT00837499|Mexican-American Women|mexican-american women
5196643|NCT00837499|African-American Women|african-american women
5196644|NCT00837499|Epidemiological|epidemiological
5196645|NCT00837499|Questionnaire|questionnaire
5196646|NCT00837499|Survey|survey
5196647|NCT00837499|Interview|interview
5196648|NCT00837486|Treatment Resistant Depression|treatment resistant depression
5196649|NCT00837486|Treatment Refractory Depression|treatment refractory depression
5196650|NCT00837486|Deep Brain Stimulation|deep brain stimulation
5196651|NCT00837486|Depression|depression
5196652|NCT00837473|Bone Void Filler|bone void filler
5196653|NCT00837473|Iliac Crest Bone Void Filler|iliac crest bone void filler
5196654|NCT00837473|Back Surgery and Autograft Bone|back surgery and autograft bone
5196655|NCT00837473|Autograft Bone|autograft bone
5196656|NCT00837473|Allograft Bone|allograft bone
5196657|NCT00837460|Hand|hand
5196658|NCT00837460|Rehabilitation|rehabilitation
5196659|NCT00837434|tumor necrosis factor (TNF) blockade|tumor necrosis factor (tnf) blockade
5196660|NCT00837434|inflammatory autoimmune disorder|inflammatory autoimmune disorder
5196661|NCT00837421|sepsis|sepsis
5196662|NCT00837421|registry|registry
5196663|NCT00837408|Diabetes|diabetes
5196664|NCT00837408|Genetics|genetics
5196665|NCT00837408|Asians|asians
5196666|NCT00837408|Type 2 Diabetes|type 2 diabetes
5196667|NCT00837395|premenstrual increase in asthma symptoms|premenstrual increase in asthma symptoms
5196668|NCT00837369|Stress echocardiography|stress echocardiography
5196669|NCT00837369|SPECT|spect
5196670|NCT00837369|Myocardial perfusion imaging|myocardial perfusion imaging
5196671|NCT00837343|Bipolar disorder|bipolar disorder
5196672|NCT00837330|polypoidal choroidal vasculopathy|polypoidal choroidal vasculopathy
5197651|NCT00832962|Rhesus D|rhesus d
5196673|NCT00837330|choroidal neovascularization|choroidal neovascularization
5196674|NCT00837330|ranibizumab|ranibizumab
5196675|NCT00837330|Lucentis|lucentis
5196676|NCT00837317|Phenols|phenols
5196677|NCT00837317|Laser-Doppler|laser-doppler
5196678|NCT00837317|Olive Oil|olive oil
5196679|NCT00837317|Sunflower Oil|sunflower oil
5196680|NCT00837317|Dimethylpolysiloxane|dimethylpolysiloxane
5196681|NCT00837317|Postprandial|postprandial
5196682|NCT00837317|Inflammation|inflammation
5196683|NCT00837317|Oxidative Stress|oxidative stress
5196684|NCT00837291|osteoarthritis|osteoarthritis
5196685|NCT00837291|knee|knee
5196686|NCT00837291|CF101|cf101
5196687|NCT00837278|IVF|ivf
5196688|NCT00837278|angiogenic factors|angiogenic factors
5196689|NCT00837278|cytokines|cytokines
5196690|NCT00837265|Breast Cancer Supportive Care Neutropenia|breast cancer supportive care neutropenia
5196691|NCT00837252|Central Serous Chorioretinopathy|central serous chorioretinopathy
5196692|NCT00837252|Finasteride|finasteride
5196693|NCT00837252|Proscar|proscar
5196694|NCT00837252|Retinal Eye Disease|retinal eye disease
5196695|NCT00837239|HuaChanSu|huachansu
5196696|NCT00837239|HCS|hcs
5196697|NCT00837239|Gastrointestinal|gastrointestinal
5196698|NCT00837239|Gastrointestinal Disease|gastrointestinal disease
5196699|NCT00837239|Metastases|metastases
5196700|NCT00837239|Cancer|cancer
5196701|NCT00837239|Pancreatic cancer|pancreatic cancer
5196702|NCT00837239|Placebo|placebo
5196703|NCT00837239|Gemcitabine|gemcitabine
5196704|NCT00837239|Gemcitabine Hydrocholoride|gemcitabine hydrocholoride
5196705|NCT00837239|Gemzar|gemzar
5196706|NCT00837239|Fudan UniversityCancer Hospital|fudan universitycancer hospital
5196707|NCT00837213|Acne|acne
5196708|NCT00837200|lymphoma|lymphoma
5196709|NCT00837200|myeloma|myeloma
5196710|NCT00837187|dexmedetomidine|dexmedetomidine
5196711|NCT00837187|intranasal|intranasal
5196712|NCT00837187|pharmacokinetics|pharmacokinetics
5196713|NCT00837187|pharmacodynamics|pharmacodynamics
5196714|NCT00837174|non-Hodgkin Lymphoma|non-hodgkin lymphoma
5196715|NCT00837174|aggressive lymphoma|aggressive lymphoma
5196716|NCT00837174|indolent lymphoma|indolent lymphoma
5196717|NCT00837174|B cell lymphoma|b cell lymphoma
5196718|NCT00837174|T cell lymphoma|t cell lymphoma
5196719|NCT00837174|Diffuse large B cell lymphoma|diffuse large b cell lymphoma
5196720|NCT00837174|anaplastic large B cell lymphoma|anaplastic large b cell lymphoma
5196721|NCT00837174|lymphoblastic lymphoma|lymphoblastic lymphoma
5196722|NCT00837174|Burkitt's lymphoma|burkitt's lymphoma
5196723|NCT00837174|transformed follicular center cell lymphoma|transformed follicular center cell lymphoma
5196724|NCT00837174|transformed marginal zone lymphoma|transformed marginal zone lymphoma
5196725|NCT00837174|transformed small lymphocytic lymphoma|transformed small lymphocytic lymphoma
5196726|NCT00837174|grade 3 follicular center cell lymphoma|grade 3 follicular center cell lymphoma
5196727|NCT00837174|blastic form marginal zone lymphoma|blastic form marginal zone lymphoma
5196728|NCT00837174|transformed cutaneous T cell lymphoma|transformed cutaneous t cell lymphoma
5196729|NCT00837174|mycosis fungoides stage IV|mycosis fungoides stage iv
5196730|NCT00837174|angioimmunoblastic lymphadenopathy-like T-cell lymphoma|angioimmunoblastic lymphadenopathy-like t-cell lymphoma
5196731|NCT00837174|nasal NK/T cell lymphoma|nasal nk/t cell lymphoma
5196732|NCT00837174|peripheral T-cell lymphoma|peripheral t-cell lymphoma
5196733|NCT00837174|small lymphocytic lymphoma|small lymphocytic lymphoma
5196734|NCT00837174|lymphoplasmacytic lymphoma|lymphoplasmacytic lymphoma
5196735|NCT00837174|follicular center cell lymphoma grade 1|follicular center cell lymphoma grade 1
5196736|NCT00837174|follicular center cell lymphoma grade 2|follicular center cell lymphoma grade 2
5196737|NCT00837174|mantle cell lymphoma|mantle cell lymphoma
5196738|NCT00837174|marginal zone lymphoma|marginal zone lymphoma
5196739|NCT00837174|mycosis fungoides|mycosis fungoides
5196740|NCT00837161|High Intensity Focused Ultrasound Ablation|high intensity focused ultrasound ablation
5196741|NCT00837161|Uterine Fibroids|uterine fibroids
5196742|NCT00837161|Leiomyomata|leiomyomata
5196743|NCT00837161|Non-Invasive Treatment of Uterine Fibroids|non-invasive treatment of uterine fibroids
5196744|NCT00837161|MRI-Guided|mri-guided
5196745|NCT00837161|Fibroids|fibroids
5196746|NCT00837161|Uterine Leiomyomata|uterine leiomyomata
5196747|NCT00837148|Sarcoma|sarcoma
5196748|NCT00837148|Bone|bone
5196749|NCT00837148|BAY 43-9006 (SORAFENIB)|bay 43-9006 (sorafenib)
5196750|NCT00837148|DACARBAZINE|dacarbazine
5196751|NCT00837148|08-068|08-068
5196752|NCT00837135|Pancreatic Cancer|pancreatic cancer
5196753|NCT00837122|Diabetes|diabetes
5196754|NCT00837122|Genetics|genetics
5196755|NCT00837122|Type 2 Diabetes|type 2 diabetes
5196756|NCT00837083|hypercholesterolemia|hypercholesterolemia
5196757|NCT00837083|cholesterol|cholesterol
5196758|NCT00837083|LDL-cholesterol|ldl-cholesterol
5196759|NCT00837083|rosuvastatin|rosuvastatin
5196760|NCT00837083|Crestor|crestor
5196761|NCT00837070|Zygapophyseal|zygapophyseal
5196762|NCT00837070|joint|joint
5196763|NCT00837070|cyst|cyst
5196764|NCT00837070|Fluoroscopy|fluoroscopy
5196765|NCT00837070|guided|guided
5196766|NCT00837070|percutaneous|percutaneous
5196767|NCT00837070|Lumbar|lumbar
5196768|NCT00837031|Pancreatic|pancreatic
5196769|NCT00837031|Pancreatic Cancer|pancreatic cancer
5198055|NCT00831337|Chemokines|chemokines
5196770|NCT00837031|Lenalidomide|lenalidomide
5196771|NCT00837031|Revlimid|revlimid
5196772|NCT00837031|Gemcitabine|gemcitabine
5196773|NCT00837018|OSAS|osas
5196774|NCT00837018|exercise|exercise
5196775|NCT00837018|metabolic|metabolic
5196776|NCT00837018|cardio-vascular|cardio-vascular
5196777|NCT00837005|dobutamine stress|dobutamine stress
5196778|NCT00837005|inducible ischemia|inducible ischemia
5196779|NCT00837005|CAD|cad
5196780|NCT00836992|anal cancer|anal cancer
5196781|NCT00836992|colon cancer|colon cancer
5196782|NCT00836992|rectal cancer|rectal cancer
5196783|NCT00836992|esophageal cancer|esophageal cancer
5196784|NCT00836992|extrahepatic bile duct cancer|extrahepatic bile duct cancer
5196785|NCT00836992|gallbladder cancer|gallbladder cancer
5196786|NCT00836992|gastric cancer|gastric cancer
5196787|NCT00836992|adult primary liver cancer|adult primary liver cancer
5196788|NCT00836992|pancreatic cancer|pancreatic cancer
5196789|NCT00836992|small intestine cancer|small intestine cancer
5196790|NCT00836992|non-small cell lung cancer|non-small cell lung cancer
5196791|NCT00836992|small cell lung cancer|small cell lung cancer
5196792|NCT00836992|head and neck cancer|head and neck cancer
5196793|NCT00836979|Urinary Incontinence|urinary incontinence
5196794|NCT00836979|Incontinence|incontinence
5196795|NCT00836979|bladder problems|bladder problems
5196796|NCT00836979|bladder dysfunction|bladder dysfunction
5196797|NCT00836953|Influenza|influenza
5196798|NCT00836953|Fluzone®|fluzone®
5196799|NCT00836953|Children|children
5196800|NCT00836940|Type 2 diabetes mellitus|type 2 diabetes mellitus
5196801|NCT00836940|GRC 8200|grc 8200
5196802|NCT00836914|Allergic Rhinitis|allergic rhinitis
5196803|NCT00836914|Allergy|allergy
5196804|NCT00836914|Phosphatidylinositol 3-kinase|phosphatidylinositol 3-kinase
5196805|NCT00836901|Bioequivalence|bioequivalence
5196806|NCT00836901|Healthy Subjects|healthy subjects
5196807|NCT00836888|ONO-4538|ono-4538
5196808|NCT00836888|MDX-1106|mdx-1106
5196809|NCT00836888|solid tumors|solid tumors
5196810|NCT00836875|Pediatrics voriconazole invasive fungal infection invasive aspergillosis immunocompromized|pediatrics voriconazole invasive fungal infection invasive aspergillosis immunocompromized
5196811|NCT00836862|Hemodialysis|hemodialysis
5196812|NCT00836862|Vascular access|vascular access
5196813|NCT00836862|Arteriovenous fistula|arteriovenous fistula
5196814|NCT00836849|Bioequivalence|bioequivalence
5196815|NCT00836849|Healthy Subjects|healthy subjects
5196816|NCT00836836|Childhood epilepsy|childhood epilepsy
5196817|NCT00836836|ketogenic diet|ketogenic diet
5196818|NCT00836823|Patient-reported most bothersome symptom|patient-reported most bothersome symptom
5196819|NCT00836823|Patient-reported symptom-specific goal achievement|patient-reported symptom-specific goal achievement
5196820|NCT00836823|Medical treatment|medical treatment
5196821|NCT00836810|Circadian variations of cytokines in PMR|circadian variations of cytokines in pmr
5196822|NCT00836810|effect of TRT Prednisone in cytokines|effect of trt prednisone in cytokines
5196823|NCT00836797|Alveolar Bone Loss|alveolar bone loss
5196824|NCT00836797|Alveolar ridge|alveolar ridge
5196825|NCT00836797|Alveolar Process|alveolar process
5196826|NCT00836784|Old tooth brush|old tooth brush
5196827|NCT00836784|Plaque removal|plaque removal
5196828|NCT00836771|Infant formula|infant formula
5196829|NCT00836771|Probiotic microorganisms|probiotic microorganisms
5196830|NCT00836771|prebiotic|prebiotic
5196831|NCT00836745|Advanced renal cell Cancer|advanced renal cell cancer
5196832|NCT00836745|Non interventional study|non interventional study
5196833|NCT00836745|Renal Cancer|renal cancer
5196834|NCT00836745|Sutent|sutent
5196835|NCT00836745|Metastatic|metastatic
5196836|NCT00836745|Advanced Renal Cell Carcinoma|advanced renal cell carcinoma
5196837|NCT00836732|celle therapy|celle therapy
5196838|NCT00836732|cell culture|cell culture
5196839|NCT00836732|mesenchymal stem cells|mesenchymal stem cells
5196840|NCT00836719|Multiple sclerosis|multiple sclerosis
5196841|NCT00836719|safety|safety
5196842|NCT00836719|open label|open label
5196843|NCT00836719|Polyphenon E|polyphenon e
5196844|NCT00836719|EGCG|egcg
5196845|NCT00836719|NAA|naa
5196846|NCT00836719|N-acetyl-aspartate|n-acetyl-aspartate
5196847|NCT00836719|MRI|mri
5196848|NCT00836706|Bioequivalence|bioequivalence
5196849|NCT00836706|Healthy Subjects|healthy subjects
5196850|NCT00836693|Erectile Dysfunction|erectile dysfunction
5196851|NCT00836667|Bioequivalence|bioequivalence
5196852|NCT00836667|Healthy Subjects|healthy subjects
5196853|NCT00836654|EpCAM positive tumor|epcam positive tumor
5196854|NCT00836654|malignant ascites|malignant ascites
5196855|NCT00836654|intraperitoneal|intraperitoneal
5196856|NCT00836641|preschool asthma|preschool asthma
5196857|NCT00836641|sequential pneumococcal immunization|sequential pneumococcal immunization
5196858|NCT00836641|immunogenicity|immunogenicity
5196859|NCT00836641|safety|safety
5196860|NCT00836589|Long-term safety and reliability of ICD leads|long-term safety and reliability of icd leads
5196861|NCT00836576|Bioequivalence|bioequivalence
5196862|NCT00836576|Healthy Subjects|healthy subjects
5196863|NCT00836563|Hemodialysis|hemodialysis
5196864|NCT00836563|Arteriovenous Graft|arteriovenous graft
5196865|NCT00836550|HIV|hiv
5196866|NCT00836550|HIV knowledge measure|hiv knowledge measure
5196867|NCT00836550|Teen HIV testing|teen hiv testing
5196868|NCT00836550|HIV Seronegativity|hiv seronegativity
5196869|NCT00836537|Bioequivalence|bioequivalence
5196870|NCT00836537|Healthy Subjects|healthy subjects
5196871|NCT00836524|IUGR|iugr
5196872|NCT00836524|Preeclampsia|preeclampsia
5196873|NCT00836524|ultrasound|ultrasound
5196874|NCT00836524|YKL-40|ykl-40
5196875|NCT00836472|Bioequivalence|bioequivalence
5196876|NCT00836472|Healthy Subjects|healthy subjects
5196877|NCT00836459|Humans|humans
5196878|NCT00836459|Middle Aged|middle aged
5196879|NCT00836459|Behavior Therapy|behavior therapy
5196880|NCT00836459|Directive Counseling|directive counseling
5196881|NCT00836459|Health Behavior|health behavior
5196882|NCT00836459|Interview, Psychological|interview, psychological
5196883|NCT00836459|Motivation|motivation
5196884|NCT00836459|Exercise|exercise
5196885|NCT00836459|Physical Fitness|physical fitness
5196886|NCT00836459|Self Efficacy|self efficacy
5196887|NCT00836459|Life Style|life style
5196888|NCT00836459|Health Promotion|health promotion
5196889|NCT00836459|Health Knowledge, Attitudes, Practice|health knowledge, attitudes, practice
5196890|NCT00836459|Body Mass Index|body mass index
5196891|NCT00836459|Monitoring, Ambulatory|monitoring, ambulatory
5196892|NCT00836459|Walking|walking
5196893|NCT00836446|school-aged|school-aged
5196894|NCT00836446|children|children
5196895|NCT00836446|obesity|obesity
5196896|NCT00836446|cardiovascular risk|cardiovascular risk
5196897|NCT00836446|physical activity|physical activity
5196898|NCT00836433|staff education|staff education
5196899|NCT00836433|complexity science|complexity science
5196900|NCT00836433|social constructivist theory|social constructivist theory
5196901|NCT00836420|ammonia|ammonia
5196902|NCT00836420|acute liver failure|acute liver failure
5196903|NCT00836420|brain edema|brain edema
5196904|NCT00836420|oxidative metabolism|oxidative metabolism
5196905|NCT00836420|intracranial pressure|intracranial pressure
5196906|NCT00836407|pancreatic cancer|pancreatic cancer
5196907|NCT00836407|vaccine|vaccine
5196908|NCT00836407|immunotherapy|immunotherapy
5196909|NCT00836407|antibody|antibody
5196910|NCT00836407|CTLA-4|ctla-4
5196911|NCT00836394|arthritis|arthritis
5196912|NCT00836394|juvenile idiopathic arthritis|juvenile idiopathic arthritis
5196913|NCT00836394|pediatric|pediatric
5196914|NCT00836394|intervention|intervention
5196915|NCT00836394|vibration therapy|vibration therapy
5196917|NCT00836381|Overactive bladder|overactive bladder
5196918|NCT00836381|Antimuscarinics|antimuscarinics
5196919|NCT00836381|Patient-reported goal achievement|patient-reported goal achievement
5196920|NCT00836368|Asthma|asthma
5196921|NCT00836368|Asthmatic|asthmatic
5196922|NCT00836368|Allergy|allergy
5196923|NCT00836368|Allergic|allergic
5196924|NCT00836368|Gamma-tocopherol|gamma-tocopherol
5196925|NCT00836368|Vitamin|vitamin
5196926|NCT00836368|Vitamin E|vitamin e
5196927|NCT00836355|stroke|stroke
5196928|NCT00836355|magnetic resonance imaging|magnetic resonance imaging
5196929|NCT00836355|enoxaparin|enoxaparin
5196930|NCT00836355|minocycline|minocycline
5196931|NCT00836355|NIH stroke scale|nih stroke scale
5196932|NCT00836355|modified Rankin scale|modified rankin scale
5196933|NCT00836355|neuroprotection|neuroprotection
5196934|NCT00836342|Non-melanoma skin cancer|non-melanoma skin cancer
5196935|NCT00836342|Basal cell carcinoma|basal cell carcinoma
5196936|NCT00836342|Squamous cell carcinoma|squamous cell carcinoma
5196937|NCT00836329|Neurologic|neurologic
5196938|NCT00836329|Diabetes|diabetes
5196939|NCT00836329|Cardiac Surgery|cardiac surgery
5196940|NCT00836329|Stroke|stroke
5196941|NCT00836316|laparoscopic cholecystectomy|laparoscopic cholecystectomy
5196942|NCT00836290|risk reduction|risk reduction
5196943|NCT00836290|HIV prevention|hiv prevention
5196944|NCT00836290|HIV education|hiv education
5196945|NCT00836290|HIV Seronegativity|hiv seronegativity
5196946|NCT00836277|Panitumumab|panitumumab
5196947|NCT00836277|Irinotecan|irinotecan
5196948|NCT00836277|Esophageal Adenocarcinoma|esophageal adenocarcinoma
5196949|NCT00836277|Phase II|phase ii
5196950|NCT00836264|Morphine|morphine
5196951|NCT00836264|Phenotype|phenotype
5196952|NCT00836264|Genotype|genotype
5196953|NCT00836264|Tonsillectomy|tonsillectomy
5196954|NCT00836264|Adenoidectomy|adenoidectomy
5196955|NCT00836264|Opioid Receptors|opioid receptors
5196956|NCT00836264|Genome-Wide Association|genome-wide association
5196957|NCT00836264|Pharmacokinetics|pharmacokinetics
5196958|NCT00836251|energy expenditure|energy expenditure
5196959|NCT00836251|schizophrenia|schizophrenia
5196960|NCT00836238|Prostate Cancer|prostate cancer
5196961|NCT00836238|Neural Functioning Assessment|neural functioning assessment
5196962|NCT00836238|Physical Assessment|physical assessment
5196963|NCT00836238|Questionnaire|questionnaire
5196964|NCT00836238|Objective Measures of Functional Status|objective measures of functional status
5196965|NCT00836238|Physical Function|physical function
5196966|NCT00836238|Symptom Assessment Interview|symptom assessment interview
5196967|NCT00836238|Elderly|elderly
5196968|NCT00836225|diabetes|diabetes
5196969|NCT00836225|SGLT2 inhibitor|sglt2 inhibitor
5196970|NCT00836212|HIV|hiv
5198254|NCT00830570|warfarin|warfarin
5196971|NCT00836212|Adjusting Antiretroviral Therapy|adjusting antiretroviral therapy
5196972|NCT00836212|Dosage using Therapeutic Drug Monitoring|dosage using therapeutic drug monitoring
5196973|NCT00836212|Swiss HIV Cohort Study|swiss hiv cohort study
5196974|NCT00836212|HIV Geneva|hiv geneva
5196975|NCT00836212|lopinavir|lopinavir
5196976|NCT00836212|efavirenz|efavirenz
5196977|NCT00836212|Treatment Experienced|treatment experienced
5196978|NCT00836199|smoking cessation|smoking cessation
5196979|NCT00836199|NicVAX|nicvax
5196980|NCT00836199|smoking vaccine|smoking vaccine
5196981|NCT00836199|smoking abstinence|smoking abstinence
5196982|NCT00836199|smoking|smoking
5196983|NCT00836199|tobacco cessation|tobacco cessation
5196984|NCT00836173|CARBOPLATIN|carboplatin
5196985|NCT00836173|DEXAMETHASONE|dexamethasone
5196986|NCT00836173|DIFFUSE LARGE B-CELL LYMPHOMA|diffuse large b-cell lymphoma
5196987|NCT00836173|ETOPOSIDE|etoposide
5196988|NCT00836173|GALLIUM NITRATE|gallium nitrate
5196989|NCT00836173|IFOSFAMIDE|ifosfamide
5196990|NCT00836173|PHASE II|phase ii
5196991|NCT00836173|RELAPSED OR REFRACTORY|relapsed or refractory
5196992|NCT00836173|RITUXIMAB|rituximab
5196993|NCT00836160|EGFR-TKI therapy|egfr-tki therapy
5196994|NCT00836160|NSCLC|nsclc
5196995|NCT00836160|Efficacy|efficacy
5196996|NCT00836134|pain relief after umbilical hernia repair|pain relief after umbilical hernia repair
5196997|NCT00836134|morphine consumption|morphine consumption
5196998|NCT00836134|plasma bupivacaine levels|plasma bupivacaine levels
5196999|NCT00836121|Teratoma|teratoma
5197000|NCT00836121|Mediastinum|mediastinum
5197001|NCT00836108|Lung Diseases, Obstructive|lung diseases, obstructive
5197002|NCT00836108|Breathing Exercises|breathing exercises
5197003|NCT00836108|Exercise Tolerance|exercise tolerance
5197004|NCT00836108|Dyspnea|dyspnea
5197005|NCT00836108|Arm Exercise|arm exercise
5197006|NCT00836095|laryngeal mask, proseal|laryngeal mask, proseal
5197007|NCT00836082|Healthy volunteers|healthy volunteers
5197008|NCT00836069|Generalized Anxiety Disorder|generalized anxiety disorder
5197009|NCT00836056|Bioequivalence|bioequivalence
5197010|NCT00836056|Healthy Subjects|healthy subjects
5197011|NCT00836043|CLL|cll
5197012|NCT00836043|alemtuzumab|alemtuzumab
5197013|NCT00836004|Bioequivalence|bioequivalence
5197014|NCT00836004|Healthy Subjects|healthy subjects
5197015|NCT00835991|Bioequivalence|bioequivalence
5197016|NCT00835991|Healthy Subjects|healthy subjects
5197017|NCT00835978|axitinib or AG-013736 dose titration (increase) renal cell carcinoma|axitinib or ag-013736 dose titration (increase) renal cell carcinoma
5197018|NCT00835978|kidney cancer|kidney cancer
5197019|NCT00835965|Laparoscopic|laparoscopic
5197020|NCT00835965|Surgery|surgery
5197021|NCT00835965|Postoperative|postoperative
5197022|NCT00835965|Nausea|nausea
5197023|NCT00835965|Vomiting|vomiting
5197024|NCT00835965|Aprepitant|aprepitant
5197025|NCT00835965|Dexamethasone|dexamethasone
5197026|NCT00835965|Postoperative Nausea, Postoperative Vomiting|postoperative nausea, postoperative vomiting
5197027|NCT00835939|Achilles|achilles
5197028|NCT00835939|Tendinopathy|tendinopathy
5197029|NCT00835939|Sclerotherapy|sclerotherapy
5197030|NCT00835939|Neovascularisation|neovascularisation
5197031|NCT00835939|sports medicine|sports medicine
5197032|NCT00835939|interventional radiology|interventional radiology
5197033|NCT00835926|Influenza|influenza
5197034|NCT00835926|Fluzone®|fluzone®
5197035|NCT00835913|Autonomic nervous system|autonomic nervous system
5197036|NCT00835913|Sepsis shock|sepsis shock
5197037|NCT00835913|severe sepsis|severe sepsis
5197038|NCT00835913|sinusal change|sinusal change
5197039|NCT00835913|Myocardiac fixing|myocardiac fixing
5197040|NCT00835913|NTproBNP|ntprobnp
5197041|NCT00835913|Patient in intensive care unit with sepsis shock or severe|patient in intensive care unit with sepsis shock or severe
5197042|NCT00835913|Sepsis|sepsis
5197043|NCT00835900|smoking cessation|smoking cessation
5197044|NCT00835900|varenicline|varenicline
5197045|NCT00835900|smoking cessation treatment|smoking cessation treatment
5197046|NCT00835874|probiotic|probiotic
5197047|NCT00835874|preterm|preterm
5197048|NCT00835874|lactation|lactation
5197049|NCT00835874|breast feeding|breast feeding
5197050|NCT00835874|necrotizing enterocolitis|necrotizing enterocolitis
5197051|NCT00835874|sepsis|sepsis
5197052|NCT00835874|bacterial cultures|bacterial cultures
5197053|NCT00835874|lactating mother|lactating mother
5197054|NCT00835874|breast feeding of at least 50% of enteric feeding volume|breast feeding of at least 50% of enteric feeding volume
5197055|NCT00835874|Infant, very low birth weight|infant, very low birth weight
5197056|NCT00835861|Non Insulin Dependent Diabetes|non insulin dependent diabetes
5197057|NCT00835861|Pregnancy|pregnancy
5197058|NCT00835848|ST-segment elevation myocardial infarction|st-segment elevation myocardial infarction
5197059|NCT00835848|Primary PCI|primary pci
5197060|NCT00835848|Postconditioning|postconditioning
5197061|NCT00835835|Multiple Sclerosis|multiple sclerosis
5197062|NCT00835835|gait|gait
5197063|NCT00835835|falls|falls
5197064|NCT00835835|lokomat|lokomat
5197065|NCT00835835|body-weight support treadmill training|body-weight support treadmill training
5197066|NCT00835822|Chronic Venous Insufficiency, Venocur Triplex®|chronic venous insufficiency, venocur triplex®
5197165|NCT00835302|Mobilization|mobilization
5197067|NCT00835809|Acute respiratory insufficiency respiratory|acute respiratory insufficiency respiratory
5197068|NCT00835809|Biomarkers|biomarkers
5197069|NCT00835809|Emergency|emergency
5197070|NCT00835809|Intensive care unit|intensive care unit
5197071|NCT00835809|Prospective|prospective
5197072|NCT00835809|Patient hospitalize in emergency or in intensive care unit|patient hospitalize in emergency or in intensive care unit
5197073|NCT00835809|for acute respiratory insufficiency|for acute respiratory insufficiency
5197074|NCT00835796|Bioequivalence|bioequivalence
5197075|NCT00835796|Healthy Subjects|healthy subjects
5197076|NCT00835770|relapsing|relapsing
5197077|NCT00835770|multiple sclerosis|multiple sclerosis
5197078|NCT00835770|remitting|remitting
5197079|NCT00835770|oral|oral
5197080|NCT00835744|ovulation induction|ovulation induction
5197081|NCT00835744|clomiphene citrate|clomiphene citrate
5197082|NCT00835744|gonadotropins|gonadotropins
5197083|NCT00835731|induced abortion|induced abortion
5197084|NCT00835731|misoprostol|misoprostol
5197085|NCT00835731|cervical ripening|cervical ripening
5197086|NCT00835731|second trimester abortion|second trimester abortion
5197087|NCT00835731|Dilapan-S|dilapan-s
5197088|NCT00835705|Bioequivalence|bioequivalence
5197089|NCT00835705|Healthy Subjects|healthy subjects
5197090|NCT00835692|Bioequivalence|bioequivalence
5197091|NCT00835692|Healthy Subjects|healthy subjects
5197092|NCT00835666|Bioequivalence|bioequivalence
5197093|NCT00835666|Healthy Subjects|healthy subjects
5197094|NCT00835640|Bioequivalence|bioequivalence
5197095|NCT00835640|Healthy Subjects|healthy subjects
5197096|NCT00835627|Treatment|treatment
5197097|NCT00835627|Cognitive Behavior Therapy|cognitive behavior therapy
5197098|NCT00835627|pharmacotherapy|pharmacotherapy
5197099|NCT00835627|psychogenic nonepileptic seizures|psychogenic nonepileptic seizures
5197100|NCT00835627|pseudoseizures|pseudoseizures
5197101|NCT00835627|dissociative seizures|dissociative seizures
5197102|NCT00835627|conversion disorder|conversion disorder
5197103|NCT00835614|Bioequivalence|bioequivalence
5197104|NCT00835614|Healthy Subjects|healthy subjects
5197105|NCT00835588|Bioequivalence|bioequivalence
5197106|NCT00835588|Healthy Subjects|healthy subjects
5197107|NCT00835575|Bioequivalence|bioequivalence
5197108|NCT00835575|Healthy Subjects|healthy subjects
5197109|NCT00835562|Shoulder fractures|shoulder fractures
5197110|NCT00835562|Proximal humeral fractures|proximal humeral fractures
5197111|NCT00835562|Randomised clinical trial|randomised clinical trial
5197112|NCT00835562|elderly|elderly
5197113|NCT00835562|Displaced four-part fractures of the proximal humerus|displaced four-part fractures of the proximal humerus
5197114|NCT00835549|Bioequivalence|bioequivalence
5197115|NCT00835549|Healthy Subjects|healthy subjects
5197116|NCT00835536|Bioequivalence|bioequivalence
5197117|NCT00835536|Healthy Subjects|healthy subjects
5197118|NCT00835523|frozen-thawed embryo replacement|frozen-thawed embryo replacement
5197119|NCT00835523|GnRH agonist|gnrh agonist
5197120|NCT00835523|GnRH antagonist|gnrh antagonist
5197121|NCT00835523|ovarian hyperstimulation|ovarian hyperstimulation
5197122|NCT00835510|Tinea pedis|tinea pedis
5197123|NCT00835497|Bioequivalence|bioequivalence
5197124|NCT00835497|Healthy Subjects|healthy subjects
5197125|NCT00835484|Bioequivalence|bioequivalence
5197126|NCT00835484|Healthy Subjects|healthy subjects
5197127|NCT00835471|Lung cancer|lung cancer
5197128|NCT00835471|non-small-cell|non-small-cell
5197129|NCT00835471|erlotinib|erlotinib
5197130|NCT00835471|chemotherapy|chemotherapy
5197131|NCT00835458|gastric fistula|gastric fistula
5197132|NCT00835458|perforation|perforation
5197133|NCT00835458|endoscopy|endoscopy
5197134|NCT00835458|closure|closure
5197135|NCT00835458|endolumenal|endolumenal
5197136|NCT00835432|Lateral augmentation|lateral augmentation
5197137|NCT00835432|GBR|gbr
5197138|NCT00835432|BoneCeramic|boneceramic
5197139|NCT00835432|collagen membrane|collagen membrane
5197140|NCT00835432|histomorphometry|histomorphometry
5197141|NCT00835432|morphometry|morphometry
5197142|NCT00835432|reentry|reentry
5197143|NCT00835432|biopsy|biopsy
5197144|NCT00835419|metastatic malignant melanoma with cyclin D1 positivity|metastatic malignant melanoma with cyclin d1 positivity
5197145|NCT00835406|Bioequivalence|bioequivalence
5197146|NCT00835406|Healthy Subjects|healthy subjects
5197147|NCT00835393|Bioequivalence|bioequivalence
5197148|NCT00835393|Healthy Subjects|healthy subjects
5197149|NCT00835367|Bioequivalence|bioequivalence
5197150|NCT00835367|Healthy Subjects|healthy subjects
5197151|NCT00835354|Bioequivalence|bioequivalence
5197152|NCT00835354|Healthy Subjects|healthy subjects
5197153|NCT00835341|oral epithelial dysplasia|oral epithelial dysplasia
5197154|NCT00835341|p16 methylation|p16 methylation
5197155|NCT00835341|prognosis|prognosis
5197156|NCT00835341|malignant transformation|malignant transformation
5197157|NCT00835341|oral squamous cell carcinoma|oral squamous cell carcinoma
5197158|NCT00835328|hyperinsulinism|hyperinsulinism
5197159|NCT00835328|hypoglycemia|hypoglycemia
5197160|NCT00835328|ATP- sensitive potassium channel (KATP)|atp- sensitive potassium channel (katp)
5197161|NCT00835315|interdigital psoriasis (psoriasis alba)|interdigital psoriasis (psoriasis alba)
5197162|NCT00835302|Cervical|cervical
5197163|NCT00835302|Thoracic|thoracic
5197164|NCT00835302|Manipulation|manipulation
5197166|NCT00835302|Clinical prediction rule|clinical prediction rule
5197167|NCT00835302|Shoulder pain.|shoulder pain.
5197168|NCT00835289|Clinical Trials, Randomized|clinical trials, randomized
5197169|NCT00835276|Bioequivalence|bioequivalence
5197170|NCT00835276|Healthy Subjects|healthy subjects
5197171|NCT00835263|Bioequivalence|bioequivalence
5197172|NCT00835263|Healthy Subjects|healthy subjects
5197173|NCT00835250|Transvaginal cholecystectomy|transvaginal cholecystectomy
5197174|NCT00835250|NOTES|notes
5197175|NCT00835250|Minilaparoscopy|minilaparoscopy
5197176|NCT00835250|Endoscopic surgery|endoscopic surgery
5197177|NCT00835250|Cholecystectomy|cholecystectomy
5197178|NCT00835250|Surgical translumenal endoscopic surgery|surgical translumenal endoscopic surgery
5197179|NCT00835250|Transvaginal translumenal endoscopic surgery|transvaginal translumenal endoscopic surgery
5197180|NCT00835237|Boostrix®|boostrix®
5197181|NCT00835237|adults|adults
5197182|NCT00835224|Spinal Cord Injury|spinal cord injury
5197183|NCT00835224|Orthostatic Hypotension|orthostatic hypotension
5197184|NCT00835224|Blood Pressure|blood pressure
5197185|NCT00835224|Midodrine Hydrochloride|midodrine hydrochloride
5197186|NCT00835224|L-NAME|l-name
5197187|NCT00835211|Bioequivalence|bioequivalence
5197188|NCT00835211|Healthy Subjects|healthy subjects
5197189|NCT00835185|Antibodies, Monoclonal|antibodies, monoclonal
5197190|NCT00835185|Colorectal Neoplasms|colorectal neoplasms
5197191|NCT00835172|Bioequivalence|bioequivalence
5197192|NCT00835172|Healthy Subjects|healthy subjects
5197193|NCT00835159|Postoperative Delirium|postoperative delirium
5197194|NCT00835159|Postoperative Cognitive Dysfunction|postoperative cognitive dysfunction
5197195|NCT00835159|Rivastigmine|rivastigmine
5197196|NCT00835159|Exelon|exelon
5197197|NCT00835159|Memory impairment|memory impairment
5197198|NCT00835159|Delirium|delirium
5197199|NCT00835159|Cognitive function|cognitive function
5197200|NCT00835146|Bioequivalence|bioequivalence
5197201|NCT00835146|Healthy Subjects|healthy subjects
5197202|NCT00835133|family|family
5197203|NCT00835133|history|history
5197204|NCT00835133|pancreas|pancreas
5197205|NCT00835133|cancer|cancer
5197206|NCT00835133|melanoma|melanoma
5197207|NCT00835133|genetic|genetic
5197208|NCT00835107|Bipolar Depression|bipolar depression
5197209|NCT00835107|Sleep|sleep
5197210|NCT00835107|Polysomnograph|polysomnograph
5197211|NCT00835107|Slow Wave Sleep|slow wave sleep
5197212|NCT00835107|Ziprasidone|ziprasidone
5197213|NCT00835107|Antipsychotic|antipsychotic
5197214|NCT00835107|Placebo|placebo
5197215|NCT00835081|Bioequivalence|bioequivalence
5197216|NCT00835081|Healthy Subjects|healthy subjects
5197217|NCT00835068|Hemophilia B|hemophilia b
5197218|NCT00835068|observational|observational
5197219|NCT00835068|post marketing study|post marketing study
5197220|NCT00835055|rectal cancer with neoadjuvant treatment|rectal cancer with neoadjuvant treatment
5197221|NCT00835055|standardized clinical tests|standardized clinical tests
5197222|NCT00835055|tumor markers on tumor tissue|tumor markers on tumor tissue
5197223|NCT00835042|Bioequivalence|bioequivalence
5197224|NCT00835042|Healthy Subjects|healthy subjects
5197225|NCT00835029|oral|oral
5197226|NCT00835029|candida|candida
5197227|NCT00835029|denture|denture
5197228|NCT00835029|clotrimazole|clotrimazole
5197229|NCT00835029|slow releases|slow releases
5197230|NCT00835016|Early psychosocial stimulation, RCT, Depressed mother|early psychosocial stimulation, rct, depressed mother
5197231|NCT00835003|Neonatal admission|neonatal admission
5197232|NCT00835003|Elective Caesarean Section|elective caesarean section
5197233|NCT00835003|Timing|timing
5197234|NCT00835003|Choice behavior|choice behavior
5197235|NCT00835003|Intraoperative complications|intraoperative complications
5197236|NCT00835003|Postoperative complications|postoperative complications
5197237|NCT00834990|Bioequivalence|bioequivalence
5197238|NCT00834990|Healthy Subjects|healthy subjects
5197239|NCT00834977|Bioequivalence|bioequivalence
5197240|NCT00834977|Healthy Subjects|healthy subjects
5197241|NCT00834964|Bioequivalence|bioequivalence
5197242|NCT00834964|Healthy Subjects|healthy subjects
5197243|NCT00834951|Diffuse large B-cell lymphoma|diffuse large b-cell lymphoma
5197244|NCT00834951|Elderly patients|elderly patients
5197245|NCT00834951|Low dose total body irradiation|low dose total body irradiation
5197246|NCT00834951|RCHOP14|rchop14
5197247|NCT00834938|diabetes mellitus, type 2|diabetes mellitus, type 2
5197248|NCT00834938|Insulin resistance|insulin resistance
5197249|NCT00834938|bariatric surgery|bariatric surgery
5197250|NCT00834938|Glucagon-Like Peptide 1|glucagon-like peptide 1
5197251|NCT00834938|Gastric Inhibitory Polypeptide|gastric inhibitory polypeptide
5197252|NCT00834938|insulin|insulin
5197253|NCT00834938|glucagon|glucagon
5197254|NCT00834938|ghrelin|ghrelin
5197255|NCT00834938|adiponectin|adiponectin
5197256|NCT00834938|Cytokines|cytokines
5197257|NCT00834938|gastric bypass|gastric bypass
5197258|NCT00834938|Obesity|obesity
5197259|NCT00834925|atrial fibrillation with rapid ventricular response|atrial fibrillation with rapid ventricular response
5197260|NCT00834912|Healthy Subjects|healthy subjects
5197261|NCT00834899|Sickle cell disease|sickle cell disease
5197262|NCT00834899|Pain crisis|pain crisis
5197263|NCT00834899|Acute pain episode|acute pain episode
5197264|NCT00834899|Eptifibatide|eptifibatide
5197265|NCT00834899|Antiplatelet therapy|antiplatelet therapy
5197266|NCT00834899|Safety|safety
5197267|NCT00834899|Treatment|treatment
5197268|NCT00834873|Bioequivalence|bioequivalence
5197269|NCT00834873|Healthy Subjects|healthy subjects
5197270|NCT00834860|chronic hepatitis C|chronic hepatitis c
5197271|NCT00834860|sustained virological response|sustained virological response
5197272|NCT00834860|peginterferon|peginterferon
5197273|NCT00834860|ribavirin|ribavirin
5197274|NCT00834860|neoplasm|neoplasm
5197275|NCT00834847|Bioequivalence|bioequivalence
5197276|NCT00834847|Healthy Subjects|healthy subjects
5197277|NCT00834834|Suicidal and Self-Injurious Behavior|suicidal and self-injurious behavior
5197278|NCT00834821|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
5197279|NCT00834821|ADHD, Predominantly Inattentive Type|adhd, predominantly inattentive type
5197280|NCT00834821|Inattention|inattention
5197281|NCT00834821|Psychosocial Intervention|psychosocial intervention
5197282|NCT00834821|Behavioral Intervention|behavioral intervention
5197283|NCT00834808|Healthy volunteers|healthy volunteers
5197284|NCT00834795|Bioequivalence|bioequivalence
5197285|NCT00834795|Healthy Subjects|healthy subjects
5197286|NCT00834782|PK|pk
5197287|NCT00834782|IOP|iop
5197288|NCT00834756|Bioequivalence|bioequivalence
5197289|NCT00834756|Healthy Subjects|healthy subjects
5197290|NCT00834743|Bioequivalence|bioequivalence
5197291|NCT00834743|Healthy Subjects|healthy subjects
5197292|NCT00834717|Bioequivalence|bioequivalence
5197293|NCT00834717|Healthy Subjects|healthy subjects
5197294|NCT00834704|PEGPH20|pegph20
5197295|NCT00834704|PEGylated recombinant human hyaluronidase|pegylated recombinant human hyaluronidase
5197296|NCT00834704|Metastatic or locally advanced solid tumor|metastatic or locally advanced solid tumor
5197297|NCT00834691|Inflammation|inflammation
5197298|NCT00834691|Oxidative stress|oxidative stress
5197299|NCT00834691|Estimated glomerular filtration rate|estimated glomerular filtration rate
5197300|NCT00834678|male breast cancer|male breast cancer
5197301|NCT00834678|recurrent breast cancer|recurrent breast cancer
5197302|NCT00834678|stage IIIB breast cancer|stage iiib breast cancer
5197303|NCT00834678|stage IIIC breast cancer|stage iiic breast cancer
5197304|NCT00834678|stage IV breast cancer|stage iv breast cancer
5197305|NCT00834678|estrogen receptor-negative breast cancer|estrogen receptor-negative breast cancer
5197306|NCT00834678|HER2-negative breast cancer|her2-negative breast cancer
5197307|NCT00834678|progesterone receptor-negative breast cancer|progesterone receptor-negative breast cancer
5197308|NCT00834678|triple-negative breast cancer|triple-negative breast cancer
5197309|NCT00834652|Metabolic Diseases|metabolic diseases
5197310|NCT00834652|Depressive Disorder, Major|depressive disorder, major
5197311|NCT00834652|Depressive Disorder|depressive disorder
5197312|NCT00834652|Glucose Metabolism Disorders|glucose metabolism disorders
5197313|NCT00834652|Depression Recurrence|depression recurrence
5197314|NCT00834639|Bioequivalence|bioequivalence
5197315|NCT00834639|Healthy Subjects|healthy subjects
5197316|NCT00834626|Ileal Interposition|ileal interposition
5197317|NCT00834626|Sleeve Gastrectomy|sleeve gastrectomy
5197318|NCT00834626|Type-2 Diabetes|type-2 diabetes
5197319|NCT00834613|Bioequivalence|bioequivalence
5197320|NCT00834613|Healthy Subjects|healthy subjects
5197321|NCT00834587|Bioequivalence|bioequivalence
5197322|NCT00834587|Healthy Subjects|healthy subjects
5197323|NCT00834574|Bioequivalence|bioequivalence
5197324|NCT00834574|Healthy Subjects|healthy subjects
5197325|NCT00834561|Bioequivalence|bioequivalence
5197326|NCT00834561|Healthy Subjects|healthy subjects
5197327|NCT00834548|Magnetic resonance|magnetic resonance
5197328|NCT00834548|whole body|whole body
5197329|NCT00834548|angiography|angiography
5197330|NCT00834548|hybrid protocol|hybrid protocol
5197331|NCT00834548|MRI|mri
5197332|NCT00834535|Bioequivalence|bioequivalence
5197333|NCT00834535|Healthy Subjects|healthy subjects
5197334|NCT00834522|Bioequivalence|bioequivalence
5197335|NCT00834522|Healthy Subjects|healthy subjects
5197336|NCT00834483|Safety|safety
5197337|NCT00834483|Efficacy|efficacy
5197338|NCT00834483|Cost-savings|cost-savings
5197339|NCT00834483|Cosmesis|cosmesis
5197340|NCT00834483|Safety and efficacy of wound closure|safety and efficacy of wound closure
5197341|NCT00834483|Cost-savings potential|cost-savings potential
5197342|NCT00834483|Cosmesis of the wound/scar|cosmesis of the wound/scar
5197343|NCT00834457|AIDS-related Kaposi's sarcoma|aids-related kaposi's sarcoma
5197344|NCT00834457|antiretroviral therapy|antiretroviral therapy
5197345|NCT00834444|Bioequivalence|bioequivalence
5197346|NCT00834444|Healthy Subjects|healthy subjects
5197347|NCT00834431|Bioequivalence|bioequivalence
5197348|NCT00834431|Healthy Subjects|healthy subjects
5197349|NCT00834418|Bioequivalence|bioequivalence
5197350|NCT00834418|Healthy Subjects|healthy subjects
5197351|NCT00834405|Bioequivalence|bioequivalence
5197352|NCT00834405|Healthy Subjects|healthy subjects
5197353|NCT00834379|Bioequivalence|bioequivalence
5197354|NCT00834379|Healthy Subjects|healthy subjects
5197355|NCT00834366|Healthy volunteers|healthy volunteers
5197356|NCT00834340|Bioequivalence|bioequivalence
5197357|NCT00834340|Healthy Subjects|healthy subjects
5197358|NCT00834327|Restless Legs Syndrome|restless legs syndrome
5197359|NCT00834301|End Stage Renal Disease|end stage renal disease
5197360|NCT00834301|Inflammation|inflammation
5197361|NCT00834288|Healthy subjects|healthy subjects
5197362|NCT00834288|Pharmacokinetics|pharmacokinetics
5197363|NCT00834288|Bioavailability|bioavailability
5197364|NCT00834275|Bioequivalence|bioequivalence
5197365|NCT00834275|Healthy Subjects|healthy subjects
5197366|NCT00834249|Bioequivalence|bioequivalence
5197367|NCT00834249|Healthy Subjects|healthy subjects
5197368|NCT00834236|gastric cancer|gastric cancer
5197369|NCT00834236|proteomics|proteomics
5197370|NCT00834236|gastric juice|gastric juice
5197371|NCT00834223|refractory chronic forms of open angle glaucoma (OAG)|refractory chronic forms of open angle glaucoma (oag)
5197372|NCT00834223|OAG|oag
5197373|NCT00834223|glaucoma|glaucoma
5197374|NCT00834197|Bioequivalence|bioequivalence
5197375|NCT00834197|Healthy Subjects|healthy subjects
5197376|NCT00834184|nikkomycin Z|nikkomycin z
5197377|NCT00834184|evaluate safety, tolerance and pharmacokinetics of nikkomycin Z|evaluate safety, tolerance and pharmacokinetics of nikkomycin z
5197378|NCT00834158|Hepatocellular Carcinoma|hepatocellular carcinoma
5197379|NCT00834158|Hepatitis B|hepatitis b
5197380|NCT00834158|Transarterial chemoembolization (TACE)|transarterial chemoembolization (tace)
5197381|NCT00834158|Portal vein embolization (PVE)|portal vein embolization (pve)
5197382|NCT00834158|Surgical resection|surgical resection
5197383|NCT00834158|Disease-free survival|disease-free survival
5197384|NCT00834158|Overall survival|overall survival
5197385|NCT00834145|Edema|edema
5197386|NCT00834145|Right heart failure|right heart failure
5197387|NCT00834145|Cor pulmonale|cor pulmonale
5197388|NCT00834145|Pump|pump
5197389|NCT00834145|Leg compression|leg compression
5197390|NCT00834132|Bioequivalence|bioequivalence
5197391|NCT00834132|Healthy Subjects|healthy subjects
5197392|NCT00834106|HPV 6/11/16/18 Infection|hpv 6/11/16/18 infection
5197393|NCT00834093|Epstein-Barr Virus|epstein-barr virus
5197394|NCT00834093|NPC|npc
5197395|NCT00834093|EBV|ebv
5197396|NCT00834093|immunotherapy|immunotherapy
5197397|NCT00834080|opioid dependence|opioid dependence
5197398|NCT00834080|VIVITROL|vivitrol
5197399|NCT00834080|opioid-related disorders|opioid-related disorders
5197400|NCT00834067|Bioequivalence|bioequivalence
5197401|NCT00834067|Healthy Subjects|healthy subjects
5197402|NCT00834041|aliskiren|aliskiren
5197403|NCT00834041|pediatric|pediatric
5197404|NCT00834041|hypertension|hypertension
5197405|NCT00834041|pharmacokinetics (PK)|pharmacokinetics (pk)
5197406|NCT00834041|pharmacodynamics (PD)|pharmacodynamics (pd)
5197407|NCT00834041|plasma renin activity|plasma renin activity
5197408|NCT00834041|mini-tablet formulation|mini-tablet formulation
5197409|NCT00834028|hepatocellular carcinoma|hepatocellular carcinoma
5197410|NCT00834028|vascular endothelial growth factor|vascular endothelial growth factor
5197411|NCT00834028|angiopoietin|angiopoietin
5197412|NCT00834028|cathepsin|cathepsin
5197413|NCT00834015|spinal fusion|spinal fusion
5197414|NCT00834015|pain|pain
5197415|NCT00834015|disability|disability
5197416|NCT00834015|muscle strength|muscle strength
5197417|NCT00834015|mobility|mobility
5197418|NCT00834015|quality of life|quality of life
5197419|NCT00834015|lumbar|lumbar
5197420|NCT00834015|isthmic or degenerative spondylolisthesis|isthmic or degenerative spondylolisthesis
5197421|NCT00834002|AML in remission|aml in remission
5197422|NCT00833950|Tinnitus|tinnitus
5197423|NCT00833950|Phase Out|phase out
5197424|NCT00833937|Bioequivalence|bioequivalence
5197425|NCT00833937|Healthy Subjects|healthy subjects
5197426|NCT00833924|Low Profile|low profile
5197427|NCT00833924|Abdominal Aortic Aneurysms|abdominal aortic aneurysms
5197428|NCT00833924|Endovascular|endovascular
5197429|NCT00833911|Moderate to severe symptomatic osteoarthritis of the knee|moderate to severe symptomatic osteoarthritis of the knee
5197430|NCT00833898|depression|depression
5197431|NCT00833898|stress|stress
5197432|NCT00833898|caregiving|caregiving
5197433|NCT00833898|anxiety|anxiety
5197434|NCT00833898|psychoeducation intervention|psychoeducation intervention
5197435|NCT00833898|psycho-oncology|psycho-oncology
5197436|NCT00833885|Non pharmaceutical measures|non pharmaceutical measures
5197437|NCT00833859|stereotactic radiosurgery|stereotactic radiosurgery
5197438|NCT00833859|borderline resectable pancreatic cancer|borderline resectable pancreatic cancer
5197439|NCT00833859|gastrointestinal|gastrointestinal
5197440|NCT00833859|pancreas|pancreas
5197441|NCT00833846|Mitochondria in Platelets|mitochondria in platelets
5197442|NCT00833846|Mitochondria in Diabetes|mitochondria in diabetes
5197443|NCT00833846|Insulin Resistance and Mitochondria|insulin resistance and mitochondria
5197444|NCT00833846|Diabetes|diabetes
5197445|NCT00833846|Insulin Resistance|insulin resistance
5197446|NCT00833820|ALS|als
5197447|NCT00833820|transcranial brain stimulation|transcranial brain stimulation
5197448|NCT00833807|Melanoma|melanoma
5197449|NCT00833807|Metastatic Melanoma to the Liver|metastatic melanoma to the liver
5197450|NCT00833807|Liver metastasis|liver metastasis
5197451|NCT00833807|Nab-paclitaxel|nab-paclitaxel
5197452|NCT00833807|Abraxane|abraxane
5197453|NCT00833807|Paclitaxel (protein-bound)|paclitaxel (protein-bound)
5197454|NCT00833807|intraarterial intrahepatic administration|intraarterial intrahepatic administration
5197455|NCT00833807|Hepatic Artery|hepatic artery
5197456|NCT00833807|Hepatic Arterial Infusion|hepatic arterial infusion
5197457|NCT00833807|Hepatic Administration|hepatic administration
5197458|NCT00833781|HIV vaccine|hiv vaccine
5197459|NCT00833781|Dendritic cells|dendritic cells
5197460|NCT00833781|treatment experienced|treatment experienced
5197461|NCT00833755|Pain|pain
5197462|NCT00833755|Chronic pain|chronic pain
5197463|NCT00833755|Opioid induced hyperalgesia|opioid induced hyperalgesia
5197464|NCT00833755|Opioid therapy|opioid therapy
5197465|NCT00833742|somatization|somatization
5197466|NCT00833742|psychosomatic|psychosomatic
5197467|NCT00833742|short-term|short-term
5197468|NCT00833742|dynamic|dynamic
5197469|NCT00833742|psychotherapy|psychotherapy
5197470|NCT00833729|psoriasis|psoriasis
5197471|NCT00833729|etanercept|etanercept
5197472|NCT00833729|adalimumab|adalimumab
5197473|NCT00833729|moderate to severe plaque psoriasis|moderate to severe plaque psoriasis
5197474|NCT00833703|cyanotic congenital heart disease|cyanotic congenital heart disease
5197475|NCT00833703|shunt palliation|shunt palliation
5197476|NCT00833703|thrombosis|thrombosis
5197477|NCT00833703|clopidogrel|clopidogrel
5197478|NCT00833690|Parkinson's disease|parkinson's disease
5197479|NCT00833690|Parkinson disease|parkinson disease
5197480|NCT00833690|PD|pd
5197481|NCT00833690|inosine|inosine
5197482|NCT00833690|urate|urate
5197483|NCT00833690|uric acid|uric acid
5197484|NCT00833690|cerebrospinal fluid|cerebrospinal fluid
5197485|NCT00833677|Coping skills|coping skills
5197486|NCT00833677|Chinese|chinese
5197487|NCT00833677|Immigrant|immigrant
5197488|NCT00833677|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
5197489|NCT00833677|Family research|family research
5197490|NCT00833664|Bioequivalence|bioequivalence
5197491|NCT00833664|Healthy Subjects|healthy subjects
5197492|NCT00833651|Transplant|transplant
5197493|NCT00833651|Immunology|immunology
5197494|NCT00833651|Immunosuppression|immunosuppression
5197495|NCT00833638|Erectile Dysfunction|erectile dysfunction
5197496|NCT00833625|Gastrointestinal|gastrointestinal
5197497|NCT00833625|Esophagus|esophagus
5197498|NCT00833625|Cancer of the esophagus|cancer of the esophagus
5197499|NCT00833625|Biopsy|biopsy
5197500|NCT00833625|EGD|egd
5197501|NCT00833625|Esophagogastroduodenoscopy|esophagogastroduodenoscopy
5197502|NCT00833625|PET/CT|pet/ct
5197503|NCT00833625|Positive Emission Tomography/Computerized Tomography|positive emission tomography/computerized tomography
5197504|NCT00833625|Esophageal Cancer|esophageal cancer
5197505|NCT00833625|Chemoradiation|chemoradiation
5197506|NCT00833625|Chemotherapy|chemotherapy
5197507|NCT00833625|Radiation Therapy|radiation therapy
5197508|NCT00833612|IABC|iabc
5197509|NCT00833612|AMI|ami
5197510|NCT00833599|Lymphedema|lymphedema
5197511|NCT00833599|Genetic|genetic
5197512|NCT00833599|Lymphatic Disorder|lymphatic disorder
5197513|NCT00833599|Lipedema|lipedema
5197514|NCT00833599|Vascular Malformation|vascular malformation
5197515|NCT00833599|Vascular Anomaly|vascular anomaly
5197516|NCT00833599|Dercum Disease|dercum disease
5197517|NCT00833586|Bioequivalence|bioequivalence
5197518|NCT00833586|Healthy Subjects|healthy subjects
5197519|NCT00833573|GERD digestive expression|gerd digestive expression
5197520|NCT00833573|ages|ages
5197521|NCT00833560|Multiple Myeloma|multiple myeloma
5197522|NCT00833560|Untreated multiple myeloma|untreated multiple myeloma
5197523|NCT00833560|Bortezomib|bortezomib
5197524|NCT00833560|VELCADE|velcade
5197525|NCT00833560|Cyclophosphamide|cyclophosphamide
5197526|NCT00833560|Dexamethasone|dexamethasone
5197527|NCT00833560|Chemotherapy|chemotherapy
5197528|NCT00833560|Remission therapy|remission therapy
5197529|NCT00833560|Induction therapy|induction therapy
5197530|NCT00833560|Stem Cell Transplantation|stem cell transplantation
5197531|NCT00833547|sleep|sleep
5197532|NCT00833547|schizophrenia|schizophrenia
5197533|NCT00833547|procedural learning|procedural learning
5197534|NCT00833547|motor skill|motor skill
5197535|NCT00833534|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
5197536|NCT00833534|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
5197537|NCT00833534|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5197538|NCT00833534|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5197539|NCT00833534|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
5197540|NCT00833534|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5197541|NCT00833534|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5197542|NCT00833534|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
5197543|NCT00833534|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
5197544|NCT00833521|Bioequivalence|bioequivalence
5197545|NCT00833521|Healthy Subjects|healthy subjects
5197546|NCT00833508|Exercise capacity|exercise capacity
5197547|NCT00833508|Chemoradiotherapy|chemoradiotherapy
5197548|NCT00833508|Colorectal cancer|colorectal cancer
5197549|NCT00833469|women|women
5197550|NCT00833469|postpartum depression|postpartum depression
5197551|NCT00833469|anxiety|anxiety
5197552|NCT00833456|schizophrenia|schizophrenia
5197553|NCT00833456|Seroquel SR|seroquel sr
5197554|NCT00833456|atypical antipsychotics|atypical antipsychotics
5197555|NCT00833456|assessment of functioning|assessment of functioning
5197556|NCT00833456|GAF scale|gaf scale
5197557|NCT00833443|Methamphetamine|methamphetamine
5197558|NCT00833443|Addiction|addiction
5197559|NCT00833443|Pharmacogenomics|pharmacogenomics
5197560|NCT00833443|Amphetamine|amphetamine
5197561|NCT00833443|Bupropion|bupropion
5197562|NCT00833443|Meth|meth
5197563|NCT00833443|Crank|crank
5197564|NCT00833443|Crystal|crystal
5197565|NCT00833430|AVN|avn
5197566|NCT00833430|Femoral Head Collapse|femoral head collapse
5197567|NCT00833417|BCC|bcc
5197568|NCT00833417|Hedgehog Pathway Inhibitor|hedgehog pathway inhibitor
5197569|NCT00833417|Hedgehog|hedgehog
5197570|NCT00833417|Basal Cell Cancer|basal cell cancer
5197571|NCT00833404|Smoking|smoking
5197572|NCT00833404|Smoking Cessation|smoking cessation
5197573|NCT00833404|Quit Smoking|quit smoking
5197574|NCT00833404|Stop Smoking|stop smoking
5197575|NCT00833404|Nicotine Patch|nicotine patch
5197576|NCT00833404|Nicotine Replacement Therapy|nicotine replacement therapy
5197577|NCT00833404|Sexual Functioning|sexual functioning
5197578|NCT00833404|Erectile Functioning|erectile functioning
5197579|NCT00833404|Sexual Health|sexual health
5197580|NCT00833391|healthy volunteer|healthy volunteer
5197581|NCT00833391|formulations|formulations
5197582|NCT00833391|bioavailability|bioavailability
5197583|NCT00833391|pharmacokinetics|pharmacokinetics
5197584|NCT00833378|Drug interaction, SB-497115 (eltrombopag), Kaletra (Lopinavir, Ritonavir),thrombocytopenia, pharmacokinetics|drug interaction, sb-497115 (eltrombopag), kaletra (lopinavir, ritonavir),thrombocytopenia, pharmacokinetics
5197585|NCT00833365|premature infants|premature infants
5197586|NCT00833365|PDA|pda
5197587|NCT00833365|ibuprofen|ibuprofen
5197588|NCT00833313|Atrial fibrillation|atrial fibrillation
5197589|NCT00833313|Gene expression|gene expression
5197590|NCT00833313|Genetic|genetic
5197591|NCT00833300|Delirium|delirium
5197592|NCT00833300|Agitation|agitation
5197593|NCT00833300|Intensive Care|intensive care
5197594|NCT00833300|Critical Care|critical care
5197595|NCT00833300|Antipsychotics|antipsychotics
5197596|NCT00833300|Olanzapine|olanzapine
5197597|NCT00833300|Haloperidol|haloperidol
5197598|NCT00833287|immunoregulatory|immunoregulatory
5197599|NCT00833287|dysfunction|dysfunction
5197600|NCT00833287|obesity|obesity
5197601|NCT00833261|recurrent hypopharynx Cancer|recurrent hypopharynx cancer
5197602|NCT00833261|recurrent larynx Cancer|recurrent larynx cancer
5197603|NCT00833261|recurrent verrucous carcinoma|recurrent verrucous carcinoma
5197604|NCT00833261|squamous cell carcinoma|squamous cell carcinoma
5197605|NCT00833261|recurrent oral cavity cancer|recurrent oral cavity cancer
5197606|NCT00833261|recurrent metastatic occult primary cancer|recurrent metastatic occult primary cancer
5197607|NCT00833261|recurrent oropharynx cacner|recurrent oropharynx cacner
5197608|NCT00833261|recurrent paranasal sinus and nasal cavity cancer|recurrent paranasal sinus and nasal cavity cancer
5197609|NCT00833261|tongue cancer|tongue cancer
5197610|NCT00833222|premature birth|premature birth
5197611|NCT00833209|Orbitofrontal cortex|orbitofrontal cortex
5197612|NCT00833209|Medication Overuse Headache|medication overuse headache
5197613|NCT00833209|Chronic headache|chronic headache
5197614|NCT00833209|withdrawal|withdrawal
5197615|NCT00833170|pediatric inflammatory bowel disease|pediatric inflammatory bowel disease
5197616|NCT00833170|multiple site study|multiple site study
5197617|NCT00833157|Knee Osteoarthritis|knee osteoarthritis
5197618|NCT00833157|exercise|exercise
5197619|NCT00833157|strength training|strength training
5197620|NCT00833157|Glucosamine|glucosamine
5197621|NCT00833157|Dietary supplement|dietary supplement
5197622|NCT00833157|Ibuprofen|ibuprofen
5197623|NCT00833157|NSAID|nsaid
5197624|NCT00833144|heart failure|heart failure
5197625|NCT00833144|dyspnea|dyspnea
5197626|NCT00833144|ultrasound|ultrasound
5197627|NCT00833131|Rectal cancer|rectal cancer
5197628|NCT00833131|Preoperative radiotherapy and consolidating chemotherapy|preoperative radiotherapy and consolidating chemotherapy
5197629|NCT00833118|Surgery|surgery
5197630|NCT00833118|General Anesthesia|general anesthesia
5197631|NCT00833118|Intubation|intubation
5197632|NCT00833105|Incomplete Spinal Cord Injury|incomplete spinal cord injury
5197633|NCT00833105|Rehabilitation|rehabilitation
5197634|NCT00833105|Upper Extremity|upper extremity
5197635|NCT00833105|AMES device|ames device
5197636|NCT00833105|Incomplete SCI|incomplete sci
5197637|NCT00833105|Quadriplegia|quadriplegia
5197638|NCT00833092|magnesium|magnesium
5197639|NCT00833092|Nutritional Requirements|nutritional requirements
5197640|NCT00833092|Sleep|sleep
5197641|NCT00833079|Atopic Dermatitis|atopic dermatitis
5197642|NCT00833066|hay fever|hay fever
5197643|NCT00833066|grass pollen allergy|grass pollen allergy
5197644|NCT00833040|Cancer breakthrough pain|cancer breakthrough pain
5197645|NCT00833001|Anterior vaginal prolapse (medial, lateral,apical cystocele)|anterior vaginal prolapse (medial, lateral,apical cystocele)
5197646|NCT00833001|Posterior vaginal prolapse (rectocele and/or enterocele)|posterior vaginal prolapse (rectocele and/or enterocele)
5197647|NCT00833001|Vault prolapse (enterocele, uterine/vaginal vault prolapse)|vault prolapse (enterocele, uterine/vaginal vault prolapse)
5197648|NCT00832988|pacing thresholds|pacing thresholds
5197649|NCT00832988|sensing|sensing
5197650|NCT00832988|impedance|impedance
5197652|NCT00832962|Anti-D allo-immunization|anti-d allo-immunization
5197653|NCT00832962|Fetal RHD genotyping|fetal rhd genotyping
5197654|NCT00832962|anti-D immunoglobulins|anti-d immunoglobulins
5197655|NCT00832962|anti-D prophylaxis|anti-d prophylaxis
5197656|NCT00832949|Mixed methods research (qualitative and quantitative)|mixed methods research (qualitative and quantitative)
5197657|NCT00832949|Peer support|peer support
5197658|NCT00832949|Early inflammatory arthritis|early inflammatory arthritis
5197659|NCT00832949|Self-management|self-management
5197660|NCT00832949|Patient education|patient education
5197661|NCT00832923|parental empowerment|parental empowerment
5197662|NCT00832923|parent self-efficacy|parent self-efficacy
5197663|NCT00832910|Body image|body image
5197664|NCT00832910|Rheumatoid Arthritis|rheumatoid arthritis
5197665|NCT00832897|Keratoconus|keratoconus
5197666|NCT00832897|riboflavin|riboflavin
5197667|NCT00832897|cornea|cornea
5197668|NCT00832897|crosslinking|crosslinking
5197669|NCT00832884|partial|partial
5197670|NCT00832884|onset|onset
5197671|NCT00832884|epilepsy|epilepsy
5197672|NCT00832884|pediatric|pediatric
5197673|NCT00832884|lacosamide|lacosamide
5197674|NCT00832884|partial onset epilepsy|partial onset epilepsy
5197675|NCT00832884|vimpat|vimpat
5197676|NCT00832871|Mifepristone|mifepristone
5197677|NCT00832871|RU-486|ru-486
5197678|NCT00832871|Compassionate Use|compassionate use
5197679|NCT00832871|Antiprogesterone|antiprogesterone
5197680|NCT00832845|Late-life schizophrenia (LLS)|late-life schizophrenia (lls)
5197681|NCT00832845|Cognitive Behavioural Social Skills Training (CBSST)|cognitive behavioural social skills training (cbsst)
5197682|NCT00832845|Randomized|randomized
5197683|NCT00832832|Glaucoma|glaucoma
5197684|NCT00832832|Eye drop|eye drop
5197685|NCT00832832|Intraocular pressure|intraocular pressure
5197686|NCT00832832|Eyelid closure|eyelid closure
5197687|NCT00832819|Cancer|cancer
5197688|NCT00832819|Lung Cancer|lung cancer
5197689|NCT00832806|smoking|smoking
5197690|NCT00832806|Champix|champix
5197691|NCT00832806|Integrated Voice Response technology|integrated voice response technology
5197692|NCT00832793|Mixed methods research (qualitative and quantitative)|mixed methods research (qualitative and quantitative)
5197693|NCT00832793|Peer support|peer support
5197694|NCT00832793|Early inflammatory arthritis|early inflammatory arthritis
5197695|NCT00832793|Self-management|self-management
5197696|NCT00832793|Patient education|patient education
5197697|NCT00832780|Lung cancer|lung cancer
5197698|NCT00832780|radiation therapy|radiation therapy
5197699|NCT00832780|SBRT|sbrt
5197700|NCT00832780|Stereotactic Body Radiation Therapy|stereotactic body radiation therapy
5197701|NCT00832780|Tomotherapy|tomotherapy
5197702|NCT00832780|other solid tumors|other solid tumors
5197703|NCT00832767|Laparoscopic Cholecystectomy|laparoscopic cholecystectomy
5197704|NCT00832767|Single Incision Laparoscopic Surgery|single incision laparoscopic surgery
5197705|NCT00832767|Surgical Procedures, Minimally Invasive|surgical procedures, minimally invasive
5197706|NCT00832754|malaria|malaria
5197707|NCT00832754|rapid diagnostic test|rapid diagnostic test
5197708|NCT00832754|artemisinin|artemisinin
5197709|NCT00832754|Ghana|ghana
5197710|NCT00832741|GLP-1|glp-1
5197711|NCT00832741|Type 1 diabetes|type 1 diabetes
5197712|NCT00832741|Glycemic control|glycemic control
5197713|NCT00832741|Incretin hormone|incretin hormone
5197714|NCT00832715|Lung|lung
5197715|NCT00832715|Lung Cancer|lung cancer
5197716|NCT00832715|NSCLC|nsclc
5197717|NCT00832715|Non Small Cell Lung Cancer|non small cell lung cancer
5197718|NCT00832715|Squamous Cell|squamous cell
5197719|NCT00832715|Adenocarcinoma|adenocarcinoma
5197720|NCT00832715|Large Cell|large cell
5197721|NCT00832715|Endobronchial Ultrasound Transbronchial Needle Aspiration|endobronchial ultrasound transbronchial needle aspiration
5197722|NCT00832715|Mediastinal lymph node negative disease|mediastinal lymph node negative disease
5197723|NCT00832715|Mediastinal Nodal Metastasis|mediastinal nodal metastasis
5197724|NCT00832715|EBUS-FNA|ebus-fna
5197725|NCT00832715|Endobronchial Ultrasound Fine Needle Aspiration|endobronchial ultrasound fine needle aspiration
5197726|NCT00832715|EBUS guided needle mediastinal lymph node biopsy|ebus guided needle mediastinal lymph node biopsy
5197727|NCT00832715|Biopsy|biopsy
5197728|NCT00832715|PET scan|pet scan
5197729|NCT00832715|Positron Emission Tomography|positron emission tomography
5197730|NCT00832715|CT Scans|ct scans
5197731|NCT00832715|Computed Tomography Scans|computed tomography scans
5197732|NCT00832715|Lymph node|lymph node
5197733|NCT00832715|Mediastinoscopy|mediastinoscopy
5197734|NCT00832715|Bronchoscope|bronchoscope
5197735|NCT00832702|Cardiac|cardiac
5197736|NCT00832702|MRI|mri
5197737|NCT00832702|Coronary Vascular Dysfunction|coronary vascular dysfunction
5197738|NCT00832689|toxicity|toxicity
5197739|NCT00832676|Mixed methods research (qualitative and quantitative)|mixed methods research (qualitative and quantitative)
5197740|NCT00832676|Peer support|peer support
5197741|NCT00832676|Early inflammatory arthritis|early inflammatory arthritis
5197742|NCT00832676|Self-management|self-management
5197743|NCT00832676|Patient education|patient education
5197744|NCT00832663|Muscle regeneration|muscle regeneration
5197745|NCT00832663|Satellite cells|satellite cells
5197746|NCT00832663|electrical stimulation|electrical stimulation
5197747|NCT00832663|eccentric contractions|eccentric contractions
5197748|NCT00832663|myogenic precursor cells|myogenic precursor cells
5197749|NCT00832650|Healthy; Fesoterodine; Solifenacin|healthy; fesoterodine; solifenacin
5197750|NCT00832637|Liver|liver
5197751|NCT00832637|Gallbladder|gallbladder
5197752|NCT00832637|Bile duct|bile duct
5197753|NCT00832637|Gemzar|gemzar
5197754|NCT00832637|Eloxatin|eloxatin
5197755|NCT00832637|Tarceva|tarceva
5197756|NCT00832637|erlotinib|erlotinib
5197757|NCT00832637|Gem-ox|gem-ox
5197758|NCT00832611|Lung Disease|lung disease
5197759|NCT00832611|Chronic Airflow Obstruction|chronic airflow obstruction
5197760|NCT00832611|Chronic Bronchitis|chronic bronchitis
5197761|NCT00832611|Chronic Emphysema|chronic emphysema
5197762|NCT00832598|18F-FACBC|18f-facbc
5197763|NCT00832598|PET scan imaging|pet scan imaging
5197764|NCT00832598|08-142|08-142
5197765|NCT00832585|Atopic|atopic
5197766|NCT00832585|Dermatitis|dermatitis
5197767|NCT00832585|chronic|chronic
5197768|NCT00832585|skin|skin
5197769|NCT00832572|Coronary Artery Disease|coronary artery disease
5197770|NCT00832572|Pain|pain
5197771|NCT00832572|Peripheral Neuropathy|peripheral neuropathy
5197772|NCT00832572|Polyneuropathy|polyneuropathy
5197773|NCT00832559|CAVATAK|cavatak
5197774|NCT00832559|Coxsackievirus A21|coxsackievirus a21
5197775|NCT00832559|CVA21|cva21
5197776|NCT00832559|Oncolytic virotherapy|oncolytic virotherapy
5197777|NCT00832533|Vitamin D|vitamin d
5197778|NCT00832533|Serum 25-Hydroxyvitamin D|serum 25-hydroxyvitamin d
5197779|NCT00832533|UV exposure|uv exposure
5197780|NCT00832533|Ultraviolet Light Exposure|ultraviolet light exposure
5197781|NCT00832533|Skin Melanoma Advanced|skin melanoma advanced
5197782|NCT00832520|Advanced cancer|advanced cancer
5197783|NCT00832520|weight loss|weight loss
5197784|NCT00832520|Remeron|remeron
5197785|NCT00832520|body weight|body weight
5197786|NCT00832507|PAH|pah
5197787|NCT00832507|pulmonary hypertension|pulmonary hypertension
5197788|NCT00832507|cicletanine|cicletanine
5197789|NCT00832507|cicletanine HCL|cicletanine hcl
5197790|NCT00832507|cardiovascular|cardiovascular
5197791|NCT00832507|endothelin receptor antagonist|endothelin receptor antagonist
5197792|NCT00832507|ERA|era
5197793|NCT00832507|monotherapy|monotherapy
5197794|NCT00832507|combination therapy|combination therapy
5197795|NCT00832507|phosphodiesterase type-5 inhibitor|phosphodiesterase type-5 inhibitor
5197796|NCT00832507|PDE5i|pde5i
5197797|NCT00832507|parenteral prostanoid|parenteral prostanoid
5197798|NCT00832507|PH|ph
5197799|NCT00832507|pulmonary|pulmonary
5197800|NCT00832481|Repaglinide|repaglinide
5197801|NCT00832481|Metformin|metformin
5197802|NCT00832468|insomnia|insomnia
5197803|NCT00832468|ear acupressure|ear acupressure
5197804|NCT00832442|Beta blocker|beta blocker
5197805|NCT00832442|Heart Failure|heart failure
5197806|NCT00832442|Meta analysis|meta analysis
5197807|NCT00832442|Individual patient data|individual patient data
5197808|NCT00832429|Sebaceous Gland Carcinoma of the Eyelid|sebaceous gland carcinoma of the eyelid
5197809|NCT00832429|Eyelid Sebaceous Gland Carcinoma|eyelid sebaceous gland carcinoma
5197810|NCT00832429|Cancer of the eyelid|cancer of the eyelid
5197811|NCT00832429|Eye Cancer|eye cancer
5197812|NCT00832429|Tumors of the Eye|tumors of the eye
5197813|NCT00832429|Sentinel Lymph Node Localization and Biopsy|sentinel lymph node localization and biopsy
5197814|NCT00832429|SLN|sln
5197815|NCT00832429|Metastatic Disease|metastatic disease
5197816|NCT00832429|Metastatic Cancer of the Eyelid|metastatic cancer of the eyelid
5197817|NCT00832429|Lymphatic Mapping|lymphatic mapping
5197818|NCT00832429|SLN Mapping/Biopsy|sln mapping/biopsy
5197819|NCT00832429|SLN Biopsy Procedure|sln biopsy procedure
5197820|NCT00832429|SLN Biopsy|sln biopsy
5197821|NCT00832429|Lymph Nodes|lymph nodes
5197822|NCT00832429|Tc99m-Sulfur Colloid|tc99m-sulfur colloid
5197823|NCT00832429|Single Photon Emission Computed Tomography|single photon emission computed tomography
5197824|NCT00832429|Computed Tomography|computed tomography
5197825|NCT00832429|SPECT/CT|spect/ct
5197826|NCT00832403|atrophic rhinitis|atrophic rhinitis
5197827|NCT00832403|implants|implants
5197828|NCT00832403|Polytetrafluoroethylene|polytetrafluoroethylene
5197829|NCT00832364|Psoriasis|psoriasis
5197830|NCT00832364|Moderate to Severe Plaque Psoriasis|moderate to severe plaque psoriasis
5197831|NCT00832351|Stroke|stroke
5197832|NCT00832351|Brain infarction|brain infarction
5197833|NCT00832351|Intracerebral hemorrhage|intracerebral hemorrhage
5197834|NCT00832351|Early Mobilisation|early mobilisation
5197835|NCT00832338|Breast cancer|breast cancer
5197836|NCT00832338|Tumors, Breast|tumors, breast
5197837|NCT00832338|Cancer of the breast|cancer of the breast
5197838|NCT00832325|Childhood Survivor|childhood survivor
5197839|NCT00832325|survivors|survivors
5197840|NCT00832325|Young Adult Cancer Survivors|young adult cancer survivors
5197841|NCT00832325|Childhood cancers|childhood cancers
5197842|NCT00832325|09-001|09-001
5197843|NCT00832312|Osteoarthritis|osteoarthritis
5197844|NCT00832312|Knee|knee
5197845|NCT00832312|Pain management|pain management
5197846|NCT00832312|Ozone therapy|ozone therapy
5197847|NCT00832312|Intraarticular injection|intraarticular injection
5197848|NCT00832286|genomic techniques,intestinal microbiome|genomic techniques,intestinal microbiome
5197849|NCT00832273|Expanded access to ELAD® in patients with liver failure|expanded access to elad® in patients with liver failure
5197850|NCT00832247|Hepatitis C|hepatitis c
5197851|NCT00832247|Cirrhosis|cirrhosis
5197852|NCT00832247|Stem cell|stem cell
5197853|NCT00832234|Morbus Waldenstrom|morbus waldenstrom
5197854|NCT00832234|Waldenstroms Macroglobulinemia|waldenstroms macroglobulinemia
5197855|NCT00832234|Therapy|therapy
5197856|NCT00832234|Rituximab|rituximab
5197857|NCT00832234|Dexamethasone|dexamethasone
5197858|NCT00832234|Bortezomib|bortezomib
5197859|NCT00832221|PET|pet
5197860|NCT00832221|Phase 1|phase 1
5197861|NCT00832221|Depression|depression
5197862|NCT00832221|SEROQUEL|seroquel
5197863|NCT00832221|Positron Emission Tomography|positron emission tomography
5197864|NCT00832221|Drug profile comparison|drug profile comparison
5197865|NCT00832195|running|running
5197866|NCT00832195|injury|injury
5197867|NCT00832195|pronation|pronation
5197868|NCT00832195|footwear.|footwear.
5197869|NCT00832169|Pain|pain
5197870|NCT00832156|Burns|burns
5197871|NCT00832156|Cultured autologous keratinocytes|cultured autologous keratinocytes
5197872|NCT00832156|Wound healing|wound healing
5197873|NCT00832156|Wound closure|wound closure
5197874|NCT00832156|Scar quality|scar quality
5197875|NCT00832143|neonatal illness|neonatal illness
5197876|NCT00832143|qualified care seeking|qualified care seeking
5197877|NCT00832143|Behaviour change|behaviour change
5197878|NCT00832143|Urban slums|urban slums
5197879|NCT00832143|India|india
5197880|NCT00832143|Neonatal morbidity|neonatal morbidity
5197881|NCT00832143|Care seeking for neonatal illnesses|care seeking for neonatal illnesses
5197882|NCT00832143|Qualified medical care seeking|qualified medical care seeking
5197883|NCT00832143|Integrated management of neonatal and childhood illnesses (IMNCI)|integrated management of neonatal and childhood illnesses (imnci)
5197884|NCT00832117|Lung Cancer (NSCLC)|lung cancer (nsclc)
5197885|NCT00832091|Venous Stasis Ulcers|venous stasis ulcers
5197886|NCT00832091|venous insufficiency|venous insufficiency
5197887|NCT00832091|leg ulcers|leg ulcers
5197888|NCT00832091|Thymosin Beta 4|thymosin beta 4
5197889|NCT00832091|Laminin-5|laminin-5
5197890|NCT00832065|Sleep Apnea Syndrome|sleep apnea syndrome
5197891|NCT00832065|Sleep Apnea|sleep apnea
5197892|NCT00832065|CPAP|cpap
5197893|NCT00832065|Low testosterone|low testosterone
5197894|NCT00832065|Sexual Dysfunction|sexual dysfunction
5197895|NCT00832052|elderly, multi-dose, safety, efficacy|elderly, multi-dose, safety, efficacy
5197896|NCT00832039|sepsis|sepsis
5197897|NCT00832039|adjunctive therapy|adjunctive therapy
5197898|NCT00832039|sodium-selenite|sodium-selenite
5197899|NCT00832039|procalcitonin|procalcitonin
5197900|NCT00832026|sleep apnea|sleep apnea
5197901|NCT00832026|snoring|snoring
5197902|NCT00832026|sleep apnea treatment|sleep apnea treatment
5197903|NCT00832026|TNI|tni
5197904|NCT00832026|Trans nasal insuflation|trans nasal insuflation
5197905|NCT00832026|Open CPAP|open cpap
5197906|NCT00832013|Propofol|propofol
5197907|NCT00832013|sedation|sedation
5197908|NCT00832013|pediatric|pediatric
5197909|NCT00832013|Induction of sedation|induction of sedation
5197910|NCT00831987|Fluzone®|fluzone®
5197911|NCT00831987|Influenza|influenza
5197912|NCT00831987|Adults|adults
5197913|NCT00831974|mastocytosis|mastocytosis
5197914|NCT00831974|indolent|indolent
5197915|NCT00831974|handicap|handicap
5197916|NCT00831974|wild-type|wild-type
5197917|NCT00831974|systemic|systemic
5197918|NCT00831974|not D816V mutated|not d816v mutated
5197919|NCT00831961|Antibiotic resistance, Conjunctival flora, Intravitreal injections|antibiotic resistance, conjunctival flora, intravitreal injections
5197920|NCT00831935|Acoustic properties of voice in depression|acoustic properties of voice in depression
5197921|NCT00831922|Rheumatoid Arthritis|rheumatoid arthritis
5197922|NCT00831922|DMARD failure|dmard failure
5197923|NCT00831922|ACR|acr
5197924|NCT00831909|Lung Cancer|lung cancer
5197925|NCT00831909|NSCLC management|nsclc management
5197926|NCT00831909|NSCLC use of health care resources|nsclc use of health care resources
5197927|NCT00831883|Adolescent|adolescent
5197928|NCT00831883|Adolescent behavior|adolescent behavior
5197929|NCT00831883|Health behavior|health behavior
5197930|NCT00831883|Sexual Behavior|sexual behavior
5197931|NCT00831883|Incarceration|incarceration
5197932|NCT00831883|Behavioral Intervention|behavioral intervention
5197933|NCT00831883|Risk Reduction Behavior|risk reduction behavior
5197934|NCT00831870|EndoSure Sensor|endosure sensor
5197935|NCT00831870|s2 Sensor|s2 sensor
5197936|NCT00831870|abdominal aortic aneurysm|abdominal aortic aneurysm
5197937|NCT00831831|perinatal|perinatal
5197938|NCT00831831|intimate partner violence|intimate partner violence
5197939|NCT00831831|randomized controlled trial|randomized controlled trial
5197940|NCT00831831|preterm|preterm
5197941|NCT00831831|hemorrhage|hemorrhage
5197942|NCT00831831|safety|safety
5197943|NCT00831818|breastfeeding|breastfeeding
5197944|NCT00831818|ghrelin|ghrelin
5197945|NCT00831818|PYY|pyy
5197946|NCT00831818|appetite-regulation|appetite-regulation
5197947|NCT00831805|geriatrics|geriatrics
5197948|NCT00831805|psycho-cognitive troubles|psycho-cognitive troubles
5197949|NCT00831805|elderly|elderly
5197950|NCT00831805|mobile unit|mobile unit
5197951|NCT00831805|elderly patients|elderly patients
5197952|NCT00831792|Prostate Cancer|prostate cancer
5197953|NCT00831792|Advanced Prostate Cancer|advanced prostate cancer
5197954|NCT00831792|Castrate Resistant Prostate Cancer|castrate resistant prostate cancer
5197955|NCT00831792|Prostate Specific Antigen|prostate specific antigen
5197956|NCT00831792|PSA|psa
5197957|NCT00831792|Castration-Resistant Prostate Cancer Patients|castration-resistant prostate cancer patients
5197958|NCT00831792|TK1258|tk1258
5197959|NCT00831792|CHIR-258|chir-258
5197960|NCT00831766|Hematopoietic|hematopoietic
5197961|NCT00831766|Myeloid and Monocytic Leukemia|myeloid and monocytic leukemia
5197962|NCT00831766|AML|aml
5197963|NCT00831753|Diphtheria|diphtheria
5197964|NCT00831753|Tetanus|tetanus
5197965|NCT00831753|Pertussis|pertussis
5197966|NCT00831753|whooping cough|whooping cough
5197967|NCT00831753|Haemophilus influenzae type b|haemophilus influenzae type b
5197968|NCT00831753|Hepatitis B|hepatitis b
5197969|NCT00831753|Poliomyelitis|poliomyelitis
5197970|NCT00831740|Stroke|stroke
5197971|NCT00831740|Communication|communication
5197972|NCT00831740|Speech and Language Therapy|speech and language therapy
5197973|NCT00831727|expressive writing|expressive writing
5197974|NCT00831727|trauma|trauma
5197975|NCT00831727|intervention|intervention
5197976|NCT00831727|posttraumatic stress|posttraumatic stress
5197977|NCT00831714|Prophylaxis of Venous Thromboembolism|prophylaxis of venous thromboembolism
5197978|NCT00831701|Adrenergic alpha antagonists|adrenergic alpha antagonists
5197979|NCT00831701|drug therapy|drug therapy
5197980|NCT00831701|tamsulosin|tamsulosin
5197981|NCT00831701|ureter|ureter
5197982|NCT00831688|Meniere|meniere
5197983|NCT00831688|vertigo|vertigo
5197984|NCT00831688|overpressure treatment|overpressure treatment
5197985|NCT00831688|caloric irrigation|caloric irrigation
5197986|NCT00831688|hearing levels|hearing levels
5197987|NCT00831688|vertigo severity|vertigo severity
5197988|NCT00831688|functional disability scale|functional disability scale
5197989|NCT00831675|Influenza|influenza
5197990|NCT00831675|Fluzone® vaccine|fluzone® vaccine
5197991|NCT00831675|Infants|infants
5197992|NCT00831675|Toddlers|toddlers
5197993|NCT00831636|CP-4055|cp-4055
5197994|NCT00831636|Cancer|cancer
5197995|NCT00831636|Metastatic|metastatic
5197996|NCT00831636|Solid tumors|solid tumors
5197997|NCT00831636|advanced ovarian cancer|advanced ovarian cancer
5197998|NCT00831636|stage III and IV ovarian cancer|stage iii and iv ovarian cancer
5197999|NCT00831636|advanced epithelian ovarian cancer|advanced epithelian ovarian cancer
5198000|NCT00831623|hypofractionation|hypofractionation
5198001|NCT00831623|proton beam radiation|proton beam radiation
5198002|NCT00831610|bariatric surgery|bariatric surgery
5198003|NCT00831610|plastic surgery|plastic surgery
5198004|NCT00831610|abdominal wall|abdominal wall
5198005|NCT00831610|skin|skin
5198006|NCT00831610|sensation|sensation
5198007|NCT00831610|abdominoplasty|abdominoplasty
5198008|NCT00831597|Lymphoma|lymphoma
5198009|NCT00831597|B-Cell|b-cell
5198010|NCT00831571|oxaliplatin|oxaliplatin
5198011|NCT00831571|hypersensitivity|hypersensitivity
5198012|NCT00831532|Dimebon Hepatic Impairment|dimebon hepatic impairment
5198013|NCT00831506|digoxin dimebon drug-drug interaction study|digoxin dimebon drug-drug interaction study
5198014|NCT00831493|Pancreas|pancreas
5198015|NCT00831493|Pancreatic Cancer|pancreatic cancer
5198016|NCT00831493|Locally Advanced Pancreatic Cancer|locally advanced pancreatic cancer
5198017|NCT00831493|LAPC|lapc
5198018|NCT00831493|Non-Metastatic|non-metastatic
5198019|NCT00831493|Unresectable|unresectable
5198020|NCT00831493|Vorinostat|vorinostat
5198021|NCT00831493|XRT|xrt
5198022|NCT00831493|RT|rt
5198023|NCT00831493|Radiation Therapy|radiation therapy
5198024|NCT00831493|SAHA|saha
5198025|NCT00831493|Suberoylanilide Hydroxamic Acid|suberoylanilide hydroxamic acid
5198026|NCT00831493|MSK-390|msk-390
5198027|NCT00831480|Renal cell carcinoma|renal cell carcinoma
5198028|NCT00831480|Everolimus|everolimus
5198029|NCT00831480|Neoadjuvant|neoadjuvant
5198030|NCT00831480|advanced kidney cancer|advanced kidney cancer
5198031|NCT00831467|Hormonal refractory prostate cancer|hormonal refractory prostate cancer
5198032|NCT00831467|RNA vaccine|rna vaccine
5198033|NCT00831441|NOS|nos
5198034|NCT00831428|asthma|asthma
5198035|NCT00831428|rhinitis|rhinitis
5198036|NCT00831428|swimmers|swimmers
5198037|NCT00831428|mannitol|mannitol
5198038|NCT00831415|Open-label Long-term extension study|open-label long-term extension study
5198039|NCT00831402|woman|woman
5198040|NCT00831376|Asthma|asthma
5198041|NCT00831376|Genotype|genotype
5198042|NCT00831376|Beta2adrenoreceptor|beta2adrenoreceptor
5198043|NCT00831376|Levosalbutamol|levosalbutamol
5198044|NCT00831363|gait analysis|gait analysis
5198045|NCT00831363|minimal invasive approach|minimal invasive approach
5198046|NCT00831363|transgluteal approach|transgluteal approach
5198047|NCT00831363|THA|tha
5198048|NCT00831350|RVO|rvo
5198049|NCT00831350|PVD|pvd
5198050|NCT00831337|VSL3|vsl3
5198051|NCT00831337|Probiotics|probiotics
5198052|NCT00831337|Gut microbiota|gut microbiota
5198053|NCT00831337|Cytokines|cytokines
5198054|NCT00831337|Portal hypertension|portal hypertension
5198056|NCT00831337|Liver cirrhosis|liver cirrhosis
5198057|NCT00831311|Diphtheria|diphtheria
5198058|NCT00831311|Tetanus|tetanus
5198059|NCT00831311|Pertussis|pertussis
5198060|NCT00831311|Whooping cough|whooping cough
5198061|NCT00831311|Hepatitis B|hepatitis b
5198062|NCT00831311|Poliomyelitis|poliomyelitis
5198063|NCT00831311|Haemophilus influenzae type b|haemophilus influenzae type b
5198064|NCT00831298|alzheimer disease|alzheimer disease
5198065|NCT00831298|sleep disturbance|sleep disturbance
5198066|NCT00831298|apathy|apathy
5198067|NCT00831298|memory loss|memory loss
5198068|NCT00831285|Healthy volunteers|healthy volunteers
5198069|NCT00831259|stroke|stroke
5198070|NCT00831259|PFO|pfo
5198071|NCT00831259|embolism|embolism
5198072|NCT00831246|Ileus,|ileus,
5198073|NCT00831246|Gynecologic surgery,|gynecologic surgery,
5198074|NCT00831246|Post-operative,|post-operative,
5198075|NCT00831246|Flatus|flatus
5198076|NCT00831220|COPD|copd
5198077|NCT00831220|exacerbations|exacerbations
5198078|NCT00831220|EPCs|epcs
5198079|NCT00831220|Erythropoietin|erythropoietin
5198080|NCT00831220|C-RP|c-rp
5198081|NCT00831220|COPD and endothelial dysfunction|copd and endothelial dysfunction
5198082|NCT00831207|B-2 microglobulin|b-2 microglobulin
5198083|NCT00831207|Serum cytokines|serum cytokines
5198084|NCT00831207|HIV-1|hiv-1
5198085|NCT00831207|Resistance|resistance
5198086|NCT00831207|HAART|haart
5198087|NCT00831207|Therapeutic failure|therapeutic failure
5198088|NCT00831207|Genotyping.|genotyping.
5198089|NCT00831194|Type 2 Diabetes|type 2 diabetes
5198090|NCT00831194|Obesity|obesity
5198091|NCT00831194|Weight loss|weight loss
5198092|NCT00831194|PDA|pda
5198093|NCT00831194|Stress|stress
5198094|NCT00831194|Dietary lapse|dietary lapse
5198095|NCT00831194|salivary alpha amylase|salivary alpha amylase
5198096|NCT00831181|stage II rectal cancer|stage ii rectal cancer
5198097|NCT00831181|stage III rectal cancer|stage iii rectal cancer
5198098|NCT00831181|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5198099|NCT00831168|neonatal|neonatal
5198100|NCT00831168|premature babies|premature babies
5198101|NCT00831168|healthcare research|healthcare research
5198102|NCT00831168|Babies born before 27 weeks gestation|babies born before 27 weeks gestation
5198103|NCT00831155|smoking|smoking
5198104|NCT00831155|nicotine patches|nicotine patches
5198105|NCT00831155|extinction based treatment|extinction based treatment
5198106|NCT00831142|Prostate Cancer|prostate cancer
5198107|NCT00831142|MRI|mri
5198108|NCT00831142|Prostatectomy|prostatectomy
5198109|NCT00831116|near infrared spectroscopy|near infrared spectroscopy
5198110|NCT00831116|LipiScan|lipiscan
5198111|NCT00831116|lipid core|lipid core
5198112|NCT00831116|percutaneous coronary intervention|percutaneous coronary intervention
5198113|NCT00831116|myocardial infarction|myocardial infarction
5198114|NCT00831116|NIRS|nirs
5198115|NCT00831116|intravascular imaging|intravascular imaging
5198116|NCT00831103|EPB348|epb348
5198117|NCT00831103|Valomaciclovir Stearate|valomaciclovir stearate
5198118|NCT00831103|Valacyclovir|valacyclovir
5198119|NCT00831103|Herpes Zoster|herpes zoster
5198120|NCT00831103|Shingles|shingles
5198121|NCT00831077|Healthy volunteers|healthy volunteers
5198122|NCT00831064|bowel preparation quality|bowel preparation quality
5198123|NCT00831064|colonoscopy|colonoscopy
5198124|NCT00831051|Bunionectomy|bunionectomy
5198125|NCT00831038|pulmonary function tests|pulmonary function tests
5198126|NCT00831038|infants|infants
5198127|NCT00831038|chronic lung disease|chronic lung disease
5198128|NCT00831038|dysphagia|dysphagia
5198129|NCT00831038|chronic aspiration|chronic aspiration
5198130|NCT00831025|Immunotherapy|immunotherapy
5198131|NCT00831025|Allergoid|allergoid
5198132|NCT00831025|Depigmented|depigmented
5198133|NCT00831025|Polymerized|polymerized
5198134|NCT00831025|Allergen-extract|allergen-extract
5198135|NCT00831025|Rhinoconjunctivitis|rhinoconjunctivitis
5198136|NCT00831012|Dengue Vaccine|dengue vaccine
5198137|NCT00831012|Dengue Virus|dengue virus
5198138|NCT00831012|Dengue Hemorrhagic Fever|dengue hemorrhagic fever
5198139|NCT00831012|Dengue Shock Syndrome|dengue shock syndrome
5198140|NCT00830999|fat metabolism|fat metabolism
5198141|NCT00830999|exercise|exercise
5198142|NCT00830999|liver|liver
5198143|NCT00830999|lipoproteins|lipoproteins
5198144|NCT00830999|triglycerides|triglycerides
5198145|NCT00830986|Mental Cognition Change|mental cognition change
5198146|NCT00830986|Fat Embolism|fat embolism
5198147|NCT00830986|Bone Marrow Debris Emboli|bone marrow debris emboli
5198148|NCT00830986|Computer Assisted Total Knee Arthroplasty|computer assisted total knee arthroplasty
5198149|NCT00830986|Conventional Instrumented Total Knee Arthroplasty|conventional instrumented total knee arthroplasty
5198150|NCT00830973|Estrogen Antagonists|estrogen antagonists
5198151|NCT00830973|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal
5198152|NCT00830973|Hormone Antagonists|hormone antagonists
5198153|NCT00830973|Hormones|hormones
5198154|NCT00830973|Hormone Substitutes|hormone substitutes
5198155|NCT00830973|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators
5198156|NCT00830973|Estrogen Receptor Modulators|estrogen receptor modulators
5198157|NCT00830973|Neoplasms|neoplasms
5198158|NCT00830973|Neoplasms by Site|neoplasms by site
5198159|NCT00830947|Orthodontic|orthodontic
5198160|NCT00830947|Extraction|extraction
5198161|NCT00830947|Device|device
5198162|NCT00830947|Space Closure|space closure
5198163|NCT00830947|Orthodontic malocclusion|orthodontic malocclusion
5198164|NCT00830934|pelvic girdle pain|pelvic girdle pain
5198165|NCT00830934|symphysio pubic dysfunction|symphysio pubic dysfunction
5198166|NCT00830934|group care|group care
5198167|NCT00830934|individual care|individual care
5198168|NCT00830921|Histocytologically proven thoracic malignancy|histocytologically proven thoracic malignancy
5198169|NCT00830908|seborrheic dermatitis|seborrheic dermatitis
5198170|NCT00830895|Renal cell carcinoma|renal cell carcinoma
5198171|NCT00830895|Non-clear cell|non-clear cell
5198172|NCT00830895|RAD001|rad001
5198173|NCT00830895|Metastatic, non-clear cell, renal cell carcinoma|metastatic, non-clear cell, renal cell carcinoma
5198174|NCT00830882|asthma|asthma
5198175|NCT00830882|levosalbutamol|levosalbutamol
5198176|NCT00830882|genotype|genotype
5198177|NCT00830882|bronchoprotection|bronchoprotection
5198178|NCT00830856|Cryptococcal Meningitis|cryptococcal meningitis
5198179|NCT00830856|HIV|hiv
5198180|NCT00830856|Fluconazole|fluconazole
5198181|NCT00830856|Antiretroviral therapy|antiretroviral therapy
5198182|NCT00830856|Africa|africa
5198183|NCT00830856|treatment naive|treatment naive
5198184|NCT00830843|SAH|sah
5198185|NCT00830843|sedation|sedation
5198186|NCT00830843|anesthesia|anesthesia
5198187|NCT00830817|Topical cream application|topical cream application
5198188|NCT00830817|Mild to moderate psoriasis|mild to moderate psoriasis
5198189|NCT00830804|Treatment Naive|treatment naive
5198190|NCT00830778|pancreas|pancreas
5198191|NCT00830778|surgery|surgery
5198192|NCT00830778|cancer|cancer
5198193|NCT00830778|pancreaticoduodenectomy (PD)|pancreaticoduodenectomy (pd)
5198194|NCT00830778|peri-ampullary tumours (ampulla, duodenum, distal bile duct, and miscellaneous tumours)|peri-ampullary tumours (ampulla, duodenum, distal bile duct, and miscellaneous tumours)
5198195|NCT00830778|pancreatic tumors|pancreatic tumors
5198196|NCT00830778|peri-ampullary tumors|peri-ampullary tumors
5198197|NCT00830752|alexithymia|alexithymia
5198198|NCT00830739|Smoking Cessation|smoking cessation
5198199|NCT00830739|Dopamine|dopamine
5198200|NCT00830739|Cognitive Control|cognitive control
5198201|NCT00830739|Reward Processing|reward processing
5198202|NCT00830739|Varenicline|varenicline
5198203|NCT00830726|Aquaporin|aquaporin
5198204|NCT00830726|Epithelial Sodium Channels|epithelial sodium channels
5198205|NCT00830726|Heart Failure|heart failure
5198206|NCT00830726|Valvular heart disease|valvular heart disease
5198207|NCT00830726|Ischemic heart disease|ischemic heart disease
5198208|NCT00830713|vitiligo|vitiligo
5198209|NCT00830713|skin transplantation|skin transplantation
5198210|NCT00830713|non-cultured|non-cultured
5198211|NCT00830713|melanocyte|melanocyte
5198212|NCT00830713|surgery|surgery
5198213|NCT00830700|ADHD|adhd
5198214|NCT00830700|telemental health|telemental health
5198215|NCT00830700|TMH|tmh
5198216|NCT00830700|telepsychiatry|telepsychiatry
5198217|NCT00830700|rural mental health services for children|rural mental health services for children
5198218|NCT00830687|subcapital femoral fractures|subcapital femoral fractures
5198219|NCT00830687|transcervical femoral fractures|transcervical femoral fractures
5198220|NCT00830687|TARGON FN|targon fn
5198221|NCT00830674|XLH|xlh
5198222|NCT00830661|transsphincteric anal fistula|transsphincteric anal fistula
5198223|NCT00830661|cryptoglandular origin|cryptoglandular origin
5198224|NCT00830661|anal fistula repair|anal fistula repair
5198225|NCT00830661|Ligation of Intersphincteric Fistula Track (LIFT) procedure|ligation of intersphincteric fistula track (lift) procedure
5198226|NCT00830661|anal fistula plug (Plug)|anal fistula plug (plug)
5198227|NCT00830661|surgical repair|surgical repair
5198228|NCT00830648|varicella-zoster virus|varicella-zoster virus
5198229|NCT00830648|varicella|varicella
5198230|NCT00830635|long-term effects of cancer treatment|long-term effects of cancer treatment
5198231|NCT00830635|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
5198232|NCT00830635|depression|depression
5198233|NCT00830635|stage IA breast cancer|stage ia breast cancer
5198234|NCT00830635|stage IB breast cancer|stage ib breast cancer
5198235|NCT00830635|stage II breast cancer|stage ii breast cancer
5198236|NCT00830635|stage I prostate cancer|stage i prostate cancer
5198237|NCT00830635|stage II prostate cancer|stage ii prostate cancer
5198238|NCT00830622|HIV/AIDS|hiv/aids
5198239|NCT00830622|Adherence|adherence
5198240|NCT00830622|Antiretroviral Therapy, ART, ARV|antiretroviral therapy, art, arv
5198241|NCT00830622|Mobile phone, cell phone, telephone|mobile phone, cell phone, telephone
5198242|NCT00830622|Text message, SMS|text message, sms
5198243|NCT00830622|Telemedicine|telemedicine
5198244|NCT00830622|Africa|africa
5198245|NCT00830622|Resource-limited setting|resource-limited setting
5198246|NCT00830622|Counseling, support|counseling, support
5198247|NCT00830622|treatment experienced|treatment experienced
5198248|NCT00830609|Chronic Hepatitis C|chronic hepatitis c
5198249|NCT00830609|Genotype 3|genotype 3
5198250|NCT00830609|High viral load|high viral load
5198251|NCT00830570|CYP2C9|cyp2c9
5198252|NCT00830570|VKORC1|vkorc1
5198253|NCT00830570|polymorphism|polymorphism
5198255|NCT00830570|Coumadin|coumadin
5198256|NCT00830557|recurrent pancreatic cancer|recurrent pancreatic cancer
5198257|NCT00830557|stage I pancreatic cancer|stage i pancreatic cancer
5198258|NCT00830557|stage II pancreatic cancer|stage ii pancreatic cancer
5198259|NCT00830557|stage III pancreatic cancer|stage iii pancreatic cancer
5198260|NCT00830557|stage IV pancreatic cancer|stage iv pancreatic cancer
5198261|NCT00830557|recurrent islet cell carcinoma|recurrent islet cell carcinoma
5198262|NCT00830557|pancreatic alpha cell carcinoma|pancreatic alpha cell carcinoma
5198263|NCT00830557|pancreatic beta islet cell carcinoma|pancreatic beta islet cell carcinoma
5198264|NCT00830557|pancreatic delta cell carcinoma|pancreatic delta cell carcinoma
5198265|NCT00830557|pancreatic G-cell carcinoma|pancreatic g-cell carcinoma
5198266|NCT00830544|neoadjuvant chemotherapy breast cancer|neoadjuvant chemotherapy breast cancer
5198267|NCT00830544|Breast cancer patients with tumors over one cm|breast cancer patients with tumors over one cm
5198268|NCT00830531|Hypoxic-ischemic encephalopathy|hypoxic-ischemic encephalopathy
5198269|NCT00830531|Neonatal stroke|neonatal stroke
5198270|NCT00830531|Intracranial hemorrhage|intracranial hemorrhage
5198271|NCT00830531|Perinatal asphyxia|perinatal asphyxia
5198272|NCT00830531|Neonatal Seizures|neonatal seizures
5198273|NCT00830518|Drug therapy|drug therapy
5198274|NCT00830505|fluticasone|fluticasone
5198275|NCT00830505|salmeterol|salmeterol
5198276|NCT00830505|bronchoprotection|bronchoprotection
5198277|NCT00830492|clomiphene citrate|clomiphene citrate
5198278|NCT00830492|GnRH agonist|gnrh agonist
5198279|NCT00830492|GnRH antagonist|gnrh antagonist
5198280|NCT00830492|in vitro fertilization|in vitro fertilization
5198281|NCT00830492|clinical pregnancy|clinical pregnancy
5198282|NCT00830492|pregnancy|pregnancy
5198283|NCT00830466|port wine stain|port wine stain
5198284|NCT00830453|Brain injury with sequelae from stroke, anoxia, or trauma|brain injury with sequelae from stroke, anoxia, or trauma
5198285|NCT00830427|asthma bronchial diseases|asthma bronchial diseases
5198286|NCT00830414|Bioequivalence|bioequivalence
5198287|NCT00830414|Healthy Subjects|healthy subjects
5198288|NCT00830401|intra-uterine abnormalities|intra-uterine abnormalities
5198289|NCT00830401|intracavitary pathology|intracavitary pathology
5198290|NCT00830401|hysteroscopy|hysteroscopy
5198291|NCT00830401|IVF|ivf
5198292|NCT00830401|ICSI|icsi
5198293|NCT00830401|polyp|polyp
5198294|NCT00830401|myoma|myoma
5198295|NCT00830401|adhesion|adhesion
5198296|NCT00830401|septum|septum
5198297|NCT00830401|endometritis|endometritis
5198298|NCT00830388|tinea versicolor|tinea versicolor
5198299|NCT00830388|ketoconazole|ketoconazole
5198300|NCT00830375|Buying|buying
5198301|NCT00830375|Shopping|shopping
5198302|NCT00830375|Impulse Control|impulse control
5198303|NCT00830362|cocaine|cocaine
5198304|NCT00830362|cocaine-dependent|cocaine-dependent
5198305|NCT00830362|propranolol|propranolol
5198306|NCT00830362|craving|craving
5198307|NCT00830362|beta-blockade|beta-blockade
5198308|NCT00830362|cue exposure|cue exposure
5198309|NCT00830362|drug|drug
5198310|NCT00830362|addiction|addiction
5198311|NCT00830362|memory|memory
5198312|NCT00830362|addictive behavior|addictive behavior
5198313|NCT00830349|Bioequivalence|bioequivalence
5198314|NCT00830349|Healthy Subjects|healthy subjects
5198315|NCT00830336|Bioequivalence|bioequivalence
5198316|NCT00830336|Healthy Subjects|healthy subjects
5198317|NCT00830310|Patient Non-Adherence|patient non-adherence
5198318|NCT00830310|Patient Non-Compliance|patient non-compliance
5198319|NCT00830310|Patient Nonadherence|patient nonadherence
5198320|NCT00830310|Patient Noncompliance|patient noncompliance
5198321|NCT00830310|Patient Refusal of Treatment|patient refusal of treatment
5198322|NCT00830310|Refusal of Treatment|refusal of treatment
5198323|NCT00830310|Treatment Refusal|treatment refusal
5198324|NCT00830297|TIP|tip
5198325|NCT00830297|NODAT|nodat
5198326|NCT00830297|hyperglycemia|hyperglycemia
5198327|NCT00830297|long-acting insulin|long-acting insulin
5198328|NCT00830297|post-transplant hyperglycemia|post-transplant hyperglycemia
5198329|NCT00830284|Pediatric Acute Respiratory Distress Syndrome (ARDS)|pediatric acute respiratory distress syndrome (ards)
5198330|NCT00830284|Pediatric Acute Lung Injury (ALI)|pediatric acute lung injury (ali)
5198331|NCT00830271|surgical site infection|surgical site infection
5198332|NCT00830271|wound complications|wound complications
5198333|NCT00830271|suture|suture
5198334|NCT00830271|antiseptic|antiseptic
5198335|NCT00830271|wound closure|wound closure
5198336|NCT00830258|Bioequivalence|bioequivalence
5198337|NCT00830258|Healthy Subjects|healthy subjects
5198338|NCT00830245|EGFR mutation|egfr mutation
5198339|NCT00830245|Erlotinib|erlotinib
5198340|NCT00830245|Lung cancer|lung cancer
5198341|NCT00830245|leptomeningeal carcinomatosis in EGFR mutation positive non-small cell lung cancer|leptomeningeal carcinomatosis in egfr mutation positive non-small cell lung cancer
5198342|NCT00830232|Stroke|stroke
5198343|NCT00830232|Carotid stenosis|carotid stenosis
5198344|NCT00830232|stents|stents
5198345|NCT00830219|Bioequivalence|bioequivalence
5198346|NCT00830219|Healthy Subjects|healthy subjects
5198347|NCT00830206|Bioequivalence|bioequivalence
5198348|NCT00830206|Healthy Subjects|healthy subjects
5198349|NCT00830193|N-acetylcysteine|n-acetylcysteine
5198350|NCT00830193|prevention|prevention
5198351|NCT00830193|contrast-induced nephropathy|contrast-induced nephropathy
5198352|NCT00830193|critically ill adults|critically ill adults
5198353|NCT00830180|Cancer pain|cancer pain
5198354|NCT00830180|NGF|ngf
5198355|NCT00830180|open-label extension|open-label extension
5198356|NCT00830154|stutter|stutter
5198357|NCT00830154|stuttering|stuttering
5198358|NCT00830154|Adults with a history of stuttering|adults with a history of stuttering
5198359|NCT00830141|Ghrelin|ghrelin
5198360|NCT00830141|obesity|obesity
5198361|NCT00830141|idiopathic short stature (ISS)|idiopathic short stature (iss)
5198362|NCT00830115|PPI therapy|ppi therapy
5198363|NCT00830115|Pantoprazole|pantoprazole
5198364|NCT00830115|eGERD (Erosive Gastroesophageal Reflux Disease)|egerd (erosive gastroesophageal reflux disease)
5198365|NCT00830115|NERD (Non-Erosive Reflux Disease)|nerd (non-erosive reflux disease)
5198366|NCT00830102|Mild to Moderate Asthma|mild to moderate asthma
5198367|NCT00830089|Transversus abdominis plane block|transversus abdominis plane block
5198368|NCT00830089|Laparoscopic colorectal surgery|laparoscopic colorectal surgery
5198369|NCT00830089|Analgesia|analgesia
5198370|NCT00830063|monoclonal antibody|monoclonal antibody
5198371|NCT00830063|RN624|rn624
5198372|NCT00830063|PF-04383119|pf-04383119
5198373|NCT00830063|nerve growth factor|nerve growth factor
5198374|NCT00830063|anti-nerve growth factor|anti-nerve growth factor
5198375|NCT00830063|OA|oa
5198376|NCT00830063|pain|pain
5198377|NCT00830050|fMRI functional magnetic resonance imaging Pain|fmri functional magnetic resonance imaging pain
5198378|NCT00830037|anemia|anemia
5198379|NCT00830037|iron|iron
5198380|NCT00830037|kidney disease|kidney disease
5198381|NCT00830037|progression|progression
5198382|NCT00830037|glomerular filtration rate|glomerular filtration rate
5198383|NCT00830024|Bioequivalence|bioequivalence
5198384|NCT00830024|Healthy Subjects|healthy subjects
5198385|NCT00830011|diabetes|diabetes
5198386|NCT00830011|neuropathy|neuropathy
5198387|NCT00830011|chronic pain|chronic pain
5198388|NCT00830011|Cognitive behavioral therapy|cognitive behavioral therapy
5198389|NCT00829998|Bioequivalence|bioequivalence
5198390|NCT00829998|Healthy Subjects|healthy subjects
5198391|NCT00829985|Rhinitis, Allergic, Perennial|rhinitis, allergic, perennial
5198392|NCT00829985|Rhinitis, Allergic, Seasonal|rhinitis, allergic, seasonal
5198393|NCT00829985|Immunotherapy|immunotherapy
5198394|NCT00829985|Asthma|asthma
5198395|NCT00829985|Nasal Allergies|nasal allergies
5198396|NCT00829985|Hypersensitivity|hypersensitivity
5198397|NCT00829959|Ovary, Cancer|ovary, cancer
5198398|NCT00829959|Ovarian Cancer|ovarian cancer
5198399|NCT00829959|Breast Cancer|breast cancer
5198400|NCT00829959|Hereditary Breast and Ovarian Cancer Syndrome|hereditary breast and ovarian cancer syndrome
5198401|NCT00829959|HBOC|hboc
5198402|NCT00829959|Genetic testing|genetic testing
5198403|NCT00829959|Pregnancy|pregnancy
5198404|NCT00829959|Fertility|fertility
5198405|NCT00829959|Prenatal diagnostic testing|prenatal diagnostic testing
5198406|NCT00829946|Strength training|strength training
5198407|NCT00829946|Anorexia|anorexia
5198408|NCT00829946|Girls|girls
5198409|NCT00829946|Quality of life|quality of life
5198410|NCT00829946|Functional mobility|functional mobility
5198411|NCT00829933|Atrial fibrillation|atrial fibrillation
5198412|NCT00829933|Factor Xa inhibition|factor xa inhibition
5198413|NCT00829920|Bladder cancer|bladder cancer
5198414|NCT00829907|Healthy volunteer study|healthy volunteer study
5198415|NCT00829894|Bioequivalence|bioequivalence
5198416|NCT00829894|Healthy Subjects|healthy subjects
5198417|NCT00829881|Attention|attention
5198418|NCT00829868|Bioequivalence|bioequivalence
5198419|NCT00829868|Healthy Subjects|healthy subjects
5198420|NCT00829855|pulmonary edema|pulmonary edema
5198421|NCT00829855|hypertension|hypertension
5198422|NCT00829855|echocardiography|echocardiography
5198423|NCT00829842|chlorexidine|chlorexidine
5198424|NCT00829842|ventilator-associated pneumonia|ventilator-associated pneumonia
5198425|NCT00829842|nosocomial pneumonia|nosocomial pneumonia
5198426|NCT00829842|heart surgery|heart surgery
5198427|NCT00829842|oral hygiene|oral hygiene
5198428|NCT00829829|Metabolism, Inborn Errors|metabolism, inborn errors
5198429|NCT00829829|Allopurinol|allopurinol
5198430|NCT00829829|Metabolic Diseases|metabolic diseases
5198431|NCT00829829|Genetic Diseases, Inborn|genetic diseases, inborn
5198432|NCT00829829|Musculoskeletal Diseases|musculoskeletal diseases
5198433|NCT00829829|Joint Diseases|joint diseases
5198434|NCT00829829|Arthritis|arthritis
5198435|NCT00829829|Rheumatic Diseases|rheumatic diseases
5198436|NCT00829829|Metabolic disorder|metabolic disorder
5198437|NCT00829829|Purine-Pyrimidine Metabolism, Inborn Errors|purine-pyrimidine metabolism, inborn errors
5198438|NCT00829829|Gout|gout
5198439|NCT00829816|Alzheimers disease|alzheimers disease
5198440|NCT00829816|donepezil|donepezil
5198441|NCT00829816|memantine|memantine
5198442|NCT00829803|To acquire developmental data to prospectively support SNAP|to acquire developmental data to prospectively support snap
5198443|NCT00829803|II index ranges at the studied anesthetic states.|ii index ranges at the studied anesthetic states.
5198444|NCT00829790|Bioequivalence|bioequivalence
5198445|NCT00829790|Healthy Subjects|healthy subjects
5198446|NCT00829777|Naloxone|naloxone
5198447|NCT00829777|6β-Naltrexol|6β-naltrexol
5198448|NCT00829777|Opioid-dependent|opioid-dependent
5198449|NCT00829777|Pharmacokinetics|pharmacokinetics
5198450|NCT00829777|peripheral effects of withdrawal|peripheral effects of withdrawal
5198451|NCT00829777|central effects of withdrawal|central effects of withdrawal
5198452|NCT00829764|Bioequivalence|bioequivalence
5198453|NCT00829764|Healthy Subjects|healthy subjects
5198454|NCT00829751|staining|staining
5198455|NCT00829751|toxicity|toxicity
5198456|NCT00829751|fluorometry|fluorometry
5198457|NCT00829751|dye diffusion|dye diffusion
5198458|NCT00829751|anterior chamber|anterior chamber
5198459|NCT00829738|PPI therapy|ppi therapy
5198460|NCT00829738|pantoprazole|pantoprazole
5198461|NCT00829738|GERD (Erosive Gastroesophageal Reflux Disease)|gerd (erosive gastroesophageal reflux disease)
5198462|NCT00829725|subcapital femoral fractures|subcapital femoral fractures
5198463|NCT00829725|transcervical femoral fractures|transcervical femoral fractures
5198464|NCT00829725|TARGON FN|targon fn
5198465|NCT00829712|Bioequivalence|bioequivalence
5198466|NCT00829712|Healthy Subjects|healthy subjects
5198467|NCT00829699|endothelial function|endothelial function
5198468|NCT00829699|fibrinolytic balance|fibrinolytic balance
5198469|NCT00829686|abscess|abscess
5198470|NCT00829686|cellulitis|cellulitis
5198471|NCT00829686|antibiotics|antibiotics
5198472|NCT00829686|MRSA|mrsa
5198473|NCT00829673|Bioequivalence|bioequivalence
5198474|NCT00829673|Healthy Subjects|healthy subjects
5198475|NCT00829660|Acarbose|acarbose
5198476|NCT00829647|CLL|cll
5198477|NCT00829647|dasatinib|dasatinib
5198478|NCT00829647|lenalidomide|lenalidomide
5198479|NCT00829647|sprycel|sprycel
5198480|NCT00829647|revlimid|revlimid
5198481|NCT00829647|CLL relapsed or refractory to fludarabine|cll relapsed or refractory to fludarabine
5198482|NCT00829634|methamphetamine|methamphetamine
5198483|NCT00829634|inpatient|inpatient
5198484|NCT00829634|d-MA|d-ma
5198485|NCT00829634|l-MA|l-ma
5198486|NCT00829634|APRL|aprl
5198487|NCT00829634|San Francisco|san francisco
5198488|NCT00829634|metabolism|metabolism
5198489|NCT00829634|Metabolism of methamphetamine|metabolism of methamphetamine
5198490|NCT00829621|BMP-2|bmp-2
5198491|NCT00829621|Incisional Vacuum Assisted Closure (IVAC)|incisional vacuum assisted closure (ivac)
5198492|NCT00829608|RRP|rrp
5198493|NCT00829608|Recurrent Respiratory Papillomatosis|recurrent respiratory papillomatosis
5198494|NCT00829608|HPV vaccine|hpv vaccine
5198495|NCT00829608|HPV|hpv
5198496|NCT00829595|inflammatory bowel disease|inflammatory bowel disease
5198497|NCT00829595|Crohn disease|crohn disease
5198498|NCT00829595|ulcerative colitis|ulcerative colitis
5198499|NCT00829595|immunosuppression|immunosuppression
5198500|NCT00829595|anti tumor necrosis alpha|anti tumor necrosis alpha
5198501|NCT00829595|pneumovax|pneumovax
5198502|NCT00829595|pneumococcal vaccine|pneumococcal vaccine
5198503|NCT00829569|Intralipid|intralipid
5198504|NCT00829569|Omegaven|omegaven
5198505|NCT00829569|fish oil|fish oil
5198506|NCT00829569|hyperinsulinemic isoglycemic clamps|hyperinsulinemic isoglycemic clamps
5198507|NCT00829569|C-peptide glucagon test|c-peptide glucagon test
5198508|NCT00829569|indirect calorimetry|indirect calorimetry
5198509|NCT00829569|F2-isoprostanes|f2-isoprostanes
5198510|NCT00829543|Spodyloarthropathy|spodyloarthropathy
5198511|NCT00829543|Guide-free sacroiliac injection|guide-free sacroiliac injection
5198512|NCT00829530|Bioequivalence|bioequivalence
5198513|NCT00829530|Healthy Subjects|healthy subjects
5198514|NCT00829517|Contraception|contraception
5198515|NCT00829517|sexually transmitted diseases|sexually transmitted diseases
5198516|NCT00829504|Bioequivalence|bioequivalence
5198517|NCT00829504|Healthy Subjects|healthy subjects
5198518|NCT00829491|Cardiovascular Disease Prevention|cardiovascular disease prevention
5198519|NCT00829491|Behavior change|behavior change
5198520|NCT00829491|Risk Reduction|risk reduction
5198521|NCT00829478|Atrial fibrillation|atrial fibrillation
5198522|NCT00829478|Cerebrovascular accident|cerebrovascular accident
5198523|NCT00829478|Anticoagulation|anticoagulation
5198524|NCT00829478|Decision-making|decision-making
5198525|NCT00829452|Bioequivalence|bioequivalence
5198526|NCT00829452|Healthy Subjects|healthy subjects
5198527|NCT00829439|Angelman syndrome|angelman syndrome
5198528|NCT00829439|Levodopa|levodopa
5198529|NCT00829439|Carbidopa|carbidopa
5198531|NCT00829426|Bioequivalence|bioequivalence
5198532|NCT00829426|Healthy Subjects|healthy subjects
5198533|NCT00829400|Neuropsychology|neuropsychology
5198534|NCT00829400|Cognitive Remediation|cognitive remediation
5198535|NCT00829400|Vocational Rehabilitation|vocational rehabilitation
5198536|NCT00829400|Schizophrenia|schizophrenia
5198537|NCT00829400|Severe and persistent mental illness|severe and persistent mental illness
5198538|NCT00829400|Chronic and disabling mental illness|chronic and disabling mental illness
5198539|NCT00829387|Diabetes|diabetes
5198540|NCT00829387|Pain|pain
5198541|NCT00829387|Neuropathic Pain|neuropathic pain
5198542|NCT00829374|Alzheimer's disease|alzheimer's disease
5198543|NCT00829374|clinical trial|clinical trial
5198544|NCT00829374|mitochondria|mitochondria
5198545|NCT00829374|memory loss|memory loss
5198546|NCT00829374|neurodegenerative disease|neurodegenerative disease
5198547|NCT00829374|dementia|dementia
5198548|NCT00829374|investigational drug|investigational drug
5198549|NCT00829361|Telemedicine|telemedicine
5198550|NCT00829361|Acute stroke|acute stroke
5198551|NCT00829361|Rural|rural
5198552|NCT00829361|thrombosis|thrombosis
5198553|NCT00829361|consultation|consultation
5198554|NCT00829361|Stroke|stroke
5198555|NCT00829361|Cerebral Infarction|cerebral infarction
5198556|NCT00829361|Vascular diseases|vascular diseases
5198557|NCT00829361|brain ischemia|brain ischemia
5198558|NCT00829361|brain infarction|brain infarction
5198559|NCT00829361|brain diseases|brain diseases
5198560|NCT00829361|cerebrovascular disorders|cerebrovascular disorders
5198561|NCT00829348|Compliance|compliance
5198562|NCT00829348|Chronic|chronic
5198563|NCT00829348|Pharmacotherapy|pharmacotherapy
5198564|NCT00829348|Statins|statins
5198565|NCT00829335|Intraoperative ultrasound|intraoperative ultrasound
5198566|NCT00829335|Segmentectomy|segmentectomy
5198567|NCT00829335|HCC|hcc
5198568|NCT00829309|Bioequivalence|bioequivalence
5198569|NCT00829309|Healthy Subjects|healthy subjects
5198570|NCT00829296|diabetes|diabetes
5198571|NCT00829296|hypertension|hypertension
5198572|NCT00829296|aortic impedance|aortic impedance
5198573|NCT00829283|Experimental|experimental
5198574|NCT00829283|Comparator|comparator
5198575|NCT00829244|Infertility|infertility
5198576|NCT00829244|Assisted reproductive technology|assisted reproductive technology
5198577|NCT00829231|Liver disease|liver disease
5198578|NCT00829218|Irritable Bowel Syndrome|irritable bowel syndrome
5198579|NCT00829218|Fibromyalgia|fibromyalgia
5198580|NCT00829218|Glutamate|glutamate
5198581|NCT00829218|Diet|diet
5198582|NCT00829218|Food additives|food additives
5198583|NCT00829205|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5198584|NCT00829192|Actinic keratoses (AK)|actinic keratoses (ak)
5198585|NCT00829192|Squamous cell carcinomas (SCC)|squamous cell carcinomas (scc)
5198586|NCT00829192|CUV1647|cuv1647
5198587|NCT00829192|Afamelanotide|afamelanotide
5198588|NCT00829192|Clinuvel|clinuvel
5198589|NCT00829192|Photoprotection|photoprotection
5198590|NCT00829192|Organ transplant|organ transplant
5198591|NCT00829179|Asthma|asthma
5198592|NCT00829153|Fistula patency|fistula patency
5198593|NCT00829127|volunteers|volunteers
5198594|NCT00829114|AE|ae
5198595|NCT00829114|AIDS|aids
5198596|NCT00829114|ALT|alt
5198597|NCT00829114|ART|art
5198598|NCT00829114|AST|ast
5198599|NCT00829114|DCF|dcf
5198600|NCT00829114|DMC|dmc
5198601|NCT00829114|FDA|fda
5198602|NCT00829114|GCP|gcp
5198603|NCT00829114|HB sAg|hb sag
5198604|NCT00829114|ICH|ich
5198605|NCT00829114|IND|ind
5198606|NCT00829114|IRB|irb
5198607|NCT00829114|IU|iu
5198608|NCT00829114|mg|mg
5198609|NCT00829114|mm3|mm3
5198610|NCT00829114|PCR|pcr
5198611|NCT00829114|SAE|sae
5198612|NCT00829114|ULN|uln
5198613|NCT00829114|WB|wb
5198614|NCT00829114|COC|coc
5198615|NCT00829114|Combined Oral Contraceptives|combined oral contraceptives
5198616|NCT00829101|unilateral cleft lip and palate|unilateral cleft lip and palate
5198617|NCT00829101|primary palatal surgery|primary palatal surgery
5198618|NCT00829101|articulation|articulation
5198619|NCT00829101|phonology|phonology
5198620|NCT00829101|one stage palatal repair|one stage palatal repair
5198621|NCT00829101|two stage palatal repair|two stage palatal repair
5198622|NCT00829088|Mass balance|mass balance
5198623|NCT00829088|AZD2066|azd2066
5198624|NCT00829088|Pain|pain
5198625|NCT00829088|Pain conditions|pain conditions
5198626|NCT00829062|Type 1 diabetes|type 1 diabetes
5198627|NCT00829062|Insulin pump|insulin pump
5198628|NCT00829062|Glycemic variability|glycemic variability
5198629|NCT00829036|Rehabilitation|rehabilitation
5198630|NCT00829036|Sensory Aid|sensory aid
5198631|NCT00829023|Positive aerobic or anaerobic cultures|positive aerobic or anaerobic cultures
5198632|NCT00829010|Human Immunodeficiency Virus|human immunodeficiency virus
5198633|NCT00829010|Booster vaccination|booster vaccination
5198634|NCT00829010|Safety|safety
5198635|NCT00829010|Primary vaccination|primary vaccination
5198636|NCT00829010|Pneumococcal vaccine|pneumococcal vaccine
5198637|NCT00829010|Immunogenicity|immunogenicity
5198638|NCT00829010|Pneumococcal disease|pneumococcal disease
5198639|NCT00828997|rheumatoid arthritis|rheumatoid arthritis
5198640|NCT00828997|spondylarthropathy|spondylarthropathy
5198641|NCT00828997|immunological response following vaccination with Prevenar|immunological response following vaccination with prevenar
5198642|NCT00828971|Complicated skin and skin structure infections|complicated skin and skin structure infections
5198643|NCT00828971|cSSSI|csssi
5198644|NCT00828958|schizophrenia|schizophrenia
5198645|NCT00828958|Risperidone|risperidone
5198646|NCT00828958|Long acting injectable|long acting injectable
5198647|NCT00828958|Intradeltoidal injection|intradeltoidal injection
5198648|NCT00828919|VEGFR inhibitor|vegfr inhibitor
5198649|NCT00828919|angi-angiogenic|angi-angiogenic
5198650|NCT00828919|tyrosine kinase inhibitor|tyrosine kinase inhibitor
5198651|NCT00828906|Glaucoma|glaucoma
5198652|NCT00828906|IOP|iop
5198653|NCT00828906|DuoTrav|duotrav
5198654|NCT00828893|drain under scanner|drain under scanner
5198655|NCT00828867|healthy subjects|healthy subjects
5198656|NCT00828867|FTIH, single dose, food effect, healthy subjects, double-blind|ftih, single dose, food effect, healthy subjects, double-blind
5198657|NCT00828854|breast cancer|breast cancer
5198658|NCT00828854|estrogen receptor postive|estrogen receptor postive
5198659|NCT00828828|Influenza Vaccine|influenza vaccine
5198660|NCT00828828|Sarcoidosis|sarcoidosis
5198661|NCT00828828|Antibody|antibody
5198662|NCT00828815|HIV-negative|hiv-negative
5198663|NCT00828815|buprenorphine/nalaxone|buprenorphine/nalaxone
5198664|NCT00828815|norbuprenorphine|norbuprenorphine
5198665|NCT00828815|opioid-dependent|opioid-dependent
5198666|NCT00828815|TMC125-TiDP2-C188|tmc125-tidp2-c188
5198667|NCT00828815|TMC125-C188|tmc125-c188
5198668|NCT00828815|TMC125|tmc125
5198669|NCT00828815|HIV Infections|hiv infections
5198670|NCT00828802|Myelodysplastic Syndromes|myelodysplastic syndromes
5198671|NCT00828802|MDS|mds
5198672|NCT00828789|Hepatitis C|hepatitis c
5198673|NCT00828789|HCV|hcv
5198674|NCT00828789|HIV|hiv
5198675|NCT00828789|AIDS|aids
5198676|NCT00828789|Telaprevir|telaprevir
5198677|NCT00828789|Efavirenz|efavirenz
5198678|NCT00828789|Tenofovir disproxil fumarate|tenofovir disproxil fumarate
5198679|NCT00828789|Healthy volunteer|healthy volunteer
5198680|NCT00828789|VX-950-C134|vx-950-c134
5198681|NCT00828789|VX-950-TiDP24-C134|vx-950-tidp24-c134
5198682|NCT00828789|HIV Infections|hiv infections
5198683|NCT00828776|TTPa|ttpa
5198684|NCT00828776|Anti-Xa|anti-xa
5198685|NCT00828776|Adverse Reactions|adverse reactions
5198686|NCT00828763|healthy volunteer|healthy volunteer
5198687|NCT00828763|radiolabelled|radiolabelled
5198688|NCT00828750|eltrombopag|eltrombopag
5198689|NCT00828750|thrombopoietin receptor agonist|thrombopoietin receptor agonist
5198690|NCT00828750|ITP|itp
5198691|NCT00828750|blood platelet|blood platelet
5198692|NCT00828711|Misoprostol vaginal insert|misoprostol vaginal insert
5198693|NCT00828711|Induction of labor|induction of labor
5198694|NCT00828711|Cervical ripening|cervical ripening
5198695|NCT00828711|Rate of cesarean section|rate of cesarean section
5198696|NCT00828698|Death, sudden|death, sudden
5198697|NCT00828698|All cause mortality|all cause mortality
5198698|NCT00828685|Return to Work|return to work
5198699|NCT00828685|CRPP|crpp
5198700|NCT00828685|ORIF|orif
5198701|NCT00828685|Distal Radius|distal radius
5198702|NCT00828672|assess activity|assess activity
5198703|NCT00828672|bevacizumab|bevacizumab
5198704|NCT00828672|capecitabine|capecitabine
5198705|NCT00828672|radiation therapy|radiation therapy
5198706|NCT00828672|oxaliplatin|oxaliplatin
5198707|NCT00828672|pre-operative treatment|pre-operative treatment
5198708|NCT00828672|TME (total mesorectal excision).|tme (total mesorectal excision).
5198709|NCT00828659|Abuse potential|abuse potential
5198710|NCT00828646|Healthy Subjects|healthy subjects
5198711|NCT00828633|stage I prostate cancer|stage i prostate cancer
5198712|NCT00828633|stage II prostate cancer|stage ii prostate cancer
5198713|NCT00828607|Contrast Enhanced Ultrasound (CEUS)|contrast enhanced ultrasound (ceus)
5198714|NCT00828607|Liver tumors|liver tumors
5198715|NCT00828607|Hepatocellular carcinoma|hepatocellular carcinoma
5198716|NCT00828607|Hemangioma|hemangioma
5198717|NCT00828607|Focal Nodular Hyperplasia|focal nodular hyperplasia
5198718|NCT00828607|Hepatic metastases|hepatic metastases
5198719|NCT00828594|Hepatocellular carcinoma|hepatocellular carcinoma
5198720|NCT00828594|dose-finding study|dose-finding study
5198721|NCT00828594|randomized trial|randomized trial
5198722|NCT00828594|medical treatment|medical treatment
5198723|NCT00828594|RAD001|rad001
5198724|NCT00828594|sorafenib|sorafenib
5198725|NCT00828594|Advanced hepatocellular cancer (HCC)|advanced hepatocellular cancer (hcc)
5198726|NCT00828568|Actinic Keratosis|actinic keratosis
5198727|NCT00828555|HPV vaccine|hpv vaccine
5198728|NCT00828555|Tdap vaccine|tdap vaccine
5198729|NCT00828542|Adverse Effects|adverse effects
5198730|NCT00828542|Etonogestrel|etonogestrel
5198731|NCT00828542|Postpartum period|postpartum period
5198732|NCT00828542|Contraception|contraception
5198733|NCT00828542|Hemostasis|hemostasis
5198734|NCT00828542|Metabolism|metabolism
5198735|NCT00828529|TMC207-TiDP13-C110|tmc207-tidp13-c110
5198736|NCT00828529|TMC207-C110|tmc207-c110
5198737|NCT00828529|TMC207|tmc207
5198738|NCT00828529|Drug-drug interaction|drug-drug interaction
5198739|NCT00828529|Tuberculosis|tuberculosis
5198740|NCT00828529|HIV|hiv
5198741|NCT00828529|Kaletra|kaletra
5198742|NCT00828529|Lopinavir|lopinavir
5198743|NCT00828529|Ritonavir|ritonavir
5198744|NCT00828529|Open-label|open-label
5198745|NCT00828529|HIV Infections|hiv infections
5198746|NCT00828516|lymphedema|lymphedema
5198747|NCT00828516|male breast cancer|male breast cancer
5198748|NCT00828516|stage IA breast cancer|stage ia breast cancer
5198749|NCT00828516|stage IB breast cancer|stage ib breast cancer
5198750|NCT00828516|stage II breast cancer|stage ii breast cancer
5198751|NCT00828516|recurrent breast cancer|recurrent breast cancer
5198752|NCT00828516|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
5198753|NCT00828516|stage I squamous cell carcinoma of the hypopharynx|stage i squamous cell carcinoma of the hypopharynx
5198806|NCT00828516|salivary gland anaplastic carcinoma|salivary gland anaplastic carcinoma
5198754|NCT00828516|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
5198755|NCT00828516|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
5198756|NCT00828516|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
5198757|NCT00828516|stage I squamous cell carcinoma of the larynx|stage i squamous cell carcinoma of the larynx
5198758|NCT00828516|stage I verrucous carcinoma of the larynx|stage i verrucous carcinoma of the larynx
5198759|NCT00828516|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
5198760|NCT00828516|stage II verrucous carcinoma of the larynx|stage ii verrucous carcinoma of the larynx
5198858|NCT00828243|Pulmonary surfactants|pulmonary surfactants
5198761|NCT00828516|recurrent adenoid cystic carcinoma of the oral cavity|recurrent adenoid cystic carcinoma of the oral cavity
5198762|NCT00828516|recurrent mucoepidermoid carcinoma of the oral cavity|recurrent mucoepidermoid carcinoma of the oral cavity
5198763|NCT00828516|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
5198764|NCT00828516|stage I adenoid cystic carcinoma of the oral cavity|stage i adenoid cystic carcinoma of the oral cavity
5198765|NCT00828516|stage I mucoepidermoid carcinoma of the oral cavity|stage i mucoepidermoid carcinoma of the oral cavity
5198766|NCT00828516|stage I verrucous carcinoma of the oral cavity|stage i verrucous carcinoma of the oral cavity
5198767|NCT00828516|stage II adenoid cystic carcinoma of the oral cavity|stage ii adenoid cystic carcinoma of the oral cavity
5198768|NCT00828516|stage II mucoepidermoid carcinoma of the oral cavity|stage ii mucoepidermoid carcinoma of the oral cavity
5198769|NCT00828516|stage II verrucous carcinoma of the oral cavity|stage ii verrucous carcinoma of the oral cavity
5198770|NCT00828516|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
5198771|NCT00828516|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
5198772|NCT00828516|recurrent basal cell carcinoma of the lip|recurrent basal cell carcinoma of the lip
5198773|NCT00828516|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
5198774|NCT00828516|stage I basal cell carcinoma of the lip|stage i basal cell carcinoma of the lip
5198775|NCT00828516|stage II basal cell carcinoma of the lip|stage ii basal cell carcinoma of the lip
5198776|NCT00828516|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
5198777|NCT00828516|recurrent lymphoepithelioma of the nasopharynx|recurrent lymphoepithelioma of the nasopharynx
5198778|NCT00828516|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
5198779|NCT00828516|stage I lymphoepithelioma of the nasopharynx|stage i lymphoepithelioma of the nasopharynx
5198780|NCT00828516|stage I squamous cell carcinoma of the nasopharynx|stage i squamous cell carcinoma of the nasopharynx
5198781|NCT00828516|stage II lymphoepithelioma of the nasopharynx|stage ii lymphoepithelioma of the nasopharynx
5198782|NCT00828516|stage II squamous cell carcinoma of the nasopharynx|stage ii squamous cell carcinoma of the nasopharynx
5198783|NCT00828516|recurrent lymphoepithelioma of the oropharynx|recurrent lymphoepithelioma of the oropharynx
5198784|NCT00828516|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
5198785|NCT00828516|stage I lymphoepithelioma of the oropharynx|stage i lymphoepithelioma of the oropharynx
5198786|NCT00828516|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
5198787|NCT00828516|stage II lymphoepithelioma of the oropharynx|stage ii lymphoepithelioma of the oropharynx
5198788|NCT00828516|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
5198789|NCT00828516|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity
5198790|NCT00828516|recurrent inverted papilloma of the paranasal sinus and nasal cavity|recurrent inverted papilloma of the paranasal sinus and nasal cavity
5198791|NCT00828516|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity
5198792|NCT00828516|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
5198793|NCT00828516|stage I esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage i esthesioneuroblastoma of the paranasal sinus and nasal cavity
5198794|NCT00828516|stage I inverted papilloma of the paranasal sinus and nasal cavity|stage i inverted papilloma of the paranasal sinus and nasal cavity
5198795|NCT00828516|stage I midline lethal granuloma of the paranasal sinus and nasal cavity|stage i midline lethal granuloma of the paranasal sinus and nasal cavity
5198796|NCT00828516|stage I squamous cell carcinoma of the paranasal sinus and nasal cavity|stage i squamous cell carcinoma of the paranasal sinus and nasal cavity
5198797|NCT00828516|stage II esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage ii esthesioneuroblastoma of the paranasal sinus and nasal cavity
5198798|NCT00828516|stage II inverted papilloma of the paranasal sinus and nasal cavity|stage ii inverted papilloma of the paranasal sinus and nasal cavity
5198799|NCT00828516|stage II midline lethal granuloma of the paranasal sinus and nasal cavity|stage ii midline lethal granuloma of the paranasal sinus and nasal cavity
5198800|NCT00828516|stage II squamous cell carcinoma of the paranasal sinus and nasal cavity|stage ii squamous cell carcinoma of the paranasal sinus and nasal cavity
5198801|NCT00828516|low-grade salivary gland mucoepidermoid carcinoma|low-grade salivary gland mucoepidermoid carcinoma
5198802|NCT00828516|recurrent salivary gland cancer|recurrent salivary gland cancer
5198803|NCT00828516|salivary gland acinic cell tumor|salivary gland acinic cell tumor
5198804|NCT00828516|salivary gland adenocarcinoma|salivary gland adenocarcinoma
5198805|NCT00828516|salivary gland adenoid cystic carcinoma|salivary gland adenoid cystic carcinoma
5200296|NCT00823173|ESBA105|esba105
5198807|NCT00828516|salivary gland malignant mixed cell type tumor|salivary gland malignant mixed cell type tumor
5198808|NCT00828516|salivary gland poorly differentiated carcinoma|salivary gland poorly differentiated carcinoma
5198809|NCT00828516|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
5198810|NCT00828516|stage I salivary gland cancer|stage i salivary gland cancer
5198811|NCT00828516|stage II salivary gland cancer|stage ii salivary gland cancer
5198812|NCT00828516|tongue cancer|tongue cancer
5198813|NCT00828503|Certi-CMV|certi-cmv
5198814|NCT00828503|immunosuppressive switch (to Certican)|immunosuppressive switch (to certican)
5198815|NCT00828503|renal transplant|renal transplant
5198816|NCT00828490|Fraud and Abuse|fraud and abuse
5198817|NCT00828490|opioids|opioids
5198818|NCT00828464|Dermatosis, Dermatitis, Dry skin, Irritated skin|dermatosis, dermatitis, dry skin, irritated skin
5198819|NCT00828451|newborn|newborn
5198820|NCT00828451|necrotizing enterocolitis|necrotizing enterocolitis
5198821|NCT00828451|genetics|genetics
5198822|NCT00828451|growth factors|growth factors
5198823|NCT00828451|metabolism|metabolism
5198824|NCT00828425|Diabetes Mellitus|diabetes mellitus
5198825|NCT00828425|retinopathy|retinopathy
5198826|NCT00828425|Management of diabetic patients with retinopathy|management of diabetic patients with retinopathy
5198827|NCT00828399|Radiotherapy|radiotherapy
5198828|NCT00828399|Diarrhoea|diarrhoea
5198829|NCT00828399|Glutamine|glutamine
5198830|NCT00828399|Oxydative stress|oxydative stress
5198831|NCT00828399|Calprotectin|calprotectin
5198832|NCT00828399|Citrulline|citrulline
5198833|NCT00828386|Nasopharyngeal cancers|nasopharyngeal cancers
5198834|NCT00828386|induction chemotherapy|induction chemotherapy
5198835|NCT00828386|radiochemotherapy|radiochemotherapy
5198836|NCT00828360|Heart Failure|heart failure
5198837|NCT00828360|CRT|crt
5198838|NCT00828360|Dobutamine echocardiography|dobutamine echocardiography
5198839|NCT00828334|transcatheter occlusion of patent ductus arteriosus|transcatheter occlusion of patent ductus arteriosus
5198840|NCT00828321|Bioequivalency|bioequivalency
5198841|NCT00828321|Healthy Volunteers|healthy volunteers
5198842|NCT00828308|localized|localized
5198843|NCT00828308|high risk|high risk
5198844|NCT00828308|prostate cancer|prostate cancer
5198845|NCT00828308|neoadjuvant treatment|neoadjuvant treatment
5198846|NCT00828295|Postoperative Nausea and Vomiting|postoperative nausea and vomiting
5198847|NCT00828295|palonosetron|palonosetron
5198848|NCT00828295|pediatric|pediatric
5198849|NCT00828282|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
5198850|NCT00828282|Simvastatin|simvastatin
5198851|NCT00828282|Zocor|zocor
5198852|NCT00828269|Patients with Chronic Hepatitis C|patients with chronic hepatitis c
5198853|NCT00828256|arthroscopic repair|arthroscopic repair
5198854|NCT00828256|rotator cuff|rotator cuff
5198855|NCT00828256|tears|tears
5198856|NCT00828256|shoulder|shoulder
5198857|NCT00828256|chronic tear of rotator cuff|chronic tear of rotator cuff
5198859|NCT00828243|Pulmonary surfactant associated protein B|pulmonary surfactant associated protein b
5198860|NCT00828243|Pulmonary surfactant associated protein C|pulmonary surfactant associated protein c
5198861|NCT00828243|ATP-binding cassette protein sub member family A3|atp-binding cassette protein sub member family a3
5198862|NCT00828230|budesonide|budesonide
5198863|NCT00828230|placebo|placebo
5198864|NCT00828230|acute radiation proctitis|acute radiation proctitis
5198865|NCT00828230|late radiation proctitis|late radiation proctitis
5198866|NCT00828230|Prevention of acute radiation proctitis|prevention of acute radiation proctitis
5198867|NCT00828230|Prevention of late radiation proctitis|prevention of late radiation proctitis
5198868|NCT00828217|adapted physical activity|adapted physical activity
5198869|NCT00828217|hospital|hospital
5198870|NCT00828217|health-related quality of life|health-related quality of life
5198871|NCT00828217|satisfaction with care|satisfaction with care
5198872|NCT00828217|child|child
5198873|NCT00828217|adolescent|adolescent
5198874|NCT00828217|randomized controlled trial|randomized controlled trial
5198875|NCT00828217|physical activity|physical activity
5198876|NCT00828217|quality of life|quality of life
5198877|NCT00828191|Luteal support in IVF|luteal support in ivf
5198878|NCT00828178|SLE|sle
5198879|NCT00828178|atherosclerosis|atherosclerosis
5198880|NCT00828178|omega-3|omega-3
5198881|NCT00828126|Metastatic Melanoma|metastatic melanoma
5198882|NCT00828126|AJCC Stage III Melanoma|ajcc stage iii melanoma
5198883|NCT00828126|AJCC stage IV Melanoma|ajcc stage iv melanoma
5198884|NCT00828126|PET-CT|pet-ct
5198885|NCT00828126|Positron Emission Tomography-Computed Tomography|positron emission tomography-computed tomography
5198886|NCT00828126|Contrast-enhanced Computed Tomography Scan|contrast-enhanced computed tomography scan
5198887|NCT00828126|CT|ct
5198888|NCT00828126|Conventional Imaging|conventional imaging
5198889|NCT00828126|False Positive Rate|false positive rate
5198890|NCT00828126|Fluorodeoxyglucose|fluorodeoxyglucose
5198891|NCT00828126|FDG|fdg
5198892|NCT00828126|Surgery|surgery
5198893|NCT00828113|smoking|smoking
5198894|NCT00828113|relapse|relapse
5198895|NCT00828113|withdrawal|withdrawal
5198896|NCT00828087|acute myocardial infarction|acute myocardial infarction
5198897|NCT00828087|primary percutaneous coronary intervention|primary percutaneous coronary intervention
5198898|NCT00828087|drug-eluting stent|drug-eluting stent
5198899|NCT00828074|stage IV breast cancer|stage iv breast cancer
5198900|NCT00828074|recurrent breast cancer|recurrent breast cancer
5198901|NCT00828035|robotics|robotics
5198902|NCT00828035|laparoscopy|laparoscopy
5198903|NCT00828035|surgery|surgery
5198904|NCT00828035|computer assisted|computer assisted
5198905|NCT00828022|measles-positive NSCLC|measles-positive nsclc
5198906|NCT00828022|measles vaccine|measles vaccine
5198907|NCT00828022|consolidation|consolidation
5198908|NCT00828022|Stage 3B with pleural effusion or stage 4 non-small cell lung cancer in remission|stage 3b with pleural effusion or stage 4 non-small cell lung cancer in remission
5198909|NCT00828009|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5198910|NCT00828009|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5198911|NCT00828009|adenocarcinoma of the lung|adenocarcinoma of the lung
5198912|NCT00828009|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
5198913|NCT00828009|large cell lung cancer|large cell lung cancer
5198914|NCT00827996|Apocrine glands|apocrine glands
5198915|NCT00827996|abcesses|abcesses
5198916|NCT00827983|Luteal Phase Support in IVF patients|luteal phase support in ivf patients
5198917|NCT00827970|mass screening|mass screening
5198918|NCT00827957|Hypothermia|hypothermia
5198919|NCT00827957|Internal cooling|internal cooling
5198920|NCT00827957|External cooling|external cooling
5198921|NCT00827957|Cardiac arrest|cardiac arrest
5198922|NCT00827944|Uncomplicated primary inguinal hernias|uncomplicated primary inguinal hernias
5198923|NCT00827931|tranexamic acid|tranexamic acid
5198924|NCT00827931|major abdominal surgery|major abdominal surgery
5198925|NCT00827931|blood loss|blood loss
5198926|NCT00827918|Acute Exacerbation of Schizophrenia|acute exacerbation of schizophrenia
5198927|NCT00827905|Non-Contact|non-contact
5198928|NCT00827905|Radar|radar
5198929|NCT00827905|Respiratory|respiratory
5198930|NCT00827905|Respiration|respiration
5198931|NCT00827905|Breathing|breathing
5198932|NCT00827905|Rate|rate
5198933|NCT00827905|Frequency|frequency
5198934|NCT00827905|Respiratory Mechanics|respiratory mechanics
5198935|NCT00827905|Respiratory Rate Measurement|respiratory rate measurement
5198936|NCT00827892|Intracerebral Hemorrhage|intracerebral hemorrhage
5198937|NCT00827892|Treatment|treatment
5198938|NCT00827892|MRI|mri
5198939|NCT00827879|Intimate partner aggression|intimate partner aggression
5198940|NCT00827879|Couples intervention|couples intervention
5198941|NCT00827879|PTSD|ptsd
5198942|NCT00827879|Veterans|veterans
5198943|NCT00827879|Prevention|prevention
5198944|NCT00827879|Violence Prevention|violence prevention
5198945|NCT00827879|Prevention of pertetration of intimate partner aggression.|prevention of pertetration of intimate partner aggression.
5198946|NCT00827866|Tobacco quitline|tobacco quitline
5198947|NCT00827866|Childhood cancer survivors|childhood cancer survivors
5198948|NCT00827866|Adult-onset cancer survivors|adult-onset cancer survivors
5198949|NCT00827853|Diabetes|diabetes
5198950|NCT00827853|Peripheral Vascular Disease (PVD)|peripheral vascular disease (pvd)
5198951|NCT00827853|Superficial Femoral Artery (SFA)|superficial femoral artery (sfa)
5198952|NCT00827853|Cryoplasty|cryoplasty
5198953|NCT00827853|Restenosis|restenosis
5198954|NCT00827827|Stroke|stroke
5198955|NCT00827827|Exercise|exercise
5198956|NCT00827827|Strength Training|strength training
5198957|NCT00827827|Skeletal Muscle|skeletal muscle
5198958|NCT00827827|Insulin Sensitivity|insulin sensitivity
5198959|NCT00827801|Cancer|cancer
5198960|NCT00827801|Heart Failure|heart failure
5198961|NCT00827801|HF|hf
5198962|NCT00827801|Cancer and Concurrent Heart Failure|cancer and concurrent heart failure
5198963|NCT00827801|MDASI-HF Symptom Management Program|mdasi-hf symptom management program
5198964|NCT00827801|MDASI-HF|mdasi-hf
5198965|NCT00827801|MDASI-HF questionnaire|mdasi-hf questionnaire
5198966|NCT00827801|M. D. Anderson Symptom Inventory - Heart Failure|m. d. anderson symptom inventory - heart failure
5198967|NCT00827801|Questionnaire|questionnaire
5198968|NCT00827801|Symptom Management Gap|symptom management gap
5198969|NCT00827788|contrast media|contrast media
5198970|NCT00827788|angiography|angiography
5198971|NCT00827788|percutaneous coronary intervention|percutaneous coronary intervention
5198972|NCT00827775|Hypertension|hypertension
5198973|NCT00827775|Hemodialysis|hemodialysis
5198974|NCT00827762|phenylketonuria|phenylketonuria
5198975|NCT00827762|Kuvan|kuvan
5198976|NCT00827762|sapropterin|sapropterin
5198977|NCT00827762|behavior|behavior
5198978|NCT00827762|cognition|cognition
5198979|NCT00827762|executive abilities|executive abilities
5198980|NCT00827762|attention|attention
5198981|NCT00827749|swallowing disorders|swallowing disorders
5198982|NCT00827749|geriatrics|geriatrics
5198983|NCT00827736|anal fissure|anal fissure
5198984|NCT00827736|fissura ani|fissura ani
5198986|NCT00827736|ISDN|isdn
5198987|NCT00827736|Nitric oxide donor|nitric oxide donor
5198988|NCT00827723|Hepatic functional reserve|hepatic functional reserve
5198989|NCT00827723|Hepatocellular carcinoma (HCC)|hepatocellular carcinoma (hcc)
5198990|NCT00827723|Indocyanine Green retention rate at 15 minutes (ICG-R15')|indocyanine green retention rate at 15 minutes (icg-r15')
5198991|NCT00827723|Portal Pressure (PP)|portal pressure (pp)
5198992|NCT00827723|Hepatic Portal Venous Gradient (HPVG)|hepatic portal venous gradient (hpvg)
5198993|NCT00827723|Alcoholic and Viral Cirrhosis|alcoholic and viral cirrhosis
5198994|NCT00827723|Makuuchi criteria|makuuchi criteria
5198995|NCT00827723|Barcelona Clinic of Liver Cancer (BCLC)|barcelona clinic of liver cancer (bclc)
5198996|NCT00827723|Hepatic resection|hepatic resection
5198997|NCT00827710|diabetes|diabetes
5198998|NCT00827710|registry|registry
5198999|NCT00827710|computer|computer
5199000|NCT00827710|self management|self management
5199001|NCT00827697|Gonorrhea|gonorrhea
5199002|NCT00827697|Chlamydia|chlamydia
5199003|NCT00827697|Rectal|rectal
5199004|NCT00827684|KRAS mutation|kras mutation
5199005|NCT00827658|anesthesia, local|anesthesia, local
5199006|NCT00827658|ulnar nerve|ulnar nerve
5199007|NCT00827658|hand|hand
5199008|NCT00827658|surgery, plastic|surgery, plastic
5199009|NCT00827658|blinded|blinded
5199010|NCT00827658|randomized|randomized
5199011|NCT00827658|prospective|prospective
5199012|NCT00827658|local anesthesia|local anesthesia
5199013|NCT00827658|volar wrist block|volar wrist block
5199014|NCT00827658|hypothenar palm block|hypothenar palm block
5199015|NCT00827658|hand surgery|hand surgery
5199016|NCT00827632|Ovarian Suppression|ovarian suppression
5199017|NCT00827632|Oral Contraceptives|oral contraceptives
5199018|NCT00827632|Obese and Normal BMI|obese and normal bmi
5199019|NCT00827619|Peripheral Arterial Disease|peripheral arterial disease
5199020|NCT00827606|pediatric heterozygous familial hypercholesterolemia|pediatric heterozygous familial hypercholesterolemia
5199021|NCT00827580|HFS|hfs
5199022|NCT00827580|patients with breast or colon cancer receiving capecitabine|patients with breast or colon cancer receiving capecitabine
5199023|NCT00827567|Breast cancer|breast cancer
5199024|NCT00827567|metastatic breast|metastatic breast
5199025|NCT00827567|triple negative|triple negative
5199026|NCT00827567|ER/PR negative|er/pr negative
5199027|NCT00827567|Her2 Neu negative|her2 neu negative
5199028|NCT00827554|Liver Neoplasms|liver neoplasms
5199029|NCT00827554|Liver Diseases|liver diseases
5199030|NCT00827554|Digestive System Diseases|digestive system diseases
5199031|NCT00827554|Digestive System Neoplasms|digestive system neoplasms
5199032|NCT00827554|Carcinoma, Hepatocellular|carcinoma, hepatocellular
5199033|NCT00827554|Gastrointestinal Neoplasms|gastrointestinal neoplasms
5199034|NCT00827554|Adenocarcinoma|adenocarcinoma
5199035|NCT00827554|Hepatocellular carcinoma|hepatocellular carcinoma
5199036|NCT00827554|Neoplasms|neoplasms
5199037|NCT00827554|Transarterial chemoembolization|transarterial chemoembolization
5199038|NCT00827554|Nadroparin|nadroparin
5199039|NCT00827554|low-molecular-weight heparin|low-molecular-weight heparin
5199040|NCT00827554|chemoembolization|chemoembolization
5199041|NCT00827541|tigecycline|tigecycline
5199042|NCT00827541|complicated intra-abdominal infections (cIAI)|complicated intra-abdominal infections (ciai)
5199043|NCT00827541|complicated skin and soft tissue infections (cSSTI).|complicated skin and soft tissue infections (cssti).
5199044|NCT00827528|Pelvic Organ Prolapse|pelvic organ prolapse
5199045|NCT00827528|Surgical Treatment|surgical treatment
5199046|NCT00827515|Relative Bioavailability Effect of food|relative bioavailability effect of food
5199047|NCT00827502|TRULIMAX (AZITHROMYCIN ) NON-INTERVENTIONAL STUDY|trulimax (azithromycin ) non-interventional study
5199048|NCT00827489|schizophrenia|schizophrenia
5199049|NCT00827476|ovary|ovary
5199050|NCT00827476|human|human
5199051|NCT00827476|transplantaion|transplantaion
5199052|NCT00827476|ovarian failure|ovarian failure
5199053|NCT00827463|aneamia|aneamia
5199054|NCT00827463|aneamia during the maternity|aneamia during the maternity
5199055|NCT00827450|hepatic steatosis|hepatic steatosis
5199056|NCT00827450|coffee|coffee
5199057|NCT00827450|fructose|fructose
5199058|NCT00827450|lipids|lipids
5199059|NCT00827424|physical activity (PA)|physical activity (pa)
5199060|NCT00827424|obesity|obesity
5199061|NCT00827424|life style modification|life style modification
5199062|NCT00827424|physical activity|physical activity
5199063|NCT00827424|diet|diet
5199064|NCT00827424|BMI reduction|bmi reduction
5199065|NCT00827424|clinical and metabolic measure|clinical and metabolic measure
5199066|NCT00827424|health expenditure|health expenditure
5199067|NCT00827424|improvement of patient readiness for lifestyle change|improvement of patient readiness for lifestyle change
5199068|NCT00827411|Drug Eluting Stent|drug eluting stent
5199069|NCT00827411|Percutaneous coronary intervention|percutaneous coronary intervention
5199070|NCT00827411|Oral antiplatelet therapy|oral antiplatelet therapy
5199071|NCT00827411|Clopidogrel/Aspirin|clopidogrel/aspirin
5199072|NCT00827411|Acute Coronary Syndrome|acute coronary syndrome
5199073|NCT00827398|MSC|msc
5199074|NCT00827398|GVHD|gvhd
5199075|NCT00827398|Adults|adults
5199076|NCT00827398|Children|children
5199077|NCT00827398|steroid refractory acute GVHD occurring after allogeneic stem cell transplantation|steroid refractory acute gvhd occurring after allogeneic stem cell transplantation
5199078|NCT00827359|everolimus|everolimus
5199079|NCT00827333|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5199080|NCT00827333|stage I non-small cell lung cancer|stage i non-small cell lung cancer
5199081|NCT00827333|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
5199082|NCT00827333|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5199083|NCT00827333|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5199084|NCT00827333|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5199085|NCT00827307|breast carcinoma; goserelin; Mammographic density|breast carcinoma; goserelin; mammographic density
5199086|NCT00827294|Phantom limb pain|phantom limb pain
5199087|NCT00827294|Mirror therapy|mirror therapy
5199088|NCT00827294|amputation|amputation
5199089|NCT00827294|Limb loss|limb loss
5199090|NCT00827294|treatment|treatment
5199091|NCT00827281|DCS|dcs
5199092|NCT00827281|CBT|cbt
5199093|NCT00827281|smoking|smoking
5199094|NCT00827281|tobacco|tobacco
5199095|NCT00827268|Dyslexia|dyslexia
5199096|NCT00827268|Reading|reading
5199097|NCT00827268|Aphasia|aphasia
5199098|NCT00827268|Stroke|stroke
5199099|NCT00827242|Signs and Symptoms|signs and symptoms
5199100|NCT00827242|Prostatic Hyperplasia|prostatic hyperplasia
5199101|NCT00827242|Hyperplasia|hyperplasia
5199102|NCT00827242|Genital Diseases, Male|genital diseases, male
5199103|NCT00827242|Prostatic Diseases|prostatic diseases
5199104|NCT00827242|BPH-LUTS|bph-luts
5199105|NCT00827229|Active labor|active labor
5199106|NCT00827229|Term pregnancy|term pregnancy
5199107|NCT00827229|Vertex presentation|vertex presentation
5199108|NCT00827229|Single fetus|single fetus
5199109|NCT00827216|Gastric emptying|gastric emptying
5199110|NCT00827216|emergency anesthesia|emergency anesthesia
5199111|NCT00827216|intravenous erythromycin|intravenous erythromycin
5199112|NCT00827203|cancer|cancer
5199113|NCT00827203|metastatic|metastatic
5199114|NCT00827203|Elesclomol Sodium|elesclomol sodium
5199115|NCT00827203|tumor|tumor
5199116|NCT00827203|Advanced solid tumors that are metastatic and unresectable|advanced solid tumors that are metastatic and unresectable
5199117|NCT00827190|Acute Ischemic Stroke|acute ischemic stroke
5199118|NCT00827177|dose escalation|dose escalation
5199119|NCT00827177|safety|safety
5199120|NCT00827177|tolerability|tolerability
5199121|NCT00827177|tumor|tumor
5199122|NCT00827177|PK|pk
5199123|NCT00827177|hepatocellular carcinoma|hepatocellular carcinoma
5199124|NCT00827177|renal cell carcinoma|renal cell carcinoma
5199125|NCT00827177|melanoma|melanoma
5199126|NCT00827177|non-small cell lung cancer|non-small cell lung cancer
5199127|NCT00827177|breast cancer|breast cancer
5199128|NCT00827164|head and neck cancer|head and neck cancer
5199129|NCT00827164|resistance training|resistance training
5199130|NCT00827164|nutrition counseling|nutrition counseling
5199131|NCT00827164|radiation therapy|radiation therapy
5199132|NCT00827164|pharyngeal or laryngeal cancer|pharyngeal or laryngeal cancer
5199133|NCT00827151|amenorrhea|amenorrhea
5199134|NCT00827151|athletes|athletes
5199135|NCT00827151|bone loss|bone loss
5199136|NCT00827151|eumenorrhea|eumenorrhea
5199137|NCT00827125|active stage|active stage
5199138|NCT00827125|labor|labor
5199139|NCT00827125|progression|progression
5199140|NCT00827125|pregnant woman during active phases of labor|pregnant woman during active phases of labor
5199141|NCT00827112|CCR5-tropic HIV-1 virus|ccr5-tropic hiv-1 virus
5199142|NCT00827099|accelerated phase cml|accelerated phase cml
5199143|NCT00827099|adult ALL in remission|adult all in remission
5199144|NCT00827099|adult AML in remission|adult aml in remission
5199145|NCT00827099|adult AML with 11q23 (MLL) abnormalities|adult aml with 11q23 (mll) abnormalities
5199146|NCT00827099|adult AML with inv(16)(p13;q22)|adult aml with inv(16)(p13;q22)
5199147|NCT00827099|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5199148|NCT00827099|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5199149|NCT00827099|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5199150|NCT00827099|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5199151|NCT00827099|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5199152|NCT00827099|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5199153|NCT00827099|prolymphocytic leukemia|prolymphocytic leukemia
5199154|NCT00827099|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
5199155|NCT00827099|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5199156|NCT00827099|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5199157|NCT00827099|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5199158|NCT00827099|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
5199159|NCT00827099|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
5199160|NCT00827099|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5199161|NCT00827099|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5199162|NCT00827099|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5199163|NCT00827099|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5199164|NCT00827099|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
5199165|NCT00827099|cutaneous B-cell non-Hodgkin lymphoma|cutaneous b-cell non-hodgkin lymphoma
5199166|NCT00827099|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5199167|NCT00827099|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5199168|NCT00827099|adult grade III lymphomatoid granulomatosis|adult grade iii lymphomatoid granulomatosis
5199169|NCT00827099|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
5199170|NCT00827099|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
5199171|NCT00827099|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5199172|NCT00827099|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5199173|NCT00827099|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5199174|NCT00827099|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5199175|NCT00827099|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5199176|NCT00827099|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5199177|NCT00827099|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
5199178|NCT00827099|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5199179|NCT00827099|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5199180|NCT00827099|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5199181|NCT00827099|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5199182|NCT00827099|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5199183|NCT00827099|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5199184|NCT00827099|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
5199185|NCT00827099|stage I multiple myeloma|stage i multiple myeloma
5199186|NCT00827099|stage II multiple myeloma|stage ii multiple myeloma
5199187|NCT00827099|stage III multiple myeloma|stage iii multiple myeloma
5199188|NCT00827099|refractory multiple myeloma|refractory multiple myeloma
5199189|NCT00827099|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5199190|NCT00827099|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5199191|NCT00827099|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5199192|NCT00827086|influencing factors (smoking, nutrition, education)|influencing factors (smoking, nutrition, education)
5199193|NCT00827060|primary care|primary care
5199194|NCT00827060|procalcitonin|procalcitonin
5199195|NCT00827060|acute respiratory tract infection|acute respiratory tract infection
5199196|NCT00827047|hepatocellular carcinoma|hepatocellular carcinoma
5199197|NCT00827047|Surgical resection|surgical resection
5199198|NCT00827047|total hemihepatic vascular exclusion|total hemihepatic vascular exclusion
5199199|NCT00827047|occlusion|occlusion
5199200|NCT00827047|bleeding|bleeding
5199201|NCT00827047|overall survival|overall survival
5199202|NCT00827034|Dimebon Warfarin Drug-Drug Interaction|dimebon warfarin drug-drug interaction
5199203|NCT00826995|patient Education|patient education
5199204|NCT00826995|dermatology Patient Education|dermatology patient education
5199205|NCT00826995|melanoma|melanoma
5199206|NCT00826995|melanoma education|melanoma education
5199207|NCT00826995|malignant melanoma|malignant melanoma
5199208|NCT00826995|melanoma detection|melanoma detection
5199209|NCT00826969|Asthma|asthma
5199210|NCT00826969|Ciclesonide|ciclesonide
5199211|NCT00826943|Allergic Rhinitis|allergic rhinitis
5199212|NCT00826930|High Grade Glioma|high grade glioma
5199213|NCT00826930|Brain Tumor|brain tumor
5199214|NCT00826930|Solid Tumor|solid tumor
5199215|NCT00826930|Partial Debulking|partial debulking
5199216|NCT00826930|Tumor Resection|tumor resection
5199217|NCT00826930|Tumor Tissue Hypoxia|tumor tissue hypoxia
5199218|NCT00826930|Radiation Sensitizer|radiation sensitizer
5199219|NCT00826930|Cancerous Tumor|cancerous tumor
5199220|NCT00826917|3D, 2D, ultrasound, volumetry, multiplanar, VOCALTM, XI VOCALTM, fetal, gestational sac, placenta|3d, 2d, ultrasound, volumetry, multiplanar, vocaltm, xi vocaltm, fetal, gestational sac, placenta
5199221|NCT00826904|Fetal programming|fetal programming
5199222|NCT00826904|Fetal macrosomia|fetal macrosomia
5199223|NCT00826904|Fetal health|fetal health
5199224|NCT00826904|Gestational diabetes|gestational diabetes
5199225|NCT00826904|Maternal health|maternal health
5199226|NCT00826904|Maternal obesity|maternal obesity
5199227|NCT00826878|tivozanib|tivozanib
5199228|NCT00826878|AV-951|av-951
5199229|NCT00826839|In vitro fertilization|in vitro fertilization
5199230|NCT00826839|Poor responder patients|poor responder patients
5199231|NCT00826839|Randomized clinical trial|randomized clinical trial
5199232|NCT00826839|Estrogen patch|estrogen patch
5199233|NCT00826839|Gonadotropin-releasing hormone antagonist|gonadotropin-releasing hormone antagonist
5199234|NCT00826839|Oral contraceptive pill|oral contraceptive pill
5199235|NCT00826839|Microdose lupron|microdose lupron
5199236|NCT00826826|Atrial fibrillation|atrial fibrillation
5199237|NCT00826826|Amiodarone|amiodarone
5199238|NCT00826826|Arrhythmias, Cardiac|arrhythmias, cardiac
5199239|NCT00826826|Catheter ablation|catheter ablation
5199240|NCT00826813|Dysphagia|dysphagia
5199241|NCT00826813|esophageal cancer|esophageal cancer
5199242|NCT00826813|stent|stent
5199243|NCT00826813|brachytherapy|brachytherapy
5199244|NCT00826800|BEVACIZUMAB (AVASTIN)|bevacizumab (avastin)
5199245|NCT00826800|FLUOROURACIL|fluorouracil
5199246|NCT00826800|LEUCOVORIN|leucovorin
5199247|NCT00826800|OXALIPLATIN|oxaliplatin
5199248|NCT00826800|Chemotherapy|chemotherapy
5199249|NCT00826774|Body Weight|body weight
5199250|NCT00826774|Overweight|overweight
5199251|NCT00826774|Hypertension|hypertension
5199252|NCT00826774|Hyperglycemia|hyperglycemia
5199253|NCT00826748|COPD|copd
5199254|NCT00826748|inhaled steroids|inhaled steroids
5199255|NCT00826748|gene expression|gene expression
5199256|NCT00826748|smoker's lungs|smoker's lungs
5199257|NCT00826735|third stage of labor|third stage of labor
5199258|NCT00826735|bleeding|bleeding
5199259|NCT00826735|guided imagery|guided imagery
5199260|NCT00826735|childbirth|childbirth
5199261|NCT00826696|preeclampsia|preeclampsia
5199262|NCT00826683|Non-small cell lung cancer|non-small cell lung cancer
5199263|NCT00826683|Endothelial cell progenitor|endothelial cell progenitor
5199264|NCT00826683|Angiogenesis|angiogenesis
5199265|NCT00826683|Vascular endothelial cell growth factor|vascular endothelial cell growth factor
5199266|NCT00826683|Healthy control|healthy control
5199267|NCT00826683|COPD patients|copd patients
5199268|NCT00826683|NSCLC patients|nsclc patients
5199269|NCT00826670|Antibiotic resistance|antibiotic resistance
5199270|NCT00826670|ESBL carriage|esbl carriage
5199271|NCT00826657|B12 deficiency|b12 deficiency
5199272|NCT00826657|methylmalonic acid|methylmalonic acid
5199273|NCT00826657|homocystein|homocystein
5199274|NCT00826657|vitamin B12 supplementation intervention|vitamin b12 supplementation intervention
5199275|NCT00826644|Small cell lung cancer|small cell lung cancer
5199276|NCT00826644|Camptothecin|camptothecin
5199277|NCT00826644|Response rate|response rate
5199278|NCT00826631|weight|weight
5199279|NCT00826631|metabolism|metabolism
5199280|NCT00826631|cholesterol|cholesterol
5199281|NCT00826631|insulin|insulin
5199282|NCT00826618|Uveitis|uveitis
5199283|NCT00826618|Cystoid Macular Edema|cystoid macular edema
5199284|NCT00826605|Weight loss, urobilinogen|weight loss, urobilinogen
5199285|NCT00826592|patient education|patient education
5199286|NCT00826592|dermatology patient education|dermatology patient education
5199287|NCT00826592|atopic dermatitis|atopic dermatitis
5199288|NCT00826592|atopic dermatitis education|atopic dermatitis education
5199289|NCT00826592|atopic eczema|atopic eczema
5199290|NCT00826592|infantile eczema|infantile eczema
5199291|NCT00826592|hand eczema|hand eczema
5199292|NCT00826579|Sentinel lymph node|sentinel lymph node
5199293|NCT00826579|Lymph node analysis|lymph node analysis
5199294|NCT00826579|Bone marrow analysis|bone marrow analysis
5199295|NCT00826566|COPD|copd
5199296|NCT00826566|caffeine|caffeine
5199297|NCT00826566|chronic systemic inflammation|chronic systemic inflammation
5199298|NCT00826566|oxidative stress|oxidative stress
5199299|NCT00826566|supplementation|supplementation
5199300|NCT00826566|stable COPD GOLD stage II with CRP levels ≥ 3 mg/l|stable copd gold stage ii with crp levels ≥ 3 mg/l
5199301|NCT00826553|sedative|sedative
5199302|NCT00826553|GABA|gaba
5199303|NCT00826553|alpha 2 agonist|alpha 2 agonist
5199304|NCT00826553|propofol|propofol
5199305|NCT00826553|midazolam|midazolam
5199306|NCT00826553|lorazepam|lorazepam
5199307|NCT00826553|dexmedetomidine|dexmedetomidine
5199308|NCT00826553|sleep|sleep
5199309|NCT00826553|electroencephalogram|electroencephalogram
5199310|NCT00826553|polysomnogram|polysomnogram
5199311|NCT00826553|ICU|icu
5199312|NCT00826514|Chronic Prostatis|chronic prostatis
5199313|NCT00826488|Breast Cancer|breast cancer
5199314|NCT00826488|Mammography|mammography
5199315|NCT00826488|Benign masses|benign masses
5199316|NCT00826488|Breast Lump|breast lump
5199317|NCT00826488|Breast Biopsy|breast biopsy
5199318|NCT00826488|Breast Mass|breast mass
5199319|NCT00826475|Migraine|migraine
5199320|NCT00826475|Headache|headache
5199321|NCT00826462|Randomised|randomised
5199322|NCT00826462|Placebo-controlled|placebo-controlled
5199323|NCT00826462|double blind|double blind
5199324|NCT00826462|Intervention study|intervention study
5199325|NCT00826462|Primary health care|primary health care
5199326|NCT00826449|Advanced Solid Tumors|advanced solid tumors
5199327|NCT00826449|Advanced Cancer|advanced cancer
5199328|NCT00826449|Non-Small Cell Lung Cancer|non-small cell lung cancer
5199329|NCT00826449|NSCLC|nsclc
5199330|NCT00826449|Solid Tumor Malignancy|solid tumor malignancy
5199331|NCT00826449|Dasatinib|dasatinib
5199332|NCT00826449|BMS-354825|bms-354825
5199333|NCT00826449|Sprycel®|sprycel®
5199334|NCT00826449|Erlotinib|erlotinib
5199335|NCT00826449|Erlotinib hydrochloride|erlotinib hydrochloride
5199336|NCT00826449|Tarceva|tarceva
5199337|NCT00826449|OSI-774|osi-774
5199338|NCT00826423|treatment with Triple antibiotic therapy|treatment with triple antibiotic therapy
5199339|NCT00826410|Laparotomy|laparotomy
5199340|NCT00826410|Surgical site infection|surgical site infection
5199341|NCT00826410|Drainage|drainage
5199342|NCT00826397|Aromatase Inhibitors|aromatase inhibitors
5199343|NCT00826397|Joint Pain|joint pain
5199344|NCT00826397|Symptoms Control|symptoms control
5199345|NCT00826397|Acupuncture|acupuncture
5199346|NCT00826384|hepatocellular carcinoma|hepatocellular carcinoma
5199347|NCT00826384|transcatheter arterial chemoembolization|transcatheter arterial chemoembolization
5199348|NCT00826384|overall survival|overall survival
5199349|NCT00826371|AMD|amd
5199350|NCT00826371|Ranibizumab|ranibizumab
5199351|NCT00826358|Adverse events|adverse events
5199352|NCT00826358|Pharmacokinetic|pharmacokinetic
5199353|NCT00826345|Peripheral Neuropathy|peripheral neuropathy
5199354|NCT00826345|Neuropathy|neuropathy
5199355|NCT00826345|HIV|hiv
5199356|NCT00826345|AIDS|aids
5199357|NCT00826345|DSP|dsp
5199358|NCT00826345|alternative therapies|alternative therapies
5199359|NCT00826332|ultrasound|ultrasound
5199360|NCT00826332|IVF|ivf
5199361|NCT00826332|Embryo transfer|embryo transfer
5199362|NCT00826332|Pregnancy rate|pregnancy rate
5199363|NCT00826332|female patient undergoing IVF|female patient undergoing ivf
5199364|NCT00826319|Chronic Kidney Disease|chronic kidney disease
5199365|NCT00826319|Renal Insufficiency|renal insufficiency
5199366|NCT00826319|Biomarkers|biomarkers
5199367|NCT00826319|Observational|observational
5199368|NCT00826306|patient education|patient education
5199369|NCT00826306|dermatology patient education|dermatology patient education
5199370|NCT00826306|sunscreen|sunscreen
5199371|NCT00826306|sunscreen education|sunscreen education
5199372|NCT00826306|skin cancer|skin cancer
5199373|NCT00826280|pharmacologic stress|pharmacologic stress
5199374|NCT00826280|ischemia|ischemia
5199375|NCT00826280|coronary artery disease (CAD)|coronary artery disease (cad)
5199376|NCT00826254|vitamin K|vitamin k
5199377|NCT00826254|Bone Mineral Density|bone mineral density
5199378|NCT00826254|undercarboxylated osteocalcin|undercarboxylated osteocalcin
5199379|NCT00826241|Brain Tumor|brain tumor
5199380|NCT00826241|Central Nervous System|central nervous system
5199381|NCT00826241|CNS|cns
5199382|NCT00826241|Spinal Cord Tumor|spinal cord tumor
5199383|NCT00826241|Anaplastic Ependymoma|anaplastic ependymoma
5199384|NCT00826241|Supratentorial Ependymoma|supratentorial ependymoma
5199385|NCT00826241|Infratentorial Ependymoma|infratentorial ependymoma
5199386|NCT00826241|Spinal Cord Ependymoma|spinal cord ependymoma
5199387|NCT00826241|Lapatinib|lapatinib
5199388|NCT00826241|GW572016|gw572016
5199389|NCT00826241|Temozolomide|temozolomide
5199390|NCT00826241|Temodar|temodar
5199391|NCT00826215|mechanical|mechanical
5199392|NCT00826215|neck pain|neck pain
5199393|NCT00826215|chronic|chronic
5199394|NCT00826215|acupuncture|acupuncture
5199395|NCT00826215|chronic mechanical neck pain|chronic mechanical neck pain
5199396|NCT00826202|schizophrenia|schizophrenia
5199397|NCT00826202|d-serine|d-serine
5199398|NCT00826202|prodrome|prodrome
5199399|NCT00826189|Probiotics|probiotics
5199400|NCT00826189|Asthma|asthma
5199401|NCT00826189|Allergic Rhinitis|allergic rhinitis
5199402|NCT00826150|ovarian cancer|ovarian cancer
5199403|NCT00826150|H19 gene|h19 gene
5199404|NCT00826150|plasmid|plasmid
5199405|NCT00826137|prebiotics|prebiotics
5199406|NCT00826137|Antibiotic-associated diarrhea|antibiotic-associated diarrhea
5199407|NCT00826124|low back pain|low back pain
5199408|NCT00826124|radiculopathy|radiculopathy
5199409|NCT00826124|sciatica|sciatica
5199410|NCT00826111|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
5199411|NCT00826111|Glutamate|glutamate
5199412|NCT00826111|Glutamine|glutamine
5199413|NCT00826111|GABA|gaba
5199414|NCT00826111|Lexapro|lexapro
5199415|NCT00826111|Lunesta|lunesta
5199416|NCT00826111|Escitalopram|escitalopram
5199417|NCT00826111|Eszopiclone|eszopiclone
5199418|NCT00826098|Total knee replacement|total knee replacement
5199419|NCT00826098|Platelet Rich Plasma|platelet rich plasma
5199420|NCT00826098|PRP|prp
5199421|NCT00826098|Biologic|biologic
5199422|NCT00826098|Randomized|randomized
5199423|NCT00826085|Breast Cancer|breast cancer
5199424|NCT00826085|Recurrent Chest Wall Cancer|recurrent chest wall cancer
5199425|NCT00826085|Loco-regional Recurrent Breast Cancer|loco-regional recurrent breast cancer
5199426|NCT00826085|Breast Cancer Recurrence at the Chest Wall|breast cancer recurrence at the chest wall
5199427|NCT00826072|Single Nucleotide Polymorphism|single nucleotide polymorphism
5199428|NCT00826072|cardiopulmonary bypass|cardiopulmonary bypass
5199429|NCT00826072|cardiac surgery|cardiac surgery
5199430|NCT00826059|acute ischemic stroke|acute ischemic stroke
5199431|NCT00826059|randomized clinical trial|randomized clinical trial
5199432|NCT00826059|effectiveness|effectiveness
5199433|NCT00826059|safety|safety
5199434|NCT00826046|GVHD|gvhd
5199435|NCT00826046|Prochymal|prochymal
5199436|NCT00826046|Graft vs Host Disease|graft vs host disease
5199437|NCT00826033|Fluorine-18-α-methyltyrosine|fluorine-18-α-methyltyrosine
5199438|NCT00826033|Positron emission tomography|positron emission tomography
5199439|NCT00826033|Lung cancer|lung cancer
5199440|NCT00826033|chemotherapy|chemotherapy
5199441|NCT00826033|monitoring|monitoring
5199442|NCT00826020|PN|pn
5199443|NCT00826020|parenteral nutrition|parenteral nutrition
5199444|NCT00826020|fat emulsions|fat emulsions
5199445|NCT00826020|omega-6 fatty acid|omega-6 fatty acid
5199446|NCT00826020|liver disease|liver disease
5199447|NCT00826020|fatty acid deficiency|fatty acid deficiency
5199448|NCT00826007|perioperative hypoglycemia diabetes surgery|perioperative hypoglycemia diabetes surgery
5199449|NCT00826007|surgery|surgery
5199450|NCT00825994|menopause|menopause
5199451|NCT00825994|perimenopause|perimenopause
5199452|NCT00825994|postmenopause|postmenopause
5199453|NCT00825994|depression|depression
5199454|NCT00825994|mood|mood
5199455|NCT00825994|sleep|sleep
5199456|NCT00825994|hot flashes|hot flashes
5199457|NCT00825968|Electrophysiological|electrophysiological
5199458|NCT00825968|Heart Disease|heart disease
5199459|NCT00825968|Cardiology|cardiology
5199460|NCT00825968|Atrial Fibrillation|atrial fibrillation
5199461|NCT00825968|Risk Factors|risk factors
5199462|NCT00825968|Follow-up|follow-up
5199463|NCT00825968|Outcomes|outcomes
5200399|NCT00822783|Omalizumab|omalizumab
5199464|NCT00825942|Asteroid hyalosis|asteroid hyalosis
5199465|NCT00825942|Opthalmic Study|opthalmic study
5199466|NCT00825929|pharmacokinetics|pharmacokinetics
5199467|NCT00825929|pregnancy|pregnancy
5199468|NCT00825929|antiretrovirals|antiretrovirals
5199469|NCT00825929|neonates|neonates
5199470|NCT00825929|HIV|hiv
5199471|NCT00825929|treatment experienced|treatment experienced
5199472|NCT00825916|AZX100|azx100
5199473|NCT00825916|Patient and Observer Scar Assessment Scale|patient and observer scar assessment scale
5199474|NCT00825916|POSAS|posas
5199475|NCT00825916|Visual Analog Scale|visual analog scale
5199476|NCT00825916|VAS|vas
5199477|NCT00825916|Keloid|keloid
5199478|NCT00825916|Scarring|scarring
5199479|NCT00825916|Scar reduction|scar reduction
5199480|NCT00825916|Scar prevention|scar prevention
5199481|NCT00825903|aquatic exercise|aquatic exercise
5199482|NCT00825903|asthma|asthma
5199483|NCT00825890|high cup disc ratio|high cup disc ratio
5199484|NCT00825890|glaucoma suspect|glaucoma suspect
5199485|NCT00825877|Hepatitis C|hepatitis c
5199486|NCT00825877|Sustained Virological Response|sustained virological response
5199487|NCT00825877|HALT-C|halt-c
5199488|NCT00825877|Peginterferon and Ribavirin|peginterferon and ribavirin
5199489|NCT00825877|HCV RNA|hcv rna
5199490|NCT00825838|Body weight|body weight
5199491|NCT00825838|Body composition|body composition
5199492|NCT00825838|Resting metabolic rate and fat oxidation in men|resting metabolic rate and fat oxidation in men
5199493|NCT00825838|class I obese|class i obese
5199494|NCT00825825|Citalopram|citalopram
5199495|NCT00825825|Escitalopram|escitalopram
5199496|NCT00825825|Celexa|celexa
5199497|NCT00825825|Lexapro|lexapro
5199498|NCT00825825|fMRI|fmri
5199499|NCT00825825|antidepressant|antidepressant
5199500|NCT00825825|healthy volunteers|healthy volunteers
5199501|NCT00825799|biomarker|biomarker
5199502|NCT00825799|depression|depression
5199503|NCT00825799|blood test|blood test
5199504|NCT00825786|surgery for arm hand or elbow|surgery for arm hand or elbow
5199505|NCT00825786|mepivacaine|mepivacaine
5199506|NCT00825786|ropivacaine|ropivacaine
5199507|NCT00825786|hand surgery|hand surgery
5199508|NCT00825786|elbow surgery|elbow surgery
5199509|NCT00825786|forearm surgery|forearm surgery
5199510|NCT00825773|TVF|tvf
5199511|NCT00825773|TLF|tlf
5199512|NCT00825773|MACE|mace
5199513|NCT00825773|Ischemia-driven Target Vessel Failure (TVF) at 12 months.|ischemia-driven target vessel failure (tvf) at 12 months.
5199514|NCT00825773|Ischemia-driven Target Lesion Failure (TLF) at 12 months defined as a|ischemia-driven target lesion failure (tlf) at 12 months defined as a
5199515|NCT00825773|composite of cardiac death that can not be clearly attributed to a vessel|composite of cardiac death that can not be clearly attributed to a vessel
5199516|NCT00825773|other than the target vessel, target vessel MI (Q and Non-Q wave) and|other than the target vessel, target vessel mi (q and non-q wave) and
5199517|NCT00825773|ischemia-driven TLR.|ischemia-driven tlr.
5199518|NCT00825773|Rates of stent thrombosis, defined (per ARC definition) as definite or probable|rates of stent thrombosis, defined (per arc definition) as definite or probable
5199519|NCT00825773|and categorized as early, late or very late.|and categorized as early, late or very late.
5199520|NCT00825773|Major Adverse Cardiac Events (MACE) defined as cardiac death, target|major adverse cardiac events (mace) defined as cardiac death, target
5199521|NCT00825773|vessel MI (Q and Non-Q wave), or target lesion revascularization (TLR) at 30|vessel mi (q and non-q wave), or target lesion revascularization (tlr) at 30
5199522|NCT00825773|days, 6 months, 12 months and 2 to 5 years annually.|days, 6 months, 12 months and 2 to 5 years annually.
5199523|NCT00825760|Antimicrobial Photodynamic Therapy|antimicrobial photodynamic therapy
5199524|NCT00825760|Photodynamic Therapy|photodynamic therapy
5199525|NCT00825760|PDT|pdt
5199526|NCT00825760|Red light|red light
5199527|NCT00825760|Visible light|visible light
5199528|NCT00825760|Antimicrobial|antimicrobial
5199529|NCT00825760|Antibacterial|antibacterial
5199530|NCT00825760|Wound healing|wound healing
5199531|NCT00825760|Wound management|wound management
5199532|NCT00825760|Leg ulcer|leg ulcer
5199533|NCT00825760|Chronic venous leg ulcer|chronic venous leg ulcer
5199534|NCT00825760|Chronic wound|chronic wound
5199535|NCT00825760|Wound therapy|wound therapy
5199536|NCT00825760|Antimicrobial therapy|antimicrobial therapy
5199537|NCT00825747|Cataract|cataract
5199538|NCT00825747|Cataract surgery|cataract surgery
5199539|NCT00825747|intraocular lens|intraocular lens
5199540|NCT00825747|Aspheric lens|aspheric lens
5199541|NCT00825734|Metastatic Breast Cancer|metastatic breast cancer
5199542|NCT00825734|Sorafenib|sorafenib
5199543|NCT00825734|Nexavar|nexavar
5199544|NCT00825734|Ixabepilone|ixabepilone
5199545|NCT00825734|Ixempra|ixempra
5199546|NCT00825721|Cataract Study|cataract study
5199547|NCT00825721|Ophthalmic Study|ophthalmic study
5199548|NCT00825721|Agerelated cataract|agerelated cataract
5199549|NCT00825721|Nuclear Cataract|nuclear cataract
5199550|NCT00825721|Low grade nuclear cataracts|low grade nuclear cataracts
5199551|NCT00825708|ADHD|adhd
5199552|NCT00825682|Breast cancer|breast cancer
5199553|NCT00825682|Radiation therapy|radiation therapy
5199554|NCT00825682|Reflexology|reflexology
5199555|NCT00825682|Fatigue|fatigue
5199556|NCT00825682|Quality of life|quality of life
5199557|NCT00825682|Sleep disturbance|sleep disturbance
5199558|NCT00825669|hepatocellular carcinoma|hepatocellular carcinoma
5199559|NCT00825669|Portal vein tumor thrombus|portal vein tumor thrombus
5199560|NCT00825669|laser ablation|laser ablation
5199561|NCT00825656|Allergic Rhinitis|allergic rhinitis
5199562|NCT00825656|Capsaicin|capsaicin
5199563|NCT00825656|Homeopathic|homeopathic
5199564|NCT00825656|Sinol|sinol
5199565|NCT00825656|Sinol-M|sinol-m
5199566|NCT00825630|HP|hp
5199567|NCT00825630|UBT|ubt
5199568|NCT00825630|PPI|ppi
5199569|NCT00825617|TS|ts
5199570|NCT00825617|HRT|hrt
5199571|NCT00825617|Liver function tests|liver function tests
5199572|NCT00825604|stable coronary artery disease|stable coronary artery disease
5199573|NCT00825604|quality of life|quality of life
5199574|NCT00825604|target achievement|target achievement
5199575|NCT00825604|physical training|physical training
5199576|NCT00825604|percutaneous coronary intervention|percutaneous coronary intervention
5199577|NCT00825591|optic nerve hypoplasia|optic nerve hypoplasia
5199578|NCT00825591|septo-optic dysplasia|septo-optic dysplasia
5199579|NCT00825591|melatonin|melatonin
5199580|NCT00825591|circadian rhythm|circadian rhythm
5199581|NCT00825578|intrabronchial valve|intrabronchial valve
5199582|NCT00825578|heterogeneous emphysema|heterogeneous emphysema
5199583|NCT00825578|non-upper lobe|non-upper lobe
5199584|NCT00825565|Epidermolysis bullosa|epidermolysis bullosa
5199585|NCT00825552|Risperidone|risperidone
5199586|NCT00825552|Severe mood dysregulation|severe mood dysregulation
5199587|NCT00825552|bipolar|bipolar
5199588|NCT00825552|children|children
5199589|NCT00825539|Schizophrenia|schizophrenia
5199590|NCT00825539|Manic depression|manic depression
5199591|NCT00825539|anxiety|anxiety
5199592|NCT00825526|Mindfulness Based Stress Reduction (MBSR)|mindfulness based stress reduction (mbsr)
5199593|NCT00825526|Stress Reduction|stress reduction
5199594|NCT00825526|hypertension|hypertension
5199595|NCT00825526|high blood pressure|high blood pressure
5199596|NCT00825526|ambulatory blood pressure monitoring|ambulatory blood pressure monitoring
5199597|NCT00825500|Migraine headache|migraine headache
5199598|NCT00825500|Loxapine|loxapine
5199599|NCT00825500|Staccato|staccato
5199600|NCT00825487|metastatic|metastatic
5199601|NCT00825487|hematologic|hematologic
5199602|NCT00825487|malignancy|malignancy
5199603|NCT00825487|multiple|multiple
5199604|NCT00825487|myeloma|myeloma
5199605|NCT00825487|malignant|malignant
5199606|NCT00825487|lymphoma|lymphoma
5199607|NCT00825487|chronic|chronic
5199608|NCT00825487|lymphocytic|lymphocytic
5199609|NCT00825487|leukemia|leukemia
5199610|NCT00825487|acute|acute
5199611|NCT00825487|myelogenous|myelogenous
5199612|NCT00825487|promyelocytic|promyelocytic
5199613|NCT00825487|dose escalation|dose escalation
5199614|NCT00825487|safety|safety
5199615|NCT00825487|tolerability|tolerability
5199616|NCT00825487|pharmacodynamics|pharmacodynamics
5199617|NCT00825487|tumor|tumor
5199618|NCT00825487|PK|pk
5199619|NCT00825474|small hepatocellular carcinoma|small hepatocellular carcinoma
5199620|NCT00825474|partial hepatectomy|partial hepatectomy
5199621|NCT00825474|TACE plus PEI|tace plus pei
5199622|NCT00825461|Anorexia Nervosa|anorexia nervosa
5199623|NCT00825448|alcohol addiction|alcohol addiction
5199624|NCT00825435|Coronary CT angiogram|coronary ct angiogram
5199625|NCT00825435|Cardiac imaging|cardiac imaging
5199626|NCT00825435|Cost analysis|cost analysis
5199627|NCT00825435|acute chest pain|acute chest pain
5199628|NCT00825435|risk stratification|risk stratification
5199629|NCT00825435|cumulative costs over 90-days of providing treatment services|cumulative costs over 90-days of providing treatment services
5199630|NCT00825422|Posterior lumbar arthrodesis|posterior lumbar arthrodesis
5199631|NCT00825422|Degenerative spine|degenerative spine
5199632|NCT00825422|Postoperative analgesia|postoperative analgesia
5199633|NCT00825422|Local anesthesic|local anesthesic
5199634|NCT00825422|Continuous wound infusion catheter|continuous wound infusion catheter
5199635|NCT00825422|Pain|pain
5199636|NCT00825422|lumbar vertebrae|lumbar vertebrae
5199637|NCT00825422|Spinal fusion|spinal fusion
5199638|NCT00825383|Diabetes|diabetes
5199639|NCT00825383|lipids|lipids
5199640|NCT00825383|fiber|fiber
5199641|NCT00825370|Hydromorphone|hydromorphone
5199642|NCT00825370|acute pain|acute pain
5199643|NCT00825370|Protocolized|protocolized
5199644|NCT00825370|Efficacy|efficacy
5199645|NCT00825370|Safety|safety
5199646|NCT00825357|biological markers|biological markers
5199647|NCT00825357|sepsis|sepsis
5199648|NCT00825357|acute lung injury|acute lung injury
5199649|NCT00825344|postoperative pain|postoperative pain
5199650|NCT00825344|inguinal hernia|inguinal hernia
5199651|NCT00825344|chronic postsurgical pain|chronic postsurgical pain
5199652|NCT00825344|cytokine|cytokine
5199653|NCT00825344|preemptive analgesia|preemptive analgesia
5199654|NCT00825344|patients with inguinal hernia scheduled for surgery|patients with inguinal hernia scheduled for surgery
5199655|NCT00825331|guide wire|guide wire
5199656|NCT00825331|cardiac catheterization|cardiac catheterization
5199657|NCT00825331|ultrasound-guided examination of the access site|ultrasound-guided examination of the access site
5199658|NCT00825331|graduated scheme|graduated scheme
5200796|NCT00821132|FALS|fals
5199659|NCT00825331|elective and non elective cardiac catheterization|elective and non elective cardiac catheterization
5199660|NCT00825318|End-stage renal disease|end-stage renal disease
5199661|NCT00825318|Chronic kidney disease|chronic kidney disease
5199662|NCT00825318|Hemodialysis|hemodialysis
5199663|NCT00825305|vaccine|vaccine
5199664|NCT00825305|prevention|prevention
5199665|NCT00825305|rabies|rabies
5199666|NCT00825305|Rabies disease|rabies disease
5199667|NCT00825292|colon polyps, colon adenomas|colon polyps, colon adenomas
5199668|NCT00825279|Biodegradable polymer|biodegradable polymer
5199669|NCT00825279|Drug Eluting Stent|drug eluting stent
5199670|NCT00825279|In stent restenosis|in stent restenosis
5199671|NCT00825279|stent thrombosis|stent thrombosis
5199672|NCT00825279|Bare Metal Stent|bare metal stent
5199673|NCT00825266|pulmonary hypertension & insulin resistance|pulmonary hypertension & insulin resistance
5199674|NCT00825240|Colorectal Cancer|colorectal cancer
5199675|NCT00825240|Cancer Survivorship Study|cancer survivorship study
5199676|NCT00825240|Questionnaires|questionnaires
5199677|NCT00825240|Survivorship|survivorship
5199678|NCT00825240|Survivor Health|survivor health
5199679|NCT00825240|Health Promotion|health promotion
5199680|NCT00825240|Behavior Changes|behavior changes
5199681|NCT00825240|Computer-assisted intervention program|computer-assisted intervention program
5199682|NCT00825227|Cancer|cancer
5199683|NCT00825227|Fatigue|fatigue
5199684|NCT00825227|Taxanes|taxanes
5199685|NCT00825201|peritoneal carcinomatosis|peritoneal carcinomatosis
5199686|NCT00825201|peritoneal cavity cancer|peritoneal cavity cancer
5199687|NCT00825201|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5199688|NCT00825201|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5199689|NCT00825201|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5199690|NCT00825175|Down syndrome|down syndrome
5199691|NCT00825175|Gait|gait
5199692|NCT00825175|Motor Development|motor development
5199693|NCT00825175|Orthoses|orthoses
5199694|NCT00825136|Panic Disorder|panic disorder
5199695|NCT00825136|Temperature Biofeedback|temperature biofeedback
5199696|NCT00825136|Internet|internet
5199697|NCT00825123|healthy individuals|healthy individuals
5199698|NCT00825110|colorectal|colorectal
5199699|NCT00825110|cancer|cancer
5199700|NCT00825110|gene expression|gene expression
5199701|NCT00825110|biomarker|biomarker
5199702|NCT00825110|genomic mismatch repair|genomic mismatch repair
5199703|NCT00825097|Spastic equinovarus foot|spastic equinovarus foot
5199704|NCT00825097|Stroke|stroke
5199705|NCT00825097|Tibial neurotomy|tibial neurotomy
5199706|NCT00825097|Botulinum toxin type A|botulinum toxin type a
5199707|NCT00825097|Selective tibial neurotomy|selective tibial neurotomy
5199708|NCT00825084|Dimebon, Japanese and Western population, pharmacokinetics|dimebon, japanese and western population, pharmacokinetics
5199709|NCT00825071|Postoperative Nausea and Vomiting|postoperative nausea and vomiting
5199710|NCT00825071|Ondansetron|ondansetron
5199711|NCT00825071|Dexamethasone|dexamethasone
5199712|NCT00825058|Depression|depression
5199713|NCT00825045|dopamine|dopamine
5199714|NCT00825045|D2|d2
5199715|NCT00825045|D3|d3
5199716|NCT00825045|caudate|caudate
5199717|NCT00825045|putamen|putamen
5199718|NCT00825045|globus pallidus|globus pallidus
5199719|NCT00825045|antipsychotic|antipsychotic
5199720|NCT00825045|risperidone|risperidone
5199721|NCT00825045|geriatric|geriatric
5199722|NCT00825045|Brief Psychiatric Rating Scale|brief psychiatric rating scale
5199723|NCT00825045|PET|pet
5199724|NCT00825045|radiotracer|radiotracer
5199725|NCT00825045|[11C]-(+)-PHNO|[11c]-(+)-phno
5199726|NCT00825045|[11C]-raclopride|[11c]-raclopride
5199727|NCT00825032|Pulmonary disease, chronic obstructive|pulmonary disease, chronic obstructive
5199728|NCT00825032|Upper extremity|upper extremity
5199729|NCT00825032|Exercise therapy|exercise therapy
5199730|NCT00825019|Depression|depression
5199731|NCT00825006|Cardiac resynchronization therapy|cardiac resynchronization therapy
5199732|NCT00825006|Anodal stimulation|anodal stimulation
5199733|NCT00824993|Blood Cancer|blood cancer
5199734|NCT00824993|Calcium|calcium
5199735|NCT00824993|Vitamin D|vitamin d
5199736|NCT00824993|Ibandronate|ibandronate
5199737|NCT00824993|Boniva|boniva
5199738|NCT00824993|Hematological Malignancies|hematological malignancies
5199739|NCT00824993|Bone Marrow Transplantation|bone marrow transplantation
5199740|NCT00824993|BMT|bmt
5199741|NCT00824993|Osteoporosis|osteoporosis
5199742|NCT00824993|Bone Loss|bone loss
5199743|NCT00824993|Allogeneic Bone Marrow Transplantation|allogeneic bone marrow transplantation
5199744|NCT00824954|0 to 30 years|0 to 30 years
5199745|NCT00824954|Refractory Acute GVHD|refractory acute gvhd
5199746|NCT00824941|Abdominal Pain|abdominal pain
5199747|NCT00824941|Women's Health and Disease|women's health and disease
5199748|NCT00824941|Gut|gut
5199749|NCT00824941|Symptoms|symptoms
5199750|NCT00824941|Brain|brain
5199751|NCT00824941|Chronic Abdominal Pain|chronic abdominal pain
5199752|NCT00824928|Prostate Cancer|prostate cancer
5199753|NCT00824928|Recurrent Prostate Cancer|recurrent prostate cancer
5199754|NCT00824928|Prostate Cancer Recurrence|prostate cancer recurrence
5199755|NCT00824928|Radiation Failure|radiation failure
5199756|NCT00824928|Salvage Cryotherapy|salvage cryotherapy
5199757|NCT00824915|Lead Integrity Algorithm|lead integrity algorithm
5199758|NCT00824902|Prostate Cancer|prostate cancer
5199759|NCT00824902|Prostate|prostate
5199760|NCT00824902|Radical Prostatectomy|radical prostatectomy
5199761|NCT00824902|Tissue Elastography|tissue elastography
5199762|NCT00824902|Tissue Elastography Imaging|tissue elastography imaging
5199763|NCT00824902|Software Program Measuring Prostate Elasticity|software program measuring prostate elasticity
5199764|NCT00824902|Elasticity/Tissue Strain-Hardening Imaging|elasticity/tissue strain-hardening imaging
5199765|NCT00824902|Ultrasound|ultrasound
5199766|NCT00824876|Mammae cancer patients|mammae cancer patients
5199767|NCT00824863|pityrosporum folliculitis|pityrosporum folliculitis
5199768|NCT00824863|ketoconazole 2% foam|ketoconazole 2% foam
5199769|NCT00824850|Single site|single site
5199770|NCT00824850|single dose|single dose
5199771|NCT00824850|Participated in Wyeth D118-P8|participated in wyeth d118-p8
5199772|NCT00824837|beta 2 microglobulin|beta 2 microglobulin
5199773|NCT00824837|haemodialysis|haemodialysis
5199774|NCT00824837|albumin|albumin
5199775|NCT00824824|Retinal Vascular Autoregulation|retinal vascular autoregulation
5199776|NCT00824811|Epiphora|epiphora
5199777|NCT00824811|Breast Cancer|breast cancer
5199778|NCT00824811|Lung Cancer|lung cancer
5199779|NCT00824811|Prostate Cancer|prostate cancer
5199780|NCT00824811|Non-small cell lung cancer|non-small cell lung cancer
5199781|NCT00824811|Bladder Cancer|bladder cancer
5199782|NCT00824811|Esophageal Cancer|esophageal cancer
5199783|NCT00824811|Head and Neck Cancer|head and neck cancer
5199784|NCT00824811|HNC|hnc
5199785|NCT00824811|Small Cell Lung Cancer|small cell lung cancer
5199786|NCT00824811|SCLC|sclc
5199787|NCT00824811|Ovarian Cancer|ovarian cancer
5199788|NCT00824811|Stomach Cancer|stomach cancer
5199789|NCT00824811|Canalicular Stenosis|canalicular stenosis
5199790|NCT00824811|Excessive tearing|excessive tearing
5199791|NCT00824811|Eye inflammation|eye inflammation
5199792|NCT00824811|Cyclosporine Ophthalmic Emulsion 0.05%|cyclosporine ophthalmic emulsion 0.05%
5199793|NCT00824811|Docetaxel|docetaxel
5199794|NCT00824811|Taxotere|taxotere
5199795|NCT00824811|Restasis®|restasis®
5199796|NCT00824811|Cyclosporine|cyclosporine
5199797|NCT00824811|Cyclosporine eye drops|cyclosporine eye drops
5199798|NCT00824811|FML Forte®|fml forte®
5199799|NCT00824811|Fluorometholone 0.25% ophthalmic suspension|fluorometholone 0.25% ophthalmic suspension
5199800|NCT00824811|Fluorometholone eye drops|fluorometholone eye drops
5199801|NCT00824811|Fluorometholone|fluorometholone
5199802|NCT00824811|Refresh Endura™|refresh endura™
5199803|NCT00824811|Lubricant eye drops|lubricant eye drops
5199804|NCT00824811|Eye drops|eye drops
5199805|NCT00824798|gait|gait
5199806|NCT00824798|haemophilia|haemophilia
5199807|NCT00824798|arthropathy|arthropathy
5199808|NCT00824785|epirubicin|epirubicin
5199809|NCT00824785|oxaliplatin|oxaliplatin
5199810|NCT00824785|capecitabine|capecitabine
5199811|NCT00824785|panitumumab|panitumumab
5199812|NCT00824772|pharmacogenetics|pharmacogenetics
5199813|NCT00824759|Healthy subjects|healthy subjects
5199814|NCT00824759|CABG|cabg
5199815|NCT00824759|Patients undergoing coronary artery bypass graft under cardiopulmonary bypass|patients undergoing coronary artery bypass graft under cardiopulmonary bypass
5199816|NCT00824746|Gefitinib|gefitinib
5199817|NCT00824746|Recurrence|recurrence
5199818|NCT00824746|Carcinoma, Non-Small-Cell Lung|carcinoma, non-small-cell lung
5199819|NCT00824733|recurrent breast cancer|recurrent breast cancer
5199820|NCT00824733|stage IV breast cancer|stage iv breast cancer
5199821|NCT00824733|stage IIIA breast cancer|stage iiia breast cancer
5199822|NCT00824733|stage IIIB breast cancer|stage iiib breast cancer
5199823|NCT00824733|stage IIIC breast cancer|stage iiic breast cancer
5199824|NCT00824733|HER2-positive breast cancer|her2-positive breast cancer
5199825|NCT00824733|male breast cancer|male breast cancer
5199826|NCT00824707|primary liver cancer|primary liver cancer
5199827|NCT00824707|hepatitis B virus|hepatitis b virus
5199828|NCT00824707|anti-virus therapy|anti-virus therapy
5199829|NCT00824694|Glucose|glucose
5199830|NCT00824694|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
5199831|NCT00824694|HbA1c|hba1c
5199832|NCT00824681|Psychological adjustment of family|psychological adjustment of family
5199833|NCT00824681|family of patients|family of patients
5199834|NCT00824681|children of patients|children of patients
5199835|NCT00824681|intensive care unit|intensive care unit
5199836|NCT00824681|burn|burn
5199837|NCT00824681|music therapy|music therapy
5199838|NCT00824681|music|music
5199839|NCT00824681|music program|music program
5199840|NCT00824681|anxiety|anxiety
5199841|NCT00824681|coping|coping
5199842|NCT00824681|adjustment|adjustment
5199843|NCT00824681|psychological stressor|psychological stressor
5199844|NCT00824681|emotional stressor|emotional stressor
5199845|NCT00824655|Healthy Subjects|healthy subjects
5199846|NCT00824655|Vaccines|vaccines
5199847|NCT00824655|Pneumococcal|pneumococcal
5199848|NCT00824642|Asthma|asthma
5199849|NCT00824642|Exercise training|exercise training
5199850|NCT00824642|TENS|tens
5199851|NCT00824642|Acupuncture|acupuncture
5199852|NCT00824642|FEV1|fev1
5199853|NCT00824629|Embryo transfer|embryo transfer
5199854|NCT00824629|IVF|ivf
5200797|NCT00821132|ALS|als
5199855|NCT00824629|Ultrasound embryo transfer|ultrasound embryo transfer
5199856|NCT00824590|Dimebon|dimebon
5199857|NCT00824590|renal impairment|renal impairment
5199858|NCT00824590|pharmacokinetics|pharmacokinetics
5199859|NCT00824577|heart rate variability|heart rate variability
5199860|NCT00824577|autonomic function|autonomic function
5199861|NCT00824577|heart function|heart function
5199862|NCT00824564|Tranexamic Acid|tranexamic acid
5199863|NCT00824564|Blood Loss|blood loss
5199864|NCT00824564|Long Bone Fracture Surgery|long bone fracture surgery
5199865|NCT00824551|Acute Thermal Burns|acute thermal burns
5199866|NCT00824551|Hyperbaric Oxygen Therapy|hyperbaric oxygen therapy
5199867|NCT00824551|Burns conversion|burns conversion
5199868|NCT00824538|stage IA breast cancer|stage ia breast cancer
5199869|NCT00824538|stage IB breast cancer|stage ib breast cancer
5199870|NCT00824538|stage II breast cancer|stage ii breast cancer
5199871|NCT00824538|stage IIIA breast cancer|stage iiia breast cancer
5199872|NCT00824538|stage IIIB breast cancer|stage iiib breast cancer
5199873|NCT00824538|stage IIIC breast cancer|stage iiic breast cancer
5199874|NCT00824486|child|child
5199875|NCT00824486|injury prevention|injury prevention
5199876|NCT00824460|Hemodialysis|hemodialysis
5199877|NCT00824447|randomised|randomised
5199878|NCT00824447|double-blind|double-blind
5199879|NCT00824447|placebo-controlled|placebo-controlled
5199880|NCT00824447|long-term efficacy and safety|long-term efficacy and safety
5199881|NCT00824447|Oralgen® Grass Pollen|oralgen® grass pollen
5199882|NCT00824447|allergic rhinoconjunctivitis|allergic rhinoconjunctivitis
5199883|NCT00824447|Allergy|allergy
5199884|NCT00824447|Rhinoconjunctivitis|rhinoconjunctivitis
5199885|NCT00824447|Immunotherapy|immunotherapy
5199886|NCT00824447|Grass pollen extract|grass pollen extract
5199887|NCT00824434|Atherosclerosis|atherosclerosis
5199888|NCT00824434|Coronary Artery Disease|coronary artery disease
5199889|NCT00824421|HIV-1. Treatment Naive|hiv-1. treatment naive
5199890|NCT00824421|HIV Infections|hiv infections
5199891|NCT00824421|treatment naive|treatment naive
5199892|NCT00824395|diabetes|diabetes
5199893|NCT00824395|type 1|type 1
5199894|NCT00824395|type 2|type 2
5199895|NCT00824395|metabolic syndrome|metabolic syndrome
5199896|NCT00824395|mitochondria|mitochondria
5199897|NCT00824369|HIV-1|hiv-1
5199898|NCT00824369|Rollover|rollover
5199899|NCT00824369|Safety.|safety.
5199900|NCT00824369|HIV Infections|hiv infections
5199901|NCT00824369|treatment experienced|treatment experienced
5199902|NCT00824356|Allergic Rhinitis|allergic rhinitis
5199903|NCT00824356|Proof-of-Concept|proof-of-concept
5199904|NCT00824330|Aging|aging
5199905|NCT00824330|Type 2 diabetes|type 2 diabetes
5199906|NCT00824330|exercise|exercise
5199907|NCT00824330|walking|walking
5199908|NCT00824330|glucose metabolism|glucose metabolism
5199909|NCT00824330|arterial baroreceptors|arterial baroreceptors
5199910|NCT00824330|heart rate variability|heart rate variability
5199911|NCT00824330|cerebral autoregulation|cerebral autoregulation
5199912|NCT00824330|tilt table study|tilt table study
5199913|NCT00824330|transcranial Doppler|transcranial doppler
5199914|NCT00824330|autonomic nervous system|autonomic nervous system
5199915|NCT00824304|cognitive performance|cognitive performance
5199916|NCT00824304|growth|growth
5199917|NCT00824304|iron|iron
5199918|NCT00824304|zinc|zinc
5199919|NCT00824291|Major Depressive Disorder|major depressive disorder
5199920|NCT00824278|Pediatrics|pediatrics
5199921|NCT00824278|Distresss Screening|distresss screening
5199922|NCT00824278|Cancer|cancer
5199923|NCT00824278|Neurofibromatosis|neurofibromatosis
5199924|NCT00824278|HIV|hiv
5199925|NCT00824278|Pediatric Cancer|pediatric cancer
5199926|NCT00824278|Distress Screening|distress screening
5199927|NCT00824265|Relapsed|relapsed
5199928|NCT00824265|Oncology|oncology
5199929|NCT00824265|Safety|safety
5199930|NCT00824265|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
5199931|NCT00824265|Ofatumumab|ofatumumab
5199932|NCT00824265|Efficacy|efficacy
5199933|NCT00824252|Head And Neck Cancer|head and neck cancer
5199934|NCT00824252|HNC|hnc
5199935|NCT00824252|Radiation Therapy|radiation therapy
5199936|NCT00824252|Spousal Support|spousal support
5199937|NCT00824252|Emotional Disclosure|emotional disclosure
5199938|NCT00824252|Observational|observational
5199939|NCT00824252|Social Constraints|social constraints
5199940|NCT00824252|Questionnaires|questionnaires
5199941|NCT00824252|Videotaped Interview|videotaped interview
5199942|NCT00824252|Quality of Life|quality of life
5199943|NCT00824239|critical care|critical care
5199944|NCT00824239|sedation|sedation
5199945|NCT00824239|Mechanically ventilated patients|mechanically ventilated patients
5199946|NCT00824226|primary hypoparathyroidism|primary hypoparathyroidism
5199947|NCT00824226|secondary hypoparathyroidism|secondary hypoparathyroidism
5199948|NCT00824226|magnesium|magnesium
5199949|NCT00824213|Whole Body SPECT imaging|whole body spect imaging
5199950|NCT00824200|Sleep|sleep
5199951|NCT00824200|Quality of life|quality of life
5199952|NCT00824200|nocturia|nocturia
5199953|NCT00824187|Premenstrual Dysphoric Disorder ( PMDD)|premenstrual dysphoric disorder ( pmdd)
5199954|NCT00824187|Oral contraceptive|oral contraceptive
5200798|NCT00821132|ALS/FTD|als/ftd
5199955|NCT00824174|Questionnaire|questionnaire
5199956|NCT00824174|Head and Neck Cancer|head and neck cancer
5199957|NCT00824174|Skin Cancer|skin cancer
5199958|NCT00824174|Body Image|body image
5199959|NCT00824174|Surgical Treatment|surgical treatment
5199960|NCT00824174|Oral Cavity Cancer|oral cavity cancer
5199961|NCT00824174|Cutaneous Cancer|cutaneous cancer
5199962|NCT00824148|Real-time glucose monitoring system|real-time glucose monitoring system
5199963|NCT00824148|HbA1c|hba1c
5199964|NCT00824148|Quality of life|quality of life
5199965|NCT00824148|Hypoglycemia|hypoglycemia
5199966|NCT00824135|Stem Cell Transplantation, Hematopoietic|stem cell transplantation, hematopoietic
5199967|NCT00824135|Peripheral Blood Stem Cell Transplantation|peripheral blood stem cell transplantation
5199968|NCT00824135|Maximal Tolerated Dose|maximal tolerated dose
5199969|NCT00824135|Clofarabine|clofarabine
5199970|NCT00824135|Hematological Malignancies|hematological malignancies
5199971|NCT00824135|Apheresis|apheresis
5199972|NCT00824109|Aneurysmal disease of the abdominal aorta|aneurysmal disease of the abdominal aorta
5199973|NCT00824109|Occlusive disease of the abdominal aorta|occlusive disease of the abdominal aorta
5199974|NCT00824096|endotracheal intubation|endotracheal intubation
5199975|NCT00824096|cuff-leak test|cuff-leak test
5199976|NCT00824096|post-extubation stridor|post-extubation stridor
5199977|NCT00824096|bronchoscopy|bronchoscopy
5199978|NCT00824096|corticosteroids|corticosteroids
5199979|NCT00824096|Cuff-leak volume less than 24%|cuff-leak volume less than 24%
5199980|NCT00824083|bone tumors|bone tumors
5199981|NCT00824083|long-term function|long-term function
5199982|NCT00824083|daily activity|daily activity
5199983|NCT00824083|late sequelae|late sequelae
5199984|NCT00824070|Bioavailability|bioavailability
5199985|NCT00824057|Phase I|phase i
5199986|NCT00824044|Major Depressive Disorder (MDD)|major depressive disorder (mdd)
5199987|NCT00824044|Cognitive Behavioral Therapy (CBT)|cognitive behavioral therapy (cbt)
5199988|NCT00824044|Escitalopram|escitalopram
5199989|NCT00824044|Quantitative EEG (QEEG)|quantitative eeg (qeeg)
5199990|NCT00824031|schizophrenia|schizophrenia
5199991|NCT00824031|medical mental care|medical mental care
5199992|NCT00824031|caregiver|caregiver
5199993|NCT00824031|Sapin|sapin
5199994|NCT00824005|Congestive Heart Failure|congestive heart failure
5199995|NCT00824005|Regional Wall Motion|regional wall motion
5199996|NCT00824005|Perfusion Defects|perfusion defects
5199997|NCT00823979|HIV-1 NNRTI Treatment Experienced|hiv-1 nnrti treatment experienced
5199998|NCT00823979|may have Protease inhibitor experience|may have protease inhibitor experience
5199999|NCT00823953|diabetes type 2|diabetes type 2
5200000|NCT00823940|FTIH|ftih
5200001|NCT00823940|Glucagon|glucagon
5200002|NCT00823940|Safety|safety
5200003|NCT00823940|GSK1362885|gsk1362885
5200004|NCT00823940|Pharmacokinetics|pharmacokinetics
5200005|NCT00823940|Tolerability|tolerability
5200006|NCT00823940|Pharmacodynamics|pharmacodynamics
5200007|NCT00823927|lung damage|lung damage
5200008|NCT00823927|cigarette smoking|cigarette smoking
5200009|NCT00823927|HIV-seropositive|hiv-seropositive
5200010|NCT00823927|emphysema|emphysema
5200011|NCT00823914|Psoriasis|psoriasis
5200012|NCT00823914|Quality of Life|quality of life
5200013|NCT00823901|rosacea|rosacea
5200014|NCT00823901|clindamycin|clindamycin
5200015|NCT00823901|tretinoin|tretinoin
5200016|NCT00823901|clinical study|clinical study
5200017|NCT00823901|treatment|treatment
5200018|NCT00823888|Knee Osteoarthritis|knee osteoarthritis
5200019|NCT00823888|pneumatic bracing|pneumatic bracing
5200020|NCT00823862|HCV|hcv
5200021|NCT00823862|Immunostimulatory sequence (ISS)|immunostimulatory sequence (iss)
5200022|NCT00823862|TLR9 (toll-like receptor 9)|tlr9 (toll-like receptor 9)
5200023|NCT00823862|interferon (IFN)|interferon (ifn)
5200024|NCT00823862|ribavirin|ribavirin
5200025|NCT00823849|type 2 diabetes mellitus, with Arteriosclerosis obliterans|type 2 diabetes mellitus, with arteriosclerosis obliterans
5200026|NCT00823836|Ropinirole, advanced Parkinson's disease, L-dopa adjunctive therapy|ropinirole, advanced parkinson's disease, l-dopa adjunctive therapy
5200027|NCT00823823|Casting techniques|casting techniques
5200028|NCT00823823|Bivalved cast|bivalved cast
5200029|NCT00823823|Circumferential cast|circumferential cast
5200030|NCT00823823|Displaced distal radius fracture|displaced distal radius fracture
5200031|NCT00823823|Children|children
5200032|NCT00823810|Colorectal cancer|colorectal cancer
5200033|NCT00823810|Response to treatment|response to treatment
5200034|NCT00823810|FDG PET/CT|fdg pet/ct
5200035|NCT00823784|hemorrhoids|hemorrhoids
5200036|NCT00823784|stapler|stapler
5200037|NCT00823784|Doppler|doppler
5200038|NCT00823784|artery ligation|artery ligation
5200039|NCT00823784|outcome|outcome
5200040|NCT00823784|recurrence|recurrence
5200041|NCT00823758|Acetaminophen|acetaminophen
5200042|NCT00823758|Liver|liver
5200043|NCT00823758|Centers for Education and Research on Therapeutics|centers for education and research on therapeutics
5200044|NCT00823758|CERTS|certs
5200045|NCT00823758|Over-the-counter Acetaminophen|over-the-counter acetaminophen
5200046|NCT00823758|OTC|otc
5200047|NCT00823758|Self-administration|self-administration
5200048|NCT00823758|Parental administration|parental administration
5200049|NCT00823758|Houston|houston
5200050|NCT00823758|Texas|texas
5200051|NCT00823758|Liver toxicity|liver toxicity
5200052|NCT00823758|Qualitative study|qualitative study
5200053|NCT00823758|Pharmacists|pharmacists
5200054|NCT00823758|Adolescents|adolescents
5200055|NCT00823758|Primary care physicians|primary care physicians
5200056|NCT00823758|Family Practitioners|family practitioners
5200057|NCT00823758|General Internist|general internist
5200058|NCT00823732|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5200059|NCT00823732|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5200060|NCT00823732|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5200061|NCT00823719|Salvage chemotherapy|salvage chemotherapy
5200062|NCT00823719|relapsed|relapsed
5200063|NCT00823719|grade 3B follicular lymphoma|grade 3b follicular lymphoma
5200064|NCT00823719|efficacy|efficacy
5200065|NCT00823719|safety|safety
5200066|NCT00823719|DHAP|dhap
5200067|NCT00823719|ofatumumab|ofatumumab
5200068|NCT00823719|refractory|refractory
5200069|NCT00823719|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
5200070|NCT00823719|Diffuse Large B Cell Lymphoma (DLBCL)|diffuse large b cell lymphoma (dlbcl)
5200071|NCT00823719|Oncology|oncology
5200072|NCT00823719|ICE|ice
5200073|NCT00823719|Transformed follicular lymphoma|transformed follicular lymphoma
5200074|NCT00823706|chronic angle closure hyperopia|chronic angle closure hyperopia
5200075|NCT00823667|stage I non-small cell lung cancer|stage i non-small cell lung cancer
5200076|NCT00823667|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
5200077|NCT00823667|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5200078|NCT00823654|Breast|breast
5200079|NCT00823654|Questionaires|questionaires
5200080|NCT00823654|Blood draw|blood draw
5200081|NCT00823654|BRCA1|brca1
5200082|NCT00823654|BRCA2|brca2
5200083|NCT00823654|08-156|08-156
5200084|NCT00823641|HAM/TSP|ham/tsp
5200085|NCT00823641|HTLV-I|htlv-i
5200086|NCT00823602|GnRH antagonist|gnrh antagonist
5200087|NCT00823602|GnRH agonist|gnrh agonist
5200088|NCT00823602|pregnancy rate|pregnancy rate
5200089|NCT00823602|Ovarian stimulation|ovarian stimulation
5200090|NCT00823589|ELDERLY POPULATION|elderly population
5200091|NCT00823576|Arthodeses rachis lombar|arthodeses rachis lombar
5200092|NCT00823576|Spinal Surgery|spinal surgery
5200093|NCT00823550|Chronic hepatitis B|chronic hepatitis b
5200094|NCT00823550|Advanced fibrosis|advanced fibrosis
5200095|NCT00823550|Lamivudine|lamivudine
5200096|NCT00823550|Entecavir|entecavir
5200097|NCT00823524|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5200098|NCT00823524|acute undifferentiated leukemia|acute undifferentiated leukemia
5200099|NCT00823524|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5200100|NCT00823524|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5200101|NCT00823524|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5200102|NCT00823524|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5200103|NCT00823524|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5200104|NCT00823524|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
5200105|NCT00823524|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5200106|NCT00823524|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5200107|NCT00823524|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5200108|NCT00823524|mast cell leukemia|mast cell leukemia
5200109|NCT00823524|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
5200110|NCT00823524|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
5200111|NCT00823524|prolymphocytic leukemia|prolymphocytic leukemia
5200112|NCT00823524|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5200113|NCT00823524|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5200114|NCT00823524|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
5200115|NCT00823524|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5200116|NCT00823524|refractory hairy cell leukemia|refractory hairy cell leukemia
5200117|NCT00823524|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5200118|NCT00823524|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5200119|NCT00823524|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
5200120|NCT00823524|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5200121|NCT00823524|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
5200122|NCT00823524|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5200123|NCT00823524|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
5200124|NCT00823524|adult grade III lymphomatoid granulomatosis|adult grade iii lymphomatoid granulomatosis
5200125|NCT00823524|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
5200126|NCT00823524|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5200127|NCT00823524|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
5200128|NCT00823524|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5200129|NCT00823524|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5200130|NCT00823524|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5200131|NCT00823524|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5200132|NCT00823524|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5200133|NCT00823524|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5200134|NCT00823524|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5200135|NCT00823524|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5200136|NCT00823524|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5200137|NCT00823524|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5200138|NCT00823524|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
5200139|NCT00823524|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
5200140|NCT00823524|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5200141|NCT00823524|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5200142|NCT00823524|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5200143|NCT00823524|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5200144|NCT00823524|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5200145|NCT00823524|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5200146|NCT00823524|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5200147|NCT00823524|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5200148|NCT00823524|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5200149|NCT00823524|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5200150|NCT00823524|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5200151|NCT00823524|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5200152|NCT00823524|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5200153|NCT00823524|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
5200154|NCT00823524|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
5200155|NCT00823524|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5200156|NCT00823524|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5200157|NCT00823524|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5200158|NCT00823524|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5200159|NCT00823524|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5200160|NCT00823524|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5200161|NCT00823524|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5200162|NCT00823524|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5200163|NCT00823524|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5200164|NCT00823524|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5200165|NCT00823524|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5200166|NCT00823524|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
5200167|NCT00823524|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5200168|NCT00823524|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5200169|NCT00823524|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5200170|NCT00823524|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5200171|NCT00823524|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5200172|NCT00823524|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5200173|NCT00823524|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5200174|NCT00823524|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5200175|NCT00823524|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5200176|NCT00823524|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5200177|NCT00823524|intraocular lymphoma|intraocular lymphoma
5200178|NCT00823524|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
5200179|NCT00823524|primary central nervous system Hodgkin lymphoma|primary central nervous system hodgkin lymphoma
5200180|NCT00823524|post-transplant lymphoproliferative disorder|post-transplant lymphoproliferative disorder
5200181|NCT00823524|chronic eosinophilic leukemia|chronic eosinophilic leukemia
5200182|NCT00823524|chronic neutrophilic leukemia|chronic neutrophilic leukemia
5200183|NCT00823524|primary myelofibrosis|primary myelofibrosis
5200184|NCT00823524|essential thrombocythemia|essential thrombocythemia
5200185|NCT00823524|polycythemia vera|polycythemia vera
5200186|NCT00823524|extramedullary plasmacytoma|extramedullary plasmacytoma
5200187|NCT00823524|isolated plasmacytoma of bone|isolated plasmacytoma of bone
5200188|NCT00823524|stage II multiple myeloma|stage ii multiple myeloma
5200189|NCT00823524|stage III multiple myeloma|stage iii multiple myeloma
5200190|NCT00823524|primary systemic amyloidosis|primary systemic amyloidosis
5200191|NCT00823524|refractory multiple myeloma|refractory multiple myeloma
5200192|NCT00823524|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5200193|NCT00823524|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5200194|NCT00823524|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5200195|NCT00823524|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
5200196|NCT00823524|cutaneous B-cell non-Hodgkin lymphoma|cutaneous b-cell non-hodgkin lymphoma
5200197|NCT00823524|Waldenström macroglobulinemia|waldenström macroglobulinemia
5200198|NCT00823524|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5200199|NCT00823511|HPV|hpv
5200200|NCT00823511|Human Papillomavirus Infection|human papillomavirus infection
5200201|NCT00823511|Cervix Uteri|cervix uteri
5200202|NCT00823511|Cancer Control|cancer control
5200203|NCT00823511|Risk Assessment, Detection & Intervention|risk assessment, detection & intervention
5200204|NCT00823511|Sexually Transmitted|sexually transmitted
5200205|NCT00823511|Neoplasia|neoplasia
5200206|NCT00823511|Carcinogenesis|carcinogenesis
5200207|NCT00823511|Cervix|cervix
5200208|NCT00823498|Cancer Prevention|cancer prevention
5200209|NCT00823498|African American|african american
5200210|NCT00823498|African American Parents|african american parents
5200211|NCT00823498|African American Youth|african american youth
5200212|NCT00823498|Public Housing|public housing
5200213|NCT00823498|Physical Activity|physical activity
5200214|NCT00823498|Focus Groups|focus groups
5200215|NCT00823498|Housing Developments|housing developments
5200216|NCT00823498|Houston Public Housing|houston public housing
5200217|NCT00823498|Photovoice Project|photovoice project
5200218|NCT00823498|Prevention|prevention
5200219|NCT00823472|embryonic structures|embryonic structures
5200220|NCT00823472|sperm injections, intracytoplasmic|sperm injections, intracytoplasmic
5200221|NCT00823472|IVF|ivf
5200222|NCT00823472|GnRH antagonist|gnrh antagonist
5200223|NCT00823472|ovarian stimulation|ovarian stimulation
5200224|NCT00823472|cycle day 2 versus cycle day 5|cycle day 2 versus cycle day 5
5200225|NCT00823459|Low-grade glioma|low-grade glioma
5200226|NCT00823459|astrocytoma|astrocytoma
5200227|NCT00823459|oligodendroglioma|oligodendroglioma
5200228|NCT00823459|mixed oligoastrocytoma|mixed oligoastrocytoma
5200229|NCT00823433|Penicillin|penicillin
5200230|NCT00823433|Group B Streptococcus|group b streptococcus
5200231|NCT00823433|Pregnancy|pregnancy
5200232|NCT00823433|Labor|labor
5200233|NCT00823420|PCOS and normal ovulatory patients|pcos and normal ovulatory patients
5200234|NCT00823420|aneuploidy|aneuploidy
5200235|NCT00823420|in-vitro maturation of oocytes|in-vitro maturation of oocytes
5200236|NCT00823407|MDA|mda
5200237|NCT00823407|MDMA|mdma
5200238|NCT00823407|Ecstasy|ecstasy
5200239|NCT00823407|entactogen|entactogen
5200240|NCT00823407|pharmacokinetics|pharmacokinetics
5200241|NCT00823407|pharmacodynamics|pharmacodynamics
5200242|NCT00823407|Pharmacokinetics and pharmacodynamics of MDA studies in healthy volunteers|pharmacokinetics and pharmacodynamics of mda studies in healthy volunteers
5200243|NCT00823394|African American|african american
5200244|NCT00823394|Adults|adults
5200245|NCT00823394|African American Cancer Prevention Project|african american cancer prevention project
5200246|NCT00823394|Health Disparities|health disparities
5200247|NCT00823394|Questionnaire|questionnaire
5200248|NCT00823394|Body Measurements|body measurements
5200249|NCT00823394|Self-help|self-help
5200250|NCT00823394|Cancer Rates|cancer rates
5200251|NCT00823394|Prevention|prevention
5200252|NCT00823381|obesity|obesity
5200253|NCT00823381|metabolic syndrome|metabolic syndrome
5200254|NCT00823381|diabetes|diabetes
5200255|NCT00823381|aging|aging
5200256|NCT00823381|calorie restriction|calorie restriction
5200257|NCT00823381|resveratrol|resveratrol
5200258|NCT00823381|antioxidant|antioxidant
5200259|NCT00823368|fragile X syndrome|fragile x syndrome
5200260|NCT00823368|biomarkers|biomarkers
5200261|NCT00823342|HBe, Hepatitis, Vireda (TENOFOVIR, CLEVUDINE), HBV, HBe Ag negative|hbe, hepatitis, vireda (tenofovir, clevudine), hbv, hbe ag negative
5200262|NCT00823329|measurement of energy expenditure of physical activity|measurement of energy expenditure of physical activity
5200263|NCT00823329|analysis of body composition and hydration status|analysis of body composition and hydration status
5200264|NCT00823316|Mesenchymal Stem Cells|mesenchymal stem cells
5200265|NCT00823316|Allogeneic Transplantation|allogeneic transplantation
5200266|NCT00823316|Engraftment|engraftment
5200267|NCT00823316|GvHD|gvhd
5200268|NCT00823316|Childhood|childhood
5200269|NCT00823316|unrelated HSCT|unrelated hsct
5200270|NCT00823303|PTH|pth
5200271|NCT00823303|Active Vitamin D|active vitamin d
5200272|NCT00823303|hypercalcemia|hypercalcemia
5200273|NCT00823303|Chronic Kidney Disease|chronic kidney disease
5200274|NCT00823290|HCC|hcc
5200275|NCT00823290|sorafenib|sorafenib
5200276|NCT00823290|HDAC|hdac
5200277|NCT00823290|LBH589|lbh589
5200278|NCT00823290|Panobinostat|panobinostat
5200279|NCT00823264|Anticonvulsants|anticonvulsants
5200280|NCT00823264|Toxicology|toxicology
5200281|NCT00823264|multidose charcoal|multidose charcoal
5200282|NCT00823264|phenytoin|phenytoin
5200283|NCT00823225|Diabetes|diabetes
5200284|NCT00823225|urokinase|urokinase
5200285|NCT00823225|ulcer healing|ulcer healing
5200286|NCT00823225|major amputation|major amputation
5200287|NCT00823225|survival|survival
5200288|NCT00823212|drug-eluting stents|drug-eluting stents
5200289|NCT00823212|DES|des
5200290|NCT00823212|atherosclerotic|atherosclerotic
5200291|NCT00823186|cervical carcinoma|cervical carcinoma
5200292|NCT00823186|neoadjuvant chemotherapy|neoadjuvant chemotherapy
5200293|NCT00823173|Uveitis|uveitis
5200294|NCT00823173|TNF-alpha|tnf-alpha
5200295|NCT00823173|Topical|topical
5200297|NCT00823173|scFv antibody fragment|scfv antibody fragment
5200298|NCT00823173|ocular inflammation|ocular inflammation
5200299|NCT00823160|Pericardial window|pericardial window
5200300|NCT00823160|Sternotomy|sternotomy
5200301|NCT00823160|Haemopericardium|haemopericardium
5200303|NCT00823147|Systemic Inflammation|systemic inflammation
5200304|NCT00823147|Pain Catastrophizing|pain catastrophizing
5200305|NCT00823121|Fresh embryo transfer|fresh embryo transfer
5200306|NCT00823121|frozen- thawed embryo transfer|frozen- thawed embryo transfer
5200307|NCT00823121|vitrification|vitrification
5200308|NCT00823121|endometrial receptivity|endometrial receptivity
5200309|NCT00823121|implantation rate|implantation rate
5200310|NCT00823121|pregnancy|pregnancy
5200311|NCT00823121|ART|art
5200312|NCT00823108|GIK, septic shock, sepsis|gik, septic shock, sepsis
5200313|NCT00823095|chronic cutaneous ulcers|chronic cutaneous ulcers
5200314|NCT00823095|Nitric Oxide|nitric oxide
5200315|NCT00823095|topically applied|topically applied
5200316|NCT00823095|Biofilm|biofilm
5200317|NCT00823095|Colonized chronic non-healing ulcers|colonized chronic non-healing ulcers
5200318|NCT00823082|antithrombin|antithrombin
5200319|NCT00823082|ATIII|atiii
5200320|NCT00823082|acquired deficiency|acquired deficiency
5200321|NCT00823082|anticoagulants|anticoagulants
5200322|NCT00823082|cardiopulmonary bypass|cardiopulmonary bypass
5200323|NCT00823082|surgery|surgery
5200324|NCT00823082|complications|complications
5200325|NCT00823082|postoperative outcomes|postoperative outcomes
5200326|NCT00823069|Correction of Nasolabial Folds|correction of nasolabial folds
5200327|NCT00823056|Probiotics|probiotics
5200328|NCT00823056|Infections|infections
5200329|NCT00823056|Children|children
5200330|NCT00823030|Interstitial Cystitis|interstitial cystitis
5200331|NCT00823030|Intravesical Lidocaine|intravesical lidocaine
5200332|NCT00823017|ICU environment|icu environment
5200333|NCT00823017|Auditory stimulation|auditory stimulation
5200334|NCT00823017|Properties of relaxation music|properties of relaxation music
5200335|NCT00823017|music|music
5200336|NCT00823017|music therapy|music therapy
5200337|NCT00823017|pain|pain
5200338|NCT00823017|anxiety|anxiety
5200339|NCT00823017|cortisol|cortisol
5200340|NCT00823017|IgA|iga
5200341|NCT00823017|biomarkers|biomarkers
5200342|NCT00823017|relaxation music|relaxation music
5200343|NCT00823004|controlled ovarian hyperstimulation|controlled ovarian hyperstimulation
5200344|NCT00823004|pregnancy rate|pregnancy rate
5200345|NCT00823004|Poor responders|poor responders
5200346|NCT00823004|GnRH antagonist|gnrh antagonist
5200347|NCT00823004|GnRH agonist|gnrh agonist
5200348|NCT00823004|letrozole|letrozole
5200349|NCT00823004|in vitro fertilization|in vitro fertilization
5200350|NCT00822991|Sonazoid|sonazoid
5200351|NCT00822991|Early detection|early detection
5200352|NCT00822991|Hepatocellular carcinoma|hepatocellular carcinoma
5200353|NCT00822991|Liver cirrhosis|liver cirrhosis
5200354|NCT00822978|healthy|healthy
5200355|NCT00822978|volunteers|volunteers
5200356|NCT00822978|subjects|subjects
5200357|NCT00822965|Pacemakers|pacemakers
5200358|NCT00822965|PM|pm
5200359|NCT00822965|Implantable cardioverter-defibrillators|implantable cardioverter-defibrillators
5200360|NCT00822965|ICD|icd
5200361|NCT00822965|Implantable pulse generators|implantable pulse generators
5200362|NCT00822965|Educational Interventions|educational interventions
5200363|NCT00822913|Botulinum A toxin|botulinum a toxin
5200364|NCT00822913|Parkinson's disease|parkinson's disease
5200365|NCT00822900|Trauma|trauma
5200366|NCT00822900|Brain Injury|brain injury
5200367|NCT00822887|malignant|malignant
5200368|NCT00822887|gliomas|gliomas
5200369|NCT00822874|PCOS and normal ovulatory patients|pcos and normal ovulatory patients
5200370|NCT00822874|aneuploidy|aneuploidy
5200371|NCT00822874|in-vitro maturation of oocytes|in-vitro maturation of oocytes
5200372|NCT00822848|stage II adult soft tissue sarcoma|stage ii adult soft tissue sarcoma
5200373|NCT00822848|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
5200374|NCT00822822|Questionnaire|questionnaire
5200375|NCT00822822|Electronic Health History|electronic health history
5200376|NCT00822809|Cancer|cancer
5200377|NCT00822809|Neoplasms|neoplasms
5200378|NCT00822809|Carcinoma|carcinoma
5200379|NCT00822809|Malignant Ascites|malignant ascites
5200380|NCT00822809|Drug therapy|drug therapy
5200381|NCT00822809|Antineoplastic Protocols|antineoplastic protocols
5200382|NCT00822809|Immunotherapy|immunotherapy
5200383|NCT00822809|Phase III|phase iii
5200384|NCT00822809|trifunctional antibody|trifunctional antibody
5200385|NCT00822809|monoclonal antibody|monoclonal antibody
5200386|NCT00822809|EpCAM|epcam
5200387|NCT00822796|Hypothermia|hypothermia
5200388|NCT00822796|Severe burns|severe burns
5200389|NCT00822796|Warming catheter|warming catheter
5200390|NCT00822796|Thermogard™|thermogard™
5200391|NCT00822796|Coagulopathy|coagulopathy
5200392|NCT00822783|Serum IgE levels|serum ige levels
5200393|NCT00822783|inflammatory cells in the skin|inflammatory cells in the skin
5200394|NCT00822783|inflammatory cells in the blood|inflammatory cells in the blood
5200395|NCT00822783|IgE|ige
5200396|NCT00822783|IgE depletion|ige depletion
5200397|NCT00822783|atopic dermatitis|atopic dermatitis
5200398|NCT00822783|atopic eczema|atopic eczema
5200400|NCT00822770|Blood Stem Cell Transplantation|blood stem cell transplantation
5200401|NCT00822770|Bone Marrow Transplantation|bone marrow transplantation
5200402|NCT00822770|Bone Marrow Cell Transplantation|bone marrow cell transplantation
5200403|NCT00822770|Stem Cell Transplantation|stem cell transplantation
5200404|NCT00822770|Allogeneic Hematopoietic Transplantation|allogeneic hematopoietic transplantation
5200405|NCT00822770|Advanced Myeloid Leukemia|advanced myeloid leukemia
5200406|NCT00822770|Acute Myeloid Leukemia|acute myeloid leukemia
5200407|NCT00822770|AML|aml
5200408|NCT00822770|Myelodysplastic syndrome|myelodysplastic syndrome
5200409|NCT00822770|MDS|mds
5200410|NCT00822770|Chronic Myeloid Leukemia|chronic myeloid leukemia
5200411|NCT00822770|CML|cml
5200412|NCT00822770|Graft Versus Host Disease|graft versus host disease
5200413|NCT00822770|GVHD|gvhd
5200414|NCT00822770|ATG|atg
5200415|NCT00822770|Busulfan|busulfan
5200416|NCT00822770|Busulfex™|busulfex™
5200417|NCT00822770|Myleran®|myleran®
5200418|NCT00822770|Filgrastim|filgrastim
5200419|NCT00822770|Neupogen|neupogen
5200420|NCT00822770|Fludarabine|fludarabine
5200421|NCT00822770|Fludarabine Phosphate|fludarabine phosphate
5200422|NCT00822770|Fludara™|fludara™
5200423|NCT00822770|G-CSF|g-csf
5200424|NCT00822770|Plerixafor|plerixafor
5200425|NCT00822770|Antithymocyte globulin|antithymocyte globulin
5200426|NCT00822770|Thymoglobulin|thymoglobulin
5200427|NCT00822757|study in healthy subjects|study in healthy subjects
5200428|NCT00822744|Depression|depression
5200429|NCT00822744|Major Depressive Episode|major depressive episode
5200430|NCT00822744|Antidepressant|antidepressant
5200431|NCT00822731|Lymphoma|lymphoma
5200432|NCT00822731|prognosis|prognosis
5200433|NCT00822731|morbidity|morbidity
5200434|NCT00822718|obestatin|obestatin
5200435|NCT00822718|ghrelin|ghrelin
5200436|NCT00822718|stomach cancer|stomach cancer
5200437|NCT00822718|distal gastrectomy|distal gastrectomy
5200438|NCT00822705|Appetite, energy consumption, gastrointestinal hormones|appetite, energy consumption, gastrointestinal hormones
5200439|NCT00822692|Abscess|abscess
5200440|NCT00822692|Cellulitis|cellulitis
5200441|NCT00822692|Antibiotics|antibiotics
5200442|NCT00822692|MRSA|mrsa
5200443|NCT00822679|Acute Coronary Syndrome|acute coronary syndrome
5200444|NCT00822679|cytokines|cytokines
5200445|NCT00822679|pro-coagulant mediators|pro-coagulant mediators
5200446|NCT00822679|sleep disorders|sleep disorders
5200447|NCT00822666|Platelet aggregation|platelet aggregation
5200448|NCT00822666|Platelet|platelet
5200449|NCT00822666|Thrombosis|thrombosis
5200450|NCT00822666|Clopidogrel|clopidogrel
5200451|NCT00822653|hemodialysis treatment|hemodialysis treatment
5200452|NCT00822653|pump stimulation|pump stimulation
5200453|NCT00822653|reduce hypotensive episodes|reduce hypotensive episodes
5200454|NCT00822640|Prosthesis Design|prosthesis design
5200455|NCT00822640|Range of Motion, Articular|range of motion, articular
5200456|NCT00822640|Arthroplasty, Replacement, Knee|arthroplasty, replacement, knee
5200457|NCT00822627|Influenza|influenza
5200458|NCT00822627|vaccination|vaccination
5200459|NCT00822627|Emergency Department|emergency department
5200460|NCT00822614|Pain|pain
5200461|NCT00822601|Repetitive Transcranial Magnetic Stimulation|repetitive transcranial magnetic stimulation
5200462|NCT00822601|Supplementary Motor Area|supplementary motor area
5200463|NCT00822601|Obsessive-Compulsive Disorder|obsessive-compulsive disorder
5200464|NCT00822601|Sham rTMS|sham rtms
5200465|NCT00822601|Placebo-controlled|placebo-controlled
5200466|NCT00822601|Randomized|randomized
5200467|NCT00822601|Double-blind|double-blind
5200468|NCT00822601|fMRI|fmri
5200469|NCT00822601|DSM-IV Obsessive-Compulsive Disorder|dsm-iv obsessive-compulsive disorder
5200470|NCT00822575|mosquito bites|mosquito bites
5200471|NCT00822575|itching|itching
5200472|NCT00822562|hepatocellular carcinoma|hepatocellular carcinoma
5200473|NCT00822562|surgery|surgery
5200474|NCT00822549|Morphine titration|morphine titration
5200475|NCT00822549|Sub acute pain|sub acute pain
5200476|NCT00822549|Major orthopaedic surgery|major orthopaedic surgery
5200477|NCT00822549|Pharmacokinetics|pharmacokinetics
5200478|NCT00822549|Pharmacodynamics|pharmacodynamics
5200479|NCT00822549|Genetic polymorphism|genetic polymorphism
5200480|NCT00822549|PACU|pacu
5200481|NCT00822549|Patients undergoing major scheduled orthopaedic surgery|patients undergoing major scheduled orthopaedic surgery
5200482|NCT00822536|Drug-eluting stent|drug-eluting stent
5200483|NCT00822536|Clopidogrel|clopidogrel
5200484|NCT00822536|Stent thrombosis|stent thrombosis
5200485|NCT00822536|Myocardial infarction|myocardial infarction
5200486|NCT00822510|Psychosocial Intervention|psychosocial intervention
5200487|NCT00822510|Men with Prostate Cancer & Partners|men with prostate cancer & partners
5200488|NCT00822497|music therapy|music therapy
5200489|NCT00822497|pain|pain
5200490|NCT00822497|anxiety|anxiety
5200491|NCT00822497|muscle tension|muscle tension
5200492|NCT00822471|Diabetes|diabetes
5200493|NCT00822471|Self-Management Education|self-management education
5200494|NCT00822471|Library|library
5200495|NCT00822471|Emergency Department Visits|emergency department visits
5200496|NCT00822471|African American|african american
5200497|NCT00822471|CVD prevention|cvd prevention
5200498|NCT00822471|Prevention|prevention
5200499|NCT00822471|Uncontrolled diabetes|uncontrolled diabetes
5200500|NCT00822445|Biomarker|biomarker
5200501|NCT00822445|S100 protein|s100 protein
5200502|NCT00822445|Traumatic brain injury|traumatic brain injury
5200503|NCT00822445|Craniocerebral tomodensitometry|craniocerebral tomodensitometry
5200504|NCT00822445|Neurological sequelae|neurological sequelae
5200505|NCT00822432|biomarkers|biomarkers
5200506|NCT00822432|ABC transporters|abc transporters
5200507|NCT00822432|MRP2|mrp2
5200508|NCT00822432|MTX pharmacokinetics|mtx pharmacokinetics
5200509|NCT00822419|sternotomy pain|sternotomy pain
5200510|NCT00822406|allergy|allergy
5200511|NCT00822406|rhinitis|rhinitis
5200512|NCT00822406|homeopathy|homeopathy
5200513|NCT00822406|double-blind|double-blind
5200514|NCT00822393|Treosulfan|treosulfan
5200515|NCT00822393|Busulfan|busulfan
5200516|NCT00822393|Conditioning|conditioning
5200517|NCT00822393|Allogeneic|allogeneic
5200518|NCT00822393|Transplantation|transplantation
5200519|NCT00822380|Anemia|anemia
5200520|NCT00822380|Iron|iron
5200521|NCT00822380|Children|children
5200522|NCT00822380|Micronutrients|micronutrients
5200523|NCT00822354|Secondary Raynaud's Phenomenon|secondary raynaud's phenomenon
5200524|NCT00822328|Probiotics|probiotics
5200525|NCT00822328|Lactobacillus|lactobacillus
5200526|NCT00822328|Intestine|intestine
5200527|NCT00822328|Flora|flora
5200528|NCT00822315|HIV|hiv
5200529|NCT00822315|Tuberculosis|tuberculosis
5200530|NCT00822315|Pharmacokinetics|pharmacokinetics
5200531|NCT00822315|Raltegravir|raltegravir
5200532|NCT00822315|France|france
5200533|NCT00822315|Brazil|brazil
5200534|NCT00822315|treatment naive|treatment naive
5200535|NCT00822302|atherosclerosis|atherosclerosis
5200536|NCT00822302|stroke|stroke
5200537|NCT00822302|ischaemia|ischaemia
5200538|NCT00822289|radioactive iodine|radioactive iodine
5200539|NCT00822289|Helicobacter pylori|helicobacter pylori
5200540|NCT00822289|Thyroid diseases|thyroid diseases
5200541|NCT00822289|CagA|caga
5200542|NCT00822276|Methicillin-resistant Staphylococcus aureus|methicillin-resistant staphylococcus aureus
5200543|NCT00822276|MRSA|mrsa
5200544|NCT00822276|Methicillin-sensitive Staphylococcus aureus|methicillin-sensitive staphylococcus aureus
5200545|NCT00822276|MSSA|mssa
5200546|NCT00822276|Atopic Dermatitis|atopic dermatitis
5200547|NCT00822276|Eczema Herpeticum|eczema herpeticum
5200548|NCT00822263|mild traumatic brain injury|mild traumatic brain injury
5200549|NCT00822263|anti-oxidant|anti-oxidant
5200550|NCT00822263|early treatment|early treatment
5200551|NCT00822224|acute pain|acute pain
5200552|NCT00822224|MEOPA|meopa
5200553|NCT00822224|Dementia|dementia
5200554|NCT00822211|Diabetes Mellitus|diabetes mellitus
5200555|NCT00822211|HbA1c reduction|hba1c reduction
5200556|NCT00822211|vildagliptin|vildagliptin
5200557|NCT00822211|add-on to metformin|add-on to metformin
5200558|NCT00822211|Chinese patients|chinese patients
5200559|NCT00822198|peripheral neuropathy|peripheral neuropathy
5200560|NCT00822198|diabetes|diabetes
5200561|NCT00822198|plantar vibration|plantar vibration
5200562|NCT00822172|Peripheral Vascular Disease|peripheral vascular disease
5200563|NCT00822172|Peripheral Arterial Disease|peripheral arterial disease
5200564|NCT00822172|Intermittent Claudication|intermittent claudication
5200565|NCT00822172|Peak Walking Time|peak walking time
5200566|NCT00822172|Claudication Onset Time|claudication onset time
5200567|NCT00822172|Cilostazol|cilostazol
5200568|NCT00822172|Carnitine|carnitine
5200569|NCT00822159|Fixation failure|fixation failure
5200570|NCT00822159|Bone strength|bone strength
5200571|NCT00822159|DensiProbe|densiprobe
5200572|NCT00822146|CRT|crt
5200573|NCT00822133|ketamine|ketamine
5200574|NCT00822133|preemption|preemption
5200575|NCT00822133|postoperative|postoperative
5200576|NCT00822133|pain|pain
5200577|NCT00822133|safety|safety
5200578|NCT00822120|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5200579|NCT00822120|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5200580|NCT00822120|adult lymphocyte depletion Hodgkin lymphoma|adult lymphocyte depletion hodgkin lymphoma
5200581|NCT00822120|adult lymphocyte predominant Hodgkin lymphoma|adult lymphocyte predominant hodgkin lymphoma
5200582|NCT00822120|adult mixed cellularity Hodgkin lymphoma|adult mixed cellularity hodgkin lymphoma
5200583|NCT00822120|adult nodular sclerosis Hodgkin lymphoma|adult nodular sclerosis hodgkin lymphoma
5200584|NCT00822120|HIV infection|hiv infection
5200585|NCT00822107|Hypokalemia|hypokalemia
5200586|NCT00822107|Bartter Syndrome|bartter syndrome
5200587|NCT00822107|Salt Wasting|salt wasting
5200588|NCT00822094|Acute|acute
5200589|NCT00822094|Myeloid|myeloid
5200590|NCT00822094|Leukemia|leukemia
5200591|NCT00822094|Adult|adult
5200592|NCT00822094|First|first
5200593|NCT00822094|Relapse|relapse
5200594|NCT00822094|AML|aml
5200595|NCT00822094|Acute Myelogenous leukemia|acute myelogenous leukemia
5200596|NCT00822094|Leukemia, Myeloid|leukemia, myeloid
5200597|NCT00822094|Leukemia, Myeloid, Acute|leukemia, myeloid, acute
5200598|NCT00822094|Acute myelocytic leukemia|acute myelocytic leukemia
5200599|NCT00822068|stroke|stroke
5200600|NCT00822068|aphasia|aphasia
5200601|NCT00822068|rehabilitation|rehabilitation
5200602|NCT00822068|transcranial direct current stimulation|transcranial direct current stimulation
5200603|NCT00822068|intensive training|intensive training
5200604|NCT00822068|chronic aphasia after stroke|chronic aphasia after stroke
5200605|NCT00822042|Lipodystrophy|lipodystrophy
5200606|NCT00822042|Adipokines|adipokines
5200607|NCT00822042|Glucocorticoids|glucocorticoids
5200608|NCT00822042|Patients with glucocorticoids|patients with glucocorticoids
5200609|NCT00822016|Best Supportive Care|best supportive care
5200610|NCT00822016|Protocol of Standard Practice|protocol of standard practice
5200611|NCT00822016|Carcinoma of the Lung|carcinoma of the lung
5200612|NCT00822003|GLP-1|glp-1
5200613|NCT00822003|insulin|insulin
5200614|NCT00822003|glucose|glucose
5200615|NCT00821990|Failed after previous chemotherapy|failed after previous chemotherapy
5200616|NCT00821977|Type 2 Diabetes|type 2 diabetes
5200617|NCT00821977|Vildagliptin|vildagliptin
5200618|NCT00821964|Breast Cancer|breast cancer
5200619|NCT00821964|Stage IV|stage iv
5200620|NCT00821964|cream|cream
5200621|NCT00821964|topical|topical
5200622|NCT00821938|Narrow QRS|narrow qrs
5200623|NCT00821938|CRT|crt
5200624|NCT00821925|osteoporosis|osteoporosis
5200625|NCT00821899|diabetes type 1|diabetes type 1
5200626|NCT00821899|bone marrow transplantation|bone marrow transplantation
5200627|NCT00821886|Breast Cancer|breast cancer
5200628|NCT00821886|Neoadjuvant|neoadjuvant
5200629|NCT00821886|Ixabepilone|ixabepilone
5200630|NCT00821886|Carboplatin|carboplatin
5200631|NCT00821886|Trastuzumab|trastuzumab
5200632|NCT00821873|Cartilage injury|cartilage injury
5200633|NCT00821873|OATS|oats
5200634|NCT00821873|Knee injury|knee injury
5200635|NCT00821873|allograft|allograft
5200636|NCT00821873|autograft|autograft
5200637|NCT00821860|epithelial mesothelioma|epithelial mesothelioma
5200638|NCT00821860|recurrent malignant mesothelioma|recurrent malignant mesothelioma
5200639|NCT00821860|sarcomatous mesothelioma|sarcomatous mesothelioma
5200640|NCT00821860|malignant pleural effusion|malignant pleural effusion
5200641|NCT00821860|stage IA malignant mesothelioma|stage ia malignant mesothelioma
5200642|NCT00821860|stage IB malignant mesothelioma|stage ib malignant mesothelioma
5200643|NCT00821860|stage II malignant mesothelioma|stage ii malignant mesothelioma
5200644|NCT00821860|stage III malignant mesothelioma|stage iii malignant mesothelioma
5200645|NCT00821860|stage IV malignant mesothelioma|stage iv malignant mesothelioma
5200646|NCT00821847|HIV|hiv
5200647|NCT00821847|glomerular filtration rate|glomerular filtration rate
5200648|NCT00821847|cockcroft|cockcroft
5200649|NCT00821847|MDRD formula|mdrd formula
5200650|NCT00821847|creatinine|creatinine
5200651|NCT00821847|cystatin C|cystatin c
5200652|NCT00821847|isotopic clearance|isotopic clearance
5200653|NCT00821847|EDTA-51Cr|edta-51cr
5200654|NCT00821847|DEXA scan|dexa scan
5200655|NCT00821834|Old Myocardial infarction|old myocardial infarction
5200656|NCT00821834|Platelet Aggregation Inhibitors|platelet aggregation inhibitors
5200657|NCT00821834|Angioplasty|angioplasty
5200658|NCT00821834|Transluminal|transluminal
5200659|NCT00821834|Percutaneous Coronary|percutaneous coronary
5200660|NCT00821834|Stents|stents
5200661|NCT00821795|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
5200662|NCT00821795|insulin|insulin
5200663|NCT00821795|therapy|therapy
5200664|NCT00821782|Bacteria|bacteria
5200665|NCT00821782|Oral flora bacteria|oral flora bacteria
5200666|NCT00821782|Resistance|resistance
5200667|NCT00821756|Suicidal behaviour|suicidal behaviour
5200668|NCT00821756|Attempted suicide|attempted suicide
5200669|NCT00821756|Self harm|self harm
5200670|NCT00821756|Suicide|suicide
5200671|NCT00821756|Health system contacts|health system contacts
5200672|NCT00821756|Contacts with health system|contacts with health system
5200673|NCT00821730|Mixed methods research (qualitative and quantitative)|mixed methods research (qualitative and quantitative)
5200674|NCT00821730|Peer support|peer support
5200675|NCT00821730|Early inflammatory arthritis|early inflammatory arthritis
5200676|NCT00821730|Self-management|self-management
5200677|NCT00821730|Patient education|patient education
5200678|NCT00821717|Chronic Heart Failure|chronic heart failure
5200679|NCT00821717|Iron deficiency|iron deficiency
5200680|NCT00821717|Iron deficiency anaemia|iron deficiency anaemia
5200681|NCT00821717|Anaemia|anaemia
5200682|NCT00821717|Heart disease|heart disease
5200683|NCT00821691|cerebral infarction|cerebral infarction
5200684|NCT00821678|telemedicine|telemedicine
5200685|NCT00821678|rural|rural
5200686|NCT00821678|veterans|veterans
5200687|NCT00821678|care management|care management
5200688|NCT00821678|psychotherapy|psychotherapy
5200689|NCT00821665|Type 2 diabetes|type 2 diabetes
5200690|NCT00821665|Glycemic control|glycemic control
5200691|NCT00821665|(postprandial) Hyperglycemia|(postprandial) hyperglycemia
5200692|NCT00821665|Sucrose|sucrose
5200693|NCT00821652|Tumor|tumor
5200694|NCT00821652|NY-ESO-1 expression|ny-eso-1 expression
5200695|NCT00821652|Tumors that often express NY-ESO-1.|tumors that often express ny-eso-1.
5200696|NCT00821626|Influenza|influenza
5200697|NCT00821626|Rapid flu test|rapid flu test
5200698|NCT00821626|Returning travelers with fever|returning travelers with fever
5200699|NCT00821600|Risperidone|risperidone
5200700|NCT00821600|Antipsychotic|antipsychotic
5200701|NCT00821600|Pharmacokinetic|pharmacokinetic
5200702|NCT00821600|Long-acting Injectable|long-acting injectable
5200703|NCT00821587|Hepatitis C Post Liver Transplant|hepatitis c post liver transplant
5200704|NCT00821574|Hypertension, dyslipidemia|hypertension, dyslipidemia
5200705|NCT00821561|Persistent|persistent
5200706|NCT00821561|cornea|cornea
5200707|NCT00821561|defect|defect
5200708|NCT00821561|Nexagon|nexagon
5200709|NCT00821561|Coda|coda
5200710|NCT00821548|facioscapulohumeral muscular dystrophy|facioscapulohumeral muscular dystrophy
5200711|NCT00821548|electrostimulation|electrostimulation
5200712|NCT00821548|training|training
5200713|NCT00821535|pharmacokinetics, Japanese, healthy volunteer, maraviroc|pharmacokinetics, japanese, healthy volunteer, maraviroc
5200714|NCT00821522|Acute Kidney Insufficiency|acute kidney insufficiency
5200715|NCT00821522|Acute Renal Insufficiency|acute renal insufficiency
5200716|NCT00821522|Acute Kidney Injury|acute kidney injury
5200717|NCT00821522|Cardiac Surgical Procedures|cardiac surgical procedures
5200718|NCT00821522|Ischemic Preconditioning|ischemic preconditioning
5200719|NCT00821509|virus infection|virus infection
5200720|NCT00821509|hygiene|hygiene
5200721|NCT00821509|transmission|transmission
5200722|NCT00821509|intervention|intervention
5200723|NCT00821496|Multiple dose administration|multiple dose administration
5200724|NCT00821496|Oral Contraceptives|oral contraceptives
5200725|NCT00821470|osteonecrosis|osteonecrosis
5200726|NCT00821470|bone marrow|bone marrow
5200727|NCT00821470|core decompression|core decompression
5200728|NCT00821470|femoral head|femoral head
5200729|NCT00821457|existing scars the are two to six months old|existing scars the are two to six months old
5200730|NCT00821444|schizophrenia, pharmacokinetics, bioavailability, food effect|schizophrenia, pharmacokinetics, bioavailability, food effect
5200731|NCT00821405|Number : 250~300 patients|number : 250~300 patients
5200732|NCT00821405|Correlation between PET, glucose loading and peritoneal thickness/calcification|correlation between pet, glucose loading and peritoneal thickness/calcification
5200733|NCT00821379|PCOS|pcos
5200734|NCT00821379|Polycystic Ovary Syndrome|polycystic ovary syndrome
5200735|NCT00821379|Pregnancy Complications|pregnancy complications
5200736|NCT00821379|Gestational Diabetes|gestational diabetes
5200737|NCT00821379|Pre eclampsia|pre eclampsia
5200738|NCT00821379|Prediction Model|prediction model
5200739|NCT00821379|Pre conceptional|pre conceptional
5200740|NCT00821366|HIV/AIDS|hiv/aids
5200741|NCT00821366|Food security|food security
5200742|NCT00821366|treatment experienced|treatment experienced
5200743|NCT00821353|Atrial fibrillation|atrial fibrillation
5200744|NCT00821353|Hypertrophic cardiomyopathy|hypertrophic cardiomyopathy
5200745|NCT00821353|RF ablation|rf ablation
5200746|NCT00821353|Antiarrhythmic drugs|antiarrhythmic drugs
5200747|NCT00821340|Leber congenital amaurosis|leber congenital amaurosis
5200748|NCT00821340|LCA|lca
5200749|NCT00821340|RPE65|rpe65
5200750|NCT00821340|RPE65-associated Leber congenital amaurosis|rpe65-associated leber congenital amaurosis
5200751|NCT00821340|Retinal disease due to RPE65 mutations|retinal disease due to rpe65 mutations
5200752|NCT00821301|Multiple myeloma|multiple myeloma
5200753|NCT00821288|cancer survivorship|cancer survivorship
5200754|NCT00821288|survivorship prescription|survivorship prescription
5200755|NCT00821288|cancer related anxiety|cancer related anxiety
5200756|NCT00821275|Uterine Artery Embolization|uterine artery embolization
5200757|NCT00821275|Leiomyoma|leiomyoma
5200758|NCT00821275|myomectomy|myomectomy
5200759|NCT00821275|hysterectomy|hysterectomy
5200760|NCT00821275|pregnancy|pregnancy
5200761|NCT00821275|complication|complication
5200762|NCT00821275|ovarian function|ovarian function
5200763|NCT00821275|quality of life|quality of life
5200764|NCT00821262|Sevoflurane|sevoflurane
5200765|NCT00821262|Anesthesia|anesthesia
5200766|NCT00821262|Troponin|troponin
5200767|NCT00821262|Myocardial Preconditioning|myocardial preconditioning
5200768|NCT00821262|Surgery, Cardiac|surgery, cardiac
5200769|NCT00821262|Stents|stents
5200770|NCT00821262|Non-cardiac Surgery|non-cardiac surgery
5200771|NCT00821262|Surgery|surgery
5200772|NCT00821249|plasma cell dyscrasia|plasma cell dyscrasia
5200773|NCT00821249|plasmacytoma|plasmacytoma
5200774|NCT00821249|kinesin spindle protein|kinesin spindle protein
5200775|NCT00821249|anti-mitotic|anti-mitotic
5200776|NCT00821236|Myopia|myopia
5200777|NCT00821236|LASIK|lasik
5200778|NCT00821236|Astigmatism|astigmatism
5200779|NCT00821236|Laser Vision Correction|laser vision correction
5200780|NCT00821236|Excimer Laser|excimer laser
5200781|NCT00821223|phacoemulsification|phacoemulsification
5200782|NCT00821223|manual small incision cataract surgery|manual small incision cataract surgery
5200783|NCT00821223|visual acuity|visual acuity
5200784|NCT00821223|contrast sensitivity|contrast sensitivity
5200785|NCT00821223|quality of vision|quality of vision
5200786|NCT00821210|Obstructive sleep apnea|obstructive sleep apnea
5200787|NCT00821210|myocardial infarction|myocardial infarction
5200788|NCT00821197|obesity|obesity
5200789|NCT00821197|laparoscopy|laparoscopy
5200790|NCT00821197|bariatric|bariatric
5200791|NCT00821197|super obesity|super obesity
5200792|NCT00821184|urinary incontinence|urinary incontinence
5200793|NCT00821184|overactive bladder|overactive bladder
5200794|NCT00821184|urinary frequency|urinary frequency
5200795|NCT00821145|abdominal aortic aneurysms|abdominal aortic aneurysms
5200799|NCT00821132|SALS|sals
5200800|NCT00821132|MND|mnd
5200801|NCT00821132|PLS|pls
5200802|NCT00821119|non invasive ventilation|non invasive ventilation
5200803|NCT00821119|mechanical ventilation|mechanical ventilation
5200804|NCT00821119|pulmonary morbidity|pulmonary morbidity
5200805|NCT00821119|preterm infant|preterm infant
5200806|NCT00821119|Respiratory distress syndrome|respiratory distress syndrome
5200807|NCT00821119|nasal intermittent positive pressure|nasal intermittent positive pressure
5200808|NCT00821119|nasal continuous positive pressure|nasal continuous positive pressure
5200809|NCT00821119|bronchopulmonary dysplasia|bronchopulmonary dysplasia
5200810|NCT00821106|Coronary angiography|coronary angiography
5200811|NCT00821106|percutaneous coronary intervention|percutaneous coronary intervention
5200812|NCT00821106|Transradial approach|transradial approach
5200813|NCT00821093|respiratory|respiratory
5200814|NCT00821093|dyspnea|dyspnea
5200815|NCT00821093|breathlessness|breathlessness
5200816|NCT00821093|COPD|copd
5200817|NCT00821093|indacaterol|indacaterol
5200818|NCT00821093|long-acting β2-agonist|long-acting β2-agonist
5200819|NCT00821080|vandetanib|vandetanib
5200820|NCT00821080|sirolimus|sirolimus
5200821|NCT00821080|recurrent glioblastoma|recurrent glioblastoma
5200822|NCT00019539|adult solid tumor|adult solid tumor
5200823|NCT00019539|body system/site cancer|body system/site cancer
5200824|NCT00019539|cancer|cancer
5200825|NCT00019539|kidney tumor|kidney tumor
5200826|NCT00019539|kidney/urinary cancer|kidney/urinary cancer
5200827|NCT00019539|recurrent renal cell cancer|recurrent renal cell cancer
5200828|NCT00019539|renal cell cancer|renal cell cancer
5200829|NCT00019539|solid tumor|solid tumor
5200830|NCT00019539|stage IV renal cell cancer|stage iv renal cell cancer
5200831|NCT00019539|stage, renal cell cancer|stage, renal cell cancer
5200832|NCT00821054|Phase I Food Effect|phase i food effect
5200833|NCT00821041|insomnia|insomnia
5200834|NCT00821041|online systems|online systems
5200835|NCT00821028|atherosclerosis|atherosclerosis
5200836|NCT00821028|angioplasty|angioplasty
5200837|NCT00821028|peripheral arterial disease|peripheral arterial disease
5200838|NCT00821015|cryoablation|cryoablation
5200839|NCT00821015|recurring arrhythmia|recurring arrhythmia
5200840|NCT00821015|stroke|stroke
5200841|NCT00821015|RF ablation|rf ablation
5200842|NCT00821015|LA ablation|la ablation
5200843|NCT00821015|nodal ablation|nodal ablation
5200844|NCT00821015|catheter ablation|catheter ablation
5200845|NCT00821002|Glaucoma|glaucoma
5200846|NCT00820989|Healthy Immune System|healthy immune system
5200847|NCT00820976|G-CSF|g-csf
5200848|NCT00820976|AML|aml
5200849|NCT00820976|survival|survival
5200850|NCT00820963|adult giant cell glioblastoma|adult giant cell glioblastoma
5200851|NCT00820963|adult glioblastoma|adult glioblastoma
5200852|NCT00820963|adult gliosarcoma|adult gliosarcoma
5200853|NCT00820924|HER-2|her-2
5200854|NCT00820924|Circulating Tumour Cell (CTC)|circulating tumour cell (ctc)
5200855|NCT00820924|EGFR|egfr
5200856|NCT00820924|Lapatinib (GW572016)|lapatinib (gw572016)
5200857|NCT00820924|Breast Cancer|breast cancer
5200858|NCT00820911|Kidney transplant|kidney transplant
5200859|NCT00820911|AEB071|aeb071
5200860|NCT00820872|male breast cancer|male breast cancer
5200861|NCT00820872|stage I breast cancer|stage i breast cancer
5200862|NCT00820872|stage II breast cancer|stage ii breast cancer
5200863|NCT00820872|stage IIIA breast cancer|stage iiia breast cancer
5200864|NCT00820872|stage IIIB breast cancer|stage iiib breast cancer
5200865|NCT00820859|Cognition disorder|cognition disorder
5200866|NCT00820859|nursing home residents|nursing home residents
5200867|NCT00820859|agitation|agitation
5200868|NCT00820859|behavior disorder|behavior disorder
5200869|NCT00820846|HIV Seronegativity|hiv seronegativity
5200870|NCT00820846|HIV Preventive Vaccine|hiv preventive vaccine
5200871|NCT00820833|infant formula|infant formula
5200872|NCT00820833|obesity|obesity
5200873|NCT00820833|growth|growth
5200874|NCT00820820|Atopic Dermatitis|atopic dermatitis
5200875|NCT00820820|immunosuppression|immunosuppression
5200876|NCT00820820|Measles vaccine|measles vaccine
5200877|NCT00820820|T lymphocytes|t lymphocytes
5200878|NCT00820820|Atopic Dermatitis in adults|atopic dermatitis in adults
5200879|NCT00820807|dietary fiber|dietary fiber
5200880|NCT00820807|fiber|fiber
5200881|NCT00820807|insulin sensitivity|insulin sensitivity
5200882|NCT00820807|insulin resistance|insulin resistance
5200883|NCT00820807|glucose metabolism|glucose metabolism
5200884|NCT00820794|Drug-drug interaction, lithium, PD 0332334, pharmacokinetics|drug-drug interaction, lithium, pd 0332334, pharmacokinetics
5200885|NCT00820781|bleeding gastric varices|bleeding gastric varices
5200886|NCT00820781|cirrhosis of the liver|cirrhosis of the liver
5200887|NCT00820781|portacaval shunt|portacaval shunt
5200888|NCT00820781|endoscopic variceal sclerotherapy|endoscopic variceal sclerotherapy
5200889|NCT00820781|endoscopic variceal ligation|endoscopic variceal ligation
5200890|NCT00820781|Bleeding gastric varices due to cirrhosis of the liver|bleeding gastric varices due to cirrhosis of the liver
5200891|NCT00820742|A5751025|a5751025
5200892|NCT00820729|interstitial lung disease|interstitial lung disease
5200893|NCT00820729|pulmonary hypertension|pulmonary hypertension
5200894|NCT00820729|biomarkers|biomarkers
5200895|NCT00820729|NT-pro-BNP|nt-pro-bnp
5200896|NCT00820729|von Willebrand factor|von willebrand factor
5200897|NCT00820729|D-dimer|d-dimer
5200898|NCT00820729|Exhaled NO|exhaled no
5200899|NCT00820729|Troponin-t|troponin-t
5200900|NCT00820716|Asthma|asthma
5200901|NCT00820716|Asthmatic subjects|asthmatic subjects
5200902|NCT00820716|Exercise training|exercise training
5200903|NCT00820716|Constant load|constant load
5200904|NCT00820716|Alternate load|alternate load
5200905|NCT00820703|Nexagon|nexagon
5200906|NCT00820703|CoDa|coda
5200907|NCT00820703|ulcer|ulcer
5200908|NCT00820703|diabetic|diabetic
5200909|NCT00820703|foot|foot
5200910|NCT00820690|neoadjuvant chemotherapy|neoadjuvant chemotherapy
5200911|NCT00820690|advanced breast cancer|advanced breast cancer
5200912|NCT00820690|microarray|microarray
5200913|NCT00820690|correlation analysis|correlation analysis
5200914|NCT00820690|oncoplastic surgery|oncoplastic surgery
5200915|NCT00820651|Nonalcoholic steatohepatitis|nonalcoholic steatohepatitis
5200916|NCT00820651|Insulinresistance|insulinresistance
5200917|NCT00820651|Diet and exercise|diet and exercise
5200918|NCT00820651|Nutritional supplement|nutritional supplement
5200919|NCT00820651|Nonalcoholic fatty liver disease|nonalcoholic fatty liver disease
5200920|NCT00820651|Lifestyle modifications|lifestyle modifications
5200921|NCT00820638|neurorobotics|neurorobotics
5200922|NCT00820638|occupational therapy|occupational therapy
5200923|NCT00820599|Sapien Valve|sapien valve
5200924|NCT00820599|Cardiovascular Diseases|cardiovascular diseases
5200925|NCT00820599|Valvular Heart Disease|valvular heart disease
5200926|NCT00820599|Aortic Stenosis|aortic stenosis
5200927|NCT00820599|Heart Valve Therapy|heart valve therapy
5200928|NCT00820599|Transfemoral|transfemoral
5200929|NCT00820599|Transcatheter|transcatheter
5200930|NCT00820586|Intramyocardial|intramyocardial
5200931|NCT00820586|Autologous|autologous
5200932|NCT00820586|Bone|bone
5200933|NCT00820586|Marrow|marrow
5200934|NCT00820586|Randomized|randomized
5200935|NCT00820586|Percutaneous|percutaneous
5200936|NCT00820586|CD34+|cd34+
5200937|NCT00820586|Refractory|refractory
5200938|NCT00820586|Angina|angina
5200939|NCT00820586|Pectoris.|pectoris.
5200940|NCT00820573|Diabetes|diabetes
5200941|NCT00820547|inflammatory breast cancer|inflammatory breast cancer
5200942|NCT00820547|stage IIIA breast cancer|stage iiia breast cancer
5200943|NCT00820547|stage IIIB breast cancer|stage iiib breast cancer
5200944|NCT00820547|stage IIIC breast cancer|stage iiic breast cancer
5200945|NCT00820547|male breast cancer|male breast cancer
5200946|NCT00820547|HER2-negative breast cancer|her2-negative breast cancer
5200947|NCT00820534|cold sore|cold sore
5200948|NCT00820508|Haematological disease|haematological disease
5200949|NCT00820508|Lymphoid malignancy|lymphoid malignancy
5200950|NCT00820508|Histone deacetylase inhibitor|histone deacetylase inhibitor
5200951|NCT00820508|dose escalation|dose escalation
5200952|NCT00820495|Smokeless tobacco|smokeless tobacco
5200953|NCT00820495|Chewing Tobacco|chewing tobacco
5200954|NCT00820495|Internet|internet
5200955|NCT00820495|Adolescent|adolescent
5200956|NCT00820469|Rituximab|rituximab
5200957|NCT00820469|Plasma exchange|plasma exchange
5200958|NCT00820469|Autoimmune diseases|autoimmune diseases
5200959|NCT00820456|colorectal cancer|colorectal cancer
5200960|NCT00820456|colorectal neoplasm|colorectal neoplasm
5200961|NCT00820456|colorectal neoplasms|colorectal neoplasms
5200962|NCT00820456|metastasis|metastasis
5200963|NCT00820456|metastases|metastases
5200964|NCT00820456|liver|liver
5200965|NCT00820456|hepatic metastasis|hepatic metastasis
5200966|NCT00820456|liver metastasis|liver metastasis
5200967|NCT00820456|perfusion imaging|perfusion imaging
5200968|NCT00820456|MRI|mri
5200969|NCT00820456|magnetic resonance imaging|magnetic resonance imaging
5200970|NCT00820456|dynamic contrast enhanced MRI|dynamic contrast enhanced mri
5200971|NCT00820456|dynamic contrast enhanced magnetic resonance imaging|dynamic contrast enhanced magnetic resonance imaging
5200972|NCT00820430|osteoarthritis|osteoarthritis
5200973|NCT00820430|knee|knee
5200974|NCT00820430|magnetic resonance imaging|magnetic resonance imaging
5200975|NCT00820430|knee cartilage|knee cartilage
5200976|NCT00820430|reproducibility|reproducibility
5200977|NCT00820417|cetuximab|cetuximab
5200978|NCT00820417|monoclonal|monoclonal
5200979|NCT00820417|antibody|antibody
5200980|NCT00820417|epidermal|epidermal
5200981|NCT00820417|growth|growth
5200982|NCT00820417|factor|factor
5200983|NCT00820417|receptor|receptor
5200984|NCT00820417|EGFR|egfr
5200985|NCT00820417|Gefitinib|gefitinib
5200986|NCT00820417|tyrosine|tyrosine
5200987|NCT00820417|kinase|kinase
5200988|NCT00820417|inhibitor|inhibitor
5200989|NCT00820417|advanced|advanced
5200990|NCT00820417|cancer|cancer
5200991|NCT00820391|Post-traumatic Stress disorder (PTSD)|post-traumatic stress disorder (ptsd)
5200992|NCT00820378|Aortic dimension|aortic dimension
5200993|NCT00820378|Atherosclerosis|atherosclerosis
5200994|NCT00820378|Vascular disease|vascular disease
5200995|NCT00820378|Risk factors|risk factors
5200996|NCT00820365|Inflammatory Bowel Disease (IBD)|inflammatory bowel disease (ibd)
5200997|NCT00820365|Crohn's Disease|crohn's disease
5200998|NCT00820365|Ulcerative Colitis|ulcerative colitis
5200999|NCT00820365|SC12267|sc12267
5201000|NCT00820365|4SC-101|4sc-101
5201001|NCT00820365|Phase II|phase ii
5201002|NCT00820352|HFNEF|hfnef
5201003|NCT00820352|HFPEF|hfpef
5201004|NCT00820352|Secondary Pulmonary Hypertension|secondary pulmonary hypertension
5201005|NCT00820352|Endothelin Receptor Blockade|endothelin receptor blockade
5201006|NCT00820339|hepatocellular carcinoma|hepatocellular carcinoma
5201007|NCT00820339|hepatic vein|hepatic vein
5201008|NCT00820339|Surgical resection|surgical resection
5201009|NCT00820339|occlusion|occlusion
5201010|NCT00820339|time to recurrence|time to recurrence
5201011|NCT00820339|overall survival|overall survival
5201012|NCT00820313|Coronary Heart Disease|coronary heart disease
5201013|NCT00820313|Biomarkers of Cardiovascular Disease|biomarkers of cardiovascular disease
5201014|NCT00820313|Health Related Quality of Life|health related quality of life
5201015|NCT00820313|Diabetes|diabetes
5201016|NCT00820313|Diet|diet
5201017|NCT00820287|Testicular cancer|testicular cancer
5201018|NCT00820287|incidence|incidence
5201019|NCT00820287|young men|young men
5201020|NCT00820261|Genotypes|genotypes
5201021|NCT00820261|Epidemiology|epidemiology
5201022|NCT00820261|Diarrhea|diarrhea
5201023|NCT00820248|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
5201024|NCT00820248|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
5201025|NCT00820248|stage III verrucous carcinoma of the larynx|stage iii verrucous carcinoma of the larynx
5201026|NCT00820248|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
5201027|NCT00820248|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5201028|NCT00820248|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5201029|NCT00820248|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
5201030|NCT00820248|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5201031|NCT00820248|stage III verrucous carcinoma of the oral cavity|stage iii verrucous carcinoma of the oral cavity
5201032|NCT00820248|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
5201033|NCT00820248|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
5201034|NCT00820248|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5201035|NCT00820222|ErbB2|erbb2
5201036|NCT00820222|HERCEPTIN|herceptin
5201037|NCT00820222|XELODA|xeloda
5201038|NCT00820222|ErbB1|erbb1
5201039|NCT00820222|TYKERB|tykerb
5201040|NCT00820222|metastatic breast cancer|metastatic breast cancer
5201041|NCT00820222|trastuzumab|trastuzumab
5201042|NCT00820222|breast cancer|breast cancer
5201043|NCT00820222|capecitabine|capecitabine
5201044|NCT00820222|lapatinib|lapatinib
5201045|NCT00820222|brain metastases|brain metastases
5201046|NCT00820222|HER2 positive|her2 positive
5201047|NCT00820222|TYVERB|tyverb
5201048|NCT00820196|Venous ulcer|venous ulcer
5201049|NCT00820196|Nexagon|nexagon
5201050|NCT00820196|CoDa|coda
5201051|NCT00820183|Hypertension|hypertension
5201052|NCT00820183|Intervention|intervention
5201053|NCT00820183|Primary Care|primary care
5201054|NCT00820183|Quality improvement|quality improvement
5201055|NCT00820170|Breast|breast
5201056|NCT00820170|Cancer|cancer
5201057|NCT00820170|DASATINIB|dasatinib
5201058|NCT00820170|TAXOL (PACLITAXEL)|taxol (paclitaxel)
5201059|NCT00820170|08-122|08-122
5201060|NCT00820157|Carcinoma, Hepatocellular|carcinoma, hepatocellular
5201061|NCT00820157|Chemoembolization, Therapeutic|chemoembolization, therapeutic
5201062|NCT00820157|Cytoreductive|cytoreductive
5201063|NCT00820144|immune response|immune response
5201064|NCT00820144|b-subunit of cholera toxin|b-subunit of cholera toxin
5201065|NCT00820144|mucosal way|mucosal way
5201066|NCT00820144|healthy volonteers|healthy volonteers
5201067|NCT00820144|vaccine|vaccine
5201068|NCT00820118|ANTIRETROVIRAL THERAPY|antiretroviral therapy
5201069|NCT00820118|STRUCTURED TREATMENT INTERRUPTIONS|structured treatment interruptions
5201070|NCT00820118|treatment naive|treatment naive
5201071|NCT00820105|Migraine|migraine
5201072|NCT00820105|Aura|aura
5201073|NCT00820105|Migraine headache|migraine headache
5201074|NCT00820092|Xerecept|xerecept
5201075|NCT00820092|Pharmacokinetics|pharmacokinetics
5201076|NCT00820092|Japanese versus Caucasians|japanese versus caucasians
5201077|NCT00820079|Gastroesophageal reflux|gastroesophageal reflux
5201078|NCT00820079|Heartburn|heartburn
5201079|NCT00820079|Regurgitation|regurgitation
5201080|NCT00820053|hepatocellular carcinoma|hepatocellular carcinoma
5201081|NCT00820053|adjuvant therapy|adjuvant therapy
5201082|NCT00820053|TACE|tace
5201083|NCT00820053|time to recurrence|time to recurrence
5201084|NCT00820053|overall survival|overall survival
5201085|NCT00820014|ESBA105|esba105
5201086|NCT00820014|scFv antibody fragment|scfv antibody fragment
5201087|NCT00820014|cataract surgery|cataract surgery
5201088|NCT00820014|pharmacokinetics|pharmacokinetics
5201089|NCT00820014|biodistribution|biodistribution
5201090|NCT00820014|Irvine-Gass syndrome|irvine-gass syndrome
5201091|NCT00820001|Cognitive Behavioral Therapy|cognitive behavioral therapy
5201448|NCT00818948|Nephritis|nephritis
5201092|NCT00820001|Multimodal Treatment|multimodal treatment
5201093|NCT00820001|Physiological Parameters|physiological parameters
5201094|NCT00820001|Hormone Concentration in pubertal development|hormone concentration in pubertal development
5201095|NCT00820001|Treatment as usual comparison|treatment as usual comparison
5201096|NCT00819988|Postoperative|postoperative
5201097|NCT00819988|Perioperative|perioperative
5201098|NCT00819988|Orthopedic surgery|orthopedic surgery
5201099|NCT00819988|Vascular surgery|vascular surgery
5201100|NCT00819988|Gabapentinoid|gabapentinoid
5201101|NCT00819975|Casein|casein
5201102|NCT00819975|Whey|whey
5201103|NCT00819975|postprandial|postprandial
5201104|NCT00819975|Triglyceride|triglyceride
5201105|NCT00819975|Free fatty acids|free fatty acids
5201106|NCT00819975|Retinyl palmitate|retinyl palmitate
5201107|NCT00819975|Incretins|incretins
5201108|NCT00819975|Type 2 Diabetes|type 2 diabetes
5201109|NCT00819949|Robot|robot
5201110|NCT00819949|Treadmill|treadmill
5201111|NCT00819949|Rehabilitation|rehabilitation
5201112|NCT00819949|Freezing of gait|freezing of gait
5201113|NCT00819936|abdominal aorta surgery|abdominal aorta surgery
5201114|NCT00819936|Physical Training|physical training
5201115|NCT00819936|backward walking|backward walking
5201116|NCT00819936|physiotherapy|physiotherapy
5201117|NCT00819923|Titanium|titanium
5201118|NCT00819923|everolimus|everolimus
5201119|NCT00819923|drug eluting stent|drug eluting stent
5201120|NCT00819923|stent thrombosis|stent thrombosis
5201121|NCT00819923|restenosis|restenosis
5201122|NCT00819923|percutaneous coronary intervention|percutaneous coronary intervention
5201123|NCT00819923|acute coronary syndrome|acute coronary syndrome
5201124|NCT00819910|Type 4 hyperlipidemia|type 4 hyperlipidemia
5201125|NCT00819910|Rosiglitazone|rosiglitazone
5201126|NCT00819910|Fenofibrate|fenofibrate
5201127|NCT00819897|MS|ms
5201128|NCT00819897|CIS|cis
5201129|NCT00819897|IFN|ifn
5201130|NCT00819897|MRI|mri
5201131|NCT00819897|OCT|oct
5201132|NCT00819897|QOL|qol
5201133|NCT00819884|Type II Diabetes|type ii diabetes
5201134|NCT00819884|24 hour glucose profile|24 hour glucose profile
5201135|NCT00819858|weight loss|weight loss
5201136|NCT00819858|weight gain|weight gain
5201137|NCT00819858|malnutrition|malnutrition
5201138|NCT00819858|convalescence|convalescence
5201139|NCT00819858|malaria|malaria
5201140|NCT00819858|RUTF|rutf
5201141|NCT00819858|RUF|ruf
5201142|NCT00819858|supplementation|supplementation
5201143|NCT00819858|nutrition|nutrition
5201144|NCT00819845|Duchenne|duchenne
5201145|NCT00819845|Becker muscular dystrophy|becker muscular dystrophy
5201146|NCT00819845|cardioprotective therapy|cardioprotective therapy
5201147|NCT00819845|cardiac magnetic resonance|cardiac magnetic resonance
5201148|NCT00819845|ultrasound tissue characterization|ultrasound tissue characterization
5201149|NCT00819832|vertebral compression fractures|vertebral compression fractures
5201150|NCT00819832|VCF|vcf
5201151|NCT00819832|Spinal|spinal
5201152|NCT00819832|Broken spinal bones|broken spinal bones
5201153|NCT00819832|Kyphoplasty|kyphoplasty
5201154|NCT00819832|vertebroplasty|vertebroplasty
5201155|NCT00819832|Cavity SpineWand|cavity spinewand
5201156|NCT00819832|Circulating Tumor Cell Burden|circulating tumor cell burden
5201157|NCT00819832|CTCB|ctcb
5201158|NCT00819832|Spine pain|spine pain
5201159|NCT00819832|Coblation|coblation
5201160|NCT00819832|plasma radiofrequency ablation|plasma radiofrequency ablation
5201161|NCT00819832|Plasma-mediated ablation technology|plasma-mediated ablation technology
5201162|NCT00819832|precise molecular dissociation (ablation) process|precise molecular dissociation (ablation) process
5201163|NCT00819832|medical cement|medical cement
5201164|NCT00819793|Cardiac Dysfunction|cardiac dysfunction
5201165|NCT00819793|Failure-to-wean from CPB|failure-to-wean from cpb
5201166|NCT00819793|CentriMag|centrimag
5201167|NCT00819793|Levitronix|levitronix
5201168|NCT00819793|Thoratec Corporation|thoratec corporation
5201169|NCT00819780|Colon Cancer|colon cancer
5201170|NCT00819780|Colorectal Cancer|colorectal cancer
5201171|NCT00819780|Rectal Cancer|rectal cancer
5201172|NCT00819780|Panitumumab|panitumumab
5201173|NCT00819780|Vectibix|vectibix
5201174|NCT00819780|modified FOLFOX 6|modified folfox 6
5201175|NCT00819780|mFOLFOX 6|mfolfox 6
5201176|NCT00819780|FOLFOX|folfox
5201177|NCT00819780|Bevacizumab|bevacizumab
5201178|NCT00819780|Avastin|avastin
5201179|NCT00819780|First-Line|first-line
5201180|NCT00819780|metastatic|metastatic
5201181|NCT00819767|hypertension|hypertension
5201182|NCT00819767|systolic blood pressure|systolic blood pressure
5201183|NCT00819767|exercise test|exercise test
5201184|NCT00819767|cardiovascular disease|cardiovascular disease
5201185|NCT00819767|aliskiren|aliskiren
5201186|NCT00819767|valsartan|valsartan
5201187|NCT00819715|Preterm infants|preterm infants
5201188|NCT00819715|small for gestational age|small for gestational age
5201189|NCT00819715|electrogastrography|electrogastrography
5201190|NCT00819702|child abuse prevention|child abuse prevention
5201191|NCT00819702|primary care|primary care
5201192|NCT00819702|professional education in primary care|professional education in primary care
5201193|NCT00819650|hepatocellular carcinoma|hepatocellular carcinoma
5201194|NCT00819650|adjuvant therapy|adjuvant therapy
5201195|NCT00819650|Licartin|licartin
5201196|NCT00819650|time to recurrence|time to recurrence
5201197|NCT00819650|overall survival|overall survival
5201198|NCT00819637|Acute asthma|acute asthma
5201199|NCT00819637|Arformoterol|arformoterol
5201200|NCT00819637|Long acting beta agonists|long acting beta agonists
5201201|NCT00819624|fibromyalgia methodology pain sleep fatigue|fibromyalgia methodology pain sleep fatigue
5201202|NCT00819611|Attention deficit disorder with hyperactivity|attention deficit disorder with hyperactivity
5201203|NCT00819611|Working memory training|working memory training
5201204|NCT00819611|Placebo|placebo
5201205|NCT00819611|Behavioral symptoms|behavioral symptoms
5201206|NCT00819611|Neuropsychology|neuropsychology
5201207|NCT00819611|Electropsychophysiology|electropsychophysiology
5201208|NCT00819585|Gout|gout
5201209|NCT00819585|Chronic gout|chronic gout
5201210|NCT00819585|Gouty arthritis|gouty arthritis
5201211|NCT00819585|Gout flares|gout flares
5201212|NCT00819572|Osteoarthritis|osteoarthritis
5201213|NCT00819572|TNF-alpha|tnf-alpha
5201214|NCT00819572|DLX105|dlx105
5201215|NCT00819572|scFv antibody fragment|scfv antibody fragment
5201216|NCT00819572|pain|pain
5201217|NCT00819572|fragment|fragment
5201218|NCT00819572|antibody fragment|antibody fragment
5201219|NCT00819559|Rectal neoplasm|rectal neoplasm
5201220|NCT00819559|Clinical stage|clinical stage
5201221|NCT00819559|T3N0|t3n0
5201222|NCT00819559|Preoperative chemoradiotherapy|preoperative chemoradiotherapy
5201223|NCT00819559|Laparoscopic|laparoscopic
5201224|NCT00819559|Open resection|open resection
5201225|NCT00819546|AML|aml
5201226|NCT00819546|MDS|mds
5201227|NCT00819520|pediculosis capitis|pediculosis capitis
5201228|NCT00819520|pediculus|pediculus
5201229|NCT00819507|Skin barrier|skin barrier
5201230|NCT00819507|Atopic Dermatitis|atopic dermatitis
5201231|NCT00819507|Corticosteroid|corticosteroid
5201232|NCT00819507|Effects on skin severity and barrier function|effects on skin severity and barrier function
5201233|NCT00819494|Contrast media skin test|contrast media skin test
5201234|NCT00819494|Skin test|skin test
5201235|NCT00819494|hypersensitivity|hypersensitivity
5201236|NCT00819494|contrast media|contrast media
5201237|NCT00819481|Total knee replacement|total knee replacement
5201238|NCT00819455|Diabetes|diabetes
5201239|NCT00819455|Prevention of Diabetes|prevention of diabetes
5201240|NCT00819455|Lifestyle Modification|lifestyle modification
5201241|NCT00819455|Text messages|text messages
5201242|NCT00819442|heart failure|heart failure
5201243|NCT00819442|desmin|desmin
5201244|NCT00819442|ubiquitin|ubiquitin
5201245|NCT00819429|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
5201246|NCT00819429|Conduct Disorder|conduct disorder
5201247|NCT00819429|Oppositional Defiant Disorder|oppositional defiant disorder
5201248|NCT00819429|Omega 3 Supplements|omega 3 supplements
5201249|NCT00819429|Social Skills Training|social skills training
5201250|NCT00819429|Dietary Intake|dietary intake
5201251|NCT00819429|Aggression|aggression
5201252|NCT00819429|Nutrition|nutrition
5201253|NCT00819429|Disruptive Behaviors Disorder|disruptive behaviors disorder
5201254|NCT00819416|randomized controlled trial|randomized controlled trial
5201255|NCT00819416|clinical trial|clinical trial
5201256|NCT00819403|triglycerides|triglycerides
5201257|NCT00819403|hypertension|hypertension
5201258|NCT00819403|low hdl|low hdl
5201259|NCT00819403|obesity|obesity
5201260|NCT00819377|Valvular surgery|valvular surgery
5201261|NCT00819377|pulmonary artery pressure|pulmonary artery pressure
5201262|NCT00819364|Autism|autism
5201263|NCT00819364|early intervention|early intervention
5201264|NCT00819364|BCRI model|bcri model
5201265|NCT00819351|acute lymphoblastic leukemia|acute lymphoblastic leukemia
5201266|NCT00819351|child|child
5201267|NCT00819351|PEG-Asparaginase|peg-asparaginase
5201268|NCT00819351|EFS|efs
5201269|NCT00819351|efficacy|efficacy
5201270|NCT00819351|childhood acute lymphoblastic leukemia|childhood acute lymphoblastic leukemia
5201271|NCT00819338|Non-alcoholic fatty liver disease|non-alcoholic fatty liver disease
5201272|NCT00819338|Polyunsaturated fatty acids|polyunsaturated fatty acids
5201273|NCT00819338|Omega-3|omega-3
5201274|NCT00819325|diabetes|diabetes
5201275|NCT00819325|stents|stents
5201276|NCT00819325|restenosis|restenosis
5201277|NCT00819325|thiazolidinediones|thiazolidinediones
5201278|NCT00819325|coronary atherosclerosis|coronary atherosclerosis
5201279|NCT00819312|Contraceptives,|contraceptives,
5201280|NCT00819312|Oral Hormonal;|oral hormonal;
5201281|NCT00819312|Contraceptive Methods;|contraceptive methods;
5201282|NCT00819312|Female|female
5201283|NCT00819299|Presbyopia|presbyopia
5201284|NCT00819299|accommodation|accommodation
5201285|NCT00819299|near visual acuity|near visual acuity
5201286|NCT00819299|LASIK|lasik
5201287|NCT00819286|open heart surgery|open heart surgery
5201288|NCT00819273|hsCRP|hscrp
5201289|NCT00819260|Mammaplasty|mammaplasty
5201290|NCT00819260|Electrocoagulation|electrocoagulation
5201291|NCT00819260|Breast|breast
5201292|NCT00819234|Leptin|leptin
5201293|NCT00819234|Pramlintide|pramlintide
5201294|NCT00819234|Obese|obese
5201295|NCT00819234|Symlin|symlin
5201296|NCT00819234|Amylin|amylin
5201297|NCT00819221|advanced tumors|advanced tumors
5201298|NCT00819221|solid tumors|solid tumors
5201299|NCT00819221|dose escalation|dose escalation
5201300|NCT00819221|combination|combination
5201301|NCT00819221|AZD2281|azd2281
5201302|NCT00819221|liposomal doxorubicin|liposomal doxorubicin
5201303|NCT00819221|pharmacology|pharmacology
5201305|NCT00819221|multicenter|multicenter
5201306|NCT00819208|fatigue|fatigue
5201307|NCT00819208|sleep disorders|sleep disorders
5201308|NCT00819208|depression|depression
5201309|NCT00819208|anxiety disorder|anxiety disorder
5201310|NCT00819208|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
5201311|NCT00819208|cognitive/functional effects|cognitive/functional effects
5201312|NCT00819208|stage II colon cancer|stage ii colon cancer
5201313|NCT00819208|stage III colon cancer|stage iii colon cancer
5201314|NCT00819208|adenocarcinoma of the colon|adenocarcinoma of the colon
5201315|NCT00819195|relapsing-remitting|relapsing-remitting
5201316|NCT00819195|multiple sclerosis|multiple sclerosis
5201317|NCT00819195|Copaxone|copaxone
5201318|NCT00819195|glatiramer acetate|glatiramer acetate
5201319|NCT00819195|MS|ms
5201320|NCT00819182|Menopause|menopause
5201321|NCT00819182|Breast Cancer|breast cancer
5201322|NCT00819182|Hot Flash|hot flash
5201323|NCT00819182|Night Sweats|night sweats
5201324|NCT00819169|AMG 655|amg 655
5201325|NCT00819169|AMG 479|amg 479
5201326|NCT00819169|Apoptosis|apoptosis
5201327|NCT00819169|Monoclonal Antibody|monoclonal antibody
5201328|NCT00819169|Tumor Necrosis Factor|tumor necrosis factor
5201329|NCT00819169|Insulin-like Growth Factor|insulin-like growth factor
5201330|NCT00819143|Tissue Procurement|tissue procurement
5201331|NCT00819143|Sample Collection|sample collection
5201332|NCT00819143|Chronic Myelogenous Leukemia|chronic myelogenous leukemia
5201333|NCT00819143|Laboratory Research|laboratory research
5201334|NCT00819117|Epicardial leads|epicardial leads
5201335|NCT00819117|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
5201336|NCT00819104|Primary hypertension|primary hypertension
5201337|NCT00819104|Metoprolol XL|metoprolol xl
5201338|NCT00819104|Amlodipine|amlodipine
5201339|NCT00819078|adolescent|adolescent
5201340|NCT00819078|bupropion|bupropion
5201341|NCT00819078|smoking|smoking
5201342|NCT00819078|cessation|cessation
5201343|NCT00819078|depression|depression
5201344|NCT00819065|Botulinum toxin A|botulinum toxin a
5201345|NCT00819065|Spasticity|spasticity
5201346|NCT00819065|Randomized Clinical Trial|randomized clinical trial
5201347|NCT00819000|Specialty Pharmacy|specialty pharmacy
5201348|NCT00819000|Therapy Management|therapy management
5201349|NCT00819000|Medication Compliance|medication compliance
5201350|NCT00819000|Medication Adherence|medication adherence
5201351|NCT00819000|Medication Persistence|medication persistence
5201352|NCT00819000|Health Outcomes|health outcomes
5201353|NCT00818987|Operative|operative
5201354|NCT00818987|Non operative|non operative
5201355|NCT00818961|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5201356|NCT00818961|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5201357|NCT00818961|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5201358|NCT00818961|adult AML with 11q23 (MLL) abnormalities|adult aml with 11q23 (mll) abnormalities
5201359|NCT00818961|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5201360|NCT00818961|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5201361|NCT00818961|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5201362|NCT00818961|prolymphocytic leukemia|prolymphocytic leukemia
5201363|NCT00818961|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
5201364|NCT00818961|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5201365|NCT00818961|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5201366|NCT00818961|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5201367|NCT00818961|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
5201368|NCT00818961|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
5201369|NCT00818961|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
5201370|NCT00818961|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
5201371|NCT00818961|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
5201372|NCT00818961|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5201373|NCT00818961|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
5201374|NCT00818961|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5201375|NCT00818961|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5201376|NCT00818961|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5201377|NCT00818961|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
5201378|NCT00818961|cutaneous B-cell non-Hodgkin lymphoma|cutaneous b-cell non-hodgkin lymphoma
5201379|NCT00818961|recurrent cutaneous T-cell NHL|recurrent cutaneous t-cell nhl
5201380|NCT00818961|stage I cutaneous T-cell NHL|stage i cutaneous t-cell nhl
5201381|NCT00818961|stage II cutaneous T-cell NHL|stage ii cutaneous t-cell nhl
5201382|NCT00818961|stage III cutaneous T-cell NHL|stage iii cutaneous t-cell nhl
5201383|NCT00818961|stage IV cutaneous T-cell NHL|stage iv cutaneous t-cell nhl
5201449|NCT00818909|Dry eye|dry eye
5201384|NCT00818961|extranodal marginal zone B-cell lymphoma of mucosal tissue|extranodal marginal zone b-cell lymphoma of mucosal tissue
5201385|NCT00818961|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5201386|NCT00818961|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5201387|NCT00818961|contiguous st II adult diffuse large cell lymphoma|contiguous st ii adult diffuse large cell lymphoma
5201388|NCT00818961|contiguous st II adult diffuse mixed cell lymphoma|contiguous st ii adult diffuse mixed cell lymphoma
5201389|NCT00818961|contiguous st II adult diffuse sm cleaved cell lymphoma|contiguous st ii adult diffuse sm cleaved cell lymphoma
5201390|NCT00818961|contiguous st II grade 1 follicular lymphoma|contiguous st ii grade 1 follicular lymphoma
5201391|NCT00818961|contiguous st II grade 2 follicular lymphoma|contiguous st ii grade 2 follicular lymphoma
5201392|NCT00818961|contiguous st II grade 3 follicular lymphoma|contiguous st ii grade 3 follicular lymphoma
5201393|NCT00818961|contiguous st II mantle cell lymphoma|contiguous st ii mantle cell lymphoma
5201394|NCT00818961|contiguous st II marginal zone lymphoma|contiguous st ii marginal zone lymphoma
5201395|NCT00818961|contiguous st II small lymphocytic lymphoma|contiguous st ii small lymphocytic lymphoma
5201396|NCT00818961|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
5201397|NCT00818961|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
5201398|NCT00818961|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
5201399|NCT00818961|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
5201400|NCT00818961|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
5201401|NCT00818961|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
5201402|NCT00818961|stage I mantle cell lymphoma|stage i mantle cell lymphoma
5201403|NCT00818961|stage I marginal zone lymphoma|stage i marginal zone lymphoma
5201404|NCT00818961|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
5201405|NCT00818961|noncontiguous st II adult diffuse large cell lymphoma|noncontiguous st ii adult diffuse large cell lymphoma
5201406|NCT00818961|noncontiguous st II adult diffuse mixed cell lymphoma|noncontiguous st ii adult diffuse mixed cell lymphoma
5201407|NCT00818961|noncontiguous st II adult diffuse sm cleaved cell lymphoma|noncontiguous st ii adult diffuse sm cleaved cell lymphoma
5201408|NCT00818961|noncontiguous st II grade 1 follicular lymphoma|noncontiguous st ii grade 1 follicular lymphoma
5201409|NCT00818961|noncontiguous st II grade 2 follicular lymphoma|noncontiguous st ii grade 2 follicular lymphoma
5201410|NCT00818961|noncontiguous st II grade 3 follicular lymphoma|noncontiguous st ii grade 3 follicular lymphoma
5201411|NCT00818961|noncontiguous st II mantle cell lymphoma|noncontiguous st ii mantle cell lymphoma
5201412|NCT00818961|noncontiguous st II marginal zone lymphoma|noncontiguous st ii marginal zone lymphoma
5201413|NCT00818961|noncontiguous st II small lymphocytic lymphoma|noncontiguous st ii small lymphocytic lymphoma
5201414|NCT00818961|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5201415|NCT00818961|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5201416|NCT00818961|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5201417|NCT00818961|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5201418|NCT00818961|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5201419|NCT00818961|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5201420|NCT00818961|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5201421|NCT00818961|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5201422|NCT00818961|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5201423|NCT00818961|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5201424|NCT00818961|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5201425|NCT00818961|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5201426|NCT00818961|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5201427|NCT00818961|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5201428|NCT00818961|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5201429|NCT00818961|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5201430|NCT00818961|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5201431|NCT00818961|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5201432|NCT00818961|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5201433|NCT00818961|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5201434|NCT00818961|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5201435|NCT00818961|recurrent adult gr III lymphomatoid granulomatosis|recurrent adult gr iii lymphomatoid granulomatosis
5201436|NCT00818961|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5201437|NCT00818961|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5201438|NCT00818961|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5201439|NCT00818961|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5201440|NCT00818961|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5201441|NCT00818961|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5201442|NCT00818961|de novo MDS|de novo mds
5201443|NCT00818961|previously treated MDS|previously treated mds
5201444|NCT00818961|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5201445|NCT00818961|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
5201446|NCT00818961|myelodysplastic/myeloproliferative disease|myelodysplastic/myeloproliferative disease
5201447|NCT00818948|Lupus|lupus
5201450|NCT00818909|Systane|systane
5201451|NCT00818909|Moderate to severe dry eye|moderate to severe dry eye
5201452|NCT00818896|thyroid deficiency|thyroid deficiency
5201453|NCT00818896|pregnancy|pregnancy
5201454|NCT00818896|post-partum thyroid dysfunction|post-partum thyroid dysfunction
5201455|NCT00818896|permanent hypothyroidism|permanent hypothyroidism
5201456|NCT00818883|Essential Hypertension|essential hypertension
5201457|NCT00818883|Hypertensive|hypertensive
5201458|NCT00818883|Blood Pressure, High|blood pressure, high
5201459|NCT00818883|Vascular Disease|vascular disease
5201460|NCT00818883|Cardiovascular Disease|cardiovascular disease
5201461|NCT00818883|Drug Therapy|drug therapy
5201462|NCT00818870|Gastroesophageal Reflux|gastroesophageal reflux
5201463|NCT00818870|GERD|gerd
5201464|NCT00818870|Nocturnal GERD|nocturnal gerd
5201465|NCT00818870|Heartburn|heartburn
5201466|NCT00818870|Nighttime Heartburn|nighttime heartburn
5201467|NCT00818870|Nocturnal Heartburn|nocturnal heartburn
5201468|NCT00818857|cancer screening|cancer screening
5201469|NCT00818857|screening disparities|screening disparities
5201470|NCT00818857|underserved populations|underserved populations
5201471|NCT00818844|Nepafenac|nepafenac
5201472|NCT00818844|vitrectomy surgery|vitrectomy surgery
5201473|NCT00818844|Epiretinal membrane surgery|epiretinal membrane surgery
5201474|NCT00818831|Advanced, refractory solid tumors|advanced, refractory solid tumors
5201475|NCT00818818|Leishmaniasis|leishmaniasis
5201476|NCT00818818|Cutaneous leishmaniasis|cutaneous leishmaniasis
5201477|NCT00818818|Leishmania braziliensis|leishmania braziliensis
5201478|NCT00818818|Pentavalent antimonial|pentavalent antimonial
5201479|NCT00818818|Glucantime|glucantime
5201480|NCT00818805|conjunctivitis|conjunctivitis
5201481|NCT00818792|Percutaneous coronary intervention|percutaneous coronary intervention
5201482|NCT00818792|Drug-eluting stent|drug-eluting stent
5201483|NCT00818792|Chronic kidney disease|chronic kidney disease
5201484|NCT00818792|Restenosis|restenosis
5201485|NCT00818779|diabetes|diabetes
5201486|NCT00818779|heart disease|heart disease
5201487|NCT00818779|atherosclerosis|atherosclerosis
5201488|NCT00818766|Thoracic Surgery|thoracic surgery
5201489|NCT00818766|Antibiotic Prophylaxis|antibiotic prophylaxis
5201490|NCT00818766|Chest Tube|chest tube
5201491|NCT00818727|Bone density|bone density
5201492|NCT00818727|SSRI|ssri
5201493|NCT00818727|newborn infants|newborn infants
5201494|NCT00818714|IIIA, selected IIIB|iiia, selected iiib
5201495|NCT00818714|(T1N2-3M0, T2N2-3M0, T3N1-3M0)|(t1n2-3m0, t2n2-3m0, t3n1-3m0)
5201496|NCT00818701|Congestive Heart Failure|congestive heart failure
5201497|NCT00818701|Congestive Heart Failure with a NYHF Class 2-3|congestive heart failure with a nyhf class 2-3
5201498|NCT00818701|Ejection Fraction of 35 or less|ejection fraction of 35 or less
5201499|NCT00818688|Superficial thrombophlebitis (ST)|superficial thrombophlebitis (st)
5201500|NCT00818688|Deep-vein thrombosis|deep-vein thrombosis
5201501|NCT00818688|Symptomatic pulmonary embolism|symptomatic pulmonary embolism
5201502|NCT00818688|Symptomatic Superficial Thrombophlebitis of the lower limbs|symptomatic superficial thrombophlebitis of the lower limbs
5201503|NCT00818662|Alzheimer´s|alzheimer´s
5201504|NCT00818662|Dementia|dementia
5201505|NCT00818662|Dementia of Alzheimer Type|dementia of alzheimer type
5201506|NCT00818662|Immunoglobulins|immunoglobulins
5201507|NCT00818662|Gammaglobulins|gammaglobulins
5201508|NCT00818662|Immune Globulin Intravenous (IGIV)|immune globulin intravenous (igiv)
5201509|NCT00818662|Intravenous Immune Globulin (IVIG)|intravenous immune globulin (ivig)
5201510|NCT00818662|Antibodies|antibodies
5201511|NCT00818662|Amyloid|amyloid
5201512|NCT00818662|Immunotherapy|immunotherapy
5201513|NCT00818649|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5201514|NCT00818649|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5201515|NCT00818649|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5201516|NCT00818649|refractory anemia with excess blasts|refractory anemia with excess blasts
5201517|NCT00818649|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
5201518|NCT00818649|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
5201519|NCT00818649|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
5201520|NCT00818649|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
5201521|NCT00818649|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
5201522|NCT00818649|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
5201523|NCT00818649|adult erythroleukemia (M6a)|adult erythroleukemia (m6a)
5201524|NCT00818649|adult pure erythroid leukemia (M6b)|adult pure erythroid leukemia (m6b)
5201525|NCT00818649|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
5201526|NCT00818649|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5201527|NCT00818649|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
5201528|NCT00818649|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5201529|NCT00818649|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5201530|NCT00818649|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5201531|NCT00818649|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5201532|NCT00818636|expressive writing|expressive writing
5201533|NCT00818636|ruminating|ruminating
5201534|NCT00818636|ruminative thinking|ruminative thinking
5201535|NCT00818636|experiential avoidance|experiential avoidance
5201536|NCT00818636|depression|depression
5201538|NCT00818636|drinking|drinking
5201539|NCT00818636|emotional processing|emotional processing
5201540|NCT00818610|Community-acquired infections|community-acquired infections
5201541|NCT00818610|Pneumonia|pneumonia
5201542|NCT00818610|Clinical Stability|clinical stability
5201543|NCT00818610|Antibiotics|antibiotics
5201544|NCT00818610|Combination therapy|combination therapy
5201545|NCT00818610|Atypical bacteria|atypical bacteria
5201546|NCT00818597|septic shock|septic shock
5201547|NCT00818597|immunoparalysis|immunoparalysis
5201548|NCT00818597|extracorporeal|extracorporeal
5201549|NCT00818597|granulocyte bioreactor|granulocyte bioreactor
5201550|NCT00818597|plasmapheresis|plasmapheresis
5201551|NCT00818584|Micafungin|micafungin
5201552|NCT00818584|Candida|candida
5201553|NCT00818584|Neonates|neonates
5201554|NCT00818584|Mycamine|mycamine
5201555|NCT00818584|FK463|fk463
5201556|NCT00818571|Renal impairment|renal impairment
5201557|NCT00818571|Diabetes|diabetes
5201558|NCT00818571|vildagliptin|vildagliptin
5201559|NCT00818571|Galvus|galvus
5201560|NCT00818571|Eucreas|eucreas
5201561|NCT00818558|non small cell lung cancer|non small cell lung cancer
5201562|NCT00818545|aging|aging
5201563|NCT00818545|barrier function|barrier function
5201564|NCT00818545|transcriptomic|transcriptomic
5201565|NCT00818532|Corneal astigmatism|corneal astigmatism
5201566|NCT00818532|Low diopter|low diopter
5201567|NCT00818532|Corneal measurement|corneal measurement
5201568|NCT00818532|Corneal astigmatism < 1 Diopter|corneal astigmatism < 1 diopter
5201569|NCT00818519|Moderate Acne Vulgaris|moderate acne vulgaris
5201570|NCT00818519|Oral contraceptive|oral contraceptive
5201571|NCT00818519|Female|female
5201572|NCT00818506|Depression|depression
5201573|NCT00818506|Major depressive disorder|major depressive disorder
5201574|NCT00818506|Coronary artery disease|coronary artery disease
5201575|NCT00818506|White Matter Hyperintensities|white matter hyperintensities
5201576|NCT00818506|White Matter Lesions|white matter lesions
5201577|NCT00818506|Coronary artery calcification|coronary artery calcification
5201578|NCT00818493|total knee arthroplasty|total knee arthroplasty
5201579|NCT00818493|total hip arthroplasty|total hip arthroplasty
5201580|NCT00818480|prostate cancer|prostate cancer
5201581|NCT00818480|melanoma|melanoma
5201582|NCT00818480|lymphoma|lymphoma
5201583|NCT00818480|YM155|ym155
5201584|NCT00818467|Skin tone|skin tone
5201585|NCT00818467|Vitamin D|vitamin d
5201586|NCT00818441|lung cancer adenocarcinoma HER2|lung cancer adenocarcinoma her2
5201587|NCT00818428|Phonological Awareness|phonological awareness
5201588|NCT00818428|Speech Articulation Disorder|speech articulation disorder
5201589|NCT00818428|Development Articulation Disorder|development articulation disorder
5201590|NCT00818428|Phonological Impairment|phonological impairment
5201591|NCT00818428|Dyslexia|dyslexia
5201592|NCT00818428|Speech Therapy|speech therapy
5201593|NCT00818428|School Transition|school transition
5201594|NCT00818402|Quality of life|quality of life
5201595|NCT00818402|symptoms|symptoms
5201596|NCT00818389|Amyotrophic lateral sclerosis|amyotrophic lateral sclerosis
5201597|NCT00818389|ALS|als
5201598|NCT00818389|Lou Gehrig's disease|lou gehrig's disease
5201599|NCT00818389|riluzole|riluzole
5201600|NCT00818389|lithium|lithium
5201601|NCT00818389|neurodegeneration|neurodegeneration
5201602|NCT00818376|Chlorhexidine|chlorhexidine
5201603|NCT00818376|adverse effects|adverse effects
5201604|NCT00818376|staining|staining
5201605|NCT00818376|dental calculus|dental calculus
5201606|NCT00818376|dental plaque|dental plaque
5201607|NCT00818363|Postoperative pain|postoperative pain
5201608|NCT00818363|shoulder surgery|shoulder surgery
5201609|NCT00818363|opioid|opioid
5201610|NCT00818311|Light emitting diode|light emitting diode
5201611|NCT00818311|tolerance|tolerance
5201612|NCT00818311|photomodulation|photomodulation
5201613|NCT00818298|schizophrenia|schizophrenia
5201614|NCT00818298|schizoaffective disorder|schizoaffective disorder
5201615|NCT00818298|PET Scan|pet scan
5201616|NCT00818298|ziprasidone|ziprasidone
5201617|NCT00818298|dopamine|dopamine
5201618|NCT00818298|D2|d2
5201619|NCT00818298|receptor|receptor
5201620|NCT00818298|antagonist|antagonist
5201621|NCT00818298|occupancy|occupancy
5201622|NCT00818298|dissociation|dissociation
5201623|NCT00818298|affinity|affinity
5201624|NCT00818298|constant|constant
5201625|NCT00818298|Ki|ki
5201626|NCT00818298|ligand|ligand
5201627|NCT00818298|raclopride|raclopride
5201628|NCT00818298|half-life|half-life
5201629|NCT00818298|striatal|striatal
5201630|NCT00818298|plasma dynamics|plasma dynamics
5201631|NCT00818298|central dynamics|central dynamics
5201632|NCT00818298|plasma drug level|plasma drug level
5201633|NCT00818298|compliance|compliance
5201634|NCT00818298|antipsychotic|antipsychotic
5201635|NCT00818298|pharmacotherapy|pharmacotherapy
5201636|NCT00818298|twice daily dosing|twice daily dosing
5201637|NCT00818298|BID dosing|bid dosing
5201638|NCT00818298|once daily dosing|once daily dosing
5201639|NCT00818298|od dosing|od dosing
5201640|NCT00818298|qd dosing|qd dosing
5201641|NCT00818298|dosing schedule|dosing schedule
5201642|NCT00818233|dynamic contour tonometry|dynamic contour tonometry
5201643|NCT00818233|variability|variability
5201644|NCT00818233|pulse amplitude|pulse amplitude
5201645|NCT00818233|Ocular pulse amplitude|ocular pulse amplitude
5201646|NCT00818220|intraventricular hemorrhage|intraventricular hemorrhage
5201647|NCT00818220|sepsis|sepsis
5201648|NCT00818220|motor function|motor function
5201649|NCT00818220|motor functioning at 7 months corrected age|motor functioning at 7 months corrected age
5201650|NCT00818220|cytokines in cord blood and at 6 and 20 hours of age|cytokines in cord blood and at 6 and 20 hours of age
5201651|NCT00818220|stem cells in cord blood and at 20 hours of age|stem cells in cord blood and at 20 hours of age
5201652|NCT00818207|Smoking cessation|smoking cessation
5201653|NCT00818207|quit rates|quit rates
5201654|NCT00818207|reimbursement|reimbursement
5201655|NCT00818207|drug coverage|drug coverage
5201656|NCT00818207|effectiveness|effectiveness
5201657|NCT00818207|cost-effectiveness|cost-effectiveness
5201658|NCT00818207|health policy|health policy
5201659|NCT00818207|drug utilization|drug utilization
5201660|NCT00818207|adherence|adherence
5201661|NCT00818207|urine cotinine.|urine cotinine.
5201662|NCT00818194|Tacrolimus|tacrolimus
5201663|NCT00818194|cyclosporine A|cyclosporine a
5201664|NCT00818194|renal plasma flow|renal plasma flow
5201665|NCT00818194|glomerular filtration rate|glomerular filtration rate
5201666|NCT00818194|human|human
5201667|NCT00818194|pharmacodynamics|pharmacodynamics
5201668|NCT00818194|pharmacokinetics|pharmacokinetics
5201669|NCT00818194|Pharmacodynamics of tacrolimus|pharmacodynamics of tacrolimus
5201670|NCT00818181|Type I - Allergy, rhinoconjunctivitis|type i - allergy, rhinoconjunctivitis
5201671|NCT00818129|Phase I|phase i
5201672|NCT00818129|Japan|japan
5201673|NCT00818129|Japanese|japanese
5201674|NCT00818129|oral solution|oral solution
5201675|NCT00818116|Cataract|cataract
5201676|NCT00818116|visual acuity|visual acuity
5201677|NCT00818116|AcrySof ReSTOR Aspheric Intraoculare Lens|acrysof restor aspheric intraoculare lens
5201678|NCT00818116|Bilateral cataract|bilateral cataract
5201679|NCT00818103|Multiple Sclerosis,Genetics,Pathogenesis,Pathology,Therapy|multiple sclerosis,genetics,pathogenesis,pathology,therapy
5201680|NCT00818090|thymic epithelial tumor|thymic epithelial tumor
5201681|NCT00818090|paclitaxel|paclitaxel
5201682|NCT00818090|cisplatin|cisplatin
5201683|NCT00818090|thymic carcinoma|thymic carcinoma
5201684|NCT00818090|invasive thymoma|invasive thymoma
5201685|NCT00818051|stage IA breast cancer|stage ia breast cancer
5201686|NCT00818051|stage IB breast cancer|stage ib breast cancer
5201687|NCT00818051|stage II breast cancer|stage ii breast cancer
5201688|NCT00818051|stage IIIA breast cancer|stage iiia breast cancer
5201689|NCT00818038|RRMS|rrms
5201690|NCT00818038|Relapsing Remitting|relapsing remitting
5201692|NCT00818025|Transplantation|transplantation
5201693|NCT00818025|Self-care agency|self-care agency
5201694|NCT00818025|Self-care behaviors|self-care behaviors
5201695|NCT00818025|Hand-held device|hand-held device
5201696|NCT00818012|atrial fibrillation|atrial fibrillation
5201697|NCT00818012|atrial electromechanical interval|atrial electromechanical interval
5201698|NCT00818012|direct current cardioversion|direct current cardioversion
5201699|NCT00818012|pulse wave velocity|pulse wave velocity
5201700|NCT00817999|Platelet Aggregation Inhibition|platelet aggregation inhibition
5201701|NCT00817986|Acute back pain in the lumbar region|acute back pain in the lumbar region
5201702|NCT00817973|Whey protein|whey protein
5201703|NCT00817973|gluten|gluten
5201704|NCT00817973|casein|casein
5201705|NCT00817973|cod protein|cod protein
5201706|NCT00817973|GLP-1|glp-1
5201707|NCT00817973|postprandial|postprandial
5201708|NCT00817973|triglyceride|triglyceride
5201709|NCT00817973|free fatty acids|free fatty acids
5201710|NCT00817973|chylomicrons|chylomicrons
5201711|NCT00817973|retinyl palmitate|retinyl palmitate
5201712|NCT00817973|type 2 diabetes|type 2 diabetes
5201713|NCT00817973|GIP|gip
5201714|NCT00817973|Postprandial incretins|postprandial incretins
5201715|NCT00817960|Dual tasking|dual tasking
5201716|NCT00817960|Postural Control|postural control
5201717|NCT00817960|Methylphenidate (Ritalin)|methylphenidate (ritalin)
5201718|NCT00817960|old adults|old adults
5201719|NCT00817947|Airway clearance|airway clearance
5201720|NCT00817947|Cystic fibrosis|cystic fibrosis
5201721|NCT00817947|High frequency chest wall oscillation|high frequency chest wall oscillation
5201722|NCT00817934|Efficacy|efficacy
5201723|NCT00817934|patient's tolerance|patient's tolerance
5201724|NCT00817934|patient's safety|patient's safety
5201725|NCT00817921|premature renal function|premature renal function
5201726|NCT00817921|ibuprofen|ibuprofen
5201727|NCT00817921|blood pressure|blood pressure
5201728|NCT00817921|Renal function|renal function
5201729|NCT00817908|liver transplant|liver transplant
5201730|NCT00817908|lung transplant|lung transplant
5201731|NCT00817908|kidney transplant|kidney transplant
5201732|NCT00817908|heart transplant|heart transplant
5201733|NCT00817908|CMV CMI|cmv cmi
5201734|NCT00817908|Transplant|transplant
5201735|NCT00817895|hepatocellular carcinoma|hepatocellular carcinoma
5201736|NCT00817895|liver resection|liver resection
5201737|NCT00817895|intraoperative chemotherapy|intraoperative chemotherapy
5201738|NCT00817882|vocational|vocational
5201739|NCT00817882|rehabilitation|rehabilitation
5201740|NCT00817882|work|work
5201741|NCT00817882|ability|ability
5201742|NCT00817882|low back pain|low back pain
5201743|NCT00817869|Floors and Floorcoverings|floors and floorcoverings
5201744|NCT00817869|Health Services for the Aged|health services for the aged
5201745|NCT00817869|Fractures, bone|fractures, bone
5201746|NCT00817869|Delirium, Dementia, Amnestic, Cognitive Disorders|delirium, dementia, amnestic, cognitive disorders
5201747|NCT00817869|Frail Elderly|frail elderly
5201748|NCT00817869|Aged, 80 and over|aged, 80 and over
5201749|NCT00817843|Postprandial hypertriglyceridemia|postprandial hypertriglyceridemia
5201750|NCT00817843|Metabolic syndrome|metabolic syndrome
5201751|NCT00817843|Endothelial function|endothelial function
5201752|NCT00817843|Flow mediated dilatation|flow mediated dilatation
5201753|NCT00817843|EndoPAT|endopat
5201754|NCT00817843|Simvastatin|simvastatin
5201755|NCT00817843|Ezetimibe|ezetimibe
5201756|NCT00817830|Coronaropathy|coronaropathy
5201757|NCT00817830|lodenafil carbonate|lodenafil carbonate
5201758|NCT00817830|Erectile dysfunction|erectile dysfunction
5201759|NCT00817830|Treatment|treatment
5201760|NCT00817830|QT interval|qt interval
5201761|NCT00817830|Phosphodiesterase inhibitors|phosphodiesterase inhibitors
5201762|NCT00817830|Cardiac arrhythmia|cardiac arrhythmia
5201763|NCT00817830|Effort testPhosphodiesterase 5 inhibitors|effort testphosphodiesterase 5 inhibitors
5201764|NCT00817830|Cardiovascular test|cardiovascular test
5201765|NCT00817804|noninvasive ventilation|noninvasive ventilation
5201766|NCT00817791|CABG|cabg
5201767|NCT00817791|hyperbaric oxygen|hyperbaric oxygen
5201768|NCT00817791|preconditioning|preconditioning
5201769|NCT00817791|S100B|s100b
5201771|NCT00817791|Troponin I|troponin i
5201772|NCT00817791|CABG surgery|cabg surgery
5201773|NCT00817791|neuroprotection|neuroprotection
5201774|NCT00817778|Type II Diabetes|type ii diabetes
5201775|NCT00817765|interaction|interaction
5201776|NCT00817765|pharmacokinetics|pharmacokinetics
5201777|NCT00817765|boosting|boosting
5201778|NCT00817765|drug-drug interaction|drug-drug interaction
5201779|NCT00817765|safety|safety
5201780|NCT00817752|stress|stress
5201781|NCT00817752|inflammation|inflammation
5201782|NCT00817752|natural remedy|natural remedy
5201783|NCT00817752|cytokines|cytokines
5201784|NCT00817752|interleukin|interleukin
5201785|NCT00817752|inflammatory conditions|inflammatory conditions
5201786|NCT00817752|auto-immune disorders|auto-immune disorders
5201787|NCT00817739|Drug therapy|drug therapy
5201788|NCT00817726|Rapid Eye Movement Sleep Behavior Disorder|rapid eye movement sleep behavior disorder
5201789|NCT00817726|Parkinson's Disease|parkinson's disease
5201790|NCT00817726|Parkinsonian Syndromes|parkinsonian syndromes
5201791|NCT00817726|Atypical Parkinson's|atypical parkinson's
5201792|NCT00817726|RBD|rbd
5201793|NCT00817726|PD|pd
5201794|NCT00817726|fMRI|fmri
5201795|NCT00817726|PSP|psp
5201796|NCT00817726|MSA|msa
5201797|NCT00817713|Human Immunodeficiency Virus|human immunodeficiency virus
5201798|NCT00817713|Helminthiasis|helminthiasis
5201799|NCT00817713|treatment naive|treatment naive
5201800|NCT00817713|co-infection|co-infection
5201801|NCT00817713|immune modulation|immune modulation
5201802|NCT00817700|Sleep|sleep
5201803|NCT00817700|young adults|young adults
5201804|NCT00817700|middle-age adults|middle-age adults
5201805|NCT00817700|older adults|older adults
5201806|NCT00817674|CKD|ckd
5201807|NCT00817674|Kidney Disease|kidney disease
5201808|NCT00817674|poor sleep|poor sleep
5201809|NCT00817674|CKD progression|ckd progression
5201810|NCT00817661|vitamin A|vitamin a
5201811|NCT00817661|influenza vaccine|influenza vaccine
5201812|NCT00817661|passive immunity|passive immunity
5201813|NCT00817661|pregnant mothers|pregnant mothers
5201814|NCT00817661|vitamin A suplementation|vitamin a suplementation
5201815|NCT00817661|Influenza vaccination|influenza vaccination
5201816|NCT00817661|Infant immune responses|infant immune responses
5201817|NCT00817648|schizophrenia|schizophrenia
5201818|NCT00817648|antipsychotics|antipsychotics
5201819|NCT00817648|quetiapine|quetiapine
5201820|NCT00817648|risperidone|risperidone
5201821|NCT00817648|efficacy|efficacy
5201822|NCT00817648|safety|safety
5201823|NCT00817648|multicenter|multicenter
5201824|NCT00817648|rater-blind|rater-blind
5201825|NCT00817648|randomized|randomized
5201826|NCT00817648|chinese|chinese
5201827|NCT00817648|han|han
5201828|NCT00817635|Blood Pressure|blood pressure
5201829|NCT00817635|Hypertension|hypertension
5201830|NCT00817635|Resistant Hypertension|resistant hypertension
5201831|NCT00817622|diabetes mellitus type 2|diabetes mellitus type 2
5201832|NCT00817622|EPA|epa
5201833|NCT00817622|leptin|leptin
5201834|NCT00817622|adiponectin|adiponectin
5201835|NCT00817609|Angongniuhuang Pill|angongniuhuang pill
5201836|NCT00817609|consciousness level of patients who suffered from a stroke|consciousness level of patients who suffered from a stroke
5201837|NCT00817583|Phase 2 Clinical Trial|phase 2 clinical trial
5201838|NCT00817583|NPC|npc
5201839|NCT00817583|neoadjuvant chemotherapy|neoadjuvant chemotherapy
5202278|NCT00816192|Ablation|ablation
5201840|NCT00817583|concurrent chemoradiation|concurrent chemoradiation
5201841|NCT00817570|Trans Femoral Amputees Balance Reactions|trans femoral amputees balance reactions
5201842|NCT00817557|Contact lenses|contact lenses
5201843|NCT00817557|Loteprednol|loteprednol
5201844|NCT00817557|Effect on CL dryness|effect on cl dryness
5201845|NCT00817544|3098004|3098004
5201846|NCT00817544|Healthy volunteers|healthy volunteers
5201847|NCT00817531|Breast Cancer|breast cancer
5201848|NCT00817505|Type I diabetes|type i diabetes
5201849|NCT00817505|bioavailability|bioavailability
5201850|NCT00817492|Sleep|sleep
5201851|NCT00817492|CKD|ckd
5201852|NCT00817492|kidney|kidney
5201853|NCT00817492|PSG|psg
5201854|NCT00817492|polysomnography|polysomnography
5201855|NCT00817492|Decreased sleep time|decreased sleep time
5201856|NCT00817492|Decreased sleep quality|decreased sleep quality
5201857|NCT00817479|Subject has intraabdominal disease either proven or strongly|subject has intraabdominal disease either proven or strongly
5201858|NCT00817479|suspected to be ovarian or primary peritoneal cancer|suspected to be ovarian or primary peritoneal cancer
5201859|NCT00817466|bronchiolitis|bronchiolitis
5201860|NCT00817466|infants|infants
5201861|NCT00817466|racemic adrenaline|racemic adrenaline
5201862|NCT00817466|inhalations|inhalations
5201863|NCT00817466|treatment|treatment
5201864|NCT00817453|Parkinson's Disease|parkinson's disease
5201865|NCT00817440|growth hormone insulin signaltransduction signalpathways|growth hormone insulin signaltransduction signalpathways
5201866|NCT00817440|growth hormone and insulin signalpathways|growth hormone and insulin signalpathways
5201867|NCT00817427|Chronic Kidney Disease|chronic kidney disease
5201868|NCT00817427|Poor sleep|poor sleep
5201869|NCT00817427|CKD|ckd
5201870|NCT00817427|Kidney Failure|kidney failure
5201871|NCT00817414|Blood Pressure|blood pressure
5201872|NCT00817414|Hypertension|hypertension
5201873|NCT00817414|Cortisol|cortisol
5201874|NCT00817401|asphyxia|asphyxia
5201875|NCT00817401|hypothermia|hypothermia
5201876|NCT00817401|hypoxic-ischemic encephalopathy|hypoxic-ischemic encephalopathy
5201877|NCT00817401|neonates|neonates
5201878|NCT00817388|Interstitial cystitis|interstitial cystitis
5201879|NCT00817388|pelvic pain|pelvic pain
5201880|NCT00817375|Pharmacogenomics|pharmacogenomics
5201881|NCT00817375|Prediction of Antidepressant Response|prediction of antidepressant response
5201882|NCT00817375|Depressed Patients|depressed patients
5201883|NCT00817362|Breast Cancer|breast cancer
5201884|NCT00817362|Advanced Breast Cancer|advanced breast cancer
5201885|NCT00817362|Metastatic Breast Cancer|metastatic breast cancer
5201886|NCT00817362|HER2 Positive Breast Cancer|her2 positive breast cancer
5201887|NCT00817362|Cancer of the breast|cancer of the breast
5201888|NCT00817362|Trastuzumab|trastuzumab
5201889|NCT00817362|Herceptin|herceptin
5201890|NCT00817349|Angio-Seal|angio-seal
5201891|NCT00817349|Peripheral vascular disease|peripheral vascular disease
5201892|NCT00817349|Vascular closure device|vascular closure device
5201893|NCT00817349|Arterial closure|arterial closure
5201894|NCT00817349|Coronary artery disease|coronary artery disease
5201895|NCT00817349|Arterial hemostasis|arterial hemostasis
5201896|NCT00817349|Coronary cardiac catheterization|coronary cardiac catheterization
5201897|NCT00817349|Percutaneous coronary intervention|percutaneous coronary intervention
5201898|NCT00817349|Interventional catheterization|interventional catheterization
5201899|NCT00817349|Diagnostic catheterization|diagnostic catheterization
5201900|NCT00817349|Common femoral artery|common femoral artery
5201901|NCT00817349|Manual compression|manual compression
5201902|NCT00817349|Vascular intervention|vascular intervention
5201903|NCT00817349|Angiogram|angiogram
5201904|NCT00817349|Coronary intervention|coronary intervention
5201905|NCT00817349|Coronary angioplasty|coronary angioplasty
5201906|NCT00817349|Angiography|angiography
5201907|NCT00817349|Arteriotomy|arteriotomy
5201908|NCT00817349|Vascular access|vascular access
5201909|NCT00817336|biomarker|biomarker
5201910|NCT00817336|EEG|eeg
5201911|NCT00817336|schizophrenia|schizophrenia
5201912|NCT00817336|NMDA|nmda
5201913|NCT00817336|D-serine|d-serine
5201914|NCT00817323|bipolar depression|bipolar depression
5201915|NCT00817323|atypical antipsychotic|atypical antipsychotic
5201916|NCT00817323|remission|remission
5201917|NCT00817323|depletion|depletion
5201918|NCT00817323|mood|mood
5201919|NCT00817297|noninvasive ventilation|noninvasive ventilation
5201920|NCT00817284|Newly diagnosed patients with glioblastoma multiforme.|newly diagnosed patients with glioblastoma multiforme.
5201921|NCT00817284|Performance status 0-2.|performance status 0-2.
5201922|NCT00817271|Type II Diabetes|type ii diabetes
5201923|NCT00817271|Counter-regulatory response|counter-regulatory response
5201924|NCT00817271|Hypoglycemia|hypoglycemia
5201925|NCT00817258|Phase 2 Clinical Trial|phase 2 clinical trial
5201926|NCT00817258|NPC|npc
5201927|NCT00817258|radiation therapy|radiation therapy
5201928|NCT00817258|chemotherapy|chemotherapy
5201929|NCT00817245|CSR|csr
5201930|NCT00817245|Helicobacter pylori|helicobacter pylori
5201931|NCT00817232|tennis elbow|tennis elbow
5201932|NCT00817232|microcurrent|microcurrent
5201933|NCT00817232|tissue healing|tissue healing
5201934|NCT00817206|kidney transplantation|kidney transplantation
5201935|NCT00817206|renal transplantation|renal transplantation
5202279|NCT00816192|RF|rf
5201936|NCT00817206|maintenance immunosuppression|maintenance immunosuppression
5201937|NCT00817206|tacrolimus|tacrolimus
5201938|NCT00817206|Prevention of acute allograft rejection|prevention of acute allograft rejection
5201939|NCT00817193|Clinical trial|clinical trial
5201940|NCT00817193|Short Physical Performance Battery|short physical performance battery
5201941|NCT00817193|Disability|disability
5201942|NCT00817193|Senior Housing|senior housing
5201943|NCT00817193|Aging|aging
5201944|NCT00817180|physiotherapy|physiotherapy
5201945|NCT00817180|airway clearance techniques|airway clearance techniques
5201946|NCT00817180|Positive Expiratory Pressure Technique|positive expiratory pressure technique
5201947|NCT00817180|high frequency Chest Wall Oscillation|high frequency chest wall oscillation
5201948|NCT00817180|vest|vest
5201949|NCT00817167|Known or suspected lung disease|known or suspected lung disease
5201950|NCT00817167|Candidates for non-emergency bronchoscopy|candidates for non-emergency bronchoscopy
5201951|NCT00817154|Older persons with SMI|older persons with smi
5201952|NCT00817128|Complex Regional Pain Syndrome Type I|complex regional pain syndrome type i
5201953|NCT00817128|Sympathetic Reflex Dystrophy|sympathetic reflex dystrophy
5201954|NCT00817128|Pain Exposure Physical Therapy|pain exposure physical therapy
5201955|NCT00817128|Pharmacological treatment|pharmacological treatment
5201956|NCT00817128|Functional recovery|functional recovery
5201957|NCT00817115|Region-of-Interest Imaging|region-of-interest imaging
5201958|NCT00817115|X-ray Fovea Imaging|x-ray fovea imaging
5201959|NCT00817115|Cardiovascular Diseases|cardiovascular diseases
5201960|NCT00817115|Radiation Dosage|radiation dosage
5201961|NCT00817115|Radiographic Image Enhancement|radiographic image enhancement
5201962|NCT00817115|Radiography, Interventional|radiography, interventional
5201963|NCT00817102|coronary artery stenoses|coronary artery stenoses
5201964|NCT00817063|retinoid treatment|retinoid treatment
5201965|NCT00817063|fingertip dermatitis|fingertip dermatitis
5201966|NCT00817063|hyperkeratotic hand eczema|hyperkeratotic hand eczema
5201967|NCT00817063|vesicular hand eczema|vesicular hand eczema
5201968|NCT00817063|pompholyx|pompholyx
5201969|NCT00817037|Chronic kidney disease|chronic kidney disease
5201970|NCT00817037|Proteinuria|proteinuria
5201971|NCT00817037|Blood pressure|blood pressure
5201972|NCT00817037|Arterial stiffness|arterial stiffness
5201973|NCT00817037|Endothelin antagonist|endothelin antagonist
5201974|NCT00817037|Sitaxsentan|sitaxsentan
5201975|NCT00817024|Coronary Heart Disease|coronary heart disease
5201976|NCT00817024|PCI|pci
5201977|NCT00817024|Traditional Chinese Medicine|traditional chinese medicine
5201978|NCT00817024|Quality of Life|quality of life
5201979|NCT00817011|depression|depression
5201980|NCT00817011|pharmacogenomics|pharmacogenomics
5201981|NCT00817011|antidepressant response|antidepressant response
5201982|NCT00817011|biological markers|biological markers
5201983|NCT00817011|clinical variables|clinical variables
5201984|NCT00816998|Radius fractures|radius fractures
5201985|NCT00816985|Female|female
5201986|NCT00816985|Lymphedema|lymphedema
5201987|NCT00816959|Lymphocytic Predominant Hodgkin's Lymphoma|lymphocytic predominant hodgkin's lymphoma
5201988|NCT00816959|Late, widespread and recurrent LPHD|late, widespread and recurrent lphd
5201989|NCT00816946|malnutrition|malnutrition
5201990|NCT00816946|growth|growth
5201991|NCT00816933|pain|pain
5201992|NCT00816933|operative times|operative times
5201993|NCT00816933|complication|complication
5201994|NCT00816933|time to return for normal life|time to return for normal life
5201995|NCT00816933|pain using VAS score|pain using vas score
5201996|NCT00816920|distal DVT|distal dvt
5201997|NCT00816920|calf DVT|calf dvt
5201998|NCT00816920|DVT diagnosis|dvt diagnosis
5201999|NCT00816920|management of patients with suspected leg DVT|management of patients with suspected leg dvt
5202000|NCT00816907|Schizoaffective Disorder|schizoaffective disorder
5202001|NCT00816894|schizophrenia|schizophrenia
5202002|NCT00816894|treatment resistance|treatment resistance
5202003|NCT00816894|D-serine|d-serine
5202004|NCT00816894|Olanzapine|olanzapine
5202005|NCT00816894|treatment refractory schizophrenia|treatment refractory schizophrenia
5202006|NCT00816881|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
5202007|NCT00816881|flutter|flutter
5202008|NCT00816881|airway clearance|airway clearance
5202009|NCT00816881|sputum|sputum
5202010|NCT00816881|Physical Therapy Techniques|physical therapy techniques
5202132|NCT00816530|Breast Neoplasms|breast neoplasms
5202011|NCT00816868|stage IIIB/IV adenocarcinoma non-small cell lung cancer|stage iiib/iv adenocarcinoma non-small cell lung cancer
5202012|NCT00816855|Phase 2 Clinical Trial|phase 2 clinical trial
5202013|NCT00816855|NPC|npc
5202014|NCT00816855|neoadjuvant chemotherapy|neoadjuvant chemotherapy
5202015|NCT00816855|concurrent chemoradiation|concurrent chemoradiation
5202016|NCT00816842|citrulline|citrulline
5202017|NCT00816842|malabsorption|malabsorption
5202018|NCT00816842|Villous atrophy|villous atrophy
5202019|NCT00816842|enteropathy|enteropathy
5202020|NCT00816829|Dyslipidemia|dyslipidemia
5202021|NCT00816829|Sleep Apnea Syndromes|sleep apnea syndromes
5202022|NCT00816829|Fenofibrate|fenofibrate
5202023|NCT00816829|Obese|obese
5202024|NCT00816829|Overweight or obese patients|overweight or obese patients
5202025|NCT00816816|Phase 2 Clinical Trial|phase 2 clinical trial
5202026|NCT00816816|NPC|npc
5202471|NCT00815464|Herbalist|herbalist
5202027|NCT00816816|neoadjuvant chemotherapy|neoadjuvant chemotherapy
5202028|NCT00816816|concurrent chemoradiation|concurrent chemoradiation
5202029|NCT00816803|Spinal cord injury|spinal cord injury
5202030|NCT00816790|Septic shock|septic shock
5202031|NCT00816790|Acute Renal Failure|acute renal failure
5202032|NCT00816790|Antimicrobial|antimicrobial
5202033|NCT00816790|Drug Dosing|drug dosing
5202034|NCT00816790|Feasibility Study|feasibility study
5202035|NCT00816777|Cancer|cancer
5202036|NCT00816777|Carcinoma|carcinoma
5202037|NCT00816777|Colon Cancer|colon cancer
5202038|NCT00816777|Colorectal Cancer|colorectal cancer
5202039|NCT00816777|Gastric Cancer|gastric cancer
5202040|NCT00816777|Gastrointestinal Cancer|gastrointestinal cancer
5202041|NCT00816777|Metastases|metastases
5202042|NCT00816777|Metastatic Cancer|metastatic cancer
5202043|NCT00816777|Metastatic Colorectal Cancer|metastatic colorectal cancer
5202044|NCT00816777|Oncology|oncology
5202045|NCT00816777|Rectal Cancer|rectal cancer
5202046|NCT00816764|clinical trial, phase 1|clinical trial, phase 1
5202047|NCT00816764|carcinoma|carcinoma
5202048|NCT00816764|pharmacokinetics|pharmacokinetics
5202049|NCT00816764|safety|safety
5202050|NCT00816764|ovarian|ovarian
5202051|NCT00816751|Local anesthesia|local anesthesia
5202052|NCT00816751|Paracervical|paracervical
5202053|NCT00816751|Intracervical|intracervical
5202054|NCT00816751|Abortion|abortion
5202055|NCT00816751|Pain|pain
5202056|NCT00816751|Local anesthesia for elective first trimester abortion|local anesthesia for elective first trimester abortion
5202057|NCT00816738|Nd: YAG laser|nd: yag laser
5202058|NCT00816738|recurrent corneal erosions|recurrent corneal erosions
5202059|NCT00816738|trauma|trauma
5202060|NCT00816738|anterior stromal puncture|anterior stromal puncture
5202061|NCT00816725|Postnatal Depression|postnatal depression
5202062|NCT00816725|Cognitive Behavioral Therapy|cognitive behavioral therapy
5202063|NCT00816725|Mood Management|mood management
5202064|NCT00816725|Self-help|self-help
5202065|NCT00816725|Internet|internet
5202066|NCT00816712|Males with low-normal serum total testosterone levels.|males with low-normal serum total testosterone levels.
5202067|NCT00816699|Anxiety|anxiety
5202068|NCT00816699|preprint anesthetic risk information|preprint anesthetic risk information
5202069|NCT00816686|clinical trial, phase 1|clinical trial, phase 1
5202070|NCT00816686|carcinoma, advanced renal cell|carcinoma, advanced renal cell
5202071|NCT00816686|kidney|kidney
5202072|NCT00816686|pharmacokinetics|pharmacokinetics
5202073|NCT00816686|safety|safety
5202074|NCT00816686|AGS-16M18|ags-16m18
5202075|NCT00816673|Insomnia|insomnia
5202076|NCT00816673|Primary insomnia|primary insomnia
5202077|NCT00816673|sleep latency|sleep latency
5202078|NCT00816673|non restorative sleep|non restorative sleep
5202079|NCT00816673|sleep quality|sleep quality
5202080|NCT00816673|Double-Blind|double-blind
5202081|NCT00816673|Placebo Controlled|placebo controlled
5202082|NCT00816673|Parallel-Group|parallel-group
5202083|NCT00816673|Sleep Laboratory Study|sleep laboratory study
5202084|NCT00816647|Patella|patella
5202085|NCT00816647|Dislocation|dislocation
5202086|NCT00816647|Knee|knee
5202087|NCT00816647|Medial Patellofemoral Ligament|medial patellofemoral ligament
5202088|NCT00816634|First line chemotherapy|first line chemotherapy
5202089|NCT00816634|Advanced or recurrent esophageal squamous cell carcinoma|advanced or recurrent esophageal squamous cell carcinoma
5202090|NCT00816621|Internationally Adopted Children|internationally adopted children
5202091|NCT00816621|Adoption|adoption
5202092|NCT00816621|Attachment|attachment
5202093|NCT00816621|Inattention|inattention
5202094|NCT00816621|Prevention|prevention
5202095|NCT00816608|diabetes|diabetes
5202096|NCT00816608|prediabetes|prediabetes
5202097|NCT00816608|impaired fasting glucose (IFG)|impaired fasting glucose (ifg)
5202098|NCT00816608|impaired glucose tolerance (IGT)|impaired glucose tolerance (igt)
5202099|NCT00816608|body weight|body weight
5202100|NCT00816595|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
5202101|NCT00816595|stage 0 chronic lymphocytic leukemia|stage 0 chronic lymphocytic leukemia
5202102|NCT00816595|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
5202103|NCT00816595|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
5202104|NCT00816595|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5202105|NCT00816595|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5202106|NCT00816595|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
5202107|NCT00816595|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5202108|NCT00816595|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5202109|NCT00816595|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
5202110|NCT00816595|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
5202111|NCT00816582|Post-menopausal hormone receptor positive recurrent/metastatic breast cancer.|post-menopausal hormone receptor positive recurrent/metastatic breast cancer.
5202112|NCT00816582|PET/CT|pet/ct
5202113|NCT00816582|Recurrent or metastatic|recurrent or metastatic
5202114|NCT00816569|Orthokeratology|orthokeratology
5202115|NCT00816569|Keratoconus|keratoconus
5202116|NCT00816530|breast|breast
5202117|NCT00816530|breast cancer|breast cancer
5202118|NCT00816530|breast screening|breast screening
5202119|NCT00816530|breast cancer screening|breast cancer screening
5202120|NCT00816530|ultrasound|ultrasound
5202121|NCT00816530|ultrasonography|ultrasonography
5202122|NCT00816530|mammogram|mammogram
5202123|NCT00816530|mammography|mammography
5202124|NCT00816530|breast density|breast density
5202125|NCT00816530|dense breasts|dense breasts
5202126|NCT00816530|early detection|early detection
5202127|NCT00816530|somo v|somo v
5202128|NCT00816530|somo•v|somo•v
5202129|NCT00816530|U-Systems|u-systems
5202130|NCT00816530|Automated Breast Ultrasound|automated breast ultrasound
5202131|NCT00816530|Ultrasonography, Mammary|ultrasonography, mammary
5202133|NCT00816530|Breast Density > 50% (BI-RADS III & IV)|breast density > 50% (bi-rads iii & iv)
5202134|NCT00816517|Psoriasis|psoriasis
5202135|NCT00816517|Botulinum toxin|botulinum toxin
5202137|NCT00816504|Permeability factor|permeability factor
5202138|NCT00816504|Galactose|galactose
5202139|NCT00816504|Primary FSGS, resistant to immunosuppressive medication|primary fsgs, resistant to immunosuppressive medication
5202140|NCT00816491|patient with long-standing UC|patient with long-standing uc
5202141|NCT00816478|FSGS|fsgs
5202142|NCT00816478|Permeability factor|permeability factor
5202143|NCT00816478|Galactose|galactose
5202144|NCT00816478|Primary FSGS, resistant to immunosuppressive medication|primary fsgs, resistant to immunosuppressive medication
5202145|NCT00816465|Hoodia gordoni|hoodia gordoni
5202146|NCT00816465|NASH|nash
5202147|NCT00816465|NAFLD|nafld
5202148|NCT00816452|Osteoporosis|osteoporosis
5202149|NCT00816452|Prostate Cancer|prostate cancer
5202150|NCT00816452|Osteoporosis in male with Prostate Cancer|osteoporosis in male with prostate cancer
5202151|NCT00816439|Positron Emission Tomography|positron emission tomography
5202152|NCT00816439|Brain Imaging|brain imaging
5202153|NCT00816439|Alcoholism|alcoholism
5202154|NCT00816426|Tuberculosis|tuberculosis
5202155|NCT00816426|Lesions|lesions
5202156|NCT00816426|Pharmacokinetics|pharmacokinetics
5202157|NCT00816426|Maldistribution|maldistribution
5202158|NCT00816426|Histopathology|histopathology
5202159|NCT00816413|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5202160|NCT00816413|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5202161|NCT00816413|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5202162|NCT00816413|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5202163|NCT00816413|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5202164|NCT00816413|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5202165|NCT00816413|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5202166|NCT00816413|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5202167|NCT00816413|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5202168|NCT00816413|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5202169|NCT00816413|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5202170|NCT00816413|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5202171|NCT00816413|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5202172|NCT00816413|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5202173|NCT00816413|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5202174|NCT00816413|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5202175|NCT00816413|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5202176|NCT00816413|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5202177|NCT00816413|essential thrombocythemia|essential thrombocythemia
5202178|NCT00816413|polycythemia vera|polycythemia vera
5202179|NCT00816413|primary myelofibrosis|primary myelofibrosis
5202180|NCT00816413|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5202181|NCT00816413|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5202182|NCT00816413|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5202183|NCT00816413|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5202184|NCT00816413|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5202185|NCT00816413|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5202186|NCT00816413|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5202187|NCT00816413|aplastic anemia|aplastic anemia
5202188|NCT00816413|chronic eosinophilic leukemia|chronic eosinophilic leukemia
5202189|NCT00816413|chronic neutrophilic leukemia|chronic neutrophilic leukemia
5202190|NCT00816413|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
5202191|NCT00816413|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
5202192|NCT00816413|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
5202193|NCT00816413|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5202194|NCT00816413|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5202195|NCT00816413|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
5202196|NCT00816413|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
5202197|NCT00816413|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5202198|NCT00816413|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5202199|NCT00816413|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
5202200|NCT00816413|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
5202201|NCT00816413|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5202202|NCT00816413|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5202203|NCT00816413|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5202204|NCT00816413|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5202205|NCT00816413|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
5202206|NCT00816413|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
5202207|NCT00816413|stage I marginal zone lymphoma|stage i marginal zone lymphoma
5202208|NCT00816413|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5202209|NCT00816413|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5202210|NCT00816413|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
5202211|NCT00816413|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
5202212|NCT00816413|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
5202213|NCT00816413|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5202214|NCT00816413|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5202215|NCT00816413|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
5202216|NCT00816413|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5202217|NCT00816413|stage I mantle cell lymphoma|stage i mantle cell lymphoma
5202218|NCT00816413|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
5202219|NCT00816413|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
5202220|NCT00816413|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
5202221|NCT00816413|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
5202222|NCT00816413|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
5202223|NCT00816413|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5202224|NCT00816413|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5202225|NCT00816374|cutaneous malignant melanoma|cutaneous malignant melanoma
5202226|NCT00816374|CMM|cmm
5202227|NCT00816374|total cutaneous examination|total cutaneous examination
5202228|NCT00816374|TCE|tce
5202229|NCT00816374|skin self-examination|skin self-examination
5202230|NCT00816374|SSE|sse
5202231|NCT00816374|first degree relatives|first degree relatives
5202232|NCT00816374|FDR|fdr
5202233|NCT00816374|skin cancer protection|skin cancer protection
5202234|NCT00816374|skin cancer screening|skin cancer screening
5202235|NCT00816348|Cholestasis|cholestasis
5202236|NCT00816348|Parenteral Nutrition Associated Liver Disease|parenteral nutrition associated liver disease
5202237|NCT00816335|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5202238|NCT00816309|physiotherapy|physiotherapy
5202239|NCT00816309|bronchiectasis|bronchiectasis
5202240|NCT00816296|NAFLD|nafld
5202241|NCT00816296|Obesity|obesity
5202242|NCT00816296|Microbiome|microbiome
5202243|NCT00816283|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5202244|NCT00816283|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5202245|NCT00816283|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5202246|NCT00816283|Philadelphia chromosome positive adult precursor acute lymphoblastic leukemia|philadelphia chromosome positive adult precursor acute lymphoblastic leukemia
5202247|NCT00816283|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5202248|NCT00816283|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
5202249|NCT00816270|Blepharoptosis|blepharoptosis
5202250|NCT00816270|Dermatochalasis|dermatochalasis
5202251|NCT00816270|octyl 2-cyanoacrylate|octyl 2-cyanoacrylate
5202252|NCT00816270|Suture Techniques|suture techniques
5202253|NCT00816270|Tissue Adhesive|tissue adhesive
5202254|NCT00816257|lung tissue repository|lung tissue repository
5202255|NCT00816244|Breast cancer|breast cancer
5202256|NCT00816244|Postmenopausal|postmenopausal
5202257|NCT00816244|Neo-adjuvant|neo-adjuvant
5202258|NCT00816244|Tumor proliferation|tumor proliferation
5202259|NCT00816244|Statin|statin
5202260|NCT00816244|Atorvastatin|atorvastatin
5202261|NCT00816244|Ki67|ki67
5202262|NCT00816244|Translational research|translational research
5202263|NCT00816244|Cell cycle regulators|cell cycle regulators
5202264|NCT00816244|Gene expression|gene expression
5202265|NCT00816244|Genomic profiling|genomic profiling
5202266|NCT00816244|Apoptosis|apoptosis
5202267|NCT00816244|Window-of-opportunity|window-of-opportunity
5202268|NCT00816231|Prevention Intervention|prevention intervention
5202269|NCT00816231|Alcohol|alcohol
5202270|NCT00816231|Tobacco|tobacco
5202271|NCT00816231|Nicotine|nicotine
5202272|NCT00816231|Craving|craving
5202273|NCT00816231|Cue Reactivity|cue reactivity
5202274|NCT00816231|Cross Cue Reactions|cross cue reactions
5202275|NCT00816192|FA|fa
5202276|NCT00816192|Atrial fibrillation|atrial fibrillation
5202277|NCT00816192|Catheter|catheter
5202280|NCT00816179|Pancreatic head mass|pancreatic head mass
5202281|NCT00816179|Pancreatic cancer|pancreatic cancer
5202282|NCT00816179|NOTES|notes
5202283|NCT00816179|Endoscopic peritoneoscopy|endoscopic peritoneoscopy
5202284|NCT00816179|Whipple|whipple
5202285|NCT00816179|palliative gastrojejunostomy|palliative gastrojejunostomy
5202286|NCT00816166|Ischemic stroke|ischemic stroke
5202287|NCT00816166|Transient Ischemic Attack|transient ischemic attack
5202288|NCT00816166|Intracranial Stenting|intracranial stenting
5202289|NCT00816153|Pleth variability Index|pleth variability index
5202290|NCT00816153|Fluid management|fluid management
5202291|NCT00816153|Fluid management during surgery|fluid management during surgery
5202292|NCT00816140|Helicobacter pylori|helicobacter pylori
5202293|NCT00816140|levofloxacin|levofloxacin
5202294|NCT00816140|clarithromycin|clarithromycin
5202295|NCT00816140|ERADICATION RATE|eradication rate
5202296|NCT00816127|liver cirrhosis|liver cirrhosis
5202297|NCT00816127|coagulopathy|coagulopathy
5202298|NCT00816127|desmopressin|desmopressin
5202299|NCT00816127|blood transfusion|blood transfusion
5202300|NCT00816114|Imatinib|imatinib
5202301|NCT00816114|Gleevec|gleevec
5202302|NCT00816114|Chronic Myelogenous Leukemia|chronic myelogenous leukemia
5202303|NCT00816114|CML|cml
5202304|NCT00816101|Curettage and electrodesiccation|curettage and electrodesiccation
5202305|NCT00816101|acute wounds|acute wounds
5202306|NCT00816101|partial thickness wounds|partial thickness wounds
5202307|NCT00816088|chemotherapy|chemotherapy
5202308|NCT00816088|Stem cell transplantation|stem cell transplantation
5202309|NCT00816075|distilled water|distilled water
5202310|NCT00816075|recurrent|recurrent
5202311|NCT00816075|bladder|bladder
5202312|NCT00816075|mitomycin|mitomycin
5202313|NCT00816062|Aortic Aneurysm|aortic aneurysm
5202314|NCT00816062|Aneurysm|aneurysm
5202315|NCT00816062|Abdominal Aortic Aneurysm|abdominal aortic aneurysm
5202316|NCT00816062|Talent|talent
5202317|NCT00816062|Medtronic|medtronic
5202318|NCT00816049|acute lymphoblastic leukemia|acute lymphoblastic leukemia
5202319|NCT00816049|child|child
5202320|NCT00816049|6-mercaptopurine|6-mercaptopurine
5202321|NCT00816049|minimal residual disease|minimal residual disease
5202322|NCT00816049|efficacy|efficacy
5202323|NCT00816049|childhood acute lymphoblastic leukemia|childhood acute lymphoblastic leukemia
5202324|NCT00816036|Smoking Cessation|smoking cessation
5202325|NCT00816036|Practice Guidelines|practice guidelines
5202326|NCT00816036|Inpatient|inpatient
5202327|NCT00816036|Effectiveness Trial|effectiveness trial
5202328|NCT00816036|Veterans Administration|veterans administration
5202329|NCT00816036|Relapse prevention|relapse prevention
5202330|NCT00816010|drug compliance|drug compliance
5202331|NCT00816010|lifestyle modification|lifestyle modification
5202332|NCT00815997|radial artery|radial artery
5202333|NCT00815997|transradial intervention|transradial intervention
5202334|NCT00815997|stent|stent
5202335|NCT00815984|Asthma|asthma
5202336|NCT00815984|Allergic Rhinitis|allergic rhinitis
5202337|NCT00815984|Atopic Dermatitis|atopic dermatitis
5202338|NCT00815984|Children|children
5202339|NCT00815984|lung function|lung function
5202340|NCT00815984|skin prick tests|skin prick tests
5202341|NCT00815984|FeNO|feno
5202342|NCT00815971|EGFR mutations|egfr mutations
5202343|NCT00815971|EGFR inhibitor|egfr inhibitor
5202344|NCT00815971|erlotinib|erlotinib
5202345|NCT00815958|knee replacement surgery|knee replacement surgery
5202346|NCT00815958|Reamer-Irrigator-Aspirator|reamer-irrigator-aspirator
5202347|NCT00815958|femoral reaming|femoral reaming
5202348|NCT00815958|fat embolism|fat embolism
5202349|NCT00815945|leiomyosarcoma|leiomyosarcoma
5202350|NCT00815945|carcinosarcoma|carcinosarcoma
5202351|NCT00815945|mixed epithelial mesenchymal tumor|mixed epithelial mesenchymal tumor
5202352|NCT00815945|endometrial stroma sarcomas|endometrial stroma sarcomas
5202353|NCT00815945|Müllerian mixed tumors|müllerian mixed tumors
5202354|NCT00815945|carcinosarcoma of the uterus|carcinosarcoma of the uterus
5202355|NCT00815945|mesenchymal tumors of the ovary or uterus|mesenchymal tumors of the ovary or uterus
5202356|NCT00815945|mixed epithelial mesenchymal tumors of the ovary or uterus|mixed epithelial mesenchymal tumors of the ovary or uterus
5202357|NCT00815919|cGVHD|cgvhd
5202358|NCT00815919|Velcade|velcade
5202359|NCT00815919|bortezomib|bortezomib
5202360|NCT00815893|Dexmedetomidine|dexmedetomidine
5202361|NCT00815893|Fiberoptic nasal intubation|fiberoptic nasal intubation
5202362|NCT00815893|satisfaction|satisfaction
5202363|NCT00815880|Heart Failure|heart failure
5202364|NCT00815880|Device|device
5202365|NCT00815880|Implantable|implantable
5202366|NCT00815880|Active|active
5202367|NCT00815880|Class III and Class IV|class iii and class iv
5202368|NCT00815880|Counterpulsation|counterpulsation
5202369|NCT00815867|kidney failure|kidney failure
5202370|NCT00815867|kidney transplant|kidney transplant
5202371|NCT00815867|graft function|graft function
5202372|NCT00815867|haemoglobin|haemoglobin
5202373|NCT00815867|epoetin|epoetin
5202374|NCT00815854|Antipsychotic|antipsychotic
5202375|NCT00815854|Metabolic Syndrome|metabolic syndrome
5202376|NCT00815854|Insulin Resistance|insulin resistance
5202377|NCT00815854|Endothelial Function|endothelial function
5202470|NCT00815464|Therapeutics|therapeutics
5202378|NCT00815841|Determine the effect of MPH on a diagnostic continuous performance task that assesses attention and on a decision making test in young healthy adults|determine the effect of mph on a diagnostic continuous performance task that assesses attention and on a decision making test in young healthy adults
5202379|NCT00815828|Gestational Diabetes|gestational diabetes
5202380|NCT00815828|Resistance Exercise|resistance exercise
5202381|NCT00815828|Pregnancy|pregnancy
5202382|NCT00815828|Insulin|insulin
5202383|NCT00815815|Anorexia Nervosa|anorexia nervosa
5202384|NCT00815802|Children in day care centers|children in day care centers
5202385|NCT00815802|cytomegalovirus excretion|cytomegalovirus excretion
5202386|NCT00815776|Temporomandibular disorders|temporomandibular disorders
5202387|NCT00815763|randomized trial|randomized trial
5202388|NCT00815763|ischemic stroke|ischemic stroke
5202389|NCT00815763|Ginsenoside-Rd|ginsenoside-rd
5202390|NCT00815750|Prostate Cancer|prostate cancer
5202391|NCT00815737|Lung Infection After Cerebral Hemorrhage|lung infection after cerebral hemorrhage
5202392|NCT00815737|Prevention of Pneumonia|prevention of pneumonia
5202393|NCT00815737|Rhubarb|rhubarb
5202394|NCT00815724|Daily Inhaled Corticosteroids|daily inhaled corticosteroids
5202395|NCT00815724|Distributed Learning|distributed learning
5202396|NCT00815724|E-learning|e-learning
5202397|NCT00815711|IPF|ipf
5202398|NCT00815698|pain|pain
5202399|NCT00815685|n-3 fatty acids|n-3 fatty acids
5202400|NCT00815685|nutritional treatment|nutritional treatment
5202401|NCT00815685|molecular pathogenesis|molecular pathogenesis
5202402|NCT00815672|Exercise|exercise
5202403|NCT00815672|Prostate cancer|prostate cancer
5202404|NCT00815672|Fatigue|fatigue
5202405|NCT00815659|plasma lipid profile|plasma lipid profile
5202406|NCT00815659|metabolic syndrome|metabolic syndrome
5202407|NCT00815646|Immersion pulmonary edema|immersion pulmonary edema
5202408|NCT00815646|Diving|diving
5202409|NCT00815646|Swimming|swimming
5202410|NCT00815646|Pulmonary edema|pulmonary edema
5202411|NCT00815646|Cold water immersion|cold water immersion
5202412|NCT00815633|PRP|prp
5202413|NCT00815633|Pityriasis Rubra Pilaris|pityriasis rubra pilaris
5202414|NCT00815633|Amevive|amevive
5202415|NCT00815633|Alefacept|alefacept
5202416|NCT00815633|Biologic|biologic
5202417|NCT00815633|Immunosuppressant|immunosuppressant
5202418|NCT00815633|Severe skin disease|severe skin disease
5202419|NCT00815620|neuroendocrine tumors|neuroendocrine tumors
5202420|NCT00815620|transcatheter arterial chemoembolization|transcatheter arterial chemoembolization
5202421|NCT00815620|selective internal radiotherapy|selective internal radiotherapy
5202422|NCT00815620|surgery|surgery
5202423|NCT00815620|radio-frequency ablation|radio-frequency ablation
5202424|NCT00815620|peptide-receptor radiotherapy|peptide-receptor radiotherapy
5202425|NCT00815620|progression-free survival|progression-free survival
5202426|NCT00815620|quality of life|quality of life
5202427|NCT00815620|overall survival|overall survival
5202428|NCT00815620|weight|weight
5202429|NCT00815620|time of hospitalization|time of hospitalization
5202430|NCT00815607|melanoma|melanoma
5202431|NCT00815607|biologic|biologic
5202432|NCT00815607|immunotherapy|immunotherapy
5202433|NCT00815607|cancer|cancer
5202434|NCT00815594|bleb|bleb
5202435|NCT00815594|vascular change|vascular change
5202436|NCT00815594|bevacizumab|bevacizumab
5202437|NCT00815594|trabeculectomy|trabeculectomy
5202438|NCT00815594|Bleb vascularity associated with increased scarring activity|bleb vascularity associated with increased scarring activity
5202439|NCT00815594|Conjunctival scarring finally leads to the obstruction of the fistula tract created by the filtering surgery|conjunctival scarring finally leads to the obstruction of the fistula tract created by the filtering surgery
5202440|NCT00815594|the recombinant human anti-VEGF antibody could inhibit angiogenesis of conjunctiva.|the recombinant human anti-vegf antibody could inhibit angiogenesis of conjunctiva.
5202441|NCT00815581|children between 1 to 10 years old|children between 1 to 10 years old
5202442|NCT00815581|amblyopy|amblyopy
5202443|NCT00815568|fludarabine|fludarabine
5202444|NCT00815568|busulfan|busulfan
5202445|NCT00815568|total body irradiation|total body irradiation
5202446|NCT00815568|conditioning regimen|conditioning regimen
5202447|NCT00815555|receptor positive breast cancer|receptor positive breast cancer
5202448|NCT00815555|Tamoxifen treatment|tamoxifen treatment
5202449|NCT00815555|CYP2D6 status|cyp2d6 status
5202450|NCT00815555|relapse|relapse
5202451|NCT00815529|Acupuncture|acupuncture
5202452|NCT00815529|Chronic low back pain|chronic low back pain
5202453|NCT00815529|Qualitative study|qualitative study
5202454|NCT00815516|candidiasis|candidiasis
5202455|NCT00815516|candida|candida
5202456|NCT00815516|Neonate|neonate
5202457|NCT00815516|candidemia|candidemia
5202458|NCT00815516|Micafungin|micafungin
5202459|NCT00815516|Mycamine|mycamine
5202460|NCT00815516|amphotericin B deoxycholate|amphotericin b deoxycholate
5202461|NCT00815503|Anesthetics|anesthetics
5202462|NCT00815503|Local infiltration|local infiltration
5202463|NCT00815503|Periacetabular osteotomy|periacetabular osteotomy
5202464|NCT00815490|Spectroscopy, near infrared|spectroscopy, near infrared
5202465|NCT00815490|Oximetry|oximetry
5202466|NCT00815490|Hypoxemia|hypoxemia
5202467|NCT00815490|Tissue oxygenation|tissue oxygenation
5202468|NCT00815464|Chronic Hepatitis B|chronic hepatitis b
5202469|NCT00815464|Liquid Acupuncture(Herb Acupoint Injection)|liquid acupuncture(herb acupoint injection)
5202472|NCT00815464|Acupoint|acupoint
5202473|NCT00815438|Transvaginal|transvaginal
5202474|NCT00815438|Cholecystectomy|cholecystectomy
5202475|NCT00815438|NOTES|notes
5202476|NCT00815438|Endoscopic|endoscopic
5202477|NCT00815425|African American|african american
5202478|NCT00815386|mitral valve|mitral valve
5202479|NCT00815386|heart failure|heart failure
5202480|NCT00815386|mitral regurgitation|mitral regurgitation
5202481|NCT00815386|annuloplasty|annuloplasty
5202482|NCT00815386|coronary sinus|coronary sinus
5202483|NCT00815373|Ocular Blood flow|ocular blood flow
5202484|NCT00815373|Ocular hypertension|ocular hypertension
5202485|NCT00815373|POAG|poag
5202486|NCT00815373|Ocular hemodynamics|ocular hemodynamics
5202487|NCT00815373|Xalacom|xalacom
5202488|NCT00815373|Cosopt|cosopt
5202489|NCT00815360|diabetic macular edema|diabetic macular edema
5202490|NCT00815347|Asthma|asthma
5202491|NCT00815334|vesicoureteral reflux|vesicoureteral reflux
5202492|NCT00815334|low compliant bladder|low compliant bladder
5202493|NCT00815321|chronic myeloid leukemia|chronic myeloid leukemia
5202494|NCT00815321|autologous cytokine induced killer cells|autologous cytokine induced killer cells
5202495|NCT00815321|Chronic myeloid leukemia in blast crisis treated with chemotherapy or kinase inhibitors|chronic myeloid leukemia in blast crisis treated with chemotherapy or kinase inhibitors
5202496|NCT00815321|Chronic myeloid leukemia with mutation resistant to kinase inhibitors|chronic myeloid leukemia with mutation resistant to kinase inhibitors
5202497|NCT00815321|chronic myeloid leukemia with good response to kinase inhibitor and stable persistence of residual disease|chronic myeloid leukemia with good response to kinase inhibitor and stable persistence of residual disease
5202498|NCT00815308|Therapeutic|therapeutic
5202499|NCT00815308|Drug Therapy, combination|drug therapy, combination
5202500|NCT00815308|Radiotherapy|radiotherapy
5202501|NCT00815295|squamous cell cancer, head and neck|squamous cell cancer, head and neck
5202502|NCT00815269|Inhalant anesthetic|inhalant anesthetic
5202503|NCT00815269|Vasodilation|vasodilation
5202504|NCT00815269|General anesthesia|general anesthesia
5202505|NCT00815269|Ultrasonography|ultrasonography
5202506|NCT00815256|Cornea degeneration|cornea degeneration
5202507|NCT00815256|keratoconus|keratoconus
5202508|NCT00815256|collagen cross linking|collagen cross linking
5202509|NCT00815256|CXL|cxl
5202510|NCT00815256|Riboflavin|riboflavin
5202511|NCT00815243|fracture|fracture
5202512|NCT00815243|coxarthrosis|coxarthrosis
5202513|NCT00815243|complication|complication
5202514|NCT00815243|congenital abnormalities|congenital abnormalities
5202515|NCT00815243|bone|bone
5202516|NCT00815243|joint|joint
5202517|NCT00815243|telemedicine|telemedicine
5202518|NCT00815243|transportation|transportation
5202519|NCT00815243|decision making|decision making
5202520|NCT00815243|outcomes|outcomes
5202521|NCT00815230|radiation injury|radiation injury
5202522|NCT00815230|computed tomography|computed tomography
5202523|NCT00815230|reactive oxygen species|reactive oxygen species
5202524|NCT00815230|free radicals|free radicals
5202525|NCT00815217|Lipoaspirate|lipoaspirate
5202526|NCT00815217|Diabetes Mellitus|diabetes mellitus
5202527|NCT00815217|Mesenchymal Stem cells|mesenchymal stem cells
5202528|NCT00815217|Fat grafts|fat grafts
5202529|NCT00815217|venous stasis|venous stasis
5202530|NCT00815204|PTSD|ptsd
5202531|NCT00815204|HPA axis|hpa axis
5202532|NCT00815204|Pituitary volume|pituitary volume
5202533|NCT00815191|temperature|temperature
5202534|NCT00815191|surgery|surgery
5202535|NCT00815191|heating device|heating device
5202536|NCT00815178|inspiratory muscle weakness|inspiratory muscle weakness
5202537|NCT00815178|autonomic modulation|autonomic modulation
5202538|NCT00815178|diabetes mellitus|diabetes mellitus
5202539|NCT00815178|heart rate variability|heart rate variability
5202540|NCT00815178|functional capacity|functional capacity
5202541|NCT00815165|cytomegalovirus, CMV, cell-mediated immunity, children, sub-study|cytomegalovirus, cmv, cell-mediated immunity, children, sub-study
5202542|NCT00815152|high grade glioma|high grade glioma
5202543|NCT00815152|Coping skills intervention|coping skills intervention
5202544|NCT00815152|caregivers|caregivers
5202545|NCT00815139|Coronary artery disease, stent|coronary artery disease, stent
5202546|NCT00815113|Gastric cancer|gastric cancer
5202547|NCT00815113|screening|screening
5202548|NCT00815113|high-risk|high-risk
5202549|NCT00815113|relatives|relatives
5202550|NCT00815113|gastroscopy|gastroscopy
5202551|NCT00815100|Ivabradine|ivabradine
5202552|NCT00815100|Acute coronary syndrome.|acute coronary syndrome.
5202553|NCT00815100|Inflammation|inflammation
5202554|NCT00815100|C-reactive protein|c-reactive protein
5202555|NCT00815100|Atherosclerosis|atherosclerosis
5202556|NCT00815087|Nasopharyngeal carcinoma|nasopharyngeal carcinoma
5202557|NCT00815087|functional electrical stimulation|functional electrical stimulation
5202558|NCT00815074|Military Women|military women
5202559|NCT00815074|Women's Health|women's health
5202560|NCT00815074|Genitourinary Symptoms|genitourinary symptoms
5202561|NCT00815074|Illness Behaviors|illness behaviors
5202562|NCT00815074|To determine how women manage genitourinary symptoms while deployed.|to determine how women manage genitourinary symptoms while deployed.
5202563|NCT00815061|prevalence|prevalence
5202564|NCT00815061|Incidence|incidence
5202565|NCT00815061|crohn's disease|crohn's disease
5202566|NCT00815061|ulcerative colitis|ulcerative colitis
5202567|NCT00815061|Epidemiology|epidemiology
5202568|NCT00815048|Remifentanil|remifentanil
5202569|NCT00815048|Endotracheal intubation|endotracheal intubation
5202570|NCT00815048|Premedication|premedication
5202571|NCT00815048|Sedation|sedation
5202572|NCT00815048|Endotracheal Intubation in Neonates|endotracheal intubation in neonates
5202573|NCT00815035|Peanut Allergy|peanut allergy
5202574|NCT00815022|Temperature|temperature
5202575|NCT00815022|Spinal anesthesia|spinal anesthesia
5202576|NCT00815022|Cesarean section|cesarean section
5202577|NCT00815022|Cephalad sensory blockade|cephalad sensory blockade
5202578|NCT00815022|Regional anesthesia|regional anesthesia
5202579|NCT00815009|NAFLD|nafld
5202580|NCT00815009|NASH|nash
5202581|NCT00814983|myeloablative|myeloablative
5202582|NCT00814983|stem cell|stem cell
5202583|NCT00814983|naive T-cell depleted|naive t-cell depleted
5202584|NCT00814983|allogeneic|allogeneic
5202585|NCT00814970|PAD|pad
5202586|NCT00814970|peripheral arterial disease|peripheral arterial disease
5202587|NCT00814970|stent|stent
5202588|NCT00814970|SFA|sfa
5202589|NCT00814970|PPA|ppa
5202590|NCT00814957|positron emission tomography|positron emission tomography
5202591|NCT00814957|addiction|addiction
5202592|NCT00814944|dry eye|dry eye
5202593|NCT00814944|sirolimus|sirolimus
5202594|NCT00814944|rapamycin|rapamycin
5202595|NCT00814918|acne vulgaris|acne vulgaris
5202596|NCT00814918|acne|acne
5202597|NCT00814918|dermatalogy|dermatalogy
5202598|NCT00814905|chorioamnionitis|chorioamnionitis
5202599|NCT00814905|antibiotics|antibiotics
5202600|NCT00814905|cesarean|cesarean
5202601|NCT00814905|vaginal delivery|vaginal delivery
5202602|NCT00814892|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5202603|NCT00814892|recurrent prostate cancer|recurrent prostate cancer
5202604|NCT00814892|stage I prostate cancer|stage i prostate cancer
5202605|NCT00814892|stage IIB prostate cancer|stage iib prostate cancer
5202606|NCT00814892|stage IIA prostate cancer|stage iia prostate cancer
5202607|NCT00814892|stage III prostate cancer|stage iii prostate cancer
5202608|NCT00814892|stage IV prostate cancer|stage iv prostate cancer
5202609|NCT00814879|Acquired Immune Deficiency Syndrome|acquired immune deficiency syndrome
5202610|NCT00814879|AIDS|aids
5202611|NCT00814879|Anti-Infective Agents|anti-infective agents
5202612|NCT00814879|Antiretroviral|antiretroviral
5202613|NCT00814879|Antiviral Agents|antiviral agents
5202614|NCT00814879|Atazanavir|atazanavir
5202615|NCT00814879|Human Immunodeficiency Virus|human immunodeficiency virus
5202616|NCT00814879|HIV|hiv
5202617|NCT00814879|HIV Protease Inhibitors|hiv protease inhibitors
5202618|NCT00814879|NRTI|nrti
5202619|NCT00814879|Nucleoside Reverse Transcriptase Inhibitors|nucleoside reverse transcriptase inhibitors
5202620|NCT00814879|Raltegravir|raltegravir
5202621|NCT00814879|Resistance|resistance
5202622|NCT00814879|treatment experienced|treatment experienced
5202623|NCT00814866|Rheumatoid arthritis|rheumatoid arthritis
5202624|NCT00814866|arthritis|arthritis
5202625|NCT00814866|osteoclasts|osteoclasts
5202626|NCT00814866|bone|bone
5202627|NCT00814853|Extubation|extubation
5202628|NCT00814853|testing|testing
5202629|NCT00814853|ventilator weaning|ventilator weaning
5202630|NCT00814853|Pediatric extubation|pediatric extubation
5202631|NCT00814840|Heart failure|heart failure
5202632|NCT00814840|Dyssynchrony|dyssynchrony
5202633|NCT00814840|Cardiac resynchronization|cardiac resynchronization
5202634|NCT00814840|Triple-site pacing|triple-site pacing
5202635|NCT00814827|Interferon-Gamma|interferon-gamma
5202636|NCT00814827|Autoantibodies|autoantibodies
5202637|NCT00814827|Mycobacteria|mycobacteria
5202638|NCT00814827|Opportunistic Infections|opportunistic infections
5202639|NCT00814827|Immunodeficiency|immunodeficiency
5202640|NCT00814801|Alzheimer's Disease|alzheimer's disease
5202641|NCT00814801|Cognitive dysfunction|cognitive dysfunction
5202642|NCT00814801|Dementia|dementia
5202643|NCT00814801|Galantamine|galantamine
5202644|NCT00814801|R113675|r113675
5202645|NCT00814788|stage IV prostate cancer|stage iv prostate cancer
5202646|NCT00814788|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5202647|NCT00814788|recurrent prostate cancer|recurrent prostate cancer
5202648|NCT00814775|Laryngeal mask|laryngeal mask
5202649|NCT00814775|Difficult intubation|difficult intubation
5202650|NCT00814762|immunogenicity|immunogenicity
5202651|NCT00814762|HIV|hiv
5202652|NCT00814762|reactogenicity|reactogenicity
5202653|NCT00814762|safety|safety
5202654|NCT00814762|vaccine|vaccine
5202655|NCT00814762|HIV Infections|hiv infections
5202656|NCT00814749|stress urinary incontinence|stress urinary incontinence
5202657|NCT00814749|urodynamics|urodynamics
5202658|NCT00814749|randomized clinical trial|randomized clinical trial
5202659|NCT00814749|surgery|surgery
5202660|NCT00814710|Pneumococcal disease|pneumococcal disease
5202661|NCT00814710|Pneumococcal vaccine|pneumococcal vaccine
5202662|NCT00814710|Safety|safety
5202663|NCT00814710|Primary vaccination|primary vaccination
5202664|NCT00814710|Immunogenicity|immunogenicity
5202665|NCT00814697|Alzheimer|alzheimer
5202666|NCT00814697|Language|language
5202667|NCT00814697|Treatment|treatment
5202668|NCT00814697|TMS|tms
5202669|NCT00814697|rTMS|rtms
5202670|NCT00814671|Tuberculosis|tuberculosis
5202671|NCT00814671|Pharmacokinetics|pharmacokinetics
5202672|NCT00814658|Dementia|dementia
5202673|NCT00814658|Mixed Dementia|mixed dementia
5202674|NCT00814658|Galantamine|galantamine
5202675|NCT00814658|Reminyl ER|reminyl er
5202676|NCT00814658|Nimodipine|nimodipine
5202677|NCT00814632|vulvodynia|vulvodynia
5202678|NCT00814632|pelvic pain|pelvic pain
5202679|NCT00814632|vulvar pain|vulvar pain
5202680|NCT00814619|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5202681|NCT00814619|stage III rectal cancer|stage iii rectal cancer
5202682|NCT00814619|stage II rectal cancer|stage ii rectal cancer
5202683|NCT00814606|genotype 1 hepatitis C|genotype 1 hepatitis c
5202684|NCT00814606|hepatitis C|hepatitis c
5202685|NCT00814606|HCV|hcv
5202686|NCT00814606|liver|liver
5202687|NCT00814593|adult giant cell glioblastoma|adult giant cell glioblastoma
5202688|NCT00814593|adult gliosarcoma|adult gliosarcoma
5202689|NCT00814593|adult glioblastoma|adult glioblastoma
5202690|NCT00814580|analgesia|analgesia
5202691|NCT00814580|postoperative pain|postoperative pain
5202692|NCT00814580|opioid|opioid
5202693|NCT00814580|rotator cuff repair|rotator cuff repair
5202694|NCT00814580|labral tear repair|labral tear repair
5202695|NCT00814580|Bankart procedure|bankart procedure
5202696|NCT00814580|oxycodone|oxycodone
5202697|NCT00814580|tapentadol|tapentadol
5202698|NCT00814580|arthroscopic shoulder surgery|arthroscopic shoulder surgery
5202699|NCT00814567|recurrent breast cancer|recurrent breast cancer
5202700|NCT00814567|stage IA breast cancer|stage ia breast cancer
5202701|NCT00814567|stage II breast cancer|stage ii breast cancer
5202702|NCT00814567|invasive ductal breast carcinoma|invasive ductal breast carcinoma
5202703|NCT00814567|invasive ductal breast carcinoma with predominant intraductal component|invasive ductal breast carcinoma with predominant intraductal component
5202704|NCT00814554|obesity|obesity
5202705|NCT00814554|nutrition|nutrition
5202706|NCT00814554|cluster randomized trial|cluster randomized trial
5202707|NCT00814554|high school|high school
5202708|NCT00814554|primary prevention|primary prevention
5202709|NCT00814541|refractory multiple myeloma|refractory multiple myeloma
5202710|NCT00814541|stage I multiple myeloma|stage i multiple myeloma
5202711|NCT00814541|stage II multiple myeloma|stage ii multiple myeloma
5202712|NCT00814541|stage III multiple myeloma|stage iii multiple myeloma
5202713|NCT00814528|actinic keratosis|actinic keratosis
5202714|NCT00814528|skin lesions|skin lesions
5202715|NCT00814528|5-ALA|5-ala
5202716|NCT00814528|AK|ak
5202717|NCT00814528|Blu-Light|blu-light
5202718|NCT00814515|Moderate|moderate
5202719|NCT00814515|Severe|severe
5202720|NCT00814515|Dry|dry
5202721|NCT00814515|Eye|eye
5202722|NCT00814515|Ciclosporin|ciclosporin
5202723|NCT00814515|Cyclosporine|cyclosporine
5202724|NCT00814502|Alzheimer disease|alzheimer disease
5202725|NCT00814502|Dementia, vascular|dementia, vascular
5202726|NCT00814502|Actigraphy|actigraphy
5202727|NCT00814502|Circadian dysregulation|circadian dysregulation
5202728|NCT00814502|Sleep Disorders|sleep disorders
5202729|NCT00814502|Circadian rhythm|circadian rhythm
5202730|NCT00814489|Non-typable Haemophilus influenzae|non-typable haemophilus influenzae
5202731|NCT00814489|protein vaccine|protein vaccine
5202732|NCT00814489|Streptococcus pneumoniae|streptococcus pneumoniae
5202733|NCT00814489|young adults|young adults
5202734|NCT00814476|Medtronic CareLink|medtronic carelink
5202735|NCT00814476|therapy management|therapy management
5202736|NCT00814476|diabetes|diabetes
5202737|NCT00814476|insulin pump|insulin pump
5202738|NCT00814476|Blood glucose monitor|blood glucose monitor
5202739|NCT00814463|tumors metastatic to brain|tumors metastatic to brain
5202740|NCT00814463|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5202741|NCT00814450|Biopsy|biopsy
5202742|NCT00814450|Fine needle aspiration|fine needle aspiration
5202743|NCT00814424|EtCO2|etco2
5202744|NCT00814424|supplemental oxygen delivery|supplemental oxygen delivery
5202745|NCT00814424|ERCP|ercp
5202746|NCT00814411|contraception|contraception
5202747|NCT00814411|noninferiority|noninferiority
5202748|NCT00814411|intention|intention
5202749|NCT00814411|family planning counseling|family planning counseling
5202750|NCT00814411|post abortion care|post abortion care
5202751|NCT00814411|Family planning intention among women with unmet need|family planning intention among women with unmet need
5202752|NCT00814398|Infertility|infertility
5202753|NCT00814398|IVF|ivf
5202754|NCT00814398|SET|set
5202755|NCT00814398|DET|det
5202756|NCT00814398|Blastocyst|blastocyst
5202757|NCT00814359|mucositis|mucositis
5202758|NCT00814359|radiation|radiation
5202759|NCT00814359|magic mouthwash|magic mouthwash
5202760|NCT00814359|sucralfate|sucralfate
5202761|NCT00814359|benzydamine|benzydamine
5202762|NCT00814359|diphenhydramine|diphenhydramine
5202763|NCT00814359|dexamethasone|dexamethasone
5202764|NCT00814359|nystatin|nystatin
5202765|NCT00814346|Mild Alzheimer's disease (AD) patients|mild alzheimer's disease (ad) patients
5202766|NCT00814346|Memory complaint patients with cognitive impairment (MC)|memory complaint patients with cognitive impairment (mc)
5202767|NCT00814346|Memory complaint patients cognitively normal (CNE)|memory complaint patients cognitively normal (cne)
5202768|NCT00814333|epistaxis|epistaxis
5202769|NCT00814307|Antirheumatic Agents Clinical Trial|antirheumatic agents clinical trial
5202770|NCT00814294|Type 2|type 2
5202771|NCT00814281|particulate air pollution|particulate air pollution
5202772|NCT00814281|leukotriene|leukotriene
5202773|NCT00814281|asthma|asthma
5202774|NCT00814281|montelukast|montelukast
5202775|NCT00814281|vascular endothelial dysfunction|vascular endothelial dysfunction
5202776|NCT00814281|nitric oxide(NO)endothelin (ET) system|nitric oxide(no)endothelin (et) system
5202777|NCT00814255|Primary FSGS|primary fsgs
5202778|NCT00814255|Steroid Resistant|steroid resistant
5202779|NCT00814255|Rosiglitazone|rosiglitazone
5202780|NCT00814255|Adalimumab|adalimumab
5202781|NCT00814255|Resistant primary FSGS|resistant primary fsgs
5202782|NCT00814255|GALACTOSE|galactose
5202783|NCT00814242|Hepatocellular Carcinoma|hepatocellular carcinoma
5202784|NCT00814242|Adjacent to Major Blood Vessels|adjacent to major blood vessels
5202785|NCT00814242|Surgical resection|surgical resection
5202786|NCT00814242|Ppercutaneous radiationfrequency ablation|ppercutaneous radiationfrequency ablation
5202787|NCT00814242|Time to recurrence|time to recurrence
5202788|NCT00814242|Disease-free survival|disease-free survival
5202789|NCT00814242|Overall survival|overall survival
5202790|NCT00814229|influenza|influenza
5202791|NCT00814229|H9N2|h9n2
5202792|NCT00814229|vaccine|vaccine
5202793|NCT00814216|Efficacy|efficacy
5202794|NCT00814216|safety|safety
5202795|NCT00814216|QAV680|qav680
5202796|NCT00814216|pharmacokinetics|pharmacokinetics
5202797|NCT00814216|corticosteroid|corticosteroid
5202798|NCT00814216|asthma|asthma
5202799|NCT00814203|COPD|copd
5202800|NCT00814190|Type 2 Diabetes|type 2 diabetes
5202801|NCT00814190|Internet Therapeutic Intervention|internet therapeutic intervention
5202802|NCT00814177|warfarin|warfarin
5202803|NCT00814177|dosing|dosing
5202804|NCT00814177|prothrombin time|prothrombin time
5202805|NCT00814177|Heart valve prosthesis|heart valve prosthesis
5202806|NCT00814164|adult erythroleukemia (M6a)|adult erythroleukemia (m6a)
5202807|NCT00814164|adult pure erythroid leukemia (M6b)|adult pure erythroid leukemia (m6b)
5202808|NCT00814164|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
5202809|NCT00814164|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
5202810|NCT00814164|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
5202811|NCT00814164|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
5202812|NCT00814164|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
5202813|NCT00814164|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
5202814|NCT00814164|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
5202815|NCT00814164|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
5202816|NCT00814164|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5202817|NCT00814164|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5202818|NCT00814164|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5202819|NCT00814164|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5202820|NCT00814164|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5202821|NCT00814151|Blood culture|blood culture
5202822|NCT00814151|Staphylococcus aureus|staphylococcus aureus
5202823|NCT00814151|Bacteremia|bacteremia
5202824|NCT00814151|MRSA|mrsa
5202825|NCT00814151|MSSA|mssa
5202826|NCT00814151|MicroPhage|microphage
5202827|NCT00814138|myasthenia gravis|myasthenia gravis
5202828|NCT00814125|Endometrial|endometrial
5202829|NCT00814125|Endometrial histological findings|endometrial histological findings
5202830|NCT00814099|Acute Respiratory Failure|acute respiratory failure
5202831|NCT00814099|Acute Lung Injury|acute lung injury
5202832|NCT00814073|Mastocytosis with handicap|mastocytosis with handicap
5202833|NCT00814073|Mastocytosis|mastocytosis
5202834|NCT00814073|Smouldering systemic mastocytosis|smouldering systemic mastocytosis
5202835|NCT00814073|Indolent systemic mastocytosis|indolent systemic mastocytosis
5202836|NCT00814073|Cutaneous mastocytosis|cutaneous mastocytosis
5202837|NCT00814073|Mast cell|mast cell
5202838|NCT00814073|Mast cell infiltration|mast cell infiltration
5202839|NCT00814073|Skin|skin
5202840|NCT00814073|Bone marrow|bone marrow
5202841|NCT00814073|Pruritus|pruritus
5202842|NCT00814073|Flushes|flushes
5202843|NCT00814073|c-kit|c-kit
5202844|NCT00814073|c-kit mutation|c-kit mutation
5202845|NCT00814073|Wild Type|wild type
5202846|NCT00814073|Mutation Asp-816-Val(D816V)|mutation asp-816-val(d816v)
5202847|NCT00814047|ultrasonography|ultrasonography
5202848|NCT00814034|Aromatase Inhibitors|aromatase inhibitors
5202849|NCT00814034|Coagulation parameters|coagulation parameters
5202850|NCT00814034|Tamoxifen|tamoxifen
5202851|NCT00814021|recurrent renal cell cancer|recurrent renal cell cancer
5202852|NCT00814021|stage IV renal cell cancer|stage iv renal cell cancer
5202853|NCT00814021|tumors metastatic to brain|tumors metastatic to brain
5202854|NCT00813969|Mesenchymal Stem Cell|mesenchymal stem cell
5202855|NCT00813969|MSC|msc
5202856|NCT00813969|Autologous|autologous
5202857|NCT00813969|Multiple Sclerosis|multiple sclerosis
5202858|NCT00813956|triple negative breast cancer|triple negative breast cancer
5202859|NCT00813943|Newly diagnosed Glioblastoma (WHO Grade IV)|newly diagnosed glioblastoma (who grade iv)
5202860|NCT00813943|Cilengitide|cilengitide
5202861|NCT00813943|Temozolomide|temozolomide
5202862|NCT00813943|Radiotherapy|radiotherapy
5202863|NCT00813930|Diabetes|diabetes
5202864|NCT00813930|Lifestyle Intervention|lifestyle intervention
5202865|NCT00813930|Cardiovascular risk reduction|cardiovascular risk reduction
5202866|NCT00813891|ranibizumab|ranibizumab
5202867|NCT00813891|verteporfin|verteporfin
5202868|NCT00813878|breast cancer|breast cancer
5202869|NCT00813878|breast cancer in situ|breast cancer in situ
5202870|NCT00813865|Amicus Therapeutics|amicus therapeutics
5202871|NCT00813865|AT2101|at2101
5202872|NCT00813865|afegostat tartrate|afegostat tartrate
5202873|NCT00813865|isofagomine tartrate|isofagomine tartrate
5202874|NCT00813852|obstructive sleep apnea|obstructive sleep apnea
5202875|NCT00813852|skeletal muscle|skeletal muscle
5202876|NCT00813852|magnetic stimulation|magnetic stimulation
5202877|NCT00813852|magnetic resonance spectroscopy|magnetic resonance spectroscopy
5202878|NCT00813852|inflammatory markers|inflammatory markers
5202879|NCT00813852|exercise|exercise
5202880|NCT00813839|SmartCare|smartcare
5202881|NCT00813839|Spontaneous Breathing Trials|spontaneous breathing trials
5202882|NCT00813839|Mechanical Ventilation|mechanical ventilation
5202883|NCT00813839|Weaning|weaning
5202884|NCT00813839|Patients requiring prolonged mechanical ventilation (>72 hours)|patients requiring prolonged mechanical ventilation (>72 hours)
5202885|NCT00813826|PHN|phn
5202886|NCT00813826|Pain after Shingles|pain after shingles
5202887|NCT00813800|Smoking|smoking
5202888|NCT00813800|Bipolar Disorder|bipolar disorder
5202889|NCT00813800|Depression|depression
5202890|NCT00813787|Magnetic Resonance Imaging|magnetic resonance imaging
5202891|NCT00813787|Glioma|glioma
5202892|NCT00813774|Cimzia|cimzia
5202893|NCT00813774|certolizumab pegol|certolizumab pegol
5202894|NCT00813774|Bioavailability|bioavailability
5202895|NCT00813774|Healthy volunteers|healthy volunteers
5202896|NCT00813748|Asthma|asthma
5202897|NCT00813748|Anaphylaxis|anaphylaxis
5202898|NCT00813735|Insomnia|insomnia
5202899|NCT00813735|Major Depression|major depression
5202900|NCT00813735|Geriatric|geriatric
5202901|NCT00813722|adherence|adherence
5202902|NCT00813722|blood pressure|blood pressure
5202903|NCT00813722|hypertension|hypertension
5202904|NCT00813722|compliance|compliance
5202905|NCT00813722|atenolol|atenolol
5202906|NCT00813722|hydrochlorothiazide|hydrochlorothiazide
5202907|NCT00813722|amlodipine|amlodipine
5202908|NCT00813722|losartan|losartan
5202909|NCT00813709|Interferon 1-beta|interferon 1-beta
5202910|NCT00813709|Clinical Definite Multiple Sclerosis|clinical definite multiple sclerosis
5202911|NCT00813696|chemotherapy|chemotherapy
5202912|NCT00813696|advanced cancer|advanced cancer
5202913|NCT00813696|inoperable|inoperable
5202914|NCT00813696|Stage II, III, IV|stage ii, iii, iv
5202915|NCT00813683|Acupuncture, moxybustion,|acupuncture, moxybustion,
5202916|NCT00813683|Cephalic version,|cephalic version,
5202917|NCT00813683|Breech presentation|breech presentation
5202918|NCT00813631|Malignant fungating wound|malignant fungating wound
5202919|NCT00813631|Head and neck|head and neck
5202920|NCT00813631|Ionic silver-releasing dressing|ionic silver-releasing dressing
5202921|NCT00813631|Wound care|wound care
5202922|NCT00813631|RCT|rct
5202923|NCT00813618|Acute GvHD of at least Grade II severity|acute gvhd of at least grade ii severity
5202924|NCT00813605|AMG 655|amg 655
5202925|NCT00813605|AMG 479|amg 479
5202926|NCT00813605|Colon Cancer|colon cancer
5202927|NCT00813605|Rectal Cancer|rectal cancer
5202928|NCT00813605|Monoclonal Antibody|monoclonal antibody
5202929|NCT00813605|Clinical Trial|clinical trial
5202930|NCT00813605|Colorectal Cancer|colorectal cancer
5202931|NCT00813605|metastatic colorectal cancer|metastatic colorectal cancer
5202932|NCT00813605|metastatic cancer|metastatic cancer
5202933|NCT00813605|antibody-2nd line|antibody-2nd line
5202934|NCT00813605|KRAS|kras
5202935|NCT00813605|adenocarcinoma|adenocarcinoma
5202936|NCT00813592|meningioma|meningioma
5202937|NCT00813592|brain|brain
5202938|NCT00813579|assess the safety of living kidney donation|assess the safety of living kidney donation
5202939|NCT00813566|cancer|cancer
5202940|NCT00813566|imaging|imaging
5202941|NCT00813566|PET scanning|pet scanning
5202942|NCT00813553|physical fitness|physical fitness
5202943|NCT00813553|exercise|exercise
5202944|NCT00813553|amino acid|amino acid
5202945|NCT00813540|Colonic Neoplasms|colonic neoplasms
5202946|NCT00813540|Aerobic Exercise|aerobic exercise
5202947|NCT00813540|Weight Lifting|weight lifting
5202948|NCT00813540|Body Composition|body composition
5202949|NCT00813527|Drug Therapy|drug therapy
5202950|NCT00813527|Lipid Metabolism Disorders|lipid metabolism disorders
5202951|NCT00813527|Hyperlipidemias|hyperlipidemias
5202952|NCT00813527|Hypercholesterolemia|hypercholesterolemia
5202953|NCT00813527|Hypertriglyceridemia|hypertriglyceridemia
5202954|NCT00813514|AMD|amd
5202955|NCT00813514|VEGF genotyping|vegf genotyping
5202956|NCT00813514|complement H gene polymorphism|complement h gene polymorphism
5202957|NCT00813514|Vascular Endothelial Growth Factor A|vascular endothelial growth factor a
5202958|NCT00813501|graft versus host disease|graft versus host disease
5202959|NCT00813501|infection|infection
5202960|NCT00813501|therapy-related toxicity|therapy-related toxicity
5202961|NCT00813501|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5202962|NCT00813501|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5202963|NCT00813501|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5202964|NCT00813501|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5202965|NCT00813501|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5202966|NCT00813501|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5202967|NCT00813501|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5202968|NCT00813501|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5202969|NCT00813501|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5202970|NCT00813501|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5202971|NCT00813501|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5202972|NCT00813501|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5202973|NCT00813501|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5202974|NCT00813501|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5202975|NCT00813501|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5202976|NCT00813501|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5202977|NCT00813501|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5202978|NCT00813501|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5202979|NCT00813501|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5202980|NCT00813501|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5202981|NCT00813501|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5202982|NCT00813501|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5202983|NCT00813501|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5202984|NCT00813501|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5202985|NCT00813501|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5202986|NCT00813501|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5202987|NCT00813501|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5202988|NCT00813501|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5202989|NCT00813501|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5202990|NCT00813501|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5202991|NCT00813501|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5202992|NCT00813501|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5202993|NCT00813501|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5202994|NCT00813501|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5202995|NCT00813501|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5202996|NCT00813501|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5202997|NCT00813501|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5202998|NCT00813501|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5202999|NCT00813501|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5203000|NCT00813501|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5203001|NCT00813501|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5203002|NCT00813501|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5203003|NCT00813501|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5203004|NCT00813501|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5203005|NCT00813501|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
5203006|NCT00813501|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5203007|NCT00813501|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
5203008|NCT00813501|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
5203009|NCT00813501|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
5203010|NCT00813501|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
5203011|NCT00813501|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5203012|NCT00813501|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5203013|NCT00813501|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5203014|NCT00813501|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5203015|NCT00813501|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
5203016|NCT00813501|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
5203017|NCT00813501|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5203018|NCT00813501|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5203019|NCT00813501|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5203690|NCT00811044|diabetes|diabetes
5203020|NCT00813501|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5203021|NCT00813501|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5203022|NCT00813501|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5203023|NCT00813501|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5203024|NCT00813501|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5203025|NCT00813501|atypical chronic myeloid leukemia, BCR-ABL negative|atypical chronic myeloid leukemia, bcr-abl negative
5203026|NCT00813501|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5203027|NCT00813501|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5203028|NCT00813501|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5203029|NCT00813501|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5203030|NCT00813501|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5203031|NCT00813501|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5203032|NCT00813501|refractory hairy cell leukemia|refractory hairy cell leukemia
5203033|NCT00813501|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5203034|NCT00813501|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5203035|NCT00813501|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5203036|NCT00813501|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5203037|NCT00813501|chronic eosinophilic leukemia|chronic eosinophilic leukemia
5203038|NCT00813501|primary myelofibrosis|primary myelofibrosis
5203039|NCT00813501|chronic neutrophilic leukemia|chronic neutrophilic leukemia
5203040|NCT00813501|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5203041|NCT00813501|disseminated neuroblastoma|disseminated neuroblastoma
5203042|NCT00813501|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
5203043|NCT00813501|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5203044|NCT00813501|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5203045|NCT00813501|stage I multiple myeloma|stage i multiple myeloma
5203046|NCT00813501|stage II multiple myeloma|stage ii multiple myeloma
5203047|NCT00813501|stage III multiple myeloma|stage iii multiple myeloma
5203048|NCT00813501|refractory multiple myeloma|refractory multiple myeloma
5203049|NCT00813488|Breakthrough Pain|breakthrough pain
5203050|NCT00813488|Opioid-tolerant|opioid-tolerant
5203051|NCT00813488|Chronic Pain|chronic pain
5203052|NCT00813475|cardio vascular outcome|cardio vascular outcome
5203053|NCT00813449|Endostar|endostar
5203054|NCT00813449|advanced melanoma|advanced melanoma
5203055|NCT00813449|combined chemotherapy|combined chemotherapy
5203056|NCT00813436|ToM|tom
5203057|NCT00813436|Theory of Mind|theory of mind
5203058|NCT00813436|Simulation|simulation
5203059|NCT00813436|Empathy|empathy
5203060|NCT00813436|Oxytocin|oxytocin
5203061|NCT00813436|Schizophrenia|schizophrenia
5203062|NCT00813384|Cancer|cancer
5203063|NCT00813384|Solid Tumors|solid tumors
5203064|NCT00813384|Phase 1|phase 1
5203065|NCT00813384|C-met inhibitor|c-met inhibitor
5203066|NCT00813384|Clinical Trial|clinical trial
5203067|NCT00813371|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
5203068|NCT00813371|acute lung injury|acute lung injury
5203069|NCT00813371|Airway Pressure Release Ventilation|airway pressure release ventilation
5203070|NCT00813371|ARDSnet|ardsnet
5203071|NCT00813371|Bi-level|bi-level
5203072|NCT00813371|respiratory failure|respiratory failure
5203073|NCT00813371|trauma|trauma
5203074|NCT00813371|APRV|aprv
5203075|NCT00813358|Endovascular Aneurysm Repair|endovascular aneurysm repair
5203076|NCT00813358|Aortic Aneurysm|aortic aneurysm
5203077|NCT00813358|Thoracic|thoracic
5203078|NCT00813345|anesthesia propofol ambulatory rhythm|anesthesia propofol ambulatory rhythm
5203079|NCT00813332|Endostar|endostar
5203080|NCT00813332|NSCLC|nsclc
5203081|NCT00813332|Docetaxel|docetaxel
5203082|NCT00813332|Combined therapy|combined therapy
5203083|NCT00813332|second-line chemotherapy|second-line chemotherapy
5203084|NCT00813319|GARDASIL|gardasil
5203085|NCT00813319|HPV|hpv
5203086|NCT00813319|Vaccination|vaccination
5203087|NCT00813306|GERD|gerd
5203088|NCT00813306|TLESR|tlesr
5203089|NCT00813306|reflux|reflux
5203090|NCT00813293|Hepatocellular Cancer|hepatocellular cancer
5203091|NCT00813293|HCC|hcc
5203092|NCT00813293|Liver Cancer|liver cancer
5203093|NCT00813293|radiofrequency ablation|radiofrequency ablation
5203094|NCT00813293|RFA|rfa
5203095|NCT00813293|sorafenib|sorafenib
5203096|NCT00813293|nexavaar|nexavaar
5203097|NCT00813293|liver directed therapy|liver directed therapy
5203098|NCT00813293|interventional radiology|interventional radiology
5203099|NCT00813267|Mesenchymal Stem Cells|mesenchymal stem cells
5203100|NCT00813267|Osteonecrosis of the Femoral Head|osteonecrosis of the femoral head
5203101|NCT00813254|Platinum-Resistant Ovarian Cancer|platinum-resistant ovarian cancer
5203102|NCT00813254|Platinum-based chemotherapy|platinum-based chemotherapy
5203103|NCT00813254|Ovarian Cancer|ovarian cancer
5203104|NCT00813254|Ovary|ovary
5203105|NCT00813254|Epithelial ovarian cancer|epithelial ovarian cancer
5203106|NCT00813254|Quality of Life|quality of life
5203107|NCT00813254|Cost Utility Analysis|cost utility analysis
5203108|NCT00813254|Sexual functioning|sexual functioning
5203109|NCT00813254|Questionnaire|questionnaire
5203110|NCT00813254|Caregiver|caregiver
5203111|NCT00813241|Ankylosing spondylitis,Rheumatoid Arthritis,Adenomatous Polyposis Coli,Osteoarthritis,Dysmenorrhoea,pharmacokinetic study|ankylosing spondylitis,rheumatoid arthritis,adenomatous polyposis coli,osteoarthritis,dysmenorrhoea,pharmacokinetic study
5203112|NCT00813228|Immune Function|immune function
5203113|NCT00813228|DDP-4|ddp-4
5203114|NCT00813228|Sitagliptin|sitagliptin
5203115|NCT00813228|GLP-1|glp-1
5203116|NCT00813228|TGF Beta|tgf beta
5203117|NCT00813215|Type 2 diabetes mellitus|type 2 diabetes mellitus
5203118|NCT00813215|Postprandial dysmetabolism|postprandial dysmetabolism
5203119|NCT00813215|Postprandial inflammation|postprandial inflammation
5203120|NCT00813215|Relatives|relatives
5203121|NCT00813215|Meal challenge|meal challenge
5203122|NCT00813202|Nesiritide|nesiritide
5203123|NCT00813202|Natrecor|natrecor
5203124|NCT00813202|Quanke|quanke
5203125|NCT00813202|Acute Decompensated Heart Failure|acute decompensated heart failure
5203126|NCT00813189|glucocorticoid therapy|glucocorticoid therapy
5203127|NCT00813189|muscle function|muscle function
5203128|NCT00813189|growth hormone treatment|growth hormone treatment
5203129|NCT00813176|Obesity|obesity
5203130|NCT00813176|One-Lung Ventilation|one-lung ventilation
5203131|NCT00813176|Anesthesia|anesthesia
5203132|NCT00813176|Thoracic|thoracic
5203133|NCT00813176|One-lung ventilation in the morbidly obese patient|one-lung ventilation in the morbidly obese patient
5203134|NCT00813163|Phase II study|phase ii study
5203135|NCT00813163|Second line|second line
5203136|NCT00813163|Pancreatic cancer|pancreatic cancer
5203137|NCT00813163|Metastatic|metastatic
5203138|NCT00813150|Multiple myeloma|multiple myeloma
5203139|NCT00813150|Bortezomib|bortezomib
5203140|NCT00813150|Dexamethasone|dexamethasone
5203141|NCT00813150|Cyclophosphamide|cyclophosphamide
5203142|NCT00813150|Oncology|oncology
5203143|NCT00813137|Colorectal Cancer|colorectal cancer
5203144|NCT00813137|chemotherapy|chemotherapy
5203145|NCT00813137|recombinant human endostatin|recombinant human endostatin
5203146|NCT00813124|Chronic Myelogenous Leukemia|chronic myelogenous leukemia
5203147|NCT00813124|CML|cml
5203148|NCT00813124|Donor stem cell transplant|donor stem cell transplant
5203149|NCT00813124|Allogeneic stem cell transplantation|allogeneic stem cell transplantation
5203150|NCT00813124|Stem cell transplant|stem cell transplant
5203151|NCT00813124|ATG|atg
5203152|NCT00813124|Antithymocyte globulin|antithymocyte globulin
5203153|NCT00813124|Vidaza|vidaza
5203154|NCT00813124|Azacitidine|azacitidine
5203155|NCT00813124|5-Azacitidine|5-azacitidine
5203156|NCT00813124|5-Aza|5-aza
5203157|NCT00813124|5-AZC|5-azc
5203158|NCT00813124|Ladakamycin|ladakamycin
5203159|NCT00813124|NSC-102816|nsc-102816
5203160|NCT00813124|allotx|allotx
5203161|NCT00813124|Busulfan|busulfan
5203162|NCT00813124|Busulfex|busulfex
5203163|NCT00813124|Myleran|myleran
5203164|NCT00813124|Fludarabine|fludarabine
5203165|NCT00813124|Fludarabine Phosphate|fludarabine phosphate
5203166|NCT00813124|Tacrolimus|tacrolimus
5203167|NCT00813124|Methotrexate|methotrexate
5203168|NCT00813124|Azacitidine maintenance therapy|azacitidine maintenance therapy
5203169|NCT00813124|molecular remission|molecular remission
5203170|NCT00813124|HLA compatible donor|hla compatible donor
5203171|NCT00813124|Engraftment|engraftment
5203172|NCT00813124|Chimerism|chimerism
5203173|NCT00813124|Graft vs host disease|graft vs host disease
5203174|NCT00813124|GVHD|gvhd
5203175|NCT00813111|Postsurgical pain|postsurgical pain
5203176|NCT00813111|Analgesia|analgesia
5203177|NCT00813111|Breast augmentation|breast augmentation
5203178|NCT00813085|Diabetes|diabetes
5203179|NCT00813085|Computerized clinical decision support|computerized clinical decision support
5203180|NCT00813085|shared care|shared care
5203181|NCT00813085|patient self-monitoring|patient self-monitoring
5203182|NCT00813085|quality of care|quality of care
5203183|NCT00813085|complex interventions|complex interventions
5203184|NCT00813085|composite outcomes|composite outcomes
5203185|NCT00813072|Gastric Cancer|gastric cancer
5203186|NCT00813072|Stomach Cancer|stomach cancer
5203187|NCT00813072|Gastroesophageal|gastroesophageal
5203188|NCT00813072|Gastroesophageal Junction|gastroesophageal junction
5203189|NCT00813072|Esophageal Cancer|esophageal cancer
5203190|NCT00813072|phase II|phase ii
5203191|NCT00813072|PEP02|pep02
5203192|NCT00813072|randomization|randomization
5203193|NCT00813072|randomisation|randomisation
5203194|NCT00813072|adenocarcinoma|adenocarcinoma
5203195|NCT00813072|locally advanced|locally advanced
5203196|NCT00813072|metastatic|metastatic
5203197|NCT00813072|simon's two|simon's two
5203198|NCT00813059|NAION|naion
5203199|NCT00813059|bevacizumab|bevacizumab
5203200|NCT00813033|create a patient decision aid for endoscopy|create a patient decision aid for endoscopy
5203201|NCT00813033|evaluate efficacy of a patient decision aid for endoscopy|evaluate efficacy of a patient decision aid for endoscopy
5203202|NCT00813007|Cervical Cancer|cervical cancer
5203203|NCT00813007|Cervix|cervix
5203204|NCT00813007|Questionnaire|questionnaire
5203205|NCT00813007|Adenocarcinoma of uterine cervix|adenocarcinoma of uterine cervix
5203206|NCT00813007|Squamous cell carcinoma of uterine cervix|squamous cell carcinoma of uterine cervix
5203207|NCT00813007|Adenosquamous carcinoma of uterine cervix|adenosquamous carcinoma of uterine cervix
5203208|NCT00813007|Abdominal radical trachelectomy|abdominal radical trachelectomy
5203209|NCT00813007|Trachelectomy|trachelectomy
5203210|NCT00813007|Quality of life|quality of life
5203211|NCT00813007|Sexual functioning|sexual functioning
5203212|NCT00812994|Depression|depression
5203213|NCT00812994|BDNF|bdnf
5203214|NCT00812994|neurotrophic factor|neurotrophic factor
5203215|NCT00812994|neurosetroid|neurosetroid
5203216|NCT00812994|allopregnanolone|allopregnanolone
5203217|NCT00812981|Pandemic influenza|pandemic influenza
5203218|NCT00812968|Myelodysplastic Syndromes|myelodysplastic syndromes
5203219|NCT00812968|Lenalidomide|lenalidomide
5203220|NCT00812955|Dyslipidemia|dyslipidemia
5203221|NCT00812955|Hypercholesterolemia|hypercholesterolemia
5203222|NCT00812955|Hypertriglyceridemia|hypertriglyceridemia
5203223|NCT00812942|average-risk subjects for|average-risk subjects for
5203224|NCT00812929|Asthma, Exercise Induced Asthma, Exercise Induced Bronchospasm|asthma, exercise induced asthma, exercise induced bronchospasm
5203225|NCT00812916|Persistent or longstanding persistent atrial fibrillation|persistent or longstanding persistent atrial fibrillation
5203226|NCT00812903|Neck|neck
5203227|NCT00812903|Pain|pain
5203228|NCT00812903|Exercise|exercise
5203229|NCT00812903|Pilots|pilots
5203230|NCT00812903|Crew|crew
5203231|NCT00812877|pulp capping|pulp capping
5203232|NCT00812877|MTA|mta
5203233|NCT00812877|CaOH|caoh
5203234|NCT00812877|Mineral Trioxide Aggregate|mineral trioxide aggregate
5203235|NCT00812877|Calcium Hydroxide|calcium hydroxide
5203236|NCT00812864|Capecitabine|capecitabine
5203237|NCT00812864|pharmacocinetics|pharmacocinetics
5203238|NCT00812864|Breast metastatic cancer|breast metastatic cancer
5203239|NCT00812864|colorectal metastatic cancer|colorectal metastatic cancer
5203240|NCT00812864|Elderly patients|elderly patients
5203241|NCT00812851|ALS|als
5203242|NCT00812851|cramps|cramps
5203243|NCT00812851|THC|thc
5203244|NCT00812851|Dronabinol|dronabinol
5203245|NCT00812825|Safety Tolerability Pharmacokinetics/pharmacodynamics|safety tolerability pharmacokinetics/pharmacodynamics
5203246|NCT00812812|paroxetine|paroxetine
5203247|NCT00812812|selective serotonin reuptake inhibitor|selective serotonin reuptake inhibitor
5203248|NCT00812812|CDRS-R|cdrs-r
5203249|NCT00812812|children and adolescents|children and adolescents
5203250|NCT00812799|randomised|randomised
5203251|NCT00812799|double-blind|double-blind
5203252|NCT00812799|placebo-controlled|placebo-controlled
5203253|NCT00812799|efficacy and safety|efficacy and safety
5203254|NCT00812799|Oralgen® Grass Pollen|oralgen® grass pollen
5203255|NCT00812799|allergic rhinoconjunctivitis|allergic rhinoconjunctivitis
5203256|NCT00812799|allergy|allergy
5203257|NCT00812799|rhinoconjunctivitis|rhinoconjunctivitis
5203258|NCT00812799|immunotherapy|immunotherapy
5203259|NCT00812799|grass pollen extract|grass pollen extract
5203260|NCT00812786|heart transplantation|heart transplantation
5203261|NCT00812786|immunosuppressive drugs|immunosuppressive drugs
5203262|NCT00812786|individual dose adjustment|individual dose adjustment
5203263|NCT00812786|harmacokinetics|harmacokinetics
5203264|NCT00812786|modelling|modelling
5203265|NCT00812773|GSK2190915|gsk2190915
5203266|NCT00812773|Repeat|repeat
5203267|NCT00812773|Oral|oral
5203268|NCT00812773|Dose|dose
5203269|NCT00812773|Challenge|challenge
5203270|NCT00812773|Asthma|asthma
5203271|NCT00812773|Allergen|allergen
5203272|NCT00812760|Electroretinography|electroretinography
5203273|NCT00812760|levodopa|levodopa
5203274|NCT00812747|surgical wound infection|surgical wound infection
5203275|NCT00812747|risk factor|risk factor
5203276|NCT00812734|Neuropathic pain|neuropathic pain
5203277|NCT00812734|chronic pain|chronic pain
5203278|NCT00812734|postoperative|postoperative
5203279|NCT00812734|surgery|surgery
5203280|NCT00812734|anesthesiology|anesthesiology
5203281|NCT00812734|Scheduled surgery|scheduled surgery
5203282|NCT00812721|higher order aberrations|higher order aberrations
5203283|NCT00812721|tear blur|tear blur
5203284|NCT00812708|aniridia|aniridia
5203285|NCT00812708|Morcher iris diaphragms|morcher iris diaphragms
5203286|NCT00812708|modified capsule tension ring|modified capsule tension ring
5203287|NCT00812708|artificial iris|artificial iris
5203288|NCT00812708|iris reconstruction lens|iris reconstruction lens
5203289|NCT00812708|glare sensitivity|glare sensitivity
5203290|NCT00812708|photophobia|photophobia
5203291|NCT00812695|Obstructive sleep apnea|obstructive sleep apnea
5203292|NCT00812695|Refractory hypertension|refractory hypertension
5203293|NCT00812695|Heart remodeling|heart remodeling
5203294|NCT00812695|Arterial stiffness|arterial stiffness
5203295|NCT00812695|CPAP|cpap
5203296|NCT00812682|SYMBICORT AMD|symbicort amd
5203297|NCT00812669|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
5203298|NCT00812669|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5203299|NCT00812669|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
5203300|NCT00812669|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
5203301|NCT00812669|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5203302|NCT00812669|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5203303|NCT00812643|pharmacokinetics|pharmacokinetics
5203304|NCT00812630|male hormonal contraception|male hormonal contraception
5203305|NCT00812630|Blood pressure, sperm concentration|blood pressure, sperm concentration
5203306|NCT00812578|Type 2 diabetes|type 2 diabetes
5203307|NCT00812578|Vitamin D insufficiency|vitamin d insufficiency
5203308|NCT00812578|Insulin secretion|insulin secretion
5203309|NCT00812578|Insulin sensitivity|insulin sensitivity
5203310|NCT00812578|Pulsatility|pulsatility
5203311|NCT00812539|Diabetes|diabetes
5203312|NCT00812539|Blood glucose monitoring|blood glucose monitoring
5203313|NCT00812539|Internet|internet
5203314|NCT00812526|Choroid|choroid
5203315|NCT00812526|Regional blood flow|regional blood flow
5203316|NCT00812526|Autoregulation|autoregulation
5203317|NCT00812526|Laser Doppler flowmetry|laser doppler flowmetry
5203318|NCT00812513|rhPDGF-BB|rhpdgf-bb
5203319|NCT00812513|Platelet derived growth factor|platelet derived growth factor
5203320|NCT00812513|Burns|burns
5203321|NCT00812513|Thermal burns|thermal burns
5203322|NCT00812513|Electric burns|electric burns
5203323|NCT00812500|assess the effect of age on the EAR and RDA for protein|assess the effect of age on the ear and rda for protein
5203324|NCT00812487|congestive heart failure|congestive heart failure
5203325|NCT00812487|diabetes mellitus|diabetes mellitus
5203326|NCT00812487|hyperglycemia|hyperglycemia
5203327|NCT00812474|cerebral blood flow|cerebral blood flow
5203328|NCT00812461|Pharmacologic Actions|pharmacologic actions
5203329|NCT00812461|Alcohol-Related Disorders|alcohol-related disorders
5203330|NCT00812461|Alcoholism|alcoholism
5203331|NCT00812461|Mental Disorders|mental disorders
5203332|NCT00812461|Central Nervous System Agents|central nervous system agents
5203333|NCT00812448|prophylaxis|prophylaxis
5203334|NCT00812448|influenza infection|influenza infection
5203335|NCT00812448|catechins|catechins
5203336|NCT00812448|prophylaxis of influenza infection|prophylaxis of influenza infection
5203337|NCT00812435|STEMI|stemi
5203338|NCT00812435|Patients|patients
5203339|NCT00812435|male or female|male or female
5203340|NCT00812435|greater than 18 years of age|greater than 18 years of age
5203341|NCT00812435|presenting with ST elevation myocardial infarction|presenting with st elevation myocardial infarction
5203342|NCT00812422|Fever due to acute upper respiratory tract infection|fever due to acute upper respiratory tract infection
5203343|NCT00812409|Measuring markers of metabolic syndrome in overweight and obese adults.|measuring markers of metabolic syndrome in overweight and obese adults.
5203344|NCT00812396|Biomarkers of muscle anabolism|biomarkers of muscle anabolism
5203345|NCT00812370|DVT|dvt
5203346|NCT00812370|Deep Venous Thrombosis|deep venous thrombosis
5203347|NCT00812370|UNBLOCK|unblock
5203348|NCT00812370|Bivalirudin|bivalirudin
5203349|NCT00812370|Angiomax|angiomax
5203350|NCT00812357|Symbicort Turbuhaler|symbicort turbuhaler
5203351|NCT00812357|asthma|asthma
5203352|NCT00812357|cohort study|cohort study
5203353|NCT00812357|France|france
5203354|NCT00812344|pharmacokinetics|pharmacokinetics
5203355|NCT00812331|Hepatitis C|hepatitis c
5203356|NCT00812331|TMC435|tmc435
5203357|NCT00812318|HIV infected subjects|hiv infected subjects
5203358|NCT00812318|Healthy volunteer|healthy volunteer
5203359|NCT00812318|GSK1265744.|gsk1265744.
5203360|NCT00812292|TMC278|tmc278
5203361|NCT00812292|TMC278-C145|tmc278-c145
5203362|NCT00812292|TMC278-TiDP38-C145|tmc278-tidp38-c145
5203363|NCT00812292|concept pediatric formulations of TMC278|concept pediatric formulations of tmc278
5203364|NCT00812292|HIV Infections|hiv infections
5203365|NCT00812279|Smokers with acceptable health conditions|smokers with acceptable health conditions
5203366|NCT00812266|SCLC|sclc
5203367|NCT00812266|Extensive disease|extensive disease
5203368|NCT00812266|topotecan|topotecan
5203369|NCT00812253|Heart failure|heart failure
5203370|NCT00812253|Hyperglycemia|hyperglycemia
5203371|NCT00812253|Hospital|hospital
5203372|NCT00812253|Diabetes Mellitus|diabetes mellitus
5203373|NCT00812240|Gastro-Intestinal Stromal Tumour|gastro-intestinal stromal tumour
5203374|NCT00812240|GIST|gist
5203375|NCT00812240|non resectable|non resectable
5203376|NCT00812240|recurrent post-surgery|recurrent post-surgery
5203377|NCT00812240|first line of treatment|first line of treatment
5203378|NCT00812240|metastatic|metastatic
5203379|NCT00812240|locally advanced|locally advanced
5203380|NCT00812227|Depression|depression
5203381|NCT00812227|Psychotherapy|psychotherapy
5203382|NCT00812227|Neuroimaging|neuroimaging
5203383|NCT00812227|Subjects with Major Depressive Disorder (MDD)|subjects with major depressive disorder (mdd)
5203384|NCT00812214|insomnia|insomnia
5203385|NCT00812214|migraine|migraine
5203386|NCT00812214|eszopiclone|eszopiclone
5203387|NCT00812214|insomnia in migraineurs|insomnia in migraineurs
5203388|NCT00812201|Heart failure|heart failure
5203389|NCT00812201|auto threshold|auto threshold
5203390|NCT00812201|pacing|pacing
5203391|NCT00812201|CRT-P or CRT-D recipients, threshold measurements|crt-p or crt-d recipients, threshold measurements
5203392|NCT00812188|Morphea|morphea
5203393|NCT00812188|Plaque morphea|plaque morphea
5203394|NCT00812188|Localized Scleroderma|localized scleroderma
5203395|NCT00812175|Hepatocellular Carcinoma|hepatocellular carcinoma
5203396|NCT00812175|HCC|hcc
5203397|NCT00812175|Sorafenib|sorafenib
5203398|NCT00812149|Type-2 Deiodinase|type-2 deiodinase
5203399|NCT00812149|Genetic Polymorphism|genetic polymorphism
5203400|NCT00812149|Triiodothyronine (T3)|triiodothyronine (t3)
5203401|NCT00812149|Thyrotropin Releasing Hormone (TRH) Test|thyrotropin releasing hormone (trh) test
5203402|NCT00812136|Using Parent Mentors to Improve Asthma Care for Urban Minority Children|using parent mentors to improve asthma care for urban minority children
5203403|NCT00812123|kidney transplantation|kidney transplantation
5203404|NCT00812123|calcineurin inhibitor free|calcineurin inhibitor free
5203405|NCT00812123|protocol biopsy|protocol biopsy
5203406|NCT00812123|Cyclosporin A|cyclosporin a
5203407|NCT00812123|Sirolimus|sirolimus
5203408|NCT00812110|Influenza prevention|influenza prevention
5203409|NCT00812097|Breast Augmentation|breast augmentation
5203410|NCT00812097|Breast Reconstruction|breast reconstruction
5203411|NCT00812097|Breast Revision|breast revision
5203412|NCT00812097|Silicone gel|silicone gel
5203413|NCT00812097|Contour Profile Gel|contour profile gel
5203414|NCT00812097|Siltex®|siltex®
5203415|NCT00812084|Quality of life|quality of life
5203416|NCT00812084|health resources|health resources
5203417|NCT00812084|costs|costs
5203418|NCT00812084|community-acquired pneumonia|community-acquired pneumonia
5203419|NCT00812071|volunteers|volunteers
5203420|NCT00812058|Bipolar Depression|bipolar depression
5203421|NCT00812058|Bipolar Disease|bipolar disease
5203422|NCT00812058|Bipolar Disorder|bipolar disorder
5203423|NCT00812058|Bipolar|bipolar
5203424|NCT00812058|Manic Depression|manic depression
5203425|NCT00812058|Manic Depressive Disorder|manic depressive disorder
5203426|NCT00812045|Induced sputum|induced sputum
5203427|NCT00812045|cystic fibrosis|cystic fibrosis
5203428|NCT00812045|biomarker|biomarker
5203429|NCT00812045|CYBER|cyber
5203430|NCT00812032|NIDDM|niddm
5203431|NCT00812032|Aspirin|aspirin
5203432|NCT00812032|platelet inhibition|platelet inhibition
5203433|NCT00812032|Aspirin treatment|aspirin treatment
5203434|NCT00812019|H5N1 Influenza|h5n1 influenza
5203435|NCT00812019|Pandemic Flu|pandemic flu
5203436|NCT00812019|MF59 Adjuvant|mf59 adjuvant
5203437|NCT00812019|Cell Culture-Derived|cell culture-derived
5203438|NCT00812019|Safety|safety
5203439|NCT00812019|Immunogenicity|immunogenicity
5203440|NCT00812019|Vaccination|vaccination
5203441|NCT00812019|H5N1 influenza pandemic|h5n1 influenza pandemic
5203442|NCT00811954|Treatment naive|treatment naive
5203443|NCT00811954|Treatment inexperienced|treatment inexperienced
5203444|NCT00811941|Pharmacologic Actions|pharmacologic actions
5203445|NCT00811941|Alcohol-Related Disorders|alcohol-related disorders
5203446|NCT00811941|Alcoholism|alcoholism
5203447|NCT00811941|Mental Disorders|mental disorders
5203448|NCT00811941|Central Nervous System Agents|central nervous system agents
5203449|NCT00811928|high-risk leukopenic patients|high-risk leukopenic patients
5203450|NCT00811915|Sirolimus|sirolimus
5203451|NCT00811915|Tacrolimus|tacrolimus
5203452|NCT00811915|Kidney transplantation|kidney transplantation
5203453|NCT00811915|Kidney Transplant Recipients|kidney transplant recipients
5203454|NCT00811902|Multiple sclerosis|multiple sclerosis
5203455|NCT00811876|Prostate cancer|prostate cancer
5203456|NCT00811863|Nephrogenic Systemic Fibrosis|nephrogenic systemic fibrosis
5203457|NCT00811863|Renal Insufficiency|renal insufficiency
5203458|NCT00811863|Gadoversetamide|gadoversetamide
5203459|NCT00811863|OptiMARK|optimark
5203460|NCT00811863|Magnetic Resonance Imaging|magnetic resonance imaging
5203461|NCT00811837|Sunburn|sunburn
5203462|NCT00811837|Remifentanil|remifentanil
5203463|NCT00811837|Hyperalgesia|hyperalgesia
5203464|NCT00811824|Weight loss|weight loss
5203465|NCT00811824|Physical activity|physical activity
5203466|NCT00811824|Dietary change|dietary change
5203467|NCT00811811|Hypertension|hypertension
5203468|NCT00811811|Biofeedback|biofeedback
5203469|NCT00811811|Relaxation training|relaxation training
5203470|NCT00811798|Hong Kong|hong kong
5203471|NCT00811798|Human papillomavirus|human papillomavirus
5203472|NCT00811798|Safety|safety
5203473|NCT00811785|Copper Deficiency|copper deficiency
5203474|NCT00811785|Menkes Disease|menkes disease
5203475|NCT00811785|Neurodevelopment|neurodevelopment
5203476|NCT00811785|Occipital Horn Syndrome|occipital horn syndrome
5203477|NCT00811772|Randomized controlled trial|randomized controlled trial
5203478|NCT00811772|Bare metal stent|bare metal stent
5203479|NCT00811772|Drug eluting stent|drug eluting stent
5203480|NCT00811759|stage IV melanoma|stage iv melanoma
5203481|NCT00811759|stage III melanoma|stage iii melanoma
5203482|NCT00811759|recurrent melanoma|recurrent melanoma
5203483|NCT00811746|obstructive sleep apnea|obstructive sleep apnea
5203484|NCT00811746|eszopiclone|eszopiclone
5203485|NCT00811746|ramelteon|ramelteon
5203486|NCT00811746|polysomnography|polysomnography
5203487|NCT00811733|Waldenstrom's Macroglobulinemia|waldenstrom's macroglobulinemia
5203488|NCT00811733|Ofatumumab|ofatumumab
5203489|NCT00811720|Alcohol-Related Disorders|alcohol-related disorders
5203490|NCT00811720|Alcoholism|alcoholism
5203491|NCT00811720|Mental Disorders|mental disorders
5203492|NCT00811720|Central Nervous System Agents|central nervous system agents
5203493|NCT00811707|ultrasound image|ultrasound image
5203494|NCT00811707|epidural space|epidural space
5203495|NCT00811694|glaucoma|glaucoma
5203496|NCT00811694|ficker stimulation|ficker stimulation
5203497|NCT00811694|ocular blood flow|ocular blood flow
5203498|NCT00811681|Friedreich's ataxia|friedreich's ataxia
5203499|NCT00811681|Pioglitazone|pioglitazone
5203500|NCT00811668|Sleep Apnea Syndromes|sleep apnea syndromes
5203501|NCT00811668|heart diseases|heart diseases
5203502|NCT00811655|tumors metastatic to brain|tumors metastatic to brain
5203503|NCT00811655|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5203504|NCT00811642|refractory or first line medication intolerable invasive fungal infection|refractory or first line medication intolerable invasive fungal infection
5203505|NCT00811629|Receptor for advanced glycation end products (RAGE)|receptor for advanced glycation end products (rage)
5203506|NCT00811629|Soluble RAGE (sRAGE)|soluble rage (srage)
5203507|NCT00811629|Acute Lung Injury (ALI)|acute lung injury (ali)
5203508|NCT00811629|Acute respiratory distress syndrome (ARDS)|acute respiratory distress syndrome (ards)
5203509|NCT00811629|Severe sepsis|severe sepsis
5203510|NCT00811629|Septic shock|septic shock
5203511|NCT00811629|Alveolar epithelium|alveolar epithelium
5203512|NCT00811629|Mechanical ventilation|mechanical ventilation
5203513|NCT00811629|Intensive Care Unit (ICU)|intensive care unit (icu)
5203514|NCT00811616|Coronary artery disease|coronary artery disease
5203515|NCT00811616|Supralimus-Core™|supralimus-core™
5203516|NCT00811616|de novo native coronary artery lesion|de novo native coronary artery lesion
5203517|NCT00811603|Antibiotic|antibiotic
5203518|NCT00811603|Prophylaxis|prophylaxis
5203519|NCT00811603|Cesarean|cesarean
5203520|NCT00811603|Infection|infection
5203521|NCT00811603|Antibiotic prophylaxis|antibiotic prophylaxis
5203522|NCT00811590|Cancer|cancer
5203523|NCT00811590|Polyps|polyps
5203524|NCT00811577|AZX100|azx100
5203525|NCT00811577|Patient and Observer Scar Assessment Scale|patient and observer scar assessment scale
5203526|NCT00811577|POSAS|posas
5203527|NCT00811577|Visual Analog Scale|visual analog scale
5203528|NCT00811577|VAS|vas
5203529|NCT00811577|Trocar|trocar
5203530|NCT00811577|Scarring|scarring
5203531|NCT00811577|Scar reduction|scar reduction
5203532|NCT00811577|Scar prevention|scar prevention
5203533|NCT00811551|Heart Failure|heart failure
5203534|NCT00811551|Impedance Monitoring|impedance monitoring
5203535|NCT00811551|Wedge Pressure|wedge pressure
5203536|NCT00811538|ischemic stroke|ischemic stroke
5203537|NCT00811538|endovascular treatment|endovascular treatment
5203538|NCT00811538|Thrombolysis|thrombolysis
5203539|NCT00811538|outcome|outcome
5203540|NCT00811525|Breast Augmentation|breast augmentation
5203541|NCT00811525|Breast Reconstruction|breast reconstruction
5203542|NCT00811525|Breast Revision|breast revision
5203543|NCT00811525|Silicone gel|silicone gel
5203544|NCT00811525|Contour Profile Gel|contour profile gel
5203545|NCT00811525|Siltex|siltex
5203546|NCT00811512|retina|retina
5203547|NCT00811512|fold|fold
5203548|NCT00811512|fovea|fovea
5203549|NCT00811473|Bipolar Depression|bipolar depression
5203550|NCT00811473|Depression|depression
5203551|NCT00811473|Children|children
5203552|NCT00811473|Adolescents|adolescents
5203553|NCT00811473|Seroquel|seroquel
5203554|NCT00811473|Bipolar Depression in Children and Adolescents|bipolar depression in children and adolescents
5203555|NCT00811434|encephalopathy|encephalopathy
5203556|NCT00811434|pediatric liver disease|pediatric liver disease
5203557|NCT00811434|pediatric cirrhosis|pediatric cirrhosis
5203558|NCT00811434|serum ammonia levels|serum ammonia levels
5203559|NCT00811421|Malaria|malaria
5203560|NCT00811421|Pregnancy|pregnancy
5203561|NCT00811421|HIV|hiv
5203562|NCT00811421|Prevention|prevention
5203563|NCT00811421|Malaria prevention|malaria prevention
5203564|NCT00811408|human papilloma virus infection|human papilloma virus infection
5203565|NCT00811408|cervical squamous cell carcinoma|cervical squamous cell carcinoma
5203566|NCT00811408|cervical adenocarcinoma|cervical adenocarcinoma
5203567|NCT00811408|stage IB cervical cancer|stage ib cervical cancer
5203568|NCT00811408|stage II cervical cancer|stage ii cervical cancer
5203569|NCT00811408|stage III cervical cancer|stage iii cervical cancer
5203570|NCT00811408|stage IVA cervical cancer|stage iva cervical cancer
5203571|NCT00811382|CRT|crt
5203572|NCT00811382|therapy of AF|therapy of af
5203573|NCT00811382|telecardiology|telecardiology
5203574|NCT00811382|home monitoring|home monitoring
5203575|NCT00811382|cardiovascular hospitalization|cardiovascular hospitalization
5203576|NCT00811382|cardiovascular mortality|cardiovascular mortality
5203577|NCT00811369|Breast Cancer|breast cancer
5203578|NCT00811369|Bone Metastases|bone metastases
5203579|NCT00811369|Telopeptide|telopeptide
5203580|NCT00811369|Zactima|zactima
5203581|NCT00811369|Fulvestrant|fulvestrant
5203582|NCT00811356|Food Effect|food effect
5203583|NCT00811356|Drug-Drug Interaction|drug-drug interaction
5203584|NCT00811356|Antimalarial|antimalarial
5203585|NCT00811356|First Time In Human|first time in human
5203586|NCT00811356|Single Dose|single dose
5203587|NCT00811356|Repeat Dose|repeat dose
5203588|NCT00811343|anti TNF Therapy|anti tnf therapy
5203589|NCT00811343|Tuberculosis|tuberculosis
5203590|NCT00811343|Tuberculin test|tuberculin test
5203591|NCT00811343|QFTB-G|qftb-g
5203592|NCT00811343|T-SPOT.TB|t-spot.tb
5203593|NCT00811343|Need anti TNF Therapy|need anti tnf therapy
5203594|NCT00811330|Left ventricular hypertrophy|left ventricular hypertrophy
5203595|NCT00811330|Aortic valve stenosis|aortic valve stenosis
5203596|NCT00811330|Aortic valve replacement|aortic valve replacement
5203597|NCT00811330|Cardiopulmonary bypass|cardiopulmonary bypass
5203598|NCT00811330|Statins|statins
5203599|NCT00811330|Myocardial preconditioning|myocardial preconditioning
5203600|NCT00811330|Left ventricular reverse remodeling|left ventricular reverse remodeling
5203601|NCT00811317|diabetes|diabetes
5203602|NCT00811317|glucose|glucose
5203603|NCT00811317|hyperglycemia|hyperglycemia
5203604|NCT00811317|hypoglycemia|hypoglycemia
5203605|NCT00811317|insulin|insulin
5203606|NCT00811317|glucagon|glucagon
5203607|NCT00811317|counter-regulation|counter-regulation
5203608|NCT00811317|closed-loop|closed-loop
5203609|NCT00811317|feedback|feedback
5203610|NCT00811317|control|control
5203611|NCT00811317|dual-infusion|dual-infusion
5203612|NCT00811317|subcutaneous|subcutaneous
5203613|NCT00811317|automated|automated
5203614|NCT00811317|artificial pancreas|artificial pancreas
5203615|NCT00811317|intensive insulin therapy|intensive insulin therapy
5203616|NCT00811304|ultrasound|ultrasound
5203617|NCT00811304|labor epidural|labor epidural
5203618|NCT00811304|failed epidural|failed epidural
5203619|NCT00811304|outcome|outcome
5203620|NCT00811304|Epidural insertion under realtime ultrasound guidance|epidural insertion under realtime ultrasound guidance
5203621|NCT00811291|B-vitamins|b-vitamins
5203622|NCT00811291|Folic-Acid|folic-acid
5203623|NCT00811291|kindergarten kids|kindergarten kids
5203624|NCT00811291|cognitive tests|cognitive tests
5203625|NCT00811291|Healthy kids|healthy kids
5203626|NCT00811291|second part low urine vitamine-B-metabolites|second part low urine vitamine-b-metabolites
5203627|NCT00811278|inhaled corticosteroids|inhaled corticosteroids
5203628|NCT00811265|ExAblate MRgFUS|exablate mrgfus
5203629|NCT00811265|Focused ultrasound|focused ultrasound
5203630|NCT00811265|Magnetic resonance imaging|magnetic resonance imaging
5203631|NCT00811265|Prostate cancer|prostate cancer
5203632|NCT00811265|Radical prostatectomy candidate|radical prostatectomy candidate
5203633|NCT00811252|Depression|depression
5203634|NCT00811252|Elderly|elderly
5203635|NCT00811252|Acute treatment|acute treatment
5203636|NCT00811239|antivenom|antivenom
5203637|NCT00811239|snake bite|snake bite
5203638|NCT00811239|Bungarus multicinctus|bungarus multicinctus
5203639|NCT00811239|Vietnam|vietnam
5203640|NCT00811226|Hypertension Stage I|hypertension stage i
5203641|NCT00811226|Hypertension Stage II|hypertension stage ii
5203642|NCT00811200|radiation|radiation
5203643|NCT00811200|retinopathy|retinopathy
5203644|NCT00811200|maculopathy|maculopathy
5203645|NCT00811200|choroidopathy|choroidopathy
5203646|NCT00811200|uveal|uveal
5203647|NCT00811200|melanoma|melanoma
5203648|NCT00811200|lucentis|lucentis
5203649|NCT00811200|ranibizumab|ranibizumab
5203650|NCT00811200|kenalog|kenalog
5203651|NCT00811200|triamcinolone acetonide|triamcinolone acetonide
5203652|NCT00811200|radiation retinopathy after irradiation of uveal melanoma|radiation retinopathy after irradiation of uveal melanoma
5203653|NCT00811200|radiation maculopathy after irradiation of uveal melanoma|radiation maculopathy after irradiation of uveal melanoma
5203654|NCT00811200|radiation choroidopathy after irradiation of uveal melanoma|radiation choroidopathy after irradiation of uveal melanoma
5203655|NCT00811187|Hysteroscopy|hysteroscopy
5203656|NCT00811187|Pain medication|pain medication
5203657|NCT00811187|Lidocaine|lidocaine
5203658|NCT00811187|Office Procedures|office procedures
5203659|NCT00811161|Remodeling|remodeling
5203660|NCT00811161|Airgent|airgent
5203661|NCT00811161|Hyaluronic acid|hyaluronic acid
5203662|NCT00811161|Collagen formation|collagen formation
5203663|NCT00811148|Brain Neoplasms|brain neoplasms
5203664|NCT00811148|Central Nervous System Diseases|central nervous system diseases
5203665|NCT00811148|Central Nervous System Neoplasms|central nervous system neoplasms
5203666|NCT00811148|Brain Diseases|brain diseases
5203667|NCT00811148|Nervous System Neoplasms|nervous system neoplasms
5203668|NCT00811122|Alzheimer's disease|alzheimer's disease
5203669|NCT00811122|AD|ad
5203670|NCT00811122|Frontotemporal dementia|frontotemporal dementia
5203671|NCT00811122|FTD|ftd
5203672|NCT00811109|Acute Kidney Injury|acute kidney injury
5203673|NCT00811109|Critical care|critical care
5203674|NCT00811109|Hypotension|hypotension
5203675|NCT00811109|Renal replacement therapy|renal replacement therapy
5203676|NCT00811109|Efficacy|efficacy
5203677|NCT00811109|Tolerance|tolerance
5203678|NCT00811109|Outcome|outcome
5203679|NCT00811096|Malaria, Vivax/*drug therapy|malaria, vivax/*drug therapy
5203680|NCT00811096|Tinidazole/pharmacology/*therapeutic use|tinidazole/pharmacology/*therapeutic use
5203681|NCT00811096|Recurrence|recurrence
5203682|NCT00811096|Plasmodium vivax/*drug effects|plasmodium vivax/*drug effects
5203683|NCT00811083|autism|autism
5203684|NCT00811083|toxic metals|toxic metals
5203685|NCT00811083|DMSA|dmsa
5203686|NCT00811083|dimercaptosuccinic acid|dimercaptosuccinic acid
5203687|NCT00811083|chelation|chelation
5203688|NCT00811070|CML. Chronic myelocytic leukemia. Philadelphia Chromosome. Japanese. SKI-606. Bosutinib. Imatinib resistant. Imatinib intolerant|cml. chronic myelocytic leukemia. philadelphia chromosome. japanese. ski-606. bosutinib. imatinib resistant. imatinib intolerant
5203689|NCT00811057|Preterm Labor in Pregnancy|preterm labor in pregnancy
5203691|NCT00811044|genetics|genetics
5203692|NCT00811044|oral glucose tolerance testing|oral glucose tolerance testing
5203693|NCT00811044|family history of diabetes|family history of diabetes
5203694|NCT00811044|gestational diabetes|gestational diabetes
5203695|NCT00811031|Prostate|prostate
5203696|NCT00811031|prostate gland|prostate gland
5203697|NCT00811031|prostate cancer markers|prostate cancer markers
5203698|NCT00811031|Taxotere®|taxotere®
5203699|NCT00811031|Docetaxel|docetaxel
5203700|NCT00811031|Prednisone|prednisone
5203701|NCT00811031|Castration Resistant Prostate Cancer|castration resistant prostate cancer
5203702|NCT00811031|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5203703|NCT00811018|Open-label study|open-label study
5203704|NCT00811005|acitretin|acitretin
5203705|NCT00811005|fumaric acid ester|fumaric acid ester
5203706|NCT00811005|pustular palmoplantar psoriasis|pustular palmoplantar psoriasis
5203707|NCT00811005|PUVA|puva
5203708|NCT00810992|dietary, behavior|dietary, behavior
5203709|NCT00810992|IDF criteria|idf criteria
5203710|NCT00810992|coronary artery disease|coronary artery disease
5203711|NCT00810992|Traditional Tibetan Medicine|traditional tibetan medicine
5203712|NCT00810992|coronary artery disease in patients, who have an increased cardiovascular risk profile according to the criteria by the International Diabetes Federation (IDF)|coronary artery disease in patients, who have an increased cardiovascular risk profile according to the criteria by the international diabetes federation (idf)
5203713|NCT00810940|TBI|tbi
5203714|NCT00810940|closed head injury|closed head injury
5203715|NCT00810940|severe head trauma|severe head trauma
5203716|NCT00810940|traumatic brain injury|traumatic brain injury
5203717|NCT00810914|Patient controlled epidural anesthesia|patient controlled epidural anesthesia
5203718|NCT00810914|Pain control in labor|pain control in labor
5203719|NCT00810901|ethnic minority adolescents|ethnic minority adolescents
5203720|NCT00810901|designated organ donor|designated organ donor
5203721|NCT00810888|intracerebral hemorrhage|intracerebral hemorrhage
5203722|NCT00810888|ICH|ich
5203723|NCT00810888|computed tomography angiography|computed tomography angiography
5203724|NCT00810888|CTA|cta
5203725|NCT00810888|recombinant activated factor seven|recombinant activated factor seven
5203726|NCT00810888|rFVIIa|rfviia
5203727|NCT00810888|NovoSeven|novoseven
5203728|NCT00810888|recombinant activated factor VII|recombinant activated factor vii
5203729|NCT00810875|pregnancy|pregnancy
5203730|NCT00810875|immunity|immunity
5203731|NCT00810875|cord blood|cord blood
5203732|NCT00810875|influenza vaccines|influenza vaccines
5203733|NCT00810875|disease transmission, vertical|disease transmission, vertical
5203734|NCT00810862|African American children|african american children
5203735|NCT00810849|Tuberculosis, pericardium|tuberculosis, pericardium
5203736|NCT00810823|Diabetes|diabetes
5203737|NCT00810823|gastric bypass|gastric bypass
5203738|NCT00810823|type 2 diabetes and gastric bypass|type 2 diabetes and gastric bypass
5203739|NCT00810810|Blood Component Transfusion|blood component transfusion
5203740|NCT00810810|Leukoreduction|leukoreduction
5203741|NCT00810810|HLA antibody|hla antibody
5203742|NCT00810810|Immunosuppression|immunosuppression
5203743|NCT00810797|recurrent breast cancer|recurrent breast cancer
5203744|NCT00810797|stage IV breast cancer|stage iv breast cancer
5203745|NCT00810784|Venous Thromboembolism|venous thromboembolism
5203746|NCT00810784|Prevention|prevention
5203747|NCT00810784|Quality Improvement|quality improvement
5203748|NCT00810784|Education|education
5203749|NCT00810784|Compliance with VTE prophylaxis|compliance with vte prophylaxis
5203750|NCT00810771|Hospitals, Veterans|hospitals, veterans
5203751|NCT00810771|Mass Screening/utilization|mass screening/utilization
5203752|NCT00810771|Patient Preference|patient preference
5203753|NCT00810771|Prevention & Control|prevention & control
5203754|NCT00810771|Epidemiology|epidemiology
5203755|NCT00810758|HCV|hcv
5203756|NCT00810758|Toll-like receptor 7|toll-like receptor 7
5203757|NCT00810758|Multiple oral dose escalation study of PF-04878691|multiple oral dose escalation study of pf-04878691
5203758|NCT00810745|ODS|ods
5203759|NCT00810745|stapled transanal rectal resection|stapled transanal rectal resection
5203760|NCT00810732|This study is being conducted to evaluate sitaxsentan dosing in subjects with chronic kidney disease.|this study is being conducted to evaluate sitaxsentan dosing in subjects with chronic kidney disease.
5203761|NCT00810732|B1321005|b1321005
5203762|NCT00810719|recurrent pancreatic cancer|recurrent pancreatic cancer
5203763|NCT00810719|stage IV pancreatic cancer|stage iv pancreatic cancer
5203764|NCT00810706|Breast Cancer|breast cancer
5203765|NCT00810706|Aromatase inhibitors|aromatase inhibitors
5203766|NCT00810706|Exemestane|exemestane
5203767|NCT00810706|Tamoxifen|tamoxifen
5203768|NCT00810706|Lipids|lipids
5203769|NCT00810693|Pulmonary arterial hypertension|pulmonary arterial hypertension
5203770|NCT00810693|PH|ph
5203771|NCT00810693|Stimulator|stimulator
5203772|NCT00810680|chronic lymphocytic leukemia|chronic lymphocytic leukemia
5203773|NCT00810680|relapsed|relapsed
5203774|NCT00810680|refractory|refractory
5203775|NCT00810680|valproic acid|valproic acid
5203776|NCT00810680|valproate|valproate
5203777|NCT00810667|Schizophrenia|schizophrenia
5203778|NCT00810667|Cognition|cognition
5203779|NCT00810667|BACS|bacs
5203780|NCT00810667|Risperidone|risperidone
5203781|NCT00810667|Augmentation therapy|augmentation therapy
5203782|NCT00810667|Add-on therapy|add-on therapy
5203783|NCT00810667|Lu AE58054|lu ae58054
5203784|NCT00810654|Celiac disease|celiac disease
5203785|NCT00810654|Coeliac disease|coeliac disease
5203786|NCT00810654|treatment|treatment
5203787|NCT00810654|AN-PEP|an-pep
5203788|NCT00810654|prolyl endoprotease|prolyl endoprotease
5203789|NCT00810654|gluten|gluten
5203790|NCT00810641|BPPV(benign paroxysmal positional vertigo)|bppv(benign paroxysmal positional vertigo)
5203791|NCT00810641|HC-BPPV(BPPV involving the horizontal semicircular canal)|hc-bppv(bppv involving the horizontal semicircular canal)
5203792|NCT00810641|Nystagmus|nystagmus
5203793|NCT00810641|Treatment outcome|treatment outcome
5203794|NCT00810641|Horizontal Canal Benign Paroxysmal Positional Vertigo|horizontal canal benign paroxysmal positional vertigo
5203795|NCT00810628|Parkinson's disease|parkinson's disease
5203796|NCT00810628|depression|depression
5203797|NCT00810628|Parkinson's disease with mild to moderate depression.|parkinson's disease with mild to moderate depression.
5203798|NCT00810615|chronic TBI|chronic tbi
5203799|NCT00810615|cognitive function|cognitive function
5203800|NCT00810615|PTSD|ptsd
5203801|NCT00810615|HBO|hbo
5203802|NCT00810615|hyperbaric|hyperbaric
5203803|NCT00810615|oxygen|oxygen
5203804|NCT00810615|chronic brain injury|chronic brain injury
5203805|NCT00810576|Relapsed T-Cell Non-Hodgkin's Lymphoma|relapsed t-cell non-hodgkin's lymphoma
5203806|NCT00810576|Refractory T-Cell Non-Hodgkin's Lymphoma|refractory t-cell non-hodgkin's lymphoma
5203808|NCT00810576|T-cell NHL|t-cell nhl
5203809|NCT00810576|vorinostat|vorinostat
5203810|NCT00810576|SAHA|saha
5203811|NCT00810576|Suberoylanilide Hydroxamic Acid|suberoylanilide hydroxamic acid
5203812|NCT00810576|MSK-390|msk-390
5203813|NCT00810576|Zolinza|zolinza
5203814|NCT00810576|Bortezomib|bortezomib
5203815|NCT00810576|Velcade|velcade
5203816|NCT00810576|LDP-341|ldp-341
5203817|NCT00810576|MLN341|mln341
5203818|NCT00810576|PS-341|ps-341
5203819|NCT00810576|Peripheral T-cell lymphoma|peripheral t-cell lymphoma
5203820|NCT00810576|CD 30 + anaplastic large cell lymphoma|cd 30 + anaplastic large cell lymphoma
5203821|NCT00810576|Angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
5203822|NCT00810576|Angiocentric/nasal type T/NK-cell lymphoma|angiocentric/nasal type t/nk-cell lymphoma
5203823|NCT00810576|Intestinal T-cell lymphoma|intestinal t-cell lymphoma
5203824|NCT00810576|Hepatosplenic gamma delta T-cell lymphoma|hepatosplenic gamma delta t-cell lymphoma
5203825|NCT00810576|Subcutaneous panniculitic T-cell lymphoma|subcutaneous panniculitic t-cell lymphoma
5203826|NCT00810576|Transformed Mycosis fungoides|transformed mycosis fungoides
5203827|NCT00810563|pain|pain
5203828|NCT00810563|tubal ligation|tubal ligation
5203829|NCT00810563|bupivacaine|bupivacaine
5203830|NCT00810563|laparoscopy|laparoscopy
5203831|NCT00810524|Chronic hepatitis B|chronic hepatitis b
5203832|NCT00810524|antiviral treatment|antiviral treatment
5203833|NCT00810524|long term prognosis|long term prognosis
5203834|NCT00810485|Gastroesophageal reflux|gastroesophageal reflux
5203835|NCT00810485|Proton pump inhibitor|proton pump inhibitor
5203836|NCT00810485|Heartburn|heartburn
5203837|NCT00810485|Regurgitation|regurgitation
5203838|NCT00810472|Penetrating keratoplasty|penetrating keratoplasty
5203839|NCT00810472|HLA matching|hla matching
5203840|NCT00810472|Corneal diseases that require penetrating keratoplasty|corneal diseases that require penetrating keratoplasty
5203841|NCT00810420|Hypoglycemia|hypoglycemia
5203842|NCT00810420|EEG|eeg
5203843|NCT00810420|type 1 diabetes|type 1 diabetes
5203844|NCT00810420|neuroglycopenia|neuroglycopenia
5203845|NCT00810420|Hypoglycemia is a potential dangerous condition|hypoglycemia is a potential dangerous condition
5203846|NCT00810420|EEG is changed during hypoglycemia|eeg is changed during hypoglycemia
5203847|NCT00810420|A hypoglycemia alarm based on EEG-measures may prevent development of severe hypoglycemia|a hypoglycemia alarm based on eeg-measures may prevent development of severe hypoglycemia
5203848|NCT00810394|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5203849|NCT00810381|Nitrovasodilators|nitrovasodilators
5203850|NCT00810381|ONH blood flow|onh blood flow
5203851|NCT00810381|Choroidal blood flow|choroidal blood flow
5203852|NCT00810381|Nitroglycerin|nitroglycerin
5203853|NCT00810381|Isosorbide Dinitrate|isosorbide dinitrate
5203854|NCT00810381|Sodium nitroprusside|sodium nitroprusside
5203855|NCT00810381|Laser-Doppler Flowmetry|laser-doppler flowmetry
5203856|NCT00810381|Regional Blood Flow|regional blood flow
5203857|NCT00810368|Carnosine|carnosine
5203858|NCT00810368|antioxidant|antioxidant
5203859|NCT00810368|Persian Gulf War|persian gulf war
5203860|NCT00810368|Gulf War Syndrome|gulf war syndrome
5203861|NCT00810368|GWI|gwi
5203862|NCT00810368|Gulf War Illness|gulf war illness
5203863|NCT00810368|Exercise|exercise
5203864|NCT00810368|Chronic Fatigue|chronic fatigue
5203865|NCT00810368|Fibromyalgia|fibromyalgia
5203866|NCT00810368|Veterans|veterans
5203867|NCT00810368|Irritable Bowel Syndrome|irritable bowel syndrome
5203868|NCT00810368|Migraine headaches|migraine headaches
5203869|NCT00810368|Neuropathy|neuropathy
5203870|NCT00810368|Multiple Chemical Sensitivity|multiple chemical sensitivity
5203871|NCT00810355|Schizophrenia Spectrum Disorders|schizophrenia spectrum disorders
5203872|NCT00810355|Cognitive Behavior Therapy|cognitive behavior therapy
5203873|NCT00810355|work|work
5203874|NCT00810342|physical activity standard|physical activity standard
5203875|NCT00810342|exercise|exercise
5203876|NCT00810329|CFS,FM,CSF,Proteomics,Pain,Fatigue,GWI,IBS,IC,MCS.|cfs,fm,csf,proteomics,pain,fatigue,gwi,ibs,ic,mcs.
5203877|NCT00810316|Alprazolam|alprazolam
5203878|NCT00810316|Alprazolam extended release|alprazolam extended release
5203879|NCT00810316|Clonazepam|clonazepam
5203880|NCT00810316|Pharmacokinetics|pharmacokinetics
5203881|NCT00810316|Mexican population|mexican population
5203882|NCT00810316|Healthy|healthy
5203883|NCT00810290|Metabolic syndrome|metabolic syndrome
5203884|NCT00810290|Latino health|latino health
5203885|NCT00810290|Community participatory research|community participatory research
5203886|NCT00810290|Translational Research|translational research
5203887|NCT00810264|Long-term safety and reliability of a bipolar left ventricular lead on congestive heart failure patients|long-term safety and reliability of a bipolar left ventricular lead on congestive heart failure patients
5203888|NCT00810251|rib fracture|rib fracture
5203889|NCT00810251|flail chest|flail chest
5203890|NCT00810251|plate|plate
5203891|NCT00810251|chest trauma|chest trauma
5203892|NCT00810251|osteosynthesis|osteosynthesis
5203893|NCT00810251|mechanical ventilation|mechanical ventilation
5203894|NCT00810251|respirator|respirator
5203895|NCT00810238|Heart failure|heart failure
5203896|NCT00810238|Cell therapy|cell therapy
5203897|NCT00810225|CNDP1|cndp1
5203898|NCT00810225|carnosine dipeptidase 1|carnosine dipeptidase 1
5203899|NCT00810225|Persian Gulf War|persian gulf war
5203900|NCT00810225|Gulf War Syndrome|gulf war syndrome
5203901|NCT00810225|GWI|gwi
5203902|NCT00810225|Gulf War Illness|gulf war illness
5203903|NCT00810225|Exercise|exercise
5203904|NCT00810225|Chronic Fatigue|chronic fatigue
5203905|NCT00810225|Fibromyalgia|fibromyalgia
5203906|NCT00810225|Veterans|veterans
5203907|NCT00810225|Irritable Bowel Syndrome|irritable bowel syndrome
5203908|NCT00810225|Migraine headaches|migraine headaches
5203909|NCT00810225|Neuropathy|neuropathy
5203910|NCT00810225|Multiple Chemical Sensitivity|multiple chemical sensitivity
5203911|NCT00810212|Degenerative disc disease|degenerative disc disease
5203912|NCT00810212|Spondylolisthesis|spondylolisthesis
5203913|NCT00810212|Spinal stenosis|spinal stenosis
5203914|NCT00810212|Stem cell|stem cell
5203915|NCT00810212|Spinal Fusion|spinal fusion
5203916|NCT00810173|type 2 diabetes|type 2 diabetes
5203917|NCT00810173|physical activity|physical activity
5203918|NCT00810173|behavior change|behavior change
5203919|NCT00810173|profile personality|profile personality
5203920|NCT00810173|phone call support|phone call support
5203921|NCT00810160|probiotic|probiotic
5203922|NCT00810160|prebiotic|prebiotic
5203923|NCT00810160|oligosaccharides|oligosaccharides
5203924|NCT00810160|GOS|gos
5203925|NCT00810160|galacto oligosaccharides|galacto oligosaccharides
5203926|NCT00810160|Bifidobacterium infantis|bifidobacterium infantis
5203927|NCT00810160|Bifidobacterium animalis|bifidobacterium animalis
5203928|NCT00810134|Superficial femoral artery occlusion (TASC II B or C)|superficial femoral artery occlusion (tasc ii b or c)
5203929|NCT00810108|HIV/AIDS|hiv/aids
5203930|NCT00810108|pediatrics|pediatrics
5203931|NCT00810108|resource-limited settings|resource-limited settings
5203932|NCT00810108|lopinavir|lopinavir
5203933|NCT00810108|ritonavir|ritonavir
5203934|NCT00810108|Kaletra®|kaletra®
5203935|NCT00810108|antiretroviral treatment|antiretroviral treatment
5203936|NCT00810108|crushed tablets|crushed tablets
5203937|NCT00810108|treatment experienced|treatment experienced
5203938|NCT00810095|Cerebral Infarction|cerebral infarction
5203939|NCT00810095|Stroke|stroke
5203940|NCT00810095|Vascular Diseases|vascular diseases
5203941|NCT00810095|Central Nervous System Diseases|central nervous system diseases
5203942|NCT00810095|Penumbra|penumbra
5203943|NCT00810095|Functional Outcome|functional outcome
5203944|NCT00810095|Aphasia|aphasia
5203945|NCT00810095|Hemiplegia|hemiplegia
5203946|NCT00810095|Left sided weakness|left sided weakness
5203947|NCT00810095|Right Sided weakness|right sided weakness
5203948|NCT00810069|Major Depressive Disorder|major depressive disorder
5203949|NCT00810069|MDD|mdd
5203950|NCT00810069|Depression|depression
5203951|NCT00810056|Child abuse and neglect|child abuse and neglect
5203952|NCT00810056|Out-of-home care|out-of-home care
5203953|NCT00810056|Mentoring|mentoring
5203954|NCT00810056|Skills groups|skills groups
5203955|NCT00810056|Assessment|assessment
5203956|NCT00810030|ferric carboxymaltose|ferric carboxymaltose
5203957|NCT00810030|iron sucrose|iron sucrose
5203958|NCT00810030|Iron-Deficiency Anemia|iron-deficiency anemia
5203959|NCT00810030|Crohn's Disease|crohn's disease
5203960|NCT00810030|Ulcerative Colitis|ulcerative colitis
5203961|NCT00810030|Ferritin|ferritin
5203962|NCT00810030|Transferrin|transferrin
5203963|NCT00810017|Her2 Positive|her2 positive
5203964|NCT00810017|Breast Cancer|breast cancer
5203965|NCT00810017|Metastatic|metastatic
5203966|NCT00809991|Prostate Cancer|prostate cancer
5203967|NCT00809965|Rivaroxaban|rivaroxaban
5203968|NCT00809965|Acute Coronary Syndrome|acute coronary syndrome
5203969|NCT00809965|ACS|acs
5203970|NCT00809965|Aspirin|aspirin
5203971|NCT00809965|Thienopyridine|thienopyridine
5203972|NCT00809965|Unstable Angina|unstable angina
5203973|NCT00809965|Myocardial Infarction|myocardial infarction
5203974|NCT00809965|Anticoagulation|anticoagulation
5203975|NCT00809965|Clopidogrel (Plavix)|clopidogrel (plavix)
5203976|NCT00809939|preterm delivery|preterm delivery
5203977|NCT00809939|short cervical length|short cervical length
5203978|NCT00809939|progesterone|progesterone
5203979|NCT00809926|Hypertension, aliskiren and valsartan|hypertension, aliskiren and valsartan
5203980|NCT00809913|Urinary Tract Infection|urinary tract infection
5203981|NCT00809913|Fever|fever
5203982|NCT00809913|Acute Pyelonephritis|acute pyelonephritis
5203983|NCT00809913|Treatment duration|treatment duration
5203984|NCT00809913|Febrile Urinary Tract Infection Treatment Duration|febrile urinary tract infection treatment duration
5203985|NCT00809887|catheter fungal infections, antimicrobial lock therapy, micafungin, central venous catheter|catheter fungal infections, antimicrobial lock therapy, micafungin, central venous catheter
5203986|NCT00809874|Postprandial Period|postprandial period
5203987|NCT00809874|Postprandial Lipaemia|postprandial lipaemia
5203988|NCT00809874|Incretins|incretins
5203989|NCT00809874|Subclinical Inflammation|subclinical inflammation
5203990|NCT00809874|Obesity|obesity
5203991|NCT00809874|Atherosclerosis|atherosclerosis
5203992|NCT00809874|Triglyceride|triglyceride
5203993|NCT00809874|Lipoproteins|lipoproteins
5203994|NCT00809835|Cocaine|cocaine
5203995|NCT00809835|Methadone|methadone
5203996|NCT00809835|CBT|cbt
5203997|NCT00809822|IVIG in pemphigoid|ivig in pemphigoid
5203998|NCT00809822|Patients with bullous pemphigoid unresponsive to corticosteroids|patients with bullous pemphigoid unresponsive to corticosteroids
5203999|NCT00809809|Cold sores|cold sores
5204000|NCT00809809|Zinc|zinc
5204001|NCT00809809|HSL|hsl
5204002|NCT00809809|Herpes simple labialis|herpes simple labialis
5204003|NCT00809783|Tanezumab OA arthritis|tanezumab oa arthritis
5204004|NCT00809770|stimulant abuse|stimulant abuse
5204005|NCT00809770|drug abuse|drug abuse
5204006|NCT00809770|schizophrenia|schizophrenia
5204007|NCT00809770|bipolar disorder|bipolar disorder
5204008|NCT00809770|major depressive disorder|major depressive disorder
5204009|NCT00809770|contingency management|contingency management
5204010|NCT00809770|psychosocial treatment|psychosocial treatment
5204011|NCT00809757|Asthma|asthma
5204012|NCT00809731|Schizophrenia remission status by 8-item PANSS|schizophrenia remission status by 8-item panss
5204013|NCT00809718|Raltegravir|raltegravir
5204014|NCT00809718|Pharmacokinetics|pharmacokinetics
5204015|NCT00809718|Rifapentine|rifapentine
5204016|NCT00809718|Drug Kinetics|drug kinetics
5204017|NCT00809692|histamine biotransformation|histamine biotransformation
5204018|NCT00809692|laser Doppler flowimetry|laser doppler flowimetry
5204019|NCT00809692|pediatric pharmacology|pediatric pharmacology
5204020|NCT00809679|Postherpetic neuralgia|postherpetic neuralgia
5204021|NCT00809679|Varicella Zoster|varicella zoster
5204022|NCT00809679|Shingles|shingles
5204023|NCT00809679|Neuropathic pain|neuropathic pain
5204024|NCT00809679|Analgesia|analgesia
5204025|NCT00809679|Pain|pain
5204026|NCT00809666|pregnancy|pregnancy
5204027|NCT00809666|hypertension|hypertension
5204028|NCT00809666|mercury sphygmomanometry|mercury sphygmomanometry
5204029|NCT00809666|blood pressure|blood pressure
5204030|NCT00809666|automated blood pressure|automated blood pressure
5204031|NCT00809666|pre eclampsia|pre eclampsia
5204032|NCT00809666|Hypertension in pregnancy|hypertension in pregnancy
5204033|NCT00809653|Air pollution|air pollution
5204034|NCT00809653|Face mask|face mask
5204035|NCT00809653|Myocardial ischaemia|myocardial ischaemia
5204036|NCT00809653|Heart rate variability|heart rate variability
5204037|NCT00809653|Angina pectoris|angina pectoris
5204038|NCT00809653|Coronary heart disease|coronary heart disease
5204039|NCT00809640|low back pain|low back pain
5204040|NCT00809640|prevention|prevention
5204041|NCT00809640|schoolchildren|schoolchildren
5204042|NCT00809640|education campaign|education campaign
5204043|NCT00809627|headache|headache
5204044|NCT00809627|caffeine|caffeine
5204045|NCT00809627|pain|pain
5204046|NCT00809614|Psoriatic arthritis|psoriatic arthritis
5204047|NCT00809614|IgG1K monoclonal antibody|igg1k monoclonal antibody
5204048|NCT00809614|Interleukin -17A neutralizing|interleukin -17a neutralizing
5204049|NCT00809588|vaccination|vaccination
5204050|NCT00809588|GM-CSF|gm-csf
5204051|NCT00809588|autologous|autologous
5204052|NCT00809588|irradiated|irradiated
5204053|NCT00809575|adult|adult
5204054|NCT00809575|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5204055|NCT00809575|Quality of life|quality of life
5204056|NCT00809575|Patient reported outcomes|patient reported outcomes
5204057|NCT00809549|Stroke|stroke
5204058|NCT00809549|GCSF|gcsf
5204059|NCT00809549|Hematopoeitic|hematopoeitic
5204060|NCT00809549|Neupogen|neupogen
5204061|NCT00809549|Filgrastim|filgrastim
5204062|NCT00809536|metformin, PD 0332334, organic cation transporter, OCT2, pharmacokinetics|metformin, pd 0332334, organic cation transporter, oct2, pharmacokinetics
5204063|NCT00809523|SAD|sad
5204064|NCT00809523|winter depression|winter depression
5204065|NCT00809497|PLC for treatment of peripheral arterial diseases|plc for treatment of peripheral arterial diseases
5204066|NCT00809484|Arimidex|arimidex
5204067|NCT00809484|Bone Mineral density|bone mineral density
5204068|NCT00809484|Bisphosphonates|bisphosphonates
5204069|NCT00809484|Aromatase Inhibitors|aromatase inhibitors
5204070|NCT00809471|ED|ed
5204071|NCT00809471|Erectile Dysfunction|erectile dysfunction
5204072|NCT00809471|Dysfunction|dysfunction
5204073|NCT00809471|Diabetic|diabetic
5204074|NCT00809471|Erectile|erectile
5204075|NCT00809458|Vitamin E|vitamin e
5204076|NCT00809458|Prostate Cancer|prostate cancer
5204077|NCT00809458|Alpha-tocopherol (α-tocopherol)|alpha-tocopherol (α-tocopherol)
5204078|NCT00809432|Air pollution|air pollution
5204079|NCT00809432|Heart rate|heart rate
5204080|NCT00809432|Heart rate variability|heart rate variability
5204081|NCT00809432|Blood pressure|blood pressure
5204082|NCT00809432|Face mask|face mask
5204083|NCT00809419|Brachytherapy|brachytherapy
5204084|NCT00809419|EpiRad|epirad
5204085|NCT00809419|Macular Degeneration|macular degeneration
5204086|NCT00809419|Ranibizumab|ranibizumab
5204087|NCT00809393|Antifibrinolytic|antifibrinolytic
5204088|NCT00809393|Tranexamic acid|tranexamic acid
5204089|NCT00809393|Cardiopulmonary bypass|cardiopulmonary bypass
5204090|NCT00809393|Transfusion|transfusion
5204091|NCT00809393|Hemorrhage|hemorrhage
5204092|NCT00809380|Conscious sedation|conscious sedation
5204093|NCT00809380|Parental presence|parental presence
5204094|NCT00809380|Invasive procedure|invasive procedure
5204095|NCT00809380|Children|children
5204096|NCT00809380|Anxiety|anxiety
5204097|NCT00809367|MDS|mds
5204098|NCT00809367|AML|aml
5204099|NCT00809367|banking study|banking study
5204100|NCT00809354|monoclonal antibody|monoclonal antibody
5204101|NCT00809354|nerve growth factor (NGF)|nerve growth factor (ngf)
5204102|NCT00809354|anti-NGF|anti-ngf
5204103|NCT00809354|tanezumab|tanezumab
5204104|NCT00809354|PF-04383119|pf-04383119
5204105|NCT00809354|RN624|rn624
5204106|NCT00809354|osteoarthritis (OA)|osteoarthritis (oa)
5204107|NCT00809341|B-Cell|b-cell
5204108|NCT00809341|non-Hodgkin's|non-hodgkin's
5204109|NCT00809341|Lymphoma|lymphoma
5204110|NCT00809315|Child abuse and neglect|child abuse and neglect
5204111|NCT00809315|Out-of-home care|out-of-home care
5204112|NCT00809315|Mentoring|mentoring
5204113|NCT00809315|Skills groups|skills groups
5204114|NCT00809315|Assessment|assessment
5204115|NCT00809315|Functioning as a result of maltreatment and placement in out-of-home care|functioning as a result of maltreatment and placement in out-of-home care
5204116|NCT00809289|Thorough QT/QTc study|thorough qt/qtc study
5204117|NCT00809276|Acute lymphocytic leukemia (ALL)|acute lymphocytic leukemia (all)
5204118|NCT00809276|Acute myeloid leukemia (AML)|acute myeloid leukemia (aml)
5204119|NCT00809276|Acute Leukemia|acute leukemia
5204120|NCT00809276|Refractory or Relapsed AML|refractory or relapsed aml
5204121|NCT00809276|Myelodysplastic syndrome (MDS)|myelodysplastic syndrome (mds)
5204122|NCT00809276|Chronic myeloid leukemia (CML)|chronic myeloid leukemia (cml)
5204123|NCT00809276|Chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5204124|NCT00809276|Hodgkin's Lymphoma|hodgkin's lymphoma
5204125|NCT00809276|Non-Hodgkin's lymphoma|non-hodgkin's lymphoma
5204126|NCT00809276|Philadelphia-negative myeloproliferative disorder|philadelphia-negative myeloproliferative disorder
5204127|NCT00809276|Hematologic Malignancies|hematologic malignancies
5204128|NCT00809276|Transplantation|transplantation
5204129|NCT00809276|Busulfan|busulfan
5204130|NCT00809276|Fludarabine|fludarabine
5204131|NCT00809276|Cytoxan|cytoxan
5204132|NCT00809276|Bone Marrow|bone marrow
5204133|NCT00809276|Allogeneic|allogeneic
5204134|NCT00809276|Related donor|related donor
5204135|NCT00809276|unrelated donor|unrelated donor
5204136|NCT00809263|homeopathy|homeopathy
5204137|NCT00809263|homeopathic drug proving|homeopathic drug proving
5204138|NCT00809263|Document symptoms associated with administration of a homeopathic remedy.|document symptoms associated with administration of a homeopathic remedy.
5204139|NCT00809250|vaccination|vaccination
5204140|NCT00809250|AML|aml
5204141|NCT00809250|CMML|cmml
5204142|NCT00809250|MDS-RAEB|mds-raeb
5204143|NCT00809237|Non-small cell lung cancer|non-small cell lung cancer
5204144|NCT00809237|Gefitinib|gefitinib
5204145|NCT00809237|Hydroxychloroquine|hydroxychloroquine
5204146|NCT00809224|ALS|als
5204147|NCT00809224|amyotrophic lateral sclerosis|amyotrophic lateral sclerosis
5204148|NCT00809224|brain-computer interface|brain-computer interface
5204149|NCT00809224|functional magnetic resonance imaging|functional magnetic resonance imaging
5204150|NCT00809224|radiology|radiology
5204151|NCT00809224|fMRI|fmri
5204152|NCT00809211|chronic myelogenous leukemia, BCR-ABL1 positive|chronic myelogenous leukemia, bcr-abl1 positive
5204153|NCT00809211|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5204154|NCT00809198|Sodium Hyaluronate, Kynex, Carboxymethylcellulose sodium|sodium hyaluronate, kynex, carboxymethylcellulose sodium
5204155|NCT00809198|Refresh Plus|refresh plus
5204156|NCT00809198|Dry Eye|dry eye
5204157|NCT00809198|Cornea Staining|cornea staining
5204158|NCT00809198|TBUT|tbut
5204159|NCT00809185|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5204160|NCT00809185|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5204161|NCT00809185|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5204162|NCT00809172|Atopic-dermatitis|atopic-dermatitis
5204163|NCT00809172|scorad|scorad
5204164|NCT00809172|methotrexate|methotrexate
5204165|NCT00809172|ciclosporin|ciclosporin
5204166|NCT00809159|ankylosing spondylitis|ankylosing spondylitis
5204167|NCT00809146|Status Epilepticus|status epilepticus
5204168|NCT00809146|Emergency Medical Services|emergency medical services
5204169|NCT00809146|Anticonvulsants|anticonvulsants
5204170|NCT00809146|Drug Administration Routes|drug administration routes
5204171|NCT00809146|Seizures|seizures
5204172|NCT00809120|Electrostimulation|electrostimulation
5204173|NCT00809120|COPD|copd
5204174|NCT00809120|Tolerance|tolerance
5204175|NCT00809120|Muscle fatigue|muscle fatigue
5204176|NCT00809120|Cardio-respiratory response|cardio-respiratory response
5204177|NCT00809107|natural cycle|natural cycle
5204178|NCT00809107|FET|fet
5204179|NCT00809107|spontaneous LH pic|spontaneous lh pic
5204180|NCT00809107|HCG|hcg
5204181|NCT00809081|periampullar carcinoma|periampullar carcinoma
5204182|NCT00809081|Pancreaticoduodenectomy|pancreaticoduodenectomy
5204183|NCT00809081|Enteral feeding|enteral feeding
5204184|NCT00809081|Total Parenteral Support|total parenteral support
5204185|NCT00809068|Menopause|menopause
5204186|NCT00809068|menopausal symptoms|menopausal symptoms
5204187|NCT00809068|tibolone|tibolone
5204188|NCT00809068|HDL-C|hdl-c
5204189|NCT00809068|fenofibrate|fenofibrate
5204190|NCT00809042|Hydroxyurea|hydroxyurea
5204191|NCT00809042|magnesium chloride|magnesium chloride
5204192|NCT00809042|L-carnitine|l-carnitine
5204193|NCT00809042|β-thalassemia intermedia|β-thalassemia intermedia
5204194|NCT00809029|GIP|gip
5204195|NCT00809029|OBESITY|obesity
5204196|NCT00809029|HSL|hsl
5204197|NCT00809029|LPL|lpl
5204198|NCT00809029|ADIPOCYTOKINES|adipocytokines
5204199|NCT00809029|BARIATRIC SURGERY|bariatric surgery
5204200|NCT00809016|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
5204201|NCT00809016|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
5204202|NCT00809016|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5204203|NCT00809016|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
5204204|NCT00809016|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
5204205|NCT00809016|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5204206|NCT00809016|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
5204207|NCT00809016|stage III verrucous carcinoma of the larynx|stage iii verrucous carcinoma of the larynx
5204208|NCT00809016|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
5204209|NCT00809016|recurrent adenoid cystic carcinoma of the oral cavity|recurrent adenoid cystic carcinoma of the oral cavity
5204210|NCT00809016|recurrent mucoepidermoid carcinoma of the oral cavity|recurrent mucoepidermoid carcinoma of the oral cavity
5204211|NCT00809016|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
5204212|NCT00809016|stage III adenoid cystic carcinoma of the oral cavity|stage iii adenoid cystic carcinoma of the oral cavity
5204213|NCT00809016|stage III mucoepidermoid carcinoma of the oral cavity|stage iii mucoepidermoid carcinoma of the oral cavity
5204214|NCT00809016|stage III verrucous carcinoma of the oral cavity|stage iii verrucous carcinoma of the oral cavity
5204215|NCT00809016|stage IV adenoid cystic carcinoma of the oral cavity|stage iv adenoid cystic carcinoma of the oral cavity
5204216|NCT00809016|stage IV mucoepidermoid carcinoma of the oral cavity|stage iv mucoepidermoid carcinoma of the oral cavity
5204217|NCT00809016|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
5204218|NCT00809016|recurrent basal cell carcinoma of the lip|recurrent basal cell carcinoma of the lip
5204219|NCT00809016|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
5204220|NCT00809016|stage III basal cell carcinoma of the lip|stage iii basal cell carcinoma of the lip
5204221|NCT00809016|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
5204222|NCT00809016|stage IV basal cell carcinoma of the lip|stage iv basal cell carcinoma of the lip
5204223|NCT00809016|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5204224|NCT00809016|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
5204225|NCT00809016|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
5204226|NCT00809016|untreated metastatic squamous neck cancer with occult primary|untreated metastatic squamous neck cancer with occult primary
5204227|NCT00809016|recurrent lymphoepithelioma of the oropharynx|recurrent lymphoepithelioma of the oropharynx
5204228|NCT00809016|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
5204229|NCT00809016|stage III lymphoepithelioma of the oropharynx|stage iii lymphoepithelioma of the oropharynx
5204230|NCT00809016|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
5204231|NCT00809016|stage IV lymphoepithelioma of the oropharynx|stage iv lymphoepithelioma of the oropharynx
5204232|NCT00809016|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5204233|NCT00809016|high-grade salivary gland mucoepidermoid carcinoma|high-grade salivary gland mucoepidermoid carcinoma
5204234|NCT00809016|low-grade salivary gland mucoepidermoid carcinoma|low-grade salivary gland mucoepidermoid carcinoma
5204235|NCT00809016|recurrent salivary gland cancer|recurrent salivary gland cancer
5204236|NCT00809016|salivary gland acinic cell tumor|salivary gland acinic cell tumor
5204237|NCT00809016|salivary gland adenocarcinoma|salivary gland adenocarcinoma
5204330|NCT00808665|General Anesthesia|general anesthesia
5204238|NCT00809016|salivary gland adenoid cystic carcinoma|salivary gland adenoid cystic carcinoma
5204239|NCT00809016|salivary gland anaplastic carcinoma|salivary gland anaplastic carcinoma
5204240|NCT00809016|salivary gland malignant mixed cell type tumor|salivary gland malignant mixed cell type tumor
5204241|NCT00809016|salivary gland poorly differentiated carcinoma|salivary gland poorly differentiated carcinoma
5204242|NCT00809016|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
5204243|NCT00809016|stage III salivary gland cancer|stage iii salivary gland cancer
5204244|NCT00809016|stage IV salivary gland cancer|stage iv salivary gland cancer
5204245|NCT00809003|Non dry eyed(normals)|non dry eyed(normals)
5204246|NCT00808990|Non Alcoholic Fatty Liver Disease|non alcoholic fatty liver disease
5204247|NCT00808990|Non Alcoholic SteatoHepatitis|non alcoholic steatohepatitis
5204248|NCT00808990|Small bowel bacterial overgrowth|small bowel bacterial overgrowth
5204249|NCT00808990|Probiotics|probiotics
5204250|NCT00808990|Patients with Non Alcoholic Fatty Liver Disease|patients with non alcoholic fatty liver disease
5204251|NCT00808964|CABG|cabg
5204252|NCT00808964|anticoagulant|anticoagulant
5204253|NCT00808964|Off-Pump CABG|off-pump cabg
5204254|NCT00808951|Uncomplicated malaria|uncomplicated malaria
5204255|NCT00808951|P falciparum|p falciparum
5204256|NCT00808951|Children|children
5204257|NCT00808951|National treatment protocol|national treatment protocol
5204258|NCT00808951|Burkina Faso|burkina faso
5204259|NCT00808951|Artemether-lumefantrine|artemether-lumefantrine
5204260|NCT00808951|Artesunate-amodiaquine|artesunate-amodiaquine
5204261|NCT00808951|In vivo efficacy|in vivo efficacy
5204262|NCT00808951|In vitro efficacy|in vitro efficacy
5204263|NCT00808925|acclimation|acclimation
5204264|NCT00808925|heat|heat
5204265|NCT00808925|cytokines|cytokines
5204266|NCT00808925|stress|stress
5204267|NCT00808925|inflammation|inflammation
5204268|NCT00808912|phosphodiesterase|phosphodiesterase
5204269|NCT00808912|sildenafil|sildenafil
5204270|NCT00808912|pulmonary hypertension|pulmonary hypertension
5204271|NCT00808912|exercise performance|exercise performance
5204272|NCT00808912|air pollution|air pollution
5204273|NCT00808899|Neuroblastoma|neuroblastoma
5204274|NCT00808886|cataract|cataract
5204275|NCT00808886|locs3|locs3
5204276|NCT00808886|pentacam|pentacam
5204277|NCT00808873|attempted suicide|attempted suicide
5204278|NCT00808873|socio-educational intervention|socio-educational intervention
5204279|NCT00808873|follow up study|follow up study
5204280|NCT00808860|Herbal medicine|herbal medicine
5204281|NCT00808860|Type 2 diabetes|type 2 diabetes
5204282|NCT00808860|Gynostemma pentaphyllum Tea|gynostemma pentaphyllum tea
5204283|NCT00808860|Insulin sensitivity|insulin sensitivity
5204284|NCT00808860|add-on|add-on
5204285|NCT00808808|FluMist, TIV, vaccination rates|flumist, tiv, vaccination rates
5204286|NCT00808795|Acute kidney injury|acute kidney injury
5204287|NCT00808795|contrast-induced nephropathy|contrast-induced nephropathy
5204288|NCT00808795|Chronic kidney disease|chronic kidney disease
5204289|NCT00808795|Diabetes mellitus|diabetes mellitus
5204290|NCT00808795|N-acetylcysteine|n-acetylcysteine
5204291|NCT00808782|Pervasive Developmental Disorders|pervasive developmental disorders
5204292|NCT00808782|Asperger Syndrome|asperger syndrome
5204293|NCT00808782|Autism|autism
5204294|NCT00808756|Carbohydrates|carbohydrates
5204295|NCT00808756|Infant|infant
5204296|NCT00808756|Intestine|intestine
5204297|NCT00808756|Faeces|faeces
5204298|NCT00808756|Growth|growth
5204299|NCT00808756|Diet|diet
5204300|NCT00808743|Familial adenomatous polyposis|familial adenomatous polyposis
5204301|NCT00808743|Adenomatous Polyposis Coli|adenomatous polyposis coli
5204302|NCT00808743|Digestive System Neoplasms|digestive system neoplasms
5204303|NCT00808743|Gastrointestinal Disease|gastrointestinal disease
5204304|NCT00808743|Intestinal disease|intestinal disease
5204305|NCT00808743|Intestinal neoplasms|intestinal neoplasms
5204306|NCT00808743|Gastrointestinal neoplasms|gastrointestinal neoplasms
5204307|NCT00808743|Polyps|polyps
5204308|NCT00808743|Adenoma|adenoma
5204309|NCT00808743|Adenomatous Polyps|adenomatous polyps
5204310|NCT00808743|Neoplastic Syndromes, Hereditary|neoplastic syndromes, hereditary
5204311|NCT00808743|Digestive System Diseases|digestive system diseases
5204312|NCT00808743|Genetic Diseases, Inborn|genetic diseases, inborn
5204313|NCT00808743|Chemoprevention|chemoprevention
5204314|NCT00808743|Celecoxib|celecoxib
5204315|NCT00808743|Ursodeoxycholic acid|ursodeoxycholic acid
5204316|NCT00808743|Anti-Inflammatory agents, Non-Steroidal|anti-inflammatory agents, non-steroidal
5204317|NCT00808743|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors
5204318|NCT00808730|Asthma, airway remodelling, smooth muscle, mitochondria|asthma, airway remodelling, smooth muscle, mitochondria
5204319|NCT00808717|Myocardial Infarction|myocardial infarction
5204320|NCT00808717|Coronary Angioplasty|coronary angioplasty
5204321|NCT00808717|Myocardial infarction, Angioplasty, Transluminal, Percutaneous Coronary|myocardial infarction, angioplasty, transluminal, percutaneous coronary
5204322|NCT00808704|asphyxia|asphyxia
5204323|NCT00808704|erythropoietin|erythropoietin
5204324|NCT00808704|neonates|neonates
5204325|NCT00808678|Adverse Events|adverse events
5204326|NCT00808665|Lumbar Fusion|lumbar fusion
5204327|NCT00808665|Inflammation|inflammation
5204328|NCT00808665|Dexmedetomidine|dexmedetomidine
5204329|NCT00808665|Length of Hospital Stay|length of hospital stay
5204331|NCT00808665|Anti-inflammatory|anti-inflammatory
5204332|NCT00808665|GPCR|gpcr
5204333|NCT00808665|Cytokine|cytokine
5204334|NCT00808665|Immune Response|immune response
5204335|NCT00808639|pegfilgrastim|pegfilgrastim
5204336|NCT00808639|MVAC|mvac
5204337|NCT00808600|lung transplantation|lung transplantation
5204338|NCT00808600|heart-lung transplantation|heart-lung transplantation
5204339|NCT00808600|rehabilitation|rehabilitation
5204340|NCT00808600|resource-activating training|resource-activating training
5204341|NCT00808600|anaerobic exercise training|anaerobic exercise training
5204342|NCT00808587|Genomic Scan|genomic scan
5204343|NCT00808587|Personalized Medicine|personalized medicine
5204344|NCT00808587|Gene testing|gene testing
5204345|NCT00808574|Obstructive sleep apnea|obstructive sleep apnea
5204346|NCT00808574|Internet|internet
5204347|NCT00808574|Screening|screening
5204348|NCT00808574|Health belief model|health belief model
5204349|NCT00808548|stress|stress
5204350|NCT00808548|carer's experiences|carer's experiences
5204351|NCT00808548|Prader-willi syndrome|prader-willi syndrome
5204352|NCT00808548|personal experiences|personal experiences
5204353|NCT00808535|Endothelial dysfunction|endothelial dysfunction
5204354|NCT00808535|Cardiac Perfusion MRI|cardiac perfusion mri
5204355|NCT00808535|Vasomotor Stress|vasomotor stress
5204356|NCT00808535|Cold Pressor Test|cold pressor test
5204357|NCT00808535|Adenosine Stress|adenosine stress
5204358|NCT00808522|Breast Cancer|breast cancer
5204359|NCT00808522|Chemoprevention|chemoprevention
5204360|NCT00808522|Tamoxifen|tamoxifen
5204361|NCT00808522|Breast density|breast density
5204362|NCT00808522|Hcg|hcg
5204363|NCT00808509|adalimumab,Remission,drug discontinuation|adalimumab,remission,drug discontinuation
5204364|NCT00808496|Magnetic resonance imaging|magnetic resonance imaging
5204365|NCT00808496|Radiography|radiography
5204366|NCT00808496|Randomized controlled trial|randomized controlled trial
5204367|NCT00808496|Antirheumatic agents|antirheumatic agents
5204368|NCT00808483|total hip arthroplasty|total hip arthroplasty
5204369|NCT00808483|physical functioning|physical functioning
5204370|NCT00808483|training program|training program
5204371|NCT00808483|self-efficacy|self-efficacy
5204372|NCT00808483|exercise therapy|exercise therapy
5204373|NCT00808483|walking|walking
5204374|NCT00808470|Noise|noise
5204375|NCT00808470|Hearing Loss|hearing loss
5204376|NCT00808470|Tinnitus|tinnitus
5204377|NCT00808470|Antioxidant|antioxidant
5204378|NCT00808470|Vasodilator|vasodilator
5204379|NCT00808470|Beta-Carotene|beta-carotene
5204380|NCT00808470|Vitamin C|vitamin c
5204381|NCT00808470|Vitamin E|vitamin e
5204382|NCT00808470|Magnesium|magnesium
5204383|NCT00808457|chest ultrasound|chest ultrasound
5204384|NCT00808457|pneumonia|pneumonia
5204385|NCT00808457|X-ray|x-ray
5204386|NCT00808457|CT|ct
5204387|NCT00808457|Sensitivity and specificity of chest ultrasound in diagnosing pneumonia|sensitivity and specificity of chest ultrasound in diagnosing pneumonia
5204388|NCT00808444|Pneumococcal vaccine|pneumococcal vaccine
5204389|NCT00808444|Immunogenicity|immunogenicity
5204390|NCT00808444|Primary vaccination|primary vaccination
5204391|NCT00808444|Safety|safety
5204392|NCT00808444|Pneumococcal disease|pneumococcal disease
5204393|NCT00808431|Obesity|obesity
5204394|NCT00808431|Diabetes|diabetes
5204395|NCT00808431|Physical Activity|physical activity
5204396|NCT00808431|Child Feeding|child feeding
5204397|NCT00808431|Growth Trajectories|growth trajectories
5204398|NCT00808431|Family based|family based
5204399|NCT00808418|prostate|prostate
5204401|NCT00808418|metastatic|metastatic
5204402|NCT00808418|castration|castration
5204403|NCT00808418|refractory|refractory
5204404|NCT00808418|elesclomol|elesclomol
5204405|NCT00808418|sodium|sodium
5204406|NCT00808418|docetaxel|docetaxel
5204407|NCT00808418|prednisone|prednisone
5204408|NCT00808405|herpes simplex virus|herpes simplex virus
5204409|NCT00808405|acyclovir|acyclovir
5204410|NCT00808405|HSV shedding|hsv shedding
5204411|NCT00808405|women|women
5204412|NCT00808405|Africa|africa
5204413|NCT00808392|vaccine|vaccine
5204414|NCT00808392|prevention|prevention
5204415|NCT00808392|haemophilus influenzae type b|haemophilus influenzae type b
5204416|NCT00808392|children|children
5204417|NCT00808379|Unresectable rectal cancers|unresectable rectal cancers
5204418|NCT00808353|CVD|cvd
5204419|NCT00808327|Cesarean section|cesarean section
5204420|NCT00808327|Spinal|spinal
5204421|NCT00808314|Lexiscan(TM)|lexiscan(tm)
5204422|NCT00808314|Dipyridamole|dipyridamole
5204423|NCT00808314|Myocardial Perfusion|myocardial perfusion
5204424|NCT00808314|Positron Emission Computed Tomography|positron emission computed tomography
5204425|NCT00808301|Coeliac disease|coeliac disease
5204426|NCT00808301|Oat|oat
5204427|NCT00808288|COPD Respiratory Long acting beta agonist|copd respiratory long acting beta agonist
5204428|NCT00808275|dietary calcium|dietary calcium
5204429|NCT00808275|weight loss|weight loss
5204430|NCT00808262|anti-TNFa|anti-tnfa
5204431|NCT00808262|immunization|immunization
5204432|NCT00808262|kinoid|kinoid
5204433|NCT00808262|crohn's disease|crohn's disease
5204434|NCT00808249|Generalized Anxiety Disorder|generalized anxiety disorder
5204435|NCT00808249|GAD|gad
5204436|NCT00808249|Anxiety|anxiety
5204437|NCT00808236|Cardiac Arrest|cardiac arrest
5204438|NCT00808236|Pre-hospital|pre-hospital
5204439|NCT00808236|Mild hypothermia|mild hypothermia
5204440|NCT00808236|Resuscitation|resuscitation
5204441|NCT00808223|alefacept|alefacept
5204442|NCT00808223|adolescent|adolescent
5204443|NCT00808223|psoriasis|psoriasis
5204444|NCT00808210|RA|ra
5204445|NCT00808210|Arthritis|arthritis
5204446|NCT00808197|AMD|amd
5204447|NCT00808197|choroidal blood flow|choroidal blood flow
5204448|NCT00808197|fellow eye in patients with unilateral choroidal neovascularisation|fellow eye in patients with unilateral choroidal neovascularisation
5204449|NCT00808184|Histologically or cytologically proven solid tumour for which CPT-11 given by the Folfiri regimen|histologically or cytologically proven solid tumour for which cpt-11 given by the folfiri regimen
5204450|NCT00808171|lumbar punction|lumbar punction
5204451|NCT00808171|myelogram|myelogram
5204452|NCT00808171|pain assessment|pain assessment
5204453|NCT00808171|nitrous oxide and EMLA|nitrous oxide and emla
5204454|NCT00808171|Leukemia and non Hodgkin lymphoma|leukemia and non hodgkin lymphoma
5204455|NCT00808145|Treatment of advanced liver cancer|treatment of advanced liver cancer
5204456|NCT00808132|Postmenopausal Women|postmenopausal women
5204457|NCT00808132|Bazedoxifene/Conjugated Estrogens|bazedoxifene/conjugated estrogens
5204458|NCT00808106|Albinism|albinism
5204459|NCT00808106|Oculocutaneous Albinism|oculocutaneous albinism
5204460|NCT00808106|Pigmentation|pigmentation
5204461|NCT00808106|Natural History|natural history
5204462|NCT00808106|Vesical Biology|vesical biology
5204463|NCT00808093|Food Effect|food effect
5204464|NCT00808093|GSK256073F|gsk256073f
5204465|NCT00808093|TRIS Salt|tris salt
5204466|NCT00808080|AML|aml
5204467|NCT00808054|Pain|pain
5204468|NCT00808054|preterm neonate|preterm neonate
5204469|NCT00808054|pain assessment|pain assessment
5204470|NCT00808054|EMLA|emla
5204471|NCT00808054|oral glucose|oral glucose
5204472|NCT00808041|Neoadjuvant Treatment|neoadjuvant treatment
5204473|NCT00808041|Therapy Response|therapy response
5204474|NCT00808041|Breast Computed Tomography|breast computed tomography
5204475|NCT00808015|Observational non-interventional trial|observational non-interventional trial
5204476|NCT00808002|Maraviroc|maraviroc
5204477|NCT00808002|CCR5 antagonists|ccr5 antagonists
5204478|NCT00808002|Primary HIV Infection|primary hiv infection
5204479|NCT00808002|HIV-1 reservoir|hiv-1 reservoir
5204480|NCT00808002|eradication|eradication
5204481|NCT00808002|treatment naive|treatment naive
5204482|NCT00807976|Diabetes mellitus|diabetes mellitus
5204483|NCT00807976|Elderly|elderly
5204484|NCT00807976|Orthostatic hypotension|orthostatic hypotension
5204485|NCT00807963|Pharmacokinetics|pharmacokinetics
5204486|NCT00807963|rHuPH20|rhuph20
5204487|NCT00807937|Generalized Anxiety Disorder|generalized anxiety disorder
5204488|NCT00807937|GAD|gad
5204489|NCT00807937|Anxiety|anxiety
5204490|NCT00807924|Fibroadenomas|fibroadenomas
5204491|NCT00807924|Papillomas|papillomas
5204492|NCT00807924|Breast|breast
5204493|NCT00807924|Minimally invasive|minimally invasive
5204494|NCT00807924|Interstitial laser therapy|interstitial laser therapy
5204495|NCT00807924|Laser ablation|laser ablation
5204496|NCT00807924|Benign|benign
5204497|NCT00807924|Non-cancerous|non-cancerous
5204498|NCT00807924|Breast lesion|breast lesion
5204499|NCT00807924|Breast tumor|breast tumor
5204500|NCT00807911|rectal cancer|rectal cancer
5204501|NCT00807911|adjuvant chemotherapy|adjuvant chemotherapy
5204502|NCT00807911|FOLFOX|folfox
5204503|NCT00807898|Gardasil|gardasil
5204504|NCT00807898|HPV vaccine|hpv vaccine
5204505|NCT00807898|decision making|decision making
5204506|NCT00807898|mother|mother
5204507|NCT00807898|daughter|daughter
5204508|NCT00807885|dehydration|dehydration
5204509|NCT00807885|fluid therapy|fluid therapy
5204510|NCT00807885|hyaluronoglucosaminidase|hyaluronoglucosaminidase
5204511|NCT00807885|hyaluronidase|hyaluronidase
5204512|NCT00807885|hypodermoclysis|hypodermoclysis
5204513|NCT00807885|clysis|clysis
5204514|NCT00807885|subcutaneous hydration|subcutaneous hydration
5204515|NCT00807885|subcutaneous rehydration|subcutaneous rehydration
5204516|NCT00807885|hyaluronan|hyaluronan
5204517|NCT00807885|rHuPH20|rhuph20
5204518|NCT00807872|Radioimmunoimaging|radioimmunoimaging
5204519|NCT00807872|AL Amyloidosis|al amyloidosis
5204520|NCT00807872|PET/CT|pet/ct
5204521|NCT00807859|AMG 386|amg 386
5204522|NCT00807859|Paclitaxel|paclitaxel
5204523|NCT00807859|Trastuzumab|trastuzumab
5204524|NCT00807859|Capecitabine|capecitabine
5204525|NCT00807859|Lapatinib|lapatinib
5204526|NCT00807859|HER2-positive|her2-positive
5204527|NCT00807859|metastatic breast cancer|metastatic breast cancer
5204528|NCT00807859|locally recurrent breast cancer|locally recurrent breast cancer
5204529|NCT00807859|Taxol|taxol
5204530|NCT00807859|Herceptin|herceptin
5204531|NCT00807859|Xeloda|xeloda
5204532|NCT00807859|Tykerb|tykerb
5204533|NCT00807859|anti-angiogenic therapy|anti-angiogenic therapy
5204534|NCT00807846|Juvenile Arthritis; Juvenile Rheumatoid Arthritis;Blood Pressure;Juvenile Idiopathic Arthritis|juvenile arthritis; juvenile rheumatoid arthritis;blood pressure;juvenile idiopathic arthritis
5204535|NCT00807833|SAH|sah
5204536|NCT00807833|TBI|tbi
5204537|NCT00807820|Prostate Cancer|prostate cancer
5204538|NCT00807807|Plasma Homocysteine Concentration|plasma homocysteine concentration
5204539|NCT00807807|Folate|folate
5204540|NCT00807807|Homocysteine|homocysteine
5204541|NCT00807807|Supplements|supplements
5204542|NCT00807807|Folic Acid|folic acid
5204543|NCT00807755|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5204544|NCT00807755|extensive stage small cell lung cancer|extensive stage small cell lung cancer
5204545|NCT00807755|recurrent small cell lung cancer|recurrent small cell lung cancer
5204546|NCT00807742|Contingency management for smoking for substance abusers|contingency management for smoking for substance abusers
5204547|NCT00807742|Contingency reinforcement for smoking abstinence|contingency reinforcement for smoking abstinence
5204548|NCT00807742|Contingency Management|contingency management
5204549|NCT00807742|Noncontingent Reinforcement|noncontingent reinforcement
5204550|NCT00807729|Laparoscopy|laparoscopy
5204551|NCT00807729|Endoscopic retrograde cholangiopancreatography|endoscopic retrograde cholangiopancreatography
5204552|NCT00807729|Sphincterotomy|sphincterotomy
5204553|NCT00807729|Common bile duct stones|common bile duct stones
5204554|NCT00807729|Laparoscoopic common bile duct exploration|laparoscoopic common bile duct exploration
5204555|NCT00807729|Cost efficiency|cost efficiency
5204556|NCT00807729|Examination of efficacy, safety, cost of intervention for patients with choleclithiasis and likely common bile duct stones|examination of efficacy, safety, cost of intervention for patients with choleclithiasis and likely common bile duct stones
5204557|NCT00807716|physiotherapy|physiotherapy
5204558|NCT00807716|functional outcome|functional outcome
5204559|NCT00807716|activity level|activity level
5204560|NCT00807716|self efficacy|self efficacy
5204561|NCT00807716|task oriented exercises|task oriented exercises
5204562|NCT00807703|Parkinson|parkinson
5204563|NCT00807703|deep brain stimulation (DBS)|deep brain stimulation (dbs)
5204564|NCT00807703|subthalamic nucleus (STN)|subthalamic nucleus (stn)
5204565|NCT00807703|Parkinson patients|parkinson patients
5204566|NCT00807690|vitiligo|vitiligo
5204567|NCT00807690|tacrolimus ointment 0.1%|tacrolimus ointment 0.1%
5204568|NCT00807690|narrowband UVB (TL01)|narrowband uvb (tl01)
5204569|NCT00807677|Chronic myelogenous leukemia (CML) in chronic phase, accelerated phase, or blast crisis|chronic myelogenous leukemia (cml) in chronic phase, accelerated phase, or blast crisis
5204570|NCT00807677|Intermediate or high risk myelodysplastic syndrome|intermediate or high risk myelodysplastic syndrome
5204571|NCT00807677|Philadelphia chromosome-negative CML (including blast phase)|philadelphia chromosome-negative cml (including blast phase)
5204572|NCT00807677|All subtypes of myeloid metaplasia with myelofibrosis; advanced polycythemia|all subtypes of myeloid metaplasia with myelofibrosis; advanced polycythemia
5204573|NCT00807651|Diabetes Mellitus|diabetes mellitus
5204574|NCT00807651|Stem cells|stem cells
5204575|NCT00807651|Autologous stem cell transplantation|autologous stem cell transplantation
5204576|NCT00807651|Autoimmune diseases|autoimmune diseases
5204577|NCT00807625|HIV/AIDS|hiv/aids
5204578|NCT00807625|Contraception|contraception
5204579|NCT00807625|Birth control|birth control
5204580|NCT00807625|CD4+|cd4+
5204581|NCT00807625|Viral Load|viral load
5204582|NCT00807625|T-cell activation|t-cell activation
5204583|NCT00807625|B-cell activation|b-cell activation
5204584|NCT00807625|Hormonal|hormonal
5204585|NCT00807625|Intrauterine device|intrauterine device
5204586|NCT00807625|Depo Provera|depo provera
5204587|NCT00807625|Women|women
5204588|NCT00807625|IUCD|iucd
5204589|NCT00807625|treatment naive|treatment naive
5204590|NCT00807612|AMG 479|amg 479
5204591|NCT00807612|IGF-1R|igf-1r
5204592|NCT00807612|Apoptosis|apoptosis
5204593|NCT00807612|Monoclonal Antibody|monoclonal antibody
5204594|NCT00807612|Advanced Squamous Non-Small Cell Lung Cancer|advanced squamous non-small cell lung cancer
5204595|NCT00807612|antibody 1st-line|antibody 1st-line
5204596|NCT00807599|CYCLOPHOSPHAMIDE (CYTOXAN)|cyclophosphamide (cytoxan)
5204597|NCT00807599|DEXAMETHASONE|dexamethasone
5204598|NCT00807599|G-CSF|g-csf
5204599|NCT00807599|Lenalidomide|lenalidomide
5204600|NCT00807599|MELPHALAN|melphalan
5204601|NCT00807599|PEG-FILGRASTIM (NEULASTA)|peg-filgrastim (neulasta)
5204602|NCT00807599|08-121|08-121
5204603|NCT00807586|Atrial Fibrillation|atrial fibrillation
5204604|NCT00807586|Corticosteroid|corticosteroid
5204605|NCT00807586|Radiofrequency catheter ablation for atrial fibrillation|radiofrequency catheter ablation for atrial fibrillation
5204606|NCT00807573|BEVACIZUMAB (AVASTIN)|bevacizumab (avastin)
5204607|NCT00807573|PEMETREXED (ALTIMA)|pemetrexed (altima)
5204608|NCT00807573|TAXOL (PACLITAXEL)|taxol (paclitaxel)
5204609|NCT00807573|08-109|08-109
5204610|NCT00807560|Overweight|overweight
5204611|NCT00807560|Obesity|obesity
5204612|NCT00807560|Adolescents|adolescents
5204613|NCT00807560|Family Therapy|family therapy
5204614|NCT00807534|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
5204615|NCT00807534|Exercise|exercise
5204616|NCT00807534|3-min constant rate stepping test|3-min constant rate stepping test
5204617|NCT00807534|3-min constant rate walking test|3-min constant rate walking test
5204618|NCT00807534|Bronchodilation|bronchodilation
5204619|NCT00807534|Ipratropium bromide|ipratropium bromide
5204620|NCT00807495|MLN8237|mln8237
5204621|NCT00807495|Alisertib|alisertib
5204622|NCT00807495|Drug therapy|drug therapy
5204623|NCT00807482|Primary Ciliary Dyskinesia|primary ciliary dyskinesia
5204624|NCT00807482|Mucociliary Clearance|mucociliary clearance
5204625|NCT00807482|Genetic Mutation|genetic mutation
5204626|NCT00807469|COPD|copd
5204627|NCT00807469|smoking|smoking
5204628|NCT00807469|susceptibility|susceptibility
5204629|NCT00807469|inflammation|inflammation
5204630|NCT00807469|genetic|genetic
5204631|NCT00807443|HIV-1|hiv-1
5204632|NCT00807443|integrase inhibitor (raltegravir)|integrase inhibitor (raltegravir)
5204633|NCT00807443|the cell reservoir of HIV-1|the cell reservoir of hiv-1
5204634|NCT00807443|treatment experienced|treatment experienced
5204635|NCT00807430|Bruxism|bruxism
5204636|NCT00807430|EMG|emg
5204637|NCT00807430|Biofeedback|biofeedback
5204638|NCT00807404|ductal intraepithelial neoplasia|ductal intraepithelial neoplasia
5204639|NCT00807391|lung cancer|lung cancer
5204640|NCT00807391|transbronchial biopsy|transbronchial biopsy
5204641|NCT00807391|transbronchial catheter aspiration|transbronchial catheter aspiration
5204642|NCT00807391|transbronchial needle aspiration|transbronchial needle aspiration
5204643|NCT00807391|peripheral pulmonary lesion|peripheral pulmonary lesion
5204644|NCT00807391|bronchoscopy|bronchoscopy
5204645|NCT00807378|CNS viral infection|cns viral infection
5204647|NCT00807378|HYBRIDIZATION|hybridization
5204648|NCT00807365|Growth Hormone-Releasing Hormone|growth hormone-releasing hormone
5204649|NCT00807365|Growth Hormone Insufficiency|growth hormone insufficiency
5204650|NCT00807365|Aging|aging
5204651|NCT00807365|Growth Hormone|growth hormone
5204652|NCT00807365|Physiological Effects of Drugs|physiological effects of drugs
5204653|NCT00807365|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists
5204654|NCT00807365|Hormones|hormones
5204655|NCT00807352|Triage|triage
5204656|NCT00807352|Pediatrics|pediatrics
5204657|NCT00807352|Emergency Department|emergency department
5204658|NCT00807339|CyberKnife|cyberknife
5204659|NCT00807326|Antidiarrheals|antidiarrheals
5204660|NCT00807313|Oligometastatic disease|oligometastatic disease
5204661|NCT00807313|Colorectal cancer|colorectal cancer
5204662|NCT00807313|Stereotactic body radiotherapy|stereotactic body radiotherapy
5204663|NCT00807313|Tomotherapy|tomotherapy
5204664|NCT00807313|Metabolic response|metabolic response
5204665|NCT00807313|Stage IV|stage iv
5204666|NCT00807300|percutaneous treatment|percutaneous treatment
5204667|NCT00807287|jejunal tube placement|jejunal tube placement
5204668|NCT00807274|Adult congenital heart disease|adult congenital heart disease
5204669|NCT00807274|Heart failure|heart failure
5204670|NCT00807274|Renal failure|renal failure
5204671|NCT00807274|Proteinuria|proteinuria
5204672|NCT00807235|Lucinactant|lucinactant
5204673|NCT00807235|Nasal continuous positive airway pressure (nCPAP)|nasal continuous positive airway pressure (ncpap)
5204674|NCT00807235|Respiratory distress syndrome (RDS)|respiratory distress syndrome (rds)
5204675|NCT00807235|Pediatric|pediatric
5204676|NCT00807235|Premature|premature
5204677|NCT00807222|ADHD|adhd
5204678|NCT00807222|Vyvanse|vyvanse
5204679|NCT00807222|lisdexamfetamine dimesylate|lisdexamfetamine dimesylate
5204680|NCT00807222|LDX|ldx
5204681|NCT00807222|sleep|sleep
5204682|NCT00807209|Pain|pain
5204683|NCT00807209|postoperative|postoperative
5204684|NCT00807209|thoracotomy|thoracotomy
5204685|NCT00807196|Allogeneic Stem Cell Transplantation|allogeneic stem cell transplantation
5204686|NCT00807196|Zevalin|zevalin
5204687|NCT00807196|Non-Hodgkins Lymphoma|non-hodgkins lymphoma
5204688|NCT00807170|Non-small Cell Lung Cancer (NSCLC)|non-small cell lung cancer (nsclc)
5204689|NCT00807170|Whole Brain Radiotherapy|whole brain radiotherapy
5204690|NCT00807170|metastasis|metastasis
5204691|NCT00807157|PROBIOSTICK®|probiostick®
5204692|NCT00807157|Probiotic|probiotic
5204693|NCT00807157|Anxiety|anxiety
5204694|NCT00807157|Daily stress|daily stress
5204695|NCT00807144|Kidney transplant|kidney transplant
5204696|NCT00807144|Rejection|rejection
5204697|NCT00807144|Adherence|adherence
5204698|NCT00807144|Quality of life|quality of life
5204699|NCT00807131|pharmacy care|pharmacy care
5204700|NCT00807131|hypertension|hypertension
5204701|NCT00807131|primary care|primary care
5204702|NCT00807131|adherence|adherence
5204703|NCT00807118|bioequivalence, food effect|bioequivalence, food effect
5204704|NCT00807105|MOOD EVALUATION|mood evaluation
5204705|NCT00807079|recurrent cervical cancer|recurrent cervical cancer
5204706|NCT00807079|stage IVB cervical cancer|stage ivb cervical cancer
5204707|NCT00807079|stage IVA cervical cancer|stage iva cervical cancer
5204708|NCT00807079|cervical adenocarcinoma|cervical adenocarcinoma
5204709|NCT00807079|cervical adenosquamous cell carcinoma|cervical adenosquamous cell carcinoma
5204710|NCT00807079|cervical squamous cell carcinoma|cervical squamous cell carcinoma
5204711|NCT00807066|QUALITY OF LIFE|quality of life
5204712|NCT00807053|Seasonal Allergic Rhinitis|seasonal allergic rhinitis
5204713|NCT00807053|Ciclesonide|ciclesonide
5204714|NCT00807053|SAR|sar
5204715|NCT00807040|Ischemic Mitral Regurgitation|ischemic mitral regurgitation
5204716|NCT00807040|Mitral Valve Disease|mitral valve disease
5204717|NCT00807040|Severe Mitral Regurgitation|severe mitral regurgitation
5204718|NCT00807027|Glioblastoma|glioblastoma
5204719|NCT00807027|Newly diagnosed Glioblastoma|newly diagnosed glioblastoma
5204720|NCT00807014|Differin|differin
5204721|NCT00807014|quality of life|quality of life
5204722|NCT00807014|Acne|acne
5204723|NCT00807014|Duac|duac
5204724|NCT00807014|Acne Vulgaris|acne vulgaris
5204725|NCT00807001|Hepatitis C, HCV, treatment-naive|hepatitis c, hcv, treatment-naive
5204726|NCT00806988|Ischemic Mitral Regurgitation|ischemic mitral regurgitation
5204727|NCT00806988|Mitral Valve Regurgitation|mitral valve regurgitation
5204728|NCT00806910|Heart Failure|heart failure
5204729|NCT00806910|conivaptan|conivaptan
5204730|NCT00806910|Diuresis|diuresis
5204731|NCT00806884|Cystic Fibrosis|cystic fibrosis
5204732|NCT00806884|Musculoskeletal Physiotherapy|musculoskeletal physiotherapy
5204733|NCT00806884|Manual therapy|manual therapy
5204734|NCT00806884|Posture|posture
5204735|NCT00806884|Pain|pain
5204736|NCT00806845|HIV|hiv
5204737|NCT00806845|B-lymphocyte|b-lymphocyte
5204738|NCT00806832|Medical clowns|medical clowns
5204739|NCT00806832|Cataract surgery|cataract surgery
5204740|NCT00806832|Blood pressure|blood pressure
5204741|NCT00806832|Heart rate|heart rate
5204742|NCT00806806|pain management|pain management
5204743|NCT00806806|postoperative|postoperative
5204744|NCT00806780|gallstones|gallstones
5204745|NCT00806780|cholangiography|cholangiography
5204746|NCT00806767|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5204747|NCT00806767|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5204748|NCT00806767|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5204749|NCT00806767|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5204750|NCT00806767|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5204751|NCT00806767|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5204752|NCT00806767|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5204753|NCT00806767|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5204754|NCT00806767|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5204755|NCT00806767|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5204756|NCT00806767|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5204757|NCT00806767|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5204758|NCT00806767|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5204759|NCT00806767|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5204760|NCT00806767|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5204761|NCT00806767|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5204762|NCT00806767|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5204763|NCT00806767|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5204764|NCT00806767|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5204765|NCT00806767|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5204766|NCT00806767|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5204767|NCT00806767|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5204768|NCT00806767|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5204769|NCT00806767|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5204770|NCT00806767|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5204771|NCT00806767|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5204772|NCT00806767|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5204773|NCT00806767|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5204774|NCT00806767|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5204775|NCT00806767|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5204776|NCT00806767|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5204777|NCT00806767|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5204778|NCT00806767|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5204779|NCT00806767|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5204780|NCT00806767|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5204781|NCT00806767|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5204782|NCT00806767|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5204783|NCT00806767|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5204784|NCT00806767|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5204785|NCT00806767|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5204786|NCT00806767|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5204787|NCT00806767|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5204788|NCT00806767|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5204789|NCT00806767|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5204790|NCT00806767|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
5204791|NCT00806767|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5204792|NCT00806767|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
5204793|NCT00806767|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
5204867|NCT00806650|stage III renal cell cancer|stage iii renal cell cancer
5204794|NCT00806767|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
5204795|NCT00806767|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
5204796|NCT00806767|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5204797|NCT00806767|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5204798|NCT00806767|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5204799|NCT00806767|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5204800|NCT00806767|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
5204801|NCT00806767|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
5204802|NCT00806767|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5204803|NCT00806767|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5204804|NCT00806767|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5204805|NCT00806767|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5204806|NCT00806767|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5204807|NCT00806767|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5204808|NCT00806767|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5204809|NCT00806767|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5204810|NCT00806767|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
5204811|NCT00806767|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5204812|NCT00806767|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5204813|NCT00806767|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5204814|NCT00806767|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5204815|NCT00806767|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5204816|NCT00806767|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5204817|NCT00806767|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5204818|NCT00806767|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5204819|NCT00806767|refractory hairy cell leukemia|refractory hairy cell leukemia
5204820|NCT00806767|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5204821|NCT00806767|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5204822|NCT00806767|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5204823|NCT00806767|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5204824|NCT00806767|chronic eosinophilic leukemia|chronic eosinophilic leukemia
5204825|NCT00806767|primary myelofibrosis|primary myelofibrosis
5204826|NCT00806767|chronic neutrophilic leukemia|chronic neutrophilic leukemia
5204827|NCT00806767|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5204828|NCT00806767|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
5204829|NCT00806767|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5204830|NCT00806767|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5204831|NCT00806767|stage I multiple myeloma|stage i multiple myeloma
5204832|NCT00806767|stage II multiple myeloma|stage ii multiple myeloma
5204833|NCT00806767|stage III multiple myeloma|stage iii multiple myeloma
5204834|NCT00806767|refractory multiple myeloma|refractory multiple myeloma
5204835|NCT00806754|Perennial Allergic Rhinitis|perennial allergic rhinitis
5204836|NCT00806754|Ciclesonide|ciclesonide
5204838|NCT00806741|L-NG-Monomethyl Arginine|l-ng-monomethyl arginine
5204839|NCT00806741|Optic Nerve Head blood flow|optic nerve head blood flow
5204840|NCT00806741|Intraocular Pressure|intraocular pressure
5204841|NCT00806741|Regional blood flow|regional blood flow
5204842|NCT00806741|Ocular Physiology|ocular physiology
5204843|NCT00806741|Optic Disk|optic disk
5204844|NCT00806715|hemochromatosis|hemochromatosis
5204845|NCT00806715|Iron overload|iron overload
5204846|NCT00806715|Stem cell transplant|stem cell transplant
5204847|NCT00806715|Pediatrics|pediatrics
5204848|NCT00806715|Pediatric Stem cell transplant|pediatric stem cell transplant
5204849|NCT00806689|heart rhythm surveillance|heart rhythm surveillance
5204850|NCT00806689|follow-up|follow-up
5204851|NCT00806689|atrial fibrillation success|atrial fibrillation success
5204852|NCT00806676|chronic kidney disease|chronic kidney disease
5204853|NCT00806676|children|children
5204854|NCT00806676|dialysis|dialysis
5204855|NCT00806676|kidney transplant|kidney transplant
5204856|NCT00806676|human papilloma virus|human papilloma virus
5204857|NCT00806676|Gardasil|gardasil
5204858|NCT00806676|Chronic kidney disease (non-dialysis, dialysis, and kidney transplant) secondary to any cause.|chronic kidney disease (non-dialysis, dialysis, and kidney transplant) secondary to any cause.
5204859|NCT00806663|mCRC|mcrc
5204860|NCT00806663|colorectal cancer|colorectal cancer
5204861|NCT00806663|FOLFIRI|folfiri
5204862|NCT00806663|sunitinib|sunitinib
5204863|NCT00806663|DCE-MRI|dce-mri
5204864|NCT00806663|DCE-USI|dce-usi
5204865|NCT00806650|stage I renal cell cancer|stage i renal cell cancer
5204866|NCT00806650|stage II renal cell cancer|stage ii renal cell cancer
5205542|NCT00803725|mepivacaine|mepivacaine
5204868|NCT00806650|stage IV renal cell cancer|stage iv renal cell cancer
5204869|NCT00806637|Vessel sealing system|vessel sealing system
5204870|NCT00806637|uvulopalatoplasty|uvulopalatoplasty
5204871|NCT00806637|UPPP|uppp
5204872|NCT00806637|uvulopalatal flap|uvulopalatal flap
5204873|NCT00806637|bleeding|bleeding
5204874|NCT00806637|operative time|operative time
5204875|NCT00806637|adverse effects|adverse effects
5204876|NCT00806611|pancreatic cancer|pancreatic cancer
5204877|NCT00806611|periampullary cancer|periampullary cancer
5204878|NCT00806611|resectable|resectable
5204879|NCT00806611|unresectable|unresectable
5204880|NCT00806611|celiac plexus neurolysis|celiac plexus neurolysis
5204881|NCT00806611|surgery|surgery
5204882|NCT00806598|Myelodysplastic Syndrome|myelodysplastic syndrome
5204883|NCT00806598|Aplastic Anemia|aplastic anemia
5204884|NCT00806598|Thymoglobulin|thymoglobulin
5204885|NCT00806598|Cyclosporine|cyclosporine
5204886|NCT00806598|Methylprednisolone|methylprednisolone
5204887|NCT00806598|G-CSF|g-csf
5204888|NCT00806572|Diabetes, juvenile diabetes, teplizumab|diabetes, juvenile diabetes, teplizumab
5204889|NCT00806559|effects clinical space|effects clinical space
5204890|NCT00806559|follow-up appointments|follow-up appointments
5204891|NCT00806520|Continuous Glucose Monitoring|continuous glucose monitoring
5204892|NCT00806520|Exenatide Once Weekly or|exenatide once weekly or
5204893|NCT00806520|Januvia or|januvia or
5204894|NCT00806520|Actos|actos
5204895|NCT00806507|Tissue Doppler Imaging|tissue doppler imaging
5204896|NCT00806507|B-type natriuretic peptide|b-type natriuretic peptide
5204897|NCT00806507|Advia Centaur immunoassay system|advia centaur immunoassay system
5204898|NCT00806507|GE Vivid ultrasound machine|ge vivid ultrasound machine
5204899|NCT00806507|Roche 2010 system|roche 2010 system
5204900|NCT00806507|Echocardiography|echocardiography
5204901|NCT00806507|Herceptin|herceptin
5204902|NCT00806494|Fesoterodine|fesoterodine
5204903|NCT00806494|Open Label|open label
5204904|NCT00806494|Flexible Dose|flexible dose
5204905|NCT00806494|OAB|oab
5204906|NCT00806481|Phosphate|phosphate
5204907|NCT00806468|nycturia|nycturia
5204908|NCT00806468|Parkinson syndrome|parkinson syndrome
5204909|NCT00806468|desmopressin|desmopressin
5204910|NCT00806468|Nocturnal polyuria in patients with Parkinson syndrome|nocturnal polyuria in patients with parkinson syndrome
5204911|NCT00806455|to determine how often exercise-induced bronchospasm|to determine how often exercise-induced bronchospasm
5204912|NCT00806455|occurs in cystic fibrosis|occurs in cystic fibrosis
5204913|NCT00806455|Exercise-induced bronchospasm in cystic fibrosis|exercise-induced bronchospasm in cystic fibrosis
5204914|NCT00806442|Asthma|asthma
5204915|NCT00806442|Fatty acids|fatty acids
5204916|NCT00806442|Leukotrienes|leukotrienes
5204917|NCT00806442|Diet|diet
5204918|NCT00806429|appendicitis|appendicitis
5204919|NCT00806429|surgery|surgery
5204920|NCT00806429|laparoscopy|laparoscopy
5204921|NCT00806429|natural orifice transluminal surgery|natural orifice transluminal surgery
5204922|NCT00806403|thrombolysis|thrombolysis
5204923|NCT00806403|primary PCI|primary pci
5204924|NCT00806403|abciximab|abciximab
5204925|NCT00806403|ST-segment resolution|st-segment resolution
5204926|NCT00806403|TIMI flow|timi flow
5204927|NCT00806390|ejection fraction|ejection fraction
5204928|NCT00806390|anthracyclines|anthracyclines
5204929|NCT00806390|beta-adrenergic blockade|beta-adrenergic blockade
5204930|NCT00806390|Patients receiving anthracyclines|patients receiving anthracyclines
5204931|NCT00806377|Electromagnetic field|electromagnetic field
5204932|NCT00806377|Oversensing|oversensing
5204933|NCT00806377|Non-thoracic surgery|non-thoracic surgery
5204934|NCT00806364|Healthy Volunteers|healthy volunteers
5204935|NCT00806364|Allergy|allergy
5204936|NCT00806364|Bone Marrow|bone marrow
5204937|NCT00806364|Buccal Mucosa|buccal mucosa
5204938|NCT00806364|HV|hv
5204939|NCT00806364|Healthy Volunteer|healthy volunteer
5204940|NCT00806351|Candidiasis; Invasive Candidiasis; Candida; Candidemia; Fungal Infection; Neutropenia|candidiasis; invasive candidiasis; candida; candidemia; fungal infection; neutropenia
5204941|NCT00806325|Severe Sepsis|severe sepsis
5204942|NCT00806325|Acute Myeloid Leukemia|acute myeloid leukemia
5204943|NCT00806325|Sepsis in patients being treated for Acute Myeloid Leukemia|sepsis in patients being treated for acute myeloid leukemia
5204944|NCT00806312|MiRNA|mirna
5204945|NCT00806312|pulmonary arterial hypertension|pulmonary arterial hypertension
5204946|NCT00806273|debridement|debridement
5204947|NCT00806273|root canal|root canal
5204948|NCT00806260|Overweight|overweight
5204949|NCT00806260|Obesity|obesity
5204950|NCT00806260|coordination|coordination
5204951|NCT00806260|psychomotor|psychomotor
5204952|NCT00806247|Tapentadol|tapentadol
5204953|NCT00806247|Bunionectomy|bunionectomy
5204954|NCT00806247|Analgesia|analgesia
5204955|NCT00806247|Acute pain|acute pain
5204956|NCT00806247|Postsurgical pain|postsurgical pain
5204957|NCT00806234|Weight Gain|weight gain
5204958|NCT00806234|Obesity|obesity
5204959|NCT00806234|IMPACT|impact
5204960|NCT00806234|Antipsychotic Treatment|antipsychotic treatment
5204961|NCT00806234|Excessive Weight Gain Associated With Antipsychotic Treatment|excessive weight gain associated with antipsychotic treatment
5204962|NCT00806234|Hybrid Efficacy/Effectiveness Design|hybrid efficacy/effectiveness design
5205543|NCT00803725|fentanyl|fentanyl
5204963|NCT00806234|Reducing Weight Gain|reducing weight gain
5204964|NCT00806234|Improving Metabolic Parameters|improving metabolic parameters
5204965|NCT00806234|Aripiprazole|aripiprazole
5204966|NCT00806234|Metformin|metformin
5204967|NCT00806234|Risperdal|risperdal
5204968|NCT00806234|Seroquel|seroquel
5204969|NCT00806234|Quetiapine|quetiapine
5204970|NCT00806234|Olanzapine|olanzapine
5204971|NCT00806234|Zyprexa|zyprexa
5204972|NCT00806234|Geodon|geodon
5204973|NCT00806234|Risperidone|risperidone
5204974|NCT00806234|Abilify|abilify
5204975|NCT00806234|Trilafon|trilafon
5204976|NCT00806234|Perphenazine|perphenazine
5204977|NCT00806234|Glucophage|glucophage
5204978|NCT00806234|Paliperidone|paliperidone
5204979|NCT00806234|Olanzapine/fluoxetine|olanzapine/fluoxetine
5204980|NCT00806221|Atopic Dermatitis|atopic dermatitis
5204981|NCT00806221|Prevention|prevention
5204982|NCT00806221|Skin Barrier|skin barrier
5204983|NCT00806195|vaccine|vaccine
5204984|NCT00806195|infants|infants
5204985|NCT00806195|healthy|healthy
5204986|NCT00806195|meningitis|meningitis
5204987|NCT00806195|meningococcal|meningococcal
5204988|NCT00806182|paraneoplastic|paraneoplastic
5204989|NCT00806182|neuroblastoma|neuroblastoma
5204990|NCT00806182|Kinsbourne syndrome|kinsbourne syndrome
5204991|NCT00806182|autoimmune disease|autoimmune disease
5204992|NCT00806182|immunotherapy|immunotherapy
5204993|NCT00806182|ataxia|ataxia
5204994|NCT00806169|combined therapy|combined therapy
5204995|NCT00806169|DRP|drp
5204996|NCT00806169|efficacy|efficacy
5204997|NCT00806169|safety|safety
5204998|NCT00806169|sustainability|sustainability
5204999|NCT00806169|macular edema due to DRP|macular edema due to drp
5205000|NCT00806143|Depression|depression
5205001|NCT00806143|TMS|tms
5205002|NCT00806117|Cervical cancer|cervical cancer
5205003|NCT00806117|Concurrent chemoradiation|concurrent chemoradiation
5205004|NCT00806117|Randomized controlled clinical trials|randomized controlled clinical trials
5205005|NCT00806091|AM proteomes will be compared between smokers with and without COPD|am proteomes will be compared between smokers with and without copd
5205006|NCT00806078|Healthy|healthy
5205007|NCT00806078|Bioequivalence|bioequivalence
5205008|NCT00806078|Pharmacokinetics|pharmacokinetics
5205009|NCT00806039|Kidney Failure, Acute|kidney failure, acute
5205010|NCT00806039|Renal Insufficiency, Acute|renal insufficiency, acute
5205011|NCT00806039|Kidney Failure|kidney failure
5205012|NCT00806039|Renal Insufficiency|renal insufficiency
5205013|NCT00806026|RLS|rls
5205014|NCT00806013|genotype|genotype
5205015|NCT00806000|Prevalence of Exercised induced asthma in athletes|prevalence of exercised induced asthma in athletes
5205016|NCT00805974|diapasom|diapasom
5205017|NCT00805974|sleep quality|sleep quality
5205018|NCT00805974|type I diabete|type i diabete
5205019|NCT00805974|blood pressure|blood pressure
5205020|NCT00805974|plasma glucose|plasma glucose
5205021|NCT00805974|daytime and nighttime variations|daytime and nighttime variations
5205022|NCT00805961|Glioblastoma Multiforme|glioblastoma multiforme
5205023|NCT00805961|Radiation Therapy|radiation therapy
5205024|NCT00805961|Temozolomide|temozolomide
5205025|NCT00805961|Bevacizumab|bevacizumab
5205026|NCT00805961|Everolimus|everolimus
5205027|NCT00805948|thoracic aneurysm|thoracic aneurysm
5205028|NCT00805948|thoracic aortic aneurysms|thoracic aortic aneurysms
5205029|NCT00805948|Thoracic Endovascular Aneurysm Repair (TEVAR)|thoracic endovascular aneurysm repair (tevar)
5205030|NCT00805948|Talent Thoracic Stent Graft|talent thoracic stent graft
5205031|NCT00805935|pre-menopausal women|pre-menopausal women
5205032|NCT00805935|PCOS|pcos
5205033|NCT00805935|polycystic ovarian syndrome|polycystic ovarian syndrome
5205034|NCT00805935|infertility|infertility
5205035|NCT00805935|IVF|ivf
5205036|NCT00805935|in vitro fertilization|in vitro fertilization
5205037|NCT00805883|Prostate Neoplasm|prostate neoplasm
5205038|NCT00805883|Localized|localized
5205039|NCT00805883|Photothermal|photothermal
5205040|NCT00805883|Radical Prostatectomy|radical prostatectomy
5205041|NCT00805844|Spine|spine
5205042|NCT00805844|Motor Evoked Potentials|motor evoked potentials
5205043|NCT00805831|sutureless vascular bypass|sutureless vascular bypass
5205044|NCT00805805|Copper|copper
5205045|NCT00805805|ceruloplasmin|ceruloplasmin
5205046|NCT00805805|tetrathiomolybdate|tetrathiomolybdate
5205047|NCT00805792|Ischemic stroke|ischemic stroke
5205048|NCT00805792|treatment|treatment
5205049|NCT00805792|recovery|recovery
5205050|NCT00805792|donepezil|donepezil
5205051|NCT00805792|Aricept|aricept
5205052|NCT00805779|Overactive Bladder|overactive bladder
5205053|NCT00805779|Overactive Urinary Bladder|overactive urinary bladder
5205054|NCT00805779|Bladder, Overactive|bladder, overactive
5205055|NCT00805779|Overactive Detrusor|overactive detrusor
5205056|NCT00805779|Detrusor, Overactive|detrusor, overactive
5205057|NCT00805779|Overactive Detrusor Function|overactive detrusor function
5205058|NCT00805779|Detrusor Function, Overactive|detrusor function, overactive
5205059|NCT00805766|Infliximab|infliximab
5205060|NCT00805766|REMICADE|remicade
5205061|NCT00805766|Crohn's disease|crohn's disease
5205062|NCT00805740|Candidiasis; Invasive Candidiasis; Deep Tissue Candidiasis; Candida; Candidemia; Fungal Infection|candidiasis; invasive candidiasis; deep tissue candidiasis; candida; candidemia; fungal infection
5205063|NCT00805714|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors
5205064|NCT00805701|prostate|prostate
5205065|NCT00805701|cancer|cancer
5205066|NCT00805701|avodart|avodart
5205067|NCT00805701|dutasteride|dutasteride
5205068|NCT00805701|mitcheson|mitcheson
5205069|NCT00805688|Questionnaire|questionnaire
5205070|NCT00805688|Pancreas|pancreas
5205071|NCT00805688|Pancreatic Cancer|pancreatic cancer
5205072|NCT00805688|Metastatic Disease|metastatic disease
5205073|NCT00805688|symptom outcomes|symptom outcomes
5205074|NCT00805688|Biomarkers|biomarkers
5205075|NCT00805688|Pedometer|pedometer
5205076|NCT00805688|MDASI-GI symptom assessment|mdasi-gi symptom assessment
5205077|NCT00805688|interactive voice response telephone system|interactive voice response telephone system
5205078|NCT00805688|IVRS|ivrs
5205079|NCT00805675|Chronic HBV|chronic hbv
5205080|NCT00805675|Asian adult subjects with chronic HBV, in immune tolerant phase, and positive for hepatitis B e antigen (HBeAg)|asian adult subjects with chronic hbv, in immune tolerant phase, and positive for hepatitis b e antigen (hbeag)
5205081|NCT00805662|IUI|iui
5205082|NCT00805662|oxytocin|oxytocin
5205083|NCT00805649|ARMD|armd
5205084|NCT00805649|combined therapy|combined therapy
5205085|NCT00805649|efficacy|efficacy
5205086|NCT00805649|safety|safety
5205087|NCT00805636|cell death|cell death
5205088|NCT00805636|PET imaging|pet imaging
5205089|NCT00805636|brain metastases|brain metastases
5205090|NCT00805636|stereotactic radiosurgery|stereotactic radiosurgery
5205091|NCT00805623|sucrose|sucrose
5205092|NCT00805623|sucking|sucking
5205093|NCT00805623|pain relief|pain relief
5205094|NCT00805623|infant|infant
5205095|NCT00805623|require venous puncture|require venous puncture
5205096|NCT00805610|Liver Failure|liver failure
5205097|NCT00805610|Hepatocyte Transplantation|hepatocyte transplantation
5205098|NCT00805610|Liver Transplantation|liver transplantation
5205099|NCT00805597|breast cancer|breast cancer
5205100|NCT00805597|mastectomy|mastectomy
5205101|NCT00805597|one to three positive nodes|one to three positive nodes
5205102|NCT00805597|radiotherapy|radiotherapy
5205103|NCT00805571|Rejection|rejection
5205104|NCT00805571|Infection|infection
5205105|NCT00805571|Side effect of immunosuppressive drug (nephrotoxicity)|side effect of immunosuppressive drug (nephrotoxicity)
5205106|NCT00805558|Chronic Periodontitis|chronic periodontitis
5205107|NCT00805558|antibiotics|antibiotics
5205108|NCT00805532|PTSD|ptsd
5205109|NCT00805532|depression|depression
5205110|NCT00805532|behavior therapy|behavior therapy
5205111|NCT00805532|veterans|veterans
5205112|NCT00805532|behavioral activation|behavioral activation
5205113|NCT00805532|usual care|usual care
5205114|NCT00805519|Osteoarthritis of the Knee|osteoarthritis of the knee
5205115|NCT00805519|Glucosamine Chondroitin sulfate|glucosamine chondroitin sulfate
5205116|NCT00805519|Prednisolone|prednisolone
5205117|NCT00805519|Chloroquine|chloroquine
5205118|NCT00805506|continuous glucose monitoring accuracy|continuous glucose monitoring accuracy
5205119|NCT00805493|Mania|mania
5205120|NCT00805493|Bipolar|bipolar
5205121|NCT00805493|Bipolar Disorder|bipolar disorder
5205122|NCT00805493|Bipolar Manic-Depressive Illness|bipolar manic-depressive illness
5205123|NCT00805493|Bipolar Mood Disorder|bipolar mood disorder
5205124|NCT00805480|Plaque|plaque
5205125|NCT00805480|psoriasis|psoriasis
5205126|NCT00805480|inflammatory skin disease|inflammatory skin disease
5205127|NCT00805480|skin condition, thickening|skin condition, thickening
5205128|NCT00805480|flaking|flaking
5205129|NCT00805480|scaly patches|scaly patches
5205130|NCT00805480|skin disease|skin disease
5205131|NCT00805467|RA|ra
5205132|NCT00805454|Healthy Volunteers|healthy volunteers
5205133|NCT00805454|Phase I|phase i
5205134|NCT00805454|Pet Scan|pet scan
5205135|NCT00805441|Alcoholic|alcoholic
5205136|NCT00805415|Oral Contraceptive|oral contraceptive
5205137|NCT00805415|Ovulation Inhibition|ovulation inhibition
5205138|NCT00805389|Adjuvant Systems|adjuvant systems
5205139|NCT00805389|Hepatitis B|hepatitis b
5205140|NCT00805376|Brain|brain
5205141|NCT00805376|Brain Cancer|brain cancer
5205142|NCT00805376|Central Nervous System Diseases|central nervous system diseases
5205143|NCT00805376|CNS|cns
5205144|NCT00805376|Conditionally Replication-Competent Adenovirus|conditionally replication-competent adenovirus
5205145|NCT00805376|Delta-24-RGD|delta-24-rgd
5205146|NCT00805376|DNX-2401|dnx-2401
5205147|NCT00805376|Recurrent Malignant Gliomas|recurrent malignant gliomas
5205148|NCT00805376|malignant brain tumor|malignant brain tumor
5205149|NCT00805350|Insomnia|insomnia
5205150|NCT00805350|Sleep Maintenance|sleep maintenance
5205151|NCT00805350|Polysomnography|polysomnography
5205152|NCT00805337|Cancer amplitude-modulated electromagnetic fields|cancer amplitude-modulated electromagnetic fields
5205153|NCT00805311|Internal Carotid Artery Stenosis|internal carotid artery stenosis
5205154|NCT00805311|Carotid Endarterectomy|carotid endarterectomy
5205155|NCT00805311|Stroke|stroke
5205156|NCT00805311|Cerebrovascular|cerebrovascular
5205157|NCT00805311|Atherosclerosis|atherosclerosis
5205158|NCT00805298|third molar|third molar
5205159|NCT00805298|postoperative pain|postoperative pain
5205160|NCT00805298|thermography|thermography
5205161|NCT00805298|postoperative inflammation|postoperative inflammation
5205162|NCT00805298|methylprednisolone|methylprednisolone
5205163|NCT00805298|local anaesthetic|local anaesthetic
5205164|NCT00805298|postoperative pain after removal of lower third molars|postoperative pain after removal of lower third molars
5205165|NCT00805298|inflammation after removal of lower third molars|inflammation after removal of lower third molars
5205166|NCT00805285|Inflammatory Bowel Disease|inflammatory bowel disease
5205167|NCT00805285|Ulcerative Colitis|ulcerative colitis
5205168|NCT00805285|Budesonide|budesonide
5205169|NCT00805285|Corticosteroids|corticosteroids
5205170|NCT00805272|HIV|hiv
5205171|NCT00805272|tuberculosis|tuberculosis
5205172|NCT00805272|IGRA|igra
5205173|NCT00805272|diagnosis|diagnosis
5205174|NCT00805272|treatment naive|treatment naive
5205175|NCT00805259|cognitive function|cognitive function
5205176|NCT00805259|elderly|elderly
5205177|NCT00805259|technology|technology
5205178|NCT00805259|financial incentives|financial incentives
5205179|NCT00805259|General maintenance of cognitive function|general maintenance of cognitive function
5205180|NCT00805246|Pulmonary embolism|pulmonary embolism
5205181|NCT00805246|PE|pe
5205182|NCT00805246|CT|ct
5205183|NCT00805246|Biomarker|biomarker
5205184|NCT00805246|Prognosis|prognosis
5205185|NCT00805246|Risk Prediction|risk prediction
5205186|NCT00805233|Neovascular|neovascular
5205187|NCT00805233|AMD|amd
5205188|NCT00805233|Treatment|treatment
5205189|NCT00805233|Lucentis|lucentis
5205190|NCT00805233|Bromfenac|bromfenac
5205191|NCT00805220|frail elderly walking capacity walk training Nordic Walking|frail elderly walking capacity walk training nordic walking
5205192|NCT00805207|sleep apnea|sleep apnea
5205193|NCT00805207|obese|obese
5205194|NCT00805207|Very-low density lipoprotein (VLDL) metabolism|very-low density lipoprotein (vldl) metabolism
5205195|NCT00805207|isotope tracer|isotope tracer
5205196|NCT00805207|women|women
5205197|NCT00805155|Bioequivalence|bioequivalence
5205198|NCT00805155|Mometasone Furoate|mometasone furoate
5205199|NCT00805142|Pain|pain
5205200|NCT00805142|Cancer|cancer
5205201|NCT00805142|Tapentadol|tapentadol
5205202|NCT00805129|URETER|ureter
5205203|NCT00805129|URINARY BLADDER|urinary bladder
5205204|NCT00805129|RAD001|rad001
5205205|NCT00805129|Everolimus|everolimus
5205206|NCT00805129|Urothelium|urothelium
5205207|NCT00805129|08-123|08-123
5205208|NCT00805103|Brain Metastases|brain metastases
5205209|NCT00805103|Stereotactic radiosurgery (SRS)|stereotactic radiosurgery (srs)
5205210|NCT00805103|Hypofractionated stereotactic radiotherapy (HSRT)|hypofractionated stereotactic radiotherapy (hsrt)
5205211|NCT00805103|Recurrent Brain Metastases|recurrent brain metastases
5205212|NCT00805090|Renal|renal
5205213|NCT00805090|Hepatic|hepatic
5205214|NCT00805090|Healthy|healthy
5205215|NCT00805077|interoperative care|interoperative care
5205216|NCT00805077|Tidal volume|tidal volume
5205217|NCT00805077|Postoperative complications|postoperative complications
5205218|NCT00805077|Pneumonectomy|pneumonectomy
5205219|NCT00805077|Lobectomy|lobectomy
5205220|NCT00805077|Mechanical ventilation|mechanical ventilation
5205221|NCT00805051|Aortic stenosis|aortic stenosis
5205222|NCT00805051|aortic valve replacement|aortic valve replacement
5205223|NCT00805051|von Willebrand disease|von willebrand disease
5205224|NCT00805051|blood loss|blood loss
5205225|NCT00805012|S-1|s-1
5205226|NCT00805012|docetaxel|docetaxel
5205227|NCT00805012|head and neck cancer|head and neck cancer
5205228|NCT00805012|Recurrent or metastatic head and neck squamous cell carcinoma|recurrent or metastatic head and neck squamous cell carcinoma
5205229|NCT00804999|confocal microscopy|confocal microscopy
5205230|NCT00804999|contact lens wear|contact lens wear
5205231|NCT00804999|contact lens solutions|contact lens solutions
5205232|NCT00804999|sodium fluorescein|sodium fluorescein
5205233|NCT00804973|Migraine|migraine
5205234|NCT00804973|Headache|headache
5205235|NCT00804960|Cost of Infertility Treatment|cost of infertility treatment
5205236|NCT00804960|Ovulation Induction|ovulation induction
5205237|NCT00804960|Letrozole|letrozole
5205238|NCT00804960|In Vitro Fertilization|in vitro fertilization
5205239|NCT00804947|Autologous transplantation|autologous transplantation
5205240|NCT00804947|Multiple Myeloma|multiple myeloma
5205241|NCT00804947|Intravenous Busulfan|intravenous busulfan
5205242|NCT00804921|bevacizumab|bevacizumab
5205243|NCT00804921|intra-ocular pressure|intra-ocular pressure
5205244|NCT00804921|acetazolamide|acetazolamide
5205245|NCT00804921|anterior chamber paracentesis|anterior chamber paracentesis
5205246|NCT00804921|brimonidine|brimonidine
5205247|NCT00804921|macular edema secondary to diabetic retinopathy or macular degeneration|macular edema secondary to diabetic retinopathy or macular degeneration
5205248|NCT00804908|Temozolomide|temozolomide
5205249|NCT00804908|Skin cancer|skin cancer
5205250|NCT00804908|Melanoma|melanoma
5205251|NCT00804908|Metastatic Melanoma|metastatic melanoma
5205252|NCT00804908|ABT-888|abt-888
5205253|NCT00804908|MM|mm
5205254|NCT00804895|cluster headache|cluster headache
5205255|NCT00804895|greater occipital nerve block|greater occipital nerve block
5205256|NCT00804895|cortivazol|cortivazol
5205257|NCT00804882|Metabolic syndrome|metabolic syndrome
5205258|NCT00804882|Heart failure|heart failure
5205259|NCT00804882|Mexican Americans|mexican americans
5205260|NCT00804882|Ethnic differences|ethnic differences
5205261|NCT00804882|Echocardiography|echocardiography
5205262|NCT00804830|adjuvant|adjuvant
5205263|NCT00804830|Anaplastic thyroid cancer|anaplastic thyroid cancer
5205264|NCT00804817|self management|self management
5205265|NCT00804817|adherence|adherence
5205266|NCT00804817|activity enhancement|activity enhancement
5205267|NCT00804817|oral mucositis prevention|oral mucositis prevention
5205268|NCT00804817|and mal nutrition prevention|and mal nutrition prevention
5205269|NCT00804817|cancer|cancer
5205270|NCT00804817|hematopoietic stem cell transplantation (HSCT)|hematopoietic stem cell transplantation (hsct)
5205271|NCT00804817|loss of activity|loss of activity
5205272|NCT00804804|Sleep|sleep
5205273|NCT00804804|aging|aging
5205274|NCT00804804|cognitives processes|cognitives processes
5205275|NCT00804804|constant routine|constant routine
5205276|NCT00804791|dry eye|dry eye
5205277|NCT00804791|autofluorescence|autofluorescence
5205278|NCT00804791|residence time|residence time
5205279|NCT00804778|CAD|cad
5205280|NCT00804778|CABG|cabg
5205281|NCT00804778|CO|co
5205282|NCT00804778|CI|ci
5205283|NCT00804778|thermodilution|thermodilution
5205284|NCT00804778|USCOM|uscom
5205285|NCT00804765|Prevention|prevention
5205286|NCT00804765|child obesity|child obesity
5205287|NCT00804765|pregnancy|pregnancy
5205288|NCT00804765|overweight women|overweight women
5205289|NCT00804765|obese women|obese women
5205290|NCT00804752|Patients with Chronic Hepatitis C|patients with chronic hepatitis c
5205291|NCT00804739|Major Depression|major depression
5205292|NCT00804739|Postpartum Depression|postpartum depression
5205293|NCT00804739|Perinatal Depression|perinatal depression
5205294|NCT00804739|Treatment Feasibility|treatment feasibility
5205295|NCT00804739|Treatment Engagement|treatment engagement
5205296|NCT00804739|Treatment Adherence|treatment adherence
5205297|NCT00804739|Postpartum|postpartum
5205298|NCT00804739|Interpersonal Psychotherapy|interpersonal psychotherapy
5205299|NCT00804739|IPT|ipt
5205300|NCT00804739|Sertraline|sertraline
5205301|NCT00804739|Zoloft|zoloft
5205302|NCT00804726|Cataract extraction|cataract extraction
5205303|NCT00804726|Phacoemulsification|phacoemulsification
5205304|NCT00804713|TB|tb
5205305|NCT00804713|tuberculosis diagnosis|tuberculosis diagnosis
5205306|NCT00804713|TB screening|tb screening
5205307|NCT00804700|synchronous|synchronous
5205308|NCT00804700|exercise|exercise
5205309|NCT00804700|music|music
5205310|NCT00804700|heartbeat|heartbeat
5205311|NCT00804700|tunes|tunes
5205312|NCT00804687|Allergy|allergy
5205313|NCT00804687|Rhinitis|rhinitis
5205314|NCT00804687|Allergic Rhinitis|allergic rhinitis
5205315|NCT00804687|JNJ-39220675|jnj-39220675
5205316|NCT00804687|Pseudoephedrine|pseudoephedrine
5205317|NCT00804674|bupivacain|bupivacain
5205318|NCT00804674|breast|breast
5205319|NCT00804674|reconstruction|reconstruction
5205320|NCT00804674|diep|diep
5205321|NCT00804674|pain|pain
5205322|NCT00804674|postoperative|postoperative
5205323|NCT00804674|catheter|catheter
5205324|NCT00804674|anesthesia|anesthesia
5205325|NCT00804661|sleep|sleep
5205326|NCT00804661|nocturnal hypoventilation|nocturnal hypoventilation
5205327|NCT00804661|sleep quality|sleep quality
5205328|NCT00804661|lung function|lung function
5205329|NCT00804622|HBeAg positive compensated chronic hepatitis B|hbeag positive compensated chronic hepatitis b
5205330|NCT00804583|Cystic Fibrosis|cystic fibrosis
5205331|NCT00804583|Liver Disease|liver disease
5205332|NCT00804583|Genetic Modifiers|genetic modifiers
5205333|NCT00804557|Male Urinary Disorders|male urinary disorders
5205334|NCT00804557|Urinary catheterization|urinary catheterization
5205335|NCT00804557|Urinary retention|urinary retention
5205336|NCT00804544|Integrated SPECT/CT|integrated spect/ct
5205337|NCT00804544|99mTc-sestMIBI|99mtc-sestmibi
5205338|NCT00804544|Chemosensitivity|chemosensitivity
5205339|NCT00804531|Low back pain|low back pain
5205340|NCT00804531|steroid injection|steroid injection
5205341|NCT00804531|inter-vertebral disc|inter-vertebral disc
5205342|NCT00804531|randomized trial|randomized trial
5205343|NCT00804531|Lack of efficacy of usual recommended treatments|lack of efficacy of usual recommended treatments
5205344|NCT00804531|More than 40 on the pain numeric scale (0-100)|more than 40 on the pain numeric scale (0-100)
5205345|NCT00804531|Inflammatory discopathy (MODIC I) on MRI|inflammatory discopathy (modic i) on mri
5205346|NCT00804518|Aging|aging
5205347|NCT00804518|Diastolic dysfunction|diastolic dysfunction
5205348|NCT00804518|Systolic function|systolic function
5205349|NCT00804518|Exercise|exercise
5205350|NCT00804518|Echocardiography|echocardiography
5205351|NCT00804518|tissue Doppler imaging|tissue doppler imaging
5205352|NCT00804518|Cardiac function|cardiac function
5205353|NCT00804505|Substantial equivalence to control device|substantial equivalence to control device
5205354|NCT00804492|To organize a multidisciplinary team for integrated falls prevention|to organize a multidisciplinary team for integrated falls prevention
5205355|NCT00804492|To draft a guideline for falls prevention in the elderly|to draft a guideline for falls prevention in the elderly
5205356|NCT00804492|To set up a multidisciplinary fall clinic|to set up a multidisciplinary fall clinic
5205473|NCT00804089|Acupuncture Points|acupuncture points
5205357|NCT00804492|To set up a falls prevention classroom|to set up a falls prevention classroom
5205358|NCT00804492|To enhance cooperate between hospitals and primary care units for falls prevention|to enhance cooperate between hospitals and primary care units for falls prevention
5205359|NCT00804466|Human Papillomavirus|human papillomavirus
5205360|NCT00804466|Natural History|natural history
5205361|NCT00804466|Cervical Cancer|cervical cancer
5205362|NCT00804466|Screening|screening
5205363|NCT00804453|Chronic Kidney Failure|chronic kidney failure
5205364|NCT00804453|Hemodialysis|hemodialysis
5205365|NCT00804453|Biocompatibility|biocompatibility
5205366|NCT00804440|bioequivalency|bioequivalency
5205367|NCT00804440|ibuprofen|ibuprofen
5205368|NCT00804427|Fish oil|fish oil
5205369|NCT00804427|Triglycerides|triglycerides
5205370|NCT00804427|Low-density Lipoprotein (LDL) cholesterol|low-density lipoprotein (ldl) cholesterol
5205371|NCT00804427|Low-density Lipoprotein (LDL) subclass|low-density lipoprotein (ldl) subclass
5205372|NCT00804427|Low-density Lipoprotein (LDL) particle size|low-density lipoprotein (ldl) particle size
5205373|NCT00804427|Low-density Lipoprotein (LDL) phenotype|low-density lipoprotein (ldl) phenotype
5205374|NCT00804414|Diabetes|diabetes
5205375|NCT00804414|Diabetic ulcer|diabetic ulcer
5205376|NCT00804414|Chronic ulcer|chronic ulcer
5205377|NCT00804414|SBG|sbg
5205378|NCT00804401|bioequivalency|bioequivalency
5205379|NCT00804401|Naproxen|naproxen
5205380|NCT00804388|Vitamine E|vitamine e
5205381|NCT00804388|E-poly|e-poly
5205382|NCT00804388|Hip|hip
5205383|NCT00804388|Degenerative joint disease|degenerative joint disease
5205384|NCT00804375|stump pain|stump pain
5205385|NCT00804349|Heart Decompensation|heart decompensation
5205386|NCT00804349|Heart Failure, Congestive|heart failure, congestive
5205387|NCT00804349|Heart Failure, Left-Sided|heart failure, left-sided
5205388|NCT00804349|Heart Failure, Right-Sided|heart failure, right-sided
5205389|NCT00804349|Apnea, Sleep|apnea, sleep
5205390|NCT00804349|Sleep Apnea, Mixed Central and Obstructive|sleep apnea, mixed central and obstructive
5205391|NCT00804349|Sleep Hypopnea|sleep hypopnea
5205392|NCT00804349|Sleep-Disordered Breathing|sleep-disordered breathing
5205393|NCT00804336|pasireotide|pasireotide
5205394|NCT00804336|SOM230|som230
5205395|NCT00804336|RAD001|rad001
5205396|NCT00804310|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5205397|NCT00804297|Hypoglycemia|hypoglycemia
5205398|NCT00804297|Diabetes Mellitus|diabetes mellitus
5205399|NCT00804297|Octreotide|octreotide
5205400|NCT00804284|DAPTACEL®|daptacel®
5205401|NCT00804284|PENTACEL®|pentacel®
5205402|NCT00804284|Diphtheria|diphtheria
5205403|NCT00804284|Tetanus|tetanus
5205404|NCT00804284|Pertussis|pertussis
5205405|NCT00804284|Haemophilus influenzae type b|haemophilus influenzae type b
5205406|NCT00804258|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5205407|NCT00804258|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
5205408|NCT00804258|stage I ovarian epithelial cancer|stage i ovarian epithelial cancer
5205409|NCT00804258|stage I ovarian germ cell tumor|stage i ovarian germ cell tumor
5205410|NCT00804258|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
5205411|NCT00804258|stage II ovarian germ cell tumor|stage ii ovarian germ cell tumor
5205412|NCT00804258|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5205413|NCT00804258|stage III ovarian germ cell tumor|stage iii ovarian germ cell tumor
5205414|NCT00804258|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5205415|NCT00804258|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
5205416|NCT00804245|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5205417|NCT00804245|stage I prostate cancer|stage i prostate cancer
5205418|NCT00804245|stage II prostate cancer|stage ii prostate cancer
5205419|NCT00804245|stage III prostate cancer|stage iii prostate cancer
5205420|NCT00804245|stage IV prostate cancer|stage iv prostate cancer
5205421|NCT00804232|Diabetes type1; children|diabetes type1; children
5205422|NCT00804219|low responsiveness after vaccination|low responsiveness after vaccination
5205423|NCT00804206|Intravitreal injection of Bevacizumab|intravitreal injection of bevacizumab
5205424|NCT00804206|Visual acuity|visual acuity
5205425|NCT00804206|central retinal thickness|central retinal thickness
5205426|NCT00804206|color studies, Farnsworth-Munsell|color studies, farnsworth-munsell
5205427|NCT00804206|electroretinogram studies|electroretinogram studies
5205428|NCT00804193|Tinea Pedis|tinea pedis
5205429|NCT00804193|Ciclopirox Olamine|ciclopirox olamine
5205430|NCT00804180|anxiety|anxiety
5205431|NCT00804180|injection|injection
5205432|NCT00804180|needle|needle
5205433|NCT00804180|pediatric|pediatric
5205434|NCT00804180|youth|youth
5205435|NCT00804180|children|children
5205436|NCT00804180|adolescents|adolescents
5205437|NCT00804180|cognitive behavioral|cognitive behavioral
5205438|NCT00804180|behavioral|behavioral
5205439|NCT00804180|exposure|exposure
5205440|NCT00804180|group|group
5205441|NCT00804180|treatment|treatment
5205442|NCT00804180|chronic illness|chronic illness
5205443|NCT00804180|adherence|adherence
5205444|NCT00804167|Hypertensive patients aged of 75 years and older|hypertensive patients aged of 75 years and older
5205445|NCT00804167|renal damage|renal damage
5205544|NCT00803725|duration of anesthesia|duration of anesthesia
5205545|NCT00803725|knee arthroscopy|knee arthroscopy
5205546|NCT00803725|regional anesthesia|regional anesthesia
5206962|NCT00798174|CHF|chf
5205446|NCT00804167|Clinical characteristics of hypertensive patients aged of 75 years and older seen in general practitioner consultation according to their renal damage|clinical characteristics of hypertensive patients aged of 75 years and older seen in general practitioner consultation according to their renal damage
5205447|NCT00804154|Pain|pain
5205448|NCT00804154|Vanilloid|vanilloid
5205449|NCT00804154|Capsaicin|capsaicin
5205450|NCT00804154|Cancer Pain|cancer pain
5205451|NCT00804154|Resiniferatoxin|resiniferatoxin
5205452|NCT00804141|treatment for opioid-induced constipation|treatment for opioid-induced constipation
5205453|NCT00804128|ductal breast carcinoma in situ|ductal breast carcinoma in situ
5205454|NCT00804115|Exfoliation Syndrome|exfoliation syndrome
5205455|NCT00804115|Latanoprost|latanoprost
5205456|NCT00804115|Timolol|timolol
5205457|NCT00804115|Pilocarpine|pilocarpine
5205458|NCT00804102|Retinitis pigmentosa|retinitis pigmentosa
5205459|NCT00804102|Macula off|macula off
5205460|NCT00804102|Primary open angle Glaucoma|primary open angle glaucoma
5205461|NCT00804102|Hereditary Macular Degeneration|hereditary macular degeneration
5205462|NCT00804102|Treated Retina detachment|treated retina detachment
5205463|NCT00804102|Retinal Artery Occlusion|retinal artery occlusion
5205464|NCT00804102|Retinal Vein Occlusion,|retinal vein occlusion,
5205465|NCT00804102|Non-Arthritic-Anterior-Ischemic Optic-Neuropathy|non-arthritic-anterior-ischemic optic-neuropathy
5205466|NCT00804102|Hereditary autosomal dominant Optic atrophy|hereditary autosomal dominant optic atrophy
5205467|NCT00804102|dry Age-related Macular Degeneration|dry age-related macular degeneration
5205468|NCT00804102|Ischemic Macula edema|ischemic macula edema
5205469|NCT00804089|Low Back Pain, Chronic|low back pain, chronic
5205470|NCT00804089|Acupuncture|acupuncture
5205471|NCT00804089|Dry Needling|dry needling
5205472|NCT00804089|Acupressure|acupressure
5205474|NCT00804089|Trigger Points, Myofascial|trigger points, myofascial
5205475|NCT00804076|gene therapy|gene therapy
5205476|NCT00804076|replication defective HSV vector|replication defective hsv vector
5205477|NCT00804076|pain|pain
5205478|NCT00804076|enkephalin|enkephalin
5205479|NCT00804076|intradermal|intradermal
5205480|NCT00804063|glaucoma|glaucoma
5205481|NCT00804063|citrate|citrate
5205482|NCT00804050|Myelodysplastic Syndromes|myelodysplastic syndromes
5205483|NCT00804050|Erythropoietin|erythropoietin
5205484|NCT00804050|Acid 13-Cis-Retinoic|acid 13-cis-retinoic
5205485|NCT00804050|Dihydroxyvitamin D3|dihydroxyvitamin d3
5205486|NCT00804050|low or intermediate-1 IPSS|low or intermediate-1 ipss
5205487|NCT00804050|MDS low risk|mds low risk
5205488|NCT00804037|Snoring and Mild Apnea|snoring and mild apnea
5205489|NCT00804024|Heart Diseases. Vascular Diseases.|heart diseases. vascular diseases.
5205490|NCT00804011|Snakebite|snakebite
5205491|NCT00804011|Weaning|weaning
5205492|NCT00804011|Mechanical ventilation|mechanical ventilation
5205493|NCT00803985|Inguinal hernia|inguinal hernia
5205494|NCT00803985|TEP|tep
5205495|NCT00803985|Lichtenstein|lichtenstein
5205496|NCT00803985|mesh|mesh
5205497|NCT00803985|Randomized|randomized
5205498|NCT00803985|Chronic pain|chronic pain
5205499|NCT00803985|Sexual dysfunction|sexual dysfunction
5205500|NCT00803972|Humalog|humalog
5205501|NCT00803972|Humulin R|humulin r
5205502|NCT00803972|rHuPH20|rhuph20
5205503|NCT00803972|Hylenex|hylenex
5205504|NCT00803959|Stress urinary incontinence, Mixed, Urge|stress urinary incontinence, mixed, urge
5205505|NCT00803946|bioequivalency|bioequivalency
5205506|NCT00803946|ibuprofen|ibuprofen
5205507|NCT00803933|first stage|first stage
5205508|NCT00803933|Trypanosoma brucei gambiense|trypanosoma brucei gambiense
5205509|NCT00803933|T. b. gambiense|t. b. gambiense
5205510|NCT00803933|sleeping sickness|sleeping sickness
5205511|NCT00803933|First stage T. b. gambiense sleeping sickness|first stage t. b. gambiense sleeping sickness
5205512|NCT00803920|exenatide twice daily or once weekly|exenatide twice daily or once weekly
5205513|NCT00803920|continuous glucose monitoring|continuous glucose monitoring
5205514|NCT00803907|immunomodulator|immunomodulator
5205515|NCT00803907|Carcinoma, Basal Cell|carcinoma, basal cell
5205516|NCT00803894|Biomarkers of Notch inhibition|biomarkers of notch inhibition
5205517|NCT00803855|single dose|single dose
5205518|NCT00803855|pharmacokinetics|pharmacokinetics
5205519|NCT00803855|safety|safety
5205520|NCT00803855|healthy volunteers|healthy volunteers
5205521|NCT00803855|food interaction|food interaction
5205522|NCT00803855|AZD1446|azd1446
5205523|NCT00803842|erlotinib|erlotinib
5205524|NCT00803842|rash|rash
5205525|NCT00803842|supportive care|supportive care
5205526|NCT00803816|endogoneous|endogoneous
5205527|NCT00803816|posterior|posterior
5205528|NCT00803816|intermediate|intermediate
5205529|NCT00803803|Pilocarpine|pilocarpine
5205530|NCT00803803|POAG|poag
5205531|NCT00803803|IOP|iop
5205532|NCT00803803|Concentration|concentration
5205533|NCT00803803|Frequency|frequency
5205534|NCT00803803|Primary open-angle glaucoma|primary open-angle glaucoma
5205535|NCT00803803|Primary open-angle glaucoma suspect|primary open-angle glaucoma suspect
5205536|NCT00803764|bioequivalency|bioequivalency
5205537|NCT00803764|naproxen|naproxen
5205538|NCT00803751|Laryngoscopy [E04.580.373]|laryngoscopy [e04.580.373]
5205539|NCT00803738|Vulvovaginal Candidiasis|vulvovaginal candidiasis
5205540|NCT00803738|Terconazole|terconazole
5205541|NCT00803725|spinal anesthesia|spinal anesthesia
5205547|NCT00803725|Spinal anesthesia for knee arthroscopy|spinal anesthesia for knee arthroscopy
5205548|NCT00803699|selenium|selenium
5205549|NCT00803673|Healthy volunteers|healthy volunteers
5205550|NCT00803673|New formulation|new formulation
5205551|NCT00803660|hypertension|hypertension
5205552|NCT00803660|BP|bp
5205553|NCT00803660|diabetes|diabetes
5205554|NCT00803660|anti-hypertensive treatment|anti-hypertensive treatment
5205555|NCT00803660|ACE-I|ace-i
5205556|NCT00803660|ARB|arb
5205557|NCT00803647|NSABP|nsabp
5205558|NCT00803647|Cetuximab|cetuximab
5205559|NCT00803647|FOLFOX7|folfox7
5205560|NCT00803647|Oxaliplatin|oxaliplatin
5205561|NCT00803647|Leucovorin|leucovorin
5205562|NCT00803647|5-FU|5-fu
5205563|NCT00803647|colorectal cancer|colorectal cancer
5205564|NCT00803647|KRAS wild type|kras wild type
5205565|NCT00803647|metastatic colorectal cancer|metastatic colorectal cancer
5205566|NCT00803647|Erbitux|erbitux
5205567|NCT00803647|Eloxatin|eloxatin
5205568|NCT00803647|Liver resection|liver resection
5205569|NCT00803647|Liver ablation|liver ablation
5205570|NCT00803647|Metastasectomy|metastasectomy
5205571|NCT00803634|Hypertension|hypertension
5205572|NCT00803634|Antihypertensive Agent|antihypertensive agent
5205573|NCT00803634|Calcium Channel Blocker|calcium channel blocker
5205574|NCT00803608|Plantar|plantar
5205575|NCT00803608|Ulcer|ulcer
5205576|NCT00803608|Diabetes|diabetes
5205577|NCT00803595|Influenza|influenza
5205578|NCT00803595|Neuraminidase inhibitor|neuraminidase inhibitor
5205579|NCT00803569|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5205580|NCT00803569|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
5205581|NCT00803569|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5205582|NCT00803569|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5205583|NCT00803569|fallopian tube cancer|fallopian tube cancer
5205584|NCT00803569|peritoneal cavity cancer|peritoneal cavity cancer
5205585|NCT00803543|HSV-2|hsv-2
5205586|NCT00803543|Herpes Simplex|herpes simplex
5205587|NCT00803543|HSV Type 2|hsv type 2
5205588|NCT00803543|HIV|hiv
5205589|NCT00803543|HIV/HSV|hiv/hsv
5205590|NCT00803543|treatment experienced|treatment experienced
5205591|NCT00803530|myelodysplastic syndromes|myelodysplastic syndromes
5205592|NCT00803530|arsenic trioxide|arsenic trioxide
5205593|NCT00803530|ascorbic acid|ascorbic acid
5205594|NCT00803517|chronic central serous chorioretinopathy|chronic central serous chorioretinopathy
5205595|NCT00803517|multifocal electroretinogram|multifocal electroretinogram
5205596|NCT00803517|central retinal function after treatment in chronic serous chorioretinopathy|central retinal function after treatment in chronic serous chorioretinopathy
5205597|NCT00803504|optic disc morphology|optic disc morphology
5205598|NCT00803504|ocular blood flow|ocular blood flow
5205599|NCT00803504|retina|retina
5205600|NCT00803504|ocular physiology|ocular physiology
5205601|NCT00803491|Rheumatic diseases|rheumatic diseases
5205602|NCT00803491|Problem based learning|problem based learning
5205603|NCT00803491|Health-related quality of life|health-related quality of life
5205604|NCT00803491|Empowerment|empowerment
5205605|NCT00803491|Self-care|self-care
5205606|NCT00803478|IntraLase LASIK for primary myopia|intralase lasik for primary myopia
5205607|NCT00803465|Bioequivalence|bioequivalence
5205608|NCT00803465|Fluticasone Propionate|fluticasone propionate
5205609|NCT00803452|Meibomian gland dysfunction|meibomian gland dysfunction
5205610|NCT00803452|Lid margin disease|lid margin disease
5205611|NCT00803452|doxycycline|doxycycline
5205612|NCT00803452|azithromycin|azithromycin
5205613|NCT00803452|essential fatty acid|essential fatty acid
5205614|NCT00803439|Bioequivalence|bioequivalence
5205615|NCT00803439|Clobetasol Propionate|clobetasol propionate
5205616|NCT00803426|ultrasound-guided regional anesthesia|ultrasound-guided regional anesthesia
5205617|NCT00803426|nerve block|nerve block
5205618|NCT00803426|popliteal fossa|popliteal fossa
5205619|NCT00803426|sciatic nerve|sciatic nerve
5205620|NCT00803426|common peroneal nerve|common peroneal nerve
5205621|NCT00803426|tibial nerve|tibial nerve
5205622|NCT00803426|onset time|onset time
5205623|NCT00803426|ankle surgery|ankle surgery
5205624|NCT00803426|foot surgery|foot surgery
5205625|NCT00803413|Chronic low back pain|chronic low back pain
5205626|NCT00803413|Back School|back school
5205627|NCT00803413|Walking|walking
5205628|NCT00803413|Physical activity|physical activity
5205629|NCT00803400|Panic disorder|panic disorder
5205630|NCT00803400|Exercise|exercise
5205631|NCT00803400|Alprazolam|alprazolam
5205632|NCT00803400|Aerobic|aerobic
5205633|NCT00803387|ocular dryness|ocular dryness
5205634|NCT00803387|ocular irritation|ocular irritation
5205635|NCT00803387|open-angle glaucoma|open-angle glaucoma
5205636|NCT00803387|ocular hypertension|ocular hypertension
5205637|NCT00803387|TravatanZ|travatanz
5205638|NCT00803387|Xalatan|xalatan
5205639|NCT00803361|anxiety|anxiety
5205640|NCT00803348|continuous femoral nerve blockade|continuous femoral nerve blockade
5205641|NCT00803348|knee arthroplasty|knee arthroplasty
5205642|NCT00803348|knee replacement|knee replacement
5205643|NCT00803348|regional anesthesia|regional anesthesia
5205644|NCT00803348|readiness to discharge|readiness to discharge
5205739|NCT00802919|nicotinic receptors|nicotinic receptors
5205645|NCT00803348|Femoral nerve blockade for total knee arthroplasty|femoral nerve blockade for total knee arthroplasty
5205646|NCT00803335|pelvic organ prolapse|pelvic organ prolapse
5205647|NCT00803335|vaginal atrophy|vaginal atrophy
5205648|NCT00803335|atrophic vaginitis|atrophic vaginitis
5205649|NCT00803335|postmenopausal|postmenopausal
5205650|NCT00803335|posthysterectomy|posthysterectomy
5205651|NCT00803335|vaginal health|vaginal health
5205652|NCT00803335|vaginal cytology|vaginal cytology
5205653|NCT00803335|vaginal maturity index|vaginal maturity index
5205654|NCT00803335|vaginal histology|vaginal histology
5205655|NCT00803335|quality of life questionnaires|quality of life questionnaires
5205656|NCT00803322|TB|tb
5205657|NCT00803322|community|community
5205658|NCT00803322|community health workers|community health workers
5205659|NCT00803322|Ethiopia|ethiopia
5205660|NCT00803322|identify suspects of pulmonary tuberculosis|identify suspects of pulmonary tuberculosis
5205661|NCT00803322|collect sputum specimen for examination|collect sputum specimen for examination
5205662|NCT00803322|treat smear positive cases in the community|treat smear positive cases in the community
5205663|NCT00803309|Chronic HCV-genotype 2/3|chronic hcv-genotype 2/3
5205664|NCT00803309|Efficacy of treatment extension|efficacy of treatment extension
5205665|NCT00803309|PegIntron|pegintron
5205666|NCT00803309|pegylated interferon alpha-2b|pegylated interferon alpha-2b
5205667|NCT00803309|Rebetol|rebetol
5205668|NCT00803309|ribavirin|ribavirin
5205669|NCT00803283|Pain|pain
5205670|NCT00803283|Hydromorphone hydrochloride OROS|hydromorphone hydrochloride oros
5205671|NCT00803283|Morphine|morphine
5205672|NCT00803270|Stress urinary incontinence, Mixed, Urge|stress urinary incontinence, mixed, urge
5205673|NCT00803257|Carpal Tunnel Syndrome|carpal tunnel syndrome
5205674|NCT00803257|Splint|splint
5205675|NCT00803257|Hand exercises|hand exercises
5205676|NCT00803244|allergic rhinoconjunctivitis|allergic rhinoconjunctivitis
5205677|NCT00803218|Bioequivalence|bioequivalence
5205678|NCT00803218|Fluticasone Propionate|fluticasone propionate
5205679|NCT00803205|Cystic fibrosis|cystic fibrosis
5205680|NCT00803205|Nonsense mutation|nonsense mutation
5205681|NCT00803205|Premature stop codon|premature stop codon
5205682|NCT00803205|PTC124|ptc124
5205683|NCT00803205|Ataluren|ataluren
5205684|NCT00803192|bioavailability|bioavailability
5205685|NCT00803192|famotidine|famotidine
5205686|NCT00803179|CF|cf
5205687|NCT00803166|Bioequivalence|bioequivalence
5205688|NCT00803166|Halobetasol Propionate|halobetasol propionate
5205689|NCT00803153|Panretinal photocoagulation|panretinal photocoagulation
5205690|NCT00803153|Bruch rupture|bruch rupture
5205691|NCT00803153|Choroidal detachment|choroidal detachment
5205692|NCT00803153|complication rates|complication rates
5205693|NCT00803140|scarring|scarring
5205694|NCT00803127|vaginal infection, color appearance|vaginal infection, color appearance
5205695|NCT00803114|Postpartum perineal pain|postpartum perineal pain
5205696|NCT00803114|Epidural morphine|epidural morphine
5205697|NCT00803114|Randomised clinical trial|randomised clinical trial
5205698|NCT00803101|Anticoagulant reversal|anticoagulant reversal
5205699|NCT00803101|Prothrombin Complex Concentrate|prothrombin complex concentrate
5205700|NCT00803101|Coagulopathy|coagulopathy
5205701|NCT00803101|Coumarin derivatives|coumarin derivatives
5205702|NCT00803101|Emergency surgery|emergency surgery
5205703|NCT00803101|Invasive procedures|invasive procedures
5205704|NCT00803101|Vitamin K|vitamin k
5205705|NCT00803101|Reversal of coagulopathy induced by coumarin derivatives|reversal of coagulopathy induced by coumarin derivatives
5205706|NCT00803101|Kcentra|kcentra
5205707|NCT00803049|Multiple Sclerosis|multiple sclerosis
5205708|NCT00803049|Oral treatment|oral treatment
5205709|NCT00803036|spreading cortical depression|spreading cortical depression
5205710|NCT00803036|electroencephalography|electroencephalography
5205711|NCT00803036|traumatic brain injury|traumatic brain injury
5205712|NCT00803036|intensive care|intensive care
5205713|NCT00803036|vascular hypotension|vascular hypotension
5205714|NCT00803036|intracranial hypertension|intracranial hypertension
5205715|NCT00803010|Acute Graft Versus Host Disease (aGVHD)|acute graft versus host disease (agvhd)
5205716|NCT00803010|GVHD|gvhd
5205717|NCT00803010|graft-versus-host disease|graft-versus-host disease
5205718|NCT00803010|tacrolimus|tacrolimus
5205719|NCT00803010|sirolimus|sirolimus
5205720|NCT00803010|methotrexate|methotrexate
5205721|NCT00803010|combination therapy|combination therapy
5205722|NCT00803010|GVHD prophylaxis|gvhd prophylaxis
5205723|NCT00802971|Reactive hypoglycaemia|reactive hypoglycaemia
5205724|NCT00802971|Fiber|fiber
5205725|NCT00802971|Prevalence|prevalence
5205726|NCT00802971|Randomised controlled trial|randomised controlled trial
5205727|NCT00802971|Idiopathic reactive hypoglycemia|idiopathic reactive hypoglycemia
5205728|NCT00802958|Bioequivalence|bioequivalence
5205729|NCT00802958|Halobetasol Propionate|halobetasol propionate
5205730|NCT00802932|breast cancer|breast cancer
5205731|NCT00802932|female|female
5205732|NCT00802932|metallic markers|metallic markers
5205733|NCT00802932|image guided radiation therapy|image guided radiation therapy
5205734|NCT00802932|IGRT|igrt
5205735|NCT00802919|schizophrenia|schizophrenia
5205736|NCT00802919|smoking|smoking
5205737|NCT00802919|nicotine|nicotine
5205738|NCT00802919|cognitive deficits|cognitive deficits
5205740|NCT00802919|Cognitive Deficits in Schizophrenia|cognitive deficits in schizophrenia
5205741|NCT00802906|micropulselaserphotocoagulation|micropulselaserphotocoagulation
5205742|NCT00802906|bevacizumab|bevacizumab
5205743|NCT00802906|CSC|csc
5205744|NCT00802893|Isolated Systolic Hypertension with Endothelial Dysfunction|isolated systolic hypertension with endothelial dysfunction
5205745|NCT00802867|DAPTACEL®|daptacel®
5205746|NCT00802867|PENTACEL™|pentacel™
5205747|NCT00802867|Diphtheria|diphtheria
5205748|NCT00802867|Tetanus|tetanus
5205749|NCT00802867|Pertussis|pertussis
5205750|NCT00802867|Haemophilus influenzae type b|haemophilus influenzae type b
5205751|NCT00802854|anidulafungin|anidulafungin
5205752|NCT00802854|safety|safety
5205753|NCT00802854|efficacy|efficacy
5205754|NCT00802841|Chronic|chronic
5205755|NCT00802841|Myelogenous|myelogenous
5205756|NCT00802841|Leukemia|leukemia
5205757|NCT00802841|CML|cml
5205758|NCT00802841|Chronic Phase|chronic phase
5205759|NCT00802841|Suboptimal Response|suboptimal response
5205760|NCT00802828|bioavailability|bioavailability
5205761|NCT00802828|famotidine|famotidine
5205762|NCT00802763|VAGINAL INFECTION|vaginal infection
5205763|NCT00802763|COLOR APPEARANCE|color appearance
5205764|NCT00802763|ELEVATED Ph|elevated ph
5205765|NCT00802737|Maintenance|maintenance
5205766|NCT00802737|Retreatment|retreatment
5205767|NCT00802737|Chronic lymphocytic leukemia|chronic lymphocytic leukemia
5205768|NCT00802737|B-Cell Chronic Lymphocytic Leukemia|b-cell chronic lymphocytic leukemia
5205769|NCT00802737|Ofatumumab|ofatumumab
5205770|NCT00802724|low back pain|low back pain
5205771|NCT00802724|classification|classification
5205772|NCT00802724|spine|spine
5205773|NCT00802711|stage IA breast cancer|stage ia breast cancer
5205774|NCT00802711|stage IB breast cancer|stage ib breast cancer
5205775|NCT00802711|stage II breast cancer|stage ii breast cancer
5205776|NCT00802711|invasive ductal breast carcinoma|invasive ductal breast carcinoma
5205777|NCT00802698|Biphasic waveform|biphasic waveform
5205778|NCT00802698|Central retinal artery occlusion|central retinal artery occlusion
5205779|NCT00802698|To describe the effect of Transcorneal Electrical Stimulation (TES) with a non conventional biphasic bipolar waveform|to describe the effect of transcorneal electrical stimulation (tes) with a non conventional biphasic bipolar waveform
5205780|NCT00802698|in central retinal artery occlusion|in central retinal artery occlusion
5205781|NCT00802685|Patent ductus arteriosus|patent ductus arteriosus
5205782|NCT00802685|Respiratory outcome|respiratory outcome
5205783|NCT00802672|Tinea Pedis|tinea pedis
5205784|NCT00802672|Ciclopirox Olamine|ciclopirox olamine
5205785|NCT00802646|first-time mother|first-time mother
5205786|NCT00802646|epidural request|epidural request
5205787|NCT00802646|vaginal childbirth|vaginal childbirth
5205788|NCT00802633|Tissue sealing device|tissue sealing device
5205789|NCT00802633|Articulating stapling device|articulating stapling device
5205790|NCT00802633|Radical cystectomy|radical cystectomy
5205791|NCT00802620|Amniotic membrane|amniotic membrane
5205792|NCT00802620|Conjunctival autograft|conjunctival autograft
5205793|NCT00802620|Recurrent pterygia|recurrent pterygia
5205794|NCT00802620|compare amniotic membrane associated with conjunctival autograft versus conjunctival autograft alone in the treatment of recurrent pterygia|compare amniotic membrane associated with conjunctival autograft versus conjunctival autograft alone in the treatment of recurrent pterygia
5205795|NCT00802607|Bone Diseases|bone diseases
5205796|NCT00802607|Connective Tissue Diseases|connective tissue diseases
5205797|NCT00802594|first stage|first stage
5205798|NCT00802594|T.b. gambiense|t.b. gambiense
5205799|NCT00802594|sleeping sickness|sleeping sickness
5205800|NCT00802594|Patients with first stage T.b. gambiense sleeping sickness|patients with first stage t.b. gambiense sleeping sickness
5205801|NCT00802581|sciatic nerve block|sciatic nerve block
5205802|NCT00802581|local anesthetic|local anesthetic
5205803|NCT00802581|lidocaine|lidocaine
5205804|NCT00802581|ankle surgery|ankle surgery
5205805|NCT00802581|foot surgery|foot surgery
5205806|NCT00802581|ultrasound-guided regional anesthesia|ultrasound-guided regional anesthesia
5205807|NCT00802581|circumferential spread|circumferential spread
5205808|NCT00802581|anesthetic infiltration|anesthetic infiltration
5205809|NCT00802568|stage I multiple myeloma|stage i multiple myeloma
5205810|NCT00802568|stage II multiple myeloma|stage ii multiple myeloma
5205811|NCT00802568|stage III multiple myeloma|stage iii multiple myeloma
5205812|NCT00802568|refractory multiple myeloma|refractory multiple myeloma
5205813|NCT00802568|osteolytic lesions of multiple myeloma|osteolytic lesions of multiple myeloma
5205814|NCT00802555|HCC|hcc
5205815|NCT00802555|Cirrhotic Patients with Hepatocellular Carcinoma|cirrhotic patients with hepatocellular carcinoma
5205816|NCT00802542|Hypertension|hypertension
5205817|NCT00802542|blood pressure|blood pressure
5205818|NCT00802542|Atacand|atacand
5205819|NCT00802529|Meniere's disease|meniere's disease
5205820|NCT00802529|transtympanic steroids|transtympanic steroids
5205821|NCT00802529|Randomised controlled trial|randomised controlled trial
5205822|NCT00802503|Critically ill|critically ill
5205823|NCT00802503|nutrition|nutrition
5205824|NCT00802503|randomised controlled clinical trial|randomised controlled clinical trial
5205825|NCT00802503|human|human
5205826|NCT00802503|adult|adult
5205827|NCT00802503|Supplemental parenteral nutrition|supplemental parenteral nutrition
5205828|NCT00802490|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
5205829|NCT00802490|Electroencephalogram biofeedback|electroencephalogram biofeedback
5205830|NCT00802490|Inattention|inattention
5205831|NCT00802490|Brain-Computer Interface System|brain-computer interface system
5205832|NCT00802477|mastectomy|mastectomy
5205833|NCT00802477|seroma|seroma
5205834|NCT00802477|lymph node dissection|lymph node dissection
5205835|NCT00802464|Cytokine|cytokine
5205836|NCT00802464|Vaccine|vaccine
5205837|NCT00802464|Herpes Zoster (HZ)|herpes zoster (hz)
5205838|NCT00802464|Cell mediated immunity (CMI)|cell mediated immunity (cmi)
5205839|NCT00802464|Antibody response|antibody response
5205840|NCT00802464|Varicella Zoster Virus (VZV)|varicella zoster virus (vzv)
5205841|NCT00802464|Shingles|shingles
5205842|NCT00802451|Bioavailability|bioavailability
5205843|NCT00802451|Mesalamine|mesalamine
5205844|NCT00802438|asthma|asthma
5205845|NCT00802438|allergic inflammation|allergic inflammation
5205846|NCT00802438|interleukin-5|interleukin-5
5205847|NCT00802425|Sudden hearing loss|sudden hearing loss
5205848|NCT00802425|Sudden deafness|sudden deafness
5205849|NCT00802425|Acoustic trauma|acoustic trauma
5205850|NCT00802425|Noise trauma|noise trauma
5205851|NCT00802412|tobacco use disorders|tobacco use disorders
5205852|NCT00802412|alcoholism|alcoholism
5205853|NCT00802399|Cornea|cornea
5205854|NCT00802399|Dry eye|dry eye
5205855|NCT00802399|lacrimal punctual occlusion|lacrimal punctual occlusion
5205856|NCT00802399|lacrimal film|lacrimal film
5205857|NCT00802399|ocular surface|ocular surface
5205858|NCT00802386|BACTERIAL VAGINOSIS|bacterial vaginosis
5205859|NCT00802386|IUD INSERTION|iud insertion
5205860|NCT00802373|Overactive Bladder|overactive bladder
5205861|NCT00802360|Healthy, pre-menopausal women, age 18-42 with a history of infertility and requiring IVF|healthy, pre-menopausal women, age 18-42 with a history of infertility and requiring ivf
5205862|NCT00802347|Delayed Graft Function|delayed graft function
5205863|NCT00802347|Kidney Transplant|kidney transplant
5205864|NCT00802347|Renal Transplant|renal transplant
5205865|NCT00802347|small interfering ribonucleic acid (siRNA)|small interfering ribonucleic acid (sirna)
5205866|NCT00802334|generic lopinavir/ritonavir|generic lopinavir/ritonavir
5205867|NCT00802334|therapeutic drug monitoring|therapeutic drug monitoring
5205868|NCT00802334|safety and efficacy|safety and efficacy
5205869|NCT00802321|steroid 5AReductase|steroid 5areductase
5205870|NCT00802321|genetic polymorphism|genetic polymorphism
5205871|NCT00802321|GABA receptor|gaba receptor
5205872|NCT00802295|Ovarian|ovarian
5205873|NCT00802295|hyperstimulation|hyperstimulation
5205874|NCT00802295|Embryo|embryo
5205875|NCT00802295|Aneuploidy|aneuploidy
5205876|NCT00802295|Ovarian hyperstimulation and Embryo Aneuploidy Rates|ovarian hyperstimulation and embryo aneuploidy rates
5205877|NCT00802282|healthy volunteers|healthy volunteers
5205878|NCT00802282|spirituality|spirituality
5205879|NCT00802282|psilocybin|psilocybin
5205880|NCT00802282|meditation|meditation
5205881|NCT00802269|Proliferative diabetic retinopathy|proliferative diabetic retinopathy
5205882|NCT00802269|Laser photocoagulation|laser photocoagulation
5205883|NCT00802269|Pain|pain
5205884|NCT00802256|pulpotomy|pulpotomy
5205885|NCT00802256|primary molar teeth|primary molar teeth
5205886|NCT00802256|MTA|mta
5205887|NCT00802256|NEC|nec
5205888|NCT00802256|CEM|cem
5205889|NCT00802256|Primary Molar Teeth Which Require Pulpotomy Treatment|primary molar teeth which require pulpotomy treatment
5205890|NCT00802243|Bullous pemphigoid|bullous pemphigoid
5205891|NCT00802243|leflunomide|leflunomide
5205892|NCT00802243|corticosteroid treatment reduction|corticosteroid treatment reduction
5205893|NCT00802243|Patients are screened by: the physicians in different departments of the hospital, the liberal dermatologists and the general practicioners.|patients are screened by: the physicians in different departments of the hospital, the liberal dermatologists and the general practicioners.
5205894|NCT00802243|Phase I: Patients will be referred to the investigators of Dupuytren Hospital Dermatology Department.|phase i: patients will be referred to the investigators of dupuytren hospital dermatology department.
5205895|NCT00802243|Phase II: Patients will be referred to the investigators of Purpan (Toulouse), Haut Leveque (Pessac) and Dupuytren (Limoges) Hospitals.|phase ii: patients will be referred to the investigators of purpan (toulouse), haut leveque (pessac) and dupuytren (limoges) hospitals.
5205896|NCT00802217|Pharmacokinetics|pharmacokinetics
5205897|NCT00802217|Safety|safety
5205898|NCT00802217|Tolerability|tolerability
5205899|NCT00802217|Healthy Volunteers|healthy volunteers
5205900|NCT00802204|Obesity|obesity
5205901|NCT00802204|Insulin Resistance|insulin resistance
5205902|NCT00802204|Neuroendocrine regulation|neuroendocrine regulation
5205903|NCT00802204|Eating behaviors|eating behaviors
5205904|NCT00802204|Dopamine signaling|dopamine signaling
5205905|NCT00802165|Asymptomatic normals|asymptomatic normals
5205906|NCT00802152|Diabetes|diabetes
5205907|NCT00802152|Hypertension|hypertension
5205908|NCT00802139|iron deficiency anemia|iron deficiency anemia
5205909|NCT00802139|pregnant women with iron deficiency anemia|pregnant women with iron deficiency anemia
5205910|NCT00802113|Autologous Stem Cell Transplant|autologous stem cell transplant
5205911|NCT00802113|Cord Blood Transplant|cord blood transplant
5205912|NCT00802113|Allogeneic Stem Cell Transplant|allogeneic stem cell transplant
5205913|NCT00802113|Relapsed Lymphoma|relapsed lymphoma
5205914|NCT00802100|Schizoaffective Disorder|schizoaffective disorder
5205915|NCT00802087|Hydrocodone|hydrocodone
5205916|NCT00802087|Pharmacokinetics|pharmacokinetics
5205917|NCT00802087|Safety & Tolerability|safety & tolerability
5205918|NCT00802074|Healthy Subjects|healthy subjects
5205919|NCT00802074|Pharmacokinetics study|pharmacokinetics study
5205920|NCT00802074|Pharmacokinetics of medications|pharmacokinetics of medications
5205921|NCT00802061|progressive glaucoma despite controlled IOP|progressive glaucoma despite controlled iop
5205922|NCT00802048|Sternotomy|sternotomy
5205923|NCT00802048|Postoperative hyperalgesia|postoperative hyperalgesia
5205924|NCT00802048|Intralesional anesthetic infusion|intralesional anesthetic infusion
5205925|NCT00802048|Ropivacaïne|ropivacaïne
5205926|NCT00802048|Chronic|chronic
5205927|NCT00802048|Postoperative pain|postoperative pain
5205928|NCT00802048|Cardiac surgery|cardiac surgery
5205929|NCT00802048|Sternum|sternum
5205930|NCT00802048|Cardiac surgical procedures|cardiac surgical procedures
5205931|NCT00802035|ALK29|alk29
5205932|NCT00802035|Alcohol Dependence|alcohol dependence
5205933|NCT00802035|Pharmacokinetics|pharmacokinetics
5205934|NCT00802022|diabetic neuropathies|diabetic neuropathies
5205935|NCT00802022|electric stimulation therapy|electric stimulation therapy
5205936|NCT00802009|ultrasound-guided regional anesthesia|ultrasound-guided regional anesthesia
5205937|NCT00802009|nerve block|nerve block
5205938|NCT00802009|brachial plexus|brachial plexus
5205939|NCT00802009|mepivicaine|mepivicaine
5205940|NCT00802009|dexamethasone|dexamethasone
5205941|NCT00802009|hand wrist surgery|hand wrist surgery
5205942|NCT00802009|duration|duration
5205943|NCT00802009|anesthetic duration following brachial plexus/nerve block for hand/wrist surgery|anesthetic duration following brachial plexus/nerve block for hand/wrist surgery
5205944|NCT00801996|prostate cancer|prostate cancer
5205945|NCT00801996|genetics|genetics
5205946|NCT00801970|Fear of childbirth|fear of childbirth
5205947|NCT00801970|Tokophobia|tokophobia
5205948|NCT00801970|Anxiety|anxiety
5205949|NCT00801970|Labor|labor
5205950|NCT00801970|Pregnancy|pregnancy
5205951|NCT00801970|Cognitive-behavioral|cognitive-behavioral
5205952|NCT00801970|Psychoanalysis|psychoanalysis
5205953|NCT00801970|Group Therapy|group therapy
5205954|NCT00801970|etiology|etiology
5205955|NCT00801957|atopic dermatitis|atopic dermatitis
5205956|NCT00801957|meningitis|meningitis
5205957|NCT00801957|vaccination|vaccination
5205958|NCT00801957|tacrolimus|tacrolimus
5205959|NCT00801957|steroids|steroids
5205960|NCT00801957|equivalence response|equivalence response
5205961|NCT00801957|meningococcal vaccine|meningococcal vaccine
5205962|NCT00801944|Overactive Bladder|overactive bladder
5205963|NCT00801931|Cord Blood Transplant|cord blood transplant
5205964|NCT00801931|Allogeneic Stem Cell Transplant|allogeneic stem cell transplant
5205965|NCT00801918|lymphoma|lymphoma
5205966|NCT00801918|pediatric|pediatric
5205967|NCT00801918|adolescent|adolescent
5205968|NCT00801918|relapsed|relapsed
5205969|NCT00801918|refractory|refractory
5205970|NCT00801918|denileukin diftitox|denileukin diftitox
5205971|NCT00801918|Ontak|ontak
5205972|NCT00801905|Macular thickening|macular thickening
5205973|NCT00801905|Macular edema|macular edema
5205974|NCT00801905|Pan-retinal photocoagulation|pan-retinal photocoagulation
5205975|NCT00801905|Nepafenac|nepafenac
5205976|NCT00801905|Topical non-steroidal anti inflammatory agents|topical non-steroidal anti inflammatory agents
5205977|NCT00801892|daytime sleepiness|daytime sleepiness
5205978|NCT00801892|obstructive sleep apnea|obstructive sleep apnea
5205979|NCT00801892|type 2 diabetes mellitus|type 2 diabetes mellitus
5205980|NCT00801892|diabetes management|diabetes management
5205981|NCT00801879|mupirocin|mupirocin
5205982|NCT00801879|Staphylococcus aureus|staphylococcus aureus
5205983|NCT00801879|colonization|colonization
5205984|NCT00801879|infection|infection
5205985|NCT00801879|HIV|hiv
5205986|NCT00801866|Panretinal Photocoagulation|panretinal photocoagulation
5205987|NCT00801866|Macular Edema|macular edema
5205988|NCT00801866|Intravitreal Bevacizumab|intravitreal bevacizumab
5205989|NCT00801853|asthma|asthma
5205990|NCT00801853|allergy|allergy
5205991|NCT00801853|atopy|atopy
5205992|NCT00801853|atopic|atopic
5205993|NCT00801853|wheeze|wheeze
5205994|NCT00801827|Obesity|obesity
5205995|NCT00801827|Addiction|addiction
5205996|NCT00801827|PET imaging|pet imaging
5205997|NCT00801814|viscous|viscous
5205998|NCT00801814|fibre|fibre
5205999|NCT00801814|polysaccharide|polysaccharide
5206000|NCT00801814|blood glucose|blood glucose
5206001|NCT00801814|post prandial|post prandial
5206002|NCT00801801|Docetaxel|docetaxel
5206003|NCT00801801|Sorafenib|sorafenib
5206004|NCT00801775|calorimetry|calorimetry
5206005|NCT00801736|Recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5206006|NCT00801736|Stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5206007|NCT00801736|Stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5206008|NCT00801723|Ulcerative Colitis|ulcerative colitis
5206009|NCT00801697|HIV Seronegativity|hiv seronegativity
5206010|NCT00801697|HIV Preventive Vaccine|hiv preventive vaccine
5206011|NCT00801697|Adenovirus|adenovirus
5206012|NCT00801684|COPD|copd
5206013|NCT00801684|pulmonary|pulmonary
5206014|NCT00801684|inhalation|inhalation
5206015|NCT00801671|obstructive sleep apnea|obstructive sleep apnea
5206016|NCT00801671|obstructive sleep apnea syndrome|obstructive sleep apnea syndrome
5206017|NCT00801671|hypertension|hypertension
5206018|NCT00801671|systemic hypertension|systemic hypertension
5206019|NCT00801671|ambulatory blood pressure monitoring|ambulatory blood pressure monitoring
5206020|NCT00801658|glaucoma|glaucoma
5206021|NCT00801658|SLT|slt
5206022|NCT00801658|Laser treatment|laser treatment
5206023|NCT00801658|IOP|iop
5206024|NCT00801658|glaucoma treated with eye drops but IOP not controlled|glaucoma treated with eye drops but iop not controlled
5206025|NCT00801645|Obesity|obesity
5206026|NCT00801645|Cardiovascular disease|cardiovascular disease
5206027|NCT00801645|Endothelial function|endothelial function
5206028|NCT00801645|Blood pressure|blood pressure
5206029|NCT00801645|Exercise|exercise
5206030|NCT00801645|Physical activity|physical activity
5206031|NCT00801645|Metabolic syndrome|metabolic syndrome
5206032|NCT00801645|Children|children
5206033|NCT00801645|Pediatric|pediatric
5206034|NCT00801632|renal allograft tolerance|renal allograft tolerance
5206035|NCT00801632|mixed chimerism|mixed chimerism
5206036|NCT00801632|kidney transplant|kidney transplant
5206037|NCT00801632|bone marrow transplant|bone marrow transplant
5206038|NCT00801632|antirejection|antirejection
5206039|NCT00801632|immunosuppression|immunosuppression
5206040|NCT00801606|Micronutrient|micronutrient
5206041|NCT00801606|Childhood Tuberculosis|childhood tuberculosis
5206042|NCT00801593|JIA|jia
5206043|NCT00801580|relapsed ALL|relapsed all
5206044|NCT00801580|refractory ALL|refractory all
5206045|NCT00801580|relapsed adult acute lymphoid leukemia|relapsed adult acute lymphoid leukemia
5206046|NCT00801567|Bipolar disorder|bipolar disorder
5206047|NCT00801567|Schizophrenia|schizophrenia
5206048|NCT00801567|Healthy volunteer|healthy volunteer
5206049|NCT00801567|Brain imaging|brain imaging
5206050|NCT00801567|Photic stimulation|photic stimulation
5206051|NCT00801554|Autism Spectrum Disorder|autism spectrum disorder
5206052|NCT00801554|ASD|asd
5206053|NCT00801554|Autism|autism
5206054|NCT00801554|Asperger's Syndrome|asperger's syndrome
5206055|NCT00801554|PDD-NOS|pdd-nos
5206056|NCT00801554|Pervasive Developmental Disorders- Not Otherwise Specified|pervasive developmental disorders- not otherwise specified
5206057|NCT00801554|Adults|adults
5206058|NCT00801554|Children|children
5206059|NCT00801541|AMD|amd
5206060|NCT00801528|ropivacaine|ropivacaine
5206061|NCT00801528|diclofenac|diclofenac
5206062|NCT00801528|local anesthetic instillation|local anesthetic instillation
5206063|NCT00801515|Compassionate|compassionate
5206064|NCT00801515|HIV|hiv
5206065|NCT00801515|CCR5|ccr5
5206066|NCT00801502|Omega-3|omega-3
5206067|NCT00801502|Oily fish|oily fish
5206068|NCT00801502|Antioxidant|antioxidant
5206069|NCT00801502|Selenium|selenium
5206070|NCT00801502|Atopic disease|atopic disease
5206071|NCT00801502|Pregnancy|pregnancy
5206072|NCT00801502|Nutrient status|nutrient status
5206073|NCT00801489|Leukemia|leukemia
5206074|NCT00801489|Acute Myelogenous Leukemia|acute myelogenous leukemia
5206075|NCT00801489|AML|aml
5206076|NCT00801476|Breast Cancer|breast cancer
5206077|NCT00801476|Magnetic Resonance Imaging|magnetic resonance imaging
5206078|NCT00801476|Preoperative MRI|preoperative mri
5206079|NCT00801463|Focal Segmental Glomerulosclerosis|focal segmental glomerulosclerosis
5206080|NCT00801463|Prednisone|prednisone
5206081|NCT00801463|Tripterygium Wilfordii|tripterygium wilfordii
5206082|NCT00801450|diabetes|diabetes
5206083|NCT00801450|macular edema|macular edema
5206084|NCT00801450|triamcinolone|triamcinolone
5206085|NCT00801450|cataract|cataract
5206086|NCT00801450|refractory diabetic macular edema|refractory diabetic macular edema
5206087|NCT00801437|glaucoma, open-angle, non-interventional study, safety, tolerability|glaucoma, open-angle, non-interventional study, safety, tolerability
5206088|NCT00801424|abdominal surgery|abdominal surgery
5206089|NCT00801424|hypothermia|hypothermia
5206090|NCT00801424|wound dessication|wound dessication
5206091|NCT00801424|warming|warming
5206092|NCT00801411|stage II breast cancer|stage ii breast cancer
5206093|NCT00801398|Opioid tolerant|opioid tolerant
5206094|NCT00801398|Pediatric|pediatric
5206095|NCT00801398|Pain|pain
5206096|NCT00801398|Non malignant|non malignant
5206097|NCT00801398|Malignant|malignant
5206098|NCT00801385|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5206099|NCT00801385|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5206100|NCT00801385|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5206101|NCT00801372|pregnant, healthy females older than 18 who signed an informed consent for the termination of the pregnancy.|pregnant, healthy females older than 18 who signed an informed consent for the termination of the pregnancy.
5206102|NCT00801372|pregnant healthy couples older than 18 who signed an informed consent for a c-section.|pregnant healthy couples older than 18 who signed an informed consent for a c-section.
5206103|NCT00801372|healthy male newborns, undergoing surgical circumcision who's parents older than 18 signed an informed consent.|healthy male newborns, undergoing surgical circumcision who's parents older than 18 signed an informed consent.
5206104|NCT00801359|cataract|cataract
5206105|NCT00801359|phacoemulsification|phacoemulsification
5206106|NCT00801359|irrigation solution|irrigation solution
5206107|NCT00801359|endothelial cell density|endothelial cell density
5206108|NCT00801359|corneal thickness|corneal thickness
5206109|NCT00801346|fatigue|fatigue
5206307|NCT00800540|glaucoma|glaucoma
5206110|NCT00801346|long-term effects secondary to cancer therapy in children|long-term effects secondary to cancer therapy in children
5206111|NCT00801346|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
5206112|NCT00801346|B-cell childhood acute lymphoblastic leukemia|b-cell childhood acute lymphoblastic leukemia
5206113|NCT00801346|T-cell childhood acute lymphoblastic leukemia|t-cell childhood acute lymphoblastic leukemia
5206114|NCT00801333|ALS|als
5206115|NCT00801320|tumor harvest|tumor harvest
5206116|NCT00801320|tumor collection|tumor collection
5206117|NCT00801320|tumor storage|tumor storage
5206118|NCT00801307|evaluate Inspiratory Capacity (IC) measured by spirometry|evaluate inspiratory capacity (ic) measured by spirometry
5206119|NCT00801281|Lymphoma|lymphoma
5206120|NCT00801281|Immunochemotherapy|immunochemotherapy
5206121|NCT00801281|Induction therapy|induction therapy
5206122|NCT00801281|Maintenance therapy|maintenance therapy
5206123|NCT00801281|Follicular lymphoma grade 1,2,3a|follicular lymphoma grade 1,2,3a
5206124|NCT00801281|Marginal zone lymphoma, including MALT type|marginal zone lymphoma, including malt type
5206125|NCT00801281|Small lymphocytic lymphoma (BM inv. <30%)|small lymphocytic lymphoma (bm inv. <30%)
5206126|NCT00801268|polycystic kidney disease|polycystic kidney disease
5206127|NCT00801268|tripterygium wilfordii|tripterygium wilfordii
5206128|NCT00801229|ADHD|adhd
5206129|NCT00801229|young adults|young adults
5206130|NCT00801229|driving|driving
5206131|NCT00801229|Vyvanse|vyvanse
5206132|NCT00801229|lisdexamfetamine|lisdexamfetamine
5206133|NCT00801216|B-cell lymphomas|b-cell lymphomas
5206134|NCT00801216|lymphomatous meningitis|lymphomatous meningitis
5206135|NCT00801216|liposomal cytarabine|liposomal cytarabine
5206136|NCT00801216|autologous transplant|autologous transplant
5206137|NCT00801216|CNS involvement|cns involvement
5206138|NCT00801216|Secondary CNS lymphomas|secondary cns lymphomas
5206139|NCT00801203|Stress Urinary Incontinence|stress urinary incontinence
5206140|NCT00801190|colloid|colloid
5206141|NCT00801190|CABG|cabg
5206142|NCT00801190|cardiopulmonary bypass|cardiopulmonary bypass
5206143|NCT00801190|bleeding|bleeding
5206144|NCT00801177|Tumors|tumors
5206145|NCT00801177|Antibodies, Monoclonal|antibodies, monoclonal
5206146|NCT00801164|Diabetes Type 2|diabetes type 2
5206147|NCT00801164|Periodontitis|periodontitis
5206148|NCT00801138|ropivacaine|ropivacaine
5206149|NCT00801138|bupivacaine|bupivacaine
5206150|NCT00801138|glucocorticoid|glucocorticoid
5206151|NCT00801112|Bioimpedance|bioimpedance
5206152|NCT00801112|Fluid status|fluid status
5206153|NCT00801112|Peritoneal Dialysis|peritoneal dialysis
5206154|NCT00801112|Extra-cellular fluid volume|extra-cellular fluid volume
5206155|NCT00801099|Postoperative wound infection|postoperative wound infection
5206156|NCT00801099|surgical site infection|surgical site infection
5206157|NCT00801099|antimicrobial prophylaxis|antimicrobial prophylaxis
5206158|NCT00801099|developing countries|developing countries
5206159|NCT00801099|Sub-Saharan Africa|sub-saharan africa
5206160|NCT00801099|reduction of SSI using preoperative antibiotics|reduction of ssi using preoperative antibiotics
5206161|NCT00801086|Alopecia|alopecia
5206162|NCT00801086|Hair loss|hair loss
5206163|NCT00801086|Radiation|radiation
5206164|NCT00801086|Whole brain radiotherapy|whole brain radiotherapy
5206165|NCT00801086|Radiation-induced alopecia|radiation-induced alopecia
5206166|NCT00801073|Amniotic membrane|amniotic membrane
5206167|NCT00801073|Cornea|cornea
5206168|NCT00801073|Scleral thinning|scleral thinning
5206169|NCT00801060|Fludara|fludara
5206170|NCT00801060|CD23|cd23
5206171|NCT00801060|Cyclophosphamide|cyclophosphamide
5206172|NCT00801060|Antibody|antibody
5206173|NCT00801060|Fludarabine|fludarabine
5206174|NCT00801060|CLL|cll
5206175|NCT00801060|Rituximab|rituximab
5206176|NCT00801060|Mabthera|mabthera
5206177|NCT00801060|Biogen Idec|biogen idec
5206178|NCT00801060|Lumiliximab|lumiliximab
5206179|NCT00801060|Rituxan|rituxan
5206180|NCT00801060|Cytoxan|cytoxan
5206181|NCT00801060|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
5206182|NCT00801047|Epidural|epidural
5206183|NCT00801047|Labor|labor
5206184|NCT00801047|Remifentanil|remifentanil
5206185|NCT00801034|hypertension|hypertension
5206186|NCT00801034|potassium|potassium
5206187|NCT00801034|blood pressure|blood pressure
5206188|NCT00801021|Cystitis|cystitis
5206189|NCT00801021|Urinary Tract Infections|urinary tract infections
5206190|NCT00801008|young adult|young adult
5206191|NCT00801008|cancer|cancer
5206192|NCT00801008|exercise|exercise
5206193|NCT00801008|relaxation|relaxation
5206194|NCT00800995|ARMD|armd
5206195|NCT00800995|SOD|sod
5206196|NCT00800982|Obese patients (BMI>30)|obese patients (bmi>30)
5206197|NCT00800982|Patients with moderate to severe psoriasis|patients with moderate to severe psoriasis
5206198|NCT00800969|Adenocarcinoma of the stomach and esophagogastric junction|adenocarcinoma of the stomach and esophagogastric junction
5206199|NCT00800956|Radiolabel ADME study Healthy volunteers|radiolabel adme study healthy volunteers
5206200|NCT00800943|Leukemia|leukemia
5206201|NCT00800943|Chronic|chronic
5206202|NCT00800943|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
5206203|NCT00800943|CAMPATH|campath
5206204|NCT00800943|Alemtuzumab|alemtuzumab
5206205|NCT00800943|MabCampath|mabcampath
5206961|NCT00798174|DFT|dft
5206206|NCT00800943|Subcutaneous|subcutaneous
5206208|NCT00800943|C-CLL|c-cll
5206209|NCT00800943|Residual|residual
5206210|NCT00800930|Shigellosis|shigellosis
5206211|NCT00800930|sodium butyrate|sodium butyrate
5206212|NCT00800930|antimicrobial peptides|antimicrobial peptides
5206213|NCT00800930|LL-37|ll-37
5206214|NCT00800930|innate immunity|innate immunity
5206215|NCT00800930|The aims are to assess efficacy of sodium butyrate enema in|the aims are to assess efficacy of sodium butyrate enema in
5206216|NCT00800930|marked improvement in clinical features|marked improvement in clinical features
5206217|NCT00800930|endoscopic findings|endoscopic findings
5206218|NCT00800930|histological features|histological features
5206219|NCT00800930|Induction of LL-37 in the rectum.|induction of ll-37 in the rectum.
5206220|NCT00800904|Asthma|asthma
5206221|NCT00800904|Inhaled corticosteroid|inhaled corticosteroid
5206222|NCT00800904|Thai patient eligibility|thai patient eligibility
5206223|NCT00800904|Persistent asthma|persistent asthma
5206224|NCT00800878|Chronic Kidney Disease|chronic kidney disease
5206225|NCT00800878|Renal insufficiency|renal insufficiency
5206226|NCT00800852|adiponectin|adiponectin
5206227|NCT00800852|adiponectin receptor|adiponectin receptor
5206228|NCT00800852|Prader-Willi syndrome|prader-willi syndrome
5206229|NCT00800839|Post-allogeneic transplantation|post-allogeneic transplantation
5206230|NCT00800839|Graft-versus-Host Disease Prophylaxis|graft-versus-host disease prophylaxis
5206231|NCT00800839|Graft-versus-Host Disease|graft-versus-host disease
5206232|NCT00800839|GVHD|gvhd
5206233|NCT00800839|Hematologic malignancies|hematologic malignancies
5206234|NCT00800839|Leukemia|leukemia
5206235|NCT00800839|Lymphoma|lymphoma
5206236|NCT00800839|Myeloma|myeloma
5206237|NCT00800839|Human Leukocyte Antigen|human leukocyte antigen
5206238|NCT00800839|HLA|hla
5206239|NCT00800839|Busulfan|busulfan
5206240|NCT00800839|Cyclophosphamide|cyclophosphamide
5206241|NCT00800839|Fludarabine|fludarabine
5206242|NCT00800839|Mesna|mesna
5206243|NCT00800839|Cytoxan®|cytoxan®
5206244|NCT00800839|Neosar®|neosar®
5206245|NCT00800839|Busulfex|busulfex
5206246|NCT00800839|Myleran®|myleran®
5206247|NCT00800839|Fludarabine Phosphate|fludarabine phosphate
5206248|NCT00800813|Prostate|prostate
5206249|NCT00800813|Erectile function|erectile function
5206250|NCT00800813|Peyronie's Plaque|peyronie's plaque
5206251|NCT00800813|08-135|08-135
5206252|NCT00800800|progression of aortic stenosis|progression of aortic stenosis
5206253|NCT00800787|Chronic hepatitis B liver disease|chronic hepatitis b liver disease
5206254|NCT00800774|LASIK|lasik
5206255|NCT00800774|safety|safety
5206256|NCT00800774|efficacy|efficacy
5206257|NCT00800774|stability|stability
5206258|NCT00800774|high anisometropia|high anisometropia
5206259|NCT00800774|patients 8 to 15 years old|patients 8 to 15 years old
5206260|NCT00800774|conventional treatments have failed|conventional treatments have failed
5206261|NCT00800722|hypervascular anomalies|hypervascular anomalies
5206262|NCT00800709|Alzheimer's Disease|alzheimer's disease
5206263|NCT00800709|tau protein|tau protein
5206264|NCT00800709|PET|pet
5206265|NCT00800709|Memantine|memantine
5206266|NCT00800696|antibiotics|antibiotics
5206267|NCT00800696|Hospitalization|hospitalization
5206268|NCT00800696|oral care|oral care
5206269|NCT00800670|tuberculosis|tuberculosis
5206270|NCT00800670|vaccine|vaccine
5206271|NCT00800670|adenovirus|adenovirus
5206272|NCT00800657|Cardiac Resynchronization|cardiac resynchronization
5206273|NCT00800657|Dilated Cardiomyopathy|dilated cardiomyopathy
5206274|NCT00800657|Stem Cells Therapy|stem cells therapy
5206275|NCT00800657|Heart Failure|heart failure
5206276|NCT00800657|Stem Cells/Cardiac Pacing, Artificial|stem cells/cardiac pacing, artificial
5206277|NCT00800644|Cervical Cancer|cervical cancer
5206278|NCT00800644|Endometrial Cancer|endometrial cancer
5206279|NCT00800644|Vaginal Cancer|vaginal cancer
5206280|NCT00800644|Cervix|cervix
5206281|NCT00800644|Endometrial|endometrial
5206282|NCT00800644|X-ray|x-ray
5206283|NCT00800644|Computed tomography|computed tomography
5206284|NCT00800644|Magnetic resonance imaging|magnetic resonance imaging
5206285|NCT00800644|Vagina|vagina
5206286|NCT00800644|Pelvic radiation therapy|pelvic radiation therapy
5206287|NCT00800644|Bone density|bone density
5206288|NCT00800644|Bone mineral density test|bone mineral density test
5206289|NCT00800644|Pelvic fractures|pelvic fractures
5206290|NCT00800644|Gynecologic Oncology|gynecologic oncology
5206291|NCT00800644|Bone turnover|bone turnover
5206292|NCT00800592|Sildenafil, Revatio, PAH, IV, Bolus|sildenafil, revatio, pah, iv, bolus
5206293|NCT00800579|cystic fibrosis|cystic fibrosis
5206294|NCT00800579|CF|cf
5206295|NCT00800579|mucociliary clearance|mucociliary clearance
5206296|NCT00800579|amiloride|amiloride
5206297|NCT00800579|ENaC|enac
5206298|NCT00800579|ENaC Inhibitor|enac inhibitor
5206299|NCT00800579|airway hydration|airway hydration
5206300|NCT00800579|epithelial sodium channel inhibitor|epithelial sodium channel inhibitor
5206301|NCT00800566|Clofarabine|clofarabine
5206302|NCT00800566|Leukemia|leukemia
5206303|NCT00800566|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
5206304|NCT00800553|sleep deprivation|sleep deprivation
5206305|NCT00800553|fMRI|fmri
5206306|NCT00800553|double blind crossover study|double blind crossover study
5206308|NCT00800540|ocular perfusion pressure|ocular perfusion pressure
5206309|NCT00800540|ocular blood flow|ocular blood flow
5206310|NCT00800540|open angle glaucoma requiring more than one IOP-lowering medication|open angle glaucoma requiring more than one iop-lowering medication
5206311|NCT00800527|sternotomy|sternotomy
5206312|NCT00800527|pain|pain
5206313|NCT00800527|paresthesia|paresthesia
5206314|NCT00800527|Poststernotomy chest pain|poststernotomy chest pain
5206315|NCT00800527|Poststernotomy chest paresthesia|poststernotomy chest paresthesia
5206316|NCT00800514|perception of time, traumatic brain injury, amantadine|perception of time, traumatic brain injury, amantadine
5206317|NCT00800501|ALS|als
5206318|NCT00800501|VEGF165|vegf165
5206319|NCT00800501|Safety|safety
5206320|NCT00800501|Intracerebroventricular|intracerebroventricular
5206321|NCT00800501|Infusion|infusion
5206322|NCT00800501|Implantable|implantable
5206323|NCT00800488|Fever|fever
5206324|NCT00800488|Infant|infant
5206325|NCT00800488|Procalcitonin|procalcitonin
5206326|NCT00800488|Serious Bacterial Infection|serious bacterial infection
5206327|NCT00800475|bioavailability|bioavailability
5206328|NCT00800475|Gemfibrozil|gemfibrozil
5206329|NCT00800449|Haptoglobin|haptoglobin
5206330|NCT00800449|sepsis|sepsis
5206331|NCT00800449|premature babies|premature babies
5206332|NCT00800423|corneal edema|corneal edema
5206333|NCT00800423|postoperative corneal edema|postoperative corneal edema
5206334|NCT00800423|central corneal thickness|central corneal thickness
5206335|NCT00800423|visual acuity|visual acuity
5206336|NCT00800423|postoperative|postoperative
5206337|NCT00800423|brimonidine|brimonidine
5206338|NCT00800423|timolol|timolol
5206339|NCT00800423|cataract surgery|cataract surgery
5206340|NCT00800410|Randomized Controlled Trial|randomized controlled trial
5206341|NCT00800371|JIA|jia
5206342|NCT00800358|Secondary hyperparathyroidism|secondary hyperparathyroidism
5206343|NCT00800358|End stage renal disease|end stage renal disease
5206344|NCT00800358|Haemodialysis|haemodialysis
5206345|NCT00800358|Peritoneal dialysis|peritoneal dialysis
5206346|NCT00800358|Paricalcitol (Zemplar)|paricalcitol (zemplar)
5206347|NCT00800358|Calcitriol|calcitriol
5206348|NCT00800345|Gynecologic tumors|gynecologic tumors
5206349|NCT00800332|Rhinoconjunctivitis due to house dust mite allergy|rhinoconjunctivitis due to house dust mite allergy
5206350|NCT00800319|Alcohol dependence|alcohol dependence
5206351|NCT00800319|Opioid antagonist|opioid antagonist
5206352|NCT00800319|RDC-0313|rdc-0313
5206353|NCT00800306|sepsis|sepsis
5206354|NCT00800306|septic shock|septic shock
5206355|NCT00800306|microcirculation|microcirculation
5206356|NCT00800306|levosimendan|levosimendan
5206357|NCT00800306|dobutamine|dobutamine
5206358|NCT00800306|inotropes|inotropes
5206359|NCT00800306|inhaled nitric oxide|inhaled nitric oxide
5206360|NCT00800293|bioequivalence|bioequivalence
5206361|NCT00800293|betamethasone dipropionate|betamethasone dipropionate
5206362|NCT00800293|Bioequivalency|bioequivalency
5206363|NCT00800280|cimetidine, PD 0332334, organic cation transporter, OCT2, pharmacokinetics|cimetidine, pd 0332334, organic cation transporter, oct2, pharmacokinetics
5206364|NCT00800267|glaucoma|glaucoma
5206365|NCT00800267|ocular hypertension|ocular hypertension
5206366|NCT00800267|Fixed combination latanoprost-timolol|fixed combination latanoprost-timolol
5206367|NCT00800267|latanoprost|latanoprost
5206368|NCT00800267|timolol|timolol
5206369|NCT00800254|electrical stimulation|electrical stimulation
5206370|NCT00800254|total knee arthroplasty|total knee arthroplasty
5206371|NCT00800254|quadriceps|quadriceps
5206372|NCT00800254|muscle|muscle
5206373|NCT00800254|arthroscopy|arthroscopy
5206374|NCT00800241|Asthma|asthma
5206375|NCT00800241|Symbicort SMART|symbicort smart
5206376|NCT00800241|Thai patient eligibility|thai patient eligibility
5206377|NCT00800241|Persistent asthma|persistent asthma
5206378|NCT00800228|salt|salt
5206379|NCT00800228|blood pressure|blood pressure
5206380|NCT00800228|breathing|breathing
5206381|NCT00800215|Epilepsy|epilepsy
5206382|NCT00800150|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5206383|NCT00800150|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5206384|NCT00800150|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5206385|NCT00800150|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5206386|NCT00800150|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5206387|NCT00800150|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5206388|NCT00800150|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5206389|NCT00800150|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
5206390|NCT00800150|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5206391|NCT00800150|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
5206392|NCT00800150|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
5206393|NCT00800150|adult grade III lymphomatoid granulomatosis|adult grade iii lymphomatoid granulomatosis
5206394|NCT00800150|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
5206395|NCT00800150|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5206396|NCT00800150|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
5206397|NCT00800150|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5206398|NCT00800150|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5206399|NCT00800150|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5206400|NCT00800150|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5206401|NCT00800150|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5206402|NCT00800150|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5206403|NCT00800150|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5206404|NCT00800150|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5206405|NCT00800150|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5206406|NCT00800150|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
5206407|NCT00800150|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
5206408|NCT00800150|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5206409|NCT00800150|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5206410|NCT00800150|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5206411|NCT00800150|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5206412|NCT00800150|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5206413|NCT00800150|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5206414|NCT00800150|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5206415|NCT00800150|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5206416|NCT00800150|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5206417|NCT00800150|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5206418|NCT00800150|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5206419|NCT00800150|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5206420|NCT00800150|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
5206421|NCT00800150|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
5206422|NCT00800150|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5206423|NCT00800150|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5206424|NCT00800150|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5206425|NCT00800150|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5206426|NCT00800150|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5206427|NCT00800150|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5206428|NCT00800150|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5206429|NCT00800150|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5206430|NCT00800150|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5206431|NCT00800150|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5206432|NCT00800150|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
5206551|NCT00799760|oseltamivir|oseltamivir
5206433|NCT00800150|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5206434|NCT00800150|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5206435|NCT00800150|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5206436|NCT00800150|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5206437|NCT00800150|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5206438|NCT00800150|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5206439|NCT00800150|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5206440|NCT00800150|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5206441|NCT00800150|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5206442|NCT00800150|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5206443|NCT00800150|intraocular lymphoma|intraocular lymphoma
5206444|NCT00800150|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
5206445|NCT00800150|primary myelofibrosis|primary myelofibrosis
5206446|NCT00800150|stage II multiple myeloma|stage ii multiple myeloma
5206447|NCT00800150|stage III multiple myeloma|stage iii multiple myeloma
5206448|NCT00800150|refractory multiple myeloma|refractory multiple myeloma
5206449|NCT00800150|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5206450|NCT00800150|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5206451|NCT00800150|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5206452|NCT00800150|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
5206453|NCT00800150|cutaneous B-cell non-Hodgkin lymphoma|cutaneous b-cell non-hodgkin lymphoma
5206454|NCT00800150|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
5206455|NCT00800137|coumadin|coumadin
5206456|NCT00800137|device surgery|device surgery
5206457|NCT00800137|pocket hematoma|pocket hematoma
5206458|NCT00800137|Pocket hematoma and device surgery|pocket hematoma and device surgery
5206459|NCT00800124|hip fracture|hip fracture
5206460|NCT00800124|hemiprosthesis|hemiprosthesis
5206461|NCT00800124|bone cement|bone cement
5206462|NCT00800124|clinical outcome|clinical outcome
5206463|NCT00800111|failed penetrating keratoplasty|failed penetrating keratoplasty
5206464|NCT00800085|first degree relatives of type 1 diabetes patients|first degree relatives of type 1 diabetes patients
5206465|NCT00800085|hyperglycemic clamp test|hyperglycemic clamp test
5206466|NCT00800072|to verify accurrancy of data collected by the NOWOX|to verify accurrancy of data collected by the nowox
5206467|NCT00800059|Relapse|relapse
5206468|NCT00800059|Refractory|refractory
5206469|NCT00800046|Mitral valve|mitral valve
5206470|NCT00800046|Mitral regurgitation|mitral regurgitation
5206471|NCT00800046|Functional mitral regurgitation|functional mitral regurgitation
5206472|NCT00800046|MR|mr
5206473|NCT00800046|FMR|fmr
5206474|NCT00800046|Heart valve|heart valve
5206475|NCT00800046|Mitral valve insufficiency|mitral valve insufficiency
5206476|NCT00800046|Valve repair|valve repair
5206477|NCT00800046|Valve disorder|valve disorder
5206478|NCT00800046|Cardiac surgery|cardiac surgery
5206479|NCT00800033|metabolic syndrome|metabolic syndrome
5206480|NCT00800033|lipids|lipids
5206481|NCT00800033|blood pressure|blood pressure
5206482|NCT00800033|body composition|body composition
5206483|NCT00800007|Hepatitis C, HCV, ANZ-521, Listeria|hepatitis c, hcv, anz-521, listeria
5206484|NCT00799994|glaucoma|glaucoma
5206485|NCT00799994|intraocular pressure|intraocular pressure
5206486|NCT00799994|multifocal visually evoked potentials|multifocal visually evoked potentials
5206487|NCT00799968|Thrombolytic therapy|thrombolytic therapy
5206488|NCT00799968|Urokinase|urokinase
5206489|NCT00799968|Efficacy|efficacy
5206490|NCT00799968|Safety|safety
5206491|NCT00799955|Cesarean delivery|cesarean delivery
5206492|NCT00799955|post-operative analgesia|post-operative analgesia
5206493|NCT00799955|TAP block|tap block
5206494|NCT00799955|ultrasound|ultrasound
5206495|NCT00799942|Nystagmus, congenital idiopathic|nystagmus, congenital idiopathic
5206496|NCT00799929|IVF Research Study|ivf research study
5206497|NCT00799929|Infertility Sudy|infertility sudy
5206498|NCT00799929|in vitro fertilization|in vitro fertilization
5206499|NCT00799929|Mini IVF|mini ivf
5206500|NCT00799929|Conventional IVF|conventional ivf
5206501|NCT00799916|Sepsis|sepsis
5206502|NCT00799916|Fluid resuscitation|fluid resuscitation
5206503|NCT00799916|Voluven|voluven
5206504|NCT00799916|Colloids|colloids
5206505|NCT00799916|Saline solution|saline solution
5206506|NCT00799916|Crystalloids|crystalloids
5206507|NCT00799916|Sublingual microcirculation|sublingual microcirculation
5206508|NCT00799903|heart disease|heart disease
5206509|NCT00799903|Lp-PLA2 inhibitor|lp-pla2 inhibitor
5206510|NCT00799903|cardiovascular disease|cardiovascular disease
5206511|NCT00799903|coronary heart disease|coronary heart disease
5206512|NCT00799903|CV risk|cv risk
5206513|NCT00799903|Atherosclerosis|atherosclerosis
5206514|NCT00799890|primary or secondary chronic-progressive|primary or secondary chronic-progressive
5206515|NCT00799890|sunphenon egcg|sunphenon egcg
5206516|NCT00799890|brain atrophy|brain atrophy
5206517|NCT00799890|T2 lesions|t2 lesions
5206518|NCT00799877|Psoriasis|psoriasis
5206519|NCT00799877|Moderate Psoriasis|moderate psoriasis
5206520|NCT00799877|Severe Psoriasis|severe psoriasis
5206521|NCT00799877|Chronic Plaque Psoriasis|chronic plaque psoriasis
5206522|NCT00799877|Severe Chronic Plaque Psoriasis|severe chronic plaque psoriasis
5206523|NCT00799877|Registry|registry
5206524|NCT00799864|HIV Infection|hiv infection
5206525|NCT00799864|Antiretroviral|antiretroviral
5206526|NCT00799864|HIV-1|hiv-1
5206527|NCT00799864|AIDS|aids
5206528|NCT00799864|Children|children
5206529|NCT00799864|Rilpivirine (TMC278)|rilpivirine (tmc278)
5206530|NCT00799864|Pediatric|pediatric
5206531|NCT00799851|advanced liver disease|advanced liver disease
5206532|NCT00799851|esophageal varices|esophageal varices
5206533|NCT00799851|band ligation|band ligation
5206534|NCT00799851|cyanoacrylate injection|cyanoacrylate injection
5206535|NCT00799825|papillomavirus|papillomavirus
5206536|NCT00799825|HPV vaccine|hpv vaccine
5206537|NCT00799825|cervical cancer|cervical cancer
5206538|NCT00799825|HPV|hpv
5206539|NCT00799825|human papillomavirus|human papillomavirus
5206540|NCT00799812|antimicrobial|antimicrobial
5206541|NCT00799812|antisepsis|antisepsis
5206542|NCT00799799|Nk cells infusion|nk cells infusion
5206543|NCT00799799|minimal residual disease in AML patients|minimal residual disease in aml patients
5206544|NCT00799799|trafficking of NK cells after infusion|trafficking of nk cells after infusion
5206545|NCT00799799|cytolytic effects on leukemic cells|cytolytic effects on leukemic cells
5206546|NCT00799773|TTP|ttp
5206547|NCT00799773|Rituximab|rituximab
5206548|NCT00799773|Plasma Exchange|plasma exchange
5206549|NCT00799760|influenza A|influenza a
5206550|NCT00799760|neuraminidase inhibitor|neuraminidase inhibitor
5206552|NCT00799760|zanamivir|zanamivir
5206553|NCT00799760|treatment outcome|treatment outcome
5206554|NCT00799760|resistance|resistance
5206555|NCT00799760|mutation|mutation
5206556|NCT00799760|combination therapy|combination therapy
5206557|NCT00799760|monotherapy|monotherapy
5206558|NCT00799760|pandemic|pandemic
5206559|NCT00799760|primary care|primary care
5206560|NCT00799760|randomized controlled trials|randomized controlled trials
5206561|NCT00799760|antiviral agent|antiviral agent
5206562|NCT00799747|safety|safety
5206563|NCT00799747|tolerability|tolerability
5206564|NCT00799747|pharmacokinetics|pharmacokinetics
5206565|NCT00799747|AZD4017Japanese|azd4017japanese
5206566|NCT00799734|hot flushes|hot flushes
5206567|NCT00799734|night sweats|night sweats
5206568|NCT00799734|menopausal symptoms|menopausal symptoms
5206569|NCT00799734|osteoporosis|osteoporosis
5206570|NCT00799734|complementary and alternative medicine|complementary and alternative medicine
5206571|NCT00799721|ROP|rop
5206572|NCT00799721|VLBW|vlbw
5206573|NCT00799721|Epo|epo
5206574|NCT00799721|IUGR|iugr
5206575|NCT00799721|VEGF|vegf
5206576|NCT00799721|sFLT-1|sflt-1
5206577|NCT00799721|very low birth weight infants|very low birth weight infants
5206578|NCT00799721|retinopathy of prematurity|retinopathy of prematurity
5206579|NCT00799721|erythropoietin therapy and risk of ROP|erythropoietin therapy and risk of rop
5206580|NCT00799708|Biomarkers of estrogen receptor beta activation|biomarkers of estrogen receptor beta activation
5206581|NCT00799695|diabetic retinopathy|diabetic retinopathy
5206582|NCT00799695|screening|screening
5206583|NCT00799695|annual|annual
5206584|NCT00799682|Dry Eye|dry eye
5206585|NCT00799682|Monotherapy for Ocular Hypertension, Glaucoma|monotherapy for ocular hypertension, glaucoma
5206586|NCT00799682|Ocular Hypertension|ocular hypertension
5206587|NCT00799682|Chronic Open-Angle Glaucoma|chronic open-angle glaucoma
5206588|NCT00799682|Chronic Angle-Closure Glaucoma|chronic angle-closure glaucoma
5206589|NCT00799682|Iridotomy|iridotomy
5206590|NCT00799682|Iridectomy|iridectomy
5206591|NCT00799682|Pseudo Exfoliate|pseudo exfoliate
5206592|NCT00799682|Pigmentary Glaucoma|pigmentary glaucoma
5206593|NCT00799682|Systemic Non-Glaucoma Medications|systemic non-glaucoma medications
5206594|NCT00799682|Hyperemia|hyperemia
5206595|NCT00799669|hypopharyngeal cancer|hypopharyngeal cancer
5206596|NCT00799669|laryngeal cancer|laryngeal cancer
5206597|NCT00799669|lip and oral cavity cancer|lip and oral cavity cancer
5206598|NCT00799669|nasopharyngeal cancer|nasopharyngeal cancer
5206599|NCT00799669|oropharyngeal cancer|oropharyngeal cancer
5206600|NCT00799669|paranasal sinus and nasal cavity cancer|paranasal sinus and nasal cavity cancer
5206601|NCT00799669|tobacco use disorder|tobacco use disorder
5206602|NCT00799656|Diabetic neuropathy|diabetic neuropathy
5206603|NCT00799656|painful pain|painful pain
5206604|NCT00799656|postoperative|postoperative
5206605|NCT00799643|Type 2 Diabetes Mellitus (T2D)|type 2 diabetes mellitus (t2d)
5206606|NCT00799643|Inflammation|inflammation
5206607|NCT00799643|Obesity|obesity
5206608|NCT00799643|Metabolic Syndrome|metabolic syndrome
5206609|NCT00799643|Salicylates|salicylates
5206610|NCT00799630|energy drink|energy drink
5206611|NCT00799630|exercise|exercise
5206612|NCT00799630|BCAA|bcaa
5206613|NCT00799630|peripheral and central fatigue|peripheral and central fatigue
5206614|NCT00799617|Testosterone|testosterone
5206615|NCT00799617|Mobility disability|mobility disability
5206616|NCT00799617|Decreased libido|decreased libido
5206617|NCT00799617|Age associated memory impairment|age associated memory impairment
5206618|NCT00799617|Low vitality|low vitality
5206619|NCT00799617|Anemia|anemia
5206620|NCT00799604|Hypertension|hypertension
5206621|NCT00799604|Antihypertensive Agent|antihypertensive agent
5206622|NCT00799604|Calcium Channel Blocker|calcium channel blocker
5206623|NCT00799591|Registre MONTRAVERS|registre montravers
5206624|NCT00799578|NASH, NAFLD,nonalcoholic steatohepatitis|nash, nafld,nonalcoholic steatohepatitis
5206625|NCT00799565|Mitral Valve prolapse|mitral valve prolapse
5206626|NCT00799565|echography|echography
5206627|NCT00799565|genetic study|genetic study
5206628|NCT00799565|study case-witness|study case-witness
5206629|NCT00799565|Patients with a Mitral Valve Prolapse|patients with a mitral valve prolapse
5206630|NCT00799552|Keratoconjunctivitis Sicca|keratoconjunctivitis sicca
5206631|NCT00799552|Dry eye|dry eye
5206632|NCT00799552|Resolvin|resolvin
5206633|NCT00799539|Prednisone|prednisone
5206634|NCT00799539|Bortezomib|bortezomib
5206635|NCT00799539|Melphalan|melphalan
5206636|NCT00799526|Ex Vivo Conjunctival Epithelial Cell|ex vivo conjunctival epithelial cell
5206637|NCT00799526|Transplantation|transplantation
5206638|NCT00799513|Lenalidomide|lenalidomide
5206639|NCT00799513|revlimid|revlimid
5206640|NCT00799513|large B-cell lymphoma|large b-cell lymphoma
5206641|NCT00799513|relapse|relapse
5206642|NCT00799487|ADHD|adhd
5206643|NCT00799487|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
5206644|NCT00799435|Diabetes|diabetes
5206645|NCT00799435|Diastolic Heart Failure|diastolic heart failure
5206646|NCT00799435|Aortic Stiffness|aortic stiffness
5206647|NCT00799435|Exenatide|exenatide
5206648|NCT00799422|Conjunctival Staining|conjunctival staining
5206649|NCT00799422|lens parameters|lens parameters
5206650|NCT00799422|lens fit|lens fit
5206651|NCT00799409|ADHD|adhd
5206652|NCT00799409|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
5206653|NCT00799383|Risperidone|risperidone
5206654|NCT00799383|hyperprolactinemia|hyperprolactinemia
5206655|NCT00799383|children|children
5206656|NCT00799383|adolescents|adolescents
5206657|NCT00799383|antipsychotics|antipsychotics
5206658|NCT00799383|prevention|prevention
5206659|NCT00799383|calcium|calcium
5206660|NCT00799383|vitamin D|vitamin d
5206661|NCT00799383|Risperidone-induced hyperprolactinemia|risperidone-induced hyperprolactinemia
5206662|NCT00799370|Osteotomy|osteotomy
5206663|NCT00799370|Weight bearing|weight bearing
5206664|NCT00799370|Opening wedge|opening wedge
5206665|NCT00799357|ultrasound|ultrasound
5206666|NCT00799344|Coronary Stent|coronary stent
5206667|NCT00799331|Healthy volunteers|healthy volunteers
5206668|NCT00799279|smoking|smoking
5206669|NCT00799279|cessation|cessation
5206670|NCT00799279|family medicine|family medicine
5206671|NCT00799279|evidence-based|evidence-based
5206672|NCT00799279|knowledge translation|knowledge translation
5206673|NCT00799279|smoking cessation, primary care|smoking cessation, primary care
5206674|NCT00799266|Osteoporosis, children and adolescents, zoledronic acid, chronic inflammation, Duchenne muscular dystrophy, glucocorticoids|osteoporosis, children and adolescents, zoledronic acid, chronic inflammation, duchenne muscular dystrophy, glucocorticoids
5206675|NCT00799266|Osteoporosis|osteoporosis
5206676|NCT00799266|chronic inflammatory conditions|chronic inflammatory conditions
5206677|NCT00799266|zoledronic acid|zoledronic acid
5206678|NCT00799240|lung cancer|lung cancer
5206679|NCT00799240|stage IIIb|stage iiib
5206680|NCT00799240|pleural effusion|pleural effusion
5206681|NCT00799240|stage IV|stage iv
5206682|NCT00799240|metastatic lung cancer|metastatic lung cancer
5206683|NCT00799240|non squamous lung cancer|non squamous lung cancer
5206684|NCT00799240|IGF-1R|igf-1r
5206685|NCT00799240|Pemetrexed|pemetrexed
5206686|NCT00799240|Cisplatin|cisplatin
5206687|NCT00799214|bacterial vaginosis|bacterial vaginosis
5206688|NCT00799214|intravaginal|intravaginal
5206689|NCT00799214|boric acid|boric acid
5206690|NCT00799214|metronidazole|metronidazole
5206691|NCT00799214|placebo controlled|placebo controlled
5206692|NCT00799214|double-blind|double-blind
5206693|NCT00799214|randomized|randomized
5206694|NCT00799214|multicenter|multicenter
5206695|NCT00799214|non-inferiority|non-inferiority
5206696|NCT00799201|Enteral nutrition|enteral nutrition
5206697|NCT00799201|Constipation|constipation
5206698|NCT00799201|Gastrointestinal motility|gastrointestinal motility
5206699|NCT00799201|Naloxone|naloxone
5206700|NCT00799201|Docusate|docusate
5206701|NCT00799201|Bowel stimulant|bowel stimulant
5206702|NCT00799201|Stool softener|stool softener
5206703|NCT00799188|Cardiac Transplantation|cardiac transplantation
5206704|NCT00799188|Skin cancer|skin cancer
5206705|NCT00799188|Everolimus|everolimus
5206706|NCT00799175|Postoperative pain|postoperative pain
5206707|NCT00799175|Local infiltration analgesia|local infiltration analgesia
5206708|NCT00799175|Knee arthroplasty|knee arthroplasty
5206709|NCT00799149|Post-operative pain|post-operative pain
5206710|NCT00799149|Knee arthroscopy|knee arthroscopy
5206711|NCT00799149|Gabapentin|gabapentin
5206712|NCT00799149|Etoricoxib|etoricoxib
5206713|NCT00799149|Elective ambulatory knee arthroscopy|elective ambulatory knee arthroscopy
5206714|NCT00799136|Lymphoma Large B Cell Diffuse|lymphoma large b cell diffuse
5206715|NCT00799136|Acquired Immunodeficiency|acquired immunodeficiency
5206716|NCT00799123|NT-proBNP|nt-probnp
5206717|NCT00799110|dendritic cells|dendritic cells
5206718|NCT00799110|fusion vaccines|fusion vaccines
5206719|NCT00799110|GM-CSF|gm-csf
5206720|NCT00799110|imiquimod|imiquimod
5206721|NCT00799084|symptom management|symptom management
5206722|NCT00799084|cancer|cancer
5206723|NCT00799084|chemotherapy treatment|chemotherapy treatment
5206724|NCT00799084|Behavioral Research|behavioral research
5206725|NCT00799084|Physiological Effects of Drugs|physiological effects of drugs
5206726|NCT00799084|Clinical Trial, Phase II|clinical trial, phase ii
5206727|NCT00799071|prophylaxis|prophylaxis
5206728|NCT00799071|CGD|cgd
5206729|NCT00799071|pharmacokinetics|pharmacokinetics
5206730|NCT00799058|HIV-1 infections|hiv-1 infections
5206731|NCT00799045|Migraine|migraine
5206732|NCT00799045|atrial septal defects|atrial septal defects
5206733|NCT00799045|transcatheter|transcatheter
5206734|NCT00799045|clopidogrel|clopidogrel
5206735|NCT00799032|Coronary Stent|coronary stent
5206736|NCT00799019|EPO antibody mediated PRCA|epo antibody mediated prca
5206737|NCT00799019|Erythropoiesis stimulating agents|erythropoiesis stimulating agents
5206738|NCT00799006|Single Ascending Dose Study in Overweight subjects|single ascending dose study in overweight subjects
5206739|NCT00798993|Chronic kidney failure|chronic kidney failure
5206740|NCT00798993|25 hydroxyvitamin D|25 hydroxyvitamin d
5206741|NCT00798993|falls|falls
5206742|NCT00798993|exercise|exercise
5206743|NCT00798993|quadriceps strength|quadriceps strength
5206744|NCT00798980|Mirena|mirena
5206745|NCT00798980|Nulliparous|nulliparous
5206746|NCT00798980|Intrauterine Devices|intrauterine devices
5206747|NCT00798967|SBS|sbs
5206748|NCT00798967|short bowel syndrome|short bowel syndrome
5206749|NCT00798967|TPN|tpn
5206750|NCT00798967|parenteral nutrition|parenteral nutrition
5206751|NCT00798967|PN|pn
5206752|NCT00798915|Diabetes|diabetes
5206753|NCT00798915|Blood Sugar|blood sugar
5206754|NCT00798915|Xenin-25|xenin-25
5206755|NCT00798915|GIP|gip
5206756|NCT00798915|Insulin|insulin
5206757|NCT00798902|DDD|ddd
5206758|NCT00798902|Spondylolisthesis|spondylolisthesis
5206759|NCT00798902|Spine Fusion|spine fusion
5206760|NCT00798902|Lumbar Spine|lumbar spine
5206761|NCT00798902|Bone Graft|bone graft
5206762|NCT00798889|Solid tumors|solid tumors
5206763|NCT00798863|submandibular gland|submandibular gland
5206764|NCT00798863|video assisted neck surgery|video assisted neck surgery
5206765|NCT00798850|Claudication|claudication
5206766|NCT00798850|Vascular claudication|vascular claudication
5206767|NCT00798850|Peripheral Vascular Disease|peripheral vascular disease
5206768|NCT00798850|Peripheral arterial disease|peripheral arterial disease
5206769|NCT00798850|Peripheral arterial occlusive disease|peripheral arterial occlusive disease
5206770|NCT00798850|Angioplasty|angioplasty
5206771|NCT00798850|Femoral angioplasty|femoral angioplasty
5206772|NCT00798850|Superficial femoral artery|superficial femoral artery
5206773|NCT00798850|Femoral arterial disease|femoral arterial disease
5206774|NCT00798850|Exercise|exercise
5206775|NCT00798850|Supervised exercise|supervised exercise
5206776|NCT00798850|Exercise therapy|exercise therapy
5206777|NCT00798850|Exercise programme|exercise programme
5206778|NCT00798850|Infrainuginal|infrainuginal
5206779|NCT00798850|Quality of life|quality of life
5206780|NCT00798850|SF36|sf36
5206781|NCT00798850|Questionnaire|questionnaire
5206782|NCT00798850|VascuQol|vascuqol
5206783|NCT00798850|Randomised|randomised
5206784|NCT00798850|Randomised trial|randomised trial
5206785|NCT00798850|Combination therapy|combination therapy
5206786|NCT00798850|Intermittent Claudication due to Femoropopliteal Disease|intermittent claudication due to femoropopliteal disease
5206787|NCT00798837|prostate|prostate
5206788|NCT00798837|cancer|cancer
5206789|NCT00798837|IMRT|imrt
5206790|NCT00798837|radiation|radiation
5206791|NCT00798824|tube feeding|tube feeding
5206792|NCT00798824|premature infant|premature infant
5206793|NCT00798811|brain tumor|brain tumor
5206794|NCT00798811|high-dose chemotherapy|high-dose chemotherapy
5206795|NCT00798811|autologous stem cell transplantation|autologous stem cell transplantation
5206796|NCT00798811|infant|infant
5206797|NCT00798785|diabetes mellitus type 1|diabetes mellitus type 1
5206798|NCT00798785|pancreatic beta cell|pancreatic beta cell
5206799|NCT00798785|transplantation|transplantation
5206800|NCT00798772|HIV infection|hiv infection
5206801|NCT00798772|Micronutrients|micronutrients
5206802|NCT00798772|Antioxidants|antioxidants
5206803|NCT00798759|Open-angle glaucoma|open-angle glaucoma
5206804|NCT00798759|Ocular hypertension|ocular hypertension
5206805|NCT00798746|Esophageal cancer|esophageal cancer
5206806|NCT00798746|pyloric drainage|pyloric drainage
5206807|NCT00798746|pyloric drainage procedure|pyloric drainage procedure
5206808|NCT00798746|reflux|reflux
5206809|NCT00798746|reflux symptoms|reflux symptoms
5206810|NCT00798746|esophagectomy|esophagectomy
5206811|NCT00798746|Quality of Life|quality of life
5206812|NCT00798746|Health-related quality of life|health-related quality of life
5206813|NCT00798746|HRQL|hrql
5206814|NCT00798720|non small cell lung cancer|non small cell lung cancer
5206815|NCT00798720|HDAC|hdac
5206816|NCT00798720|proteasome inhibitor|proteasome inhibitor
5206817|NCT00798707|Major Depressive Disorder|major depressive disorder
5206818|NCT00798694|glaucoma|glaucoma
5206819|NCT00798694|impression cytology|impression cytology
5206820|NCT00798694|ocular surface changes|ocular surface changes
5206821|NCT00798694|prostaglandins|prostaglandins
5206822|NCT00798681|parenteral nutrition|parenteral nutrition
5206823|NCT00798681|ready-to-use|ready-to-use
5206824|NCT00798681|customized nutrition formulation|customized nutrition formulation
5206825|NCT00798681|olive oil|olive oil
5206826|NCT00798681|soybean oil|soybean oil
5206827|NCT00798681|LCT/MCT|lct/mct
5206828|NCT00798681|Clinoleic|clinoleic
5206829|NCT00798681|oliclinomel|oliclinomel
5206830|NCT00798681|number of infections associated with TPN delivery system|number of infections associated with tpn delivery system
5206831|NCT00798681|BSI|bsi
5206832|NCT00798681|Infection rates|infection rates
5206833|NCT00798668|Endocrine and Gastrointestinal Response to Food|endocrine and gastrointestinal response to food
5206834|NCT00798655|panitumumab|panitumumab
5206835|NCT00798655|cisplatin|cisplatin
5206836|NCT00798655|radiation|radiation
5206837|NCT00798642|Hypnotherapy|hypnotherapy
5206838|NCT00798642|Ulcerative Colitis|ulcerative colitis
5206839|NCT00798642|Inflammatory Bowel Disease|inflammatory bowel disease
5206840|NCT00798642|Gastrointestinal Diseases|gastrointestinal diseases
5206841|NCT00798642|Digestive System Diseases|digestive system diseases
5206842|NCT00798642|Intestinal Diseases|intestinal diseases
5206843|NCT00798642|Colonic Diseases|colonic diseases
5206844|NCT00798629|stage III melanoma|stage iii melanoma
5206845|NCT00798629|stage IV melanoma|stage iv melanoma
5206846|NCT00798629|recurrent melanoma|recurrent melanoma
5206847|NCT00798629|mucosal melanoma|mucosal melanoma
5206848|NCT00798616|bronchiolitis|bronchiolitis
5206849|NCT00798616|steroids|steroids
5206850|NCT00798616|corticosteroids|corticosteroids
5206851|NCT00798616|albuterol|albuterol
5206852|NCT00798616|child|child
5206853|NCT00798616|infant|infant
5206854|NCT00798616|pediatric|pediatric
5206855|NCT00798603|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5206856|NCT00798603|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5206857|NCT00798603|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5206858|NCT00798603|adenocarcinoma of the lung|adenocarcinoma of the lung
5206859|NCT00798603|adenosquamous cell lung cancer|adenosquamous cell lung cancer
5206860|NCT00798590|Intensive insulin therapy (IIT)|intensive insulin therapy (iit)
5206861|NCT00798590|Insulin infusion|insulin infusion
5206862|NCT00798590|Tight glycemic control|tight glycemic control
5206863|NCT00798590|Intensive Care Units|intensive care units
5206864|NCT00798577|Bacterial Conjunctivitis|bacterial conjunctivitis
5206865|NCT00798564|Exercise|exercise
5206866|NCT00798564|Mannitol|mannitol
5206867|NCT00798538|Buprenorphine|buprenorphine
5206868|NCT00798538|HIV|hiv
5206869|NCT00798538|Drug Abuse|drug abuse
5206870|NCT00798538|Drug Addiction|drug addiction
5206871|NCT00798538|Drug Dependence|drug dependence
5206872|NCT00798538|Drug Use Disorders|drug use disorders
5206873|NCT00798538|Drug Use Disorder|drug use disorder
5206874|NCT00798538|Substance Abuse|substance abuse
5206875|NCT00798538|Opiate Addiction|opiate addiction
5206876|NCT00798538|Substance-related disorders|substance-related disorders
5206877|NCT00798525|thrombocytopenia|thrombocytopenia
5206878|NCT00798525|Heparin|heparin
5206879|NCT00798525|Lepirudin|lepirudin
5206880|NCT00798525|Argatroban|argatroban
5206881|NCT00798525|critically ill patients|critically ill patients
5206882|NCT00798512|carotid artery stenting|carotid artery stenting
5206883|NCT00798512|cerebral protection|cerebral protection
5206884|NCT00798512|stroke|stroke
5206885|NCT00798512|ischemic lesion|ischemic lesion
5206886|NCT00798512|DW-MRI|dw-mri
5206887|NCT00798499|haemophilia|haemophilia
5206888|NCT00798499|patients with haemophilia|patients with haemophilia
5206889|NCT00798473|Crohn's disease|crohn's disease
5206890|NCT00798473|Osteopenia|osteopenia
5206891|NCT00798473|Osteoporosis|osteoporosis
5206892|NCT00798473|Bisphosphonates|bisphosphonates
5206893|NCT00798473|Zoledronate|zoledronate
5206894|NCT00798460|Chronic hepatitis B|chronic hepatitis b
5206895|NCT00798460|lamivudine resistance|lamivudine resistance
5206896|NCT00798460|clevudine|clevudine
5206897|NCT00798447|post OP|post op
5206898|NCT00798434|Overactive bladder syndrome|overactive bladder syndrome
5206899|NCT00798434|fesoterodine|fesoterodine
5206900|NCT00798434|elderly|elderly
5206901|NCT00798434|flexible dose regimen|flexible dose regimen
5206902|NCT00798434|urgency|urgency
5206903|NCT00798434|frequency|frequency
5206904|NCT00798434|urge urinary incontinence|urge urinary incontinence
5206905|NCT00798434|anticholinergic|anticholinergic
5206906|NCT00798434|antimuscarinic|antimuscarinic
5206907|NCT00798421|Influenza, transmission|influenza, transmission
5206908|NCT00798408|Evaluate the effects of energy-yielding fluids and solids endocrine and metabolic response to food in the elderly|evaluate the effects of energy-yielding fluids and solids endocrine and metabolic response to food in the elderly
5206909|NCT00798369|Acute flares|acute flares
5206910|NCT00798369|Gout|gout
5206911|NCT00798369|Anti-interleukin-1β monoclonal antibody|anti-interleukin-1β monoclonal antibody
5206912|NCT00798369|Colchicine|colchicine
5206913|NCT00798369|Triamcinolone acetonide|triamcinolone acetonide
5206914|NCT00798356|atrial fibrillation, yoga|atrial fibrillation, yoga
5206915|NCT00798343|Influenza, heterosubtypic immune responses|influenza, heterosubtypic immune responses
5206916|NCT00798330|Cancer|cancer
5206917|NCT00798330|Blood stream infections|blood stream infections
5206918|NCT00798330|Bacteremia|bacteremia
5206919|NCT00798330|Dental procedure|dental procedure
5206920|NCT00798330|Central venous catheters|central venous catheters
5206921|NCT00798330|Mediport|mediport
5206922|NCT00798330|PICC line|picc line
5206923|NCT00798304|Meningococcal B vaccine|meningococcal b vaccine
5206924|NCT00798304|infants|infants
5206925|NCT00798304|safety|safety
5206926|NCT00798304|immunogenicity|immunogenicity
5206927|NCT00798278|Empyema|empyema
5206928|NCT00798278|Urokinase|urokinase
5206929|NCT00798278|Thoracoscopic|thoracoscopic
5206930|NCT00798278|Childhood|childhood
5206931|NCT00798265|HPV Vaccination|hpv vaccination
5206932|NCT00798265|HPV Immunogenicity|hpv immunogenicity
5206933|NCT00798265|HIV Infection|hiv infection
5206934|NCT00798265|HIV Negative|hiv negative
5206935|NCT00798265|Adolescents and Young Adults|adolescents and young adults
5206936|NCT00798265|Healthy Volunteer|healthy volunteer
5206937|NCT00798265|HV|hv
5206938|NCT00798265|Adolescent|adolescent
5206939|NCT00798252|metastatic, chemotherapy combination|metastatic, chemotherapy combination
5206940|NCT00798239|DDD|ddd
5206941|NCT00798239|Spondylolisthesis|spondylolisthesis
5206942|NCT00798239|Spine Fusion|spine fusion
5206943|NCT00798239|Lumbar Spine|lumbar spine
5206944|NCT00798239|Bone Graft|bone graft
5206945|NCT00798226|Asthma|asthma
5206946|NCT00798226|Eczema|eczema
5206947|NCT00798226|Sensitization|sensitization
5206948|NCT00798226|Allergy|allergy
5206949|NCT00798200|Cancer|cancer
5206950|NCT00798200|Oncology|oncology
5206951|NCT00798200|Rehabilitation|rehabilitation
5206952|NCT00798200|Endurance|endurance
5206953|NCT00798200|Strength|strength
5206954|NCT00798187|Prostate Cancer|prostate cancer
5206955|NCT00798187|Breast Cancer|breast cancer
5206956|NCT00798187|Behavioral Intervention|behavioral intervention
5206957|NCT00798187|Cancer Support Programs|cancer support programs
5206958|NCT00798187|Social Comparison|social comparison
5206959|NCT00798187|Heterogeneous support group|heterogeneous support group
5206960|NCT00798187|Homogeneous support group|homogeneous support group
5206963|NCT00798174|ICD|icd
5206964|NCT00798148|Neuroblastoma|neuroblastoma
5206965|NCT00798148|MIBG|mibg
5206966|NCT00798148|Autologous Peripheral Stem Cell Transplantation|autologous peripheral stem cell transplantation
5206967|NCT00798122|sex|sex
5206968|NCT00798122|acute coronary syndromes|acute coronary syndromes
5206969|NCT00798122|normal angiogram|normal angiogram
5206970|NCT00798122|no obstruction at angiography|no obstruction at angiography
5206971|NCT00798122|women|women
5206972|NCT00798109|Schizophrenia|schizophrenia
5206973|NCT00798109|Cannabis misuse comorbidity|cannabis misuse comorbidity
5206974|NCT00798109|Motivational interview|motivational interview
5206975|NCT00798109|Randomised open trial|randomised open trial
5206976|NCT00798096|T Cell Lymphoma|t cell lymphoma
5206977|NCT00798096|Lymphoma|lymphoma
5206978|NCT00798070|Lymph node positive or high risk lymph node negative breast|lymph node positive or high risk lymph node negative breast
5206979|NCT00798070|cancer|cancer
5206980|NCT00798057|Pituitary tumor|pituitary tumor
5206981|NCT00798057|Outcomes|outcomes
5206982|NCT00798057|Proton radiation|proton radiation
5206983|NCT00798044|quality improvement|quality improvement
5206984|NCT00798044|feedback|feedback
5206985|NCT00798044|substance use disorders|substance use disorders
5206986|NCT00798031|dental implant|dental implant
5206987|NCT00798031|upper jaw|upper jaw
5206988|NCT00798031|posterior tooth loss|posterior tooth loss
5206989|NCT00798031|short dental implant|short dental implant
5206990|NCT00798031|Adults, 18 years of age and older|adults, 18 years of age and older
5206991|NCT00798031|Missing a minimum of two posterior teeth in their upper jaw|missing a minimum of two posterior teeth in their upper jaw
5206992|NCT00798031|Subjects in need of dental implants|subjects in need of dental implants
5206993|NCT00798031|the research study is survival and function of the implants|the research study is survival and function of the implants
5206994|NCT00798018|lidocaine|lidocaine
5206995|NCT00798018|tetracaine|tetracaine
5206996|NCT00798018|tracheal intubation|tracheal intubation
5206997|NCT00798018|pharyngitis|pharyngitis
5206998|NCT00798005|NV1FGF|nv1fgf
5206999|NCT00798005|PAOD|paod
5207000|NCT00798005|CLI|cli
5207001|NCT00797992|Bevacizumab|bevacizumab
5207002|NCT00797992|Myopia|myopia
5207003|NCT00797992|Complications|complications
5207004|NCT00797992|Neovascularization|neovascularization
5207005|NCT00797992|OCT|oct
5207006|NCT00797979|Craniotomy|craniotomy
5207007|NCT00797979|Skull fixation|skull fixation
5207008|NCT00797979|Skull Grip|skull grip
5207009|NCT00797979|Reconstructive cranial surgery|reconstructive cranial surgery
5207010|NCT00797966|OPC-34712, Major Depressive Disorder, Adjunctive Treatment|opc-34712, major depressive disorder, adjunctive treatment
5207011|NCT00797953|Angina Pectoris Treatment|angina pectoris treatment
5207012|NCT00797940|GBM|gbm
5207013|NCT00797940|Glioblastoma|glioblastoma
5207014|NCT00797940|Glioblastoma Multiforme|glioblastoma multiforme
5207015|NCT00797940|Brain Tumor|brain tumor
5207016|NCT00797940|Brain Cancer|brain cancer
5207017|NCT00797940|Glioma|glioma
5207018|NCT00797927|schizophrenia|schizophrenia
5207019|NCT00797927|quetiapine|quetiapine
5207020|NCT00797927|conventional antipsychotics|conventional antipsychotics
5207021|NCT00797927|magnetic resonance spectroscopy|magnetic resonance spectroscopy
5207022|NCT00797914|Colonoscopy|colonoscopy
5207023|NCT00797914|Instrumentation|instrumentation
5207024|NCT00797914|Force Monitoring|force monitoring
5207025|NCT00797914|Quality Control|quality control
5207026|NCT00797914|Training|training
5207027|NCT00797888|diabetes|diabetes
5207028|NCT00797888|behavioral intervention|behavioral intervention
5207029|NCT00797888|HbA1c|hba1c
5207030|NCT00797888|health disparities|health disparities
5207031|NCT00797875|proprioceptive neuromuscular facilitation stretching technique, total knee arthroplasty, range of motion|proprioceptive neuromuscular facilitation stretching technique, total knee arthroplasty, range of motion
5207032|NCT00797862|Aliskiren|aliskiren
5207033|NCT00797862|Amlodipine|amlodipine
5207034|NCT00797862|Hypertension|hypertension
5207035|NCT00797862|SPA1000|spa1000
5207036|NCT00797862|Norvasc|norvasc
5207037|NCT00797849|phantom limb pain|phantom limb pain
5207038|NCT00797849|amputees|amputees
5207039|NCT00797849|Farabloc|farabloc
5207040|NCT00797849|Phantom limb pain in the missing limb of Veteran amputees|phantom limb pain in the missing limb of veteran amputees
5207041|NCT00797836|Occupational Diseases|occupational diseases
5207042|NCT00797836|Tuberculosis|tuberculosis
5207043|NCT00797836|Tuberculin Test|tuberculin test
5207044|NCT00797836|Immunoassay|immunoassay
5207045|NCT00797823|diabetes|diabetes
5207046|NCT00797823|pancreas|pancreas
5207047|NCT00797823|beta cell|beta cell
5207048|NCT00797823|glucagon|glucagon
5207049|NCT00797823|insulin|insulin
5207050|NCT00797823|hypoglycemia|hypoglycemia
5207051|NCT00797810|Acute lymphoblastic leukemia of the mature B-cell type|acute lymphoblastic leukemia of the mature b-cell type
5207052|NCT00797810|High-grade non-Hodgkin's lymphoma|high-grade non-hodgkin's lymphoma
5207053|NCT00797797|fibromyalgia|fibromyalgia
5207054|NCT00797797|milnacipran|milnacipran
5207055|NCT00797797|pregabalin|pregabalin
5207056|NCT00797797|treatment|treatment
5207057|NCT00797797|Forest Research Institute|forest research institute
5207058|NCT00797771|Insulin delivery|insulin delivery
5207252|NCT00796952|Swallowing|swallowing
5207059|NCT00797758|Cord blood transplantation|cord blood transplantation
5207060|NCT00797758|Conditioning regimen|conditioning regimen
5207061|NCT00797758|Acute myeloid leukaemia|acute myeloid leukaemia
5207062|NCT00797758|SORROR comorbidity index|sorror comorbidity index
5207063|NCT00797758|Quality of life|quality of life
5207064|NCT00797758|Innate immunity|innate immunity
5207065|NCT00797758|Immune reconstitution post transplant|immune reconstitution post transplant
5207066|NCT00797758|Umbilical Cord Blood Stem Cell Transplantation|umbilical cord blood stem cell transplantation
5207067|NCT00797758|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
5207068|NCT00797745|genotype 1 infection|genotype 1 infection
5207069|NCT00797732|acupuncture|acupuncture
5207070|NCT00797732|dysphagia|dysphagia
5207071|NCT00797732|chemoradiation related effects|chemoradiation related effects
5207072|NCT00797732|squamous cell carcinoma of the head and neck|squamous cell carcinoma of the head and neck
5207073|NCT00797732|nasopharyngeal cancer|nasopharyngeal cancer
5207074|NCT00797732|oropharynx cancer|oropharynx cancer
5207075|NCT00797732|hypopharynx cancer|hypopharynx cancer
5207076|NCT00797732|larynx cancer|larynx cancer
5207077|NCT00797719|MPM|mpm
5207078|NCT00797719|Short hemithoracic IMRT|short hemithoracic imrt
5207079|NCT00797693|First trimester|first trimester
5207080|NCT00797693|missed abortion|missed abortion
5207081|NCT00797693|misoprostol|misoprostol
5207082|NCT00797693|cervical ripening|cervical ripening
5207083|NCT00797693|oral|oral
5207084|NCT00797693|vaginal|vaginal
5207085|NCT00797693|first trimester missed abortion|first trimester missed abortion
5207086|NCT00797680|Pediatric cardiac arrest|pediatric cardiac arrest
5207087|NCT00797654|Sexual Risks for HIV|sexual risks for hiv
5207088|NCT00797654|Psychosocial Sequelae Relating to Childhood Sexual Abuse|psychosocial sequelae relating to childhood sexual abuse
5207089|NCT00797641|bleeding|bleeding
5207090|NCT00797641|ulcer|ulcer
5207091|NCT00797641|hemorrhage|hemorrhage
5207092|NCT00797641|gastrointestinal diseases|gastrointestinal diseases
5207093|NCT00797641|digestive system disease|digestive system disease
5207094|NCT00797641|peptic ulcer|peptic ulcer
5207095|NCT00797641|proton pump inhibitor|proton pump inhibitor
5207096|NCT00797602|Chordomas|chordomas
5207097|NCT00797602|Chondrosarcomas|chondrosarcomas
5207098|NCT00797602|Cancer|cancer
5207099|NCT00797602|Outcomes|outcomes
5207100|NCT00797602|Proton radiation|proton radiation
5207101|NCT00797589|aorta valve|aorta valve
5207102|NCT00797589|mitral valve|mitral valve
5207103|NCT00797589|coronary artery bypass grafting surgery|coronary artery bypass grafting surgery
5207104|NCT00797589|perfusion|perfusion
5207105|NCT00797589|priming|priming
5207106|NCT00797576|left atrial appendage thrombi|left atrial appendage thrombi
5207107|NCT00797576|transesophageal echocardiogram|transesophageal echocardiogram
5207108|NCT00797576|cardiac magnetic resonance imaging|cardiac magnetic resonance imaging
5207109|NCT00797576|atrial fibrillation|atrial fibrillation
5207110|NCT00797576|cardioversion|cardioversion
5207111|NCT00797550|posterolateral spine fusion|posterolateral spine fusion
5207112|NCT00797550|bone graft|bone graft
5207113|NCT00797537|Inflammation of bone and cartilage|inflammation of bone and cartilage
5207114|NCT00797511|Diphtheria|diphtheria
5207115|NCT00797511|Tetanus|tetanus
5207116|NCT00797511|Pertussis|pertussis
5207117|NCT00797511|Poliomyelitis|poliomyelitis
5207118|NCT00797498|Nasal Cavity|nasal cavity
5207119|NCT00797498|Paranasal Sinuses|paranasal sinuses
5207120|NCT00797498|Proton Radiation|proton radiation
5207121|NCT00797498|Outcomes|outcomes
5207122|NCT00797485|stage IV colon cancer|stage iv colon cancer
5207123|NCT00797485|stage IV rectal cancer|stage iv rectal cancer
5207124|NCT00797472|Hodgkin's Lymphoma|hodgkin's lymphoma
5207125|NCT00797472|R-mabHD|r-mabhd
5207126|NCT00797472|ABVD treatment|abvd treatment
5207127|NCT00797472|Hodgkin's Disease|hodgkin's disease
5207128|NCT00797459|Correction of Nasolabial Folds|correction of nasolabial folds
5207129|NCT00797446|Oropharyngeal|oropharyngeal
5207130|NCT00797446|cancer|cancer
5207131|NCT00797446|proton|proton
5207132|NCT00797446|radiation|radiation
5207133|NCT00797446|outcomes|outcomes
5207134|NCT00797433|testosterone|testosterone
5207135|NCT00797433|mechanical ventilation|mechanical ventilation
5207136|NCT00797420|fluconazole|fluconazole
5207137|NCT00797420|pharmacokinetic|pharmacokinetic
5207138|NCT00797420|candidiasis|candidiasis
5207139|NCT00797420|sepsis|sepsis
5207140|NCT00797420|pediatric|pediatric
5207141|NCT00797420|infants|infants
5207142|NCT00797420|antifungal|antifungal
5207143|NCT00797420|candidemia|candidemia
5207144|NCT00797420|fungemia|fungemia
5207145|NCT00797420|loading dose|loading dose
5207146|NCT00797407|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors
5207147|NCT00797407|Creatine|creatine
5207148|NCT00797407|Adverse Effects|adverse effects
5207149|NCT00797407|Muscle Toxicity|muscle toxicity
5207150|NCT00797394|prostate|prostate
5207151|NCT00797394|dietary supplements|dietary supplements
5207152|NCT00797394|saw palmetto|saw palmetto
5207153|NCT00797394|canada|canada
5207154|NCT00797381|MK-0518|mk-0518
5207155|NCT00797381|HIV|hiv
5207156|NCT00797381|AIDS|aids
5207157|NCT00797381|hemophilia|hemophilia
5207158|NCT00797381|treatment experienced|treatment experienced
5207159|NCT00797368|ankle sprain|ankle sprain
5207160|NCT00797368|manual therapy|manual therapy
5207161|NCT00797368|exercise|exercise
5207162|NCT00797368|physical therapy|physical therapy
5207163|NCT00797368|Patients who have sustained an inversion ankle sprain|patients who have sustained an inversion ankle sprain
5207164|NCT00797342|rheumatoid arthritis First in human safety pharmacokinetics pharmacodynamics|rheumatoid arthritis first in human safety pharmacokinetics pharmacodynamics
5207165|NCT00797329|psychiatric patients with violent behavior|psychiatric patients with violent behavior
5207166|NCT00797316|Hypertension|hypertension
5207167|NCT00797316|Metabolic Syndrome|metabolic syndrome
5207168|NCT00797316|aliskiren|aliskiren
5207169|NCT00797316|hydrochlorothiazide|hydrochlorothiazide
5207170|NCT00797316|systolic blood pressure|systolic blood pressure
5207171|NCT00797316|diastolic blood pressure|diastolic blood pressure
5207172|NCT00797316|stage 2|stage 2
5207173|NCT00797303|bevacizumab|bevacizumab
5207174|NCT00797303|cornea|cornea
5207175|NCT00797303|neovascularization|neovascularization
5207176|NCT00797290|Nasopharynx Cancer, Proton Radiation, Outcomes|nasopharynx cancer, proton radiation, outcomes
5207177|NCT00797277|schizophrenia|schizophrenia
5207178|NCT00797277|schizoaffective disorder|schizoaffective disorder
5207179|NCT00797277|olanzapine|olanzapine
5207180|NCT00797277|haloperidol|haloperidol
5207181|NCT00797277|lorazepam|lorazepam
5207182|NCT00797277|agitation|agitation
5207183|NCT00797264|Ketamine|ketamine
5207184|NCT00797264|Morphine|morphine
5207185|NCT00797264|PCA|pca
5207186|NCT00797264|Hyperalgesia|hyperalgesia
5207187|NCT00797264|Nor-ketamine|nor-ketamine
5207188|NCT00797251|Colorectal liver metastasis|colorectal liver metastasis
5207189|NCT00797251|hepatocellular carcinoma|hepatocellular carcinoma
5207190|NCT00797251|liver surgery|liver surgery
5207191|NCT00797251|intraoperative ultrasound|intraoperative ultrasound
5207192|NCT00797251|finger-compression|finger-compression
5207193|NCT00797238|Gene Expression|gene expression
5207194|NCT00797238|Carcinoma, Non-Small-Cell Lung|carcinoma, non-small-cell lung
5207195|NCT00797238|Chemotherapy|chemotherapy
5207196|NCT00797225|bone mineral density|bone mineral density
5207197|NCT00797225|Endometriosis|endometriosis
5207198|NCT00797225|Pelvic Pain|pelvic pain
5207199|NCT00797199|Breast Cancer Risk|breast cancer risk
5207200|NCT00797199|Hormone Replacement Therapy|hormone replacement therapy
5207201|NCT00797199|Optical Transillumination Spectroscopy|optical transillumination spectroscopy
5207202|NCT00797199|Optical Breast Spectroscopy|optical breast spectroscopy
5207203|NCT00797199|Transillumination Breast Spectroscopy|transillumination breast spectroscopy
5207204|NCT00797186|diabetes|diabetes
5207205|NCT00797186|dyslipidemia|dyslipidemia
5207206|NCT00797186|microvascular dysfunction|microvascular dysfunction
5207207|NCT00797186|imaging|imaging
5207208|NCT00797160|propofol|propofol
5207209|NCT00797160|midazolam|midazolam
5207210|NCT00797160|neonate|neonate
5207211|NCT00797160|tracheal intubation|tracheal intubation
5207212|NCT00797121|Cholangiocarcinoma|cholangiocarcinoma
5207213|NCT00797121|Drainage|drainage
5207214|NCT00797095|Adolescence|adolescence
5207215|NCT00797095|Obesity|obesity
5207216|NCT00797095|Substance use|substance use
5207217|NCT00797095|Prevalence|prevalence
5207218|NCT00797095|Social and Environmental Contexts|social and environmental contexts
5207219|NCT00797095|Survey|survey
5207220|NCT00797082|Diabetic|diabetic
5207221|NCT00797082|Coronary disease|coronary disease
5207222|NCT00797082|Atherosclerosis|atherosclerosis
5207223|NCT00797082|Magnetic resonance imaging|magnetic resonance imaging
5207224|NCT00797082|Myocardial Perfusion Scintigraphy|myocardial perfusion scintigraphy
5207225|NCT00797082|Coronary angiography|coronary angiography
5207226|NCT00797056|G-CSF|g-csf
5207227|NCT00797056|angiogenesis|angiogenesis
5207228|NCT00797056|endothelial progenitor cell|endothelial progenitor cell
5207229|NCT00797056|limb ischemia|limb ischemia
5207230|NCT00797056|revascularization|revascularization
5207231|NCT00797043|Carcinoma of the skin of the head and neck|carcinoma of the skin of the head and neck
5207232|NCT00797043|Proton radiation|proton radiation
5207233|NCT00797043|Outcomes|outcomes
5207234|NCT00797030|dry eye syndromes|dry eye syndromes
5207235|NCT00797030|keratoconjuntivitis sicca / drug therapy|keratoconjuntivitis sicca / drug therapy
5207236|NCT00797030|cyclosporine|cyclosporine
5207237|NCT00797030|ophthalmic solutions|ophthalmic solutions
5207238|NCT00797030|HIV seropositivity|hiv seropositivity
5207239|NCT00797017|Chronic Pain|chronic pain
5207240|NCT00797017|Fentanyl Matrix|fentanyl matrix
5207241|NCT00797017|Spinal disorder-related pain|spinal disorder-related pain
5207242|NCT00797004|olfactory dysfunction|olfactory dysfunction
5207243|NCT00796991|Untreated Advanced Melanoma|untreated advanced melanoma
5207244|NCT00796978|stage I breast cancer|stage i breast cancer
5207245|NCT00796978|stage II breast cancer|stage ii breast cancer
5207246|NCT00796978|stage IIIA breast cancer|stage iiia breast cancer
5207247|NCT00796978|stage IIIB breast cancer|stage iiib breast cancer
5207248|NCT00796978|stage IIIC breast cancer|stage iiic breast cancer
5207249|NCT00796978|HER2-positive breast cancer|her2-positive breast cancer
5207250|NCT00796965|Phase 1|phase 1
5207251|NCT00796952|Head/ neck cancer|head/ neck cancer
5207253|NCT00796952|behavioral treatment|behavioral treatment
5207254|NCT00796939|Delayed Sleep Phase Syndrome|delayed sleep phase syndrome
5207255|NCT00796939|Sleep|sleep
5207256|NCT00796900|Hyperthermia|hyperthermia
5207257|NCT00796900|subarachnoidal hemorrhage|subarachnoidal hemorrhage
5207258|NCT00796900|placebo controlled|placebo controlled
5207259|NCT00796900|double blinded|double blinded
5207260|NCT00796900|Dantrolene|dantrolene
5207261|NCT00796887|Ischemic Stroke|ischemic stroke
5207262|NCT00796887|Recovery of Function|recovery of function
5207263|NCT00796887|Extended-release niacin|extended-release niacin
5207264|NCT00796874|stage I prostate cancer|stage i prostate cancer
5207265|NCT00796874|stage II prostate cancer|stage ii prostate cancer
5207266|NCT00796861|malignant ascites|malignant ascites
5207267|NCT00796835|Schizophrenia|schizophrenia
5207268|NCT00796835|Mood disorders|mood disorders
5207269|NCT00796835|Antipsychotic drugs|antipsychotic drugs
5207270|NCT00796835|ER OROS Paliperidone|er oros paliperidone
5207271|NCT00796822|Endothelial Function|endothelial function
5207272|NCT00796822|Inflammation|inflammation
5207273|NCT00796809|TNF inhibitors|tnf inhibitors
5207274|NCT00796809|Biologic agents|biologic agents
5207275|NCT00796809|coccidioidomycosis|coccidioidomycosis
5207276|NCT00796809|Rheumatoid arthritis|rheumatoid arthritis
5207277|NCT00796796|Non-small cell lung cancer|non-small cell lung cancer
5207278|NCT00796796|temsirolimus|temsirolimus
5207279|NCT00796796|radiation therapy|radiation therapy
5207280|NCT00796783|Cushing's Disease|cushing's disease
5207281|NCT00796783|Cushing's Syndrome|cushing's syndrome
5207282|NCT00796783|Cushings|cushings
5207283|NCT00796783|Pituitary|pituitary
5207284|NCT00796783|ACTH|acth
5207285|NCT00796783|Adrenocorticotropic hormone|adrenocorticotropic hormone
5207286|NCT00796783|Ectopic|ectopic
5207287|NCT00796783|Adrenal adenoma|adrenal adenoma
5207288|NCT00796783|Adrenal carcinoma|adrenal carcinoma
5207289|NCT00796783|Adrenal autonomy|adrenal autonomy
5207290|NCT00796783|Cortisol|cortisol
5207291|NCT00796783|Hypercortisolemia|hypercortisolemia
5207292|NCT00796783|Cushinoid|cushinoid
5207293|NCT00796783|Moon facies|moon facies
5207294|NCT00796783|Dorsalcervical fat|dorsalcervical fat
5207295|NCT00796783|Plethora|plethora
5207296|NCT00796783|Hirsutism|hirsutism
5207297|NCT00796783|Violaceous striae|violaceous striae
5207298|NCT00796783|Hormone|hormone
5207299|NCT00796783|Contraceptive|contraceptive
5207300|NCT00796783|Endocrine|endocrine
5207301|NCT00796783|Cushing Syndrome|cushing syndrome
5207302|NCT00796783|Ectopic ACTH Secretion|ectopic acth secretion
5207303|NCT00796770|HIV|hiv
5207304|NCT00796770|Vaccine|vaccine
5207305|NCT00796770|HAART|haart
5207306|NCT00796770|HIV-1|hiv-1
5207307|NCT00796770|AIDS|aids
5207308|NCT00796770|Dendritic Cells|dendritic cells
5207309|NCT00796770|DALIA|dalia
5207310|NCT00796744|Diabetes mellitus|diabetes mellitus
5207311|NCT00796744|Diabetic neuropathy|diabetic neuropathy
5207312|NCT00796744|Peripheral vascular disease|peripheral vascular disease
5207313|NCT00796744|Infection|infection
5207314|NCT00796744|Topical application|topical application
5207315|NCT00796744|plantar foot ulcers|plantar foot ulcers
5207316|NCT00796731|B-cell lymphoma|b-cell lymphoma
5207317|NCT00796731|NHL|nhl
5207318|NCT00796692|Heparin|heparin
5207319|NCT00796692|Low molecular weight heparin|low molecular weight heparin
5207320|NCT00796692|Safety|safety
5207321|NCT00796692|Efficacy|efficacy
5207322|NCT00796692|Cost effective|cost effective
5207323|NCT00796679|paricalcitol|paricalcitol
5207324|NCT00796679|chronic kidney disease|chronic kidney disease
5207325|NCT00796679|cardiac hypertrophy|cardiac hypertrophy
5207326|NCT00796666|endothelin receptor antagonist (ETRA)|endothelin receptor antagonist (etra)
5207327|NCT00796666|Sitaxsentan|sitaxsentan
5207328|NCT00796640|Schizophrenia|schizophrenia
5207329|NCT00796640|Mood disorders|mood disorders
5207330|NCT00796640|Antipsychotic drugs|antipsychotic drugs
5207331|NCT00796640|ER Paliperidone|er paliperidone
5207332|NCT00796627|Wound Healing|wound healing
5207333|NCT00796627|Burns|burns
5207334|NCT00796627|HIF-1|hif-1
5207335|NCT00796627|CAC|cac
5207336|NCT00796614|tamsulosin|tamsulosin
5207337|NCT00796614|pediatric|pediatric
5207338|NCT00796614|neurogenic bladder|neurogenic bladder
5207339|NCT00796601|double-blind placebo-controlled maintenance of efficacy|double-blind placebo-controlled maintenance of efficacy
5207340|NCT00796588|preconditioning|preconditioning
5207341|NCT00796588|remote|remote
5207342|NCT00796575|multiple ascending dose healthy volunteers|multiple ascending dose healthy volunteers
5207343|NCT00796575|pharmacokinetics|pharmacokinetics
5207344|NCT00796575|pharmacodynamics|pharmacodynamics
5207345|NCT00796562|Leukemia|leukemia
5207346|NCT00796562|Lymphoma|lymphoma
5207347|NCT00796562|Hematologic malignancies|hematologic malignancies
5207348|NCT00796562|ALL|all
5207349|NCT00796562|AML|aml
5207350|NCT00796562|MDS|mds
5207351|NCT00796562|Transplantation|transplantation
5207352|NCT00796562|Mismatched|mismatched
5207353|NCT00796562|Haploidentical|haploidentical
5207354|NCT00796562|Busulfan|busulfan
5207355|NCT00796562|Cyclophosphamide|cyclophosphamide
5207356|NCT00796562|Cellcept|cellcept
5207357|NCT00796562|Tacrolimus|tacrolimus
5207358|NCT00796562|TBI|tbi
5207359|NCT00796562|CMMOL|cmmol
5207360|NCT00796562|CML|cml
5207361|NCT00796562|JMML|jmml
5207362|NCT00796536|Acute Pain|acute pain
5207363|NCT00796536|Low Back Pain|low back pain
5207364|NCT00796536|Back Pain|back pain
5207365|NCT00796536|Functional Magnetic Resonance Imaging (fMRI)|functional magnetic resonance imaging (fmri)
5207366|NCT00796536|Cognitive Behavioral Therapy|cognitive behavioral therapy
5207367|NCT00796536|Pain Education|pain education
5207368|NCT00796523|colic|colic
5207369|NCT00796523|crying|crying
5207370|NCT00796523|clinical trial|clinical trial
5207371|NCT00796510|endothelin receptor antagonist (ETRA)|endothelin receptor antagonist (etra)
5207372|NCT00796510|sitaxsentan|sitaxsentan
5207373|NCT00796497|Obsessive Compulsive Disorder|obsessive compulsive disorder
5207374|NCT00796497|5-ht3|5-ht3
5207375|NCT00796497|ondansetron|ondansetron
5207376|NCT00796484|Cancer|cancer
5207377|NCT00796484|Solid Tumors|solid tumors
5207378|NCT00796471|Schizophrenia|schizophrenia
5207379|NCT00796471|Mood Disorders|mood disorders
5207380|NCT00796471|Antipsychotic drugs|antipsychotic drugs
5207381|NCT00796471|Paliperidone ER|paliperidone er
5207382|NCT00796458|pain|pain
5207383|NCT00796458|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5207384|NCT00796458|recurrent prostate cancer|recurrent prostate cancer
5207385|NCT00796458|stage IV prostate cancer|stage iv prostate cancer
5207386|NCT00796458|stage III prostate cancer|stage iii prostate cancer
5207387|NCT00796445|DERMA|derma
5207388|NCT00796445|Tumor antigen|tumor antigen
5207389|NCT00796445|Immunotherapeutic|immunotherapeutic
5207390|NCT00796445|Adjuvant cancer therapy|adjuvant cancer therapy
5207391|NCT00796445|Melanoma|melanoma
5207392|NCT00796445|ASCI|asci
5207393|NCT00796432|Schizophrenia|schizophrenia
5207394|NCT00796432|mood disorders|mood disorders
5207395|NCT00796432|antipsychotic drugs|antipsychotic drugs
5207396|NCT00796432|dopamine|dopamine
5207397|NCT00796432|receptor occupancy|receptor occupancy
5207398|NCT00796432|OROS paliperidone|oros paliperidone
5207399|NCT00796419|Acute lung injury (ALI)|acute lung injury (ali)
5207400|NCT00796419|Acute respiratory distress syndrome (ARDS)|acute respiratory distress syndrome (ards)
5207401|NCT00796419|Respiratory failure|respiratory failure
5207402|NCT00796367|Obesity|obesity
5207403|NCT00796354|Constipation|constipation
5207404|NCT00796354|Irritable Bowel Syndrome|irritable bowel syndrome
5207405|NCT00796341|invitro-fertilization ,embryo transfer,endometrial injury|invitro-fertilization ,embryo transfer,endometrial injury
5207406|NCT00796315|Pharmacokinetic study|pharmacokinetic study
5207407|NCT00796302|Conduct Disorder|conduct disorder
5207408|NCT00796302|Attention Deficit and Disruptive Behavior Disorders|attention deficit and disruptive behavior disorders
5207409|NCT00796289|anovulatory/oligoovulatory infertility|anovulatory/oligoovulatory infertility
5207410|NCT00796276|Schizophrenia|schizophrenia
5207411|NCT00796276|Mood disorders|mood disorders
5207412|NCT00796276|Antipsychotics|antipsychotics
5207413|NCT00796276|Pharmacokinetics|pharmacokinetics
5207414|NCT00796276|Enantiomer|enantiomer
5207415|NCT00796276|IR OROS Paliperidone|ir oros paliperidone
5207416|NCT00796276|ER OROS Paliperidone|er oros paliperidone
5207417|NCT00796263|Acute HIV infection|acute hiv infection
5207418|NCT00796263|Chronic HIV infection|chronic hiv infection
5207419|NCT00796237|stroke|stroke
5207420|NCT00796237|bone|bone
5207421|NCT00796237|gait|gait
5207422|NCT00796237|muscle|muscle
5207423|NCT00796237|vibration|vibration
5207424|NCT00796237|motor balance|motor balance
5207425|NCT00796224|azithromycin, pharmacokinetics, pediatrics|azithromycin, pharmacokinetics, pediatrics
5207426|NCT00796211|Psoriasis|psoriasis
5207428|NCT00796211|nortriptyline|nortriptyline
5207429|NCT00796211|loratadine|loratadine
5207430|NCT00796211|CombinatoRx|combinatorx
5207431|NCT00796211|Dermatology|dermatology
5207432|NCT00796211|Erythema|erythema
5207433|NCT00796211|Pruritus|pruritus
5207434|NCT00796198|Glaucoma|glaucoma
5207435|NCT00796198|Intraocular pressure|intraocular pressure
5207436|NCT00796198|Ocular diastolic perfusion pressure|ocular diastolic perfusion pressure
5207437|NCT00796198|Dorzolamide/timolol Fixed combination|dorzolamide/timolol fixed combination
5207438|NCT00796198|Heidelberg Retina Flowmeter|heidelberg retina flowmeter
5207439|NCT00796185|Schizophrenia|schizophrenia
5207440|NCT00796185|Schizoaffective Disorder|schizoaffective disorder
5207441|NCT00796185|Mood Disorders|mood disorders
5207442|NCT00796185|Antipsychotic drugs|antipsychotic drugs
5207443|NCT00796185|Paliperidone ER|paliperidone er
5207444|NCT00796172|Hypertension|hypertension
5207445|NCT00796172|High Blood Pressure|high blood pressure
5207446|NCT00796172|Blood Lipid Management|blood lipid management
5207447|NCT00796159|Efficacy; Tolerability; Safety; Essential Hypertension|efficacy; tolerability; safety; essential hypertension
5207448|NCT00796133|NES/E2|nes/e2
5207449|NCT00796133|transdermal gel delivery|transdermal gel delivery
5207450|NCT00796133|contraception|contraception
5207451|NCT00796133|ovulation|ovulation
5207452|NCT00796133|bleeding patterns|bleeding patterns
5207453|NCT00796120|Sarcomas|sarcomas
5207454|NCT00796120|Trabectedin|trabectedin
5207455|NCT00796120|Doxorubicin|doxorubicin
5207456|NCT00796120|Ifosfamide|ifosfamide
5207457|NCT00796120|YONDELIS|yondelis
5207458|NCT00796081|Schizophrenia|schizophrenia
5207459|NCT00796081|Schizoaffective disorder|schizoaffective disorder
5207460|NCT00796081|Schizophreniform disorders|schizophreniform disorders
5207461|NCT00796081|Mood disorders|mood disorders
5207462|NCT00796081|Antipshychotic drugs|antipshychotic drugs
5207463|NCT00796081|Pediatrics|pediatrics
5207464|NCT00796081|ER OROS Paliperidone, Paliperidone ER|er oros paliperidone, paliperidone er
5207465|NCT00796042|Pressure Ulcer|pressure ulcer
5207466|NCT00796042|Bed Sores|bed sores
5207467|NCT00796042|Bedsore|bedsore
5207468|NCT00796042|Decubitus Ulcer|decubitus ulcer
5207469|NCT00796042|Pressure Sore|pressure sore
5207470|NCT00796042|Best rest|best rest
5207471|NCT00796042|mobility|mobility
5207472|NCT00796042|pressure management|pressure management
5207473|NCT00796029|Schizophrenia|schizophrenia
5207474|NCT00796029|Mood disorders|mood disorders
5207475|NCT00796029|Antipsychotic drugs: 14C-paliperidone|antipsychotic drugs: 14c-paliperidone
5207476|NCT00796003|Myelodysplastic syndrome|myelodysplastic syndrome
5207477|NCT00796003|MDS|mds
5207478|NCT00796003|Decitabine|decitabine
5207479|NCT00796003|JNJ-30979754|jnj-30979754
5207480|NCT00795990|Efficacy of early vs late use of ibuprofen for PDA closure|efficacy of early vs late use of ibuprofen for pda closure
5207481|NCT00795977|preoperative|preoperative
5207482|NCT00795977|intratumor|intratumor
5207483|NCT00795977|dendritic cells|dendritic cells
5207484|NCT00795977|pancreatic cancer|pancreatic cancer
5207485|NCT00795977|OK-432|ok-432
5207486|NCT00795964|tidal volume|tidal volume
5207487|NCT00795964|predicted body weight|predicted body weight
5207488|NCT00795964|lung function|lung function
5207489|NCT00795964|respiratory outcome|respiratory outcome
5207490|NCT00795964|Respiratory Function Tests|respiratory function tests
5207491|NCT00795964|surgery|surgery
5207492|NCT00795951|allergic|allergic
5207493|NCT00795951|contact dermatitis|contact dermatitis
5207494|NCT00795951|contact allergy|contact allergy
5207495|NCT00795951|Type IV|type iv
5207496|NCT00795951|Children|children
5207497|NCT00795951|TRUE TEST|true test
5207498|NCT00795925|propiverine|propiverine
5207499|NCT00795925|anticholinergics|anticholinergics
5207500|NCT00795925|urinary incontinence|urinary incontinence
5207501|NCT00795925|overactive bladder|overactive bladder
5207502|NCT00795925|children|children
5207503|NCT00795925|dose-finding in children aged 5-10 years|dose-finding in children aged 5-10 years
5207504|NCT00795912|Systolic heart failure|systolic heart failure
5207505|NCT00795912|HMG CoA reductase inhibitors|hmg coa reductase inhibitors
5207506|NCT00795912|B-type natriuretic peptide|b-type natriuretic peptide
5207507|NCT00795912|Inflammation|inflammation
5207508|NCT00795912|Myocardial collagen turnover|myocardial collagen turnover
5207509|NCT00795899|Safety and efficacy of experimental treatment|safety and efficacy of experimental treatment
5207510|NCT00795886|ALL|all
5207511|NCT00795886|Cancer|cancer
5207512|NCT00795886|Stem Cell Transplant|stem cell transplant
5207513|NCT00795873|Heart failure|heart failure
5207514|NCT00795873|cardiac resynchronization therapy|cardiac resynchronization therapy
5207515|NCT00795860|Insulin sensitivity|insulin sensitivity
5207516|NCT00795860|fat metabolism|fat metabolism
5207517|NCT00795860|inflammation|inflammation
5207518|NCT00795847|Hypertensive patients with morning hypertension|hypertensive patients with morning hypertension
5207519|NCT00795834|polyphenolics|polyphenolics
5207520|NCT00795834|flavonols|flavonols
5207521|NCT00795834|lipids|lipids
5207522|NCT00795834|endothelial function|endothelial function
5207523|NCT00795834|vascular risk factors|vascular risk factors
5207524|NCT00795808|Polycystic ovary syndrome|polycystic ovary syndrome
5207525|NCT00795808|PCOS|pcos
5207526|NCT00795808|Anovulation|anovulation
5207527|NCT00795808|Infertility|infertility
5207528|NCT00795808|Anovulatory polycystic ovary syndrome (PCOS)|anovulatory polycystic ovary syndrome (pcos)
5207529|NCT00795795|Chromosomal abnormalities in preimplantation embryos|chromosomal abnormalities in preimplantation embryos
5207530|NCT00795782|Papillary thyroid carcinoma|papillary thyroid carcinoma
5207531|NCT00795782|Lymph node dissection|lymph node dissection
5207532|NCT00795782|Lymph node metastasis|lymph node metastasis
5207533|NCT00795782|Prophylactic node dissection|prophylactic node dissection
5207534|NCT00795782|Central lymph node metastasis|central lymph node metastasis
5207535|NCT00795756|Adults|adults
5207536|NCT00795756|Central nervous system prophylaxis|central nervous system prophylaxis
5207537|NCT00795756|Minimal residual disease|minimal residual disease
5207538|NCT00795743|Central Venous Catheterization|central venous catheterization
5207539|NCT00795743|coagulopathy|coagulopathy
5207540|NCT00795743|thromboelastography|thromboelastography
5207541|NCT00795730|Alzheimer's Disease|alzheimer's disease
5207542|NCT00795730|schizophrenia|schizophrenia
5207543|NCT00795717|HIV|hiv
5207544|NCT00795717|cardiovascular risk|cardiovascular risk
5207545|NCT00795717|atherogenic lipid profile|atherogenic lipid profile
5207546|NCT00795717|brachial artery reactivity|brachial artery reactivity
5207547|NCT00795717|omega three fatty acids|omega three fatty acids
5207548|NCT00795704|Herbal Supplement|herbal supplement
5207549|NCT00795704|Type 2 Diabetes|type 2 diabetes
5207550|NCT00795704|Mulberry|mulberry
5207551|NCT00795704|Hemoglobin A1C|hemoglobin a1c
5207552|NCT00795691|diabetes|diabetes
5207553|NCT00795691|low-carbohydrate diet|low-carbohydrate diet
5207554|NCT00795691|weight loss|weight loss
5207555|NCT00795691|obesity|obesity
5207556|NCT00795691|dietary intervention|dietary intervention
5207557|NCT00795678|tumors metastatic to brain|tumors metastatic to brain
5207558|NCT00795678|stage IV breast cancer|stage iv breast cancer
5207559|NCT00795665|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5207560|NCT00795665|adult glioblastoma|adult glioblastoma
5207561|NCT00795665|adult gliosarcoma|adult gliosarcoma
5207562|NCT00795665|adult giant cell glioblastoma|adult giant cell glioblastoma
5207563|NCT00795665|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
5207564|NCT00795665|adult mixed glioma|adult mixed glioma
5207565|NCT00795665|recurrent adult brain tumor|recurrent adult brain tumor
5207566|NCT00795652|Postpartum depression|postpartum depression
5207567|NCT00795652|Distance therapy|distance therapy
5207568|NCT00795652|depression|depression
5207569|NCT00795652|Distance Treatment|distance treatment
5207570|NCT00795652|Barriers to care|barriers to care
5207571|NCT00795639|Sitaxsentan|sitaxsentan
5207572|NCT00795639|endothelin receptor antagonist|endothelin receptor antagonist
5207573|NCT00795626|nursing education|nursing education
5207574|NCT00795626|cardiovascular risk factors|cardiovascular risk factors
5207575|NCT00795626|coronary heart disease|coronary heart disease
5207576|NCT00795613|PET|pet
5207577|NCT00795574|Hidradenitis Suppurativa|hidradenitis suppurativa
5207578|NCT00795561|Hyperemesis gravidarum|hyperemesis gravidarum
5207579|NCT00795561|nausea|nausea
5207580|NCT00795561|vomiting|vomiting
5207581|NCT00795561|pregnancy|pregnancy
5207582|NCT00795561|day care|day care
5207583|NCT00795561|inpatient management|inpatient management
5207584|NCT00795561|Nausea and vomiting of pregnancy|nausea and vomiting of pregnancy
5207585|NCT00795548|Myelodysplastic syndrome (MDS)|myelodysplastic syndrome (mds)
5207586|NCT00795548|Acute myeloid leukemia (AML)|acute myeloid leukemia (aml)
5207587|NCT00795548|Stem cell transplantation|stem cell transplantation
5207588|NCT00795548|5-Azacitidine|5-azacitidine
5207589|NCT00795548|Donor lymphocyte infusion|donor lymphocyte infusion
5207590|NCT00795548|MDS or AML relapsed after stem cell transplantation|mds or aml relapsed after stem cell transplantation
5207591|NCT00795535|Injury|injury
5207592|NCT00795496|Atopic dermatitis|atopic dermatitis
5207593|NCT00795496|Bronchial hyperreactivity|bronchial hyperreactivity
5207594|NCT00795496|Skin prick tests|skin prick tests
5207595|NCT00795496|Serum IgE|serum ige
5207596|NCT00795496|Mantoux test|mantoux test
5207597|NCT00795483|Osteoporosis|osteoporosis
5207598|NCT00795483|HIV infection|hiv infection
5207599|NCT00795483|Bisphosphonates|bisphosphonates
5207600|NCT00795483|Zoledronic acid|zoledronic acid
5207601|NCT00795470|urinary tract infection|urinary tract infection
5207602|NCT00795470|critically ill|critically ill
5207603|NCT00795470|ICU|icu
5207604|NCT00795470|antimicrobial|antimicrobial
5207605|NCT00795470|Catheter associated urinary tract infections|catheter associated urinary tract infections
5207606|NCT00795457|vaccine|vaccine
5207607|NCT00795457|WHO Grade II Astrocytoma|who grade ii astrocytoma
5207608|NCT00795457|WHO Grade II Oligo-Astrocytoma|who grade ii oligo-astrocytoma
5207609|NCT00795444|HIV-1|hiv-1
5207610|NCT00795444|CCR5 coreceptor antagonist (Maraviroc)|ccr5 coreceptor antagonist (maraviroc)
5207611|NCT00795444|the cell reservoir of HIV-1|the cell reservoir of hiv-1
5207612|NCT00795418|Active immunization|active immunization
5207613|NCT00795418|Alzheimer's disease|alzheimer's disease
5207614|NCT00795418|Antibody|antibody
5207615|NCT00795418|Vaccine|vaccine
5207616|NCT00795418|Central Nervous System Diseases|central nervous system diseases
5207617|NCT00795418|Neurodegenerative diseases|neurodegenerative diseases
5207618|NCT00795405|sporting events|sporting events
5207619|NCT00795405|stress|stress
5207620|NCT00795405|myocardial ischemia|myocardial ischemia
5207621|NCT00795405|ST-segment depression|st-segment depression
5207622|NCT00795405|blood pressure|blood pressure
5207623|NCT00795392|Psychology|psychology
5207624|NCT00795392|Postoperative outcome|postoperative outcome
5207625|NCT00795392|Surgical Operation|surgical operation
5207626|NCT00795379|Psychotherapy|psychotherapy
5207627|NCT00795366|TBI, trauma, brain|tbi, trauma, brain
5207628|NCT00795353|plaque psoriasis|plaque psoriasis
5207629|NCT00795353|psoriasis|psoriasis
5207630|NCT00795353|alefacept|alefacept
5207631|NCT00795353|Amevive|amevive
5207632|NCT00795340|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5207633|NCT00795340|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5207634|NCT00795340|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5207635|NCT00795314|Opioids|opioids
5207636|NCT00795314|General anesthesia|general anesthesia
5207637|NCT00795301|tumor|tumor
5207638|NCT00795288|subarachnoid hemorrhage|subarachnoid hemorrhage
5207639|NCT00795288|vasospasm|vasospasm
5207640|NCT00795288|cerebral blood flow|cerebral blood flow
5207641|NCT00795288|cerebral metabolism|cerebral metabolism
5207642|NCT00795288|autoregulation|autoregulation
5207643|NCT00795288|statin|statin
5207644|NCT00795288|Vasospasm associated with Subarachnoid hemorrhage|vasospasm associated with subarachnoid hemorrhage
5207645|NCT00795275|pre-diabetes|pre-diabetes
5207646|NCT00795275|isotopes|isotopes
5207647|NCT00795275|insulin secretion|insulin secretion
5207648|NCT00795275|insulin action|insulin action
5207649|NCT00795275|GLP-1|glp-1
5207650|NCT00795275|simple obesity|simple obesity
5207651|NCT00795275|impaired fasting glucose|impaired fasting glucose
5207652|NCT00795262|brachial artery reactivity|brachial artery reactivity
5207653|NCT00795236|melatonin|melatonin
5207654|NCT00795210|HIV lipodystrophy|hiv lipodystrophy
5207655|NCT00795210|growth hormone|growth hormone
5207656|NCT00795210|growth hormone releasing hormone|growth hormone releasing hormone
5207657|NCT00795197|Gaucher Disease,|gaucher disease,
5207658|NCT00795197|acid B-glucosidase,|acid b-glucosidase,
5207659|NCT00795197|gluco cerebrosidase,|gluco cerebrosidase,
5207660|NCT00795197|glucosylceramide,|glucosylceramide,
5207661|NCT00795184|Barrett's Esophagus|barrett's esophagus
5207662|NCT00795184|EsoGastroDuodenoscopy|esogastroduodenoscopy
5207663|NCT00795184|Barrett's Carcinoma|barrett's carcinoma
5207664|NCT00795184|adenocarcinoma|adenocarcinoma
5207665|NCT00795184|Cellvizio|cellvizio
5207666|NCT00795184|endomicroscopy|endomicroscopy
5207667|NCT00795184|random biopsy|random biopsy
5207668|NCT00795145|Linezolid, QTc interval, pharmacokinetics, therapeutic dose, supra-therapeutic dose|linezolid, qtc interval, pharmacokinetics, therapeutic dose, supra-therapeutic dose
5207669|NCT00795132|cancer|cancer
5207670|NCT00795132|Hematologic Malignancies|hematologic malignancies
5207671|NCT00795132|Hematopoietic Cell Transplantation|hematopoietic cell transplantation
5207672|NCT00795119|Near Infrared Spectroscopy|near infrared spectroscopy
5207673|NCT00795119|Diagnosis|diagnosis
5207674|NCT00795119|Children|children
5207675|NCT00795106|Capsaicin|capsaicin
5207676|NCT00795106|hydrogel|hydrogel
5207677|NCT00795106|myofascial pain syndrome|myofascial pain syndrome
5207678|NCT00795106|neck pain|neck pain
5207679|NCT00795093|GERD|gerd
5207680|NCT00795093|PPI|ppi
5207681|NCT00795093|partial responders|partial responders
5207682|NCT00795080|CVJ malformations|cvj malformations
5207683|NCT00795054|Stem cell transplantation|stem cell transplantation
5207684|NCT00795054|Financial impact|financial impact
5207685|NCT00795041|vitrification|vitrification
5207686|NCT00795041|ovarian stimulation|ovarian stimulation
5207687|NCT00795041|reproductive medicine|reproductive medicine
5207688|NCT00795028|older women|older women
5207689|NCT00795028|hip fracture|hip fracture
5207690|NCT00795028|exercise intervention|exercise intervention
5207691|NCT00795015|postoperative blood glucose control|postoperative blood glucose control
5207692|NCT00795015|IV insulin infusion|iv insulin infusion
5207693|NCT00794989|breast cancer|breast cancer
5207694|NCT00794989|atypical ductal breast hyperplasia|atypical ductal breast hyperplasia
5207695|NCT00794989|lobular breast carcinoma in situ|lobular breast carcinoma in situ
5207696|NCT00794989|ductal breast carcinoma in situ|ductal breast carcinoma in situ
5207697|NCT00794989|breast cancer prevention|breast cancer prevention
5207698|NCT00794989|high risk breast cancer|high risk breast cancer
5207699|NCT00794950|Bladder Cancer|bladder cancer
5207700|NCT00794950|High Risk Non-muscle Invasive Lower Urinary Tract Urothelial Carcinoma|high risk non-muscle invasive lower urinary tract urothelial carcinoma
5207701|NCT00794924|probiotics|probiotics
5207702|NCT00794924|elderly|elderly
5207703|NCT00794924|motility|motility
5207704|NCT00794924|diarrhea|diarrhea
5207705|NCT00794911|Liver Transplantation|liver transplantation
5207706|NCT00794911|Quality of Life|quality of life
5207707|NCT00794911|Chronic HCV|chronic hcv
5207708|NCT00794911|Hepatitis C Virus|hepatitis c virus
5207709|NCT00794911|Cirrhosis|cirrhosis
5207710|NCT00794911|Liver disease|liver disease
5207711|NCT00794885|hypertension|hypertension
5207712|NCT00794885|stroke|stroke
5207713|NCT00794885|cardiovascular events|cardiovascular events
5207714|NCT00794885|enalapril|enalapril
5207715|NCT00794885|folic acid|folic acid
5207716|NCT00794885|randomized controlled trial|randomized controlled trial
5207717|NCT00794885|MTHFR C677T genotype|mthfr c677t genotype
5207718|NCT00794872|Cardiovascular autonomic neuropathy|cardiovascular autonomic neuropathy
5207719|NCT00794872|Chemoreflex sensitivity|chemoreflex sensitivity
5207720|NCT00794872|Chronic kidney disease|chronic kidney disease
5207721|NCT00794872|Sudden cardiac arrest|sudden cardiac arrest
5207722|NCT00794820|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
5207723|NCT00794820|CLL|cll
5207724|NCT00794820|Leukemia|leukemia
5207725|NCT00794820|Fludarabine phosphate|fludarabine phosphate
5207726|NCT00794820|Cyclophosphamide|cyclophosphamide
5207727|NCT00794820|Rituximab|rituximab
5207728|NCT00794820|FCR|fcr
5207729|NCT00794820|Cytoxan®|cytoxan®
5207730|NCT00794820|Neosar®|neosar®
5207731|NCT00794820|Rituxan®|rituxan®
5207732|NCT00794807|Alefacept|alefacept
5207733|NCT00794807|Skin Diseases|skin diseases
5207734|NCT00794807|Psoriasis|psoriasis
5207735|NCT00794807|Skin Diseases, Papulosquamos|skin diseases, papulosquamos
5207736|NCT00794807|Therapeutic Uses|therapeutic uses
5207737|NCT00794807|Dermatologic Agents|dermatologic agents
5207738|NCT00794781|Cancer|cancer
5207739|NCT00794781|solid tumors|solid tumors
5207740|NCT00794755|Vitamin K|vitamin k
5207741|NCT00794755|Vitamin K1 (Phytonadione)|vitamin k1 (phytonadione)
5207742|NCT00794755|Unstable INR|unstable inr
5207743|NCT00794755|VTE or Thrombosis|vte or thrombosis
5207744|NCT00794755|Warfarin|warfarin
5207745|NCT00794755|Anticoagulation Control|anticoagulation control
5207746|NCT00794755|Patients on warfarin with unstable anticoagulation control|patients on warfarin with unstable anticoagulation control
5207747|NCT00794742|Burn|burn
5207748|NCT00794742|Antimicrobial|antimicrobial
5207749|NCT00794742|Bacteria|bacteria
5207750|NCT00794742|Resistance|resistance
5207751|NCT00794742|Biofilm|biofilm
5207752|NCT00794742|Pathogen|pathogen
5207753|NCT00794729|Healthy Volunteers|healthy volunteers
5207754|NCT00794729|Consents|consents
5207755|NCT00794703|Antifungal|antifungal
5207756|NCT00794703|micafungin|micafungin
5207757|NCT00794703|itraconazole|itraconazole
5207758|NCT00794690|cimicifuga racemosa|cimicifuga racemosa
5207759|NCT00794690|liver blood flow and functions|liver blood flow and functions
5207760|NCT00794677|Hypercholesterolemia|hypercholesterolemia
5207761|NCT00794677|Oxysterol|oxysterol
5207762|NCT00794677|Ezetimibe|ezetimibe
5207763|NCT00794677|Zetia|zetia
5207764|NCT00794651|osteoarthritis|osteoarthritis
5207765|NCT00794651|testing kit|testing kit
5207766|NCT00794651|knee|knee
5207767|NCT00794638|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
5207768|NCT00794638|Diffuse Large B-Cell Lymphoma|diffuse large b-cell lymphoma
5207769|NCT00794638|Mantle cell Lymphoma|mantle cell lymphoma
5207770|NCT00794638|Transformed lymphoma, transformed to diffuse large B-cell lymphoma|transformed lymphoma, transformed to diffuse large b-cell lymphoma
5207771|NCT00794638|Follicular Lymphoma|follicular lymphoma
5207772|NCT00794625|Attention-Deficit/Hyperactivity Disorder|attention-deficit/hyperactivity disorder
5207773|NCT00794625|Aggressive Behavior|aggressive behavior
5207774|NCT00794625|Oppositional Defiant Disorder|oppositional defiant disorder
5207775|NCT00794625|Conduct Disorder|conduct disorder
5207776|NCT00794586|cystic fibrosis|cystic fibrosis
5207777|NCT00794586|CF|cf
5207778|NCT00794586|inhaled antibiotic|inhaled antibiotic
5207779|NCT00794586|antipseudomonal antibiotic|antipseudomonal antibiotic
5207780|NCT00794586|tobramycin|tobramycin
5207781|NCT00794586|fosfomycin|fosfomycin
5207782|NCT00794586|lung infection|lung infection
5207783|NCT00794586|pseudomonal infection|pseudomonal infection
5207784|NCT00794586|FTI|fti
5207785|NCT00794573|Smoking Cessation|smoking cessation
5207786|NCT00794573|Cardiac Population|cardiac population
5207787|NCT00794573|Acute Coronary Syndrome|acute coronary syndrome
5207788|NCT00794573|Varenicline|varenicline
5207789|NCT00794573|Champix|champix
5207790|NCT00794560|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight
5207791|NCT00794560|compliance|compliance
5207792|NCT00794560|drug safety|drug safety
5207793|NCT00794560|self-administration|self-administration
5207794|NCT00794560|ambulatory Care|ambulatory care
5207795|NCT00794560|Pharmaceutical Services|pharmaceutical services
5207796|NCT00794547|lung cancer; nsclc|lung cancer; nsclc
5207797|NCT00794508|Severe Combined Immune Deficiency|severe combined immune deficiency
5207798|NCT00794508|Adenosine Deaminase Deficiency|adenosine deaminase deficiency
5207799|NCT00794508|Gene Therapy|gene therapy
5207800|NCT00794508|Hematopoietic Stem Cells|hematopoietic stem cells
5207801|NCT00794508|Retroviral Vector|retroviral vector
5207802|NCT00794508|ADA-deficient SCID|ada-deficient scid
5207803|NCT00794469|Resting metabolic rate|resting metabolic rate
5207804|NCT00794456|Passiflora|passiflora
5207805|NCT00794456|Crataegus|crataegus
5207806|NCT00794456|Herbal|herbal
5207807|NCT00794456|Valeriana|valeriana
5207808|NCT00794456|anxiety|anxiety
5207809|NCT00794443|ONO-5920|ono-5920
5207810|NCT00794443|YM529|ym529
5207811|NCT00794443|Bone mineral density|bone mineral density
5207812|NCT00794443|Minodronic acid|minodronic acid
5207813|NCT00794430|Safety|safety
5207814|NCT00794430|Tolerability|tolerability
5207815|NCT00794430|Efficacy|efficacy
5207816|NCT00794430|Patients|patients
5207817|NCT00794430|Diabetic peripheral neuropathic pain.|diabetic peripheral neuropathic pain.
5207818|NCT00794417|advanced cancer|advanced cancer
5207819|NCT00794417|lung cancer|lung cancer
5207820|NCT00794417|NSCLC|nsclc
5207821|NCT00794417|Non-small Cell Lung Cancer|non-small cell lung cancer
5207822|NCT00794417|aflibercept|aflibercept
5207823|NCT00794417|chemotherapy|chemotherapy
5207824|NCT00794391|Vulnerable Populations|vulnerable populations
5207825|NCT00794391|Injecting drug users|injecting drug users
5207826|NCT00794391|IDU|idu
5207827|NCT00794391|Risky injecting practices|risky injecting practices
5207828|NCT00794391|Psychotherapy, brief|psychotherapy, brief
5207829|NCT00794391|Motivational interviewing|motivational interviewing
5207830|NCT00794391|Educational activities|educational activities
5207831|NCT00794391|Clinical trial|clinical trial
5207832|NCT00794391|Risk behavior|risk behavior
5207833|NCT00794391|risk reduction behavior|risk reduction behavior
5207834|NCT00794365|Smoking; smoking cessation; Philippines; Varenicline|smoking; smoking cessation; philippines; varenicline
5207835|NCT00794352|Inflammation|inflammation
5207836|NCT00794352|Multiple Sclerosis|multiple sclerosis
5207837|NCT00794352|Neuroimmunology|neuroimmunology
5207838|NCT00794352|Immune Disorder|immune disorder
5207839|NCT00794352|Neuroimaging|neuroimaging
5207840|NCT00794352|Central Nervous System Disease|central nervous system disease
5207841|NCT00794352|Healthy Volunteers|healthy volunteers
5207842|NCT00794352|HV|hv
5207843|NCT00794339|cervical squamous cell carcinoma|cervical squamous cell carcinoma
5207844|NCT00794339|stage IIB cervical cancer|stage iib cervical cancer
5207845|NCT00794339|stage III cervical cancer|stage iii cervical cancer
5207846|NCT00794339|stage IV cervical cancer|stage iv cervical cancer
5207847|NCT00794339|stage IVA cervical cancer|stage iva cervical cancer
5207848|NCT00794339|stage IB cervical cancer|stage ib cervical cancer
5207849|NCT00794339|stage IIA cervical cancer|stage iia cervical cancer
5207850|NCT00794326|Chronic Kidney Failure|chronic kidney failure
5207851|NCT00794326|Peritoneal Dialysis|peritoneal dialysis
5207852|NCT00794326|Low sodium solution|low sodium solution
5207853|NCT00794326|Hypertension|hypertension
5207854|NCT00794326|Total Body Water|total body water
5207855|NCT00794313|Parkinsons disease|parkinsons disease
5207856|NCT00794313|dyskinesia|dyskinesia
5207857|NCT00794313|amantadine|amantadine
5207858|NCT00794313|efficacy|efficacy
5207859|NCT00794300|reproducibility|reproducibility
5207860|NCT00794300|contrast agent|contrast agent
5207861|NCT00794300|magnetic resonance imaging|magnetic resonance imaging
5207862|NCT00794300|infarct size|infarct size
5207863|NCT00794300|myocardial salvage index|myocardial salvage index
5207864|NCT00794300|myocardial salvage assessment|myocardial salvage assessment
5207865|NCT00794274|Sarcodiosis|sarcodiosis
5207866|NCT00794274|tumor necrosis factor|tumor necrosis factor
5207867|NCT00794261|Myeloma|myeloma
5207868|NCT00794261|lymphoma|lymphoma
5207869|NCT00794261|high-dose chemotherapy|high-dose chemotherapy
5207870|NCT00794261|PSC infusion, autologous|psc infusion, autologous
5207871|NCT00794261|neutropenia|neutropenia
5207872|NCT00794261|thrombocytopenia|thrombocytopenia
5207873|NCT00794261|hospital stay|hospital stay
5207874|NCT00794261|infection|infection
5207875|NCT00794261|Autologous PSC transplantation for patients with lymphoma or myeloma treated with high-dose chemotherapy|autologous psc transplantation for patients with lymphoma or myeloma treated with high-dose chemotherapy
5207876|NCT00794222|Cellular phones|cellular phones
5207877|NCT00794222|mental health|mental health
5207878|NCT00794222|Early intervention|early intervention
5207879|NCT00794222|prevention|prevention
5207880|NCT00794222|momentary sampling|momentary sampling
5207881|NCT00794222|Adolescent|adolescent
5207882|NCT00794209|AeroLEF, fentanyl, liposome encapsulated, opioid|aerolef, fentanyl, liposome encapsulated, opioid
5207883|NCT00794196|Medication adherence|medication adherence
5207884|NCT00794196|Antidepressive agents|antidepressive agents
5207885|NCT00794196|Primary care|primary care
5207886|NCT00794196|Pharmaceutical care|pharmaceutical care
5207887|NCT00794183|heart failure|heart failure
5207888|NCT00794183|CRT|crt
5207889|NCT00794183|CHF|chf
5207890|NCT00794170|Treatment Compliance|treatment compliance
5207891|NCT00794157|COPD|copd
5207892|NCT00794157|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
5207893|NCT00794157|indacaterol|indacaterol
5207894|NCT00794157|long acting β2-agonist|long acting β2-agonist
5207895|NCT00794144|Allergic Rhinitis|allergic rhinitis
5207896|NCT00794144|Pediatric|pediatric
5207897|NCT00794144|PATANASE|patanase
5207898|NCT00794131|cancer|cancer
5207899|NCT00794131|vaccinia virus|vaccinia virus
5207900|NCT00794131|vaccinia|vaccinia
5207901|NCT00794131|oncolytic|oncolytic
5207902|NCT00794131|oncolytic virus|oncolytic virus
5207903|NCT00794131|biological|biological
5207904|NCT00794131|imaging|imaging
5207905|NCT00794105|Gas|gas
5207906|NCT00794105|Middle ear|middle ear
5207907|NCT00794079|Healthy volunteers|healthy volunteers
5207908|NCT00794079|young adults|young adults
5207909|NCT00794079|Aged|aged
5207910|NCT00794066|PAD|pad
5207911|NCT00794066|Stroke|stroke
5207912|NCT00794066|ICH|ich
5207913|NCT00794066|prevalence|prevalence
5207914|NCT00794053|Sentinel lymph node|sentinel lymph node
5207915|NCT00794053|thyroid cancer|thyroid cancer
5207916|NCT00794053|neck dissection|neck dissection
5207917|NCT00794040|Irritability|irritability
5207918|NCT00794040|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
5207919|NCT00794040|Explosive|explosive
5207920|NCT00794040|Tantrums|tantrums
5207921|NCT00794040|Bipolar Mood Disorder|bipolar mood disorder
5207922|NCT00794040|Mood Disorder|mood disorder
5207923|NCT00794040|Childhood Mood Disorder|childhood mood disorder
5207924|NCT00794040|ADHD|adhd
5207925|NCT00794027|heart failure|heart failure
5207926|NCT00794027|yoga|yoga
5207927|NCT00794027|quality of life|quality of life
5207928|NCT00794014|Angioplasty, Transluminal, Percutaneous Coronary|angioplasty, transluminal, percutaneous coronary
5207929|NCT00794001|myocardial infarction|myocardial infarction
5207930|NCT00794001|angioplasty|angioplasty
5207931|NCT00794001|data feedback|data feedback
5207932|NCT00794001|continuous quality improvement|continuous quality improvement
5207933|NCT00794001|STEMI|stemi
5207934|NCT00794001|Feedback|feedback
5207935|NCT00794001|Quality Assurance, Health Care|quality assurance, health care
5207936|NCT00794001|Emergency service hospital|emergency service hospital
5207937|NCT00793988|vibration|vibration
5207938|NCT00793988|local anaesthesia|local anaesthesia
5207939|NCT00793988|ptosis surgery|ptosis surgery
5207940|NCT00793988|blepharoplasty|blepharoplasty
5207941|NCT00793988|Upper eyelid surgery|upper eyelid surgery
5207942|NCT00793988|dermatochalasis +/- blepharoptosis|dermatochalasis +/- blepharoptosis
5207943|NCT00793975|Tumors|tumors
5207944|NCT00793975|Antibodies, Monoclonal|antibodies, monoclonal
5207945|NCT00793962|breast cancer|breast cancer
5207946|NCT00793962|mastectomy|mastectomy
5207947|NCT00793962|radiotherapy|radiotherapy
5207948|NCT00793962|fractionation|fractionation
5207949|NCT00793936|Right Double Lumen Tube|right double lumen tube
5207950|NCT00793923|Exudative Age Related Macular Degeneration|exudative age related macular degeneration
5207951|NCT00793910|Gabapentin|gabapentin
5207952|NCT00793910|PRK|prk
5207953|NCT00793910|pain|pain
5207954|NCT00793897|Subjects with Advanced or Metastatic Solid Tumors or Neoplasms|subjects with advanced or metastatic solid tumors or neoplasms
5207955|NCT00793884|Diabetes|diabetes
5207956|NCT00793884|Latino population|latino population
5207957|NCT00793871|sunitinib|sunitinib
5207958|NCT00793871|Phase IV|phase iv
5207959|NCT00793871|gastrointestinal stomal tumor|gastrointestinal stomal tumor
5207960|NCT00793871|imatinib resistant or intolerant|imatinib resistant or intolerant
5207961|NCT00793871|Chinese|chinese
5207962|NCT00793845|tandem high-dose chemotherapy for high-risk neuroblastoma|tandem high-dose chemotherapy for high-risk neuroblastoma
5207963|NCT00793832|weight loss|weight loss
5207964|NCT00793819|nocturia|nocturia
5207965|NCT00793819|BPH|bph
5207966|NCT00793819|benign prostate hyperplasia|benign prostate hyperplasia
5207967|NCT00793819|nocturia in men with benign prostate hyperplasia|nocturia in men with benign prostate hyperplasia
5207968|NCT00793806|chronic kidney disease|chronic kidney disease
5207969|NCT00793780|obesity|obesity
5207970|NCT00793780|schizophrenia|schizophrenia
5207971|NCT00793780|schizoaffective disorder|schizoaffective disorder
5207972|NCT00793780|weight loss|weight loss
5207973|NCT00793767|Erythropoietin|erythropoietin
5207974|NCT00793767|human muscle tissue|human muscle tissue
5207975|NCT00793767|insulin sensitivity|insulin sensitivity
5207976|NCT00793767|substrate metabolism|substrate metabolism
5207977|NCT00793741|Type 1 diabetes|type 1 diabetes
5207978|NCT00793741|Hypoglycemia unawareness|hypoglycemia unawareness
5207979|NCT00793741|Islet transplant|islet transplant
5207980|NCT00793728|Morbid obesity|morbid obesity
5207981|NCT00793728|High risk|high risk
5207982|NCT00793715|acute pancreatitis|acute pancreatitis
5207983|NCT00793715|abdominal compartment syndrome|abdominal compartment syndrome
5207984|NCT00793715|decompressive laparotomy|decompressive laparotomy
5207985|NCT00793715|percutaneous abdominal puncture|percutaneous abdominal puncture
5207986|NCT00793715|Mortality of patients treated in both arms|mortality of patients treated in both arms
5207987|NCT00793702|tuberculosis|tuberculosis
5207988|NCT00793702|diagnosis|diagnosis
5207989|NCT00793702|ESAT-6|esat-6
5207990|NCT00793702|CFP-10|cfp-10
5207991|NCT00793702|skin test|skin test
5207992|NCT00793702|Skin test for the diagnosis of tuberculosis infection|skin test for the diagnosis of tuberculosis infection
5207993|NCT00793689|parathyroid|parathyroid
5207994|NCT00793689|thyroidectomy|thyroidectomy
5207995|NCT00793689|hypoparathyroidism|hypoparathyroidism
5207996|NCT00793689|Parathyroid function after total thyroidectomy|parathyroid function after total thyroidectomy
5207997|NCT00793676|GPCR expression|gpcr expression
5207998|NCT00793676|transcriptomic|transcriptomic
5207999|NCT00793676|white blood cells|white blood cells
5208000|NCT00793676|diagnostic|diagnostic
5208001|NCT00793676|Control|control
5208002|NCT00793663|Xenon|xenon
5208003|NCT00793663|Sevoflurane|sevoflurane
5208004|NCT00793663|Postoperative Nausea and vomiting|postoperative nausea and vomiting
5208005|NCT00793663|Depth of anaesthesia|depth of anaesthesia
5208006|NCT00793650|Cancer|cancer
5208007|NCT00793650|Multiple Myeloma|multiple myeloma
5208008|NCT00793650|Peripheral Blood Stem Cell Transplant|peripheral blood stem cell transplant
5208009|NCT00793637|Angular stable locking system|angular stable locking system
5208010|NCT00793637|Handling test|handling test
5208011|NCT00793637|Complications|complications
5208012|NCT00793611|Overactive Bladder|overactive bladder
5208013|NCT00793611|Hypnotherapy|hypnotherapy
5208014|NCT00793598|CMX001|cmx001
5208015|NCT00793598|Kidney transplant|kidney transplant
5208016|NCT00793598|HSCT transplant|hsct transplant
5208017|NCT00793598|BK Virus|bk virus
5208018|NCT00793598|Post kidney transplant patients with BK virus viruria > 10^4|post kidney transplant patients with bk virus viruria > 10^4
5208019|NCT00793598|Post HSCT transplant patients with BK virus viruria > 10^4|post hsct transplant patients with bk virus viruria > 10^4
5208020|NCT00793585|IgA nephropathy|iga nephropathy
5208021|NCT00793559|septic shock refractory to catecholamines|septic shock refractory to catecholamines
5208022|NCT00793546|Bosutinib|bosutinib
5208023|NCT00793546|Exemestane|exemestane
5208024|NCT00793546|postmenopausal|postmenopausal
5208025|NCT00793546|breast cancer|breast cancer
5208026|NCT00793520|fibromyalgia|fibromyalgia
5208027|NCT00793520|milnacipran|milnacipran
5208028|NCT00793520|Forest Laboratories|forest laboratories
5208029|NCT00793507|childhood caries|childhood caries
5208030|NCT00793494|Irritable bowel syndrome|irritable bowel syndrome
5208031|NCT00793494|Children|children
5208032|NCT00793494|Pediatrics|pediatrics
5208033|NCT00793494|Probiotics|probiotics
5208034|NCT00793481|Metabolic Syndrome|metabolic syndrome
5208035|NCT00793468|nicotine dependence|nicotine dependence
5208036|NCT00793468|smoking|smoking
5208037|NCT00793468|pharmacological treatment|pharmacological treatment
5208038|NCT00793468|relapse prevention|relapse prevention
5208039|NCT00793455|education|education
5208040|NCT00793455|preventive service|preventive service
5208041|NCT00793455|screening|screening
5208042|NCT00793442|sepsis|sepsis
5208043|NCT00793442|severe sepsis|severe sepsis
5208044|NCT00793442|septic shock|septic shock
5208045|NCT00793442|endothelium|endothelium
5208046|NCT00793442|microcirculation|microcirculation
5208047|NCT00793442|biomarkers|biomarkers
5208048|NCT00793429|electrocardiographic safety|electrocardiographic safety
5208049|NCT00793429|pharmacokinetics|pharmacokinetics
5208050|NCT00793416|Normal Pressure Hydrocephalus|normal pressure hydrocephalus
5208051|NCT00793416|Valve Adjustment|valve adjustment
5208052|NCT00793416|Blocked Shunt in NPH patients|blocked shunt in nph patients
5208053|NCT00793416|Diagnosis of blockage|diagnosis of blockage
5208054|NCT00793403|Observational cohort|observational cohort
5208055|NCT00793403|prospectives|prospectives
5208056|NCT00793403|multicentre|multicentre
5208057|NCT00793403|the Italian study RA patient CLARA and PRO-CLARA|the italian study ra patient clara and pro-clara
5208058|NCT00793390|aggressive breast cancer|aggressive breast cancer
5208059|NCT00793390|Inflammatory Breast Cancer|inflammatory breast cancer
5208060|NCT00793390|IBC|ibc
5208061|NCT00793364|Cholesterol, stanol-ester, mediterranean diet, cardiac risk|cholesterol, stanol-ester, mediterranean diet, cardiac risk
5208062|NCT00793351|reduced intensity stem cell transplantation for neuroblastoma|reduced intensity stem cell transplantation for neuroblastoma
5208063|NCT00793351|relapsed neuroblastoma after high-dose chemotherapy and autologous stem cell rescue|relapsed neuroblastoma after high-dose chemotherapy and autologous stem cell rescue
5208064|NCT00793338|Heart failure|heart failure
5208065|NCT00793338|Sildenafil|sildenafil
5208066|NCT00793338|Cardiopulmonary exercise test|cardiopulmonary exercise test
5208067|NCT00793338|quality of life|quality of life
5208068|NCT00793338|6 minute walk test|6 minute walk test
5208069|NCT00793286|inguinal hernia|inguinal hernia
5208070|NCT00793286|laparoscopy|laparoscopy
5208071|NCT00793286|mesh|mesh
5208072|NCT00793234|TKR|tkr
5208073|NCT00793234|VTE|vte
5208074|NCT00793234|DVT|dvt
5208075|NCT00793221|Coronary stent.|coronary stent.
5208076|NCT00793221|Restenosis.|restenosis.
5208077|NCT00793221|Coronary artery disease.|coronary artery disease.
5208078|NCT00793221|Chronic total occlusion.|chronic total occlusion.
5208079|NCT00793208|Lung cancer|lung cancer
5208080|NCT00793208|non small cell|non small cell
5208081|NCT00793208|vaccine|vaccine
5208082|NCT00793208|carcinoma|carcinoma
5208083|NCT00793208|immunization|immunization
5208084|NCT00793208|autologous Tumor|autologous tumor
5208085|NCT00793208|vaccination|vaccination
5208086|NCT00793195|Neonates|neonates
5208087|NCT00793195|Short Bowel Syndrome|short bowel syndrome
5208088|NCT00793195|Intestinal Failure|intestinal failure
5208089|NCT00793195|Liver Failure|liver failure
5208090|NCT00793195|Parenteral Nutrition|parenteral nutrition
5208091|NCT00793195|Intralipid|intralipid
5208092|NCT00793195|SMOF|smof
5208093|NCT00793182|Renal|renal
5208094|NCT00793182|Kidney|kidney
5208095|NCT00793182|Contrast Induced Nephropathy|contrast induced nephropathy
5208096|NCT00793169|squamous cell carcinoma of the head or neck|squamous cell carcinoma of the head or neck
5208097|NCT00793156|uremic pruritus|uremic pruritus
5208098|NCT00793143|morbid obesity|morbid obesity
5208099|NCT00793143|laparoscopic sleeve gastrectomy|laparoscopic sleeve gastrectomy
5208100|NCT00793143|LSG|lsg
5208101|NCT00793143|laparoscopic gastric bypass|laparoscopic gastric bypass
5208102|NCT00793143|LGB|lgb
5208103|NCT00793143|comorbidities|comorbidities
5208104|NCT00793143|diabetes|diabetes
5208105|NCT00793143|excessive weight loss|excessive weight loss
5208106|NCT00793143|weight loss|weight loss
5208107|NCT00793130|Ulcerative|ulcerative
5208108|NCT00793130|Colitis|colitis
5208109|NCT00793130|Coltect|coltect
5208110|NCT00793130|Curcumin|curcumin
5208111|NCT00793130|Green tea|green tea
5208112|NCT00793130|Selenium|selenium
5208113|NCT00793130|inflammation|inflammation
5208114|NCT00793130|bowel|bowel
5208115|NCT00793117|chronic sinusitis|chronic sinusitis
5208116|NCT00793117|FESS|fess
5208117|NCT00793117|packing|packing
5208118|NCT00793104|allograft|allograft
5208119|NCT00793104|knee injury|knee injury
5208120|NCT00793104|cartilage injury|cartilage injury
5208121|NCT00793104|Osteochondral defects in the articular femoral cartilage|osteochondral defects in the articular femoral cartilage
5208122|NCT00793078|sepsis|sepsis
5208123|NCT00793078|arterial blood pressure|arterial blood pressure
5208124|NCT00793078|complexity|complexity
5208125|NCT00793078|variability|variability
5208126|NCT00793065|electronic health records|electronic health records
5208127|NCT00793065|health information technology|health information technology
5208128|NCT00793065|physician incentives|physician incentives
5208129|NCT00793065|quality of health care|quality of health care
5208130|NCT00793052|trismus|trismus
5208131|NCT00793052|Edema|edema
5208132|NCT00793052|pain|pain
5208133|NCT00793013|Acute Lung Injury|acute lung injury
5208134|NCT00793013|Adult Respiratory Distress Syndrome|adult respiratory distress syndrome
5208135|NCT00793013|Airway Pressure Release Ventilation|airway pressure release ventilation
5208136|NCT00793013|Acute Kidney Injury|acute kidney injury
5208137|NCT00793013|Pressure Trial|pressure trial
5208138|NCT00793000|Safety tolerability pharmacokinetics PK first in human FIH|safety tolerability pharmacokinetics pk first in human fih
5208139|NCT00792974|Cognitive behavioral education|cognitive behavioral education
5208140|NCT00792974|COPD (Chronic Obstructive Pulmonary Disease), GOLD II-IV|copd (chronic obstructive pulmonary disease), gold ii-iv
5208141|NCT00792961|Prostate cancer|prostate cancer
5208142|NCT00792961|Robotic surgery|robotic surgery
5208143|NCT00792961|Endomicroscopy|endomicroscopy
5208144|NCT00792922|Trachoma|trachoma
5208145|NCT00792922|Azithromycin|azithromycin
5208146|NCT00792922|Mass treatment|mass treatment
5208147|NCT00792909|Pneumococcal vaccine|pneumococcal vaccine
5208148|NCT00792909|Pneumococcal disease|pneumococcal disease
5208149|NCT00792909|Safety|safety
5208150|NCT00792909|Immunogenicity|immunogenicity
5208151|NCT00792883|PICU|picu
5208152|NCT00792883|BIA|bia
5208153|NCT00792883|Phase angle|phase angle
5208154|NCT00792883|RQ|rq
5208155|NCT00792883|EEM|eem
5208156|NCT00792883|Compliance|compliance
5208157|NCT00792883|Resistance|resistance
5208158|NCT00792883|Curves|curves
5208159|NCT00792883|Polymorphisms|polymorphisms
5208160|NCT00792883|NF-kappa B|nf-kappa b
5208161|NCT00792883|Scores|scores
5208162|NCT00792883|PIM 2|pim 2
5208163|NCT00792883|PRISM I|prism i
5208164|NCT00792870|Obesity|obesity
5208165|NCT00792870|Weight loss|weight loss
5208166|NCT00792870|Internet|internet
5208167|NCT00792857|Parathyroid Diseases|parathyroid diseases
5208168|NCT00792857|Renal Insufficiency|renal insufficiency
5208169|NCT00792857|Kidney Failure, Chronic|kidney failure, chronic
5208170|NCT00792857|Hyperparathyroidism, Secondary|hyperparathyroidism, secondary
5208171|NCT00792857|Vitamin D|vitamin d
5208172|NCT00792857|Hyperparathyroidism|hyperparathyroidism
5208173|NCT00792857|Renal Insufficiency, Chronic|renal insufficiency, chronic
5208174|NCT00792857|Kidney Diseases|kidney diseases
5208175|NCT00792857|Kidney Failure|kidney failure
5208176|NCT00792818|Osteoarthritis, Knee, Curcumin, Multicenter, RCT|osteoarthritis, knee, curcumin, multicenter, rct
5208177|NCT00792805|COPD|copd
5208178|NCT00792805|indacaterol|indacaterol
5208179|NCT00792805|long-acting β2-agonist|long-acting β2-agonist
5208180|NCT00792805|adults|adults
5208181|NCT00792792|tissue transfer|tissue transfer
5208182|NCT00792779|Morbid obesity|morbid obesity
5208183|NCT00792779|General anaesthesia|general anaesthesia
5208184|NCT00792779|Propofol|propofol
5208185|NCT00792779|Sevoflurane|sevoflurane
5208186|NCT00792766|Tuberous Sclerosis Complex (TSC)|tuberous sclerosis complex (tsc)
5208187|NCT00792766|Angiolipoma|angiolipoma
5208188|NCT00792766|mTOR|mtor
5208189|NCT00792766|Everolimus|everolimus
5208190|NCT00792753|Coronary Artery Disease|coronary artery disease
5208191|NCT00792727|Pain|pain
5208192|NCT00792727|Knee|knee
5208193|NCT00792727|Arthritis|arthritis
5208194|NCT00792727|Knee pain|knee pain
5208195|NCT00792701|stage I non-small cell lung cancer|stage i non-small cell lung cancer
5208196|NCT00792688|burn wounds|burn wounds
5208197|NCT00792688|wound healing|wound healing
5208198|NCT00792675|exercise|exercise
5208199|NCT00792675|disease activity|disease activity
5208200|NCT00792675|inflammation|inflammation
5208201|NCT00792675|resistance training|resistance training
5208202|NCT00792675|rehabilitation|rehabilitation
5208203|NCT00792662|Diabetes Mellitus|diabetes mellitus
5208204|NCT00792662|Alzheimer's Disease|alzheimer's disease
5208205|NCT00792662|Apathy|apathy
5208206|NCT00792662|Methylphenidate|methylphenidate
5208207|NCT00792662|Dementia|dementia
5208208|NCT00792636|sumatriptan and naproxen sodium|sumatriptan and naproxen sodium
5208209|NCT00792636|migraine with or without aura|migraine with or without aura
5208210|NCT00792636|naproxen sodium|naproxen sodium
5208211|NCT00792636|sumatriptan|sumatriptan
5208212|NCT00792636|blood pressure|blood pressure
5208213|NCT00792636|migraine headaches|migraine headaches
5208214|NCT00792623|Varicella|varicella
5208215|NCT00792623|VarilrixTM|varilrixtm
5208216|NCT00792610|youth|youth
5208217|NCT00792610|hepatitis B|hepatitis b
5208218|NCT00792610|vaccination|vaccination
5208219|NCT00792610|booster|booster
5208220|NCT00792610|immunity response|immunity response
5208221|NCT00792584|etravirine|etravirine
5208222|NCT00792584|efavirenz|efavirenz
5208223|NCT00792584|anxiety|anxiety
5208224|NCT00792584|depression|depression
5208225|NCT00792584|sleep quality|sleep quality
5208226|NCT00792584|HIV|hiv
5208227|NCT00792584|NNRTI|nnrti
5208228|NCT00792584|Tritherapy|tritherapy
5208229|NCT00792584|compliance|compliance
5208230|NCT00792584|stocrin|stocrin
5208231|NCT00792584|To replace efavirenz in long-term users with etravirine|to replace efavirenz in long-term users with etravirine
5208232|NCT00792584|To investigate effect of such replacement on patient preference, sleep quality, daytime sleepiness, and anxiety|to investigate effect of such replacement on patient preference, sleep quality, daytime sleepiness, and anxiety
5208233|NCT00792519|alcohol use|alcohol use
5208234|NCT00792519|HIV|hiv
5208235|NCT00792519|cognitive behavioral treatment|cognitive behavioral treatment
5208236|NCT00792519|Kenya|kenya
5208237|NCT00792519|hazardous/binge drinking|hazardous/binge drinking
5208238|NCT00792519|alcohol abuse/dependence|alcohol abuse/dependence
5208239|NCT00792493|Healthy volunteer study|healthy volunteer study
5208240|NCT00792480|Obesity|obesity
5208241|NCT00792480|Pregnancy|pregnancy
5208242|NCT00792480|Exercise|exercise
5208243|NCT00792480|Nutrition|nutrition
5208244|NCT00792480|obesity in pregnancy|obesity in pregnancy
5208245|NCT00792454|Chronic kidney disease|chronic kidney disease
5208246|NCT00792454|End stage renal disease|end stage renal disease
5208247|NCT00792454|Exercise|exercise
5208248|NCT00792454|Cardiovascular disease|cardiovascular disease
5208249|NCT00792441|Specific inspiratory muscle training(SIMT)|specific inspiratory muscle training(simt)
5208250|NCT00792441|Loaded deep breathing|loaded deep breathing
5208251|NCT00792441|Weaning|weaning
5208252|NCT00792441|Mechanical ventilation|mechanical ventilation
5208253|NCT00792441|Respiratory muscle|respiratory muscle
5208254|NCT00792428|Stroke|stroke
5208255|NCT00792428|Ischemia|ischemia
5208256|NCT00792428|Infarction|infarction
5208257|NCT00792428|Cerebrovascular Disorder|cerebrovascular disorder
5208258|NCT00792428|Central Nervous System Diseases|central nervous system diseases
5208259|NCT00792428|Brain Infarction|brain infarction
5208260|NCT00792428|Brain Ischemia|brain ischemia
5208261|NCT00792428|Rehabilitation|rehabilitation
5208262|NCT00792428|Recovery|recovery
5208263|NCT00792428|Neurorehabilitation|neurorehabilitation
5208264|NCT00792428|Plasticity|plasticity
5208265|NCT00792415|Abstinence syndrome symptoms|abstinence syndrome symptoms
5208266|NCT00792415|Withdrawal symptoms|withdrawal symptoms
5208267|NCT00792415|Opioid dependence|opioid dependence
5208268|NCT00792402|chronic heart failure|chronic heart failure
5208269|NCT00792402|Computerized clinical guidelines|computerized clinical guidelines
5208270|NCT00792402|Primary care|primary care
5208271|NCT00792389|Gallstones|gallstones
5208272|NCT00792389|Gallbladder|gallbladder
5208273|NCT00792389|Cholecystectomy|cholecystectomy
5208274|NCT00792389|Gallstone disease|gallstone disease
5208275|NCT00792376|NSAID|nsaid
5208276|NCT00792376|tendon|tendon
5208277|NCT00792376|pain|pain
5208278|NCT00792376|stiffness|stiffness
5208279|NCT00792376|Achilles|achilles
5208280|NCT00792363|KRAS|kras
5208281|NCT00792350|Carcinoma, Hepatocellular|carcinoma, hepatocellular
5208282|NCT00792350|Sorafenib|sorafenib
5208283|NCT00792311|Tsui test|tsui test
5208284|NCT00792311|Epidural Analgesia|epidural analgesia
5208285|NCT00792285|Colon cancer|colon cancer
5208286|NCT00792285|Prevention|prevention
5208287|NCT00792285|Screening|screening
5208288|NCT00792285|Telephone|telephone
5208289|NCT00792272|aspirin resistance|aspirin resistance
5208290|NCT00792272|aspirin resistance in hemodialysis patients|aspirin resistance in hemodialysis patients
5208291|NCT00792246|pharmacokinetics|pharmacokinetics
5208292|NCT00792246|pediatric|pediatric
5208293|NCT00792246|bioavailability|bioavailability
5208294|NCT00792233|Poly JIA|poly jia
5208296|NCT00792233|Remission|remission
5208297|NCT00792220|stroke|stroke
5208298|NCT00792220|mobile stroke unit|mobile stroke unit
5208299|NCT00792220|thrombolysis|thrombolysis
5208300|NCT00792220|stroke management|stroke management
5208301|NCT00792220|computerized tomography|computerized tomography
5208302|NCT00792194|Cystic fibrosis|cystic fibrosis
5208303|NCT00792194|Exercise training|exercise training
5208304|NCT00792194|Home training|home training
5208305|NCT00792194|Aerobic capacity|aerobic capacity
5208306|NCT00792181|The focus is the pain reduce in the first 15 minutes for patients suffering an acute myocardial infarction, treated by caregivers in Ambulance service.|the focus is the pain reduce in the first 15 minutes for patients suffering an acute myocardial infarction, treated by caregivers in ambulance service.
5208307|NCT00792155|PKD|pkd
5208308|NCT00792142|neurotoxicity|neurotoxicity
5208309|NCT00792142|stage I multiple myeloma|stage i multiple myeloma
5208310|NCT00792142|stage II multiple myeloma|stage ii multiple myeloma
5208311|NCT00792142|stage III multiple myeloma|stage iii multiple myeloma
5208312|NCT00792129|MIS|mis
5208313|NCT00792129|Minimally invasive|minimally invasive
5208314|NCT00792129|Atavi|atavi
5208315|NCT00792129|Flex Posure|flex posure
5208316|NCT00792129|retractor|retractor
5208317|NCT00792129|Patients with chronic low back and/or leg pain who are candidates for elective lumbar interbody fusion through a posterior unilateral approach,|patients with chronic low back and/or leg pain who are candidates for elective lumbar interbody fusion through a posterior unilateral approach,
5208318|NCT00792129|for inclusion in the study.|for inclusion in the study.
5208319|NCT00792129|If the patient meets all of the eligibility criteria,|if the patient meets all of the eligibility criteria,
5208320|NCT00792129|they will be enrolled into the study and have either the MiLIF or open procedure depending on the surgeon they present to|they will be enrolled into the study and have either the milif or open procedure depending on the surgeon they present to
5208321|NCT00792129|(i.e., what group their surgeon agreed to participate in.)|(i.e., what group their surgeon agreed to participate in.)
5208322|NCT00792090|allergy|allergy
5208323|NCT00792090|cow's milk|cow's milk
5208324|NCT00792090|sensibilisation|sensibilisation
5208325|NCT00792090|fermented milk|fermented milk
5208326|NCT00792090|infant formula|infant formula
5208327|NCT00792077|Leukemia|leukemia
5208328|NCT00792077|Lenalidomide|lenalidomide
5208329|NCT00792077|Actigraph|actigraph
5208330|NCT00792077|Sleep Test Study|sleep test study
5208331|NCT00792077|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
5208332|NCT00792077|CC-5013|cc-5013
5208333|NCT00792077|Revlimid|revlimid
5208334|NCT00792064|quality of life|quality of life
5208335|NCT00792064|adverse effects|adverse effects
5208336|NCT00792051|influenza|influenza
5208337|NCT00792051|vaccination|vaccination
5208338|NCT00792051|children|children
5208339|NCT00792051|Influenza-like illness|influenza-like illness
5208340|NCT00792038|Psychological tests|psychological tests
5208341|NCT00792038|Magnetic Resonance Imaging|magnetic resonance imaging
5208342|NCT00792038|Cognitive therapy|cognitive therapy
5208343|NCT00792025|metastatic transitional cell cancer of the renal pelvis and ureter|metastatic transitional cell cancer of the renal pelvis and ureter
5208344|NCT00792025|recurrent transitional cell cancer of the renal pelvis and ureter|recurrent transitional cell cancer of the renal pelvis and ureter
5208345|NCT00792025|regional transitional cell cancer of the renal pelvis and ureter|regional transitional cell cancer of the renal pelvis and ureter
5208346|NCT00792025|stage III bladder cancer|stage iii bladder cancer
5208347|NCT00792025|stage IV bladder cancer|stage iv bladder cancer
5208348|NCT00792025|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
5208349|NCT00792025|recurrent bladder cancer|recurrent bladder cancer
5208350|NCT00792012|Glioblastoma Multiforme|glioblastoma multiforme
5208351|NCT00791999|Rheumatoid Arthritis|rheumatoid arthritis
5208352|NCT00791999|Certolizumab Pegol|certolizumab pegol
5208353|NCT00791999|Cimzia|cimzia
5208354|NCT00791986|Breathing exercise|breathing exercise
5208355|NCT00791986|blood pressure|blood pressure
5208356|NCT00791986|hypertension|hypertension
5208357|NCT00791960|Cesarean Section|cesarean section
5208358|NCT00791960|Dimenhydrinate|dimenhydrinate
5208359|NCT00791960|Gravol|gravol
5208360|NCT00791960|Antiemetics|antiemetics
5208361|NCT00791921|Rheumatoid Arthritis|rheumatoid arthritis
5208362|NCT00791921|Certolizumab Pegol|certolizumab pegol
5208363|NCT00791921|Cimzia|cimzia
5208364|NCT00791869|bupropion|bupropion
5208365|NCT00791869|smoking|smoking
5208366|NCT00791869|pharmacokinetics|pharmacokinetics
5208367|NCT00791869|Pharmacokinetics of bupropion|pharmacokinetics of bupropion
5208368|NCT00791843|CHF|chf
5208369|NCT00791830|Residual renal function|residual renal function
5208370|NCT00791830|Haemodialysis|haemodialysis
5208371|NCT00791830|Applanation tonometry|applanation tonometry
5208372|NCT00791830|Cardiac output|cardiac output
5208373|NCT00791830|Quality of life|quality of life
5208374|NCT00791830|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers
5208375|NCT00791817|pharmacokinetics study|pharmacokinetics study
5208376|NCT00791804|Pain|pain
5208377|NCT00791804|Post Op pain|post op pain
5208378|NCT00791804|Fentanyl|fentanyl
5208379|NCT00791804|Pain Control|pain control
5208380|NCT00791804|Surgery|surgery
5208381|NCT00791791|Anesthesia General|anesthesia general
5208382|NCT00791791|Anesthetics Inhalation|anesthetics inhalation
5208383|NCT00791791|Stress measurement|stress measurement
5208384|NCT00791791|Surgical Stress|surgical stress
5208385|NCT00791791|Diagnostic Techniques and Procedures|diagnostic techniques and procedures
5208386|NCT00791778|Peritoneal Neoplasma|peritoneal neoplasma
5208387|NCT00791765|Scalp|scalp
5208388|NCT00791765|Psoriasis|psoriasis
5208389|NCT00791765|Plaque Psoriasis|plaque psoriasis
5208390|NCT00791765|Skin Diseases|skin diseases
5208391|NCT00791765|Moderate to severe plaque psoriasis|moderate to severe plaque psoriasis
5208392|NCT00791765|etanercept|etanercept
5208393|NCT00791752|Safety and Tolerability|safety and tolerability
5208394|NCT00791739|fibromyalgia|fibromyalgia
5208395|NCT00791739|trazodone|trazodone
5208396|NCT00791739|pregabalin|pregabalin
5208397|NCT00791739|Fibromyalgia Impact Questionnaire (FIQ)|fibromyalgia impact questionnaire (fiq)
5208398|NCT00791739|Pittsburgh Sleep Quality Inventory (PSQI)|pittsburgh sleep quality inventory (psqi)
5208399|NCT00791739|Brief Pain Inventory (BPI)|brief pain inventory (bpi)
5208400|NCT00791726|microperimetry|microperimetry
5208401|NCT00791726|macular edema|macular edema
5208402|NCT00791726|uveitis|uveitis
5208403|NCT00791726|Retinal sensitivity as measured with fundus related microperimetry|retinal sensitivity as measured with fundus related microperimetry
5208404|NCT00791713|Paliperidone ER|paliperidone er
5208405|NCT00791713|Antipsychotic drugs|antipsychotic drugs
5208406|NCT00791713|Selective serotonin reuptake inhibitors|selective serotonin reuptake inhibitors
5208407|NCT00791713|Mood disorders|mood disorders
5208408|NCT00791713|Schizophrenia|schizophrenia
5208409|NCT00791700|Open label pharmacokinetic safety and efficacy in HIV-1 infected pediatrics|open label pharmacokinetic safety and efficacy in hiv-1 infected pediatrics
5208410|NCT00791687|Antioxidant enzymes|antioxidant enzymes
5208411|NCT00791687|Glutathione|glutathione
5208412|NCT00791687|Oxidative stress|oxidative stress
5208413|NCT00791687|Prematurity|prematurity
5208414|NCT00791687|Respiratory distress|respiratory distress
5208415|NCT00791687|Non enzymatic antioxidant defense system|non enzymatic antioxidant defense system
5208416|NCT00791687|Enzymatic antioxidant defense system|enzymatic antioxidant defense system
5208417|NCT00791674|Opiates|opiates
5208418|NCT00791674|sleep apnea|sleep apnea
5208419|NCT00791674|ventilatory failure|ventilatory failure
5208420|NCT00791648|aki|aki
5208421|NCT00791648|delirium|delirium
5208422|NCT00791648|statin|statin
5208423|NCT00791648|short-term|short-term
5208424|NCT00791648|cardiac|cardiac
5208425|NCT00791635|Cervical Cancer|cervical cancer
5208426|NCT00791635|Vaginal Cancer|vaginal cancer
5208427|NCT00791635|Endometrial Cancer|endometrial cancer
5208428|NCT00791635|Cervix|cervix
5208429|NCT00791635|Endometrial|endometrial
5208430|NCT00791635|Pelvic Exenteration|pelvic exenteration
5208431|NCT00791635|Pelvic Exenteration Surgery|pelvic exenteration surgery
5208432|NCT00791635|Questionnaire|questionnaire
5208433|NCT00791635|Gynecologic Cancer|gynecologic cancer
5208434|NCT00791635|Vagina|vagina
5208435|NCT00791635|Vulva|vulva
5208436|NCT00791635|Gynecologic Malignancy|gynecologic malignancy
5208437|NCT00791622|Paliperidone ER|paliperidone er
5208438|NCT00791622|Schizophernia|schizophernia
5208439|NCT00791622|Mood Disorders, Antipsychotic drugs|mood disorders, antipsychotic drugs
5208440|NCT00791622|Cardiovascular|cardiovascular
5208441|NCT00791622|Schizoaffective Disorder|schizoaffective disorder
5208442|NCT00791609|cancer|cancer
5208443|NCT00791596|Ergonomic intervention|ergonomic intervention
5208444|NCT00791596|Musculoskeletal disorders|musculoskeletal disorders
5208445|NCT00791596|Low back pain|low back pain
5208446|NCT00791596|Posture|posture
5208447|NCT00791596|Video display terminal|video display terminal
5208448|NCT00791583|Emergency Medicine (EM)|emergency medicine (em)
5208449|NCT00791583|Central Venous Catheter (CVC)|central venous catheter (cvc)
5208450|NCT00791583|Maximal Barrier Precaution (MBP)|maximal barrier precaution (mbp)
5208451|NCT00791583|Precaution Technique during Central Venous Cathether Placement|precaution technique during central venous cathether placement
5208452|NCT00791544|monoclonal antibody, anti IGF1R|monoclonal antibody, anti igf1r
5208453|NCT00791531|Methotrexate|methotrexate
5208454|NCT00791531|Malaria|malaria
5208455|NCT00791518|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
5208456|NCT00791518|Spirometry|spirometry
5208457|NCT00791505|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
5208458|NCT00791505|pulmonary infection|pulmonary infection
5208459|NCT00791505|antibiotic|antibiotic
5208460|NCT00791492|FAP|fap
5208461|NCT00791492|Familial Amyloid Polyneuropathy|familial amyloid polyneuropathy
5208462|NCT00791492|ATTR-PN|attr-pn
5208463|NCT00791492|transthyretin|transthyretin
5208464|NCT00791492|TTR|ttr
5208465|NCT00791492|amyloid|amyloid
5208466|NCT00791492|polyneuropathy|polyneuropathy
5208467|NCT00791492|familial|familial
5208468|NCT00791492|hereditary|hereditary
5208469|NCT00791492|amyloidosis|amyloidosis
5208470|NCT00791492|FoldRx|foldrx
5208471|NCT00791479|Diabetes, type 2 diabetes|diabetes, type 2 diabetes
5208472|NCT00791466|Iodine deficiency|iodine deficiency
5208473|NCT00791466|Pregnancy|pregnancy
5208474|NCT00791466|Thyroid function|thyroid function
5208475|NCT00791466|Infant development|infant development
5208476|NCT00791466|Growth|growth
5208477|NCT00791453|Diabetic patients at the Clarksdale Diabetes|diabetic patients at the clarksdale diabetes
5208478|NCT00791453|and Metabolism Clinic and must be between the|and metabolism clinic and must be between the
5208479|NCT00791453|ages of 18 and 64 years of age.|ages of 18 and 64 years of age.
5208480|NCT00791440|Schizophrenia|schizophrenia
5208481|NCT00791440|Schizoaffective|schizoaffective
5208482|NCT00791440|Schizophreniform|schizophreniform
5208483|NCT00791440|Psychosis|psychosis
5208484|NCT00791440|Psychotic|psychotic
5208485|NCT00791440|Hallucinations|hallucinations
5208486|NCT00791440|Delusions|delusions
5208487|NCT00791440|Paranoia|paranoia
5208488|NCT00791440|Paranoid|paranoid
5208489|NCT00791440|Voices|voices
5208490|NCT00791440|CBT|cbt
5208491|NCT00791440|Cognitive Behavior Therapy|cognitive behavior therapy
5208492|NCT00791440|Cognitive Therapy|cognitive therapy
5208493|NCT00791401|Schizophrenia|schizophrenia
5208494|NCT00791401|Mood disorders|mood disorders
5208495|NCT00791401|Antipsychotic drugs|antipsychotic drugs
5208496|NCT00791401|ER OROS Paliperidone|er oros paliperidone
5208497|NCT00791388|Pharmacokinetics|pharmacokinetics
5208498|NCT00791375|young adult|young adult
5208499|NCT00791375|cancer|cancer
5208500|NCT00791375|exercise|exercise
5208501|NCT00791375|physical activity|physical activity
5208502|NCT00791362|accreditation|accreditation
5208503|NCT00791362|cardiovascular disease|cardiovascular disease
5208504|NCT00791362|primary care|primary care
5208505|NCT00791349|Schizophrenia|schizophrenia
5208506|NCT00791349|Schizoaffective Disorder|schizoaffective disorder
5208507|NCT00791349|Mood Disorders|mood disorders
5208508|NCT00791349|Antipsychotic drugs|antipsychotic drugs
5208509|NCT00791349|Cardiovascular|cardiovascular
5208510|NCT00791349|Immediate release (IR) Paliperidone|immediate release (ir) paliperidone
5208511|NCT00791336|NSCLC|nsclc
5208512|NCT00791336|chemotherapy|chemotherapy
5208513|NCT00791336|radiation therapy|radiation therapy
5208514|NCT00791336|nelfinavir|nelfinavir
5208515|NCT00791336|NFV|nfv
5208516|NCT00791310|Medical ICU|medical icu
5208517|NCT00791310|Severe sepsis|severe sepsis
5208518|NCT00791297|CDB-2914|cdb-2914
5208519|NCT00791297|Contraceptive Vaginal Rings|contraceptive vaginal rings
5208520|NCT00791297|ovulation|ovulation
5208521|NCT00791297|endometrial changes|endometrial changes
5208522|NCT00791297|bleeding patterns|bleeding patterns
5208523|NCT00791297|normal cycling women|normal cycling women
5208524|NCT00791297|Inhibition of ovulation, endometrial changes and bleeding patterns in normal cycling women|inhibition of ovulation, endometrial changes and bleeding patterns in normal cycling women
5208525|NCT00791284|Schizophrenia|schizophrenia
5208526|NCT00791284|Mood disorders|mood disorders
5208527|NCT00791284|Antipsychotic drugs|antipsychotic drugs
5208528|NCT00791284|intermediate release (IR) Paliperidone|intermediate release (ir) paliperidone
5208529|NCT00791271|Melanoma|melanoma
5208530|NCT00791271|Malignant melanoma|malignant melanoma
5208531|NCT00791271|Unresectable|unresectable
5208532|NCT00791271|Decitabine|decitabine
5208533|NCT00791271|PEG Interferon Alpha-2b|peg interferon alpha-2b
5208534|NCT00791271|PEG Intron|peg intron
5208535|NCT00791271|5-Aza-Deoxycytidine|5-aza-deoxycytidine
5208536|NCT00791271|Dacogen|dacogen
5208537|NCT00791245|ISTO Technologies, Inc|isto technologies, inc
5208538|NCT00791245|cartilage repair|cartilage repair
5208539|NCT00791245|arthroscopy|arthroscopy
5208540|NCT00791245|361 HCT/P|361 hct/p
5208541|NCT00791245|human tissue|human tissue
5208542|NCT00791245|biologic|biologic
5208543|NCT00791245|knee|knee
5208544|NCT00791232|Extended-release paliperidone|extended-release paliperidone
5208545|NCT00791232|Schizophrenia, Mood disorders, Antipsychotic drugs|schizophrenia, mood disorders, antipsychotic drugs
5208546|NCT00791232|ER OROS paliperidone|er oros paliperidone
5208547|NCT00791219|Onychomycosis|onychomycosis
5208548|NCT00791206|exercise|exercise
5208549|NCT00791206|ischemia|ischemia
5208550|NCT00791206|MRI|mri
5208551|NCT00791206|MRI spectroscopy|mri spectroscopy
5208552|NCT00791206|Ischemia preconditioning|ischemia preconditioning
5208553|NCT00791193|Paliperidone ER|paliperidone er
5208554|NCT00791193|Antipsychotic drugs|antipsychotic drugs
5208555|NCT00791193|Schizophrenia|schizophrenia
5208556|NCT00791193|Mood disorders|mood disorders
5208557|NCT00791180|dynamic stabilization|dynamic stabilization
5208558|NCT00791180|Dynesys|dynesys
5208559|NCT00791180|fusion success|fusion success
5208560|NCT00791180|Immobilization of spinal segments as an adjunct to fusion in the treatment of the following:|immobilization of spinal segments as an adjunct to fusion in the treatment of the following:
5208561|NCT00791180|acute and chronic instabilities or deformities of the thoracic, lumbar, and sacral spine|acute and chronic instabilities or deformities of the thoracic, lumbar, and sacral spine
5208562|NCT00791180|degenerative spondylolisthesis with objective evidence of neurologic impairment|degenerative spondylolisthesis with objective evidence of neurologic impairment
5208563|NCT00791180|failed previous fusion (pseudarthrosis).|failed previous fusion (pseudarthrosis).
5208564|NCT00791167|Mood Disorders, Antipsychotic drugs|mood disorders, antipsychotic drugs
5208565|NCT00791167|Schizophrenia|schizophrenia
5208566|NCT00791167|Paliperidone ER|paliperidone er
5208567|NCT00791154|Extensive disease|extensive disease
5208568|NCT00791154|Extrathoracic metasasis|extrathoracic metasasis
5208569|NCT00791154|Malignant pericardial effusion|malignant pericardial effusion
5208570|NCT00791154|Malignant pleural effusion|malignant pleural effusion
5208571|NCT00791154|Contralateral hilar adenopathy|contralateral hilar adenopathy
5208572|NCT00791141|Head and Neck Cancer|head and neck cancer
5208573|NCT00791141|Radiation therapy|radiation therapy
5208574|NCT00791141|Chemotherapy|chemotherapy
5208575|NCT00791141|Chemoradiotherapy|chemoradiotherapy
5208576|NCT00791141|adjuvant cetuximab administration|adjuvant cetuximab administration
5208577|NCT00791128|Type 2 Diabetes|type 2 diabetes
5208578|NCT00791115|Prostate cancer|prostate cancer
5208579|NCT00791115|prostatectomy|prostatectomy
5208580|NCT00791115|radiotherapy|radiotherapy
5208581|NCT00791115|prostatectomy after radiotherapy|prostatectomy after radiotherapy
5208582|NCT00791089|Radiofrequency Ablation|radiofrequency ablation
5208583|NCT00791089|atrial fibrillation|atrial fibrillation
5208584|NCT00791076|Insulin pump therapy|insulin pump therapy
5208585|NCT00791076|Type 1 diabetic|type 1 diabetic
5208586|NCT00791076|Chronic pancreatitis|chronic pancreatitis
5208587|NCT00791076|Pancreatic resection|pancreatic resection
5208588|NCT00791076|Pancreatic polypeptide|pancreatic polypeptide
5208589|NCT00791063|cell death|cell death
5208590|NCT00791063|Apoptosis|apoptosis
5208591|NCT00791063|PET imaging|pet imaging
5208592|NCT00791063|brain metastases|brain metastases
5208593|NCT00791063|whole brain radiation therapy|whole brain radiation therapy
5208594|NCT00791050|Hypothermia/complications/etiology|hypothermia/complications/etiology
5208595|NCT00791050|coronary artery bypass/adverse effects|coronary artery bypass/adverse effects
5208596|NCT00791024|Analgesia Tests|analgesia tests
5208597|NCT00791024|Analog Pain Scale|analog pain scale
5208598|NCT00791024|Pain Measurement|pain measurement
5208599|NCT00791011|Lymphoma|lymphoma
5208600|NCT00791011|AMG 655|amg 655
5208601|NCT00791011|Trail receptor|trail receptor
5208602|NCT00791011|Apoptosis|apoptosis
5208603|NCT00791011|Vorinostat|vorinostat
5208604|NCT00791011|Bortezomib|bortezomib
5208605|NCT00791011|SAHA|saha
5208606|NCT00791011|Velcade|velcade
5208607|NCT00790998|onchocerciasis|onchocerciasis
5208608|NCT00790998|river blindness|river blindness
5208609|NCT00790998|onchocerca volvulus|onchocerca volvulus
5208610|NCT00790998|moxidectin|moxidectin
5208611|NCT00790998|ivermectin|ivermectin
5208612|NCT00790972|MRSA|mrsa
5208613|NCT00790972|sinofresh|sinofresh
5208614|NCT00790972|nasal spray|nasal spray
5208615|NCT00790959|Intimate Partner Violence|intimate partner violence
5208616|NCT00790959|HIV/AIDS|hiv/aids
5208617|NCT00790959|Gender|gender
5208618|NCT00790959|Prevention|prevention
5208619|NCT00790959|Community mobilisation|community mobilisation
5208620|NCT00790959|Uganda|uganda
5208621|NCT00790946|valsartan|valsartan
5208622|NCT00790946|Metabolic syndrome|metabolic syndrome
5208623|NCT00790933|Drug therapy|drug therapy
5208624|NCT00790920|Acute ischemic stroke|acute ischemic stroke
5208625|NCT00790920|Angiography|angiography
5208626|NCT00790920|Desmoteplase|desmoteplase
5208627|NCT00790920|Thrombolytic|thrombolytic
5208628|NCT00790907|Unstable angina|unstable angina
5208629|NCT00790907|Non ST elevation myocardial infarction|non st elevation myocardial infarction
5208630|NCT00790907|PCI|pci
5208631|NCT00790907|unfractionated heparin|unfractionated heparin
5208632|NCT00790907|fondaparinux|fondaparinux
5208633|NCT00790907|acute coronary syndrome|acute coronary syndrome
5208634|NCT00790881|malaria|malaria
5208635|NCT00790881|HIV|hiv
5208636|NCT00790881|AIDS|aids
5208637|NCT00790881|nevirapine|nevirapine
5208638|NCT00790881|lumefantrine|lumefantrine
5208639|NCT00790881|artemether|artemether
5208640|NCT00790881|drug interaction|drug interaction
5208641|NCT00790881|pharmacokinetics|pharmacokinetics
5208642|NCT00790868|Panic Disorder|panic disorder
5208643|NCT00790868|Anxiety|anxiety
5208644|NCT00790868|D-cycloserine|d-cycloserine
5208645|NCT00790868|DCS|dcs
5208646|NCT00790868|Cognitive Behavioral Therapy|cognitive behavioral therapy
5208647|NCT00790868|CBT|cbt
5208648|NCT00790855|Bendamustine|bendamustine
5208649|NCT00790855|Acute Leukemia|acute leukemia
5208650|NCT00790855|Leukemia|leukemia
5208651|NCT00790855|Acute myeloid leukemia|acute myeloid leukemia
5208652|NCT00790855|Myelodysplastic Syndrome|myelodysplastic syndrome
5208653|NCT00790855|Acute lymphoblastic leukemia|acute lymphoblastic leukemia
5208654|NCT00790855|Chronic myeloid leukemia|chronic myeloid leukemia
5208655|NCT00790855|MDS|mds
5208656|NCT00790855|ALL|all
5208657|NCT00790855|AML|aml
5208658|NCT00790855|CML|cml
5208659|NCT00790842|Refractory Multiple Myeloma|refractory multiple myeloma
5208660|NCT00790842|Relapsed Multiple Myeloma|relapsed multiple myeloma
5208661|NCT00790842|Multiple Myeloma with Renal Dysfunction|multiple myeloma with renal dysfunction
5208662|NCT00790842|Stage I Multiple Myeloma|stage i multiple myeloma
5208663|NCT00790842|Stage II Multiple Myeloma|stage ii multiple myeloma
5208664|NCT00790842|Stage III Multiple Myeloma|stage iii multiple myeloma
5208665|NCT00790829|preemptive|preemptive
5208666|NCT00790829|Nicotine Patch|nicotine patch
5208667|NCT00790829|Open Abdominal Surgery|open abdominal surgery
5208668|NCT00790816|Cancer|cancer
5208669|NCT00790816|lapatinib|lapatinib
5208670|NCT00790816|Combination therapy|combination therapy
5208671|NCT00790816|Chronic administration|chronic administration
5208672|NCT00790803|uveitis|uveitis
5208673|NCT00790803|cystoid macular edema|cystoid macular edema
5208674|NCT00790777|Paliperidone ER|paliperidone er
5208675|NCT00790777|Schizophrenia, Mood disorders, Antipsychotic drugs|schizophrenia, mood disorders, antipsychotic drugs
5208676|NCT00790751|ED|ed
5208677|NCT00790751|Erectile Dysfunction|erectile dysfunction
5208678|NCT00790751|Dysfunction|dysfunction
5208679|NCT00790751|Erectile|erectile
5208680|NCT00790738|bipolar disorder|bipolar disorder
5208681|NCT00790738|depression|depression
5208682|NCT00790738|treatment|treatment
5208683|NCT00790738|randomized controlled trial|randomized controlled trial
5208684|NCT00790699|diabetes|diabetes
5208685|NCT00790699|Symlin|symlin
5208686|NCT00790699|pramlintide acetate|pramlintide acetate
5208687|NCT00790699|insulin|insulin
5208688|NCT00790699|multiple injection port|multiple injection port
5208689|NCT00790699|I-PORT|i-port
5208690|NCT00790686|Ureteral obstruction|ureteral obstruction
5208691|NCT00790686|Urologic surgical procedure|urologic surgical procedure
5208692|NCT00790686|Stents|stents
5208693|NCT00790686|Endoscopy|endoscopy
5208694|NCT00790686|Urology|urology
5208695|NCT00790673|Hepatitis C|hepatitis c
5208696|NCT00790673|Viral hepatitis|viral hepatitis
5208697|NCT00790660|ASP1941|asp1941
5208698|NCT00790660|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
5208699|NCT00790647|primary systemic amyloidosis|primary systemic amyloidosis
5208700|NCT00790595|Prostatectomy|prostatectomy
5208701|NCT00790582|ALS|als
5208702|NCT00790582|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
5208703|NCT00790582|Lou Gehrig's Disease|lou gehrig's disease
5208704|NCT00790582|Lithium|lithium
5208705|NCT00790582|Lithium Carbonate|lithium carbonate
5208706|NCT00790569|bladder cancer|bladder cancer
5208707|NCT00790569|cervical cancer|cervical cancer
5208708|NCT00790569|esophageal cancer|esophageal cancer
5208709|NCT00790569|gastric cancer|gastric cancer
5208710|NCT00790569|renal cell carcinoma|renal cell carcinoma
5208711|NCT00790569|adult primary liver cancer|adult primary liver cancer
5208712|NCT00790569|non-small cell lung cancer|non-small cell lung cancer
5208713|NCT00790569|small cell lung cancer|small cell lung cancer
5208714|NCT00790569|pancreatic cancer|pancreatic cancer
5208715|NCT00790569|hypopharyngeal cancer|hypopharyngeal cancer
5208716|NCT00790569|laryngeal cancer|laryngeal cancer
5208717|NCT00790569|lip and oral cavity cancer|lip and oral cavity cancer
5208718|NCT00790569|nasopharyngeal cancer|nasopharyngeal cancer
5208719|NCT00790569|oropharyngeal cancer|oropharyngeal cancer
5208720|NCT00790569|paranasal sinus and nasal cavity cancer|paranasal sinus and nasal cavity cancer
5208721|NCT00790569|adult acute myeloid leukemia|adult acute myeloid leukemia
5208722|NCT00790569|tobacco use disorder|tobacco use disorder
5208723|NCT00790543|Crohn's Disease|crohn's disease
5208724|NCT00790543|Inflammatory Bowel Disease|inflammatory bowel disease
5208725|NCT00790530|Diabetes|diabetes
5208726|NCT00790530|Information Technology|information technology
5208727|NCT00790530|Health Plans|health plans
5208728|NCT00790517|Weight loss|weight loss
5208729|NCT00790517|Diabetes prevention|diabetes prevention
5208730|NCT00790517|Serious mental illness|serious mental illness
5208731|NCT00790517|Antipsychotic medications|antipsychotic medications
5208732|NCT00790517|Lifestyle intervention|lifestyle intervention
5208733|NCT00790517|Antipsychotic Agents|antipsychotic agents
5208734|NCT00790504|Pelvic floor|pelvic floor
5208735|NCT00790504|Transperineal ultrasound|transperineal ultrasound
5208736|NCT00790504|Multiple pregnancy|multiple pregnancy
5208737|NCT00790504|Singleton pregnancy|singleton pregnancy
5208738|NCT00790504|Female pelvic floor|female pelvic floor
5208739|NCT00790491|reduction in risk of heart disease and diabetes|reduction in risk of heart disease and diabetes
5208740|NCT00790478|Ulcerative Colitis|ulcerative colitis
5208741|NCT00790478|Melatonin|melatonin
5208742|NCT00790478|Gastrointestinal|gastrointestinal
5208743|NCT00790478|Irritable Bowel syndrome|irritable bowel syndrome
5208744|NCT00790478|Sleep|sleep
5208745|NCT00790478|Pilot Study|pilot study
5208746|NCT00790465|achalasia|achalasia
5208747|NCT00790465|lower esophageal sphincter|lower esophageal sphincter
5208748|NCT00790465|nitric oxide|nitric oxide
5208749|NCT00790465|dark chocolate|dark chocolate
5208750|NCT00790465|flavanols|flavanols
5208751|NCT00790452|Brain|brain
5208752|NCT00790452|Hematologic Disorder|hematologic disorder
5208753|NCT00790452|Venous Thromboembolism|venous thromboembolism
5208754|NCT00790452|Glioblastoma|glioblastoma
5208755|NCT00790452|Aspirin|aspirin
5208756|NCT00790452|Placebo|placebo
5208757|NCT00790452|VTE|vte
5208758|NCT00790452|ASA|asa
5208759|NCT00790452|DVT|dvt
5208760|NCT00790439|Insulin dependence|insulin dependence
5208761|NCT00790426|Advanced urothelial cancer|advanced urothelial cancer
5208762|NCT00790413|Radiotherapy|radiotherapy
5208763|NCT00790413|Immunotherapy|immunotherapy
5208764|NCT00790413|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
5208765|NCT00790400|Angiomyolipoma|angiomyolipoma
5208766|NCT00790400|AML|aml
5208767|NCT00790400|Tuberous Sclerosis Complex|tuberous sclerosis complex
5208768|NCT00790400|TSC|tsc
5208769|NCT00790400|mTOR|mtor
5208770|NCT00790400|RAD001|rad001
5208771|NCT00790400|Mammalian Target of Rapamycin|mammalian target of rapamycin
5208772|NCT00790400|Everolimus|everolimus
5208773|NCT00790400|Afinitor|afinitor
5208774|NCT00790400|SEGA|sega
5208775|NCT00790400|Subependymal Giant Cell Astrocytoma|subependymal giant cell astrocytoma
5208776|NCT00790400|Seizures|seizures
5208777|NCT00790400|Tuberous sclerosis complex (TSC)|tuberous sclerosis complex (tsc)
5208778|NCT00790400|Tuberous sclerosis|tuberous sclerosis
5208779|NCT00790400|benign tumors of brain|benign tumors of brain
5208780|NCT00790400|kidney|kidney
5208781|NCT00790400|heart|heart
5208782|NCT00790400|eyes|eyes
5208783|NCT00790400|lungs|lungs
5208784|NCT00790400|skinTSC1|skintsc1
5208785|NCT00790400|TSC2|tsc2
5208786|NCT00790400|hamaratin|hamaratin
5208787|NCT00790400|tuberin, tumor growth suppressors|tuberin, tumor growth suppressors
5208788|NCT00790400|gyri|gyri
5208789|NCT00790400|tubers|tubers
5208790|NCT00790400|Sporadic Lymphangioleiomyomatosis.|sporadic lymphangioleiomyomatosis.
5208791|NCT00790400|Lymphangioleiomyomatosis (LAM)|lymphangioleiomyomatosis (lam)
5208792|NCT00790400|rare lung disease|rare lung disease
5208793|NCT00790387|enoxaparin|enoxaparin
5208794|NCT00790387|tirofiban|tirofiban
5208795|NCT00790387|percutaneous intervention|percutaneous intervention
5208796|NCT00790387|platelet inhibition|platelet inhibition
5208797|NCT00790387|CD40L|cd40l
5208798|NCT00790387|Mac-1|mac-1
5208799|NCT00790387|prothrombin fragment 1+2.|prothrombin fragment 1+2.
5208800|NCT00790374|Pharmacodynamic profile and safety of BN83495|pharmacodynamic profile and safety of bn83495
5208801|NCT00790361|cervical spondylotic myelopathy|cervical spondylotic myelopathy
5208802|NCT00790361|spinal cord compression|spinal cord compression
5208803|NCT00790361|magnetic resonance spectroscopy|magnetic resonance spectroscopy
5208804|NCT00790361|functional magnetic resonance imaging|functional magnetic resonance imaging
5208805|NCT00790361|brain plasticity|brain plasticity
5208806|NCT00790335|deep vein thrombosis|deep vein thrombosis
5208807|NCT00790335|deep venous thrombosis|deep venous thrombosis
5208808|NCT00790335|post thrombotic syndrome|post thrombotic syndrome
5208809|NCT00790335|blood clot|blood clot
5208810|NCT00790335|thrombolysis|thrombolysis
5208811|NCT00790335|tissue plasminogen activator|tissue plasminogen activator
5208812|NCT00790335|rt-PA|rt-pa
5208813|NCT00790335|Activase|activase
5208814|NCT00790335|mechanical thrombectomy|mechanical thrombectomy
5208815|NCT00790335|pharmacomechanical|pharmacomechanical
5208816|NCT00790335|ATTRACT|attract
5208817|NCT00790322|Cancer|cancer
5208818|NCT00790322|Radiation therapy|radiation therapy
5208819|NCT00790322|Radiotherapy|radiotherapy
5208820|NCT00790322|Oral Mucositis|oral mucositis
5208821|NCT00790322|SBG|sbg
5208822|NCT00790309|Obesity|obesity
5208823|NCT00790309|Diabetes|diabetes
5208824|NCT00790309|Bariatric surgery|bariatric surgery
5208825|NCT00790296|cancer fatigue|cancer fatigue
5208826|NCT00790283|Treatment of de novo lesions in native coronary arteries|treatment of de novo lesions in native coronary arteries
5208827|NCT00790270|Cervical strain|cervical strain
5208828|NCT00790270|whiplash|whiplash
5208829|NCT00790270|ibuprofen|ibuprofen
5208830|NCT00790270|cyclobenzaprine|cyclobenzaprine
5208831|NCT00790257|Diabetes|diabetes
5208832|NCT00790257|Islets transplantation|islets transplantation
5208833|NCT00790257|Encapsulation|encapsulation
5208834|NCT00790244|Soft-tissue sarcomas|soft-tissue sarcomas
5208835|NCT00790244|prognostic factors|prognostic factors
5208836|NCT00790244|adjuvant|adjuvant
5208837|NCT00790244|chemotherapy|chemotherapy
5208838|NCT00790244|radiotherapy|radiotherapy
5208839|NCT00790244|metastases-free survival|metastases-free survival
5208840|NCT00790244|toxicity|toxicity
5208841|NCT00790244|High malignancy grade|high malignancy grade
5208842|NCT00790244|High-risk for metastases|high-risk for metastases
5208843|NCT00790244|Adult|adult
5208844|NCT00790231|urinary bladder|urinary bladder
5208845|NCT00790231|thoracic epidural analgesia|thoracic epidural analgesia
5208846|NCT00790231|urodynamics|urodynamics
5208847|NCT00790231|open kidney surgery with lumbotomy|open kidney surgery with lumbotomy
5208848|NCT00790218|Hepatocellular carcinoma|hepatocellular carcinoma
5208849|NCT00790218|Hepatoma|hepatoma
5208850|NCT00790218|HCC|hcc
5208851|NCT00790192|Schizophrenia|schizophrenia
5208852|NCT00790192|SM-13496|sm-13496
5208853|NCT00790192|Latuda|latuda
5208854|NCT00790192|Lurasidone|lurasidone
5208855|NCT00790179|Continuous lumbar plexus,Femoral,hydromorphone|continuous lumbar plexus,femoral,hydromorphone
5208856|NCT00790153|Type 2 diabetes, hormonal response|type 2 diabetes, hormonal response
5208857|NCT00790140|Esophageal Cancer|esophageal cancer
5208858|NCT00790140|esophagectomy|esophagectomy
5208859|NCT00790140|enteral feeding|enteral feeding
5208860|NCT00790140|body composition|body composition
5208861|NCT00790140|immunology|immunology
5208862|NCT00790114|Phase I|phase i
5208863|NCT00790088|Diabetes Mellitus, Type 1|diabetes mellitus, type 1
5208864|NCT00790088|continuous glucose monitoring|continuous glucose monitoring
5208865|NCT00790088|sensor-augmented pump therapy|sensor-augmented pump therapy
5208866|NCT00790075|agitation|agitation
5208867|NCT00790075|Episodes of agitation regardless of diagnosis|episodes of agitation regardless of diagnosis
5208868|NCT00790062|Uterine atony|uterine atony
5208869|NCT00790062|Postpartum hemorrhage|postpartum hemorrhage
5208870|NCT00790062|clinical trial|clinical trial
5208871|NCT00790062|Prophylactic oxytocin|prophylactic oxytocin
5208872|NCT00790036|Diffuse large B cell lymphoma|diffuse large b cell lymphoma
5208873|NCT00790036|DLBCL|dlbcl
5208874|NCT00790036|poor risk|poor risk
5208875|NCT00790036|R-IPI 3-5|r-ipi 3-5
5208876|NCT00790036|adjuvant therapy|adjuvant therapy
5208877|NCT00790036|after R-CHOP or R-EPOCH|after r-chop or r-epoch
5208878|NCT00790036|after R-CHOP|after r-chop
5208879|NCT00790036|B-cell lymphoma|b-cell lymphoma
5208880|NCT00790036|lymphoma|lymphoma
5208881|NCT00790036|b cells|b cells
5208882|NCT00790036|blood cancer|blood cancer
5208883|NCT00790036|lymph nodes|lymph nodes
5208884|NCT00790036|Hodgkin's|hodgkin's
5208885|NCT00790036|non-Hodgkin|non-hodgkin
5208886|NCT00790023|SAR|sar
5208887|NCT00790010|bevacizumab|bevacizumab
5208888|NCT00790010|ipilimumab|ipilimumab
5208889|NCT00790010|unresectable stage III melanoma|unresectable stage iii melanoma
5208890|NCT00790010|unresectable stage IV melanoma|unresectable stage iv melanoma
5208891|NCT00789997|COPD Exacerbation|copd exacerbation
5208892|NCT00789997|Etanercept|etanercept
5208893|NCT00789997|TNF alpha|tnf alpha
5208894|NCT00789997|Randomized|randomized
5208895|NCT00789984|Keratic precipitates|keratic precipitates
5208896|NCT00789971|orbital floor triamcinolone|orbital floor triamcinolone
5208897|NCT00789971|phacoemulsification|phacoemulsification
5208898|NCT00789971|post op inflammation|post op inflammation
5208899|NCT00789971|cmo|cmo
5208900|NCT00789958|cholangiocarcinoma of the extrahepatic bile duct|cholangiocarcinoma of the extrahepatic bile duct
5208901|NCT00789958|cholangiocarcinoma of the gallbladder|cholangiocarcinoma of the gallbladder
5208902|NCT00789958|localized extrahepatic bile duct cancer|localized extrahepatic bile duct cancer
5208903|NCT00789958|localized gallbladder cancer|localized gallbladder cancer
5208904|NCT00789958|unresectable extrahepatic bile duct cancer|unresectable extrahepatic bile duct cancer
5208905|NCT00789958|unresectable gallbladder cancer|unresectable gallbladder cancer
5208906|NCT00789958|metastatic extrahepatic bile duct cancer|metastatic extrahepatic bile duct cancer
5208907|NCT00789958|metastatic gallbladder cancer|metastatic gallbladder cancer
5208908|NCT00789945|type 1 diabetes|type 1 diabetes
5208909|NCT00789945|continuous glucose monitoring|continuous glucose monitoring
5208910|NCT00789945|Intensive Insulin therapy|intensive insulin therapy
5208911|NCT00789919|Mild Preeclampsia|mild preeclampsia
5208912|NCT00789906|Computerized Neuropsychological Assessment|computerized neuropsychological assessment
5208913|NCT00789906|Development of Population Norms of the Computerized Neuropsychological Assessment|development of population norms of the computerized neuropsychological assessment
5208914|NCT00789893|external beam pelvic radiation|external beam pelvic radiation
5208915|NCT00789893|brachytherapy|brachytherapy
5208916|NCT00789880|Vitamin D3|vitamin d3
5208917|NCT00789880|Atopic Dermatitis|atopic dermatitis
5208918|NCT00789880|Antimicrobial Peptide Expression|antimicrobial peptide expression
5208919|NCT00789867|Single dose|single dose
5208920|NCT00789867|Pilot|pilot
5208921|NCT00789867|Safety|safety
5208922|NCT00789867|Gene expression|gene expression
5208923|NCT00789867|Tolerability|tolerability
5208924|NCT00789867|CFTR gene|cftr gene
5208925|NCT00789867|Cystic fibrosis|cystic fibrosis
5208926|NCT00789867|Non-viral|non-viral
5208927|NCT00789854|Depression|depression
5208928|NCT00789854|MDD|mdd
5208929|NCT00789854|TRD|trd
5208930|NCT00789841|Neuroendocrine tumor|neuroendocrine tumor
5208931|NCT00789841|Carcinoid syndrome|carcinoid syndrome
5208932|NCT00789841|Motility|motility
5208933|NCT00789841|Transit time|transit time
5208934|NCT00789828|SEGA|sega
5208935|NCT00789828|Tuberous Sclerosis|tuberous sclerosis
5208936|NCT00789828|Subependymal Giant Cell Astrocytoma|subependymal giant cell astrocytoma
5208937|NCT00789828|mTOR|mtor
5208938|NCT00789828|RAD001|rad001
5208939|NCT00789828|Mamalian Target Rapamycin|mamalian target rapamycin
5208940|NCT00789828|Everolimus|everolimus
5208941|NCT00789828|TSC|tsc
5208942|NCT00789815|flexible bronchoscopy|flexible bronchoscopy
5208943|NCT00789815|sedation|sedation
5208944|NCT00789815|bispectral index|bispectral index
5208945|NCT00789802|contraception|contraception
5208946|NCT00789802|progestin contraception|progestin contraception
5208947|NCT00789802|intrauterine contraception|intrauterine contraception
5208948|NCT00789802|unscheduled bleeding|unscheduled bleeding
5208949|NCT00789802|placebo|placebo
5208950|NCT00789789|Cohort|cohort
5208951|NCT00789789|HIV uninfected volunteers|hiv uninfected volunteers
5208952|NCT00789789|HIV preventive vaccine|hiv preventive vaccine
5208953|NCT00789789|Long term safety|long term safety
5208954|NCT00789763|pancreatic cancer|pancreatic cancer
5208955|NCT00789763|Pancreatic cancer locally advanced|pancreatic cancer locally advanced
5208956|NCT00789724|acute myocardial infarction|acute myocardial infarction
5208957|NCT00789698|Schizophrenia|schizophrenia
5208958|NCT00789698|SM-13496|sm-13496
5208959|NCT00789698|Latuda|latuda
5208960|NCT00789698|Lurasidone|lurasidone
5208961|NCT00789685|Open label|open label
5208962|NCT00789672|Amblyopia|amblyopia
5208963|NCT00789672|Patching|patching
5208964|NCT00789672|Levodopa|levodopa
5208965|NCT00789659|Fracture fixation, internal|fracture fixation, internal
5208966|NCT00789659|Obesity|obesity
5208967|NCT00789659|Pelvis|pelvis
5208968|NCT00789659|Negative pressure wound therapy|negative pressure wound therapy
5208969|NCT00789659|Vacuum-assisted closure|vacuum-assisted closure
5208970|NCT00789646|corneal ulcer|corneal ulcer
5208971|NCT00789646|painless|painless
5208972|NCT00789646|subconjunctival injection|subconjunctival injection
5208973|NCT00789646|antibiotics|antibiotics
5208974|NCT00789646|antifungal|antifungal
5208975|NCT00789646|lidocaine|lidocaine
5208976|NCT00789633|Pancreatic cancer|pancreatic cancer
5208977|NCT00789633|Advanced pancreatic cancer|advanced pancreatic cancer
5208978|NCT00789633|Metastatic pancreatic cancer|metastatic pancreatic cancer
5208979|NCT00789633|Gemcitabine|gemcitabine
5208980|NCT00789633|Chemo-naive|chemo-naive
5208981|NCT00789620|intravenous lidocaine|intravenous lidocaine
5208982|NCT00789620|laparoscopic urological surgery|laparoscopic urological surgery
5208983|NCT00789620|hospital stay|hospital stay
5208984|NCT00789620|pain|pain
5208985|NCT00789620|fatigue|fatigue
5208986|NCT00789620|length of stay|length of stay
5208987|NCT00789607|prostate cancer|prostate cancer
5208988|NCT00789607|individualized radiotherapy|individualized radiotherapy
5208989|NCT00789607|fiducial markers|fiducial markers
5208990|NCT00789607|MRI|mri
5208991|NCT00789607|ultrasound|ultrasound
5208992|NCT00789607|High-Risk Localized Prostate Cancer|high-risk localized prostate cancer
5208993|NCT00789594|Monitoring|monitoring
5208994|NCT00789594|Testing|testing
5208995|NCT00789594|Medications|medications
5208996|NCT00789594|Patients receiving medications and having laboratory tests|patients receiving medications and having laboratory tests
5208997|NCT00789581|Breast Cancer|breast cancer
5208998|NCT00789581|Adjuvant|adjuvant
5208999|NCT00789581|Doxorubicin|doxorubicin
5209000|NCT00789581|Cyclophosphamide|cyclophosphamide
5209001|NCT00789581|Paclitaxel|paclitaxel
5209002|NCT00789581|Ixabepilone|ixabepilone
5209003|NCT00789581|TITAN|titan
5209004|NCT00789568|Hyperphenylalanemia due to Phenylketonuria|hyperphenylalanemia due to phenylketonuria
5209005|NCT00789555|nasal allergy|nasal allergy
5209006|NCT00789555|nasal spray|nasal spray
5209007|NCT00789555|seasonal allergy|seasonal allergy
5209008|NCT00789555|perennial allergy|perennial allergy
5209009|NCT00789542|stroke|stroke
5209209|NCT00788762|myocilin|myocilin
5209010|NCT00789542|deep vein thrombosis|deep vein thrombosis
5209011|NCT00789542|doppler|doppler
5209012|NCT00789529|Contact lenses, wettability, Contact Lens Disinfectant Solutions, pre-lens tear film|contact lenses, wettability, contact lens disinfectant solutions, pre-lens tear film
5209013|NCT00789516|Coagulation markers, thalassemia disease post SCT|coagulation markers, thalassemia disease post sct
5209014|NCT00789503|dietary fortification|dietary fortification
5209015|NCT00789503|Vitamin D3|vitamin d3
5209016|NCT00789503|Osteomalacia|osteomalacia
5209017|NCT00789503|bread|bread
5209018|NCT00789503|bone mineral density|bone mineral density
5209019|NCT00789503|geriatrics|geriatrics
5209020|NCT00789503|cholecalciferol|cholecalciferol
5209021|NCT00789503|calcidiol|calcidiol
5209022|NCT00789503|osteoporosis|osteoporosis
5209023|NCT00789503|dual-energy photon absorptiometry|dual-energy photon absorptiometry
5209024|NCT00789503|bread fortification|bread fortification
5209025|NCT00789490|pregnancy|pregnancy
5209026|NCT00789490|relative bioavailability|relative bioavailability
5209027|NCT00789490|iron|iron
5209028|NCT00789490|folic acid|folic acid
5209029|NCT00789490|ferric pyrophosphate|ferric pyrophosphate
5209030|NCT00789490|Study focus is to compare the relative bioavailability of SuppleFem Sprinkles to the current tradtional tablet Materna in pregnant women|study focus is to compare the relative bioavailability of supplefem sprinkles to the current tradtional tablet materna in pregnant women
5209031|NCT00789464|Urinary Tract Infection|urinary tract infection
5209032|NCT00789464|Probiotics|probiotics
5209033|NCT00789464|Dietary Supplements|dietary supplements
5209034|NCT00789464|Bacteriuria|bacteriuria
5209035|NCT00789451|Ischaemia reperfusion|ischaemia reperfusion
5209036|NCT00789451|t-PA|t-pa
5209037|NCT00789451|Fibrinolysis|fibrinolysis
5209038|NCT00789451|Endothelial function|endothelial function
5209039|NCT00789438|Analgesia|analgesia
5209040|NCT00789438|Sedation|sedation
5209041|NCT00789438|Spinal|spinal
5209042|NCT00789438|Stress|stress
5209043|NCT00789438|Surgical|surgical
5209044|NCT00789438|Surgical Stress|surgical stress
5209045|NCT00789438|Pain|pain
5209046|NCT00789425|osteoporosis|osteoporosis
5209047|NCT00789425|osteopenia|osteopenia
5209048|NCT00789425|olive extract|olive extract
5209049|NCT00789425|oleuropein|oleuropein
5209050|NCT00789412|Analgesia|analgesia
5209051|NCT00789412|Sedation|sedation
5209052|NCT00789412|Critical Illness|critical illness
5209053|NCT00789412|Intensive Care|intensive care
5209054|NCT00789399|deep vein thrombosis|deep vein thrombosis
5209055|NCT00789399|coronary artery bypass surgery|coronary artery bypass surgery
5209056|NCT00789399|Venous thromboembolism|venous thromboembolism
5209057|NCT00789386|Capsaicin|capsaicin
5209058|NCT00789386|Remifentanil|remifentanil
5209059|NCT00789386|Hyperalgesia|hyperalgesia
5209060|NCT00789360|Healthy volunteers|healthy volunteers
5209061|NCT00789347|Neuropathic pain|neuropathic pain
5209062|NCT00789347|Cortical excitability|cortical excitability
5209063|NCT00789347|Transcranial magnetic stimulation|transcranial magnetic stimulation
5209064|NCT00789347|Contact Heat evoked potential|contact heat evoked potential
5209065|NCT00789347|peripheral nerve stimulation|peripheral nerve stimulation
5209066|NCT00789347|neurotrophic factors|neurotrophic factors
5209067|NCT00789308|Insulin dependence|insulin dependence
5209068|NCT00789295|Mediterranean diet|mediterranean diet
5209069|NCT00789295|Postprandial lipids|postprandial lipids
5209070|NCT00789295|Postprandial glucose|postprandial glucose
5209071|NCT00789295|High fibre diet|high fibre diet
5209072|NCT00789295|Low- CHO diet|low- cho diet
5209073|NCT00789295|High MUFA diet|high mufa diet
5209074|NCT00789295|Dietary approach|dietary approach
5209075|NCT00789282|chronic disease|chronic disease
5209076|NCT00789282|Family Physician|family physician
5209077|NCT00789282|primary care network|primary care network
5209078|NCT00789282|practice-based model|practice-based model
5209079|NCT00789282|type 2 diabetes|type 2 diabetes
5209080|NCT00789282|complications|complications
5209081|NCT00789282|sequelae|sequelae
5209082|NCT00789269|lung infection after ischemic Stroke|lung infection after ischemic stroke
5209083|NCT00789269|prevention of pneumonia|prevention of pneumonia
5209084|NCT00789269|rhubarb|rhubarb
5209085|NCT00789256|Acute Myelogenous Leukemia|acute myelogenous leukemia
5209086|NCT00789256|AML|aml
5209087|NCT00789256|Myelodysplastic Syndromes|myelodysplastic syndromes
5209088|NCT00789256|MDS|mds
5209089|NCT00789256|Melphalan|melphalan
5209090|NCT00789256|Bortezomib|bortezomib
5209091|NCT00789256|Velcade|velcade
5209092|NCT00789243|Ischaemia reperfusion|ischaemia reperfusion
5209093|NCT00789243|t-PA|t-pa
5209094|NCT00789243|Fibrinolysis|fibrinolysis
5209095|NCT00789243|Endothelial function|endothelial function
5209096|NCT00789243|Local and remote ischaemic preconditioning|local and remote ischaemic preconditioning
5209097|NCT00789230|umbilical|umbilical
5209098|NCT00789230|hernia|hernia
5209099|NCT00789230|mesh|mesh
5209100|NCT00789217|Penicillin|penicillin
5209101|NCT00789217|Beta-Lactams|beta-lactams
5209102|NCT00789217|Allergy|allergy
5209103|NCT00789217|Hypersensitivity|hypersensitivity
5209104|NCT00789204|exercise|exercise
5209105|NCT00789204|low back pain|low back pain
5209106|NCT00789204|posture|posture
5209107|NCT00789204|rehabilitation|rehabilitation
5209108|NCT00789178|memory disturbances|memory disturbances
5209109|NCT00789165|Brugada syndrome|brugada syndrome
5209110|NCT00789165|quinidine|quinidine
5209111|NCT00789165|Asymptomatic Brugada Syndrome|asymptomatic brugada syndrome
5209112|NCT00789113|lamotrigine|lamotrigine
5209113|NCT00789113|epilepsy|epilepsy
5209114|NCT00789113|metabolism|metabolism
5209115|NCT00789113|bipolar disorder|bipolar disorder
5209116|NCT00789113|bipolar depression|bipolar depression
5209117|NCT00789113|glucuronidation|glucuronidation
5209118|NCT00789100|telehealth|telehealth
5209119|NCT00789100|telemonitor|telemonitor
5209120|NCT00789100|telemedicine|telemedicine
5209121|NCT00789100|Co-morbidities|co-morbidities
5209122|NCT00789087|Pleural Effusion.|pleural effusion.
5209123|NCT00789087|Talc.|talc.
5209124|NCT00789087|Pleurodesis.|pleurodesis.
5209125|NCT00789087|Quality of Life.|quality of life.
5209126|NCT00789087|Thoracoscopy.|thoracoscopy.
5209127|NCT00789074|Smoking cessation|smoking cessation
5209128|NCT00789074|Tobacco dependence|tobacco dependence
5209129|NCT00789074|Varenicline|varenicline
5209130|NCT00789074|Preloading|preloading
5209131|NCT00789061|Acute hearing loss in patients with SLC26A4 mutations|acute hearing loss in patients with slc26a4 mutations
5209132|NCT00789048|hip|hip
5209133|NCT00789048|arthroplasty|arthroplasty
5209134|NCT00789048|radiograph|radiograph
5209135|NCT00789022|First-Psychotic-Episode (FPE)|first-psychotic-episode (fpe)
5209136|NCT00789022|Glutamatergic system|glutamatergic system
5209137|NCT00789022|Glycine|glycine
5209138|NCT00789022|D-Serine|d-serine
5209139|NCT00789022|Oxytocin|oxytocin
5209140|NCT00789022|Estrogen|estrogen
5209141|NCT00789009|HIV|hiv
5209142|NCT00789009|Natural History|natural history
5209143|NCT00789009|Stored Sample|stored sample
5209144|NCT00789009|AIDS|aids
5209145|NCT00788996|Tobacco Smoke Pollution/prevention and control|tobacco smoke pollution/prevention and control
5209146|NCT00788996|Parent-Child Relations|parent-child relations
5209147|NCT00788996|Environmental Tobacco Smoke (ETS)|environmental tobacco smoke (ets)
5209148|NCT00788983|Induced hypoxia|induced hypoxia
5209149|NCT00788983|Pulse oximeter|pulse oximeter
5209150|NCT00788983|Nonin Medical|nonin medical
5209151|NCT00788983|Verification of SpO2 accuracy|verification of spo2 accuracy
5209152|NCT00788970|Acupressure|acupressure
5209153|NCT00788970|Shiatsu|shiatsu
5209154|NCT00788970|Schizophrenia|schizophrenia
5209155|NCT00788957|panitumumab|panitumumab
5209156|NCT00788957|vectibix|vectibix
5209158|NCT00788957|AMG 479|amg 479
5209159|NCT00788957|colon cancer|colon cancer
5209160|NCT00788957|rectal cancer|rectal cancer
5209161|NCT00788957|colorectal cancer|colorectal cancer
5209162|NCT00788957|metastatic colorectal cancer|metastatic colorectal cancer
5209163|NCT00788957|EGFR inhibitor|egfr inhibitor
5209164|NCT00788957|IGF inhibitor|igf inhibitor
5209165|NCT00788957|c-MET inhibitor|c-met inhibitor
5209166|NCT00788931|Breast Cancer|breast cancer
5209167|NCT00788931|HER2 positive|her2 positive
5209168|NCT00788931|adult-female|adult-female
5209169|NCT00788931|LBH589|lbh589
5209170|NCT00788931|HDAC inhibitor|hdac inhibitor
5209171|NCT00788931|panobinostat|panobinostat
5209172|NCT00788931|metastatic breast|metastatic breast
5209173|NCT00788931|adult female patients|adult female patients
5209174|NCT00788918|Chronic Hepatitis C|chronic hepatitis c
5209175|NCT00788918|cognitive dysfunction|cognitive dysfunction
5209176|NCT00788918|MRI|mri
5209177|NCT00788918|MR spectroscopy|mr spectroscopy
5209178|NCT00788918|interferon|interferon
5209179|NCT00788918|ribavirin|ribavirin
5209180|NCT00788918|sustained virologic response, major depressive disorder|sustained virologic response, major depressive disorder
5209181|NCT00788905|Hemodialysis|hemodialysis
5209182|NCT00788892|Acute|acute
5209183|NCT00788892|Myeloid|myeloid
5209184|NCT00788892|Leukemia|leukemia
5209185|NCT00788892|elderly|elderly
5209186|NCT00788892|Newly|newly
5209187|NCT00788892|Diagnosed|diagnosed
5209188|NCT00788879|Behavioral Journalism|behavioral journalism
5209189|NCT00788879|Mexican-Americans|mexican-americans
5209190|NCT00788879|Obesity|obesity
5209191|NCT00788879|Nutrition|nutrition
5209192|NCT00788879|Physical Activity|physical activity
5209193|NCT00788879|Border Health|border health
5209194|NCT00788866|Neuroprotection|neuroprotection
5209195|NCT00788866|Antioxidants|antioxidants
5209196|NCT00788866|Neonatal brain injury|neonatal brain injury
5209197|NCT00788866|Pomegranate juice|pomegranate juice
5209198|NCT00788853|DiabCare Asia 2008, Cross-sectional survey, Glycemic control, Psychosocial well-being, Diabetic complications, Quality of life.|diabcare asia 2008, cross-sectional survey, glycemic control, psychosocial well-being, diabetic complications, quality of life.
5209199|NCT00788827|diabetes type I|diabetes type i
5209200|NCT00788827|diabetes type 2|diabetes type 2
5209201|NCT00788827|renal transplant|renal transplant
5209202|NCT00788827|stem cells|stem cells
5209203|NCT00788827|successful renal transplant|successful renal transplant
5209204|NCT00788788|Airway obstruction|airway obstruction
5209205|NCT00788788|Heliox|heliox
5209206|NCT00788788|Different Helium content|different helium content
5209207|NCT00788775|nilotinib|nilotinib
5209208|NCT00788762|glaucoma|glaucoma
5209210|NCT00788749|chronic rhinosinusitis|chronic rhinosinusitis
5209211|NCT00788749|nasal polyps|nasal polyps
5209212|NCT00788749|oral steroid|oral steroid
5209213|NCT00788749|intranasal steroid|intranasal steroid
5209214|NCT00788749|medical polypectomy|medical polypectomy
5209215|NCT00788736|venous thromboembolism|venous thromboembolism
5209216|NCT00788736|long-term oral anticoagulant therapy|long-term oral anticoagulant therapy
5209217|NCT00788736|warfarin|warfarin
5209218|NCT00788736|bleeding risk|bleeding risk
5209219|NCT00788736|clinical prediction rule|clinical prediction rule
5209220|NCT00788736|predictors|predictors
5209221|NCT00788736|deep vein thrombosis|deep vein thrombosis
5209222|NCT00788736|pulmonary embolism|pulmonary embolism
5209223|NCT00788736|vitamin k antagonist|vitamin k antagonist
5209224|NCT00788736|side effect|side effect
5209225|NCT00788723|Severe Brain Injury|severe brain injury
5209226|NCT00788723|Excitability|excitability
5209227|NCT00788723|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
5209228|NCT00788684|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
5209229|NCT00788684|Rituximab|rituximab
5209230|NCT00788684|Chronic Lymphoid Leukemia|chronic lymphoid leukemia
5209231|NCT00788684|Hematological Malignancies|hematological malignancies
5209232|NCT00788684|ABT-263|abt-263
5209233|NCT00788684|Navitoclax|navitoclax
5209234|NCT00788684|CD20-Positive Lymphoid Malignancies|cd20-positive lymphoid malignancies
5209235|NCT00788671|Endometrioid Endometrial Carcinoma|endometrioid endometrial carcinoma
5209236|NCT00788671|Complex Atypical Hyperplasia|complex atypical hyperplasia
5209237|NCT00788671|Levonorgestrel Intrauterine Device|levonorgestrel intrauterine device
5209238|NCT00788671|Endometrial Biopsy|endometrial biopsy
5209239|NCT00788671|Endometrium|endometrium
5209240|NCT00788671|Hyperplasia of lining of the uterus (womb)|hyperplasia of lining of the uterus (womb)
5209241|NCT00788671|Questionnaires|questionnaires
5209242|NCT00788671|Progesterone|progesterone
5209243|NCT00788671|Estrogen|estrogen
5209244|NCT00788671|Postmenopausal|postmenopausal
5209245|NCT00788671|Endometrial|endometrial
5209246|NCT00788671|Mirena|mirena
5209247|NCT00788671|Intrauterine Device|intrauterine device
5209248|NCT00788671|Birth control|birth control
5209249|NCT00788671|IUD|iud
5209250|NCT00788671|LIUD|liud
5209251|NCT00788671|CAH|cah
5209252|NCT00788671|G1EEC|g1eec
5209253|NCT00788671|Grade 1 endometrial cancer|grade 1 endometrial cancer
5209254|NCT00788671|Early endometrial cancer|early endometrial cancer
5209255|NCT00788658|Obstructed constipation|obstructed constipation
5209256|NCT00788658|Quality of life|quality of life
5209257|NCT00788645|Smoking|smoking
5209258|NCT00788645|COPD|copd
5209259|NCT00788645|Chronic Obstructive Lung Disease|chronic obstructive lung disease
5209260|NCT00788645|COPD Exacerbations|copd exacerbations
5209261|NCT00788645|Viruses and Bacteria associated with COPD exacerbations|viruses and bacteria associated with copd exacerbations
5209262|NCT00788632|Osteoporosis|osteoporosis
5209263|NCT00788632|BMD|bmd
5209264|NCT00788632|Bisphosphonates|bisphosphonates
5209265|NCT00788632|Educational materials|educational materials
5209266|NCT00788632|Patient Stories|patient stories
5209267|NCT00788619|Infertility|infertility
5209268|NCT00788619|Assisted reproductive technology|assisted reproductive technology
5209269|NCT00788619|Nitric oxide|nitric oxide
5209270|NCT00788606|diffused large B cell lymphoma, DLBCL, R-Chop, bevacizumab|diffused large b cell lymphoma, dlbcl, r-chop, bevacizumab
5209271|NCT00788606|Diffuse large B-cell non-Hodgkin's lymphoma.|diffuse large b-cell non-hodgkin's lymphoma.
5209272|NCT00788593|Chronic Pancreatitis|chronic pancreatitis
5209273|NCT00788593|Exocrine Pancreatic Insufficiency|exocrine pancreatic insufficiency
5209274|NCT00788580|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5209275|NCT00788554|groin|groin
5209276|NCT00788554|inguinal|inguinal
5209277|NCT00788554|hernia|hernia
5209278|NCT00788554|lichtenstein|lichtenstein
5209279|NCT00788554|TEP|tep
5209280|NCT00788541|Open-Angle Glaucoma|open-angle glaucoma
5209281|NCT00788541|Intraocular Pressure|intraocular pressure
5209282|NCT00788541|Anecortave Acetate|anecortave acetate
5209283|NCT00788528|Obesity|obesity
5209284|NCT00788515|insomnia|insomnia
5209285|NCT00788515|sleep maintenance|sleep maintenance
5209286|NCT00788489|breast cancer|breast cancer
5209287|NCT00788489|FDG-PET|fdg-pet
5209288|NCT00788489|MRI|mri
5209289|NCT00788489|chemotherapy|chemotherapy
5209290|NCT00788489|ultrasonography|ultrasonography
5209291|NCT00788476|Needs Assessment Survey|needs assessment survey
5209292|NCT00788476|Childhood Cancer Survivors|childhood cancer survivors
5209293|NCT00788476|Parents|parents
5209294|NCT00788476|Primary Caregiver|primary caregiver
5209295|NCT00788476|Survey|survey
5209296|NCT00788463|administration, intranasal|administration, intranasal
5209297|NCT00788463|aerosol|aerosol
5209298|NCT00788463|beclomethasone|beclomethasone
5209299|NCT00788463|QVAR|qvar
5209300|NCT00788463|corticosteroids|corticosteroids
5209301|NCT00788463|nasal polyps|nasal polyps
5209302|NCT00788463|rhinomanometry|rhinomanometry
5209303|NCT00788463|Rhinitis Quality of Life Questionnaire|rhinitis quality of life questionnaire
5209304|NCT00788463|Quality of Life|quality of life
5209305|NCT00788424|AS101 Psoriasis|as101 psoriasis
5209306|NCT00788385|Hydrocephalus|hydrocephalus
5209307|NCT00788385|High Pressure|high pressure
5209308|NCT00788385|Shunt Blockage|shunt blockage
5209309|NCT00788372|Chronic pain|chronic pain
5209310|NCT00788372|Fentanyl Patch|fentanyl patch
5209311|NCT00788359|cystic fibrosis|cystic fibrosis
5209312|NCT00788359|pulmonary exacerbation|pulmonary exacerbation
5209313|NCT00788359|biomarkers|biomarkers
5209314|NCT00788346|Heavily marketed medications|heavily marketed medications
5209315|NCT00788346|Prescribing|prescribing
5209316|NCT00788346|Health information technology|health information technology
5209317|NCT00788346|Education|education
5209318|NCT00788333|Advanced or Metastatic Her-2-positive Breast Cancer|advanced or metastatic her-2-positive breast cancer
5209319|NCT00788320|Tuberculosis|tuberculosis
5209320|NCT00788320|vitamin D|vitamin d
5209321|NCT00788320|immune system|immune system
5209322|NCT00788307|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5209323|NCT00788307|recurrent prostate cancer|recurrent prostate cancer
5209324|NCT00788307|stage I prostate cancer|stage i prostate cancer
5209325|NCT00788307|stage II prostate cancer|stage ii prostate cancer
5209326|NCT00788294|Pharmacokinetics tanezumab subcutaneous bioavailability intravenous Japanese subjects|pharmacokinetics tanezumab subcutaneous bioavailability intravenous japanese subjects
5209327|NCT00788242|Cardiac surgery|cardiac surgery
5209328|NCT00788242|Cardioprotection|cardioprotection
5209329|NCT00788242|Aortocoronary bypass graft|aortocoronary bypass graft
5209330|NCT00788242|Aortic stenosis|aortic stenosis
5209331|NCT00788229|Dry Eye Syndromes|dry eye syndromes
5209332|NCT00788229|Keratoconjunctivitis Sicca|keratoconjunctivitis sicca
5209333|NCT00788229|artificial tears|artificial tears
5209334|NCT00788229|carboxymethylcellulose sodium|carboxymethylcellulose sodium
5209335|NCT00788229|sodium hyaluronate|sodium hyaluronate
5209336|NCT00788216|Radical hysterectomy|radical hysterectomy
5209337|NCT00788216|Whole pelvic radiation|whole pelvic radiation
5209338|NCT00788216|Brachytherapy|brachytherapy
5209339|NCT00788216|Chemoradiation|chemoradiation
5209340|NCT00788216|Complications|complications
5209341|NCT00788216|Quality of Life|quality of life
5209342|NCT00788190|Distal Radius Fracture|distal radius fracture
5209343|NCT00788190|Elderly|elderly
5209344|NCT00788190|Prospective randomized trial|prospective randomized trial
5209345|NCT00788190|Outcomes|outcomes
5209346|NCT00788190|Pain and Function|pain and function
5209347|NCT00788190|Surgical Vs. conservative management|surgical vs. conservative management
5209348|NCT00788190|Fractures with borderline alignment|fractures with borderline alignment
5209349|NCT00788177|age-related macular degeneration|age-related macular degeneration
5209350|NCT00788177|subretinal injection|subretinal injection
5209351|NCT00788177|Pegaptanib|pegaptanib
5209352|NCT00788177|Macugen|macugen
5209353|NCT00788164|cervical cancer|cervical cancer
5209354|NCT00788164|cervical intraepithelial neoplasia grade 3|cervical intraepithelial neoplasia grade 3
5209355|NCT00788164|therapeutic vaccine|therapeutic vaccine
5209356|NCT00788164|treatment|treatment
5209357|NCT00788164|CIN|cin
5209358|NCT00788164|HPV|hpv
5209359|NCT00788164|vaccine|vaccine
5209360|NCT00788164|Hopkins|hopkins
5209361|NCT00788164|Trimble|trimble
5209362|NCT00788151|Dengue virus|dengue virus
5209363|NCT00788151|Dengue fever|dengue fever
5209364|NCT00788151|Dengue hemorrhagic fever|dengue hemorrhagic fever
5209365|NCT00788151|Dengue diseases|dengue diseases
5209366|NCT00788151|Dengue vaccine|dengue vaccine
5209367|NCT00788138|Cystic Fibrosis|cystic fibrosis
5209368|NCT00788138|Vitamin D|vitamin d
5209369|NCT00788138|Anti-microbial peptides|anti-microbial peptides
5209370|NCT00788125|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
5209371|NCT00788125|metastatic childhood soft tissue sarcoma|metastatic childhood soft tissue sarcoma
5209372|NCT00788125|metastatic Ewing sarcoma/peripheral primitive neuroectodermal tumor|metastatic ewing sarcoma/peripheral primitive neuroectodermal tumor
5209373|NCT00788125|metastatic osteosarcoma|metastatic osteosarcoma
5209374|NCT00788125|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
5209375|NCT00788125|recurrent childhood soft tissue sarcoma|recurrent childhood soft tissue sarcoma
5209376|NCT00788125|recurrent Ewing sarcoma/peripheral primitive neuroectodermal tumor|recurrent ewing sarcoma/peripheral primitive neuroectodermal tumor
5209377|NCT00788125|recurrent osteosarcoma|recurrent osteosarcoma
5209378|NCT00788125|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
5209379|NCT00788125|recurrent Wilms tumor and other childhood kidney tumors|recurrent wilms tumor and other childhood kidney tumors
5209380|NCT00788125|recurrent neuroblastoma|recurrent neuroblastoma
5209381|NCT00788125|stage 4S neuroblastoma|stage 4s neuroblastoma
5209382|NCT00788125|childhood extracranial germ cell tumor|childhood extracranial germ cell tumor
5209383|NCT00788125|childhood malignant ovarian germ cell tumor|childhood malignant ovarian germ cell tumor
5209384|NCT00788125|childhood malignant testicular germ cell tumor|childhood malignant testicular germ cell tumor
5209385|NCT00788125|childhood teratoma|childhood teratoma
5209386|NCT00788125|clear cell sarcoma of the kidney|clear cell sarcoma of the kidney
5209387|NCT00788125|childhood renal cell carcinoma|childhood renal cell carcinoma
5209388|NCT00788125|recurrent renal cell cancer|recurrent renal cell cancer
5209389|NCT00788125|congenital mesoblastic nephroma|congenital mesoblastic nephroma
5209390|NCT00788125|cystic nephroma|cystic nephroma
5209391|NCT00788125|peripheral primitive neuroectodermal tumor of the kidney|peripheral primitive neuroectodermal tumor of the kidney
5209392|NCT00788125|rhabdoid tumor of the kidney|rhabdoid tumor of the kidney
5209393|NCT00788125|disseminated neuroblastoma|disseminated neuroblastoma
5209394|NCT00788125|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
5209395|NCT00788125|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
5209396|NCT00788125|recurrent childhood liver cancer|recurrent childhood liver cancer
5209397|NCT00788125|stage IV childhood liver cancer|stage iv childhood liver cancer
5209398|NCT00788125|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
5209399|NCT00788125|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
5209400|NCT00788125|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
5209401|NCT00788125|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
5209402|NCT00788125|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
5209403|NCT00788125|recurrent childhood grade III lymphomatoid granulomatosis|recurrent childhood grade iii lymphomatoid granulomatosis
5209404|NCT00788125|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
5209405|NCT00788125|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
5209406|NCT00788125|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
5209407|NCT00788125|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
5209408|NCT00788125|childhood diffuse large cell lymphoma|childhood diffuse large cell lymphoma
5209409|NCT00788125|childhood grade III lymphomatoid granulomatosis|childhood grade iii lymphomatoid granulomatosis
5209410|NCT00788125|childhood immunoblastic large cell lymphoma|childhood immunoblastic large cell lymphoma
5209411|NCT00788125|childhood nasal type extranodal NK/T-cell lymphoma|childhood nasal type extranodal nk/t-cell lymphoma
5209412|NCT00788125|Burkitt lymphoma|burkitt lymphoma
5209413|NCT00788125|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
5209414|NCT00788125|recurrent childhood anaplastic large cell lymphoma|recurrent childhood anaplastic large cell lymphoma
5209415|NCT00788125|stage IV childhood anaplastic large cell lymphoma|stage iv childhood anaplastic large cell lymphoma
5209416|NCT00788125|childhood central nervous system choriocarcinoma|childhood central nervous system choriocarcinoma
5209417|NCT00788125|childhood central nervous system embryonal tumor|childhood central nervous system embryonal tumor
5209418|NCT00788125|childhood central nervous system germ cell tumor|childhood central nervous system germ cell tumor
5209419|NCT00788125|childhood central nervous system germinoma|childhood central nervous system germinoma
5209420|NCT00788125|childhood central nervous system mixed germ cell tumor|childhood central nervous system mixed germ cell tumor
5209421|NCT00788125|childhood central nervous system teratoma|childhood central nervous system teratoma
5209422|NCT00788125|childhood central nervous system yolk sac tumor|childhood central nervous system yolk sac tumor
5209423|NCT00788125|recurrent childhood central nervous system embryonal tumor|recurrent childhood central nervous system embryonal tumor
5209424|NCT00788125|childhood choroid plexus tumor|childhood choroid plexus tumor
5209425|NCT00788125|childhood craniopharyngioma|childhood craniopharyngioma
5209426|NCT00788125|childhood ependymoblastoma|childhood ependymoblastoma
5209427|NCT00788125|childhood medulloepithelioma|childhood medulloepithelioma
5209428|NCT00788125|childhood infratentorial ependymoma|childhood infratentorial ependymoma
5209429|NCT00788125|childhood supratentorial ependymoma|childhood supratentorial ependymoma
5209430|NCT00788125|childhood oligodendroglioma|childhood oligodendroglioma
5209431|NCT00788125|childhood pineal parenchymal tumor|childhood pineal parenchymal tumor
5209432|NCT00788125|childhood grade I meningioma|childhood grade i meningioma
5209433|NCT00788125|childhood grade II meningioma|childhood grade ii meningioma
5209434|NCT00788125|childhood grade III meningioma|childhood grade iii meningioma
5209435|NCT00788125|recurrent childhood cerebellar astrocytoma|recurrent childhood cerebellar astrocytoma
5209436|NCT00788125|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
5209437|NCT00788125|recurrent childhood ependymoma|recurrent childhood ependymoma
5209438|NCT00788125|recurrent childhood medulloblastoma|recurrent childhood medulloblastoma
5209439|NCT00788125|recurrent childhood pineoblastoma|recurrent childhood pineoblastoma
5209440|NCT00788125|recurrent childhood supratentorial primitive neuroectodermal tumor|recurrent childhood supratentorial primitive neuroectodermal tumor
5209441|NCT00788125|recurrent childhood visual pathway and hypothalamic glioma|recurrent childhood visual pathway and hypothalamic glioma
5209442|NCT00788125|recurrent uterine sarcoma|recurrent uterine sarcoma
5209443|NCT00788125|childhood high-grade cerebellar astrocytoma|childhood high-grade cerebellar astrocytoma
5209444|NCT00788125|childhood high-grade cerebral astrocytoma|childhood high-grade cerebral astrocytoma
5209445|NCT00788125|childhood low-grade cerebellar astrocytoma|childhood low-grade cerebellar astrocytoma
5209446|NCT00788125|childhood low-grade cerebral astrocytoma|childhood low-grade cerebral astrocytoma
5209447|NCT00788125|childhood atypical teratoid/rhabdoid tumor|childhood atypical teratoid/rhabdoid tumor
5209448|NCT00788125|primary central nervous system Hodgkin lymphoma|primary central nervous system hodgkin lymphoma
5209449|NCT00788125|childhood extragonadal germ cell tumor|childhood extragonadal germ cell tumor
5209450|NCT00788125|recurrent childhood malignant germ cell tumor|recurrent childhood malignant germ cell tumor
5209451|NCT00788125|recurrent childhood brain stem glioma|recurrent childhood brain stem glioma
5209452|NCT00788125|recurrent childhood subependymal giant cell astrocytoma|recurrent childhood subependymal giant cell astrocytoma
5209453|NCT00788125|recurrent childhood brain tumor|recurrent childhood brain tumor
5209454|NCT00788125|recurrent childhood spinal cord neoplasm|recurrent childhood spinal cord neoplasm
5209708|NCT00787527|PTCL|ptcl
5209455|NCT00788112|ductal breast carcinoma in situ|ductal breast carcinoma in situ
5209456|NCT00788099|Aplidin|aplidin
5209457|NCT00788099|Plitidepsin|plitidepsin
5209458|NCT00788099|Tumors|tumors
5209459|NCT00788099|Lymphomas|lymphomas
5209460|NCT00788073|fragile X syndrome|fragile x syndrome
5209461|NCT00788073|irritability|irritability
5209462|NCT00788073|behavior problems|behavior problems
5209463|NCT00788060|Renal Cell Carcinoma|renal cell carcinoma
5209464|NCT00788060|Rad001|rad001
5209465|NCT00788060|Sutent|sutent
5209466|NCT00788034|Relapse prevention|relapse prevention
5209467|NCT00788034|GAD|gad
5209468|NCT00788034|Maintenance|maintenance
5209469|NCT00788034|Double-blind|double-blind
5209470|NCT00788034|Multicentre|multicentre
5209471|NCT00788021|Transplant|transplant
5209472|NCT00788021|Immunity|immunity
5209473|NCT00788021|Immunosuppression|immunosuppression
5209474|NCT00788008|spinal, joint|spinal, joint
5209475|NCT00787995|Mucopolysaccharidosis IV type A|mucopolysaccharidosis iv type a
5209476|NCT00787995|MPS IV Type A|mps iv type a
5209477|NCT00787995|Mucopolysaccharidosis IVA|mucopolysaccharidosis iva
5209478|NCT00787995|MPS IVA|mps iva
5209479|NCT00787995|Morquio A Syndrome|morquio a syndrome
5209480|NCT00787995|Lysosomal Storage Disorder|lysosomal storage disorder
5209481|NCT00787995|LSD|lsd
5209482|NCT00787995|N-acetylgalactosamine-6-sulfatase|n-acetylgalactosamine-6-sulfatase
5209483|NCT00787995|galactose-6-sulfatase|galactose-6-sulfatase
5209484|NCT00787995|GALNS|galns
5209485|NCT00787995|enzyme replacement therapy|enzyme replacement therapy
5209486|NCT00787995|ERT|ert
5209487|NCT00787982|brain|brain
5209488|NCT00787982|metastasis|metastasis
5209489|NCT00787982|neoplasm|neoplasm
5209490|NCT00787982|tumor|tumor
5209491|NCT00787982|Patients with secondary brain neoplasms|patients with secondary brain neoplasms
5209492|NCT00787982|laser therapy|laser therapy
5209493|NCT00787982|laser interstitial thermal therapy|laser interstitial thermal therapy
5209494|NCT00787969|stage I mantle cell lymphoma|stage i mantle cell lymphoma
5209495|NCT00787969|Stage II Contiguous Mantle Cell Lymphoma|stage ii contiguous mantle cell lymphoma
5209496|NCT00787969|Stage II Non-Contiguous Mantle Cell Lymphoma|stage ii non-contiguous mantle cell lymphoma
5209497|NCT00787969|Stage III Mantle Cell Lymphoma|stage iii mantle cell lymphoma
5209498|NCT00787969|Stage IV Mantle Cell Lymphoma|stage iv mantle cell lymphoma
5209499|NCT00787943|Acne|acne
5209500|NCT00787930|BPD|bpd
5209501|NCT00787917|Cystic Fibrosis|cystic fibrosis
5209502|NCT00787917|Allergic Bronchopulmonary Aspergillosis|allergic bronchopulmonary aspergillosis
5209503|NCT00787917|omalizumab|omalizumab
5209504|NCT00787917|oral corticosteroid use|oral corticosteroid use
5209505|NCT00787917|anti-immunoglobulin E|anti-immunoglobulin e
5209506|NCT00787904|Osteoporosis, T-cells|osteoporosis, t-cells
5209507|NCT00787891|Gastroesophageal Reflux Disease (GERD)|gastroesophageal reflux disease (gerd)
5209508|NCT00787891|Erosive Gastroesophageal Reflux Disease|erosive gastroesophageal reflux disease
5209509|NCT00787891|Ulcerative Gastroesophageal Reflux Disease|ulcerative gastroesophageal reflux disease
5209510|NCT00787891|Endoscopy|endoscopy
5209511|NCT00787891|Pediatrics|pediatrics
5209512|NCT00787891|Rabeprazole|rabeprazole
5209513|NCT00787865|Diffusion Tensor Imaging|diffusion tensor imaging
5209514|NCT00787865|DTI|dti
5209515|NCT00787865|Newborn|newborn
5209516|NCT00787865|Krabbe Disease|krabbe disease
5209517|NCT00787865|Motor Development|motor development
5209518|NCT00787865|Motor Disability|motor disability
5209519|NCT00787852|dasatinib|dasatinib
5209520|NCT00787852|radiation|radiation
5209521|NCT00787852|paclitaxel|paclitaxel
5209522|NCT00787852|carboplatin|carboplatin
5209523|NCT00787852|NSCLC|nsclc
5209524|NCT00787852|safety addition of dasatinib to chemo RT stage III NSCLC|safety addition of dasatinib to chemo rt stage iii nsclc
5209525|NCT00787839|type 2 diabetes mellitus|type 2 diabetes mellitus
5209526|NCT00787839|prediabetic state|prediabetic state
5209527|NCT00787839|mass screening|mass screening
5209528|NCT00787839|glucose tolerance test|glucose tolerance test
5209529|NCT00787826|Live Vaccine Strain (LVS)|live vaccine strain (lvs)
5209530|NCT00787813|N-acetyl cysteine (NAC)|n-acetyl cysteine (nac)
5209531|NCT00787813|Cervical cerclage|cervical cerclage
5209532|NCT00787813|cervical cerclage for cervical insufficiency|cervical cerclage for cervical insufficiency
5209533|NCT00787800|Shock prevention|shock prevention
5209534|NCT00787800|Single vs. Dual Chamber|single vs. dual chamber
5209535|NCT00787800|Reduce ventricular pacing|reduce ventricular pacing
5209536|NCT00787800|Atrial Fibrillation|atrial fibrillation
5209537|NCT00787800|Remote Monitoring|remote monitoring
5209538|NCT00787800|ICD|icd
5209539|NCT00787800|Implantable Cardioverter Defibrillator|implantable cardioverter defibrillator
5209540|NCT00787774|HIV|hiv
5209541|NCT00787774|resistance|resistance
5209542|NCT00787774|integrase|integrase
5209543|NCT00787761|accelerated phase CML|accelerated phase cml
5209544|NCT00787761|blastic phase CML|blastic phase cml
5209545|NCT00787761|Philadelphia chromosome positive CML|philadelphia chromosome positive cml
5209546|NCT00787761|stage I CLL|stage i cll
5209547|NCT00787761|stage II CLL|stage ii cll
5209548|NCT00787761|stage III CLL|stage iii cll
5209549|NCT00787761|stage IV CLL|stage iv cll
5209550|NCT00787761|stage I multiple myeloma|stage i multiple myeloma
5209709|NCT00787527|CD 30|cd 30
5209551|NCT00787761|stage II multiple myeloma|stage ii multiple myeloma
5209552|NCT00787761|stage III multiple myeloma|stage iii multiple myeloma
5209553|NCT00787761|adult AML with 11q23 (MLL) abnormalities|adult aml with 11q23 (mll) abnormalities
5209554|NCT00787761|adult CML in remission|adult cml in remission
5209555|NCT00787761|adult ALL in remission|adult all in remission
5209556|NCT00787761|stage IV renal cell cancer|stage iv renal cell cancer
5209557|NCT00787761|de novo MDS|de novo mds
5209558|NCT00787761|previously treated MDS|previously treated mds
5209559|NCT00787761|secondary MDS|secondary mds
5209560|NCT00787761|atypical CML, BCR-ABL negative|atypical cml, bcr-abl negative
5209561|NCT00787761|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5209562|NCT00787761|MDS/myeloproliferative neoplasm, unclassifiable|mds/myeloproliferative neoplasm, unclassifiable
5209563|NCT00787761|primary myelofibrosis|primary myelofibrosis
5209564|NCT00787761|chronic neutrophilic leukemia|chronic neutrophilic leukemia
5209565|NCT00787761|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5209566|NCT00787761|clear cell renal cell carcinoma|clear cell renal cell carcinoma
5209567|NCT00787761|adult AML with inv(16)(p13;q22)|adult aml with inv(16)(p13;q22)
5209568|NCT00787761|adult AML with t(15;17)(q22;q12)|adult aml with t(15;17)(q22;q12)
5209569|NCT00787761|adult AML with t(16;16)(p13;q22)|adult aml with t(16;16)(p13;q22)
5209570|NCT00787761|adult AML with t(8;21)(q22;q22)|adult aml with t(8;21)(q22;q22)
5209571|NCT00787761|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
5209572|NCT00787761|AML/transient myeloproliferative disorder|aml/transient myeloproliferative disorder
5209573|NCT00787761|Burkitt lymphoma|burkitt lymphoma
5209574|NCT00787761|chronic phase CML|chronic phase cml
5209575|NCT00787761|extranodal marginal zone B-cell lymphoma of mucosa tissue|extranodal marginal zone b-cell lymphoma of mucosa tissue
5209576|NCT00787761|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5209577|NCT00787761|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5209578|NCT00787761|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5209579|NCT00787761|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5209580|NCT00787761|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5209581|NCT00787761|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5209582|NCT00787761|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5209583|NCT00787761|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5209584|NCT00787761|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5209585|NCT00787761|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5209586|NCT00787761|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5209587|NCT00787761|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5209588|NCT00787761|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5209589|NCT00787761|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5209590|NCT00787761|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5209591|NCT00787761|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5209592|NCT00787761|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5209593|NCT00787761|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5209594|NCT00787761|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5209595|NCT00787761|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5209596|NCT00787761|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5209597|NCT00787761|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5209598|NCT00787761|contiguous st II adult diffuse small cleaved cell lymphoma|contiguous st ii adult diffuse small cleaved cell lymphoma
5209599|NCT00787761|noncontiguous st II diffuse small cleaved cell lymphoma|noncontiguous st ii diffuse small cleaved cell lymphoma
5209600|NCT00787761|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5209601|NCT00787761|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5209602|NCT00787761|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5209603|NCT00787761|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
5209604|NCT00787761|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
5209605|NCT00787761|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5209606|NCT00787761|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5209607|NCT00787761|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5209608|NCT00787761|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5209609|NCT00787761|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5209610|NCT00787761|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5209611|NCT00787761|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5209612|NCT00787761|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5209613|NCT00787761|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
5209614|NCT00787761|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
5209615|NCT00787761|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5209616|NCT00787761|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5209617|NCT00787761|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5209618|NCT00787761|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
5209619|NCT00787761|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
5209620|NCT00787761|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5209621|NCT00787761|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5209622|NCT00787761|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5209623|NCT00787761|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
5209624|NCT00787761|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5209625|NCT00787761|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5209626|NCT00787761|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5209627|NCT00787761|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
5209628|NCT00787761|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
5209629|NCT00787761|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
5209630|NCT00787761|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
5209631|NCT00787761|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5209632|NCT00787761|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
5209633|NCT00787748|Cardiovascular|cardiovascular
5209634|NCT00787748|COPD|copd
5209635|NCT00787748|Population|population
5209636|NCT00787748|Prevalence|prevalence
5209637|NCT00787748|Underdiagnosis|underdiagnosis
5209638|NCT00787722|High dose immunosuppressive therapy|high dose immunosuppressive therapy
5209639|NCT00787722|Hematopoietic stem cell support|hematopoietic stem cell support
5209640|NCT00787709|Obesity prevention|obesity prevention
5209641|NCT00787709|Health promotion|health promotion
5209642|NCT00787709|School based curriculum|school based curriculum
5209643|NCT00787696|HIV prevention|hiv prevention
5209644|NCT00787696|female adolescent offenders|female adolescent offenders
5209645|NCT00787696|sexual risk reduction|sexual risk reduction
5209646|NCT00787696|alcohol and other drug abuse|alcohol and other drug abuse
5209647|NCT00787683|Patients with ventricular arrhythmias and the prevention of sudden cardiac death|patients with ventricular arrhythmias and the prevention of sudden cardiac death
5209648|NCT00787670|Obese|obese
5209649|NCT00787670|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
5209650|NCT00787670|Gastric Bypass surgery|gastric bypass surgery
5209651|NCT00787670|Risk of cardiovascular diseases|risk of cardiovascular diseases
5209652|NCT00787657|Clinically Isolated Syndrome (CIS)|clinically isolated syndrome (cis)
5209653|NCT00787644|Asthma|asthma
5209654|NCT00787644|Adipose Tissue|adipose tissue
5209655|NCT00787644|Asthmatics|asthmatics
5209656|NCT00787644|Pioglitazone|pioglitazone
5209657|NCT00787644|Actos|actos
5209658|NCT00787644|Obesity|obesity
5209659|NCT00787644|Exacerbation|exacerbation
5209660|NCT00787644|Fat|fat
5209661|NCT00787644|Overweight|overweight
5209662|NCT00787644|Leptin|leptin
5209663|NCT00787644|Adiponectin|adiponectin
5209664|NCT00787644|Wheezing|wheezing
5209665|NCT00787644|Vermont|vermont
5209666|NCT00787644|Pulmonary|pulmonary
5209667|NCT00787644|Lung|lung
5209668|NCT00787631|birch pollen pollen allergy|birch pollen pollen allergy
5209669|NCT00787631|oral allergy syndrome to apple|oral allergy syndrome to apple
5209670|NCT00787631|cross reactivity|cross reactivity
5209671|NCT00787631|bet v 1|bet v 1
5209672|NCT00787631|mal d 1|mal d 1
5209673|NCT00787618|Renal impairment|renal impairment
5209674|NCT00787605|Hypertension, diabetes mellitus, aliskiren, hydrochlorothiazide, systolic blood pressure, diastolic blood pressure, amlodipine, stage 2|hypertension, diabetes mellitus, aliskiren, hydrochlorothiazide, systolic blood pressure, diastolic blood pressure, amlodipine, stage 2
5209675|NCT00787592|Burns|burns
5209676|NCT00787592|children|children
5209677|NCT00787592|collagenase|collagenase
5209678|NCT00787592|silver sulfadiazine|silver sulfadiazine
5209679|NCT00787592|Childhood burns|childhood burns
5209680|NCT00787579|Myopia, bifocal, children|myopia, bifocal, children
5209681|NCT00787566|Highly emetogenic chemotherapy induced nausea and vomiting|highly emetogenic chemotherapy induced nausea and vomiting
5209682|NCT00787553|hysterectomy|hysterectomy
5209683|NCT00787553|antibiotic prophylaxis|antibiotic prophylaxis
5209684|NCT00787553|bacterial vaginosis|bacterial vaginosis
5209685|NCT00787553|tinidazole|tinidazole
5209686|NCT00787553|cefazolin|cefazolin
5209687|NCT00787540|Coronary disease|coronary disease
5209688|NCT00787540|Psychosocial|psychosocial
5209689|NCT00787540|Nursing|nursing
5209690|NCT00787527|Lymphoma|lymphoma
5209691|NCT00787527|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
5209692|NCT00787527|SAHA|saha
5209693|NCT00787527|Vorinostat|vorinostat
5209694|NCT00787527|Suberoylanilide Hydroxamic Acid|suberoylanilide hydroxamic acid
5209695|NCT00787527|MSK-390|msk-390
5209696|NCT00787527|CHOP|chop
5209697|NCT00787527|Cyclophosphamide|cyclophosphamide
5209698|NCT00787527|Doxorubicin|doxorubicin
5209699|NCT00787527|AD|ad
5209700|NCT00787527|Hydroxydaunomycin hydrochloride|hydroxydaunomycin hydrochloride
5209701|NCT00787527|Cytoxan|cytoxan
5209702|NCT00787527|Neosar|neosar
5209703|NCT00787527|Vincristine|vincristine
5209704|NCT00787527|Prednisone|prednisone
5209705|NCT00787527|Untreated T-cell|untreated t-cell
5209706|NCT00787527|T-cell NHL|t-cell nhl
5209707|NCT00787527|Peripheral T-cell lymphoma|peripheral t-cell lymphoma
5209710|NCT00787527|Anaplastic large cell lymphoma|anaplastic large cell lymphoma
5209711|NCT00787527|Angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
5209712|NCT00787527|Intestinal T-cell lymphoma|intestinal t-cell lymphoma
5209713|NCT00787527|Subcutaneous panniculitic T-cell lymphoma|subcutaneous panniculitic t-cell lymphoma
5209714|NCT00787514|ovarian cancer, folate receptor, plasma|ovarian cancer, folate receptor, plasma
5209715|NCT00787501|Major Depressive Disorder|major depressive disorder
5209716|NCT00787501|Depression|depression
5209717|NCT00787501|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors
5209718|NCT00787501|Cognitive Behavior Therapy|cognitive behavior therapy
5209719|NCT00787501|Cognitive Therapy|cognitive therapy
5209720|NCT00787501|antidepressant medications|antidepressant medications
5209721|NCT00787488|Ovarian|ovarian
5209722|NCT00787488|debulked|debulked
5209723|NCT00787488|recurrent|recurrent
5209724|NCT00787488|Stage III|stage iii
5209725|NCT00787488|Stage IV|stage iv
5209726|NCT00787475|Diabetes|diabetes
5209727|NCT00787475|Community health worker|community health worker
5209728|NCT00787475|Community outreach|community outreach
5209729|NCT00787462|Neuropathic|neuropathic
5209730|NCT00787462|Neuropathic pain|neuropathic pain
5209731|NCT00787462|Nerve pain|nerve pain
5209732|NCT00787462|Pain|pain
5209733|NCT00787462|Chronic pain|chronic pain
5209734|NCT00787462|Pregabalin|pregabalin
5209735|NCT00787462|Lyrica|lyrica
5209736|NCT00787462|Small fiber neuropathy|small fiber neuropathy
5209737|NCT00787462|Neuropathy|neuropathy
5209738|NCT00787436|portal hypertension|portal hypertension
5209739|NCT00787436|Gastroesophageal|gastroesophageal
5209740|NCT00787436|Varices|varices
5209741|NCT00787436|Liver disease|liver disease
5209742|NCT00787436|cirrhosis|cirrhosis
5209743|NCT00787423|Field Tools|field tools
5209744|NCT00787423|Drug Use|drug use
5209745|NCT00787423|Psychological Stress|psychological stress
5209746|NCT00787423|Ecological Momentary Assessment|ecological momentary assessment
5209747|NCT00787423|Global Positioning Units|global positioning units
5209748|NCT00787410|malignant mesothelioma|malignant mesothelioma
5209749|NCT00787410|IRESSA|iressa
5209750|NCT00787410|ZD1839|zd1839
5209751|NCT00787397|Sleep difficulties in pediatric anxiety disorder|sleep difficulties in pediatric anxiety disorder
5209752|NCT00787397|Neural correlates of pediatric anxiety disorder|neural correlates of pediatric anxiety disorder
5209753|NCT00787397|Social correlates of pediatric anxiety disorder|social correlates of pediatric anxiety disorder
5209754|NCT00787397|Generalized Anxiety Disorder in pediatric populations|generalized anxiety disorder in pediatric populations
5209755|NCT00787397|Separation Anxiety Disorder in pediatric populations|separation anxiety disorder in pediatric populations
5209756|NCT00787397|Social Phobia in pediatric populations|social phobia in pediatric populations
5209757|NCT00787384|Hypereosinophilic syndrome (HES)|hypereosinophilic syndrome (hes)
5209758|NCT00787384|chronic eosinophilic leukaemia (CEL)|chronic eosinophilic leukaemia (cel)
5209759|NCT00787384|chronic idiopathic hypereosinophilia (CIH)|chronic idiopathic hypereosinophilia (cih)
5209760|NCT00787384|Imatinib|imatinib
5209761|NCT00787384|Response|response
5209762|NCT00787384|Timing to response|timing to response
5209763|NCT00787371|alanine transaminase|alanine transaminase
5209764|NCT00787358|osteoporosis|osteoporosis
5209765|NCT00787358|intertrochanteric|intertrochanteric
5209766|NCT00787358|hip fracture|hip fracture
5209767|NCT00787358|compression hip screw|compression hip screw
5209768|NCT00787358|surgical fixation|surgical fixation
5209769|NCT00787345|precaution technique during central venous catheter placement.|precaution technique during central venous catheter placement.
5209770|NCT00787332|Suspected Heparin Induced Thrombocytopenia (HIT)|suspected heparin induced thrombocytopenia (hit)
5209771|NCT00787319|Ophthalmology|ophthalmology
5209772|NCT00787319|Age-related macular degeneration|age-related macular degeneration
5209773|NCT00787319|outpatients|outpatients
5209774|NCT00787306|chronic disease management|chronic disease management
5209775|NCT00787306|decision aids|decision aids
5209776|NCT00787306|cardiovascular risk factors|cardiovascular risk factors
5209777|NCT00787293|Heart Failure|heart failure
5209778|NCT00787293|Mitral Regurgitation|mitral regurgitation
5209779|NCT00787293|Percutaneous|percutaneous
5209780|NCT00787293|Coronary sinus|coronary sinus
5209781|NCT00787280|obese|obese
5209782|NCT00787280|overweight|overweight
5209783|NCT00787280|fMRI|fmri
5209784|NCT00787280|Diet|diet
5209785|NCT00787267|NSCLC|nsclc
5209786|NCT00787267|Lung Cancer|lung cancer
5209787|NCT00787267|Dasatinib|dasatinib
5209788|NCT00787267|Genomics|genomics
5209789|NCT00787267|Genomics analysis|genomics analysis
5209790|NCT00787267|Genomic signature|genomic signature
5209791|NCT00787254|Curling Ulcer|curling ulcer
5209792|NCT00787254|Gastric Ulcer|gastric ulcer
5209793|NCT00787254|Nonsteroid anti-inflammatory drug|nonsteroid anti-inflammatory drug
5209794|NCT00787254|Drug Therapy|drug therapy
5209795|NCT00787241|Platelets|platelets
5209796|NCT00787241|Labor|labor
5209797|NCT00787241|Preeclampsia|preeclampsia
5209798|NCT00787215|oral glucose tolerance test|oral glucose tolerance test
5209799|NCT00787215|Hong Kong Chinese|hong kong chinese
5209800|NCT00787202|treatment of ulcerative colitis; CP 690 550|treatment of ulcerative colitis; cp 690 550
5209998|NCT00786396|HIV|hiv
5209801|NCT00787189|sensorineural hearing loss|sensorineural hearing loss
5209802|NCT00787189|tinnitus|tinnitus
5209803|NCT00787189|word recognition|word recognition
5209804|NCT00787176|Oxytocin|oxytocin
5209805|NCT00787176|Labor, Obstetric|labor, obstetric
5209806|NCT00787176|Non-reassuring fetal heart rate|non-reassuring fetal heart rate
5209807|NCT00787176|epidural|epidural
5209808|NCT00787163|pPROM|pprom
5209809|NCT00787163|oligohydramnios|oligohydramnios
5209810|NCT00787163|amnioinfusion|amnioinfusion
5209811|NCT00787163|prematurity|prematurity
5209812|NCT00787163|Early premature rupture of membranes in pregnancy|early premature rupture of membranes in pregnancy
5209813|NCT00787111|Drug: Fluoxetine|drug: fluoxetine
5209814|NCT00787098|therapeutic mobility|therapeutic mobility
5209815|NCT00787098|acute care|acute care
5209816|NCT00787098|nursing|nursing
5209817|NCT00787098|inflammatory markers|inflammatory markers
5209818|NCT00787085|Funguria|funguria
5209819|NCT00787085|Epidemiology|epidemiology
5209820|NCT00787085|Urinary Tract Infections|urinary tract infections
5209821|NCT00787059|Adenylyl Cyclase|adenylyl cyclase
5209822|NCT00787059|AC6|ac6
5209823|NCT00787059|adenovirus|adenovirus
5209824|NCT00787059|gene therapy|gene therapy
5209825|NCT00787059|congestive heart failure|congestive heart failure
5209826|NCT00787059|intracoronary|intracoronary
5209827|NCT00787059|nitroprusside|nitroprusside
5209828|NCT00787033|Focal Adhesion Kinase; Advanced Non-Hematologic Malignancies|focal adhesion kinase; advanced non-hematologic malignancies
5209829|NCT00787020|Cerebrospinal Fluid|cerebrospinal fluid
5209830|NCT00787020|Ventriculostomy|ventriculostomy
5209831|NCT00787020|Subarachnoid hemorrhage|subarachnoid hemorrhage
5209832|NCT00787020|vasospasm|vasospasm
5209833|NCT00787020|Human Subjects|human subjects
5209834|NCT00787007|healthy volunteers|healthy volunteers
5209835|NCT00787007|pharmacokinetics|pharmacokinetics
5209836|NCT00786994|Actinic Keratoses|actinic keratoses
5209837|NCT00786968|mucopolysaccharidosis|mucopolysaccharidosis
5209838|NCT00786968|Hurler-Scheie|hurler-scheie
5209839|NCT00786968|Scheie|scheie
5209840|NCT00786968|laronidase|laronidase
5209841|NCT00786968|spinal cord compression|spinal cord compression
5209842|NCT00786968|central nervous system|central nervous system
5209843|NCT00786968|enzyme replacement therapy|enzyme replacement therapy
5209844|NCT00786968|intrathecal|intrathecal
5209845|NCT00786942|osteotomy|osteotomy
5209846|NCT00786942|knee|knee
5209847|NCT00786942|varus deformity|varus deformity
5209848|NCT00786942|bone graft|bone graft
5209849|NCT00786929|Conversion to more aggressive treatment of recurrent fluid collection|conversion to more aggressive treatment of recurrent fluid collection
5209850|NCT00786916|pain|pain
5209851|NCT00786916|propofol|propofol
5209852|NCT00786916|lidocaine|lidocaine
5209853|NCT00786916|sedation|sedation
5209854|NCT00786916|pediatric|pediatric
5209855|NCT00786890|Prediabetes (IFG, IGT)|prediabetes (ifg, igt)
5209856|NCT00786890|Hong Kong Chinese|hong kong chinese
5209857|NCT00786890|Cardiovascular risk factors|cardiovascular risk factors
5209858|NCT00786877|pneumonia|pneumonia
5209859|NCT00786864|Randomised controlled trial|randomised controlled trial
5209860|NCT00786864|low back pain|low back pain
5209861|NCT00786864|exercise|exercise
5209862|NCT00786864|children|children
5209863|NCT00786864|school-based|school-based
5209864|NCT00786864|prevalence|prevalence
5209865|NCT00786864|intensity|intensity
5209866|NCT00786851|MANTLE CELL LYMPHOMA (MCL)|mantle cell lymphoma (mcl)
5209867|NCT00786851|Lenalidomide (Len)|lenalidomide (len)
5209868|NCT00786851|Dexamethasone (Dex)|dexamethasone (dex)
5209869|NCT00786838|Solid tumor|solid tumor
5209870|NCT00786838|Advanced solid tumor|advanced solid tumor
5209871|NCT00786838|Malignant tumors|malignant tumors
5209872|NCT00786838|Sarcoma|sarcoma
5209873|NCT00786838|Breast tumor|breast tumor
5209874|NCT00786838|Ovarian tumor|ovarian tumor
5209875|NCT00786838|QT interval|qt interval
5209876|NCT00786838|Trabectedin|trabectedin
5209877|NCT00786838|Yondelis|yondelis
5209878|NCT00786838|Ecteinascidin 743|ecteinascidin 743
5209879|NCT00786838|ET743|et743
5209880|NCT00786825|Type 1 diabetes|type 1 diabetes
5209881|NCT00786825|Hypoglycemia unawareness|hypoglycemia unawareness
5209882|NCT00786812|Leukemia|leukemia
5209883|NCT00786812|adult chronic myeloid leukemia|adult chronic myeloid leukemia
5209884|NCT00786812|imatinib|imatinib
5209885|NCT00786812|nilotinib|nilotinib
5209886|NCT00786786|Any person with a spinal cord injury|any person with a spinal cord injury
5209887|NCT00786786|at least 18 years of age|at least 18 years of age
5209888|NCT00786773|GERD|gerd
5209889|NCT00786773|reflux symptom|reflux symptom
5209890|NCT00786773|heartburn|heartburn
5209891|NCT00786773|acid regurgitation|acid regurgitation
5209892|NCT00786773|PPI|ppi
5209893|NCT00786773|H2RA|h2ra
5209894|NCT00786773|antacid|antacid
5209895|NCT00786760|HPV|hpv
5209896|NCT00786760|Papillomavirus|papillomavirus
5209897|NCT00786760|Infection|infection
5209898|NCT00786760|Sexually transmitted disease|sexually transmitted disease
5209899|NCT00786760|STD|std
5209900|NCT00786747|Computer-assisted instruction|computer-assisted instruction
5209901|NCT00786747|Health knowledge, attitudes, practice|health knowledge, attitudes, practice
5209902|NCT00786747|Mass screening|mass screening
5209903|NCT00786747|Patient acceptance of health care|patient acceptance of health care
5209904|NCT00786747|Patient education as topic|patient education as topic
5209905|NCT00786747|Primary health care|primary health care
5209906|NCT00786747|Self-efficacy|self-efficacy
5209907|NCT00786734|pitavastatin|pitavastatin
5209908|NCT00786734|PCI|pci
5209909|NCT00786734|stable angina|stable angina
5209910|NCT00786721|Mitochondria and Metabolic Syndrome|mitochondria and metabolic syndrome
5209911|NCT00786708|renal|renal
5209912|NCT00786708|kidney|kidney
5209913|NCT00786708|lipocalin|lipocalin
5209914|NCT00786708|urine|urine
5209915|NCT00786708|biomarker|biomarker
5209916|NCT00786708|Azotemia|azotemia
5209917|NCT00786708|Renal insufficiency, chronic|renal insufficiency, chronic
5209918|NCT00786708|Renal failure, acute|renal failure, acute
5209919|NCT00786708|Hydronephrosis|hydronephrosis
5209920|NCT00786695|noncardiac chest pain|noncardiac chest pain
5209921|NCT00786695|gastroesophageal reflux disease|gastroesophageal reflux disease
5209922|NCT00786695|diagnostic test|diagnostic test
5209923|NCT00786695|proton pump inhibitor|proton pump inhibitor
5209924|NCT00786695|esomeprazole|esomeprazole
5209925|NCT00786682|stage IV prostate cancer|stage iv prostate cancer
5209926|NCT00786682|recurrent prostate cancer|recurrent prostate cancer
5209927|NCT00786656|Navigation|navigation
5209928|NCT00786656|Coordination|coordination
5209929|NCT00786656|Cancer Care|cancer care
5209930|NCT00786656|Patient Experience|patient experience
5209931|NCT00786656|Cancer|cancer
5209932|NCT00786656|Patient Survey|patient survey
5209933|NCT00786643|Gamma Interferon|gamma interferon
5209934|NCT00786643|5-FU|5-fu
5209935|NCT00786643|LV|lv
5209936|NCT00786630|Drug treatment entry and retention|drug treatment entry and retention
5209937|NCT00786630|Drug injection frequency|drug injection frequency
5209938|NCT00786630|HIV risk behaviors|hiv risk behaviors
5209939|NCT00786630|Hepatitis C risk behaviors|hepatitis c risk behaviors
5209940|NCT00786591|Acute pancreatitis|acute pancreatitis
5209941|NCT00786591|biological markers|biological markers
5209942|NCT00786591|substance P|substance p
5209943|NCT00786591|hydrogen sulfide|hydrogen sulfide
5209944|NCT00786591|disease severity index|disease severity index
5209945|NCT00786578|training|training
5209946|NCT00786578|intramyocellular lipid|intramyocellular lipid
5209947|NCT00786578|insulin resistance|insulin resistance
5209948|NCT00786552|recurrent/advanced thyroid cancer|recurrent/advanced thyroid cancer
5209949|NCT00786552|papillary or anaplastic thyroid cancer|papillary or anaplastic thyroid cancer
5209950|NCT00786539|mitochondrial|mitochondrial
5209951|NCT00786526|Mechanical ventilation|mechanical ventilation
5209952|NCT00786526|Ventilator induced diaphragmatic dysfunction|ventilator induced diaphragmatic dysfunction
5209953|NCT00786526|Weaning|weaning
5209954|NCT00786526|Neuromuscular diseases- Respiratory function tests|neuromuscular diseases- respiratory function tests
5209955|NCT00786526|Intubated patients in intensive care unit|intubated patients in intensive care unit
5209956|NCT00786513|Cystic fibrosis|cystic fibrosis
5209957|NCT00786513|Pseudomonas aeruginosa|pseudomonas aeruginosa
5209958|NCT00786513|biofilm|biofilm
5209959|NCT00786513|antibiotic susceptibility testing|antibiotic susceptibility testing
5209960|NCT00786513|pediatrics|pediatrics
5209961|NCT00786500|Herbal medicine|herbal medicine
5209962|NCT00786500|Type 2 diabetes|type 2 diabetes
5209963|NCT00786500|Insulin sensitivity|insulin sensitivity
5209964|NCT00786500|Insulin secretion|insulin secretion
5209965|NCT00786487|insulin resistance|insulin resistance
5209966|NCT00786487|lipid metabolism|lipid metabolism
5209967|NCT00786487|lipid infusion|lipid infusion
5209968|NCT00786487|glycerol infusion|glycerol infusion
5209969|NCT00786487|skeletal muscle|skeletal muscle
5209970|NCT00786487|diabetes|diabetes
5209971|NCT00786474|Bridging Anticoagulation|bridging anticoagulation
5209972|NCT00786461|silver nitrate|silver nitrate
5209973|NCT00786461|marsupialisation|marsupialisation
5209974|NCT00786448|Overactive Bladder|overactive bladder
5209975|NCT00786422|Embolism and Thrombosis|embolism and thrombosis
5209976|NCT00786422|Pulmonary Embolism|pulmonary embolism
5209977|NCT00786422|Embolism|embolism
5209978|NCT00786422|Venous Thrombosis|venous thrombosis
5209979|NCT00786422|Thrombosis|thrombosis
5209980|NCT00786422|Enzyme Inducers|enzyme inducers
5209981|NCT00786422|CYP Inducers|cyp inducers
5209982|NCT00786422|Cohort Study|cohort study
5209983|NCT00786422|Pharmacologic Actions|pharmacologic actions
5209984|NCT00786422|Respiratory Tract Diseases|respiratory tract diseases
5209985|NCT00786422|Lung Diseases|lung diseases
5209986|NCT00786422|Vascular Diseases|vascular diseases
5209987|NCT00786422|Human Immunodeficiency Virus (HIV)|human immunodeficiency virus (hiv)
5209988|NCT00786422|Neurologic disease|neurologic disease
5209989|NCT00786422|Additional relevant MeSH terms:|additional relevant mesh terms:
5209990|NCT00786422|Fibrin Modulating Agents|fibrin modulating agents
5209991|NCT00786422|Anticoagulants|anticoagulants
5209992|NCT00786422|Therapeutic Uses|therapeutic uses
5209993|NCT00786422|Hematologic Agents|hematologic agents
5209994|NCT00786422|Enzyme Inhibitors|enzyme inhibitors
5209995|NCT00786422|Cardiovascular Diseases|cardiovascular diseases
5209996|NCT00786422|Cardiovascular Agents|cardiovascular agents
5209997|NCT00786409|Lupus|lupus
5209999|NCT00786396|AIDS|aids
5210000|NCT00786396|substance abuse|substance abuse
5210001|NCT00786396|directly administered antiretroviral therapy|directly administered antiretroviral therapy
5210002|NCT00786396|adherence|adherence
5210003|NCT00786396|Substance Abuse and Dependency|substance abuse and dependency
5210004|NCT00786383|Phase I|phase i
5210005|NCT00786383|cancer|cancer
5210006|NCT00786383|solid tumors|solid tumors
5210007|NCT00786383|1121B|1121b
5210008|NCT00786383|VEGFR-2|vegfr-2
5210009|NCT00786383|Anti-Vascular Endothelial Growth Factor Receptor 2|anti-vascular endothelial growth factor receptor 2
5210010|NCT00786370|propofol|propofol
5210011|NCT00786370|dexmedetomidine|dexmedetomidine
5210012|NCT00786370|cataract|cataract
5210013|NCT00786370|respiratory|respiratory
5210014|NCT00786370|blood pressure|blood pressure
5210015|NCT00786370|Cataract surgery|cataract surgery
5210016|NCT00786357|shift-work|shift-work
5210017|NCT00786357|sleep|sleep
5210018|NCT00786357|nurse|nurse
5210019|NCT00786357|relaxation|relaxation
5210020|NCT00786344|Health Promotion: Wellness Programs|health promotion: wellness programs
5210021|NCT00786344|Occupational Therapy|occupational therapy
5210022|NCT00786344|Quality of Life|quality of life
5210023|NCT00786344|Health|health
5210024|NCT00786344|Biomarkers|biomarkers
5210025|NCT00786331|second line treatment|second line treatment
5210026|NCT00786331|pemetrexed|pemetrexed
5210027|NCT00786331|carboplatin|carboplatin
5210028|NCT00786318|Psychosis|psychosis
5210029|NCT00786318|Agitation|agitation
5210030|NCT00786318|Delirium|delirium
5210031|NCT00786305|Nebulization|nebulization
5210032|NCT00786305|ceftazidime|ceftazidime
5210033|NCT00786305|amikacin|amikacin
5210034|NCT00786305|pneumonia|pneumonia
5210035|NCT00786305|Pseudomonas aeruginosa|pseudomonas aeruginosa
5210036|NCT00786305|mechanical ventilation|mechanical ventilation
5210037|NCT00786305|Ventilator-associated pneumonia|ventilator-associated pneumonia
5210038|NCT00786305|treatment|treatment
5210039|NCT00786279|atherosclerosis|atherosclerosis
5210040|NCT00786266|shift-work|shift-work
5210041|NCT00786266|sleep|sleep
5210042|NCT00786266|nurse|nurse
5210043|NCT00786266|relaxation|relaxation
5210044|NCT00786253|Erectile dysfunction|erectile dysfunction
5210045|NCT00786253|Vardenafil|vardenafil
5210046|NCT00786240|Bioequivalence|bioequivalence
5210047|NCT00786240|Therapeutic Equivalency|therapeutic equivalency
5210048|NCT00786214|Functional Dyspepsia|functional dyspepsia
5210049|NCT00786214|Acupuncture|acupuncture
5210050|NCT00786214|Traditional Chinese Medicine|traditional chinese medicine
5210051|NCT00786201|CNTO 888|cnto 888
5210052|NCT00786201|Idiopathic Pulmonary Fibrosis|idiopathic pulmonary fibrosis
5210053|NCT00786201|IPF|ipf
5210054|NCT00786188|Menopause|menopause
5210055|NCT00786188|Vasomotor Symptoms|vasomotor symptoms
5210056|NCT00786188|Hot flash|hot flash
5210057|NCT00786188|Perimenopause|perimenopause
5210058|NCT00786188|Nonhormonal therapies|nonhormonal therapies
5210059|NCT00786188|Climacteric symptoms|climacteric symptoms
5210060|NCT00786188|Mesafem|mesafem
5210061|NCT00786188|Low-Dose Mesylate salt of Paroxetine (LDMP)|low-dose mesylate salt of paroxetine (ldmp)
5210062|NCT00786149|Underserved populations|underserved populations
5210063|NCT00786149|Homelessness|homelessness
5210064|NCT00786149|Nicotine replacement therapy|nicotine replacement therapy
5210065|NCT00786149|Counseling|counseling
5210066|NCT00786149|Cancer Prevention and control|cancer prevention and control
5210067|NCT00786136|diabetes mellitus|diabetes mellitus
5210068|NCT00786136|chronic kidney disease|chronic kidney disease
5210069|NCT00786136|contrast induced acute kidney injury|contrast induced acute kidney injury
5210070|NCT00786136|angiography|angiography
5210071|NCT00786123|irritable bowel syndrome|irritable bowel syndrome
5210072|NCT00786123|rectal hypersensitivity|rectal hypersensitivity
5210073|NCT00786123|probiotics|probiotics
5210074|NCT00786123|melatonin|melatonin
5210075|NCT00786123|brain-gut axis|brain-gut axis
5210076|NCT00786110|Sorafenib|sorafenib
5210077|NCT00786110|Paclitaxel|paclitaxel
5210078|NCT00786110|Disease free survival|disease free survival
5210079|NCT00786084|Hiatal hernia|hiatal hernia
5210080|NCT00786084|PEH|peh
5210081|NCT00786084|paraesophageal hernia|paraesophageal hernia
5210082|NCT00786084|synthetic mesh|synthetic mesh
5210083|NCT00786084|small intestine submucosa|small intestine submucosa
5210084|NCT00786071|Rett syndrome.|rett syndrome.
5210085|NCT00786071|Nutritional status.|nutritional status.
5210086|NCT00786071|Metabolic alterations.|metabolic alterations.
5210087|NCT00786058|refractory pancreatic cancer|refractory pancreatic cancer
5210088|NCT00786058|gemcitabine|gemcitabine
5210089|NCT00786058|phase III|phase iii
5210090|NCT00786058|second line|second line
5210091|NCT00786045|stroke|stroke
5210092|NCT00786045|rehabilitation|rehabilitation
5210093|NCT00786045|walking|walking
5210094|NCT00786032|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
5210095|NCT00786032|Brain Computer Interface (BCI)|brain computer interface (bci)
5210096|NCT00786032|Lou Gehrig's disease|lou gehrig's disease
5210097|NCT00786019|Type|type
5210099|NCT00786019|Diabetes|diabetes
5210100|NCT00786019|Blood|blood
5210101|NCT00786019|Vessel|vessel
5210102|NCT00786019|Function|function
5210103|NCT00786019|Exercise|exercise
5210104|NCT00786019|Program|program
5210105|NCT00786019|Intervention|intervention
5210106|NCT00786019|Vitamin|vitamin
5210107|NCT00786019|C|c
5210108|NCT00786019|Men|men
5210109|NCT00786019|Women|women
5210110|NCT00786019|Blood vessel function|blood vessel function
5210111|NCT00786006|pancreatic cancer|pancreatic cancer
5210112|NCT00786006|gemcitabine|gemcitabine
5210113|NCT00786006|oxaliplatin|oxaliplatin
5210114|NCT00786006|irinotecan|irinotecan
5210115|NCT00786006|fluorouracil|fluorouracil
5210116|NCT00786006|Failure to gemcitabine chemotherapy|failure to gemcitabine chemotherapy
5210117|NCT00785993|Egg banking, clinical outcome|egg banking, clinical outcome
5210118|NCT00785980|quinine sulfate|quinine sulfate
5210119|NCT00785980|ciprofloxacin|ciprofloxacin
5210120|NCT00785980|drug interactions|drug interactions
5210121|NCT00785980|cytochrome p450|cytochrome p450
5210122|NCT00785980|male|male
5210123|NCT00785980|female|female
5210124|NCT00785980|adult|adult
5210125|NCT00785980|pharmacokinetics|pharmacokinetics
5210126|NCT00785967|V(D)J recombination; RAG-1/2 recombinase function|v(d)j recombination; rag-1/2 recombinase function
5210127|NCT00785954|Heart Diseases|heart diseases
5210128|NCT00785954|Myocardial Ischemia|myocardial ischemia
5210129|NCT00785954|Infarction|infarction
5210130|NCT00785954|Myocardial Infarction|myocardial infarction
5210131|NCT00785941|Tumors|tumors
5210132|NCT00785941|Antibodies, Monoclonal|antibodies, monoclonal
5210133|NCT00785928|Arthritis|arthritis
5210134|NCT00785915|AZD6765|azd6765
5210135|NCT00785915|Japanese and Caucasian Healthy Volunteers|japanese and caucasian healthy volunteers
5210136|NCT00785915|Phase I study|phase i study
5210137|NCT00785915|Single and multiple Ascending Dose|single and multiple ascending dose
5210138|NCT00785915|Japanese volunteers|japanese volunteers
5210139|NCT00785889|Colorectal cancer screening|colorectal cancer screening
5210140|NCT00785889|optical colonoscopy|optical colonoscopy
5210141|NCT00785889|water method|water method
5210142|NCT00785889|sedation|sedation
5210143|NCT00785876|Paediatric|paediatric
5210144|NCT00785876|Emergency Department|emergency department
5210145|NCT00785876|Ankle|ankle
5210146|NCT00785876|Injury|injury
5210147|NCT00785876|Low risk ankle rule|low risk ankle rule
5210148|NCT00785863|hyperalgesia|hyperalgesia
5210149|NCT00785863|remifentanil|remifentanil
5210150|NCT00785863|ketorolac|ketorolac
5210151|NCT00785863|parecoxib|parecoxib
5210152|NCT00785863|COX-1 inhibitor|cox-1 inhibitor
5210153|NCT00785863|COX-2 inhibitor|cox-2 inhibitor
5210154|NCT00785837|Hydrotherapy|hydrotherapy
5210155|NCT00785837|Perinatal Care|perinatal care
5210156|NCT00785837|Neonatology|neonatology
5210157|NCT00785824|Lactation|lactation
5210158|NCT00785824|Endocrine System Diseases|endocrine system diseases
5210159|NCT00785824|Musculoskeletal System Disease|musculoskeletal system disease
5210160|NCT00785824|Hormone|hormone
5210161|NCT00785824|Physiological Properties|physiological properties
5210162|NCT00785798|Relapsed Lymphomas|relapsed lymphomas
5210163|NCT00785798|Refractory Lymphomas|refractory lymphomas
5210164|NCT00785785|Unresectable GIST|unresectable gist
5210165|NCT00785785|metastatic GIST|metastatic gist
5210166|NCT00785785|nilotinib|nilotinib
5210167|NCT00785785|AMN107|amn107
5210168|NCT00785785|imatinib|imatinib
5210169|NCT00785785|STI571|sti571
5210170|NCT00785772|Gabapentin Pharmacokinetics|gabapentin pharmacokinetics
5210171|NCT00785759|Alzheimer's Disease|alzheimer's disease
5210172|NCT00785746|elderly, balance, core, strength|elderly, balance, core, strength
5210173|NCT00785733|asthma|asthma
5210174|NCT00785707|sensorineural hearing loss|sensorineural hearing loss
5210175|NCT00785707|cochlear implant|cochlear implant
5210176|NCT00785668|Asthma|asthma
5210177|NCT00785668|Allergy|allergy
5210178|NCT00785668|Interleukin-4|interleukin-4
5210179|NCT00785668|Interleukin-13|interleukin-13
5210180|NCT00785668|IL-4|il-4
5210181|NCT00785668|IL-13|il-13
5210182|NCT00785668|Pharmacokinetics|pharmacokinetics
5210183|NCT00785668|Safety|safety
5210184|NCT00785668|Tolerability|tolerability
5210185|NCT00785668|Aerovance|aerovance
5210186|NCT00785668|dry powder|dry powder
5210187|NCT00785629|phosphorus|phosphorus
5210188|NCT00785629|secondary hyperparathyroidism|secondary hyperparathyroidism
5210189|NCT00785629|vascular calcification|vascular calcification
5210190|NCT00785616|HIV|hiv
5210191|NCT00785616|Adherence|adherence
5210192|NCT00785616|MEMS|mems
5210193|NCT00785603|Depression|depression
5210194|NCT00785603|pain|pain
5210195|NCT00785603|CYP2D6|cyp2d6
5210196|NCT00785603|interactions|interactions
5210197|NCT00785603|Pupillometry|pupillometry
5210198|NCT00785603|Tramadol|tramadol
5210199|NCT00785603|Paroxetine|paroxetine
5210200|NCT00785603|MR-ratio|mr-ratio
5210201|NCT00785564|T-wave memory|t-wave memory
5210202|NCT00785564|Sick Sinus Syndrome|sick sinus syndrome
5210203|NCT00785551|male|male
5210204|NCT00785551|female|female
5210205|NCT00785551|pharmacokinetics|pharmacokinetics
5210206|NCT00785551|normal and impaired renal function|normal and impaired renal function
5210207|NCT00785538|Tumors|tumors
5210208|NCT00785538|Antibodies, Monoclonal|antibodies, monoclonal
5210209|NCT00785525|Healthy Unrelated Stem Cell Donors|healthy unrelated stem cell donors
5210210|NCT00785512|nebivolol|nebivolol
5210211|NCT00785512|Bystolic®|bystolic®
5210212|NCT00785512|Hypertension|hypertension
5210213|NCT00785512|blood pressure|blood pressure
5210214|NCT00785512|withdrawal|withdrawal
5210215|NCT00785499|obesity|obesity
5210216|NCT00785499|metabolic syndrome|metabolic syndrome
5210217|NCT00785499|milk components|milk components
5210218|NCT00785499|casein|casein
5210219|NCT00785499|whey|whey
5210220|NCT00785499|children|children
5210221|NCT00785499|adolescent|adolescent
5210222|NCT00785486|midazolam|midazolam
5210223|NCT00785486|drug interactions|drug interactions
5210224|NCT00785486|cytochrome p450|cytochrome p450
5210225|NCT00785447|Cardiopulmonary Resuscitation|cardiopulmonary resuscitation
5210226|NCT00785447|Respiratory Physiology|respiratory physiology
5210227|NCT00785447|Mouth to mouth ventilation|mouth to mouth ventilation
5210228|NCT00785447|Mouth to nose ventilation|mouth to nose ventilation
5210229|NCT00785434|MDD|mdd
5210230|NCT00785434|escitalopram|escitalopram
5210231|NCT00785421|heparin|heparin
5210232|NCT00785421|LMWH|lmwh
5210233|NCT00785421|pancreatic cancer|pancreatic cancer
5210234|NCT00785408|obesity|obesity
5210235|NCT00785408|overweight|overweight
5210236|NCT00785408|weight loss|weight loss
5210237|NCT00785408|Amylin|amylin
5210238|NCT00785408|AC2307|ac2307
5210239|NCT00785382|Pain, Pregabalin, Lyrica, Breast surgery|pain, pregabalin, lyrica, breast surgery
5210240|NCT00785369|skin disorders|skin disorders
5210241|NCT00785369|skin cancer|skin cancer
5210242|NCT00785369|melanoma|melanoma
5210243|NCT00785369|lentigo maligna|lentigo maligna
5210244|NCT00785356|Uterine fibroids|uterine fibroids
5210245|NCT00785356|Anemia|anemia
5210246|NCT00785343|stroke|stroke
5210247|NCT00785343|acute|acute
5210248|NCT00785343|arm|arm
5210249|NCT00785343|robot|robot
5210250|NCT00785343|therapy|therapy
5210251|NCT00785343|arm paresis|arm paresis
5210252|NCT00785330|rituximab|rituximab
5210253|NCT00785330|Non-Hodgkin's lymphoma|non-hodgkin's lymphoma
5210254|NCT00785330|diffuse large B cell lymphoma|diffuse large b cell lymphoma
5210255|NCT00785330|peripheral t cell lymphoma|peripheral t cell lymphoma
5210256|NCT00785330|graft-versus-host disease|graft-versus-host disease
5210257|NCT00785330|graft-versus-lymphoma effect|graft-versus-lymphoma effect
5210258|NCT00785330|allogeneic haematopoietic stem cell transplantation|allogeneic haematopoietic stem cell transplantation
5210259|NCT00785330|relapsed or primary progressive aggressive Non-Hodgkin's lymphoma|relapsed or primary progressive aggressive non-hodgkin's lymphoma
5210260|NCT00785317|Postmenopausal Hormone Replacement Therapy|postmenopausal hormone replacement therapy
5210261|NCT00785278|Wheelchair Set-Up|wheelchair set-up
5210262|NCT00785278|Shoulder Joint Forces|shoulder joint forces
5210263|NCT00785278|Manual Wheelchair Users|manual wheelchair users
5210264|NCT00785278|Paraplegia|paraplegia
5210265|NCT00785278|Upper Limb Pain|upper limb pain
5210266|NCT00785278|Secondary Injury to Spinal Cord Injury|secondary injury to spinal cord injury
5210267|NCT00785278|Biomechanics|biomechanics
5210268|NCT00785265|Live Donor Kidney Transplantation|live donor kidney transplantation
5210269|NCT00785265|LDKT|ldkt
5210270|NCT00785265|African Americans|african americans
5210271|NCT00785265|Disparity|disparity
5210272|NCT00785265|Education|education
5210273|NCT00785252|Catheters, Indwelling|catheters, indwelling
5210274|NCT00785239|Malignant Airway Disease|malignant airway disease
5210275|NCT00785239|Benign Airway Disease|benign airway disease
5210276|NCT00785239|Lung Cancer|lung cancer
5210277|NCT00785239|Emphysema|emphysema
5210278|NCT00785239|Chronic Bronchitis|chronic bronchitis
5210279|NCT00785239|COPD|copd
5210280|NCT00785239|Asthma|asthma
5210281|NCT00785239|Sarcoidosis|sarcoidosis
5210282|NCT00785239|Mesothelioma|mesothelioma
5210283|NCT00785239|CryoSpray Ablation|cryospray ablation
5210284|NCT00785239|Cryotherapy|cryotherapy
5210285|NCT00785239|Cryospray|cryospray
5210286|NCT00785239|Cryo|cryo
5210287|NCT00785213|rosiglitazone|rosiglitazone
5210288|NCT00785213|quinine sulfate|quinine sulfate
5210289|NCT00785213|drug interactions|drug interactions
5210290|NCT00785213|cytochrome p450|cytochrome p450
5210291|NCT00785200|MRSA|mrsa
5210292|NCT00785200|Methicillin-resistant Staphylococcus aureus|methicillin-resistant staphylococcus aureus
5210293|NCT00785200|Chlorhexidine|chlorhexidine
5210294|NCT00785200|Asymptomatic colonization|asymptomatic colonization
5210295|NCT00785200|Asymptomatic colonization, MRSA|asymptomatic colonization, mrsa
5210296|NCT00785200|Skin and soft tissue infections|skin and soft tissue infections
5210297|NCT00785187|UVB induced skin erythema|uvb induced skin erythema
5210298|NCT00785174|noninvasive ventilation, continuous posi|noninvasive ventilation, continuous posi
5210299|NCT00785161|Penumbra System|penumbra system
5210300|NCT00785161|Mechanical Thrombectomy|mechanical thrombectomy
5210301|NCT00785161|Ischemic Stroke|ischemic stroke
5210302|NCT00785161|Intervention|intervention
5210303|NCT00785161|Neurovascular|neurovascular
5210304|NCT00785161|Thrombus|thrombus
5210305|NCT00785161|Imaging|imaging
5210306|NCT00785161|Ischemic Penumbra|ischemic penumbra
5210307|NCT00785161|Functional Outcome|functional outcome
5210308|NCT00785135|vision, binocular|vision, binocular
5210309|NCT00785135|vision disparity|vision disparity
5210310|NCT00785135|headache|headache
5210311|NCT00785135|dizziness|dizziness
5210312|NCT00785135|anxiety|anxiety
5210313|NCT00785135|neck pain|neck pain
5210314|NCT00785135|learning disorders|learning disorders
5210315|NCT00785135|asthenopia|asthenopia
5210316|NCT00785135|motion sickness|motion sickness
5210317|NCT00785135|depth perception|depth perception
5210318|NCT00785135|gait disorder|gait disorder
5210319|NCT00785135|diplopia|diplopia
5210320|NCT00785135|photophobia|photophobia
5210321|NCT00785135|agoraphobia|agoraphobia
5210322|NCT00785135|panic disorder|panic disorder
5210323|NCT00785122|cancer vaccine|cancer vaccine
5210324|NCT00785109|aortic valve calcification|aortic valve calcification
5210325|NCT00785109|vitamin K supplementation|vitamin k supplementation
5210326|NCT00785096|Perception, surgical complications, patients, nurses and physicians|perception, surgical complications, patients, nurses and physicians
5210327|NCT00785083|Asthma, adrenergic beta agonists, multiple sclerosis, pulmonary function tests, forced expiratory volume|asthma, adrenergic beta agonists, multiple sclerosis, pulmonary function tests, forced expiratory volume
5210328|NCT00785070|Perioperative|perioperative
5210329|NCT00785070|Obstructive Sleep Apnea|obstructive sleep apnea
5210330|NCT00785070|Screening|screening
5210331|NCT00785070|Home Sleep Testing|home sleep testing
5210332|NCT00785057|Hypertension|hypertension
5210333|NCT00785057|Stroke|stroke
5210334|NCT00785057|Neurology|neurology
5210335|NCT00785057|JNC7|jnc7
5210336|NCT00785057|2007 ESH-ESC guidelines|2007 esh-esc guidelines
5210337|NCT00785057|survey|survey
5210338|NCT00785044|Heart Failure|heart failure
5210339|NCT00785044|MIBG|mibg
5210340|NCT00785044|123I-mIBG|123i-mibg
5210341|NCT00785031|risk management|risk management
5210342|NCT00785031|Self Management|self management
5210343|NCT00785031|Self-Efficacy|self-efficacy
5210344|NCT00785031|Disease management|disease management
5210345|NCT00785031|nurse practitioner|nurse practitioner
5210346|NCT00785031|internet|internet
5210347|NCT00785031|risk factors|risk factors
5210348|NCT00785031|vascular diseases|vascular diseases
5210349|NCT00785031|economic evaluation|economic evaluation
5210350|NCT00785018|Endotoxin|endotoxin
5210351|NCT00785018|C1-inhibitor|c1-inhibitor
5210352|NCT00785018|Inflammation|inflammation
5210353|NCT00785018|Sepsis|sepsis
5210354|NCT00785018|Multi organ dysfunction syndrome|multi organ dysfunction syndrome
5210355|NCT00785018|Complement activation|complement activation
5210356|NCT00785005|Diabetes|diabetes
5210357|NCT00785005|Exercise|exercise
5210358|NCT00785005|Women|women
5210359|NCT00785005|Research|research
5210360|NCT00785005|Bike|bike
5210361|NCT00785005|Type|type
5210362|NCT00785005|Control|control
5210363|NCT00785005|Healthy|healthy
5210364|NCT00784992|NLDO|nldo
5210365|NCT00784992|DCR|dcr
5210366|NCT00784992|silicone tubes|silicone tubes
5210367|NCT00784992|stent|stent
5210368|NCT00784979|Renal|renal
5210369|NCT00784979|Transplant|transplant
5210370|NCT00784979|PRA|pra
5210371|NCT00784966|Islet transplantation|islet transplantation
5210372|NCT00784966|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
5210373|NCT00784966|Kidney Transplantation|kidney transplantation
5210374|NCT00784953|Symbicort SMART|symbicort smart
5210375|NCT00784953|budesonide|budesonide
5210376|NCT00784953|formoterol|formoterol
5210377|NCT00784953|ICS/LABA|ics/laba
5210378|NCT00784953|Asthma Control Questionnaire|asthma control questionnaire
5210379|NCT00784953|Not optimally controlled asthma|not optimally controlled asthma
5210380|NCT00784927|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
5210381|NCT00784927|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
5210382|NCT00784927|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5210383|NCT00784927|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5210384|NCT00784927|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5210385|NCT00784927|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
5210386|NCT00784927|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
5210387|NCT00784927|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5210388|NCT00784927|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5210389|NCT00784927|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5210390|NCT00784927|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
5210391|NCT00784927|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
5210392|NCT00784927|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
5210393|NCT00784927|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5210394|NCT00784927|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5210395|NCT00784927|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
5210396|NCT00784927|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5210397|NCT00784927|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5210398|NCT00784927|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5210488|NCT00784563|Rehabilitation|rehabilitation
5210399|NCT00784927|stage I marginal zone lymphoma|stage i marginal zone lymphoma
5210400|NCT00784927|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
5210401|NCT00784927|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
5210402|NCT00784927|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5210403|NCT00784927|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5210404|NCT00784914|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5210405|NCT00784914|adult diffuse astrocytoma|adult diffuse astrocytoma
5210406|NCT00784914|adult craniopharyngioma|adult craniopharyngioma
5210407|NCT00784914|adult choroid plexus tumor|adult choroid plexus tumor
5210408|NCT00784914|adult brain stem glioma|adult brain stem glioma
5210409|NCT00784914|tumors metastatic to brain|tumors metastatic to brain
5210410|NCT00784914|recurrent adult brain tumor|recurrent adult brain tumor
5210411|NCT00784914|adult gliosarcoma|adult gliosarcoma
5210412|NCT00784914|adult giant cell glioblastoma|adult giant cell glioblastoma
5210413|NCT00784914|adult ependymoblastoma|adult ependymoblastoma
5210414|NCT00784914|adult medulloblastoma|adult medulloblastoma
5210415|NCT00784914|adult supratentorial primitive neuroectodermal tumor (PNET)|adult supratentorial primitive neuroectodermal tumor (pnet)
5210416|NCT00784914|adult anaplastic ependymoma|adult anaplastic ependymoma
5210417|NCT00784914|adult ependymoma|adult ependymoma
5210418|NCT00784914|adult myxopapillary ependymoma|adult myxopapillary ependymoma
5210419|NCT00784914|adult subependymoma|adult subependymoma
5210420|NCT00784914|adult mixed glioma|adult mixed glioma
5210421|NCT00784914|meningeal melanocytoma|meningeal melanocytoma
5210422|NCT00784914|adult meningeal hemangiopericytoma|adult meningeal hemangiopericytoma
5210423|NCT00784914|adult grade I meningioma|adult grade i meningioma
5210424|NCT00784914|adult grade II meningioma|adult grade ii meningioma
5210425|NCT00784914|adult grade III meningioma|adult grade iii meningioma
5210426|NCT00784914|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
5210427|NCT00784914|adult oligodendroglioma|adult oligodendroglioma
5210428|NCT00784914|adult pineoblastoma|adult pineoblastoma
5210429|NCT00784914|adult pineocytoma|adult pineocytoma
5210430|NCT00784901|Macular Thickness Analyzed by Optical Coherence Tomography in Retinitis Pigmemtosa|macular thickness analyzed by optical coherence tomography in retinitis pigmemtosa
5210431|NCT00784888|aromatase inhibitor|aromatase inhibitor
5210432|NCT00784888|quality of life|quality of life
5210433|NCT00784888|safety|safety
5210434|NCT00784888|postmenopausal breast cancer|postmenopausal breast cancer
5210435|NCT00784849|Breast cancer|breast cancer
5210436|NCT00784849|diagnostic|diagnostic
5210437|NCT00784849|lymph nodes|lymph nodes
5210438|NCT00784836|Multiple Sclerosis - Relapsing|multiple sclerosis - relapsing
5210439|NCT00784810|Efficacy, tolerability, moderate/severe, oxycodone/naloxone|efficacy, tolerability, moderate/severe, oxycodone/naloxone
5210440|NCT00784810|codeine/paracetamol, chronic low back pain, osteoarthritis|codeine/paracetamol, chronic low back pain, osteoarthritis
5210441|NCT00784784|antiviral drugs|antiviral drugs
5210442|NCT00784784|influenza vaccines|influenza vaccines
5210443|NCT00784771|Hypnotherapy|hypnotherapy
5210444|NCT00784771|Hypnosis|hypnosis
5210445|NCT00784771|PTSD|ptsd
5210446|NCT00784758|Asthma|asthma
5210447|NCT00784758|Lung Diseases|lung diseases
5210448|NCT00784758|Respiratory Tract Diseases|respiratory tract diseases
5210449|NCT00784745|incretin effect|incretin effect
5210450|NCT00784745|type 2 diabetes|type 2 diabetes
5210451|NCT00784745|GLP-1|glp-1
5210452|NCT00784745|GIP|gip
5210453|NCT00784745|dexamethasone|dexamethasone
5210454|NCT00784732|Seasonal Allergic Rhinitis|seasonal allergic rhinitis
5210455|NCT00784732|Environmental Exposure Chamber|environmental exposure chamber
5210456|NCT00784732|nasal lavage|nasal lavage
5210457|NCT00784719|Dry eye|dry eye
5210458|NCT00784706|stroke rehabilitation|stroke rehabilitation
5210459|NCT00784706|perceptual deficits|perceptual deficits
5210460|NCT00784706|kinematic analysis|kinematic analysis
5210461|NCT00784693|Endometriosis|endometriosis
5210462|NCT00784693|pain|pain
5210463|NCT00784693|tanezumab|tanezumab
5210464|NCT00784693|nerve growth factor|nerve growth factor
5210465|NCT00784693|questionnaires|questionnaires
5210466|NCT00784667|Colorectal neoplasm|colorectal neoplasm
5210467|NCT00784667|Metastasis|metastasis
5210468|NCT00784615|Phenotypes of Polycystic Ovary Syndrome|phenotypes of polycystic ovary syndrome
5210469|NCT00784615|Cardiovascular risk factors|cardiovascular risk factors
5210470|NCT00784615|Adiponectin|adiponectin
5210471|NCT00784615|C Reactive Protein|c reactive protein
5210472|NCT00784602|prolapse|prolapse
5210473|NCT00784602|pelvic organ prolapse|pelvic organ prolapse
5210474|NCT00784589|Corticothérapy|corticothérapy
5210475|NCT00784589|Rituximab|rituximab
5210476|NCT00784589|therapeutic efficacity|therapeutic efficacity
5210477|NCT00784589|therapeutic tolerance|therapeutic tolerance
5210478|NCT00784576|Delirium|delirium
5210479|NCT00784576|Cardiac Surgery|cardiac surgery
5210480|NCT00784576|Depression|depression
5210481|NCT00784576|Cognitive Impairment|cognitive impairment
5210482|NCT00784576|Diagnostic Criteria for Delirium|diagnostic criteria for delirium
5210483|NCT00784576|Memorial Delirium Assessment Scale|memorial delirium assessment scale
5210484|NCT00784576|Delirium Index|delirium index
5210485|NCT00784563|Parkinson Disease|parkinson disease
5210486|NCT00784563|Exercise/*physiology|exercise/*physiology
5210487|NCT00784563|*Physical Fitness|*physical fitness
5210489|NCT00784563|Cognition|cognition
5210490|NCT00784550|Spirometry|spirometry
5210491|NCT00784550|COPD|copd
5210492|NCT00784537|Hodgkin's lymphoma|hodgkin's lymphoma
5210493|NCT00784537|ABVD|abvd
5210494|NCT00784537|FDG-PET (18-Fluoro-deoxy-D-glucose Positron Emission Tomography)|fdg-pet (18-fluoro-deoxy-d-glucose positron emission tomography)
5210495|NCT00784537|Radiotherapy|radiotherapy
5210496|NCT00784524|stage IV breast cancer|stage iv breast cancer
5210497|NCT00784524|recurrent breast cancer|recurrent breast cancer
5210498|NCT00784524|metastatic breast cancer|metastatic breast cancer
5210499|NCT00784511|diabetes|diabetes
5210500|NCT00784511|vitamin D|vitamin d
5210501|NCT00784511|African Americans|african americans
5210502|NCT00784511|overweight|overweight
5210503|NCT00784511|insulin sensitivity|insulin sensitivity
5210504|NCT00784511|glucose control|glucose control
5210505|NCT00784498|Procedural sedation and analgesia|procedural sedation and analgesia
5210506|NCT00784498|Emergency Department|emergency department
5210507|NCT00784498|propofol versus ketamine and midazolam|propofol versus ketamine and midazolam
5210508|NCT00784498|painful orthopedic manipulations|painful orthopedic manipulations
5210509|NCT00784485|Asthma|asthma
5210510|NCT00784485|Respiratory Tract Diseases|respiratory tract diseases
5210511|NCT00784485|Lung Diseases|lung diseases
5210512|NCT00784485|Dyspnea|dyspnea
5210513|NCT00784472|PCNL|pcnl
5210514|NCT00784472|oxycodone|oxycodone
5210515|NCT00784472|morphine|morphine
5210516|NCT00784472|visceral pain|visceral pain
5210517|NCT00784459|Asthma|asthma
5210518|NCT00784459|Allergy|allergy
5210519|NCT00784446|AIO|aio
5210520|NCT00784446|colorectal cancer|colorectal cancer
5210521|NCT00784446|0205|0205
5210522|NCT00784446|Capecitabine|capecitabine
5210523|NCT00784446|Oxaliplatin|oxaliplatin
5210524|NCT00784446|Bevacizumab|bevacizumab
5210525|NCT00784446|Imatinib|imatinib
5210526|NCT00784433|alcohol diabetes CVD|alcohol diabetes cvd
5210527|NCT00784420|Drug Interaction, Pharmacokinetics|drug interaction, pharmacokinetics
5210528|NCT00784407|thyroid surgery|thyroid surgery
5210529|NCT00784407|total thyroidectomy|total thyroidectomy
5210530|NCT00784407|harmonic scalpel|harmonic scalpel
5210531|NCT00784381|Renal failure|renal failure
5210532|NCT00784381|Elderly|elderly
5210533|NCT00784381|Drug Therapy Computer-Assisted|drug therapy computer-assisted
5210534|NCT00784381|Quality of care|quality of care
5210535|NCT00784381|Patients With Impaired Renal Function|patients with impaired renal function
5210536|NCT00784381|Inappropriateness of target drug prescribed|inappropriateness of target drug prescribed
5210537|NCT00784368|Mycoses|mycoses
5210538|NCT00784368|Candidiasis|candidiasis
5210539|NCT00784368|Aspergillosis|aspergillosis
5210540|NCT00784368|Cryptococcosis|cryptococcosis
5210541|NCT00784368|Blastomycosis|blastomycosis
5210542|NCT00784368|Histoplasmosis|histoplasmosis
5210543|NCT00784368|Neutropenia|neutropenia
5210544|NCT00784368|Itraconazole|itraconazole
5210545|NCT00784368|JK1211|jk1211
5210546|NCT00784355|recurrence of idiopathic pancreatitis|recurrence of idiopathic pancreatitis
5210547|NCT00784355|laparoscopic cholecystectomy|laparoscopic cholecystectomy
5210548|NCT00784355|etiology of pancreatitis|etiology of pancreatitis
5210549|NCT00784342|COPD|copd
5210550|NCT00784329|Lung Cancer|lung cancer
5210551|NCT00784329|Squamous Cell Lung Cancer|squamous cell lung cancer
5210552|NCT00784329|Bronchial carcinoma in situ|bronchial carcinoma in situ
5210553|NCT00784329|Central Airway Diseases|central airway diseases
5210554|NCT00784316|Prevention|prevention
5210555|NCT00784303|Thyroid Cancer|thyroid cancer
5210556|NCT00784277|Pain medication|pain medication
5210557|NCT00784277|Arthritis|arthritis
5210558|NCT00784277|Joint pain|joint pain
5210559|NCT00784277|Analgesia|analgesia
5210560|NCT00784277|Analgesics|analgesics
5210561|NCT00784277|tapentadol|tapentadol
5210562|NCT00784277|CG5503|cg5503
5210563|NCT00784277|Nucynta|nucynta
5210564|NCT00784264|Asymptomatic atherosclerosis|asymptomatic atherosclerosis
5210565|NCT00784264|Intima media thickness (IMT)|intima media thickness (imt)
5210566|NCT00784264|central obesity|central obesity
5210567|NCT00784264|cardiovascular disease|cardiovascular disease
5210568|NCT00784251|Pain|pain
5210569|NCT00784251|Leg pain|leg pain
5210570|NCT00784251|Back pain|back pain
5210571|NCT00784251|PROMIS|promis
5210572|NCT00784238|Schizophrenia|schizophrenia
5210573|NCT00784238|Paliperidone Extended-release|paliperidone extended-release
5210574|NCT00784238|Paliperidone|paliperidone
5210575|NCT00784238|R076477|r076477
5210576|NCT00784225|cataract|cataract
5210577|NCT00784225|advanced macular degeneration|advanced macular degeneration
5210578|NCT00784212|Photosensitive Epilepsy, photic stimulation, electroencephalogram|photosensitive epilepsy, photic stimulation, electroencephalogram
5210579|NCT00784199|MDD|mdd
5210580|NCT00784199|Depression|depression
5210581|NCT00784186|Pregnancy termination|pregnancy termination
5210582|NCT00784186|abortion|abortion
5210583|NCT00784186|medical abortion|medical abortion
5210584|NCT00784186|2nd trimester|2nd trimester
5210585|NCT00784186|mifepristone|mifepristone
5210586|NCT00784186|misoprostol|misoprostol
5210587|NCT00784173|Syndrome|syndrome
5210588|NCT00784173|Velocardiofacial|velocardiofacial
5210589|NCT00784173|Middle ear|middle ear
5210590|NCT00784173|Inner ear|inner ear
5210591|NCT00784173|Malformation|malformation
5210592|NCT00784147|HIV|hiv
5210593|NCT00784147|CD4|cd4
5210594|NCT00784147|experienced|experienced
5210595|NCT00784147|resistant|resistant
5210596|NCT00784147|resistance|resistance
5210597|NCT00784147|monoclonal|monoclonal
5210598|NCT00784147|antibody|antibody
5210599|NCT00784147|infusion|infusion
5210600|NCT00784147|ibalizumab|ibalizumab
5210601|NCT00784147|TNX355|tnx355
5210602|NCT00784147|TNX-355|tnx-355
5210603|NCT00784147|TMB355|tmb355
5210604|NCT00784147|TMB-355|tmb-355
5210605|NCT00784134|intraventricular hemorrhage thrombolysis|intraventricular hemorrhage thrombolysis
5210606|NCT00784095|quality of life|quality of life
5210607|NCT00784082|Sickle cell disease, hydroxyurea, inflammation|sickle cell disease, hydroxyurea, inflammation
5210608|NCT00784043|Cochlear implant|cochlear implant
5210609|NCT00784043|hearing loss|hearing loss
5210610|NCT00784030|Autosomal Dominant Polycystic Kidney Disease|autosomal dominant polycystic kidney disease
5210611|NCT00784030|Polycystic Kidney Disease|polycystic kidney disease
5210612|NCT00784030|Water Loading|water loading
5210613|NCT00784030|Biomarkers|biomarkers
5210614|NCT00784017|Children with previously untreated acute lymphoblastic leukemia|children with previously untreated acute lymphoblastic leukemia
5210615|NCT00784004|breathing patterns,|breathing patterns,
5210616|NCT00784004|unidirectional breathing,|unidirectional breathing,
5210617|NCT00784004|mask ventilation,|mask ventilation,
5210618|NCT00784004|respiratory physiology|respiratory physiology
5210619|NCT00783991|IVF|ivf
5210620|NCT00783991|PDA|pda
5210621|NCT00783991|PC|pc
5210622|NCT00783991|CAT|cat
5210623|NCT00783991|COPD|copd
5210624|NCT00783991|MDD|mdd
5210625|NCT00783991|RA|ra
5210626|NCT00783978|Surfactant protein C|surfactant protein c
5210627|NCT00783978|Interstitial|interstitial
5210628|NCT00783978|lung|lung
5210629|NCT00783978|Children|children
5210630|NCT00783965|nevoid basal cell carcinoma syndrome|nevoid basal cell carcinoma syndrome
5210631|NCT00783965|basal cell carcinoma of the skin|basal cell carcinoma of the skin
5210632|NCT00783952|Mixed venous oxygen saturation|mixed venous oxygen saturation
5210633|NCT00783952|Tissue oxygenation|tissue oxygenation
5210634|NCT00783952|Near infrared spectroscopy|near infrared spectroscopy
5210635|NCT00783913|Direct Current Stimulation|direct current stimulation
5210636|NCT00783913|Rehabilitation|rehabilitation
5210637|NCT00783913|Motor Learning|motor learning
5210638|NCT00783913|Stroke|stroke
5210639|NCT00783900|Prevention|prevention
5210640|NCT00783887|Cilia|cilia
5210641|NCT00783887|Axoneme|axoneme
5210642|NCT00783887|Dynein|dynein
5210643|NCT00783887|Gene|gene
5210644|NCT00783887|Ultrastructure|ultrastructure
5210645|NCT00783887|Linkage analysis|linkage analysis
5210646|NCT00783848|CHF|chf
5210647|NCT00783835|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
5210648|NCT00783835|Methylphenidate|methylphenidate
5210649|NCT00783835|Concerta|concerta
5210650|NCT00783835|CONQoL|conqol
5210651|NCT00783822|breast neoplasms|breast neoplasms
5210652|NCT00783822|genetic counseling|genetic counseling
5210653|NCT00783809|intracranial pressure|intracranial pressure
5210654|NCT00783809|intracranial hypertension|intracranial hypertension
5210655|NCT00783809|ultrasound|ultrasound
5210656|NCT00783809|emergency|emergency
5210657|NCT00783809|traumatic brain injury|traumatic brain injury
5210658|NCT00783809|ocular ultrasound|ocular ultrasound
5210659|NCT00783796|Coronary artery disease|coronary artery disease
5210660|NCT00783796|Atherosclerosis|atherosclerosis
5210661|NCT00783796|Myocardial ischemia|myocardial ischemia
5210662|NCT00783783|Psychiatric disorders|psychiatric disorders
5210663|NCT00783783|Neurodevelopmental disorders|neurodevelopmental disorders
5210664|NCT00783783|Autism|autism
5210665|NCT00783783|Risperidone|risperidone
5210666|NCT00783783|Pharmacogenetics|pharmacogenetics
5210667|NCT00783783|Pharmacokinetics|pharmacokinetics
5210668|NCT00783770|Breastfeeding|breastfeeding
5210669|NCT00783770|Infant|infant
5210670|NCT00783770|Preterm|preterm
5210671|NCT00783770|Nutrition|nutrition
5210672|NCT00783757|neo-adjuvant chemotherapy|neo-adjuvant chemotherapy
5210673|NCT00783757|TOBI|tobi
5210674|NCT00783757|breast imaging|breast imaging
5210675|NCT00783757|optical imaging|optical imaging
5210676|NCT00783731|intubation|intubation
5210677|NCT00783679|Cardiac output|cardiac output
5210678|NCT00783679|Noninvasive cardiac output measurement|noninvasive cardiac output measurement
5210679|NCT00783679|Thermodilution|thermodilution
5210680|NCT00783653|AML|aml
5210681|NCT00783653|FLT3|flt3
5210682|NCT00783653|acute myeloid leukemia|acute myeloid leukemia
5210683|NCT00783653|FLT 3 inhibitor|flt 3 inhibitor
5210684|NCT00783653|FLT3 mutated AML|flt3 mutated aml
5210685|NCT00783627|Endothelium|endothelium
5210686|NCT00783627|progenitors|progenitors
5210687|NCT00783627|stem cells|stem cells
5210688|NCT00783627|sickle cell|sickle cell
5210689|NCT00783614|HIV|hiv
5210690|NCT00783614|Cardiovascular Disease|cardiovascular disease
5210691|NCT00783614|Endothelial Dysfunction|endothelial dysfunction
5210692|NCT00783601|Chronic Asthma|chronic asthma
5210693|NCT00783588|Chronic lymphocytic leukemia|chronic lymphocytic leukemia
5210694|NCT00783588|CLL|cll
5210695|NCT00783588|Leukemia|leukemia
5210696|NCT00783588|Leukemia, Lymphocytic, Chronic, B-Cell|leukemia, lymphocytic, chronic, b-cell
5210697|NCT00783588|Leukemia, B-Cell|leukemia, b-cell
5210698|NCT00783588|Immune System Diseases|immune system diseases
5210699|NCT00783588|ISF35|isf35
5210700|NCT00783588|Ad-ISF35|ad-isf35
5210701|NCT00783588|Immunotherapy|immunotherapy
5210702|NCT00783588|Immune therapy|immune therapy
5210703|NCT00783588|Active immune therapy|active immune therapy
5210704|NCT00783575|Crohn's disease|crohn's disease
5210705|NCT00783575|Ulcerative colitis|ulcerative colitis
5210706|NCT00783575|Inflammatory bowel disease|inflammatory bowel disease
5210707|NCT00783575|NOD2,CARD 15 mutations|nod2,card 15 mutations
5210708|NCT00783562|Low back pain|low back pain
5210709|NCT00783562|Neck pain|neck pain
5210710|NCT00783562|Functional disability|functional disability
5210711|NCT00783562|Nursery school teachers|nursery school teachers
5210712|NCT00783562|Exercise program|exercise program
5210713|NCT00783562|Prevention|prevention
5210714|NCT00783549|tolerability|tolerability
5210715|NCT00783549|pharmacodynamics|pharmacodynamics
5210716|NCT00783549|pharmacokinetics|pharmacokinetics
5210717|NCT00783549|safety|safety
5210718|NCT00783536|An randomized, open label, multicenter study to compare the ef|an randomized, open label, multicenter study to compare the ef
5210719|NCT00783510|JIA|jia
5210720|NCT00783510|Juvenile Idiopathic Arthritis|juvenile idiopathic arthritis
5210721|NCT00783510|Juvenile Arthritis|juvenile arthritis
5210722|NCT00783510|Polyarticular JIA|polyarticular jia
5210723|NCT00783510|Polyarticular-course JIA|polyarticular-course jia
5210724|NCT00783497|High Blood Pressure|high blood pressure
5210725|NCT00783497|Stress|stress
5210726|NCT00783484|First in Human (FIH), PF-03716539, PK enhancer|first in human (fih), pf-03716539, pk enhancer
5210727|NCT00783445|Metabolic Cardiovascular Syndrome|metabolic cardiovascular syndrome
5210728|NCT00783445|Metabolic Syndrome|metabolic syndrome
5210729|NCT00783445|Obesity|obesity
5210730|NCT00783445|Hyperglycemia|hyperglycemia
5210731|NCT00783419|tubo-ovarian abscess, pelvic-inflammatory disease|tubo-ovarian abscess, pelvic-inflammatory disease
5210732|NCT00783406|COPD|copd
5210733|NCT00783380|Influenza vaccination|influenza vaccination
5210734|NCT00783380|Subunit|subunit
5210735|NCT00783380|Virosomal|virosomal
5210736|NCT00783380|HIV/AIDS|hiv/aids
5210737|NCT00783380|Renal Dialysis|renal dialysis
5210738|NCT00783380|Kidney transplantation|kidney transplantation
5210739|NCT00783380|Rheumatologic diseases|rheumatologic diseases
5210740|NCT00783380|Immunogenicity|immunogenicity
5210741|NCT00783380|Reactogenicity|reactogenicity
5210742|NCT00783367|Revlimid|revlimid
5210743|NCT00783367|Celgene brand of lenalidomide|celgene brand of lenalidomide
5210744|NCT00783367|lenalidomide|lenalidomide
5210745|NCT00783367|Rituxan|rituxan
5210746|NCT00783367|CD20 antibody, rituximab|cd20 antibody, rituximab
5210747|NCT00783367|rituximab|rituximab
5210748|NCT00783367|Follicular Lymphoma|follicular lymphoma
5210749|NCT00783367|Marginal Zone B-Cell Lymphoma|marginal zone b-cell lymphoma
5210750|NCT00783367|Lymphoma, Small Lymphocytic|lymphoma, small lymphocytic
5210751|NCT00783367|Waldenstrom Macroglobulinemia|waldenstrom macroglobulinemia
5210752|NCT00783367|Mantle-Cell Lymphoma|mantle-cell lymphoma
5210753|NCT00783367|Antigens, CD20|antigens, cd20
5210754|NCT00783367|refractory|refractory
5210755|NCT00783367|resistantRefractory/progressive lymphoma less than 6 months from first rituximab dose of previous rituximab-containing regimen|resistantrefractory/progressive lymphoma less than 6 months from first rituximab dose of previous rituximab-containing regimen
5210756|NCT00783367|Previously treated|previously treated
5210757|NCT00783367|Treated with rituximab|treated with rituximab
5210758|NCT00783328|solid tumor|solid tumor
5210759|NCT00783315|Hypertension|hypertension
5210760|NCT00783315|Diabetes|diabetes
5210761|NCT00783315|Hypercholesterolemia|hypercholesterolemia
5210762|NCT00783302|CAD|cad
5210763|NCT00783302|Visipaque|visipaque
5210764|NCT00783302|CCTA|ccta
5210765|NCT00783250|COPD|copd
5210766|NCT00783250|Respiratory Mechanics|respiratory mechanics
5210767|NCT00783250|Bronchodilators|bronchodilators
5210768|NCT00783250|COPD patients with poor reversibility|copd patients with poor reversibility
5210769|NCT00783185|psychotic disorders|psychotic disorders
5210770|NCT00783185|cannabis|cannabis
5210771|NCT00783185|intervention|intervention
5210772|NCT00783172|pancreas|pancreas
5210773|NCT00783172|pancreatic cancer|pancreatic cancer
5210774|NCT00783172|cancer|cancer
5210775|NCT00783172|Opioid Growth Factor|opioid growth factor
5210776|NCT00783172|OGF|ogf
5210777|NCT00783172|gemcitabine|gemcitabine
5210778|NCT00783172|chemotherapy|chemotherapy
5210779|NCT00783159|Muscle power|muscle power
5210780|NCT00783159|Frailty|frailty
5210781|NCT00783159|Exercise|exercise
5210782|NCT00783159|Vitamin D|vitamin d
5210783|NCT00783120|schizophrenia, negative symptoms, TMS, magnetic stimulation|schizophrenia, negative symptoms, tms, magnetic stimulation
5210784|NCT00783107|Gold Stage III COPD|gold stage iii copd
5210785|NCT00783081|Intermittent Claudication|intermittent claudication
5210786|NCT00783081|Peripheral Arterial Disease|peripheral arterial disease
5210787|NCT00783068|Endotoxin|endotoxin
5210788|NCT00783068|GTS-21|gts-21
5210789|NCT00783068|Vagal activity|vagal activity
5210790|NCT00783068|Autonomic balance|autonomic balance
5210791|NCT00783055|Autonomy|autonomy
5210792|NCT00783055|Older people|older people
5210793|NCT00783055|Physically frail|physically frail
5210794|NCT00783055|Nursing home|nursing home
5210795|NCT00783055|Intervention study|intervention study
5210796|NCT00783042|TTDE-CFR|ttde-cfr
5210797|NCT00783042|coronary artery function|coronary artery function
5210798|NCT00783042|cardiovascular biomarkers|cardiovascular biomarkers
5210799|NCT00783042|rosuvastatin|rosuvastatin
5210800|NCT00783042|Crestor|crestor
5210801|NCT00783029|Vasodilation|vasodilation
5210802|NCT00783029|Vessel Reactivity|vessel reactivity
5210803|NCT00783029|Dynamic Vessel Analyzer|dynamic vessel analyzer
5210804|NCT00783029|Retina|retina
5210805|NCT00783016|appendicitis|appendicitis
5210806|NCT00783016|diagnosis|diagnosis
5210807|NCT00783003|Tolerability|tolerability
5210808|NCT00783003|Muscarinic Receptor Antagonist, Anticholinergic|muscarinic receptor antagonist, anticholinergic
5210809|NCT00783003|Safety|safety
5210810|NCT00783003|Anticholinergic|anticholinergic
5210811|NCT00783003|ß2 agonist|ß2 agonist
5210812|NCT00783003|Pharmacokinetics|pharmacokinetics
5210813|NCT00782990|stress urinary incontinence|stress urinary incontinence
5210814|NCT00782990|female incontinence|female incontinence
5210815|NCT00782990|surgical treatment|surgical treatment
5210816|NCT00782990|Female stress urinary incontinence|female stress urinary incontinence
5210817|NCT00782977|Apneic oxygenation|apneic oxygenation
5210818|NCT00782977|Apneic diffusion oxygenation|apneic diffusion oxygenation
5210819|NCT00782964|Depression|depression
5210820|NCT00782964|Major Depressive Disorder|major depressive disorder
5210821|NCT00782964|SSRI resistant depression|ssri resistant depression
5210822|NCT00782964|strategies in depression|strategies in depression
5210823|NCT00782925|Low back pain|low back pain
5210824|NCT00782925|recurrence|recurrence
5210825|NCT00782925|chronic low back pain|chronic low back pain
5210826|NCT00782925|educational program|educational program
5210827|NCT00782925|physical therapy|physical therapy
5210828|NCT00782925|home exercise|home exercise
5210829|NCT00782925|compliance|compliance
5210830|NCT00782912|postpartum anemia, postpartum depression|postpartum anemia, postpartum depression
5210831|NCT00782899|Schizophrenia|schizophrenia
5210832|NCT00782899|subjective well-being|subjective well-being
5210833|NCT00782899|depressive symptoms|depressive symptoms
5210834|NCT00782899|schizophrenia course|schizophrenia course
5210835|NCT00782886|Pathfinder|pathfinder
5210836|NCT00782886|Liver|liver
5210837|NCT00782886|Resection|resection
5210838|NCT00782886|Surgery|surgery
5210839|NCT00782886|To evaluate the effectiveness of image-guided liver surgery by measuring variables before, during and following surgery.|to evaluate the effectiveness of image-guided liver surgery by measuring variables before, during and following surgery.
5210954|NCT00782379|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5210840|NCT00782886|Completeness of resection and the accuracy of the resection, as determined by preoperative predicted RLV|completeness of resection and the accuracy of the resection, as determined by preoperative predicted rlv
5210841|NCT00782873|propofol|propofol
5210842|NCT00782873|sedation|sedation
5210843|NCT00782873|safety|safety
5210844|NCT00782873|obesity|obesity
5210845|NCT00782860|Early pregnancy failure|early pregnancy failure
5210846|NCT00782860|Misoprostol|misoprostol
5210847|NCT00782860|Gestational sac volume|gestational sac volume
5210848|NCT00782847|diabetes mellitus|diabetes mellitus
5210849|NCT00782847|diabetic nephropathy|diabetic nephropathy
5210850|NCT00782847|hypertension|hypertension
5210851|NCT00782834|GIST|gist
5210852|NCT00782834|Nilotinib|nilotinib
5210853|NCT00782821|Kidney|kidney
5210854|NCT00782821|Renal|renal
5210855|NCT00782821|Rejection|rejection
5210856|NCT00782821|High risk|high risk
5210857|NCT00782821|Induction|induction
5210858|NCT00782821|Immunology|immunology
5210859|NCT00782821|Transplantation|transplantation
5210860|NCT00782821|B Cell|b cell
5210861|NCT00782821|Allograft|allograft
5210862|NCT00782821|Desensitization|desensitization
5210863|NCT00782808|HIV DNA in Monocytes|hiv dna in monocytes
5210864|NCT00782795|Chronic pancreatitis|chronic pancreatitis
5210865|NCT00782795|Insulin resistance|insulin resistance
5210866|NCT00782756|Radiation|radiation
5210867|NCT00782756|BEVACIZUMAB|bevacizumab
5210868|NCT00782756|AVASTIN|avastin
5210869|NCT00782756|TEMOZOLOMIDE|temozolomide
5210870|NCT00782756|newly diagnosed|newly diagnosed
5210871|NCT00782756|Glioblastoma|glioblastoma
5210872|NCT00782756|GBM|gbm
5210873|NCT00782756|malignant glioma|malignant glioma
5210874|NCT00782756|Radiotherapy|radiotherapy
5210875|NCT00782756|08-126|08-126
5210876|NCT00782743|phenprocoumon|phenprocoumon
5210877|NCT00782743|anticoagulation|anticoagulation
5210878|NCT00782743|acetylic salicylic acid|acetylic salicylic acid
5210879|NCT00782743|Need for new anticoagulation treatment|need for new anticoagulation treatment
5210880|NCT00782730|bladder volume measurement|bladder volume measurement
5210881|NCT00782730|pregnancy|pregnancy
5210882|NCT00782730|bladder function|bladder function
5210883|NCT00782730|Postvoid residual volume assessment|postvoid residual volume assessment
5210884|NCT00782730|Bladder volumes|bladder volumes
5210885|NCT00782717|diabetic retinopathy|diabetic retinopathy
5210886|NCT00782717|cystoid macular edema;|cystoid macular edema;
5210887|NCT00782704|A self-administered questionnaire to collect data from patients, physicians and nurses about the severity of postoperative surgical complications.|a self-administered questionnaire to collect data from patients, physicians and nurses about the severity of postoperative surgical complications.
5210888|NCT00782704|Based on this questionnaire we will develop the morbidity index|based on this questionnaire we will develop the morbidity index
5210889|NCT00782691|FDG-PET segmentation tools|fdg-pet segmentation tools
5210890|NCT00782691|Head-and-neck cancer|head-and-neck cancer
5210891|NCT00782691|Histological validation|histological validation
5210892|NCT00782665|postoperative|postoperative
5210893|NCT00782665|infection|infection
5210894|NCT00782665|c-section|c-section
5210895|NCT00782652|myocaridal infarction|myocaridal infarction
5210896|NCT00782652|right ventricular infarction|right ventricular infarction
5210897|NCT00782652|cardiogenic shock|cardiogenic shock
5210898|NCT00782652|RVAD|rvad
5210899|NCT00782652|Right ventricular assist device|right ventricular assist device
5210900|NCT00782652|cardiac disease|cardiac disease
5210901|NCT00782652|right ventricle|right ventricle
5210902|NCT00782652|cardiac shock|cardiac shock
5210903|NCT00782652|heart dysfunction|heart dysfunction
5210904|NCT00782626|RAD001|rad001
5210905|NCT00782613|Psoriasis|psoriasis
5210906|NCT00782613|The primary objective of this study will be to evaluate the|the primary objective of this study will be to evaluate the
5210907|NCT00782613|efficacy of topical ALT-2074 applied twice daily for 28|efficacy of topical alt-2074 applied twice daily for 28
5210908|NCT00782613|days for treatment of chronic plaque psoriasis in adult|days for treatment of chronic plaque psoriasis in adult
5210909|NCT00782613|subjects.|subjects.
5210910|NCT00782613|The secondary objective will be to evaluate the safety|the secondary objective will be to evaluate the safety
5210911|NCT00782613|of topical ALT-2074 applied twice daily for 28 days for|of topical alt-2074 applied twice daily for 28 days for
5210912|NCT00782613|treatment of chronic plaque psoriasis in adult subjects.|treatment of chronic plaque psoriasis in adult subjects.
5210913|NCT00782613|Tertiary objectives will be to provide visual documentation|tertiary objectives will be to provide visual documentation
5210914|NCT00782613|of the improvement of psoriatic plaques treated with|of the improvement of psoriatic plaques treated with
5210915|NCT00782613|ALT-2074 using digital photography, and to determine the|alt-2074 using digital photography, and to determine the
5210916|NCT00782613|extent of systemic absorption of topically applied ALT-2074|extent of systemic absorption of topically applied alt-2074
5210917|NCT00782613|based on a pharmacokinetic measurement of blood|based on a pharmacokinetic measurement of blood
5210918|NCT00782613|concentration.|concentration.
5210919|NCT00782600|Pharmacokinetics Immediate Release Oral Suspension Controlled Release Formulation|pharmacokinetics immediate release oral suspension controlled release formulation
5210920|NCT00782587|Non-Muscle-Invasive Bladder Cancer|non-muscle-invasive bladder cancer
5210921|NCT00782587|Superficial Bladder Cancer|superficial bladder cancer
5210922|NCT00782587|recombinant human hyaluronidase|recombinant human hyaluronidase
5210923|NCT00782587|rHuPH20|rhuph20
5210924|NCT00782587|Chemophase®|chemophase®
5210925|NCT00782587|Mitomycin|mitomycin
5210926|NCT00782574|Advanced solid tumours|advanced solid tumours
5210927|NCT00782574|Poly(ADP ribose) polymerases|poly(adp ribose) polymerases
5210928|NCT00782574|homologous deficiency|homologous deficiency
5210929|NCT00782574|BRCA1|brca1
5210930|NCT00782561|steroid resistant focal segmental glomerulosclerosis|steroid resistant focal segmental glomerulosclerosis
5210931|NCT00782561|FSGS|fsgs
5210932|NCT00782561|adolescent focal segmental glomerulosclerosis|adolescent focal segmental glomerulosclerosis
5210933|NCT00782561|focal segmental glomerulosclerosis|focal segmental glomerulosclerosis
5210934|NCT00782548|KADIAN|kadian
5210935|NCT00782548|morphine|morphine
5210936|NCT00782548|Avinza|avinza
5210937|NCT00782548|30 mg|30 mg
5210938|NCT00782548|bioequivalence|bioequivalence
5210939|NCT00782548|fed|fed
5210940|NCT00782483|Diagnosis|diagnosis
5210941|NCT00782483|Port Wine Stain|port wine stain
5210942|NCT00782483|PWS|pws
5210943|NCT00782405|antidepressant action|antidepressant action
5210944|NCT00782405|clinical psychopharmacology|clinical psychopharmacology
5210945|NCT00782392|Nutrition|nutrition
5210946|NCT00782392|Infant Formula|infant formula
5210947|NCT00782379|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5210948|NCT00782379|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5210949|NCT00782379|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5210950|NCT00782379|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5210951|NCT00782379|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5210952|NCT00782379|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5210953|NCT00782379|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5210955|NCT00782379|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5210956|NCT00782379|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5210957|NCT00782379|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5210958|NCT00782379|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5210959|NCT00782379|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5210960|NCT00782379|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5210961|NCT00782379|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5210962|NCT00782379|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5210963|NCT00782379|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5210964|NCT00782379|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5210965|NCT00782379|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5210966|NCT00782379|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5210967|NCT00782379|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5210968|NCT00782379|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5210969|NCT00782379|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5210970|NCT00782379|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5210971|NCT00782379|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5210972|NCT00782379|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5210973|NCT00782379|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5210974|NCT00782379|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
5210975|NCT00782379|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
5210976|NCT00782379|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
5210977|NCT00782379|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5210978|NCT00782379|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5210979|NCT00782379|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5210980|NCT00782379|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5210981|NCT00782379|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5210982|NCT00782379|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5210983|NCT00782379|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5210984|NCT00782379|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5210985|NCT00782379|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5210986|NCT00782379|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5210987|NCT00782379|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5210988|NCT00782379|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5210989|NCT00782379|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5210990|NCT00782379|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5210991|NCT00782379|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5210992|NCT00782379|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5210993|NCT00782379|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5210994|NCT00782379|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5210995|NCT00782379|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5210996|NCT00782379|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5210997|NCT00782379|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5210998|NCT00782379|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5210999|NCT00782379|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5211000|NCT00782379|prolymphocytic leukemia|prolymphocytic leukemia
5211001|NCT00782366|predictive genomics|predictive genomics
5211002|NCT00782366|personalized medicine|personalized medicine
5211003|NCT00782366|personal genomics|personal genomics
5211004|NCT00782366|direct-to-consumer genetic testing|direct-to-consumer genetic testing
5211005|NCT00782366|genetic knowledge|genetic knowledge
5211006|NCT00782366|genetic attitudes|genetic attitudes
5211007|NCT00782353|HCV|hcv
5211008|NCT00782340|NOH|noh
5211009|NCT00782340|Neurogenic Orthostatic Hypotension|neurogenic orthostatic hypotension
5211010|NCT00782340|Orthostatic hypotension|orthostatic hypotension
5211011|NCT00782340|PAF|paf
5211012|NCT00782340|Pure Autonomic Failure|pure autonomic failure
5211013|NCT00782340|MSA|msa
5211014|NCT00782340|Multiple System Atrophy|multiple system atrophy
5211015|NCT00782340|Neuropathy|neuropathy
5211016|NCT00782340|Autonomic Failure|autonomic failure
5211017|NCT00782340|Parkinson|parkinson
5211018|NCT00782340|Dopamine Deficiency|dopamine deficiency
5211019|NCT00782340|Dopamine|dopamine
5211020|NCT00782340|Droxidopa|droxidopa
5211021|NCT00782314|asthma|asthma
5211022|NCT00782314|SMART|smart
5211023|NCT00782314|Symbicort Turbuhaler|symbicort turbuhaler
5211024|NCT00782314|asthma control|asthma control
5211025|NCT00782301|HIV and Hepatitis co-infection|hiv and hepatitis co-infection
5211026|NCT00782288|digitoxin|digitoxin
5211027|NCT00782288|inflammatory markers|inflammatory markers
5211028|NCT00782288|cytokines|cytokines
5211029|NCT00782288|gene expression|gene expression
5211030|NCT00782275|RCC|rcc
5211031|NCT00782275|avastin|avastin
5211032|NCT00782275|temsirolimus|temsirolimus
5211033|NCT00782223|hips, spine, lower limb, digital radiograph measurements, TraumaCad, digital software|hips, spine, lower limb, digital radiograph measurements, traumacad, digital software
5211034|NCT00782223|Measurements of orthopaedic parameters on digital X-rays using particular software|measurements of orthopaedic parameters on digital x-rays using particular software
5211035|NCT00782197|osteoarthritis|osteoarthritis
5211036|NCT00782197|knee|knee
5211037|NCT00782197|PRGF|prgf
5211038|NCT00782197|autologous plasma|autologous plasma
5211039|NCT00782197|plasma preparations|plasma preparations
5211040|NCT00782197|treatment|treatment
5211041|NCT00782171|Dental implants|dental implants
5211042|NCT00782158|HIV|hiv
5211043|NCT00782158|Hepatitis B|hepatitis b
5211044|NCT00782158|Coinfection|coinfection
5211045|NCT00782158|Liver Fibrosis|liver fibrosis
5211046|NCT00782158|Transient Elastography|transient elastography
5211047|NCT00782145|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
5211048|NCT00782145|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
5211049|NCT00782145|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
5211050|NCT00782145|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
5211051|NCT00782145|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
5211052|NCT00782145|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5211053|NCT00782145|atypical chronic myeloid leukemia, BCR-ABL negative|atypical chronic myeloid leukemia, bcr-abl negative
5211054|NCT00782145|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5211055|NCT00782145|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
5211056|NCT00782145|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
5211177|NCT00781729|Quality of Life|quality of life
5211057|NCT00782145|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
5211058|NCT00782145|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5211059|NCT00782145|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5211060|NCT00782145|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
5211061|NCT00782145|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5211062|NCT00782145|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5211063|NCT00782145|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5211064|NCT00782145|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5211065|NCT00782145|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
5211066|NCT00782145|primary myelofibrosis|primary myelofibrosis
5211067|NCT00782145|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5211068|NCT00782145|disseminated neuroblastoma|disseminated neuroblastoma
5211069|NCT00782145|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
5211070|NCT00782145|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
5211071|NCT00782145|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5211072|NCT00782145|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
5211073|NCT00782145|recurrent neuroblastoma|recurrent neuroblastoma
5211074|NCT00782145|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
5211075|NCT00782145|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5211076|NCT00782132|Infertility Services, HIV, pregnancy planning|infertility services, hiv, pregnancy planning
5211077|NCT00782093|AMD|amd
5211078|NCT00782080|ADHD|adhd
5211079|NCT00782080|children|children
5211080|NCT00782080|adolescents|adolescents
5211081|NCT00782080|St. John`s Wort|st. john`s wort
5211082|NCT00782080|Valerian extract|valerian extract
5211083|NCT00782080|Safety|safety
5211084|NCT00782080|Efficacy|efficacy
5211085|NCT00782067|Aggressive systemic mastocytosis|aggressive systemic mastocytosis
5211086|NCT00782067|mast cell leukemia|mast cell leukemia
5211087|NCT00782067|C-Findings|c-findings
5211088|NCT00782067|tyrosine kinase inhibitor|tyrosine kinase inhibitor
5211089|NCT00782067|KIT mutation|kit mutation
5211090|NCT00782067|AHNMD|ahnmd
5211091|NCT00782067|Systemic|systemic
5211092|NCT00782067|Aggressive|aggressive
5211093|NCT00782054|pruritus|pruritus
5211094|NCT00782054|itch|itch
5211095|NCT00782054|burn|burn
5211096|NCT00782054|endopeptidase|endopeptidase
5211097|NCT00782054|moisturizer|moisturizer
5211098|NCT00782054|randomized controlled|randomized controlled
5211099|NCT00782028|primary care, high-risk families, maternal depression|primary care, high-risk families, maternal depression
5211100|NCT00782015|almonds|almonds
5211101|NCT00782015|heart disease|heart disease
5211102|NCT00782015|vascular reactivity|vascular reactivity
5211103|NCT00782015|inflammation|inflammation
5211104|NCT00782015|dyslipidemia|dyslipidemia
5211105|NCT00782015|oxidative stress|oxidative stress
5211106|NCT00782002|Solid Tumors|solid tumors
5211107|NCT00782002|VEGF-A|vegf-a
5211108|NCT00782002|stromal cells|stromal cells
5211109|NCT00782002|endothelial cells|endothelial cells
5211110|NCT00782002|malignant cells|malignant cells
5211111|NCT00781989|early rheumatoid arthritis|early rheumatoid arthritis
5211112|NCT00781989|biomarkers|biomarkers
5211113|NCT00781989|ultrasound|ultrasound
5211114|NCT00781963|cognitive behavior therapy|cognitive behavior therapy
5211115|NCT00781963|insomnia|insomnia
5211116|NCT00781950|PAD|pad
5211117|NCT00781950|Peripheral Arterial Disease|peripheral arterial disease
5211118|NCT00781950|Diabetes|diabetes
5211119|NCT00781950|Atherosclerosis|atherosclerosis
5211120|NCT00781950|Flax|flax
5211121|NCT00781950|Flaxseeds|flaxseeds
5211122|NCT00781950|Functional Foods|functional foods
5211123|NCT00781950|Essential Fatty Acids|essential fatty acids
5211124|NCT00781950|Winnipeg|winnipeg
5211125|NCT00781911|Islet Cell|islet cell
5211126|NCT00781911|CARCINOMA, ISLET CELL|carcinoma, islet cell
5211127|NCT00781911|Octreotide|octreotide
5211128|NCT00781911|depot octreotide acetate|depot octreotide acetate
5211129|NCT00781911|Insulin-Like Growth Factor (IGF) 1|insulin-like growth factor (igf) 1
5211130|NCT00781911|Metastatic, Carcinoid or Islet Cell|metastatic, carcinoid or islet cell
5211131|NCT00781911|Neuroendocrine Tumors|neuroendocrine tumors
5211132|NCT00781898|Depot naltrexone|depot naltrexone
5211133|NCT00781898|Parolees|parolees
5211134|NCT00781898|Opioid addiction prevention|opioid addiction prevention
5211135|NCT00781898|Medication Treatment Alternatives|medication treatment alternatives
5211136|NCT00781898|Prevention of Relapse to Opioid Addiction|prevention of relapse to opioid addiction
5211137|NCT00781872|multiple sclerosis (MS)|multiple sclerosis (ms)
5211138|NCT00781872|bone marrow stromal cells|bone marrow stromal cells
5211139|NCT00781872|stem cells|stem cells
5211140|NCT00781833|Therapeutic Electric Stimulation|therapeutic electric stimulation
5211141|NCT00781833|Functional Electric Stimulation|functional electric stimulation
5211142|NCT00781833|Implantable Stimulator|implantable stimulator
5211143|NCT00781833|Muscle Strength|muscle strength
5211144|NCT00781833|Muscle Spasticity|muscle spasticity
5211145|NCT00781820|Bifonazole|bifonazole
5211146|NCT00781820|Placebo|placebo
5211147|NCT00781820|Urea|urea
5211148|NCT00781820|Nail fungus|nail fungus
5211149|NCT00781807|Heart-Assist-Devices|heart-assist-devices
5211150|NCT00781807|Rehabilitation|rehabilitation
5211151|NCT00781807|Outcome Assessment (Health Care)|outcome assessment (health care)
5211152|NCT00781807|Exercise Capacity|exercise capacity
5211153|NCT00781807|Ergometry|ergometry
5211154|NCT00781807|Social Support|social support
5211155|NCT00781807|Quality of Life|quality of life
5211156|NCT00781807|Nutrition Assessment|nutrition assessment
5211157|NCT00781807|Nutrition Therapy|nutrition therapy
5211158|NCT00781807|Neuropsychological Tests|neuropsychological tests
5211159|NCT00781781|Myeloid and Lymphoid malignances|myeloid and lymphoid malignances
5211160|NCT00781768|Bone Marrow Transplant|bone marrow transplant
5211161|NCT00781768|Nausea|nausea
5211162|NCT00781768|Vomiting|vomiting
5211163|NCT00781768|NK-1 antagonist|nk-1 antagonist
5211164|NCT00781755|smoking cessation|smoking cessation
5211165|NCT00781755|varenicline|varenicline
5211166|NCT00781755|schizophrenia|schizophrenia
5211167|NCT00781755|serious mental illness|serious mental illness
5211168|NCT00781755|Nicotine addiction|nicotine addiction
5211169|NCT00781755|Smoking Behavior|smoking behavior
5211170|NCT00781742|Depression|depression
5211171|NCT00781742|Depressive Disorder|depressive disorder
5211172|NCT00781742|MDD|mdd
5211173|NCT00781729|Kyphosis|kyphosis
5211174|NCT00781729|Yoga|yoga
5211175|NCT00781729|Aging|aging
5211176|NCT00781729|Physical performance|physical performance
5211178|NCT00781716|ST elevation myocardial infarction|st elevation myocardial infarction
5211179|NCT00781716|Drug eluting stents|drug eluting stents
5211180|NCT00781690|Chronic kidney failure|chronic kidney failure
5211181|NCT00781690|Heparin|heparin
5211182|NCT00781690|Hemodialysis|hemodialysis
5211183|NCT00781690|Biocompatibility|biocompatibility
5211184|NCT00781677|Major Depressive Disorder|major depressive disorder
5211185|NCT00781677|Depression|depression
5211186|NCT00781677|Anxiety|anxiety
5211187|NCT00781638|Pediatric UC, Adacolumn apheresis|pediatric uc, adacolumn apheresis
5211188|NCT00781625|probiotics|probiotics
5211189|NCT00781625|QoL|qol
5211190|NCT00781625|inflammation|inflammation
5211191|NCT00781625|nutritional factors|nutritional factors
5211192|NCT00781625|prophylactic aid|prophylactic aid
5211193|NCT00781625|Lactobacillus rhamnosus GR-1|lactobacillus rhamnosus gr-1
5211194|NCT00781625|Lactobacillus reuteri RC-14|lactobacillus reuteri rc-14
5211195|NCT00781625|Recurrent lower UTI in women|recurrent lower uti in women
5211196|NCT00781599|African american|african american
5211197|NCT00781599|smokers|smokers
5211198|NCT00781599|smoking cessation|smoking cessation
5211199|NCT00781599|African American smokers|african american smokers
5211200|NCT00781586|Energy expenditure|energy expenditure
5211201|NCT00781586|Nutritional|nutritional
5211202|NCT00781586|Weight control|weight control
5211203|NCT00781573|Drug Eluting Stent|drug eluting stent
5211204|NCT00781573|Clopidogrel|clopidogrel
5211205|NCT00781573|Optimal duration of clopidogrel post DES stent implantation|optimal duration of clopidogrel post des stent implantation
5211206|NCT00781560|Hyperlipidemia|hyperlipidemia
5211207|NCT00781560|Chinese National Adult Lipid Treatment Guideline (2007)|chinese national adult lipid treatment guideline (2007)
5211208|NCT00781560|Crestor®|crestor®
5211209|NCT00781547|growth hormone|growth hormone
5211210|NCT00781547|obesity|obesity
5211211|NCT00781547|abdominal obesity|abdominal obesity
5211212|NCT00781534|Health Supplements|health supplements
5211213|NCT00781534|Ginseng|ginseng
5211214|NCT00781534|Diabetes|diabetes
5211215|NCT00781508|heart failure, left sided|heart failure, left sided
5211216|NCT00781508|ventricular dysfunction|ventricular dysfunction
5211217|NCT00781508|diastolic dysfunction|diastolic dysfunction
5211218|NCT00781508|sildenafil|sildenafil
5211219|NCT00781495|insulin|insulin
5211220|NCT00781482|Positron Emission Tomography|positron emission tomography
5211221|NCT00781482|GABA receptor binding|gaba receptor binding
5211222|NCT00781482|Hypnotic Drugs|hypnotic drugs
5211223|NCT00781482|Eszopiclone|eszopiclone
5211224|NCT00781482|Zolpidem|zolpidem
5211225|NCT00781482|[11-C] Flumazenil|[11-c] flumazenil
5211226|NCT00781482|Molecular imaging of the brain|molecular imaging of the brain
5211227|NCT00781469|Rheumatoid arthritis|rheumatoid arthritis
5211228|NCT00781469|RNA|rna
5211229|NCT00781469|Synovium|synovium
5211230|NCT00781469|Peripheral blood mononuclear cells|peripheral blood mononuclear cells
5211231|NCT00781456|Migraine headache|migraine headache
5211232|NCT00781456|menstrual|menstrual
5211233|NCT00781456|oral contraceptive|oral contraceptive
5211234|NCT00781456|Menstrually-Related Migraine Headache|menstrually-related migraine headache
5211235|NCT00781443|Asthma|asthma
5211236|NCT00781417|vitamin D|vitamin d
5211237|NCT00781417|Chronic Kidney Disease|chronic kidney disease
5211238|NCT00781417|parathyroid hormone|parathyroid hormone
5211239|NCT00781417|Chronic kidney disease Stage II and III|chronic kidney disease stage ii and iii
5211240|NCT00781404|adenosine|adenosine
5211241|NCT00781404|angioplasty|angioplasty
5211242|NCT00781404|acute myocardial infarction|acute myocardial infarction
5211243|NCT00781404|acute coronary syndrome with ST segment elevation|acute coronary syndrome with st segment elevation
5211244|NCT00781404|infarct size|infarct size
5211245|NCT00781404|rescued myocardium|rescued myocardium
5211246|NCT00781391|Systemic embolic events|systemic embolic events
5211247|NCT00781378|Thrombolytic therapy|thrombolytic therapy
5211248|NCT00781378|Recombinant tissue plasminogen activator|recombinant tissue plasminogen activator
5211249|NCT00781378|Efficacy|efficacy
5211250|NCT00781378|Safety|safety
5211251|NCT00781365|Hypertension|hypertension
5211252|NCT00781365|Telemonitoring|telemonitoring
5211253|NCT00781365|Pharmacy management|pharmacy management
5211254|NCT00781352|nitrous oxide|nitrous oxide
5211255|NCT00781352|cancer recurrence|cancer recurrence
5211256|NCT00781352|colorectal surgery|colorectal surgery
5211257|NCT00781339|Bacteriuria|bacteriuria
5211258|NCT00781339|Catheterized|catheterized
5211259|NCT00781339|Chronically Catheterized|chronically catheterized
5211260|NCT00781326|Depressive Disorder, Major|depressive disorder, major
5211261|NCT00781326|Cerebrovascular Disorders|cerebrovascular disorders
5211262|NCT00781326|Risk Factors|risk factors
5211263|NCT00781326|Nimodipine|nimodipine
5211264|NCT00781300|Intraocular pressure|intraocular pressure
5211265|NCT00781300|Pterygium|pterygium
5211266|NCT00781300|Surgery|surgery
5211267|NCT00781300|Steroids|steroids
5211268|NCT00781300|Glaucoma|glaucoma
5211269|NCT00781287|human immunodeficiency virus|human immunodeficiency virus
5211270|NCT00781287|raltegravir|raltegravir
5211271|NCT00781287|primary HIV infection|primary hiv infection
5211272|NCT00781287|HIV-1|hiv-1
5211273|NCT00781261|hip|hip
5211274|NCT00781261|collapse femoral head|collapse femoral head
5211275|NCT00781261|bisphosphonates|bisphosphonates
5211276|NCT00781261|osteonecrosis|osteonecrosis
5211277|NCT00781248|enteral feeding|enteral feeding
5211278|NCT00781248|Subject who requires nasogastric tube|subject who requires nasogastric tube
5211279|NCT00781209|irradiation|irradiation
5211280|NCT00781209|stereotactic radiosurgery|stereotactic radiosurgery
5211281|NCT00781209|posterior fossa|posterior fossa
5211282|NCT00781209|cerebellar metastases|cerebellar metastases
5211283|NCT00781196|phenytoin|phenytoin
5211284|NCT00781196|gum hyperplasia|gum hyperplasia
5211285|NCT00781196|phenytoin induced gingival overgrowth|phenytoin induced gingival overgrowth
5211286|NCT00781196|plaque index|plaque index
5211287|NCT00781196|gingival overgrowth grade|gingival overgrowth grade
5211288|NCT00781183|COPD|copd
5211289|NCT00781183|rehabilitation|rehabilitation
5211290|NCT00781183|walking|walking
5211291|NCT00781170|Multiple Myeloma|multiple myeloma
5211292|NCT00781170|Plasmocytoma|plasmocytoma
5211293|NCT00781170|Stem Cell Transplantation|stem cell transplantation
5211294|NCT00781157|Spinal induced hypotension in cesarean delivery|spinal induced hypotension in cesarean delivery
5211295|NCT00781118|Acute Myocardial Infarction (MI)|acute myocardial infarction (mi)
5211296|NCT00781118|ST Shift|st shift
5211297|NCT00781118|Coronary Occlusion|coronary occlusion
5211298|NCT00781118|Acute Coronary Syndrome|acute coronary syndrome
5211299|NCT00781105|Chronic hepatitis B|chronic hepatitis b
5211300|NCT00781105|Adult|adult
5211301|NCT00781105|HBV DNA suppression|hbv dna suppression
5211302|NCT00781105|Telbivudine|telbivudine
5211303|NCT00781092|Dry Eyes|dry eyes
5211304|NCT00781092|LASIK|lasik
5211305|NCT00781092|Laser Vision Correction|laser vision correction
5211306|NCT00781079|Organization Innovation|organization innovation
5211307|NCT00781079|Opinion Leaders|opinion leaders
5211308|NCT00781079|Schizophrenia|schizophrenia
5211309|NCT00781066|POSTPARTUM HEMORRHAGE|postpartum hemorrhage
5211310|NCT00781066|PREVENTION|prevention
5211311|NCT00781066|CORD TRACTION|cord traction
5211312|NCT00781066|THIRD STAGE LABOR|third stage labor
5211313|NCT00781053|skin fibrosis|skin fibrosis
5211314|NCT00781053|systemic scleroderma|systemic scleroderma
5211315|NCT00781053|systemic sclerosis|systemic sclerosis
5211316|NCT00781053|p144|p144
5211317|NCT00781053|orphan drug|orphan drug
5211318|NCT00781040|Severe sepsis in neutropenic haematological patients|severe sepsis in neutropenic haematological patients
5211319|NCT00781001|neuropathic pain|neuropathic pain
5211320|NCT00781001|diabetic neuropathy|diabetic neuropathy
5211321|NCT00781001|cannabis|cannabis
5211322|NCT00781001|marijuana|marijuana
5211323|NCT00780975|Aplidin|aplidin
5211324|NCT00780975|Plitidepsin|plitidepsin
5211325|NCT00780975|Prostate|prostate
5211326|NCT00780975|Cancer|cancer
5211327|NCT00780962|NAC|nac
5211328|NCT00780962|Radiocontrast Nephropathy|radiocontrast nephropathy
5211329|NCT00780962|N-Acetylcysteine|n-acetylcysteine
5211330|NCT00780962|RCN|rcn
5211331|NCT00780962|RCIN|rcin
5211332|NCT00780962|Creatinine|creatinine
5211333|NCT00780962|Computerized Tomography|computerized tomography
5211334|NCT00780962|CT|ct
5211335|NCT00780962|Emergency Department|emergency department
5211336|NCT00780962|ED|ed
5211337|NCT00780949|Crohn's Disease, inflammatory bowel disease, Peyer's patches|crohn's disease, inflammatory bowel disease, peyer's patches
5211338|NCT00780897|PREMATURE OVARIAN FAILURE (POF)|premature ovarian failure (pof)
5211339|NCT00780897|GENETIC ANALYSIS|genetic analysis
5211340|NCT00780897|PHYSIOPATHOLOGIC ANALYSIS|physiopathologic analysis
5211341|NCT00780884|acupuncture|acupuncture
5211342|NCT00780884|schizophrenia|schizophrenia
5211343|NCT00780884|insomnia|insomnia
5211344|NCT00780858|GnRH antagonist|gnrh antagonist
5211345|NCT00780858|IUI|iui
5211346|NCT00780845|Acute Kidney failure|acute kidney failure
5211347|NCT00780845|Clinical outcomes|clinical outcomes
5211348|NCT00780845|On-pump|on-pump
5211349|NCT00780845|Coronary artery bypass grafting|coronary artery bypass grafting
5211350|NCT00780845|Morbidity|morbidity
5211351|NCT00780845|Mortality|mortality
5211352|NCT00780832|overactive bladder|overactive bladder
5211353|NCT00780832|dietary caffeine|dietary caffeine
5211354|NCT00780832|anticholinergic medication|anticholinergic medication
5211355|NCT00780832|lifestyle modification|lifestyle modification
5211356|NCT00780832|incontinence|incontinence
5211357|NCT00780832|urinary frequency|urinary frequency
5211358|NCT00780806|MnB|mnb
5211359|NCT00780806|rLP2086|rlp2086
5211360|NCT00780806|blood collection|blood collection
5211361|NCT00780806|vaccination|vaccination
5211362|NCT00780793|Rheumatoid arthritis|rheumatoid arthritis
5211363|NCT00780793|Remission|remission
5211364|NCT00780793|Therapeutic strategy|therapeutic strategy
5211365|NCT00780793|DMARDs|dmards
5211366|NCT00780793|Biological agents|biological agents
5211367|NCT00780780|triamcinolone|triamcinolone
5211368|NCT00780780|nepafenac|nepafenac
5211369|NCT00780780|DME|dme
5211370|NCT00780780|edema macular|edema macular
5211371|NCT00780767|angiojet|angiojet
5211372|NCT00780767|massive pulmonary embolism|massive pulmonary embolism
5211373|NCT00780767|RHEOLYTIC THROMBECTOMY|rheolytic thrombectomy
5211374|NCT00780767|patients presenting with massive pulmonary embolism|patients presenting with massive pulmonary embolism
5211375|NCT00780754|prostate cancer|prostate cancer
5211376|NCT00780754|chemoprevention|chemoprevention
5211377|NCT00780754|dutasteride|dutasteride
5211378|NCT00780741|Nasolacrimal duct obstruction|nasolacrimal duct obstruction
5211379|NCT00780741|Simple probing|simple probing
5211380|NCT00780715|Diabetes therapies|diabetes therapies
5211381|NCT00780715|Pharmacogenetics|pharmacogenetics
5211382|NCT00780702|Cocaine|cocaine
5211383|NCT00780702|Treatment|treatment
5211384|NCT00780702|Airpiprazole|airpiprazole
5211385|NCT00780702|Methadone|methadone
5211386|NCT00780702|Relapse|relapse
5211387|NCT00780702|HIV|hiv
5211388|NCT00780702|Ecological Momentary Assessment (EMA)|ecological momentary assessment (ema)
5211389|NCT00780702|Contingency Management|contingency management
5211390|NCT00780676|Dasatinib|dasatinib
5211391|NCT00780676|Metastatic Breast Cancer|metastatic breast cancer
5211392|NCT00780676|Sprycel|sprycel
5211393|NCT00780676|BMS-354825|bms-354825
5211394|NCT00780676|Genetic testing|genetic testing
5211395|NCT00780676|AZD6244|azd6244
5211396|NCT00780676|Selumetinib|selumetinib
5211397|NCT00780663|Neuroendocrine|neuroendocrine
5211398|NCT00780663|Carcinoid|carcinoid
5211399|NCT00780663|NET|net
5211400|NCT00780663|MEN-1|men-1
5211401|NCT00780663|Islet cell|islet cell
5211402|NCT00780637|Heart Transplant|heart transplant
5211403|NCT00780637|Endothelial Function|endothelial function
5211404|NCT00780637|Fibrinolysis|fibrinolysis
5211405|NCT00780637|Transplant recipients at baseline|transplant recipients at baseline
5211406|NCT00780624|RDS|rds
5211407|NCT00780624|Infant, newborn|infant, newborn
5211408|NCT00780624|NIPPV|nippv
5211409|NCT00780624|CPAP|cpap
5211410|NCT00780598|Acute Myeloid Leukemia|acute myeloid leukemia
5211411|NCT00780598|AML|aml
5211412|NCT00780598|Cancer|cancer
5211413|NCT00780598|Hematological malignancies|hematological malignancies
5211414|NCT00780598|Elderly|elderly
5211415|NCT00780598|Refractory|refractory
5211416|NCT00780598|Relapsed|relapsed
5211417|NCT00780598|Blood disorder|blood disorder
5211418|NCT00780572|Safety Management|safety management
5211419|NCT00780572|Risk Management|risk management
5211420|NCT00780572|surveillance|surveillance
5211421|NCT00780572|triggers|triggers
5211422|NCT00780559|Neuropathy|neuropathy
5211423|NCT00780559|diabetes|diabetes
5211424|NCT00780546|tuberculosis|tuberculosis
5211425|NCT00780546|spatial epidemiology|spatial epidemiology
5211426|NCT00780546|geographic information system|geographic information system
5211427|NCT00780520|glutamine inflammation HSP70 sepsis|glutamine inflammation hsp70 sepsis
5211428|NCT00780481|Obesity|obesity
5211429|NCT00780481|Endothelial Function|endothelial function
5211430|NCT00780481|Fibrinolytic Balance|fibrinolytic balance
5211431|NCT00780481|Baseline|baseline
5211432|NCT00780468|Weight loss|weight loss
5211433|NCT00780468|Diet|diet
5211434|NCT00780468|Obesity|obesity
5211435|NCT00780455|KineSEP|kinesep
5211436|NCT00780455|Rehabilitation|rehabilitation
5211437|NCT00780455|Betaferon|betaferon
5211438|NCT00780442|substance related disorders|substance related disorders
5211439|NCT00780429|kidney|kidney
5211440|NCT00780429|transplant|transplant
5211441|NCT00780429|Mycophenolic acid|mycophenolic acid
5211442|NCT00780429|Inosine monophosphate dehydrogenase|inosine monophosphate dehydrogenase
5211443|NCT00780416|Chronic Hepatitis C|chronic hepatitis c
5211444|NCT00780416|Protease Inhibitor|protease inhibitor
5211445|NCT00780416|Telaprevir|telaprevir
5211446|NCT00780416|Peginterferon Alfa-2b|peginterferon alfa-2b
5211447|NCT00780416|Ribavirin|ribavirin
5211448|NCT00780390|RSD|rsd
5211449|NCT00780390|SCS|scs
5211450|NCT00780390|CRPS|crps
5211451|NCT00780390|Complex regional pain syndrome patients before undergoing spinal cord stimulator implant and under other treatments|complex regional pain syndrome patients before undergoing spinal cord stimulator implant and under other treatments
5211452|NCT00780377|Heart Transplant|heart transplant
5211453|NCT00780377|Fibrinolysis|fibrinolysis
5211454|NCT00780377|Resting conditions|resting conditions
5211455|NCT00780364|stroke; sour taste; cold temperature; pharyngeal swallowing|stroke; sour taste; cold temperature; pharyngeal swallowing
5211456|NCT00780351|vancomycin, SLEDD-f|vancomycin, sledd-f
5211457|NCT00780325|Cyclooxygenase-2|cyclooxygenase-2
5211458|NCT00780325|Carbonic anhydrase|carbonic anhydrase
5211459|NCT00780325|Eicosanoids|eicosanoids
5211460|NCT00780325|Healthy volunteers|healthy volunteers
5211461|NCT00780312|radiotherapy|radiotherapy
5211462|NCT00780312|trismus|trismus
5211463|NCT00780312|physiotherapy|physiotherapy
5211464|NCT00780312|lymphoedema|lymphoedema
5211465|NCT00780312|late side effects|late side effects
5211466|NCT00780312|fibrosis|fibrosis
5211467|NCT00780312|decreased cervical range of motion|decreased cervical range of motion
5211468|NCT00780312|quality of life|quality of life
5211469|NCT00780299|Plasma epuration|plasma epuration
5211470|NCT00780299|Hemofiltration|hemofiltration
5211471|NCT00780299|Cardiac arrest|cardiac arrest
5211472|NCT00780299|Shock|shock
5211473|NCT00780299|Inflammatory mediators|inflammatory mediators
5211474|NCT00780273|subjects with edentulous mandible|subjects with edentulous mandible
5211475|NCT00780260|HIV/AIDS|hiv/aids
5211476|NCT00780260|African Americans|african americans
5211477|NCT00780260|Women|women
5211478|NCT00780260|Case Management|case management
5211479|NCT00780247|Vitamin D|vitamin d
5211480|NCT00780247|Sun|sun
5211481|NCT00780247|Latitude|latitude
5211482|NCT00780247|Vitamin D status|vitamin d status
5211483|NCT00780234|chemoprevention|chemoprevention
5211484|NCT00780234|lung cancer|lung cancer
5211485|NCT00780234|pioglitazone|pioglitazone
5211486|NCT00780221|CRP|crp
5211487|NCT00780221|coronary artery disease|coronary artery disease
5211488|NCT00780221|polymorphisms|polymorphisms
5211489|NCT00780208|Attention Deficit Hyperactivity ADHD|attention deficit hyperactivity adhd
5211490|NCT00780195|hypoglycemia|hypoglycemia
5211491|NCT00780195|African Americans|african americans
5211492|NCT00780182|Bioavailability|bioavailability
5211493|NCT00780156|Drug eluting stent|drug eluting stent
5211494|NCT00780156|Dual antiplatelet therapy|dual antiplatelet therapy
5211495|NCT00780156|bleeding|bleeding
5211496|NCT00780156|stent thrombosis|stent thrombosis
5211497|NCT00780156|follow-up of the drug eluting stent|follow-up of the drug eluting stent
5211498|NCT00780143|Tumor|tumor
5211499|NCT00780143|Leukemia|leukemia
5211500|NCT00780143|Plitidepsin|plitidepsin
5211501|NCT00780143|Aplidin|aplidin
5211502|NCT00780117|CURRARINO syndrome|currarino syndrome
5211503|NCT00780117|Sacrococcygeal teratoma|sacrococcygeal teratoma
5211504|NCT00780117|HLXB9 (MNX1) gene|hlxb9 (mnx1) gene
5211505|NCT00780117|Alpha foeto protein|alpha foeto protein
5211506|NCT00780117|Prognosis factors|prognosis factors
5211507|NCT00780104|Advanced myeloid leukemias|advanced myeloid leukemias
5211508|NCT00780104|AML|aml
5211509|NCT00780104|Leukemia|leukemia
5211510|NCT00780104|Relapsed myeloid leukemias|relapsed myeloid leukemias
5211511|NCT00780104|Refractory myeloid leukemias|refractory myeloid leukemias
5211512|NCT00780104|MEC|mec
5211513|NCT00780104|Rapamycin|rapamycin
5211514|NCT00780104|Sirolimus|sirolimus
5211515|NCT00780091|optimization|optimization
5211516|NCT00780091|risk scale|risk scale
5211517|NCT00780091|non inferiority|non inferiority
5211518|NCT00780091|cluster randomization|cluster randomization
5211519|NCT00780091|monitoring strategies|monitoring strategies
5211520|NCT00780078|Intensive care unit|intensive care unit
5211521|NCT00780078|Extubation failure|extubation failure
5211522|NCT00780078|Physiotherapist|physiotherapist
5211523|NCT00780078|Pre-extubation bedside tests|pre-extubation bedside tests
5211524|NCT00780078|Swallowing disorders|swallowing disorders
5211525|NCT00780052|Hematologic Malignancies|hematologic malignancies
5211526|NCT00780052|c-myb|c-myb
5211527|NCT00780052|c-myb AS ODN|c-myb as odn
5211528|NCT00780026|liver|liver
5211529|NCT00780026|transplant|transplant
5211530|NCT00780026|blood sugar|blood sugar
5211531|NCT00780013|Bioequivalence metformin hydrochloride|bioequivalence metformin hydrochloride
5211532|NCT00779987|Dry eye|dry eye
5211533|NCT00779987|Autologous serum|autologous serum
5211534|NCT00779987|Ocular Surface Disease Index|ocular surface disease index
5211535|NCT00779974|Total Shoulder Arthroplasty|total shoulder arthroplasty
5211536|NCT00779974|Osteoarthritis|osteoarthritis
5211537|NCT00779961|pediatric|pediatric
5211538|NCT00779961|cleft palate|cleft palate
5211539|NCT00779961|plastic surgery|plastic surgery
5211540|NCT00779961|palatoplasty|palatoplasty
5211541|NCT00779961|pharyngoplasty|pharyngoplasty
5211542|NCT00779948|Femoral Neck Fracture|femoral neck fracture
5211543|NCT00779948|Internal Fixation|internal fixation
5211544|NCT00779948|Dynamic Hip Screw|dynamic hip screw
5211545|NCT00779922|Multiple Myeloma|multiple myeloma
5211546|NCT00779922|impaired renal function|impaired renal function
5211547|NCT00779909|vitamin D|vitamin d
5211548|NCT00779909|gingivitis|gingivitis
5211549|NCT00779909|periodontal disease|periodontal disease
5211550|NCT00779909|inflammation|inflammation
5211551|NCT00779896|To evaluate therapeutic potential of tazarotene 0.1% cream for the treatment of Stage I-IIA CTCL. Patients with Stage I-IIA disease are enrolled into the study|to evaluate therapeutic potential of tazarotene 0.1% cream for the treatment of stage i-iia ctcl. patients with stage i-iia disease are enrolled into the study
5211552|NCT00779896|Stage I-IIA disease CTCL|stage i-iia disease ctcl
5211553|NCT00779883|Chronic lymphocytic leukemia|chronic lymphocytic leukemia
5211554|NCT00779883|CLL|cll
5211555|NCT00779883|Leukemia|leukemia
5211556|NCT00779883|Leukemia, Lymphocytic, Chronic, B-Cell|leukemia, lymphocytic, chronic, b-cell
5211557|NCT00779883|Leukemia, B-Cell|leukemia, b-cell
5211558|NCT00779883|Immune System Diseases|immune system diseases
5211559|NCT00779883|ISF35|isf35
5211560|NCT00779883|Ad-ISF35|ad-isf35
5211561|NCT00779883|Immunotherapy|immunotherapy
5211562|NCT00779883|Immune therapy|immune therapy
5211563|NCT00779883|Active immune therapy|active immune therapy
5211564|NCT00779870|asthma severity|asthma severity
5211565|NCT00779870|airway smooth muscle|airway smooth muscle
5211566|NCT00779870|oxidative stress|oxidative stress
5211567|NCT00779857|left atrial appendage|left atrial appendage
5211568|NCT00779857|laa|laa
5211569|NCT00779857|atrial fibrillation|atrial fibrillation
5211570|NCT00779857|afib|afib
5211571|NCT00779857|af|af
5211572|NCT00779857|stroke|stroke
5211573|NCT00779857|tia|tia
5211574|NCT00779844|Anesthesia|anesthesia
5211575|NCT00779844|Obesity|obesity
5211576|NCT00779831|Bioequivalence Pseudoephedrine hydrochloride 120 mg extended release tablets|bioequivalence pseudoephedrine hydrochloride 120 mg extended release tablets
5211577|NCT00779805|Bioequivalence Pseudoephedrine hydrochloride 120 mg ER tablets|bioequivalence pseudoephedrine hydrochloride 120 mg er tablets
5211578|NCT00779792|Irritant contact dermatitis|irritant contact dermatitis
5211579|NCT00779792|experimental contact dermatitis|experimental contact dermatitis
5211580|NCT00779792|treatment|treatment
5211581|NCT00779792|efficacy|efficacy
5211582|NCT00779792|topical steroids|topical steroids
5211583|NCT00779792|topical immune modulators|topical immune modulators
5211584|NCT00779792|glycerol|glycerol
5211585|NCT00779779|Gastroenteritis|gastroenteritis
5211586|NCT00779766|Human papillomavirus|human papillomavirus
5211587|NCT00779766|vaccine|vaccine
5211588|NCT00779766|cervical cancer|cervical cancer
5211589|NCT00779766|cervical infection|cervical infection
5211590|NCT00779753|Parenteral Feeding|parenteral feeding
5211591|NCT00779753|Neonate|neonate
5211592|NCT00779753|Lysine|lysine
5211593|NCT00779727|women|women
5211594|NCT00779727|increased|increased
5211595|NCT00779727|risk|risk
5211596|NCT00779714|metastatic (AJCC stage IV)|metastatic (ajcc stage iv)
5211597|NCT00779714|first-line chemotherapy|first-line chemotherapy
5211598|NCT00779714|ex-vivo chemosensitivity profiling|ex-vivo chemosensitivity profiling
5211599|NCT00779714|evaluation of biomarkers|evaluation of biomarkers
5211600|NCT00779701|Hyperglycemia|hyperglycemia
5211601|NCT00779701|Glycemic control|glycemic control
5211602|NCT00779688|Endoscopic Retrograde Cholangiopancreatography|endoscopic retrograde cholangiopancreatography
5211603|NCT00779688|ERCP|ercp
5211604|NCT00779688|bile duct cancer|bile duct cancer
5211605|NCT00779688|pancreatic duct cancer|pancreatic duct cancer
5211606|NCT00779688|gall bladder|gall bladder
5211607|NCT00779688|pancreas|pancreas
5211608|NCT00779688|duodenoscope|duodenoscope
5211609|NCT00779688|Cellvizio|cellvizio
5211610|NCT00779688|endomicroscopy|endomicroscopy
5211611|NCT00779688|cholangiopancreatoscopy|cholangiopancreatoscopy
5211612|NCT00779688|Biliary Tract Neoplasms (suspected)|biliary tract neoplasms (suspected)
5211613|NCT00779688|Biliary Tract Mass (suspected)|biliary tract mass (suspected)
5211614|NCT00779688|Biliary Tract Stricture (suspected)|biliary tract stricture (suspected)
5211615|NCT00779688|Pancreatic Duct Neoplasms (suspected)|pancreatic duct neoplasms (suspected)
5211616|NCT00779688|Pancreatic Duct Mass (suspected)|pancreatic duct mass (suspected)
5211617|NCT00779688|Pancreatic Duct Stricture (suspected)|pancreatic duct stricture (suspected)
5211618|NCT00779662|Rheumatic Heart Disease|rheumatic heart disease
5211619|NCT00779662|Streptococcus|streptococcus
5211620|NCT00779662|Fiji|fiji
5211621|NCT00779649|Colonoscopy,|colonoscopy,
5211622|NCT00779649|Prep|prep
5211623|NCT00779649|MoviPrep|moviprep
5211624|NCT00779649|HalfLytely|halflytely
5211625|NCT00779649|The effectiveness of colonoscopy preps|the effectiveness of colonoscopy preps
5211626|NCT00779597|self care|self care
5211627|NCT00779597|symptom management|symptom management
5211628|NCT00779597|pain|pain
5211629|NCT00779597|cancer|cancer
5211630|NCT00779597|nurse coaching|nurse coaching
5211631|NCT00779597|patient education|patient education
5211632|NCT00779571|Polycystic Ovary Syndrome|polycystic ovary syndrome
5211633|NCT00779571|Morbid Obesity|morbid obesity
5211634|NCT00779571|Type 2 DM|type 2 dm
5211635|NCT00779571|Coronary heart disease|coronary heart disease
5211636|NCT00779532|Electrocardiography|electrocardiography
5211637|NCT00779532|Pharmacokinetics|pharmacokinetics
5211638|NCT00779519|Obesity|obesity
5211639|NCT00779519|Class 1|class 1
5211640|NCT00779519|Class 2|class 2
5211641|NCT00779519|Weight Loss|weight loss
5211642|NCT00779519|AgRP|agrp
5211643|NCT00779519|TTP435|ttp435
5211644|NCT00779519|alphaMSH|alphamsh
5211645|NCT00779519|Agouti-Related Protein|agouti-related protein
5211646|NCT00779519|alpha-melanocyte stimulating hormone|alpha-melanocyte stimulating hormone
5211647|NCT00779506|Acute schizophrenia|acute schizophrenia
5211648|NCT00779506|PANSS|panss
5211649|NCT00779493|irritable bowel syndrome|irritable bowel syndrome
5211650|NCT00779493|constipation|constipation
5211651|NCT00779493|diarrhea|diarrhea
5211652|NCT00779493|gas|gas
5211653|NCT00779493|bloating|bloating
5211654|NCT00779493|abdominal pain|abdominal pain
5211655|NCT00779493|disturbance of defecation|disturbance of defecation
5211656|NCT00779493|irritable colon|irritable colon
5211657|NCT00779480|Acute Myelogenous Leukemia|acute myelogenous leukemia
5211658|NCT00779480|Safety|safety
5211659|NCT00779480|Dose Tolerance|dose tolerance
5211660|NCT00779480|Pharmacokinetics/Pharmacodynamics|pharmacokinetics/pharmacodynamics
5211661|NCT00779480|FLT-3|flt-3
5211662|NCT00779467|non narcotic|non narcotic
5211663|NCT00779467|epidural|epidural
5211664|NCT00779467|labor pain|labor pain
5211665|NCT00779467|Non narcotic treatment of labor pain|non narcotic treatment of labor pain
5211666|NCT00779454|KRAS wild-type|kras wild-type
5211667|NCT00779454|Cholangiocarcinoma|cholangiocarcinoma
5211668|NCT00779454|Inoperable|inoperable
5211669|NCT00779441|Bioequivalence zolpidem 10mg tablets|bioequivalence zolpidem 10mg tablets
5211670|NCT00779428|This is an open-label continuing treatment protocol in patients with advanced malignancies who will receive Tanespimycin|this is an open-label continuing treatment protocol in patients with advanced malignancies who will receive tanespimycin
5211671|NCT00779415|Partial Thickness|partial thickness
5211672|NCT00779415|Rotator Cuff|rotator cuff
5211673|NCT00779402|cancer|cancer
5211674|NCT00779402|prostate cancer|prostate cancer
5211675|NCT00779402|prostatectomy|prostatectomy
5211676|NCT00779402|PSA|psa
5211677|NCT00779402|sipuleucel-T|sipuleucel-t
5211678|NCT00779402|PROVENGE|provenge
5211679|NCT00779402|APC8015|apc8015
5211680|NCT00779402|non-metastatic|non-metastatic
5211681|NCT00779402|nonmetastatic|nonmetastatic
5211682|NCT00779402|androgen-sensitive|androgen-sensitive
5211683|NCT00779402|androgen sensitive|androgen sensitive
5211684|NCT00779402|biochemical recurrence|biochemical recurrence
5211685|NCT00779402|biochemically recurrent|biochemically recurrent
5211686|NCT00779402|immune therapy|immune therapy
5211687|NCT00779402|immunotherapy|immunotherapy
5211688|NCT00779402|vaccine|vaccine
5211689|NCT00779402|dendritic cells|dendritic cells
5211690|NCT00779402|antigen-presenting cells|antigen-presenting cells
5211691|NCT00779402|antigen presenting cells|antigen presenting cells
5211692|NCT00779402|cancer vaccine|cancer vaccine
5211693|NCT00779402|therapeutic vaccine|therapeutic vaccine
5211694|NCT00779402|therapeutic cancer vaccine|therapeutic cancer vaccine
5211695|NCT00779402|biologic|biologic
5211696|NCT00779402|booster|booster
5211697|NCT00779389|Head and Neck cancer|head and neck cancer
5211698|NCT00779376|Bioequivalence|bioequivalence
5211699|NCT00779363|obese,|obese,
5211700|NCT00779363|Diabetes|diabetes
5211701|NCT00779350|Bioequivalence sertraline 100 mg tablets fasting conditions|bioequivalence sertraline 100 mg tablets fasting conditions
5211702|NCT00779337|Epstein-Barr virus|epstein-barr virus
5211703|NCT00779337|lymphoma|lymphoma
5211704|NCT00779337|immunotherapy|immunotherapy
5211705|NCT00779324|traumatic brain injury|traumatic brain injury
5211706|NCT00779324|irritability|irritability
5211707|NCT00779324|aggression|aggression
5211708|NCT00779324|amantadine|amantadine
5211709|NCT00779324|behavior|behavior
5211710|NCT00779311|Metastatic Colorectal Cancer|metastatic colorectal cancer
5211711|NCT00779298|rye whole-meal bread|rye whole-meal bread
5211712|NCT00779298|white-wheat bread|white-wheat bread
5211984|NCT00777751|ECG|ecg
5211713|NCT00779298|gastric emptying rate|gastric emptying rate
5211714|NCT00779298|postprandial glucose response|postprandial glucose response
5211715|NCT00779298|healthy subjects|healthy subjects
5211716|NCT00779272|neoadjuvant chemotherapy|neoadjuvant chemotherapy
5211717|NCT00779272|clinically postoperative outcome|clinically postoperative outcome
5211718|NCT00779272|liver regeneration after liver resection|liver regeneration after liver resection
5211719|NCT00779259|quinine sulfate|quinine sulfate
5211720|NCT00779259|theophylline|theophylline
5211721|NCT00779259|drug interactions|drug interactions
5211722|NCT00779259|cytochrome p450|cytochrome p450
5211723|NCT00779259|humans|humans
5211724|NCT00779259|male|male
5211725|NCT00779259|adult|adult
5211726|NCT00779246|Methicillin resistance|methicillin resistance
5211727|NCT00779246|Infection control|infection control
5211728|NCT00779246|Staphylococcus aureus|staphylococcus aureus
5211729|NCT00779246|Cross infection|cross infection
5211730|NCT00779246|Epidemiology|epidemiology
5211731|NCT00779246|Chlorhexidine|chlorhexidine
5211732|NCT00779233|Bioequivalence|bioequivalence
5211733|NCT00779207|obesity|obesity
5211734|NCT00779207|aging|aging
5211735|NCT00779207|exercise|exercise
5211736|NCT00779207|diet|diet
5211737|NCT00779207|weight loss|weight loss
5211738|NCT00779207|physical function|physical function
5211739|NCT00779207|Obesity in the Elderly|obesity in the elderly
5211740|NCT00779181|Hypertension|hypertension
5211741|NCT00779181|High blood pressure|high blood pressure
5211742|NCT00779181|Htn|htn
5211743|NCT00779181|Addrenex|addrenex
5211744|NCT00779168|recurrent prostate cancer|recurrent prostate cancer
5211745|NCT00779168|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5211746|NCT00779142|resistant diabetic macular edema|resistant diabetic macular edema
5211747|NCT00779103|puberty|puberty
5211748|NCT00779103|precocious puberty|precocious puberty
5211749|NCT00779103|early puberty|early puberty
5211750|NCT00779103|early onset puberty|early onset puberty
5211751|NCT00779103|histrelin|histrelin
5211752|NCT00779103|histrelin subcutaneous implant|histrelin subcutaneous implant
5211753|NCT00779103|implant therapy|implant therapy
5211754|NCT00779077|device characteristics|device characteristics
5211755|NCT00779064|Atrial Fibrillation|atrial fibrillation
5211756|NCT00779051|Bioequivalence Zolpidem 10mg tablets|bioequivalence zolpidem 10mg tablets
5211757|NCT00779038|IONSYS|ionsys
5211758|NCT00779038|Fentanyl Iontophoretic Transdermal System|fentanyl iontophoretic transdermal system
5211759|NCT00779038|Postoperative pain|postoperative pain
5211760|NCT00778986|heart failure|heart failure
5211761|NCT00778986|remote patient monitoring|remote patient monitoring
5211762|NCT00778986|telemonitoring|telemonitoring
5211763|NCT00778986|home monitoring|home monitoring
5211764|NCT00778986|randomized controlled trial|randomized controlled trial
5211765|NCT00778986|self care|self care
5211766|NCT00778973|Bioequivalence sertraline 100 mg tablets under fed conditions|bioequivalence sertraline 100 mg tablets under fed conditions
5211767|NCT00778947|Breast Reconstruction|breast reconstruction
5211768|NCT00778947|Halmonic Scalpel|halmonic scalpel
5211769|NCT00778947|diathermy|diathermy
5211770|NCT00778947|Free Tissue Transfer|free tissue transfer
5211771|NCT00778921|Aliskiren|aliskiren
5211772|NCT00778921|Amlodipine|amlodipine
5211773|NCT00778921|Non-responder to Amlodipine|non-responder to amlodipine
5211774|NCT00778908|Nasopharyngeal carcinoma|nasopharyngeal carcinoma
5211775|NCT00778908|Locally advanced disease|locally advanced disease
5211776|NCT00778908|Intensity-modulated radiation therapy|intensity-modulated radiation therapy
5211777|NCT00778908|Accelerated hyperfractionation|accelerated hyperfractionation
5211778|NCT00778908|Concomitant boost radiation therapy|concomitant boost radiation therapy
5211779|NCT00778908|Concurrent chemotherapy|concurrent chemotherapy
5211780|NCT00778895|Flu|flu
5211781|NCT00778895|Safety|safety
5211782|NCT00778895|Immunogenicity|immunogenicity
5211783|NCT00778895|Flu vaccine|flu vaccine
5211784|NCT00778895|Influenza|influenza
5211785|NCT00778895|Virus|virus
5211786|NCT00778882|Chronic Granulomatous Disease|chronic granulomatous disease
5211787|NCT00778882|Retroviral Vector|retroviral vector
5211788|NCT00778882|Gene Therapy|gene therapy
5211789|NCT00778843|Chronic hepatitis C|chronic hepatitis c
5211790|NCT00778843|Oxidative stress|oxidative stress
5211791|NCT00778843|Antioxidant|antioxidant
5211792|NCT00778843|Cytokines|cytokines
5211793|NCT00778843|Nutritional supplement|nutritional supplement
5211794|NCT00778830|mCRC|mcrc
5211795|NCT00778804|CVD risk|cvd risk
5211796|NCT00778804|self monitoring|self monitoring
5211797|NCT00778804|Internet|internet
5211798|NCT00778804|telemedicine|telemedicine
5211799|NCT00778791|Bioequivalence metformin HC1 750 mg extended-release tablets|bioequivalence metformin hc1 750 mg extended-release tablets
5211915|NCT00778128|Solid tumours|solid tumours
5211800|NCT00778778|Bioequivalence cefprozil 500mg tablets fasting conditions|bioequivalence cefprozil 500mg tablets fasting conditions
5211801|NCT00778765|Bioequivalence gabapentin fed conditions|bioequivalence gabapentin fed conditions
5211802|NCT00778752|Multiple Myeloma|multiple myeloma
5211803|NCT00778752|Stem Cell Transplantation|stem cell transplantation
5211804|NCT00778752|Revlimid|revlimid
5211805|NCT00778752|Lenalidomide|lenalidomide
5212185|NCT00777010|memory loss|memory loss
5211806|NCT00778739|bioequivalence 1) CEFPROZIL FOR ORAL SUSPENSION USP 250 mg/ 5 mL fed conditions|bioequivalence 1) cefprozil for oral suspension usp 250 mg/ 5 ml fed conditions
5211807|NCT00778726|Bioequivalence benazepril and hydrochlorothiazide tablets|bioequivalence benazepril and hydrochlorothiazide tablets
5211808|NCT00778713|Bioequivalence|bioequivalence
5211809|NCT00778674|Bioequivalence Benazepril HCl Hydrochlorothiazide Tablets|bioequivalence benazepril hcl hydrochlorothiazide tablets
5211810|NCT00778661|Bioequivalence|bioequivalence
5211811|NCT00778648|Common cold|common cold
5211812|NCT00778648|prevention|prevention
5211813|NCT00778648|dietary supplement|dietary supplement
5211814|NCT00778609|Combined Oral Contraceptives|combined oral contraceptives
5211815|NCT00778609|Pelvic Pain|pelvic pain
5211816|NCT00778609|Headache|headache
5211817|NCT00778596|Hepatitis B|hepatitis b
5211818|NCT00778596|Telbivudine|telbivudine
5211819|NCT00778596|Prednisolone|prednisolone
5211820|NCT00778583|Bioequivalence Nitrofurantoin capsules|bioequivalence nitrofurantoin capsules
5211821|NCT00778557|CEFPROZIL FOR ORAL SUSPENSION USP 250 mg/ 5 mL, Bioequivalence fasting conditions|cefprozil for oral suspension usp 250 mg/ 5 ml, bioequivalence fasting conditions
5211822|NCT00778544|Bioequivalence amoxicillin-clavulanic acid 600 mg 42.9 mg per 5 mL oral suspension|bioequivalence amoxicillin-clavulanic acid 600 mg 42.9 mg per 5 ml oral suspension
5211823|NCT00778531|injectable implant|injectable implant
5211824|NCT00778531|nasolabial folds|nasolabial folds
5211825|NCT00778531|Correction of nasolabial folds|correction of nasolabial folds
5211826|NCT00778518|growth hormone|growth hormone
5211827|NCT00778518|growth hormone deficiency|growth hormone deficiency
5211828|NCT00778518|GHD|ghd
5211829|NCT00778518|PEG|peg
5211830|NCT00778518|pegylated|pegylated
5211831|NCT00778518|IGF-1|igf-1
5211832|NCT00778505|Anesthesia|anesthesia
5211833|NCT00778492|Thrombelastogram|thrombelastogram
5211834|NCT00778492|Microvascular bleeding|microvascular bleeding
5211835|NCT00778492|antiplatelet medication|antiplatelet medication
5211836|NCT00778492|cardiac surgery|cardiac surgery
5211837|NCT00778492|consumption of blood products|consumption of blood products
5211838|NCT00778492|preoperative platelet mapping derived from modified TEG|preoperative platelet mapping derived from modified teg
5211839|NCT00778492|postoperative bleeding|postoperative bleeding
5211840|NCT00778466|Bioequivalence metformin hydrochloride 1000 mg tablets fed conditions|bioequivalence metformin hydrochloride 1000 mg tablets fed conditions
5211841|NCT00778453|stroke rehabilitation|stroke rehabilitation
5211842|NCT00778453|kinematic analysis|kinematic analysis
5211843|NCT00778453|upper extremity training|upper extremity training
5211844|NCT00778453|predictors|predictors
5211845|NCT00778440|Injuries|injuries
5211846|NCT00778440|Traffic Injuries|traffic injuries
5211847|NCT00778440|Preventive medicine|preventive medicine
5211848|NCT00778440|Observational studies|observational studies
5211849|NCT00778440|Primary care|primary care
5211850|NCT00778427|Bioequivalence metformin hydrochloride 1000 mg tablets fasting conditions|bioequivalence metformin hydrochloride 1000 mg tablets fasting conditions
5211851|NCT00778414|Bioequivalence Amoxicillin Clavulanic acid 600mg 42.9 mg per 5 mL oral suspension|bioequivalence amoxicillin clavulanic acid 600mg 42.9 mg per 5 ml oral suspension
5211852|NCT00778401|Bioequivalence Gabapentin tablets 800 mg fasting conditions|bioequivalence gabapentin tablets 800 mg fasting conditions
5211853|NCT00778388|Pseudomonas Aeruginosa|pseudomonas aeruginosa
5211854|NCT00778375|Leukemia|leukemia
5211855|NCT00778375|Acute Myeloid Leukemia|acute myeloid leukemia
5211856|NCT00778375|Myelodysplastic Syndrome|myelodysplastic syndrome
5211857|NCT00778375|AML|aml
5211858|NCT00778375|MDS|mds
5211859|NCT00778375|Clofarabine|clofarabine
5211860|NCT00778375|Ara-C|ara-c
5211861|NCT00778375|Cytarabine|cytarabine
5211862|NCT00778375|Decitabine|decitabine
5211863|NCT00778362|OPSI|opsi
5211864|NCT00778362|Splenectomy|splenectomy
5211865|NCT00778349|Bioavailability Metformin solution 100 mg/mL|bioavailability metformin solution 100 mg/ml
5211866|NCT00778336|Peripheral Thrombosis|peripheral thrombosis
5211867|NCT00778336|DVT|dvt
5211868|NCT00778336|Limb Ischemia|limb ischemia
5211869|NCT00778336|AV Access|av access
5211870|NCT00778336|AngioJet|angiojet
5211871|NCT00778336|Thrombectomy|thrombectomy
5211872|NCT00778323|remote ischemic preconditioning|remote ischemic preconditioning
5211873|NCT00778323|cervical compression myelopathy|cervical compression myelopathy
5211874|NCT00778323|spinal cord|spinal cord
5211875|NCT00778323|neuron-specific enolase|neuron-specific enolase
5211876|NCT00778323|s-100B|s-100b
5211877|NCT00778310|Attention Deficit Disorder with Hyperactivity|attention deficit disorder with hyperactivity
5211878|NCT00778310|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
5211879|NCT00778310|ADHD|adhd
5211880|NCT00778297|prevention|prevention
5211881|NCT00778297|influenza|influenza
5211882|NCT00778297|infection|infection
5211883|NCT00778297|vaccine|vaccine
5211884|NCT00778297|Influenza vaccine|influenza vaccine
5211885|NCT00778297|Influenza in humans|influenza in humans
5211886|NCT00778284|Bioequivalence|bioequivalence
5211887|NCT00778271|Bioequivalence gabapentin 400mg capsules fasting conditions|bioequivalence gabapentin 400mg capsules fasting conditions
5211888|NCT00778258|Food Allergy|food allergy
5211889|NCT00778258|Milk Allergy|milk allergy
5211890|NCT00778245|Bioequivalence cefprozil 500mg tablets fed conditions|bioequivalence cefprozil 500mg tablets fed conditions
5211983|NCT00777751|Electrocardiograms|electrocardiograms
5211891|NCT00778232|Bioequivalence Gabapentin tablets 800 mg fed conditions|bioequivalence gabapentin tablets 800 mg fed conditions
5211892|NCT00778219|heart rate variability, tracheal intubation|heart rate variability, tracheal intubation
5211893|NCT00778206|Phenylketonuria|phenylketonuria
5211894|NCT00778206|Hyperphenylalaninemia|hyperphenylalaninemia
5211895|NCT00778206|PKU|pku
5211896|NCT00778206|Phenylalanine|phenylalanine
5211897|NCT00778193|NSAID|nsaid
5211898|NCT00778193|ulcer|ulcer
5211899|NCT00778193|gastroduodenal ulcer|gastroduodenal ulcer
5211900|NCT00778193|naproxen|naproxen
5211901|NCT00778193|aspirin|aspirin
5211902|NCT00778193|ASA|asa
5211903|NCT00778193|celecoxib|celecoxib
5211904|NCT00778193|clopidogrel|clopidogrel
5211905|NCT00778193|healing|healing
5211906|NCT00778193|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors
5211907|NCT00778193|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal
5211908|NCT00778193|Platelet Aggregation Inhibitors|platelet aggregation inhibitors
5211909|NCT00778193|Wound Healing|wound healing
5211910|NCT00778180|Bioequivalence furosemide 80 mg tablets|bioequivalence furosemide 80 mg tablets
5211911|NCT00778141|Bioequivalecne metformin HC1 750 mg extended-release tablets|bioequivalecne metformin hc1 750 mg extended-release tablets
5211912|NCT00778128|CP-4126|cp-4126
5211913|NCT00778128|Cancer|cancer
5211914|NCT00778128|Metastatic|metastatic
5211916|NCT00778128|Gemzitabine|gemzitabine
5211917|NCT00778128|Gemzar|gemzar
5211918|NCT00778115|Bioequivalence Loperamide HCl 2 mg and simethicone 125 mg tablets|bioequivalence loperamide hcl 2 mg and simethicone 125 mg tablets
5211919|NCT00778089|skin test|skin test
5211920|NCT00778089|ArteFill|artefill
5211921|NCT00778089|Skin test prior to administration of ArteFill® implant|skin test prior to administration of artefill® implant
5211922|NCT00778076|Knee OA, Hyaluronic acid, Gait, Pain, Synovial fluid|knee oa, hyaluronic acid, gait, pain, synovial fluid
5211923|NCT00778063|dexmedetomidine|dexmedetomidine
5211924|NCT00778063|pressure equalization tubes in the ear|pressure equalization tubes in the ear
5211925|NCT00778063|myringotomy|myringotomy
5211926|NCT00778063|sevoflurane|sevoflurane
5211927|NCT00778050|Bioequivalence, amoxicillin 600mg fasting conditions|bioequivalence, amoxicillin 600mg fasting conditions
5211928|NCT00778037|Bioequivalence Cyclobenzaprine hydrochloride 10 mg tablet fasting conditions|bioequivalence cyclobenzaprine hydrochloride 10 mg tablet fasting conditions
5211929|NCT00778024|Bioequivalence fluoxetine HCL 40 mg capsules fasting conditions|bioequivalence fluoxetine hcl 40 mg capsules fasting conditions
5211930|NCT00778011|Nausea|nausea
5211931|NCT00778011|Vomiting|vomiting
5211932|NCT00778011|Ondansetron|ondansetron
5211933|NCT00778011|Metoclopramide|metoclopramide
5211934|NCT00778011|Randomized|randomized
5211935|NCT00778011|Double-Blind|double-blind
5211936|NCT00778011|nausea and vomiting in the emergency department|nausea and vomiting in the emergency department
5211937|NCT00777998|Multiple Myeloma|multiple myeloma
5211938|NCT00777998|Stem Cell Transplantation|stem cell transplantation
5211939|NCT00777998|Thalidomide|thalidomide
5211940|NCT00777998|DLI|dli
5211941|NCT00777985|Cardiovascular system|cardiovascular system
5211942|NCT00777985|Sleep|sleep
5211943|NCT00777985|Endothelial function|endothelial function
5211944|NCT00777985|Endothelin system|endothelin system
5211945|NCT00777972|Bioequivalence Fosinopril sodium and hydrochlorothiazide 20-12.5 mg tablets fasting conditions|bioequivalence fosinopril sodium and hydrochlorothiazide 20-12.5 mg tablets fasting conditions
5211946|NCT00777946|Aliskiren, Amlodipine, Non-responder to aliskiren|aliskiren, amlodipine, non-responder to aliskiren
5211947|NCT00777907|neurovascular embolization|neurovascular embolization
5211948|NCT00777907|therapeutic embolization|therapeutic embolization
5211949|NCT00777894|advanced adult primary liver cancer|advanced adult primary liver cancer
5211950|NCT00777894|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
5211951|NCT00777894|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
5211952|NCT00777855|warfarin|warfarin
5211953|NCT00777855|pharmacokinetics|pharmacokinetics
5211954|NCT00777855|drug transporter|drug transporter
5211955|NCT00777855|healthy volunteer|healthy volunteer
5211956|NCT00777855|drug interaction|drug interaction
5211957|NCT00777855|rifampin|rifampin
5211958|NCT00777829|Nap|nap
5211959|NCT00777829|Pharmacology|pharmacology
5211960|NCT00777829|Memory|memory
5211961|NCT00777829|Visual Learning|visual learning
5211962|NCT00777829|Verbal Memory|verbal memory
5211963|NCT00777829|Motor Learning|motor learning
5211964|NCT00777816|Rheumatoid|rheumatoid
5211965|NCT00777816|Arthritis|arthritis
5211966|NCT00777790|Meningitis|meningitis
5211967|NCT00777790|Meningococcemia|meningococcemia
5211968|NCT00777790|Neisseria meningitidis|neisseria meningitidis
5211969|NCT00777777|multi-vessel, therapy, surgery, CABG|multi-vessel, therapy, surgery, cabg
5211970|NCT00777764|Xolair|xolair
5211971|NCT00777764|Asthma|asthma
5211972|NCT00777764|Skin Tests|skin tests
5211973|NCT00777751|Chest Tumor|chest tumor
5211974|NCT00777751|Heart|heart
5211975|NCT00777751|Lung Cancer|lung cancer
5211976|NCT00777751|Esophageal Cancer|esophageal cancer
5211977|NCT00777751|Thymoma|thymoma
5211978|NCT00777751|Radiation dose to the heart|radiation dose to the heart
5211979|NCT00777751|Cardiac Enzymes|cardiac enzymes
5211980|NCT00777751|Cardiac Biomarkers|cardiac biomarkers
5211981|NCT00777751|Radiation Therapy|radiation therapy
5211982|NCT00777751|RT|rt
5211985|NCT00777738|Advanced Waldenström's macroglobulinemia|advanced waldenström's macroglobulinemia
5211986|NCT00777738|Bortezomib|bortezomib
5211987|NCT00777738|Dexamethasone|dexamethasone
5211988|NCT00777738|Safety|safety
5211989|NCT00777738|Efficacy|efficacy
5211990|NCT00777712|Wound healing|wound healing
5211991|NCT00777712|diabetes|diabetes
5211992|NCT00777712|inflammatory cell|inflammatory cell
5211993|NCT00777712|monocyte|monocyte
5211994|NCT00777712|leukocyte|leukocyte
5211995|NCT00777712|macrophage|macrophage
5211996|NCT00777699|Cancer|cancer
5211997|NCT00777699|Solid Tumors|solid tumors
5211998|NCT00777699|NSCLC|nsclc
5211999|NCT00777686|Intracranial Glioblastoma|intracranial glioblastoma
5212000|NCT00777686|Intracranial Gliosarcoma|intracranial gliosarcoma
5212001|NCT00777686|glioblastoma|glioblastoma
5212002|NCT00777686|recurrent glioblastoma|recurrent glioblastoma
5212003|NCT00777686|gliosarcoma|gliosarcoma
5212004|NCT00777686|brain cancer|brain cancer
5212005|NCT00777686|magnetic resonance spectroscopy|magnetic resonance spectroscopy
5212006|NCT00777686|MRS|mrs
5212007|NCT00777686|magnetic resonance imaging|magnetic resonance imaging
5212008|NCT00777686|MRI|mri
5212009|NCT00777686|MRI/MRS|mri/mrs
5212010|NCT00777686|Recurrent Glioblastoma Treated with Antiangiogenic agents|recurrent glioblastoma treated with antiangiogenic agents
5212011|NCT00777686|contrast enhanced MRI|contrast enhanced mri
5212012|NCT00777686|DCE-MRI|dce-mri
5212013|NCT00777686|diffusion-weighted MRI|diffusion-weighted mri
5212014|NCT00777686|DSC|dsc
5212015|NCT00777686|DW-MRI|dw-mri
5212016|NCT00777673|Breast Cancer|breast cancer
5212017|NCT00777673|Triple Negative|triple negative
5212018|NCT00777673|Neoadjuvant|neoadjuvant
5212019|NCT00777673|Neoadjuvant therapy|neoadjuvant therapy
5212020|NCT00777673|ER, PR and HER2 Negative|er, pr and her2 negative
5212021|NCT00777634|Binge Eating Disorder|binge eating disorder
5212022|NCT00777634|Eating Disorder|eating disorder
5212023|NCT00777595|QTc|qtc
5212024|NCT00777595|CHF 4226 HFA|chf 4226 hfa
5212025|NCT00777595|pMDI|pmdi
5212026|NCT00777595|Carmoterol|carmoterol
5212027|NCT00777582|Poly (ADP ribose) polymerases|poly (adp ribose) polymerases
5212028|NCT00777582|Homologous Recombination Deficiency (HRD)|homologous recombination deficiency (hrd)
5212029|NCT00777582|Advanced solid tumours|advanced solid tumours
5212030|NCT00777569|Smoking|smoking
5212031|NCT00777569|PREPS|preps
5212032|NCT00777569|Harm reduction|harm reduction
5212033|NCT00777569|Biomarkers of tobacco exposure|biomarkers of tobacco exposure
5212034|NCT00777569|Compensatory smoking|compensatory smoking
5212035|NCT00777543|Bioavailability|bioavailability
5212036|NCT00777543|Ferulic acid|ferulic acid
5212037|NCT00777543|Phenolic compounds|phenolic compounds
5212038|NCT00777543|Colonic metabolites|colonic metabolites
5212039|NCT00777543|Immunomodulatory effects|immunomodulatory effects
5212040|NCT00777543|No disease|no disease
5212041|NCT00777517|Cardiovascular Diseases|cardiovascular diseases
5212042|NCT00777504|angiogenesis|angiogenesis
5212043|NCT00777504|inhibitor|inhibitor
5212044|NCT00777504|duration of therapy|duration of therapy
5212045|NCT00777504|GIST|gist
5212046|NCT00777491|stage II bladder cancer|stage ii bladder cancer
5212047|NCT00777491|stage III bladder cancer|stage iii bladder cancer
5212048|NCT00777491|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
5212049|NCT00777478|Sunitinib|sunitinib
5212050|NCT00777478|Capecitabine|capecitabine
5212051|NCT00777478|Irinotecan|irinotecan
5212052|NCT00777478|colorectal cancer|colorectal cancer
5212053|NCT00777465|Acute kidney injury|acute kidney injury
5212054|NCT00777465|Kidney failure|kidney failure
5212055|NCT00777465|Risk factors|risk factors
5212056|NCT00777465|Clinical outcomes|clinical outcomes
5212057|NCT00777465|Cardiac valve surgery|cardiac valve surgery
5212058|NCT00777465|Coronary artery bypass grafting|coronary artery bypass grafting
5212059|NCT00777465|Morbidity|morbidity
5212060|NCT00777465|Mortality|mortality
5212061|NCT00777452|quality of life|quality of life
5212062|NCT00777452|localized prostate cancer|localized prostate cancer
5212063|NCT00777452|FACT-P|fact-p
5212064|NCT00777439|Dopamine|dopamine
5212065|NCT00777439|Domperidone|domperidone
5212066|NCT00777439|Gastroparesis|gastroparesis
5212067|NCT00777439|Gastrointestinal Diseases|gastrointestinal diseases
5212068|NCT00777439|Neurologic Manifestations|neurologic manifestations
5212069|NCT00777439|Stomach Diseases|stomach diseases
5212070|NCT00777439|Digestive System Diseases|digestive system diseases
5212071|NCT00777439|Esophagitis|esophagitis
5212072|NCT00777439|Esophageal Disorders|esophageal disorders
5212073|NCT00777439|Paralysis|paralysis
5212074|NCT00777426|HIV positive with HAD|hiv positive with had
5212075|NCT00777413|Bioequiavlence Minocycline Tablets|bioequiavlence minocycline tablets
5212076|NCT00777400|Kidney transplant|kidney transplant
5212077|NCT00777400|T regulatory cells|t regulatory cells
5212078|NCT00777400|Efalizumab|efalizumab
5212079|NCT00777400|Rejection|rejection
5212080|NCT00777400|Safely convert renal transplant from mycophenolate mofetil and Calcineurin inhibitor to efalizumab and sirolimus|safely convert renal transplant from mycophenolate mofetil and calcineurin inhibitor to efalizumab and sirolimus
5212081|NCT00777387|human oocyte cryopreservation|human oocyte cryopreservation
5212082|NCT00777387|slow-freeze|slow-freeze
5212083|NCT00777387|vitrification|vitrification
5212084|NCT00777361|Mass balance|mass balance
5212085|NCT00777361|AZD3480, Pharmacokinetics, Healthy volunteers|azd3480, pharmacokinetics, healthy volunteers
5212086|NCT00777322|keratoconus|keratoconus
5212087|NCT00777322|pellucid marginal degeneration|pellucid marginal degeneration
5212088|NCT00777322|corneal ectasia|corneal ectasia
5212089|NCT00777322|collagen cross-linking|collagen cross-linking
5212090|NCT00777322|riboflavin|riboflavin
5212091|NCT00777322|UV light|uv light
5212092|NCT00777322|excimer laser|excimer laser
5212093|NCT00777322|Topography-Computer Assisted Treatment (T-Cat)|topography-computer assisted treatment (t-cat)
5212094|NCT00777322|Wavelight Allegretto laser|wavelight allegretto laser
5212095|NCT00777309|NSCLC|nsclc
5212096|NCT00777296|Cystic Fibrosis|cystic fibrosis
5212097|NCT00777296|Respiratory Infections|respiratory infections
5212098|NCT00777296|Pulmonary Cystic Fibrosis|pulmonary cystic fibrosis
5212099|NCT00777296|CFTR|cftr
5212100|NCT00777270|episiotomy|episiotomy
5212101|NCT00777270|perineal lesion|perineal lesion
5212102|NCT00777270|vaginal trauma|vaginal trauma
5212103|NCT00777257|Meningitis|meningitis
5212104|NCT00777257|Meningococcemia|meningococcemia
5212105|NCT00777257|Pertussis|pertussis
5212106|NCT00777257|Neisseria meningitidis|neisseria meningitidis
5212107|NCT00777257|Tetanus|tetanus
5212108|NCT00777257|Diphtheria|diphtheria
5212109|NCT00777244|mitotane|mitotane
5212110|NCT00777244|adjuvant therapy|adjuvant therapy
5212111|NCT00777244|disease free survival|disease free survival
5212112|NCT00777231|Sickle Cell|sickle cell
5212113|NCT00777231|Stem Cell|stem cell
5212114|NCT00777231|Tolerance|tolerance
5212115|NCT00777231|Bone Marrow Transplant|bone marrow transplant
5212116|NCT00777231|Total Body Irradiation (TBI)|total body irradiation (tbi)
5212117|NCT00777231|Apheresis|apheresis
5212118|NCT00777231|Aplastic Anemia|aplastic anemia
5212119|NCT00777231|Hemoglobinopathies|hemoglobinopathies
5212120|NCT00777231|Non Malignant|non malignant
5212121|NCT00777218|migraine|migraine
5212122|NCT00777205|Peer Support|peer support
5212123|NCT00777205|Quality of Life|quality of life
5212124|NCT00777205|Telephone|telephone
5212125|NCT00777192|colon cancer|colon cancer
5212126|NCT00777192|Cancers of the colon and rectum|cancers of the colon and rectum
5212127|NCT00777192|Oxaliplatin|oxaliplatin
5212128|NCT00777192|oxaliplatin chemotherapy|oxaliplatin chemotherapy
5212129|NCT00777192|inflammatory cytokines|inflammatory cytokines
5212130|NCT00777192|neurocognitive symptoms|neurocognitive symptoms
5212131|NCT00777192|neuropsychiatric symptoms|neuropsychiatric symptoms
5212132|NCT00777179|Vandetanib, NSCLC, Maintenance, Phase II|vandetanib, nsclc, maintenance, phase ii
5212133|NCT00777166|oxytocin|oxytocin
5212134|NCT00777166|ST depression|st depression
5212135|NCT00777166|cesarean section|cesarean section
5212136|NCT00777166|blood loss|blood loss
5212137|NCT00777153|Cancer|cancer
5212138|NCT00777153|Tumour|tumour
5212139|NCT00777153|Advanced Solid Tumour|advanced solid tumour
5212140|NCT00777153|GBM|gbm
5212141|NCT00777153|Glioblastoma|glioblastoma
5212142|NCT00777140|Stroke|stroke
5212143|NCT00777140|Ischemic Stroke|ischemic stroke
5212144|NCT00777140|Thrombolytic treatment|thrombolytic treatment
5212145|NCT00777140|Middle cerebral artery occlusion|middle cerebral artery occlusion
5212146|NCT00777140|Deferoxamine|deferoxamine
5212147|NCT00777140|Iron chelator|iron chelator
5212148|NCT00777140|Acute Ischemic Stroke treated with Intravenous Thrombolytic|acute ischemic stroke treated with intravenous thrombolytic
5212149|NCT00777127|actinic keratosis|actinic keratosis
5212150|NCT00777127|invasive SCC|invasive scc
5212151|NCT00777127|in situ SCC|in situ scc
5212152|NCT00777127|histological classification|histological classification
5212153|NCT00777127|histological progression|histological progression
5212154|NCT00777127|clinical clearance|clinical clearance
5212155|NCT00777127|cryotherapy|cryotherapy
5212156|NCT00777114|relapsed non-Hodgkin's lymphoma|relapsed non-hodgkin's lymphoma
5212157|NCT00777101|HER2|her2
5212158|NCT00777101|ErbB2|erbb2
5212159|NCT00777101|metastatic|metastatic
5212160|NCT00777101|neratinib|neratinib
5212161|NCT00777101|lapatinib|lapatinib
5212162|NCT00777101|capecitabine|capecitabine
5212163|NCT00777101|HKI-272|hki-272
5212164|NCT00777101|Nerlynx|nerlynx
5212165|NCT00777101|PB-272|pb-272
5212166|NCT00777088|neurovascular embolization|neurovascular embolization
5212167|NCT00777088|therapeutic embolization|therapeutic embolization
5212168|NCT00777075|nitrate|nitrate
5212169|NCT00777075|nitric oxide|nitric oxide
5212170|NCT00777075|asymmetric dimethylarginine|asymmetric dimethylarginine
5212171|NCT00777075|blood pressure|blood pressure
5212172|NCT00777075|NOS|nos
5212173|NCT00777075|IIEF|iief
5212174|NCT00777062|alcohol|alcohol
5212175|NCT00777062|cocaine|cocaine
5212176|NCT00777062|addiction|addiction
5212177|NCT00777062|alcoholism|alcoholism
5212178|NCT00777062|substance dependence|substance dependence
5212179|NCT00777062|substance abuse|substance abuse
5212180|NCT00777036|Leukemia, Pediatric|leukemia, pediatric
5212181|NCT00777023|Hot Flashes|hot flashes
5212182|NCT00777023|Hot Flushes|hot flushes
5212183|NCT00777023|Postmenopausal symptoms|postmenopausal symptoms
5212184|NCT00777023|Vasomotor symptoms|vasomotor symptoms
5212186|NCT00777010|mild cognitive impairment|mild cognitive impairment
5212187|NCT00777010|forgetfulness|forgetfulness
5212188|NCT00776997|Gastroesophageal Reflux|gastroesophageal reflux
5212189|NCT00776958|A Lynne Cohen Consortium Project|a lynne cohen consortium project
5212190|NCT00776958|Multi-Center Database Registry|multi-center database registry
5212191|NCT00776958|High Risk|high risk
5212192|NCT00776958|Cancer|cancer
5212193|NCT00776958|Breast|breast
5212194|NCT00776958|BRCA1 or BRCA2 gene|brca1 or brca2 gene
5212195|NCT00776958|Ovary|ovary
5212196|NCT00776958|Questionnaire|questionnaire
5212197|NCT00776919|Acne Vulgaris|acne vulgaris
5212198|NCT00776919|Acne|acne
5212199|NCT00776880|Surgical operation|surgical operation
5212200|NCT00776867|Pediatric|pediatric
5212201|NCT00776867|solid tumors|solid tumors
5212202|NCT00776867|Pediatric solid tumors|pediatric solid tumors
5212203|NCT00776867|08-091|08-091
5212204|NCT00776841|Phase-I|phase-i
5212205|NCT00776841|Hypercholesterolemia|hypercholesterolemia
5212206|NCT00776841|Obesity|obesity
5212207|NCT00776841|fatty liver|fatty liver
5212208|NCT00776841|Part A: Healthy male volunteers Part B: Mildly overweight, otherwise healthy hypercholesterolemic male volunteers|part a: healthy male volunteers part b: mildly overweight, otherwise healthy hypercholesterolemic male volunteers
5212209|NCT00776828|cilostazol|cilostazol
5212210|NCT00776828|clopidogrel|clopidogrel
5212211|NCT00776828|statin|statin
5212212|NCT00776828|drug-eluting stent|drug-eluting stent
5212213|NCT00776802|GCS-100|gcs-100
5212214|NCT00776802|Diffuse Large B-cell Lymphoma|diffuse large b-cell lymphoma
5212215|NCT00776802|DLBCL|dlbcl
5212216|NCT00776802|Relapsed or refractory DLBCL|relapsed or refractory dlbcl
5212217|NCT00776802|Etoposide; Dexamethasone|etoposide; dexamethasone
5212218|NCT00776789|Skin to skin contact|skin to skin contact
5212219|NCT00776789|Salivary cortisol|salivary cortisol
5212220|NCT00776789|Breast feeding Behavior|breast feeding behavior
5212221|NCT00776776|BMI > 40|bmi > 40
5212222|NCT00776776|Obesity|obesity
5212223|NCT00776776|Adolescents|adolescents
5212224|NCT00776776|Weight Loss Surgery|weight loss surgery
5212225|NCT00776737|Attention Deficit Disorder|attention deficit disorder
5212226|NCT00776737|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
5212227|NCT00776737|Computer Aided Learning|computer aided learning
5212228|NCT00776737|Attention Deficits|attention deficits
5212229|NCT00776737|Healthy Volunteer|healthy volunteer
5212230|NCT00776737|HV|hv
5212231|NCT00776724|breast ca|breast ca
5212232|NCT00776724|phase III|phase iii
5212233|NCT00776724|Tailored neoadjuvant chemotherapy|tailored neoadjuvant chemotherapy
5212234|NCT00776724|stage II/III|stage ii/iii
5212235|NCT00776711|Healthy|healthy
5212236|NCT00776711|Avian Influenza|avian influenza
5212237|NCT00776711|Immunity|immunity
5212238|NCT00776711|Preventive|preventive
5212239|NCT00776711|Bird Flu|bird flu
5212240|NCT00776711|Healthy Volunteer|healthy volunteer
5212241|NCT00776711|HV|hv
5212242|NCT00776711|Influenza|influenza
5212243|NCT00776672|Bioequivalence Fosinopril Tablets|bioequivalence fosinopril tablets
5212244|NCT00776659|An Observational Study of Indian Breast Cancer Patients Receiving Adjuvant Therapy with Aromasin|an observational study of indian breast cancer patients receiving adjuvant therapy with aromasin
5212245|NCT00776659|Antineoplastic Hormonal Drugs|antineoplastic hormonal drugs
5212246|NCT00776659|Aromasin|aromasin
5212247|NCT00776646|bioequivalence hydrochlorothiazide 50 mg tablet fasting conditions|bioequivalence hydrochlorothiazide 50 mg tablet fasting conditions
5212248|NCT00776633|aspirin|aspirin
5212249|NCT00776633|clopidogrel|clopidogrel
5212250|NCT00776633|oral anticoagulation|oral anticoagulation
5212251|NCT00776633|warfarin|warfarin
5212252|NCT00776633|drug eluting stent|drug eluting stent
5212253|NCT00776633|phenprocoumon|phenprocoumon
5212254|NCT00776620|Bioequivalence Glimepiride Tablets|bioequivalence glimepiride tablets
5212255|NCT00776607|LADA|lada
5212256|NCT00776607|Latent autoimmune diabetes in adults|latent autoimmune diabetes in adults
5212257|NCT00776607|Type 1.5|type 1.5
5212258|NCT00776607|Slowly progressive type 1 diabetes|slowly progressive type 1 diabetes
5212259|NCT00776594|Androgen deprivation therapy|androgen deprivation therapy
5212260|NCT00776594|ADT|adt
5212261|NCT00776594|bevacizumab|bevacizumab
5212262|NCT00776581|Combined spinal-epidural analgesia|combined spinal-epidural analgesia
5212263|NCT00776581|Patient-controlled analgesia|patient-controlled analgesia
5212264|NCT00776581|Epidural analgesia|epidural analgesia
5212265|NCT00776555|Not required|not required
5212266|NCT00776542|bioequivalence Minocycline Tablets|bioequivalence minocycline tablets
5212267|NCT00776529|sensorimotor training|sensorimotor training
5212268|NCT00776529|Strengthening|strengthening
5212269|NCT00776529|Balance|balance
5212270|NCT00776516|Healthy volunteer subjects|healthy volunteer subjects
5212271|NCT00776516|CYP3A4 inducer|cyp3a4 inducer
5212272|NCT00776516|rifampin|rifampin
5212273|NCT00776516|drug interaction|drug interaction
5212274|NCT00776516|pharmacokinetics|pharmacokinetics
5212275|NCT00776516|YM178|ym178
5212276|NCT00776516|mirabegron|mirabegron
5212277|NCT00776503|Epigenetic|epigenetic
5212278|NCT00776503|Myelodysplasia|myelodysplasia
5212279|NCT00776503|Cytarabine|cytarabine
5212280|NCT00776490|Bioequivalence Glimepiride Tablets|bioequivalence glimepiride tablets
5212281|NCT00776451|AMD|amd
5212282|NCT00776438|Influenza|influenza
5212283|NCT00776438|Orthomyxoviruses|orthomyxoviruses
5212284|NCT00776438|Myxovirus Infection|myxovirus infection
5212285|NCT00776438|Inactivated Split-virion influenza vaccine|inactivated split-virion influenza vaccine
5212286|NCT00776438|Adults|adults
5212287|NCT00776438|Elderly|elderly
5212288|NCT00776412|Immunologic Non-Responder|immunologic non-responder
5212289|NCT00776412|Cardiovascular Disease|cardiovascular disease
5212290|NCT00776412|D-dimer|d-dimer
5212291|NCT00776412|Antiretroviral|antiretroviral
5212292|NCT00776412|Mortality|mortality
5212293|NCT00776412|HIV Positive|hiv positive
5212294|NCT00776412|HIV Negative|hiv negative
5212295|NCT00776412|Healthy Volunteer|healthy volunteer
5212296|NCT00776412|HV|hv
5212297|NCT00776399|Colorectal cancer|colorectal cancer
5212298|NCT00776399|lung metastasis|lung metastasis
5212299|NCT00776399|radiofrequency ablation|radiofrequency ablation
5212300|NCT00776399|metastasectomy|metastasectomy
5212301|NCT00776399|Lung metastasis from colorectal cancer|lung metastasis from colorectal cancer
5212302|NCT00776373|ALL|all
5212303|NCT00776373|Burkitt's Lymphoma|burkitt's lymphoma
5212304|NCT00776373|Adult T-Cell leukemia/lymphoma|adult t-cell leukemia/lymphoma
5212305|NCT00776373|Lymphoblastic leukemia|lymphoblastic leukemia
5212306|NCT00776373|CML in lymphoid blast crisis patients|cml in lymphoid blast crisis patients
5212307|NCT00776373|HiVAC|hivac
5212308|NCT00776373|Rapamycin|rapamycin
5212309|NCT00776360|oxytocin|oxytocin
5212310|NCT00776360|gastroparesis|gastroparesis
5212311|NCT00776360|diabetics|diabetics
5212312|NCT00776360|The effect of oxytocin on gastric emptying|the effect of oxytocin on gastric emptying
5212313|NCT00776347|Dementia with Lewy bodies (DLB)|dementia with lewy bodies (dlb)
5212314|NCT00776347|FDG-PET|fdg-pet
5212315|NCT00776334|bioequivalence Fosinopril Tablets|bioequivalence fosinopril tablets
5212316|NCT00776321|hypercholesterolemia|hypercholesterolemia
5212317|NCT00776321|dyslipidemia|dyslipidemia
5212318|NCT00776321|thyroid|thyroid
5212319|NCT00776321|safety|safety
5212320|NCT00776308|molecular breast imaging|molecular breast imaging
5212321|NCT00776308|breast cancer|breast cancer
5212322|NCT00776308|mammography|mammography
5212323|NCT00776295|Small Cell Lung Cancer|small cell lung cancer
5212324|NCT00776295|SCLC|sclc
5212325|NCT00776295|Limited Stage Small Cell Lung Cancer|limited stage small cell lung cancer
5212326|NCT00776282|bioequivalence loratadine 10 mg orally disintegrating|bioequivalence loratadine 10 mg orally disintegrating
5212327|NCT00776282|tablets fed conditions|tablets fed conditions
5212328|NCT00776269|Argon laser|argon laser
5212329|NCT00776269|Trichiasis|trichiasis
5212330|NCT00776269|Radiofrequency|radiofrequency
5212331|NCT00776269|Patients with trichiasis|patients with trichiasis
5212332|NCT00776256|satiety|satiety
5212333|NCT00776256|food intake|food intake
5212334|NCT00776243|incretin|incretin
5212335|NCT00776243|GLP-1|glp-1
5212336|NCT00776243|GIP|gip
5212337|NCT00776243|intensive insulin therapy|intensive insulin therapy
5212338|NCT00776217|bioequivalence loratadine 10 mg orally disintegrating tablets fasting|bioequivalence loratadine 10 mg orally disintegrating tablets fasting
5212339|NCT00776204|Coronary Artery Disease|coronary artery disease
5212340|NCT00776204|Drug eluting stent|drug eluting stent
5212341|NCT00776204|Percutaneous Coronary Interventions|percutaneous coronary interventions
5212342|NCT00776204|Optical Coherence Tomography|optical coherence tomography
5212343|NCT00776191|Physioneal 35|physioneal 35
5212344|NCT00776191|Physioneal 40|physioneal 40
5212345|NCT00776191|children|children
5212346|NCT00776191|chronic peritoneal dialysis|chronic peritoneal dialysis
5212347|NCT00776178|Survival Study|survival study
5212348|NCT00776178|Bladder Cancer|bladder cancer
5212349|NCT00776178|Cancer Recurrence|cancer recurrence
5212350|NCT00776178|Tumor Markers/Heterogeneity|tumor markers/heterogeneity
5212351|NCT00776139|Cetirizine Hydrochloride 10 mg tablet fasting conditions|cetirizine hydrochloride 10 mg tablet fasting conditions
5212352|NCT00776126|Breast|breast
5212353|NCT00776126|3D Digital Mammography|3d digital mammography
5212354|NCT00776126|Digital Breast Tomosynthesis|digital breast tomosynthesis
5212355|NCT00776113|Bioequivalence Carvedilol fasting|bioequivalence carvedilol fasting
5212356|NCT00776100|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5212357|NCT00776100|adenosquamous cell lung cancer|adenosquamous cell lung cancer
5212358|NCT00776100|squamous cell lung cancer|squamous cell lung cancer
5212359|NCT00776100|large cell lung cancer|large cell lung cancer
5212360|NCT00776100|adenocarcinoma of the lung|adenocarcinoma of the lung
5212361|NCT00776100|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
5212362|NCT00776087|Medical costs|medical costs
5212363|NCT00776087|Telemonitoring|telemonitoring
5212364|NCT00776087|Implantable cardioverter-defibrillator|implantable cardioverter-defibrillator
5212365|NCT00776074|Leiomyoma|leiomyoma
5212366|NCT00776074|Uterine Fibroids|uterine fibroids
5212367|NCT00776074|Drug Therapy|drug therapy
5212368|NCT00776074|Uterine Neoplasms|uterine neoplasms
5212369|NCT00776074|Fibroid Tumor|fibroid tumor
5212370|NCT00776035|Obesity|obesity
5212371|NCT00776035|Heart|heart
5212372|NCT00776035|Failure|failure
5212373|NCT00776035|PET|pet
5212374|NCT00776035|radiation|radiation
5212375|NCT00776035|metabolism|metabolism
5212376|NCT00776022|Bioequivalence Cetirizine Hydrochloride 10 mg tablet fed conditions|bioequivalence cetirizine hydrochloride 10 mg tablet fed conditions
5212377|NCT00776009|ADHD, children, subjects, laboratory classroom|adhd, children, subjects, laboratory classroom
5212378|NCT00775996|bioequivalence Clorazepate Tablets|bioequivalence clorazepate tablets
5212379|NCT00775970|Obesity|obesity
5212380|NCT00775970|Weight loss maintenance|weight loss maintenance
5212381|NCT00775970|Spontaneous physical activity|spontaneous physical activity
5212382|NCT00775970|Lipid oxydation|lipid oxydation
5212383|NCT00775970|Walking|walking
5212384|NCT00775944|Tobacco|tobacco
5212385|NCT00775944|Cigarette|cigarette
5212386|NCT00775944|Smoking|smoking
5212387|NCT00775944|Counselling|counselling
5212388|NCT00775944|Nicotine Replacement Therapy|nicotine replacement therapy
5212389|NCT00775944|Telephone|telephone
5212390|NCT00775944|Quitline|quitline
5212391|NCT00775944|Helpline|helpline
5212392|NCT00775931|osteopetrosis|osteopetrosis
5212393|NCT00775918|Bioequivalence Doxycycline monohydrate 100mg tablets fed conditions|bioequivalence doxycycline monohydrate 100mg tablets fed conditions
5212394|NCT00775905|Bioequivalence amlodipine tablets fasting|bioequivalence amlodipine tablets fasting
5212395|NCT00775892|ACL|acl
5212396|NCT00775892|Ligament|ligament
5212397|NCT00775879|Général anesthesia|général anesthesia
5212398|NCT00775879|Gynecology|gynecology
5212399|NCT00775866|prostate cancer, magnetic resonance imaging, guided imagery|prostate cancer, magnetic resonance imaging, guided imagery
5212400|NCT00775853|Biomarkers|biomarkers
5212401|NCT00775853|Catecholamines|catecholamines
5212402|NCT00775853|18F-Fluoro-L-dopa|18f-fluoro-l-dopa
5212403|NCT00775853|Fluorodopamine|fluorodopamine
5212404|NCT00775853|Parkinson's Disease|parkinson's disease
5212405|NCT00775853|Parkinson Disease|parkinson disease
5212406|NCT00775853|PD|pd
5212407|NCT00775840|Cardiac Failure|cardiac failure
5212408|NCT00775840|Congestive Heart Failure|congestive heart failure
5212409|NCT00775840|Drug Therapy|drug therapy
5212410|NCT00775840|Hypertension|hypertension
5212411|NCT00775840|Diabetes Mellitus|diabetes mellitus
5212412|NCT00775827|bioequivalence fenofibrate tablets|bioequivalence fenofibrate tablets
5212413|NCT00775814|Hypertension|hypertension
5212414|NCT00775814|Drug Therapy|drug therapy
5212415|NCT00775814|Blood Pressure|blood pressure
5212416|NCT00775814|Insulin, Resistant|insulin, resistant
5212417|NCT00775788|Fat Injection to Breast|fat injection to breast
5212418|NCT00775788|Fat Grafting to Breast|fat grafting to breast
5212419|NCT00775762|Symptomatic Polyvascular disease|symptomatic polyvascular disease
5212420|NCT00775762|Multiple recurrent cardiovascular events|multiple recurrent cardiovascular events
5212421|NCT00775749|post operative nausea and vomiting|post operative nausea and vomiting
5212422|NCT00775749|gynecological surgery|gynecological surgery
5212423|NCT00775749|outpatient surgery|outpatient surgery
5212424|NCT00775749|nicotine patch|nicotine patch
5212425|NCT00775749|laparoscopic surgery|laparoscopic surgery
5212426|NCT00775723|6sulphatoxymelatonin|6sulphatoxymelatonin
5212427|NCT00775723|preterm infants|preterm infants
5212428|NCT00775723|melatonin is low in preterm infants at least until the age of 6 months|melatonin is low in preterm infants at least until the age of 6 months
5212429|NCT00775697|wheezing|wheezing
5212430|NCT00775697|children|children
5212431|NCT00775697|montelukast|montelukast
5212432|NCT00775697|bronchodilators|bronchodilators
5212433|NCT00775697|lung function|lung function
5212434|NCT00775697|Rint|rint
5212435|NCT00775684|Exenatide|exenatide
5212436|NCT00775684|Sitagliptin|sitagliptin
5212437|NCT00775684|Glimepiride|glimepiride
5212438|NCT00775684|Glucagon-Like Peptide-1|glucagon-like peptide-1
5212439|NCT00775684|Impaired Fasting Glucose|impaired fasting glucose
5212440|NCT00775684|Type 2 Diabetes|type 2 diabetes
5212441|NCT00775684|Beta-cell Function|beta-cell function
5212442|NCT00775684|Beta-cell Secretory Capacity|beta-cell secretory capacity
5212443|NCT00775684|Glucose-potentiated arginine|glucose-potentiated arginine
5212444|NCT00775658|allergy|allergy
5212445|NCT00775658|skin testing|skin testing
5212446|NCT00775658|eye drops|eye drops
5212447|NCT00775658|antihistamines|antihistamines
5212448|NCT00775645|neurotoxicity|neurotoxicity
5212449|NCT00775645|chemotherapeutic agent toxicity|chemotherapeutic agent toxicity
5212450|NCT00775645|fatigue|fatigue
5212451|NCT00775645|neuropathy|neuropathy
5212452|NCT00775645|stage IA breast cancer|stage ia breast cancer
5212453|NCT00775645|stage IB breast cancer|stage ib breast cancer
5212454|NCT00775645|stage II breast cancer|stage ii breast cancer
5212455|NCT00775645|stage IIIA breast cancer|stage iiia breast cancer
5212456|NCT00775645|stage IIIB breast cancer|stage iiib breast cancer
5212457|NCT00775645|stage IIIC breast cancer|stage iiic breast cancer
5212458|NCT00775632|Graft Versus Host Disease|graft versus host disease
5212459|NCT00775632|Alemtuzumab|alemtuzumab
5212460|NCT00775632|Campath|campath
5212461|NCT00775632|Bone Marrow Transplants|bone marrow transplants
5212462|NCT00775619|bioequivalence Carvedilol 12.5 mg tablets fed conditions|bioequivalence carvedilol 12.5 mg tablets fed conditions
5212463|NCT00775606|AIDS, HIV|aids, hiv
5212464|NCT00775593|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5212465|NCT00775593|adult acute basophilic leukemia|adult acute basophilic leukemia
5212466|NCT00775593|adult acute eosinophilic leukemia|adult acute eosinophilic leukemia
5212556|NCT00775203|Unipolar|unipolar
5212467|NCT00775593|adult erythroleukemia (M6a)|adult erythroleukemia (m6a)
5212468|NCT00775593|adult pure erythroid leukemia (M6b)|adult pure erythroid leukemia (m6b)
5212469|NCT00775593|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
5212470|NCT00775593|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
5212471|NCT00775593|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
5212472|NCT00775593|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
5212473|NCT00775593|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
5212474|NCT00775593|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
5212475|NCT00775593|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
5212476|NCT00775593|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5212477|NCT00775593|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5212478|NCT00775593|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5212479|NCT00775593|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5212480|NCT00775580|bioequivalence Atenolol Tablets|bioequivalence atenolol tablets
5212481|NCT00775567|Fructose|fructose
5212482|NCT00775567|Intolerance|intolerance
5212483|NCT00775567|Adaptation|adaptation
5212484|NCT00775567|Prebiotic|prebiotic
5212485|NCT00775567|Healthy men or women 18-40|healthy men or women 18-40
5212486|NCT00775541|Diabetes|diabetes
5212487|NCT00775541|Type 2 Diabetes|type 2 diabetes
5212488|NCT00775528|Cystic Fibrosis|cystic fibrosis
5212489|NCT00775528|Pancreatic Exocrine Insufficiency|pancreatic exocrine insufficiency
5212490|NCT00775515|chronic|chronic
5212491|NCT00775515|prostatitis|prostatitis
5212492|NCT00775515|prostate|prostate
5212493|NCT00775515|pain|pain
5212494|NCT00775515|pelvic|pelvic
5212495|NCT00775515|pelvis|pelvis
5212496|NCT00775515|inflamation|inflamation
5212497|NCT00775502|Multiple myeloma|multiple myeloma
5212498|NCT00775502|GM-2 ganglioside|gm-2 ganglioside
5212499|NCT00775502|monoclonal antibody|monoclonal antibody
5212500|NCT00775502|Potelligent design|potelligent design
5212501|NCT00775502|Treatment of subjects who have failed previous treatment|treatment of subjects who have failed previous treatment
5212502|NCT00775489|glaucoma, steroid, nasal|glaucoma, steroid, nasal
5212503|NCT00775476|Systemic lupus erythematosus (SLE), an autoimmune disease|systemic lupus erythematosus (sle), an autoimmune disease
5212504|NCT00775463|Scleroderma, Diffuse|scleroderma, diffuse
5212505|NCT00775463|Scleroderma, Limited|scleroderma, limited
5212506|NCT00775463|Scleroderma, Systemic|scleroderma, systemic
5212507|NCT00775463|Ulcer|ulcer
5212508|NCT00775463|prostacyclin|prostacyclin
5212509|NCT00775450|Influenza|influenza
5212510|NCT00775450|Orthomyxovirus Infection|orthomyxovirus infection
5212511|NCT00775450|Inactivated Split-virion influenza vaccine|inactivated split-virion influenza vaccine
5212512|NCT00775450|Elderly|elderly
5212513|NCT00775437|juvenile idiopathic arthritis|juvenile idiopathic arthritis
5212514|NCT00775437|compassionate use|compassionate use
5212515|NCT00775437|open label|open label
5212516|NCT00775424|HIV infection|hiv infection
5212517|NCT00775424|DNA vaccine|dna vaccine
5212518|NCT00775424|IL-12 adjuvant|il-12 adjuvant
5212519|NCT00775424|IL-15 adjuvant|il-15 adjuvant
5212520|NCT00775398|Hemostasis|hemostasis
5212521|NCT00775398|Thrombin-JMI|thrombin-jmi
5212522|NCT00775398|Thrombin|thrombin
5212523|NCT00775398|Blood Coagulation|blood coagulation
5212524|NCT00775385|Chemotherapy, Adjuvant|chemotherapy, adjuvant
5212525|NCT00775372|Bioequivalence study of clarithromycin 250mg/5mL powdder|bioequivalence study of clarithromycin 250mg/5ml powdder
5212526|NCT00775359|bioequivalence fenofibrate tablets|bioequivalence fenofibrate tablets
5212527|NCT00775333|Carpal Tunnel Syndrome|carpal tunnel syndrome
5212528|NCT00775333|Diabetes|diabetes
5212529|NCT00775333|APB strength|apb strength
5212530|NCT00775333|Sensory Function|sensory function
5212531|NCT00775333|Pillar Pain|pillar pain
5212532|NCT00775333|Cold Intolerance|cold intolerance
5212533|NCT00775333|Patient Satisfaction|patient satisfaction
5212534|NCT00775320|Brain scan|brain scan
5212535|NCT00775307|Non-small cell lung cancer|non-small cell lung cancer
5212536|NCT00775307|Stage I|stage i
5212537|NCT00775307|adjuvant therapy|adjuvant therapy
5212538|NCT00775307|Adjuvant Drug Therapy|adjuvant drug therapy
5212539|NCT00775281|Tachykinin receptors|tachykinin receptors
5212540|NCT00775281|Protein expression|protein expression
5212541|NCT00775281|Contractile proteins|contractile proteins
5212542|NCT00775281|Inflammatory proteins|inflammatory proteins
5212543|NCT00775268|18F Fluorothymidine|18f fluorothymidine
5212544|NCT00775268|PET/CT|pet/ct
5212545|NCT00775268|FLT|flt
5212546|NCT00775268|Lymphoma|lymphoma
5212547|NCT00775268|FDG|fdg
5212548|NCT00775255|Bioequiavelnce clarithromycin|bioequiavelnce clarithromycin
5212549|NCT00775242|Menopause|menopause
5212550|NCT00775242|Hormone Replacement Therapy|hormone replacement therapy
5212551|NCT00775242|Microspheres|microspheres
5212552|NCT00775242|Progesterone|progesterone
5212553|NCT00775242|Estradiol|estradiol
5212554|NCT00775242|Hot flashes|hot flashes
5212555|NCT00775229|hair pulling|hair pulling
5212557|NCT00775190|birth control pills|birth control pills
5212558|NCT00775190|oral contraceptives|oral contraceptives
5212559|NCT00775190|brand name|brand name
5212560|NCT00775190|generic|generic
5212561|NCT00775190|side effects|side effects
5212562|NCT00775190|oral contraceptive side effects|oral contraceptive side effects
5212563|NCT00775190|dysfunctional uterine bleeding|dysfunctional uterine bleeding
5212564|NCT00775190|pre-menstrual symptoms|pre-menstrual symptoms
5212565|NCT00775177|Bioequivalence Doxycycline monohydrate 100mg tablets fed conditions|bioequivalence doxycycline monohydrate 100mg tablets fed conditions
5212566|NCT00775164|Obese children with insulin resistance|obese children with insulin resistance
5212567|NCT00775151|Bioequivalence amlodipine 10 mg tablet under fed conditions|bioequivalence amlodipine 10 mg tablet under fed conditions
5212568|NCT00775138|Bronchiectasis|bronchiectasis
5212569|NCT00775138|Respiratory Infections|respiratory infections
5212570|NCT00775138|Amikacin|amikacin
5212571|NCT00775138|Genetic Diseases, Inborn|genetic diseases, inborn
5212572|NCT00775138|Respiratory Tract Diseases|respiratory tract diseases
5212573|NCT00775138|Cystic Fibrosis|cystic fibrosis
5212574|NCT00775138|Respiratory Tract Infections|respiratory tract infections
5212575|NCT00775138|Lung Diseases|lung diseases
5212576|NCT00775138|Infant, Newborn, Diseases|infant, newborn, diseases
5212577|NCT00775138|Pancreatic Diseases|pancreatic diseases
5212578|NCT00775125|VX-950-TiDP24-C124|vx-950-tidp24-c124
5212579|NCT00775125|VX-950-C124|vx-950-c124
5212580|NCT00775125|HCV|hcv
5212581|NCT00775125|DDI|ddi
5212582|NCT00775125|telaprevir|telaprevir
5212583|NCT00775125|darunavir|darunavir
5212584|NCT00775125|ritonavir|ritonavir
5212585|NCT00775125|fosamprenavir|fosamprenavir
5212586|NCT00775125|interaction|interaction
5212587|NCT00775125|pharmacokinetics|pharmacokinetics
5212588|NCT00775125|steady-state|steady-state
5212589|NCT00775112|supportive care|supportive care
5212590|NCT00775112|lumbar puncture|lumbar puncture
5212591|NCT00775112|childhood disease|childhood disease
5212592|NCT00775112|pediatric hemato-oncology|pediatric hemato-oncology
5212593|NCT00775099|Air Pollution|air pollution
5212594|NCT00775099|Particles|particles
5212595|NCT00775099|Particulate Matter|particulate matter
5212596|NCT00775099|Vascular function|vascular function
5212597|NCT00775099|Endothelial function|endothelial function
5212598|NCT00775099|Thrombosis|thrombosis
5212599|NCT00775086|ORTHO EVRA|ortho evra
5212600|NCT00775086|contraception|contraception
5212601|NCT00775086|NGMN|ngmn
5212602|NCT00775086|contraceptive patch|contraceptive patch
5212603|NCT00775086|bioequivalence|bioequivalence
5212604|NCT00775086|EE|ee
5212605|NCT00775086|norelgestromin|norelgestromin
5212606|NCT00775086|ethinyl estradiol|ethinyl estradiol
5212607|NCT00775073|Liver cancer|liver cancer
5212608|NCT00775073|HCC|hcc
5212609|NCT00775047|depo medroxyprogesterone acetate|depo medroxyprogesterone acetate
5212610|NCT00775047|Depo Provera|depo provera
5212611|NCT00775047|contraceptive compliance|contraceptive compliance
5212612|NCT00775047|pharmacists|pharmacists
5212613|NCT00775047|Compliance in receiving additional Depo Provera injections|compliance in receiving additional depo provera injections
5212614|NCT00775047|Satisfaction in receiving Depo Provera injections at a pharmacy compared with usual clinic|satisfaction in receiving depo provera injections at a pharmacy compared with usual clinic
5212615|NCT00775008|weight loss, health information, e-health|weight loss, health information, e-health
5212616|NCT00774995|Engerix-B|engerix-b
5212617|NCT00774995|Hepatitis B|hepatitis b
5212618|NCT00774982|Crohns Disease|crohns disease
5212619|NCT00774982|Pharmacokinetics|pharmacokinetics
5212620|NCT00774982|Local Targeted Delivery to the Ileum|local targeted delivery to the ileum
5212621|NCT00774982|Delayed Release|delayed release
5212622|NCT00774982|Immunology Measurements|immunology measurements
5212623|NCT00774982|Pharmacokinetics in Crohns Disease Patients|pharmacokinetics in crohns disease patients
5212624|NCT00774943|Systemic lupus erythematosus|systemic lupus erythematosus
5212625|NCT00774943|ICOSL|icosl
5212626|NCT00774943|B7RP-1|b7rp-1
5212627|NCT00774943|Costimulation|costimulation
5212628|NCT00774930|Carcinoid tumor|carcinoid tumor
5212629|NCT00774930|Somatuline Depot|somatuline depot
5212630|NCT00774930|Lanreotide Autogel|lanreotide autogel
5212631|NCT00774930|Neuroendocrine tumor|neuroendocrine tumor
5212632|NCT00774930|NET|net
5212633|NCT00774930|Diarrhea|diarrhea
5212634|NCT00774930|Flushing|flushing
5212635|NCT00774930|Carcinoid tumour|carcinoid tumour
5212636|NCT00774930|Neuroendocrine tumour|neuroendocrine tumour
5212637|NCT00774930|Diarrhoea|diarrhoea
5212638|NCT00774917|numen|numen
5212639|NCT00774917|hyperplasia|hyperplasia
5212640|NCT00774904|Type 2 Diabetes|type 2 diabetes
5212641|NCT00774904|Diabetic Nephropathy|diabetic nephropathy
5212642|NCT00774904|Glucose Metabolism|glucose metabolism
5212643|NCT00774904|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers
5212644|NCT00774891|Echocardiography- exercise|echocardiography- exercise
5212645|NCT00774891|Echocardiography- dobutamine|echocardiography- dobutamine
5212646|NCT00774891|Wall stress|wall stress
5212647|NCT00774891|Ventricular volume-left|ventricular volume-left
5212648|NCT00774891|Ischemia|ischemia
5212649|NCT00774891|Angina|angina
5212650|NCT00774891|Heart diseases|heart diseases
5212651|NCT00774891|Stress echocardiography|stress echocardiography
5212652|NCT00774891|Ventricular volume|ventricular volume
5212653|NCT00774891|Vascular diseases|vascular diseases
5212654|NCT00774878|Breast cancer|breast cancer
5212655|NCT00774878|Breast Tumors|breast tumors
5212656|NCT00774878|Anti IGF-1R|anti igf-1r
5212657|NCT00774878|Hormonosensitivity|hormonosensitivity
5212658|NCT00774865|Robotic|robotic
5212659|NCT00774865|CABG|cabg
5212660|NCT00774865|LITA|lita
5212661|NCT00774865|Patency|patency
5212662|NCT00774865|Long|long
5212663|NCT00774865|Term|term
5212664|NCT00774852|lupus|lupus
5212665|NCT00774852|systemic lupus erythematosus|systemic lupus erythematosus
5212666|NCT00774852|lupus nephritis|lupus nephritis
5212667|NCT00774852|SLE|sle
5212668|NCT00774852|abatacept|abatacept
5212669|NCT00774852|CTLA4|ctla4
5212670|NCT00774852|CTLA4Ig|ctla4ig
5212671|NCT00774852|glomerulonephritis|glomerulonephritis
5212672|NCT00774839|Newly Diagnosed|newly diagnosed
5212673|NCT00774839|Colon|colon
5212674|NCT00774839|Stage II|stage ii
5212675|NCT00774839|Stage III|stage iii
5212676|NCT00774826|Follicular lymphoma|follicular lymphoma
5212677|NCT00774826|Rituximab|rituximab
5212678|NCT00774813|Depression|depression
5212679|NCT00774813|Mild|mild
5212680|NCT00774813|Moderate|moderate
5212681|NCT00774813|Anxiety|anxiety
5212682|NCT00774813|Kalaco Scientific, Inc.|kalaco scientific, inc.
5212683|NCT00774800|Recombinant Hyaluronidase|recombinant hyaluronidase
5212684|NCT00774800|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
5212685|NCT00774800|Humalog|humalog
5212686|NCT00774800|Humulin R|humulin r
5212687|NCT00774800|rHuPH20|rhuph20
5212688|NCT00774800|Hylenex|hylenex
5212689|NCT00774787|Combination treatment|combination treatment
5212690|NCT00774787|Imiquimod|imiquimod
5212691|NCT00774787|Cryotherapy|cryotherapy
5212692|NCT00774774|Influenza, human|influenza, human
5212693|NCT00774774|Masks|masks
5212694|NCT00774774|Disease Transmission, Horizontal|disease transmission, horizontal
5212695|NCT00774761|Chronic|chronic
5212696|NCT00774761|Obstructive|obstructive
5212697|NCT00774761|Pulmonary|pulmonary
5212698|NCT00774761|Disease|disease
5212699|NCT00774761|COPD|copd
5212700|NCT00774761|Pharmacodynamic|pharmacodynamic
5212701|NCT00774761|Pharmacokinetic|pharmacokinetic
5212702|NCT00774748|low molecular weight heparin|low molecular weight heparin
5212703|NCT00774748|enoxaparin|enoxaparin
5212704|NCT00774748|Lovenox|lovenox
5212705|NCT00774748|Insuflon|insuflon
5212706|NCT00774748|subcutaneous catheter|subcutaneous catheter
5212707|NCT00774748|once or twice daily dosing of subcutaneous enoxaparin|once or twice daily dosing of subcutaneous enoxaparin
5212708|NCT00774735|healthy volunteer|healthy volunteer
5212709|NCT00774735|darunavir|darunavir
5212710|NCT00774735|lopinavir|lopinavir
5212711|NCT00774735|ritonavir|ritonavir
5212712|NCT00774735|GSK1349572|gsk1349572
5212713|NCT00774735|integrase|integrase
5212714|NCT00774735|pharmacokinetics|pharmacokinetics
5212715|NCT00774709|Heart failure|heart failure
5212716|NCT00774709|Preserved ejection fraction|preserved ejection fraction
5212717|NCT00774709|Diastolic dysfunction|diastolic dysfunction
5212718|NCT00774709|Dyssynchrony|dyssynchrony
5212719|NCT00774709|Echocardiography|echocardiography
5212720|NCT00774709|Patients with acute heart failure clinically|patients with acute heart failure clinically
5212721|NCT00774709|diagnosed|diagnosed
5212722|NCT00774709|BNP level > 100 ng / l or NT-proBNP > 300 ng /l|bnp level > 100 ng / l or nt-probnp > 300 ng /l
5212723|NCT00774709|Preserved left ventricular ejection fraction(LVEF|preserved left ventricular ejection fraction(lvef
5212724|NCT00774709|≥ 45%)|≥ 45%)
5212725|NCT00774696|Bioequivalence study of clarithromycin|bioequivalence study of clarithromycin
5212726|NCT00774683|Pilot|pilot
5212727|NCT00774683|Pharmacokinetics|pharmacokinetics
5212728|NCT00774683|Raltegravir|raltegravir
5212729|NCT00774683|Cervicovaginal|cervicovaginal
5212730|NCT00774683|HIV|hiv
5212731|NCT00774683|Women|women
5212732|NCT00774657|Aortic Stenosis|aortic stenosis
5212733|NCT00774657|Valvular heart disease|valvular heart disease
5212734|NCT00774657|Heart disease|heart disease
5212735|NCT00774657|Cardiovascular disease|cardiovascular disease
5212736|NCT00774657|Two dimensional echocardiography|two dimensional echocardiography
5212737|NCT00774657|Three dimensional echocardiography|three dimensional echocardiography
5212738|NCT00774631|Meningitis|meningitis
5212739|NCT00774631|Hypothermia|hypothermia
5212740|NCT00774631|Intensive care|intensive care
5212741|NCT00774618|Rib Fracture|rib fracture
5212742|NCT00774618|Thoracic Injuries|thoracic injuries
5212743|NCT00774618|Flail Chest|flail chest
5212744|NCT00774618|Rib Fracture Repair|rib fracture repair
5212745|NCT00774618|Rib Fracture ORIF|rib fracture orif
5212746|NCT00774618|Chronic rib fractures|chronic rib fractures
5212747|NCT00774618|Non-healing rib fractures|non-healing rib fractures
5212748|NCT00774618|Rib Fracture Non-union|rib fracture non-union
5212749|NCT00774605|percutaneous, transcutaneous, topical, varenicline, transdermal, transdermal delivery system, patch|percutaneous, transcutaneous, topical, varenicline, transdermal, transdermal delivery system, patch
5212750|NCT00774592|Adolescent Risk Reduction|adolescent risk reduction
5212751|NCT00774592|HIV/AIDS Prevention|hiv/aids prevention
5212752|NCT00774592|Behavioral Change|behavioral change
5212753|NCT00774592|HIV|hiv
5212754|NCT00774579|growth hormone|growth hormone
5212755|NCT00774579|growth hormone deficiency|growth hormone deficiency
5212756|NCT00774579|liver fat|liver fat
5212757|NCT00774579|liver steatosis|liver steatosis
5212758|NCT00774579|growth hormone replacement|growth hormone replacement
5212759|NCT00774566|catheter ablation|catheter ablation
5212760|NCT00774566|randomized|randomized
5212761|NCT00774566|cryo|cryo
5212762|NCT00774566|radiofrequency|radiofrequency
5212763|NCT00774566|atrial fibrillation|atrial fibrillation
5212764|NCT00774566|cryo-balloon|cryo-balloon
5212765|NCT00774566|PV-Isolation|pv-isolation
5212766|NCT00774553|Type 2 diabetes|type 2 diabetes
5212767|NCT00774540|Acute pain|acute pain
5212768|NCT00774540|Inflammatory pain|inflammatory pain
5212769|NCT00774540|Inflammatory mediators|inflammatory mediators
5212770|NCT00774540|Pain relief|pain relief
5212771|NCT00774540|Microdialysis|microdialysis
5212772|NCT00774514|Air Pollution|air pollution
5212773|NCT00774514|Nitrogen Dioxide|nitrogen dioxide
5212774|NCT00774514|NO2|no2
5212775|NCT00774514|Endothelial dysfunction|endothelial dysfunction
5212776|NCT00774501|Anesthesia|anesthesia
5212777|NCT00774501|suspended ventilation|suspended ventilation
5212778|NCT00774488|Euglycemic-hyperinsulinemic clamp|euglycemic-hyperinsulinemic clamp
5212779|NCT00774488|fat biopsies|fat biopsies
5212780|NCT00774488|microarray analysis|microarray analysis
5212781|NCT00774488|quantitative real time PCR|quantitative real time pcr
5212782|NCT00774488|overnutrition|overnutrition
5212783|NCT00774488|low grade-inflammation|low grade-inflammation
5212784|NCT00774475|Clopidogrel therapy|clopidogrel therapy
5212785|NCT00774475|platelet function inhibition|platelet function inhibition
5212786|NCT00774462|Myositis|myositis
5212787|NCT00774462|Anti-synthetase|anti-synthetase
5212788|NCT00774462|Anti-SRP|anti-srp
5212789|NCT00774462|Myasthenia gravis|myasthenia gravis
5212790|NCT00774462|Rituximab|rituximab
5212791|NCT00774449|lung transplantation|lung transplantation
5212792|NCT00774449|bronchiolitis obliterans syndrome|bronchiolitis obliterans syndrome
5212793|NCT00774449|broncholaveolar lavage|broncholaveolar lavage
5212794|NCT00774449|high-resolution computertomography|high-resolution computertomography
5212795|NCT00774449|quality of life|quality of life
5212796|NCT00774436|focal cryotherapy|focal cryotherapy
5212797|NCT00774436|low-risk prostate cancer|low-risk prostate cancer
5212798|NCT00774423|Spinal muscular atrophies (SMA)|spinal muscular atrophies (sma)
5212799|NCT00774423|Degeneration of the motor neurons|degeneration of the motor neurons
5212800|NCT00774423|Anterior horn of the spinal cord|anterior horn of the spinal cord
5212801|NCT00774423|Riluzole|riluzole
5212802|NCT00774384|Neisseria meningitidis|neisseria meningitidis
5212803|NCT00774384|Mucosal|mucosal
5212804|NCT00774384|Vaccination|vaccination
5212805|NCT00774384|Immunity|immunity
5212806|NCT00774384|T cells|t cells
5212807|NCT00774384|T regulatory cells|t regulatory cells
5212808|NCT00774371|Overweight|overweight
5212809|NCT00774371|Obese|obese
5212810|NCT00774371|Breast cancer survivors|breast cancer survivors
5212811|NCT00774371|Weight loss|weight loss
5212812|NCT00774371|Physical activity|physical activity
5212813|NCT00774371|Exercise|exercise
5212814|NCT00774371|Cognitive behavioral therapy|cognitive behavioral therapy
5212815|NCT00774358|Primary Immunodeficiency|primary immunodeficiency
5212816|NCT00774319|HNSCC|hnscc
5212817|NCT00774319|neo Adjuvant|neo adjuvant
5212818|NCT00774319|Chemoradiation therapy|chemoradiation therapy
5212819|NCT00774319|TPF|tpf
5212820|NCT00774306|vascular risk|vascular risk
5212821|NCT00774306|lipid fractions|lipid fractions
5212822|NCT00774306|lipoprotein(a)|lipoprotein(a)
5212823|NCT00774306|C-reactive protein|c-reactive protein
5212824|NCT00774306|subarachnoid hemorrhage|subarachnoid hemorrhage
5212825|NCT00774306|antiepileptic drug|antiepileptic drug
5212826|NCT00774306|randomized|randomized
5212827|NCT00774306|seizure|seizure
5212828|NCT00774306|cholesterol|cholesterol
5212829|NCT00774293|Homoeopathic treatment,|homoeopathic treatment,
5212830|NCT00774293|heart surgery,|heart surgery,
5212831|NCT00774293|randomized clinical trial|randomized clinical trial
5212832|NCT00774254|Health Disparities|health disparities
5212833|NCT00774254|Risk Communication|risk communication
5212834|NCT00774254|Numeracy|numeracy
5212835|NCT00774254|Doctor-Patient Communication|doctor-patient communication
5212836|NCT00774254|Virtual Reality Technology|virtual reality technology
5212837|NCT00774254|Communication|communication
5212838|NCT00774228|Cataract or intraocular lens placement surgery|cataract or intraocular lens placement surgery
5212839|NCT00774215|Pelvic Organ Prolapse|pelvic organ prolapse
5212840|NCT00774215|Cystocele|cystocele
5212841|NCT00774215|Rectocele|rectocele
5212842|NCT00774215|Enterocele|enterocele
5212843|NCT00774215|Synthetic Mesh|synthetic mesh
5212844|NCT00774215|Vaginal Mesh|vaginal mesh
5212845|NCT00774215|Transobturator|transobturator
5212846|NCT00774202|Pts w/ Chronic ITP who have fail/relap after Rituxan rx|pts w/ chronic itp who have fail/relap after rituxan rx
5212847|NCT00774189|Bioequivalence clarithromycin 250mg tablets fasting|bioequivalence clarithromycin 250mg tablets fasting
5212848|NCT00774176|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5212849|NCT00774176|COPD|copd
5213107|NCT00773110|albumin|albumin
5212850|NCT00774176|COPD Exacerbation|copd exacerbation
5212851|NCT00774176|Genetic markers COPD|genetic markers copd
5212852|NCT00774176|Gene expression in COPD exacerbations|gene expression in copd exacerbations
5212853|NCT00774176|COPD Exacerbation Symptom Reporting|copd exacerbation symptom reporting
5212854|NCT00774176|COPD Exacerbation Disease Management|copd exacerbation disease management
5212855|NCT00774176|COPD Treatment|copd treatment
5212856|NCT00774176|Breathing disorders|breathing disorders
5212857|NCT00774176|Emphysema|emphysema
5212858|NCT00774176|COPD with Healthy Control comparators for genetic association studies.|copd with healthy control comparators for genetic association studies.
5212859|NCT00774163|probiotics|probiotics
5212860|NCT00774163|lactobacillus|lactobacillus
5212861|NCT00774163|reuteri|reuteri
5212862|NCT00774163|none (safety only)|none (safety only)
5212863|NCT00774150|Neural correlates of pediatric anxiety disorder|neural correlates of pediatric anxiety disorder
5212864|NCT00774150|Social correlates of pediatric anxiety disorder|social correlates of pediatric anxiety disorder
5212865|NCT00774150|Generalized Anxiety Disorder in pediatric populations|generalized anxiety disorder in pediatric populations
5212866|NCT00774150|Separation Anxiety Disorder in pediatric populations|separation anxiety disorder in pediatric populations
5212867|NCT00774150|Social Phobia in pediatric populations|social phobia in pediatric populations
5212868|NCT00774137|Acute Kidney Injury|acute kidney injury
5212869|NCT00774137|IL-18|il-18
5212870|NCT00774137|NGAL|ngal
5212871|NCT00774137|Cystatin C|cystatin c
5212872|NCT00774137|Biomarkers|biomarkers
5212873|NCT00774137|Dialysis|dialysis
5212874|NCT00774124|GDM, pregnancy, macrosomia|gdm, pregnancy, macrosomia
5212875|NCT00774111|healthy volunteer|healthy volunteer
5212876|NCT00774111|pharmacokinetics|pharmacokinetics
5212877|NCT00774111|GSK1349572|gsk1349572
5212878|NCT00774111|integrase|integrase
5212879|NCT00774111|etravirine|etravirine
5212880|NCT00774098|all adult patients (>18 years) planned to undergo a major liver resection|all adult patients (>18 years) planned to undergo a major liver resection
5212881|NCT00774085|Schizophrenia|schizophrenia
5212882|NCT00774085|Risperidone|risperidone
5212883|NCT00774085|Risperdal Consta|risperdal consta
5212884|NCT00774085|Propective|propective
5212885|NCT00774085|Retrospective|retrospective
5212886|NCT00774085|Mental disorders|mental disorders
5212887|NCT00774085|Observational|observational
5212888|NCT00774072|subjects with cystic fibrosis and pseudomonas aeruginosa colonization in the upper airways|subjects with cystic fibrosis and pseudomonas aeruginosa colonization in the upper airways
5213119|NCT00773058|adrenal insufficiency|adrenal insufficiency
5212889|NCT00774059|Breast ptosis, Breast lift|breast ptosis, breast lift
5212890|NCT00774046|Therapy-related myelodysplastic syndrome/ Therapy -related Acute myeloid leukemia|therapy-related myelodysplastic syndrome/ therapy -related acute myeloid leukemia
5212891|NCT00774046|Myelodysplastic syndrome|myelodysplastic syndrome
5212892|NCT00774046|Acute myeloid leukemia|acute myeloid leukemia
5212893|NCT00774033|Keratinocytes|keratinocytes
5212894|NCT00774033|Cell spray|cell spray
5212895|NCT00774033|Deep partial thickness burns|deep partial thickness burns
5212896|NCT00774033|Full thickness burns|full thickness burns
5212897|NCT00774020|Paget's Disease of Bone|paget's disease of bone
5212898|NCT00774020|Serum Alkaline Phosphatase|serum alkaline phosphatase
5212899|NCT00774007|Irritable bowel syndrome, abdominal pain, abdominal bloating, immune cells, mast cells|irritable bowel syndrome, abdominal pain, abdominal bloating, immune cells, mast cells
5212900|NCT00773994|anterior palatal eminence|anterior palatal eminence
5212901|NCT00773994|palatal elevation above the maxillary plane|palatal elevation above the maxillary plane
5212902|NCT00773994|anterior uvular prolapse|anterior uvular prolapse
5212903|NCT00773994|"inverted-V present in base view."|"inverted-v present in base view."
5212904|NCT00773981|anastomotic leakage|anastomotic leakage
5212905|NCT00773942|Medication therapy management|medication therapy management
5212906|NCT00773942|Pharmacist|pharmacist
5212907|NCT00773942|Chronic care|chronic care
5212908|NCT00773942|Medicare|medicare
5212909|NCT00773942|Medicaid|medicaid
5212910|NCT00773942|Medication reconciliation|medication reconciliation
5212911|NCT00773942|Adverse drug events|adverse drug events
5212912|NCT00773942|Drug related problems|drug related problems
5212913|NCT00773916|Attention Deficit Disorder|attention deficit disorder
5212914|NCT00773916|Attention Deficit Disorders with Hyperactivity|attention deficit disorders with hyperactivity
5212915|NCT00773916|Hyperkinetic Syndrome|hyperkinetic syndrome
5212916|NCT00773916|Family Function|family function
5212917|NCT00773916|Adverse Factors|adverse factors
5212918|NCT00773916|Parental Psychopathology|parental psychopathology
5212919|NCT00773877|RNFL thickness|rnfl thickness
5212920|NCT00773864|Healthcare employees who work in the rehabilitation center|healthcare employees who work in the rehabilitation center
5212921|NCT00773851|ventral hernia|ventral hernia
5212922|NCT00773851|laparoscopy|laparoscopy
5212923|NCT00773851|mesh|mesh
5212924|NCT00773851|recurrence|recurrence
5212925|NCT00773825|Genomic imprinting|genomic imprinting
5212926|NCT00773825|Reproductive techniques, assisted|reproductive techniques, assisted
5212927|NCT00773825|Beckwith-Wiedemann syndrome|beckwith-wiedemann syndrome
5212928|NCT00773825|Angelman syndrome|angelman syndrome
5212929|NCT00773812|Autistic Disorder|autistic disorder
5212930|NCT00773812|Autism|autism
5212931|NCT00773812|Mecamylamine|mecamylamine
5213108|NCT00773097|Prevention|prevention
5212932|NCT00773812|Pervasive Developmental Disorder-Not Otherwise Specified|pervasive developmental disorder-not otherwise specified
5212933|NCT00773799|To define activities and patient characteristics likely to lead to dissemination of resistant bacteria in rehabilitation centers and|to define activities and patient characteristics likely to lead to dissemination of resistant bacteria in rehabilitation centers and
5212934|NCT00773799|To define specific risk factors for acquisition of resistant bacteria (ESBL producers and MRSA) in rehabilitation centers.|to define specific risk factors for acquisition of resistant bacteria (esbl producers and mrsa) in rehabilitation centers.
5212935|NCT00773799|ESBL producers|esbl producers
5212936|NCT00773799|MRSA|mrsa
5212937|NCT00773786|COPD|copd
5212938|NCT00773786|Bronchodilator|bronchodilator
5212939|NCT00773786|arformoterol|arformoterol
5212940|NCT00773786|tiotropium|tiotropium
5212941|NCT00773773|Biomarkers - PSA, hK2 and solubilized|biomarkers - psa, hk2 and solubilized
5212942|NCT00773773|urokinase-receptor forms (su-PAR)|urokinase-receptor forms (su-par)
5212943|NCT00773773|08-114|08-114
5212944|NCT00773760|opioids|opioids
5212945|NCT00773760|COMT|comt
5212946|NCT00773760|SNP|snp
5212947|NCT00773760|analgesia|analgesia
5212948|NCT00773760|postoperative pain|postoperative pain
5212949|NCT00773747|Neoplasms, Plasma Cell|neoplasms, plasma cell
5212950|NCT00773747|Neoplasms by Histologic Type|neoplasms by histologic type
5212951|NCT00773747|Neoplasms|neoplasms
5212952|NCT00773747|Hemostatic Disorders|hemostatic disorders
5212953|NCT00773747|Vascular Diseases|vascular diseases
5212954|NCT00773747|Cardiovascular Diseases|cardiovascular diseases
5212955|NCT00773747|Paraproteinemias|paraproteinemias
5212956|NCT00773747|Blood Protein Disorders|blood protein disorders
5212957|NCT00773747|Hematologic Diseases|hematologic diseases
5212958|NCT00773747|Hemorrhagic Disorders|hemorrhagic disorders
5212959|NCT00773747|Lymphoproliferative Disorders|lymphoproliferative disorders
5212960|NCT00773747|Immunoproliferative Disorders|immunoproliferative disorders
5212961|NCT00773747|Immune System Diseases|immune system diseases
5212962|NCT00773747|Vorinostat|vorinostat
5212963|NCT00773747|Bortezomib|bortezomib
5212964|NCT00773747|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal
5212965|NCT00773747|Analgesics, Non-Narcotic|analgesics, non-narcotic
5212966|NCT00773747|Analgesics|analgesics
5212967|NCT00773747|Sensory System Agents|sensory system agents
5212968|NCT00773747|Peripheral Nervous System Agents|peripheral nervous system agents
5212969|NCT00773747|Physiological Effects of Drugs|physiological effects of drugs
5212970|NCT00773747|Pharmacologic Actions|pharmacologic actions
5212971|NCT00773747|Anti-Inflammatory Agents|anti-inflammatory agents
5212972|NCT00773747|Therapeutic Uses|therapeutic uses
5212973|NCT00773747|Antirheumatic Agents|antirheumatic agents
5212974|NCT00773747|Antineoplastic Agents|antineoplastic agents
5212975|NCT00773747|Enzyme Inhibitors|enzyme inhibitors
5212976|NCT00773747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
5212977|NCT00773747|Anticarcinogenic Agents|anticarcinogenic agents
5212978|NCT00773734|moderate-to-severe plaque-type psoriasis|moderate-to-severe plaque-type psoriasis
5212979|NCT00773708|HIV infection|hiv infection
5212980|NCT00773708|Discordant patient|discordant patient
5212981|NCT00773708|CD4 recovery|cd4 recovery
5212982|NCT00773708|intensification antiretroviral therapy|intensification antiretroviral therapy
5212983|NCT00773708|raltegravir|raltegravir
5212984|NCT00773708|"HIV-1 infected patient classified as discordant who showed high level of CD8+HLADR+CD38+ and cell death values at the screening"|"hiv-1 infected patient classified as discordant who showed high level of cd8+hladr+cd38+ and cell death values at the screening"
5212985|NCT00773682|osteoarthritis|osteoarthritis
5212986|NCT00773682|hands|hands
5212987|NCT00773682|mud-packs therapy|mud-packs therapy
5212988|NCT00773682|balneotherapy|balneotherapy
5212989|NCT00773682|Osteoarthritis of the hands|osteoarthritis of the hands
5212990|NCT00773669|male breast cancer|male breast cancer
5212991|NCT00773669|Male breast cancer patients diagnosed and/or|male breast cancer patients diagnosed and/or
5212992|NCT00773669|treated at Summa Health System/Akron City Hospital|treated at summa health system/akron city hospital
5212993|NCT00773669|from the reference year of 1995 through 2007.|from the reference year of 1995 through 2007.
5212994|NCT00773656|Radiotherapy|radiotherapy
5212995|NCT00773656|Biologically effective dose|biologically effective dose
5212996|NCT00773656|Radiation injury|radiation injury
5212997|NCT00773643|to procure human temporalis muscle, subcutaneous adipose (fat), and bone tissue samples from children with craniosynostosis,|to procure human temporalis muscle, subcutaneous adipose (fat), and bone tissue samples from children with craniosynostosis,
5212998|NCT00773643|to grow cells from these tissues in vitro|to grow cells from these tissues in vitro
5212999|NCT00773643|to evaluate the osteogenic potentials of these cell types.|to evaluate the osteogenic potentials of these cell types.
5213000|NCT00773617|Bulimia Nervosa|bulimia nervosa
5213001|NCT00773617|Treatment Efficacy|treatment efficacy
5213002|NCT00773617|Integrative Cognitive Affective Therapy|integrative cognitive affective therapy
5213003|NCT00773617|Cognitive Behavior Therapy|cognitive behavior therapy
5213004|NCT00773604|blepharospasm|blepharospasm
5213005|NCT00773604|Deep brain Stimulation|deep brain stimulation
5213006|NCT00773604|cervical dystonia|cervical dystonia
5213007|NCT00773604|cranial dystonia|cranial dystonia
5213008|NCT00773604|generalized dystonia|generalized dystonia
5213009|NCT00773604|subthalamic nucleus|subthalamic nucleus
5213010|NCT00773604|DBS|dbs
5213011|NCT00773591|Sleep-related breathing disorders|sleep-related breathing disorders
5213012|NCT00773591|Snoring|snoring
5213013|NCT00773578|Children|children
5213014|NCT00773578|Tobacco smoke exposure|tobacco smoke exposure
5213015|NCT00773578|Exhaled nitric oxide|exhaled nitric oxide
5213016|NCT00773578|Nasal lavage|nasal lavage
5213017|NCT00773578|Cytokines|cytokines
5213018|NCT00773565|patients with obesity (BMI > 30 kg/m2)|patients with obesity (bmi > 30 kg/m2)
5213019|NCT00773552|OAB|oab
5213020|NCT00773552|overactive bladder|overactive bladder
5213021|NCT00773552|urinary urge|urinary urge
5213022|NCT00773552|urge incontinence|urge incontinence
5213023|NCT00773552|urge|urge
5213024|NCT00773539|atrial fibrillation|atrial fibrillation
5213025|NCT00773539|pulmonary veins|pulmonary veins
5213026|NCT00773539|ablation|ablation
5213027|NCT00773500|Medication Errors|medication errors
5213028|NCT00773487|Asthma GINA 1|asthma gina 1
5213029|NCT00773487|Mild intermittant asthma|mild intermittant asthma
5213030|NCT00773448|Cancer|cancer
5213031|NCT00773448|Screening|screening
5213032|NCT00773435|Upper respiratory tract infections|upper respiratory tract infections
5213033|NCT00773435|Children|children
5213034|NCT00773435|Echinacea|echinacea
5213035|NCT00773435|Prevention|prevention
5213036|NCT00773435|Immune modulation|immune modulation
5213037|NCT00773422|smoking lapse behavior|smoking lapse behavior
5213038|NCT00773422|smoking cessation|smoking cessation
5213039|NCT00773422|varenicline|varenicline
5213040|NCT00773422|naltrexone|naltrexone
5213041|NCT00773422|medication effect on smoking lapse behavior|medication effect on smoking lapse behavior
5213042|NCT00773370|stroke|stroke
5213043|NCT00773370|exercise|exercise
5213044|NCT00773357|smoking lapse behavior|smoking lapse behavior
5213045|NCT00773357|smoking cessation|smoking cessation
5213046|NCT00773357|guanfacine|guanfacine
5213047|NCT00773357|carvedilol|carvedilol
5213048|NCT00773357|medication effect on smoking lapse behavior|medication effect on smoking lapse behavior
5213049|NCT00773357|medication effect on smoking cessation|medication effect on smoking cessation
5213050|NCT00773357|stress|stress
5213051|NCT00773357|gender differences|gender differences
5213052|NCT00773344|Solid Tumors (dose escalation/Phase 1)|solid tumors (dose escalation/phase 1)
5213053|NCT00773344|Breast Cancer (recommended dose phase/Phase 2)|breast cancer (recommended dose phase/phase 2)
5213054|NCT00773318|LM/SL|lm/sl
5213055|NCT00773318|SPECT/low-dose multislice CT|spect/low-dose multislice ct
5213056|NCT00773305|seed implantation|seed implantation
5213057|NCT00773292|HAM/TSP|ham/tsp
5213058|NCT00773266|Aphakia|aphakia
5213059|NCT00773266|Secondary IOL-Implantation|secondary iol-implantation
5213060|NCT00773266|Iris-Fixated IOL|iris-fixated iol
5213061|NCT00773266|Artisan|artisan
5213062|NCT00773266|Anterior Segment OCT|anterior segment oct
5213063|NCT00773266|Aphakia - secondary iris-fixated IOL position|aphakia - secondary iris-fixated iol position
5213064|NCT00773253|dystonia|dystonia
5213065|NCT00773253|cervical dystonia|cervical dystonia
5213066|NCT00773253|Botox|botox
5213067|NCT00773253|idiopathic primary cervical dystonia|idiopathic primary cervical dystonia
5213068|NCT00773227|Oculopharyngeal muscular dystrophy|oculopharyngeal muscular dystrophy
5213069|NCT00773227|Swallowing disorders, dysphagia|swallowing disorders, dysphagia
5213070|NCT00773227|Pharyngeal propulsion|pharyngeal propulsion
5213071|NCT00773227|Upper oesophageal sphincter|upper oesophageal sphincter
5213072|NCT00773227|Cricopharyngeal muscle|cricopharyngeal muscle
5213073|NCT00773227|Autologous myoblasts|autologous myoblasts
5213074|NCT00773227|Autograft|autograft
5213075|NCT00773227|Myotomy of the upper oesophageal sphincter|myotomy of the upper oesophageal sphincter
5213076|NCT00773227|Fibroscopy of swallowing|fibroscopy of swallowing
5213077|NCT00773227|Videofluoroscopy of swallowing|videofluoroscopy of swallowing
5213078|NCT00773214|Obesity|obesity
5213079|NCT00773214|Appetite|appetite
5213080|NCT00773214|Body composition|body composition
5213081|NCT00773214|Energy compensation|energy compensation
5213082|NCT00773201|Long QT syndrome|long qt syndrome
5213083|NCT00773201|Cardiac repolarisation|cardiac repolarisation
5213084|NCT00773201|Genome-wide association|genome-wide association
5213085|NCT00773201|Electrophysiology|electrophysiology
5213086|NCT00773201|Drugs/adverse effects|drugs/adverse effects
5213087|NCT00773175|pediatric|pediatric
5213088|NCT00773175|hylenex|hylenex
5213089|NCT00773175|subcutaneous infusion|subcutaneous infusion
5213090|NCT00773175|hyaluronidase|hyaluronidase
5213091|NCT00773175|rHuPH20|rhuph20
5213092|NCT00773175|recombinant human hyaluronidase|recombinant human hyaluronidase
5213093|NCT00773149|Adult Acute Lymphocytic Leukemia|adult acute lymphocytic leukemia
5213094|NCT00773149|Alemtuzumab|alemtuzumab
5213095|NCT00773136|Bimatoprost|bimatoprost
5213096|NCT00773136|Eyelash lengthening|eyelash lengthening
5213097|NCT00773136|Prostaglandin Analogs|prostaglandin analogs
5213098|NCT00773136|Cosmetics|cosmetics
5213099|NCT00773123|RT-View|rt-view
5213100|NCT00773123|Spectral domain OCT|spectral domain oct
5213101|NCT00773123|Ganglion cell layer|ganglion cell layer
5213102|NCT00773123|RNFL|rnfl
5213103|NCT00773123|Visual field defect|visual field defect
5213104|NCT00773110|hemolysis|hemolysis
5213105|NCT00773110|systemic inflammatory response syndrome|systemic inflammatory response syndrome
5213106|NCT00773110|cardiopulmonary bypass|cardiopulmonary bypass
5213109|NCT00773097|Colorectal Cancer|colorectal cancer
5213110|NCT00773084|Diastolic Heart Failure|diastolic heart failure
5213111|NCT00773084|Hispanic Americans|hispanic americans
5213112|NCT00773084|Aliskiren|aliskiren
5213113|NCT00773084|Spironolactone|spironolactone
5213114|NCT00773084|Lisinopril|lisinopril
5213115|NCT00773084|Diastolic Heart Failure in Hispanic Americans|diastolic heart failure in hispanic americans
5213116|NCT00773071|Cervical cancer, vulvar cancer, LM/SL, SPECT/CT|cervical cancer, vulvar cancer, lm/sl, spect/ct
5213117|NCT00773058|acute respiratory distress syndrome|acute respiratory distress syndrome
5213118|NCT00773058|glucocorticoid|glucocorticoid
5213120|NCT00773045|pain scores|pain scores
5213121|NCT00773045|critically ill patients|critically ill patients
5213122|NCT00773045|ICU|icu
5213123|NCT00773045|pain management|pain management
5213124|NCT00773045|pain measurement|pain measurement
5213125|NCT00773019|infusion pump|infusion pump
5213126|NCT00773019|implantable|implantable
5213127|NCT00773019|performance|performance
5213128|NCT00773006|coronary artery disease|coronary artery disease
5213129|NCT00773006|percutaneous coronary intervention|percutaneous coronary intervention
5213130|NCT00773006|anticoagulation|anticoagulation
5213131|NCT00772993|glaucoma|glaucoma
5213132|NCT00772993|myopia|myopia
5213133|NCT00772993|myopia with glaucoma|myopia with glaucoma
5213134|NCT00772993|normal control|normal control
5213135|NCT00772954|Clostridium difficile diarrhea|clostridium difficile diarrhea
5213136|NCT00772954|Clostridium difficile toxoid vaccine|clostridium difficile toxoid vaccine
5213137|NCT00772928|Pertussis|pertussis
5213138|NCT00772928|Whooping cough|whooping cough
5213139|NCT00772928|Diphtheria|diphtheria
5213140|NCT00772928|Tetanus|tetanus
5213141|NCT00772928|Haemophilus influenzae|haemophilus influenzae
5213142|NCT00772928|Poliovirus Types 1, 2, and 3.|poliovirus types 1, 2, and 3.
5213143|NCT00772915|stage I multiple myeloma|stage i multiple myeloma
5213144|NCT00772915|stage II multiple myeloma|stage ii multiple myeloma
5213145|NCT00772915|stage III multiple myeloma|stage iii multiple myeloma
5213146|NCT00772902|HIV-1|hiv-1
5213147|NCT00772902|LDL|ldl
5213148|NCT00772902|HDL|hdl
5213149|NCT00772902|non-HDL cholesterol|non-hdl cholesterol
5213150|NCT00772902|triglycerides|triglycerides
5213151|NCT00772902|cholesterol|cholesterol
5213152|NCT00772889|Elderly|elderly
5213153|NCT00772889|Vaccine|vaccine
5213154|NCT00772889|Influenza|influenza
5213155|NCT00772876|P1446A-05|p1446a-05
5213156|NCT00772876|Advanced refractory malignancies|advanced refractory malignancies
5213157|NCT00772876|Phase I|phase i
5213158|NCT00772850|Humeral fracture; Antegrade nailing; Rotator cuff|humeral fracture; antegrade nailing; rotator cuff
5213159|NCT00772837|Functional Dyspepsia|functional dyspepsia
5213160|NCT00772837|Helicobacter Pylori eradication|helicobacter pylori eradication
5213161|NCT00772837|Quality of Life|quality of life
5213162|NCT00772837|Dyspeptic Symptoms|dyspeptic symptoms
5213163|NCT00772824|Breast cancer|breast cancer
5213164|NCT00772824|Chemotherapy|chemotherapy
5213165|NCT00772824|Epirubicin|epirubicin
5213166|NCT00772824|Glutamine|glutamine
5213167|NCT00772824|FEC chemotherapy|fec chemotherapy
5213168|NCT00772798|ovarian cancer|ovarian cancer
5213169|NCT00772798|HDAC inhibitor|hdac inhibitor
5213170|NCT00772798|vorinostat|vorinostat
5213171|NCT00772785|opioid dependence|opioid dependence
5213172|NCT00772785|opioid addiction|opioid addiction
5213173|NCT00772785|buprenorphine|buprenorphine
5213174|NCT00772785|methadone|methadone
5213175|NCT00772785|heroin|heroin
5213176|NCT00772785|implant|implant
5213177|NCT00772785|opioid withdrawal|opioid withdrawal
5213178|NCT00772785|opioid pain medication|opioid pain medication
5213179|NCT00772785|suboxone|suboxone
5213180|NCT00772772|Vitamin D3 repletion|vitamin d3 repletion
5213181|NCT00772772|levels of endotoxin|levels of endotoxin
5213182|NCT00772772|intestinal permeability|intestinal permeability
5213183|NCT00772772|accelerated atherosclerosis|accelerated atherosclerosis
5213184|NCT00772759|AZD3199|azd3199
5213185|NCT00772759|Japanese Healthy Volunteers|japanese healthy volunteers
5213186|NCT00772759|Phase I study|phase i study
5213187|NCT00772759|Single and Multiple Ascending Dose|single and multiple ascending dose
5213188|NCT00772759|safety|safety
5213189|NCT00772759|tolerability|tolerability
5213190|NCT00772759|PK|pk
5213191|NCT00772746|panic|panic
5213192|NCT00772746|respiration|respiration
5213193|NCT00772746|anxiety|anxiety
5213194|NCT00772746|exercise|exercise
5213195|NCT00772746|cognition|cognition
5213196|NCT00772733|Quality assurance|quality assurance
5213197|NCT00772733|rehabilitation|rehabilitation
5213198|NCT00772733|chronic care model|chronic care model
5213199|NCT00772733|COPD|copd
5213200|NCT00772707|contact lens solution|contact lens solution
5213201|NCT00772707|OPTI-FREE RepleniSH|opti-free replenish
5213202|NCT00772707|contact lenses|contact lenses
5213203|NCT00772694|testicular cancer|testicular cancer
5213204|NCT00772694|germ cell cancer|germ cell cancer
5213205|NCT00772694|sorafenib|sorafenib
5213206|NCT00772668|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5213207|NCT00772668|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5213208|NCT00772668|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5213209|NCT00772668|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5213210|NCT00772668|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5213211|NCT00772668|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5213212|NCT00772655|Follicular Lymphoma|follicular lymphoma
5213213|NCT00772655|First line therapy|first line therapy
5213214|NCT00772655|Zevalin|zevalin
5213215|NCT00772655|90Yttrium-Ibritumomab Tiuxetan|90yttrium-ibritumomab tiuxetan
5213216|NCT00772655|Yttrium|yttrium
5213217|NCT00772655|Rituximab|rituximab
5213218|NCT00772655|Radio-immuno therapy|radio-immuno therapy
5213219|NCT00772642|Cross-Sectional|cross-sectional
5213220|NCT00772642|Plasmodium Falciparum Malaria|plasmodium falciparum malaria
5213221|NCT00772642|Cord Blood|cord blood
5213222|NCT00772642|Immunology|immunology
5213223|NCT00772642|Mali|mali
5213224|NCT00772642|Malaria|malaria
5213225|NCT00772629|Menactra®|menactra®
5213226|NCT00772629|Meningitis|meningitis
5213227|NCT00772629|Meningococcemia|meningococcemia
5213228|NCT00772629|Neisseria meningitidis|neisseria meningitidis
5213229|NCT00772616|Anesthesia|anesthesia
5213230|NCT00772616|Analgesia|analgesia
5213231|NCT00772616|Patient-Controlled Analgesia|patient-controlled analgesia
5213232|NCT00772616|Hyperalgesia|hyperalgesia
5213233|NCT00772603|Partial onset epilepsy|partial onset epilepsy
5213234|NCT00772603|Partial onset seizures|partial onset seizures
5213235|NCT00772590|HIV|hiv
5213236|NCT00772590|antiretroviral therapy intensification|antiretroviral therapy intensification
5213237|NCT00772590|suboptimal CD4+ T cell response|suboptimal cd4+ t cell response
5213238|NCT00772590|virological suppression|virological suppression
5213239|NCT00772590|bovine colostrum|bovine colostrum
5213240|NCT00772590|raltegravir|raltegravir
5213241|NCT00772577|Hypertension, Obese, aliskiren, hydrochlorothiazide, systolic blood pressure, diastolic blood pressure, ramipril, stage 2|hypertension, obese, aliskiren, hydrochlorothiazide, systolic blood pressure, diastolic blood pressure, ramipril, stage 2
5213242|NCT00772564|Acute ST Elevation Myocardial Infarction|acute st elevation myocardial infarction
5213243|NCT00772525|Visual acuity|visual acuity
5213244|NCT00772525|Contrast sensitivity|contrast sensitivity
5213245|NCT00772525|Visual Evoked Potentials|visual evoked potentials
5213246|NCT00772525|Optical Coherence Tomography|optical coherence tomography
5213247|NCT00772512|PF-04802540, polysomnography, REM, cross over|pf-04802540, polysomnography, rem, cross over
5213248|NCT00772486|Chronic lymphocytic leukemia|chronic lymphocytic leukemia
5213249|NCT00772486|Leukemia|leukemia
5213250|NCT00772486|Leukemia, Lymphocytic, Chronic, B-Cell|leukemia, lymphocytic, chronic, b-cell
5213251|NCT00772486|Leukemia, B-Cell|leukemia, b-cell
5213252|NCT00772486|Immune System Diseases|immune system diseases
5213253|NCT00772486|Rituximab|rituximab
5213254|NCT00772486|Fludarabine|fludarabine
5213255|NCT00772486|Cyclophosphamide|cyclophosphamide
5213256|NCT00772486|ISF35|isf35
5213257|NCT00772486|Ad-ISF35|ad-isf35
5213258|NCT00772486|Refractory|refractory
5213259|NCT00772486|Resistant|resistant
5213260|NCT00772486|17p-|17p-
5213261|NCT00772486|del 17p|del 17p
5213262|NCT00772486|17p|17p
5213263|NCT00772486|Resistant CLL|resistant cll
5213264|NCT00772486|Refractory CLL|refractory cll
5213265|NCT00772486|17p- CLL|17p- cll
5213266|NCT00772486|CLL|cll
5213267|NCT00772460|patient warming|patient warming
5213268|NCT00772460|convective warming|convective warming
5213269|NCT00772460|conductive warming|conductive warming
5213270|NCT00772460|intraoperative normothermia|intraoperative normothermia
5213271|NCT00772460|accidental hypothermia|accidental hypothermia
5213272|NCT00772460|intraoperative hypothermia|intraoperative hypothermia
5213273|NCT00772447|Skin Infections|skin infections
5213274|NCT00772447|Complicated Bacterial Skin and Skin Structure Infection due to Gram-positive Pathogens|complicated bacterial skin and skin structure infection due to gram-positive pathogens
5213275|NCT00772421|Epilepsy|epilepsy
5213276|NCT00772421|Recruitment rhythm|recruitment rhythm
5213277|NCT00772421|DBS|dbs
5213278|NCT00772408|pulmonary tuberculosis|pulmonary tuberculosis
5213279|NCT00772408|Toll-like receptor 2 gene polymorphisms|toll-like receptor 2 gene polymorphisms
5213280|NCT00772408|blood lymphocyte subsets|blood lymphocyte subsets
5213281|NCT00772408|systemic symptoms|systemic symptoms
5213282|NCT00772408|pleural effusion|pleural effusion
5213283|NCT00772395|Periprosthetic bone loss risedronate bisphosphonates|periprosthetic bone loss risedronate bisphosphonates
5213284|NCT00772382|Chronic Kidney Disease|chronic kidney disease
5213285|NCT00772382|Dialysis|dialysis
5213286|NCT00772382|Hyperphosphatemia|hyperphosphatemia
5213287|NCT00772382|Phosphate binder|phosphate binder
5213288|NCT00772369|Pertussis|pertussis
5213289|NCT00772369|Whooping cough|whooping cough
5213290|NCT00772369|Diphtheria|diphtheria
5213291|NCT00772369|Tetanus|tetanus
5213292|NCT00772369|Haemophilus influenzae|haemophilus influenzae
5213293|NCT00772369|Poliovirus Types 1, 2, and 3.|poliovirus types 1, 2, and 3.
5213294|NCT00772343|Diarrhea|diarrhea
5213295|NCT00772343|Clostridium difficile infection|clostridium difficile infection
5213296|NCT00772343|Clostridium difficile toxoid|clostridium difficile toxoid
5213297|NCT00772330|MIDI Arrow|midi arrow
5213298|NCT00772330|Glaucoma Drainage Device|glaucoma drainage device
5213299|NCT00772330|GDD|gdd
5213300|NCT00772330|InnFocus|innfocus
5213301|NCT00772330|Glaucoma treatment|glaucoma treatment
5213302|NCT00772317|Recurrent|recurrent
5213303|NCT00772317|prostate cancer|prostate cancer
5213304|NCT00772317|ebrt|ebrt
5213305|NCT00772317|hifu|hifu
5213306|NCT00772304|rhinitis|rhinitis
5213307|NCT00772291|inguinal|inguinal
5213308|NCT00772291|hernia|hernia
5213309|NCT00772291|chronic|chronic
5213310|NCT00772291|pain|pain
5213311|NCT00772291|pregabalin|pregabalin
5213312|NCT00772291|chronic pain after inguinal herniorraphy|chronic pain after inguinal herniorraphy
5213313|NCT00772278|carotid stenosis|carotid stenosis
5213314|NCT00772278|asymptomatic|asymptomatic
5213315|NCT00772278|carotid stenting|carotid stenting
5213316|NCT00772278|carotid endarterectomy|carotid endarterectomy
5213317|NCT00772265|Bioequivalence|bioequivalence
5213318|NCT00772265|pharmacokinetic|pharmacokinetic
5213319|NCT00772265|Pharmacodynamic|pharmacodynamic
5213320|NCT00772265|Isophane insulin|isophane insulin
5213321|NCT00772252|Liver support treatment|liver support treatment
5213322|NCT00772239|Coagulation Management|coagulation management
5213323|NCT00772239|Cardiac surgery|cardiac surgery
5213324|NCT00772239|Bleeding|bleeding
5213325|NCT00772239|Rotem|rotem
5213326|NCT00772226|laparoscopic cholecystectomy|laparoscopic cholecystectomy
5213327|NCT00772226|pain|pain
5213328|NCT00772226|PONV|ponv
5213329|NCT00772226|music|music
5213330|NCT00772226|therapy|therapy
5213331|NCT00772226|fatigue after elective laparoscopic cholecystectomy|fatigue after elective laparoscopic cholecystectomy
5213332|NCT00772213|multiple trauma|multiple trauma
5213333|NCT00772213|outcome and process assessment|outcome and process assessment
5213334|NCT00772187|Laparoscopic surgery (general surgery).|laparoscopic surgery (general surgery).
5213335|NCT00772174|Glucose Metabolism Disorder|glucose metabolism disorder
5213336|NCT00772174|Dysmetabolic Syndrome|dysmetabolic syndrome
5213337|NCT00772174|Type II Diabetes|type ii diabetes
5213338|NCT00772174|Diabetes Mellitus, Lipoatrophic|diabetes mellitus, lipoatrophic
5213339|NCT00772174|Dyslipidemia|dyslipidemia
5213340|NCT00772174|Drug Therapy|drug therapy
5213341|NCT00772161|ADHD|adhd
5213342|NCT00772161|Attention Deficit Disorder|attention deficit disorder
5213343|NCT00772161|Attention Deficit an Disruptive Behavior Disorders|attention deficit an disruptive behavior disorders
5213344|NCT00772161|Children|children
5213345|NCT00772161|Central Nervous System Stimulants|central nervous system stimulants
5213346|NCT00772161|Methylphenidate|methylphenidate
5213347|NCT00772161|Pharmacokinetics|pharmacokinetics
5213348|NCT00772161|Area Under Curve|area under curve
5213349|NCT00772161|Therapeutic Equivalency|therapeutic equivalency
5213350|NCT00772161|Psychopharmacology|psychopharmacology
5213351|NCT00772148|Liver|liver
5213352|NCT00772148|Hepatic|hepatic
5213353|NCT00772148|Transplantation|transplantation
5213354|NCT00772148|Immunosuppression|immunosuppression
5213355|NCT00772148|Tacrolimus|tacrolimus
5213356|NCT00772148|Prograf|prograf
5213357|NCT00772135|pulmonary hypertension|pulmonary hypertension
5213358|NCT00772135|congenital heart defects|congenital heart defects
5213359|NCT00772135|exercise|exercise
5213360|NCT00772135|phosphodiesterase inhibitors|phosphodiesterase inhibitors
5213361|NCT00772135|Exercise induced pulmonary arterial hypertensive response in congenital heart disease|exercise induced pulmonary arterial hypertensive response in congenital heart disease
5213362|NCT00772122|Recurrent Miscarriage|recurrent miscarriage
5213363|NCT00772122|G-CSF|g-csf
5213364|NCT00772122|pregnancy outcome|pregnancy outcome
5213365|NCT00772122|pregnancy outcome of pregnancies treated with G-CSF|pregnancy outcome of pregnancies treated with g-csf
5213366|NCT00772122|treatment of recurrent miscarriage|treatment of recurrent miscarriage
5213367|NCT00772109|Influenza|influenza
5213368|NCT00772109|Orthomyxoviruses|orthomyxoviruses
5213369|NCT00772109|Inactivated Split-virion influenza vaccine|inactivated split-virion influenza vaccine
5213370|NCT00772109|Fluzone®|fluzone®
5213371|NCT00772109|Adults|adults
5213372|NCT00772070|Menactra®|menactra®
5213373|NCT00772070|Menomune®|menomune®
5213374|NCT00772070|Meningitis|meningitis
5213375|NCT00772070|Meningococcemia|meningococcemia
5213376|NCT00772070|Neisseria meningitidis|neisseria meningitidis
5213377|NCT00772044|OSA|osa
5213378|NCT00772044|sleep apnea|sleep apnea
5213379|NCT00772044|apnea|apnea
5213380|NCT00772044|AHI|ahi
5213381|NCT00772031|chronic migraine, migraine prevention, chronic headache|chronic migraine, migraine prevention, chronic headache
5213382|NCT00772018|stage 0 bladder cancer|stage 0 bladder cancer
5213383|NCT00771992|Asthma GINA 1|asthma gina 1
5213384|NCT00771979|Healthy Volunteers|healthy volunteers
5213385|NCT00771979|Relative Bioavailability|relative bioavailability
5213386|NCT00771966|patients with cancer in the prostate|patients with cancer in the prostate
5213387|NCT00771953|apricoxib|apricoxib
5213388|NCT00771953|docetaxel|docetaxel
5213389|NCT00771953|pemetrexed|pemetrexed
5213390|NCT00771953|Stage IIIb or Stage IV|stage iiib or stage iv
5213391|NCT00771927|Vimpat®|vimpat®
5213392|NCT00771927|Lacosamide|lacosamide
5213393|NCT00771927|LCM|lcm
5213394|NCT00771927|epilepsy|epilepsy
5213395|NCT00771927|epilepsies|epilepsies
5213396|NCT00771927|seizure|seizure
5213397|NCT00771927|partial seizure|partial seizure
5213398|NCT00771927|partial onset|partial onset
5213399|NCT00771927|seizure disorder|seizure disorder
5213400|NCT00771927|single seizure|single seizure
5213401|NCT00771927|motor seizure|motor seizure
5213402|NCT00771927|convulsions|convulsions
5213403|NCT00771927|add-on|add-on
5213404|NCT00771927|AED|aed
5213405|NCT00771927|anti-epileptic|anti-epileptic
5213406|NCT00771927|anti-epileptic drug|anti-epileptic drug
5213407|NCT00771927|seizure control|seizure control
5213408|NCT00771927|open-label|open-label
5213409|NCT00771927|post authorization|post authorization
5213410|NCT00771927|PASS|pass
5213411|NCT00771927|late stage|late stage
5213412|NCT00771927|trial|trial
5213413|NCT00771927|study|study
5213414|NCT00771927|phase 4|phase 4
5213415|NCT00771927|phase IV|phase iv
5213416|NCT00771914|aspirin|aspirin
5213417|NCT00771914|omega 3 fatty acids|omega 3 fatty acids
5213418|NCT00771914|Lovaza|lovaza
5213419|NCT00771914|myocardial infarction|myocardial infarction
5213420|NCT00771914|aspirin resistance|aspirin resistance
5213421|NCT00771914|cardiovascular disease|cardiovascular disease
5213422|NCT00771901|obesity|obesity
5213423|NCT00771901|insulin resistance|insulin resistance
5213424|NCT00771901|type II diabetes|type ii diabetes
5213425|NCT00771862|pain|pain
5213426|NCT00771862|amputation|amputation
5213427|NCT00771862|phantom limb|phantom limb
5213428|NCT00771862|stump pain|stump pain
5213429|NCT00771862|catheter|catheter
5213430|NCT00771862|nerve block|nerve block
5213431|NCT00771862|peripheral nerve block|peripheral nerve block
5213432|NCT00771862|ucsd|ucsd
5213433|NCT00771862|post-amputation phantom limb or stump pain|post-amputation phantom limb or stump pain
5213434|NCT00771849|Meningitis|meningitis
5213435|NCT00771849|Meningococcemia|meningococcemia
5213436|NCT00771849|Neisseria meningitidis|neisseria meningitidis
5213437|NCT00771836|Stem cell transplantation|stem cell transplantation
5213438|NCT00771836|Airway hyper-reactivity|airway hyper-reactivity
5213439|NCT00771836|methacholine|methacholine
5213440|NCT00771836|pediatric|pediatric
5213441|NCT00771810|Ovarian Cancer|ovarian cancer
5213442|NCT00771810|Thrombocytopenia|thrombocytopenia
5213443|NCT00771810|Cytopenia|cytopenia
5213444|NCT00771810|Chemotherapy|chemotherapy
5213445|NCT00771797|PAOD|paod
5213446|NCT00771797|diabetis|diabetis
5213447|NCT00771797|vascular function|vascular function
5213448|NCT00771797|in diabetics with PAOD|in diabetics with paod
5213449|NCT00771784|Endotracheal intubation|endotracheal intubation
5213450|NCT00771784|tracheostomy|tracheostomy
5213451|NCT00771784|laryngeal mask|laryngeal mask
5213452|NCT00771771|Stroke|stroke
5213453|NCT00771771|Rehabilitation|rehabilitation
5213454|NCT00771771|Early Supported Discharge|early supported discharge
5213455|NCT00771771|ESD|esd
5213456|NCT00771771|RCT|rct
5213457|NCT00771758|Vertebral compression fracture|vertebral compression fracture
5213458|NCT00771758|Osteoporosis|osteoporosis
5213459|NCT00771758|Acute pain|acute pain
5213460|NCT00771758|Analgesic|analgesic
5213461|NCT00771758|Oxycodone|oxycodone
5213462|NCT00771758|Tapentadol|tapentadol
5213463|NCT00771732|toe nail fungus|toe nail fungus
5213464|NCT00771719|VAP|vap
5213465|NCT00771706|Pediatric Cough, Quality of Life|pediatric cough, quality of life
5213466|NCT00771706|Drug (including placebo)|drug (including placebo)
5213467|NCT00771693|NIDDM|niddm
5213468|NCT00771693|Platelet Activation|platelet activation
5213469|NCT00771693|Postprandial hyperglycemia|postprandial hyperglycemia
5213470|NCT00771693|insulin|insulin
5213471|NCT00771667|Interleukin-12|interleukin-12
5213472|NCT00771667|Inflammation|inflammation
5213473|NCT00771667|Research study|research study
5213474|NCT00771667|Ustekinumab|ustekinumab
5213475|NCT00771667|CNTO1275|cnto1275
5213476|NCT00771667|Interleukin-23|interleukin-23
5213477|NCT00771641|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
5213478|NCT00771641|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5213479|NCT00771641|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
5213480|NCT00771641|stage II lymphoepithelioma of the oropharynx|stage ii lymphoepithelioma of the oropharynx
5213481|NCT00771641|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
5213482|NCT00771641|stage III lymphoepithelioma of the oropharynx|stage iii lymphoepithelioma of the oropharynx
5213483|NCT00771641|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5213484|NCT00771641|stage IV lymphoepithelioma of the oropharynx|stage iv lymphoepithelioma of the oropharynx
5213485|NCT00771641|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
5213486|NCT00771641|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
5213487|NCT00771641|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5213488|NCT00771641|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
5213617|NCT00771056|untreated|untreated
5213489|NCT00771641|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5213490|NCT00771628|Intubation, Flex-It, stylet, GlideScope|intubation, flex-it, stylet, glidescope
5213491|NCT00771615|human|human
5213492|NCT00771615|Avian|avian
5213493|NCT00771615|safety|safety
5213494|NCT00771615|vaccines|vaccines
5213495|NCT00771615|influenza|influenza
5213496|NCT00771615|pandemic|pandemic
5213497|NCT00771615|immunogenicity|immunogenicity
5213498|NCT00771615|H5N1|h5n1
5213499|NCT00771602|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
5213500|NCT00771602|Leukemia|leukemia
5213501|NCT00771602|CLL|cll
5213502|NCT00771602|PLL|pll
5213503|NCT00771602|SLL|sll
5213504|NCT00771602|Rituximab|rituximab
5213505|NCT00771602|Rituxan|rituxan
5213506|NCT00771602|Alemtuzumab|alemtuzumab
5213507|NCT00771602|Campath|campath
5213508|NCT00771576|Diabetes Mellitus|diabetes mellitus
5213509|NCT00771576|T1DM|t1dm
5213510|NCT00771563|Non-Small Cell Lung Cancer|non-small cell lung cancer
5213511|NCT00771563|chemotherapy|chemotherapy
5213512|NCT00771563|Low Molecular Weight Heparin|low molecular weight heparin
5213513|NCT00771537|HIV Testing|hiv testing
5213514|NCT00771537|Persuasion|persuasion
5213515|NCT00771537|Health Communication|health communication
5213516|NCT00771537|Clinical Trials Participation|clinical trials participation
5213517|NCT00771537|Attitudes toward Health|attitudes toward health
5213518|NCT00771537|Diagnostic Tests|diagnostic tests
5213519|NCT00771537|Behavioral Research|behavioral research
5213520|NCT00771537|Intervention Studies|intervention studies
5213521|NCT00771524|Pharmacokinetics|pharmacokinetics
5213522|NCT00771524|Hip replacement|hip replacement
5213523|NCT00771524|Ceftobiprole|ceftobiprole
5213524|NCT00771498|rifampin|rifampin
5213525|NCT00771498|lopinavir|lopinavir
5213526|NCT00771498|drug interaction|drug interaction
5213527|NCT00771498|pharmacokinetic|pharmacokinetic
5213528|NCT00771459|Local infiltration analgesia|local infiltration analgesia
5213529|NCT00771459|postoperative pain|postoperative pain
5213530|NCT00771459|ropivacaine|ropivacaine
5213531|NCT00771446|Hepatitis, acute|hepatitis, acute
5213532|NCT00771446|Acute Hepatitis OR Chronic Hepatitis|acute hepatitis or chronic hepatitis
5213533|NCT00771433|neutropenia|neutropenia
5213534|NCT00771433|chemotherapeutic agent toxicity|chemotherapeutic agent toxicity
5213535|NCT00771433|recurrent breast cancer|recurrent breast cancer
5213536|NCT00771433|stage I breast cancer|stage i breast cancer
5213537|NCT00771433|stage II breast cancer|stage ii breast cancer
5213538|NCT00771433|stage IIIA breast cancer|stage iiia breast cancer
5213539|NCT00771433|stage IIIB breast cancer|stage iiib breast cancer
5213540|NCT00771433|stage IIIC breast cancer|stage iiic breast cancer
5213541|NCT00771433|stage IV breast cancer|stage iv breast cancer
5213542|NCT00771407|Ostomy creation|ostomy creation
5213543|NCT00771407|Parastomal hernia|parastomal hernia
5213544|NCT00771394|Vesicare|vesicare
5213545|NCT00771394|Solifenacin succinate|solifenacin succinate
5213546|NCT00771394|Tamsulosin|tamsulosin
5213547|NCT00771394|Overactive Bladder|overactive bladder
5213548|NCT00771394|BPH|bph
5213549|NCT00771381|18F-FAZA|18f-faza
5213550|NCT00771381|18F-FDG|18f-fdg
5213551|NCT00771381|Positron Emission Tomography|positron emission tomography
5213552|NCT00771381|Cell Hypoxia|cell hypoxia
5213553|NCT00771303|Pregnancy|pregnancy
5213554|NCT00771303|Pulmonary embolism|pulmonary embolism
5213555|NCT00771303|MSCT|msct
5213556|NCT00771290|Rectal sparing|rectal sparing
5213557|NCT00771290|Colon cancer|colon cancer
5213558|NCT00771277|Brain Injuries|brain injuries
5213559|NCT00771277|Caregivers|caregivers
5213560|NCT00771277|Volunteer Workers|volunteer workers
5213561|NCT00771277|Social Networks|social networks
5213562|NCT00771264|Overactive Bladder|overactive bladder
5213563|NCT00771251|Rheumatoid arthritis|rheumatoid arthritis
5213564|NCT00771251|Fully Human anti-TNFa monoclonal antibody|fully human anti-tnfa monoclonal antibody
5213565|NCT00771251|CNTO148|cnto148
5213566|NCT00771251|Golimumab|golimumab
5213567|NCT00771238|pressure ulcers|pressure ulcers
5213568|NCT00771238|Therapy mattresses|therapy mattresses
5213569|NCT00771238|Incidence of pressure ulcers|incidence of pressure ulcers
5213570|NCT00771225|genital prolapse|genital prolapse
5213571|NCT00771225|surgery|surgery
5213572|NCT00771225|fascial repair|fascial repair
5213573|NCT00771225|mesh|mesh
5213574|NCT00771225|prolift|prolift
5213575|NCT00771212|Pain|pain
5213576|NCT00771212|Observational|observational
5213577|NCT00771212|Taiwan|taiwan
5213578|NCT00771199|Cancer pain|cancer pain
5213579|NCT00771199|Pain|pain
5213580|NCT00771199|Fentanyl|fentanyl
5213581|NCT00771199|Durogesic|durogesic
5213582|NCT00771199|Cancer|cancer
5213583|NCT00771199|Transdermal|transdermal
5213584|NCT00771186|pediatric|pediatric
5213585|NCT00771186|Laryngeal EMG|laryngeal emg
5213586|NCT00771173|Phenazopyrdine|phenazopyrdine
5213587|NCT00771173|post operative bladder catheritization|post operative bladder catheritization
5213588|NCT00771173|VAS scores|vas scores
5213589|NCT00771173|Bladder pain related to indwelling foley catheters.|bladder pain related to indwelling foley catheters.
5213590|NCT00771173|Bladder irritaion related to indwelling foley catheters.|bladder irritaion related to indwelling foley catheters.
5213591|NCT00771147|Advanced Renal Cell Carcinoma ( RCC)|advanced renal cell carcinoma ( rcc)
5213592|NCT00771134|Depression|depression
5213593|NCT00771134|Bipolar I Disorder|bipolar i disorder
5213594|NCT00771134|Bipolar II Disorder|bipolar ii disorder
5213595|NCT00771134|Placebo-controlled|placebo-controlled
5213596|NCT00771134|Double-blind|double-blind
5213597|NCT00771134|Randomised controlled|randomised controlled
5213598|NCT00771134|Multicenter|multicenter
5213599|NCT00771134|Clinical study|clinical study
5213600|NCT00771134|Mania|mania
5213601|NCT00771108|NAFLD|nafld
5213602|NCT00771108|Obesity|obesity
5213603|NCT00771108|Metabolic Syndrome|metabolic syndrome
5213604|NCT00771108|Nonalcoholic Fatty Liver Disease|nonalcoholic fatty liver disease
5213605|NCT00771095|weight loss|weight loss
5213606|NCT00771095|elaboration|elaboration
5213607|NCT00771095|self efficacy|self efficacy
5213608|NCT00771082|inflammatory markers|inflammatory markers
5213609|NCT00771082|bone markers|bone markers
5213610|NCT00771082|OA|oa
5213611|NCT00771069|Hypertension|hypertension
5213612|NCT00771069|Type II DM|type ii dm
5213613|NCT00771069|DM related complication|dm related complication
5213614|NCT00771069|JNC7|jnc7
5213615|NCT00771069|2007 ESH-ESC guidelines|2007 esh-esc guidelines
5213616|NCT00771069|survey|survey
5213618|NCT00771017|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5213619|NCT00771017|recurrent prostate cancer|recurrent prostate cancer
5213620|NCT00771017|stage II prostate cancer|stage ii prostate cancer
5213621|NCT00771017|stage III prostate cancer|stage iii prostate cancer
5213622|NCT00771017|stage I prostate cancer|stage i prostate cancer
5213623|NCT00771004|drug effects|drug effects
5213624|NCT00771004|Type II Diabetes|type ii diabetes
5213625|NCT00771004|Angioplasty, Transluminal, Percutaneous Coronary|angioplasty, transluminal, percutaneous coronary
5213626|NCT00771004|Drug Therapy|drug therapy
5213627|NCT00771004|Heart|heart
5213628|NCT00771004|physiology|physiology
5213629|NCT00771004|function|function
5213630|NCT00770991|Polyp, Familial Adenomatous Polyposis, Prevention|polyp, familial adenomatous polyposis, prevention
5213631|NCT00770978|ICU|icu
5213632|NCT00770965|Plaque psoriasis, skin condition, thickening, flaking, skin disease, autoimmune disease|plaque psoriasis, skin condition, thickening, flaking, skin disease, autoimmune disease
5213633|NCT00770952|Glucose Metabolism Disorder|glucose metabolism disorder
5213634|NCT00770952|Dysmetabolic Syndrome|dysmetabolic syndrome
5213635|NCT00770952|Type II Diabetes|type ii diabetes
5213636|NCT00770952|Diabetes Mellitus, Lipoatrophic|diabetes mellitus, lipoatrophic
5213637|NCT00770952|Dyslipidemia|dyslipidemia
5213638|NCT00770952|Drug Therapy|drug therapy
5213639|NCT00770939|Complete healing of chronic diabetic foot ulcers|complete healing of chronic diabetic foot ulcers
5213640|NCT00770939|Platelet Rich Fibrin|platelet rich fibrin
5213641|NCT00770939|Vivostat|vivostat
5213642|NCT00770939|Growth factor treatment|growth factor treatment
5213643|NCT00770939|Treatment of chronic diabetic foot ulcers|treatment of chronic diabetic foot ulcers
5213644|NCT00770926|risk reduction|risk reduction
5213645|NCT00770926|minority|minority
5213646|NCT00770926|diabetes prevention|diabetes prevention
5213647|NCT00770926|lifestyle program|lifestyle program
5213648|NCT00770926|behavior change|behavior change
5213649|NCT00770913|reflux esophagitis|reflux esophagitis
5213650|NCT00770913|rabeprazole|rabeprazole
5213651|NCT00770913|GERD|gerd
5213652|NCT00770913|Japan|japan
5213653|NCT00770887|Undesired fertility|undesired fertility
5213654|NCT00770861|nebivolol|nebivolol
5213655|NCT00770861|Bystolic ™|bystolic ™
5213656|NCT00770861|Hypertension|hypertension
5213657|NCT00770861|Hispanic|hispanic
5213658|NCT00770861|Hypertension in Hispanic patients|hypertension in hispanic patients
5213659|NCT00770848|CRPC|crpc
5213660|NCT00770835|Glucose Metabolism Disorder|glucose metabolism disorder
5213661|NCT00770835|Dysmetabolic Syndrome|dysmetabolic syndrome
5213662|NCT00770835|Type II Diabetes|type ii diabetes
5213663|NCT00770835|Diabetes Mellitus, Lipoatrophic|diabetes mellitus, lipoatrophic
5213664|NCT00770835|Dyslipidemia|dyslipidemia
5213665|NCT00770835|Drug Therapy|drug therapy
5213666|NCT00770822|Primary|primary
5213667|NCT00770822|Prostate|prostate
5213668|NCT00770822|Cancer|cancer
5213669|NCT00770822|Primary T1c/T2a organ confined prostate cancer|primary t1c/t2a organ confined prostate cancer
5213670|NCT00770822|organ-confined|organ-confined
5213671|NCT00770796|Contrast induced nephropathy|contrast induced nephropathy
5213672|NCT00770770|Macular edema secondary to RVO|macular edema secondary to rvo
5213673|NCT00770744|Schizophrenia|schizophrenia
5213674|NCT00770744|Antipsychotic|antipsychotic
5213675|NCT00770744|Olanzapine|olanzapine
5213676|NCT00770744|Lu 31-130|lu 31-130
5213677|NCT00770731|Torisel|torisel
5213678|NCT00770731|Temsirolimus|temsirolimus
5213679|NCT00770731|Hycamtin|hycamtin
5213680|NCT00770731|Topotecan hydrochloride|topotecan hydrochloride
5213681|NCT00770731|Velcade|velcade
5213682|NCT00770731|Bortezomib|bortezomib
5213683|NCT00770731|FDG-PET Scans|fdg-pet scans
5213684|NCT00770731|18F-Fluoro-2-Deoxyglucose Positron Emission Tomography|18f-fluoro-2-deoxyglucose positron emission tomography
5213685|NCT00770718|intracranial hemorrhage|intracranial hemorrhage
5213686|NCT00770718|warfarin|warfarin
5213687|NCT00770718|anticoagulant|anticoagulant
5213688|NCT00770718|Factor VII|factor vii
5213689|NCT00770718|Prothrombin|prothrombin
5213690|NCT00770692|insomnia|insomnia
5213691|NCT00770692|primary insomnia|primary insomnia
5213692|NCT00770692|insomnia associated with psychiatric or physical disorder(s)|insomnia associated with psychiatric or physical disorder(s)
5213693|NCT00770666|Tobacco dependence treatment|tobacco dependence treatment
5213694|NCT00770653|Glucose Metabolism Disorder|glucose metabolism disorder
5213695|NCT00770653|Dysmetabolic Syndrome|dysmetabolic syndrome
5213696|NCT00770653|Type II Diabetes|type ii diabetes
5213697|NCT00770653|Diabetes Mellitus, Lipoatrophic|diabetes mellitus, lipoatrophic
5213698|NCT00770653|Dyslipidemia|dyslipidemia
5213699|NCT00770653|Hyperlipidemias|hyperlipidemias
5213700|NCT00770653|Drug Therapy|drug therapy
5213701|NCT00770640|Glucose Metabolism Disorder|glucose metabolism disorder
5213702|NCT00770640|Dysmetabolic Syndrome|dysmetabolic syndrome
5213703|NCT00770640|Type II Diabetes|type ii diabetes
5213704|NCT00770640|Diabetes Mellitus, Lipoatrophic|diabetes mellitus, lipoatrophic
5213705|NCT00770640|Dyslipidemia|dyslipidemia
5213706|NCT00770640|Drug Therapy|drug therapy
5213707|NCT00770627|160 children|160 children
5213708|NCT00770627|parallel group|parallel group
5213709|NCT00770614|Contrast Induced Nephropathy|contrast induced nephropathy
5213710|NCT00770601|NOMID|nomid
5213711|NCT00770601|CINCA Syndrome|cinca syndrome
5213712|NCT00770601|Canakinumab|canakinumab
5213713|NCT00770588|non-small cell lung cancer (NSCLC)|non-small cell lung cancer (nsclc)
5213714|NCT00770588|Gefitinib|gefitinib
5213715|NCT00770575|Biological Markers|biological markers
5213716|NCT00770575|Biochemical Markers|biochemical markers
5213717|NCT00770575|Carotid Artery, Internal|carotid artery, internal
5213718|NCT00770575|Carotid Artery, Common|carotid artery, common
5213719|NCT00770575|Marker, Surrogate|marker, surrogate
5213720|NCT00770575|Vascular Diseases|vascular diseases
5213721|NCT00770575|Diabetes Mellitus|diabetes mellitus
5213722|NCT00770575|Drug Therapy|drug therapy
5213723|NCT00770536|fallopian tube cancer|fallopian tube cancer
5213724|NCT00770536|Gynecological Malignancy|gynecological malignancy
5213725|NCT00770536|primary peritoneal cancer of predominantly epithelial origin|primary peritoneal cancer of predominantly epithelial origin
5213726|NCT00770536|Stage II to IV ovarian cancer|stage ii to iv ovarian cancer
5213727|NCT00770523|patients without comorbidity|patients without comorbidity
5213728|NCT00770510|Primary insomnia|primary insomnia
5213729|NCT00770497|drug effects|drug effects
5213730|NCT00770497|Hypertension|hypertension
5213731|NCT00770497|Vascular Resistance|vascular resistance
5213732|NCT00770497|Drug Therapy|drug therapy
5213733|NCT00770497|physiopathology, vascular|physiopathology, vascular
5213734|NCT00770484|Exercise|exercise
5213735|NCT00770484|Propanolol|propanolol
5213736|NCT00770484|Beta blockers|beta blockers
5213737|NCT00770471|adult glioblastoma|adult glioblastoma
5213738|NCT00770471|adult gliosarcoma|adult gliosarcoma
5213739|NCT00770471|adult giant cell glioblastoma|adult giant cell glioblastoma
5213740|NCT00770458|Down Syndrome|down syndrome
5213741|NCT00770445|Glucose Metabolism Disorder|glucose metabolism disorder
5213742|NCT00770445|Dysmetabolic Syndrome|dysmetabolic syndrome
5213743|NCT00770445|Type II Diabetes|type ii diabetes
5213744|NCT00770445|Diabetes Mellitus, Lipoatrophic|diabetes mellitus, lipoatrophic
5213745|NCT00770445|Dyslipidemia|dyslipidemia
5213746|NCT00770445|Drug Therapy|drug therapy
5213747|NCT00770432|Human Experimentation|human experimentation
5213748|NCT00770419|depression|depression
5213749|NCT00770419|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
5213750|NCT00770419|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5213751|NCT00770419|acute undifferentiated leukemia|acute undifferentiated leukemia
5213752|NCT00770419|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5213753|NCT00770419|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5213754|NCT00770419|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5213755|NCT00770419|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5213756|NCT00770419|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5213757|NCT00770419|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5213758|NCT00770419|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5213759|NCT00770419|atypical chronic myeloid leukemia, BCR-ABL negative|atypical chronic myeloid leukemia, bcr-abl negative
5213760|NCT00770419|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5213761|NCT00770419|mast cell leukemia|mast cell leukemia
5213762|NCT00770419|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
5213763|NCT00770419|prolymphocytic leukemia|prolymphocytic leukemia
5213764|NCT00770419|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5213765|NCT00770419|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5213766|NCT00770419|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
5213767|NCT00770419|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5213768|NCT00770419|refractory hairy cell leukemia|refractory hairy cell leukemia
5213769|NCT00770419|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5213770|NCT00770419|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5213771|NCT00770419|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
5213772|NCT00770419|AIDS-related diffuse large cell lymphoma|aids-related diffuse large cell lymphoma
5213927|NCT00769925|Generalized Anxiety|generalized anxiety
5213773|NCT00770419|AIDS-related diffuse mixed cell lymphoma|aids-related diffuse mixed cell lymphoma
5213774|NCT00770419|AIDS-related diffuse small cleaved cell lymphoma|aids-related diffuse small cleaved cell lymphoma
5213775|NCT00770419|AIDS-related immunoblastic large cell lymphoma|aids-related immunoblastic large cell lymphoma
5213776|NCT00770419|AIDS-related lymphoblastic lymphoma|aids-related lymphoblastic lymphoma
5213777|NCT00770419|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
5213778|NCT00770419|AIDS-related primary CNS lymphoma|aids-related primary cns lymphoma
5213779|NCT00770419|AIDS-related small noncleaved cell lymphoma|aids-related small noncleaved cell lymphoma
5213780|NCT00770419|HIV-associated Hodgkin lymphoma|hiv-associated hodgkin lymphoma
5213781|NCT00770419|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5213782|NCT00770419|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5213783|NCT00770419|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
5213784|NCT00770419|cutaneous B-cell non-Hodgkin lymphoma|cutaneous b-cell non-hodgkin lymphoma
5213785|NCT00770419|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5213786|NCT00770419|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5213787|NCT00770419|adult grade III lymphomatoid granulomatosis|adult grade iii lymphomatoid granulomatosis
5213788|NCT00770419|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
5213789|NCT00770419|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
5213790|NCT00770419|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5213791|NCT00770419|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5213792|NCT00770419|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5213793|NCT00770419|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5213794|NCT00770419|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5213795|NCT00770419|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5213796|NCT00770419|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5213797|NCT00770419|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
5213798|NCT00770419|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5213799|NCT00770419|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5213800|NCT00770419|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5213801|NCT00770419|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5213802|NCT00770419|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5213803|NCT00770419|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5213804|NCT00770419|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5213805|NCT00770419|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5213806|NCT00770419|intraocular lymphoma|intraocular lymphoma
5213807|NCT00770419|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
5213808|NCT00770419|primary central nervous system Hodgkin lymphoma|primary central nervous system hodgkin lymphoma
5213809|NCT00770419|chronic eosinophilic leukemia|chronic eosinophilic leukemia
5213810|NCT00770419|chronic neutrophilic leukemia|chronic neutrophilic leukemia
5213811|NCT00770419|primary myelofibrosis|primary myelofibrosis
5213812|NCT00770419|primary systemic amyloidosis|primary systemic amyloidosis
5213813|NCT00770419|refractory multiple myeloma|refractory multiple myeloma
5213814|NCT00770419|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5213815|NCT00770419|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5213816|NCT00770419|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
5213817|NCT00770393|squamous cell carcinoma of the pyriform sinus|squamous cell carcinoma of the pyriform sinus
5213818|NCT00770393|laryngeal preservation|laryngeal preservation
5213819|NCT00770393|patients with biopsy-proven previously untreated resectable T3 with fixed cord involvement squamous cell carcinoma of the pyriform sinus|patients with biopsy-proven previously untreated resectable t3 with fixed cord involvement squamous cell carcinoma of the pyriform sinus
5213820|NCT00770380|smoking|smoking
5213821|NCT00770367|Cardiovascular risk|cardiovascular risk
5213822|NCT00770367|biological markers|biological markers
5213823|NCT00770354|Breast cancer|breast cancer
5213824|NCT00770328|Plasma PAI-1 level at 0, 4, 8 weeks|plasma pai-1 level at 0, 4, 8 weeks
5213825|NCT00770328|Plasma hsCRP level at 0, 4, 8 weeks|plasma hscrp level at 0, 4, 8 weeks
5213826|NCT00770328|Plasma TNF-a level at 0, 4, 8 weeks|plasma tnf-a level at 0, 4, 8 weeks
5213827|NCT00770302|DPP-4 inhibitors|dpp-4 inhibitors
5213828|NCT00770302|HBA1c|hba1c
5213829|NCT00770302|Incretins|incretins
5213830|NCT00770302|Pharmacokinetics|pharmacokinetics
5213831|NCT00770276|obesity WHO I-III|obesity who i-iii
5213832|NCT00770276|metabolic syndrome|metabolic syndrome
5213833|NCT00770276|Framingham risk score|framingham risk score
5213834|NCT00770276|subclinical atherosclerosis|subclinical atherosclerosis
5213835|NCT00770276|endothelial dysfunction|endothelial dysfunction
5213836|NCT00770263|any solid tumors|any solid tumors
5213837|NCT00770250|asthma symptoms|asthma symptoms
5213838|NCT00770250|words used by patients and physicians|words used by patients and physicians
5213839|NCT00770250|express asthma symptoms|express asthma symptoms
5213841|NCT00770237|Nicotine|nicotine
5213842|NCT00770237|Schizophrenia|schizophrenia
5213928|NCT00769925|Social Phobia|social phobia
5213843|NCT00770224|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
5213844|NCT00770224|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
5213845|NCT00770224|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
5213846|NCT00770224|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5213847|NCT00770224|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5213848|NCT00770224|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5213849|NCT00770224|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5213850|NCT00770224|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5213851|NCT00770224|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5213852|NCT00770224|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5213853|NCT00770224|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5213854|NCT00770224|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5213855|NCT00770198|liver|liver
5213856|NCT00770198|alcohol|alcohol
5213857|NCT00770198|HCV|hcv
5213858|NCT00770185|endometrial adenocarcinoma|endometrial adenocarcinoma
5213859|NCT00770185|endometrial adenosquamous cell carcinoma|endometrial adenosquamous cell carcinoma
5213860|NCT00770185|endometrial clear cell carcinoma|endometrial clear cell carcinoma
5213861|NCT00770185|endometrial papillary carcinoma|endometrial papillary carcinoma
5213862|NCT00770185|recurrent endometrial carcinoma|recurrent endometrial carcinoma
5213863|NCT00770185|stage III endometrial carcinoma|stage iii endometrial carcinoma
5213864|NCT00770185|stage IV endometrial carcinoma|stage iv endometrial carcinoma
5213865|NCT00770172|chemotherapeutic agent toxicity|chemotherapeutic agent toxicity
5213866|NCT00770172|neutropenia|neutropenia
5213867|NCT00770172|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5213868|NCT00770120|recurrent malignant mesothelioma|recurrent malignant mesothelioma
5213869|NCT00770120|stage II malignant mesothelioma|stage ii malignant mesothelioma
5213870|NCT00770120|stage III malignant mesothelioma|stage iii malignant mesothelioma
5213871|NCT00770120|stage IV malignant mesothelioma|stage iv malignant mesothelioma
5213872|NCT00770094|LASIK|lasik
5213873|NCT00770094|Laser Vision correction|laser vision correction
5213874|NCT00770094|Myopia|myopia
5213875|NCT00770094|Myopia with astigmatism|myopia with astigmatism
5213876|NCT00770094|Nearsighted|nearsighted
5213877|NCT00770081|Type 2 diabetes|type 2 diabetes
5213878|NCT00770081|vildagliptin|vildagliptin
5213879|NCT00770068|Mood Disorders|mood disorders
5213880|NCT00770068|Major Depressive Disorder|major depressive disorder
5213881|NCT00770068|Bipolar Disorder|bipolar disorder
5213882|NCT00770068|Tree Pollen|tree pollen
5213883|NCT00770068|Ragweed Pollen|ragweed pollen
5213884|NCT00770068|Rhinitis|rhinitis
5213885|NCT00770068|Allergic|allergic
5213886|NCT00770068|Seasonal|seasonal
5213887|NCT00770068|Allergens|allergens
5213888|NCT00770055|stage IV breast cancer|stage iv breast cancer
5213889|NCT00770055|recurrent breast cancer|recurrent breast cancer
5213890|NCT00770016|insulin sensitivity|insulin sensitivity
5213891|NCT00770016|Substrate metabolism|substrate metabolism
5213892|NCT00770016|Fatty liver|fatty liver
5213893|NCT00770016|intramyocellular lipid|intramyocellular lipid
5213894|NCT00770016|intracellular signaling|intracellular signaling
5213895|NCT00770003|patients|patients
5213896|NCT00770003|allergic rhinitis|allergic rhinitis
5213897|NCT00770003|tolerability|tolerability
5213898|NCT00770003|safety|safety
5213899|NCT00770003|nasal symptoms|nasal symptoms
5213900|NCT00769990|bone metastases|bone metastases
5213901|NCT00769990|pain|pain
5213902|NCT00769990|recurrent breast cancer|recurrent breast cancer
5213903|NCT00769990|stage IV breast cancer|stage iv breast cancer
5213904|NCT00769990|recurrent prostate cancer|recurrent prostate cancer
5213905|NCT00769990|stage IV prostate cancer|stage iv prostate cancer
5213906|NCT00769990|recurrent melanoma|recurrent melanoma
5213907|NCT00769990|stage IV melanoma|stage iv melanoma
5213908|NCT00769990|recurrent renal cell cancer|recurrent renal cell cancer
5213909|NCT00769990|stage IV renal cell cancer|stage iv renal cell cancer
5213910|NCT00769990|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5213911|NCT00769990|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5213912|NCT00769990|extensive stage small cell lung cancer|extensive stage small cell lung cancer
5213913|NCT00769990|recurrent small cell lung cancer|recurrent small cell lung cancer
5213914|NCT00769964|Healthy (Dysmenorrhea)|healthy (dysmenorrhea)
5213915|NCT00769951|pain|pain
5213916|NCT00769951|depression|depression
5213917|NCT00769951|weight changes|weight changes
5213918|NCT00769951|cognitive/functional effects|cognitive/functional effects
5213919|NCT00769951|malnutrition|malnutrition
5213920|NCT00769951|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
5213921|NCT00769951|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5213922|NCT00769951|hematopoietic/lymphoid cancer|hematopoietic/lymphoid cancer
5213923|NCT00769938|Atrial fibrillation|atrial fibrillation
5213924|NCT00769938|Percutaneous coronary stenting|percutaneous coronary stenting
5213925|NCT00769938|Bleeding complications|bleeding complications
5213926|NCT00769938|Triple therapy|triple therapy
5213929|NCT00769925|Separation Anxiety|separation anxiety
5213930|NCT00769925|Phobia|phobia
5213931|NCT00769899|AZD7325|azd7325
5213932|NCT00769899|Japanese Healthy Volunteers|japanese healthy volunteers
5213933|NCT00769899|Phase I study|phase i study
5213934|NCT00769899|Single Ascending Dose|single ascending dose
5213935|NCT00769873|anticoagulation|anticoagulation
5213936|NCT00769873|thrombosis|thrombosis
5213937|NCT00769873|portal vein thrombosis|portal vein thrombosis
5213938|NCT00769873|splenic vein thrombosis|splenic vein thrombosis
5213939|NCT00769873|splenectomy|splenectomy
5213940|NCT00769873|randomized|randomized
5213941|NCT00769873|laparoscopic splenectomy|laparoscopic splenectomy
5213942|NCT00769873|lovenox|lovenox
5213943|NCT00769860|myositis|myositis
5213944|NCT00769860|IBM|ibm
5213945|NCT00769860|inclusion body myositis|inclusion body myositis
5213946|NCT00769847|Endoscopic, craniosynostosis, sagittal, synostosis|endoscopic, craniosynostosis, sagittal, synostosis
5213947|NCT00769834|chronic kidney disease|chronic kidney disease
5213948|NCT00769834|chronic renal insufficiency|chronic renal insufficiency
5213949|NCT00769834|uremia|uremia
5213950|NCT00769834|disc edema|disc edema
5213951|NCT00769834|papilledema|papilledema
5213952|NCT00769834|idiopathic intracranial hypertension|idiopathic intracranial hypertension
5213953|NCT00769834|pseudotumor cerebri|pseudotumor cerebri
5213954|NCT00769821|lymphedema|lymphedema
5213955|NCT00769821|perioperative/postoperative complications|perioperative/postoperative complications
5213956|NCT00769821|cancer survivor|cancer survivor
5213957|NCT00769821|stage I breast cancer|stage i breast cancer
5213958|NCT00769821|stage II breast cancer|stage ii breast cancer
5213959|NCT00769821|stage IIIA breast cancer|stage iiia breast cancer
5213960|NCT00769821|stage IIIB breast cancer|stage iiib breast cancer
5213961|NCT00769821|stage IIIC breast cancer|stage iiic breast cancer
5213962|NCT00769821|stage IV breast cancer|stage iv breast cancer
5213963|NCT00769795|prostate cancer|prostate cancer
5213964|NCT00769795|prostatic neoplasm|prostatic neoplasm
5213965|NCT00769795|androgen deprivation therapy|androgen deprivation therapy
5213966|NCT00769795|insulin-like growth factor receptor I|insulin-like growth factor receptor i
5213967|NCT00769795|neoadjuvant|neoadjuvant
5213968|NCT00769795|prostatectomy|prostatectomy
5213969|NCT00769782|gastrointestinal stromal tumor|gastrointestinal stromal tumor
5213970|NCT00769782|liver metastases|liver metastases
5213971|NCT00769769|Health Status|health status
5213972|NCT00769756|Different Strategies to Fight Obesity in Families|different strategies to fight obesity in families
5213973|NCT00769730|hepatocellular carcinoma|hepatocellular carcinoma
5213974|NCT00769730|hepatitis B virus|hepatitis b virus
5213975|NCT00769730|transcatheter arterial chemoembolization|transcatheter arterial chemoembolization
5213976|NCT00769717|obesity|obesity
5213977|NCT00769717|wellness|wellness
5213978|NCT00769717|cardiovascular disease prevention|cardiovascular disease prevention
5213979|NCT00769717|health at every size|health at every size
5213980|NCT00769717|weight loss|weight loss
5213981|NCT00769704|Melanoma|melanoma
5213982|NCT00769704|OncoVEX^GM-CSF|oncovex^gm-csf
5213983|NCT00769704|GM-CSF|gm-csf
5213984|NCT00769704|Stage IIIb, IIIc and IV Disease|stage iiib, iiic and iv disease
5213985|NCT00769704|oncolytic|oncolytic
5213986|NCT00769704|OncoVex|oncovex
5213987|NCT00769704|T-Vec|t-vec
5213988|NCT00769704|talimogene laherparepvec|talimogene laherparepvec
5213989|NCT00769691|Cardiac surgery|cardiac surgery
5213990|NCT00769691|Cerebral blood flow autoregulation|cerebral blood flow autoregulation
5213991|NCT00769678|Biventricular Pacing|biventricular pacing
5213992|NCT00769665|Dry Eye|dry eye
5213993|NCT00769665|re-wetting drops|re-wetting drops
5213994|NCT00769652|malnutrition|malnutrition
5213995|NCT00769652|non-small cell lung cancer|non-small cell lung cancer
5213996|NCT00769652|small cell lung cancer|small cell lung cancer
5213997|NCT00769652|stage III prostate cancer|stage iii prostate cancer
5213998|NCT00769652|stage IV prostate cancer|stage iv prostate cancer
5213999|NCT00769652|pancreatic cancer|pancreatic cancer
5214000|NCT00769652|weight changes|weight changes
5214001|NCT00769626|Low Back Pain|low back pain
5214002|NCT00769626|Clinical Practice Guidelines|clinical practice guidelines
5214003|NCT00769626|Spinal Manipulation|spinal manipulation
5214004|NCT00769626|Physical Therapy Techniques|physical therapy techniques
5214005|NCT00769613|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5214006|NCT00769613|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5214007|NCT00769613|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5214008|NCT00769613|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5214009|NCT00769613|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5214010|NCT00769613|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5214011|NCT00769613|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5214012|NCT00769613|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5214013|NCT00769613|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5214014|NCT00769613|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5214015|NCT00769613|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5214016|NCT00769613|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5214017|NCT00769613|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5214018|NCT00769613|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5214019|NCT00769613|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5214020|NCT00769613|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5214021|NCT00769613|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5214022|NCT00769613|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5214023|NCT00769613|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5214024|NCT00769613|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5214025|NCT00769613|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5214026|NCT00769613|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5214027|NCT00769613|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5214028|NCT00769613|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5214029|NCT00769613|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5214030|NCT00769613|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5214031|NCT00769613|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5214032|NCT00769613|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5214033|NCT00769613|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5214034|NCT00769613|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5214035|NCT00769613|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5214036|NCT00769613|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5214037|NCT00769613|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5214038|NCT00769613|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
5214039|NCT00769613|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
5214040|NCT00769613|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
5214041|NCT00769613|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5214042|NCT00769613|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5214043|NCT00769613|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5214044|NCT00769613|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5214045|NCT00769613|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5214046|NCT00769613|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5214047|NCT00769613|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5214048|NCT00769613|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
5214049|NCT00769613|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5214050|NCT00769613|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5214051|NCT00769613|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5214052|NCT00769613|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5214053|NCT00769613|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
5214054|NCT00769613|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5214055|NCT00769613|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
5214056|NCT00769613|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
5214057|NCT00769613|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
5214058|NCT00769613|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
5214059|NCT00769613|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5214060|NCT00769613|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5214061|NCT00769613|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5214062|NCT00769613|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5214063|NCT00769613|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
5214064|NCT00769613|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
5214065|NCT00769613|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5214066|NCT00769613|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5214067|NCT00769613|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5214068|NCT00769613|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5214069|NCT00769613|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5214070|NCT00769613|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5214071|NCT00769613|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5214072|NCT00769613|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5214073|NCT00769613|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
5214074|NCT00769613|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5214075|NCT00769613|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
5214149|NCT00769483|Pancreatic Cancer|pancreatic cancer
5214076|NCT00769613|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
5214077|NCT00769613|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
5214078|NCT00769613|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5214079|NCT00769613|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5214080|NCT00769613|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
5214081|NCT00769613|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5214082|NCT00769613|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5214083|NCT00769613|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5214084|NCT00769613|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5214085|NCT00769613|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5214086|NCT00769613|refractory hairy cell leukemia|refractory hairy cell leukemia
5214087|NCT00769613|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5214088|NCT00769613|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5214089|NCT00769613|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5214090|NCT00769613|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5214091|NCT00769613|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
5214092|NCT00769613|chronic eosinophilic leukemia|chronic eosinophilic leukemia
5214093|NCT00769613|primary myelofibrosis|primary myelofibrosis
5214094|NCT00769613|chronic neutrophilic leukemia|chronic neutrophilic leukemia
5214095|NCT00769613|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5214096|NCT00769613|disseminated neuroblastoma|disseminated neuroblastoma
5214097|NCT00769613|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
5214098|NCT00769613|high risk metastatic gestational trophoblastic tumor|high risk metastatic gestational trophoblastic tumor
5214099|NCT00769613|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
5214100|NCT00769613|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5214101|NCT00769613|recurrent Wilms tumor and other childhood kidney tumors|recurrent wilms tumor and other childhood kidney tumors
5214102|NCT00769613|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
5214103|NCT00769613|recurrent neuroblastoma|recurrent neuroblastoma
5214104|NCT00769613|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5214105|NCT00769613|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
5214106|NCT00769613|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
5214107|NCT00769613|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5214108|NCT00769613|stage I multiple myeloma|stage i multiple myeloma
5214109|NCT00769613|stage II multiple myeloma|stage ii multiple myeloma
5214110|NCT00769613|stage III multiple myeloma|stage iii multiple myeloma
5214111|NCT00769613|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
5214112|NCT00769613|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5214113|NCT00769613|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5214114|NCT00769613|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
5214115|NCT00769613|stage IIIA breast cancer|stage iiia breast cancer
5214116|NCT00769613|stage IIIB breast cancer|stage iiib breast cancer
5214117|NCT00769613|stage IIIC breast cancer|stage iiic breast cancer
5214118|NCT00769613|stage IV breast cancer|stage iv breast cancer
5214119|NCT00769613|refractory multiple myeloma|refractory multiple myeloma
5214120|NCT00769613|cytomegalovirus infection|cytomegalovirus infection
5214121|NCT00769600|Recurrent Non-Small Cell Lung Cancer|recurrent non-small cell lung cancer
5214122|NCT00769587|aggressive systemic mastocytosis|aggressive systemic mastocytosis
5214123|NCT00769587|smoldering systemic mastocytosis|smoldering systemic mastocytosis
5214124|NCT00769561|Temporomandibular disorders|temporomandibular disorders
5214125|NCT00769561|Biofeedback|biofeedback
5214126|NCT00769561|Cognitive behavioral therapy|cognitive behavioral therapy
5214127|NCT00769561|Pain|pain
5214128|NCT00769548|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5214129|NCT00769548|stage I prostate cancer|stage i prostate cancer
5214130|NCT00769548|stage IIB prostate cancer|stage iib prostate cancer
5214131|NCT00769548|stage IIA prostate cancer|stage iia prostate cancer
5214132|NCT00769548|stage III prostate cancer|stage iii prostate cancer
5214133|NCT00769548|stage IV prostate cancer|stage iv prostate cancer
5214134|NCT00769535|heat shock protein70|heat shock protein70
5214135|NCT00769535|tumor necrosis factor-alpha promoter|tumor necrosis factor-alpha promoter
5214136|NCT00769535|polymorphism|polymorphism
5214137|NCT00769522|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
5214138|NCT00769522|stage 0 chronic lymphocytic leukemia|stage 0 chronic lymphocytic leukemia
5214139|NCT00769522|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
5214140|NCT00769522|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
5214141|NCT00769522|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5214142|NCT00769522|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5214143|NCT00769509|energy expenditure|energy expenditure
5214144|NCT00769509|indirect calorimetry|indirect calorimetry
5214145|NCT00769509|human milk|human milk
5214146|NCT00769509|preterm formula|preterm formula
5214147|NCT00769509|premature infant|premature infant
5214148|NCT00769483|Pancreas|pancreas
5214150|NCT00769483|Advanced cancer of the pancreas|advanced cancer of the pancreas
5214151|NCT00769483|Pancreatic Adenocarcinoma|pancreatic adenocarcinoma
5214152|NCT00769483|MK-0646|mk-0646
5214153|NCT00769483|Gemcitabine|gemcitabine
5214154|NCT00769483|Gemzar|gemzar
5214155|NCT00769483|Erlotinib hydrochloride|erlotinib hydrochloride
5214156|NCT00769483|Erlotinib|erlotinib
5214157|NCT00769483|OSI-774|osi-774
5214158|NCT00769483|Tarceva|tarceva
5214159|NCT00769470|stage I breast cancer|stage i breast cancer
5214160|NCT00769470|stage II breast cancer|stage ii breast cancer
5214161|NCT00769470|stage IIIA breast cancer|stage iiia breast cancer
5214162|NCT00769470|stage IIIB breast cancer|stage iiib breast cancer
5214163|NCT00769470|stage IIIC breast cancer|stage iiic breast cancer
5214164|NCT00769470|HER2-positive breast cancer|her2-positive breast cancer
5214165|NCT00769431|stage I prostate cancer|stage i prostate cancer
5214166|NCT00769431|stage IIB prostate cancer|stage iib prostate cancer
5214167|NCT00769431|stage IIA prostate cancer|stage iia prostate cancer
5214168|NCT00769405|recurrent colon cancer|recurrent colon cancer
5214169|NCT00769405|stage IV colon cancer|stage iv colon cancer
5214170|NCT00769405|recurrent rectal cancer|recurrent rectal cancer
5214171|NCT00769405|stage IV rectal cancer|stage iv rectal cancer
5214172|NCT00769405|peritoneal carcinomatosis|peritoneal carcinomatosis
5214173|NCT00769392|Macular Degeneration|macular degeneration
5214174|NCT00769392|Intravitreal injections|intravitreal injections
5214175|NCT00769392|Eye anesthesia-Topical/subconjunctival|eye anesthesia-topical/subconjunctival
5214176|NCT00769392|Eye-surgical procedures|eye-surgical procedures
5214177|NCT00769392|Ophthalmologic anesthesia methods|ophthalmologic anesthesia methods
5214178|NCT00769327|chronic myelogenous leukemia, BCR-ABL1 positive|chronic myelogenous leukemia, bcr-abl1 positive
5214179|NCT00769327|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5214180|NCT00769301|Symptoms|symptoms
5214181|NCT00769301|pain|pain
5214182|NCT00769301|fatigue|fatigue
5214183|NCT00769301|depression|depression
5214184|NCT00769301|sleeplessness|sleeplessness
5214185|NCT00769301|genetic markers|genetic markers
5214186|NCT00769301|caregiver burden.|caregiver burden.
5214187|NCT00769275|silent ischemia|silent ischemia
5214188|NCT00769275|type 2 diabetes mellitus|type 2 diabetes mellitus
5214189|NCT00769275|screening|screening
5214190|NCT00769275|cardiac outcome|cardiac outcome
5214191|NCT00769275|Prevalence silent myocardial ischemia|prevalence silent myocardial ischemia
5214192|NCT00769275|Cardiac outcome in screened and not-screened subjects|cardiac outcome in screened and not-screened subjects
5214193|NCT00769262|Premature neonates|premature neonates
5214194|NCT00769262|Thermoregulation|thermoregulation
5214195|NCT00769262|Isolette|isolette
5214196|NCT00769262|Feeding status|feeding status
5214197|NCT00769249|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
5214198|NCT00769249|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5214199|NCT00769223|radiation toxicity|radiation toxicity
5214200|NCT00769223|recurrent prostate cancer|recurrent prostate cancer
5214201|NCT00769223|stage IIB prostate cancer|stage iib prostate cancer
5214202|NCT00769223|stage IIA prostate cancer|stage iia prostate cancer
5214203|NCT00769223|stage III prostate cancer|stage iii prostate cancer
5214204|NCT00769223|stage I prostate cancer|stage i prostate cancer
5214205|NCT00769223|stage IV prostate cancer|stage iv prostate cancer
5214206|NCT00769223|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5214207|NCT00769197|optic disc cupping|optic disc cupping
5214208|NCT00769197|cerebral palsy|cerebral palsy
5214209|NCT00769197|static encephalopathy|static encephalopathy
5214210|NCT00769197|optic disc|optic disc
5214211|NCT00769197|optic nerve|optic nerve
5214212|NCT00769197|periventricular Leukomalacia|periventricular leukomalacia
5214213|NCT00769184|chronic plaque psoriasis|chronic plaque psoriasis
5214214|NCT00769171|Complicated Intra-Abdominal Infections|complicated intra-abdominal infections
5214215|NCT00769158|Alcohol|alcohol
5214216|NCT00769158|Alcoholism|alcoholism
5214217|NCT00769158|Alcohol Dependence|alcohol dependence
5214218|NCT00769145|Corneal neovascularization|corneal neovascularization
5214219|NCT00769145|Ranibizumab|ranibizumab
5214220|NCT00769145|Corneal transplantation|corneal transplantation
5214221|NCT00769119|bronchiectasis|bronchiectasis
5214222|NCT00769119|Phase II|phase ii
5214223|NCT00769106|hepatocellular carcinoma|hepatocellular carcinoma
5214224|NCT00769106|recurrent|recurrent
5214225|NCT00769106|cytokine-induced killer cell|cytokine-induced killer cell
5214226|NCT00769093|ferumoxytol|ferumoxytol
5214227|NCT00769093|diagnostic imaging|diagnostic imaging
5214228|NCT00769080|PSP|psp
5214229|NCT00769080|Standard Treatment|standard treatment
5214230|NCT00769080|Standard Treatment plus PSP|standard treatment plus psp
5214231|NCT00769067|Lung cancer|lung cancer
5214232|NCT00769067|advanced|advanced
5214233|NCT00769067|second or third line|second or third line
5214234|NCT00769054|Postoperative pain|postoperative pain
5214235|NCT00769054|PONV|ponv
5214236|NCT00769028|Systemic sclerosis|systemic sclerosis
5214237|NCT00769028|Diffuse cutaneous systemic sclerosis|diffuse cutaneous systemic sclerosis
5214238|NCT00769028|Scleroderma|scleroderma
5214239|NCT00769028|Biological|biological
5214240|NCT00769028|Hyperimmune caprine serum|hyperimmune caprine serum
5214241|NCT00769028|Goat Serum|goat serum
5214242|NCT00769015|age-related macular degeneration|age-related macular degeneration
5214243|NCT00769015|depression|depression
5214244|NCT00769015|vision loss|vision loss
5214245|NCT00769002|influenza|influenza
5214246|NCT00769002|flu|flu
5214247|NCT00769002|vaccine|vaccine
5214248|NCT00769002|vaccination|vaccination
5214249|NCT00769002|immune response|immune response
5214250|NCT00769002|FluShield|flushield
5214251|NCT00769002|FluMist|flumist
5214252|NCT00769002|PET-CT|pet-ct
5214253|NCT00769002|Healthy Volunteers|healthy volunteers
5214254|NCT00768989|Combination Therapy|combination therapy
5214255|NCT00768976|Participant must have participated in a clinical trial conducted by the Summa Health System Hospitals Cancer Research Program.|participant must have participated in a clinical trial conducted by the summa health system hospitals cancer research program.
5214256|NCT00768976|Participant should have been registered for clinical trial participation three months prior to receiving the satisfaction survey.|participant should have been registered for clinical trial participation three months prior to receiving the satisfaction survey.
5214257|NCT00768963|ranibizumab|ranibizumab
5214258|NCT00768963|pterygium|pterygium
5214259|NCT00768950|Seronegative spondyloarthropathies|seronegative spondyloarthropathies
5214260|NCT00768950|Endoscopic capsule examination|endoscopic capsule examination
5214261|NCT00768950|Small bowel and colon lesions|small bowel and colon lesions
5214262|NCT00768950|Nonsteroidal anti-inflammatory drugs|nonsteroidal anti-inflammatory drugs
5214263|NCT00768950|Anti TNF Alpha Drugs|anti tnf alpha drugs
5214264|NCT00768937|hepatocellular carcinoma|hepatocellular carcinoma
5214265|NCT00768937|sorafenib|sorafenib
5214266|NCT00768937|transarterial chemoembolization|transarterial chemoembolization
5214267|NCT00768937|tumor angiogenesis|tumor angiogenesis
5214268|NCT00768937|angiogenic factors|angiogenic factors
5214269|NCT00768924|Bone Void Filler|bone void filler
5214270|NCT00768924|Post-Harvest Iliac Crest|post-harvest iliac crest
5214271|NCT00768924|Ability of CopiOs to fill the post-harvest iliac crest bone void created by a surgeon during spinal fusion.|ability of copios to fill the post-harvest iliac crest bone void created by a surgeon during spinal fusion.
5214272|NCT00768911|glioblastoma|glioblastoma
5214273|NCT00768911|Glioblastoma multiforme (newly diagnosed)|glioblastoma multiforme (newly diagnosed)
5214274|NCT00768898|conjunctival|conjunctival
5214275|NCT00768898|staining|staining
5214276|NCT00768872|activity, spinal cord stimulation, pain|activity, spinal cord stimulation, pain
5214277|NCT00768859|breast cancer|breast cancer
5214278|NCT00768859|HER2 positive|her2 positive
5214279|NCT00768859|neo-adjuvant|neo-adjuvant
5214280|NCT00768859|trastuzumab|trastuzumab
5214281|NCT00768859|paclitaxel|paclitaxel
5214282|NCT00768859|carboplatin|carboplatin
5214284|NCT00768846|Stent|stent
5214285|NCT00768846|DES|des
5214286|NCT00768846|CAD|cad
5214287|NCT00768833|S.pneumoniae healthy subjects|s.pneumoniae healthy subjects
5214288|NCT00768833|Healthy subjects|healthy subjects
5214289|NCT00768820|Velocardiofacial syndrome|velocardiofacial syndrome
5214290|NCT00768820|Williams syndrome|williams syndrome
5214291|NCT00768820|fragile X syndrome|fragile x syndrome
5214292|NCT00768820|cognitive phenotype|cognitive phenotype
5214293|NCT00768820|psychiatric phenotype|psychiatric phenotype
5214294|NCT00768794|thrush|thrush
5214295|NCT00768781|insomnia|insomnia
5214296|NCT00768781|hyperarousal|hyperarousal
5214297|NCT00768781|mindfulness meditation|mindfulness meditation
5214298|NCT00768781|complementary and alternative medicine|complementary and alternative medicine
5214299|NCT00768781|cognitive-behavioral therapy|cognitive-behavioral therapy
5214300|NCT00768768|iontophoresis|iontophoresis
5214301|NCT00768768|terbinafine|terbinafine
5214302|NCT00768768|onychomycosis|onychomycosis
5214303|NCT00768755|non-squamous NSCLC|non-squamous nsclc
5214304|NCT00768755|axitinib|axitinib
5214305|NCT00768755|pemetrexed/cisplatin|pemetrexed/cisplatin
5214306|NCT00768742|Uterine Fibroid RF Ablation|uterine fibroid rf ablation
5214307|NCT00768742|Intrauterine Ultrasound|intrauterine ultrasound
5214308|NCT00768742|VizAblate|vizablate
5214309|NCT00768729|End stage renal disease|end stage renal disease
5214310|NCT00768729|Kidney transplantation|kidney transplantation
5214311|NCT00768729|Renal transplantation|renal transplantation
5214312|NCT00768729|Kidney failure|kidney failure
5214313|NCT00768729|Children|children
5214314|NCT00768729|Adolescents|adolescents
5214315|NCT00768729|Sirolimus|sirolimus
5214316|NCT00768729|Rapamycin|rapamycin
5214317|NCT00768729|CellCept|cellcept
5214318|NCT00768729|Mycophenolate mofetil (MMF)|mycophenolate mofetil (mmf)
5214319|NCT00768729|Azathioprine|azathioprine
5214320|NCT00768703|Congenital diaphragmatic hernia|congenital diaphragmatic hernia
5214321|NCT00768703|lung-head ratio|lung-head ratio
5214322|NCT00768703|percutaneous tracheal occlusion|percutaneous tracheal occlusion
5214323|NCT00768703|fetal intervention|fetal intervention
5214324|NCT00768677|binge eating behavior|binge eating behavior
5214325|NCT00768677|adolescents|adolescents
5214326|NCT00768664|recurrent or metastatic squamous cell cancer of the Head and Neck; no prior systemic therapy for recurrence|recurrent or metastatic squamous cell cancer of the head and neck; no prior systemic therapy for recurrence
5214327|NCT00768638|Chronic kidney disease|chronic kidney disease
5214328|NCT00768612|Acute, Schizophrenia, Phase2a, Vabicaserin|acute, schizophrenia, phase2a, vabicaserin
5214329|NCT00768599|Econazole|econazole
5214330|NCT00768599|Foam|foam
5214331|NCT00768599|Quinnova|quinnova
5214332|NCT00768573|taste test|taste test
5214333|NCT00768534|Acute Otitis Media|acute otitis media
5214334|NCT00768534|Serotype distribution|serotype distribution
5214335|NCT00768508|Alcohol|alcohol
5214336|NCT00768508|Alcohol Dependence|alcohol dependence
5214337|NCT00768508|Alcoholism|alcoholism
5214338|NCT00768495|revascularization|revascularization
5214339|NCT00768495|claudication|claudication
5214340|NCT00768495|hyperspectral|hyperspectral
5214341|NCT00768495|oxygenation|oxygenation
5214342|NCT00768495|limb ischemia|limb ischemia
5214343|NCT00768482|opioid dependence|opioid dependence
5214344|NCT00768482|opioid addiction|opioid addiction
5214345|NCT00768482|buprenorphine|buprenorphine
5214346|NCT00768482|methadone|methadone
5214347|NCT00768482|heroin|heroin
5214348|NCT00768482|implant|implant
5214349|NCT00768482|opioid withdrawal|opioid withdrawal
5214350|NCT00768482|opioid pain medication|opioid pain medication
5214351|NCT00768482|suboxone|suboxone
5214352|NCT00768469|HKI-272|hki-272
5214353|NCT00768469|Paclitaxel|paclitaxel
5214354|NCT00768469|Combination|combination
5214355|NCT00768469|Solid Tumor|solid tumor
5214356|NCT00768443|GERD|gerd
5214357|NCT00768443|PPI|ppi
5214358|NCT00768417|Nuts|nuts
5214359|NCT00768417|Lipids|lipids
5214360|NCT00768417|Mastication|mastication
5214361|NCT00768417|Bioaccessibility|bioaccessibility
5214362|NCT00768417|Satiety|satiety
5214363|NCT00768417|Hormones|hormones
5214364|NCT00768417|Human|human
5214365|NCT00768391|Tumors|tumors
5214366|NCT00768391|Lymphoma|lymphoma
5214367|NCT00768391|Antibodies, Monoclonal|antibodies, monoclonal
5214368|NCT00768378|Physical Therapy (Specialty)|physical therapy (specialty)
5214369|NCT00768378|Balance dysfunction or disorder|balance dysfunction or disorder
5214370|NCT00768378|Vestibular|vestibular
5214371|NCT00768378|Rehabilitation|rehabilitation
5214372|NCT00768365|adrenal incidentaloma|adrenal incidentaloma
5214373|NCT00768365|cardiovascular risk|cardiovascular risk
5214374|NCT00768352|Pediatric|pediatric
5214375|NCT00768352|Resident|resident
5214376|NCT00768352|Depression|depression
5214377|NCT00768352|Screening|screening
5214378|NCT00768352|Substance Abuse|substance abuse
5214379|NCT00768352|Pediatric Resident knowledge of mental health topics|pediatric resident knowledge of mental health topics
5214380|NCT00768352|Pediatric Resident current practices for screening and treating mental health disorders|pediatric resident current practices for screening and treating mental health disorders
5214381|NCT00768352|Pediatric Resident mental health care competency|pediatric resident mental health care competency
5214382|NCT00768339|antisense|antisense
5214383|NCT00768339|AEG35156|aeg35156
5214384|NCT00768339|lymphocytic|lymphocytic
5214385|NCT00768339|lymphoma|lymphoma
5214386|NCT00768339|leukemia|leukemia
5214387|NCT00768339|B-cell|b-cell
5214388|NCT00768326|Schizophrenia|schizophrenia
5214389|NCT00768326|Antipsychotic|antipsychotic
5214390|NCT00768326|Lu 31-130|lu 31-130
5214391|NCT00768313|scoliosis correction rod strength adolescent|scoliosis correction rod strength adolescent
5214392|NCT00768300|idiopathic pulmonary fibrosis|idiopathic pulmonary fibrosis
5214393|NCT00768300|interstitial lung disease|interstitial lung disease
5214394|NCT00768300|ambrisentan|ambrisentan
5214395|NCT00768274|Cholesterol|cholesterol
5214396|NCT00768274|High density lipoprotein|high density lipoprotein
5214397|NCT00768274|Dyslipidemia|dyslipidemia
5214398|NCT00768274|Atherosclerosis|atherosclerosis
5214399|NCT00768274|Apolipoprotein A-I|apolipoprotein a-i
5214400|NCT00768261|Dementia of the Alzheimer type|dementia of the alzheimer type
5214401|NCT00768248|pain|pain
5214402|NCT00768248|phantom limb|phantom limb
5214403|NCT00768248|stump pain|stump pain
5214404|NCT00768248|catheter|catheter
5214405|NCT00768248|nerve block|nerve block
5214406|NCT00768248|peripheral nerve block|peripheral nerve block
5214407|NCT00768248|NMCSD|nmcsd
5214408|NCT00768248|Post-Amputation Phantom Limb or Stump Pain|post-amputation phantom limb or stump pain
5214409|NCT00768235|Sedentary elderly women that had medical assignment|sedentary elderly women that had medical assignment
5214410|NCT00768222|wound healing|wound healing
5214411|NCT00768209|Pharmacokinetics|pharmacokinetics
5214412|NCT00768196|GERD|gerd
5214413|NCT00768196|Korea|korea
5214414|NCT00768196|typical symptom|typical symptom
5214415|NCT00768196|quality of life|quality of life
5214416|NCT00768196|Naturalistic|naturalistic
5214417|NCT00768196|epidemiological|epidemiological
5214418|NCT00768183|KADIAN|kadian
5214419|NCT00768183|morphine|morphine
5214420|NCT00768183|alcohol|alcohol
5214421|NCT00768183|water|water
5214422|NCT00768183|Ethanol|ethanol
5214423|NCT00768183|solution|solution
5214424|NCT00768183|fed|fed
5214425|NCT00768183|fasting|fasting
5214426|NCT00768157|hepatocellular carcinoma|hepatocellular carcinoma
5214427|NCT00768157|hepatitis B virus|hepatitis b virus
5214428|NCT00768157|surgery|surgery
5214429|NCT00768157|anti-virus|anti-virus
5214430|NCT00768157|recurrence|recurrence
5214431|NCT00768144|Sutent|sutent
5214432|NCT00768144|sunitinib|sunitinib
5214433|NCT00768118|healthy, no evidence of disease|healthy, no evidence of disease
5214434|NCT00768105|Type 2 diabetes|type 2 diabetes
5214435|NCT00768079|Benralizumab|benralizumab
5214436|NCT00768079|MEDI-563|medi-563
5214437|NCT00768079|Asthma|asthma
5214438|NCT00768066|Chronic Ischemic Left Ventricular Dysfunction|chronic ischemic left ventricular dysfunction
5214439|NCT00768053|EULAR-RAID|eular-raid
5214440|NCT00768053|active rheumatoid arthritis|active rheumatoid arthritis
5214441|NCT00768053|etanercept|etanercept
5214442|NCT00768040|Diabetes|diabetes
5214443|NCT00768040|Macular edema|macular edema
5214444|NCT00768040|Aliskiren|aliskiren
5214445|NCT00768040|Diabetic retinopathy|diabetic retinopathy
5214446|NCT00768040|Diabetes mellitus type 1|diabetes mellitus type 1
5214447|NCT00768040|Diabetes mellitus type 2|diabetes mellitus type 2
5214448|NCT00768027|hyperspectral imaging|hyperspectral imaging
5214449|NCT00768027|tissue oxygenation|tissue oxygenation
5214450|NCT00768027|wounds|wounds
5214451|NCT00768027|wound healing|wound healing
5214452|NCT00768027|prevention|prevention
5214453|NCT00768027|hyperbaric|hyperbaric
5214454|NCT00767988|Probiotics|probiotics
5214455|NCT00767988|Spina Bifida|spina bifida
5214456|NCT00767988|Dietary Supplements|dietary supplements
5214457|NCT00767988|Bacteriuria|bacteriuria
5214458|NCT00767988|Urinary Tract Infection (UTI)|urinary tract infection (uti)
5214459|NCT00767962|recurrent primary spontaneous pneumothorax|recurrent primary spontaneous pneumothorax
5214460|NCT00767949|wet|wet
5214461|NCT00767949|AMD|amd
5214462|NCT00767923|hyperspectral imaging|hyperspectral imaging
5214463|NCT00767923|tissue oxygenation|tissue oxygenation
5214464|NCT00767923|foot amputation|foot amputation
5214465|NCT00767923|critical limb ischemia|critical limb ischemia
5214466|NCT00767923|tissue necrosis|tissue necrosis
5214467|NCT00767897|Dose response relationship|dose response relationship
5214468|NCT00767897|immunity|immunity
5214469|NCT00767884|panretinal photocoagulation|panretinal photocoagulation
5214470|NCT00767884|diabetic retinopathy|diabetic retinopathy
5214471|NCT00767884|optic nerve head changes|optic nerve head changes
5214472|NCT00767871|Panic disorder|panic disorder
5214473|NCT00767871|PET|pet
5214474|NCT00767871|Escitaopram|escitaopram
5214475|NCT00767858|Genetic|genetic
5214476|NCT00767858|Genetic Literacy|genetic literacy
5214477|NCT00767858|Human Genetic Research|human genetic research
5214478|NCT00767858|Cultural Congruence|cultural congruence
5214479|NCT00767858|Interview|interview
5214480|NCT00767845|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
5214481|NCT00767845|stage I prostate cancer|stage i prostate cancer
5214482|NCT00767845|stage II prostate cancer|stage ii prostate cancer
5214483|NCT00767845|stage III prostate cancer|stage iii prostate cancer
5214484|NCT00767819|progressive GIST|progressive gist
5214485|NCT00767819|progressive sarcoma|progressive sarcoma
5214486|NCT00767767|anesthetic drugs, associative memory, fear|anesthetic drugs, associative memory, fear
5214487|NCT00767754|panic disorder|panic disorder
5214488|NCT00767754|paroxetine|paroxetine
5214489|NCT00767754|PET|pet
5214490|NCT00767741|diabetes|diabetes
5214491|NCT00767741|post prandial glucose level|post prandial glucose level
5214492|NCT00767741|insulin|insulin
5214493|NCT00767741|pharmacokinetics|pharmacokinetics
5214494|NCT00767741|pharmacodynamics|pharmacodynamics
5214495|NCT00767728|UC|uc
5214496|NCT00767728|ulcerative colitis|ulcerative colitis
5214497|NCT00767728|IBD|ibd
5214498|NCT00767728|Inflammatory Bowel Disease|inflammatory bowel disease
5214499|NCT00767702|Genetic/Genomic Researchers|genetic/genomic researchers
5214500|NCT00767702|Human Genetic Variation|human genetic variation
5214501|NCT00767702|Interviews|interviews
5214502|NCT00767702|Research Design|research design
5214503|NCT00767702|Race/Ethnicity|race/ethnicity
5214504|NCT00767702|Interview|interview
5214505|NCT00767676|Contact sensitization|contact sensitization
5214506|NCT00767676|Healthy Adult Volunteers|healthy adult volunteers
5214507|NCT00767650|Aplastic Anemia|aplastic anemia
5214508|NCT00767650|Cyclosporine|cyclosporine
5214509|NCT00767650|Campath|campath
5214510|NCT00767650|Neurophyschological Side Effect|neurophyschological side effect
5214511|NCT00767611|Infertility|infertility
5214512|NCT00767611|Sperm|sperm
5214513|NCT00767611|Embryo Development|embryo development
5214514|NCT00767611|In Vitro Fertilization|in vitro fertilization
5214515|NCT00767598|CYP3A5|cyp3a5
5214516|NCT00767598|sildenafil|sildenafil
5214517|NCT00767598|udenafil|udenafil
5214518|NCT00767598|vardenafil|vardenafil
5214519|NCT00767585|breast cancer|breast cancer
5214520|NCT00767585|aromatase inhibitors|aromatase inhibitors
5214521|NCT00767585|bone mineral density|bone mineral density
5214522|NCT00767585|osteoporosis|osteoporosis
5214523|NCT00767572|Coarctation of the aorta|coarctation of the aorta
5214524|NCT00767572|cross over design|cross over design
5214525|NCT00767572|atorvastatin|atorvastatin
5214526|NCT00767572|endothelial function|endothelial function
5214527|NCT00767559|Deep Vein Thrombosis, anticoagulants, surgery, pulmonary embolus, warfarin, fondaparinox|deep vein thrombosis, anticoagulants, surgery, pulmonary embolus, warfarin, fondaparinox
5214528|NCT00767546|seborrhic dermatitis|seborrhic dermatitis
5214529|NCT00767546|parkinson's disease|parkinson's disease
5214530|NCT00767546|Parkinson disease parkinsonism and seborrhic dermatitis|parkinson disease parkinsonism and seborrhic dermatitis
5214625|NCT00766987|coronary artery disease|coronary artery disease
5214531|NCT00767520|Advanced Estrogen Receptor Positive Breast Cancer|advanced estrogen receptor positive breast cancer
5214532|NCT00767494|OAG|oag
5214533|NCT00767494|OH|oh
5214534|NCT00767494|Open-angle glaucoma or ocular hypertension|open-angle glaucoma or ocular hypertension
5214535|NCT00767481|glaucoma|glaucoma
5214536|NCT00767481|Patients with open-angle glaucoma or ocular hypertension|patients with open-angle glaucoma or ocular hypertension
5214537|NCT00767468|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
5214538|NCT00767468|advanced adult primary liver cancer|advanced adult primary liver cancer
5214539|NCT00767468|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
5214540|NCT00767468|recurrent adult primary liver cancer|recurrent adult primary liver cancer
5214541|NCT00767455|cumulative irritation|cumulative irritation
5214542|NCT00767455|healthy adult volunteers|healthy adult volunteers
5214543|NCT00767429|accelerometer|accelerometer
5214544|NCT00767429|fall risk|fall risk
5214545|NCT00767429|target group|target group
5214546|NCT00767429|field measurements|field measurements
5214547|NCT00767416|MEDI-559|medi-559
5214548|NCT00767416|Respiratory Syncytial Virus|respiratory syncytial virus
5214549|NCT00767416|RSV|rsv
5214550|NCT00767416|Pediatric|pediatric
5214551|NCT00767416|Vaccine|vaccine
5214552|NCT00767416|respiratory syncytial virus, RSV, pediatric, vaccine|respiratory syncytial virus, rsv, pediatric, vaccine
5214553|NCT00767390|ACL Patch Placement|acl patch placement
5214554|NCT00767377|Time to Progression|time to progression
5214555|NCT00767377|Overall survival|overall survival
5214556|NCT00767377|Response rate|response rate
5214557|NCT00767377|Quality of Live|quality of live
5214558|NCT00767377|Toxicities|toxicities
5214559|NCT00767364|Infant|infant
5214560|NCT00767338|Infertility|infertility
5214561|NCT00767338|Pregnancy|pregnancy
5214562|NCT00767338|Men|men
5214563|NCT00767338|Palpable varicocele|palpable varicocele
5214564|NCT00767338|Abnormal semen analysis|abnormal semen analysis
5214565|NCT00767338|Intrauterine insemination|intrauterine insemination
5214566|NCT00767338|Microsurgical varicocelectomy|microsurgical varicocelectomy
5214567|NCT00767312|HIV|hiv
5214568|NCT00767312|Antiretrovial Therapy|antiretrovial therapy
5214569|NCT00767312|Viremia|viremia
5214570|NCT00767312|Genetic Analysis|genetic analysis
5214571|NCT00767312|Single Copy Assay|single copy assay
5214572|NCT00767286|stage IIB prostate cancer|stage iib prostate cancer
5214573|NCT00767286|stage IIA prostate cancer|stage iia prostate cancer
5214574|NCT00767286|stage III prostate cancer|stage iii prostate cancer
5214575|NCT00767286|stage IV prostate cancer|stage iv prostate cancer
5214576|NCT00767260|type 2 diabetes mellitus|type 2 diabetes mellitus
5214577|NCT00767260|bone marrow mononuclear cell|bone marrow mononuclear cell
5214578|NCT00767260|hyperbaric oxygen therapy|hyperbaric oxygen therapy
5214579|NCT00767247|Arterial Hypertension|arterial hypertension
5214580|NCT00767208|type 2 diabetic subjects|type 2 diabetic subjects
5214581|NCT00767195|pulmonary edema|pulmonary edema
5214582|NCT00767195|cardiogenic|cardiogenic
5214583|NCT00767195|non-cardiogenic|non-cardiogenic
5214584|NCT00767195|mortality|mortality
5214585|NCT00767195|length of stay|length of stay
5214586|NCT00767182|preeclampsia|preeclampsia
5214587|NCT00767182|eclampsia|eclampsia
5214588|NCT00767182|retroplacental hematoma|retroplacental hematoma
5214589|NCT00767182|vascular IUGR|vascular iugr
5214590|NCT00767182|IUFD|iufd
5214591|NCT00767182|placental volume|placental volume
5214592|NCT00767169|Edentatio (Toothlessness)|edentatio (toothlessness)
5214593|NCT00767156|Sea buckthorn oil, Oral and topical treatment, Skin aging|sea buckthorn oil, oral and topical treatment, skin aging
5214594|NCT00767130|single nucleotide polymorphisms, SNP, LDL cholesterol, statin myopathy, atorvastatin, simvastatin, rosuvastatin|single nucleotide polymorphisms, snp, ldl cholesterol, statin myopathy, atorvastatin, simvastatin, rosuvastatin
5214595|NCT00767117|TMC125-C197|tmc125-c197
5214596|NCT00767117|TMC125-TiDP2-C197|tmc125-tidp2-c197
5214597|NCT00767117|HIV|hiv
5214598|NCT00767117|DDI|ddi
5214599|NCT00767117|Lopinavir|lopinavir
5214600|NCT00767117|Intelence|intelence
5214601|NCT00767117|Kaletra|kaletra
5214602|NCT00767117|Ritonavir|ritonavir
5214603|NCT00767117|Etravirine|etravirine
5214604|NCT00767117|Interaction|interaction
5214605|NCT00767117|Pharmacokinetics|pharmacokinetics
5214606|NCT00767117|Steady-state|steady-state
5214607|NCT00767091|Parkinson's disease|parkinson's disease
5214608|NCT00767091|Apathy|apathy
5214609|NCT00767091|Rivastigmine|rivastigmine
5214610|NCT00767091|transdermal patch|transdermal patch
5214611|NCT00767091|anticholinesterasic|anticholinesterasic
5214612|NCT00767091|acetylcholine|acetylcholine
5214613|NCT00767052|Healthy Volunteer|healthy volunteer
5214614|NCT00767052|Safety|safety
5214615|NCT00767052|Tolerability|tolerability
5214616|NCT00767052|Pharmacokinetics|pharmacokinetics
5214617|NCT00767052|AZD1236|azd1236
5214618|NCT00767039|Very Premature|very premature
5214619|NCT00767039|RDS|rds
5214620|NCT00767039|Surfactant|surfactant
5214621|NCT00767026|Epilepsy|epilepsy
5214622|NCT00767026|Caregiver Burden|caregiver burden
5214623|NCT00767026|Parenting a Child with a Chronic Illness|parenting a child with a chronic illness
5214624|NCT00767013|DSCT, coronary artery disease, aortic valve stenosis|dsct, coronary artery disease, aortic valve stenosis
5214626|NCT00766987|FDG PET viability imaging|fdg pet viability imaging
5214627|NCT00766987|morbidity and mortality|morbidity and mortality
5214628|NCT00766987|revascularization|revascularization
5214629|NCT00766987|resource utilization|resource utilization
5214630|NCT00766974|Chronic Venous Disease|chronic venous disease
5214631|NCT00766974|C3|c3
5214632|NCT00766974|Edema|edema
5214633|NCT00766974|Compression Garments|compression garments
5214634|NCT00766974|Compression Stockings|compression stockings
5214635|NCT00766974|Bioimpedance|bioimpedance
5214636|NCT00766961|Peptic ulcer bleeding uncontrolled by endoscopic therapy.|peptic ulcer bleeding uncontrolled by endoscopic therapy.
5214637|NCT00766935|Lymphedema|lymphedema
5214638|NCT00766935|Bioimpedance|bioimpedance
5214639|NCT00766909|Insulin pulsatility|insulin pulsatility
5214640|NCT00766909|Insulin secretion|insulin secretion
5214641|NCT00766909|Insulin sensitivity|insulin sensitivity
5214642|NCT00766909|Calcineurin inhibitor|calcineurin inhibitor
5214643|NCT00766909|Cyclosporine|cyclosporine
5214644|NCT00766909|Tacrolimus|tacrolimus
5214645|NCT00766896|Stroke|stroke
5214646|NCT00766896|Cerebral Infarction|cerebral infarction
5214647|NCT00766896|Acute Coronary Syndrome|acute coronary syndrome
5214648|NCT00766896|Cardiovascular Diseases|cardiovascular diseases
5214649|NCT00766896|Vascular Diseases|vascular diseases
5214650|NCT00766896|Platelet Activation|platelet activation
5214651|NCT00766896|Platelets|platelets
5214652|NCT00766896|Platelet Function Tests|platelet function tests
5214653|NCT00766896|Aspirin|aspirin
5214654|NCT00766896|Atherosclerosis|atherosclerosis
5214655|NCT00766896|Ischemia|ischemia
5214656|NCT00766896|Thrombosis|thrombosis
5214657|NCT00766883|Allogeneic HSCT|allogeneic hsct
5214658|NCT00766883|Psychosocial Distress|psychosocial distress
5214659|NCT00766883|Coping|coping
5214660|NCT00766883|Cognitive Behavior Therapy|cognitive behavior therapy
5214661|NCT00766883|Self Efficacy|self efficacy
5214662|NCT00766883|Allogeneic Stem Cell Transplant|allogeneic stem cell transplant
5214663|NCT00766870|Efficacy|efficacy
5214664|NCT00766870|Safety|safety
5214665|NCT00766870|Depression|depression
5214666|NCT00766870|Interventional|interventional
5214667|NCT00766870|Placebo|placebo
5214668|NCT00766870|Short-term|short-term
5214669|NCT00766870|Major Depressive Disorder|major depressive disorder
5214670|NCT00766870|Major Depressive Episode|major depressive episode
5214671|NCT00766857|Exenatide|exenatide
5214672|NCT00766857|Type 2 diabetes mellitus|type 2 diabetes mellitus
5214673|NCT00766857|Congestive heart failure|congestive heart failure
5214674|NCT00766857|Incretin hormones|incretin hormones
5214675|NCT00766857|GLP-1 agonist|glp-1 agonist
5214676|NCT00766857|Cardiac metabolism|cardiac metabolism
5214677|NCT00766857|Insulin resistance|insulin resistance
5214678|NCT00766857|Cardiac MRI|cardiac mri
5214679|NCT00766844|vasospasm|vasospasm
5214680|NCT00766844|spinal cord stimulation|spinal cord stimulation
5214681|NCT00766844|aneurysm|aneurysm
5214682|NCT00766844|subarachnoid hemorrhage|subarachnoid hemorrhage
5214683|NCT00766831|Cancer pain|cancer pain
5214684|NCT00766831|Hydromorphone OROS|hydromorphone oros
5214685|NCT00766831|Jurnista|jurnista
5214686|NCT00766779|hematopoietic cell transplantation|hematopoietic cell transplantation
5214687|NCT00766779|Acute Myeloid Leukemia|acute myeloid leukemia
5214688|NCT00766779|first Complete Remission|first complete remission
5214689|NCT00766766|Environmental Tobacco Exposure|environmental tobacco exposure
5214690|NCT00766753|HLA-A2 positive|hla-a2 positive
5214691|NCT00766753|Malignant Gliomas|malignant gliomas
5214692|NCT00766753|Vaccine|vaccine
5214693|NCT00766740|ST elevation myocardial infarction|st elevation myocardial infarction
5214694|NCT00766740|thrombectomy|thrombectomy
5214695|NCT00766740|primary PCI|primary pci
5214696|NCT00766675|Pain|pain
5214697|NCT00766675|Fibromyalgia|fibromyalgia
5214698|NCT00766675|Ultracet|ultracet
5214699|NCT00766675|Tramadol Hydrochloride|tramadol hydrochloride
5214700|NCT00766675|Acetaminophen|acetaminophen
5214701|NCT00766662|Malaria|malaria
5214702|NCT00766662|Intermittent Preventive Treatment|intermittent preventive treatment
5214703|NCT00766662|EPI vaccine coverage|epi vaccine coverage
5214704|NCT00766662|Resistance of P. falciparum to Sulfadoxine- Pyrimethamine|resistance of p. falciparum to sulfadoxine- pyrimethamine
5214705|NCT00766649|Age Related Macular Degeneration (AMD)|age related macular degeneration (amd)
5214706|NCT00766649|Geographic Atrophy|geographic atrophy
5214707|NCT00766649|Sirolimus|sirolimus
5214708|NCT00766649|Age-Related Macular Degeneration|age-related macular degeneration
5214709|NCT00766649|AMD|amd
5214710|NCT00766636|Adenocarcinoma of the pancreatic head|adenocarcinoma of the pancreatic head
5214711|NCT00766636|Pancreaticoduodenectomy|pancreaticoduodenectomy
5214712|NCT00766636|Preoperative chemotherapy|preoperative chemotherapy
5214713|NCT00766636|Chemoradiation|chemoradiation
5214714|NCT00766636|Resectable pancreatic cancer|resectable pancreatic cancer
5214715|NCT00766636|Surgical removal of the pancreas and duodenum|surgical removal of the pancreas and duodenum
5214716|NCT00766636|External-beam radiation therapy|external-beam radiation therapy
5214717|NCT00766636|EBRT|ebrt
5214718|NCT00766636|Gemcitabine|gemcitabine
5214719|NCT00766636|Erlotinib|erlotinib
5214720|NCT00766623|endothelium,|endothelium,
5214721|NCT00766623|postprandial|postprandial
5214722|NCT00766623|microvascular|microvascular
5214723|NCT00766623|macrovascular|macrovascular
5214724|NCT00766597|Treatment Experienced|treatment experienced
5214725|NCT00766584|Aging|aging
5214726|NCT00766584|Autonomic nervous system|autonomic nervous system
5214727|NCT00766584|stroke|stroke
5214728|NCT00766584|Myocardiac infarction|myocardiac infarction
5214729|NCT00766584|Prospective cohort|prospective cohort
5214730|NCT00766584|Sleep apnea/hypopnea|sleep apnea/hypopnea
5214731|NCT00766571|VACTERL Association|vacterl association
5214732|NCT00766571|VATER Association|vater association
5214733|NCT00766571|Multiple Congenital Anomalies|multiple congenital anomalies
5214734|NCT00766571|VACTERL|vacterl
5214735|NCT00766571|Congenital Defects|congenital defects
5214736|NCT00766571|Birth Defects|birth defects
5214737|NCT00766571|Congenital Abnormalities|congenital abnormalities
5214738|NCT00766558|anorexia|anorexia
5214739|NCT00766558|bulimia|bulimia
5214740|NCT00766558|eating disorder not otherwise specified|eating disorder not otherwise specified
5214741|NCT00766519|fluid responsiveness|fluid responsiveness
5214742|NCT00766519|monitoring|monitoring
5214743|NCT00766519|arterial pulse pressure|arterial pulse pressure
5214744|NCT00766506|IONSYS|ionsys
5214745|NCT00766506|Fentanyl|fentanyl
5214746|NCT00766506|Morphine|morphine
5214747|NCT00766506|PCA|pca
5214748|NCT00766506|Postoperative pain|postoperative pain
5214749|NCT00766506|Mobilization|mobilization
5214750|NCT00766493|carotid artery stenosis|carotid artery stenosis
5214751|NCT00766493|embolic protection device|embolic protection device
5214752|NCT00766493|distal embolic filter|distal embolic filter
5214753|NCT00766493|minimizing risks of carotid artery stenting|minimizing risks of carotid artery stenting
5214754|NCT00766480|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
5214755|NCT00766480|stage IIA esophageal cancer|stage iia esophageal cancer
5214756|NCT00766480|stage IIB esophageal cancer|stage iib esophageal cancer
5214757|NCT00766480|stage IIIA esophageal cancer|stage iiia esophageal cancer
5214758|NCT00766480|stage IIIB esophageal cancer|stage iiib esophageal cancer
5214759|NCT00766480|stage IIIC esophageal cancer|stage iiic esophageal cancer
5214760|NCT00766467|armodafinil|armodafinil
5214761|NCT00766467|Nuvigil|nuvigil
5214762|NCT00766467|fatigue|fatigue
5214763|NCT00766454|breast cancer|breast cancer
5214764|NCT00766441|diabetes|diabetes
5214765|NCT00766441|hypoglycemia|hypoglycemia
5214766|NCT00766441|ramadan|ramadan
5214767|NCT00766441|fasting|fasting
5214768|NCT00766415|COPD|copd
5214769|NCT00766415|Moderate to severe COPD|moderate to severe copd
5214770|NCT00766402|Spondylitis, ankylosing|spondylitis, ankylosing
5214771|NCT00766402|Pain|pain
5214772|NCT00766402|Ultracet|ultracet
5214773|NCT00766402|Diclofenac|diclofenac
5214774|NCT00766402|Voltaren|voltaren
5214775|NCT00766402|Tramadol/acetaminophen|tramadol/acetaminophen
5214776|NCT00766389|Glaucoma|glaucoma
5214777|NCT00766389|Retinal nerve fiber layer|retinal nerve fiber layer
5214778|NCT00766389|Cirrus OCT|cirrus oct
5214779|NCT00766389|Stratus OCT|stratus oct
5214780|NCT00766363|Alzheimer's Disease|alzheimer's disease
5214781|NCT00766363|Central Nervous System Diseases|central nervous system diseases
5214782|NCT00766363|Pharmacokinetics|pharmacokinetics
5214783|NCT00766363|Cognition|cognition
5214784|NCT00766350|fibromyalgia|fibromyalgia
5214785|NCT00766350|quetiapine|quetiapine
5214786|NCT00766350|amitriptyline|amitriptyline
5214787|NCT00766337|wet AMD|wet amd
5214788|NCT00766298|Exercise|exercise
5214789|NCT00766298|Weight Loss|weight loss
5214790|NCT00766298|Physical Activity|physical activity
5214791|NCT00766298|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
5214792|NCT00766285|Baculovirus, influenza, stem cell transplant|baculovirus, influenza, stem cell transplant
5214793|NCT00766272|Rehabilitation|rehabilitation
5214794|NCT00766272|Treadmill|treadmill
5214795|NCT00766272|MS|ms
5214796|NCT00766272|Gait|gait
5214797|NCT00766272|Robot|robot
5214798|NCT00766259|methicillin-resistant Staphylococcus|methicillin-resistant staphylococcus
5214799|NCT00766259|colonization|colonization
5214800|NCT00766246|Non-Small Cell Lung Cancer|non-small cell lung cancer
5214801|NCT00766246|Advanced Non-Small Cell Lung Cancer|advanced non-small cell lung cancer
5214802|NCT00766246|Lung Cancer|lung cancer
5214803|NCT00766233|Hyperthermia|hyperthermia
5214804|NCT00766233|superficial tumor treatment|superficial tumor treatment
5214805|NCT00766233|superficial tumors|superficial tumors
5214806|NCT00766220|Colon|colon
5214807|NCT00766220|Liver|liver
5214808|NCT00766220|Colorectal cancer|colorectal cancer
5214809|NCT00766220|Colorectal cancer metastases to the liver|colorectal cancer metastases to the liver
5214810|NCT00766220|Metastases to the liver|metastases to the liver
5214811|NCT00766220|Colorectal cancer mets to liver|colorectal cancer mets to liver
5214812|NCT00766220|Colon cancer metastasized to liver|colon cancer metastasized to liver
5214813|NCT00766220|Yttrium microspheres|yttrium microspheres
5214814|NCT00766220|SIR-Spheres|sir-spheres
5214815|NCT00766220|Yttrium-90|yttrium-90
5214816|NCT00766220|Cetuximab|cetuximab
5214817|NCT00766220|C225|c225
5214818|NCT00766220|Erbitux|erbitux
5214819|NCT00766220|IMC-C225|imc-c225
5214820|NCT00766220|Irinotecan|irinotecan
5214821|NCT00766220|CPT-11|cpt-11
5214822|NCT00766220|Liver directed therapy|liver directed therapy
5214823|NCT00766207|Teratogens|teratogens
5214824|NCT00766207|Abnormalities, Drug-Induced|abnormalities, drug-induced
5214825|NCT00766207|Contraception|contraception
5214826|NCT00766181|IV placement; Parent satisfaction level|iv placement; parent satisfaction level
5214827|NCT00766168|contact lens|contact lens
5214828|NCT00766168|rigid gas permeable|rigid gas permeable
5214829|NCT00766168|refractive index|refractive index
5214830|NCT00766155|stage II rectal cancer|stage ii rectal cancer
5214831|NCT00766155|stage III rectal cancer|stage iii rectal cancer
5214832|NCT00766155|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5214833|NCT00766142|adenocarcinoma of the colon|adenocarcinoma of the colon
5214834|NCT00766142|recurrent colon cancer|recurrent colon cancer
5214835|NCT00766142|stage IV colon cancer|stage iv colon cancer
5214836|NCT00766142|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5214837|NCT00766142|recurrent rectal cancer|recurrent rectal cancer
5214838|NCT00766142|stage IV rectal cancer|stage iv rectal cancer
5214839|NCT00766142|peritoneal carcinomatosis|peritoneal carcinomatosis
5214840|NCT00766129|saphenous vein graft, TAXUS stent, Chopin stent|saphenous vein graft, taxus stent, chopin stent
5214841|NCT00766116|AML|aml
5214842|NCT00766103|Cerebral metabolism, perfusion, induced hypothermia|cerebral metabolism, perfusion, induced hypothermia
5214843|NCT00766064|posttraumatic stress disorder|posttraumatic stress disorder
5214844|NCT00766051|Neurophysiologically Based Occupational Therapy Intervention (NBOTI)|neurophysiologically based occupational therapy intervention (nboti)
5214845|NCT00766051|NBOTI|nboti
5214846|NCT00766051|NICU|nicu
5214847|NCT00766051|NCCU|nccu
5214848|NCT00766051|Developmental Biology|developmental biology
5214849|NCT00766051|Critical Period|critical period
5214850|NCT00766051|Brain Development|brain development
5214851|NCT00766051|Sensory Integration|sensory integration
5214852|NCT00766051|Neurodevelopment|neurodevelopment
5214853|NCT00766051|Sensitive Period|sensitive period
5214854|NCT00766038|Mood disorders|mood disorders
5214855|NCT00766038|Cognitive disorders|cognitive disorders
5214856|NCT00766038|Fatigue|fatigue
5214857|NCT00766038|Metabolic disorders|metabolic disorders
5214858|NCT00766025|Taiwanese Subjects|taiwanese subjects
5214859|NCT00766025|CYP2C19|cyp2c19
5214860|NCT00766025|Poor Metabolizers|poor metabolizers
5214861|NCT00766025|Extensive Metabolizers|extensive metabolizers
5214862|NCT00766025|Taiwanese Subjects identified as CYP2C19 Poor or Extensive Metabolizers|taiwanese subjects identified as cyp2c19 poor or extensive metabolizers
5214863|NCT00766012|safety|safety
5214864|NCT00766012|tolerability|tolerability
5214865|NCT00766012|pharmacokinetics|pharmacokinetics
5214866|NCT00766012|AZD2066|azd2066
5214867|NCT00766012|Japanese|japanese
5214868|NCT00765999|Constipation|constipation
5214869|NCT00765999|Chronic Constipation|chronic constipation
5214870|NCT00765999|Irritable Bowel Syndrome With Constipation|irritable bowel syndrome with constipation
5214871|NCT00765999|Linaclotide|linaclotide
5214872|NCT00765986|18F-FAZA|18f-faza
5214873|NCT00765986|18F-FDG|18f-fdg
5214874|NCT00765986|Positron Emission Tomography|positron emission tomography
5214875|NCT00765973|Other Advanced Solid Tumors|other advanced solid tumors
5214876|NCT00765960|Vision|vision
5214877|NCT00765947|Essential Hypertension ( mild to moderate)|essential hypertension ( mild to moderate)
5214878|NCT00765934|Healthy|healthy
5214879|NCT00765921|glaucoma, neovascular|glaucoma, neovascular
5214880|NCT00765921|macular edema|macular edema
5214881|NCT00765921|eye enucleation|eye enucleation
5214882|NCT00765921|antibodies, monoclonal|antibodies, monoclonal
5214883|NCT00765921|radiation oncology|radiation oncology
5214884|NCT00765895|idiopathic gastroparesis|idiopathic gastroparesis
5214885|NCT00765882|Constipation|constipation
5214886|NCT00765882|Chronic Constipation|chronic constipation
5214887|NCT00765882|Linaclotide|linaclotide
5214888|NCT00765869|Decision support techniques|decision support techniques
5214889|NCT00765856|Opioid tolerant|opioid tolerant
5214890|NCT00765856|Pediatric|pediatric
5214891|NCT00765856|Male 6-17 years of age|male 6-17 years of age
5214892|NCT00765856|Female 6-17 years of age|female 6-17 years of age
5214893|NCT00765856|Pain|pain
5214894|NCT00765856|Non malignant|non malignant
5214895|NCT00765856|Malignant|malignant
5214896|NCT00765843|heel pain|heel pain
5214897|NCT00765830|Type 2 diabetes, vildagliptin|type 2 diabetes, vildagliptin
5214898|NCT00765817|diabetes|diabetes
5214899|NCT00765817|exenatide|exenatide
5214900|NCT00765817|Amylin|amylin
5214901|NCT00765817|Lilly|lilly
5214902|NCT00765817|metformin|metformin
5214903|NCT00765817|pioglitazone|pioglitazone
5214904|NCT00765817|insulin glargine|insulin glargine
5214905|NCT00765804|Dry Eye|dry eye
5214906|NCT00765804|Iontophoresis|iontophoresis
5214907|NCT00765804|Ophthalmic Delivery|ophthalmic delivery
5214908|NCT00765791|head and neck cancer|head and neck cancer
5214909|NCT00765791|oral cancer|oral cancer
5214910|NCT00765791|oropharyngeal cancer|oropharyngeal cancer
5214911|NCT00765791|laryngeal cancer|laryngeal cancer
5214912|NCT00765791|selective neck dissection|selective neck dissection
5214913|NCT00765791|submuscular recess|submuscular recess
5214914|NCT00765791|level 2b|level 2b
5214915|NCT00765778|resistant bacteria rehabilitation centers|resistant bacteria rehabilitation centers
5214916|NCT00765765|stage IV breast cancer|stage iv breast cancer
5214917|NCT00765765|recurrent breast cancer|recurrent breast cancer
5214918|NCT00765765|male breast cancer|male breast cancer
5214919|NCT00765752|Insomnia|insomnia
5214920|NCT00765752|depression|depression
5214921|NCT00765752|GABA|gaba
5214922|NCT00765752|magnetic resonance spectroscopy|magnetic resonance spectroscopy
5214923|NCT00765752|MRS|mrs
5214924|NCT00765752|Sleep|sleep
5214925|NCT00765752|antidepressant medication use|antidepressant medication use
5214926|NCT00765739|muscle fibers|muscle fibers
5214927|NCT00765739|aging|aging
5214928|NCT00765726|hemophilia|hemophilia
5214929|NCT00765726|hemophilia A|hemophilia a
5214930|NCT00765726|ReFacto|refacto
5214931|NCT00765726|Xyntha|xyntha
5214932|NCT00765726|moroctocog alfa|moroctocog alfa
5214933|NCT00765726|bleeding disorder|bleeding disorder
5214934|NCT00765713|Sleep apnea|sleep apnea
5214935|NCT00765713|CPAP|cpap
5214936|NCT00765713|Ventricular arrhythmias|ventricular arrhythmias
5214937|NCT00765713|Defibrillator therapies|defibrillator therapies
5214938|NCT00765700|Sprain|sprain
5214939|NCT00765700|Strain|strain
5214940|NCT00765700|Pain|pain
5214941|NCT00765700|Ankle Pain|ankle pain
5214942|NCT00765700|Shoulder Pain|shoulder pain
5214943|NCT00765700|Elbow Pain|elbow pain
5214944|NCT00765700|Tennis Elbow|tennis elbow
5214945|NCT00765700|Knee pain|knee pain
5214946|NCT00765700|Wrist Pain|wrist pain
5214947|NCT00765700|Hand Pain|hand pain
5214948|NCT00765700|Muscle, Bone and Cartilage Disorders|muscle, bone and cartilage disorders
5214949|NCT00765674|aliskiren|aliskiren
5214950|NCT00765674|antihypertensive|antihypertensive
5214951|NCT00765674|hypertension|hypertension
5214952|NCT00765674|renin inhibitor|renin inhibitor
5214953|NCT00765674|moderate-severe hypertension|moderate-severe hypertension
5214954|NCT00765661|Kidney|kidney
5214955|NCT00765661|Transplantation|transplantation
5214956|NCT00765661|Immunosuppression|immunosuppression
5214957|NCT00765661|Tacrolimus|tacrolimus
5214958|NCT00765661|Prograf|prograf
5214959|NCT00765648|hypertension|hypertension
5214960|NCT00765648|emergency department|emergency department
5214961|NCT00765648|Nicardipine|nicardipine
5214962|NCT00765648|Labetalol|labetalol
5214963|NCT00765648|hypertensive emergency|hypertensive emergency
5214964|NCT00765648|hypertensive urgency|hypertensive urgency
5214965|NCT00765635|complete occlusion of the ear canal due to cerumen|complete occlusion of the ear canal due to cerumen
5214966|NCT00765622|Urinary incontinence|urinary incontinence
5214967|NCT00765622|pelvic floor|pelvic floor
5214968|NCT00765622|functional evaluation|functional evaluation
5214969|NCT00765609|Paediatric|paediatric
5214970|NCT00765609|Analgesic|analgesic
5214971|NCT00765609|Prescribing|prescribing
5214972|NCT00765609|Parents|parents
5214973|NCT00765596|Obesity|obesity
5214974|NCT00765596|Insulin resistance|insulin resistance
5214975|NCT00765596|Gastric tube|gastric tube
5214976|NCT00765596|Ghrelin|ghrelin
5214977|NCT00765583|Wrinkles (Nasolabial Folds)|wrinkles (nasolabial folds)
5214978|NCT00765570|large tumors in the head & neck, lung, abdomen or pelvis|large tumors in the head & neck, lung, abdomen or pelvis
5214979|NCT00765557|To determine if laxative therapy can resolve Urge Syndrome, and if so, in which patients.|to determine if laxative therapy can resolve urge syndrome, and if so, in which patients.
5214980|NCT00765557|To determine usefulness of KUB, an abdominal X-ray of the kidneys, ureters, and bladder.|to determine usefulness of kub, an abdominal x-ray of the kidneys, ureters, and bladder.
5214981|NCT00765557|To predict the bowel activity of children with Urge Syndrome, who are most likely to respond to laxatives, with the use of the Bowel/Bladder questionnaire.|to predict the bowel activity of children with urge syndrome, who are most likely to respond to laxatives, with the use of the bowel/bladder questionnaire.
5214982|NCT00765544|MS|ms
5214983|NCT00765544|Rehabilitation|rehabilitation
5214984|NCT00765544|Treadmill|treadmill
5214985|NCT00765544|Robot|robot
5214986|NCT00765544|Foot-drop|foot-drop
5214987|NCT00765531|To determine the prevalence of genetic mutations in a population.|to determine the prevalence of genetic mutations in a population.
5214988|NCT00765531|To identify stone formers with significant family history of stones.|to identify stone formers with significant family history of stones.
5214989|NCT00765531|To follow a cohort of pediatric stone formers an their families to report the long-term recurrence rats and therapeutic outcomes.|to follow a cohort of pediatric stone formers an their families to report the long-term recurrence rats and therapeutic outcomes.
5214990|NCT00765518|Ischemic Dilated Cardiomyopathy|ischemic dilated cardiomyopathy
5214991|NCT00765518|Non-Ischemic Dilated Cardiomyopathy|non-ischemic dilated cardiomyopathy
5214992|NCT00765518|ixmyelocel-T|ixmyelocel-t
5214993|NCT00765505|Insulin Resistance|insulin resistance
5214994|NCT00765505|Obesity|obesity
5214995|NCT00765505|Exercise Training|exercise training
5214996|NCT00765505|Physical Activity|physical activity
5214997|NCT00765492|Phase I|phase i
5214998|NCT00765479|stage IIB prostate cancer|stage iib prostate cancer
5214999|NCT00765479|stage IIA prostate cancer|stage iia prostate cancer
5215000|NCT00765466|Explore the effect of AVR118 4.0 mL, given subcutaneously on appetite|explore the effect of avr118 4.0 ml, given subcutaneously on appetite
5215001|NCT00765453|Heart attack|heart attack
5215002|NCT00765453|Anterior Myocardial infarction (MI)|anterior myocardial infarction (mi)
5215003|NCT00765453|adult stem cells|adult stem cells
5215264|NCT00764153|Function|function
5215004|NCT00765453|bone marrow progenitor cells|bone marrow progenitor cells
5215005|NCT00765453|bone marrow stem cells|bone marrow stem cells
5215006|NCT00765453|autologous|autologous
5215007|NCT00765453|left ventricular function|left ventricular function
5215008|NCT00765453|intracoronary injection|intracoronary injection
5215009|NCT00765440|infection|infection
5215010|NCT00765440|malnutrition|malnutrition
5215011|NCT00765440|stage I adenoid cystic carcinoma of the oral cavity|stage i adenoid cystic carcinoma of the oral cavity
5215012|NCT00765440|stage I mucoepidermoid carcinoma of the oral cavity|stage i mucoepidermoid carcinoma of the oral cavity
5215013|NCT00765440|stage I verrucous carcinoma of the oral cavity|stage i verrucous carcinoma of the oral cavity
5215014|NCT00765440|stage II adenoid cystic carcinoma of the oral cavity|stage ii adenoid cystic carcinoma of the oral cavity
5215015|NCT00765440|stage II mucoepidermoid carcinoma of the oral cavity|stage ii mucoepidermoid carcinoma of the oral cavity
5215016|NCT00765440|stage II verrucous carcinoma of the oral cavity|stage ii verrucous carcinoma of the oral cavity
5215017|NCT00765440|stage III adenoid cystic carcinoma of the oral cavity|stage iii adenoid cystic carcinoma of the oral cavity
5215018|NCT00765440|stage III mucoepidermoid carcinoma of the oral cavity|stage iii mucoepidermoid carcinoma of the oral cavity
5215019|NCT00765440|stage III verrucous carcinoma of the oral cavity|stage iii verrucous carcinoma of the oral cavity
5215020|NCT00765440|stage IV adenoid cystic carcinoma of the oral cavity|stage iv adenoid cystic carcinoma of the oral cavity
5215021|NCT00765440|stage IV mucoepidermoid carcinoma of the oral cavity|stage iv mucoepidermoid carcinoma of the oral cavity
5215022|NCT00765440|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
5215023|NCT00765440|stage I squamous cell carcinoma of the larynx|stage i squamous cell carcinoma of the larynx
5215024|NCT00765440|stage I verrucous carcinoma of the larynx|stage i verrucous carcinoma of the larynx
5215025|NCT00765440|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
5215026|NCT00765440|stage II verrucous carcinoma of the larynx|stage ii verrucous carcinoma of the larynx
5215027|NCT00765440|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
5215028|NCT00765440|stage III verrucous carcinoma of the larynx|stage iii verrucous carcinoma of the larynx
5215029|NCT00765440|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5215030|NCT00765440|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
5215031|NCT00765440|stage I lymphoepithelioma of the oropharynx|stage i lymphoepithelioma of the oropharynx
5215032|NCT00765440|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
5215033|NCT00765440|stage II lymphoepithelioma of the oropharynx|stage ii lymphoepithelioma of the oropharynx
5215034|NCT00765440|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
5215035|NCT00765440|stage III lymphoepithelioma of the oropharynx|stage iii lymphoepithelioma of the oropharynx
5215036|NCT00765440|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
5215037|NCT00765440|stage IV lymphoepithelioma of the oropharynx|stage iv lymphoepithelioma of the oropharynx
5215038|NCT00765440|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5215039|NCT00765440|stage I squamous cell carcinoma of the hypopharynx|stage i squamous cell carcinoma of the hypopharynx
5215040|NCT00765440|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
5215041|NCT00765440|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
5215042|NCT00765440|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5215043|NCT00765440|tongue cancer|tongue cancer
5215044|NCT00765401|Abdominal Pain|abdominal pain
5215045|NCT00765401|Cystic Fibrosis|cystic fibrosis
5215046|NCT00765401|H. pylori|h. pylori
5215047|NCT00765401|Children|children
5215048|NCT00765388|urostomy, 1-piece, cross-over, randomised, preference|urostomy, 1-piece, cross-over, randomised, preference
5215049|NCT00765375|acne|acne
5215050|NCT00765375|Botox|botox
5215051|NCT00765375|cosmetic treatments|cosmetic treatments
5215052|NCT00765336|Spermatogenesis in Healthy Males|spermatogenesis in healthy males
5215053|NCT00765323|Octreotide|octreotide
5215054|NCT00765323|Sandostatin LAR|sandostatin lar
5215055|NCT00765323|Growth hormone|growth hormone
5215056|NCT00765323|IGF-1|igf-1
5215057|NCT00765310|atherosclerosis|atherosclerosis
5215058|NCT00765310|lipoic acid|lipoic acid
5215059|NCT00765310|thioctic acid|thioctic acid
5215060|NCT00765310|triglycerides|triglycerides
5215061|NCT00765310|overweight|overweight
5215062|NCT00765310|obesity|obesity
5215063|NCT00765310|oxidative stress|oxidative stress
5215064|NCT00765310|inflammation|inflammation
5215065|NCT00765297|fall risk|fall risk
5215066|NCT00765297|movement characteristics|movement characteristics
5215067|NCT00765297|stumble detection|stumble detection
5215068|NCT00765297|accelerometry|accelerometry
5215069|NCT00765284|HDL|hdl
5215070|NCT00765284|RCT|rct
5215071|NCT00765284|Cholesterol|cholesterol
5215072|NCT00765245|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
5215073|NCT00765245|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
5215074|NCT00765245|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5215075|NCT00765245|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5215076|NCT00765245|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5215077|NCT00765232|laparoscopic|laparoscopic
5215078|NCT00765232|donor|donor
5215079|NCT00765232|nephrectomy|nephrectomy
5215080|NCT00765219|Generalized Anxiety Disorder|generalized anxiety disorder
5215081|NCT00765219|Geriatric|geriatric
5215082|NCT00765180|colonoscopy|colonoscopy
5215083|NCT00765180|hood|hood
5215084|NCT00765180|NBI|nbi
5215085|NCT00765141|wound debridement|wound debridement
5215086|NCT00765141|removed orthopedic implants|removed orthopedic implants
5215087|NCT00765141|removed catheters or shunts|removed catheters or shunts
5215088|NCT00765141|excised tonsils|excised tonsils
5215089|NCT00765141|amputated tissue|amputated tissue
5215090|NCT00765141|sputum, stool|sputum, stool
5215091|NCT00765141|or other excretions.|or other excretions.
5215092|NCT00765128|Percutaneous|percutaneous
5215093|NCT00765128|Nephrolithotomy|nephrolithotomy
5215094|NCT00765128|Kidney stones|kidney stones
5215095|NCT00765102|Multiple Myelonoma|multiple myelonoma
5215096|NCT00765102|Romidepsin|romidepsin
5215097|NCT00765102|Bortezomib|bortezomib
5215098|NCT00765076|Vaccine|vaccine
5215099|NCT00765076|Elderly|elderly
5215100|NCT00765076|Influenza|influenza
5215101|NCT00765063|Diabetic Foot Ulcers Neuroischaemic|diabetic foot ulcers neuroischaemic
5215102|NCT00765050|Cellular therapy|cellular therapy
5215103|NCT00765050|CD133+|cd133+
5215104|NCT00765024|strongyloidiasis, ivermectin, albendazole|strongyloidiasis, ivermectin, albendazole
5215105|NCT00765011|Head and Neck Cancer|head and neck cancer
5215106|NCT00764998|Influenza|influenza
5215107|NCT00764998|HIV|hiv
5215108|NCT00764998|Influenza Vaccine|influenza vaccine
5215109|NCT00764998|Efficacy|efficacy
5215110|NCT00764985|Syncope|syncope
5215111|NCT00764985|Pre-Syncope|pre-syncope
5215112|NCT00764985|Fainting|fainting
5215231|NCT00764270|inflammation|inflammation
5215232|NCT00764244|Diabetes|diabetes
5215113|NCT00764972|To evaluate the use of sorafenib added to vinorelbine chemotherapy, to find out which are the doses of two drugs can be safely combined|to evaluate the use of sorafenib added to vinorelbine chemotherapy, to find out which are the doses of two drugs can be safely combined
5215114|NCT00764933|information programme|information programme
5215115|NCT00764933|anxiety reduction|anxiety reduction
5215116|NCT00764933|multicenter trial|multicenter trial
5215117|NCT00764933|intensive care|intensive care
5215118|NCT00764933|critical care|critical care
5215119|NCT00764920|human skin|human skin
5215120|NCT00764907|T-cell childhood acute lymphoblastic leukemia|t-cell childhood acute lymphoblastic leukemia
5215121|NCT00764907|B-cell childhood acute lymphoblastic leukemia|b-cell childhood acute lymphoblastic leukemia
5215122|NCT00764907|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
5215123|NCT00764881|Oral contraceptive|oral contraceptive
5215124|NCT00764881|Sexual dysfunction|sexual dysfunction
5215125|NCT00764881|Libido|libido
5215126|NCT00764829|hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
5215127|NCT00764829|fludarabine|fludarabine
5215128|NCT00764829|mycophenolate mofetil|mycophenolate mofetil
5215129|NCT00764829|mycophenolic acid|mycophenolic acid
5215130|NCT00764829|biomarkers|biomarkers
5215131|NCT00764816|Chronic kidney disease, stages 3 and 4|chronic kidney disease, stages 3 and 4
5215132|NCT00764816|phosphaturia|phosphaturia
5215133|NCT00764816|phosphorus|phosphorus
5215134|NCT00764816|PTH|pth
5215135|NCT00764816|FGF23|fgf23
5215136|NCT00764816|Dietary protein source|dietary protein source
5215137|NCT00764777|Peripheral Vascular Disease|peripheral vascular disease
5215138|NCT00764777|Intermittent Claudication|intermittent claudication
5215139|NCT00764777|Critical limb Ischemia|critical limb ischemia
5215140|NCT00764777|TASC A|tasc a
5215141|NCT00764777|TASC B|tasc b
5215142|NCT00764777|TASC C|tasc c
5215143|NCT00764777|TASC D|tasc d
5215144|NCT00764777|balloon-expandable stent|balloon-expandable stent
5215145|NCT00764777|Self-expanding stent|self-expanding stent
5215146|NCT00764777|TASC|tasc
5215147|NCT00764764|shoulder pain|shoulder pain
5215148|NCT00764764|rotator cuff|rotator cuff
5215149|NCT00764764|impingement|impingement
5215150|NCT00764764|cervical referred pain|cervical referred pain
5215151|NCT00764764|neural tension|neural tension
5215152|NCT00764738|ARMD|armd
5215153|NCT00764738|AMD|amd
5215154|NCT00764738|exudative AMD|exudative amd
5215155|NCT00764712|Tight glycemia control|tight glycemia control
5215156|NCT00764712|cardiac surgery patients|cardiac surgery patients
5215157|NCT00764699|poor growth|poor growth
5215158|NCT00764699|inflammatory bowel disease|inflammatory bowel disease
5215159|NCT00764686|Exercise|exercise
5215160|NCT00764686|Education|education
5215161|NCT00764686|Hydrotherapy|hydrotherapy
5215162|NCT00764686|Physical Therapy Modalities|physical therapy modalities
5215163|NCT00764647|family caregivers|family caregivers
5215164|NCT00764647|caregiver education|caregiver education
5215165|NCT00764647|caregiver burden|caregiver burden
5215166|NCT00764647|caregiver hardiness|caregiver hardiness
5215167|NCT00764647|caregiver depressive symptoms|caregiver depressive symptoms
5215168|NCT00764621|Gadolinium ethoxybenzyl DTPA|gadolinium ethoxybenzyl dtpa
5215169|NCT00764621|Contrast media|contrast media
5215170|NCT00764621|Outcome Assessment (Health Care)|outcome assessment (health care)
5215171|NCT00764621|Magnetic Resonance Imaging|magnetic resonance imaging
5215172|NCT00764621|Tomography, X-Ray Computed|tomography, x-ray computed
5215173|NCT00764621|Liver|liver
5215174|NCT00764595|gastrointestinal stromal tumor|gastrointestinal stromal tumor
5215175|NCT00764595|liver metastases|liver metastases
5215176|NCT00764582|Corneal penetration of levofloxacin and moxifloxacin|corneal penetration of levofloxacin and moxifloxacin
5215177|NCT00764569|oral tissue|oral tissue
5215178|NCT00764556|Glucose|glucose
5215179|NCT00764556|Insulin|insulin
5215180|NCT00764556|COPD|copd
5215181|NCT00764556|Exacerbations|exacerbations
5215182|NCT00764556|Tight glycaemic control|tight glycaemic control
5215183|NCT00764556|Acute hospital ward|acute hospital ward
5215184|NCT00764543|To measure 24-hour ambulatory blood pressure in children who have unilateral hydronephrosis or multicystic-dysplastic kidneys|to measure 24-hour ambulatory blood pressure in children who have unilateral hydronephrosis or multicystic-dysplastic kidneys
5215185|NCT00764543|To compare these blood pressure measurements between the children who require surgical correction and those who do not need surgical correction.|to compare these blood pressure measurements between the children who require surgical correction and those who do not need surgical correction.
5215186|NCT00764465|Healthy Subjects|healthy subjects
5215187|NCT00764465|Pharmacokinetics study|pharmacokinetics study
5215188|NCT00764465|Pharmacokinetics of medications|pharmacokinetics of medications
5215189|NCT00764426|alcoholic beverages|alcoholic beverages
5215190|NCT00764426|non-alcoholic beverages|non-alcoholic beverages
5215191|NCT00764426|inflammation|inflammation
5215192|NCT00764426|Serum concentration of inflammatory markers before and after intervention|serum concentration of inflammatory markers before and after intervention
5215193|NCT00764413|EDSS|edss
5215194|NCT00764413|methylprednisolone|methylprednisolone
5215195|NCT00764413|circadian rhythms|circadian rhythms
5215196|NCT00764413|MSFC|msfc
5215197|NCT00764400|aphasia|aphasia
5215198|NCT00764400|anomia|anomia
5215199|NCT00764400|speech therapy|speech therapy
5215200|NCT00764400|rehabilitation|rehabilitation
5215201|NCT00764387|Neoplastic CNS lesions|neoplastic cns lesions
5215202|NCT00764387|Contrast enhanced MRI|contrast enhanced mri
5215203|NCT00764387|Comparison|comparison
5215204|NCT00764374|YM443|ym443
5215205|NCT00764374|Z-338|z-338
5215206|NCT00764374|Acotiamide|acotiamide
5215207|NCT00764374|Rome III|rome iii
5215208|NCT00764374|Signs and symptoms, digestive|signs and symptoms, digestive
5215209|NCT00764361|Diabetic|diabetic
5215210|NCT00764361|Ulcer|ulcer
5215211|NCT00764361|Wound|wound
5215212|NCT00764348|Acute and Chronic Wounds|acute and chronic wounds
5215213|NCT00764322|menopausal symptoms|menopausal symptoms
5215214|NCT00764322|recurrent breast cancer|recurrent breast cancer
5215215|NCT00764322|stage I breast cancer|stage i breast cancer
5215216|NCT00764322|stage II breast cancer|stage ii breast cancer
5215217|NCT00764322|stage IIIA breast cancer|stage iiia breast cancer
5215218|NCT00764322|stage IIIB breast cancer|stage iiib breast cancer
5215219|NCT00764322|stage IIIC breast cancer|stage iiic breast cancer
5215220|NCT00764322|stage IV breast cancer|stage iv breast cancer
5215221|NCT00764322|ductal breast carcinoma in situ|ductal breast carcinoma in situ
5215222|NCT00764322|breast cancer in situ|breast cancer in situ
5215223|NCT00764296|acute wounds and chronic wounds|acute wounds and chronic wounds
5215224|NCT00764270|atherosclerosis|atherosclerosis
5215225|NCT00764270|lipoic acid|lipoic acid
5215226|NCT00764270|thioctic acid|thioctic acid
5215227|NCT00764270|triglycerides|triglycerides
5215228|NCT00764270|overweight|overweight
5215229|NCT00764270|obesity|obesity
5215230|NCT00764270|oxidative stress|oxidative stress
5215233|NCT00764244|Macular edema|macular edema
5215234|NCT00764244|Optical Coherence tomography|optical coherence tomography
5215235|NCT00764244|VitrectomyLaser therapy|vitrectomylaser therapy
5215236|NCT00764244|Intravitreal triamcinolone injection|intravitreal triamcinolone injection
5215237|NCT00764231|acute myeloid leukemia|acute myeloid leukemia
5215238|NCT00764231|exercise|exercise
5215239|NCT00764231|fatigue|fatigue
5215240|NCT00764231|quality of life|quality of life
5215241|NCT00764231|home-based|home-based
5215242|NCT00764231|AML|aml
5215243|NCT00764218|Obstructive sleep apnea syndrome|obstructive sleep apnea syndrome
5215244|NCT00764218|Hypertension|hypertension
5215245|NCT00764218|Cardiovascular phenotype|cardiovascular phenotype
5215246|NCT00764205|ACS|acs
5215247|NCT00764205|non STEMI|non stemi
5215248|NCT00764205|ECG troponin|ecg troponin
5215249|NCT00764205|iSTAT|istat
5215250|NCT00764205|Acute coronary syndrome without ST-segment elevation|acute coronary syndrome without st-segment elevation
5215251|NCT00764192|hemodialysis|hemodialysis
5215252|NCT00764192|Flow-mediated dilation|flow-mediated dilation
5215253|NCT00764192|nictric oxide|nictric oxide
5215254|NCT00764192|endothelial function|endothelial function
5215255|NCT00764179|Neonates with intra-uterine growth delay|neonates with intra-uterine growth delay
5215256|NCT00764166|PSA (biochemical)|psa (biochemical)
5215257|NCT00764166|Progression- free Survival|progression- free survival
5215258|NCT00764166|Clinical progress|clinical progress
5215259|NCT00764166|Overall survival|overall survival
5215260|NCT00764166|Tolerance to the treatment|tolerance to the treatment
5215261|NCT00764166|Quality of Live|quality of live
5215262|NCT00764153|Displaced Femoral Neck Fractures|displaced femoral neck fractures
5215263|NCT00764153|Treatment|treatment
5215265|NCT00764153|Pain|pain
5215266|NCT00764153|Quality of life|quality of life
5215267|NCT00764153|Complications|complications
5215268|NCT00764153|Reoperations|reoperations
5215269|NCT00764153|Internal Fixation|internal fixation
5215270|NCT00764153|Hemiarthroplasty|hemiarthroplasty
5215271|NCT00764153|Activities of Daily Living|activities of daily living
5215272|NCT00764140|tumor growth factor|tumor growth factor
5215273|NCT00764127|adolescent|adolescent
5215274|NCT00764127|obesity|obesity
5215275|NCT00764127|bariatric surgery|bariatric surgery
5215276|NCT00764127|eating|eating
5215277|NCT00764114|Spondylodiscitis|spondylodiscitis
5215278|NCT00764114|Duration treatment|duration treatment
5215279|NCT00764114|Antibiotic|antibiotic
5215280|NCT00764114|men or women more than 18 years|men or women more than 18 years
5215281|NCT00764114|proved bacterial spondylodiscitis|proved bacterial spondylodiscitis
5215282|NCT00764114|patient for which is decided a treatment antibiotic|patient for which is decided a treatment antibiotic
5215283|NCT00764114|the diagnosis on clinical|the diagnosis on clinical
5215284|NCT00764114|Radiological|radiological
5215285|NCT00764114|microbiological criteria|microbiological criteria
5215286|NCT00764088|full Thickness wounds|full thickness wounds
5215287|NCT00764075|heart failure; EF<35%; NYHA II, III or IV|heart failure; ef<35%; nyha ii, iii or iv
5215288|NCT00764062|Amoxicillin|amoxicillin
5215289|NCT00764062|Drug resistance, microbial|drug resistance, microbial
5215290|NCT00764062|Streptococcus|streptococcus
5215291|NCT00764062|Surgery, oral|surgery, oral
5215292|NCT00764049|Albumin dialysis|albumin dialysis
5215293|NCT00764049|Artificial liver support|artificial liver support
5215294|NCT00764049|Acute on chronic liver failure|acute on chronic liver failure
5215295|NCT00764036|phase I|phase i
5215296|NCT00764036|safety|safety
5215297|NCT00764023|wound debridement|wound debridement
5215298|NCT00764023|removed orthopedic implants|removed orthopedic implants
5215299|NCT00764023|removed catheters or shunts|removed catheters or shunts
5215300|NCT00764023|excised tonsils, amputated tissue|excised tonsils, amputated tissue
5215301|NCT00764023|sputum|sputum
5215302|NCT00764023|stool|stool
5215303|NCT00764023|other excretions.|other excretions.
5215304|NCT00763997|dipyrone|dipyrone
5215305|NCT00763997|platelet aggregation|platelet aggregation
5215306|NCT00763997|neuraxial blockage|neuraxial blockage
5215307|NCT00763997|ibuprofen|ibuprofen
5215308|NCT00763997|platelet aggregation under dipyrone compared to ibuprofen, acetaminophen and parecoxib/valdecoxib|platelet aggregation under dipyrone compared to ibuprofen, acetaminophen and parecoxib/valdecoxib
5215309|NCT00763997|neuraxial blockage in patients receiving ibuprofen is critical in special circumstances, but traditionally not fpr dipyrone|neuraxial blockage in patients receiving ibuprofen is critical in special circumstances, but traditionally not fpr dipyrone
5215310|NCT00763984|Bladder Control for Women|bladder control for women
5215311|NCT00763984|Exercising Your Pelvic Muscles|exercising your pelvic muscles
5215312|NCT00763984|Kegel Exercises: How to Strengthen Pelvic Floor Muscles|kegel exercises: how to strengthen pelvic floor muscles
5215313|NCT00763984|Kegel Exercises for Your Pelvic Muscles|kegel exercises for your pelvic muscles
5215314|NCT00763984|Pelvic Floor Disorders|pelvic floor disorders
5215315|NCT00763984|Pelvic Support Problems|pelvic support problems
5215316|NCT00763984|Pregnancy|pregnancy
5215317|NCT00763984|Pregnancy Childbirth and Bladder Control|pregnancy childbirth and bladder control
5215318|NCT00763984|Urinary Incontinence|urinary incontinence
5215319|NCT00763984|Urinary Incontinence: Embarrassing but Treatable|urinary incontinence: embarrassing but treatable
5215320|NCT00763958|opiates|opiates
5215321|NCT00763958|HIV|hiv
5215322|NCT00763945|Acute coronary Syndrome|acute coronary syndrome
5215323|NCT00763945|STEMI|stemi
5215324|NCT00763945|NSTEMI|nstemi
5215325|NCT00763945|Registry|registry
5215326|NCT00763919|Patient Non-Adherence|patient non-adherence
5215327|NCT00763919|Patient Non-Compliance|patient non-compliance
5215328|NCT00763919|Patient Nonadherence|patient nonadherence
5215329|NCT00763919|Patient Noncompliance|patient noncompliance
5215330|NCT00763919|Patient Refusal of Treatment|patient refusal of treatment
5215331|NCT00763919|Refusal of Treatment|refusal of treatment
5215332|NCT00763919|Treatment Refusal|treatment refusal
5215333|NCT00763906|septic shock|septic shock
5215334|NCT00763906|fuzzy logic|fuzzy logic
5215335|NCT00763906|norepinephrine weaning|norepinephrine weaning
5215336|NCT00763893|Marfan syndrome|marfan syndrome
5215337|NCT00763893|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers
5215338|NCT00763893|Aortic Aneurysm, Thoracic|aortic aneurysm, thoracic
5215339|NCT00763880|Hematoma block|hematoma block
5215340|NCT00763880|Lidocaine|lidocaine
5215341|NCT00763880|Forearm fracture|forearm fracture
5215342|NCT00763880|Radius fracture|radius fracture
5215343|NCT00763880|Ulna fracture|ulna fracture
5215344|NCT00763880|Ketamine|ketamine
5215345|NCT00763880|Midazolam|midazolam
5215346|NCT00763880|Procedural sedation|procedural sedation
5215347|NCT00763867|Heart Failure, Diastolic|heart failure, diastolic
5215348|NCT00763867|Decompensated Heart Failure|decompensated heart failure
5215349|NCT00763867|Sildenafil|sildenafil
5215350|NCT00763867|Exercise Capacity|exercise capacity
5215351|NCT00763841|Auditory hallucinations|auditory hallucinations
5215352|NCT00763828|Myocardial Infarction|myocardial infarction
5215353|NCT00763828|Hypothermia, Induced|hypothermia, induced
5215354|NCT00763815|hyperglycemia GLP-1 pioglitazone|hyperglycemia glp-1 pioglitazone
5215355|NCT00763789|conscious sedation|conscious sedation
5215356|NCT00763789|remifentanil|remifentanil
5215357|NCT00763789|hysteroscopic surgery|hysteroscopic surgery
5215358|NCT00763789|anesthesia recovery period|anesthesia recovery period
5215359|NCT00763789|ambulatory surgery|ambulatory surgery
5215360|NCT00763789|patient satisfaction|patient satisfaction
5215361|NCT00763789|length of stay|length of stay
5215362|NCT00763776|Liver cirrhosis|liver cirrhosis
5215363|NCT00763776|Hepatectomy|hepatectomy
5215364|NCT00763776|Liver parenchyma transection|liver parenchyma transection
5215365|NCT00763776|Randomized controlled trial|randomized controlled trial
5215366|NCT00763763|Imatinib mesylate|imatinib mesylate
5215367|NCT00763763|Combination therapy|combination therapy
5215368|NCT00763763|Leukemia, Lymphocytic, Acute|leukemia, lymphocytic, acute
5215369|NCT00763763|Philadelphia Chromosome|philadelphia chromosome
5215370|NCT00763763|Blast Crisis|blast crisis
5215371|NCT00763763|Leukemia, Myeloid, Chronic|leukemia, myeloid, chronic
5215372|NCT00763750|glioblastoma multiforme or anaplastic glioma|glioblastoma multiforme or anaplastic glioma
5215373|NCT00763737|congenital diaphragmatic hernia|congenital diaphragmatic hernia
5215374|NCT00763737|fetal surgery|fetal surgery
5215375|NCT00763737|pulmonary hypoplasia|pulmonary hypoplasia
5215376|NCT00763737|observed/expected lung to head ratio|observed/expected lung to head ratio
5215377|NCT00763737|liver position|liver position
5215379|NCT00763737|fetoscopic endoluminal tracheal occlusion|fetoscopic endoluminal tracheal occlusion
5215380|NCT00763737|standardized neonatal care|standardized neonatal care
5215381|NCT00763711|Urinary Incontinence|urinary incontinence
5215382|NCT00763711|ISD|isd
5215383|NCT00763698|Left heart pacing lead|left heart pacing lead
5215384|NCT00763698|Cardiac resynchronization therapy (CRT)|cardiac resynchronization therapy (crt)
5215385|NCT00763698|Heart failure|heart failure
5215386|NCT00763698|ICD|icd
5215387|NCT00763685|preoperative pain prophylaxis|preoperative pain prophylaxis
5215388|NCT00763685|postoperative pain|postoperative pain
5215389|NCT00763672|Preeclampsia|preeclampsia
5215390|NCT00763672|Hypertension|hypertension
5215391|NCT00763672|Intra uterine growth retardation|intra uterine growth retardation
5215392|NCT00763672|Antiangiogenic factor|antiangiogenic factor
5215393|NCT00763672|Prevention|prevention
5215394|NCT00763646|Gastric or Gastroesophageal Junction Adenocarcinoma|gastric or gastroesophageal junction adenocarcinoma
5215395|NCT00763633|nausea|nausea
5215396|NCT00763633|vomiting|vomiting
5215397|NCT00763633|pregnancy|pregnancy
5215398|NCT00763633|B6|b6
5215399|NCT00763620|Community acquired pneumonia|community acquired pneumonia
5215400|NCT00763620|Nosocomial pneumonia|nosocomial pneumonia
5215401|NCT00763620|Mini bronchoalveolar lavage|mini bronchoalveolar lavage
5215402|NCT00763620|Endotracheal aspirates|endotracheal aspirates
5215403|NCT00763620|Expectorated sputum|expectorated sputum
5215404|NCT00763607|non small cell lung cancer patients|non small cell lung cancer patients
5215405|NCT00763594|Major Depression|major depression
5215406|NCT00763594|Interpersonal Psychotherapy|interpersonal psychotherapy
5215407|NCT00763594|Brief Relational Therapy|brief relational therapy
5215408|NCT00763594|Outcome research|outcome research
5215409|NCT00763581|Patient Non-Adherence|patient non-adherence
5215410|NCT00763581|Patient Non-Compliance|patient non-compliance
5215411|NCT00763581|Patient Nonadherence|patient nonadherence
5215412|NCT00763581|Patient Noncompliance|patient noncompliance
5215413|NCT00763581|Patient Refusal of Treatment|patient refusal of treatment
5215414|NCT00763581|Treatment Refusal|treatment refusal
5215415|NCT00763581|Refusal of Treatment|refusal of treatment
5215416|NCT00763568|Chronic hepatitis C|chronic hepatitis c
5215417|NCT00763568|Viral hepatitis|viral hepatitis
5215418|NCT00763555|psoriasis|psoriasis
5215419|NCT00763555|spray|spray
5215420|NCT00763555|calcitriol|calcitriol
5215421|NCT00763516|Pancreatic Cancer|pancreatic cancer
5215422|NCT00763516|Proton radiation|proton radiation
5215423|NCT00763516|Chemotherapy|chemotherapy
5215424|NCT00763516|Xeloda|xeloda
5215425|NCT00763516|Gemzar|gemzar
5215426|NCT00763516|Resectable|resectable
5215427|NCT00763516|Surgery|surgery
5215428|NCT00763503|psoriasis|psoriasis
5215429|NCT00763503|PK|pk
5215430|NCT00763503|calcitriol|calcitriol
5215431|NCT00763490|umbilical cord blood|umbilical cord blood
5215432|NCT00763490|stem cell transplant|stem cell transplant
5215433|NCT00763490|leukemia|leukemia
5215434|NCT00763490|multiple myeloma|multiple myeloma
5215435|NCT00763490|lymphoma|lymphoma
5215436|NCT00763477|Cystic fibrosis|cystic fibrosis
5215437|NCT00763477|Weight|weight
5215438|NCT00763477|Appetite|appetite
5215439|NCT00763477|Ghrelin|ghrelin
5215440|NCT00763477|Cystic fibrosis with low BMI|cystic fibrosis with low bmi
5215441|NCT00763464|Coronary Artery Disease|coronary artery disease
5215442|NCT00763464|ischemia diagnostic|ischemia diagnostic
5215443|NCT00763451|hyperglycemia, GLP-1|hyperglycemia, glp-1
5215444|NCT00763438|Schizophrenia|schizophrenia
5215445|NCT00763438|Sertindole|sertindole
5215446|NCT00763438|Safety study|safety study
5215447|NCT00763425|polypectomy|polypectomy
5215448|NCT00763425|colonic polyp|colonic polyp
5215449|NCT00763425|colorectal polyp|colorectal polyp
5215450|NCT00763425|colorectal cancer prevention|colorectal cancer prevention
5215451|NCT00763412|Cystic Fibrosis|cystic fibrosis
5215452|NCT00763412|Diabetes|diabetes
5215453|NCT00763412|Cystic Fibrosis Related Diabetes|cystic fibrosis related diabetes
5215454|NCT00763412|Pre-diabetes|pre-diabetes
5215455|NCT00763412|oral hypoglycemic agents|oral hypoglycemic agents
5215456|NCT00763412|Repaglinide|repaglinide
5215457|NCT00763412|treatment|treatment
5215458|NCT00763412|inflammatory markers|inflammatory markers
5215459|NCT00763412|Lung function|lung function
5215460|NCT00763412|nutrition|nutrition
5215461|NCT00763399|probiotics|probiotics
5215462|NCT00763386|Total Knee Arthroplasty|total knee arthroplasty
5215463|NCT00763386|Osteoarthritis|osteoarthritis
5215464|NCT00763386|Knee|knee
5215465|NCT00763373|Lower respiratory infection|lower respiratory infection
5215466|NCT00763373|Upper respiratory infection|upper respiratory infection
5215467|NCT00763373|Urinary tract infection|urinary tract infection
5215468|NCT00763373|Soft tissue infection|soft tissue infection
5215469|NCT00763373|Hepatobiliary infection|hepatobiliary infection
5215470|NCT00763360|Cataract|cataract
5215471|NCT00763347|Glucose Metabolism Disorder|glucose metabolism disorder
5215472|NCT00763347|Dysmetabolic Syndrome|dysmetabolic syndrome
5215473|NCT00763347|Type II Diabetes|type ii diabetes
5215474|NCT00763347|Diabetes Mellitus, Lipoatrophic|diabetes mellitus, lipoatrophic
5215475|NCT00763347|Dyslipidemia|dyslipidemia
5215476|NCT00763347|Drug Therapy|drug therapy
5215477|NCT00763321|Effect on sleep interference by pain|effect on sleep interference by pain
5215478|NCT00763308|Weight|weight
5215479|NCT00763308|Blood Pressure|blood pressure
5215480|NCT00763308|Smoking Status|smoking status
5215481|NCT00763308|Cardiovascular Risk Profile|cardiovascular risk profile
5215482|NCT00763295|latent tuberculosis|latent tuberculosis
5215483|NCT00763295|HIV|hiv
5215484|NCT00763295|IFN-γ based assay|ifn-γ based assay
5215485|NCT00763282|Spinal cord injuries|spinal cord injuries
5215486|NCT00763282|Pressure ulcers|pressure ulcers
5215487|NCT00763282|Health behavior|health behavior
5215488|NCT00763282|self management|self management
5215489|NCT00763282|Rehabilitation|rehabilitation
5215490|NCT00763282|Outcome assessment|outcome assessment
5215491|NCT00763282|QUERI|queri
5215492|NCT00763282|Veterans|veterans
5215493|NCT00763243|profound bilateral hearing loss with cochlear implants|profound bilateral hearing loss with cochlear implants
5215494|NCT00763230|Depression|depression
5215495|NCT00763230|Treatment|treatment
5215496|NCT00763230|Transcranial direct current stimulation|transcranial direct current stimulation
5215497|NCT00763217|inflammation|inflammation
5215498|NCT00763217|coagulation|coagulation
5215499|NCT00763217|neuroprotection|neuroprotection
5215500|NCT00763217|drugs|drugs
5215501|NCT00763217|clinical neurology|clinical neurology
5215502|NCT00763217|pharmacology|pharmacology
5215503|NCT00763217|biological factors|biological factors
5215504|NCT00763204|Plaque Type Psoriasis|plaque type psoriasis
5215505|NCT00763204|Topical|topical
5215506|NCT00763178|PTSD|ptsd
5215507|NCT00763152|prostate|prostate
5215508|NCT00763152|prostate bed|prostate bed
5215509|NCT00763152|periprostatic|periprostatic
5215510|NCT00763139|RA|ra
5215511|NCT00763139|Rheumatoid Arthritis|rheumatoid arthritis
5215512|NCT00763126|parturient|parturient
5215513|NCT00763126|epidural analgesia|epidural analgesia
5215514|NCT00763126|labor|labor
5215515|NCT00763126|spouse|spouse
5215516|NCT00763126|Stress levels|stress levels
5215517|NCT00763126|Salivary amylase|salivary amylase
5215518|NCT00763100|Breast cancer|breast cancer
5215519|NCT00763100|Three dimensional versus two dimensional|three dimensional versus two dimensional
5215520|NCT00763100|Breast cancer surveillance|breast cancer surveillance
5215521|NCT00763100|Tomosynthesis|tomosynthesis
5215522|NCT00763087|diabetes mellitus|diabetes mellitus
5215523|NCT00763087|peripheral neuropathy|peripheral neuropathy
5215524|NCT00763087|exercise|exercise
5215525|NCT00763074|Intra-Abdominal Fat|intra-abdominal fat
5215526|NCT00763074|Adipokines|adipokines
5215527|NCT00763074|Exercise|exercise
5215528|NCT00763074|Diet therapy|diet therapy
5215529|NCT00763061|Glaucoma|glaucoma
5215530|NCT00763035|Coronary Artery Disease|coronary artery disease
5215531|NCT00763035|Coronary Vessels|coronary vessels
5215532|NCT00763035|Myocardial Ischemia|myocardial ischemia
5215533|NCT00763035|Coronary Disease|coronary disease
5215534|NCT00763035|Ischemic heart disease|ischemic heart disease
5215535|NCT00763035|asthma|asthma
5215536|NCT00763035|copd|copd
5215537|NCT00763022|Glucose Metabolism Disorder|glucose metabolism disorder
5215538|NCT00763022|Dysmetabolic Syndrome|dysmetabolic syndrome
5215539|NCT00763022|Type II Diabetes|type ii diabetes
5215540|NCT00763022|Diabetes Mellitus, Lipoatrophic|diabetes mellitus, lipoatrophic
5215541|NCT00763022|Dyslipidemia|dyslipidemia
5215542|NCT00763022|Drug Therapy|drug therapy
5215543|NCT00762957|Glucose Metabolism Disorder|glucose metabolism disorder
5215544|NCT00762957|Dysmetabolic Syndrome|dysmetabolic syndrome
5215545|NCT00762957|Type II Diabetes|type ii diabetes
5215546|NCT00762957|Diabetes Mellitus, Lipoatrophic|diabetes mellitus, lipoatrophic
5215547|NCT00762957|Dyslipidemia|dyslipidemia
5215548|NCT00762957|Drug Therapy|drug therapy
5215549|NCT00762944|Patients requiring total joint reconstruction due to:|patients requiring total joint reconstruction due to:
5215550|NCT00762944|Arthritis (osteo-, rheumatoid, traumatic) malignancy|arthritis (osteo-, rheumatoid, traumatic) malignancy
5215551|NCT00762944|Ankylosis functional deformity|ankylosis functional deformity
5215552|NCT00762944|Avascular necrosis revisions|avascular necrosis revisions
5215553|NCT00762944|Benign neoplasms fracture|benign neoplasms fracture
5215554|NCT00762944|Multiple operated joints|multiple operated joints
5215555|NCT00762931|bronchoconstriction|bronchoconstriction
5215556|NCT00762931|neuromodulation|neuromodulation
5215557|NCT00762931|neurostimulation|neurostimulation
5215558|NCT00762931|vagus nerve stimulation|vagus nerve stimulation
5215559|NCT00762931|vagal nerve stimulation|vagal nerve stimulation
5215560|NCT00762931|nVNS|nvns
5215561|NCT00762931|VNS|vns
5215562|NCT00762931|non invasive|non invasive
5215563|NCT00762931|gammacore|gammacore
5215564|NCT00762918|cystic fibrosis|cystic fibrosis
5215565|NCT00762918|vitamin d|vitamin d
5215566|NCT00762918|inflammation|inflammation
5215567|NCT00762905|cyanoacrylate|cyanoacrylate
5215568|NCT00762905|LiquiBand Laparoscopic|liquiband laparoscopic
5215569|NCT00762905|Dermabond|dermabond
5215570|NCT00762905|The rate of complete dermal apposition|the rate of complete dermal apposition
5215571|NCT00762905|The rate of wound infections and wound dehiscence|the rate of wound infections and wound dehiscence
5215572|NCT00762905|The rate of optimal cosmesis|the rate of optimal cosmesis
5215573|NCT00762892|Raltegravir|raltegravir
5215574|NCT00762892|Integrase inhibitor|integrase inhibitor
5215575|NCT00762892|Protease inhibitor|protease inhibitor
5215576|NCT00762892|Naive patients|naive patients
5215577|NCT00762892|HIV disease|hiv disease
5215578|NCT00762892|Lipids|lipids
5215579|NCT00762892|Treatment Naïve|treatment naïve
5215580|NCT00762879|Juvenile Idiopathic Arthritis|juvenile idiopathic arthritis
5215581|NCT00762879|JIA|jia
5215582|NCT00762879|Arthritis|arthritis
5215583|NCT00762879|Osteoporosis|osteoporosis
5215584|NCT00762879|Osteoporosis in Children|osteoporosis in children
5215585|NCT00762866|Major Depressive Disorder|major depressive disorder
5215586|NCT00762866|Depression|depression
5215587|NCT00762866|Bipolar I Disorder|bipolar i disorder
5215588|NCT00762866|Bipolar II Disorder|bipolar ii disorder
5215589|NCT00762866|Bipolar Disorder NOS|bipolar disorder nos
5215590|NCT00762866|Psychotic Disorder|psychotic disorder
5215591|NCT00762866|Schizophrenia|schizophrenia
5215592|NCT00762866|Schizoaffective Disorder|schizoaffective disorder
5215593|NCT00762840|Periapical lesions|periapical lesions
5215594|NCT00762840|Apical Periodontitis|apical periodontitis
5215595|NCT00762840|endodontic procedure|endodontic procedure
5215596|NCT00762840|root canal treatment|root canal treatment
5215597|NCT00762814|Parkinson disease|parkinson disease
5215598|NCT00762814|Individuals|individuals
5215599|NCT00762814|frequent|frequent
5215600|NCT00762814|freezing|freezing
5215601|NCT00762814|during|during
5215602|NCT00762814|gait|gait
5215603|NCT00762801|RLIP76|rlip76
5215604|NCT00762801|Cancer|cancer
5215605|NCT00762801|apoptosis|apoptosis
5215606|NCT00762775|Bone resorption|bone resorption
5215607|NCT00762775|Calcium homeostasis|calcium homeostasis
5215608|NCT00762775|Bone markers|bone markers
5215609|NCT00762775|Calcium and Vitamin D supplementation|calcium and vitamin d supplementation
5215610|NCT00762775|Parathyroid hormone levels|parathyroid hormone levels
5215611|NCT00762775|Interaction between calcium and vitamin D supplementation|interaction between calcium and vitamin d supplementation
5215612|NCT00762736|Glucose Metabolism Disorder|glucose metabolism disorder
5215613|NCT00762736|Dysmetabolic Syndrome|dysmetabolic syndrome
5215614|NCT00762736|Type II Diabetes|type ii diabetes
5215615|NCT00762736|Diabetes Mellitus, Lipoatrophic|diabetes mellitus, lipoatrophic
5215616|NCT00762736|Dyslipidemia|dyslipidemia
5215617|NCT00762736|Drug Therapy|drug therapy
5215618|NCT00762723|Degenerative Disc Disease|degenerative disc disease
5215619|NCT00762723|Spinal Stenosis|spinal stenosis
5215620|NCT00762723|Spondylolisthesis|spondylolisthesis
5215621|NCT00762723|ALIF|alif
5215622|NCT00762723|fusion success|fusion success
5215623|NCT00762723|Anterior Lumbar Plate|anterior lumbar plate
5215624|NCT00762723|fixed versus variable screw configurations|fixed versus variable screw configurations
5215625|NCT00762723|Anterior Lumbar Interbody Fusion to treat spinal instability|anterior lumbar interbody fusion to treat spinal instability
5215626|NCT00762710|Alcohol|alcohol
5215627|NCT00762710|Abuse|abuse
5215628|NCT00762710|Use|use
5215629|NCT00762710|Disorder|disorder
5215630|NCT00762710|Dependence|dependence
5215631|NCT00762710|Symptoms|symptoms
5215632|NCT00762710|Alcoholic|alcoholic
5215633|NCT00762710|Alcoholism|alcoholism
5215634|NCT00762710|Prazosin|prazosin
5215635|NCT00762710|Drug|drug
5215636|NCT00762710|Medicine|medicine
5215637|NCT00762710|Medication|medication
5215638|NCT00762710|Treatment|treatment
5215639|NCT00762710|Study|study
5215640|NCT00762710|Placebo|placebo
5215641|NCT00762710|Medical|medical
5215642|NCT00762710|Management|management
5215643|NCT00762710|Craving|craving
5215644|NCT00762710|Consumption|consumption
5215645|NCT00762710|Binge|binge
5215646|NCT00762710|Drinking|drinking
5215647|NCT00762710|Drink|drink
5215648|NCT00762710|Heavy|heavy
5215649|NCT00762697|diabetic, venous insufficiency|diabetic, venous insufficiency
5215650|NCT00762684|Glucose Metabolism Disorder|glucose metabolism disorder
5215651|NCT00762684|Dysmetabolic Syndrome|dysmetabolic syndrome
5215652|NCT00762684|Type II Diabetes|type ii diabetes
5215653|NCT00762684|Diabetes Mellitus, Lipoatrophic|diabetes mellitus, lipoatrophic
5215654|NCT00762684|Dyslipidemia|dyslipidemia
5215655|NCT00762658|Plaque Type Psoriasis|plaque type psoriasis
5215656|NCT00762658|Topical|topical
5215657|NCT00762645|IOP lowering efficacy|iop lowering efficacy
5215658|NCT00762645|CACG|cacg
5215659|NCT00762632|patients with c-kit+ AML|patients with c-kit+ aml
5215660|NCT00762606|Cataract|cataract
5215661|NCT00762593|urinary stress incontinence|urinary stress incontinence
5215662|NCT00762593|urinary stress incontinence in women|urinary stress incontinence in women
5215663|NCT00762580|rotator cuff|rotator cuff
5215664|NCT00762580|rehabilitation|rehabilitation
5215665|NCT00762554|analgesia|analgesia
5215666|NCT00762554|cesarean section|cesarean section
5215667|NCT00762554|fentanyl|fentanyl
5215668|NCT00762554|Depodur|depodur
5215669|NCT00762554|Post-cesarean section analgesia|post-cesarean section analgesia
5215670|NCT00762541|Myopia|myopia
5215671|NCT00762541|Laser In Situ Keratomileusis|laser in situ keratomileusis
5215672|NCT00762541|Laser Therapy|laser therapy
5215673|NCT00762541|Laser Corneal Surgery|laser corneal surgery
5215674|NCT00762541|Refractive Surgical Procedures|refractive surgical procedures
5215675|NCT00762541|Ophthalmologic Surgical Procedure|ophthalmologic surgical procedure
5215676|NCT00762541|Operative Surgical Procedures|operative surgical procedures
5215677|NCT00762541|Therapeutics|therapeutics
5215678|NCT00762489|Temporal artery thermometry|temporal artery thermometry
5215679|NCT00762489|Rectal temperature|rectal temperature
5215680|NCT00762489|Axillary temperature|axillary temperature
5215681|NCT00762489|Newborns|newborns
5215682|NCT00762489|Temperature measurement|temperature measurement
5215683|NCT00762476|cold, common|cold, common
5215684|NCT00762476|rhinovirus|rhinovirus
5215685|NCT00762424|Kidney stone|kidney stone
5215686|NCT00762424|Ureterolithiasis|ureterolithiasis
5215687|NCT00762424|Tamsulosin|tamsulosin
5215688|NCT00762424|Flowmax|flowmax
5215689|NCT00762424|Emergency Department|emergency department
5215690|NCT00762411|Alzheimer's Disease|alzheimer's disease
5215691|NCT00762398|Major surgery, excpected blood loss, arterial line|major surgery, excpected blood loss, arterial line
5215692|NCT00762372|anesthesia|anesthesia
5215693|NCT00762372|desflurane|desflurane
5215694|NCT00762359|Curling Ulcer|curling ulcer
5215695|NCT00762359|Gastric Ulcer|gastric ulcer
5215696|NCT00762359|Aspirin|aspirin
5215697|NCT00762359|Acetylsalicylic Acid|acetylsalicylic acid
5215698|NCT00762359|Drug Therapy|drug therapy
5215699|NCT00762346|non small cell lung cancer|non small cell lung cancer
5215700|NCT00762346|NTX|ntx
5215701|NCT00762346|zometa|zometa
5215702|NCT00762320|HIV|hiv
5215703|NCT00762320|Kaletra|kaletra
5215704|NCT00762320|treatment Experienced|treatment experienced
5215705|NCT00762294|breast cancer|breast cancer
5215706|NCT00762294|arimidex|arimidex
5215707|NCT00762294|femara|femara
5215708|NCT00762294|bone health|bone health
5215709|NCT00762281|Hyperopia|hyperopia
5215710|NCT00762281|Laser In Situ Keratomileusis|laser in situ keratomileusis
5215711|NCT00762281|Laser Therapy|laser therapy
5215712|NCT00762281|Laser Corneal Surgery|laser corneal surgery
5215713|NCT00762281|Refractive Surgical Procedures|refractive surgical procedures
5215714|NCT00762281|Ophthalmologic Surgical Procedure|ophthalmologic surgical procedure
5215715|NCT00762281|Operative Surgical Procedures|operative surgical procedures
5215716|NCT00762281|Therapeutics|therapeutics
5215717|NCT00762268|SAMe|same
5215718|NCT00762268|alternative treatments|alternative treatments
5215719|NCT00762268|bipolar disorder|bipolar disorder
5215720|NCT00762268|depression|depression
5215721|NCT00762268|bipolar depression|bipolar depression
5215722|NCT00762268|treatment-resistant depression|treatment-resistant depression
5215723|NCT00762255|recurrent glioblastoma|recurrent glioblastoma
5215724|NCT00762255|multiple agents|multiple agents
5215725|NCT00762255|immunotherapy|immunotherapy
5215726|NCT00762255|chemotherapy|chemotherapy
5215727|NCT00762255|brain and nervous system|brain and nervous system
5215728|NCT00762242|metabolomics|metabolomics
5215729|NCT00762242|flow-mediated vasodilation|flow-mediated vasodilation
5215730|NCT00762229|Cholesterol|cholesterol
5215731|NCT00762229|Ezetimibe|ezetimibe
5215732|NCT00762216|Cataract|cataract
5215733|NCT00762190|Glucose Metabolism Disorder|glucose metabolism disorder
5215734|NCT00762190|Dysmetabolic Syndrome|dysmetabolic syndrome
5215735|NCT00762190|Type II Diabetes|type ii diabetes
5215736|NCT00762190|Diabetes Mellitus, Lipoatrophic|diabetes mellitus, lipoatrophic
5215737|NCT00762190|Dyslipidemia|dyslipidemia
5215738|NCT00762190|Drug Therapy|drug therapy
5215739|NCT00762164|Hypercholesterolemia|hypercholesterolemia
5215740|NCT00762164|Statins|statins
5215741|NCT00762164|Ezetimibe|ezetimibe
5215742|NCT00762151|Dental Plaque|dental plaque
5215743|NCT00762138|Platelet rich plasma|platelet rich plasma
5215744|NCT00762138|wounds|wounds
5215745|NCT00762138|leg ulcers|leg ulcers
5215746|NCT00762138|pressure ulcers|pressure ulcers
5215747|NCT00762138|diabetic ulcers|diabetic ulcers
5215748|NCT00762138|management of mechanically or surgically-debrided wounds|management of mechanically or surgically-debrided wounds
5215749|NCT00762125|Fibromyalgia Syndrome|fibromyalgia syndrome
5215750|NCT00762125|FMS|fms
5215751|NCT00762125|Physical Therapy|physical therapy
5215752|NCT00762125|Psychotherapy|psychotherapy
5215753|NCT00762125|Group Counseling|group counseling
5215754|NCT00762125|Individual Counseling|individual counseling
5215755|NCT00762125|Chronic Pain|chronic pain
5215756|NCT00762112|Glucose Metabolism Disorder|glucose metabolism disorder
5215757|NCT00762112|Dysmetabolic Syndrome|dysmetabolic syndrome
5215758|NCT00762112|Type II Diabetes|type ii diabetes
5215759|NCT00762112|Diabetes Mellitus, Lipoatrophic|diabetes mellitus, lipoatrophic
5215760|NCT00762112|Dyslipidemia|dyslipidemia
5215761|NCT00762112|Drug Therapy.|drug therapy.
5215762|NCT00762099|Arthroplasty, Hip|arthroplasty, hip
5215763|NCT00762099|Hip replacement|hip replacement
5215764|NCT00762099|Pain Management|pain management
5215765|NCT00762099|Functional Rehabilitation|functional rehabilitation
5215766|NCT00762099|Anxiety|anxiety
5215767|NCT00762099|Perioperative|perioperative
5215768|NCT00762099|Pregabalin|pregabalin
5215769|NCT00762099|Arthroplasty|arthroplasty
5215770|NCT00762086|Peripheral Arterial Disease|peripheral arterial disease
5215771|NCT00762086|intermittent pneumatic compression treatment|intermittent pneumatic compression treatment
5215772|NCT00762086|Initial claudication|initial claudication
5215773|NCT00762073|eosinophilic esophagitis|eosinophilic esophagitis
5215774|NCT00762060|colorectal surgery|colorectal surgery
5215775|NCT00762047|Fecal Incontinence|fecal incontinence
5215776|NCT00762021|cataract|cataract
5215777|NCT00762008|biomarkers|biomarkers
5215778|NCT00761995|Raised IOP|raised iop
5215779|NCT00761969|peripheral arterial disease|peripheral arterial disease
5215780|NCT00761969|secondary prevention|secondary prevention
5215781|NCT00761969|cardiovascular /atherothrombotic events|cardiovascular /atherothrombotic events
5215782|NCT00761969|European guidelines|european guidelines
5215783|NCT00761969|Cardiovascular disease prevention|cardiovascular disease prevention
5215784|NCT00761956|Total Knee Arthroplasty|total knee arthroplasty
5215785|NCT00761956|Osteoarthritis|osteoarthritis
5215786|NCT00761956|Knee|knee
5215787|NCT00761943|Adhesive Capsulitis|adhesive capsulitis
5215788|NCT00761943|Bursitis|bursitis
5215789|NCT00761943|Frozen Shoulder|frozen shoulder
5215790|NCT00761904|hypertension|hypertension
5215791|NCT00761904|hyperlipidemia|hyperlipidemia
5215792|NCT00761904|free generic samples|free generic samples
5215793|NCT00761891|aspirin|aspirin
5215794|NCT00761891|cyclooxygenase-1|cyclooxygenase-1
5215795|NCT00761891|aspirin resistance|aspirin resistance
5215796|NCT00761891|aspirin nonresponse|aspirin nonresponse
5215797|NCT00761891|platelet|platelet
5215798|NCT00761891|Normal volunteers|normal volunteers
5215799|NCT00761878|Skin aging|skin aging
5215800|NCT00761878|Skin wrinkling|skin wrinkling
5215801|NCT00761865|Lateral Ankle Sprin|lateral ankle sprin
5215802|NCT00761865|Air Cast Stirrup Brace|air cast stirrup brace
5215803|NCT00761865|High Tide Fracture Boot|high tide fracture boot
5215804|NCT00761839|wound healing|wound healing
5215805|NCT00761839|self-management|self-management
5215806|NCT00761839|patient education|patient education
5215807|NCT00761826|Mixed Astigmatism|mixed astigmatism
5215808|NCT00761826|Laser In Situ Keratomileusis|laser in situ keratomileusis
5215809|NCT00761826|Laser Therapy|laser therapy
5215810|NCT00761826|Laser Corneal Surgery|laser corneal surgery
5215811|NCT00761826|Refractive Surgical Procedures|refractive surgical procedures
5215812|NCT00761826|Ophthalmologic Surgical Procedure|ophthalmologic surgical procedure
5215813|NCT00761826|Operative Surgical Procedures|operative surgical procedures
5215814|NCT00761826|Therapeutics|therapeutics
5215815|NCT00761813|Sliding Hip Screw Fixation|sliding hip screw fixation
5215816|NCT00761813|Cannulated Screw Fixation|cannulated screw fixation
5215817|NCT00761787|allograft|allograft
5215818|NCT00761787|rejection|rejection
5215819|NCT00761787|biopsy|biopsy
5215820|NCT00761787|gene|gene
5215821|NCT00761787|expression|expression
5215822|NCT00761787|cardiology|cardiology
5215823|NCT00761787|heart|heart
5215824|NCT00761787|transplant|transplant
5215825|NCT00761774|Epilepsy|epilepsy
5215826|NCT00761774|Monotherapy|monotherapy
5215827|NCT00761774|Partial Onset Seizures|partial onset seizures
5215828|NCT00761761|Sensoril|sensoril
5215829|NCT00761761|Bipolar Illness|bipolar illness
5215830|NCT00761761|Cognitive enhancement|cognitive enhancement
5215831|NCT00761748|Urostomy,|urostomy,
5215832|NCT00761748|2-piece,|2-piece,
5215833|NCT00761748|preference,|preference,
5215834|NCT00761722|Acute Myeloid Leukemia|acute myeloid leukemia
5215835|NCT00761722|Myelodysplastic Syndromes|myelodysplastic syndromes
5215836|NCT00761722|Lymphoma|lymphoma
5215837|NCT00761722|Multiple Myeloma|multiple myeloma
5215838|NCT00761722|Chronic Myelomonocytic Leukemia (CMML)|chronic myelomonocytic leukemia (cmml)
5215839|NCT00761709|Open Angle Glaucoma|open angle glaucoma
5215840|NCT00761709|Ocular Hypertension|ocular hypertension
5215841|NCT00761696|solid tumor malignancies|solid tumor malignancies
5215842|NCT00761683|Endometriosis|endometriosis
5215843|NCT00761657|Kidney|kidney
5215844|NCT00761657|Chronic Kidney Disease|chronic kidney disease
5215845|NCT00761657|CKD|ckd
5215846|NCT00761657|Stage 3 or 4 Chronic Kidney Disease|stage 3 or 4 chronic kidney disease
5215847|NCT00761657|Renal|renal
5215848|NCT00761657|Anemia|anemia
5215849|NCT00761657|Oral anemia treatment|oral anemia treatment
5215850|NCT00761657|Hemoglobin levels|hemoglobin levels
5215851|NCT00761657|Blood count|blood count
5215852|NCT00761657|Erythropoietin|erythropoietin
5215853|NCT00761644|Metastatic cancer|metastatic cancer
5215854|NCT00761644|Doxil|doxil
5215855|NCT00761644|Liposomal doxorubicin|liposomal doxorubicin
5215856|NCT00761644|Doxorubicin hydrochloride (liposomal)|doxorubicin hydrochloride (liposomal)
5215857|NCT00761644|Avastin|avastin
5215858|NCT00761644|Bevacizumab|bevacizumab
5215859|NCT00761644|Anti-VEGF monoclonal antibody|anti-vegf monoclonal antibody
5215860|NCT00761644|rhuMAb-VEGF|rhumab-vegf
5215861|NCT00761644|Torisel|torisel
5215862|NCT00761644|Temsirolimus|temsirolimus
5215863|NCT00761644|CCI-779|cci-779
5215864|NCT00761644|Dynamic contrast-enhanced magnetic resonance imaging|dynamic contrast-enhanced magnetic resonance imaging
5215865|NCT00761644|DCE-MRI scan|dce-mri scan
5215866|NCT00761618|Intrapleural catheter|intrapleural catheter
5215867|NCT00761618|IPC|ipc
5215868|NCT00761618|Pleurodesis|pleurodesis
5215869|NCT00761618|PD|pd
5215870|NCT00761618|Pleural effusion|pleural effusion
5215871|NCT00761618|Fluid in the chest cavity|fluid in the chest cavity
5215872|NCT00761618|Recurrent malignant pleural effusion|recurrent malignant pleural effusion
5215873|NCT00761618|MPE|mpe
5215874|NCT00761618|Pleural inflammatory response|pleural inflammatory response
5215875|NCT00761605|Schizophrenia|schizophrenia
5215876|NCT00761605|Paliperidone|paliperidone
5215877|NCT00761605|Paliperidone extended-release|paliperidone extended-release
5215878|NCT00761605|Antipsychotics Agents|antipsychotics agents
5215879|NCT00761579|Schizophrenia|schizophrenia
5215880|NCT00761579|Paliperidone|paliperidone
5215881|NCT00761579|Antipsychotics Agents|antipsychotics agents
5215882|NCT00761566|Elite swimmers|elite swimmers
5215883|NCT00761566|Exercise|exercise
5215884|NCT00761566|Preconditioning|preconditioning
5215885|NCT00761553|The study is designed to determine the effects of food supplements and strength training.|the study is designed to determine the effects of food supplements and strength training.
5215886|NCT00761501|Phase I|phase i
5215887|NCT00761501|Healthy Volunteer|healthy volunteer
5215888|NCT00761488|Visual acuity,|visual acuity,
5215889|NCT00761488|corneal and|corneal and
5215890|NCT00761488|refractive|refractive
5215891|NCT00761488|cylinder|cylinder
5215892|NCT00761488|following|following
5215893|NCT00761488|implantation of the|implantation of the
5215894|NCT00761488|AcrySof® Toric|acrysof® toric
5215895|NCT00761475|incisional hernia|incisional hernia
5215896|NCT00761462|Pediatrics|pediatrics
5215897|NCT00761462|Safety|safety
5215898|NCT00761462|Musculoskeletal System|musculoskeletal system
5215899|NCT00761462|Neurologic Manifestations|neurologic manifestations
5215900|NCT00761462|Joint Diseases|joint diseases
5215901|NCT00761462|Joint Deformities, Acquired|joint deformities, acquired
5215902|NCT00761449|MDS|mds
5215903|NCT00761449|AML|aml
5215904|NCT00761449|Lenalidomide|lenalidomide
5215905|NCT00761449|monosomy 5|monosomy 5
5215906|NCT00761449|del5q|del5q
5215907|NCT00761410|Arthroplasty|arthroplasty
5215908|NCT00761410|Knee|knee
5215909|NCT00761410|Replacement|replacement
5215910|NCT00761410|High Flexion|high flexion
5215911|NCT00761410|PFC Sigma RP-F|pfc sigma rp-f
5215912|NCT00761397|Oropharyngeal cancer|oropharyngeal cancer
5215913|NCT00761397|Dysphagic|dysphagic
5215914|NCT00761397|Swallowing exercises|swallowing exercises
5215915|NCT00761397|Swallowing rehabilitative regimens|swallowing rehabilitative regimens
5215916|NCT00761397|PREPARE|prepare
5215917|NCT00761397|Patients' Radiation Expectations|patients' radiation expectations
5215918|NCT00761397|Prevention, Adherence, Rehabilitative Exercises|prevention, adherence, rehabilitative exercises
5215919|NCT00761384|B-cell lymphoma|b-cell lymphoma
5215920|NCT00761384|Refractory|refractory
5215921|NCT00761384|Recurrent|recurrent
5215922|NCT00761384|90Y-ibritumomab|90y-ibritumomab
5215923|NCT00761384|Stem cells support|stem cells support
5215924|NCT00761384|Dosimetry study|dosimetry study
5215925|NCT00761371|external genital and perianal warts|external genital and perianal warts
5215926|NCT00761358|Acotiamide|acotiamide
5215927|NCT00761345|pancreatic cancer|pancreatic cancer
5215928|NCT00761345|locally advanced|locally advanced
5215929|NCT00761345|unresectable|unresectable
5215930|NCT00761345|metastatic pancreatic cancer|metastatic pancreatic cancer
5215931|NCT00761319|Open-angle glaucoma|open-angle glaucoma
5215932|NCT00761319|ocular hypertension|ocular hypertension
5215933|NCT00761306|Major Depressive Disorder|major depressive disorder
5215934|NCT00761306|Long-term|long-term
5215935|NCT00761306|Safety|safety
5215936|NCT00761306|Open-label|open-label
5215937|NCT00761280|Anaplastic astrocytoma|anaplastic astrocytoma
5215938|NCT00761280|Glioblastoma|glioblastoma
5215939|NCT00761280|Antisense|antisense
5215940|NCT00761280|Cancer|cancer
5215941|NCT00761280|Transforming Growth Factor beta 2|transforming growth factor beta 2
5215942|NCT00761280|Targeted therapy|targeted therapy
5215943|NCT00761280|Brain tumor|brain tumor
5215944|NCT00761280|Glioma|glioma
5215945|NCT00761280|Central Nervous System (CNS)|central nervous system (cns)
5215946|NCT00761280|Convection Enhanced Delivery (CED)|convection enhanced delivery (ced)
5215947|NCT00761280|Intratumoral administration|intratumoral administration
5215948|NCT00761267|Anidulafungin|anidulafungin
5215949|NCT00761267|pediatrics|pediatrics
5215950|NCT00761267|candidemia|candidemia
5215951|NCT00761267|invasive candidiasis|invasive candidiasis
5215952|NCT00761267|safety|safety
5215953|NCT00761254|Domperidone|domperidone
5215954|NCT00761254|Gastroparesis|gastroparesis
5215955|NCT00761241|pancreas cancer|pancreas cancer
5215956|NCT00761241|combined modality therapy|combined modality therapy
5215957|NCT00761228|Vegetative State|vegetative state
5215958|NCT00761228|Minimally Conscious State|minimally conscious state
5215959|NCT00761228|Coma|coma
5215960|NCT00761228|Traumatic Brain Injury|traumatic brain injury
5215961|NCT00761215|Skin|skin
5215962|NCT00761215|Infection|infection
5215963|NCT00761215|Complicated Skin and Skin Structure Infection|complicated skin and skin structure infection
5215964|NCT00761189|Paliperidone|paliperidone
5215965|NCT00761189|R076477|r076477
5215966|NCT00761189|Schizophrenia|schizophrenia
5215967|NCT00761176|Diabetes|diabetes
5215968|NCT00761176|Ulcers|ulcers
5215969|NCT00761176|Wounds|wounds
5215970|NCT00761163|The purpose of this study is to identify the body's response to aerobic vs. resistance exercise|the purpose of this study is to identify the body's response to aerobic vs. resistance exercise
5215971|NCT00761150|Effect on sleep interference by pain|effect on sleep interference by pain
5215972|NCT00761137|sialorrhea|sialorrhea
5215973|NCT00761137|drooling|drooling
5215974|NCT00761137|excessive salivation|excessive salivation
5215975|NCT00761137|parkinson's disease|parkinson's disease
5215976|NCT00761124|PSA screening|psa screening
5215977|NCT00761124|Prostate cancer and Latino men|prostate cancer and latino men
5215978|NCT00761111|information booklet|information booklet
5215979|NCT00761111|low back beliefs|low back beliefs
5215980|NCT00761111|education|education
5215981|NCT00761111|disc hernia|disc hernia
5215982|NCT00761111|discectomy|discectomy
5215983|NCT00761111|A common monoradicular sciatica|a common monoradicular sciatica
5215984|NCT00761111|on a slipped disc|on a slipped disc
5215985|NCT00761111|with a clinical radio|with a clinical radio
5215986|NCT00761111|agreement requiring a surgical treatment|agreement requiring a surgical treatment
5215987|NCT00761111|carried out|carried out
5215988|NCT00761111|one duration|one duration
5215989|NCT00761111|of evolution higher|of evolution higher
5215990|NCT00761111|than four weeks|than four weeks
5215991|NCT00761111|at naive subjects|at naive subjects
5215992|NCT00761111|of any rachidian interventional treatment|of any rachidian interventional treatment
5215993|NCT00761111|after failure of an good ambulatory|after failure of an good ambulatory
5215994|NCT00761098|Cirrhosis|cirrhosis
5215996|NCT00761072|Propofol|propofol
5215997|NCT00761072|Remifentanil|remifentanil
5215998|NCT00761072|Total Intravenous Anesthesia|total intravenous anesthesia
5215999|NCT00761059|analgesia|analgesia
5216000|NCT00761059|infant, premature|infant, premature
5216001|NCT00761059|glucose|glucose
5216002|NCT00761059|nasopharyngeal suctioning|nasopharyngeal suctioning
5216003|NCT00761033|children undergoing intravenous placement in the pediatric emergency department|children undergoing intravenous placement in the pediatric emergency department
5216004|NCT00761020|Malaria|malaria
5216005|NCT00761020|Diagnosis|diagnosis
5216006|NCT00761020|Biomarker|biomarker
5216007|NCT00761007|Irritable Bowel Syndrome|irritable bowel syndrome
5216008|NCT00761007|Bowel disease|bowel disease
5216009|NCT00760994|Alcohol|alcohol
5216010|NCT00760994|Alcoholic|alcoholic
5216011|NCT00760994|Alcoholism|alcoholism
5216012|NCT00760994|Post-traumatic stress disorder|post-traumatic stress disorder
5216013|NCT00760994|PTSD|ptsd
5216014|NCT00760994|Experiential acceptance|experiential acceptance
5216015|NCT00760994|Mindfulness|mindfulness
5216016|NCT00760994|Meditation|meditation
5216017|NCT00760994|Meditate|meditate
5216018|NCT00760994|Cognitive restructuring|cognitive restructuring
5216019|NCT00760994|Cognitive|cognitive
5216020|NCT00760994|Behavioral|behavioral
5216021|NCT00760994|Therapy|therapy
5216022|NCT00760994|Treatment|treatment
5216023|NCT00760994|Study|study
5216024|NCT00760994|Intervention|intervention
5216025|NCT00760968|Rheumatoid Arthritis|rheumatoid arthritis
5216026|NCT00760968|Drug Therapy|drug therapy
5216027|NCT00760955|Asymmetric Diabetic Proximal Motor Neuropathy|asymmetric diabetic proximal motor neuropathy
5216028|NCT00760955|Diabetic Amyotrophy|diabetic amyotrophy
5216029|NCT00760955|Diabetic Autonomic Neuropathy|diabetic autonomic neuropathy
5216030|NCT00760955|Diabetic Polyneuropathy|diabetic polyneuropathy
5216031|NCT00760955|Neuralgia, Diabetic|neuralgia, diabetic
5216032|NCT00760955|Symmetric Diabetic Proximal Motor Neuropathy|symmetric diabetic proximal motor neuropathy
5216033|NCT00760955|Drug Therapy|drug therapy
5216034|NCT00760942|Low birth weight|low birth weight
5216035|NCT00760942|neonates|neonates
5216036|NCT00760942|premature infants|premature infants
5216037|NCT00760942|nutrition|nutrition
5216038|NCT00760942|human milk fortification|human milk fortification
5216039|NCT00760942|Infant|infant
5216040|NCT00760916|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
5216041|NCT00760903|Moderate brain trauma|moderate brain trauma
5216042|NCT00760890|Iron, breastfed infant|iron, breastfed infant
5216043|NCT00760877|MYELOGENOUS|myelogenous
5216044|NCT00760877|LEUKEMIA|leukemia
5216045|NCT00760877|Chronic Phase|chronic phase
5216046|NCT00760877|CML|cml
5216047|NCT00760864|Rheumatoid Arthritis|rheumatoid arthritis
5216048|NCT00760864|Drug Therapy|drug therapy
5216049|NCT00760851|Probiotics|probiotics
5216050|NCT00760851|Child, preschool|child, preschool
5216051|NCT00760851|Child Day Care Centers|child day care centers
5216052|NCT00760851|Health|health
5216053|NCT00760851|Immune system|immune system
5216054|NCT00760838|Inadequately controlled severe asthma|inadequately controlled severe asthma
5216055|NCT00760825|cholera|cholera
5216056|NCT00760825|vibrios|vibrios
5216057|NCT00760825|oral cholera vaccine|oral cholera vaccine
5216058|NCT00760812|Autism|autism
5216059|NCT00760812|Autism Spectrum Disorders|autism spectrum disorders
5216060|NCT00760812|Pervasive Developmental Disorders|pervasive developmental disorders
5216061|NCT00760812|Toddlers|toddlers
5216062|NCT00760812|Intervention|intervention
5216063|NCT00760799|Lumbar Disc Herniation|lumbar disc herniation
5216064|NCT00760786|IVUS-VH|ivus-vh
5216065|NCT00760786|Plaque characterization|plaque characterization
5216066|NCT00760786|Omega3-fatty acid|omega3-fatty acid
5216067|NCT00760786|Atorvastatin|atorvastatin
5216068|NCT00760773|Probiotic treatment|probiotic treatment
5216069|NCT00760773|Daycare attendance|daycare attendance
5216070|NCT00760773|Pediatric|pediatric
5216071|NCT00760773|Emergency department|emergency department
5216072|NCT00760747|ADHD|adhd
5216073|NCT00760747|Children|children
5216074|NCT00760747|Stimulant|stimulant
5216075|NCT00760747|Atomoxetine|atomoxetine
5216076|NCT00760747|Adolescents|adolescents
5216077|NCT00760734|Chronic traumatic brain injury|chronic traumatic brain injury
5216078|NCT00760734|Post concussion syndrome|post concussion syndrome
5216079|NCT00760734|Post traumatic stress disorder|post traumatic stress disorder
5216080|NCT00760734|Chronic post traumatic stress disorder|chronic post traumatic stress disorder
5216081|NCT00760721|Hepatitis B Screening|hepatitis b screening
5216082|NCT00760721|Korean Americans|korean americans
5216083|NCT00760708|nucleosides|nucleosides
5216084|NCT00760708|neurotransmitter|neurotransmitter
5216085|NCT00760708|myocardial ischemia|myocardial ischemia
5216086|NCT00760708|Adenosine|adenosine
5216087|NCT00760695|anorexia nervosa|anorexia nervosa
5216088|NCT00760695|chronic|chronic
5216089|NCT00760695|dronabinol|dronabinol
5216090|NCT00760695|weight gain|weight gain
5216091|NCT00760695|EDI|edi
5216092|NCT00760682|osteoradionecrosis|osteoradionecrosis
5216093|NCT00760682|hyperbaric oxygen|hyperbaric oxygen
5216094|NCT00760682|sequestrectomy|sequestrectomy
5216095|NCT00760669|Spondylitis, Ankylosing|spondylitis, ankylosing
5216096|NCT00760669|Arthritis, Rheumatoid|arthritis, rheumatoid
5216097|NCT00760669|Psoriasis|psoriasis
5216098|NCT00760669|Arthritis, Psoriatic|arthritis, psoriatic
5216099|NCT00760669|Infliximab|infliximab
5216100|NCT00760669|Remicade|remicade
5216101|NCT00760656|Health outcomes in adults who survived pediatric cancer|health outcomes in adults who survived pediatric cancer
5216102|NCT00760656|Survivors of Pediatric Cancer|survivors of pediatric cancer
5216103|NCT00760630|abnormal stress test|abnormal stress test
5216104|NCT00760630|fractional flow reserve|fractional flow reserve
5216105|NCT00760630|pressure drop coefficient|pressure drop coefficient
5216106|NCT00760630|lesion flow coefficient|lesion flow coefficient
5216107|NCT00760617|Influenza|influenza
5216108|NCT00760617|Elderly|elderly
5216109|NCT00760604|Esophageal neoplasms|esophageal neoplasms
5216110|NCT00760604|Esophagectomy|esophagectomy
5216111|NCT00760591|Acute kidney failure|acute kidney failure
5216112|NCT00760591|Colonoscopy|colonoscopy
5216113|NCT00760591|Neutrophil gelatinase-associated lipocalin|neutrophil gelatinase-associated lipocalin
5216114|NCT00760552|Hypertension|hypertension
5216115|NCT00760552|Adherence|adherence
5216116|NCT00760552|Pharmacist|pharmacist
5216117|NCT00760552|Interdisciplinary|interdisciplinary
5216118|NCT00760552|Randomized Controlled|randomized controlled
5216119|NCT00760552|Primary Care|primary care
5216120|NCT00760539|Glaucoma|glaucoma
5216121|NCT00760539|Hypertension|hypertension
5216122|NCT00760526|Continuous Glucose Monitor|continuous glucose monitor
5216123|NCT00760513|non alcoholic fatty liver disease|non alcoholic fatty liver disease
5216124|NCT00760513|NAFLD|nafld
5216125|NCT00760513|fish oil|fish oil
5216126|NCT00760513|intervention|intervention
5216127|NCT00760513|RCT|rct
5216128|NCT00760513|biomarkers|biomarkers
5216129|NCT00760487|Cataract AcrySof Toric IOL|cataract acrysof toric iol
5216130|NCT00760487|Bilateral cataract|bilateral cataract
5216131|NCT00760474|Fibromyalgia; fMRI; pain; pregabalin; Lyrica; imaging|fibromyalgia; fmri; pain; pregabalin; lyrica; imaging
5216132|NCT00760435|Kawasaki disease|kawasaki disease
5216133|NCT00760435|Infliximab|infliximab
5216134|NCT00760435|Remicade|remicade
5216135|NCT00760435|Pediatrics|pediatrics
5216136|NCT00760409|recurrent tumor|recurrent tumor
5216137|NCT00760396|healthy volunteers|healthy volunteers
5216138|NCT00760383|Total Knee Arthroplasty|total knee arthroplasty
5216139|NCT00760383|Osteoarthritis|osteoarthritis
5216140|NCT00760383|Muscle Metabolism|muscle metabolism
5216141|NCT00760383|Rehabilitation|rehabilitation
5216142|NCT00760383|Physical Therapy|physical therapy
5216143|NCT00760370|bone marker|bone marker
5216144|NCT00760370|bisphosphonate|bisphosphonate
5216145|NCT00760370|Zometa|zometa
5216146|NCT00760370|retention|retention
5216147|NCT00760370|breast cancer|breast cancer
5216148|NCT00760370|multiple myeloma|multiple myeloma
5216149|NCT00760370|CTX|ctx
5216150|NCT00760370|bone specific ALP|bone specific alp
5216151|NCT00760357|Critical Ischemia|critical ischemia
5216152|NCT00760344|Glucose Metabolism Disorder|glucose metabolism disorder
5216153|NCT00760344|Dysmetabolic Syndrome|dysmetabolic syndrome
5216154|NCT00760344|Type II Diabetes|type ii diabetes
5216155|NCT00760344|Diabetes Mellitus, Lipoatrophic|diabetes mellitus, lipoatrophic
5216156|NCT00760344|Dyslipidemia|dyslipidemia
5216157|NCT00760344|Drug Therapy|drug therapy
5216158|NCT00760331|HNF1B|hnf1b
5216159|NCT00760331|TCF2|tcf2
5216160|NCT00760331|MODY-5|mody-5
5216161|NCT00760331|CAKUT|cakut
5216162|NCT00760331|Anomaly of renal development|anomaly of renal development
5216163|NCT00760318|cervical dystonia, keppra, botox, spasmodic torticollis|cervical dystonia, keppra, botox, spasmodic torticollis
5216164|NCT00760305|cancer pain|cancer pain
5216165|NCT00760305|bone metastasis|bone metastasis
5216166|NCT00760305|patient education|patient education
5216167|NCT00760305|psychoeducational education|psychoeducational education
5216168|NCT00760305|side effects|side effects
5216169|NCT00760305|analgesics|analgesics
5216170|NCT00760292|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
5216171|NCT00760292|Genetic Variants|genetic variants
5216172|NCT00760292|SNP|snp
5216173|NCT00760292|DNA microarray|dna microarray
5216174|NCT00760279|Bacterial infection|bacterial infection
5216175|NCT00760279|Azithromycin|azithromycin
5216176|NCT00760266|Hypertension|hypertension
5216177|NCT00760266|older population|older population
5216178|NCT00760266|aliskiren|aliskiren
5216179|NCT00760266|hydrochlorothiazide|hydrochlorothiazide
5216180|NCT00760266|systolic blood pressure|systolic blood pressure
5216181|NCT00760266|diastolic blood pressure|diastolic blood pressure
5216182|NCT00760266|amlodipine, stage 2|amlodipine, stage 2
5216183|NCT00760253|target control infusion|target control infusion
5216184|NCT00760253|alfentanyl|alfentanyl
5216185|NCT00760253|propofol|propofol
5216186|NCT00760253|BIS|bis
5216187|NCT00760240|compliance|compliance
5216188|NCT00760240|eyedrop instillation|eyedrop instillation
5216189|NCT00760240|How patients with low vision due to glaucoma or retinal pathology instill eyedrops into their own eyes.|how patients with low vision due to glaucoma or retinal pathology instill eyedrops into their own eyes.
5216190|NCT00760214|Essential Hypertension|essential hypertension
5216191|NCT00760214|Hypertension|hypertension
5216192|NCT00760214|Drug Therapy|drug therapy
5216193|NCT00760214|Blood Pressure, High|blood pressure, high
5216194|NCT00760214|Vascular Disease|vascular disease
5216195|NCT00760214|Cardiovascular Disease|cardiovascular disease
5216196|NCT00760201|executive|executive
5216197|NCT00760201|administrator|administrator
5216198|NCT00760201|perceptions|perceptions
5216199|NCT00760201|legal counsel|legal counsel
5216200|NCT00760201|end of life|end of life
5216201|NCT00760188|knee replacement|knee replacement
5216202|NCT00760175|Lung transplant Recipients|lung transplant recipients
5216203|NCT00760175|Vaxigrip|vaxigrip
5216204|NCT00760162|Chronic Kidney failure stage three and four|chronic kidney failure stage three and four
5216205|NCT00760162|Probiotics|probiotics
5216206|NCT00760162|Kibow Biotics|kibow biotics
5216207|NCT00760162|Enteric Dialysis|enteric dialysis
5216208|NCT00760162|Gut based removal uremic toxin removal|gut based removal uremic toxin removal
5216209|NCT00760149|tuberculosis|tuberculosis
5216210|NCT00760149|rifampicin|rifampicin
5216211|NCT00760149|pharmacokinetics|pharmacokinetics
5216212|NCT00760149|pharmacodynamics|pharmacodynamics
5216213|NCT00760136|patellofemoral pain|patellofemoral pain
5216214|NCT00760136|quadriceps contraction|quadriceps contraction
5216215|NCT00760123|Lymphedema|lymphedema
5216216|NCT00760123|Prevention|prevention
5216217|NCT00760123|Breast cancer|breast cancer
5216218|NCT00760123|Physical therapy|physical therapy
5216219|NCT00760110|Morning BP|morning bp
5216220|NCT00760110|Clinic BP|clinic bp
5216467|NCT00758992|gene transfer|gene transfer
5216221|NCT00760110|micro- and macrovascular complications|micro- and macrovascular complications
5216222|NCT00760084|Acute Myelogenous Leukemia|acute myelogenous leukemia
5216223|NCT00760084|Myelodysplastic Syndrome|myelodysplastic syndrome
5216224|NCT00760084|Dacogen|dacogen
5216225|NCT00760084|Decitabine|decitabine
5216226|NCT00760071|cystic fibrosis,|cystic fibrosis,
5216227|NCT00760071|lung disease,|lung disease,
5216228|NCT00760071|MRI,|mri,
5216229|NCT00760071|morphology,|morphology,
5216230|NCT00760071|function|function
5216231|NCT00760071|morphological MRI|morphological mri
5216232|NCT00760071|functional MRI|functional mri
5216233|NCT00760071|correlation to clinical data|correlation to clinical data
5216234|NCT00760058|cataract, intraocular lens|cataract, intraocular lens
5216235|NCT00760032|Cirrhosis|cirrhosis
5216236|NCT00760032|Ascites|ascites
5216237|NCT00760032|Lipopolysaccharide binding protein|lipopolysaccharide binding protein
5216238|NCT00760032|Infections|infections
5216239|NCT00760032|Cytokines|cytokines
5216240|NCT00760032|Ciprofloxacin|ciprofloxacin
5216241|NCT00760019|vascular inflammation|vascular inflammation
5216242|NCT00760019|endothelium-dependent flow-mediated blood vessel function|endothelium-dependent flow-mediated blood vessel function
5216243|NCT00760006|cleft secondary palate|cleft secondary palate
5216244|NCT00760006|primary closure of secondary cleft palate|primary closure of secondary cleft palate
5216245|NCT00760006|Prophylactic Antibiotics|prophylactic antibiotics
5216246|NCT00760006|Unasyn|unasyn
5216247|NCT00760006|Cleft Palate|cleft palate
5216248|NCT00759993|weight gain|weight gain
5216249|NCT00759993|Obesity|obesity
5216250|NCT00759993|Psychiatry|psychiatry
5216251|NCT00759993|Medication|medication
5216252|NCT00759993|Induced|induced
5216253|NCT00759980|Thrombocytopenia|thrombocytopenia
5216254|NCT00759980|Platelet transfusion|platelet transfusion
5216255|NCT00759967|Randomized|randomized
5216256|NCT00759967|Cross-Over|cross-over
5216257|NCT00759967|Conventional|conventional
5216258|NCT00759967|Daily|daily
5216259|NCT00759967|Hemodialysis|hemodialysis
5216260|NCT00759954|bioequivalence|bioequivalence
5216261|NCT00759954|morphine sulfate sustained release capsules|morphine sulfate sustained release capsules
5216262|NCT00759954|KADIAN capsules|kadian capsules
5216263|NCT00759954|200 mg|200 mg
5216264|NCT00759954|applesauce|applesauce
5216265|NCT00759941|Glaucoma|glaucoma
5216266|NCT00759928|Refractory Solid Tumors|refractory solid tumors
5216267|NCT00759928|Unresectable Stage III/IV|unresectable stage iii/iv
5216268|NCT00759928|Sorafenib|sorafenib
5216269|NCT00759928|Erlotinib|erlotinib
5216270|NCT00759928|Pharmacokinetics|pharmacokinetics
5216271|NCT00759915|10 mg|10 mg
5216272|NCT00759915|KADIAN capsules|kadian capsules
5216273|NCT00759915|20 mg|20 mg
5216274|NCT00759915|fed conditions|fed conditions
5216275|NCT00759915|bioequivalence|bioequivalence
5216276|NCT00759902|bioequivalence|bioequivalence
5216277|NCT00759902|10 mg|10 mg
5216278|NCT00759902|KADIAN capsules|kadian capsules
5216279|NCT00759902|20 mg|20 mg
5216280|NCT00759902|under fasted conditions|under fasted conditions
5216281|NCT00759889|venous leg ulcer|venous leg ulcer
5216282|NCT00759876|Duchenne muscular dystrophy|duchenne muscular dystrophy
5216283|NCT00759876|Nonsense mutation|nonsense mutation
5216284|NCT00759876|Premature stop codon|premature stop codon
5216286|NCT00759876|PTC124|ptc124
5216287|NCT00759876|Ataluren|ataluren
5216288|NCT00759850|Acute Myocardial Infarction|acute myocardial infarction
5216289|NCT00759850|Drug Eluting Stent|drug eluting stent
5216290|NCT00759850|Primary PCI|primary pci
5216291|NCT00759824|Small cell lung carcinoma|small cell lung carcinoma
5216292|NCT00759824|Valproic acid|valproic acid
5216293|NCT00759824|Adriamycin|adriamycin
5216294|NCT00759824|Cyclophosphamide|cyclophosphamide
5216295|NCT00759824|Vindesine|vindesine
5216296|NCT00759824|Second-line chemotherapy|second-line chemotherapy
5216297|NCT00759811|Heart Failure|heart failure
5216298|NCT00759811|Myocardial Ischemia|myocardial ischemia
5216299|NCT00759811|Methotrexate|methotrexate
5216300|NCT00759811|Inflammation|inflammation
5216301|NCT00759811|Anti-Inflammatory Agents|anti-inflammatory agents
5216302|NCT00759811|Inflammation Mediators|inflammation mediators
5216303|NCT00759798|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
5216304|NCT00759798|Leukemia|leukemia
5216305|NCT00759798|FCR|fcr
5216306|NCT00759798|Fludarabine|fludarabine
5216307|NCT00759798|Cyclophosphamide|cyclophosphamide
5216308|NCT00759798|Rituximab|rituximab
5216309|NCT00759772|Anorexia Nervosa|anorexia nervosa
5216310|NCT00759772|Disordered Eating|disordered eating
5216311|NCT00759772|Osteoporosis|osteoporosis
5216312|NCT00759772|Parathyroid Hormone|parathyroid hormone
5216313|NCT00759772|Bone|bone
5216314|NCT00759759|bioequivalence|bioequivalence
5216315|NCT00759759|morphine sulfate sustained release capsules|morphine sulfate sustained release capsules
5216316|NCT00759759|KADIAN capsules|kadian capsules
5216317|NCT00759759|200 mg|200 mg
5216318|NCT00759746|Weight loss maintenance|weight loss maintenance
5216319|NCT00759733|pregnancy|pregnancy
5216320|NCT00759733|heart disease|heart disease
5216321|NCT00759733|heart function testing|heart function testing
5216322|NCT00759733|echocardiography|echocardiography
5216323|NCT00759733|B-type natriuretic peptide|b-type natriuretic peptide
5216324|NCT00759733|obstetrical care|obstetrical care
5216325|NCT00759720|Glucose Metabolism Disorder|glucose metabolism disorder
5216326|NCT00759720|Dysmetabolic Syndrome|dysmetabolic syndrome
5216327|NCT00759720|Type II Diabetes|type ii diabetes
5216328|NCT00759720|Diabetes Mellitus, Lipoatrophic|diabetes mellitus, lipoatrophic
5216329|NCT00759720|Dyslipidemia|dyslipidemia
5216330|NCT00759720|Drug Therapy|drug therapy
5216331|NCT00759707|saphenous vein bypass grafts|saphenous vein bypass grafts
5216332|NCT00759707|flow-mediated vasodilation|flow-mediated vasodilation
5216333|NCT00759681|Arterial Surgery|arterial surgery
5216334|NCT00759681|Open vascular Surgery|open vascular surgery
5216335|NCT00759681|Sealant|sealant
5216336|NCT00759655|hemophilia A|hemophilia a
5216337|NCT00759655|Xyntha|xyntha
5216338|NCT00759655|ReFacto|refacto
5216339|NCT00759655|moroctocog alfa|moroctocog alfa
5216340|NCT00759655|bleeding disorder|bleeding disorder
5216341|NCT00759642|breast cancer|breast cancer
5216342|NCT00759642|hormone receptor positive|hormone receptor positive
5216343|NCT00759642|HER-2 negative|her-2 negative
5216344|NCT00759616|Knee Replacement|knee replacement
5216345|NCT00759603|Leukemia|leukemia
5216346|NCT00759603|CLL|cll
5216347|NCT00759603|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
5216348|NCT00759603|SLL|sll
5216349|NCT00759603|Small Lymphocytic Lymphoma|small lymphocytic lymphoma
5216350|NCT00759603|Lenalidomide|lenalidomide
5216351|NCT00759603|Revlimid|revlimid
5216352|NCT00759603|Rituximab|rituximab
5216353|NCT00759603|Rituxan|rituxan
5216354|NCT00759551|Blood Pressure|blood pressure
5216355|NCT00759551|Drug Therapy|drug therapy
5216356|NCT00759551|Systolic Pressure|systolic pressure
5216357|NCT00759551|Diastolic Pressure|diastolic pressure
5216358|NCT00759551|Vascular Diseases|vascular diseases
5216359|NCT00759538|Lung Transplantation|lung transplantation
5216360|NCT00759538|Pulmonary Rehabilitation|pulmonary rehabilitation
5216361|NCT00759538|Exercise tolerance|exercise tolerance
5216362|NCT00759538|Quality of Life|quality of life
5216363|NCT00759499|study of debridement tissue for research purposes.|study of debridement tissue for research purposes.
5216364|NCT00759499|open wound|open wound
5216365|NCT00759486|craniofacial fracture|craniofacial fracture
5216366|NCT00759486|Subjects who are in the active phase of craniofacial skeletal growth, and have sustained a craniofacial fracture|subjects who are in the active phase of craniofacial skeletal growth, and have sustained a craniofacial fracture
5216367|NCT00759473|substance-related disorders|substance-related disorders
5216368|NCT00759460|Schizophrenia|schizophrenia
5216369|NCT00759434|Varicose veins|varicose veins
5216370|NCT00759434|Chronic venous insufficiency|chronic venous insufficiency
5216371|NCT00759434|Venous ulceration|venous ulceration
5216372|NCT00759434|Surgery|surgery
5216373|NCT00759434|Endovenous Laser|endovenous laser
5216374|NCT00759421|Schizophrenia|schizophrenia
5216375|NCT00759408|primary pulmonary hypertension|primary pulmonary hypertension
5216376|NCT00759408|secondary pulmonary hypertension due to left heart failure|secondary pulmonary hypertension due to left heart failure
5216377|NCT00759408|secondary pulmonary hypertension due to other causes|secondary pulmonary hypertension due to other causes
5216378|NCT00759408|patients without pulmonary disease or pulmonary hypertension|patients without pulmonary disease or pulmonary hypertension
5216379|NCT00759395|Anxious Major Depressive Disorder|anxious major depressive disorder
5216380|NCT00759382|Non small cell lung carcinoma|non small cell lung carcinoma
5216381|NCT00759382|PET scan|pet scan
5216382|NCT00759382|Observational study|observational study
5216383|NCT00759382|Non metastatic|non metastatic
5216384|NCT00759382|treated|treated
5216385|NCT00759382|curative intent|curative intent
5216386|NCT00759369|ADPKD|adpkd
5216387|NCT00759356|bioavailability|bioavailability
5216388|NCT00759356|KADIAN|kadian
5216389|NCT00759356|200 mg|200 mg
5216390|NCT00759356|morphine sulfate sustained release capsules|morphine sulfate sustained release capsules
5216391|NCT00759356|100 mg|100 mg
5216392|NCT00759356|fed conditions|fed conditions
5216393|NCT00759343|Kidney stones|kidney stones
5216394|NCT00759343|urinary stone disease|urinary stone disease
5216395|NCT00759343|urinary stones|urinary stones
5216396|NCT00759343|urine|urine
5216397|NCT00759343|serum|serum
5216398|NCT00759330|Flurbiprofen, low back pain, chronic low back pain|flurbiprofen, low back pain, chronic low back pain
5216399|NCT00759317|normal controls|normal controls
5216400|NCT00759304|Aging|aging
5216401|NCT00759304|cardiovascular risk factors|cardiovascular risk factors
5216402|NCT00759304|Autonomic nervous system|autonomic nervous system
5216403|NCT00759304|stroke|stroke
5216404|NCT00759304|Myocardiac infarction|myocardiac infarction
5216405|NCT00759304|Neuropsychological evaluation|neuropsychological evaluation
5216406|NCT00759304|Prospective cohort|prospective cohort
5216407|NCT00759291|free fatty acids|free fatty acids
5216408|NCT00759291|insulin-mediated|insulin-mediated
5216409|NCT00759291|endothelium-dependent vasodilation|endothelium-dependent vasodilation
5216410|NCT00759291|metabolic syndrome|metabolic syndrome
5216411|NCT00759278|pregnancy|pregnancy
5216412|NCT00759278|umbilical artery systolic to diastolic flow ratio|umbilical artery systolic to diastolic flow ratio
5216413|NCT00759278|middle cerebral artery peak systolic flow|middle cerebral artery peak systolic flow
5216414|NCT00759278|antihypertensive medication|antihypertensive medication
5216415|NCT00759265|Muscle strength|muscle strength
5216416|NCT00759265|Physical activity|physical activity
5216417|NCT00759265|Mobility|mobility
5216418|NCT00759265|Gait analysis|gait analysis
5216419|NCT00759252|diagnosis of dementia|diagnosis of dementia
5216420|NCT00759252|perceptions of risk|perceptions of risk
5216421|NCT00759252|dementia screening|dementia screening
5216422|NCT00759239|Open-angle glaucoma (with or without pseudoexfoliation or pigment dispersion component), or ocular hypertension|open-angle glaucoma (with or without pseudoexfoliation or pigment dispersion component), or ocular hypertension
5216423|NCT00759226|esophageal cancer|esophageal cancer
5216424|NCT00759226|Gemcitabine|gemcitabine
5216425|NCT00759226|Cisplatin|cisplatin
5216426|NCT00759226|5-FU|5-fu
5216427|NCT00759226|Folinic Acid|folinic acid
5216428|NCT00759226|inoperable esophageal cancer|inoperable esophageal cancer
5216429|NCT00759213|Discharge planning|discharge planning
5216430|NCT00759213|Family needs|family needs
5216431|NCT00759213|Family concerns|family concerns
5216432|NCT00759213|NICU|nicu
5216433|NCT00759213|Infants|infants
5216434|NCT00759200|Chronic hepatitis C|chronic hepatitis c
5216435|NCT00759200|genotype 2|genotype 2
5216436|NCT00759200|genotype 3|genotype 3
5216437|NCT00759200|albumin interferon alfa-2b|albumin interferon alfa-2b
5216438|NCT00759200|alb-interferon|alb-interferon
5216439|NCT00759174|Optic Neuropathy Acute NAION PDE5 Inhibitor|optic neuropathy acute naion pde5 inhibitor
5216440|NCT00759161|Plaque Type Psoriasis|plaque type psoriasis
5216441|NCT00759161|Topical|topical
5216442|NCT00759148|pink eye|pink eye
5216443|NCT00759148|conjunctivitis|conjunctivitis
5216444|NCT00759148|moxifloxacin|moxifloxacin
5216445|NCT00759148|fluoroquinolone|fluoroquinolone
5216446|NCT00759135|Benign Prostatic Hyperplasia|benign prostatic hyperplasia
5216447|NCT00759135|BPH|bph
5216448|NCT00759135|Enlarged Prostate|enlarged prostate
5216449|NCT00759122|mdd|mdd
5216450|NCT00759122|major depressive disorder|major depressive disorder
5216451|NCT00759122|depression|depression
5216452|NCT00759096|bilateral implantation|bilateral implantation
5216453|NCT00759096|ReSTOR Aspheric IOL|restor aspheric iol
5216454|NCT00759096|uniocular unaided distance|uniocular unaided distance
5216455|NCT00759096|binocular unaided distance|binocular unaided distance
5216456|NCT00759096|intermediate visual acuity|intermediate visual acuity
5216457|NCT00759096|near visual acuity|near visual acuity
5216458|NCT00759083|HIT|hit
5216459|NCT00759083|HITTS|hitts
5216460|NCT00759070|Treatment Naïve|treatment naïve
5216461|NCT00759057|Spinal Stenosis|spinal stenosis
5216462|NCT00759057|Spinal Instability|spinal instability
5216463|NCT00759057|Leg Pain|leg pain
5216464|NCT00759018|GVHD|gvhd
5216465|NCT00759018|Prochymal|prochymal
5216466|NCT00759018|Graft vs Host Disease|graft vs host disease
5216468|NCT00758966|OCD,|ocd,
5216469|NCT00758966|naltrexone,|naltrexone,
5216470|NCT00758966|fluoxetine,|fluoxetine,
5216471|NCT00758966|obsessive-compulsive disorder|obsessive-compulsive disorder
5216472|NCT00758940|Clinical|clinical
5216473|NCT00758940|assessment|assessment
5216474|NCT00758940|of visual|of visual
5216475|NCT00758940|function|function
5216476|NCT00758940|with the Acrysof ReSTOR|with the acrysof restor
5216477|NCT00758940|multifocal IOL|multifocal iol
5216478|NCT00758927|diabetes mellitus|diabetes mellitus
5216479|NCT00758927|combined hyperlipidemia|combined hyperlipidemia
5216480|NCT00758927|OMACOR|omacor
5216481|NCT00758927|small dense LDL|small dense ldl
5216482|NCT00758927|HDL subfraction|hdl subfraction
5216483|NCT00758914|Vitamin E|vitamin e
5216484|NCT00758849|NOH|noh
5216485|NCT00758849|Orthostatic hypotension|orthostatic hypotension
5216486|NCT00758849|PAF|paf
5216487|NCT00758849|MSA|msa
5216488|NCT00758849|Shy-Drager syndrome|shy-drager syndrome
5216489|NCT00758849|Olivopontocerebellar atrophy|olivopontocerebellar atrophy
5216490|NCT00758849|Striatonigral degeneration|striatonigral degeneration
5216491|NCT00758849|Autonomic Failure|autonomic failure
5216492|NCT00758849|Parkinson|parkinson
5216493|NCT00758849|Fipamezole|fipamezole
5216494|NCT00758849|JP-1730|jp-1730
5216495|NCT00758823|head lice|head lice
5216496|NCT00758810|Health Education|health education
5216497|NCT00758810|Myocardial Infarction|myocardial infarction
5216498|NCT00758810|Acute Coronary Syndrome|acute coronary syndrome
5216499|NCT00758810|Quality of Life|quality of life
5216500|NCT00758797|metastatic melanoma|metastatic melanoma
5216501|NCT00758758|Anterior Cervical Discectomy and Fusion,|anterior cervical discectomy and fusion,
5216502|NCT00758758|Degenerative Disc Disease,|degenerative disc disease,
5216503|NCT00758758|Cervical Spine,|cervical spine,
5216504|NCT00758758|Herniated Disc|herniated disc
5216505|NCT00758745|Cataract|cataract
5216506|NCT00758745|Patients|patients
5216507|NCT00758745|bilateral|bilateral
5216508|NCT00758745|age related|age related
5216509|NCT00758745|undergoing|undergoing
5216510|NCT00758745|phacoemulsification|phacoemulsification
5216511|NCT00758732|Cancer|cancer
5216512|NCT00758732|Ovarian cancer|ovarian cancer
5216513|NCT00758732|Chemotherapy|chemotherapy
5216514|NCT00758732|Docetaxel|docetaxel
5216515|NCT00758732|Carboplatin|carboplatin
5216516|NCT00758732|Pegylated doxorubicin|pegylated doxorubicin
5216517|NCT00758732|Platinum sensitive|platinum sensitive
5216518|NCT00758719|Spinal Fusion|spinal fusion
5216519|NCT00758719|DDD|ddd
5216520|NCT00758706|COPD|copd
5216521|NCT00758693|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
5216522|NCT00758693|Bendamustine|bendamustine
5216523|NCT00758693|Treanda|treanda
5216524|NCT00758693|Rituximab|rituximab
5216525|NCT00758693|Rituxan|rituxan
5216526|NCT00758667|capsular contracture|capsular contracture
5216527|NCT00758667|capsulectomy|capsulectomy
5216528|NCT00758667|mesna|mesna
5216529|NCT00758667|Capsular contracture after breast implant placement|capsular contracture after breast implant placement
5216530|NCT00758654|myocardial strain|myocardial strain
5216531|NCT00758654|Strain-Encoded MRI|strain-encoded mri
5216532|NCT00758654|dobutamine stress MRI|dobutamine stress mri
5216533|NCT00758654|ischemia|ischemia
5216534|NCT00758654|strain rate reserve|strain rate reserve
5216535|NCT00758641|plantar fasciitis|plantar fasciitis
5216536|NCT00758641|platelet rich plasma|platelet rich plasma
5216537|NCT00758641|GPS|gps
5216538|NCT00758615|Obesity|obesity
5216539|NCT00758615|Physical activity|physical activity
5216540|NCT00758615|Injury Prevention|injury prevention
5216541|NCT00758615|Pedestrian safety|pedestrian safety
5216542|NCT00758615|Self efficacy|self efficacy
5216543|NCT00758615|School|school
5216544|NCT00758615|Walking School Bus|walking school bus
5216545|NCT00758615|Safe Routes to School|safe routes to school
5216546|NCT00758589|Asthma|asthma
5216547|NCT00758576|Cataract|cataract
5216548|NCT00758550|Visual function;|visual function;
5216549|NCT00758550|Refractive cylinder;|refractive cylinder;
5216550|NCT00758550|AcrySof® Toric;|acrysof® toric;
5216551|NCT00758550|AcrySof® Natural|acrysof® natural
5216552|NCT00758537|Assessment of tryptophan and tryptophan catabolites and IDO-activity in patients with chronic kidney disease|assessment of tryptophan and tryptophan catabolites and ido-activity in patients with chronic kidney disease
5216553|NCT00758524|Essential hypertension|essential hypertension
5216554|NCT00758524|phase 2 study|phase 2 study
5216555|NCT00758524|antihypertensive agent|antihypertensive agent
5216556|NCT00758511|cortisol|cortisol
5216557|NCT00758511|pain|pain
5216558|NCT00758511|pain management|pain management
5216559|NCT00758511|preterm infants|preterm infants
5216560|NCT00758511|sucrose|sucrose
5216561|NCT00758511|facilitated tucking|facilitated tucking
5216562|NCT00758459|COPD|copd
5216563|NCT00758433|Adverse Events|adverse events
5216564|NCT00758433|Erythema Rating|erythema rating
5216565|NCT00758433|Pharmacokinetics|pharmacokinetics
5216566|NCT00758433|Civamide|civamide
5216567|NCT00758433|Phase 1|phase 1
5216568|NCT00758433|Pain|pain
5216569|NCT00758433|Patch|patch
5216570|NCT00758420|Varicose Veins|varicose veins
5216571|NCT00758407|Fatigue, Cancer, Methylphenidate,|fatigue, cancer, methylphenidate,
5216572|NCT00758381|pancreatic cancer|pancreatic cancer
5216573|NCT00758381|advanced or metastatic|advanced or metastatic
5216574|NCT00758381|sorafenib|sorafenib
5216575|NCT00758368|Parkinson's disease|parkinson's disease
5216576|NCT00758368|PD|pd
5216577|NCT00758368|pulsatile apomorphine|pulsatile apomorphine
5216578|NCT00758368|dyskinesia|dyskinesia
5216579|NCT00758368|apomorphine|apomorphine
5216580|NCT00758368|continuous dopaminergic stimulation|continuous dopaminergic stimulation
5216581|NCT00758342|IOP lowering efficacy and safety of Azopt plus Travatan|iop lowering efficacy and safety of azopt plus travatan
5216582|NCT00758316|Malignant|malignant
5216583|NCT00758316|Pleural|pleural
5216584|NCT00758316|Effusions|effusions
5216585|NCT00758316|Thoracoscopy|thoracoscopy
5216586|NCT00758316|Catheter|catheter
5216587|NCT00758303|Triglycerides|triglycerides
5216588|NCT00758303|Cholesterol|cholesterol
5216589|NCT00758277|prevention of alcohol relapse|prevention of alcohol relapse
5216590|NCT00758264|Safety|safety
5216591|NCT00758264|Routine infancy vaccination|routine infancy vaccination
5216592|NCT00758264|Meningococcal vaccine|meningococcal vaccine
5216593|NCT00758264|Immunogenicity|immunogenicity
5216594|NCT00758264|Pneumococcal vaccine|pneumococcal vaccine
5216595|NCT00758251|Schizophrenia|schizophrenia
5216596|NCT00758251|Seroquel XR|seroquel xr
5216597|NCT00758251|CGI|cgi
5216598|NCT00758238|hypertension|hypertension
5216599|NCT00758238|self-management|self-management
5216600|NCT00758238|e-health|e-health
5216601|NCT00758225|Duchenne Muscular Dystrophy|duchenne muscular dystrophy
5216602|NCT00758225|DMD|dmd
5216603|NCT00758225|Duchenne|duchenne
5216604|NCT00758225|Idebenone|idebenone
5216605|NCT00758212|Influenza in Humans|influenza in humans
5216606|NCT00758212|Acquired Immune Deficiency Syndrome|acquired immune deficiency syndrome
5216607|NCT00758212|Immunization, Active|immunization, active
5216608|NCT00758186|Colorectal cancer|colorectal cancer
5216609|NCT00758186|Endoscopic stent|endoscopic stent
5216610|NCT00758186|Intestinal obstruction|intestinal obstruction
5216611|NCT00758186|Laparoscopy|laparoscopy
5216612|NCT00758173|prostate cancer|prostate cancer
5216613|NCT00758160|Attention Deficit Disorder With Hyperactivity|attention deficit disorder with hyperactivity
5216614|NCT00758160|Methylphenidate|methylphenidate
5216615|NCT00758160|Concerta|concerta
5216616|NCT00758147|force feedback joystick|force feedback joystick
5216617|NCT00758147|stroke|stroke
5216618|NCT00758147|haptics|haptics
5216619|NCT00758147|kinematics|kinematics
5216620|NCT00758147|rehabilitation|rehabilitation
5216621|NCT00758147|robotics|robotics
5216622|NCT00758147|Force feedback joystick in stroke rehabilitation|force feedback joystick in stroke rehabilitation
5216623|NCT00758108|Genotype/Phenotype Correlation|genotype/phenotype correlation
5216624|NCT00758108|Energy Homeostasis|energy homeostasis
5216625|NCT00758108|Nociception|nociception
5216626|NCT00758108|Obesity|obesity
5216627|NCT00758108|Behavior and Neurocognition|behavior and neurocognition
5216628|NCT00758108|WAGR Syndrome|wagr syndrome
5216629|NCT00758108|Wilm's Tumor|wilm's tumor
5216630|NCT00758108|Aniridia|aniridia
5216631|NCT00758108|Mental Retardation|mental retardation
5216632|NCT00758108|Urogenital Abnormalities|urogenital abnormalities
5216633|NCT00758108|Healthy Volunteer|healthy volunteer
5216634|NCT00758082|type 1 diabetes|type 1 diabetes
5216635|NCT00758082|PDA phone (Personal Digital Assistant)|pda phone (personal digital assistant)
5216636|NCT00758082|HbA1c|hba1c
5216637|NCT00758056|endometrial cancer|endometrial cancer
5216638|NCT00758043|Genotype 1|genotype 1
5216639|NCT00758030|Schizophrenia|schizophrenia
5216640|NCT00758030|Paliperidone|paliperidone
5216641|NCT00758017|low back pain|low back pain
5216642|NCT00758017|acupuncture|acupuncture
5216643|NCT00758004|Cardiovascular Diseases|cardiovascular diseases
5216644|NCT00757991|healthy, no evidence of disease|healthy, no evidence of disease
5216645|NCT00757978|Schizophrenia|schizophrenia
5216646|NCT00757978|negative symptoms|negative symptoms
5216647|NCT00757978|clozapine|clozapine
5216648|NCT00757965|colon cancer|colon cancer
5216649|NCT00757965|rectal cancer|rectal cancer
5216650|NCT00757952|ovarian epithelial cancer|ovarian epithelial cancer
5216651|NCT00757939|Alzheimer's Disease, MRI, PET|alzheimer's disease, mri, pet
5216652|NCT00757900|influenza, human|influenza, human
5216653|NCT00757887|malaria|malaria
5216654|NCT00757887|plasmodium|plasmodium
5216655|NCT00757887|falciparum|falciparum
5216656|NCT00757887|human|human
5216657|NCT00757887|experimental infection|experimental infection
5216658|NCT00757874|Female urogenital disease|female urogenital disease
5216659|NCT00757874|skin disease|skin disease
5216660|NCT00757848|cystic fibrosis|cystic fibrosis
5216661|NCT00757835|24-hour IOP|24-hour iop
5216662|NCT00757835|exfoliative glaucoma|exfoliative glaucoma
5216663|NCT00757835|travoprost/timolol|travoprost/timolol
5216664|NCT00757835|latanoprost/timolol|latanoprost/timolol
5216665|NCT00757835|fixed combinations|fixed combinations
5216666|NCT00757783|HIV|hiv
5216667|NCT00757783|AIDS|aids
5216668|NCT00757783|Immunodeficiency Virus, Human|immunodeficiency virus, human
5216669|NCT00757783|PREZISTA|prezista
5216670|NCT00757783|darunavir|darunavir
5216671|NCT00757783|TMC114|tmc114
5216672|NCT00757783|Protease Inhibitor|protease inhibitor
5216673|NCT00757783|Truvada|truvada
5216674|NCT00757783|Atazanavir|atazanavir
5216675|NCT00757783|REYATAZ|reyataz
5216676|NCT00757783|HIV Infections|hiv infections
5216677|NCT00757783|Treatment Naïve|treatment naïve
5216678|NCT00757770|Gastroenteritis|gastroenteritis
5216679|NCT00757757|Prostate cancer|prostate cancer
5216680|NCT00757757|bone metastases|bone metastases
5216681|NCT00757757|anti-M-CSF|anti-m-csf
5216682|NCT00757757|M-CSF antibody|m-csf antibody
5216683|NCT00757757|M-CSF|m-csf
5216684|NCT00757757|Prostate Cancer with bone metastases|prostate cancer with bone metastases
5216685|NCT00757744|drug counseling|drug counseling
5216686|NCT00757744|HIV risks|hiv risks
5216687|NCT00757744|methadone maintenance|methadone maintenance
5216688|NCT00757744|HIV Seronegativity|hiv seronegativity
5216689|NCT00757718|Sleep Disordered Breathing|sleep disordered breathing
5216690|NCT00757718|Obstructive Sleep Apnea|obstructive sleep apnea
5216691|NCT00757718|Gestational Hypertension|gestational hypertension
5216692|NCT00757718|Preeclampsia|preeclampsia
5216693|NCT00757705|Schizophrenia|schizophrenia
5216694|NCT00757705|Paliperidone Extended-Release|paliperidone extended-release
5216695|NCT00757692|Vandetanib (ZD6474)|vandetanib (zd6474)
5216696|NCT00757692|Hormone|hormone
5216697|NCT00757692|Refractory|refractory
5216698|NCT00757692|Prostate Cancer|prostate cancer
5216699|NCT00757692|Chemotherapy|chemotherapy
5216700|NCT00757692|Naïve|naïve
5216701|NCT00757666|Pacemaker|pacemaker
5216702|NCT00757640|gastric cancer, surgery, prophylactic cholecystectomy|gastric cancer, surgery, prophylactic cholecystectomy
5216703|NCT00757614|AIDS-related lymphoma|aids-related lymphoma
5216704|NCT00757614|cutaneous lymphoma|cutaneous lymphoma
5216705|NCT00757614|adult Hodgkin lymphoma|adult hodgkin lymphoma
5216706|NCT00757614|adult non-Hodgkin lymphoma|adult non-hodgkin lymphoma
5216707|NCT00757614|intraocular lymphoma|intraocular lymphoma
5216708|NCT00757614|adult T-cell leukemia/lymphoma|adult t-cell leukemia/lymphoma
5216709|NCT00757614|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
5216710|NCT00757614|primary central nervous system Hodgkin lymphoma|primary central nervous system hodgkin lymphoma
5216711|NCT00757614|noncutaneous extranodal lymphoma|noncutaneous extranodal lymphoma
5216712|NCT00757614|adult astrocytic tumors|adult astrocytic tumors
5216713|NCT00757614|adult brain stem glioma|adult brain stem glioma
5216714|NCT00757614|adult choroid plexus tumor|adult choroid plexus tumor
5216715|NCT00757614|adult craniopharyngioma|adult craniopharyngioma
5216716|NCT00757614|adult embryonal tumor|adult embryonal tumor
5216717|NCT00757614|adult ependymal tumors|adult ependymal tumors
5216718|NCT00757614|adult meningeal tumor|adult meningeal tumor
5216719|NCT00757614|adult oligodendroglial tumors|adult oligodendroglial tumors
5216720|NCT00757614|adult pineal parenchymal tumor|adult pineal parenchymal tumor
5216721|NCT00757614|adult brain tumor|adult brain tumor
5216722|NCT00757614|intraocular melanoma|intraocular melanoma
5216723|NCT00757614|bladder cancer|bladder cancer
5216724|NCT00757614|clear cell sarcoma of the kidney|clear cell sarcoma of the kidney
5216725|NCT00757614|congenital mesoblastic nephroma|congenital mesoblastic nephroma
5216726|NCT00757614|esophageal cancer|esophageal cancer
5216727|NCT00757614|melanoma|melanoma
5216728|NCT00757614|pancreatic cancer|pancreatic cancer
5216729|NCT00757614|peripheral primitive neuroectodermal tumor of the kidney|peripheral primitive neuroectodermal tumor of the kidney
5216730|NCT00757614|renal cell carcinoma|renal cell carcinoma
5216731|NCT00757614|rhabdoid tumor of the kidney|rhabdoid tumor of the kidney
5216732|NCT00757614|transitional cell cancer of the renal pelvis and ureter|transitional cell cancer of the renal pelvis and ureter
5216733|NCT00757575|PNEUMONET JAPAN STUDY|pneumonet japan study
5216734|NCT00757549|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
5216735|NCT00757549|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
5216736|NCT00757549|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
5216737|NCT00757549|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
5216738|NCT00757549|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
5216739|NCT00757549|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
5216740|NCT00757549|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5216741|NCT00757549|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5216742|NCT00757549|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5216743|NCT00757536|Rhegmatogenous retinal detachment|rhegmatogenous retinal detachment
5216744|NCT00757536|primary vitrectomy|primary vitrectomy
5216745|NCT00757536|encircling band|encircling band
5216746|NCT00757536|endolaser treatment|endolaser treatment
5216747|NCT00757523|Acne Vulgaris|acne vulgaris
5216748|NCT00757523|Akne|akne
5216749|NCT00757523|Acne|acne
5216750|NCT00757523|Akne Vulgaris|akne vulgaris
5216751|NCT00757510|Congenital Heart Disease|congenital heart disease
5216752|NCT00757497|Treatment Study|treatment study
5216753|NCT00757497|Psychosis|psychosis
5216754|NCT00757497|Electrical Stimulation|electrical stimulation
5216755|NCT00757497|Refractory|refractory
5216756|NCT00757497|Novel|novel
5216757|NCT00757497|Childhood Onset Psychotic Disorders|childhood onset psychotic disorders
5216758|NCT00757497|Schizophrenia|schizophrenia
5216759|NCT00757471|Macular hole surgery|macular hole surgery
5216760|NCT00757471|membranepeeling|membranepeeling
5216761|NCT00757471|closure rate|closure rate
5216762|NCT00757471|vitreoretinal dyes|vitreoretinal dyes
5216763|NCT00757458|Propofol|propofol
5216764|NCT00757458|Bacterial growth|bacterial growth
5216765|NCT00757458|Fungal growth|fungal growth
5216766|NCT00757458|EDTA|edta
5216767|NCT00757458|Target controlled infusion|target controlled infusion
5216768|NCT00757445|Antibiotic therapy|antibiotic therapy
5216769|NCT00757445|Microbiological diagnosis|microbiological diagnosis
5216770|NCT00757419|Safety|safety
5216771|NCT00757419|tolerability|tolerability
5216772|NCT00757419|healthy subjects|healthy subjects
5216773|NCT00757406|Lymphedema|lymphedema
5216774|NCT00757406|Bioimpedance|bioimpedance
5216775|NCT00757393|Growth hormone|growth hormone
5216776|NCT00757393|Pediatrics|pediatrics
5216777|NCT00757393|Vitamin D|vitamin d
5216778|NCT00757393|Calcium|calcium
5216779|NCT00757393|Exercise|exercise
5216780|NCT00757380|epiretinal membranes|epiretinal membranes
5216781|NCT00757380|vitreoretinal dyes|vitreoretinal dyes
5216782|NCT00757380|membranepeeling|membranepeeling
5216783|NCT00757367|Healthy subjects|healthy subjects
5216784|NCT00757367|insulin|insulin
5216785|NCT00757367|bronchoscope|bronchoscope
5216786|NCT00757367|serum insulin|serum insulin
5216787|NCT00757367|serum C-Peptide|serum c-peptide
5216788|NCT00757367|BAL fluid|bal fluid
5216789|NCT00757367|FDKP|fdkp
5216790|NCT00757328|Bipolar depression Treatment|bipolar depression treatment
5216791|NCT00757315|acne keloidalis nuchae|acne keloidalis nuchae
5216792|NCT00757315|NdYag laser|ndyag laser
5216793|NCT00757315|AKN|akn
5216794|NCT00757315|acne keloidalis|acne keloidalis
5216795|NCT00757315|AK|ak
5216796|NCT00757315|dermatitis papillaris capillitii|dermatitis papillaris capillitii
5216797|NCT00757315|folliculitis keloidalis nuchae|folliculitis keloidalis nuchae
5216798|NCT00757315|sycosis nuchae|sycosis nuchae
5216799|NCT00757315|acne keloid|acne keloid
5216800|NCT00757315|keloidal folliculitis|keloidal folliculitis
5216801|NCT00757315|lichen keloidalis nuchae|lichen keloidalis nuchae
5216802|NCT00757315|folliculitis nuchae scleroticans|folliculitis nuchae scleroticans
5216803|NCT00757315|sycosis framboesiformis|sycosis framboesiformis
5216804|NCT00757302|breast cancer|breast cancer
5216805|NCT00757302|CarolIReS|carolires
5216806|NCT00757302|intraoperative gamma camera|intraoperative gamma camera
5216807|NCT00757302|lymphoscintigraphy|lymphoscintigraphy
5216808|NCT00757302|sentinel lymph node|sentinel lymph node
5216809|NCT00757302|Hundred and ten patients with infiltrative breast cancer or ductal carcinoma in situ (DCIS), diagnosed preoperatively by core biopsy or cytology.|hundred and ten patients with infiltrative breast cancer or ductal carcinoma in situ (dcis), diagnosed preoperatively by core biopsy or cytology.
5216810|NCT00757289|Tennis Elbow|tennis elbow
5216811|NCT00757276|Copeptin|copeptin
5216812|NCT00757276|Diabetes insipidus|diabetes insipidus
5216813|NCT00757276|diagnostic marker|diagnostic marker
5216814|NCT00757276|Vasopressin|vasopressin
5216815|NCT00757276|antidiuretic hormone (ADH)|antidiuretic hormone (adh)
5216816|NCT00757263|ovarian epithelial cancer|ovarian epithelial cancer
5216817|NCT00757263|ovarian germ cell tumor|ovarian germ cell tumor
5216818|NCT00757263|ovarian sarcoma|ovarian sarcoma
5216819|NCT00757263|ovarian stromal cancer|ovarian stromal cancer
5216820|NCT00757250|HIV|hiv
5216821|NCT00757250|AIDS|aids
5216822|NCT00757250|Human Immunodeficiency Virus|human immunodeficiency virus
5216823|NCT00757250|CD4+ T-lymphocytes|cd4+ t-lymphocytes
5216824|NCT00757250|treatment Experienced|treatment experienced
5216825|NCT00757237|aztreonam lysine|aztreonam lysine
5216826|NCT00757237|tobramycin inhalation solution|tobramycin inhalation solution
5216827|NCT00757237|tobramycin nebuliser solution|tobramycin nebuliser solution
5216828|NCT00757237|cystic fibrosis|cystic fibrosis
5216829|NCT00757237|pseudomonas aeruginosa|pseudomonas aeruginosa
5216830|NCT00757237|lung infection|lung infection
5216831|NCT00757237|CFQ-R|cfq-r
5216832|NCT00757237|inhaled antibiotic|inhaled antibiotic
5216833|NCT00757211|breast cancer|breast cancer
5216834|NCT00757211|male breast cancer|male breast cancer
5216835|NCT00757198|pain, postoperative, opioid, PCA, cardiac surgery|pain, postoperative, opioid, pca, cardiac surgery
5216836|NCT00757185|skin blood flow|skin blood flow
5216837|NCT00757185|microcirculation|microcirculation
5216838|NCT00757172|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
5216839|NCT00757172|adenocarcinoma of the gastroesophageal junction|adenocarcinoma of the gastroesophageal junction
5216840|NCT00757172|stage II esophageal cancer|stage ii esophageal cancer
5216841|NCT00757172|stage III esophageal cancer|stage iii esophageal cancer
5216842|NCT00757172|stage IV esophageal cancer|stage iv esophageal cancer
5216843|NCT00757159|Periodontal disease|periodontal disease
5216844|NCT00757159|Hydroxyapatite|hydroxyapatite
5216845|NCT00757159|Enamel matrix protein|enamel matrix protein
5216846|NCT00757159|Regeneration|regeneration
5216847|NCT00757159|Human|human
5216848|NCT00757146|chronic lung disease|chronic lung disease
5216849|NCT00757146|bronchopulmonary dysplasia|bronchopulmonary dysplasia
5216850|NCT00757146|inhaled nitric oxide|inhaled nitric oxide
5216851|NCT00757146|premature infants|premature infants
5216852|NCT00757120|COPD|copd
5216853|NCT00757120|Cigarette Smoke-Induced Inflammation|cigarette smoke-induced inflammation
5216854|NCT00757120|EMMPRIN|emmprin
5216855|NCT00757120|Matrix Metalloproteinase|matrix metalloproteinase
5216856|NCT00757107|Short femoral stem|short femoral stem
5216857|NCT00757107|Stress shielding|stress shielding
5216858|NCT00757107|Stem migration|stem migration
5216859|NCT00757107|Implant Survival|implant survival
5216860|NCT00757107|DEXA|dexa
5216861|NCT00757107|Radiostereometric analysis|radiostereometric analysis
5216862|NCT00757094|Fasting|fasting
5216863|NCT00757094|Chemotherapy|chemotherapy
5216864|NCT00757094|Cancer|cancer
5216865|NCT00757068|Non-smoking|non-smoking
5216866|NCT00757068|Women|women
5216867|NCT00757068|Pregnancy|pregnancy
5216868|NCT00757068|Treatment|treatment
5216869|NCT00757068|Mood|mood
5216870|NCT00757068|Weight|weight
5216871|NCT00757068|Supportive|supportive
5216872|NCT00757068|Adjustment|adjustment
5216873|NCT00757055|Heart failure|heart failure
5216874|NCT00757055|Diastolic heart failure|diastolic heart failure
5216875|NCT00757055|Heart failure with preserved systolic function|heart failure with preserved systolic function
5216876|NCT00757055|Heart failure with normal ejection fraction|heart failure with normal ejection fraction
5216877|NCT00757055|Ivabradine|ivabradine
5216878|NCT00757055|Diastolic dysfunction|diastolic dysfunction
5216879|NCT00757042|atopic dermatitis|atopic dermatitis
5216880|NCT00757042|skin diseases|skin diseases
5216881|NCT00757042|healthy volunteer|healthy volunteer
5216882|NCT00757029|ADHD,|adhd,
5216883|NCT00757029|norepinephrine transporter|norepinephrine transporter
5216884|NCT00757029|pharmacogenetics|pharmacogenetics
5216885|NCT00757016|low back pain|low back pain
5216886|NCT00757016|randomised controlled trial|randomised controlled trial
5216887|NCT00757016|slow release corticosteroid|slow release corticosteroid
5216888|NCT00757016|injection treatment|injection treatment
5216889|NCT00756977|Colonoscopy|colonoscopy
5216890|NCT00756977|screening|screening
5216891|NCT00756964|cardiac surgery|cardiac surgery
5216892|NCT00756964|hyperuricemia|hyperuricemia
5216893|NCT00756951|SCV-07|scv-07
5216894|NCT00756951|Oral Mucositis|oral mucositis
5216895|NCT00756925|CRH|crh
5216896|NCT00756925|cocaine|cocaine
5216897|NCT00756925|functional magnetic resonance imaging|functional magnetic resonance imaging
5216898|NCT00756925|gender differences|gender differences
5216899|NCT00756912|ANC|anc
5216900|NCT00756912|BMT|bmt
5216901|NCT00756912|graft versus leukemia|graft versus leukemia
5216902|NCT00756912|graft vs. host disease|graft vs. host disease
5216903|NCT00756912|MD2 (endotoxin binding-protein)|md2 (endotoxin binding-protein)
5216904|NCT00756912|undergo allogeneic BMT|undergo allogeneic bmt
5216905|NCT00756912|myeloablative|myeloablative
5216906|NCT00756912|conditioning|conditioning
5216907|NCT00756912|therapy|therapy
5216908|NCT00756899|Vitamin D deficiency, insulin resistance, obesity, bone|vitamin d deficiency, insulin resistance, obesity, bone
5216909|NCT00756873|Elective tonsillectomy|elective tonsillectomy
5216910|NCT00756847|Solid Tumors|solid tumors
5216911|NCT00756847|NSCLC|nsclc
5216912|NCT00756847|Ovarian Cancer|ovarian cancer
5216913|NCT00756847|Endometrial Cancer|endometrial cancer
5217645|NCT00753909|Paclitaxel|paclitaxel
5216914|NCT00756821|Spinal Muscular Atrophy|spinal muscular atrophy
5216915|NCT00756821|Blood Biomarkers|blood biomarkers
5216916|NCT00756821|Urine Biomarkers|urine biomarkers
5216917|NCT00756821|Type I Spinal Muscular Atrophy|type i spinal muscular atrophy
5216918|NCT00756821|Type II Spinal Muscular Atrophy|type ii spinal muscular atrophy
5216919|NCT00756821|Type III Spinal Muscular Atrophy|type iii spinal muscular atrophy
5216920|NCT00756821|Modified Hammersmith Functional Motor Scale|modified hammersmith functional motor scale
5216921|NCT00756821|Disease severity|disease severity
5216922|NCT00756821|Biomarkers|biomarkers
5216923|NCT00756808|latent tuberculosis in elderly|latent tuberculosis in elderly
5216924|NCT00756782|hepatocellular carcinoma|hepatocellular carcinoma
5216925|NCT00756756|G-CSF|g-csf
5216926|NCT00756756|Myocardial infarction|myocardial infarction
5216927|NCT00756743|PF-04802540 multiple dose safety study|pf-04802540 multiple dose safety study
5216928|NCT00756730|lopinavir|lopinavir
5216929|NCT00756730|ritonavir|ritonavir
5216930|NCT00756730|atazanavir|atazanavir
5216931|NCT00756730|fosamprenavir|fosamprenavir
5216932|NCT00756730|darunavir|darunavir
5216933|NCT00756730|anti-retroviral|anti-retroviral
5216934|NCT00756730|AIDS|aids
5216935|NCT00756730|HIV|hiv
5216936|NCT00756730|LARD|lard
5216937|NCT00756730|triglyceride|triglyceride
5216938|NCT00756730|protease inhibitors|protease inhibitors
5216939|NCT00756730|treatment Experienced|treatment experienced
5216940|NCT00756717|MK-0752|mk-0752
5216941|NCT00756717|Tamoxifen|tamoxifen
5216942|NCT00756717|Letroxole|letroxole
5216943|NCT00756704|Smoking Cessation|smoking cessation
5216944|NCT00756704|Emergency Medicine|emergency medicine
5216945|NCT00756704|Emergency Nursing|emergency nursing
5216946|NCT00756704|Effectiveness Trial|effectiveness trial
5216947|NCT00756704|Implementation|implementation
5216948|NCT00756704|Relapse prevention|relapse prevention
5216949|NCT00756691|18F-FAZA|18f-faza
5216950|NCT00756691|Positron Emission Tomography|positron emission tomography
5216951|NCT00756691|Radiation dosimetry|radiation dosimetry
5216952|NCT00756691|Pharmacokinetics|pharmacokinetics
5216953|NCT00756665|prostate|prostate
5216954|NCT00756665|cancer|cancer
5216955|NCT00756639|small cell carcinoma of the bladder|small cell carcinoma of the bladder
5216956|NCT00756639|urothelial carcinoma|urothelial carcinoma
5216957|NCT00756639|genitourinary bladder|genitourinary bladder
5216958|NCT00756639|urothelium|urothelium
5216959|NCT00756639|bladder|bladder
5216960|NCT00756639|bladder cancer|bladder cancer
5217213|NCT00755651|Endometrial polyps|endometrial polyps
5216961|NCT00756639|prophylactic cranial irradiation|prophylactic cranial irradiation
5216962|NCT00756639|PCI|pci
5216963|NCT00756639|brain metastasis|brain metastasis
5216964|NCT00756639|genitourinary|genitourinary
5216965|NCT00756639|radiation|radiation
5216966|NCT00756639|TCC|tcc
5216967|NCT00756639|adenocarcinoma|adenocarcinoma
5216968|NCT00756626|Bottle Weaning|bottle weaning
5216969|NCT00756626|Bottle Feeding|bottle feeding
5216970|NCT00756626|Overweight in toddlers|overweight in toddlers
5216971|NCT00756626|Bottle use|bottle use
5216972|NCT00756626|excess weight for length|excess weight for length
5216973|NCT00756600|Infants|infants
5216974|NCT00756600|scheduled|scheduled
5216975|NCT00756600|unilateral|unilateral
5216976|NCT00756600|bilateral|bilateral
5216977|NCT00756600|repair|repair
5216978|NCT00756587|Cup Feeding|cup feeding
5216979|NCT00756587|late Preterm|late preterm
5216980|NCT00756574|N95|n95
5216981|NCT00756574|Respirator|respirator
5216982|NCT00756574|mask|mask
5216983|NCT00756574|influenza|influenza
5216984|NCT00756574|efficacy|efficacy
5216985|NCT00756561|Fine Needle Aspiration|fine needle aspiration
5216986|NCT00756561|Male Health|male health
5216987|NCT00756561|Male Contraception|male contraception
5216988|NCT00756548|colonoscopy|colonoscopy
5216989|NCT00756548|screening|screening
5216990|NCT00756535|Exercise Therapy|exercise therapy
5216991|NCT00756535|Length of Stay|length of stay
5216992|NCT00756535|Disability Evaluation|disability evaluation
5216993|NCT00756522|COPD|copd
5216994|NCT00756509|unresectable or metastatic GIST|unresectable or metastatic gist
5216995|NCT00756509|1st. line treatment|1st. line treatment
5216996|NCT00756483|Resistance|resistance
5216997|NCT00756483|Exercise|exercise
5216998|NCT00756470|Breast Cancer|breast cancer
5216999|NCT00756470|Inflammatory Breast Cancer|inflammatory breast cancer
5217000|NCT00756470|IBC|ibc
5217001|NCT00756470|ErbB2 overexpression|erbb2 overexpression
5217002|NCT00756470|Lapatinib|lapatinib
5217003|NCT00756470|Paclitaxel|paclitaxel
5217004|NCT00756470|5-Fluorouracil|5-fluorouracil
5217005|NCT00756470|Epirubicin|epirubicin
5217006|NCT00756470|Cyclophosphamide|cyclophosphamide
5217007|NCT00756470|Neoadjuvant Chemotherapy|neoadjuvant chemotherapy
5217008|NCT00756457|PTTD|pttd
5217009|NCT00756457|Tendinopathy|tendinopathy
5217010|NCT00756457|Tendon Injuries|tendon injuries
5217011|NCT00756457|Muscular Diseases|muscular diseases
5217012|NCT00756457|Foot Diseases|foot diseases
5217013|NCT00756444|PK Study, Metastatic Recurrent|pk study, metastatic recurrent
5217014|NCT00756405|Adults|adults
5217015|NCT00756405|Antioxidants|antioxidants
5217646|NCT00753909|Carboplatin|carboplatin
5217016|NCT00756405|Inflammatory markers|inflammatory markers
5217017|NCT00756405|Diet|diet
5217018|NCT00756405|Supplements|supplements
5217019|NCT00756392|3T MR Spectroscopy|3t mr spectroscopy
5217020|NCT00756392|Prostate Imaging|prostate imaging
5217021|NCT00756379|Cardiovascular disease|cardiovascular disease
5217022|NCT00756379|Atherosclerosis|atherosclerosis
5217023|NCT00756379|Coronary artery disease|coronary artery disease
5217024|NCT00756379|Coronary perfusion defect|coronary perfusion defect
5217025|NCT00756379|Absolute coronary flow|absolute coronary flow
5217026|NCT00756379|Lifestyle management|lifestyle management
5217027|NCT00756379|Cardiovascular rehabilitation|cardiovascular rehabilitation
5217028|NCT00756379|Cardiovascular dietary guidelines|cardiovascular dietary guidelines
5217029|NCT00756366|positron emission tomography|positron emission tomography
5217030|NCT00756366|myocardial energetics|myocardial energetics
5217031|NCT00756366|sympathetic nerve function|sympathetic nerve function
5217032|NCT00756353|Heroin|heroin
5217033|NCT00756353|Buprenorphine use|buprenorphine use
5217034|NCT00756327|pediatric eyes|pediatric eyes
5217035|NCT00756327|bilateral cataract|bilateral cataract
5217036|NCT00756327|IOL implantation|iol implantation
5217037|NCT00756327|Aqualase capsule wash|aqualase capsule wash
5217038|NCT00756327|posterior capsule opacification|posterior capsule opacification
5217039|NCT00756314|Ambulatory Care Facilities|ambulatory care facilities
5217040|NCT00756314|abortion care|abortion care
5217041|NCT00756314|contraception|contraception
5217042|NCT00756314|counseling|counseling
5217043|NCT00756314|outpatient clinic|outpatient clinic
5217044|NCT00756288|Actinic Keratoses|actinic keratoses
5217045|NCT00756288|Blue light therapy|blue light therapy
5217046|NCT00756288|photosensitizer|photosensitizer
5217047|NCT00756288|Retinoid|retinoid
5217048|NCT00756275|Tobacco Smoking|tobacco smoking
5217049|NCT00756275|Smoking Cessation|smoking cessation
5217050|NCT00756275|Nicotine Dependence|nicotine dependence
5217051|NCT00756275|Tobacco Use Disorder|tobacco use disorder
5217052|NCT00756262|Vancomycin Resistant enterococcal colonization|vancomycin resistant enterococcal colonization
5217053|NCT00756262|Probiotics|probiotics
5217054|NCT00756262|LGG|lgg
5217055|NCT00756262|Lactobacillus rhamnosus|lactobacillus rhamnosus
5217056|NCT00756249|Acute ischemic stroke|acute ischemic stroke
5217057|NCT00756249|Erythropoietin|erythropoietin
5217058|NCT00756249|Carbamylated|carbamylated
5217059|NCT00756249|Neuroprotection|neuroprotection
5217060|NCT00756197|Radiation Proctitis|radiation proctitis
5217061|NCT00756197|Radiation Induced Proctitis|radiation induced proctitis
5217062|NCT00756184|Glaucoma|glaucoma
5217063|NCT00756184|Adherence|adherence
5217064|NCT00756184|Teaching|teaching
5217065|NCT00756171|Cholestatic|cholestatic
5217066|NCT00756171|pruritus|pruritus
5217067|NCT00756171|of any cause|of any cause
5217068|NCT00756158|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
5217069|NCT00756158|dopaminergic|dopaminergic
5217070|NCT00756158|noradrenergic|noradrenergic
5217071|NCT00756158|endophenotype|endophenotype
5217072|NCT00756158|molecular genetics|molecular genetics
5217073|NCT00756158|candidate gene|candidate gene
5217074|NCT00756158|Family-based Association study|family-based association study
5217075|NCT00756145|stage V|stage v
5217076|NCT00756145|treated|treated
5217077|NCT00756145|hemodiafiltration|hemodiafiltration
5217078|NCT00756132|Breast|breast
5217079|NCT00756132|Neoplasm|neoplasm
5217080|NCT00756132|Locally Advanced|locally advanced
5217081|NCT00756132|Stage IV|stage iv
5217082|NCT00756132|Stage III|stage iii
5217083|NCT00756132|Cognitive Function|cognitive function
5217084|NCT00756132|Cytokines|cytokines
5217085|NCT00756132|Inflammatory|inflammatory
5217086|NCT00756132|Node positive|node positive
5217087|NCT00756106|adult glioblastoma|adult glioblastoma
5217214|NCT00755651|Endometrial cancer|endometrial cancer
5217088|NCT00756106|adult giant cell glioblastoma|adult giant cell glioblastoma
5217089|NCT00756106|adult gliosarcoma|adult gliosarcoma
5217090|NCT00756106|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5217091|NCT00756106|adult anaplastic ependymoma|adult anaplastic ependymoma
5217092|NCT00756106|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
5217093|NCT00756106|adult mixed glioma|adult mixed glioma
5217094|NCT00756093|Dry Eye, Artificial Tears,|dry eye, artificial tears,
5217095|NCT00756067|Streptococcus pneumoniae|streptococcus pneumoniae
5217096|NCT00756067|pneumococcal vaccine|pneumococcal vaccine
5217097|NCT00756041|Diabetic Mononeuropathy|diabetic mononeuropathy
5217098|NCT00756041|Diabetic Neuralgia|diabetic neuralgia
5217099|NCT00756041|Mononeuropathy, Diabetic|mononeuropathy, diabetic
5217100|NCT00756041|Neuralgia, Diabetic|neuralgia, diabetic
5217101|NCT00756041|Diabetic Polyneuropathy|diabetic polyneuropathy
5217102|NCT00756041|Drug Therapy|drug therapy
5217103|NCT00756028|OHSS|ohss
5217104|NCT00756028|quality of life|quality of life
5217105|NCT00756028|IVF|ivf
5217106|NCT00756028|ICSI|icsi
5217107|NCT00756028|GnRH-agonist|gnrh-agonist
5217108|NCT00756028|GnRH-antagonist|gnrh-antagonist
5217109|NCT00756015|rotator cuff|rotator cuff
5217110|NCT00756015|post-operative immobilization protocol|post-operative immobilization protocol
5217111|NCT00756015|post-operative early motion protocol|post-operative early motion protocol
5217112|NCT00756015|physical therapy|physical therapy
5217113|NCT00756015|cuff repair integrity|cuff repair integrity
5217114|NCT00756015|ultrasound|ultrasound
5217115|NCT00756002|Chronic Insomnia|chronic insomnia
5217116|NCT00756002|DIMS (Disorders of Initiating and Maintaining Sleep)|dims (disorders of initiating and maintaining sleep)
5217117|NCT00756002|Disorders of Initiating and Maintaining Sleep|disorders of initiating and maintaining sleep
5217118|NCT00756002|Insomnia Disorder Sleep Initiation Dysfunction|insomnia disorder sleep initiation dysfunction
5217119|NCT00756002|Transient Insomnia|transient insomnia
5217120|NCT00756002|Drug Therapy|drug therapy
5217121|NCT00756002|Sleep Disorders, Intrinsic|sleep disorders, intrinsic
5217122|NCT00755976|stage IV melanoma|stage iv melanoma
5217123|NCT00755950|Acute|acute
5217124|NCT00755950|Hepatitis|hepatitis
5217125|NCT00755950|Silymarin|silymarin
5217126|NCT00755950|Global Health|global health
5217127|NCT00755911|dental|dental
5217128|NCT00755911|tooth|tooth
5217129|NCT00755911|implant|implant
5217130|NCT00755911|extraction|extraction
5217131|NCT00755911|Oral|oral
5217132|NCT00755911|Surgical|surgical
5217133|NCT00755911|Procedures|procedures
5217134|NCT00755898|cancer|cancer
5217135|NCT00755898|diagnostic test|diagnostic test
5217136|NCT00755898|urine|urine
5217137|NCT00755898|amantadine acetylation|amantadine acetylation
5217138|NCT00755885|stage IIIA breast cancer|stage iiia breast cancer
5217139|NCT00755885|stage IIIB breast cancer|stage iiib breast cancer
5217140|NCT00755885|stage IIIC breast cancer|stage iiic breast cancer
5217141|NCT00755885|stage IV breast cancer|stage iv breast cancer
5217142|NCT00755885|recurrent breast cancer|recurrent breast cancer
5217143|NCT00755885|estrogen receptor-positive breast cancer|estrogen receptor-positive breast cancer
5217144|NCT00755885|progesterone receptor-positive breast cancer|progesterone receptor-positive breast cancer
5217145|NCT00755859|IgA nephropathy|iga nephropathy
5217146|NCT00755859|steroids|steroids
5217147|NCT00755859|azathioprine|azathioprine
5217148|NCT00755859|chronic kidney disease progression|chronic kidney disease progression
5217149|NCT00755859|proteinuria|proteinuria
5217150|NCT00755846|Diabetes Mellitus|diabetes mellitus
5217151|NCT00755846|Drug Therapy|drug therapy
5217152|NCT00755846|Diabetes Mellitus, Type II|diabetes mellitus, type ii
5217153|NCT00755846|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
5217154|NCT00755846|Hyperinsulinism|hyperinsulinism
5217155|NCT00755846|Insulin Resistance|insulin resistance
5217156|NCT00755807|Central Neuropathic Pain|central neuropathic pain
5217157|NCT00755807|Multiple Sclerosis|multiple sclerosis
5217158|NCT00755781|lung transplant|lung transplant
5217159|NCT00755781|lung transplant recipient|lung transplant recipient
5217160|NCT00755781|bronchiolitis obliterans syndrome|bronchiolitis obliterans syndrome
5217161|NCT00755781|bronchiolitis obliterans|bronchiolitis obliterans
5217162|NCT00755781|single lung transplant|single lung transplant
5217163|NCT00755781|double lung transplant|double lung transplant
5217164|NCT00755781|heart-lung transplant|heart-lung transplant
5217165|NCT00755781|Aerosol|aerosol
5217166|NCT00755768|hemodialysis|hemodialysis
5217167|NCT00755768|phosphate|phosphate
5217168|NCT00755768|calcium phosphate product|calcium phosphate product
5217169|NCT00755768|dietician|dietician
5217170|NCT00755768|dietetic advice|dietetic advice
5217171|NCT00755742|obesity|obesity
5217172|NCT00755742|insulin resistance|insulin resistance
5217173|NCT00755742|metabolic syndrome|metabolic syndrome
5217174|NCT00755742|hepatitis C|hepatitis c
5217175|NCT00755742|adipokine|adipokine
5217176|NCT00755742|TNF|tnf
5217177|NCT00755742|leptin|leptin
5217178|NCT00755742|adiponectin|adiponectin
5217179|NCT00755742|fatigue|fatigue
5217180|NCT00755742|mood|mood
5217181|NCT00755742|depression|depression
5217182|NCT00755742|exercise|exercise
5217183|NCT00755742|diet|diet
5217184|NCT00755742|counseling|counseling
5217185|NCT00755742|behavior modification|behavior modification
5217186|NCT00755729|Preoperative oral carbohydrate|preoperative oral carbohydrate
5217187|NCT00755729|Insulin resistance|insulin resistance
5217188|NCT00755729|phosphatidylinositol-3-kinase|phosphatidylinositol-3-kinase
5217189|NCT00755716|nicotine patch|nicotine patch
5217190|NCT00755716|smoking|smoking
5217191|NCT00755716|topiramate|topiramate
5217192|NCT00755703|Influenza|influenza
5217193|NCT00755703|Vaccine|vaccine
5217194|NCT00755703|Pandemic|pandemic
5217195|NCT00755703|Avian influenza|avian influenza
5217196|NCT00755703|Adenovirus strain 5|adenovirus strain 5
5217197|NCT00755703|Vectored vaccine|vectored vaccine
5217198|NCT00755703|Intranasal|intranasal
5217199|NCT00755703|Tissue-culture derived|tissue-culture derived
5217200|NCT00755703|Non-replicating|non-replicating
5217201|NCT00755690|Chronic Kidney Disease|chronic kidney disease
5217202|NCT00755690|CKD|ckd
5217203|NCT00755690|Diet|diet
5217204|NCT00755690|Dietary Phosphate|dietary phosphate
5217205|NCT00755690|Mineral Metabolism|mineral metabolism
5217206|NCT00755690|FGF-23|fgf-23
5217207|NCT00755664|homocysteine|homocysteine
5217208|NCT00755664|folate acid,|folate acid,
5217209|NCT00755664|vitamin B|vitamin b
5217210|NCT00755664|random controlled trail|random controlled trail
5217211|NCT00755651|Menorrhagia|menorrhagia
5217212|NCT00755651|Uterine fibroids|uterine fibroids
5217215|NCT00755599|Papanicolaou Smear|papanicolaou smear
5217216|NCT00755599|Vaginitis|vaginitis
5217217|NCT00755599|Patient Satisfaction|patient satisfaction
5217218|NCT00755586|Brachial plexus|brachial plexus
5217219|NCT00755586|Muscle denervation|muscle denervation
5217220|NCT00755586|Stem cell transplantation|stem cell transplantation
5217221|NCT00755586|Bone marrow cells|bone marrow cells
5217222|NCT00755586|Satellite cells|satellite cells
5217223|NCT00755586|Fibrosis|fibrosis
5217224|NCT00755573|Pain|pain
5217225|NCT00755573|Neuropathic pain|neuropathic pain
5217226|NCT00755560|Toxocara|toxocara
5217227|NCT00755560|Pediatrics|pediatrics
5217228|NCT00755560|Albendazole|albendazole
5217229|NCT00755560|eosinophilia|eosinophilia
5217230|NCT00755560|parasitology|parasitology
5217231|NCT00755560|pediatric clinical pharmacology|pediatric clinical pharmacology
5217232|NCT00755547|Childhood|childhood
5217233|NCT00755547|insulin sensitivity|insulin sensitivity
5217234|NCT00755547|steatosis, spectroscopy|steatosis, spectroscopy
5217235|NCT00755534|Metastatic colorectal cancer|metastatic colorectal cancer
5217236|NCT00755534|Second line|second line
5217237|NCT00755534|Irinotecan|irinotecan
5217238|NCT00755534|Cetuximab (Erbitux)|cetuximab (erbitux)
5217239|NCT00755534|Capecitabine (Xeloda)|capecitabine (xeloda)
5217240|NCT00755521|Fibromyalgia|fibromyalgia
5217241|NCT00755521|tenderness|tenderness
5217242|NCT00755521|widespread pain|widespread pain
5217243|NCT00755521|comrbidity|comrbidity
5217244|NCT00755508|Chronic Insomnia|chronic insomnia
5217245|NCT00755508|DIMS (Disorders of Initiating and Maintaining Sleep)|dims (disorders of initiating and maintaining sleep)
5217246|NCT00755508|Disorders of Initiating and Maintaining Sleep|disorders of initiating and maintaining sleep
5217247|NCT00755508|Insomnia Disorder Sleep Initiation Dysfunction|insomnia disorder sleep initiation dysfunction
5217248|NCT00755508|Transient Insomnia|transient insomnia
5217249|NCT00755508|Drug Therapy|drug therapy
5217250|NCT00755508|Sleep Disorders, Intrinsic|sleep disorders, intrinsic
5217251|NCT00755495|Chronic Insomnia|chronic insomnia
5217252|NCT00755495|DIMS (Disorders of Initiating and Maintaining Sleep)|dims (disorders of initiating and maintaining sleep)
5217253|NCT00755495|Disorders of Initiating and Maintaining Sleep|disorders of initiating and maintaining sleep
5217254|NCT00755495|Insomnia Disorder Sleep Initiation Dysfunction|insomnia disorder sleep initiation dysfunction
5217255|NCT00755495|Transient Insomnia|transient insomnia
5217256|NCT00755495|Drug Therapy|drug therapy
5217257|NCT00755495|Sleep Disorders, Intrinsic|sleep disorders, intrinsic
5217258|NCT00755482|Osteoarthritis|osteoarthritis
5217259|NCT00755482|Clinical trial|clinical trial
5217260|NCT00755482|Aquamin F|aquamin f
5217261|NCT00755482|NSAID|nsaid
5217262|NCT00755469|Reperfusion injury|reperfusion injury
5217263|NCT00755469|Post-Conditioning|post-conditioning
5217264|NCT00755469|Infarct size|infarct size
5217265|NCT00755456|Peritoneal dialysis|peritoneal dialysis
5217266|NCT00755456|L-carnitine|l-carnitine
5217267|NCT00755456|Insulin resistance|insulin resistance
5217268|NCT00755456|Glucose homeostasis|glucose homeostasis
5217269|NCT00755456|Dyslipidemia|dyslipidemia
5217270|NCT00755430|autism spectrum disorders (ASD)|autism spectrum disorders (asd)
5217271|NCT00755430|structural and functional connectivity|structural and functional connectivity
5217272|NCT00755430|diffusion spectrum imaging (DSI)|diffusion spectrum imaging (dsi)
5217273|NCT00755430|functional magnetic resonance imaging (fMRI)|functional magnetic resonance imaging (fmri)
5217274|NCT00755430|siblings|siblings
5217275|NCT00755430|repeated follow-up measurement|repeated follow-up measurement
5217276|NCT00755417|Hot flashes|hot flashes
5217277|NCT00755417|Hot flushes|hot flushes
5217278|NCT00755417|Postmenopausal symptoms|postmenopausal symptoms
5217279|NCT00755417|Vasomotor symptoms|vasomotor symptoms
5217280|NCT00755404|Peritoneal dialysis|peritoneal dialysis
5217281|NCT00755404|L-carnitine|l-carnitine
5217282|NCT00755404|Diabetes|diabetes
5217283|NCT00755404|Glucose homeostasis|glucose homeostasis
5217284|NCT00755404|Dyslipidemia|dyslipidemia
5217285|NCT00755391|BN and subthreshold BN|bn and subthreshold bn
5217286|NCT00755378|Phase I|phase i
5217287|NCT00755365|pelvic fractures|pelvic fractures
5217288|NCT00755365|angioembolism|angioembolism
5217289|NCT00755365|Treatment at Hershey Medical Center|treatment at hershey medical center
5217290|NCT00755365|Angioembolization in Operating Room|angioembolization in operating room
5217291|NCT00755339|Repetitive TMS (rTMS)|repetitive tms (rtms)
5217292|NCT00755339|Magnetoencephalogram|magnetoencephalogram
5217293|NCT00755339|Transcranial Magnetic Stimulation (TMS)|transcranial magnetic stimulation (tms)
5217294|NCT00755339|Tourette Syndrome|tourette syndrome
5217295|NCT00755339|Tic Disorder|tic disorder
5217296|NCT00755339|Tourete Syndrome|tourete syndrome
5217297|NCT00755326|OA|oa
5217298|NCT00755313|cognitive/functional effects|cognitive/functional effects
5217299|NCT00755313|fatigue|fatigue
5217300|NCT00755313|long-term effects secondary to cancer therapy in adults|long-term effects secondary to cancer therapy in adults
5217301|NCT00755313|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
5217302|NCT00755313|chemotherapeutic agent toxicity|chemotherapeutic agent toxicity
5217303|NCT00755313|neurotoxicity|neurotoxicity
5217304|NCT00755313|stage IA breast cancer|stage ia breast cancer
5217305|NCT00755313|stage IB breast cancer|stage ib breast cancer
5217306|NCT00755313|stage II breast cancer|stage ii breast cancer
5217307|NCT00755313|stage IIIA breast cancer|stage iiia breast cancer
5217308|NCT00755313|stage IIIB breast cancer|stage iiib breast cancer
5217309|NCT00755313|stage IIIC breast cancer|stage iiic breast cancer
5217310|NCT00755313|estrogen receptor-negative breast cancer|estrogen receptor-negative breast cancer
5217311|NCT00755313|estrogen receptor-positive breast cancer|estrogen receptor-positive breast cancer
5217312|NCT00755313|progesterone receptor-negative breast cancer|progesterone receptor-negative breast cancer
5217313|NCT00755313|progesterone receptor-positive breast cancer|progesterone receptor-positive breast cancer
5217314|NCT00755300|Total knee replacement|total knee replacement
5217315|NCT00755300|esophageal echocardiography|esophageal echocardiography
5217316|NCT00755274|Influenza|influenza
5217317|NCT00755274|Orthomyxoviruses|orthomyxoviruses
5217318|NCT00755274|Orthomyxoviridae Infections|orthomyxoviridae infections
5217319|NCT00755274|Influenza vaccine|influenza vaccine
5217320|NCT00755261|STS|sts
5217321|NCT00755248|Coronary Artery Bypass Grafting (CABG)|coronary artery bypass grafting (cabg)
5217322|NCT00755248|outcome|outcome
5217323|NCT00755248|saphenous graft patency|saphenous graft patency
5217324|NCT00755248|biochemical factors|biochemical factors
5217325|NCT00755248|genomics|genomics
5217326|NCT00755235|Depression|depression
5217327|NCT00755235|Primary care|primary care
5217328|NCT00755235|Effectiveness|effectiveness
5217329|NCT00755235|Care management|care management
5217330|NCT00755222|Peyronie's disease|peyronie's disease
5217331|NCT00755222|penile plaque|penile plaque
5217332|NCT00755222|penile curvature|penile curvature
5217333|NCT00755209|Traumatic brain injury (TBI)|traumatic brain injury (tbi)
5217334|NCT00755209|Adults|adults
5217335|NCT00755209|Moderately severe TBI|moderately severe tbi
5217336|NCT00755209|Delayed traumatic intracranial haemorrhage|delayed traumatic intracranial haemorrhage
5217337|NCT00755209|Expanding traumatic intracranial haemorrhage|expanding traumatic intracranial haemorrhage
5217338|NCT00755209|Progressive intracranial haemorrhage (PIH)|progressive intracranial haemorrhage (pih)
5217339|NCT00755209|Antifibrinolytic agent|antifibrinolytic agent
5217340|NCT00755209|Tranexamic acid (TXA)|tranexamic acid (txa)
5217341|NCT00755209|Randomised, placebo-controlled trial|randomised, placebo-controlled trial
5217342|NCT00755209|Human|human
5217343|NCT00755196|Plaque Type Psoriasis|plaque type psoriasis
5217344|NCT00755196|Topical|topical
5217345|NCT00755183|Meibomian Gland Dysfunction|meibomian gland dysfunction
5217346|NCT00755183|Dry Eye Syndrome|dry eye syndrome
5217347|NCT00755170|Vinorelbine|vinorelbine
5217348|NCT00755170|Bevacizumab|bevacizumab
5217349|NCT00755170|Chemotherapy|chemotherapy
5217350|NCT00755157|Cancer|cancer
5217351|NCT00755157|SCLC|sclc
5217352|NCT00755157|Docetaxel|docetaxel
5217353|NCT00755157|Bevacizumab|bevacizumab
5217354|NCT00755157|Chemotherapy|chemotherapy
5217355|NCT00755131|Cardiac Rehabilitation|cardiac rehabilitation
5217356|NCT00755131|High Mobility Group Box proteins|high mobility group box proteins
5217357|NCT00755131|Inflammatory markers|inflammatory markers
5217358|NCT00755131|Cardiopulmonary Functional Capacity|cardiopulmonary functional capacity
5217359|NCT00755131|Maximal Oxygen Consumption|maximal oxygen consumption
5217360|NCT00755131|Echocardiography|echocardiography
5217361|NCT00755131|Left Ventricular Ejection Fraction|left ventricular ejection fraction
5217362|NCT00755131|Left Ventricular Chambers Dilation|left ventricular chambers dilation
5217363|NCT00755131|Left Ventricular Remodeling|left ventricular remodeling
5217364|NCT00755131|Left Atrium Remodeling|left atrium remodeling
5217365|NCT00755131|Cardiac Remodeling|cardiac remodeling
5217366|NCT00755131|Exercise Training|exercise training
5217367|NCT00755118|Metastatic colorectal cancer|metastatic colorectal cancer
5217368|NCT00755118|Second line|second line
5217369|NCT00755118|Irinotecan|irinotecan
5217370|NCT00755118|Cetuximab|cetuximab
5217371|NCT00755118|Bevacizumab|bevacizumab
5217372|NCT00755105|body iron excretion|body iron excretion
5217373|NCT00755105|Iron isotopes|iron isotopes
5217374|NCT00755092|Doula|doula
5217375|NCT00755092|Psychological care|psychological care
5217376|NCT00755092|Labor analgesia|labor analgesia
5217377|NCT00755079|spinal cord injury|spinal cord injury
5217378|NCT00755079|beta-2 agonist|beta-2 agonist
5217379|NCT00755079|respiratory muscle strength|respiratory muscle strength
5217380|NCT00755079|pulmonary function test|pulmonary function test
5217381|NCT00755053|Clotrimazole|clotrimazole
5217382|NCT00755053|Ovule|ovule
5217383|NCT00755053|Tablet|tablet
5217384|NCT00755053|Vulvovaginal candidiasis|vulvovaginal candidiasis
5217385|NCT00755053|Non-inferiority|non-inferiority
5217386|NCT00755040|graft versus host disease|graft versus host disease
5217387|NCT00755040|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5217388|NCT00755040|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5217389|NCT00755040|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5217390|NCT00755040|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5217391|NCT00755040|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5217392|NCT00755040|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5217456|NCT00755001|Total Hip Replacement|total hip replacement
5217393|NCT00755040|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5217394|NCT00755040|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5217395|NCT00755040|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5217396|NCT00755040|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5217397|NCT00755040|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5217398|NCT00755040|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5217399|NCT00755040|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5217400|NCT00755040|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5217401|NCT00755040|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5217402|NCT00755040|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5217403|NCT00755040|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5217404|NCT00755040|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5217405|NCT00755040|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5217406|NCT00755040|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5217407|NCT00755040|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5217408|NCT00755040|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5217409|NCT00755040|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5217410|NCT00755040|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5217411|NCT00755040|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5217412|NCT00755040|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5217413|NCT00755040|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5217414|NCT00755040|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5217415|NCT00755040|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5217416|NCT00755040|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
5217417|NCT00755040|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5217418|NCT00755040|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
5217419|NCT00755040|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
5217420|NCT00755040|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
5217421|NCT00755040|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
5217422|NCT00755040|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5217423|NCT00755040|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5217424|NCT00755040|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5217425|NCT00755040|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5217426|NCT00755040|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
5217427|NCT00755040|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
5217428|NCT00755040|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5217429|NCT00755040|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5217430|NCT00755040|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5217431|NCT00755040|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5217432|NCT00755040|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5217433|NCT00755040|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5217434|NCT00755040|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5217435|NCT00755040|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5217436|NCT00755040|atypical chronic myeloid leukemia, BCR-ABL negative|atypical chronic myeloid leukemia, bcr-abl negative
5217437|NCT00755040|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5217438|NCT00755040|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5217439|NCT00755040|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5217440|NCT00755040|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5217441|NCT00755040|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5217442|NCT00755040|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5217443|NCT00755040|chronic eosinophilic leukemia|chronic eosinophilic leukemia
5217444|NCT00755040|primary myelofibrosis|primary myelofibrosis
5217445|NCT00755040|chronic neutrophilic leukemia|chronic neutrophilic leukemia
5217446|NCT00755040|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5217447|NCT00755040|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
5217448|NCT00755040|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5217449|NCT00755040|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5217450|NCT00755040|stage I multiple myeloma|stage i multiple myeloma
5217451|NCT00755040|stage II multiple myeloma|stage ii multiple myeloma
5217452|NCT00755040|stage III multiple myeloma|stage iii multiple myeloma
5217453|NCT00755027|Parkinson's disease|parkinson's disease
5217454|NCT00755027|Apathy|apathy
5217455|NCT00755027|Rasagiline|rasagiline
5217457|NCT00754949|Blepharoconjunctivitis,|blepharoconjunctivitis,
5217458|NCT00754949|Ophthalmology|ophthalmology
5217459|NCT00754936|Depression|depression
5217460|NCT00754923|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5217461|NCT00754923|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5217462|NCT00754923|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5217463|NCT00754923|adenocarcinoma of the lung|adenocarcinoma of the lung
5217464|NCT00754923|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
5217465|NCT00754923|large cell lung cancer|large cell lung cancer
5217466|NCT00754910|stage I non-small cell lung cancer|stage i non-small cell lung cancer
5217467|NCT00754910|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
5217468|NCT00754910|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5217469|NCT00754910|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5217470|NCT00754910|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5217471|NCT00754910|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5217472|NCT00754897|Phone Interview|phone interview
5217473|NCT00754897|Anesthesia|anesthesia
5217474|NCT00754897|Siblings|siblings
5217475|NCT00754897|Inguinal Hernia|inguinal hernia
5217476|NCT00754897|Neurologic Examination|neurologic examination
5217477|NCT00754897|Developmental Delay Disorders|developmental delay disorders
5217478|NCT00754884|salmon calcitonin|salmon calcitonin
5217479|NCT00754884|endorphins|endorphins
5217480|NCT00754884|treatment|treatment
5217481|NCT00754884|fibromyalgia|fibromyalgia
5217482|NCT00754858|extensive stage small cell lung cancer|extensive stage small cell lung cancer
5217483|NCT00754845|stage I breast cancer|stage i breast cancer
5217484|NCT00754845|stage II breast cancer|stage ii breast cancer
5217485|NCT00754845|stage IIIA breast cancer|stage iiia breast cancer
5217486|NCT00754845|stage IIIB breast cancer|stage iiib breast cancer
5217487|NCT00754845|stage IIIC breast cancer|stage iiic breast cancer
5217488|NCT00754832|Multiple sclerosis|multiple sclerosis
5217489|NCT00754832|fatigue|fatigue
5217490|NCT00754832|ginseng|ginseng
5217491|NCT00754806|HALS|hals
5217492|NCT00754806|open splenectomy|open splenectomy
5217493|NCT00754806|splenomegaly|splenomegaly
5217494|NCT00754806|HALS as a hybrid approach of pure laparoscopy and open surgery has some definite advantages over open surgery|hals as a hybrid approach of pure laparoscopy and open surgery has some definite advantages over open surgery
5217495|NCT00754806|In the HALS group, incision length is significantly shorter|in the hals group, incision length is significantly shorter
5217496|NCT00754806|In the HALS group, postoperative pain is less than with open surgery|in the hals group, postoperative pain is less than with open surgery
5217497|NCT00754806|In the HALS group, postoperative hospital stay is shorter than with open surgery|in the hals group, postoperative hospital stay is shorter than with open surgery
5217498|NCT00754780|NF1|nf1
5217499|NCT00754780|plexiform neurofibroma|plexiform neurofibroma
5217500|NCT00754767|neurotoxicity|neurotoxicity
5217501|NCT00754767|chemotherapeutic agent toxicity|chemotherapeutic agent toxicity
5217502|NCT00754767|stage IV breast cancer|stage iv breast cancer
5217503|NCT00754767|recurrent breast cancer|recurrent breast cancer
5217504|NCT00754754|brain|brain
5217505|NCT00754754|surgery|surgery
5217506|NCT00754754|retraction|retraction
5217507|NCT00754754|injury|injury
5217508|NCT00754754|monitoring|monitoring
5217509|NCT00754741|medication adherence|medication adherence
5217510|NCT00754741|motivational interviewing|motivational interviewing
5217511|NCT00754715|Multiple dosing study,|multiple dosing study,
5217512|NCT00754715|safety|safety
5217513|NCT00754702|Vinorelbine metronomic-lapatinib|vinorelbine metronomic-lapatinib
5217514|NCT00754702|Chemotherapy|chemotherapy
5217515|NCT00754702|Targeted therapy|targeted therapy
5217516|NCT00754689|Rimonabant/metformin combination|rimonabant/metformin combination
5217517|NCT00754663|exercise|exercise
5217518|NCT00754663|implantable cardioverter-defibrillator|implantable cardioverter-defibrillator
5217519|NCT00754663|arrhythmia|arrhythmia
5217520|NCT00754637|Joint|joint
5217521|NCT00754637|Osteoarthritis|osteoarthritis
5217522|NCT00754637|Avascular Necrosis|avascular necrosis
5217523|NCT00754546|exercise;|exercise;
5217524|NCT00754546|treadmill;|treadmill;
5217525|NCT00754546|cycle ergometer;|cycle ergometer;
5217526|NCT00754546|breathlessness;|breathlessness;
5217527|NCT00754546|leg discomfort|leg discomfort
5217528|NCT00754533|cardiac rehabilitation|cardiac rehabilitation
5217529|NCT00754533|coronary heart disease|coronary heart disease
5217530|NCT00754533|interval training|interval training
5217531|NCT00754533|continuous training|continuous training
5217532|NCT00754533|ventilatory threshold|ventilatory threshold
5217533|NCT00754481|Paediatrics|paediatrics
5217534|NCT00754468|Barrett's Esophagus|barrett's esophagus
5217535|NCT00754468|Esophageal Cancer|esophageal cancer
5217536|NCT00754468|Esophageal Dysplasia|esophageal dysplasia
5217537|NCT00754468|Low Grade Dysplasia|low grade dysplasia
5217538|NCT00754468|High Grade Dysplasia|high grade dysplasia
5217539|NCT00754442|hyperparathyroidism|hyperparathyroidism
5217540|NCT00754442|parathyroid|parathyroid
5217541|NCT00754442|vitamin D|vitamin d
5217542|NCT00754442|vitamin D deficiency|vitamin d deficiency
5217543|NCT00754416|Shoulder Replacement|shoulder replacement
5217544|NCT00754403|Glucose Metabolism Disorder|glucose metabolism disorder
5217545|NCT00754403|Dysmetabolic Syndrome|dysmetabolic syndrome
5217546|NCT00754403|Type II Diabetes|type ii diabetes
5217547|NCT00754403|Diabetes Mellitus, Lipoatrophic|diabetes mellitus, lipoatrophic
5217548|NCT00754403|Dyslipidemia|dyslipidemia
5217549|NCT00754403|Drug Therapy|drug therapy
5217550|NCT00754390|dietary zinc absorption|dietary zinc absorption
5217551|NCT00754390|dietary phytic acid|dietary phytic acid
5217552|NCT00754390|dietary calcium|dietary calcium
5217553|NCT00754377|Education|education
5217554|NCT00754377|Program Evaluation|program evaluation
5217555|NCT00754377|Quality of Health Care|quality of health care
5217556|NCT00754377|Medical Residents|medical residents
5217557|NCT00754351|docetaxel|docetaxel
5217558|NCT00754351|gemcitabine|gemcitabine
5217559|NCT00754351|bevacizumab|bevacizumab
5217560|NCT00754351|chemotherapy|chemotherapy
5217561|NCT00754338|comfort|comfort
5217562|NCT00754338|wetability|wetability
5217563|NCT00754338|protein deposit|protein deposit
5217564|NCT00754338|lipid deposit|lipid deposit
5217565|NCT00754312|breast cancer|breast cancer
5217566|NCT00754299|nonunion/malunion osseous fractures|nonunion/malunion osseous fractures
5217567|NCT00754299|nicotine dependent|nicotine dependent
5217568|NCT00754299|chronic osseous infection|chronic osseous infection
5217569|NCT00754299|infected osseous nonunions|infected osseous nonunions
5217570|NCT00754299|Fracture nonunion or infection|fracture nonunion or infection
5217571|NCT00754286|Aromatherapy|aromatherapy
5217572|NCT00754247|Keloid|keloid
5217573|NCT00754247|Hypertrophic scar|hypertrophic scar
5217574|NCT00754247|Hydrocortisone, silicone, vitamin E lotion|hydrocortisone, silicone, vitamin e lotion
5217576|NCT00754247|Onion extract gel|onion extract gel
5217577|NCT00754247|OE|oe
5217578|NCT00754247|Cetearyl alcohol lotion|cetearyl alcohol lotion
5217579|NCT00754247|CEA|cea
5217580|NCT00754234|iron absorption|iron absorption
5217581|NCT00754234|iron requirements|iron requirements
5217582|NCT00754234|dietary guidelines|dietary guidelines
5217583|NCT00754234|MyPyramid|mypyramid
5217584|NCT00754221|Phase 3, safety study, [S,S]-Reboxetine, Fibromyalgia|phase 3, safety study, [s,s]-reboxetine, fibromyalgia
5217585|NCT00754208|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
5217586|NCT00754208|Stimulant Treatment|stimulant treatment
5217587|NCT00754208|Young Children|young children
5217588|NCT00754195|Thoracotomy|thoracotomy
5217589|NCT00754182|thyroidectomy|thyroidectomy
5217590|NCT00754182|surgery|surgery
5217591|NCT00754182|synthetic glue|synthetic glue
5217592|NCT00754182|subcuticular suture|subcuticular suture
5217593|NCT00754169|Traumatic Brain Injury|traumatic brain injury
5217594|NCT00754169|Brain Imaging|brain imaging
5217595|NCT00754169|Brain Plasticity|brain plasticity
5217596|NCT00754169|Neuroplasticity|neuroplasticity
5217597|NCT00754169|Neuropsychological Testing|neuropsychological testing
5217598|NCT00754169|Head Injury|head injury
5217599|NCT00754169|Healthy Volunteer|healthy volunteer
5217600|NCT00754156|Closure, Wounds|closure, wounds
5217601|NCT00754143|Type 1 or Type 2 diabetes|type 1 or type 2 diabetes
5217602|NCT00754143|proteinuria|proteinuria
5217603|NCT00754117|diffuse large b cell lymphoma|diffuse large b cell lymphoma
5217604|NCT00754117|newly diagnosed|newly diagnosed
5217605|NCT00754078|tomotherapy|tomotherapy
5217606|NCT00754065|Oral contraceptive|oral contraceptive
5217607|NCT00754065|Estradiol valerate and dienogest|estradiol valerate and dienogest
5217608|NCT00754065|EV/DNG|ev/dng
5217609|NCT00754065|comparative tolerability|comparative tolerability
5217610|NCT00754052|Pediatric|pediatric
5217611|NCT00754052|Down syndrome|down syndrome
5217612|NCT00754052|Downs|downs
5217613|NCT00754052|Cognitive Dysfunction of Down syndrome|cognitive dysfunction of down syndrome
5217614|NCT00754039|Mixed hyperlipidemia|mixed hyperlipidemia
5217615|NCT00754026|Shoulder surgery|shoulder surgery
5217616|NCT00754013|pediatric|pediatric
5217617|NCT00754013|Down syndrome|down syndrome
5217618|NCT00754013|cognitive dysfunction|cognitive dysfunction
5217619|NCT00754013|Downs|downs
5217620|NCT00754013|Aricept|aricept
5217621|NCT00754013|children with Down syndrome|children with down syndrome
5217622|NCT00753987|Cystic Fibrosis|cystic fibrosis
5217623|NCT00753987|Hypertonic Saline|hypertonic saline
5217624|NCT00753987|Infants|infants
5217625|NCT00753961|Shiftworkers|shiftworkers
5217626|NCT00753961|volunteers|volunteers
5217627|NCT00753948|Tetraplegia|tetraplegia
5217628|NCT00753948|Mild asthma|mild asthma
5217629|NCT00753948|Exhaled Nitric Oxide|exhaled nitric oxide
5217630|NCT00753948|NOS inhibitor|nos inhibitor
5217631|NCT00753948|Spinal cord injury|spinal cord injury
5217632|NCT00753948|Pulmonary Function|pulmonary function
5217633|NCT00753935|aspirin|aspirin
5217634|NCT00753935|aspirin resistance|aspirin resistance
5217635|NCT00753935|aspirin nonresponse|aspirin nonresponse
5217636|NCT00753935|cyclooxygenase|cyclooxygenase
5217637|NCT00753935|thromboxane|thromboxane
5217638|NCT00753935|oxidative stress|oxidative stress
5217639|NCT00753922|Breast Reconstruction|breast reconstruction
5217640|NCT00753922|Breast Augmentation|breast augmentation
5217641|NCT00753922|Revision|revision
5217642|NCT00753922|Silicone breast implants|silicone breast implants
5217643|NCT00753922|Round low-bleed|round low-bleed
5217644|NCT00753909|Non Small Cell Lung Cancer|non small cell lung cancer
5217647|NCT00753909|Bevacizumab|bevacizumab
5217648|NCT00753896|Amylin|amylin
5217649|NCT00753896|Lilly|lilly
5217650|NCT00753896|exenatide once weekly|exenatide once weekly
5217651|NCT00753896|thiazolidinedione|thiazolidinedione
5217652|NCT00753896|metformin|metformin
5217653|NCT00753870|current|current
5217654|NCT00753870|no health problems|no health problems
5217655|NCT00753870|no daily cough from smoking|no daily cough from smoking
5217656|NCT00753857|risk communication|risk communication
5217657|NCT00753857|probability sample by random digit dialing|probability sample by random digit dialing
5217658|NCT00753844|peptide vaccine|peptide vaccine
5217659|NCT00753844|URLC10|urlc10
5217660|NCT00753831|Blepharoptosis|blepharoptosis
5217661|NCT00753831|Ophthalmoplegia|ophthalmoplegia
5217662|NCT00753831|Blepharospasm|blepharospasm
5217663|NCT00753818|infant formula|infant formula
5217664|NCT00753818|visual development|visual development
5217665|NCT00753805|mare's milk|mare's milk
5217666|NCT00753805|atopic dermatitis|atopic dermatitis
5217667|NCT00753805|endogenous eczema|endogenous eczema
5217668|NCT00753805|SCORAD|scorad
5217669|NCT00753805|Bifidobacteria|bifidobacteria
5217670|NCT00753792|multiple sclerosis|multiple sclerosis
5217671|NCT00753792|relapse|relapse
5217672|NCT00753792|methylprednisolone|methylprednisolone
5217673|NCT00753766|A1c|a1c
5217674|NCT00753766|Blood Glucose Management|blood glucose management
5217675|NCT00753766|Blood Pressure|blood pressure
5217676|NCT00753766|Case Management|case management
5217677|NCT00753766|Diabetes Mellitus|diabetes mellitus
5217678|NCT00753766|Intervention study|intervention study
5217679|NCT00753766|Multifactorial|multifactorial
5217680|NCT00753766|Peri-operative complications|peri-operative complications
5217681|NCT00753766|Pre-operative|pre-operative
5217682|NCT00753753|stent thrombosis|stent thrombosis
5217683|NCT00753753|clopidogrel|clopidogrel
5217684|NCT00753753|aspirin|aspirin
5217685|NCT00753753|bleeding|bleeding
5217686|NCT00753753|coronary|coronary
5217687|NCT00753753|angioplasty|angioplasty
5217688|NCT00753740|Cancer|cancer
5217689|NCT00753740|Neoplasms|neoplasms
5217690|NCT00753740|Solid Tumor|solid tumor
5217691|NCT00753740|Ovarian Cancer|ovarian cancer
5217692|NCT00753740|Solid Malignancies|solid malignancies
5217693|NCT00753727|soft tissue|soft tissue
5217694|NCT00753727|Sarcoma|sarcoma
5217695|NCT00753727|Sunitinib|sunitinib
5217696|NCT00753727|neoadjuvant|neoadjuvant
5217697|NCT00753727|radiotherapy|radiotherapy
5217698|NCT00753714|ZD6474|zd6474
5217699|NCT00753714|VANDETANIB|vandetanib
5217700|NCT00753714|ZACTIMA|zactima
5217701|NCT00753714|ADVANCED|advanced
5217702|NCT00753714|NSCLC|nsclc
5217703|NCT00753714|LUNG CANCER|lung cancer
5217704|NCT00753714|ELDERLY PATIENTS|elderly patients
5217705|NCT00753714|GEMCITABINE|gemcitabine
5217706|NCT00753714|PHASE II|phase ii
5217707|NCT00753714|RANDOMIZED|randomized
5217708|NCT00753714|DOUBLE-BLIND|double-blind
5217709|NCT00753714|histologically or cytologically-confirmed advanced (stage IIIB with supraclavicular lymph node metastases or pleural effusion or stage IV) NSCLC|histologically or cytologically-confirmed advanced (stage iiib with supraclavicular lymph node metastases or pleural effusion or stage iv) nsclc
5217710|NCT00753688|metastatic soft-tissue sarcoma|metastatic soft-tissue sarcoma
5217711|NCT00753688|pazopanib|pazopanib
5217712|NCT00753688|Soft Tissue Sarcoma|soft tissue sarcoma
5217713|NCT00753688|placebo|placebo
5217714|NCT00753675|Intrahepatic|intrahepatic
5217715|NCT00753675|Cholangiocarcinoma|cholangiocarcinoma
5217716|NCT00753675|Vandetanib|vandetanib
5217717|NCT00753675|Zactima|zactima
5217718|NCT00753675|Advanced|advanced
5217719|NCT00753675|Biliary|biliary
5217720|NCT00753675|Tract|tract
5217721|NCT00753675|Gallbladder|gallbladder
5217722|NCT00753675|Extrahepatic Bile Duct|extrahepatic bile duct
5217723|NCT00753675|Intrahepatic Cholangiocarcinoma|intrahepatic cholangiocarcinoma
5217724|NCT00753675|Ampullary Carcinoma|ampullary carcinoma
5217725|NCT00753662|TMS AD H2 coil|tms ad h2 coil
5217726|NCT00753649|Infant|infant
5217727|NCT00753649|First nation|first nation
5217728|NCT00753649|Aboriginal|aboriginal
5217729|NCT00753649|Canada|canada
5217730|NCT00753636|Parkinson's disease|parkinson's disease
5217731|NCT00753636|Isradipine|isradipine
5217732|NCT00753636|Neuroprotection|neuroprotection
5217733|NCT00753623|Pain|pain
5217734|NCT00753623|Neuropathic pain|neuropathic pain
5217735|NCT00753623|Pain scores|pain scores
5217736|NCT00753610|EPC|epc
5217737|NCT00753610|CCRT|ccrt
5217738|NCT00753610|Cervical cancer|cervical cancer
5217739|NCT00753597|B cell depletion|b cell depletion
5217740|NCT00753597|steroidogenesis|steroidogenesis
5217741|NCT00753571|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
5217742|NCT00753571|Cistanche Total Glycosides|cistanche total glycosides
5217743|NCT00753571|Randomized Control Trial Study|randomized control trial study
5217744|NCT00753545|Serous,|serous,
5217745|NCT00753545|Ovarian cancer,|ovarian cancer,
5217746|NCT00753545|PARP,|parp,
5217747|NCT00753545|BRCA1,|brca1,
5217748|NCT00753545|BRCA2,|brca2,
5217749|NCT00753545|Poly(ADP ribose) polymerases,|poly(adp ribose) polymerases,
5217750|NCT00753545|Platinum sensitive,|platinum sensitive,
5217851|NCT00753233|Electrophysiology Study|electrophysiology study
5217751|NCT00753545|Homologous Recombination Deficiency (HRD)|homologous recombination deficiency (hrd)
5217752|NCT00753532|Carotid artery stenoses|carotid artery stenoses
5217753|NCT00753532|Brain ischaemia|brain ischaemia
5217754|NCT00753532|stroke|stroke
5217755|NCT00753532|Lipid abnormalities|lipid abnormalities
5217756|NCT00753532|Fatty Liver|fatty liver
5217757|NCT00753519|Parkinson's Disease|parkinson's disease
5217758|NCT00753519|Brain Stimulation|brain stimulation
5217759|NCT00753519|Motor Cortex|motor cortex
5217760|NCT00753519|Bradykinesia|bradykinesia
5217761|NCT00753519|Parkinson Disease|parkinson disease
5217762|NCT00753519|PD|pd
5217763|NCT00753480|EOC|eoc
5217764|NCT00753480|PPC|ppc
5217765|NCT00753480|FTC|ftc
5217766|NCT00753467|HBV|hbv
5217767|NCT00753467|Treatment|treatment
5217768|NCT00753467|Interferon-gamma|interferon-gamma
5217769|NCT00753467|combination|combination
5217770|NCT00753467|Hepsera|hepsera
5217771|NCT00753467|Actimmune|actimmune
5217772|NCT00753467|HBV DNA|hbv dna
5217773|NCT00753454|Rheumatoid Arthritis|rheumatoid arthritis
5217774|NCT00753454|Joint Disease|joint disease
5217775|NCT00753454|Arthritis|arthritis
5217776|NCT00753454|Certolizumab pegol|certolizumab pegol
5217777|NCT00753454|Cimzia|cimzia
5217778|NCT00753441|Pancreatic cancer|pancreatic cancer
5217779|NCT00753441|Bile duct obstruction|bile duct obstruction
5217780|NCT00753441|Stent|stent
5217781|NCT00753441|Bypass|bypass
5217782|NCT00753428|HIV-free survival|hiv-free survival
5217783|NCT00753428|Community based evaluation|community based evaluation
5217784|NCT00753428|Pregnancy|pregnancy
5217785|NCT00753428|Under 2 child survival|under 2 child survival
5217786|NCT00753428|PMTCT|pmtct
5217787|NCT00753428|Pediatric HIV infection|pediatric hiv infection
5217788|NCT00753428|HAART|haart
5217789|NCT00753428|Routine ART|routine art
5217790|NCT00753428|HIV Seronegativity|hiv seronegativity
5217791|NCT00753415|Urinary Bladder Neoplasms|urinary bladder neoplasms
5217792|NCT00753415|Breast Neoplasms|breast neoplasms
5217793|NCT00753415|Renal Cell carcinoma|renal cell carcinoma
5217794|NCT00753415|Melanoma|melanoma
5217795|NCT00753415|Prostatic Neoplasms|prostatic neoplasms
5217796|NCT00753415|Colonic Neoplasms|colonic neoplasms
5217797|NCT00753415|Urologic Neoplasms|urologic neoplasms
5217798|NCT00753415|Urogenital Neoplasms|urogenital neoplasms
5217799|NCT00753415|Urinary Bladder Diseases|urinary bladder diseases
5217800|NCT00753415|Urologic Diseases|urologic diseases
5217801|NCT00753415|Breast Diseases|breast diseases
5217802|NCT00753415|Skin Diseases|skin diseases
5217803|NCT00753415|Neoplasms|neoplasms
5217926|NCT00752934|ages 1-18 years|ages 1-18 years
5217804|NCT00753415|Glandular and Epithelial Neoplasms by Histologic Type|glandular and epithelial neoplasms by histologic type
5217805|NCT00753415|Adenocarcinoma|adenocarcinoma
5217806|NCT00753415|Kidney Neoplasms|kidney neoplasms
5217807|NCT00753415|Kidney Diseases|kidney diseases
5217808|NCT00753415|Neuroendocrine Tumors|neuroendocrine tumors
5217809|NCT00753415|Neuroectodermal Tumors|neuroectodermal tumors
5217810|NCT00753415|Neoplasms, Germ Cell and Embryonal|neoplasms, germ cell and embryonal
5217811|NCT00753415|Neoplasms, Nerve Tissue|neoplasms, nerve tissue
5217812|NCT00753415|Nevi and Melanomas|nevi and melanomas
5217813|NCT00753415|Genital Neoplasms|genital neoplasms
5217814|NCT00753415|Male Genital Diseases|male genital diseases
5217815|NCT00753415|Male, Prostatic Diseases|male, prostatic diseases
5217816|NCT00753415|Colorectal Neoplasms|colorectal neoplasms
5217817|NCT00753415|Intestinal Neoplasms|intestinal neoplasms
5217818|NCT00753389|Postoperative residual curarization,|postoperative residual curarization,
5217819|NCT00753389|muscle relaxants,|muscle relaxants,
5217820|NCT00753389|morbidity mortality|morbidity mortality
5217821|NCT00753363|Glucose Metabolism|glucose metabolism
5217822|NCT00753350|obesity|obesity
5217823|NCT00753324|PMTCT|pmtct
5217824|NCT00753324|HAART|haart
5217825|NCT00753324|Pregnancy|pregnancy
5217826|NCT00753324|HIV Infection|hiv infection
5217827|NCT00753324|HIV Transmission|hiv transmission
5217828|NCT00753324|HIV Seronegativity|hiv seronegativity
5217829|NCT00753311|migraine|migraine
5217830|NCT00753311|rizatriptan|rizatriptan
5217831|NCT00753311|unilateral trigeminal autonomic symptoms|unilateral trigeminal autonomic symptoms
5217832|NCT00753311|Migraine with or without aura|migraine with or without aura
5217833|NCT00753272|Efficacy|efficacy
5217834|NCT00753272|Influenza Vaccines|influenza vaccines
5217835|NCT00753272|Influenza|influenza
5217836|NCT00753272|Vaccine|vaccine
5217837|NCT00753272|Elderly|elderly
5217838|NCT00753259|atrial fibrillation|atrial fibrillation
5217839|NCT00753259|disease management program|disease management program
5217840|NCT00753259|integrated chronic care program|integrated chronic care program
5217841|NCT00753259|guideline|guideline
5217842|NCT00753259|stroke|stroke
5217843|NCT00753259|heart failure|heart failure
5217844|NCT00753259|quality of life|quality of life
5217845|NCT00753259|costs|costs
5217846|NCT00753246|glioblastoma multiforma|glioblastoma multiforma
5217847|NCT00753233|Hypertrophic Cardiomyopathy|hypertrophic cardiomyopathy
5217848|NCT00753233|Children|children
5217849|NCT00753233|Sudden Death|sudden death
5217850|NCT00753233|Arrhythmias|arrhythmias
5217852|NCT00753220|Metastatic|metastatic
5217853|NCT00753220|Androgen|androgen
5217854|NCT00753220|Independent|independent
5217855|NCT00753220|Prostate Cancer|prostate cancer
5217856|NCT00753220|(AIPC),|(aipc),
5217857|NCT00753220|Hormone-refractory|hormone-refractory
5217858|NCT00753220|(HRPC),|(hrpc),
5217859|NCT00753220|cryotherapy,|cryotherapy,
5217860|NCT00753220|dendritic cell,|dendritic cell,
5217861|NCT00753220|immunotherapy|immunotherapy
5217862|NCT00753220|Chemo-naïve|chemo-naïve
5217863|NCT00753220|lymph nodes|lymph nodes
5217864|NCT00753220|bone|bone
5217865|NCT00753207|stage IV breast cancer|stage iv breast cancer
5217866|NCT00753207|recurrent breast cancer|recurrent breast cancer
5217867|NCT00753194|hearing|hearing
5217868|NCT00753194|newborn|newborn
5217869|NCT00753194|otoacoustic emissions|otoacoustic emissions
5217870|NCT00753168|glaucoma, open angle, ocular hypertension, beta blocker, beta adrenergic, intraocular pressure|glaucoma, open angle, ocular hypertension, beta blocker, beta adrenergic, intraocular pressure
5217871|NCT00753155|HRQoL;|hrqol;
5217872|NCT00753155|exercise|exercise
5217873|NCT00753155|capacity|capacity
5217874|NCT00753142|Hyperglycemia|hyperglycemia
5217875|NCT00753129|Prone position|prone position
5217876|NCT00753129|ALI/ARDS|ali/ards
5217877|NCT00753129|Head elevation|head elevation
5217878|NCT00753103|Infliximab|infliximab
5217879|NCT00753103|Vasculitis|vasculitis
5217880|NCT00753103|antitnf monoclonal antibody|antitnf monoclonal antibody
5217881|NCT00753064|Red Scorpion envenomation|red scorpion envenomation
5217882|NCT00753064|Composite clinical scoring system|composite clinical scoring system
5217883|NCT00753064|AScVS|ascvs
5217884|NCT00753064|Prazosin|prazosin
5217885|NCT00753064|Superiority|superiority
5217886|NCT00753051|clozapine-resistant schizophrenics|clozapine-resistant schizophrenics
5217887|NCT00753051|haloperidol augmenting clozapine|haloperidol augmenting clozapine
5217888|NCT00753051|electroconvulsive therapy augmenting clozapine|electroconvulsive therapy augmenting clozapine
5217889|NCT00753038|carcinoma|carcinoma
5217890|NCT00753038|squamous cell|squamous cell
5217891|NCT00753038|head|head
5217892|NCT00753038|neck|neck
5217893|NCT00753038|REOLYSIN|reolysin
5217894|NCT00753038|chemotherapy|chemotherapy
5217895|NCT00753038|Carboplatin|carboplatin
5217896|NCT00753038|Paclitaxel|paclitaxel
5217897|NCT00753025|lower extremity ischemia|lower extremity ischemia
5217898|NCT00753025|Bone marrow|bone marrow
5217899|NCT00753025|Progenitor cells|progenitor cells
5217900|NCT00753025|Neoangiogenesis|neoangiogenesis
5217901|NCT00753012|cardiovascular testing|cardiovascular testing
5217902|NCT00753012|home blood pressure monitoring|home blood pressure monitoring
5217903|NCT00753012|office home blood pressure monitoring|office home blood pressure monitoring
5217904|NCT00753012|cardiopulmonary exercise testing|cardiopulmonary exercise testing
5217905|NCT00753012|transthoracic echocardiography|transthoracic echocardiography
5217906|NCT00753012|Lisdexamfetamine|lisdexamfetamine
5217907|NCT00753012|Vyvanse|vyvanse
5217908|NCT00753012|normotensive and hypertensive adults with ADHD|normotensive and hypertensive adults with adhd
5217909|NCT00753012|ADHD medication.|adhd medication.
5217911|NCT00752999|Lupus|lupus
5217912|NCT00752986|ZD6474|zd6474
5217913|NCT00752986|Vandetanib|vandetanib
5217914|NCT00752986|Zactima|zactima
5217915|NCT00752986|Fulvestrant|fulvestrant
5217916|NCT00752986|Faslodex|faslodex
5217917|NCT00752986|Breast Cancer|breast cancer
5217918|NCT00752986|Advanced, Metastatic|advanced, metastatic
5217919|NCT00752986|Hormone Receptor Positive|hormone receptor positive
5217920|NCT00752986|Post-Menopausal Patients|post-menopausal patients
5217921|NCT00752986|post-menopausal women with hormone receptor positive advanced breast cancer|post-menopausal women with hormone receptor positive advanced breast cancer
5217922|NCT00752973|Head Lice|head lice
5217923|NCT00752960|single nucleotide polymorphism, SNP, aripiprazole, olanzapine, quetiapine, risperidone, ziprasidone, metabolic syndrome|single nucleotide polymorphism, snp, aripiprazole, olanzapine, quetiapine, risperidone, ziprasidone, metabolic syndrome
5217924|NCT00752934|nursing homes|nursing homes
5217925|NCT00752934|children|children
5217927|NCT00752934|spastic quadriplegia|spastic quadriplegia
5217928|NCT00752921|Etoricoxib, Fasting Headache, Headache, Yom Kippur|etoricoxib, fasting headache, headache, yom kippur
5217929|NCT00752895|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
5217930|NCT00752895|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
5217931|NCT00752895|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5217932|NCT00752895|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5217933|NCT00752882|Ceftazidime|ceftazidime
5217934|NCT00752882|Pharmacokinetics|pharmacokinetics
5217935|NCT00752882|Pseudomonas|pseudomonas
5217936|NCT00752882|aeruginosa|aeruginosa
5217937|NCT00752882|Meningitis|meningitis
5217938|NCT00752882|Patients|patients
5217939|NCT00752882|hospitalised|hospitalised
5217940|NCT00752882|cerebrolesion|cerebrolesion
5217941|NCT00752882|acquired|acquired
5217942|NCT00752882|pneumopathy|pneumopathy
5217943|NCT00752882|mechanic|mechanic
5217944|NCT00752882|ventilation|ventilation
5217945|NCT00752869|low testosterone|low testosterone
5217946|NCT00752856|HIV treatment|hiv treatment
5217947|NCT00752856|Treatment-naive|treatment-naive
5217949|NCT00752843|mifepristone|mifepristone
5217950|NCT00752843|CORLUX|corlux
5217951|NCT00752843|fluvastatin|fluvastatin
5217952|NCT00752843|Lescol|lescol
5217953|NCT00752843|drug-drug interaction|drug-drug interaction
5217954|NCT00752843|DDI|ddi
5217955|NCT00752843|pharmacokinetics|pharmacokinetics
5217956|NCT00752830|AZD0328|azd0328
5217957|NCT00752830|Food Effect|food effect
5217958|NCT00752817|Virtual Reality|virtual reality
5217959|NCT00752817|Simulator|simulator
5217960|NCT00752817|Proficiency|proficiency
5217961|NCT00752817|Laparoscopic|laparoscopic
5217962|NCT00752817|Colectomy|colectomy
5217963|NCT00752817|Education|education
5217964|NCT00752817|Surgical Training|surgical training
5217965|NCT00752804|ICU patients with acute renal failure after cardiac surgery|icu patients with acute renal failure after cardiac surgery
5217966|NCT00752791|Anemia|anemia
5217967|NCT00752791|Drug Therapy|drug therapy
5217968|NCT00752791|Peritoneal Dialysis.|peritoneal dialysis.
5217969|NCT00752778|MRI, PET scan|mri, pet scan
5217970|NCT00752765|knee osteoarthritis|knee osteoarthritis
5217971|NCT00752765|bariatric surgery|bariatric surgery
5217972|NCT00752765|weight loss|weight loss
5217973|NCT00752765|knee pain|knee pain
5217974|NCT00752752|Marathon Running|marathon running
5217975|NCT00752752|Cardiac Ischemia|cardiac ischemia
5217976|NCT00752752|Magnetic Resonance Imaging|magnetic resonance imaging
5217977|NCT00752739|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5217978|NCT00752739|stage I prostate cancer|stage i prostate cancer
5217979|NCT00752739|stage II prostate cancer|stage ii prostate cancer
5217980|NCT00752739|stage III prostate cancer|stage iii prostate cancer
5217981|NCT00752739|stage IV prostate cancer|stage iv prostate cancer
5217982|NCT00752726|overweight, orlistat, body composition|overweight, orlistat, body composition
5217983|NCT00752713|AMI,|ami,
5217984|NCT00752713|Reperfusion|reperfusion
5217985|NCT00752713|successful|successful
5217986|NCT00752700|Patients|patients
5217987|NCT00752700|radically|radically
5217988|NCT00752700|treated|treated
5217989|NCT00752687|Phase 1|phase 1
5217990|NCT00752674|Low back pain|low back pain
5217991|NCT00752674|physical therapy|physical therapy
5217992|NCT00752674|pain|pain
5217993|NCT00752661|osteoarthritis|osteoarthritis
5217994|NCT00752661|low back pain|low back pain
5217995|NCT00752661|oral drug|oral drug
5217996|NCT00752661|tramadol|tramadol
5217997|NCT00752648|TMC435350-TiDP16-C106|tmc435350-tidp16-c106
5217998|NCT00752648|TMC435350-C106|tmc435350-c106
5217999|NCT00752648|Bioavailability|bioavailability
5218000|NCT00752648|Pharmacokinetics|pharmacokinetics
5218001|NCT00752635|TriCilest|tricilest
5218002|NCT00752635|acne vulgaris|acne vulgaris
5218003|NCT00752609|Anemia|anemia
5218004|NCT00752609|Drug Therapy|drug therapy
5218005|NCT00752609|Hemodialysis|hemodialysis
5218006|NCT00752609|Kidney Failure|kidney failure
5218007|NCT00752596|patients|patients
5218008|NCT00752596|with ICD|with icd
5218009|NCT00752583|Chronic renal insufficiency (patients under dialysis)|chronic renal insufficiency (patients under dialysis)
5218010|NCT00752570|Metastatic Colorectal Cancer|metastatic colorectal cancer
5218011|NCT00752570|colorectal cancer|colorectal cancer
5218012|NCT00752570|colon cancer|colon cancer
5218013|NCT00752557|Bone mineral density|bone mineral density
5218014|NCT00752557|bone morphogenetic protein|bone morphogenetic protein
5218015|NCT00752557|osteoporosis|osteoporosis
5218016|NCT00752544|TMC435350|tmc435350
5218017|NCT00752544|HCV|hcv
5218018|NCT00752544|Hepatitis C|hepatitis c
5218019|NCT00752544|TMC435350-TiDP16-C109|tmc435350-tidp16-c109
5218020|NCT00752544|TMC435350-C109|tmc435350-c109
5218021|NCT00752531|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5218022|NCT00752531|COPD|copd
5218023|NCT00752518|bolus|bolus
5218024|NCT00752518|intravenous|intravenous
5218025|NCT00752518|proteasome inhibitor|proteasome inhibitor
5218026|NCT00752518|multiple myeloma|multiple myeloma
5218027|NCT00752518|refractory|refractory
5218028|NCT00752518|relapse|relapse
5218029|NCT00752505|Fibromyalgia|fibromyalgia
5218030|NCT00752492|Isocapnic hyperpnoea|isocapnic hyperpnoea
5218031|NCT00752492|obesity|obesity
5218032|NCT00752492|isoflurane|isoflurane
5218033|NCT00752492|Recovery of obese patient from isoflurane anesthesia|recovery of obese patient from isoflurane anesthesia
5218034|NCT00752479|living|living
5218035|NCT00752479|related|related
5218036|NCT00752466|Healthy volunteers|healthy volunteers
5218037|NCT00752466|drug interaction|drug interaction
5218038|NCT00752466|Flunarizine|flunarizine
5218039|NCT00752466|Topiramate|topiramate
5218040|NCT00752466|Migraine|migraine
5218041|NCT00752453|ICU|icu
5218042|NCT00752453|patients|patients
5218043|NCT00752453|lactate|lactate
5218044|NCT00752453|acidosis|acidosis
5218045|NCT00752440|Diabetes Mellitus|diabetes mellitus
5218046|NCT00752440|Autonomic Neuropathy|autonomic neuropathy
5218047|NCT00752440|Inspiratory Muscle training|inspiratory muscle training
5218048|NCT00752427|Schizophrenia: paliperidone|schizophrenia: paliperidone
5218049|NCT00752414|COPD|copd
5218050|NCT00752414|Patients|patients
5218051|NCT00752401|Vitamin D|vitamin d
5218052|NCT00752401|Cholecalciferol|cholecalciferol
5218053|NCT00752401|Vitamin D3|vitamin d3
5218054|NCT00752401|25-hydroxyvitamin D3|25-hydroxyvitamin d3
5218055|NCT00752401|Immunomodulation|immunomodulation
5218056|NCT00752401|Vitamin D deficiency|vitamin d deficiency
5218057|NCT00752401|Kidney transplantation|kidney transplantation
5218058|NCT00752401|Renal transplantation|renal transplantation
5218059|NCT00752401|Graft function|graft function
5218060|NCT00752401|Acute rejection|acute rejection
5218061|NCT00752401|Renal osteodystrophy|renal osteodystrophy
5218062|NCT00752401|Posttransplant bone loss|posttransplant bone loss
5218063|NCT00752375|pyelonephritis|pyelonephritis
5218064|NCT00752375|pediatric pyelonephritis|pediatric pyelonephritis
5218065|NCT00752375|vesicoureteral reflux|vesicoureteral reflux
5218066|NCT00752375|DMSA scan|dmsa scan
5218067|NCT00752362|Supralimus®,|supralimus®,
5218068|NCT00752362|Infinnium®,|infinnium®,
5218069|NCT00752362|Matrix®,|matrix®,
5218070|NCT00752362|Restenosis|restenosis
5218071|NCT00752362|Percutaneous|percutaneous
5218072|NCT00752362|Revascularization|revascularization
5218073|NCT00752362|Techniques|techniques
5218074|NCT00752362|Metallic|metallic
5218075|NCT00752362|Platform|platform
5218076|NCT00752362|Agents|agents
5218077|NCT00752362|Antiproliferative|antiproliferative
5218078|NCT00752362|Properties|properties
5218079|NCT00752349|Videofluoroscopic|videofluoroscopic
5218080|NCT00752349|swallowing|swallowing
5218081|NCT00752349|study|study
5218082|NCT00752349|(VFSS)|(vfss)
5218083|NCT00752349|ultrasound|ultrasound
5218084|NCT00752336|HRQoL|hrqol
5218085|NCT00752336|exercise capacity|exercise capacity
5218086|NCT00752323|adult giant cell glioblastoma|adult giant cell glioblastoma
5218087|NCT00752323|adult glioblastoma|adult glioblastoma
5218088|NCT00752323|adult gliosarcoma|adult gliosarcoma
5218089|NCT00752323|recurrent adult brain tumor|recurrent adult brain tumor
5218090|NCT00752310|TMC114-TiDP29-C169|tmc114-tidp29-c169
5218091|NCT00752310|TMC114-C169|tmc114-c169
5218092|NCT00752310|Darunavir (suspension formulation)|darunavir (suspension formulation)
5218093|NCT00752297|Botulinum Toxin Type A|botulinum toxin type a
5218094|NCT00752297|Botulinum Toxin|botulinum toxin
5218095|NCT00752297|Glabellar Rhytides|glabellar rhytides
5218096|NCT00752297|Rhytides|rhytides
5218097|NCT00752297|Frown Lines|frown lines
5218098|NCT00752297|Neuromuscular Agents|neuromuscular agents
5218099|NCT00752297|Neurotoxin|neurotoxin
5218100|NCT00752297|Forehead|forehead
5218101|NCT00752297|Eyebrow|eyebrow
5218102|NCT00752297|Wrinkle|wrinkle
5218103|NCT00752284|coronectomy|coronectomy
5218104|NCT00752284|neurosensory deficit|neurosensory deficit
5218105|NCT00752284|third molar surgery|third molar surgery
5218106|NCT00752271|Arthroscopic|arthroscopic
5218107|NCT00752258|Botulinum Toxin Type A|botulinum toxin type a
5218108|NCT00752258|Botulinum Toxin|botulinum toxin
5218109|NCT00752258|Glabellar Rhytides|glabellar rhytides
5218110|NCT00752258|Rhytides|rhytides
5218111|NCT00752258|Frown Lines|frown lines
5218112|NCT00752258|Neuromuscular Agents|neuromuscular agents
5218113|NCT00752258|Neurotoxin|neurotoxin
5218114|NCT00752258|Forehead|forehead
5218115|NCT00752258|Eyebrow|eyebrow
5218116|NCT00752258|Wrinkle|wrinkle
5218117|NCT00752258|Frown Lines Between the Eyebrows|frown lines between the eyebrows
5218118|NCT00752245|ICU patients with acute renal failure with sepsis/multi-organ failure|icu patients with acute renal failure with sepsis/multi-organ failure
5218119|NCT00752232|Phase IIa|phase iia
5218120|NCT00752232|multiple ascending dose study of ACC-001|multiple ascending dose study of acc-001
5218121|NCT00752206|AZD0530|azd0530
5218122|NCT00752206|Saracatinib|saracatinib
5218123|NCT00752206|Osteosarcoma|osteosarcoma
5218124|NCT00752206|Recurrent|recurrent
5218125|NCT00752206|Localized|localized
5218126|NCT00752206|to the Lung|to the lung
5218127|NCT00752180|pharmacokinetics|pharmacokinetics
5218128|NCT00752180|pharmacodynamics|pharmacodynamics
5218129|NCT00752180|type 1 diabetics|type 1 diabetics
5218130|NCT00752180|recombinant human insulin|recombinant human insulin
5218131|NCT00752167|exercise induced bronchospasm|exercise induced bronchospasm
5218132|NCT00752167|asthma|asthma
5218133|NCT00752167|athlete|athlete
5218134|NCT00752167|sports|sports
5218135|NCT00752167|eucapnic voluntary hyperventilation|eucapnic voluntary hyperventilation
5218136|NCT00752167|albuterol|albuterol
5218137|NCT00752154|Subjects|subjects
5218138|NCT00752154|active|active
5218139|NCT00752154|Rheumatoid|rheumatoid
5218140|NCT00752154|Arthritis|arthritis
5218141|NCT00752154|revised|revised
5218142|NCT00752154|American|american
5218143|NCT00752154|College|college
5218144|NCT00752154|Rheumatology|rheumatology
5218145|NCT00752154|Criteria|criteria
5218146|NCT00752128|Drug Eluting Stent|drug eluting stent
5218147|NCT00752128|Interventional Cardiology|interventional cardiology
5218148|NCT00752128|Percutaneous Coronary Intervention|percutaneous coronary intervention
5218149|NCT00752115|non-small cell lung cancer|non-small cell lung cancer
5218150|NCT00752115|previously untreated|previously untreated
5218151|NCT00752102|Secondary Hyperparathryoidism|secondary hyperparathryoidism
5218152|NCT00752102|Chronic Kidney Disease|chronic kidney disease
5218153|NCT00752102|Vitamin D|vitamin d
5218154|NCT00752102|Coronary Calcification|coronary calcification
5218478|NCT00751023|Addiction|addiction
5218155|NCT00752102|Bone metabolism|bone metabolism
5218156|NCT00752089|enamel fluoride uptake|enamel fluoride uptake
5218157|NCT00752089|erosion|erosion
5218158|NCT00752089|enamel remineralization|enamel remineralization
5218159|NCT00752076|EGFR mutation|egfr mutation
5218160|NCT00752076|NSCLC cell line|nsclc cell line
5218161|NCT00752076|Malignant pleural effusion|malignant pleural effusion
5218162|NCT00752063|Sorafenib|sorafenib
5218163|NCT00752063|Capecitabine|capecitabine
5218164|NCT00752063|Oxaliplatin|oxaliplatin
5218165|NCT00752063|Advanced Hepatocellular Carcinoma|advanced hepatocellular carcinoma
5218166|NCT00752063|Metastatic Hepatocellular Carcinoma|metastatic hepatocellular carcinoma
5218167|NCT00752050|Botulinum Toxin Type A|botulinum toxin type a
5218168|NCT00752050|Botulinum Toxin|botulinum toxin
5218169|NCT00752050|Glabellar Rhytides|glabellar rhytides
5218170|NCT00752050|Rhytides|rhytides
5218171|NCT00752050|Frown Lines|frown lines
5218172|NCT00752050|Neuromuscular Agents|neuromuscular agents
5218173|NCT00752050|Neurotoxin|neurotoxin
5218174|NCT00752050|Forehead|forehead
5218175|NCT00752050|Eyebrow|eyebrow
5218176|NCT00752050|Wrinkle|wrinkle
5218177|NCT00752037|HIV|hiv
5218178|NCT00752037|Protease Inhibitor|protease inhibitor
5218179|NCT00752037|Integrase Inhibitor|integrase inhibitor
5218180|NCT00752037|Treatment Experienced|treatment experienced
5218181|NCT00752037|Naive|naive
5218182|NCT00752024|HICH|hich
5218183|NCT00752024|Suction drainages|suction drainages
5218184|NCT00752024|TTAC|ttac
5218185|NCT00752011|Cancer|cancer
5218186|NCT00752011|Solid Tumors|solid tumors
5218187|NCT00752011|Advanced Cancer|advanced cancer
5218188|NCT00752011|Carboplatin|carboplatin
5218189|NCT00752011|Paraplatin|paraplatin
5218190|NCT00752011|TAS-106|tas-106
5218191|NCT00752011|Antitumor Activity|antitumor activity
5218192|NCT00752011|Biomarkers|biomarkers
5218193|NCT00751998|biliary|biliary
5218194|NCT00751998|ERCP|ercp
5218195|NCT00751998|cholangioscopy|cholangioscopy
5218196|NCT00751998|pancreatic|pancreatic
5218197|NCT00751985|Heavy drinking|heavy drinking
5218198|NCT00751985|Ultra-brief intervention|ultra-brief intervention
5218199|NCT00751985|Brief intervention|brief intervention
5218200|NCT00751985|Alcohol prevention|alcohol prevention
5218201|NCT00751985|Randomized trial|randomized trial
5218202|NCT00751985|Personal normative feedback|personal normative feedback
5218203|NCT00751985|Self-help material|self-help material
5218204|NCT00751985|Web-based|web-based
5218205|NCT00751985|Intervention Studies|intervention studies
5218206|NCT00751985|prevention & control|prevention & control
5218207|NCT00751959|Continuous positive airway pressure (CPAP)|continuous positive airway pressure (cpap)
5218208|NCT00751959|extremely preterm infant|extremely preterm infant
5218209|NCT00751959|Idiopathic respiratory distress syndrome (IRDS)|idiopathic respiratory distress syndrome (irds)
5218210|NCT00751959|Surfactant|surfactant
5218211|NCT00751946|Posttraumatic Stress Disorder|posttraumatic stress disorder
5218212|NCT00751946|PTSD|ptsd
5218213|NCT00751946|psychotherapy|psychotherapy
5218214|NCT00751946|adolescents|adolescents
5218215|NCT00751946|clinical trial|clinical trial
5218216|NCT00751933|Ulcerative colitis|ulcerative colitis
5218217|NCT00751933|Vaccines|vaccines
5218218|NCT00751933|Oats|oats
5218219|NCT00751920|Magnetic Resonance Imaging|magnetic resonance imaging
5218220|NCT00751920|Pediatrics|pediatrics
5218221|NCT00751920|Multi-Detector Computed Tomography|multi-detector computed tomography
5218222|NCT00751920|Computed Tomography|computed tomography
5218223|NCT00751920|Detection|detection
5218224|NCT00751907|Cerebral blood flow|cerebral blood flow
5218225|NCT00751894|Children|children
5218226|NCT00751894|cancer|cancer
5218227|NCT00751894|Bone marrow transplantation|bone marrow transplantation
5218228|NCT00751894|Stem cell mobilization|stem cell mobilization
5218229|NCT00751894|G-CSF|g-csf
5218230|NCT00751894|Children with solid malignancies|children with solid malignancies
5218231|NCT00751881|relapsing multiple sclerosis|relapsing multiple sclerosis
5218232|NCT00751868|breast cancer|breast cancer
5218233|NCT00751842|Diabetes|diabetes
5218234|NCT00751842|Juvenile Diabetes|juvenile diabetes
5218235|NCT00751842|Diabetes type 1|diabetes type 1
5218236|NCT00751842|Autoimmune Diabetes|autoimmune diabetes
5218237|NCT00751842|Insulin dependent Diabetes|insulin dependent diabetes
5218238|NCT00751842|Type 1 diabetes|type 1 diabetes
5218239|NCT00751842|Type 1 diabetes mellitus|type 1 diabetes mellitus
5218240|NCT00751842|Diamyd|diamyd
5218241|NCT00751842|rhGAD65|rhgad65
5218242|NCT00751842|GAD|gad
5218243|NCT00751842|GAD-alum|gad-alum
5218244|NCT00751816|musculoskeletal complications|musculoskeletal complications
5218245|NCT00751816|stage I squamous cell carcinoma of the hypopharynx|stage i squamous cell carcinoma of the hypopharynx
5218246|NCT00751816|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
5218247|NCT00751816|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
5218248|NCT00751816|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5218249|NCT00751816|stage I squamous cell carcinoma of the larynx|stage i squamous cell carcinoma of the larynx
5218250|NCT00751816|stage I verrucous carcinoma of the larynx|stage i verrucous carcinoma of the larynx
5218476|NCT00751023|Methamphetamine|methamphetamine
5218251|NCT00751816|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
5218252|NCT00751816|stage II verrucous carcinoma of the larynx|stage ii verrucous carcinoma of the larynx
5218253|NCT00751816|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
5218254|NCT00751816|stage III verrucous carcinoma of the larynx|stage iii verrucous carcinoma of the larynx
5218255|NCT00751816|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5218256|NCT00751816|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
5218257|NCT00751816|stage I adenoid cystic carcinoma of the oral cavity|stage i adenoid cystic carcinoma of the oral cavity
5218258|NCT00751816|stage I mucoepidermoid carcinoma of the oral cavity|stage i mucoepidermoid carcinoma of the oral cavity
5218259|NCT00751816|stage I verrucous carcinoma of the oral cavity|stage i verrucous carcinoma of the oral cavity
5218260|NCT00751816|stage II adenoid cystic carcinoma of the oral cavity|stage ii adenoid cystic carcinoma of the oral cavity
5218261|NCT00751816|stage II mucoepidermoid carcinoma of the oral cavity|stage ii mucoepidermoid carcinoma of the oral cavity
5218262|NCT00751816|stage II verrucous carcinoma of the oral cavity|stage ii verrucous carcinoma of the oral cavity
5218263|NCT00751816|stage III adenoid cystic carcinoma of the oral cavity|stage iii adenoid cystic carcinoma of the oral cavity
5218264|NCT00751816|stage III mucoepidermoid carcinoma of the oral cavity|stage iii mucoepidermoid carcinoma of the oral cavity
5218265|NCT00751816|stage III verrucous carcinoma of the oral cavity|stage iii verrucous carcinoma of the oral cavity
5218266|NCT00751816|stage IV adenoid cystic carcinoma of the oral cavity|stage iv adenoid cystic carcinoma of the oral cavity
5218267|NCT00751816|stage IV mucoepidermoid carcinoma of the oral cavity|stage iv mucoepidermoid carcinoma of the oral cavity
5218268|NCT00751816|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
5218269|NCT00751816|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
5218270|NCT00751816|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
5218271|NCT00751816|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
5218272|NCT00751816|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5218273|NCT00751816|stage I basal cell carcinoma of the lip|stage i basal cell carcinoma of the lip
5218274|NCT00751816|stage II basal cell carcinoma of the lip|stage ii basal cell carcinoma of the lip
5218275|NCT00751816|stage III basal cell carcinoma of the lip|stage iii basal cell carcinoma of the lip
5218276|NCT00751816|stage IV basal cell carcinoma of the lip|stage iv basal cell carcinoma of the lip
5218277|NCT00751816|stage I lymphoepithelioma of the nasopharynx|stage i lymphoepithelioma of the nasopharynx
5218278|NCT00751816|stage I squamous cell carcinoma of the nasopharynx|stage i squamous cell carcinoma of the nasopharynx
5218279|NCT00751816|stage II lymphoepithelioma of the nasopharynx|stage ii lymphoepithelioma of the nasopharynx
5218280|NCT00751816|stage II squamous cell carcinoma of the nasopharynx|stage ii squamous cell carcinoma of the nasopharynx
5218281|NCT00751816|stage III lymphoepithelioma of the nasopharynx|stage iii lymphoepithelioma of the nasopharynx
5218282|NCT00751816|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
5218283|NCT00751816|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
5218284|NCT00751816|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
5218285|NCT00751816|stage I lymphoepithelioma of the oropharynx|stage i lymphoepithelioma of the oropharynx
5218510|NCT00750815|B Cell|b cell
5218286|NCT00751816|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
5218287|NCT00751816|stage II lymphoepithelioma of the oropharynx|stage ii lymphoepithelioma of the oropharynx
5218288|NCT00751816|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
5218289|NCT00751816|stage III lymphoepithelioma of the oropharynx|stage iii lymphoepithelioma of the oropharynx
5218290|NCT00751816|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
5218291|NCT00751816|stage IV lymphoepithelioma of the oropharynx|stage iv lymphoepithelioma of the oropharynx
5218292|NCT00751816|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5218293|NCT00751816|stage I esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage i esthesioneuroblastoma of the paranasal sinus and nasal cavity
5218294|NCT00751816|stage I inverted papilloma of the paranasal sinus and nasal cavity|stage i inverted papilloma of the paranasal sinus and nasal cavity
5218295|NCT00751816|stage I midline lethal granuloma of the paranasal sinus and nasal cavity|stage i midline lethal granuloma of the paranasal sinus and nasal cavity
5218296|NCT00751816|stage I squamous cell carcinoma of the paranasal sinus and nasal cavity|stage i squamous cell carcinoma of the paranasal sinus and nasal cavity
5218297|NCT00751816|stage II esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage ii esthesioneuroblastoma of the paranasal sinus and nasal cavity
5218298|NCT00751816|stage II inverted papilloma of the paranasal sinus and nasal cavity|stage ii inverted papilloma of the paranasal sinus and nasal cavity
5218299|NCT00751816|stage II midline lethal granuloma of the paranasal sinus and nasal cavity|stage ii midline lethal granuloma of the paranasal sinus and nasal cavity
5218300|NCT00751816|stage II squamous cell carcinoma of the paranasal sinus and nasal cavity|stage ii squamous cell carcinoma of the paranasal sinus and nasal cavity
5218301|NCT00751816|stage III esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iii esthesioneuroblastoma of the paranasal sinus and nasal cavity
5218302|NCT00751816|stage III inverted papilloma of the paranasal sinus and nasal cavity|stage iii inverted papilloma of the paranasal sinus and nasal cavity
5218477|NCT00751023|Modafinil|modafinil
5218303|NCT00751816|stage III midline lethal granuloma of the paranasal sinus and nasal cavity|stage iii midline lethal granuloma of the paranasal sinus and nasal cavity
5218304|NCT00751816|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
5218305|NCT00751816|stage IV esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iv esthesioneuroblastoma of the paranasal sinus and nasal cavity
5218306|NCT00751816|stage IV inverted papilloma of the paranasal sinus and nasal cavity|stage iv inverted papilloma of the paranasal sinus and nasal cavity
5218307|NCT00751816|stage IV midline lethal granuloma of the paranasal sinus and nasal cavity|stage iv midline lethal granuloma of the paranasal sinus and nasal cavity
5218308|NCT00751816|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
5218309|NCT00751816|high-grade salivary gland mucoepidermoid carcinoma|high-grade salivary gland mucoepidermoid carcinoma
5218310|NCT00751816|low-grade salivary gland mucoepidermoid carcinoma|low-grade salivary gland mucoepidermoid carcinoma
5218311|NCT00751816|salivary gland acinic cell tumor|salivary gland acinic cell tumor
5218312|NCT00751816|salivary gland adenocarcinoma|salivary gland adenocarcinoma
5218313|NCT00751816|salivary gland adenoid cystic carcinoma|salivary gland adenoid cystic carcinoma
5218314|NCT00751816|salivary gland anaplastic carcinoma|salivary gland anaplastic carcinoma
5218315|NCT00751816|salivary gland malignant mixed cell type tumor|salivary gland malignant mixed cell type tumor
5218316|NCT00751816|salivary gland poorly differentiated carcinoma|salivary gland poorly differentiated carcinoma
5218317|NCT00751816|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
5218318|NCT00751816|stage I salivary gland cancer|stage i salivary gland cancer
5218319|NCT00751816|stage II salivary gland cancer|stage ii salivary gland cancer
5218320|NCT00751816|stage III salivary gland cancer|stage iii salivary gland cancer
5218321|NCT00751816|stage IV salivary gland cancer|stage iv salivary gland cancer
5218322|NCT00751790|triptorelin, 6-month formulation, advanced prostate cancer|triptorelin, 6-month formulation, advanced prostate cancer
5218323|NCT00751712|Aortic Arch|aortic arch
5218324|NCT00751699|Pharmacokinetics|pharmacokinetics
5218325|NCT00751686|Gastroenteritis|gastroenteritis
5218326|NCT00751686|Burden|burden
5218327|NCT00751686|Rotavirus|rotavirus
5218328|NCT00751686|< 5 years|< 5 years
5218329|NCT00751686|Greece|greece
5218330|NCT00751686|Children|children
5218331|NCT00751660|small cell lung cancer|small cell lung cancer
5218332|NCT00751660|non-small cell lung cancer|non-small cell lung cancer
5218333|NCT00751660|tobacco use disorder|tobacco use disorder
5218334|NCT00751647|CF|cf
5218335|NCT00751634|subarachnoid hemorrhage|subarachnoid hemorrhage
5218336|NCT00751634|intracerebral hemorrhage|intracerebral hemorrhage
5218337|NCT00751634|fever|fever
5218338|NCT00751621|Immune globulin subcutaneous|immune globulin subcutaneous
5218339|NCT00751621|SCIG|scig
5218340|NCT00751621|primary immunodeficiency|primary immunodeficiency
5218341|NCT00751621|PID|pid
5218342|NCT00751608|Familial hypercholesterolemia, endothelial function, venous occlusion plethysmography, forearm blood flow, ApoAI-mimetic, endothelial dependent vasodilation|familial hypercholesterolemia, endothelial function, venous occlusion plethysmography, forearm blood flow, apoai-mimetic, endothelial dependent vasodilation
5218343|NCT00751595|HIV|hiv
5218344|NCT00751595|Tat protein|tat protein
5218345|NCT00751595|Therapeutic vaccine|therapeutic vaccine
5218346|NCT00751595|HAART|haart
5218347|NCT00751595|HIV Therapeutic Vaccine|hiv therapeutic vaccine
5218348|NCT00751595|Treatment Experienced|treatment experienced
5218349|NCT00751582|nutrition|nutrition
5218350|NCT00751582|education|education
5218351|NCT00751582|supplementation|supplementation
5218352|NCT00751569|umbilical cord blood|umbilical cord blood
5218353|NCT00751556|Naproxen Sodium|naproxen sodium
5218354|NCT00751556|Bioavailability|bioavailability
5218355|NCT00751543|To evaluate the longitudinal change of tumor perfusion in the course of radiation therapy in adenocarcinoma and squamous cell carcinoma using perfusion MDCT|to evaluate the longitudinal change of tumor perfusion in the course of radiation therapy in adenocarcinoma and squamous cell carcinoma using perfusion mdct
5218356|NCT00751543|Comparison between adenocarcinoma and squamous cell carcinoma will be evaluated according to the derived perfusion parameter obtained from perfusion MDCT|comparison between adenocarcinoma and squamous cell carcinoma will be evaluated according to the derived perfusion parameter obtained from perfusion mdct
5218357|NCT00751530|HIV|hiv
5218358|NCT00751530|AIDS|aids
5218359|NCT00751530|raltegravir|raltegravir
5218360|NCT00751530|BRAVO|bravo
5218361|NCT00751530|protease inhibitor|protease inhibitor
5218362|NCT00751530|treatment Experienced|treatment experienced
5218363|NCT00751517|Vasculitis|vasculitis
5218364|NCT00751517|Cyclophosphamide|cyclophosphamide
5218365|NCT00751517|Methotrexate|methotrexate
5218366|NCT00751517|Systemic Necrotizing Vasculitides|systemic necrotizing vasculitides
5218367|NCT00751504|Quetiapine|quetiapine
5218368|NCT00751504|Psychotic depression|psychotic depression
5218369|NCT00751491|Stable angina|stable angina
5218370|NCT00751491|Percutaneous Coronary Intervention|percutaneous coronary intervention
5218371|NCT00751491|Myonecrosis|myonecrosis
5218372|NCT00751478|ALO-01|alo-01
5218373|NCT00751478|morphine|morphine
5218374|NCT00751478|Determination of the relative pharmacodynamic effects|determination of the relative pharmacodynamic effects
5218375|NCT00751478|(including drug-liking), pharmacokinetics, and safety of|(including drug-liking), pharmacokinetics, and safety of
5218376|NCT00751478|ALO-01 when administered whole or crushed and compared to|alo-01 when administered whole or crushed and compared to
5218377|NCT00751478|equivalent doses of immediate release morphine and placebo|equivalent doses of immediate release morphine and placebo
5218378|NCT00751465|Social Anxiety Disorder|social anxiety disorder
5218379|NCT00751465|Social Phobia|social phobia
5218380|NCT00751465|Fear of blushing|fear of blushing
5218381|NCT00751465|attention|attention
5218382|NCT00751465|attention training|attention training
5218383|NCT00751465|cognitive behavior therapy|cognitive behavior therapy
5218384|NCT00751452|Children|children
5218385|NCT00751452|Allogeneic bone marrow transplantation|allogeneic bone marrow transplantation
5218386|NCT00751452|Intestinal damage|intestinal damage
5218387|NCT00751452|Citrulline|citrulline
5218388|NCT00751452|Graft versus Host Disease|graft versus host disease
5218389|NCT00751452|0 to 18 years old|0 to 18 years old
5218390|NCT00751439|Oximeter|oximeter
5218391|NCT00751439|Arterial blood gas|arterial blood gas
5218392|NCT00751439|comparison|comparison
5218393|NCT00751426|Interferon-alpha|interferon-alpha
5218394|NCT00751426|hepatitis c|hepatitis c
5218395|NCT00751426|Drug addiction|drug addiction
5218396|NCT00751426|methadone|methadone
5218397|NCT00751426|psychiatric disorder|psychiatric disorder
5218398|NCT00751426|Safety and efficacy of Interferon-alpha i patients with a psychiatric disorder.|safety and efficacy of interferon-alpha i patients with a psychiatric disorder.
5218399|NCT00751400|Non-prescription|non-prescription
5218400|NCT00751361|Rheopheresis|rheopheresis
5218401|NCT00751361|Dry Age Related Macular Degeneration|dry age related macular degeneration
5218402|NCT00751361|AMD|amd
5218403|NCT00751361|apheresis|apheresis
5218404|NCT00751361|microcirculation|microcirculation
5218405|NCT00751348|second year of life|second year of life
5218406|NCT00751348|one-dose schedule|one-dose schedule
5218407|NCT00751348|varicella|varicella
5218408|NCT00751348|rubella|rubella
5218409|NCT00751348|measles|measles
5218410|NCT00751348|mumps|mumps
5218411|NCT00751335|Obstructive Sleep Apnea|obstructive sleep apnea
5218412|NCT00751335|Humidification|humidification
5218413|NCT00751335|Continuous Positive Airway Pressure|continuous positive airway pressure
5218414|NCT00751322|Pulmonary|pulmonary
5218415|NCT00751322|Protein|protein
5218416|NCT00751309|allograft|allograft
5218417|NCT00751309|rejection|rejection
5218418|NCT00751309|biopsy|biopsy
5218419|NCT00751309|gene|gene
5218420|NCT00751309|expression|expression
5218421|NCT00751309|pulmonary|pulmonary
5218422|NCT00751309|lung|lung
5218423|NCT00751309|transplant|transplant
5218424|NCT00751296|Lenalidomide|lenalidomide
5218425|NCT00751296|immunomodulatory drug (IMiD®)|immunomodulatory drug (imid®)
5218426|NCT00751296|Thalidomide analogues|thalidomide analogues
5218427|NCT00751270|Immunotherapy|immunotherapy
5218428|NCT00751270|Gene therapy|gene therapy
5218429|NCT00751270|Tumor Vaccine|tumor vaccine
5218430|NCT00751270|Cytotoxicity|cytotoxicity
5218431|NCT00751270|Radiation|radiation
5218432|NCT00751257|Nicotine|nicotine
5218433|NCT00751257|N-acetylcysteine|n-acetylcysteine
5218434|NCT00751257|smoking reduction|smoking reduction
5218435|NCT00751244|women|women
5218436|NCT00751244|posttraumatic stress disorder|posttraumatic stress disorder
5218437|NCT00751244|PTSD|ptsd
5218438|NCT00751244|psychotherapy|psychotherapy
5218439|NCT00751244|clinical trial|clinical trial
5218440|NCT00751244|emotion regulation|emotion regulation
5218441|NCT00751231|PCI|pci
5218442|NCT00751231|percutaneous coronary intervention|percutaneous coronary intervention
5218443|NCT00751205|Peripheral Neuropathy|peripheral neuropathy
5218444|NCT00751205|Prostate Carcinoma|prostate carcinoma
5218445|NCT00751205|Ovarian Carcinoma|ovarian carcinoma
5218446|NCT00751192|Men who have sex with men|men who have sex with men
5218447|NCT00751192|Peru|peru
5218448|NCT00751192|HIV testing|hiv testing
5218449|NCT00751192|video|video
5218450|NCT00751192|online|online
5218451|NCT00751192|Internet|internet
5218452|NCT00751192|HIV Seronegativity|hiv seronegativity
5218453|NCT00751153|drug substitution|drug substitution
5218454|NCT00751153|Raltegravir|raltegravir
5218455|NCT00751153|Atazanavir|atazanavir
5218456|NCT00751153|treatment Experienced|treatment experienced
5218457|NCT00751140|surgical candidates|surgical candidates
5218458|NCT00751140|upper urinary tract|upper urinary tract
5218459|NCT00751140|urothelial carcinoma|urothelial carcinoma
5218460|NCT00751140|lymph node dissection|lymph node dissection
5218461|NCT00751127|open angle glaucoma|open angle glaucoma
5218462|NCT00751127|ocular hypertension|ocular hypertension
5218463|NCT00751101|palmar-plantar erythrodysesthesia|palmar-plantar erythrodysesthesia
5218464|NCT00751101|chemotherapeutic agent toxicity|chemotherapeutic agent toxicity
5218465|NCT00751101|stage IV breast cancer|stage iv breast cancer
5218466|NCT00751101|recurrent breast cancer|recurrent breast cancer
5218467|NCT00751088|single-incision|single-incision
5218468|NCT00751088|sling|sling
5218469|NCT00751088|stress incontinence|stress incontinence
5218470|NCT00751088|surgery|surgery
5218471|NCT00751088|treatment|treatment
5218472|NCT00751088|Female urinary stress incontinence|female urinary stress incontinence
5218473|NCT00751062|open angle glaucoma ocular hypertension|open angle glaucoma ocular hypertension
5218474|NCT00751049|open angle glaucoma ocular hypertension|open angle glaucoma ocular hypertension
5218475|NCT00751036|GIST|gist
5218479|NCT00751023|Craving|craving
5218480|NCT00751023|Cognitive|cognitive
5218481|NCT00751010|Vulvar pain|vulvar pain
5218482|NCT00751010|Vulvodynia|vulvodynia
5218483|NCT00751010|Interstitial cystitis|interstitial cystitis
5218484|NCT00750971|ASSIST|assist
5218485|NCT00750971|SLE|sle
5218486|NCT00750971|Stem Cell Transplantation|stem cell transplantation
5218487|NCT00750971|Tolerance|tolerance
5218488|NCT00750958|cardiac rhythm changes|cardiac rhythm changes
5218489|NCT00750945|Parkinson's disease|parkinson's disease
5218490|NCT00750945|Cueing training|cueing training
5218491|NCT00750945|Treadmill training|treadmill training
5218492|NCT00750945|Music|music
5218493|NCT00750893|Gastroenteritis|gastroenteritis
5218494|NCT00750867|multiple system atrophy, MSA,|multiple system atrophy, msa,
5218495|NCT00750867|intravenous immunoglobulin, IVIg|intravenous immunoglobulin, ivig
5218496|NCT00750854|arthritis|arthritis
5218497|NCT00750854|osteoarthritis|osteoarthritis
5218498|NCT00750854|fibromyalgia|fibromyalgia
5218499|NCT00750854|connective tissue disorder|connective tissue disorder
5218500|NCT00750841|advanced cancer|advanced cancer
5218501|NCT00750841|metastatic|metastatic
5218502|NCT00750841|rifampicin|rifampicin
5218503|NCT00750841|pharmacokinetics|pharmacokinetics
5218504|NCT00750841|Phase I|phase i
5218505|NCT00750841|Advanced solid tumours|advanced solid tumours
5218506|NCT00750828|Saliva|saliva
5218507|NCT00750828|Sjögren's Syndrome|sjögren's syndrome
5218508|NCT00750828|GCF|gcf
5218509|NCT00750828|Oral Mucosal Wetness|oral mucosal wetness
5218511|NCT00750815|hematologic malignancy|hematologic malignancy
5218512|NCT00750815|plasma|plasma
5218513|NCT00750815|bone marrow|bone marrow
5218514|NCT00750802|Phase I|phase i
5218515|NCT00750776|Quality assurance|quality assurance
5218516|NCT00750776|medical treatment|medical treatment
5218517|NCT00750776|Patient satisfaction|patient satisfaction
5218518|NCT00750763|Mucosal inflammation|mucosal inflammation
5218519|NCT00750763|Fleet|fleet
5218520|NCT00750763|Picoprep|picoprep
5218521|NCT00750763|Colonlytely|colonlytely
5218522|NCT00750763|Colonoscopy|colonoscopy
5218523|NCT00750763|tolerability|tolerability
5218524|NCT00750763|efficacy|efficacy
5218525|NCT00750737|Hematologic Malignancies|hematologic malignancies
5218526|NCT00750737|Blood Cancer|blood cancer
5218527|NCT00750737|Lymphatic Cancer|lymphatic cancer
5218528|NCT00750737|Amphotericin B Lipid Complex|amphotericin b lipid complex
5218529|NCT00750737|Amphotericin B|amphotericin b
5218530|NCT00750737|ABLC|ablc
5218531|NCT00750737|Fungizone|fungizone
5218532|NCT00750737|Noxafil|noxafil
5218533|NCT00750737|SCH56592|sch56592
5218534|NCT00750737|Posaconazole|posaconazole
5218535|NCT00750737|Invasive fungal infections|invasive fungal infections
5218536|NCT00750737|IFI|ifi
5218537|NCT00750737|Hematopoietic Stem Cell Transplant|hematopoietic stem cell transplant
5218538|NCT00750737|HSCT|hsct
5218539|NCT00750737|Bone Marrow Transplant|bone marrow transplant
5218540|NCT00750737|Allogeneic hematopoietic stem cell transplant|allogeneic hematopoietic stem cell transplant
5218541|NCT00750724|Hyaluronic acid,|hyaluronic acid,
5218542|NCT00750724|OA knee,|oa knee,
5218543|NCT00750724|MRI|mri
5218544|NCT00750698|lung cancer|lung cancer
5218545|NCT00750698|non small cell lung cancer|non small cell lung cancer
5218546|NCT00750685|Primary Breast Reconstruction|primary breast reconstruction
5218547|NCT00750672|Endometrial neoplasia|endometrial neoplasia
5218548|NCT00750672|Follow-up care|follow-up care
5218549|NCT00750672|survivorship|survivorship
5218550|NCT00750672|Primary care provider|primary care provider
5218551|NCT00750659|Chronic myeloid leukemia|chronic myeloid leukemia
5218552|NCT00750659|Ph+ acute lymphoblastic leukemia|ph+ acute lymphoblastic leukemia
5218553|NCT00750659|stem cell transplantation|stem cell transplantation
5218554|NCT00750659|nilotinib|nilotinib
5218555|NCT00750646|compliance|compliance
5218556|NCT00750646|eye drop administration|eye drop administration
5218557|NCT00750646|MEMS|mems
5218558|NCT00750646|adherence|adherence
5218559|NCT00750633|swimmer's ear|swimmer's ear
5218560|NCT00750633|ear drops|ear drops
5218561|NCT00750633|ear infection|ear infection
5218562|NCT00750633|ear pain|ear pain
5218563|NCT00750633|ear inflammation|ear inflammation
5218564|NCT00750620|mild, moderate, and severe renal impaired subjects|mild, moderate, and severe renal impaired subjects
5218565|NCT00750620|normal renal function subjects|normal renal function subjects
5218566|NCT00750620|Glomerular filtration rate (GFR)|glomerular filtration rate (gfr)
5218567|NCT00750620|Modification of Diet in Renal Disease (MDRD) formula|modification of diet in renal disease (mdrd) formula
5218568|NCT00750620|YM178|ym178
5218569|NCT00750620|pharmacokinetics|pharmacokinetics
5218570|NCT00750594|Children|children
5218571|NCT00750594|Migraine headaches|migraine headaches
5218572|NCT00750581|Patent Ductus Arteriosus|patent ductus arteriosus
5218573|NCT00750568|Bronchial asthma|bronchial asthma
5218574|NCT00750568|Asthma, bronchial|asthma, bronchial
5218575|NCT00750568|Status Asthmaticus|status asthmaticus
5218576|NCT00750568|Terbutaline sulfate|terbutaline sulfate
5218577|NCT00750555|squamous cell cancer of head and neck|squamous cell cancer of head and neck
5218578|NCT00750555|SCCHN|scchn
5218579|NCT00750529|sleep|sleep
5218580|NCT00750529|Alzheimer|alzheimer
5218581|NCT00750529|old patients|old patients
5218582|NCT00750516|Lactic acid|lactic acid
5218583|NCT00750516|hypotension|hypotension
5218584|NCT00750516|sepsis|sepsis
5218585|NCT00750503|tobacco cessation|tobacco cessation
5218586|NCT00750503|behavioral therapy|behavioral therapy
5218587|NCT00750503|pharmacotherapy|pharmacotherapy
5218588|NCT00750503|workplace|workplace
5218589|NCT00750503|oral cancer screening|oral cancer screening
5218590|NCT00750503|Tobacco Quit rates|tobacco quit rates
5218591|NCT00750477|osteoarthritis|osteoarthritis
5218592|NCT00750477|arthritis|arthritis
5218593|NCT00750477|knee|knee
5218594|NCT00750477|eggshell|eggshell
5218595|NCT00750477|membrane|membrane
5218596|NCT00750477|OPTION|option
5218597|NCT00750451|fertilization in vitro|fertilization in vitro
5218598|NCT00750451|assisted reproduction|assisted reproduction
5218599|NCT00750451|recurrent implantation failure|recurrent implantation failure
5218600|NCT00750451|low molecular weight heparin|low molecular weight heparin
5218601|NCT00750451|heparin|heparin
5218602|NCT00750451|luteal phase|luteal phase
5218603|NCT00750438|Obesity|obesity
5218604|NCT00750438|Short chain fatty acids|short chain fatty acids
5218605|NCT00750438|Appetite|appetite
5218606|NCT00750438|Body weight|body weight
5218607|NCT00750438|Insulin sensitivity|insulin sensitivity
5218608|NCT00750438|Propionate|propionate
5218609|NCT00750438|Propionate ester|propionate ester
5218610|NCT00750425|advanced cancer,|advanced cancer,
5218611|NCT00750425|metastatic|metastatic
5218612|NCT00750425|ketoconazole|ketoconazole
5218613|NCT00750425|pharmacokinetics|pharmacokinetics
5218614|NCT00750425|Phase I|phase i
5218615|NCT00750412|TeenScreen|teenscreen
5218616|NCT00750412|Mental Health|mental health
5218617|NCT00750412|Adolescent Mental Health|adolescent mental health
5218618|NCT00750412|Social Work|social work
5218619|NCT00750399|radiation|radiation
5218620|NCT00750399|retinopathy|retinopathy
5218621|NCT00750399|ranibizumab|ranibizumab
5218622|NCT00750399|melanoma|melanoma
5218623|NCT00750399|choroid|choroid
5218624|NCT00750386|Cancer|cancer
5218625|NCT00750386|Ovarian cancer|ovarian cancer
5218626|NCT00750386|Dose-dense chemotherapy|dose-dense chemotherapy
5218627|NCT00750373|Endocarditis|endocarditis
5218628|NCT00750360|Influenza|influenza
5218629|NCT00750360|Korea|korea
5218630|NCT00750360|FluarixTM|fluarixtm
5218631|NCT00750347|pain,|pain,
5218632|NCT00750347|analgesia|analgesia
5218633|NCT00750347|Healthy volunteers|healthy volunteers
5218634|NCT00750334|Oral Clofarabine,|oral clofarabine,
5218635|NCT00750334|relapsed/refractory MDS,|relapsed/refractory mds,
5218636|NCT00750334|Myelodysplastic|myelodysplastic
5218637|NCT00750295|Chronic kidney disease,|chronic kidney disease,
5218638|NCT00750295|hemodialysis,|hemodialysis,
5218639|NCT00750295|serum phosphorus,|serum phosphorus,
5218640|NCT00750295|phosphate binders|phosphate binders
5218641|NCT00750282|Alzheimer Disease|alzheimer disease
5218642|NCT00750282|Amyloid beta-Protein|amyloid beta-protein
5218643|NCT00750269|stage I non-small cell lung cancer|stage i non-small cell lung cancer
5218644|NCT00750256|tolerability|tolerability
5218645|NCT00750256|Safety|safety
5218646|NCT00750256|pharmacokinetics|pharmacokinetics
5218647|NCT00750230|arthritis|arthritis
5218648|NCT00750230|osteoarthritis|osteoarthritis
5218649|NCT00750230|fibromyalgia|fibromyalgia
5218650|NCT00750230|connective tissue disorder|connective tissue disorder
5218651|NCT00750217|transfer methadone buprenorphine patch heroin addiction|transfer methadone buprenorphine patch heroin addiction
5218652|NCT00750204|Acute Lung Injury|acute lung injury
5218653|NCT00750204|ALI|ali
5218654|NCT00750204|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
5218655|NCT00750204|Mechanical Ventilation|mechanical ventilation
5218656|NCT00750204|Sedation|sedation
5218657|NCT00750204|Critical Illness|critical illness
5218658|NCT00750204|Ventilator Induced Lung Injury|ventilator induced lung injury
5218659|NCT00750204|VILI|vili
5218660|NCT00750204|Cytokines|cytokines
5218661|NCT00750204|Protective Ventilation|protective ventilation
5218662|NCT00750204|Airway Pressure Release Ventilation|airway pressure release ventilation
5218663|NCT00750204|APRV|aprv
5218664|NCT00750204|Breathing Comfort|breathing comfort
5218665|NCT00750204|Dyssynchrony|dyssynchrony
5218666|NCT00750204|Asynchrony|asynchrony
5218667|NCT00750191|Lower Back Pain|lower back pain
5218668|NCT00750165|Obstructive Sleep Apnea|obstructive sleep apnea
5218669|NCT00750165|Humidification|humidification
5218670|NCT00750165|Continuous Positive Airway Pressure|continuous positive airway pressure
5218671|NCT00750152|tinea cruris|tinea cruris
5218672|NCT00750152|jock itch|jock itch
5218673|NCT00750139|Tinea Pedis|tinea pedis
5218674|NCT00750139|Athlete's foot|athlete's foot
5218675|NCT00750126|Allograft|allograft
5218676|NCT00750126|Children|children
5218677|NCT00750126|malignancy|malignancy
5218678|NCT00750126|Reduced Intensity Conditioning|reduced intensity conditioning
5218679|NCT00750126|Fludarabin|fludarabin
5218680|NCT00750126|Busulfex|busulfex
5218681|NCT00750126|Thymoglobulin|thymoglobulin
5218682|NCT00750100|infertility|infertility
5218683|NCT00750100|IVF|ivf
5218684|NCT00750100|hCG|hcg
5218685|NCT00750100|primary infertility|primary infertility
5218686|NCT00750100|secondary infertility|secondary infertility
5218687|NCT00750100|patients requiring in-vitro fertilisation|patients requiring in-vitro fertilisation
5218688|NCT00750087|Schizophrenia|schizophrenia
5218689|NCT00750074|mechanical ventilation|mechanical ventilation
5218690|NCT00750061|Spinal Cord Injury|spinal cord injury
5218691|NCT00750048|pain,|pain,
5218692|NCT00750048|sensitization,|sensitization,
5218693|NCT00750048|analgesia|analgesia
5218694|NCT00750035|Total hysterectomy|total hysterectomy
5218695|NCT00750035|subtotal hysterectomy|subtotal hysterectomy
5218696|NCT00750035|urinary function|urinary function
5218697|NCT00750035|bowel function|bowel function
5218698|NCT00750035|sexual function|sexual function
5218699|NCT00750035|Quality of life|quality of life
5218700|NCT00750035|Psychological function|psychological function
5218701|NCT00750009|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5218702|NCT00750009|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5218703|NCT00750009|acute undifferentiated leukemia|acute undifferentiated leukemia
5218704|NCT00750009|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5218705|NCT00750009|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5218706|NCT00750009|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5218707|NCT00750009|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5218708|NCT00750009|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5218709|NCT00750009|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5218710|NCT00750009|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5218711|NCT00750009|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
5218712|NCT00750009|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5218713|NCT00750009|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
5218714|NCT00750009|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
5218715|NCT00750009|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
5218716|NCT00750009|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5218717|NCT00750009|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5218718|NCT00750009|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
5218719|NCT00750009|mast cell leukemia|mast cell leukemia
5218720|NCT00750009|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
5218721|NCT00750009|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
5218722|NCT00750009|prolymphocytic leukemia|prolymphocytic leukemia
5218723|NCT00750009|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5218724|NCT00750009|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5218725|NCT00750009|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
5218726|NCT00750009|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5218727|NCT00750009|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5218728|NCT00750009|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5218729|NCT00750009|refractory hairy cell leukemia|refractory hairy cell leukemia
5218730|NCT00750009|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5218731|NCT00750009|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5218732|NCT00750009|stage 0 chronic lymphocytic leukemia|stage 0 chronic lymphocytic leukemia
5218733|NCT00750009|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
5218734|NCT00750009|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
5218735|NCT00750009|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
5218736|NCT00750009|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
5218737|NCT00750009|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
5218738|NCT00750009|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5218739|NCT00750009|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
5218740|NCT00750009|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5218741|NCT00750009|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
5218742|NCT00750009|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
5218743|NCT00750009|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
5218744|NCT00750009|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
5218745|NCT00750009|untreated childhood acute myeloid leukemia and other myeloid malignancies|untreated childhood acute myeloid leukemia and other myeloid malignancies
5218746|NCT00750009|untreated hairy cell leukemia|untreated hairy cell leukemia
5218747|NCT00750009|AIDS-related diffuse large cell lymphoma|aids-related diffuse large cell lymphoma
5218748|NCT00750009|AIDS-related diffuse mixed cell lymphoma|aids-related diffuse mixed cell lymphoma
5218749|NCT00750009|AIDS-related diffuse small cleaved cell lymphoma|aids-related diffuse small cleaved cell lymphoma
5218750|NCT00750009|AIDS-related immunoblastic large cell lymphoma|aids-related immunoblastic large cell lymphoma
5218751|NCT00750009|AIDS-related lymphoblastic lymphoma|aids-related lymphoblastic lymphoma
5218752|NCT00750009|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
5218753|NCT00750009|AIDS-related primary CNS lymphoma|aids-related primary cns lymphoma
5218754|NCT00750009|AIDS-related small noncleaved cell lymphoma|aids-related small noncleaved cell lymphoma
5218755|NCT00750009|HIV-associated Hodgkin lymphoma|hiv-associated hodgkin lymphoma
5218756|NCT00750009|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5218757|NCT00750009|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
5218758|NCT00750009|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
5218759|NCT00750009|stage I childhood Hodgkin lymphoma|stage i childhood hodgkin lymphoma
5218760|NCT00750009|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
5218761|NCT00750009|stage II childhood Hodgkin lymphoma|stage ii childhood hodgkin lymphoma
5218762|NCT00750009|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5218763|NCT00750009|stage III childhood Hodgkin lymphoma|stage iii childhood hodgkin lymphoma
5218764|NCT00750009|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5218765|NCT00750009|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
5218766|NCT00750009|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5218767|NCT00750009|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
5218768|NCT00750009|cutaneous B-cell non-Hodgkin lymphoma|cutaneous b-cell non-hodgkin lymphoma
5218769|NCT00750009|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5218770|NCT00750009|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
5218771|NCT00750009|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
5218772|NCT00750009|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
5218773|NCT00750009|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
5218774|NCT00750009|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5218775|NCT00750009|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
5218776|NCT00750009|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
5218777|NCT00750009|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
5218778|NCT00750009|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
5218779|NCT00750009|adult grade III lymphomatoid granulomatosis|adult grade iii lymphomatoid granulomatosis
5218780|NCT00750009|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
5218781|NCT00750009|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
5218782|NCT00750009|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5218783|NCT00750009|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5218784|NCT00750009|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5218785|NCT00750009|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
5218786|NCT00750009|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
5218787|NCT00750009|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
5218788|NCT00750009|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
5218789|NCT00750009|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
5218790|NCT00750009|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
5218791|NCT00750009|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
5218792|NCT00750009|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
5218793|NCT00750009|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
5218794|NCT00750009|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
5218795|NCT00750009|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
5218796|NCT00750009|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
5218797|NCT00750009|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
5218798|NCT00750009|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
5218799|NCT00750009|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
5218800|NCT00750009|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
5218801|NCT00750009|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
5218802|NCT00750009|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
5218803|NCT00750009|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
5218804|NCT00750009|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
5218805|NCT00750009|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
5218806|NCT00750009|stage I mantle cell lymphoma|stage i mantle cell lymphoma
5218807|NCT00750009|stage I marginal zone lymphoma|stage i marginal zone lymphoma
5218808|NCT00750009|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
5218809|NCT00750009|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
5218810|NCT00750009|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5218811|NCT00750009|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
5218812|NCT00750009|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
5218874|NCT00750009|Burkitt lymphoma|burkitt lymphoma
5218813|NCT00750009|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
5218814|NCT00750009|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
5218815|NCT00750009|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5218816|NCT00750009|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5218817|NCT00750009|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5218818|NCT00750009|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5218819|NCT00750009|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
5218820|NCT00750009|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
5218821|NCT00750009|stage I childhood large cell lymphoma|stage i childhood large cell lymphoma
5218822|NCT00750009|stage I childhood lymphoblastic lymphoma|stage i childhood lymphoblastic lymphoma
5218823|NCT00750009|stage I childhood small noncleaved cell lymphoma|stage i childhood small noncleaved cell lymphoma
5218824|NCT00750009|stage II childhood large cell lymphoma|stage ii childhood large cell lymphoma
5218825|NCT00750009|stage II childhood lymphoblastic lymphoma|stage ii childhood lymphoblastic lymphoma
5218826|NCT00750009|stage II childhood small noncleaved cell lymphoma|stage ii childhood small noncleaved cell lymphoma
5218827|NCT00750009|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5218828|NCT00750009|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5218829|NCT00750009|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5218830|NCT00750009|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5218831|NCT00750009|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5218832|NCT00750009|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5218833|NCT00750009|stage III childhood large cell lymphoma|stage iii childhood large cell lymphoma
5218834|NCT00750009|stage III childhood lymphoblastic lymphoma|stage iii childhood lymphoblastic lymphoma
5218937|NCT00749866|Side Effects|side effects
5218835|NCT00750009|stage III childhood small noncleaved cell lymphoma|stage iii childhood small noncleaved cell lymphoma
5218836|NCT00750009|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5218837|NCT00750009|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5218838|NCT00750009|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5218839|NCT00750009|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5218840|NCT00750009|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5218841|NCT00750009|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5218842|NCT00750009|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5218843|NCT00750009|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5218844|NCT00750009|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5218845|NCT00750009|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5218846|NCT00750009|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5218847|NCT00750009|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5218848|NCT00750009|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
5218849|NCT00750009|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
5218850|NCT00750009|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
5218851|NCT00750009|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5218852|NCT00750009|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5218853|NCT00750009|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5218854|NCT00750009|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5218855|NCT00750009|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5218856|NCT00750009|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5218857|NCT00750009|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5218858|NCT00750009|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5218859|NCT00750009|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5218860|NCT00750009|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5218861|NCT00750009|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
5218862|NCT00750009|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5218863|NCT00750009|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5218864|NCT00750009|recurrent childhood grade III lymphomatoid granulomatosis|recurrent childhood grade iii lymphomatoid granulomatosis
5218865|NCT00750009|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
5218866|NCT00750009|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
5218867|NCT00750009|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
5218868|NCT00750009|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5218869|NCT00750009|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5218870|NCT00750009|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5218871|NCT00750009|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5218872|NCT00750009|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5218873|NCT00750009|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5218875|NCT00750009|childhood diffuse large cell lymphoma|childhood diffuse large cell lymphoma
5218876|NCT00750009|childhood grade III lymphomatoid granulomatosis|childhood grade iii lymphomatoid granulomatosis
5218877|NCT00750009|childhood immunoblastic large cell lymphoma|childhood immunoblastic large cell lymphoma
5218878|NCT00750009|childhood nasal type extranodal NK/T-cell lymphoma|childhood nasal type extranodal nk/t-cell lymphoma
5218879|NCT00750009|intraocular lymphoma|intraocular lymphoma
5218880|NCT00750009|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
5218881|NCT00750009|primary central nervous system Hodgkin lymphoma|primary central nervous system hodgkin lymphoma
5218882|NCT00750009|post-transplant lymphoproliferative disorder|post-transplant lymphoproliferative disorder
5218883|NCT00750009|chronic eosinophilic leukemia|chronic eosinophilic leukemia
5218884|NCT00750009|chronic neutrophilic leukemia|chronic neutrophilic leukemia
5218885|NCT00750009|primary myelofibrosis|primary myelofibrosis
5218886|NCT00750009|essential thrombocythemia|essential thrombocythemia
5218887|NCT00750009|polycythemia vera|polycythemia vera
5218888|NCT00750009|extramedullary plasmacytoma|extramedullary plasmacytoma
5218889|NCT00750009|isolated plasmacytoma of bone|isolated plasmacytoma of bone
5218890|NCT00750009|stage I multiple myeloma|stage i multiple myeloma
5218891|NCT00750009|stage II multiple myeloma|stage ii multiple myeloma
5218892|NCT00750009|stage III multiple myeloma|stage iii multiple myeloma
5218893|NCT00750009|primary systemic amyloidosis|primary systemic amyloidosis
5218894|NCT00750009|refractory multiple myeloma|refractory multiple myeloma
5218895|NCT00750009|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5218896|NCT00750009|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5218897|NCT00750009|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5218898|NCT00750009|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
5218899|NCT00750009|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
5218900|NCT00750009|recurrent childhood anaplastic large cell lymphoma|recurrent childhood anaplastic large cell lymphoma
5218901|NCT00750009|stage I childhood anaplastic large cell lymphoma|stage i childhood anaplastic large cell lymphoma
5218902|NCT00750009|stage II childhood anaplastic large cell lymphoma|stage ii childhood anaplastic large cell lymphoma
5218903|NCT00750009|stage III childhood anaplastic large cell lymphoma|stage iii childhood anaplastic large cell lymphoma
5218904|NCT00750009|stage IV childhood anaplastic large cell lymphoma|stage iv childhood anaplastic large cell lymphoma
5218905|NCT00749970|schizophrenia|schizophrenia
5218906|NCT00749970|subjective well-being|subjective well-being
5218907|NCT00749970|psychometric validation|psychometric validation
5218908|NCT00749957|AAV|aav
5218909|NCT00749957|adeno-associated virus|adeno-associated virus
5218910|NCT00749957|RPE65|rpe65
5218911|NCT00749957|Leber congenital amaurosis|leber congenital amaurosis
5218912|NCT00749957|LCA|lca
5218913|NCT00749957|gene therapy|gene therapy
5218914|NCT00749957|human gene transfer|human gene transfer
5218915|NCT00749944|nicotine withdrawal, smoking cessation, varenicline|nicotine withdrawal, smoking cessation, varenicline
5218916|NCT00749931|IDC, DCIS, ILC|idc, dcis, ilc
5218917|NCT00749918|vitamin D|vitamin d
5218918|NCT00749918|Cholecalciferol|cholecalciferol
5218919|NCT00749918|Insulin sensitivity|insulin sensitivity
5218920|NCT00749918|MinMod Millennium|minmod millennium
5218921|NCT00749918|FSIGT|fsigt
5218922|NCT00749918|modified frequently sampled IV glucose tolerance test|modified frequently sampled iv glucose tolerance test
5218923|NCT00749892|Transitional Cell Carcinoma|transitional cell carcinoma
5218924|NCT00749892|Bladder Cancer|bladder cancer
5218925|NCT00749892|Urothelial Cancer|urothelial cancer
5218926|NCT00749892|Erlotinib Hydrochloride|erlotinib hydrochloride
5218927|NCT00749892|Tarceva|tarceva
5218928|NCT00749892|OSI-774|osi-774
5218929|NCT00749892|TCC|tcc
5218930|NCT00749879|PK|pk
5218931|NCT00749879|Pharmacokinetics|pharmacokinetics
5218932|NCT00749866|Nebulised antibiotics|nebulised antibiotics
5218933|NCT00749866|Non cystic fibrosis bronchiectasis|non cystic fibrosis bronchiectasis
5218934|NCT00749866|Bacterial Load|bacterial load
5218935|NCT00749866|Inflammation|inflammation
5218936|NCT00749866|Quality of Life|quality of life
5218938|NCT00749853|ovarian stimulation|ovarian stimulation
5218939|NCT00749853|FSH|fsh
5218940|NCT00749853|genotyping|genotyping
5218941|NCT00749853|polymorphism|polymorphism
5218942|NCT00749840|Acquired Immune Deficiency Syndrome|acquired immune deficiency syndrome
5218943|NCT00749840|Human Immunodeficiency Virus|human immunodeficiency virus
5218944|NCT00749840|Questionnaire|questionnaire
5218945|NCT00749840|AIDS|aids
5218946|NCT00749840|HIV|hiv
5218947|NCT00749840|Highly Active Antiretroviral Therapy|highly active antiretroviral therapy
5218948|NCT00749840|HAART|haart
5218949|NCT00749840|Steps of HIV Care|steps of hiv care
5218950|NCT00749840|CDC|cdc
5218951|NCT00749827|Contrast Induced Nephropathy, fluid prophylaxis|contrast induced nephropathy, fluid prophylaxis
5218952|NCT00749814|sleep patterns in children in the night prior to surgery and post surgery.|sleep patterns in children in the night prior to surgery and post surgery.
5218953|NCT00749814|the influence of melatonin on sleep patterns|the influence of melatonin on sleep patterns
5218954|NCT00749801|drug naive|drug naive
5218955|NCT00749801|Dyslipidemic|dyslipidemic
5218956|NCT00749801|nattokinase|nattokinase
5218957|NCT00749801|fibrinolytic|fibrinolytic
5218958|NCT00749775|Eplerenone|eplerenone
5218959|NCT00749775|Selara|selara
5218960|NCT00749775|Hypertension|hypertension
5218961|NCT00749775|Good post-marketing study Practice|good post-marketing study practice
5218962|NCT00749775|Drug use Investigation|drug use investigation
5218963|NCT00749775|Regulatory Post Marketing Commitment Plan|regulatory post marketing commitment plan
5218964|NCT00749775|ESSENCE|essence
5218965|NCT00749762|DURING|during
5218966|NCT00749762|PRONE|prone
5218967|NCT00749762|SUPINE|supine
5218968|NCT00749762|POSITIONING|positioning
5218969|NCT00749749|Abdominal Hysterectomy|abdominal hysterectomy
5218970|NCT00749749|Postoperative pain|postoperative pain
5218971|NCT00749736|vitamin D|vitamin d
5218972|NCT00749736|determine|determine
5218973|NCT00749736|normal|normal
5218974|NCT00749736|intrapatient|intrapatient
5218975|NCT00749736|interpatient|interpatient
5218976|NCT00749736|variability|variability
5218977|NCT00749736|measures|measures
5218978|NCT00749736|immune system|immune system
5218979|NCT00749723|brain tumor|brain tumor
5218980|NCT00749723|relapse|relapse
5218981|NCT00749723|children|children
5218982|NCT00749723|etoposide|etoposide
5218983|NCT00749723|intraventricular|intraventricular
5218984|NCT00749723|temozolomide|temozolomide
5218985|NCT00749710|femoral neck fractures|femoral neck fractures
5218986|NCT00749710|pertrochanteric fractures|pertrochanteric fractures
5218987|NCT00749710|antiaggregant therapy|antiaggregant therapy
5218988|NCT00749710|clopidogrel|clopidogrel
5218989|NCT00749710|plavix|plavix
5218990|NCT00749697|radioiodine|radioiodine
5218991|NCT00749697|differentiated thyroid cancers|differentiated thyroid cancers
5218992|NCT00749697|dosimetry|dosimetry
5218993|NCT00749697|metastases|metastases
5218994|NCT00749684|interferon-alpha|interferon-alpha
5218995|NCT00749658|Tobacco|tobacco
5218996|NCT00749658|Nicotine|nicotine
5218997|NCT00749658|Smoking|smoking
5218998|NCT00749658|Varenicline|varenicline
5218999|NCT00749658|Bupropion|bupropion
5219000|NCT00749658|Human laboratory study|human laboratory study
5219001|NCT00749658|Stress tolerance|stress tolerance
5219002|NCT00749658|Startle response|startle response
5219003|NCT00749658|Cognitive assessment|cognitive assessment
5219004|NCT00749658|Progressive ratio|progressive ratio
5219005|NCT00749658|Motivation|motivation
5219006|NCT00749645|Arthritis, Rheumatoid, Andrographolides treatment, Efficacy.|arthritis, rheumatoid, andrographolides treatment, efficacy.
5219007|NCT00749632|urinary incontinence, urge|urinary incontinence, urge
5219008|NCT00749632|urinary urge incontinence|urinary urge incontinence
5219009|NCT00749632|urge incontinence|urge incontinence
5219010|NCT00749632|over active bladder|over active bladder
5219011|NCT00749619|Tunneled Cuffed Catheter|tunneled cuffed catheter
5219012|NCT00749619|Catheter Lock Solution|catheter lock solution
5219013|NCT00749619|Catheter Related Bacteremia|catheter related bacteremia
5219014|NCT00749606|Obesity|obesity
5219015|NCT00749606|Metabolic syndrome|metabolic syndrome
5219016|NCT00749606|Weight loss|weight loss
5219017|NCT00749606|Diabetes prevention|diabetes prevention
5219018|NCT00749593|Congenital Adrenal Hyperplasia|congenital adrenal hyperplasia
5219019|NCT00749593|Quality of Life|quality of life
5219020|NCT00749593|Genotype|genotype
5219021|NCT00749593|Metabolic outcomes|metabolic outcomes
5219022|NCT00749580|Safety|safety
5219023|NCT00749567|NSCLC|nsclc
5219024|NCT00749567|TKI's|tki's
5219025|NCT00749567|Anti-VEGF|anti-vegf
5219026|NCT00749554|Cooled Radiofrequency|cooled radiofrequency
5219027|NCT00749554|Disc biacuplasty|disc biacuplasty
5219028|NCT00749554|TransDiscal system|transdiscal system
5219029|NCT00749554|Discogenic pain|discogenic pain
5219030|NCT00749541|vitamin d coronary catheterization|vitamin d coronary catheterization
5219031|NCT00749528|Wheezing|wheezing
5219032|NCT00749528|Hair trace elements|hair trace elements
5219033|NCT00749528|Hair toxic metals|hair toxic metals
5219034|NCT00749528|Oxidative stress|oxidative stress
5219035|NCT00749515|Thalassemia|thalassemia
5219036|NCT00749515|Iron|iron
5219037|NCT00749515|Chelation|chelation
5219038|NCT00749502|Neoplasms|neoplasms
5219039|NCT00749502|Ovarian neoplasms|ovarian neoplasms
5219040|NCT00749502|Prostatic neoplasms|prostatic neoplasms
5219041|NCT00749502|Endocrine gland neoplasms|endocrine gland neoplasms
5219042|NCT00749502|Ovarian diseases|ovarian diseases
5219043|NCT00749502|Adnexal diseases|adnexal diseases
5219044|NCT00749502|Genital diseases, female|genital diseases, female
5219045|NCT00749502|Genital diseases, male|genital diseases, male
5219046|NCT00749502|Genital neoplasms, female|genital neoplasms, female
5219047|NCT00749502|Urogenital neoplasms|urogenital neoplasms
5219048|NCT00749502|Endocrine system diseases|endocrine system diseases
5219049|NCT00749502|Gonadal disorders|gonadal disorders
5219050|NCT00749502|Genital neoplasms, male|genital neoplasms, male
5219051|NCT00749502|Prostatic diseases|prostatic diseases
5219052|NCT00749489|Pain|pain
5219053|NCT00749489|Hip Fractures|hip fractures
5219054|NCT00749489|Femoral Fractures|femoral fractures
5219055|NCT00749489|Analgesics|analgesics
5219056|NCT00749489|Opioid|opioid
5219057|NCT00749489|Nerve Block|nerve block
5219058|NCT00749489|Geriatric|geriatric
5219059|NCT00749489|Nerve Stimulation|nerve stimulation
5219345|NCT00748215|diarrhea|diarrhea
5219060|NCT00749463|nicotine dependence, smoking cessation, NRT|nicotine dependence, smoking cessation, nrt
5219061|NCT00749450|stage II colon cancer|stage ii colon cancer
5219062|NCT00749450|stage III colon cancer|stage iii colon cancer
5219063|NCT00749450|stage II rectal cancer|stage ii rectal cancer
5219064|NCT00749450|stage III rectal cancer|stage iii rectal cancer
5219065|NCT00749437|stage I breast cancer|stage i breast cancer
5219066|NCT00749437|stage II breast cancer|stage ii breast cancer
5219067|NCT00749437|ductal breast carcinoma in situ|ductal breast carcinoma in situ
5219068|NCT00749437|invasive ductal breast carcinoma|invasive ductal breast carcinoma
5219069|NCT00749437|medullary ductal breast carcinoma with lymphocytic infiltrate|medullary ductal breast carcinoma with lymphocytic infiltrate
5219070|NCT00749437|papillary ductal breast carcinoma|papillary ductal breast carcinoma
5219071|NCT00749437|tubular ductal breast carcinoma|tubular ductal breast carcinoma
5219072|NCT00749437|mucinous ductal breast carcinoma|mucinous ductal breast carcinoma
5219073|NCT00749437|breast cancer in situ|breast cancer in situ
5219074|NCT00749411|COPD|copd
5219075|NCT00749411|long-acting beta agonist|long-acting beta agonist
5219076|NCT00749411|Emphysema|emphysema
5219077|NCT00749411|Chronic Bronchitis|chronic bronchitis
5219078|NCT00749411|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
5219079|NCT00749411|bronchodilator|bronchodilator
5219080|NCT00749411|long acting muscarinic antagonist|long acting muscarinic antagonist
5219081|NCT00749359|healthy volunteers|healthy volunteers
5219082|NCT00749359|paroxetine|paroxetine
5219083|NCT00749346|TTFields|ttfields
5219084|NCT00749346|NSCLC|nsclc
5219085|NCT00749346|Alimta|alimta
5219086|NCT00749346|Pemetrexed|pemetrexed
5219087|NCT00749333|Healthy Volunteer|healthy volunteer
5219088|NCT00749333|Safety|safety
5219089|NCT00749333|Tolerability|tolerability
5219090|NCT00749333|AZD8566|azd8566
5219091|NCT00749333|study|study
5219092|NCT00749320|MRI|mri
5219093|NCT00749320|Sunitinib|sunitinib
5219094|NCT00749320|Pazopanib|pazopanib
5219095|NCT00749307|Heart rate variability|heart rate variability
5219096|NCT00749307|Docosahexaenoic acid|docosahexaenoic acid
5219097|NCT00749307|DHA|dha
5219098|NCT00749307|Long chain fatty acids|long chain fatty acids
5219099|NCT00749307|Long chain polyunsaturated fatty acids|long chain polyunsaturated fatty acids
5219100|NCT00749307|Algal fatty acids|algal fatty acids
5219101|NCT00749307|Schizochytrium|schizochytrium
5219102|NCT00749307|Omega 3|omega 3
5219103|NCT00749307|Death, Sudden, Cardiac|death, sudden, cardiac
5219104|NCT00749307|Arrhythmias, Cardiac|arrhythmias, cardiac
5219105|NCT00749281|atherosclerosis|atherosclerosis
5219106|NCT00749281|ngal|ngal
5219107|NCT00749281|coronary artery disease|coronary artery disease
5219108|NCT00749268|hernia|hernia
5219109|NCT00749255|Breast Cancer|breast cancer
5219110|NCT00749255|Digital archiver software|digital archiver software
5219111|NCT00749242|Traumatic vertebral fracture|traumatic vertebral fracture
5219112|NCT00749242|Vertebroplasty|vertebroplasty
5219113|NCT00749242|Balloon kyphoplasty|balloon kyphoplasty
5219114|NCT00749242|Bohler bracing|bohler bracing
5219115|NCT00749229|Traumatic vertebral fracture|traumatic vertebral fracture
5219116|NCT00749229|Balloon Kyphoplasty|balloon kyphoplasty
5219117|NCT00749229|type A3.2, or A3.3 or B1 or C1 in the MAGERL CLASSIFICATION|type a3.2, or a3.3 or b1 or c1 in the magerl classification
5219118|NCT00749203|Stress Disorders, Post-Traumatic|stress disorders, post-traumatic
5219119|NCT00749203|PTSD|ptsd
5219120|NCT00749203|anxiety disorder|anxiety disorder
5219121|NCT00749203|ketamine|ketamine
5219122|NCT00749203|depression|depression
5219123|NCT00749203|depressed mood|depressed mood
5219124|NCT00749177|traditional healing|traditional healing
5219125|NCT00749177|anxiety|anxiety
5219126|NCT00749177|depression|depression
5219127|NCT00749177|aboriginal|aboriginal
5219128|NCT00749177|children|children
5219129|NCT00749177|youth|youth
5219130|NCT00749164|Mesenchymal stem cells|mesenchymal stem cells
5219131|NCT00749164|Umbilical cord|umbilical cord
5219132|NCT00749164|graft-vs-host disease|graft-vs-host disease
5219133|NCT00749164|Steroid resistant|steroid resistant
5219134|NCT00749151|smoking cessation|smoking cessation
5219135|NCT00749151|telephone help line|telephone help line
5219136|NCT00749138|hepatitis C, tamoxifen|hepatitis c, tamoxifen
5219137|NCT00749125|Emotional Circuitry|emotional circuitry
5219138|NCT00749125|fMRI|fmri
5219139|NCT00749112|Idiopathic Thrombocytopenic Purpura|idiopathic thrombocytopenic purpura
5219140|NCT00749112|Anemia|anemia
5219141|NCT00749112|Hemolytic|hemolytic
5219142|NCT00749112|Autoimmune|autoimmune
5219143|NCT00749112|Alemtuzumab|alemtuzumab
5219144|NCT00749112|Rituximab|rituximab
5219145|NCT00749086|Osteoporosis|osteoporosis
5219146|NCT00749086|Non-traumatic vertebral fracture|non-traumatic vertebral fracture
5219147|NCT00749086|Vertebral compression|vertebral compression
5219148|NCT00749086|Balloon kyphoplasty|balloon kyphoplasty
5219149|NCT00749086|Vertebroplasty|vertebroplasty
5219150|NCT00749073|Spinal Stenosis|spinal stenosis
5219151|NCT00749073|Lumbar Spinal Stenosis|lumbar spinal stenosis
5219152|NCT00749073|Laminotomy|laminotomy
5219153|NCT00749073|Laminectomy|laminectomy
5219154|NCT00749073|Spine Surgery|spine surgery
5219155|NCT00749060|osteoporosis|osteoporosis
5219447|NCT00747851|PMNs|pmns
5219156|NCT00749060|non-traumatic vertebral fracture|non-traumatic vertebral fracture
5219157|NCT00749060|vertebral compression|vertebral compression
5219158|NCT00749060|Balloon kyphoplasty|balloon kyphoplasty
5219159|NCT00749060|vertebroplasty|vertebroplasty
5219160|NCT00749047|Pioglitazone|pioglitazone
5219161|NCT00749047|Open study|open study
5219162|NCT00749047|Proteinuria|proteinuria
5219163|NCT00749047|Glomerular selectivity indices|glomerular selectivity indices
5219164|NCT00749034|Safety|safety
5219165|NCT00749034|Immunogenicity|immunogenicity
5219166|NCT00749034|Tuberculosis|tuberculosis
5219167|NCT00749034|Vaccination|vaccination
5219168|NCT00749034|Vaccination against tuberculosis|vaccination against tuberculosis
5219169|NCT00749034|Safety and immunogenicity of VPM1002 in comparison with BCG|safety and immunogenicity of vpm1002 in comparison with bcg
5219170|NCT00749021|choroidal neovascularization|choroidal neovascularization
5219171|NCT00749021|vascularized|vascularized
5219172|NCT00749008|Cerebral palsy|cerebral palsy
5219173|NCT00749008|Generalized movements|generalized movements
5219174|NCT00749008|Fidgety movements|fidgety movements
5219175|NCT00749008|Prechtl|prechtl
5219176|NCT00748982|AZD1305|azd1305
5219177|NCT00748982|anti-arrhythmics|anti-arrhythmics
5219178|NCT00748982|safety|safety
5219179|NCT00748969|MPS I|mps i
5219180|NCT00748969|MPS II|mps ii
5219181|NCT00748969|MPS VI|mps vi
5219182|NCT00748969|growth hormone|growth hormone
5219183|NCT00748969|short stature|short stature
5219184|NCT00748956|Mood Disorder|mood disorder
5219185|NCT00748956|Anxiety Disorders|anxiety disorders
5219186|NCT00748943|chlorine|chlorine
5219187|NCT00748943|dioxide|dioxide
5219188|NCT00748943|mouthwash|mouthwash
5219189|NCT00748943|halitosis|halitosis
5219190|NCT00748943|bacteria|bacteria
5219192|NCT00748904|cirrhosis of liver and progressive renal failure|cirrhosis of liver and progressive renal failure
5219193|NCT00748891|Cancer|cancer
5219194|NCT00748891|tumour|tumour
5219195|NCT00748891|advanced sold tumour|advanced sold tumour
5219196|NCT00748891|imaging|imaging
5219197|NCT00748891|DCE-CT Scan|dce-ct scan
5219198|NCT00748891|DCE-MRI scan|dce-mri scan
5219199|NCT00748891|Cediranib|cediranib
5219200|NCT00748891|Recentin|recentin
5219201|NCT00748878|To better understand platelet function during ECMO|to better understand platelet function during ecmo
5219202|NCT00748865|Dry Eye|dry eye
5219203|NCT00748865|Artificial Tears|artificial tears
5219204|NCT00748839|HIT|hit
5219205|NCT00748839|Heparin-induced thrombocytopenia|heparin-induced thrombocytopenia
5219206|NCT00748839|heparin treatment|heparin treatment
5219207|NCT00748839|venous thrombosis|venous thrombosis
5219208|NCT00748839|arterial thrombosis|arterial thrombosis
5219209|NCT00748839|predictive clinical score|predictive clinical score
5219210|NCT00748839|biological test|biological test
5219211|NCT00748839|anti-H-PF4 antibodies|anti-h-pf4 antibodies
5219212|NCT00748813|Influenza vaccine|influenza vaccine
5219213|NCT00748800|HIV prevention|hiv prevention
5219214|NCT00748800|HIV seronegativity|hiv seronegativity
5219215|NCT00748774|Primary Brain Tumor|primary brain tumor
5219216|NCT00748774|Caregivers|caregivers
5219217|NCT00748774|Symptom Severity|symptom severity
5219218|NCT00748774|Questionnaire|questionnaire
5219219|NCT00748774|M.D. Anderson Symptom Inventory-Brain Tumor|m.d. anderson symptom inventory-brain tumor
5219220|NCT00748774|MDASI-BT|mdasi-bt
5219221|NCT00748761|Obsessive-Compulsive Disorder|obsessive-compulsive disorder
5219222|NCT00748761|OCD|ocd
5219223|NCT00748761|Cognitive-Behavioral Therapy|cognitive-behavioral therapy
5219224|NCT00748761|CBT|cbt
5219225|NCT00748761|MRSI|mrsi
5219226|NCT00748761|Glutamate|glutamate
5219227|NCT00748735|cardiac resynchronization therapy|cardiac resynchronization therapy
5219228|NCT00748735|echocardiography|echocardiography
5219229|NCT00748735|heart failure|heart failure
5219230|NCT00748735|left ventricular function|left ventricular function
5219231|NCT00748735|pacing|pacing
5219232|NCT00748735|myocardial deformation imaging|myocardial deformation imaging
5219233|NCT00748735|Optimal Definition of Left Ventricular Lead Position in Cardiac Resynchronization Therapy|optimal definition of left ventricular lead position in cardiac resynchronization therapy
5219234|NCT00748722|Breast reconstruction|breast reconstruction
5219235|NCT00748722|Perforator flaps|perforator flaps
5219236|NCT00748722|CT Angiography|ct angiography
5219237|NCT00748696|sarcopenia|sarcopenia
5219238|NCT00748696|elderly|elderly
5219239|NCT00748696|resistance training|resistance training
5219240|NCT00748696|oral nutritional supplement|oral nutritional supplement
5219241|NCT00748683|elderly|elderly
5219242|NCT00748683|longterm care|longterm care
5219243|NCT00748644|Wegener's granulomatosis,|wegener's granulomatosis,
5219244|NCT00748644|microscopic polyangiitis,|microscopic polyangiitis,
5219245|NCT00748644|ANCA-associated vasculitis,|anca-associated vasculitis,
5219246|NCT00748644|rituximab,|rituximab,
5219247|NCT00748644|azathioprine|azathioprine
5219248|NCT00748631|Vertebral fracture|vertebral fracture
5219249|NCT00748631|Vertebral compression fracture|vertebral compression fracture
5219250|NCT00748631|Multiple Myeloma Bone marrow diseases|multiple myeloma bone marrow diseases
5219251|NCT00748631|Vertebral metastases|vertebral metastases
5219252|NCT00748631|Balloon Kyphoplasty|balloon kyphoplasty
5219344|NCT00748254|Rheumatoid arthritis|rheumatoid arthritis
5219253|NCT00748618|Kidney transplantation (KTX)|kidney transplantation (ktx)
5219254|NCT00748618|Vitamin D deficiency|vitamin d deficiency
5219255|NCT00748618|Cardiovascular Disease (CVD)|cardiovascular disease (cvd)
5219256|NCT00748618|Vascular risk|vascular risk
5219257|NCT00748618|Parathyroid hormone (PTH)|parathyroid hormone (pth)
5219258|NCT00748618|Carotid intima media thickness (CIMT)|carotid intima media thickness (cimt)
5219259|NCT00748618|Insulin resistance (IR)|insulin resistance (ir)
5219260|NCT00748605|Obesity|obesity
5219261|NCT00748592|Insomnia, Primary Insomnia, Chronic Insomnia, DIMS (Disorders of Initiating and Maintaining Sleep), Disorders of Initiating and Maintaining Sleep|insomnia, primary insomnia, chronic insomnia, dims (disorders of initiating and maintaining sleep), disorders of initiating and maintaining sleep
5219262|NCT00748566|Ziprasidone|ziprasidone
5219263|NCT00748566|metabolic syndrome|metabolic syndrome
5219264|NCT00748566|risk factors|risk factors
5219265|NCT00748566|schizophrenia|schizophrenia
5219266|NCT00748566|psychotic disorders.|psychotic disorders.
5219267|NCT00748540|sensorineural hearing loss|sensorineural hearing loss
5219268|NCT00748540|conductive hearing loss|conductive hearing loss
5219269|NCT00748540|mixed hearing loss|mixed hearing loss
5219270|NCT00748527|fallopian tube cancer|fallopian tube cancer
5219271|NCT00748527|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5219272|NCT00748527|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5219273|NCT00748527|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5219274|NCT00748527|peritoneal cavity cancer|peritoneal cavity cancer
5219275|NCT00748514|capsular incision|capsular incision
5219276|NCT00748514|biochemical recurrence|biochemical recurrence
5219277|NCT00748514|radical perineal prostatectomy|radical perineal prostatectomy
5219278|NCT00748501|Amyotrophic Lateral Sclerosis,|amyotrophic lateral sclerosis,
5219279|NCT00748501|ALS,|als,
5219280|NCT00748501|Lou Gehrig's Disease|lou gehrig's disease
5219281|NCT00748488|Parkinson|parkinson
5219282|NCT00748488|Physical Therapy|physical therapy
5219283|NCT00748488|Physical Activity|physical activity
5219284|NCT00748462|Acne scar, Wrinkle, Pigmentation, Fractional CO2 laser|acne scar, wrinkle, pigmentation, fractional co2 laser
5219285|NCT00748449|Colorectal advanced adenoma|colorectal advanced adenoma
5219286|NCT00748449|Colorectal cancer polypectomy (endoscopic)|colorectal cancer polypectomy (endoscopic)
5219287|NCT00748449|Colectomy|colectomy
5219288|NCT00748449|Colonoscopy with anaesthesia|colonoscopy with anaesthesia
5219289|NCT00748449|CT-colonography|ct-colonography
5219290|NCT00748436|Obese females|obese females
5219291|NCT00748436|Weight loss|weight loss
5219292|NCT00748436|Betahistine|betahistine
5219293|NCT00748423|Inhaled drug|inhaled drug
5219294|NCT00748423|Acute lung injury|acute lung injury
5219295|NCT00748423|Nitric oxide|nitric oxide
5219296|NCT00748423|Sickle cell|sickle cell
5219297|NCT00748410|CD11b|cd11b
5219298|NCT00748410|Ulcerative colitis|ulcerative colitis
5219299|NCT00748410|99mTc-HMPAO-labelled leukocyte scintigraphy|99mtc-hmpao-labelled leukocyte scintigraphy
5219300|NCT00748384|HMP, CNV, AMD, PHP, HPHP, foresee|hmp, cnv, amd, php, hphp, foresee
5219301|NCT00748371|platelet aggregation|platelet aggregation
5219302|NCT00748371|granule secretion|granule secretion
5219303|NCT00748371|thromboxane production|thromboxane production
5219304|NCT00748371|prostacyclin production|prostacyclin production
5219305|NCT00748358|metastatic prostate carcinoma|metastatic prostate carcinoma
5219306|NCT00748358|sunitinib [Substance Name]|sunitinib [substance name]
5219307|NCT00748358|Clinical Trial, Phase II [Publication Type]|clinical trial, phase ii [publication type]
5219308|NCT00748345|Caspofungin,|caspofungin,
5219309|NCT00748345|burn patients,|burn patients,
5219310|NCT00748345|pharmacokinetics,|pharmacokinetics,
5219311|NCT00748345|optimal dose,|optimal dose,
5219312|NCT00748345|antifungal treatment|antifungal treatment
5219313|NCT00748319|Receptors KIR|receptors kir
5219314|NCT00748319|Polymerase chain reaction|polymerase chain reaction
5219315|NCT00748319|Diagnosis|diagnosis
5219316|NCT00748319|Lymphoma T-cell cutaneous|lymphoma t-cell cutaneous
5219317|NCT00748319|Mycosis fungicides|mycosis fungicides
5219318|NCT00748319|Sezary syndrome|sezary syndrome
5219319|NCT00748319|Differential diagnosis from dermatitis|differential diagnosis from dermatitis
5219320|NCT00748306|challenge|challenge
5219321|NCT00748306|early asthmatic response|early asthmatic response
5219322|NCT00748306|mild asthmatics|mild asthmatics
5219323|NCT00748306|Allergen|allergen
5219324|NCT00748306|methacholine|methacholine
5219325|NCT00748293|Colonoscopy|colonoscopy
5219326|NCT00748293|Colon cleansing|colon cleansing
5219327|NCT00748293|Low-reside diet|low-reside diet
5219328|NCT00748293|Compliance|compliance
5219329|NCT00748293|PEG-ELS|peg-els
5219330|NCT00748280|Endodontics|endodontics
5219331|NCT00748280|CEM cement|cem cement
5219332|NCT00748280|Calcium enriched mixture|calcium enriched mixture
5219333|NCT00748280|MTA|mta
5219334|NCT00748280|Root Canal Therapy|root canal therapy
5219335|NCT00748280|Pain|pain
5219336|NCT00748280|Pulpotomy|pulpotomy
5219337|NCT00748280|Human|human
5219338|NCT00748280|Permanent|permanent
5219339|NCT00748280|Molar teeth|molar teeth
5219340|NCT00748267|anxiety disorder|anxiety disorder
5219341|NCT00748267|pain|pain
5219342|NCT00748267|nausea and vomiting|nausea and vomiting
5219343|NCT00748267|breast cancer|breast cancer
5219346|NCT00748215|chemotherapeutic agent toxicity|chemotherapeutic agent toxicity
5219347|NCT00748215|recurrent colon cancer|recurrent colon cancer
5219348|NCT00748215|recurrent rectal cancer|recurrent rectal cancer
5219349|NCT00748215|stage IV colon cancer|stage iv colon cancer
5219350|NCT00748215|stage IV rectal cancer|stage iv rectal cancer
5219351|NCT00748202|Hereditary angioedema|hereditary angioedema
5219352|NCT00748202|C1-Esterase inhibitor|c1-esterase inhibitor
5219353|NCT00748202|intravenous|intravenous
5219354|NCT00748202|subcutaneous|subcutaneous
5219355|NCT00748202|pharmacokinetic|pharmacokinetic
5219356|NCT00748189|Safety|safety
5219357|NCT00748189|Untreated|untreated
5219358|NCT00748189|Efficacy|efficacy
5219359|NCT00748189|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
5219360|NCT00748189|Chronic Lymphocytic Leukemia (CLL), untreated|chronic lymphocytic leukemia (cll), untreated
5219361|NCT00748189|Ofatumumab|ofatumumab
5219362|NCT00748189|Oncology|oncology
5219363|NCT00748163|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5219364|NCT00748150|flu|flu
5219365|NCT00748150|influenza|influenza
5219366|NCT00748150|influenza vaccine antigen|influenza vaccine antigen
5219367|NCT00748150|immunogenicity|immunogenicity
5219368|NCT00748150|antibody response|antibody response
5219369|NCT00748150|intra muscular|intra muscular
5219370|NCT00748150|elderly|elderly
5219371|NCT00748150|non-elderly|non-elderly
5219372|NCT00748137|Type 1 Diabetes|type 1 diabetes
5219373|NCT00748137|Youth|youth
5219374|NCT00748137|Insulin dose|insulin dose
5219375|NCT00748111|Sudden death|sudden death
5219376|NCT00748111|Out of hospital cardiac arrest|out of hospital cardiac arrest
5219377|NCT00748111|Acute myocardial infarction|acute myocardial infarction
5219378|NCT00748111|Acute coronary syndrome|acute coronary syndrome
5219379|NCT00748098|PSG|psg
5219380|NCT00748098|Restless Legs Syndrome|restless legs syndrome
5219381|NCT00748098|gabapentin enacarbil|gabapentin enacarbil
5219382|NCT00748098|XP13512|xp13512
5219383|NCT00748098|GSK1838262|gsk1838262
5219384|NCT00748098|sleep disturbance|sleep disturbance
5219385|NCT00748098|RLS|rls
5219386|NCT00748098|polysomnography|polysomnography
5219387|NCT00748085|Malignant Airway Disease|malignant airway disease
5219388|NCT00748085|Lung Cancer|lung cancer
5219389|NCT00748085|Inoperable Lung Cancer|inoperable lung cancer
5219390|NCT00748085|Mesothelioma|mesothelioma
5219391|NCT00748085|Endoluminal Tumor|endoluminal tumor
5219392|NCT00748072|Vasopressin|vasopressin
5219393|NCT00748072|bleeding|bleeding
5219394|NCT00748072|biopsy|biopsy
5219395|NCT00748072|ultrasonography|ultrasonography
5219396|NCT00748059|autonomic nervous system diseases|autonomic nervous system diseases
5219397|NCT00748059|blood pressure|blood pressure
5219398|NCT00748059|congenital|congenital
5219399|NCT00748059|orthostasis|orthostasis
5219400|NCT00748059|catecholamines|catecholamines
5219401|NCT00748046|Biodistribution|biodistribution
5219402|NCT00748046|Radiation dosimetry|radiation dosimetry
5219403|NCT00748046|Pharmacokinetics|pharmacokinetics
5219404|NCT00748046|Safety|safety
5219405|NCT00748007|Down syndrome, cholinesterase inhibitor, Rivastigmine|down syndrome, cholinesterase inhibitor, rivastigmine
5219406|NCT00747994|Paget's disease of bone|paget's disease of bone
5219407|NCT00747994|Relatives|relatives
5219408|NCT00747994|Mutations screening|mutations screening
5219409|NCT00747994|Haplotypes analysis|haplotypes analysis
5219410|NCT00747994|Linkage analysis|linkage analysis
5219411|NCT00747994|< 55 years|< 55 years
5219412|NCT00747994|4 > or = WAFFECTED Bones|4 > or = waffected bones
5219413|NCT00747994|bone deformity|bone deformity
5219414|NCT00747981|CT Scan|ct scan
5219415|NCT00747981|Endoscopy|endoscopy
5219416|NCT00747981|Aspiration|aspiration
5219417|NCT00747981|Foreign Bodies|foreign bodies
5219418|NCT00747955|Human Performance|human performance
5219419|NCT00747955|Physical Disability|physical disability
5219420|NCT00747955|Functional Outcome Measures|functional outcome measures
5219421|NCT00747955|Health Volunteer|health volunteer
5219422|NCT00747955|HV|hv
5219423|NCT00747942|overweight|overweight
5219424|NCT00747942|physical inactivity|physical inactivity
5219425|NCT00747942|physical fitness|physical fitness
5219426|NCT00747942|lifestyle change|lifestyle change
5219427|NCT00747929|Obesity|obesity
5219428|NCT00747916|Parietal pleura|parietal pleura
5219429|NCT00747916|Neoplasms|neoplasms
5219430|NCT00747916|Pleural Surface|pleural surface
5219431|NCT00747916|Pleural Neoplasms|pleural neoplasms
5219432|NCT00747916|Lung Cancer|lung cancer
5219433|NCT00747903|basal cell carcinoma of the skin|basal cell carcinoma of the skin
5219434|NCT00747903|recurrent skin cancer|recurrent skin cancer
5219435|NCT00747877|stage II multiple myeloma|stage ii multiple myeloma
5219436|NCT00747877|stage III multiple myeloma|stage iii multiple myeloma
5219437|NCT00747877|refractory multiple myeloma|refractory multiple myeloma
5219438|NCT00747877|stage I multiple myeloma|stage i multiple myeloma
5219439|NCT00747864|Gestational Age|gestational age
5219440|NCT00747864|Urine|urine
5219441|NCT00747864|Concentration|concentration
5219442|NCT00747864|of S100B|of s100b
5219443|NCT00747851|protein|protein
5219444|NCT00747851|synthesis|synthesis
5219445|NCT00747851|response|response
5219446|NCT00747851|PAF-stimulated|paf-stimulated
5219448|NCT00747851|collected|collected
5219449|NCT00747838|Afib|afib
5219450|NCT00747838|Atrial Fibrillation|atrial fibrillation
5219451|NCT00747838|Maze|maze
5219452|NCT00747838|Mini-Maze|mini-maze
5219453|NCT00747825|cancer|cancer
5219454|NCT00747825|oncology|oncology
5219455|NCT00747825|melanoma|melanoma
5219456|NCT00747825|tumor|tumor
5219457|NCT00747812|Headache|headache
5219458|NCT00747812|Migraine|migraine
5219459|NCT00747812|Refractory|refractory
5219460|NCT00747812|Chronic|chronic
5219461|NCT00747812|Pain|pain
5219462|NCT00747799|recurrent or metastatic Nasopharyngeal Neoplasms|recurrent or metastatic nasopharyngeal neoplasms
5219463|NCT00747773|Lung Cancer|lung cancer
5219464|NCT00747773|CryoPsray Ablation|cryopsray ablation
5219465|NCT00747773|CSA therapy|csa therapy
5219466|NCT00747773|CSA treatment|csa treatment
5219467|NCT00747773|Lobectomy|lobectomy
5219468|NCT00747773|lung resection|lung resection
5219469|NCT00747760|TSH Receptor, resistance TSH, Hyperthyrortropinemia|tsh receptor, resistance tsh, hyperthyrortropinemia
5219470|NCT00747747|Sinusitis|sinusitis
5219471|NCT00747734|Neuropilin-1|neuropilin-1
5219472|NCT00747734|NRP1|nrp1
5219473|NCT00747734|anti-NRP1|anti-nrp1
5219474|NCT00747734|anti-angiogenic|anti-angiogenic
5219475|NCT00747708|heart failure|heart failure
5219476|NCT00747708|coronary heart disease|coronary heart disease
5219477|NCT00747708|adult stem cells|adult stem cells
5219478|NCT00747708|bone marrow progenitor cells|bone marrow progenitor cells
5219479|NCT00747708|bone marrow stem cells|bone marrow stem cells
5219480|NCT00747708|autologous|autologous
5219481|NCT00747708|granulocyte-colony stimulating factor|granulocyte-colony stimulating factor
5219482|NCT00747708|left ventricular function|left ventricular function
5219483|NCT00747708|intracoronary injection|intracoronary injection
5219484|NCT00747708|intramyocardial injection|intramyocardial injection
5219485|NCT00747695|Pediatric Pharmacokinetics|pediatric pharmacokinetics
5219486|NCT00747695|Pediatric Pharmacodynamics|pediatric pharmacodynamics
5219487|NCT00747695|Rabeprazole|rabeprazole
5219488|NCT00747695|Pediatric GERD|pediatric gerd
5219489|NCT00747695|Aciphex|aciphex
5219490|NCT00747682|Cerebral Perfusion,|cerebral perfusion,
5219491|NCT00747682|Oxygenation,|oxygenation,
5219492|NCT00747682|Electrical|electrical
5219493|NCT00747682|Activity|activity
5219494|NCT00747656|Electrocardiography|electrocardiography
5219495|NCT00747656|Emergency medical services|emergency medical services
5219496|NCT00747656|Emergency medicine|emergency medicine
5219497|NCT00747656|Health services|health services
5219498|NCT00747656|Cost effectiveness|cost effectiveness
5219499|NCT00747643|tobacco|tobacco
5219500|NCT00747643|nicotine|nicotine
5219501|NCT00747643|smoking|smoking
5219502|NCT00747643|reward|reward
5219503|NCT00747643|reinforcement|reinforcement
5219504|NCT00747643|craving|craving
5219505|NCT00747643|cues|cues
5219506|NCT00747643|conditioned stimuli|conditioned stimuli
5219507|NCT00747643|cue reactivity|cue reactivity
5219508|NCT00747630|Fetal Alcohol Syndrome|fetal alcohol syndrome
5219509|NCT00747630|Teen pregnancy|teen pregnancy
5219510|NCT00747617|polycystic ovary syndrome|polycystic ovary syndrome
5219511|NCT00747617|androgens|androgens
5219512|NCT00747617|ovary|ovary
5219513|NCT00747617|LH|lh
5219514|NCT00747604|Growth Hormone (GH) Insensitivity Syndrome|growth hormone (gh) insensitivity syndrome
5219515|NCT00747604|Insulin-like Growth Factor Deficiency (IGFD)|insulin-like growth factor deficiency (igfd)
5219516|NCT00747604|Short Stature|short stature
5219517|NCT00747604|Insulin-like Growth Factor (IGF-1)|insulin-like growth factor (igf-1)
5219518|NCT00747604|Growth|growth
5219519|NCT00747591|urine|urine
5219520|NCT00747591|concentration|concentration
5219521|NCT00747591|of S100B|of s100b
5219522|NCT00747578|ankylosing spondylitis (AS), costs,|ankylosing spondylitis (as), costs,
5219523|NCT00747578|rheumatoid arthritis (RA),|rheumatoid arthritis (ra),
5219524|NCT00747578|systemic lupus erythematosus (SLE),|systemic lupus erythematosus (sle),
5219525|NCT00747578|health-related|health-related
5219526|NCT00747578|quality of life (HRQOL)|quality of life (hrqol)
5219527|NCT00747578|compare|compare
5219528|NCT00747578|utility|utility
5219529|NCT00747578|patients|patients
5219530|NCT00747565|cataract, tecnis, multifocal, intraocular lens|cataract, tecnis, multifocal, intraocular lens
5219531|NCT00747552|IAP measurements|iap measurements
5219532|NCT00747552|Abdominal compartment syndrome|abdominal compartment syndrome
5219533|NCT00747552|NICU patients|nicu patients
5219534|NCT00747552|Intra-abdominal Hypertension|intra-abdominal hypertension
5219535|NCT00747539|Hepatitis C Virus|hepatitis c virus
5219536|NCT00747539|HCV|hcv
5219537|NCT00747539|Human Immunodeficiency Virus|human immunodeficiency virus
5219538|NCT00747539|Coinfection|coinfection
5219539|NCT00747526|Gastroesophageal Reflux Disease (GERD)|gastroesophageal reflux disease (gerd)
5219540|NCT00747526|Pediatrics|pediatrics
5219541|NCT00747526|Pharmacokinetics|pharmacokinetics
5219542|NCT00747526|Pharmacodynamics|pharmacodynamics
5219543|NCT00747526|Rabeprazole|rabeprazole
5219544|NCT00747526|GERD|gerd
5219545|NCT00747526|Aciphex|aciphex
5219546|NCT00747513|school|school
5219547|NCT00747513|prevention|prevention
5219548|NCT00747513|overweight|overweight
5219549|NCT00747513|children|children
5219550|NCT00747513|diet|diet
5219551|NCT00747513|physical activity|physical activity
5219552|NCT00747513|fitness|fitness
5219553|NCT00747487|Leber|leber
5219554|NCT00747487|LHON|lhon
5219555|NCT00747487|Leber's Hereditary Optic Neuropathy|leber's hereditary optic neuropathy
5219556|NCT00747487|Idebenone|idebenone
5219557|NCT00747461|Benign Airway Disease|benign airway disease
5219558|NCT00747461|Airway Injury|airway injury
5219559|NCT00747461|Sarcoidosis|sarcoidosis
5219560|NCT00747461|Wegener's Granulomatosis|wegener's granulomatosis
5219561|NCT00747461|Rhinoscleroma|rhinoscleroma
5219562|NCT00747461|Recurrent Respiratory Papillomatosis(RRP)|recurrent respiratory papillomatosis(rrp)
5219563|NCT00747448|Barrett's Esophagus|barrett's esophagus
5219564|NCT00747448|High Grade Dysplasia|high grade dysplasia
5219565|NCT00747448|Low Grade Dysplasia|low grade dysplasia
5219566|NCT00747448|Squamous Dysplasia|squamous dysplasia
5219567|NCT00747448|Esophageal Cancer|esophageal cancer
5219568|NCT00747448|CryoSpray Ablation|cryospray ablation
5219569|NCT00747448|Cryotherapy|cryotherapy
5219570|NCT00747448|Cryospray|cryospray
5219571|NCT00747435|sensorineural hearing loss|sensorineural hearing loss
5219572|NCT00747435|ski slope audiogram|ski slope audiogram
5219573|NCT00747435|electric acoustic stimulation|electric acoustic stimulation
5219574|NCT00747409|postprandial glucose, diastolic function, analogue insulins|postprandial glucose, diastolic function, analogue insulins
5219575|NCT00747396|Romania,|romania,
5219576|NCT00747396|children,|children,
5219577|NCT00747396|foster care,|foster care,
5219578|NCT00747396|institutionalization,|institutionalization,
5219579|NCT00747396|brain function,|brain function,
5219580|NCT00747396|MRI,|mri,
5219581|NCT00747396|attachment,|attachment,
5219582|NCT00747396|language,|language,
5219583|NCT00747396|growth,|growth,
5219584|NCT00747396|IQ,|iq,
5219585|NCT00747396|psychiatric symptomatology|psychiatric symptomatology
5219586|NCT00747396|early intervention|early intervention
5219587|NCT00747383|Diabetes Mellitus|diabetes mellitus
5219588|NCT00747383|GLP1|glp1
5219589|NCT00747383|DPP4|dpp4
5219590|NCT00747370|stress urinary incontinence|stress urinary incontinence
5219591|NCT00747370|Tension free vaginal tape|tension free vaginal tape
5219592|NCT00747370|tension free vaginal tape obturator|tension free vaginal tape obturator
5219593|NCT00747370|genital prolapse|genital prolapse
5219594|NCT00747344|Psoriasis|psoriasis
5219595|NCT00747344|Psoriatic Arthritis|psoriatic arthritis
5219596|NCT00747344|Ustekinumab|ustekinumab
5219597|NCT00747344|CNTO 1275|cnto 1275
5219598|NCT00747331|Cardiopulmonary bypass|cardiopulmonary bypass
5219599|NCT00747331|Lactic acidosis|lactic acidosis
5219600|NCT00747331|Oxygen delivery|oxygen delivery
5219601|NCT00747331|Acute renal failure|acute renal failure
5219602|NCT00747331|outcome|outcome
5219603|NCT00747331|cardiac|cardiac
5219604|NCT00747331|surgery|surgery
5219605|NCT00747318|Moderate to Severe|moderate to severe
5219606|NCT00747305|stage IV renal cell cancer|stage iv renal cell cancer
5219607|NCT00747305|clear cell renal cell carcinoma|clear cell renal cell carcinoma
5219608|NCT00747305|recurrent renal cell cancer|recurrent renal cell cancer
5219609|NCT00747292|laparoscopic|laparoscopic
5219610|NCT00747292|colon|colon
5219611|NCT00747292|analgesia|analgesia
5219612|NCT00747292|fluid optimised|fluid optimised
5219613|NCT00747253|laser interstitial thermal therapy|laser interstitial thermal therapy
5219614|NCT00747253|laser therapy|laser therapy
5219615|NCT00747253|thermal therapy|thermal therapy
5219616|NCT00747253|brain tumors|brain tumors
5219617|NCT00747253|recurrent brain tumor|recurrent brain tumor
5219618|NCT00747253|progressive brain tumor|progressive brain tumor
5219619|NCT00747253|glioblastoma multiforme tumor|glioblastoma multiforme tumor
5219620|NCT00747240|Ile198Thr|ile198thr
5219621|NCT00747240|Ala379Val|ala379val
5219622|NCT00747240|variants|variants
5219623|NCT00747240|PAF-AH|paf-ah
5219624|NCT00747227|cataract|cataract
5219625|NCT00747227|monofocal|monofocal
5219626|NCT00747227|intraocular lens|intraocular lens
5219627|NCT00747227|acrylic|acrylic
5219628|NCT00747214|Rheumatoid Arthritis|rheumatoid arthritis
5219629|NCT00747214|RA|ra
5219630|NCT00747214|DMARD|dmard
5219631|NCT00747214|CRP|crp
5219632|NCT00747201|Replicating Effective Programs|replicating effective programs
5219633|NCT00747201|Care Management|care management
5219634|NCT00747201|Implementation|implementation
5219635|NCT00747201|Intervention|intervention
5219636|NCT00747188|Problem-based learning (PBL)|problem-based learning (pbl)
5219637|NCT00747188|lecture|lecture
5219638|NCT00747188|nursing|nursing
5219639|NCT00747188|education|education
5219640|NCT00747188|none of students had any prior exposure to PBL|none of students had any prior exposure to pbl
5219641|NCT00747175|Type 2 diabetes|type 2 diabetes
5219642|NCT00747162|Compartment Syndrome|compartment syndrome
5219643|NCT00747162|Muscle Oxygenation|muscle oxygenation
5219644|NCT00747162|Skin Pigmentation|skin pigmentation
5219645|NCT00747149|diabetes|diabetes
5219646|NCT00747149|type 2|type 2
5219647|NCT00747136|Barrett's|barrett's
5219648|NCT00747136|Dysplasia|dysplasia
5219649|NCT00747136|esophageal cancer|esophageal cancer
5219650|NCT00747136|Patients|patients
5219651|NCT00747110|5-ASA|5-asa
5219652|NCT00747110|mesalamine|mesalamine
5219653|NCT00747110|mesalazine|mesalazine
5219654|NCT00747110|budesonide|budesonide
5219655|NCT00747110|ulcerative colitis|ulcerative colitis
5219656|NCT00747084|unsedated colonoscopy|unsedated colonoscopy
5219657|NCT00747071|Clostridium difficile|clostridium difficile
5219658|NCT00747071|diarrhea|diarrhea
5219659|NCT00747071|colostrum|colostrum
5219660|NCT00747058|phase 1, human study, healthy volunteers|phase 1, human study, healthy volunteers
5219661|NCT00747045|Chronic Thromboembolic Pulmonary Hypertension|chronic thromboembolic pulmonary hypertension
5219662|NCT00747045|Lung Injury|lung injury
5219663|NCT00747045|Ventilation Strategies|ventilation strategies
5219664|NCT00746993|Contraception|contraception
5219665|NCT00746993|Counseling|counseling
5219666|NCT00746980|alopecia|alopecia
5219667|NCT00746980|areata|areata
5219668|NCT00746980|universalis|universalis
5219669|NCT00746980|severe|severe
5219670|NCT00746980|ophiasis|ophiasis
5219671|NCT00746980|variants|variants
5219672|NCT00746954|buspirone|buspirone
5219673|NCT00746954|acetazolamide|acetazolamide
5219674|NCT00746941|PML|pml
5219675|NCT00746941|Human Polyomavirus JC|human polyomavirus jc
5219676|NCT00746941|HIV|hiv
5219677|NCT00746941|Central Nervous System Disease|central nervous system disease
5219678|NCT00746941|Mefloquine|mefloquine
5219679|NCT00746941|JC Virus|jc virus
5219680|NCT00746928|Blood pressure|blood pressure
5219681|NCT00746928|Hypertension|hypertension
5219682|NCT00746928|sympathetic control|sympathetic control
5219683|NCT00746928|chemosensitivity|chemosensitivity
5219684|NCT00746928|baroreflex|baroreflex
5219814|NCT00746408|Information supply|information supply
5219685|NCT00746915|Patients undergoing elective pain relief treatment of lumbar epidural steroid injection under fluoroscopy|patients undergoing elective pain relief treatment of lumbar epidural steroid injection under fluoroscopy
5219686|NCT00746902|Refractory hypertension|refractory hypertension
5219687|NCT00746902|Obstructive sleep apnea syndrome|obstructive sleep apnea syndrome
5219688|NCT00746902|Obesity|obesity
5219689|NCT00746902|Leptinemia|leptinemia
5219690|NCT00746902|RHOOSAS study|rhoosas study
5219691|NCT00746889|osteoarthritis|osteoarthritis
5219692|NCT00746889|knee|knee
5219693|NCT00746889|corticosteroids|corticosteroids
5219694|NCT00746889|ultrasound|ultrasound
5219695|NCT00746876|Hip|hip
5219696|NCT00746876|Fracture|fracture
5219697|NCT00746876|Femoral neck|femoral neck
5219698|NCT00746876|Hemiarthroplasty|hemiarthroplasty
5219699|NCT00746876|Bipolar|bipolar
5219700|NCT00746876|Unipolar|unipolar
5219701|NCT00746876|Displaced femoral neck fractures|displaced femoral neck fractures
5219702|NCT00746863|mid-urethral sling|mid-urethral sling
5219703|NCT00746863|pubovaginal sling|pubovaginal sling
5219704|NCT00746863|postoperative pain|postoperative pain
5219705|NCT00746863|visual analog scale|visual analog scale
5219706|NCT00746863|suprapubic approach|suprapubic approach
5219707|NCT00746863|SPARC sling|sparc sling
5219708|NCT00746850|acute cholecystitis|acute cholecystitis
5219709|NCT00746850|laparoscopic cholecystectomy|laparoscopic cholecystectomy
5219710|NCT00746850|conversion rate|conversion rate
5219711|NCT00746850|morbidity|morbidity
5219712|NCT00746850|mortality|mortality
5219713|NCT00746850|postoperative pain|postoperative pain
5219714|NCT00746850|hospital stay|hospital stay
5219715|NCT00746837|AZD5672|azd5672
5219716|NCT00746824|Obesity|obesity
5219717|NCT00746824|weight loss|weight loss
5219718|NCT00746824|7TM Pharma|7tm pharma
5219719|NCT00746824|TM30339|tm30339
5219720|NCT00746824|Y4 receptor antagonist|y4 receptor antagonist
5219721|NCT00746811|cholesterol|cholesterol
5219722|NCT00746811|hypercholesterolemia|hypercholesterolemia
5219723|NCT00746811|omega 3|omega 3
5219724|NCT00746798|West Nile Fever|west nile fever
5219725|NCT00746798|ChimeriVax|chimerivax
5219726|NCT00746798|West Nile Virus Vaccine|west nile virus vaccine
5219727|NCT00746785|Olanzapine|olanzapine
5219728|NCT00746772|antioxidant|antioxidant
5219729|NCT00746772|oral lichen planus|oral lichen planus
5219730|NCT00746772|treatment|treatment
5219731|NCT00746772|purslane|purslane
5219732|NCT00746759|Lung Cancer|lung cancer
5219733|NCT00746759|Smoker|smoker
5219734|NCT00746759|Former Smoker|former smoker
5219735|NCT00746759|Gene Expression|gene expression
5219736|NCT00746759|Bronchoscopy|bronchoscopy
5219737|NCT00746746|Advanced Melanoma|advanced melanoma
5219738|NCT00746733|Drug|drug
5219739|NCT00746733|Interaction|interaction
5219740|NCT00746733|Study|study
5219741|NCT00746720|hip replacement|hip replacement
5219742|NCT00746720|osteoarthritis|osteoarthritis
5219743|NCT00746720|etoricoxib|etoricoxib
5219744|NCT00746720|pain|pain
5219745|NCT00746720|cerebrospinal fluid|cerebrospinal fluid
5219746|NCT00746720|pharmacokinetics|pharmacokinetics
5219747|NCT00746707|adhesive glue, perineal tear, suture|adhesive glue, perineal tear, suture
5219748|NCT00746668|Reading|reading
5219749|NCT00746668|Macular Degeneration|macular degeneration
5219750|NCT00746668|Rehabilitation|rehabilitation
5219751|NCT00746668|Vision, Low|vision, low
5219752|NCT00746655|Hepatocellular|hepatocellular
5219753|NCT00746642|glucose measurements|glucose measurements
5219754|NCT00746616|Total Hip Arthroplasty,|total hip arthroplasty,
5219755|NCT00746616|Acetabular Cup,|acetabular cup,
5219756|NCT00746616|Hip Resurfacing|hip resurfacing
5219757|NCT00746616|Young,|young,
5219758|NCT00746616|active|active
5219759|NCT00746616|patients|patients
5219760|NCT00746590|hepatocellular carcinoma|hepatocellular carcinoma
5219761|NCT00746590|liver cancer|liver cancer
5219762|NCT00746590|Prolarix|prolarix
5219763|NCT00746590|tretazicar|tretazicar
5219764|NCT00746590|caricotamide|caricotamide
5219765|NCT00746590|Phase 2|phase 2
5219766|NCT00746590|tumor|tumor
5219767|NCT00746590|chemotherapy|chemotherapy
5219768|NCT00746564|Implantable Cardiac Monitor|implantable cardiac monitor
5219769|NCT00746564|Arrhythmias|arrhythmias
5219770|NCT00746564|Atrial Fibrillation|atrial fibrillation
5219771|NCT00746551|iron deficiency anemia|iron deficiency anemia
5219772|NCT00746551|pregnancy|pregnancy
5219773|NCT00746551|third trimester|third trimester
5219774|NCT00746551|intravenous iron|intravenous iron
5219775|NCT00746551|efficacy|efficacy
5219776|NCT00746551|a randomized trial|a randomized trial
5219777|NCT00746551|Female|female
5219778|NCT00746551|Ferric Compounds/therapeutic use*|ferric compounds/therapeutic use*
5219779|NCT00746551|Infusions, Intravenous|infusions, intravenous
5219780|NCT00746551|Hematologic/therapy*|hematologic/therapy*
5219781|NCT00746538|Hilar cholangiocarcinoma|hilar cholangiocarcinoma
5219782|NCT00746538|biliary stent|biliary stent
5219783|NCT00746538|plastic stent|plastic stent
5219784|NCT00746538|metallic stent|metallic stent
5219785|NCT00746538|quality of life|quality of life
5219786|NCT00746525|stroke|stroke
5219787|NCT00746525|motor learning|motor learning
5219788|NCT00746525|rehabilitation of upper extremity|rehabilitation of upper extremity
5219789|NCT00746525|functional electrical stimulation|functional electrical stimulation
5219790|NCT00746525|FES|fes
5219791|NCT00746525|brain computer interface|brain computer interface
5219792|NCT00746525|BCI|bci
5219793|NCT00746525|coordination|coordination
5219794|NCT00746525|motor control|motor control
5219795|NCT00746460|primary prevention|primary prevention
5219796|NCT00746460|patient knowledge|patient knowledge
5219797|NCT00746460|nurse|nurse
5219798|NCT00746460|exercise|exercise
5219799|NCT00746460|smoking cessation|smoking cessation
5219800|NCT00746460|weight loss|weight loss
5219801|NCT00746447|maintenance|maintenance
5219802|NCT00746447|5-ASA|5-asa
5219803|NCT00746447|mesalamine|mesalamine
5219804|NCT00746447|mesalazine|mesalazine
5219805|NCT00746447|ulcerative colitis|ulcerative colitis
5219806|NCT00746434|Mild plaque psoriasis,|mild plaque psoriasis,
5219807|NCT00746434|Moderate plaque psoriasis,|moderate plaque psoriasis,
5219808|NCT00746434|0.5% Roflumilast cream|0.5% roflumilast cream
5219809|NCT00746421|Cognition|cognition
5219810|NCT00746421|attention|attention
5219811|NCT00746421|bipolar|bipolar
5219812|NCT00746421|disability|disability
5219813|NCT00746408|Internet|internet
5219815|NCT00746408|Tailoring|tailoring
5219816|NCT00746408|Patient empowerment|patient empowerment
5219817|NCT00746408|Headaches|headaches
5219818|NCT00746408|Consumer Health Information|consumer health information
5219819|NCT00746408|Information Services|information services
5219820|NCT00746408|Information Storage and Retrieval|information storage and retrieval
5219821|NCT00746408|Information Systems|information systems
5219822|NCT00746395|capsule|capsule
5219823|NCT00746395|endoscopy|endoscopy
5219824|NCT00746395|prokinetic|prokinetic
5219825|NCT00746395|lubiprostone|lubiprostone
5219826|NCT00746395|Normal|normal
5219827|NCT00746395|volunteers|volunteers
5219828|NCT00746382|Mild atopic dermatitis, Roflumilast cream 0.5%|mild atopic dermatitis, roflumilast cream 0.5%
5219830|NCT00746369|Prevention|prevention
5219831|NCT00746369|Adolescents|adolescents
5219832|NCT00746369|HIV Seronegativity|hiv seronegativity
5219833|NCT00746356|heart failure|heart failure
5219834|NCT00746356|cardiac resynchronization therapy|cardiac resynchronization therapy
5219835|NCT00746356|autocapture|autocapture
5219836|NCT00746356|Current RF|current rf
5219837|NCT00746356|Promote RF|promote rf
5219838|NCT00746343|Bipolar I Disorder|bipolar i disorder
5219839|NCT00746343|Medical Risks|medical risks
5219840|NCT00746343|Integrated Risk Reduction Intervention|integrated risk reduction intervention
5219841|NCT00746343|Currently in Remission|currently in remission
5219842|NCT00746343|BMI|bmi
5219843|NCT00746330|Asthma|asthma
5219844|NCT00746330|Children|children
5219845|NCT00746330|Persistent asthma|persistent asthma
5219846|NCT00746304|botulinum|botulinum
5219847|NCT00746304|esotropia|esotropia
5219848|NCT00746278|Ovarian Cysts|ovarian cysts
5219849|NCT00746278|Electrocoagulation|electrocoagulation
5219850|NCT00746278|Ovarian Function Tests|ovarian function tests
5219851|NCT00746278|Laparoscopy|laparoscopy
5219852|NCT00746265|behavioral interventions for weight loss|behavioral interventions for weight loss
5219853|NCT00746252|bipolar|bipolar
5219854|NCT00746252|children|children
5219855|NCT00746252|antipsychotic|antipsychotic
5219856|NCT00746252|side effect|side effect
5219857|NCT00746239|insomnia|insomnia
5219858|NCT00746239|sleep difficulty|sleep difficulty
5219859|NCT00746239|panic disorder|panic disorder
5219860|NCT00746239|nocturnal panic attacks|nocturnal panic attacks
5219861|NCT00746239|anxiety|anxiety
5219862|NCT00746226|birch pollen|birch pollen
5219863|NCT00746213|Thoracotomy|thoracotomy
5219864|NCT00746213|Chronic Pain|chronic pain
5219865|NCT00746200|chronic constipation|chronic constipation
5219866|NCT00746200|electroacupuncture|electroacupuncture
5219867|NCT00746200|randomized controlled trial|randomized controlled trial
5219868|NCT00746174|insulin sensitivity|insulin sensitivity
5219869|NCT00746174|magnetic resonance spectroscopy (MRS)|magnetic resonance spectroscopy (mrs)
5219870|NCT00746174|lipotoxicity|lipotoxicity
5219871|NCT00746174|lipid oxidation|lipid oxidation
5219872|NCT00746174|thiazolidinediones|thiazolidinediones
5219873|NCT00746174|intracellular|intracellular
5219874|NCT00746174|triglyceride|triglyceride
5219875|NCT00746174|content|content
5219876|NCT00746161|total gastrectomy|total gastrectomy
5219877|NCT00746161|double tract reconstruction|double tract reconstruction
5219878|NCT00746161|gastric cancer|gastric cancer
5219879|NCT00746161|Total gastrectomy in patients with gastric cancer|total gastrectomy in patients with gastric cancer
5219880|NCT00746148|Polycystic Ovary Syndrome|polycystic ovary syndrome
5219881|NCT00746148|Reflexology|reflexology
5219882|NCT00746148|Complementary and Alternative Medicine|complementary and alternative medicine
5219883|NCT00746148|Endocrinopathy|endocrinopathy
5219884|NCT00746148|Oligo|oligo
5219885|NCT00746148|Amenorrhoea|amenorrhoea
5219886|NCT00746135|Heart failure (NYHA class III and IV)|heart failure (nyha class iii and iv)
5219887|NCT00746135|Ventricular Dyssynchrony|ventricular dyssynchrony
5219888|NCT00746109|randomized|randomized
5219889|NCT00746109|clinical trial|clinical trial
5219890|NCT00746109|ultrasound|ultrasound
5219891|NCT00746109|prospective|prospective
5219892|NCT00746109|abscess|abscess
5219893|NCT00746109|packing|packing
5219894|NCT00746109|incision and drainage|incision and drainage
5219895|NCT00746109|superficial soft tissue infection|superficial soft tissue infection
5219896|NCT00746083|pediatric|pediatric
5219897|NCT00746083|obesity|obesity
5219898|NCT00746083|African American|african american
5219899|NCT00746083|adolescents|adolescents
5219900|NCT00746083|intervention|intervention
5219901|NCT00746083|home-based|home-based
5219902|NCT00746083|community-based|community-based
5219903|NCT00746070|cardiovascular disease, endothelium function, aldosterone|cardiovascular disease, endothelium function, aldosterone
5219904|NCT00746057|Renal graft|renal graft
5219905|NCT00746057|chronic rejection|chronic rejection
5219906|NCT00746057|tolerance|tolerance
5219907|NCT00746057|DNA chip|dna chip
5219908|NCT00746057|biopsy|biopsy
5219909|NCT00746044|Healthy|healthy
5219910|NCT00746031|MTI|mti
5219911|NCT00746031|Fibroids|fibroids
5219912|NCT00746031|Novel|novel
5219913|NCT00746031|MR imaging|mr imaging
5219914|NCT00746031|techniques|techniques
5219915|NCT00746018|ovary|ovary
5219916|NCT00746018|uterus|uterus
5219917|NCT00746018|cervix|cervix
5219918|NCT00746018|08-092|08-092
5219919|NCT00746005|mild cognitive impairment|mild cognitive impairment
5219920|NCT00745992|Voriconazole|voriconazole
5219921|NCT00745992|Antifungal Agents|antifungal agents
5219922|NCT00745992|Invasive fungal infections|invasive fungal infections
5219923|NCT00745992|Therapeutic drug monitoring|therapeutic drug monitoring
5219924|NCT00745992|CYP Genetic polymorphism|cyp genetic polymorphism
5219925|NCT00745966|Bipolar|bipolar
5219926|NCT00745966|atypical antipsychotics|atypical antipsychotics
5219927|NCT00745966|quality of life|quality of life
5219928|NCT00745966|observational|observational
5219929|NCT00745953|Metabolic syndrome|metabolic syndrome
5219930|NCT00745953|Lipotoxicity|lipotoxicity
5219931|NCT00745953|Insulin sensitivity|insulin sensitivity
5219932|NCT00745953|Myocardial triglyceride levels|myocardial triglyceride levels
5219933|NCT00745953|Hepatic triglyceride levels|hepatic triglyceride levels
5219934|NCT00745953|Magnetic resonance spectroscopy|magnetic resonance spectroscopy
5219935|NCT00745940|Mindfulness-Based Cognitive Therapy|mindfulness-based cognitive therapy
5219936|NCT00745940|MBCT|mbct
5219937|NCT00745940|Depression|depression
5219938|NCT00745940|Traumatic Brain Injury|traumatic brain injury
5219939|NCT00745940|TBI|tbi
5219940|NCT00745927|Colorectal neoplasm|colorectal neoplasm
5219941|NCT00745927|Colorectal cancer|colorectal cancer
5219942|NCT00745927|Screening colonoscopy|screening colonoscopy
5219943|NCT00745927|CO2 insufflations|co2 insufflations
5219944|NCT00745927|Colonoscopy|colonoscopy
5219945|NCT00745914|PPAR-gamma, diabetic, kidney disease, atherosclerosis|ppar-gamma, diabetic, kidney disease, atherosclerosis
5219946|NCT00745901|contraception|contraception
5219947|NCT00745901|bleeding|bleeding
5219948|NCT00745901|cycle control|cycle control
5219949|NCT00745888|oxidative stress|oxidative stress
5219950|NCT00745888|intensive care|intensive care
5219951|NCT00745888|Postoperative intensive care|postoperative intensive care
5219952|NCT00745875|NSCLC|nsclc
5219953|NCT00745875|Phase II|phase ii
5219954|NCT00745875|ZD4054|zd4054
5219955|NCT00745875|Pemetrexed|pemetrexed
5219956|NCT00745875|Lung Cancer|lung cancer
5219957|NCT00745862|Skin|skin
5219958|NCT00745849|non-allergic rhinitis, laryngopharyngeal reflux|non-allergic rhinitis, laryngopharyngeal reflux
5219959|NCT00745836|insulin sensitivity|insulin sensitivity
5219960|NCT00745823|HIV Infections|hiv infections
5219961|NCT00745823|Treatment Naïve|treatment naïve
5219962|NCT00745810|cardiopulmonary bypass|cardiopulmonary bypass
5219963|NCT00745810|oxidative injuries|oxidative injuries
5219964|NCT00745797|nonsmall cell lung cancer|nonsmall cell lung cancer
5219965|NCT00745797|brain metastasis|brain metastasis
5219966|NCT00745797|prophylactic cranial irradiation|prophylactic cranial irradiation
5219967|NCT00745784|Young Bereaved Spouses|young bereaved spouses
5219968|NCT00745771|pharmacokinetics|pharmacokinetics
5219969|NCT00745771|of Diractin®|of diractin®
5219970|NCT00745771|safety|safety
5219971|NCT00745771|efficacy|efficacy
5219972|NCT00745771|exercise|exercise
5219973|NCT00745758|SAH, vasospasm, ADMA|sah, vasospasm, adma
5219974|NCT00745732|Non-Small Cell Lung Cancer|non-small cell lung cancer
5219975|NCT00745732|Lung Cancer|lung cancer
5219976|NCT00745732|NSCLC|nsclc
5219977|NCT00745732|ZD6474|zd6474
5219978|NCT00745732|ZACTIMA|zactima
5219979|NCT00745732|Vandetanib|vandetanib
5219980|NCT00745732|Inoperable NSCLC|inoperable nsclc
5219981|NCT00745732|Unresectable NSCLC|unresectable nsclc
5219982|NCT00745732|Radiation Therapy|radiation therapy
5219983|NCT00745732|Palliative radiation therapy|palliative radiation therapy
5219984|NCT00745732|Angiogenesis|angiogenesis
5219985|NCT00745719|parathyroidectomy|parathyroidectomy
5219986|NCT00745719|cardiovascular|cardiovascular
5219987|NCT00745719|bone|bone
5219988|NCT00745719|endstage renal disease|endstage renal disease
5219989|NCT00745693|Endothelin|endothelin
5219990|NCT00745693|Air pollution|air pollution
5219991|NCT00745693|Diesel exhaust|diesel exhaust
5219992|NCT00745693|Vascular function|vascular function
5219993|NCT00745693|exposure|exposure
5219994|NCT00745680|Left ventricular remodeling, acute myocardial infarction|left ventricular remodeling, acute myocardial infarction
5219995|NCT00745667|laparoscopic|laparoscopic
5219996|NCT00745667|peptic ulcer|peptic ulcer
5219997|NCT00745654|Lung Transplantation|lung transplantation
5219998|NCT00745654|Chronic pain|chronic pain
5219999|NCT00745654|Thoracotomy|thoracotomy
5220000|NCT00745641|radiation injury|radiation injury
5220001|NCT00745641|computed tomography|computed tomography
5220002|NCT00745641|reactive oxygen species|reactive oxygen species
5220003|NCT00745641|free radicals|free radicals
5220004|NCT00745628|coronary heart disease|coronary heart disease
5220005|NCT00745628|secondary prevention|secondary prevention
5220006|NCT00745602|direct current cardioversion, cerebral blood flow|direct current cardioversion, cerebral blood flow
5220007|NCT00745589|vascular,|vascular,
5220008|NCT00745589|valvular calcification,|valvular calcification,
5220009|NCT00745589|phosphate binder,|phosphate binder,
5220010|NCT00745589|sevelamer,|sevelamer,
5220011|NCT00745589|endstage renal disease|endstage renal disease
5220012|NCT00745589|peritoneal dialysis|peritoneal dialysis
5220013|NCT00745563|infertility|infertility
5220014|NCT00745563|insemination|insemination
5220015|NCT00745563|slow release|slow release
5220016|NCT00745550|SB1518|sb1518
5220017|NCT00745550|Chronic Idiopathic Myelofibrosis|chronic idiopathic myelofibrosis
5220018|NCT00745550|Myeloproliferative disorders|myeloproliferative disorders
5220019|NCT00745550|Polycythemia Vera|polycythemia vera
5220020|NCT00745550|Essential Thrombocythemia|essential thrombocythemia
5220021|NCT00745550|JAK2 inhibitor|jak2 inhibitor
5220022|NCT00745537|postpartum major depression|postpartum major depression
5220023|NCT00745537|adolescent mothers|adolescent mothers
5220024|NCT00745537|telephone depression care management|telephone depression care management
5220025|NCT00745537|barriers to depression care|barriers to depression care
5220026|NCT00745524|Attention-deficit hyperactivity disorder|attention-deficit hyperactivity disorder
5220027|NCT00745524|adolescent|adolescent
5220028|NCT00745524|adult|adult
5220029|NCT00745524|high risk population|high risk population
5220030|NCT00745524|functional impairment|functional impairment
5220031|NCT00745524|quality of life|quality of life
5220032|NCT00745511|AMD|amd
5220033|NCT00745511|Avastin|avastin
5220034|NCT00745511|ORA102|ora102
5220035|NCT00745511|macular degeneration|macular degeneration
5220036|NCT00745511|neo-vascular age related macular degeneration (AMD)|neo-vascular age related macular degeneration (amd)
5220037|NCT00745498|Proliferative diabetic retinopathy|proliferative diabetic retinopathy
5220038|NCT00745498|vitrectomy|vitrectomy
5220039|NCT00745498|bevacizumab|bevacizumab
5220040|NCT00745498|vitreous hemorrhage|vitreous hemorrhage
5220041|NCT00745485|Osteoporosis|osteoporosis
5220042|NCT00745485|zoledronic acid|zoledronic acid
5220043|NCT00745485|postmenopausal women|postmenopausal women
5220044|NCT00745472|AEP|aep
5220045|NCT00745472|experimental pain|experimental pain
5220046|NCT00745472|healthy volunteers|healthy volunteers
5220047|NCT00745459|Patients|patients
5220048|NCT00745459|undergoing|undergoing
5220049|NCT00745459|gastric|gastric
5220050|NCT00745459|endoscopy|endoscopy
5220051|NCT00745446|Air pollution|air pollution
5220052|NCT00745446|Diesel exhaust|diesel exhaust
5220053|NCT00745446|Endothelial function|endothelial function
5220054|NCT00745446|Vascular function|vascular function
5220055|NCT00745446|Particle trap|particle trap
5220056|NCT00745446|Thrombosis|thrombosis
5220057|NCT00745446|effects|effects
5220058|NCT00745446|inhalation|inhalation
5220059|NCT00745420|Sickle Cell Disease|sickle cell disease
5220060|NCT00745420|Sickle Cell Anemia|sickle cell anemia
5220061|NCT00745407|adipocytokines|adipocytokines
5220062|NCT00745407|insulin sensitivity|insulin sensitivity
5220063|NCT00745407|hypertriglyceridemic patients|hypertriglyceridemic patients
5220064|NCT00745394|NIRS|nirs
5220065|NCT00745394|bypass|bypass
5220066|NCT00745394|cardiopulmonary|cardiopulmonary
5220068|NCT00745394|monitoring|monitoring
5220069|NCT00745394|system|system
5220070|NCT00745381|PANCREAS|pancreas
5220071|NCT00745381|STOMACH|stomach
5220072|NCT00745381|Questionnaire|questionnaire
5220073|NCT00745381|08-105|08-105
5220074|NCT00745368|HIV|hiv
5220075|NCT00745368|Raltegravir|raltegravir
5220076|NCT00745368|pharmacokinetics|pharmacokinetics
5220077|NCT00745368|Treatment Experienced|treatment experienced
5220078|NCT00745355|Quality of Life|quality of life
5220079|NCT00745355|Questionnaires|questionnaires
5220080|NCT00745355|08-076|08-076
5220081|NCT00745342|type 1 diabetes|type 1 diabetes
5220082|NCT00745342|glycemic control|glycemic control
5220083|NCT00745342|family conflict|family conflict
5220084|NCT00745342|quality of life|quality of life
5220085|NCT00745342|parental involvement|parental involvement
5220086|NCT00745316|Heart Failure|heart failure
5220087|NCT00745316|Renal Insufficiency|renal insufficiency
5220088|NCT00745316|Congestive Heart Failure|congestive heart failure
5220089|NCT00745303|Tai Chi Chuan; Lipid; Cytokine|tai chi chuan; lipid; cytokine
5220090|NCT00745290|Total knee arthroplasty|total knee arthroplasty
5220091|NCT00745290|Pain|pain
5220092|NCT00745290|Analgesia|analgesia
5220093|NCT00745277|carbidopa|carbidopa
5220094|NCT00745277|levodopa|levodopa
5220095|NCT00745277|Parkinson's disease|parkinson's disease
5220096|NCT00745264|heat|heat
5220097|NCT00745264|exercise|exercise
5220098|NCT00745251|Sleep apnea; obesity|sleep apnea; obesity
5220099|NCT00745238|endothelial function|endothelial function
5220100|NCT00745238|peripheral arterial tone|peripheral arterial tone
5220101|NCT00745238|systemic inflammation|systemic inflammation
5220102|NCT00745238|oxidative stress|oxidative stress
5220103|NCT00745238|respiratory and peripheral muscular function|respiratory and peripheral muscular function
5220104|NCT00745225|peritoneal dialysis, cardiovascular, PPAR-gamma|peritoneal dialysis, cardiovascular, ppar-gamma
5220105|NCT00745212|venous thromboembolism diseases|venous thromboembolism diseases
5220106|NCT00745212|placental vascular pathologies|placental vascular pathologies
5220107|NCT00745212|antithrombotic treatment|antithrombotic treatment
5220108|NCT00745212|symptomatic thromboembolic events|symptomatic thromboembolic events
5220109|NCT00745212|pregnant women|pregnant women
5220110|NCT00745212|score|score
5220111|NCT00745212|therapeutic strategies|therapeutic strategies
5220112|NCT00745212|heparin|heparin
5220113|NCT00745212|aspirin|aspirin
5220114|NCT00745212|pregnancy pathology|pregnancy pathology
5220115|NCT00745199|End Stage Renal Disease|end stage renal disease
5220116|NCT00745199|Cromolyn Sodium|cromolyn sodium
5220117|NCT00745199|Pruritus|pruritus
5220118|NCT00745199|Tryptase|tryptase
5220119|NCT00745160|Questionaires|questionaires
5220120|NCT00745147|constipation|constipation
5220121|NCT00745147|traditional Chinese medicine|traditional chinese medicine
5220122|NCT00745147|Chinese herbal formula|chinese herbal formula
5220123|NCT00745147|lactulose|lactulose
5220124|NCT00745147|cost-effective|cost-effective
5220125|NCT00745147|long-term care|long-term care
5220126|NCT00745134|Rectum|rectum
5220127|NCT00745134|Rectal Cancer|rectal cancer
5220128|NCT00745134|Colon Cancer|colon cancer
5220129|NCT00745134|Curcumin|curcumin
5220130|NCT00745134|Diferuloylmethane|diferuloylmethane
5220131|NCT00745134|Capecitabine|capecitabine
5220132|NCT00745134|Radiation Therapy|radiation therapy
5220133|NCT00745134|RT|rt
5220134|NCT00745134|XRT|xrt
5220135|NCT00745134|Surgery for Rectal Cancer|surgery for rectal cancer
5220136|NCT00745095|Safety|safety
5220137|NCT00745095|Efficacy|efficacy
5220138|NCT00745095|Colonoscopy|colonoscopy
5220139|NCT00745095|PIEE|piee
5220140|NCT00745095|MoviPrep|moviprep
5220141|NCT00745095|Neostigmine|neostigmine
5220142|NCT00745095|Glycopyrrolate|glycopyrrolate
5220143|NCT00745069|Tapentadol|tapentadol
5220144|NCT00745069|Osteoarthritis|osteoarthritis
5220145|NCT00745069|Analgesia|analgesia
5220146|NCT00745069|Chronic pain|chronic pain
5220147|NCT00745056|Cognition|cognition
5220148|NCT00745056|Memory|memory
5220149|NCT00745056|Hormone Therapy|hormone therapy
5220150|NCT00745056|HT|ht
5220151|NCT00745043|COPD|copd
5220152|NCT00745043|Betablockers|betablockers
5220153|NCT00745043|bronchodilator|bronchodilator
5220154|NCT00745043|exercise capacity|exercise capacity
5220155|NCT00745043|methacholine challenge|methacholine challenge
5220156|NCT00745030|Parkinson's disease|parkinson's disease
5220157|NCT00745030|Multiple Systems Atrophy|multiple systems atrophy
5220158|NCT00745030|Lewy Body Dementia|lewy body dementia
5220159|NCT00745017|recurrent depression|recurrent depression
5220160|NCT00745017|major depressive disorder|major depressive disorder
5220161|NCT00745017|interpersonal therapy|interpersonal therapy
5220555|NCT00743561|MSA|msa
5220162|NCT00745017|cognitive behavioral therapy|cognitive behavioral therapy
5220163|NCT00745017|antidepressant therapies|antidepressant therapies
5220164|NCT00745017|outome predictors|outome predictors
5220165|NCT00745017|personality dimensions|personality dimensions
5220166|NCT00745004|IBS D|ibs d
5220167|NCT00744978|Efficacy|efficacy
5220168|NCT00744978|Safety|safety
5220169|NCT00744978|Pharmacokinetics|pharmacokinetics
5220170|NCT00744978|Alzheimer's disease|alzheimer's disease
5220171|NCT00744952|Large-vessel vasculitis|large-vessel vasculitis
5220172|NCT00744939|Gadolinium|gadolinium
5220173|NCT00744939|NSF|nsf
5220174|NCT00744939|Renal Impairment|renal impairment
5220175|NCT00744939|chemically induced|chemically induced
5220176|NCT00744939|adverse effects|adverse effects
5220177|NCT00744939|Contrast Media|contrast media
5220178|NCT00744939|complications|complications
5220179|NCT00744913|Pregnancy|pregnancy
5220180|NCT00744913|Women|women
5220181|NCT00744913|Nicotine replacement therapy|nicotine replacement therapy
5220182|NCT00744913|Smoking cessation|smoking cessation
5220183|NCT00744900|Pemetrexed, Non-Small Cell Lung Cancer, brain metastasis|pemetrexed, non-small cell lung cancer, brain metastasis
5220184|NCT00744887|TMC114-TiDP3-C181|tmc114-tidp3-c181
5220185|NCT00744887|TMC114-C181, health volunteers, Darunavir, ritonavir oral solution|tmc114-c181, health volunteers, darunavir, ritonavir oral solution
5220186|NCT00744874|atrial fibrillation|atrial fibrillation
5220187|NCT00744861|Lumbar Fusion|lumbar fusion
5220188|NCT00744861|exospine|exospine
5220189|NCT00744861|Exo-Spine|exo-spine
5220190|NCT00744848|hemorrhoids|hemorrhoids
5220191|NCT00744835|atrial fibrillation|atrial fibrillation
5220192|NCT00744822|Lung Transplantation|lung transplantation
5220193|NCT00744822|Infections|infections
5220194|NCT00744822|Graft Rejection|graft rejection
5220195|NCT00744809|TMC278-C152|tmc278-c152
5220196|NCT00744809|TMC278-TiDP6-C152|tmc278-tidp6-c152
5220197|NCT00744809|Healthy Volunteers|healthy volunteers
5220198|NCT00744809|QT/QTc interval|qt/qtc interval
5220199|NCT00744796|Endothelial Dystrophy|endothelial dystrophy
5220200|NCT00744796|Fuchs' Endothelial Corneal Dystrophy|fuchs' endothelial corneal dystrophy
5220201|NCT00744770|TMC278-TiDP6-C121|tmc278-tidp6-c121
5220202|NCT00744770|TMC278-C121|tmc278-c121
5220203|NCT00744770|open-label|open-label
5220204|NCT00744770|drug-drug interaction|drug-drug interaction
5220205|NCT00744770|methadone|methadone
5220206|NCT00744770|TMC278|tmc278
5220207|NCT00744757|5-aza-2'-deoxycytidine|5-aza-2'-deoxycytidine
5220208|NCT00744757|decitabine|decitabine
5220209|NCT00744757|dacogen|dacogen
5220210|NCT00744757|Myelodysplastic Syndrome|myelodysplastic syndrome
5220211|NCT00744744|stage 0 bladder cancer|stage 0 bladder cancer
5220212|NCT00744731|Partial-onset Seizures|partial-onset seizures
5220213|NCT00744731|Simple Partial Seizures|simple partial seizures
5220214|NCT00744731|Complex Partial Seizures|complex partial seizures
5220215|NCT00744705|Retinal nerve fiber layer|retinal nerve fiber layer
5220216|NCT00744705|Glaucoma|glaucoma
5220217|NCT00744705|Myopia|myopia
5220218|NCT00744692|Immunodeficiencies|immunodeficiencies
5220219|NCT00744692|Congenital Marrow Failures|congenital marrow failures
5220220|NCT00744692|Hemoglobinopathies|hemoglobinopathies
5220221|NCT00744692|Inborn Errors of Metabolism|inborn errors of metabolism
5220222|NCT00744692|SCIDS|scids
5220223|NCT00744692|Wiskott Aldrich|wiskott aldrich
5220224|NCT00744692|FEL|fel
5220225|NCT00744692|HLH|hlh
5220226|NCT00744692|IPEX|ipex
5220227|NCT00744692|LAD|lad
5220228|NCT00744692|Sickle Cell|sickle cell
5220229|NCT00744692|Thalassemia|thalassemia
5220230|NCT00744692|Omenn's Syndrome|omenn's syndrome
5220231|NCT00744692|Hurler's Syndrome|hurler's syndrome
5220232|NCT00744692|MLD|mld
5220233|NCT00744692|ALD|ald
5220234|NCT00744692|Sanfilippo|sanfilippo
5220235|NCT00744692|Krabbe|krabbe
5220236|NCT00744692|Hunter's syndrome|hunter's syndrome
5220237|NCT00744692|TaySachs|taysachs
5220238|NCT00744692|Diamond Blackfan Anemia|diamond blackfan anemia
5220239|NCT00744692|transplant|transplant
5220240|NCT00744692|MPS|mps
5220241|NCT00744692|Gaucher|gaucher
5220242|NCT00744679|MS|ms
5220243|NCT00744679|Multiple Sclerosis|multiple sclerosis
5220244|NCT00744666|Intravitreal triamcinolone acetonide|intravitreal triamcinolone acetonide
5220245|NCT00744666|Side-effects|side-effects
5220246|NCT00744666|Ocular hypertension|ocular hypertension
5220247|NCT00744666|Glaucoma|glaucoma
5220248|NCT00744666|Prevention|prevention
5220249|NCT00744666|Vitreoretinal diseases requiring IVTA for treatment|vitreoretinal diseases requiring ivta for treatment
5220250|NCT00744653|Breast Cancer|breast cancer
5220251|NCT00744653|Recurrence|recurrence
5220252|NCT00744640|advanced pancreatic cancer|advanced pancreatic cancer
5220253|NCT00744640|palliative chemotherapy|palliative chemotherapy
5220254|NCT00744640|first-line therapy|first-line therapy
5220255|NCT00744640|capecitabine|capecitabine
5220256|NCT00744640|oxaliplatin|oxaliplatin
5220257|NCT00744640|gemcitabine|gemcitabine
5220258|NCT00744640|dose-finding study|dose-finding study
5220259|NCT00744640|Phase II|phase ii
5220260|NCT00744627|Generalized Anxiety Disorder|generalized anxiety disorder
5220261|NCT00744627|Anxiety Disorders|anxiety disorders
5220262|NCT00744627|Drug Therapy|drug therapy
5220263|NCT00744614|PC02|pc02
5220264|NCT00744614|Respiratory Rate|respiratory rate
5220265|NCT00744614|Arterial blood gas|arterial blood gas
5220266|NCT00744614|Intubation|intubation
5220267|NCT00744614|Capnography|capnography
5220268|NCT00744601|impulsivity|impulsivity
5220269|NCT00744601|cocaine dependence|cocaine dependence
5220270|NCT00744601|relapse|relapse
5220271|NCT00744601|neuroimaging|neuroimaging
5220272|NCT00744601|functional magnetic resonance imaging (fMRI)|functional magnetic resonance imaging (fmri)
5220273|NCT00744601|single photon emission computed tomography (SPECT)|single photon emission computed tomography (spect)
5220274|NCT00744588|substance abuse|substance abuse
5220275|NCT00744588|alcohol dependence|alcohol dependence
5220276|NCT00744588|hypothalamic-pituitary-adrenal (HPA) system|hypothalamic-pituitary-adrenal (hpa) system
5220277|NCT00744588|cosyntropin|cosyntropin
5220278|NCT00744588|corticotropin-releasing Hormone (CRH)|corticotropin-releasing hormone (crh)
5220279|NCT00744588|pituitary-adrenal system|pituitary-adrenal system
5220280|NCT00744588|stress|stress
5220281|NCT00744588|trauma|trauma
5220282|NCT00744588|neurosteroids|neurosteroids
5220283|NCT00744588|cortisol|cortisol
5220284|NCT00744588|relapse|relapse
5220285|NCT00744575|back pain|back pain
5220286|NCT00744575|eeg|eeg
5220287|NCT00744575|chronic pain|chronic pain
5220288|NCT00744562|Phase 1,|phase 1,
5220289|NCT00744562|dose escalation,|dose escalation,
5220290|NCT00744562|histologically|histologically
5220291|NCT00744562|confirmed|confirmed
5220292|NCT00744562|malignancy|malignancy
5220293|NCT00744562|metastatic|metastatic
5220294|NCT00744549|Male Urogenital Diseases|male urogenital diseases
5220295|NCT00744549|Antioxidants|antioxidants
5220296|NCT00744549|Vitamin E|vitamin e
5220297|NCT00744549|Vitamin D|vitamin d
5220298|NCT00744549|Lycopene|lycopene
5220299|NCT00744549|Selenium|selenium
5220300|NCT00744536|Myelodysplastic syndrome|myelodysplastic syndrome
5220301|NCT00744536|Chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5220302|NCT00744536|High intermediate risk and high risk IPSS score|high intermediate risk and high risk ipss score
5220303|NCT00744536|Angiogenesis|angiogenesis
5220304|NCT00744536|Metronomic chemotherapy|metronomic chemotherapy
5220305|NCT00744536|Myelodysplastic Myeloproliferative Diseases|myelodysplastic myeloproliferative diseases
5220306|NCT00744523|carotid artery stenting|carotid artery stenting
5220307|NCT00744523|stroke|stroke
5220308|NCT00744523|cerebral protection|cerebral protection
5220309|NCT00744523|high surgical risk|high surgical risk
5220310|NCT00744510|Polycystic Ovary Syndrome|polycystic ovary syndrome
5220311|NCT00744510|Reflexology|reflexology
5220312|NCT00744510|Complementary and Alternative Medicine|complementary and alternative medicine
5220313|NCT00744510|Endocrinopathy|endocrinopathy
5220314|NCT00744510|Oligo|oligo
5220315|NCT00744510|Amenorrhoea|amenorrhoea
5220316|NCT00744484|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5220317|NCT00744484|COPD|copd
5220318|NCT00744484|Physical group training|physical group training
5220319|NCT00744484|Water exercise|water exercise
5220320|NCT00744484|Cardiorespiratory fitness|cardiorespiratory fitness
5220321|NCT00744484|Functional exercise capacity|functional exercise capacity
5220322|NCT00744484|Health related quality of life|health related quality of life
5220323|NCT00744471|monoclonal antibody RN624 PF-04383119 nerve growth factor anti-nerve growth OA|monoclonal antibody rn624 pf-04383119 nerve growth factor anti-nerve growth oa
5220324|NCT00744458|Primary Health care in rural Africa|primary health care in rural africa
5220325|NCT00744458|Chronic non-communicable diseases|chronic non-communicable diseases
5220326|NCT00744458|Patient Compliance|patient compliance
5220327|NCT00744458|Treatment adherence|treatment adherence
5220328|NCT00744445|hemodialysis|hemodialysis
5220329|NCT00744445|erythropoietin|erythropoietin
5220330|NCT00744419|GERD|gerd
5220331|NCT00744419|pharmacokinetics|pharmacokinetics
5220332|NCT00744419|pantoprazole|pantoprazole
5220333|NCT00744419|neonates|neonates
5220334|NCT00744419|infants|infants
5220335|NCT00744406|recurrent depression|recurrent depression
5220336|NCT00744406|major depressive disorder|major depressive disorder
5220337|NCT00744406|interpersonal therapy|interpersonal therapy
5220338|NCT00744406|cognitive behavioral therapy|cognitive behavioral therapy
5220339|NCT00744406|antidepressant treatment|antidepressant treatment
5220340|NCT00744406|outcome predictors|outcome predictors
5220341|NCT00744406|personality dimensions|personality dimensions
5220342|NCT00744393|sleep|sleep
5220343|NCT00744393|critically ill|critically ill
5220344|NCT00744393|mechanical ventilation|mechanical ventilation
5220345|NCT00744380|Analgesia|analgesia
5220346|NCT00744380|Mechanical ventilation|mechanical ventilation
5220347|NCT00744354|refractory multiple myeloma|refractory multiple myeloma
5220348|NCT00744354|stage I multiple myeloma|stage i multiple myeloma
5220349|NCT00744354|stage II multiple myeloma|stage ii multiple myeloma
5220350|NCT00744354|stage III multiple myeloma|stage iii multiple myeloma
5220351|NCT00744341|SLV320; Acute Decompensated Heart Failure (ADHF); chronic heart failure; renal failure; I.V. doses; hospitalization|slv320; acute decompensated heart failure (adhf); chronic heart failure; renal failure; i.v. doses; hospitalization
5220352|NCT00744328|Postpartum depression|postpartum depression
5220353|NCT00744328|estradiol|estradiol
5220354|NCT00744328|Postpartum major depressive disorder|postpartum major depressive disorder
5220355|NCT00744315|myocardial revascularization|myocardial revascularization
5220356|NCT00744315|myocardial ischemia|myocardial ischemia
5220357|NCT00744315|genetics, medical|genetics, medical
5220358|NCT00744315|Angiogenesis Inducing Agents|angiogenesis inducing agents
5220359|NCT00744302|Dialysate calcium|dialysate calcium
5220360|NCT00744302|Mineral metabolism|mineral metabolism
5220361|NCT00744302|Parathyroid hormone|parathyroid hormone
5220362|NCT00744302|Calcification|calcification
5220363|NCT00744302|Cardiovascular disease|cardiovascular disease
5220364|NCT00744302|Haemodialysis|haemodialysis
5220365|NCT00744289|Hepatitis B|hepatitis b
5220366|NCT00744289|People who inject drugs|people who inject drugs
5220367|NCT00744289|Financial incentive|financial incentive
5220368|NCT00744289|Vaccine completion|vaccine completion
5220369|NCT00744276|fibrocystic breast disease|fibrocystic breast disease
5220370|NCT00744276|fibrocystic disease of breast|fibrocystic disease of breast
5220371|NCT00744276|breast pain|breast pain
5220372|NCT00744276|mastalgia|mastalgia
5220373|NCT00744276|cyclic mastalgia|cyclic mastalgia
5220374|NCT00744276|cystic breast disease|cystic breast disease
5220375|NCT00744250|Exocrine Pancreatic Insufficiency|exocrine pancreatic insufficiency
5220376|NCT00744250|Chronic Pancreatitis|chronic pancreatitis
5220377|NCT00744250|Cystic fibrosis|cystic fibrosis
5220378|NCT00744250|Pancrelipase|pancrelipase
5220379|NCT00744250|Pancrecarb|pancrecarb
5220380|NCT00744250|Intraduodenal aspiration|intraduodenal aspiration
5220381|NCT00744250|Bioavailability|bioavailability
5220382|NCT00744237|nebivolol|nebivolol
5220383|NCT00744237|Bystolic ™|bystolic ™
5220384|NCT00744237|Hypertension|hypertension
5220385|NCT00744237|Diabetes|diabetes
5220386|NCT00744198|Autologous|autologous
5220387|NCT00744198|Biological|biological
5220388|NCT00744198|Mesh|mesh
5220389|NCT00744198|Polypropylene|polypropylene
5220390|NCT00744198|Sling|sling
5220391|NCT00744198|Synthetic|synthetic
5220392|NCT00744198|Stress incontinence|stress incontinence
5220393|NCT00744198|Surgery|surgery
5220394|NCT00744198|TOT|tot
5220395|NCT00744198|Treatment|treatment
5220396|NCT00744185|infantile capillary hemangiomas|infantile capillary hemangiomas
5220397|NCT00744185|propranolol|propranolol
5220398|NCT00744185|ultrasonography|ultrasonography
5220399|NCT00744172|hysterectomy|hysterectomy
5220400|NCT00744172|vaginal|vaginal
5220401|NCT00744172|laparoscopy|laparoscopy
5220402|NCT00744172|abdominal|abdominal
5220403|NCT00744172|complication|complication
5220404|NCT00744172|quality of life|quality of life
5220405|NCT00744172|cost-effectiveness|cost-effectiveness
5220406|NCT00744172|Morbidity of three types of hysterectomy|morbidity of three types of hysterectomy
5220407|NCT00744159|colon cancer|colon cancer
5220408|NCT00744159|laparoscopic colorectal surgery|laparoscopic colorectal surgery
5220409|NCT00744159|cellular immunity|cellular immunity
5220410|NCT00744159|HLA-DR expression on monocyte|hla-dr expression on monocyte
5220411|NCT00744133|Plasmodium falciparum, NF54, Anopheles stephensi, mosquito, malaria|plasmodium falciparum, nf54, anopheles stephensi, mosquito, malaria
5220412|NCT00744120|cancer|cancer
5220413|NCT00744107|Ischemic coronary artery disease in native coronary arteries|ischemic coronary artery disease in native coronary arteries
5220414|NCT00744107|Single stent|single stent
5220415|NCT00744107|RVD 2.5- 4.0mm|rvd 2.5- 4.0mm
5220416|NCT00744107|Lesion length up to 26mm|lesion length up to 26mm
5220417|NCT00744107|de novo or previously unstented lesions|de novo or previously unstented lesions
5220418|NCT00744094|resistance training|resistance training
5220419|NCT00744094|protein supplementation|protein supplementation
5220420|NCT00744094|hypertrophy|hypertrophy
5220421|NCT00744068|Stimulant|stimulant
5220422|NCT00744068|Drug treatment|drug treatment
5220423|NCT00744068|Continuing care|continuing care
5220424|NCT00744068|Telephone support|telephone support
5220425|NCT00744068|Aftercare|aftercare
5220426|NCT00744055|alcohol dependence|alcohol dependence
5220427|NCT00744055|post traumatic stress disorder|post traumatic stress disorder
5220428|NCT00744055|treatment|treatment
5220429|NCT00744055|prazosin|prazosin
5220430|NCT00744042|Hypophosphatasia|hypophosphatasia
5220431|NCT00744042|HPP|hpp
5220432|NCT00744042|Bone Disease|bone disease
5220433|NCT00744042|Soft Bones|soft bones
5220434|NCT00744042|Low Alkaline Phosphatase|low alkaline phosphatase
5220435|NCT00744042|genetic metabolic disorder|genetic metabolic disorder
5220436|NCT00744042|alkaline phosphatase|alkaline phosphatase
5220437|NCT00744042|tissue non-specific alkaline phosphatase|tissue non-specific alkaline phosphatase
5220438|NCT00744042|rickets|rickets
5220439|NCT00744042|osteomalacia|osteomalacia
5220440|NCT00744029|prehospital delays|prehospital delays
5220441|NCT00744029|intervention|intervention
5220442|NCT00744029|population-based|population-based
5220443|NCT00744029|stroke|stroke
5220444|NCT00744016|UC|uc
5220445|NCT00744016|Ulcerative colitis|ulcerative colitis
5220446|NCT00744016|IBD|ibd
5220447|NCT00744016|Inflammatory bowel disease|inflammatory bowel disease
5220448|NCT00743990|Cough symptoms|cough symptoms
5220449|NCT00743990|Cold symptoms|cold symptoms
5220450|NCT00743990|Congestion|congestion
5220451|NCT00743990|Children|children
5220452|NCT00743990|URI|uri
5220556|NCT00743561|sleep apnea|sleep apnea
5220453|NCT00743990|Alternative cough symptom treatment|alternative cough symptom treatment
5220454|NCT00743951|patient decision aids|patient decision aids
5220455|NCT00743951|patient preferences|patient preferences
5220456|NCT00743951|osteoarthritis|osteoarthritis
5220457|NCT00743951|joint replacement|joint replacement
5220458|NCT00743951|waiting times|waiting times
5220459|NCT00743925|Unstable Angina|unstable angina
5220460|NCT00743925|STEMI|stemi
5220461|NCT00743925|NSTEMI|nstemi
5220462|NCT00743925|ACS|acs
5220463|NCT00743925|Acute Coronary Syndrome|acute coronary syndrome
5220464|NCT00743925|C14.280.647.124|c14.280.647.124
5220465|NCT00743925|C14.280.647.500|c14.280.647.500
5220466|NCT00743912|rifaximin|rifaximin
5220467|NCT00743912|midazolam|midazolam
5220468|NCT00743912|pharmacokinetics|pharmacokinetics
5220469|NCT00743899|Angioplasty, Transluminal, Percutaneous Coronary|angioplasty, transluminal, percutaneous coronary
5220470|NCT00743899|Everolimus-eluting stent|everolimus-eluting stent
5220471|NCT00743873|medial retinaculum tear s/p patella dislocation|medial retinaculum tear s/p patella dislocation
5220472|NCT00743860|darapladib|darapladib
5220473|NCT00743860|pharmacokinetics|pharmacokinetics
5220474|NCT00743860|metabolite|metabolite
5220475|NCT00743860|SB-480848|sb-480848
5220476|NCT00743847|schizophrenia, treatment, cognition|schizophrenia, treatment, cognition
5220477|NCT00743808|hypertension|hypertension
5220478|NCT00743808|diabetes|diabetes
5220479|NCT00743808|quality improvement|quality improvement
5220480|NCT00743808|blood pressure|blood pressure
5220481|NCT00743795|Hepatitis C|hepatitis c
5220482|NCT00743795|HCV|hcv
5220483|NCT00743795|Rapid Virologic Response|rapid virologic response
5220484|NCT00743795|Sustained Virologic Response|sustained virologic response
5220485|NCT00743795|HCV RNA|hcv rna
5220486|NCT00743795|Polymerase inhibitor|polymerase inhibitor
5220487|NCT00743795|GS-9190|gs-9190
5220488|NCT00743782|Hypoparathyroidism|hypoparathyroidism
5220489|NCT00743782|Parathyroid Hormone 1-34|parathyroid hormone 1-34
5220490|NCT00743769|Myocardial Infarction|myocardial infarction
5220491|NCT00743769|Myocardial Ischemia|myocardial ischemia
5220492|NCT00743769|Myocardial Diseases|myocardial diseases
5220493|NCT00743769|Infarction|infarction
5220494|NCT00743756|obesity|obesity
5220495|NCT00743756|diabetes|diabetes
5220496|NCT00743756|endothelial function|endothelial function
5220497|NCT00743756|insulin sensitivity|insulin sensitivity
5220498|NCT00743743|dementia|dementia
5220499|NCT00743743|Alzheimer disease|alzheimer disease
5220500|NCT00743743|cognition|cognition
5220501|NCT00743743|function|function
5220502|NCT00743743|behavior|behavior
5220503|NCT00743743|treatment|treatment
5220504|NCT00743730|developmental delay|developmental delay
5220505|NCT00743730|cognitive impairment|cognitive impairment
5220506|NCT00743730|pain control|pain control
5220507|NCT00743730|post operative pain|post operative pain
5220508|NCT00743730|opioid|opioid
5220509|NCT00743730|pain assessment|pain assessment
5220510|NCT00743730|Parent Nurse controlled Analgesic|parent nurse controlled analgesic
5220511|NCT00743730|patient controlled analgesic|patient controlled analgesic
5220512|NCT00743730|children|children
5220513|NCT00743730|pain|pain
5220514|NCT00743730|analgesic|analgesic
5220515|NCT00743730|safety|safety
5220516|NCT00743730|parent satisfaction|parent satisfaction
5220517|NCT00743730|nurse satisfaction|nurse satisfaction
5220518|NCT00743730|Pediatric|pediatric
5220519|NCT00743717|total knee arthroplasty|total knee arthroplasty
5220520|NCT00743717|osteoarthritis|osteoarthritis
5220521|NCT00743717|ceramic bearing|ceramic bearing
5220522|NCT00743717|zirconia|zirconia
5220523|NCT00743691|Ethiopia|ethiopia
5220524|NCT00743691|Community|community
5220525|NCT00743691|Community based|community based
5220526|NCT00743691|Health extension Worker|health extension worker
5220527|NCT00743691|Health Extension Program|health extension program
5220528|NCT00743678|Colorectal Cancer|colorectal cancer
5220529|NCT00743678|Unresectable liver metastasis|unresectable liver metastasis
5220530|NCT00743678|FOLFOX6|folfox6
5220531|NCT00743678|Cetuximab|cetuximab
5220532|NCT00743678|Neoadjuvant therapy|neoadjuvant therapy
5220533|NCT00743665|Youth|youth
5220534|NCT00743665|consensus|consensus
5220535|NCT00743665|criteria|criteria
5220536|NCT00743665|CVS|cvs
5220537|NCT00743652|13 valent Pneumococcal Conjugate Vaccine|13 valent pneumococcal conjugate vaccine
5220538|NCT00743652|Antibody Response|antibody response
5220539|NCT00743652|safety|safety
5220540|NCT00743652|Alaskan Native Children|alaskan native children
5220541|NCT00743639|Cardiomyopathy|cardiomyopathy
5220542|NCT00743639|stem cell|stem cell
5220543|NCT00743639|cardiac failure|cardiac failure
5220544|NCT00743626|Pap test|pap test
5220545|NCT00743626|HPV|hpv
5220546|NCT00743626|Healthy patients screened for cervical cancer tests.|healthy patients screened for cervical cancer tests.
5220547|NCT00743613|Erectile Dysfunction|erectile dysfunction
5220548|NCT00743613|ED|ed
5220549|NCT00743613|Peripheral Arterial Disease|peripheral arterial disease
5220550|NCT00743613|PAD|pad
5220551|NCT00743613|Ankle-Brachial Index|ankle-brachial index
5220552|NCT00743613|ABI|abi
5220553|NCT00743600|ultrasound|ultrasound
5220554|NCT00743600|rotator cuff|rotator cuff
5220557|NCT00743561|ambulatory polygraphy|ambulatory polygraphy
5220558|NCT00743561|polysomnography|polysomnography
5220559|NCT00743548|interdental self-care aids|interdental self-care aids
5220560|NCT00743548|plaque|plaque
5220561|NCT00743548|bleeding gums|bleeding gums
5220562|NCT00743535|Cystocele|cystocele
5220563|NCT00743535|Mesh|mesh
5220564|NCT00743535|Prolapse|prolapse
5220565|NCT00743535|Sling|sling
5220566|NCT00743535|Stress incontinence|stress incontinence
5220567|NCT00743535|Surgery|surgery
5220569|NCT00743535|TVT|tvt
5220570|NCT00743535|Treatment|treatment
5220571|NCT00743522|Reducing shocks|reducing shocks
5220572|NCT00743509|sarcoma|sarcoma
5220573|NCT00743509|Cyclophosphamide|cyclophosphamide
5220574|NCT00743509|Sirolimus|sirolimus
5220575|NCT00743509|Progressive or recurrent, advanced (unresectable or metastatic) high-grade osteosarcoma, Ewing's or soft tissue sarcoma previously treated with chemotherapy.|progressive or recurrent, advanced (unresectable or metastatic) high-grade osteosarcoma, ewing's or soft tissue sarcoma previously treated with chemotherapy.
5220576|NCT00743483|cystic fibrosis|cystic fibrosis
5220577|NCT00743483|pancreatic insufficiency|pancreatic insufficiency
5220578|NCT00743483|bucelipase alfa|bucelipase alfa
5220579|NCT00743483|bile salt stimulating lipase|bile salt stimulating lipase
5220580|NCT00743483|BSSL|bssl
5220581|NCT00743483|coefficient of fat absorption|coefficient of fat absorption
5220582|NCT00743470|HIV co-infected with tuberculosis|hiv co-infected with tuberculosis
5220583|NCT00743457|Possible VPS failure with symptom such as headache|possible vps failure with symptom such as headache
5220584|NCT00743457|vomiting|vomiting
5220585|NCT00743457|lethargy|lethargy
5220586|NCT00743457|VPS failure|vps failure
5220587|NCT00743444|GERD|gerd
5220588|NCT00743444|transient lower esophageal sphincter relaxations (TLESRs)|transient lower esophageal sphincter relaxations (tlesrs)
5220589|NCT00743444|reflux|reflux
5220590|NCT00743405|schizophrenia|schizophrenia
5220591|NCT00743405|M1 receptor agonist|m1 receptor agonist
5220592|NCT00743405|safety|safety
5220593|NCT00743405|pharmacokinetics|pharmacokinetics
5220594|NCT00743405|GSK1034702|gsk1034702
5220595|NCT00743379|Phase 1/2|phase 1/2
5220596|NCT00743379|Advanced Solid Tumors|advanced solid tumors
5220597|NCT00743379|Hypoxia|hypoxia
5220598|NCT00743379|Prodrug|prodrug
5220599|NCT00743379|Dose-Escalation|dose-escalation
5220600|NCT00743379|Evofosfamide|evofosfamide
5220601|NCT00743366|quetiapine|quetiapine
5220602|NCT00743366|smoked marijuana|smoked marijuana
5220603|NCT00743366|marijuana use|marijuana use
5220604|NCT00743353|laryngeal|laryngeal
5220605|NCT00743353|squamous cell|squamous cell
5220606|NCT00743353|anaplastic astrocytoma|anaplastic astrocytoma
5220607|NCT00743353|oligodendroglioma|oligodendroglioma
5220608|NCT00743353|glioblastoma multiforme|glioblastoma multiforme
5220609|NCT00743340|HIV-1 infection|hiv-1 infection
5220610|NCT00743340|emtricitabine|emtricitabine
5220611|NCT00743340|pediatrics|pediatrics
5220612|NCT00743340|pediatric patients|pediatric patients
5220613|NCT00743327|hormone therapy|hormone therapy
5220614|NCT00743314|lymphedema|lymphedema
5220615|NCT00743314|stage I breast cancer|stage i breast cancer
5220616|NCT00743314|stage II breast cancer|stage ii breast cancer
5220617|NCT00743301|CVD|cvd
5220618|NCT00743301|Palm olein|palm olein
5220619|NCT00743301|Olive oil|olive oil
5220620|NCT00743301|Lard|lard
5220621|NCT00743301|healthy men|healthy men
5220622|NCT00743301|metabolic syndrome|metabolic syndrome
5220623|NCT00743301|Risk of cardiovascular disease and metabolic syndrome|risk of cardiovascular disease and metabolic syndrome
5220624|NCT00743288|stage I multiple myeloma|stage i multiple myeloma
5220625|NCT00743288|stage II multiple myeloma|stage ii multiple myeloma
5220626|NCT00743288|stage III multiple myeloma|stage iii multiple myeloma
5220627|NCT00743288|refractory multiple myeloma|refractory multiple myeloma
5220628|NCT00743275|Influenza|influenza
5220629|NCT00743262|laryngectomy|laryngectomy
5220630|NCT00743262|larynx cancer|larynx cancer
5220631|NCT00743249|Dry eye|dry eye
5220632|NCT00743249|Tear duct|tear duct
5220633|NCT00743249|Punctal plug|punctal plug
5220634|NCT00743236|perioperative/postoperative complications|perioperative/postoperative complications
5220635|NCT00743236|urinary complications|urinary complications
5220636|NCT00743236|long-term effects secondary to cancer therapy in adults|long-term effects secondary to cancer therapy in adults
5220637|NCT00743236|stage I renal cell cancer|stage i renal cell cancer
5220638|NCT00743223|temporomandibular disorder|temporomandibular disorder
5220639|NCT00743223|orofacial pain|orofacial pain
5220640|NCT00743223|posture of the head|posture of the head
5220641|NCT00743210|pregnancy|pregnancy
5220642|NCT00743210|obesity|obesity
5220643|NCT00743210|asymmetric dimethylarginine|asymmetric dimethylarginine
5220644|NCT00743210|L-arginine|l-arginine
5220645|NCT00743210|L-citrulline|l-citrulline
5220646|NCT00743197|coronary artery disease (CAD)|coronary artery disease (cad)
5220647|NCT00743197|chest pain|chest pain
5220648|NCT00743197|myocardial ischemia|myocardial ischemia
5220649|NCT00743197|endothelial function|endothelial function
5220650|NCT00743184|BPH|bph
5220651|NCT00743184|LUTS|luts
5220652|NCT00743184|Lower urinary tract symptoms (LUTS)|lower urinary tract symptoms (luts)
5220653|NCT00743171|Lung transplantation|lung transplantation
5220654|NCT00743171|Home spirometry|home spirometry
5220655|NCT00743171|non-adherence|non-adherence
5220656|NCT00743171|outcomes|outcomes
5220657|NCT00743171|bronchiolitis obliterans|bronchiolitis obliterans
5220658|NCT00743158|ztr|ztr
5220659|NCT00743158|transfer impedance|transfer impedance
5220660|NCT00743158|cystic fibrosis|cystic fibrosis
5220661|NCT00743158|pulmonary function test|pulmonary function test
5220662|NCT00743158|pft|pft
5220663|NCT00743145|naltrexone|naltrexone
5220664|NCT00743145|smoked marijuana|smoked marijuana
5220665|NCT00743145|marijuana use|marijuana use
5220666|NCT00743132|evaluation|evaluation
5220667|NCT00743132|incidence|incidence
5220668|NCT00743132|liver surgery|liver surgery
5220669|NCT00743132|resection|resection
5220670|NCT00743132|impact|impact
5220671|NCT00743132|postoperative|postoperative
5220672|NCT00743132|mortality|mortality
5220673|NCT00743119|oral thc|oral thc
5220674|NCT00743119|cannabis|cannabis
5220675|NCT00743119|pain|pain
5220676|NCT00743119|analgesic effects|analgesic effects
5220677|NCT00743119|dronabinol|dronabinol
5220678|NCT00743106|nephrectomy|nephrectomy
5220679|NCT00743106|fenoldopam|fenoldopam
5220680|NCT00743106|atrophic minimally functioning kidney|atrophic minimally functioning kidney
5220681|NCT00743093|acetaminophen|acetaminophen
5220682|NCT00743093|protein adducts|protein adducts
5220683|NCT00743093|drug safety|drug safety
5220684|NCT00743093|alanine aminotransferase|alanine aminotransferase
5220685|NCT00743093|Alanine Amino Transferase|alanine amino transferase
5220686|NCT00743080|laparoscopy|laparoscopy
5220687|NCT00743080|myomectomy|myomectomy
5220688|NCT00743080|myomas|myomas
5220689|NCT00743080|morcellator|morcellator
5220690|NCT00743080|supracervical hysterectomy|supracervical hysterectomy
5220691|NCT00743080|surgery|surgery
5220692|NCT00743080|symptomatic uterine myomas|symptomatic uterine myomas
5220694|NCT00743067|MET inhibitor|met inhibitor
5220695|NCT00743067|GSK1363089|gsk1363089
5220696|NCT00743067|Solid Tumors|solid tumors
5220697|NCT00743067|c-Met|c-met
5220698|NCT00743054|Carcinoma, Renal Cell|carcinoma, renal cell
5220699|NCT00743054|MicroRNAs|micrornas
5220700|NCT00743041|PTSD, EFT, depression, anxiety, telephone|ptsd, eft, depression, anxiety, telephone
5220701|NCT00743028|Other hematological and non-hematological malignancies|other hematological and non-hematological malignancies
5220702|NCT00743002|TT223|tt223
5220703|NCT00742989|osteopathic|osteopathic
5220704|NCT00742989|lymphatic|lymphatic
5220705|NCT00742989|treatment|treatment
5220706|NCT00742989|OLT|olt
5220707|NCT00742989|normal|normal
5220708|NCT00742976|Weight gain in insulin treated type 2 diabetes|weight gain in insulin treated type 2 diabetes
5220709|NCT00742976|extracellular volume|extracellular volume
5220710|NCT00742976|insulin treatment|insulin treatment
5220711|NCT00742976|sodium retention|sodium retention
5220712|NCT00742963|TH-302|th-302
5220713|NCT00742963|Advanced Soft Tissue Sarcoma|advanced soft tissue sarcoma
5220714|NCT00742963|Doxorubicin|doxorubicin
5220715|NCT00742963|Phase 1/2|phase 1/2
5220716|NCT00742950|Corneal incision|corneal incision
5220717|NCT00742950|Cataract surgery|cataract surgery
5220718|NCT00742950|Phacoemulsification|phacoemulsification
5220719|NCT00742950|Surgically induced astigmatism|surgically induced astigmatism
5220720|NCT00742950|Corneal Topography|corneal topography
5220721|NCT00742937|Hypovitaminosis A|hypovitaminosis a
5220722|NCT00742924|metastatic osteosarcoma|metastatic osteosarcoma
5220723|NCT00742911|Solid Tumors, Liver|solid tumors, liver
5220724|NCT00742898|Quasi-experimental design|quasi-experimental design
5220725|NCT00742898|Non-targeted opt-out rapid HIV screening|non-targeted opt-out rapid hiv screening
5220726|NCT00742898|Diagnostic rapid HIV testing|diagnostic rapid hiv testing
5220727|NCT00742898|Emergency department|emergency department
5220728|NCT00742898|Effectiveness|effectiveness
5220729|NCT00742898|Efficiency|efficiency
5220730|NCT00742898|Health services research|health services research
5220731|NCT00742898|Program evaluation|program evaluation
5220732|NCT00742898|Effectiveness and efficiency of non-targeted rapid HIV screening in the ED|effectiveness and efficiency of non-targeted rapid hiv screening in the ed
5220733|NCT00742885|Immunogenicity|immunogenicity
5220734|NCT00742885|Safety|safety
5220735|NCT00742885|Pandemic Influenza|pandemic influenza
5220736|NCT00742872|Mosapride|mosapride
5220737|NCT00742872|Irritable Bowel Syndrome|irritable bowel syndrome
5220738|NCT00742872|Constipation|constipation
5220739|NCT00742859|Atrial Fibrillation|atrial fibrillation
5220740|NCT00742859|Betrixaban|betrixaban
5220741|NCT00742859|Factor Xa inhibitor|factor xa inhibitor
5220742|NCT00742859|Warfarin|warfarin
5220743|NCT00742846|Adhesive Capsulitis|adhesive capsulitis
5220744|NCT00742846|Subacromial injection|subacromial injection
5220745|NCT00742846|Intraarticular injection|intraarticular injection
5220746|NCT00742833|Overactive bladder|overactive bladder
5220747|NCT00742833|Frequency|frequency
5220748|NCT00742833|Micturition|micturition
5220749|NCT00742833|Urgency|urgency
5220750|NCT00742833|Urge urinary incontinence|urge urinary incontinence
5220751|NCT00742833|β3-agonist|β3-agonist
5220752|NCT00742820|bioequivalence|bioequivalence
5220753|NCT00742807|sensation|sensation
5220754|NCT00742807|relief|relief
5220755|NCT00742807|during|during
5220756|NCT00742807|surgery|surgery
5220757|NCT00742781|Crohn's|crohn's
5220758|NCT00742781|vitamin D|vitamin d
5220759|NCT00742768|absorption|absorption
5220760|NCT00742768|encapsulation|encapsulation
5220761|NCT00742768|menaquinone|menaquinone
5220762|NCT00742768|Bio-availability|bio-availability
5220763|NCT00742755|Follow-up of breast abnormalities|follow-up of breast abnormalities
5220764|NCT00742755|Korean American immigrants|korean american immigrants
5220765|NCT00742742|Walnut|walnut
5220766|NCT00742742|Lipids|lipids
5220767|NCT00742742|Blood Glucose|blood glucose
5220768|NCT00742729|Colorectal cancer screening|colorectal cancer screening
5220769|NCT00742729|Fecal occult blood test|fecal occult blood test
5220770|NCT00742729|Endoscopies|endoscopies
5220771|NCT00742729|Filipino American immigrants|filipino american immigrants
5220772|NCT00742729|Community based organizations and churches|community based organizations and churches
5220773|NCT00742716|Parathyroid Diseases|parathyroid diseases
5220774|NCT00742716|Renal Insufficiency|renal insufficiency
5220775|NCT00742716|Kidney Failure, Chronic|kidney failure, chronic
5220776|NCT00742716|Hyperparathyroidism, Secondary|hyperparathyroidism, secondary
5220777|NCT00742716|Vitamin D|vitamin d
5220778|NCT00742716|Hyperparathyroidism|hyperparathyroidism
5220779|NCT00742716|Renal Insufficiency, Chronic|renal insufficiency, chronic
5220780|NCT00742716|Kidney Diseases|kidney diseases
5220781|NCT00742716|Kidney Failure|kidney failure
5220782|NCT00742690|cirrhosis|cirrhosis
5220783|NCT00742690|type 1 hepatorenal syndrome|type 1 hepatorenal syndrome
5220784|NCT00742690|terlipressin|terlipressin
5220785|NCT00742690|albumin|albumin
5220786|NCT00742690|effective circulating volume|effective circulating volume
5220787|NCT00742690|Patients|patients
5220788|NCT00742690|with|with
5220789|NCT00742677|female reproductive cancer|female reproductive cancer
5220790|NCT00742664|Prader-Willi Syndrome|prader-willi syndrome
5220791|NCT00742664|Compulsive behavior|compulsive behavior
5220792|NCT00742664|Hoarding|hoarding
5220793|NCT00742664|Obsessive-compulsive disorder|obsessive-compulsive disorder
5220794|NCT00742664|Children|children
5220795|NCT00742664|Treatment|treatment
5220796|NCT00742664|genetically|genetically
5220797|NCT00742664|confirmed|confirmed
5220798|NCT00742664|diagnosis|diagnosis
5220799|NCT00742638|CCMD-3,|ccmd-3,
5220800|NCT00742638|CRF,|crf,
5220801|NCT00742638|EPS,|eps,
5220802|NCT00742638|GCP,|gcp,
5220803|NCT00742638|ICH,|ich,
5220804|NCT00742638|ITT,|itt,
5220805|NCT00742638|LOCF,|locf,
5220806|NCT00742638|MADRS,|madrs,
5220807|NCT00742638|PANSS,|panss,
5220808|NCT00742638|YMRS.|ymrs.
5220809|NCT00742638|Acute|acute
5220810|NCT00742638|manic|manic
5220811|NCT00742638|patients|patients
5220812|NCT00742638|with|with
5220813|NCT00742638|bipolar|bipolar
5220814|NCT00742638|disorder|disorder
5220815|NCT00742612|Carotid Endarterectomy|carotid endarterectomy
5220816|NCT00742612|von Willebrand Factor|von willebrand factor
5220817|NCT00742612|Microembolic Signal|microembolic signal
5220818|NCT00742599|Stomach Diseases|stomach diseases
5220819|NCT00742586|Gene Expression Changes in Blood Cells|gene expression changes in blood cells
5220820|NCT00742586|RNA|rna
5220821|NCT00742586|Pure Autonomic Failure|pure autonomic failure
5220822|NCT00742586|Multiply System Atrophy|multiply system atrophy
5220823|NCT00742586|Parkinson's Plus|parkinson's plus
5220824|NCT00742573|Major Depressive Disorder|major depressive disorder
5220825|NCT00742573|Mood Disorders|mood disorders
5220826|NCT00742573|Hispanic|hispanic
5220827|NCT00742560|Multiple Myeloma|multiple myeloma
5220828|NCT00742547|prevention|prevention
5220829|NCT00742547|health services research|health services research
5220830|NCT00742534|Bronchopulmonary Dysplasia|bronchopulmonary dysplasia
5220831|NCT00742534|Prematurity|prematurity
5220832|NCT00742534|Lung Disease|lung disease
5220833|NCT00742534|preterm infants|preterm infants
5220834|NCT00742521|cortisol|cortisol
5220835|NCT00742521|catecholamines|catecholamines
5220836|NCT00742521|Type 1 DM|type 1 dm
5220837|NCT00742508|carvedilol phosphate|carvedilol phosphate
5220838|NCT00742508|ß-blocker|ß-blocker
5220839|NCT00742508|SK&F-105517-D|sk&f-105517-d
5220840|NCT00742508|Chronic heart failure(CHF)|chronic heart failure(chf)
5220841|NCT00742469|TD|td
5220842|NCT00742469|traveller's diarrhea|traveller's diarrhea
5220843|NCT00742469|campylobacter|campylobacter
5220844|NCT00742469|shigella|shigella
5220845|NCT00742469|salmonella|salmonella
5220846|NCT00742469|E. coli|e. coli
5220847|NCT00742469|diarrhea|diarrhea
5220848|NCT00742456|Microcirculation|microcirculation
5220849|NCT00742456|Insulin|insulin
5220850|NCT00742456|Hypertension|hypertension
5220851|NCT00742456|Obesity|obesity
5220852|NCT00742443|Scar Revision|scar revision
5220853|NCT00742430|aspirin resistance|aspirin resistance
5220854|NCT00742430|coronary artery disease|coronary artery disease
5220855|NCT00742430|clopidogrel resistance|clopidogrel resistance
5220856|NCT00742430|major adverse cardiac events|major adverse cardiac events
5220857|NCT00742430|multiplate platelet function analyser|multiplate platelet function analyser
5220858|NCT00742430|percutaneous coronary intervention|percutaneous coronary intervention
5220859|NCT00742417|Alzheimer's|alzheimer's
5220860|NCT00742417|Dementia|dementia
5220861|NCT00742417|Senile|senile
5220862|NCT00742417|Loss of cognitive abilities|loss of cognitive abilities
5220863|NCT00742417|Old age|old age
5220864|NCT00742417|Elderly|elderly
5220865|NCT00742417|Aging|aging
5220866|NCT00742417|Albumin|albumin
5220867|NCT00742417|Caregiver|caregiver
5220868|NCT00742417|amyloid|amyloid
5220869|NCT00742417|beta amyloid|beta amyloid
5220870|NCT00742417|Central Nervous System Diseases|central nervous system diseases
5220871|NCT00742417|Brain Disease|brain disease
5220872|NCT00742417|Mental Disorders|mental disorders
5220873|NCT00742417|Plasma Exchange|plasma exchange
5220874|NCT00742404|stage I multiple myeloma|stage i multiple myeloma
5220875|NCT00742404|stage II multiple myeloma|stage ii multiple myeloma
5220876|NCT00742404|stage III multiple myeloma|stage iii multiple myeloma
5220877|NCT00742391|Peplin|peplin
5220878|NCT00742391|Actinic keratosis|actinic keratosis
5220879|NCT00742391|PEP005|pep005
5220880|NCT00742378|Glaucoma|glaucoma
5220881|NCT00742378|Retinal nerve fiber layer|retinal nerve fiber layer
5220882|NCT00742378|Cirrus OCT|cirrus oct
5220883|NCT00742365|Seasonal Affective Disorder|seasonal affective disorder
5220884|NCT00742365|Light Therapy|light therapy
5220885|NCT00742365|Seasonal Depression|seasonal depression
5220886|NCT00742365|Psychiatric Disorder|psychiatric disorder
5220887|NCT00742365|Bright Light|bright light
5220888|NCT00742365|Major Depressive Disorder|major depressive disorder
5220889|NCT00742365|Bipolar Disorder|bipolar disorder
5220890|NCT00742339|cirrhosis|cirrhosis
5220891|NCT00742339|hepatorenal syndrome|hepatorenal syndrome
5220892|NCT00742339|terlipressin|terlipressin
5220893|NCT00742339|midodrine|midodrine
5220894|NCT00742339|octreotide|octreotide
5220895|NCT00742339|human albumin|human albumin
5220896|NCT00742339|effective circulating volume|effective circulating volume
5220897|NCT00742339|The criteria which will be used for the diagnosis of HRS will be the criteria which were recently published by the International Ascites Club|the criteria which will be used for the diagnosis of hrs will be the criteria which were recently published by the international ascites club
5220898|NCT00742339|Patients with cirrhosis and type 2 HRS only with serum creatinine value > 2.5 mg/dl|patients with cirrhosis and type 2 hrs only with serum creatinine value > 2.5 mg/dl
5220899|NCT00742339|All patients with cirrhosis and type 1 HRS|all patients with cirrhosis and type 1 hrs
5220900|NCT00742326|HIV|hiv
5220901|NCT00742326|Hepatitis C|hepatitis c
5220902|NCT00742326|Liver Disease|liver disease
5220903|NCT00742326|Fatty Liver|fatty liver
5220904|NCT00742326|Steatosis|steatosis
5220905|NCT00742313|Endoscopic|endoscopic
5220906|NCT00742313|saphenous|saphenous
5220907|NCT00742313|vein|vein
5220908|NCT00742313|harvest|harvest
5220909|NCT00742300|ASCT|asct
5220910|NCT00742300|Tolerance induction|tolerance induction
5220911|NCT00742300|SLE|sle
5220912|NCT00742300|Transplantation|transplantation
5220913|NCT00742300|Autoimmune diseases|autoimmune diseases
5220914|NCT00742287|smoking|smoking
5220915|NCT00742287|oligomeric proanthocyanidins|oligomeric proanthocyanidins
5220916|NCT00742287|polyphenols|polyphenols
5220917|NCT00742287|supplementation|supplementation
5220918|NCT00742287|vascular function|vascular function
5220919|NCT00742287|oxidative stress|oxidative stress
5220920|NCT00742287|inflammation|inflammation
5220921|NCT00742261|Pharmacokinetics|pharmacokinetics
5220922|NCT00742261|Safety|safety
5220923|NCT00742261|MET|met
5220924|NCT00742261|Bioavailability|bioavailability
5220925|NCT00742261|Patients|patients
5220926|NCT00742261|GSK1363089A|gsk1363089a
5220927|NCT00742261|GSK1363089G|gsk1363089g
5220928|NCT00742261|GSK1363089|gsk1363089
5220929|NCT00742261|Relative|relative
5220930|NCT00742248|COPD|copd
5220931|NCT00742222|Electronic brachytherapy registry|electronic brachytherapy registry
5220932|NCT00742222|Multi-society registry|multi-society registry
5220933|NCT00742222|Breast cancer registry|breast cancer registry
5220934|NCT00742209|migraine|migraine
5220935|NCT00742209|prophylaxis|prophylaxis
5220936|NCT00742209|prevention|prevention
5220937|NCT00742196|Parapapillary atrophy|parapapillary atrophy
5220938|NCT00742196|Retinal nerve fiber layer thickness|retinal nerve fiber layer thickness
5220939|NCT00742196|Glaucoma|glaucoma
5220940|NCT00742196|Cirrus OCT|cirrus oct
5220941|NCT00742170|opioid dependence|opioid dependence
5220942|NCT00742170|opioid detoxification|opioid detoxification
5220943|NCT00742170|electroacupuncture|electroacupuncture
5220944|NCT00742170|adjunctive treatment|adjunctive treatment
5220945|NCT00742170|alternative/complementary medicine|alternative/complementary medicine
5220946|NCT00742157|Growth Hormone|growth hormone
5220947|NCT00742157|TPN|tpn
5220948|NCT00742157|Total Parenteral Nutrition|total parenteral nutrition
5220949|NCT00742157|Glutamine|glutamine
5220950|NCT00742157|Short Bowel Syndrome|short bowel syndrome
5220951|NCT00742157|Increase in absorption of small bowel.|increase in absorption of small bowel.
5220952|NCT00742144|CD20 positive|cd20 positive
5220953|NCT00742144|Chronic lymphocytic leukemia|chronic lymphocytic leukemia
5220954|NCT00742144|Follicular lymphoma|follicular lymphoma
5220955|NCT00742144|GSK1841157|gsk1841157
5220956|NCT00742144|Japanese patient|japanese patient
5220957|NCT00742144|Ofatumumab|ofatumumab
5220958|NCT00742131|MET inhibitor|met inhibitor
5220959|NCT00742131|c-Met|c-met
5220960|NCT00742131|XL880|xl880
5220961|NCT00742131|GSK1363089|gsk1363089
5220962|NCT00742131|Solid Tumors|solid tumors
5220963|NCT00742105|PI3K|pi3k
5220964|NCT00742105|mTOR|mtor
5220965|NCT00742105|Advanced solid tumor|advanced solid tumor
5220966|NCT00742105|Adult|adult
5220967|NCT00742079|Paranoid Schizophrenia|paranoid schizophrenia
5220968|NCT00742079|Paranoid Delusions|paranoid delusions
5220969|NCT00742079|CBT|cbt
5220970|NCT00742079|D-Cycloserine|d-cycloserine
5220971|NCT00742066|Hypertension|hypertension
5220972|NCT00742066|Insulin resistance|insulin resistance
5220973|NCT00742066|Microcirculation|microcirculation
5220974|NCT00742066|Angiotensin II receptor blocker|angiotensin ii receptor blocker
5220975|NCT00742053|ECG PICC|ecg picc
5220976|NCT00742053|Patients undergoing PICC placement|patients undergoing picc placement
5220977|NCT00742040|up-titration|up-titration
5220978|NCT00742040|captopril|captopril
5220979|NCT00742040|pediatric|pediatric
5220980|NCT00742040|cardiac patients|cardiac patients
5220981|NCT00742027|Classical Hodgkin Lymphoma|classical hodgkin lymphoma
5220982|NCT00742027|Classical Hodgkin's Lymphoma|classical hodgkin's lymphoma
5220983|NCT00742027|Hodgkin Lymphoma|hodgkin lymphoma
5220984|NCT00742027|Hodgkin's Lymphoma|hodgkin's lymphoma
5220985|NCT00742027|Nodular sclerosing|nodular sclerosing
5220986|NCT00742027|Mixed-cellularity|mixed-cellularity
5220987|NCT00742027|Lymphocyte-rich|lymphocyte-rich
5220988|NCT00742027|Lymphocyte depleted|lymphocyte depleted
5220989|NCT00742027|HL|hl
5220990|NCT00742027|Classical HL|classical hl
5220991|NCT00742027|Refractory Hodgkin's Lymphoma|refractory hodgkin's lymphoma
5220992|NCT00742027|Refractory Hodgkin Lymphoma|refractory hodgkin lymphoma
5220993|NCT00742027|Refractory HL|refractory hl
5220994|NCT00742014|Pulmonary arterial hypertension|pulmonary arterial hypertension
5220995|NCT00742014|Pediatrics|pediatrics
5220996|NCT00742014|Sildenafil|sildenafil
5220997|NCT00742014|Catheterization|catheterization
5220998|NCT00742014|Right ventricular contractility|right ventricular contractility
5220999|NCT00742001|red blood cells|red blood cells
5221000|NCT00742001|transfusion|transfusion
5221001|NCT00742001|recovery|recovery
5221002|NCT00742001|feasibility|feasibility
5221003|NCT00742001|white blood cell inactivation|white blood cell inactivation
5221004|NCT00741988|Non-Small Cell Lung Cancer|non-small cell lung cancer
5221005|NCT00741988|Advanced Disease|advanced disease
5221006|NCT00741988|Untreated|untreated
5221007|NCT00741988|Ixabepilone|ixabepilone
5221008|NCT00741988|Carboplatin|carboplatin
5221009|NCT00741988|Bevacizumab|bevacizumab
5221010|NCT00741975|HIV prevention|hiv prevention
5221011|NCT00741949|Respiratory failure|respiratory failure
5221012|NCT00741949|Target Controlled Infusion|target controlled infusion
5221013|NCT00741949|TCI|tci
5221014|NCT00741949|Propofol|propofol
5221015|NCT00741949|Noninvasive ventilation|noninvasive ventilation
5221016|NCT00741949|Broncho-alveolar lavage|broncho-alveolar lavage
5221017|NCT00741936|Functional Constipation|functional constipation
5221018|NCT00741936|Chinese Herbal Medicine|chinese herbal medicine
5221019|NCT00741936|MaZiRenWan|mazirenwan
5221020|NCT00741936|Hemp Seed Pill|hemp seed pill
5221021|NCT00741936|Traditional Chinese Medicine|traditional chinese medicine
5221022|NCT00741936|Herbal Medicine|herbal medicine
5221023|NCT00741923|beans|beans
5221024|NCT00741923|pulses|pulses
5221025|NCT00741923|satiety|satiety
5221026|NCT00741923|appetite|appetite
5221027|NCT00741923|obesity|obesity
5221028|NCT00741923|overweight|overweight
5221029|NCT00741923|diabetes|diabetes
5221030|NCT00741923|metabolic syndrome|metabolic syndrome
5221031|NCT00741923|hypertension|hypertension
5221032|NCT00741923|blood glucose|blood glucose
5221033|NCT00741923|insulin|insulin
5221034|NCT00741923|cholesterol|cholesterol
5221035|NCT00741923|HDL|hdl
5221036|NCT00741923|LDL|ldl
5221037|NCT00741923|leptin|leptin
5221038|NCT00741923|GLP-1|glp-1
5221039|NCT00741923|adiponectin|adiponectin
5221040|NCT00741923|Peptide YY|peptide yy
5221041|NCT00741923|diet|diet
5221042|NCT00741910|Crohn's Disease|crohn's disease
5221043|NCT00741910|TNF-alpha inhibitor|tnf-alpha inhibitor
5221044|NCT00741910|MAP Kinase inhibitor|map kinase inhibitor
5221045|NCT00741910|CNI-1493|cni-1493
5221046|NCT00741871|Lymphoid malignancies|lymphoid malignancies
5221047|NCT00741871|Hodgkin's Lymphoma|hodgkin's lymphoma
5221048|NCT00741871|Diffuse large B cell lymphoma|diffuse large b cell lymphoma
5221049|NCT00741858|Chiari malformation;|chiari malformation;
5221050|NCT00741858|Duraplasty;|duraplasty;
5221051|NCT00741858|Posterior fossa decompression;|posterior fossa decompression;
5221052|NCT00741858|Duragen;|duragen;
5221053|NCT00741858|Duraguard|duraguard
5221054|NCT00741832|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
5221055|NCT00741832|dynamic hyperinflation|dynamic hyperinflation
5221056|NCT00741832|dyspnea|dyspnea
5221057|NCT00741832|recovery|recovery
5221058|NCT00741832|positive expiratory pressure|positive expiratory pressure
5221059|NCT00741832|exercise|exercise
5221060|NCT00741819|pulmonary arterial hypertension|pulmonary arterial hypertension
5221061|NCT00741819|PAH|pah
5221062|NCT00741819|treprostinil sodium|treprostinil sodium
5221063|NCT00741819|inhalation|inhalation
5221064|NCT00741819|ventavis|ventavis
5221065|NCT00741819|iloprost|iloprost
5221066|NCT00741806|vaccination|vaccination
5221067|NCT00741806|avian|avian
5221068|NCT00741793|Rheumatoid arthritis; psoriatic arthritis; axial spondyloarthritis|rheumatoid arthritis; psoriatic arthritis; axial spondyloarthritis
5221069|NCT00741793|Remicade®|remicade®
5221070|NCT00741793|Simponi®|simponi®
5221071|NCT00741793|Simponi® I.V|simponi® i.v
5221072|NCT00741793|Stelara®|stelara®
5221073|NCT00741793|Registry|registry
5221074|NCT00741793|BioTRAC|biotrac
5221075|NCT00741767|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5221076|NCT00741767|COPD|copd
5221077|NCT00741767|Sleep|sleep
5221078|NCT00741767|Sleep quality|sleep quality
5221079|NCT00741767|Lung hyperinflation|lung hyperinflation
5221080|NCT00741754|salivary flow|salivary flow
5221081|NCT00741754|oral neoplasm|oral neoplasm
5221082|NCT00741754|calcium hydroxide|calcium hydroxide
5221083|NCT00741754|sodium dodecylsulphate|sodium dodecylsulphate
5221084|NCT00741754|radiotherapy.|radiotherapy.
5221085|NCT00741741|TMC278-C150|tmc278-c150
5221086|NCT00741741|TMC278-TiDP15-C150|tmc278-tidp15-c150
5221087|NCT00741741|HIV-1 infected patients|hiv-1 infected patients
5221088|NCT00741741|Intramuscular or subcutaneous injection|intramuscular or subcutaneous injection
5221089|NCT00741741|Nanosuspension|nanosuspension
5221090|NCT00741741|Therapy|therapy
5221091|NCT00741741|Prevention|prevention
5221092|NCT00741741|Healthy volunteers|healthy volunteers
5221093|NCT00741741|HIV Infections|hiv infections
5221094|NCT00741728|epidemiology|epidemiology
5221095|NCT00741728|risk factors|risk factors
5221096|NCT00741728|heart rate|heart rate
5221097|NCT00741728|baroreflex sensitivity|baroreflex sensitivity
5221098|NCT00741728|sudden death|sudden death
5221099|NCT00741715|primary hypercholesterolemia|primary hypercholesterolemia
5221100|NCT00741702|Hypertension|hypertension
5221101|NCT00741702|Type 2 diabetes|type 2 diabetes
5221102|NCT00741702|First Nations populations|first nations populations
5221103|NCT00741689|Japanese|japanese
5221104|NCT00741689|healthy|healthy
5221105|NCT00741689|volunteers|volunteers
5221106|NCT00741663|cirrhosis|cirrhosis
5221107|NCT00741663|ascites|ascites
5221108|NCT00741663|diuretic therapy|diuretic therapy
5221109|NCT00741663|potassium canrenoate|potassium canrenoate
5221110|NCT00741663|furosemide|furosemide
5221111|NCT00741663|hyperkalemia|hyperkalemia
5221112|NCT00741663|plasma renin activity|plasma renin activity
5221113|NCT00741663|nitric oxide|nitric oxide
5221114|NCT00741663|serum sodium concentration|serum sodium concentration
5221115|NCT00741663|refractory ascites|refractory ascites
5221116|NCT00741663|Nonazotemic patients with cirrhosis and moderate ascites|nonazotemic patients with cirrhosis and moderate ascites
5221117|NCT00741650|Musculoskeletal pain|musculoskeletal pain
5221118|NCT00741650|Brief cognitive intervention|brief cognitive intervention
5221119|NCT00741650|Cognitive behavior therapy|cognitive behavior therapy
5221120|NCT00741650|Intervention Study|intervention study
5221121|NCT00741650|Health prevention|health prevention
5221122|NCT00741650|workplace intervention|workplace intervention
5221123|NCT00741637|Vibrio Cholerae|vibrio cholerae
5221124|NCT00741637|Diarrhea|diarrhea
5221125|NCT00741637|Live oral Vaccines|live oral vaccines
5221126|NCT00741637|Immunogenicity|immunogenicity
5221127|NCT00741637|Safety|safety
5221128|NCT00741637|HIV|hiv
5221129|NCT00741624|refractive surgery|refractive surgery
5221130|NCT00741585|Ambulatory blood pressure monitoring|ambulatory blood pressure monitoring
5221131|NCT00741585|Chronotherapy|chronotherapy
5221132|NCT00741585|Circadian|circadian
5221133|NCT00741585|Non-dipper|non-dipper
5221134|NCT00741585|Type 2 diabetes|type 2 diabetes
5221135|NCT00741585|Resistant hypertension|resistant hypertension
5221136|NCT00741585|Total mortality|total mortality
5221137|NCT00741572|sarcoidosis|sarcoidosis
5221138|NCT00741572|fibrosis|fibrosis
5221139|NCT00741572|oxidative stress|oxidative stress
5221140|NCT00741572|inflammation|inflammation
5221141|NCT00741572|triggers|triggers
5221142|NCT00741572|individual sensitivity|individual sensitivity
5221143|NCT00741559|epilepsy|epilepsy
5221144|NCT00741559|pediatrics|pediatrics
5221145|NCT00741559|magnetoencephalography|magnetoencephalography
5221146|NCT00741559|electroencephalography|electroencephalography
5221147|NCT00741559|positron emission tomography|positron emission tomography
5221148|NCT00741546|Vitamin D|vitamin d
5221149|NCT00741546|malnutrition|malnutrition
5221150|NCT00741546|cardiac surgery|cardiac surgery
5221151|NCT00741546|study|study
5221152|NCT00741546|emphasize|emphasize
5221153|NCT00741546|importance|importance
5221154|NCT00741546|significant|significant
5221155|NCT00741546|high risk patient|high risk patient
5221156|NCT00741520|Obstructive Sleep Apnea|obstructive sleep apnea
5221157|NCT00741520|Blood Pressure|blood pressure
5221158|NCT00741520|PreHypertension|prehypertension
5221159|NCT00741520|Masked Hypertension|masked hypertension
5221160|NCT00741507|Anesthetics|anesthetics
5221161|NCT00741507|Sedatives|sedatives
5221162|NCT00741507|Analgesics|analgesics
5221163|NCT00741494|infertility|infertility
5221164|NCT00741494|ICSI|icsi
5221165|NCT00741494|hyaluronan binding|hyaluronan binding
5221166|NCT00741494|sperm|sperm
5221167|NCT00741494|sperm selection|sperm selection
5221168|NCT00741494|male factor|male factor
5221169|NCT00741494|hyaluronan|hyaluronan
5221170|NCT00741494|sperm maturity|sperm maturity
5221171|NCT00741494|clinical pregnancy rates|clinical pregnancy rates
5221172|NCT00741494|hyaluronan binding assay|hyaluronan binding assay
5221173|NCT00741494|HBA|hba
5221174|NCT00741494|PICSI|picsi
5221175|NCT00741481|metastatic colorectal cancer|metastatic colorectal cancer
5221176|NCT00741481|fdg pet|fdg pet
5221177|NCT00741481|response evaluation|response evaluation
5221178|NCT00741468|Drug-drug interactions|drug-drug interactions
5221179|NCT00741468|DDI|ddi
5221180|NCT00741455|Non-myeloablative transplant|non-myeloablative transplant
5221181|NCT00741455|Chronic Myelogenous Leukemia|chronic myelogenous leukemia
5221182|NCT00741455|Acute Myelogenous Leukemia|acute myelogenous leukemia
5221183|NCT00741455|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
5221184|NCT00741455|Multiple Myeloma|multiple myeloma
5221185|NCT00741455|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
5221186|NCT00741455|Myelodysplastic syndrome|myelodysplastic syndrome
5221187|NCT00741455|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
5221188|NCT00741455|Hodgkin's Disease|hodgkin's disease
5221189|NCT00741416|Heart Disease|heart disease
5221190|NCT00741416|Biorepository|biorepository
5221191|NCT00741416|Biobank|biobank
5221192|NCT00741403|Phase I|phase i
5221193|NCT00741403|malignancies|malignancies
5221194|NCT00741403|refractory|refractory
5221195|NCT00741403|relapsed|relapsed
5221196|NCT00741390|Diabetes|diabetes
5221197|NCT00741390|Lancets|lancets
5221198|NCT00741390|Pain|pain
5221199|NCT00741377|Multiple myeloma|multiple myeloma
5221200|NCT00741377|bone disease|bone disease
5221201|NCT00741377|antibody|antibody
5221202|NCT00741364|vitamin D|vitamin d
5221203|NCT00741364|prostate cancer|prostate cancer
5221204|NCT00741364|prostatectomy|prostatectomy
5221205|NCT00741364|pathology|pathology
5221206|NCT00741364|immunohistochemistry|immunohistochemistry
5221207|NCT00741351|Anesthesia|anesthesia
5221208|NCT00741351|Craniotomy|craniotomy
5221209|NCT00741351|Neurosurgery|neurosurgery
5221210|NCT00741338|MPS I, Mucopolysaccharidosis, Hurler syndrome|mps i, mucopolysaccharidosis, hurler syndrome
5221211|NCT00741312|pregnancy|pregnancy
5221212|NCT00741312|preeclampsia|preeclampsia
5221213|NCT00741312|exercise|exercise
5221214|NCT00741299|bipolar affective disorder, Smoking|bipolar affective disorder, smoking
5221215|NCT00741286|Cerebral infarction|cerebral infarction
5221216|NCT00741286|Cilostazol|cilostazol
5221217|NCT00741286|Aspirin|aspirin
5221218|NCT00741286|Transcranial Doppler|transcranial doppler
5221219|NCT00741286|Pulsatile Index|pulsatile index
5221220|NCT00741260|Solid Tumor|solid tumor
5221221|NCT00741260|erbB2+ Breast Cancer|erbb2+ breast cancer
5221222|NCT00741260|Prior trastuzumab|prior trastuzumab
5221223|NCT00741260|Metastatic|metastatic
5221224|NCT00741260|Neratinib|neratinib
5221225|NCT00741260|HKI-272|hki-272
5221226|NCT00741260|Nerlynx|nerlynx
5221227|NCT00741260|HER2|her2
5221228|NCT00741260|PB-272|pb-272
5221229|NCT00741247|staging|staging
5221230|NCT00741247|Endobronchial ultrasound|endobronchial ultrasound
5221231|NCT00741247|Endoscopic ultrasound|endoscopic ultrasound
5221232|NCT00741234|SB939|sb939
5221233|NCT00741234|Myelodysplastic Syndrome|myelodysplastic syndrome
5221234|NCT00741234|Combination with azacitidine|combination with azacitidine
5221235|NCT00741234|Solid malignancies|solid malignancies
5221236|NCT00741234|Hematologic malignancies|hematologic malignancies
5221237|NCT00741234|HDAC inhibitor|hdac inhibitor
5221238|NCT00741234|Refractory to standard therapy|refractory to standard therapy
5221239|NCT00741221|Cancer|cancer
5221240|NCT00741221|NSCLC|nsclc
5221241|NCT00741221|Docetaxel|docetaxel
5221242|NCT00741221|Bevacizumab|bevacizumab
5221243|NCT00741208|asthma|asthma
5221244|NCT00741208|soy isoflavone|soy isoflavone
5221245|NCT00741208|genistein|genistein
5221246|NCT00741208|soy|soy
5221247|NCT00741195|Cancer|cancer
5221248|NCT00741195|NSCLC|nsclc
5221249|NCT00741195|Docetaxel|docetaxel
5221250|NCT00741195|Bevacizumab|bevacizumab
5221251|NCT00741182|Fracture|fracture
5221252|NCT00741182|Osteoporosis|osteoporosis
5221253|NCT00741182|Forsteo|forsteo
5221254|NCT00741182|Teriparatide|teriparatide
5221255|NCT00741182|Fracture healing|fracture healing
5221256|NCT00741169|TMC435350-TiDP16-C105|tmc435350-tidp16-c105
5221257|NCT00741169|TMC435350-C105|tmc435350-c105
5221258|NCT00741169|Hepatitis C|hepatitis c
5221259|NCT00741169|HCV|hcv
5221260|NCT00741169|Rifampin|rifampin
5221261|NCT00741156|pediatric|pediatric
5221262|NCT00741156|hypertension|hypertension
5221263|NCT00741156|congestive cardiomyopathy|congestive cardiomyopathy
5221264|NCT00741156|angiotensin-converting enzyme inhibitor|angiotensin-converting enzyme inhibitor
5221265|NCT00741156|cardiac catheterization|cardiac catheterization
5221266|NCT00741143|Food Fortification|food fortification
5221267|NCT00741143|Iron deficiency|iron deficiency
5221268|NCT00741143|NaFeEdta|nafeedta
5221269|NCT00741143|Iron deficiency anemia|iron deficiency anemia
5221270|NCT00741143|Cognition|cognition
5221271|NCT00741130|retinal nerve fiber layer|retinal nerve fiber layer
5221272|NCT00741130|optic nerve head|optic nerve head
5221273|NCT00741130|Cirrus OCT|cirrus oct
5221274|NCT00741117|Pulse Oximetry|pulse oximetry
5221275|NCT00741117|Blood Gas Analysis|blood gas analysis
5221276|NCT00741117|Liver Disease|liver disease
5221277|NCT00741117|Hyperbilirubinemia|hyperbilirubinemia
5221278|NCT00741091|Cerebrovascular Disease|cerebrovascular disease
5221279|NCT00741091|Carotid Stent|carotid stent
5221280|NCT00741091|Stent|stent
5221281|NCT00741091|Carotid Endarterectomy (CEA)|carotid endarterectomy (cea)
5221282|NCT00741078|endothelial|endothelial
5221283|NCT00741078|function|function
5221284|NCT00741078|insulin|insulin
5221285|NCT00741078|sensitivity|sensitivity
5221286|NCT00741065|Coronary Artery Bypass Grafting|coronary artery bypass grafting
5221287|NCT00741065|Myocardial Regeneration|myocardial regeneration
5221288|NCT00741052|V. cholerae,|v. cholerae,
5221289|NCT00741052|ciprofloxacin,|ciprofloxacin,
5221290|NCT00741052|azithromycin,|azithromycin,
5221291|NCT00741052|randomized|randomized
5221292|NCT00741039|Breast|breast
5221293|NCT00741039|Lung|lung
5221294|NCT00741039|Prostate|prostate
5221295|NCT00741039|Vaccine|vaccine
5221296|NCT00741026|Insulin Resistance|insulin resistance
5221297|NCT00741026|Diabetes mellitus|diabetes mellitus
5221298|NCT00741026|Antipsychotic|antipsychotic
5221299|NCT00741013|randomized|randomized
5221300|NCT00741013|positron emission tomography|positron emission tomography
5221301|NCT00741013|lung inflammation|lung inflammation
5221302|NCT00741013|lovastatin|lovastatin
5221303|NCT00741013|recombinant human activated protein C|recombinant human activated protein c
5221304|NCT00741013|endotoxin|endotoxin
5221305|NCT00741013|fluorodeoxyglucose|fluorodeoxyglucose
5221306|NCT00740987|Mechanical device|mechanical device
5221307|NCT00740987|Intermittent pneumatic compression|intermittent pneumatic compression
5221308|NCT00740987|Venous thromboembolism prophylaxis|venous thromboembolism prophylaxis
5221309|NCT00740987|Intensive care unit|intensive care unit
5221310|NCT00740987|Hospitalization|hospitalization
5221311|NCT00740987|Intensive|intensive
5221312|NCT00740987|Care|care
5221313|NCT00740987|Unit|unit
5221314|NCT00740961|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
5221315|NCT00740961|cognitive/functional effects|cognitive/functional effects
5221316|NCT00740961|breast cancer|breast cancer
5221317|NCT00740961|colon cancer|colon cancer
5221318|NCT00740948|Sjogren's disease|sjogren's disease
5221319|NCT00740948|Rituximab|rituximab
5221320|NCT00740948|Treatment|treatment
5221321|NCT00740948|anti CD20|anti cd20
5221322|NCT00740935|prevention|prevention
5221323|NCT00740935|rotavirus vaccine|rotavirus vaccine
5221324|NCT00740935|gastroenteritis|gastroenteritis
5221325|NCT00740935|systematic vaccination|systematic vaccination
5221326|NCT00740935|infants|infants
5221327|NCT00740935|aged 6 to 12 weeks|aged 6 to 12 weeks
5221328|NCT00740922|Becaplermin gel|becaplermin gel
5221329|NCT00740922|Target Ulcer|target ulcer
5221330|NCT00740922|Retrospective Studies|retrospective studies
5221331|NCT00740922|Diabetic Foot|diabetic foot
5221332|NCT00740922|Neoplasms|neoplasms
5221333|NCT00740922|Long-Term Safety|long-term safety
5221334|NCT00740922|Topical Administration|topical administration
5221335|NCT00740909|Trich|trich
5221336|NCT00740909|Hair Pulling|hair pulling
5221337|NCT00740909|Cognitive Behavioral Therapy|cognitive behavioral therapy
5221338|NCT00740909|Behavioral Therapy|behavioral therapy
5221339|NCT00740896|Cigarette Smoking|cigarette smoking
5221340|NCT00740896|Airway dendritic cells|airway dendritic cells
5221341|NCT00740883|venous thromboembolism|venous thromboembolism
5221342|NCT00740883|warfarin|warfarin
5221343|NCT00740883|duration of anticoagulation|duration of anticoagulation
5221344|NCT00740883|recurrent venous thromboembolism|recurrent venous thromboembolism
5221345|NCT00740883|anticoagulant-related bleeding|anticoagulant-related bleeding
5221346|NCT00740857|Dental pain analgesia|dental pain analgesia
5221347|NCT00740844|Intermittent pneumatic compression|intermittent pneumatic compression
5221348|NCT00740844|Hospitalization|hospitalization
5221349|NCT00740844|Intensive care unit|intensive care unit
5221350|NCT00740844|High bleeding risk|high bleeding risk
5221351|NCT00740844|Venous thromboembolism prophylaxis|venous thromboembolism prophylaxis
5221352|NCT00740831|Uterine Myomas|uterine myomas
5221353|NCT00740779|prostatitis, chronic pelvic pain|prostatitis, chronic pelvic pain
5221354|NCT00740766|Perinatal Outcomes|perinatal outcomes
5221355|NCT00740766|Obesity|obesity
5221356|NCT00740766|Pregnant women|pregnant women
5221357|NCT00740753|liver tumor|liver tumor
5221358|NCT00740753|cancer|cancer
5221359|NCT00740753|hepatoma|hepatoma
5221360|NCT00740753|yttrium|yttrium
5221361|NCT00740740|Aneurysm|aneurysm
5221362|NCT00740740|Rupture|rupture
5221363|NCT00740727|Disaster|disaster
5221364|NCT00740727|Mass casualty incident|mass casualty incident
5221365|NCT00740727|Prehospital|prehospital
5221366|NCT00740727|Rehydration|rehydration
5221367|NCT00740727|Intravascular access|intravascular access
5221368|NCT00740714|Parkinson disease|parkinson disease
5221369|NCT00740714|PD|pd
5221370|NCT00740714|Coenzyme Q10|coenzyme q10
5221371|NCT00740714|CoQ|coq
5221372|NCT00740701|TMS|tms
5221373|NCT00740701|fMRI|fmri
5221374|NCT00740701|verbal working memory|verbal working memory
5221375|NCT00740701|classical conditioning|classical conditioning
5221376|NCT00740701|eyeblink|eyeblink
5221377|NCT00740701|classical eyeblink conditioning|classical eyeblink conditioning
5221378|NCT00740701|Healthy subjects|healthy subjects
5221379|NCT00740701|Memory|memory
5221380|NCT00740675|adverse drug events|adverse drug events
5221381|NCT00740675|outpatient|outpatient
5221382|NCT00740662|morbid obesity|morbid obesity
5221383|NCT00740662|small bowel|small bowel
5221384|NCT00740662|gastric bypass|gastric bypass
5221385|NCT00740662|weight loss|weight loss
5221386|NCT00740636|TEMOZOLOMIDE|temozolomide
5221387|NCT00740636|Lung|lung
5221388|NCT00740623|Partial Onset Seizures|partial onset seizures
5221389|NCT00740623|Simple Partial Seizures|simple partial seizures
5221390|NCT00740623|Complex Partial Seizures|complex partial seizures
5221391|NCT00740597|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
5221392|NCT00740597|stage I adult soft tissue sarcoma|stage i adult soft tissue sarcoma
5221393|NCT00740597|stage II adult soft tissue sarcoma|stage ii adult soft tissue sarcoma
5221394|NCT00740597|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
5221395|NCT00740597|adult alveolar soft-part sarcoma|adult alveolar soft-part sarcoma
5221396|NCT00740597|adult epithelioid sarcoma|adult epithelioid sarcoma
5221397|NCT00740597|adult extraskeletal chondrosarcoma|adult extraskeletal chondrosarcoma
5221398|NCT00740597|adult extraskeletal osteosarcoma|adult extraskeletal osteosarcoma
5221399|NCT00740597|adult fibrosarcoma|adult fibrosarcoma
5221400|NCT00740597|adult malignant fibrous histiocytoma|adult malignant fibrous histiocytoma
5221401|NCT00740597|adult malignant hemangiopericytoma|adult malignant hemangiopericytoma
5221402|NCT00740597|adult malignant mesenchymoma|adult malignant mesenchymoma
5221403|NCT00740597|adult neurofibrosarcoma|adult neurofibrosarcoma
5221404|NCT00740597|adult rhabdomyosarcoma|adult rhabdomyosarcoma
5221405|NCT00740597|dermatofibrosarcoma protuberans|dermatofibrosarcoma protuberans
5221406|NCT00740584|Prevention|prevention
5221407|NCT00740571|neuralgia|neuralgia
5221408|NCT00740571|off-label|off-label
5221409|NCT00740571|cancer|cancer
5221410|NCT00740558|HRV|hrv
5221411|NCT00740558|Activator|activator
5221412|NCT00740558|Chiropractic|chiropractic
5221413|NCT00740558|VLF|vlf
5221414|NCT00740558|HF|hf
5221415|NCT00740558|LF|lf
5221416|NCT00740558|LF/HF|lf/hf
5221417|NCT00740532|EGFR, HER-2, HER-3, MET, KRAS|egfr, her-2, her-3, met, kras
5221418|NCT00740506|Behavioral|behavioral
5221419|NCT00740506|Environmental|environmental
5221420|NCT00740506|Delivery|delivery
5221421|NCT00740506|Pregnancy|pregnancy
5221422|NCT00740493|recurrent venous thromboembolism|recurrent venous thromboembolism
5221423|NCT00740493|idiopathic deep vein thrombosis|idiopathic deep vein thrombosis
5221424|NCT00740493|optimal duration of anticoagulation|optimal duration of anticoagulation
5221425|NCT00740480|Evaluation|evaluation
5221426|NCT00740480|ENTact™|entact™
5221427|NCT00740480|Septal|septal
5221428|NCT00740480|Staple|staple
5221429|NCT00740480|System|system
5221430|NCT00740480|tissue|tissue
5221431|NCT00740480|approximation|approximation
5221432|NCT00740480|during|during
5221433|NCT00740480|septoplasties|septoplasties
5221434|NCT00740467|graft versus host disease|graft versus host disease
5221435|NCT00740467|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5221436|NCT00740467|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5221437|NCT00740467|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5221438|NCT00740467|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5221439|NCT00740467|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5221440|NCT00740467|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5221441|NCT00740467|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5221442|NCT00740467|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5221443|NCT00740467|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5221444|NCT00740467|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5221445|NCT00740467|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5221446|NCT00740467|refractory multiple myeloma|refractory multiple myeloma
5221564|NCT00740103|Semapimod|semapimod
5221447|NCT00740467|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5221448|NCT00740467|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5221449|NCT00740467|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
5221450|NCT00740467|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5221451|NCT00740467|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
5221452|NCT00740467|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5221453|NCT00740467|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5221454|NCT00740467|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5221455|NCT00740467|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5221456|NCT00740467|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5221457|NCT00740467|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5221458|NCT00740467|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
5221459|NCT00740467|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5221460|NCT00740467|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5221461|NCT00740467|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
5221462|NCT00740467|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5221463|NCT00740467|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5221464|NCT00740467|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5221465|NCT00740467|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5221466|NCT00740467|recurrent grade I lymphomatoid granulomatosis|recurrent grade i lymphomatoid granulomatosis
5221467|NCT00740467|recurrent grade II lymphomatoid granulomatosis|recurrent grade ii lymphomatoid granulomatosis
5221468|NCT00740467|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5221469|NCT00740467|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5221470|NCT00740467|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5221471|NCT00740467|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5221472|NCT00740467|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5221473|NCT00740454|pregnancy|pregnancy
5221474|NCT00740454|postpartum|postpartum
5221475|NCT00740454|deep vein thrombosis|deep vein thrombosis
5221476|NCT00740454|venous thromboembolism|venous thromboembolism
5221477|NCT00740454|diagnosis|diagnosis
5221478|NCT00740454|compression ultrasonography|compression ultrasonography
5221479|NCT00740441|renal cell carcinoma|renal cell carcinoma
5221480|NCT00740441|rcc|rcc
5221481|NCT00740441|kidney cancer|kidney cancer
5221482|NCT00740428|Pelvic floor,|pelvic floor,
5221483|NCT00740428|muscular dysfunction,|muscular dysfunction,
5221484|NCT00740428|urinary incontinence|urinary incontinence
5221485|NCT00740415|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
5221486|NCT00740415|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5221487|NCT00740415|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5221488|NCT00740415|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5221489|NCT00740389|TMC125-C187|tmc125-c187
5221490|NCT00740389|TMC125-TiDP2-C187|tmc125-tidp2-c187
5221491|NCT00740389|HIV|hiv
5221492|NCT00740389|AIDS|aids
5221493|NCT00740389|Fungal Infection|fungal infection
5221494|NCT00740389|Pharmacokinetics|pharmacokinetics
5221495|NCT00740376|osteoarthritis|osteoarthritis
5221496|NCT00740363|renal transplantation|renal transplantation
5221497|NCT00740363|diabetes|diabetes
5221498|NCT00740363|glucose intolerance|glucose intolerance
5221499|NCT00740363|impaired glucose tolerance|impaired glucose tolerance
5221500|NCT00740337|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5221501|NCT00740337|COPD|copd
5221502|NCT00740337|Emphysema|emphysema
5221503|NCT00740337|Natural Killer T-cell|natural killer t-cell
5221504|NCT00740337|Interleukin-13|interleukin-13
5221505|NCT00740337|Innate Immune Signaling|innate immune signaling
5221506|NCT00740324|During|during
5221507|NCT00740324|Endoscopy|endoscopy
5221508|NCT00740324|Gastric|gastric
5221509|NCT00740324|Peristalsis|peristalsis
5221510|NCT00740311|Prevention of the reduction of the alveolar crest|prevention of the reduction of the alveolar crest
5221511|NCT00740298|infants|infants
5221512|NCT00740298|undergoing|undergoing
5221513|NCT00740298|vaccinations|vaccinations
5221514|NCT00740285|scleroderma|scleroderma
5221515|NCT00740285|scleroderma - limited or diffuse types|scleroderma - limited or diffuse types
5221516|NCT00740285|lidocaine|lidocaine
5221517|NCT00740285|effectiveness|effectiveness
5221518|NCT00740272|brady-tachy syndrome|brady-tachy syndrome
5221519|NCT00740272|AF ablation|af ablation
5221520|NCT00740259|flunarizine|flunarizine
5221521|NCT00740259|schizophrenia|schizophrenia
5221522|NCT00740259|antipsychotic|antipsychotic
5221523|NCT00740233|fibromyalgia|fibromyalgia
5221524|NCT00740233|irritable bowel syndrome|irritable bowel syndrome
5221525|NCT00740233|interstitial cystitis|interstitial cystitis
5221526|NCT00740233|chronic fatigue syndrome|chronic fatigue syndrome
5221527|NCT00740233|vulvodynia|vulvodynia
5221528|NCT00740233|chronic stress|chronic stress
5221529|NCT00740233|chronic pain|chronic pain
5221530|NCT00740233|stress-related conditions|stress-related conditions
5221531|NCT00740233|functional GI disorders|functional gi disorders
5221532|NCT00740220|hypoxemia|hypoxemia
5221533|NCT00740220|anoxia|anoxia
5221534|NCT00740220|oxygen|oxygen
5221535|NCT00740220|dyspnea|dyspnea
5221536|NCT00740220|pulmonary disease|pulmonary disease
5221537|NCT00740220|chronic obstructive|chronic obstructive
5221538|NCT00740194|Physiology|physiology
5221539|NCT00740194|males|males
5221540|NCT00740181|myelodysplasia|myelodysplasia
5221541|NCT00740181|refractory leukemia|refractory leukemia
5221542|NCT00740181|acute leukemia|acute leukemia
5221543|NCT00740168|bevacizumab|bevacizumab
5221544|NCT00740168|cancer|cancer
5221545|NCT00740155|Dengue virus|dengue virus
5221546|NCT00740155|Dengue fever|dengue fever
5221547|NCT00740155|Dengue hemorrhagic fever|dengue hemorrhagic fever
5221548|NCT00740155|Dengue diseases|dengue diseases
5221549|NCT00740142|L ornithine L aspartate|l ornithine l aspartate
5221550|NCT00740142|Lactulose|lactulose
5221551|NCT00740142|Hepatic encephalopathy|hepatic encephalopathy
5221552|NCT00740142|LOLA|lola
5221553|NCT00740129|Paget's Disease|paget's disease
5221554|NCT00740129|Zoledronic acid|zoledronic acid
5221555|NCT00740129|Reclast®/Aclasta®|reclast®/aclasta®
5221556|NCT00740129|infusion|infusion
5221557|NCT00740129|re-treatment|re-treatment
5221558|NCT00740129|re-lapse|re-lapse
5221559|NCT00740116|Tumor of ovary|tumor of ovary
5221560|NCT00740116|Surgical blood loss|surgical blood loss
5221561|NCT00740116|Postoperative blood loss|postoperative blood loss
5221562|NCT00740116|Preventive therapy|preventive therapy
5221563|NCT00740116|Thromboembolism|thromboembolism
5221565|NCT00740103|Crohn's Disease|crohn's disease
5221566|NCT00740103|TNF-alpha inhibitor|tnf-alpha inhibitor
5221567|NCT00740103|MAP Kinase inhibitor|map kinase inhibitor
5221568|NCT00740103|CNI-1493|cni-1493
5221569|NCT00740090|Malaria|malaria
5221570|NCT00740090|Reactogenicity, Safety, Immunogenicity|reactogenicity, safety, immunogenicity
5221571|NCT00740090|Maleria Endemic|maleria endemic
5221572|NCT00740090|Plasmodium Falciparum|plasmodium falciparum
5221573|NCT00740090|Dose Escalating|dose escalating
5221574|NCT00740077|cranberry|cranberry
5221575|NCT00740077|flavonoid|flavonoid
5221576|NCT00740077|phenolic acid|phenolic acid
5221577|NCT00740077|phytochemical|phytochemical
5221578|NCT00740077|bioavailability|bioavailability
5221579|NCT00740064|HIV infections|hiv infections
5221580|NCT00740038|Stress Management|stress management
5221581|NCT00740038|Quality of Life|quality of life
5221582|NCT00740038|Exercise|exercise
5221583|NCT00740038|Cancer|cancer
5221584|NCT00740038|Chemotherapy|chemotherapy
5221585|NCT00740025|QD dose|qd dose
5221586|NCT00740025|BID dosing|bid dosing
5221587|NCT00740025|peak estradiol|peak estradiol
5221588|NCT00740025|oocytes|oocytes
5221589|NCT00740025|implantation rate|implantation rate
5221590|NCT00740025|pregnancy rate|pregnancy rate
5221591|NCT00740012|Nocturnal glucose profiles|nocturnal glucose profiles
5221592|NCT00740012|continuous glucose profiles|continuous glucose profiles
5221593|NCT00739999|heterozygous familial hypercholesterolemia (HeFH); atorvastatin; pediatric|heterozygous familial hypercholesterolemia (hefh); atorvastatin; pediatric
5221594|NCT00739986|Crohn's Disease|crohn's disease
5221595|NCT00739986|TNF-alpha|tnf-alpha
5221596|NCT00739986|IL-6|il-6
5221597|NCT00739986|MAP Kinase|map kinase
5221598|NCT00739986|CNI-1493|cni-1493
5221599|NCT00739973|Hypertension, Aliskiren, Amlodipine|hypertension, aliskiren, amlodipine
5221600|NCT00739947|Observational|observational
5221601|NCT00739947|rotator cuff tear|rotator cuff tear
5221602|NCT00739947|arthroscopic|arthroscopic
5221603|NCT00739947|surgical|surgical
5221604|NCT00739947|outcome study|outcome study
5221605|NCT00739934|Open-Label|open-label
5221606|NCT00739934|Pharmacokinetics|pharmacokinetics
5221607|NCT00739934|Intravenous to oral switch|intravenous to oral switch
5221608|NCT00739934|Safety|safety
5221609|NCT00739934|Voriconazole|voriconazole
5221610|NCT00739934|Immunocompromise|immunocompromise
5221611|NCT00739934|Children|children
5221612|NCT00739934|High Risk For Systemic Fungal Infection.|high risk for systemic fungal infection.
5221613|NCT00739921|PCR Analysis|pcr analysis
5221614|NCT00739921|Allergic fungal sinusitis|allergic fungal sinusitis
5221615|NCT00739921|Chronic rhinosinusitis|chronic rhinosinusitis
5221616|NCT00739921|Nasal Polyps|nasal polyps
5221617|NCT00739908|MDD|mdd
5221618|NCT00739895|athletes|athletes
5221619|NCT00739882|Efalizumab,|efalizumab,
5221620|NCT00739882|Chronic plaque psoriasis|chronic plaque psoriasis
5221621|NCT00739882|moderate to severe|moderate to severe
5221622|NCT00739882|involving|involving
5221623|NCT00739882|hands|hands
5221624|NCT00739882|feet|feet
5221625|NCT00739869|Silent Infarcts|silent infarcts
5221626|NCT00739869|Magnetic Resonance Imaging|magnetic resonance imaging
5221627|NCT00739869|MRI|mri
5221628|NCT00739869|Subclinical Cerebrovascular Disease|subclinical cerebrovascular disease
5221629|NCT00739869|White Matter Grade Abnormalities|white matter grade abnormalities
5221630|NCT00739869|Total Brain Volume|total brain volume
5221631|NCT00739869|Ventricular and Hippocampal Volume|ventricular and hippocampal volume
5221632|NCT00739869|Subclinical Vascular Abnormalities|subclinical vascular abnormalities
5221633|NCT00739869|Cerebrovascular Disease|cerebrovascular disease
5221634|NCT00739869|CVD|cvd
5221635|NCT00739869|Subclinical CVD|subclinical cvd
5221636|NCT00739856|posttraumatic stress disorder|posttraumatic stress disorder
5221637|NCT00739856|electroconvulsive therapy|electroconvulsive therapy
5221638|NCT00739856|medication refractoriness|medication refractoriness
5221639|NCT00739843|Dementia,|dementia,
5221640|NCT00739843|Cognitive Disorders,|cognitive disorders,
5221641|NCT00739843|Hemodialysis|hemodialysis
5221642|NCT00739791|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5221643|NCT00739791|stage I prostate cancer|stage i prostate cancer
5221644|NCT00739791|stage IIB prostate cancer|stage iib prostate cancer
5221645|NCT00739791|stage IIA prostate cancer|stage iia prostate cancer
5221646|NCT00739765|Trauma|trauma
5221647|NCT00739765|Psychotherapy|psychotherapy
5221648|NCT00739765|Anxiety|anxiety
5221649|NCT00739752|Attitude to Health|attitude to health
5221650|NCT00739752|Communication|communication
5221651|NCT00739752|Intervention Studies|intervention studies
5221652|NCT00739752|Health Promotion|health promotion
5221653|NCT00739752|Psychology, Medical|psychology, medical
5221654|NCT00739752|Sexual Behavior|sexual behavior
5221655|NCT00739752|Behavioral Research|behavioral research
5221656|NCT00739752|Vaccination|vaccination
5221657|NCT00739713|dry eye|dry eye
5221658|NCT00739713|sea buckthorn|sea buckthorn
5221659|NCT00739713|Hippophaë|hippophaë
5221660|NCT00739700|hemodynamics|hemodynamics
5221661|NCT00739700|blood pressure|blood pressure
5221662|NCT00739700|blood pressure monitors|blood pressure monitors
5221663|NCT00739687|Chronic Heart Failure|chronic heart failure
5221664|NCT00739661|Systemic Hedgehog|systemic hedgehog
5221665|NCT00739661|Hedgehog Pathway Inhibitor|hedgehog pathway inhibitor
5221666|NCT00739648|COPD|copd
5221667|NCT00739648|Patients|patients
5221668|NCT00739622|TMC278-TiDP6-C136|tmc278-tidp6-c136
5221669|NCT00739622|TMC278-C136|tmc278-c136
5221670|NCT00739622|Healthy Volunteer|healthy volunteer
5221671|NCT00739596|Hypertension|hypertension
5221672|NCT00739596|African American|african american
5221673|NCT00739596|aliskiren|aliskiren
5221674|NCT00739596|hydrochlorothiazide|hydrochlorothiazide
5221675|NCT00739596|systolic blood pressure|systolic blood pressure
5221676|NCT00739596|diastolic blood pressure|diastolic blood pressure
5221677|NCT00739596|amlodipine|amlodipine
5221678|NCT00739596|stage 2|stage 2
5221679|NCT00739583|Skin preparation|skin preparation
5221680|NCT00739583|Skin marking|skin marking
5221681|NCT00739583|site marking|site marking
5221682|NCT00739583|Site identification|site identification
5221683|NCT00739570|Activator|activator
5221684|NCT00739570|EMG|emg
5221685|NCT00739570|Thermography|thermography
5221686|NCT00739570|Diagnostic|diagnostic
5221687|NCT00739570|X-Rays|x-rays
5221688|NCT00739557|elective TAAA repair|elective taaa repair
5221689|NCT00739544|Reference Values|reference values
5221690|NCT00739544|Sensory Thresholds|sensory thresholds
5221691|NCT00739544|Pain Threshold|pain threshold
5221692|NCT00739544|Breast Neoplasms|breast neoplasms
5221693|NCT00739531|Asthma|asthma
5221694|NCT00739531|nitric oxide|nitric oxide
5221696|NCT00739531|FENO|feno
5221697|NCT00739531|Apieron INSIGHT|apieron insight
5221698|NCT00739531|Aerocrine NIOX|aerocrine niox
5221699|NCT00739518|Neurological|neurological
5221700|NCT00739518|MRI|mri
5221701|NCT00739505|Hypophosphatasia|hypophosphatasia
5221702|NCT00739505|Bone Disease|bone disease
5221703|NCT00739505|Soft Bones|soft bones
5221704|NCT00739505|Low Alkaline Phosphatase|low alkaline phosphatase
5221705|NCT00739505|genetic metabolic disorder|genetic metabolic disorder
5221706|NCT00739505|alkaline phosphatase|alkaline phosphatase
5221707|NCT00739505|tissue non-specific alkaline phosphatase|tissue non-specific alkaline phosphatase
5221708|NCT00739505|rickets|rickets
5221709|NCT00739505|osteomalacia|osteomalacia
5221710|NCT00739492|weight loss, obesity, financial incentives|weight loss, obesity, financial incentives
5221711|NCT00739479|Metabolic Syndrome|metabolic syndrome
5221712|NCT00739479|METS|mets
5221713|NCT00739479|Obesity|obesity
5221714|NCT00739479|Partially Hydrolyzed Whey Protein|partially hydrolyzed whey protein
5221715|NCT00739479|Partially Hydrolyzed Gelatin|partially hydrolyzed gelatin
5221716|NCT00739479|PHWP|phwp
5221717|NCT00739479|PHG|phg
5221718|NCT00739479|Weight Loss|weight loss
5221719|NCT00739466|Liposomal Alendronate|liposomal alendronate
5221720|NCT00739466|Percutaneous coronary intervention|percutaneous coronary intervention
5221721|NCT00739466|Coronary stenting|coronary stenting
5221722|NCT00739466|de novo stenotic lesions|de novo stenotic lesions
5221723|NCT00739466|Native coronary arteries|native coronary arteries
5221724|NCT00739466|Restenosis|restenosis
5221725|NCT00739466|Bare metal stent|bare metal stent
5221726|NCT00739466|Presillion CoCr coronary stent|presillion cocr coronary stent
5221727|NCT00739453|Advanced cancer|advanced cancer
5221728|NCT00739453|Non-small cell lung cancer|non-small cell lung cancer
5221729|NCT00739453|Pancreatic cancer|pancreatic cancer
5221730|NCT00739453|Colorectal cancer|colorectal cancer
5221731|NCT00739453|Prostate cancer|prostate cancer
5221732|NCT00739414|Histone Deacetylases|histone deacetylases
5221733|NCT00739414|HDAC inhibitor|hdac inhibitor
5221734|NCT00739414|LBH589|lbh589
5221735|NCT00739414|Advanced solid tumor|advanced solid tumor
5221736|NCT00739414|Adult|adult
5221737|NCT00739401|AAA|aaa
5221738|NCT00739401|Aneurysm|aneurysm
5221739|NCT00739401|Suprarenal|suprarenal
5221740|NCT00739401|Proximal|proximal
5221741|NCT00739401|Cuff|cuff
5221742|NCT00739401|Extension|extension
5221743|NCT00739401|Endograft|endograft
5221744|NCT00739401|Endovascular repair|endovascular repair
5221745|NCT00739401|EVAR|evar
5221746|NCT00739401|Endoleak|endoleak
5221747|NCT00739401|Type I|type i
5221842|NCT00739102|Nitinol Self-Expandable Stent System|nitinol self-expandable stent system
5221748|NCT00739388|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5221749|NCT00739388|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5221750|NCT00739388|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5221751|NCT00739388|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5221752|NCT00739388|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5221753|NCT00739388|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
5221754|NCT00739388|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
5221755|NCT00739388|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
5221756|NCT00739388|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
5221757|NCT00739388|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
5221758|NCT00739388|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
5221759|NCT00739388|adult erythroleukemia (M6a)|adult erythroleukemia (m6a)
5221760|NCT00739388|adult pure erythroid leukemia (M6b)|adult pure erythroid leukemia (m6b)
5221761|NCT00739388|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
5221762|NCT00739375|Influence|influence
5221763|NCT00739375|of av access|of av access
5221764|NCT00739375|flow|flow
5221765|NCT00739375|development|development
5221766|NCT00739362|Behavioral Weight Loss Treatment|behavioral weight loss treatment
5221767|NCT00739362|Obesity|obesity
5221768|NCT00739362|Appetite Control|appetite control
5221769|NCT00739362|Weight Loss|weight loss
5221770|NCT00739362|Transcranial Direct Current Stimulation (TDCS)|transcranial direct current stimulation (tdcs)
5221771|NCT00739349|Dry Eye|dry eye
5221772|NCT00739349|Cyclosporine|cyclosporine
5221773|NCT00739336|diabetes mellitus|diabetes mellitus
5221774|NCT00739336|obesity|obesity
5221775|NCT00739336|prevention|prevention
5221776|NCT00739310|High Frequency Chest Wall Oscillation|high frequency chest wall oscillation
5221777|NCT00739310|Cerebral Palsy|cerebral palsy
5221778|NCT00739310|Restrictive lung disease|restrictive lung disease
5221779|NCT00739297|Chronic asthma|chronic asthma
5221780|NCT00739284|preferred|preferred
5221781|NCT00739284|procedure|procedure
5221782|NCT00739284|drainage|drainage
5221783|NCT00739284|obstructed|obstructed
5221784|NCT00739284|kidney|kidney
5221785|NCT00739284|stone|stone
5221786|NCT00739258|HIV-infected person|hiv-infected person
5221787|NCT00739258|Entamoeba|entamoeba
5221788|NCT00739258|Cryptosporidium|cryptosporidium
5221789|NCT00739258|Giardia|giardia
5221790|NCT00739258|ELISA|elisa
5221791|NCT00739258|PCR|pcr
5221792|NCT00739258|IDU|idu
5221793|NCT00739258|Gonorrhea|gonorrhea
5221794|NCT00739258|Chlamydial trachomatis|chlamydial trachomatis
5221795|NCT00739258|Syphilis|syphilis
5221796|NCT00739258|Genital warts|genital warts
5221797|NCT00739258|Herpes simplex virus|herpes simplex virus
5221798|NCT00739232|Safety and tolerability of HSD-016|safety and tolerability of hsd-016
5221799|NCT00739219|Asthma|asthma
5221800|NCT00739219|inflammation|inflammation
5221801|NCT00739219|nitric oxide|nitric oxide
5221802|NCT00739219|eNO|eno
5221803|NCT00739219|FENO|feno
5221804|NCT00739206|uncomplicated|uncomplicated
5221805|NCT00739206|severe|severe
5221806|NCT00739206|treatment|treatment
5221807|NCT00739206|Plasmodium Falciparum|plasmodium falciparum
5221808|NCT00739193|Blood Pressure|blood pressure
5221809|NCT00739180|Childhood obesity|childhood obesity
5221810|NCT00739180|Abdominal obesity|abdominal obesity
5221811|NCT00739180|Visceral fat|visceral fat
5221812|NCT00739180|Insulin resistance|insulin resistance
5221813|NCT00739180|Liver fat|liver fat
5221814|NCT00739180|Skeletal muscle lipid|skeletal muscle lipid
5221815|NCT00739180|Fitness|fitness
5221816|NCT00739167|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
5221817|NCT00739167|advanced adult primary liver cancer|advanced adult primary liver cancer
5221818|NCT00739167|liver metastases|liver metastases
5221819|NCT00739167|recurrent adult primary liver cancer|recurrent adult primary liver cancer
5221820|NCT00739154|glaucoma|glaucoma
5221821|NCT00739154|Phenytoin|phenytoin
5221822|NCT00739154|retinal nerve fiber layer|retinal nerve fiber layer
5221823|NCT00739154|corrected pattern standard deviation|corrected pattern standard deviation
5221824|NCT00739154|visual acuity|visual acuity
5221825|NCT00739154|optic disc cupping|optic disc cupping
5221826|NCT00739141|CYCLOPHOSPHAMIDE (CYTOXAN)|cyclophosphamide (cytoxan)
5221827|NCT00739141|CYCLOSPORINE A|cyclosporine a
5221828|NCT00739141|FLUDARABINE|fludarabine
5221829|NCT00739141|G-CSF|g-csf
5221830|NCT00739141|MYCOPHENOLATE MOFETIL (MMF)|mycophenolate mofetil (mmf)
5221831|NCT00739141|THI0TEPA|thi0tepa
5221832|NCT00739141|UMBILICAL CORD BLOOD (UCB)|umbilical cord blood (ucb)
5221833|NCT00739141|08-087|08-087
5221834|NCT00739128|celiac disease|celiac disease
5221835|NCT00739128|hepatitis B vaccine|hepatitis b vaccine
5221836|NCT00739115|Respiratory|respiratory
5221837|NCT00739115|Distress|distress
5221838|NCT00739115|Prematurity|prematurity
5221839|NCT00739115|Heliox|heliox
5221840|NCT00739115|CPAP|cpap
5221841|NCT00739102|Superficial Femoral Artery|superficial femoral artery
5221843|NCT00739089|hemodynamics|hemodynamics
5221844|NCT00739089|oxygen|oxygen
5221845|NCT00739089|renal dialysis|renal dialysis
5221846|NCT00739089|shock|shock
5221847|NCT00739089|sepsis|sepsis
5221848|NCT00739089|hypotension|hypotension
5221849|NCT00739089|lactic acidosis|lactic acidosis
5221850|NCT00739063|Breast cancer|breast cancer
5221851|NCT00739063|Carcinoma of the breast|carcinoma of the breast
5221852|NCT00739063|Stage IV|stage iv
5221853|NCT00739063|Triple receptor-negative|triple receptor-negative
5221854|NCT00739063|Triple receptor-negative breast cancer|triple receptor-negative breast cancer
5221855|NCT00739063|Metastatic triple receptor-negative breast cancer|metastatic triple receptor-negative breast cancer
5221856|NCT00739063|Epidermal growth factor receptor|epidermal growth factor receptor
5221857|NCT00739063|EGFR|egfr
5221858|NCT00739063|EGFR-overexpressing|egfr-overexpressing
5221859|NCT00739063|GFR inhibitor erlotinib|gfr inhibitor erlotinib
5221860|NCT00739063|Erlotinib hydrochloride|erlotinib hydrochloride
5221861|NCT00739063|Erlotinib|erlotinib
5221862|NCT00739063|Tarceva|tarceva
5221863|NCT00739063|OSI-774|osi-774
5221864|NCT00739024|Migraine|migraine
5221865|NCT00739024|Headache|headache
5221866|NCT00738998|Breast Cancer|breast cancer
5221867|NCT00738998|Aromatase Inhibitors|aromatase inhibitors
5221868|NCT00738998|Symptom Assessment|symptom assessment
5221869|NCT00738998|Questionnaire|questionnaire
5221870|NCT00738998|Survey|survey
5221871|NCT00738998|Phone Call|phone call
5221872|NCT00738998|Arimidex|arimidex
5221873|NCT00738998|Anastrozole|anastrozole
5221874|NCT00738959|AZD0328|azd0328
5221875|NCT00738959|Japanese|japanese
5221876|NCT00738959|Caucasian|caucasian
5221877|NCT00738959|pharmacokinetics|pharmacokinetics
5221878|NCT00738959|safety|safety
5221879|NCT00738959|tolerability|tolerability
5221880|NCT00738946|Intermittent Preventive treatment|intermittent preventive treatment
5221881|NCT00738946|insecticide treated bednets|insecticide treated bednets
5221882|NCT00738946|malaria|malaria
5221883|NCT00738933|Atherosclerosis|atherosclerosis
5221884|NCT00738933|Plant sterols|plant sterols
5221885|NCT00738933|Plant stanols|plant stanols
5221886|NCT00738933|Aortic valve|aortic valve
5221887|NCT00738907|Type 1 diabetes|type 1 diabetes
5221888|NCT00738894|cryptogenic|cryptogenic
5221889|NCT00738894|stroke|stroke
5221890|NCT00738894|transient ischemic attack|transient ischemic attack
5221891|NCT00738894|TIA|tia
5221892|NCT00738894|PFO|pfo
5221893|NCT00738894|Patent foramen ovale|patent foramen ovale
5221894|NCT00738894|HELEX|helex
5221895|NCT00738894|Septal Occluder|septal occluder
5221896|NCT00738894|PFO Occluder|pfo occluder
5221897|NCT00738868|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
5221898|NCT00738868|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
5221899|NCT00738868|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
5221900|NCT00738868|stage III verrucous carcinoma of the larynx|stage iii verrucous carcinoma of the larynx
5221901|NCT00738868|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
5221902|NCT00738868|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
5221903|NCT00738868|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
5221904|NCT00738868|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
5221905|NCT00738868|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
5221906|NCT00738868|stage III verrucous carcinoma of the oral cavity|stage iii verrucous carcinoma of the oral cavity
5221907|NCT00738868|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
5221908|NCT00738868|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
5221909|NCT00738868|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
5221910|NCT00738868|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
5221911|NCT00738868|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
5221912|NCT00738868|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
5221913|NCT00738868|recurrent salivary gland cancer|recurrent salivary gland cancer
5221914|NCT00738868|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
5221915|NCT00738868|stage III salivary gland cancer|stage iii salivary gland cancer
5221916|NCT00738855|Adhesions|adhesions
5221917|NCT00738855|Oral contrast|oral contrast
5221918|NCT00738855|Exploration|exploration
5221919|NCT00738842|Uric|uric
5221920|NCT00738842|Acid|acid
5221921|NCT00738842|Level|level
5221922|NCT00738829|CLL|cll
5221923|NCT00738829|untreated|untreated
5221924|NCT00738829|immune therapy|immune therapy
5221925|NCT00738829|dose escalation|dose escalation
5221926|NCT00738829|maximum tolerated dose|maximum tolerated dose
5221927|NCT00738829|maintenance therapy|maintenance therapy
5221928|NCT00738829|Lenalidomide|lenalidomide
5221929|NCT00738829|Rituximab|rituximab
5221930|NCT00738829|Fludarabine|fludarabine
5221931|NCT00738816|Medication review|medication review
5221932|NCT00738816|Patient|patient
5221933|NCT00738816|Safety|safety
5221934|NCT00738816|Drug|drug
5221935|NCT00738816|Prescriptions|prescriptions
5221936|NCT00738816|Drug-use|drug-use
5221937|NCT00738803|leg length|leg length
5221938|NCT00738803|hip arthroplasty|hip arthroplasty
5221939|NCT00738803|offset|offset
5221940|NCT00738790|rectal cancer|rectal cancer
5221941|NCT00738790|preoperative radiotherapy and local excision|preoperative radiotherapy and local excision
5221942|NCT00738777|pre-operative|pre-operative
5221943|NCT00738777|endocrine treatment|endocrine treatment
5221944|NCT00738777|drug resistance|drug resistance
5221945|NCT00738764|cancer|cancer
5221946|NCT00738764|antibody|antibody
5221947|NCT00738764|Phase 1 Clinical Trial|phase 1 clinical trial
5221948|NCT00738751|NSCLC|nsclc
5221949|NCT00738751|Metastatic|metastatic
5221950|NCT00738751|erlotinib|erlotinib
5221951|NCT00738751|aerodigestive tract cancers|aerodigestive tract cancers
5221952|NCT00738751|non-small cell lung cancer|non-small cell lung cancer
5221953|NCT00738751|H&N cancer|h&n cancer
5221954|NCT00738738|Generalized Anxiety Disorder Elderly|generalized anxiety disorder elderly
5221955|NCT00738725|High risk plaque|high risk plaque
5221956|NCT00738725|High-risk plaque|high-risk plaque
5221957|NCT00738725|Vulnerable plaque|vulnerable plaque
5221958|NCT00738725|Atherosclerotic Disease|atherosclerotic disease
5221959|NCT00738725|Heart Disease|heart disease
5221960|NCT00738725|Stroke|stroke
5221961|NCT00738712|Vascular MRI|vascular mri
5221962|NCT00738712|Abdominal MRI|abdominal mri
5221963|NCT00738712|Pelvic MRI|pelvic mri
5221964|NCT00738712|Breast MRI|breast mri
5221965|NCT00738712|Magnetic Resonance Imaging (MRI)|magnetic resonance imaging (mri)
5221966|NCT00738699|ovarian cancer|ovarian cancer
5221967|NCT00738699|relapsed ovarian cancer|relapsed ovarian cancer
5221968|NCT00738699|refractory ovarian cancer|refractory ovarian cancer
5221969|NCT00738686|coronary artery disease|coronary artery disease
5221970|NCT00738686|drug-eluting stent|drug-eluting stent
5221971|NCT00738686|percutaneous coronary intervention|percutaneous coronary intervention
5221972|NCT00738686|major adverse cardiac event|major adverse cardiac event
5221973|NCT00738686|in-stent restenosis|in-stent restenosis
5221974|NCT00738686|stent thrombosis|stent thrombosis
5221975|NCT00738673|Hormone refractory prostate cancer|hormone refractory prostate cancer
5221976|NCT00738673|Agonist treatment failure|agonist treatment failure
5221977|NCT00738660|type1 DM|type1 dm
5221978|NCT00738660|microalbuminuria|microalbuminuria
5221979|NCT00738660|nephropathy|nephropathy
5221980|NCT00738660|albumin excretion rate|albumin excretion rate
5221981|NCT00738660|dual blockade|dual blockade
5221982|NCT00738660|ACEI|acei
5221983|NCT00738660|ARB|arb
5221984|NCT00738647|Filling materials|filling materials
5221985|NCT00738647|Restorative materials|restorative materials
5221986|NCT00738647|clinical trial|clinical trial
5221987|NCT00738647|Resin based composite|resin based composite
5221988|NCT00738634|Depression|depression
5221989|NCT00738634|Motor Activity|motor activity
5221990|NCT00738634|Adolescent|adolescent
5221991|NCT00738621|PONV|ponv
5221992|NCT00738621|breast surgery|breast surgery
5221993|NCT00738621|prevention|prevention
5221994|NCT00738621|antiemetics|antiemetics
5221995|NCT00738608|morphine|morphine
5221996|NCT00738608|consumption|consumption
5221997|NCT00738608|postoperative|postoperative
5221998|NCT00738608|pain|pain
5221999|NCT00738608|Pain during 24h postoperative|pain during 24h postoperative
5222000|NCT00738608|Morphine consumption in 24h postoperative|morphine consumption in 24h postoperative
5222001|NCT00738595|Smoking Cessation|smoking cessation
5222002|NCT00738569|Chronic inflammation|chronic inflammation
5222003|NCT00738569|memory cells|memory cells
5222004|NCT00738569|activated t-lymphocytes|activated t-lymphocytes
5222005|NCT00738543|Antiseptics|antiseptics
5222006|NCT00738543|Administration, cutaneous|administration, cutaneous
5222007|NCT00738543|Iodophors|iodophors
5222008|NCT00738543|Chlorine compounds|chlorine compounds
5222009|NCT00738543|Anti-infecting agents, local|anti-infecting agents, local
5222010|NCT00738517|heart failure|heart failure
5222011|NCT00738517|coronary heart disease|coronary heart disease
5222012|NCT00738517|autoantibodies|autoantibodies
5222013|NCT00738517|immunoadsorption|immunoadsorption
5222014|NCT00738517|immunoglobulin substitution|immunoglobulin substitution
5222015|NCT00738504|Intensive insulin therapy|intensive insulin therapy
5222016|NCT00738504|Carbohydrate restrictive strategy|carbohydrate restrictive strategy
5222017|NCT00738504|RIFLE Criteria|rifle criteria
5222018|NCT00738504|Acute Kidney Injury|acute kidney injury
5222019|NCT00738504|Critically ill patients|critically ill patients
5222020|NCT00738504|Acute|acute
5222021|NCT00738491|Angina pectoris|angina pectoris
5222022|NCT00738491|Exercise capacity|exercise capacity
5222023|NCT00738491|Myocardial ischaemia|myocardial ischaemia
5222024|NCT00738491|Air pollution|air pollution
5222025|NCT00738478|distal gastrectomy|distal gastrectomy
5222026|NCT00738478|quality of life|quality of life
5222027|NCT00738452|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5222028|NCT00738452|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
5222029|NCT00738452|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5222030|NCT00738452|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5222031|NCT00738439|scoliosis|scoliosis
5222032|NCT00738439|kyphosis|kyphosis
5222033|NCT00738439|treatment outcomes|treatment outcomes
5222034|NCT00738439|spinal deformity|spinal deformity
5222035|NCT00738426|non-invasive body contouring of waists hips and thighs|non-invasive body contouring of waists hips and thighs
5222036|NCT00738413|Iron chelation|iron chelation
5222037|NCT00738413|Iron balance|iron balance
5222038|NCT00738413|Secondary iron overload|secondary iron overload
5222039|NCT00738413|deferoxamine|deferoxamine
5222040|NCT00738413|deferasirox|deferasirox
5222041|NCT00738400|Vardenafil|vardenafil
5222042|NCT00738400|Erectile Dysfunction|erectile dysfunction
5222043|NCT00738400|Double-blind study|double-blind study
5222044|NCT00738387|Tumor vascular disrupting agent|tumor vascular disrupting agent
5222045|NCT00738387|VDA|vda
5222046|NCT00738387|ASA404|asa404
5222047|NCT00738387|non-small cell lung cancer|non-small cell lung cancer
5222048|NCT00738387|NSCLC|nsclc
5222049|NCT00738361|ciliary body and choroid melanoma, medium/large size|ciliary body and choroid melanoma, medium/large size
5222050|NCT00738361|iris melanoma|iris melanoma
5222051|NCT00738361|metastatic intraocular melanoma|metastatic intraocular melanoma
5222052|NCT00738361|recurrent intraocular melanoma|recurrent intraocular melanoma
5222053|NCT00738361|extraocular extension melanoma|extraocular extension melanoma
5222054|NCT00738348|surgery|surgery
5222055|NCT00738335|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5222056|NCT00738335|tumors metastatic to brain|tumors metastatic to brain
5222057|NCT00738335|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5222058|NCT00738322|AZD1305|azd1305
5222059|NCT00738322|safety|safety
5222060|NCT00738322|pharmacokinetics|pharmacokinetics
5222061|NCT00738322|single ascending doses|single ascending doses
5222062|NCT00738322|Japanese|japanese
5222063|NCT00738322|male|male
5222064|NCT00738309|Treatment Outcomes|treatment outcomes
5222065|NCT00738309|Spinal Deformity|spinal deformity
5222066|NCT00738309|Scheuermann's Kyphosis|scheuermann's kyphosis
5222067|NCT00738283|Zinc|zinc
5222068|NCT00738283|Copper|copper
5222069|NCT00738283|Neonate|neonate
5222070|NCT00738257|Renal|renal
5222071|NCT00738257|transplant,|transplant,
5222072|NCT00738257|pamidronate,|pamidronate,
5222073|NCT00738257|ciclosporin,|ciclosporin,
5222074|NCT00738257|Ciclosporin A,|ciclosporin a,
5222075|NCT00738257|steroids,|steroids,
5222076|NCT00738257|bone mineral density,|bone mineral density,
5222077|NCT00738257|fracture rates|fracture rates
5222078|NCT00738257|immunosuppressive|immunosuppressive
5222079|NCT00738257|regimen|regimen
5222080|NCT00738244|hearing aid algorithm|hearing aid algorithm
5222081|NCT00738244|wind-noise suppression|wind-noise suppression
5222082|NCT00738231|risk factors; coronary arterial hearth disease|risk factors; coronary arterial hearth disease
5222083|NCT00738218|Coronary Artery Disease|coronary artery disease
5222084|NCT00738218|Computed Tomography|computed tomography
5222085|NCT00738218|Angiography|angiography
5222086|NCT00738205|Electronic device|electronic device
5222087|NCT00738205|Growth hormone treatment|growth hormone treatment
5222088|NCT00738192|Postoperative analgesia|postoperative analgesia
5222089|NCT00738192|Opioids|opioids
5222090|NCT00738192|Laparoscopic surgery|laparoscopic surgery
5222091|NCT00738179|Continuous Positive Airway Pressure (CPAP)|continuous positive airway pressure (cpap)
5222092|NCT00738179|Obstructive Sleep Apnea (OSA)|obstructive sleep apnea (osa)
5222093|NCT00738179|Cardiovascular (CV)|cardiovascular (cv)
5222094|NCT00738179|Cardiovascular Disease|cardiovascular disease
5222095|NCT00738179|Clinical Trial|clinical trial
5222096|NCT00738166|diet, organic, health|diet, organic, health
5222097|NCT00738166|healthy people|healthy people
5222098|NCT00738140|insulin sensitivity|insulin sensitivity
5222099|NCT00738140|Diabetes Prevention Program|diabetes prevention program
5222100|NCT00738140|lifestyle intervention|lifestyle intervention
5222101|NCT00738127|Acute trans-scaphoid perilunate dislocations|acute trans-scaphoid perilunate dislocations
5222102|NCT00738127|Open reduction and internal fixation|open reduction and internal fixation
5222103|NCT00738127|Kirschner-wire|kirschner-wire
5222104|NCT00738127|Range of motion|range of motion
5222105|NCT00738114|non-cardiac|non-cardiac
5222106|NCT00738114|surgery|surgery
5222107|NCT00738114|mortality|mortality
5222108|NCT00738114|morbidity|morbidity
5222109|NCT00738114|perioperative|perioperative
5222110|NCT00738114|period|period
5222111|NCT00738101|Omega-3|omega-3
5222112|NCT00738101|Omegaven|omegaven
5222113|NCT00738101|Cholestasis|cholestasis
5222114|NCT00738101|Liver damage|liver damage
5222115|NCT00738088|Sulphonylurea|sulphonylurea
5222116|NCT00738088|Pharmacogenetics|pharmacogenetics
5222117|NCT00738062|NOH|noh
5222118|NCT00738062|Neurogenic Orthostatic Hypotension|neurogenic orthostatic hypotension
5222119|NCT00738062|Orthostatic hypotension|orthostatic hypotension
5222120|NCT00738062|PAF|paf
5222121|NCT00738062|Pure Autonomic Failure|pure autonomic failure
5222122|NCT00738062|MSA|msa
5222123|NCT00738062|Multiple System Atrophy|multiple system atrophy
5222124|NCT00738062|Neuropathy|neuropathy
5222125|NCT00738062|Autonomic Failure|autonomic failure
5222126|NCT00738062|Parkinson|parkinson
5222225|NCT00737763|Diabetes|diabetes
5222127|NCT00738062|Dopamine Deficiency|dopamine deficiency
5222128|NCT00738062|Dopamine|dopamine
5222129|NCT00738062|Droxidopa|droxidopa
5222130|NCT00738049|atherosclerosis|atherosclerosis
5222131|NCT00738049|coronary artery disease|coronary artery disease
5222132|NCT00738049|myocardial perfusion defect|myocardial perfusion defect
5222133|NCT00738049|endothelial dysfunction|endothelial dysfunction
5222134|NCT00738049|endothelin receptor blockade|endothelin receptor blockade
5222135|NCT00738036|Analgesics|analgesics
5222136|NCT00738036|Opioid|opioid
5222137|NCT00738036|Opioid maintenance therapy|opioid maintenance therapy
5222138|NCT00738036|Acute pain|acute pain
5222139|NCT00738023|diabetes,|diabetes,
5222140|NCT00738023|hypertension,|hypertension,
5222141|NCT00738023|free-fatty acids|free-fatty acids
5222142|NCT00738010|NMES|nmes
5222143|NCT00738010|ACL|acl
5222144|NCT00738010|Atrophy Prevention|atrophy prevention
5222145|NCT00738010|Accelerated Recovery|accelerated recovery
5222146|NCT00738010|Knee Surgery|knee surgery
5222147|NCT00737997|Pediatrics|pediatrics
5222148|NCT00737997|Scoliosis|scoliosis
5222149|NCT00737997|Morphine|morphine
5222150|NCT00737997|Surgery|surgery
5222151|NCT00737997|Analgesia|analgesia
5222152|NCT00737984|Infertility|infertility
5222153|NCT00737984|Clinical pregnancy rate|clinical pregnancy rate
5222154|NCT00737971|avastin|avastin
5222155|NCT00737971|bevacizumab|bevacizumab
5222156|NCT00737971|triamcinolone|triamcinolone
5222157|NCT00737971|diabetic macular edema|diabetic macular edema
5222158|NCT00737971|macular edema|macular edema
5222159|NCT00737971|intravitreal injection|intravitreal injection
5222160|NCT00737958|Angina pectoris|angina pectoris
5222161|NCT00737958|Air pollution|air pollution
5222162|NCT00737958|Diesel exhaust|diesel exhaust
5222163|NCT00737958|Myocardial ischaemia|myocardial ischaemia
5222164|NCT00737958|Exercise capacity|exercise capacity
5222165|NCT00737919|Cholesterol|cholesterol
5222166|NCT00737919|Plant sterols|plant sterols
5222167|NCT00737919|Atherosclerotic carotid plaques|atherosclerotic carotid plaques
5222168|NCT00737906|Chronic rhinitis|chronic rhinitis
5222169|NCT00737906|Nasal Obstruction|nasal obstruction
5222170|NCT00737906|Nasal Obstruction Symptoms|nasal obstruction symptoms
5222171|NCT00737906|Failed Medical Management for Nasal Obstruction|failed medical management for nasal obstruction
5222172|NCT00737906|Inflammation of the nasal mucosa|inflammation of the nasal mucosa
5222173|NCT00737906|Pediatric Turbinate reduction|pediatric turbinate reduction
5222174|NCT00737906|Coblation|coblation
5222175|NCT00737906|Arthrocare|arthrocare
5222176|NCT00737906|ENT|ent
5222177|NCT00737906|Failed Medical Management for Chronic Sinusitis|failed medical management for chronic sinusitis
5222178|NCT00737906|Turbinate|turbinate
5222179|NCT00737906|Inferior Turbinate Hypertrophy|inferior turbinate hypertrophy
5222180|NCT00737906|Bilateral Inferior Turbinate Hypertrophy|bilateral inferior turbinate hypertrophy
5222181|NCT00737906|Turbinate Hypertrophy|turbinate hypertrophy
5222182|NCT00737906|Inferior Turbinate|inferior turbinate
5222183|NCT00737906|Bilateral Inferior Turbinate|bilateral inferior turbinate
5222184|NCT00737893|Erythropoietin|erythropoietin
5222185|NCT00737893|Radical Prostatectomy|radical prostatectomy
5222186|NCT00737893|Erectile Dysfunction|erectile dysfunction
5222187|NCT00737893|Prostate Cancer|prostate cancer
5222188|NCT00737880|Pancreas Clinical, Donor|pancreas clinical, donor
5222189|NCT00737880|Pancreas Clinical, Preservation Solutions|pancreas clinical, preservation solutions
5222190|NCT00737880|Organ Preservation and Procurement, Surgery|organ preservation and procurement, surgery
5222191|NCT00737880|Organ Procurement, Ischemia reperfusion Injury|organ procurement, ischemia reperfusion injury
5222192|NCT00737880|Organ Preservation and Procurement|organ preservation and procurement
5222193|NCT00737867|lung cancer|lung cancer
5222194|NCT00737867|chemotherapy|chemotherapy
5222195|NCT00737867|vinorelbine|vinorelbine
5222196|NCT00737867|gemcitabine|gemcitabine
5222197|NCT00737867|carboplatin|carboplatin
5222198|NCT00737867|advanced lung cancer|advanced lung cancer
5222199|NCT00737867|non-small cell lung cancer|non-small cell lung cancer
5222200|NCT00737854|OLP|olp
5222201|NCT00737854|Free Soft Tissue Graft|free soft tissue graft
5222202|NCT00737854|Treatment|treatment
5222203|NCT00737841|stress|stress
5222204|NCT00737841|brain-gut interactions|brain-gut interactions
5222205|NCT00737841|visceral perception|visceral perception
5222206|NCT00737841|gastrointestinal motility|gastrointestinal motility
5222207|NCT00737841|emotion|emotion
5222208|NCT00737828|Cardiopulmonary exercise test|cardiopulmonary exercise test
5222209|NCT00737828|CPX|cpx
5222210|NCT00737828|CPEX|cpex
5222211|NCT00737828|surgical outcome|surgical outcome
5222212|NCT00737828|colorectal surgery|colorectal surgery
5222213|NCT00737828|risk stratification|risk stratification
5222214|NCT00737815|Randomized Controlled Trial|randomized controlled trial
5222215|NCT00737815|Magnesium|magnesium
5222216|NCT00737815|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
5222217|NCT00737815|Inflammation|inflammation
5222218|NCT00737802|GERD|gerd
5222219|NCT00737802|Heartburn|heartburn
5222220|NCT00737802|Esophageal reflux|esophageal reflux
5222221|NCT00737802|Barretts esophagus|barretts esophagus
5222222|NCT00737802|Normal subjects|normal subjects
5222223|NCT00737763|efalizumab|efalizumab
5222224|NCT00737763|Raptiva|raptiva
5222226|NCT00737763|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
5222227|NCT00737750|Neuromuscular electrical stimulation (NMES)|neuromuscular electrical stimulation (nmes)
5222228|NCT00737750|Knee Surgery|knee surgery
5222229|NCT00737750|Anterior cruciate ligament|anterior cruciate ligament
5222230|NCT00737750|Atrophy Prevention|atrophy prevention
5222231|NCT00737750|Accelerated Recovery|accelerated recovery
5222232|NCT00737737|Analgesia|analgesia
5222233|NCT00737737|Chronic Pain|chronic pain
5222234|NCT00737737|Neuroendocrine Axis|neuroendocrine axis
5222235|NCT00737737|Degenerative Diseases|degenerative diseases
5222236|NCT00737724|Enzyme-Linked ImmunoSpot|enzyme-linked immunospot
5222237|NCT00737724|Deferred treatment|deferred treatment
5222238|NCT00737724|Immune Recovery Inflammatory Syndrome|immune recovery inflammatory syndrome
5222239|NCT00737698|COPD|copd
5222240|NCT00737698|exercise|exercise
5222241|NCT00737698|repetitive magnetic stimulation|repetitive magnetic stimulation
5222242|NCT00737698|quadriceps strength|quadriceps strength
5222243|NCT00737685|Pediatric|pediatric
5222244|NCT00737685|UBMT|ubmt
5222245|NCT00737685|Severe|severe
5222246|NCT00737672|Hemodialysis|hemodialysis
5222247|NCT00737672|Stent Graft|stent graft
5222248|NCT00737672|Venous Anastomosis|venous anastomosis
5222249|NCT00737672|Arteriovenous Grafts|arteriovenous grafts
5222250|NCT00737659|Renal Transplant|renal transplant
5222251|NCT00737659|Renal|renal
5222252|NCT00737659|Transplant|transplant
5222253|NCT00737659|MMF|mmf
5222254|NCT00737659|MPA|mpa
5222255|NCT00737659|Recipients|recipients
5222256|NCT00737646|Cancer|cancer
5222257|NCT00737646|Colorectal cancer|colorectal cancer
5222258|NCT00737646|Patient education|patient education
5222259|NCT00737646|Physician education|physician education
5222260|NCT00737633|Diabetes|diabetes
5222261|NCT00737633|Type 2 Diabetes|type 2 diabetes
5222262|NCT00737633|Diabetes Mellitus|diabetes mellitus
5222263|NCT00737633|Metabolic Diseases|metabolic diseases
5222264|NCT00737633|Glucose Metabolism Disorders|glucose metabolism disorders
5222265|NCT00737633|Glycemic Control|glycemic control
5222266|NCT00737620|Renal Failure, End Stage|renal failure, end stage
5222267|NCT00737620|Blood Vessel Grafting|blood vessel grafting
5222268|NCT00737620|Hemodialysis|hemodialysis
5222269|NCT00737620|Surgical Arteriovenous Shunt|surgical arteriovenous shunt
5222270|NCT00737607|outcome|outcome
5222271|NCT00737607|surgery|surgery
5222272|NCT00737607|lumbar spinal stenosis|lumbar spinal stenosis
5222273|NCT00737607|minimally invasive|minimally invasive
5222274|NCT00737581|Subject's|subject's
5222275|NCT00737581|response|response
5222276|NCT00737581|changes|changes
5222277|NCT00737581|in spinal|in spinal
5222278|NCT00737581|cord|cord
5222279|NCT00737581|stimulation|stimulation
5222280|NCT00737581|during|during
5222281|NCT00737581|postural|postural
5222282|NCT00737568|Tenofovir DF|tenofovir df
5222283|NCT00737568|Emtricitabine|emtricitabine
5222284|NCT00737568|Chronic hepatitis B|chronic hepatitis b
5222285|NCT00737568|Combination therapy|combination therapy
5222286|NCT00737555|Solid tumour|solid tumour
5222287|NCT00737555|Solid tumor|solid tumor
5222288|NCT00737555|Pharmacokinetic|pharmacokinetic
5222289|NCT00737555|Interaction|interaction
5222290|NCT00737555|dose escalation|dose escalation
5222291|NCT00737555|cancer|cancer
5222292|NCT00737555|paclitaxel|paclitaxel
5222293|NCT00737542|management|management
5222294|NCT00737542|post|post
5222295|NCT00737529|Mantle Cell Lymphoma|mantle cell lymphoma
5222296|NCT00737529|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
5222297|NCT00737529|CC-5013|cc-5013
5222298|NCT00737529|Revlimid|revlimid
5222299|NCT00737529|Lenalidomide|lenalidomide
5222300|NCT00737516|Registry|registry
5222301|NCT00737516|Unrelated Umbilical Cord Blood donor|unrelated umbilical cord blood donor
5222302|NCT00737516|Hematopoietic Reconstitution|hematopoietic reconstitution
5222303|NCT00737516|Center for Cord Blood|center for cord blood
5222304|NCT00737516|Bone Marrow Transplantation|bone marrow transplantation
5222305|NCT00737503|vaccine effectiveness, rotavirus, diarrhoea, Bangladesh|vaccine effectiveness, rotavirus, diarrhoea, bangladesh
5222306|NCT00737451|urticaria|urticaria
5222307|NCT00737451|goiter|goiter
5222308|NCT00737438|BEVACIZUMAB (AVASTIN)|bevacizumab (avastin)
5222309|NCT00737438|CAPECITABINE (ORAL)|capecitabine (oral)
5222310|NCT00737438|CISPLATIN|cisplatin
5222311|NCT00737438|EPIRUBICIN|epirubicin
5222312|NCT00737438|IRINOTECAN (CPT-11) CAMPTOSAR|irinotecan (cpt-11) camptosar
5222313|NCT00737438|TAXOTERE (DOCETAXEL)|taxotere (docetaxel)
5222314|NCT00737438|ESOPHAGUS|esophagus
5222316|NCT00737438|08-081|08-081
5222317|NCT00737425|laparoscopic-assisted surgery|laparoscopic-assisted surgery
5222318|NCT00737425|abdominal|abdominal
5222319|NCT00737425|pain relief|pain relief
5222320|NCT00737425|wound healing|wound healing
5222321|NCT00737425|low intensity ultrasound|low intensity ultrasound
5222322|NCT00737412|Bio-K+CL1285|bio-k+cl1285
5222323|NCT00737412|Probiotics|probiotics
5222324|NCT00737412|Traveler's Diarrhea|traveler's diarrhea
5222325|NCT00737412|Lactobacillus Acidophilus|lactobacillus acidophilus
5222326|NCT00737412|Lactobacillus Casei|lactobacillus casei
5222327|NCT00737399|depression|depression
5222328|NCT00737399|anxiety|anxiety
5222329|NCT00737399|pain|pain
5222330|NCT00737399|insomnia|insomnia
5222331|NCT00737399|cancer|cancer
5222332|NCT00737399|cholangiocarcinoma|cholangiocarcinoma
5222333|NCT00737399|EFT (Emotional Freedom Techniques)|eft (emotional freedom techniques)
5222334|NCT00737386|Leishmania tropica|leishmania tropica
5222335|NCT00737386|Hyrax|hyrax
5222336|NCT00737386|Sandfly|sandfly
5222337|NCT00737347|type 2 diabetes|type 2 diabetes
5222338|NCT00737347|obesity|obesity
5222339|NCT00737347|weight gain|weight gain
5222340|NCT00737347|thiazolidinediones|thiazolidinediones
5222341|NCT00737334|Carotid stenosis|carotid stenosis
5222342|NCT00737334|EEGo|eego
5222343|NCT00737334|nonlinear EEG|nonlinear eeg
5222344|NCT00737334|BIS|bis
5222345|NCT00737334|cerebral oximetry|cerebral oximetry
5222346|NCT00737334|FORE-SIGHT cerebral oximeter|fore-sight cerebral oximeter
5222347|NCT00737334|cerebral monitoring|cerebral monitoring
5222348|NCT00737334|arterial jugular venous lactate difference|arterial jugular venous lactate difference
5222349|NCT00737334|cerebral ischemia|cerebral ischemia
5222350|NCT00737334|carotid endarterectomy|carotid endarterectomy
5222351|NCT00737321|Impact of ischemia|impact of ischemia
5222352|NCT00737321|Impact of stress and|impact of stress and
5222353|NCT00737321|Identify patterns of gene expression|identify patterns of gene expression
5222354|NCT00737308|crowns|crowns
5222355|NCT00737308|ceramics|ceramics
5222356|NCT00737295|Biliary|biliary
5222357|NCT00737295|Dyskinesia|dyskinesia
5222358|NCT00737295|Gallbladder|gallbladder
5222359|NCT00737295|Cholecystitis|cholecystitis
5222360|NCT00737282|Uterine Fibroids|uterine fibroids
5222361|NCT00737269|Complicated Skin and Soft-Tissue Infection|complicated skin and soft-tissue infection
5222362|NCT00737269|Skin Infection|skin infection
5222363|NCT00737269|Skin Infection Registry|skin infection registry
5222364|NCT00737269|cSSTI Registry|cssti registry
5222365|NCT00737243|Carcinoma of Unknown Primary Site|carcinoma of unknown primary site
5222366|NCT00737243|Molecular profiling assay|molecular profiling assay
5222367|NCT00737243|Bevacizumab|bevacizumab
5222368|NCT00737243|Erlotinib|erlotinib
5222369|NCT00737243|Paclitaxel|paclitaxel
5222370|NCT00737243|Carboplatin|carboplatin
5222371|NCT00737230|long-term effects secondary to cancer therapy in adults|long-term effects secondary to cancer therapy in adults
5222372|NCT00737230|long-term effects secondary to cancer therapy in children|long-term effects secondary to cancer therapy in children
5222373|NCT00737230|gastrointestinal complications|gastrointestinal complications
5222374|NCT00737230|radiation toxicity|radiation toxicity
5222375|NCT00737230|prostate cancer|prostate cancer
5222376|NCT00737230|bladder cancer|bladder cancer
5222377|NCT00737230|vulvar cancer|vulvar cancer
5222378|NCT00737230|vaginal cancer|vaginal cancer
5222379|NCT00737230|cervical cancer|cervical cancer
5222380|NCT00737230|endometrial cancer|endometrial cancer
5222381|NCT00737230|anal cancer|anal cancer
5222382|NCT00737230|rectal cancer|rectal cancer
5222383|NCT00737230|malignant testicular germ cell tumor|malignant testicular germ cell tumor
5222384|NCT00737204|HIV|hiv
5222385|NCT00737204|AIDS|aids
5222386|NCT00737204|Armodafinil|armodafinil
5222387|NCT00737204|Depression|depression
5222388|NCT00737191|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5222389|NCT00737191|hematopoietic/lymphoid cancer|hematopoietic/lymphoid cancer
5222390|NCT00737191|pain|pain
5222391|NCT00737178|IUD|iud
5222392|NCT00737178|Intrauterine device|intrauterine device
5222393|NCT00737178|Intrauterine contraception|intrauterine contraception
5222394|NCT00737178|Medication abortion|medication abortion
5222395|NCT00737178|Medical abortion|medical abortion
5222396|NCT00737165|Suicide, Prevention|suicide, prevention
5222397|NCT00737165|Community|community
5222398|NCT00737152|RAS 130|ras 130
5222399|NCT00737152|Exercise|exercise
5222400|NCT00737152|Diabetes Mellitus|diabetes mellitus
5222401|NCT00737152|Type II Diabetes|type ii diabetes
5222402|NCT00737152|Diabetes|diabetes
5222403|NCT00737152|Aerobic|aerobic
5222404|NCT00737139|Hip|hip
5222405|NCT00737139|Knee|knee
5222406|NCT00737139|Arthroplasty|arthroplasty
5222407|NCT00737139|Epinephrine|epinephrine
5222408|NCT00737139|Hemostasis|hemostasis
5222409|NCT00737126|Diabetic nephropathies|diabetic nephropathies
5222410|NCT00737126|Hyperhomocysteinemia|hyperhomocysteinemia
5222411|NCT00737126|Folic acid|folic acid
5222412|NCT00737126|Endothelial dysfunction|endothelial dysfunction
5222413|NCT00737113|allogeneic stem cell transplantation|allogeneic stem cell transplantation
5222414|NCT00737113|Engrafted|engrafted
5222415|NCT00737113|subjects|subjects
5222416|NCT00737087|total shoulder replacement|total shoulder replacement
5222417|NCT00737087|rotator cuff|rotator cuff
5222418|NCT00737087|osteoarthritis|osteoarthritis
5222419|NCT00737087|rheumatoid arthritis|rheumatoid arthritis
5222420|NCT00737087|Delta Extend|delta extend
5222421|NCT00737074|Fibrovascular proliferation|fibrovascular proliferation
5222422|NCT00737074|Internal limiting membrane peeling|internal limiting membrane peeling
5222423|NCT00737074|Macular detachment|macular detachment
5222424|NCT00737074|Macular hole|macular hole
5222425|NCT00737074|Proliferative diabetic retinopathy.|proliferative diabetic retinopathy.
5222426|NCT00737061|Female|female
5222427|NCT00737061|Sterilization|sterilization
5222428|NCT00737048|Pain|pain
5222429|NCT00737048|Tooth extraction|tooth extraction
5222430|NCT00737048|Oral surgery|oral surgery
5222431|NCT00737048|Postoperative pain|postoperative pain
5222432|NCT00737048|JNS013|jns013
5222433|NCT00737048|Tramadol hydrochloride|tramadol hydrochloride
5222434|NCT00737048|Acetaminophen|acetaminophen
5222435|NCT00737035|Intimate Partner Homicide|intimate partner homicide
5222436|NCT00737035|Parental Homicide|parental homicide
5222437|NCT00737035|Guardians of Child Survivors of Parental Homicide|guardians of child survivors of parental homicide
5222438|NCT00737035|Post-Traumatic Stress Disorder|post-traumatic stress disorder
5222439|NCT00737035|Uxoricide Project|uxoricide project
5222440|NCT00737022|Diabetic vitrectomy|diabetic vitrectomy
5222441|NCT00737022|Epiretinal membrane (ERM)|epiretinal membrane (erm)
5222442|NCT00737022|Macular appearance|macular appearance
5222443|NCT00737022|Optical coherence tomography (OCT)|optical coherence tomography (oct)
5222444|NCT00737022|Visual function|visual function
5222445|NCT00737009|Breast cancer|breast cancer
5222446|NCT00737009|adherence|adherence
5222447|NCT00737009|anastrozole|anastrozole
5222448|NCT00737009|post-menopausal women|post-menopausal women
5222449|NCT00736996|Metabolic Syndrome|metabolic syndrome
5222450|NCT00736996|Mild Cognitive Impairment|mild cognitive impairment
5222451|NCT00736996|Insulin Resistance|insulin resistance
5222452|NCT00736996|Endurance Exercise|endurance exercise
5222453|NCT00736983|Perianal fistulas|perianal fistulas
5222454|NCT00736983|Crohn's disease|crohn's disease
5222455|NCT00736970|ridaforolimus|ridaforolimus
5222456|NCT00736970|deforolimus|deforolimus
5222457|NCT00736970|AP23573|ap23573
5222458|NCT00736970|breast cancer|breast cancer
5222459|NCT00736957|Chronic Pain|chronic pain
5222460|NCT00736957|Acetaminophen|acetaminophen
5222461|NCT00736957|Tramadol|tramadol
5222462|NCT00736957|JNS013|jns013
5222463|NCT00736931|Brivaracetam|brivaracetam
5222464|NCT00736931|Cognitive neurophysiological tests (CNT)|cognitive neurophysiological tests (cnt)
5222465|NCT00736931|Neuropsychological assessments|neuropsychological assessments
5222466|NCT00736918|Suicide Attempt|suicide attempt
5222467|NCT00736905|TMC278-TiDP6-C130|tmc278-tidp6-c130
5222468|NCT00736905|TMC278-C130|tmc278-c130
5222469|NCT00736905|healthy volunteer|healthy volunteer
5222470|NCT00736905|hepatic impairment|hepatic impairment
5222471|NCT00736905|HIV Infections|hiv infections
5222472|NCT00736892|Acute lung injury|acute lung injury
5222473|NCT00736892|Acute respiratory distress syndrome|acute respiratory distress syndrome
5222474|NCT00736892|Mechanical ventilation|mechanical ventilation
5222475|NCT00736892|Prognosis|prognosis
5222476|NCT00736892|Definitions|definitions
5222477|NCT00736879|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
5222478|NCT00736879|Diabetes Mellitus|diabetes mellitus
5222479|NCT00736879|Endocrine System Diseases|endocrine system diseases
5222480|NCT00736879|Glucose Metabolism Disorders|glucose metabolism disorders
5222481|NCT00736879|Metabolic Diseases|metabolic diseases
5222482|NCT00736866|acetylcysteine|acetylcysteine
5222483|NCT00736866|contrast-induced nephropathy|contrast-induced nephropathy
5222484|NCT00736866|angiography|angiography
5222485|NCT00736866|angioplasty with or without Stent|angioplasty with or without stent
5222486|NCT00736853|Chronic pain|chronic pain
5222487|NCT00736853|Acetoaminophen|acetoaminophen
5222488|NCT00736853|Tramadol|tramadol
5222489|NCT00736853|Osteoarthritis of the knee|osteoarthritis of the knee
5222490|NCT00736853|Low back pain|low back pain
5222491|NCT00736840|Methacetin|methacetin
5222492|NCT00736840|Breath|breath
5222493|NCT00736840|Test|test
5222494|NCT00736840|Cirrhosis|cirrhosis
5222495|NCT00736827|BK virus|bk virus
5222496|NCT00736827|acute renal failure|acute renal failure
5222497|NCT00736827|hemodiafiltration|hemodiafiltration
5222498|NCT00736827|humans|humans
5222499|NCT00736827|patients|patients
5222500|NCT00736827|polytrauma|polytrauma
5222501|NCT00736827|surgery|surgery
5222502|NCT00736827|complement|complement
5222503|NCT00736827|inflammation|inflammation
5222504|NCT00736827|inflammatory response|inflammatory response
5222505|NCT00736827|biomarkers|biomarkers
5222506|NCT00736827|cytokines|cytokines
5222507|NCT00736827|cell surface markers|cell surface markers
5222508|NCT00736827|functional polymorphisms|functional polymorphisms
5222509|NCT00736827|infections|infections
5222510|NCT00736827|systemic inflammatory response syndrome|systemic inflammatory response syndrome
5222511|NCT00736827|SIRS|sirs
5222512|NCT00736827|sepsis|sepsis
5222513|NCT00736827|severe sepsis|severe sepsis
5222514|NCT00736827|shock|shock
5222515|NCT00736827|organ dysfunctions|organ dysfunctions
5222516|NCT00736827|SOFA|sofa
5222517|NCT00736827|severity of disease|severity of disease
5222518|NCT00736827|APACHEII|apacheii
5222519|NCT00736827|SAPSII|sapsii
5222520|NCT00736827|SPAPS3|spaps3
5222521|NCT00736827|length of stay|length of stay
5222522|NCT00736827|outcome|outcome
5222523|NCT00736827|mortality|mortality
5222524|NCT00736814|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5222525|NCT00736814|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5222526|NCT00736801|Airway hyperresponsiveness|airway hyperresponsiveness
5222527|NCT00736788|AZD1704,|azd1704,
5222528|NCT00736788|Japanese|japanese
5222529|NCT00736788|Healthy|healthy
5222530|NCT00736788|Volunteers,|volunteers,
5222531|NCT00736788|Phase I study,|phase i study,
5222532|NCT00736788|Single Ascending Dose|single ascending dose
5222533|NCT00736788|Safety,|safety,
5222534|NCT00736788|Tolerability|tolerability
5222535|NCT00736788|Pharmacokinetics|pharmacokinetics
5222536|NCT00736775|AD|ad
5222537|NCT00736775|Alzheimer's|alzheimer's
5222538|NCT00736775|Alzheimers|alzheimers
5222539|NCT00736762|Global postural re-education|global postural re-education
5222540|NCT00736762|Balance|balance
5222541|NCT00736762|Physical therapy|physical therapy
5222542|NCT00736762|older people|older people
5222543|NCT00736723|NT-proBNP|nt-probnp
5222544|NCT00736723|myocardial dysfunction|myocardial dysfunction
5222545|NCT00736723|humans|humans
5222546|NCT00736723|patients|patients
5222547|NCT00736723|polytrauma|polytrauma
5222548|NCT00736723|complement|complement
5222549|NCT00736723|inflammation|inflammation
5222550|NCT00736723|inflammatory response|inflammatory response
5222551|NCT00736723|biomarkers|biomarkers
5222552|NCT00736723|cytokines|cytokines
5222553|NCT00736723|cell surface markers|cell surface markers
5222554|NCT00736723|functional polymorphisms|functional polymorphisms
5222555|NCT00736723|infections|infections
5222556|NCT00736723|systemic inflammatory response syndrome|systemic inflammatory response syndrome
5222557|NCT00736723|SIRS|sirs
5222558|NCT00736723|sepsis|sepsis
5222559|NCT00736723|severe sepsis|severe sepsis
5222560|NCT00736723|shock|shock
5222561|NCT00736723|organ dysfunctions|organ dysfunctions
5222562|NCT00736723|SOFA|sofa
5222563|NCT00736723|severity of disease|severity of disease
5222564|NCT00736723|APACHEII|apacheii
5222565|NCT00736723|SAPSII|sapsii
5222566|NCT00736723|SPAPS3|spaps3
5222567|NCT00736723|length of stay|length of stay
5222568|NCT00736723|outcome|outcome
5222569|NCT00736723|mortality|mortality
5222570|NCT00736710|Repetitive Transcranial Magnetic Stimulation|repetitive transcranial magnetic stimulation
5222571|NCT00736710|Cigarette smoking|cigarette smoking
5222572|NCT00736710|Schizophrenia|schizophrenia
5222573|NCT00736710|Randomized|randomized
5222574|NCT00736710|Double-blind|double-blind
5222575|NCT00736710|Placebo-controlled|placebo-controlled
5222576|NCT00736710|longitudinal|longitudinal
5222577|NCT00736710|nicotine patch|nicotine patch
5222578|NCT00736684|Femoral fractures [MeSH]|femoral fractures [mesh]
5222579|NCT00736684|hip fractures [MeSH]|hip fractures [mesh]
5222580|NCT00736684|trochanteric fractures (femoral neck fractures [MeSH])|trochanteric fractures (femoral neck fractures [mesh])
5222581|NCT00736684|intramedullary nailing (fracture fixation, intramedullary [MeSH])|intramedullary nailing (fracture fixation, intramedullary [mesh])
5222582|NCT00736684|complex femoral fractures|complex femoral fractures
5222583|NCT00736684|femoral nail|femoral nail
5222584|NCT00736684|surgical treatment (surgical procedures, operative [MeSH])|surgical treatment (surgical procedures, operative [mesh])
5222585|NCT00736684|complications|complications
5222586|NCT00736658|Japanese|japanese
5222587|NCT00736658|MAD|mad
5222588|NCT00736658|Multiple ascending dose|multiple ascending dose
5222589|NCT00736658|Chronic pain|chronic pain
5222590|NCT00736645|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5222591|NCT00736645|stage I prostate cancer|stage i prostate cancer
5222592|NCT00736645|stage II prostate cancer|stage ii prostate cancer
5222593|NCT00736632|Vitamin D|vitamin d
5222594|NCT00736632|Insulin Resistance|insulin resistance
5222595|NCT00736632|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
5222596|NCT00736632|Cardiovascular Disease|cardiovascular disease
5222597|NCT00736619|MAB C225(CETUXIMAB)(ANTI-EGFR)|mab c225(cetuximab)(anti-egfr)
5222598|NCT00736619|TAXOL (PACLITAXEL)|taxol (paclitaxel)
5222599|NCT00736619|Radiation Therapy|radiation therapy
5222600|NCT00736619|08-084|08-084
5222601|NCT00736606|simvastatin|simvastatin
5222602|NCT00736606|AZD5672|azd5672
5222603|NCT00736593|Wound|wound
5222604|NCT00736593|Healing|healing
5222605|NCT00736580|Cesarean delivery|cesarean delivery
5222606|NCT00736580|Surgical Needles|surgical needles
5222607|NCT00736580|blunt-tip needles|blunt-tip needles
5222608|NCT00736580|surgical glove perforation|surgical glove perforation
5222609|NCT00736567|Diarrhea|diarrhea
5222610|NCT00736567|Diagnostic|diagnostic
5222611|NCT00736567|Pediatric|pediatric
5222612|NCT00736554|Staphylococcus aureus|staphylococcus aureus
5222613|NCT00736554|CA-MRSA|ca-mrsa
5222614|NCT00736554|skin and soft tissue infections|skin and soft tissue infections
5222615|NCT00736554|resistance|resistance
5222616|NCT00736554|emergency department|emergency department
5222617|NCT00736541|ARF|arf
5222618|NCT00736541|OLT|olt
5222619|NCT00736541|NAC|nac
5222620|NCT00736541|I/R injury|i/r injury
5222621|NCT00736528|safety, tolerability, pharmacokinetics, cognition|safety, tolerability, pharmacokinetics, cognition
5222622|NCT00736515|combination therapy,monotherapy,gliclazide MR,insulin,CGMS|combination therapy,monotherapy,gliclazide mr,insulin,cgms
5222623|NCT00736489|Asthma|asthma
5222624|NCT00736489|airway obstruction|airway obstruction
5222625|NCT00736489|beta2-agonist|beta2-agonist
5222626|NCT00736489|efficacy|efficacy
5222627|NCT00736489|inhalation|inhalation
5222822|NCT00735566|TNM stage|tnm stage
5222628|NCT00736476|helicobacter pylori infection|helicobacter pylori infection
5222629|NCT00736476|vaccination|vaccination
5222630|NCT00736476|adults|adults
5222631|NCT00736463|HDL cholesterol|hdl cholesterol
5222632|NCT00736463|statin|statin
5222633|NCT00736463|inflammation|inflammation
5222634|NCT00736463|atherosclerosis|atherosclerosis
5222635|NCT00736463|prevention|prevention
5222636|NCT00736463|patients with low baseline HDL cholesterol|patients with low baseline hdl cholesterol
5222637|NCT00736437|UV-induced|uv-induced
5222638|NCT00736437|Herpes labialis|herpes labialis
5222639|NCT00736437|time to healing|time to healing
5222640|NCT00736424|Epilepsy|epilepsy
5222641|NCT00736424|SUDEP|sudep
5222642|NCT00736424|DBS|dbs
5222643|NCT00736411|infertility|infertility
5222644|NCT00736411|IVF|ivf
5222645|NCT00736411|acupuncture|acupuncture
5222646|NCT00736385|nonalcoholic fatty liver disease|nonalcoholic fatty liver disease
5222647|NCT00736372|cancer|cancer
5222648|NCT00736372|metastatic cancer|metastatic cancer
5222649|NCT00736372|advanced or metastatic cancer|advanced or metastatic cancer
5222650|NCT00736346|Panic Disorder|panic disorder
5222651|NCT00736346|anxiety|anxiety
5222652|NCT00736346|chest pain|chest pain
5222653|NCT00736346|emergency department|emergency department
5222654|NCT00736346|cognitive-behavioral treatment|cognitive-behavioral treatment
5222655|NCT00736320|Hodgkin Lymphoma|hodgkin lymphoma
5222656|NCT00736320|early stage|early stage
5222657|NCT00736320|PET|pet
5222658|NCT00736307|limbal stem cell deficiency|limbal stem cell deficiency
5222659|NCT00736294|Catheter Ablation, Radiofrequency|catheter ablation, radiofrequency
5222660|NCT00736294|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors
5222661|NCT00736281|Sublingual Immunotherapy for Food Allergy|sublingual immunotherapy for food allergy
5222662|NCT00736281|Food Drops for Food Allergy|food drops for food allergy
5222663|NCT00736268|Lung Disease|lung disease
5222664|NCT00736268|Chronic Bronchitis|chronic bronchitis
5222665|NCT00736268|Emphysema|emphysema
5222666|NCT00736268|Caregiver stress|caregiver stress
5222667|NCT00736268|COPD|copd
5222668|NCT00736268|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5222669|NCT00736255|ADHD|adhd
5222670|NCT00736255|Smoking|smoking
5222671|NCT00736242|HIV|hiv
5222672|NCT00736229|hyperglycemia|hyperglycemia
5222673|NCT00736229|acute coronary syndromes|acute coronary syndromes
5222674|NCT00736229|myocardial infarction|myocardial infarction
5222675|NCT00736216|cervical cancer|cervical cancer
5222676|NCT00736216|human papilloma virus infection|human papilloma virus infection
5222677|NCT00736203|fMRI|fmri
5222678|NCT00736203|non-smokers|non-smokers
5222679|NCT00736190|Hepatitis B|hepatitis b
5222680|NCT00736190|Hepatitis|hepatitis
5222681|NCT00736190|Tenofovir disoproxil fumarate|tenofovir disoproxil fumarate
5222682|NCT00736190|Tenofovir DF|tenofovir df
5222683|NCT00736190|Asian-American|asian-american
5222684|NCT00736177|IVF|ivf
5222685|NCT00736177|blastocyst transfer|blastocyst transfer
5222686|NCT00736177|endometrium|endometrium
5222687|NCT00736177|embryo cryopreservation|embryo cryopreservation
5222688|NCT00736164|stage I prostate cancer|stage i prostate cancer
5222689|NCT00736164|stage II prostate cancer|stage ii prostate cancer
5222690|NCT00736164|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5222691|NCT00736125|postoperative cognitive dysfunction|postoperative cognitive dysfunction
5222692|NCT00736125|total knee arthroplasty|total knee arthroplasty
5222693|NCT00736125|cerebral emboli|cerebral emboli
5222694|NCT00736125|carbon dioxide lavage|carbon dioxide lavage
5222695|NCT00736125|pulsatile saline lavage|pulsatile saline lavage
5222696|NCT00736112|Food Allergy in Children|food allergy in children
5222697|NCT00736112|Otitis Media with Effusion (OME)|otitis media with effusion (ome)
5222698|NCT00736112|Recurrent Middle Ear Infections|recurrent middle ear infections
5222699|NCT00736112|Middle Ear Fluid|middle ear fluid
5222700|NCT00736112|Food Allergy and Otitis Media with Effusion|food allergy and otitis media with effusion
5222701|NCT00736112|Recurrent middle ear fluid in children <4 years old|recurrent middle ear fluid in children <4 years old
5222702|NCT00736112|Chronic ear infections in children <4 years old|chronic ear infections in children <4 years old
5222703|NCT00736086|femoral artery|femoral artery
5222704|NCT00736086|post-percutaneous cardiac catheterization|post-percutaneous cardiac catheterization
5222705|NCT00736086|post-percutaneous peripheral vascular catheterization|post-percutaneous peripheral vascular catheterization
5222706|NCT00736086|post-percutaneous diagnostic catheterization|post-percutaneous diagnostic catheterization
5222707|NCT00736086|early ambulation|early ambulation
5222708|NCT00736086|vascular closure|vascular closure
5222709|NCT00736073|pancreatitis|pancreatitis
5222710|NCT00736060|Fever|fever
5222711|NCT00736060|Blood cultures|blood cultures
5222712|NCT00736047|Smokers|smokers
5222713|NCT00736047|smoking cessation|smoking cessation
5222714|NCT00736047|vaccine|vaccine
5222715|NCT00736047|antibodies|antibodies
5222716|NCT00736047|anti-nicotine|anti-nicotine
5222717|NCT00736034|Age Associated Memory Impairment|age associated memory impairment
5222718|NCT00736021|PTSD|ptsd
5222719|NCT00736021|Pharmacological Treatment|pharmacological treatment
5222720|NCT00736021|SSRI|ssri
5222721|NCT00736021|Escitalopram|escitalopram
5222722|NCT00736021|Anxiety Disorders|anxiety disorders
5222723|NCT00736008|Factor V Leiden|factor v leiden
5222724|NCT00736008|Prothrombin Mutation|prothrombin mutation
5222725|NCT00736008|Hypercoagulability|hypercoagulability
5222726|NCT00736008|Pediatrics|pediatrics
5222727|NCT00735969|Non-Responder|non-responder
5222728|NCT00735969|Relapser|relapser
5222729|NCT00735969|High Dose Ribavirin|high dose ribavirin
5222730|NCT00735969|Peginterferon|peginterferon
5222731|NCT00735969|Chronic Hepatitis C|chronic hepatitis c
5222732|NCT00735956|Screening|screening
5222733|NCT00735956|Brief Intervention|brief intervention
5222734|NCT00735943|Pegaptanib|pegaptanib
5222735|NCT00735943|macular degeneration|macular degeneration
5222736|NCT00735943|vascular endothelial growth factor|vascular endothelial growth factor
5222737|NCT00735904|AG-013736|ag-013736
5222738|NCT00735904|axitinib|axitinib
5222739|NCT00735904|cisplatin|cisplatin
5222740|NCT00735904|gemcitabine|gemcitabine
5222741|NCT00735904|NSCLC|nsclc
5222742|NCT00735904|squamous cell|squamous cell
5222743|NCT00735904|lung cancer|lung cancer
5222744|NCT00735878|Lung Cancer|lung cancer
5222745|NCT00735878|Advanced Lung Cancer|advanced lung cancer
5222746|NCT00735878|NSCLC|nsclc
5222747|NCT00735865|Dry Eye Syndrome|dry eye syndrome
5222748|NCT00735865|Punctal Occlusion|punctal occlusion
5222749|NCT00735865|Punctal Plugs|punctal plugs
5222750|NCT00735865|Tear Drainage duct blockage|tear drainage duct blockage
5222751|NCT00735852|endometriosis|endometriosis
5222752|NCT00735852|chronic cyclical pelvic pain|chronic cyclical pelvic pain
5222753|NCT00735826|resectable|resectable
5222754|NCT00735826|stage I-III|stage i-iii
5222755|NCT00735826|NSCLC|nsclc
5222756|NCT00735826|non-small cell lung cancer|non-small cell lung cancer
5222757|NCT00735826|vorinostat|vorinostat
5222758|NCT00735826|proof of principle|proof of principle
5222759|NCT00735826|resectable stage I to III NSCLC|resectable stage i to iii nsclc
5222760|NCT00735813|Catheterization, Central|catheterization, central
5222761|NCT00735813|Catheterization, Peripheral|catheterization, peripheral
5222762|NCT00735813|Infection|infection
5222763|NCT00735813|Methods|methods
5222764|NCT00735813|Sepsis|sepsis
5222765|NCT00735813|Microscopy, Electron, Scanning|microscopy, electron, scanning
5222766|NCT00735813|Sonication|sonication
5222767|NCT00735813|Taurolidine|taurolidine
5222768|NCT00735813|Catheters, Indwelling|catheters, indwelling
5222769|NCT00735813|Pediatrics|pediatrics
5222770|NCT00735800|Dementia|dementia
5222771|NCT00735800|Caregivers|caregivers
5222772|NCT00735800|Alzheimer's disease|alzheimer's disease
5222773|NCT00735774|Healthy volunteer study|healthy volunteer study
5222774|NCT00735748|Patients who will undergo a general anesthesia for a procedure in short stay|patients who will undergo a general anesthesia for a procedure in short stay
5222775|NCT00735735|low back pain|low back pain
5222776|NCT00735735|chronic|chronic
5222777|NCT00735735|Substance P|substance p
5222778|NCT00735722|AF|af
5222779|NCT00735722|CAD|cad
5222780|NCT00735709|Depression|depression
5222781|NCT00735709|Depressive Disorder|depressive disorder
5222782|NCT00735709|Mood Disorder|mood disorder
5222783|NCT00735709|Mental Disorder|mental disorder
5222784|NCT00735709|Melancholia, Involutional|melancholia, involutional
5222785|NCT00735709|Paraphrenia, Involutional|paraphrenia, involutional
5222786|NCT00735709|Drug Therapy|drug therapy
5222787|NCT00735696|Non Small Cell Lung Cancer|non small cell lung cancer
5222788|NCT00735696|Lung|lung
5222789|NCT00735696|NSCLC|nsclc
5222790|NCT00735683|Weight loss|weight loss
5222791|NCT00735683|Weight-loss drugs|weight-loss drugs
5222792|NCT00735683|Obesity|obesity
5222793|NCT00735683|Overweight|overweight
5222794|NCT00735683|Body weight|body weight
5222795|NCT00735683|Diet|diet
5222796|NCT00735683|Metabolic Disorder|metabolic disorder
5222797|NCT00735683|Nutrition Disorder|nutrition disorder
5222798|NCT00735670|SCI|sci
5222799|NCT00735657|Efficiency|efficiency
5222800|NCT00735657|Pars|pars
5222801|NCT00735657|Plana|plana
5222802|NCT00735657|Vitrectomy|vitrectomy
5222803|NCT00735644|Japanese encephalitis, Hepatitis A, Inactivated Mouse-Brain|japanese encephalitis, hepatitis a, inactivated mouse-brain
5222804|NCT00735631|Patients entering the post-operative cardiac intensive care unit following coronary artery reconstruction surgery.|patients entering the post-operative cardiac intensive care unit following coronary artery reconstruction surgery.
5222805|NCT00735618|Advanced Cancer|advanced cancer
5222806|NCT00735618|Cancer Patients|cancer patients
5222807|NCT00735618|Relaxation Therapy|relaxation therapy
5222808|NCT00735618|Relaxation and Heart Rate Variability|relaxation and heart rate variability
5222809|NCT00735618|Guided Relaxation|guided relaxation
5222810|NCT00735618|HRV|hrv
5222811|NCT00735618|Stress, Anxiety, and Panic Disorder|stress, anxiety, and panic disorder
5222812|NCT00735605|obstructed defecation|obstructed defecation
5222813|NCT00735605|constipation|constipation
5222814|NCT00735605|puborectalis|puborectalis
5222815|NCT00735592|X rays findings|x rays findings
5222816|NCT00735579|major abdominal surgery|major abdominal surgery
5222817|NCT00735579|coagulation|coagulation
5222818|NCT00735579|extracellular matrix proteins|extracellular matrix proteins
5222819|NCT00735579|wound healing after major abdominal surgery|wound healing after major abdominal surgery
5222820|NCT00735566|gastric cancer|gastric cancer
5222821|NCT00735566|antiangiogenic factors|antiangiogenic factors
5222823|NCT00735553|Uterine Fibroids|uterine fibroids
5222824|NCT00735527|seizures|seizures
5222825|NCT00735527|status epilepticus|status epilepticus
5222826|NCT00735527|lorazepam|lorazepam
5222827|NCT00735527|intra-nasal|intra-nasal
5222828|NCT00735514|radiation toxicity|radiation toxicity
5222829|NCT00735514|sexuality and reproductive issues|sexuality and reproductive issues
5222830|NCT00735514|stage I endometrial carcinoma|stage i endometrial carcinoma
5222831|NCT00735514|stage II endometrial carcinoma|stage ii endometrial carcinoma
5222832|NCT00735514|stage IB cervical cancer|stage ib cervical cancer
5222833|NCT00735514|stage IIA cervical cancer|stage iia cervical cancer
5222834|NCT00735514|stage IIB cervical cancer|stage iib cervical cancer
5222835|NCT00735514|stage III cervical cancer|stage iii cervical cancer
5222836|NCT00735488|Thalassemia|thalassemia
5222837|NCT00735488|Sickle cell anemia|sickle cell anemia
5222838|NCT00735488|Carrier detection|carrier detection
5222839|NCT00735488|Prenatal Diagnosis|prenatal diagnosis
5222840|NCT00735488|Genetic counseling|genetic counseling
5222841|NCT00735462|external genital warts|external genital warts
5222842|NCT00735462|perianal warts|perianal warts
5222843|NCT00735462|condylomata acuminata|condylomata acuminata
5222844|NCT00735462|human papilloma virus|human papilloma virus
5222845|NCT00735462|HPV types 6 and 11|hpv types 6 and 11
5222846|NCT00735436|Malignant glioma|malignant glioma
5222847|NCT00735436|Glioblastoma multiforme|glioblastoma multiforme
5222848|NCT00735436|GBM|gbm
5222849|NCT00735436|Gliosarcoma|gliosarcoma
5222850|NCT00735436|Gliadel|gliadel
5222851|NCT00735436|Carmustine|carmustine
5222852|NCT00735436|Irinotecan|irinotecan
5222853|NCT00735436|CPT-11|cpt-11
5222854|NCT00735436|Camptosar|camptosar
5222855|NCT00735436|Avastin|avastin
5222856|NCT00735436|Bevacizumab|bevacizumab
5222857|NCT00735423|Healthy children|healthy children
5222858|NCT00735423|Brain Function|brain function
5222859|NCT00735423|Diet|diet
5222860|NCT00735423|Nutrition|nutrition
5222861|NCT00735423|Language|language
5222862|NCT00735423|fMRI|fmri
5222863|NCT00735423|ERP|erp
5222864|NCT00735423|Behavior|behavior
5222865|NCT00735410|Influenza vaccine|influenza vaccine
5222866|NCT00735410|Seasonal|seasonal
5222867|NCT00735410|Split|split
5222868|NCT00735397|Partial onset seizures|partial onset seizures
5222869|NCT00735384|sepsis|sepsis
5222870|NCT00735384|critical illness|critical illness
5222871|NCT00735384|muscle, skeletal|muscle, skeletal
5222872|NCT00735384|myopathy|myopathy
5222873|NCT00735384|isometric contraction|isometric contraction
5222874|NCT00735384|intensive care units|intensive care units
5222875|NCT00735384|torque|torque
5222876|NCT00735384|muscular atrophy|muscular atrophy
5222877|NCT00735384|malignant hyperthermia|malignant hyperthermia
5222878|NCT00735384|skin resistance|skin resistance
5222879|NCT00735358|gastric variceal bleeding|gastric variceal bleeding
5222880|NCT00735358|cyanoacrylate|cyanoacrylate
5222881|NCT00735358|rebleeding|rebleeding
5222882|NCT00735358|complication|complication
5222883|NCT00735358|survival|survival
5222884|NCT00735358|acute gastric variceal bleeding|acute gastric variceal bleeding
5222885|NCT00735345|Esophageal cancer|esophageal cancer
5222886|NCT00735345|Pre-operative|pre-operative
5222887|NCT00735345|Chemo-immunotherapy|chemo-immunotherapy
5222888|NCT00735345|Radiochemo-immunotherapy|radiochemo-immunotherapy
5222889|NCT00735345|EGFR|egfr
5222890|NCT00735345|Radiosensitivity|radiosensitivity
5222891|NCT00735345|Resection|resection
5222892|NCT00735332|Melanoma|melanoma
5222893|NCT00735332|Metastatic Melanoma|metastatic melanoma
5222894|NCT00735332|Phase II|phase ii
5222895|NCT00735332|Skin Cancer|skin cancer
5222896|NCT00735319|Neonatal Jaundice|neonatal jaundice
5222897|NCT00735319|Physiological Neonatal Jaundice|physiological neonatal jaundice
5222898|NCT00735319|Neonatal Hyperbilirubinemia|neonatal hyperbilirubinemia
5222899|NCT00735319|Transcutaneous Bilirubinometer|transcutaneous bilirubinometer
5222900|NCT00735306|Locally advanced|locally advanced
5222901|NCT00735306|Unresectable|unresectable
5222902|NCT00735293|hyperhidrosis|hyperhidrosis
5222903|NCT00735293|bromidrosis|bromidrosis
5222904|NCT00735293|bromhidrosis|bromhidrosis
5222905|NCT00735293|osmidrosis|osmidrosis
5222906|NCT00735293|hircismus|hircismus
5222907|NCT00735293|excessive|excessive
5222908|NCT00735293|underarm|underarm
5222909|NCT00735293|sweat|sweat
5222910|NCT00735293|perspiration|perspiration
5222911|NCT00735293|Body Odor|body odor
5222912|NCT00735280|Coronary artery disease, stent, heparin|coronary artery disease, stent, heparin
5222913|NCT00735267|Generalized Anxiety Disorder|generalized anxiety disorder
5222914|NCT00735254|post|post
5222915|NCT00735254|surgical|surgical
5222916|NCT00735241|colon cancer|colon cancer
5222917|NCT00735241|colorectal cancer|colorectal cancer
5222918|NCT00735241|liver metastases|liver metastases
5222919|NCT00735241|SIR-Spheres Microspheres|sir-spheres microspheres
5222920|NCT00735241|yttrium-90|yttrium-90
5222921|NCT00735241|FOLFOX|folfox
5222922|NCT00735241|Bevacizumab|bevacizumab
5222923|NCT00735241|chemo-radiation|chemo-radiation
5222924|NCT00735228|surgery|surgery
5222925|NCT00735228|artificial pancreas|artificial pancreas
5222926|NCT00735228|tight glycemic control|tight glycemic control
5222927|NCT00735228|Liver|liver
5222928|NCT00735215|Breast cancer,|breast cancer,
5222929|NCT00735215|fulvestrant,|fulvestrant,
5222930|NCT00735215|postmenopausal,|postmenopausal,
5222931|NCT00735215|women|women
5222932|NCT00735215|locally advanced,|locally advanced,
5222933|NCT00735215|hormone receptor-positive.|hormone receptor-positive.
5222934|NCT00735189|warfarin|warfarin
5222935|NCT00735189|anticoagulation|anticoagulation
5222936|NCT00735189|anticoagulation clinics|anticoagulation clinics
5222937|NCT00735176|Radiculopathy, cervical|radiculopathy, cervical
5222938|NCT00735176|Nerve Root Compression|nerve root compression
5222939|NCT00735176|Disc, intervertebral|disc, intervertebral
5222940|NCT00735176|Intervertebral Disk Displacement|intervertebral disk displacement
5222941|NCT00735176|Spondylosis|spondylosis
5222942|NCT00735176|Spinal Osteophytosis|spinal osteophytosis
5222943|NCT00735176|Arthroplasty, replacement|arthroplasty, replacement
5222944|NCT00735176|Diskectomy|diskectomy
5222945|NCT00735176|Spinal Fusion|spinal fusion
5222946|NCT00735163|algorithm|algorithm
5222947|NCT00735163|tight glycemic control|tight glycemic control
5222948|NCT00735163|glucose control|glucose control
5222949|NCT00735163|intensive care|intensive care
5222950|NCT00735163|insulin|insulin
5222951|NCT00735163|ICU|icu
5222952|NCT00735150|Breast|breast
5222953|NCT00735150|Ovary|ovary
5222954|NCT00735150|Mutation carrier|mutation carrier
5222955|NCT00735137|Twins|twins
5222956|NCT00735137|Short cervix|short cervix
5222957|NCT00735137|Preterm birth|preterm birth
5222958|NCT00735137|Vaginal pessary|vaginal pessary
5222959|NCT00735124|analgesia requirement and post operative pain|analgesia requirement and post operative pain
5222960|NCT00735111|QOL|qol
5222961|NCT00735111|Quality of Life|quality of life
5222962|NCT00735111|KPS|kps
5222963|NCT00735111|Karnofsky Performance Status|karnofsky performance status
5222964|NCT00735111|Cancer|cancer
5222965|NCT00735098|Knee Osteoarthritis|knee osteoarthritis
5222966|NCT00735098|arthritis|arthritis
5222967|NCT00735085|Brain Injury|brain injury
5222968|NCT00735072|HIV infection|hiv infection
5222969|NCT00735072|T cell activation|t cell activation
5222970|NCT00735072|Antiretroviral Therapy|antiretroviral therapy
5222971|NCT00735072|CCR5|ccr5
5222972|NCT00735072|Maraviroc|maraviroc
5222973|NCT00735059|dialysis membrane|dialysis membrane
5222974|NCT00735059|Polynephron|polynephron
5222975|NCT00735059|Elisio H|elisio h
5222976|NCT00735059|Polyethersulfone|polyethersulfone
5222977|NCT00735059|Diapes|diapes
5222978|NCT00735059|PES-DS|pes-ds
5222979|NCT00735059|online post-dilution hemodiafiltration|online post-dilution hemodiafiltration
5222980|NCT00735059|hemodialysis|hemodialysis
5222981|NCT00735059|protein-bound toxins|protein-bound toxins
5222982|NCT00735059|beta-2-microglobulin|beta-2-microglobulin
5222983|NCT00735059|hemodialysis patients|hemodialysis patients
5222984|NCT00735046|Early dementia in Alzheimer's disease (MMSE ≥ 21)|early dementia in alzheimer's disease (mmse ≥ 21)
5222985|NCT00735033|Physical therapy|physical therapy
5222986|NCT00735033|Physical therapy modalities|physical therapy modalities
5222987|NCT00735033|Cerebral Vascular Accident (CVA)|cerebral vascular accident (cva)
5222988|NCT00735020|influenza|influenza
5222989|NCT00735020|vaccine|vaccine
5222990|NCT00735020|adjuvants|adjuvants
5222991|NCT00735020|flu|flu
5222992|NCT00735007|Multiple Sclerosis|multiple sclerosis
5222993|NCT00734968|Urinary tract infection (UTI)|urinary tract infection (uti)
5222994|NCT00734968|suburethral sling|suburethral sling
5222995|NCT00734968|Prevention|prevention
5222996|NCT00734968|Nitrofurantoin|nitrofurantoin
5222997|NCT00734968|Prophylaxis|prophylaxis
5222998|NCT00734955|Partial Mastectomy|partial mastectomy
5222999|NCT00734955|Lumpectomy|lumpectomy
5223000|NCT00734955|Mastectomy|mastectomy
5223001|NCT00734942|young carers|young carers
5223002|NCT00734942|family support|family support
5223003|NCT00734942|children (up to the age of 18) of chronically ill parents|children (up to the age of 18) of chronically ill parents
5223004|NCT00734929|PONV|ponv
5223005|NCT00734929|nausea|nausea
5223006|NCT00734929|emesis|emesis
5223007|NCT00734929|antiemetics|antiemetics
5223008|NCT00734929|aprepitant|aprepitant
5223009|NCT00734929|ondansetron|ondansetron
5223010|NCT00734929|dexamethasone|dexamethasone
5223011|NCT00734916|total parenteral nutrition|total parenteral nutrition
5223012|NCT00734916|infections|infections
5223013|NCT00734916|Infectious complications related to parenteral nutrition|infectious complications related to parenteral nutrition
5223014|NCT00734903|Women|women
5223015|NCT00734903|Substance Use Disorders|substance use disorders
5223016|NCT00734903|Treatment Efficacy|treatment efficacy
5223017|NCT00734903|Women's Health|women's health
5223018|NCT00734903|Outcome Assessment (Health Care)|outcome assessment (health care)
5223019|NCT00734890|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5223020|NCT00734890|AIDS-related diffuse large cell lymphoma|aids-related diffuse large cell lymphoma
5223021|NCT00734890|AIDS-related diffuse mixed cell lymphoma|aids-related diffuse mixed cell lymphoma
5223022|NCT00734890|AIDS-related diffuse small cleaved cell lymphoma|aids-related diffuse small cleaved cell lymphoma
5223183|NCT00734539|Neonate|neonate
5223023|NCT00734890|AIDS-related immunoblastic large cell lymphoma|aids-related immunoblastic large cell lymphoma
5223024|NCT00734890|AIDS-related lymphoblastic lymphoma|aids-related lymphoblastic lymphoma
5223025|NCT00734890|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
5223026|NCT00734890|AIDS-related small noncleaved cell lymphoma|aids-related small noncleaved cell lymphoma
5223027|NCT00734890|HIV-associated Hodgkin lymphoma|hiv-associated hodgkin lymphoma
5223028|NCT00734890|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5223029|NCT00734890|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5223030|NCT00734890|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5223031|NCT00734890|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5223032|NCT00734890|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
5223033|NCT00734890|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5223034|NCT00734890|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5223035|NCT00734890|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5223036|NCT00734890|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
5223037|NCT00734890|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5223038|NCT00734890|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5223039|NCT00734890|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5223040|NCT00734890|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5223041|NCT00734890|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5223042|NCT00734890|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5223043|NCT00734890|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5223044|NCT00734890|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5223045|NCT00734890|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
5223046|NCT00734890|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5223047|NCT00734890|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
5223048|NCT00734890|Waldenström macroglobulinemia|waldenström macroglobulinemia
5223049|NCT00734890|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5223050|NCT00734890|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5223051|NCT00734890|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5223052|NCT00734890|intraocular lymphoma|intraocular lymphoma
5223053|NCT00734890|post-transplant lymphoproliferative disorder|post-transplant lymphoproliferative disorder
5223054|NCT00734890|cutaneous B-cell non-Hodgkin lymphoma|cutaneous b-cell non-hodgkin lymphoma
5223055|NCT00734890|small intestine lymphoma|small intestine lymphoma
5223056|NCT00734890|adenocarcinoma of the lung|adenocarcinoma of the lung
5223057|NCT00734890|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
5223058|NCT00734890|large cell lung cancer|large cell lung cancer
5223059|NCT00734890|adenosquamous cell lung cancer|adenosquamous cell lung cancer
5223060|NCT00734890|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5223061|NCT00734890|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5223062|NCT00734890|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5223063|NCT00734890|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5223064|NCT00734890|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5223065|NCT00734890|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5223066|NCT00734890|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5223067|NCT00734890|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5223068|NCT00734890|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5223069|NCT00734890|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5223070|NCT00734890|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5223071|NCT00734890|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
5223072|NCT00734890|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
5223073|NCT00734890|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5223074|NCT00734890|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5223075|NCT00734890|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5223076|NCT00734890|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5223077|NCT00734890|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5223078|NCT00734890|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
5223079|NCT00734890|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5223080|NCT00734890|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5223081|NCT00734890|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5223082|NCT00734890|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5223083|NCT00734890|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5223084|NCT00734890|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5223085|NCT00734890|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5223086|NCT00734890|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5223087|NCT00734890|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
5223088|NCT00734890|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
5223089|NCT00734890|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5223090|NCT00734890|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5223091|NCT00734890|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5223092|NCT00734890|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5223093|NCT00734890|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5223094|NCT00734890|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
5223095|NCT00734890|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5223096|NCT00734864|Dasatinib|dasatinib
5223097|NCT00734864|Sprycel|sprycel
5223098|NCT00734864|Temozolomide|temozolomide
5223099|NCT00734864|Temodar|temodar
5223100|NCT00734864|Recurrent Malignant Glioma|recurrent malignant glioma
5223101|NCT00734864|Malignant Glioma|malignant glioma
5223102|NCT00734864|glioblastoma multiforme|glioblastoma multiforme
5223103|NCT00734864|gliosarcoma|gliosarcoma
5223104|NCT00734864|anaplastic astrocytoma|anaplastic astrocytoma
5223105|NCT00734864|anaplastic oligodendroglioma|anaplastic oligodendroglioma
5223106|NCT00734864|anaplastic mixed glioma|anaplastic mixed glioma
5223107|NCT00734864|glioma|glioma
5223108|NCT00734851|prostate cancer|prostate cancer
5223109|NCT00734851|sunitinib|sunitinib
5223110|NCT00734851|docetaxel|docetaxel
5223111|NCT00734851|PSA|psa
5223112|NCT00734851|radiation|radiation
5223113|NCT00734851|PSA recurrence|psa recurrence
5223114|NCT00734851|No metastatic disease|no metastatic disease
5223115|NCT00734838|Breast Cancer|breast cancer
5223116|NCT00734838|Breast Biopsy|breast biopsy
5223117|NCT00734838|Reduction mammoplasty|reduction mammoplasty
5223118|NCT00734825|Appendicitis|appendicitis
5223119|NCT00734825|IV Contrast|iv contrast
5223120|NCT00734825|Oral Contrast|oral contrast
5223121|NCT00734825|CT scan|ct scan
5223122|NCT00734812|Hysterectomy|hysterectomy
5223123|NCT00734812|Laparoscopic|laparoscopic
5223124|NCT00734799|Posttraumatic Stress Disorder|posttraumatic stress disorder
5223125|NCT00734799|Insomnia,|insomnia,
5223126|NCT00734799|Imagery Rehearsal Therapy,|imagery rehearsal therapy,
5223127|NCT00734799|IRT,|irt,
5223128|NCT00734799|Cognitive Behavioral Therapy for Insomnia,|cognitive behavioral therapy for insomnia,
5223129|NCT00734799|CBTI.|cbti.
5223130|NCT00734786|gonyautoxin|gonyautoxin
5223131|NCT00734773|neurotoxicity|neurotoxicity
5223132|NCT00734773|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
5223133|NCT00734773|primary central nervous system Hodgkin lymphoma|primary central nervous system hodgkin lymphoma
5223134|NCT00734760|patient education|patient education
5223135|NCT00734760|acute coronary syndrome|acute coronary syndrome
5223136|NCT00734760|prehospital delay to treatment|prehospital delay to treatment
5223137|NCT00734747|GERD|gerd
5223138|NCT00734747|Gastroesophageal Reflux|gastroesophageal reflux
5223139|NCT00734747|Fundoplication|fundoplication
5223140|NCT00734747|Endoluminal|endoluminal
5223141|NCT00734747|Gastroesophageal Flap Valve|gastroesophageal flap valve
5223142|NCT00734734|Prophylaxis of Influenza|prophylaxis of influenza
5223143|NCT00734734|Influenza Vaccines|influenza vaccines
5223144|NCT00734734|MF59C.1|mf59c.1
5223145|NCT00734721|intravitreal injection|intravitreal injection
5223146|NCT00734695|BURN|burn
5223147|NCT00734695|EYE|eye
5223148|NCT00734695|VITAMIN C|vitamin c
5223149|NCT00734695|ASCORBIC ACID|ascorbic acid
5223150|NCT00734682|Glioblastoma|glioblastoma
5223151|NCT00734682|Gliosarcoma|gliosarcoma
5223152|NCT00734682|Anaplastic Astrocytoma|anaplastic astrocytoma
5223153|NCT00734682|Anaplastic Oligodendroglioma|anaplastic oligodendroglioma
5223154|NCT00734682|Anaplastic Mixed Oligoastrocytoma|anaplastic mixed oligoastrocytoma
5223155|NCT00734682|Malignant Astrocytoma NOS|malignant astrocytoma nos
5223156|NCT00734682|Nanoliposomal CPT-11|nanoliposomal cpt-11
5223157|NCT00734682|liposomal irinotecan|liposomal irinotecan
5223158|NCT00734669|Diabetes|diabetes
5223159|NCT00734669|Hypoglycemia|hypoglycemia
5223160|NCT00734656|steroid 5Alpha Reductase|steroid 5alpha reductase
5223161|NCT00734656|dutasteride|dutasteride
5223162|NCT00734656|neuroactive steroid|neuroactive steroid
5223163|NCT00734643|Hypoplastic Left Heart Syndrome|hypoplastic left heart syndrome
5223164|NCT00734643|Family coping|family coping
5223165|NCT00734643|Complex Congenital Heart Disease|complex congenital heart disease
5223166|NCT00734630|nebivolol|nebivolol
5223167|NCT00734630|Bystolic ™|bystolic ™
5223168|NCT00734630|lisinopril|lisinopril
5223169|NCT00734630|losartan|losartan
5223170|NCT00734630|Hypertension|hypertension
5223171|NCT00734617|Cigarette|cigarette
5223172|NCT00734617|Nicotine|nicotine
5223173|NCT00734591|Observational Study Exubera|observational study exubera
5223174|NCT00734565|vaccine|vaccine
5223175|NCT00734565|prevention|prevention
5223176|NCT00734565|haemophilus influenzae type b|haemophilus influenzae type b
5223177|NCT00734565|children|children
5223178|NCT00734552|Continuous Ambulatory Peritoneal Dialysis|continuous ambulatory peritoneal dialysis
5223179|NCT00734552|α-Keto Acid|α-keto acid
5223180|NCT00734552|Low Protein Diet|low protein diet
5223181|NCT00734552|Residual Renal Function|residual renal function
5223182|NCT00734539|Candida|candida
5223184|NCT00734539|Fluconazole|fluconazole
5223185|NCT00734539|Prophylaxis|prophylaxis
5223186|NCT00734539|Colonization|colonization
5223187|NCT00734539|Resistance|resistance
5223188|NCT00734526|Glioblastoma|glioblastoma
5223189|NCT00734526|Gliosarcoma|gliosarcoma
5223190|NCT00734526|Brain Cancer|brain cancer
5223191|NCT00734526|Sorafenib|sorafenib
5223192|NCT00734526|Temozolomide|temozolomide
5223193|NCT00734526|Radiation|radiation
5223194|NCT00734526|Radiotherapy|radiotherapy
5223196|NCT00734513|GI Cancer|gi cancer
5223197|NCT00734513|Emotional Disclosure|emotional disclosure
5223198|NCT00734513|Behavioral Intervention|behavioral intervention
5223199|NCT00734513|Partner|partner
5223200|NCT00734513|Couples|couples
5223201|NCT00734487|Spectral Domain Optical Coherence Tomography|spectral domain optical coherence tomography
5223202|NCT00734487|Optical Coherence Tomography|optical coherence tomography
5223203|NCT00734487|AREDS2|areds2
5223204|NCT00734487|AMD|amd
5223205|NCT00734487|Age-related macular degeneration|age-related macular degeneration
5223206|NCT00734487|Drusen|drusen
5223207|NCT00734474|Diabetes, type 2 diabetes|diabetes, type 2 diabetes
5223208|NCT00734461|Non-physically dependent subjects|non-physically dependent subjects
5223209|NCT00734461|history of opioid abuse|history of opioid abuse
5223210|NCT00734448|gestational diabetes mellitus|gestational diabetes mellitus
5223211|NCT00734448|carbohydrate intolerance|carbohydrate intolerance
5223212|NCT00734448|myo-inositol|myo-inositol
5223213|NCT00734448|insulin resistance|insulin resistance
5223214|NCT00734435|schizophrenia|schizophrenia
5223215|NCT00734435|schizophreniform|schizophreniform
5223216|NCT00734435|schizoaffective disorder|schizoaffective disorder
5223217|NCT00734435|Zyprexa|zyprexa
5223218|NCT00734435|olanzapine|olanzapine
5223219|NCT00734422|Phobic Disorders (Fear of Flying)|phobic disorders (fear of flying)
5223220|NCT00734422|Virtual Reality Exposure Therapy|virtual reality exposure therapy
5223221|NCT00734422|Fear extinction|fear extinction
5223222|NCT00734422|Yohimbine|yohimbine
5223223|NCT00734409|Mechanical ventilation|mechanical ventilation
5223224|NCT00734409|Human|human
5223225|NCT00734409|conscious sedation|conscious sedation
5223226|NCT00734409|bispectral index|bispectral index
5223227|NCT00734409|monitoring|monitoring
5223228|NCT00734409|critical care|critical care
5223229|NCT00734409|propofol|propofol
5223230|NCT00734396|Mesenchymal stem cells|mesenchymal stem cells
5223231|NCT00734396|Allograft rejection|allograft rejection
5223232|NCT00734396|Subclinical rejection|subclinical rejection
5223233|NCT00734383|coronary artery bypass surgery|coronary artery bypass surgery
5223234|NCT00734383|coronary artery bypass grafting|coronary artery bypass grafting
5223235|NCT00734383|cardiopulmonary bypass|cardiopulmonary bypass
5223236|NCT00734383|diabetes|diabetes
5223237|NCT00734383|myocardial injury markers,|myocardial injury markers,
5223238|NCT00734383|sex differences|sex differences
5223239|NCT00734383|cardiac anesthesia|cardiac anesthesia
5223240|NCT00734383|inhalational anesthetics|inhalational anesthetics
5223241|NCT00734370|Panic Disorder and Agoraphobia|panic disorder and agoraphobia
5223242|NCT00734370|Virtual Reality Exposure Therapy|virtual reality exposure therapy
5223243|NCT00734357|contrast|contrast
5223244|NCT00734357|ct|ct
5223245|NCT00734357|cat scan|cat scan
5223246|NCT00734357|kidney|kidney
5223247|NCT00734357|nephrotoxicity|nephrotoxicity
5223248|NCT00734357|Computerized Emission Tomography|computerized emission tomography
5223249|NCT00734331|inflammatory bowel disease|inflammatory bowel disease
5223250|NCT00734331|micro RNA|micro rna
5223251|NCT00734331|cholinergic tone|cholinergic tone
5223252|NCT00734331|inflammation|inflammation
5223253|NCT00734318|Severe asthma|severe asthma
5223254|NCT00734318|Fluticasone|fluticasone
5223255|NCT00734318|Formoterol|formoterol
5223256|NCT00734305|cancer, solid tumors, oncology, Phase I, ErbB3, HER3|cancer, solid tumors, oncology, phase i, erbb3, her3
5223257|NCT00734305|(erbB-3, HER-3)|(erbb-3, her-3)
5223258|NCT00734292|Asthma|asthma
5223259|NCT00734292|Asthma Mild to Moderate|asthma mild to moderate
5223260|NCT00734279|Puberty|puberty
5223261|NCT00734279|Delayed|delayed
5223262|NCT00734279|Early|early
5223263|NCT00734279|Precocious|precocious
5223264|NCT00734279|Peripubertal|peripubertal
5223265|NCT00734279|Gonadotropin|gonadotropin
5223266|NCT00734279|FSH|fsh
5223267|NCT00734279|LH|lh
5223268|NCT00734266|COPD|copd
5223269|NCT00734266|CPB|cpb
5223270|NCT00734266|Leukotrienes|leukotrienes
5223271|NCT00734253|Nephropathy|nephropathy
5223272|NCT00734253|Kidney Disease|kidney disease
5223273|NCT00734253|Diabetes|diabetes
5223274|NCT00734253|Pyridoxamine|pyridoxamine
5223275|NCT00734253|Pyridorin|pyridorin
5223276|NCT00734253|NephroGenex|nephrogenex
5223277|NCT00734253|PYR-210|pyr-210
5223278|NCT00734227|Survival and control of hemorrhage|survival and control of hemorrhage
5223279|NCT00734214|Parenteral Fluids|parenteral fluids
5223280|NCT00734214|Isotonic|isotonic
5223281|NCT00734214|Hypotonic|hypotonic
5223282|NCT00734214|Pediatric|pediatric
5223283|NCT00734214|Fluid overload|fluid overload
5223284|NCT00734201|Study effects on blood pressure and weight in obese subjects|study effects on blood pressure and weight in obese subjects
5223285|NCT00734175|Vaccine|vaccine
5223286|NCT00734175|Influenza|influenza
5223287|NCT00734162|tenofovir|tenofovir
5223288|NCT00734162|adolescents|adolescents
5223289|NCT00734162|chronic hepatitis B|chronic hepatitis b
5223290|NCT00734149|Multiple myeloma|multiple myeloma
5223291|NCT00734136|Angiogenic Factors|angiogenic factors
5223292|NCT00734136|Hepatorenal Syndrome|hepatorenal syndrome
5223293|NCT00734136|Liver Disease|liver disease
5223294|NCT00734136|Renal Failure|renal failure
5223295|NCT00734136|Liver Cirrhosis|liver cirrhosis
5223296|NCT00734136|Ascites|ascites
5223297|NCT00734123|Atherosclerosis|atherosclerosis
5223298|NCT00734123|Cardiovascular Prevention|cardiovascular prevention
5223299|NCT00734123|Carotid Intima-Media Thickness|carotid intima-media thickness
5223300|NCT00734123|Ankle-Brachial Index|ankle-brachial index
5223301|NCT00734110|Arthroplasty, Replacement, Knee, P.F.C. Sigma RPF, Sigma RP|arthroplasty, replacement, knee, p.f.c. sigma rpf, sigma rp
5223302|NCT00734097|heartburn|heartburn
5223303|NCT00734097|reflux|reflux
5223304|NCT00734097|proton|proton
5223305|NCT00734097|pump|pump
5223306|NCT00734097|inhibitor|inhibitor
5223307|NCT00734084|Arthroplasty|arthroplasty
5223308|NCT00734084|Knee|knee
5223309|NCT00734084|UKA|uka
5223310|NCT00734084|Partial|partial
5223311|NCT00734084|Preservation|preservation
5223312|NCT00734071|Generalized Anxiety Disorder|generalized anxiety disorder
5223313|NCT00734071|Mood Disorder|mood disorder
5223314|NCT00734071|Affective Disorder|affective disorder
5223315|NCT00734071|Anxiety Disorder|anxiety disorder
5223316|NCT00734071|Drug Therapy|drug therapy
5223317|NCT00734058|Ablation|ablation
5223318|NCT00734058|AF|af
5223319|NCT00734058|Atrial Fibrillation|atrial fibrillation
5223320|NCT00734058|Cardiac|cardiac
5223321|NCT00734058|Endocardial|endocardial
5223322|NCT00734058|Endocardium|endocardium
5223323|NCT00734058|EP|ep
5223324|NCT00734058|Electrophysiology|electrophysiology
5223325|NCT00734058|Epicardial|epicardial
5223326|NCT00734058|Epicardium|epicardium
5223327|NCT00734058|Heart|heart
5223328|NCT00734058|Interventional|interventional
5223329|NCT00734058|Lesion|lesion
5223330|NCT00734058|PVI|pvi
5223331|NCT00734058|Pulmonary Vein|pulmonary vein
5223332|NCT00734058|MAZE|maze
5223333|NCT00734058|Surgery|surgery
5223334|NCT00734058|Surgical|surgical
5223335|NCT00734058|Treatment|treatment
5223336|NCT00734058|Patients with persistent AF with 3 months duration|patients with persistent af with 3 months duration
5223337|NCT00734058|Requiring concomitant open heart surgery|requiring concomitant open heart surgery
5223338|NCT00734045|Congestive Heart Failure (CHF)|congestive heart failure (chf)
5223339|NCT00734045|NT-proBNP|nt-probnp
5223340|NCT00734032|SB-480848|sb-480848
5223341|NCT00734032|Dyslipidaemia|dyslipidaemia
5223342|NCT00734019|Arthroplasty, Replacement, Knee, TKR, PFC Sigma|arthroplasty, replacement, knee, tkr, pfc sigma
5223343|NCT00734006|Cortico-cortical|cortico-cortical
5223344|NCT00734006|connectivity|connectivity
5223345|NCT00734006|Transcranial|transcranial
5223346|NCT00734006|Magnetic|magnetic
5223347|NCT00734006|Stimulation|stimulation
5223348|NCT00733993|substance abuse|substance abuse
5223349|NCT00733993|cocaine|cocaine
5223350|NCT00733993|caffeine|caffeine
5223351|NCT00733993|impulsivity|impulsivity
5223352|NCT00733980|Depressive Disorder, Major|depressive disorder, major
5223353|NCT00733967|Methamphetamine|methamphetamine
5223354|NCT00733967|Chantix|chantix
5223355|NCT00733967|Varenicline|varenicline
5223356|NCT00733941|Exercise test|exercise test
5223357|NCT00733941|Running|running
5223358|NCT00733941|Arterial diameter|arterial diameter
5223359|NCT00733941|Monitoring, physiologic|monitoring, physiologic
5223360|NCT00733941|Oxygen Consumption|oxygen consumption
5223361|NCT00733928|Arthroplasty,|arthroplasty,
5223362|NCT00733928|Replacement,|replacement,
5223363|NCT00733928|Knee,|knee,
5223364|NCT00733928|P.F.C.|p.f.c.
5223365|NCT00733928|Sigma|sigma
5223366|NCT00733928|all-polyethylene|all-polyethylene
5223367|NCT00733915|Arthroplasty, knee, TKA, TKR, Duofix, Porocoat, LCS|arthroplasty, knee, tka, tkr, duofix, porocoat, lcs
5223368|NCT00733902|monoclonal antibody|monoclonal antibody
5223369|NCT00733902|RN624|rn624
5223370|NCT00733902|PF-04383119|pf-04383119
5223371|NCT00733902|nerve growth factor|nerve growth factor
5223372|NCT00733902|anti-nerve growth factor|anti-nerve growth factor
5223373|NCT00733902|OA|oa
5223374|NCT00733902|pain|pain
5223375|NCT00733889|esophageal carcinoma|esophageal carcinoma
5223376|NCT00733889|cetuximab|cetuximab
5223377|NCT00733889|docetaxel|docetaxel
5223378|NCT00733889|cisplatin|cisplatin
5223379|NCT00733889|5-fluorouracil|5-fluorouracil
5223380|NCT00733876|Acute Renal Failure Cardiac Surgery Stem Cell|acute renal failure cardiac surgery stem cell
5223381|NCT00733863|Active immunization|active immunization
5223382|NCT00733863|Alzheimer disease|alzheimer disease
5223383|NCT00733863|Antibody|antibody
5223384|NCT00733863|Central Nervous System Diseases|central nervous system diseases
5223385|NCT00733863|Neurodegenerative diseases|neurodegenerative diseases
5223386|NCT00733863|Vaccine|vaccine
5223387|NCT00733824|Plerixafor|plerixafor
5223388|NCT00733824|Lymphoma|lymphoma
5223389|NCT00733824|Hematopoietic Stem Cell Mobilization|hematopoietic stem cell mobilization
5223390|NCT00733824|Transplantation, Autologous|transplantation, autologous
5223391|NCT00733824|Receptors, CXCR4|receptors, cxcr4
5223392|NCT00733811|thalassemia major|thalassemia major
5223393|NCT00733811|chelation treatment|chelation treatment
5223394|NCT00733811|secondary hemochromatosis|secondary hemochromatosis
5223395|NCT00733798|Melanoma|melanoma
5223396|NCT00733798|Malignant melanoma|malignant melanoma
5223397|NCT00733798|metastatic melanoma|metastatic melanoma
5223398|NCT00733798|Phase 1|phase 1
5223399|NCT00733798|Phase 2|phase 2
5223400|NCT00733785|Rosiglitazone XR|rosiglitazone xr
5223401|NCT00733785|Pharmacokinetics|pharmacokinetics
5223402|NCT00733785|Strength Equivalence.|strength equivalence.
5223403|NCT00733785|Alzheimers Disease|alzheimers disease
5223404|NCT00733785|Repeat dose|repeat dose
5223405|NCT00733785|Dose proportionality|dose proportionality
5223406|NCT00733772|flaxseed|flaxseed
5223407|NCT00733772|lignans|lignans
5223408|NCT00733772|alpha-Linolenic Acid|alpha-linolenic acid
5223409|NCT00733772|LDL Cholesterol|ldl cholesterol
5223410|NCT00733746|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
5223411|NCT00733746|stage I pancreatic cancer|stage i pancreatic cancer
5223412|NCT00733746|stage II pancreatic cancer|stage ii pancreatic cancer
5223413|NCT00733733|kidney|kidney
5223414|NCT00733733|transplantation|transplantation
5223415|NCT00733733|non-heart-beating donor|non-heart-beating donor
5223416|NCT00733733|delayed graft function|delayed graft function
5223417|NCT00733733|Antithymocyte globulin|antithymocyte globulin
5223418|NCT00733733|ischemia-reperfusion damage|ischemia-reperfusion damage
5223419|NCT00733707|adherence|adherence
5223420|NCT00733707|oral contraceptive pills|oral contraceptive pills
5223421|NCT00733707|contraception|contraception
5223422|NCT00733707|text messaging|text messaging
5223423|NCT00733694|Arthroplasty, Replacement, Knee,LCS|arthroplasty, replacement, knee,lcs
5223424|NCT00733681|Arthroplasty, Replacement, Knee|arthroplasty, replacement, knee
5223425|NCT00733681|Prosthesis Failure|prosthesis failure
5223426|NCT00733681|Revision surgery|revision surgery
5223427|NCT00733668|considered|considered
5223428|NCT00733668|entry|entry
5223429|NCT00733668|into|into
5223430|NCT00733668|the study|the study
5223431|NCT00733668|SSRI|ssri
5223432|NCT00733668|Seroquel|seroquel
5223433|NCT00733668|Quetiapine|quetiapine
5223434|NCT00733668|fumarate|fumarate
5223435|NCT00733668|antipsychotic|antipsychotic
5223436|NCT00733642|antibody amyloid Alzheimer's Disease AD|antibody amyloid alzheimer's disease ad
5223437|NCT00733616|advanced gastric adenocarcinoma|advanced gastric adenocarcinoma
5223438|NCT00733616|docetaxel|docetaxel
5223439|NCT00733616|oxaliplatin|oxaliplatin
5223440|NCT00733616|capecitabine|capecitabine
5223441|NCT00733616|intermediate general status|intermediate general status
5223442|NCT00733603|Interstitial Cystitis|interstitial cystitis
5223443|NCT00733603|IC|ic
5223444|NCT00733603|Painful Bladder Syndrome|painful bladder syndrome
5223445|NCT00733603|PBS|pbs
5223446|NCT00733603|Bladder Pain|bladder pain
5223447|NCT00733603|Pelvic Pain|pelvic pain
5223448|NCT00733590|defibrillator, implanted|defibrillator, implanted
5223449|NCT00733590|genomics|genomics
5223450|NCT00733590|electrocardiography|electrocardiography
5223451|NCT00733590|electrophysiological study|electrophysiological study
5223452|NCT00733590|proteomics|proteomics
5223453|NCT00733577|diabetes|diabetes
5223454|NCT00733577|pharmacodynamics|pharmacodynamics
5223455|NCT00733577|safety|safety
5223456|NCT00733577|pharmacokinetics|pharmacokinetics
5223457|NCT00733564|Local anesthetic|local anesthetic
5223458|NCT00733564|Propofol|propofol
5223459|NCT00733564|Sevoflurane|sevoflurane
5223460|NCT00733551|motilin|motilin
5223461|NCT00733551|gastric emptying|gastric emptying
5223462|NCT00733551|GSK962040|gsk962040
5223463|NCT00733551|oral dose|oral dose
5223464|NCT00733538|stage I multiple myeloma|stage i multiple myeloma
5223465|NCT00733525|Bulimia Nervosa|bulimia nervosa
5223466|NCT00733512|ReSTOR Aspheric +4 IOL|restor aspheric +4 iol
5223467|NCT00733499|Arthroplasty, replacement, Knee, LCS Duofix, Porocoat|arthroplasty, replacement, knee, lcs duofix, porocoat
5223468|NCT00733486|Arthroplasty, Replacement, Knee, LCS Complete APG (MeSH);|arthroplasty, replacement, knee, lcs complete apg (mesh);
5223469|NCT00733473|Wheezing|wheezing
5223470|NCT00733473|Acute asthma|acute asthma
5223471|NCT00733473|Children|children
5223472|NCT00733460|BFPET|bfpet
5223473|NCT00733460|Coronary Artery Disease|coronary artery disease
5223474|NCT00733460|Myocardial Perfusion Imaging|myocardial perfusion imaging
5223475|NCT00733460|Radiation Dosimetry|radiation dosimetry
5223476|NCT00733447|Biventricular failure|biventricular failure
5223477|NCT00733434|Microsurgery|microsurgery
5223478|NCT00733434|Head and neck|head and neck
5223479|NCT00733434|Prostaglandin E1|prostaglandin e1
5223480|NCT00733434|Thrombosis|thrombosis
5223481|NCT00733434|Complication|complication
5223482|NCT00733421|Day surgery|day surgery
5223483|NCT00733421|Hallux Valgus|hallux valgus
5223484|NCT00733421|Pain|pain
5223485|NCT00733421|Analgesics|analgesics
5223486|NCT00733395|Muscle pain|muscle pain
5223487|NCT00733382|migraine|migraine
5223488|NCT00733382|dexamethasone|dexamethasone
5223489|NCT00733382|dihydroergotamine|dihydroergotamine
5223490|NCT00733369|Arthroplasty|arthroplasty
5223491|NCT00733369|Replacement|replacement
5223492|NCT00733369|Knee|knee
5223493|NCT00733369|PFC Sigma RPF|pfc sigma rpf
5223494|NCT00733369|PFC Sigma RP|pfc sigma rp
5223495|NCT00733356|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
5223496|NCT00733356|ADHD|adhd
5223497|NCT00733356|ADD|add
5223498|NCT00733356|reading|reading
5223499|NCT00733356|brain hemodynamics|brain hemodynamics
5223500|NCT00733356|brain imaging|brain imaging
5223501|NCT00733356|attention|attention
5223502|NCT00733356|Near-Infrared Spectroscopy|near-infrared spectroscopy
5223503|NCT00733356|NIRS|nirs
5223504|NCT00733356|MSIT|msit
5223505|NCT00733343|heart failure|heart failure
5223506|NCT00733343|sleep disordered breathing|sleep disordered breathing
5223507|NCT00733343|sleep apnea|sleep apnea
5223508|NCT00733343|left ventricular systolic dysfunction|left ventricular systolic dysfunction
5223509|NCT00733343|SBAS|sbas
5223510|NCT00733343|HF|hf
5223511|NCT00733330|Arthroplasty, Knee, TKA, TKR, CAS, minimally invasive|arthroplasty, knee, tka, tkr, cas, minimally invasive
5223512|NCT00733317|Wheezing|wheezing
5223513|NCT00733317|Acute asthma|acute asthma
5223514|NCT00733317|Children|children
5223515|NCT00733317|Budesonide|budesonide
5223516|NCT00733317|Emergency room|emergency room
5223517|NCT00733304|age-related macular degeneration (AMD)|age-related macular degeneration (amd)
5223518|NCT00733304|choroidal neovascularization (CNV)|choroidal neovascularization (cnv)
5223519|NCT00733304|vascular endothelial growth factor (VEGF)|vascular endothelial growth factor (vegf)
5223520|NCT00733304|pazopanib|pazopanib
5223521|NCT00733304|angiogenesis|angiogenesis
5223522|NCT00733291|Daily disposable contact lenses|daily disposable contact lenses
5223523|NCT00733291|Multi-purpose disinfecting solutions|multi-purpose disinfecting solutions
5223524|NCT00733278|Postpartum contraception|postpartum contraception
5223525|NCT00733278|Copper IUD|copper iud
5223526|NCT00733265|Renal Impairment|renal impairment
5223527|NCT00733252|non-small cell lung cancer|non-small cell lung cancer
5223528|NCT00733252|small cell lung cancer|small cell lung cancer
5223529|NCT00733252|benign respiratory tract neoplasm|benign respiratory tract neoplasm
5223530|NCT00733252|lung papilloma|lung papilloma
5223531|NCT00733252|recurrent respiratory papillomatosis|recurrent respiratory papillomatosis
5223532|NCT00733252|squamous lung dysplasia|squamous lung dysplasia
5223533|NCT00733252|malignant mesothelioma|malignant mesothelioma
5223534|NCT00733252|pulmonary carcinoid tumor|pulmonary carcinoid tumor
5223535|NCT00733252|lung metastases|lung metastases
5223536|NCT00733239|methadone|methadone
5223537|NCT00733239|opioid dependence|opioid dependence
5223539|NCT00733226|wheezing|wheezing
5223540|NCT00733226|asthma|asthma
5223541|NCT00733226|childhood|childhood
5223542|NCT00733226|OM-85 BV|om-85 bv
5223543|NCT00733226|Broncho-Vaxom|broncho-vaxom
5223544|NCT00733213|Prostate Cancer, Treatment alternatives, Metastasis|prostate cancer, treatment alternatives, metastasis
5223545|NCT00733200|Minor Liver Resection|minor liver resection
5223546|NCT00733200|Major Liver Resection|major liver resection
5223547|NCT00733200|Hilar|hilar
5223548|NCT00733174|IGT|igt
5223549|NCT00733161|passive leg exercise|passive leg exercise
5223550|NCT00733161|congestive heart failure|congestive heart failure
5223551|NCT00733161|endothelium-derived factors|endothelium-derived factors
5223552|NCT00733161|elderly|elderly
5223553|NCT00733148|glucose, interstitial, intensive care|glucose, interstitial, intensive care
5223554|NCT00733135|peripheral vascular disease|peripheral vascular disease
5223555|NCT00733135|atherectomy|atherectomy
5223556|NCT00733135|atherosclerosis|atherosclerosis
5223557|NCT00733135|calcified lesions|calcified lesions
5223558|NCT00733109|CIN2|cin2
5223559|NCT00733109|management|management
5223560|NCT00733096|radiculopathy|radiculopathy
5223561|NCT00733096|sciatica|sciatica
5223562|NCT00733096|low back pain|low back pain
5223563|NCT00733083|tonsillectomy|tonsillectomy
5223564|NCT00733083|paediatric|paediatric
5223565|NCT00733083|pain|pain
5223566|NCT00733083|child|child
5223567|NCT00733083|opiates|opiates
5223568|NCT00733083|pre-emptive|pre-emptive
5223569|NCT00733083|oxycodone|oxycodone
5223570|NCT00733083|morphine|morphine
5223571|NCT00733083|dexamethasone|dexamethasone
5223572|NCT00733070|CTO|cto
5223573|NCT00733070|Chronic Total Occlusion|chronic total occlusion
5223574|NCT00733070|Revascularization|revascularization
5223575|NCT00733057|Minocycline|minocycline
5223576|NCT00733057|Schizophrenia|schizophrenia
5223577|NCT00733057|Negative symptoms|negative symptoms
5223578|NCT00733057|Cognitive|cognitive
5223579|NCT00733044|Objective tinnitus|objective tinnitus
5223580|NCT00733044|Tinnitus|tinnitus
5223581|NCT00733044|RCT|rct
5223582|NCT00733044|Specialised treatment|specialised treatment
5223583|NCT00733044|Usual care|usual care
5223584|NCT00733044|Cost-effectiveness|cost-effectiveness
5223585|NCT00733031|Phase I,|phase i,
5223586|NCT00733031|cancer,|cancer,
5223587|NCT00733031|solid tumors,|solid tumors,
5223588|NCT00733031|advanced solid malignancies,|advanced solid malignancies,
5223589|NCT00733031|dose escalation,|dose escalation,
5223590|NCT00733031|combination treatment,|combination treatment,
5223591|NCT00733031|TRK inhibitor|trk inhibitor
5223592|NCT00733018|Nutrigenomics|nutrigenomics
5223593|NCT00733018|Gene Expression|gene expression
5223594|NCT00733018|Diet, Carbohydrate-Restricted|diet, carbohydrate-restricted
5223595|NCT00733018|Life Style|life style
5223596|NCT00733018|Health Behavior|health behavior
5223597|NCT00732992|Solid tumor|solid tumor
5223598|NCT00732992|malignancy|malignancy
5223599|NCT00732992|sunitinib|sunitinib
5223600|NCT00732992|pemetrexed|pemetrexed
5223601|NCT00732992|phase 1|phase 1
5223602|NCT00732992|neoplasms|neoplasms
5223603|NCT00732979|Elective|elective
5223604|NCT00732979|hepatic|hepatic
5223605|NCT00732979|resection|resection
5223606|NCT00732979|due to any|due to any
5223607|NCT00732979|reason.|reason.
5223608|NCT00732966|cyp2c9|cyp2c9
5223609|NCT00732966|losartan|losartan
5223610|NCT00732966|pharmacogenetics|pharmacogenetics
5223611|NCT00732966|pharmacokinetics|pharmacokinetics
5223612|NCT00732966|pharmacodynamics|pharmacodynamics
5223613|NCT00732953|patients with coronary artery disease|patients with coronary artery disease
5223614|NCT00732953|percutaneous coronary intervention|percutaneous coronary intervention
5223615|NCT00732953|stent implantation|stent implantation
5223616|NCT00732953|paclitaxel eluting balloon|paclitaxel eluting balloon
5223617|NCT00732953|angiographic follow-up|angiographic follow-up
5223618|NCT00732953|clinical follow-up|clinical follow-up
5223619|NCT00732940|SLE|sle
5223620|NCT00732940|Lupus|lupus
5223621|NCT00732940|Systemic Lupus Erythematosus|systemic lupus erythematosus
5223622|NCT00732940|Antibodies|antibodies
5223623|NCT00732940|Autoimmune Diseases|autoimmune diseases
5223624|NCT00732940|Belimumab|belimumab
5223625|NCT00732927|thrombosis, vein, retina|thrombosis, vein, retina
5223626|NCT00732914|Renal Cell Carcinoma|renal cell carcinoma
5223627|NCT00732914|Sunitinib|sunitinib
5223628|NCT00732914|Sorafenib|sorafenib
5223629|NCT00732914|Sequential|sequential
5223630|NCT00732901|substance abuse|substance abuse
5223631|NCT00732901|cocaine|cocaine
5223632|NCT00732901|impulsivity|impulsivity
5223633|NCT00732901|serotonin|serotonin
5223634|NCT00732901|Remeron|remeron
5223635|NCT00732901|Mirtzapine|mirtzapine
5223636|NCT00732901|Lexapro|lexapro
5223637|NCT00732901|Escatilopram|escatilopram
5223638|NCT00732888|Pharmacokinetics|pharmacokinetics
5223639|NCT00732888|Healthy volunteers|healthy volunteers
5223640|NCT00732888|No condition|no condition
5223641|NCT00732888|Pharmacokinetics study|pharmacokinetics study
5223642|NCT00732862|Type 2 diabetes|type 2 diabetes
5223643|NCT00732862|intensive therapy|intensive therapy
5223644|NCT00732849|immunonutrition|immunonutrition
5223645|NCT00732849|surgical patients|surgical patients
5223646|NCT00732849|postoperative period|postoperative period
5223647|NCT00732836|Liver Cancer|liver cancer
5223648|NCT00732836|Solid Cancer|solid cancer
5223649|NCT00732836|Abraxane|abraxane
5223650|NCT00732836|nab paclitaxel|nab paclitaxel
5223651|NCT00732836|HAI abraxane|hai abraxane
5223652|NCT00732836|HAI|hai
5223653|NCT00732836|hepatic arterial infusion|hepatic arterial infusion
5223654|NCT00732836|hepatic metastases|hepatic metastases
5223655|NCT00732797|Dizziness|dizziness
5223656|NCT00732797|Self-management|self-management
5223657|NCT00732797|booklet-based|booklet-based
5223658|NCT00732797|vestibular rehabilitation|vestibular rehabilitation
5223659|NCT00732784|Pharmacokinetics|pharmacokinetics
5223660|NCT00732784|Healthy volunteers|healthy volunteers
5223661|NCT00732784|No condition|no condition
5223662|NCT00732784|Pharmacokinetics study|pharmacokinetics study
5223663|NCT00732771|primary hyperaldosteronism|primary hyperaldosteronism
5223664|NCT00732771|hypokalemia|hypokalemia
5223665|NCT00732771|hypertension|hypertension
5223666|NCT00732771|aldosterone synthase inhibitor|aldosterone synthase inhibitor
5223667|NCT00732758|Vitamin D Deficiency|vitamin d deficiency
5223668|NCT00732758|Vitamin D Insufficiency|vitamin d insufficiency
5223669|NCT00732758|Child|child
5223670|NCT00732758|Adolescent|adolescent
5223671|NCT00732758|African American|african american
5223672|NCT00732758|Caucasian|caucasian
5223673|NCT00732758|Definition|definition
5223674|NCT00732758|Preadolescent|preadolescent
5223675|NCT00732745|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
5223676|NCT00732745|adenocarcinoma of the gastroesophageal junction|adenocarcinoma of the gastroesophageal junction
5223677|NCT00732745|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
5223678|NCT00732745|stage III esophageal cancer|stage iii esophageal cancer
5223679|NCT00732745|stage IV esophageal cancer|stage iv esophageal cancer
5223680|NCT00732745|recurrent esophageal cancer|recurrent esophageal cancer
5223681|NCT00732732|diarrhea|diarrhea
5223682|NCT00732732|Plantain|plantain
5223683|NCT00732732|Green banana|green banana
5223684|NCT00732732|Infants|infants
5223685|NCT00732732|Children|children
5223686|NCT00732706|FNB|fnb
5223687|NCT00732706|Femoral Nerve|femoral nerve
5223688|NCT00732706|Sartorius Twitch|sartorius twitch
5223689|NCT00732706|Quadriceps Twitch|quadriceps twitch
5223690|NCT00732706|Analgesia|analgesia
5223691|NCT00732706|Anesthesia|anesthesia
5223692|NCT00732693|Premature ovarian failure|premature ovarian failure
5223872|NCT00731991|Muscle|muscle
5223693|NCT00732693|Sex hormone replacement|sex hormone replacement
5223694|NCT00732693|HRT|hrt
5223695|NCT00732693|Blood pressure|blood pressure
5223696|NCT00732693|Bone mineral density|bone mineral density
5223697|NCT00732693|Bone metabolism|bone metabolism
5223698|NCT00732693|Uterine function|uterine function
5223699|NCT00732680|Empty nose syndrome|empty nose syndrome
5223700|NCT00732680|Over resection of turbinate|over resection of turbinate
5223701|NCT00732680|Atrophic rhinitis|atrophic rhinitis
5223702|NCT00732654|Food Allergy|food allergy
5223703|NCT00732654|Oral Immunotherapy|oral immunotherapy
5223704|NCT00732654|Immunoglobulin E|immunoglobulin e
5223705|NCT00732615|Hypoparathyroidism|hypoparathyroidism
5223706|NCT00732602|Glucagon|glucagon
5223707|NCT00732602|Glucose-dependent Insulinotropic Polypeptide|glucose-dependent insulinotropic polypeptide
5223708|NCT00732602|Glucagon-Like peptide 2|glucagon-like peptide 2
5223709|NCT00732589|suprascapular nerve block|suprascapular nerve block
5223710|NCT00732589|shoulder pain|shoulder pain
5223711|NCT00732589|hemiplegia|hemiplegia
5223712|NCT00732576|Cardiovascular|cardiovascular
5223713|NCT00732576|Calcification|calcification
5223714|NCT00732563|stage I non-small cell lung cancer|stage i non-small cell lung cancer
5223715|NCT00732563|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
5223716|NCT00732550|cholelithiasis|cholelithiasis
5223717|NCT00732550|cholecystitis|cholecystitis
5223718|NCT00732537|Hypoxia|hypoxia
5223719|NCT00732537|Respiratory failure|respiratory failure
5223720|NCT00732537|Infant, term|infant, term
5223721|NCT00732537|Nitric oxide|nitric oxide
5223722|NCT00732524|Hyperglycemia|hyperglycemia
5223723|NCT00732524|Glucose toxicity|glucose toxicity
5223724|NCT00732524|Glargine|glargine
5223725|NCT00732524|Glipizide|glipizide
5223726|NCT00732511|Endothelial dysfunction|endothelial dysfunction
5223727|NCT00732511|Blood vessel stiffness|blood vessel stiffness
5223728|NCT00732511|Nitric oxide|nitric oxide
5223729|NCT00732511|Oxidative stress|oxidative stress
5223730|NCT00732498|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
5223731|NCT00732498|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
5223732|NCT00732498|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
5223733|NCT00732498|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5223734|NCT00732498|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5223735|NCT00732498|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5223736|NCT00732498|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5223737|NCT00732498|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5223738|NCT00732498|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5223739|NCT00732498|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5223740|NCT00732498|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5223741|NCT00732498|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5223742|NCT00732498|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5223743|NCT00732498|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5223744|NCT00732498|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5223745|NCT00732485|Burn injury|burn injury
5223746|NCT00732485|Fenofibrate|fenofibrate
5223747|NCT00732485|Insulin resistance|insulin resistance
5223748|NCT00732485|Mitochondrial function|mitochondrial function
5223749|NCT00732485|Fat oxidation|fat oxidation
5223750|NCT00732485|PPAR|ppar
5223751|NCT00732485|Protein|protein
5223752|NCT00732485|Glucose|glucose
5223753|NCT00732485|Wound|wound
5223754|NCT00732472|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
5223755|NCT00732472|Magnesium stearate|magnesium stearate
5223756|NCT00732472|GSK573719|gsk573719
5223757|NCT00732459|myocardial protection|myocardial protection
5223758|NCT00732459|cardiac surgery|cardiac surgery
5223759|NCT00732459|heart valve replacement|heart valve replacement
5223760|NCT00732446|moxifloxacin|moxifloxacin
5223761|NCT00732446|dexamethasone|dexamethasone
5223762|NCT00732446|ocular inflammation|ocular inflammation
5223763|NCT00732446|ocular infection|ocular infection
5223764|NCT00732420|pazopanib|pazopanib
5223765|NCT00732420|Phase I|phase i
5223766|NCT00732420|topotecan|topotecan
5223767|NCT00732420|Advanced Solid Tumors|advanced solid tumors
5223768|NCT00732407|aliskiren|aliskiren
5223769|NCT00732407|arteial stiffness|arteial stiffness
5223770|NCT00732407|platelet function|platelet function
5223771|NCT00732407|diabetes mellitus|diabetes mellitus
5223772|NCT00732355|syphilis|syphilis
5223773|NCT00732342|Alcohol Abuse|alcohol abuse
5223774|NCT00732342|Contingency Management|contingency management
5223775|NCT00732342|Treatment Duration|treatment duration
5223776|NCT00732316|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5223777|NCT00732316|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5223778|NCT00732316|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5223779|NCT00732316|acute undifferentiated leukemia|acute undifferentiated leukemia
5223780|NCT00732316|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5223781|NCT00732316|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
5223782|NCT00732316|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
5223783|NCT00732316|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
5223784|NCT00732316|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
5223785|NCT00732316|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5223786|NCT00732316|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5223787|NCT00732316|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5223788|NCT00732316|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5223789|NCT00732316|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5223790|NCT00732316|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5223791|NCT00732316|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5223792|NCT00732316|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5223793|NCT00732316|refractory anemia with excess blasts|refractory anemia with excess blasts
5223794|NCT00732316|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
5223795|NCT00732316|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5223796|NCT00732316|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5223797|NCT00732290|Healthy volunteer|healthy volunteer
5223798|NCT00732290|Pharmacokinetic|pharmacokinetic
5223799|NCT00732290|pharmacodynamic|pharmacodynamic
5223800|NCT00732290|Polymorphism, Genetic|polymorphism, genetic
5223801|NCT00732277|sepsis|sepsis
5223802|NCT00732277|septicaemia|septicaemia
5223803|NCT00732277|septicemia|septicemia
5223804|NCT00732277|paediatric|paediatric
5223805|NCT00732277|pediatric|pediatric
5223806|NCT00732277|children|children
5223807|NCT00732251|Bipolar Disorder|bipolar disorder
5223808|NCT00732251|Stable Bipolar Disorder|stable bipolar disorder
5223809|NCT00732251|Mania|mania
5223810|NCT00732251|Mixed mania|mixed mania
5223811|NCT00732251|Allopurinol|allopurinol
5223812|NCT00732238|Spinal Cord Injury|spinal cord injury
5223813|NCT00732238|Urinary Tract Infection|urinary tract infection
5223814|NCT00732238|Catheter Dependent|catheter dependent
5223815|NCT00732225|DisCoVisc OVD|discovisc ovd
5223816|NCT00732225|Ophthalmic Viscosurgical Device|ophthalmic viscosurgical device
5223817|NCT00732212|UGI Bleeding|ugi bleeding
5223818|NCT00732212|Ulcer or variceal hemorrhage|ulcer or variceal hemorrhage
5223819|NCT00732212|Stigmata of recent hemorrhage|stigmata of recent hemorrhage
5223820|NCT00732212|Endoscopy|endoscopy
5223821|NCT00732212|Randomized Controlled Trial|randomized controlled trial
5223822|NCT00732212|Non-variceal UGI hemorrhage|non-variceal ugi hemorrhage
5223823|NCT00732212|Variceal hemorrhage|variceal hemorrhage
5223824|NCT00732199|apneic threshold|apneic threshold
5223825|NCT00732199|central apnea|central apnea
5223826|NCT00732199|intermittent hypoxia|intermittent hypoxia
5223827|NCT00732199|aging|aging
5223828|NCT00732199|ventilation|ventilation
5223829|NCT00732199|chemoresponsiveness|chemoresponsiveness
5223830|NCT00732199|carbon-dioxide reserve|carbon-dioxide reserve
5223831|NCT00732173|stage I endometrial carcinoma|stage i endometrial carcinoma
5223832|NCT00732173|stage II endometrial carcinoma|stage ii endometrial carcinoma
5223833|NCT00732160|Glucose|glucose
5223834|NCT00732160|Insulin|insulin
5223835|NCT00732147|triglycerides|triglycerides
5223836|NCT00732147|endogenous|endogenous
5223837|NCT00732147|glucose|glucose
5223838|NCT00732147|production|production
5223839|NCT00732121|Type 2 Diabetes|type 2 diabetes
5223840|NCT00732108|migraine|migraine
5223841|NCT00732108|headache|headache
5223842|NCT00732108|dizziness|dizziness
5223843|NCT00732108|vertigo|vertigo
5223844|NCT00732108|topiramate|topiramate
5223845|NCT00732108|Topamax|topamax
5223846|NCT00732095|Self-change|self-change
5223847|NCT00732095|Natural recovery|natural recovery
5223848|NCT00732095|Alcohol Drinking|alcohol drinking
5223849|NCT00732095|Mechanisms of Change|mechanisms of change
5223850|NCT00732095|Advertisements|advertisements
5223851|NCT00732082|LAG-3 and gemcitabine treatment for advanced pancreas cancer|lag-3 and gemcitabine treatment for advanced pancreas cancer
5223852|NCT00732069|hemodialysis|hemodialysis
5223853|NCT00732069|oxidative stress|oxidative stress
5223854|NCT00732069|inflammation|inflammation
5223855|NCT00732069|kallikrein-kinin|kallikrein-kinin
5223856|NCT00732069|angiotensin receptor blockade|angiotensin receptor blockade
5223857|NCT00732069|angiotensin converting enzyme inhibition|angiotensin converting enzyme inhibition
5223858|NCT00732069|RAAS|raas
5223859|NCT00732069|fibrinolysis|fibrinolysis
5223860|NCT00732069|endothelial dysfunction|endothelial dysfunction
5223861|NCT00732056|Metastatic Breast Cancer|metastatic breast cancer
5223862|NCT00732056|Recurrent Breast Cancer|recurrent breast cancer
5223863|NCT00732043|prostate cancer|prostate cancer
5223864|NCT00732043|prostate-specific antigen|prostate-specific antigen
5223865|NCT00732043|PSA|psa
5223866|NCT00732043|pomegranate|pomegranate
5223867|NCT00732030|Toric IOL|toric iol
5223868|NCT00732017|Sprain|sprain
5223869|NCT00732017|Electric stimulation|electric stimulation
5223870|NCT00732017|Physical trauma|physical trauma
5223871|NCT00732017|Inflammation|inflammation
5223873|NCT00731978|Near-Infrared Spectroscopy|near-infrared spectroscopy
5223874|NCT00731978|Intraoperative Care|intraoperative care
5223875|NCT00731965|Arthritis, Juvenile Rheumatoid|arthritis, juvenile rheumatoid
5223876|NCT00731965|Measles-Mumps-Rubella Vaccine|measles-mumps-rubella vaccine
5223877|NCT00731965|Serology|serology
5223878|NCT00731965|Lymphocytes|lymphocytes
5223879|NCT00731952|surgically resectable|surgically resectable
5223880|NCT00731939|Erectile Dysfunction|erectile dysfunction
5223881|NCT00731939|Penile implant|penile implant
5223882|NCT00731939|Titan|titan
5223883|NCT00731913|Surgical wounds|surgical wounds
5223884|NCT00731913|Sutures|sutures
5223885|NCT00731900|pharmacogenetic|pharmacogenetic
5223886|NCT00731900|study|study
5223887|NCT00731900|Topirmate|topirmate
5223888|NCT00731900|induced|induced
5223889|NCT00731887|Burn injury|burn injury
5223890|NCT00731887|Burn recovery|burn recovery
5223891|NCT00731874|Kidney transplantation|kidney transplantation
5223892|NCT00731874|Immunosuppression|immunosuppression
5223893|NCT00731874|Minimization|minimization
5223894|NCT00731874|Tacrolimus|tacrolimus
5223895|NCT00731874|Prograf|prograf
5223896|NCT00731874|Thymoglobulin|thymoglobulin
5223897|NCT00731848|prostate cancer|prostate cancer
5223898|NCT00731848|prostate-specific antigens|prostate-specific antigens
5223899|NCT00731848|PSA|psa
5223900|NCT00731835|Vascular|vascular
5223901|NCT00731822|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5223902|NCT00731822|Novel Dry Powder Inhaler|novel dry powder inhaler
5223903|NCT00731822|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
5223904|NCT00731822|GW685698/GW642444|gw685698/gw642444
5223905|NCT00731809|Crohn's disease|crohn's disease
5223906|NCT00731796|Stroke|stroke
5223907|NCT00731796|Retrochiasmatic|retrochiasmatic
5223908|NCT00731796|Vision|vision
5223909|NCT00731796|VFD|vfd
5223910|NCT00731783|Abscesses|abscesses
5223911|NCT00731783|Furunculosis|furunculosis
5223912|NCT00731783|Staphylococcus aureus colonization|staphylococcus aureus colonization
5223913|NCT00731783|Staphylococcal Skin Infections|staphylococcal skin infections
5223914|NCT00731783|MRSA|mrsa
5223915|NCT00731770|COPD|copd
5223916|NCT00731770|sleep|sleep
5223917|NCT00731770|daytime somnolence|daytime somnolence
5223918|NCT00731718|Head Lice|head lice
5223919|NCT00731692|FTY720, primary progressive multiple sclerosis,PPMS|fty720, primary progressive multiple sclerosis,ppms
5223920|NCT00731679|IBS|ibs
5223921|NCT00731679|Abdominal pain|abdominal pain
5223922|NCT00731679|Bloating|bloating
5223923|NCT00731679|Diarrhea|diarrhea
5223924|NCT00731679|Rifaximin|rifaximin
5223925|NCT00731666|penile length|penile length
5223926|NCT00731666|IPP|ipp
5223927|NCT00731666|Erectile dysfunction|erectile dysfunction
5223928|NCT00731653|depression|depression
5223929|NCT00731653|combination|combination
5223930|NCT00731640|AcrySof|acrysof
5223931|NCT00731640|ReSTOR|restor
5223932|NCT00731640|Multifocal|multifocal
5223933|NCT00731640|Intraocular Lens|intraocular lens
5223934|NCT00731627|intracranial aneurysm|intracranial aneurysm
5223935|NCT00731614|cognitive therapy|cognitive therapy
5223936|NCT00731614|mirror training|mirror training
5223937|NCT00731614|nondirective therapy|nondirective therapy
5223938|NCT00731614|veterans|veterans
5223939|NCT00731614|amputees|amputees
5223940|NCT00731601|shock|shock
5223941|NCT00731601|peptic ulcer bleeding|peptic ulcer bleeding
5223942|NCT00731601|rebleeding|rebleeding
5223943|NCT00731575|asthma|asthma
5223944|NCT00731575|child|child
5223945|NCT00731575|pathogenesis|pathogenesis
5223946|NCT00731575|rhinovirus|rhinovirus
5223947|NCT00731575|prednisolone|prednisolone
5223948|NCT00731575|Prevention|prevention
5223949|NCT00731575|pediatric|pediatric
5223950|NCT00731562|food, varenicline, pharmacokinetics, bioavailability|food, varenicline, pharmacokinetics, bioavailability
5223951|NCT00731549|Aripiprazole|aripiprazole
5223952|NCT00731549|IM Depot|im depot
5223953|NCT00731549|Schizophrenia|schizophrenia
5223954|NCT00731549|Intramuscular|intramuscular
5223955|NCT00731536|Hepatosplenic T-cell Lymphoma|hepatosplenic t-cell lymphoma
5223956|NCT00731536|Remicade|remicade
5223957|NCT00731536|Infliximab|infliximab
5223958|NCT00731536|Dutch national database of pathology|dutch national database of pathology
5223959|NCT00731536|PALGA|palga
5223960|NCT00731536|Autoimmune disease|autoimmune disease
5223961|NCT00731536|Non-Hodgkin lymphoma|non-hodgkin lymphoma
5223962|NCT00731523|FTY720, Pharmacokinetics, Renal insufficiency|fty720, pharmacokinetics, renal insufficiency
5223963|NCT00731510|Acute mountain sickness|acute mountain sickness
5223964|NCT00731510|Body composition,Hypoxia|body composition,hypoxia
5223965|NCT00731510|Carbohydrate supplementation|carbohydrate supplementation
5223966|NCT00731510|Expedition,|expedition,
5223967|NCT00731510|Hydration,|hydration,
5223968|NCT00731510|Hypoxia|hypoxia
5223969|NCT00731510|Performance|performance
5223970|NCT00731497|SODIS|sodis
5223971|NCT00731497|Drinking Water|drinking water
5223972|NCT00731497|Disinfection|disinfection
5223973|NCT00731497|Intervention Trial|intervention trial
5223974|NCT00731484|Dry Eye Disease|dry eye disease
5223975|NCT00731484|Tear Osmolarity|tear osmolarity
5223976|NCT00731484|Tear Osmolality|tear osmolality
5223977|NCT00731458|OCT;|oct;
5223978|NCT00731458|Cirrus;|cirrus;
5223979|NCT00731458|Stratus;|stratus;
5223980|NCT00731458|macular thickness|macular thickness
5223981|NCT00731445|Z-208|z-208
5223982|NCT00731432|gingivitis, diabetes mellitus, herbal, oral inflammation|gingivitis, diabetes mellitus, herbal, oral inflammation
5223983|NCT00731419|biliary|biliary
5223984|NCT00731419|obstruction|obstruction
5223985|NCT00731419|malignant|malignant
5223986|NCT00731419|stent|stent
5223987|NCT00731419|palliation|palliation
5223988|NCT00731393|Thiomersal-free influenza split vaccine 2003/2004|thiomersal-free influenza split vaccine 2003/2004
5223989|NCT00731393|Influsplit SSW®/Fluarix™ 2003/2004|influsplit ssw®/fluarix™ 2003/2004
5223990|NCT00731393|Influenza|influenza
5223991|NCT00731380|Abraxane|abraxane
5223992|NCT00731380|Head and Neck Cancer|head and neck cancer
5223993|NCT00731380|Determine|determine
5223994|NCT00731380|Maximum|maximum
5223995|NCT00731380|Tolerated dose|tolerated dose
5223996|NCT00731380|ABI-007|abi-007
5223997|NCT00731380|Combination|combination
5223998|NCT00731380|Cisplatin|cisplatin
5223999|NCT00731380|5-Fluorouracil|5-fluorouracil
5224000|NCT00731380|Patients|patients
5224001|NCT00731354|lipoplasty|lipoplasty
5224002|NCT00731354|liposuction|liposuction
5224003|NCT00731354|VASER|vaser
5224004|NCT00731354|body contouring|body contouring
5224005|NCT00731354|body sculpting|body sculpting
5224006|NCT00731354|Any patient|any patient
5224007|NCT00731354|expressing|expressing
5224008|NCT00731354|interest|interest
5224009|NCT00731354|in elective surgery|in elective surgery
5224010|NCT00731341|Uterine fibroids|uterine fibroids
5224011|NCT00731341|Leiomyoma|leiomyoma
5224012|NCT00731341|Menorrhagia|menorrhagia
5224013|NCT00731341|Hysteroscopic cryoablation|hysteroscopic cryoablation
5224014|NCT00731341|Minimally invasive|minimally invasive
5224015|NCT00731328|refractory anemia|refractory anemia
5224016|NCT00731328|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
5224017|NCT00731328|refractory cytopenia with multilineage dysplasia|refractory cytopenia with multilineage dysplasia
5224018|NCT00731328|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
5224019|NCT00731328|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5224020|NCT00731328|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5224021|NCT00731328|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5224022|NCT00731328|aplastic anemia|aplastic anemia
5224023|NCT00731328|paroxysmal nocturnal hemoglobinuria|paroxysmal nocturnal hemoglobinuria
5224024|NCT00731315|UTI|uti
5224025|NCT00731315|Kiosk|kiosk
5224026|NCT00731315|Computer Assisted Care|computer assisted care
5224027|NCT00731315|cystitis|cystitis
5224028|NCT00731289|Osteoarthritis|osteoarthritis
5224029|NCT00731289|Knee|knee
5224030|NCT00731289|Hyaluronan|hyaluronan
5224031|NCT00731289|Gait Analysis|gait analysis
5224032|NCT00731276|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5224033|NCT00731263|Cancer|cancer
5224034|NCT00731263|Advance solid tumours|advance solid tumours
5224035|NCT00731263|Dose Escalation|dose escalation
5224036|NCT00731263|Preliminary efficacy|preliminary efficacy
5224037|NCT00731263|AZD8055|azd8055
5224038|NCT00731263|Tor kinase inhibitor|tor kinase inhibitor
5224039|NCT00731263|Oral administration|oral administration
5224040|NCT00731250|Capsaicin challenge|capsaicin challenge
5224041|NCT00731237|Drug Eluting Stent|drug eluting stent
5224042|NCT00731237|Percutaneous Coronary Intervention|percutaneous coronary intervention
5224043|NCT00731237|Everolimus|everolimus
5224044|NCT00731224|Alzheimer's disease, rivastigmine, patch|alzheimer's disease, rivastigmine, patch
5224045|NCT00731211|Renal Cell Carcinoma|renal cell carcinoma
5224046|NCT00731211|Metastatic|metastatic
5224047|NCT00731211|Pazopanib|pazopanib
5224048|NCT00731211|Previously-treated|previously-treated
5224049|NCT00731198|ERCP|ercp
5224050|NCT00731198|Drotaverine hydrochloride|drotaverine hydrochloride
5224051|NCT00731198|Hyoscine-N-butylbromide|hyoscine-n-butylbromide
5224052|NCT00731185|functional|functional
5224053|NCT00731185|endoscopic|endoscopic
5224054|NCT00731185|sinus|sinus
5224055|NCT00731185|surgery|surgery
5224056|NCT00731172|crohns disease|crohns disease
5224057|NCT00731146|Interscalene Brachial Plexus Block|interscalene brachial plexus block
5224058|NCT00731146|Regional Anesthesia|regional anesthesia
5224059|NCT00731146|Ultrasound guided peripheral nerve block|ultrasound guided peripheral nerve block
5224060|NCT00731146|Minimum Effective Anesthetic Volume|minimum effective anesthetic volume
5224061|NCT00731146|Nerve Stimulator guided peripheral nerve block|nerve stimulator guided peripheral nerve block
5224062|NCT00731133|disulfiram|disulfiram
5224063|NCT00731133|methamphetamine dependence|methamphetamine dependence
5224064|NCT00731133|open label|open label
5224065|NCT00731120|Generalized Anxiety Disorder|generalized anxiety disorder
5224066|NCT00731120|Mood Disorder|mood disorder
5224067|NCT00731120|Affective Disorder|affective disorder
5224068|NCT00731120|Anxiety Disorder|anxiety disorder
5224069|NCT00731120|Drug Therapy|drug therapy
5224070|NCT00731107|Veress Needle|veress needle
5224071|NCT00731107|XCEL bladeless trocar|xcel bladeless trocar
5224658|NCT00728754|multicenter|multicenter
5224072|NCT00731107|Laparoscopic entry techniques|laparoscopic entry techniques
5224073|NCT00731094|overweight|overweight
5224074|NCT00731094|sedentary lifestyle|sedentary lifestyle
5224075|NCT00731094|exercise|exercise
5224076|NCT00731094|primary health care|primary health care
5224077|NCT00731094|controlled clinical trials, randomized|controlled clinical trials, randomized
5224078|NCT00731068|Achilles tendon|achilles tendon
5224079|NCT00731042|Skin health|skin health
5224080|NCT00731029|Influenza|influenza
5224081|NCT00731029|Thiomersal-free influenza split vaccine 2002/2003|thiomersal-free influenza split vaccine 2002/2003
5224082|NCT00731029|Influsplit SSW®/Fluarix™ 2002/2003|influsplit ssw®/fluarix™ 2002/2003
5224083|NCT00731003|serotonin|serotonin
5224084|NCT00731003|gut permeability|gut permeability
5224085|NCT00731003|visceral sensitivity|visceral sensitivity
5224086|NCT00731003|irritable bowel syndrome|irritable bowel syndrome
5224087|NCT00730990|Positron Emission Tomography study in healthy volunteers for ligand qualification and receptor occupancy determination.|positron emission tomography study in healthy volunteers for ligand qualification and receptor occupancy determination.
5224088|NCT00730964|Surveillance|surveillance
5224089|NCT00730964|Optison|optison
5224090|NCT00730964|Perflutren|perflutren
5224091|NCT00730964|Echocardiography|echocardiography
5224092|NCT00730964|Subjects receive Optison during enhanced echocardiography|subjects receive optison during enhanced echocardiography
5224093|NCT00730938|fibrin|fibrin
5224094|NCT00730938|endophthalmitis|endophthalmitis
5224095|NCT00730938|cataract extraction|cataract extraction
5224096|NCT00730938|Lens|lens
5224097|NCT00730938|implantation,|implantation,
5224098|NCT00730938|intraocular|intraocular
5224099|NCT00730886|Uterine Fibroids|uterine fibroids
5224100|NCT00730886|Unexplained Infertility|unexplained infertility
5224101|NCT00730886|MRgFUS|mrgfus
5224102|NCT00730886|ExAblate|exablate
5224103|NCT00730886|Focused Ultrasound|focused ultrasound
5224104|NCT00730886|Myomectomy|myomectomy
5224105|NCT00730860|radiofrequency ablation|radiofrequency ablation
5224106|NCT00730860|Cancer of Liver|cancer of liver
5224107|NCT00730860|postoperative|postoperative
5224108|NCT00730860|transhepatic arterial chemoembolization|transhepatic arterial chemoembolization
5224109|NCT00730860|prospective|prospective
5224110|NCT00730847|Cervarix|cervarix
5224111|NCT00730847|Filipinos|filipinos
5224112|NCT00730847|Safety and reactogenicity|safety and reactogenicity
5224113|NCT00730847|Human papillomavirus|human papillomavirus
5224114|NCT00730834|tinnitus|tinnitus
5224115|NCT00730834|ringing in the ears|ringing in the ears
5224116|NCT00730834|buzzing|buzzing
5224117|NCT00730834|static|static
5224118|NCT00730834|hyperacusis|hyperacusis
5224119|NCT00730834|loudness discomfort|loudness discomfort
5224120|NCT00730834|Clinically|clinically
5224121|NCT00730834|significant|significant
5224122|NCT00730834|discomfort|discomfort
5224123|NCT00730808|Enteral nutritional regimen prior to surgery|enteral nutritional regimen prior to surgery
5224124|NCT00730795|Tuberculosis vaccine|tuberculosis vaccine
5224125|NCT00730769|Valganciclovir|valganciclovir
5224126|NCT00730769|Ganciclovir|ganciclovir
5224127|NCT00730769|Pharmacokinetics|pharmacokinetics
5224128|NCT00730769|Solid organ transplantation|solid organ transplantation
5224129|NCT00730769|Transplant|transplant
5224130|NCT00730756|Adolescents|adolescents
5224131|NCT00730756|Irritant(non-allergic)rhinitis|irritant(non-allergic)rhinitis
5224132|NCT00730756|Adults|adults
5224133|NCT00730756|GW685698|gw685698
5224134|NCT00730756|Air Pollution|air pollution
5224135|NCT00730730|Iliac Artery, Peripheral Vascular Disease (PVD)|iliac artery, peripheral vascular disease (pvd)
5224136|NCT00730704|Human Papilloma Virus vaccines|human papilloma virus vaccines
5224137|NCT00730704|HPV|hpv
5224138|NCT00730704|Gardasil|gardasil
5224139|NCT00730704|Post partum|post partum
5224140|NCT00730691|Generalized Anxiety Disorder|generalized anxiety disorder
5224141|NCT00730691|Mood Disorder|mood disorder
5224142|NCT00730691|Affective Disorder|affective disorder
5224143|NCT00730691|Anxiety Disorder|anxiety disorder
5224144|NCT00730691|Drug Therapy|drug therapy
5224145|NCT00730678|Metabolism|metabolism
5224146|NCT00730678|Pharmacogenetic testing|pharmacogenetic testing
5224147|NCT00730665|PPI partial responders with non-erosive GERD.|ppi partial responders with non-erosive gerd.
5224148|NCT00730652|Medarex Inc.|medarex inc.
5224149|NCT00730626|Probiotics|probiotics
5224150|NCT00730626|Immunity|immunity
5224151|NCT00730626|Immune response|immune response
5224152|NCT00730626|Intestinal microflora|intestinal microflora
5224153|NCT00730626|Blood lipids|blood lipids
5224154|NCT00730626|Phagocytosis activity|phagocytosis activity
5224155|NCT00730613|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5224156|NCT00730613|adult diffuse astrocytoma|adult diffuse astrocytoma
5224157|NCT00730613|adult pilocytic astrocytoma|adult pilocytic astrocytoma
5224158|NCT00730613|adult subependymal giant cell astrocytoma|adult subependymal giant cell astrocytoma
5224159|NCT00730613|adult anaplastic ependymoma|adult anaplastic ependymoma
5224160|NCT00730613|adult ependymoma|adult ependymoma
5224161|NCT00730613|adult myxopapillary ependymoma|adult myxopapillary ependymoma
5224162|NCT00730613|adult subependymoma|adult subependymoma
5224163|NCT00730613|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
5224164|NCT00730613|adult oligodendroglioma|adult oligodendroglioma
5224165|NCT00730613|adult brain stem glioma|adult brain stem glioma
5224166|NCT00730613|adult giant cell glioblastoma|adult giant cell glioblastoma
5224167|NCT00730613|adult glioblastoma|adult glioblastoma
5224168|NCT00730613|recurrent adult brain tumor|recurrent adult brain tumor
5224169|NCT00730613|adult gliosarcoma|adult gliosarcoma
5224170|NCT00730613|adult mixed glioma|adult mixed glioma
5224171|NCT00730613|adult pineal gland astrocytoma|adult pineal gland astrocytoma
5224172|NCT00730600|Thai Traditional massage|thai traditional massage
5224173|NCT00730600|Bone Formation|bone formation
5224174|NCT00730600|Bone Resorption|bone resorption
5224175|NCT00730587|Nutrition|nutrition
5224176|NCT00730587|Body Fat|body fat
5224177|NCT00730587|Infant|infant
5224178|NCT00730587|Healthy Babies|healthy babies
5224179|NCT00730561|nerve conduction velocity|nerve conduction velocity
5224180|NCT00730561|hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
5224181|NCT00730535|Overactive bladder, Tolterodine,Symptoms Relapse, Predictor|overactive bladder, tolterodine,symptoms relapse, predictor
5224182|NCT00730522|Methamphetamine|methamphetamine
5224183|NCT00730522|Dependency|dependency
5224184|NCT00730522|Addiction|addiction
5224185|NCT00730522|vigabatrin|vigabatrin
5224186|NCT00730509|cystic fibrosis|cystic fibrosis
5224187|NCT00730509|folate|folate
5224188|NCT00730509|vitamin B12|vitamin b12
5224189|NCT00730496|Embryo culture supernatant|embryo culture supernatant
5224190|NCT00730496|injection|injection
5224191|NCT00730496|embryo transfer|embryo transfer
5224192|NCT00730496|embryo implantation rate|embryo implantation rate
5224193|NCT00730483|liver metastases|liver metastases
5224194|NCT00730483|metastatic gastrointestinal carcinoid tumor|metastatic gastrointestinal carcinoid tumor
5224195|NCT00730483|regional gastrointestinal carcinoid tumor|regional gastrointestinal carcinoid tumor
5224196|NCT00730483|islet cell carcinoma|islet cell carcinoma
5224197|NCT00730483|gastrinoma|gastrinoma
5224198|NCT00730483|insulinoma|insulinoma
5224199|NCT00730483|glucagonoma|glucagonoma
5224200|NCT00730483|pancreatic polypeptide tumor|pancreatic polypeptide tumor
5224201|NCT00730483|somatostatinoma|somatostatinoma
5224202|NCT00730470|Human Epidermal Growth Factor Receptor 3|human epidermal growth factor receptor 3
5224203|NCT00730470|HER3|her3
5224204|NCT00730470|Heregulin|heregulin
5224205|NCT00730470|erb B3|erb b3
5224206|NCT00730470|Solid Tumors|solid tumors
5224207|NCT00730470|Phase I Clinical Study|phase i clinical study
5224208|NCT00730457|influenza|influenza
5224209|NCT00730457|recombinant|recombinant
5224210|NCT00730457|hemagglutinin|hemagglutinin
5224211|NCT00730457|vaccine|vaccine
5224212|NCT00730444|Neuroblastoma|neuroblastoma
5224213|NCT00730444|Nuclear medicine|nuclear medicine
5224214|NCT00730444|Diagnostic scintigraphy|diagnostic scintigraphy
5224215|NCT00730444|Known and suspected neuroblastoma|known and suspected neuroblastoma
5224216|NCT00730431|Hepatitis C, healthy volunteers|hepatitis c, healthy volunteers
5224217|NCT00730418|Benign Prostatic Hyperplasia|benign prostatic hyperplasia
5224218|NCT00730418|alpha Adrenergic Blockers|alpha adrenergic blockers
5224219|NCT00730418|alpha-1 Adrenergic Receptor|alpha-1 adrenergic receptor
5224220|NCT00730405|Distal, Subungual onychomycosis|distal, subungual onychomycosis
5224221|NCT00730405|onychomycosis|onychomycosis
5224222|NCT00730405|nail fungus|nail fungus
5224223|NCT00730405|Toenail fungus|toenail fungus
5224224|NCT00730392|Type 1 diabetes, Etanercept, honeymoon period|type 1 diabetes, etanercept, honeymoon period
5224225|NCT00730366|Malaria|malaria
5224226|NCT00730366|Pregnancy|pregnancy
5224227|NCT00730366|Intermittent Preventive Treatment|intermittent preventive treatment
5224228|NCT00730340|Tonsillectomy, tonsillar fossa, wound closure|tonsillectomy, tonsillar fossa, wound closure
5224229|NCT00730314|unrelated|unrelated
5224230|NCT00730314|BMT|bmt
5224231|NCT00730314|HSCT|hsct
5224232|NCT00730314|bone marrow transplantation|bone marrow transplantation
5224233|NCT00730314|sickle cell disease|sickle cell disease
5224234|NCT00730314|thalassemia|thalassemia
5224235|NCT00730314|CGD|cgd
5224236|NCT00730314|HLH|hlh
5224237|NCT00730314|Blackfan-Diamond anemia|blackfan-diamond anemia
5224238|NCT00730314|Hurler|hurler
5224239|NCT00730314|leukodystrophy|leukodystrophy
5224240|NCT00730314|LAD I|lad i
5224241|NCT00730314|Genetic diseases|genetic diseases
5224242|NCT00730314|Red blood cell defects|red blood cell defects
5224243|NCT00730314|Leukocyte defects and immune deficiencies|leukocyte defects and immune deficiencies
5224244|NCT00730314|Hereditary Lymphohistiocytosis|hereditary lymphohistiocytosis
5224245|NCT00730314|chronic granulomatous disease|chronic granulomatous disease
5224246|NCT00730314|Wiskott-Aldrich syndrome|wiskott-aldrich syndrome
5224247|NCT00730314|Chediak Higashi syndrome|chediak higashi syndrome
5224248|NCT00730314|CD40 ligand deficiency|cd40 ligand deficiency
5224249|NCT00730314|Hyper IgM syndrome|hyper igm syndrome
5224250|NCT00730314|leucocytes adhesion defect type 1|leucocytes adhesion defect type 1
5224251|NCT00730314|Osteopetrosis|osteopetrosis
5224252|NCT00730314|congenital neutropenia|congenital neutropenia
5224253|NCT00730314|X-linked lymphoproliferative disease|x-linked lymphoproliferative disease
5224254|NCT00730314|Platelets defects|platelets defects
5224255|NCT00730314|Congenital amegakaryocytic thrombocytopenia|congenital amegakaryocytic thrombocytopenia
5224256|NCT00730314|Metabolic and storage disorders|metabolic and storage disorders
5224257|NCT00730314|Hurler disease|hurler disease
5224258|NCT00730314|leukodystrophies|leukodystrophies
5224259|NCT00730314|Niemann-Pick disease|niemann-pick disease
5224260|NCT00730314|Fucosidosis|fucosidosis
5224261|NCT00730314|Stem cell defects|stem cell defects
5224262|NCT00730314|reticular agenesis|reticular agenesis
5224263|NCT00730301|Emphysema|emphysema
5224264|NCT00730301|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
5224265|NCT00730301|Lung volume reduction|lung volume reduction
5224266|NCT00730301|Lung function|lung function
5224267|NCT00730288|Dengue|dengue
5224268|NCT00730288|Dengue fever|dengue fever
5224269|NCT00730288|Dengue hemorrhagic fever|dengue hemorrhagic fever
5224270|NCT00730288|Dengue virus|dengue virus
5224271|NCT00730262|Glioblastoma Multiforme (GBM)|glioblastoma multiforme (gbm)
5224272|NCT00730262|Phase II|phase ii
5224273|NCT00730262|Brain Cancer|brain cancer
5224274|NCT00730249|ADHD|adhd
5224275|NCT00730249|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
5224276|NCT00730249|adult|adult
5224277|NCT00730249|methylphenidate hydrochloride|methylphenidate hydrochloride
5224278|NCT00730249|Medikinet retard|medikinet retard
5224279|NCT00730249|controlled clinical trial|controlled clinical trial
5224280|NCT00730249|safety|safety
5224281|NCT00730249|randomized, double-blind, placebo-controlled trial|randomized, double-blind, placebo-controlled trial
5224282|NCT00730249|treatment|treatment
5224283|NCT00730249|central nervous system stimulants|central nervous system stimulants
5224284|NCT00730249|therapeutic uses|therapeutic uses
5224285|NCT00730223|Nevirapine|nevirapine
5224286|NCT00730223|Efavirenz|efavirenz
5224287|NCT00730223|pharmacokinetics|pharmacokinetics
5224288|NCT00730223|healthy|healthy
5224289|NCT00730223|CYP2B6|cyp2b6
5224290|NCT00730223|HIV/AIDS|hiv/aids
5224291|NCT00730210|Hypoparathyroidism|hypoparathyroidism
5224292|NCT00730210|HypoPTH|hypopth
5224293|NCT00730210|PTH|pth
5224294|NCT00730184|acid-base|acid-base
5224295|NCT00730184|potassium|potassium
5224296|NCT00730184|acidosis|acidosis
5224297|NCT00730184|osteoporosis|osteoporosis
5224298|NCT00730184|sarcopenia|sarcopenia
5224299|NCT00730184|calcium absorption|calcium absorption
5224300|NCT00730184|dietary protein|dietary protein
5224301|NCT00730145|pharmacokinetics, PD-0332334, hemodialysis, renal dialysis|pharmacokinetics, pd-0332334, hemodialysis, renal dialysis
5224302|NCT00730119|Non-invasive Blood Pressure (NIBP)|non-invasive blood pressure (nibp)
5224303|NCT00730119|GE Monitor|ge monitor
5224304|NCT00730119|Temperature|temperature
5224305|NCT00730119|SpO2|spo2
5224306|NCT00730119|Respiration, ECG|respiration, ecg
5224307|NCT00730106|Gastroesophageal reflux disease|gastroesophageal reflux disease
5224308|NCT00730106|Alarm symptoms|alarm symptoms
5224309|NCT00730106|Gastrointestinal endoscopy|gastrointestinal endoscopy
5224310|NCT00730093|Vitamin B12 absorption|vitamin b12 absorption
5224311|NCT00730093|Pregnancy|pregnancy
5224312|NCT00730080|phenylketonuria|phenylketonuria
5224313|NCT00730080|sapropterin|sapropterin
5224314|NCT00730080|Kuvan|kuvan
5224315|NCT00730080|cognition|cognition
5224316|NCT00730080|executive abilities|executive abilities
5224317|NCT00730080|brain|brain
5224318|NCT00730067|COPD|copd
5224319|NCT00730067|Pulmonary hypertension|pulmonary hypertension
5224320|NCT00730067|Sildenafil|sildenafil
5224321|NCT00730067|NT-pro BNP|nt-pro bnp
5224322|NCT00730067|apelin|apelin
5224323|NCT00730054|Remifentanil|remifentanil
5224324|NCT00730054|clonidine|clonidine
5224325|NCT00730054|acute pain|acute pain
5224326|NCT00730054|respiration|respiration
5224327|NCT00730054|sedation|sedation
5224328|NCT00730054|cognitive function|cognitive function
5224329|NCT00730041|obstructive sleep apnea|obstructive sleep apnea
5224330|NCT00730041|continuous positive air pressure|continuous positive air pressure
5224331|NCT00730028|Methicillin-resistant Staphylococcus aureus (MRSA), cellulitis, abscess, children, elderly|methicillin-resistant staphylococcus aureus (mrsa), cellulitis, abscess, children, elderly
5224332|NCT00730002|Lupus|lupus
5224333|NCT00729989|Meconium Aspiration|meconium aspiration
5224334|NCT00729989|Respiratory Distress|respiratory distress
5224335|NCT00729989|Meconium Stained Amniotic Fluid|meconium stained amniotic fluid
5224336|NCT00729976|Ibuprofen|ibuprofen
5224337|NCT00729976|Suppository|suppository
5224338|NCT00729976|febrile children|febrile children
5224339|NCT00729937|Methicillin, Staphylococcus aureus, MRSA|methicillin, staphylococcus aureus, mrsa
5224340|NCT00729924|Raltegravir|raltegravir
5224341|NCT00729924|CSF|csf
5224342|NCT00729924|ABCB1 SNP|abcb1 snp
5224343|NCT00729924|HIV/AIDS|hiv/aids
5224344|NCT00729911|Atrial fibrillation Ablation|atrial fibrillation ablation
5224345|NCT00729885|Vertigo|vertigo
5224346|NCT00729885|Benign Paroxysmal Positional Vertigo|benign paroxysmal positional vertigo
5224347|NCT00729885|BPPV|bppv
5224348|NCT00729885|Positional Vertigo|positional vertigo
5224349|NCT00729872|AG011|ag011
5224350|NCT00729872|Ulcerative Colitis|ulcerative colitis
5224351|NCT00729872|human Interleukin-10|human interleukin-10
5224352|NCT00729859|HDL|hdl
5224353|NCT00729859|Insulin sensitivity|insulin sensitivity
5224354|NCT00729859|testosterone|testosterone
5224355|NCT00729859|estradiol|estradiol
5224356|NCT00729859|cholesterol|cholesterol
5224659|NCT00728754|randomized|randomized
5224357|NCT00729846|choroidal neovascularization|choroidal neovascularization
5224358|NCT00729846|macular degeneration|macular degeneration
5224359|NCT00729846|macular edema|macular edema
5224360|NCT00729846|intravitreal bevacizumab|intravitreal bevacizumab
5224361|NCT00729846|vegf|vegf
5224362|NCT00729846|verteporfin PDT|verteporfin pdt
5224363|NCT00729820|PERSONALITY|personality
5224364|NCT00729820|COGNITIVE PERFORMANCE|cognitive performance
5224365|NCT00729820|the practical usefulness (validity) of processing speed, accuracy of performance and personality measures in predicting impulsive behavior|the practical usefulness (validity) of processing speed, accuracy of performance and personality measures in predicting impulsive behavior
5224366|NCT00729807|recurrent melanoma|recurrent melanoma
5224367|NCT00729794|Vasopressin|vasopressin
5224368|NCT00729794|Epinephrine|epinephrine
5224369|NCT00729794|Adrenal Cortex Hormones|adrenal cortex hormones
5224370|NCT00729794|Heart Arrest|heart arrest
5224371|NCT00729781|nasal obstruction|nasal obstruction
5224372|NCT00729781|airway resistance|airway resistance
5224373|NCT00729781|soft tissue collapse|soft tissue collapse
5224374|NCT00729781|cosmetic contour deformity|cosmetic contour deformity
5224375|NCT00729768|Renal transplant|renal transplant
5224376|NCT00729768|Raptiva|raptiva
5224377|NCT00729755|Creatine|creatine
5224378|NCT00729755|Augmentation|augmentation
5224379|NCT00729755|Major Depressive Disorder|major depressive disorder
5224380|NCT00729755|Efficacy|efficacy
5224381|NCT00729755|Brain Energy Metabolism|brain energy metabolism
5224382|NCT00729729|Comparative|comparative
5224383|NCT00729729|bioavailability|bioavailability
5224384|NCT00729729|of PCA|of pca
5224385|NCT00729729|formulations|formulations
5224386|NCT00729716|Microfracture|microfracture
5224387|NCT00729716|Cartilage repair|cartilage repair
5224388|NCT00729716|Autologous chondrocyte implantation|autologous chondrocyte implantation
5224389|NCT00729703|ICD|icd
5224390|NCT00729703|Minimized|minimized
5224391|NCT00729703|ventricular|ventricular
5224392|NCT00729703|pacing|pacing
5224393|NCT00729703|indication|indication
5224394|NCT00729703|Clinical outcome|clinical outcome
5224395|NCT00729703|Inappropriate shock|inappropriate shock
5224396|NCT00729690|Pregabalin|pregabalin
5224397|NCT00729690|CSF|csf
5224398|NCT00729690|Neurotransmitter|neurotransmitter
5224399|NCT00729677|nausea and vomiting|nausea and vomiting
5224400|NCT00729677|colon cancer|colon cancer
5224401|NCT00729677|rectal cancer|rectal cancer
5224402|NCT00729638|relapsed multiple myeloma|relapsed multiple myeloma
5224403|NCT00729638|refractory multiple myeloma|refractory multiple myeloma
5224404|NCT00729638|RAD001|rad001
5224405|NCT00729638|lenalidomide|lenalidomide
5224406|NCT00729625|stroke, rehabilitation, robotics|stroke, rehabilitation, robotics
5224407|NCT00729612|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5224408|NCT00729612|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5224409|NCT00729612|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5224410|NCT00729612|squamous cell lung cancer|squamous cell lung cancer
5224411|NCT00729573|Microbicide|microbicide
5224412|NCT00729573|HIV Seronegativity|hiv seronegativity
5224413|NCT00729573|Bone Mineral Density|bone mineral density
5224414|NCT00729560|PCOS|pcos
5224415|NCT00729547|Depression|depression
5224416|NCT00729547|Biofeedback|biofeedback
5224417|NCT00729547|Psychophysiology|psychophysiology
5224418|NCT00729534|Perception|perception
5224419|NCT00729534|Focus Group|focus group
5224420|NCT00729534|Perception of Clinical Research Participation|perception of clinical research participation
5224421|NCT00729521|Fall injury hospitalization|fall injury hospitalization
5224422|NCT00729521|Fall injury emergency department visit|fall injury emergency department visit
5224423|NCT00729521|Fall injury death|fall injury death
5224424|NCT00729508|Cat allergy|cat allergy
5224425|NCT00729508|Immunotherapy|immunotherapy
5224426|NCT00729508|Cat-PAD|cat-pad
5224427|NCT00729508|Environmental Exposure Chamber|environmental exposure chamber
5224428|NCT00729495|Phase I,|phase i,
5224429|NCT00729495|Healthy|healthy
5224430|NCT00729495|Volunteer|volunteer
5224431|NCT00729495|Study|study
5224432|NCT00729482|RAD001 (everolimus)|rad001 (everolimus)
5224433|NCT00729482|second-line treatment|second-line treatment
5224434|NCT00729482|advanced gastric cancer|advanced gastric cancer
5224435|NCT00729469|Vulvar and vaginal atrophy in postmenopausal women|vulvar and vaginal atrophy in postmenopausal women
5224436|NCT00729469|Menopausal symptoms|menopausal symptoms
5224437|NCT00729469|Vaginal atrophy|vaginal atrophy
5224438|NCT00729469|Urogenital atrophy|urogenital atrophy
5224439|NCT00729456|Diabetes|diabetes
5224440|NCT00729456|Education|education
5224441|NCT00729456|Ulcer|ulcer
5224442|NCT00729456|Foot|foot
5224443|NCT00729456|Behaviour|behaviour
5224444|NCT00729443|Single dose|single dose
5224445|NCT00729443|Phase 1|phase 1
5224446|NCT00729443|Safety of AZD3241|safety of azd3241
5224447|NCT00729443|tolerability of AZD3241|tolerability of azd3241
5224448|NCT00729430|Heart Attack|heart attack
5224449|NCT00729430|Sudden Cardiac Death|sudden cardiac death
5224450|NCT00729430|Peri-infarct Zone|peri-infarct zone
5224451|NCT00729430|Omega-3 Fatty Acids|omega-3 fatty acids
5224452|NCT00729430|Biological Markers|biological markers
5224959|NCT00727636|vaccine|vaccine
5224453|NCT00729430|Cytogenetic Analysis|cytogenetic analysis
5224454|NCT00729430|Cardiac Arrest|cardiac arrest
5224455|NCT00729417|incontinence|incontinence
5224456|NCT00729417|obstetric risk factors|obstetric risk factors
5224457|NCT00729417|women|women
5224458|NCT00729417|of age 18|of age 18
5224459|NCT00729417|above|above
5224460|NCT00729404|Female Contraception|female contraception
5224461|NCT00729404|Ovulation Inhibition|ovulation inhibition
5224462|NCT00729391|HIV|hiv
5224463|NCT00729391|Sexual Risk|sexual risk
5224464|NCT00729391|Substance Abuse|substance abuse
5224465|NCT00729391|Victimization|victimization
5224466|NCT00729391|Violence|violence
5224467|NCT00729391|Voluntary Counseling and Testing (VCT)|voluntary counseling and testing (vct)
5224468|NCT00729365|Urine albumin excretion rates|urine albumin excretion rates
5224469|NCT00729365|Nighttime and daytime blood pressure|nighttime and daytime blood pressure
5224470|NCT00729365|Endothelial Dysfunction|endothelial dysfunction
5224471|NCT00729352|NQO1, ozone, airway mucociliary clearance.|nqo1, ozone, airway mucociliary clearance.
5224472|NCT00729339|Gastroesophageal reflux disease|gastroesophageal reflux disease
5224473|NCT00729339|Mosapride|mosapride
5224474|NCT00729339|Lansoprazole|lansoprazole
5224475|NCT00729326|diabetes|diabetes
5224476|NCT00729326|exenatide|exenatide
5224477|NCT00729326|sitagliptin|sitagliptin
5224478|NCT00729326|Amylin|amylin
5224479|NCT00729326|Lilly|lilly
5224480|NCT00729326|metformin|metformin
5224481|NCT00729326|thiazolidinedione|thiazolidinedione
5224482|NCT00729313|Treatment|treatment
5224483|NCT00729300|cocaine|cocaine
5224484|NCT00729300|disulfiram|disulfiram
5224485|NCT00729300|antabuse|antabuse
5224486|NCT00729300|addiction|addiction
5224487|NCT00729300|stimulant|stimulant
5224488|NCT00729287|stage 0 bladder cancer|stage 0 bladder cancer
5224489|NCT00729287|stage I bladder cancer|stage i bladder cancer
5224490|NCT00729287|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
5224491|NCT00729261|mechanical ventilation|mechanical ventilation
5224492|NCT00729261|extubation|extubation
5224493|NCT00729261|outcomes|outcomes
5224494|NCT00729261|brain injury|brain injury
5224495|NCT00729248|Transplants|transplants
5224496|NCT00729248|Kidney Transplantation|kidney transplantation
5224497|NCT00729248|Immunosuppression|immunosuppression
5224498|NCT00729248|Assay|assay
5224499|NCT00729248|Graft Rejection|graft rejection
5224500|NCT00729235|Slow VT, CRT-D, ATP therapy|slow vt, crt-d, atp therapy
5224501|NCT00729235|Incidence|incidence
5224502|NCT00729235|of slow VTs|of slow vts
5224503|NCT00729235|in CRT-D patients|in crt-d patients
5224504|NCT00729235|Clinical|clinical
5224505|NCT00729235|relevance|relevance
5224506|NCT00729235|treatment|treatment
5224507|NCT00729235|VTs|vts
5224508|NCT00729235|during|during
5224509|NCT00729235|2-years|2-years
5224510|NCT00729235|follow-up|follow-up
5224511|NCT00729196|Obesity|obesity
5224512|NCT00729196|Type 2 Diabetes|type 2 diabetes
5224513|NCT00729196|Glycemic Load|glycemic load
5224514|NCT00729196|Weight Loss|weight loss
5224515|NCT00729196|Glycated Hemoglobin|glycated hemoglobin
5224516|NCT00729170|Milk|milk
5224517|NCT00729170|Calcium|calcium
5224518|NCT00729170|Weight loss|weight loss
5224519|NCT00729170|Bone density|bone density
5224520|NCT00729170|Appetite|appetite
5224521|NCT00729144|fecal incontinence|fecal incontinence
5224522|NCT00729144|bowel incontinence|bowel incontinence
5224523|NCT00729144|pelvic floor disorder|pelvic floor disorder
5224774|NCT00728247|Biomechanics|biomechanics
5224524|NCT00729131|Ozone, TNF, TNF promoter polymorphism, airway hyperresponsiveness.|ozone, tnf, tnf promoter polymorphism, airway hyperresponsiveness.
5224525|NCT00729118|stage I multiple myeloma|stage i multiple myeloma
5224526|NCT00729118|stage II multiple myeloma|stage ii multiple myeloma
5224527|NCT00729118|stage III multiple myeloma|stage iii multiple myeloma
5224528|NCT00729118|refractory multiple myeloma|refractory multiple myeloma
5224529|NCT00729092|PET SCAN|pet scan
5224530|NCT00729092|PAIN LEVELS|pain levels
5224531|NCT00729079|Diabetes Prevention|diabetes prevention
5224532|NCT00729079|Pre-Diabetes|pre-diabetes
5224533|NCT00729079|Exercise|exercise
5224534|NCT00729079|Fat Intake|fat intake
5224535|NCT00729079|Fasting blood sugar|fasting blood sugar
5224536|NCT00729079|tobacco cessation|tobacco cessation
5224538|NCT00729053|cell|cell
5224539|NCT00729053|renal carcinoma|renal carcinoma
5224540|NCT00729053|metastatic|metastatic
5224541|NCT00729053|recurrent|recurrent
5224542|NCT00729053|treatment naive|treatment naive
5224543|NCT00729040|heart|heart
5224544|NCT00729040|weight|weight
5224545|NCT00729040|Overweight|overweight
5224546|NCT00729040|bmi|bmi
5224547|NCT00729040|diabetes|diabetes
5224548|NCT00729040|type 2|type 2
5224549|NCT00729040|diabetic|diabetic
5224550|NCT00729040|walk|walk
5224551|NCT00729040|walk*|walk*
5224552|NCT00729040|diab*|diab*
5224553|NCT00729040|obese|obese
5224554|NCT00729040|exercise|exercise
5224555|NCT00729040|activity|activity
5224556|NCT00729040|coronary|coronary
5224557|NCT00729040|pedometer|pedometer
5224558|NCT00729027|hypercholesterolemia|hypercholesterolemia
5224559|NCT00729014|herbal nephropathy|herbal nephropathy
5224560|NCT00729014|Chinese herbal nephropathy|chinese herbal nephropathy
5224561|NCT00729014|nephrotoxicity|nephrotoxicity
5224562|NCT00729014|renal disease|renal disease
5224563|NCT00729014|adverse drug reaction|adverse drug reaction
5224564|NCT00729014|Chinese herbal medicine|chinese herbal medicine
5224565|NCT00729001|Rotavirus Gastroenteritis|rotavirus gastroenteritis
5224566|NCT00729001|Human rotavirus vaccine|human rotavirus vaccine
5224567|NCT00728988|Asia Lipitor Pre-treatment in Acute Coronary Syndrome|asia lipitor pre-treatment in acute coronary syndrome
5224568|NCT00728975|constipation|constipation
5224569|NCT00728975|cancer|cancer
5224570|NCT00728975|palliative care|palliative care
5224571|NCT00728975|terminal|terminal
5224572|NCT00728975|bowel|bowel
5224573|NCT00728962|dental implants|dental implants
5224574|NCT00728962|Osseotite Certain Prevail|osseotite certain prevail
5224575|NCT00728962|multicenter|multicenter
5224576|NCT00728962|observational|observational
5224577|NCT00728962|clinical study|clinical study
5224578|NCT00728962|partial edentulism|partial edentulism
5224579|NCT00728962|single stage|single stage
5224580|NCT00728962|immediate occlusal loading|immediate occlusal loading
5224581|NCT00728962|crestal bone level|crestal bone level
5224582|NCT00728962|short fixed bridge|short fixed bridge
5224583|NCT00728949|breast cancer|breast cancer
5224584|NCT00728949|Postmenopausal|postmenopausal
5224585|NCT00728949|Hormones|hormones
5224586|NCT00728949|Antiestrogen|antiestrogen
5224587|NCT00728936|Hepatitis C|hepatitis c
5224588|NCT00728936|unresponsive to pegylated interferon and ribavirin therapy|unresponsive to pegylated interferon and ribavirin therapy
5224589|NCT00728936|HCV|hcv
5224590|NCT00728923|OCD|ocd
5224591|NCT00728910|Low HDL cholesterol|low hdl cholesterol
5224592|NCT00728910|High triglycerides|high triglycerides
5224593|NCT00728910|niacin|niacin
5224594|NCT00728910|fibrate|fibrate
5224595|NCT00728897|Healthy volunteer|healthy volunteer
5224596|NCT00728897|relative bioavailability.|relative bioavailability.
5224597|NCT00728884|dental implants|dental implants
5224598|NCT00728884|Certain Prevail|certain prevail
5224599|NCT00728884|multicenter|multicenter
5224600|NCT00728884|clinical study|clinical study
5224601|NCT00728884|partial edentulism|partial edentulism
5224602|NCT00728884|total edentulism|total edentulism
5224603|NCT00728884|platform switching|platform switching
5224604|NCT00728884|single stage|single stage
5224605|NCT00728884|early loading|early loading
5224606|NCT00728884|crestal bone level|crestal bone level
5224607|NCT00728884|single tooth replacements|single tooth replacements
5224608|NCT00728884|short or long fixed bridges|short or long fixed bridges
5224609|NCT00728884|overdenture|overdenture
5224610|NCT00728884|fixed denture|fixed denture
5224611|NCT00728871|cervical cancer, HPV, immunity|cervical cancer, hpv, immunity
5224612|NCT00728858|Hypertension|hypertension
5224613|NCT00728858|SNP|snp
5224614|NCT00728858|Nifedipine|nifedipine
5224615|NCT00728858|Barnidipine|barnidipine
5224616|NCT00728845|adenocarcinoma of the lung|adenocarcinoma of the lung
5224617|NCT00728845|large cell lung cancer|large cell lung cancer
5224618|NCT00728845|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5224619|NCT00728845|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5224620|NCT00728845|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5224621|NCT00728832|extended release epidural morphine|extended release epidural morphine
5224622|NCT00728832|morphine|morphine
5224623|NCT00728832|thoracic epidural|thoracic epidural
5224624|NCT00728832|pharmacokinetics|pharmacokinetics
5224625|NCT00728832|pharmacodynamics|pharmacodynamics
5224626|NCT00728832|postoperative pain|postoperative pain
5224627|NCT00728832|upper abdominal surgery|upper abdominal surgery
5224628|NCT00728819|Inpatients|inpatients
5224629|NCT00728819|Requiring|requiring
5224630|NCT00728819|DL PICC|dl picc
5224631|NCT00728819|Access|access
5224632|NCT00728819|Medications|medications
5224633|NCT00728819|Blood|blood
5224634|NCT00728806|Continuous Ambulatory Peritoneal Dialysis|continuous ambulatory peritoneal dialysis
5224635|NCT00728806|Ultrafiltration failure|ultrafiltration failure
5224636|NCT00728806|Biomarker|biomarker
5224637|NCT00728806|Proteomics|proteomics
5224638|NCT00728793|Advanced Solid Tumors|advanced solid tumors
5224639|NCT00728793|EGFR|egfr
5224640|NCT00728793|HDAC|hdac
5224641|NCT00728793|Her2|her2
5224642|NCT00728793|Open-Label|open-label
5224643|NCT00728793|Dose-Escalation|dose-escalation
5224644|NCT00728780|Adverse events|adverse events
5224645|NCT00728780|Pharmacokinetic variables|pharmacokinetic variables
5224646|NCT00728767|Heavy drinking|heavy drinking
5224647|NCT00728767|Brief intervention|brief intervention
5224648|NCT00728767|Alcohol prevention|alcohol prevention
5224649|NCT00728767|Randomized trial|randomized trial
5224650|NCT00728767|Motivational interviewing|motivational interviewing
5224651|NCT00728767|Intervention Studies|intervention studies
5224652|NCT00728767|prevention & control|prevention & control
5224653|NCT00728754|dental implants|dental implants
5224654|NCT00728754|Osseotite Certain Prevail|osseotite certain prevail
5224655|NCT00728754|Lateralized|lateralized
5224656|NCT00728754|non-lateralized|non-lateralized
5224657|NCT00728754|Osseotite Certain|osseotite certain
5224660|NCT00728754|clinical study|clinical study
5224661|NCT00728754|partial edentulism|partial edentulism
5224662|NCT00728754|single stage|single stage
5224663|NCT00728754|early loading|early loading
5224664|NCT00728754|crestal bone level|crestal bone level
5224665|NCT00728754|short fixed bridge|short fixed bridge
5224666|NCT00728741|Neural Networks|neural networks
5224667|NCT00728741|Cortical Activation|cortical activation
5224668|NCT00728741|Strategy|strategy
5224669|NCT00728741|fMRI|fmri
5224670|NCT00728741|Healthy Volunteer|healthy volunteer
5224671|NCT00728741|HV|hv
5224672|NCT00728728|pregnenolone|pregnenolone
5224673|NCT00728728|schizophrenia|schizophrenia
5224674|NCT00728728|cognitive|cognitive
5224675|NCT00728728|positive symptom|positive symptom
5224676|NCT00728728|negative symptom|negative symptom
5224677|NCT00728728|placebo control|placebo control
5224678|NCT00728715|Budesonide|budesonide
5224679|NCT00728715|Formoterol|formoterol
5224680|NCT00728715|Non cystic fibrosis bronchiectasis|non cystic fibrosis bronchiectasis
5224681|NCT00728689|Orthopoxviral|orthopoxviral
5224682|NCT00728689|Smallpox|smallpox
5224683|NCT00728689|Monkey pox|monkey pox
5224684|NCT00728676|PKU,|pku,
5224685|NCT00728676|Phe,|phe,
5224686|NCT00728676|PAH,|pah,
5224687|NCT00728676|Kuvan,|kuvan,
5224688|NCT00728676|Trp,|trp,
5224689|NCT00728676|Tyr|tyr
5224690|NCT00728663|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5224691|NCT00728663|recurrent prostate cancer|recurrent prostate cancer
5224692|NCT00728663|stage IV prostate cancer|stage iv prostate cancer
5224693|NCT00728650|hepatocellular carcinoma|hepatocellular carcinoma
5224694|NCT00728650|colorectal carcinoma metastatic to liver|colorectal carcinoma metastatic to liver
5224695|NCT00728650|primary liver cancer|primary liver cancer
5224696|NCT00728637|Prevention|prevention
5224697|NCT00728624|Antibiotic susceptibility; beta lactamase; ESBLs|antibiotic susceptibility; beta lactamase; esbls
5224698|NCT00728598|Proliferative diabetic retinopathy|proliferative diabetic retinopathy
5224699|NCT00728598|Angiogenesis|angiogenesis
5224700|NCT00728598|Vitreous levels|vitreous levels
5224701|NCT00728598|Vascular endothelial growth factor|vascular endothelial growth factor
5224702|NCT00728598|Fractalkine|fractalkine
5224703|NCT00728598|Growth factor|growth factor
5224704|NCT00728559|laparoscopy|laparoscopy
5224705|NCT00728559|preemptive|preemptive
5224706|NCT00728559|postoperative|postoperative
5224707|NCT00728559|pain|pain
5224708|NCT00728559|trocar|trocar
5224709|NCT00728559|site|site
5224710|NCT00728546|tuberculosis|tuberculosis
5224711|NCT00728546|isoniazid|isoniazid
5224712|NCT00728546|Arylamine N-acetyl transferase|arylamine n-acetyl transferase
5224713|NCT00728546|genotyping|genotyping
5224714|NCT00728546|hepatotoxicity|hepatotoxicity
5224715|NCT00728546|pharmacogenetics|pharmacogenetics
5224716|NCT00728533|Prostate Cancer requiring Androgen Ablation Therapy|prostate cancer requiring androgen ablation therapy
5224717|NCT00728520|Leukemia|leukemia
5224718|NCT00728520|Azacitidine|azacitidine
5224719|NCT00728520|Untreated|untreated
5224720|NCT00728520|Elderly|elderly
5224721|NCT00728507|Tuberculosis|tuberculosis
5224722|NCT00728507|Moxifloxacin|moxifloxacin
5224723|NCT00728507|Rifapentine|rifapentine
5224724|NCT00728468|Phase 1|phase 1
5224725|NCT00728468|PF-00299804|pf-00299804
5224726|NCT00728468|Dextromethorphan|dextromethorphan
5224727|NCT00728468|CYP2D6 Inhibition|cyp2d6 inhibition
5224728|NCT00728468|Cancer Patients|cancer patients
5224729|NCT00728442|Clinical practice guidelines|clinical practice guidelines
5224730|NCT00728442|Guideline adherence|guideline adherence
5224731|NCT00728442|Clinical decision support systems|clinical decision support systems
5224732|NCT00728442|Randomized controlled trial|randomized controlled trial
5224733|NCT00728442|Intervention study|intervention study
5224734|NCT00728429|cardiac toxicity|cardiac toxicity
5224735|NCT00728429|chemotherapeutic agent toxicity|chemotherapeutic agent toxicity
5224736|NCT00728429|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5224737|NCT00728390|advanced cancer refractory advanced non-small cell lung cancer|advanced cancer refractory advanced non-small cell lung cancer
5224738|NCT00728377|gestational diabetes|gestational diabetes
5224739|NCT00728377|physical activity|physical activity
5224740|NCT00728377|behavior change|behavior change
5224741|NCT00728377|glucose tolerance|glucose tolerance
5224742|NCT00728377|pregnancy|pregnancy
5224743|NCT00728364|Anderson Fabry disease|anderson fabry disease
5224744|NCT00728364|chronic kidney disease|chronic kidney disease
5224745|NCT00728364|prevalence|prevalence
5224746|NCT00728351|Type 2 diabetes, vildagliptin|type 2 diabetes, vildagliptin
5224747|NCT00728338|docosahexenoic acid (DHA)|docosahexenoic acid (dha)
5224748|NCT00728338|dietary supplement|dietary supplement
5224749|NCT00728338|n-3 polyunsaturated fatty acid|n-3 polyunsaturated fatty acid
5224750|NCT00728338|cardiovascular disease|cardiovascular disease
5224751|NCT00728325|PTSD|ptsd
5224752|NCT00728325|Vocational Rehabilitation|vocational rehabilitation
5224753|NCT00728325|Supported Employment|supported employment
5224754|NCT00728312|Methamphetamine|methamphetamine
5224755|NCT00728312|Therapeutics|therapeutics
5224756|NCT00728312|Psychopharmacology|psychopharmacology
5224757|NCT00728312|Amphetamine|amphetamine
5224758|NCT00728299|Coronary artery disease, carotid intima-media thickness|coronary artery disease, carotid intima-media thickness
5224759|NCT00728286|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
5224760|NCT00728286|Acute Coronary Syndrome|acute coronary syndrome
5224761|NCT00728286|Platelet dependent thrombogenicity|platelet dependent thrombogenicity
5224762|NCT00728273|Efficacy|efficacy
5224763|NCT00728273|Vietnam|vietnam
5224764|NCT00728273|school children|school children
5224765|NCT00728273|anemia|anemia
5224766|NCT00728273|fortification|fortification
5224767|NCT00728273|micronutrient|micronutrient
5224768|NCT00728260|Meningitis|meningitis
5224769|NCT00728260|Meningococcal disease|meningococcal disease
5224770|NCT00728260|Menactra vaccine|menactra vaccine
5224771|NCT00728247|Cervical Spine|cervical spine
5224772|NCT00728247|Kinematics|kinematics
5224773|NCT00728247|Manipulation|manipulation
5224775|NCT00728234|aEEG|aeeg
5224776|NCT00728234|preterm infants|preterm infants
5224777|NCT00728234|predictive value|predictive value
5224778|NCT00728234|outcome|outcome
5224779|NCT00728221|Ginseng|ginseng
5224780|NCT00728221|Korean Red Ginseng|korean red ginseng
5224781|NCT00728221|Ginsenoside|ginsenoside
5224782|NCT00728221|Flow Mediated Dilation|flow mediated dilation
5224783|NCT00728221|Endothelial Function|endothelial function
5224784|NCT00728221|Hypertension|hypertension
5224785|NCT00728208|Young|young
5224786|NCT00728208|Elderly|elderly
5224787|NCT00728208|Randomised|randomised
5224788|NCT00728208|GSK372475|gsk372475
5224789|NCT00728195|Schizophrenia|schizophrenia
5224790|NCT00728195|Central Nervous System|central nervous system
5224791|NCT00728195|JNJ-37822681|jnj-37822681
5224792|NCT00728182|Stroke|stroke
5224793|NCT00728182|Vascular cognitive impairment|vascular cognitive impairment
5224794|NCT00728182|Coiling|coiling
5224795|NCT00728182|Endovascular repair|endovascular repair
5224796|NCT00728182|Brain aneurysm|brain aneurysm
5224797|NCT00728182|NA-1|na-1
5224798|NCT00728169|Asthma|asthma
5224799|NCT00728169|Focus Group|focus group
5224800|NCT00728169|Community Based Participatory Research|community based participatory research
5224801|NCT00728156|Type 2 Diabetes mellitus|type 2 diabetes mellitus
5224802|NCT00728156|Coronary artery disease|coronary artery disease
5224803|NCT00728156|Platelet dependent thrombogenicity|platelet dependent thrombogenicity
5224804|NCT00728156|Aspirin|aspirin
5224805|NCT00728156|Clopidogrel|clopidogrel
5224806|NCT00728156|Badimon Chamber|badimon chamber
5224807|NCT00728130|carcinoma|carcinoma
5224808|NCT00728130|upper|upper
5224809|NCT00728130|aerodigestive|aerodigestive
5224810|NCT00728130|tract|tract
5224811|NCT00728130|submandibular|submandibular
5224812|NCT00728130|gland|gland
5224813|NCT00728117|indomethacin|indomethacin
5224814|NCT00728117|ibuprofen|ibuprofen
5224815|NCT00728117|preterm infant|preterm infant
5224816|NCT00728104|Learn|learn
5224817|NCT00728104|L-Carnitine|l-carnitine
5224818|NCT00728104|Co-enzyme Q10|co-enzyme q10
5224819|NCT00728104|Effective|effective
5224820|NCT00728104|These supplements|these supplements
5224821|NCT00728104|Compared|compared
5224822|NCT00728104|Standard|standard
5224823|NCT00728091|aquaretic|aquaretic
5224824|NCT00728091|SIADH|siadh
5224825|NCT00728078|hepatocellular carcinoma|hepatocellular carcinoma
5224826|NCT00728078|liver cancer|liver cancer
5224827|NCT00728078|radiofrequency ablation|radiofrequency ablation
5224828|NCT00728078|thalidomide|thalidomide
5224829|NCT00728052|Tolerability|tolerability
5224830|NCT00728052|dose escalation|dose escalation
5224831|NCT00728052|GSK598809|gsk598809
5224832|NCT00728052|Pharmacodynamics|pharmacodynamics
5224833|NCT00728052|Safety|safety
5224834|NCT00728052|single|single
5224835|NCT00728052|placebo|placebo
5224836|NCT00728052|Smokers|smokers
5224837|NCT00728052|Pharmacokinetics|pharmacokinetics
5224838|NCT00728039|Youth|youth
5224839|NCT00728039|Consensus|consensus
5224840|NCT00728039|Criteria|criteria
5224842|NCT00728026|Chart must reveal the following procedures:|chart must reveal the following procedures:
5224843|NCT00728026|Heart rate variability,|heart rate variability,
5224844|NCT00728026|Deep Breathing Test,|deep breathing test,
5224845|NCT00728026|Valsalva maneuver,|valsalva maneuver,
5224846|NCT00728026|Table test,|table test,
5224847|NCT00728026|Thermoregulatory Sweat Testing,|thermoregulatory sweat testing,
5224848|NCT00728026|Quantitative Sudomotor Axon Reflex Test (QSART),|quantitative sudomotor axon reflex test (qsart),
5224849|NCT00728026|Vital signs,|vital signs,
5224850|NCT00728026|postural changes in heart rate and blood pressure,|postural changes in heart rate and blood pressure,
5224851|NCT00728026|composite autonomic score|composite autonomic score
5224852|NCT00728013|Acute coronary syndrome|acute coronary syndrome
5224853|NCT00728013|intensive lipid-lowering|intensive lipid-lowering
5224854|NCT00728013|statins|statins
5224855|NCT00728000|Pancreatic Cancer|pancreatic cancer
5224856|NCT00727987|Rheumatoid arthritis|rheumatoid arthritis
5224857|NCT00727987|Fully Human anti-TNFa monoclonal antibody|fully human anti-tnfa monoclonal antibody
5224858|NCT00727987|CNTO148|cnto148
5224859|NCT00727987|Golimumab|golimumab
5224860|NCT00727974|Genome Wide Scan (GWS)|genome wide scan (gws)
5224861|NCT00727974|Mitochondrial scan|mitochondrial scan
5224862|NCT00727974|Family trios|family trios
5224863|NCT00727948|Breast cancer|breast cancer
5224864|NCT00727948|Angiogenesis|angiogenesis
5224865|NCT00727948|Aspirin|aspirin
5224866|NCT00727948|Tamoxifen|tamoxifen
5224867|NCT00727935|Women|women
5224868|NCT00727935|parturients|parturients
5224869|NCT00727935|with|with
5224870|NCT00727935|realization|realization
5224871|NCT00727935|episiotomy|episiotomy
5224872|NCT00727922|Neuropathy|neuropathy
5224873|NCT00727922|Oxaliplatin|oxaliplatin
5224874|NCT00727922|Mangafodipir|mangafodipir
5224875|NCT00727909|Hearing loss|hearing loss
5224876|NCT00727909|Hearing Aids|hearing aids
5224877|NCT00727909|Speech Perception|speech perception
5224878|NCT00727909|Persons with Hearing Impairment|persons with hearing impairment
5224879|NCT00727896|Life style modification,|life style modification,
5224880|NCT00727896|Type 2 diabetes,|type 2 diabetes,
5224881|NCT00727896|SMS,|sms,
5224882|NCT00727896|Patient adherence|patient adherence
5224883|NCT00727883|Breast Cancer|breast cancer
5224884|NCT00727883|Adjuvant TAM|adjuvant tam
5224885|NCT00727883|post-menopausal|post-menopausal
5224886|NCT00727883|women|women
5224887|NCT00727870|Shave Biopsy management|shave biopsy management
5224888|NCT00727870|"Biopsy/adverse effects[Mesh]"|"biopsy/adverse effects[mesh]"
5224889|NCT00727870|"Biopsy/complications[Mesh])"|"biopsy/complications[mesh])"
5224890|NCT00727857|Glucose Metabolism Disorder|glucose metabolism disorder
5224891|NCT00727857|Dysmetabolic Syndrome|dysmetabolic syndrome
5224892|NCT00727857|Type II Diabetes|type ii diabetes
5224893|NCT00727857|Diabetes Mellitus, Lipoatrophic|diabetes mellitus, lipoatrophic
5224894|NCT00727857|Dyslipidemia|dyslipidemia
5224895|NCT00727857|Drug Therapy|drug therapy
5224896|NCT00727844|XDR-TB|xdr-tb
5224897|NCT00727844|Linezolid|linezolid
5224898|NCT00727844|Drug Resistance|drug resistance
5224899|NCT00727844|Computed Tomography|computed tomography
5224900|NCT00727844|Pharmacokinetics|pharmacokinetics
5224901|NCT00727844|Tuberculosis|tuberculosis
5224902|NCT00727844|Drug Resistance Tuberculosis|drug resistance tuberculosis
5224903|NCT00727844|MDR-TB|mdr-tb
5224904|NCT00727831|neurotoxicity|neurotoxicity
5224905|NCT00727831|chemotherapeutic agent toxicity|chemotherapeutic agent toxicity
5224906|NCT00727831|mucositis|mucositis
5224907|NCT00727831|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
5224908|NCT00727831|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
5224909|NCT00727831|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5224910|NCT00727831|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
5224911|NCT00727831|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5224912|NCT00727831|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5224913|NCT00727792|participants|participants
5224914|NCT00727792|scheduled|scheduled
5224915|NCT00727792|clinically|clinically
5224916|NCT00727792|ordered|ordered
5224917|NCT00727792|MRI|mri
5224918|NCT00727779|diabetes, metabolic syndrome, type 2 diabetes|diabetes, metabolic syndrome, type 2 diabetes
5224919|NCT00727766|Clofarabine|clofarabine
5224920|NCT00727766|Clolar|clolar
5224921|NCT00727766|AML|aml
5224922|NCT00727766|Consolidation|consolidation
5224923|NCT00727753|Macular Degeneration|macular degeneration
5224924|NCT00727753|Age-Related Maculopathies|age-related maculopathies
5224925|NCT00727740|Cholangiopancreatography, Endoscopic Retrograde|cholangiopancreatography, endoscopic retrograde
5224926|NCT00727740|Pancreatitis|pancreatitis
5224927|NCT00727740|Indomethacin|indomethacin
5224928|NCT00727727|Piribedil (trade name: Clarium)|piribedil (trade name: clarium)
5224929|NCT00727727|non-ergot dopamine agonist|non-ergot dopamine agonist
5224930|NCT00727727|Morbus Parkinson|morbus parkinson
5224931|NCT00727727|Tolerability|tolerability
5224932|NCT00727727|Efficacy|efficacy
5224933|NCT00727727|Post Marketing Surveillance|post marketing surveillance
5224934|NCT00727714|Cement dust exposure|cement dust exposure
5224935|NCT00727714|Cross-shift study|cross-shift study
5224936|NCT00727714|Lung function indices|lung function indices
5224937|NCT00727714|Exhaled nitric oxide|exhaled nitric oxide
5224938|NCT00727714|Serum inflammatory markers|serum inflammatory markers
5224939|NCT00727701|varicose ulcer|varicose ulcer
5224940|NCT00727701|veteran|veteran
5224941|NCT00727701|recurrence|recurrence
5224942|NCT00727701|aftercare|aftercare
5224943|NCT00727675|chronic pain|chronic pain
5224944|NCT00727675|opioid dependence|opioid dependence
5224945|NCT00727675|Cognitive Behavioral Therapy (CBT)|cognitive behavioral therapy (cbt)
5224946|NCT00727662|Breast Cancer|breast cancer
5224947|NCT00727662|Fatigue|fatigue
5224948|NCT00727662|Proinflammatory Cytokines|proinflammatory cytokines
5224949|NCT00727662|Physical functioning|physical functioning
5224950|NCT00727662|Quality of life|quality of life
5224951|NCT00727649|fecal incontinence|fecal incontinence
5224952|NCT00727649|adults|adults
5224953|NCT00727649|diarrhea|diarrhea
5224954|NCT00727636|inflammatory bowel disease (IBD)|inflammatory bowel disease (ibd)
5224955|NCT00727636|immunogenicity|immunogenicity
5224956|NCT00727636|safety|safety
5224957|NCT00727636|HPV|hpv
5224958|NCT00727636|Gardasil|gardasil
5224960|NCT00727623|acute coronary syndrome|acute coronary syndrome
5224961|NCT00727623|myocardial infarction|myocardial infarction
5224962|NCT00727623|predictors of mortality|predictors of mortality
5224963|NCT00727623|reperfusion therapy|reperfusion therapy
5224964|NCT00727610|Adverse drug event|adverse drug event
5224965|NCT00727610|harm|harm
5224966|NCT00727610|patient safety|patient safety
5224967|NCT00727610|clinical decision support|clinical decision support
5224968|NCT00727610|Adverse drug related event|adverse drug related event
5224969|NCT00727584|spinal cord compression|spinal cord compression
5224970|NCT00727584|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5224971|NCT00727571|Anemia|anemia
5224972|NCT00727571|Chronic Kidney Disease|chronic kidney disease
5224973|NCT00727571|Quality of Life|quality of life
5224974|NCT00727571|CKD|ckd
5224975|NCT00727571|Chronic Renal Insufficiency|chronic renal insufficiency
5224976|NCT00727558|refractive error|refractive error
5224977|NCT00727532|clear cell renal cell carcinoma|clear cell renal cell carcinoma
5224978|NCT00727532|hereditary clear cell renal cell carcinoma|hereditary clear cell renal cell carcinoma
5224979|NCT00727532|recurrent renal cell cancer|recurrent renal cell cancer
5224980|NCT00727532|stage I renal cell cancer|stage i renal cell cancer
5224981|NCT00727532|stage II renal cell cancer|stage ii renal cell cancer
5224982|NCT00727532|stage III renal cell cancer|stage iii renal cell cancer
5224983|NCT00727532|stage IV renal cell cancer|stage iv renal cell cancer
5224984|NCT00727519|Hemodialysis|hemodialysis
5224985|NCT00727519|Nephrology|nephrology
5224986|NCT00727519|Pomegranate Juice|pomegranate juice
5224987|NCT00727519|Israel|israel
5224988|NCT00727493|osteoporosis,|osteoporosis,
5224989|NCT00727493|bisphosphonate|bisphosphonate
5224990|NCT00727493|therapy|therapy
5224991|NCT00727493|dental implant|dental implant
5224992|NCT00727480|vascularity|vascularity
5224993|NCT00727480|fingertips|fingertips
5224994|NCT00727467|auditory cueing device|auditory cueing device
5224995|NCT00727467|Parkinson's disease|parkinson's disease
5224996|NCT00727467|freezing|freezing
5224997|NCT00727467|gait|gait
5224998|NCT00727467|mobility|mobility
5224999|NCT00727454|Obstructive sleep apnea|obstructive sleep apnea
5225000|NCT00727454|CPAP|cpap
5225001|NCT00727454|Heart remodeling|heart remodeling
5225002|NCT00727454|Cardiovascular disease|cardiovascular disease
5225003|NCT00727454|MRI|mri
5225004|NCT00727441|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
5225005|NCT00727441|stage I pancreatic cancer|stage i pancreatic cancer
5225006|NCT00727441|stage II pancreatic cancer|stage ii pancreatic cancer
5225007|NCT00727428|FluLaval® TF|flulaval® tf
5225008|NCT00727428|Safety|safety
5225009|NCT00727428|Immunogenicity|immunogenicity
5225010|NCT00727428|Influenza|influenza
5225011|NCT00727415|advanced or progressive chronic lymphocytic leukemia|advanced or progressive chronic lymphocytic leukemia
5225012|NCT00727415|Lenalidomide|lenalidomide
5225013|NCT00727415|Fludarabine|fludarabine
5225014|NCT00727389|Prevention|prevention
5225015|NCT00727389|Quality of Health Care|quality of health care
5225016|NCT00727389|Health Care Evaluation Mechanisms|health care evaluation mechanisms
5225017|NCT00727376|esophageal|esophageal
5225018|NCT00727376|stenting|stenting
5225019|NCT00727363|probiotics|probiotics
5225020|NCT00727363|lactobacillus reuteri|lactobacillus reuteri
5225021|NCT00727363|preterm infants|preterm infants
5225022|NCT00727363|nosocomial infection|nosocomial infection
5225023|NCT00727363|necrotizing enterocolitis|necrotizing enterocolitis
5225024|NCT00727350|NSCLC|nsclc
5225025|NCT00727350|Novalis|novalis
5225026|NCT00727350|Stereotactic|stereotactic
5225027|NCT00727350|SBRT|sbrt
5225028|NCT00727350|T1, T2 or T3NO NSCLC|t1, t2 or t3no nsclc
5225029|NCT00727337|auditory perception|auditory perception
5225030|NCT00727337|rehabilitation of hearing impaired|rehabilitation of hearing impaired
5225031|NCT00727324|Ulcerative Colitis|ulcerative colitis
5225032|NCT00727324|UC|uc
5225033|NCT00727324|moderate|moderate
5225034|NCT00727324|severe|severe
5225035|NCT00727324|LPS|lps
5225036|NCT00727324|Alkaline Phosphatase|alkaline phosphatase
5225037|NCT00727324|AP|ap
5225038|NCT00727324|BIAP|biap
5225039|NCT00727324|Mucositis|mucositis
5225040|NCT00727285|Cystic Fibrosis|cystic fibrosis
5225041|NCT00727285|pulmonary exacerbation|pulmonary exacerbation
5225042|NCT00727285|gene expression|gene expression
5225043|NCT00727285|biomarker|biomarker
5225044|NCT00727285|inflammation|inflammation
5225045|NCT00727285|CF pulmonary exacerbation|cf pulmonary exacerbation
5225046|NCT00727272|Bioavailability|bioavailability
5225047|NCT00727246|Traumatic Brain Injury|traumatic brain injury
5225048|NCT00727246|FMRI|fmri
5225049|NCT00727246|Memory|memory
5225050|NCT00727246|Cognition|cognition
5225051|NCT00727246|Neuropsychology|neuropsychology
5225052|NCT00727233|Neuroblastosis Type I|neuroblastosis type i
5225053|NCT00727233|Plexiform Neurofibromas|plexiform neurofibromas
5225054|NCT00727233|Angiogenesis Inhibitor|angiogenesis inhibitor
5225055|NCT00727233|Kinase Inhibitor|kinase inhibitor
5225056|NCT00727233|Neurofibromatosis Type 1|neurofibromatosis type 1
5225057|NCT00727233|NF1|nf1
5225058|NCT00727233|Plexiform Neurofibroma|plexiform neurofibroma
5225059|NCT00727220|type 1 diabetes|type 1 diabetes
5225060|NCT00727220|continuous glucose sensor monitoring|continuous glucose sensor monitoring
5225061|NCT00727207|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5225062|NCT00727207|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
5225063|NCT00727207|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5225064|NCT00727207|stage I mantle cell lymphoma|stage i mantle cell lymphoma
5225065|NCT00727207|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5225066|NCT00727207|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5225067|NCT00727181|aortic valve|aortic valve
5225068|NCT00727181|heart valve|heart valve
5225069|NCT00727181|tissue valve|tissue valve
5225070|NCT00727181|bioprosthesis|bioprosthesis
5225071|NCT00727181|valve disorder|valve disorder
5225072|NCT00727181|valve disease|valve disease
5225073|NCT00727181|cardiac surgery|cardiac surgery
5225074|NCT00727181|aortic valve stenosis|aortic valve stenosis
5225075|NCT00727181|aortic valve regurgitation|aortic valve regurgitation
5225076|NCT00727168|prevalence study|prevalence study
5225077|NCT00727168|glaucoma|glaucoma
5225078|NCT00727142|NPH|nph
5225079|NCT00727142|Hydrocephalus|hydrocephalus
5225080|NCT00727142|Shunt|shunt
5225081|NCT00727129|vasomotor symptoms|vasomotor symptoms
5225082|NCT00727129|estrogen|estrogen
5225083|NCT00727129|estradiol|estradiol
5225084|NCT00727129|hot flashes|hot flashes
5225085|NCT00727103|Varenicline|varenicline
5225086|NCT00727103|Smoking cessation|smoking cessation
5225087|NCT00727103|Schizophrenia|schizophrenia
5225088|NCT00727103|Schizoaffective disorder|schizoaffective disorder
5225089|NCT00727103|Alcohol dependence|alcohol dependence
5225090|NCT00727103|Nicotine dependence|nicotine dependence
5225091|NCT00727064|Healthy Subjects|healthy subjects
5225092|NCT00727051|invasive coronary angiography|invasive coronary angiography
5225093|NCT00727051|multidetector coronary CTA|multidetector coronary cta
5225094|NCT00727051|coronary artery disease|coronary artery disease
5225095|NCT00727051|detecting coronary artery disease|detecting coronary artery disease
5225096|NCT00727038|glaucoma|glaucoma
5225097|NCT00727038|neovascular glaucoma|neovascular glaucoma
5225098|NCT00727038|new onset glaucoma|new onset glaucoma
5225099|NCT00727038|retinal ischemia|retinal ischemia
5225100|NCT00727038|central retinal vein occlusion|central retinal vein occlusion
5225101|NCT00727038|proliferative diabetic retinopathy|proliferative diabetic retinopathy
5225102|NCT00727038|ocular ischemic syndrome|ocular ischemic syndrome
5225103|NCT00727038|carotid stenosis|carotid stenosis
5225104|NCT00727038|vascular endothelial growth factor|vascular endothelial growth factor
5225105|NCT00727038|neovascular|neovascular
5225106|NCT00727025|skin closure devices|skin closure devices
5225107|NCT00727025|linear scars|linear scars
5225108|NCT00727012|mitral valve|mitral valve
5225109|NCT00727012|heart valve|heart valve
5225110|NCT00727012|valve repair|valve repair
5225111|NCT00727012|valve disorder|valve disorder
5225112|NCT00727012|valve disease|valve disease
5225113|NCT00727012|cardiac surgery|cardiac surgery
5225114|NCT00726999|Gabapentin|gabapentin
5225115|NCT00726999|Pediatric Spinal Fusion|pediatric spinal fusion
5225116|NCT00726999|Narcotic Use|narcotic use
5225117|NCT00726986|extensive stage small cell lung cancer|extensive stage small cell lung cancer
5225118|NCT00726973|Macular edema|macular edema
5225119|NCT00726960|Heroin abuse|heroin abuse
5225120|NCT00726960|Opioids|opioids
5225121|NCT00726960|Opiates|opiates
5225122|NCT00726960|Substance abuse|substance abuse
5225123|NCT00726960|Addiction|addiction
5225124|NCT00726934|Neutropenic Diet|neutropenic diet
5225125|NCT00726934|Food Safety Guidelines|food safety guidelines
5225126|NCT00726934|child|child
5225127|NCT00726934|cancer|cancer
5225128|NCT00726908|Obesity|obesity
5225129|NCT00726908|diet|diet
5225130|NCT00726908|carbohydrate|carbohydrate
5225131|NCT00726908|insulin|insulin
5225132|NCT00726895|Bioavailability|bioavailability
5225133|NCT00726882|HCV Infection|hcv infection
5225134|NCT00726869|Patients After One to three Prior Therapies|patients after one to three prior therapies
5225135|NCT00726843|Headache|headache
5225136|NCT00726843|Complementary and Alternative Medicine|complementary and alternative medicine
5225137|NCT00726843|Pediatric|pediatric
5225138|NCT00726843|Yoga|yoga
5225139|NCT00726830|pain|pain
5225140|NCT00726830|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5225141|NCT00726830|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5225142|NCT00726830|acute undifferentiated leukemia|acute undifferentiated leukemia
5225143|NCT00726830|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5225144|NCT00726830|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5225145|NCT00726830|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5225146|NCT00726830|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5225147|NCT00726830|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5225148|NCT00726830|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
5225149|NCT00726830|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5225150|NCT00726830|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5225151|NCT00726830|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5225152|NCT00726830|mast cell leukemia|mast cell leukemia
5225153|NCT00726830|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
5225154|NCT00726830|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
5225155|NCT00726830|prolymphocytic leukemia|prolymphocytic leukemia
5225156|NCT00726830|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5225157|NCT00726830|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5225158|NCT00726830|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
5225159|NCT00726830|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5225160|NCT00726830|refractory hairy cell leukemia|refractory hairy cell leukemia
5225161|NCT00726830|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5225162|NCT00726830|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5225163|NCT00726830|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
5225164|NCT00726830|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5225165|NCT00726830|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
5225166|NCT00726830|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5225167|NCT00726830|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
5225168|NCT00726830|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
5225169|NCT00726830|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
5225170|NCT00726830|untreated hairy cell leukemia|untreated hairy cell leukemia
5225171|NCT00726830|adult grade III lymphomatoid granulomatosis|adult grade iii lymphomatoid granulomatosis
5225172|NCT00726830|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
5225173|NCT00726830|AIDS-related diffuse large cell lymphoma|aids-related diffuse large cell lymphoma
5225174|NCT00726830|AIDS-related diffuse mixed cell lymphoma|aids-related diffuse mixed cell lymphoma
5225175|NCT00726830|AIDS-related diffuse small cleaved cell lymphoma|aids-related diffuse small cleaved cell lymphoma
5225176|NCT00726830|AIDS-related immunoblastic large cell lymphoma|aids-related immunoblastic large cell lymphoma
5225177|NCT00726830|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
5225178|NCT00726830|AIDS-related primary CNS lymphoma|aids-related primary cns lymphoma
5225179|NCT00726830|AIDS-related small noncleaved cell lymphoma|aids-related small noncleaved cell lymphoma
5225180|NCT00726830|AIDS-related lymphoblastic lymphoma|aids-related lymphoblastic lymphoma
5225181|NCT00726830|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5225182|NCT00726830|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
5225183|NCT00726830|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5225184|NCT00726830|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5225185|NCT00726830|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5225186|NCT00726830|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5225187|NCT00726830|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5225188|NCT00726830|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5225189|NCT00726830|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5225190|NCT00726830|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5225191|NCT00726830|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5225192|NCT00726830|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5225193|NCT00726830|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
5225194|NCT00726830|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
5225195|NCT00726830|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5225196|NCT00726830|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5225197|NCT00726830|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5225198|NCT00726830|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5225199|NCT00726830|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5225200|NCT00726830|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5225201|NCT00726830|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5225202|NCT00726830|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5225203|NCT00726830|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5225204|NCT00726830|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5225205|NCT00726830|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5225206|NCT00726830|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5225207|NCT00726830|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5225208|NCT00726830|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
5225209|NCT00726830|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
5225210|NCT00726830|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5225211|NCT00726830|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5225212|NCT00726830|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5225213|NCT00726830|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5225375|NCT00726388|diclofenac|diclofenac
5225214|NCT00726830|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5225215|NCT00726830|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5225216|NCT00726830|HIV-associated Hodgkin lymphoma|hiv-associated hodgkin lymphoma
5225217|NCT00726830|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5225218|NCT00726830|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5225219|NCT00726830|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5225220|NCT00726830|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5225221|NCT00726830|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5225222|NCT00726830|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
5225223|NCT00726830|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5225224|NCT00726830|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5225225|NCT00726830|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5225226|NCT00726830|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5225227|NCT00726830|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5225228|NCT00726830|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5225229|NCT00726830|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5225230|NCT00726830|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5225231|NCT00726830|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5225232|NCT00726830|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5225233|NCT00726830|intraocular lymphoma|intraocular lymphoma
5225234|NCT00726830|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
5225235|NCT00726830|primary central nervous system Hodgkin lymphoma|primary central nervous system hodgkin lymphoma
5225236|NCT00726830|post-transplant lymphoproliferative disorder|post-transplant lymphoproliferative disorder
5225237|NCT00726830|chronic eosinophilic leukemia|chronic eosinophilic leukemia
5225238|NCT00726830|chronic neutrophilic leukemia|chronic neutrophilic leukemia
5225239|NCT00726830|primary myelofibrosis|primary myelofibrosis
5225240|NCT00726830|essential thrombocythemia|essential thrombocythemia
5225241|NCT00726830|polycythemia vera|polycythemia vera
5225242|NCT00726830|extramedullary plasmacytoma|extramedullary plasmacytoma
5225243|NCT00726830|isolated plasmacytoma of bone|isolated plasmacytoma of bone
5225244|NCT00726830|monoclonal gammopathy of undetermined significance|monoclonal gammopathy of undetermined significance
5225245|NCT00726830|stage II multiple myeloma|stage ii multiple myeloma
5225246|NCT00726830|stage III multiple myeloma|stage iii multiple myeloma
5225247|NCT00726830|primary systemic amyloidosis|primary systemic amyloidosis
5225248|NCT00726830|refractory multiple myeloma|refractory multiple myeloma
5225249|NCT00726830|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5225250|NCT00726830|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5225251|NCT00726830|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5225252|NCT00726830|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
5225253|NCT00726830|cutaneous B-cell non-Hodgkin lymphoma|cutaneous b-cell non-hodgkin lymphoma
5225254|NCT00726830|Waldenström macroglobulinemia|waldenström macroglobulinemia
5225255|NCT00726817|butyrate, visceral perception, compliance|butyrate, visceral perception, compliance
5225256|NCT00726791|chronic pain|chronic pain
5225257|NCT00726791|pain disorder|pain disorder
5225258|NCT00726778|race/ethnicity|race/ethnicity
5225259|NCT00726778|insulin senistivity|insulin senistivity
5225260|NCT00726778|genetic admixture|genetic admixture
5225261|NCT00726778|type 2 diabetes|type 2 diabetes
5225262|NCT00726778|obesity|obesity
5225263|NCT00726778|body composition|body composition
5225264|NCT00726778|Insulin dynamics|insulin dynamics
5225265|NCT00726778|Racial/ethnic differences|racial/ethnic differences
5225266|NCT00726752|solid tumor|solid tumor
5225267|NCT00726752|Axitinib|axitinib
5225268|NCT00726752|Pharmacokinetics|pharmacokinetics
5225269|NCT00726752|Phase 1|phase 1
5225270|NCT00726739|recurrent melanoma|recurrent melanoma
5225271|NCT00726713|Metanx|metanx
5225272|NCT00726713|diabetes|diabetes
5225273|NCT00726713|neuropathy|neuropathy
5225274|NCT00726713|folic acid|folic acid
5225275|NCT00726713|folate|folate
5225276|NCT00726713|L-methylfolate|l-methylfolate
5225277|NCT00726713|vitamin B6|vitamin b6
5225278|NCT00726713|Pyridoxal 5'-phosphate|pyridoxal 5'-phosphate
5225279|NCT00726713|vitamin B12|vitamin b12
5225280|NCT00726713|methylcobalamin|methylcobalamin
5225281|NCT00726700|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5225282|NCT00726700|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
5225283|NCT00726700|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5225284|NCT00726700|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5225285|NCT00726700|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
5225286|NCT00726700|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
5225287|NCT00726700|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5225288|NCT00726700|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5225289|NCT00726700|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
5225290|NCT00726700|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5225291|NCT00726700|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
5225292|NCT00726700|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
5225293|NCT00726700|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5225294|NCT00726700|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
5225295|NCT00726700|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5225296|NCT00726700|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
5225297|NCT00726700|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5225298|NCT00726700|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5225299|NCT00726700|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5225300|NCT00726700|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5225301|NCT00726700|stage I mantle cell lymphoma|stage i mantle cell lymphoma
5225302|NCT00726700|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
5225303|NCT00726700|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5225304|NCT00726700|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
5225305|NCT00726700|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
5225306|NCT00726700|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
5225307|NCT00726700|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5225308|NCT00726700|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5225309|NCT00726700|stage I marginal zone lymphoma|stage i marginal zone lymphoma
5225310|NCT00726700|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
5225311|NCT00726700|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
5225312|NCT00726687|Cancer|cancer
5225313|NCT00726687|Indibulin|indibulin
5225314|NCT00726687|Capecitabine|capecitabine
5225315|NCT00726687|Xeloda|xeloda
5225316|NCT00726674|Diabetes HbA1C|diabetes hba1c
5225317|NCT00726661|Metastatic Breast Cancer|metastatic breast cancer
5225318|NCT00726661|Locally Recurrent Breast Cancer|locally recurrent breast cancer
5225319|NCT00726661|Avastin|avastin
5225320|NCT00726648|CDP323|cdp323
5225321|NCT00726648|Relapsing multiple sclerosis|relapsing multiple sclerosis
5225322|NCT00726648|Blood biomarkers|blood biomarkers
5225323|NCT00726622|rectal cancer|rectal cancer
5225324|NCT00726622|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5225325|NCT00726596|recurrent prostate cancer|recurrent prostate cancer
5225326|NCT00726596|stage IV prostate cancer|stage iv prostate cancer
5225327|NCT00726596|Prostate-Specific Antigen|prostate-specific antigen
5225328|NCT00726583|Cancer|cancer
5225329|NCT00726583|Solid Tumors|solid tumors
5225330|NCT00726583|Carcinoma|carcinoma
5225331|NCT00726583|PI-3K|pi-3k
5225332|NCT00726583|PI3 kinase|pi3 kinase
5225333|NCT00726583|PI3K|pi3k
5225334|NCT00726570|Disorders, Blood coagulation|disorders, blood coagulation
5225335|NCT00726570|Deep Vein Thrombosis|deep vein thrombosis
5225336|NCT00726570|Perioperative Care|perioperative care
5225337|NCT00726570|Digestive System Surgical Procedures|digestive system surgical procedures
5225338|NCT00726544|thrombocytopenia|thrombocytopenia
5225339|NCT00726544|microangiopathic hemolytic anemia|microangiopathic hemolytic anemia
5225340|NCT00726544|von Willebrand Factor|von willebrand factor
5225341|NCT00726544|ADAMTS13|adamts13
5225342|NCT00726531|Falls prevention|falls prevention
5225343|NCT00726531|Exercise promotion|exercise promotion
5225344|NCT00726531|Older people|older people
5225345|NCT00726466|Age Related Macular Degeneration|age related macular degeneration
5225346|NCT00726466|AMD|amd
5225347|NCT00726466|CNV|cnv
5225348|NCT00726453|TARGET VESSEL REVASCULARIZATION (TVR)|target vessel revascularization (tvr)
5225349|NCT00726453|MYOCARDIAL INFARCTION (MI)|myocardial infarction (mi)
5225350|NCT00726453|TARGET VESSEL FAILURE (TVF)|target vessel failure (tvf)
5225351|NCT00726453|TARGET LESION REVASCULARIZATION (TLR)|target lesion revascularization (tlr)
5225352|NCT00726453|TARGET LESION FAILURE (TLF)|target lesion failure (tlf)
5225353|NCT00726453|STENT THROMBOSIS|stent thrombosis
5225354|NCT00726453|RESTENOTIC LESION|restenotic lesion
5225355|NCT00726453|PERCUTANEOUS CORONARY INTERVENTION (PCI)|percutaneous coronary intervention (pci)
5225356|NCT00726440|Type 1 Diabetes|type 1 diabetes
5225357|NCT00726440|Real Time Continuous Glucose Monitoring System|real time continuous glucose monitoring system
5225358|NCT00726440|HbA1c|hba1c
5225359|NCT00726440|Navigator®|navigator®
5225360|NCT00726427|pharmacokinetics|pharmacokinetics
5225361|NCT00726427|pharmacodynamics|pharmacodynamics
5225362|NCT00726427|AZD1656|azd1656
5225363|NCT00726427|safety|safety
5225364|NCT00726427|tolerability|tolerability
5225365|NCT00726427|Healthy Volunteers|healthy volunteers
5225366|NCT00726414|Bioavailability|bioavailability
5225367|NCT00726401|Allergies|allergies
5225368|NCT00726401|Nasal|nasal
5225369|NCT00726401|Congestion|congestion
5225370|NCT00726401|Sneezing|sneezing
5225371|NCT00726401|Pruritus|pruritus
5225372|NCT00726401|Teary|teary
5225373|NCT00726401|Eyes|eyes
5225374|NCT00726388|safety|safety
5225376|NCT00726388|pain, postoperative|pain, postoperative
5225377|NCT00726375|(GVHD)|(gvhd)
5225378|NCT00726362|Statin|statin
5225379|NCT00726362|LDL-C|ldl-c
5225380|NCT00726336|healthy volunteer|healthy volunteer
5225381|NCT00726336|pharmacokinetics|pharmacokinetics
5225382|NCT00726336|GSK1349572|gsk1349572
5225383|NCT00726336|integrase|integrase
5225384|NCT00726323|c-Met|c-met
5225385|NCT00726323|Papillary Renal Cell Carcinoma(PRC)|papillary renal cell carcinoma(prc)
5225386|NCT00726323|Sporadic papillary renal cell carcinoma,|sporadic papillary renal cell carcinoma,
5225387|NCT00726323|Clear cell renal carcinoma|clear cell renal carcinoma
5225388|NCT00726323|Hereditary papillary renal cell carcinoma,|hereditary papillary renal cell carcinoma,
5225389|NCT00726310|Spondylolisthesis|spondylolisthesis
5225390|NCT00726310|Instability|instability
5225391|NCT00726284|HNP|hnp
5225392|NCT00726271|obesity|obesity
5225393|NCT00726271|appetite set point|appetite set point
5225394|NCT00726219|Major|major
5225395|NCT00726219|knee|knee
5225396|NCT00726219|surgery|surgery
5225397|NCT00726180|Breast cancer|breast cancer
5225398|NCT00726180|Women|women
5225399|NCT00726180|w/Her2|w/her2
5225400|NCT00726180|positive|positive
5225401|NCT00726180|ERnegative|ernegative
5225402|NCT00726180|not metastasized|not metastasized
5225403|NCT00726167|Ventilator associated Pneumonia|ventilator associated pneumonia
5225404|NCT00726167|mechanically ventilated|mechanically ventilated
5225405|NCT00726167|procalcitonin|procalcitonin
5225406|NCT00726167|pneumonia scores|pneumonia scores
5225407|NCT00726154|Bipolar Disorder|bipolar disorder
5225408|NCT00726154|Circadian Rhythm|circadian rhythm
5225409|NCT00726154|Moderators|moderators
5225410|NCT00726154|Lithium|lithium
5225411|NCT00726154|Quetiapine|quetiapine
5225412|NCT00726141|Brief Intervention|brief intervention
5225413|NCT00726141|Smoking Cessation|smoking cessation
5225414|NCT00726141|Motivational Interviewing|motivational interviewing
5225415|NCT00726141|Expert System|expert system
5225416|NCT00726141|Readiness to Change|readiness to change
5225417|NCT00726141|Hormonal Contraceptive|hormonal contraceptive
5225418|NCT00726141|Adolescents|adolescents
5225419|NCT00726128|DDD|ddd
5225420|NCT00726102|Zinc nutrition|zinc nutrition
5225421|NCT00726102|Growth|growth
5225422|NCT00726102|Development|development
5225423|NCT00726102|China|china
5225424|NCT00726102|Infants|infants
5225425|NCT00726102|Toddlers|toddlers
5225426|NCT00726076|Epilepsy|epilepsy
5225427|NCT00726076|Medication|medication
5225428|NCT00726076|Stress|stress
5225429|NCT00726076|Sleep|sleep
5225430|NCT00726076|Lifestyle Management|lifestyle management
5225431|NCT00726063|dental implants|dental implants
5225432|NCT00726063|Nanotite implant|nanotite implant
5225433|NCT00726063|Osseotite implants|osseotite implants
5225434|NCT00726063|multicenter|multicenter
5225435|NCT00726063|randomized|randomized
5225436|NCT00726063|clinical study|clinical study
5225437|NCT00726063|partial edentulism|partial edentulism
5225438|NCT00726063|prosthesis|prosthesis
5225439|NCT00726050|Theta Burst Stimulation|theta burst stimulation
5225440|NCT00726050|Somatosensory Stimulation|somatosensory stimulation
5225441|NCT00726050|Somatosensory Cortex|somatosensory cortex
5225442|NCT00726050|Tactile Discrimination|tactile discrimination
5225443|NCT00726050|Healthy Volunteer|healthy volunteer
5225444|NCT00726050|HV|hv
5225445|NCT00726037|Denileukin diftitox|denileukin diftitox
5225446|NCT00726037|Metastatic Pancreatic Cancer|metastatic pancreatic cancer
5225447|NCT00726037|Ontak|ontak
5225448|NCT00726037|Regulatory T-cell|regulatory t-cell
5225449|NCT00726011|due|due
5225450|NCT00726011|cancer treatment|cancer treatment
5225451|NCT00725998|Cochlear Implantation.|cochlear implantation.
5225452|NCT00725998|Cochlear nerve.|cochlear nerve.
5225453|NCT00725998|Child.|child.
5225454|NCT00725998|study|study
5225455|NCT00725998|ECAP|ecap
5225456|NCT00725998|During|during
5225457|NCT00725998|First year|first year
5225458|NCT00725985|Clinically Isolated Syndrome (CIS)|clinically isolated syndrome (cis)
5225459|NCT00725985|Early MS|early ms
5225460|NCT00725985|Multiple Sclerosis|multiple sclerosis
5225461|NCT00725972|Improve|improve
5225462|NCT00725972|Patient care|patient care
5225463|NCT00725972|Applying|applying
5225464|NCT00725972|Systematic|systematic
5225465|NCT00725972|Fashion|fashion
5225466|NCT00725972|Proven|proven
5225467|NCT00725972|Resuscitation|resuscitation
5225468|NCT00725972|Algorithms|algorithms
5225469|NCT00725972|High risk|high risk
5225470|NCT00725972|Surgical|surgical
5225471|NCT00725959|HIV Prevention|hiv prevention
5225472|NCT00725959|Social Networking|social networking
5225473|NCT00725959|Technology Based Intervention|technology based intervention
5225474|NCT00725920|PTSD,|ptsd,
5225475|NCT00725920|posttraumatic|posttraumatic
5225476|NCT00725920|stress|stress
5225477|NCT00725920|disorder,|disorder,
5225478|NCT00725920|randomization,|randomization,
5225479|NCT00725920|placebo,|placebo,
5225480|NCT00725920|controlled|controlled
5225481|NCT00725907|PRP|prp
5225482|NCT00725907|ATFL|atfl
5225483|NCT00725881|PAD|pad
5225586|NCT00725478|Efficacy|efficacy
5225484|NCT00725881|Peripheral arterial disease|peripheral arterial disease
5225485|NCT00725881|Peripheral artery disease|peripheral artery disease
5225486|NCT00725881|Intermittent claudication|intermittent claudication
5225487|NCT00725881|IC|ic
5225488|NCT00725881|atherosclerosis|atherosclerosis
5225489|NCT00725881|leg pain|leg pain
5225490|NCT00725881|walking pain|walking pain
5225491|NCT00725868|Major adverse|major adverse
5225492|NCT00725855|Schizophrenia|schizophrenia
5225493|NCT00725855|P50 Sensory Gating|p50 sensory gating
5225494|NCT00725855|Mismatched Negativity|mismatched negativity
5225495|NCT00725829|coagulation|coagulation
5225496|NCT00725829|cholesterol|cholesterol
5225497|NCT00725829|acute ischemia|acute ischemia
5225498|NCT00725829|fibrin clot|fibrin clot
5225499|NCT00725803|Hepatitis C|hepatitis c
5225500|NCT00725803|HCV|hcv
5225501|NCT00725803|Fibrosis|fibrosis
5225502|NCT00725803|Apoptosis|apoptosis
5225503|NCT00725803|GS-9450|gs-9450
5225504|NCT00725790|Erectile Dysfunction|erectile dysfunction
5225505|NCT00725790|Spinal Cord Injury|spinal cord injury
5225506|NCT00725764|VEGFR2|vegfr2
5225507|NCT00725764|XL880|xl880
5225508|NCT00725764|foretinib|foretinib
5225509|NCT00725764|Squamous Cell Cancer of the Head and Neck|squamous cell cancer of the head and neck
5225510|NCT00725764|MET|met
5225511|NCT00725764|GSK1363089|gsk1363089
5225512|NCT00725738|Myocardial|myocardial
5225513|NCT00725738|Infarction,|infarction,
5225514|NCT00725738|Stem|stem
5225515|NCT00725738|Cell|cell
5225516|NCT00725738|Therapy|therapy
5225517|NCT00725712|c-Met|c-met
5225518|NCT00725712|Metastatic Gastric Carcinoma|metastatic gastric carcinoma
5225519|NCT00725712|adenocarcinoma|adenocarcinoma
5225520|NCT00725712|Gastric cancer|gastric cancer
5225521|NCT00725712|GSK1363089|gsk1363089
5225522|NCT00725712|XL880|xl880
5225523|NCT00725712|MET inhibitor|met inhibitor
5225524|NCT00725686|"Choroidal Neovascularization (CNV) WET AMD"|"choroidal neovascularization (cnv) wet amd"
5225525|NCT00725673|COPD|copd
5225526|NCT00725673|Osteoporosis|osteoporosis
5225527|NCT00725673|BMD|bmd
5225528|NCT00725673|DEXA-scan|dexa-scan
5225529|NCT00725660|pre eclampsia|pre eclampsia
5225530|NCT00725660|doppler|doppler
5225531|NCT00725660|uterine|uterine
5225532|NCT00725660|arteries|arteries
5225533|NCT00725660|angiogenic|angiogenic
5225534|NCT00725660|factors|factors
5225535|NCT00725647|N terminal B type natriuretic peptide|n terminal b type natriuretic peptide
5225536|NCT00725647|echocardiography|echocardiography
5225537|NCT00725647|diagnosis|diagnosis
5225538|NCT00725647|atrial natriuretic peptides|atrial natriuretic peptides
5225539|NCT00725647|preterm infant|preterm infant
5225540|NCT00725634|Neoplasms,|neoplasms,
5225541|NCT00725634|Lymphoma,|lymphoma,
5225542|NCT00725634|Multiple Myeloma,|multiple myeloma,
5225543|NCT00725634|Neoplasms, Plasma Cell,|neoplasms, plasma cell,
5225544|NCT00725634|Neoplasms by Histologic Type,|neoplasms by histologic type,
5225545|NCT00725634|Lymphoproliferative Disorders,|lymphoproliferative disorders,
5225546|NCT00725634|Lymphatic Diseases, Immunoproliferative Disorders|lymphatic diseases, immunoproliferative disorders
5225547|NCT00725634|Immune System Diseases Hemostatic Disorders|immune system diseases hemostatic disorders
5225548|NCT00725634|Vascular Diseases|vascular diseases
5225549|NCT00725634|Cardiovascular Diseases|cardiovascular diseases
5225550|NCT00725634|Paraproteinemias|paraproteinemias
5225551|NCT00725634|Blood Protein Disorders|blood protein disorders
5225552|NCT00725634|Hematologic Diseases|hematologic diseases
5225553|NCT00725634|Hemorrhagic Disorders|hemorrhagic disorders
5225554|NCT00725634|Erlotinib|erlotinib
5225555|NCT00725634|Protein Kinase Inhibitors|protein kinase inhibitors
5225556|NCT00725634|Enzyme Inhibitors,|enzyme inhibitors,
5225557|NCT00725634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
5225558|NCT00725634|Pharmacologic Actions|pharmacologic actions
5225559|NCT00725608|Suboxone|suboxone
5225560|NCT00725608|Subutex|subutex
5225561|NCT00725608|Buprenorphine|buprenorphine
5225562|NCT00725608|Naloxone|naloxone
5225563|NCT00725595|Cheyne Stocks respiration|cheyne stocks respiration
5225564|NCT00725595|heart failure|heart failure
5225565|NCT00725595|sleep apnea|sleep apnea
5225566|NCT00725595|ventilator|ventilator
5225567|NCT00725569|Caesarian Section|caesarian section
5225568|NCT00725569|Homeopathy|homeopathy
5225569|NCT00725569|Pain|pain
5225570|NCT00725569|Analgesia|analgesia
5225571|NCT00725556|Autism|autism
5225572|NCT00725556|Asperger Syndrome|asperger syndrome
5225573|NCT00725530|Lens deposits|lens deposits
5225574|NCT00725530|Soft contact lens wearers|soft contact lens wearers
5225575|NCT00725517|Icodextrin|icodextrin
5225576|NCT00725517|ultrafiltration|ultrafiltration
5225577|NCT00725517|creatinine clearance|creatinine clearance
5225578|NCT00725517|urea nitrogen clearance|urea nitrogen clearance
5225579|NCT00725491|Reproductive|reproductive
5225580|NCT00725491|techniques|techniques
5225581|NCT00725491|assisted|assisted
5225582|NCT00725478|Piribedil (trade name: CLARIUM)|piribedil (trade name: clarium)
5225583|NCT00725478|non-ergot dopamine agonist|non-ergot dopamine agonist
5225584|NCT00725478|Morbus Parkinson|morbus parkinson
5225585|NCT00725478|Tolerability|tolerability
5225587|NCT00725478|Post Marketing Surveillance|post marketing surveillance
5225588|NCT00725465|laparoscopy|laparoscopy
5225589|NCT00725465|CO2 colonoscopy|co2 colonoscopy
5225590|NCT00725465|intraoperative CO2 colonoscopy|intraoperative co2 colonoscopy
5225591|NCT00725465|combined Lap-CO2 procedure|combined lap-co2 procedure
5225592|NCT00725465|to evaluate simultaneous CO2 laparoscopy and colonoscopy safety and physiologic effects on patients from the additional CO2 insufflation|to evaluate simultaneous co2 laparoscopy and colonoscopy safety and physiologic effects on patients from the additional co2 insufflation
5225593|NCT00725426|healthy subjects|healthy subjects
5225594|NCT00725400|Colorectal Cancer|colorectal cancer
5225595|NCT00725400|Erbitux|erbitux
5225596|NCT00725400|Cetuximab|cetuximab
5225597|NCT00725400|Surgery|surgery
5225598|NCT00725400|Radiation|radiation
5225599|NCT00725348|Psoriasis|psoriasis
5225600|NCT00725335|ischemia|ischemia
5225601|NCT00725335|liver cancer|liver cancer
5225602|NCT00725335|radical excision|radical excision
5225603|NCT00725335|prognosis|prognosis
5225604|NCT00725309|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5225605|NCT00725309|COPD|copd
5225606|NCT00725309|Elastin|elastin
5225607|NCT00725309|ELN|eln
5225608|NCT00725283|Leukemia|leukemia
5225609|NCT00725283|ASCI|asci
5225610|NCT00725283|Complete remission|complete remission
5225611|NCT00725283|Immunotherapy|immunotherapy
5225612|NCT00725283|adult|adult
5225613|NCT00725283|Acute Myeloid Leukemia|acute myeloid leukemia
5225614|NCT00725283|Tumor antigen|tumor antigen
5225615|NCT00725283|WT1|wt1
5225616|NCT00725244|Radiation Injuries|radiation injuries
5225617|NCT00725244|Telangiectasis|telangiectasis
5225618|NCT00725244|Bipolar Eletrocoagulation|bipolar eletrocoagulation
5225619|NCT00725244|Argon Plasma Coagulation|argon plasma coagulation
5225620|NCT00725231|T cell lymphoma|t cell lymphoma
5225621|NCT00725218|NSAIDs|nsaids
5225622|NCT00725218|Postoperative pain|postoperative pain
5225623|NCT00725218|Analgesia|analgesia
5225624|NCT00725218|Abortion|abortion
5225625|NCT00725192|PTSD|ptsd
5225626|NCT00725192|Posttraumatic Stress Disorder|posttraumatic stress disorder
5225627|NCT00725192|Physical Assault|physical assault
5225628|NCT00725192|Physical Abuse|physical abuse
5225629|NCT00725192|Sexual Assault|sexual assault
5225630|NCT00725192|Sexual Abuse|sexual abuse
5225631|NCT00725192|Interpersonal Assault|interpersonal assault
5225632|NCT00725192|Cognitive Processing Therapy|cognitive processing therapy
5225633|NCT00725192|Sleep Impairment|sleep impairment
5225634|NCT00725192|Insomnia|insomnia
5225635|NCT00725192|Hypnosis|hypnosis
5225636|NCT00725179|acetaminophen toxicity|acetaminophen toxicity
5225637|NCT00725179|n-acetylcysteine|n-acetylcysteine
5225638|NCT00725179|liver toxicity|liver toxicity
5225639|NCT00725166|Aging|aging
5225640|NCT00725166|Biopsy|biopsy
5225641|NCT00725166|Skeletal muscle|skeletal muscle
5225642|NCT00725166|Molecular biology|molecular biology
5225643|NCT00725166|Genetic markers|genetic markers
5225644|NCT00725166|Gene expression regulation|gene expression regulation
5225645|NCT00725166|Young and old men|young and old men
5225646|NCT00725166|Healthy volunteers|healthy volunteers
5225647|NCT00725153|Contact lens deposits|contact lens deposits
5225648|NCT00725153|Soft contact lenses|soft contact lenses
5225649|NCT00725153|Myopia|myopia
5225650|NCT00725140|Migraine|migraine
5225651|NCT00725140|Early intervention|early intervention
5225652|NCT00725140|Primary Care|primary care
5225653|NCT00725140|Almotriptan|almotriptan
5225654|NCT00725127|Aspirin|aspirin
5225655|NCT00725127|Chronotherapy|chronotherapy
5225656|NCT00725127|Primary prevention|primary prevention
5225657|NCT00725127|Impaired fasting glucose|impaired fasting glucose
5225658|NCT00725127|Type 2 diabetes|type 2 diabetes
5225659|NCT00725127|Total mortality|total mortality
5225660|NCT00725127|Myocardial infarction|myocardial infarction
5225661|NCT00725127|Stroke|stroke
5225662|NCT00725127|Angina pectoris|angina pectoris
5225663|NCT00725127|Chronic kidney disease|chronic kidney disease
5225664|NCT00725114|due|due
5225665|NCT00725114|cancer|cancer
5225666|NCT00725114|treatment|treatment
5225667|NCT00725088|ST-Elevated Myocardial Infarction|st-elevated myocardial infarction
5225668|NCT00725088|Exercise Training|exercise training
5225669|NCT00725088|Rehabilitation|rehabilitation
5225670|NCT00725075|Negative symptoms|negative symptoms
5225671|NCT00725075|Glycine Uptake inhibitor|glycine uptake inhibitor
5225672|NCT00725075|Add-on treatment|add-on treatment
5225673|NCT00725075|Second Generation Antipsychotic|second generation antipsychotic
5225674|NCT00725062|graft versus host disease|graft versus host disease
5225675|NCT00725062|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5225676|NCT00725062|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5225677|NCT00725062|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5225678|NCT00725062|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5225679|NCT00725062|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5225680|NCT00725062|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5225751|NCT00724984|Lymphoma, Non-Hodgkin|lymphoma, non-hodgkin
5225681|NCT00725062|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5225682|NCT00725062|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5225683|NCT00725062|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5225684|NCT00725062|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5225685|NCT00725062|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5225686|NCT00725062|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5225687|NCT00725062|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5225688|NCT00725062|stage I multiple myeloma|stage i multiple myeloma
5225689|NCT00725062|stage II multiple myeloma|stage ii multiple myeloma
5225690|NCT00725062|stage III multiple myeloma|stage iii multiple myeloma
5225691|NCT00725062|refractory multiple myeloma|refractory multiple myeloma
5225692|NCT00725062|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5225693|NCT00725062|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5225694|NCT00725062|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5225695|NCT00725062|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5225696|NCT00725062|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5225697|NCT00725062|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5225698|NCT00725062|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5225699|NCT00725062|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5225700|NCT00725062|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5225701|NCT00725062|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5225702|NCT00725062|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5225703|NCT00725062|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5225704|NCT00725062|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5225705|NCT00725062|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5225706|NCT00725062|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5225707|NCT00725062|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5225708|NCT00725062|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5225709|NCT00725062|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5225710|NCT00725062|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5225711|NCT00725062|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5225712|NCT00725062|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5225713|NCT00725062|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5225714|NCT00725062|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5225715|NCT00725062|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5225716|NCT00725062|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5225717|NCT00725062|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5225718|NCT00725062|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5225719|NCT00725062|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5225720|NCT00725062|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5225721|NCT00725062|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5225722|NCT00725062|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5225723|NCT00725062|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5225724|NCT00725062|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5225725|NCT00725062|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5225726|NCT00725062|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5225727|NCT00725062|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5225728|NCT00725062|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5225729|NCT00725062|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5225730|NCT00725062|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5225731|NCT00725062|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5225732|NCT00725062|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5225733|NCT00725049|dental implants|dental implants
5225734|NCT00725049|Nanotite Certain implant|nanotite certain implant
5225735|NCT00725049|Osseotite|osseotite
5225736|NCT00725049|multicenter|multicenter
5225737|NCT00725049|randomized|randomized
5225738|NCT00725049|clinical study|clinical study
5225739|NCT00725049|partial edentulism|partial edentulism
5225740|NCT00725049|crestal bone level|crestal bone level
5225741|NCT00725049|short fixed bridge|short fixed bridge
5225742|NCT00725049|cost analysis|cost analysis
5225743|NCT00725023|Pain, chronic pain, tennis elbow, lateral epicondylitis|pain, chronic pain, tennis elbow, lateral epicondylitis
5225744|NCT00724997|live attenuated flu vaccines|live attenuated flu vaccines
5225745|NCT00724997|Influenza A (H1N1)|influenza a (h1n1)
5225746|NCT00724997|intranasally application|intranasally application
5225747|NCT00724997|replication-deficient influenza virus|replication-deficient influenza virus
5225748|NCT00724984|PCI-24781|pci-24781
5225749|NCT00724984|Lymphoma|lymphoma
5225750|NCT00724984|Hodgkin Disease|hodgkin disease
5225752|NCT00724984|Lymphoma, Large B-Cell, Diffuse|lymphoma, large b-cell, diffuse
5225753|NCT00724984|Lymphoma, Follicular|lymphoma, follicular
5225754|NCT00724984|Lymphoma, B-Cell, Marginal Zone|lymphoma, b-cell, marginal zone
5225755|NCT00724984|Leukemia, Lymphocytic, Chronic, B-Cell|leukemia, lymphocytic, chronic, b-cell
5225756|NCT00724984|Lymphoma, Mantle Cell|lymphoma, mantle cell
5225757|NCT00724984|Lymphoma, T-Cell, Cutaneous|lymphoma, t-cell, cutaneous
5225758|NCT00724984|Lymphoma, T-Cell, Peripheral|lymphoma, t-cell, peripheral
5225759|NCT00724971|B-cell Non-Hodgkin's Lymphoma|b-cell non-hodgkin's lymphoma
5225760|NCT00724971|NHL|nhl
5225761|NCT00724919|ESBL|esbl
5225762|NCT00724906|Essential Tremor|essential tremor
5225763|NCT00724906|Parkinsonian Tremor|parkinsonian tremor
5225764|NCT00724906|Parkinson Disease|parkinson disease
5225765|NCT00724906|Upper Extremity Tremor with duration of less than 2 years|upper extremity tremor with duration of less than 2 years
5225766|NCT00724906|Diagnosis|diagnosis
5225767|NCT00724906|Subjects|subjects
5225768|NCT00724906|Upper|upper
5225769|NCT00724906|Extremity|extremity
5225770|NCT00724906|Tremor|tremor
5225771|NCT00724906|Less|less
5225772|NCT00724906|Than 2 years|than 2 years
5225773|NCT00724880|coronary artery bypass grafting|coronary artery bypass grafting
5225774|NCT00724880|clopidogrel|clopidogrel
5225775|NCT00724880|post-operative bleeding|post-operative bleeding
5225776|NCT00724867|Systemic Lupus Erythematosus|systemic lupus erythematosus
5225777|NCT00724867|Belimumab|belimumab
5225778|NCT00724867|SLE|sle
5225779|NCT00724867|Antibodies|antibodies
5225780|NCT00724867|Lupus|lupus
5225781|NCT00724867|Autoimmune Diseases|autoimmune diseases
5225782|NCT00724828|Bacterial otitis media|bacterial otitis media
5225783|NCT00724828|pneumoniae|pneumoniae
5225784|NCT00724828|sepsis|sepsis
5225785|NCT00724828|bacteremia|bacteremia
5225786|NCT00724828|meningitis|meningitis
5225787|NCT00724828|Streptococcus pneumoniae carriage rate|streptococcus pneumoniae carriage rate
5225788|NCT00724802|babies with canavan disease|babies with canavan disease
5225789|NCT00724789|Neonatal outcome|neonatal outcome
5225790|NCT00724789|Congenital malformations|congenital malformations
5225791|NCT00724789|In-Vitro fertilization|in-vitro fertilization
5225792|NCT00724789|Controlled ovarian stimulation|controlled ovarian stimulation
5225793|NCT00724789|Follow-up|follow-up
5225794|NCT00724776|Chronic hepatitis C, Albinterferon alfa 2b, phase I, Japan|chronic hepatitis c, albinterferon alfa 2b, phase i, japan
5225795|NCT00724763|acupuncture, high blood pressure, HRV|acupuncture, high blood pressure, hrv
5225796|NCT00724724|Stroke|stroke
5225797|NCT00724724|Transient Ischemic Attack|transient ischemic attack
5225798|NCT00724711|HIV|hiv
5225799|NCT00724711|HIV 1|hiv 1
5225800|NCT00724685|Ropivacaine|ropivacaine
5225801|NCT00724685|elastomeric pump|elastomeric pump
5225802|NCT00724685|patient controlled analgesia|patient controlled analgesia
5225803|NCT00724685|morphine consumption|morphine consumption
5225804|NCT00724659|Arthrogram|arthrogram
5225805|NCT00724659|Contrast|contrast
5225806|NCT00724659|Joint|joint
5225807|NCT00724659|Ultrasound|ultrasound
5225808|NCT00724646|parents|parents
5225809|NCT00724646|medically fragile|medically fragile
5225810|NCT00724646|death|death
5225811|NCT00724646|end-of-life care|end-of-life care
5225812|NCT00724646|surveys|surveys
5225813|NCT00724633|dialysate|dialysate
5225814|NCT00724633|sodium|sodium
5225815|NCT00724633|hemodialysis|hemodialysis
5225816|NCT00724633|blood pressure|blood pressure
5225817|NCT00724633|thirst|thirst
5225818|NCT00724633|intradialytic symptoms|intradialytic symptoms
5225819|NCT00724633|interdialytic weight gain|interdialytic weight gain
5225820|NCT00724633|extracellular fluid balance|extracellular fluid balance
5225821|NCT00724633|mechanisms|mechanisms
5225822|NCT00724607|Concussion, traumatic brain injury|concussion, traumatic brain injury
5225823|NCT00724607|Screening|screening
5225824|NCT00724607|neuroimaging|neuroimaging
5225825|NCT00724607|Posttraumatic stress disorder|posttraumatic stress disorder
5225826|NCT00724594|chorioamnionitis|chorioamnionitis
5225827|NCT00724594|maternal chorioamnionitis|maternal chorioamnionitis
5225828|NCT00724594|neonatal white matter injury|neonatal white matter injury
5225829|NCT00724594|N-acetylcysteine|n-acetylcysteine
5225830|NCT00724594|NAC|nac
5225831|NCT00724594|anti-oxidant treatment|anti-oxidant treatment
5225832|NCT00724581|Atrial fibrillation, amiodarone|atrial fibrillation, amiodarone
5225833|NCT00724568|Newly Diagnosed Multiple Myeloma|newly diagnosed multiple myeloma
5225834|NCT00724555|stroke|stroke
5225835|NCT00724555|tissue plasminogen activator|tissue plasminogen activator
5225836|NCT00724555|tPA|tpa
5225837|NCT00724529|Crohn's Disease|crohn's disease
5225838|NCT00724529|Ankylosing Spondylitis|ankylosing spondylitis
5225839|NCT00724516|Mammogram|mammogram
5225840|NCT00724516|Biopsy|biopsy
5225841|NCT00724516|Needle|needle
5225842|NCT00724516|Wire|wire
5225843|NCT00724516|Localization|localization
5225844|NCT00724516|Compression|compression
5225845|NCT00724516|Paddle|paddle
5225846|NCT00724503|colon cancer|colon cancer
5225847|NCT00724503|Colorectal carcinoma|colorectal carcinoma
5225848|NCT00724503|liver metastases|liver metastases
5225849|NCT00724503|SIR-Spheres microspheres|sir-spheres microspheres
5225850|NCT00724503|yttrium-90|yttrium-90
5225851|NCT00724503|FOLFOX|folfox
5225852|NCT00724503|bevacizumab|bevacizumab
5225853|NCT00724503|metastatic colorectal cancer|metastatic colorectal cancer
5225854|NCT00724490|Deep Brain Stimulation|deep brain stimulation
5225855|NCT00724490|Obsessive Compulsive Disorder|obsessive compulsive disorder
5225856|NCT00724490|Nucleus Accumbens|nucleus accumbens
5225857|NCT00724438|Contraception|contraception
5225858|NCT00724438|Implanon|implanon
5225859|NCT00724438|Obesity|obesity
5225860|NCT00724438|Blood spots|blood spots
5225861|NCT00724438|Implant|implant
5225862|NCT00724438|Pharmacokinetics|pharmacokinetics
5225863|NCT00724412|Dry Eye|dry eye
5225864|NCT00724412|Corneal Staining|corneal staining
5225865|NCT00724360|relapsed/refractory|relapsed/refractory
5225866|NCT00724360|HER2|her2
5225867|NCT00724360|positive|positive
5225868|NCT00724360|B-ALL|b-all
5225869|NCT00724360|trastuzumab|trastuzumab
5225870|NCT00724347|Auditory Perception|auditory perception
5225871|NCT00724347|Hearing Loss|hearing loss
5225872|NCT00724347|Presbycusis|presbycusis
5225873|NCT00724347|Perceptual Learning|perceptual learning
5225874|NCT00724347|Hearing Prosthesis|hearing prosthesis
5225875|NCT00724347|Speech Discrimination|speech discrimination
5225876|NCT00724347|Delayed Treatment|delayed treatment
5225877|NCT00724334|myelofibrosis|myelofibrosis
5225878|NCT00724321|iloprost|iloprost
5225879|NCT00724321|hypoxic|hypoxic
5225880|NCT00724321|pulmonary|pulmonary
5225881|NCT00724321|vasoconstriction|vasoconstriction
5225882|NCT00724321|altitude|altitude
5225883|NCT00724308|Smoking|smoking
5225884|NCT00724308|Smoking Cessation|smoking cessation
5225885|NCT00724308|Tobacco|tobacco
5225886|NCT00724308|Mental Health|mental health
5225887|NCT00724282|sleep|sleep
5225888|NCT00724282|eszopiclone|eszopiclone
5225889|NCT00724282|insulin secretion|insulin secretion
5225890|NCT00724282|insulin action|insulin action
5225891|NCT00724282|glucose tolerance|glucose tolerance
5225892|NCT00724269|Contact lens wear|contact lens wear
5225893|NCT00724269|multi-purpose solution|multi-purpose solution
5225894|NCT00724269|corneal staining|corneal staining
5225895|NCT00724256|Pyelonephritis.|pyelonephritis.
5225896|NCT00724256|Urinary Tract Infections.|urinary tract infections.
5225897|NCT00724256|Children.|children.
5225898|NCT00724256|Randomised controlled trial.|randomised controlled trial.
5225899|NCT00724256|Therapy.|therapy.
5225900|NCT00724256|Ceftibuten.|ceftibuten.
5225901|NCT00724204|probiotics|probiotics
5225902|NCT00724204|safety|safety
5225903|NCT00724204|fecal microbiota|fecal microbiota
5225904|NCT00724204|infections|infections
5225905|NCT00724178|Pediatric HIV infection, bone mineral content, bone mineral density, Vitamin D, calcium Dual x-ray absorptiometry|pediatric hiv infection, bone mineral content, bone mineral density, vitamin d, calcium dual x-ray absorptiometry
5225906|NCT00724165|physical activity|physical activity
5225907|NCT00724165|Latinas|latinas
5225908|NCT00724152|coping skills|coping skills
5225909|NCT00724152|psychology|psychology
5225910|NCT00724152|audiology|audiology
5225911|NCT00724152|veterans|veterans
5225912|NCT00724152|tinnitus|tinnitus
5225913|NCT00724152|adult|adult
5225914|NCT00724152|intervention studies|intervention studies
5225915|NCT00724152|tinnitus, noise induced|tinnitus, noise induced
5225916|NCT00724152|noise|noise
5225917|NCT00724152|auditory perception|auditory perception
5225918|NCT00724126|Diarrhea|diarrhea
5225919|NCT00724126|Rifaximin|rifaximin
5225920|NCT00724126|IBS|ibs
5225921|NCT00724126|Abdominal pain|abdominal pain
5225922|NCT00724126|Bloating|bloating
5225923|NCT00724113|Shoulder capsulitis|shoulder capsulitis
5225924|NCT00724113|ARTHRO distension|arthro distension
5225925|NCT00724113|Mobilisation|mobilisation
5225926|NCT00724113|Randomised clinical trial|randomised clinical trial
5225927|NCT00724100|Malignancy|malignancy
5225928|NCT00724100|Solid tumor|solid tumor
5225929|NCT00724100|Tubulin inhibitor|tubulin inhibitor
5225930|NCT00724087|short sleep duration|short sleep duration
5225931|NCT00724087|energy expenditure|energy expenditure
5225932|NCT00724087|insulin secretion|insulin secretion
5225933|NCT00724087|insulin action|insulin action
5225934|NCT00724087|lipid turnover|lipid turnover
5225935|NCT00724087|free fatty acids|free fatty acids
5225936|NCT00724074|Arthritis of the knee|arthritis of the knee
5225937|NCT00724074|Knee replacement|knee replacement
5225938|NCT00724074|Osteoarthritis, knee|osteoarthritis, knee
5225939|NCT00724074|Arthroplasty, knee|arthroplasty, knee
5225940|NCT00724061|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5225941|NCT00724061|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
5225942|NCT00724061|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
5225943|NCT00724061|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
5225944|NCT00724061|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
5225945|NCT00724061|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5225946|NCT00724061|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
5225947|NCT00724061|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
5226048|NCT00723528|Psoriasis|psoriasis
5225948|NCT00724061|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
5225949|NCT00724061|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
5225950|NCT00724048|Huntington Disease|huntington disease
5225951|NCT00724035|Anesthesia|anesthesia
5225952|NCT00724035|Upper extremity|upper extremity
5225953|NCT00724035|Nerve block|nerve block
5225954|NCT00724035|Ultrasound|ultrasound
5225955|NCT00724035|Brachial plexus|brachial plexus
5225956|NCT00724022|Kidney transplant status|kidney transplant status
5225957|NCT00724022|Steroid free|steroid free
5225958|NCT00724022|Reduced|reduced
5225959|NCT00724022|Calcineurin|calcineurin
5225960|NCT00724022|Inhibitor|inhibitor
5225961|NCT00724022|Immunosuppression|immunosuppression
5225962|NCT00723970|Major Depressive Disorder|major depressive disorder
5225963|NCT00723970|Insomnia|insomnia
5225964|NCT00723970|Hot Flashes|hot flashes
5225965|NCT00723970|Menopause|menopause
5225966|NCT00723970|Quetiapine|quetiapine
5225967|NCT00723944|dental implants|dental implants
5225968|NCT00723944|Osseotite Certain Prevail|osseotite certain prevail
5225969|NCT00723944|Lateralized|lateralized
5225970|NCT00723944|non-lateralized|non-lateralized
5225971|NCT00723944|Osseotite Certain|osseotite certain
5225972|NCT00723944|multicenter|multicenter
5225973|NCT00723944|randomized|randomized
5225974|NCT00723944|clinical study|clinical study
5225975|NCT00723944|partial edentulism|partial edentulism
5225976|NCT00723944|single stage|single stage
5225977|NCT00723944|early loading|early loading
5225978|NCT00723944|crestal bone level|crestal bone level
5225979|NCT00723944|short fixed bridge|short fixed bridge
5225980|NCT00723918|HIV-associated neuropathy|hiv-associated neuropathy
5225981|NCT00723918|HIV|hiv
5225982|NCT00723918|AIDS|aids
5225983|NCT00723918|cannabinoid|cannabinoid
5225984|NCT00723918|Cannabis|cannabis
5225985|NCT00723918|methadone|methadone
5225986|NCT00723918|distal sensory polyneuropathy|distal sensory polyneuropathy
5225987|NCT00723918|polyneuropathy|polyneuropathy
5225988|NCT00723905|Crohn's Disease, Rheumatoid Arthritis|crohn's disease, rheumatoid arthritis
5225989|NCT00723866|Botulinum toxin, Spasticity, Stroke, Rehabilitation.|botulinum toxin, spasticity, stroke, rehabilitation.
5225990|NCT00723853|Obesity|obesity
5225991|NCT00723853|Type 2 diabetes|type 2 diabetes
5225992|NCT00723853|African American children|african american children
5225993|NCT00723853|African American youth|african american youth
5225994|NCT00723853|Community based|community based
5225995|NCT00723853|Family oriented|family oriented
5225996|NCT00723853|Obesity & Risk of type 2 diabetes|obesity & risk of type 2 diabetes
5225997|NCT00723840|EuroQOL (EQ-5D)|euroqol (eq-5d)
5225998|NCT00723814|normal|normal
5225999|NCT00723801|Marfan syndrome|marfan syndrome
5226000|NCT00723801|Losartan|losartan
5226001|NCT00723801|Atenolol|atenolol
5226002|NCT00723801|Diastolic Function|diastolic function
5226003|NCT00723801|Aortic Stiffness|aortic stiffness
5226004|NCT00723788|Appendicitis|appendicitis
5226005|NCT00723788|Children|children
5226006|NCT00723788|Magnetic Resonance Imaging|magnetic resonance imaging
5226007|NCT00723775|KALETRA|kaletra
5226008|NCT00723775|GSK706769|gsk706769
5226009|NCT00723775|HIV|hiv
5226010|NCT00723775|healthy volunteers|healthy volunteers
5226011|NCT00723762|Valproic acid|valproic acid
5226012|NCT00723762|Urea cycle|urea cycle
5226013|NCT00723762|Ornithine|ornithine
5226014|NCT00723762|Valproate|valproate
5226015|NCT00723762|Side effect|side effect
5226016|NCT00723749|Suboxone|suboxone
5226017|NCT00723749|Subutex|subutex
5226018|NCT00723749|Buprenorphine|buprenorphine
5226019|NCT00723749|Naloxone|naloxone
5226020|NCT00723697|Subutex|subutex
5226021|NCT00723684|ADHD|adhd
5226022|NCT00723684|Children|children
5226023|NCT00723684|EEG-Neurofeedback|eeg-neurofeedback
5226024|NCT00723658|Waldenström macroglobulinemia|waldenström macroglobulinemia
5226025|NCT00723619|asthma|asthma
5226026|NCT00723619|spirometry|spirometry
5226027|NCT00723619|FENO|feno
5226028|NCT00723619|normal values for spirometry in childhood|normal values for spirometry in childhood
5226029|NCT00723619|normal values for FENO in childhood|normal values for feno in childhood
5226030|NCT00723606|Intramuscular ziprasidone, agitation, efficacy and safety|intramuscular ziprasidone, agitation, efficacy and safety
5226031|NCT00723593|Graft-Versus-Host Disease|graft-versus-host disease
5226032|NCT00723593|Gastrointestinal|gastrointestinal
5226033|NCT00723593|Apoptotic Assay|apoptotic assay
5226034|NCT00723593|Serum Proteomic Pattern Analysis|serum proteomic pattern analysis
5226035|NCT00723593|Mucosal Biopsy|mucosal biopsy
5226036|NCT00723593|Graft Versus Host Disease|graft versus host disease
5226037|NCT00723593|GVHD|gvhd
5226038|NCT00723580|Kabuki Syndrome|kabuki syndrome
5226039|NCT00723580|Actigraphy|actigraphy
5226040|NCT00723580|Treatment Response Measurement|treatment response measurement
5226041|NCT00723567|Spectrin Gene|spectrin gene
5226042|NCT00723567|Hereditary Elliptocytosis (HE)|hereditary elliptocytosis (he)
5226043|NCT00723567|Hereditary Pyropoikilocytosis (HPP)|hereditary pyropoikilocytosis (hpp)
5226044|NCT00723567|Genetics|genetics
5226045|NCT00723554|pulmonary arterial hypertension|pulmonary arterial hypertension
5226046|NCT00723554|inhaled therapy|inhaled therapy
5226047|NCT00723554|power disc-15|power disc-15
5226049|NCT00723528|Ustekinumab|ustekinumab
5226050|NCT00723528|CNTO 1275|cnto 1275
5226051|NCT00723515|White spot lesion|white spot lesion
5226052|NCT00723515|Tooth remineralization|tooth remineralization
5226053|NCT00723515|Fluoride varnishes|fluoride varnishes
5226054|NCT00723502|Helicobacter pylori|helicobacter pylori
5226055|NCT00723502|Eradication|eradication
5226056|NCT00723502|Dyspepsia|dyspepsia
5226057|NCT00723489|Yellow Fever Vaccine|yellow fever vaccine
5226058|NCT00723489|Scarification Method|scarification method
5226059|NCT00723489|Atopic Dermatitis|atopic dermatitis
5226060|NCT00723489|IgG antibodies|igg antibodies
5226061|NCT00723476|Quality of Life|quality of life
5226062|NCT00723476|Adolescent|adolescent
5226063|NCT00723476|Advance Care Planning|advance care planning
5226064|NCT00723476|Palliative Care|palliative care
5226065|NCT00723476|End-of-Life Care|end-of-life care
5226066|NCT00723476|HIV/AIDS|hiv/aids
5226067|NCT00723476|Psychological Adjustment|psychological adjustment
5226068|NCT00723450|Bipolar I pediatric lamictal adolescent|bipolar i pediatric lamictal adolescent
5226069|NCT00723437|nail, psoriasis, NAPSI,acitretin|nail, psoriasis, napsi,acitretin
5226070|NCT00723424|AZD5672|azd5672
5226071|NCT00723424|digoxin|digoxin
5226072|NCT00723411|Diabetes|diabetes
5226073|NCT00723411|Juvenile Diabetes|juvenile diabetes
5226074|NCT00723411|Diabetes type 1|diabetes type 1
5226075|NCT00723411|Autoimmune Diabetes|autoimmune diabetes
5226076|NCT00723411|Insulin dependent Diabetes|insulin dependent diabetes
5226077|NCT00723411|Type 1 diabetes|type 1 diabetes
5226078|NCT00723411|Type 1 diabetes mellitus|type 1 diabetes mellitus
5226079|NCT00723411|Diamyd|diamyd
5226080|NCT00723411|rhGAD65|rhgad65
5226081|NCT00723411|GAD|gad
5226082|NCT00723411|GAD-alum|gad-alum
5226083|NCT00723398|omega-3 fatty acids|omega-3 fatty acids
5226084|NCT00723398|antiestrogens|antiestrogens
5226085|NCT00723398|breast cancer prevention|breast cancer prevention
5226086|NCT00723398|breast density|breast density
5226087|NCT00723398|biomarkers of mammary carcinogenesis|biomarkers of mammary carcinogenesis
5226088|NCT00723385|cholesterol|cholesterol
5226089|NCT00723385|LDL-cholesterol|ldl-cholesterol
5226090|NCT00723385|cholecalciferol|cholecalciferol
5226091|NCT00723385|lipids|lipids
5226092|NCT00723385|C-reactive protein|c-reactive protein
5226093|NCT00723359|Multiple Myeloma|multiple myeloma
5226094|NCT00723359|Refractory|refractory
5226095|NCT00723359|Relapsed|relapsed
5226096|NCT00723346|Relapse|relapse
5226097|NCT00723346|Lymphoma lymphoblastic|lymphoma lymphoblastic
5226098|NCT00723333|Bone Marrow Transplant|bone marrow transplant
5226099|NCT00723333|Myelofibrosis|myelofibrosis
5226100|NCT00723333|Stem Cell Transplant|stem cell transplant
5226101|NCT00723333|Allogenic Transplant|allogenic transplant
5226102|NCT00723320|Atherosclerosis|atherosclerosis
5226103|NCT00723320|Atorvastatin|atorvastatin
5226104|NCT00723320|Therapeutic lifestyle change|therapeutic lifestyle change
5226105|NCT00723320|CIMT|cimt
5226107|NCT00723320|PWV|pwv
5226108|NCT00723307|No diabetes mellitus|no diabetes mellitus
5226109|NCT00723307|Elevated waist circumference|elevated waist circumference
5226110|NCT00723294|invasive ductal breast carcinoma|invasive ductal breast carcinoma
5226111|NCT00723294|male breast cancer|male breast cancer
5226112|NCT00723294|stage IA breast cancer|stage ia breast cancer
5226113|NCT00723294|stage IB breast cancer|stage ib breast cancer
5226114|NCT00723294|stage II breast cancer|stage ii breast cancer
5226115|NCT00723281|transplant coronary artery disease|transplant coronary artery disease
5226116|NCT00723281|CT angiography|ct angiography
5226117|NCT00723281|conventional angiography|conventional angiography
5226118|NCT00723281|intravascular ultrasound|intravascular ultrasound
5226119|NCT00723281|Heart transplant patients with known transplant coronary artery disease|heart transplant patients with known transplant coronary artery disease
5226120|NCT00723268|Oral ulcers|oral ulcers
5226121|NCT00723216|Prevention|prevention
5226122|NCT00723216|venous thromboembolism|venous thromboembolism
5226123|NCT00723216|curative surgery|curative surgery
5226124|NCT00723203|Philadelphia chromosome positive adult precursor acute lymphoblastic leukemia|philadelphia chromosome positive adult precursor acute lymphoblastic leukemia
5226125|NCT00723203|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5226126|NCT00723203|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5226127|NCT00723190|CLONICEL|clonicel
5226128|NCT00723190|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
5226129|NCT00723190|clonidine HCl sustained release|clonidine hcl sustained release
5226130|NCT00723177|opioid withdrawal, analgesia|opioid withdrawal, analgesia
5226131|NCT00723164|Sevoflurane induction|sevoflurane induction
5226132|NCT00723164|Premedication|premedication
5226133|NCT00723164|laryngeal mask airway|laryngeal mask airway
5226134|NCT00723164|Anesthesia, inhalation [E03.155.197.197]|anesthesia, inhalation [e03.155.197.197]
5226135|NCT00723125|Breast Cancer|breast cancer
5226136|NCT00723112|Myelodysplastic Syndrome|myelodysplastic syndrome
5226137|NCT00723112|Erythropoiesis|erythropoiesis
5226138|NCT00723112|Ineffective Hematopoiesis|ineffective hematopoiesis
5226139|NCT00723112|Erythroid Progenitors|erythroid progenitors
5226140|NCT00723112|Dyserythropoiesis|dyserythropoiesis
5226141|NCT00723086|docetaxel, prednisolone, drug combination|docetaxel, prednisolone, drug combination
5226142|NCT00723073|micafungin, caspofungin, febrile neutropenia|micafungin, caspofungin, febrile neutropenia
5226143|NCT00723047|Patients|patients
5226144|NCT00723047|CD complicated|cd complicated
5226145|NCT00723047|least|least
5226146|NCT00723047|One perianal fistula|one perianal fistula
5226147|NCT00723047|Draining|draining
5226148|NCT00723047|2 months duration|2 months duration
5226149|NCT00723021|Bronchodilator|bronchodilator
5226150|NCT00723008|anxiety|anxiety
5226151|NCT00723008|insomnia|insomnia
5226152|NCT00723008|pain|pain
5226153|NCT00723008|Alpha Stim|alpha stim
5226154|NCT00723008|Cranial electrotherapy stimulation|cranial electrotherapy stimulation
5226155|NCT00722995|Morbid obesity|morbid obesity
5226156|NCT00722995|Sleeve gastrectomy|sleeve gastrectomy
5226157|NCT00722995|Gastric bypass|gastric bypass
5226158|NCT00722995|Complications|complications
5226159|NCT00722995|Efficacity|efficacity
5226160|NCT00722995|Safety|safety
5226161|NCT00722995|Compare|compare
5226162|NCT00722982|coxarthrosis|coxarthrosis
5226163|NCT00722982|hip|hip
5226164|NCT00722982|RSA|rsa
5226165|NCT00722982|DXA|dxa
5226166|NCT00722982|C-stem AMT|c-stem amt
5226167|NCT00722982|Marathon|marathon
5226168|NCT00722969|non-small cell lung cancer|non-small cell lung cancer
5226169|NCT00722969|erlotinib|erlotinib
5226170|NCT00722969|sorafenib|sorafenib
5226171|NCT00722956|atorvastatin|atorvastatin
5226172|NCT00722956|AZD5672|azd5672
5226173|NCT00722943|infant|infant
5226174|NCT00722943|premature|premature
5226175|NCT00722943|message|message
5226176|NCT00722943|therapy|therapy
5226177|NCT00722943|NICU|nicu
5226178|NCT00722943|neonatal intensive care unit|neonatal intensive care unit
5226179|NCT00722943|cortisol level|cortisol level
5226180|NCT00722943|stress|stress
5226181|NCT00722943|postnatal|postnatal
5226182|NCT00722943|weight gain|weight gain
5226183|NCT00722943|DMT|dmt
5226184|NCT00722943|Development Message Therapy|development message therapy
5226185|NCT00722943|growth|growth
5226186|NCT00722930|Follicular Lymphoma|follicular lymphoma
5226187|NCT00722930|High-risk FLIPI|high-risk flipi
5226188|NCT00722930|R-CHOP|r-chop
5226189|NCT00722930|GOTEL|gotel
5226190|NCT00722930|Partial|partial
5226191|NCT00722930|Complete|complete
5226192|NCT00722930|Response|response
5226193|NCT00722930|Induction|induction
5226194|NCT00722930|Chemotherapy|chemotherapy
5226195|NCT00722917|Glucose Metabolism Disorder|glucose metabolism disorder
5226196|NCT00722917|Dysmetabolic Syndrome|dysmetabolic syndrome
5226197|NCT00722917|Type II Diabetes|type ii diabetes
5226198|NCT00722917|Diabetes Mellitus, Lipoatrophic|diabetes mellitus, lipoatrophic
5226199|NCT00722917|Dyslipidemia|dyslipidemia
5226200|NCT00722917|Drug Therapy|drug therapy
5226201|NCT00722904|post-intervention surveillance of aortic coarctation|post-intervention surveillance of aortic coarctation
5226202|NCT00722904|MRA and 2D phase contrast imaging|mra and 2d phase contrast imaging
5226203|NCT00722904|4D Flow velocity mapping|4d flow velocity mapping
5226204|NCT00722904|Patients undergoing routine post-intervention surveillance of aortic coarctation|patients undergoing routine post-intervention surveillance of aortic coarctation
5226205|NCT00722904|Healthy volunteers|healthy volunteers
5226206|NCT00722891|Eye Diseases|eye diseases
5226207|NCT00722878|Primary Ciliary Dyskinesia|primary ciliary dyskinesia
5226208|NCT00722865|Avastin|avastin
5226209|NCT00722865|bevacizumab|bevacizumab
5226210|NCT00722865|ABVD|abvd
5226211|NCT00722865|angiogenesis|angiogenesis
5226212|NCT00722865|antiangiogenic|antiangiogenic
5226213|NCT00722865|Hodgkin|hodgkin
5226214|NCT00722839|cytomegalovirus infection|cytomegalovirus infection
5226215|NCT00722826|Pulmonary Regurgitation|pulmonary regurgitation
5226216|NCT00722826|Tetralogy of Fallot|tetralogy of fallot
5226217|NCT00722800|YAZ|yaz
5226218|NCT00722800|oral contraceptive|oral contraceptive
5226219|NCT00722800|hidradenitis suppurativa|hidradenitis suppurativa
5226220|NCT00722774|Vaccine|vaccine
5226221|NCT00722774|Influenza|influenza
5226222|NCT00722761|YAZ|yaz
5226223|NCT00722761|oral contraceptive|oral contraceptive
5226224|NCT00722761|Acne vulgaris|acne vulgaris
5226225|NCT00722748|Genebank|genebank
5226226|NCT00722748|Gene registry|gene registry
5226227|NCT00722748|Cardiac Arrythmia Disease|cardiac arrythmia disease
5226228|NCT00722735|uncomplicated Urinary Tract Infection in Women|uncomplicated urinary tract infection in women
5226229|NCT00722735|Antibacterial Chemotherapy|antibacterial chemotherapy
5226230|NCT00722735|Proof-of-Concept|proof-of-concept
5226231|NCT00722709|Pain|pain
5226232|NCT00722709|Fatigue|fatigue
5226233|NCT00722709|Colon|colon
5226234|NCT00722709|Surgery|surgery
5226235|NCT00722709|ERAS|eras
5226236|NCT00722709|Fastrack|fastrack
5226237|NCT00722709|Local anaesthetic|local anaesthetic
5226238|NCT00722709|Peritoneum|peritoneum
5226239|NCT00722709|Metabolic|metabolic
5226240|NCT00722709|Endocrine|endocrine
5226241|NCT00722709|Post surgical metabolic response|post surgical metabolic response
5226242|NCT00722709|Complications|complications
5226243|NCT00722709|Time to passage of flatus|time to passage of flatus
5226244|NCT00722709|Time to passage of stool|time to passage of stool
5226245|NCT00722709|Time to discharge from facility|time to discharge from facility
5226246|NCT00722709|Re-admission rate|re-admission rate
5226247|NCT00722696|Metabolism|metabolism
5226248|NCT00722696|Muscles|muscles
5226249|NCT00722696|Exercise|exercise
5226250|NCT00722670|risk reduction|risk reduction
5226251|NCT00722670|prevention|prevention
5226252|NCT00722670|HIV prevention|hiv prevention
5226253|NCT00722657|asthma|asthma
5226254|NCT00722657|epidemiology|epidemiology
5226255|NCT00722644|HIV|hiv
5226256|NCT00722644|Medication Adherence|medication adherence
5226257|NCT00722644|Stress Management|stress management
5226258|NCT00722644|CD4/Viral Loads|cd4/viral loads
5226259|NCT00722644|Cognitive Behavioral Treatment|cognitive behavioral treatment
5226260|NCT00722618|Infertility|infertility
5226261|NCT00722605|lung|lung
5226262|NCT00722605|esophageal|esophageal
5226263|NCT00722605|cone beam ct scan|cone beam ct scan
5226264|NCT00722592|cancer|cancer
5226265|NCT00722592|ovarian|ovarian
5226266|NCT00722592|platinum-resistant|platinum-resistant
5226267|NCT00722592|Phase II|phase ii
5226268|NCT00722592|EC145|ec145
5226269|NCT00722592|EC20|ec20
5226270|NCT00722579|Coronary Artery Disease|coronary artery disease
5226271|NCT00722553|Transitional Cell Carcinoma of the Urinary Bladder|transitional cell carcinoma of the urinary bladder
5226272|NCT00722553|Transitional Cell Carcinoma|transitional cell carcinoma
5226273|NCT00722553|Bladder Cancer|bladder cancer
5226274|NCT00722553|Urinary Bladder Cancer|urinary bladder cancer
5226275|NCT00722553|Bladder|bladder
5226276|NCT00722553|Carcinoma|carcinoma
5226277|NCT00722553|Urinary|urinary
5226278|NCT00722553|Metastatic|metastatic
5226279|NCT00722553|Relapsed|relapsed
5226280|NCT00722527|Primary Familial and Congenital Polycythemia|primary familial and congenital polycythemia
5226281|NCT00722527|Polycythemia|polycythemia
5226282|NCT00722527|Molecular Biology|molecular biology
5226283|NCT00722527|Genetics|genetics
5226284|NCT00722527|Erythropoiesis|erythropoiesis
5226285|NCT00722527|EPOR mutation|epor mutation
5226286|NCT00722527|Thrombocytosis|thrombocytosis
5226287|NCT00722527|Hypoxia|hypoxia
5226288|NCT00722475|recurrent miscarriage|recurrent miscarriage
5226289|NCT00722475|immunology|immunology
5226290|NCT00722475|intravenous immunoglobulin|intravenous immunoglobulin
5226291|NCT00722475|miscarriage|miscarriage
5226292|NCT00722462|Infertility|infertility
5226293|NCT00722462|IVF|ivf
5226294|NCT00722462|Acupuncture|acupuncture
5226295|NCT00722436|antifibrinolytic, tranexamic acid|antifibrinolytic, tranexamic acid
5226296|NCT00722423|Hepatitis C|hepatitis c
5226297|NCT00722423|integrated care|integrated care
5226298|NCT00722423|alpha interferon|alpha interferon
5226299|NCT00722423|mental health|mental health
5226300|NCT00722410|Carbapenem|carbapenem
5226301|NCT00722410|resistant|resistant
5226302|NCT00722410|Klebsiella pneumoniae|klebsiella pneumoniae
5226303|NCT00722410|Carpapenemases|carpapenemases
5226304|NCT00722410|Probiotics|probiotics
5226305|NCT00722410|VSL3|vsl3
5226306|NCT00722397|genetics, pediatrics|genetics, pediatrics
5226307|NCT00722384|AMD|amd
5226308|NCT00722384|Macular Degeneration|macular degeneration
5226309|NCT00722384|Opko Health|opko health
5226310|NCT00722384|Acuity Pharmaceuticals|acuity pharmaceuticals
5226311|NCT00722384|bevasiranib|bevasiranib
5226312|NCT00722384|Cand5|cand5
5226313|NCT00722384|Age-Related|age-related
5226314|NCT00722345|Obesity|obesity
5226315|NCT00722345|Physical activity|physical activity
5226316|NCT00722345|Adolescents|adolescents
5226317|NCT00722345|Exercise counseling intervention|exercise counseling intervention
5226318|NCT00722332|HBIG (Hepatitis B Immune Globulin)|hbig (hepatitis b immune globulin)
5226319|NCT00722332|Chronic Hepatitis B Recurrence|chronic hepatitis b recurrence
5226320|NCT00722332|Liver Transplant|liver transplant
5226321|NCT00722319|oral anticoagulation|oral anticoagulation
5226322|NCT00722319|warfarin|warfarin
5226323|NCT00722319|percutaneous coronary intervention|percutaneous coronary intervention
5226324|NCT00722319|stent|stent
5226325|NCT00722319|antiplatelet agents|antiplatelet agents
5226326|NCT00722306|non-restorative|non-restorative
5226327|NCT00722306|sleep|sleep
5226328|NCT00722293|Solid tumors|solid tumors
5226329|NCT00722293|Cancer|cancer
5226330|NCT00722293|Neoplasms, Ovarian|neoplasms, ovarian
5226331|NCT00722293|doxorubicin|doxorubicin
5226332|NCT00722293|epirubicin|epirubicin
5226333|NCT00722293|anti-angiogenesis|anti-angiogenesis
5226334|NCT00722293|pharmacodynamics|pharmacodynamics
5226335|NCT00722293|pazopanib (GW786034)|pazopanib (gw786034)
5226336|NCT00722293|pharmacokinetics|pharmacokinetics
5226337|NCT00722293|Soft Tissue|soft tissue
5226338|NCT00722293|Sarcoma|sarcoma
5226339|NCT00722280|Amputation, upper limb, composite tissue, immunosuppression|amputation, upper limb, composite tissue, immunosuppression
5226340|NCT00722267|severe COPD|severe copd
5226341|NCT00722267|COPD symptoms|copd symptoms
5226342|NCT00722267|variability of symptoms|variability of symptoms
5226343|NCT00722267|patient's perception|patient's perception
5226344|NCT00722254|Myeloproliferative Disorder|myeloproliferative disorder
5226345|NCT00722254|Primary Myelofibrosis|primary myelofibrosis
5226346|NCT00722254|Primary Pulmonary Hypertension|primary pulmonary hypertension
5226347|NCT00722254|Secondary Myelofibrosis|secondary myelofibrosis
5226718|NCT00720850|monosomy 5|monosomy 5
5226348|NCT00722254|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
5226349|NCT00722254|Flolan|flolan
5226350|NCT00722254|Clonality|clonality
5226351|NCT00722254|CD34+ cells|cd34+ cells
5226352|NCT00722254|Hematologic abnormalities|hematologic abnormalities
5226353|NCT00722241|Continuous Glucose Monitoring|continuous glucose monitoring
5226354|NCT00722241|Interstitial Fluid|interstitial fluid
5226355|NCT00722241|Diabetes Mellitus|diabetes mellitus
5226356|NCT00722215|Endothelin antagonist|endothelin antagonist
5226357|NCT00722215|Chronic kidney disease|chronic kidney disease
5226358|NCT00722215|Proteinuria|proteinuria
5226359|NCT00722215|Cardiovascular disease|cardiovascular disease
5226360|NCT00722215|Blood pressure|blood pressure
5226361|NCT00722215|Arterial stiffness|arterial stiffness
5226362|NCT00722215|Endothelial function|endothelial function
5226363|NCT00722189|Mycoses|mycoses
5226364|NCT00722176|Schizophrenia|schizophrenia
5226365|NCT00722163|Cognitive Behavioural therapy|cognitive behavioural therapy
5226366|NCT00722163|Psychosis|psychosis
5226367|NCT00722150|Artesunate|artesunate
5226368|NCT00722150|Plasmodium Falciparum|plasmodium falciparum
5226369|NCT00722150|Cambodia|cambodia
5226370|NCT00722124|tobacco use|tobacco use
5226371|NCT00722124|cigarettes|cigarettes
5226372|NCT00722124|smokers|smokers
5226373|NCT00722111|tongue|tongue
5226374|NCT00722111|pressure|pressure
5226375|NCT00722098|Melanoma|melanoma
5226376|NCT00722098|Dendritic Cell|dendritic cell
5226377|NCT00722098|Vaccine|vaccine
5226378|NCT00722098|Immunotherapy|immunotherapy
5226379|NCT00722098|Cyclophosphamide|cyclophosphamide
5226380|NCT00722085|Amniotic Fluid Sludge|amniotic fluid sludge
5226381|NCT00722085|Cerclage|cerclage
5226382|NCT00722085|Ultrasound|ultrasound
5226383|NCT00722085|Preterm Delivery|preterm delivery
5226384|NCT00722085|Neonatal|neonatal
5226385|NCT00722072|male breast cancer|male breast cancer
5226386|NCT00722072|stage IIIA breast cancer|stage iiia breast cancer
5226387|NCT00722072|stage IIIB breast cancer|stage iiib breast cancer
5226388|NCT00722072|stage IIIC breast cancer|stage iiic breast cancer
5226389|NCT00722072|stage IV breast cancer|stage iv breast cancer
5226390|NCT00722072|recurrent breast cancer|recurrent breast cancer
5226391|NCT00722046|Alzheimer's disease|alzheimer's disease
5226392|NCT00722046|antibody|antibody
5226393|NCT00722046|amyloid|amyloid
5226394|NCT00722033|preterm|preterm
5226395|NCT00722033|aEEG|aeeg
5226396|NCT00722033|apneas|apneas
5226397|NCT00722033|surfactant|surfactant
5226398|NCT00722033|indomethacin|indomethacin
5226399|NCT00722033|aminophyline|aminophyline
5226400|NCT00722020|Asthma|asthma
5226401|NCT00722020|Bronchial Disease|bronchial disease
5226402|NCT00722020|Status Asthmaticus|status asthmaticus
5226403|NCT00722020|High Frequency Chest Wall Oscillation|high frequency chest wall oscillation
5226404|NCT00722020|the Vest|the vest
5226405|NCT00722020|HFCWO|hfcwo
5226406|NCT00722007|hip resurfacing|hip resurfacing
5226407|NCT00722007|osteoarthritis|osteoarthritis
5226408|NCT00722007|avascular necrosis|avascular necrosis
5226409|NCT00722007|rheumatoid arthritis|rheumatoid arthritis
5226410|NCT00721994|hip resurfacing|hip resurfacing
5226411|NCT00721994|osteoarthritis|osteoarthritis
5226412|NCT00721994|avascular necrosis|avascular necrosis
5226413|NCT00721994|rheumatoid arthritis|rheumatoid arthritis
5226414|NCT00721981|patient preference|patient preference
5226415|NCT00721981|oncology|oncology
5226416|NCT00721981|chemotherapy|chemotherapy
5226417|NCT00721981|NSCLC|nsclc
5226418|NCT00721968|Open angle|open angle
5226419|NCT00721968|Glaucoma|glaucoma
5226420|NCT00721968|Cataract|cataract
5226421|NCT00721968|Surgery|surgery
5226422|NCT00721955|Bipolar 1 disorder,|bipolar 1 disorder,
5226423|NCT00721955|agitation,|agitation,
5226424|NCT00721955|acute,|acute,
5226425|NCT00721955|treatment|treatment
5226426|NCT00721929|adrenal glands, adrenal masses|adrenal glands, adrenal masses
5226427|NCT00721890|chemoprevention|chemoprevention
5226428|NCT00721890|green tea|green tea
5226429|NCT00721890|relapse free-survival|relapse free-survival
5226430|NCT00721890|proteases|proteases
5226431|NCT00721864|Paroxysmal Nocturnal Hemoglobinuria|paroxysmal nocturnal hemoglobinuria
5226432|NCT00721864|PIG-A Mutation|pig-a mutation
5226433|NCT00721864|Prion Protein|prion protein
5226434|NCT00721864|Hematopoietic stem cells|hematopoietic stem cells
5226435|NCT00721864|Clonal disorder|clonal disorder
5226436|NCT00721838|adolescent obesity|adolescent obesity
5226437|NCT00721838|eating behavior|eating behavior
5226438|NCT00721838|dietary intake|dietary intake
5226439|NCT00721825|Stroke|stroke
5226440|NCT00721825|Cerebral infarct|cerebral infarct
5226441|NCT00721825|Rehabilitation|rehabilitation
5226442|NCT00721825|Double blind Randomized|double blind randomized
5226443|NCT00721825|Placebo controlled|placebo controlled
5226444|NCT00721825|Traditional Chinese Medicine|traditional chinese medicine
5226445|NCT00721825|Neuroaid|neuroaid
5226446|NCT00721812|pharmacokinetics|pharmacokinetics
5226447|NCT00721812|Phase 1|phase 1
5226448|NCT00721812|first time in humans|first time in humans
5226449|NCT00721812|IBD|ibd
5226450|NCT00721812|safety|safety
5226451|NCT00721812|human volunteers|human volunteers
5226452|NCT00721799|Positron-Emission Tomography|positron-emission tomography
5226453|NCT00721799|radiation therapy|radiation therapy
5226454|NCT00721799|cisplatin|cisplatin
5226455|NCT00721799|chemotherapy|chemotherapy
5226456|NCT00721799|FLT|flt
5226457|NCT00721786|Smoking cessation|smoking cessation
5226458|NCT00721786|Cigarette smoking|cigarette smoking
5226459|NCT00721786|Tobacco smoking|tobacco smoking
5226460|NCT00721786|Internet interventions|internet interventions
5226461|NCT00721786|Spanish-speaking|spanish-speaking
5226462|NCT00721773|Continuous Ambulatory Peritoneal Dialysis|continuous ambulatory peritoneal dialysis
5226463|NCT00721773|Angiotensin-converting Enzyme Inhibitor|angiotensin-converting enzyme inhibitor
5226464|NCT00721773|Angiotensin II Receptor Blocker|angiotensin ii receptor blocker
5226465|NCT00721773|Renin angiotensin system inhibitor|renin angiotensin system inhibitor
5226466|NCT00721773|Residual Renal Function|residual renal function
5226467|NCT00721760|Hip fractures|hip fractures
5226468|NCT00721760|Heparin Low-Molecular-Weight|heparin low-molecular-weight
5226469|NCT00721760|Randomized Controlled Trial|randomized controlled trial
5226470|NCT00721747|breast cancer patients her2 negative pathological responses|breast cancer patients her2 negative pathological responses
5226471|NCT00721734|Myeloma|myeloma
5226472|NCT00721734|Renal Insufficiency|renal insufficiency
5226473|NCT00721734|Proteasome|proteasome
5226474|NCT00721734|Hematological|hematological
5226475|NCT00721734|carfilzomib|carfilzomib
5226476|NCT00721734|PR-171|pr-171
5226477|NCT00721721|Dietary Sodium|dietary sodium
5226478|NCT00721721|Dietary Potassium|dietary potassium
5226479|NCT00721721|Genes|genes
5226480|NCT00721721|Genomics|genomics
5226481|NCT00721708|histidine dipeptides|histidine dipeptides
5226482|NCT00721708|carnosine|carnosine
5226483|NCT00721708|anserine|anserine
5226484|NCT00721695|Cataract|cataract
5226485|NCT00721695|Cataract Extraction|cataract extraction
5226486|NCT00721695|Lens Implantation|lens implantation
5226487|NCT00721695|Phacoemulsification|phacoemulsification
5226488|NCT00721682|Pediatry|pediatry
5226489|NCT00721682|Ill-treatment|ill-treatment
5226490|NCT00721682|Pain|pain
5226491|NCT00721682|maltreated children|maltreated children
5226492|NCT00721669|solid tumor|solid tumor
5226493|NCT00721656|Dry eye syndromes|dry eye syndromes
5226494|NCT00721656|Corneal diseases|corneal diseases
5226495|NCT00721656|Conjunctival Diseases|conjunctival diseases
5226496|NCT00721643|Angelica keiskei|angelica keiskei
5226497|NCT00721643|absorption kinetics|absorption kinetics
5226498|NCT00721643|quercetin|quercetin
5226499|NCT00721630|CAPECITABINE|capecitabine
5226500|NCT00721630|LAPATINIB|lapatinib
5226501|NCT00721604|shock|shock
5226502|NCT00721604|fluid responsiveness|fluid responsiveness
5226503|NCT00721604|volume expansion|volume expansion
5226504|NCT00721591|Recurrent Pregnancy Loss|recurrent pregnancy loss
5226505|NCT00721591|Habitual abortion|habitual abortion
5226506|NCT00721591|Fetal demise|fetal demise
5226507|NCT00721591|Antiphospholipid antibodies|antiphospholipid antibodies
5226508|NCT00721591|Inherited thrombophilia|inherited thrombophilia
5226509|NCT00721578|Observational study|observational study
5226510|NCT00721578|Effectiveness|effectiveness
5226511|NCT00721578|Safety|safety
5226512|NCT00721578|Tolerability|tolerability
5226513|NCT00721578|Systemic Fungal Infection|systemic fungal infection
5226514|NCT00721565|Breast Cancer|breast cancer
5226515|NCT00721565|Exercise|exercise
5226516|NCT00721565|Social Cognitive Theory|social cognitive theory
5226517|NCT00721565|Adherence|adherence
5226518|NCT00721565|Symptoms|symptoms
5226519|NCT00721565|Body Composition|body composition
5226520|NCT00721552|beta-cell function|beta-cell function
5226521|NCT00721552|glucocorticoid-induced diabetes|glucocorticoid-induced diabetes
5226522|NCT00721552|glucocorticoid|glucocorticoid
5226523|NCT00721552|DPP-4 inhibitors|dpp-4 inhibitors
5226524|NCT00721552|sitagliptin|sitagliptin
5226525|NCT00721552|diabetes mellitus|diabetes mellitus
5226526|NCT00721552|steroid diabetes|steroid diabetes
5226527|NCT00721552|insulin resistance|insulin resistance
5226528|NCT00721552|insulin sensitivity|insulin sensitivity
5226529|NCT00721526|alcohol dependence|alcohol dependence
5226530|NCT00721526|alcoholism|alcoholism
5226531|NCT00721526|anxiety disorder|anxiety disorder
5226532|NCT00721526|pharmacotherapy|pharmacotherapy
5226533|NCT00721526|disulfiram|disulfiram
5226534|NCT00721526|lorazepam|lorazepam
5226535|NCT00721513|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
5226536|NCT00721513|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5226537|NCT00721513|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
5226538|NCT00721513|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5226539|NCT00721513|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
5226540|NCT00721513|stage III verrucous carcinoma of the larynx|stage iii verrucous carcinoma of the larynx
5226541|NCT00721513|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5226542|NCT00721513|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
5226543|NCT00721487|C. albicans|c. albicans
5226544|NCT00721487|fluconazole|fluconazole
5226545|NCT00721461|Assess|assess
5226546|NCT00721461|Tolerability|tolerability
5226547|NCT00721461|MedPulser DDS device|medpulser dds device
5226548|NCT00721448|Pharmacokinetics|pharmacokinetics
5226549|NCT00721422|Pharmacokinetics of PD 0332334 in subjects with renal insufficiency|pharmacokinetics of pd 0332334 in subjects with renal insufficiency
5226550|NCT00721409|hormone-receptor positive advanced breast cancer|hormone-receptor positive advanced breast cancer
5226551|NCT00721396|Meningococcal disease,|meningococcal disease,
5226552|NCT00721396|Neisseria meningitidis serogroup B,|neisseria meningitidis serogroup b,
5226553|NCT00721396|Prevention,|prevention,
5226554|NCT00721396|Vaccination,|vaccination,
5226555|NCT00721396|Infants|infants
5226556|NCT00721383|caregiving, Alzheimer's disease, physical activity|caregiving, alzheimer's disease, physical activity
5226557|NCT00721370|sentinel lymph node mapping|sentinel lymph node mapping
5226558|NCT00721370|breast cancer|breast cancer
5226559|NCT00721370|near infrared imaging|near infrared imaging
5226560|NCT00721357|muscles|muscles
5226561|NCT00721357|work|work
5226562|NCT00721357|Magnetic Resonance Imaging|magnetic resonance imaging
5226563|NCT00721357|control groups|control groups
5226564|NCT00721344|Healthy males and females|healthy males and females
5226565|NCT00721331|CombinatoRx|combinatorx
5226566|NCT00721331|Atopic|atopic
5226567|NCT00721331|Dermatitis|dermatitis
5226568|NCT00721331|Topical|topical
5226569|NCT00721331|CRx-197|crx-197
5226570|NCT00721331|Normal Healthy Volunteers|normal healthy volunteers
5226571|NCT00721318|chronic widespread pain|chronic widespread pain
5226572|NCT00721318|fibromyalgia|fibromyalgia
5226573|NCT00721318|rheumatoid arthritis|rheumatoid arthritis
5226574|NCT00721318|Estonia|estonia
5226575|NCT00721305|Type 1 human immunodeficiency virus infection|type 1 human immunodeficiency virus infection
5226576|NCT00721305|Lovastatin|lovastatin
5226577|NCT00721305|Adaptive Immunity|adaptive immunity
5226578|NCT00721305|Cellular cholesterol|cellular cholesterol
5226579|NCT00721305|Rho GTPases|rho gtpases
5226580|NCT00721305|Lymphocyte function-associated antigen-1|lymphocyte function-associated antigen-1
5226581|NCT00721253|ReSTOR|restor
5226582|NCT00721240|responder|responder
5226583|NCT00721240|leucotriene antagonist|leucotriene antagonist
5226584|NCT00721214|Myelodysplastic Syndrome|myelodysplastic syndrome
5226585|NCT00721214|5-azacytidine|5-azacytidine
5226586|NCT00721214|allogeneic stem cell transplantation|allogeneic stem cell transplantation
5226587|NCT00721201|subclinical Cushing's|subclinical cushing's
5226588|NCT00721175|biliary stent|biliary stent
5226589|NCT00721175|plastic stent|plastic stent
5226590|NCT00721175|metallic stent|metallic stent
5226591|NCT00721175|Complex hilar cholangiocarcinoma (Bismuth type II,III,IV)|complex hilar cholangiocarcinoma (bismuth type ii,iii,iv)
5226592|NCT00721162|Ovarian Cancer,|ovarian cancer,
5226593|NCT00721162|Fallopian Tube Cancer|fallopian tube cancer
5226594|NCT00721162|Primary Peritoneal Carcinoma|primary peritoneal carcinoma
5226595|NCT00721149|Atrial Fibrillation|atrial fibrillation
5226596|NCT00721149|Paroxysmal Atrial Fibrillation|paroxysmal atrial fibrillation
5226597|NCT00721149|Ablation|ablation
5226598|NCT00721149|Non-randomized|non-randomized
5226599|NCT00721136|bleeding|bleeding
5226600|NCT00721136|anticoagulation|anticoagulation
5226601|NCT00721136|pacemaker|pacemaker
5226602|NCT00721136|implantable cardioverter-defibrillator|implantable cardioverter-defibrillator
5226603|NCT00721136|"patients undergoing implantation of a pacemaker or defibrillator (ICD)"|"patients undergoing implantation of a pacemaker or defibrillator (icd)"
5226604|NCT00721110|pain control|pain control
5226605|NCT00721110|nausea|nausea
5226606|NCT00721110|surgery recovery|surgery recovery
5226607|NCT00721097|Severe asthma|severe asthma
5226608|NCT00721097|exacerbation|exacerbation
5226609|NCT00721097|predictive factors|predictive factors
5226610|NCT00721097|Severe|severe
5226611|NCT00721084|short sleep duration|short sleep duration
5226612|NCT00721084|maximal aerobic capacity|maximal aerobic capacity
5226613|NCT00721084|body fat|body fat
5226614|NCT00721084|visceral adiposity|visceral adiposity
5226615|NCT00721084|activity-related energy expenditure|activity-related energy expenditure
5226616|NCT00721084|energy metabolism|energy metabolism
5226617|NCT00721071|Pediatrics|pediatrics
5226618|NCT00721071|Cystic Fibrosis|cystic fibrosis
5226619|NCT00721071|Hypertonic Saline|hypertonic saline
5226620|NCT00721071|Induced Sputum|induced sputum
5226621|NCT00721071|Expectorated Sputum|expectorated sputum
5226622|NCT00721058|Eligible|eligible
5226623|NCT00721058|Operable|operable
5226624|NCT00721058|Disease|disease
5226625|NCT00721058|Conserving|conserving
5226626|NCT00721058|Therapy|therapy
5226627|NCT00721058|Visible mass on mammography|visible mass on mammography
5226628|NCT00721058|Ultrasound > 0.5 cm|ultrasound > 0.5 cm
5226629|NCT00721058|Histologically|histologically
5226630|NCT00721058|Proven|proven
5226631|NCT00721045|Heart Failure|heart failure
5226632|NCT00721045|Congestive Heart Failure|congestive heart failure
5226633|NCT00721032|Ventricular tachycardia (VT)|ventricular tachycardia (vt)
5226634|NCT00721032|Implantable cardioverter-defibrillator (ICD)|implantable cardioverter-defibrillator (icd)
5226635|NCT00721032|Ablation|ablation
5226636|NCT00721032|Cardiomyopathy|cardiomyopathy
5226637|NCT00721032|Electrophysiology study|electrophysiology study
5226638|NCT00721019|short sleep duration|short sleep duration
5226639|NCT00721019|glucose clamp technique|glucose clamp technique
5226640|NCT00721019|insulin secretion|insulin secretion
5226641|NCT00721019|insulin action|insulin action
5226642|NCT00721019|lipid turnover|lipid turnover
5226643|NCT00721019|free fatty acids|free fatty acids
5226644|NCT00721006|peripheral artery disease|peripheral artery disease
5226645|NCT00721006|peripheral vascular disease|peripheral vascular disease
5226646|NCT00721006|PAD|pad
5226647|NCT00721006|PVD|pvd
5226648|NCT00720993|Colorectal cancer screening|colorectal cancer screening
5226649|NCT00720993|Gene expression|gene expression
5226650|NCT00720993|RTPCR|rtpcr
5226651|NCT00720980|granuloma annulare, ROM|granuloma annulare, rom
5226652|NCT00720967|Renal dysfunction|renal dysfunction
5226653|NCT00720967|Hemodialysis|hemodialysis
5226654|NCT00720967|Modified ultrafiltration|modified ultrafiltration
5226655|NCT00720967|Open heart surgery|open heart surgery
5226656|NCT00720954|Thoracoscopy|thoracoscopy
5226657|NCT00720954|Pleural needle biopsy|pleural needle biopsy
5226658|NCT00720954|Malignant pleural diseases|malignant pleural diseases
5226659|NCT00720954|Mesothelioma|mesothelioma
5226660|NCT00720954|Diagnosis|diagnosis
5226661|NCT00720954|Pleurisy tuberculosis|pleurisy tuberculosis
5226662|NCT00720954|Patients with pleural diseases and pleural effusion should have been included in the study.|patients with pleural diseases and pleural effusion should have been included in the study.
5226663|NCT00720941|SUTENT|sutent
5226664|NCT00720941|Locally advanced and/or metastatic renal cell carcinoma|locally advanced and/or metastatic renal cell carcinoma
5226665|NCT00720941|Pazopanib|pazopanib
5226666|NCT00720941|Sunitinib|sunitinib
5226667|NCT00720941|GW786034|gw786034
5226668|NCT00720941|Renal cell carcinoma|renal cell carcinoma
5226669|NCT00720928|Behcet's disease|behcet's disease
5226670|NCT00720928|posterior uveitis|posterior uveitis
5226671|NCT00720928|flucinolone acetonide|flucinolone acetonide
5226672|NCT00720928|RETISERT|retisert
5226673|NCT00720915|unprovoked deep vein thrombosis|unprovoked deep vein thrombosis
5226674|NCT00720915|unprovoked pulmonary embolism|unprovoked pulmonary embolism
5226675|NCT00720915|anticoagulant therapy|anticoagulant therapy
5226676|NCT00720889|short sleep duration|short sleep duration
5226677|NCT00720889|glucose clamp technique|glucose clamp technique
5226678|NCT00720889|insulin secretion|insulin secretion
5226679|NCT00720889|insulin action|insulin action
5226680|NCT00720889|lipid turnover|lipid turnover
5226681|NCT00720889|free fatty acids|free fatty acids
5226682|NCT00720876|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
5226683|NCT00720876|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
5226684|NCT00720876|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
5226685|NCT00720876|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5226686|NCT00720876|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5226687|NCT00720876|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5226688|NCT00720876|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5226689|NCT00720876|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5226690|NCT00720876|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5226691|NCT00720876|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
5226692|NCT00720876|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
5226693|NCT00720876|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
5226694|NCT00720876|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5226695|NCT00720876|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5226696|NCT00720876|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5226697|NCT00720876|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5226698|NCT00720876|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5226699|NCT00720876|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5226700|NCT00720876|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
5226822|NCT00720538|Ulcerative, colitis.|ulcerative, colitis.
5226701|NCT00720876|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5226702|NCT00720876|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5226703|NCT00720876|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
5226704|NCT00720876|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5226705|NCT00720876|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5226706|NCT00720876|stage I marginal zone lymphoma|stage i marginal zone lymphoma
5226707|NCT00720876|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5226708|NCT00720876|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5226709|NCT00720876|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
5226710|NCT00720876|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5226711|NCT00720876|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5226712|NCT00720876|stage I mantle cell lymphoma|stage i mantle cell lymphoma
5226713|NCT00720876|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5226714|NCT00720876|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5226716|NCT00720850|AML|aml
5226717|NCT00720850|Lenalidomide|lenalidomide
5226719|NCT00720850|monosomy del5q|monosomy del5q
5226720|NCT00720837|Brain Tumor|brain tumor
5226721|NCT00720837|Brain Cancer|brain cancer
5226722|NCT00720837|MR-guided laser thermal ablation of brain tumors|mr-guided laser thermal ablation of brain tumors
5226723|NCT00720837|Visualase® Thermal Therapy System|visualase® thermal therapy system
5226724|NCT00720837|Magnetic Resonance Thermal Imaging|magnetic resonance thermal imaging
5226725|NCT00720837|MRTI|mrti
5226726|NCT00720837|Visualase Cooled Laser Application System|visualase cooled laser application system
5226727|NCT00720837|Laser Interstitial Thermal Therapy|laser interstitial thermal therapy
5226728|NCT00720837|LITT|litt
5226729|NCT00720824|Immunizations|immunizations
5226730|NCT00720824|Children|children
5226731|NCT00720824|Injections|injections
5226732|NCT00720824|aged 4-6 Years|aged 4-6 years
5226733|NCT00720824|Hypnosis|hypnosis
5226734|NCT00720811|Malaria ACT|malaria act
5226735|NCT00720811|Rapid|rapid
5226736|NCT00720811|Diagnosis|diagnosis
5226737|NCT00720811|Community|community
5226738|NCT00720811|health|health
5226739|NCT00720811|worker|worker
5226740|NCT00720811|Artemesinin|artemesinin
5226741|NCT00720811|based|based
5226742|NCT00720811|Combination|combination
5226743|NCT00720811|Therapy|therapy
5226744|NCT00720811|Anti Malarial|anti malarial
5226745|NCT00720811|Treatment|treatment
5226746|NCT00720811|antibiotics|antibiotics
5226747|NCT00720785|Metastatic Solid Tumor|metastatic solid tumor
5226748|NCT00720785|Chronic Myelogenous Leukemia (CML)|chronic myelogenous leukemia (cml)
5226749|NCT00720785|Small Lymphocytic Lymphoma (SLL)|small lymphocytic lymphoma (sll)
5226750|NCT00720785|Chronic Lymphocytic Leukemia (CLL)|chronic lymphocytic leukemia (cll)
5226751|NCT00720785|Multiple Myeloma|multiple myeloma
5226752|NCT00720785|Lung Cancer|lung cancer
5226753|NCT00720785|Prostate Cancer|prostate cancer
5226754|NCT00720785|Colon Cancer|colon cancer
5226755|NCT00720785|Kidney Cancer|kidney cancer
5226756|NCT00720785|Pancreatic Cancer|pancreatic cancer
5226757|NCT00720785|Leukemia|leukemia
5226758|NCT00720785|Chronic Myelogenous Leukemia|chronic myelogenous leukemia
5226759|NCT00720785|CML|cml
5226760|NCT00720785|Small Lymphocytic Lymphoma|small lymphocytic lymphoma
5226761|NCT00720785|SLL|sll
5226762|NCT00720785|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
5226763|NCT00720785|CLL|cll
5226764|NCT00720772|coronary calcification|coronary calcification
5226765|NCT00720772|vascular calcification|vascular calcification
5226766|NCT00720772|sodium thiosulfate|sodium thiosulfate
5226767|NCT00720759|stroke|stroke
5226768|NCT00720759|hemiparesis|hemiparesis
5226769|NCT00720759|randomized controlled trial|randomized controlled trial
5226770|NCT00720759|d-cycloserine|d-cycloserine
5226771|NCT00720759|distributed practice|distributed practice
5226772|NCT00720759|constraint induced movement therapy|constraint induced movement therapy
5226773|NCT00720733|HIV|hiv
5226774|NCT00720733|Mood|mood
5226775|NCT00720733|Emotion|emotion
5226776|NCT00720733|Coping|coping
5226777|NCT00720733|Aids|aids
5226778|NCT00720733|Affect|affect
5226779|NCT00720733|Adults|adults
5226780|NCT00720733|Diagnosed|diagnosed
5226781|NCT00720707|Coronally advanced flap|coronally advanced flap
5226782|NCT00720707|gingival recession|gingival recession
5226783|NCT00720707|enamel matrix protein|enamel matrix protein
5226784|NCT00720707|acellular dermal matrix|acellular dermal matrix
5226785|NCT00720707|root coverage|root coverage
5226786|NCT00720668|hepatitis B|hepatitis b
5226787|NCT00720668|hepatocellular carcinoma|hepatocellular carcinoma
5226788|NCT00720668|radiofrequency ablation|radiofrequency ablation
5226789|NCT00720668|reactivation|reactivation
5226790|NCT00720655|coronary heart disease|coronary heart disease
5226791|NCT00720629|graft versus host disease|graft versus host disease
5226792|NCT00720629|GVHD|gvhd
5226793|NCT00720629|allogeneic transplant|allogeneic transplant
5226794|NCT00720629|GVHD prevention|gvhd prevention
5226795|NCT00720629|unrelated donors|unrelated donors
5226796|NCT00720629|mismatched unrelated donors|mismatched unrelated donors
5226797|NCT00720629|hematological malignancies|hematological malignancies
5226798|NCT00720629|Leukemia|leukemia
5226799|NCT00720629|Lymphoma|lymphoma
5226800|NCT00720629|Myelodysplastic Syndrome|myelodysplastic syndrome
5226801|NCT00720629|Myelofibrosis|myelofibrosis
5226802|NCT00720629|Aplastic Anemia|aplastic anemia
5226803|NCT00720629|Multiple Myeloma|multiple myeloma
5226804|NCT00720616|Growth hormone|growth hormone
5226805|NCT00720616|Metabolic syndrome|metabolic syndrome
5226806|NCT00720616|Insulin sensitivity|insulin sensitivity
5226807|NCT00720603|Autologous Stem Cell Transplant|autologous stem cell transplant
5226808|NCT00720577|Peripheral Arterial Disease|peripheral arterial disease
5226809|NCT00720577|PAD|pad
5226810|NCT00720577|Lower extremity peripheral arterial atherosclerotic plaque|lower extremity peripheral arterial atherosclerotic plaque
5226811|NCT00720577|RNA Expression|rna expression
5226812|NCT00720577|Lipid Biomarkers|lipid biomarkers
5226813|NCT00720564|adult glioblastoma|adult glioblastoma
5226814|NCT00720564|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5226815|NCT00720564|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
5226816|NCT00720564|adult gliosarcoma|adult gliosarcoma
5226817|NCT00720564|adult mixed glioma|adult mixed glioma
5226818|NCT00720551|STISIM|stisim
5226819|NCT00720551|Alcohol|alcohol
5226820|NCT00720538|Inflammatory bowel diseases.|inflammatory bowel diseases.
5226821|NCT00720538|Crohn disease.|crohn disease.
5226823|NCT00720538|Randomised controlled trial.|randomised controlled trial.
5226824|NCT00720538|Therapy.|therapy.
5226825|NCT00720538|Thalidomide.|thalidomide.
5226826|NCT00720538|Children.|children.
5226827|NCT00720525|arterial stiffness|arterial stiffness
5226828|NCT00720525|arterial wave reflections|arterial wave reflections
5226829|NCT00720525|diastolic heart failure|diastolic heart failure
5226830|NCT00720512|adenocarcinoma of the colon|adenocarcinoma of the colon
5226831|NCT00720512|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5226832|NCT00720512|recurrent colon cancer|recurrent colon cancer
5226833|NCT00720512|recurrent rectal cancer|recurrent rectal cancer
5226834|NCT00720512|stage IV colon cancer|stage iv colon cancer
5226835|NCT00720512|stage IV rectal cancer|stage iv rectal cancer
5226836|NCT00720512|stage III rectal cancer|stage iii rectal cancer
5226837|NCT00720512|stage III colon cancer|stage iii colon cancer
5226838|NCT00720473|Bipolar depression|bipolar depression
5226839|NCT00720473|Elderly|elderly
5226840|NCT00720473|Lamotrigine|lamotrigine
5226841|NCT00720473|Brain energy metabolism|brain energy metabolism
5226842|NCT00720460|Magnetic Resonance Imaging|magnetic resonance imaging
5226843|NCT00720460|Minimally Invasive Therapy|minimally invasive therapy
5226844|NCT00720460|Transcatheter Therapeutics|transcatheter therapeutics
5226845|NCT00720460|Healthy Volunteers|healthy volunteers
5226846|NCT00720460|Gadolinium Contrast|gadolinium contrast
5226847|NCT00720460|Healthy Volunteer|healthy volunteer
5226848|NCT00720460|HV|hv
5226849|NCT00720447|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5226850|NCT00720447|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5226851|NCT00720421|Phase I|phase i
5226852|NCT00720421|pharmacodynamic study|pharmacodynamic study
5226853|NCT00720408|Immunosuppressant|immunosuppressant
5226854|NCT00720408|Graft loss|graft loss
5226855|NCT00720408|Combination drug therapy|combination drug therapy
5226856|NCT00720408|Randomized controlled trial|randomized controlled trial
5226857|NCT00720408|Open level method|open level method
5226858|NCT00720395|Psychiatry|psychiatry
5226859|NCT00720395|Pregnancy|pregnancy
5226860|NCT00720369|Bipolar depression|bipolar depression
5226861|NCT00720369|elderly|elderly
5226862|NCT00720369|Coenzyme Q10|coenzyme q10
5226863|NCT00720369|Magnetic resonance spectroscopy|magnetic resonance spectroscopy
5226864|NCT00720356|adult glioblastoma|adult glioblastoma
5226865|NCT00720356|adult gliosarcoma|adult gliosarcoma
5226866|NCT00720330|Inguinal Herniorrhaphy|inguinal herniorrhaphy
5226867|NCT00720330|Pain assessment|pain assessment
5226868|NCT00720330|Outcomes|outcomes
5226869|NCT00720317|Diabetic Retinopathy|diabetic retinopathy
5226870|NCT00720317|Sickle Cell Trait|sickle cell trait
5226871|NCT00720317|Vision Loss|vision loss
5226872|NCT00720317|Eye disease|eye disease
5226873|NCT00720304|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
5226874|NCT00720304|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5226875|NCT00720304|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
5226876|NCT00720304|stage III verrucous carcinoma of the larynx|stage iii verrucous carcinoma of the larynx
5226877|NCT00720304|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5226878|NCT00720304|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
5226879|NCT00720304|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
5226880|NCT00720304|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5226881|NCT00720304|stage III verrucous carcinoma of the oral cavity|stage iii verrucous carcinoma of the oral cavity
5226882|NCT00720304|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
5226883|NCT00720304|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
5226884|NCT00720304|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
5226885|NCT00720304|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
5226886|NCT00720304|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
5226887|NCT00720304|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5226888|NCT00720291|Metronidazole|metronidazole
5226889|NCT00720291|BV|bv
5226890|NCT00720291|Pregnancy|pregnancy
5226891|NCT00720265|Organ Transplantation|organ transplantation
5226892|NCT00720265|Tacrolimus|tacrolimus
5226893|NCT00720265|Prograf|prograf
5226894|NCT00720265|FK506MR|fk506mr
5226895|NCT00720226|COPD|copd
5226896|NCT00720226|emphysema|emphysema
5226897|NCT00720226|angiotensin receptor blocker|angiotensin receptor blocker
5226898|NCT00720200|Communication|communication
5226899|NCT00720200|Intensive Care Units|intensive care units
5226900|NCT00720200|Palliative Care|palliative care
5226901|NCT00720200|End-of-Life Issues|end-of-life issues
5226902|NCT00720200|Talking with Your Doctor|talking with your doctor
5226903|NCT00720200|Coping with Chronic Illness|coping with chronic illness
5226977|NCT00719914|Integrilin|integrilin
5226904|NCT00720161|metformin, spina bifida, duchenne, insulin resistance|metformin, spina bifida, duchenne, insulin resistance
5226905|NCT00720148|Solid tumors|solid tumors
5226906|NCT00720122|Bone density|bone density
5226907|NCT00720122|Bone turnover markers|bone turnover markers
5226908|NCT00720122|rhIGF-1|rhigf-1
5226909|NCT00720122|Bone structure|bone structure
5226910|NCT00720122|Anorexia nervosa|anorexia nervosa
5226911|NCT00720096|Persistent Ovarian Cancer|persistent ovarian cancer
5226912|NCT00720096|Genomic directed salvage chemotherapy|genomic directed salvage chemotherapy
5226913|NCT00720096|Genomic Microarray|genomic microarray
5226914|NCT00720083|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
5226915|NCT00720083|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5226916|NCT00720083|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
5226917|NCT00720083|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5226918|NCT00720083|stage III verrucous carcinoma of the oral cavity|stage iii verrucous carcinoma of the oral cavity
5226919|NCT00720083|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
5226920|NCT00720083|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
5226921|NCT00720083|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5226922|NCT00720070|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
5226923|NCT00720070|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
5226924|NCT00720070|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
5226925|NCT00720070|stage I squamous cell carcinoma of the larynx|stage i squamous cell carcinoma of the larynx
5226926|NCT00720070|stage I verrucous carcinoma of the larynx|stage i verrucous carcinoma of the larynx
5226927|NCT00720070|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
5226928|NCT00720070|stage II verrucous carcinoma of the larynx|stage ii verrucous carcinoma of the larynx
5226929|NCT00720070|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
5226930|NCT00720070|stage III verrucous carcinoma of the larynx|stage iii verrucous carcinoma of the larynx
5226931|NCT00720070|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
5226932|NCT00720070|stage I verrucous carcinoma of the oral cavity|stage i verrucous carcinoma of the oral cavity
5226933|NCT00720070|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
5226934|NCT00720070|stage II verrucous carcinoma of the oral cavity|stage ii verrucous carcinoma of the oral cavity
5226935|NCT00720070|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
5226936|NCT00720070|stage III verrucous carcinoma of the oral cavity|stage iii verrucous carcinoma of the oral cavity
5226937|NCT00720070|stage I squamous cell carcinoma of the hypopharynx|stage i squamous cell carcinoma of the hypopharynx
5226938|NCT00720070|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
5226939|NCT00720070|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
5226940|NCT00720070|tongue cancer|tongue cancer
5226941|NCT00720057|Dental Pain|dental pain
5226942|NCT00720057|Analgesia|analgesia
5226943|NCT00720031|Melanoma,|melanoma,
5226944|NCT00720031|Melan-A tumor reactive T cell clones,|melan-a tumor reactive t cell clones,
5226945|NCT00720031|immunotherapy|immunotherapy
5226946|NCT00720031|HLA-A2 melanoma patients with|hla-a2 melanoma patients with
5226947|NCT00720031|either loco-regional or lymphnode metastasis|either loco-regional or lymphnode metastasis
5226948|NCT00720031|transit nodules not surgically resectable|transit nodules not surgically resectable
5226949|NCT00720031|-measurable cutaneous or visceral metastasis .|-measurable cutaneous or visceral metastasis .
5226950|NCT00720031|Patients' tumor express Melan-A/MART-1 antigen.|patients' tumor express melan-a/mart-1 antigen.
5226951|NCT00720005|Cataract|cataract
5226952|NCT00720005|cataract extraction|cataract extraction
5226953|NCT00720005|intraocular lens|intraocular lens
5226954|NCT00720005|age related|age related
5226955|NCT00719992|Exercise tolerance test|exercise tolerance test
5226956|NCT00719992|HS-CRP|hs-crp
5226957|NCT00719992|Coronary angiography|coronary angiography
5226958|NCT00719992|Patients|patients
5226959|NCT00719979|Major Depressive Disorder|major depressive disorder
5226960|NCT00719979|Cognitive Behavior Therapy|cognitive behavior therapy
5226961|NCT00719979|Technology Assisted|technology assisted
5226962|NCT00719979|Internet|internet
5226963|NCT00719979|Primary Care|primary care
5226964|NCT00719966|stage IA breast cancer|stage ia breast cancer
5226965|NCT00719966|stage IB breast cancer|stage ib breast cancer
5226966|NCT00719966|stage II breast cancer|stage ii breast cancer
5226967|NCT00719966|stage IIIA breast cancer|stage iiia breast cancer
5226968|NCT00719966|stage IIIB breast cancer|stage iiib breast cancer
5226969|NCT00719966|stage IIIC breast cancer|stage iiic breast cancer
5226970|NCT00719966|stage IV breast cancer|stage iv breast cancer
5226971|NCT00719966|ductal breast carcinoma in situ|ductal breast carcinoma in situ
5226972|NCT00719953|Cognitex|cognitex
5226973|NCT00719953|subjects|subjects
5226974|NCT00719940|tinnitus, cognitive behavioral therapy, CBT|tinnitus, cognitive behavioral therapy, cbt
5226975|NCT00719927|Social Support|social support
5226976|NCT00719914|eptifibatide|eptifibatide
5226978|NCT00719914|ST-Elevation Myocardial Infarction|st-elevation myocardial infarction
5226979|NCT00719914|Acute Myocardial Infarction|acute myocardial infarction
5226980|NCT00719849|chronic myelogenous leukemia|chronic myelogenous leukemia
5226981|NCT00719849|acute lymphoblastic leukemia|acute lymphoblastic leukemia
5226982|NCT00719849|acute myeloid leukemia|acute myeloid leukemia
5226983|NCT00719849|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
5226984|NCT00719849|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5226985|NCT00719849|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5226986|NCT00719849|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5226987|NCT00719849|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5226988|NCT00719849|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5226989|NCT00719849|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5226990|NCT00719849|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5226991|NCT00719849|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
5226992|NCT00719849|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5226993|NCT00719849|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5226994|NCT00719849|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5226995|NCT00719849|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5226996|NCT00719849|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5226997|NCT00719849|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5226998|NCT00719849|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5226999|NCT00719849|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
5227000|NCT00719849|childhood diffuse large cell lymphoma|childhood diffuse large cell lymphoma
5227001|NCT00719849|childhood immunoblastic large cell lymphoma|childhood immunoblastic large cell lymphoma
5227002|NCT00719849|refractory multiple myeloma|refractory multiple myeloma
5227003|NCT00719849|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5227004|NCT00719849|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5227005|NCT00719849|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5227006|NCT00719849|myelodysplastic/myeloproliferative disease|myelodysplastic/myeloproliferative disease
5227007|NCT00719849|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
5227008|NCT00719849|recurrent childhood anaplastic large cell lymphoma|recurrent childhood anaplastic large cell lymphoma
5227009|NCT00719849|refractory anemia|refractory anemia
5227010|NCT00719849|refractory anemia with excess blasts|refractory anemia with excess blasts
5227011|NCT00719849|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
5227012|NCT00719849|refractory cytopenia with multilineage dysplasia|refractory cytopenia with multilineage dysplasia
5227013|NCT00719849|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5227014|NCT00719849|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5227015|NCT00719849|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5227016|NCT00719849|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5227017|NCT00719849|stage III childhood anaplastic large cell lymphoma|stage iii childhood anaplastic large cell lymphoma
5227018|NCT00719849|stage III childhood large cell lymphoma|stage iii childhood large cell lymphoma
5227019|NCT00719849|stage IV childhood anaplastic large cell lymphoma|stage iv childhood anaplastic large cell lymphoma
5227020|NCT00719849|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
5227021|NCT00719849|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5227022|NCT00719849|stage III childhood Hodgkin lymphoma|stage iii childhood hodgkin lymphoma
5227023|NCT00719849|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5227024|NCT00719849|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
5227025|NCT00719849|stage II multiple myeloma|stage ii multiple myeloma
5227026|NCT00719849|stage III multiple myeloma|stage iii multiple myeloma
5227027|NCT00719849|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5227028|NCT00719849|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5227029|NCT00719849|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5227030|NCT00719849|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5227031|NCT00719849|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5227032|NCT00719849|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5227033|NCT00719849|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5227034|NCT00719849|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5227035|NCT00719849|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5227036|NCT00719849|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5227037|NCT00719849|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5227038|NCT00719849|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5227039|NCT00719849|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
5227040|NCT00719849|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5227041|NCT00719849|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5227042|NCT00719849|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
5227043|NCT00719849|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
5227044|NCT00719849|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
5227045|NCT00719849|chronic eosinophilic leukemia|chronic eosinophilic leukemia
5227046|NCT00719849|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
5227047|NCT00719849|chronic neutrophilic leukemia|chronic neutrophilic leukemia
5227048|NCT00719849|essential thrombocythemia|essential thrombocythemia
5227049|NCT00719849|polycythemia vera|polycythemia vera
5227050|NCT00719836|SB1518|sb1518
5227051|NCT00719836|Chronic Idiopathic Myelofibrosis|chronic idiopathic myelofibrosis
5227052|NCT00719836|JAK2 Inhibitor|jak2 inhibitor
5227053|NCT00719823|Maraviroc Compassionate Use|maraviroc compassionate use
5227054|NCT00719810|complicated|complicated
5227055|NCT00719810|skin|skin
5227056|NCT00719797|stage IV rectal cancer|stage iv rectal cancer
5227057|NCT00719797|stage IV colon cancer|stage iv colon cancer
5227058|NCT00719797|stage III rectal cancer|stage iii rectal cancer
5227059|NCT00719797|stage III colon cancer|stage iii colon cancer
5227060|NCT00719784|Respiratory|respiratory
5227061|NCT00719784|Pulmonary|pulmonary
5227062|NCT00719784|Thoracic|thoracic
5227063|NCT00719784|Chest|chest
5227064|NCT00719784|Lung|lung
5227065|NCT00719771|Osteoarthritis|osteoarthritis
5227066|NCT00719771|Glenohumeral joint|glenohumeral joint
5227067|NCT00719771|Glenoid|glenoid
5227068|NCT00719771|Shoulder arthroplasty|shoulder arthroplasty
5227069|NCT00719758|TRK-100STP,|trk-100stp,
5227070|NCT00719758|beraprost sodium,|beraprost sodium,
5227071|NCT00719758|Careload LA|careload la
5227072|NCT00719758|AST-120|ast-120
5227073|NCT00719758|Spherical carbon adsorbent|spherical carbon adsorbent
5227074|NCT00719758|Drug-drug interaction|drug-drug interaction
5227075|NCT00719745|Organ transplantation|organ transplantation
5227076|NCT00719745|Tacrolimus|tacrolimus
5227077|NCT00719745|Prograf|prograf
5227079|NCT00719732|ReSTOR Aspheric +3 IOL|restor aspheric +3 iol
5227080|NCT00719719|Mast Cell|mast cell
5227081|NCT00719719|Tryptase|tryptase
5227082|NCT00719719|Bone Marrow|bone marrow
5227083|NCT00719719|Hives|hives
5227084|NCT00719719|Adult|adult
5227085|NCT00719719|Anaphylaxis|anaphylaxis
5227086|NCT00719706|Bipolar disorder|bipolar disorder
5227087|NCT00719706|Bipolar depression|bipolar depression
5227088|NCT00719706|Natural substances|natural substances
5227089|NCT00719706|Depression|depression
5227090|NCT00719693|Food effect, phase I|food effect, phase i
5227091|NCT00719693|adverse events|adverse events
5227092|NCT00719680|CVID|cvid
5227093|NCT00719680|XLA|xla
5227094|NCT00719667|OPCAB|opcab
5227095|NCT00719667|coronary|coronary
5227096|NCT00719667|bypass|bypass
5227097|NCT00719667|grafting|grafting
5227098|NCT00719667|off pump|off pump
5227099|NCT00719654|Preeclampsia|preeclampsia
5227100|NCT00719654|Proteome|proteome
5227101|NCT00719654|Pregnancy|pregnancy
5227102|NCT00719641|Colonoscopy|colonoscopy
5227103|NCT00719641|Looping|looping
5227104|NCT00719641|Prevent Looping|prevent looping
5227105|NCT00719641|Colon Cancer Screening|colon cancer screening
5227106|NCT00719641|Segmental Stiffening Wire|segmental stiffening wire
5227107|NCT00719628|Postoperative|postoperative
5227108|NCT00719628|Cognitive|cognitive
5227109|NCT00719628|Dysfunction|dysfunction
5227110|NCT00719615|Thyroid Cancer|thyroid cancer
5227111|NCT00719615|Thyroid Nodules|thyroid nodules
5227112|NCT00719615|Vitamin D|vitamin d
5227113|NCT00719602|Coinfection|coinfection
5227114|NCT00719589|Voiding Dysfunction|voiding dysfunction
5227115|NCT00719589|Interstim|interstim
5227116|NCT00719576|Cartilage legions|cartilage legions
5227117|NCT00719576|symptomatic focal cartilage defects|symptomatic focal cartilage defects
5227118|NCT00719576|microfracture|microfracture
5227119|NCT00719576|MACI|maci
5227120|NCT00719576|autologous chondrocyte|autologous chondrocyte
5227121|NCT00719563|fatigue|fatigue
5227122|NCT00719563|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5227123|NCT00719563|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5227124|NCT00719563|acute undifferentiated leukemia|acute undifferentiated leukemia
5227125|NCT00719563|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5227126|NCT00719563|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5227127|NCT00719563|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5227128|NCT00719563|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5227129|NCT00719563|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5227130|NCT00719563|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5227131|NCT00719563|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5227132|NCT00719563|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
5227133|NCT00719563|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5227134|NCT00719563|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5227135|NCT00719563|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5227136|NCT00719563|mast cell leukemia|mast cell leukemia
5227137|NCT00719563|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
5227138|NCT00719563|prolymphocytic leukemia|prolymphocytic leukemia
5227139|NCT00719563|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5227140|NCT00719563|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5227141|NCT00719563|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
5227142|NCT00719563|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5227143|NCT00719563|refractory hairy cell leukemia|refractory hairy cell leukemia
5227144|NCT00719563|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5227145|NCT00719563|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5227146|NCT00719563|stage 0 chronic lymphocytic leukemia|stage 0 chronic lymphocytic leukemia
5227147|NCT00719563|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
5227148|NCT00719563|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
5227149|NCT00719563|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
5227150|NCT00719563|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
5227151|NCT00719563|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
5227152|NCT00719563|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5227153|NCT00719563|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
5227154|NCT00719563|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5227155|NCT00719563|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
5227156|NCT00719563|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
5227157|NCT00719563|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5227158|NCT00719563|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
5227159|NCT00719563|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
5227160|NCT00719563|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5227161|NCT00719563|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5227162|NCT00719563|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5227163|NCT00719563|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
5227164|NCT00719563|cutaneous B-cell non-Hodgkin lymphoma|cutaneous b-cell non-hodgkin lymphoma
5227165|NCT00719563|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5227166|NCT00719563|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
5227167|NCT00719563|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
5227168|NCT00719563|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
5227169|NCT00719563|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
5227170|NCT00719563|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5227171|NCT00719563|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
5227172|NCT00719563|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
5227173|NCT00719563|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
5227174|NCT00719563|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
5227175|NCT00719563|adult grade III lymphomatoid granulomatosis|adult grade iii lymphomatoid granulomatosis
5227176|NCT00719563|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
5227177|NCT00719563|Waldenström macroglobulinemia|waldenström macroglobulinemia
5227178|NCT00719563|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5227179|NCT00719563|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5227180|NCT00719563|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5227181|NCT00719563|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
5227182|NCT00719563|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
5227183|NCT00719563|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
5227184|NCT00719563|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
5227185|NCT00719563|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
5227186|NCT00719563|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
5227187|NCT00719563|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
5227188|NCT00719563|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
5227189|NCT00719563|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
5227190|NCT00719563|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
5227191|NCT00719563|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
5227192|NCT00719563|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
5227193|NCT00719563|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
5227194|NCT00719563|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
5227195|NCT00719563|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
5227196|NCT00719563|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
5227197|NCT00719563|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
5227198|NCT00719563|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
5227199|NCT00719563|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
5227200|NCT00719563|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
5227201|NCT00719563|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
5227202|NCT00719563|stage I mantle cell lymphoma|stage i mantle cell lymphoma
5227203|NCT00719563|stage I marginal zone lymphoma|stage i marginal zone lymphoma
5227204|NCT00719563|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
5227205|NCT00719563|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
5227206|NCT00719563|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5227207|NCT00719563|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
5227208|NCT00719563|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
5227209|NCT00719563|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
5227210|NCT00719563|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
5227211|NCT00719563|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5227212|NCT00719563|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5227213|NCT00719563|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5227214|NCT00719563|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5227215|NCT00719563|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
5227216|NCT00719563|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
5227217|NCT00719563|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5227218|NCT00719563|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5227219|NCT00719563|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5227220|NCT00719563|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5227221|NCT00719563|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5227222|NCT00719563|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5227223|NCT00719563|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5227224|NCT00719563|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5227225|NCT00719563|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5227226|NCT00719563|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5227227|NCT00719563|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5227228|NCT00719563|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5227229|NCT00719563|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5227230|NCT00719563|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5227231|NCT00719563|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5227232|NCT00719563|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5227233|NCT00719563|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5227234|NCT00719563|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5227235|NCT00719563|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5227236|NCT00719563|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5227237|NCT00719563|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5227238|NCT00719563|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5227239|NCT00719563|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5227240|NCT00719563|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5227241|NCT00719563|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5227242|NCT00719563|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5227243|NCT00719563|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5227244|NCT00719563|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5227245|NCT00719563|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
5227246|NCT00719563|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5227247|NCT00719563|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5227248|NCT00719563|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5227249|NCT00719563|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5227250|NCT00719563|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5227251|NCT00719563|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5227252|NCT00719563|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5227253|NCT00719563|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5227254|NCT00719563|intraocular lymphoma|intraocular lymphoma
5227255|NCT00719563|post-transplant lymphoproliferative disorder|post-transplant lymphoproliferative disorder
5227256|NCT00719563|chronic eosinophilic leukemia|chronic eosinophilic leukemia
5227257|NCT00719563|chronic neutrophilic leukemia|chronic neutrophilic leukemia
5227258|NCT00719563|primary myelofibrosis|primary myelofibrosis
5227259|NCT00719563|essential thrombocythemia|essential thrombocythemia
5227260|NCT00719563|polycythemia vera|polycythemia vera
5227261|NCT00719563|extramedullary plasmacytoma|extramedullary plasmacytoma
5227262|NCT00719563|isolated plasmacytoma of bone|isolated plasmacytoma of bone
5227263|NCT00719563|monoclonal gammopathy of undetermined significance|monoclonal gammopathy of undetermined significance
5227264|NCT00719563|stage I multiple myeloma|stage i multiple myeloma
5227265|NCT00719563|stage II multiple myeloma|stage ii multiple myeloma
5227266|NCT00719563|stage III multiple myeloma|stage iii multiple myeloma
5227267|NCT00719563|primary systemic amyloidosis|primary systemic amyloidosis
5227268|NCT00719563|refractory multiple myeloma|refractory multiple myeloma
5227269|NCT00719563|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5227270|NCT00719563|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5227271|NCT00719563|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5227272|NCT00719563|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
5227273|NCT00719550|Locally Advanced|locally advanced
5227274|NCT00719550|Metastatic|metastatic
5227275|NCT00719537|preeclampsia|preeclampsia
5227276|NCT00719537|progesterone|progesterone
5227277|NCT00719537|aspirin|aspirin
5227278|NCT00719537|prevent|prevent
5227279|NCT00719537|soluble fms-like tyrosine kinase (sFlt-1)|soluble fms-like tyrosine kinase (sflt-1)
5227280|NCT00719537|Placental Growth Factor (PlGF)|placental growth factor (plgf)
5227281|NCT00719537|risk|risk
5227282|NCT00719524|Neoplasms|neoplasms
5227283|NCT00719524|Antineoplastic Combined Chemotherapy Protocol|antineoplastic combined chemotherapy protocol
5227284|NCT00719511|Rhinoconjunctivitis|rhinoconjunctivitis
5227285|NCT00719511|Allergic|allergic
5227286|NCT00719498|Epo-alpha|epo-alpha
5227287|NCT00719498|Cardiac arrest|cardiac arrest
5227288|NCT00719498|Mild hypothermia|mild hypothermia
5227289|NCT00719485|lumbar decompression|lumbar decompression
5227290|NCT00719472|Follicular NHL|follicular nhl
5227291|NCT00719472|NHL|nhl
5227292|NCT00719472|Large B-Cell NHL|large b-cell nhl
5227293|NCT00719446|Acute Lung Injury|acute lung injury
5227294|NCT00719433|stroke|stroke
5227295|NCT00719433|chronic|chronic
5227296|NCT00719433|rehabilitation|rehabilitation
5227297|NCT00719433|robot therapy|robot therapy
5227298|NCT00719433|arm therapy|arm therapy
5227299|NCT00719420|Randomized clinical trial|randomized clinical trial
5227300|NCT00719420|Helicobacter pylori|helicobacter pylori
5227301|NCT00719420|clarithromycin|clarithromycin
5227302|NCT00719420|metronidazole|metronidazole
5227303|NCT00719420|amoxicillin|amoxicillin
5227304|NCT00719420|proton pump inhibitor|proton pump inhibitor
5227305|NCT00719420|Colombia|colombia
5227306|NCT00719407|birth asphyxia|birth asphyxia
5227307|NCT00719407|neonatal encephalopathy|neonatal encephalopathy
5227308|NCT00719407|hypoxic-ischemic encephalopathy|hypoxic-ischemic encephalopathy
5227309|NCT00719407|neuroprotection|neuroprotection
5227310|NCT00719407|neonate|neonate
5227311|NCT00719394|alzheimer Disease|alzheimer disease
5227312|NCT00719368|Groin hernia|groin hernia
5227313|NCT00719368|pain|pain
5227314|NCT00719368|chronic|chronic
5227315|NCT00719368|quantitative sensory testing|quantitative sensory testing
5227316|NCT00719368|Persistent postoperative pain|persistent postoperative pain
5227317|NCT00719342|Retinal vessel diameter|retinal vessel diameter
5227318|NCT00719342|Flicker-induced vasodilatation|flicker-induced vasodilatation
5227319|NCT00719342|Optic nerve head blood flow|optic nerve head blood flow
5227320|NCT00719342|Ocular Physiology|ocular physiology
5227321|NCT00719342|Regional Blood Flow|regional blood flow
5227322|NCT00719329|chlorhexidine|chlorhexidine
5227323|NCT00719329|umbilical cord|umbilical cord
5227324|NCT00719316|Renin inhibitor|renin inhibitor
5227325|NCT00719316|Patients|patients
5227326|NCT00719316|ACE inhibitor or ARB|ace inhibitor or arb
5227327|NCT00719316|Chronic Kidney Disease|chronic kidney disease
5227328|NCT00719316|Hypertension|hypertension
5227329|NCT00719290|Primary Angle Closure Glaucoma|primary angle closure glaucoma
5227330|NCT00719290|Phacoemulsification|phacoemulsification
5227331|NCT00719290|Goniosynechialysis|goniosynechialysis
5227332|NCT00719290|Outflow facility|outflow facility
5227333|NCT00719277|cardiac arrhythmia|cardiac arrhythmia
5227334|NCT00719277|syncope|syncope
5227335|NCT00719277|ECG|ecg
5227336|NCT00719277|implantable ECG monitor|implantable ecg monitor
5227337|NCT00719277|ILR|ilr
5227338|NCT00719264|Renal cell carcinoma|renal cell carcinoma
5227339|NCT00719264|Adults|adults
5227340|NCT00719264|Bevacizumab|bevacizumab
5227341|NCT00719264|RAD001|rad001
5227342|NCT00719264|Everolimus|everolimus
5227343|NCT00719264|Interferon|interferon
5227344|NCT00719264|Clear|clear
5227345|NCT00719264|Roferon|roferon
5227346|NCT00719264|Avastin|avastin
5227347|NCT00719264|Nephrectomy|nephrectomy
5227348|NCT00719264|newly diagnosed|newly diagnosed
5227349|NCT00719251|Complications of Diabetes Mellitus|complications of diabetes mellitus
5227350|NCT00719251|Electric stimulation|electric stimulation
5227351|NCT00719251|Low-Level Laser Therapy|low-level laser therapy
5227352|NCT00719199|Colorectal cancer|colorectal cancer
5227353|NCT00719199|metastatic cancer|metastatic cancer
5227354|NCT00719199|prior therapy|prior therapy
5227355|NCT00719199|1b|1b
5227356|NCT00719186|Polycystic Ovary Syndrome|polycystic ovary syndrome
5227357|NCT00719186|Infertility|infertility
5227358|NCT00719186|Pregnancy|pregnancy
5227359|NCT00719186|Women|women
5227360|NCT00719173|nausea and vomiting|nausea and vomiting
5227361|NCT00719173|breast cancer|breast cancer
5227362|NCT00719160|Gastric acid|gastric acid
5227363|NCT00719160|Dietary protein|dietary protein
5227364|NCT00719160|Calcium|calcium
5227365|NCT00719160|Intestinal absorption|intestinal absorption
5227366|NCT00719160|Calcium sensing receptor|calcium sensing receptor
5227367|NCT00719108|Diabetes, Healthy Volunteers|diabetes, healthy volunteers
5227368|NCT00719095|prescription opioid|prescription opioid
5227369|NCT00719095|opioid detoxification|opioid detoxification
5227370|NCT00719095|buprenorphine|buprenorphine
5227371|NCT00719095|naltrexone|naltrexone
5227372|NCT00719095|community reinforcement approach|community reinforcement approach
5227373|NCT00719095|prescription opioid abuse|prescription opioid abuse
5227374|NCT00719082|Human Stability|human stability
5227375|NCT00719082|Geriatric|geriatric
5227376|NCT00719082|Posturography|posturography
5227377|NCT00719069|healthy subjects who smoke|healthy subjects who smoke
5227378|NCT00719069|healthy subjects|healthy subjects
5227379|NCT00719056|teicoplanin|teicoplanin
5227380|NCT00719056|prophylaxis|prophylaxis
5227381|NCT00719056|arthroplasty|arthroplasty
5227382|NCT00719056|surgical site infections|surgical site infections
5227383|NCT00719043|Influenza|influenza
5227384|NCT00719043|H5N1|h5n1
5227385|NCT00719043|Avian|avian
5227386|NCT00719043|Vaccines|vaccines
5227387|NCT00719043|Safety|safety
5227388|NCT00719043|Immunogenicity|immunogenicity
5227389|NCT00719043|Pandemic|pandemic
5227390|NCT00719043|Human|human
5227391|NCT00719017|Brachytherapy|brachytherapy
5227392|NCT00719017|Early stage edometrial cancer|early stage edometrial cancer
5227393|NCT00719017|Quality of life|quality of life
5227394|NCT00719017|Recurrence|recurrence
5227395|NCT00719017|Treatment|treatment
5227396|NCT00719017|Vaginectomy|vaginectomy
5227397|NCT00719004|Anatomy|anatomy
5227398|NCT00719004|Foot|foot
5227399|NCT00719004|Sonography|sonography
5227400|NCT00719004|Medical|medical
5227401|NCT00718991|CLI|cli
5227402|NCT00718991|excimer laser|excimer laser
5227403|NCT00718991|debulking|debulking
5227404|NCT00718978|bioengineered|bioengineered
5227405|NCT00718978|ski|ski
5227406|NCT00718978|keratinocytes|keratinocytes
5227407|NCT00718978|fibroblasts|fibroblasts
5227408|NCT00718978|skin|skin
5227409|NCT00718978|culture|culture
5227410|NCT00718978|autologous|autologous
5227411|NCT00718978|CSS|css
5227412|NCT00718978|full-thickness loss of substance from:|full-thickness loss of substance from:
5227413|NCT00718978|burns|burns
5227414|NCT00718978|ulcers|ulcers
5227415|NCT00718978|giant nevi|giant nevi
5227416|NCT00718978|cicatricial outcomes|cicatricial outcomes
5227417|NCT00718965|Primary hypercholesterolemia|primary hypercholesterolemia
5227418|NCT00718952|Pulmonary Hypertension|pulmonary hypertension
5227419|NCT00718939|Diastolic Heart Failure|diastolic heart failure
5227420|NCT00718939|Cardiac dysfunction|cardiac dysfunction
5227421|NCT00718939|Heart Failure|heart failure
5227422|NCT00718926|dry eye|dry eye
5227423|NCT00718926|Thiol redox|thiol redox
5227424|NCT00718926|Oxidative stress|oxidative stress
5227425|NCT00718913|Adjuvant Gastric Cancer|adjuvant gastric cancer
5227426|NCT00718913|Adjuvant chemotherapy|adjuvant chemotherapy
5227427|NCT00718913|Adjuvant chemo-radiation|adjuvant chemo-radiation
5227428|NCT00718913|Capecitabine|capecitabine
5227429|NCT00718874|obesity, puberty, diabetes,insulin dynamics|obesity, puberty, diabetes,insulin dynamics
5227430|NCT00718861|Osteoporosis|osteoporosis
5227431|NCT00718861|zoledronic acid|zoledronic acid
5227432|NCT00718861|post-menopausal|post-menopausal
5227433|NCT00718848|hemodialysis|hemodialysis
5227434|NCT00718848|left ventricular hypertrophy|left ventricular hypertrophy
5227435|NCT00718848|left ventricular systolic function|left ventricular systolic function
5227436|NCT00718835|smoking cessation|smoking cessation
5227437|NCT00718835|behavioral treatment|behavioral treatment
5227438|NCT00718835|contingency management|contingency management
5227439|NCT00718835|opioid maintenance|opioid maintenance
5227440|NCT00718835|methadone|methadone
5227441|NCT00718835|buprenorphine|buprenorphine
5227442|NCT00718822|clinical outcome|clinical outcome
5227443|NCT00718822|ICSI cycles|icsi cycles
5227444|NCT00718822|low oxygen|low oxygen
5227445|NCT00718822|poor responders|poor responders
5227446|NCT00718822|pregnancy rate|pregnancy rate
5227447|NCT00718822|prospective randomized study|prospective randomized study
5227448|NCT00718796|cardiovascular disease|cardiovascular disease
5227449|NCT00718796|naturopathic medicine|naturopathic medicine
5227450|NCT00718796|natural health products|natural health products
5227451|NCT00718796|lifestyle intervention|lifestyle intervention
5227452|NCT00718796|dietary advice|dietary advice
5227453|NCT00718796|coronary heart disease|coronary heart disease
5227454|NCT00718770|Not respond|not respond
5227455|NCT00718770|Radioactive iodine|radioactive iodine
5227456|NCT00718770|Therapy|therapy
5227457|NCT00718770|Shows signs|shows signs
5227458|NCT00718770|Aggressive behavior|aggressive behavior
5227459|NCT00718744|Allergen-extract|allergen-extract
5227460|NCT00718744|Standardization|standardization
5227461|NCT00718731|Alzheimer Disease|alzheimer disease
5227462|NCT00718718|Arthritis, Rheumatoid|arthritis, rheumatoid
5227463|NCT00718718|Rheumatoid Arthritis|rheumatoid arthritis
5227464|NCT00718718|Active Rheumatoid Arthritis|active rheumatoid arthritis
5227465|NCT00718718|CNTO 136|cnto 136
5227466|NCT00718718|Interleukin-6|interleukin-6
5227467|NCT00718718|Anti-interleukin-6 monoclonal antibody|anti-interleukin-6 monoclonal antibody
5227468|NCT00718718|Methotrexate|methotrexate
5227469|NCT00718718|Placebo|placebo
5227470|NCT00718705|Prematurity|prematurity
5227471|NCT00718705|Ureaplasma spp|ureaplasma spp
5227472|NCT00718705|Mycoplasma Hominis|mycoplasma hominis
5227473|NCT00718705|Amniotic fluid|amniotic fluid
5227474|NCT00718705|Josamycine|josamycine
5227475|NCT00718692|Idiopathic|idiopathic
5227476|NCT00718692|ITP|itp
5227477|NCT00718666|Safety|safety
5227478|NCT00718666|Vaccines, conjugate|vaccines, conjugate
5227479|NCT00718666|Immunogenicity|immunogenicity
5227480|NCT00718666|Meningococcal vaccine|meningococcal vaccine
5227481|NCT00718666|Booster vaccination|booster vaccination
5227482|NCT00718666|Primary vaccination|primary vaccination
5227483|NCT00718666|Neisseria meningitides|neisseria meningitides
5227484|NCT00718666|Toddlers|toddlers
5227485|NCT00718666|Humans|humans
5227486|NCT00718666|Meningococcal disease|meningococcal disease
5227487|NCT00718653|Macular pigment, lutein, green tea extract, antioxidant|macular pigment, lutein, green tea extract, antioxidant
5227488|NCT00718640|Multiple Myeloma|multiple myeloma
5227489|NCT00718640|Velcade|velcade
5227490|NCT00718640|Bortezomib|bortezomib
5227491|NCT00718640|Dexamethasone|dexamethasone
5227492|NCT00718627|Urea cycle Disorders|urea cycle disorders
5227493|NCT00718627|Carbamoylphosphate synthetase I deficiency|carbamoylphosphate synthetase i deficiency
5227494|NCT00718627|Ornithine transcarbamoylase deficiency|ornithine transcarbamoylase deficiency
5227495|NCT00718627|Argininosuccinate synthase deficiency|argininosuccinate synthase deficiency
5227496|NCT00718627|Citrullinemia|citrullinemia
5227497|NCT00718627|newborns|newborns
5227498|NCT00718627|infants|infants
5227499|NCT00718627|liver cell transplantation|liver cell transplantation
5227500|NCT00718627|liver cell infusion|liver cell infusion
5227501|NCT00718614|Choroidal blood flow|choroidal blood flow
5227502|NCT00718614|Laser Doppler flowmetry|laser doppler flowmetry
5227503|NCT00718614|Diabetic Retinopathy|diabetic retinopathy
5227504|NCT00718614|Diabetic Neuropathy|diabetic neuropathy
5227505|NCT00718601|Myeloma|myeloma
5227506|NCT00718601|Multiple Myeloma|multiple myeloma
5227507|NCT00718601|Relapsed Multiple Myeloma|relapsed multiple myeloma
5227508|NCT00718601|Refractory Multiple Myeloma|refractory multiple myeloma
5227509|NCT00718601|Relapsed or Refractory Multiple Myeloma|relapsed or refractory multiple myeloma
5227510|NCT00718588|RA|ra
5227511|NCT00718575|Liver Disease|liver disease
5227512|NCT00718575|Transplantation|transplantation
5227513|NCT00718562|nilotinib|nilotinib
5227514|NCT00718562|AMN107|amn107
5227515|NCT00718562|Sunitinib|sunitinib
5227516|NCT00718562|Sunitinib malate|sunitinib malate
5227517|NCT00718562|Imatinib|imatinib
5227518|NCT00718562|Imatinib mesylate|imatinib mesylate
5227519|NCT00718562|Tyrosine|tyrosine
5227520|NCT00718536|Atazanavir|atazanavir
5227521|NCT00718536|Raltegravir|raltegravir
5227522|NCT00718536|once-daily|once-daily
5227523|NCT00718536|pharmacokinetics|pharmacokinetics
5227524|NCT00718536|HIV|hiv
5227525|NCT00718497|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
5227526|NCT00718497|Cerebrospinal Fluid|cerebrospinal fluid
5227527|NCT00718497|Neurodegenerative Disease|neurodegenerative disease
5227528|NCT00718497|Motor Neuron Disease|motor neuron disease
5227529|NCT00718497|Autonomic Nervous System|autonomic nervous system
5227530|NCT00718497|Neurodegenerative Diseases|neurodegenerative diseases
5227531|NCT00718497|Movement Disorders|movement disorders
5227532|NCT00718484|Sarcoma|sarcoma
5227533|NCT00718484|Soft Tissue Sarcoma|soft tissue sarcoma
5227534|NCT00718484|Doxorubicin|doxorubicin
5227535|NCT00718484|anthracyclin|anthracyclin
5227536|NCT00718484|Palifosfamide|palifosfamide
5227537|NCT00718484|IFOS|ifos
5227538|NCT00718471|STEMI|stemi
5227539|NCT00718471|Primary PCI|primary pci
5227540|NCT00718471|Anticoagulation|anticoagulation
5227541|NCT00718458|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
5227542|NCT00718458|Cerebrospinal Fluid|cerebrospinal fluid
5227543|NCT00718458|Neurodegenerative Disease|neurodegenerative disease
5227544|NCT00718458|Motor Neuron Disease|motor neuron disease
5227545|NCT00718458|Autonomic Nervous System|autonomic nervous system
5227546|NCT00718458|Neurodegenerative Diseases|neurodegenerative diseases
5227547|NCT00718458|Movement Disorders|movement disorders
5227548|NCT00718445|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
5227549|NCT00718445|Cerebrospinal Fluid|cerebrospinal fluid
5227550|NCT00718445|Neurodegenerative Disease|neurodegenerative disease
5227551|NCT00718445|Motor Neuron Disease|motor neuron disease
5227552|NCT00718445|Autonomic Nervous System|autonomic nervous system
5227553|NCT00718445|Neurodegenerative Diseases|neurodegenerative diseases
5227554|NCT00718445|Movement Disorders|movement disorders
5227555|NCT00718432|Frailty|frailty
5227556|NCT00718432|Osteoporosis|osteoporosis
5227557|NCT00718432|Depression|depression
5227558|NCT00718419|Waldenstrom's Macroglobulinemia|waldenstrom's macroglobulinemia
5227559|NCT00718419|Multiple Myeloma|multiple myeloma
5227560|NCT00718406|Acute coronary syndrome|acute coronary syndrome
5227561|NCT00718406|Chest pain|chest pain
5227562|NCT00718406|Betablockers|betablockers
5227563|NCT00718406|Morphine|morphine
5227564|NCT00718406|Prehospital phase|prehospital phase
5227565|NCT00718393|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
5227566|NCT00718393|Cerebrospinal Fluid|cerebrospinal fluid
5227567|NCT00718393|Neurodegenerative Disease|neurodegenerative disease
5227568|NCT00718393|Motor Neuron Disease|motor neuron disease
5227569|NCT00718393|Autonomic Nervous System|autonomic nervous system
5227570|NCT00718393|Neurodegenerative Diseases|neurodegenerative diseases
5227571|NCT00718393|Movement Disorders|movement disorders
5227572|NCT00718354|Bleeding events|bleeding events
5227573|NCT00718341|Fragile X Syndrome, adults, efficacy|fragile x syndrome, adults, efficacy
5227574|NCT00718328|Intracerebral|intracerebral
5227575|NCT00718328|Hemorrhage|hemorrhage
5227576|NCT00718328|Edema|edema
5227577|NCT00718328|Statins|statins
5227578|NCT00718302|Ankle Fractures|ankle fractures
5227579|NCT00718302|Displaced Lateral Malleolus Fractures|displaced lateral malleolus fractures
5227580|NCT00718302|Antiglide Plating|antiglide plating
5227581|NCT00718302|Lateral Plating|lateral plating
5227582|NCT00718289|Citric acid|citric acid
5227583|NCT00718289|citrate|citrate
5227584|NCT00718289|acetic acid|acetic acid
5227585|NCT00718289|acetate|acetate
5227586|NCT00718289|haemodialysis|haemodialysis
5227587|NCT00718289|calcium|calcium
5227588|NCT00718289|hypotension|hypotension
5227589|NCT00718289|haemodynamics|haemodynamics
5227590|NCT00718289|Dialysate for Haemodialysis|dialysate for haemodialysis
5227591|NCT00718276|Healthy postmenopausal women|healthy postmenopausal women
5227592|NCT00718250|Acute myeloid leukaemia|acute myeloid leukaemia
5227593|NCT00718250|Cancer vaccines|cancer vaccines
5227594|NCT00718250|Immunotherapy|immunotherapy
5227595|NCT00718237|Gastroenteritis|gastroenteritis
5227596|NCT00718237|Rotavirus|rotavirus
5227597|NCT00718224|Knee surgery|knee surgery
5227598|NCT00718224|VTE prevention|vte prevention
5227599|NCT00718198|Inpatient|inpatient
5227600|NCT00718198|Computer Physician Order Entry|computer physician order entry
5227601|NCT00718198|Diabetes Mellitus|diabetes mellitus
5227602|NCT00718185|Sildenafil|sildenafil
5227603|NCT00718185|Pediatrics|pediatrics
5227604|NCT00718172|Ribavirin Pretreatment|ribavirin pretreatment
5227605|NCT00718172|Gene Expression|gene expression
5227606|NCT00718172|Peginterferon|peginterferon
5227607|NCT00718172|Hepatitis C|hepatitis c
5227608|NCT00718172|Liver Biopsy|liver biopsy
5227609|NCT00718172|HCV|hcv
5227610|NCT00718159|Acute Myeloid Leukemia|acute myeloid leukemia
5227611|NCT00718159|Myeloid Leukemia|myeloid leukemia
5227612|NCT00718159|Relapsed|relapsed
5227613|NCT00718159|Refractory|refractory
5227614|NCT00718146|Influenza|influenza
5227615|NCT00718146|Orthomyxoviridae Infections|orthomyxoviridae infections
5227616|NCT00718146|Orthomyxoviruses|orthomyxoviruses
5227617|NCT00718146|Split-virion influenza vaccine|split-virion influenza vaccine
5227618|NCT00718133|Asthma|asthma
5227619|NCT00718133|Allergy|allergy
5227620|NCT00718133|Respiratory|respiratory
5227621|NCT00718133|Pollution|pollution
5227622|NCT00718133|Children|children
5227623|NCT00718133|Air pollution|air pollution
5227624|NCT00718120|Fluviral|fluviral
5227625|NCT00718120|Influenza|influenza
5227626|NCT00718107|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
5227627|NCT00718107|Cerebrospinal Fluid|cerebrospinal fluid
5227628|NCT00718107|Neurodegenerative Disease|neurodegenerative disease
5227629|NCT00718107|Motor Neuron Disease|motor neuron disease
5227630|NCT00718107|Autonomic Nervous System|autonomic nervous system
5227631|NCT00718107|Neurodegenerative Diseases|neurodegenerative diseases
5227632|NCT00718107|Movement Disorders|movement disorders
5227633|NCT00718107|Quality of Life|quality of life
5227634|NCT00718094|Ulcerative colitis|ulcerative colitis
5227635|NCT00718094|EGCG|egcg
5227636|NCT00718094|Green tea polyphenols|green tea polyphenols
5227637|NCT00718094|Inflammatory bowel disease|inflammatory bowel disease
5227638|NCT00718094|Colitis|colitis
5227639|NCT00718094|IBD|ibd
5227640|NCT00718094|Green tea|green tea
5227641|NCT00718068|Potassium chloride|potassium chloride
5227642|NCT00718068|Preparations, Pharmaceutical|preparations, pharmaceutical
5227643|NCT00718068|Hypokalemia|hypokalemia
5227644|NCT00718068|Critical Care|critical care
5227645|NCT00718068|Adult|adult
5227646|NCT00718068|Randomized Controlled Trial|randomized controlled trial
5227647|NCT00718055|MRI|mri
5227648|NCT00718055|liverspecific|liverspecific
5227649|NCT00718055|contrast|contrast
5227650|NCT00718055|colorectal|colorectal
5227651|NCT00718055|metastases|metastases
5227652|NCT00718042|healthy donors|healthy donors
5227653|NCT00718029|Human Immunodeficiency Virus|human immunodeficiency virus
5227654|NCT00718029|Cerebrospinal Fluid|cerebrospinal fluid
5227655|NCT00718029|Raltegravir|raltegravir
5227656|NCT00718029|Drug Concentrations|drug concentrations
5227657|NCT00718016|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
5227658|NCT00718016|Cerebrospinal Fluid|cerebrospinal fluid
5227659|NCT00718016|Neurodegenerative Disease|neurodegenerative disease
5227660|NCT00718016|Motor Neuron Disease|motor neuron disease
5227661|NCT00718016|Autonomic Nervous System|autonomic nervous system
5227662|NCT00718016|Neurodegenerative Diseases|neurodegenerative diseases
5227663|NCT00718016|Movement Disorders|movement disorders
5228039|NCT00716729|Strength|strength
5227664|NCT00718003|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
5227665|NCT00718003|Cerebrospinal Fluid|cerebrospinal fluid
5227666|NCT00718003|Neurodegenerative Disease|neurodegenerative disease
5227667|NCT00718003|Motor Neuron Disease|motor neuron disease
5227668|NCT00718003|Autonomic Nervous System|autonomic nervous system
5227669|NCT00718003|Neurodegenerative Diseases|neurodegenerative diseases
5227670|NCT00718003|Movement Disorders|movement disorders
5227671|NCT00717990|Colorectal cancer|colorectal cancer
5227672|NCT00717990|Bevacizumab|bevacizumab
5227673|NCT00717990|XELIRI|xeliri
5227674|NCT00717951|advanced breast cancer|advanced breast cancer
5227675|NCT00717951|docetaxol|docetaxol
5227676|NCT00717951|capecitabine|capecitabine
5227677|NCT00717951|cisplatin|cisplatin
5227678|NCT00717925|B-cell Non-Hodgkin's Lymphoma|b-cell non-hodgkin's lymphoma
5227679|NCT00717925|NHL|nhl
5227680|NCT00717912|BLOOD GLUCOSE|blood glucose
5227681|NCT00717912|glycemic index|glycemic index
5227682|NCT00717912|rates of digestion and absorption of food|rates of digestion and absorption of food
5227683|NCT00717899|Asthma|asthma
5227684|NCT00717899|Allergy|allergy
5227685|NCT00717899|Respiratory|respiratory
5227686|NCT00717899|Pollution|pollution
5227687|NCT00717899|Children|children
5227688|NCT00717899|Air pollution|air pollution
5227689|NCT00717886|Breast|breast
5227690|NCT00717886|Lymph Nodes|lymph nodes
5227691|NCT00717873|Mucus Clearance|mucus clearance
5227692|NCT00717873|Secretion Clearance|secretion clearance
5227693|NCT00717873|HFCWO|hfcwo
5227694|NCT00717808|Tranilast|tranilast
5227695|NCT00717808|Rheumatoid Arthritis|rheumatoid arthritis
5227696|NCT00717808|Pharmacokinetics|pharmacokinetics
5227697|NCT00717808|Methotrexate|methotrexate
5227698|NCT00717795|Survivor|survivor
5227699|NCT00717795|Physical Activity|physical activity
5227700|NCT00717795|NED|ned
5227701|NCT00717795|08-067|08-067
5227702|NCT00717782|botulinum toxin|botulinum toxin
5227703|NCT00717782|thrombosed external haemorrhoids|thrombosed external haemorrhoids
5227704|NCT00717782|pain|pain
5227705|NCT00717769|Atopic Dermatitis|atopic dermatitis
5227706|NCT00717756|liver cancer, second line|liver cancer, second line
5227707|NCT00717743|RCC|rcc
5227708|NCT00717743|patients|patients
5227709|NCT00717743|scheduled|scheduled
5227710|NCT00717743|nephrectomy|nephrectomy
5227711|NCT00717730|Nutrition|nutrition
5227712|NCT00717730|Children|children
5227713|NCT00717730|Folate|folate
5227714|NCT00717730|Vitamin B12|vitamin b12
5227715|NCT00717730|India|india
5227716|NCT00717730|Homocysteine|homocysteine
5227717|NCT00717730|Methyl Malonic Acid|methyl malonic acid
5227718|NCT00717717|Cancer Survivor|cancer survivor
5227719|NCT00717717|Physical Activity|physical activity
5227720|NCT00717717|Health Behavior|health behavior
5227721|NCT00717717|Psychosocial Well-being|psychosocial well-being
5227722|NCT00717717|Coaching|coaching
5227723|NCT00717717|Long Term|long term
5227724|NCT00717717|Consequences|consequences
5227725|NCT00717717|Chemotherapy|chemotherapy
5227726|NCT00717717|Motivation|motivation
5227727|NCT00717704|Malignant solid tumor|malignant solid tumor
5227728|NCT00717704|Phase 1|phase 1
5227729|NCT00717704|Dose escalation|dose escalation
5227730|NCT00717704|Metastatic or locally advanced/unresectable|metastatic or locally advanced/unresectable
5227731|NCT00717704|Disease progression through standard therapy|disease progression through standard therapy
5227732|NCT00717691|Hallux Limitus|hallux limitus
5227733|NCT00717691|Dynamic Splinting|dynamic splinting
5227734|NCT00717691|Dynasplint|dynasplint
5227735|NCT00717678|Immunosuppressant|immunosuppressant
5227736|NCT00717678|Combination drug therapy|combination drug therapy
5227737|NCT00717678|Graft loss|graft loss
5227738|NCT00717678|Randomized controlled trial|randomized controlled trial
5227739|NCT00717678|Open level method|open level method
5227740|NCT00717665|Hypertension|hypertension
5227741|NCT00717665|Telemanagement|telemanagement
5227742|NCT00717665|Home blood pressure monitoring|home blood pressure monitoring
5227743|NCT00717665|Self care|self care
5227744|NCT00717639|diagnostic accuracy|diagnostic accuracy
5227745|NCT00717639|magnetic resonance angiography|magnetic resonance angiography
5227746|NCT00717639|steady state|steady state
5227747|NCT00717639|digital subtraction angiography|digital subtraction angiography
5227748|NCT00717639|peripheral arteries|peripheral arteries
5227749|NCT00717626|Hemophilia|hemophilia
5227750|NCT00717626|Prophylaxis|prophylaxis
5227751|NCT00717626|Youth|youth
5227752|NCT00717626|Young Adults|young adults
5227753|NCT00717626|Feasibility|feasibility
5227754|NCT00717600|bacteriuria|bacteriuria
5227755|NCT00717600|urinary tract infection|urinary tract infection
5227756|NCT00717600|probiotics|probiotics
5227757|NCT00717600|lactobacillus|lactobacillus
5227758|NCT00717600|vagina|vagina
5227759|NCT00717600|bladder|bladder
5227760|NCT00717600|neurogenic bladder|neurogenic bladder
5227761|NCT00717600|spina bifida|spina bifida
5227762|NCT00717600|myelomeningocele|myelomeningocele
5227763|NCT00717600|neuropathic bladder|neuropathic bladder
5227764|NCT00717587|stage IV renal cell cancer|stage iv renal cell cancer
5227765|NCT00717587|recurrent renal cell cancer|recurrent renal cell cancer
5227766|NCT00717574|depth of sedation|depth of sedation
5227767|NCT00717574|nitrous oxide|nitrous oxide
5227768|NCT00717574|general anesthesia|general anesthesia
5227769|NCT00717574|anesthesia indices|anesthesia indices
5227770|NCT00717561|CAP|cap
5227771|NCT00717561|Community-acquired pneumonia|community-acquired pneumonia
5227772|NCT00717548|Somatic Complaints|somatic complaints
5227773|NCT00717535|health status unknown|health status unknown
5227774|NCT00717522|Soft Tissue Sarcoma|soft tissue sarcoma
5227775|NCT00717522|CC-4047|cc-4047
5227776|NCT00717522|Pomalidomide|pomalidomide
5227777|NCT00717509|schizophrenia|schizophrenia
5227778|NCT00717509|metabolic side effect|metabolic side effect
5227779|NCT00717509|clozapine|clozapine
5227780|NCT00717509|genetic polymorphism|genetic polymorphism
5227781|NCT00717496|Breastfeeding|breastfeeding
5227782|NCT00717496|Telephone Support|telephone support
5227783|NCT00717496|Latino|latino
5227784|NCT00717470|Kidney|kidney
5227785|NCT00717470|Prograf|prograf
5227786|NCT00717470|Transplant|transplant
5227787|NCT00717470|Advagraf|advagraf
5227788|NCT00717470|Immunosuppression|immunosuppression
5227789|NCT00717470|FK506|fk506
5227790|NCT00717444|Substance Abuse|substance abuse
5227791|NCT00717444|HIV|hiv
5227792|NCT00717444|Contingency Management|contingency management
5227793|NCT00717444|Physical Activity|physical activity
5227794|NCT00717431|Deep Brain Stimulation|deep brain stimulation
5227795|NCT00717431|Seizures|seizures
5227796|NCT00717431|Epilepsy|epilepsy
5227797|NCT00717392|ADHD|adhd
5227798|NCT00717392|ASD|asd
5227799|NCT00717379|Organ Transplantation|organ transplantation
5227800|NCT00717379|Tacrolimus|tacrolimus
5227801|NCT00717379|Prograf|prograf
5227802|NCT00717379|Kidney|kidney
5227803|NCT00717379|Immunosuppression|immunosuppression
5227804|NCT00717340|tivozanib|tivozanib
5227805|NCT00717340|AV-951|av-951
5227806|NCT00717327|MRL|mrl
5227807|NCT00717327|Adolescents|adolescents
5227808|NCT00717327|Health Literacy|health literacy
5227809|NCT00717301|TBI, traumatic brain injury, S100B, head CT scan|tbi, traumatic brain injury, s100b, head ct scan
5227810|NCT00717288|diabetes|diabetes
5227811|NCT00717288|hyperglycemia|hyperglycemia
5227812|NCT00717288|open heart surgery|open heart surgery
5227813|NCT00717288|cardiothoracic surgery|cardiothoracic surgery
5227814|NCT00717288|detemir|detemir
5227815|NCT00717288|insulin infusion|insulin infusion
5227816|NCT00717288|intravenous insulin|intravenous insulin
5227817|NCT00717275|Brain Metastases|brain metastases
5227818|NCT00717275|Temozolomide|temozolomide
5227819|NCT00717275|Temodar|temodar
5227820|NCT00717275|TMZ|tmz
5227821|NCT00717275|Stereotactic Radiosurgery|stereotactic radiosurgery
5227822|NCT00717275|SRS|srs
5227823|NCT00717236|Certolizumab pegol|certolizumab pegol
5227824|NCT00717236|Cimzia|cimzia
5227825|NCT00717236|Rheumatoid Arthritis|rheumatoid arthritis
5227826|NCT00717236|Joint Disease|joint disease
5227827|NCT00717236|Chronic Arthritis|chronic arthritis
5227828|NCT00717223|Diabetes|diabetes
5227829|NCT00717223|Type 1 diabetes mellitus|type 1 diabetes mellitus
5227830|NCT00717223|Type 2 diabetes mellitus|type 2 diabetes mellitus
5227831|NCT00717223|Literacy|literacy
5227832|NCT00717223|Glycemic control|glycemic control
5227833|NCT00717210|1p/19q loss|1p/19q loss
5227834|NCT00717210|MGMT|mgmt
5227835|NCT00717210|prognostic factors|prognostic factors
5227836|NCT00717210|PCV|pcv
5227837|NCT00717210|temozolomide|temozolomide
5227838|NCT00717197|HGG|hgg
5227839|NCT00717197|anaplastic astrocytoma|anaplastic astrocytoma
5227840|NCT00717197|anaplastic oligodendroglioma|anaplastic oligodendroglioma
5227841|NCT00717197|anaplastic mixed glioma|anaplastic mixed glioma
5227842|NCT00717197|glioblastoma multiforme|glioblastoma multiforme
5227843|NCT00717197|GBM|gbm
5227844|NCT00717197|Xeloda|xeloda
5227845|NCT00717197|capecitabine|capecitabine
5227846|NCT00717171|electrical stimulation|electrical stimulation
5227847|NCT00717171|pain|pain
5227848|NCT00717171|medication|medication
5227849|NCT00717171|edema|edema
5227850|NCT00717171|interferential|interferential
5227851|NCT00717171|neuromuscular|neuromuscular
5227852|NCT00717171|high voltage pulsed current|high voltage pulsed current
5227853|NCT00717171|knee|knee
5227854|NCT00717158|Health Behavior|health behavior
5227855|NCT00717158|Lifestyle|lifestyle
5227856|NCT00717158|health care costs|health care costs
5227857|NCT00717158|quality of life|quality of life
5227858|NCT00717145|bioequivalence|bioequivalence
5227859|NCT00717132|weight|weight
5227860|NCT00717132|cost effectiveness|cost effectiveness
5227861|NCT00717132|obesity|obesity
5227862|NCT00717132|family based behavioral treatment|family based behavioral treatment
5227863|NCT00717119|GI|gi
5227864|NCT00717119|NSAID|nsaid
5227865|NCT00717119|Complications|complications
5227866|NCT00717119|Treated|treated
5227867|NCT00717119|Patients|patients
5227868|NCT00717106|ILR|ilr
5227869|NCT00717106|ECG monitoring|ecg monitoring
5227870|NCT00717106|cardiac arrhythmia|cardiac arrhythmia
5227871|NCT00717106|syncope|syncope
5227872|NCT00717106|presyncope|presyncope
5227873|NCT00717106|fainting|fainting
5227874|NCT00717080|Retinitis Pigmentosa|retinitis pigmentosa
5227875|NCT00717080|Cataract|cataract
5227876|NCT00717067|maraviroc, pharmacokinetics, renal impairment|maraviroc, pharmacokinetics, renal impairment
5227877|NCT00717054|postoperative nausea and vomiting|postoperative nausea and vomiting
5227878|NCT00717041|Depression|depression
5227879|NCT00717041|Anxiety|anxiety
5227880|NCT00717041|Cognitive Impairment|cognitive impairment
5227881|NCT00717041|Emergency medicine|emergency medicine
5227882|NCT00717041|prehospital care|prehospital care
5227883|NCT00717028|Cerebral palsy|cerebral palsy
5227884|NCT00717028|Dysphagia|dysphagia
5227885|NCT00717028|Deglutition|deglutition
5227886|NCT00717028|Endoscopy|endoscopy
5227887|NCT00717015|Hormone Receptor Positive Breast Cancer|hormone receptor positive breast cancer
5227888|NCT00716989|Cutaneous immune system|cutaneous immune system
5227889|NCT00716989|innate immunity|innate immunity
5227890|NCT00716989|tuberculin skin tests|tuberculin skin tests
5227891|NCT00716989|intradermal vaccination|intradermal vaccination
5227892|NCT00716989|pathophysiology|pathophysiology
5227893|NCT00716989|Healthy subjects|healthy subjects
5227894|NCT00716989|Immunosuppressed patients|immunosuppressed patients
5227895|NCT00716976|ototoxicity|ototoxicity
5227896|NCT00716976|childhood central nervous system germ cell tumor|childhood central nervous system germ cell tumor
5227897|NCT00716976|childhood extracranial germ cell tumor|childhood extracranial germ cell tumor
5227898|NCT00716976|childhood extragonadal germ cell tumor|childhood extragonadal germ cell tumor
5227899|NCT00716976|childhood malignant testicular germ cell tumor|childhood malignant testicular germ cell tumor
5227900|NCT00716976|childhood malignant ovarian germ cell tumor|childhood malignant ovarian germ cell tumor
5227901|NCT00716976|childhood teratoma|childhood teratoma
5227902|NCT00716976|childhood medulloblastoma|childhood medulloblastoma
5227903|NCT00716976|disseminated neuroblastoma|disseminated neuroblastoma
5227904|NCT00716976|regional neuroblastoma|regional neuroblastoma
5227905|NCT00716976|localized resectable neuroblastoma|localized resectable neuroblastoma
5227906|NCT00716976|localized unresectable neuroblastoma|localized unresectable neuroblastoma
5227907|NCT00716976|stage 4S neuroblastoma|stage 4s neuroblastoma
5227908|NCT00716976|localized osteosarcoma|localized osteosarcoma
5227909|NCT00716976|metastatic osteosarcoma|metastatic osteosarcoma
5227910|NCT00716976|childhood hepatoblastoma|childhood hepatoblastoma
5227911|NCT00716976|stage I childhood liver cancer|stage i childhood liver cancer
5227912|NCT00716976|stage II childhood liver cancer|stage ii childhood liver cancer
5227913|NCT00716976|stage III childhood liver cancer|stage iii childhood liver cancer
5227914|NCT00716976|stage IV childhood liver cancer|stage iv childhood liver cancer
5227915|NCT00716963|late allergic response|late allergic response
5227916|NCT00716963|fluticasone propionate|fluticasone propionate
5227917|NCT00716937|pilonidal sinus|pilonidal sinus
5227918|NCT00716937|karydakis|karydakis
5227919|NCT00716937|laying open|laying open
5227920|NCT00716911|cytomegalovirus infection|cytomegalovirus infection
5227921|NCT00716911|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5227922|NCT00716911|atypical chronic myeloid leukemia, BCR-ABL negative|atypical chronic myeloid leukemia, bcr-abl negative
5227923|NCT00716911|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5227924|NCT00716911|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5227925|NCT00716911|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5227926|NCT00716911|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5227927|NCT00716911|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5227928|NCT00716911|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5227929|NCT00716911|refractory hairy cell leukemia|refractory hairy cell leukemia
5227930|NCT00716911|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5227931|NCT00716911|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5227932|NCT00716911|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5227933|NCT00716911|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5227934|NCT00716911|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5227935|NCT00716911|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5227936|NCT00716911|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5227937|NCT00716911|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5227938|NCT00716911|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5227939|NCT00716911|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5227940|NCT00716911|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5227941|NCT00716911|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5227942|NCT00716911|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5227943|NCT00716911|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5227944|NCT00716911|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5227945|NCT00716911|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5227946|NCT00716911|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5227947|NCT00716911|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5227948|NCT00716911|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5227949|NCT00716911|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5227950|NCT00716911|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5227951|NCT00716911|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5227952|NCT00716911|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5227953|NCT00716911|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5227954|NCT00716911|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5227955|NCT00716911|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5227956|NCT00716911|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5227957|NCT00716911|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5227958|NCT00716911|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5227959|NCT00716911|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5227960|NCT00716911|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5227961|NCT00716911|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5227962|NCT00716911|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5227963|NCT00716911|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5227964|NCT00716911|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5227965|NCT00716911|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5227966|NCT00716911|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5227967|NCT00716911|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5227968|NCT00716911|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5227969|NCT00716911|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5227970|NCT00716911|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5227971|NCT00716911|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5227972|NCT00716911|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5227973|NCT00716911|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5227974|NCT00716911|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5227975|NCT00716911|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5227976|NCT00716911|chronic eosinophilic leukemia|chronic eosinophilic leukemia
5227977|NCT00716911|chronic neutrophilic leukemia|chronic neutrophilic leukemia
5227978|NCT00716911|primary myelofibrosis|primary myelofibrosis
5227979|NCT00716911|stage II multiple myeloma|stage ii multiple myeloma
5227980|NCT00716911|stage III multiple myeloma|stage iii multiple myeloma
5227981|NCT00716911|refractory multiple myeloma|refractory multiple myeloma
5227982|NCT00716911|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5227983|NCT00716911|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5227984|NCT00716911|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5227985|NCT00716911|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
5227986|NCT00716911|stage I multiple myeloma|stage i multiple myeloma
5227987|NCT00716898|Condition|condition
5227988|NCT00716898|Cancer|cancer
5227989|NCT00716898|Patients|patients
5227990|NCT00716898|Thrombosis|thrombosis
5227991|NCT00716898|Unstable|unstable
5227992|NCT00716898|Angina|angina
5227993|NCT00716898|Pectoris|pectoris
5227994|NCT00716885|Heart failure|heart failure
5227995|NCT00716885|Oxidative stress|oxidative stress
5227996|NCT00716885|Endothelial Progenitor Cells|endothelial progenitor cells
5227997|NCT00716885|White blood cells|white blood cells
5227998|NCT00716872|cancer|cancer
5227999|NCT00716872|sleep|sleep
5228000|NCT00716872|insomnia|insomnia
5228001|NCT00716872|Internet|internet
5228002|NCT00716872|SHUTi|shuti
5228003|NCT00716833|pain|pain
5228004|NCT00716833|coxibe|coxibe
5228005|NCT00716833|preemptive|preemptive
5228006|NCT00716833|abdominothoracic|abdominothoracic
5228007|NCT00716833|sensibilisation|sensibilisation
5228008|NCT00716833|Analgesia|analgesia
5228009|NCT00716807|BMS|bms
5228010|NCT00716807|TMD|tmd
5228011|NCT00716794|Prostate cancer|prostate cancer
5228012|NCT00716794|HE3235|he3235
5228013|NCT00716794|Apoptone|apoptone
5228014|NCT00716781|Group B streptococcus|group b streptococcus
5228015|NCT00716781|Sepsis|sepsis
5228016|NCT00716781|Infants|infants
5228017|NCT00716781|Diagnosis|diagnosis
5228018|NCT00716781|Physical examination|physical examination
5228019|NCT00716781|Laboratory tests|laboratory tests
5228020|NCT00716768|Laparoscopic|laparoscopic
5228021|NCT00716768|Inguinal Hernia|inguinal hernia
5228022|NCT00716768|Infants|infants
5228023|NCT00716755|Positron emission tomography|positron emission tomography
5228024|NCT00716755|antipsychotics|antipsychotics
5228025|NCT00716755|risperidone|risperidone
5228026|NCT00716755|olanzapine|olanzapine
5228027|NCT00716755|Dopamine|dopamine
5228028|NCT00716755|D2 receptor|d2 receptor
5228029|NCT00716755|elderly|elderly
5228030|NCT00716755|schizophrenia|schizophrenia
5228031|NCT00716755|schizoaffective disorder|schizoaffective disorder
5228032|NCT00716755|schizophreniform disorder|schizophreniform disorder
5228033|NCT00716755|delusional disorder|delusional disorder
5228034|NCT00716755|psychotic disorder NOS|psychotic disorder nos
5228035|NCT00716729|Questionnaire|questionnaire
5228036|NCT00716729|Hip|hip
5228037|NCT00716729|Groin|groin
5228038|NCT00716729|Disability|disability
5228040|NCT00716729|To develop two new outcome measures for patients with hip and groin disability|to develop two new outcome measures for patients with hip and groin disability
5228041|NCT00716716|Hemophilia B severe, previously treated patients|hemophilia b severe, previously treated patients
5228042|NCT00716703|Appendicitis|appendicitis
5228043|NCT00716703|Computed tomography|computed tomography
5228044|NCT00716703|pediatric|pediatric
5228045|NCT00716703|child|child
5228046|NCT00716703|sensitivity|sensitivity
5228047|NCT00716703|specificity|specificity
5228048|NCT00716703|contrast administration route|contrast administration route
5228049|NCT00716703|time factors|time factors
5228050|NCT00716690|Stem cell transplantation|stem cell transplantation
5228051|NCT00716690|GVHD|gvhd
5228052|NCT00716677|difficult asthma|difficult asthma
5228053|NCT00716677|respiratory inductance plethysmography|respiratory inductance plethysmography
5228054|NCT00716664|cystic fibrosis|cystic fibrosis
5228055|NCT00716664|musculoskeletal|musculoskeletal
5228056|NCT00716664|exercise capacity|exercise capacity
5228057|NCT00716664|posture|posture
5228058|NCT00716664|lung function|lung function
5228059|NCT00716664|physical functioning|physical functioning
5228060|NCT00716612|Coenzyme Q 10|coenzyme q 10
5228061|NCT00716612|Statin|statin
5228062|NCT00716612|Myalgia|myalgia
5228063|NCT00716599|malaria|malaria
5228064|NCT00716599|diagnosis|diagnosis
5228065|NCT00716599|rapid diagnostic test|rapid diagnostic test
5228066|NCT00716599|rapid diagnostic tests|rapid diagnostic tests
5228067|NCT00716599|fever case management|fever case management
5228068|NCT00716599|training|training
5228069|NCT00716599|fever case management in malaria-endemic areas|fever case management in malaria-endemic areas
5228070|NCT00716573|Cardiac transplantation|cardiac transplantation
5228071|NCT00716573|Chronic renal insufficiency|chronic renal insufficiency
5228072|NCT00716573|Everolimus|everolimus
5228073|NCT00716521|mobile actigraphy inpatient polysomnography actigraphy ambien|mobile actigraphy inpatient polysomnography actigraphy ambien
5228074|NCT00716508|Patella tendon rupute, suture anchors, repair patella tendon|patella tendon rupute, suture anchors, repair patella tendon
5228075|NCT00716482|breast|breast
5228076|NCT00716482|lesion|lesion
5228077|NCT00716482|ultrasound|ultrasound
5228078|NCT00716482|BI-RADS|bi-rads
5228079|NCT00716482|malignancy|malignancy
5228080|NCT00716482|women|women
5228081|NCT00716469|Neurofibroma|neurofibroma
5228082|NCT00716469|Plexiform|plexiform
5228083|NCT00716469|NF1|nf1
5228084|NCT00716469|Photo dynamic therapy|photo dynamic therapy
5228085|NCT00716456|MAB C225(CETUXIMAB)(ANTI-EGFR)|mab c225(cetuximab)(anti-egfr)
5228086|NCT00716456|OSI-774, TARCEVA (ERLOTINIB)|osi-774, tarceva (erlotinib)
5228087|NCT00716456|Lung|lung
5228088|NCT00716456|Adenocarcinoma|adenocarcinoma
5228089|NCT00716456|Lung cancer|lung cancer
5228090|NCT00716443|Nasolabial folds|nasolabial folds
5228091|NCT00716443|wrinkles|wrinkles
5228092|NCT00716443|topical anesthetic|topical anesthetic
5228093|NCT00716430|acute coronary syndromes|acute coronary syndromes
5228094|NCT00716430|quality improvement|quality improvement
5228095|NCT00716404|FlowMedica|flowmedica
5228096|NCT00716404|Benephit|benephit
5228097|NCT00716404|TRT|trt
5228098|NCT00716404|Patients|patients
5228099|NCT00716404|Components|components
5228100|NCT00716404|Benephit Infusion System|benephit infusion system
5228101|NCT00716404|Planned|planned
5228102|NCT00716404|To be used|to be used
5228103|NCT00716391|Head and Neck Cancer|head and neck cancer
5228104|NCT00716378|Simulated Driving|simulated driving
5228105|NCT00716378|Risky Driving Behavior|risky driving behavior
5228106|NCT00716378|Social Influences|social influences
5228107|NCT00716365|angiography|angiography
5228108|NCT00716365|hemostasis|hemostasis
5228109|NCT00716365|femoral artery|femoral artery
5228110|NCT00716365|duplex|duplex
5228111|NCT00716352|non-ST elevation acute coronary syndrome|non-st elevation acute coronary syndrome
5228112|NCT00716352|educational intervention|educational intervention
5228113|NCT00716352|evidence based practice|evidence based practice
5228114|NCT00716352|guidelines|guidelines
5228115|NCT00716339|pseudophakic accommodation|pseudophakic accommodation
5228116|NCT00716326|Transcutaneous Electrical Nerve Stimulation|transcutaneous electrical nerve stimulation
5228117|NCT00716326|Chronic pain|chronic pain
5228118|NCT00716326|Neuropathic pain|neuropathic pain
5228119|NCT00716326|Short-term efficacy|short-term efficacy
5228120|NCT00716326|Long-term efficacy|long-term efficacy
5228121|NCT00716300|obesity|obesity
5228122|NCT00716300|CVD|cvd
5228123|NCT00716300|HDL kinetics|hdl kinetics
5228124|NCT00716300|Anti-inflammatory and anti-oxidation studies|anti-inflammatory and anti-oxidation studies
5228125|NCT00716300|30 subjects recruited (15 MetS and 15 lean controls)|30 subjects recruited (15 mets and 15 lean controls)
5228126|NCT00716261|Parkinson's disease|parkinson's disease
5228127|NCT00716261|Audio feedback|audio feedback
5228128|NCT00716261|postural control|postural control
5228129|NCT00716235|ADHD|adhd
5228130|NCT00716235|ASD|asd
5228131|NCT00716235|PDD|pdd
5228132|NCT00716235|DCD|dcd
5228133|NCT00716235|Executive Functions|executive functions
5228134|NCT00716196|thin prep|thin prep
5228135|NCT00716196|EUS|eus
5228136|NCT00716183|mastitis|mastitis
5228137|NCT00716183|Staphylococcus|staphylococcus
5228138|NCT00716183|Streptococcus|streptococcus
5228139|NCT00716183|lactation|lactation
5228140|NCT00716183|breastfeeding|breastfeeding
5228141|NCT00716170|Diabetes Mellitus|diabetes mellitus
5228142|NCT00716170|Glucagon|glucagon
5228143|NCT00716170|Insulin|insulin
5228144|NCT00716170|Incretin hormones|incretin hormones
5228145|NCT00716170|Glucose-dependent insulinotropic polypeptide|glucose-dependent insulinotropic polypeptide
5228146|NCT00716170|Glucagon-like peptide-1|glucagon-like peptide-1
5228147|NCT00716170|Glucagon-like peptide-2|glucagon-like peptide-2
5228148|NCT00716144|Psoriasis|psoriasis
5228149|NCT00716131|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
5228150|NCT00716131|Cerebrospinal Fluid|cerebrospinal fluid
5228151|NCT00716131|Neurodegenerative Disease|neurodegenerative disease
5228152|NCT00716131|Motor Neuron Disease|motor neuron disease
5228153|NCT00716131|Autonomic Nervous System|autonomic nervous system
5228154|NCT00716131|Neurodegenerative Diseases|neurodegenerative diseases
5228155|NCT00716131|Movement Disorders|movement disorders
5228156|NCT00716118|Oocyte Cryopreservation|oocyte cryopreservation
5228157|NCT00716118|Slow-Freeze|slow-freeze
5228158|NCT00716118|Egg Freezing|egg freezing
5228159|NCT00716118|Meiotic Spindle|meiotic spindle
5228160|NCT00716118|Mitochondria|mitochondria
5228161|NCT00716118|Human Oocytes Freezing.|human oocytes freezing.
5228162|NCT00716105|Infant formula|infant formula
5228163|NCT00716105|Protein metabolism|protein metabolism
5228164|NCT00716079|Cerebral Hemorrhage|cerebral hemorrhage
5228165|NCT00716079|Stroke|stroke
5228166|NCT00716079|antihypertensive drugs|antihypertensive drugs
5228167|NCT00716079|blood pressure|blood pressure
5228168|NCT00716079|disability|disability
5228169|NCT00716079|clinical trial|clinical trial
5228170|NCT00716079|outcomes|outcomes
5228171|NCT00716053|emphysema|emphysema
5228172|NCT00716053|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
5228173|NCT00716053|COPD|copd
5228174|NCT00716053|lung volume reduction|lung volume reduction
5228175|NCT00716053|LVRS|lvrs
5228176|NCT00716053|BLVR|blvr
5228177|NCT00716053|Aeris|aeris
5228178|NCT00716040|AIDS treatment|aids treatment
5228179|NCT00716040|HAART adherence|haart adherence
5228180|NCT00716040|intervention|intervention
5228181|NCT00716014|Pachyonychia Congenita|pachyonychia congenita
5228182|NCT00716014|siRNA|sirna
5228183|NCT00716001|patients with chronic renal failure undergoing elective percutaneous coronary intervention|patients with chronic renal failure undergoing elective percutaneous coronary intervention
5228184|NCT00715988|Methadone|methadone
5228185|NCT00715988|analgesia|analgesia
5228186|NCT00715988|newborns|newborns
5228187|NCT00715988|QT prolongation|qt prolongation
5228188|NCT00715988|Young Infants|young infants
5228189|NCT00715975|clobetasol|clobetasol
5228190|NCT00715975|halobetasol|halobetasol
5228191|NCT00715975|psoriasis|psoriasis
5228192|NCT00715975|evaluating the efficacy and tolerability of the drug Halobetasol propionate|evaluating the efficacy and tolerability of the drug halobetasol propionate
5228193|NCT00715962|Hospitalization|hospitalization
5228194|NCT00715962|Aged|aged
5228195|NCT00715949|traumatic brain injury|traumatic brain injury
5228196|NCT00715949|pediatric|pediatric
5228197|NCT00715949|neurocognitive|neurocognitive
5228198|NCT00715949|concussion|concussion
5228199|NCT00715936|Integrated early child development, growth and health|integrated early child development, growth and health
5228200|NCT00715936|Psychosocial stimulation|psychosocial stimulation
5228201|NCT00715936|Care for child development|care for child development
5228202|NCT00715923|informed consent document|informed consent document
5228203|NCT00715923|ethics|ethics
5228204|NCT00715910|Meningococcal vaccine|meningococcal vaccine
5228205|NCT00715910|Booster vaccination|booster vaccination
5228206|NCT00715910|Immunogenicity|immunogenicity
5228207|NCT00715910|Meningococcal disease|meningococcal disease
5228208|NCT00715910|Safety|safety
5228209|NCT00715897|chronic neurological deficient due to stroke|chronic neurological deficient due to stroke
5228210|NCT00715884|Atherosclerosis|atherosclerosis
5228211|NCT00715884|de novo native coronary lesion|de novo native coronary lesion
5228212|NCT00715871|smoking|smoking
5228213|NCT00715871|smoke cessation|smoke cessation
5228214|NCT00715871|stop smoking|stop smoking
5228215|NCT00715871|quit smoking|quit smoking
5228216|NCT00715871|nicotine replacement therapy|nicotine replacement therapy
5228217|NCT00715871|Smoke Break|smoke break
5228218|NCT00715871|liquid cigarette|liquid cigarette
5228219|NCT00715871|liquid nicotine cigarette|liquid nicotine cigarette
5228220|NCT00715858|Alzheimer's disease|alzheimer's disease
5228221|NCT00715858|dementia|dementia
5228222|NCT00715858|inflammation|inflammation
5228223|NCT00715858|cytokine|cytokine
5228224|NCT00715858|biomarker|biomarker
5228225|NCT00715858|cerebrospinal fluid|cerebrospinal fluid
5228226|NCT00715858|serum|serum
5228227|NCT00715858|doxycycline|doxycycline
5228228|NCT00715858|rifampin|rifampin
5228229|NCT00715845|cardiovascular disease|cardiovascular disease
5228230|NCT00715845|embolism|embolism
5228231|NCT00715845|microemboli|microemboli
5228232|NCT00715845|cognitive decline|cognitive decline
5228233|NCT00715845|mitral valve repair|mitral valve repair
5228234|NCT00715845|cerebral microemboli|cerebral microemboli
5228337|NCT00715481|Albuminuria|albuminuria
5228235|NCT00715845|coronary artery bypass graft|coronary artery bypass graft
5228236|NCT00715845|CABG|cabg
5228237|NCT00715845|transcranial doppler|transcranial doppler
5228238|NCT00715845|transesophageal echocardiogram|transesophageal echocardiogram
5228239|NCT00715845|magnetic resonance imaging|magnetic resonance imaging
5228240|NCT00715845|carbon dioxide|carbon dioxide
5228241|NCT00715832|Breast cancer|breast cancer
5228242|NCT00715832|Dendritic cell vaccine|dendritic cell vaccine
5228243|NCT00715832|OFA/iLRP|ofa/ilrp
5228244|NCT00715832|Patients|patients
5228245|NCT00715832|Line|line
5228246|NCT00715832|Chemotherapy|chemotherapy
5228247|NCT00715832|Setting|setting
5228248|NCT00715832|Four different lines|four different lines
5228249|NCT00715806|claustrophobia|claustrophobia
5228250|NCT00715806|magnetic resonance imaging|magnetic resonance imaging
5228251|NCT00715806|MRI|mri
5228252|NCT00715806|anxiety|anxiety
5228253|NCT00715806|open design|open design
5228254|NCT00715806|severely anxious patients|severely anxious patients
5228255|NCT00715793|Decitabine|decitabine
5228256|NCT00715793|Temozolomide|temozolomide
5228257|NCT00715793|Metastatic|metastatic
5228258|NCT00715793|Melanoma|melanoma
5228259|NCT00715793|Non-resectable|non-resectable
5228260|NCT00715793|Stage IIIB melanoma|stage iiib melanoma
5228261|NCT00715793|stage IV melanoma|stage iv melanoma
5228262|NCT00715793|TMZ|tmz
5228263|NCT00715793|DTIC|dtic
5228264|NCT00715793|promoter methylation|promoter methylation
5228265|NCT00715793|skin cancer|skin cancer
5228266|NCT00715793|chemotherapy|chemotherapy
5228267|NCT00715767|BLS training|bls training
5228268|NCT00715767|CPR|cpr
5228269|NCT00715767|post graduate education|post graduate education
5228270|NCT00715767|resource-limited settings|resource-limited settings
5228271|NCT00715767|medical education|medical education
5228272|NCT00715767|CPR retention|cpr retention
5228273|NCT00715767|cultural barriers|cultural barriers
5228274|NCT00715741|atelectasis|atelectasis
5228275|NCT00715741|oxygen|oxygen
5228276|NCT00715741|saturation|saturation
5228277|NCT00715728|Plastic surgery|plastic surgery
5228278|NCT00715728|Warming|warming
5228279|NCT00715728|Core temperature|core temperature
5228280|NCT00715728|Bair Hugger|bair hugger
5228281|NCT00715728|Hot Dog heating system|hot dog heating system
5228282|NCT00715715|Hepatitis B e Antigen|hepatitis b e antigen
5228283|NCT00715715|HBeAg-positive chronic hepatitis B|hbeag-positive chronic hepatitis b
5228284|NCT00715702|AZD5672|azd5672
5228285|NCT00715676|Osteoporosis|osteoporosis
5228286|NCT00715676|2-methylene-19-nor-(20S)-1a, 25-dihydroxyvitamin D3|2-methylene-19-nor-(20s)-1a, 25-dihydroxyvitamin d3
5228287|NCT00715676|Vitamin D|vitamin d
5228288|NCT00715676|Bone Density Conservation Agents|bone density conservation agents
5228289|NCT00715676|Bone Regeneration|bone regeneration
5228290|NCT00715650|Rehabilitation, Vocational|rehabilitation, vocational
5228291|NCT00715650|Compensation and Redress|compensation and redress
5228292|NCT00715650|disability evaluation|disability evaluation
5228293|NCT00715637|AML|aml
5228294|NCT00715637|Leukemia|leukemia
5228295|NCT00715637|MDS|mds
5228296|NCT00715637|Amonafide|amonafide
5228297|NCT00715637|Cytarabine|cytarabine
5228298|NCT00715637|Daunorubicin|daunorubicin
5228299|NCT00715637|Lymphatic disorders|lymphatic disorders
5228300|NCT00715624|hyperglycemia, GLP-1, metformin, insulin|hyperglycemia, glp-1, metformin, insulin
5228301|NCT00715611|pemetrexed|pemetrexed
5228302|NCT00715611|cisplatin|cisplatin
5228303|NCT00715611|IMRT|imrt
5228304|NCT00715611|PLEURA|pleura
5228305|NCT00715611|Malignant|malignant
5228306|NCT00715611|08-053|08-053
5228307|NCT00715598|Pain Assessment|pain assessment
5228308|NCT00715598|Measurement|measurement
5228309|NCT00715585|diabetes|diabetes
5228310|NCT00715585|education|education
5228311|NCT00715585|health literacy|health literacy
5228312|NCT00715572|hypothyroidism, treatment, thyroxine, triiodothyronine|hypothyroidism, treatment, thyroxine, triiodothyronine
5228313|NCT00715559|Major depressive disorder, depression|major depressive disorder, depression
5228314|NCT00715559|neurotrophic|neurotrophic
5228315|NCT00715559|brain-derived neurotrophic factor|brain-derived neurotrophic factor
5228316|NCT00715559|antidepressant|antidepressant
5228317|NCT00715559|cysteamine|cysteamine
5228318|NCT00715546|Adipose-derived stem cell|adipose-derived stem cell
5228319|NCT00715546|Lipodystrophy|lipodystrophy
5228320|NCT00715533|acute (< 24 hours) stroke|acute (< 24 hours) stroke
5228321|NCT00715533|stroke|stroke
5228322|NCT00715533|TIA|tia
5228323|NCT00715533|MRI|mri
5228324|NCT00715533|imaging|imaging
5228325|NCT00715533|acute|acute
5228326|NCT00715520|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
5228327|NCT00715520|Rehabilitation|rehabilitation
5228328|NCT00715520|Stroke|stroke
5228329|NCT00715520|Plasticity|plasticity
5228330|NCT00715507|decision making|decision making
5228331|NCT00715507|graphic display|graphic display
5228332|NCT00715494|brain injuries, dementia, myopathies, muscle disorders|brain injuries, dementia, myopathies, muscle disorders
5228333|NCT00715481|Type 2 diabetes|type 2 diabetes
5228334|NCT00715481|Cardiovascular disease|cardiovascular disease
5228335|NCT00715481|Diabetic Nephropathy|diabetic nephropathy
5228336|NCT00715481|Glomerular filtration rate|glomerular filtration rate
5228338|NCT00715455|CAD|cad
5228339|NCT00715455|PCI|pci
5228340|NCT00715455|ANTICOAGULANT|anticoagulant
5228341|NCT00715442|Kidney|kidney
5228342|NCT00715442|Renal Cell Carcinoma|renal cell carcinoma
5228343|NCT00715442|RCC|rcc
5228344|NCT00715442|Sutent|sutent
5228345|NCT00715442|Sunitinib malate|sunitinib malate
5228346|NCT00715442|Clear cell|clear cell
5228347|NCT00715442|SU011248|su011248
5228348|NCT00715442|Nephrectomy|nephrectomy
5228349|NCT00715442|Surgical removal of kidney|surgical removal of kidney
5228350|NCT00715442|Cytoreductive nephrectomy|cytoreductive nephrectomy
5228351|NCT00715429|leg cramps|leg cramps
5228352|NCT00715429|vitamin D deficiency|vitamin d deficiency
5228353|NCT00715416|peripheral vascular diseases|peripheral vascular diseases
5228354|NCT00715416|Intermittent Claudication|intermittent claudication
5228355|NCT00715416|Angioplasty|angioplasty
5228356|NCT00715390|Children|children
5228357|NCT00715390|Cardiac Arrhythmia|cardiac arrhythmia
5228358|NCT00715390|General Anesthesia|general anesthesia
5228359|NCT00715377|benztropine|benztropine
5228360|NCT00715377|Anticholinergic antiparkinsonian agents|anticholinergic antiparkinsonian agents
5228361|NCT00715377|antipsychotics|antipsychotics
5228362|NCT00715377|elderly population|elderly population
5228363|NCT00715377|side-effects|side-effects
5228364|NCT00715338|Exhaled Breath Condensate|exhaled breath condensate
5228365|NCT00715338|elective surgery|elective surgery
5228366|NCT00715338|mechanical ventilation|mechanical ventilation
5228367|NCT00715338|Isofurans|isofurans
5228368|NCT00715338|thrombomodulin|thrombomodulin
5228369|NCT00715338|requiring|requiring
5228370|NCT00715338|mechanical|mechanical
5228371|NCT00715338|ventilation|ventilation
5228372|NCT00715325|colonoscopy|colonoscopy
5228373|NCT00715325|disposable|disposable
5228374|NCT00715325|single use|single use
5228375|NCT00715312|Inflammation|inflammation
5228376|NCT00715312|LDL|ldl
5228377|NCT00715312|Oleic acid|oleic acid
5228378|NCT00715312|Palmitic acid|palmitic acid
5228379|NCT00715312|trans fatty acid|trans fatty acid
5228380|NCT00715312|C-reactive protein|c-reactive protein
5228381|NCT00715286|epithelial ovarian cancer|epithelial ovarian cancer
5228382|NCT00715286|neoadjuvant chemotherapy|neoadjuvant chemotherapy
5228383|NCT00715286|randomized study|randomized study
5228384|NCT00715273|Magnetic Resonance Imaging|magnetic resonance imaging
5228385|NCT00715273|Atherosclerotic Plaque|atherosclerotic plaque
5228386|NCT00715273|Lipid Lowering Therapy|lipid lowering therapy
5228387|NCT00715247|Myeloproliferative Disorders|myeloproliferative disorders
5228388|NCT00715247|Hematological Malignancies|hematological malignancies
5228389|NCT00715247|Polycythemia Vera|polycythemia vera
5228390|NCT00715247|Essential Thrombocythemia|essential thrombocythemia
5228391|NCT00715247|Myelofibrosis|myelofibrosis
5228392|NCT00715247|Genetics|genetics
5228393|NCT00715247|Chronic Leukemia|chronic leukemia
5228394|NCT00715234|adolescent reminder/recall|adolescent reminder/recall
5228395|NCT00715234|adolescent vaccines|adolescent vaccines
5228396|NCT00715234|Tdap|tdap
5228397|NCT00715234|Meningococcal|meningococcal
5228398|NCT00715234|HPV|hpv
5228399|NCT00715234|Reminder cards|reminder cards
5228400|NCT00715234|Recall messages|recall messages
5228401|NCT00715234|vaccine|vaccine
5228402|NCT00715234|conjugate|conjugate
5228403|NCT00715221|Diabetes|diabetes
5228404|NCT00715195|Cognitive behavioral|cognitive behavioral
5228405|NCT00715195|Long-term study|long-term study
5228406|NCT00715195|Education|education
5228407|NCT00715182|Renal Cell Cancer|renal cell cancer
5228408|NCT00715156|allergy, peach, birch|allergy, peach, birch
5228409|NCT00715156|recombinants allergens diagnosis|recombinants allergens diagnosis
5228410|NCT00715156|OAS|oas
5228411|NCT00715156|LTP|ltp
5228412|NCT00715156|systemic reactions|systemic reactions
5228413|NCT00715156|subjects with severe reaction to other fruits|subjects with severe reaction to other fruits
5228414|NCT00715143|hip|hip
5228415|NCT00715143|replacement|replacement
5228416|NCT00715143|ceramic|ceramic
5228417|NCT00715143|orthopaedic|orthopaedic
5228418|NCT00715143|joint|joint
5228419|NCT00715143|degenerative|degenerative
5228420|NCT00715143|non-inflammatory|non-inflammatory
5228421|NCT00715143|osteoarthritis|osteoarthritis
5228422|NCT00715143|avascular necrosis|avascular necrosis
5228423|NCT00715143|congenital hip dysplasia|congenital hip dysplasia
5228424|NCT00715143|traumatic arthritis|traumatic arthritis
5228425|NCT00715130|Energy|energy
5228426|NCT00715130|Obesity|obesity
5228427|NCT00715130|Energy Balance|energy balance
5228428|NCT00715130|Physical Activity|physical activity
5228429|NCT00715130|Dietary Intake|dietary intake
5228430|NCT00715130|Overweight|overweight
5228431|NCT00715130|Sedentary|sedentary
5228432|NCT00715130|Worksite|worksite
5228433|NCT00715130|Body Mass Index|body mass index
5228434|NCT00715130|Weight Maintenance|weight maintenance
5228435|NCT00715117|children|children
5228436|NCT00715117|pediatric|pediatric
5228437|NCT00715117|Crohn's Disease|crohn's disease
5228438|NCT00715117|naltrexone|naltrexone
5228439|NCT00715117|LDN|ldn
5228440|NCT00715117|IBD|ibd
5228441|NCT00715117|Inflammatory bowel disease|inflammatory bowel disease
5228442|NCT00715091|NSAIDS|nsaids
5228443|NCT00715091|ankylosing spondylitis|ankylosing spondylitis
5228444|NCT00715091|SpA|spa
5228445|NCT00715091|Spondyloarthritis|spondyloarthritis
5228446|NCT00715091|radiographic changes|radiographic changes
5228447|NCT00715078|prostate cancer|prostate cancer
5228448|NCT00715078|prostate|prostate
5228449|NCT00715078|immune therapy|immune therapy
5228450|NCT00715078|immunotherapy|immunotherapy
5228451|NCT00715078|vaccine|vaccine
5228452|NCT00715078|dendritic cells|dendritic cells
5228453|NCT00715078|antigen-presenting cells|antigen-presenting cells
5228454|NCT00715078|antigen presenting cells|antigen presenting cells
5228455|NCT00715078|cancer vaccine|cancer vaccine
5228456|NCT00715078|prostate specific antigen (PSA)|prostate specific antigen (psa)
5228457|NCT00715078|prostatic adenocarcinoma|prostatic adenocarcinoma
5228458|NCT00715065|syncope|syncope
5228459|NCT00715065|faint|faint
5228460|NCT00715065|blood|blood
5228461|NCT00715065|blood injury phobia|blood injury phobia
5228462|NCT00715065|phobia|phobia
5228463|NCT00715052|neurologic deficiency due traumatic brain injury|neurologic deficiency due traumatic brain injury
5228464|NCT00715039|generalized anxiety disorder|generalized anxiety disorder
5228465|NCT00715039|onset of efficacy|onset of efficacy
5228466|NCT00715039|Daily Assessment of Symptoms-Anxiety (DAS-A)|daily assessment of symptoms-anxiety (das-a)
5228467|NCT00715039|Methods|methods
5228468|NCT00715026|Arthritis|arthritis
5228469|NCT00715026|Total Hip|total hip
5228470|NCT00715026|Ceramic|ceramic
5228471|NCT00715026|Hip Replacement|hip replacement
5228472|NCT00715026|Total Hip Arthroplasty (THA)|total hip arthroplasty (tha)
5228473|NCT00715026|Joint Disease|joint disease
5228474|NCT00715013|recurrent Glioblastoma|recurrent glioblastoma
5228475|NCT00715000|Preterm babies hydration|preterm babies hydration
5228476|NCT00715000|Oral rehydration solution|oral rehydration solution
5228477|NCT00715000|Continuous gastric drip|continuous gastric drip
5228478|NCT00715000|Fluid therapy|fluid therapy
5228479|NCT00715000|Premature babies comfort|premature babies comfort
5228480|NCT00715000|Infant care|infant care
5228481|NCT00715000|Technical challenge for the nurses/doctors in charge|technical challenge for the nurses/doctors in charge
5228482|NCT00714987|ARDS|ards
5228483|NCT00714987|Mechanical ventilation|mechanical ventilation
5228484|NCT00714987|PEEP with low level|peep with low level
5228485|NCT00714987|PEEP with high level|peep with high level
5228486|NCT00714987|EVLW|evlw
5228487|NCT00714987|Picco® system|picco® system
5228488|NCT00714987|PaO2/FiO2 ratio|pao2/fio2 ratio
5228489|NCT00714974|Neuromuscular blocking agents|neuromuscular blocking agents
5228490|NCT00714974|Bispectral analysis|bispectral analysis
5228491|NCT00714948|Bladder|bladder
5228492|NCT00714948|Urinary|urinary
5228493|NCT00714948|SORAFENIB|sorafenib
5228494|NCT00714948|CISPLATIN|cisplatin
5228495|NCT00714948|GEMCITABINE|gemcitabine
5228496|NCT00714935|Risk Factors|risk factors
5228497|NCT00714935|Risk Reduction Behavior|risk reduction behavior
5228498|NCT00714935|Counseling|counseling
5228499|NCT00714909|Breast cancer|breast cancer
5228500|NCT00714909|Catheter related thrombosis|catheter related thrombosis
5228501|NCT00714909|Diagnosis|diagnosis
5228502|NCT00714909|Echography doppler|echography doppler
5228503|NCT00714909|Risk factors|risk factors
5228504|NCT00714896|smoking cessation|smoking cessation
5228505|NCT00714896|nicotine dependence|nicotine dependence
5228506|NCT00714896|stage-based intervention|stage-based intervention
5228507|NCT00714896|nicotine replacement medications|nicotine replacement medications
5228508|NCT00714896|counseling|counseling
5228509|NCT00714896|substance abuse treatment|substance abuse treatment
5228510|NCT00714883|drug-eluting stents|drug-eluting stents
5228511|NCT00714883|Percutaneous coronary intervention (PCI)|percutaneous coronary intervention (pci)
5228513|NCT00714870|Quality of life|quality of life
5228514|NCT00714857|ICU patients|icu patients
5228515|NCT00714857|Dexmedetomidine|dexmedetomidine
5228516|NCT00714857|Sedation|sedation
5228517|NCT00714857|Judged|judged
5228518|NCT00714857|Attending|attending
5228519|NCT00714857|Physician|physician
5228520|NCT00714844|insulin therapy|insulin therapy
5228521|NCT00714844|insulin detemir|insulin detemir
5228522|NCT00714844|waist circumference|waist circumference
5228523|NCT00714831|Physical activity promotion|physical activity promotion
5228524|NCT00714831|Primary health care|primary health care
5228525|NCT00714831|Adherence|adherence
5228526|NCT00714818|Schizophrenia|schizophrenia
5228527|NCT00714818|Bipolar Disorder|bipolar disorder
5228528|NCT00714818|Schizoaffective disorder|schizoaffective disorder
5228529|NCT00714818|Genetic Counseling|genetic counseling
5228530|NCT00714818|Risk perception|risk perception
5228531|NCT00714818|Stigma|stigma
5228532|NCT00714818|Control|control
5228533|NCT00714818|Knowledge|knowledge
5228534|NCT00714818|family members|family members
5228535|NCT00714818|Sibling parent or child with schizophrenia|sibling parent or child with schizophrenia
5228536|NCT00714818|Sibling parent or child with bipolar disorder|sibling parent or child with bipolar disorder
5228537|NCT00714818|Sibling parent or child with schizoaffective disorder|sibling parent or child with schizoaffective disorder
5228538|NCT00714805|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
5228539|NCT00714805|Gastric Motility|gastric motility
5228835|NCT00713570|COMT|comt
5228540|NCT00714805|Autonomic Nervous System|autonomic nervous system
5228541|NCT00714805|Neurodegenerative Diseases|neurodegenerative diseases
5228542|NCT00714805|Movement Disorders|movement disorders
5228543|NCT00714805|Gastrointestinal Motility|gastrointestinal motility
5228544|NCT00714779|Major depressive Disorder|major depressive disorder
5228545|NCT00714779|fluoxetine|fluoxetine
5228546|NCT00714779|short-term psychodynamic psychotherapy|short-term psychodynamic psychotherapy
5228547|NCT00714779|PET|pet
5228548|NCT00714753|stage I prostate cancer|stage i prostate cancer
5228549|NCT00714753|stage II prostate cancer|stage ii prostate cancer
5228550|NCT00714753|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5228551|NCT00714740|apnea, sleep, altitude, hypoxia|apnea, sleep, altitude, hypoxia
5228552|NCT00714727|migraine|migraine
5228553|NCT00714727|headache|headache
5228554|NCT00714727|acupuncture|acupuncture
5228555|NCT00714714|acne|acne
5228556|NCT00714714|irritation|irritation
5228557|NCT00714714|objective sensory methods|objective sensory methods
5228558|NCT00714688|Adult|adult
5228559|NCT00714688|ADHD|adhd
5228560|NCT00714688|Concerta|concerta
5228561|NCT00714675|citrulline|citrulline
5228562|NCT00714675|protein-energy malnutrition|protein-energy malnutrition
5228563|NCT00714675|aged|aged
5228564|NCT00714675|protein biosynthesis|protein biosynthesis
5228565|NCT00714675|amino acid|amino acid
5228566|NCT00714662|high flux hemodialysis|high flux hemodialysis
5228567|NCT00714649|Head and Neck Squamous Cell Carcinoma treated with surgery|head and neck squamous cell carcinoma treated with surgery
5228568|NCT00714649|and/or radiotherapy|and/or radiotherapy
5228569|NCT00714636|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
5228570|NCT00714636|Cerebrospinal Fluid|cerebrospinal fluid
5228571|NCT00714636|Neurodegenerative Disease|neurodegenerative disease
5228572|NCT00714636|Motor Neuron Disease|motor neuron disease
5228573|NCT00714636|Autonomic Nervous System|autonomic nervous system
5228574|NCT00714636|Neurodegenerative Diseases|neurodegenerative diseases
5228575|NCT00714636|Movement Disorders|movement disorders
5228576|NCT00714623|Coronary Artery Disease|coronary artery disease
5228577|NCT00714623|Coronary Restenosis|coronary restenosis
5228578|NCT00714623|Coronary Thrombosis|coronary thrombosis
5228579|NCT00714623|Drug-Eluting Stents|drug-eluting stents
5228580|NCT00714623|Angioplasty, Transluminal, Percutaneous Coronary|angioplasty, transluminal, percutaneous coronary
5228581|NCT00714610|Serum metal ion concentration|serum metal ion concentration
5228582|NCT00714597|Venous thrombosis|venous thrombosis
5228583|NCT00714597|Primary prevention|primary prevention
5228584|NCT00714584|Infusions, Intravenous|infusions, intravenous
5228585|NCT00714584|Safety|safety
5228586|NCT00714584|Pharmacokinetics|pharmacokinetics
5228587|NCT00714584|Naltrexone|naltrexone
5228588|NCT00714584|Administration, Oral|administration, oral
5228589|NCT00714571|cognitive rehabilitation|cognitive rehabilitation
5228590|NCT00714571|explicit memory training|explicit memory training
5228591|NCT00714571|mild cognitive impairment|mild cognitive impairment
5228592|NCT00714571|Alzheimer's disease|alzheimer's disease
5228593|NCT00714571|traumatic brain injury|traumatic brain injury
5228594|NCT00714571|veterans|veterans
5228595|NCT00714558|Pharmacokinetics|pharmacokinetics
5228596|NCT00714558|Administration, Oral|administration, oral
5228597|NCT00714558|Naltrexone|naltrexone
5228598|NCT00714558|Biological Availability|biological availability
5228599|NCT00714558|Infusions, Intravenous|infusions, intravenous
5228600|NCT00714558|Fentanyl|fentanyl
5228601|NCT00714558|Safety|safety
5228602|NCT00714558|Naloxone|naloxone
5228603|NCT00714545|Coronary Artery Disease|coronary artery disease
5228604|NCT00714545|Coronary Restenosis|coronary restenosis
5228605|NCT00714545|Brachytherapy|brachytherapy
5228606|NCT00714532|smoking cessation|smoking cessation
5228607|NCT00714532|Asian American|asian american
5228608|NCT00714532|Chinese American|chinese american
5228609|NCT00714532|smoking reduction|smoking reduction
5228610|NCT00714532|stage-based intervention|stage-based intervention
5228611|NCT00714532|expert system|expert system
5228612|NCT00714532|nicotine replacement|nicotine replacement
5228613|NCT00714532|counseling|counseling
5228614|NCT00714519|Xenaderm|xenaderm
5228615|NCT00714519|partial|partial
5228616|NCT00714519|thickness|thickness
5228617|NCT00714519|wounds|wounds
5228618|NCT00714519|Nursing Homes|nursing homes
5228619|NCT00714506|obesity|obesity
5228620|NCT00714506|physical activity|physical activity
5228621|NCT00714506|older adults|older adults
5228622|NCT00714506|functional disability|functional disability
5228623|NCT00714493|rheumatoid arthritis|rheumatoid arthritis
5228624|NCT00714493|remicade|remicade
5228625|NCT00714493|infliximab|infliximab
5228626|NCT00714493|Centocor|centocor
5228627|NCT00714493|etanercept|etanercept
5228628|NCT00714493|enbrel|enbrel
5228629|NCT00714493|adalimumab|adalimumab
5228630|NCT00714493|humira|humira
5228631|NCT00714493|restart|restart
5228632|NCT00714493|swollen joints|swollen joints
5228633|NCT00714493|tender joints.|tender joints.
5228634|NCT00714480|Thymoglobulin|thymoglobulin
5228635|NCT00714480|Renal Transplant|renal transplant
5228636|NCT00714480|Kidney Transplant|kidney transplant
5228637|NCT00714480|Immunosuppression|immunosuppression
5228638|NCT00714480|Induction therapy|induction therapy
5228639|NCT00714467|smoking cessation|smoking cessation
5228640|NCT00714467|Asian|asian
5228641|NCT00714467|Chinese American|chinese american
5228642|NCT00714467|family support|family support
5228643|NCT00714467|social support|social support
5228644|NCT00714467|stage-based intervention|stage-based intervention
5228645|NCT00714441|Diabetes Type 2|diabetes type 2
5228646|NCT00714441|Distress|distress
5228647|NCT00714441|Problem Solving Therapy|problem solving therapy
5228648|NCT00714441|Computer Automated Self-Management (CASM)|computer automated self-management (casm)
5228649|NCT00714428|Traumatic Brain Injury|traumatic brain injury
5228650|NCT00714428|Quality of Life|quality of life
5228651|NCT00714402|UTI|uti
5228652|NCT00714389|Urogynecology|urogynecology
5228653|NCT00714376|Prostate cancer|prostate cancer
5228654|NCT00714376|High-risk prostate cancer|high-risk prostate cancer
5228655|NCT00714376|Radical prostatectomy|radical prostatectomy
5228656|NCT00714376|Early rising PSA|early rising psa
5228657|NCT00714376|Taxotere|taxotere
5228658|NCT00714376|Docetaxel|docetaxel
5228659|NCT00714350|Information Display|information display
5228660|NCT00714350|situational awareness|situational awareness
5228661|NCT00714350|Create intuitive visualization|create intuitive visualization
5228662|NCT00714337|Formulation|formulation
5228663|NCT00714337|pharmacokinetics|pharmacokinetics
5228664|NCT00714324|Nutrition|nutrition
5228665|NCT00714324|Screening|screening
5228666|NCT00714311|borderline personality disorder|borderline personality disorder
5228667|NCT00714311|randomized controlled trial|randomized controlled trial
5228668|NCT00714311|Transference-Focused Psychotherapy|transference-focused psychotherapy
5228669|NCT00714311|treatment by experienced community psychotherapists|treatment by experienced community psychotherapists
5228670|NCT00714298|biological markers|biological markers
5228671|NCT00714298|emergency service hospital|emergency service hospital
5228672|NCT00714298|heart fatty acid binding protein|heart fatty acid binding protein
5228673|NCT00714298|ischemia modified albumin|ischemia modified albumin
5228674|NCT00714285|Primary study|primary study
5228675|NCT00714285|immunogenicity|immunogenicity
5228676|NCT00714285|safety|safety
5228677|NCT00714259|Low Grade B Cell Malignancies|low grade b cell malignancies
5228678|NCT00714259|nonmyeloablative transplant|nonmyeloablative transplant
5228679|NCT00714259|allogeneic|allogeneic
5228680|NCT00714246|advanced non small cell lung cancer|advanced non small cell lung cancer
5228681|NCT00714233|Polycystic Ovary Syndrome|polycystic ovary syndrome
5228682|NCT00714233|Overweight Adolescent Girls|overweight adolescent girls
5228683|NCT00714233|Irregular Menstrual Cycles|irregular menstrual cycles
5228684|NCT00714220|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
5228685|NCT00714220|Gastric Motility|gastric motility
5228686|NCT00714220|Autonomic Nervous System|autonomic nervous system
5228687|NCT00714220|Neurodegenerative Diseases|neurodegenerative diseases
5228688|NCT00714220|Movement Disorders|movement disorders
5228689|NCT00714220|Substrate Utilization|substrate utilization
5228690|NCT00714207|adolescents|adolescents
5228691|NCT00714207|smoking|smoking
5228692|NCT00714207|smoking cessation|smoking cessation
5228693|NCT00714207|tobacco use|tobacco use
5228694|NCT00714194|sedation|sedation
5228695|NCT00714194|delirium|delirium
5228696|NCT00714194|sleep|sleep
5228697|NCT00714194|sedation withdrawal|sedation withdrawal
5228698|NCT00714194|ICU patients|icu patients
5228699|NCT00714181|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5228700|NCT00714168|Weight Loss|weight loss
5228701|NCT00714168|Weight Control|weight control
5228702|NCT00714155|Colpocleisis|colpocleisis
5228703|NCT00714142|Renal blood flow|renal blood flow
5228704|NCT00714142|PET imaging|pet imaging
5228705|NCT00714129|Steatosis|steatosis
5228706|NCT00714129|Diabetes|diabetes
5228707|NCT00714116|safety|safety
5228708|NCT00714116|pharmacokinetics|pharmacokinetics
5228709|NCT00714103|Leukemia|leukemia
5228710|NCT00714103|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
5228711|NCT00714103|CLL|cll
5228712|NCT00714103|8-Chloro-Adenosine|8-chloro-adenosine
5228713|NCT00714103|purine analogues|purine analogues
5228714|NCT00714103|Cancer|cancer
5228715|NCT00714090|repetitive Transcranial Magnetic Stimulation (rTMS)|repetitive transcranial magnetic stimulation (rtms)
5228716|NCT00714090|Major depressive disorders|major depressive disorders
5228717|NCT00714090|Depression|depression
5228718|NCT00714090|Venlafaxine|venlafaxine
5228719|NCT00714077|rectal cancer|rectal cancer
5228720|NCT00714077|concurrent chemoradiotherapy|concurrent chemoradiotherapy
5228721|NCT00714077|adjuvant therapy|adjuvant therapy
5228722|NCT00714077|phase III study|phase iii study
5228723|NCT00714038|Quality development project|quality development project
5228724|NCT00714038|primary care nurses|primary care nurses
5228725|NCT00714038|asthma|asthma
5228726|NCT00714038|patient compliance|patient compliance
5228727|NCT00714038|follow-up|follow-up
5228728|NCT00714025|RAD001|rad001
5228729|NCT00714025|TCC|tcc
5228730|NCT00714025|Palliative treatment|palliative treatment
5228731|NCT00714025|advance or metastatic TCC|advance or metastatic tcc
5228732|NCT00714025|Failure after Platinum-based chemotherapy|failure after platinum-based chemotherapy
5228733|NCT00714012|Display development|display development
5228734|NCT00714012|Intuitive display use|intuitive display use
5228735|NCT00714012|visualizations are intuitive|visualizations are intuitive
5228736|NCT00713999|Sexually transmitted infections|sexually transmitted infections
5228737|NCT00713999|Urogenital schistosomiasis|urogenital schistosomiasis
5228738|NCT00713999|Schistosoma haematobium|schistosoma haematobium
5228739|NCT00713999|Reproductive health|reproductive health
5228740|NCT00713999|Pelvic examination|pelvic examination
5228741|NCT00713999|Ultrasonography|ultrasonography
5228742|NCT00713999|Questionnaire|questionnaire
5228743|NCT00713999|Madagascar|madagascar
5228744|NCT00713986|Pain|pain
5228745|NCT00713986|Newborn Infant|newborn infant
5228746|NCT00713986|Analgesia|analgesia
5228747|NCT00713960|Quality development project|quality development project
5228748|NCT00713960|primary care nurses|primary care nurses
5228749|NCT00713960|cardiovascular disease|cardiovascular disease
5228750|NCT00713960|secondary prevention|secondary prevention
5228751|NCT00713960|follow-up|follow-up
5228752|NCT00713947|Gastric lesions induced by low dose of aspirin|gastric lesions induced by low dose of aspirin
5228753|NCT00713947|Helicobacter pylori|helicobacter pylori
5228754|NCT00713934|Autologous Bone marrow stem cells|autologous bone marrow stem cells
5228755|NCT00713934|Cirrhosis|cirrhosis
5228756|NCT00713921|Female|female
5228757|NCT00713921|Diabetics|diabetics
5228758|NCT00713921|Stroke|stroke
5228759|NCT00713908|Voiding dysfunction following TVT placement|voiding dysfunction following tvt placement
5228760|NCT00713895|smoking cessation|smoking cessation
5228761|NCT00713895|randomized trial|randomized trial
5228762|NCT00713895|Asian|asian
5228763|NCT00713895|Chinese American|chinese american
5228764|NCT00713895|stages of change|stages of change
5228765|NCT00713882|Survivors|survivors
5228766|NCT00713882|Quality of Life|quality of life
5228767|NCT00713869|Oocyte cryopreservation|oocyte cryopreservation
5228768|NCT00713869|Slow freeze|slow freeze
5228769|NCT00713843|Neck Pain|neck pain
5228770|NCT00713843|Manuel Therapy Utrecht|manuel therapy utrecht
5228771|NCT00713843|Physiotherapy|physiotherapy
5228772|NCT00713830|hyperglycemia, GLP-1|hyperglycemia, glp-1
5228773|NCT00713817|Pain|pain
5228774|NCT00713817|Peripheral Neuropathy|peripheral neuropathy
5228775|NCT00713804|Schizophrenia|schizophrenia
5228776|NCT00713804|Bipolar Disorder|bipolar disorder
5228777|NCT00713804|Schizoaffective disorder|schizoaffective disorder
5228778|NCT00713804|Genetic Counseling|genetic counseling
5228779|NCT00713804|Risk perception|risk perception
5228780|NCT00713804|Stigma|stigma
5228781|NCT00713804|Control|control
5228782|NCT00713804|Knowledge|knowledge
5228783|NCT00713791|Healthy Volunteers|healthy volunteers
5228784|NCT00713791|ZD4054|zd4054
5228785|NCT00713778|Ovarian Cysts|ovarian cysts
5228786|NCT00713778|Electrocoagulation|electrocoagulation
5228787|NCT00713778|Ovarian Function Tests|ovarian function tests
5228788|NCT00713778|Laparoscopy|laparoscopy
5228789|NCT00713765|Healthy volunteers|healthy volunteers
5228790|NCT00713752|HIV-negative|hiv-negative
5228791|NCT00713739|kidney stones|kidney stones
5228792|NCT00713739|ureteral stones|ureteral stones
5228793|NCT00713739|medical expulsion therapy|medical expulsion therapy
5228794|NCT00713726|Pain|pain
5228795|NCT00713726|Analgesia|analgesia
5228796|NCT00713726|Newborn Infant|newborn infant
5228797|NCT00713726|Opioids|opioids
5228798|NCT00713726|Side-effects|side-effects
5228799|NCT00713726|Intensive care|intensive care
5228800|NCT00713726|Postoperative|postoperative
5228801|NCT00713713|Respiratory Distress Syndrome, Adult|respiratory distress syndrome, adult
5228802|NCT00713713|Tidal volume|tidal volume
5228803|NCT00713713|cardiac output|cardiac output
5228804|NCT00713713|Respiration, Artificial|respiration, artificial
5228805|NCT00713713|Protective ventilation|protective ventilation
5228806|NCT00713700|patent ductus arteriosus|patent ductus arteriosus
5228807|NCT00713700|PDA|pda
5228808|NCT00713687|photodynamic therapy|photodynamic therapy
5228809|NCT00713687|PDT|pdt
5228810|NCT00713687|gemcitabine|gemcitabine
5228811|NCT00713687|oxaliplatin|oxaliplatin
5228812|NCT00713687|cholangiocarcinoma|cholangiocarcinoma
5228813|NCT00713674|Methicillin resistance|methicillin resistance
5228814|NCT00713661|Colorectal Anastomosis|colorectal anastomosis
5228815|NCT00713661|Colorectal Resection|colorectal resection
5228816|NCT00713661|Tachosil|tachosil
5228817|NCT00713635|Congenital Heart Disease|congenital heart disease
5228818|NCT00713622|Partial|partial
5228819|NCT00713622|onset|onset
5228820|NCT00713622|seizures|seizures
5228821|NCT00713609|Acne|acne
5228822|NCT00713609|Acne Vulgaris|acne vulgaris
5228823|NCT00713609|Pimples|pimples
5228824|NCT00713596|Nasal Surgery|nasal surgery
5228825|NCT00713596|Septorhinoplasty|septorhinoplasty
5228826|NCT00713596|fibrin glue|fibrin glue
5228827|NCT00713596|fibrinogen|fibrinogen
5228828|NCT00713596|Swelling|swelling
5228829|NCT00713596|fibrin|fibrin
5228830|NCT00713596|tisseel|tisseel
5228831|NCT00713583|Cocaine, levodopa, contingency management|cocaine, levodopa, contingency management
5228832|NCT00713570|intellectual functioning|intellectual functioning
5228833|NCT00713570|memory,visual-spatial and perceptual functions|memory,visual-spatial and perceptual functions
5228834|NCT00713570|cognitive abilities|cognitive abilities
5228836|NCT00713570|BDNF|bdnf
5228837|NCT00713570|neuron biological systemic pathway candidate genes|neuron biological systemic pathway candidate genes
5228838|NCT00713570|Chinese|chinese
5228839|NCT00713570|Taiwan|taiwan
5228840|NCT00713570|Healthy subjects|healthy subjects
5228841|NCT00713557|coronary angioplasty|coronary angioplasty
5228842|NCT00713544|Rheumatoid Arthritis|rheumatoid arthritis
5228843|NCT00713544|RA|ra
5228844|NCT00713544|AZD5672|azd5672
5228845|NCT00713531|HIV-negative|hiv-negative
5228846|NCT00713531|male and female clients|male and female clients
5228847|NCT00713531|ages 18-50 years|ages 18-50 years
5228848|NCT00713531|seeking HIV counseling|seeking hiv counseling
5228849|NCT00713531|testing at TRCARC|testing at trcarc
5228850|NCT00713518|AMD Age Related Macular Degeneration Choroidal Neovascularization Monet|amd age related macular degeneration choroidal neovascularization monet
5228851|NCT00713505|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
5228852|NCT00713505|long-term effects secondary to cancer therapy in children|long-term effects secondary to cancer therapy in children
5228853|NCT00713505|cancer survivor|cancer survivor
5228854|NCT00713505|cognitive/functional effects|cognitive/functional effects
5228855|NCT00713505|childhood acute lymphoblastic leukemia|childhood acute lymphoblastic leukemia
5228856|NCT00713505|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
5228857|NCT00713505|childhood anaplastic large cell lymphoma|childhood anaplastic large cell lymphoma
5228858|NCT00713505|childhood large cell lymphoma|childhood large cell lymphoma
5228859|NCT00713505|childhood lymphoblastic lymphoma|childhood lymphoblastic lymphoma
5228860|NCT00713505|childhood small noncleaved cell lymphoma|childhood small noncleaved cell lymphoma
5228861|NCT00713505|childhood nasal type extranodal NK/T-cell lymphoma|childhood nasal type extranodal nk/t-cell lymphoma
5228862|NCT00713505|childhood grade III lymphomatoid granulomatosis|childhood grade iii lymphomatoid granulomatosis
5228863|NCT00713505|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
5228864|NCT00713492|Alcohol|alcohol
5228865|NCT00713492|Self -Administration|self -administration
5228866|NCT00713492|Intoxication|intoxication
5228867|NCT00713492|Healthy Volunteer|healthy volunteer
5228868|NCT00713492|HV|hv
5228869|NCT00713479|methamphetamine|methamphetamine
5228870|NCT00713479|varenicline|varenicline
5228871|NCT00713479|Chantix|chantix
5228872|NCT00713479|stimulant|stimulant
5228873|NCT00713479|crystal meth|crystal meth
5228874|NCT00713466|CLIPP cases|clipp cases
5228875|NCT00713466|Pediatric clerkship|pediatric clerkship
5228876|NCT00713466|Standardizing|standardizing
5228877|NCT00713466|Students' exposure|students' exposure
5228878|NCT00713466|Essential|essential
5228879|NCT00713466|Enhancing|enhancing
5228880|NCT00713466|Experience|experience
5228881|NCT00713453|Pompe disease|pompe disease
5228882|NCT00713453|muscle|muscle
5228883|NCT00713453|enzyme replacement therapy|enzyme replacement therapy
5228884|NCT00713440|Incretin Effect|incretin effect
5228885|NCT00713440|Steroids|steroids
5228886|NCT00713440|Glucagon-Like Peptide 1|glucagon-like peptide 1
5228887|NCT00713440|Gastric Inhibitory Peptide|gastric inhibitory peptide
5228888|NCT00713440|Glucose-dependent Insulinotropic Polypeptide|glucose-dependent insulinotropic polypeptide
5228889|NCT00713440|Insulin|insulin
5228890|NCT00713440|C-peptide|c-peptide
5228891|NCT00713440|Glucagon|glucagon
5228892|NCT00713427|Biliary|biliary
5228893|NCT00713427|Strictures|strictures
5228894|NCT00713427|Malignant|malignant
5228895|NCT00713427|Neoplasm|neoplasm
5228896|NCT00713427|Palliation|palliation
5228897|NCT00713414|Spasmodic Dysphonia|spasmodic dysphonia
5228898|NCT00713414|Dystonia|dystonia
5228899|NCT00713414|Basal Ganglia|basal ganglia
5228900|NCT00713414|PET Imaging|pet imaging
5228901|NCT00713414|fMRI|fmri
5228902|NCT00713414|Voice Disorder|voice disorder
5228903|NCT00713414|Healthy Volunteer|healthy volunteer
5228904|NCT00713414|HV|hv
5228905|NCT00713375|Autonomic Nervous System|autonomic nervous system
5228906|NCT00713375|Subarachnoid Hemorrhage|subarachnoid hemorrhage
5228907|NCT00713375|Intracranial Hemorrhages|intracranial hemorrhages
5228908|NCT00713375|Cerebral Hemorrhage|cerebral hemorrhage
5228909|NCT00713362|Aspiration, chest tube, pneumothorax, thoracoscopic surgery|aspiration, chest tube, pneumothorax, thoracoscopic surgery
5228910|NCT00713349|White|white
5228911|NCT00713349|Petrolatum|petrolatum
5228912|NCT00713349|Xenaderm|xenaderm
5228913|NCT00713349|Vehicle|vehicle
5228914|NCT00713349|Partial thickness wounds|partial thickness wounds
5228915|NCT00713349|Healing|healing
5228916|NCT00713349|Cryo-surgery|cryo-surgery
5228917|NCT00713336|ZD4054|zd4054
5228918|NCT00713336|Healthy Volunteers|healthy volunteers
5228919|NCT00713336|QT interval|qt interval
5228920|NCT00713323|Pain|pain
5228921|NCT00713323|Peripheral Neuropathy|peripheral neuropathy
5228922|NCT00713297|medication errors|medication errors
5228923|NCT00713297|computerized physician order entry|computerized physician order entry
5228924|NCT00713297|pharmaceutical care|pharmaceutical care
5228925|NCT00713297|chemotherapeutic agents|chemotherapeutic agents
5228926|NCT00713297|reengineering|reengineering
5228927|NCT00713284|Kidney transplantation|kidney transplantation
5228928|NCT00713284|Sirolimus|sirolimus
5228929|NCT00713284|Immunosuppression|immunosuppression
5228930|NCT00713284|Tacrolimus|tacrolimus
5228931|NCT00713271|Healthy male|healthy male
5228932|NCT00713271|tolerability|tolerability
5228933|NCT00713271|safety|safety
5228934|NCT00713271|inhalation|inhalation
5228935|NCT00713258|Postmenopausal women|postmenopausal women
5228936|NCT00713258|Back pain|back pain
5228937|NCT00713258|Osteoporosis related fracture|osteoporosis related fracture
5228938|NCT00713245|Pompe disease|pompe disease
5228939|NCT00713245|late onset|late onset
5228940|NCT00713232|naming test|naming test
5228941|NCT00713219|IMRT|imrt
5228942|NCT00713219|cetuximab|cetuximab
5228943|NCT00713219|docetaxel|docetaxel
5228944|NCT00713206|Dental implants, maxilla, sinus lift, augmentation|dental implants, maxilla, sinus lift, augmentation
5228945|NCT00713193|Idiopathic TTP|idiopathic ttp
5228946|NCT00713193|Treatment|treatment
5228947|NCT00713193|Exacerbation|exacerbation
5228948|NCT00713193|Relapse|relapse
5228949|NCT00713193|Plasma Exchange|plasma exchange
5228950|NCT00713167|Grape Seed Extract|grape seed extract
5228951|NCT00713167|Hyperlipidemia|hyperlipidemia
5228952|NCT00713154|Radiotherapy|radiotherapy
5228953|NCT00713154|induced|induced
5228954|NCT00713128|nausea vomiting colorectal cancer|nausea vomiting colorectal cancer
5228955|NCT00713115|laparoscopy, needlescopy, adrenalectomy|laparoscopy, needlescopy, adrenalectomy
5228956|NCT00713102|in-flight emergency|in-flight emergency
5228957|NCT00713089|Eczema|eczema
5228958|NCT00713089|Asthma|asthma
5228959|NCT00713089|Allergic rhinitis|allergic rhinitis
5228960|NCT00713089|Singapore|singapore
5228961|NCT00713089|Indonesia|indonesia
5228962|NCT00713089|Gastrointestinal Flora|gastrointestinal flora
5228963|NCT00713076|multi-purpose solution|multi-purpose solution
5228964|NCT00713076|contact lens wearers|contact lens wearers
5228965|NCT00713076|Contact lense wearers|contact lense wearers
5228966|NCT00713063|smoking cessation|smoking cessation
5228967|NCT00713063|exercise|exercise
5228968|NCT00713063|physical activity|physical activity
5228969|NCT00713063|health education|health education
5228970|NCT00713050|stroke|stroke
5228971|NCT00713050|aphasia|aphasia
5228972|NCT00713050|imitation|imitation
5228973|NCT00713050|mirror neuron|mirror neuron
5228974|NCT00713037|fluoromisonidazole|fluoromisonidazole
5228975|NCT00713037|PET scan|pet scan
5228976|NCT00713037|Hypoxia-PET|hypoxia-pet
5228977|NCT00713037|IMPT|impt
5228978|NCT00713024|Pain; Functional neuroimaging; Neuropathy; Thermal sensation|pain; functional neuroimaging; neuropathy; thermal sensation
5228979|NCT00713011|Adalat XL|adalat xl
5228980|NCT00713011|Diltiazem|diltiazem
5228981|NCT00713011|Tiazac XC|tiazac xc
5228982|NCT00713011|Proteinuria|proteinuria
5228983|NCT00712998|radiation injuries|radiation injuries
5228984|NCT00712998|free radicals|free radicals
5228985|NCT00712998|reactive oxygen species|reactive oxygen species
5228986|NCT00712998|radiation injury from X-ray computed tomography|radiation injury from x-ray computed tomography
5228987|NCT00712998|free radical production|free radical production
5228988|NCT00712998|blood reactive oxygen species level|blood reactive oxygen species level
5228989|NCT00712985|Breast cancer|breast cancer
5228990|NCT00712985|aromatase inhibitors|aromatase inhibitors
5228991|NCT00712972|knee injection|knee injection
5228992|NCT00712972|parapatellar|parapatellar
5228993|NCT00712959|Pertussis|pertussis
5228994|NCT00712959|Tetanus|tetanus
5228995|NCT00712959|Diphtheria|diphtheria
5228996|NCT00712959|Acellular pertussis|acellular pertussis
5228997|NCT00712959|ADACEL®,|adacel®,
5228998|NCT00712959|Tdap vaccine|tdap vaccine
5228999|NCT00712933|SLE|sle
5229000|NCT00712933|Belimumab|belimumab
5229001|NCT00712933|Antibodies|antibodies
5229002|NCT00712933|Systemic Lupus Erythematosus|systemic lupus erythematosus
5229003|NCT00712933|Lupus|lupus
5229004|NCT00712933|Autoimmune Diseases|autoimmune diseases
5229005|NCT00712907|vitamin C|vitamin c
5229006|NCT00712907|retinal blood flow|retinal blood flow
5229007|NCT00712907|intraocular pressure|intraocular pressure
5229008|NCT00712907|retinal vessel diameter|retinal vessel diameter
5229009|NCT00712894|Acute myocardial infarction|acute myocardial infarction
5229010|NCT00712894|Percutaneous coronary intervention|percutaneous coronary intervention
5229011|NCT00712894|No-reflow phenomenon|no-reflow phenomenon
5229012|NCT00712894|Vasodilator agents|vasodilator agents
5229013|NCT00712855|Liver Cancer|liver cancer
5229014|NCT00712842|Diabetes|diabetes
5229015|NCT00712842|ocular blood flow|ocular blood flow
5229016|NCT00712829|Prostate cancer|prostate cancer
5229017|NCT00712829|Imaging|imaging
5229018|NCT00712816|osteoarthritis|osteoarthritis
5229019|NCT00712816|total knee arthroplasty|total knee arthroplasty
5229020|NCT00712816|cryotherapy|cryotherapy
5229021|NCT00712790|First line treatment for Hepatocellular Carcinoma|first line treatment for hepatocellular carcinoma
5229022|NCT00712777|Brimonidine|brimonidine
5229023|NCT00712777|alpha 2 receptor polymorphism|alpha 2 receptor polymorphism
5229024|NCT00712777|Intraocular Pressure|intraocular pressure
5229025|NCT00712764|Adenosine|adenosine
5229026|NCT00712764|Choroidal blood flow|choroidal blood flow
5229027|NCT00712764|Suction cup|suction cup
5229028|NCT00712751|Rectum|rectum
5229029|NCT00712751|Quality of Life|quality of life
5229030|NCT00712751|Sexual Health|sexual health
5229031|NCT00712751|08-073|08-073
5229032|NCT00712738|Nifedipine|nifedipine
5229033|NCT00712738|Thalassemia|thalassemia
5229034|NCT00712738|Hemochromatosis|hemochromatosis
5229035|NCT00712738|Iron Overload|iron overload
5229036|NCT00712738|Iron Excretion|iron excretion
5229037|NCT00712712|bone metastases|bone metastases
5229038|NCT00712712|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5229039|NCT00712712|pain|pain
5229040|NCT00712699|Preschool|preschool
5229041|NCT00712699|Children|children
5229042|NCT00712699|ADHD|adhd
5229043|NCT00712699|Medication|medication
5229044|NCT00712699|Controlled Study|controlled study
5229045|NCT00712699|Placebo|placebo
5229046|NCT00712699|Mixed Amphetamine Salts|mixed amphetamine salts
5229047|NCT00712673|hyperglycemia, GLP-1, metformin|hyperglycemia, glp-1, metformin
5229048|NCT00712660|prevention|prevention
5229049|NCT00712660|relapse|relapse
5229050|NCT00712660|schizophrenia|schizophrenia
5229051|NCT00712634|cytomegalovirus infection|cytomegalovirus infection
5229052|NCT00712621|Genetics Home Reference related topics|genetics home reference related topics
5229053|NCT00712621|breast cancer|breast cancer
5229054|NCT00712621|breast cancer related to depression|breast cancer related to depression
5229055|NCT00712621|Condition|condition
5229056|NCT00712621|Stage I-IV Carcinoma of Breast|stage i-iv carcinoma of breast
5229057|NCT00712608|Term|term
5229058|NCT00712608|Infant|infant
5229059|NCT00712608|Formula|formula
5229060|NCT00712595|Uterine fibroids|uterine fibroids
5229061|NCT00712595|mifepristone|mifepristone
5229062|NCT00712595|antiprogestins|antiprogestins
5229063|NCT00712582|Non-Hodgkin|non-hodgkin
5229064|NCT00712582|Lymphoma|lymphoma
5229065|NCT00712582|Rituximab|rituximab
5229066|NCT00712582|Cyclophosphamide|cyclophosphamide
5229067|NCT00712582|Doxorubicin|doxorubicin
5229068|NCT00712582|Vincristine|vincristine
5229069|NCT00712582|ifosfamide|ifosfamide
5229070|NCT00712582|etoposide|etoposide
5229071|NCT00712582|carboplatin|carboplatin
5229072|NCT00712582|stem cell transplant|stem cell transplant
5229073|NCT00712582|08-026|08-026
5229074|NCT00712569|Communication|communication
5229075|NCT00712569|Internet|internet
5229076|NCT00712569|Physician|physician
5229077|NCT00712569|Patient|patient
5229078|NCT00712569|08-079|08-079
5229079|NCT00712556|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5229080|NCT00712556|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5229081|NCT00712556|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5229082|NCT00712556|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5229083|NCT00712556|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5229084|NCT00712556|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5229085|NCT00712556|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5229086|NCT00712556|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5229087|NCT00712556|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5229088|NCT00712556|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5229089|NCT00712556|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5229090|NCT00712556|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5229091|NCT00712556|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5229092|NCT00712556|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5229093|NCT00712556|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5229094|NCT00712556|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5229095|NCT00712556|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5229096|NCT00712556|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5229097|NCT00712556|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5229098|NCT00712556|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5229099|NCT00712556|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5229100|NCT00712556|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5229101|NCT00712556|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5229102|NCT00712556|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5229103|NCT00712556|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5229104|NCT00712556|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5229105|NCT00712556|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5229106|NCT00712556|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5229107|NCT00712556|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5229108|NCT00712556|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5229109|NCT00712556|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
5229110|NCT00712556|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
5229111|NCT00712556|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
5229112|NCT00712556|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5229113|NCT00712556|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5229114|NCT00712556|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5229115|NCT00712556|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5229116|NCT00712556|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5229117|NCT00712556|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5229118|NCT00712556|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5229119|NCT00712556|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5229120|NCT00712556|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5229121|NCT00712556|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5229122|NCT00712556|NC stage II adult immunoblastic large cell lymphoma|nc stage ii adult immunoblastic large cell lymphoma
5229123|NCT00712556|NC stage II adult lymphoblastic lymphoma|nc stage ii adult lymphoblastic lymphoma
5229124|NCT00712556|NC stage II grade 1 follicular lymphoma|nc stage ii grade 1 follicular lymphoma
5229125|NCT00712556|NC stage II grade 2 follicular lymphoma|nc stage ii grade 2 follicular lymphoma
5229126|NCT00712556|NC stage II grade 3 follicular lymphoma|nc stage ii grade 3 follicular lymphoma
5229127|NCT00712556|NC stage II mantle cell lymphoma|nc stage ii mantle cell lymphoma
5229128|NCT00712556|NC stage II marginal zone lymphoma|nc stage ii marginal zone lymphoma
5229129|NCT00712556|NC stage II small lymphocytic lymphoma|nc stage ii small lymphocytic lymphoma
5229130|NCT00712543|constipation|constipation
5229131|NCT00712543|laxative|laxative
5229132|NCT00712543|lactulose|lactulose
5229133|NCT00712543|Kristalose®|kristalose®
5229134|NCT00712530|HIV|hiv
5229135|NCT00712530|Vaccine|vaccine
5229136|NCT00712530|Immune Therapy|immune therapy
5229137|NCT00712530|DermaVir|dermavir
5229138|NCT00712517|postoperative pain|postoperative pain
5229139|NCT00712517|Piritramid|piritramid
5229140|NCT00712517|propofol|propofol
5229141|NCT00712517|sevoflurane|sevoflurane
5229142|NCT00712517|varicose vein|varicose vein
5229143|NCT00712517|Anesthesia|anesthesia
5229144|NCT00712504|advanced solid tumors, non small cell lung cancer, pulmonary neoplasms, sunitinib (SUTENT), docetaxel (Taxotere), Angiogenesis Inhibitors|advanced solid tumors, non small cell lung cancer, pulmonary neoplasms, sunitinib (sutent), docetaxel (taxotere), angiogenesis inhibitors
5229145|NCT00712491|wet AMD|wet amd
5229146|NCT00712491|CNV|cnv
5229147|NCT00712465|Atrial fibrillation|atrial fibrillation
5229148|NCT00712465|interaction|interaction
5229149|NCT00712465|pharmacokinetic|pharmacokinetic
5229150|NCT00712452|fertility|fertility
5229151|NCT00712452|chemotherapy|chemotherapy
5229152|NCT00712439|DPN,|dpn,
5229153|NCT00712439|Diabetic|diabetic
5229154|NCT00712439|Peripheral|peripheral
5229155|NCT00712439|Neuropathy|neuropathy
5229156|NCT00712439|Painful|painful
5229157|NCT00712426|Huntington's disease|huntington's disease
5229158|NCT00712426|Creatine|creatine
5229159|NCT00712426|Mitochondrial Dysfunction|mitochondrial dysfunction
5229160|NCT00712426|Total Functional Capacity|total functional capacity
5229161|NCT00712426|UHDRS|uhdrs
5229162|NCT00712413|Helicobacter pylori infection|helicobacter pylori infection
5229163|NCT00712413|Quadruple therapy|quadruple therapy
5229164|NCT00712413|Safety|safety
5229165|NCT00712413|Efficacy|efficacy
5229166|NCT00712413|Tolerability|tolerability
5229167|NCT00712413|BID dosing|bid dosing
5229168|NCT00712400|Latanoprost|latanoprost
5229169|NCT00712400|Choroidal Blood Flow|choroidal blood flow
5229170|NCT00712400|Intraocular Pressure|intraocular pressure
5229171|NCT00712374|Malaria|malaria
5229172|NCT00712374|All causes mortality|all causes mortality
5229173|NCT00712374|Cost effectiveness|cost effectiveness
5229174|NCT00712361|Invasive|invasive
5229175|NCT00712361|Non-Invasive|non-invasive
5229176|NCT00712361|Peripheral blood parameters|peripheral blood parameters
5229177|NCT00712361|Finger mounted device|finger mounted device
5229178|NCT00712361|Blood tissue|blood tissue
5229179|NCT00712361|Tissue color distribution|tissue color distribution
5229180|NCT00712361|Accuracy|accuracy
5229181|NCT00712361|Tissue pigmentation|tissue pigmentation
5229182|NCT00712361|pH|ph
5229183|NCT00712361|Hemoglobin|hemoglobin
5229184|NCT00712361|Hematocrit|hematocrit
5229185|NCT00712361|SpO2|spo2
5229186|NCT00712361|Blood pressure|blood pressure
5229187|NCT00712361|Pulse|pulse
5229188|NCT00712361|CO2|co2
5229189|NCT00712348|Gaucher disease|gaucher disease
5229190|NCT00712348|imiglucerase|imiglucerase
5229191|NCT00712348|glucocerebrosidase|glucocerebrosidase
5229192|NCT00712348|enzyme replacement therapy|enzyme replacement therapy
5229193|NCT00712348|lysosomal storage disorder|lysosomal storage disorder
5229194|NCT00712335|asthmatics|asthmatics
5229195|NCT00712335|smokers|smokers
5229196|NCT00712335|inhaled corticosteroids|inhaled corticosteroids
5229197|NCT00712335|leukotriene receptor antagonists|leukotriene receptor antagonists
5229198|NCT00712322|Pediatric, Children, Urodynamics, Oral Suspension, Overactive bladder, Dose-finding, Neurogenic Detrusor Overactivity, Meningomyelocele, Spinal cord injury|pediatric, children, urodynamics, oral suspension, overactive bladder, dose-finding, neurogenic detrusor overactivity, meningomyelocele, spinal cord injury
5229199|NCT00712309|atherosclerotic|atherosclerotic
5229200|NCT00712309|lesions|lesions
5229201|NCT00712296|Asthma|asthma
5229202|NCT00712296|alternative medicine|alternative medicine
5229203|NCT00712296|complementary medicine|complementary medicine
5229204|NCT00712296|herbal therapy|herbal therapy
5229205|NCT00712283|fitness to drive|fitness to drive
5229206|NCT00712283|operate machines|operate machines
5229207|NCT00712283|To determine the fitness to drive and operate machines.|to determine the fitness to drive and operate machines.
5229208|NCT00712270|Schizophrenia|schizophrenia
5229209|NCT00712270|Antipsychotic drug treatment response|antipsychotic drug treatment response
5229210|NCT00712270|Risperidone|risperidone
5229211|NCT00712270|Aripiprazole|aripiprazole
5229212|NCT00712270|Fallypride|fallypride
5229213|NCT00712270|Positron emission tomography|positron emission tomography
5229214|NCT00712270|Magnetic Resonance Imaging|magnetic resonance imaging
5229215|NCT00712270|Dopamine D2 Receptors|dopamine d2 receptors
5229216|NCT00712257|treatment of superficial femoral artery instent restenosis|treatment of superficial femoral artery instent restenosis
5229217|NCT00712244|Discovisc|discovisc
5229218|NCT00712244|Ophthalmic Viscosurgical Device|ophthalmic viscosurgical device
5229219|NCT00712231|pseudophakic|pseudophakic
5229220|NCT00712231|anterior chamber depth|anterior chamber depth
5229221|NCT00712231|Pentacam|pentacam
5229222|NCT00712218|Ovarian cancer, FIGO stage IIB-IV|ovarian cancer, figo stage iib-iv
5229223|NCT00712205|Asthma|asthma
5229224|NCT00712205|Vitamin D|vitamin d
5229225|NCT00712192|coronary artery bypass grafting|coronary artery bypass grafting
5229226|NCT00712192|endoscopic vein harvest|endoscopic vein harvest
5229227|NCT00712192|saphenous vein|saphenous vein
5229228|NCT00712192|endothelial cells|endothelial cells
5229229|NCT00712192|eNOS|enos
5229230|NCT00712192|ET-1|et-1
5229231|NCT00712179|Stroke|stroke
5229232|NCT00712179|walking|walking
5229233|NCT00712179|Treadmill|treadmill
5229234|NCT00712179|body weight support system|body weight support system
5229235|NCT00712166|cystic fibrosis|cystic fibrosis
5229236|NCT00712166|pseudomonas aeruginosa|pseudomonas aeruginosa
5229237|NCT00712166|lung infection|lung infection
5229238|NCT00712166|CFQ-R|cfq-r
5229239|NCT00712166|inhaled antibiotic|inhaled antibiotic
5229240|NCT00712166|aztreonam lysine|aztreonam lysine
5229241|NCT00712153|multislice computed tomography|multislice computed tomography
5229242|NCT00712153|coronary artery bypass grafting|coronary artery bypass grafting
5229243|NCT00712153|Patients|patients
5229244|NCT00712153|underwent|underwent
5229245|NCT00712153|surgeries|surgeries
5229246|NCT00712140|stage IA breast cancer|stage ia breast cancer
5229247|NCT00712140|stage IB breast cancer|stage ib breast cancer
5229248|NCT00712140|stage II breast cancer|stage ii breast cancer
5229249|NCT00712140|stage IIIA breast cancer|stage iiia breast cancer
5229250|NCT00712140|HER2-positive breast cancer|her2-positive breast cancer
5229251|NCT00712127|Body Fat|body fat
5229252|NCT00712127|Exercise|exercise
5229253|NCT00712127|Metabolic syndrome|metabolic syndrome
5229254|NCT00712127|Obesity|obesity
5229255|NCT00712127|Nutrition|nutrition
5229256|NCT00712127|Physical Activity|physical activity
5229257|NCT00712127|Weight Loss|weight loss
5229258|NCT00712114|phase I|phase i
5229259|NCT00712114|safety|safety
5229260|NCT00712114|tolerance|tolerance
5229261|NCT00712114|rheumatoid arthritis|rheumatoid arthritis
5229262|NCT00712114|pharmacokinetics|pharmacokinetics
5229263|NCT00712114|methotrexate|methotrexate
5229264|NCT00712114|anti-inflammatory|anti-inflammatory
5229265|NCT00712101|infarction|infarction
5229266|NCT00712101|intervention|intervention
5229267|NCT00712101|stent|stent
5229268|NCT00712101|abciximab|abciximab
5229269|NCT00712101|platelets|platelets
5229270|NCT00712088|HIV|hiv
5229271|NCT00712088|Unsafe Sex|unsafe sex
5229272|NCT00712088|High Risk Sex|high risk sex
5229273|NCT00712088|HIV Prevention|hiv prevention
5229274|NCT00712088|African-American|african-american
5229275|NCT00712088|gay|gay
5229276|NCT00712088|bisexual|bisexual
5229277|NCT00712088|intervention trial|intervention trial
5229278|NCT00712075|Cognitive Behavioral Therapy|cognitive behavioral therapy
5229279|NCT00712075|Social Skills Training|social skills training
5229280|NCT00712075|Experience Sampling Method|experience sampling method
5229281|NCT00712075|Computer-assisted therapy|computer-assisted therapy
5229282|NCT00712075|schizophrenia|schizophrenia
5229283|NCT00712062|PCNSL|pcnsl
5229284|NCT00712062|Pemetrexed|pemetrexed
5229285|NCT00712062|Alimta|alimta
5229286|NCT00712062|Recurrent|recurrent
5229287|NCT00712062|Progressive|progressive
5229288|NCT00712049|intima-media-thickness|intima-media-thickness
5229289|NCT00712049|dyslipidemia|dyslipidemia
5229290|NCT00712049|progression of atherosclerosis|progression of atherosclerosis
5229291|NCT00712049|peripheral artery disease|peripheral artery disease
5229292|NCT00712049|major cardiovascular events|major cardiovascular events
5229293|NCT00712036|Heroin dependence|heroin dependence
5229294|NCT00712036|Interim Methadone Treatment|interim methadone treatment
5229295|NCT00712036|Counseling|counseling
5229296|NCT00712023|Hypothermia|hypothermia
5229297|NCT00712023|Vascular surgery|vascular surgery
5229298|NCT00712023|Forced-air warming mattress|forced-air warming mattress
5229299|NCT00712023|Circulating-water mattress|circulating-water mattress
5229300|NCT00712010|Glucose|glucose
5229301|NCT00712010|Insulin|insulin
5229302|NCT00711997|H19 gene, plasmid, diphtheria toxin, pancreatic cancer|h19 gene, plasmid, diphtheria toxin, pancreatic cancer
5229303|NCT00711984|renal artery stenosis|renal artery stenosis
5229304|NCT00711984|stent|stent
5229305|NCT00711984|comparison of treatments|comparison of treatments
5229306|NCT00711984|progression|progression
5229307|NCT00711984|atherosclerosis|atherosclerosis
5229308|NCT00711984|peripheral artery disease|peripheral artery disease
5229309|NCT00711984|major cardiovascular events|major cardiovascular events
5229310|NCT00711958|Chemotherapy associated anemia in cancer patients|chemotherapy associated anemia in cancer patients
5229311|NCT00711945|Crohn's disease|crohn's disease
5229312|NCT00711945|Relapse|relapse
5229313|NCT00711945|outcomes|outcomes
5229314|NCT00711945|growth|growth
5229315|NCT00711932|Ovarian Cancer|ovarian cancer
5229316|NCT00711932|TRA-8|tra-8
5229317|NCT00711932|Monoclonal Antibody|monoclonal antibody
5229318|NCT00711932|Tissue Slice Technology|tissue slice technology
5229319|NCT00711906|Malaria|malaria
5229320|NCT00711906|Pregnancy|pregnancy
5229321|NCT00711906|HIV|hiv
5229322|NCT00711906|Intermittent Preventive Treatment|intermittent preventive treatment
5229323|NCT00711906|Safety|safety
5229324|NCT00711906|Efficacy|efficacy
5229325|NCT00711880|Pain|pain
5229326|NCT00711880|Peripheral Neuropathy|peripheral neuropathy
5229327|NCT00711854|Staphylococcal infection|staphylococcal infection
5229328|NCT00711841|HELLP syndrome|hellp syndrome
5229329|NCT00711841|dexamethasone|dexamethasone
5229330|NCT00711841|postpartum period|postpartum period
5229331|NCT00711841|class I HELLP syndrome|class i hellp syndrome
5229332|NCT00711815|Women of the state of Alabama|women of the state of alabama
5229333|NCT00711815|CIN 1|cin 1
5229334|NCT00711815|negative biopsy|negative biopsy
5229335|NCT00711815|normal colposcopy|normal colposcopy
5229336|NCT00711815|HPV|hpv
5229337|NCT00711802|Complicated|complicated
5229338|NCT00711802|Skin|skin
5229339|NCT00711802|Structure|structure
5229340|NCT00711789|Acute renal failure|acute renal failure
5229341|NCT00711789|Septic shock|septic shock
5229342|NCT00711789|angiotensin II|angiotensin ii
5229343|NCT00711789|neutrophil gelatinase associated lipocalin (NGAL)|neutrophil gelatinase associated lipocalin (ngal)
5229344|NCT00711789|cystatin C|cystatin c
5229345|NCT00711776|Aciclovir cream 5%|aciclovir cream 5%
5229346|NCT00711776|Volunteer|volunteer
5229347|NCT00711776|Japanese|japanese
5229348|NCT00711776|Male|male
5229349|NCT00711776|Bioequivalence|bioequivalence
5229350|NCT00711763|Preterm Infant|preterm infant
5229351|NCT00711763|Parenteral nutrition cycling|parenteral nutrition cycling
5229352|NCT00711763|TPN cycling|tpn cycling
5229353|NCT00711763|Hypercalcuria|hypercalcuria
5229354|NCT00711750|underwent|underwent
5229355|NCT00711750|specific|specific
5229356|NCT00711750|creation|creation
5229357|NCT00711750|hospital|hospital
5229358|NCT00711750|November 2003|november 2003
5229359|NCT00711750|October 2005|october 2005
5229360|NCT00711737|metabolic parameters|metabolic parameters
5229361|NCT00711737|escitalopram|escitalopram
5229362|NCT00711737|metabolic syndrome|metabolic syndrome
5229363|NCT00711737|antidepressant|antidepressant
5229364|NCT00711724|Attention Deficit Hyperactivity Disorder (ADHD)|attention deficit hyperactivity disorder (adhd)
5229365|NCT00711724|Adolescent|adolescent
5229366|NCT00711711|Physical Therapy - Therapeutics - Edema|physical therapy - therapeutics - edema
5229367|NCT00711711|Arthroplasty replacement knee|arthroplasty replacement knee
5229368|NCT00711711|Treatment outcome|treatment outcome
5229369|NCT00711685|Topical vancomycin|topical vancomycin
5229370|NCT00711685|mediastinitis|mediastinitis
5229371|NCT00711685|coronary|coronary
5229372|NCT00711685|artery|artery
5229373|NCT00711685|bypass|bypass
5229374|NCT00711685|graft|graft
5229375|NCT00711685|Patients|patients
5229376|NCT00711672|Personal Communication|personal communication
5229377|NCT00711672|Doctor Patient Relations|doctor patient relations
5229378|NCT00711672|Narrative Medicine|narrative medicine
5229379|NCT00711659|Physical exam|physical exam
5229380|NCT00711659|Pediatric clerkship|pediatric clerkship
5229381|NCT00711659|Medical students|medical students
5229382|NCT00711646|Spasticity|spasticity
5229383|NCT00711646|Multiple Sclerosis|multiple sclerosis
5229384|NCT00711633|Premature birth,|premature birth,
5229385|NCT00711633|infant,|infant,
5229386|NCT00711633|infant formula,|infant formula,
5229387|NCT00711633|bacterial colonization,|bacterial colonization,
5229388|NCT00711633|Bifidobacterium,|bifidobacterium,
5229389|NCT00711633|calprotectin|calprotectin
5229390|NCT00711620|sepsis|sepsis
5229391|NCT00711620|Immunotherapy|immunotherapy
5229392|NCT00711620|Thymosin|thymosin
5229393|NCT00711607|pharmacokinetics (PK)|pharmacokinetics (pk)
5229394|NCT00711607|combined oral contraceptive|combined oral contraceptive
5229395|NCT00711607|nomegestrol acetate|nomegestrol acetate
5229396|NCT00711607|estradiol|estradiol
5229397|NCT00711607|NOMAC|nomac
5229398|NCT00711607|E2|e2
5229399|NCT00711607|NOMAC-E2|nomac-e2
5229400|NCT00711607|pharmacokinetics|pharmacokinetics
5229401|NCT00711581|Cholecystectomy|cholecystectomy
5229402|NCT00711581|Cholecystectomy, Laparoscopic|cholecystectomy, laparoscopic
5229403|NCT00711581|Laparoscopy|laparoscopy
5229404|NCT00711568|depression|depression
5229405|NCT00711568|magnetic stimulation|magnetic stimulation
5229406|NCT00711555|nausea|nausea
5229407|NCT00711555|vomiting|vomiting
5229408|NCT00711555|multiple days|multiple days
5229409|NCT00711555|chemotherapy|chemotherapy
5229410|NCT00711555|serotonin receptor antagonist|serotonin receptor antagonist
5229411|NCT00711555|quality of life|quality of life
5229412|NCT00711555|therapy|therapy
5229413|NCT00711555|corticosteroids|corticosteroids
5229414|NCT00711555|aprepitant|aprepitant
5229415|NCT00711555|rescue therapy|rescue therapy
5229416|NCT00711542|intracoronary progenitor cell therapy|intracoronary progenitor cell therapy
5229417|NCT00711542|NSTEMI|nstemi
5229418|NCT00711542|coronary flow reserve|coronary flow reserve
5229419|NCT00711542|randomized doubleblind Placebo-controlled trial|randomized doubleblind placebo-controlled trial
5229420|NCT00711529|hot flashes|hot flashes
5229421|NCT00711529|breast cancer|breast cancer
5229422|NCT00711529|Hypnotherapy|hypnotherapy
5229423|NCT00711529|Quality of Life|quality of life
5229424|NCT00711529|Gabapentin|gabapentin
5229425|NCT00711503|endogenous insulin production|endogenous insulin production
5229426|NCT00711503|C-peptide level|c-peptide level
5229427|NCT00711503|insulin requirement|insulin requirement
5229428|NCT00711490|Diabetic Macular Edema|diabetic macular edema
5229429|NCT00711490|Diabetic Retinopathy|diabetic retinopathy
5229430|NCT00711490|Rapamycin|rapamycin
5229431|NCT00711490|Sirolimus|sirolimus
5229432|NCT00711490|Diabetes|diabetes
5229433|NCT00711477|obesity|obesity
5229434|NCT00711477|overweight|overweight
5229435|NCT00711477|magnetic resonance imaging|magnetic resonance imaging
5229436|NCT00711477|naltrexone|naltrexone
5229437|NCT00711477|bupropion|bupropion
5229438|NCT00711464|cognition, pharmacology, memory, attention|cognition, pharmacology, memory, attention
5229439|NCT00711451|systemic vascular resistance|systemic vascular resistance
5229440|NCT00711451|pregnancy|pregnancy
5229441|NCT00711451|scheduled cesarean delivery|scheduled cesarean delivery
5229442|NCT00711451|syncytiotrophoblast apoptosis|syncytiotrophoblast apoptosis
5229443|NCT00711451|continuous wave Doppler|continuous wave doppler
5229444|NCT00711438|Breathlessness|breathlessness
5229445|NCT00711438|Dyspnoea|dyspnoea
5229446|NCT00711438|Dyspnea|dyspnea
5229447|NCT00711438|Palliative care|palliative care
5229448|NCT00711438|RCT|rct
5229449|NCT00711438|Randomised controlled trial|randomised controlled trial
5229450|NCT00711438|COPD|copd
5229451|NCT00711438|Chronic respiratory disease|chronic respiratory disease
5229452|NCT00711425|Jaw, Edentulous, Partially (posterior mandible)|jaw, edentulous, partially (posterior mandible)
5229453|NCT00711412|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
5229454|NCT00711412|stage I esophageal cancer|stage i esophageal cancer
5229455|NCT00711412|stage II esophageal cancer|stage ii esophageal cancer
5229456|NCT00711412|stage III esophageal cancer|stage iii esophageal cancer
5229457|NCT00711412|stage IV esophageal cancer|stage iv esophageal cancer
5229458|NCT00711399|Respiratory sounds|respiratory sounds
5229460|NCT00711399|Cough|cough
5229461|NCT00711386|pharmacokinetics|pharmacokinetics
5229462|NCT00711386|CCR5|ccr5
5229463|NCT00711386|Healthy volunteers|healthy volunteers
5229464|NCT00711386|GSK706769|gsk706769
5229465|NCT00711373|VCA|vca
5229466|NCT00711373|composite tissue allotransplantation|composite tissue allotransplantation
5229467|NCT00711373|amputation|amputation
5229468|NCT00711373|Hand|hand
5229469|NCT00711360|heart failure|heart failure
5229470|NCT00711360|implantable cardioverter-defibrillator|implantable cardioverter-defibrillator
5229471|NCT00711360|intrathoracic impedance|intrathoracic impedance
5229472|NCT00711360|cardiac resynchronization therapy|cardiac resynchronization therapy
5229473|NCT00711360|home monitoring|home monitoring
5229474|NCT00711347|Discovisc|discovisc
5229475|NCT00711347|Ophthalmic Visco Surgical Device|ophthalmic visco surgical device
5229476|NCT00711321|Alzheimer|alzheimer
5229477|NCT00711321|Morbus Alzheimer|morbus alzheimer
5229478|NCT00711321|Vaccine|vaccine
5229479|NCT00711321|Alzheimer Vaccine|alzheimer vaccine
5229480|NCT00711321|A-beta immunotherapy|a-beta immunotherapy
5229481|NCT00711308|pulmonary embolism|pulmonary embolism
5229482|NCT00711308|low molecular weight heparin|low molecular weight heparin
5229483|NCT00711308|vitamin K antagonist|vitamin k antagonist
5229484|NCT00711308|Longterm|longterm
5229485|NCT00711295|Influenza (Pandemic)|influenza (pandemic)
5229486|NCT00711282|Replacement of non-restorable single tooth/teeth|replacement of non-restorable single tooth/teeth
5229487|NCT00711256|Sunscreen|sunscreen
5229488|NCT00711256|Application|application
5229489|NCT00711256|Vitamin D|vitamin d
5229490|NCT00711256|Sun protection factor|sun protection factor
5229491|NCT00711256|Clothing|clothing
5229492|NCT00711243|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5229493|NCT00711243|adenocarcinoma of the stomach|adenocarcinoma of the stomach
5229494|NCT00711243|stage III gastric cancer|stage iii gastric cancer
5229495|NCT00711243|stage IV gastric cancer|stage iv gastric cancer
5229496|NCT00711230|HIV|hiv
5229497|NCT00711230|Vaccine|vaccine
5229498|NCT00711230|Immune Therapy|immune therapy
5229499|NCT00711230|DermaVir|dermavir
5229500|NCT00711204|Severe|severe
5229501|NCT00711204|Alzheimer's Disease|alzheimer's disease
5229594|NCT00710827|NEBIDO,|nebido,
5229595|NCT00710827|Hypogonadism,|hypogonadism,
5229596|NCT00710827|Symptomatic late onset,|symptomatic late onset,
5229502|NCT00711191|pancreas cancer; cancer of the pancreas; gemcitabine; chemotherapy; monoclonal antibody; immunotherapy; CD40|pancreas cancer; cancer of the pancreas; gemcitabine; chemotherapy; monoclonal antibody; immunotherapy; cd40
5229503|NCT00711165|Asthma|asthma
5229504|NCT00711165|Nitric Oxide|nitric oxide
5229505|NCT00711165|Exhaled Breath Condensate|exhaled breath condensate
5229506|NCT00711165|Methacholine Challenge|methacholine challenge
5229507|NCT00711152|diabetes|diabetes
5229508|NCT00711152|protocol-driven structured care|protocol-driven structured care
5229509|NCT00711152|web-based|web-based
5229510|NCT00711152|joint asia diabetes evaluation|joint asia diabetes evaluation
5229511|NCT00711139|Alzheimer|alzheimer
5229512|NCT00711139|Morbus Alzheimer|morbus alzheimer
5229513|NCT00711139|Alzheimer Vaccine|alzheimer vaccine
5229514|NCT00711139|Vaccine|vaccine
5229515|NCT00711139|AD|ad
5229516|NCT00711139|A-beta immunotherapy|a-beta immunotherapy
5229517|NCT00711126|intravenous,|intravenous,
5229518|NCT00711126|tolerability|tolerability
5229519|NCT00711126|pharmacokinetics,|pharmacokinetics,
5229520|NCT00711126|oral,|oral,
5229521|NCT00711126|pharmacodynamics,|pharmacodynamics,
5229522|NCT00711126|safety,|safety,
5229523|NCT00711126|GW642444,|gw642444,
5229524|NCT00711126|inhaled,|inhaled,
5229525|NCT00711113|Jaw, Edentulous, Partially (posterior maxilla)|jaw, edentulous, partially (posterior maxilla)
5229526|NCT00711100|Substitution for cigarettes|substitution for cigarettes
5229527|NCT00711100|Oral tobacco products|oral tobacco products
5229528|NCT00711087|Spinal Cord Injury|spinal cord injury
5229529|NCT00711087|Bladder|bladder
5229530|NCT00711087|Botulinum toxin (BOTOX-A|botulinum toxin (botox-a
5229531|NCT00711087|Detrusor External Sphincter Dyssynergia|detrusor external sphincter dyssynergia
5229532|NCT00711074|pharmacokinetics|pharmacokinetics
5229533|NCT00711074|mass balance|mass balance
5229534|NCT00711074|radiolabel|radiolabel
5229535|NCT00711074|AZD5672|azd5672
5229536|NCT00711048|GERD|gerd
5229537|NCT00711048|healthy volunteer|healthy volunteer
5229538|NCT00711048|esophagus|esophagus
5229539|NCT00711048|pain|pain
5229540|NCT00711035|CMV|cmv
5229541|NCT00711035|Adenovirus|adenovirus
5229542|NCT00711035|EBV|ebv
5229543|NCT00711035|non-myeloablative transplants|non-myeloablative transplants
5229544|NCT00711035|Prior allogeneic hematopoietic stem cell transplant|prior allogeneic hematopoietic stem cell transplant
5229545|NCT00711022|Jaw, Edentulous (maxilla, with poor bone quality and quantity)|jaw, edentulous (maxilla, with poor bone quality and quantity)
5229546|NCT00711009|Human Immunodeficiency Virus infection|human immunodeficiency virus infection
5229547|NCT00710996|AcrySof IQ IOL|acrysof iq iol
5229548|NCT00710983|Mortality|mortality
5229549|NCT00710983|Morbidity|morbidity
5229550|NCT00710983|Growth|growth
5229551|NCT00710983|Immunology|immunology
5229552|NCT00710970|Urinary Bladder Neoplasms|urinary bladder neoplasms
5229553|NCT00710970|Previous Chemotherapy|previous chemotherapy
5229554|NCT00710970|Tamoxifen|tamoxifen
5229555|NCT00710970|Anti-tumor activity|anti-tumor activity
5229556|NCT00710957|Vitamin D|vitamin d
5229557|NCT00710957|Physical Function|physical function
5229558|NCT00710957|Falls|falls
5229559|NCT00710957|Aging|aging
5229560|NCT00710957|CHS|chs
5229561|NCT00710944|Jaw, Edentulous, Partially (missing/extracted/avulsed teeth in the maxilla within zone 15(4)-25(13))|jaw, edentulous, partially (missing/extracted/avulsed teeth in the maxilla within zone 15(4)-25(13))
5229562|NCT00710931|Bilateral Cataract|bilateral cataract
5229563|NCT00710931|IOL|iol
5229564|NCT00710931|ReSTOR|restor
5229565|NCT00710931|Aspheric|aspheric
5229566|NCT00710905|Cataract IOL ReSTOR Aspheric|cataract iol restor aspheric
5229567|NCT00710905|Bilateral cataract|bilateral cataract
5229568|NCT00710892|suicide gene-modified allodepleted donor lymphocytes|suicide gene-modified allodepleted donor lymphocytes
5229569|NCT00710892|given to recipients of haploidentical stem cell transplants|given to recipients of haploidentical stem cell transplants
5229570|NCT00710892|Stage III|stage iii
5229571|NCT00710892|Stage IV|stage iv
5229572|NCT00710892|Myelodysplastic syndrome|myelodysplastic syndrome
5229573|NCT00710892|AML after first relapse|aml after first relapse
5229574|NCT00710892|primary refractory disease|primary refractory disease
5229575|NCT00710892|CML|cml
5229576|NCT00710892|Hemophagocytic lymphohistiocytosis (HLH)|hemophagocytic lymphohistiocytosis (hlh)
5229577|NCT00710892|familial hemophagocytic lymphohistiocytosis (FLH)|familial hemophagocytic lymphohistiocytosis (flh)
5229578|NCT00710892|viral-associated hemophagocytic syndrome (VAHS)|viral-associated hemophagocytic syndrome (vahs)
5229579|NCT00710892|Severe chronic active Epstein Barr virus infection (SCAEBV)|severe chronic active epstein barr virus infection (scaebv)
5229580|NCT00710892|T or NK cell malignancy|t or nk cell malignancy
5229581|NCT00710892|X-linked lymphoproliferative disease (XLP)|x-linked lymphoproliferative disease (xlp)
5229582|NCT00710879|Efficacy|efficacy
5229583|NCT00710866|Influenza Vaccines|influenza vaccines
5229584|NCT00710866|Infant|infant
5229585|NCT00710866|Dose-Response Relationship, Immunologic|dose-response relationship, immunologic
5229586|NCT00710853|Geriatric|geriatric
5229587|NCT00710853|Qi gong|qi gong
5229588|NCT00710853|Yoga|yoga
5229589|NCT00710853|Tai chi|tai chi
5229590|NCT00710853|Geriatric Assessment|geriatric assessment
5229591|NCT00710840|Knee Replacement|knee replacement
5229592|NCT00710840|Knee OA|knee oa
5229593|NCT00710840|OA|oa
5229597|NCT00710827|Testosterone deficiency|testosterone deficiency
5229598|NCT00710814|Roux-en-Y gastric bypass|roux-en-y gastric bypass
5229599|NCT00710814|Leptin|leptin
5229600|NCT00710814|Bariatric surgery|bariatric surgery
5229601|NCT00710814|Overweight after Roux-en-Y gastric bypass surgery|overweight after roux-en-y gastric bypass surgery
5229602|NCT00710801|Hepatitis C Virus|hepatitis c virus
5229603|NCT00710801|HCV|hcv
5229604|NCT00710801|Liver Transplant|liver transplant
5229605|NCT00710801|Cyclosporine|cyclosporine
5229606|NCT00710801|Tacrolimus|tacrolimus
5229607|NCT00710801|Myfortic|myfortic
5229608|NCT00710788|QT interval|qt interval
5229609|NCT00710788|QT dispersion|qt dispersion
5229610|NCT00710788|arrhythmias|arrhythmias
5229611|NCT00710788|death|death
5229612|NCT00710788|TC score|tc score
5229613|NCT00710775|Aortic valve stenosis|aortic valve stenosis
5229614|NCT00710775|Heart surgery|heart surgery
5229615|NCT00710775|Endovascular techniques|endovascular techniques
5229616|NCT00710749|Lower urinary tract symptoms leading to lower flow rates|lower urinary tract symptoms leading to lower flow rates
5229617|NCT00710697|Bladder Cancer|bladder cancer
5229618|NCT00710697|Breast Cancer|breast cancer
5229619|NCT00710697|Colorectal Cancer|colorectal cancer
5229620|NCT00710697|Gastrointestinal Neoplasm|gastrointestinal neoplasm
5229621|NCT00710697|Head and Neck Cancer|head and neck cancer
5229622|NCT00710697|Lung Cancer|lung cancer
5229623|NCT00710697|Ovarian Cancer|ovarian cancer
5229624|NCT00710697|Pancreatic Cancer|pancreatic cancer
5229625|NCT00710697|Prostrate Cancer|prostrate cancer
5229626|NCT00710684|Alzheimer's disease cognition SB-742457|alzheimer's disease cognition sb-742457
5229627|NCT00710671|HIV positive|hiv positive
5229628|NCT00710671|YMSM|ymsm
5229629|NCT00710671|risk factors|risk factors
5229630|NCT00710671|coping|coping
5229631|NCT00710671|identity development|identity development
5229632|NCT00710671|psychosocial needs|psychosocial needs
5229633|NCT00710658|Internet support|internet support
5229634|NCT00710658|Tailored information|tailored information
5229635|NCT00710658|Self-management|self-management
5229636|NCT00710658|Quality of life|quality of life
5229637|NCT00710658|Online messaging|online messaging
5229638|NCT00710658|Online discussion groups|online discussion groups
5229639|NCT00710645|Multiple Sclerosis|multiple sclerosis
5229640|NCT00710645|Spasticity|spasticity
5229641|NCT00710632|cachexia|cachexia
5229642|NCT00710632|lung cancer|lung cancer
5229643|NCT00710632|gastrointestinal cancer|gastrointestinal cancer
5229644|NCT00710632|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5229645|NCT00710632|hematopoietic/lymphoid cancer|hematopoietic/lymphoid cancer
5229646|NCT00710606|contraceptive ring|contraceptive ring
5229647|NCT00710606|obesity|obesity
5229648|NCT00710606|pharmacokinetics|pharmacokinetics
5229649|NCT00710606|pharmacodynamics|pharmacodynamics
5229650|NCT00710606|Pharmacokinetics of the contraceptive ring in obese women.|pharmacokinetics of the contraceptive ring in obese women.
5229651|NCT00710593|Highly-active antiretroviral therapy|highly-active antiretroviral therapy
5229652|NCT00710593|Human papillomavirus|human papillomavirus
5229653|NCT00710593|HPV vaccine|hpv vaccine
5229654|NCT00710567|Heart Failure|heart failure
5229655|NCT00710567|LVAS|lvas
5229656|NCT00710567|LVAD|lvad
5229657|NCT00710567|Rotary Pump|rotary pump
5229658|NCT00710554|Pain|pain
5229659|NCT00710554|Peripheral Neuropathy|peripheral neuropathy
5229660|NCT00710554|Allodynia|allodynia
5229661|NCT00710541|non invasive ventilation|non invasive ventilation
5229662|NCT00710541|COPD|copd
5229663|NCT00710541|hypercapnia|hypercapnia
5229664|NCT00710541|GOLD stage IV|gold stage iv
5229665|NCT00710528|CLL|cll
5229666|NCT00710528|NHL|nhl
5229667|NCT00710528|AML|aml
5229668|NCT00710528|MM|mm
5229669|NCT00710528|Phosphatidylinositol 3-kinase|phosphatidylinositol 3-kinase
5229670|NCT00710515|Melanoma|melanoma
5229671|NCT00710515|Phase I|phase i
5229672|NCT00710515|AZD6244|azd6244
5229673|NCT00710502|Transvaginal|transvaginal
5229674|NCT00710502|NOTES|notes
5229675|NCT00710502|Cholecystectomy|cholecystectomy
5229676|NCT00710502|Laparoscopic|laparoscopic
5229677|NCT00710489|Acne|acne
5229678|NCT00710489|Actinic Keratosis|actinic keratosis
5229679|NCT00710489|Dysplastic Nevi|dysplastic nevi
5229680|NCT00710489|Eczema|eczema
5229681|NCT00710489|Psoriasis|psoriasis
5229682|NCT00710489|Vitiligo|vitiligo
5229683|NCT00710489|Skin Cancer|skin cancer
5229684|NCT00710489|Rosacea|rosacea
5229685|NCT00710489|Leg or Foot Ulcers|leg or foot ulcers
5229686|NCT00710489|Atopic Dermatosis|atopic dermatosis
5229687|NCT00710463|COPD|copd
5229688|NCT00710463|non invasive ventilation|non invasive ventilation
5229689|NCT00710463|pulmonary rehabilitation|pulmonary rehabilitation
5229690|NCT00710450|IL13|il13
5229691|NCT00710450|leukotriene|leukotriene
5229692|NCT00710450|histamine|histamine
5229693|NCT00710450|IL4|il4
5229694|NCT00710450|Must be allergic asthma or allergic rhinitis|must be allergic asthma or allergic rhinitis
5229695|NCT00710437|Dexmedetomidine|dexmedetomidine
5229696|NCT00710437|Carotid Endarterectomy|carotid endarterectomy
5229697|NCT00710437|Electroencephalogram|electroencephalogram
5229698|NCT00710424|Pain|pain
5229699|NCT00710424|diabetic neuropathy|diabetic neuropathy
5229700|NCT00710411|humans|humans
5229701|NCT00710411|patients|patients
5229702|NCT00710411|polytrauma|polytrauma
5229703|NCT00710411|complement|complement
5229704|NCT00710411|inflammation|inflammation
5229705|NCT00710411|inflammatory response|inflammatory response
5229706|NCT00710411|biomarkers|biomarkers
5229707|NCT00710411|cytokines|cytokines
5229708|NCT00710411|cell surface markers|cell surface markers
5229709|NCT00710411|apoptosis|apoptosis
5229710|NCT00710411|NF-kappaB|nf-kappab
5229711|NCT00710411|functional polymorphisms|functional polymorphisms
5229712|NCT00710411|mesenchymal stem cell|mesenchymal stem cell
5229713|NCT00710411|severity of injury|severity of injury
5229714|NCT00710411|ISS|iss
5229715|NCT00710411|infections|infections
5229716|NCT00710411|systemic inflammatory response syndrome|systemic inflammatory response syndrome
5229717|NCT00710411|SIRS|sirs
5229718|NCT00710411|sepsis|sepsis
5229719|NCT00710411|severe sepsis|severe sepsis
5229720|NCT00710411|shock|shock
5229721|NCT00710411|organ dysfunctions|organ dysfunctions
5229722|NCT00710411|SOFA|sofa
5229723|NCT00710411|severity of disease|severity of disease
5229724|NCT00710411|APACHEII|apacheii
5229725|NCT00710411|SAPSII|sapsii
5229726|NCT00710411|SPAPS3|spaps3
5229727|NCT00710411|length of stay|length of stay
5229728|NCT00710411|wound healing|wound healing
5229729|NCT00710411|outcome|outcome
5229730|NCT00710411|mortality|mortality
5229731|NCT00710398|Dairy Products|dairy products
5229732|NCT00710398|Dietary Protein|dietary protein
5229733|NCT00710398|Body Composition|body composition
5229734|NCT00710398|Fat mass loss|fat mass loss
5229735|NCT00710398|Lean mass gain|lean mass gain
5229736|NCT00710398|Pre-menopausal Women|pre-menopausal women
5229737|NCT00710359|Cobalamin deficiency|cobalamin deficiency
5229738|NCT00710359|Infant|infant
5229739|NCT00710359|Nutrition|nutrition
5229740|NCT00710359|Cobalamin supplementation|cobalamin supplementation
5229741|NCT00710359|Feeding problems|feeding problems
5229742|NCT00710359|Gastrointestinal symptoms|gastrointestinal symptoms
5229743|NCT00710346|Leiomyoma|leiomyoma
5229744|NCT00710346|Uterus|uterus
5229745|NCT00710346|Fibroids|fibroids
5229746|NCT00710346|Surgical|surgical
5229747|NCT00710320|Children core temperature,|children core temperature,
5229748|NCT00710320|Pediatric surgery,|pediatric surgery,
5229749|NCT00710320|Anesthesia induction|anesthesia induction
5229750|NCT00710294|Refractory Hypertension|refractory hypertension
5229751|NCT00710294|High Blood Pressure|high blood pressure
5229752|NCT00710294|Uncontrolled Blood Pressure|uncontrolled blood pressure
5229753|NCT00710281|Intracranial Aneurysm|intracranial aneurysm
5229754|NCT00710281|Subarachnoid arterial aneurysm|subarachnoid arterial aneurysm
5229755|NCT00710281|Aneurysm|aneurysm
5229756|NCT00710281|Brain Aneurysm|brain aneurysm
5229757|NCT00710281|Cerebral Aneurysm|cerebral aneurysm
5229758|NCT00710281|Wall Shear Stress(WSS)|wall shear stress(wss)
5229759|NCT00710281|Hemodynamic Stress|hemodynamic stress
5229760|NCT00710281|Subarachnoid Hemorrhage(SAH)|subarachnoid hemorrhage(sah)
5229761|NCT00710268|Bevacizumab|bevacizumab
5229762|NCT00710268|Poly(ADP ribose) polymerases|poly(adp ribose) polymerases
5229763|NCT00710268|Metastatic Solid Tumours|metastatic solid tumours
5229764|NCT00710268|PARP inhibitor|parp inhibitor
5229765|NCT00710255|Asthma|asthma
5229766|NCT00710255|Exercise induced bronchospasm|exercise induced bronchospasm
5229767|NCT00710255|Hyperpnea induced bronchospasm|hyperpnea induced bronchospasm
5229768|NCT00710255|leukotrienes|leukotrienes
5229769|NCT00710255|adenosine|adenosine
5229770|NCT00710255|exhaled breath condensate|exhaled breath condensate
5229771|NCT00710242|prolonged labor|prolonged labor
5229772|NCT00710229|age related macular degeneration|age related macular degeneration
5229773|NCT00710229|Ranibizumab-Lucentis|ranibizumab-lucentis
5229774|NCT00710229|Bevacizumab-Avastin|bevacizumab-avastin
5229775|NCT00710216|Viral kinetics|viral kinetics
5229776|NCT00710216|Viral dynamics|viral dynamics
5229777|NCT00710216|Telbivudine|telbivudine
5229778|NCT00710216|Lamivudine|lamivudine
5229779|NCT00710203|Dermatosis Papulosa Nigra|dermatosis papulosa nigra
5229780|NCT00710203|seborrheic keratoses|seborrheic keratoses
5229781|NCT00710190|Drug Resistant Hypertension|drug resistant hypertension
5229782|NCT00710190|Refractory Hypertension|refractory hypertension
5229783|NCT00710190|High Blood Pressure|high blood pressure
5229784|NCT00710190|Baroreflex Hypertension Therapy|baroreflex hypertension therapy
5229785|NCT00710177|PPHN|pphn
5229786|NCT00710177|PTGS1|ptgs1
5229787|NCT00710177|NSAID|nsaid
5229788|NCT00710151|neurotoxicity|neurotoxicity
5229789|NCT00710151|cognition in survivors|cognition in survivors
5229790|NCT00710151|diagnostic imaging|diagnostic imaging
5229791|NCT00710138|Cobalamin deficiency|cobalamin deficiency
5229792|NCT00710138|Infant|infant
5229793|NCT00710138|Nutrition|nutrition
5229794|NCT00710138|Cobalamin supplementation|cobalamin supplementation
5229795|NCT00710138|Neurodevelopment|neurodevelopment
5229796|NCT00710138|Neurological symptoms|neurological symptoms
5229797|NCT00710112|CLD|cld
5229798|NCT00710112|VLBW infants|vlbw infants
5229799|NCT00710112|Toll like Receptors|toll like receptors
5229800|NCT00710112|Biomarkers|biomarkers
5229801|NCT00710099|iontophoresis|iontophoresis
5229802|NCT00710099|cutaneous microcirculation|cutaneous microcirculation
5229803|NCT00710099|sildenafil|sildenafil
5229804|NCT00710099|Healthy volunteers|healthy volunteers
5229805|NCT00710086|Remifentanil|remifentanil
5229806|NCT00710086|Patient-controlled analgesia|patient-controlled analgesia
5229807|NCT00710086|Intravenous analgesia|intravenous analgesia
5229808|NCT00710073|Chronic pelvic pain syndrome|chronic pelvic pain syndrome
5229809|NCT00710073|Neuromodulation|neuromodulation
5229810|NCT00710060|HIV|hiv
5229811|NCT00710060|Popular Opinion Leader|popular opinion leader
5229812|NCT00710060|POL|pol
5229813|NCT00710060|Behavioral Intervention|behavioral intervention
5229814|NCT00710060|STD|std
5229815|NCT00710060|STI|sti
5229816|NCT00710060|Community|community
5229817|NCT00710060|Prevention|prevention
5229818|NCT00710060|International|international
5229819|NCT00710060|Global|global
5229820|NCT00710047|ZD4054|zd4054
5229821|NCT00710047|Zibotentan|zibotentan
5229822|NCT00710047|Healthy Volunteers|healthy volunteers
5229823|NCT00710034|Oral Tobacco Products|oral tobacco products
5229824|NCT00710034|Snus|snus
5229825|NCT00710034|Smoking Substitution|smoking substitution
5229826|NCT00710034|Harm Reduction|harm reduction
5229827|NCT00710034|Biomarkers of Tobacco Exposure|biomarkers of tobacco exposure
5229828|NCT00710021|Systemic lupus erythematosus|systemic lupus erythematosus
5229829|NCT00710021|SLE|sle
5229830|NCT00710021|Vitamin D3|vitamin d3
5229831|NCT00710021|Vitamin D deficiency|vitamin d deficiency
5229832|NCT00710021|IFN alpha expression|ifn alpha expression
5229833|NCT00710008|type 2 diabetes,|type 2 diabetes,
5229834|NCT00710008|exercise training,|exercise training,
5229835|NCT00710008|ATP-synthesis,|atp-synthesis,
5229836|NCT00710008|intramyocellular lipids,|intramyocellular lipids,
5229837|NCT00710008|hepatocellular lipids|hepatocellular lipids
5229838|NCT00710008|first degree relatives of|first degree relatives of
5229839|NCT00710008|patients|patients
5229840|NCT00709982|Norgestimate|norgestimate
5229841|NCT00709982|Contraceptives, Oral|contraceptives, oral
5229842|NCT00709982|Ortho-Cyclen|ortho-cyclen
5229843|NCT00709982|Folic Acid|folic acid
5229844|NCT00709982|Ethinyl Estradiol|ethinyl estradiol
5229845|NCT00709969|Malaria|malaria
5229846|NCT00709969|co-artemether|co-artemether
5229847|NCT00709969|auditory|auditory
5229848|NCT00709969|Plasmodium falciparum|plasmodium falciparum
5229849|NCT00709969|marsh fever|marsh fever
5229850|NCT00709969|remittent fever|remittent fever
5229851|NCT00709969|artemether|artemether
5229852|NCT00709969|artemisinins|artemisinins
5229853|NCT00709969|lumefantrine|lumefantrine
5229854|NCT00709969|child|child
5229855|NCT00709969|infant|infant
5229856|NCT00709969|Africa|africa
5229857|NCT00709956|Ventavis|ventavis
5229858|NCT00709956|iloprost|iloprost
5229859|NCT00709956|inhaled treatment|inhaled treatment
5229860|NCT00709956|pulmonary arterial hypertension|pulmonary arterial hypertension
5229861|NCT00709904|venous thromboprophylaxis|venous thromboprophylaxis
5229862|NCT00709904|primary prevention|primary prevention
5229863|NCT00709904|orthopedic surgery|orthopedic surgery
5229864|NCT00709878|skin rash, lapatinib, cetuximab, erlotinib, panitumumab|skin rash, lapatinib, cetuximab, erlotinib, panitumumab
5229865|NCT00709865|renal insufficiency|renal insufficiency
5229866|NCT00709865|diuretic|diuretic
5229867|NCT00709865|congestive heart failure|congestive heart failure
5229868|NCT00709865|acute decompensated heart failure|acute decompensated heart failure
5229869|NCT00709852|Patients referred for a contrast-enhanced MRI of the CNS|patients referred for a contrast-enhanced mri of the cns
5229870|NCT00709852|CNS Imaging|cns imaging
5229871|NCT00709839|glucocorticoid|glucocorticoid
5229872|NCT00709839|hydrocortisone|hydrocortisone
5229873|NCT00709839|carbohydrate metabolism|carbohydrate metabolism
5229874|NCT00709839|appetite-regulatory hormones|appetite-regulatory hormones
5229875|NCT00709813|Symptom management|symptom management
5229876|NCT00709813|Cancer|cancer
5229877|NCT00709813|Patient-centered care|patient-centered care
5229878|NCT00709800|Pandemic Influenza|pandemic influenza
5229879|NCT00709800|Avian Influenza|avian influenza
5229880|NCT00709800|DNA Vaccines|dna vaccines
5229881|NCT00709800|Antibody|antibody
5229882|NCT00709800|T Cells|t cells
5229883|NCT00709800|HA/NP/M2|ha/np/m2
5229884|NCT00709787|Epidemiology, hypertension, risk factors, coronary heart disease, patient management, compliance with medication|epidemiology, hypertension, risk factors, coronary heart disease, patient management, compliance with medication
5229885|NCT00709761|Erbb2|erbb2
5229886|NCT00709761|ABRAXANE|abraxane
5229887|NCT00709761|MBC|mbc
5229888|NCT00709761|first or second line therapy|first or second line therapy
5229889|NCT00709761|Metastatic Breast Cancer|metastatic breast cancer
5229890|NCT00709761|TYKERB|tykerb
5229891|NCT00709748|Transcutaneous electrical nerve stimulation|transcutaneous electrical nerve stimulation
5229892|NCT00709748|TENS|tens
5229893|NCT00709748|Empi|empi
5229894|NCT00709748|Electrotherapy|electrotherapy
5229895|NCT00709748|Back pain|back pain
5229896|NCT00709748|Lower back pain|lower back pain
5229897|NCT00709748|Chronic lower back pain|chronic lower back pain
5229898|NCT00709735|stress disorders|stress disorders
5229899|NCT00709735|post-traumatic|post-traumatic
5229900|NCT00709735|memory|memory
5229901|NCT00709735|propranolol|propranolol
5229902|NCT00709735|psychophysiology|psychophysiology
5229903|NCT00709722|Lupus nephritis|lupus nephritis
5229904|NCT00709722|Deoxyspergualin|deoxyspergualin
5229905|NCT00709722|Immunosuppression|immunosuppression
5229906|NCT00709709|stenosis|stenosis
5229907|NCT00709709|coronaropathy|coronaropathy
5229908|NCT00709709|stent|stent
5229909|NCT00709709|bypass surgery|bypass surgery
5229910|NCT00709709|suspect|suspect
5229911|NCT00709709|known|known
5229912|NCT00709696|Tobacco|tobacco
5229913|NCT00709696|nicotine|nicotine
5229914|NCT00709696|smoking|smoking
5229915|NCT00709696|varenicline|varenicline
5229916|NCT00709696|human laboratory study|human laboratory study
5229917|NCT00709696|stress tolerance|stress tolerance
5229918|NCT00709696|startle response|startle response
5229919|NCT00709696|cognitive assessment|cognitive assessment
5229920|NCT00709696|progressive ratio|progressive ratio
5229921|NCT00709670|MSCT|msct
5229922|NCT00709670|Echocardiography|echocardiography
5229923|NCT00709670|Coronarography|coronarography
5229924|NCT00709670|Acute coronary syndrome without ST segment elevation|acute coronary syndrome without st segment elevation
5229925|NCT00709670|normal ECG|normal ecg
5229926|NCT00709670|normal troponin|normal troponin
5229927|NCT00709670|Acute|acute
5229928|NCT00709657|Age-related macular degeneration|age-related macular degeneration
5229929|NCT00709657|anti-VEGF|anti-vegf
5229930|NCT00709644|Ortho Tri-Cyclen Lo|ortho tri-cyclen lo
5229931|NCT00709644|Contraceptives, Oral|contraceptives, oral
5229932|NCT00709644|Norgestimate|norgestimate
5229933|NCT00709644|Ethinyl Estradiol|ethinyl estradiol
5229934|NCT00709644|Folic Acid|folic acid
5229935|NCT00709644|Female Contraception|female contraception
5229936|NCT00709631|Malignant transformation of leg ulcer|malignant transformation of leg ulcer
5229937|NCT00709631|MARJOLIN's ulcer|marjolin's ulcer
5229938|NCT00709631|Biopsy|biopsy
5229939|NCT00709631|Leg ulcer|leg ulcer
5229940|NCT00709631|Chronic wound|chronic wound
5229941|NCT00709631|Squamous cell carcinoma|squamous cell carcinoma
5229942|NCT00709631|Basal cell carcinoma|basal cell carcinoma
5229943|NCT00709618|Erbb2|erbb2
5229944|NCT00709618|MBC|mbc
5229945|NCT00709618|First or Second line therapy|first or second line therapy
5229946|NCT00709618|Metastatic Breast Cancer|metastatic breast cancer
5229947|NCT00709618|Vinorelbine|vinorelbine
5229948|NCT00709618|Tykerb|tykerb
5229949|NCT00709605|HIV Negative|hiv negative
5229950|NCT00709605|Healthy|healthy
5229951|NCT00709605|Immunity|immunity
5229952|NCT00709605|Preventive|preventive
5229953|NCT00709605|Virus|virus
5229954|NCT00709605|Healthy Volunteer|healthy volunteer
5229955|NCT00709605|HV|hv
5229956|NCT00709592|total body irradiation|total body irradiation
5229957|NCT00709592|Allogeneic Peripheral Blood Stem Cell Transplantation|allogeneic peripheral blood stem cell transplantation
5229958|NCT00709592|thymoglobulin|thymoglobulin
5229959|NCT00709579|Patients needing an oral corticotherapy|patients needing an oral corticotherapy
5229960|NCT00709579|Patients needing a topical corticotherapy|patients needing a topical corticotherapy
5229961|NCT00709579|Corticotherapy|corticotherapy
5229962|NCT00709566|Hip|hip
5229963|NCT00709566|osteoarthritis|osteoarthritis
5229964|NCT00709566|exercise|exercise
5229965|NCT00709566|manual therapy|manual therapy
5229966|NCT00709553|ZD4054|zd4054
5229967|NCT00709553|Healthy Volunteers|healthy volunteers
5229968|NCT00709527|AMD|amd
5229969|NCT00709514|Oneness|oneness
5229970|NCT00709514|DCB-WH1|dcb-wh1
5229971|NCT00709514|DCB-WH1-CP001|dcb-wh1-cp001
5229972|NCT00709514|chronic|chronic
5229973|NCT00709514|diabetic|diabetic
5229974|NCT00709514|foot ulcers|foot ulcers
5229975|NCT00709514|topical ointment|topical ointment
5229976|NCT00709501|weight loss|weight loss
5229977|NCT00709501|obesity|obesity
5229978|NCT00709501|overweight|overweight
5229979|NCT00709488|Litx™ BPH System|litx™ bph system
5229980|NCT00709488|LS11|ls11
5229981|NCT00709488|Talaporfin sodium|talaporfin sodium
5229982|NCT00709462|Breast cancer|breast cancer
5229983|NCT00709462|Colorectal cancer|colorectal cancer
5229984|NCT00709462|Pancreatic cancer|pancreatic cancer
5229985|NCT00709462|Bladder cancer|bladder cancer
5229986|NCT00709462|Ovarian cancer|ovarian cancer
5229987|NCT00709462|Metastatic cancer|metastatic cancer
5229988|NCT00709462|Locally advanced cancer|locally advanced cancer
5229989|NCT00709462|Cancer Vaccine|cancer vaccine
5229990|NCT00709462|Vaccine|vaccine
5229991|NCT00709449|Age-related macular degeneration|age-related macular degeneration
5229992|NCT00709449|Glaucoma|glaucoma
5229993|NCT00709436|orthopedic|orthopedic
5229994|NCT00709436|ketamine|ketamine
5229995|NCT00709436|pain|pain
5229996|NCT00709410|Cholera, Diarrhea, Vaccination, Vaccines|cholera, diarrhea, vaccination, vaccines
5229997|NCT00709397|HIV-1|hiv-1
5229998|NCT00709397|drug resistance|drug resistance
5229999|NCT00709397|raltegravir|raltegravir
5230000|NCT00709397|integrase inhibitor|integrase inhibitor
5230001|NCT00709371|obesity|obesity
5230002|NCT00709371|zonisamide|zonisamide
5230003|NCT00709371|bupropion|bupropion
5230004|NCT00709358|bacteria|bacteria
5230005|NCT00709358|fungi|fungi
5230006|NCT00709358|real time PCR|real time pcr
5230007|NCT00709358|adequate antimicrobial therapy|adequate antimicrobial therapy
5230008|NCT00709358|microbial DNA|microbial dna
5230009|NCT00709358|microbial diagnosis|microbial diagnosis
5230010|NCT00709345|Antipsychotic Medications|antipsychotic medications
5230011|NCT00709345|Behavioral Interventions|behavioral interventions
5230012|NCT00709332|Norgestimate|norgestimate
5230013|NCT00709332|Folic Acid|folic acid
5230014|NCT00709332|Ortho-Cyclen|ortho-cyclen
5230015|NCT00709332|Female contraception|female contraception
5230016|NCT00709332|Ethinyl Estradiol|ethinyl estradiol
5230017|NCT00709332|Drug Interactions|drug interactions
5230018|NCT00709332|Pharmacokinetics|pharmacokinetics
5230019|NCT00709332|Contraceptives, Oral|contraceptives, oral
5230020|NCT00709319|Diabetic retinopathy|diabetic retinopathy
5230021|NCT00709319|Diabetic macular edema|diabetic macular edema
5230022|NCT00709319|dme|dme
5230023|NCT00709319|vitrectomy|vitrectomy
5230024|NCT00709293|Ischemia Reperfusion Injury|ischemia reperfusion injury
5230025|NCT00709293|Pediatric Heart Transplant|pediatric heart transplant
5230026|NCT00709293|ATG|atg
5230027|NCT00709293|Induction Therapy|induction therapy
5230028|NCT00709280|Cystic Fibrosis|cystic fibrosis
5230029|NCT00709280|hypertonic saline|hypertonic saline
5230030|NCT00709280|inhaled saline|inhaled saline
5230031|NCT00709267|Folic Acid|folic acid
5230032|NCT00709267|Chemistry, Analytical|chemistry, analytical
5230033|NCT00709267|Administration, Oral|administration, oral
5230034|NCT00709267|Infusions, Intravenous|infusions, intravenous
5230035|NCT00709267|Biological Availability|biological availability
5230036|NCT00709267|Safety|safety
5230037|NCT00709254|AeroLEF|aerolef
5230038|NCT00709254|fentanyl|fentanyl
5230039|NCT00709254|pharmacokinetics|pharmacokinetics
5230040|NCT00709254|liposome|liposome
5230041|NCT00709254|encapsulated|encapsulated
5230042|NCT00709241|Heart failure|heart failure
5230043|NCT00709241|Psychosocial factors|psychosocial factors
5230044|NCT00709241|Depression|depression
5230045|NCT00709241|Patient compliance|patient compliance
5230046|NCT00709215|refractory TdT-positive leukemia|refractory tdt-positive leukemia
5230047|NCT00709215|ALL|all
5230048|NCT00709215|AML|aml
5230049|NCT00709215|blastic CML|blastic cml
5230050|NCT00709189|Pharmacokinetics|pharmacokinetics
5230051|NCT00709189|Ethinyl Estradiol|ethinyl estradiol
5230052|NCT00709189|Drug Interactions|drug interactions
5230053|NCT00709189|Norgestimate|norgestimate
5230054|NCT00709189|Contraceptives, Oral|contraceptives, oral
5230055|NCT00709189|Ortho-Cyclen|ortho-cyclen
5230056|NCT00709189|Folic Acid|folic acid
5230057|NCT00709176|Quality of Life|quality of life
5230058|NCT00709176|Randomized Clinical Trial|randomized clinical trial
5230059|NCT00709176|Advanced Cancer|advanced cancer
5230060|NCT00709176|Breast Cancer|breast cancer
5230061|NCT00709176|Colorectal Cancer|colorectal cancer
5230062|NCT00709176|Lung Cancer|lung cancer
5230063|NCT00709176|Prostate Cancer|prostate cancer
5230064|NCT00709176|Family caregiver|family caregiver
5230065|NCT00709176|cancer survivorship|cancer survivorship
5230066|NCT00709176|coping|coping
5230067|NCT00709176|communication|communication
5230068|NCT00709176|uncertainty|uncertainty
5230069|NCT00709176|support|support
5230070|NCT00709176|depression|depression
5230071|NCT00709176|self-efficacy|self-efficacy
5230072|NCT00709176|benefits of illness|benefits of illness
5230073|NCT00709176|Caregivers|caregivers
5230074|NCT00709163|Pediatric|pediatric
5230075|NCT00709163|Dilated Cardiomyopathy|dilated cardiomyopathy
5230076|NCT00709163|Nesiritide|nesiritide
5230077|NCT00709150|Major Depression|major depression
5230078|NCT00709150|Diabetes|diabetes
5230079|NCT00709150|Hispanics|hispanics
5230080|NCT00709150|Collaborative Depression Care Management|collaborative depression care management
5230081|NCT00709137|resistant hypertensions|resistant hypertensions
5230082|NCT00709137|spironolactone|spironolactone
5230083|NCT00709137|amiloride|amiloride
5230084|NCT00709137|ambulatory blood pressure monitoring|ambulatory blood pressure monitoring
5230085|NCT00709124|Respiration, Artificial|respiration, artificial
5230086|NCT00709124|Critical Illness|critical illness
5230087|NCT00709124|Intensive Care Units|intensive care units
5230088|NCT00709124|Electric Stimulation Therapy|electric stimulation therapy
5230089|NCT00709124|Muscle Weakness|muscle weakness
5230090|NCT00709124|Paresis|paresis
5230091|NCT00709124|Mechanically|mechanically
5230092|NCT00709124|Ventilated|ventilated
5230093|NCT00709124|Patients|patients
5230094|NCT00709124|Admitted|admitted
5230095|NCT00709124|Medical|medical
5230096|NCT00709111|CCR5 antagonist|ccr5 antagonist
5230097|NCT00709111|CD4 T-cell count|cd4 t-cell count
5230098|NCT00709111|immune activation|immune activation
5230099|NCT00709111|treatment experienced|treatment experienced
5230100|NCT00709098|pulmonary arterial hypertension|pulmonary arterial hypertension
5230101|NCT00709098|inhaled treatment|inhaled treatment
5230102|NCT00709098|inhalation solution|inhalation solution
5230103|NCT00709098|iloprost|iloprost
5230104|NCT00709098|Ventavis|ventavis
5230105|NCT00709085|single nucleotide polymorphism|single nucleotide polymorphism
5230106|NCT00709072|stuttering|stuttering
5230107|NCT00709072|relapse|relapse
5230108|NCT00709072|Lidcombe Program|lidcombe program
5230109|NCT00709072|Preschool children|preschool children
5230110|NCT00709059|hepatitis C|hepatitis c
5230111|NCT00709046|Endoscopic treatment|endoscopic treatment
5230112|NCT00709046|Peptic ulcer|peptic ulcer
5230113|NCT00709046|Bleeding|bleeding
5230114|NCT00709046|Thermocoagulation|thermocoagulation
5230115|NCT00709046|Proton pump inhibitors|proton pump inhibitors
5230116|NCT00709033|refractory|refractory
5230117|NCT00709033|relapsed|relapsed
5230118|NCT00709033|low|low
5230119|NCT00709033|intermediate-grade|intermediate-grade
5230120|NCT00709033|Non-Hodgkin lymphoma|non-hodgkin lymphoma
5230121|NCT00709033|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
5230122|NCT00709020|cancer survivor|cancer survivor
5230123|NCT00709020|breast cancer|breast cancer
5230124|NCT00708981|Diabetic Nephropathy|diabetic nephropathy
5230125|NCT00708968|randomized clinical trial|randomized clinical trial
5230126|NCT00708968|coping|coping
5230127|NCT00708968|quality of life|quality of life
5230128|NCT00708968|family|family
5230129|NCT00708968|family caregiver|family caregiver
5230130|NCT00708968|cancer survivorship|cancer survivorship
5230131|NCT00708968|communication|communication
5230132|NCT00708968|uncertainty|uncertainty
5230133|NCT00708968|support|support
5230134|NCT00708968|family education|family education
5230135|NCT00708968|Caregivers|caregivers
5230136|NCT00708955|Evaluation and Treatment|evaluation and treatment
5230137|NCT00708955|Eye Diseases|eye diseases
5230138|NCT00708942|Cervical intraepithelial neoplasia (CIN)|cervical intraepithelial neoplasia (cin)
5230139|NCT00708929|Age-related macular degeneration|age-related macular degeneration
5230140|NCT00708929|Complement factor H|complement factor h
5230141|NCT00708929|Choroidal blood flow|choroidal blood flow
5230142|NCT00708916|Cutaneous lupus|cutaneous lupus
5230143|NCT00708916|Intervention|intervention
5230144|NCT00708916|Discoid lupus|discoid lupus
5230145|NCT00708916|Phosphodiesterase 5 inhibitor|phosphodiesterase 5 inhibitor
5230146|NCT00708903|Thorough QTc study|thorough qtc study
5230147|NCT00708890|Substance use disorders|substance use disorders
5230148|NCT00708890|Self-help groups|self-help groups
5230149|NCT00708890|Twelve Step groups|twelve step groups
5230150|NCT00708877|cancer|cancer
5230151|NCT00708877|cholangiocarcinoma|cholangiocarcinoma
5230152|NCT00708851|psoriasis|psoriasis
5230153|NCT00708812|Non-small Cell Lung Cancer|non-small cell lung cancer
5230154|NCT00708812|Endostar|endostar
5230155|NCT00708812|Paclitaxel|paclitaxel
5230156|NCT00708812|Carboplatin|carboplatin
5230157|NCT00708760|web based learning|web based learning
5230158|NCT00708760|moderate sedation|moderate sedation
5230159|NCT00708747|Immunoglobulins|immunoglobulins
5230160|NCT00708747|inhibitor proteins|inhibitor proteins
5230161|NCT00708747|human albumin|human albumin
5230162|NCT00708747|systemic inflammatory response syndrome|systemic inflammatory response syndrome
5230163|NCT00708747|interleukins|interleukins
5230164|NCT00708747|standardized serum-protein solution|standardized serum-protein solution
5230165|NCT00708734|exercise|exercise
5230166|NCT00708721|hypomethylating therapy|hypomethylating therapy
5230167|NCT00708721|CML|cml
5230168|NCT00708721|myelodysplastic syndromes|myelodysplastic syndromes
5230169|NCT00708708|Plaque-type psoriasis|plaque-type psoriasis
5230170|NCT00708695|nurse|nurse
5230171|NCT00708695|home visits|home visits
5230172|NCT00708695|pregnancy|pregnancy
5230173|NCT00708695|welfare|welfare
5230174|NCT00708695|child development|child development
5230175|NCT00708695|Child Rearing|child rearing
5230176|NCT00708695|Reproductive Behavior|reproductive behavior
5230177|NCT00708695|Risk Reduction Behavior|risk reduction behavior
5230178|NCT00708656|IBD|ibd
5230179|NCT00708656|Colitis|colitis
5230180|NCT00708656|UC|uc
5230181|NCT00708630|yellow fever vaccine|yellow fever vaccine
5230182|NCT00708630|patient information|patient information
5230183|NCT00708630|symptom reports|symptom reports
5230184|NCT00708630|patient satisfaction|patient satisfaction
5230185|NCT00708617|Liver fibrosis|liver fibrosis
5230186|NCT00708617|Alcoholic liver disease|alcoholic liver disease
5230187|NCT00708617|Non invasive diagnostic methods|non invasive diagnostic methods
5230188|NCT00708617|Transient elastography|transient elastography
5230189|NCT00708617|Fibrotest|fibrotest
5230190|NCT00708604|Diabetes Mellitus|diabetes mellitus
5230191|NCT00708604|Kidney Transplantation|kidney transplantation
5230192|NCT00708604|Islet Transplantation|islet transplantation
5230193|NCT00708604|Sirolimus/Tacrolimus/MMF-based Immunosuppressive Regimen|sirolimus/tacrolimus/mmf-based immunosuppressive regimen
5230194|NCT00708565|To study the effects of iloprost on hypoxic pulmonary vasoconstriction at high altitude|to study the effects of iloprost on hypoxic pulmonary vasoconstriction at high altitude
5230195|NCT00708552|Alzheimer's disease|alzheimer's disease
5230196|NCT00708552|Cognition|cognition
5230197|NCT00708552|SB-742457|sb-742457
5230198|NCT00708526|hypercapnia|hypercapnia
5230199|NCT00708526|hyperpnoea|hyperpnoea
5230200|NCT00708526|accelerated recovery|accelerated recovery
5230201|NCT00708513|Cell Saver|cell saver
5230202|NCT00708513|Liver Tumors|liver tumors
5230203|NCT00708513|Liver Cancer|liver cancer
5230699|NCT00706394|34mm|34mm
5230204|NCT00708513|Surgical Oncology|surgical oncology
5230205|NCT00708513|Whipple|whipple
5230206|NCT00708513|Blood Transfusion|blood transfusion
5230207|NCT00708513|Blood salvage|blood salvage
5230208|NCT00708513|cancer surgery|cancer surgery
5230209|NCT00708513|blood loss|blood loss
5230210|NCT00708500|Treatment failure|treatment failure
5230211|NCT00708487|in vitro fertilization|in vitro fertilization
5230212|NCT00708487|oxygen concentration|oxygen concentration
5230213|NCT00708487|blastocyst|blastocyst
5230214|NCT00708487|live birth|live birth
5230215|NCT00708487|embryo|embryo
5230216|NCT00708474|Bone graft|bone graft
5230217|NCT00708474|Bone void filler|bone void filler
5230218|NCT00708474|Bone plug|bone plug
5230219|NCT00708474|OsseoFit™|osseofit™
5230220|NCT00708474|knee|knee
5230221|NCT00708474|bone graft sites in the knee|bone graft sites in the knee
5230222|NCT00708461|obesity|obesity
5230223|NCT00708461|obesity prevention|obesity prevention
5230224|NCT00708461|worksite|worksite
5230225|NCT00708461|environment|environment
5230226|NCT00708461|intervention|intervention
5230227|NCT00708448|NSCLC|nsclc
5230228|NCT00708435|Anticoagulant reversal|anticoagulant reversal
5230229|NCT00708435|Prothrombin|prothrombin
5230230|NCT00708435|Complex|complex
5230231|NCT00708435|Concentrate|concentrate
5230232|NCT00708435|Coagulopathy|coagulopathy
5230233|NCT00708435|induced by|induced by
5230234|NCT00708435|coumarin|coumarin
5230235|NCT00708435|derivatives|derivatives
5230236|NCT00708435|Kcentra|kcentra
5230237|NCT00708422|Ocular surface health|ocular surface health
5230238|NCT00708422|OSDI|osdi
5230239|NCT00708422|TFBUT|tfbut
5230240|NCT00708422|Glaucoma|glaucoma
5230241|NCT00708422|Ocular hypertension|ocular hypertension
5230242|NCT00708422|Corneal staining|corneal staining
5230243|NCT00708409|Ross operation|ross operation
5230244|NCT00708409|autograft procedure|autograft procedure
5230245|NCT00708409|pulmonary homograft|pulmonary homograft
5230246|NCT00708409|root replacement technique|root replacement technique
5230247|NCT00708409|subcoronary implantation technique|subcoronary implantation technique
5230248|NCT00708396|Patients|patients
5230249|NCT00708396|suffer|suffer
5230250|NCT00708396|from|from
5230251|NCT00708383|embryo development|embryo development
5230252|NCT00708383|embryo quality|embryo quality
5230253|NCT00708383|implantation|implantation
5230254|NCT00708383|IVF/ICSI outcome|ivf/icsi outcome
5230255|NCT00708383|multiple pregnancy|multiple pregnancy
5230256|NCT00708370|Interventional|interventional
5230257|NCT00708370|Non-drug|non-drug
5230258|NCT00708370|Disease Management Program|disease management program
5230259|NCT00708370|Cardiovascular Risk Control|cardiovascular risk control
5230260|NCT00708370|Dyslipidemias|dyslipidemias
5230261|NCT00708370|Primary Care Centers|primary care centers
5230262|NCT00708357|eNOS Gene Polymorphism|enos gene polymorphism
5230263|NCT00708357|ocular blood flow|ocular blood flow
5230264|NCT00708331|Cataract|cataract
5230265|NCT00708331|Extraction|extraction
5230266|NCT00708331|Intraocular Lens|intraocular lens
5230267|NCT00708331|Hydrophilic Acrylic|hydrophilic acrylic
5230268|NCT00708318|AeroLEF|aerolef
5230269|NCT00708318|fentanyl|fentanyl
5230270|NCT00708318|pharmacokinetic|pharmacokinetic
5230271|NCT00708318|liposome|liposome
5230272|NCT00708318|encapsulated|encapsulated
5230273|NCT00708305|toothpaste|toothpaste
5230274|NCT00708305|plaque fluid|plaque fluid
5230275|NCT00708305|fluoride|fluoride
5230276|NCT00708292|AUY922|auy922
5230277|NCT00708292|Multiple Myeloma|multiple myeloma
5230278|NCT00708292|HSP90 inhibitors|hsp90 inhibitors
5230279|NCT00708292|Phase I/II|phase i/ii
5230280|NCT00708279|angina pectoris, osteopathic manipulation|angina pectoris, osteopathic manipulation
5230281|NCT00708266|Obesity|obesity
5230282|NCT00708266|Diabetes|diabetes
5230283|NCT00708266|Non-esterified fatty acids|non-esterified fatty acids
5230284|NCT00708266|Cytokines|cytokines
5230285|NCT00708266|Inflammation|inflammation
5230286|NCT00708266|Subcutaneous fat|subcutaneous fat
5230287|NCT00708266|Adipose tissue|adipose tissue
5230288|NCT00708253|balloon assisted enteroscopy|balloon assisted enteroscopy
5230289|NCT00708253|single balloon enteroscopy|single balloon enteroscopy
5230290|NCT00708253|double balloon enteroscopy|double balloon enteroscopy
5230291|NCT00708253|insertion depth|insertion depth
5230292|NCT00708227|Asthma|asthma
5230293|NCT00708227|Pharmacogenetics|pharmacogenetics
5230294|NCT00708227|Salmeterol|salmeterol
5230295|NCT00708227|African American|african american
5230296|NCT00708227|White|white
5230297|NCT00708201|ileus|ileus
5230298|NCT00708201|POI|poi
5230299|NCT00708188|Stroke, ischemic, etiology, TOAST, CT, multidetector|stroke, ischemic, etiology, toast, ct, multidetector
5230300|NCT00708175|Glucose Metabolism Disorder|glucose metabolism disorder
5230301|NCT00708175|Dysmetabolic Syndrome|dysmetabolic syndrome
5230302|NCT00708175|Type II Diabetes|type ii diabetes
5230303|NCT00708175|Diabetes Mellitus|diabetes mellitus
5230304|NCT00708175|Lipoatrophic|lipoatrophic
5230305|NCT00708175|Postmenopausal|postmenopausal
5230306|NCT00708162|HIV|hiv
5230307|NCT00708162|HIV I|hiv i
5230308|NCT00708162|Treatment Experienced|treatment experienced
5230309|NCT00708149|lansoprazole, weaning,stress ulcer prophylaxis|lansoprazole, weaning,stress ulcer prophylaxis
5230310|NCT00708136|Falls|falls
5230311|NCT00708136|elderly|elderly
5230312|NCT00708136|Balance|balance
5230313|NCT00708136|speed of stepping|speed of stepping
5230314|NCT00708136|Stability|stability
5230315|NCT00708136|ELDERLY FALLERS|elderly fallers
5230316|NCT00708123|remineralization|remineralization
5230317|NCT00708123|enamel|enamel
5230318|NCT00708123|fluoride|fluoride
5230319|NCT00708123|caries|caries
5230320|NCT00708123|in situ|in situ
5230321|NCT00708110|dose-ranging study|dose-ranging study
5230322|NCT00708110|phase IIa|phase iia
5230323|NCT00708110|integrase inhibitor|integrase inhibitor
5230324|NCT00708110|HIV-1 infection|hiv-1 infection
5230325|NCT00708097|fluoride|fluoride
5230326|NCT00708097|in situ|in situ
5230327|NCT00708097|remineralization|remineralization
5230328|NCT00708097|enamel|enamel
5230329|NCT00708097|caries|caries
5230330|NCT00708084|Rabies post-exposure prophylaxis|rabies post-exposure prophylaxis
5230331|NCT00708084|Monoclonal antibody|monoclonal antibody
5230332|NCT00708058|Implanted cardiac defibrillators|implanted cardiac defibrillators
5230333|NCT00708058|Congestive Heart Failure|congestive heart failure
5230334|NCT00708058|Emergency Department|emergency department
5230335|NCT00708045|Breast Cancer|breast cancer
5230336|NCT00708019|cancer pain|cancer pain
5230337|NCT00708019|bone metastasis|bone metastasis
5230338|NCT00708019|psychoeducational intervention|psychoeducational intervention
5230339|NCT00708019|nurse coaching|nurse coaching
5230340|NCT00708019|patient education|patient education
5230341|NCT00708019|breast cancer|breast cancer
5230342|NCT00707993|Glucose Metabolism Disorder|glucose metabolism disorder
5230343|NCT00707993|Dysmetabolic Syndrome|dysmetabolic syndrome
5230344|NCT00707993|Type II Diabetes|type ii diabetes
5230345|NCT00707993|Diabetes Mellitus|diabetes mellitus
5230346|NCT00707993|Lipoatrophic|lipoatrophic
5230347|NCT00707993|Dyslipidemia|dyslipidemia
5230348|NCT00707993|Drug Therapy|drug therapy
5230349|NCT00707980|Major Depressive Disorder|major depressive disorder
5230350|NCT00707980|Depression|depression
5230351|NCT00707980|Melancholia|melancholia
5230352|NCT00707980|Mood Disorder|mood disorder
5230353|NCT00707980|Dysthymic Disorder|dysthymic disorder
5230354|NCT00707980|Drug Therapy|drug therapy
5230355|NCT00707967|Tuberculosis vaccine|tuberculosis vaccine
5230356|NCT00707954|Diabetes|diabetes
5230357|NCT00707954|TA-7284|ta-7284
5230358|NCT00707941|Influenza like illness|influenza like illness
5230359|NCT00707941|Pneumonia|pneumonia
5230360|NCT00707941|Bronchiolitis|bronchiolitis
5230361|NCT00707941|Upper respiratory tract illness|upper respiratory tract illness
5230362|NCT00707941|Otitis media|otitis media
5230363|NCT00707941|Viral shedding|viral shedding
5230364|NCT00707941|Nasopharyngeal wash|nasopharyngeal wash
5230365|NCT00707941|Viral culture|viral culture
5230366|NCT00707941|PCR|pcr
5230367|NCT00707928|retained placenta|retained placenta
5230368|NCT00707915|aged|aged
5230369|NCT00707915|benzodiazepines|benzodiazepines
5230370|NCT00707915|hypnotics|hypnotics
5230371|NCT00707915|cognition|cognition
5230372|NCT00707915|posture|posture
5230373|NCT00707902|Sore throats,|sore throats,
5230374|NCT00707902|Pharyngitis|pharyngitis
5230375|NCT00707902|Acute|acute
5230376|NCT00707876|Peripheral arterial disease (PAD); Magnetic Resonance Angiography (MRA); Magnetic Resonance Imaging (MRI), imaging agent or biomarker|peripheral arterial disease (pad); magnetic resonance angiography (mra); magnetic resonance imaging (mri), imaging agent or biomarker
5230377|NCT00707863|Escitalopram|escitalopram
5230378|NCT00707863|Lexapro|lexapro
5230379|NCT00707863|fMRI|fmri
5230380|NCT00707863|pictures|pictures
5230381|NCT00707850|Hepatitis C|hepatitis c
5230382|NCT00707850|Thalassemia|thalassemia
5230383|NCT00707850|Pegasys|pegasys
5230384|NCT00707850|Ribavirin|ribavirin
5230385|NCT00707824|pruritus|pruritus
5230386|NCT00707824|epidural morphine|epidural morphine
5230387|NCT00707811|Dyspnea|dyspnea
5230388|NCT00707811|Shortness of Breath|shortness of breath
5230389|NCT00707811|Trouble Breathing|trouble breathing
5230390|NCT00707811|ST2|st2
5230391|NCT00707811|IL-33|il-33
5230392|NCT00707798|Young adults|young adults
5230393|NCT00707798|Pneumococcal vaccine,|pneumococcal vaccine,
5230394|NCT00707798|Streptococcus pneumoniae,|streptococcus pneumoniae,
5230395|NCT00707785|vitamin A|vitamin a
5230396|NCT00707785|Treatment|treatment
5230397|NCT00707785|neonates|neonates
5230398|NCT00707785|newborn|newborn
5230399|NCT00707785|sepsis|sepsis
5230400|NCT00707785|necrotizing enterocolitis|necrotizing enterocolitis
5230401|NCT00707785|meningitis|meningitis
5230402|NCT00707785|pneumonia|pneumonia
5230403|NCT00707772|Hepatitis C|hepatitis c
5230404|NCT00707772|Hemophilia|hemophilia
5230405|NCT00707772|Pegasys|pegasys
5230406|NCT00707772|Ribavirin|ribavirin
5230407|NCT00707759|Pediatric renal transplantation,Bone metabolism (DXA-pQCT)|pediatric renal transplantation,bone metabolism (dxa-pqct)
5230408|NCT00707759|mRNAFOXP3/IL-17,Steroid withdrawal|mrnafoxp3/il-17,steroid withdrawal
5230409|NCT00707746|statin intolerant|statin intolerant
5230410|NCT00707746|hypercholesterolemia|hypercholesterolemia
5230898|NCT00705536|Insulin|insulin
5230411|NCT00707707|breast cancer|breast cancer
5230412|NCT00707707|triple negative|triple negative
5230413|NCT00707707|metastatic|metastatic
5230414|NCT00707694|95 years of age and older|95 years of age and older
5230415|NCT00707681|microbio, MS-20, Hepatoma, Advanced Hepatocellular Carcinoma|microbio, ms-20, hepatoma, advanced hepatocellular carcinoma
5230416|NCT00707668|Diabetes|diabetes
5230417|NCT00707668|metabolic syndrome|metabolic syndrome
5230418|NCT00707668|dyslipidemia|dyslipidemia
5230419|NCT00707668|osteoporosis|osteoporosis
5230420|NCT00707642|West Nile Virus|west nile virus
5230421|NCT00707642|West Nile Vaccine|west nile vaccine
5230422|NCT00707642|West Nile virus disease|west nile virus disease
5230423|NCT00707642|Hawaii Biotech|hawaii biotech
5230424|NCT00707629|type 1 diabetes|type 1 diabetes
5230425|NCT00707629|neurocognitive measures|neurocognitive measures
5230426|NCT00707629|behavioral measures|behavioral measures
5230427|NCT00707603|Insulin resistance|insulin resistance
5230428|NCT00707603|Liver fat|liver fat
5230429|NCT00707603|Muscle fat|muscle fat
5230430|NCT00707603|Abdominal fat|abdominal fat
5230431|NCT00707603|Cytokines|cytokines
5230432|NCT00707577|Worksite Wellness|worksite wellness
5230433|NCT00707577|Weight loss and maintenance|weight loss and maintenance
5230434|NCT00707577|Physical Activity|physical activity
5230435|NCT00707577|Health and Fitness interventions|health and fitness interventions
5230436|NCT00707577|Healthy eating|healthy eating
5230437|NCT00707577|Weight loss|weight loss
5230438|NCT00707577|Maintenance programs|maintenance programs
5230439|NCT00707564|hemostasis|hemostasis
5230440|NCT00707564|tooth extractions|tooth extractions
5230441|NCT00707551|AZD1305|azd1305
5230442|NCT00707551|Verapamil|verapamil
5230443|NCT00707551|Ketoconazole|ketoconazole
5230444|NCT00707551|pharmacokinetics|pharmacokinetics
5230445|NCT00707525|aneuploidies, natural cycle, stimulated cycle, preimplantation genetic diagnosis|aneuploidies, natural cycle, stimulated cycle, preimplantation genetic diagnosis
5230446|NCT00707486|Hemostasis, tooth extractions, third molar|hemostasis, tooth extractions, third molar
5230447|NCT00707473|Carcinoma of Paranasal Sinuses|carcinoma of paranasal sinuses
5230448|NCT00707473|Paranasal Sinuses|paranasal sinuses
5230449|NCT00707473|Nasal Sinuses|nasal sinuses
5230450|NCT00707473|Nasal Cavity|nasal cavity
5230451|NCT00707473|Squamous Cell Carcinoma|squamous cell carcinoma
5230452|NCT00707473|Undifferentiated Carcinoma|undifferentiated carcinoma
5230453|NCT00707473|Poorly Differentiated Carcinoma|poorly differentiated carcinoma
5230454|NCT00707473|Docetaxel|docetaxel
5230455|NCT00707473|5-Fluorouracil|5-fluorouracil
5230456|NCT00707473|Cisplatin|cisplatin
5230457|NCT00707473|Platinol®|platinol®
5230458|NCT00707473|Platinol®-AQ|platinol®-aq
5230459|NCT00707460|Diabetes|diabetes
5230460|NCT00707460|Cardiovascular|cardiovascular
5230461|NCT00707460|Obesity|obesity
5230462|NCT00707460|First.Nation|first.nation
5230463|NCT00707460|Aboriginal (Health)|aboriginal (health)
5230464|NCT00707460|Dietary|dietary
5230465|NCT00707460|Intervention|intervention
5230466|NCT00707460|Nutrition|nutrition
5230467|NCT00707460|Traditional (Diet)|traditional (diet)
5230468|NCT00707460|Sandy Lake (Health & Diabetes Project)|sandy lake (health & diabetes project)
5230469|NCT00707460|(High) protein|(high) protein
5230470|NCT00707460|(High) fibre (er)|(high) fibre (er)
5230471|NCT00707460|(Low) carbohydrate|(low) carbohydrate
5230472|NCT00707447|diabetes-prevention|diabetes-prevention
5230473|NCT00707447|lifestyle modification|lifestyle modification
5230474|NCT00707447|behavior therapy|behavior therapy
5230475|NCT00707447|self-management|self-management
5230476|NCT00707434|Continuous Glucose Monitor|continuous glucose monitor
5230477|NCT00707434|Medtronic Guardian|medtronic guardian
5230478|NCT00707434|Guardian® blood-sugar monitoring device|guardian® blood-sugar monitoring device
5230479|NCT00707434|Glucose Monitoring|glucose monitoring
5230480|NCT00707434|Critically Ill|critically ill
5230482|NCT00707434|Intensive Care Unit|intensive care unit
5230483|NCT00707434|Glycemic Excursions|glycemic excursions
5230484|NCT00707434|Glucose Control|glucose control
5230485|NCT00707434|Glucose Testing|glucose testing
5230486|NCT00707434|Hyperglycemia|hyperglycemia
5230487|NCT00707434|Hypoglycemia|hypoglycemia
5230488|NCT00707434|Insulin Infusion|insulin infusion
5230489|NCT00707382|Pharmacogenetics|pharmacogenetics
5230490|NCT00707382|Compliance|compliance
5230491|NCT00707382|Antipsychotic drugs|antipsychotic drugs
5230492|NCT00707382|Schizophrenia|schizophrenia
5230493|NCT00707369|Periodontitis|periodontitis
5230494|NCT00707369|Mechanical Debridement|mechanical debridement
5230495|NCT00707369|Antibiotics|antibiotics
5230496|NCT00707369|Attachment loss|attachment loss
5230497|NCT00707369|Randomized controlled trial|randomized controlled trial
5230498|NCT00707356|Prostatic disease|prostatic disease
5230499|NCT00707356|genital neoplasm, male|genital neoplasm, male
5230500|NCT00707356|Urogenital neoplasm|urogenital neoplasm
5230501|NCT00707356|Genital disease|genital disease
5230502|NCT00707356|male|male
5230503|NCT00707356|Male urogenital disease|male urogenital disease
5230504|NCT00707356|Neoplasms|neoplasms
5230505|NCT00707356|Neoplasm by site|neoplasm by site
5230506|NCT00707356|prostatic neoplasm|prostatic neoplasm
5230507|NCT00707356|Carcinoma|carcinoma
5230508|NCT00707330|oxidative stress|oxidative stress
5230509|NCT00707330|8-oxo-deoxyguanine|8-oxo-deoxyguanine
5230510|NCT00707330|8-oxodG|8-oxodg
5230511|NCT00707330|clarithromycin|clarithromycin
5230512|NCT00707330|malondialdehyde|malondialdehyde
5230513|NCT00707330|mda|mda
5230514|NCT00707330|vitamine C|vitamine c
5230515|NCT00707330|ascorbic acid|ascorbic acid
5230516|NCT00707317|M. tuberculosis|m. tuberculosis
5230517|NCT00707317|latent tuberculosis infection|latent tuberculosis infection
5230518|NCT00707317|Quantiferon assay|quantiferon assay
5230519|NCT00707317|ELISPOT assay|elispot assay
5230520|NCT00707317|tuberculin skin test|tuberculin skin test
5230521|NCT00707317|immunocompromised patients|immunocompromised patients
5230522|NCT00707304|Non Small Cell Lung Cancer|non small cell lung cancer
5230523|NCT00707304|Talactoferrin|talactoferrin
5230524|NCT00707304|Dendritic Cell Recruiter and Activator|dendritic cell recruiter and activator
5230525|NCT00707304|Immunomodulatory agent|immunomodulatory agent
5230526|NCT00707291|contact lens|contact lens
5230527|NCT00707291|normal|normal
5230528|NCT00707252|Non-small cell lung cancer|non-small cell lung cancer
5230529|NCT00707252|Erlotinib|erlotinib
5230530|NCT00707252|Polyphenon E|polyphenon e
5230531|NCT00707252|Tarceva|tarceva
5230532|NCT00707252|Advanced Non-small Cell Lung Cancer Stage IIIb or IV|advanced non-small cell lung cancer stage iiib or iv
5230533|NCT00707239|Hospital-acquired pneumonia|hospital-acquired pneumonia
5230534|NCT00707239|Ventilator-associated pneumonia|ventilator-associated pneumonia
5230535|NCT00707226|Laser Doppler flowmetry|laser doppler flowmetry
5230536|NCT00707226|Choroidal blood flow|choroidal blood flow
5230537|NCT00707226|Fundus pulsation amplitude|fundus pulsation amplitude
5230538|NCT00707226|Intraocular Pressure|intraocular pressure
5230539|NCT00707200|severe malarial anemia (SMA)|severe malarial anemia (sma)
5230540|NCT00707200|cerebral malarial (CM)|cerebral malarial (cm)
5230541|NCT00707200|lactic acidosis|lactic acidosis
5230542|NCT00707200|hyperparasitemia|hyperparasitemia
5230543|NCT00707200|respiratory distress|respiratory distress
5230544|NCT00707200|hypoxia|hypoxia
5230545|NCT00707200|death|death
5230546|NCT00707200|transfusion|transfusion
5230547|NCT00707187|systemic sclerosis|systemic sclerosis
5230548|NCT00707187|scleroderma|scleroderma
5230549|NCT00707187|raynaud phenomenon|raynaud phenomenon
5230550|NCT00707174|Lentigo Maligna|lentigo maligna
5230551|NCT00707148|pertussis, diptheria, tetanus, vaccine, Tdap|pertussis, diptheria, tetanus, vaccine, tdap
5230552|NCT00707122|serum albumin, severe sepsis, septic shock, fluid therapy, hypoalbuminemia, critically ill|serum albumin, severe sepsis, septic shock, fluid therapy, hypoalbuminemia, critically ill
5230553|NCT00707083|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
5230554|NCT00707083|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
5230555|NCT00707083|B-cell childhood acute lymphoblastic leukemia|b-cell childhood acute lymphoblastic leukemia
5230556|NCT00707083|T-cell childhood acute lymphoblastic leukemia|t-cell childhood acute lymphoblastic leukemia
5230557|NCT00707070|psoriasis|psoriasis
5230558|NCT00707070|acitretin|acitretin
5230559|NCT00707070|efalizumab|efalizumab
5230560|NCT00707031|hyperglycemia, GLP-1, metformin|hyperglycemia, glp-1, metformin
5230561|NCT00707005|antibiotic susceptibility|antibiotic susceptibility
5230562|NCT00707005|bacterial flora|bacterial flora
5230563|NCT00707005|fluoroquinolone|fluoroquinolone
5230564|NCT00707005|LASIK|lasik
5230565|NCT00707005|refractive surgery|refractive surgery
5230566|NCT00706992|MART-1 Peptide|mart-1 peptide
5230567|NCT00706992|Melanoma|melanoma
5230568|NCT00706992|Adjuvant Therapy|adjuvant therapy
5230569|NCT00706992|Gene Therapy|gene therapy
5230570|NCT00706992|T Cell Persistence|t cell persistence
5230571|NCT00706979|smoking|smoking
5230572|NCT00706979|smoking cessation|smoking cessation
5230573|NCT00706979|nicotine replacement therapy|nicotine replacement therapy
5230574|NCT00706966|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5230575|NCT00706966|stage IIB prostate cancer|stage iib prostate cancer
5230576|NCT00706966|stage IIA prostate cancer|stage iia prostate cancer
5230577|NCT00706966|benign prostatic hyperplasia|benign prostatic hyperplasia
5230578|NCT00706953|pegylated liposomal doxorubicin|pegylated liposomal doxorubicin
5230579|NCT00706953|VELCADE|velcade
5230580|NCT00706953|DOXIL|doxil
5230581|NCT00706953|relapsed|relapsed
5230582|NCT00706953|Multiple Myeloma|multiple myeloma
5230583|NCT00706940|dry eye|dry eye
5230584|NCT00706940|Optical coherence tomography|optical coherence tomography
5230585|NCT00706927|xalacom|xalacom
5230586|NCT00706927|combigan|combigan
5230587|NCT00706927|ocular blood flow|ocular blood flow
5230588|NCT00706914|Airflow Obstruction, Chronic|airflow obstruction, chronic
5230589|NCT00706914|Chronic Airflow Obstruction|chronic airflow obstruction
5230590|NCT00706914|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5230591|NCT00706914|Chronic Obstructive Airway Disease|chronic obstructive airway disease
5230592|NCT00706914|Chronic Obstructive Lung Disease|chronic obstructive lung disease
5230593|NCT00706914|COPD|copd
5230594|NCT00706914|COAD|coad
5230595|NCT00706901|MI|mi
5230596|NCT00706901|IHMD|ihmd
5230597|NCT00706888|Reduction of cardiovascular factor of risk|reduction of cardiovascular factor of risk
5230598|NCT00706875|GTD survivors|gtd survivors
5230599|NCT00706875|questionnaires|questionnaires
5230600|NCT00706875|GTD|gtd
5230601|NCT00706862|Non small cell lung cancer|non small cell lung cancer
5230602|NCT00706862|Talactoferrin|talactoferrin
5230603|NCT00706862|Dendritic cell recruiter and activator|dendritic cell recruiter and activator
5230604|NCT00706862|DCRA|dcra
5230605|NCT00706862|Immunomodulatory agent|immunomodulatory agent
5230606|NCT00706862|Lactoferrin|lactoferrin
5230607|NCT00706849|familial hypercholesterolemia|familial hypercholesterolemia
5230608|NCT00706836|anxiety|anxiety
5230609|NCT00706836|functional magnetic resonance imaging|functional magnetic resonance imaging
5230610|NCT00706836|fMRI|fmri
5230611|NCT00706836|pregabalin|pregabalin
5230612|NCT00706836|Lyrica|lyrica
5230613|NCT00706823|Endotracheal Intubation|endotracheal intubation
5230614|NCT00706823|Supraglottic Airway|supraglottic airway
5230615|NCT00706810|Cancer|cancer
5230616|NCT00706810|Brain cancer|brain cancer
5230617|NCT00706810|Meningioma|meningioma
5230618|NCT00706797|Moderate Rheumatoid Arthritis|moderate rheumatoid arthritis
5230619|NCT00706784|Healthy women 18-40 years of age|healthy women 18-40 years of age
5230620|NCT00706771|sodium bicarbonate|sodium bicarbonate
5230621|NCT00706771|serum neutrophil gelatinase associated lipocalin|serum neutrophil gelatinase associated lipocalin
5230622|NCT00706771|renal impairment|renal impairment
5230623|NCT00706771|renal failure|renal failure
5230624|NCT00706771|systemic inflammatory response syndrome|systemic inflammatory response syndrome
5230625|NCT00706771|defined|defined
5230626|NCT00706771|by serum NGAL ≥ 100 ng/ml.|by serum ngal ≥ 100 ng/ml.
5230627|NCT00706758|Irritable bowel syndrome|irritable bowel syndrome
5230628|NCT00706758|Patient education|patient education
5230629|NCT00706745|atherosclerosis|atherosclerosis
5230630|NCT00706745|dietary supplements|dietary supplements
5230631|NCT00706745|randomised controlled trial|randomised controlled trial
5230632|NCT00706745|arterial stiffness|arterial stiffness
5230633|NCT00706745|linoleic acid|linoleic acid
5230634|NCT00706732|Influenza|influenza
5230635|NCT00706732|Flu|flu
5230636|NCT00706732|A/Wyoming/03/2003|a/wyoming/03/2003
5230637|NCT00706732|Alphavirus|alphavirus
5230638|NCT00706719|Adult Onset Idiopathic Hypothalamic Hypogonadism (AIHH)|adult onset idiopathic hypothalamic hypogonadism (aihh)
5230639|NCT00706719|Secondary hypogonadism|secondary hypogonadism
5230640|NCT00706719|Semen volume|semen volume
5230641|NCT00706719|Sperm count|sperm count
5230642|NCT00706719|Sperm motility|sperm motility
5230643|NCT00706706|sunitinib Phase IV metastatic renal cell carcinoma Chinese|sunitinib phase iv metastatic renal cell carcinoma chinese
5230644|NCT00706693|hypoglycemia|hypoglycemia
5230645|NCT00706693|treatment|treatment
5230646|NCT00706693|glucose|glucose
5230647|NCT00706693|sucrose|sucrose
5230648|NCT00706693|fructose|fructose
5230649|NCT00706654|Aripiprazole|aripiprazole
5230650|NCT00706654|Intramuscular (IM) depot|intramuscular (im) depot
5230651|NCT00706654|Schizophrenia|schizophrenia
5230652|NCT00706615|stage IV breast cancer|stage iv breast cancer
5230653|NCT00706615|recurrent breast cancer|recurrent breast cancer
5230654|NCT00706602|COPD|copd
5230655|NCT00706602|prognosis|prognosis
5230656|NCT00706602|prediction rule|prediction rule
5230657|NCT00706602|health-related quality of life|health-related quality of life
5230658|NCT00706602|risk factors|risk factors
5230659|NCT00706602|derivation|derivation
5230660|NCT00706602|validation|validation
5230661|NCT00706602|exacerbation|exacerbation
5230662|NCT00706602|mortality|mortality
5230663|NCT00706602|primary care|primary care
5230664|NCT00706602|treatment|treatment
5230665|NCT00706602|decision making|decision making
5230666|NCT00706589|Chronic Motor Tic disorder|chronic motor tic disorder
5230667|NCT00706589|Chronic Phonic Tic disorder|chronic phonic tic disorder
5230668|NCT00706589|Tourette's disorder|tourette's disorder
5230669|NCT00706589|Aripiprazole|aripiprazole
5230670|NCT00706589|Abilify|abilify
5230671|NCT00706589|Children|children
5230672|NCT00706589|Adolescent|adolescent
5230673|NCT00706576|Hepatocellular cancer|hepatocellular cancer
5230674|NCT00706576|HCC|hcc
5230675|NCT00706576|Opioid growth factor|opioid growth factor
5230676|NCT00706576|OGF|ogf
5230677|NCT00706576|Cirrhosis|cirrhosis
5230678|NCT00706550|pneumococcal polysaccharide vaccine|pneumococcal polysaccharide vaccine
5230679|NCT00706537|Pharmacokinetic safety NASH patients|pharmacokinetic safety nash patients
5230680|NCT00706511|OSA|osa
5230681|NCT00706511|Diabetes|diabetes
5230682|NCT00706511|Metabolism|metabolism
5230683|NCT00706511|Gender|gender
5230684|NCT00706485|Y-90 plaque applicator|y-90 plaque applicator
5230685|NCT00706485|dural brachytherapy|dural brachytherapy
5230686|NCT00706446|Asthma|asthma
5230687|NCT00706446|Pharmacogenetics|pharmacogenetics
5230688|NCT00706446|Beta agonists|beta agonists
5230689|NCT00706446|salmeterol|salmeterol
5230690|NCT00706446|formoterol|formoterol
5230691|NCT00706446|tiotropium|tiotropium
5230692|NCT00706446|beta adrenergic receptor|beta adrenergic receptor
5230693|NCT00706446|single nucleotide polymorphism|single nucleotide polymorphism
5230694|NCT00706433|Photodynamic Therapy|photodynamic therapy
5230695|NCT00706420|Diabetes Mellitus|diabetes mellitus
5230696|NCT00706420|Islet Transplantation Alone|islet transplantation alone
5230697|NCT00706420|Glucocorticoid-free Immunosuppressive Regimen|glucocorticoid-free immunosuppressive regimen
5230698|NCT00706394|Powerlink|powerlink
5230700|NCT00706394|Abdominal Aortic Aneurysm|abdominal aortic aneurysm
5230701|NCT00706394|EVAR|evar
5230702|NCT00706381|Deiodinase|deiodinase
5230703|NCT00706381|Bile Acids|bile acids
5230704|NCT00706381|Cholecystokinin|cholecystokinin
5230705|NCT00706381|Thyroid Hormones|thyroid hormones
5230706|NCT00706381|Energy Expenditure|energy expenditure
5230707|NCT00706381|Health Volunteer|health volunteer
5230708|NCT00706381|HV|hv
5230709|NCT00706368|Sexually transmitted infections|sexually transmitted infections
5230710|NCT00706368|Acceptability|acceptability
5230711|NCT00706368|Adolescent vaginitis|adolescent vaginitis
5230712|NCT00706342|Adult Refractory Immune Thrombocytopenic Purpura (ITP)|adult refractory immune thrombocytopenic purpura (itp)
5230713|NCT00706329|Minimally invasive surgery|minimally invasive surgery
5230714|NCT00706329|Umbilical hernia|umbilical hernia
5230715|NCT00706329|Infant|infant
5230716|NCT00706316|Nasopharygneal Cancer|nasopharygneal cancer
5230717|NCT00706316|Epstein Barr Virus|epstein barr virus
5230718|NCT00706316|(EBV)-Specific Cytotoxic T-Lymphocytes|(ebv)-specific cytotoxic t-lymphocytes
5230719|NCT00706316|Recurrent|recurrent
5230720|NCT00706316|Metastatic|metastatic
5230721|NCT00706316|EBV-Positive Nasopharygneal Cancer|ebv-positive nasopharygneal cancer
5230722|NCT00706303|COPD|copd
5230723|NCT00706303|self management|self management
5230724|NCT00706290|anxiety|anxiety
5230725|NCT00706290|depression|depression
5230726|NCT00706290|quality of life|quality of life
5230727|NCT00706290|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
5230728|NCT00706290|advanced cancer|advanced cancer
5230729|NCT00706290|metastatic cancer|metastatic cancer
5230730|NCT00706290|stage IV cancer|stage iv cancer
5230731|NCT00706290|cognitive behavioral therapy|cognitive behavioral therapy
5230732|NCT00706277|forced vital capacity|forced vital capacity
5230733|NCT00706277|forced expired volume in 1 s|forced expired volume in 1 s
5230734|NCT00706264|Short cervix|short cervix
5230735|NCT00706264|preterm birth|preterm birth
5230736|NCT00706264|arabin pessary|arabin pessary
5230737|NCT00706238|metastatic,|metastatic,
5230738|NCT00706238|Melanoma,|melanoma,
5230739|NCT00706238|Antigen-Specific Cancer Immunotherapeutic,|antigen-specific cancer immunotherapeutic,
5230740|NCT00706238|ASCI|asci
5230741|NCT00706238|MAGE-A3|mage-a3
5230742|NCT00706238|tumor antigen,|tumor antigen,
5230743|NCT00706199|bone marrow|bone marrow
5230744|NCT00706199|antigen expression|antigen expression
5230745|NCT00706199|volunteers|volunteers
5230746|NCT00706186|Mild Alzheimer's|mild alzheimer's
5230747|NCT00706186|Disease|disease
5230748|NCT00706173|Post-traumatic stress disorder|post-traumatic stress disorder
5230749|NCT00706173|PTSD|ptsd
5230750|NCT00706173|Cortisol|cortisol
5230751|NCT00706173|hydrocortisone|hydrocortisone
5230752|NCT00706173|pharmacological treatment|pharmacological treatment
5230753|NCT00706160|Epilepsy|epilepsy
5230754|NCT00706160|Language|language
5230755|NCT00706160|fMRI|fmri
5230756|NCT00706160|Magnetoencephalogram|magnetoencephalogram
5230757|NCT00706160|Temporal Lobe Epilepsy|temporal lobe epilepsy
5230758|NCT00706160|Partial Epilepsy|partial epilepsy
5230759|NCT00706160|Healthy Volunteer|healthy volunteer
5230760|NCT00706160|HV|hv
5230761|NCT00706147|Hereditary ALS|hereditary als
5230762|NCT00706147|Hereditary neurological disease|hereditary neurological disease
5230763|NCT00706147|Lou Gehrig's Disease|lou gehrig's disease
5230764|NCT00706147|Motor Neuron Disease|motor neuron disease
5230765|NCT00706147|Amyotrophic Lateral Sclerosis (ALS)|amyotrophic lateral sclerosis (als)
5230766|NCT00706147|Familial ALS|familial als
5230767|NCT00706147|Neuromuscular disease|neuromuscular disease
5230768|NCT00706147|SOD1 mutation|sod1 mutation
5230769|NCT00706147|Superoxide dismutase|superoxide dismutase
5230770|NCT00706147|SOD1 positive ALS|sod1 positive als
5230771|NCT00706147|inherited ALS|inherited als
5230772|NCT00706134|Hypertension|hypertension
5230773|NCT00706134|≥ 65 years|≥ 65 years
5230774|NCT00706134|aliskiren|aliskiren
5230775|NCT00706134|placebo|placebo
5230776|NCT00706134|light meal|light meal
5230777|NCT00706121|colon cancer|colon cancer
5230778|NCT00706121|rectal cancer|rectal cancer
5230779|NCT00706121|adenomatous polyp|adenomatous polyp
5230780|NCT00706095|Cancer|cancer
5230781|NCT00706095|advanced solid tumors|advanced solid tumors
5230782|NCT00706069|Metastatic Breast Cancer|metastatic breast cancer
5230783|NCT00706069|Vinorelbine oral|vinorelbine oral
5230784|NCT00706069|Capecitabine|capecitabine
5230785|NCT00706043|Low back pain|low back pain
5230786|NCT00706030|Metastatic breast cancer|metastatic breast cancer
5230787|NCT00706030|HKI-272|hki-272
5230788|NCT00706030|Neratinib|neratinib
5230789|NCT00706030|Nerlynx|nerlynx
5230790|NCT00706030|PB-272|pb-272
5230791|NCT00706004|constipation|constipation
5230792|NCT00706004|cystic fibrosis|cystic fibrosis
5230793|NCT00706004|lubiprostone|lubiprostone
5230794|NCT00706004|Constipation in adults with cystic fibrosis|constipation in adults with cystic fibrosis
5230795|NCT00705978|Pancreatic Exocrine Insufficiency Due to Chronic Pancreatitis|pancreatic exocrine insufficiency due to chronic pancreatitis
5230796|NCT00705965|Coronary artery disease|coronary artery disease
5230797|NCT00705965|depression|depression
5230899|NCT00705523|alcohol|alcohol
5230798|NCT00705965|psychotherapy|psychotherapy
5230799|NCT00705965|randomized controlled trial|randomized controlled trial
5230800|NCT00705952|No diabetes medications|no diabetes medications
5230801|NCT00705952|New onset|new onset
5230802|NCT00705939|Gaucher Disease|gaucher disease
5230803|NCT00705939|Enzyme replacement therapy|enzyme replacement therapy
5230804|NCT00705926|Acute Infection|acute infection
5230805|NCT00705926|HIV|hiv
5230806|NCT00705926|HAART|haart
5230807|NCT00705926|Treatment Naive|treatment naive
5230808|NCT00705913|aortic valve|aortic valve
5230809|NCT00705913|heart valve|heart valve
5230810|NCT00705913|valve replacement|valve replacement
5230811|NCT00705913|valve disease|valve disease
5230812|NCT00705900|psoriasis|psoriasis
5230813|NCT00705887|Ultraviolet Rays|ultraviolet rays
5230814|NCT00705887|Motivation|motivation
5230815|NCT00705887|Health Education|health education
5230816|NCT00705887|Randomized Controlled Trial|randomized controlled trial
5230817|NCT00705887|Health Knowledge, Attitudes, Practice|health knowledge, attitudes, practice
5230818|NCT00705874|cancer|cancer
5230819|NCT00705874|advanced cancer|advanced cancer
5230820|NCT00705874|solid tumors|solid tumors
5230821|NCT00705874|lymphoma|lymphoma
5230822|NCT00705874|CGC-11047|cgc-11047
5230823|NCT00705861|Erectile dysfunction|erectile dysfunction
5230824|NCT00705861|Diabetes Mellitus|diabetes mellitus
5230825|NCT00705861|SK3530|sk3530
5230826|NCT00705848|trachea|trachea
5230827|NCT00705848|malacia|malacia
5230828|NCT00705848|stenosis|stenosis
5230829|NCT00705835|Prostate|prostate
5230830|NCT00705835|ALHYDROGEL|alhydrogel
5230831|NCT00705835|RS-PSMA|rs-psma
5230832|NCT00705809|Epidemiology|epidemiology
5230833|NCT00705809|Peripheral T-Cell Lymphoma|peripheral t-cell lymphoma
5230834|NCT00705796|Hypogonadism|hypogonadism
5230835|NCT00705796|Spermatogenesis|spermatogenesis
5230836|NCT00705796|Quality of Life|quality of life
5230837|NCT00705783|Aripiprazole|aripiprazole
5230838|NCT00705783|Intramuscular (IM) depot|intramuscular (im) depot
5230839|NCT00705783|Schizophrenia|schizophrenia
5230840|NCT00705770|Open-Angle Glaucoma|open-angle glaucoma
5230841|NCT00705770|Intraocular Pressure|intraocular pressure
5230842|NCT00705770|Anecortave Acetate|anecortave acetate
5230843|NCT00705757|periocular skin pigmentation|periocular skin pigmentation
5230844|NCT00705757|Lumigan|lumigan
5230845|NCT00705757|Travatan|travatan
5230846|NCT00705757|Xalatan|xalatan
5230847|NCT00705757|latanoprost|latanoprost
5230848|NCT00705757|bimatoprost|bimatoprost
5230849|NCT00705757|travoprost|travoprost
5230850|NCT00705731|Colorectal cancer (CRC)|colorectal cancer (crc)
5230851|NCT00705731|Colorectal cancer screening|colorectal cancer screening
5230852|NCT00705731|Colonoscopy|colonoscopy
5230853|NCT00705731|Fecal occult blood test (FOBT)|fecal occult blood test (fobt)
5230854|NCT00705731|Cost-effectiveness|cost-effectiveness
5230855|NCT00705718|Endurant Stent Graft System|endurant stent graft system
5230856|NCT00705718|Abdominal Aortic Aneurysms|abdominal aortic aneurysms
5230857|NCT00705718|Endovascular Treatment|endovascular treatment
5230858|NCT00705705|High-Risk Behavior|high-risk behavior
5230859|NCT00705705|Men Who Have Sex With Men|men who have sex with men
5230860|NCT00705705|HIV Seronegativity|hiv seronegativity
5230861|NCT00705692|Tetanus|tetanus
5230862|NCT00705692|Vaccines|vaccines
5230863|NCT00705692|Renal Dialysis|renal dialysis
5230864|NCT00705692|Levamisole|levamisole
5230865|NCT00705679|Microbicide|microbicide
5230866|NCT00705679|HIV Seronegativity|hiv seronegativity
5230867|NCT00705653|cancer|cancer
5230868|NCT00705653|advanced cancer|advanced cancer
5230869|NCT00705653|solid tumors|solid tumors
5230870|NCT00705653|CGC-11047|cgc-11047
5230871|NCT00705653|PG-11047|pg-11047
5230872|NCT00705640|stage II melanoma|stage ii melanoma
5230873|NCT00705640|stage III melanoma|stage iii melanoma
5230874|NCT00705640|stage IV melanoma|stage iv melanoma
5230875|NCT00705640|ciliary body and choroid melanoma, medium/large size|ciliary body and choroid melanoma, medium/large size
5230876|NCT00705640|ciliary body and choroid melanoma, small size|ciliary body and choroid melanoma, small size
5230877|NCT00705640|conjunctival melanoma|conjunctival melanoma
5230878|NCT00705640|extraocular extension melanoma|extraocular extension melanoma
5230879|NCT00705640|iris melanoma|iris melanoma
5230880|NCT00705640|metastatic intraocular melanoma|metastatic intraocular melanoma
5230881|NCT00705640|recurrent intraocular melanoma|recurrent intraocular melanoma
5230882|NCT00705627|nasopharyngeal carcinoma|nasopharyngeal carcinoma
5230883|NCT00705627|neoadjuvant chemotherapy|neoadjuvant chemotherapy
5230884|NCT00705627|concurrent chemotherapy|concurrent chemotherapy
5230885|NCT00705627|randomized controlled clinical trials|randomized controlled clinical trials
5230886|NCT00705601|Nonrestorative Sleep, Restorative Sleep Questionnaire Refinement|nonrestorative sleep, restorative sleep questionnaire refinement
5230887|NCT00705575|Essential Hypertension|essential hypertension
5230888|NCT00705575|Stage II|stage ii
5230889|NCT00705549|Advanced|advanced
5230890|NCT00705549|NSCLC|nsclc
5230891|NCT00705549|ERCC1|ercc1
5230892|NCT00705549|RRM1|rrm1
5230893|NCT00705549|BCRA1|bcra1
5230894|NCT00705549|Alimta|alimta
5230895|NCT00705549|Gemcitabine|gemcitabine
5230896|NCT00705536|rHuPH20|rhuph20
5230897|NCT00705536|Hyaluronidase|hyaluronidase
5230900|NCT00705523|treatment|treatment
5230901|NCT00705523|nicotinic acetylcholine receptors|nicotinic acetylcholine receptors
5230902|NCT00705523|pharmacotherapy|pharmacotherapy
5230903|NCT00705523|outpatient|outpatient
5230904|NCT00705510|Cyclosporine|cyclosporine
5230905|NCT00705510|Unstable tear film|unstable tear film
5230906|NCT00705510|Meibomian gland|meibomian gland
5230907|NCT00705510|Meibomian gland dysfunction|meibomian gland dysfunction
5230908|NCT00705497|Radiofrequency tumor ablation|radiofrequency tumor ablation
5230909|NCT00705497|RFA|rfa
5230910|NCT00705458|stress myocardial perfusion imaging|stress myocardial perfusion imaging
5230911|NCT00705458|coronary computed tomography angiography|coronary computed tomography angiography
5230912|NCT00705445|Malnutrition|malnutrition
5230913|NCT00705445|Diarrhea|diarrhea
5230914|NCT00705445|Pneumonia|pneumonia
5230915|NCT00705445|Growth|growth
5230916|NCT00705445|Zinc Supplements|zinc supplements
5230917|NCT00705445|Microbiome|microbiome
5230918|NCT00705419|Treatment Experienced|treatment experienced
5230919|NCT00705354|Sinusitis|sinusitis
5230920|NCT00705354|Chronic Sinusitis|chronic sinusitis
5230921|NCT00705354|Nasal Surgery|nasal surgery
5230922|NCT00705354|Functional Endoscopic Sinus Surgery (FESS)|functional endoscopic sinus surgery (fess)
5230923|NCT00705354|Enoscopic Sinus Surgery (ESS)|enoscopic sinus surgery (ess)
5230924|NCT00705341|Normal Controls|normal controls
5230925|NCT00705328|low-income families|low-income families
5230926|NCT00705328|children|children
5230927|NCT00705328|recreation|recreation
5230928|NCT00705328|family healthy lifestyle|family healthy lifestyle
5230929|NCT00705328|linkages to community resources|linkages to community resources
5230930|NCT00705328|Families with low incomes|families with low incomes
5230931|NCT00705328|working poor|working poor
5230932|NCT00705328|welfare recipients|welfare recipients
5230933|NCT00705315|breast cancer|breast cancer
5230934|NCT00705315|chemotherapy|chemotherapy
5230935|NCT00705315|biological therapy|biological therapy
5230936|NCT00705302|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5230937|NCT00705302|Outpatient|outpatient
5230938|NCT00705302|Patient education|patient education
5230939|NCT00705302|Pulmonary rehabilitation|pulmonary rehabilitation
5230940|NCT00705302|Self-management|self-management
5230941|NCT00705250|Bendamustine HCL|bendamustine hcl
5230942|NCT00705237|sinusitis|sinusitis
5230943|NCT00705185|Major Depressive Disorder|major depressive disorder
5230944|NCT00705185|Blood Test|blood test
5230945|NCT00705159|Blepharokeratoconjunctivitis|blepharokeratoconjunctivitis
5230946|NCT00705146|Osteoarthritis, carpometacarpal joint|osteoarthritis, carpometacarpal joint
5230947|NCT00705146|Thumb splints|thumb splints
5230948|NCT00705146|AUSCAN-HI 3.1|auscan-hi 3.1
5230949|NCT00705146|Grip and pinch strength|grip and pinch strength
5230950|NCT00705133|pulmonary hypertension|pulmonary hypertension
5230951|NCT00705133|pulmonary fibrosis|pulmonary fibrosis
5230952|NCT00705133|interstitial lung disease|interstitial lung disease
5230953|NCT00705120|Osteogenesis Imperfecta|osteogenesis imperfecta
5230954|NCT00705120|Bone Marrow Cell Transplantation|bone marrow cell transplantation
5230955|NCT00705120|Mesenchymal Stem Cells|mesenchymal stem cells
5230956|NCT00705120|Stem Cell Transplantation, Mesenchymal|stem cell transplantation, mesenchymal
5230957|NCT00705094|cardiovascular risk factors|cardiovascular risk factors
5230958|NCT00705094|cardiac function|cardiac function
5230960|NCT00705094|Chemotherapy|chemotherapy
5230961|NCT00705055|Anthropometry|anthropometry
5230962|NCT00705055|face recognition|face recognition
5230963|NCT00705055|genetic disease|genetic disease
5230964|NCT00705055|newborn infant|newborn infant
5230965|NCT00705016|Randomized treatment|randomized treatment
5230966|NCT00705016|open-label|open-label
5230967|NCT00705016|controlled|controlled
5230968|NCT00705016|recurrent|recurrent
5230969|NCT00705016|metastatic|metastatic
5230970|NCT00705016|SCCHN|scchn
5230971|NCT00705016|suitable|suitable
5230972|NCT00705016|for local therapy|for local therapy
5230973|NCT00705003|depression|depression
5230974|NCT00704990|Attention Deficit Disorder|attention deficit disorder
5230975|NCT00704990|Pediatrics|pediatrics
5230976|NCT00704990|Attention|attention
5230977|NCT00704990|Impulsivity|impulsivity
5230978|NCT00704990|Complementary Therapies|complementary therapies
5230979|NCT00704938|recurrent renal cell cancer|recurrent renal cell cancer
5230980|NCT00704938|stage IV renal cell cancer|stage iv renal cell cancer
5230981|NCT00704938|recurrent melanoma|recurrent melanoma
5230982|NCT00704938|stage IV melanoma|stage iv melanoma
5230983|NCT00704938|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5230984|NCT00704925|Lambert Eaton Myasthenic Syndrome|lambert eaton myasthenic syndrome
5230985|NCT00704925|3,4 DAP|3,4 dap
5230986|NCT00704925|3,4 Diaminopyridine|3,4 diaminopyridine
5230987|NCT00704912|Polycystic Ovary Syndrome|polycystic ovary syndrome
5230988|NCT00704886|dementia|dementia
5230989|NCT00704860|healthy volunteers treatment resistant major depression hippocampus atrophy MRI serotonin genotyping|healthy volunteers treatment resistant major depression hippocampus atrophy mri serotonin genotyping
5230990|NCT00704847|Osteoarthritis, oral salmon calcitonin, treatment, efficacy,|osteoarthritis, oral salmon calcitonin, treatment, efficacy,
5230991|NCT00704847|tolerability|tolerability
5230992|NCT00704834|Multiple Sclerosis|multiple sclerosis
5230993|NCT00704834|Relapsing Remitting Multiple Sclerosis|relapsing remitting multiple sclerosis
5230994|NCT00704834|Chronic Progressive Multiple Sclerosis|chronic progressive multiple sclerosis
5230995|NCT00704834|Clinically Isolated Syndrome|clinically isolated syndrome
5230996|NCT00704834|Normal Controls|normal controls
5230997|NCT00704834|Blood Draw|blood draw
5230998|NCT00704821|Cancer|cancer
5230999|NCT00704821|PTC299|ptc299
5231000|NCT00704821|VEGF|vegf
5231001|NCT00704821|Angiogenesis|angiogenesis
5231002|NCT00704821|Post-transcriptional control|post-transcriptional control
5231003|NCT00704821|Docetaxel|docetaxel
5231004|NCT00704743|Colles fracture treatment|colles fracture treatment
5231005|NCT00704743|Displaced fracture of distal radius|displaced fracture of distal radius
5231006|NCT00704743|distal radius fracture treatment|distal radius fracture treatment
5231007|NCT00704743|RCT|rct
5231008|NCT00704743|Emergency Department|emergency department
5231009|NCT00704743|cast|cast
5231010|NCT00704743|splint|splint
5231011|NCT00704743|treatment|treatment
5231012|NCT00704730|Medullary Thyroid Cancer|medullary thyroid cancer
5231013|NCT00704730|MTC|mtc
5231014|NCT00704704|high risk MDS|high risk mds
5231015|NCT00704704|IPSS|ipss
5231016|NCT00704704|5-AZA-Cytidine|5-aza-cytidine
5231017|NCT00704704|Thalidomide|thalidomide
5231018|NCT00704704|response rate|response rate
5231019|NCT00704704|cytogenetic response|cytogenetic response
5231020|NCT00704704|QOL questionaries|qol questionaries
5231021|NCT00704704|INT-2 or High risk MDS|int-2 or high risk mds
5231022|NCT00704678|Chronic Kidney Disease|chronic kidney disease
5231023|NCT00704678|hemodialysis|hemodialysis
5231024|NCT00704678|hyperphosphatemia|hyperphosphatemia
5231025|NCT00704678|Asian|asian
5231026|NCT00704678|patients|patients
5231027|NCT00704665|Diffuse Scleroderma|diffuse scleroderma
5231028|NCT00704665|Skin score|skin score
5231029|NCT00704639|Head and Neck|head and neck
5231030|NCT00704639|Cetuximab|cetuximab
5231031|NCT00704639|Carboplatin|carboplatin
5231032|NCT00704639|Radiotherapy|radiotherapy
5231033|NCT00704626|Multiple Sclerosis|multiple sclerosis
5231034|NCT00704626|Autoimmune disease|autoimmune disease
5231035|NCT00704626|Inflammatory disease|inflammatory disease
5231036|NCT00704626|Myasthenia Gravis|myasthenia gravis
5231037|NCT00704626|Transverse Myelitis|transverse myelitis
5231038|NCT00704600|Locally advanced rectal cancer|locally advanced rectal cancer
5231039|NCT00704600|nelfinavir|nelfinavir
5231040|NCT00704600|radiosensitivity|radiosensitivity
5231041|NCT00704600|chemoradiation|chemoradiation
5231042|NCT00704587|cancer occurence|cancer occurence
5231043|NCT00704587|cancer recurrence|cancer recurrence
5231044|NCT00704587|neo-adjuvant treatment response measurement|neo-adjuvant treatment response measurement
5231045|NCT00704561|Acute Myocardial Infarction|acute myocardial infarction
5231046|NCT00704561|Percutaneous Coronary Interventions|percutaneous coronary interventions
5231047|NCT00704561|Optical Coherence Tomography|optical coherence tomography
5231048|NCT00704561|Thrombus|thrombus
5231049|NCT00704509|Schizophrenia|schizophrenia
5231050|NCT00704509|Antipsychotic|antipsychotic
5231051|NCT00704509|Bifeprunox|bifeprunox
5231052|NCT00704496|Sleep, Pseudoephedrine|sleep, pseudoephedrine
5231053|NCT00704483|Chronic Kidney Disease|chronic kidney disease
5231054|NCT00704483|hemodialysis|hemodialysis
5231055|NCT00704483|hyperphosphatemia|hyperphosphatemia
5231056|NCT00704483|hemodiafiltration|hemodiafiltration
5231057|NCT00704470|Patient Simulation|patient simulation
5231058|NCT00704470|Education, Medical, Continuing|education, medical, continuing
5231059|NCT00704470|Education, Medical, Graduate|education, medical, graduate
5231060|NCT00704470|Stress|stress
5231061|NCT00704457|Interstitial Cystitis|interstitial cystitis
5231062|NCT00704457|IC|ic
5231063|NCT00704457|Sacral Nerve Stimulation|sacral nerve stimulation
5231064|NCT00704431|SB-480848|sb-480848
5231065|NCT00704431|darapladib|darapladib
5231066|NCT00704431|tolerability|tolerability
5231067|NCT00704418|Cataract extraction|cataract extraction
5231068|NCT00704418|intraocular lens implantation|intraocular lens implantation
5231069|NCT00704405|hepatitis C|hepatitis c
5231070|NCT00704392|Solid tumors|solid tumors
5231071|NCT00704392|NSCLC|nsclc
5231072|NCT00704379|traumatic brain injury|traumatic brain injury
5231073|NCT00704379|TBI|tbi
5231074|NCT00704379|mood disorders|mood disorders
5231075|NCT00704379|anxiety disorders|anxiety disorders
5231076|NCT00704379|community reintegration|community reintegration
5231077|NCT00704379|executive function|executive function
5231078|NCT00704379|sertraline|sertraline
5231079|NCT00704379|diffusion tensor imaging|diffusion tensor imaging
5231080|NCT00704366|Advanced carcinoma|advanced carcinoma
5231081|NCT00704327|Cognitive Functions|cognitive functions
5231082|NCT00704327|Brain Ischemia|brain ischemia
5231083|NCT00704327|Cerebral Atrophy|cerebral atrophy
5231084|NCT00704327|Dementia|dementia
5231085|NCT00704327|Intracranial atherosclerosis|intracranial atherosclerosis
5231086|NCT00704327|Memory impairment|memory impairment
5231087|NCT00704314|Insulin resistance|insulin resistance
5231088|NCT00704314|Statins|statins
5231089|NCT00704314|Muscle and liver triglycerides|muscle and liver triglycerides
5231090|NCT00704301|Delirium|delirium
5231091|NCT00704301|Confusion|confusion
5231092|NCT00704288|GBM|gbm
5231093|NCT00704288|Malignant gliomas|malignant gliomas
5231094|NCT00704275|dry eye|dry eye
5231095|NCT00704249|HIV infection|hiv infection
5231096|NCT00704249|nevirapine|nevirapine
5231097|NCT00704249|Treatment Experienced|treatment experienced
5231098|NCT00704236|Traditional Chinese Treatment|traditional chinese treatment
5231099|NCT00704210|Low Back Pain|low back pain
5231100|NCT00704171|Elective pulmonary resection via open thoracotomy.|elective pulmonary resection via open thoracotomy.
5231101|NCT00704158|CR011-vcMMAE|cr011-vcmmae
5231102|NCT00704158|locally advanced breast cancer|locally advanced breast cancer
5231103|NCT00704158|metastatic breast cancer|metastatic breast cancer
5231104|NCT00704158|breast cancer|breast cancer
5231105|NCT00704158|CuraGen|curagen
5231106|NCT00704145|Drug Eluting Stents|drug eluting stents
5231107|NCT00704145|Percutaneous Coronary Interventions|percutaneous coronary interventions
5231108|NCT00704145|Optical Coherence Tomography|optical coherence tomography
5231109|NCT00704119|Rhudex|rhudex
5231110|NCT00704119|pharmacokinetic study|pharmacokinetic study
5231111|NCT00704106|Hepatitis B|hepatitis b
5231112|NCT00704106|HBV|hbv
5231113|NCT00704106|Treatment|treatment
5231114|NCT00704093|pacing|pacing
5231115|NCT00704093|perfusion|perfusion
5231116|NCT00704093|oxidative metabolism|oxidative metabolism
5231117|NCT00704093|efficiency|efficiency
5231118|NCT00704080|GBM|gbm
5231119|NCT00704080|Anaplastic glioma|anaplastic glioma
5231120|NCT00704067|vocational rehabilitation|vocational rehabilitation
5231121|NCT00704067|supported employment|supported employment
5231122|NCT00704067|cognitive training|cognitive training
5231123|NCT00704067|cognitive remediation|cognitive remediation
5231124|NCT00704067|cognitive rehabilitation|cognitive rehabilitation
5231125|NCT00704067|veterans|veterans
5231126|NCT00704054|Pediatric|pediatric
5231127|NCT00704054|Solid Tumor|solid tumor
5231128|NCT00704054|CNS Tumor|cns tumor
5231129|NCT00704054|Lymphoma|lymphoma
5231130|NCT00704015|Smoking cessation|smoking cessation
5231131|NCT00704015|Acute injury|acute injury
5231132|NCT00704015|Musculoskeletal|musculoskeletal
5231133|NCT00704015|Postoperative complications|postoperative complications
5231134|NCT00704002|neck fracture of the fifth metacarpal|neck fracture of the fifth metacarpal
5231135|NCT00704002|displacement|displacement
5231136|NCT00704002|antegrade intramedullary splinting|antegrade intramedullary splinting
5231137|NCT00704002|conservative treatment|conservative treatment
5231138|NCT00703989|hyperglycemia|hyperglycemia
5231139|NCT00703989|diabetic complications|diabetic complications
5231140|NCT00703989|advanced glycation endproducts|advanced glycation endproducts
5231141|NCT00703989|hexosamine pathway|hexosamine pathway
5231142|NCT00703989|prostacyclin synthase|prostacyclin synthase
5231143|NCT00703989|reactive oxygen species|reactive oxygen species
5231144|NCT00703976|head and neck cancers|head and neck cancers
5231145|NCT00703963|International normalized ratio (INR)|international normalized ratio (inr)
5231146|NCT00703950|Sucking patterns|sucking patterns
5231147|NCT00703950|preterm infants|preterm infants
5231148|NCT00703950|breastfeeding|breastfeeding
5231149|NCT00703924|cutaneous leishmaniasis topical treatment safety efficacy|cutaneous leishmaniasis topical treatment safety efficacy
5231150|NCT00703898|HIV|hiv
5231151|NCT00703898|nevirapine|nevirapine
5231152|NCT00703898|durability|durability
5231153|NCT00703898|AIDS|aids
5231154|NCT00703898|Treatment Naïve|treatment naïve
5231155|NCT00703885|functional magnetic resonance imaging|functional magnetic resonance imaging
5231156|NCT00703885|fMRI|fmri
5231157|NCT00703885|alprazolam|alprazolam
5231158|NCT00703885|anxiety disorders|anxiety disorders
5231159|NCT00703872|Chronic Hepatitis C|chronic hepatitis c
5231160|NCT00703872|Naive|naive
5231161|NCT00703872|Nonresponders|nonresponders
5231162|NCT00703872|Interferon|interferon
5231163|NCT00703872|Patients with Chronic Hepatitis C|patients with chronic hepatitis c
5231164|NCT00703859|Radiotherapy plus temozolomide plus DCA|radiotherapy plus temozolomide plus dca
5231165|NCT00703859|PK profile of DCA|pk profile of dca
5231166|NCT00703859|MGMT promoter methylation status|mgmt promoter methylation status
5231167|NCT00703859|Newly diagnosed Glioblastoma multiform tumours|newly diagnosed glioblastoma multiform tumours
5231168|NCT00703846|Phase 4|phase 4
5231169|NCT00703846|Seborrheic|seborrheic
5231170|NCT00703846|Ketoconazole|ketoconazole
5231171|NCT00703846|Dermatitis|dermatitis
5231172|NCT00703794|ev3 Neurovascular|ev3 neurovascular
5231173|NCT00703794|aneurysms|aneurysms
5231174|NCT00703794|cerebrovascular|cerebrovascular
5231175|NCT00703794|endovascular|endovascular
5231176|NCT00703794|neurovascular therapies|neurovascular therapies
5231177|NCT00703794|RACER|racer
5231178|NCT00703794|AXIUM|axium
5231179|NCT00703794|The AXIUM Progressive Coil System|the axium progressive coil system
5231180|NCT00703794|ev3|ev3
5231181|NCT00703794|MTI|mti
5231182|NCT00703794|Micro Therapeutics|micro therapeutics
5231183|NCT00703794|FX detachable coil system|fx detachable coil system
5231184|NCT00703794|K060747|k060747
5231185|NCT00703794|brain diseases|brain diseases
5231186|NCT00703781|Cataract extraction with intraocular lens implantation|cataract extraction with intraocular lens implantation
5231187|NCT00703768|Quality of Life|quality of life
5231282|NCT00703339|hypertension, pulmonary|hypertension, pulmonary
5231188|NCT00703768|Androgen Deprivation Therapy|androgen deprivation therapy
5231189|NCT00703768|Goserelin|goserelin
5231190|NCT00703755|Diabetes|diabetes
5231191|NCT00703755|Hypertriglyceridaemia|hypertriglyceridaemia
5231192|NCT00703755|Metabolic Syndrome|metabolic syndrome
5231193|NCT00703716|mini-invasive|mini-invasive
5231194|NCT00703716|dynamic screw-plate|dynamic screw-plate
5231195|NCT00703716|Surfix|surfix
5231196|NCT00703716|Lock-screw|lock-screw
5231197|NCT00703703|Heart rate, overactive bladder|heart rate, overactive bladder
5231198|NCT00703677|progressive supranuclear palsy|progressive supranuclear palsy
5231199|NCT00703677|corticobasal degeneration|corticobasal degeneration
5231200|NCT00703677|PSP|psp
5231201|NCT00703677|CBD|cbd
5231202|NCT00703677|lithium|lithium
5231203|NCT00703677|tau|tau
5231204|NCT00703651|Influenza|influenza
5231205|NCT00703651|Orthomyxoviridae Infection|orthomyxoviridae infection
5231206|NCT00703651|Inactivated, Split-virion influenza vaccine|inactivated, split-virion influenza vaccine
5231207|NCT00703651|Intradermal injection|intradermal injection
5231208|NCT00703651|Adults.|adults.
5231209|NCT00703612|Diabetes Mellitus|diabetes mellitus
5231210|NCT00703612|Adipose-derived stem cells|adipose-derived stem cells
5231211|NCT00703612|Adipose stromal vascular fraction|adipose stromal vascular fraction
5231212|NCT00703612|Autologous|autologous
5231213|NCT00703612|Hyperglycemia|hyperglycemia
5231214|NCT00703599|Diabetes Mellitus|diabetes mellitus
5231215|NCT00703599|Adipose-derived stem cells|adipose-derived stem cells
5231216|NCT00703599|Adipose stromal vascular fraction|adipose stromal vascular fraction
5231217|NCT00703599|Autologous|autologous
5231218|NCT00703599|Insulin-dependence|insulin-dependence
5231219|NCT00703586|Maraviroc|maraviroc
5231220|NCT00703586|Treatment Experienced|treatment experienced
5231221|NCT00703573|Atopic Dermatitis|atopic dermatitis
5231222|NCT00703560|HCV|hcv
5231223|NCT00703560|Genotype 1|genotype 1
5231224|NCT00703560|HIV co-infection|hiv co-infection
5231225|NCT00703560|viral kinetics|viral kinetics
5231226|NCT00703560|HCV quasi-species|hcv quasi-species
5231227|NCT00703560|Hepatitis C genotype 1|hepatitis c genotype 1
5231228|NCT00703560|HIV Infections|hiv infections
5231229|NCT00703547|Depression|depression
5231230|NCT00703534|GERD|gerd
5231231|NCT00703534|Acid Reflux|acid reflux
5231232|NCT00703534|Heartburn|heartburn
5231233|NCT00703534|Regurgitation|regurgitation
5231234|NCT00703534|non-acid reflux|non-acid reflux
5231235|NCT00703534|PRO measures|pro measures
5231236|NCT00703521|rabies vaccination|rabies vaccination
5231237|NCT00703521|pre-exposure prophylaxis|pre-exposure prophylaxis
5231238|NCT00703521|rabies virus neutralizing antibody|rabies virus neutralizing antibody
5231239|NCT00703521|Antibody response|antibody response
5231240|NCT00703521|immunologic memory of rabies vaccination|immunologic memory of rabies vaccination
5231241|NCT00703521|Safety of rabies vaccination administered in pre-exposure regimens both intramuscular and intradermal routes|safety of rabies vaccination administered in pre-exposure regimens both intramuscular and intradermal routes
5231242|NCT00703508|PCOS|pcos
5231243|NCT00703495|traumatic|traumatic
5231244|NCT00703495|brain injury|brain injury
5231245|NCT00703495|brain regional oxygen saturation (rSO2)|brain regional oxygen saturation (rso2)
5231246|NCT00703495|brain tissue oxygenation (PbtO2)|brain tissue oxygenation (pbto2)
5231247|NCT00703495|cerebral perfusion pressure (CPP)|cerebral perfusion pressure (cpp)
5231248|NCT00703482|Ventricular diastolic Function|ventricular diastolic function
5231249|NCT00703482|Diabetes|diabetes
5231250|NCT00703469|Hep C|hep c
5231251|NCT00703456|Functional ankle instability|functional ankle instability
5231252|NCT00703456|Balance training|balance training
5231253|NCT00703443|Genetics|genetics
5231254|NCT00703443|Dilated Cardiomyopathy|dilated cardiomyopathy
5231255|NCT00703443|Hypertrophic Cardiomyopathy|hypertrophic cardiomyopathy
5231256|NCT00703443|Mitochondrial Cardiomyopathy|mitochondrial cardiomyopathy
5231257|NCT00703443|Noncompaction Cardiomyopathy|noncompaction cardiomyopathy
5231258|NCT00703443|Restrictive Cardiomyopathy|restrictive cardiomyopathy
5231259|NCT00703443|Heart Failure|heart failure
5231260|NCT00703430|Alzheimer's disease, agitation, aggression, dementia|alzheimer's disease, agitation, aggression, dementia
5231261|NCT00703417|osteoporosis|osteoporosis
5231262|NCT00703417|diabetes|diabetes
5231263|NCT00703404|Anti-Retroviral Therapy|anti-retroviral therapy
5231264|NCT00703404|HIV|hiv
5231265|NCT00703404|Virologic Response|virologic response
5231266|NCT00703404|Treatment Naïve|treatment naïve
5231267|NCT00703391|Chronic|chronic
5231268|NCT00703391|obstructive|obstructive
5231269|NCT00703391|pulmonary|pulmonary
5231270|NCT00703391|lung|lung
5231271|NCT00703391|respiratory disease|respiratory disease
5231272|NCT00703391|tolerability|tolerability
5231273|NCT00703391|placebo-controlled|placebo-controlled
5231274|NCT00703391|pharmacokinetics|pharmacokinetics
5231275|NCT00703391|COPD|copd
5231276|NCT00703365|Hepatocellular Carcinoma (HCC)|hepatocellular carcinoma (hcc)
5231277|NCT00703352|Transposition of the great arteries.|transposition of the great arteries.
5231278|NCT00703352|Transposition of the great vessels.|transposition of the great vessels.
5231279|NCT00703352|Mustard.|mustard.
5231280|NCT00703352|Senning.|senning.
5231281|NCT00703339|fibrosis, pulmonary|fibrosis, pulmonary
5231283|NCT00703339|exercise, aerobic|exercise, aerobic
5231284|NCT00703326|Metastatic breast cancer|metastatic breast cancer
5231285|NCT00703326|HER2 negative breast cancer|her2 negative breast cancer
5231286|NCT00703326|locally recurrent breast cancer|locally recurrent breast cancer
5231287|NCT00703313|Study drug concentration in human tears|study drug concentration in human tears
5231288|NCT00703274|ischemic stroke|ischemic stroke
5231289|NCT00703274|stroke|stroke
5231290|NCT00703274|cerebrovascular stroke|cerebrovascular stroke
5231291|NCT00703274|cerebrovascular accident|cerebrovascular accident
5231292|NCT00703274|CVA|cva
5231293|NCT00703274|community health services|community health services
5231294|NCT00703274|community health workers|community health workers
5231295|NCT00703274|navigators|navigators
5231296|NCT00703274|health education|health education
5231297|NCT00703274|barriers to care|barriers to care
5231298|NCT00703274|healthcare access|healthcare access
5231299|NCT00703274|healthcare disparities|healthcare disparities
5231300|NCT00703248|Human Immunodeficiency Virus (HIV)|human immunodeficiency virus (hiv)
5231301|NCT00703248|complementary therapies|complementary therapies
5231302|NCT00703222|high-risk neuroblastoma|high-risk neuroblastoma
5231303|NCT00703222|single autologous stem cell rescue|single autologous stem cell rescue
5231304|NCT00703209|symptomatic diabetic neuropathy|symptomatic diabetic neuropathy
5231305|NCT00703209|diabetes|diabetes
5231306|NCT00703209|burning feet|burning feet
5231307|NCT00703209|Diabetic Neuropathy|diabetic neuropathy
5231308|NCT00703209|Loss of sensation in the foot|loss of sensation in the foot
5231309|NCT00703209|Neuropathy|neuropathy
5231310|NCT00703209|Painful Diabetic Neuropathy|painful diabetic neuropathy
5231311|NCT00703196|cervical cancer|cervical cancer
5231312|NCT00703196|human papilloma virus infection|human papilloma virus infection
5231313|NCT00703196|low-grade squamous intraepithelial lesion|low-grade squamous intraepithelial lesion
5231314|NCT00703196|high-grade squamous intraepithelial lesion|high-grade squamous intraepithelial lesion
5231315|NCT00703196|atypical squamous cells of undetermined significance|atypical squamous cells of undetermined significance
5231316|NCT00703196|cervical intraepithelial neoplasia grade 1|cervical intraepithelial neoplasia grade 1
5231317|NCT00703196|cervical intraepithelial neoplasia grade 2|cervical intraepithelial neoplasia grade 2
5231318|NCT00703196|cervical intraepithelial neoplasia grade 3|cervical intraepithelial neoplasia grade 3
5231319|NCT00703144|Pharmacokinetics|pharmacokinetics
5231320|NCT00703144|piperacillin/tazobactam.|piperacillin/tazobactam.
5231321|NCT00703144|Septic patients|septic patients
5231322|NCT00703144|oliguric renal failure|oliguric renal failure
5231323|NCT00703144|continuous veno-venous hemodiafiltration.|continuous veno-venous hemodiafiltration.
5231324|NCT00703131|fistula|fistula
5231325|NCT00703131|anal fistula|anal fistula
5231326|NCT00703118|Hepatitis C, Chronic|hepatitis c, chronic
5231327|NCT00703118|Telaprevir|telaprevir
5231328|NCT00703118|Peg-IFN-alfa-2a|peg-ifn-alfa-2a
5231329|NCT00703118|Ribavirin|ribavirin
5231330|NCT00703105|ovarian cancer|ovarian cancer
5231331|NCT00703105|Tregs|tregs
5231332|NCT00703105|vaccine|vaccine
5231333|NCT00703105|Recurrent Ovarian Cancer|recurrent ovarian cancer
5231334|NCT00703079|Acromegaly|acromegaly
5231335|NCT00703079|GH|gh
5231336|NCT00703079|IGF-I|igf-i
5231337|NCT00703079|Octreotide-LAR|octreotide-lar
5231338|NCT00703079|Lanreotide|lanreotide
5231339|NCT00703079|Transsphenoidal surgery|transsphenoidal surgery
5231340|NCT00703066|Malaria|malaria
5231341|NCT00703066|Vaccine|vaccine
5231342|NCT00703066|GMZ2|gmz2
5231343|NCT00703066|Safety|safety
5231344|NCT00703066|African|african
5231345|NCT00703066|immunogenicity|immunogenicity
5231346|NCT00703053|influenza, H5N1, vaccine, avian influenza, parent protocol|influenza, h5n1, vaccine, avian influenza, parent protocol
5231347|NCT00703040|Care engagement|care engagement
5231348|NCT00703040|Linkage to care|linkage to care
5231349|NCT00703040|HIV Infections|hiv infections
5231350|NCT00703027|diabetes mellitus|diabetes mellitus
5231351|NCT00703027|care decision|care decision
5231352|NCT00703027|data mining|data mining
5231353|NCT00703014|Neonatal outcome|neonatal outcome
5231354|NCT00703014|Congenital malformations|congenital malformations
5231355|NCT00703014|In-Vitro fertilization|in-vitro fertilization
5231356|NCT00703014|Controlled ovarian stimulation|controlled ovarian stimulation
5231357|NCT00703014|Follow-up|follow-up
5231358|NCT00702988|Neonatal outcome|neonatal outcome
5231359|NCT00702988|Congenital malformations|congenital malformations
5231360|NCT00702988|In-Vitro Fertilization|in-vitro fertilization
5231361|NCT00702988|Controlled ovarian stimulation|controlled ovarian stimulation
5231362|NCT00702988|Follow-up|follow-up
5231363|NCT00702975|phase II|phase ii
5231364|NCT00702975|NSCLC|nsclc
5231365|NCT00702975|bevacizumab|bevacizumab
5231366|NCT00702975|erlotinib|erlotinib
5231367|NCT00702975|metastatic NSCLC|metastatic nsclc
5231368|NCT00702962|lung cancer|lung cancer
5231369|NCT00702962|small cell lung cancer|small cell lung cancer
5231370|NCT00702949|breast cancer|breast cancer
5231371|NCT00702949|hot flashes|hot flashes
5231372|NCT00702923|Stage D0 Prostate Cancer|stage d0 prostate cancer
5231373|NCT00702923|Rising PSA|rising psa
5231374|NCT00702923|Casodex|casodex
5231375|NCT00702923|Tremelimumab|tremelimumab
5231376|NCT00702910|Asthma patients|asthma patients
5231377|NCT00702910|Magnesium stearate|magnesium stearate
5231378|NCT00702910|Tolerability|tolerability
5231379|NCT00702910|Safety|safety
5231380|NCT00702910|Lactose|lactose
5231381|NCT00702910|GW642444M|gw642444m
5231382|NCT00702910|Pharmacodynamics|pharmacodynamics
5231383|NCT00702910|Efficacy|efficacy
5231384|NCT00702910|Pharmacokinetics|pharmacokinetics
5231385|NCT00702884|recurrent esophageal cancer|recurrent esophageal cancer
5231386|NCT00702884|stage IIIA esophageal cancer|stage iiia esophageal cancer
5231387|NCT00702884|stage IIIB esophageal cancer|stage iiib esophageal cancer
5231388|NCT00702884|stage IIIC esophageal cancer|stage iiic esophageal cancer
5231389|NCT00702884|stage IV esophageal cancer|stage iv esophageal cancer
5231390|NCT00702871|Ventilator Associated Pneumonia|ventilator associated pneumonia
5231391|NCT00702871|antimicrobial susceptibility pattern|antimicrobial susceptibility pattern
5231392|NCT00702871|stress ulcer prophylaxis|stress ulcer prophylaxis
5231393|NCT00702858|Breast Cancer|breast cancer
5231394|NCT00702858|Joint Pain|joint pain
5231395|NCT00702858|Aromatase Inhibitors|aromatase inhibitors
5231396|NCT00702845|In vitro fertilization|in vitro fertilization
5231397|NCT00702845|Pharmacological effects of drugs|pharmacological effects of drugs
5231398|NCT00702845|Hormones|hormones
5231399|NCT00702845|Hormone Substitutes and Hormone Antagonists|hormone substitutes and hormone antagonists
5231400|NCT00702845|Pharmacological Actions|pharmacological actions
5231401|NCT00702845|Randomized|randomized
5231402|NCT00702845|Multi-center|multi-center
5231403|NCT00702845|Multi-national|multi-national
5231404|NCT00702845|Double-blind|double-blind
5231405|NCT00702845|Active-controlled|active-controlled
5231406|NCT00702845|Equivalence|equivalence
5231407|NCT00702832|Vestibular rehabilitation|vestibular rehabilitation
5231408|NCT00702832|acute vestibular injury|acute vestibular injury
5231409|NCT00702832|Dizziness|dizziness
5231410|NCT00702832|Nausea|nausea
5231411|NCT00702832|Nystagmus|nystagmus
5231412|NCT00702832|Daily life activities|daily life activities
5231413|NCT00702832|Balance|balance
5231414|NCT00702832|physiotherapy|physiotherapy
5231415|NCT00702819|Pan-Vascular Endothelial Growth Factor Blockade|pan-vascular endothelial growth factor blockade
5231416|NCT00702819|Safety|safety
5231417|NCT00702806|Pharmacological effects of drugs|pharmacological effects of drugs
5231418|NCT00702806|Hormones|hormones
5231419|NCT00702806|Hormone substitutes and Hormone Antagonists|hormone substitutes and hormone antagonists
5231420|NCT00702806|Pharmacological Actions|pharmacological actions
5231421|NCT00702806|Randomized|randomized
5231422|NCT00702806|Multi-center|multi-center
5231423|NCT00702806|Multi-national|multi-national
5231424|NCT00702793|Smoking cessation|smoking cessation
5231425|NCT00702793|schizophrenia|schizophrenia
5231426|NCT00702793|schizoaffective|schizoaffective
5231427|NCT00702793|psychosis|psychosis
5231428|NCT00702793|varenicline|varenicline
5231429|NCT00702793|champix|champix
5231430|NCT00702793|chantix|chantix
5231431|NCT00702793|nicotine dependence|nicotine dependence
5231432|NCT00702780|Alzheimer's disease|alzheimer's disease
5231433|NCT00702780|escitalopram|escitalopram
5231434|NCT00702780|MRI|mri
5231435|NCT00702767|This study was completed in October 2006|this study was completed in october 2006
5231436|NCT00702741|Knee|knee
5231437|NCT00702741|Meniscus|meniscus
5231438|NCT00702741|Meniscectomy|meniscectomy
5231439|NCT00702741|Mesenchymal Stem Cells|mesenchymal stem cells
5231440|NCT00702741|MSCs|mscs
5231441|NCT00702741|Adult Human Stem Cells|adult human stem cells
5231442|NCT00702741|Osiris|osiris
5231443|NCT00702741|Chondrogen|chondrogen
5231444|NCT00702728|Contrast induced nephropathy|contrast induced nephropathy
5231445|NCT00702728|Furosemide|furosemide
5231446|NCT00702728|Percutaneous coronary interventions|percutaneous coronary interventions
5231447|NCT00702728|Saline hydration|saline hydration
5231448|NCT00702702|Uterine fibroids|uterine fibroids
5231449|NCT00702702|Anemia|anemia
5231450|NCT00702689|Skin Sclerosis|skin sclerosis
5231451|NCT00702689|Graft Versus Host Disease|graft versus host disease
5231452|NCT00702676|Healthy Volunteers|healthy volunteers
5231453|NCT00702663|Hepatitis B|hepatitis b
5231454|NCT00702663|Hepatitis B vaccination|hepatitis b vaccination
5231455|NCT00702663|booster effect|booster effect
5231456|NCT00702663|Taiwan|taiwan
5231457|NCT00702663|young adults|young adults
5231458|NCT00702637|Traumatic Brain Injury|traumatic brain injury
5231459|NCT00702637|Fatigue|fatigue
5231460|NCT00702637|Modafinil|modafinil
5231461|NCT00702637|Somnolence|somnolence
5231462|NCT00702624|Neonatal outcome|neonatal outcome
5231463|NCT00702624|Congenital malformations|congenital malformations
5231464|NCT00702624|In-Vitro fertilization|in-vitro fertilization
5231465|NCT00702624|Controlled ovarian stimulation|controlled ovarian stimulation
5231466|NCT00702624|Follow-up|follow-up
5231467|NCT00702611|Ulcerative Colitis|ulcerative colitis
5231468|NCT00702611|Inflammatory Bowel disease|inflammatory bowel disease
5231469|NCT00702611|Steroid dependent|steroid dependent
5231470|NCT00702611|Adacolumn|adacolumn
5231471|NCT00702611|Apheresis|apheresis
5231472|NCT00702611|Granulocyte Monocyte apheresis|granulocyte monocyte apheresis
5231473|NCT00702611|GMA apheresis|gma apheresis
5231474|NCT00702611|Granulocytapheresis|granulocytapheresis
5231475|NCT00702598|Depression|depression
5231476|NCT00702598|occupational function|occupational function
5231477|NCT00702598|rating scales|rating scales
5231478|NCT00702598|RCT|rct
5231479|NCT00702598|cognitive behaviour therapy|cognitive behaviour therapy
5231480|NCT00702598|CBT|cbt
5231481|NCT00702598|escitalopram|escitalopram
5231482|NCT00702598|antidepressants|antidepressants
5231483|NCT00702585|Ovulation Induction|ovulation induction
5231484|NCT00702585|Pharmacological effects of drugs|pharmacological effects of drugs
5231485|NCT00702585|Hormones|hormones
5231486|NCT00702585|Hormone substitutes and Hormone Antagonists|hormone substitutes and hormone antagonists
5231487|NCT00702585|Pharmacological Actions|pharmacological actions
5231488|NCT00702585|Randomized|randomized
5231489|NCT00702585|Multi-center|multi-center
5231490|NCT00702585|Multi-national|multi-national
5231491|NCT00702572|Phase I|phase i
5231492|NCT00702572|Advanced non-small cell lung cancer|advanced non-small cell lung cancer
5231493|NCT00702546|In-vitro fertilization|in-vitro fertilization
5231494|NCT00702546|Controlled Ovarian Stimulation|controlled ovarian stimulation
5231495|NCT00702546|Cumulative pregnancy data|cumulative pregnancy data
5231496|NCT00702546|Follow-up|follow-up
5231497|NCT00702533|Hyper/Hyposecretion|hyper/hyposecretion
5231498|NCT00702533|Gastric Analysis|gastric analysis
5231499|NCT00702533|Gastric pH|gastric ph
5231500|NCT00702533|SmartPill|smartpill
5231501|NCT00702533|ph Monitoring|ph monitoring
5231502|NCT00702533|Gastric Secretion|gastric secretion
5231503|NCT00702533|Gastric Acid Output|gastric acid output
5231504|NCT00702533|Healthy Volunteer|healthy volunteer
5231505|NCT00702533|HV|hv
5231506|NCT00702520|Neonatal outcome|neonatal outcome
5231507|NCT00702520|Congenital malformations|congenital malformations
5231508|NCT00702520|In-Vitro fertilization|in-vitro fertilization
5231509|NCT00702520|Controlled ovarian stimulation|controlled ovarian stimulation
5231510|NCT00702520|Follow-up|follow-up
5231511|NCT00702507|Diaper dermatitis complicated by candidiasis|diaper dermatitis complicated by candidiasis
5231512|NCT00702494|placental growth factor|placental growth factor
5231513|NCT00702494|monoclonal antibody|monoclonal antibody
5231514|NCT00702494|Phase I|phase i
5231515|NCT00702494|solid tumors|solid tumors
5231516|NCT00702494|Patients with solid tumors|patients with solid tumors
5231517|NCT00702481|Head and Neck Squamous Cell Cancer|head and neck squamous cell cancer
5231518|NCT00702481|Chemoradiation|chemoradiation
5231519|NCT00702481|EGFR monoclonal antibody|egfr monoclonal antibody
5231520|NCT00702468|Spasticity|spasticity
5231521|NCT00702468|Multiple Sclerosis|multiple sclerosis
5231522|NCT00702455|Weight loss maintenance.|weight loss maintenance.
5231523|NCT00702455|Interactive phone and mail-based intervention.|interactive phone and mail-based intervention.
5231524|NCT00702442|Nausea, Vomiting|nausea, vomiting
5231525|NCT00702442|Vomiting episodes|vomiting episodes
5231526|NCT00702416|Analgesia, Patient-controlled|analgesia, patient-controlled
5231527|NCT00702416|Anesthesia, Regional|anesthesia, regional
5231528|NCT00702416|Ultrasound|ultrasound
5231529|NCT00702416|Postoperative Pain|postoperative pain
5231530|NCT00702416|Brachial Plexus|brachial plexus
5231531|NCT00702364|Attention|attention
5231532|NCT00702364|Traumatic Brain INjury|traumatic brain injury
5231533|NCT00702364|Atomoxetine|atomoxetine
5231534|NCT00702364|Strattera|strattera
5231535|NCT00702351|Infertility|infertility
5231536|NCT00702351|Pharmacological effects of drugs|pharmacological effects of drugs
5231537|NCT00702351|Drug therapy|drug therapy
5231538|NCT00702351|Hormones|hormones
5231539|NCT00702351|GnRH agonist|gnrh agonist
5231540|NCT00702351|RecFSH|recfsh
5231541|NCT00702351|Corifollitropin alfa|corifollitropin alfa
5231542|NCT00702351|Open-label|open-label
5231543|NCT00702338|Neonatal outcome|neonatal outcome
5231544|NCT00702338|Congenital malformations|congenital malformations
5231545|NCT00702338|Ovulation Induction|ovulation induction
5231546|NCT00702338|Follow-up|follow-up
5231547|NCT00702325|Asthma|asthma
5231548|NCT00702312|Blood pressure|blood pressure
5231549|NCT00702299|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5231550|NCT00702299|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5231551|NCT00702299|peritoneal cavity cancer|peritoneal cavity cancer
5231552|NCT00702299|fallopian tube cancer|fallopian tube cancer
5231553|NCT00702286|Surface acoustic ultrasound|surface acoustic ultrasound
5231554|NCT00702286|biofilm formation|biofilm formation
5231555|NCT00702286|percoutaneous nephrostomy tube|percoutaneous nephrostomy tube
5231556|NCT00702286|Patients requiring per coetaneous drainage due to urinary|patients requiring per coetaneous drainage due to urinary
5231557|NCT00702286|tract obstruction|tract obstruction
5231558|NCT00702286|To evaluate the efficacy of surface acoustic wave in|to evaluate the efficacy of surface acoustic wave in
5231559|NCT00702286|reducing pain and improving drainage|reducing pain and improving drainage
5231560|NCT00702273|In-vitro fertilization|in-vitro fertilization
5231561|NCT00702273|Controlled Ovarian Stimulation|controlled ovarian stimulation
5231562|NCT00702273|Cumulative pregnancy data|cumulative pregnancy data
5231563|NCT00702273|Follow-up|follow-up
5231564|NCT00702247|Multiple Myeloma - Nonmyeloablative transplantation - Autologous Transplant - Graft versus myeloma|multiple myeloma - nonmyeloablative transplantation - autologous transplant - graft versus myeloma
5231658|NCT00701909|Level of drowsiness|level of drowsiness
5231565|NCT00702247|Newly diagnosed multiple myeloma|newly diagnosed multiple myeloma
5231566|NCT00702247|Tandem Auto-Allo Transplant|tandem auto-allo transplant
5231567|NCT00702247|Overall survival|overall survival
5231568|NCT00702247|Event free survival|event free survival
5231569|NCT00702247|Disease response|disease response
5231570|NCT00702234|Neonatal outcome|neonatal outcome
5231571|NCT00702234|Congenital malformations|congenital malformations
5231572|NCT00702234|In-Vitro fertilization|in-vitro fertilization
5231573|NCT00702234|Controlled ovarian stimulation|controlled ovarian stimulation
5231574|NCT00702234|Follow-up|follow-up
5231575|NCT00702221|high blood pressure|high blood pressure
5231576|NCT00702221|vaccines|vaccines
5231577|NCT00702208|cervical cytology|cervical cytology
5231578|NCT00702208|Pap smear|pap smear
5231579|NCT00702208|self-sampling|self-sampling
5231580|NCT00702208|abnormal|abnormal
5231581|NCT00702208|normal|normal
5231582|NCT00702195|Neonatal outcome|neonatal outcome
5231583|NCT00702195|Congenital malformations|congenital malformations
5231584|NCT00702195|In-Vitro Fertilization|in-vitro fertilization
5231585|NCT00702195|Controlled ovarian stimulation|controlled ovarian stimulation
5231586|NCT00702195|Follow-up|follow-up
5231587|NCT00702195|Ovulation Induction|ovulation induction
5231588|NCT00702195|Neonates|neonates
5231589|NCT00702182|Lung Cancer|lung cancer
5231590|NCT00702182|Vinorelbine|vinorelbine
5231591|NCT00702182|Erlotinib|erlotinib
5231592|NCT00702182|Phase 1|phase 1
5231593|NCT00702169|high frequency ventilation monitoring|high frequency ventilation monitoring
5231594|NCT00702169|lung disease|lung disease
5231595|NCT00702169|Respiratory distress syndrome|respiratory distress syndrome
5231596|NCT00702169|lung barotrauma|lung barotrauma
5231597|NCT00702169|mechanical ventilation|mechanical ventilation
5231598|NCT00702169|endotracheal tube displacement|endotracheal tube displacement
5231599|NCT00702169|endotracheal tube occlusion|endotracheal tube occlusion
5231600|NCT00702169|one lung intubation|one lung intubation
5231601|NCT00702156|Heart Failure|heart failure
5231602|NCT00702156|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5231603|NCT00702156|Beta-blockers|beta-blockers
5231604|NCT00702156|Pulmonary Function|pulmonary function
5231605|NCT00702130|Ventilator Associated Pneumonia|ventilator associated pneumonia
5231606|NCT00702104|prostate cancer|prostate cancer
5231607|NCT00702078|COPD|copd
5231608|NCT00702078|home-based treatment|home-based treatment
5231609|NCT00702078|early intervention|early intervention
5231610|NCT00702065|Multiple Sclerosis Quality of life|multiple sclerosis quality of life
5231611|NCT00702052|Mantle Cell Lymphoma|mantle cell lymphoma
5231612|NCT00702052|Lymphoma|lymphoma
5231613|NCT00702052|B-Cell Lymphoma|b-cell lymphoma
5231614|NCT00702052|Mantle Zone Lymphoma|mantle zone lymphoma
5231615|NCT00702052|Refractory Lymphoma|refractory lymphoma
5231616|NCT00702052|Aggressive Lymphoma|aggressive lymphoma
5231617|NCT00702052|PILLAR-1|pillar-1
5231618|NCT00702026|Irritable Bowel Syndrome|irritable bowel syndrome
5231619|NCT00702026|Hypersensitivity|hypersensitivity
5231620|NCT00702026|Probiotics|probiotics
5231621|NCT00702026|Multispecies|multispecies
5231622|NCT00702013|P-glycoprotein|p-glycoprotein
5231623|NCT00702013|lymphocyte|lymphocyte
5231624|NCT00702013|HIV|hiv
5231625|NCT00702013|children|children
5231626|NCT00702013|ontogenesis|ontogenesis
5231627|NCT00702013|Ontogenesis P-gp in human lymphocytes|ontogenesis p-gp in human lymphocytes
5231628|NCT00702013|Study of the influence of HIV infection|study of the influence of hiv infection
5231629|NCT00702013|Antiretroviral treatments on P-gp activity|antiretroviral treatments on p-gp activity
5231630|NCT00702013|Expression in human lymphocytes|expression in human lymphocytes
5231631|NCT00702000|ICU acquired paresis|icu acquired paresis
5231632|NCT00701987|Cutaneous Metastatic Melanoma|cutaneous metastatic melanoma
5231633|NCT00701974|Non-inferiority based on efficiency|non-inferiority based on efficiency
5231634|NCT00701961|Mefloquine-artesunate|mefloquine-artesunate
5231635|NCT00701961|Malaria|malaria
5231636|NCT00701961|Pregnancy|pregnancy
5231637|NCT00701961|Pharmacokinetics|pharmacokinetics
5231638|NCT00701961|Sub-Saharan Africa|sub-saharan africa
5231639|NCT00701961|P falciparum malaria infection in pregnancy|p falciparum malaria infection in pregnancy
5231640|NCT00701948|Late onset neonatal sepsis|late onset neonatal sepsis
5231641|NCT00701948|Nosocomial bacterial infection|nosocomial bacterial infection
5231642|NCT00701948|Inflammatory markers|inflammatory markers
5231643|NCT00701948|multiplex dosage|multiplex dosage
5231644|NCT00701935|diabetes mellitus|diabetes mellitus
5231645|NCT00701935|Amylin|amylin
5231646|NCT00701935|Lilly|lilly
5231647|NCT00701922|lung transplantation|lung transplantation
5231648|NCT00701922|Bronchiolitis Obliterans|bronchiolitis obliterans
5231649|NCT00701922|Epstein-Barr Virus Infections|epstein-barr virus infections
5231650|NCT00701922|Paramyxoviridae Infections|paramyxoviridae infections
5231651|NCT00701922|Herpesviridae|herpesviridae
5231652|NCT00701909|wound care|wound care
5231653|NCT00701909|procedural pain intensity|procedural pain intensity
5231654|NCT00701909|procedural hyperalgesia|procedural hyperalgesia
5231655|NCT00701909|wound care pain intensity|wound care pain intensity
5231656|NCT00701909|wound care hyperalgesia|wound care hyperalgesia
5231657|NCT00701909|Wound care pain quality|wound care pain quality
5231659|NCT00701909|level of nausea|level of nausea
5231660|NCT00701909|Level of vomiting|level of vomiting
5231661|NCT00701909|Level of hallucinations|level of hallucinations
5231662|NCT00701909|Level of dysphoria|level of dysphoria
5231663|NCT00701896|HIV|hiv
5231664|NCT00701896|Positive|positive
5231665|NCT00701896|Smokers|smokers
5231666|NCT00701896|Varenicline|varenicline
5231667|NCT00701883|Cholesterol|cholesterol
5231668|NCT00701883|Hyperlipidemia|hyperlipidemia
5231669|NCT00701883|HDL|hdl
5231670|NCT00701883|LDL|ldl
5231671|NCT00701883|Triglycerides|triglycerides
5231672|NCT00701883|Dyslipidemia|dyslipidemia
5231673|NCT00701870|NSCLC|nsclc
5231674|NCT00701870|Chemotherapy induced neutropenia|chemotherapy induced neutropenia
5231675|NCT00701870|CIN|cin
5231676|NCT00701857|stage III esophageal cancer|stage iii esophageal cancer
5231677|NCT00701857|stage IV esophageal cancer|stage iv esophageal cancer
5231678|NCT00701844|Aplastic Anemia|aplastic anemia
5231679|NCT00701844|Lymphatic Diseases|lymphatic diseases
5231680|NCT00701844|Leukemia|leukemia
5231681|NCT00701844|Leukemia, Lymphoid|leukemia, lymphoid
5231682|NCT00701844|Immunoproliferative Disorders|immunoproliferative disorders
5231683|NCT00701844|Precursor Cell Lymphoblastic Leukemia-Lymphoma|precursor cell lymphoblastic leukemia-lymphoma
5231684|NCT00701844|Anemia|anemia
5231685|NCT00701844|Quality of Life|quality of life
5231686|NCT00701844|Lymphoproliferative Disorders|lymphoproliferative disorders
5231687|NCT00701844|Lymphoma|lymphoma
5231688|NCT00701844|Multiple Myeloma|multiple myeloma
5231689|NCT00701805|Secondary hyperparathyroidism|secondary hyperparathyroidism
5231690|NCT00701805|Hemodialysis|hemodialysis
5231691|NCT00701805|paricalcitol|paricalcitol
5231692|NCT00701792|cirrhosis transplantation|cirrhosis transplantation
5231693|NCT00701779|Benign Prostatic Hyperplasia|benign prostatic hyperplasia
5231694|NCT00701779|Dutasteride|dutasteride
5231695|NCT00701779|Tamsulosin|tamsulosin
5231696|NCT00701753|Pharmacogenetic|pharmacogenetic
5231697|NCT00701753|DNA|dna
5231698|NCT00701753|RNA|rna
5231699|NCT00701753|Antipsychotic|antipsychotic
5231700|NCT00701753|Olanzapine|olanzapine
5231701|NCT00701753|Risperidone|risperidone
5231702|NCT00701753|Quetiapine|quetiapine
5231703|NCT00701753|Personalized medicine|personalized medicine
5231704|NCT00701740|photoaging|photoaging
5231705|NCT00701740|isotretinoin|isotretinoin
5231706|NCT00701740|profilometry|profilometry
5231707|NCT00701740|digital analysis|digital analysis
5231708|NCT00701727|metabolic diseases|metabolic diseases
5231709|NCT00701727|metabolic disorder|metabolic disorder
5231710|NCT00701727|dyslipidemias|dyslipidemias
5231711|NCT00701727|lipid metabolism disorders|lipid metabolism disorders
5231712|NCT00701714|Treatment|treatment
5231713|NCT00701714|associated|associated
5231714|NCT00701714|with CRI|with cri
5231715|NCT00701688|Mucositis, Oral|mucositis, oral
5231716|NCT00701688|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
5231717|NCT00701688|Allogeneic Transplantation|allogeneic transplantation
5231718|NCT00701688|Pharmacokinetics|pharmacokinetics
5231719|NCT00701688|Maximum Tolerated Dose|maximum tolerated dose
5231720|NCT00701675|sertraline|sertraline
5231721|NCT00701675|pharmacotherapy|pharmacotherapy
5231722|NCT00701675|geriatric|geriatric
5231723|NCT00701649|mild essential hypertension|mild essential hypertension
5231724|NCT00701649|moderate essential hypertension|moderate essential hypertension
5231725|NCT00701636|Daptomycin|daptomycin
5231726|NCT00701636|Antibiotic Prophylaxis|antibiotic prophylaxis
5231727|NCT00701636|Pharmacokinetics|pharmacokinetics
5231728|NCT00701636|Surgical Wound Infection|surgical wound infection
5231729|NCT00701636|Staphylococcus aureus|staphylococcus aureus
5231730|NCT00701636|Cardiopulmonary Bypass Surgery|cardiopulmonary bypass surgery
5231731|NCT00701623|The intention of this work is to verify the effectiveness and safety of sodium heparin in the treatment of burns of the skin.|the intention of this work is to verify the effectiveness and safety of sodium heparin in the treatment of burns of the skin.
5231732|NCT00701610|Von Willebramd Factor (VWF)|von willebramd factor (vwf)
5231733|NCT00701610|All infants born in our hospital since August 2007 ill august 2009 will enter.|all infants born in our hospital since august 2007 ill august 2009 will enter.
5231734|NCT00701610|Therombocytopenia, maternal aspirin will be excluded|therombocytopenia, maternal aspirin will be excluded
5231735|NCT00701597|ocular blood flow dysregulation, glaucoma, endothelin-1|ocular blood flow dysregulation, glaucoma, endothelin-1
5231736|NCT00701584|Phytoestrogens|phytoestrogens
5231737|NCT00701584|Isoflavones|isoflavones
5231738|NCT00701584|Lignans|lignans
5231739|NCT00701584|Breast cancer survival|breast cancer survival
5231740|NCT00701584|breast cancer recurrence|breast cancer recurrence
5231741|NCT00701571|Virtual Reality|virtual reality
5231742|NCT00701571|Oncology|oncology
5231743|NCT00701571|Lumbar puncture|lumbar puncture
5231744|NCT00701545|von Willebrand disease|von willebrand disease
5231745|NCT00701545|VWD, Humate-P®|vwd, humate-p®
5231746|NCT00701545|Infusion volume reduced|infusion volume reduced
5231747|NCT00701545|ivr|ivr
5231748|NCT00701532|Cocaine|cocaine
5231749|NCT00701532|Substance abuse|substance abuse
5231750|NCT00701532|Addiction|addiction
5231751|NCT00701532|Dependence|dependence
5231752|NCT00701532|Modafinil|modafinil
5231753|NCT00701532|Brain imaging|brain imaging
5231754|NCT00701519|CHF,|chf,
5231755|NCT00701519|Sleep apnea,|sleep apnea,
5231756|NCT00701519|Obstructive sleep apnea,|obstructive sleep apnea,
5231757|NCT00701519|Heart failure|heart failure
5231758|NCT00701506|Knee|knee
5231759|NCT00701506|Osteoarthritis|osteoarthritis
5231760|NCT00701506|Treatment|treatment
5231761|NCT00701506|Electrostimulation|electrostimulation
5231762|NCT00701493|Topiramate|topiramate
5231763|NCT00701493|Topiramate oral liquid|topiramate oral liquid
5231764|NCT00701493|TOPAMAX Sprinkle capsule|topamax sprinkle capsule
5231765|NCT00701493|topiramate capsules|topiramate capsules
5231766|NCT00701480|acne|acne
5231767|NCT00701480|skin cleanser|skin cleanser
5231768|NCT00701480|Hibiscus sabdariffa|hibiscus sabdariffa
5231769|NCT00701480|Roselle|roselle
5231770|NCT00701480|safety|safety
5231771|NCT00701480|efficacy|efficacy
5231772|NCT00701467|ICD|icd
5231773|NCT00701467|ICD implanted patients|icd implanted patients
5231774|NCT00701454|Thai-muslim|thai-muslim
5231775|NCT00701454|Thai-HALAL|thai-halal
5231776|NCT00701454|Diabetes|diabetes
5231777|NCT00701454|Hypertension|hypertension
5231778|NCT00701454|Hyperlipidemia|hyperlipidemia
5231779|NCT00701454|Metabolic syndrome|metabolic syndrome
5231780|NCT00701441|sleep apnea,|sleep apnea,
5231781|NCT00701441|oxidative stress|oxidative stress
5231782|NCT00701428|Hypertension|hypertension
5231783|NCT00701428|Sleep Apnea|sleep apnea
5231784|NCT00701428|Angiotensin II antagonist|angiotensin ii antagonist
5231785|NCT00701428|CPAP|cpap
5231786|NCT00701415|α-GAL, α-Galactosidase-A, r-hαGAL|α-gal, α-galactosidase-a, r-hαgal
5231787|NCT00701402|time to lipid-lowering drug implementation|time to lipid-lowering drug implementation
5231788|NCT00701402|dyslipidemic patients|dyslipidemic patients
5231789|NCT00701376|Gastric Bypass surgery|gastric bypass surgery
5231790|NCT00701376|Hepatic disease|hepatic disease
5231791|NCT00701376|Hepatic function|hepatic function
5231792|NCT00701350|Pregnancy|pregnancy
5231793|NCT00701350|Intra-amniotic Infection|intra-amniotic infection
5231794|NCT00701350|Preterm Birth|preterm birth
5231795|NCT00701350|Preterm Premature Rupture of Membranes|preterm premature rupture of membranes
5231796|NCT00701337|Estrogen Replacement Therapy|estrogen replacement therapy
5231797|NCT00701337|menopausal women|menopausal women
5231798|NCT00701311|Prostatitis|prostatitis
5231799|NCT00701311|Pelvic pain|pelvic pain
5231800|NCT00701285|heart failure|heart failure
5231801|NCT00701285|pitavastatin|pitavastatin
5231802|NCT00701285|pravastatin|pravastatin
5231803|NCT00701285|statin|statin
5231804|NCT00701259|Frequent heartburn, proton pump inhibitor, lansoprazole|frequent heartburn, proton pump inhibitor, lansoprazole
5231805|NCT00701259|Treatment of|treatment of
5231806|NCT00701259|over 14 days|over 14 days
5231807|NCT00701246|Anemia|anemia
5231808|NCT00701246|Iron deficiency anemia|iron deficiency anemia
5231809|NCT00701246|Infants|infants
5231810|NCT00701246|Children|children
5231811|NCT00701246|Clinical trials|clinical trials
5231812|NCT00701246|Ferrous sulfate|ferrous sulfate
5231813|NCT00701246|Folic acid|folic acid
5231814|NCT00701246|Daycare centers|daycare centers
5231815|NCT00701246|Anaemia in children|anaemia in children
5231816|NCT00701246|born at term|born at term
5231817|NCT00701246|non-twins|non-twins
5231818|NCT00701246|with parental approval for participation in the study|with parental approval for participation in the study
5231819|NCT00701246|growth|growth
5231820|NCT00701220|Cardiovascular Disease|cardiovascular disease
5231821|NCT00701220|Cardiomyopathy|cardiomyopathy
5231822|NCT00701220|Heart Disease|heart disease
5231823|NCT00701220|Myocardial Disease|myocardial disease
5231824|NCT00701220|Myocardial Ischemia|myocardial ischemia
5231825|NCT00701207|To determine if nicotine treatment reduces lung inflammation|to determine if nicotine treatment reduces lung inflammation
5231826|NCT00701194|placement instability|placement instability
5231827|NCT00701194|disruptive behavior disorders|disruptive behavior disorders
5231828|NCT00701194|school readiness|school readiness
5231829|NCT00701194|developmental delays|developmental delays
5231830|NCT00701194|cortisol|cortisol
5231831|NCT00701194|executive functioning|executive functioning
5231832|NCT00701194|therapeutic foster care|therapeutic foster care
5231833|NCT00701194|prevention|prevention
5231834|NCT00701194|early intervention|early intervention
5231835|NCT00701181|Phase II|phase ii
5231836|NCT00701181|Prospective|prospective
5231837|NCT00701181|Randomized|randomized
5231838|NCT00701181|Diabetic Macular Edema|diabetic macular edema
5231839|NCT00701181|PF-04523655|pf-04523655
5231840|NCT00701181|Laser|laser
5231841|NCT00701129|Glycogenesis 2|glycogenesis 2
5231842|NCT00701129|Acid|acid
5231843|NCT00701129|Maltase|maltase
5231844|NCT00701129|Deficiency|deficiency
5231845|NCT00701090|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
5231846|NCT00701090|Non Insulin Dependent|non insulin dependent
5231847|NCT00701077|Brugada syndrome|brugada syndrome
5231848|NCT00701077|Electrophysiological study|electrophysiological study
5231849|NCT00701077|Ion channel blockade|ion channel blockade
5231850|NCT00701064|posttraumatic stress disorder|posttraumatic stress disorder
5231851|NCT00701064|phototherapy|phototherapy
5231852|NCT00701064|anxiety|anxiety
5231853|NCT00701064|depression|depression
5231854|NCT00701064|sleep|sleep
5231855|NCT00701064|negative ion generator|negative ion generator
5231856|NCT00701038|Sleep apnea,|sleep apnea,
5231857|NCT00701038|obstructive sleep apnea,|obstructive sleep apnea,
5231858|NCT00701038|heart failure,|heart failure,
5231859|NCT00701038|CHF|chf
5231860|NCT00701025|inflammation in asthmatic and non-asthmatic participants|inflammation in asthmatic and non-asthmatic participants
5231861|NCT00701012|low or high ligation|low or high ligation
5231862|NCT00700986|Electroretinography|electroretinography
5231863|NCT00700986|Rheumatoid Arthritis|rheumatoid arthritis
5231864|NCT00700986|Anti-TNF|anti-tnf
5231865|NCT00700986|Disease Modifying Anti-Rheumatic Drugs (DMARD)|disease modifying anti-rheumatic drugs (dmard)
5231866|NCT00700973|anger|anger
5231867|NCT00700973|psychotherapy, brief|psychotherapy, brief
5231868|NCT00700973|diagnosis, dual|diagnosis, dual
5231869|NCT00700947|Heart Disease|heart disease
5231870|NCT00700947|Mitral Regurgitation|mitral regurgitation
5231871|NCT00700947|Heart Valve Disease|heart valve disease
5231872|NCT00700947|Mitral Valve Insufficiency|mitral valve insufficiency
5231873|NCT00700947|Heart Surgery|heart surgery
5231874|NCT00700947|Heart Valve Surgery|heart valve surgery
5231875|NCT00700934|FEV1|fev1
5231876|NCT00700934|mortality|mortality
5231877|NCT00700934|Quality of life|quality of life
5231878|NCT00700908|type 2 diabetes|type 2 diabetes
5231879|NCT00700908|telephone intervention|telephone intervention
5231880|NCT00700908|automated|automated
5231881|NCT00700882|stage IV melanoma|stage iv melanoma
5231882|NCT00700882|acral lentiginous malignant melanoma|acral lentiginous malignant melanoma
5231883|NCT00700882|mucosal melanoma|mucosal melanoma
5231884|NCT00700882|recurrent melanoma|recurrent melanoma
5231885|NCT00700882|stage IIIA melanoma|stage iiia melanoma
5231886|NCT00700882|stage IIIB melanoma|stage iiib melanoma
5231887|NCT00700882|stage IIIC melanoma|stage iiic melanoma
5231888|NCT00700869|Altered level of consciousness|altered level of consciousness
5231889|NCT00700869|Tracheal tube withdrawal|tracheal tube withdrawal
5231890|NCT00700869|Respiration|respiration
5231891|NCT00700869|Artificial Respiration|artificial respiration
5231892|NCT00700869|Physiology|physiology
5231893|NCT00700856|diabetes|diabetes
5231894|NCT00700856|cardiovascular disease|cardiovascular disease
5231895|NCT00700856|pioglitazone|pioglitazone
5231896|NCT00700856|sulphonylurea|sulphonylurea
5231897|NCT00700856|metformin monotherapy|metformin monotherapy
5231898|NCT00700856|hypoglycemic therapy|hypoglycemic therapy
5231899|NCT00700843|bariatric surgery|bariatric surgery
5231900|NCT00700843|long term follow up|long term follow up
5231901|NCT00700843|gastric partitioning surgery|gastric partitioning surgery
5231902|NCT00700843|Roux-en-Y gastric bypass surgery|roux-en-y gastric bypass surgery
5231903|NCT00700843|obesity|obesity
5231904|NCT00700804|Calcium retention|calcium retention
5231905|NCT00700804|dietary protein|dietary protein
5231906|NCT00700804|dietary calcium|dietary calcium
5231907|NCT00700791|Single and bilateral body contouring surgical sites.|single and bilateral body contouring surgical sites.
5231908|NCT00700778|breast cancer|breast cancer
5231909|NCT00700778|BRCA1 mutation carrier|brca1 mutation carrier
5231910|NCT00700739|Cervical|cervical
5231911|NCT00700739|Disc|disc
5231912|NCT00700739|Arthroplasty|arthroplasty
5231913|NCT00700739|Spinal|spinal
5231914|NCT00700726|blood test|blood test
5231915|NCT00700726|asthma|asthma
5231916|NCT00700726|skin test|skin test
5231917|NCT00700713|Meningitis|meningitis
5231918|NCT00700713|Meningococcemia|meningococcemia
5231919|NCT00700713|Neisseria meningitidis|neisseria meningitidis
5231920|NCT00700713|Menactra®|menactra®
5231921|NCT00700700|Congestive Heart Failure|congestive heart failure
5231922|NCT00700700|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
5231923|NCT00700700|Dyspnea|dyspnea
5231924|NCT00700700|Exercise Tolerance|exercise tolerance
5231925|NCT00700687|cardiovascular prophylactic therapy|cardiovascular prophylactic therapy
5231926|NCT00700674|EEG entropy|eeg entropy
5231927|NCT00700674|Elderly|elderly
5231928|NCT00700674|Decreases|decreases
5231929|NCT00700674|POCD|pocd
5231930|NCT00700674|Use of EEG entropy|use of eeg entropy
5231931|NCT00700674|Geriatric|geriatric
5231932|NCT00700635|Meningitis; Meningococcal infection, Neisseria meningitidis|meningitis; meningococcal infection, neisseria meningitidis
5231933|NCT00700609|Depression|depression
5231934|NCT00700609|Family Therapy|family therapy
5231935|NCT00700609|Adolescents|adolescents
5231936|NCT00700596|Salvia|salvia
5231937|NCT00700596|SA|sa
5231938|NCT00700596|Salvinorin|salvinorin
5231939|NCT00700596|Psychotomimetic Effects|psychotomimetic effects
5231940|NCT00700583|nocturia|nocturia
5231941|NCT00700583|bladder|bladder
5231942|NCT00700583|urination disorders|urination disorders
5231943|NCT00700583|hydrochlorothiazide|hydrochlorothiazide
5231944|NCT00700583|terazosin|terazosin
5231945|NCT00700557|Antibiotic Associated Diarrhea|antibiotic associated diarrhea
5231946|NCT00700557|probiotics|probiotics
5231947|NCT00700557|treatment|treatment
5231948|NCT00700544|AML|aml
5231949|NCT00700544|elderly patients|elderly patients
5231950|NCT00700544|Treatment outcome|treatment outcome
5231951|NCT00700531|Hemodialysis|hemodialysis
5231952|NCT00700531|Multiple myeloma|multiple myeloma
5231953|NCT00700531|Cast nephropathy|cast nephropathy
5231954|NCT00700531|Kidney failure|kidney failure
5231955|NCT00700518|Raynaud's Syndrome|raynaud's syndrome
5231956|NCT00700518|Raynaud's Disease|raynaud's disease
5231957|NCT00700518|RP|rp
5231958|NCT00700505|Benign Prostatic Hyperplasia|benign prostatic hyperplasia
5231959|NCT00700505|BPH|bph
5231960|NCT00700505|Benign Prostatic Hypertrophy|benign prostatic hypertrophy
5231961|NCT00700505|Urinary Retention|urinary retention
5231962|NCT00700505|Shy Bladder|shy bladder
5231963|NCT00700505|Urinary Hesitancy|urinary hesitancy
5231964|NCT00700505|Bashful Bladder|bashful bladder
5231965|NCT00700505|Paruresis|paruresis
5231966|NCT00700492|subfertility|subfertility
5231967|NCT00700492|pregnancy rate|pregnancy rate
5231968|NCT00700492|miscarriage|miscarriage
5231969|NCT00700479|vascular endothelium|vascular endothelium
5231970|NCT00700479|nitric oxide|nitric oxide
5231971|NCT00700479|aldosterone|aldosterone
5231972|NCT00700479|vascular biology|vascular biology
5231973|NCT00700466|Outcome assessment, patients;|outcome assessment, patients;
5231974|NCT00700466|autonomic nervous system;|autonomic nervous system;
5231975|NCT00700466|perioperative care;|perioperative care;
5231976|NCT00700466|adrenergic beta antagonist|adrenergic beta antagonist
5231977|NCT00700466|Autonomic regulation|autonomic regulation
5231978|NCT00700466|Perioperative beta-blockade|perioperative beta-blockade
5231979|NCT00700466|outcome|outcome
5231980|NCT00700440|Radiotherapy|radiotherapy
5231981|NCT00700440|chemotherapy|chemotherapy
5231982|NCT00700440|Drug Targeting|drug targeting
5231983|NCT00700440|loco-regionally advanced nasopharyngeal carcinoma|loco-regionally advanced nasopharyngeal carcinoma
5231984|NCT00700440|Safety.|safety.
5231985|NCT00700440|efficacy|efficacy
5231986|NCT00700427|ADHD|adhd
5231987|NCT00700427|Adult|adult
5231988|NCT00700427|long term|long term
5231989|NCT00700427|maintenance of response|maintenance of response
5231990|NCT00700427|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
5231991|NCT00700388|Chronic bronchitis|chronic bronchitis
5231992|NCT00700388|COPD|copd
5231993|NCT00700388|Bronchiectasis|bronchiectasis
5231994|NCT00700375|Patients undergoing an emergent coronary procedure|patients undergoing an emergent coronary procedure
5231995|NCT00700362|Complications|complications
5231996|NCT00700362|Hyperglycemia|hyperglycemia
5231997|NCT00700362|Insulin infusion|insulin infusion
5231998|NCT00700349|depression|depression
5231999|NCT00700349|stress|stress
5232000|NCT00700349|microcredit|microcredit
5232001|NCT00700349|poverty|poverty
5232002|NCT00700349|South Africa|south africa
5232003|NCT00700336|malignant pleural mesothelioma|malignant pleural mesothelioma
5232004|NCT00700336|solid tumors|solid tumors
5232005|NCT00700323|ADHD|adhd
5232006|NCT00700323|ADHD diagnosed children|adhd diagnosed children
5232007|NCT00700310|Partial onset seizures|partial onset seizures
5232008|NCT00700310|E2007|e2007
5232009|NCT00700310|perampanel|perampanel
5232010|NCT00700310|refractory partial seizures|refractory partial seizures
5232011|NCT00700310|adjunctive therapy|adjunctive therapy
5232012|NCT00700310|seizure frequency|seizure frequency
5232013|NCT00700310|reduction in seizure frequency|reduction in seizure frequency
5232014|NCT00700310|safety|safety
5232015|NCT00700310|concomitant AED(s)|concomitant aed(s)
5232016|NCT00700297|Oral aphthosis|oral aphthosis
5232017|NCT00700297|Genital aphthosis|genital aphthosis
5232018|NCT00700297|Psuedofolliculitis|psuedofolliculitis
5232019|NCT00700297|Erythem nodusom|erythem nodusom
5232020|NCT00700297|Joint manifestations|joint manifestations
5232021|NCT00700297|Colchicine|colchicine
5232022|NCT00700284|HIV-I|hiv-i
5232023|NCT00700284|Reverse transcriptase inhibitors|reverse transcriptase inhibitors
5232024|NCT00700284|HIV Seronegativity|hiv seronegativity
5232025|NCT00700271|Hypertension|hypertension
5232026|NCT00700271|ambulatory blood pressure monitoring|ambulatory blood pressure monitoring
5232027|NCT00700245|Obese|obese
5232028|NCT00700245|Adults|adults
5232029|NCT00700232|genetics|genetics
5232030|NCT00700232|gene expression|gene expression
5232031|NCT00700232|MDR3|mdr3
5232032|NCT00700232|estrogens|estrogens
5232033|NCT00700232|cholestasis|cholestasis
5232034|NCT00700232|pregnancy|pregnancy
5232035|NCT00700232|controls|controls
5232036|NCT00700219|Preterm Labor|preterm labor
5232037|NCT00700219|Preterm Birth|preterm birth
5232038|NCT00700219|Intra-amniotic Infection|intra-amniotic infection
5232039|NCT00700219|Pregnancy|pregnancy
5232040|NCT00700219|Women|women
5232041|NCT00700206|Hematology|hematology
5232042|NCT00700206|MDS|mds
5232043|NCT00700206|Myelodysplastic Syndrome|myelodysplastic syndrome
5232044|NCT00700206|Low Risk MDS|low risk mds
5232045|NCT00700206|Intermediate-1 risk MDS|intermediate-1 risk mds
5232046|NCT00700206|Int-1 risk MDS|int-1 risk mds
5232047|NCT00700206|Telintra|telintra
5232048|NCT00700206|ezatiostat hydrochloride|ezatiostat hydrochloride
5232049|NCT00700206|ezatiostat|ezatiostat
5232050|NCT00700206|TLK199|tlk199
5232051|NCT00700206|Glutathione|glutathione
5232052|NCT00700206|Glutathione analog|glutathione analog
5232053|NCT00700206|Glutathione Transferase|glutathione transferase
5232054|NCT00700206|Glutathione Transferase inhibitor|glutathione transferase inhibitor
5232249|NCT00699322|sitagliptin|sitagliptin
5232055|NCT00700206|Glutathione Transferase P1-1 inhibitor|glutathione transferase p1-1 inhibitor
5232056|NCT00700206|GSTp1-1 inhibitor|gstp1-1 inhibitor
5232057|NCT00700206|Apoptosis|apoptosis
5232058|NCT00700206|Differentiation|differentiation
5232059|NCT00700206|Enzyme inhibitor|enzyme inhibitor
5232060|NCT00700167|ANTIGENBEARING DENDRITIC CELLS|antigenbearing dendritic cells
5232061|NCT00700167|98-098|98-098
5232062|NCT00700154|Vascular Surgery|vascular surgery
5232063|NCT00700154|Complications|complications
5232064|NCT00700154|Hyperglycemia|hyperglycemia
5232065|NCT00700154|Insulin infusion|insulin infusion
5232066|NCT00700154|Diabetic ulcers|diabetic ulcers
5232067|NCT00700154|Infection|infection
5232068|NCT00700141|Tachosil|tachosil
5232069|NCT00700141|thyroid|thyroid
5232070|NCT00700141|parathyroid|parathyroid
5232071|NCT00700141|fleece-bound hemostasispathologic processes|fleece-bound hemostasispathologic processes
5232072|NCT00700141|hemorrhage|hemorrhage
5232073|NCT00700141|thyroid surgery|thyroid surgery
5232074|NCT00700128|headaches|headaches
5232075|NCT00700128|migraines|migraines
5232076|NCT00700128|breakthrough bleeding|breakthrough bleeding
5232077|NCT00700128|breakthrough spotting|breakthrough spotting
5232078|NCT00700128|menstrually associated migraines|menstrually associated migraines
5232079|NCT00700128|breakthrough bleeding or breakthrough spotting|breakthrough bleeding or breakthrough spotting
5232080|NCT00700115|HAART|haart
5232081|NCT00700115|lopinavir/ritonavir|lopinavir/ritonavir
5232082|NCT00700115|raltegravir|raltegravir
5232083|NCT00700115|HIV/AIDS patients on HAART|hiv/aids patients on haart
5232084|NCT00700115|Treatment Experienced|treatment experienced
5232085|NCT00700089|Attempted suicide|attempted suicide
5232086|NCT00700089|Assertive intervention|assertive intervention
5232087|NCT00700089|Prevention|prevention
5232088|NCT00700089|Treatment|treatment
5232089|NCT00700076|ORG 25935|org 25935
5232090|NCT00700076|Ketamine|ketamine
5232091|NCT00700076|healthy subjects|healthy subjects
5232092|NCT00700063|Peplin|peplin
5232093|NCT00700063|Actinic keratosis|actinic keratosis
5232094|NCT00700063|PEP005|pep005
5232095|NCT00700050|Cystic Fibrosis|cystic fibrosis
5232096|NCT00700050|Sex hormones|sex hormones
5232097|NCT00700050|Pseudomonas aeruginosa|pseudomonas aeruginosa
5232098|NCT00700050|Paediatrics|paediatrics
5232099|NCT00700024|Body composition|body composition
5232100|NCT00700024|Physical activity|physical activity
5232101|NCT00700024|Metabolic syndrome|metabolic syndrome
5232102|NCT00700011|Myelodysplastic Syndromes|myelodysplastic syndromes
5232103|NCT00699998|ACS|acs
5232104|NCT00699985|Psychological Symptoms|psychological symptoms
5232105|NCT00699985|Behcet's Disease|behcet's disease
5232106|NCT00699972|E2007|e2007
5232107|NCT00699972|perampanel|perampanel
5232108|NCT00699972|refractory partial seizures|refractory partial seizures
5232109|NCT00699972|adjunctive therapy|adjunctive therapy
5232110|NCT00699972|seizure frequency|seizure frequency
5232111|NCT00699972|partial onset seizures|partial onset seizures
5232112|NCT00699972|reduction in seizure frequency|reduction in seizure frequency
5232113|NCT00699972|safety|safety
5232114|NCT00699972|concomitant AED(s)|concomitant aed(s)
5232115|NCT00699959|Coronary patients|coronary patients
5232116|NCT00699959|heart failure|heart failure
5232117|NCT00699959|dyslipidemia|dyslipidemia
5232118|NCT00699946|delirium, atypical antipsychotics, olanzapine, orthopedic|delirium, atypical antipsychotics, olanzapine, orthopedic
5232119|NCT00699933|acute pancreatitis|acute pancreatitis
5232120|NCT00699933|interventional therapy|interventional therapy
5232121|NCT00699933|CT-guided drainage therapy|ct-guided drainage therapy
5232122|NCT00699933|percutaneous necrosectomy|percutaneous necrosectomy
5232123|NCT00699933|Comparison of different diagnostic procedures: MRI, CT, Ultrasound|comparison of different diagnostic procedures: mri, ct, ultrasound
5232124|NCT00699933|Evaluation of interventional therapy including percutaneous drainage techniques und necrosectomies|evaluation of interventional therapy including percutaneous drainage techniques und necrosectomies
5232125|NCT00699907|Ovarian epithelial cancer|ovarian epithelial cancer
5232126|NCT00699907|High risk|high risk
5232127|NCT00699907|Biomarkers|biomarkers
5232128|NCT00699894|PONV|ponv
5232129|NCT00699894|prevention of postoperative nausea and vomiting|prevention of postoperative nausea and vomiting
5232130|NCT00699894|aprepitant|aprepitant
5232131|NCT00699894|ondansetron|ondansetron
5232132|NCT00699894|orthognathic surgery|orthognathic surgery
5232133|NCT00699881|Time to Progression|time to progression
5232134|NCT00699881|Toxicity|toxicity
5232135|NCT00699881|Overall survival|overall survival
5232136|NCT00699881|Response rate|response rate
5232137|NCT00699881|Quality of live|quality of live
5232138|NCT00699855|Growth Hormon Deficiency and|growth hormon deficiency and
5232139|NCT00699855|Turner Syndrome in pre-pubertal children|turner syndrome in pre-pubertal children
5232140|NCT00699855|Long term follow-up of predictive markers|long term follow-up of predictive markers
5232141|NCT00699842|Myelodysplastic Syndrome|myelodysplastic syndrome
5232142|NCT00699842|MDS|mds
5232143|NCT00699842|Low to Intermediate-1 MDS|low to intermediate-1 mds
5232144|NCT00699842|Non-deletion 5q|non-deletion 5q
5232145|NCT00699842|Lenalidomide|lenalidomide
5232146|NCT00699790|Diabetes|diabetes
5232147|NCT00699790|NOS|nos
5232148|NCT00699764|Herpes simplex candidate vaccine|herpes simplex candidate vaccine
5232149|NCT00699764|Herpes simplex|herpes simplex
5232150|NCT00699751|Hormone Refractory Prostate Cancer|hormone refractory prostate cancer
5232151|NCT00699751|Bone Metastases|bone metastases
5232152|NCT00699751|Radium-223|radium-223
5232153|NCT00699738|Healthy women during pregnancy and in the postpartum period|healthy women during pregnancy and in the postpartum period
5232154|NCT00699725|Compliance|compliance
5232155|NCT00699725|gastroprotector therapy|gastroprotector therapy
5232156|NCT00699725|NSAID|nsaid
5232157|NCT00699725|risk factors|risk factors
5232158|NCT00699712|ADHF|adhf
5232159|NCT00699712|AHF|ahf
5232160|NCT00699712|HF|hf
5232161|NCT00699699|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
5232162|NCT00699686|Diabetes|diabetes
5232163|NCT00699686|Insulin|insulin
5232164|NCT00699686|Endothelium|endothelium
5232165|NCT00699686|Cardiovascular disease|cardiovascular disease
5232166|NCT00699686|Stem cells|stem cells
5232167|NCT00699673|Brain natriuretic peptide|brain natriuretic peptide
5232168|NCT00699673|EuroScore|euroscore
5232169|NCT00699673|Cardiac surgery|cardiac surgery
5232170|NCT00699673|Cardiopulmonary bypass|cardiopulmonary bypass
5232171|NCT00699673|Coronary artery disease|coronary artery disease
5232172|NCT00699673|Valvular disease|valvular disease
5232173|NCT00699673|Risk stratification in cardiac surgery|risk stratification in cardiac surgery
5232174|NCT00699660|Disability Examination|disability examination
5232175|NCT00699660|Clinician Administered PTSD Scale|clinician administered ptsd scale
5232176|NCT00699660|Quality of Care|quality of care
5232177|NCT00699634|Neuropathic|neuropathic
5232178|NCT00699634|Pain|pain
5232179|NCT00699634|Phantom|phantom
5232180|NCT00699634|Limb|limb
5232181|NCT00699621|Intracerebral hemorrhage|intracerebral hemorrhage
5232182|NCT00699621|Hematoma enlargement|hematoma enlargement
5232183|NCT00699621|Antiplatelet agent|antiplatelet agent
5232184|NCT00699621|Platelet transfusion|platelet transfusion
5232185|NCT00699621|Outcome|outcome
5232186|NCT00699608|Zopiclone|zopiclone
5232187|NCT00699608|Hypnotic|hypnotic
5232188|NCT00699608|Residual effects|residual effects
5232189|NCT00699608|Eszopiclone|eszopiclone
5232190|NCT00699582|E2007 (perampanel)|e2007 (perampanel)
5232191|NCT00699582|refractory partial seizures|refractory partial seizures
5232192|NCT00699582|adjunctive therapy|adjunctive therapy
5232193|NCT00699582|seizure frequency|seizure frequency
5232194|NCT00699582|reduction in seizure frequency|reduction in seizure frequency
5232195|NCT00699582|partial onset seizures|partial onset seizures
5232196|NCT00699582|safety|safety
5232197|NCT00699582|concomitant AED(s)|concomitant aed(s)
5232198|NCT00699569|hyperimmune colostrum|hyperimmune colostrum
5232199|NCT00699569|mucositis|mucositis
5232200|NCT00699556|alcohol|alcohol
5232201|NCT00699556|nicotine|nicotine
5232202|NCT00699556|smoking cessation|smoking cessation
5232203|NCT00699556|smoking cessation medications|smoking cessation medications
5232204|NCT00699530|Prolactin|prolactin
5232205|NCT00699530|Insulin resistance|insulin resistance
5232206|NCT00699530|Glucose tolerance|glucose tolerance
5232207|NCT00699530|Body Composition|body composition
5232208|NCT00699530|Substrate metabolism|substrate metabolism
5232209|NCT00699517|tubulin modulator|tubulin modulator
5232210|NCT00699517|endothelium|endothelium
5232211|NCT00699517|combretastatin|combretastatin
5232212|NCT00699517|cisplatin|cisplatin
5232213|NCT00699504|ECG|ecg
5232214|NCT00699504|QT|qt
5232215|NCT00699504|Effect of study drug on healthy volunteers|effect of study drug on healthy volunteers
5232216|NCT00699478|vitamin B12 deficiency|vitamin b12 deficiency
5232217|NCT00699478|post total gastrectomy|post total gastrectomy
5232218|NCT00699478|stomach cancer|stomach cancer
5232219|NCT00699465|Thromboprophylaxis|thromboprophylaxis
5232220|NCT00699465|Prevention of venous thromboembolism after ICH|prevention of venous thromboembolism after ich
5232221|NCT00699465|Enoxaparin|enoxaparin
5232222|NCT00699465|Intermittent pneumatic compression|intermittent pneumatic compression
5232223|NCT00699452|aortic stenosis|aortic stenosis
5232224|NCT00699452|valve|valve
5232225|NCT00699452|candesartan|candesartan
5232226|NCT00699439|Medical Informatics|medical informatics
5232227|NCT00699439|Asthma|asthma
5232228|NCT00699439|Emergency Service, Hospital|emergency service, hospital
5232229|NCT00699439|Bayesian Method|bayesian method
5232230|NCT00699387|Chagas disease|chagas disease
5232231|NCT00699387|Pediatrics|pediatrics
5232232|NCT00699387|benznidazole|benznidazole
5232233|NCT00699387|population pharmacokinetics|population pharmacokinetics
5232234|NCT00699387|neglected diseases|neglected diseases
5232235|NCT00699387|parasitology|parasitology
5232236|NCT00699387|pediatric clinical pharmacology|pediatric clinical pharmacology
5232237|NCT00699374|sunitinib|sunitinib
5232238|NCT00699374|phase 3|phase 3
5232239|NCT00699374|randomized|randomized
5232240|NCT00699374|hepatocellular|hepatocellular
5232241|NCT00699374|liver|liver
5232242|NCT00699361|Pantoprazole|pantoprazole
5232243|NCT00699361|congestive heart failure|congestive heart failure
5232244|NCT00699335|pain|pain
5232245|NCT00699335|fentanyl|fentanyl
5232246|NCT00699335|transdermal patch|transdermal patch
5232247|NCT00699322|glucose variability|glucose variability
5232248|NCT00699322|oxidative stress|oxidative stress
5232250|NCT00699322|glimepiride|glimepiride
5232251|NCT00699309|Total Hip Replacement|total hip replacement
5232252|NCT00699309|Total Hip Arthroplasty|total hip arthroplasty
5232253|NCT00699309|Minimally Invasive|minimally invasive
5232254|NCT00699309|Microplasty|microplasty
5232255|NCT00699309|Hip Arthritis|hip arthritis
5232256|NCT00699296|LBH589|lbh589
5232257|NCT00699296|HDAC inhibitor|hdac inhibitor
5232258|NCT00699296|cutaneous T-ceII lymphoma|cutaneous t-ceii lymphoma
5232259|NCT00699296|adult T-cell leukemia|adult t-cell leukemia
5232260|NCT00699283|Epilepsy; Monotherapy|epilepsy; monotherapy
5232261|NCT00699283|Partial Onset Seizures|partial onset seizures
5232262|NCT00699283|Adults and Adolescents|adults and adolescents
5232263|NCT00699270|Total Shoulder Arthroplasty|total shoulder arthroplasty
5232264|NCT00699270|Total Shoulder Replacement|total shoulder replacement
5232265|NCT00699270|Shoulder Arthritis|shoulder arthritis
5232266|NCT00699257|Partial Knee Arthroplasty|partial knee arthroplasty
5232267|NCT00699257|Partial Knee Replacement|partial knee replacement
5232268|NCT00699257|Arthritis of Medial Compartment of the Knee|arthritis of medial compartment of the knee
5232269|NCT00699257|Oxford Knee|oxford knee
5232270|NCT00699244|forearm|forearm
5232271|NCT00699244|hand|hand
5232272|NCT00699244|elbow|elbow
5232273|NCT00699244|wrist|wrist
5232274|NCT00699244|brachial plexus|brachial plexus
5232275|NCT00699244|infraclavicular block|infraclavicular block
5232276|NCT00699231|Hepatitis B|hepatitis b
5232277|NCT00699231|Engerix™-B|engerix™-b
5232278|NCT00699231|Recombinant hepatitis B vaccine|recombinant hepatitis b vaccine
5232279|NCT00699231|Adjuvant|adjuvant
5232280|NCT00699218|Bipolar|bipolar
5232281|NCT00699218|Depression|depression
5232282|NCT00699218|TMS|tms
5232283|NCT00699218|repetitive Transcranial Magnetic Stimulation|repetitive transcranial magnetic stimulation
5232284|NCT00699218|treatment|treatment
5232285|NCT00699218|Efficacy|efficacy
5232286|NCT00699218|Safety|safety
5232287|NCT00699192|Blood pressure|blood pressure
5232288|NCT00699192|hypertension|hypertension
5232289|NCT00699192|elderly|elderly
5232290|NCT00699166|IBS|ibs
5232291|NCT00699166|Diarrhea|diarrhea
5232292|NCT00699166|gastrointestinal functional disorder|gastrointestinal functional disorder
5232293|NCT00699166|IBS-D|ibs-d
5232294|NCT00699127|anxiety|anxiety
5232295|NCT00699127|parents|parents
5232296|NCT00699127|NICU|nicu
5232297|NCT00699127|prematurity|prematurity
5232298|NCT00699127|Anxiety of parents to NICU infants|anxiety of parents to nicu infants
5232299|NCT00699114|Pain|pain
5232300|NCT00699114|Analgesics|analgesics
5232301|NCT00699114|Molar|molar
5232302|NCT00699114|Third|third
5232303|NCT00699114|Acetaminophen|acetaminophen
5232304|NCT00699114|Paracetamol|paracetamol
5232305|NCT00699114|Ibuprofen|ibuprofen
5232306|NCT00699114|Codeine|codeine
5232307|NCT00699114|Placebo|placebo
5232308|NCT00699101|Breast Cancer|breast cancer
5232309|NCT00699101|Conture®|conture®
5232310|NCT00699101|Brachytherapy|brachytherapy
5232311|NCT00699088|Total Hip Arthroplasty|total hip arthroplasty
5232312|NCT00699088|Total Hip Replacement|total hip replacement
5232313|NCT00699088|Minimally Invasive|minimally invasive
5232314|NCT00699088|Microplasty|microplasty
5232315|NCT00699062|antileukotriene|antileukotriene
5232316|NCT00699062|small airway|small airway
5232317|NCT00699062|airway remodeling|airway remodeling
5232318|NCT00699062|HRCT|hrct
5232319|NCT00699049|Alpha blocker|alpha blocker
5232320|NCT00699049|Tamsulosin|tamsulosin
5232321|NCT00699049|Solifenacin|solifenacin
5232322|NCT00699049|Overactive Bladder|overactive bladder
5232323|NCT00699049|Urgency incontinence|urgency incontinence
5232324|NCT00699036|nonalcoholic steatohepatitis (NASH)|nonalcoholic steatohepatitis (nash)
5232325|NCT00699036|fatty liver|fatty liver
5232326|NCT00699036|insulin resistance|insulin resistance
5232327|NCT00699023|postprandial lipemia|postprandial lipemia
5232328|NCT00699023|type 2 diabetes|type 2 diabetes
5232329|NCT00699023|ezetimibe|ezetimibe
5232330|NCT00699023|hypercholesterolemia|hypercholesterolemia
5232331|NCT00699010|Abuse Liability|abuse liability
5232332|NCT00699010|Abuse Prevention|abuse prevention
5232333|NCT00699010|Abuse Resistance|abuse resistance
5232334|NCT00699010|Abuse Deterrence|abuse deterrence
5232335|NCT00698997|autism|autism
5232336|NCT00698997|autism spectrum disorder|autism spectrum disorder
5232337|NCT00698997|intensive intervention for toddlers with autism|intensive intervention for toddlers with autism
5232338|NCT00698997|PDD NOS|pdd nos
5232339|NCT00698997|early steps study|early steps study
5232340|NCT00698997|early start denver model|early start denver model
5232341|NCT00698997|early intervention for infants and toddlers with autism|early intervention for infants and toddlers with autism
5232342|NCT00698997|toddler treatment|toddler treatment
5232343|NCT00698997|Sally Rogers|sally rogers
5232344|NCT00698997|University of California, Davis|university of california, davis
5232345|NCT00698997|University of Michigan|university of michigan
5232346|NCT00698997|MIND Institute|mind institute
5232347|NCT00698984|Soy Isoflavones, Bone Mineral Density, Bone Mineral Content, postmenopausal Women, Bone Markers, Bone Health, Phytoestrogens|soy isoflavones, bone mineral density, bone mineral content, postmenopausal women, bone markers, bone health, phytoestrogens
5232744|NCT00697242|Hepatitis B|hepatitis b
5232348|NCT00698958|Respiratory insufficiency|respiratory insufficiency
5232349|NCT00698958|Hypercapnic chronic respiratory failure secondary to neuromuscular diseases or alterations of thoracic cage|hypercapnic chronic respiratory failure secondary to neuromuscular diseases or alterations of thoracic cage
5232350|NCT00698932|DPP-4 inhibitors|dpp-4 inhibitors
5232351|NCT00698932|HBA1c|hba1c
5232352|NCT00698932|Incretins|incretins
5232353|NCT00698919|Bacterial DNA|bacterial dna
5232354|NCT00698919|Systemic inflammatory response syndrome|systemic inflammatory response syndrome
5232355|NCT00698919|Infection|infection
5232356|NCT00698919|Intensive Care Unit|intensive care unit
5232357|NCT00698906|Hepatitis B|hepatitis b
5232358|NCT00698906|HBV-MPL|hbv-mpl
5232359|NCT00698906|Recombinant Hepatitis B vaccine|recombinant hepatitis b vaccine
5232360|NCT00698893|Herpes simplex|herpes simplex
5232361|NCT00698893|Herpes simplex candidate (gD) vaccine|herpes simplex candidate (gd) vaccine
5232362|NCT00698880|Portal vein embolization|portal vein embolization
5232363|NCT00698880|Hepatic vein embolization|hepatic vein embolization
5232364|NCT00698880|Liver regeneration|liver regeneration
5232365|NCT00698867|Total Elbow Arthroplasty|total elbow arthroplasty
5232366|NCT00698867|Total Elbow Replacement|total elbow replacement
5232367|NCT00698867|Osteoarthritis|osteoarthritis
5232368|NCT00698867|Elbow arthritis|elbow arthritis
5232369|NCT00698854|Total Knee Arthroplasty|total knee arthroplasty
5232370|NCT00698854|Total Knee Replacement|total knee replacement
5232371|NCT00698854|Knee Arthritis|knee arthritis
5232372|NCT00698828|Cachexia, COPD, Chronic Obstructive Pulmonary Disease|cachexia, copd, chronic obstructive pulmonary disease
5232373|NCT00698763|An ischaemic cerebrovascular event (stroke or TIA)|an ischaemic cerebrovascular event (stroke or tia)
5232374|NCT00698750|Fractured Humeral Head|fractured humeral head
5232375|NCT00698750|Traumatic Arthritis|traumatic arthritis
5232376|NCT00698750|Resurfacing Shoulder|resurfacing shoulder
5232377|NCT00698750|Shoulder Replacement|shoulder replacement
5232378|NCT00698750|Shoulder Arthritis|shoulder arthritis
5232379|NCT00698737|Opioid|opioid
5232380|NCT00698737|Cocaine|cocaine
5232381|NCT00698711|Prostate cancer|prostate cancer
5232382|NCT00698711|MUC-2-KLH|muc-2-klh
5232383|NCT00698711|QS 21|qs 21
5232384|NCT00698698|tear proteins|tear proteins
5232385|NCT00698698|diabetic retinopathy|diabetic retinopathy
5232386|NCT00698698|HPLC|hplc
5232387|NCT00698698|Mass spectroscopy|mass spectroscopy
5232388|NCT00698685|Allogeneic Hematopoietic Cell Transplantation|allogeneic hematopoietic cell transplantation
5232389|NCT00698685|Preparative Regimen|preparative regimen
5232390|NCT00698685|Pentostatin|pentostatin
5232391|NCT00698685|Alemtuzumab|alemtuzumab
5232392|NCT00698685|Hodgkin Disease and Lymphoma, non-Hodgkin|hodgkin disease and lymphoma, non-hodgkin
5232393|NCT00698685|leukemia, myeloid, acute|leukemia, myeloid, acute
5232394|NCT00698685|leukemia, lymphocytic, acute|leukemia, lymphocytic, acute
5232395|NCT00698685|leukemia, myeloid, chronic|leukemia, myeloid, chronic
5232396|NCT00698685|leukemia, lymphocytic, chronic|leukemia, lymphocytic, chronic
5232397|NCT00698685|Multiple Myeloma|multiple myeloma
5232398|NCT00698685|Myelodysplastic Syndromes|myelodysplastic syndromes
5232399|NCT00698685|Carcinoma, Renal Cell|carcinoma, renal cell
5232400|NCT00698672|RSA|rsa
5232401|NCT00698646|Systolic blood pressure|systolic blood pressure
5232402|NCT00698646|Diastolic blood pressure|diastolic blood pressure
5232403|NCT00698646|Valsartan|valsartan
5232404|NCT00698646|Hydrochlorothiazide|hydrochlorothiazide
5232405|NCT00698633|Hip arthroplasty|hip arthroplasty
5232406|NCT00698607|Everolimus|everolimus
5232407|NCT00698607|Sirolimus|sirolimus
5232408|NCT00698607|drug eluting stent|drug eluting stent
5232409|NCT00698607|Clopidogrel|clopidogrel
5232410|NCT00698581|Epilepsy; Monotherapy|epilepsy; monotherapy
5232411|NCT00698581|Partial Onset Seizures|partial onset seizures
5232412|NCT00698581|Adults and Adolescents|adults and adolescents
5232413|NCT00698568|Herpes simplex, Herpes simplex candidate vaccine|herpes simplex, herpes simplex candidate vaccine
5232414|NCT00698555|Hepatitis B|hepatitis b
5232415|NCT00698555|HBV-MPL|hbv-mpl
5232416|NCT00698555|Recombinant hepatitis B vaccine|recombinant hepatitis b vaccine
5232417|NCT00698542|PSST|psst
5232418|NCT00698542|sepsis|sepsis
5232419|NCT00698542|Neuro Care Unit|neuro care unit
5232420|NCT00698542|Surviving Sepsis Campaign|surviving sepsis campaign
5232421|NCT00698542|SSC|ssc
5232422|NCT00698529|Technology Transfer|technology transfer
5232423|NCT00698529|HIV Seronegativity|hiv seronegativity
5232424|NCT00698516|Bevacizumab|bevacizumab
5232425|NCT00698516|Small Cell Lung Cancer (SCLC)|small cell lung cancer (sclc)
5232426|NCT00698516|Topotecan|topotecan
5232427|NCT00698503|Metal on Metal|metal on metal
5232428|NCT00698503|Total Hip Arthroplasty|total hip arthroplasty
5232429|NCT00698503|Total Hip Replacement|total hip replacement
5232430|NCT00698490|Herpes simplex|herpes simplex
5232431|NCT00698490|Herpes simplex candidate vaccine|herpes simplex candidate vaccine
5232432|NCT00698464|Pasireotide|pasireotide
5232433|NCT00698464|PK profile,|pk profile,
5232434|NCT00698464|Single dose|single dose
5232435|NCT00698464|Pasireotide subcutaneous injection|pasireotide subcutaneous injection
5232436|NCT00698464|Safety|safety
5232437|NCT00698464|Mild hepatic impaired patients|mild hepatic impaired patients
5232438|NCT00698464|Moderate hepatic impaired patients|moderate hepatic impaired patients
5232543|NCT00698009|Natural Killer Cell|natural killer cell
5232439|NCT00698464|Severe hepatic impaired patients|severe hepatic impaired patients
5232440|NCT00698451|Ovarian cancer|ovarian cancer
5232441|NCT00698451|fallopian tube cancer|fallopian tube cancer
5232442|NCT00698451|primary peritoneal cancer|primary peritoneal cancer
5232443|NCT00698451|DOXIL|doxil
5232444|NCT00698451|carboplatin|carboplatin
5232445|NCT00698451|bevacizumab|bevacizumab
5232446|NCT00698438|At least 18 years of age|at least 18 years of age
5232447|NCT00698438|Open-angle glaucoma|open-angle glaucoma
5232448|NCT00698425|Iontophoresis|iontophoresis
5232449|NCT00698425|Ophthalmology|ophthalmology
5232450|NCT00698412|Knee osteoarthritis|knee osteoarthritis
5232451|NCT00698412|Daily cane use|daily cane use
5232452|NCT00698412|Pain|pain
5232453|NCT00698412|Function|function
5232454|NCT00698412|Quality of life|quality of life
5232455|NCT00698412|Energy consumption during the gait|energy consumption during the gait
5232456|NCT00698399|liver|liver
5232457|NCT00698399|transplant|transplant
5232458|NCT00698399|TMAO|tmao
5232459|NCT00698399|NGAL|ngal
5232460|NCT00698399|cystatin-C|cystatin-c
5232461|NCT00698399|Ischemia Reperfusion Injury|ischemia reperfusion injury
5232462|NCT00698399|Liver Transplant|liver transplant
5232463|NCT00698399|LTx|ltx
5232464|NCT00698399|allantion|allantion
5232465|NCT00698386|Micronutrient Zinc|micronutrient zinc
5232466|NCT00698386|Category I PTB|category i ptb
5232467|NCT00698386|RNTCP|rntcp
5232468|NCT00698386|DOTS|dots
5232469|NCT00698386|Sputum smear conversion|sputum smear conversion
5232470|NCT00698386|Reduced relapse|reduced relapse
5232471|NCT00698386|Immunopathogenesis|immunopathogenesis
5232472|NCT00698386|Category-I|category-i
5232473|NCT00698373|Fluorine-18-α-methyltyrosine,|fluorine-18-α-methyltyrosine,
5232474|NCT00698373|Positron emission tomography,|positron emission tomography,
5232475|NCT00698373|Fluorine-18-fluorodeoxyglucose,|fluorine-18-fluorodeoxyglucose,
5232476|NCT00698373|Lung cancer,|lung cancer,
5232477|NCT00698360|chronic kidney disease|chronic kidney disease
5232478|NCT00698360|melatonin|melatonin
5232479|NCT00698360|erythropoietin|erythropoietin
5232480|NCT00698360|circadian rhythm|circadian rhythm
5232481|NCT00698347|Total Knee Replacement|total knee replacement
5232482|NCT00698347|Total Knee Arthroplasty|total knee arthroplasty
5232483|NCT00698347|Hip Arthritis|hip arthritis
5232484|NCT00698334|HIV infection|hiv infection
5232485|NCT00698334|Acquired immunodeficiency syndrome|acquired immunodeficiency syndrome
5232486|NCT00698334|Tuberculosis|tuberculosis
5232487|NCT00698321|HIV/STD Prevention|hiv/std prevention
5232488|NCT00698321|HIV Seronegativity|hiv seronegativity
5232489|NCT00698295|schizophrenia|schizophrenia
5232490|NCT00698295|atypical antipsychotics|atypical antipsychotics
5232491|NCT00698295|EEG|eeg
5232492|NCT00698243|OSI-027|osi-027
5232493|NCT00698243|Solid tumor|solid tumor
5232494|NCT00698243|Lymphoma|lymphoma
5232495|NCT00698204|Mucositis|mucositis
5232496|NCT00698204|Head and Neck Cancer|head and neck cancer
5232497|NCT00698204|Head and Neck Neoplasms|head and neck neoplasms
5232498|NCT00698204|Stomatitis|stomatitis
5232499|NCT00698191|Lupus Erythematosus,Systemic|lupus erythematosus,systemic
5232500|NCT00698191|Lupus Nephritis|lupus nephritis
5232501|NCT00698191|Mesenchymal Stem Cells|mesenchymal stem cells
5232502|NCT00698191|Transplantation|transplantation
5232503|NCT00698178|Gastroesophageal reflux disease|gastroesophageal reflux disease
5232504|NCT00698178|Waist circumference|waist circumference
5232505|NCT00698178|Body mass index|body mass index
5232506|NCT00698178|Obesity|obesity
5232507|NCT00698152|Total Hip Arthroplasty|total hip arthroplasty
5232508|NCT00698152|Total Hip Replacement|total hip replacement
5232509|NCT00698152|Hip Arthritis|hip arthritis
5232510|NCT00698152|Polyethylene|polyethylene
5232511|NCT00698139|heart failure|heart failure
5232512|NCT00698139|chronotropic incompetence|chronotropic incompetence
5232513|NCT00698113|anxiety|anxiety
5232514|NCT00698113|depression|depression
5232515|NCT00698113|stress|stress
5232516|NCT00698113|cancer symptoms|cancer symptoms
5232517|NCT00698113|pediatric cancer|pediatric cancer
5232518|NCT00698113|massage|massage
5232519|NCT00698113|parent delivered massage|parent delivered massage
5232520|NCT00698100|DNA|dna
5232521|NCT00698100|HU & MOUSE|hu & mouse
5232522|NCT00698100|TYROSINASE|tyrosinase
5232523|NCT00698087|Hepatitis B|hepatitis b
5232524|NCT00698087|Engerix™-B|engerix™-b
5232525|NCT00698087|Adjuvanted recombinant hepatitis B vaccine|adjuvanted recombinant hepatitis b vaccine
5232526|NCT00698061|Hepatitis B|hepatitis b
5232527|NCT00698061|Adjuvanted vaccine|adjuvanted vaccine
5232528|NCT00698048|Sepsis|sepsis
5232529|NCT00698048|Septic Shock|septic shock
5232530|NCT00698048|Vasopressin|vasopressin
5232531|NCT00698048|Copeptin|copeptin
5232532|NCT00698048|Paediatrics|paediatrics
5232533|NCT00698035|Vaginal Testosterone Cream|vaginal testosterone cream
5232534|NCT00698035|ESTRING|estring
5232535|NCT00698022|healthy|healthy
5232536|NCT00698022|weight gain|weight gain
5232537|NCT00698022|anti-psychotic|anti-psychotic
5232538|NCT00698022|risperidone|risperidone
5232539|NCT00698022|mifepristone|mifepristone
5232540|NCT00698022|mitigation|mitigation
5232541|NCT00698022|weight loss|weight loss
5232542|NCT00698009|Neuroblastoma|neuroblastoma
5232544|NCT00698009|NK Cell Infusion|nk cell infusion
5232545|NCT00698009|Haploidentical Natural Killer (NK) Cells|haploidentical natural killer (nk) cells
5232546|NCT00698009|Fludarabine|fludarabine
5232547|NCT00698009|Fludarabine Phosphate|fludarabine phosphate
5232548|NCT00698009|Fludara|fludara
5232549|NCT00698009|Cyclophosphamide|cyclophosphamide
5232550|NCT00698009|Cytoxan|cytoxan
5232551|NCT00698009|Neosar|neosar
5232552|NCT00698009|Interleukin-2|interleukin-2
5232553|NCT00698009|IL-2|il-2
5232554|NCT00698009|Proleukin|proleukin
5232555|NCT00698009|Mesna|mesna
5232556|NCT00698009|Mesnex|mesnex
5232557|NCT00698009|Infusion of NK cells|infusion of nk cells
5232558|NCT00698009|Pediatric NK Cell Infusion|pediatric nk cell infusion
5232559|NCT00698009|Pediatric Neuroblastoma|pediatric neuroblastoma
5232560|NCT00698009|Pediatric NK|pediatric nk
5232561|NCT00698009|Pediatric|pediatric
5232562|NCT00697983|Osteoporosis|osteoporosis
5232563|NCT00697983|ATP|atp
5232564|NCT00697983|Purinergic receptors|purinergic receptors
5232565|NCT00697983|Bone mineral density|bone mineral density
5232566|NCT00697983|Single nucleotide polymorphism|single nucleotide polymorphism
5232567|NCT00697970|Hepatitis B|hepatitis b
5232568|NCT00697970|Engerix™-B|engerix™-b
5232569|NCT00697970|Recombinant Hepatitis B vaccine|recombinant hepatitis b vaccine
5232570|NCT00697970|Adjuvant|adjuvant
5232571|NCT00697957|acceleration|acceleration
5232572|NCT00697957|bone density|bone density
5232573|NCT00697957|cardiovascular diseases|cardiovascular diseases
5232574|NCT00697957|exercise|exercise
5232575|NCT00697957|female|female
5232576|NCT00697957|fragility fractures|fragility fractures
5232577|NCT00697957|impact intensity|impact intensity
5232578|NCT00697957|intervention studies|intervention studies
5232579|NCT00697957|osteoporosis|osteoporosis
5232580|NCT00697957|premenopause|premenopause
5232581|NCT00697944|FUNGAL INFECTION|fungal infection
5232582|NCT00697944|SEPSIS|sepsis
5232583|NCT00697944|INTENSIVE CARE|intensive care
5232584|NCT00697944|AMBISOME|ambisome
5232585|NCT00697944|PREEMPTIVE TREATMENT|preemptive treatment
5232586|NCT00697944|Sepsis with candida colonisation|sepsis with candida colonisation
5232587|NCT00697931|Hepatitis B|hepatitis b
5232588|NCT00697931|Engerix™-B|engerix™-b
5232589|NCT00697931|Recombinant Hepatitis B vaccine|recombinant hepatitis b vaccine
5232590|NCT00697931|Adjuvant|adjuvant
5232591|NCT00697918|Partial onset seizure|partial onset seizure
5232592|NCT00697918|Adjunctive therapy|adjunctive therapy
5232593|NCT00697905|nasopharyngeal carcinoma|nasopharyngeal carcinoma
5232594|NCT00697905|Gemcitabine-Carboplatin|gemcitabine-carboplatin
5232595|NCT00697892|Human Immunodeficiency Virus|human immunodeficiency virus
5232596|NCT00697892|Drug Interactions|drug interactions
5232597|NCT00697879|tumour|tumour
5232598|NCT00697879|Solid tumour|solid tumour
5232599|NCT00697879|histone deacetylase inhibitor|histone deacetylase inhibitor
5232600|NCT00697879|dose escalation|dose escalation
5232601|NCT00697879|cancer|cancer
5232602|NCT00697866|Adjuvanted hepatitis B vaccine|adjuvanted hepatitis b vaccine
5232603|NCT00697866|Hepatitis B|hepatitis b
5232604|NCT00697866|Recombinant hepatitis B vaccine|recombinant hepatitis b vaccine
5232605|NCT00697853|Hepatitis B|hepatitis b
5232606|NCT00697853|Adjuvanted hepatitis B vaccine|adjuvanted hepatitis b vaccine
5232607|NCT00697853|Recombinant hepatitis B vaccine|recombinant hepatitis b vaccine
5232608|NCT00697840|Hepatitis B|hepatitis b
5232609|NCT00697840|Engerix™-B|engerix™-b
5232610|NCT00697840|Recombinant hepatitis B vaccine|recombinant hepatitis b vaccine
5232611|NCT00697840|Adjuvant|adjuvant
5232612|NCT00697814|Hypogonadotropic hypogonadism|hypogonadotropic hypogonadism
5232613|NCT00697814|Prolactinoma|prolactinoma
5232614|NCT00697788|pediatric|pediatric
5232615|NCT00697788|burn|burn
5232616|NCT00697788|sedation|sedation
5232617|NCT00697775|Hepatitis B|hepatitis b
5232618|NCT00697775|Recombinant hepatitis B vaccine|recombinant hepatitis b vaccine
5232619|NCT00697775|Adjuvant|adjuvant
5232620|NCT00697762|Partial onset seizure|partial onset seizure
5232621|NCT00697762|Adjunctive therapy|adjunctive therapy
5232622|NCT00697749|Recombinant hepatitis B vaccine|recombinant hepatitis b vaccine
5232623|NCT00697749|Adjuvanted hepatitis B vaccine|adjuvanted hepatitis b vaccine
5232624|NCT00697749|Hepatitis B|hepatitis b
5232625|NCT00697736|Systemic Scleroderma|systemic scleroderma
5232626|NCT00697736|Echocardiography|echocardiography
5232627|NCT00697723|Coronary artery bypass graft|coronary artery bypass graft
5232628|NCT00697723|Intra-aortic balloon pump|intra-aortic balloon pump
5232629|NCT00697723|transit-time flowmetry|transit-time flowmetry
5232630|NCT00697710|Atopic Dermatitis|atopic dermatitis
5232631|NCT00697697|asthmatic children|asthmatic children
5232632|NCT00697684|Reduced Intensity Allogeneic Stem Cell Transplant|reduced intensity allogeneic stem cell transplant
5232633|NCT00697684|Clofarabine|clofarabine
5232634|NCT00697684|Rabbit Antithymocyte Globulin|rabbit antithymocyte globulin
5232635|NCT00697684|Total Lymphoid Radiation|total lymphoid radiation
5232636|NCT00697671|NK cell infusion|nk cell infusion
5232637|NCT00697671|Immunotherapy|immunotherapy
5232638|NCT00697671|hematologic malignancy|hematologic malignancy
5232639|NCT00697671|Miltenyi Biotec device|miltenyi biotec device
5232640|NCT00697671|haploidentical donor|haploidentical donor
5232641|NCT00697658|Paliperidone ER|paliperidone er
5232642|NCT00697658|Schizophrenia|schizophrenia
5232643|NCT00697645|Stroke,|stroke,
5232644|NCT00697645|Cerebrovascular disease,|cerebrovascular disease,
5232645|NCT00697645|Transcranial magnetic stimulation,|transcranial magnetic stimulation,
5232646|NCT00697645|rehabilitation|rehabilitation
5232647|NCT00697632|MET|met
5232648|NCT00697632|AXL|axl
5232649|NCT00697632|VEGFR|vegfr
5232650|NCT00697632|NSCLC|nsclc
5232651|NCT00697632|HNSCC (Head and neck squamous cell carcinoma)|hnscc (head and neck squamous cell carcinoma)
5232652|NCT00697632|Tumor|tumor
5232653|NCT00697632|Safety|safety
5232654|NCT00697632|Phase 1|phase 1
5232655|NCT00697632|Solid tumor|solid tumor
5232656|NCT00697606|Seprafilm®|seprafilm®
5232657|NCT00697606|cesarean|cesarean
5232658|NCT00697606|adhesions|adhesions
5232659|NCT00697606|primary|primary
5232660|NCT00697606|repeat|repeat
5232661|NCT00697593|Efalizumab|efalizumab
5232662|NCT00697593|Chronic Plaque Psoriasis|chronic plaque psoriasis
5232663|NCT00697593|Transition from systemic therapies on to Efalizumab|transition from systemic therapies on to efalizumab
5232664|NCT00697580|Obesity|obesity
5232665|NCT00697580|Type 2 Diabetes|type 2 diabetes
5232666|NCT00697580|Cardiovascular risk|cardiovascular risk
5232667|NCT00697580|Cancer|cancer
5232668|NCT00697580|Latino|latino
5232669|NCT00697580|Adolescents|adolescents
5232670|NCT00697580|Strength Training|strength training
5232671|NCT00697580|Circuit Training|circuit training
5232672|NCT00697580|Nutrition|nutrition
5232673|NCT00697567|Herpes simplex|herpes simplex
5232674|NCT00697567|Herpes simplex vaccine|herpes simplex vaccine
5232675|NCT00697554|Hepatitis B|hepatitis b
5232676|NCT00697554|Adjuvanted hepatitis B vaccine|adjuvanted hepatitis b vaccine
5232677|NCT00697541|erythematous rosacea|erythematous rosacea
5232678|NCT00697541|facial gel|facial gel
5232679|NCT00697541|brimonidine|brimonidine
5232680|NCT00697541|ophthalmic solution|ophthalmic solution
5232681|NCT00697528|Graves|graves
5232682|NCT00697528|Color Doppler Imaging|color doppler imaging
5232683|NCT00697528|Graves' Ophthalmopathy|graves' ophthalmopathy
5232684|NCT00697528|Orbital Venous Flow|orbital venous flow
5232685|NCT00697489|Pelvic organ prolapse|pelvic organ prolapse
5232686|NCT00697489|Urinary incontinence|urinary incontinence
5232687|NCT00697489|Mesh|mesh
5232688|NCT00697476|second line chemotherapy|second line chemotherapy
5232689|NCT00697463|Teriparatide|teriparatide
5232690|NCT00697463|Forteo|forteo
5232691|NCT00697463|Osteopenia|osteopenia
5232692|NCT00697463|Osteoporosis|osteoporosis
5232693|NCT00697463|Fracture|fracture
5232694|NCT00697463|Low Bone Density|low bone density
5232695|NCT00697463|Premenopausal women|premenopausal women
5232696|NCT00697411|Aicardi syndrome|aicardi syndrome
5232697|NCT00697411|Microphthalmia with linear skin defects (MLS) syndrome|microphthalmia with linear skin defects (mls) syndrome
5232698|NCT00697411|X-linked disorders|x-linked disorders
5232699|NCT00697372|Angioplasty, Transluminal, Percutaneous Coronary|angioplasty, transluminal, percutaneous coronary
5232700|NCT00697372|Drug-Eluting Stents|drug-eluting stents
5232701|NCT00697359|Atrial fibrillation|atrial fibrillation
5232702|NCT00697359|Monitoring|monitoring
5232703|NCT00697359|Pulmonary vein isolation|pulmonary vein isolation
5232704|NCT00697359|Implantable loop recorder|implantable loop recorder
5232705|NCT00697346|Drug therapy|drug therapy
5232706|NCT00697333|NSCLC|nsclc
5232707|NCT00697333|FDG-PET|fdg-pet
5232708|NCT00697333|Radiotherapy|radiotherapy
5232709|NCT00697333|planning|planning
5232710|NCT00697333|target volumes|target volumes
5232711|NCT00697307|bioequivalence|bioequivalence
5232712|NCT00697307|contraception|contraception
5232713|NCT00697307|contraceptive patch|contraceptive patch
5232714|NCT00697307|ORTHO EVRA|ortho evra
5232715|NCT00697307|norelgestromin|norelgestromin
5232716|NCT00697307|NGMN|ngmn
5232717|NCT00697307|ethinyl estradiol|ethinyl estradiol
5232718|NCT00697307|EE|ee
5232719|NCT00697294|Vitamin D deficiency|vitamin d deficiency
5232720|NCT00697294|Infants|infants
5232721|NCT00697294|Breast feeding|breast feeding
5232722|NCT00697281|allergic rhinitis|allergic rhinitis
5232723|NCT00697281|human|human
5232724|NCT00697281|clinical trial|clinical trial
5232725|NCT00697281|efficacy|efficacy
5232726|NCT00697281|safety|safety
5232727|NCT00697281|challenge test|challenge test
5232728|NCT00697268|Depression|depression
5232729|NCT00697268|Depression Treatment|depression treatment
5232730|NCT00697268|Unipolar Depression|unipolar depression
5232731|NCT00697268|Citalopram|citalopram
5232732|NCT00697268|Serotonin|serotonin
5232733|NCT00697268|Major Depression|major depression
5232734|NCT00697268|Healthy Volunteer|healthy volunteer
5232735|NCT00697268|HV|hv
5232736|NCT00697255|Pharmacological effects of drugs|pharmacological effects of drugs
5232737|NCT00697255|Hormones|hormones
5232738|NCT00697255|Hormone Substitutes and Hormone Antagonists|hormone substitutes and hormone antagonists
5232739|NCT00697255|Pharmacological Actions|pharmacological actions
5232740|NCT00697255|Monofollicular growth|monofollicular growth
5232741|NCT00697255|Randomized|randomized
5232742|NCT00697255|Open-label|open-label
5232743|NCT00697255|Active-controlled|active-controlled
5232745|NCT00697242|Engerix™-B|engerix™-b
5232746|NCT00697242|Recombinant Hepatitis B vaccine|recombinant hepatitis b vaccine
5232747|NCT00697229|Hepatitis B|hepatitis b
5232748|NCT00697229|Engerix™-B|engerix™-b
5232749|NCT00697229|Recombinant hepatitis B vaccine|recombinant hepatitis b vaccine
5232750|NCT00697216|Hepatitis B|hepatitis b
5232751|NCT00697216|Recombinant hepatitis B vaccine|recombinant hepatitis b vaccine
5232752|NCT00697216|Adjuvanted hepatitis B vaccine|adjuvanted hepatitis b vaccine
5232753|NCT00697177|Gastro-oesophageal reflux|gastro-oesophageal reflux
5232754|NCT00697177|24 hour oesophageal pH monitoring|24 hour oesophageal ph monitoring
5232755|NCT00697177|Physiotherapy Airway clearance techniques|physiotherapy airway clearance techniques
5232756|NCT00697177|Exercise|exercise
5232757|NCT00697164|Malaria|malaria
5232758|NCT00697164|Treatment|treatment
5232759|NCT00697164|Adjunctive|adjunctive
5232760|NCT00697164|Erythropoietin|erythropoietin
5232761|NCT00697164|Survival|survival
5232762|NCT00697151|cerebrovascular diseases|cerebrovascular diseases
5232763|NCT00697151|ischemic stroke|ischemic stroke
5232764|NCT00697151|patent foramen ovale|patent foramen ovale
5232765|NCT00697151|warfarin|warfarin
5232766|NCT00697151|aspirin|aspirin
5232767|NCT00697151|transesophageal echocardiography|transesophageal echocardiography
5232768|NCT00697138|Cocaine|cocaine
5232769|NCT00697138|Dependence|dependence
5232770|NCT00697138|Pharmacotherapies|pharmacotherapies
5232771|NCT00697125|Hepatitis B|hepatitis b
5232772|NCT00697125|Engerix™-B|engerix™-b
5232773|NCT00697125|Recombinant hepatitis B vaccine|recombinant hepatitis b vaccine
5232774|NCT00697099|VTE prevention|vte prevention
5232775|NCT00697099|Total Hip Replacement|total hip replacement
5232776|NCT00697099|Heparin Low-Molecular-Weight|heparin low-molecular-weight
5232777|NCT00697086|Heart disease|heart disease
5232778|NCT00697073|Friedreich's Ataxia|friedreich's ataxia
5232779|NCT00697073|Idebenone|idebenone
5232780|NCT00697073|ICARS|icars
5232781|NCT00697060|Metastatic|metastatic
5232782|NCT00697060|Previously treated|previously treated
5232783|NCT00697047|Colorectal Neoplasms|colorectal neoplasms
5232784|NCT00697047|Mass Screening|mass screening
5232785|NCT00697047|Population Surveillance|population surveillance
5232786|NCT00697047|Randomized controlled trial|randomized controlled trial
5232787|NCT00697047|Occult Blood|occult blood
5232788|NCT00697047|Colonoscopy|colonoscopy
5232789|NCT00697047|Sigmoidoscopy|sigmoidoscopy
5232790|NCT00697047|Health Behavior|health behavior
5232791|NCT00697047|Colorectal Screening|colorectal screening
5232792|NCT00697021|Thromboelastography|thromboelastography
5232793|NCT00697021|Aspirin|aspirin
5232794|NCT00697021|Clopidogrel|clopidogrel
5232795|NCT00697021|Plavix|plavix
5232796|NCT00697021|Resistance|resistance
5232797|NCT00697021|Platelet|platelet
5232798|NCT00697021|Coronary Stenting|coronary stenting
5232799|NCT00697021|Bare Metal Stent|bare metal stent
5232800|NCT00697021|Dual antiplatelet therapy|dual antiplatelet therapy
5232801|NCT00697021|Overreactivity|overreactivity
5232802|NCT00697021|Primary Coronary Intervention|primary coronary intervention
5232803|NCT00697008|GERD|gerd
5232804|NCT00697008|CLINICAL GUIDELINE|clinical guideline
5232805|NCT00697008|Symptoms|symptoms
5232806|NCT00697008|clinical outcome|clinical outcome
5232807|NCT00696982|Arterial stiffness|arterial stiffness
5232808|NCT00696982|Augmentation index|augmentation index
5232809|NCT00696982|diabetes mellitus|diabetes mellitus
5232810|NCT00696956|local drug delivery|local drug delivery
5232811|NCT00696956|balloon angioplasty|balloon angioplasty
5232812|NCT00696956|safety and tolerance of paclitaxel coated PTA balloons|safety and tolerance of paclitaxel coated pta balloons
5232813|NCT00696956|in inhibiting restenosis of below the knee arteries|in inhibiting restenosis of below the knee arteries
5232814|NCT00696956|Efficacy of paclitaxel coated PTA balloons|efficacy of paclitaxel coated pta balloons
5232815|NCT00696956|in inhibiting restenosis of below the knee arteries (late lumen loss)|in inhibiting restenosis of below the knee arteries (late lumen loss)
5232816|NCT00696943|cell death|cell death
5232817|NCT00696943|PET imaging|pet imaging
5232818|NCT00696943|brain metastases|brain metastases
5232819|NCT00696943|stereotactic radiosurgery|stereotactic radiosurgery
5232820|NCT00696930|Malignant Carcinoid Tumors|malignant carcinoid tumors
5232821|NCT00696917|Hepatitis B|hepatitis b
5232822|NCT00696917|Adjuvanted Hepatitis B vaccine|adjuvanted hepatitis b vaccine
5232823|NCT00696917|Recombinant Hepatitis B vaccine|recombinant hepatitis b vaccine
5232824|NCT00696891|Adjuvanted hepatitis B vaccine, hepatitis B, Engerix™-B|adjuvanted hepatitis b vaccine, hepatitis b, engerix™-b
5232825|NCT00696878|Infertility|infertility
5232826|NCT00696878|Pharmacological effects of drugs|pharmacological effects of drugs
5232827|NCT00696878|Hormones, Hormone Substitutes and Hormone Antagonists|hormones, hormone substitutes and hormone antagonists
5232828|NCT00696878|Pharmacological Actions|pharmacological actions
5232829|NCT00696878|Multi-center|multi-center
5232830|NCT00696865|Safety|safety
5232831|NCT00696865|Tolerability|tolerability
5232832|NCT00696865|Phase I|phase i
5232833|NCT00696852|Mindfulness|mindfulness
5232834|NCT00696852|Meditation|meditation
5232835|NCT00696852|Yoga|yoga
5232836|NCT00696852|Inflammatory Markers|inflammatory markers
5232837|NCT00696839|Behavior Therapy|behavior therapy
5232838|NCT00696839|Anti-Retroviral Agents|anti-retroviral agents
5232839|NCT00696839|Relaxation|relaxation
5232840|NCT00696839|Clinical Nursing Research|clinical nursing research
5232841|NCT00696839|Complementary Therapies|complementary therapies
5232842|NCT00696813|Registry|registry
5232843|NCT00696813|Healthcare Utilization|healthcare utilization
5232844|NCT00696813|Outcome|outcome
5232845|NCT00696813|Safety|safety
5232846|NCT00696813|Efficacy|efficacy
5232847|NCT00696813|Cost-effectiveness|cost-effectiveness
5232848|NCT00696813|Paliperidone ER|paliperidone er
5232849|NCT00696813|Invega®|invega®
5232850|NCT00696813|Oral antipsychotics|oral antipsychotics
5232851|NCT00696800|Infertility|infertility
5232852|NCT00696800|Pharmacological effect of drugs|pharmacological effect of drugs
5232853|NCT00696800|Hormones|hormones
5232854|NCT00696800|Hormone substitutes and hormone antagonists|hormone substitutes and hormone antagonists
5232855|NCT00696800|Pharmacological actions|pharmacological actions
5232856|NCT00696800|Randomized|randomized
5232857|NCT00696800|Multi-center|multi-center
5232858|NCT00696800|Multi-national|multi-national
5232859|NCT00696800|Double-blind|double-blind
5232860|NCT00696800|Active-controlled|active-controlled
5232861|NCT00696800|Non-inferiority|non-inferiority
5232862|NCT00696761|LUTS|luts
5232864|NCT00696761|bladder outlet obstruction|bladder outlet obstruction
5232865|NCT00696761|bladder contractility|bladder contractility
5232866|NCT00696748|metabolic syndrome|metabolic syndrome
5232867|NCT00696748|hypogonadism|hypogonadism
5232868|NCT00696748|testosterone undecanoate|testosterone undecanoate
5232869|NCT00696735|Phase III study patients with follicular lymphoma|phase iii study patients with follicular lymphoma
5232870|NCT00696709|Herpes Zoster (Shingles)|herpes zoster (shingles)
5232871|NCT00696696|Pancreatic adenocarcinoma|pancreatic adenocarcinoma
5232872|NCT00696696|metastatic|metastatic
5232873|NCT00696696|EGRF inhibitor|egrf inhibitor
5232874|NCT00696696|targeted therapy|targeted therapy
5232875|NCT00696696|combined cancer therapy|combined cancer therapy
5232876|NCT00696696|kinase inhibitor|kinase inhibitor
5232877|NCT00696696|VEGF-R inhibitor|vegf-r inhibitor
5232878|NCT00696683|scorpion|scorpion
5232879|NCT00696683|sting|sting
5232880|NCT00696683|envenomation|envenomation
5232881|NCT00696683|antivenom|antivenom
5232882|NCT00696631|Heart disease|heart disease
5232883|NCT00696631|morbidity|morbidity
5232884|NCT00696618|HIV prevention|hiv prevention
5232885|NCT00696618|MSM|msm
5232886|NCT00696618|Enema|enema
5232887|NCT00696618|HIV Seronegativity|hiv seronegativity
5232888|NCT00696605|Hypoosmolality|hypoosmolality
5232889|NCT00696605|Hyperosmolality|hyperosmolality
5232890|NCT00696605|Copeptin|copeptin
5232891|NCT00696605|Vasopressin|vasopressin
5232892|NCT00696592|Age-Related Macular Degeneration|age-related macular degeneration
5232893|NCT00696592|Choroidal Neovascularization|choroidal neovascularization
5232894|NCT00696592|Bevacizumab|bevacizumab
5232895|NCT00696592|Photodynamic Therapy|photodynamic therapy
5232896|NCT00696579|BCG|bcg
5232897|NCT00696579|Gemcitabine|gemcitabine
5232898|NCT00696579|Intravesical|intravesical
5232899|NCT00696579|Therapy|therapy
5232900|NCT00696579|Superficial|superficial
5232901|NCT00696579|Transitional|transitional
5232902|NCT00696579|Cell carcinoma|cell carcinoma
5232903|NCT00696566|Thrombosis|thrombosis
5232904|NCT00696566|Platelet aggregation inhibitor|platelet aggregation inhibitor
5232905|NCT00696566|Blood platelets|blood platelets
5232906|NCT00696566|P2 receptor|p2 receptor
5232907|NCT00696566|Cytochrome P450|cytochrome p450
5232908|NCT00696540|Bronchiolitis, respiratory distress, hypertonic saline|bronchiolitis, respiratory distress, hypertonic saline
5232909|NCT00696527|Infiltrative breast cancer-Clinical practice|infiltrative breast cancer-clinical practice
5232910|NCT00696527|Women with infiltrative breast cancer|women with infiltrative breast cancer
5232911|NCT00696514|fracture|fracture
5232912|NCT00696514|cognition|cognition
5232913|NCT00696501|Neuromuscular mapping|neuromuscular mapping
5232914|NCT00696501|Spinal surgery|spinal surgery
5232915|NCT00696501|Neurodiagnostics|neurodiagnostics
5232916|NCT00696501|Segmental root innervation|segmental root innervation
5232917|NCT00696501|Dermatomal innervation|dermatomal innervation
5232918|NCT00696501|Myotomal innervation|myotomal innervation
5232919|NCT00696501|Nerve roots|nerve roots
5232920|NCT00696501|Sensory|sensory
5232921|NCT00696501|Signs and Symptoms|signs and symptoms
5232922|NCT00696462|forced-air warming|forced-air warming
5232923|NCT00696462|Bair Hugger|bair hugger
5232924|NCT00696462|cesarean section|cesarean section
5232925|NCT00696462|postoperative infection|postoperative infection
5232926|NCT00696462|surgical site infections|surgical site infections
5232927|NCT00696436|Essential Hypertension|essential hypertension
5232928|NCT00696436|Cardiovascular Disease|cardiovascular disease
5232929|NCT00696436|High Blood Pressure|high blood pressure
5232930|NCT00696436|Drug Therapy|drug therapy
5232931|NCT00696423|Infanrix/Hib|infanrix/hib
5232932|NCT00696423|Chinese children|chinese children
5232933|NCT00696410|Heart Failure|heart failure
5232934|NCT00696410|Cardiomyopathy|cardiomyopathy
5232935|NCT00696410|Remodeling|remodeling
5232936|NCT00696410|Antioxidant|antioxidant
5232937|NCT00696410|Zinc|zinc
5232938|NCT00696410|Copper|copper
5232939|NCT00696384|Essential Hypertension|essential hypertension
5232940|NCT00696384|Cardiovascular Disease|cardiovascular disease
5232941|NCT00696384|High Blood Pressure|high blood pressure
5232942|NCT00696384|Drug Therapy|drug therapy
5232943|NCT00696371|Neuroinflammation|neuroinflammation
5232944|NCT00696371|PBR28|pbr28
5232945|NCT00696371|PET Imaging|pet imaging
5232946|NCT00696371|Health Volunteer|health volunteer
5232947|NCT00696371|HV|hv
5232948|NCT00696358|Vitiligo|vitiligo
5232949|NCT00696345|colorectal cancer|colorectal cancer
5232950|NCT00696345|screening|screening
5232951|NCT00696345|biomarker|biomarker
5232952|NCT00696345|plasma|plasma
5232953|NCT00696345|blood|blood
5232954|NCT00696332|ALS|als
5232955|NCT00696319|Rupture of the anterior cruciate ligament of the knee|rupture of the anterior cruciate ligament of the knee
5232956|NCT00696306|Acute Ischemic Stroke|acute ischemic stroke
5232957|NCT00696306|Stroke|stroke
5232958|NCT00696306|MRI|mri
5232959|NCT00696306|DTI|dti
5232960|NCT00696306|Diffusion Tensor Imaging|diffusion tensor imaging
5232961|NCT00696306|SWI|swi
5232962|NCT00696306|Susceptibility Weighted Imaging|susceptibility weighted imaging
5232963|NCT00696306|Outcome|outcome
5232964|NCT00696306|Axonal Injury|axonal injury
5232965|NCT00696280|nausea|nausea
5232966|NCT00696280|vomiting|vomiting
5232967|NCT00696280|Carboplatin|carboplatin
5232968|NCT00696280|cancer|cancer
5232969|NCT00696280|delayed emesis following treatment with carboplatin|delayed emesis following treatment with carboplatin
5232970|NCT00696241|Essential Hypertension|essential hypertension
5232971|NCT00696241|Cardiovascular Disease|cardiovascular disease
5232972|NCT00696241|High Blood Pressure|high blood pressure
5232973|NCT00696241|Drug Therapy|drug therapy
5232974|NCT00696215|Parkinson's disease|parkinson's disease
5232975|NCT00696215|rasagiline|rasagiline
5232976|NCT00696215|cognition|cognition
5232977|NCT00696215|MAO-B|mao-b
5232978|NCT00696202|Mirena|mirena
5232979|NCT00696202|Levonorgestrel|levonorgestrel
5232980|NCT00696202|Intrauterine device|intrauterine device
5232981|NCT00696202|Efficacy|efficacy
5232982|NCT00696202|Tolerability|tolerability
5232983|NCT00696202|First year of use|first year of use
5232984|NCT00696189|Post operative visual loss (POVL)|post operative visual loss (povl)
5232985|NCT00696189|Intraocular pressure (IOP)|intraocular pressure (iop)
5232986|NCT00696189|Nitrous oxide|nitrous oxide
5232987|NCT00696176|STAT 3 DECOY|stat 3 decoy
5232988|NCT00696150|ultrasound|ultrasound
5232989|NCT00696150|hip|hip
5232990|NCT00696150|pain|pain
5232991|NCT00696124|lower leg ischemia|lower leg ischemia
5232992|NCT00696124|peripheral artery disease|peripheral artery disease
5232993|NCT00696111|PCOS|pcos
5232994|NCT00696111|OSA|osa
5232995|NCT00696111|Metabolism|metabolism
5232996|NCT00696111|Diabetes|diabetes
5232997|NCT00696085|fetal alcohol exposure|fetal alcohol exposure
5232998|NCT00696085|blood markers of alcohol use|blood markers of alcohol use
5232999|NCT00696085|brief intervention|brief intervention
5233000|NCT00696059|Rheumatoid arthritis|rheumatoid arthritis
5233001|NCT00696059|Computed tomography|computed tomography
5233002|NCT00696059|Magnetic resonance imaging|magnetic resonance imaging
5233003|NCT00696059|Radiography|radiography
5233004|NCT00696059|Tumor necrosis factor alpha antagonists|tumor necrosis factor alpha antagonists
5233005|NCT00696046|CORD BLOOD CELLS|cord blood cells
5233006|NCT00696046|INTRA BONE MARROW INJECTION|intra bone marrow injection
5233007|NCT00696046|ENGRAFTMENT|engraftment
5233008|NCT00696046|transplants|transplants
5233009|NCT00696033|Benzodiazepines|benzodiazepines
5233010|NCT00696033|Lorazepam|lorazepam
5233011|NCT00696033|Diazepam|diazepam
5233012|NCT00696033|Memory|memory
5233013|NCT00696033|Perceptual priming|perceptual priming
5233014|NCT00696033|Functional brain imaging|functional brain imaging
5233015|NCT00696033|FMRI|fmri
5233016|NCT00696007|Upper GU Tract Transitional Cell Carinoma|upper gu tract transitional cell carinoma
5233017|NCT00696007|Nephroureterectomy|nephroureterectomy
5233018|NCT00696007|Chemotherapy|chemotherapy
5233019|NCT00696007|Gemcitabine|gemcitabine
5233020|NCT00696007|Cisplatin|cisplatin
5233021|NCT00695981|Rotator cuff|rotator cuff
5233022|NCT00695981|Arthroscopic surgery|arthroscopic surgery
5233023|NCT00695981|Open surgery|open surgery
5233024|NCT00695981|Physiotherapy|physiotherapy
5233025|NCT00695981|Physical therapy|physical therapy
5233026|NCT00695981|Effectiveness|effectiveness
5233027|NCT00695981|RCT|rct
5233028|NCT00695981|cost-effectiveness|cost-effectiveness
5233029|NCT00695955|Essential Hypertension|essential hypertension
5233030|NCT00695955|Cardiovascular Disease|cardiovascular disease
5233031|NCT00695955|High Blood Pressure|high blood pressure
5233032|NCT00695955|Drug Therapy|drug therapy
5233033|NCT00695942|preeclampsia|preeclampsia
5233034|NCT00695942|eclampsia|eclampsia
5233035|NCT00695942|retroplacental hematoma|retroplacental hematoma
5233036|NCT00695942|vascular IUGR|vascular iugr
5233037|NCT00695942|IUFD|iufd
5233038|NCT00695942|VTE|vte
5233039|NCT00695929|cardiac surgery with cardiopulmonary bypass|cardiac surgery with cardiopulmonary bypass
5233040|NCT00695903|Gram-positive bacterial infections|gram-positive bacterial infections
5233041|NCT00695903|Staph Aureus|staph aureus
5233042|NCT00695903|Bacteremia|bacteremia
5233043|NCT00695903|MRSA|mrsa
5233044|NCT00695903|Infective Endocarditis|infective endocarditis
5233045|NCT00695903|Right-sided Infective endocarditis|right-sided infective endocarditis
5233046|NCT00695903|SABIE|sabie
5233047|NCT00695903|SAIE|saie
5233048|NCT00695903|RIE|rie
5233049|NCT00695890|Pupillometry|pupillometry
5233050|NCT00695890|Sevoflorane|sevoflorane
5233051|NCT00695890|Propofol|propofol
5233052|NCT00695877|HIV Seronegativity|hiv seronegativity
5233053|NCT00695877|HIV Preventive Vaccine|hiv preventive vaccine
5233054|NCT00695851|PCK3145|pck3145
5233055|NCT00695851|Prostate|prostate
5233056|NCT00695838|GERD symptoms- Waist circumference|gerd symptoms- waist circumference
5233057|NCT00695838|Patients with symptomatic GERD|patients with symptomatic gerd
5233058|NCT00695812|Neurodevelopmental disorders|neurodevelopmental disorders
5233059|NCT00695812|Autism Spectrum Disorders|autism spectrum disorders
5233060|NCT00695812|Broader autism phenotype|broader autism phenotype
5233061|NCT00695812|Siblings|siblings
5233062|NCT00695812|Cognitive language and social emotional development|cognitive language and social emotional development
5233063|NCT00695812|to identify siblings who manifest any autism or broader autism phenotype characteristics|to identify siblings who manifest any autism or broader autism phenotype characteristics
5233064|NCT00695799|Propofol|propofol
5233065|NCT00695799|Anesthesia care provider|anesthesia care provider
5233066|NCT00695799|Pollution|pollution
5233067|NCT00695799|Operating room|operating room
5233068|NCT00695799|Environment|environment
5233069|NCT00695786|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
5233070|NCT00695786|Lymphoma|lymphoma
5233071|NCT00695786|Lenalidomide|lenalidomide
5233072|NCT00695786|Revlimid|revlimid
5233073|NCT00695786|Rituximab|rituximab
5233074|NCT00695786|Rituxan|rituxan
5233075|NCT00695773|Prostate Cancer Surgery|prostate cancer surgery
5233076|NCT00695773|Laparoscopic surgery for Prostate Cancer|laparoscopic surgery for prostate cancer
5233077|NCT00695773|Prostatectomy|prostatectomy
5233078|NCT00695773|Urologic Surgical Procedures|urologic surgical procedures
5233079|NCT00695747|Glaucoma|glaucoma
5233080|NCT00695747|Cataracts|cataracts
5233081|NCT00695747|Phacoemulsification(IOL)|phacoemulsification(iol)
5233082|NCT00695747|Trabeculectomy|trabeculectomy
5233083|NCT00695734|hemodialysis|hemodialysis
5233084|NCT00695734|end stage renal failure|end stage renal failure
5233085|NCT00695734|tuberculosis|tuberculosis
5233086|NCT00695734|latent tuberculosis infection|latent tuberculosis infection
5233087|NCT00695734|Patients under hemodialysis for end stage renal failure|patients under hemodialysis for end stage renal failure
5233088|NCT00695708|schizophrenia|schizophrenia
5233089|NCT00695708|neuroplasticity|neuroplasticity
5233090|NCT00695708|sensory gating|sensory gating
5233091|NCT00695708|cognitive impairment|cognitive impairment
5233093|NCT00695708|Disorders with Psychotic Features|disorders with psychotic features
5233094|NCT00695695|Parents|parents
5233095|NCT00695695|Down Syndrome|down syndrome
5233096|NCT00695695|Hope|hope
5233097|NCT00695695|Uncertainty|uncertainty
5233098|NCT00695695|Adaptation|adaptation
5233099|NCT00695695|DS|ds
5233100|NCT00695695|Survey|survey
5233101|NCT00695682|Remicade|remicade
5233102|NCT00695682|Infliximab|infliximab
5233103|NCT00695682|CSME|csme
5233104|NCT00695682|BDR|bdr
5233105|NCT00695682|CNV|cnv
5233106|NCT00695682|AMD|amd
5233107|NCT00695669|H5N1|h5n1
5233108|NCT00695669|immunogenicity|immunogenicity
5233109|NCT00695669|influenza|influenza
5233110|NCT00695669|Avian|avian
5233111|NCT00695669|pandemic|pandemic
5233112|NCT00695669|vaccines|vaccines
5233113|NCT00695669|human|human
5233114|NCT00695669|safety|safety
5233115|NCT00695656|Hypertension|hypertension
5233116|NCT00695656|general practitioner consultation|general practitioner consultation
5233117|NCT00695656|Patients with hypertension|patients with hypertension
5233118|NCT00695630|conscious sedation|conscious sedation
5233119|NCT00695630|dental anxiety/drug therapy|dental anxiety/drug therapy
5233120|NCT00695630|behavior/drug effects|behavior/drug effects
5233121|NCT00695617|MARS treatment|mars treatment
5233122|NCT00695617|Citrate anticoagulation|citrate anticoagulation
5233123|NCT00695604|Acute asthma|acute asthma
5233124|NCT00695604|fluticasone|fluticasone
5233125|NCT00695604|inhaled corticosteroids|inhaled corticosteroids
5233126|NCT00695591|Home sleep testing neuromuscular disease|home sleep testing neuromuscular disease
5233127|NCT00695591|Neuromuscular disease patients with FEV1<50% of predicted|neuromuscular disease patients with fev1<50% of predicted
5233128|NCT00695552|Major depression, exercise|major depression, exercise
5233129|NCT00695539|Rosuvastatin|rosuvastatin
5233130|NCT00695539|hypercholesterolaemia|hypercholesterolaemia
5233131|NCT00695526|cranberry|cranberry
5233132|NCT00695526|total to HDL cholesterol ratio|total to hdl cholesterol ratio
5233133|NCT00695526|type 2 diabetes|type 2 diabetes
5233134|NCT00695513|Food supplement|food supplement
5233135|NCT00695513|Haemodialysis|haemodialysis
5233136|NCT00695500|Varenicline|varenicline
5233137|NCT00695500|Alcohol|alcohol
5233138|NCT00695500|Alcohol Use|alcohol use
5233139|NCT00695487|Anesthesia|anesthesia
5233140|NCT00695487|THC|thc
5233141|NCT00695487|Postoperative Nausea|postoperative nausea
5233142|NCT00695474|Hypovitaminosis D|hypovitaminosis d
5233143|NCT00695474|Type 2 diabetes|type 2 diabetes
5233144|NCT00695474|Glycemic control|glycemic control
5233145|NCT00695474|Inflammation|inflammation
5233146|NCT00695474|Blood pressure|blood pressure
5233147|NCT00695461|Colorectal surgery|colorectal surgery
5233148|NCT00695461|Probiotics|probiotics
5233149|NCT00695461|Lactobacillus|lactobacillus
5233150|NCT00695461|Bacterial translocation|bacterial translocation
5233151|NCT00695461|Postoperative complications|postoperative complications
5233152|NCT00695461|Inflammatory reaction|inflammatory reaction
5233153|NCT00695448|Phosphoinositide 3-kinase inhibitor|phosphoinositide 3-kinase inhibitor
5233154|NCT00695448|solid tumors|solid tumors
5233155|NCT00695435|normal volunteers|normal volunteers
5233156|NCT00695435|anti-infective|anti-infective
5233157|NCT00695435|tobramycin|tobramycin
5233158|NCT00695422|high-grade squamous intraepithelial lesion|high-grade squamous intraepithelial lesion
5233159|NCT00695422|low-grade squamous intraepithelial lesion|low-grade squamous intraepithelial lesion
5233160|NCT00695422|human papilloma virus infection|human papilloma virus infection
5233161|NCT00695422|AIDS-related diffuse large cell lymphoma|aids-related diffuse large cell lymphoma
5233162|NCT00695422|AIDS-related diffuse mixed cell lymphoma|aids-related diffuse mixed cell lymphoma
5233163|NCT00695422|AIDS-related diffuse small cleaved cell lymphoma|aids-related diffuse small cleaved cell lymphoma
5233164|NCT00695422|AIDS-related immunoblastic large cell lymphoma|aids-related immunoblastic large cell lymphoma
5233165|NCT00695422|AIDS-related Kaposi sarcoma|aids-related kaposi sarcoma
5233166|NCT00695422|AIDS-related lymphoblastic lymphoma|aids-related lymphoblastic lymphoma
5233167|NCT00695422|AIDS-related malignancies|aids-related malignancies
5233168|NCT00695422|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
5233169|NCT00695422|AIDS-related primary CNS lymphoma|aids-related primary cns lymphoma
5233170|NCT00695422|AIDS-related small noncleaved cell lymphoma|aids-related small noncleaved cell lymphoma
5233171|NCT00695422|multicentric Castleman disease|multicentric castleman disease
5233172|NCT00695422|HIV Infections|hiv infections
5233173|NCT00695409|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5233174|NCT00695409|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5233175|NCT00695409|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5233176|NCT00695409|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5233177|NCT00695409|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5233178|NCT00695409|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5233179|NCT00695409|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5233180|NCT00695409|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5233181|NCT00695409|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5233182|NCT00695409|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5233183|NCT00695409|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5233184|NCT00695409|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5233185|NCT00695409|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5233186|NCT00695409|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5233187|NCT00695409|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5233188|NCT00695409|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5233189|NCT00695409|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5233190|NCT00695409|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5233191|NCT00695396|MDS|mds
5233192|NCT00695396|Myelodysplastic syndromes|myelodysplastic syndromes
5233193|NCT00695396|Anemia|anemia
5233194|NCT00695396|Epoetin alfa|epoetin alfa
5233195|NCT00695396|EPO|epo
5233196|NCT00695383|Exercise therapy|exercise therapy
5233197|NCT00695383|Physiotherapy|physiotherapy
5233198|NCT00695383|Critical illness|critical illness
5233199|NCT00695383|Intensive care|intensive care
5233200|NCT00695383|Muscle weakness|muscle weakness
5233201|NCT00695383|Mechanical ventilation|mechanical ventilation
5233202|NCT00695370|Children|children
5233203|NCT00695370|cancer|cancer
5233204|NCT00695370|Bone marrow transplantation|bone marrow transplantation
5233205|NCT00695370|Mobilization|mobilization
5233206|NCT00695370|G-CSF|g-csf
5233207|NCT00695370|Children with solid malignancies|children with solid malignancies
5233208|NCT00695357|Asthma treatment|asthma treatment
5233209|NCT00695357|GINA 2006|gina 2006
5233210|NCT00695357|patient perception|patient perception
5233211|NCT00695344|Effect of everolimus in graft vascular cardiac illness|effect of everolimus in graft vascular cardiac illness
5233212|NCT00695331|Labor Augmentation|labor augmentation
5233213|NCT00695331|Misoprostol|misoprostol
5233214|NCT00695331|Oxytocin|oxytocin
5233215|NCT00695318|AMD|amd
5233216|NCT00695318|Age-Related Macular Degeneration|age-related macular degeneration
5233217|NCT00695318|Geographic Atrophy|geographic atrophy
5233218|NCT00695318|GA|ga
5233219|NCT00695305|rilapladib,|rilapladib,
5233220|NCT00695305|Lp-PLA2,|lp-pla2,
5233221|NCT00695305|atherosclerosis|atherosclerosis
5233222|NCT00695305|SB-659032,|sb-659032,
5233223|NCT00695305|FDG-PET,|fdg-pet,
5233224|NCT00695292|Small Cell Lung Cancer|small cell lung cancer
5233225|NCT00695292|Extensive Stage|extensive stage
5233226|NCT00695292|irinotecan|irinotecan
5233227|NCT00695292|carboplatin|carboplatin
5233228|NCT00695292|sunitinib|sunitinib
5233229|NCT00695279|Gene therapy|gene therapy
5233230|NCT00695253|AAA|aaa
5233231|NCT00695240|Continuous bupivacaine infusion|continuous bupivacaine infusion
5233232|NCT00695240|Analgesia|analgesia
5233233|NCT00695227|laryngopharyngeal reflux|laryngopharyngeal reflux
5233234|NCT00695227|extraesophageal reflux symptoms|extraesophageal reflux symptoms
5233235|NCT00695214|Obstructive Sleep Apnea|obstructive sleep apnea
5233236|NCT00695214|Propofol|propofol
5233237|NCT00695214|Sleep Endoscopy|sleep endoscopy
5233238|NCT00695201|DEXAMETHASONE|dexamethasone
5233239|NCT00695201|FLOXURIDINE|floxuridine
5233240|NCT00695201|IRINOTECAN (CPT-11) CAMPTOSAR|irinotecan (cpt-11) camptosar
5233241|NCT00695201|OXALIPLATIN|oxaliplatin
5233242|NCT00695188|rheumatoid arthritis|rheumatoid arthritis
5233243|NCT00695188|MTX polyglutamates|mtx polyglutamates
5233244|NCT00695188|clinical outcome|clinical outcome
5233245|NCT00695175|Hypertension|hypertension
5233246|NCT00695175|Private cardiology consultation|private cardiology consultation
5233247|NCT00695175|Patients with hypertension|patients with hypertension
5233248|NCT00695162|noise|noise
5233249|NCT00695162|speech intelligibility|speech intelligibility
5233250|NCT00695162|cognition|cognition
5233251|NCT00695149|Spinal cord Injury|spinal cord injury
5233252|NCT00695149|Central nervous system|central nervous system
5233253|NCT00695149|Regeneration|regeneration
5233254|NCT00695149|Bone marrow stromal cells|bone marrow stromal cells
5233255|NCT00695149|Transplantation|transplantation
5233256|NCT00695136|Autism|autism
5233257|NCT00695136|Cognitive Disorder|cognitive disorder
5233258|NCT00695136|Sleep|sleep
5233259|NCT00695136|Autism Spectrum Disorder|autism spectrum disorder
5233260|NCT00695136|ASD|asd
5233261|NCT00695123|Bone Marrow Transplant|bone marrow transplant
5233262|NCT00695123|Sickle Cell Disease|sickle cell disease
5233263|NCT00695123|G-CSF|g-csf
5233264|NCT00695123|Apheresis|apheresis
5233265|NCT00695123|SD|sd
5233266|NCT00695123|Healthy Volunteer|healthy volunteer
5233267|NCT00695123|HV|hv
5233268|NCT00695110|testosterone|testosterone
5233269|NCT00695110|male hypogonadism|male hypogonadism
5233270|NCT00695110|low testosterone|low testosterone
5233271|NCT00695097|Rituximab|rituximab
5233272|NCT00695097|Renal Transplant Rejection|renal transplant rejection
5233273|NCT00695097|B cells|b cells
5233274|NCT00695097|Patients with biopsy proven acute rejection cellular infiltrate, B cells|patients with biopsy proven acute rejection cellular infiltrate, b cells
5233275|NCT00695084|multiple sclerosis|multiple sclerosis
5233276|NCT00695071|Healthy Volunteers|healthy volunteers
5233277|NCT00695058|Stress incontinence|stress incontinence
5233278|NCT00695058|urge incontinence|urge incontinence
5233279|NCT00695058|overactive bladder syndrome|overactive bladder syndrome
5233280|NCT00695058|vibration|vibration
5233281|NCT00695058|nerve stimulation|nerve stimulation
5233282|NCT00695045|Pain, Postoperative|pain, postoperative
5233283|NCT00695045|Arthroplasty, Replacement, Knee|arthroplasty, replacement, knee
5233284|NCT00695045|Morphine|morphine
5233285|NCT00695045|Injections, Intrathecal|injections, intrathecal
5233286|NCT00695032|renal toxicity|renal toxicity
5233287|NCT00695032|chemotherapeutic agent toxicity|chemotherapeutic agent toxicity
5233288|NCT00695032|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5233289|NCT00695019|Prevention of Relapse|prevention of relapse
5233290|NCT00695019|HCV genotype 1b|hcv genotype 1b
5233291|NCT00695019|Recurrence|recurrence
5233292|NCT00695006|manual therapy, cervical traction, cervical radiculopathy|manual therapy, cervical traction, cervical radiculopathy
5233293|NCT00694993|first time in human|first time in human
5233294|NCT00694993|Allergic rhinitis,|allergic rhinitis,
5233295|NCT00694980|UC|uc
5233296|NCT00694980|Ulcerative Colitis|ulcerative colitis
5233297|NCT00694967|short cervix, cervical funneling, spontaneous preterm birth, cerclage, progesterone|short cervix, cervical funneling, spontaneous preterm birth, cerclage, progesterone
5233298|NCT00694954|Iron deficiency anemia|iron deficiency anemia
5233299|NCT00694954|Wireless capsule endoscopy|wireless capsule endoscopy
5233300|NCT00694954|Obscure-occult gastrointestinal bleeding|obscure-occult gastrointestinal bleeding
5233301|NCT00694941|ONO-2506PO|ono-2506po
5233302|NCT00694941|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
5233303|NCT00694941|ALS|als
5233304|NCT00694915|STCC (Superficial Transitional Cell Carcinoma)|stcc (superficial transitional cell carcinoma)
5233305|NCT00694902|Healthy Volunteers|healthy volunteers
5233306|NCT00694889|Psychosis|psychosis
5233307|NCT00694889|First Episode|first episode
5233308|NCT00694889|Schizophrenia|schizophrenia
5233309|NCT00694889|Cognitive Remediation|cognitive remediation
5233310|NCT00694876|Health Literacy|health literacy
5233311|NCT00694876|Patient Nonadherence|patient nonadherence
5233312|NCT00694876|Patient Noncompliance|patient noncompliance
5233313|NCT00694876|Follow Up|follow up
5233314|NCT00694876|India|india
5233315|NCT00694876|Glaucoma|glaucoma
5233316|NCT00694863|high risk for ESRD|high risk for esrd
5233317|NCT00694863|immunosuppressive treatment|immunosuppressive treatment
5233318|NCT00694863|membranous nephropathy|membranous nephropathy
5233319|NCT00694863|ACTH|acth
5233320|NCT00694850|Interstitial lung disease associated pulmonary hypertension|interstitial lung disease associated pulmonary hypertension
5233321|NCT00694837|glioblastoma|glioblastoma
5233322|NCT00694837|nelfinavir|nelfinavir
5233323|NCT00694837|functional imaging|functional imaging
5233324|NCT00694837|AKT pathway|akt pathway
5233325|NCT00694824|Coronary artery calcification|coronary artery calcification
5233326|NCT00694824|calcium score|calcium score
5233327|NCT00694824|(TGF) b1,|(tgf) b1,
5233328|NCT00694824|fetuin A|fetuin a
5233329|NCT00694824|osteoprotegerin (OPG)|osteoprotegerin (opg)
5233330|NCT00694824|fibroblast growth factor (FGF) 23,|fibroblast growth factor (fgf) 23,
5233331|NCT00694824|matrix gla protein (MGP)|matrix gla protein (mgp)
5233332|NCT00694824|hemodialysis patients|hemodialysis patients
5233333|NCT00694811|Obesity|obesity
5233334|NCT00694811|Weight loss|weight loss
5233335|NCT00694811|Diet|diet
5233336|NCT00694811|Very-low-energy diet|very-low-energy diet
5233337|NCT00694811|Predictive factors|predictive factors
5233338|NCT00694811|Re-feeding|re-feeding
5233339|NCT00694798|STCC|stcc
5233340|NCT00694798|Superficial Transitional Cell Carcinoma- BCG refractor|superficial transitional cell carcinoma- bcg refractor
5233341|NCT00694772|Obstructive sleep apnea|obstructive sleep apnea
5233342|NCT00694772|OSA|osa
5233343|NCT00694772|Apnea hypopnea index|apnea hypopnea index
5233344|NCT00694772|AHI|ahi
5233345|NCT00694772|Coblation|coblation
5233346|NCT00694772|Electrocautery|electrocautery
5233347|NCT00694772|Tonsillectomy|tonsillectomy
5233348|NCT00694772|Tonsillotomy|tonsillotomy
5233349|NCT00694759|Polycystic ovary syndrome|polycystic ovary syndrome
5233350|NCT00694759|insulin|insulin
5233351|NCT00694759|PCOS|pcos
5233352|NCT00694759|cortisol regulation|cortisol regulation
5233353|NCT00694759|regulation|regulation
5233354|NCT00694746|ALT|alt
5233355|NCT00694746|Non-Alcoholic Fatty Liver Disease|non-alcoholic fatty liver disease
5233356|NCT00694746|Adolescents|adolescents
5233357|NCT00694746|Overweight|overweight
5233358|NCT00694746|Treatment|treatment
5233359|NCT00694733|Obesity|obesity
5233360|NCT00694733|Menopausal Syndrome|menopausal syndrome
5233361|NCT00694733|Cortisol|cortisol
5233362|NCT00694720|Cheyne-stokes breathing|cheyne-stokes breathing
5233363|NCT00694694|Malaria|malaria
5233364|NCT00694694|Africa|africa
5233365|NCT00694694|Child|child
5233366|NCT00694681|Telephonic care management|telephonic care management
5233367|NCT00694668|Deliberate Self-Harm|deliberate self-harm
5233368|NCT00694668|Self-Injurious Behaviour|self-injurious behaviour
5233369|NCT00694668|Suicidal Behaviour|suicidal behaviour
5233370|NCT00694668|Cognitive behavioural therapy|cognitive behavioural therapy
5233371|NCT00694668|Mindfulness Based cognitive therapy|mindfulness based cognitive therapy
5233372|NCT00694655|Yellow Fever|yellow fever
5233373|NCT00694655|Vaccine|vaccine
5233374|NCT00694655|Immunity|immunity
5233375|NCT00694655|yellow fever vaccine|yellow fever vaccine
5233376|NCT00694655|CD8 T cell responses|cd8 t cell responses
5233377|NCT00694642|Refractory angina|refractory angina
5233378|NCT00694629|pulmonary tuberculosis|pulmonary tuberculosis
5233379|NCT00694629|treatment|treatment
5233380|NCT00694616|Obstructive sleep apnea|obstructive sleep apnea
5233381|NCT00694616|Metabolic syndrome|metabolic syndrome
5233382|NCT00694616|Insulin resistance|insulin resistance
5233383|NCT00694616|Hypertension|hypertension
5233384|NCT00694616|Dyslipidemia|dyslipidemia
5233385|NCT00694616|Continuous positive airway pressure (CPAP)|continuous positive airway pressure (cpap)
5233386|NCT00694603|cetuximab|cetuximab
5233387|NCT00694603|tyrosine kinase inhibitor|tyrosine kinase inhibitor
5233388|NCT00694590|AMD3100|amd3100
5233389|NCT00694590|Rituximab|rituximab
5233390|NCT00694590|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
5233391|NCT00694590|CLL|cll
5233392|NCT00694590|Small Lymphocytic Lymphoma|small lymphocytic lymphoma
5233393|NCT00694590|SLL|sll
5233394|NCT00694577|non-invasive breast cancer|non-invasive breast cancer
5233395|NCT00694577|early invasive breast cancer|early invasive breast cancer
5233396|NCT00694577|radiation|radiation
5233397|NCT00694577|PBI|pbi
5233398|NCT00694564|abdominal pain|abdominal pain
5233399|NCT00694564|children|children
5233400|NCT00694551|vaccine|vaccine
5233401|NCT00694551|PSMA|psma
5233402|NCT00694551|TARP|tarp
5233403|NCT00694551|immunology|immunology
5233404|NCT00694551|PSA|psa
5233405|NCT00694538|Interferential laser therapy|interferential laser therapy
5233406|NCT00694525|21OHD|21ohd
5233407|NCT00694525|21-hydroxylase deficiency|21-hydroxylase deficiency
5233408|NCT00694525|CAH|cah
5233409|NCT00694499|Morbidity|morbidity
5233410|NCT00694499|Mortality|mortality
5233411|NCT00694486|otitis|otitis
5233412|NCT00694486|Eustachian tube function|eustachian tube function
5233413|NCT00694486|Normal middle ear status|normal middle ear status
5233414|NCT00694473|hyperglycemia|hyperglycemia
5233415|NCT00694473|hypoglycemia|hypoglycemia
5233416|NCT00694473|insulin|insulin
5233417|NCT00694473|critical illness|critical illness
5233418|NCT00694473|intensive insulin therapy|intensive insulin therapy
5233419|NCT00694473|continuous glucose monitoring|continuous glucose monitoring
5233420|NCT00694473|CGM|cgm
5233421|NCT00694473|interstitial fluid glucose|interstitial fluid glucose
5233422|NCT00694473|intensive care unit|intensive care unit
5233423|NCT00694473|Blood glucose|blood glucose
5233424|NCT00694460|rabies vaccination|rabies vaccination
5233425|NCT00694460|pre-exposure prophylaxis|pre-exposure prophylaxis
5233426|NCT00694460|rabies virus neutralizing antibody|rabies virus neutralizing antibody
5233427|NCT00694434|Cryopreservation|cryopreservation
5233428|NCT00694434|Frozen embryo transfer|frozen embryo transfer
5233429|NCT00694434|Graduated Embryo Score|graduated embryo score
5233430|NCT00694421|otitis|otitis
5233431|NCT00694421|Eustachian tube|eustachian tube
5233432|NCT00694421|virus|virus
5233433|NCT00694421|Middle ear disease|middle ear disease
5233434|NCT00694408|End stage liver disease|end stage liver disease
5233435|NCT00694408|Paediatric liver transplantation|paediatric liver transplantation
5233436|NCT00694408|Steroid free immunosuppression|steroid free immunosuppression
5233437|NCT00694395|Qualitative study|qualitative study
5233438|NCT00694395|stroke|stroke
5233439|NCT00694395|20 patients, Family or caregivers|20 patients, family or caregivers
5233440|NCT00694395|acute ischemic stroke|acute ischemic stroke
5233441|NCT00694395|delayed to receive thrombolytic therapy.|delayed to receive thrombolytic therapy.
5233442|NCT00694382|chemotherapy|chemotherapy
5233443|NCT00694369|Postoperative Dental Pain|postoperative dental pain
5233444|NCT00694343|Cesarean section|cesarean section
5233445|NCT00694343|spinal anesthesia|spinal anesthesia
5233446|NCT00694343|hypotension|hypotension
5233447|NCT00694330|vaccine|vaccine
5233448|NCT00694330|GM-K562|gm-k562
5233449|NCT00694330|malignant glioma|malignant glioma
5233450|NCT00694304|Major Depressive Disorder|major depressive disorder
5233451|NCT00694304|Long-term|long-term
5233452|NCT00694304|Safety|safety
5233453|NCT00694304|Open-label|open-label
5233454|NCT00694291|Rising PSA|rising psa
5233455|NCT00694265|Carpal Tunnel Syndrome|carpal tunnel syndrome
5233456|NCT00694265|Median Nerve|median nerve
5233457|NCT00694265|Ultrasonography|ultrasonography
5233458|NCT00694265|Prospective cohort study|prospective cohort study
5233459|NCT00694252|Breast cancer|breast cancer
5233460|NCT00694252|Tykerb|tykerb
5233461|NCT00694252|CTCs|ctcs
5233462|NCT00694239|hypertension|hypertension
5233463|NCT00694239|compliance|compliance
5233464|NCT00694226|Adolescent|adolescent
5233465|NCT00694226|Substance use|substance use
5233466|NCT00694226|Brief intervention|brief intervention
5233467|NCT00694226|Child psychiatry|child psychiatry
5233468|NCT00694213|Pandemic Influenza|pandemic influenza
5233469|NCT00694213|Avian Influenza|avian influenza
5233470|NCT00694213|DNA Vaccines|dna vaccines
5233471|NCT00694213|Antibody|antibody
5233472|NCT00694213|T Cells|t cells
5233473|NCT00694213|HA/NP/M2|ha/np/m2
5233474|NCT00694213|Biojector|biojector
5233475|NCT00694200|breast cancer|breast cancer
5233476|NCT00694200|chemotherapy|chemotherapy
5233477|NCT00694200|anti-angiogenesis therapy|anti-angiogenesis therapy
5233478|NCT00694174|Procedural Pain in Newborn Infants|procedural pain in newborn infants
5233479|NCT00694174|newborn infant|newborn infant
5233480|NCT00694174|acute procedural pain|acute procedural pain
5233481|NCT00694174|skin blood flow changes|skin blood flow changes
5233482|NCT00694174|sucrose analgesia|sucrose analgesia
5233483|NCT00694174|laser doppler imager|laser doppler imager
5233484|NCT00694174|neonatal infant pain scale|neonatal infant pain scale
5233485|NCT00694161|Transthyretin|transthyretin
5233486|NCT00694161|TTR|ttr
5233487|NCT00694161|ATTR|attr
5233488|NCT00694161|TTR amyloidosis|ttr amyloidosis
5233489|NCT00694161|cardiomyopathy|cardiomyopathy
5233490|NCT00694161|V122I|v122i
5233491|NCT00694161|wild-type TTR|wild-type ttr
5233492|NCT00694161|SSA|ssa
5233493|NCT00694161|Patients with V122I or wild-type TTR amyloid cardiomyopathy|patients with v122i or wild-type ttr amyloid cardiomyopathy
5233494|NCT00694148|Treatment of glabellar frown lines|treatment of glabellar frown lines
5233495|NCT00694135|Iontophoresis|iontophoresis
5233496|NCT00694135|Non-Infectious Acute Anterior Segment Uveitis|non-infectious acute anterior segment uveitis
5233497|NCT00694135|Ophthalmology|ophthalmology
5233498|NCT00694122|glucose|glucose
5233499|NCT00694122|cortisol|cortisol
5233500|NCT00694122|growth hormone|growth hormone
5233501|NCT00694122|glucagon|glucagon
5233502|NCT00694122|insulin|insulin
5233503|NCT00694109|Familial Hypercholesterolemia|familial hypercholesterolemia
5233504|NCT00694109|FH|fh
5233505|NCT00694109|Heterozygous Familial Hypercholesterolemia|heterozygous familial hypercholesterolemia
5233506|NCT00694109|HeFH|hefh
5233507|NCT00694109|Homozygous Familial Hypercholesterolemia|homozygous familial hypercholesterolemia
5233508|NCT00694109|HoFH|hofh
5233509|NCT00694057|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
5233510|NCT00694057|Metformin|metformin
5233511|NCT00694057|HbA1c|hba1c
5233512|NCT00694044|Safety, Tolerability, Pharmacokinetics, Cognition|safety, tolerability, pharmacokinetics, cognition
5233513|NCT00694031|Mortality|mortality
5233514|NCT00694031|Convective therapies|convective therapies
5233515|NCT00694031|On-line Hemodiafiltration|on-line hemodiafiltration
5233516|NCT00694031|Dialysis Adequacy|dialysis adequacy
5233517|NCT00694031|Age 18 or older|age 18 or older
5233518|NCT00694031|Undergoing hemodialysis|undergoing hemodialysis
5233519|NCT00694018|randomized trial|randomized trial
5233520|NCT00694018|walking|walking
5233521|NCT00694005|stent|stent
5233522|NCT00694005|bifurcation|bifurcation
5233523|NCT00694005|balloon angioplasty|balloon angioplasty
5233524|NCT00693966|HPV, Vaccine|hpv, vaccine
5233525|NCT00693953|Evoked Potentials|evoked potentials
5233526|NCT00693953|Evoked Potentials, Auditory|evoked potentials, auditory
5233527|NCT00693953|Evoked Potentials, Visual|evoked potentials, visual
5233528|NCT00693953|Electroencephalography|electroencephalography
5233529|NCT00693953|Brain Mapping|brain mapping
5233530|NCT00693940|Peripheral Arterial Disease|peripheral arterial disease
5233531|NCT00693940|PAD|pad
5233532|NCT00693927|Hematopoietic cell transplantation|hematopoietic cell transplantation
5233533|NCT00693927|Allogeneic|allogeneic
5233534|NCT00693927|Nonmyeloablative|nonmyeloablative
5233535|NCT00693927|CD8-depletion|cd8-depletion
5233536|NCT00693927|PBSC|pbsc
5233537|NCT00693927|GVHD|gvhd
5233538|NCT00693927|Hematological malignancies and renal cell carcinoma|hematological malignancies and renal cell carcinoma
5233539|NCT00693914|Brain Tumor|brain tumor
5233540|NCT00693914|Cognitive Late Effects|cognitive late effects
5233541|NCT00693914|Radiation Therapy|radiation therapy
5233542|NCT00693914|Working Memory|working memory
5233543|NCT00693888|dementia|dementia
5233544|NCT00693888|system of care|system of care
5233545|NCT00693888|level of care|level of care
5233546|NCT00693888|interventional study|interventional study
5233547|NCT00693888|evaluation|evaluation
5233548|NCT00693888|dementia diagnostic|dementia diagnostic
5233549|NCT00693888|Evaluation of the care study|evaluation of the care study
5233550|NCT00693875|incidence|incidence
5233551|NCT00693875|awareness|awareness
5233552|NCT00693875|general anesthesia|general anesthesia
5233553|NCT00693875|relevant factor|relevant factor
5233554|NCT00693875|the incidence of intra-operative awareness in China|the incidence of intra-operative awareness in china
5233555|NCT00693875|the relevant factors|the relevant factors
5233556|NCT00693862|Focus of the study is pharmacokinetics of the study drug|focus of the study is pharmacokinetics of the study drug
5233557|NCT00693849|depression|depression
5233558|NCT00693849|CNS|cns
5233559|NCT00693849|iSPOT|ispot
5233560|NCT00693849|MDD|mdd
5233561|NCT00693836|stage I non-small cell lung cancer|stage i non-small cell lung cancer
5233562|NCT00693836|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
5233563|NCT00693836|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5233564|NCT00693836|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5233565|NCT00693836|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5233566|NCT00693836|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5233567|NCT00693836|extensive stage small cell lung cancer|extensive stage small cell lung cancer
5233568|NCT00693836|limited stage small cell lung cancer|limited stage small cell lung cancer
5233569|NCT00693836|recurrent small cell lung cancer|recurrent small cell lung cancer
5233570|NCT00693823|atherosclerosis|atherosclerosis
5233571|NCT00693823|stent|stent
5233572|NCT00693823|angioplasty|angioplasty
5233573|NCT00693823|covered stent|covered stent
5233574|NCT00693797|ventricular hypertrophy|ventricular hypertrophy
5233575|NCT00693797|collagen|collagen
5233576|NCT00693797|aortic stenosis|aortic stenosis
5233577|NCT00693784|Intervertebral Disk|intervertebral disk
5233578|NCT00693784|chronic low back pain|chronic low back pain
5233579|NCT00693784|internal disc disruption|internal disc disruption
5233580|NCT00693784|degenerative disc disease|degenerative disc disease
5233581|NCT00693758|MRI|mri
5233582|NCT00693758|coronary reactivity|coronary reactivity
5233583|NCT00693758|coronary physiology|coronary physiology
5233584|NCT00693745|Acutely|acutely
5233585|NCT00693719|recurrent breast cancer|recurrent breast cancer
5233586|NCT00693719|stage IIIA breast cancer|stage iiia breast cancer
5233587|NCT00693719|stage IIIB breast cancer|stage iiib breast cancer
5233588|NCT00693719|stage IIIC breast cancer|stage iiic breast cancer
5233589|NCT00693719|stage IV breast cancer|stage iv breast cancer
5233590|NCT00693706|cell culture|cell culture
5233591|NCT00693706|Safety|safety
5233592|NCT00693706|Influenza|influenza
5233593|NCT00693706|Humans|humans
5233594|NCT00693706|Adults|adults
5233595|NCT00693706|Immunogenicity|immunogenicity
5233596|NCT00693706|Influenza vaccine|influenza vaccine
5233597|NCT00693706|Vaccine|vaccine
5233598|NCT00693680|depression|depression
5233599|NCT00693680|antidepressant treatment|antidepressant treatment
5233600|NCT00693680|zinc|zinc
5233601|NCT00693680|placebo|placebo
5233602|NCT00693667|osteoporosis|osteoporosis
5233603|NCT00693667|postmenopausal women|postmenopausal women
5233604|NCT00693667|botanical drug|botanical drug
5233605|NCT00693654|Uremic Pruritis|uremic pruritis
5233606|NCT00693641|Jellyfish|jellyfish
5233607|NCT00693641|Cyanea sp|cyanea sp
5233608|NCT00693641|Safe Sea|safe sea
5233609|NCT00693641|Prevention|prevention
5233610|NCT00693641|treatment|treatment
5233611|NCT00693641|Pain relief|pain relief
5233612|NCT00693641|Prevention of pain|prevention of pain
5233613|NCT00693628|volume|volume
5233614|NCT00693628|healing|healing
5233615|NCT00693628|shrinker|shrinker
5233616|NCT00693628|transtibial amputation|transtibial amputation
5233617|NCT00693628|individuals who have undergone transtibial amputation|individuals who have undergone transtibial amputation
5233618|NCT00693615|HPV, Vaccine|hpv, vaccine
5233807|NCT00692861|Adults|adults
5233619|NCT00693589|endothelial function|endothelial function
5233620|NCT00693589|flow mediated dilatation|flow mediated dilatation
5233621|NCT00693589|rosuvastatin|rosuvastatin
5233622|NCT00693589|folic acid|folic acid
5233623|NCT00693589|B vitamins|b vitamins
5233624|NCT00693576|renal transplant|renal transplant
5233625|NCT00693576|panel reactive antibody|panel reactive antibody
5233626|NCT00693576|sensitization|sensitization
5233627|NCT00693576|simvastatin|simvastatin
5233628|NCT00693576|immunological|immunological
5233629|NCT00693563|Spinal Cord Injury|spinal cord injury
5233630|NCT00693550|lip and oral cavity squamous cell carcinoma|lip and oral cavity squamous cell carcinoma
5233631|NCT00693550|oropharyngeal squamous cell carcinoma|oropharyngeal squamous cell carcinoma
5233632|NCT00693524|liver allograft transplantation|liver allograft transplantation
5233633|NCT00693524|sequential therapy|sequential therapy
5233634|NCT00693524|tacrolimus|tacrolimus
5233635|NCT00693511|obesity|obesity
5233636|NCT00693511|adolescents|adolescents
5233637|NCT00693511|adiposity|adiposity
5233638|NCT00693511|insulin sensitivity|insulin sensitivity
5233639|NCT00693511|type 2 diabetes|type 2 diabetes
5233640|NCT00693511|Latino|latino
5233641|NCT00693511|circuit training|circuit training
5233642|NCT00693511|physical activity|physical activity
5233643|NCT00693511|motivational interviewing|motivational interviewing
5233644|NCT00693498|pediatrics|pediatrics
5233645|NCT00693498|congenital heart disease|congenital heart disease
5233646|NCT00693472|Antipsychotic Agents|antipsychotic agents
5233647|NCT00693459|Hemorrhoids|hemorrhoids
5233648|NCT00693446|Pancreas-kidney allograft|pancreas-kidney allograft
5233649|NCT00693446|tacrolimus|tacrolimus
5233650|NCT00693446|sirolimus|sirolimus
5233651|NCT00693446|Pancreas-kidney allograft recipients|pancreas-kidney allograft recipients
5233652|NCT00693381|Transplantation|transplantation
5233653|NCT00693381|Graft Rejection|graft rejection
5233654|NCT00693381|Renal Transplantation|renal transplantation
5233655|NCT00693355|gut health|gut health
5233656|NCT00693342|stage IA primary peritoneal cavity cancer|stage ia primary peritoneal cavity cancer
5233657|NCT00693342|stage IB primary peritoneal cavity cancer|stage ib primary peritoneal cavity cancer
5233658|NCT00693342|stage IC primary peritoneal cavity cancer|stage ic primary peritoneal cavity cancer
5233659|NCT00693342|stage IIA primary peritoneal cavity cancer|stage iia primary peritoneal cavity cancer
5233660|NCT00693342|stage IIB primary peritoneal cavity cancer|stage iib primary peritoneal cavity cancer
5233661|NCT00693342|stage IIC primary peritoneal cavity cancer|stage iic primary peritoneal cavity cancer
5233662|NCT00693342|stage IIIA primary peritoneal cavity cancer|stage iiia primary peritoneal cavity cancer
5233663|NCT00693342|stage IIIB primary peritoneal cavity cancer|stage iiib primary peritoneal cavity cancer
5233785|NCT00692939|Crohn's Disease|crohn's disease
5233664|NCT00693342|stage IIIC primary peritoneal cavity cancer|stage iiic primary peritoneal cavity cancer
5233665|NCT00693342|stage IV primary peritoneal cavity cancer|stage iv primary peritoneal cavity cancer
5233666|NCT00693342|stage IA fallopian tube cancer|stage ia fallopian tube cancer
5233667|NCT00693342|stage IB fallopian tube cancer|stage ib fallopian tube cancer
5233668|NCT00693342|stage IC fallopian tube cancer|stage ic fallopian tube cancer
5233669|NCT00693342|stage IIA fallopian tube cancer|stage iia fallopian tube cancer
5233670|NCT00693342|stage IIB fallopian tube cancer|stage iib fallopian tube cancer
5233671|NCT00693342|stage IIC fallopian tube cancer|stage iic fallopian tube cancer
5233672|NCT00693342|stage IIIA fallopian tube cancer|stage iiia fallopian tube cancer
5233673|NCT00693342|stage IIIB fallopian tube cancer|stage iiib fallopian tube cancer
5233674|NCT00693342|stage IIIC fallopian tube cancer|stage iiic fallopian tube cancer
5233675|NCT00693342|stage IV fallopian tube cancer|stage iv fallopian tube cancer
5233676|NCT00693342|stage IA ovarian epithelial cancer|stage ia ovarian epithelial cancer
5233677|NCT00693342|stage IB ovarian epithelial cancer|stage ib ovarian epithelial cancer
5233678|NCT00693342|stage IC ovarian epithelial cancer|stage ic ovarian epithelial cancer
5233679|NCT00693342|stage IIA ovarian epithelial cancer|stage iia ovarian epithelial cancer
5233680|NCT00693342|stage IIB ovarian epithelial cancer|stage iib ovarian epithelial cancer
5233681|NCT00693342|stage IIC ovarian epithelial cancer|stage iic ovarian epithelial cancer
5233682|NCT00693342|stage IIIA ovarian epithelial cancer|stage iiia ovarian epithelial cancer
5233683|NCT00693342|stage IIIB ovarian epithelial cancer|stage iiib ovarian epithelial cancer
5233684|NCT00693342|stage IIIC ovarian epithelial cancer|stage iiic ovarian epithelial cancer
5233685|NCT00693342|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5233686|NCT00693329|Contrast Induced Nephrophathy (CIN)|contrast induced nephrophathy (cin)
5233687|NCT00693329|Kidney|kidney
5233688|NCT00693329|NGAL|ngal
5233689|NCT00693316|Healthy volunteer study|healthy volunteer study
5233690|NCT00693303|single subject|single subject
5233691|NCT00693303|quantitative|quantitative
5233692|NCT00693290|Colonoscopy|colonoscopy
5233693|NCT00693290|Colorectal screening|colorectal screening
5233694|NCT00693290|Colon preparation|colon preparation
5233695|NCT00693277|none - entry made in error|none - entry made in error
5233696|NCT00693264|Human Volunteers|human volunteers
5233697|NCT00693264|Hoodia|hoodia
5233698|NCT00693264|Safety|safety
5233699|NCT00693251|stent|stent
5233700|NCT00693251|bifurcation|bifurcation
5233701|NCT00693251|coronary artery stenosis|coronary artery stenosis
5233702|NCT00693251|balloon angioplasty|balloon angioplasty
5233703|NCT00693238|Prostate Cancer|prostate cancer
5233704|NCT00693238|Proton Radiation|proton radiation
5233705|NCT00693225|Erosive Esophagitis|erosive esophagitis
5233706|NCT00693225|Reflux Esophagitis|reflux esophagitis
5233707|NCT00693225|Gastroesophageal reflux disease|gastroesophageal reflux disease
5233708|NCT00693225|GERD|gerd
5233709|NCT00693225|proton pump inhibitor|proton pump inhibitor
5233710|NCT00693225|omeprazole/sodium bicarbonate|omeprazole/sodium bicarbonate
5233711|NCT00693212|ADHD|adhd
5233712|NCT00693212|Adult|adult
5233713|NCT00693212|crossover|crossover
5233714|NCT00693212|randomized|randomized
5233715|NCT00693212|Long-term|long-term
5233716|NCT00693212|Open-label|open-label
5233717|NCT00693212|methylphenidate|methylphenidate
5233718|NCT00693212|Social adjustment|social adjustment
5233719|NCT00693199|Amlodipine|amlodipine
5233720|NCT00693199|Terazosin|terazosin
5233721|NCT00693199|Lower Urinary Tract Symptoms (LUTS)|lower urinary tract symptoms (luts)
5233722|NCT00693199|Essential hypertension|essential hypertension
5233723|NCT00693199|International Prostate Symptom Score (IPSS)|international prostate symptom score (ipss)
5233724|NCT00693199|Quality Of Life (QOL)|quality of life (qol)
5233725|NCT00693173|anal|anal
5233726|NCT00693173|cancer|cancer
5233727|NCT00693173|rectal|rectal
5233728|NCT00693173|IMRT|imrt
5233729|NCT00693173|genital|genital
5233730|NCT00693173|sparing|sparing
5233731|NCT00693173|drop|drop
5233732|NCT00693173|technique|technique
5233733|NCT00693160|healthy volunteers|healthy volunteers
5233734|NCT00693160|analgesia|analgesia
5233735|NCT00693160|pain|pain
5233736|NCT00693160|Healthy subjects|healthy subjects
5233737|NCT00693147|Goiter [C19.874.283]|goiter [c19.874.283]
5233738|NCT00693147|Thyroid Neoplasms [C19.874.788]|thyroid neoplasms [c19.874.788]
5233739|NCT00693121|Traumatic Brain Injury|traumatic brain injury
5233740|NCT00693121|Posttraumatic Confusional State|posttraumatic confusional state
5233741|NCT00693121|Delirium|delirium
5233742|NCT00693121|Amantadine|amantadine
5233743|NCT00693121|Clinical trial|clinical trial
5233744|NCT00693108|Poor|poor
5233745|NCT00693108|Response|response
5233746|NCT00693108|Ovarian|ovarian
5233747|NCT00693108|Stimulation|stimulation
5233748|NCT00693108|IVF|ivf
5233749|NCT00693108|Patients|patients
5233750|NCT00693095|Grade IV Glioblastoma Multiforme|grade iv glioblastoma multiforme
5233751|NCT00693095|Newly-diagnosed|newly-diagnosed
5233752|NCT00693095|CMV positive|cmv positive
5233753|NCT00693082|PCOS|pcos
5233754|NCT00693082|flaxseed|flaxseed
5233755|NCT00693069|angioplasty|angioplasty
5233756|NCT00693069|clopidogrel|clopidogrel
5233757|NCT00693069|coronary artery disease|coronary artery disease
5233758|NCT00693069|platelets|platelets
5233759|NCT00693069|Percutaneous coronary intervention|percutaneous coronary intervention
5233760|NCT00693056|Erectile Dysfunctions|erectile dysfunctions
5233761|NCT00693056|ED|ed
5233762|NCT00693043|Pain control|pain control
5233763|NCT00693030|Coronary Artery Disease|coronary artery disease
5233764|NCT00693030|Percutaneous Coronary Interventions|percutaneous coronary interventions
5233765|NCT00693030|Drug-Eluting stents|drug-eluting stents
5233766|NCT00693030|Optical Coherence Tomography|optical coherence tomography
5233767|NCT00693030|Thrombosis|thrombosis
5233768|NCT00693030|Long lesions in native vessel requiring stents in overlap|long lesions in native vessel requiring stents in overlap
5233769|NCT00692991|Microvascular Obstruction|microvascular obstruction
5233770|NCT00692991|Cardiac MRI|cardiac mri
5233771|NCT00692991|Alcohol Ablation|alcohol ablation
5233772|NCT00692991|Diagnostic PCI|diagnostic pci
5233773|NCT00692978|Monodisperse aerosols|monodisperse aerosols
5233774|NCT00692978|Healthy Volunteers|healthy volunteers
5233775|NCT00692978|Asthmatics|asthmatics
5233776|NCT00692978|Pharmacokinetics|pharmacokinetics
5233777|NCT00692978|Randomized|randomized
5233778|NCT00692965|HIV|hiv
5233779|NCT00692965|Sleep Quality|sleep quality
5233780|NCT00692965|Sleep apnea|sleep apnea
5233781|NCT00692965|Berlin Questionnaire|berlin questionnaire
5233782|NCT00692965|Pittsburgh Sleep Quality Index|pittsburgh sleep quality index
5233783|NCT00692952|contraceptive efficacy|contraceptive efficacy
5233784|NCT00692939|Stem cell transplantation|stem cell transplantation
5233786|NCT00692926|ALDHbr|aldhbr
5233787|NCT00692926|Umbilical Cord Blood|umbilical cord blood
5233788|NCT00692926|Transplantation|transplantation
5233789|NCT00692926|Hematological malignancy|hematological malignancy
5233790|NCT00692926|MDS|mds
5233791|NCT00692926|severe aplastic anemia|severe aplastic anemia
5233792|NCT00692926|inborn error of metabolism|inborn error of metabolism
5233793|NCT00692926|congenital marrow failure or congenital immunodeficiency syndrome|congenital marrow failure or congenital immunodeficiency syndrome
5233794|NCT00692926|Hurler's Disease|hurler's disease
5233795|NCT00692926|Tay Sach's|tay sach's
5233796|NCT00692926|PMD|pmd
5233797|NCT00692926|Hunter's Syndrome|hunter's syndrome
5233798|NCT00692926|Krabbe|krabbe
5233799|NCT00692926|MLD|mld
5233800|NCT00692926|ALD|ald
5233801|NCT00692926|ALL|all
5233802|NCT00692926|AML|aml
5233803|NCT00692887|AMD|amd
5233804|NCT00692874|Quality of Life|quality of life
5233805|NCT00692861|Celiac Disease|celiac disease
5233806|NCT00692861|Ataxia|ataxia
5233808|NCT00692861|Health Volunteer|health volunteer
5233809|NCT00692861|HV|hv
5233810|NCT00692848|Procalcitonin|procalcitonin
5233811|NCT00692848|Antibiotic|antibiotic
5233812|NCT00692848|Fever without source|fever without source
5233813|NCT00692848|Fever without focus|fever without focus
5233814|NCT00692848|bacteremia|bacteremia
5233815|NCT00692848|Urinary tract infection|urinary tract infection
5233816|NCT00692835|Goiter [C19.874.283]|goiter [c19.874.283]
5233817|NCT00692835|Thyroid Neoplasms [C19.874.788]|thyroid neoplasms [c19.874.788]
5233818|NCT00692822|Neisseria gonorrheae|neisseria gonorrheae
5233819|NCT00692822|Antimicrobial Susceptibility|antimicrobial susceptibility
5233820|NCT00692822|Quinolone Resistance|quinolone resistance
5233821|NCT00692822|Sexually transmitted diseases|sexually transmitted diseases
5233822|NCT00692809|Latent tuberculosis infection|latent tuberculosis infection
5233823|NCT00692809|Human immunodeficiency virus|human immunodeficiency virus
5233824|NCT00692809|Tuberculosis|tuberculosis
5233825|NCT00692809|Natural Killer T Cells|natural killer t cells
5233826|NCT00692809|Invariant Natural Killer T Cells|invariant natural killer t cells
5233827|NCT00692809|Regulatory T cells|regulatory t cells
5233828|NCT00692809|Interferon-gamma|interferon-gamma
5233829|NCT00692796|Pulmonary fibrosis|pulmonary fibrosis
5233830|NCT00692796|Pulmonary rehabilitation|pulmonary rehabilitation
5233831|NCT00692796|Dyspnea|dyspnea
5233832|NCT00692796|Quality of life|quality of life
5233833|NCT00692783|candida|candida
5233834|NCT00692783|dubliniensis|dubliniensis
5233835|NCT00692783|candidiasis|candidiasis
5233836|NCT00692783|HIV|hiv
5233837|NCT00692783|AIDS|aids
5233838|NCT00692783|azole resistance.|azole resistance.
5233839|NCT00692770|Hepatocellular carcinoma|hepatocellular carcinoma
5233840|NCT00692770|Sorafenib|sorafenib
5233841|NCT00692770|Adjuvant|adjuvant
5233842|NCT00692770|Surgical resection|surgical resection
5233843|NCT00692770|Ablation|ablation
5233844|NCT00692770|Nexavar|nexavar
5233845|NCT00692770|Adjuvant therapy|adjuvant therapy
5233846|NCT00692770|Liver cancer|liver cancer
5233847|NCT00692770|HCC|hcc
5233848|NCT00692770|STORM|storm
5233849|NCT00692757|Hypochlorous Acid|hypochlorous acid
5233850|NCT00692757|Colony forming units|colony forming units
5233851|NCT00692757|surgical site infection|surgical site infection
5233852|NCT00692757|nosocomial infection|nosocomial infection
5233853|NCT00692757|bacterial bioburden|bacterial bioburden
5233854|NCT00692757|wound healing|wound healing
5233855|NCT00692744|Subarachnoid hemorrhage|subarachnoid hemorrhage
5233856|NCT00692744|Cerebral aneurysm|cerebral aneurysm
5233857|NCT00692744|Elderly|elderly
5233858|NCT00692731|green tea,|green tea,
5233859|NCT00692731|polyphenols,|polyphenols,
5233860|NCT00692731|weight loss,|weight loss,
5233861|NCT00692731|body fat|body fat
5233862|NCT00692705|Alzheimer´s Disease|alzheimer´s disease
5233863|NCT00692705|amyloid deposits|amyloid deposits
5233864|NCT00692705|Positron Emission Tomography|positron emission tomography
5233865|NCT00692705|phase I|phase i
5233866|NCT00692653|Localized prostate cancer|localized prostate cancer
5233867|NCT00692653|Treatment decision making|treatment decision making
5233868|NCT00692653|Tailored decision aid|tailored decision aid
5233869|NCT00692640|Cancer|cancer
5233870|NCT00692640|Solid Tumors|solid tumors
5233871|NCT00692640|NSCLC|nsclc
5233872|NCT00692627|Falciparum|falciparum
5233873|NCT00692627|malaria|malaria
5233874|NCT00692627|volume|volume
5233875|NCT00692627|haemodynamics|haemodynamics
5233876|NCT00692601|Acute Exercise protocol|acute exercise protocol
5233877|NCT00692601|Crossover design|crossover design
5233878|NCT00692601|Oxygen consumption (VO2)|oxygen consumption (vo2)
5233879|NCT00692601|Respiratory Exchange Ratio (RER)|respiratory exchange ratio (rer)
5233880|NCT00692601|Adrenergic System Agonism|adrenergic system agonism
5233881|NCT00692601|Capsiate Natura|capsiate natura
5233882|NCT00692601|Young|young
5233883|NCT00692601|Male|male
5233884|NCT00692588|Alzheimer's Disease|alzheimer's disease
5233885|NCT00692588|Magnetic Resonance Imaging|magnetic resonance imaging
5233886|NCT00692588|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
5233887|NCT00692588|Diffusion Tensor Imaging|diffusion tensor imaging
5233888|NCT00692588|Susceptibility Weighted Imaging|susceptibility weighted imaging
5233889|NCT00692588|Doxycycline|doxycycline
5233890|NCT00692588|Rifampicin|rifampicin
5233891|NCT00692575|Brain Injuries, Traumatic|brain injuries, traumatic
5233892|NCT00692575|Caregivers|caregivers
5233893|NCT00692562|Islets of Langerhans Transplantation|islets of langerhans transplantation
5233894|NCT00692562|Kidney Transplantation|kidney transplantation
5233895|NCT00692562|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
5233896|NCT00692562|alemtuzumab|alemtuzumab
5233897|NCT00692549|ultrasound|ultrasound
5233898|NCT00692549|iv access|iv access
5233899|NCT00692549|Patients with difficult iv access in emergency departments.|patients with difficult iv access in emergency departments.
5233900|NCT00692536|Obesity|obesity
5233901|NCT00692536|Postmenopausal|postmenopausal
5233902|NCT00692536|Diet intervention|diet intervention
5233903|NCT00692523|Stroke|stroke
5233904|NCT00692523|rehabilitation|rehabilitation
5233905|NCT00692523|Nintendo Wii|nintendo wii
5233906|NCT00692510|AZD3480|azd3480
5233907|NCT00692510|Cocktail|cocktail
5233908|NCT00692510|caffeine|caffeine
5233909|NCT00692510|bupropion|bupropion
5233910|NCT00692510|omeprazole|omeprazole
5233911|NCT00692510|midazolam|midazolam
5233912|NCT00692510|rosiglitazone|rosiglitazone
5233913|NCT00692510|metabolism|metabolism
5233914|NCT00692510|Drug Drug Interaction|drug drug interaction
5233915|NCT00692497|One-Stop|one-stop
5233916|NCT00692497|Public Health Research|public health research
5233917|NCT00692497|Delivery of Health Care/*standards|delivery of health care/*standards
5233918|NCT00692497|Evaluation Studies|evaluation studies
5233919|NCT00692497|Referral|referral
5233920|NCT00692497|Surgery, Outpatient|surgery, outpatient
5233921|NCT00692497|Surgery, Day|surgery, day
5233922|NCT00692497|Telemedicine|telemedicine
5233923|NCT00692484|Antimicrobial|antimicrobial
5233924|NCT00692484|Antisepsis|antisepsis
5233925|NCT00692484|Topical antisepsis|topical antisepsis
5233926|NCT00692471|Sleep|sleep
5233927|NCT00692471|Orthostatic tachycardia|orthostatic tachycardia
5233928|NCT00692471|POTS|pots
5233929|NCT00692445|depression|depression
5233930|NCT00692432|Macrophage Migration Inhibitory Factor|macrophage migration inhibitory factor
5233931|NCT00692432|MIF|mif
5233932|NCT00692432|Cardiopulmonary bypass|cardiopulmonary bypass
5233933|NCT00692432|CPB|cpb
5233934|NCT00692432|inflammation|inflammation
5233935|NCT00692432|inflammatory marker|inflammatory marker
5233936|NCT00692432|myocardial depression|myocardial depression
5233937|NCT00692432|myocardial depressant factor|myocardial depressant factor
5233938|NCT00692419|pain|pain
5233939|NCT00692419|sexual dysfunction|sexual dysfunction
5233940|NCT00692419|depression|depression
5233941|NCT00692419|symptoms|symptoms
5233942|NCT00692380|gated IMRT|gated imrt
5233943|NCT00692367|Body fat|body fat
5233944|NCT00692367|Exercise|exercise
5233945|NCT00692367|Fatty acids|fatty acids
5233946|NCT00692367|Impaired glucose tolerance|impaired glucose tolerance
5233947|NCT00692367|Insulin resistance|insulin resistance
5233948|NCT00692367|Insulin Sensitivity|insulin sensitivity
5233949|NCT00692367|Metabolic syndrome|metabolic syndrome
5233950|NCT00692367|Obesity|obesity
5233951|NCT00692367|Physical activity|physical activity
5233952|NCT00692367|Weight Loss|weight loss
5233953|NCT00692354|Advanced|advanced
5233954|NCT00692354|Solid|solid
5233955|NCT00692354|Tumour|tumour
5233956|NCT00692354|Tumor|tumor
5233957|NCT00692354|Oral|oral
5233958|NCT00692341|hepatic impairment|hepatic impairment
5233959|NCT00692328|fatigue; TMS; MEP|fatigue; tms; mep
5233960|NCT00692315|glutathione|glutathione
5233961|NCT00692315|methionine|methionine
5233962|NCT00692315|folinic acid|folinic acid
5233963|NCT00692315|redox|redox
5233964|NCT00692315|oxidative stress|oxidative stress
5233965|NCT00692315|behavior|behavior
5233966|NCT00692302|Suicide Attempts|suicide attempts
5233967|NCT00692302|Adolescents|adolescents
5233968|NCT00692302|Suicidal|suicidal
5233969|NCT00692302|Adolescent Suicide Attempters|adolescent suicide attempters
5233970|NCT00692289|Quality of Life|quality of life
5233971|NCT00692263|Healthy subjects|healthy subjects
5233972|NCT00692250|Familial Hypercholesterolemia|familial hypercholesterolemia
5233973|NCT00692237|Type 2 diabetes mellitus|type 2 diabetes mellitus
5233974|NCT00692237|Endothelial dysfunction|endothelial dysfunction
5233975|NCT00692237|Sildenafil|sildenafil
5233976|NCT00692224|neonatal jaundice|neonatal jaundice
5233977|NCT00692224|zinc|zinc
5233978|NCT00692224|hyperbilirubinemia|hyperbilirubinemia
5233979|NCT00692224|enterohepatic circulation|enterohepatic circulation
5233980|NCT00692224|bilirubin|bilirubin
5233981|NCT00692211|screening|screening
5233982|NCT00692198|COPD|copd
5233983|NCT00692185|Anorexia Nervosa|anorexia nervosa
5233984|NCT00692172|psoriasis|psoriasis
5233985|NCT00692172|alefacept|alefacept
5233986|NCT00692172|intramuscular|intramuscular
5233987|NCT00692159|TRC102|trc102
5233988|NCT00692159|Methoxyamine HCL|methoxyamine hcl
5233989|NCT00692159|Pemetrexed|pemetrexed
5233990|NCT00692159|Alimta|alimta
5233991|NCT00692159|Tracon|tracon
5233992|NCT00692159|Phase 1|phase 1
5233993|NCT00692159|Cancer|cancer
5233994|NCT00692159|BER|ber
5233995|NCT00692159|Base Excision Repair|base excision repair
5233996|NCT00692159|Small Molecule|small molecule
5233997|NCT00692159|Anti-folate|anti-folate
5233998|NCT00692159|Solid Tumor|solid tumor
5233999|NCT00692159|Neoplastic Processes|neoplastic processes
5234000|NCT00692159|Pathologic Processes|pathologic processes
5234001|NCT00692159|Pathological Conditions, Signs and Symptoms|pathological conditions, signs and symptoms
5234002|NCT00692146|Proof of Mechanism|proof of mechanism
5234003|NCT00692146|Capsaicin evoked pain|capsaicin evoked pain
5234004|NCT00692133|schizophrenia|schizophrenia
5234005|NCT00692133|bipolar disorder|bipolar disorder
5234006|NCT00692133|antipsychotic treatment|antipsychotic treatment
5234007|NCT00692133|patients´preferences|patients´preferences
5234008|NCT00692107|Radiotherapy|radiotherapy
5234009|NCT00692107|Dose|dose
5234010|NCT00692094|melatonin|melatonin
5234011|NCT00692094|circadian rhythms|circadian rhythms
5234012|NCT00692094|sleep|sleep
5234013|NCT00692081|adolescents|adolescents
5234014|NCT00692081|borderline intellectual functioning|borderline intellectual functioning
5234015|NCT00692081|social competence training|social competence training
5234016|NCT00692081|vocational training|vocational training
5234017|NCT00692081|group intervention|group intervention
5234018|NCT00692081|cognitive behavioral therapy|cognitive behavioral therapy
5234019|NCT00692081|Adolescents with borderline intellectual functioning|adolescents with borderline intellectual functioning
5234020|NCT00692068|residual renal function|residual renal function
5234021|NCT00692068|oxidative stress|oxidative stress
5234022|NCT00692068|carbonyl stress|carbonyl stress
5234023|NCT00692068|peritoneal dialysis|peritoneal dialysis
5234024|NCT00692042|Safety|safety
5234025|NCT00692042|tolerability|tolerability
5234026|NCT00692029|Normal|normal
5234027|NCT00692029|Healthy Volunteers|healthy volunteers
5234028|NCT00692016|Naproxen Sodium|naproxen sodium
5234029|NCT00691990|Goiter [C19.874.283]|goiter [c19.874.283]
5234030|NCT00691990|Thyroid Neoplasms [C19.874.788]|thyroid neoplasms [c19.874.788]
5234031|NCT00691977|Radiation Therapy|radiation therapy
5234032|NCT00691938|LBH589|lbh589
5234033|NCT00691938|Decitabine|decitabine
5234034|NCT00691938|panobinostat|panobinostat
5234035|NCT00691938|histone deacetylase|histone deacetylase
5234036|NCT00691938|methylation|methylation
5234037|NCT00691938|hypomethylation|hypomethylation
5234038|NCT00691925|refractive surgery|refractive surgery
5234039|NCT00691886|sedation|sedation
5234040|NCT00691873|Allergic|allergic
5234041|NCT00691873|Asthma|asthma
5234042|NCT00691873|Immunotherapy|immunotherapy
5234043|NCT00691860|Parastomal hernias|parastomal hernias
5234044|NCT00691860|Tolerance of lightweight meshes|tolerance of lightweight meshes
5234045|NCT00691860|Paracolostomy hernias|paracolostomy hernias
5234046|NCT00691860|Peristomal hernias|peristomal hernias
5234047|NCT00691847|Refractive surgery|refractive surgery
5234048|NCT00691834|Magnetic resonance Imaging|magnetic resonance imaging
5234049|NCT00691821|Negative-Pressure Wound Therapy|negative-pressure wound therapy
5234050|NCT00691821|Bandages|bandages
5234051|NCT00691821|Community Health Services|community health services
5234052|NCT00691795|Analgesia|analgesia
5234053|NCT00691795|Epidural|epidural
5234054|NCT00691795|Pregnancy|pregnancy
5234055|NCT00691795|Labor|labor
5234056|NCT00691795|Clonidine|clonidine
5234057|NCT00691795|Fentanyl|fentanyl
5234058|NCT00691795|Bupivacaine|bupivacaine
5234059|NCT00691795|Childbirth|childbirth
5234060|NCT00691782|African American females between the ages of 21 and 60|african american females between the ages of 21 and 60
5234061|NCT00691769|alopecia|alopecia
5234062|NCT00691769|lupus|lupus
5234063|NCT00691756|renal failure|renal failure
5234064|NCT00691756|thoracoabdominal aortic aneurysm repair|thoracoabdominal aortic aneurysm repair
5234065|NCT00691756|cold crystalloid|cold crystalloid
5234066|NCT00691756|cold blood|cold blood
5234067|NCT00691756|renal perfusion|renal perfusion
5234068|NCT00691743|Upper GI Symptoms|upper gi symptoms
5234069|NCT00691743|GERD|gerd
5234070|NCT00691743|NSAIDs|nsaids
5234071|NCT00691717|Anecortave acetate|anecortave acetate
5234072|NCT00691717|Open-angle glaucoma|open-angle glaucoma
5234073|NCT00691717|IOP|iop
5234074|NCT00691717|OHT|oht
5234075|NCT00691704|Multiple Myeloma|multiple myeloma
5234076|NCT00691691|Liver malignancy|liver malignancy
5234077|NCT00691691|Stereotactic Body Radiation Therapy|stereotactic body radiation therapy
5234078|NCT00691691|Efficacy of SBRT in liver tumors|efficacy of sbrt in liver tumors
5234079|NCT00691691|Hepatic toxicity with SBRT|hepatic toxicity with sbrt
5234080|NCT00691678|breast cancer|breast cancer
5234081|NCT00691678|aromatase inhibitor|aromatase inhibitor
5234082|NCT00691678|supportive care|supportive care
5234083|NCT00691665|Rhinitis|rhinitis
5234084|NCT00691665|Seasonal Allergic Rhinitis|seasonal allergic rhinitis
5234085|NCT00691665|allergies|allergies
5234086|NCT00691652|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5234087|NCT00691652|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5234088|NCT00691652|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5234089|NCT00691652|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5234090|NCT00691652|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5234091|NCT00691652|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5234092|NCT00691652|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5234093|NCT00691652|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
5234094|NCT00691652|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5234095|NCT00691652|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5234096|NCT00691652|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5234097|NCT00691652|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5234098|NCT00691652|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5234099|NCT00691652|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5234100|NCT00691652|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5234101|NCT00691652|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5234102|NCT00691652|cutaneous B-cell non-Hodgkin lymphoma|cutaneous b-cell non-hodgkin lymphoma
5234103|NCT00691639|Open-angle glaucoma|open-angle glaucoma
5234104|NCT00691639|IOP|iop
5234105|NCT00691626|posttraumatic stress|posttraumatic stress
5234106|NCT00691626|nightmares|nightmares
5234107|NCT00691626|sleep|sleep
5234108|NCT00691626|psychotherapy|psychotherapy
5234109|NCT00691626|imagery rehearsal|imagery rehearsal
5234110|NCT00691626|insomnia|insomnia
5234111|NCT00691626|behavioral treatment|behavioral treatment
5234112|NCT00691626|veterans|veterans
5234113|NCT00691626|Operation Iraqi Freedom|operation iraqi freedom
5234114|NCT00691626|Operation Enduring Freedom|operation enduring freedom
5234115|NCT00691613|Apoptosis|apoptosis
5234116|NCT00691613|Annexin|annexin
5234117|NCT00691613|Hypoxia|hypoxia
5234118|NCT00691613|Ischemia-Reperfusion Injury|ischemia-reperfusion injury
5234119|NCT00691600|abscess|abscess
5234120|NCT00691600|Abscesses in the pediatric emergency population|abscesses in the pediatric emergency population
5234121|NCT00691587|mechanical ventilation|mechanical ventilation
5234122|NCT00691587|mechanically ventilated|mechanically ventilated
5234123|NCT00691587|Pseudomonas aeruginosa|pseudomonas aeruginosa
5234124|NCT00691587|ventilator associated pneumonia|ventilator associated pneumonia
5234125|NCT00691574|Smith-Magenis Syndrome|smith-magenis syndrome
5234126|NCT00691574|melatonin|melatonin
5234127|NCT00691574|circadian rhythm|circadian rhythm
5234128|NCT00691574|sleep|sleep
5234129|NCT00691561|HIV Prevention|hiv prevention
5234130|NCT00691561|African American|african american
5234131|NCT00691561|Black|black
5234132|NCT00691561|gay|gay
5234133|NCT00691561|Men who have sex men|men who have sex men
5234134|NCT00691561|HIV Seronegativity|hiv seronegativity
5234135|NCT00691548|Stage IV cancer|stage iv cancer
5234136|NCT00691522|PERITUMORAL BRAIN EDEMA|peritumoral brain edema
5234137|NCT00691522|PRIMARY MALIGNANT BRAIN TUMORS|primary malignant brain tumors
5234138|NCT00691522|METASTATIC BRAIN TUMORS|metastatic brain tumors
5234139|NCT00691509|breast cancer|breast cancer
5234140|NCT00691496|HIV Prevention|hiv prevention
5234141|NCT00691496|African-American|african-american
5234142|NCT00691496|gay|gay
5234143|NCT00691496|bisexual|bisexual
5234144|NCT00691496|intervention trial|intervention trial
5234145|NCT00691496|HIV Seronegativity|hiv seronegativity
5234146|NCT00691483|smoking cessation|smoking cessation
5234147|NCT00691483|smoking treatment|smoking treatment
5234148|NCT00691483|patient self-selected quit date|patient self-selected quit date
5234149|NCT00691470|Anticoagulation|anticoagulation
5234150|NCT00691470|Vitamin K-dependent clotting factor inhibitor|vitamin k-dependent clotting factor inhibitor
5234151|NCT00691470|Coumadin|coumadin
5234152|NCT00691470|Warfarin|warfarin
5234153|NCT00691470|Atrial fibrillation|atrial fibrillation
5234154|NCT00691470|Prosthetic heart valve|prosthetic heart valve
5234155|NCT00691470|Venous thromboembolic disease|venous thromboembolic disease
5234156|NCT00691470|Myocardial infarction or cardiomyopathy|myocardial infarction or cardiomyopathy
5234157|NCT00691470|Patients with one or more of the following indications for chronic warfarin anticoagulation:|patients with one or more of the following indications for chronic warfarin anticoagulation:
5234158|NCT00691470|Atrial fibrillation (paroxysmal, persistent or permanent, not due to a reversible cause, documented by ECG) or atrial flutter;|atrial fibrillation (paroxysmal, persistent or permanent, not due to a reversible cause, documented by ecg) or atrial flutter;
5234159|NCT00691470|A prosthetic heart valve in the aortic or mitral position that requires chronic anticoagulation;|a prosthetic heart valve in the aortic or mitral position that requires chronic anticoagulation;
5234160|NCT00691470|A history of venous thromboembolic disease (DVT and/or PE) requiring long term anticoagulation (> 6 months);|a history of venous thromboembolic disease (dvt and/or pe) requiring long term anticoagulation (> 6 months);
5234161|NCT00691470|A history of myocardial infarction or cardiomyopathy requiring anticoagulation.|a history of myocardial infarction or cardiomyopathy requiring anticoagulation.
5234162|NCT00691470|Currently receiving chronic warfarin therapy for another indication not listed, with Sponsor approval.|currently receiving chronic warfarin therapy for another indication not listed, with sponsor approval.
5234163|NCT00691457|Contact lens|contact lens
5234164|NCT00691457|solution|solution
5234165|NCT00691457|confocal microscope|confocal microscope
5234166|NCT00691444|melatonin|melatonin
5234167|NCT00691444|circadian rhythms|circadian rhythms
5234168|NCT00691444|sleep|sleep
5234169|NCT00691418|perinatal|perinatal
5234170|NCT00691418|premature|premature
5234171|NCT00691418|pregnancy|pregnancy
5234172|NCT00691418|gestation|gestation
5234173|NCT00691405|Arformoterol|arformoterol
5234174|NCT00691405|(R,R)-formoterol|(r,r)-formoterol
5234175|NCT00691392|Multi-Drug Resistant Tuberculosis|multi-drug resistant tuberculosis
5234176|NCT00691392|Extensively Drug Resistant Tuberculosis|extensively drug resistant tuberculosis
5234177|NCT00691392|MDR TB|mdr tb
5234178|NCT00691392|XDR TB|xdr tb
5234179|NCT00691392|MDR|mdr
5234180|NCT00691392|XDR|xdr
5234181|NCT00691379|Breast cancer|breast cancer
5234182|NCT00691379|Triple negative|triple negative
5234183|NCT00691379|Chemotherapy|chemotherapy
5234184|NCT00691379|Anti-angiogenesis therapy|anti-angiogenesis therapy
5234185|NCT00691353|Bipolar Disorder|bipolar disorder
5234186|NCT00691353|antipsychotics|antipsychotics
5234187|NCT00691353|social functioning|social functioning
5234188|NCT00691353|mood stabilizers|mood stabilizers
5234189|NCT00691353|Bipolar Disorder Type I|bipolar disorder type i
5234190|NCT00691353|atypical antipsychotics|atypical antipsychotics
5234191|NCT00691353|monotherapy|monotherapy
5234192|NCT00691353|cotherapy|cotherapy
5234193|NCT00691340|POAG|poag
5234194|NCT00691340|Alzheimer's disease|alzheimer's disease
5234195|NCT00691340|cellular proteome|cellular proteome
5234196|NCT00691340|human leucocytes|human leucocytes
5234197|NCT00691340|vasospasm|vasospasm
5234198|NCT00691340|Healthy subjects|healthy subjects
5234199|NCT00691327|Revision of augmentation or reconstruction|revision of augmentation or reconstruction
5234200|NCT00691314|Stroke|stroke
5234201|NCT00691314|Transietn Ischemic Attack|transietn ischemic attack
5234202|NCT00691314|Stents|stents
5234203|NCT00691314|Stenosis|stenosis
5234204|NCT00691301|cervical squamous cell carcinoma|cervical squamous cell carcinoma
5234205|NCT00691301|recurrent cervical cancer|recurrent cervical cancer
5234206|NCT00691301|stage III cervical cancer|stage iii cervical cancer
5234207|NCT00691301|stage IVA cervical cancer|stage iva cervical cancer
5234208|NCT00691301|stage IVB cervical cancer|stage ivb cervical cancer
5234209|NCT00691288|omega-3 fatty acid|omega-3 fatty acid
5234210|NCT00691288|hypertriglyceridemia|hypertriglyceridemia
5234211|NCT00691288|HIV|hiv
5234212|NCT00691288|pediatric|pediatric
5234213|NCT00691288|HAART|haart
5234214|NCT00691275|dehydration|dehydration
5234215|NCT00691275|acute gastroenteritis|acute gastroenteritis
5234216|NCT00691275|ondansetron|ondansetron
5234217|NCT00691275|rehydration|rehydration
5234218|NCT00691262|Atopic dermatitis|atopic dermatitis
5234219|NCT00691262|Prograf|prograf
5234220|NCT00691262|Tacrolimus|tacrolimus
5234221|NCT00691262|FK506|fk506
5234222|NCT00691262|Tacrolimus ointment|tacrolimus ointment
5234223|NCT00691249|Diabetes|diabetes
5234224|NCT00691249|Diet|diet
5234225|NCT00691249|Fiber|fiber
5234226|NCT00691236|osteosarcoma|osteosarcoma
5234227|NCT00691236|zoledronic acid|zoledronic acid
5234228|NCT00691236|bisphosphonates|bisphosphonates
5234229|NCT00691236|adjuvant to chemotherapy|adjuvant to chemotherapy
5234230|NCT00691223|Focal dermal hypoplasia|focal dermal hypoplasia
5234231|NCT00691223|Goltz syndrome|goltz syndrome
5234232|NCT00691223|X linked disorders|x linked disorders
5234233|NCT00691223|PORCN|porcn
5234234|NCT00691223|Wnt signaling|wnt signaling
5234235|NCT00691210|Hodgkin's Disease|hodgkin's disease
5234236|NCT00691210|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
5234237|NCT00691184|Onychomycosis, Toenail fungal infection, Terbinafine HCl, Pharmacokinetics|onychomycosis, toenail fungal infection, terbinafine hcl, pharmacokinetics
5234238|NCT00691171|gastroesophageal reflux disease|gastroesophageal reflux disease
5234239|NCT00691171|GERD|gerd
5234240|NCT00691171|nonsteroidal anti-inflammatory drugs|nonsteroidal anti-inflammatory drugs
5234241|NCT00691171|peptic ulcer|peptic ulcer
5234242|NCT00691171|Diagnosed GERD|diagnosed gerd
5234243|NCT00691171|Atypical GERD symptoms|atypical gerd symptoms
5234244|NCT00691171|chronic NSAID therapy|chronic nsaid therapy
5234245|NCT00691171|Risk for ulcer|risk for ulcer
5234246|NCT00691145|Atopic dermatitis|atopic dermatitis
5234247|NCT00691145|Tacrolimus ointment|tacrolimus ointment
5234248|NCT00691132|non-small cell lung cancer|non-small cell lung cancer
5234249|NCT00691132|small cell lung cancer|small cell lung cancer
5234250|NCT00691132|tobacco use disorder|tobacco use disorder
5234251|NCT00691119|breast cancer|breast cancer
5234252|NCT00691119|radiation|radiation
5234253|NCT00691119|Relaxation and Visualization Therapy|relaxation and visualization therapy
5234254|NCT00691119|relaxation|relaxation
5234255|NCT00691119|visualization|visualization
5234256|NCT00691119|RVT|rvt
5234257|NCT00691119|complementary and alternative medicine|complementary and alternative medicine
5234258|NCT00691119|CAM|cam
5234259|NCT00691119|alternative medicine|alternative medicine
5234260|NCT00691093|observational|observational
5234261|NCT00691080|Melatonin|melatonin
5234262|NCT00691080|Sleep|sleep
5234263|NCT00691080|Autism|autism
5234264|NCT00691080|ASD|asd
5234265|NCT00691080|Sleep problems in children with autism spectrum disorder|sleep problems in children with autism spectrum disorder
5234266|NCT00691054|recurrent pancreatic cancer|recurrent pancreatic cancer
5234267|NCT00691054|stage III pancreatic cancer|stage iii pancreatic cancer
5234268|NCT00691054|stage IV pancreatic cancer|stage iv pancreatic cancer
5234269|NCT00691041|HIV Prevention|hiv prevention
5234270|NCT00691041|Men who have sex with men|men who have sex with men
5234271|NCT00691041|African American|african american
5234272|NCT00691041|Unprotected sex|unprotected sex
5234273|NCT00691041|HIV Seronegativity|hiv seronegativity
5234274|NCT00691028|Rheumatoid Arthritis|rheumatoid arthritis
5234275|NCT00691028|RA|ra
5234276|NCT00691028|Infliximab|infliximab
5234277|NCT00691028|TA-650|ta-650
5234278|NCT00691028|Remicade|remicade
5234279|NCT00691015|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5234280|NCT00691015|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5234281|NCT00691015|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5234282|NCT00691015|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5234283|NCT00691015|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5234445|NCT00690586|AVP|avp
5234284|NCT00691015|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5234285|NCT00691015|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5234286|NCT00691015|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5234287|NCT00691015|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5234288|NCT00691015|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5234289|NCT00691015|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5234290|NCT00691015|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5234291|NCT00691015|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5234292|NCT00691015|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5234293|NCT00691015|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5234294|NCT00691015|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5234295|NCT00691015|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5234296|NCT00691015|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5234297|NCT00691015|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5234298|NCT00691015|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5234299|NCT00691015|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5234300|NCT00691015|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5234301|NCT00691015|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5234302|NCT00691015|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5234303|NCT00691015|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5234304|NCT00691015|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5234305|NCT00691015|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5234306|NCT00691015|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5234307|NCT00691015|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5234308|NCT00691015|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
5234309|NCT00691015|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5234310|NCT00691015|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
5234311|NCT00691015|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
5234312|NCT00691015|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
5234313|NCT00691015|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
5234314|NCT00691015|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5234315|NCT00691015|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5234316|NCT00691015|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5234317|NCT00691015|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5234318|NCT00691015|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
5234319|NCT00691015|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
5234320|NCT00691015|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5234321|NCT00691015|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5234322|NCT00691015|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5234323|NCT00691015|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5234324|NCT00691015|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5234325|NCT00691015|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5234326|NCT00691015|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5234327|NCT00691015|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5234328|NCT00691015|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5234329|NCT00691015|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5234330|NCT00691015|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5234331|NCT00691015|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5234332|NCT00691015|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5234333|NCT00691015|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5234334|NCT00691015|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5234335|NCT00691015|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
5234336|NCT00691015|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5234337|NCT00691015|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5234338|NCT00691015|stage I multiple myeloma|stage i multiple myeloma
5234339|NCT00691015|stage II multiple myeloma|stage ii multiple myeloma
5234340|NCT00691015|stage III multiple myeloma|stage iii multiple myeloma
5234341|NCT00691015|primary myelofibrosis|primary myelofibrosis
5234342|NCT00691015|atypical chronic myeloid leukemia, BCR-ABL negative|atypical chronic myeloid leukemia, bcr-abl negative
5234343|NCT00691015|chronic eosinophilic leukemia|chronic eosinophilic leukemia
5234344|NCT00691015|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5234446|NCT00690586|ANP|anp
5234345|NCT00691015|chronic neutrophilic leukemia|chronic neutrophilic leukemia
5234346|NCT00690989|Headache|headache
5234347|NCT00690989|Adherence|adherence
5234348|NCT00690989|Followup|followup
5234349|NCT00690976|HIV Seronegativity|hiv seronegativity
5234350|NCT00690976|HIV risk behavior|hiv risk behavior
5234351|NCT00690976|Unprotected sex|unprotected sex
5234352|NCT00690976|men who have sex with men|men who have sex with men
5234353|NCT00690976|gay|gay
5234354|NCT00690976|Latino|latino
5234355|NCT00690976|Unsafe Sex|unsafe sex
5234356|NCT00690963|Radiotherapy|radiotherapy
5234357|NCT00690963|Intensity-Modulated|intensity-modulated
5234358|NCT00690963|Dose Fractionation|dose fractionation
5234359|NCT00690950|BPH|bph
5234360|NCT00690937|hypercholesterolemia, bile acid sequestrant, LDL-cholesterol|hypercholesterolemia, bile acid sequestrant, ldl-cholesterol
5234361|NCT00690924|lung cancer|lung cancer
5234362|NCT00690924|tobacco use disorder|tobacco use disorder
5234363|NCT00690924|squamous lung dysplasia|squamous lung dysplasia
5234364|NCT00690885|chronic cough|chronic cough
5234365|NCT00690885|COPD|copd
5234366|NCT00690885|IPF|ipf
5234367|NCT00690885|interferon alpha|interferon alpha
5234368|NCT00690872|recurrent lymphoepithelioma of the nasopharynx|recurrent lymphoepithelioma of the nasopharynx
5234369|NCT00690872|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
5234370|NCT00690872|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
5234371|NCT00690872|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
5234372|NCT00690859|Bipolar disorders|bipolar disorders
5234373|NCT00690859|Predictors of recurrence|predictors of recurrence
5234374|NCT00690820|Cystic Fibrosis|cystic fibrosis
5234375|NCT00690820|Pancreatic Exocrine Insufficiency|pancreatic exocrine insufficiency
5234376|NCT00690807|eczema|eczema
5234377|NCT00690781|casein|casein
5234378|NCT00690781|milk soluble proteins|milk soluble proteins
5234379|NCT00690781|protein feeding pattern|protein feeding pattern
5234380|NCT00690781|overweight|overweight
5234381|NCT00690781|obesity|obesity
5234382|NCT00690781|energy restriction|energy restriction
5234383|NCT00690781|protein metabolism|protein metabolism
5234384|NCT00690781|lean body mass|lean body mass
5234385|NCT00690781|body composition|body composition
5234386|NCT00690781|nitrogen balance|nitrogen balance
5234387|NCT00690781|protein synthesis|protein synthesis
5234388|NCT00690781|proteolysis|proteolysis
5234389|NCT00690781|spread|spread
5234390|NCT00690781|pulse|pulse
5234391|NCT00690768|Diabetic Retinopathy|diabetic retinopathy
5234392|NCT00690768|Retinal detachment|retinal detachment
5234393|NCT00690768|Vitreous Hemorrhage|vitreous hemorrhage
5234394|NCT00690768|Bevacizumab|bevacizumab
5234395|NCT00690768|preoperative|preoperative
5234396|NCT00690768|pars plana vitrectomy|pars plana vitrectomy
5234397|NCT00690755|Diabetic|diabetic
5234398|NCT00690716|Nasal CO2|nasal co2
5234399|NCT00690716|Phase II|phase ii
5234400|NCT00690716|Adaptive|adaptive
5234401|NCT00690716|Randomized|randomized
5234402|NCT00690716|Double-Blind|double-blind
5234403|NCT00690716|Placebo-Controlled|placebo-controlled
5234404|NCT00690716|Multiple-Dose|multiple-dose
5234405|NCT00690716|Multi-center|multi-center
5234406|NCT00690716|Safety|safety
5234407|NCT00690716|Efficacy|efficacy
5234408|NCT00690716|Mild Headache|mild headache
5234409|NCT00690716|Migraineur|migraineur
5234410|NCT00690703|non small cell lung cancer|non small cell lung cancer
5234411|NCT00690703|pulmonary metastases|pulmonary metastases
5234412|NCT00690703|radiofrequency ablation|radiofrequency ablation
5234413|NCT00690690|HIV Seronegativity|hiv seronegativity
5234414|NCT00690690|HIV risk behavior|hiv risk behavior
5234415|NCT00690690|Unprotected sex|unprotected sex
5234416|NCT00690690|men who have sex with men|men who have sex with men
5234417|NCT00690690|gay|gay
5234418|NCT00690690|Latino|latino
5234419|NCT00690690|unsafe sex|unsafe sex
5234420|NCT00690690|high risk sex|high risk sex
5234421|NCT00690677|LBH589|lbh589
5234422|NCT00690677|Metastatic Colorectal Cancer|metastatic colorectal cancer
5234423|NCT00690677|Refractory Colorectal Cancer|refractory colorectal cancer
5234424|NCT00690664|Hair characteristics|hair characteristics
5234425|NCT00690651|ankle|ankle
5234426|NCT00690651|fracture|fracture
5234427|NCT00690651|mobilisation|mobilisation
5234428|NCT00690651|bed rest|bed rest
5234429|NCT00690651|internal fixation|internal fixation
5234430|NCT00690638|dutogliptin|dutogliptin
5234431|NCT00690638|PHX1149|phx1149
5234432|NCT00690638|DPP4 inhibitor|dpp4 inhibitor
5234433|NCT00690625|Myofacial pain|myofacial pain
5234434|NCT00690625|Omega 3 fatty acids|omega 3 fatty acids
5234435|NCT00690612|pediatric|pediatric
5234436|NCT00690612|renal disease|renal disease
5234437|NCT00690612|high blood pressure|high blood pressure
5234438|NCT00690599|Patient satisfaction|patient satisfaction
5234439|NCT00690599|Dentist-Patient relations|dentist-patient relations
5234440|NCT00690599|Answering services|answering services
5234441|NCT00690586|Nephrotic syndrome|nephrotic syndrome
5234442|NCT00690586|Underfill and overfill theory|underfill and overfill theory
5234443|NCT00690586|Steroid resistance|steroid resistance
5234444|NCT00690586|Urine proteomics|urine proteomics
5234447|NCT00690586|Angiotensin II|angiotensin ii
5234448|NCT00690586|Renin and Aldosterone|renin and aldosterone
5234449|NCT00690573|Juvenile Rheumatoid Arthritis|juvenile rheumatoid arthritis
5234450|NCT00690560|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
5234451|NCT00690560|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5234452|NCT00690560|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
5234453|NCT00690560|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5234454|NCT00690560|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5234455|NCT00690547|Functionality|functionality
5234456|NCT00690547|Deliberately|deliberately
5234457|NCT00690547|Activated|activated
5234458|NCT00690547|Quadriceps|quadriceps
5234459|NCT00690547|Femoris|femoris
5234460|NCT00690547|During|during
5234461|NCT00690547|After|after
5234462|NCT00690547|Active|active
5234463|NCT00690547|Extension|extension
5234464|NCT00690534|sarcopenia|sarcopenia
5234465|NCT00690534|aging|aging
5234466|NCT00690534|muscle metabolism|muscle metabolism
5234467|NCT00690521|congestive heart failure|congestive heart failure
5234468|NCT00690521|diuretics|diuretics
5234469|NCT00690521|combination|combination
5234470|NCT00690508|Intubation, Trachea, Sternum,|intubation, trachea, sternum,
5234471|NCT00690508|Tube tip, Tube placement, Tube tip palpation,|tube tip, tube placement, tube tip palpation,
5234472|NCT00690508|Validate|validate
5234473|NCT00690508|use|use
5234474|NCT00690508|SSTTP|ssttp
5234475|NCT00690508|corrrect|corrrect
5234476|NCT00690508|placement|placement
5234477|NCT00690495|Anesthesia|anesthesia
5234478|NCT00690495|Induction|induction
5234479|NCT00690495|Pain|pain
5234480|NCT00690482|COPD|copd
5234481|NCT00690456|Randomized Controlled Trial|randomized controlled trial
5234482|NCT00690456|Metformin|metformin
5234483|NCT00690443|Hyperlipidemia|hyperlipidemia
5234484|NCT00690430|Carcinoid|carcinoid
5234485|NCT00690430|neuroendocrine|neuroendocrine
5234486|NCT00690430|gastroenteropancreatic|gastroenteropancreatic
5234487|NCT00690430|somatostatin analogue|somatostatin analogue
5234488|NCT00690430|Symptomatic Refractory Resistant Carcinoid Disease|symptomatic refractory resistant carcinoid disease
5234489|NCT00690404|formulation|formulation
5234490|NCT00690404|pharmacokinetic|pharmacokinetic
5234491|NCT00690404|crossover formulation|crossover formulation
5234492|NCT00690404|food effect|food effect
5234493|NCT00690404|oral solution|oral solution
5234494|NCT00690404|healthy volunteers|healthy volunteers
5234495|NCT00690391|surgery|surgery
5234496|NCT00690391|prognostic|prognostic
5234497|NCT00690391|palliation|palliation
5234498|NCT00690365|Switching|switching
5234499|NCT00690365|Quetiapine|quetiapine
5234500|NCT00690365|schizophrenia|schizophrenia
5234501|NCT00690365|unsuccessfully treated|unsuccessfully treated
5234502|NCT00690365|antipsychotics|antipsychotics
5234503|NCT00690352|Specialized Substance Abuse Supervision|specialized substance abuse supervision
5234504|NCT00690352|SSAS|ssas
5234505|NCT00690352|substance use disorder|substance use disorder
5234506|NCT00690352|felony drug offender|felony drug offender
5234507|NCT00690352|probation|probation
5234508|NCT00690352|parole|parole
5234509|NCT00690352|cognitive behavioral therapy|cognitive behavioral therapy
5234510|NCT00690352|CBT|cbt
5234511|NCT00690326|physical activity|physical activity
5234512|NCT00690326|Diabetes mellitus|diabetes mellitus
5234513|NCT00690326|Behavioral change communication|behavioral change communication
5234514|NCT00690326|Household physical activity|household physical activity
5234515|NCT00690313|Vigamox, topical antibiotics, Intravitreal injections, macular degeneration, endophthalmitis|vigamox, topical antibiotics, intravitreal injections, macular degeneration, endophthalmitis
5234516|NCT00690300|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
5234517|NCT00690300|pancreatic cancer|pancreatic cancer
5234518|NCT00690300|pancreas carcinoma|pancreas carcinoma
5234519|NCT00690300|advanced pancreatic cancer|advanced pancreatic cancer
5234520|NCT00690300|metastatic pancreatic cancer|metastatic pancreatic cancer
5234521|NCT00690300|second line|second line
5234522|NCT00690300|palliative|palliative
5234523|NCT00690300|Oxaliplatin|oxaliplatin
5234524|NCT00690300|Docetaxel|docetaxel
5234525|NCT00690300|Taxotere|taxotere
5234526|NCT00690300|Eloxatin|eloxatin
5234527|NCT00690300|Cancer of pancreas|cancer of pancreas
5234528|NCT00690300|Pancreas cancer|pancreas cancer
5234529|NCT00690287|Type 2 diabetes|type 2 diabetes
5234530|NCT00690274|schizophrenia|schizophrenia
5234531|NCT00690274|cognitive deficients|cognitive deficients
5234532|NCT00690274|cognitive enhancing|cognitive enhancing
5234533|NCT00690274|antipsychotics|antipsychotics
5234534|NCT00690261|tumor associated macrophage|tumor associated macrophage
5234535|NCT00690261|lung cancer|lung cancer
5234536|NCT00690261|outcome|outcome
5234537|NCT00690248|Acute mania|acute mania
5234538|NCT00690248|Bipolar disorder|bipolar disorder
5234539|NCT00690248|depressive symptoms|depressive symptoms
5234540|NCT00690248|mixed mania|mixed mania
5234541|NCT00690235|Schizophrenia|schizophrenia
5234542|NCT00690235|Schizoaffective|schizoaffective
5234543|NCT00690235|Olanzapine|olanzapine
5234544|NCT00690235|Zyprexa|zyprexa
5234545|NCT00690235|Clozapine|clozapine
5234546|NCT00690235|Clozaril|clozaril
5234547|NCT00690235|Pramlintide|pramlintide
5234548|NCT00690235|Diabetes|diabetes
5234549|NCT00690235|Weight Gain|weight gain
5234550|NCT00690235|Obesity|obesity
5234551|NCT00690235|Metabolic Syndrome|metabolic syndrome
5234552|NCT00690222|cataract surgery|cataract surgery
5234553|NCT00690222|phacoemulsification|phacoemulsification
5234554|NCT00690222|pupil|pupil
5234555|NCT00690222|dilation|dilation
5234556|NCT00690222|mydriasis|mydriasis
5234557|NCT00690222|intracameral|intracameral
5234558|NCT00690222|topical|topical
5234559|NCT00690222|pseudoexfoliation syndrome|pseudoexfoliation syndrome
5234560|NCT00690209|Chronic ischemic cardiomyopathy with residual viability|chronic ischemic cardiomyopathy with residual viability
5234561|NCT00690209|surgical coronary revascularization|surgical coronary revascularization
5234562|NCT00690209|stem cell therapy|stem cell therapy
5234563|NCT00690209|Chronic ischemic heart disease|chronic ischemic heart disease
5234564|NCT00690209|severe impairment of global contractility left ventricular dilation|severe impairment of global contractility left ventricular dilation
5234565|NCT00690209|residual viability|residual viability
5234566|NCT00690183|physical activity|physical activity
5234567|NCT00690183|stem cells|stem cells
5234568|NCT00690183|lifestyle|lifestyle
5234569|NCT00690170|ketamine|ketamine
5234570|NCT00690170|nicotine|nicotine
5234571|NCT00690170|schizophrenia|schizophrenia
5234572|NCT00690170|cognitive deficits|cognitive deficits
5234573|NCT00690170|P300 oddball paradigm|p300 oddball paradigm
5234574|NCT00690170|Mismatch Negativity|mismatch negativity
5234575|NCT00690170|P50 gating|p50 gating
5234576|NCT00690157|heart failure, prognosis, markers,heart transplantation|heart failure, prognosis, markers,heart transplantation
5234577|NCT00690144|simulation|simulation
5234578|NCT00690144|medical education|medical education
5234579|NCT00690144|performance of clinical reasoning and skills|performance of clinical reasoning and skills
5234580|NCT00690131|Smoking cessation, severe mental illness, behavioral treatment|smoking cessation, severe mental illness, behavioral treatment
5234581|NCT00690118|amyotrophic lateral sclerosis|amyotrophic lateral sclerosis
5234582|NCT00690118|survival time|survival time
5234583|NCT00690118|ALS functioning Rating Scale|als functioning rating scale
5234584|NCT00690118|quality of life|quality of life
5234585|NCT00690118|non-invasive ventilation|non-invasive ventilation
5234586|NCT00690118|clinical tolerability|clinical tolerability
5234587|NCT00690118|survival|survival
5234588|NCT00690105|Dermatitis, Atopic|dermatitis, atopic
5234589|NCT00690105|Dermatologic Agents|dermatologic agents
5234590|NCT00690105|Topical Drug Administration|topical drug administration
5234591|NCT00690105|Tacrolimus|tacrolimus
5234592|NCT00690105|Calcineurin|calcineurin
5234593|NCT00690105|Corticosteroid|corticosteroid
5234594|NCT00690105|Fluticasone propionate|fluticasone propionate
5234595|NCT00690105|Face|face
5234596|NCT00690092|Coccidioidin|coccidioidin
5234597|NCT00690092|Coccidioidin SD|coccidioidin sd
5234598|NCT00690092|Spherule-derived coccidioidin|spherule-derived coccidioidin
5234599|NCT00690092|Coccidioidomycosis|coccidioidomycosis
5234600|NCT00690092|Valley Fever|valley fever
5234601|NCT00690092|Coccidioides immitis|coccidioides immitis
5234602|NCT00690079|MAD|mad
5234603|NCT00690079|Multiple ascending dose|multiple ascending dose
5234604|NCT00690079|Chronic pain|chronic pain
5234605|NCT00690079|pain|pain
5234606|NCT00690066|T1DM|t1dm
5234607|NCT00690066|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
5234608|NCT00690066|Type 1 Diabetes|type 1 diabetes
5234609|NCT00690066|Diabetes Mellitus, Insulin-Dependent|diabetes mellitus, insulin-dependent
5234610|NCT00690066|Juvenile Diabetes|juvenile diabetes
5234611|NCT00690066|Adult Human Stem Cells|adult human stem cells
5234612|NCT00690066|Mesenchymal Stem Cells|mesenchymal stem cells
5234613|NCT00690066|MSCs|mscs
5234614|NCT00690066|Insulin|insulin
5234615|NCT00690066|Osiris|osiris
5234616|NCT00690066|Prochymal|prochymal
5234617|NCT00690053|Toxicity|toxicity
5234618|NCT00690053|PET|pet
5234619|NCT00690053|HX-4|hx-4
5234620|NCT00690053|cancer|cancer
5234621|NCT00690040|Induction of labor|induction of labor
5234622|NCT00690040|Ripening|ripening
5234623|NCT00690040|Single balloon catheter|single balloon catheter
5234624|NCT00690040|Double balloon catheter|double balloon catheter
5234625|NCT00690014|OAT|oat
5234626|NCT00690014|GFR|gfr
5234627|NCT00690014|renal function|renal function
5234628|NCT00690014|PAH|pah
5234629|NCT00690001|HIV-1 infection|hiv-1 infection
5234630|NCT00690001|Treatment Experienced|treatment experienced
5234631|NCT00689988|Down syndrome|down syndrome
5234632|NCT00689988|communication AIDS for disabled|communication aids for disabled
5234633|NCT00689988|language development disorders|language development disorders
5234634|NCT00689988|vocabulary|vocabulary
5234635|NCT00689988|gestures|gestures
5234636|NCT00689988|language tests|language tests
5234637|NCT00689988|child|child
5234638|NCT00689975|stage IA breast cancer|stage ia breast cancer
5234639|NCT00689975|stage IB breast cancer|stage ib breast cancer
5234640|NCT00689975|stage II breast cancer|stage ii breast cancer
5234641|NCT00689975|stage IIIA breast cancer|stage iiia breast cancer
5234642|NCT00689975|stage IIIB breast cancer|stage iiib breast cancer
5234643|NCT00689975|stage IIIC breast cancer|stage iiic breast cancer
5234644|NCT00689962|Lisfranc|lisfranc
5234645|NCT00689962|fracture|fracture
5234646|NCT00689962|dislocation|dislocation
5234647|NCT00689962|bioabsorbable|bioabsorbable
5234648|NCT00689949|folic acid|folic acid
5234649|NCT00689949|folate|folate
5234650|NCT00689949|p-aminobenzoylglutamate|p-aminobenzoylglutamate
5234651|NCT00689949|formiminoglutamate|formiminoglutamate
5234652|NCT00689949|homocysteine|homocysteine
5234653|NCT00689949|experimental validation of a new biomarker|experimental validation of a new biomarker
5234654|NCT00689936|newly diagnosed multiple myeloma|newly diagnosed multiple myeloma
5234655|NCT00689936|Lenalidomide|lenalidomide
5234656|NCT00689936|Revlimid|revlimid
5234657|NCT00689936|phase III|phase iii
5234658|NCT00689910|pharmacokinetics|pharmacokinetics
5234659|NCT00689910|pregnancy|pregnancy
5234660|NCT00689910|Raltegravir|raltegravir
5234661|NCT00689910|HIV|hiv
5234662|NCT00689910|antiretroviral|antiretroviral
5234663|NCT00689910|Treatment of HIV in pregnant women with Raltegravir|treatment of hiv in pregnant women with raltegravir
5234664|NCT00689897|Primary Dysmenorrhea|primary dysmenorrhea
5234665|NCT00689897|Deqi|deqi
5234666|NCT00689897|acupuncture|acupuncture
5234667|NCT00689897|psychology|psychology
5234668|NCT00689858|Healthy volunteers|healthy volunteers
5234669|NCT00689845|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
5234670|NCT00689845|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5234671|NCT00689845|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
5234672|NCT00689845|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5234673|NCT00689845|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5234674|NCT00689832|Dermatitis, Atopic|dermatitis, atopic
5234675|NCT00689832|Dermatologic Agents|dermatologic agents
5234676|NCT00689832|Topical Drug Administration|topical drug administration
5234677|NCT00689832|Tacrolimus|tacrolimus
5234678|NCT00689832|Calcineurin|calcineurin
5234679|NCT00689832|Corticosteroid|corticosteroid
5234680|NCT00689832|Fluticasone propionate|fluticasone propionate
5234681|NCT00689832|Child|child
5234682|NCT00689819|Hypertension|hypertension
5234683|NCT00689819|High blood pressure|high blood pressure
5234684|NCT00689819|Pre-clinical cardiac dysfunction|pre-clinical cardiac dysfunction
5234685|NCT00689806|Asthma|asthma
5234686|NCT00689793|Fatigue|fatigue
5234687|NCT00689793|Blood donation|blood donation
5234688|NCT00689793|Iron deficiency|iron deficiency
5234689|NCT00689793|Ferrous sulphate|ferrous sulphate
5234690|NCT00689793|Donation|donation
5234691|NCT00689793|Donors|donors
5234692|NCT00689793|Iron|iron
5234693|NCT00689793|Ferritin|ferritin
5234694|NCT00689793|Hemoglobin|hemoglobin
5234695|NCT00689793|Anemia|anemia
5234696|NCT00689793|Anaemia|anaemia
5234697|NCT00689793|Haemoglobin|haemoglobin
5234698|NCT00689793|Don|don
5234699|NCT00689793|Women blood donors|women blood donors
5234700|NCT00689780|Pain|pain
5234701|NCT00689780|safety|safety
5234702|NCT00689780|chronic low back pain|chronic low back pain
5234703|NCT00689767|drug eluting stent|drug eluting stent
5234704|NCT00689754|gastrointestinal hemorrhage|gastrointestinal hemorrhage
5234705|NCT00689754|gastrointestinal intubation|gastrointestinal intubation
5234706|NCT00689754|endoscopy|endoscopy
5234707|NCT00689741|HPV|hpv
5234708|NCT00689741|vaccine|vaccine
5234709|NCT00689715|Cystic tumor|cystic tumor
5234710|NCT00689715|Pancreas|pancreas
5234711|NCT00689715|EUS|eus
5234712|NCT00689702|cetuximab|cetuximab
5234713|NCT00689702|capecitabine|capecitabine
5234714|NCT00689702|radiotherapy|radiotherapy
5234715|NCT00689702|rectal cancer|rectal cancer
5234716|NCT00689676|expressive language|expressive language
5234717|NCT00689676|cognition|cognition
5234718|NCT00689676|early development|early development
5234719|NCT00689676|very low birt weight|very low birt weight
5234720|NCT00689676|prematurity|prematurity
5234721|NCT00689663|cholecystectomy|cholecystectomy
5234722|NCT00689637|AZD3480|azd3480
5234723|NCT00689637|Warfarin|warfarin
5234724|NCT00689637|Drug interaction|drug interaction
5234725|NCT00689624|Colorectal Cancer|colorectal cancer
5234726|NCT00689624|Cetuximab|cetuximab
5234727|NCT00689624|FOLFOXIRI|folfoxiri
5234728|NCT00689611|Acute coronary syndrome|acute coronary syndrome
5234729|NCT00689611|Myocardial infarction|myocardial infarction
5234730|NCT00689611|Smoking cessation|smoking cessation
5234731|NCT00689611|Zyban|zyban
5234732|NCT00689611|Secondary intervention post-ACS|secondary intervention post-acs
5234733|NCT00689598|Atrial fibrillation, spironolactone|atrial fibrillation, spironolactone
5234734|NCT00689585|Complex Regional Pain Syndrome|complex regional pain syndrome
5234735|NCT00689585|Reflex Sympathetic Dystrophy|reflex sympathetic dystrophy
5234736|NCT00689585|RSD|rsd
5234737|NCT00689585|Chronic Pain|chronic pain
5234738|NCT00689585|Ethosuximide|ethosuximide
5234739|NCT00689585|Zarontin|zarontin
5234740|NCT00689585|Anticonvulsant|anticonvulsant
5234741|NCT00689572|cocaine dependence|cocaine dependence
5234742|NCT00689572|cocaine abuse|cocaine abuse
5234743|NCT00689572|cocaine|cocaine
5234744|NCT00689572|crack|crack
5234745|NCT00689559|Alzheimer's disease|alzheimer's disease
5234746|NCT00689559|AZD3480|azd3480
5234747|NCT00689559|Aripiprazole|aripiprazole
5234748|NCT00689533|VEPTR|veptr
5234749|NCT00689533|TIS|tis
5234750|NCT00689533|scoliosis|scoliosis
5234751|NCT00689533|juvenile|juvenile
5234752|NCT00689520|Venous thromboembolism|venous thromboembolism
5234753|NCT00689520|low molecular weight heparin|low molecular weight heparin
5234754|NCT00689520|Vitamin K antagonist|vitamin k antagonist
5234755|NCT00689520|Longterm|longterm
5234756|NCT00689507|Multiple Myeloma|multiple myeloma
5234757|NCT00689507|Relapsed|relapsed
5234758|NCT00689507|Refractory|refractory
5234759|NCT00689507|Bortezomib|bortezomib
5234760|NCT00689507|Velcade|velcade
5234761|NCT00689494|Nanopaz device|nanopaz device
5234762|NCT00689494|Blood progesterone measure in using the device|blood progesterone measure in using the device
5234763|NCT00689494|Delivery progesterone|delivery progesterone
5234764|NCT00689494|Progesterone levonorgestrel|progesterone levonorgestrel
5234765|NCT00689481|Plaque-type Psoriasis|plaque-type psoriasis
5234766|NCT00689481|psoriasis|psoriasis
5234767|NCT00689468|Otitis media|otitis media
5234768|NCT00689468|Echinacea|echinacea
5234769|NCT00689468|Osteopathic Medicine|osteopathic medicine
5234770|NCT00689455|Metabolic Syndrome|metabolic syndrome
5234771|NCT00689455|Lipids|lipids
5234772|NCT00689455|Waist Circumference|waist circumference
5234773|NCT00689429|Pilon Fractures|pilon fractures
5234774|NCT00689416|imaging biomarkers|imaging biomarkers
5234775|NCT00689416|MRI|mri
5234776|NCT00689416|FDG-PET/CT scanning|fdg-pet/ct scanning
5234777|NCT00689416|Crestor|crestor
5234778|NCT00689403|AZD1305|azd1305
5234779|NCT00689403|pharmacokinetics|pharmacokinetics
5234780|NCT00689403|Properties of different ER formulations|properties of different er formulations
5234781|NCT00689377|Peripheral Arterial Disease (PAD)|peripheral arterial disease (pad)
5234782|NCT00689377|Cardiovascular Disease (CVD)|cardiovascular disease (cvd)
5234783|NCT00689377|Atherosclerotic cardiovascular disease|atherosclerotic cardiovascular disease
5234784|NCT00689377|Atherosclerosis|atherosclerosis
5234785|NCT00689377|Primary CVD prevention|primary cvd prevention
5234786|NCT00689364|Cohort Study|cohort study
5234787|NCT00689364|Colorectal Cancer|colorectal cancer
5234788|NCT00689364|Traditional Chinese Medicine|traditional chinese medicine
5234789|NCT00689364|Risk of recurrence and metastasis|risk of recurrence and metastasis
5234790|NCT00689351|Prevention|prevention
5234791|NCT00689351|against|against
5234792|NCT00689351|pneumococcal|pneumococcal
5234793|NCT00689351|disease|disease
5234794|NCT00689351|Vaccine|vaccine
5234795|NCT00689338|Candida|candida
5234796|NCT00689338|Candidemia|candidemia
5234797|NCT00689338|Systemic Candidiasis|systemic candidiasis
5234798|NCT00689338|ICU|icu
5234799|NCT00689338|Intensive Care Unit|intensive care unit
5234800|NCT00689338|Critical Care Unit|critical care unit
5234801|NCT00689338|Anidulafungin|anidulafungin
5234802|NCT00689338|Ecalta|ecalta
5234803|NCT00689338|Eraxis|eraxis
5234804|NCT00689338|Fluconazole|fluconazole
5234805|NCT00689338|Voriconazole|voriconazole
5234806|NCT00689325|Schizophrenia|schizophrenia
5234807|NCT00689325|remission|remission
5234808|NCT00689325|subjective well-being and effectiveness|subjective well-being and effectiveness
5234809|NCT00689325|Quality of Life|quality of life
5234810|NCT00689312|Gastroenteritis|gastroenteritis
5234811|NCT00689312|Pediatrics|pediatrics
5234812|NCT00689312|Rehydration therapy|rehydration therapy
5234813|NCT00689299|Sublingual Immunotherapy (SLIT)|sublingual immunotherapy (slit)
5234814|NCT00689299|Non-seasonal allergic rhinitis|non-seasonal allergic rhinitis
5234815|NCT00689299|Immunotherapy|immunotherapy
5234816|NCT00689299|Allergic rhinitis|allergic rhinitis
5234817|NCT00689299|Cat|cat
5234818|NCT00689299|Perennial allergy|perennial allergy
5234819|NCT00689299|Non-seasonal allergy|non-seasonal allergy
5234820|NCT00689286|Knee Osteoarthritis|knee osteoarthritis
5234821|NCT00689286|Neuromuscular stimulator|neuromuscular stimulator
5234822|NCT00689273|PF-04136309 CCR2 osteoarthritic pain knee, phase 2 placebo multicenter double-blind placebo-controlled|pf-04136309 ccr2 osteoarthritic pain knee, phase 2 placebo multicenter double-blind placebo-controlled
5234823|NCT00689247|AZD1305|azd1305
5234824|NCT00689247|ADME|adme
5234825|NCT00689247|pharmacokinetic|pharmacokinetic
5234826|NCT00689247|Absorption|absorption
5234827|NCT00689247|distribution|distribution
5234828|NCT00689247|metabolism|metabolism
5234829|NCT00689247|excretion|excretion
5234830|NCT00689221|newly diagnosed Glioblastoma (WHO Grade IV)|newly diagnosed glioblastoma (who grade iv)
5234831|NCT00689221|Cilengitide|cilengitide
5234832|NCT00689221|Temozolomide|temozolomide
5234833|NCT00689221|Radiotherapy|radiotherapy
5234834|NCT00689208|Clamp|clamp
5234835|NCT00689195|Curcumin|curcumin
5234836|NCT00689195|Ashwagandha|ashwagandha
5234837|NCT00689195|osteosarcoma|osteosarcoma
5234838|NCT00689195|Pharmacokinetics of curcumin and ashwagandha formulation|pharmacokinetics of curcumin and ashwagandha formulation
5234839|NCT00689195|response|response
5234840|NCT00689182|iron reduction|iron reduction
5234841|NCT00689182|iron overload|iron overload
5234842|NCT00689182|phlebotomy|phlebotomy
5234946|NCT00688909|letrozole|letrozole
5234843|NCT00689182|hematopoietic stem cell transplant|hematopoietic stem cell transplant
5234844|NCT00689169|Lymphoma|lymphoma
5234845|NCT00689169|Lymphoma Diffuse|lymphoma diffuse
5234846|NCT00689169|B-Cell lymphoma|b-cell lymphoma
5234847|NCT00689169|Aggressive lymphoma|aggressive lymphoma
5234848|NCT00689156|Epirubicin|epirubicin
5234849|NCT00689156|docetaxel|docetaxel
5234850|NCT00689156|Adjuvant chemotherapy|adjuvant chemotherapy
5234851|NCT00689156|DNA Topoisomerases, Type II|dna topoisomerases, type ii
5234852|NCT00689130|Analgesia|analgesia
5234853|NCT00689130|Bispectral Index|bispectral index
5234854|NCT00689130|BIS Variability|bis variability
5234855|NCT00689130|Electroencephalography|electroencephalography
5234856|NCT00689130|Electromyography|electromyography
5234857|NCT00689130|Monitoring, Intraoperative|monitoring, intraoperative
5234858|NCT00689130|Movement|movement
5234859|NCT00689130|Pain, Postoperative|pain, postoperative
5234860|NCT00689130|Somatic Events|somatic events
5234861|NCT00689130|Patients under general anesthesia undergoing a moderately painful procedure.|patients under general anesthesia undergoing a moderately painful procedure.
5234862|NCT00689117|Acne Vulgaris|acne vulgaris
5234863|NCT00689117|Acne|acne
5234864|NCT00689104|Micturition|micturition
5234865|NCT00689104|Urinary incontinence|urinary incontinence
5234866|NCT00689104|Urinary urge incontinence|urinary urge incontinence
5234867|NCT00689104|Overactive bladder (OAB)|overactive bladder (oab)
5234868|NCT00689104|Urgency|urgency
5234869|NCT00689104|YM178|ym178
5234870|NCT00689104|Frequency|frequency
5234871|NCT00689091|Awareness|awareness
5234872|NCT00689091|BIS Monitor|bis monitor
5234873|NCT00689091|electronic alerts|electronic alerts
5234874|NCT00689091|minimum|minimum
5234875|NCT00689091|alveolar|alveolar
5234876|NCT00689091|concentration|concentration
5234877|NCT00689078|Allergic conjunctivitis|allergic conjunctivitis
5234878|NCT00689065|siRNA|sirna
5234879|NCT00689065|RNA interference (RNAi)|rna interference (rnai)
5234880|NCT00689065|Cyclodextrin|cyclodextrin
5234881|NCT00689065|Cancer|cancer
5234882|NCT00689065|Neoplasms|neoplasms
5234883|NCT00689065|Solid Tumor|solid tumor
5234884|NCT00689065|Ovarian Cancer|ovarian cancer
5234885|NCT00689065|Lung Cancer|lung cancer
5234886|NCT00689065|Non Small Cell Lung Cancer|non small cell lung cancer
5234887|NCT00689065|Pancreatic Cancer|pancreatic cancer
5234888|NCT00689065|Breast Cancer|breast cancer
5234889|NCT00689065|Colon Cancer|colon cancer
5234890|NCT00689065|Endometrial Cancer|endometrial cancer
5234891|NCT00689065|Kidney (Renal Cell) Cancer|kidney (renal cell) cancer
5234892|NCT00689065|Melanoma|melanoma
5234893|NCT00689065|Prostate Cancer|prostate cancer
5234894|NCT00689065|Skin Cancer|skin cancer
5234895|NCT00689065|Thyroid Cancer|thyroid cancer
5234896|NCT00689065|Solid Malignancies|solid malignancies
5234897|NCT00689039|AZD1305|azd1305
5234898|NCT00689039|safety|safety
5234899|NCT00689039|pharmacokinetics|pharmacokinetics
5234900|NCT00689039|multiple ascending doses|multiple ascending doses
5234901|NCT00689039|Safety and pharmacokinetics|safety and pharmacokinetics
5234902|NCT00689026|Colonoscopy|colonoscopy
5234903|NCT00689026|Diabetes Mellitus, Type 1|diabetes mellitus, type 1
5234904|NCT00689026|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
5234905|NCT00689026|Cleansing|cleansing
5234906|NCT00689026|Preparation|preparation
5234907|NCT00689026|PEG|peg
5234908|NCT00689026|Quality|quality
5234909|NCT00689013|Herpes Zoster|herpes zoster
5234910|NCT00689013|Prevention & control|prevention & control
5234911|NCT00689013|Pharmacists|pharmacists
5234912|NCT00689013|Pharmacy|pharmacy
5234913|NCT00689013|Pharmacies|pharmacies
5234914|NCT00689013|Aged|aged
5234915|NCT00689013|Immunization|immunization
5234916|NCT00689013|Vaccination|vaccination
5234917|NCT00689000|Leukemia|leukemia
5234918|NCT00689000|AML|aml
5234919|NCT00689000|MDS|mds
5234920|NCT00689000|MM|mm
5234921|NCT00689000|Acute Myeloid Leukemia|acute myeloid leukemia
5234922|NCT00689000|Myelodysplastic Syndrome|myelodysplastic syndrome
5234923|NCT00689000|Multiple Myeloma|multiple myeloma
5234924|NCT00689000|Cancer|cancer
5234925|NCT00689000|Hematological malignancies|hematological malignancies
5234926|NCT00689000|Elderly|elderly
5234927|NCT00689000|Refractory|refractory
5234928|NCT00689000|Blood|blood
5234929|NCT00688974|type 2 diabetes|type 2 diabetes
5234930|NCT00688974|obesity|obesity
5234931|NCT00688974|gastric bypass|gastric bypass
5234932|NCT00688974|adjustable gastric banding|adjustable gastric banding
5234933|NCT00688974|BMI > 35.|bmi > 35.
5234934|NCT00688974|obesity for more than 5 years|obesity for more than 5 years
5234935|NCT00688961|omega-3 fatty acids|omega-3 fatty acids
5234936|NCT00688961|aspirin|aspirin
5234937|NCT00688961|platelet aggregation|platelet aggregation
5234938|NCT00688961|Healthy volunteers; no disease|healthy volunteers; no disease
5234939|NCT00688948|pilot clinical trial|pilot clinical trial
5234940|NCT00688935|melatonin|melatonin
5234941|NCT00688935|circadian rhythms|circadian rhythms
5234942|NCT00688935|sleep|sleep
5234943|NCT00688935|sleep disorders|sleep disorders
5234944|NCT00688909|breast cancer|breast cancer
5234945|NCT00688909|adjuvant treatment in post menopausal women|adjuvant treatment in post menopausal women
5234947|NCT00688909|arthralgia-myalgia|arthralgia-myalgia
5234948|NCT00688883|Fludarabine|fludarabine
5234949|NCT00688883|Purine analog|purine analog
5234950|NCT00688883|Indolent lymphoma|indolent lymphoma
5234951|NCT00688870|Prevention against pneumococcal disease|prevention against pneumococcal disease
5234952|NCT00688844|PKU|pku
5234953|NCT00688844|Phenylketonuria|phenylketonuria
5234954|NCT00688844|BH4|bh4
5234955|NCT00688844|Kuvan|kuvan
5234956|NCT00688844|Tetrahydrobiopterin|tetrahydrobiopterin
5234957|NCT00688844|Sapropterin Dihydrochloride|sapropterin dihydrochloride
5234958|NCT00688844|Nutrition|nutrition
5234959|NCT00688844|PHE|phe
5234960|NCT00688844|Phenylalanine|phenylalanine
5234961|NCT00688844|PAH|pah
5234962|NCT00688844|Phenylalanine hydroxylase|phenylalanine hydroxylase
5234963|NCT00688844|Neurotransmitters|neurotransmitters
5234964|NCT00688844|Serotonin|serotonin
5234965|NCT00688844|Catecholamines|catecholamines
5234966|NCT00688844|Diet|diet
5234967|NCT00688844|Body Fat|body fat
5234968|NCT00688844|Bone Density|bone density
5234969|NCT00688831|AZD1305|azd1305
5234970|NCT00688831|SAD|sad
5234971|NCT00688831|safety|safety
5234972|NCT00688831|pharmcokinetics|pharmcokinetics
5234973|NCT00688831|Safety and tolerability|safety and tolerability
5234974|NCT00688818|Co-morbid depressive and anxiety disorders|co-morbid depressive and anxiety disorders
5234975|NCT00688818|Quetiapine|quetiapine
5234976|NCT00688818|Randomized|randomized
5234977|NCT00688818|Placebo-controlled|placebo-controlled
5234978|NCT00688818|Double-blind|double-blind
5234979|NCT00688818|Major depressive disorder|major depressive disorder
5234980|NCT00688818|Dysthymic disorder|dysthymic disorder
5234981|NCT00688818|Anxiety disorders|anxiety disorders
5234982|NCT00688818|Generalized anxiety disorder|generalized anxiety disorder
5234983|NCT00688818|Social anxiety disorder|social anxiety disorder
5234984|NCT00688818|Panic disorder|panic disorder
5234985|NCT00688818|Post-traumatic stress disorder|post-traumatic stress disorder
5234986|NCT00688805|Propanolol|propanolol
5234987|NCT00688805|Substance Abuse|substance abuse
5234988|NCT00688805|Craving|craving
5234989|NCT00688805|Imagery|imagery
5234990|NCT00688805|Drug Cues|drug cues
5234991|NCT00688805|Cocaine|cocaine
5234992|NCT00688792|Asthma|asthma
5234993|NCT00688792|Children|children
5234994|NCT00688792|Adherence|adherence
5234995|NCT00688792|Maternal factors|maternal factors
5234996|NCT00688779|Healthy male|healthy male
5234997|NCT00688779|allergic rhinitis|allergic rhinitis
5234998|NCT00688779|tolerability|tolerability
5234999|NCT00688779|safety|safety
5235000|NCT00688779|intranasally|intranasally
5235001|NCT00688779|Healthy subjects|healthy subjects
5235002|NCT00688766|GIST|gist
5235003|NCT00688766|Metastatic and/or Unresectable Gastrointestinal Stromal|metastatic and/or unresectable gastrointestinal stromal
5235004|NCT00688753|renal cell carcinoma|renal cell carcinoma
5235005|NCT00688753|non clear cell carcinoma|non clear cell carcinoma
5235006|NCT00688753|papillary cell renal carcinoma|papillary cell renal carcinoma
5235007|NCT00688753|adults|adults
5235008|NCT00688753|everolimus|everolimus
5235009|NCT00688740|adjuvant treatment|adjuvant treatment
5235010|NCT00688727|non epileptic seizures|non epileptic seizures
5235011|NCT00688727|cognitive behavioural therapy|cognitive behavioural therapy
5235012|NCT00688727|dissociative disorders|dissociative disorders
5235013|NCT00688727|Seizure disorders|seizure disorders
5235014|NCT00688727|randomised controlled trial|randomised controlled trial
5235015|NCT00688714|Antiplatelet|antiplatelet
5235016|NCT00688701|hyperglycemia, GLP-1|hyperglycemia, glp-1
5235017|NCT00688688|Frequency|frequency
5235018|NCT00688688|Overactive Bladder|overactive bladder
5235019|NCT00688688|Urgency|urgency
5235020|NCT00688688|Urinary urge incontinence|urinary urge incontinence
5235021|NCT00688688|Urinary incontinence|urinary incontinence
5235022|NCT00688688|Micturition|micturition
5235023|NCT00688675|GERD|gerd
5235024|NCT00688675|Pharmacoepidemiology|pharmacoepidemiology
5235025|NCT00688662|Sphincter of Oddi Dysfunction|sphincter of oddi dysfunction
5235026|NCT00688662|Pancreatitis|pancreatitis
5235027|NCT00688662|Sphincterotomy|sphincterotomy
5235028|NCT00688623|Neuroendocrine tumors|neuroendocrine tumors
5235029|NCT00688623|non-functioning neuroendocrine tumors carcinoids|non-functioning neuroendocrine tumors carcinoids
5235030|NCT00688623|non-functioning carcinoids|non-functioning carcinoids
5235031|NCT00688623|adults|adults
5235032|NCT00688623|everolimus|everolimus
5235033|NCT00688610|primary care|primary care
5235034|NCT00688610|procalcitonin|procalcitonin
5235035|NCT00688610|antibiotic prescription|antibiotic prescription
5235036|NCT00688597|Amicus Therapeutics|amicus therapeutics
5235037|NCT00688597|Duvoglustat|duvoglustat
5235038|NCT00688597|AT2220|at2220
5235039|NCT00688584|problem drinking|problem drinking
5235040|NCT00688584|randomized control trial|randomized control trial
5235041|NCT00688584|Pamphlet-based personalized alcohol feedback (PAF)|pamphlet-based personalized alcohol feedback (paf)
5235042|NCT00688571|Pulmonary Valve|pulmonary valve
5235043|NCT00688571|Congenital Heart Disease|congenital heart disease
5235044|NCT00688545|Celecoxib|celecoxib
5235045|NCT00688545|COX-2|cox-2
5235046|NCT00688545|NSAIDs|nsaids
5235047|NCT00688545|observational study|observational study
5235048|NCT00688545|noninterventional study|noninterventional study
5235049|NCT00688545|cohort study|cohort study
5235050|NCT00688545|registry|registry
5235051|NCT00688545|epidemiologic study|epidemiologic study
5235052|NCT00688545|pediatrics|pediatrics
5235053|NCT00688545|rheumatology|rheumatology
5235054|NCT00688545|phase iv study|phase iv study
5235055|NCT00688532|Prostate cancer|prostate cancer
5235056|NCT00688532|pharmacoepidemiology study|pharmacoepidemiology study
5235057|NCT00688519|Plaque-type Psoriasis|plaque-type psoriasis
5235058|NCT00688519|Psoriasis|psoriasis
5235059|NCT00688506|Chronic pelvic pain syndrome|chronic pelvic pain syndrome
5235060|NCT00688506|Neuromodulation|neuromodulation
5235061|NCT00688506|Brain effects|brain effects
5235062|NCT00688506|Neuroimaging|neuroimaging
5235063|NCT00688493|QT|qt
5235064|NCT00688493|Healthy volunteers|healthy volunteers
5235065|NCT00688480|CKD|ckd
5235066|NCT00688480|LVH|lvh
5235067|NCT00688480|Echo LVH|echo lvh
5235068|NCT00688480|Chronic Stage 3|chronic stage 3
5235069|NCT00688467|Neutrophilic Asthma|neutrophilic asthma
5235070|NCT00688454|Hyperlipidemia|hyperlipidemia
5235071|NCT00688454|Rosuvastatin|rosuvastatin
5235072|NCT00688454|Efficacy|efficacy
5235073|NCT00688454|tolerability|tolerability
5235074|NCT00688454|CRESTOR therapy|crestor therapy
5235075|NCT00688441|Randomized|randomized
5235076|NCT00688441|Double-Blind|double-blind
5235077|NCT00688441|Multi-Center|multi-center
5235078|NCT00688441|Placebo-Controlled|placebo-controlled
5235079|NCT00688441|Phase II|phase ii
5235080|NCT00688441|Nasal Carbon Dioxide|nasal carbon dioxide
5235081|NCT00688441|Carbon Dioxide|carbon dioxide
5235082|NCT00688441|Efficacy|efficacy
5235083|NCT00688441|Safety|safety
5235084|NCT00688441|Total Nasal Symptom Score|total nasal symptom score
5235085|NCT00688441|RQLQ|rqlq
5235086|NCT00688428|esomeprazole|esomeprazole
5235087|NCT00688428|upper gi symptoms|upper gi symptoms
5235088|NCT00688428|low dose Aspirin treatment|low dose aspirin treatment
5235089|NCT00688402|Reflux Inhibitor|reflux inhibitor
5235090|NCT00688402|GERD|gerd
5235091|NCT00688402|formulations|formulations
5235092|NCT00688389|Dengue fever, CLEC5A, Mannose receptor, DC-SIGN, NALP,|dengue fever, clec5a, mannose receptor, dc-sign, nalp,
5235093|NCT00688389|decoy receptor 3 (DcR3), Toll-like receptors(TLRs),|decoy receptor 3 (dcr3), toll-like receptors(tlrs),
5235094|NCT00688389|(Nod)-like receptors (NLRs)|(nod)-like receptors (nlrs)
5235095|NCT00688376|Attention|attention
5235096|NCT00688376|cancer|cancer
5235097|NCT00688376|chemotherapy|chemotherapy
5235098|NCT00688376|donepezil|donepezil
5235099|NCT00688376|acetylcholinesterase|acetylcholinesterase
5235100|NCT00688376|inhibitor|inhibitor
5235101|NCT00688363|Diabetes control|diabetes control
5235102|NCT00688363|glycated haemoglobin|glycated haemoglobin
5235103|NCT00688363|blood-glucose-self-monitoring|blood-glucose-self-monitoring
5235104|NCT00688363|type 2-diabetes|type 2-diabetes
5235105|NCT00688363|conventional insulin therapy|conventional insulin therapy
5235106|NCT00688350|Hypertension|hypertension
5235107|NCT00688350|Aging|aging
5235108|NCT00688350|Medication adherence|medication adherence
5235109|NCT00688350|Medication compliance|medication compliance
5235110|NCT00688337|Breast cancer|breast cancer
5235111|NCT00688337|lymph nodes|lymph nodes
5235112|NCT00688337|gene-expression|gene-expression
5235113|NCT00688337|oncotype|oncotype
5235114|NCT00688337|Age over 18|age over 18
5235115|NCT00688337|Newly diagnosed breast cancer prior to surgery or treatment.|newly diagnosed breast cancer prior to surgery or treatment.
5235116|NCT00688337|No evidence of clinical nodal disease|no evidence of clinical nodal disease
5235117|NCT00688324|schizophrenia|schizophrenia
5235118|NCT00688324|schizoaffective disorder|schizoaffective disorder
5235119|NCT00688324|glutamate|glutamate
5235120|NCT00688324|NMDA receptor|nmda receptor
5235121|NCT00688324|magnetic resonance spectroscopy|magnetic resonance spectroscopy
5235122|NCT00688324|acamprosate|acamprosate
5235123|NCT00688311|HIV|hiv
5235124|NCT00688311|synbiotic|synbiotic
5235125|NCT00688311|probiotic|probiotic
5235126|NCT00688311|immune activation|immune activation
5235127|NCT00688311|blood CD4 count|blood cd4 count
5235128|NCT00688311|bacterial translocation|bacterial translocation
5235129|NCT00688311|Human Immunodeficiency Virus|human immunodeficiency virus
5235130|NCT00688285|chronic kidney disease|chronic kidney disease
5235131|NCT00688285|clinical alerts|clinical alerts
5235132|NCT00688285|late referral|late referral
5235133|NCT00688285|electronic medical record|electronic medical record
5235134|NCT00688285|Computerized clinical decision support systems (CDSS)|computerized clinical decision support systems (cdss)
5235135|NCT00688272|Safety|safety
5235136|NCT00688272|Photoirritant|photoirritant
5235137|NCT00688272|Photosensitivity|photosensitivity
5235138|NCT00688272|Placebo control|placebo control
5235139|NCT00688272|Ciprofloxacin|ciprofloxacin
5235140|NCT00688272|Eltrombopag|eltrombopag
5235141|NCT00688259|clinical trials|clinical trials
5235142|NCT00688259|psychotherapy|psychotherapy
5235143|NCT00688246|osteoporosis|osteoporosis
5235144|NCT00688246|breast cancer|breast cancer
5235145|NCT00688233|Seifi's Functional, Class II/1, Mandibular Retrognathism|seifi's functional, class ii/1, mandibular retrognathism
5235146|NCT00688220|Arthritis|arthritis
5235147|NCT00688220|Carpel tunnel syndrome|carpel tunnel syndrome
5235148|NCT00688220|Epicondylitis|epicondylitis
5235149|NCT00688207|PPAR agonist,|ppar agonist,
5235150|NCT00688207|Rosiglitazone XR,|rosiglitazone xr,
5235151|NCT00688207|BRL-049653.|brl-049653.
5235152|NCT00688207|Alzheimer's disease,|alzheimer's disease,
5235153|NCT00688194|stage IV breast cancer|stage iv breast cancer
5235154|NCT00688194|recurrent breast cancer|recurrent breast cancer
5235155|NCT00688168|Multiple Myeloma|multiple myeloma
5235156|NCT00688168|Phone Call|phone call
5235157|NCT00688168|Treatment Naive|treatment naive
5235158|NCT00688168|Inflammatory Cytokines|inflammatory cytokines
5235159|NCT00688168|Questionnaire|questionnaire
5235160|NCT00688168|Survey|survey
5235161|NCT00688168|Interactive Voice Response|interactive voice response
5235162|NCT00688168|Symptom Production|symptom production
5235163|NCT00688168|Pain|pain
5235165|NCT00688168|MM|mm
5235166|NCT00688129|school readiness|school readiness
5235167|NCT00688129|foster care|foster care
5235168|NCT00688129|maltreatment|maltreatment
5235169|NCT00688129|literacy|literacy
5235170|NCT00688129|social emotional skills|social emotional skills
5235171|NCT00688129|self regulation|self regulation
5235172|NCT00688129|caregiver involvement|caregiver involvement
5235173|NCT00688116|metastatic cancer|metastatic cancer
5235174|NCT00688116|solid tumor|solid tumor
5235175|NCT00688116|histologically or cytologically confirmed non-hematological malignancy that is metastatic or unresectable|histologically or cytologically confirmed non-hematological malignancy that is metastatic or unresectable
5235176|NCT00688116|STA-9090|sta-9090
5235177|NCT00688116|ganetespib|ganetespib
5235178|NCT00688090|Immunotherapy, Melanoma, Cancer Vaccine|immunotherapy, melanoma, cancer vaccine
5235179|NCT00688077|Fibroblast growth factor - 23|fibroblast growth factor - 23
5235180|NCT00688077|Calcitonin|calcitonin
5235181|NCT00688064|Acne|acne
5235182|NCT00688051|Cystic Fibrosis|cystic fibrosis
5235183|NCT00688051|Adherence to treatment|adherence to treatment
5235184|NCT00688038|Advanced Cancer|advanced cancer
5235185|NCT00688038|Bone Metastases|bone metastases
5235186|NCT00688038|Laser Ablation|laser ablation
5235187|NCT00688038|Magnetic Resonance Thermal Imaging|magnetic resonance thermal imaging
5235188|NCT00688038|Laser Induced Thermal Therapy|laser induced thermal therapy
5235189|NCT00688038|MRTI|mrti
5235190|NCT00688038|LITT|litt
5235191|NCT00688012|antisense|antisense
5235192|NCT00688012|microRna antagonist|microrna antagonist
5235193|NCT00688012|anti-miR-122|anti-mir-122
5235194|NCT00688012|Safety in healthy volunteers|safety in healthy volunteers
5235195|NCT00688012|Hepatitis C|hepatitis c
5235196|NCT00687999|Chronic hepatitis C|chronic hepatitis c
5235197|NCT00687999|diabetes|diabetes
5235198|NCT00687999|Insulin resistance|insulin resistance
5235199|NCT00687999|combination therapy|combination therapy
5235200|NCT00687986|surgery|surgery
5235201|NCT00687986|stereotactic radiotherapy|stereotactic radiotherapy
5235202|NCT00687986|tumor control|tumor control
5235203|NCT00687986|quality of life|quality of life
5235204|NCT00687960|Diabetes|diabetes
5235205|NCT00687960|Diet|diet
5235206|NCT00687960|Fiber|fiber
5235207|NCT00687960|Age|age
5235208|NCT00687947|FHM|fhm
5235209|NCT00687947|MA|ma
5235210|NCT00687947|healthy controls|healthy controls
5235211|NCT00687947|CGRP|cgrp
5235212|NCT00687934|metastatic cancer|metastatic cancer
5235213|NCT00687934|solid tumor|solid tumor
5235214|NCT00687934|histologically or cytologically confirmed non-hematological|histologically or cytologically confirmed non-hematological
5235215|NCT00687934|malignancy that is metastatic or unresectable for which no|malignancy that is metastatic or unresectable for which no
5235216|NCT00687934|standard therapy exists|standard therapy exists
5235217|NCT00687934|STA-9090|sta-9090
5235218|NCT00687934|ganetespib|ganetespib
5235219|NCT00687921|Knee trauma|knee trauma
5235220|NCT00687921|MRI|mri
5235221|NCT00687921|arthroscopy|arthroscopy
5235222|NCT00687921|Patients over the age of 18 who had knee trauma intent to or had MRI assessment scheduled for arthroscopy|patients over the age of 18 who had knee trauma intent to or had mri assessment scheduled for arthroscopy
5235223|NCT00687908|Acne|acne
5235224|NCT00687895|malaria microscopy primary health care children|malaria microscopy primary health care children
5235225|NCT00687882|Venous Thromboembolism|venous thromboembolism
5235226|NCT00687882|Postthrombotic Syndrome|postthrombotic syndrome
5235227|NCT00687882|Antithrombotic Therapy|antithrombotic therapy
5235228|NCT00687882|Duration of Therapy|duration of therapy
5235229|NCT00687882|Children|children
5235230|NCT00687869|stroke|stroke
5235231|NCT00687869|rehabilitation|rehabilitation
5235232|NCT00687869|patient care management|patient care management
5235233|NCT00687869|patient participation|patient participation
5235234|NCT00687856|Left Ventricular Assist Device|left ventricular assist device
5235235|NCT00687843|Gastric Cancer|gastric cancer
5235236|NCT00687843|TS-1|ts-1
5235237|NCT00687843|PSK|psk
5235238|NCT00687843|Relapse-free survival|relapse-free survival
5235239|NCT00687830|Afternoon colonoscopy|afternoon colonoscopy
5235240|NCT00687830|Morning|morning
5235241|NCT00687830|Evening|evening
5235242|NCT00687830|Bowel Preparation|bowel preparation
5235243|NCT00687830|Efficacy|efficacy
5235244|NCT00687830|Satisfaction|satisfaction
5235245|NCT00687817|NSCLC|nsclc
5235246|NCT00687804|DME|dme
5235247|NCT00687804|Diabetic|diabetic
5235248|NCT00687804|macula|macula
5235249|NCT00687804|edema|edema
5235250|NCT00687804|ranibizumab|ranibizumab
5235251|NCT00687804|RESTORE|restore
5235252|NCT00687791|patients with cataract and glaucoma|patients with cataract and glaucoma
5235253|NCT00687791|ologen|ologen
5235254|NCT00687791|oculusgen|oculusgen
5235255|NCT00687791|collagen matrix|collagen matrix
5235256|NCT00687791|Phacotrabeculectomy|phacotrabeculectomy
5235257|NCT00687791|Aeon Astron|aeon astron
5235258|NCT00687791|trabeculectomy|trabeculectomy
5235259|NCT00687791|tissue engineering|tissue engineering
5235260|NCT00687791|mitomycin-C|mitomycin-c
5235261|NCT00687778|C11-Acetate|c11-acetate
5235262|NCT00687778|FDG|fdg
5235263|NCT00687778|sarcoma|sarcoma
5235264|NCT00687778|Measurement of C11-Acetate uptake in tumors which are often non-FDG avid.|measurement of c11-acetate uptake in tumors which are often non-fdg avid.
5235265|NCT00687778|Soft tissue sarcomas|soft tissue sarcomas
5235266|NCT00687778|well-differentiated thyroid cancer|well-differentiated thyroid cancer
5235267|NCT00687778|well-differentiated and bronchoalveolar lung cancer|well-differentiated and bronchoalveolar lung cancer
5235268|NCT00687778|indolent lymphomas, neuroendocrine tumors|indolent lymphomas, neuroendocrine tumors
5235269|NCT00687778|GIST|gist
5235270|NCT00687778|uterine malignancies|uterine malignancies
5235271|NCT00687778|mucin-producing cancer|mucin-producing cancer
5235272|NCT00687778|teratoma, hepatoma|teratoma, hepatoma
5235273|NCT00687778|HCC|hcc
5235274|NCT00687778|lobular breast carcinoma|lobular breast carcinoma
5235275|NCT00687765|patients with newly diagnosed glioblastoma|patients with newly diagnosed glioblastoma
5235276|NCT00687752|fetal deglutition|fetal deglutition
5235277|NCT00687752|larynx|larynx
5235278|NCT00687752|fetal CNS pathology|fetal cns pathology
5235279|NCT00687752|sonography|sonography
5235280|NCT00687752|hydramnios|hydramnios
5235281|NCT00687739|hormone therapy|hormone therapy
5235282|NCT00687739|obesity|obesity
5235283|NCT00687739|postmenopause|postmenopause
5235284|NCT00687739|disease /disorder proneness /risk|disease /disorder proneness /risk
5235285|NCT00687739|insulin sensitivity /resistance|insulin sensitivity /resistance
5235286|NCT00687739|metabolic syndrome|metabolic syndrome
5235287|NCT00687739|women's health|women's health
5235288|NCT00687726|osteoarthritis|osteoarthritis
5235289|NCT00687726|knee|knee
5235290|NCT00687726|exercise|exercise
5235291|NCT00687726|balance|balance
5235292|NCT00687700|propranolol|propranolol
5235293|NCT00687700|B2-agonist,|b2-agonist,
5235294|NCT00687700|B-antagonist,|b-antagonist,
5235295|NCT00687687|Patients must have advanced (stage III or IV), persistent or recurrent uterine carcinosarcoma with documented disease progression.|patients must have advanced (stage iii or iv), persistent or recurrent uterine carcinosarcoma with documented disease progression.
5235296|NCT00687674|refractory multiple myeloma|refractory multiple myeloma
5235297|NCT00687661|Chronic Kidney Failure|chronic kidney failure
5235298|NCT00687661|Vascular Calcification|vascular calcification
5235299|NCT00687661|Bisphosphonates|bisphosphonates
5235300|NCT00687648|stage IV breast cancer|stage iv breast cancer
5235301|NCT00687648|recurrent breast cancer|recurrent breast cancer
5235302|NCT00687648|HER2-negative breast cancer|her2-negative breast cancer
5235303|NCT00687648|estrogen receptor-positive breast cancer|estrogen receptor-positive breast cancer
5235304|NCT00687648|progesterone receptor-positive breast cancer|progesterone receptor-positive breast cancer
5235305|NCT00687622|MEK inhibitor|mek inhibitor
5235306|NCT00687622|solid tumors|solid tumors
5235307|NCT00687622|First Time in Human|first time in human
5235308|NCT00687622|GSK1120212|gsk1120212
5235309|NCT00687622|Oncology|oncology
5235310|NCT00687622|melanoma|melanoma
5235311|NCT00687609|Attention Deficit Hyperactivity Disorder with Cannabis Abuse|attention deficit hyperactivity disorder with cannabis abuse
5235312|NCT00687609|Marihuana Abuse|marihuana abuse
5235313|NCT00687609|Comorbid Cannabis Abuse|comorbid cannabis abuse
5235314|NCT00687583|pediatrics|pediatrics
5235315|NCT00687583|anesthesia|anesthesia
5235316|NCT00687583|head movements|head movements
5235317|NCT00687583|endotracheal tube|endotracheal tube
5235318|NCT00687570|patients with rectal cancer undergoing surgery|patients with rectal cancer undergoing surgery
5235319|NCT00687570|Bowel purity degree|bowel purity degree
5235320|NCT00687570|Bowel preparation|bowel preparation
5235321|NCT00687570|Rectal cancer|rectal cancer
5235322|NCT00687570|Nutritional status|nutritional status
5235323|NCT00687570|complications with traditional bowel preparation|complications with traditional bowel preparation
5235324|NCT00687570|Complications|complications
5235325|NCT00687570|Physiological status|physiological status
5235326|NCT00687544|HIV|hiv
5235327|NCT00687492|hypercholesterolemia|hypercholesterolemia
5235328|NCT00687492|NCEP ATP III guidelines|ncep atp iii guidelines
5235329|NCT00687492|survey|survey
5235330|NCT00687479|insulin sensitivity|insulin sensitivity
5235331|NCT00687479|insulin secretion|insulin secretion
5235332|NCT00687479|infant outcome|infant outcome
5235333|NCT00687466|Cystic Fibrosis|cystic fibrosis
5235334|NCT00687466|Glucose Intolerance|glucose intolerance
5235335|NCT00687453|Glargine|glargine
5235336|NCT00687453|Type 2 diabetes|type 2 diabetes
5235337|NCT00687453|Basal insulin|basal insulin
5235338|NCT00687414|gene expression|gene expression
5235339|NCT00687414|gene sequencing|gene sequencing
5235340|NCT00687414|gene encoding|gene encoding
5235341|NCT00687414|MPD|mpd
5235342|NCT00687414|MDS|mds
5235343|NCT00687414|AML|aml
5235344|NCT00687414|mDia|mdia
5235345|NCT00687388|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors
5235346|NCT00687388|Alpha Blockers|alpha blockers
5235347|NCT00687388|Treatment Outcome|treatment outcome
5235348|NCT00687375|Inguinal|inguinal
5235349|NCT00687375|Groin hernia|groin hernia
5235350|NCT00687375|TAPP|tapp
5235351|NCT00687375|TEP|tep
5235352|NCT00687375|Comparing|comparing
5235353|NCT00687375|Two|two
5235354|NCT00687375|Techniques|techniques
5235355|NCT00687349|End-of-Life issues|end-of-life issues
5235356|NCT00687349|Talking with your doctor|talking with your doctor
5235357|NCT00687349|Coping with chronic illness|coping with chronic illness
5235358|NCT00687336|Helicobacter pylori|helicobacter pylori
5235359|NCT00687336|Treatment|treatment
5235360|NCT00687336|Upper gastrointestinal bleeding|upper gastrointestinal bleeding
5235361|NCT00687310|Asthma education|asthma education
5235362|NCT00687310|satisfaction adherence|satisfaction adherence
5235363|NCT00687310|Quality of Life|quality of life
5235364|NCT00687310|PIKO meter cluster|piko meter cluster
5235365|NCT00687310|Symbicort® Turbuhaler®|symbicort® turbuhaler®
5235366|NCT00687297|Stage IIIB Non Small Cell Lung Cancer|stage iiib non small cell lung cancer
5235367|NCT00687297|Stage IV Non Small Cell Lung Cancer|stage iv non small cell lung cancer
5235368|NCT00687297|Vandetanib|vandetanib
5235369|NCT00687297|Docetaxel plus carboplatin|docetaxel plus carboplatin
5235370|NCT00687258|Anemia|anemia
5235371|NCT00687258|Oxidative Stress|oxidative stress
5235372|NCT00687258|Erythropoietin|erythropoietin
5235373|NCT00687258|dialyser membrane|dialyser membrane
5235374|NCT00687258|Vitamin E|vitamin e
5235375|NCT00687258|Erythropoietin responsiveness|erythropoietin responsiveness
5235376|NCT00687258|Erythropoietin resistance|erythropoietin resistance
5235377|NCT00687258|hemodialysis|hemodialysis
5235378|NCT00687245|children|children
5235380|NCT00687245|GERD|gerd
5235381|NCT00687245|pediatric|pediatric
5235382|NCT00687232|Phase I|phase i
5235383|NCT00687232|Japan|japan
5235384|NCT00687232|Japanese|japanese
5235385|NCT00687232|inhalation|inhalation
5235386|NCT00687219|hepatitis C|hepatitis c
5235387|NCT00687193|Phase 2 monotherapy in Japan|phase 2 monotherapy in japan
5235388|NCT00687180|Prednisolone dosage|prednisolone dosage
5235389|NCT00687167|Therapeutic Equivalency|therapeutic equivalency
5235390|NCT00687154|DME|dme
5235391|NCT00687154|Laser|laser
5235392|NCT00687154|macular edema|macular edema
5235393|NCT00687154|retinopathy|retinopathy
5235394|NCT00687154|scatter photocoagulation|scatter photocoagulation
5235395|NCT00687141|Safety|safety
5235396|NCT00687141|tolerability|tolerability
5235397|NCT00687141|AZD0328|azd0328
5235398|NCT00687128|Insulin resistance|insulin resistance
5235399|NCT00687128|Metabolic syndrome|metabolic syndrome
5235400|NCT00687128|Aerobic exercise|aerobic exercise
5235401|NCT00687128|Exercise behavior|exercise behavior
5235402|NCT00687115|24 Hour Energy Expenditure|24 hour energy expenditure
5235403|NCT00687115|Respiratory Chamber|respiratory chamber
5235404|NCT00687115|Obesity|obesity
5235405|NCT00687115|Weight Loss|weight loss
5235406|NCT00687115|Overfeeding|overfeeding
5235407|NCT00687102|breast cancer|breast cancer
5235408|NCT00687102|Tamoxifen|tamoxifen
5235409|NCT00687102|Raloxifene|raloxifene
5235410|NCT00687102|hormone therapy|hormone therapy
5235411|NCT00687089|Opiates|opiates
5235412|NCT00687089|Subutex|subutex
5235413|NCT00687089|Buprenorphine|buprenorphine
5235414|NCT00687089|Patients who addicted to opiates|patients who addicted to opiates
5235415|NCT00687076|Endovascular Intervention|endovascular intervention
5235416|NCT00687076|MRI|mri
5235417|NCT00687076|Ultrasound|ultrasound
5235418|NCT00687076|Cholesterol Medications|cholesterol medications
5235419|NCT00687076|High Cholesterol|high cholesterol
5235420|NCT00687076|Peripheral Arterial disease|peripheral arterial disease
5235421|NCT00687076|Claudication|claudication
5235422|NCT00687076|Leg Pain|leg pain
5235423|NCT00687076|Niaspan|niaspan
5235424|NCT00687076|Extended Release Niacin|extended release niacin
5235425|NCT00687076|Zetia|zetia
5235426|NCT00687076|Ezetimibe|ezetimibe
5235427|NCT00687076|Simvastatin|simvastatin
5235428|NCT00687076|Zocor|zocor
5235429|NCT00687076|Atorvastatin|atorvastatin
5235430|NCT00687076|Lipitor|lipitor
5235431|NCT00687050|end-stage renal disease|end-stage renal disease
5235432|NCT00687050|chronic kidney disease|chronic kidney disease
5235433|NCT00687037|oral hygiene|oral hygiene
5235434|NCT00687024|Epilepsy|epilepsy
5235435|NCT00687024|Magnetic Resonance Imaging|magnetic resonance imaging
5235436|NCT00687024|Magnetoencephalography|magnetoencephalography
5235437|NCT00687011|Antiemetic|antiemetic
5235438|NCT00686998|Schizophrenia|schizophrenia
5235439|NCT00686985|Docetaxel|docetaxel
5235440|NCT00686985|Carboplatin|carboplatin
5235441|NCT00686985|chemotherapy|chemotherapy
5235442|NCT00686985|relapse SCLC|relapse sclc
5235443|NCT00686972|Bariatric Surgery|bariatric surgery
5235444|NCT00686972|Glucose Regulation|glucose regulation
5235445|NCT00686972|Cardiac Function|cardiac function
5236209|NCT00683761|Brain Tumor|brain tumor
5235446|NCT00686972|Body Composition|body composition
5235447|NCT00686946|Severe mental illness|severe mental illness
5235448|NCT00686946|Antipsychotic medications|antipsychotic medications
5235449|NCT00686946|Pregnancy|pregnancy
5235450|NCT00686946|Evidence-based guidelines|evidence-based guidelines
5235451|NCT00686946|Maternal and infant health and wellbeing|maternal and infant health and wellbeing
5235452|NCT00686933|Attention-Deficit/Hyperactivity Disorder|attention-deficit/hyperactivity disorder
5235453|NCT00686907|melatonin, circadian rhythms, sleep|melatonin, circadian rhythms, sleep
5235454|NCT00686881|hepatitis C|hepatitis c
5235455|NCT00686868|GSK1841157;|gsk1841157;
5235456|NCT00686868|rheumatoid arthritis,|rheumatoid arthritis,
5235457|NCT00686868|B-cell depletion|b-cell depletion
5235458|NCT00686868|anti-CD20 monoclonal antibody,|anti-cd20 monoclonal antibody,
5235459|NCT00686855|tacrolimus|tacrolimus
5235460|NCT00686855|dexamethasone|dexamethasone
5235461|NCT00686855|oral rinse|oral rinse
5235462|NCT00686842|HIV infection|hiv infection
5235463|NCT00686842|AIDS-related Kaposi sarcoma|aids-related kaposi sarcoma
5235464|NCT00686842|recurrent Kaposi sarcoma|recurrent kaposi sarcoma
5235465|NCT00686842|Treatment Experienced|treatment experienced
5235466|NCT00686829|HIV|hiv
5235467|NCT00686829|Treatment Experienced|treatment experienced
5235468|NCT00686816|pre-diabetic|pre-diabetic
5235469|NCT00686816|obese|obese
5235470|NCT00686803|hypertension|hypertension
5235471|NCT00686803|controlled hypertension|controlled hypertension
5235472|NCT00686803|hypertensives|hypertensives
5235473|NCT00686790|Hepatitis D|hepatitis d
5235474|NCT00686790|Hepatitis B|hepatitis b
5235475|NCT00686777|hepatitis C|hepatitis c
5235476|NCT00686764|trans-femoral amputation|trans-femoral amputation
5235477|NCT00686738|osteosarcoma|osteosarcoma
5235478|NCT00686738|transforming growth factor-beta 1|transforming growth factor-beta 1
5235479|NCT00686738|nuclear factor-kappa B|nuclear factor-kappa b
5235480|NCT00686738|positron emission tomography/computed tomography|positron emission tomography/computed tomography
5235481|NCT00686738|magnetic resonance spectroscopy|magnetic resonance spectroscopy
5235482|NCT00686738|predicting response to neoadjuvant chemotherapy|predicting response to neoadjuvant chemotherapy
5235483|NCT00686712|Glargine|glargine
5235484|NCT00686712|Type 2 diabetes|type 2 diabetes
5235485|NCT00686712|Basal insulin|basal insulin
5235486|NCT00686699|Anti-Dyskinesia Agents|anti-dyskinesia agents
5235487|NCT00686699|Antipsychotic Agents|antipsychotic agents
5235488|NCT00686673|DECISION AIDS|decision aids
5235489|NCT00686660|copd|copd
5235490|NCT00686660|rehabilitation|rehabilitation
5235491|NCT00686660|quality of life|quality of life
5235492|NCT00686660|inflammation|inflammation
5235493|NCT00686647|Coronary Angioplasty|coronary angioplasty
5235494|NCT00686647|Coronary Stents|coronary stents
5235495|NCT00686647|Scoring Balloons|scoring balloons
5235496|NCT00686647|Coronary Artery Bifurcation Lesions|coronary artery bifurcation lesions
5235497|NCT00686634|sitagliptin|sitagliptin
5235498|NCT00686634|type 2 diabetes|type 2 diabetes
5235499|NCT00686634|combination therapy|combination therapy
5235500|NCT00686608|Obesity|obesity
5235501|NCT00686556|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5235502|NCT00686556|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5235503|NCT00686556|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5235504|NCT00686556|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5235505|NCT00686556|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5235506|NCT00686556|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5235507|NCT00686556|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5235508|NCT00686556|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5235509|NCT00686556|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5235511|NCT00686556|MDS|mds
5235512|NCT00686543|Antifungal Agents|antifungal agents
5235513|NCT00686543|Anti-Infective Agents|anti-infective agents
5235514|NCT00686530|Fetal Death|fetal death
5235515|NCT00686530|Magnetic Resonance Imaging|magnetic resonance imaging
5235516|NCT00686530|Autopsy|autopsy
5235517|NCT00686530|Telencephalon|telencephalon
5235518|NCT00686530|Pyramidal Tracts|pyramidal tracts
5235519|NCT00686504|Pain|pain
5235520|NCT00686504|PET|pet
5235521|NCT00686504|Phase 1|phase 1
5235522|NCT00686504|Analgesia|analgesia
5235523|NCT00686504|Positron Emission Tomography|positron emission tomography
5235524|NCT00686504|mGlu5 receptor|mglu5 receptor
5235525|NCT00686504|Dose finding|dose finding
5235526|NCT00686504|Analgesia/Pain|analgesia/pain
5235527|NCT00686491|Asthma|asthma
5235528|NCT00686491|Environment|environment
5235529|NCT00686491|Type of sport|type of sport
5235530|NCT00686491|Cardiovascular disease|cardiovascular disease
5235531|NCT00686491|Athletes|athletes
5235532|NCT00686478|burn|burn
5235533|NCT00686478|hypertrophic scar|hypertrophic scar
5235534|NCT00686478|fibroproliferative disorder|fibroproliferative disorder
5235535|NCT00686465|recurrent cancer|recurrent cancer
5235536|NCT00686465|PET/CT|pet/ct
5235537|NCT00686465|FDG|fdg
5235538|NCT00686465|planned management|planned management
5235539|NCT00686465|actual treatment|actual treatment
5235540|NCT00686452|Asthma|asthma
5235541|NCT00686452|Airway hyperresponsiveness|airway hyperresponsiveness
5235542|NCT00686452|Swimmers|swimmers
5235543|NCT00686452|Airway inflammation|airway inflammation
5235544|NCT00686452|Airway remodelling|airway remodelling
5235545|NCT00686439|osteoarthritis|osteoarthritis
5235546|NCT00686439|adalimumab|adalimumab
5235547|NCT00686439|mri|mri
5235548|NCT00686426|Obesity|obesity
5235549|NCT00686426|Weight gain|weight gain
5235550|NCT00686426|regain|regain
5235551|NCT00686426|dairy|dairy
5235552|NCT00686426|calcium|calcium
5235553|NCT00686413|PET|pet
5235554|NCT00686413|AZD3480|azd3480
5235555|NCT00686413|PET examination|pet examination
5235556|NCT00686400|schizophrenia|schizophrenia
5235557|NCT00686400|first-episode|first-episode
5235558|NCT00686400|infection|infection
5235559|NCT00686400|Toxoplasma gondii|toxoplasma gondii
5235560|NCT00686400|levels of IgG antibodies to TG|levels of igg antibodies to tg
5235561|NCT00686387|Tissue Bank|tissue bank
5235562|NCT00686387|Glioblastoma Multiforme|glioblastoma multiforme
5235563|NCT00686387|NAT2|nat2
5235564|NCT00686387|EGFR|egfr
5235565|NCT00686387|MGMT|mgmt
5235566|NCT00686387|Brain and Spinal TumorGliomas|brain and spinal tumorgliomas
5235567|NCT00686374|Crohn's Disease|crohn's disease
5235568|NCT00686374|adalimumab|adalimumab
5235569|NCT00686361|Cystic Fibrosis|cystic fibrosis
5235570|NCT00686361|choline nutrition|choline nutrition
5235571|NCT00686361|choline and methyl metabolism|choline and methyl metabolism
5235572|NCT00686361|CF and oxidative stress|cf and oxidative stress
5235573|NCT00686348|acromegaly|acromegaly
5235574|NCT00686335|asthma|asthma
5235575|NCT00686335|nocturnal asthma|nocturnal asthma
5235576|NCT00686335|glucocorticoid dependent persistent asthma|glucocorticoid dependent persistent asthma
5235577|NCT00686335|signs and symptoms|signs and symptoms
5235578|NCT00686335|lung function|lung function
5235579|NCT00686335|prednisone|prednisone
5235580|NCT00686322|chemotherapy|chemotherapy
5235581|NCT00686322|radiotherapy|radiotherapy
5235582|NCT00686322|lung cancer|lung cancer
5235583|NCT00686309|exhaled NO|exhaled no
5235584|NCT00686309|off line|off line
5235585|NCT00686309|on line|on line
5235586|NCT00686309|comparison|comparison
5235587|NCT00686309|Bland altman method|bland altman method
5235588|NCT00686296|soft tissue abscess requiring incision and drainage|soft tissue abscess requiring incision and drainage
5235589|NCT00686283|Adolescents|adolescents
5235590|NCT00686283|Diabetes|diabetes
5235591|NCT00686283|Exercise|exercise
5235592|NCT00686270|HIV-1 infection|hiv-1 infection
5235593|NCT00686270|NRTI resistance|nrti resistance
5235594|NCT00686270|M184V mutation|m184v mutation
5235595|NCT00686270|reverse transcriptase|reverse transcriptase
5235596|NCT00686270|apricitabine|apricitabine
5235597|NCT00686270|drug resistance|drug resistance
5235598|NCT00686270|safety and tolerability|safety and tolerability
5235599|NCT00686270|therapy failure|therapy failure
5235600|NCT00686270|Treatment Experienced|treatment experienced
5235601|NCT00686257|acute respiratory insufficiency|acute respiratory insufficiency
5235602|NCT00686257|noninvasive ventilation|noninvasive ventilation
5235603|NCT00686257|oronasal face mask|oronasal face mask
5235604|NCT00686257|total face mask|total face mask
5235605|NCT00686244|metabolic syndrome|metabolic syndrome
5235606|NCT00686244|physical activity|physical activity
5235607|NCT00686244|overweight|overweight
5235608|NCT00686244|malnutrition|malnutrition
5235609|NCT00686244|prevention|prevention
5235610|NCT00686231|To determine if topical nitroglycerin acts to vasodilate the radial artery by a direct local action, or by systemic vasodilation|to determine if topical nitroglycerin acts to vasodilate the radial artery by a direct local action, or by systemic vasodilation
5235611|NCT00686231|To determine if topical nitroglycerin dilates the radial artery in the presence of local anesthetic agents used in cardiac catheterization|to determine if topical nitroglycerin dilates the radial artery in the presence of local anesthetic agents used in cardiac catheterization
5235612|NCT00686218|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5235613|NCT00686205|healthy donors|healthy donors
5235614|NCT00686205|HIV positives|hiv positives
5235615|NCT00686192|Obesity|obesity
5235616|NCT00686192|Calcium carbonate|calcium carbonate
5235617|NCT00686192|Dietary Supplements|dietary supplements
5235618|NCT00686192|Lipolysis|lipolysis
5235619|NCT00686179|TQT|tqt
5235620|NCT00686179|ECG|ecg
5235621|NCT00686179|QT|qt
5235622|NCT00686179|QTc|qtc
5235623|NCT00686179|AZD3480|azd3480
5235624|NCT00686179|ECG(QTc effects)|ecg(qtc effects)
5235625|NCT00686166|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5235626|NCT00686166|stage IIA rectal cancer|stage iia rectal cancer
5235627|NCT00686166|stage IIB rectal cancer|stage iib rectal cancer
5235628|NCT00686166|stage IIC rectal cancer|stage iic rectal cancer
5235629|NCT00686166|stage IIIA rectal cancer|stage iiia rectal cancer
5235630|NCT00686166|stage IIIB rectal cancer|stage iiib rectal cancer
5235631|NCT00686166|stage IIIC rectal cancer|stage iiic rectal cancer
5235632|NCT00686140|Schizophrenia|schizophrenia
5235633|NCT00686140|clinical trial|clinical trial
5235634|NCT00686140|risperidone|risperidone
5235635|NCT00686140|immune|immune
5235636|NCT00686140|celecoxib|celecoxib
5235637|NCT00686127|breast cancer|breast cancer
5235638|NCT00686127|neuropathic pain|neuropathic pain
5235639|NCT00686127|topical lidocaine|topical lidocaine
5235640|NCT00686127|postmastectomy pain|postmastectomy pain
5235641|NCT00686127|breast symptoms|breast symptoms
5235642|NCT00686127|breast pain|breast pain
5235643|NCT00686114|Esophageal cancer|esophageal cancer
5235644|NCT00686114|chemoradiation|chemoradiation
5235645|NCT00686114|radiosensitivity|radiosensitivity
5235646|NCT00686114|EGFR inhibition|egfr inhibition
5235647|NCT00686101|Perception of risk|perception of risk
5235648|NCT00686101|Smoking risks|smoking risks
5235649|NCT00686101|Smoking consequences|smoking consequences
5235650|NCT00686101|Quitting smoking|quitting smoking
5235651|NCT00686101|Motivation to quit smoking|motivation to quit smoking
5235652|NCT00686101|Schizophrenia|schizophrenia
5235653|NCT00686088|prostate cancer|prostate cancer
5235654|NCT00686088|locally recurrent|locally recurrent
5235655|NCT00686088|PRX302|prx302
5235656|NCT00686075|Respiratory Syncytial Virus (RSV)|respiratory syncytial virus (rsv)
5235657|NCT00686075|Parainfluenza Virus Type 3 (PIV3)|parainfluenza virus type 3 (piv3)
5235658|NCT00686075|MEDI-534|medi-534
5235659|NCT00686062|Prenatal testing|prenatal testing
5235660|NCT00686062|Amniocentesis|amniocentesis
5235661|NCT00686062|Decision making|decision making
5235662|NCT00686062|Down syndrome|down syndrome
5235663|NCT00686049|HIV Treatment Readiness Measure (HTRM)|hiv treatment readiness measure (htrm)
5235664|NCT00686049|Highly Active Antiretroviral Treatment (HAART)|highly active antiretroviral treatment (haart)
5235665|NCT00686049|Adherence|adherence
5235666|NCT00686049|Treatment readiness|treatment readiness
5235667|NCT00686049|HIV|hiv
5235668|NCT00686036|prostate cancer|prostate cancer
5235669|NCT00686036|hormone treatment|hormone treatment
5235670|NCT00686023|pertrochanteric femur fracture|pertrochanteric femur fracture
5235671|NCT00686023|DHS|dhs
5235672|NCT00686023|IMN|imn
5235673|NCT00686010|CETP Inhibitor|cetp inhibitor
5235674|NCT00686010|HDL-C|hdl-c
5235675|NCT00686010|LDL-C|ldl-c
5235676|NCT00686010|Apolipoprotein|apolipoprotein
5235677|NCT00685997|Malignant lymphoma|malignant lymphoma
5235678|NCT00685997|Hodgkin's disease|hodgkin's disease
5235679|NCT00685997|Non-Hodgkin's lymphoma|non-hodgkin's lymphoma
5235680|NCT00685997|Imaging|imaging
5235681|NCT00685997|Whole-Body MRI|whole-body mri
5235682|NCT00685997|CT|ct
5235683|NCT00685997|Radiation|radiation
5235684|NCT00685984|Type 2 diabetes|type 2 diabetes
5235685|NCT00685984|silent myocardial ischemia|silent myocardial ischemia
5235686|NCT00685984|endothelial function|endothelial function
5235687|NCT00685971|Cystic Fibrosis|cystic fibrosis
5235688|NCT00685971|Vitamin D deficiency|vitamin d deficiency
5235689|NCT00685958|Blood thinner|blood thinner
5235690|NCT00685958|enoxaparin|enoxaparin
5235691|NCT00685958|hip fracture surgery|hip fracture surgery
5235692|NCT00685958|bleeding|bleeding
5235693|NCT00685958|thromboembolism|thromboembolism
5235694|NCT00685945|Bradykinin|bradykinin
5235695|NCT00685945|Obesity|obesity
5235696|NCT00685945|Nitric Oxide Donor|nitric oxide donor
5235697|NCT00685945|tissue type plasminogen activator|tissue type plasminogen activator
5235698|NCT00685945|isosorbide dinitrate|isosorbide dinitrate
5235699|NCT00685945|phosphodiesterase inhibitor|phosphodiesterase inhibitor
5235700|NCT00685945|Renin-Angiotensin Aldosterone System|renin-angiotensin aldosterone system
5235701|NCT00685945|Fibrinolysis|fibrinolysis
5235702|NCT00685945|Angiotensin converting enzyme|angiotensin converting enzyme
5235703|NCT00685932|Postpartum pain|postpartum pain
5235704|NCT00685932|Post-cesarean pain|post-cesarean pain
5235705|NCT00685932|Surgical retractor|surgical retractor
5235706|NCT00685932|Elastic retractor|elastic retractor
5235707|NCT00685919|Dopamine|dopamine
5235708|NCT00685919|Natriuresis|natriuresis
5235709|NCT00685919|Catecholamines|catecholamines
5235710|NCT00685906|oral contraceptive|oral contraceptive
5235711|NCT00685906|birth control|birth control
5235712|NCT00685906|Healthy volunteers|healthy volunteers
5235713|NCT00685893|End-of-life issues|end-of-life issues
5235714|NCT00685893|Talking with your doctor|talking with your doctor
5235715|NCT00685893|Coping with chronic illness|coping with chronic illness
5235716|NCT00685880|thumb carpo metacarpal joint osteoarthritis|thumb carpo metacarpal joint osteoarthritis
5235717|NCT00685880|prolotherapy|prolotherapy
5235718|NCT00685880|intra articular steroid|intra articular steroid
5235719|NCT00685880|hand therapy|hand therapy
5235720|NCT00685867|Staphylococcus aureus|staphylococcus aureus
5235721|NCT00685867|Resistance|resistance
5235722|NCT00685867|Prevention|prevention
5235723|NCT00685854|Macular Telangiectasia|macular telangiectasia
5235724|NCT00685854|Vascular Endothelial Growth Factor|vascular endothelial growth factor
5235725|NCT00685854|Ranibizumab|ranibizumab
5235726|NCT00685841|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
5235727|NCT00685828|gastrointestinal stromal tumor|gastrointestinal stromal tumor
5235728|NCT00685815|IV Iron|iv iron
5235729|NCT00685815|Restless Legs Syndrome|restless legs syndrome
5235730|NCT00685815|RLS|rls
5235731|NCT00685815|Iron|iron
5235732|NCT00685789|Bell's palsy，deqi，acupuncture, neuropsychology|bell's palsy，deqi，acupuncture, neuropsychology
5235733|NCT00685776|CHD/CHD risk-equivalent disease|chd/chd risk-equivalent disease
5235734|NCT00685776|Coronary Heart Disease (CHD)|coronary heart disease (chd)
5235735|NCT00685763|Pancreatic cancer|pancreatic cancer
5235736|NCT00685763|Unresectable|unresectable
5235737|NCT00685763|Proton radiation|proton radiation
5235738|NCT00685763|Chemotherapy|chemotherapy
5235739|NCT00685750|tumor antigen|tumor antigen
5235740|NCT00685750|biomarkers|biomarkers
5235741|NCT00685737|Hyperlipidemia|hyperlipidemia
5235742|NCT00685724|pathological gambling|pathological gambling
5235743|NCT00685724|cognitive-behavioral therapy|cognitive-behavioral therapy
5235744|NCT00685724|motivational enhancement therapy|motivational enhancement therapy
5235745|NCT00685711|Cat allergy|cat allergy
5235746|NCT00685711|Immunotherapy|immunotherapy
5235747|NCT00685711|Cat-PAD|cat-pad
5235748|NCT00685698|Diabetic Foot Infections, DFI, Nemonoxacin|diabetic foot infections, dfi, nemonoxacin
5235749|NCT00685685|Therapeutic Equivalency|therapeutic equivalency
5235750|NCT00685672|labor analgesia|labor analgesia
5235751|NCT00685672|fentanyl|fentanyl
5235752|NCT00685672|epinephrine|epinephrine
5235753|NCT00685659|cocaine dependence|cocaine dependence
5235754|NCT00685659|treatment|treatment
5235755|NCT00685659|continuing care|continuing care
5235756|NCT00685659|outcomes|outcomes
5235757|NCT00685659|incentives|incentives
5235758|NCT00685659|adaptive|adaptive
5235759|NCT00685646|bone metastases|bone metastases
5235760|NCT00685646|stage IV prostate cancer|stage iv prostate cancer
5235761|NCT00685633|stage I prostate cancer|stage i prostate cancer
5235762|NCT00685633|stage II prostate cancer|stage ii prostate cancer
5235763|NCT00685633|stage III prostate cancer|stage iii prostate cancer
5235764|NCT00685633|recurrent prostate cancer|recurrent prostate cancer
5235765|NCT00685607|Pilot Study|pilot study
5235766|NCT00685607|Outcome Measures|outcome measures
5235767|NCT00685594|diabetes|diabetes
5235768|NCT00685594|vitamin D|vitamin d
5235769|NCT00685594|cholecalciferol|cholecalciferol
5235770|NCT00685594|glucose tolerance|glucose tolerance
5235771|NCT00685581|TFA|tfa
5235772|NCT00685581|SFA|sfa
5235773|NCT00685581|Clinical trial|clinical trial
5235774|NCT00685581|fat milk|fat milk
5235775|NCT00685568|colon cancer|colon cancer
5235776|NCT00685568|rectal cancer|rectal cancer
5235777|NCT00685568|familial adenomatous polyposis|familial adenomatous polyposis
5235778|NCT00685555|Screen time|screen time
5235779|NCT00685555|Fruits and Vegetable Consumption|fruits and vegetable consumption
5235780|NCT00685555|Physical Activity|physical activity
5235781|NCT00685555|Obesity|obesity
5235782|NCT00685555|Overweight|overweight
5235783|NCT00685542|diacerein|diacerein
5235784|NCT00685542|osteoarthritis|osteoarthritis
5235785|NCT00685542|hand|hand
5235786|NCT00685529|COPD|copd
5235787|NCT00685529|Arformoterol|arformoterol
5235788|NCT00685529|formoterol|formoterol
5235789|NCT00685516|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5235790|NCT00685516|recurrent prostate cancer|recurrent prostate cancer
5235791|NCT00685516|stage I prostate cancer|stage i prostate cancer
5235792|NCT00685516|stage II prostate cancer|stage ii prostate cancer
5235793|NCT00685516|stage III prostate cancer|stage iii prostate cancer
5235794|NCT00685516|stage IV prostate cancer|stage iv prostate cancer
5235795|NCT00685503|Macular Telangiectasia|macular telangiectasia
5235796|NCT00685503|Vascular Endothelial Growth Factor|vascular endothelial growth factor
5235797|NCT00685503|Ranibizumab|ranibizumab
5235798|NCT00685503|Neovascularization|neovascularization
5235799|NCT00685490|branch retinal vein occlusion|branch retinal vein occlusion
5235800|NCT00685490|internal limiting membrane|internal limiting membrane
5235801|NCT00685490|macular edema|macular edema
5235802|NCT00685490|vitrectomy|vitrectomy
5235803|NCT00685477|CCK infusion|cck infusion
5235804|NCT00685477|Gallbladder ejection fraction|gallbladder ejection fraction
5235805|NCT00685477|Normal volunteers|normal volunteers
5235806|NCT00685464|Abciximab|abciximab
5235807|NCT00685464|Reo-Pro|reo-pro
5235808|NCT00685464|Intracoronary|intracoronary
5235809|NCT00685464|PCI|pci
5235810|NCT00685451|cognitive behavior therapy|cognitive behavior therapy
5235811|NCT00685451|addiction|addiction
5235812|NCT00685451|PTSD|ptsd
5235813|NCT00685438|Environmental Medicine|environmental medicine
5235814|NCT00685438|Altitude|altitude
5235815|NCT00685438|Ultraviolet Rays|ultraviolet rays
5235816|NCT00685438|Antioxidants|antioxidants
5235817|NCT00685438|Oxidative Stress|oxidative stress
5235818|NCT00685438|Erythema|erythema
5235819|NCT00685425|Asthma|asthma
5235820|NCT00685425|Exercised induced bronchoconstriction|exercised induced bronchoconstriction
5235821|NCT00685412|CIN 2 or 3|cin 2 or 3
5235822|NCT00685412|cervical cancer|cervical cancer
5235823|NCT00685399|Uveitis|uveitis
5235824|NCT00685399|eye|eye
5235825|NCT00685399|IL-17|il-17
5235826|NCT00685399|IL-17A|il-17a
5235827|NCT00685399|IL17|il17
5235828|NCT00685399|AIN457|ain457
5235829|NCT00685399|Vogt-Koyanagi-Harada|vogt-koyanagi-harada
5235830|NCT00685399|Behcet's|behcet's
5235831|NCT00685399|Behcet|behcet
5235832|NCT00685399|Sympathetic ophthalmia|sympathetic ophthalmia
5235833|NCT00685399|Multifocal choroiditis|multifocal choroiditis
5235834|NCT00685399|Birdshot|birdshot
5235835|NCT00685399|HLA-B27|hla-b27
5235836|NCT00685399|Birdshot retinochoroiditis|birdshot retinochoroiditis
5235837|NCT00685399|Retinal vasculitis|retinal vasculitis
5235838|NCT00685399|Sarcoidosis|sarcoidosis
5235839|NCT00685399|Intermediate uveitis|intermediate uveitis
5235840|NCT00685399|Panuveitis|panuveitis
5235841|NCT00685399|Posterior uveitis|posterior uveitis
5235842|NCT00685386|endoscopic retrograde cholangiopancreatography|endoscopic retrograde cholangiopancreatography
5235843|NCT00685386|carbon dioxide|carbon dioxide
5235844|NCT00685386|randomized controlled clinical trial|randomized controlled clinical trial
5235845|NCT00685373|Cryopyrin-associated periodic syndromes (CAPS):|cryopyrin-associated periodic syndromes (caps):
5235846|NCT00685373|Familial Cold Autoinflammatory Syndrome (FCAS),|familial cold autoinflammatory syndrome (fcas),
5235847|NCT00685373|Muckle-Wells Syndrome (MWS),|muckle-wells syndrome (mws),
5235848|NCT00685373|MWS with overlapping symptoms of Neonatal Onset Multisystem Inflammatory Disease (NOMID) or Neonatal Onset Multisystem Inflammatory Disease (NOMID),|mws with overlapping symptoms of neonatal onset multisystem inflammatory disease (nomid) or neonatal onset multisystem inflammatory disease (nomid),
5235849|NCT00685373|children,|children,
5235850|NCT00685373|systemic autoinflammatory disease,|systemic autoinflammatory disease,
5235851|NCT00685373|CIAS-1 gene,|cias-1 gene,
5235852|NCT00685373|NALP-3,|nalp-3,
5235853|NCT00685373|ACZ885,|acz885,
5235854|NCT00685373|human monoclonal anti-human interleukin-1beta (IL-1beta),|human monoclonal anti-human interleukin-1beta (il-1beta),
5235855|NCT00685373|antibody,|antibody,
5235856|NCT00685373|autosomal dominant,|autosomal dominant,
5235857|NCT00685373|familial autoinflammatory syndrome|familial autoinflammatory syndrome
5235858|NCT00685360|Tuberculosis|tuberculosis
5235859|NCT00685360|Pulmonary|pulmonary
5235860|NCT00685360|Multidrug resistant|multidrug resistant
5235861|NCT00685360|Antitubercular Agents|antitubercular agents
5235862|NCT00685360|OPC 67683|opc 67683
5235863|NCT00685347|Asthma|asthma
5235864|NCT00685347|Exercised induced bronchoconstriction|exercised induced bronchoconstriction
5235865|NCT00685334|Atypical Antipsychotics|atypical antipsychotics
5235866|NCT00685334|Anorexia Nervosa|anorexia nervosa
5235867|NCT00685321|schizophrenia|schizophrenia
5235868|NCT00685321|TMS|tms
5235869|NCT00685321|brain stimulation|brain stimulation
5235870|NCT00685321|negative symptoms|negative symptoms
5235871|NCT00685321|clinical improvement|clinical improvement
5235872|NCT00685321|cognitive improvement|cognitive improvement
5235873|NCT00685308|Atherosclerosis|atherosclerosis
5235874|NCT00685308|Intracranial artery|intracranial artery
5235875|NCT00685308|Angioplasty|angioplasty
5235876|NCT00685308|Stent|stent
5235877|NCT00685295|Emergency Department|emergency department
5235878|NCT00685295|acute|acute
5235879|NCT00685269|Obstructive Sleep Apnea Syndrome|obstructive sleep apnea syndrome
5235880|NCT00685269|OSAS|osas
5235881|NCT00685256|breast cancer|breast cancer
5235882|NCT00685256|hereditary breast/ovarian cancer (BRCA1, BRCA2)|hereditary breast/ovarian cancer (brca1, brca2)
5235883|NCT00685243|Fraxel|fraxel
5235884|NCT00685243|Pulsed dye laser|pulsed dye laser
5235885|NCT00685243|Surgical scars|surgical scars
5235886|NCT00685230|scorpion sting|scorpion sting
5235887|NCT00685230|envenomation|envenomation
5235888|NCT00685230|alacramyn|alacramyn
5235889|NCT00685191|Raltegravir|raltegravir
5235890|NCT00685191|HIV|hiv
5235891|NCT00685191|dynamics|dynamics
5235892|NCT00685191|viral load|viral load
5235893|NCT00685191|Treatment Experienced|treatment experienced
5235894|NCT00685178|addiction|addiction
5235895|NCT00685178|drug dependence|drug dependence
5235896|NCT00685178|stimulant|stimulant
5235897|NCT00685139|Therapeutic Equivalency|therapeutic equivalency
5235898|NCT00685126|RAD|rad
5235899|NCT00685126|Reactive Airways Disease|reactive airways disease
5235900|NCT00685126|Levalbuterol|levalbuterol
5235901|NCT00685126|Racemic albuterol|racemic albuterol
5235902|NCT00685100|IVTA; CNV; age-related macular degeneration; PDT|ivta; cnv; age-related macular degeneration; pdt
5235903|NCT00685087|To define the natural history and the clinical, laboratory and histomorphometric features of chronic pancreatitis (CP).|to define the natural history and the clinical, laboratory and histomorphometric features of chronic pancreatitis (cp).
5235904|NCT00685087|To identify clinical and laboratory parameters that correlate with the pathophysiologic state in patients with CP.|to identify clinical and laboratory parameters that correlate with the pathophysiologic state in patients with cp.
5235905|NCT00685087|To quantify the behavioral abnormalities associated with CP.|to quantify the behavioral abnormalities associated with cp.
5235906|NCT00685087|To determine psychological and behavioral correlates of CP disease progression and outcomes.|to determine psychological and behavioral correlates of cp disease progression and outcomes.
5235907|NCT00685074|Motivational Interview|motivational interview
5235908|NCT00685074|Computer based intervention|computer based intervention
5235909|NCT00685074|Substance abuse|substance abuse
5235910|NCT00685074|post-partum|post-partum
5235911|NCT00685061|Adult, primary deceased donor kidney transplant recipients|adult, primary deceased donor kidney transplant recipients
5235912|NCT00685048|Gambling|gambling
5235913|NCT00685048|Brief Therapies|brief therapies
5235914|NCT00685048|Substance Abuse|substance abuse
5235915|NCT00685035|high frequency chest wall oscillation, cystic fibrosis|high frequency chest wall oscillation, cystic fibrosis
5235916|NCT00685022|Asthma|asthma
5235917|NCT00685022|Racemic albuterol|racemic albuterol
5235918|NCT00685009|Cognition|cognition
5235919|NCT00685009|Memory|memory
5235920|NCT00685009|Hormone Therapy|hormone therapy
5235921|NCT00684983|IGF-1R|igf-1r
5235922|NCT00684983|IMC-A12|imc-a12
5235923|NCT00684970|CRPC|crpc
5235924|NCT00684970|HRPC|hrpc
5235925|NCT00684970|metastatic prostate cancer|metastatic prostate cancer
5235926|NCT00684931|Attention|attention
5235927|NCT00684931|Deficit|deficit
5235928|NCT00684931|Disorder|disorder
5235929|NCT00684931|Hyperactivity|hyperactivity
5235930|NCT00684931|cerebellum|cerebellum
5235931|NCT00684931|alteration|alteration
5235932|NCT00684931|fronto-cerebello-frontal loops|fronto-cerebello-frontal loops
5235933|NCT00684918|AML, obatoclax|aml, obatoclax
5235934|NCT00684905|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5235935|NCT00684905|recurrent prostate cancer|recurrent prostate cancer
5235936|NCT00684905|stage I prostate cancer|stage i prostate cancer
5235937|NCT00684905|stage II prostate cancer|stage ii prostate cancer
5235938|NCT00684905|stage III prostate cancer|stage iii prostate cancer
5235939|NCT00684892|Emphysema|emphysema
5235940|NCT00684892|Endobronchial Lung Volume Reduction|endobronchial lung volume reduction
5235941|NCT00684879|Hereditary Hemorrhagic Telangiectasia|hereditary hemorrhagic telangiectasia
5235942|NCT00684879|Health Belief Model|health belief model
5235943|NCT00684879|Illness Perceptions|illness perceptions
5235944|NCT00684879|Screening|screening
5235945|NCT00684879|HHT|hht
5235946|NCT00684866|Asthma|asthma
5235947|NCT00684866|Levalbuterol|levalbuterol
5235948|NCT00684866|Racemic Albuterol|racemic albuterol
5235949|NCT00684853|AMD|amd
5235950|NCT00684853|PDT|pdt
5235951|NCT00684853|Avastin|avastin
5235952|NCT00684853|Bevacizumab|bevacizumab
5235953|NCT00684853|Full fluence|full fluence
5235954|NCT00684853|exudative|exudative
5235955|NCT00684853|CNV|cnv
5235956|NCT00684853|Drusen|drusen
5235957|NCT00684853|ARMD|armd
5235958|NCT00684853|Vetaporfin|vetaporfin
5235959|NCT00684853|efficacy|efficacy
5235960|NCT00684853|treatment|treatment
5235961|NCT00684840|Behavioral Economics|behavioral economics
5235962|NCT00684840|Drug self administration|drug self administration
5235963|NCT00684840|Opioid|opioid
5235964|NCT00684827|Asthma|asthma
5235965|NCT00684827|Racemic albuterol|racemic albuterol
5235966|NCT00684814|equivalency|equivalency
5235967|NCT00684814|Therapeutic equivalency|therapeutic equivalency
5235968|NCT00684801|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5235969|NCT00684801|recurrent small cell lung cancer|recurrent small cell lung cancer
5235970|NCT00684801|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5235971|NCT00684801|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5235972|NCT00684801|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5235973|NCT00684801|extensive stage small cell lung cancer|extensive stage small cell lung cancer
5235974|NCT00684801|recurrent pancreatic cancer|recurrent pancreatic cancer
5235975|NCT00684801|stage III pancreatic cancer|stage iii pancreatic cancer
5235976|NCT00684801|stage IV pancreatic cancer|stage iv pancreatic cancer
5235977|NCT00684801|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5235978|NCT00684801|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
5235979|NCT00684801|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5235980|NCT00684801|stage III ovarian germ cell tumor|stage iii ovarian germ cell tumor
5235981|NCT00684801|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5235982|NCT00684801|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
5235983|NCT00684801|recurrent colon cancer|recurrent colon cancer
5235984|NCT00684801|stage III colon cancer|stage iii colon cancer
5235985|NCT00684801|stage IV colon cancer|stage iv colon cancer
5235986|NCT00684801|recurrent rectal cancer|recurrent rectal cancer
5235987|NCT00684801|stage III rectal cancer|stage iii rectal cancer
5235988|NCT00684801|stage IV rectal cancer|stage iv rectal cancer
5235989|NCT00684788|opiate dependence|opiate dependence
5235990|NCT00684788|naltrexone|naltrexone
5235991|NCT00684788|reinforcement|reinforcement
5235992|NCT00684788|behavior therapy|behavior therapy
5235993|NCT00684788|cocaine dependence|cocaine dependence
5235994|NCT00684788|risk reduction behavior|risk reduction behavior
5235995|NCT00684749|Mentor BodyLogic TM System|mentor bodylogic tm system
5235996|NCT00684749|Breast augmentation|breast augmentation
5235997|NCT00684749|Breast implant choice|breast implant choice
5235998|NCT00684749|Reoperation rates|reoperation rates
5235999|NCT00684736|septic shock|septic shock
5236000|NCT00684736|shock|shock
5236001|NCT00684736|serotonin|serotonin
5236002|NCT00684736|kynurenine|kynurenine
5236003|NCT00684736|tryptophan|tryptophan
5236004|NCT00684723|Therapeutic Equivalency|therapeutic equivalency
5236005|NCT00684710|Alzheimer Disease|alzheimer disease
5236006|NCT00684697|premature infants iron neurodevelopment|premature infants iron neurodevelopment
5236007|NCT00684684|Bronchoscopy|bronchoscopy
5236008|NCT00684684|Clinically indicated for routine diagnostic bronchoscopy|clinically indicated for routine diagnostic bronchoscopy
5236009|NCT00684671|Immune memory|immune memory
5236010|NCT00684671|Combined hepatitis A and B vaccine|combined hepatitis a and b vaccine
5236011|NCT00684671|> 41 years old|> 41 years old
5236012|NCT00684658|Type 1 Diabetes|type 1 diabetes
5236013|NCT00684658|Children and Teenagers|children and teenagers
5236210|NCT00683761|GBM|gbm
5236014|NCT00684658|Coping with Chronic Illness|coping with chronic illness
5236015|NCT00684658|Adolescence|adolescence
5236016|NCT00684658|Internet psychosocial program|internet psychosocial program
5236017|NCT00684658|Coping Skills Training|coping skills training
5236018|NCT00684645|Safety and tolerability of SUTENT® in patients with metastatic or advanced renal cell carcinoma after failure of cytokines in real-life setting.|safety and tolerability of sutent® in patients with metastatic or advanced renal cell carcinoma after failure of cytokines in real-life setting.
5236019|NCT00684632|Pain, cancer|pain, cancer
5236020|NCT00684606|Induction of Labor|induction of labor
5236021|NCT00684606|Low Bishop Score|low bishop score
5236022|NCT00684606|Transcervical Foley Catheter.|transcervical foley catheter.
5236023|NCT00684606|IV Oxytocin|iv oxytocin
5236024|NCT00684580|St. Jude Alumni|st. jude alumni
5236025|NCT00684580|St. Jude Life Participants|st. jude life participants
5236026|NCT00684554|Heroin Dependence|heroin dependence
5236027|NCT00684554|Opioid Dependence|opioid dependence
5236028|NCT00684554|Primary Care|primary care
5236029|NCT00684554|Buprenorphine|buprenorphine
5236030|NCT00684541|Social Anxiety|social anxiety
5236031|NCT00684541|Information Processing|information processing
5236032|NCT00684541|Interpretation|interpretation
5236033|NCT00684528|DM 2|dm 2
5236034|NCT00684528|Metformin|metformin
5236035|NCT00684528|Januvia|januvia
5236036|NCT00684528|Community setting|community setting
5236037|NCT00684528|newly diagnosed diadetics, or diabetes patients not treated during the last year|newly diagnosed diadetics, or diabetes patients not treated during the last year
5236038|NCT00684502|Safety|safety
5236039|NCT00684502|tolerability|tolerability
5236040|NCT00684502|AZD2066|azd2066
5236041|NCT00684502|Pain conditions|pain conditions
5236042|NCT00684489|hypertension|hypertension
5236043|NCT00684489|renin-guided therapeutics|renin-guided therapeutics
5236044|NCT00684463|Antiemetic|antiemetic
5236045|NCT00684450|titration of protamine|titration of protamine
5236046|NCT00684450|exact dose|exact dose
5236047|NCT00684450|protamine|protamine
5236048|NCT00684450|neutralize heparin|neutralize heparin
5236049|NCT00684437|Health Literacy|health literacy
5236050|NCT00684437|Smoking Risk|smoking risk
5236051|NCT00684437|Focus Group|focus group
5236052|NCT00684437|Questionnaire|questionnaire
5236053|NCT00684437|Survey|survey
5236054|NCT00684411|T NHL|t nhl
5236055|NCT00684411|Gleevec|gleevec
5236056|NCT00684411|imatinib mesylate|imatinib mesylate
5236057|NCT00684398|Neurofibromatosis Type 1|neurofibromatosis type 1
5236058|NCT00684398|Quality of Life|quality of life
5236059|NCT00684398|Adaptation|adaptation
5236060|NCT00684398|Stress and Coping Model|stress and coping model
5236061|NCT00684398|NF1|nf1
5236062|NCT00684398|Survey|survey
5236063|NCT00684359|Patients having PCI with a drug eluting stent|patients having pci with a drug eluting stent
5236064|NCT00684346|18FDG-PET imaging|18fdg-pet imaging
5236065|NCT00684346|airway inflammation|airway inflammation
5236066|NCT00684346|cystic fibrosis|cystic fibrosis
5236067|NCT00684346|pediatric|pediatric
5236068|NCT00684346|pulmonary exacerbation|pulmonary exacerbation
5236069|NCT00684333|painless Injections|painless injections
5236070|NCT00684333|Subcutaneous Injections|subcutaneous injections
5236071|NCT00684333|Subcutaneous Injections to healthy volunteers|subcutaneous injections to healthy volunteers
5236072|NCT00684320|Social Anxiety Disorder|social anxiety disorder
5236073|NCT00684320|Information Processing|information processing
5236074|NCT00684320|Attention Bias|attention bias
5236075|NCT00684307|Anticoagulant Treatment|anticoagulant treatment
5236076|NCT00684307|Risk Factors For Stroke|risk factors for stroke
5236077|NCT00684294|cancer|cancer
5236078|NCT00684294|oncology|oncology
5236079|NCT00684294|solid tumor|solid tumor
5236080|NCT00684268|silibinin|silibinin
5236081|NCT00684268|chronic hepatitis C|chronic hepatitis c
5236082|NCT00684268|peginterferon|peginterferon
5236083|NCT00684268|ribavirin|ribavirin
5236084|NCT00684268|nonresponders|nonresponders
5236085|NCT00684268|efficacy of iv. silibinin|efficacy of iv. silibinin
5236086|NCT00684268|safety|safety
5236087|NCT00684255|Autoimmune Disease|autoimmune disease
5236088|NCT00684255|Reduced Intensity Transplant|reduced intensity transplant
5236089|NCT00684242|Advanced Cancer|advanced cancer
5236090|NCT00684242|Refractory Cancer Pain|refractory cancer pain
5236091|NCT00684242|Lenalidomide|lenalidomide
5236092|NCT00684242|Revlimid|revlimid
5236093|NCT00684242|CC-5103|cc-5103
5236094|NCT00684229|Anesthesia; regional|anesthesia; regional
5236095|NCT00684229|Cancer recurrence|cancer recurrence
5236096|NCT00684229|Anesthesia; inhalational|anesthesia; inhalational
5236097|NCT00684229|Analgesia; opioid|analgesia; opioid
5236098|NCT00684216|metastatic|metastatic
5236099|NCT00684216|ER positive|er positive
5236100|NCT00684216|PD during/after first line hormonal treatment|pd during/after first line hormonal treatment
5236101|NCT00684190|Reflux Inhibitor|reflux inhibitor
5236102|NCT00684190|GERD|gerd
5236103|NCT00684190|PPI Interaction|ppi interaction
5236104|NCT00684177|infection|infection
5236105|NCT00684177|retapamulin|retapamulin
5236106|NCT00684177|secondarily-infected traumatic lesions|secondarily-infected traumatic lesions
5236107|NCT00684177|placebo|placebo
5236108|NCT00684164|Euvolemic Hyponatremia|euvolemic hyponatremia
5236109|NCT00684164|Hypervolemic Hyponatremia|hypervolemic hyponatremia
5236110|NCT00684164|Neurological injury|neurological injury
5236111|NCT00684151|Lipid-lowering|lipid-lowering
5236112|NCT00684138|cataract|cataract
5236113|NCT00684138|cataract surgery|cataract surgery
5236114|NCT00684138|IOL|iol
5236115|NCT00684138|intraocular lens|intraocular lens
5236116|NCT00684138|ReSTOR|restor
5236117|NCT00684138|Replacement of cataract|replacement of cataract
5236118|NCT00684125|late cardiac tamponade|late cardiac tamponade
5236119|NCT00684112|pediatrics|pediatrics
5236120|NCT00684112|Scoliosis|scoliosis
5236121|NCT00684112|Gabapentin|gabapentin
5236122|NCT00684099|NSCLC|nsclc
5236123|NCT00684099|Pemetrexed|pemetrexed
5236124|NCT00684099|Docetaxel|docetaxel
5236125|NCT00684073|Suboxone|suboxone
5236126|NCT00684073|Subutex|subutex
5236127|NCT00684073|Buprenorphine|buprenorphine
5236128|NCT00684073|Naloxone|naloxone
5236129|NCT00684060|Acute Myocardial Infarction|acute myocardial infarction
5236130|NCT00684060|Global Left Ventricular Ejection Fraction|global left ventricular ejection fraction
5236131|NCT00684060|Regional Left Ventricular Ejection Fraction|regional left ventricular ejection fraction
5236132|NCT00684060|Left Ventricular Mass|left ventricular mass
5236133|NCT00684060|Infarct Size|infarct size
5236134|NCT00684060|End Systolic Volume|end systolic volume
5236135|NCT00684060|End Diastolic Volume|end diastolic volume
5236136|NCT00684047|Fibrin Sealant|fibrin sealant
5236137|NCT00684047|Hemostasis|hemostasis
5236138|NCT00684047|Peripheral Vascular Surgery|peripheral vascular surgery
5236139|NCT00684034|Redox state in the course of chronic renal insufficiency and hemodialysis.|redox state in the course of chronic renal insufficiency and hemodialysis.
5236140|NCT00684021|Acute Myocardial Infarction|acute myocardial infarction
5236141|NCT00684021|Global Left Ventricular Ejection Fraction|global left ventricular ejection fraction
5236142|NCT00684021|Regional Left Ventricular Ejection Fraction|regional left ventricular ejection fraction
5236143|NCT00684021|Left Ventricular Mass|left ventricular mass
5236144|NCT00684021|Infarct Size|infarct size
5236145|NCT00684021|End Systolic Volume|end systolic volume
5236146|NCT00684021|End Diastolic Volume|end diastolic volume
5236147|NCT00684008|interleukin-7|interleukin-7
5236148|NCT00684008|immune based therapies|immune based therapies
5236149|NCT00684008|graft vs host disease|graft vs host disease
5236150|NCT00684008|immune reconstitution|immune reconstitution
5236151|NCT00684008|infection|infection
5236152|NCT00684008|lymphopenia|lymphopenia
5236153|NCT00684008|hematopoetic stem cell transplantation|hematopoetic stem cell transplantation
5236154|NCT00684008|bone marrow transplantation|bone marrow transplantation
5236155|NCT00684008|peripheral blood stem cell transplant|peripheral blood stem cell transplant
5236156|NCT00684008|immunosuppression|immunosuppression
5236157|NCT00683995|Pain, Cancer|pain, cancer
5236158|NCT00683982|nitazoxanide|nitazoxanide
5236159|NCT00683982|Probiotics|probiotics
5236160|NCT00683982|Diarrhea|diarrhea
5236161|NCT00683982|Rotavirus|rotavirus
5236162|NCT00683982|Children|children
5236163|NCT00683943|Spinocerebellar Ataxia|spinocerebellar ataxia
5236164|NCT00683943|Lithium|lithium
5236165|NCT00683917|Uterine fibroids|uterine fibroids
5236166|NCT00683917|Fibroids|fibroids
5236167|NCT00683891|FOCUS|focus
5236168|NCT00683891|Weight gain|weight gain
5236169|NCT00683891|Sialorrhea|sialorrhea
5236170|NCT00683891|Treatment refractory schizophrenia|treatment refractory schizophrenia
5236171|NCT00683891|FazaClo|fazaclo
5236172|NCT00683891|Treatment resistant schizophrenia|treatment resistant schizophrenia
5236173|NCT00683891|clozapine|clozapine
5236174|NCT00683891|Hypersalivation|hypersalivation
5236175|NCT00683865|Antibiotic treatment|antibiotic treatment
5236176|NCT00683865|Pelvic infection|pelvic infection
5236177|NCT00683865|Interventional study|interventional study
5236178|NCT00683865|Female|female
5236179|NCT00683852|Depression|depression
5236180|NCT00683839|Tobacco|tobacco
5236181|NCT00683839|Smoking|smoking
5236182|NCT00683839|Smokeless|smokeless
5236183|NCT00683839|Cessation|cessation
5236184|NCT00683839|Public health clinic|public health clinic
5236185|NCT00683839|Dental patients|dental patients
5236186|NCT00683839|5 As|5 as
5236187|NCT00683839|NRT|nrt
5236188|NCT00683839|Tobacco Quit Line|tobacco quit line
5236189|NCT00683839|Smokeless tobacco|smokeless tobacco
5236190|NCT00683826|Leucine|leucine
5236191|NCT00683826|Weight Loss|weight loss
5236192|NCT00683813|cardiac rehabilitation|cardiac rehabilitation
5236193|NCT00683813|telehealth|telehealth
5236194|NCT00683813|Internet|internet
5236195|NCT00683800|Menopause|menopause
5236196|NCT00683800|Hot Flush|hot flush
5236197|NCT00683800|Hot Flash|hot flash
5236198|NCT00683800|Desvenlafaxine succinate Sustained Release|desvenlafaxine succinate sustained release
5236199|NCT00683787|recurrent gastric cancer|recurrent gastric cancer
5236200|NCT00683787|stage IV gastric cancer|stage iv gastric cancer
5236201|NCT00683787|adenocarcinoma of the stomach|adenocarcinoma of the stomach
5236202|NCT00683761|High grade recurrent glioma|high grade recurrent glioma
5236203|NCT00683761|Phase 2|phase 2
5236204|NCT00683761|Phase 1|phase 1
5236205|NCT00683761|Multi-center|multi-center
5236206|NCT00683761|Open label|open label
5236207|NCT00683761|Multiple dose|multiple dose
5236208|NCT00683761|Brain Cancer|brain cancer
5236211|NCT00683761|glioma|glioma
5236212|NCT00683761|glioblastoma|glioblastoma
5236213|NCT00683761|astrocytoma|astrocytoma
5236214|NCT00683761|oligodendroglioma|oligodendroglioma
5236215|NCT00683761|131I-TM601|131i-tm601
5236216|NCT00683761|TM601|tm601
5236217|NCT00683748|Transplantation|transplantation
5236218|NCT00683748|Immunological monitoring|immunological monitoring
5236219|NCT00683748|Immunological risk|immunological risk
5236220|NCT00683748|T cell reactivity|t cell reactivity
5236221|NCT00683748|Cellular immunity|cellular immunity
5236222|NCT00683735|Incretin, DPP-4, metformin, sitagliptin, insulin secretion|incretin, dpp-4, metformin, sitagliptin, insulin secretion
5236223|NCT00683722|COPD|copd
5236224|NCT00683722|Airflow Obstruction, Chronic|airflow obstruction, chronic
5236225|NCT00683722|Chronic Airflow Obstruction|chronic airflow obstruction
5236226|NCT00683722|Chronic Obstructive Airway Disease|chronic obstructive airway disease
5236227|NCT00683722|Chronic Obstructive Lung Disease|chronic obstructive lung disease
5236228|NCT00683722|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5236229|NCT00683722|Pulmonary Emphysema|pulmonary emphysema
5236230|NCT00683722|Chronic Bronchitis|chronic bronchitis
5236231|NCT00683722|Mesenchymal Stem Cells|mesenchymal stem cells
5236232|NCT00683722|MSCs|mscs
5236233|NCT00683722|Adult Human Stem Cells|adult human stem cells
5236234|NCT00683722|Osiris|osiris
5236235|NCT00683722|Prochymal|prochymal
5236236|NCT00683709|Bipolar and Schizoaffective Disorder|bipolar and schizoaffective disorder
5236237|NCT00683709|Clozapine|clozapine
5236238|NCT00683709|Metabolic Side Effects|metabolic side effects
5236239|NCT00683709|Diet & Exercise|diet & exercise
5236240|NCT00683709|BMI|bmi
5236241|NCT00683696|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
5236242|NCT00683696|Heart Failure|heart failure
5236243|NCT00683696|Ventricular Dyssynchrony|ventricular dyssynchrony
5236244|NCT00683696|Mechanical Dyssynchrony|mechanical dyssynchrony
5236245|NCT00683696|Intraventricular Dyssynchrony|intraventricular dyssynchrony
5236246|NCT00683696|Echocardiography|echocardiography
5236247|NCT00683696|Normal QRS|normal qrs
5236248|NCT00683696|Heart Disease|heart disease
5236249|NCT00683696|EchoCRT|echocrt
5236250|NCT00683683|cardiac arrest, hypothermia, knowledge translation|cardiac arrest, hypothermia, knowledge translation
5236251|NCT00683644|tinnitus, zinc|tinnitus, zinc
5236252|NCT00683631|liver cancer|liver cancer
5236253|NCT00683631|liver tumor|liver tumor
5236254|NCT00683631|HCC|hcc
5236255|NCT00683631|hepatocellular carcinoma|hepatocellular carcinoma
5236256|NCT00683631|hepatoma|hepatoma
5236257|NCT00683618|HMG-CoA|hmg-coa
5236258|NCT00683618|LDL-C|ldl-c
5236259|NCT00683618|CHD|chd
5236260|NCT00683579|HAART|haart
5236261|NCT00683579|DHHS guidelines|dhhs guidelines
5236262|NCT00683579|Treatment Naive|treatment naive
5236263|NCT00683566|parkinson|parkinson
5236264|NCT00683553|Acute Renal Failure|acute renal failure
5236265|NCT00683553|Acute Kidney Injury|acute kidney injury
5236266|NCT00683540|implementation|implementation
5236267|NCT00683540|evaluation|evaluation
5236268|NCT00683540|research methodology|research methodology
5236269|NCT00683540|intervention|intervention
5236270|NCT00683527|Iron supplementation|iron supplementation
5236271|NCT00683527|Timing|timing
5236272|NCT00683527|Serum ferritin|serum ferritin
5236273|NCT00683527|Very low birth weight infants|very low birth weight infants
5236274|NCT00683514|Untreated locally advanced inoperable stage IIIA or stage IIIB NSCLC amenable to radical radiotherapy to a dose of 66 Gy|untreated locally advanced inoperable stage iiia or stage iiib nsclc amenable to radical radiotherapy to a dose of 66 gy
5236275|NCT00683501|ocular hypertension|ocular hypertension
5236276|NCT00683501|elevated IOP|elevated iop
5236277|NCT00683501|glaucoma|glaucoma
5236278|NCT00683501|neuroprotection|neuroprotection
5236279|NCT00683488|Substance Abuse|substance abuse
5236280|NCT00683488|Adolescent community reinforcement approach|adolescent community reinforcement approach
5236281|NCT00683488|Adolescent Risk Behavior Assessment|adolescent risk behavior assessment
5236282|NCT00683488|Child and Adolescent Services Assessment|child and adolescent services assessment
5236283|NCT00683488|Cognitive behavioral therapy|cognitive behavioral therapy
5236284|NCT00683488|Cognitive Therapy Rating Scale|cognitive therapy rating scale
5236285|NCT00683488|Individual behavior therapy|individual behavior therapy
5236286|NCT00683488|Individual cognitive problem solving|individual cognitive problem solving
5236287|NCT00683488|Motivational enhancement therapy|motivational enhancement therapy
5236288|NCT00683488|HIV-Positive Youth With Substance Abuse|hiv-positive youth with substance abuse
5236289|NCT00683488|Complementary Therapies|complementary therapies
5236290|NCT00683475|Prostate Cancer|prostate cancer
5236291|NCT00683449|Asthma|asthma
5236292|NCT00683449|Dose-Escalation|dose-escalation
5236293|NCT00683449|Controlled|controlled
5236294|NCT00683449|MN-221|mn-221
5236295|NCT00683436|insomnia|insomnia
5236296|NCT00683397|assess|assess
5236297|NCT00683397|prevalence|prevalence
5236298|NCT00683397|thrombophilia|thrombophilia
5236299|NCT00683397|common|common
5236300|NCT00683397|VTE|vte
5236301|NCT00683397|risk factors|risk factors
5236302|NCT00683397|patients|patients
5236303|NCT00683384|Arthritis|arthritis
5236304|NCT00683384|psoriatic|psoriatic
5236305|NCT00683371|Chronic Rhinosinusitis|chronic rhinosinusitis
5236306|NCT00683371|Sinus Disease|sinus disease
5236307|NCT00683371|Allergy|allergy
5236308|NCT00683371|Maxillary Sinus|maxillary sinus
5236309|NCT00683371|Microarray|microarray
5236310|NCT00683358|cancer|cancer
5236311|NCT00683358|pancreas|pancreas
5236312|NCT00683358|advanced|advanced
5236313|NCT00683358|peptide|peptide
5236314|NCT00683358|vaccination|vaccination
5236315|NCT00683358|VEGFR1|vegfr1
5236316|NCT00683358|HLA|hla
5236317|NCT00683358|gemcitabine|gemcitabine
5236318|NCT00683358|IFA|ifa
5236319|NCT00683358|Cancer of Pancreas|cancer of pancreas
5236320|NCT00683358|Neoplasms, Pancreatic|neoplasms, pancreatic
5236321|NCT00683358|Pancreas Cancer|pancreas cancer
5236322|NCT00683332|Observational study|observational study
5236323|NCT00683332|Tigecycline|tigecycline
5236324|NCT00683332|infection|infection
5236325|NCT00683332|skin|skin
5236326|NCT00683332|abdominal|abdominal
5236327|NCT00683319|long-term effects secondary to cancer therapy in children|long-term effects secondary to cancer therapy in children
5236328|NCT00683319|cognitive/functional effects|cognitive/functional effects
5236329|NCT00683319|ototoxicity|ototoxicity
5236330|NCT00683319|childhood infratentorial ependymoma|childhood infratentorial ependymoma
5236331|NCT00683319|childhood supratentorial ependymoma|childhood supratentorial ependymoma
5236332|NCT00683293|Laparoscopic Hysterectomy|laparoscopic hysterectomy
5236333|NCT00683293|Robot-assisted Laparoscopic Hysterectomy|robot-assisted laparoscopic hysterectomy
5236334|NCT00683293|Robot-assisted Surgery|robot-assisted surgery
5236335|NCT00683280|Contingency Management|contingency management
5236336|NCT00683280|Cigarette Smoking Cessation|cigarette smoking cessation
5236337|NCT00683280|varenicline|varenicline
5236338|NCT00683267|THA, Total hip arthroplasty, total hip replacement|tha, total hip arthroplasty, total hip replacement
5236339|NCT00683254|nasal obstruction|nasal obstruction
5236340|NCT00683254|nasal stent|nasal stent
5236341|NCT00683241|Vaccine|vaccine
5236342|NCT00683241|Ovarian|ovarian
5236343|NCT00683241|Peritoneal|peritoneal
5236344|NCT00683228|Second hand Smoke|second hand smoke
5236345|NCT00683202|Assisted reproduction|assisted reproduction
5236346|NCT00683202|Ovarian response|ovarian response
5236347|NCT00683202|Uteroplacental hemodynamics|uteroplacental hemodynamics
5236348|NCT00683202|Doppler ultrasonography|doppler ultrasonography
5236349|NCT00683202|Implantation rate|implantation rate
5236350|NCT00683202|Pregnancy rate|pregnancy rate
5236351|NCT00683202|Live birth rate|live birth rate
5236352|NCT00683189|MLD|mld
5236353|NCT00683176|Diabetic Macular Edema|diabetic macular edema
5236354|NCT00683176|OCT|oct
5236355|NCT00683163|Combination of PTH and ibandronate|combination of pth and ibandronate
5236356|NCT00683163|Bone marker formation|bone marker formation
5236357|NCT00683163|Postmenopausal|postmenopausal
5236358|NCT00683163|Trabecular spine BMD|trabecular spine bmd
5236359|NCT00683150|Endothelial Function|endothelial function
5236360|NCT00683150|Abdominal Surgery|abdominal surgery
5236361|NCT00683150|Thoracic Surgery|thoracic surgery
5236362|NCT00683150|Vendy's-DTM Machine|vendy's-dtm machine
5236363|NCT00683150|Digital Thermal Monitoring|digital thermal monitoring
5236364|NCT00683150|DTM|dtm
5236365|NCT00683124|Marfan Syndrome|marfan syndrome
5236366|NCT00683124|Losartan|losartan
5236367|NCT00683124|Nebivolol|nebivolol
5236368|NCT00683124|Transforming Growth Factor Beta|transforming growth factor beta
5236369|NCT00683124|Aortic Root Dilation|aortic root dilation
5236370|NCT00683111|acute coronary syndrome|acute coronary syndrome
5236371|NCT00683111|acute myocardial infarction|acute myocardial infarction
5236372|NCT00683111|aspirin|aspirin
5236373|NCT00683111|clopidogrel|clopidogrel
5236374|NCT00683111|heparin|heparin
5236375|NCT00683111|thrombolytic|thrombolytic
5236376|NCT00683111|famotidine|famotidine
5236377|NCT00683111|esomeprazole|esomeprazole
5236378|NCT00683098|recurrent hernia|recurrent hernia
5236379|NCT00683098|endoscopic total extraperitoneal repair|endoscopic total extraperitoneal repair
5236380|NCT00683098|inguinal pain|inguinal pain
5236381|NCT00683098|questionnaire|questionnaire
5236382|NCT00683085|cancer|cancer
5236383|NCT00683085|pancreas|pancreas
5236384|NCT00683085|advanced|advanced
5236385|NCT00683085|peptide|peptide
5236386|NCT00683085|vaccination|vaccination
5236387|NCT00683085|VEGFR1|vegfr1
5236388|NCT00683085|HLA|hla
5236389|NCT00683085|gemcitabine|gemcitabine
5236390|NCT00683085|IFA|ifa
5236391|NCT00683085|Cancer of Pancreas|cancer of pancreas
5236392|NCT00683085|Neoplasms, Pancreas|neoplasms, pancreas
5236393|NCT00683085|Pancreas Cancer|pancreas cancer
5236394|NCT00683072|Ventilator|ventilator
5236395|NCT00683072|patient-ventilator asynchrony|patient-ventilator asynchrony
5236396|NCT00683046|Relapsed or refractory acute myelogenous or lymphoid leukemia.|relapsed or refractory acute myelogenous or lymphoid leukemia.
5236397|NCT00683046|Acute myeloid or lymphocytic leukemia in first remission at high-risk for recurrence.Chronic myelogenous leukemia in accelerated phase or blast-crisis.|acute myeloid or lymphocytic leukemia in first remission at high-risk for recurrence.chronic myelogenous leukemia in accelerated phase or blast-crisis.
5236398|NCT00683046|Chronic myelogenous leukemia in chronic phase|chronic myelogenous leukemia in chronic phase
5236399|NCT00683046|Chronic myelogenous leukemia in accelerated phase or blast-crisis|chronic myelogenous leukemia in accelerated phase or blast-crisis
5236500|NCT00682656|N- methyl glucamine|n- methyl glucamine
5236400|NCT00683046|Recurrent or refractory malignant lymphoma or Hodgkin's disease.|recurrent or refractory malignant lymphoma or hodgkin's disease.
5236401|NCT00683046|Chronic lymphocytic leukemia, relapsed or with poor prognostic features.|chronic lymphocytic leukemia, relapsed or with poor prognostic features.
5236402|NCT00683046|Myeloproliferative disorder (polycythemia vera, myelofibrosis) with poor prognostic features.|myeloproliferative disorder (polycythemia vera, myelofibrosis) with poor prognostic features.
5236403|NCT00683046|Severe aplastic anemia after failure of immunosuppressive therapy.|severe aplastic anemia after failure of immunosuppressive therapy.
5236404|NCT00683046|Myelodysplastic syndromes (including PNH)|myelodysplastic syndromes (including pnh)
5236405|NCT00683046|Multiple myeloma at high risk for disease recurrence.|multiple myeloma at high risk for disease recurrence.
5236406|NCT00683033|Contingency Management|contingency management
5236407|NCT00683033|Cigarette Smoking Cessation|cigarette smoking cessation
5236408|NCT00683033|Substance Abusers|substance abusers
5236409|NCT00683020|Chronic Diseases|chronic diseases
5236410|NCT00683020|Diabetes|diabetes
5236411|NCT00683020|Vulnerable population|vulnerable population
5236412|NCT00683020|Urban populations|urban populations
5236413|NCT00683020|Disease Management|disease management
5236414|NCT00683020|Health Information Technology|health information technology
5236415|NCT00683020|Safety|safety
5236416|NCT00683020|Health Literacy|health literacy
5236417|NCT00683020|Level of English Proficiency|level of english proficiency
5236418|NCT00683007|TE echo|te echo
5236419|NCT00683007|hemodilution|hemodilution
5236420|NCT00683007|hypertonic|hypertonic
5236421|NCT00683007|saline|saline
5236422|NCT00683007|Arterial Pressure Cardiac Output|arterial pressure cardiac output
5236423|NCT00682994|Advanced Cancer|advanced cancer
5236424|NCT00682994|Family Member|family member
5236425|NCT00682994|Palliative Care|palliative care
5236426|NCT00682994|Decision Making|decision making
5236427|NCT00682994|Information Disclosure|information disclosure
5236428|NCT00682994|Interview|interview
5236429|NCT00682994|Survey|survey
5236430|NCT00682994|Questionnaire|questionnaire
5236431|NCT00682981|ES-SCLC|es-sclc
5236432|NCT00682981|Obatoclax|obatoclax
5236433|NCT00682968|patient non-adherence|patient non-adherence
5236434|NCT00682968|antihypertensive agents|antihypertensive agents
5236435|NCT00682968|hypertension|hypertension
5236436|NCT00682955|Diarrhea|diarrhea
5236437|NCT00682955|Zinc Sulphate|zinc sulphate
5236438|NCT00682955|Efficacy|efficacy
5236439|NCT00682929|cannabis|cannabis
5236440|NCT00682929|marijuana|marijuana
5236441|NCT00682929|Multiple Sclerosis|multiple sclerosis
5236442|NCT00682929|spasticity|spasticity
5236443|NCT00682916|Obesity|obesity
5236444|NCT00682916|Diabetes|diabetes
5236445|NCT00682916|Soluble Fiber|soluble fiber
5236446|NCT00682916|Overweight|overweight
5236447|NCT00682903|glucose|glucose
5236448|NCT00682903|diabetes|diabetes
5236449|NCT00682903|glycemia|glycemia
5236450|NCT00682877|gastroparesis|gastroparesis
5236451|NCT00682877|Digestive|digestive
5236452|NCT00682877|Gastrointestinal|gastrointestinal
5236453|NCT00682877|Stomach|stomach
5236454|NCT00682877|Motility|motility
5236455|NCT00682877|Non-Invasive|non-invasive
5236456|NCT00682877|Capsule|capsule
5236457|NCT00682877|GI|gi
5236458|NCT00682877|Device|device
5236459|NCT00682877|Digestive System Diseases|digestive system diseases
5236460|NCT00682838|Treatment compliance|treatment compliance
5236461|NCT00682838|Self-management|self-management
5236462|NCT00682838|Telemedicine|telemedicine
5236463|NCT00682825|Anesthesia|anesthesia
5236464|NCT00682825|Awareness|awareness
5236465|NCT00682825|Bispectral|bispectral
5236466|NCT00682825|BIS|bis
5236467|NCT00682825|Recall|recall
5236468|NCT00682799|RC|rc
5236469|NCT00682799|RIC|ric
5236470|NCT00682799|MDS|mds
5236471|NCT00682799|SCT|sct
5236472|NCT00682786|rectal|rectal
5236473|NCT00682786|rectum|rectum
5236474|NCT00682786|cancer|cancer
5236475|NCT00682786|carcinoma|carcinoma
5236476|NCT00682760|Botulinum Toxin Type A|botulinum toxin type a
5236477|NCT00682760|Blepharospasm|blepharospasm
5236478|NCT00682747|xerostomia|xerostomia
5236479|NCT00682747|hyperbaric oxygenation|hyperbaric oxygenation
5236480|NCT00682747|radiotherapy|radiotherapy
5236481|NCT00682721|Bacterial Vaginosis|bacterial vaginosis
5236482|NCT00682721|Herpes Simplex Virus Type II|herpes simplex virus type ii
5236483|NCT00682708|malnutrition|malnutrition
5236484|NCT00682708|ready to use food|ready to use food
5236485|NCT00682708|Niger|niger
5236486|NCT00682695|stroke|stroke
5236487|NCT00682695|brain attack|brain attack
5236488|NCT00682695|hemorrhagic stroke|hemorrhagic stroke
5236489|NCT00682695|risk factors|risk factors
5236490|NCT00682682|Pain distraction|pain distraction
5236491|NCT00682682|Analgesic interventions|analgesic interventions
5236492|NCT00682682|Burn patients|burn patients
5236493|NCT00682669|Asthma|asthma
5236494|NCT00682669|Mindfulness-based stress reduction|mindfulness-based stress reduction
5236495|NCT00682669|Peak expiratory flow rate|peak expiratory flow rate
5236496|NCT00682669|Spirometry|spirometry
5236497|NCT00682669|Quality of life|quality of life
5236498|NCT00682656|cutaneous leishmaniasis|cutaneous leishmaniasis
5236499|NCT00682656|azithromycin|azithromycin
5236501|NCT00682643|Perennial Allergic Rhinitis|perennial allergic rhinitis
5236502|NCT00682643|fluticasone furoate|fluticasone furoate
5236503|NCT00682643|ocular safety|ocular safety
5236504|NCT00682630|Malaria|malaria
5236505|NCT00682630|anti-malarial|anti-malarial
5236506|NCT00682630|pyronaridine|pyronaridine
5236507|NCT00682630|ACT|act
5236508|NCT00682617|hip|hip
5236509|NCT00682617|osteoarthritis|osteoarthritis
5236510|NCT00682617|exercise|exercise
5236511|NCT00682617|disability|disability
5236512|NCT00682617|physical function|physical function
5236513|NCT00682604|Family Health Program; Food consumption; Nutritional status|family health program; food consumption; nutritional status
5236514|NCT00682591|hepatitis C|hepatitis c
5236515|NCT00682591|drug substitution|drug substitution
5236516|NCT00682591|neurocognitive|neurocognitive
5236517|NCT00682591|patients with stable drug substitution therapy|patients with stable drug substitution therapy
5236518|NCT00682591|patients with interferon-based antiviral therapy|patients with interferon-based antiviral therapy
5236519|NCT00682578|falciparum malaria|falciparum malaria
5236520|NCT00682578|vivax malaria|vivax malaria
5236521|NCT00682578|dihydroartemisinin-piperaquine|dihydroartemisinin-piperaquine
5236522|NCT00682539|diabetic retinopathy|diabetic retinopathy
5236523|NCT00682539|macular edema|macular edema
5236524|NCT00682539|intravitreal Avastin/ Triamcinolone / Lucentis|intravitreal avastin/ triamcinolone / lucentis
5236525|NCT00682526|EMS patients with intention to treat with coronary reperfusion therapy (PCI or thrombolytics) based on their initial presentation|ems patients with intention to treat with coronary reperfusion therapy (pci or thrombolytics) based on their initial presentation
5236526|NCT00682513|dystonia|dystonia
5236527|NCT00682513|parkinsonism|parkinsonism
5236528|NCT00682513|rapid-onset dystonia-parkinsonism|rapid-onset dystonia-parkinsonism
5236529|NCT00682513|RDP|rdp
5236530|NCT00682513|Alternating Hemiplegia of Childhood|alternating hemiplegia of childhood
5236531|NCT00682513|AHC|ahc
5236532|NCT00682500|Pneumonia|pneumonia
5236533|NCT00682500|Aspiration|aspiration
5236534|NCT00682500|Drowning|drowning
5236535|NCT00682500|inhalation|inhalation
5236536|NCT00682487|Myocardial infarction|myocardial infarction
5236537|NCT00682487|Stress|stress
5236538|NCT00682487|Hair Cortisol|hair cortisol
5236539|NCT00682474|Cigarette smoking|cigarette smoking
5236540|NCT00682474|Nicotine dependence|nicotine dependence
5236541|NCT00682474|Adolescents|adolescents
5236542|NCT00682474|Youth|youth
5236543|NCT00682474|School health|school health
5236544|NCT00682474|Randomized controlled trial|randomized controlled trial
5236545|NCT00682461|Nicotine Tolerability NRT|nicotine tolerability nrt
5236546|NCT00682448|Olanzapine|olanzapine
5236547|NCT00682448|Zyprexa|zyprexa
5236548|NCT00682448|Weight Gain|weight gain
5236549|NCT00682448|Antipsychotics|antipsychotics
5236550|NCT00682448|Metformin|metformin
5236551|NCT00682448|Glucophage|glucophage
5236552|NCT00682448|Bipolar Disorder|bipolar disorder
5236553|NCT00682448|Schizophrenia|schizophrenia
5236554|NCT00682448|Depression|depression
5236555|NCT00682448|Diabetes|diabetes
5236556|NCT00682448|Side effects|side effects
5236557|NCT00682448|Metabolic complications|metabolic complications
5236558|NCT00682448|Prevention|prevention
5236559|NCT00682448|Treatment|treatment
5236560|NCT00682448|Metabolic side effects of olanzapine|metabolic side effects of olanzapine
5236561|NCT00682435|Nonelderly patients with acute moderate to severe pain|nonelderly patients with acute moderate to severe pain
5236562|NCT00682422|pediatrics, overweight, obese, behavioral intervention|pediatrics, overweight, obese, behavioral intervention
5236563|NCT00682383|Advanced NSCLC|advanced nsclc
5236564|NCT00682383|Lung Cancer|lung cancer
5236565|NCT00682383|Mount Sinai Medical Center CCOP|mount sinai medical center ccop
5236566|NCT00682357|Osteoarthritis, intra articular steroids|osteoarthritis, intra articular steroids
5236567|NCT00682318|Fish oil|fish oil
5236568|NCT00682318|red wine|red wine
5236569|NCT00682318|alcohol|alcohol
5236570|NCT00682318|oxidative stress|oxidative stress
5236571|NCT00682318|Healthy volunteers|healthy volunteers
5236572|NCT00682305|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
5236573|NCT00682305|Hematopoeitic Stem Cell Transplantation|hematopoeitic stem cell transplantation
5236574|NCT00682292|Renal transplantation|renal transplantation
5236575|NCT00682292|Immunisation|immunisation
5236576|NCT00682292|Acute rejection|acute rejection
5236577|NCT00682292|Induction therapy|induction therapy
5236578|NCT00682292|Thymoglobulin|thymoglobulin
5236579|NCT00682292|Daclizumab|daclizumab
5236580|NCT00682292|Rejection in sensitized renal transplant recipients|rejection in sensitized renal transplant recipients
5236581|NCT00682279|lapatinib|lapatinib
5236582|NCT00682279|GW572016|gw572016
5236583|NCT00682279|topotecan|topotecan
5236584|NCT00682279|oral topotecan|oral topotecan
5236585|NCT00682279|SK&F-104864|sk&f-104864
5236586|NCT00682279|EGFR|egfr
5236587|NCT00682279|ErbB1|erbb1
5236588|NCT00682279|HER-2/neu|her-2/neu
5236589|NCT00682279|ErbB2|erbb2
5236590|NCT00682279|BCRP|bcrp
5236591|NCT00682266|Adolescent|adolescent
5236592|NCT00682266|Overweight|overweight
5236593|NCT00682266|Exercise|exercise
5236594|NCT00682266|multidisciplinary approach|multidisciplinary approach
5236595|NCT00682266|Oxygen uptake|oxygen uptake
5236999|NCT00680745|safety|safety
5236596|NCT00682266|Flow mediated dilatation|flow mediated dilatation
5236597|NCT00682266|Cardiovascular Risk Factors|cardiovascular risk factors
5236598|NCT00682253|SPECT/CT|spect/ct
5236599|NCT00682253|MRI|mri
5236600|NCT00682253|Breast neoplasms|breast neoplasms
5236601|NCT00682240|retinal morphology|retinal morphology
5236602|NCT00682240|laser treatment|laser treatment
5236603|NCT00682240|pascal laser|pascal laser
5236604|NCT00682240|HD-OCT|hd-oct
5236605|NCT00682227|Epitope peptide, CTL, Esophageal cancer, Vaccination|epitope peptide, ctl, esophageal cancer, vaccination
5236606|NCT00682214|25(OH)D, muscle strength|25(oh)d, muscle strength
5236607|NCT00682201|Pregnancy|pregnancy
5236608|NCT00682201|Blood pressure|blood pressure
5236609|NCT00682201|Cardiac output|cardiac output
5236610|NCT00682188|Overweight|overweight
5236611|NCT00682188|Obesity|obesity
5236612|NCT00682188|Adolescents|adolescents
5236613|NCT00682188|Youth|youth
5236614|NCT00682188|School health|school health
5236615|NCT00682188|Randomized controlled trial|randomized controlled trial
5236616|NCT00682188|Intervention study|intervention study
5236617|NCT00682175|Congestive Heart Failure|congestive heart failure
5236618|NCT00682162|acupuncture|acupuncture
5236619|NCT00682162|randomised controlled trial|randomised controlled trial
5236620|NCT00682162|placebo|placebo
5236621|NCT00682162|sham laser|sham laser
5236622|NCT00682162|vasomotor rhinitis|vasomotor rhinitis
5236623|NCT00682149|Oxidative stress|oxidative stress
5236624|NCT00682149|malondialdehyde|malondialdehyde
5236625|NCT00682149|glutathione|glutathione
5236626|NCT00682149|diabetes|diabetes
5236627|NCT00682149|polyphenol containing antioxidants|polyphenol containing antioxidants
5236628|NCT00682149|diet rich in vegetables|diet rich in vegetables
5236629|NCT00682149|weekly aerobic exercise|weekly aerobic exercise
5236630|NCT00682136|postoperative analgesia|postoperative analgesia
5236631|NCT00682136|abdominal surgery|abdominal surgery
5236632|NCT00682136|ropivacaine|ropivacaine
5236633|NCT00682136|local anaesthesia|local anaesthesia
5236634|NCT00682136|tap block|tap block
5236635|NCT00682136|pain management|pain management
5236636|NCT00682123|19-norandrostenedione|19-norandrostenedione
5236637|NCT00682123|steroids|steroids
5236638|NCT00682123|drugs in sport|drugs in sport
5236639|NCT00682123|World Anti-Doping Agency|world anti-doping agency
5236640|NCT00682110|End-stage liver disease|end-stage liver disease
5236641|NCT00682110|Hemodynamic measurements|hemodynamic measurements
5236642|NCT00682110|Hyperdynamic circulation|hyperdynamic circulation
5236643|NCT00682110|Pulmonary artery catheter|pulmonary artery catheter
5236644|NCT00682110|Cardiac output|cardiac output
5236645|NCT00682084|Cushing's syndrome|cushing's syndrome
5236646|NCT00682084|Glucose tolerance|glucose tolerance
5236647|NCT00682084|Insulin sensitivity|insulin sensitivity
5236648|NCT00682084|Substrate metabolism|substrate metabolism
5236649|NCT00682084|Body composition|body composition
5236650|NCT00682071|Ultrasound-guided|ultrasound-guided
5236651|NCT00682071|embryo transfer|embryo transfer
5236652|NCT00682071|in-vitro fertilization|in-vitro fertilization
5236653|NCT00682058|body composition|body composition
5236654|NCT00682058|weight loss|weight loss
5236655|NCT00682058|fat|fat
5236656|NCT00682058|fat distribution|fat distribution
5236657|NCT00682058|fat free mass|fat free mass
5236658|NCT00682058|organ|organ
5236659|NCT00682058|resting energy expenditure|resting energy expenditure
5236660|NCT00682045|tuberculosis|tuberculosis
5236661|NCT00682045|transplantation|transplantation
5236662|NCT00682032|NSCLC|nsclc
5236663|NCT00682019|Erectile Dysfunction|erectile dysfunction
5236664|NCT00682019|Vardenafil|vardenafil
5236665|NCT00682006|Omphalitis|omphalitis
5236666|NCT00682006|4% Chlorhexidine|4% chlorhexidine
5236667|NCT00682006|Newborns|newborns
5236668|NCT00681993|cosmetic|cosmetic
5236669|NCT00681993|effect|effect
5236670|NCT00681993|breast|breast
5236671|NCT00681993|irradiation|irradiation
5236672|NCT00681993|concurrent|concurrent
5236673|NCT00681993|chemotherapy|chemotherapy
5236674|NCT00681993|potential acute|potential acute
5236675|NCT00681993|late skin|late skin
5236676|NCT00681993|subcutaneous toxicities|subcutaneous toxicities
5236677|NCT00681980|TSP/HAM, HTLV-1, treatment|tsp/ham, htlv-1, treatment
5236678|NCT00681967|squamous cell cancer of the head & neck|squamous cell cancer of the head & neck
5236679|NCT00681967|Gefitinib|gefitinib
5236680|NCT00681967|IRESSA|iressa
5236681|NCT00681967|EGFR Inhibitor|egfr inhibitor
5236682|NCT00681967|EGFR-tyrosine kinase inhibitor|egfr-tyrosine kinase inhibitor
5236683|NCT00681967|Subjects with histologically proven squamous cell cancer of the head & neck|subjects with histologically proven squamous cell cancer of the head & neck
5236684|NCT00681967|Cohort 1:qualifying for postoperative radiotherapy|cohort 1:qualifying for postoperative radiotherapy
5236685|NCT00681967|(pT3, pT4, pN2b, pN2c, pN3).|(pt3, pt4, pn2b, pn2c, pn3).
5236686|NCT00681967|Cohort 2:qualifying for definite chemoradiotherapy|cohort 2:qualifying for definite chemoradiotherapy
5236687|NCT00681967|(Lateral oropharynx, tonsils: T1N2b-3, T2N1-3, T3any N;|(lateral oropharynx, tonsils: t1n2b-3, t2n1-3, t3any n;
5236688|NCT00681967|Base of tongue, vallecula: T1N1-3, T2-4 any N; Oral cavity,|base of tongue, vallecula: t1n1-3, t2-4 any n; oral cavity,
5236689|NCT00681967|glottic and supraglottic larynx; Any TN1-3, T3-4 any N;|glottic and supraglottic larynx; any tn1-3, t3-4 any n;
5237099|NCT00680264|Scoliosis|scoliosis
5236690|NCT00681967|Hypopharynx: T1N1-3, T2-4 and N)|hypopharynx: t1n1-3, t2-4 and n)
5236691|NCT00681954|TRALI|trali
5236692|NCT00681954|Randomized Autologous Transfusion|randomized autologous transfusion
5236693|NCT00681954|Intra-Operative Testing of Pulmonary Function|intra-operative testing of pulmonary function
5236694|NCT00681928|stage I breast cancer|stage i breast cancer
5236695|NCT00681928|stage II breast cancer|stage ii breast cancer
5236696|NCT00681928|stage IIIA breast cancer|stage iiia breast cancer
5236697|NCT00681928|stage IIIB breast cancer|stage iiib breast cancer
5236698|NCT00681928|stage IIIC breast cancer|stage iiic breast cancer
5236699|NCT00681915|Phase I|phase i
5236700|NCT00681915|Pharmacokinetics|pharmacokinetics
5236701|NCT00681902|Pediatric|pediatric
5236702|NCT00681902|Pain|pain
5236703|NCT00681902|Needle|needle
5236704|NCT00681902|Emergency|emergency
5236705|NCT00681902|Phlebotomy|phlebotomy
5236706|NCT00681902|Intravenous|intravenous
5236707|NCT00681902|Lidocaine|lidocaine
5236708|NCT00681902|Local|local
5236709|NCT00681902|Anesthesia|anesthesia
5236710|NCT00681876|Metastatic colorectal cancer|metastatic colorectal cancer
5236711|NCT00681876|Second line|second line
5236712|NCT00681876|Irinotecan|irinotecan
5236713|NCT00681876|Erbitux (Cetuximab)|erbitux (cetuximab)
5236714|NCT00681876|Avastin (Bevacizumab)|avastin (bevacizumab)
5236715|NCT00681850|Diabetes|diabetes
5236716|NCT00681850|Benchmarking|benchmarking
5236717|NCT00681850|quality of patient care|quality of patient care
5236718|NCT00681850|Diabetic Population|diabetic population
5236719|NCT00681837|gastroesophageal reflux|gastroesophageal reflux
5236720|NCT00681837|prevalence|prevalence
5236721|NCT00681837|childhood|childhood
5236722|NCT00681837|France|france
5236723|NCT00681811|Metazyme|metazyme
5236724|NCT00681811|Late Infantile Metachromatic Leukodystrophy|late infantile metachromatic leukodystrophy
5236725|NCT00681798|pancreatic cancer|pancreatic cancer
5236726|NCT00681798|pancreatic adenocarcinoma|pancreatic adenocarcinoma
5236727|NCT00681798|pancreas cancer|pancreas cancer
5236728|NCT00681798|dose escalation study|dose escalation study
5236729|NCT00681798|locally advanced unresectable pancreatic adenocarcinoma|locally advanced unresectable pancreatic adenocarcinoma
5236730|NCT00681798|Zactima|zactima
5236731|NCT00681798|Vandetanib|vandetanib
5236732|NCT00681798|ZD6474|zd6474
5236733|NCT00681785|thrombophylaxis and transurethral surgery|thrombophylaxis and transurethral surgery
5236734|NCT00681772|Erectile Dysfunction|erectile dysfunction
5236735|NCT00681772|Vardenafil|vardenafil
5236736|NCT00681759|Low Dose Aspirin (LDA)|low dose aspirin (lda)
5236737|NCT00681759|Cardiovascular disease|cardiovascular disease
5236738|NCT00681759|Low Dose Aspirin (LDA) use in in subjects with cardiovascular risk or disease|low dose aspirin (lda) use in in subjects with cardiovascular risk or disease
5236739|NCT00681746|Anxiety|anxiety
5236740|NCT00681746|GABA receptors|gaba receptors
5236741|NCT00681746|Positron Emission Tomography|positron emission tomography
5236742|NCT00681746|PET|pet
5236743|NCT00681746|phase I|phase i
5236744|NCT00681733|NASH Pentoxifylline Pioglitazone|nash pentoxifylline pioglitazone
5236745|NCT00681720|Anxiety|anxiety
5236746|NCT00681720|GABA receptors|gaba receptors
5236747|NCT00681720|Positron Emission Tomography|positron emission tomography
5236748|NCT00681720|PET|pet
5236749|NCT00681720|phase I|phase i
5236750|NCT00681707|Hypertension|hypertension
5236751|NCT00681707|Post stroke|post stroke
5236752|NCT00681707|JNC7|jnc7
5236753|NCT00681707|2007 ESH-ESC guidelines|2007 esh-esc guidelines
5236754|NCT00681707|survey|survey
5236755|NCT00681694|brachytherapy|brachytherapy
5236756|NCT00681694|radioactive seed implants|radioactive seed implants
5236757|NCT00681681|stroke|stroke
5236758|NCT00681681|vascular marker|vascular marker
5236759|NCT00681681|stroke risk|stroke risk
5236760|NCT00681681|risk factors|risk factors
5236761|NCT00681681|sex differences|sex differences
5236762|NCT00681668|Postpartum Depression|postpartum depression
5236763|NCT00681668|Quetiapine|quetiapine
5236764|NCT00681668|Psychotic Symptoms|psychotic symptoms
5236765|NCT00681642|Corneal epithelial wound|corneal epithelial wound
5236766|NCT00681642|Human autoserum|human autoserum
5236767|NCT00681642|Cord blood|cord blood
5236768|NCT00681629|Schizophrenia|schizophrenia
5236769|NCT00681629|Integrated Care|integrated care
5236770|NCT00681629|Quetiapine|quetiapine
5236771|NCT00681616|Anterior compartment syndrome|anterior compartment syndrome
5236772|NCT00681616|Tibia|tibia
5236773|NCT00681616|Trauma|trauma
5236774|NCT00681616|Blood circulation|blood circulation
5236775|NCT00681616|Nerve compression syndromes|nerve compression syndromes
5236776|NCT00681603|corneal neovascularization|corneal neovascularization
5236777|NCT00681603|lipid keratopathy|lipid keratopathy
5236778|NCT00681603|penetrating keratopathy|penetrating keratopathy
5236779|NCT00681603|bevacizumab|bevacizumab
5236780|NCT00681603|Avastin|avastin
5236781|NCT00681603|subconjunctival injection|subconjunctival injection
5236782|NCT00681590|vitamin D|vitamin d
5236783|NCT00681590|deficiency|deficiency
5236784|NCT00681590|elderly|elderly
5236785|NCT00681577|Peptide Vaccine|peptide vaccine
5236786|NCT00681577|URLC10|urlc10
5236787|NCT00681577|KOC1|koc1
5236788|NCT00681577|VEGFR1|vegfr1
5236789|NCT00681577|VEGFR2|vegfr2
5236790|NCT00681564|Periodontitis|periodontitis
5236791|NCT00681564|Oral health|oral health
5236792|NCT00681564|Cardiovascular disease|cardiovascular disease
5236793|NCT00681551|Detection of brain metastasis by MRI|detection of brain metastasis by mri
5236794|NCT00681551|Magnevist|magnevist
5236795|NCT00681551|Brain metastasis|brain metastasis
5236796|NCT00681551|Meglumine gadopentetate|meglumine gadopentetate
5236797|NCT00681538|Spasticity|spasticity
5236798|NCT00681538|Multiple Sclerosis|multiple sclerosis
5236799|NCT00681512|NSCLC|nsclc
5236800|NCT00681512|lung cancer|lung cancer
5236801|NCT00681512|non small cell lung cancer|non small cell lung cancer
5236802|NCT00681512|lung carcinoma|lung carcinoma
5236803|NCT00681499|Quality of Life|quality of life
5236804|NCT00681499|Liver Neoplasms|liver neoplasms
5236805|NCT00681499|Surgical procedures, Operative|surgical procedures, operative
5236806|NCT00681486|Ghrelin|ghrelin
5236807|NCT00681486|Nutrition|nutrition
5236808|NCT00681486|Cancer patients|cancer patients
5236809|NCT00681486|Survival|survival
5236810|NCT00681473|proton radiation therapy|proton radiation therapy
5236811|NCT00681473|photon radiation therapy|photon radiation therapy
5236812|NCT00681460|gestational diabetes|gestational diabetes
5236813|NCT00681460|birth weight|birth weight
5236814|NCT00681460|fetal growth|fetal growth
5236815|NCT00681460|insulin resistance|insulin resistance
5236816|NCT00681460|oxidative stress|oxidative stress
5236817|NCT00681460|inflammatory reaction|inflammatory reaction
5236818|NCT00681460|Fetal Development|fetal development
5236819|NCT00681447|lumbar disc herniation|lumbar disc herniation
5236820|NCT00681447|discogenic pain|discogenic pain
5236821|NCT00681447|lumbar interlaminar epidural|lumbar interlaminar epidural
5236822|NCT00681447|injections|injections
5236823|NCT00681434|stroke|stroke
5236824|NCT00681434|upper extremity|upper extremity
5236825|NCT00681434|hemiparesis|hemiparesis
5236826|NCT00681421|Peptide Vaccine|peptide vaccine
5236827|NCT00681421|URLC10|urlc10
5236828|NCT00681421|VEGFR1|vegfr1
5236829|NCT00681421|VEGFR2|vegfr2
5236830|NCT00681408|Steatohepatitis|steatohepatitis
5236831|NCT00681408|NASH|nash
5236832|NCT00681408|NAFLD|nafld
5236833|NCT00681408|omega 3 fatty acids|omega 3 fatty acids
5236834|NCT00681408|Exercise conditioning|exercise conditioning
5236835|NCT00681382|Asthma|asthma
5236836|NCT00681382|use of asthma medication|use of asthma medication
5236837|NCT00681382|asthma control|asthma control
5236838|NCT00681382|telephone survey|telephone survey
5236839|NCT00681382|patient's perception|patient's perception
5236840|NCT00681369|breast cancer|breast cancer
5236841|NCT00681369|fulvestrant|fulvestrant
5236842|NCT00681369|longitudinal study|longitudinal study
5236843|NCT00681369|France|france
5236844|NCT00681356|TKA|tka
5236845|NCT00681356|Total knee arthroplasty|total knee arthroplasty
5236846|NCT00681356|Total knee replacement|total knee replacement
5236847|NCT00681356|Knee surgery|knee surgery
5236848|NCT00681343|Randomized|randomized
5236849|NCT00681343|study|study
5236850|NCT00681343|effectiveness/toxicity|effectiveness/toxicity
5236851|NCT00681343|induction therapy|induction therapy
5236852|NCT00681343|recipients|recipients
5236853|NCT00681330|Peptide Vaccine|peptide vaccine
5236854|NCT00681330|URLC10|urlc10
5236855|NCT00681330|TTK|ttk
5236856|NCT00681330|KOC1|koc1
5236857|NCT00681317|Phase I|phase i
5236858|NCT00681317|Pharmacokinetics|pharmacokinetics
5236859|NCT00681304|Resected Breast Cancer|resected breast cancer
5236860|NCT00681304|Breast Cancer|breast cancer
5236861|NCT00681291|surgical mesh|surgical mesh
5236862|NCT00681291|inguinal hernia repair|inguinal hernia repair
5236863|NCT00681291|chronic groin pain|chronic groin pain
5236864|NCT00681278|Hypertension|hypertension
5236865|NCT00681278|Type II DM|type ii dm
5236866|NCT00681278|JNC7|jnc7
5236867|NCT00681278|2007 ESH-ESC guidelines|2007 esh-esc guidelines
5236868|NCT00681278|survey|survey
5236869|NCT00681265|ocular lubricants|ocular lubricants
5236870|NCT00681252|Peptide Vaccine|peptide vaccine
5236871|NCT00681252|URLC10|urlc10
5236872|NCT00681252|VEGFR1|vegfr1
5236873|NCT00681252|VEGFR2|vegfr2
5236874|NCT00681239|childhood|childhood
5236875|NCT00681239|epilepsy|epilepsy
5236876|NCT00681239|intractable|intractable
5236877|NCT00681239|seizures|seizures
5236878|NCT00681239|Atkins|atkins
5236879|NCT00681239|ketogenic|ketogenic
5236880|NCT00681226|peripheral arterial disease|peripheral arterial disease
5236881|NCT00681226|angiotensin converting enzyme inhibitors|angiotensin converting enzyme inhibitors
5236882|NCT00681226|exercise|exercise
5236883|NCT00681200|Blood Pressure Reduction|blood pressure reduction
5236884|NCT00681200|Stress Reactivity and Recovery|stress reactivity and recovery
5236885|NCT00681200|Meditation|meditation
5236886|NCT00681200|Transcendental Meditation|transcendental meditation
5236887|NCT00681200|Stress Reduction|stress reduction
5236888|NCT00681200|Stress Management|stress management
5236889|NCT00681174|Care, Postoperative|care, postoperative
5236890|NCT00681174|Analgesia|analgesia
5236891|NCT00681174|Analgesics, Opioid|analgesics, opioid
5236892|NCT00681174|Morphine|morphine
5236893|NCT00681174|Remifentanil|remifentanil
5236894|NCT00681174|Oxycodone|oxycodone
5236895|NCT00681174|Anesthesia, Regional|anesthesia, regional
5236896|NCT00681174|Anesthesia, Intravenous|anesthesia, intravenous
5236897|NCT00681174|Preanesthetic Medication|preanesthetic medication
5236898|NCT00681174|Analgesia, Patient-Controlled|analgesia, patient-controlled
5236899|NCT00681161|obstructive sleep apnea|obstructive sleep apnea
5236900|NCT00681161|OSA|osa
5236901|NCT00681161|diabetes|diabetes
5236902|NCT00681161|pre-diabetic condition|pre-diabetic condition
5236903|NCT00681161|obesity|obesity
5236904|NCT00681161|blood glucose|blood glucose
5236905|NCT00681161|continuous positive airway pressure|continuous positive airway pressure
5236906|NCT00681161|CPAP|cpap
5236907|NCT00681148|Prostate specific antigen (PSA)|prostate specific antigen (psa)
5236908|NCT00681148|Prostate cancer|prostate cancer
5236909|NCT00681148|Lower urinary tract symptoms|lower urinary tract symptoms
5236910|NCT00681148|Radioactive seed implantation|radioactive seed implantation
5236911|NCT00681135|orthodontics|orthodontics
5236912|NCT00681135|toothbrush|toothbrush
5236913|NCT00681135|interdental brush|interdental brush
5236914|NCT00681135|oral hygiene|oral hygiene
5236915|NCT00681122|Breast Cancer|breast cancer
5236916|NCT00681122|hormone therapy|hormone therapy
5236917|NCT00681122|aromatase inhibitor|aromatase inhibitor
5236918|NCT00681096|Low back pain in nurses|low back pain in nurses
5236919|NCT00681083|Obstructive Sleep Apnea|obstructive sleep apnea
5236920|NCT00681083|Humidification|humidification
5236921|NCT00681083|Continuous Positive Airway Pressure|continuous positive airway pressure
5236922|NCT00681070|laceration|laceration
5236923|NCT00681070|wound management|wound management
5236924|NCT00681070|absorbable sutures|absorbable sutures
5236925|NCT00681070|cosmetic outcomes|cosmetic outcomes
5236926|NCT00681044|monoclonal immunoglobulin deposition disease|monoclonal immunoglobulin deposition disease
5236927|NCT00681044|light chain deposition disease|light chain deposition disease
5236928|NCT00681018|premature|premature
5236929|NCT00681018|infants|infants
5236930|NCT00681005|PPI test|ppi test
5236931|NCT00681005|gastroesophageal reflux disease|gastroesophageal reflux disease
5236932|NCT00681005|CYP2C19|cyp2c19
5236933|NCT00681005|rabeprazole|rabeprazole
5236934|NCT00681005|pantoprazole|pantoprazole
5236935|NCT00680992|Giant Cell Tumor of Bone|giant cell tumor of bone
5236936|NCT00680979|Prevention|prevention
5236937|NCT00680979|Obesity|obesity
5236938|NCT00680979|Binge Eating|binge eating
5236939|NCT00680979|Adolescents|adolescents
5236940|NCT00680979|Overweight|overweight
5236941|NCT00680979|Weight Gain|weight gain
5236942|NCT00680966|Treatment efficacy|treatment efficacy
5236943|NCT00680966|Family therapy|family therapy
5236944|NCT00680966|Teens|teens
5236945|NCT00680966|Substance abuse|substance abuse
5236946|NCT00680966|Substance dependence|substance dependence
5236947|NCT00680940|NSCLC|nsclc
5236948|NCT00680927|Atrial Fibrillation|atrial fibrillation
5236949|NCT00680927|Risk of cardiac arrhythmias|risk of cardiac arrhythmias
5236950|NCT00680927|Loop recorder|loop recorder
5236951|NCT00680914|Streptococcus pneumoniae|streptococcus pneumoniae
5236952|NCT00680914|pneumococcal conjugate vaccine|pneumococcal conjugate vaccine
5236953|NCT00680901|unresectable|unresectable
5236954|NCT00680901|HER2|her2
5236955|NCT00680901|TYVERB|tyverb
5236956|NCT00680901|ErbB2|erbb2
5236957|NCT00680901|TYKERB|tykerb
5236958|NCT00680901|capecitabine|capecitabine
5236959|NCT00680901|CapeOx|capeox
5236960|NCT00680901|gastric/esophageal cancer|gastric/esophageal cancer
5236961|NCT00680901|GE junction|ge junction
5236962|NCT00680901|metastatic|metastatic
5236963|NCT00680901|lapatinib|lapatinib
5236964|NCT00680901|oxaliplatin|oxaliplatin
5236965|NCT00680888|Psychosis|psychosis
5236966|NCT00680888|adolescents|adolescents
5236967|NCT00680888|adherence|adherence
5236968|NCT00680888|quetiapine|quetiapine
5236969|NCT00680875|School Based Services|school based services
5236970|NCT00680875|Prevention|prevention
5236971|NCT00680875|Children|children
5236972|NCT00680862|HIV|hiv
5236973|NCT00680862|screening|screening
5236974|NCT00680849|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
5236975|NCT00680849|Coronary Disease|coronary disease
5236976|NCT00680836|Irritable Bowel Syndrome|irritable bowel syndrome
5236977|NCT00680836|Diarrhea|diarrhea
5236978|NCT00680836|Gulf War|gulf war
5236979|NCT00680836|Veterans|veterans
5236980|NCT00680836|Small intestinal bacterial overgrowth (SIBO)|small intestinal bacterial overgrowth (sibo)
5236981|NCT00680823|Headache|headache
5236982|NCT00680823|Migraine|migraine
5236983|NCT00680823|Ropivacaine|ropivacaine
5236984|NCT00680797|Aging|aging
5236985|NCT00680797|Hormones|hormones
5236986|NCT00680797|Insulin resistance|insulin resistance
5236987|NCT00680784|sprain|sprain
5236988|NCT00680784|ankle|ankle
5236989|NCT00680784|pain|pain
5236990|NCT00680771|Primary Insomnia|primary insomnia
5236991|NCT00680771|Insomnia|insomnia
5236992|NCT00680771|Good Sleepers|good sleepers
5236993|NCT00680771|Hep B|hep b
5236994|NCT00680771|Vaccine|vaccine
5236995|NCT00680758|male breast cancer|male breast cancer
5236996|NCT00680758|stage IV breast cancer|stage iv breast cancer
5236997|NCT00680745|Dapagliflozin|dapagliflozin
5236998|NCT00680745|efficacy|efficacy
5237000|NCT00680745|sulphonylurea|sulphonylurea
5237001|NCT00680745|Type 2 diabetes|type 2 diabetes
5237002|NCT00680732|Malaria|malaria
5237003|NCT00680732|Pregnancy|pregnancy
5237004|NCT00680732|Prevention|prevention
5237005|NCT00680732|Chloroquine|chloroquine
5237006|NCT00680732|Sulphadoxine pyrimethamine|sulphadoxine pyrimethamine
5237007|NCT00680732|Maternal anaemia|maternal anaemia
5237008|NCT00680732|Birth weight|birth weight
5237009|NCT00680732|Foetal anaemia|foetal anaemia
5237010|NCT00680719|substance abuse|substance abuse
5237011|NCT00680719|HIV risk|hiv risk
5237012|NCT00680719|Behavior and Mental Disorders|behavior and mental disorders
5237013|NCT00680719|HIV Seronegativity|hiv seronegativity
5237014|NCT00680693|IBS, functional gastrointestinal disease|ibs, functional gastrointestinal disease
5237015|NCT00680680|Urinary retention secondary to benign prostatic hyperplasia|urinary retention secondary to benign prostatic hyperplasia
5237016|NCT00680667|ductal breast carcinoma|ductal breast carcinoma
5237017|NCT00680667|stage I breast cancer|stage i breast cancer
5237018|NCT00680667|stage II breast cancer|stage ii breast cancer
5237019|NCT00680667|stage IIIA breast cancer|stage iiia breast cancer
5237020|NCT00680667|stage IIIB breast cancer|stage iiib breast cancer
5237021|NCT00680667|stage IIIC breast cancer|stage iiic breast cancer
5237022|NCT00680667|estrogen receptor-negative breast cancer|estrogen receptor-negative breast cancer
5237023|NCT00680667|progesterone receptor-negative breast cancer|progesterone receptor-negative breast cancer
5237024|NCT00680654|Pulmonary hypertension|pulmonary hypertension
5237025|NCT00680641|COPD|copd
5237026|NCT00680641|Emphysema|emphysema
5237027|NCT00680641|Simvastatin|simvastatin
5237028|NCT00680628|Pulmonary Embolism|pulmonary embolism
5237029|NCT00680628|Tenecteplase|tenecteplase
5237030|NCT00680628|Enoxaparin|enoxaparin
5237031|NCT00680628|Thrombosis|thrombosis
5237032|NCT00680628|Fibrinolytics|fibrinolytics
5237033|NCT00680615|Smokeless tobacco|smokeless tobacco
5237034|NCT00680602|behavior therapy|behavior therapy
5237035|NCT00680602|group therapy|group therapy
5237036|NCT00680602|psychopharmacology|psychopharmacology
5237037|NCT00680589|TYRP2 DNA Vaccine|tyrp2 dna vaccine
5237038|NCT00680576|adolescent substance abuse|adolescent substance abuse
5237039|NCT00680550|Atrial Fibrillation|atrial fibrillation
5237040|NCT00680550|Risk of cardiac Arrhythmias|risk of cardiac arrhythmias
5237041|NCT00680550|Loop recorder|loop recorder
5237042|NCT00680537|physical therapy program|physical therapy program
5237043|NCT00680524|telephone-based intervention for PTSD|telephone-based intervention for ptsd
5237044|NCT00680511|methamphetamine abuse|methamphetamine abuse
5237045|NCT00680498|Age-Related Macular Degeneration|age-related macular degeneration
5237046|NCT00680498|Ranibizumab|ranibizumab
5237047|NCT00680498|Lucentis|lucentis
5237048|NCT00680498|Photodynamic Therapy|photodynamic therapy
5237049|NCT00680498|Verteporfin|verteporfin
5237050|NCT00680498|Visudyne|visudyne
5237051|NCT00680485|GSK580416|gsk580416
5237052|NCT00680485|ketoconazole interaction|ketoconazole interaction
5237053|NCT00680485|pleuromutilin|pleuromutilin
5237054|NCT00680485|oral dose|oral dose
5237055|NCT00680472|Shoulder pain|shoulder pain
5237056|NCT00680472|Pain|pain
5237057|NCT00680472|Ketoprofen|ketoprofen
5237058|NCT00680472|Topical Patch|topical patch
5237059|NCT00680459|central line infection|central line infection
5237060|NCT00680459|70% ethanol|70% ethanol
5237061|NCT00680459|Sepsis|sepsis
5237062|NCT00680446|Primary Immune Deficiency|primary immune deficiency
5237063|NCT00680446|Subcutaneous|subcutaneous
5237064|NCT00680446|Immunoglobulin G|immunoglobulin g
5237065|NCT00680420|pancreas cancer|pancreas cancer
5237066|NCT00680420|pancreas cyst|pancreas cyst
5237067|NCT00680420|DNA microarray|dna microarray
5237068|NCT00680407|NASH|nash
5237069|NCT00680407|non-alcoholic steatohepatitis|non-alcoholic steatohepatitis
5237070|NCT00680394|abortion|abortion
5237071|NCT00680394|medical abortion|medical abortion
5237072|NCT00680394|mifepristone|mifepristone
5237073|NCT00680394|misoprostol|misoprostol
5237074|NCT00680381|adolescent substance abuse|adolescent substance abuse
5237075|NCT00680368|Feasibility|feasibility
5237076|NCT00680368|Supervision|supervision
5237077|NCT00680368|Assessing|assessing
5237078|NCT00680355|golden rice carotenoids|golden rice carotenoids
5237079|NCT00680355|healthy volunteers|healthy volunteers
5237080|NCT00680355|retinol equivalence|retinol equivalence
5237081|NCT00680342|hepatitis C|hepatitis c
5237082|NCT00680329|Adherence|adherence
5237083|NCT00680329|Compliance|compliance
5237084|NCT00680329|Glaucoma|glaucoma
5237085|NCT00680329|Ocular Hypertension|ocular hypertension
5237086|NCT00680316|Pulmozyme|pulmozyme
5237087|NCT00680316|CF|cf
5237088|NCT00680303|Early Stuttering|early stuttering
5237089|NCT00680303|Lidcombe Program|lidcombe program
5237090|NCT00680303|Stuttering Treatment|stuttering treatment
5237091|NCT00680303|Efficiency|efficiency
5237092|NCT00680303|Efficacy|efficacy
5237093|NCT00680303|Service Delivery|service delivery
5237094|NCT00680303|Models of intervention|models of intervention
5237095|NCT00680290|exercise, quality of life, cpx|exercise, quality of life, cpx
5237096|NCT00680277|spirulina|spirulina
5237097|NCT00680277|carotenoids|carotenoids
5237098|NCT00680264|Treatment Outcomes|treatment outcomes
5237100|NCT00680264|Cerebral Palsy|cerebral palsy
5237101|NCT00680238|Pregnancy|pregnancy
5237102|NCT00680238|implantation|implantation
5237103|NCT00680238|miscarriage|miscarriage
5237104|NCT00680238|sHLA-G|shla-g
5237105|NCT00680225|Choroidal melanoma|choroidal melanoma
5237106|NCT00680225|Lucentis|lucentis
5237107|NCT00680225|TTT-ICG|ttt-icg
5237108|NCT00680212|dietary beta-carotene|dietary beta-carotene
5237109|NCT00680212|vitamin A status|vitamin a status
5237110|NCT00680212|intrinsically labeled plant foods|intrinsically labeled plant foods
5237111|NCT00680199|Insomnia|insomnia
5237112|NCT00680199|Primary Insomnia|primary insomnia
5237113|NCT00680199|Good Sleepers|good sleepers
5237114|NCT00680199|ERP|erp
5237115|NCT00680173|Chronic Hepatitis C|chronic hepatitis c
5237116|NCT00680173|Single nucleotide polymorphisms|single nucleotide polymorphisms
5237117|NCT00680173|Sustained virological response|sustained virological response
5237118|NCT00680173|Peginterferon|peginterferon
5237119|NCT00680173|Ribavirin|ribavirin
5237120|NCT00680160|Onychomycosis|onychomycosis
5237121|NCT00680160|Fungal Nail|fungal nail
5237122|NCT00680147|HPV|hpv
5237123|NCT00680147|Gardasil|gardasil
5237124|NCT00680147|African-American|african-american
5237125|NCT00680147|adolescent|adolescent
5237126|NCT00680147|health behavior|health behavior
5237127|NCT00680147|sexually transmitted infections|sexually transmitted infections
5237128|NCT00680147|This will enroll 300 mothers of teenage girls and boys to identify barriers to HPV vaccination among low-income, African-American teens.|this will enroll 300 mothers of teenage girls and boys to identify barriers to hpv vaccination among low-income, african-american teens.
5237129|NCT00680134|Onychomycosis|onychomycosis
5237130|NCT00680134|Fungal Nail|fungal nail
5237131|NCT00680121|Alcoholism|alcoholism
5237132|NCT00680121|Benfotiamine|benfotiamine
5237133|NCT00680121|Thiamine|thiamine
5237134|NCT00680095|Onychomycosis|onychomycosis
5237135|NCT00680095|Fungal Nail|fungal nail
5237136|NCT00680082|statins|statins
5237137|NCT00680082|rosuvastatin|rosuvastatin
5237138|NCT00680082|cross sectional study|cross sectional study
5237139|NCT00680082|France|france
5237140|NCT00680082|CV risk factors|cv risk factors
5237141|NCT00680069|avian influenza,H5N1,Influenza,parent protocol|avian influenza,h5n1,influenza,parent protocol
5237142|NCT00680056|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
5237143|NCT00680056|Tiotropium|tiotropium
5237144|NCT00680056|Formoterol|formoterol
5237145|NCT00680056|Bronchodilator Agents|bronchodilator agents
5237146|NCT00680056|Exercise Tolerance|exercise tolerance
5237147|NCT00680056|Randomized Controlled Trial [Publication Type]|randomized controlled trial [publication type]
5237148|NCT00680056|COPD|copd
5237149|NCT00680043|anemia|anemia
5237150|NCT00680043|chronic kidney disease|chronic kidney disease
5237151|NCT00680043|CKD|ckd
5237152|NCT00680043|chronic renal failure|chronic renal failure
5237153|NCT00680043|CRF|crf
5237154|NCT00680043|erythropoietin|erythropoietin
5237155|NCT00680043|EPO|epo
5237156|NCT00680043|erythropoiesis stimulating agent|erythropoiesis stimulating agent
5237157|NCT00680043|ESA|esa
5237158|NCT00680043|Hematide™|hematide™
5237159|NCT00680043|hemoglobin|hemoglobin
5237160|NCT00680043|Hb|hb
5237161|NCT00680043|Hgb|hgb
5237162|NCT00680043|Omontys|omontys
5237163|NCT00680043|peginesatide|peginesatide
5237164|NCT00680043|red blood cell|red blood cell
5237165|NCT00680043|red blood cell production|red blood cell production
5237166|NCT00680030|impedance|impedance
5237167|NCT00680030|manometry|manometry
5237168|NCT00680030|motility disorders|motility disorders
5237169|NCT00680030|ineffective motility|ineffective motility
5237170|NCT00680030|diffuse esophageal spasms|diffuse esophageal spasms
5237171|NCT00680030|achlasia-like dysmotility|achlasia-like dysmotility
5237172|NCT00680017|Dyslipidemia|dyslipidemia
5237173|NCT00680017|Kidney Disease|kidney disease
5237174|NCT00680004|Dynamic CTA|dynamic cta
5237175|NCT00680004|follow-up|follow-up
5237176|NCT00680004|EVAR|evar
5237177|NCT00679991|arteriovenous fistula|arteriovenous fistula
5237178|NCT00679991|AVF|avf
5237179|NCT00679991|hemodialysis|hemodialysis
5237180|NCT00679991|vascular access|vascular access
5237181|NCT00679991|PRT 201|prt 201
5237182|NCT00679991|dose escalation|dose escalation
5237183|NCT00679991|dialysis|dialysis
5237184|NCT00679991|fistula|fistula
5237185|NCT00679991|access|access
5237186|NCT00679991|vonapanitase|vonapanitase
5237187|NCT00679991|kidney|kidney
5237188|NCT00679991|renal|renal
5237189|NCT00679978|osteoporosis|osteoporosis
5237190|NCT00679978|glucocorticoid|glucocorticoid
5237191|NCT00679978|bone mineral density|bone mineral density
5237192|NCT00679978|osteonecrosis of the femoral head|osteonecrosis of the femoral head
5237193|NCT00679965|Onychomycosis|onychomycosis
5237194|NCT00679965|Fungal Nail|fungal nail
5237195|NCT00679952|Pancreatic fistula|pancreatic fistula
5237196|NCT00679952|Pancreatic duct stent|pancreatic duct stent
5237197|NCT00679952|Closed suction drainage|closed suction drainage
5237198|NCT00679939|Type 2 diabetes mellitus|type 2 diabetes mellitus
5237199|NCT00679939|bone|bone
5237200|NCT00679939|x-ray absorptiometry|x-ray absorptiometry
5237201|NCT00679939|bone biomarkers|bone biomarkers
5237202|NCT00679939|dual-energy|dual-energy
5237203|NCT00679939|bone mineral density|bone mineral density
5237204|NCT00679926|HIV|hiv
5237205|NCT00679926|AIDS|aids
5237206|NCT00679926|HIV/AIDS|hiv/aids
5237207|NCT00679926|Treatment Naive|treatment naive
5237208|NCT00679913|Pancreatic cancer|pancreatic cancer
5237209|NCT00679913|Pancreaticoduodenectomy|pancreaticoduodenectomy
5237210|NCT00679913|Extended lymphadenectomy|extended lymphadenectomy
5237211|NCT00679900|Primary Insomnia|primary insomnia
5237212|NCT00679900|Sleep Maintenance Difficulties|sleep maintenance difficulties
5237213|NCT00679887|chiropractic|chiropractic
5237214|NCT00679887|myofascial trigger points|myofascial trigger points
5237215|NCT00679887|ischemic compression|ischemic compression
5237216|NCT00679887|shoulder pain|shoulder pain
5237217|NCT00679874|Cardiovascular Magnetic Resonance Imaging|cardiovascular magnetic resonance imaging
5237218|NCT00679874|Cardiotoxicity|cardiotoxicity
5237219|NCT00679874|Anthracyclines|anthracyclines
5237220|NCT00679874|Trastuzumab|trastuzumab
5237221|NCT00679874|Breast cancer|breast cancer
5237222|NCT00679874|Toxicity|toxicity
5237223|NCT00679861|primary medical care|primary medical care
5237224|NCT00679861|computer expert system|computer expert system
5237225|NCT00679861|motivational interviewing|motivational interviewing
5237226|NCT00679861|health behavior change counselling|health behavior change counselling
5237227|NCT00679861|stages of change|stages of change
5237228|NCT00679848|Weight Loss|weight loss
5237229|NCT00679848|Transoral Suturing|transoral suturing
5237230|NCT00679848|Experimental|experimental
5237231|NCT00679822|OSA|osa
5237232|NCT00679822|sleep apnea|sleep apnea
5237233|NCT00679822|heart failure|heart failure
5237234|NCT00679822|CHF|chf
5237235|NCT00679822|heart clinic|heart clinic
5237236|NCT00679822|clinic|clinic
5237237|NCT00679822|obstructive sleep apnea|obstructive sleep apnea
5237238|NCT00679809|Resident|resident
5237239|NCT00679809|Safety|safety
5237240|NCT00679809|Fatigue|fatigue
5237241|NCT00679809|Continuity|continuity
5237242|NCT00679809|ICU|icu
5237243|NCT00679796|varicella|varicella
5237244|NCT00679796|case-control|case-control
5237245|NCT00679783|Breast cancer|breast cancer
5237246|NCT00679783|Ovarian cancer|ovarian cancer
5237247|NCT00679783|BRCA|brca
5237248|NCT00679783|Triple negative|triple negative
5237249|NCT00679783|Poly(ADP ribose) polymerases|poly(adp ribose) polymerases
5237250|NCT00679783|Known BRCA or Recurrent High Grade Serious/ Undifferentiated Tubo- Ovarian Carcinoma|known brca or recurrent high grade serious/ undifferentiated tubo- ovarian carcinoma
5237251|NCT00679783|Known BRCA or Triple Negative Breast Cancer|known brca or triple negative breast cancer
5237252|NCT00679770|Onychomycosis|onychomycosis
5237253|NCT00679770|Fungal Nail|fungal nail
5237254|NCT00679757|Sleep apnea|sleep apnea
5237255|NCT00679757|Obstructive sleep apnea|obstructive sleep apnea
5237256|NCT00679757|Wound healing|wound healing
5237257|NCT00679757|Non-healing wounds|non-healing wounds
5237258|NCT00679744|Tay-Sachs disease.|tay-sachs disease.
5237259|NCT00679744|Sandhoff disease.|sandhoff disease.
5237260|NCT00679744|GM2 Gangliosidosis.|gm2 gangliosidosis.
5237261|NCT00679744|β-hexosaminidase deficiency.|β-hexosaminidase deficiency.
5237262|NCT00679744|Hexosaminidase|hexosaminidase
5237263|NCT00679744|Phase I clinical trial.|phase i clinical trial.
5237264|NCT00679731|Psoriasis|psoriasis
5237265|NCT00679705|Hemodynamics and arterial function of healthy females|hemodynamics and arterial function of healthy females
5237266|NCT00679692|GH,IGF-1, IGFBP-3|gh,igf-1, igfbp-3
5237267|NCT00679679|Polycystic ovary syndrome|polycystic ovary syndrome
5237268|NCT00679679|Treatment|treatment
5237269|NCT00679679|Metformin|metformin
5237270|NCT00679666|keratoconus|keratoconus
5237271|NCT00679666|ectasia|ectasia
5237272|NCT00679666|cross-linking|cross-linking
5237273|NCT00679666|riboflavin|riboflavin
5237274|NCT00679666|UVA light|uva light
5237275|NCT00679666|cornea|cornea
5237276|NCT00679640|candesartan|candesartan
5237277|NCT00679640|heart failure|heart failure
5237278|NCT00679640|cohort study|cohort study
5237279|NCT00679640|France|france
5237280|NCT00679627|Alzheimer's Disease|alzheimer's disease
5237281|NCT00679627|Galantamine|galantamine
5237282|NCT00679627|Dementia, Alzheimer type|dementia, alzheimer type
5237283|NCT00679627|Memory loss|memory loss
5237284|NCT00679614|Tramacet|tramacet
5237285|NCT00679614|naloxone|naloxone
5237286|NCT00679614|morphine|morphine
5237287|NCT00679614|analgesia|analgesia
5237288|NCT00679614|elderly|elderly
5237289|NCT00679614|elderly patients|elderly patients
5237290|NCT00679601|Onychomycosis|onychomycosis
5237291|NCT00679601|Fungal Nail|fungal nail
5237292|NCT00679588|Digestive System Surgical Procedure|digestive system surgical procedure
5237293|NCT00679588|Urologic Surgical Procedure|urologic surgical procedure
5237294|NCT00679588|Prevention of venous thromboembolism|prevention of venous thromboembolism
5237295|NCT00679588|Abdominal surgery|abdominal surgery
5237296|NCT00679575|statins|statins
5237297|NCT00679575|myocardial infarction|myocardial infarction
5237298|NCT00679575|case-referent study|case-referent study
5237299|NCT00679575|France|france
5237300|NCT00679549|Heart Failure|heart failure
5237301|NCT00679549|Obstructive Sleep Apnea|obstructive sleep apnea
5237302|NCT00679549|OSA|osa
5237303|NCT00679549|CHF|chf
5237304|NCT00679549|Sleep apnea|sleep apnea
5237305|NCT00679549|CHD|chd
5237306|NCT00679536|Reduced Toxicity|reduced toxicity
5237307|NCT00679536|Toxicity|toxicity
5237308|NCT00679536|Event Free Survival|event free survival
5237309|NCT00679536|Graft vs Host Disease|graft vs host disease
5237310|NCT00679523|Onychomycosis|onychomycosis
5237311|NCT00679523|Fungal Nail|fungal nail
5237312|NCT00679510|Rheumatoid Arthritis|rheumatoid arthritis
5237313|NCT00679510|Rosuvastatin|rosuvastatin
5237314|NCT00679510|Cardiovascular|cardiovascular
5237315|NCT00679510|Intima media thickness|intima media thickness
5237316|NCT00679497|Low risk HIV infection|low risk hiv infection
5237317|NCT00679497|HIV Seronegativity|hiv seronegativity
5237318|NCT00679497|HIV Preventive Vaccine|hiv preventive vaccine
5237319|NCT00679471|pre-term infants|pre-term infants
5237320|NCT00679471|full-term infants|full-term infants
5237321|NCT00679471|MRI|mri
5237322|NCT00679471|brain structure development|brain structure development
5237323|NCT00679471|pre term|pre term
5237324|NCT00679471|full term|full term
5237325|NCT00679458|analgesia|analgesia
5237326|NCT00679458|pain|pain
5237327|NCT00679458|buprenorphine|buprenorphine
5237328|NCT00679458|opioid|opioid
5237329|NCT00679458|naloxone|naloxone
5237330|NCT00679445|Macular|macular
5237331|NCT00679445|Degeneration|degeneration
5237332|NCT00679445|AMD|amd
5237333|NCT00679445|Wet Age-related macular degeneration|wet age-related macular degeneration
5237334|NCT00679432|Ulcerative colitis|ulcerative colitis
5237335|NCT00679406|Chronic Insomnia lasting more than 1 month|chronic insomnia lasting more than 1 month
5237336|NCT00679393|Calcaneus|calcaneus
5237337|NCT00679393|Intra-articular fracture|intra-articular fracture
5237338|NCT00679393|open reduction internal fixation|open reduction internal fixation
5237339|NCT00679393|primary subtalar fusion|primary subtalar fusion
5237340|NCT00679380|Ulcerative colitis|ulcerative colitis
5237341|NCT00679367|primary systemic amyloidosis|primary systemic amyloidosis
5237342|NCT00679341|HER2-positive breast cancer|her2-positive breast cancer
5237343|NCT00679341|HER2|her2
5237344|NCT00679341|Herceptin|herceptin
5237345|NCT00679341|Taxotere|taxotere
5237346|NCT00679341|MBC|mbc
5237347|NCT00679341|Breast cancer|breast cancer
5237348|NCT00679341|TDM1|tdm1
5237349|NCT00679341|TDM-1|tdm-1
5237350|NCT00679341|HER2-positive|her2-positive
5237351|NCT00679341|HER2+|her2+
5237352|NCT00679341|HER2 positive breast cancer|her2 positive breast cancer
5237353|NCT00679341|HER2+ breast cancer|her2+ breast cancer
5237354|NCT00679341|Armed Herceptin|armed herceptin
5237355|NCT00679341|Trastuzumab emtansine|trastuzumab emtansine
5237356|NCT00679341|Trastuzumab DM1|trastuzumab dm1
5237357|NCT00679315|female voiding dysfunction|female voiding dysfunction
5237358|NCT00679315|alpha adrenoreceptor antagonists|alpha adrenoreceptor antagonists
5237359|NCT00679315|IPSS or American Urological Association symptom index|ipss or american urological association symptom index
5237360|NCT00679302|skin abscess|skin abscess
5237361|NCT00679302|CA-MRSA|ca-mrsa
5237362|NCT00679289|KW2871|kw2871
5237363|NCT00679289|Ecromeximab|ecromeximab
5237364|NCT00679289|Anti-ganglioside|anti-ganglioside
5237365|NCT00679289|Antibody|antibody
5237366|NCT00679289|Interferon alpha|interferon alpha
5237367|NCT00679289|Metastatic melanoma|metastatic melanoma
5237368|NCT00679276|vaginal prolapse|vaginal prolapse
5237369|NCT00679263|asthma|asthma
5237370|NCT00679263|randomized|randomized
5237371|NCT00679263|placebo controlled|placebo controlled
5237372|NCT00679263|dose escalation|dose escalation
5237373|NCT00679263|safety|safety
5237374|NCT00679263|efficacy|efficacy
5237375|NCT00679263|single blind|single blind
5237376|NCT00679263|MN-221|mn-221
5237377|NCT00679250|allergic rhinitis|allergic rhinitis
5237378|NCT00679250|levocetirizine|levocetirizine
5237379|NCT00679250|nasal provocation testing|nasal provocation testing
5237380|NCT00679250|nasal allergen challenge|nasal allergen challenge
5237381|NCT00679250|nasal adenosine monophosphate challenge|nasal adenosine monophosphate challenge
5237382|NCT00679224|Pulmonary Arterial Hypertesion|pulmonary arterial hypertesion
5237383|NCT00679224|observational safety|observational safety
5237384|NCT00679211|HER2-positive breast cancer|her2-positive breast cancer
5237385|NCT00679211|HER2|her2
5237386|NCT00679211|MBC|mbc
5237387|NCT00679211|Trastuzumab emtansine|trastuzumab emtansine
5237388|NCT00679198|osteoporosis|osteoporosis
5237389|NCT00679198|fracture|fracture
5237390|NCT00679198|communication|communication
5237391|NCT00679198|prescription medication|prescription medication
5237392|NCT00679185|fatigue|fatigue
5237393|NCT00679185|stage I breast cancer|stage i breast cancer
5237394|NCT00679185|stage II breast cancer|stage ii breast cancer
5237395|NCT00679185|stage IIIA breast cancer|stage iiia breast cancer
5237396|NCT00679185|stage IIIB breast cancer|stage iiib breast cancer
5237397|NCT00679185|stage IIIC breast cancer|stage iiic breast cancer
5237398|NCT00679185|lymphedema|lymphedema
5237399|NCT00679133|c-Met|c-met
5237400|NCT00679133|VEGFR|vegfr
5237401|NCT00679133|Ron|ron
5237402|NCT00679133|Cancer|cancer
5237403|NCT00679133|Tumor|tumor
5237404|NCT00679133|Safety|safety
5237405|NCT00679133|Phase 1|phase 1
5237406|NCT00679120|Unicompartmental osteoarthrosis|unicompartmental osteoarthrosis
5237407|NCT00679120|RSA|rsa
5237408|NCT00679120|Bone-remodelling|bone-remodelling
5237409|NCT00679107|Degenerative Disc Disease|degenerative disc disease
5237410|NCT00679068|respiratory mechanics|respiratory mechanics
5237411|NCT00679068|bosentan|bosentan
5237412|NCT00679068|exercise capacity|exercise capacity
5237413|NCT00679042|Diabetes Mellitus Type 1|diabetes mellitus type 1
5237414|NCT00679042|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
5237415|NCT00679042|Islets of Langerhans Transplantation|islets of langerhans transplantation
5237416|NCT00679042|Allogeneic Islet transplantation|allogeneic islet transplantation
5237417|NCT00679003|Crohn's disease|crohn's disease
5237418|NCT00679003|Ulcerative colitis|ulcerative colitis
5237419|NCT00679003|Inflammatory bowel disease|inflammatory bowel disease
5237420|NCT00679003|Illness behavior|illness behavior
5237421|NCT00679003|Cognitive behavioral therapy|cognitive behavioral therapy
5237422|NCT00678990|Islets of Langerhans|islets of langerhans
5237423|NCT00678990|islets|islets
5237424|NCT00678990|heparin|heparin
5237425|NCT00678977|pharmacokinetics|pharmacokinetics
5237426|NCT00678977|cisplatin|cisplatin
5237427|NCT00678977|pazopanib (GW786034)|pazopanib (gw786034)
5237428|NCT00678977|Solid tumors|solid tumors
5237429|NCT00678977|anti-angiogenesis|anti-angiogenesis
5237430|NCT00678977|gemcitabine|gemcitabine
5237431|NCT00678964|NSCLC|nsclc
5237432|NCT00678964|Elderly patients|elderly patients
5237433|NCT00678938|smoking reduction|smoking reduction
5237434|NCT00678938|smoking cessation|smoking cessation
5237435|NCT00678938|stages of change|stages of change
5237436|NCT00678938|expert system interventions|expert system interventions
5237437|NCT00678912|mechanical ventilation|mechanical ventilation
5237438|NCT00678912|automated weaning|automated weaning
5237439|NCT00678912|children|children
5237440|NCT00678899|High frequency severe to profound|high frequency severe to profound
5237441|NCT00678886|Type 1 diabetes|type 1 diabetes
5237442|NCT00678886|new onset type 1 diabetes|new onset type 1 diabetes
5237443|NCT00678886|T1DM|t1dm
5237444|NCT00678886|Type l diabetes|type l diabetes
5237445|NCT00678886|juvenile diabetes|juvenile diabetes
5237446|NCT00678873|Single Incision|single incision
5237447|NCT00678873|Single Access|single access
5237448|NCT00678873|Surgery|surgery
5237449|NCT00678873|Cholecystectomy|cholecystectomy
5237450|NCT00678860|Questionnaire|questionnaire
5237451|NCT00678860|Computer Assisted Interface|computer assisted interface
5237452|NCT00678860|Quality of Life|quality of life
5237453|NCT00678860|Dry Eye|dry eye
5237454|NCT00678860|Ocular Surface Disease|ocular surface disease
5237455|NCT00678860|Healthy Volunteer|healthy volunteer
5237456|NCT00678860|HV|hv
5237457|NCT00678847|bio-electrical stimulation therapy|bio-electrical stimulation therapy
5237458|NCT00678847|chronic venous ulcers|chronic venous ulcers
5237459|NCT00678847|microcurrent|microcurrent
5237460|NCT00678847|chronic wounds|chronic wounds
5237461|NCT00678847|complete healing|complete healing
5237462|NCT00678821|Interstitial Lung Disease|interstitial lung disease
5237463|NCT00678821|Pulmonary Rehabilitation|pulmonary rehabilitation
5237464|NCT00678821|Pulmonary Hypertension|pulmonary hypertension
5237465|NCT00678821|Exercise|exercise
5237466|NCT00678795|Detrusor overactivity|detrusor overactivity
5237467|NCT00678795|Multiple Sclerosis|multiple sclerosis
5237468|NCT00678782|knee|knee
5237469|NCT00678782|synovitis|synovitis
5237470|NCT00678782|arthritis|arthritis
5237471|NCT00678782|rheumatoid arthritis|rheumatoid arthritis
5237472|NCT00678782|psoriatic arthritis|psoriatic arthritis
5237473|NCT00678782|spondyloarthropathies|spondyloarthropathies
5237474|NCT00678782|intraarticular|intraarticular
5237475|NCT00678782|etanercept|etanercept
5237476|NCT00678756|Psoriasis vulgaris,|psoriasis vulgaris,
5237477|NCT00678756|vitamin D, UVB-phototherapy, ketokonazol,|vitamin d, uvb-phototherapy, ketokonazol,
5237478|NCT00678756|Optical Coherence Tomography,|optical coherence tomography,
5237479|NCT00678756|local PASI, Nizoral|local pasi, nizoral
5237480|NCT00678743|cholesterol|cholesterol
5237481|NCT00678743|dyslipidemia|dyslipidemia
5237482|NCT00678743|omega 3|omega 3
5237483|NCT00678730|THC|thc
5237484|NCT00678730|COMT gene polymorphism|comt gene polymorphism
5237485|NCT00678730|schizophrenia|schizophrenia
5237486|NCT00678730|cannabis use|cannabis use
5237487|NCT00678717|abdominal|abdominal
5237488|NCT00678717|Pelvic|pelvic
5237489|NCT00678717|Pain|pain
5237490|NCT00678717|SCS|scs
5237491|NCT00678717|Healthy and Chronic Visceral Pain patients|healthy and chronic visceral pain patients
5237492|NCT00678717|Chronic Visceral Pain and spinal cord stimulator|chronic visceral pain and spinal cord stimulator
5237493|NCT00678704|Vardenafil|vardenafil
5237494|NCT00678704|PDE5 inhibitor|pde5 inhibitor
5237495|NCT00678704|Erectile Dysfunction|erectile dysfunction
5237496|NCT00678704|Diabetes Mellitus|diabetes mellitus
5237497|NCT00678704|Sexual Dysfunction|sexual dysfunction
5237498|NCT00678691|fibromyalgia|fibromyalgia
5237499|NCT00678691|fatigue|fatigue
5237500|NCT00678678|Physiotherapy|physiotherapy
5237501|NCT00678678|Breathing exercises|breathing exercises
5237502|NCT00678678|Bariatric Surgery|bariatric surgery
5237503|NCT00678678|Laparoscopy|laparoscopy
5237504|NCT00678665|ecg|ecg
5237505|NCT00678665|TSA2000|tsa2000
5237506|NCT00678665|Heart rate variability|heart rate variability
5237507|NCT00678665|wavelets|wavelets
5237508|NCT00678652|Meningococcal vaccine|meningococcal vaccine
5237509|NCT00678652|Neisseria meningitidis|neisseria meningitidis
5237510|NCT00678639|ACS|acs
5237511|NCT00678639|Acute Coronary Syndrome|acute coronary syndrome
5237512|NCT00678639|Chest pain|chest pain
5237513|NCT00678639|Cardiac MRI|cardiac mri
5237514|NCT00678639|CMR|cmr
5237515|NCT00678639|Risk Stratification|risk stratification
5237516|NCT00678639|Emergency Department|emergency department
5237517|NCT00678626|Key words: Docetaxel; breast cancer; breast diseases; breast neoplasms; antineoplastic agents; neoplasms;HER-2 negative; Stage IIIB or IV breast cancer.|key words: docetaxel; breast cancer; breast diseases; breast neoplasms; antineoplastic agents; neoplasms;her-2 negative; stage iiib or iv breast cancer.
5237518|NCT00678613|probiotics|probiotics
5237519|NCT00678613|cirrhosis|cirrhosis
5237520|NCT00678613|prophylaxis|prophylaxis
5237521|NCT00678613|cirrhotic|cirrhotic
5237522|NCT00678613|patients|patients
5237523|NCT00678613|with|with
5237524|NCT00678613|ascites|ascites
5237525|NCT00678613|using|using
5237526|NCT00678600|Informatics|informatics
5237527|NCT00678600|Alerts|alerts
5237528|NCT00678600|Toxicity|toxicity
5237529|NCT00678600|Virologic failure|virologic failure
5237530|NCT00678600|Suboptimal follow up|suboptimal follow up
5237531|NCT00678587|elective invasive procedure.|elective invasive procedure.
5237532|NCT00678587|platelet transfusion|platelet transfusion
5237533|NCT00678587|chronic liver disease-related thrombocytopenia|chronic liver disease-related thrombocytopenia
5237534|NCT00678587|platelets|platelets
5237535|NCT00678587|thrombopoietin|thrombopoietin
5237536|NCT00678574|hormones|hormones
5237537|NCT00678574|menses|menses
5237538|NCT00678574|PMS|pms
5237539|NCT00678574|PMDD|pmdd
5237540|NCT00678561|chronic plaque psoriasis, topical treatment|chronic plaque psoriasis, topical treatment
5237541|NCT00678535|1st line treatment for Gastric Cancer|1st line treatment for gastric cancer
5237542|NCT00678535|Cetuximab|cetuximab
5237543|NCT00678535|Capecitabine|capecitabine
5237544|NCT00678535|Xeloda|xeloda
5237545|NCT00678535|Cisplatin|cisplatin
5237546|NCT00678535|Progression-free survival|progression-free survival
5237547|NCT00678522|Atorvastatin|atorvastatin
5237548|NCT00678522|Renal function|renal function
5237549|NCT00678522|Hemodynamics|hemodynamics
5237550|NCT00678522|Diabetes type II|diabetes type ii
5237551|NCT00678522|sodium excretion|sodium excretion
5237552|NCT00678509|HLA-A*2402|hla-a*2402
5237553|NCT00678509|Peptide Vaccine|peptide vaccine
5237554|NCT00678509|TTK|ttk
5237555|NCT00678496|CBT-software|cbt-software
5237556|NCT00678496|Computerised Cognitive Behavioural Therapy|computerised cognitive behavioural therapy
5237557|NCT00678496|CCBT|ccbt
5237558|NCT00678496|Cognitive Therapy|cognitive therapy
5237559|NCT00678496|Therapy, Computer-Assisted|therapy, computer-assisted
5237560|NCT00678496|Depression|depression
5237561|NCT00678496|Multiple Sclerosis|multiple sclerosis
5237562|NCT00678483|Cholesterol|cholesterol
5237563|NCT00678483|HDL|hdl
5237564|NCT00678483|triglycerides|triglycerides
5237565|NCT00678483|insulin|insulin
5237566|NCT00678483|blood glucose|blood glucose
5237567|NCT00678457|alcohol dependence|alcohol dependence
5237568|NCT00678457|alcohol abuse|alcohol abuse
5237569|NCT00678457|drinking|drinking
5237570|NCT00678457|alcohol|alcohol
5237571|NCT00678444|Anxiety|anxiety
5237572|NCT00678444|Satisfaction|satisfaction
5237573|NCT00678444|Incomplete bladder emptying|incomplete bladder emptying
5237574|NCT00678444|Clean Intermittent Self-catheterization|clean intermittent self-catheterization
5237575|NCT00678444|Prolapse/incontinence surgery|prolapse/incontinence surgery
5237576|NCT00678431|Alzheimer's Disease|alzheimer's disease
5237577|NCT00678431|Dementia|dementia
5237578|NCT00678431|Nutritional Supplement|nutritional supplement
5237579|NCT00678431|Resveratrol|resveratrol
5237580|NCT00678418|Addiction|addiction
5237581|NCT00678418|Opiate dependence|opiate dependence
5237582|NCT00678418|Inpatient detoxification|inpatient detoxification
5237583|NCT00678418|opioid dependence|opioid dependence
5237584|NCT00678418|heroin dependence|heroin dependence
5237585|NCT00678405|Breathlessness|breathlessness
5237586|NCT00678405|Dyspnoea|dyspnoea
5237587|NCT00678405|Dyspnea|dyspnea
5237588|NCT00678405|Palliative care|palliative care
5237589|NCT00678405|RCT|rct
5237590|NCT00678405|Randomised controlled trial|randomised controlled trial
5237591|NCT00678405|Lung cancer|lung cancer
5237592|NCT00678405|COPD|copd
5237593|NCT00678405|Heart failure|heart failure
5237594|NCT00678405|Chronic respiratory disease|chronic respiratory disease
5237595|NCT00678392|Axitinib in Second Line Treatment of Patients With Metastatic Renal Cell Cancer|axitinib in second line treatment of patients with metastatic renal cell cancer
5237596|NCT00678379|Tonsillectomy|tonsillectomy
5237597|NCT00678379|Postoperative Pain|postoperative pain
5237598|NCT00678379|Clonidine|clonidine
5237599|NCT00678379|Anesthetics, Local|anesthetics, local
5237600|NCT00678366|laparoscopy|laparoscopy
5237601|NCT00678366|carbon dioxide|carbon dioxide
5237602|NCT00678366|oxygen|oxygen
5237603|NCT00678366|pain|pain
5237604|NCT00678366|inflammation|inflammation
5237605|NCT00678353|Degenerative disc disease|degenerative disc disease
5237606|NCT00678340|Randomized Controlled Trial|randomized controlled trial
5237607|NCT00678340|Single-Blind Study|single-blind study
5237608|NCT00678340|Catheter Ablation|catheter ablation
5237609|NCT00678327|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5237610|NCT00678327|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5237611|NCT00678327|adult nodular sclerosis Hodgkin lymphoma|adult nodular sclerosis hodgkin lymphoma
5237612|NCT00678327|adult lymphocyte depletion Hodgkin lymphoma|adult lymphocyte depletion hodgkin lymphoma
5237613|NCT00678327|adult lymphocyte predominant Hodgkin lymphoma|adult lymphocyte predominant hodgkin lymphoma
5237614|NCT00678327|adult mixed cellularity Hodgkin lymphoma|adult mixed cellularity hodgkin lymphoma
5237615|NCT00678327|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
5237616|NCT00678314|Anesthetics|anesthetics
5237617|NCT00678314|Local|local
5237618|NCT00678314|ropivacaine|ropivacaine
5237619|NCT00678314|Surgery|surgery
5237620|NCT00678314|Hand|hand
5237621|NCT00678314|carpel tunnel|carpel tunnel
5237622|NCT00678314|Carpal tunnel surgery|carpal tunnel surgery
5237623|NCT00678301|pneumococcal conjugate vaccine|pneumococcal conjugate vaccine
5237624|NCT00678301|Streptococcus pneumoniae|streptococcus pneumoniae
5237625|NCT00678288|Renal Cell Cancer|renal cell cancer
5237626|NCT00678288|Interferon|interferon
5237627|NCT00678275|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
5237628|NCT00678262|pain|pain
5237629|NCT00678262|ECG|ecg
5237630|NCT00678262|Heart rate variability|heart rate variability
5237631|NCT00678262|wavelets|wavelets
5237632|NCT00678249|Hemodialysis|hemodialysis
5237633|NCT00678249|Vascular Prosthesis|vascular prosthesis
5237634|NCT00678249|stenoses|stenoses
5237635|NCT00678249|grafts|grafts
5237636|NCT00678236|RSA|rsa
5237637|NCT00678236|Gonarthritis|gonarthritis
5237638|NCT00678236|Bone Cement|bone cement
5237639|NCT00678210|dose response; PASI 75 response endpoint; subjects with moderate to severe chronic plaque psoriasis|dose response; pasi 75 response endpoint; subjects with moderate to severe chronic plaque psoriasis
5237640|NCT00678197|Quality of care|quality of care
5237641|NCT00678197|Access to care|access to care
5237642|NCT00678197|Health Outcomes|health outcomes
5237643|NCT00678184|Atorvastatin|atorvastatin
5237644|NCT00678184|healthy|healthy
5237645|NCT00678184|sodium excretion|sodium excretion
5237646|NCT00678184|hemodynamics|hemodynamics
5237647|NCT00678184|tubular function|tubular function
5237648|NCT00678171|Degenerative Disc Disease|degenerative disc disease
5237649|NCT00678158|High Does Single Fraction IGRT|high does single fraction igrt
5237650|NCT00678158|Bone|bone
5237651|NCT00678158|Lymph Nodes|lymph nodes
5237652|NCT00678158|Soft Tissue|soft tissue
5237653|NCT00678145|Diabetes|diabetes
5237654|NCT00678145|Hypoglycemia|hypoglycemia
5237655|NCT00678145|HAAF|haaf
5237656|NCT00678145|Counterregulation|counterregulation
5237657|NCT00678132|PARP Inhibitor|parp inhibitor
5237658|NCT00678132|Combination Study|combination study
5237659|NCT00678132|Chemotherapy|chemotherapy
5237660|NCT00678132|Advanced Cancer|advanced cancer
5237661|NCT00678132|Neoplasms|neoplasms
5237662|NCT00678132|Cancer|cancer
5237663|NCT00678132|Solid Tumor|solid tumor
5237664|NCT00678119|Kidney cancer|kidney cancer
5237665|NCT00678119|Renal cancer|renal cancer
5237666|NCT00678119|Renal Cell Carcinoma|renal cell carcinoma
5237667|NCT00678106|dalbavancin adolescent subjects|dalbavancin adolescent subjects
5237668|NCT00678093|Low back pain|low back pain
5237669|NCT00678093|Manual therapy|manual therapy
5237670|NCT00678093|Mulligan snag|mulligan snag
5237671|NCT00678080|Type 2 diabetes mellitus|type 2 diabetes mellitus
5237672|NCT00678080|Pregnancy|pregnancy
5237673|NCT00678080|Metformin|metformin
5237674|NCT00678080|Insulin|insulin
5237675|NCT00678080|Pregnant women|pregnant women
5237676|NCT00678067|Hypercholesterolemic children|hypercholesterolemic children
5237677|NCT00678067|Docosahexaenoic acid|docosahexaenoic acid
5237678|NCT00678067|Eicosapentaenoic acid|eicosapentaenoic acid
5237679|NCT00678067|Blood lipid profile|blood lipid profile
5237680|NCT00678041|urinary catheterization|urinary catheterization
5237681|NCT00678041|urinary tract infection|urinary tract infection
5237682|NCT00678041|urinary incontinence|urinary incontinence
5237683|NCT00678041|pelvic floor prolapse|pelvic floor prolapse
5237684|NCT00678041|antibiotics|antibiotics
5237685|NCT00678028|MBL, UTI|mbl, uti
5237686|NCT00678015|NDGA|ndga
5237687|NCT00678015|Prostate Cancer|prostate cancer
5237688|NCT00678002|solid organ transplant|solid organ transplant
5237689|NCT00677989|perforated appendicitis|perforated appendicitis
5237690|NCT00677989|laparoscopic appendectomy|laparoscopic appendectomy
5237691|NCT00677989|open appendectomy|open appendectomy
5237692|NCT00677989|cytokines|cytokines
5237693|NCT00677989|free radicals|free radicals
5237694|NCT00677989|oxidized proteins|oxidized proteins
5237695|NCT00677976|fMRI|fmri
5237696|NCT00677976|IBS|ibs
5237697|NCT00677976|Brain Activation|brain activation
5237698|NCT00677963|carotid|carotid
5237699|NCT00677963|atherosclerosis|atherosclerosis
5237700|NCT00677963|arteriosclerosis|arteriosclerosis
5237701|NCT00677963|plaque|plaque
5237702|NCT00677963|neovascularization|neovascularization
5237703|NCT00677963|carotid endarterectomy|carotid endarterectomy
5237704|NCT00677950|Degenerative Disc Disease|degenerative disc disease
5237705|NCT00677937|diabetes mellitus|diabetes mellitus
5237706|NCT00677937|prevention|prevention
5237707|NCT00677937|education|education
5237708|NCT00677937|impaired glucose tolerance|impaired glucose tolerance
5237709|NCT00677937|multi-ethnic|multi-ethnic
5237710|NCT00677924|Colorectal Neoplasms|colorectal neoplasms
5237711|NCT00677924|Colorectal Tumors|colorectal tumors
5237712|NCT00677924|Colorectal Carcinoma|colorectal carcinoma
5237713|NCT00677911|Chronic pain|chronic pain
5237714|NCT00677911|Interleukin-6|interleukin-6
5237715|NCT00677911|pain catastrophizing|pain catastrophizing
5237716|NCT00677911|cytokines|cytokines
5237717|NCT00677911|cortisol|cortisol
5237718|NCT00677898|Patient-Centered Care|patient-centered care
5237719|NCT00677898|Adverse effects|adverse effects
5237720|NCT00677898|Antipsychotics|antipsychotics
5237721|NCT00677885|Alzheimer Disease|alzheimer disease
5237722|NCT00677885|Parkinson's Disease|parkinson's disease
5237723|NCT00677885|Frontotemporal Dementia|frontotemporal dementia
5237724|NCT00677885|PET Imaging|pet imaging
5237725|NCT00677885|AD|ad
5237726|NCT00677885|Parkinson Disease|parkinson disease
5237727|NCT00677885|PD|pd
5237728|NCT00677872|Moderate to severe COPD and coincident pulmonary hypertension|moderate to severe copd and coincident pulmonary hypertension
5237729|NCT00677859|Leukemia|leukemia
5237730|NCT00677859|Graft vs. Host Disease|graft vs. host disease
5237731|NCT00677859|Hematopoietic Stem Cell Transplant|hematopoietic stem cell transplant
5237732|NCT00677859|Bone Marrow Transplant|bone marrow transplant
5237733|NCT00677859|Myelodysplasia|myelodysplasia
5237734|NCT00677846|contrast agent ultrasound, vein thrombosis, vascularization|contrast agent ultrasound, vein thrombosis, vascularization
5237735|NCT00677833|P. Falciparum Malaria|p. falciparum malaria
5237736|NCT00677833|drug treatment|drug treatment
5237737|NCT00677833|clinical trial|clinical trial
5237738|NCT00677820|Influenza|influenza
5237739|NCT00677820|FluMist|flumist
5237740|NCT00677820|vaccine|vaccine
5237741|NCT00677820|prevention|prevention
5237742|NCT00677820|trivalent|trivalent
5237743|NCT00677807|COPD|copd
5237744|NCT00677807|adults|adults
5237745|NCT00677807|β2-agonist|β2-agonist
5237746|NCT00677807|indacaterol|indacaterol
5237747|NCT00677794|Video Capsule Endoscopy|video capsule endoscopy
5237748|NCT00677794|Small Bowel|small bowel
5237749|NCT00677768|Biomarkers|biomarkers
5237750|NCT00677768|Plasma|plasma
5237751|NCT00677768|Cerebrospinal Fluid|cerebrospinal fluid
5237752|NCT00677768|DNA|dna
5237753|NCT00677768|Serum|serum
5237754|NCT00677755|Medical abortion|medical abortion
5237755|NCT00677755|emergency contraception|emergency contraception
5237756|NCT00677755|mifepristone|mifepristone
5237757|NCT00677742|oral contraception|oral contraception
5237758|NCT00677742|hormonal contraception|hormonal contraception
5237759|NCT00677742|contraceptive behavior|contraceptive behavior
5237760|NCT00677742|patient compliance|patient compliance
5237761|NCT00677729|bronchiolitis|bronchiolitis
5237762|NCT00677729|hypertonic saline|hypertonic saline
5237763|NCT00677729|infants|infants
5237764|NCT00677716|glioblastoma multiforme|glioblastoma multiforme
5237765|NCT00677716|GBM|gbm
5237766|NCT00677716|brain cancer|brain cancer
5237767|NCT00677716|Cotara|cotara
5237768|NCT00677716|radioactive isotope|radioactive isotope
5237769|NCT00677716|monoclonal antibody|monoclonal antibody
5237770|NCT00677716|Glioblastoma multiforme at first relapse|glioblastoma multiforme at first relapse
5237771|NCT00677703|birth control pills|birth control pills
5237772|NCT00677703|contraception|contraception
5237773|NCT00677703|continuation|continuation
5237774|NCT00677703|text messaging|text messaging
5237775|NCT00677703|contraceptive continuation|contraceptive continuation
5237776|NCT00677703|contraceptive knowledge|contraceptive knowledge
5237777|NCT00677690|COPD|copd
5237778|NCT00677677|Lung transplant|lung transplant
5237779|NCT00677677|Liver transplant|liver transplant
5237780|NCT00677677|Kidney transplant|kidney transplant
5237781|NCT00677677|Pancreas transplant|pancreas transplant
5237782|NCT00677677|HPV|hpv
5237783|NCT00677677|Human Papillomavirus Quadrivalent Vaccine|human papillomavirus quadrivalent vaccine
5237784|NCT00677664|diabetic retinopathy|diabetic retinopathy
5237785|NCT00677664|panretinal photocoagulation|panretinal photocoagulation
5237786|NCT00677664|copaxone|copaxone
5237787|NCT00677664|nerve fiber layer thickness|nerve fiber layer thickness
5237788|NCT00677664|retinal function|retinal function
5237789|NCT00677651|adipose|adipose
5237790|NCT00677651|lean|lean
5237791|NCT00677651|obese|obese
5237792|NCT00677651|overweight|overweight
5237793|NCT00677651|healthy|healthy
5237794|NCT00677625|Liver|liver
5237795|NCT00677625|Transplant|transplant
5237796|NCT00677612|HLA-A*0201|hla-a*0201
5237797|NCT00677612|Peptide Vaccine|peptide vaccine
5237798|NCT00677612|VEGFR1|vegfr1
5237799|NCT00677612|VEGFR2|vegfr2
5237800|NCT00677599|Cardiovascular disease|cardiovascular disease
5237801|NCT00677599|type 2 diabetes|type 2 diabetes
5237802|NCT00677599|flavonoids|flavonoids
5237803|NCT00677599|cocoa|cocoa
5237804|NCT00677599|soy|soy
5237805|NCT00677599|epicatechin|epicatechin
5237806|NCT00677599|postmenopausal|postmenopausal
5237807|NCT00677599|carotid intima media thickness|carotid intima media thickness
5237808|NCT00677599|plaque volume|plaque volume
5237809|NCT00677586|colorectal neoplasms|colorectal neoplasms
5237810|NCT00677586|liver metastasis|liver metastasis
5237811|NCT00677586|surgery|surgery
5237812|NCT00677573|ART|art
5237813|NCT00677573|poor responder|poor responder
5237814|NCT00677573|GnRH antagonist|gnrh antagonist
5237815|NCT00677573|Gonadotropins|gonadotropins
5237816|NCT00677560|resistance|resistance
5237817|NCT00677560|reactance|reactance
5237818|NCT00677560|inflammation|inflammation
5237819|NCT00677547|Kidney|kidney
5237820|NCT00677547|Influenza vaccine|influenza vaccine
5237821|NCT00677547|CMI|cmi
5237822|NCT00677534|Endstage renal disease|endstage renal disease
5237823|NCT00677534|Vitamin D|vitamin d
5237824|NCT00677534|Monocyte function|monocyte function
5237825|NCT00677508|Constipation|constipation
5237826|NCT00677508|Fecal incontinence|fecal incontinence
5237827|NCT00677508|Quality of life|quality of life
5237828|NCT00677508|Health related quality of life|health related quality of life
5237829|NCT00677495|Gluten-free diet|gluten-free diet
5237830|NCT00677495|Celiac Disease|celiac disease
5237831|NCT00677495|Genetic predisposition|genetic predisposition
5237832|NCT00677495|Phage display library|phage display library
5237833|NCT00677495|Autoimmune diseases|autoimmune diseases
5237834|NCT00677482|liver transplant|liver transplant
5237835|NCT00677482|lung transplant|lung transplant
5237836|NCT00677482|kidney transplant|kidney transplant
5237837|NCT00677482|heart transplant|heart transplant
5237838|NCT00677482|CMV microRNA|cmv microrna
5237839|NCT00677469|Hyperthyroidism|hyperthyroidism
5237840|NCT00677469|Cholestyramine|cholestyramine
5237841|NCT00677456|Gastric Cancer|gastric cancer
5237842|NCT00677456|total gastrectomy|total gastrectomy
5237843|NCT00677456|reconstruction|reconstruction
5237844|NCT00677456|life quality|life quality
5237845|NCT00677443|metastatic colorectal cancer|metastatic colorectal cancer
5237846|NCT00677443|S-1|s-1
5237847|NCT00677443|Capecitabine|capecitabine
5237848|NCT00677443|Oxaliplatin|oxaliplatin
5237849|NCT00677443|non-inferiority study|non-inferiority study
5237850|NCT00677430|Breast Cancer|breast cancer
5237851|NCT00677430|Breast Reconstruction|breast reconstruction
5237852|NCT00677430|Digital Imaging|digital imaging
5237853|NCT00677430|Questionnaire|questionnaire
5237854|NCT00677430|Survey|survey
5237855|NCT00677404|Peripheral vascular diseases|peripheral vascular diseases
5237856|NCT00677404|chronic lower limb ischemia|chronic lower limb ischemia
5237857|NCT00677391|Obesity|obesity
5237858|NCT00677378|TRPV1|trpv1
5237859|NCT00677378|Nerve growth factor|nerve growth factor
5237860|NCT00677378|Capsaicin|capsaicin
5237861|NCT00677378|TrkA|trka
5237862|NCT00677378|Retrosternal pain|retrosternal pain
5237863|NCT00677378|Epigastric pain|epigastric pain
5237864|NCT00677378|Esophagitis|esophagitis
5237865|NCT00677378|Gastrointestinal symptoms|gastrointestinal symptoms
5237866|NCT00677352|Panic Disorder|panic disorder
5237867|NCT00677339|Tuberculosis|tuberculosis
5237868|NCT00677339|Adjunctive therapy|adjunctive therapy
5237869|NCT00677339|L-arginine|l-arginine
5237870|NCT00677339|Nitric oxide|nitric oxide
5237871|NCT00677339|Vitamin D|vitamin d
5237872|NCT00677326|HLA-A*0201|hla-a*0201
5237873|NCT00677326|Peptide Vaccine|peptide vaccine
5237874|NCT00677326|VEGFR1|vegfr1
5237875|NCT00677326|VEGFR2|vegfr2
5237876|NCT00677313|metreleptin|metreleptin
5237877|NCT00677313|leptin|leptin
5237878|NCT00677313|Amylin|amylin
5237879|NCT00677313|diabetes mellitus|diabetes mellitus
5237880|NCT00677313|hypertriglyceridemia|hypertriglyceridemia
5237881|NCT00677313|lipodystrophy|lipodystrophy
5237882|NCT00677300|HIV|hiv
5237883|NCT00677300|Treatment Naive|treatment naive
5237884|NCT00677287|HLA-A*2402|hla-a*2402
5237885|NCT00677287|Peptide Vaccine|peptide vaccine
5237886|NCT00677287|RNF43|rnf43
5237887|NCT00677287|TOMM34|tomm34
5237888|NCT00677287|VEGFR1|vegfr1
5237889|NCT00677287|VEGFR2|vegfr2
5237890|NCT00677274|Epidural analgesia|epidural analgesia
5237891|NCT00677274|Patient-controlled analgesia|patient-controlled analgesia
5237892|NCT00677261|Knee|knee
5237893|NCT00677261|Arthroplasty|arthroplasty
5237894|NCT00677261|Sciatic|sciatic
5237895|NCT00677261|Nerve|nerve
5237896|NCT00677261|Block|block
5237897|NCT00677261|Regional|regional
5237898|NCT00677261|Anesthesia|anesthesia
5237899|NCT00677261|Infiltration|infiltration
5237900|NCT00677261|Local Anesthetic|local anesthetic
5237901|NCT00677261|Analgesia|analgesia
5237902|NCT00677248|Eprotirome|eprotirome
5237903|NCT00677248|KB2115|kb2115
5237904|NCT00677248|dyslipidemia|dyslipidemia
5237905|NCT00677248|hypercholesterolemia|hypercholesterolemia
5237906|NCT00677248|hypertriglyceridemia|hypertriglyceridemia
5237907|NCT00677235|Hemodialysis|hemodialysis
5237908|NCT00677235|Vascular Prosthesis|vascular prosthesis
5237909|NCT00677235|Stenosis|stenosis
5237910|NCT00677235|End-stage Renal Disease (ESRD)|end-stage renal disease (esrd)
5237911|NCT00677222|Acute Myocardial Infarction, Heart Attack|acute myocardial infarction, heart attack
5237912|NCT00677209|house dust mite|house dust mite
5237913|NCT00677209|asthma|asthma
5237914|NCT00677209|autovaccine|autovaccine
5237915|NCT00677209|allergy|allergy
5237916|NCT00677196|PNL|pnl
5237917|NCT00677196|Lithoclast|lithoclast
5237918|NCT00677196|Stonebreaker|stonebreaker
5237919|NCT00677196|efficiency stone fragmentation|efficiency stone fragmentation
5237920|NCT00677183|NASH|nash
5237921|NCT00677183|Biomarker|biomarker
5237922|NCT00677157|Fatigue|fatigue
5237923|NCT00677157|Fibromyalgia|fibromyalgia
5237924|NCT00677157|Pain|pain
5237925|NCT00677157|Complex Regional Pain Syndrome|complex regional pain syndrome
5237926|NCT00677157|Reflex Sympathetic Dystrophy|reflex sympathetic dystrophy
5237927|NCT00677157|CPRS|cprs
5237928|NCT00677157|RSD|rsd
5237929|NCT00677144|Colorectal Neoplasm|colorectal neoplasm
5237930|NCT00677144|S-1|s-1
5237931|NCT00677144|Capecitabine|capecitabine
5237932|NCT00677144|Oxaliplatin|oxaliplatin
5237933|NCT00677131|pediatrics|pediatrics
5237934|NCT00677131|antibiotics|antibiotics
5237935|NCT00677131|patient education|patient education
5237936|NCT00677118|Nasopharyngeal carcinoma|nasopharyngeal carcinoma
5237937|NCT00677118|Concurrent chemoradiotherapy|concurrent chemoradiotherapy
5237938|NCT00677118|Adjuvant chemotherapy|adjuvant chemotherapy
5237939|NCT00677118|Clinical trial|clinical trial
5237940|NCT00677105|Lymphoma|lymphoma
5237941|NCT00677105|Neoplasms|neoplasms
5237942|NCT00677105|Solid Tumors|solid tumors
5237943|NCT00677105|Advanced Cancer|advanced cancer
5237944|NCT00677092|Treatment|treatment
5237945|NCT00677092|Chronic kidney disease|chronic kidney disease
5237946|NCT00677092|Fibrosing disorders|fibrosing disorders
5237947|NCT00677092|Imatinib mesylate|imatinib mesylate
5237948|NCT00677079|BRCA-1 or BRCA-2 associated advanced epithelial ovarian, fallopian tube, or primary peritoneal cancer|brca-1 or brca-2 associated advanced epithelial ovarian, fallopian tube, or primary peritoneal cancer
5237949|NCT00677079|BRCA-1|brca-1
5237950|NCT00677079|BRCA-2|brca-2
5237951|NCT00677066|bronchiolitis|bronchiolitis
5237952|NCT00677066|oxygen|oxygen
5237953|NCT00677066|children|children
5237954|NCT00677053|Unstable Angina|unstable angina
5237955|NCT00677053|Myocardial Infarction|myocardial infarction
5237956|NCT00677053|Thrombolysis|thrombolysis
5237957|NCT00677053|Anticoagulant|anticoagulant
5237958|NCT00677053|Acute Coronary Syndrome|acute coronary syndrome
5237959|NCT00677027|Beta-glucan|beta-glucan
5237960|NCT00677027|immune system|immune system
5237961|NCT00677027|Healthy subjects|healthy subjects
5237962|NCT00677014|Heart Failure|heart failure
5237963|NCT00677014|HF|hf
5237964|NCT00677014|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
5237965|NCT00677014|CRT|crt
5237966|NCT00677014|Optimization|optimization
5237967|NCT00677014|SmartDelay|smartdelay
5237968|NCT00677014|Echocardiography|echocardiography
5237969|NCT00677014|AV Delay|av delay
5237970|NCT00677001|Solid tumors|solid tumors
5237971|NCT00677001|solid malignancies|solid malignancies
5237972|NCT00677001|neoplasms|neoplasms
5237973|NCT00677001|refractory solid tumors|refractory solid tumors
5237974|NCT00677001|advanced solid tumors|advanced solid tumors
5237975|NCT00676988|Luminal Crohn's Disease|luminal crohn's disease
5237976|NCT00676988|Infliximab|infliximab
5237977|NCT00676975|Irritable Bowel disease|irritable bowel disease
5237978|NCT00676975|Traditional Chinese Medicine|traditional chinese medicine
5237979|NCT00676962|Implementation|implementation
5237980|NCT00676962|facilitation|facilitation
5237981|NCT00676962|psychotherapy|psychotherapy
5237982|NCT00676962|training|training
5237983|NCT00676949|epitope peptide|epitope peptide
5237984|NCT00676949|cyclophosphamide|cyclophosphamide
5237985|NCT00676949|interleukin-2|interleukin-2
5237986|NCT00676936|Cancer|cancer
5237987|NCT00676936|pain|pain
5237988|NCT00676936|corticosteroids|corticosteroids
5237989|NCT00676936|palliative|palliative
5237990|NCT00676936|supportive care|supportive care
5237991|NCT00676936|Cancer patients with pain|cancer patients with pain
5237992|NCT00676910|Advanced Cancer|advanced cancer
5237993|NCT00676910|Malignancies|malignancies
5237994|NCT00676910|Neoplasms|neoplasms
5237995|NCT00676910|Incurable Solid Cancers|incurable solid cancers
5237996|NCT00676897|statin, sepsis, septic shock, simvastatin|statin, sepsis, septic shock, simvastatin
5237997|NCT00676884|atopic eczema|atopic eczema
5237998|NCT00676884|atopic dermatitis|atopic dermatitis
5237999|NCT00676884|allergy|allergy
5238000|NCT00676858|Embolism|embolism
5238001|NCT00676858|Argon|argon
5238002|NCT00676845|Arterial stiffness|arterial stiffness
5238003|NCT00676845|Vascular protection|vascular protection
5238004|NCT00676832|colitis|colitis
5238005|NCT00676832|ulcerative|ulcerative
5238006|NCT00676832|moderate|moderate
5238007|NCT00676832|severe|severe
5238008|NCT00676806|Umbilical cord blood transplantation|umbilical cord blood transplantation
5238009|NCT00676806|full ablation conditioning|full ablation conditioning
5238010|NCT00676806|reduced intensity conditioning|reduced intensity conditioning
5238011|NCT00676793|breast cancer|breast cancer
5238012|NCT00676793|EGCG|egcg
5238013|NCT00676793|Polyphenon E|polyphenon e
5238014|NCT00676793|c-Met|c-met
5238015|NCT00676793|VEGF|vegf
5238016|NCT00676793|HGF|hgf
5238017|NCT00676780|EGCG|egcg
5238018|NCT00676780|polyphenols|polyphenols
5238019|NCT00676780|biomarkers|biomarkers
5238020|NCT00676780|prostate specific antigen|prostate specific antigen
5238021|NCT00676767|Aging|aging
5238022|NCT00676767|Diabetes|diabetes
5238023|NCT00676767|Diet|diet
5238024|NCT00676767|Fiber|fiber
5238025|NCT00676754|Multidrug-Resistant Tuberculosis, tuberculosis, Peru|multidrug-resistant tuberculosis, tuberculosis, peru
5238026|NCT00676728|Advanced or Refractory Leukemia|advanced or refractory leukemia
5238027|NCT00676728|Myelodysplastic Syndromes|myelodysplastic syndromes
5238028|NCT00676728|JNJ 26481585|jnj 26481585
5238029|NCT00676728|Histone-Deacetylase Inhibitor|histone-deacetylase inhibitor
5238030|NCT00676728|Advanced Leukemia|advanced leukemia
5238031|NCT00676728|Refractory Leukemia|refractory leukemia
5238032|NCT00676702|Pancrelipase|pancrelipase
5238033|NCT00676702|PANCREASE MT|pancrease mt
5238034|NCT00676702|Cross-Over Studies|cross-over studies
5238035|NCT00676702|Duodenum|duodenum
5238036|NCT00676702|Intestine, Small|intestine, small
5238037|NCT00676702|Lipase|lipase
5238038|NCT00676702|Amylases|amylases
5238039|NCT00676702|Peptide Hydrolases|peptide hydrolases
5238040|NCT00676702|Intubation|intubation
5238041|NCT00676702|Safety|safety
5238042|NCT00676702|Capsules|capsules
5238043|NCT00676689|Pulmonic|pulmonic
5238044|NCT00676689|Regurgitation|regurgitation
5238045|NCT00676689|Pulmonary Valve Conduit|pulmonary valve conduit
5238046|NCT00676689|Stenosis|stenosis
5238047|NCT00676689|Congenital Heart Defect|congenital heart defect
5238048|NCT00676676|Depression|depression
5238049|NCT00676676|Major Depressive Disorder|major depressive disorder
5238050|NCT00676663|Breast Neoplasms|breast neoplasms
5238051|NCT00676663|Breast Tumor|breast tumor
5238052|NCT00676663|Mammary Neoplasms|mammary neoplasms
5238053|NCT00676650|Docetaxel-refractory mCRPC|docetaxel-refractory mcrpc
5238054|NCT00676650|Second-line treatment with sunitinib and prednisone|second-line treatment with sunitinib and prednisone
5238055|NCT00676637|Adherence|adherence
5238056|NCT00676637|Compliance|compliance
5238057|NCT00676637|Glaucoma|glaucoma
5238058|NCT00676637|Ocular Hypertension|ocular hypertension
5238059|NCT00676624|uveitis|uveitis
5238060|NCT00676624|vitrectomy|vitrectomy
5238061|NCT00676624|infection|infection
5238062|NCT00676624|severe|severe
5238063|NCT00676611|Acetabular Fractures|acetabular fractures
5238064|NCT00676598|therapeutic hypothermia|therapeutic hypothermia
5238065|NCT00676585|Cardiac Arrest, Shock, Steroids|cardiac arrest, shock, steroids
5238066|NCT00676572|severe asthma|severe asthma
5238067|NCT00676572|corticosteroid insensitivity|corticosteroid insensitivity
5238068|NCT00676559|Diabetic|diabetic
5238069|NCT00676559|Macular|macular
5238070|NCT00676559|Edema|edema
5238071|NCT00676559|DME|dme
5238072|NCT00676559|Clinically Significant Macular Edema (CSME)|clinically significant macular edema (csme)
5238073|NCT00676533|Cipro|cipro
5238074|NCT00676533|Urinary Tract Infection|urinary tract infection
5238075|NCT00676520|Angioplasty|angioplasty
5238076|NCT00676520|Coronary Restenosis|coronary restenosis
5238077|NCT00676520|Coronary Artery Disease|coronary artery disease
5238078|NCT00676520|Coronary Artery Restenosis|coronary artery restenosis
5238079|NCT00676520|Coronary Artery Stenosis|coronary artery stenosis
5238080|NCT00676520|Total Artery Occlusion|total artery occlusion
5238081|NCT00676520|Stents|stents
5238082|NCT00676520|Stent Thrombosis|stent thrombosis
5238083|NCT00676520|Total Coronary Occlusion|total coronary occlusion
5238084|NCT00676520|Vascular Disease|vascular disease
5238085|NCT00676520|Myocardial Ischemia|myocardial ischemia
5238086|NCT00676507|Gene therapy|gene therapy
5238087|NCT00676507|Flow cytometry|flow cytometry
5238088|NCT00676507|Immunoenzyme technique|immunoenzyme technique
5238089|NCT00676507|Laboratory biomarker analysis|laboratory biomarker analysis
5238090|NCT00676507|Quality-of-life-assessment|quality-of-life-assessment
5238091|NCT00676507|Tumor cell-derivative vaccine therapy|tumor cell-derivative vaccine therapy
5238092|NCT00676481|Patient Education|patient education
5238093|NCT00676481|Emergency Medicine|emergency medicine
5238094|NCT00676481|HIV Prevention|hiv prevention
5238095|NCT00676481|HIV Seronegativity|hiv seronegativity
5238096|NCT00676468|Asthma|asthma
5238097|NCT00676468|Inflammation|inflammation
5238098|NCT00676468|Airway|airway
5238099|NCT00676468|Fish Oil|fish oil
5238100|NCT00676468|Singulair|singulair
5238101|NCT00676455|CT Software|ct software
5238102|NCT00676455|MeVis™|mevis™
5238103|NCT00676455|Metastatic pulmonary and hepatic lesion growth|metastatic pulmonary and hepatic lesion growth
5238104|NCT00676416|General anesthesia|general anesthesia
5238105|NCT00676416|Propofol|propofol
5238106|NCT00676416|Immunity|immunity
5238107|NCT00676416|Alveolar Macrophages|alveolar macrophages
5238108|NCT00676403|pregabalin, RLS, efficacy, safety|pregabalin, rls, efficacy, safety
5238109|NCT00676390|Heart Failure|heart failure
5238110|NCT00676377|Neostigmine, Post Operative, Ileus|neostigmine, post operative, ileus
5238111|NCT00676364|pediatric patients|pediatric patients
5238112|NCT00676364|pain|pain
5238113|NCT00676364|anxiety|anxiety
5238114|NCT00676364|topical anesthetic|topical anesthetic
5238686|NCT00674375|Chest Pain|chest pain
5238115|NCT00676364|randomized control trial|randomized control trial
5238116|NCT00676338|Amylin|amylin
5238117|NCT00676338|Lilly|lilly
5238118|NCT00676338|exenatide once weekly|exenatide once weekly
5238119|NCT00676338|Byetta|byetta
5238120|NCT00676338|Januvia|januvia
5238121|NCT00676338|sitagliptin|sitagliptin
5238122|NCT00676338|thiazolidinedione|thiazolidinedione
5238123|NCT00676325|anterior vaginal prolapse|anterior vaginal prolapse
5238124|NCT00676325|traditional treatment|traditional treatment
5238125|NCT00676325|mesh, graft|mesh, graft
5238126|NCT00676325|NAZCA TC™ POP REPAIR SYSTEM|nazca tc™ pop repair system
5238127|NCT00676325|colporrhaphy|colporrhaphy
5238128|NCT00676312|Osteoporosis|osteoporosis
5238129|NCT00676312|parathyroid hormone|parathyroid hormone
5238130|NCT00676312|pharmacodynamic|pharmacodynamic
5238131|NCT00676312|pharmacokinetic|pharmacokinetic
5238132|NCT00676299|Advanced Solid Cancers|advanced solid cancers
5238133|NCT00676299|Refractory Solid Cancers|refractory solid cancers
5238134|NCT00676299|Protein Kinase Inhibitors|protein kinase inhibitors
5238135|NCT00676299|Phase 1 Study|phase 1 study
5238136|NCT00676299|Oral Chemotherapy|oral chemotherapy
5238137|NCT00676286|Prostate cancer active surveillance|prostate cancer active surveillance
5238138|NCT00676286|3 Tesla MR biological imaging in prostate cancer|3 tesla mr biological imaging in prostate cancer
5238139|NCT00676286|tumor gene re-arrangements in prostate cancer|tumor gene re-arrangements in prostate cancer
5238140|NCT00676260|Glucose Metabolism Disorder|glucose metabolism disorder
5238141|NCT00676260|Dysmetabolic Syndrome|dysmetabolic syndrome
5238142|NCT00676260|Type II Diabetes|type ii diabetes
5238143|NCT00676260|Diabetes Mellitus|diabetes mellitus
5238144|NCT00676260|Lipoatrophic|lipoatrophic
5238145|NCT00676260|Dyslipidemia|dyslipidemia
5238146|NCT00676260|Drug Therapy|drug therapy
5238147|NCT00676247|Ultrasonography|ultrasonography
5238148|NCT00676247|Doppler|doppler
5238149|NCT00676247|Hemodynamics|hemodynamics
5238150|NCT00676247|Neurobehavioral development|neurobehavioral development
5238151|NCT00676234|erythropoietin|erythropoietin
5238152|NCT00676221|Renal transplant recipient|renal transplant recipient
5238153|NCT00676221|Immunosuppression|immunosuppression
5238154|NCT00676221|Gastro-intestinal symptoms|gastro-intestinal symptoms
5238155|NCT00676221|Quality of life|quality of life
5238156|NCT00676221|Cellcept|cellcept
5238157|NCT00676221|Myfortic|myfortic
5238158|NCT00676221|Kidney transplant patients.|kidney transplant patients.
5238159|NCT00676208|Shared Medical Appointments|shared medical appointments
5238160|NCT00676208|Diabetes|diabetes
5238161|NCT00676208|Education|education
5238162|NCT00676195|N-Acetyl Cysteine|n-acetyl cysteine
5238163|NCT00676169|Pseudomonas aeruginosa|pseudomonas aeruginosa
5238164|NCT00676169|EPIC|epic
5238165|NCT00676156|multiple sclerosis|multiple sclerosis
5238166|NCT00676156|lipoic acid|lipoic acid
5238167|NCT00676156|LA|la
5238168|NCT00676156|pharmacokinetics|pharmacokinetics
5238169|NCT00676156|immunological effects|immunological effects
5238170|NCT00676143|antibody|antibody
5238171|NCT00676143|immunotherapy|immunotherapy
5238172|NCT00676130|Cellulitis|cellulitis
5238173|NCT00676130|Bactrim|bactrim
5238174|NCT00676130|Trimethoprim Sulfamethoxazole|trimethoprim sulfamethoxazole
5238175|NCT00676130|MRSA|mrsa
5238176|NCT00676130|Methicillin-resistant Staphylococcus aureus|methicillin-resistant staphylococcus aureus
5238177|NCT00676117|male|male
5238178|NCT00676117|Japan|japan
5238179|NCT00676117|Japanese|japanese
5238180|NCT00676117|Healthy volunteers|healthy volunteers
5238181|NCT00676104|Traumatic Brain Injury|traumatic brain injury
5238182|NCT00676104|Trauma|trauma
5238183|NCT00676104|Hypothermia|hypothermia
5238184|NCT00676091|Pneumococcal conjugate vaccine|pneumococcal conjugate vaccine
5238185|NCT00676065|Contraception|contraception
5238186|NCT00676065|Thromboembolism|thromboembolism
5238187|NCT00676065|Breast Cancer|breast cancer
5238188|NCT00676052|COPD|copd
5238189|NCT00676052|Multicenter|multicenter
5238190|NCT00676052|GSK233705B|gsk233705b
5238191|NCT00676052|double-blind|double-blind
5238192|NCT00676052|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
5238193|NCT00676052|randomized|randomized
5238194|NCT00676039|Therapeutic Equivalency|therapeutic equivalency
5238195|NCT00676039|Human Experimentation|human experimentation
5238196|NCT00676039|Bioequivalence|bioequivalence
5238197|NCT00676039|Brand name|brand name
5238198|NCT00676039|Generic|generic
5238199|NCT00676039|Antidepressant|antidepressant
5238200|NCT00676039|Healthy volunteers|healthy volunteers
5238201|NCT00676026|menses|menses
5238202|NCT00676026|women|women
5238203|NCT00676026|healthy controls|healthy controls
5238204|NCT00676026|Healthy females with regular menstrual cycles|healthy females with regular menstrual cycles
5238205|NCT00676013|Burns|burns
5238206|NCT00676013|Skin grafting|skin grafting
5238207|NCT00676013|AlloDerm|alloderm
5238208|NCT00676013|Integra|integra
5238209|NCT00676013|Homograft|homograft
5238210|NCT00676013|Autograft|autograft
5238211|NCT00676013|Burn Scar|burn scar
5238212|NCT00675987|Impaired Fasting Glucose FPG >100-<126 mg/dL|impaired fasting glucose fpg >100-<126 mg/dl
5238213|NCT00675974|Burn|burn
5238214|NCT00675974|Scar|scar
5238215|NCT00675974|Pressure garments|pressure garments
5238216|NCT00675974|Wound healing|wound healing
5238217|NCT00675974|Burn Injury|burn injury
5238218|NCT00675961|Tomsk|tomsk
5238219|NCT00675961|TB-Alcohol|tb-alcohol
5238220|NCT00675961|Alcohol and co-occurring disease|alcohol and co-occurring disease
5238221|NCT00675961|Brief counseling intervention|brief counseling intervention
5238222|NCT00675961|Naltrexone|naltrexone
5238223|NCT00675948|Palliative Care|palliative care
5238224|NCT00675948|Pain|pain
5238225|NCT00675948|Cancer|cancer
5238226|NCT00675935|Patient falls|patient falls
5238227|NCT00675935|fall risk|fall risk
5238228|NCT00675935|fall prevention|fall prevention
5238229|NCT00675922|Burn|burn
5238230|NCT00675922|Wounds|wounds
5238231|NCT00675922|Wound infection|wound infection
5238232|NCT00675922|Topical antimicrobials|topical antimicrobials
5238233|NCT00675922|Cerium|cerium
5238234|NCT00675922|Dakins|dakins
5238235|NCT00675922|Sulfamylon Soaks|sulfamylon soaks
5238236|NCT00675922|Silver Nitrate|silver nitrate
5238237|NCT00675909|Sedation|sedation
5238238|NCT00675909|Anxiety|anxiety
5238239|NCT00675909|Minor procedures|minor procedures
5238240|NCT00675909|Emergency Department|emergency department
5238241|NCT00675896|major depression with comorbid fibromyalgia.|major depression with comorbid fibromyalgia.
5238242|NCT00675870|Acute Promyelocytic Leukemia|acute promyelocytic leukemia
5238243|NCT00675870|Cancer|cancer
5238244|NCT00675870|Leukemia|leukemia
5238245|NCT00675870|APL|apl
5238246|NCT00675870|ATRA|atra
5238247|NCT00675870|Tretinoid|tretinoid
5238248|NCT00675870|Vesanoid|vesanoid
5238249|NCT00675870|Retinoic Acid Receptor Alpha|retinoic acid receptor alpha
5238250|NCT00675870|All Trans Retinoic Acid|all trans retinoic acid
5238251|NCT00675870|Arsenic Trioxide|arsenic trioxide
5238252|NCT00675870|Trisenox|trisenox
5238253|NCT00675870|Retinoid|retinoid
5238254|NCT00675870|Relapsed or Refractory Acute Promyelocytic Leukemia|relapsed or refractory acute promyelocytic leukemia
5238255|NCT00675857|Type II diabetes|type ii diabetes
5238256|NCT00675857|Metabolic syndrome|metabolic syndrome
5238257|NCT00675844|Extension study|extension study
5238258|NCT00675844|HIV-1 infection|hiv-1 infection
5238259|NCT00675844|Treatment Naive|treatment naive
5238260|NCT00675831|CD25+|cd25+
5238261|NCT00675831|Tregs|tregs
5238262|NCT00675831|DLI|dli
5238263|NCT00675831|Donor lymphocyte infusion|donor lymphocyte infusion
5238264|NCT00675818|acute kidney injury|acute kidney injury
5238265|NCT00675818|renal replacement therapy|renal replacement therapy
5238266|NCT00675818|critical care unit|critical care unit
5238267|NCT00675818|hemodialysis|hemodialysis
5238268|NCT00675818|hemofiltration|hemofiltration
5238269|NCT00675805|intravenous immunoglobulin|intravenous immunoglobulin
5238270|NCT00675805|IVIG|ivig
5238271|NCT00675805|adverse reactions|adverse reactions
5238272|NCT00675779|endometriosis|endometriosis
5238273|NCT00675779|atorvastatin|atorvastatin
5238274|NCT00675779|oral|oral
5238275|NCT00675779|contraception|contraception
5238276|NCT00675779|pain|pain
5238277|NCT00675779|relief|relief
5238278|NCT00675779|pelvic pain in women with endometriosis|pelvic pain in women with endometriosis
5238279|NCT00675753|Genes|genes
5238280|NCT00675753|Ethnology|ethnology
5238281|NCT00675753|Cytokines|cytokines
5238282|NCT00675753|prematurity|prematurity
5238283|NCT00675727|Melanoma|melanoma
5238284|NCT00675727|Mycobacterium w|mycobacterium w
5238285|NCT00675714|anabolic agents|anabolic agents
5238286|NCT00675714|exercise|exercise
5238287|NCT00675701|To determine whether lixivaptan administration at supratherapeutic or therapeutic doses results in the prolongation of the QTc interval.|to determine whether lixivaptan administration at supratherapeutic or therapeutic doses results in the prolongation of the qtc interval.
5238288|NCT00675688|Menopause|menopause
5238289|NCT00675675|Tourette Syndrome|tourette syndrome
5238290|NCT00675675|Chronic Tic Disorder|chronic tic disorder
5238291|NCT00675675|Tics|tics
5238292|NCT00675675|Behavior Therapy|behavior therapy
5238293|NCT00675675|Habit Reversal Training|habit reversal training
5238294|NCT00675675|Child|child
5238295|NCT00675675|Adolescent|adolescent
5238296|NCT00675675|Neuroimaging|neuroimaging
5238297|NCT00675662|Obesity|obesity
5238298|NCT00675662|overweight|overweight
5238299|NCT00675662|BMI|bmi
5238300|NCT00675662|ifestyle|ifestyle
5238301|NCT00675662|diet|diet
5238302|NCT00675662|nutrition|nutrition
5238303|NCT00675662|physical activity|physical activity
5238304|NCT00675662|pre-school|pre-school
5238305|NCT00675662|toddlers|toddlers
5238306|NCT00675662|children|children
5238307|NCT00675662|Prevention of overweight and obesity in pre-school children|prevention of overweight and obesity in pre-school children
5238308|NCT00675649|Injections|injections
5238309|NCT00675649|Severe, persistent asthma|severe, persistent asthma
5238310|NCT00675636|colon cancer|colon cancer
5238311|NCT00675636|hereditary non-polyposis colon cancer|hereditary non-polyposis colon cancer
5238312|NCT00675636|rectal cancer|rectal cancer
5238313|NCT00675636|familial adenomatous polyposis|familial adenomatous polyposis
5238314|NCT00675623|Alzheimer's disease, clinical trial, memory loss, mitochondria,|alzheimer's disease, clinical trial, memory loss, mitochondria,
5238315|NCT00675623|investigational drug, neurodegenerative disease, dementia|investigational drug, neurodegenerative disease, dementia
5238316|NCT00675610|communication|communication
5238317|NCT00675610|HIV/AIDS|hiv/aids
5238318|NCT00675610|Treatment Experienced|treatment experienced
5238319|NCT00675597|Bevacizumab (Avastin)|bevacizumab (avastin)
5238320|NCT00675597|Taxotere (Docetaxel)|taxotere (docetaxel)
5238321|NCT00675597|Vinorelbine Tartrate (Navelbine)|vinorelbine tartrate (navelbine)
5238322|NCT00675597|07-178|07-178
5238323|NCT00675558|Obesity|obesity
5238324|NCT00675558|morbid obesity|morbid obesity
5238325|NCT00675558|bariatric surgery|bariatric surgery
5238326|NCT00675532|Opioids, vivitrol, naltrexone, primary care|opioids, vivitrol, naltrexone, primary care
5238327|NCT00675519|problem drinkers|problem drinkers
5238328|NCT00675506|Growth Hormone Releasing Hormone|growth hormone releasing hormone
5238329|NCT00675506|Growth Hormone Pulse|growth hormone pulse
5238330|NCT00675506|Visceral Adipose Tissue|visceral adipose tissue
5238331|NCT00675506|Carotid Intima-Media Thickness|carotid intima-media thickness
5238332|NCT00675480|myocardial infarction, thrombectomy, salvage index|myocardial infarction, thrombectomy, salvage index
5238333|NCT00675467|Pediatric Cancer|pediatric cancer
5238334|NCT00675467|Focus Group|focus group
5238335|NCT00675467|Pediatric cancer patients|pediatric cancer patients
5238336|NCT00675467|Parents of Pediatric cancer patients|parents of pediatric cancer patients
5238337|NCT00675467|Pediatric Palliative Care Program|pediatric palliative care program
5238338|NCT00675454|COPD|copd
5238339|NCT00675454|Lung Volume Reduction Surgery|lung volume reduction surgery
5238340|NCT00675454|Lung Transplant|lung transplant
5238341|NCT00675454|Quality of Life|quality of life
5238342|NCT00675441|Chronic Graft-versus-Host Disease|chronic graft-versus-host disease
5238343|NCT00675441|cGVHD|cgvhd
5238344|NCT00675441|GVHD|gvhd
5238345|NCT00675441|Lenalidomide|lenalidomide
5238346|NCT00675441|Revlimid|revlimid
5238347|NCT00675441|CC-5013|cc-5013
5238348|NCT00675441|Stem Cell Transplant|stem cell transplant
5238349|NCT00675441|Allogeneic hematopoietic stem cell transplantation|allogeneic hematopoietic stem cell transplantation
5238350|NCT00675441|Allogeneic HSCT|allogeneic hsct
5238351|NCT00675441|HSCT|hsct
5238352|NCT00675441|Post-Transplant Prophylactic Immunosuppressive Therapy|post-transplant prophylactic immunosuppressive therapy
5238353|NCT00675441|Steroids|steroids
5238354|NCT00675441|Standard-of-care steroid treatment|standard-of-care steroid treatment
5238355|NCT00675441|Corticosteroids|corticosteroids
5238356|NCT00675441|Prednisone|prednisone
5238357|NCT00675441|Medrol|medrol
5238358|NCT00675428|Relapsed or refractory Multiple Myeloma|relapsed or refractory multiple myeloma
5238359|NCT00675415|Hypoxemia|hypoxemia
5238360|NCT00675415|Capnography|capnography
5238361|NCT00675415|Apnea|apnea
5238362|NCT00675415|Sedation|sedation
5238363|NCT00675415|ERCP|ercp
5238364|NCT00675415|EUS|eus
5238365|NCT00675389|HIV|hiv
5238366|NCT00675389|AIDS|aids
5238367|NCT00675389|Community Health Workers|community health workers
5238368|NCT00675389|Mobile Phones|mobile phones
5238369|NCT00675389|Adherence|adherence
5238370|NCT00675389|Antiretroviral Therapy|antiretroviral therapy
5238371|NCT00675376|COPD|copd
5238372|NCT00675376|Lung Transplant|lung transplant
5238373|NCT00675376|Quality of Life|quality of life
5238374|NCT00675376|End Stage Lung Disease|end stage lung disease
5238375|NCT00675363|ICU|icu
5238376|NCT00675363|Sedation strategies|sedation strategies
5238377|NCT00675363|Daily sedative interruption|daily sedative interruption
5238378|NCT00675363|Sedation protocols|sedation protocols
5238379|NCT00675363|Mechanical Ventilation|mechanical ventilation
5238380|NCT00675363|Sedation|sedation
5238381|NCT00675350|Omacetaxine|omacetaxine
5238382|NCT00675350|Homoharringtonine|homoharringtonine
5238383|NCT00675350|HHT|hht
5238384|NCT00675350|Solid and hematologic malignant tumors|solid and hematologic malignant tumors
5238385|NCT00675337|iron stores|iron stores
5238386|NCT00675337|anemia|anemia
5238387|NCT00675337|iron deficiency|iron deficiency
5238388|NCT00675337|infancy|infancy
5238389|NCT00675337|placental transfusion|placental transfusion
5238390|NCT00675337|iron deficiency in infancy|iron deficiency in infancy
5238391|NCT00675337|anemia in infancy|anemia in infancy
5238392|NCT00675337|placement of neonate|placement of neonate
5238393|NCT00675324|Colonoscopy|colonoscopy
5238394|NCT00675324|Bowel preparation|bowel preparation
5238395|NCT00675324|Salt and electrolyte balance|salt and electrolyte balance
5238396|NCT00675324|Patients undergoing colonoscopy|patients undergoing colonoscopy
5238397|NCT00675324|Complication with traditional bowel preparation|complication with traditional bowel preparation
5238398|NCT00675324|Bowel purity degree without traditional bowel preparation|bowel purity degree without traditional bowel preparation
5238399|NCT00675311|Remote monitoring|remote monitoring
5238400|NCT00675311|Type 1 Diabetes|type 1 diabetes
5238401|NCT00675311|Type 2 diabetes|type 2 diabetes
5238402|NCT00675298|Prostatitis|prostatitis
5238403|NCT00675298|Cystitis, Interstitial|cystitis, interstitial
5238404|NCT00675298|Urinary Bladder, Overactive|urinary bladder, overactive
5238405|NCT00675298|Chronic pelvic pain syndrome|chronic pelvic pain syndrome
5238406|NCT00675298|Painful bladder syndrome|painful bladder syndrome
5238407|NCT00675298|Urgency|urgency
5238408|NCT00675298|Frequency|frequency
5238409|NCT00675285|airway inflammation|airway inflammation
5238410|NCT00675285|childhood asthma|childhood asthma
5238411|NCT00675285|fractional exhaled nitric oxide|fractional exhaled nitric oxide
5238412|NCT00675285|leukotriene receptor antagonists|leukotriene receptor antagonists
5238413|NCT00675285|lung function|lung function
5238414|NCT00675272|brain death|brain death
5238415|NCT00675272|subarachnoid hemorrhage|subarachnoid hemorrhage
5238416|NCT00675272|traumatic brain injury|traumatic brain injury
5238417|NCT00675272|brain injury|brain injury
5238418|NCT00675272|intracerebral hemorrhage|intracerebral hemorrhage
5238419|NCT00675272|organ donation|organ donation
5238420|NCT00675259|stage II breast cancer|stage ii breast cancer
5238421|NCT00675259|stage IIIA breast cancer|stage iiia breast cancer
5238422|NCT00675259|stage IIIB breast cancer|stage iiib breast cancer
5238423|NCT00675259|stage IIIC breast cancer|stage iiic breast cancer
5238424|NCT00675246|corticoid therapy|corticoid therapy
5238425|NCT00675246|fetal lung maturation|fetal lung maturation
5238426|NCT00675246|late preterm|late preterm
5238427|NCT00675246|respiratory distress syndrome|respiratory distress syndrome
5238428|NCT00675246|neonatal death|neonatal death
5238429|NCT00675233|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
5238430|NCT00675233|stage I squamous cell carcinoma of the larynx|stage i squamous cell carcinoma of the larynx
5238431|NCT00675233|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
5238432|NCT00675233|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5238433|NCT00675233|stage 0 laryngeal cancer|stage 0 laryngeal cancer
5238434|NCT00675207|glaucoma|glaucoma
5238435|NCT00675207|ocular hypertension|ocular hypertension
5238436|NCT00675207|adjunctive treatment|adjunctive treatment
5238437|NCT00675207|prostaglandin|prostaglandin
5238438|NCT00675207|prostaglandin analog|prostaglandin analog
5238439|NCT00675207|brimonidine|brimonidine
5238440|NCT00675207|dorzolamide|dorzolamide
5238441|NCT00675207|brinzolamide|brinzolamide
5238442|NCT00675207|alpha agonist|alpha agonist
5238443|NCT00675207|carbonic anhydrase inhibitor|carbonic anhydrase inhibitor
5238444|NCT00675207|intraocular pressure|intraocular pressure
5238445|NCT00675194|cisplatin|cisplatin
5238446|NCT00675194|capecitabine|capecitabine
5238447|NCT00675194|gastric|gastric
5238448|NCT00675194|irinotecan|irinotecan
5238449|NCT00675194|metastatic|metastatic
5238450|NCT00675194|chemotherapy|chemotherapy
5238451|NCT00675181|melatonin|melatonin
5238452|NCT00675181|skin blood flow|skin blood flow
5238453|NCT00675181|choroidal blood flow|choroidal blood flow
5238454|NCT00675181|vasospastic subjects|vasospastic subjects
5238455|NCT00675181|normal subjects|normal subjects
5238456|NCT00675168|Lung Cancer|lung cancer
5238457|NCT00675168|PET/CT|pet/ct
5238458|NCT00675168|Diagnosis|diagnosis
5238459|NCT00675155|Apoplexy|apoplexy
5238460|NCT00675155|Cerebral Stroke|cerebral stroke
5238461|NCT00675155|Cerebrovascular Accident|cerebrovascular accident
5238462|NCT00675155|Cerebrovascular Accident, Acute|cerebrovascular accident, acute
5238463|NCT00675155|Cerebrovascular Apoplexy|cerebrovascular apoplexy
5238464|NCT00675155|Cerebrovascular Stroke|cerebrovascular stroke
5238465|NCT00675142|Infertility|infertility
5238466|NCT00675142|Intra-uterine insemination|intra-uterine insemination
5238467|NCT00675142|ovarian stimulation|ovarian stimulation
5238468|NCT00675116|safety,|safety,
5238469|NCT00675116|healthy volunteers,|healthy volunteers,
5238470|NCT00675116|GW823296,|gw823296,
5238471|NCT00675116|pharmacokinetics|pharmacokinetics
5238472|NCT00675103|Gout|gout
5238473|NCT00675103|Gouty Arthritis|gouty arthritis
5238474|NCT00675103|Anti-Gout preparations|anti-gout preparations
5238475|NCT00675090|Alzheimers Disease|alzheimers disease
5238476|NCT00675077|Akinetic-Rigid Variant of Huntington Disease|akinetic-rigid variant of huntington disease
5238477|NCT00675077|Chorea, Chronic Progressive Hereditary (Huntington)|chorea, chronic progressive hereditary (huntington)
5238478|NCT00675077|Chronic Progressive Hereditary Chorea (Huntington)|chronic progressive hereditary chorea (huntington)
5238479|NCT00675077|Huntington Chorea|huntington chorea
5238480|NCT00675077|Huntington Chronic Progressive Hereditary Chorea|huntington chronic progressive hereditary chorea
5238481|NCT00675077|Huntington Disease, Akinetic-Rigid Variant|huntington disease, akinetic-rigid variant
5238482|NCT00675077|Huntington Disease, Juvenile|huntington disease, juvenile
5238483|NCT00675077|Huntington Disease, Juvenile-Onset|huntington disease, juvenile-onset
5238484|NCT00675064|pharmacokinetics,|pharmacokinetics,
5238485|NCT00675064|safety|safety
5238486|NCT00675064|single ascending dose,|single ascending dose,
5238487|NCT00675064|Healthy volunteers,|healthy volunteers,
5238488|NCT00675051|To determine if there is a trans-pulmonary gradient in the levels of EMPs in patients with PH|to determine if there is a trans-pulmonary gradient in the levels of emps in patients with ph
5238489|NCT00675051|To determine if the EMPs measured at the pulmonary capillary wedge position correlates even more strongly with the severity of PH than the circulating levels|to determine if the emps measured at the pulmonary capillary wedge position correlates even more strongly with the severity of ph than the circulating levels
5238490|NCT00675051|To determine if PH therapy with ET-1 receptor blocker will modify EMPs levels|to determine if ph therapy with et-1 receptor blocker will modify emps levels
5238491|NCT00675012|NGR-hTNF|ngr-htnf
5238492|NCT00675012|Capecitabine|capecitabine
5238493|NCT00675012|Oxaliplatin|oxaliplatin
5238494|NCT00675012|Colon cancer|colon cancer
5238495|NCT00674999|Burn|burn
5238496|NCT00674999|Partial thickness burn|partial thickness burn
5238497|NCT00674960|Brain Atrophy, Circumscribed Lobar|brain atrophy, circumscribed lobar
5238498|NCT00674960|Circumscribed Lobar Atrophy of the Brain|circumscribed lobar atrophy of the brain
5238499|NCT00674960|Lobar Atrophy (Brain)|lobar atrophy (brain)
5238500|NCT00674960|Pick Disease|pick disease
5238501|NCT00674960|Pick's Disease|pick's disease
5238502|NCT00674960|Picks Disease of Brain|picks disease of brain
5238503|NCT00674947|Relapsed|relapsed
5238504|NCT00674947|Refractory|refractory
5238505|NCT00674934|MS (Multiple Sclerosis)|ms (multiple sclerosis)
5238506|NCT00674934|Multiple Sclerosis, Acute Fulminating|multiple sclerosis, acute fulminating
5238507|NCT00674934|Sclerosis, Disseminated|sclerosis, disseminated
5238508|NCT00674921|Opportunistic Infections|opportunistic infections
5238509|NCT00674921|AIDS|aids
5238510|NCT00674921|HIV|hiv
5238511|NCT00674921|Treatment Experienced|treatment experienced
5238512|NCT00674908|Vaccine|vaccine
5238513|NCT00674908|Prevention|prevention
5238514|NCT00674908|Diphtheria|diphtheria
5238515|NCT00674908|Tetanus|tetanus
5238516|NCT00674908|Pertussis|pertussis
5238517|NCT00674908|Hepatitis B|hepatitis b
5238518|NCT00674908|Haemophilus influenzae type b|haemophilus influenzae type b
5238519|NCT00674908|Vaccine interchangeability|vaccine interchangeability
5238520|NCT00674908|Single vs mixed sequence|single vs mixed sequence
5238521|NCT00674908|Healthy infants|healthy infants
5238522|NCT00674895|Idiopathic Parkinson's Disease|idiopathic parkinson's disease
5238523|NCT00674895|Lewy Body Parkinson's Disease|lewy body parkinson's disease
5238524|NCT00674895|Paralysis Agitans|paralysis agitans
5238525|NCT00674895|Parkinson's Disease, Idiopathic|parkinson's disease, idiopathic
5238526|NCT00674895|Parkinson's Disease, Lewy Body|parkinson's disease, lewy body
5238527|NCT00674895|Primary Parkinsonism|primary parkinsonism
5238528|NCT00674882|Hematopoietic stem cell transplant|hematopoietic stem cell transplant
5238529|NCT00674882|Follow-up studies|follow-up studies
5238530|NCT00674882|Outcomes research|outcomes research
5238531|NCT00674882|Data collection|data collection
5238532|NCT00674869|sealant|sealant
5238533|NCT00674869|pit|pit
5238534|NCT00674869|child|child
5238535|NCT00674869|over|over
5238536|NCT00674869|6 years old|6 years old
5238537|NCT00674869|least|least
5238538|NCT00674843|MYOTONIC DYSTROPHY|myotonic dystrophy
5238539|NCT00674843|MYOPATHIES|myopathies
5238540|NCT00674843|Distal Myopathies|distal myopathies
5238541|NCT00674843|Muscular Dystrophy, Duchenne|muscular dystrophy, duchenne
5238542|NCT00674843|Phosphorylase Deficiency (McArdle Disease)|phosphorylase deficiency (mcardle disease)
5238543|NCT00674817|salbutamol,|salbutamol,
5238544|NCT00674817|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
5238545|NCT00674817|GSK961081 muscarinic receptor antagonist,|gsk961081 muscarinic receptor antagonist,
5238546|NCT00674817|COPD|copd
5238547|NCT00674817|ipratropium bromide,|ipratropium bromide,
5238548|NCT00674817|Asthma|asthma
5238549|NCT00674817|ß2-adrenergic agonist,|ß2-adrenergic agonist,
5238550|NCT00674804|Communicating a Diagnosis|communicating a diagnosis
5238551|NCT00674804|Cancer Diagnosis|cancer diagnosis
5238552|NCT00674804|Recurrence of Cancer|recurrence of cancer
5238553|NCT00674804|Initial Cancer Diagnosis|initial cancer diagnosis
5238554|NCT00674791|Immunotherapeutic vaccine|immunotherapeutic vaccine
5238555|NCT00674791|breast cancer|breast cancer
5238556|NCT00674791|TxN2-3M0 breast cancer|txn2-3m0 breast cancer
5238557|NCT00674791|metastatic breast cancer|metastatic breast cancer
5238558|NCT00674791|immunotherapy|immunotherapy
5238559|NCT00674791|antigen|antigen
5238560|NCT00674791|Histologically confirmed, TxN2-3M0 or metastatic breast cancer|histologically confirmed, txn2-3m0 or metastatic breast cancer
5238561|NCT00674778|Radial|radial
5238562|NCT00674778|Femoral|femoral
5238563|NCT00674778|artery|artery
5238564|NCT00674778|Invasive cardiology safety|invasive cardiology safety
5238565|NCT00674739|external genital warts|external genital warts
5238566|NCT00674739|perianal warts|perianal warts
5238567|NCT00674739|condylomata acuminata|condylomata acuminata
5238568|NCT00674739|venereal warts|venereal warts
5238569|NCT00674739|HPV types 6 and 11|hpv types 6 and 11
5238570|NCT00674726|appendicitis|appendicitis
5238571|NCT00674726|gastroenteritis|gastroenteritis
5238572|NCT00674726|temperature|temperature
5238573|NCT00674726|fever|fever
5238574|NCT00674726|acute abdomen|acute abdomen
5238575|NCT00674726|Axilo-rectal temperature in appendicitis|axilo-rectal temperature in appendicitis
5238576|NCT00674726|Axilo-rectal temperature in gastroenteritis|axilo-rectal temperature in gastroenteritis
5238577|NCT00674713|Patients undergoing laparoscopic cholecystectomy for cholelithiasis|patients undergoing laparoscopic cholecystectomy for cholelithiasis
5238578|NCT00674700|House dust mites allergy|house dust mites allergy
5238579|NCT00674674|topotecan|topotecan
5238580|NCT00674674|pharmacokinetics|pharmacokinetics
5238581|NCT00674674|neoplastic|neoplastic
5238582|NCT00674674|meningitis|meningitis
5238583|NCT00674661|ectasia|ectasia
5238584|NCT00674661|cross-linking|cross-linking
5238585|NCT00674661|crosslinking|crosslinking
5238586|NCT00674661|cornea|cornea
5238587|NCT00674661|riboflavin|riboflavin
5238588|NCT00674661|UVA|uva
5238589|NCT00674648|Multiple Diseases|multiple diseases
5238590|NCT00674648|Hematopoietic System|hematopoietic system
5238591|NCT00674648|CMV-PP65 PROTEIN SPECIFIC T CELLS|cmv-pp65 protein specific t cells
5238592|NCT00674635|adaptive study,|adaptive study,
5238593|NCT00674635|DAS28,|das28,
5238594|NCT00674635|monoclonal antibody|monoclonal antibody
5238595|NCT00674635|GSK315234A;|gsk315234a;
5238596|NCT00674635|rheumatoid arthritis,|rheumatoid arthritis,
5238597|NCT00674622|Lateral epicondylitis|lateral epicondylitis
5238598|NCT00674622|Tennis elbow|tennis elbow
5238599|NCT00674622|Prolotherapy|prolotherapy
5238600|NCT00674609|Palliative Care|palliative care
5238601|NCT00674609|Pain|pain
5238602|NCT00674609|Cancer|cancer
5238603|NCT00674596|PTX3, ramipril, endothelial dysfunction|ptx3, ramipril, endothelial dysfunction
5238604|NCT00674596|1- Diabetic proteinuria|1- diabetic proteinuria
5238605|NCT00674596|2- The aim of this study was to find out whether the|2- the aim of this study was to find out whether the
5238606|NCT00674596|beneficial effects of RAS blockage in diabetic|beneficial effects of ras blockage in diabetic
5238607|NCT00674596|proteinuria has any relation with the alteration|proteinuria has any relation with the alteration
5238608|NCT00674596|of PTX3 levels.|of ptx3 levels.
5238609|NCT00674583|Conjugate vaccine|conjugate vaccine
5238610|NCT00674583|Meningococcal disease|meningococcal disease
5238611|NCT00674583|Immunogenicity|immunogenicity
5238612|NCT00674583|Meningococcal vaccine|meningococcal vaccine
5238613|NCT00674583|Safety|safety
5238614|NCT00674570|Stress Disorders, Posttraumatic|stress disorders, posttraumatic
5238615|NCT00674570|Hydrocortisone|hydrocortisone
5238616|NCT00674570|Cycloserine|cycloserine
5238617|NCT00674570|Extinction, Psychological|extinction, psychological
5238618|NCT00674570|PTSD|ptsd
5238619|NCT00674570|San Francisco|san francisco
5238620|NCT00674557|recurrent breast cancer|recurrent breast cancer
5238621|NCT00674557|stage IIIA breast cancer|stage iiia breast cancer
5238622|NCT00674557|stage IIIB breast cancer|stage iiib breast cancer
5238623|NCT00674557|stage IIIC breast cancer|stage iiic breast cancer
5238624|NCT00674557|stage IV breast cancer|stage iv breast cancer
5238625|NCT00674557|HER2-negative breast cancer|her2-negative breast cancer
5238626|NCT00674557|estrogen receptor-positive breast cancer|estrogen receptor-positive breast cancer
5238627|NCT00674557|progesterone receptor-positive breast cancer|progesterone receptor-positive breast cancer
5238628|NCT00674544|childhood|childhood
5238629|NCT00674544|children|children
5238630|NCT00674544|obesity|obesity
5238631|NCT00674544|physical activity|physical activity
5238632|NCT00674544|nutrition|nutrition
5238633|NCT00674544|fitness|fitness
5238634|NCT00674544|family|family
5238635|NCT00674531|Arteriosclerosis|arteriosclerosis
5238636|NCT00674531|Arterial Occlusive Diseases|arterial occlusive diseases
5238637|NCT00674531|Enterovirus|enterovirus
5238638|NCT00674531|Artery resection|artery resection
5238639|NCT00674518|Health Promotion|health promotion
5238640|NCT00674518|Health Behavior Change|health behavior change
5238641|NCT00674518|Physical Activity|physical activity
5238642|NCT00674518|Dietary Change|dietary change
5238643|NCT00674518|Weight Loss|weight loss
5238644|NCT00674518|Obesity|obesity
5238645|NCT00674479|Advanced Hematologic Malignancies|advanced hematologic malignancies
5238646|NCT00674479|Cancer|cancer
5238647|NCT00674479|Blood|blood
5238648|NCT00674479|Bone marrow|bone marrow
5238649|NCT00674479|Lymph nodes|lymph nodes
5238650|NCT00674479|JAK kinase inhibitor INCB018424 phosphate|jak kinase inhibitor incb018424 phosphate
5238651|NCT00674479|Acute Myeloid Leukemia|acute myeloid leukemia
5238652|NCT00674479|AML|aml
5238653|NCT00674479|Acute Lymphocytic leukemia|acute lymphocytic leukemia
5238654|NCT00674479|ALL|all
5238655|NCT00674479|Myelodysplastic Syndrome|myelodysplastic syndrome
5238656|NCT00674479|MDS|mds
5238657|NCT00674479|Chronic myelogenous leukemia - Blast Crisis|chronic myelogenous leukemia - blast crisis
5238658|NCT00674479|CML|cml
5238659|NCT00674479|INCB018424|incb018424
5238660|NCT00674466|GLP-1, incretin, type 2 diabetes|glp-1, incretin, type 2 diabetes
5238661|NCT00674453|Osteoporosis|osteoporosis
5238662|NCT00674453|lasofoxifene|lasofoxifene
5238663|NCT00674453|bone density|bone density
5238664|NCT00674453|bone markers|bone markers
5238665|NCT00674440|Congenital Hyperinsulinism|congenital hyperinsulinism
5238666|NCT00674440|Hyperinsulinism|hyperinsulinism
5238667|NCT00674440|Persistent Hyperinsulinemic Hypoglycemia of Infancy|persistent hyperinsulinemic hypoglycemia of infancy
5238668|NCT00674440|CHI|chi
5238669|NCT00674440|PHHI|phhi
5238670|NCT00674440|F-DOPA|f-dopa
5238671|NCT00674440|L-fluoro-dihydroxyphenylalanine|l-fluoro-dihydroxyphenylalanine
5238672|NCT00674427|AML|aml
5238673|NCT00674427|ALL|all
5238674|NCT00674427|MDS|mds
5238675|NCT00674427|CLL|cll
5238676|NCT00674427|Multiple Myeloma|multiple myeloma
5238677|NCT00674414|stage IA breast cancer|stage ia breast cancer
5238678|NCT00674414|stage IB breast cancer|stage ib breast cancer
5238679|NCT00674414|stage II breast cancer|stage ii breast cancer
5238680|NCT00674414|stage IIIA breast cancer|stage iiia breast cancer
5238681|NCT00674414|HER2-positive breast cancer|her2-positive breast cancer
5238682|NCT00674388|Children|children
5238683|NCT00674388|Anesthesia|anesthesia
5238684|NCT00674388|Surgery|surgery
5238685|NCT00674388|Complication|complication
5238687|NCT00674375|Acute Myocardial Infarction|acute myocardial infarction
5238688|NCT00674375|Patient Safety|patient safety
5238689|NCT00674375|Misdiagnosis|misdiagnosis
5238690|NCT00674362|Rheumatoid Arthritis|rheumatoid arthritis
5238691|NCT00674362|Moderate to Low Disease activity|moderate to low disease activity
5238692|NCT00674362|Certolizumab pegol|certolizumab pegol
5238693|NCT00674336|Norovirus|norovirus
5238694|NCT00674336|Gastroenteritis|gastroenteritis
5238695|NCT00674336|Clinical Trial|clinical trial
5238696|NCT00674336|Stomach flu|stomach flu
5238697|NCT00674336|Oysters|oysters
5238698|NCT00674336|Shellfish|shellfish
5238699|NCT00674336|high hydrostatic pressures|high hydrostatic pressures
5238700|NCT00674323|Polypoidal choroidal vasculopathy|polypoidal choroidal vasculopathy
5238701|NCT00674323|PCV|pcv
5238702|NCT00674323|Age-related macular degeneration (AMD) variant|age-related macular degeneration (amd) variant
5238703|NCT00674323|vision|vision
5238704|NCT00674323|polyps|polyps
5238705|NCT00674323|indocyanine green angiography|indocyanine green angiography
5238706|NCT00674323|verteporfin|verteporfin
5238707|NCT00674323|ranibizumab|ranibizumab
5238708|NCT00674323|photodynamic therapy|photodynamic therapy
5238709|NCT00674297|Persistently Antiphospholipid Antibody Positive Patients|persistently antiphospholipid antibody positive patients
5238710|NCT00674271|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
5238711|NCT00674271|Mannose-Binding lectin|mannose-binding lectin
5238712|NCT00674271|Toll-Like Receptors|toll-like receptors
5238713|NCT00674271|Atherosclerosis|atherosclerosis
5238714|NCT00674271|Carotid Arteries|carotid arteries
5238715|NCT00674271|Diabetes Complications|diabetes complications
5238716|NCT00674271|Diabetic Angiopathies|diabetic angiopathies
5238717|NCT00674258|HLA-A*2402|hla-a*2402
5238718|NCT00674258|Peptide Vaccine|peptide vaccine
5238719|NCT00674258|URLC10|urlc10
5238720|NCT00674258|TTK|ttk
5238721|NCT00674258|KOC1|koc1
5238722|NCT00674245|heartburn|heartburn
5238723|NCT00674245|acid reflux|acid reflux
5238724|NCT00674245|GERD|gerd
5238725|NCT00674245|spectrum analysis|spectrum analysis
5238726|NCT00674245|electroencephalogram|electroencephalogram
5238727|NCT00674245|esophagitis|esophagitis
5238728|NCT00674245|peptic|peptic
5238729|NCT00674232|incomplete abortion|incomplete abortion
5238730|NCT00674232|spontaneous miscarriage|spontaneous miscarriage
5238731|NCT00674219|GAD|gad
5238732|NCT00674206|Metastatic breast cancer|metastatic breast cancer
5238733|NCT00674154|Vitamin D|vitamin d
5238734|NCT00674154|Primary hyperparathyroidism|primary hyperparathyroidism
5238735|NCT00674154|hypercalcemia|hypercalcemia
5238736|NCT00674141|Multiple Sclerosis, relapsing remitting, Dexamethasone|multiple sclerosis, relapsing remitting, dexamethasone
5238737|NCT00674128|pacemaker|pacemaker
5238738|NCT00674128|cardioverter-defibrillator|cardioverter-defibrillator
5238739|NCT00674128|ICD|icd
5238740|NCT00674128|cardiac resynchronization device|cardiac resynchronization device
5238741|NCT00674128|cyanoacrylate|cyanoacrylate
5238742|NCT00674128|suture|suture
5238743|NCT00674128|Dermabond|dermabond
5238744|NCT00674128|Vicryl|vicryl
5238745|NCT00674102|Vascular disrupting agent|vascular disrupting agent
5238746|NCT00674102|Non-small cell lung cancer|non-small cell lung cancer
5238747|NCT00674089|IMR|imr
5238748|NCT00674089|Newborn Mortality|newborn mortality
5238749|NCT00674089|Vitamin A Effectiveness|vitamin a effectiveness
5238750|NCT00674089|Premature Mortality|premature mortality
5238751|NCT00674089|Mortality|mortality
5238752|NCT00674063|Chronic Plaque Psoriasis|chronic plaque psoriasis
5238753|NCT00674063|Alefacept|alefacept
5238754|NCT00674050|Healthy Males or Females subjects|healthy males or females subjects
5238755|NCT00674037|recruitment|recruitment
5238756|NCT00674037|physicians participating in the recruitment of patients|physicians participating in the recruitment of patients
5238757|NCT00674024|Pazopanib|pazopanib
5238758|NCT00674024|Tyrosine Kinase Inhibitor|tyrosine kinase inhibitor
5238759|NCT00674024|Advanced Cancer|advanced cancer
5238760|NCT00674024|Pharmacokinetics|pharmacokinetics
5238761|NCT00674024|Cancer|cancer
5238762|NCT00674024|Solid Tumor|solid tumor
5238763|NCT00674024|Lymphoma|lymphoma
5238764|NCT00674011|hypertension|hypertension
5238765|NCT00674011|bevacizumab|bevacizumab
5238766|NCT00674011|metastatic breast cancer|metastatic breast cancer
5238767|NCT00673998|Isokinetic|isokinetic
5238768|NCT00673998|Fatigue|fatigue
5238769|NCT00673998|Strength|strength
5238770|NCT00673998|Older|older
5238771|NCT00673985|SFA, Edwards, Popliteal, LifeStent, PTA, Nitinol|sfa, edwards, popliteal, lifestent, pta, nitinol
5238772|NCT00673972|Functional dyspepsia|functional dyspepsia
5238773|NCT00673972|Gastric emptying|gastric emptying
5238774|NCT00673972|Helicobacter pylori|helicobacter pylori
5238775|NCT00673972|Lansoprazole|lansoprazole
5238776|NCT00673972|Epigastric pain syndrome|epigastric pain syndrome
5238777|NCT00673972|Postprandial distress syndrome|postprandial distress syndrome
5238778|NCT00673959|Dry eye|dry eye
5238779|NCT00673959|artificial tears|artificial tears
5238780|NCT00673946|bronchiolitis|bronchiolitis
5238781|NCT00673946|hospitalization|hospitalization
5238782|NCT00673946|oximetry|oximetry
5238783|NCT00673946|pediatrics|pediatrics
5238784|NCT00673920|RA|ra
5238785|NCT00673907|Wood smoke|wood smoke
5238786|NCT00673907|Health effects|health effects
5238787|NCT00673907|Human|human
5238788|NCT00673907|Airway inflammation|airway inflammation
5238789|NCT00673907|Cardiovascular effects|cardiovascular effects
5238790|NCT00673855|Dry eye|dry eye
5238791|NCT00673855|Artificial tear|artificial tear
5238792|NCT00673842|Noninvasive assessment|noninvasive assessment
5238793|NCT00673842|Holter|holter
5238794|NCT00673829|Breast Cancer|breast cancer
5238795|NCT00673829|T cells|t cells
5238796|NCT00673829|Gene Transfer|gene transfer
5238797|NCT00673816|Von Hippel Lindau|von hippel lindau
5238798|NCT00673816|Sunitinib Malate|sunitinib malate
5238799|NCT00673816|Sutent|sutent
5238800|NCT00673816|Von Hippel-Lindau Syndrome|von hippel-lindau syndrome
5238801|NCT00673816|VHL|vhl
5238802|NCT00673803|posterior capsule opacification|posterior capsule opacification
5238803|NCT00673803|micro incision|micro incision
5238804|NCT00673803|sharp optic edge|sharp optic edge
5238805|NCT00673790|nebivolol|nebivolol
5238806|NCT00673790|BYSTOLIC ™|bystolic ™
5238807|NCT00673790|hydrochlorothiazide|hydrochlorothiazide
5238808|NCT00673790|lisinopril|lisinopril
5238809|NCT00673790|Prinivil (TM)|prinivil (tm)
5238810|NCT00673790|Zestril (TM)|zestril (tm)
5238811|NCT00673790|losartan|losartan
5238812|NCT00673790|Cozaar (TM)|cozaar (tm)
5238813|NCT00673790|Impaired Fasting Glucose|impaired fasting glucose
5238814|NCT00673790|Impaired Glucose Tolerance|impaired glucose tolerance
5238815|NCT00673790|hypertension|hypertension
5238816|NCT00673777|HLA-A*0201|hla-a*0201
5238817|NCT00673777|Peptide Vaccine|peptide vaccine
5238818|NCT00673777|URLC10|urlc10
5238819|NCT00673777|VEGFR1|vegfr1
5238820|NCT00673777|VEGFR2|vegfr2
5238821|NCT00673751|mesenteric blood flow|mesenteric blood flow
5238822|NCT00673751|GLP-2|glp-2
5238823|NCT00673751|short bowel syndrome|short bowel syndrome
5238824|NCT00673751|Glucagon-Like Peptide 2|glucagon-like peptide 2
5238825|NCT00673738|Lung|lung
5238826|NCT00673738|Thoracic|thoracic
5238827|NCT00673738|Immunotherapy|immunotherapy
5238828|NCT00673738|Radiotherapy|radiotherapy
5238829|NCT00673738|LA - NSCLC|la - nsclc
5238830|NCT00673738|Non-Small Cell Lung Cancer|non-small cell lung cancer
5238831|NCT00673725|Atopic Dermatitis|atopic dermatitis
5238832|NCT00673712|Coronary Artery Bypass Graft Surgery|coronary artery bypass graft surgery
5238833|NCT00673712|Pneumonia|pneumonia
5238834|NCT00673712|Surgical Site Infection|surgical site infection
5238835|NCT00673699|NBI|nbi
5238836|NCT00673699|gastroscopy|gastroscopy
5238837|NCT00673699|biopsy|biopsy
5238838|NCT00673699|intestinal metaplasia|intestinal metaplasia
5238839|NCT00673686|Oral contraceptive|oral contraceptive
5238840|NCT00673686|Ovulation|ovulation
5238841|NCT00673686|Missing pills|missing pills
5238842|NCT00673686|Intake compliance|intake compliance
5238843|NCT00673686|Cycle control|cycle control
5238844|NCT00673660|Statins|statins
5238845|NCT00673660|Compliance|compliance
5238846|NCT00673660|Dyslipidemia|dyslipidemia
5238847|NCT00673647|cannabis|cannabis
5238848|NCT00673647|dependence|dependence
5238849|NCT00673647|marijuana|marijuana
5238850|NCT00673647|CBT|cbt
5238851|NCT00673647|efficacy of CBT for cannabis use disorders|efficacy of cbt for cannabis use disorders
5238852|NCT00673634|preoxygenation|preoxygenation
5238853|NCT00673634|method|method
5238854|NCT00673634|efficiency|efficiency
5238855|NCT00673634|obesity|obesity
5238856|NCT00673634|BiPAP|bipap
5238857|NCT00673634|FeO2|feo2
5238858|NCT00673621|Asthmatics and non-asthmatic male and female subjects|asthmatics and non-asthmatic male and female subjects
5238859|NCT00673608|Haemoglobinopathies,|haemoglobinopathies,
5238860|NCT00673608|Myelodysplastic Syndromes,|myelodysplastic syndromes,
5238861|NCT00673608|Transfusional iron overload,|transfusional iron overload,
5238862|NCT00673608|cardiac iron load|cardiac iron load
5238863|NCT00673595|smoking|smoking
5238864|NCT00673595|varenicline|varenicline
5238865|NCT00673595|flow-mediated dilation|flow-mediated dilation
5238866|NCT00673595|blood pressure|blood pressure
5238867|NCT00673595|baroreflex|baroreflex
5238868|NCT00673582|Statins|statins
5238869|NCT00673582|Intima Media Thickness|intima media thickness
5238870|NCT00673582|Plaque Area|plaque area
5238871|NCT00673569|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5238872|NCT00673569|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5238873|NCT00673569|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5238874|NCT00673569|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5238875|NCT00673556|Chronic Plaque Psoriasis|chronic plaque psoriasis
5238876|NCT00673556|Alefacept|alefacept
5238877|NCT00673543|Corticosteroids|corticosteroids
5238878|NCT00673543|Pregnancy|pregnancy
5238879|NCT00673543|Glucose control|glucose control
5238880|NCT00673530|Hospital malnutrition|hospital malnutrition
5238881|NCT00673530|Nutritional Status|nutritional status
5238882|NCT00673530|Nutrition Assessment|nutrition assessment
5238883|NCT00673530|Enteral Nutrition|enteral nutrition
5238884|NCT00673530|Parenteral Nutrition|parenteral nutrition
5238885|NCT00673530|Severity of illness index|severity of illness index
5238886|NCT00673530|cost analysis|cost analysis
5238887|NCT00673517|Acute respiratory distress syndrome|acute respiratory distress syndrome
5238888|NCT00673517|Ventilator induced lung injury|ventilator induced lung injury
5238889|NCT00673517|High frequency oscillation|high frequency oscillation
5238890|NCT00673517|Lung protective ventilation|lung protective ventilation
5238891|NCT00673517|Biomarkers|biomarkers
5238892|NCT00673517|Biotrauma|biotrauma
5238893|NCT00673504|cancer|cancer
5238894|NCT00673504|pancreatic cancer|pancreatic cancer
5238895|NCT00673504|gemcitabine|gemcitabine
5238896|NCT00673504|sunitinib|sunitinib
5238897|NCT00673504|Phase 2|phase 2
5238898|NCT00673491|Critical Pathways|critical pathways
5238899|NCT00673491|Stroke|stroke
5238900|NCT00673491|Randomized Controlled Trial|randomized controlled trial
5238901|NCT00673491|Effectiveness|effectiveness
5238902|NCT00673439|heparin-induced thrombocytopenia|heparin-induced thrombocytopenia
5238903|NCT00673439|thrombocytopenia|thrombocytopenia
5238904|NCT00673439|HIT|hit
5238905|NCT00673439|thrombosis|thrombosis
5238906|NCT00673439|blood clot|blood clot
5238907|NCT00673439|blood thinner|blood thinner
5238908|NCT00673439|anticoagulant|anticoagulant
5238909|NCT00673439|heparin|heparin
5238910|NCT00673439|warfarin|warfarin
5238911|NCT00673439|fondaparinux|fondaparinux
5238912|NCT00673439|Arixtra|arixtra
5238913|NCT00673426|enoxaparin|enoxaparin
5238914|NCT00673426|chronic renal disease|chronic renal disease
5238915|NCT00673426|Anticoagulant activity of enoxaparin sodic|anticoagulant activity of enoxaparin sodic
5238916|NCT00673413|Perception|perception
5238917|NCT00673413|Emotions|emotions
5238918|NCT00673413|Adaptation|adaptation
5238919|NCT00673413|Estomia|estomia
5238920|NCT00673400|Obstructed defecation syndrome|obstructed defecation syndrome
5238921|NCT00673400|ODS|ods
5238922|NCT00673400|Rectocele|rectocele
5238923|NCT00673400|Intussusception|intussusception
5238924|NCT00673400|STARR|starr
5238925|NCT00673387|overweight|overweight
5238926|NCT00673387|obesity|obesity
5238927|NCT00673387|pramlintide|pramlintide
5238928|NCT00673387|metreleptin|metreleptin
5238929|NCT00673387|Amylin|amylin
5238930|NCT00673374|emergency|emergency
5238931|NCT00673374|acute|acute
5238932|NCT00673374|nontraumatic|nontraumatic
5238933|NCT00673374|abdominal pain|abdominal pain
5238934|NCT00673374|tenderness|tenderness
5238935|NCT00673374|CT scan|ct scan
5238936|NCT00673374|radiation|radiation
5238937|NCT00673374|diagnosis|diagnosis
5238938|NCT00673348|Mycoses|mycoses
5238939|NCT00673348|Voriconazole|voriconazole
5238940|NCT00673335|breast cancer|breast cancer
5238941|NCT00673335|hereditary breast/ovarian cancer (BRCA1, BRCA2)|hereditary breast/ovarian cancer (brca1, brca2)
5238942|NCT00673335|BRCA1 mutation carrier|brca1 mutation carrier
5238943|NCT00673335|BRCA2 mutation carrier|brca2 mutation carrier
5238944|NCT00673322|Colorectal Cancer|colorectal cancer
5238945|NCT00673322|T cells|t cells
5238946|NCT00673322|Gene Transfer|gene transfer
5238947|NCT00673309|burns|burns
5238948|NCT00673296|Bevacizumab|bevacizumab
5238949|NCT00673296|Diabetic premacular hemorrhage|diabetic premacular hemorrhage
5238950|NCT00673296|Intravitreal gas|intravitreal gas
5238951|NCT00673283|lung cancer|lung cancer
5238952|NCT00673283|nodules|nodules
5238953|NCT00673283|radiography|radiography
5238954|NCT00673283|CT|ct
5238955|NCT00673283|Stereoscopy|stereoscopy
5238956|NCT00673257|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
5238957|NCT00673244|Renal Replacement Therapy|renal replacement therapy
5238958|NCT00673244|Dialysis|dialysis
5238959|NCT00673231|Dapagliflozin|dapagliflozin
5238960|NCT00673231|efficacy|efficacy
5238961|NCT00673231|safety|safety
5238962|NCT00673231|add on to insulin|add on to insulin
5238963|NCT00673231|Oral AntiDiabetic|oral antidiabetic
5238964|NCT00673231|Type 2 diabetes|type 2 diabetes
5238965|NCT00673218|IL13|il13
5238966|NCT00673218|Cytokines|cytokines
5238967|NCT00673218|Basophil stimulation|basophil stimulation
5238968|NCT00673205|androgen antagonists|androgen antagonists
5238969|NCT00673205|prostate neoplasms|prostate neoplasms
5238970|NCT00673179|Doxorubicin|doxorubicin
5238971|NCT00673179|AD|ad
5238972|NCT00673179|Hydroxydaunomycin hydrochloride|hydroxydaunomycin hydrochloride
5238973|NCT00673179|Cisplatin|cisplatin
5238974|NCT00673179|Paraplatin®|paraplatin®
5238975|NCT00673179|Methotrexate|methotrexate
5238976|NCT00673179|Ifosfamide|ifosfamide
5238977|NCT00673179|Osteosarcoma|osteosarcoma
5238978|NCT00673179|Sargramostim|sargramostim
5238979|NCT00673179|Leukine™|leukine™
5238980|NCT00673179|Leucovorin|leucovorin
5238981|NCT00673179|Gemcitabine|gemcitabine
5238982|NCT00673179|Gemzar|gemzar
5238983|NCT00673179|Gemcitabine Hydrochloride|gemcitabine hydrochloride
5238984|NCT00673179|GM-CSF|gm-csf
5238985|NCT00673179|Questionnaire|questionnaire
5238986|NCT00673179|Survey|survey
5238987|NCT00673166|Staff motivation|staff motivation
5238988|NCT00673166|Hospital mortality|hospital mortality
5238989|NCT00673166|Perception of quality of care|perception of quality of care
5238990|NCT00673140|ALS (Amyotrophic Lateral Sclerosis)|als (amyotrophic lateral sclerosis)
5238991|NCT00673140|Amyotrophic Lateral Sclerosis With Dementia|amyotrophic lateral sclerosis with dementia
5238992|NCT00673140|Amyotrophic Lateral Sclerosis, Guam Form|amyotrophic lateral sclerosis, guam form
5238993|NCT00673140|Dementia With Amyotrophic Lateral Sclerosis|dementia with amyotrophic lateral sclerosis
5238994|NCT00673140|Gehrig's Disease|gehrig's disease
5238995|NCT00673140|Guam Form of Amyotrophic Lateral Sclerosis|guam form of amyotrophic lateral sclerosis
5238996|NCT00673140|Lou Gehrig Disease|lou gehrig disease
5238997|NCT00673127|hormone refractory|hormone refractory
5238998|NCT00673127|KHAD|khad
5238999|NCT00673127|ketoconazole|ketoconazole
5239000|NCT00673127|dutasteride|dutasteride
5239001|NCT00673127|hydrocortisone|hydrocortisone
5239002|NCT00673114|Haplo/cord|haplo/cord
5239003|NCT00673114|hematologic malignancy|hematologic malignancy
5239004|NCT00673114|MDS|mds
5239005|NCT00673114|Aplastic Anemia|aplastic anemia
5239006|NCT00673114|AML|aml
5239007|NCT00673114|ALL|all
5239008|NCT00673114|CML|cml
5239009|NCT00673101|liver fibrosis, cirrhosis|liver fibrosis, cirrhosis
5239010|NCT00673101|FibroScan|fibroscan
5239011|NCT00673101|transient elastography|transient elastography
5239012|NCT00673101|elastometry|elastometry
5239013|NCT00673101|methotrexate|methotrexate
5239014|NCT00673101|non invasive blood markers|non invasive blood markers
5239015|NCT00673101|FibroTest|fibrotest
5239016|NCT00673101|treatment|treatment
5239017|NCT00673075|carvedilol|carvedilol
5239018|NCT00673075|Coreg (TM)|coreg (tm)
5239019|NCT00673075|hypertension|hypertension
5239020|NCT00673075|blood pressure|blood pressure
5239021|NCT00673075|coronary artery disease|coronary artery disease
5239022|NCT00673075|Nebivolol|nebivolol
5239023|NCT00673075|BYSTOLIC (TM)|bystolic (tm)
5239024|NCT00673049|IGR-1R|igr-1r
5239025|NCT00673049|Non small cell lung cancer|non small cell lung cancer
5239026|NCT00673049|CP-751|cp-751
5239027|NCT00673049|871|871
5239028|NCT00673049|Figitumumab|figitumumab
5239029|NCT00673036|Coronary syndrome|coronary syndrome
5239030|NCT00673036|Myocardial infarction|myocardial infarction
5239031|NCT00673036|French registry|french registry
5239032|NCT00673010|124-IODINE|124-iodine
5239033|NCT00673010|I-131 METAIODOBENZ SULF (MIBG)|i-131 metaiodobenz sulf (mibg)
5239034|NCT00673010|Thyroid|thyroid
5239035|NCT00673010|Parathyroid|parathyroid
5239036|NCT00672997|Glaucoma|glaucoma
5239037|NCT00672997|Hypertension|hypertension
5239038|NCT00672984|QT/QTc|qt/qtc
5239039|NCT00672958|Major Depressive Disorder|major depressive disorder
5239040|NCT00672958|Depression|depression
5239041|NCT00672958|Drug Therapy|drug therapy
5239042|NCT00672958|Major Depressive Episode|major depressive episode
5239043|NCT00672932|raltegravir|raltegravir
5239044|NCT00672932|central nervous system (CNS)|central nervous system (cns)
5239045|NCT00672932|HIV-1|hiv-1
5239046|NCT00672932|AIDS|aids
5239047|NCT00672932|cerebrospinal fluid (CSF)|cerebrospinal fluid (csf)
5239048|NCT00672932|immunoactivation|immunoactivation
5239049|NCT00672932|antiretroviral therapy|antiretroviral therapy
5239050|NCT00672932|suppression|suppression
5239051|NCT00672919|Glucose Metabolism Disorder|glucose metabolism disorder
5239052|NCT00672919|Dysmetabolic Syndrome|dysmetabolic syndrome
5239053|NCT00672919|Type II Diabetes|type ii diabetes
5239054|NCT00672919|Diabetes Mellitus, Lipoatrophic|diabetes mellitus, lipoatrophic
5239055|NCT00672919|Dyslipidemia|dyslipidemia
5239056|NCT00672919|Drug Therapy|drug therapy
5239057|NCT00672906|anorexia nervosa|anorexia nervosa
5239058|NCT00672906|group parent training|group parent training
5239059|NCT00672906|caregiver burden|caregiver burden
5239060|NCT00672906|eating disorders|eating disorders
5239061|NCT00672906|treatment|treatment
5239062|NCT00672893|central airway stenosis, lung sounds, airway obstruction, bronchial obstruction, bronchoscopic treatment|central airway stenosis, lung sounds, airway obstruction, bronchial obstruction, bronchoscopic treatment
5239063|NCT00672880|Chronic low back pain accompanied by depression|chronic low back pain accompanied by depression
5239064|NCT00672854|parenteral nutrition|parenteral nutrition
5239065|NCT00672854|lipid emulsion|lipid emulsion
5239066|NCT00672854|nosocomial infection|nosocomial infection
5239067|NCT00672854|mortality|mortality
5239068|NCT00672854|endothelial function|endothelial function
5239069|NCT00672854|inflammatory markers|inflammatory markers
5239070|NCT00672854|oxidative stress|oxidative stress
5239071|NCT00672854|immune function|immune function
5239072|NCT00672854|autonomic nervous system|autonomic nervous system
5239073|NCT00672854|insulin sensitivity|insulin sensitivity
5239074|NCT00672854|carbohydrate metabolism|carbohydrate metabolism
5239075|NCT00672841|candidemia|candidemia
5239076|NCT00672841|invasive candidiasis|invasive candidiasis
5239077|NCT00672841|preemptive antifungal therapy|preemptive antifungal therapy
5239078|NCT00672841|surveillance|surveillance
5239079|NCT00672841|β-D-Glucan (BDG)|β-d-glucan (bdg)
5239080|NCT00672828|colon cancer|colon cancer
5239081|NCT00672828|rectal cancer|rectal cancer
5239082|NCT00672815|coordinated school health|coordinated school health
5239083|NCT00672815|school health policy evaluation|school health policy evaluation
5239084|NCT00672815|physical activity|physical activity
5239085|NCT00672802|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5239086|NCT00672802|COPD|copd
5239087|NCT00672802|Insomnia|insomnia
5239088|NCT00672802|Drug Therapy|drug therapy
5239089|NCT00672789|Sickle cell anemia|sickle cell anemia
5239090|NCT00672789|Children|children
5239091|NCT00672789|Hydroxyurea|hydroxyurea
5239092|NCT00672789|Treatment Adherence|treatment adherence
5239093|NCT00672776|hippocampus|hippocampus
5239094|NCT00672776|paroxetine|paroxetine
5239095|NCT00672776|stress|stress
5239096|NCT00672776|PTSD|ptsd
5239097|NCT00672763|Crohn's Disease|crohn's disease
5239098|NCT00672763|Inflammatory Bowel Disease|inflammatory bowel disease
5239099|NCT00672763|Vitamin D|vitamin d
5239100|NCT00672763|Randomised|randomised
5239101|NCT00672763|Placebo|placebo
5239102|NCT00672750|laparoscopic|laparoscopic
5239103|NCT00672750|myomectomy|myomectomy
5239104|NCT00672750|menorrhagia|menorrhagia
5239105|NCT00672750|pelvic pain|pelvic pain
5239106|NCT00672724|Insomnia|insomnia
5239107|NCT00672724|Sleep Disorder|sleep disorder
5239108|NCT00672724|Drug Therapy|drug therapy
5239109|NCT00672711|Complex Regional Pain Syndrome|complex regional pain syndrome
5239110|NCT00672711|Chronic Post-surgical Pain|chronic post-surgical pain
5239111|NCT00672711|Genetic susceptibility|genetic susceptibility
5239112|NCT00672711|COMT|comt
5239113|NCT00672698|SURGICAL RISK|surgical risk
5239114|NCT00672698|ELDERLY|elderly
5239115|NCT00672698|MAJOR SURGERY|major surgery
5239116|NCT00672698|P-POSSUM|p-possum
5239117|NCT00672698|SAPS II|saps ii
5239118|NCT00672685|Cognitive decline|cognitive decline
5239119|NCT00672685|omega-3 fatty acids|omega-3 fatty acids
5239120|NCT00672685|nutrition|nutrition
5239121|NCT00672685|physical exercise|physical exercise
5239122|NCT00672685|cognitive training|cognitive training
5239123|NCT00672685|social activities|social activities
5239124|NCT00672685|frailty|frailty
5239125|NCT00672672|Wound healing of surgical site treated with autologous platlet gel|wound healing of surgical site treated with autologous platlet gel
5239126|NCT00672659|Lost of interest, Depressed Mood|lost of interest, depressed mood
5239127|NCT00672646|Analgesic effect|analgesic effect
5239128|NCT00672633|Omega 3 Fatty Acids|omega 3 fatty acids
5239129|NCT00672633|Triglycerides|triglycerides
5239130|NCT00672633|Lovaza|lovaza
5239131|NCT00672633|Trial|trial
5239132|NCT00672620|Major Depressive Disorder|major depressive disorder
5239133|NCT00672620|Depression|depression
5239134|NCT00672620|Drug Therapy|drug therapy
5239135|NCT00672620|Major Depressive Episode|major depressive episode
5239136|NCT00672607|premenstual syndrome, PMS, clinical trial|premenstual syndrome, pms, clinical trial
5239137|NCT00672581|Hepatic Impairment|hepatic impairment
5239138|NCT00672568|Rotator cuff, Shoulder, Arthroscopic shoulder surgery|rotator cuff, shoulder, arthroscopic shoulder surgery
5239139|NCT00672555|pilonidal sinus|pilonidal sinus
5239140|NCT00672555|recurrence|recurrence
5239141|NCT00672555|Limberg flap|limberg flap
5239142|NCT00672542|melanoma|melanoma
5239143|NCT00672542|dendritic cell|dendritic cell
5239144|NCT00672542|immunoproteasome|immunoproteasome
5239145|NCT00672542|vaccine|vaccine
5239146|NCT00672529|Childhood Asthma|childhood asthma
5239147|NCT00672529|Inhaled Corticosteroids|inhaled corticosteroids
5239148|NCT00672529|Alternative Medicine|alternative medicine
5239149|NCT00672529|Vitamins, minerals, and fish oil as Add-on Treatment|vitamins, minerals, and fish oil as add-on treatment
5239150|NCT00672516|hemorrhage|hemorrhage
5239151|NCT00672516|cardiopulmonary bypass|cardiopulmonary bypass
5239152|NCT00672516|blood component transfusion|blood component transfusion
5239153|NCT00672516|hemostasis, surgical|hemostasis, surgical
5239154|NCT00672503|indwelling urinary catheters|indwelling urinary catheters
5239155|NCT00672503|urinary tract infections|urinary tract infections
5239156|NCT00672503|foley-catheter related infections|foley-catheter related infections
5239157|NCT00672503|hospital acquired CA-UTI|hospital acquired ca-uti
5239158|NCT00672490|Acute Mania|acute mania
5239159|NCT00672490|Bipolar Disorder|bipolar disorder
5239160|NCT00672490|Quetiapine Fumarate|quetiapine fumarate
5239161|NCT00672490|Lithium|lithium
5239162|NCT00672477|opioid-induced constipation|opioid-induced constipation
5239163|NCT00672464|Schizophrenia|schizophrenia
5239164|NCT00672464|Schizoaffective|schizoaffective
5239165|NCT00672464|Cardiovascular|cardiovascular
5239166|NCT00672464|Olanzapine|olanzapine
5239167|NCT00672464|Metformin|metformin
5239168|NCT00672464|Simvastatin|simvastatin
5239169|NCT00672451|diabetic kidney disease|diabetic kidney disease
5239170|NCT00672451|albuminuria|albuminuria
5239171|NCT00672412|Treatment Experienced|treatment experienced
5239172|NCT00672399|Amylin|amylin
5239173|NCT00672399|Eli Lilly|eli lilly
5239174|NCT00672399|exenatide|exenatide
5239175|NCT00672399|moxifloxacin|moxifloxacin
5239176|NCT00672386|Diabetes|diabetes
5239177|NCT00672386|Type 2 Diabetes|type 2 diabetes
5239178|NCT00672386|Adult-Onset Diabetes Mellitus|adult-onset diabetes mellitus
5239179|NCT00672386|Metabolic Syndrome|metabolic syndrome
5239180|NCT00672386|HbA1c|hba1c
5239181|NCT00672386|Body Weight|body weight
5239182|NCT00672386|Metformin|metformin
5239183|NCT00672373|Tardive Dyskinesia|tardive dyskinesia
5239184|NCT00672373|Schizophrenia|schizophrenia
5239185|NCT00672373|Extract of Gingko Biloba|extract of gingko biloba
5239186|NCT00672360|Autism Spectrum Disorder|autism spectrum disorder
5239187|NCT00672347|caudal anesthesia, clonidine, morphine, bupivacaine|caudal anesthesia, clonidine, morphine, bupivacaine
5239188|NCT00672334|Cardiac surgery|cardiac surgery
5239289|NCT00671970|Avastin|avastin
5239189|NCT00672334|Cardiopulmonary bypass|cardiopulmonary bypass
5239190|NCT00672334|Oxidative stress|oxidative stress
5239191|NCT00672334|Acute renal dysfunction|acute renal dysfunction
5239192|NCT00672334|Sodium bicarbonate|sodium bicarbonate
5239193|NCT00672321|recurrent melanoma|recurrent melanoma
5239194|NCT00672321|stage IB melanoma|stage ib melanoma
5239195|NCT00672321|stage II melanoma|stage ii melanoma
5239196|NCT00672321|stage IIIA melanoma|stage iiia melanoma
5239197|NCT00672308|Cholera, benefiber, ORS|cholera, benefiber, ors
5239198|NCT00672295|Ovarian Cancer|ovarian cancer
5239199|NCT00672295|Peritoneal Cancer|peritoneal cancer
5239200|NCT00672295|Tubal Cancer|tubal cancer
5239201|NCT00672295|Fallopian Tube Cancer|fallopian tube cancer
5239202|NCT00672295|Dasatinib|dasatinib
5239203|NCT00672295|Sprycel|sprycel
5239204|NCT00672295|Paclitaxel|paclitaxel
5239205|NCT00672295|Taxol|taxol
5239206|NCT00672295|Carboplatin|carboplatin
5239207|NCT00672295|Paraplatin|paraplatin
5239208|NCT00672282|androgen antagonists|androgen antagonists
5239209|NCT00672282|prostate neoplasms|prostate neoplasms
5239210|NCT00672269|carcinoid|carcinoid
5239211|NCT00672269|family members|family members
5239212|NCT00672269|familial|familial
5239213|NCT00672269|tumors|tumors
5239214|NCT00672269|cancer|cancer
5239215|NCT00672256|Smoking|smoking
5239216|NCT00672256|fMRI|fmri
5239217|NCT00672243|GBM|gbm
5239218|NCT00672243|Brain tumor|brain tumor
5239219|NCT00672243|Erlotinib|erlotinib
5239220|NCT00672243|Sirolimus|sirolimus
5239221|NCT00672243|Glioblastoma multiforme|glioblastoma multiforme
5239222|NCT00672243|Glioblastoma|glioblastoma
5239223|NCT00672243|Gliosarcoma3|gliosarcoma3
5239224|NCT00672243|Tarceva|tarceva
5239225|NCT00672243|Rapamune|rapamune
5239226|NCT00672230|Lactation|lactation
5239227|NCT00672230|Breast milk|breast milk
5239228|NCT00672230|Lutein|lutein
5239229|NCT00672230|Lutein supplement|lutein supplement
5239230|NCT00672217|Breast cancer survivors, insomnia, quality of life|breast cancer survivors, insomnia, quality of life
5239231|NCT00672204|Islet transplant|islet transplant
5239232|NCT00672204|Diabetes Mellitus|diabetes mellitus
5239233|NCT00672204|Hypoglycemia|hypoglycemia
5239234|NCT00672191|HIV|hiv
5239235|NCT00672191|Human immunodeficiency virus|human immunodeficiency virus
5239236|NCT00672191|Immunodeficiency Virus, Human|immunodeficiency virus, human
5239237|NCT00672191|HIV-1|hiv-1
5239238|NCT00672191|ART|art
5239239|NCT00672191|antiretroviral therapy|antiretroviral therapy
5239240|NCT00672191|HAART|haart
5239241|NCT00672191|highly active retroviral therapy|highly active retroviral therapy
5239242|NCT00672191|cluster of differentiation CD 4+ T cell counts|cluster of differentiation cd 4+ t cell counts
5239243|NCT00672191|HIV-1 Subjects successfully ART treated|hiv-1 subjects successfully art treated
5239244|NCT00672191|Treatment Experienced|treatment experienced
5239245|NCT00672178|RCC|rcc
5239246|NCT00672178|metastatic|metastatic
5239247|NCT00672178|sorafenib|sorafenib
5239248|NCT00672165|MAB HUM 195 ACTINIUM-225 LABELED|mab hum 195 actinium-225 labeled
5239249|NCT00672165|HEMATOPOIETIC SYSTEM|hematopoietic system
5239250|NCT00672165|02-017|02-017
5239251|NCT00672152|Autologous transplantation|autologous transplantation
5239252|NCT00672152|Allogeneic transplantation|allogeneic transplantation
5239253|NCT00672139|Opioid-Induced Constipation|opioid-induced constipation
5239254|NCT00672100|Peripheral Nerve Infusion,|peripheral nerve infusion,
5239255|NCT00672100|continuous brachial plexus block,|continuous brachial plexus block,
5239256|NCT00672100|post-operative pain|post-operative pain
5239257|NCT00672100|diaphragmatic paresis|diaphragmatic paresis
5239258|NCT00672087|Chronic Prostatitis with Chronic Pelvic Pain Syndrome|chronic prostatitis with chronic pelvic pain syndrome
5239259|NCT00672087|Chronic Bacterial Prostatitis|chronic bacterial prostatitis
5239260|NCT00672087|Asymptomatic Inflammatory Prostatitis|asymptomatic inflammatory prostatitis
5239261|NCT00672087|Painful Bladder Syndrome|painful bladder syndrome
5239262|NCT00672087|Cystitis, Interstitial|cystitis, interstitial
5239263|NCT00672074|Postoperative Ileus|postoperative ileus
5239264|NCT00672061|Sleep Apnea, Obstructive|sleep apnea, obstructive
5239265|NCT00672061|Insomnia|insomnia
5239266|NCT00672061|Drug Therapy|drug therapy
5239267|NCT00672048|glaucoma|glaucoma
5239268|NCT00672048|optometrists|optometrists
5239269|NCT00672035|LT|lt
5239270|NCT00672035|Healthy Adults|healthy adults
5239271|NCT00672035|Dose Ranging|dose ranging
5239272|NCT00672035|Patch|patch
5239273|NCT00672035|Vaccine|vaccine
5239274|NCT00672009|prostate cancer|prostate cancer
5239275|NCT00672009|radical prostatectomy|radical prostatectomy
5239276|NCT00672009|ixabepilone|ixabepilone
5239277|NCT00671970|Glioblastoma|glioblastoma
5239278|NCT00671970|Gliosarcoma|gliosarcoma
5239279|NCT00671970|Recurrent MG|recurrent mg
5239280|NCT00671970|Malignant glioma|malignant glioma
5239281|NCT00671970|Glioma|glioma
5239282|NCT00671970|Glioblastoma multiforme (GBM)|glioblastoma multiforme (gbm)
5239283|NCT00671970|GBM|gbm
5239284|NCT00671970|Brain tumor|brain tumor
5239285|NCT00671970|Anaplastic astrocytoma|anaplastic astrocytoma
5239286|NCT00671970|Anaplastic oligodendroglioma|anaplastic oligodendroglioma
5239287|NCT00671970|Anaplastic oligoastrocytoma|anaplastic oligoastrocytoma
5239288|NCT00671970|Bevacizumab|bevacizumab
5239290|NCT00671970|Erlotinib|erlotinib
5239291|NCT00671970|Tarceva|tarceva
5239292|NCT00671957|Obesity|obesity
5239293|NCT00671957|Bariatric|bariatric
5239294|NCT00671957|Surgery|surgery
5239295|NCT00671957|Activity|activity
5239296|NCT00671944|protein|protein
5239297|NCT00671944|calcium|calcium
5239298|NCT00671944|parathyroid hormone|parathyroid hormone
5239299|NCT00671944|bone markers|bone markers
5239300|NCT00671944|calcium kinetics|calcium kinetics
5239301|NCT00671944|absorption|absorption
5239302|NCT00671931|dexmedetomidine|dexmedetomidine
5239303|NCT00671931|neuromonitoring|neuromonitoring
5239304|NCT00671931|spine procedures|spine procedures
5239305|NCT00671931|safe dose|safe dose
5239306|NCT00671931|1- safe dose of dexmedetomidine when used in total intravenous anesthesia for procedures require neuromonitoring|1- safe dose of dexmedetomidine when used in total intravenous anesthesia for procedures require neuromonitoring
5239307|NCT00671931|2- safe dose of propofol when uses in comination with dexmedetomidine in neuromontoring|2- safe dose of propofol when uses in comination with dexmedetomidine in neuromontoring
5239308|NCT00671931|3effect of dexmedetomidine on somatosensory evoked potential and motor evoked potentials|3effect of dexmedetomidine on somatosensory evoked potential and motor evoked potentials
5239309|NCT00671918|breast cancer|breast cancer
5239310|NCT00671918|lymph nodes|lymph nodes
5239311|NCT00671918|melanoma|melanoma
5239312|NCT00671918|surgery|surgery
5239313|NCT00671905|atrial fibrillation|atrial fibrillation
5239314|NCT00671905|PV isolation|pv isolation
5239315|NCT00671905|ablation|ablation
5239316|NCT00671905|ganglionic plexi|ganglionic plexi
5239317|NCT00671905|parasympathetic denervation|parasympathetic denervation
5239318|NCT00671892|LPS endotoxin|lps endotoxin
5239319|NCT00671892|asthma|asthma
5239320|NCT00671866|OP|op
5239321|NCT00671866|Pesticides|pesticides
5239322|NCT00671866|Long-Term Low Level Exposure|long-term low level exposure
5239323|NCT00671866|Occupational Health|occupational health
5239324|NCT00671866|Neurobehavioral Effects|neurobehavioral effects
5239325|NCT00671853|Bipolar Disorder|bipolar disorder
5239326|NCT00671853|Anxiety|anxiety
5239327|NCT00671853|Anxiety Disorders|anxiety disorders
5239328|NCT00671853|Substance Use Disorders|substance use disorders
5239329|NCT00671827|Gynecologic Cancer|gynecologic cancer
5239330|NCT00671827|Cervical Cancer|cervical cancer
5239331|NCT00671827|Endometrial Cancer|endometrial cancer
5239332|NCT00671827|Fallopian Tube Cancer|fallopian tube cancer
5239333|NCT00671827|Ovarian Cancer|ovarian cancer
5239334|NCT00671827|Uterine Cancer|uterine cancer
5239335|NCT00671827|Vaginal Cancer|vaginal cancer
5239336|NCT00671827|Vulvar Cancer|vulvar cancer
5239337|NCT00671827|Questionnaire|questionnaire
5239338|NCT00671827|Survey|survey
5239339|NCT00671827|Robot-Assisted Surgery|robot-assisted surgery
5239340|NCT00671814|antibiotic|antibiotic
5239341|NCT00671801|Malignant Gliomas|malignant gliomas
5239342|NCT00671801|Glioblastoma Multiforme|glioblastoma multiforme
5239343|NCT00671801|Gliosarcoma|gliosarcoma
5239344|NCT00671801|Anaplastic Astrocytoma|anaplastic astrocytoma
5239345|NCT00671801|Anaplastic Oligodendroglioma|anaplastic oligodendroglioma
5239346|NCT00671801|Anaplastic Oligoastrocytoma|anaplastic oligoastrocytoma
5239347|NCT00671801|Camptosar|camptosar
5239348|NCT00671801|Irinotecan|irinotecan
5239349|NCT00671801|CPT-11|cpt-11
5239350|NCT00671801|Lenalidomide|lenalidomide
5239351|NCT00671801|Revlimid|revlimid
5239352|NCT00671801|CC-5013|cc-5013
5239353|NCT00671775|Bariatric Surgery|bariatric surgery
5239354|NCT00671775|Obesity|obesity
5239355|NCT00671775|Cognitive Function|cognitive function
5239356|NCT00671736|cystic fibrosis|cystic fibrosis
5239357|NCT00671736|Moli1901|moli1901
5239358|NCT00671736|Lancovutide|lancovutide
5239359|NCT00671736|2622U90|2622u90
5239360|NCT00671736|duramycin|duramycin
5239361|NCT00671736|lung|lung
5239362|NCT00671723|Atelectasis|atelectasis
5239363|NCT00671710|malignant glial brain tumors|malignant glial brain tumors
5239364|NCT00671697|MDS|mds
5239365|NCT00671697|hypomethylating agent|hypomethylating agent
5239366|NCT00671697|oxidative stress|oxidative stress
5239367|NCT00671684|Hirschsprung's disease|hirschsprung's disease
5239368|NCT00671684|Constipation|constipation
5239369|NCT00671684|Endoscopy, digestive system|endoscopy, digestive system
5239370|NCT00671684|Diagnosis|diagnosis
5239371|NCT00671684|Colonoscopy|colonoscopy
5239372|NCT00671658|Lymphoma|lymphoma
5239373|NCT00671658|HYPER-CVAD|hyper-cvad
5239374|NCT00671658|Leukemia|leukemia
5239616|NCT00670956|hydrops|hydrops
5239375|NCT00671658|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
5239376|NCT00671658|ALL|all
5239377|NCT00671658|Remission Duration|remission duration
5239378|NCT00671658|Chemotherapy|chemotherapy
5239379|NCT00671658|Asparaginase|asparaginase
5239380|NCT00671658|Cyclophosphamide|cyclophosphamide
5239381|NCT00671658|Cytarabine|cytarabine
5239382|NCT00671658|Dexamethasone|dexamethasone
5239383|NCT00671658|Doxorubicin|doxorubicin
5239384|NCT00671658|Leukine|leukine
5239385|NCT00671658|Methotrexate|methotrexate
5239386|NCT00671658|Rituximab|rituximab
5239387|NCT00671658|Vincristine|vincristine
5239388|NCT00671645|pilot study|pilot study
5239389|NCT00671645|rectal|rectal
5239390|NCT00671645|carcinoma|carcinoma
5239391|NCT00671645|phase II|phase ii
5239392|NCT00671645|preoperative|preoperative
5239393|NCT00671645|RadioChemo|radiochemo
5239394|NCT00671645|molecular|molecular
5239395|NCT00671645|target|target
5239396|NCT00671645|therapy|therapy
5239397|NCT00671645|T3|t3
5239398|NCT00671645|ABCSG|abcsg
5239399|NCT00671645|TAKO|tako
5239400|NCT00671645|R04|r04
5239401|NCT00671645|08|08
5239402|NCT00671632|Addiction|addiction
5239403|NCT00671619|opthalmology|opthalmology
5239404|NCT00671619|antibody fragment|antibody fragment
5239405|NCT00671619|TNF alpha|tnf alpha
5239406|NCT00671606|Endometrial Cancer|endometrial cancer
5239407|NCT00671606|Lymphatic Mapping|lymphatic mapping
5239408|NCT00671606|Sentinel Node Identification|sentinel node identification
5239409|NCT00671606|Lymph Node|lymph node
5239410|NCT00671606|Intraoperative lymphatic mapping|intraoperative lymphatic mapping
5239411|NCT00671606|Total hysterectomy|total hysterectomy
5239412|NCT00671606|Bilateral salpingooophorectomy|bilateral salpingooophorectomy
5239413|NCT00671606|Lymph node staging|lymph node staging
5239414|NCT00671606|Laparotomy|laparotomy
5239415|NCT00671606|Laparoscopy|laparoscopy
5239416|NCT00671593|Allergy|allergy
5239417|NCT00671593|Asthma|asthma
5239418|NCT00671593|healthy|healthy
5239419|NCT00671593|Normal|normal
5239420|NCT00671580|Skin Infections|skin infections
5239421|NCT00671580|Complicated Skin and Skin Structure Infections|complicated skin and skin structure infections
5239422|NCT00671567|Sleep Disorder|sleep disorder
5239423|NCT00671567|Insomnia|insomnia
5239424|NCT00671554|Melanoma|melanoma
5239425|NCT00671554|Dendritic cells|dendritic cells
5239426|NCT00671554|Cell therapy|cell therapy
5239427|NCT00671554|BCG vaccine|bcg vaccine
5239428|NCT00671528|Impetiginous|impetiginous
5239429|NCT00671515|Depressive Disorder, Major|depressive disorder, major
5239430|NCT00671515|Metabolic Syndrome X|metabolic syndrome x
5239431|NCT00671515|pioglitazone|pioglitazone
5239432|NCT00671489|Patients|patients
5239433|NCT00671489|high-energy|high-energy
5239434|NCT00671489|admitted|admitted
5239435|NCT00671489|intensive care unit|intensive care unit
5239436|NCT00671489|motor vehicle accident|motor vehicle accident
5239437|NCT00671489|falling from height|falling from height
5239438|NCT00671489|other accident|other accident
5239439|NCT00671476|ductal breast carcinoma in situ|ductal breast carcinoma in situ
5239440|NCT00671463|Pancreas surgery|pancreas surgery
5239441|NCT00671463|Pancreatic adenocarcinoma|pancreatic adenocarcinoma
5239442|NCT00671463|Pancreatic neuroendocrine tumor|pancreatic neuroendocrine tumor
5239443|NCT00671463|Pancreatic duct stenting|pancreatic duct stenting
5239444|NCT00671437|squamous cell carcinoma of the head and neck|squamous cell carcinoma of the head and neck
5239445|NCT00671424|Interaction,|interaction,
5239446|NCT00671424|Diabetes,|diabetes,
5239447|NCT00671424|healthy male subjects|healthy male subjects
5239448|NCT00671424|GSK189075,|gsk189075,
5239449|NCT00671424|Diuretics,|diuretics,
5239450|NCT00671411|Ultrasound|ultrasound
5239451|NCT00671411|07-165|07-165
5239452|NCT00671398|Insomnia|insomnia
5239453|NCT00671398|Sleep Disorder|sleep disorder
5239454|NCT00671398|Drug Therapy|drug therapy
5239455|NCT00671385|screening|screening
5239456|NCT00671385|compositional analysis|compositional analysis
5239457|NCT00671385|metabolism|metabolism
5239458|NCT00671385|breast|breast
5239459|NCT00671385|breast cyst|breast cyst
5239460|NCT00671385|breast infection|breast infection
5239461|NCT00671385|breast inflammation|breast inflammation
5239462|NCT00671385|lipoma|lipoma
5239463|NCT00671385|benign growth|benign growth
5239464|NCT00671385|Women without a diagnosis for a region of interest in the breast|women without a diagnosis for a region of interest in the breast
5239465|NCT00671372|CRC|crc
5239466|NCT00671372|Metastatic CRC|metastatic crc
5239467|NCT00671372|APO2L/TRAIL|apo2l/trail
5239468|NCT00671359|Food effects|food effects
5239469|NCT00671346|Cancer|cancer
5239470|NCT00671346|Coronary artery disease|coronary artery disease
5239471|NCT00671346|Myocardial infarction|myocardial infarction
5239472|NCT00671346|Cerebrovascular stroke|cerebrovascular stroke
5239473|NCT00671346|Homocysteine|homocysteine
5239474|NCT00671346|Vitamin B Complex|vitamin b complex
5239475|NCT00671346|Folic acid|folic acid
5239476|NCT00671346|Vitamin B12|vitamin b12
5239477|NCT00671346|Vitamin B6|vitamin b6
5239478|NCT00671346|Pyridoxal phosphate|pyridoxal phosphate
5239479|NCT00671346|Osteoporotic fractures|osteoporotic fractures
5239480|NCT00671346|Diabetes|diabetes
5239481|NCT00671333|Randomized|randomized
5239482|NCT00671333|Prospective|prospective
5239483|NCT00671333|Procedure / Surgery|procedure / surgery
5239484|NCT00671320|acute ankle sprain, acute pain, South America|acute ankle sprain, acute pain, south america
5239485|NCT00671307|Gelsolin|gelsolin
5239486|NCT00671307|Trauma|trauma
5239487|NCT00671307|Pneumonia|pneumonia
5239488|NCT00671307|Peritonitis|peritonitis
5239489|NCT00671307|Burn|burn
5239490|NCT00671307|Infection|infection
5239491|NCT00671307|Sepsis|sepsis
5239492|NCT00671307|Systemic Inflammatory Response Syndrome|systemic inflammatory response syndrome
5239493|NCT00671294|Insomnia|insomnia
5239494|NCT00671281|FESS|fess
5240439|NCT00667394|Radiation|radiation
5239495|NCT00671281|Tranexamic acid|tranexamic acid
5239496|NCT00671281|Hemostasis|hemostasis
5239497|NCT00671281|Visualization|visualization
5239498|NCT00671268|Grass pollen allergy|grass pollen allergy
5239499|NCT00671268|specific immunotherapy|specific immunotherapy
5239500|NCT00671255|Chronic Insomnia|chronic insomnia
5239501|NCT00671255|Drug Therapy|drug therapy
5239502|NCT00671255|Elderly|elderly
5239503|NCT00671242|Fluorine-18-α-methyltyrosine,|fluorine-18-α-methyltyrosine,
5239980|NCT00669305|CD34 cells|cd34 cells
5239504|NCT00671242|Positron emission tomography,|positron emission tomography,
5239505|NCT00671242|Fluorine-18-fluorodeoxyglucose,|fluorine-18-fluorodeoxyglucose,
5239506|NCT00671242|Lung cancer,|lung cancer,
5239507|NCT00671242|Angiogenesis|angiogenesis
5239508|NCT00671242|The median VEGF rate was 45% (range, 10-78%).|the median vegf rate was 45% (range, 10-78%).
5239509|NCT00671242|High expression was seen in 30 patients (81%, 30/37).|high expression was seen in 30 patients (81%, 30/37).
5239510|NCT00671242|VEGF expression was statistically associated with progressively growing microvessel count.|vegf expression was statistically associated with progressively growing microvessel count.
5239511|NCT00671229|Healthy|healthy
5239512|NCT00671229|Asthma|asthma
5239513|NCT00671229|Nitric Oxide|nitric oxide
5239514|NCT00671216|safety|safety
5239515|NCT00671216|pharmacodynamics|pharmacodynamics
5239516|NCT00671216|Muscarinic Receptor Antagonist|muscarinic receptor antagonist
5239517|NCT00671216|tolerability|tolerability
5239518|NCT00671216|healthy subjects|healthy subjects
5239519|NCT00671216|GS642444|gs642444
5239520|NCT00671216|GSK233705|gsk233705
5239521|NCT00671216|Anticholinergic|anticholinergic
5239522|NCT00671216|ß2 agonist|ß2 agonist
5239523|NCT00671216|pharmacokinetics|pharmacokinetics
5239524|NCT00671203|Tissue oximetry|tissue oximetry
5239525|NCT00671203|Ischemia|ischemia
5239526|NCT00671203|Aortic Aneurysm Repair|aortic aneurysm repair
5239527|NCT00671203|Aortic Stent|aortic stent
5239528|NCT00671203|Vascular Stent|vascular stent
5239529|NCT00671203|Aortic graft|aortic graft
5239530|NCT00671203|Vascular graft|vascular graft
5239531|NCT00671190|Sleep Disorder|sleep disorder
5239532|NCT00671190|Circadian Rhythm Sleep Disorder|circadian rhythm sleep disorder
5239533|NCT00671190|Drug Therapy|drug therapy
5239534|NCT00671177|colonoscopy|colonoscopy
5239535|NCT00671177|diagnostic techniques|diagnostic techniques
5239536|NCT00671177|digestive system|digestive system
5239537|NCT00671177|endoscopy|endoscopy
5239538|NCT00671177|gastrointestinal|gastrointestinal
5239539|NCT00671151|COPD exacerbation|copd exacerbation
5239540|NCT00671151|histone|histone
5239541|NCT00671151|steroid resistance|steroid resistance
5239542|NCT00671151|inflammation|inflammation
5239543|NCT00671151|theophylline|theophylline
5239544|NCT00671138|Celiac disease|celiac disease
5239545|NCT00671138|Parasitic infections|parasitic infections
5239546|NCT00671138|necator americanus|necator americanus
5239547|NCT00671138|Immunity|immunity
5239548|NCT00671125|Sleep Disorder|sleep disorder
5239549|NCT00671125|Insomnia|insomnia
5239550|NCT00671125|Drug Therapy|drug therapy
5239551|NCT00671112|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5239552|NCT00671112|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5239553|NCT00671112|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5239554|NCT00671112|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5239555|NCT00671112|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5239556|NCT00671112|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5239557|NCT00671112|Waldenstrom's macroglobulinemia|waldenstrom's macroglobulinemia
5239558|NCT00671112|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5239559|NCT00671112|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5239560|NCT00671112|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5239561|NCT00671112|refractory hairy cell leukemia|refractory hairy cell leukemia
5239562|NCT00671112|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
5239563|NCT00671112|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5239564|NCT00671112|hairy cell leukemia|hairy cell leukemia
5239565|NCT00671112|cutaneous B and T cell lymphoma|cutaneous b and t cell lymphoma
5239566|NCT00671112|transformed lymphoma|transformed lymphoma
5239567|NCT00671112|transformed B and T cell cutaneous lymphoma|transformed b and t cell cutaneous lymphoma
5239568|NCT00671112|relapsed or refractory diffuse large B cell lymphoma|relapsed or refractory diffuse large b cell lymphoma
5239569|NCT00671112|extranodal T cell lymphomas|extranodal t cell lymphomas
5239570|NCT00671112|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5239571|NCT00671112|angioimmunoblastic T cell lymphoma|angioimmunoblastic t cell lymphoma
5239572|NCT00671112|PTCL-NOS|ptcl-nos
5239573|NCT00671112|nasal or disseminated extranodal T/NK lymphoma|nasal or disseminated extranodal t/nk lymphoma
5239574|NCT00671112|enteropathy-associated T cell lymphoma|enteropathy-associated t cell lymphoma
5239575|NCT00671112|hepatosplenic gamma/delta T cell lymphoma|hepatosplenic gamma/delta t cell lymphoma
5239576|NCT00671112|subcutaneous panniculitis-like T cell lymphoma|subcutaneous panniculitis-like t cell lymphoma
5239577|NCT00671112|T-prolymphocytic leukemia|t-prolymphocytic leukemia
5239578|NCT00671112|adult T-cell leukemia/lymphoma|adult t-cell leukemia/lymphoma
5240934|NCT00665886|Dwell time|dwell time
5239579|NCT00671112|large granular lymphocytic leukemia|large granular lymphocytic leukemia
5239580|NCT00671112|aggressive NK leukemia|aggressive nk leukemia
5239581|NCT00671099|Patients|patients
5239582|NCT00671099|with high-energy|with high-energy
5239583|NCT00671099|admitted|admitted
5239584|NCT00671099|intensive care unit|intensive care unit
5239585|NCT00671099|motor vehicle accident|motor vehicle accident
5239586|NCT00671099|falling from height|falling from height
5239587|NCT00671099|other accident|other accident
5239588|NCT00671086|Chronic Insomnia|chronic insomnia
5239589|NCT00671086|DIMS (Disorders of Initiating and Maintaining Sleep)|dims (disorders of initiating and maintaining sleep)
5239590|NCT00671086|Disorders of Initiating and Maintaining Sleep|disorders of initiating and maintaining sleep
5239591|NCT00671086|Insomnia Disorder Sleep Initiation Dysfunction|insomnia disorder sleep initiation dysfunction
5239592|NCT00671086|Transient Insomnia|transient insomnia
5239593|NCT00671086|Drug Therapy|drug therapy
5239594|NCT00671086|Sleep Disorders, Intrinsic|sleep disorders, intrinsic
5239595|NCT00671073|Airflow Obstruction, Chronic|airflow obstruction, chronic
5239596|NCT00671073|Chronic Airflow Obstruction|chronic airflow obstruction
5239597|NCT00671073|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5239598|NCT00671073|Chronic Obstructive Airway Disease|chronic obstructive airway disease
5239599|NCT00671073|Chronic Obstructive Lung Disease|chronic obstructive lung disease
5239600|NCT00671073|COPD|copd
5239601|NCT00671073|COAD|coad
5239602|NCT00671060|intrauterine fetal death|intrauterine fetal death
5239603|NCT00671060|misoprostol|misoprostol
5239604|NCT00671047|Autoimmune Diseases|autoimmune diseases
5239605|NCT00671047|Lupus|lupus
5239606|NCT00671021|platelet aggregation|platelet aggregation
5239607|NCT00671021|aspirin|aspirin
5239608|NCT00670995|Tobacco use among middle and junior high school students remains a concern among health educators.|tobacco use among middle and junior high school students remains a concern among health educators.
5239609|NCT00670995|The use of tobacco prevention programs and their integration into school-based curricula has been lacking due to a number of factors.|the use of tobacco prevention programs and their integration into school-based curricula has been lacking due to a number of factors.
5239610|NCT00670982|HER2 positive|her2 positive
5239611|NCT00670982|bevacizumab|bevacizumab
5239612|NCT00670982|vinorelbine|vinorelbine
5239613|NCT00670982|trastuzumab|trastuzumab
5239614|NCT00670969|Obesity|obesity
5239615|NCT00670956|prenatal steroids|prenatal steroids
5239617|NCT00670956|congenital cystic adenomatoid malformation of the lung|congenital cystic adenomatoid malformation of the lung
5239618|NCT00670956|prenatal intervention|prenatal intervention
5239619|NCT00670956|betamethasone|betamethasone
5239620|NCT00670956|prenatal diagnosis|prenatal diagnosis
5239621|NCT00670943|Clopidogrel discontinuation|clopidogrel discontinuation
5239622|NCT00670943|Platelet aggregation|platelet aggregation
5239623|NCT00670930|Asthma, adults, anti-immunoglobulin E ( IgE), omalizumab, airway inflammation, airway remodeling, allergy|asthma, adults, anti-immunoglobulin e ( ige), omalizumab, airway inflammation, airway remodeling, allergy
5239625|NCT00670917|hematopoietic/lymphoid cancer|hematopoietic/lymphoid cancer
5239626|NCT00670904|Smoking cessation|smoking cessation
5239627|NCT00670904|Pharmacist-delivered|pharmacist-delivered
5239628|NCT00670865|Hospitalization|hospitalization
5239629|NCT00670865|Continuity of care|continuity of care
5239630|NCT00670865|Discharge summary|discharge summary
5239631|NCT00670865|Quality improvement|quality improvement
5239632|NCT00670865|Medical records systems|medical records systems
5239633|NCT00670865|Hospital information systems|hospital information systems
5239634|NCT00670852|Glenoid component|glenoid component
5239635|NCT00670852|radiolucent lines|radiolucent lines
5239636|NCT00670852|Glenoid loosening|glenoid loosening
5239637|NCT00670852|glenohumeral arthritis|glenohumeral arthritis
5239638|NCT00670852|autologous bone graft|autologous bone graft
5239639|NCT00670839|Hepatitis B vaccination|hepatitis b vaccination
5239640|NCT00670839|GenHevac-B Pasteur|genhevac-b pasteur
5239641|NCT00670839|HIV infection|hiv infection
5239642|NCT00670826|Patient warming|patient warming
5239643|NCT00670813|Depression|depression
5239644|NCT00670813|(total) sleep deprivation|(total) sleep deprivation
5239645|NCT00670813|Modafinil|modafinil
5239646|NCT00670813|polysomnography sleep|polysomnography sleep
5239647|NCT00670800|Polycystic Ovary Syndrome|polycystic ovary syndrome
5239648|NCT00670800|Insulin resistance|insulin resistance
5239649|NCT00670800|Metformin|metformin
5239650|NCT00670800|Brain function|brain function
5239651|NCT00670787|Hypertension|hypertension
5239652|NCT00670787|combination pill|combination pill
5239653|NCT00670787|compliance|compliance
5239654|NCT00670774|Kidney|kidney
5239655|NCT00670774|Transplant|transplant
5239656|NCT00670774|donor|donor
5239657|NCT00670761|misoprostol|misoprostol
5239658|NCT00670761|incomplete abortion|incomplete abortion
5239659|NCT00670761|sublingual|sublingual
5239660|NCT00670761|postabortion care|postabortion care
5239661|NCT00670761|MVA|mva
5239662|NCT00670748|Metastatic Cancer|metastatic cancer
5239663|NCT00670748|Gene Therapy|gene therapy
5239664|NCT00670748|Immunotherapy|immunotherapy
5239665|NCT00670748|Tumor Regression|tumor regression
5239666|NCT00670748|Metastatic Melanoma|metastatic melanoma
5239667|NCT00670748|Metastatic Renal Cell Cancer|metastatic renal cell cancer
5239668|NCT00670735|Pediatric Hydrocephalus|pediatric hydrocephalus
5239669|NCT00670709|encephalography|encephalography
5239670|NCT00670709|quantitative|quantitative
5239671|NCT00670709|biomarkers|biomarkers
5239672|NCT00670696|Topical anesthesia|topical anesthesia
5239673|NCT00670696|Rapydan|rapydan
5239674|NCT00670696|Topical anaesthesia for venous cannulation|topical anaesthesia for venous cannulation
5239675|NCT00670657|candidemia|candidemia
5239676|NCT00670657|invasive candidiasis|invasive candidiasis
5239677|NCT00670657|Ambisome|ambisome
5239678|NCT00670657|liposomal amphotericin B|liposomal amphotericin b
5239679|NCT00670644|male breast cancer|male breast cancer
5239680|NCT00670644|recurrent breast cancer|recurrent breast cancer
5239681|NCT00670644|stage I breast cancer|stage i breast cancer
5239682|NCT00670644|stage II breast cancer|stage ii breast cancer
5239683|NCT00670644|stage IIIA breast cancer|stage iiia breast cancer
5239684|NCT00670644|stage IIIB breast cancer|stage iiib breast cancer
5239685|NCT00670644|stage IIIC breast cancer|stage iiic breast cancer
5239686|NCT00670644|stage IV breast cancer|stage iv breast cancer
5239687|NCT00670631|Multiple Myeloma|multiple myeloma
5239688|NCT00670631|myeloma|myeloma
5239689|NCT00670605|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5239690|NCT00670605|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
5239691|NCT00670592|HCD122|hcd122
5239692|NCT00670592|CD40|cd40
5239693|NCT00670592|NHL|nhl
5239694|NCT00670592|HL|hl
5239695|NCT00670579|TIVAD|tivad
5239696|NCT00670579|complications|complications
5239697|NCT00670579|nursing|nursing
5239698|NCT00670579|cystic fibrosis|cystic fibrosis
5239699|NCT00670579|implanted|implanted
5239700|NCT00670553|Prostate,|prostate,
5239701|NCT00670553|Head & Neck,|head & neck,
5239702|NCT00670553|Esophageal|esophageal
5239703|NCT00670540|pulmonary embolism|pulmonary embolism
5239704|NCT00670540|duplex ultrasound examination|duplex ultrasound examination
5239705|NCT00670540|recurrence|recurrence
5239706|NCT00670527|Prostate cancer|prostate cancer
5239707|NCT00670527|[18F] Fluorocholine PET/CT|[18f] fluorocholine pet/ct
5239708|NCT00670527|FCH|fch
5239709|NCT00670527|lymph node metastasis|lymph node metastasis
5239710|NCT00670527|staging|staging
5239711|NCT00670527|sensitivity|sensitivity
5239712|NCT00670527|specificity|specificity
5239713|NCT00670527|PROPET|propet
5239714|NCT00670514|RCT|rct
5239715|NCT00670514|tobacco|tobacco
5239716|NCT00670514|treatment intensity|treatment intensity
5239717|NCT00670514|dentistry|dentistry
5239718|NCT00670514|follow-up|follow-up
5239719|NCT00670514|Smoking cessation|smoking cessation
5239720|NCT00670514|Cost effectiveness|cost effectiveness
5239721|NCT00670475|osteoarthritis|osteoarthritis
5239722|NCT00670475|Knee|knee
5239723|NCT00670475|virgin olive oil|virgin olive oil
5239724|NCT00670475|piroxicam|piroxicam
5239725|NCT00670475|Topical|topical
5239726|NCT00670462|obesity, weight loss, treatment|obesity, weight loss, treatment
5239727|NCT00670449|FTY720|fty720
5239728|NCT00670449|multiple sclerosis|multiple sclerosis
5239729|NCT00670449|MS|ms
5239730|NCT00670423|Tacrolimus|tacrolimus
5239731|NCT00670423|Sirolimus|sirolimus
5239732|NCT00670423|Bortezomib|bortezomib
5239733|NCT00670423|Acute Graft Versus Host Disease|acute graft versus host disease
5239734|NCT00670423|Allogeneic Peripheral Blood Stem Cell Transplantation|allogeneic peripheral blood stem cell transplantation
5239735|NCT00670410|Neuroblastoma|neuroblastoma
5239736|NCT00670410|Autologous Transplant|autologous transplant
5239737|NCT00670410|Allogeneic Transplant|allogeneic transplant
5239738|NCT00670410|Immunotherapy|immunotherapy
5239739|NCT00670397|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
5239740|NCT00670397|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
5239741|NCT00670397|stage 0 lip and oral cavity cancer|stage 0 lip and oral cavity cancer
5239742|NCT00670384|SLIT|slit
5239743|NCT00670384|Immunotherapy|immunotherapy
5239744|NCT00670384|Short ragweed|short ragweed
5239746|NCT00670384|Seasonal allergic rhinitis|seasonal allergic rhinitis
5239747|NCT00670371|Caregiver burden|caregiver burden
5239748|NCT00670358|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
5239749|NCT00670358|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5239750|NCT00670358|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5239751|NCT00670358|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5239752|NCT00670358|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
5239753|NCT00670358|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5239754|NCT00670358|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5239755|NCT00670358|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5239756|NCT00670345|tranexamic acid|tranexamic acid
5239757|NCT00670345|prostatectomy|prostatectomy
5239758|NCT00670345|surgery|surgery
5239759|NCT00670332|coronary artery disease|coronary artery disease
5239760|NCT00670332|echocardiography|echocardiography
5239761|NCT00670332|cardiac imaging|cardiac imaging
5239762|NCT00670332|heart disease|heart disease
5241221|NCT00664729|obesity|obesity
5239763|NCT00670332|ultrasound contrast agent|ultrasound contrast agent
5239764|NCT00670332|prognosis|prognosis
5239765|NCT00670306|Cetrorelix|cetrorelix
5239766|NCT00670306|BPH|bph
5239767|NCT00670293|Anorexia Nervosa|anorexia nervosa
5239768|NCT00670293|PET Imaging|pet imaging
5239769|NCT00670293|Dopamine|dopamine
5239770|NCT00670280|Neonatal Intensive Care Units|neonatal intensive care units
5239771|NCT00670280|Infant Morbidity|infant morbidity
5239772|NCT00670280|Low Birth Weight|low birth weight
5239773|NCT00670280|Low Income Populations|low income populations
5239774|NCT00670280|MCH Research|mch research
5239775|NCT00670280|Respiratory Illnesses|respiratory illnesses
5239776|NCT00670280|Substance Exposed Infants|substance exposed infants
5239777|NCT00670280|Counseling|counseling
5239778|NCT00670267|Asthma|asthma
5239779|NCT00670267|hyperresponsiveness|hyperresponsiveness
5239780|NCT00670254|Sepsis|sepsis
5239781|NCT00670254|Septic|septic
5239782|NCT00670254|Shock|shock
5239783|NCT00670254|Glucocorticoids|glucocorticoids
5239784|NCT00670254|Hydrocortisone|hydrocortisone
5239785|NCT00670215|Prevention of infectious complications|prevention of infectious complications
5239786|NCT00670215|transrectal needle biopsies of the prostate|transrectal needle biopsies of the prostate
5239787|NCT00670215|TRNBP|trnbp
5239788|NCT00670202|Patients scheduled for elective carotid endarterectomy|patients scheduled for elective carotid endarterectomy
5239789|NCT00670163|Men Who Have Sex With Men|men who have sex with men
5239790|NCT00670111|Heart failure|heart failure
5239791|NCT00670111|exercise capacity|exercise capacity
5239792|NCT00670111|ejection fraction|ejection fraction
5239793|NCT00670111|Heart failure normal ejection fraction|heart failure normal ejection fraction
5239794|NCT00670059|Single embryo transfer/ aneuploidy screening|single embryo transfer/ aneuploidy screening
5239795|NCT00670046|recurrent prostate cancer|recurrent prostate cancer
5239796|NCT00670046|stage I prostate cancer|stage i prostate cancer
5239797|NCT00670046|stage IIB prostate cancer|stage iib prostate cancer
5239798|NCT00670046|stage IIA prostate cancer|stage iia prostate cancer
5239799|NCT00670046|stage III prostate cancer|stage iii prostate cancer
5239800|NCT00670046|stage IV prostate cancer|stage iv prostate cancer
5239801|NCT00670033|IOP|iop
5239802|NCT00670033|Open-angle glaucoma|open-angle glaucoma
5239803|NCT00670033|Ocular Hypertension|ocular hypertension
5239804|NCT00670020|Women undergoing Cesarean section after the onset of labor|women undergoing cesarean section after the onset of labor
5239805|NCT00670007|Alpha1-proteinase inhibitor deficiency|alpha1-proteinase inhibitor deficiency
5239806|NCT00670007|Chronic augmentation and maintenance therapy|chronic augmentation and maintenance therapy
5239807|NCT00670007|Emphysema|emphysema
5239808|NCT00670007|Emphysema due to Alpha 1-proteinase inhibitor deficiency|emphysema due to alpha 1-proteinase inhibitor deficiency
5239809|NCT00669994|UTI|uti
5239810|NCT00669994|Urinary Tract Infection|urinary tract infection
5239811|NCT00669981|PTSD|ptsd
5239812|NCT00669981|Relationship Distress|relationship distress
5239813|NCT00669981|Couple Therapy|couple therapy
5239814|NCT00669968|PET myocardial perfusion imaging|pet myocardial perfusion imaging
5239815|NCT00669968|Cardiac PET|cardiac pet
5239816|NCT00669968|Rubidium|rubidium
5239817|NCT00669968|Coronary Artery CT Angiogram|coronary artery ct angiogram
5239818|NCT00669968|Coronary Flow Reserve|coronary flow reserve
5239819|NCT00669968|Adenosine stress test|adenosine stress test
5239820|NCT00669955|H. Pylori|h. pylori
5239821|NCT00669955|Quadruple therapy|quadruple therapy
5239822|NCT00669955|Eradication rate|eradication rate
5239823|NCT00669955|Multinational trial|multinational trial
5239824|NCT00669955|Resistance to antibiotics|resistance to antibiotics
5239825|NCT00669955|Subjects with confirmed Helicobacter Pylori infection|subjects with confirmed helicobacter pylori infection
5239826|NCT00669942|Rheumatoid Arthritis|rheumatoid arthritis
5239827|NCT00669929|Cost effectiveness analysis of rotavirus vaccination|cost effectiveness analysis of rotavirus vaccination
5239828|NCT00669916|Plaque psoriasis|plaque psoriasis
5239829|NCT00669890|AML|aml
5239830|NCT00669890|JMML|jmml
5239831|NCT00669890|MDS|mds
5239832|NCT00669890|Allogenic Atem Cell Transplant|allogenic atem cell transplant
5239833|NCT00669890|Gemtuzumab Ozogamicin|gemtuzumab ozogamicin
5239834|NCT00669877|Burkitt's Lymphoma|burkitt's lymphoma
5239835|NCT00669877|Burkitt's Like Lymphoma|burkitt's like lymphoma
5239836|NCT00669877|Leukemia|leukemia
5239837|NCT00669877|Hyper-CVAD|hyper-cvad
5239838|NCT00669877|Rituximab|rituximab
5239839|NCT00669877|Methotrexate|methotrexate
5239840|NCT00669877|Cytarabine|cytarabine
5239841|NCT00669851|coronary artery disease|coronary artery disease
5239842|NCT00669851|echocardiography|echocardiography
5239843|NCT00669851|cardiac imaging|cardiac imaging
5239844|NCT00669851|heart disease|heart disease
5239845|NCT00669851|ultrasound contrast agent|ultrasound contrast agent
5239846|NCT00669851|myocardial contrast enhancement|myocardial contrast enhancement
5239847|NCT00669851|myocardial perfusion|myocardial perfusion
5239848|NCT00669838|Anesthesia, Local|anesthesia, local
5239849|NCT00669838|Lidocaine|lidocaine
5239850|NCT00669838|Dental care|dental care
5239851|NCT00669838|Arrhythmias, Cardiac|arrhythmias, cardiac
5239852|NCT00669838|Anxiety|anxiety
5239853|NCT00669825|Celiac Disease|celiac disease
5239854|NCT00669812|small intestine lymphoma|small intestine lymphoma
5239855|NCT00669812|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
5239856|NCT00669812|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
5239857|NCT00669812|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
5239858|NCT00669812|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
5239859|NCT00669786|Ongoing Pregnancy Rate|ongoing pregnancy rate
5239860|NCT00669760|cystic fibrosis|cystic fibrosis
5239861|NCT00669760|Staphylococcus aureus|staphylococcus aureus
5239862|NCT00669760|persistent colonization-infection|persistent colonization-infection
5239863|NCT00669760|clinical status|clinical status
5239864|NCT00669760|lung function|lung function
5239865|NCT00669747|Ductal Carcinoma In Situ|ductal carcinoma in situ
5239866|NCT00669747|DCIS|dcis
5239867|NCT00669747|Breast Cancer|breast cancer
5239868|NCT00669747|Carboplatin|carboplatin
5239869|NCT00669747|Intraductal|intraductal
5239870|NCT00669721|osteoprotegerin|osteoprotegerin
5239871|NCT00669721|RANKL|rankl
5239872|NCT00669721|heparin|heparin
5239873|NCT00669721|hemodialysis|hemodialysis
5239874|NCT00669721|anticoagulation|anticoagulation
5239875|NCT00669721|vascular calcification|vascular calcification
5239876|NCT00669708|dry skin|dry skin
5239877|NCT00669708|cooling|cooling
5239878|NCT00669708|itch|itch
5239879|NCT00669695|statins|statins
5239880|NCT00669695|cardiovascular risk|cardiovascular risk
5239881|NCT00669695|Obstructive sleep apnea syndrome (OSAS) patients|obstructive sleep apnea syndrome (osas) patients
5239882|NCT00669643|Leprosy|leprosy
5239883|NCT00669643|Communicable Diseases|communicable diseases
5239884|NCT00669643|Skin Diseases|skin diseases
5239885|NCT00669643|Multidrug Therapy|multidrug therapy
5239886|NCT00669643|MDT|mdt
5239887|NCT00669643|Uniform Multidrug Therapy|uniform multidrug therapy
5239888|NCT00669643|U-MDT|u-mdt
5239889|NCT00669630|Community-based Participatory Research (CBPR)|community-based participatory research (cbpr)
5239890|NCT00669630|Vulnerable population|vulnerable population
5239891|NCT00669630|High-risk population|high-risk population
5239892|NCT00669630|African-Americans|african-americans
5239893|NCT00669630|Health Disparities|health disparities
5239894|NCT00669630|Clinical Trial|clinical trial
5239895|NCT00669617|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
5239896|NCT00669617|COPD|copd
5239897|NCT00669617|indacaterol|indacaterol
5239898|NCT00669617|adults|adults
5239899|NCT00669604|Mother to child transmission of HIV|mother to child transmission of hiv
5239900|NCT00669604|HIV infected children|hiv infected children
5239901|NCT00669591|breast cancer|breast cancer
5239902|NCT00669591|docetaxel chemotherapy|docetaxel chemotherapy
5239903|NCT00669591|bavituximab|bavituximab
5239904|NCT00669591|monoclonal antibody|monoclonal antibody
5239905|NCT00669578|secondary myelofibrosis|secondary myelofibrosis
5239906|NCT00669578|polycythemia vera|polycythemia vera
5239907|NCT00669578|essential thrombocythemia|essential thrombocythemia
5239908|NCT00669578|primary myelofibrosis|primary myelofibrosis
5239909|NCT00669565|Locally Advanced or Metastatic Breast Cancer|locally advanced or metastatic breast cancer
5239910|NCT00669539|Amblyopia associated with strabismus|amblyopia associated with strabismus
5239911|NCT00669539|Refractive error|refractive error
5239912|NCT00669526|anxiety|anxiety
5239913|NCT00669526|depression|depression
5239914|NCT00669526|Major Depressive Disorder|major depressive disorder
5239915|NCT00669526|child|child
5239916|NCT00669526|adolescent|adolescent
5239917|NCT00669526|CBT|cbt
5239918|NCT00669526|Cognitive-Behavioral Therapy|cognitive-behavioral therapy
5239919|NCT00669526|primary care|primary care
5239920|NCT00669513|partial sleep deprivation|partial sleep deprivation
5239921|NCT00669513|endothelial dysfunction|endothelial dysfunction
5239922|NCT00669513|sympathetic activity|sympathetic activity
5239923|NCT00669513|inflammation|inflammation
5239924|NCT00669500|dietary intake|dietary intake
5239925|NCT00669500|genetic predisposition|genetic predisposition
5239926|NCT00669500|body composition|body composition
5239927|NCT00669487|HIV/AIDS patients|hiv/aids patients
5239928|NCT00669461|Constipation|constipation
5239929|NCT00669461|Parkinson's Disease|parkinson's disease
5239930|NCT00669448|Multiple chemical sensitivities|multiple chemical sensitivities
5239931|NCT00669448|MCS|mcs
5239932|NCT00669448|Mindfulness-based cognitive therapy|mindfulness-based cognitive therapy
5239933|NCT00669448|MBCT|mbct
5239934|NCT00669448|Behavioural intervention|behavioural intervention
5239935|NCT00669448|Stress|stress
5239936|NCT00669448|Illness perceptions|illness perceptions
5239937|NCT00669448|Pilot trial|pilot trial
5239938|NCT00669435|Essential hypertension|essential hypertension
5239939|NCT00669435|Liver steatosis|liver steatosis
5239940|NCT00669422|Ovarian Cancer|ovarian cancer
5239941|NCT00669422|Fallopian Tube Cancer|fallopian tube cancer
5239942|NCT00669422|Peritoneal Cancer|peritoneal cancer
5239943|NCT00669422|Uterine Neoplasms|uterine neoplasms
5239944|NCT00669422|Vulvar Cancer|vulvar cancer
5239945|NCT00669422|Endometrial Cancer|endometrial cancer
5239946|NCT00669422|Cervical Cancer|cervical cancer
5239947|NCT00669422|Assay|assay
5239948|NCT00669422|Chemotherapy|chemotherapy
5239949|NCT00669422|Recurrent|recurrent
5239950|NCT00669422|Refractory|refractory
5239951|NCT00669422|Persistent|persistent
5239952|NCT00669422|Chemoresponse|chemoresponse
5239953|NCT00669422|Sensitivity|sensitivity
5239954|NCT00669422|Precision Therapeutics|precision therapeutics
5239955|NCT00669422|ChemoFx|chemofx
5239956|NCT00669409|monoclonal antibody|monoclonal antibody
5239957|NCT00669396|contraception|contraception
5239958|NCT00669396|emergency contraception|emergency contraception
5239959|NCT00669396|pregnancy prevention after unprotected intercourse|pregnancy prevention after unprotected intercourse
5239960|NCT00669383|premature delivery|premature delivery
5239961|NCT00669383|respiratory distress syndrome|respiratory distress syndrome
5239962|NCT00669370|advanced gastric cancer|advanced gastric cancer
5239963|NCT00669370|adenocarcinoma|adenocarcinoma
5239964|NCT00669357|End stage heart disease|end stage heart disease
5239965|NCT00669344|cognition|cognition
5239966|NCT00669344|stroke|stroke
5239967|NCT00669344|VCI|vci
5239968|NCT00669344|VCIND|vcind
5239969|NCT00669344|Cognitive Impairment, No Dementia|cognitive impairment, no dementia
5239970|NCT00669331|randomized clinical trial|randomized clinical trial
5239971|NCT00669331|mannitol|mannitol
5239972|NCT00669331|mucoactive|mucoactive
5239973|NCT00669318|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5239974|NCT00669318|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5239975|NCT00669318|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
5239976|NCT00669305|Genetics|genetics
5239977|NCT00669305|Blood cells|blood cells
5239978|NCT00669305|Vector-mediated gene transfer|vector-mediated gene transfer
5239979|NCT00669305|Bone marrow|bone marrow
5239981|NCT00669292|esophageal cancer|esophageal cancer
5239982|NCT00669292|peptide|peptide
5239983|NCT00669292|URLC10|urlc10
5239984|NCT00669292|TTK|ttk
5239985|NCT00669292|CpG7909|cpg7909
5239986|NCT00669214|Raptiva|raptiva
5239987|NCT00669214|Moderate plaque psoriasis|moderate plaque psoriasis
5239988|NCT00669214|Severe plaque psoriasis|severe plaque psoriasis
5239989|NCT00669214|Scalp|scalp
5239990|NCT00669201|cartilage|cartilage
5239991|NCT00669201|osteoarthritis|osteoarthritis
5239992|NCT00669201|T2 mapping|t2 mapping
5239993|NCT00669201|MRI|mri
5239994|NCT00669201|Wrist|wrist
5239995|NCT00669188|Patient Provider Interaction|patient provider interaction
5239996|NCT00669188|Physician Training|physician training
5239997|NCT00669188|Patient Provider Training|patient provider training
5239998|NCT00669175|Naloxone|naloxone
5239999|NCT00669175|Neonate|neonate
5240000|NCT00669175|Pain|pain
5240001|NCT00669149|ptca|ptca
5240002|NCT00669149|antiaggregant therapy|antiaggregant therapy
5240003|NCT00669149|anticoagulant therapy|anticoagulant therapy
5240004|NCT00669136|AFP + GM-CSF Plasmid Prime and AFP Adenoviral Vector Boost|afp + gm-csf plasmid prime and afp adenoviral vector boost
5240005|NCT00669136|AFP Immunization|afp immunization
5240006|NCT00669123|Chondroitin sulphate|chondroitin sulphate
5240007|NCT00669123|Knee osteoarthritis|knee osteoarthritis
5240008|NCT00669123|Psoriasis|psoriasis
5240009|NCT00669110|MDD|mdd
5240010|NCT00669110|Depression|depression
5240011|NCT00669110|Pediatrics|pediatrics
5240012|NCT00669110|Major Depressive Disorder|major depressive disorder
5240013|NCT00669097|ADME|adme
5240014|NCT00669097|TKI258|tki258
5240015|NCT00669097|RTKs inhibitor|rtks inhibitor
5240016|NCT00669097|PDGRF inhibitor|pdgrf inhibitor
5240017|NCT00669097|VEGFER inhibitor|vegfer inhibitor
5240018|NCT00669084|Innate Immunity|innate immunity
5240019|NCT00669084|Malaria|malaria
5240020|NCT00669084|Plasmodium|plasmodium
5240021|NCT00669084|Hemoglobinopathy|hemoglobinopathy
5240022|NCT00669084|G6PD Deficiency|g6pd deficiency
5240023|NCT00669058|hygiene|hygiene
5240024|NCT00669045|TNKase|tnkase
5240025|NCT00669045|AMI|ami
5240026|NCT00669006|neuropathic pain|neuropathic pain
5240027|NCT00669006|database|database
5240028|NCT00669006|prospective|prospective
5240029|NCT00669006|national|national
5240030|NCT00668980|Down syndrome|down syndrome
5240031|NCT00668980|symbolic representation|symbolic representation
5240032|NCT00668980|gestures|gestures
5240033|NCT00668980|expressive language development|expressive language development
5240034|NCT00668967|Cardiovascular Diseases|cardiovascular diseases
5240035|NCT00668967|Hypertension|hypertension
5240036|NCT00668954|Diabetes|diabetes
5240037|NCT00668954|Pomegranate|pomegranate
5240038|NCT00668954|Biomarkers|biomarkers
5240039|NCT00668954|Antioxidant|antioxidant
5240040|NCT00668941|Bone Density|bone density
5240041|NCT00668941|Bone Turnover|bone turnover
5240042|NCT00668941|Histomorphometry|histomorphometry
5240043|NCT00668902|CYP2C19|cyp2c19
5240044|NCT00668902|Pantoprazole|pantoprazole
5240045|NCT00668902|Genotype|genotype
5240046|NCT00668902|Pharmacokinetics|pharmacokinetics
5240047|NCT00668902|Metabolism|metabolism
5240048|NCT00668889|Hygiene|hygiene
5240049|NCT00668876|immunonutrition|immunonutrition
5240050|NCT00668876|pancreaticoduodenectomy|pancreaticoduodenectomy
5240051|NCT00668876|Th1|th1
5240052|NCT00668876|Th2|th2
5240053|NCT00668876|Th17|th17
5240054|NCT00668837|Paliperidone|paliperidone
5240055|NCT00668837|schizophrenia|schizophrenia
5240056|NCT00668824|Congenital Heart Disease (CHD)|congenital heart disease (chd)
5240057|NCT00668811|thyroid cancer|thyroid cancer
5240058|NCT00668811|metastatic thyroid cancer|metastatic thyroid cancer
5240059|NCT00668811|differentiated thyroid cancer|differentiated thyroid cancer
5240060|NCT00668811|papillary thyroid cancer|papillary thyroid cancer
5240061|NCT00668811|follicular thyroid cancer|follicular thyroid cancer
5240062|NCT00668811|Histologically confirmed|histologically confirmed
5240063|NCT00668811|metastatic stage 2,stage 3, or stage 4 differentiated thyroid cancer|metastatic stage 2,stage 3, or stage 4 differentiated thyroid cancer
5240064|NCT00668798|cytomegalovirus breast milk preterm infants transmission|cytomegalovirus breast milk preterm infants transmission
5240065|NCT00668798|transmission of CMV via thawed frozen breast milk|transmission of cmv via thawed frozen breast milk
5240066|NCT00668785|Ranibizumab|ranibizumab
5240067|NCT00668785|Proliferative Diabetic Retinopathy|proliferative diabetic retinopathy
5240068|NCT00668785|Macular Edema following Panretinal Photocoagulation|macular edema following panretinal photocoagulation
5240069|NCT00668785|Safety and Efficacy|safety and efficacy
5240070|NCT00668785|Intravitreal Injection|intravitreal injection
5240071|NCT00668759|atrial fibrillation|atrial fibrillation
5240072|NCT00668759|atrial fib|atrial fib
5240073|NCT00668759|AF|af
5240074|NCT00668746|chronic periodontitis, antibiotic resistance|chronic periodontitis, antibiotic resistance
5240075|NCT00668733|Actinic keratoses|actinic keratoses
5240076|NCT00668733|Dermatologic disease|dermatologic disease
5240077|NCT00668720|tinnitus|tinnitus
5240078|NCT00668720|transcranial magnetic stimulation|transcranial magnetic stimulation
5240079|NCT00668707|melatonin|melatonin
5240080|NCT00668707|natural health product (NHP)|natural health product (nhp)
5240081|NCT00668707|lung cancer|lung cancer
5240082|NCT00668707|complementary and alternative medicine (CAM)|complementary and alternative medicine (cam)
5240083|NCT00668707|randomized clinical trial|randomized clinical trial
5240084|NCT00668694|Psychosocial stimulation in addition to iron supplementation will improve mental and psychomotor development, language, behavior and growth of IDA infants.|psychosocial stimulation in addition to iron supplementation will improve mental and psychomotor development, language, behavior and growth of ida infants.
5240085|NCT00668694|With the addition of stimulation IDA infants will catch up to the non-anemic infants.|with the addition of stimulation ida infants will catch up to the non-anemic infants.
5240086|NCT00668681|Abdominal Aortic Aneurysm|abdominal aortic aneurysm
5240087|NCT00668655|Rosacea, metronidazole|rosacea, metronidazole
5240088|NCT00668629|Hygiene|hygiene
5240089|NCT00668616|breast cancer with 1-3 afflicted axillary lymph nodes|breast cancer with 1-3 afflicted axillary lymph nodes
5240090|NCT00668603|Postmenopausal vasomotor symptoms|postmenopausal vasomotor symptoms
5240091|NCT00668603|Hot flush|hot flush
5240092|NCT00668603|Vascular function|vascular function
5240093|NCT00668603|Cardiac function|cardiac function
5240094|NCT00668603|Cardiovascular risk factor|cardiovascular risk factor
5240095|NCT00668590|Diabetes|diabetes
5240096|NCT00668577|Hygiene|hygiene
5240097|NCT00668564|Inborn errors of metabolism|inborn errors of metabolism
5240098|NCT00668564|Sphingolipidoses|sphingolipidoses
5240099|NCT00668564|Recessive Leukodystrophies- GLD, Krabbe disease, MLD|recessive leukodystrophies- gld, krabbe disease, mld
5240100|NCT00668564|Peroxisomal Disorders|peroxisomal disorders
5240101|NCT00668564|Wolman syndrome|wolman syndrome
5240102|NCT00668564|Niemann-Pick B patients|niemann-pick b patients
5240103|NCT00668564|Niemann-Pick C subtype 2|niemann-pick c subtype 2
5240104|NCT00668551|Parkinson disease|parkinson disease
5240105|NCT00668551|Telemedicine|telemedicine
5240106|NCT00668538|Miconazole|miconazole
5240107|NCT00668538|CYP1A2|cyp1a2
5240108|NCT00668538|CYP3A4|cyp3a4
5240109|NCT00668538|Women|women
5240110|NCT00668538|Healthy Subjects|healthy subjects
5240111|NCT00668525|Depression|depression
5240112|NCT00668525|Major Depressive Disorder|major depressive disorder
5240113|NCT00668525|Escitalopram|escitalopram
5240114|NCT00668512|metastatic cutaneous melanoma|metastatic cutaneous melanoma
5240115|NCT00668512|alpha-gal glycolipids|alpha-gal glycolipids
5240116|NCT00668486|Hygiene|hygiene
5240117|NCT00668473|systemic sclerosis angiogenesis|systemic sclerosis angiogenesis
5240118|NCT00668460|hygiene|hygiene
5240119|NCT00668447|bone density|bone density
5240120|NCT00668447|bone loss|bone loss
5240121|NCT00668447|postmenopausal|postmenopausal
5240122|NCT00668434|Back Pain|back pain
5240123|NCT00668434|Leg Pain|leg pain
5240124|NCT00668421|Myelofibrosis|myelofibrosis
5240125|NCT00668421|Essential Thrombocythemia|essential thrombocythemia
5240126|NCT00668421|Polycythemia Vera|polycythemia vera
5240127|NCT00668421|JAK2 V617F Mutation|jak2 v617f mutation
5240128|NCT00668421|Lestaurtinib|lestaurtinib
5240129|NCT00668408|OTLT|otlt
5240130|NCT00668408|COPD|copd
5240131|NCT00668408|CHRONIC HYPOXEMIA|chronic hypoxemia
5240132|NCT00668408|CHF|chf
5240133|NCT00668395|CYP2B6|cyp2b6
5240134|NCT00668395|Efavirenz|efavirenz
5240135|NCT00668395|Pharmacokinetics|pharmacokinetics
5240136|NCT00668395|Pharmacogenetics|pharmacogenetics
5240137|NCT00668395|Drug-Interactions|drug-interactions
5240138|NCT00668382|Cancerous solid tumors|cancerous solid tumors
5240139|NCT00668382|Alpha-Gal Glycosphingolipids|alpha-gal glycosphingolipids
5240140|NCT00668369|Liver Transplantation|liver transplantation
5240141|NCT00668369|Tolerance|tolerance
5240142|NCT00668369|Hepatitis C virus infection|hepatitis c virus infection
5240143|NCT00668369|Immune responses|immune responses
5241222|NCT00664729|exercise|exercise
5240144|NCT00668369|Allograft tolerance|allograft tolerance
5240145|NCT00668369|Immunosuppression weaning|immunosuppression weaning
5240146|NCT00668369|Immunosuppression minimization|immunosuppression minimization
5240147|NCT00668356|HIV disease in children|hiv disease in children
5240148|NCT00668356|HIV|hiv
5240149|NCT00668356|children|children
5240150|NCT00668356|didanosine|didanosine
5240151|NCT00668356|bioequivalence|bioequivalence
5240152|NCT00668356|pharmacokinetics|pharmacokinetics
5240153|NCT00668356|treatment experienced|treatment experienced
5240154|NCT00668343|edss attack|edss attack
5240155|NCT00668330|Bone mineral density|bone mineral density
5240156|NCT00668330|ibandronate|ibandronate
5240157|NCT00668330|alfacalcidol|alfacalcidol
5240158|NCT00668317|Hyper-responsiveness, reflux cough|hyper-responsiveness, reflux cough
5240159|NCT00668304|Sinusitis|sinusitis
5240160|NCT00668291|Endocrinology, CARNEY Complex,|endocrinology, carney complex,
5240161|NCT00668291|primary pigmented nodular adrenocortical disease (PPNAD),|primary pigmented nodular adrenocortical disease (ppnad),
5240162|NCT00668291|PRKAR1A|prkar1a
5240163|NCT00668278|Supraglottic airway|supraglottic airway
5240164|NCT00668278|I-gel|i-gel
5240165|NCT00668278|Laryngeal mask|laryngeal mask
5240166|NCT00668278|Controlled ventilation|controlled ventilation
5240167|NCT00668278|Peak airway pressure|peak airway pressure
5240168|NCT00668278|Seal pressure|seal pressure
5240169|NCT00668278|Anaesthesia|anaesthesia
5240170|NCT00668278|Surgery|surgery
5240171|NCT00668265|Generalized Anxiety Disorder|generalized anxiety disorder
5240172|NCT00668265|Opiate Dependence|opiate dependence
5240173|NCT00668265|Methadone-Maintenance|methadone-maintenance
5240174|NCT00668265|Drug Addiction Treatment|drug addiction treatment
5240175|NCT00668252|endothelial progenitor cells|endothelial progenitor cells
5240176|NCT00668252|estrogen|estrogen
5240177|NCT00668252|menopause|menopause
5240178|NCT00668252|cardiovascular risk|cardiovascular risk
5240179|NCT00668239|diffuse macular oedema|diffuse macular oedema
5240180|NCT00668239|type 2 diabetes mellitus|type 2 diabetes mellitus
5240181|NCT00668239|laser therapy|laser therapy
5240182|NCT00668226|Hygiene|hygiene
5240183|NCT00668213|Macular Degeneration|macular degeneration
5240184|NCT00668200|Paget's|paget's
5240185|NCT00668200|hypocalcemia|hypocalcemia
5240186|NCT00668200|zoledronic acid|zoledronic acid
5240187|NCT00668200|serum calcium|serum calcium
5240188|NCT00668187|Tay-Sachs disease|tay-sachs disease
5240189|NCT00668187|Sandhoff disease|sandhoff disease
5240190|NCT00668187|Late Onset Tay-Sachs disease|late onset tay-sachs disease
5240191|NCT00668187|LOTS|lots
5240192|NCT00668187|hexosaminidase A deficiency|hexosaminidase a deficiency
5240193|NCT00668187|hexosaminidase A and B deficiency|hexosaminidase a and b deficiency
5240194|NCT00668187|infantile Tay-Sachs disease|infantile tay-sachs disease
5240195|NCT00668187|adult-onset Tay-Sachs disease|adult-onset tay-sachs disease
5240196|NCT00668187|prospective|prospective
5240197|NCT00668187|natural history|natural history
5240198|NCT00668187|GM1 gangliosidosis|gm1 gangliosidosis
5240199|NCT00668187|gangliosidoses|gangliosidoses
5240200|NCT00668187|β-galactosidase|β-galactosidase
5240201|NCT00668187|β-galactosidase deficiency|β-galactosidase deficiency
5240202|NCT00668187|hexosaminidase|hexosaminidase
5240203|NCT00668187|hexosaminidase deficiency|hexosaminidase deficiency
5240204|NCT00668187|Tay-Sachs|tay-sachs
5240205|NCT00668187|Sandhoff|sandhoff
5240206|NCT00668187|juvenile Tay-Sachs|juvenile tay-sachs
5240207|NCT00668187|juvenile Tay-Sachs disease|juvenile tay-sachs disease
5240208|NCT00668187|late onset Tay-Sachs|late onset tay-sachs
5240209|NCT00668187|juvenile Sandhoff|juvenile sandhoff
5240210|NCT00668187|juvenile Sandhoff disease|juvenile sandhoff disease
5240211|NCT00668187|GM2 gangliosidosis|gm2 gangliosidosis
5240212|NCT00668148|Sarcoma|sarcoma
5240213|NCT00668148|Ewing's sarcoma / peripheral neuroectodermal tumor (PNET);|ewing's sarcoma / peripheral neuroectodermal tumor (pnet);
5240214|NCT00668148|rhabdomyosarcoma;|rhabdomyosarcoma;
5240215|NCT00668148|leiomyosarcoma;|leiomyosarcoma;
5240216|NCT00668148|adipocytic sarcoma|adipocytic sarcoma
5240217|NCT00668148|synovial sarcoma|synovial sarcoma
5240218|NCT00668135|Erectile Dysfunction|erectile dysfunction
5240219|NCT00668135|Vardenafil|vardenafil
5240220|NCT00668109|Erectile Dysfunction|erectile dysfunction
5240221|NCT00668109|Diabetes mellitus|diabetes mellitus
5240222|NCT00668109|Hypertension|hypertension
5240223|NCT00668109|Hyperlipidemia|hyperlipidemia
5240224|NCT00668109|Vardenafil|vardenafil
5240225|NCT00668096|Erectile Dysfunction|erectile dysfunction
5240226|NCT00668096|PDE5 inhibitors|pde5 inhibitors
5240227|NCT00668083|second line|second line
5240228|NCT00668083|Prostate Cancer|prostate cancer
5240229|NCT00668083|bicalutamide|bicalutamide
5240230|NCT00668083|biochemical relapse/progression in patients with Prostate Cancer treated with bicalutamide 150mg|biochemical relapse/progression in patients with prostate cancer treated with bicalutamide 150mg
5240231|NCT00668070|NASH|nash
5240232|NCT00668070|Chronic liver disease|chronic liver disease
5240233|NCT00668057|Male Erectile Dysfunction|male erectile dysfunction
5240234|NCT00668044|Ciprofloxacin regimen in compromised patients|ciprofloxacin regimen in compromised patients
5240235|NCT00668044|Ciprofloxacin|ciprofloxacin
5240236|NCT00668044|Burned patients|burned patients
5240237|NCT00668031|Transfusion requirements|transfusion requirements
5240238|NCT00668031|Hip replacement surgery|hip replacement surgery
5240239|NCT00668031|Prevention of blood loss|prevention of blood loss
5240240|NCT00668031|Bloodloss|bloodloss
5240241|NCT00668018|Male Erectile Dysfunction|male erectile dysfunction
5240242|NCT00668018|Vardenafil|vardenafil
5240243|NCT00668005|Erectile Dysfunction|erectile dysfunction
5240244|NCT00668005|Arterial hypertension|arterial hypertension
5240245|NCT00668005|Vardenafil|vardenafil
5240246|NCT00667992|Asthma hyperreactivity|asthma hyperreactivity
5240247|NCT00667979|Erectile Dysfunction|erectile dysfunction
5240248|NCT00667979|Vardenafil|vardenafil
5240249|NCT00667966|Spinal cord injury|spinal cord injury
5240250|NCT00667966|Urodynamic|urodynamic
5240251|NCT00667966|Erectile dysfunction|erectile dysfunction
5240252|NCT00667966|Vardenafil|vardenafil
5240253|NCT00667953|Temzolomide|temzolomide
5240254|NCT00667953|Gleevec|gleevec
5240255|NCT00667953|Melanoma|melanoma
5240256|NCT00667953|Advanced melanoma|advanced melanoma
5240257|NCT00667953|Phase II|phase ii
5240258|NCT00667940|Medical education|medical education
5240259|NCT00667940|faculty development|faculty development
5240260|NCT00667940|rater training|rater training
5240261|NCT00667940|clinical competence|clinical competence
5240262|NCT00667940|assessment|assessment
5240263|NCT00667927|Autologous bone marrow transplant|autologous bone marrow transplant
5240264|NCT00667927|gene marking|gene marking
5240265|NCT00667914|Hip-unit|hip-unit
5240266|NCT00667914|Geriatric care|geriatric care
5240267|NCT00667914|Mobility|mobility
5240268|NCT00667914|Site of residence|site of residence
5240269|NCT00667901|stage III melanoma|stage iii melanoma
5240270|NCT00667901|stage IV melanoma|stage iv melanoma
5240271|NCT00667888|Prostate Cancer|prostate cancer
5240272|NCT00667888|Radiation|radiation
5240273|NCT00667888|Radiotherapy|radiotherapy
5240274|NCT00667888|Intensity Modulated Radiotherapy|intensity modulated radiotherapy
5240275|NCT00667888|IMRT|imrt
5240276|NCT00667888|Hypofractionated Intensity Modulated Radiotherapy|hypofractionated intensity modulated radiotherapy
5240277|NCT00667888|HIMRT|himrt
5240278|NCT00667875|Alcohol Dependence|alcohol dependence
5240279|NCT00667875|Alcoholism|alcoholism
5240280|NCT00667875|Naltrexone|naltrexone
5240281|NCT00667875|Aripiprazole|aripiprazole
5240282|NCT00667875|Substance Abuse|substance abuse
5240283|NCT00667862|Prostate|prostate
5240284|NCT00667862|Cancer|cancer
5240285|NCT00667862|Adenocarcinoma|adenocarcinoma
5240286|NCT00667862|Prostate-Specific Antigen|prostate-specific antigen
5240287|NCT00667862|metastatic|metastatic
5240288|NCT00667862|male|male
5240289|NCT00667862|HRPC|hrpc
5240290|NCT00667862|DACi|daci
5240291|NCT00667849|Tibia|tibia
5240292|NCT00667836|Neurofibromatosis Type 1|neurofibromatosis type 1
5240293|NCT00667836|NF1|nf1
5240294|NCT00667836|Spinal Anomalies|spinal anomalies
5240295|NCT00667823|SERAPHIN|seraphin
5240296|NCT00667823|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
5240297|NCT00667823|ACT-064992|act-064992
5240298|NCT00667810|antibody|antibody
5240299|NCT00667810|immunotherapy|immunotherapy
5240300|NCT00667797|Asthma|asthma
5240301|NCT00667797|COPD|copd
5240302|NCT00667797|chronic emphysema|chronic emphysema
5240303|NCT00667797|chronic bronchitis|chronic bronchitis
5240304|NCT00667784|pediatric stem cell donor|pediatric stem cell donor
5240305|NCT00667784|emotional sequelae|emotional sequelae
5240306|NCT00667784|physical sequelae|physical sequelae
5240307|NCT00667784|psychological consequences of minor donation|psychological consequences of minor donation
5240308|NCT00667784|Bone Marrow Transplantation|bone marrow transplantation
5240309|NCT00667784|Questionnaire|questionnaire
5240310|NCT00667784|Survey|survey
5240311|NCT00667784|Sibling Donor|sibling donor
5240312|NCT00667784|Stem Cell Transplant|stem cell transplant
5240313|NCT00667784|Well-Being|well-being
5240314|NCT00667771|Alcohol|alcohol
5240315|NCT00667771|Naltrexone|naltrexone
5240316|NCT00667771|fMRI|fmri
5240317|NCT00667771|Alcoholism|alcoholism
5240318|NCT00667771|Alcoholics|alcoholics
5240319|NCT00667771|Alcohol Dependence|alcohol dependence
5240320|NCT00667745|Lithium|lithium
5240321|NCT00667745|Symptoms|symptoms
5240322|NCT00667745|Medication Changes|medication changes
5240323|NCT00667732|diabetes|diabetes
5240324|NCT00667732|insulin|insulin
5240325|NCT00667732|byetta|byetta
5240326|NCT00667732|glucose|glucose
5240327|NCT00667732|blood sugar|blood sugar
5240328|NCT00667732|metformin|metformin
5240329|NCT00667732|A1c|a1c
5240330|NCT00667719|essential hypertension|essential hypertension
5240331|NCT00667719|high blood pressure|high blood pressure
5240332|NCT00667693|intubation|intubation
5240333|NCT00667693|obese|obese
5240334|NCT00667680|tDCS, major depression|tdcs, major depression
5240335|NCT00667667|whole body vibration|whole body vibration
5240336|NCT00667667|exercise|exercise
5240337|NCT00667667|postmenopausal|postmenopausal
5240338|NCT00667667|BMD|bmd
5240339|NCT00667667|bone|bone
5240340|NCT00667667|elderly females|elderly females
5240341|NCT00667667|Caucasian race|caucasian race
5240342|NCT00667654|Osteoarthritis, Knee|osteoarthritis, knee
5240438|NCT00667394|Chemotherapy|chemotherapy
5240343|NCT00667641|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5240344|NCT00667641|recurrent breast cancer|recurrent breast cancer
5240345|NCT00667641|stage IV breast cancer|stage iv breast cancer
5240346|NCT00667641|recurrent prostate cancer|recurrent prostate cancer
5240347|NCT00667641|stage IV prostate cancer|stage iv prostate cancer
5240348|NCT00667641|recurrent colon cancer|recurrent colon cancer
5240349|NCT00667641|stage IV colon cancer|stage iv colon cancer
5240350|NCT00667641|recurrent pancreatic cancer|recurrent pancreatic cancer
5240351|NCT00667641|stage IV pancreatic cancer|stage iv pancreatic cancer
5240352|NCT00667641|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5240353|NCT00667641|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5240354|NCT00667641|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
5240355|NCT00667641|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
5240356|NCT00667641|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5240357|NCT00667641|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5240358|NCT00667641|recurrent melanoma|recurrent melanoma
5240359|NCT00667641|stage IV melanoma|stage iv melanoma
5240360|NCT00667641|stage IV papillary thyroid cancer|stage iv papillary thyroid cancer
5240361|NCT00667641|recurrent thyroid cancer|recurrent thyroid cancer
5240362|NCT00667615|vorinostat|vorinostat
5240363|NCT00667615|rituximab|rituximab
5240364|NCT00667615|cyclophosphamide|cyclophosphamide
5240365|NCT00667615|etoposide|etoposide
5240366|NCT00667615|prednisone|prednisone
5240367|NCT00667615|Quality of life|quality of life
5240368|NCT00667615|08-045|08-045
5240369|NCT00667602|Meningococcal|meningococcal
5240370|NCT00667602|ACWY|acwy
5240371|NCT00667602|Conjugate Vaccine|conjugate vaccine
5240372|NCT00667602|Meningitis|meningitis
5240373|NCT00667602|Toddlers|toddlers
5240374|NCT00667602|Infants|infants
5240375|NCT00667602|Concomitant Vaccination|concomitant vaccination
5240376|NCT00667589|sorafenib|sorafenib
5240377|NCT00667589|rash|rash
5240378|NCT00667589|hand foot skin reaction|hand foot skin reaction
5240379|NCT00667576|chronic kidney disease|chronic kidney disease
5240380|NCT00667576|secondary hyperparathyroidism|secondary hyperparathyroidism
5240381|NCT00667576|hemodialysis|hemodialysis
5240382|NCT00667576|paricalcitol|paricalcitol
5240383|NCT00667576|maxacalcitol|maxacalcitol
5240384|NCT00667563|human papilloma virus infection|human papilloma virus infection
5240385|NCT00667563|cervical cancer|cervical cancer
5240386|NCT00667563|cervical intraepithelial neoplasia|cervical intraepithelial neoplasia
5240387|NCT00667563|HIV infection|hiv infection
5240388|NCT00667550|Lower urinary tract symptoms|lower urinary tract symptoms
5240389|NCT00667550|Colorectal disorders|colorectal disorders
5240390|NCT00667550|Urinary incontinence|urinary incontinence
5240391|NCT00667550|Fecal incontinence|fecal incontinence
5240392|NCT00667550|Voiding dysfunction|voiding dysfunction
5240393|NCT00667550|Urgency frequency|urgency frequency
5240394|NCT00667550|Sexual dysfunction|sexual dysfunction
5240395|NCT00667550|Colorectal malignancies|colorectal malignancies
5240396|NCT00667550|Inflammatory bowel disease|inflammatory bowel disease
5240397|NCT00667524|Eosinophilic Esophagitis|eosinophilic esophagitis
5240398|NCT00667524|Dysphagia|dysphagia
5240399|NCT00667524|Esophageal bougienage|esophageal bougienage
5240400|NCT00667524|Esophageal Dilation|esophageal dilation
5240401|NCT00667511|ESRD|esrd
5240402|NCT00667511|End Stage Renal Disease|end stage renal disease
5240403|NCT00667511|Daily Hemodialysis|daily hemodialysis
5240404|NCT00667511|Nocturnal Hemodialysis|nocturnal hemodialysis
5240405|NCT00667511|Hemodialysis|hemodialysis
5240406|NCT00667511|Kidney Failure|kidney failure
5240407|NCT00667511|Kidney Disease|kidney disease
5240408|NCT00667498|Pediatric Obesity|pediatric obesity
5240409|NCT00667498|Insulin Resistance|insulin resistance
5240410|NCT00667498|Hyperinsulinemia|hyperinsulinemia
5240411|NCT00667498|Metformin|metformin
5240412|NCT00667498|Glucose Tolerance|glucose tolerance
5240413|NCT00667498|Microalbuminuria|microalbuminuria
5240414|NCT00667498|Adolescents|adolescents
5240415|NCT00667498|Visceral Fat|visceral fat
5240416|NCT00667472|port wine stain birthmarks|port wine stain birthmarks
5240417|NCT00667459|Cervical Disc|cervical disc
5240418|NCT00667446|GnRH analog|gnrh analog
5240419|NCT00667446|Luteinizing hormone (LH)|luteinizing hormone (lh)
5240420|NCT00667446|Gonadotrophin-releasing hormone agonist(GnRHa)|gonadotrophin-releasing hormone agonist(gnrha)
5240421|NCT00667446|Suppression of LH|suppression of lh
5240422|NCT00667446|Gonadotrophin-releasing hormone (GnRH)|gonadotrophin-releasing hormone (gnrh)
5240423|NCT00667446|CPP|cpp
5240424|NCT00667446|Leuprolide acetate|leuprolide acetate
5240425|NCT00667446|Central Precocious Puberty|central precocious puberty
5240426|NCT00667446|Depot formulation|depot formulation
5240427|NCT00667446|Lupron|lupron
5240428|NCT00667446|Tanner staging|tanner staging
5240429|NCT00667446|Pediatrics|pediatrics
5240430|NCT00667433|HIV|hiv
5240431|NCT00667433|African American|african american
5240432|NCT00667433|treatment naïve|treatment naïve
5240433|NCT00667420|gastric|gastric
5240434|NCT00667420|esophageal|esophageal
5240435|NCT00667420|panitumumab|panitumumab
5240436|NCT00667407|Asthma|asthma
5240437|NCT00667394|Brain Tumor|brain tumor
5240440|NCT00667394|Anti-Angiogenesis|anti-angiogenesis
5240441|NCT00667394|Glioblastoma|glioblastoma
5240442|NCT00667394|Glioma|glioma
5240443|NCT00667381|Ultrasound guidance|ultrasound guidance
5240444|NCT00667381|Vascular access|vascular access
5240445|NCT00667381|Vascular complications|vascular complications
5240446|NCT00667368|bacterial vaginosis, women, chlamydia, gonorrhea, mentronidazole, vaginal, children|bacterial vaginosis, women, chlamydia, gonorrhea, mentronidazole, vaginal, children
5240447|NCT00667355|Ankylosing Spondylitis|ankylosing spondylitis
5240448|NCT00667329|Waldenstrom's Macroglobulinemia|waldenstrom's macroglobulinemia
5240449|NCT00667329|Lymphoma|lymphoma
5240450|NCT00667329|2CdA|2cda
5240451|NCT00667329|Cladribine|cladribine
5240452|NCT00667329|Leustatin|leustatin
5240453|NCT00667329|Cyclophosphamide|cyclophosphamide
5240454|NCT00667329|Cytoxan|cytoxan
5240455|NCT00667329|Neosar|neosar
5240456|NCT00667329|Rituxan|rituxan
5240457|NCT00667329|Rituximab|rituximab
5240458|NCT00667316|low back pain|low back pain
5240459|NCT00667316|workers|workers
5240460|NCT00667316|disability|disability
5240461|NCT00667316|sick leave|sick leave
5240462|NCT00667303|Hematopoietic stem cell transplant|hematopoietic stem cell transplant
5240463|NCT00667290|functional ability|functional ability
5240464|NCT00667290|gait|gait
5240465|NCT00667290|musculoskeletal disorder therapy|musculoskeletal disorder therapy
5240466|NCT00667290|peripheral blood vessel disorder|peripheral blood vessel disorder
5240467|NCT00667277|Myelofibrosis|myelofibrosis
5240468|NCT00667277|Idiopathic|idiopathic
5240469|NCT00667277|Bevacizumab|bevacizumab
5240470|NCT00667277|Avastin|avastin
5240471|NCT00667277|bone marrow fibrosis|bone marrow fibrosis
5240472|NCT00667277|bone marrow angiogenesis|bone marrow angiogenesis
5240473|NCT00667277|JAK2|jak2
5240474|NCT00667264|pain|pain
5240475|NCT00667264|phantom limb|phantom limb
5240476|NCT00667264|stump pain|stump pain
5240477|NCT00667264|catheter|catheter
5240478|NCT00667264|nerve block|nerve block
5240479|NCT00667264|peripheral nerve block|peripheral nerve block
5240480|NCT00667264|ucsd|ucsd
5240481|NCT00667264|Post-amputation phantom limb or stump pain|post-amputation phantom limb or stump pain
5240482|NCT00667251|recurrent breast cancer|recurrent breast cancer
5240483|NCT00667251|HER2-positive breast cancer|her2-positive breast cancer
5240484|NCT00667251|stage IV breast cancer|stage iv breast cancer
5240485|NCT00667212|anger|anger
5240486|NCT00667212|intermittent|intermittent
5240487|NCT00667212|explosive|explosive
5240488|NCT00667199|Hormone Refractory Prostate Cancer|hormone refractory prostate cancer
5240489|NCT00667199|Bone Metastases|bone metastases
5240490|NCT00667199|Radium-223|radium-223
5240491|NCT00667199|Palliation of bone pain|palliation of bone pain
5240492|NCT00667186|HIV|hiv
5240493|NCT00667186|Prevention|prevention
5240494|NCT00667186|Public Health|public health
5240495|NCT00667186|Screening|screening
5240496|NCT00667160|Mild Atopic Dermatitis|mild atopic dermatitis
5240497|NCT00667160|Protopic|protopic
5240498|NCT00667160|Pediatric|pediatric
5240499|NCT00667134|systemic sclerosis autoantibodies|systemic sclerosis autoantibodies
5240500|NCT00667121|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
5240501|NCT00667121|breast cancer|breast cancer
5240502|NCT00667121|hot flashes|hot flashes
5240503|NCT00667121|depression|depression
5240504|NCT00667095|OAB|oab
5240505|NCT00667095|Over Active Bladder|over active bladder
5240506|NCT00667095|overactive bladder|overactive bladder
5240507|NCT00667095|Urinary Urge Incontinence|urinary urge incontinence
5240508|NCT00667095|Urinary Incontinence|urinary incontinence
5240509|NCT00667095|Botox|botox
5240510|NCT00667095|DMSO|dmso
5240511|NCT00667095|bladder instillation|bladder instillation
5240512|NCT00667095|instillation|instillation
5240513|NCT00667095|detrusor hyperreflexia|detrusor hyperreflexia
5240514|NCT00667095|urge incontinence|urge incontinence
5240515|NCT00667082|Non small Cell Lung Cancer|non small cell lung cancer
5240516|NCT00667082|Pancreatic Cancer|pancreatic cancer
5240517|NCT00667082|Melanoma|melanoma
5240518|NCT00667082|Lymphoma|lymphoma
5240519|NCT00667082|Multiple Myeloma|multiple myeloma
5240520|NCT00667069|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5240521|NCT00667069|stage III prostate cancer|stage iii prostate cancer
5240522|NCT00667069|stage IV prostate cancer|stage iv prostate cancer
5240523|NCT00667056|Chronic Allergic Contact Dermatitis|chronic allergic contact dermatitis
5240524|NCT00667056|Protopic|protopic
5240525|NCT00667043|therapeutic hypothermia|therapeutic hypothermia
5240526|NCT00667043|cardiac arrest|cardiac arrest
5240527|NCT00667043|sedation|sedation
5240528|NCT00667043|remifentanil|remifentanil
5240529|NCT00667043|propofol|propofol
5240530|NCT00667043|fentanyl|fentanyl
5240531|NCT00667043|midazolam|midazolam
5240532|NCT00667030|Inflammation|inflammation
5240533|NCT00667030|Aging|aging
5240534|NCT00667030|Metabolism|metabolism
5240535|NCT00667030|Exercise|exercise
5240536|NCT00667017|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5240537|NCT00667017|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5240538|NCT00666991|ovarian cancer|ovarian cancer
5240539|NCT00666991|Mullerian tumors|mullerian tumors
5240540|NCT00666991|peritoneal cavity carcinoma|peritoneal cavity carcinoma
5240541|NCT00666991|gastrointestinal tract tumor|gastrointestinal tract tumor
5240542|NCT00666991|GI tract tumor|gi tract tumor
5240543|NCT00666991|pancreatic cancer|pancreatic cancer
5240544|NCT00666991|colon cancer|colon cancer
5240545|NCT00666978|bladder cancer|bladder cancer
5240546|NCT00666978|cervical cancer|cervical cancer
5240547|NCT00666978|esophageal cancer|esophageal cancer
5240548|NCT00666978|gastric cancer|gastric cancer
5240549|NCT00666978|renal cell carcinoma|renal cell carcinoma
5240550|NCT00666978|adult primary liver cancer|adult primary liver cancer
5240551|NCT00666978|non-small cell lung cancer|non-small cell lung cancer
5240552|NCT00666978|small cell lung cancer|small cell lung cancer
5240553|NCT00666978|pancreatic cancer|pancreatic cancer
5240554|NCT00666978|hypopharyngeal cancer|hypopharyngeal cancer
5240555|NCT00666978|laryngeal cancer|laryngeal cancer
5240556|NCT00666978|lip and oral cavity cancer|lip and oral cavity cancer
5240557|NCT00666978|nasopharyngeal cancer|nasopharyngeal cancer
5240558|NCT00666978|oropharyngeal cancer|oropharyngeal cancer
5240559|NCT00666978|paranasal sinus and nasal cavity cancer|paranasal sinus and nasal cavity cancer
5240560|NCT00666978|adult acute myeloid leukemia|adult acute myeloid leukemia
5240561|NCT00666978|tobacco use disorder|tobacco use disorder
5240562|NCT00666965|SPM 962|spm 962
5240563|NCT00666965|rotigotine|rotigotine
5240564|NCT00666965|Idiopathic Restless Legs Syndrome|idiopathic restless legs syndrome
5240565|NCT00666965|RLS|rls
5240566|NCT00666926|Pancreatic Neoplasm|pancreatic neoplasm
5240567|NCT00666926|Head and Neck neoplasm|head and neck neoplasm
5240568|NCT00666926|Prostatic neoplasms; Focal Adhesion Kinase|prostatic neoplasms; focal adhesion kinase
5240569|NCT00666926|Phase 1|phase 1
5240570|NCT00666926|Pharmacodynamics|pharmacodynamics
5240571|NCT00666926|FDG-PET|fdg-pet
5240572|NCT00666913|breast cancer in situ|breast cancer in situ
5240573|NCT00666913|stage I breast cancer|stage i breast cancer
5240574|NCT00666913|stage II breast cancer|stage ii breast cancer
5240575|NCT00666913|stage IIIA breast cancer|stage iiia breast cancer
5240576|NCT00666913|stage IIIB breast cancer|stage iiib breast cancer
5240577|NCT00666913|stage IIIC breast cancer|stage iiic breast cancer
5240578|NCT00666913|hot flashes|hot flashes
5240579|NCT00666887|Multiple Sclerosis|multiple sclerosis
5240580|NCT00666887|Clinically Isolated Syndrome|clinically isolated syndrome
5240581|NCT00666887|Minocycline|minocycline
5240582|NCT00666887|Placebo|placebo
5240583|NCT00666874|Obesity, lifestyle, vascular inflammation|obesity, lifestyle, vascular inflammation
5240584|NCT00666848|Metabolic syndrome|metabolic syndrome
5240585|NCT00666848|Hypertension|hypertension
5240586|NCT00666848|Sitagliptin|sitagliptin
5240587|NCT00666848|Enalapril|enalapril
5240588|NCT00666835|Treatment of anemia in hemodialysis patients|treatment of anemia in hemodialysis patients
5240589|NCT00666822|stage I breast cancer|stage i breast cancer
5240590|NCT00666822|stage II breast cancer|stage ii breast cancer
5240591|NCT00666822|stage IIIA breast cancer|stage iiia breast cancer
5240592|NCT00666809|Vardenafil,|vardenafil,
5240593|NCT00666809|Tinnitus|tinnitus
5240594|NCT00666757|Severe Depressive Episode|severe depressive episode
5240595|NCT00666744|exercise|exercise
5240596|NCT00666744|frequency|frequency
5240597|NCT00666744|duration|duration
5240598|NCT00666731|male breast cancer|male breast cancer
5240599|NCT00666731|breast cancer|breast cancer
5240600|NCT00666731|ductal breast carcinoma in situ|ductal breast carcinoma in situ
5240601|NCT00666731|lobular breast carcinoma in situ|lobular breast carcinoma in situ
5240602|NCT00666731|atypical ductal breast hyperplasia|atypical ductal breast hyperplasia
5240603|NCT00666705|maraviroc|maraviroc
5240604|NCT00666705|raltegravir|raltegravir
5240605|NCT00666705|drug interaction study|drug interaction study
5240606|NCT00666705|healthy volunteers|healthy volunteers
5240607|NCT00666692|cancer|cancer
5240608|NCT00666692|carcinoma|carcinoma
5240609|NCT00666692|monoclonal antibody therapy|monoclonal antibody therapy
5240610|NCT00666692|anti-angiogenesis|anti-angiogenesis
5240611|NCT00666666|prostate Cancer|prostate cancer
5240612|NCT00666666|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5240613|NCT00666666|stage IV prostate cancer|stage iv prostate cancer
5240614|NCT00666666|newly diagnosed stage IV prostate cancer|newly diagnosed stage iv prostate cancer
5240615|NCT00666653|Parkinson's disease|parkinson's disease
5240616|NCT00666653|Dopamine Agonist|dopamine agonist
5240617|NCT00666653|Levodopa|levodopa
5240618|NCT00666653|Pharmacokinetics|pharmacokinetics
5240619|NCT00666653|Dyskinesia|dyskinesia
5240620|NCT00666640|Osteoporosis|osteoporosis
5240621|NCT00666640|Fracture|fracture
5240622|NCT00666640|DXA|dxa
5240623|NCT00666640|Dual energy x-ray absorptiometry|dual energy x-ray absorptiometry
5240624|NCT00666640|Computed tomography|computed tomography
5240625|NCT00666640|3D DXA|3d dxa
5240626|NCT00666627|Osteoporosis|osteoporosis
5240627|NCT00666627|Post-menopausal osteoporosis|post-menopausal osteoporosis
5240628|NCT00666627|Bisphosphonates|bisphosphonates
5240629|NCT00666627|Alendronate|alendronate
5240630|NCT00666627|Ibandronate|ibandronate
5240631|NCT00666627|Risedronate|risedronate
5240632|NCT00666614|Sleep|sleep
5240633|NCT00666614|Fatigue|fatigue
5240634|NCT00666614|High Dose Chemotherapy|high dose chemotherapy
5240635|NCT00666601|Microdialysis|microdialysis
5240636|NCT00666601|Antibiotic|antibiotic
5240637|NCT00666601|Healthy subjects|healthy subjects
5240638|NCT00666549|Myeloproliferative Disease|myeloproliferative disease
5240639|NCT00666549|Myelofibrosis|myelofibrosis
5240640|NCT00666549|Idiopathic Myelofibrosis|idiopathic myelofibrosis
5240641|NCT00666549|Essential Thrombocythemia|essential thrombocythemia
5240642|NCT00666549|Polycythemia Vera|polycythemia vera
5240643|NCT00666536|Hypertension|hypertension
5240644|NCT00666536|adults|adults
5240645|NCT00666536|Valsartan + Amlodipine|valsartan + amlodipine
5240646|NCT00666536|Angiotensin Receptor Blockers|angiotensin receptor blockers
5240647|NCT00666523|osteoarthritis, knee or hip|osteoarthritis, knee or hip
5240648|NCT00666510|nitric oxide|nitric oxide
5240649|NCT00666510|bronchospasm|bronchospasm
5240650|NCT00666510|anesthesia|anesthesia
5240651|NCT00666510|induced sputum|induced sputum
5240652|NCT00666510|asthma|asthma
5240653|NCT00666497|Acute Myeloid Leukemia|acute myeloid leukemia
5240654|NCT00666497|Myelodysplastic Syndrome|myelodysplastic syndrome
5240655|NCT00666497|Azacitidine|azacitidine
5240656|NCT00666497|Vidaza|vidaza
5240657|NCT00666497|MGCD0103|mgcd0103
5240658|NCT00666497|Histone deacetylase inhibitor|histone deacetylase inhibitor
5240659|NCT00666497|DNA methyltransferase inhibitor|dna methyltransferase inhibitor
5240660|NCT00666497|Epigenetic Therapy|epigenetic therapy
5240661|NCT00666484|neurotoxicity|neurotoxicity
5240662|NCT00666484|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
5240663|NCT00666484|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
5240664|NCT00666484|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5240665|NCT00666484|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5240666|NCT00666484|adult lymphocyte depletion Hodgkin lymphoma|adult lymphocyte depletion hodgkin lymphoma
5240667|NCT00666484|adult lymphocyte predominant Hodgkin lymphoma|adult lymphocyte predominant hodgkin lymphoma
5240668|NCT00666484|adult mixed cellularity Hodgkin lymphoma|adult mixed cellularity hodgkin lymphoma
5240669|NCT00666484|adult nodular sclerosis Hodgkin lymphoma|adult nodular sclerosis hodgkin lymphoma
5240670|NCT00666471|epistaxis|epistaxis
5240671|NCT00666471|Epistaxis refractory to emergency physician treatment|epistaxis refractory to emergency physician treatment
5240672|NCT00666458|Type 2 diabetes|type 2 diabetes
5240673|NCT00666458|metformin|metformin
5240674|NCT00666445|Alzheimer's Disease|alzheimer's disease
5240675|NCT00666445|Diagnosis|diagnosis
5240676|NCT00666445|Neuronal function|neuronal function
5240677|NCT00666445|Cognitive Impairment|cognitive impairment
5240678|NCT00666445|Magnetoencephalography|magnetoencephalography
5240679|NCT00666432|schizophrenia|schizophrenia
5240680|NCT00666432|bipolar|bipolar
5240681|NCT00666432|eye movements|eye movements
5240682|NCT00666432|phenotype|phenotype
5240683|NCT00666432|biochemical|biochemical
5240684|NCT00666432|relatives|relatives
5240685|NCT00666419|nonspecific low back pain|nonspecific low back pain
5240686|NCT00666419|schoolchildren|schoolchildren
5240687|NCT00666419|prevalence|prevalence
5240688|NCT00666393|IONSYS™|ionsys™
5240689|NCT00666393|Pain, Postoperative|pain, postoperative
5240690|NCT00666393|Analgesia, Patient-Controlled|analgesia, patient-controlled
5240691|NCT00666393|Opioids|opioids
5240692|NCT00666393|Pediatrics|pediatrics
5240693|NCT00666380|Malaria|malaria
5240694|NCT00666380|Vaccine|vaccine
5240695|NCT00666380|MSP-1 (merozoite surface protein-1)|msp-1 (merozoite surface protein-1)
5240696|NCT00666380|Phase 1|phase 1
5240697|NCT00666367|COPD|copd
5240698|NCT00666354|Nail Psoriasis|nail psoriasis
5240699|NCT00666354|Psoriasis|psoriasis
5240700|NCT00666354|Fingernail Psoriasis|fingernail psoriasis
5240701|NCT00666354|Methotrexate|methotrexate
5240702|NCT00666328|Hypertension|hypertension
5240703|NCT00666328|Hemorrhage|hemorrhage
5240704|NCT00666328|Intracranial Pressure|intracranial pressure
5240705|NCT00666328|Antihypertensive Agent|antihypertensive agent
5240706|NCT00666328|Calcium Channel Blocker|calcium channel blocker
5240707|NCT00666315|Consecutive euthyroid patients with multinodular goiter for whom a total Thyroidectomy under general anesthesia is indicated|consecutive euthyroid patients with multinodular goiter for whom a total thyroidectomy under general anesthesia is indicated
5240708|NCT00666302|Atopic Dermatitis|atopic dermatitis
5240709|NCT00666302|Protopic|protopic
5240710|NCT00666302|Elidel|elidel
5240711|NCT00666289|polycythemia vera|polycythemia vera
5240712|NCT00666289|essential thrombocythemia|essential thrombocythemia
5240713|NCT00666289|idiopathic myelofibrosis|idiopathic myelofibrosis
5240714|NCT00666289|family clusters|family clusters
5240715|NCT00666250|blood pressure|blood pressure
5240716|NCT00666250|dyslipidemia|dyslipidemia
5240717|NCT00666250|hyperglycemia|hyperglycemia
5240718|NCT00666237|Glaucoma|glaucoma
5240719|NCT00666237|Tube shunt surgery|tube shunt surgery
5240720|NCT00666237|Trabeculectomy|trabeculectomy
5240721|NCT00666224|Clinically Definite Multiple Sclerosis|clinically definite multiple sclerosis
5240722|NCT00666224|Clinically Isolated Syndrome|clinically isolated syndrome
5240723|NCT00666224|Multiple Sclerosis|multiple sclerosis
5240724|NCT00666211|pain|pain
5240725|NCT00666211|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5241223|NCT00664729|intensity|intensity
5240726|NCT00666211|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5240727|NCT00666211|acute undifferentiated leukemia|acute undifferentiated leukemia
5240728|NCT00666211|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5240729|NCT00666211|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5240730|NCT00666211|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5240731|NCT00666211|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5240732|NCT00666211|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5240733|NCT00666211|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5240734|NCT00666211|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5240735|NCT00666211|atypical chronic myeloid leukemia, BCR-ABL negative|atypical chronic myeloid leukemia, bcr-abl negative
5240736|NCT00666211|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5240737|NCT00666211|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5240738|NCT00666211|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5240739|NCT00666211|mast cell leukemia|mast cell leukemia
5240740|NCT00666211|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
5240741|NCT00666211|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
5240742|NCT00666211|prolymphocytic leukemia|prolymphocytic leukemia
5240743|NCT00666211|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5240744|NCT00666211|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5240745|NCT00666211|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
5240746|NCT00666211|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5240747|NCT00666211|refractory hairy cell leukemia|refractory hairy cell leukemia
5240748|NCT00666211|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5240749|NCT00666211|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5240750|NCT00666211|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
5240751|NCT00666211|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
5240752|NCT00666211|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
5240753|NCT00666211|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
5240754|NCT00666211|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
5240755|NCT00666211|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5240756|NCT00666211|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
5240757|NCT00666211|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5240758|NCT00666211|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
5240759|NCT00666211|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
5240760|NCT00666211|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
5240761|NCT00666211|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5240762|NCT00666211|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5240763|NCT00666211|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5240764|NCT00666211|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
5240765|NCT00666211|cutaneous B-cell non-Hodgkin lymphoma|cutaneous b-cell non-hodgkin lymphoma
5240766|NCT00666211|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5240767|NCT00666211|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
5240768|NCT00666211|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
5240769|NCT00666211|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
5240770|NCT00666211|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
5240771|NCT00666211|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5240772|NCT00666211|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
5240773|NCT00666211|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
5240774|NCT00666211|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
5240775|NCT00666211|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
5240776|NCT00666211|adult grade III lymphomatoid granulomatosis|adult grade iii lymphomatoid granulomatosis
5240777|NCT00666211|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
5240778|NCT00666211|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
5240779|NCT00666211|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5240780|NCT00666211|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5240781|NCT00666211|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5240782|NCT00666211|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
5240783|NCT00666211|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
5240784|NCT00666211|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
5240785|NCT00666211|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
5240786|NCT00666211|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
5240787|NCT00666211|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
5240788|NCT00666211|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
5240789|NCT00666211|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
5240790|NCT00666211|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
5240791|NCT00666211|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
5240792|NCT00666211|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
5240793|NCT00666211|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
5240794|NCT00666211|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
5240795|NCT00666211|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
5240796|NCT00666211|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
5240797|NCT00666211|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
5240798|NCT00666211|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
5240799|NCT00666211|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
5240800|NCT00666211|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
5240801|NCT00666211|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
5240802|NCT00666211|stage I mantle cell lymphoma|stage i mantle cell lymphoma
5240803|NCT00666211|stage I marginal zone lymphoma|stage i marginal zone lymphoma
5240804|NCT00666211|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
5240805|NCT00666211|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
5240806|NCT00666211|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5240807|NCT00666211|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
5240808|NCT00666211|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
5240809|NCT00666211|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
5240810|NCT00666211|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
5240811|NCT00666211|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5240812|NCT00666211|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5240813|NCT00666211|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5240814|NCT00666211|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5240815|NCT00666211|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
5240816|NCT00666211|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
5240817|NCT00666211|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5240818|NCT00666211|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5240819|NCT00666211|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5240820|NCT00666211|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5240821|NCT00666211|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5240822|NCT00666211|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5240823|NCT00666211|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5240824|NCT00666211|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5240825|NCT00666211|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5240826|NCT00666211|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5240827|NCT00666211|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5240828|NCT00666211|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5240829|NCT00666211|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5240830|NCT00666211|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5240831|NCT00666211|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5240832|NCT00666211|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5240833|NCT00666211|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5240834|NCT00666211|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5240835|NCT00666211|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5240836|NCT00666211|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5240837|NCT00666211|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5240838|NCT00666211|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5240839|NCT00666211|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5240840|NCT00666211|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5240841|NCT00666211|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5240842|NCT00666211|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5240843|NCT00666211|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5240844|NCT00666211|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5240845|NCT00666211|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
5240846|NCT00666211|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5240847|NCT00666211|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5240848|NCT00666211|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5241224|NCT00664729|weight loss|weight loss
5240849|NCT00666211|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5240850|NCT00666211|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5240851|NCT00666211|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5240852|NCT00666211|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5240853|NCT00666211|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5240854|NCT00666211|intraocular lymphoma|intraocular lymphoma
5240855|NCT00666211|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
5240856|NCT00666211|primary central nervous system Hodgkin lymphoma|primary central nervous system hodgkin lymphoma
5240857|NCT00666211|post-transplant lymphoproliferative disorder|post-transplant lymphoproliferative disorder
5240858|NCT00666211|chronic eosinophilic leukemia|chronic eosinophilic leukemia
5240859|NCT00666211|chronic neutrophilic leukemia|chronic neutrophilic leukemia
5240860|NCT00666211|primary myelofibrosis|primary myelofibrosis
5240861|NCT00666211|essential thrombocythemia|essential thrombocythemia
5240862|NCT00666211|polycythemia vera|polycythemia vera
5240863|NCT00666211|extramedullary plasmacytoma|extramedullary plasmacytoma
5240864|NCT00666211|isolated plasmacytoma of bone|isolated plasmacytoma of bone
5240865|NCT00666211|monoclonal gammopathy of undetermined significance|monoclonal gammopathy of undetermined significance
5240866|NCT00666211|stage I multiple myeloma|stage i multiple myeloma
5240867|NCT00666211|stage II multiple myeloma|stage ii multiple myeloma
5240868|NCT00666211|stage III multiple myeloma|stage iii multiple myeloma
5240869|NCT00666211|primary systemic amyloidosis|primary systemic amyloidosis
5240870|NCT00666211|refractory multiple myeloma|refractory multiple myeloma
5240871|NCT00666211|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5240872|NCT00666211|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5240873|NCT00666211|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5240874|NCT00666211|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
5240875|NCT00666211|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5240876|NCT00666185|Micafungin|micafungin
5240877|NCT00666185|Esophageal Candidiasis|esophageal candidiasis
5240878|NCT00666185|Fluconazole|fluconazole
5240879|NCT00666172|Women's Health|women's health
5240880|NCT00666172|Obesity|obesity
5240881|NCT00666172|Metabolic Syndrome|metabolic syndrome
5240882|NCT00666172|Arterial Function|arterial function
5240883|NCT00666172|Lipoproteins|lipoproteins
5240884|NCT00666172|Overweight|overweight
5240885|NCT00666159|Atopic Dermatitis|atopic dermatitis
5240886|NCT00666159|Protopic|protopic
5240887|NCT00666159|Pediatric|pediatric
5240888|NCT00666146|Schizophrenia|schizophrenia
5240889|NCT00666146|Genetics|genetics
5240890|NCT00666146|Eyetracking|eyetracking
5240891|NCT00666133|Preeclampsia|preeclampsia
5240892|NCT00666133|Eclampsia|eclampsia
5240893|NCT00666133|Magnesium Sulfate|magnesium sulfate
5240894|NCT00666107|HPV|hpv
5240895|NCT00666107|HIV|hiv
5240896|NCT00666107|Gardasil|gardasil
5240897|NCT00666107|Vaccine|vaccine
5240898|NCT00666094|Type 2-diabetes|type 2-diabetes
5240899|NCT00666094|exercise therapy|exercise therapy
5240900|NCT00666094|RCT|rct
5240901|NCT00666094|Norway|norway
5240902|NCT00666081|Pazopanib, paclitaxel, carboplatin|pazopanib, paclitaxel, carboplatin
5240903|NCT00666068|Patients with hypopituitarism|patients with hypopituitarism
5240904|NCT00666055|Sex|sex
5240905|NCT00666055|Aging|aging
5240906|NCT00666055|Antiretroviral|antiretroviral
5240907|NCT00666055|Pharmacokinetics|pharmacokinetics
5240908|NCT00666055|post-menopausal women with HIV infection|post-menopausal women with hiv infection
5240909|NCT00666055|pre-menopausal women with HIV infection|pre-menopausal women with hiv infection
5240910|NCT00666029|metabolic syndrome|metabolic syndrome
5240911|NCT00666029|Volunteers recruited from the community|volunteers recruited from the community
5240912|NCT00666016|non alcoholic steatohepatitis nash hepatoprotective hepatoprotection ALT AST new drug candidate interventional study TRO19622 Trophos cholest-4-en-3-one oxime|non alcoholic steatohepatitis nash hepatoprotective hepatoprotection alt ast new drug candidate interventional study tro19622 trophos cholest-4-en-3-one oxime
5240913|NCT00666003|Hemodynamics|hemodynamics
5240914|NCT00665977|Obstructive Sleep Apnea|obstructive sleep apnea
5240915|NCT00665977|Nasal Congestion|nasal congestion
5240916|NCT00665977|Sinus congestion|sinus congestion
5240917|NCT00665964|osteoarthritis|osteoarthritis
5240918|NCT00665964|knee|knee
5240919|NCT00665964|total knee arthroplasty|total knee arthroplasty
5240920|NCT00665964|gonarthrrsis|gonarthrrsis
5240921|NCT00665964|polyethylene|polyethylene
5240922|NCT00665964|posterior stabilized|posterior stabilized
5240923|NCT00665951|pediatric|pediatric
5240924|NCT00665951|pharmacokinetics|pharmacokinetics
5240925|NCT00665951|HIV infection|hiv infection
5240926|NCT00665938|Physical development|physical development
5240927|NCT00665899|breast cancer|breast cancer
5240928|NCT00665899|couples|couples
5240929|NCT00665899|cognitive behavioral therapy|cognitive behavioral therapy
5240930|NCT00665899|Women with early stage breast cancer and their partners.|women with early stage breast cancer and their partners.
5240931|NCT00665886|Peripheral venous catheter|peripheral venous catheter
5240932|NCT00665886|Catheter-related complication|catheter-related complication
5240933|NCT00665886|Bacterial Colonization|bacterial colonization
5240935|NCT00665886|Closed system|closed system
5240936|NCT00665886|Costs|costs
5240937|NCT00665886|Polyurethane|polyurethane
5240938|NCT00665886|Teflon|teflon
5240939|NCT00665873|Totally Implantable Venous Access Devices|totally implantable venous access devices
5240940|NCT00665873|Infections|infections
5240941|NCT00665873|Chemotherapy|chemotherapy
5240942|NCT00665873|Valuated infections TIVAD|valuated infections tivad
5240943|NCT00665860|Osteoporosis|osteoporosis
5240944|NCT00665860|Soy isoflavones|soy isoflavones
5240945|NCT00665860|Postmenopausal women|postmenopausal women
5240946|NCT00665860|Safety|safety
5240947|NCT00665860|Efficacy|efficacy
5240948|NCT00665860|Effective dosage|effective dosage
5240949|NCT00665847|HIV-1|hiv-1
5240950|NCT00665847|TMC125-TiDP35-C213|tmc125-tidp35-c213
5240951|NCT00665847|TMC125-C213|tmc125-c213
5240952|NCT00665821|nonspecific low back pain|nonspecific low back pain
5240953|NCT00665821|disability|disability
5240954|NCT00665821|sick leave|sick leave
5240955|NCT00665821|catastrophizing|catastrophizing
5240956|NCT00665821|workers|workers
5240957|NCT00665795|Dysthyroid Optic Neuropathy|dysthyroid optic neuropathy
5240958|NCT00665795|multidetector computed tomography|multidetector computed tomography
5240959|NCT00665795|color doppler|color doppler
5240960|NCT00665795|Grave´s Orbitopathy|grave´s orbitopathy
5240961|NCT00665795|Grave´s Disease|grave´s disease
5240962|NCT00665795|morphometric analysis|morphometric analysis
5240963|NCT00665782|anxiety disorder|anxiety disorder
5240964|NCT00665782|depression|depression
5240965|NCT00665782|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
5240966|NCT00665782|ductal breast carcinoma in situ|ductal breast carcinoma in situ
5240967|NCT00665782|breast cancer in situ|breast cancer in situ
5240968|NCT00665782|stage I breast cancer|stage i breast cancer
5240969|NCT00665782|stage II breast cancer|stage ii breast cancer
5240970|NCT00665782|stage IIIA breast cancer|stage iiia breast cancer
5240971|NCT00665782|stage IIIB breast cancer|stage iiib breast cancer
5240972|NCT00665782|stage IIIC breast cancer|stage iiic breast cancer
5240973|NCT00665769|hypercapnia|hypercapnia
5240974|NCT00665769|normocapnia|normocapnia
5240975|NCT00665769|chronic lung disease|chronic lung disease
5240976|NCT00665769|periventricular leukomalacia|periventricular leukomalacia
5240977|NCT00665769|intraventricular hemorrhage|intraventricular hemorrhage
5240978|NCT00665769|hypotension|hypotension
5240979|NCT00665769|cerebral autoregulation|cerebral autoregulation
5240980|NCT00665769|heart rate variability|heart rate variability
5240981|NCT00665769|autonomic nervous system|autonomic nervous system
5240982|NCT00665769|detrended fluctuation analysis|detrended fluctuation analysis
5240983|NCT00665756|Glaucoma|glaucoma
5240984|NCT00665756|Drainage implant|drainage implant
5240985|NCT00665756|Ahmed valve|ahmed valve
5240986|NCT00665756|Second trabeculectomy|second trabeculectomy
5240987|NCT00665717|interaction|interaction
5240988|NCT00665717|statins|statins
5240989|NCT00665717|pharmacokinetics|pharmacokinetics
5240990|NCT00665704|Smoking Cessation|smoking cessation
5240991|NCT00665704|Internet|internet
5240992|NCT00665704|Intervention Studies|intervention studies
5240993|NCT00665704|Health Services Accessibility|health services accessibility
5240994|NCT00665691|All Malignancies|all malignancies
5240995|NCT00665652|Neuropathy|neuropathy
5240996|NCT00665652|Nonmalignant Monoclonal Gammopathy of Undetermined Significance (MGUS)|nonmalignant monoclonal gammopathy of undetermined significance (mgus)
5240997|NCT00665652|MGUS|mgus
5240998|NCT00665639|Micafungin|micafungin
5240999|NCT00665639|Esophageal Candidiasis|esophageal candidiasis
5241000|NCT00665639|caspofungin|caspofungin
5241001|NCT00665613|warfarin use|warfarin use
5241002|NCT00665600|COPD|copd
5241003|NCT00665600|Chronic Bronchitis|chronic bronchitis
5241004|NCT00665600|Chronic Emphysema|chronic emphysema
5241005|NCT00665587|Atrial fibrillation|atrial fibrillation
5241006|NCT00665587|Maze procedure|maze procedure
5241007|NCT00665587|Mid-term results|mid-term results
5241008|NCT00665587|Long-term results|long-term results
5241009|NCT00665587|Surgical ablation|surgical ablation
5241010|NCT00665561|Maraviroc|maraviroc
5241011|NCT00665561|HIV-1|hiv-1
5241012|NCT00665561|Safety|safety
5241013|NCT00665561|Non-interventional|non-interventional
5241014|NCT00665548|Knee Osteoarthritis|knee osteoarthritis
5241015|NCT00665548|magnetic resonance imaging|magnetic resonance imaging
5241016|NCT00665548|x rays|x rays
5241017|NCT00665535|Pressure ulcers|pressure ulcers
5241018|NCT00665535|Nursing facilities|nursing facilities
5241019|NCT00665535|Elderly|elderly
5241020|NCT00665535|At risk for pressure ulcers|at risk for pressure ulcers
5241021|NCT00665522|Pain|pain
5241022|NCT00665522|Postoperative Analgesia|postoperative analgesia
5241023|NCT00665522|Patient-Controlled Opioids|patient-controlled opioids
5241024|NCT00665509|Influenza|influenza
5241025|NCT00665509|Vaccine|vaccine
5241026|NCT00665509|CHMP criteria|chmp criteria
5241027|NCT00665496|Erectile Dysfunction|erectile dysfunction
5241028|NCT00665496|Vardenafil|vardenafil
5241029|NCT00665496|Onset of action|onset of action
5241030|NCT00665470|Malignant Melanoma|malignant melanoma
5241031|NCT00665470|HLA-A2|hla-a2
5241032|NCT00665470|Immunotherapy|immunotherapy
5241225|NCT00664729|women|women
5241033|NCT00665470|Clinical Response|clinical response
5241034|NCT00665470|Skin Cancer|skin cancer
5241035|NCT00665457|stage II breast cancer|stage ii breast cancer
5241036|NCT00665457|stage IIIA breast cancer|stage iiia breast cancer
5241037|NCT00665457|stage IIIB breast cancer|stage iiib breast cancer
5241038|NCT00665457|stage IIIC breast cancer|stage iiic breast cancer
5241039|NCT00665444|bipolar disorder|bipolar disorder
5241040|NCT00665444|sedation|sedation
5241041|NCT00665444|overweight|overweight
5241042|NCT00665444|Abilify|abilify
5241043|NCT00665444|medication|medication
5241044|NCT00665418|Anesthesia|anesthesia
5241045|NCT00665418|children|children
5241046|NCT00665418|Larynx|larynx
5241047|NCT00665405|Delivery, obstetric|delivery, obstetric
5241048|NCT00665405|Atelectasis|atelectasis
5241049|NCT00665392|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
5241050|NCT00665392|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5241051|NCT00665392|tongue cancer|tongue cancer
5241052|NCT00665379|leg lymphedema|leg lymphedema
5241053|NCT00665379|volume measurement|volume measurement
5241054|NCT00665379|compression therapy|compression therapy
5241055|NCT00665379|interface pressure|interface pressure
5241056|NCT00665379|static stiffness index (SSI)|static stiffness index (ssi)
5241057|NCT00665379|volume change|volume change
5241058|NCT00665353|HIV|hiv
5241059|NCT00665353|HCV|hcv
5241060|NCT00665340|Erectile Dysfunction|erectile dysfunction
5241061|NCT00665340|Vardenafil|vardenafil
5241062|NCT00665327|Community Acquired Pneumonia|community acquired pneumonia
5241063|NCT00665327|Pneumonia,|pneumonia,
5241064|NCT00665327|CAP|cap
5241065|NCT00665314|Mobilisation stem cells|mobilisation stem cells
5241066|NCT00665314|G-CSF Mobilisation Regimen|g-csf mobilisation regimen
5241067|NCT00665314|Lymphoma|lymphoma
5241068|NCT00665314|Multiple Myeloma|multiple myeloma
5241069|NCT00665314|Adult patients with lymphoma (Non Hodgkin's Lymphoma, Hodgkin's Disease) or Multiple Myeloma who previously failed Stem Cell Collections or Collection attempts.|adult patients with lymphoma (non hodgkin's lymphoma, hodgkin's disease) or multiple myeloma who previously failed stem cell collections or collection attempts.
5241070|NCT00665301|Non-invasive Cardiac Output|non-invasive cardiac output
5241071|NCT00665288|cardiac arrest|cardiac arrest
5241072|NCT00665288|heart arrest|heart arrest
5241073|NCT00665288|CPR|cpr
5241074|NCT00665288|resuscitation|resuscitation
5241075|NCT00665288|bystander CPR|bystander cpr
5241076|NCT00665275|complementary|complementary
5241077|NCT00665275|alternative|alternative
5241078|NCT00665275|medicine|medicine
5241079|NCT00665262|analgesia|analgesia
5241080|NCT00665262|hip arthroplasty|hip arthroplasty
5241081|NCT00665262|knee arthroplasty|knee arthroplasty
5241082|NCT00665249|problem drinking|problem drinking
5241083|NCT00665249|heavy drinking|heavy drinking
5241084|NCT00665249|Alcohol|alcohol
5241085|NCT00665249|moderation|moderation
5241086|NCT00665249|motivational interviewing|motivational interviewing
5241087|NCT00665236|Migraine|migraine
5241088|NCT00665223|Huntington's Disease|huntington's disease
5241089|NCT00665210|hip arthritis|hip arthritis
5241090|NCT00665210|implant sizing|implant sizing
5241091|NCT00665197|Esophageal cancer|esophageal cancer
5241092|NCT00665197|Brachytherapy|brachytherapy
5241093|NCT00665197|Radiotherapy|radiotherapy
5241094|NCT00665197|Palliation|palliation
5241095|NCT00665197|Dysphagia|dysphagia
5241096|NCT00665184|Hypokinesia|hypokinesia
5241097|NCT00665184|Gait|gait
5241098|NCT00665184|Quality of life|quality of life
5241099|NCT00665184|Dopamine replacement|dopamine replacement
5241100|NCT00665184|Resistance training|resistance training
5241101|NCT00665171|Polycystic ovary syndrome|polycystic ovary syndrome
5241102|NCT00665171|Single nucleotide polymorphism|single nucleotide polymorphism
5241103|NCT00665171|Whole genome analysis|whole genome analysis
5241104|NCT00665171|Multigenerational family study|multigenerational family study
5241105|NCT00665158|Abdominal obesity, exercise, behaviour modification|abdominal obesity, exercise, behaviour modification
5241106|NCT00665145|Diabetes Mellitus, Type 1|diabetes mellitus, type 1
5241107|NCT00665145|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
5241108|NCT00665145|Diabetic Polyneuropathy|diabetic polyneuropathy
5241109|NCT00665145|Stem Cells|stem cells
5241110|NCT00665132|wrist|wrist
5241111|NCT00665132|hand|hand
5241112|NCT00665132|pain|pain
5241113|NCT00665132|failed CTR|failed ctr
5241114|NCT00665132|carpal tunnel syndrome|carpal tunnel syndrome
5241115|NCT00665132|CTS|cts
5241116|NCT00665132|CTR|ctr
5241117|NCT00665132|carpel tunnel release|carpel tunnel release
5241118|NCT00665132|Peripheral nerve|peripheral nerve
5241119|NCT00665132|Median nerve|median nerve
5241120|NCT00665119|Respiratory Insufficiency|respiratory insufficiency
5241121|NCT00665119|Respiration, Artificial|respiration, artificial
5241122|NCT00665119|Remifentanil|remifentanil
5241123|NCT00665119|Respiratory Mechanics|respiratory mechanics
5241124|NCT00665119|Work of Breathing|work of breathing
5241125|NCT00665106|Diabetic macular edema|diabetic macular edema
5241126|NCT00665106|Diabetes|diabetes
5241127|NCT00665106|Diabetic retinopathy|diabetic retinopathy
5241128|NCT00665067|Myeloproliferative Disease|myeloproliferative disease
5241523|NCT00663338|Stroke|stroke
5241129|NCT00665067|Myelofibrosis|myelofibrosis
5241130|NCT00665067|Idiopathic Myelofibrosis|idiopathic myelofibrosis
5241131|NCT00665067|Essential Thrombocythemia|essential thrombocythemia
5241132|NCT00665067|Polycythemia Vera|polycythemia vera
5241133|NCT00665067|Biomarkers|biomarkers
5241134|NCT00665067|Philadelphia Chromosome Negative|philadelphia chromosome negative
5241135|NCT00665067|Clonal Hematopoietic malignancies|clonal hematopoietic malignancies
5241136|NCT00665054|Vardenafil|vardenafil
5241137|NCT00665054|Erectile dysfunction|erectile dysfunction
5241138|NCT00665054|SSES-E (sexual self-efficacy scale - erectile function)|sses-e (sexual self-efficacy scale - erectile function)
5241139|NCT00665028|Anesthesia|anesthesia
5241140|NCT00665028|Postoperative myocardial ischemia|postoperative myocardial ischemia
5241141|NCT00665028|ST monitoring|st monitoring
5241142|NCT00665015|pleural effusion|pleural effusion
5241143|NCT00665015|coronary artery bypass|coronary artery bypass
5241144|NCT00665015|heart valve replacement|heart valve replacement
5241145|NCT00665002|Myeloid|myeloid
5241146|NCT00665002|Monocytic|monocytic
5241147|NCT00665002|Hematopoietic|hematopoietic
5241148|NCT00665002|Neoplasms|neoplasms
5241149|NCT00665002|Acute Myelogenous Leukemia|acute myelogenous leukemia
5241150|NCT00665002|AML|aml
5241151|NCT00665002|Myelodysplastic Syndrome|myelodysplastic syndrome
5241152|NCT00665002|MDS|mds
5241153|NCT00664989|Hemiarthroplasty Stemmed Resurfacing Conventional Shoulder|hemiarthroplasty stemmed resurfacing conventional shoulder
5241154|NCT00664976|bipolar depression|bipolar depression
5241155|NCT00664976|Electroconvulsive therapy|electroconvulsive therapy
5241156|NCT00664963|Arterial Occlusive Diseases|arterial occlusive diseases
5241157|NCT00664963|Peripheral Vascular Diseases|peripheral vascular diseases
5241158|NCT00664963|Drug eluting stent|drug eluting stent
5241159|NCT00664963|Restenosis|restenosis
5241160|NCT00664963|Below the knee|below the knee
5241161|NCT00664963|Intervention|intervention
5241162|NCT00664950|intertrochanteric hip fracture fixation|intertrochanteric hip fracture fixation
5241163|NCT00664950|interTAN IM Nail|intertan im nail
5241164|NCT00664950|sliding hip screw|sliding hip screw
5241165|NCT00664924|ICU|icu
5241166|NCT00664898|anti-CD40|anti-cd40
5241167|NCT00664898|Myeloma|myeloma
5241168|NCT00664885|non-psychiatric|non-psychiatric
5241169|NCT00664885|clinics|clinics
5241170|NCT00664872|case manager|case manager
5241171|NCT00664872|suicide|suicide
5241172|NCT00664872|attempt|attempt
5241173|NCT00664872|effectiveness|effectiveness
5241174|NCT00664859|LCP-AtorFen|lcp-atorfen
5241175|NCT00664859|Non-HDL cholesterol|non-hdl cholesterol
5241176|NCT00664859|Triglycerides|triglycerides
5241177|NCT00664859|HDL cholesterol|hdl cholesterol
5241178|NCT00664859|LDL cholesterol|ldl cholesterol
5241179|NCT00664859|Atorvastatin|atorvastatin
5241180|NCT00664859|Fenofibrate|fenofibrate
5241181|NCT00664846|Stroke|stroke
5241182|NCT00664846|Prevention Therapy|prevention therapy
5241183|NCT00664833|Erectile dysfunction|erectile dysfunction
5241184|NCT00664833|Phosphodiesterase Type 5 Inhibitors|phosphodiesterase type 5 inhibitors
5241185|NCT00664833|Patient education|patient education
5241186|NCT00664833|Impotence|impotence
5241187|NCT00664833|Vardenafil|vardenafil
5241188|NCT00664820|Rheumatoid Arthritics|rheumatoid arthritics
5241189|NCT00664820|probiotics|probiotics
5241190|NCT00664820|Lactobacillus|lactobacillus
5241191|NCT00664781|stage IIIA breast cancer|stage iiia breast cancer
5241192|NCT00664781|stage IIIB breast cancer|stage iiib breast cancer
5241193|NCT00664781|stage IIIC breast cancer|stage iiic breast cancer
5241194|NCT00664781|stage IV breast cancer|stage iv breast cancer
5241195|NCT00664781|recurrent breast cancer|recurrent breast cancer
5241196|NCT00664781|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5241197|NCT00664781|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
5241198|NCT00664781|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
5241199|NCT00664781|ovarian stromal cancer|ovarian stromal cancer
5241200|NCT00664781|ovarian sarcoma|ovarian sarcoma
5241201|NCT00664781|BRCA1 mutation carrier|brca1 mutation carrier
5241202|NCT00664781|BRCA2 mutation carrier|brca2 mutation carrier
5241203|NCT00664781|stage IIIA ovarian epithelial cancer|stage iiia ovarian epithelial cancer
5241204|NCT00664781|stage IIIA ovarian germ cell tumor|stage iiia ovarian germ cell tumor
5241205|NCT00664781|stage IIIB ovarian epithelial cancer|stage iiib ovarian epithelial cancer
5241206|NCT00664781|stage IIIB ovarian germ cell tumor|stage iiib ovarian germ cell tumor
5241207|NCT00664781|stage IIIC ovarian epithelial cancer|stage iiic ovarian epithelial cancer
5241208|NCT00664781|stage IIIC ovarian germ cell tumor|stage iiic ovarian germ cell tumor
5241209|NCT00664781|ovarian papillary serous carcinoma|ovarian papillary serous carcinoma
5241210|NCT00664768|hypoallergenicity|hypoallergenicity
5241211|NCT00664768|Cow Milk Allergy|cow milk allergy
5241212|NCT00664768|DBPCFC|dbpcfc
5241213|NCT00664768|Stool microflora|stool microflora
5241214|NCT00664768|Stool characteristics|stool characteristics
5241215|NCT00664755|Menstrual Cycle effects|menstrual cycle effects
5241216|NCT00664755|Cue Reactivity|cue reactivity
5241217|NCT00664755|Smoking Cessation|smoking cessation
5241218|NCT00664755|Impulsivity|impulsivity
5241219|NCT00664742|Metabolic syndrome,dyslipidemia,fluvastatin extended release|metabolic syndrome,dyslipidemia,fluvastatin extended release
5241220|NCT00664729|Abdominal|abdominal
5241226|NCT00664716|Rheumatoid Arthritis|rheumatoid arthritis
5241227|NCT00664716|RA|ra
5241228|NCT00664716|DMARD inadequate response|dmard inadequate response
5241229|NCT00664716|Methotrexate|methotrexate
5241230|NCT00664703|Dopamine Uptake Inhibitors|dopamine uptake inhibitors
5241231|NCT00664703|Dopamine|dopamine
5241232|NCT00664703|Methylphenidate|methylphenidate
5241233|NCT00664703|Mental Disorders Diagnosed in Childhood|mental disorders diagnosed in childhood
5241234|NCT00664703|Neurologic Manifestations|neurologic manifestations
5241235|NCT00664703|Attention Deficit and Disruptive Behavior Disorders|attention deficit and disruptive behavior disorders
5241236|NCT00664703|Hyperkinesis|hyperkinesis
5241237|NCT00664703|Dyskinesias|dyskinesias
5241238|NCT00664690|shoulder surgery|shoulder surgery
5241239|NCT00664690|analgesia|analgesia
5241240|NCT00664677|Adult|adult
5241241|NCT00664677|Leukemia|leukemia
5241242|NCT00664677|Terameprocol|terameprocol
5241243|NCT00664677|Survivin|survivin
5241244|NCT00664677|AML|aml
5241245|NCT00664677|ALL|all
5241246|NCT00664677|ATL|atl
5241247|NCT00664677|CML|cml
5241248|NCT00664677|CLL|cll
5241249|NCT00664677|CMML|cmml
5241250|NCT00664677|MDS|mds
5241251|NCT00664664|insomnia|insomnia
5241252|NCT00664664|sleep maintenance insomnia|sleep maintenance insomnia
5241253|NCT00664664|sleep quality|sleep quality
5241254|NCT00664664|non-restorative sleep|non-restorative sleep
5241255|NCT00664664|multiple awakenings|multiple awakenings
5241256|NCT00664651|joint contracture|joint contracture
5241257|NCT00664651|total knee arthroplasty|total knee arthroplasty
5241258|NCT00664612|Cervical Spine|cervical spine
5241259|NCT00664599|Ocular lesions, Visual Acuity, Retinal Vasculitis|ocular lesions, visual acuity, retinal vasculitis
5241260|NCT00664586|Terameprocol (EM-1421)|terameprocol (em-1421)
5241261|NCT00664586|Phase 1|phase 1
5241262|NCT00664586|Infusion|infusion
5241263|NCT00664586|Refractory Solid Tumors|refractory solid tumors
5241264|NCT00664586|Lymphoma|lymphoma
5241265|NCT00664586|Maximum Tolerated Dose|maximum tolerated dose
5241266|NCT00664586|Tumor Response|tumor response
5241267|NCT00664586|Tumor Markers|tumor markers
5241268|NCT00664586|Pharmacokinetics|pharmacokinetics
5241269|NCT00664573|Safety|safety
5241270|NCT00664573|Rheumatoid Arthritis|rheumatoid arthritis
5241271|NCT00664573|Baminercept alfa|baminercept alfa
5241272|NCT00664573|Methotrexate|methotrexate
5241273|NCT00664573|BG9924|bg9924
5241274|NCT00664573|Efficacy|efficacy
5241275|NCT00664547|obesity, exercise, diet, insulin resistance|obesity, exercise, diet, insulin resistance
5241276|NCT00664508|Arthroplasty|arthroplasty
5241277|NCT00664508|Hip Replacement|hip replacement
5241278|NCT00664508|motion analysis|motion analysis
5241279|NCT00664495|Obesity, exercise, diet, insulin resistance|obesity, exercise, diet, insulin resistance
5241280|NCT00664456|stage IIB prostate cancer|stage iib prostate cancer
5241281|NCT00664456|stage IIA prostate cancer|stage iia prostate cancer
5241282|NCT00664456|stage I prostate cancer|stage i prostate cancer
5241283|NCT00664443|cardiac arrest|cardiac arrest
5241285|NCT00664443|resuscitation|resuscitation
5241286|NCT00664443|bystander CPR|bystander cpr
5241287|NCT00664443|dispatch-assisted CPR|dispatch-assisted cpr
5241288|NCT00664430|Dialysis|dialysis
5241289|NCT00664430|Calcitriol Resistant|calcitriol resistant
5241290|NCT00664430|Secondary Hyperparathyroidism|secondary hyperparathyroidism
5241291|NCT00664417|Influenza|influenza
5241292|NCT00664417|A/H5N1|a/h5n1
5241293|NCT00664417|Orthomyxoviridae Infections|orthomyxoviridae infections
5241294|NCT00664417|Influenza Pandemics|influenza pandemics
5241295|NCT00664404|Smoking|smoking
5241296|NCT00664404|Smoking Cessation|smoking cessation
5241297|NCT00664404|Nicotine Withdrawal|nicotine withdrawal
5241298|NCT00664404|Nicotine Dependence|nicotine dependence
5241299|NCT00664404|Neuroregulatory Effects|neuroregulatory effects
5241300|NCT00664404|Magnetic Resonance Imaging|magnetic resonance imaging
5241301|NCT00664404|MRI|mri
5241302|NCT00664378|Multiple myeloma, relapsed, refractory|multiple myeloma, relapsed, refractory
5241303|NCT00664365|Premature ejaculation.|premature ejaculation.
5241304|NCT00664365|FTIH,|ftih,
5241305|NCT00664365|GSK958108,|gsk958108,
5241306|NCT00664365|5HT1a antagonist,|5ht1a antagonist,
5241307|NCT00664352|Double blind|double blind
5241308|NCT00664352|Placebo controlled|placebo controlled
5241309|NCT00664352|wound healing|wound healing
5241310|NCT00664339|Heart failure,|heart failure,
5241311|NCT00664339|infection,|infection,
5241312|NCT00664339|immune system,|immune system,
5241313|NCT00664339|atherosclerosis|atherosclerosis
5241314|NCT00664326|Renal Cell Carcinoma|renal cell carcinoma
5241315|NCT00664313|Linezolid|linezolid
5241316|NCT00664313|Zyvox|zyvox
5241317|NCT00664313|Peripheral Neuropathy|peripheral neuropathy
5241318|NCT00664313|Optic Neuropathy|optic neuropathy
5241319|NCT00664313|Anemia|anemia
5241320|NCT00664313|Thrombocytopenia|thrombocytopenia
5241321|NCT00664300|Gilles de la Tourette's syndrome|gilles de la tourette's syndrome
5241322|NCT00664300|Facial expression recognition of emotion|facial expression recognition of emotion
5241323|NCT00664300|Frequency levels|frequency levels
5241324|NCT00664300|Automatic and voluntary information treatment|automatic and voluntary information treatment
5241423|NCT00663793|Testosterone|testosterone
5241325|NCT00664300|Patient with Gilles de la Tourette's syndrome|patient with gilles de la tourette's syndrome
5241326|NCT00664261|tobacco use disorder|tobacco use disorder
5241327|NCT00664235|Pressure Ulcers|pressure ulcers
5241328|NCT00664235|Tissue Injury|tissue injury
5241329|NCT00664222|heart failure|heart failure
5241330|NCT00664222|insulin resistance|insulin resistance
5241331|NCT00664222|inflammatory cytokine|inflammatory cytokine
5241332|NCT00664222|spironolactone|spironolactone
5241333|NCT00664222|furosemide|furosemide
5241334|NCT00664209|Parkinson's disease|parkinson's disease
5241335|NCT00664209|levodopa|levodopa
5241336|NCT00664209|Helicobacter pylori|helicobacter pylori
5241337|NCT00664196|Prostate Cancer|prostate cancer
5241338|NCT00664196|T cells|t cells
5241339|NCT00664196|Gene Transfer|gene transfer
5241340|NCT00664183|diabetic retinopathy|diabetic retinopathy
5241341|NCT00664157|Idiopathic Parkinson's disease|idiopathic parkinson's disease
5241342|NCT00664157|L-Dopa|l-dopa
5241343|NCT00664157|Deep Brain stimulation|deep brain stimulation
5241344|NCT00664157|Facial expression recognition of emotion|facial expression recognition of emotion
5241345|NCT00664157|Frequency levels|frequency levels
5241346|NCT00664157|Automatic and voluntary information treatment|automatic and voluntary information treatment
5241347|NCT00664157|Patient with an Idiopathic Parkinson's disease|patient with an idiopathic parkinson's disease
5241348|NCT00664131|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
5241349|NCT00664131|ALL survivors|all survivors
5241350|NCT00664131|ALL neurologic symptoms|all neurologic symptoms
5241351|NCT00664131|ALL neurologic disability|all neurologic disability
5241352|NCT00664131|ALL late effects|all late effects
5241353|NCT00664118|Doula|doula
5241354|NCT00664118|Patient-controlled epidural analgesia|patient-controlled epidural analgesia
5241355|NCT00664118|Neuraxial analgesia|neuraxial analgesia
5241356|NCT00664118|Labor analgesia|labor analgesia
5241357|NCT00664105|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5241358|NCT00664105|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5241359|NCT00664092|Substance Abuse|substance abuse
5241360|NCT00664092|Ex-Offenders|ex-offenders
5241361|NCT00664092|Substance Abuse Recovery|substance abuse recovery
5241362|NCT00664079|Thyroid Deficiency|thyroid deficiency
5241363|NCT00664079|Thyroid Stimulating Hormone|thyroid stimulating hormone
5241364|NCT00664053|bone mineral density|bone mineral density
5241365|NCT00664053|bone turnover markers|bone turnover markers
5241366|NCT00664053|strength|strength
5241367|NCT00664053|balance|balance
5241368|NCT00664014|hyponatremia|hyponatremia
5241369|NCT00664014|Non-acute and non hypovolemic hyponatremia|non-acute and non hypovolemic hyponatremia
5241370|NCT00663988|face transplantation|face transplantation
5241371|NCT00663975|cystic fibrosis|cystic fibrosis
5241372|NCT00663975|pancreatic insufficiency|pancreatic insufficiency
5241373|NCT00663975|pancreatic enzymes|pancreatic enzymes
5241374|NCT00663975|pediatrics|pediatrics
5241375|NCT00663962|Thoracotomy|thoracotomy
5241376|NCT00663962|Post-surgical|post-surgical
5241377|NCT00663962|Pregabalin|pregabalin
5241378|NCT00663949|diabetes|diabetes
5241379|NCT00663949|proteinuria|proteinuria
5241380|NCT00663949|pentoxifylline|pentoxifylline
5241381|NCT00663936|Alzheimer's Disease|alzheimer's disease
5241382|NCT00663936|Alzheimer's|alzheimer's
5241383|NCT00663923|Excimer Laser|excimer laser
5241384|NCT00663923|photorefractive keratectomy|photorefractive keratectomy
5241385|NCT00663923|astigmatism|astigmatism
5241386|NCT00663910|basal cell carcinoma of the skin|basal cell carcinoma of the skin
5241387|NCT00663910|squamous cell carcinoma of the skin|squamous cell carcinoma of the skin
5241388|NCT00663910|recurrent skin cancer|recurrent skin cancer
5241389|NCT00663897|functional dyspepsia|functional dyspepsia
5241390|NCT00663897|epigastric pain syndrome|epigastric pain syndrome
5241391|NCT00663897|postprandial distress syndrome|postprandial distress syndrome
5241392|NCT00663897|proton pump inhibitor|proton pump inhibitor
5241393|NCT00663897|5 HT-4 receptor agonist|5 ht-4 receptor agonist
5241394|NCT00663884|diabetes mellitus, Type 2|diabetes mellitus, type 2
5241395|NCT00663884|mitiglinide|mitiglinide
5241396|NCT00663871|Fish Oil|fish oil
5241397|NCT00663871|Omega-3 fatty acids|omega-3 fatty acids
5241398|NCT00663871|Affect|affect
5241399|NCT00663871|Depression|depression
5241400|NCT00663871|Anger|anger
5241401|NCT00663871|Nutrition|nutrition
5241402|NCT00663871|Impulsivity|impulsivity
5241403|NCT00663871|Aggression|aggression
5241404|NCT00663871|Cognition|cognition
5241405|NCT00663871|Behavior|behavior
5241406|NCT00663845|Male Erectile Dysfunction|male erectile dysfunction
5241407|NCT00663845|Dyslipidemia|dyslipidemia
5241408|NCT00663845|Vardenafil|vardenafil
5241409|NCT00663832|Male|male
5241410|NCT00663832|Prostate|prostate
5241411|NCT00663832|Cancer|cancer
5241412|NCT00663832|HRPC|hrpc
5241413|NCT00663832|DACi|daci
5241414|NCT00663819|Low anterior colon resection|low anterior colon resection
5241415|NCT00663819|Proctectomy|proctectomy
5241416|NCT00663819|Proctocolectomy|proctocolectomy
5241417|NCT00663819|Anastomosis|anastomosis
5241418|NCT00663819|Rectal Cancer|rectal cancer
5241419|NCT00663819|Ileostomy|ileostomy
5241421|NCT00663793|Male Contraception|male contraception
5241422|NCT00663793|Hypogonadism|hypogonadism
5241424|NCT00663780|pharmacogenomics|pharmacogenomics
5241425|NCT00663780|polymorphisms|polymorphisms
5241426|NCT00663780|wound healing|wound healing
5241427|NCT00663754|Body Image|body image
5241428|NCT00663741|Unresectable / recurrent gastric cancer|unresectable / recurrent gastric cancer
5241429|NCT00663741|Sorafenib|sorafenib
5241430|NCT00663741|S-1|s-1
5241431|NCT00663741|Gastric|gastric
5241432|NCT00663741|Cisplatin|cisplatin
5241433|NCT00663741|CDDP|cddp
5241434|NCT00663728|Erectile Dysfunction|erectile dysfunction
5241435|NCT00663728|Vardenafil|vardenafil
5241436|NCT00663715|Sciatic Nerve|sciatic nerve
5241437|NCT00663715|Peripheral Nerve Block|peripheral nerve block
5241438|NCT00663715|Lower extremity surgery|lower extremity surgery
5241439|NCT00663715|Local Anesthesia|local anesthesia
5241440|NCT00663715|Ultrasound guided nerve blocks|ultrasound guided nerve blocks
5241441|NCT00663689|erlotinib|erlotinib
5241442|NCT00663650|Basal Cell Carcinoma|basal cell carcinoma
5241443|NCT00663650|BCC|bcc
5241444|NCT00663650|Periocular BCC|periocular bcc
5241445|NCT00663650|Frozen Section Control|frozen section control
5241446|NCT00663650|Permanent Section Control|permanent section control
5241447|NCT00663650|Recurrence Rates|recurrence rates
5241448|NCT00663637|endotracheal tube obstruction, occlusion|endotracheal tube obstruction, occlusion
5241449|NCT00663637|mechanical ventilation, complication|mechanical ventilation, complication
5241450|NCT00663637|work of breathing|work of breathing
5241451|NCT00663637|airway resistance|airway resistance
5241452|NCT00663637|secretions|secretions
5241453|NCT00663637|pneumonia, ventilator associated|pneumonia, ventilator associated
5241454|NCT00663637|biofilms|biofilms
5241455|NCT00663637|endotracheal tube|endotracheal tube
5241456|NCT00663611|Immune Function|immune function
5241457|NCT00663611|Metabolism|metabolism
5241458|NCT00663611|Pulsatile Growth Hormone|pulsatile growth hormone
5241459|NCT00663598|Erectile Dysfunction|erectile dysfunction
5241460|NCT00663598|Vardenafil|vardenafil
5241461|NCT00663585|Migraine|migraine
5241462|NCT00663585|Headache|headache
5241463|NCT00663585|Vipassana|vipassana
5241464|NCT00663585|Meditation|meditation
5241465|NCT00663585|Intensive|intensive
5241466|NCT00663572|Newborn|newborn
5241467|NCT00663572|nutrition|nutrition
5241468|NCT00663572|genetic|genetic
5241469|NCT00663572|feeding behaviour|feeding behaviour
5241470|NCT00663572|psychomotor development|psychomotor development
5241471|NCT00663572|long-term effects|long-term effects
5241472|NCT00663572|nutritional imprinting.|nutritional imprinting.
5241473|NCT00663559|renal|renal
5241474|NCT00663559|Sunitinib|sunitinib
5241475|NCT00663559|Unresectable and/or metastatic renal cell cancer|unresectable and/or metastatic renal cell cancer
5241476|NCT00663546|Malaria|malaria
5241477|NCT00663546|Plasmodium|plasmodium
5241478|NCT00663546|Hemoglobin E|hemoglobin e
5241479|NCT00663546|Alpha-thalssemia|alpha-thalssemia
5241480|NCT00663546|G6PD Deficiency|g6pd deficiency
5241481|NCT00663533|Vasectomy|vasectomy
5241482|NCT00663533|Contraception|contraception
5241483|NCT00663520|Cardiac disease|cardiac disease
5241484|NCT00663520|vascular dysfunction|vascular dysfunction
5241485|NCT00663520|women|women
5241486|NCT00663520|chest pain|chest pain
5241487|NCT00663520|echocardiography|echocardiography
5241488|NCT00663507|Sickle Cell Disease|sickle cell disease
5241489|NCT00663507|Immunosuppression|immunosuppression
5241490|NCT00663507|Organ & Tissue Transplantation|organ & tissue transplantation
5241491|NCT00663507|Transplantation Immunology|transplantation immunology
5241492|NCT00663494|heart failure|heart failure
5241493|NCT00663494|MMP|mmp
5241494|NCT00663494|coronary sinus|coronary sinus
5241495|NCT00663481|CoFactor|cofactor
5241496|NCT00663481|ANX-510|anx-510
5241497|NCT00663468|determine changes in patient pain level|determine changes in patient pain level
5241498|NCT00663468|determine changes in patient functionality|determine changes in patient functionality
5241499|NCT00663468|determine changes in patient life quality|determine changes in patient life quality
5241500|NCT00663455|kidney transplant recipients|kidney transplant recipients
5241501|NCT00663455|children and adolescents with kidney transplants|children and adolescents with kidney transplants
5241502|NCT00663442|ADHD|adhd
5241503|NCT00663442|side effects|side effects
5241504|NCT00663442|sleep|sleep
5241505|NCT00663442|dopamine|dopamine
5241506|NCT00663442|pharmacogenetics|pharmacogenetics
5241507|NCT00663403|daptomycin|daptomycin
5241508|NCT00663403|pharmacokinetics|pharmacokinetics
5241509|NCT00663403|renal replacement therapy|renal replacement therapy
5241510|NCT00663403|critical illness|critical illness
5241511|NCT00663403|intensive care units|intensive care units
5241512|NCT00663377|Heart Failure|heart failure
5241513|NCT00663377|Insulin Resistance|insulin resistance
5241514|NCT00663377|Losartan|losartan
5241515|NCT00663377|ACE inhibitor|ace inhibitor
5241516|NCT00663377|Inflammatory cytokine|inflammatory cytokine
5241517|NCT00663364|dry skin|dry skin
5241518|NCT00663351|Arthritis|arthritis
5241519|NCT00663351|Osteoarthritis|osteoarthritis
5241520|NCT00663351|Traumatic Arthritis|traumatic arthritis
5241521|NCT00663351|Degenerative Joint Disease|degenerative joint disease
5241522|NCT00663351|Avascular Necrosis|avascular necrosis
5241524|NCT00663338|Hemispatial neglect|hemispatial neglect
5241525|NCT00663338|Unilateral neglect|unilateral neglect
5241526|NCT00663338|Spatial neglect|spatial neglect
5241527|NCT00663338|Motor|motor
5241528|NCT00663338|Weakness|weakness
5241529|NCT00663312|Idiopathic Parkinson's disease|idiopathic parkinson's disease
5241530|NCT00663312|Deep Brain stimulation|deep brain stimulation
5241531|NCT00663312|Hepatic glucose production|hepatic glucose production
5241532|NCT00663312|Insulin|insulin
5241533|NCT00663312|Weight gain|weight gain
5241534|NCT00663312|Patient with an Idiopathic Parkinson's disease|patient with an idiopathic parkinson's disease
5241535|NCT00663299|Intracranial aneurysm|intracranial aneurysm
5241536|NCT00663247|Diverticular disease|diverticular disease
5241537|NCT00663247|Inflammation|inflammation
5241538|NCT00663247|Mesalazine|mesalazine
5241539|NCT00663234|Treatment Experienced|treatment experienced
5241540|NCT00663221|Osteoporosis prevention|osteoporosis prevention
5241541|NCT00663195|heart failure|heart failure
5241542|NCT00663195|fibrosis|fibrosis
5241543|NCT00663195|MMP|mmp
5241544|NCT00663195|spironolactone|spironolactone
5241545|NCT00663195|furosemide|furosemide
5241546|NCT00663182|Entecavir|entecavir
5241547|NCT00663182|cirrhosis|cirrhosis
5241548|NCT00663182|anti-viral|anti-viral
5241549|NCT00663182|therapy|therapy
5241550|NCT00663169|Arthritis Gouty|arthritis gouty
5241551|NCT00663169|ACZ885|acz885
5241552|NCT00663169|IL1B protein|il1b protein
5241553|NCT00663169|Pain|pain
5241554|NCT00663156|lipoaugmentation|lipoaugmentation
5241555|NCT00663156|breast augmentation|breast augmentation
5241556|NCT00663156|fat grafting|fat grafting
5241557|NCT00663156|liposuction|liposuction
5241558|NCT00663156|lipoinfiltration|lipoinfiltration
5241559|NCT00663156|Spear|spear
5241560|NCT00663156|breast implants|breast implants
5241561|NCT00663156|ASERF|aserf
5241562|NCT00663156|Lipivage|lipivage
5241563|NCT00663156|Baker|baker
5241564|NCT00663156|harvest|harvest
5241565|NCT00663156|autologous|autologous
5241566|NCT00663156|Georgetown|georgetown
5241567|NCT00663143|investigate|investigate
5241568|NCT00663143|TZD exposure|tzd exposure
5241569|NCT00663143|in vitro|in vitro
5241570|NCT00663143|alters|alters
5241571|NCT00663143|bone|bone
5241572|NCT00663143|formation|formation
5241573|NCT00663143|differentiation|differentiation
5241574|NCT00663143|capacity|capacity
5241575|NCT00663143|bone marrow|bone marrow
5241576|NCT00663143|stromal cells|stromal cells
5241577|NCT00663130|Erectile Dysfunction|erectile dysfunction
5241578|NCT00663130|Vardenafil|vardenafil
5241579|NCT00663117|naltrexone|naltrexone
5241580|NCT00663117|LDN|ldn
5241581|NCT00663117|IBD|ibd
5241582|NCT00663117|Inflammatory bowel disease|inflammatory bowel disease
5241583|NCT00663104|early menopause|early menopause
5241584|NCT00663104|exercise|exercise
5241585|NCT00663104|phytoestrogen|phytoestrogen
5241586|NCT00663104|bone|bone
5241587|NCT00663104|CHD-risk factors|chd-risk factors
5241588|NCT00663091|WPP-201|wpp-201
5241589|NCT00663078|Cognitive Behavioral Therapy|cognitive behavioral therapy
5241590|NCT00663078|expert patient programme|expert patient programme
5241591|NCT00663078|deprived population|deprived population
5241592|NCT00663078|women|women
5241593|NCT00663065|Healthy subjects over 65|healthy subjects over 65
5241594|NCT00663065|healthy subjects|healthy subjects
5241595|NCT00663052|Enbrel|enbrel
5241596|NCT00663052|Psoriasis|psoriasis
5241597|NCT00663052|Topical Psoriasis|topical psoriasis
5241598|NCT00663052|Wyeth Psoriasis|wyeth psoriasis
5241599|NCT00663052|Active Psoriasis|active psoriasis
5241600|NCT00663039|Schizophrenia|schizophrenia
5241601|NCT00663039|Eye movements|eye movements
5241602|NCT00663039|phenotype|phenotype
5241603|NCT00663039|biochemical|biochemical
5241604|NCT00663039|relatives|relatives
5241605|NCT00663026|antibody|antibody
5241606|NCT00663026|immunotherapy|immunotherapy
5241607|NCT00663013|burn|burn
5241608|NCT00663013|pain|pain
5241609|NCT00663013|anxiety|anxiety
5241610|NCT00663000|acromegaly|acromegaly
5241611|NCT00663000|diabetes|diabetes
5241612|NCT00663000|insulin resistance|insulin resistance
5241613|NCT00663000|impaired glucose tolerance|impaired glucose tolerance
5241614|NCT00662987|tonsillectomy|tonsillectomy
5241615|NCT00662987|antibiotics|antibiotics
5241616|NCT00662961|Plastic Surgery|plastic surgery
5241617|NCT00662948|Folicular Lymphoma|folicular lymphoma
5241618|NCT00662948|Consolidation|consolidation
5241619|NCT00662948|Maintenance|maintenance
5241620|NCT00662935|deep brain stimulation|deep brain stimulation
5241621|NCT00662935|cluster headache|cluster headache
5241622|NCT00662935|hypothalamus|hypothalamus
5241623|NCT00662922|critical illness|critical illness
5241624|NCT00662922|hypoglycemia|hypoglycemia
5241625|NCT00662922|neurocognitive dysfunction|neurocognitive dysfunction
5241626|NCT00662922|intensive insulin therapy|intensive insulin therapy
5241627|NCT00662909|Frequency|frequency
5241628|NCT00662909|YM178|ym178
5241629|NCT00662909|Overactive bladder (OAB)|overactive bladder (oab)
5241630|NCT00662909|Micturition|micturition
5241631|NCT00662909|Urgency|urgency
5241632|NCT00662909|Urinary urge incontinence|urinary urge incontinence
5241633|NCT00662909|Urinary incontinence|urinary incontinence
5241634|NCT00662883|ketamine|ketamine
5241635|NCT00662883|corticosteroid|corticosteroid
5241636|NCT00662883|intranasal|intranasal
5241637|NCT00662883|phase I|phase i
5241638|NCT00662883|Healthy volunteers|healthy volunteers
5241639|NCT00662870|DAPTACEL|daptacel
5241640|NCT00662870|Diphtheria|diphtheria
5241641|NCT00662870|Tetanus|tetanus
5241642|NCT00662870|Whooping Cough|whooping cough
5241643|NCT00662870|Polio|polio
5241644|NCT00662870|Haemophilus influenzae type b|haemophilus influenzae type b
5241645|NCT00662870|Pertussis|pertussis
5241646|NCT00662857|Diabetic adult male, diabetic adult female|diabetic adult male, diabetic adult female
5241647|NCT00662844|Vitamin D insufficiency,vitamin D3 treatment,young women|vitamin d insufficiency,vitamin d3 treatment,young women
5241648|NCT00662831|Diabetic Foot Ulcers Neuroischaemic|diabetic foot ulcers neuroischaemic
5241649|NCT00662805|pharmacovigilance|pharmacovigilance
5241650|NCT00662805|COPD|copd
5241651|NCT00662779|asthma|asthma
5241652|NCT00662779|exercise induced bronchospasm|exercise induced bronchospasm
5241653|NCT00662779|prevention|prevention
5241654|NCT00662779|EIB|eib
5241655|NCT00662779|children|children
5241656|NCT00662766|Black currant|black currant
5241657|NCT00662766|Berry seed|berry seed
5241658|NCT00662766|Press residue|press residue
5241659|NCT00662766|Tocopherol|tocopherol
5241660|NCT00662766|Fatty acids|fatty acids
5241661|NCT00662766|Fiber|fiber
5241662|NCT00662766|Total phenols|total phenols
5241663|NCT00662766|TEAC|teac
5241664|NCT00662766|Comet assay|comet assay
5241665|NCT00662766|Dihydroxybenzoic acid|dihydroxybenzoic acid
5241666|NCT00662753|hypertension|hypertension
5241667|NCT00662753|home blood pressure monitoring|home blood pressure monitoring
5241668|NCT00662753|nurse telephone follow up|nurse telephone follow up
5241669|NCT00662753|medically underserved populations|medically underserved populations
5241670|NCT00662727|Extracorporeal Shockwave Therapy|extracorporeal shockwave therapy
5241671|NCT00662727|Myocardial Ischemia|myocardial ischemia
5241672|NCT00662727|Refractory Angina|refractory angina
5241673|NCT00662701|Atrial Fibrillation|atrial fibrillation
5241674|NCT00662688|thromboembolism|thromboembolism
5241675|NCT00662688|chemotherapeutic agent toxicity|chemotherapeutic agent toxicity
5241676|NCT00662688|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
5241677|NCT00662688|stage IV pancreatic cancer|stage iv pancreatic cancer
5241678|NCT00662688|recurrent pancreatic cancer|recurrent pancreatic cancer
5241679|NCT00662675|Exocrine pancreatic insufficiency|exocrine pancreatic insufficiency
5241680|NCT00662675|Steatorrhea|steatorrhea
5241681|NCT00662675|Malabsorption syndromes|malabsorption syndromes
5241682|NCT00662675|Cystic fibrosis|cystic fibrosis
5241683|NCT00662675|Pediatrics|pediatrics
5241684|NCT00662675|Adult|adult
5241685|NCT00662675|Pancrelipase|pancrelipase
5241686|NCT00662662|Oropharyngeal Cancer|oropharyngeal cancer
5241687|NCT00662662|Non-Oropharyngeal Cancer|non-oropharyngeal cancer
5241688|NCT00662662|Head and Neck Cancer|head and neck cancer
5241689|NCT00662662|Squamous Cell Carcinoma|squamous cell carcinoma
5241690|NCT00662662|Squamous cell carcinoma of the head and neck|squamous cell carcinoma of the head and neck
5241691|NCT00662662|SCCHN|scchn
5241692|NCT00662662|HPV-16|hpv-16
5241693|NCT00662662|Questionnaire|questionnaire
5241694|NCT00662662|Sexual Behavior|sexual behavior
5241695|NCT00662662|Survey|survey
5241696|NCT00662649|Multiple sclerosis.|multiple sclerosis.
5241697|NCT00662649|Relapse-remitting|relapse-remitting
5241698|NCT00662649|Fingolimod|fingolimod
5241699|NCT00662623|Chronic Obstructive Sleep Apnea|chronic obstructive sleep apnea
5241700|NCT00662623|Sleep Apnea|sleep apnea
5241701|NCT00662623|Sleep Apnea Treatment|sleep apnea treatment
5241702|NCT00662597|Tumor vascular disrupting agent|tumor vascular disrupting agent
5241703|NCT00662597|VDA|vda
5241704|NCT00662597|ASA404|asa404
5241705|NCT00662597|non-small cell lung cancer|non-small cell lung cancer
5241706|NCT00662597|NSCLC|nsclc
5241707|NCT00662584|repetitive magnetic transcranial stimulation (rTMS)|repetitive magnetic transcranial stimulation (rtms)
5241708|NCT00662584|functional magnetic resonance imaging (fMRI)|functional magnetic resonance imaging (fmri)
5241709|NCT00662571|nucleotide polymorphisms|nucleotide polymorphisms
5241710|NCT00662571|disequilibrium haplotype|disequilibrium haplotype
5241711|NCT00662571|acamprosate|acamprosate
5241712|NCT00662571|differentiate|differentiate
5241713|NCT00662571|pharmacogenomic|pharmacogenomic
5241714|NCT00662571|effective individualized treatment|effective individualized treatment
5241715|NCT00662571|alcohol dependent|alcohol dependent
5241716|NCT00662571|N-methyl-D-aspartate receptor (NMDA)|n-methyl-d-aspartate receptor (nmda)
5241717|NCT00662571|metabotropic glutamate receptor|metabotropic glutamate receptor
5241718|NCT00662571|decreasing craving|decreasing craving
5241719|NCT00662571|abstinence maintenance|abstinence maintenance
5241720|NCT00662558|Chronic low back pain|chronic low back pain
5241721|NCT00662545|HIV|hiv
5241722|NCT00662545|Hepatitis B|hepatitis b
5241723|NCT00662545|treatment experienced|treatment experienced
5241724|NCT00662532|Peri-implantitis; antibiotic|peri-implantitis; antibiotic
5241725|NCT00662493|knee pain|knee pain
5241726|NCT00662493|exercise|exercise
5241727|NCT00662493|rehabilitation|rehabilitation
5241728|NCT00662480|population|population
5241729|NCT00662480|screening|screening
5241730|NCT00662480|abdominal aortic aneurysms|abdominal aortic aneurysms
5241731|NCT00662480|peripheral arterial disease|peripheral arterial disease
5241732|NCT00662480|hypertension|hypertension
5241733|NCT00662480|Prevention|prevention
5241734|NCT00662467|Myocardial Infarction|myocardial infarction
5241735|NCT00662467|Hemorrhage|hemorrhage
5241736|NCT00662467|Thromboembolism|thromboembolism
5241737|NCT00662467|Clopidogrel|clopidogrel
5241738|NCT00662467|Aspirin|aspirin
5241739|NCT00662467|Warfarin|warfarin
5241740|NCT00662454|contraceptive|contraceptive
5241741|NCT00662454|efficacy|efficacy
5241742|NCT00662454|body weight|body weight
5241743|NCT00662441|Erectile Dysfunction|erectile dysfunction
5241744|NCT00662441|Vardenafil|vardenafil
5241745|NCT00662428|cost-benefit analysis|cost-benefit analysis
5241746|NCT00662428|practice guideline|practice guideline
5241747|NCT00662428|inpatients|inpatients
5241748|NCT00662415|phantom limb pain|phantom limb pain
5241749|NCT00662415|fMRI|fmri
5241750|NCT00662415|mirror therapy|mirror therapy
5241751|NCT00662402|K Grant|k grant
5241752|NCT00662402|Career Advancement|career advancement
5241753|NCT00662402|Award|award
5241754|NCT00662402|Consultation|consultation
5241755|NCT00662402|Application|application
5241756|NCT00662402|K|k
5241757|NCT00662402|The NIH priority score of the reviewed proposal.|the nih priority score of the reviewed proposal.
5241758|NCT00662402|Percent of subjects who obtain funding for proposal.|percent of subjects who obtain funding for proposal.
5241759|NCT00662402|Percent of subjects who submit proposals for funding.|percent of subjects who submit proposals for funding.
5241760|NCT00662389|skin laxity, wrinkles, rhytids|skin laxity, wrinkles, rhytids
5241761|NCT00662363|constipation|constipation
5241762|NCT00662363|opioid|opioid
5241763|NCT00662363|rehabilitation|rehabilitation
5241764|NCT00662363|post-operative|post-operative
5241765|NCT00662363|orthopedic|orthopedic
5241766|NCT00662350|BPH|bph
5241767|NCT00662337|Bioequivalence, diphenhydramine hydrochloride|bioequivalence, diphenhydramine hydrochloride
5241768|NCT00662298|severe asthma|severe asthma
5241769|NCT00662298|prednisolone pharmacokinetics|prednisolone pharmacokinetics
5241770|NCT00662298|anti-inflammatory effects|anti-inflammatory effects
5241771|NCT00662285|iron status|iron status
5241772|NCT00662285|blood donors|blood donors
5241773|NCT00662272|Flu|flu
5241774|NCT00662272|Influenza vaccine|influenza vaccine
5241775|NCT00662272|Adjuvant|adjuvant
5241776|NCT00662272|Safety of an adjuvanted vaccine|safety of an adjuvanted vaccine
5241777|NCT00662272|Immune response to an adjuvanted vaccine|immune response to an adjuvanted vaccine
5241778|NCT00662259|Anxiety disorders|anxiety disorders
5241779|NCT00662259|Generalized anxiety|generalized anxiety
5241780|NCT00662233|alveolar childhood rhabdomyosarcoma|alveolar childhood rhabdomyosarcoma
5241781|NCT00662233|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
5241782|NCT00662233|previously untreated childhood rhabdomyosarcoma|previously untreated childhood rhabdomyosarcoma
5241783|NCT00662233|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
5241784|NCT00662233|nonmetastatic childhood soft tissue sarcoma|nonmetastatic childhood soft tissue sarcoma
5241785|NCT00662233|recurrent childhood soft tissue sarcoma|recurrent childhood soft tissue sarcoma
5241786|NCT00662233|childhood desmoplastic small round cell tumor|childhood desmoplastic small round cell tumor
5241787|NCT00662233|ovarian sarcoma|ovarian sarcoma
5241788|NCT00662233|stage II uterine sarcoma|stage ii uterine sarcoma
5241789|NCT00662233|stage III uterine sarcoma|stage iii uterine sarcoma
5241790|NCT00662233|embryonal childhood rhabdomyosarcoma|embryonal childhood rhabdomyosarcoma
5241791|NCT00662220|chronic|chronic
5241792|NCT00662220|hepatitis C|hepatitis c
5241793|NCT00662220|ribavirin|ribavirin
5241794|NCT00662220|SVR|svr
5241795|NCT00662220|genotype one|genotype one
5241796|NCT00662220|genotype four|genotype four
5241797|NCT00662207|electric stimulation|electric stimulation
5241798|NCT00662207|urethral obstruction|urethral obstruction
5241799|NCT00662207|urodynamics|urodynamics
5241800|NCT00662207|urology|urology
5241801|NCT00662194|HIV|hiv
5241802|NCT00662194|HBV|hbv
5241803|NCT00662194|HCV|hcv
5241804|NCT00662194|co-infection|co-infection
5241805|NCT00662194|innate immunity|innate immunity
5241806|NCT00662181|growth hormone|growth hormone
5241807|NCT00662181|quality of life|quality of life
5241808|NCT00662181|fat redistribution|fat redistribution
5241809|NCT00662181|sugar metabolism|sugar metabolism
5241810|NCT00662181|fat metabolism|fat metabolism
5241811|NCT00662181|cytokines|cytokines
5241812|NCT00662168|carcinoid|carcinoid
5241813|NCT00662168|familial|familial
5241814|NCT00662168|Collect and describe information about the medical and environmental factors associated with each cases of carcinoid carcinoma|collect and describe information about the medical and environmental factors associated with each cases of carcinoid carcinoma
5241815|NCT00662168|Develop a genogram representing the family cancer history of cases of Carcinoid.|develop a genogram representing the family cancer history of cases of carcinoid.
5241816|NCT00662155|Primary Insomnia|primary insomnia
5241817|NCT00662155|Cognitive Behavioral Therapy|cognitive behavioral therapy
5241818|NCT00662155|Insomnia|insomnia
5241819|NCT00662155|Sleep|sleep
5241820|NCT00662155|Zolpidem|zolpidem
5241821|NCT00662155|Ambien|ambien
5241822|NCT00662155|CBT|cbt
5241823|NCT00662155|CBT-I|cbt-i
5241824|NCT00662142|DHA|dha
5241825|NCT00662142|fMRI|fmri
5241826|NCT00662129|stage IV breast cancer|stage iv breast cancer
5241827|NCT00662129|male breast cancer|male breast cancer
5241828|NCT00662129|recurrent breast cancer|recurrent breast cancer
5241829|NCT00662116|diastolic heart failure|diastolic heart failure
5241830|NCT00662103|fatigue|fatigue
5241831|NCT00662103|long-term effects secondary to cancer therapy in adults|long-term effects secondary to cancer therapy in adults
5241832|NCT00662103|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
5241833|NCT00662103|cancer survivor|cancer survivor
5241834|NCT00662103|stage IA breast cancer|stage ia breast cancer
5241835|NCT00662103|stage IB breast cancer|stage ib breast cancer
5241836|NCT00662103|stage II breast cancer|stage ii breast cancer
5241837|NCT00662103|stage IIIA breast cancer|stage iiia breast cancer
5241838|NCT00662103|stage IIIB breast cancer|stage iiib breast cancer
5241839|NCT00662103|stage IIIC breast cancer|stage iiic breast cancer
5241840|NCT00662103|breast cancer in situ|breast cancer in situ
5241841|NCT00662090|MDS|mds
5241842|NCT00662090|JMML|jmml
5241843|NCT00662090|EWOG-MDS|ewog-mds
5241844|NCT00662090|Myelodysplastic Syndromes (MDS)|myelodysplastic syndromes (mds)
5241845|NCT00662090|Juvenile Myelomonocytic Leukemia (JMML)|juvenile myelomonocytic leukemia (jmml)
5241846|NCT00662077|osteoporosis|osteoporosis
5241847|NCT00662077|bifosfonates|bifosfonates
5241848|NCT00662077|ibandronate|ibandronate
5241849|NCT00662064|Lower urinary tract|lower urinary tract
5241850|NCT00662064|Physiology|physiology
5241851|NCT00662064|Pathology|pathology
5241852|NCT00662064|Immunohistochemistry|immunohistochemistry
5241853|NCT00662064|Urinary bladder|urinary bladder
5241854|NCT00662051|Asthma|asthma
5241855|NCT00662051|Exhaled Nitric Oxide|exhaled nitric oxide
5241856|NCT00662051|Asthma Control Test|asthma control test
5241857|NCT00662038|idiopathic|idiopathic
5241858|NCT00662038|pulmonary|pulmonary
5241859|NCT00662038|fibrosis|fibrosis
5241860|NCT00662012|Leishmaniasis|leishmaniasis
5241861|NCT00662012|Sodium stibogluconate|sodium stibogluconate
5241862|NCT00662012|Pentostam|pentostam
5241863|NCT00662012|sand fly|sand fly
5241864|NCT00661999|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5241865|NCT00661999|monoclonal gammopathy of undetermined significance|monoclonal gammopathy of undetermined significance
5241866|NCT00661999|extramedullary plasmacytoma|extramedullary plasmacytoma
5241867|NCT00661999|isolated plasmacytoma of bone|isolated plasmacytoma of bone
5241868|NCT00661999|refractory multiple myeloma|refractory multiple myeloma
5241869|NCT00661999|stage I multiple myeloma|stage i multiple myeloma
5241870|NCT00661999|stage II multiple myeloma|stage ii multiple myeloma
5241871|NCT00661999|stage III multiple myeloma|stage iii multiple myeloma
5241872|NCT00661999|primary systemic amyloidosis|primary systemic amyloidosis
5241873|NCT00661999|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
5241874|NCT00661999|post-transplant lymphoproliferative disorder|post-transplant lymphoproliferative disorder
5241875|NCT00661999|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
5241876|NCT00661999|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
5241877|NCT00661999|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
5241878|NCT00661999|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
5241879|NCT00661999|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
5241880|NCT00661999|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
5241881|NCT00661999|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5241882|NCT00661999|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
5241883|NCT00661999|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
5241884|NCT00661999|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
5241885|NCT00661999|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
5241886|NCT00661999|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5241887|NCT00661999|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
5241888|NCT00661999|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
5241889|NCT00661999|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
5241890|NCT00661999|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
5241891|NCT00661999|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5241892|NCT00661999|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
5241893|NCT00661999|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
5241894|NCT00661999|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5241895|NCT00661999|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5241896|NCT00661999|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5241897|NCT00661999|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
5241898|NCT00661999|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
5241899|NCT00661999|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5241900|NCT00661999|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5242044|NCT00661739|palliative|palliative
5241901|NCT00661999|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
5241902|NCT00661999|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5241903|NCT00661999|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
5241904|NCT00661999|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
5241905|NCT00661999|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
5241906|NCT00661999|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
5241907|NCT00661999|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5241908|NCT00661999|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5241909|NCT00661999|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5241910|NCT00661999|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5241911|NCT00661999|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
5241912|NCT00661999|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
5241913|NCT00661999|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
5241914|NCT00661999|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
5241915|NCT00661999|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
5241916|NCT00661999|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
5241917|NCT00661999|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
5241918|NCT00661999|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
5241919|NCT00661999|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
5241920|NCT00661999|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
5241921|NCT00661999|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
5241922|NCT00661999|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
5241923|NCT00661999|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
5241924|NCT00661999|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
5241925|NCT00661999|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
5241926|NCT00661999|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
5241927|NCT00661999|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
5241928|NCT00661999|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5241929|NCT00661999|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5241930|NCT00661999|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5241931|NCT00661999|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5241932|NCT00661999|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5241933|NCT00661999|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5241934|NCT00661999|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
5241935|NCT00661999|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5241936|NCT00661999|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5241937|NCT00661999|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
5241938|NCT00661999|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5241939|NCT00661999|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5241940|NCT00661999|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
5241941|NCT00661999|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
5241942|NCT00661999|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
5241943|NCT00661999|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5241944|NCT00661999|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5241945|NCT00661999|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5241946|NCT00661999|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5241947|NCT00661999|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5241948|NCT00661999|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5241949|NCT00661999|stage I mantle cell lymphoma|stage i mantle cell lymphoma
5241950|NCT00661999|stage I marginal zone lymphoma|stage i marginal zone lymphoma
5241951|NCT00661999|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5241952|NCT00661999|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5241953|NCT00661999|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5241954|NCT00661999|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5241955|NCT00661999|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
5241956|NCT00661999|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5241957|NCT00661999|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5241958|NCT00661999|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5241959|NCT00661999|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5241960|NCT00661999|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5241961|NCT00661999|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5241962|NCT00661999|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5241963|NCT00661999|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5241964|NCT00661999|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5241965|NCT00661999|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5241966|NCT00661999|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5241967|NCT00661999|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5241968|NCT00661999|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5241969|NCT00661999|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5241970|NCT00661999|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5241971|NCT00661999|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5241972|NCT00661999|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5241973|NCT00661999|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5241974|NCT00661999|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5241975|NCT00661999|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
5241976|NCT00661999|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
5241977|NCT00661999|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
5241978|NCT00661999|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5241979|NCT00661999|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5241980|NCT00661999|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5241981|NCT00661999|refractory hairy cell leukemia|refractory hairy cell leukemia
5241982|NCT00661999|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
5241983|NCT00661999|prolymphocytic leukemia|prolymphocytic leukemia
5241984|NCT00661999|anemia|anemia
5241985|NCT00661999|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
5241986|NCT00661999|acute undifferentiated leukemia|acute undifferentiated leukemia
5241987|NCT00661999|mast cell leukemia|mast cell leukemia
5241988|NCT00661999|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
5241989|NCT00661999|untreated hairy cell leukemia|untreated hairy cell leukemia
5241990|NCT00661973|asthma|asthma
5241991|NCT00661973|airway smooth muscle|airway smooth muscle
5241992|NCT00661973|inhaled corticosteroids|inhaled corticosteroids
5241993|NCT00661960|HIV Positive|hiv positive
5241994|NCT00661960|AIDS|aids
5241995|NCT00661960|Antiretroviral Therapy|antiretroviral therapy
5241996|NCT00661960|Gastrointestinal-Associated Lymphoid Tissue|gastrointestinal-associated lymphoid tissue
5241997|NCT00661960|Immune Reconstitution|immune reconstitution
5241998|NCT00661960|treatment experienced|treatment experienced
5241999|NCT00661947|fructose|fructose
5242000|NCT00661947|sucrose|sucrose
5242001|NCT00661947|high fructose corn syrup|high fructose corn syrup
5242002|NCT00661947|serum uric acid|serum uric acid
5242003|NCT00661947|lactate|lactate
5242004|NCT00661947|glucose|glucose
5242005|NCT00661947|triglycerides|triglycerides
5242006|NCT00661947|Bioavailability of fructose from two formulations|bioavailability of fructose from two formulations
5242007|NCT00661934|Subject undergoing Dialysis and Subject suffering from Cardiac Malfunction|subject undergoing dialysis and subject suffering from cardiac malfunction
5242008|NCT00661921|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
5242009|NCT00661921|AMG 108|amg 108
5242010|NCT00661921|HbA1C|hba1c
5242011|NCT00661921|glucose|glucose
5242012|NCT00661921|metformin|metformin
5242013|NCT00661921|sulfonylurea|sulfonylurea
5242014|NCT00661921|IL-1 Inhibitor|il-1 inhibitor
5242015|NCT00661921|biologic|biologic
5242016|NCT00661921|subcutaneous injection|subcutaneous injection
5242017|NCT00661895|African American|african american
5242018|NCT00661882|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
5242019|NCT00661882|recurrent pancreatic cancer|recurrent pancreatic cancer
5242020|NCT00661882|stage I pancreatic cancer|stage i pancreatic cancer
5242021|NCT00661882|stage II pancreatic cancer|stage ii pancreatic cancer
5242022|NCT00661882|stage III pancreatic cancer|stage iii pancreatic cancer
5242023|NCT00661856|Soy Isoflavones, Bone Mineral Density, Post menopausal women|soy isoflavones, bone mineral density, post menopausal women
5242024|NCT00661843|insomnia|insomnia
5242025|NCT00661843|geriatric|geriatric
5242026|NCT00661843|yoga|yoga
5242027|NCT00661843|sleep|sleep
5242028|NCT00661843|electrocardiogram|electrocardiogram
5242029|NCT00661830|advanced|advanced
5242030|NCT00661830|metastatic|metastatic
5242031|NCT00661830|biliary|biliary
5242032|NCT00661830|tract|tract
5242033|NCT00661817|Exercise|exercise
5242034|NCT00661817|Physical Fitness|physical fitness
5242035|NCT00661817|Patient Compliance|patient compliance
5242036|NCT00661817|Health Behavior|health behavior
5242037|NCT00661791|preterm infants|preterm infants
5242038|NCT00661791|massage|massage
5242039|NCT00661791|physical activity|physical activity
5242040|NCT00661791|weight gain|weight gain
5242041|NCT00661791|length of hospital stay|length of hospital stay
5242042|NCT00661791|NICU|nicu
5242043|NCT00661765|varenicline bioavailability transdermal smoking cessation|varenicline bioavailability transdermal smoking cessation
5242045|NCT00661739|Breast cancer|breast cancer
5242046|NCT00661739|metastatic|metastatic
5242047|NCT00661739|Bendamustine|bendamustine
5242048|NCT00661739|phase I|phase i
5242049|NCT00661726|Thalassemia Intermedia|thalassemia intermedia
5242050|NCT00661713|Meningococcal disease|meningococcal disease
5242051|NCT00661713|Neisseria meningitidis serogroup B|neisseria meningitidis serogroup b
5242052|NCT00661713|prevention|prevention
5242053|NCT00661713|vaccination|vaccination
5242054|NCT00661713|adolescents|adolescents
5242055|NCT00661700|Erectile Dysfunction|erectile dysfunction
5242056|NCT00661700|Quality of Life|quality of life
5242057|NCT00661674|Palonosetron|palonosetron
5242058|NCT00661674|Hydroxyzine|hydroxyzine
5242059|NCT00661674|Acute opioid withdrawal|acute opioid withdrawal
5242060|NCT00661661|Long term open label study in Japan|long term open label study in japan
5242061|NCT00661661|CP-690|cp-690
5242062|NCT00661661|550|550
5242063|NCT00661661|tofacitinib|tofacitinib
5242064|NCT00661648|surgery|surgery
5242065|NCT00661635|Laparoscopic Cholecystectomy Surgery, Acute Pain, Perioperative Pain|laparoscopic cholecystectomy surgery, acute pain, perioperative pain
5242066|NCT00661609|Anti-mitotic|anti-mitotic
5242067|NCT00661609|Eg5 Inhibitor|eg5 inhibitor
5242068|NCT00661609|Kinesin Spindle Protein Inhibitor|kinesin spindle protein inhibitor
5242069|NCT00661609|Urothelial Cancer|urothelial cancer
5242070|NCT00661609|Bladder Cancer|bladder cancer
5242071|NCT00661609|Renal Pelvis Cancer|renal pelvis cancer
5242072|NCT00661609|Urethra Cancer|urethra cancer
5242073|NCT00661609|Ureter Cancer|ureter cancer
5242074|NCT00661609|Recurrent|recurrent
5242075|NCT00661609|Advanced|advanced
5242076|NCT00661609|Stage IV|stage iv
5242077|NCT00661596|Erectile Dysfunction|erectile dysfunction
5242078|NCT00661596|Vardenafil|vardenafil
5242079|NCT00661583|trabeculectomy|trabeculectomy
5242080|NCT00661583|glaucoma|glaucoma
5242081|NCT00661583|ranibizumab|ranibizumab
5242082|NCT00661570|laryngectomy|laryngectomy
5242083|NCT00661570|larynx cancer|larynx cancer
5242084|NCT00661557|Booster vaccination|booster vaccination
5242085|NCT00661557|Meningococcal vaccine|meningococcal vaccine
5242086|NCT00661557|Meningococcal disease|meningococcal disease
5242087|NCT00661557|Safety|safety
5242088|NCT00661557|immunogenicity|immunogenicity
5242089|NCT00661544|Multiple Myeloma|multiple myeloma
5242090|NCT00661544|Ascorbic Acid|ascorbic acid
5242091|NCT00661544|Vitamin C|vitamin c
5242092|NCT00661544|Arsenic Trioxide|arsenic trioxide
5242093|NCT00661544|Trisenox|trisenox
5242094|NCT00661544|Melphalan|melphalan
5242095|NCT00661544|Autologous Stem Cell Transplant|autologous stem cell transplant
5242096|NCT00661544|Stem Cell Transplantation|stem cell transplantation
5242097|NCT00661531|Breast cancer|breast cancer
5242098|NCT00661531|Metastatic breast cancer|metastatic breast cancer
5242099|NCT00661531|ER positive breast cancer|er positive breast cancer
5242100|NCT00661531|Hormonal therapy|hormonal therapy
5242101|NCT00661492|Androgen-independent prostate cancer(AIPC)|androgen-independent prostate cancer(aipc)
5242102|NCT00661466|Gastrointestinal surgery|gastrointestinal surgery
5242103|NCT00661466|Post operative pain|post operative pain
5242104|NCT00661453|Spinal Muscular Atrophy|spinal muscular atrophy
5242105|NCT00661453|SMA|sma
5242106|NCT00661453|Valproic Acid|valproic acid
5242107|NCT00661427|Head and Neck cancer|head and neck cancer
5242108|NCT00661427|Cetuximab|cetuximab
5242109|NCT00661414|Cancer|cancer
5242110|NCT00661414|Solid tumors|solid tumors
5242111|NCT00661401|gammaglobulin|gammaglobulin
5242112|NCT00661401|subcutaneous infusion|subcutaneous infusion
5242113|NCT00661401|specific antibodies|specific antibodies
5242114|NCT00661401|primary antibody deficiency|primary antibody deficiency
5242115|NCT00661375|BAY 43-9006|bay 43-9006
5242116|NCT00661375|Phase II|phase ii
5242117|NCT00661375|Renal cell carcinoma|renal cell carcinoma
5242118|NCT00661375|Response rate|response rate
5242119|NCT00661362|DPP-4 inhibitors|dpp-4 inhibitors
5242120|NCT00661362|HbA1c|hba1c
5242121|NCT00661362|Incretins|incretins
5242122|NCT00661349|Kaletra|kaletra
5242123|NCT00661349|Nevirapina|nevirapina
5242124|NCT00661349|HCV chronic infection|hcv chronic infection
5242125|NCT00661349|Fibroscan|fibroscan
5242126|NCT00661349|hepatic fibrosis|hepatic fibrosis
5242127|NCT00661349|treatment experienced|treatment experienced
5242128|NCT00661336|stage III melanoma|stage iii melanoma
5242129|NCT00661336|recurrent melanoma|recurrent melanoma
5242130|NCT00661310|re-admissions|re-admissions
5242131|NCT00661310|medicines|medicines
5242132|NCT00661310|management|management
5242133|NCT00661310|patients|patients
5242134|NCT00661310|80 years and older|80 years and older
5242135|NCT00661310|acute|acute
5242136|NCT00661310|admissions|admissions
5242137|NCT00661310|hospital|hospital
5242138|NCT00661297|Erectile Dysfunction|erectile dysfunction
5242139|NCT00661297|Vardenafil|vardenafil
5242140|NCT00661271|mindfulness|mindfulness
5242141|NCT00661271|meditation|meditation
5242142|NCT00661271|urban youth|urban youth
5242143|NCT00661271|stress reduction|stress reduction
5242144|NCT00661271|adolescent|adolescent
5242145|NCT00661271|Stress reduction for urban youth|stress reduction for urban youth
5242236|NCT00660777|speech therapy|speech therapy
5242146|NCT00661258|HIV antiretroviral treatment adherence intervention China|hiv antiretroviral treatment adherence intervention china
5242147|NCT00661258|adherence to antiretroviral treatment|adherence to antiretroviral treatment
5242148|NCT00661258|treatment experienced|treatment experienced
5242149|NCT00661232|Myocardial Viability|myocardial viability
5242150|NCT00661232|Delayed Enhancement Magnetic Resonance Imaging|delayed enhancement magnetic resonance imaging
5242151|NCT00661232|Functional Recovery|functional recovery
5242152|NCT00661206|Clopidogrel|clopidogrel
5242153|NCT00661206|Drug-eluting stent|drug-eluting stent
5242154|NCT00661193|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5242155|NCT00661193|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5242156|NCT00661193|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5242157|NCT00661193|adenocarcinoma of the lung|adenocarcinoma of the lung
5242158|NCT00661193|large cell lung cancer|large cell lung cancer
5242159|NCT00661193|squamous cell lung cancer|squamous cell lung cancer
5242160|NCT00661141|acetaldehyde|acetaldehyde
5242161|NCT00661141|ethanol|ethanol
5242162|NCT00661141|ALDH2|aldh2
5242163|NCT00661128|Sudden Cardiac Arrest|sudden cardiac arrest
5242164|NCT00661115|Erectile dysfunction|erectile dysfunction
5242165|NCT00661115|Sexual Dysfunction|sexual dysfunction
5242166|NCT00661089|stroke|stroke
5242167|NCT00661089|shoulder pain|shoulder pain
5242168|NCT00661089|spasticity|spasticity
5242169|NCT00661063|neuropathic pain|neuropathic pain
5242170|NCT00661063|ketamine|ketamine
5242171|NCT00661063|clonidine|clonidine
5242172|NCT00661063|association|association
5242173|NCT00661024|thyroid surgery|thyroid surgery
5242174|NCT00661024|recurrent laryngeal nerves visualization|recurrent laryngeal nerves visualization
5242175|NCT00661024|intraoperative neuromonitoring|intraoperative neuromonitoring
5242176|NCT00661024|predictive values|predictive values
5242177|NCT00661011|Non-small cell lung carcinoma|non-small cell lung carcinoma
5242178|NCT00661011|Concomitant radiochemotherapy|concomitant radiochemotherapy
5242179|NCT00661011|Cisplatin|cisplatin
5242180|NCT00661011|Vinorelbine|vinorelbine
5242181|NCT00661011|Radiotherapy|radiotherapy
5242182|NCT00661011|Chemotherapy|chemotherapy
5242183|NCT00661011|Unresectable stage III non-small cell lung carcinoma|unresectable stage iii non-small cell lung carcinoma
5242184|NCT00661011|Surgery|surgery
5242185|NCT00661011|Unresectable stage III non-small cell lung carcinoma not suitable for radical radiotherapy after objective response to induction chemotherapy|unresectable stage iii non-small cell lung carcinoma not suitable for radical radiotherapy after objective response to induction chemotherapy
5242186|NCT00660998|Erectile dysfunction|erectile dysfunction
5242187|NCT00660998|Diabetes mellitus type 1|diabetes mellitus type 1
5242188|NCT00660998|Vardenafil|vardenafil
5242189|NCT00660985|Acne vulgaris|acne vulgaris
5242190|NCT00660985|Differin|differin
5242191|NCT00660985|Adapalene|adapalene
5242192|NCT00660972|HIV Integrase Inhibitors|hiv integrase inhibitors
5242193|NCT00660972|HIV Nucleoside Reverse Transcriptase Inhibitors|hiv nucleoside reverse transcriptase inhibitors
5242194|NCT00660972|Treatment Naive|treatment naive
5242195|NCT00660972|Viral Load|viral load
5242196|NCT00660959|Euvolemic|euvolemic
5242197|NCT00660959|Hyponatremia|hyponatremia
5242198|NCT00660959|Serum Sodium|serum sodium
5242199|NCT00660959|Fluid Overload|fluid overload
5242200|NCT00660959|Vasopressin Antagonist|vasopressin antagonist
5242201|NCT00660946|anticoagulation in dialysis patients|anticoagulation in dialysis patients
5242202|NCT00660946|chronic anticoagulation|chronic anticoagulation
5242203|NCT00660946|warfarin|warfarin
5242204|NCT00660946|hemodialysis|hemodialysis
5242205|NCT00660946|INR|inr
5242206|NCT00660946|Point of Care|point of care
5242207|NCT00660933|postpartum anemia|postpartum anemia
5242208|NCT00660933|intravenous iron|intravenous iron
5242209|NCT00660907|Dapagliflozin|dapagliflozin
5242210|NCT00660907|efficacy|efficacy
5242211|NCT00660907|safety|safety
5242212|NCT00660907|metformin|metformin
5242213|NCT00660907|Type 2 diabetes|type 2 diabetes
5242214|NCT00660894|adenocarcinoma of the colon|adenocarcinoma of the colon
5242215|NCT00660894|stage III colon cancer|stage iii colon cancer
5242216|NCT00660881|Lupus|lupus
5242217|NCT00660881|Monoclonal antibody|monoclonal antibody
5242218|NCT00660881|B-Cell immunotherapy|b-cell immunotherapy
5242219|NCT00660868|smell|smell
5242220|NCT00660868|olfaction|olfaction
5242221|NCT00660868|olfactory sensitivity|olfactory sensitivity
5242222|NCT00660868|smell loss|smell loss
5242223|NCT00660868|chemoreception|chemoreception
5242224|NCT00660855|laparoscopy|laparoscopy
5242225|NCT00660842|quality of life|quality of life
5242226|NCT00660842|weekly therapy|weekly therapy
5242227|NCT00660842|neurotoxicity|neurotoxicity
5242228|NCT00660816|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5242229|NCT00660816|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5242230|NCT00660816|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5242231|NCT00660803|Advanced Breast Cancer|advanced breast cancer
5242232|NCT00660803|Hormone Therapy|hormone therapy
5242233|NCT00660790|diabetes mellitus type II, therapy non-responders|diabetes mellitus type ii, therapy non-responders
5242234|NCT00660777|oropharyngeal exercises|oropharyngeal exercises
5242235|NCT00660777|obstructive sleep apnea|obstructive sleep apnea
5242237|NCT00660764|cholesterol|cholesterol
5242238|NCT00660764|coronary heart disease|coronary heart disease
5242239|NCT00660764|rosuvastatin|rosuvastatin
5242240|NCT00660764|LDL-C goal|ldl-c goal
5242241|NCT00660764|hypercholesterolemia|hypercholesterolemia
5242242|NCT00660764|secondary prevention|secondary prevention
5242243|NCT00660764|primary prevention|primary prevention
5242245|NCT00660751|Physiology of Serotonergic and Adrenergic systems|physiology of serotonergic and adrenergic systems
5242246|NCT00660738|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
5242247|NCT00660738|walking|walking
5242248|NCT00660738|exercise test|exercise test
5242249|NCT00660738|quality of life|quality of life
5242250|NCT00660738|dyspnea|dyspnea
5242251|NCT00660738|desaturation|desaturation
5242252|NCT00660725|Gemcitabine|gemcitabine
5242253|NCT00660725|Oxaliplatin|oxaliplatin
5242254|NCT00660725|Vandetanib|vandetanib
5242255|NCT00660725|Phase I|phase i
5242256|NCT00660712|Bipolar disorder|bipolar disorder
5242257|NCT00660712|patient characteristics|patient characteristics
5242258|NCT00660712|treatment characteristics|treatment characteristics
5242259|NCT00660699|Cholangiocarcinoma|cholangiocarcinoma
5242260|NCT00660699|Gallbladder|gallbladder
5242261|NCT00660699|Pancreatic|pancreatic
5242262|NCT00660699|Ampullary|ampullary
5242263|NCT00660699|Cancer|cancer
5242264|NCT00660686|randomized clinical trial|randomized clinical trial
5242265|NCT00660686|elderly|elderly
5242266|NCT00660686|cancer survivor|cancer survivor
5242267|NCT00660686|bone health|bone health
5242268|NCT00660686|body composition|body composition
5242269|NCT00660686|signs and symptoms|signs and symptoms
5242270|NCT00660686|Androgen Deprivation Therapy|androgen deprivation therapy
5242271|NCT00660673|levodopa/carbidopa intestinal gel|levodopa/carbidopa intestinal gel
5242272|NCT00660673|Severe Motor Fluctuations|severe motor fluctuations
5242273|NCT00660673|Levodopa|levodopa
5242274|NCT00660673|Carbidopa|carbidopa
5242275|NCT00660673|Parkinson's Disease|parkinson's disease
5242276|NCT00660673|Dyskinesia|dyskinesia
5242277|NCT00660660|GERD|gerd
5242278|NCT00660660|Esophageal Reflux|esophageal reflux
5242279|NCT00660660|Gastro-Esophageal Reflux|gastro-esophageal reflux
5242280|NCT00660660|Regurgitation|regurgitation
5242281|NCT00660660|Gastric|gastric
5242282|NCT00660647|Rheumatoid arthritis, adalimumab, efficacy, adverse events|rheumatoid arthritis, adalimumab, efficacy, adverse events
5242283|NCT00660634|Peripheral arterial obstructive disease|peripheral arterial obstructive disease
5242284|NCT00660634|Intermittent Claudication|intermittent claudication
5242285|NCT00660634|Endovascular treatment|endovascular treatment
5242286|NCT00660634|Flow-mediated dilation|flow-mediated dilation
5242287|NCT00660621|High Grade|high grade
5242288|NCT00660621|Malignant|malignant
5242289|NCT00660621|GBM|gbm
5242290|NCT00660608|Transfusion regulation|transfusion regulation
5242291|NCT00660595|Schizophrenia|schizophrenia
5242292|NCT00660595|Schizoaffective psychosis|schizoaffective psychosis
5242293|NCT00660595|Schizophreniformic psychosis|schizophreniformic psychosis
5242294|NCT00660595|Pilot study|pilot study
5242295|NCT00660595|Quetiapine Prolong|quetiapine prolong
5242296|NCT00660595|Risperidone|risperidone
5242297|NCT00660582|Erbitux|erbitux
5242298|NCT00660582|Colorectal cancer|colorectal cancer
5242299|NCT00660582|Oxaliplatin|oxaliplatin
5242300|NCT00660582|Flox|flox
5242301|NCT00660582|Fluorouracil + folinic acid|fluorouracil + folinic acid
5242302|NCT00660582|K-RAS|k-ras
5242303|NCT00660569|asthma treatment|asthma treatment
5242304|NCT00660569|utilization|utilization
5242305|NCT00660569|real life practice|real life practice
5242306|NCT00660530|stage 5|stage 5
5242307|NCT00660530|chronic|chronic
5242308|NCT00660530|hemodialysis|hemodialysis
5242309|NCT00660504|Extensive Disease-Small Cell Lung Cancer|extensive disease-small cell lung cancer
5242310|NCT00660491|flow mediated dilatation|flow mediated dilatation
5242311|NCT00660491|maximal oxygen uptake|maximal oxygen uptake
5242312|NCT00660491|blood lipid|blood lipid
5242313|NCT00660465|Regional BOLD signal dependency on arterial PaCO2.|regional bold signal dependency on arterial paco2.
5242314|NCT00660465|Effect of breathing exercises on brain regional O2 level.|effect of breathing exercises on brain regional o2 level.
5242315|NCT00660465|Healthy subjects|healthy subjects
5242316|NCT00660452|Allergy|allergy
5242317|NCT00660452|SLIT|slit
5242318|NCT00660452|Asthma|asthma
5242319|NCT00660452|House Dust Mites|house dust mites
5242320|NCT00660439|PTSD|ptsd
5242321|NCT00660426|cancer|cancer
5242322|NCT00660426|gastrointestinal|gastrointestinal
5242323|NCT00660426|tumor|tumor
5242324|NCT00660413|Acceleromyography|acceleromyography
5242325|NCT00660413|Mechanomyography|mechanomyography
5242326|NCT00660413|Neuromuscular block|neuromuscular block
5242327|NCT00660413|Neuromuscular monitoring|neuromuscular monitoring
5242328|NCT00660413|Dose-response|dose-response
5242329|NCT00660413|Potency|potency
5242330|NCT00660413|Rocuronium|rocuronium
5242331|NCT00660400|Myeloid|myeloid
5242332|NCT00660400|Monocytic|monocytic
5242333|NCT00660387|levodopa-carbidopa|levodopa-carbidopa
5242334|NCT00660387|Carbidopa|carbidopa
5242335|NCT00660387|levodopa|levodopa
5242336|NCT00660387|dyskinesia|dyskinesia
5242337|NCT00660387|Duodopa|duodopa
5242338|NCT00660387|levodopa-carbidopa intestinal gel|levodopa-carbidopa intestinal gel
5242339|NCT00660387|Severe Motor Fluctuations|severe motor fluctuations
5242340|NCT00660387|levodopa/carbidopa suspension|levodopa/carbidopa suspension
5242341|NCT00660387|DUOPA|duopa
5242342|NCT00660361|HIV|hiv
5242343|NCT00660361|HBV|hbv
5242344|NCT00660361|co-infection|co-infection
5242345|NCT00660361|drug resistance|drug resistance
5242346|NCT00660361|tenofovir|tenofovir
5242347|NCT00660361|HIV-HBV co-infection|hiv-hbv co-infection
5242348|NCT00660348|recurrent pancreatic cancer|recurrent pancreatic cancer
5242349|NCT00660348|stage III pancreatic cancer|stage iii pancreatic cancer
5242350|NCT00660348|stage IV pancreatic cancer|stage iv pancreatic cancer
5242351|NCT00660348|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
5242352|NCT00660348|pain|pain
5242353|NCT00660348|stage II pancreatic cancer|stage ii pancreatic cancer
5242354|NCT00660335|secretin, RG1068, MRCP, pancreas|secretin, rg1068, mrcp, pancreas
5242355|NCT00660322|Asthma|asthma
5242356|NCT00660322|Telemedicine|telemedicine
5242357|NCT00660322|Randomized controlled trial|randomized controlled trial
5242358|NCT00660309|Type 2 diabetes mellitus|type 2 diabetes mellitus
5242359|NCT00660309|renal disease|renal disease
5242360|NCT00660309|hypertension|hypertension
5242361|NCT00660309|renal blood flow|renal blood flow
5242362|NCT00660309|retinal blood flow|retinal blood flow
5242363|NCT00660309|aliskiren|aliskiren
5242364|NCT00660309|irbesartan|irbesartan
5242365|NCT00660309|captopril|captopril
5242366|NCT00660296|CO2|co2
5242367|NCT00660296|pain|pain
5242368|NCT00660296|colonoscopy|colonoscopy
5242369|NCT00660296|cancer|cancer
5242370|NCT00660296|screening|screening
5242371|NCT00660283|GBM|gbm
5242372|NCT00660283|Newly|newly
5242373|NCT00660283|diagnosed|diagnosed
5242374|NCT00660283|malignant|malignant
5242375|NCT00660283|high grade|high grade
5242376|NCT00660270|Chemotherapy|chemotherapy
5242377|NCT00660270|Radiation|radiation
5242378|NCT00660244|Arimidex|arimidex
5242379|NCT00660244|Post menopausal|post menopausal
5242380|NCT00660244|arthralgia|arthralgia
5242381|NCT00660231|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5242382|NCT00660231|stage IB mycosis fungoides/Sezary syndrome|stage ib mycosis fungoides/sezary syndrome
5242383|NCT00660231|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
5242384|NCT00660231|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
5242385|NCT00660231|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
5242386|NCT00660231|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5242387|NCT00660231|stage IB cutaneous T-cell non-Hodgkin lymphoma|stage ib cutaneous t-cell non-hodgkin lymphoma
5242388|NCT00660231|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
5242389|NCT00660231|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
5242390|NCT00660231|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
5242391|NCT00660218|Stage III and IV head and neck cancer|stage iii and iv head and neck cancer
5242392|NCT00660205|DVT|dvt
5242393|NCT00660205|PE|pe
5242394|NCT00660205|D-dimer|d-dimer
5242395|NCT00660205|cancer|cancer
5242396|NCT00660205|VTE|vte
5242397|NCT00660192|Migraine, refractory migraine, Pain, Botulinum Toxin , Botox|migraine, refractory migraine, pain, botulinum toxin , botox
5242398|NCT00660179|pulmonary arterial hypertension SERAPHIN|pulmonary arterial hypertension seraphin
5242399|NCT00660166|Natural killer cells|natural killer cells
5242400|NCT00660166|autologous stem cell transplant|autologous stem cell transplant
5242401|NCT00660166|immunotherapy|immunotherapy
5242402|NCT00660153|Advanced Colorectal Cancer and Other Gastrointestinal Cancers|advanced colorectal cancer and other gastrointestinal cancers
5242403|NCT00660153|tivozanib|tivozanib
5242404|NCT00660153|AV-951|av-951
5242405|NCT00660140|Cholangiocarcinoma|cholangiocarcinoma
5242406|NCT00660140|Gallbladder|gallbladder
5242407|NCT00660140|Cancer|cancer
5242408|NCT00660114|Cough variant asthma|cough variant asthma
5242409|NCT00660114|Pulmicort® Respules®|pulmicort® respules®
5242410|NCT00660114|Chinese patient Eligibility|chinese patient eligibility
5242411|NCT00660101|ovarian cancer|ovarian cancer
5242412|NCT00660101|vaccine|vaccine
5242413|NCT00660101|immunotherapy|immunotherapy
5242414|NCT00660101|autologous|autologous
5242415|NCT00660075|Diabetes mellitus|diabetes mellitus
5242416|NCT00660075|Postprandial|postprandial
5242417|NCT00660075|Hyperlipidemia|hyperlipidemia
5242418|NCT00660075|Atherosclerosis|atherosclerosis
5242419|NCT00660062|Major depression|major depression
5242420|NCT00660062|relapse prevention|relapse prevention
5242421|NCT00660062|ECT|ect
5242422|NCT00660062|escitalopram|escitalopram
5242423|NCT00660062|nortriptyline|nortriptyline
5242424|NCT00660036|Acute myeloid leukemia|acute myeloid leukemia
5242425|NCT00660036|Refractory|refractory
5242426|NCT00660036|Relapsed|relapsed
5242427|NCT00660036|Second line|second line
5242428|NCT00660036|Gemtuzumab ozogamicin|gemtuzumab ozogamicin
5242429|NCT00660036|Mitoxantrone|mitoxantrone
5242430|NCT00660036|Etoposide|etoposide
5242431|NCT00660036|Phase I|phase i
5242432|NCT00660036|Phase II|phase ii
5242433|NCT00660010|CPP|cpp
5242434|NCT00660010|central precocious puberty|central precocious puberty
5242435|NCT00660010|pediatrics|pediatrics
5242436|NCT00660010|suppression of LH|suppression of lh
5242437|NCT00660010|Lupron|lupron
5242438|NCT00660010|leuprolide acetate|leuprolide acetate
5242439|NCT00660010|depot formulation|depot formulation
5242440|NCT00660010|GnRHa|gnrha
5242441|NCT00660010|GnRH agonist|gnrh agonist
5242442|NCT00660010|GNRH analog|gnrh analog
5242443|NCT00660010|LH|lh
5242444|NCT00660010|Tanner staging|tanner staging
5242445|NCT00659997|Ascariasis|ascariasis
5242446|NCT00659997|Trichuriasis|trichuriasis
5242447|NCT00659997|Drug resistance|drug resistance
5242448|NCT00659984|recurrent neuroblastoma|recurrent neuroblastoma
5242449|NCT00659971|oral candidiasis|oral candidiasis
5242450|NCT00659958|zonisamide|zonisamide
5242451|NCT00659958|partial onset seizures|partial onset seizures
5242452|NCT00659958|effectiveness|effectiveness
5242453|NCT00659958|tolerability|tolerability
5242454|NCT00659945|Postoperation, nausea, vomiting, anesthesia, plastic surgery|postoperation, nausea, vomiting, anesthesia, plastic surgery
5242455|NCT00659932|diabetes|diabetes
5242456|NCT00659932|cognitive behavioural therapy|cognitive behavioural therapy
5242457|NCT00659906|randomized clinical trial|randomized clinical trial
5242458|NCT00659906|cancer survivor|cancer survivor
5242459|NCT00659906|bone health|bone health
5242460|NCT00659906|body composition|body composition
5242461|NCT00659906|signs and symptoms|signs and symptoms
5242462|NCT00659893|Peplin|peplin
5242463|NCT00659893|PEP005|pep005
5242464|NCT00659893|Actinic Keratosis|actinic keratosis
5242465|NCT00659880|Meniscus transplant|meniscus transplant
5242466|NCT00659880|Meniscal allograft|meniscal allograft
5242467|NCT00659880|MAT|mat
5242468|NCT00659880|Knee|knee
5242469|NCT00659867|Ulcerative Colitis|ulcerative colitis
5242470|NCT00659867|Endomicroscopy|endomicroscopy
5242471|NCT00659867|Chromoendoscopy|chromoendoscopy
5242472|NCT00659867|Confocal colonoscope|confocal colonoscope
5242473|NCT00659867|Surveillance colonoscopy|surveillance colonoscopy
5242474|NCT00659854|obstructive sleep apnea syndrome|obstructive sleep apnea syndrome
5242475|NCT00659854|The study examines the response of infants diagnosed with obstructive sleep apnea syndrome to diet changes|the study examines the response of infants diagnosed with obstructive sleep apnea syndrome to diet changes
5242476|NCT00659841|Seasonal Allergic Rhinitis|seasonal allergic rhinitis
5242477|NCT00659841|Ciclesonide|ciclesonide
5242478|NCT00659841|Hay Fever|hay fever
5242479|NCT00659841|SAR|sar
5242480|NCT00659828|Congenital leptin deficiency|congenital leptin deficiency
5242481|NCT00659828|Obesity|obesity
5242482|NCT00659828|Metabolic Syndrome|metabolic syndrome
5242483|NCT00659828|Diabetes|diabetes
5242484|NCT00659776|ferumoxytol|ferumoxytol
5242485|NCT00659763|IBS|ibs
5242486|NCT00659763|Diagnosis|diagnosis
5242487|NCT00659750|Perennial Allergic Rhinitis|perennial allergic rhinitis
5242488|NCT00659750|Ciclesonide|ciclesonide
5242489|NCT00659750|PAR|par
5242490|NCT00659737|Post-operative Nausea and Vomiting (PONV)|post-operative nausea and vomiting (ponv)
5242491|NCT00659724|Dialyzer|dialyzer
5242492|NCT00659698|surgical|surgical
5242493|NCT00659698|site|site
5242494|NCT00659698|infection|infection
5242495|NCT00659685|Bioequivalence|bioequivalence
5242496|NCT00659685|Ondansetron ODT|ondansetron odt
5242497|NCT00659685|Fasting|fasting
5242498|NCT00659685|To Determine Bioequivalence Under Fasting conditions|to determine bioequivalence under fasting conditions
5242499|NCT00659672|hypertension|hypertension
5242500|NCT00659672|prehypertension|prehypertension
5242501|NCT00659672|high blood pressure|high blood pressure
5242502|NCT00659672|blood pressure|blood pressure
5242503|NCT00659672|heart disease|heart disease
5242504|NCT00659646|Diabetes|diabetes
5242505|NCT00659646|ulcers|ulcers
5242506|NCT00659646|ulcerations|ulcerations
5242507|NCT00659646|infection|infection
5242508|NCT00659633|lidocaine|lidocaine
5242509|NCT00659633|allodynia|allodynia
5242510|NCT00659633|chronic regional pain syndrome|chronic regional pain syndrome
5242511|NCT00659633|pain|pain
5242512|NCT00659620|Kidney Transplant|kidney transplant
5242513|NCT00659620|Chronic Allograft Nephropathy|chronic allograft nephropathy
5242514|NCT00659620|Mesenchymal Stem Cell infusion|mesenchymal stem cell infusion
5242515|NCT00659594|Seasonal Allergic rhinitis|seasonal allergic rhinitis
5242516|NCT00659594|Ciclesonide|ciclesonide
5242517|NCT00659594|Hay Fever|hay fever
5242518|NCT00659594|SAR|sar
5242519|NCT00659568|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5242520|NCT00659568|stage III renal cell cancer|stage iii renal cell cancer
5242521|NCT00659568|stage IV renal cell cancer|stage iv renal cell cancer
5242522|NCT00659568|recurrent renal cell cancer|recurrent renal cell cancer
5242523|NCT00659568|recurrent endometrial carcinoma|recurrent endometrial carcinoma
5242524|NCT00659568|stage III endometrial carcinoma|stage iii endometrial carcinoma
5242525|NCT00659568|stage IV endometrial carcinoma|stage iv endometrial carcinoma
5242526|NCT00659568|recurrent breast cancer|recurrent breast cancer
5242527|NCT00659568|stage IIIA breast cancer|stage iiia breast cancer
5242528|NCT00659568|stage IIIB breast cancer|stage iiib breast cancer
5242529|NCT00659568|stage IIIC breast cancer|stage iiic breast cancer
5242530|NCT00659568|stage IV breast cancer|stage iv breast cancer
5242531|NCT00659568|recurrent small cell lung cancer|recurrent small cell lung cancer
5242532|NCT00659568|extensive stage small cell lung cancer|extensive stage small cell lung cancer
5242533|NCT00659568|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5242534|NCT00659568|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5242535|NCT00659568|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5242536|NCT00659568|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5242537|NCT00659568|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5242538|NCT00659568|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5242539|NCT00659568|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5242540|NCT00659568|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
5242541|NCT00659568|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
5242542|NCT00659568|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5242543|NCT00659568|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5242544|NCT00659568|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5242545|NCT00659568|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5242546|NCT00659568|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5242547|NCT00659568|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5242548|NCT00659568|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5242549|NCT00659568|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5242550|NCT00659568|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5242551|NCT00659568|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5242552|NCT00659568|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5242553|NCT00659568|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5242554|NCT00659568|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5242555|NCT00659568|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
5242556|NCT00659568|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
5242557|NCT00659568|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5242558|NCT00659568|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5242559|NCT00659568|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5242560|NCT00659568|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5242561|NCT00659568|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5242562|NCT00659568|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5242563|NCT00659568|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5242564|NCT00659568|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5242565|NCT00659568|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5242566|NCT00659568|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5242567|NCT00659568|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
5242568|NCT00659568|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5242569|NCT00659568|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5242570|NCT00659568|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5242571|NCT00659568|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
5242572|NCT00659568|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5242573|NCT00659568|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5242574|NCT00659568|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5242575|NCT00659568|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5242576|NCT00659568|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5242577|NCT00659568|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5242578|NCT00659568|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5242579|NCT00659568|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5242580|NCT00659568|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
5242581|NCT00659568|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5242582|NCT00659568|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
5242583|NCT00659568|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
5242584|NCT00659568|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
5242711|NCT00659035|oral morphine|oral morphine
5242585|NCT00659568|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5242586|NCT00659568|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5242587|NCT00659568|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5242588|NCT00659568|Waldenström macroglobulinemia|waldenström macroglobulinemia
5242589|NCT00659555|vascular endothelial growth factor,|vascular endothelial growth factor,
5242590|NCT00659555|drug interaction,|drug interaction,
5242591|NCT00659555|pharmacokinetics,|pharmacokinetics,
5242592|NCT00659555|age-related macular degeneration,|age-related macular degeneration,
5242593|NCT00659555|pazopanib,|pazopanib,
5242594|NCT00659555|angiogenesis,|angiogenesis,
5242595|NCT00659555|ketoconazole|ketoconazole
5242596|NCT00659542|inguinal hernia|inguinal hernia
5242597|NCT00659542|inguinal hernioplasty|inguinal hernioplasty
5242598|NCT00659542|mesh fixation|mesh fixation
5242599|NCT00659542|Lichtenstein hernioplasty|lichtenstein hernioplasty
5242600|NCT00659529|cystic fibrosis|cystic fibrosis
5242601|NCT00659529|inflammation|inflammation
5242602|NCT00659529|pH|ph
5242603|NCT00659529|EBC|ebc
5242604|NCT00659529|sputum biomarkers|sputum biomarkers
5242605|NCT00659529|phosphodiesterase inhibitors|phosphodiesterase inhibitors
5242606|NCT00659503|Seasonal Allergic Rhinitis|seasonal allergic rhinitis
5242607|NCT00659503|Ciclesonide|ciclesonide
5242608|NCT00659503|Hay Fever|hay fever
5242609|NCT00659503|SAR|sar
5242610|NCT00659490|Analgesic effect|analgesic effect
5242611|NCT00659490|Molar extraction|molar extraction
5242612|NCT00659464|Infrared Spectroscopy|infrared spectroscopy
5242613|NCT00659464|Syncope|syncope
5242614|NCT00659464|Tilt Table Testing|tilt table testing
5242615|NCT00659451|Hypertension|hypertension
5242616|NCT00659451|Diabetes mellitus|diabetes mellitus
5242617|NCT00659451|Heart|heart
5242618|NCT00659425|Moxetumomab pasudotox|moxetumomab pasudotox
5242619|NCT00659412|Psoriatic arthritis|psoriatic arthritis
5242620|NCT00659412|psoriasis|psoriasis
5242621|NCT00659412|Alefacept|alefacept
5242622|NCT00659399|Pretreated Ovarian Carcinoma|pretreated ovarian carcinoma
5242623|NCT00659386|Heart failure|heart failure
5242624|NCT00659386|Parvovirus B19|parvovirus b19
5242625|NCT00659386|Intravenous immuneglobulin|intravenous immuneglobulin
5242626|NCT00659373|cognitive/functional effects|cognitive/functional effects
5242627|NCT00659373|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
5242628|NCT00659373|fatigue|fatigue
5242629|NCT00659373|sleep disorders|sleep disorders
5242630|NCT00659373|stage IA breast cancer|stage ia breast cancer
5242631|NCT00659373|stage IB breast cancer|stage ib breast cancer
5242632|NCT00659373|stage II breast cancer|stage ii breast cancer
5242633|NCT00659373|stage IIIA breast cancer|stage iiia breast cancer
5242634|NCT00659334|Combidex|combidex
5242635|NCT00659334|Diagnostic imaging|diagnostic imaging
5242636|NCT00659308|pain|pain
5242637|NCT00659308|bullous keratopathy|bullous keratopathy
5242638|NCT00659308|amniotic membrane|amniotic membrane
5242639|NCT00659308|anterior stromal puncture|anterior stromal puncture
5242640|NCT00659269|Vitamin B-12|vitamin b-12
5242641|NCT00659269|Vitamin B-6|vitamin b-6
5242642|NCT00659269|Chemotherapy-Induced Neuropathy|chemotherapy-induced neuropathy
5242643|NCT00659269|Taxanes|taxanes
5242644|NCT00659269|Vinca alkaloid|vinca alkaloid
5242645|NCT00659269|Heavy metals|heavy metals
5242646|NCT00659269|Neuropathy|neuropathy
5242647|NCT00659269|Nerve pain|nerve pain
5242648|NCT00659256|Hepatitis C Virus|hepatitis c virus
5242649|NCT00659256|Atherosclerosis|atherosclerosis
5242650|NCT00659256|Intima-Media Thickness|intima-media thickness
5242651|NCT00659256|Coronary Artery Calcium Score|coronary artery calcium score
5242652|NCT00659256|Hepatitis C|hepatitis c
5242653|NCT00659243|Replacement therapy|replacement therapy
5242654|NCT00659243|Pasteurized breast milk|pasteurized breast milk
5242655|NCT00659243|Preterm infants|preterm infants
5242656|NCT00659243|BSSL|bssl
5242657|NCT00659230|PTSD|ptsd
5242658|NCT00659230|Veterans|veterans
5242659|NCT00659230|Nepicastat|nepicastat
5242660|NCT00659230|OIF/OEF|oif/oef
5242661|NCT00659217|Mesenchymal Stem Cells|mesenchymal stem cells
5242662|NCT00659217|lupus Nephritis|lupus nephritis
5242663|NCT00659191|Healthy volunteer,|healthy volunteer,
5242664|NCT00659191|HIV infected subjects|hiv infected subjects
5242665|NCT00659178|Doxil,|doxil,
5242666|NCT00659178|pegylated liposomal doxorubicin,|pegylated liposomal doxorubicin,
5242667|NCT00659178|ovarian cancer|ovarian cancer
5242668|NCT00659178|IL-18,|il-18,
5242669|NCT00659178|combination study,|combination study,
5242670|NCT00659178|immunotherapy,|immunotherapy,
5242671|NCT00659178|cytokine,|cytokine,
5242672|NCT00659165|diabetes|diabetes
5242673|NCT00659165|insulin dependent diabetes|insulin dependent diabetes
5242674|NCT00659165|diabetes mellitus|diabetes mellitus
5242675|NCT00659165|detemir|detemir
5242676|NCT00659165|levemir|levemir
5242677|NCT00659165|glargine|glargine
5242678|NCT00659165|lantus|lantus
5242679|NCT00659165|insulin|insulin
5242680|NCT00659165|appetite|appetite
5242681|NCT00659165|satiety|satiety
5242682|NCT00659165|centrally acting mediators of satiety|centrally acting mediators of satiety
5242683|NCT00659165|three factor eating questionnaire|three factor eating questionnaire
5242684|NCT00659165|PYY|pyy
5242685|NCT00659165|ghrelin|ghrelin
5242686|NCT00659165|leptin|leptin
5242687|NCT00659152|ALI/ARDS|ali/ards
5242688|NCT00659113|stage IIA esophageal cancer|stage iia esophageal cancer
5242689|NCT00659113|stage IIB esophageal cancer|stage iib esophageal cancer
5242690|NCT00659113|stage IIIA esophageal cancer|stage iiia esophageal cancer
5242691|NCT00659113|stage IIIB esophageal cancer|stage iiib esophageal cancer
5242692|NCT00659113|stage IIIC esophageal cancer|stage iiic esophageal cancer
5242693|NCT00659113|stage IV esophageal cancer|stage iv esophageal cancer
5242694|NCT00659087|Total Knee|total knee
5242695|NCT00659087|Range of Motion|range of motion
5242696|NCT00659087|Pain|pain
5242697|NCT00659074|bioequivalence|bioequivalence
5243094|NCT00657254|Sorafenib|sorafenib
5242698|NCT00659074|Ondansetron ODT|ondansetron odt
5242699|NCT00659074|Fasting|fasting
5242700|NCT00659074|To Determine Bioequivalence Under Fasting Conditions|to determine bioequivalence under fasting conditions
5242701|NCT00659061|micronutrients|micronutrients
5242702|NCT00659048|Perennial Allergic Rhinitis|perennial allergic rhinitis
5242703|NCT00659048|Ciclesonide|ciclesonide
5242704|NCT00659048|PAR|par
5242705|NCT00659035|driving|driving
5242706|NCT00659035|opioids|opioids
5242707|NCT00659035|impairment|impairment
5242708|NCT00659035|ability|ability
5242709|NCT00659035|patients|patients
5242710|NCT00659035|receiving|receiving
5242712|NCT00659035|severe|severe
5242713|NCT00659022|colorectal cancer|colorectal cancer
5242714|NCT00659022|liver metastases|liver metastases
5242715|NCT00659022|angiogenesis|angiogenesis
5242716|NCT00659022|metabolism|metabolism
5242717|NCT00659009|environmental|environmental
5242718|NCT00659009|hypobaric hypoxia|hypobaric hypoxia
5242719|NCT00659009|sleep|sleep
5242720|NCT00659009|respiratory-disturbance|respiratory-disturbance
5242721|NCT00659009|neurobehavioral performance|neurobehavioral performance
5242722|NCT00659009|Effect of altitude on sleep-related respiratory disturbance|effect of altitude on sleep-related respiratory disturbance
5242723|NCT00658970|Open label|open label
5242724|NCT00658970|Dose escalation|dose escalation
5242725|NCT00658957|Diabetes|diabetes
5242726|NCT00658957|Foot Ulcer|foot ulcer
5242727|NCT00658944|Stress urinary incontinence|stress urinary incontinence
5242728|NCT00658944|Mixed urinary incontinence|mixed urinary incontinence
5242729|NCT00658944|surgery|surgery
5242730|NCT00658944|trans obturator tape|trans obturator tape
5242731|NCT00658944|Maximum urethral closure pressure|maximum urethral closure pressure
5242732|NCT00658944|Valsalva leak point pressure|valsalva leak point pressure
5242733|NCT00658944|outcome|outcome
5242734|NCT00658931|Depression|depression
5242735|NCT00658931|Bereavement|bereavement
5242736|NCT00658931|Pilot Projects|pilot projects
5242737|NCT00658931|Antidepressant Drugs|antidepressant drugs
5242738|NCT00658918|Perennial Allergic Rhinitis|perennial allergic rhinitis
5242739|NCT00658918|Ciclesonide|ciclesonide
5242740|NCT00658918|Hay Fever|hay fever
5242741|NCT00658918|PAR|par
5242742|NCT00658905|Preterm infants|preterm infants
5242743|NCT00658905|Replacement therapy|replacement therapy
5242744|NCT00658905|Infant formula|infant formula
5242745|NCT00658905|BSSL|bssl
5242746|NCT00658905|BSSL is present in fresh mother's milk but not in infant formula.|bssl is present in fresh mother's milk but not in infant formula.
5242747|NCT00658892|recurrent melanoma|recurrent melanoma
5242748|NCT00658892|stage IV melanoma|stage iv melanoma
5242749|NCT00658866|ertapenem tissue PK|ertapenem tissue pk
5242750|NCT00658853|COPD|copd
5242751|NCT00658853|training|training
5242752|NCT00658853|VO2peak|vo2peak
5242753|NCT00658853|performance|performance
5242754|NCT00658853|ventilation|ventilation
5242755|NCT00658853|high aerobic intensity treadmill walking|high aerobic intensity treadmill walking
5242756|NCT00658853|one leg training by cycling|one leg training by cycling
5242757|NCT00658827|Inflammatory Bowel Disease|inflammatory bowel disease
5242758|NCT00658827|Rheumatoid Arthritis|rheumatoid arthritis
5242759|NCT00658827|Psoriatic Arthritis|psoriatic arthritis
5242760|NCT00658827|Ankylosing Spondylitis|ankylosing spondylitis
5242761|NCT00658827|Psoriasis|psoriasis
5242762|NCT00658827|Pregnant women exposed to infliximab|pregnant women exposed to infliximab
5242763|NCT00658775|GERD|gerd
5242764|NCT00658775|erosive GERD|erosive gerd
5242765|NCT00658775|erosive esophagitis|erosive esophagitis
5242766|NCT00658749|AIR645|air645
5242767|NCT00658749|Altair Therapeutics|altair therapeutics
5242768|NCT00658749|IL4|il4
5242769|NCT00658749|IL13|il13
5242770|NCT00658749|IL-4|il-4
5242771|NCT00658749|IL-13|il-13
5242772|NCT00658710|hemiplegia|hemiplegia
5242773|NCT00658710|stroke|stroke
5242774|NCT00658710|TRIDENT|trident
5242775|NCT00658697|Rising PSA|rising psa
5242776|NCT00658697|androgen deprivation|androgen deprivation
5242777|NCT00658697|bevacizumab (avastin)|bevacizumab (avastin)
5242778|NCT00658697|docetaxel|docetaxel
5242779|NCT00658697|lupron|lupron
5242780|NCT00658697|zoladex|zoladex
5242781|NCT00658697|bicalutamide|bicalutamide
5242782|NCT00658658|Epidermal Growth Factor|epidermal growth factor
5242783|NCT00658658|Pediatric|pediatric
5242784|NCT00658658|Solid Tumors|solid tumors
5242785|NCT00658658|Panitumumab|panitumumab
5242786|NCT00658658|Dose Limiting Toxicity|dose limiting toxicity
5242787|NCT00658645|Schizophrenia|schizophrenia
5242788|NCT00658645|Antipsychotic|antipsychotic
5242789|NCT00658645|Bifeprunox|bifeprunox
5242790|NCT00658632|GERD|gerd
5242791|NCT00658632|erosive GERD|erosive gerd
5242792|NCT00658632|erosive esophagitis|erosive esophagitis
5242793|NCT00658606|plaque psoriasis|plaque psoriasis
5242794|NCT00658606|alefacept|alefacept
5242795|NCT00658606|Amevive|amevive
5242796|NCT00658606|narrow band ultraviolet B|narrow band ultraviolet b
5242797|NCT00658606|phototherapy|phototherapy
5242798|NCT00658593|adenocarcinoma of the extrahepatic bile duct|adenocarcinoma of the extrahepatic bile duct
5242799|NCT00658593|unresectable extrahepatic bile duct cancer|unresectable extrahepatic bile duct cancer
5242897|NCT00658203|LVEDD>30 mm/m2|lvedd>30 mm/m2
5242800|NCT00658593|recurrent extrahepatic bile duct cancer|recurrent extrahepatic bile duct cancer
5242801|NCT00658593|adenocarcinoma of the gallbladder|adenocarcinoma of the gallbladder
5242802|NCT00658593|adenocarcinoma with squamous metaplasia of the gallbladder|adenocarcinoma with squamous metaplasia of the gallbladder
5242803|NCT00658593|unresectable gallbladder cancer|unresectable gallbladder cancer
5242804|NCT00658593|recurrent gallbladder cancer|recurrent gallbladder cancer
5242805|NCT00658593|liver and intrahepatic biliary tract cancer|liver and intrahepatic biliary tract cancer
5242806|NCT00658580|Small cell lung carcinoma|small cell lung carcinoma
5242807|NCT00658580|Chemotherapy|chemotherapy
5242808|NCT00658580|Phase III randomised study|phase iii randomised study
5242809|NCT00658528|GERD|gerd
5242810|NCT00658528|erosive GERD|erosive gerd
5242811|NCT00658528|erosive esophagitis|erosive esophagitis
5242812|NCT00658476|Adolescent Depression|adolescent depression
5242813|NCT00658476|Depression|depression
5242814|NCT00658476|Teenage Depression|teenage depression
5242815|NCT00658476|Los Angeles|los angeles
5242816|NCT00658463|Diabetes|diabetes
5242817|NCT00658463|Triglycerides|triglycerides
5242818|NCT00658463|HDL-cholesterol|hdl-cholesterol
5242819|NCT00658463|kinetic|kinetic
5242820|NCT00658463|rosuvastatin|rosuvastatin
5242821|NCT00658450|Malaria, Cerebral|malaria, cerebral
5242822|NCT00658437|Melanoma, Stage IV, Phase II|melanoma, stage iv, phase ii
5242823|NCT00658411|AML|aml
5242824|NCT00658411|ALL|all
5242825|NCT00658411|MDS|mds
5242826|NCT00658411|iron overload|iron overload
5242827|NCT00658411|deferoxamine|deferoxamine
5242828|NCT00658398|Alcohol|alcohol
5242829|NCT00658398|dependency|dependency
5242830|NCT00658385|GCSF|gcsf
5242831|NCT00658372|PD 0332334 phase 3 pivotal trial|pd 0332334 phase 3 pivotal trial
5242832|NCT00658359|Immunosuppression|immunosuppression
5242833|NCT00658359|JAK inhibitor|jak inhibitor
5242834|NCT00658359|kidney transplantation|kidney transplantation
5242835|NCT00658346|HIV-1 group O|hiv-1 group o
5242836|NCT00658346|HIV-1 group M|hiv-1 group m
5242837|NCT00658346|Cameroon|cameroon
5242838|NCT00658346|HIV-1 infection|hiv-1 infection
5242839|NCT00658346|treatment naïve|treatment naïve
5242840|NCT00658333|Renal Transplantation|renal transplantation
5242841|NCT00658333|Immunosuppression|immunosuppression
5242842|NCT00658333|Renal transplant recipients|renal transplant recipients
5242843|NCT00658333|Gastrointestinal symptoms associated with MMF therapy|gastrointestinal symptoms associated with mmf therapy
5242844|NCT00658320|Renal transplantation|renal transplantation
5242845|NCT00658320|everolimus|everolimus
5242846|NCT00658320|mycophenolate mofetil|mycophenolate mofetil
5242847|NCT00658320|cyclosporine|cyclosporine
5242848|NCT00658320|corticosteroid|corticosteroid
5242849|NCT00658320|basiliximab|basiliximab
5242850|NCT00658320|Banff diagnosis|banff diagnosis
5242851|NCT00658320|Acute rejection|acute rejection
5242852|NCT00658320|Therapeutic drug monitoring (TDM)|therapeutic drug monitoring (tdm)
5242853|NCT00658320|de novo renal transplant recipient|de novo renal transplant recipient
5242854|NCT00658307|repetitive transcranial magnetic stimulation|repetitive transcranial magnetic stimulation
5242855|NCT00658307|double-blind|double-blind
5242856|NCT00658307|sham-controlled|sham-controlled
5242857|NCT00658307|randomized|randomized
5242858|NCT00658281|Breast Cancer|breast cancer
5242859|NCT00658281|On Board Imager Kilovoltage|on board imager kilovoltage
5242860|NCT00658281|Cone Beam Computed Tomography|cone beam computed tomography
5242861|NCT00658281|Electronic Portal Imaging Device|electronic portal imaging device
5242862|NCT00658281|Lymph Nodes|lymph nodes
5242864|NCT00658281|OBI KV|obi kv
5242865|NCT00658268|Surgical procedures operative|surgical procedures operative
5242866|NCT00658268|Prosthesis implantation|prosthesis implantation
5242867|NCT00658268|Arthroplasty replacement|arthroplasty replacement
5242868|NCT00658255|stable asthma|stable asthma
5242869|NCT00658255|adults|adults
5242870|NCT00658255|formoterol|formoterol
5242871|NCT00658255|Symbicort|symbicort
5242872|NCT00658255|Oxis Turbuhaler|oxis turbuhaler
5242873|NCT00658255|bronchodilation|bronchodilation
5242874|NCT00658242|craniofacial|craniofacial
5242875|NCT00658242|maxillofacial|maxillofacial
5242876|NCT00658242|osteotomy|osteotomy
5242877|NCT00658242|craniectomy|craniectomy
5242878|NCT00658242|craniotomy|craniotomy
5242879|NCT00658229|Exercise|exercise
5242880|NCT00658229|Prostatic|prostatic
5242881|NCT00658229|Neoplasm|neoplasm
5242882|NCT00658229|Androgen|androgen
5242883|NCT00658229|Deprivation|deprivation
5242884|NCT00658216|Diagnosis and prognosis|diagnosis and prognosis
5242885|NCT00658216|Very elderly population|very elderly population
5242886|NCT00658216|Heart failure|heart failure
5242887|NCT00658216|Brain natriuretic peptide|brain natriuretic peptide
5242888|NCT00658216|Observational prospective study|observational prospective study
5242889|NCT00658216|Older|older
5242890|NCT00658216|Dyspneic patients aged 80|dyspneic patients aged 80
5242891|NCT00658203|CRT-P|crt-p
5242892|NCT00658203|PEA|pea
5242893|NCT00658203|Severe Heart Failure (NYHA Class III or IV)|severe heart failure (nyha class iii or iv)
5242894|NCT00658203|Cardiomyopathy of any etiology|cardiomyopathy of any etiology
5242895|NCT00658203|Sinus rhythm|sinus rhythm
5242896|NCT00658203|Reduced Left-Ventricular Ejection Fraction|reduced left-ventricular ejection fraction
5242898|NCT00658203|QRS Duration: > 150 ms or > 120 ms|qrs duration: > 150 ms or > 120 ms
5242899|NCT00658203|Aortic Pre-Ejection Delay > 140 ms|aortic pre-ejection delay > 140 ms
5242900|NCT00658203|Interventricular Mechanical Delay > 40 ms|interventricular mechanical delay > 40 ms
5242901|NCT00658203|Delayed activation of postero-lateral Left Ventricular wall|delayed activation of postero-lateral left ventricular wall
5242902|NCT00658203|Optimal and stable pharmacological treatment|optimal and stable pharmacological treatment
5242903|NCT00658190|Cervical cancer, automation, Internet, telecytology|cervical cancer, automation, internet, telecytology
5242904|NCT00658177|Erectile dysfunction|erectile dysfunction
5242905|NCT00658177|Vardenafil|vardenafil
5242906|NCT00658164|Nonalcoholic fatty liver disease associated with increased iron stores|nonalcoholic fatty liver disease associated with increased iron stores
5242907|NCT00658151|focus|focus
5242908|NCT00658151|study|study
5242909|NCT00658151|evaluate|evaluate
5242910|NCT00658151|sonographic|sonographic
5242911|NCT00658151|findings|findings
5242912|NCT00658151|colon|colon
5242913|NCT00658151|patients|patients
5242914|NCT00658151|developed|developed
5242915|NCT00658086|ALN-RSV01|aln-rsv01
5242916|NCT00658086|Respiratory Syncytial Virus|respiratory syncytial virus
5242917|NCT00658073|Kidney transplant|kidney transplant
5242918|NCT00658073|Mesenchymal stem cell (MSC)|mesenchymal stem cell (msc)
5242919|NCT00658060|FMF, Exertional leg pain|fmf, exertional leg pain
5242920|NCT00658047|Arthritis, Rheumatoid|arthritis, rheumatoid
5242921|NCT00658047|Phase II|phase ii
5242922|NCT00658047|Rheumatoid Arthritis|rheumatoid arthritis
5242923|NCT00658034|Cancer|cancer
5242924|NCT00658034|Fatigue|fatigue
5242925|NCT00658034|Acupuncture|acupuncture
5242926|NCT00658021|diabetes|diabetes
5242927|NCT00658021|adolescents|adolescents
5242928|NCT00658021|exenatide|exenatide
5242929|NCT00658021|Astra Zeneca|astra zeneca
5242930|NCT00658008|PD 0332334 phase 3 pivotal trial|pd 0332334 phase 3 pivotal trial
5242931|NCT00657995|pancreatogenic|pancreatogenic
5242932|NCT00657995|diabetes|diabetes
5242933|NCT00657995|artificial|artificial
5242934|NCT00657995|pancreas|pancreas
5242935|NCT00657969|Polymorphism, genetic|polymorphism, genetic
5242936|NCT00657969|Risk factors|risk factors
5242937|NCT00657969|Carotid Artery, Internal, Dissection|carotid artery, internal, dissection
5242938|NCT00657969|Vertebral Artery Dissection|vertebral artery dissection
5242939|NCT00657969|Genetic predisposition|genetic predisposition
5242940|NCT00657969|Outcome|outcome
5242941|NCT00657969|Therapy|therapy
5242942|NCT00657956|osteoarthritis|osteoarthritis
5242943|NCT00657956|arthroplasty|arthroplasty
5242944|NCT00657956|knee joint|knee joint
5242945|NCT00657956|radiography|radiography
5242946|NCT00657956|surgery|surgery
5242947|NCT00657956|Bone Density|bone density
5242948|NCT00657956|Outcome Assessment (Health Care)|outcome assessment (health care)
5242949|NCT00657943|carotid|carotid
5242950|NCT00657943|intima|intima
5242951|NCT00657943|media|media
5242952|NCT00657943|thickness|thickness
5242953|NCT00657943|insulin|insulin
5242954|NCT00657943|metformin|metformin
5242955|NCT00657917|leishmaniasis|leishmaniasis
5242956|NCT00657917|cutaneous|cutaneous
5242957|NCT00657917|Old World|old world
5242958|NCT00657917|Leishmania major|leishmania major
5242959|NCT00657917|Treatment|treatment
5242960|NCT00657904|androgen antagonists|androgen antagonists
5242961|NCT00657904|prostate neoplasms|prostate neoplasms
5242962|NCT00657891|Allergic Asthma|allergic asthma
5242963|NCT00657891|Anti IgE|anti ige
5242964|NCT00657891|Xolair|xolair
5242965|NCT00657891|Basophil|basophil
5242966|NCT00657891|IL-13|il-13
5242967|NCT00657891|IL-4|il-4
5242968|NCT00657891|Histamine|histamine
5242969|NCT00657878|platinum free interval|platinum free interval
5242970|NCT00657878|chemotherapy|chemotherapy
5242971|NCT00657852|pamidronate,bone loss, liver transplantation|pamidronate,bone loss, liver transplantation
5242972|NCT00657839|Benign Prostate Hyperplasia|benign prostate hyperplasia
5242973|NCT00657839|Vardenafil|vardenafil
5242974|NCT00657839|Genital Disease|genital disease
5242975|NCT00657839|Male: Signs and symptoms of Benign Prostate Hyperplasia|male: signs and symptoms of benign prostate hyperplasia
5242976|NCT00657826|Diseased Heart Valve, Replacement|diseased heart valve, replacement
5242977|NCT00657813|Alzheimer|alzheimer
5242978|NCT00657813|SPECT|spect
5242979|NCT00657800|diabetes, inpatient, education,|diabetes, inpatient, education,
5242980|NCT00657787|Posttraumatic Stress Disorder|posttraumatic stress disorder
5242981|NCT00657787|Veterans|veterans
5242982|NCT00657787|Health Services|health services
5242983|NCT00657774|Asthma|asthma
5242984|NCT00657774|Mild to Moderate|mild to moderate
5242985|NCT00657748|Leukodystrophy|leukodystrophy
5242986|NCT00657748|Canavan disease,|canavan disease,
5242987|NCT00657748|Aspartoacylase,|aspartoacylase,
5242988|NCT00657748|Lithium,|lithium,
5242989|NCT00657748|Glyceryl Triacetate|glyceryl triacetate
5242990|NCT00657735|bipolar|bipolar
5242991|NCT00657735|depression|depression
5242992|NCT00657735|prefrontal|prefrontal
5242993|NCT00657735|cortex|cortex
5242994|NCT00657735|antidepressant|antidepressant
5242995|NCT00657735|response|response
5242996|NCT00657722|Pulmonary hypertension|pulmonary hypertension
5242997|NCT00657722|Chronic thromboembolic pulmonary hypertension|chronic thromboembolic pulmonary hypertension
5242998|NCT00657722|Operability|operability
5242999|NCT00657722|Thromboendarteriectomy|thromboendarteriectomy
5243000|NCT00657722|Operative mortality rate|operative mortality rate
5243001|NCT00657722|Technical failure|technical failure
5243002|NCT00657722|Pulmonary angiography|pulmonary angiography
5243003|NCT00657722|Computed tomography|computed tomography
5243004|NCT00657709|infant|infant
5243005|NCT00657709|Meningococcal disease|meningococcal disease
5243006|NCT00657709|prevention|prevention
5243007|NCT00657709|vaccination|vaccination
5243008|NCT00657696|primary health care|primary health care
5243009|NCT00657696|organizations|organizations
5243010|NCT00657696|learning|learning
5243011|NCT00657696|quality of health care|quality of health care
5243012|NCT00657683|GBS|gbs
5243013|NCT00657683|GBS prevention|gbs prevention
5243014|NCT00657670|refractive error|refractive error
5243015|NCT00657670|spectacles|spectacles
5243016|NCT00657670|ready made spectacles|ready made spectacles
5243017|NCT00657670|vision|vision
5243018|NCT00657670|cost effectiveness|cost effectiveness
5243019|NCT00657657|Hepatitis|hepatitis
5243020|NCT00657657|vaccine|vaccine
5243021|NCT00657644|Erectile Dysfunction|erectile dysfunction
5243022|NCT00657631|Acceptance and Commitment Therapy|acceptance and commitment therapy
5243023|NCT00657631|Delusions|delusions
5243024|NCT00657618|Leishmaniasis, Sodium stibogluconate, Pentostam, sand fly|leishmaniasis, sodium stibogluconate, pentostam, sand fly
5243025|NCT00657605|Congenital leptin deficiency|congenital leptin deficiency
5243026|NCT00657605|Obesity|obesity
5243027|NCT00657605|Metabolic syndrome|metabolic syndrome
5243028|NCT00657605|Diabetes|diabetes
5243029|NCT00657566|intraabdominal|intraabdominal
5243030|NCT00657566|peritonitis|peritonitis
5243031|NCT00657566|sepsis|sepsis
5243032|NCT00657566|duration|duration
5243033|NCT00657566|antibiotics|antibiotics
5243034|NCT00657540|black widow spider|black widow spider
5243035|NCT00657540|antivenom|antivenom
5243036|NCT00657540|latrodectism|latrodectism
5243037|NCT00657527|Crestor|crestor
5243038|NCT00657527|Rosuvastatin|rosuvastatin
5243039|NCT00657527|Cholesterol|cholesterol
5243040|NCT00657527|Coronary artery disease|coronary artery disease
5243041|NCT00657527|Myocardial ischaemia.|myocardial ischaemia.
5243042|NCT00657514|hemoglobin desaturation kinetics|hemoglobin desaturation kinetics
5243043|NCT00657514|peripheral arterial disease|peripheral arterial disease
5243044|NCT00657514|chronic angina|chronic angina
5243045|NCT00657514|exercise tolerance|exercise tolerance
5243046|NCT00657501|testosterone|testosterone
5243047|NCT00657501|hypoactive sexual desire disorder|hypoactive sexual desire disorder
5243048|NCT00657501|menopause|menopause
5243049|NCT00657488|Multiple Myeloma, Thalidomide, dose, dexamethasone|multiple myeloma, thalidomide, dose, dexamethasone
5243050|NCT00657475|Heparin low dose|heparin low dose
5243051|NCT00657475|Inflammation|inflammation
5243052|NCT00657475|Blood loss|blood loss
5243053|NCT00657462|Medical Informatics Applications|medical informatics applications
5243054|NCT00657462|Software|software
5243055|NCT00657462|Utilization|utilization
5243056|NCT00657449|sprains and strains|sprains and strains
5243057|NCT00657436|Acute Coronary Syndrome|acute coronary syndrome
5243058|NCT00657436|Myocardial Infarction|myocardial infarction
5243059|NCT00657436|Coronary Artery Disease|coronary artery disease
5243060|NCT00657423|Lung Neoplasms|lung neoplasms
5243061|NCT00657423|Endostatins|endostatins
5243062|NCT00657423|Vascular Endothelial Growth Factors|vascular endothelial growth factors
5243063|NCT00657423|Fibroblast Growth Factors|fibroblast growth factors
5243064|NCT00657423|Survival Rate|survival rate
5243065|NCT00657410|idiopathic thrombocytopenic purpura|idiopathic thrombocytopenic purpura
5243066|NCT00657397|Methadone|methadone
5243067|NCT00657397|Substance Dependence|substance dependence
5243068|NCT00657384|Specify the primary condition or disease being studied Major Hepatectomy|specify the primary condition or disease being studied major hepatectomy
5243069|NCT00657371|Colorectal Cancer|colorectal cancer
5243070|NCT00657371|Colonoscopy|colonoscopy
5243071|NCT00657371|Third Eye Retroscope|third eye retroscope
5243072|NCT00657371|Third Eye Retroscope Auxiliary Imaging System|third eye retroscope auxiliary imaging system
5243073|NCT00657371|Polypectomy|polypectomy
5243074|NCT00657358|lidocaine|lidocaine
5243075|NCT00657358|allodynia|allodynia
5243076|NCT00657358|chronic regional pain syndrome|chronic regional pain syndrome
5243077|NCT00657358|pain|pain
5243078|NCT00657345|trastuzumab|trastuzumab
5243079|NCT00657345|breast cancer|breast cancer
5243080|NCT00657345|her2 positive breast cancer|her2 positive breast cancer
5243081|NCT00657306|Cirrhosis|cirrhosis
5243082|NCT00657306|Ascites|ascites
5243083|NCT00657306|Adrenal insufficiency|adrenal insufficiency
5243084|NCT00657306|Hepatorenal syndrome|hepatorenal syndrome
5243085|NCT00657306|Portal hypertension|portal hypertension
5243086|NCT00657293|COPD|copd
5243087|NCT00657293|arm training|arm training
5243088|NCT00657293|dyspnoea|dyspnoea
5243089|NCT00657293|quality of life|quality of life
5243090|NCT00657267|recurrent glioblastoma|recurrent glioblastoma
5243091|NCT00657267|temodar|temodar
5243092|NCT00657267|temozolomide|temozolomide
5243093|NCT00657254|Extension|extension
5243095|NCT00657254|Survival|survival
5243096|NCT00657241|cardiac work|cardiac work
5243097|NCT00657241|coreg cr|coreg cr
5243098|NCT00657241|valsartan|valsartan
5243099|NCT00657241|tonometry|tonometry
5243100|NCT00657228|Anaphylaxis|anaphylaxis
5243101|NCT00657228|Anaphylactoid reactions|anaphylactoid reactions
5243102|NCT00657202|NF1|nf1
5243103|NCT00657202|neurofibroma|neurofibroma
5243104|NCT00657202|ranibizumab|ranibizumab
5243105|NCT00657202|Lucentis|lucentis
5243106|NCT00657189|Sifalimumab|sifalimumab
5243107|NCT00657189|MEDI-545|medi-545
5243108|NCT00657189|Lupus erythematosus, systemic|lupus erythematosus, systemic
5243109|NCT00657163|Stroke recovery|stroke recovery
5243110|NCT00657163|Pharmacological modulation|pharmacological modulation
5243111|NCT00657163|Selective Serotonin Reuptake Inhibitor (SSRI)|selective serotonin reuptake inhibitor (ssri)
5243112|NCT00657163|Fluoxetine|fluoxetine
5243113|NCT00657163|Brain plasticity|brain plasticity
5243114|NCT00657163|Ischemic Stroke and Motor impairment|ischemic stroke and motor impairment
5243115|NCT00657163|Modulation of recovery and cerebral plasticity by Fluoxetine|modulation of recovery and cerebral plasticity by fluoxetine
5243116|NCT00657137|HER2/neu positive|her2/neu positive
5243117|NCT00657137|locally advanced or metastatic|locally advanced or metastatic
5243118|NCT00657124|AEN|aen
5243119|NCT00657111|influenza, elderly, United Kingdom|influenza, elderly, united kingdom
5243120|NCT00657098|Side effects|side effects
5243121|NCT00657098|Angiogenesis inhibitors|angiogenesis inhibitors
5243122|NCT00657098|Epidermal growth factor receptor inhibitors|epidermal growth factor receptor inhibitors
5243123|NCT00657098|Tyrosinekinase inhibitors|tyrosinekinase inhibitors
5243124|NCT00657085|Laser hair removal|laser hair removal
5243125|NCT00657072|scapholunate instability|scapholunate instability
5243126|NCT00657072|neural networks|neural networks
5243127|NCT00657072|scaphoid|scaphoid
5243128|NCT00657072|lunate|lunate
5243129|NCT00657072|Suspected torn scapholunate interosseous ligament|suspected torn scapholunate interosseous ligament
5243130|NCT00657072|Suspected other torn wrist ligaments|suspected other torn wrist ligaments
5243131|NCT00657059|IgA nephropathy|iga nephropathy
5243132|NCT00657059|mycophenolate mofetil|mycophenolate mofetil
5243133|NCT00657033|Erectile Dysfunction|erectile dysfunction
5243134|NCT00657020|nicotine|nicotine
5243135|NCT00657020|therapy|therapy
5243136|NCT00657020|fMRI/EEG|fmri/eeg
5243137|NCT00657020|replacement|replacement
5243138|NCT00657007|lupus|lupus
5243139|NCT00657007|SLE|sle
5243140|NCT00656994|Sleep Disorder|sleep disorder
5243141|NCT00656994|Insomnia|insomnia
5243142|NCT00656981|Moderate Acne Vulgaris|moderate acne vulgaris
5243143|NCT00656981|Acne|acne
5243144|NCT00656968|peptic ulcer disease|peptic ulcer disease
5243145|NCT00656968|gastric cancer|gastric cancer
5243146|NCT00656968|therapeutics|therapeutics
5243147|NCT00656955|Kidney Cancer|kidney cancer
5243148|NCT00656955|Molecular Epidemiology|molecular epidemiology
5243149|NCT00656955|Survival|survival
5243150|NCT00656955|Occupational Exposures|occupational exposures
5243151|NCT00656955|Renal Cancer|renal cancer
5243152|NCT00656942|Pain|pain
5243153|NCT00656929|Vitamin D|vitamin d
5243154|NCT00656929|Viral URI|viral uri
5243155|NCT00656929|Influenza|influenza
5243156|NCT00656929|Colds|colds
5243157|NCT00656916|Post-Transplant Constrictive Bronchiolitis|post-transplant constrictive bronchiolitis
5243158|NCT00656916|Bronchiolitis|bronchiolitis
5243159|NCT00656916|Fluticasone Propionate|fluticasone propionate
5243160|NCT00656916|Inhaled Corticosteroids|inhaled corticosteroids
5243161|NCT00656916|Lung Condition|lung condition
5243162|NCT00656916|PTCB|ptcb
5243163|NCT00656903|Lucentis|lucentis
5243164|NCT00656903|Indocyanine Green Angiography|indocyanine green angiography
5243165|NCT00656903|Choroidal Neovascularization|choroidal neovascularization
5243166|NCT00656903|Macular Degeneration|macular degeneration
5243167|NCT00656903|Ranibizumab|ranibizumab
5243168|NCT00656903|Age-Related Macular Degeneration|age-related macular degeneration
5243169|NCT00656903|AMD|amd
5243170|NCT00656890|ulcerative colitis, rectal bleeding|ulcerative colitis, rectal bleeding
5243171|NCT00656877|Fat Embolism Total Knee Arthroplasty|fat embolism total knee arthroplasty
5243172|NCT00656864|Diabetes|diabetes
5243173|NCT00656864|pioglitazone|pioglitazone
5243174|NCT00656864|GIP|gip
5243175|NCT00656851|HIV/AIDS|hiv/aids
5243176|NCT00656851|Heart disease|heart disease
5243177|NCT00656851|Diabetes|diabetes
5243178|NCT00656851|Cardiovascular disease risk|cardiovascular disease risk
5243179|NCT00656851|Dyslipidemia|dyslipidemia
5243180|NCT00656851|Visceral adiposity|visceral adiposity
5243181|NCT00656851|treatment experienced|treatment experienced
5243182|NCT00656838|colon|colon
5243183|NCT00656838|rectal|rectal
5243184|NCT00656838|cancer|cancer
5243185|NCT00656838|screening|screening
5243186|NCT00656825|P144|p144
5243187|NCT00656825|TGF-β1|tgf-β1
5243188|NCT00656825|Healthy volunteers|healthy volunteers
5243189|NCT00656825|Cutaneous tolerability|cutaneous tolerability
5243190|NCT00656825|Skin fibrosis|skin fibrosis
5243191|NCT00656825|systemic scleroderma|systemic scleroderma
5243192|NCT00656825|systemic sclerosis|systemic sclerosis
5243193|NCT00656825|Safety|safety
5243889|NCT00654290|Propranolol|propranolol
5243194|NCT00656812|advanced MALT lymphoma|advanced malt lymphoma
5243195|NCT00656812|Rituximab|rituximab
5243196|NCT00656812|2CdA|2cda
5243197|NCT00656812|chemotherapy|chemotherapy
5243198|NCT00656812|immunotherapy|immunotherapy
5243199|NCT00656773|morphine, sufentanil, acute pain, opioid, Prehospital Emergency Care|morphine, sufentanil, acute pain, opioid, prehospital emergency care
5243200|NCT00656760|unknown primary, head and neck cancer, squamous cell carcinoma|unknown primary, head and neck cancer, squamous cell carcinoma
5243201|NCT00656760|Unknown primary head and neck cancer|unknown primary head and neck cancer
5243202|NCT00656747|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
5243203|NCT00656747|Acute exacerbation of COPD (AECOPD)|acute exacerbation of copd (aecopd)
5243204|NCT00656747|chronic bronchitis|chronic bronchitis
5243205|NCT00656747|bronchitis|bronchitis
5243206|NCT00656747|chest infection|chest infection
5243207|NCT00656747|smoking|smoking
5243208|NCT00656747|lung disease|lung disease
5243209|NCT00656747|lung|lung
5243210|NCT00656747|lungs|lungs
5243211|NCT00656734|Medarex Inc.|medarex inc.
5243212|NCT00656721|bronchiectasis|bronchiectasis
5243213|NCT00656721|physiotherapy|physiotherapy
5243214|NCT00656721|flutter valve|flutter valve
5243215|NCT00656721|impulse oscillation technique|impulse oscillation technique
5243216|NCT00656708|Burns|burns
5243217|NCT00656708|Wounds|wounds
5243218|NCT00656708|Healthcare associated infections|healthcare associated infections
5243219|NCT00656708|MRSA|mrsa
5243220|NCT00656708|VRE|vre
5243221|NCT00656695|Iminoral|iminoral
5243222|NCT00656695|Neoral|neoral
5243223|NCT00656695|Acute renal transplant rejection|acute renal transplant rejection
5243224|NCT00656682|Prevention & Control|prevention & control
5243225|NCT00656682|Hyperglycemia|hyperglycemia
5243226|NCT00656682|Obesity|obesity
5243227|NCT00656682|Diabetes Mellitus|diabetes mellitus
5243228|NCT00656682|Cost Benefit Analysis|cost benefit analysis
5243229|NCT00656669|newly diagnosed breast cancer|newly diagnosed breast cancer
5243230|NCT00656669|neoadjuvant therapy|neoadjuvant therapy
5243231|NCT00656656|pemphigus|pemphigus
5243232|NCT00656656|rituximab|rituximab
5243233|NCT00656656|immunoadsorption|immunoadsorption
5243234|NCT00656656|dexamethasone|dexamethasone
5243235|NCT00656656|treatment|treatment
5243236|NCT00656656|management|management
5243237|NCT00656617|Acute Myeloid Leukemia|acute myeloid leukemia
5243238|NCT00656617|(AML)|(aml)
5243239|NCT00656617|Myelodysplastic syndrome|myelodysplastic syndrome
5243240|NCT00656617|(MDS)|(mds)
5243241|NCT00656617|Leukemia|leukemia
5243242|NCT00656617|Idarubicin|idarubicin
5243243|NCT00656617|Cytarabine|cytarabine
5243244|NCT00656617|Vorinostat|vorinostat
5243245|NCT00656617|Ara-C|ara-c
5243246|NCT00656604|recurrent breast cancer|recurrent breast cancer
5243247|NCT00656604|stage I breast cancer|stage i breast cancer
5243248|NCT00656604|stage II breast cancer|stage ii breast cancer
5243249|NCT00656604|stage IIIA breast cancer|stage iiia breast cancer
5243250|NCT00656604|stage IIIB breast cancer|stage iiib breast cancer
5243251|NCT00656604|stage IIIC breast cancer|stage iiic breast cancer
5243252|NCT00656591|Child mortality, Nepal, Community, care practices|child mortality, nepal, community, care practices
5243253|NCT00656578|Foot|foot
5243254|NCT00656578|Bunion|bunion
5243255|NCT00656578|Bunionectomy|bunionectomy
5243256|NCT00656578|Hallux Valgus Deformity|hallux valgus deformity
5243257|NCT00656578|Surgery for Transpositional first metatarsal osteotomy - Bunionectomy|surgery for transpositional first metatarsal osteotomy - bunionectomy
5243258|NCT00656565|measure inspiratory spirometry with dry powder inhaler device in series with the spirometer|measure inspiratory spirometry with dry powder inhaler device in series with the spirometer
5243259|NCT00656526|analgesia, postlaminectomy , lidocaine, dorsal root|analgesia, postlaminectomy , lidocaine, dorsal root
5243260|NCT00656513|hypopharyngeal cancer|hypopharyngeal cancer
5243261|NCT00656513|laryngeal cancer|laryngeal cancer
5243262|NCT00656513|lip and oral cavity cancer|lip and oral cavity cancer
5243263|NCT00656513|nasopharyngeal cancer|nasopharyngeal cancer
5243264|NCT00656513|paranasal sinus and nasal cavity cancer|paranasal sinus and nasal cavity cancer
5243265|NCT00656513|oropharyngeal cancer|oropharyngeal cancer
5243266|NCT00656513|salivary gland cancer|salivary gland cancer
5243267|NCT00656513|metastatic squamous neck cancer with occult primary|metastatic squamous neck cancer with occult primary
5243268|NCT00656513|xerostomia|xerostomia
5243269|NCT00656513|tongue cancer|tongue cancer
5243270|NCT00656500|surgical patients|surgical patients
5243271|NCT00656500|cigarette smoking|cigarette smoking
5243272|NCT00656500|postoperative complications|postoperative complications
5243273|NCT00656500|telephone counseling|telephone counseling
5243274|NCT00656500|quitlines|quitlines
5243275|NCT00656487|Cannabis Dependence|cannabis dependence
5243276|NCT00656487|Marijuana Dependence|marijuana dependence
5243277|NCT00656487|Cannabis Withdrawal|cannabis withdrawal
5243278|NCT00656487|Rimonabant|rimonabant
5243279|NCT00656487|cannabinoid receptor type 1 (CB1) inverse agonist|cannabinoid receptor type 1 (cb1) inverse agonist
5243280|NCT00656487|Neuropsychology|neuropsychology
5243281|NCT00656487|functional magnetic resonance imaging (fMRI)|functional magnetic resonance imaging (fmri)
5243282|NCT00656487|Endocannabinoids|endocannabinoids
5243283|NCT00656487|Cortisol|cortisol
5243284|NCT00656474|burn wounds|burn wounds
5243285|NCT00656474|wound healing|wound healing
5243286|NCT00656461|Advanced cancer|advanced cancer
5243287|NCT00656448|Acute Myelogenous Leukemia|acute myelogenous leukemia
5243288|NCT00656448|AML|aml
5243289|NCT00656448|Myelodysplastic Syndrome|myelodysplastic syndrome
5243290|NCT00656448|MDS|mds
5243291|NCT00656448|Leukemia|leukemia
5243292|NCT00656448|Procrit|procrit
5243293|NCT00656448|Epoetin Alfa|epoetin alfa
5243294|NCT00656448|Epogen|epogen
5243295|NCT00656435|proliferative diabetic retinopathy|proliferative diabetic retinopathy
5243296|NCT00656435|bevacizumab (Avastin)|bevacizumab (avastin)
5243297|NCT00656435|vitreous hemorrhage|vitreous hemorrhage
5243298|NCT00656435|long acting gas|long acting gas
5243299|NCT00656422|insulin therapy|insulin therapy
5243300|NCT00656422|hepatic fat|hepatic fat
5243301|NCT00656422|type 2 diabetes|type 2 diabetes
5243302|NCT00656422|body composition|body composition
5243303|NCT00656422|comparison of insulin detemir and insulin glargine|comparison of insulin detemir and insulin glargine
5243304|NCT00656422|Changes in Hepatic Fat|changes in hepatic fat
5243305|NCT00656422|Obesity|obesity
5243306|NCT00656409|Ataxia telangiectasia,|ataxia telangiectasia,
5243307|NCT00656409|Conjugated pneumococcal,|conjugated pneumococcal,
5243308|NCT00656409|Prevenar,|prevenar,
5243309|NCT00656409|Immunogenicity ,|immunogenicity ,
5243310|NCT00656409|Vaccine|vaccine
5243311|NCT00656396|Blood loss|blood loss
5243312|NCT00656396|Point of care monitoring|point of care monitoring
5243313|NCT00656396|FFP|ffp
5243314|NCT00656396|Major surgery|major surgery
5243315|NCT00656396|Prothrombin Time|prothrombin time
5243316|NCT00656396|Blood coagulation tests|blood coagulation tests
5243317|NCT00656383|venous ulcer, leg ulcer, stasis ulcer|venous ulcer, leg ulcer, stasis ulcer
5243318|NCT00656370|Hylenex|hylenex
5243319|NCT00656370|subcutaneous infusion|subcutaneous infusion
5243320|NCT00656370|hyaluronidase|hyaluronidase
5243321|NCT00656370|rHuPH20|rhuph20
5243322|NCT00656370|recombinant human hyaluronidase|recombinant human hyaluronidase
5243323|NCT00656344|PTSD|ptsd
5243324|NCT00656344|Substance Abuse|substance abuse
5243325|NCT00656344|WTC attacks|wtc attacks
5243326|NCT00656344|Iraq War|iraq war
5243327|NCT00656318|women|women
5243328|NCT00656318|menses|menses
5243329|NCT00656318|oral contraceptives|oral contraceptives
5243330|NCT00656318|Healthy menstruating females|healthy menstruating females
5243331|NCT00656305|Bone Cancer|bone cancer
5243332|NCT00656305|Pain Palliation|pain palliation
5243333|NCT00656305|Metastasis|metastasis
5243334|NCT00656305|Multiple Myeloma|multiple myeloma
5243335|NCT00656305|Breast Cancer|breast cancer
5243336|NCT00656305|Lung Cancer|lung cancer
5243337|NCT00656305|Prostate Cancer|prostate cancer
5243338|NCT00656305|cancer related Pain|cancer related pain
5243339|NCT00656305|Tumors|tumors
5243340|NCT00656292|Plasma concentrations of inflammatory markers|plasma concentrations of inflammatory markers
5243341|NCT00656292|C-Reactive Protein (CRP)|c-reactive protein (crp)
5243342|NCT00656292|Interleukin-6 (IL-6)|interleukin-6 (il-6)
5243343|NCT00656292|Tumor Necrosis Factor-Alpha (TNF)|tumor necrosis factor-alpha (tnf)
5243344|NCT00656292|Aspartate Aminotransferase (AST)|aspartate aminotransferase (ast)
5243345|NCT00656292|Alanine Aminotransferase (ALT)|alanine aminotransferase (alt)
5243346|NCT00656292|Creatine Kinase (CK)|creatine kinase (ck)
5243347|NCT00656279|chronic kidney disease|chronic kidney disease
5243348|NCT00656279|predialysis|predialysis
5243349|NCT00656279|hyperphosphatemia|hyperphosphatemia
5243350|NCT00656279|dietary intervention|dietary intervention
5243351|NCT00656279|intensive dietary education|intensive dietary education
5243352|NCT00656279|low phosphorus diet|low phosphorus diet
5243353|NCT00656266|renal insufficiency and/or renal failure after liver transplantation|renal insufficiency and/or renal failure after liver transplantation
5243354|NCT00656214|Lichen Planus|lichen planus
5243355|NCT00656201|Infertility|infertility
5243356|NCT00656201|In vitro fertilization|in vitro fertilization
5243357|NCT00656201|Embryo transfer|embryo transfer
5243358|NCT00656201|Crinone|crinone
5243359|NCT00656201|Intramuscular Progesterone|intramuscular progesterone
5243360|NCT00656201|Progesterone support|progesterone support
5243361|NCT00656188|Erectile Dysfunction|erectile dysfunction
5243362|NCT00656188|Vardenafil|vardenafil
5243363|NCT00656175|lipodystrophy|lipodystrophy
5243365|NCT00656175|visceral fat|visceral fat
5243366|NCT00656175|HIV|hiv
5243367|NCT00656175|women|women
5243368|NCT00656175|raltegravir|raltegravir
5243369|NCT00656175|ART|art
5243370|NCT00656175|anti HIV therapy|anti hiv therapy
5243371|NCT00656175|NNRTI|nnrti
5243372|NCT00656175|Protease inhibitor|protease inhibitor
5243373|NCT00656175|integrase inhibitor|integrase inhibitor
5243374|NCT00656175|treatment experienced|treatment experienced
5243375|NCT00656149|telerehabilitation|telerehabilitation
5243376|NCT00656149|functional electrical stimulation|functional electrical stimulation
5243377|NCT00656149|spinal cord injury|spinal cord injury
5243378|NCT00656149|hand function rehabilitation|hand function rehabilitation
5243379|NCT00656123|adenocarcinoma of the colon|adenocarcinoma of the colon
5243380|NCT00656123|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5243381|NCT00656123|stage IV colon cancer|stage iv colon cancer
5243382|NCT00656123|stage IV rectal cancer|stage iv rectal cancer
5243979|NCT00654004|protein|protein
5243383|NCT00656123|liver metastases|liver metastases
5243384|NCT00656110|Restless legs syndrome|restless legs syndrome
5243385|NCT00656110|Morton's neuroma|morton's neuroma
5243386|NCT00656110|Randomized controlled trial|randomized controlled trial
5243387|NCT00656097|Rabies post-exposure prophylaxis|rabies post-exposure prophylaxis
5243388|NCT00656071|ARDS|ards
5243389|NCT00656071|Acute respiratory distress syndrome|acute respiratory distress syndrome
5243390|NCT00656071|Adult respiratory distress syndrome|adult respiratory distress syndrome
5243391|NCT00656071|respiratory distress|respiratory distress
5243392|NCT00656058|Leukotriene|leukotriene
5243393|NCT00656058|Chronic Graft-Versus-Host Disease|chronic graft-versus-host disease
5243394|NCT00656058|Montelukast|montelukast
5243395|NCT00656058|Stem Cell Transplant|stem cell transplant
5243396|NCT00656058|Bronchiolitis Obliterans|bronchiolitis obliterans
5243397|NCT00656045|Obesity|obesity
5243398|NCT00656045|Physical Activity|physical activity
5243399|NCT00656045|Weight Loss|weight loss
5243400|NCT00656045|Exercise|exercise
5243401|NCT00656045|Dietary Intake|dietary intake
5243402|NCT00656045|Energy|energy
5243403|NCT00656045|Behavioral|behavioral
5243404|NCT00656045|Healthy Eating|healthy eating
5243405|NCT00656032|insulin resistance|insulin resistance
5243406|NCT00656032|end stage renal disease|end stage renal disease
5243407|NCT00656006|Hepatitis C|hepatitis c
5243408|NCT00656006|Chronic|chronic
5243409|NCT00656006|Genotype 2 or 3|genotype 2 or 3
5243410|NCT00656006|Treatment naive|treatment naive
5243411|NCT00655993|COPD|copd
5243412|NCT00655993|Inflammation|inflammation
5243413|NCT00655993|CRP levels|crp levels
5243414|NCT00655993|simvastatin|simvastatin
5243415|NCT00655954|COPD|copd
5243416|NCT00655954|asthma|asthma
5243417|NCT00655954|smokers|smokers
5243418|NCT00655954|healthy volunteers|healthy volunteers
5243419|NCT00655954|bronchiectasis|bronchiectasis
5243420|NCT00655954|cystic fibrosis|cystic fibrosis
5243421|NCT00655941|Osteoarthritis|osteoarthritis
5243422|NCT00655941|Obesity|obesity
5243423|NCT00655941|Weight loss|weight loss
5243424|NCT00655941|Dietary instruction|dietary instruction
5243425|NCT00655941|Exercise|exercise
5243426|NCT00655941|Attention|attention
5243427|NCT00655928|Acute lung injury|acute lung injury
5243428|NCT00655928|Lung resection|lung resection
5243429|NCT00655902|Trans fat|trans fat
5243430|NCT00655902|Obesity|obesity
5243431|NCT00655902|Insulin sensitivity|insulin sensitivity
5243432|NCT00655876|stage IIA esophageal cancer|stage iia esophageal cancer
5243433|NCT00655876|stage IIB esophageal cancer|stage iib esophageal cancer
5243434|NCT00655876|stage IIIA esophageal cancer|stage iiia esophageal cancer
5243435|NCT00655876|stage IIIB esophageal cancer|stage iiib esophageal cancer
5243436|NCT00655876|stage IIIC esophageal cancer|stage iiic esophageal cancer
5243437|NCT00655876|stage IV esophageal cancer|stage iv esophageal cancer
5243438|NCT00655876|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
5243439|NCT00655863|Glucose Metabolism Disorder|glucose metabolism disorder
5243440|NCT00655863|Dysmetabolic Syndrome|dysmetabolic syndrome
5243441|NCT00655863|Type II Diabetes|type ii diabetes
5243442|NCT00655863|Diabetes Mellitus|diabetes mellitus
5243443|NCT00655863|Lipoatrophic; Dyslipidemia|lipoatrophic; dyslipidemia
5243444|NCT00655863|Drug Therapy|drug therapy
5243445|NCT00655850|Lung Cancer|lung cancer
5243446|NCT00655850|Non-Small Cell Lung Cancer|non-small cell lung cancer
5243447|NCT00655850|Metronomic Chemotherapy|metronomic chemotherapy
5243448|NCT00655837|Antigens, CD40|antigens, cd40
5243449|NCT00655837|Antibodies, Monoclonal|antibodies, monoclonal
5243450|NCT00655837|Combined Modality Therapy|combined modality therapy
5243451|NCT00655837|Lymphoma, Large B-Cell, Diffuse|lymphoma, large b-cell, diffuse
5243452|NCT00655837|Lymphoma, Non-Hodgkin|lymphoma, non-hodgkin
5243453|NCT00655837|Hematologic Diseases|hematologic diseases
5243454|NCT00655837|Immunoproliferative Disorders|immunoproliferative disorders
5243455|NCT00655837|Lymphatic Diseases|lymphatic diseases
5243456|NCT00655837|Lymphoproliferative Disorders|lymphoproliferative disorders
5243457|NCT00655837|Lymphoma|lymphoma
5243458|NCT00655811|Healthy volunteers|healthy volunteers
5243459|NCT00655785|Epitope peptide|epitope peptide
5243461|NCT00655785|Pancreatic cancer|pancreatic cancer
5243462|NCT00655785|Vaccination VEGFR1|vaccination vegfr1
5243463|NCT00655785|VEGFR2|vegfr2
5243464|NCT00655772|chlorine|chlorine
5243465|NCT00655772|dioxide|dioxide
5243466|NCT00655772|mouthwash|mouthwash
5243467|NCT00655772|organoleptic|organoleptic
5243468|NCT00655772|measurements|measurements
5243469|NCT00655772|volatile|volatile
5243470|NCT00655772|sulfur|sulfur
5243471|NCT00655772|compounds|compounds
5243472|NCT00655746|Healthy Subjects|healthy subjects
5243473|NCT00655720|infant formula|infant formula
5243474|NCT00655707|Adult stem cell therapy|adult stem cell therapy
5243475|NCT00655694|COPD|copd
5243476|NCT00655694|smokers|smokers
5243477|NCT00655694|healthy volunteers|healthy volunteers
5243478|NCT00655681|pediatric osteoporosis|pediatric osteoporosis
5243479|NCT00655681|pediatric osteopenia|pediatric osteopenia
5243480|NCT00655681|pamidronate|pamidronate
5243481|NCT00655681|post operative osteopenia|post operative osteopenia
5243482|NCT00655668|NHL, Non-Hodgkin's Lymphoma, T-cell Lymphoma|nhl, non-hodgkin's lymphoma, t-cell lymphoma
5243483|NCT00655629|Erectile Dysfunction|erectile dysfunction
5243484|NCT00655603|GLP-1|glp-1
5243485|NCT00655603|Glucagon secretion|glucagon secretion
5243486|NCT00655603|Glucose turn-over|glucose turn-over
5243487|NCT00655590|Erectile Dysfunction|erectile dysfunction
5243488|NCT00655590|Sildenafil|sildenafil
5243489|NCT00655590|Vardenafil|vardenafil
5243490|NCT00655590|Spermatogenesis|spermatogenesis
5243491|NCT00655590|Sperm concentration|sperm concentration
5243492|NCT00655590|Sperm count|sperm count
5243493|NCT00655590|Morphology|morphology
5243494|NCT00655590|Motility|motility
5243495|NCT00655590|Reproductive hormonal|reproductive hormonal
5243496|NCT00655577|Aging|aging
5243497|NCT00655577|Osteoporosis|osteoporosis
5243498|NCT00655577|Exercise|exercise
5243499|NCT00655577|Population based|population based
5243500|NCT00655577|Randomized trial|randomized trial
5243501|NCT00655577|Falls|falls
5243502|NCT00655577|Fractures|fractures
5243503|NCT00655551|epilepsy|epilepsy
5243504|NCT00655551|seizures|seizures
5243505|NCT00655551|Lacosamide|lacosamide
5243506|NCT00655551|Vimpat|vimpat
5243507|NCT00655551|intravenous|intravenous
5243508|NCT00655525|inflammation|inflammation
5243509|NCT00655525|end stage renal disease|end stage renal disease
5243510|NCT00655512|pimecrolimus|pimecrolimus
5243511|NCT00655512|hydrocortison|hydrocortison
5243512|NCT00655512|betamethasone|betamethasone
5243513|NCT00655512|clobetasol-17-Propionat|clobetasol-17-propionat
5243514|NCT00655512|Optical Coherence Tomography|optical coherence tomography
5243515|NCT00655512|skin healthy probands|skin healthy probands
5243516|NCT00655499|adenocarcinoma of the colon|adenocarcinoma of the colon
5243517|NCT00655499|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5243518|NCT00655499|stage IV colon cancer|stage iv colon cancer
5243519|NCT00655499|recurrent rectal cancer|recurrent rectal cancer
5243520|NCT00655499|stage IV rectal cancer|stage iv rectal cancer
5243521|NCT00655499|recurrent colon cancer|recurrent colon cancer
5243522|NCT00655486|Epilepsy|epilepsy
5243523|NCT00655486|seizures|seizures
5243524|NCT00655486|antiepileptic|antiepileptic
5243525|NCT00655486|Lacosamide|lacosamide
5243526|NCT00655486|Vimpat|vimpat
5243527|NCT00655486|safety|safety
5243528|NCT00655486|adjunctive|adjunctive
5243529|NCT00655460|Glucose|glucose
5243530|NCT00655460|Insulin|insulin
5243531|NCT00655460|computer|computer
5243532|NCT00655460|critical care|critical care
5243533|NCT00655447|oophorectomy|oophorectomy
5243534|NCT00655447|ovarian conservation|ovarian conservation
5243535|NCT00655447|stroke|stroke
5243536|NCT00655447|breast cancer|breast cancer
5243537|NCT00655447|ovarian cancer|ovarian cancer
5243538|NCT00655447|other cancer|other cancer
5243539|NCT00655447|hip fracture|hip fracture
5243540|NCT00655434|Herpes simplex virus 2|herpes simplex virus 2
5243541|NCT00655434|HSV 2|hsv 2
5243542|NCT00655434|Antibody status to Herpesvirus 2, Human|antibody status to herpesvirus 2, human
5243543|NCT00655421|screening|screening
5243544|NCT00655421|oral precancers|oral precancers
5243545|NCT00655421|tobacco users|tobacco users
5243546|NCT00655421|VELScope|velscope
5243547|NCT00655421|Visual Inspection|visual inspection
5243548|NCT00655421|Toluidine Blue|toluidine blue
5243549|NCT00655408|Infants|infants
5243550|NCT00655408|Prevalence|prevalence
5243551|NCT00655408|Iron|iron
5243552|NCT00655408|Deficiency|deficiency
5243553|NCT00655408|Treatment|treatment
5243554|NCT00655395|Leukemia|leukemia
5243555|NCT00655395|MDS|mds
5243556|NCT00655382|dynamic pelvic mri|dynamic pelvic mri
5243557|NCT00655382|dynamic mri|dynamic mri
5243558|NCT00655382|STARR procedure|starr procedure
5243559|NCT00655382|STARR|starr
5243560|NCT00655382|ODS|ods
5243561|NCT00655382|obstructive defecation syndrome|obstructive defecation syndrome
5243562|NCT00655382|outlet obstruction|outlet obstruction
5243563|NCT00655382|obstructed defecation|obstructed defecation
5243564|NCT00655382|stapled trans anal rectal resection|stapled trans anal rectal resection
5243565|NCT00655356|Treatment of moderate to severe bilateral nasolabial fold wrinkles|treatment of moderate to severe bilateral nasolabial fold wrinkles
5243566|NCT00655343|GvHD|gvhd
5243567|NCT00655343|aGvHD prophylaxis|agvhd prophylaxis
5243568|NCT00655343|Matched unrelated donor|matched unrelated donor
5243569|NCT00655343|ATG|atg
5243570|NCT00655343|SCT|sct
5243571|NCT00655343|BMT|bmt
5243572|NCT00655343|polyclonal antibody|polyclonal antibody
5243573|NCT00655343|GvHD prophylaxis for patients with ALL, AML, CML, MDS, OMF|gvhd prophylaxis for patients with all, aml, cml, mds, omf
5243574|NCT00655343|Patients with allogeneic BM or PBSC transplantation|patients with allogeneic bm or pbsc transplantation
5243575|NCT00655343|Patients with a matched unrelated donor|patients with a matched unrelated donor
5243576|NCT00655330|Type 2 diabetes mellitus|type 2 diabetes mellitus
5243577|NCT00655330|Nephropathy|nephropathy
5243578|NCT00655330|valsartan|valsartan
5243579|NCT00655330|probucol|probucol
5243580|NCT00655330|Proteinuria|proteinuria
5243581|NCT00655317|acupuncture|acupuncture
5243582|NCT00655317|colon surgery|colon surgery
5243583|NCT00655317|post operative ileus|post operative ileus
5243584|NCT00655317|post ileus|post ileus
5243585|NCT00655317|ileus|ileus
5243586|NCT00655317|colectomy|colectomy
5243587|NCT00655317|colorectal pathology|colorectal pathology
5243588|NCT00655291|pain|pain
5243589|NCT00655278|Movement Disorder|movement disorder
5243590|NCT00655252|Expanded access|expanded access
5243591|NCT00655252|metastatic renal cell cancer|metastatic renal cell cancer
5243592|NCT00655252|progression despite VEGF receptors|progression despite vegf receptors
5243593|NCT00655239|Ultra High Risk of Schizophrenia|ultra high risk of schizophrenia
5243594|NCT00655239|Prodrome|prodrome
5243595|NCT00655239|Psychosis|psychosis
5243596|NCT00655239|Schizophrenia|schizophrenia
5243597|NCT00655239|Cognitive Remediation|cognitive remediation
5243598|NCT00655226|Cognitive Behavior Therapy|cognitive behavior therapy
5243599|NCT00655226|Interferon-alpha|interferon-alpha
5243600|NCT00655226|Communicable Diseases|communicable diseases
5243601|NCT00655226|Liver Diseases|liver diseases
5243602|NCT00655226|Depression|depression
5243603|NCT00655226|Hepatitis, Chronic|hepatitis, chronic
5243604|NCT00655226|Interferons|interferons
5243605|NCT00655226|Ribavirin|ribavirin
5243606|NCT00655226|Hepatitis, Viral, Human|hepatitis, viral, human
5243607|NCT00655226|Infection|infection
5243608|NCT00655226|Hepatitis|hepatitis
5243609|NCT00655226|Mood Disorders|mood disorders
5243610|NCT00655226|Peginterferon alfa-2a|peginterferon alfa-2a
5243611|NCT00655226|Hepatitis C|hepatitis c
5243612|NCT00655226|Interferon Alfa-2a|interferon alfa-2a
5243613|NCT00655226|Interferon Alfa-2b|interferon alfa-2b
5243614|NCT00655226|Depressive Disorder, Major|depressive disorder, major
5243615|NCT00655226|Depressive Disorder|depressive disorder
5243616|NCT00655213|Pacing, AV conduction disorders, minimized ventricular pacing, AF|pacing, av conduction disorders, minimized ventricular pacing, af
5243617|NCT00655174|autism|autism
5243618|NCT00655174|fluvoxamine|fluvoxamine
5243619|NCT00655174|sertraline|sertraline
5243620|NCT00655174|selective seratonin reuptake inhibitors|selective seratonin reuptake inhibitors
5243621|NCT00655174|paediatrics|paediatrics
5243622|NCT00655161|NSCLC|nsclc
5243623|NCT00655161|Cancer Immunotherapy|cancer immunotherapy
5243624|NCT00655148|DTaP-IPV|dtap-ipv
5243625|NCT00655148|Clinical Trial|clinical trial
5243626|NCT00655148|Safety|safety
5243627|NCT00655148|Immunogenicity|immunogenicity
5243628|NCT00655109|Allergic conjunctivitis|allergic conjunctivitis
5243629|NCT00655109|Allergic rhinoconjunctivitis|allergic rhinoconjunctivitis
5243630|NCT00655096|Screening Protocol|screening protocol
5243631|NCT00655096|Eye Diseases|eye diseases
5243632|NCT00655083|Infantile colic|infantile colic
5243633|NCT00655083|Abdominal Cramps|abdominal cramps
5243634|NCT00655083|Colicky Pain|colicky pain
5243635|NCT00655083|Functional gastrointestinal disorders|functional gastrointestinal disorders
5243636|NCT00655070|Hibernating Myocardium|hibernating myocardium
5243637|NCT00655070|Blood Flow|blood flow
5243638|NCT00655070|Ultrasound|ultrasound
5243639|NCT00655070|PET imaging|pet imaging
5243640|NCT00655057|Dopamine Transporter|dopamine transporter
5243641|NCT00655057|Biomarker|biomarker
5243642|NCT00655057|SPECT Brain Imaging|spect brain imaging
5243643|NCT00655057|Antidepressant Therapy|antidepressant therapy
5243644|NCT00655031|Punicaceae|punicaceae
5243645|NCT00655031|Pomegranate|pomegranate
5243646|NCT00655018|Non-Alcoholic Fatty Liver Disease (NAFLD)|non-alcoholic fatty liver disease (nafld)
5243647|NCT00655018|Non-Alcoholic Steatohepatitis (NASH)|non-alcoholic steatohepatitis (nash)
5243648|NCT00655018|Liver histology|liver histology
5243649|NCT00655018|Insulin Resistance|insulin resistance
5243650|NCT00655018|Weight loss|weight loss
5243651|NCT00655018|Alpha-tocopherol|alpha-tocopherol
5243652|NCT00655018|ascorbic acid|ascorbic acid
5243653|NCT00655005|head and neck cancer|head and neck cancer
5243654|NCT00654966|Urotensin II|urotensin ii
5243655|NCT00654966|Soluble epoxide hydrolase|soluble epoxide hydrolase
5243656|NCT00654966|Iontophoresis|iontophoresis
5243657|NCT00654966|Healthy volunteers|healthy volunteers
5243658|NCT00654953|cocaine dependence|cocaine dependence
5243659|NCT00654953|depressive symptoms|depressive symptoms
5243660|NCT00654953|relapse|relapse
5243661|NCT00654953|sertraline|sertraline
5243662|NCT00654953|gabapentin|gabapentin
5243663|NCT00654927|multiple sclerosis|multiple sclerosis
5243664|NCT00654927|MS|ms
5243665|NCT00654927|walking|walking
5243666|NCT00654927|leg strength|leg strength
5243667|NCT00654927|demyelination|demyelination
5243668|NCT00654914|Sexual Dysfunction|sexual dysfunction
5243669|NCT00654901|Diphtheria|diphtheria
5243670|NCT00654901|Tetanus|tetanus
5243671|NCT00654901|Pertussis|pertussis
5243672|NCT00654901|Hepatitis B|hepatitis b
5243673|NCT00654901|Poliomyelitis|poliomyelitis
5243674|NCT00654901|Invasive Haemophilus influenzae type b.|invasive haemophilus influenzae type b.
5243675|NCT00654901|Haemophilus Influenzae Type B Infection|haemophilus influenzae type b infection
5243676|NCT00654888|cataract extraction|cataract extraction
5243677|NCT00654888|surgery|surgery
5243678|NCT00654888|corneal disease|corneal disease
5243679|NCT00654875|Essential Hypertension|essential hypertension
5243680|NCT00654849|Electrosurgery|electrosurgery
5243681|NCT00654849|Gyrus Pk|gyrus pk
5243682|NCT00654849|abdominal hysterectomy|abdominal hysterectomy
5243683|NCT00654849|Blood Loss, Surgical|blood loss, surgical
5243684|NCT00654849|Length of stay|length of stay
5243685|NCT00654849|Overall cost|overall cost
5243686|NCT00654836|recurrent breast cancer|recurrent breast cancer
5243687|NCT00654836|stage III breast cancer|stage iii breast cancer
5243688|NCT00654836|stage IV breast cancer|stage iv breast cancer
5243689|NCT00654810|functional ability|functional ability
5243690|NCT00654810|gait|gait
5243691|NCT00654810|musculoskeletal disorder therapy|musculoskeletal disorder therapy
5243692|NCT00654810|peripheral blood vessel disorder|peripheral blood vessel disorder
5243693|NCT00654797|Glucose|glucose
5243694|NCT00654797|Insulin|insulin
5243695|NCT00654797|computer|computer
5243696|NCT00654797|critical care|critical care
5243697|NCT00654784|Duchenne Muscular Dystrophy|duchenne muscular dystrophy
5243698|NCT00654784|DMD|dmd
5243699|NCT00654784|Duchenne|duchenne
5243700|NCT00654771|protein/creatinine ratio|protein/creatinine ratio
5243701|NCT00654771|clean catch urine|clean catch urine
5243702|NCT00654771|catheterized urine|catheterized urine
5243703|NCT00654758|cancer|cancer
5243704|NCT00654758|carcinoma|carcinoma
5243705|NCT00654758|chemotherapy|chemotherapy
5243706|NCT00654758|monoclonal antibody therapy|monoclonal antibody therapy
5243707|NCT00654758|anti-angiogenesis|anti-angiogenesis
5243708|NCT00654745|blood pressure reduction|blood pressure reduction
5243709|NCT00654732|Hodgkin Lymphoma|hodgkin lymphoma
5243710|NCT00654732|Lymphoma|lymphoma
5243711|NCT00654732|Adriamycin|adriamycin
5243712|NCT00654732|Doxorubicin Hydrochloride|doxorubicin hydrochloride
5243713|NCT00654732|Adriamycin PFS®|adriamycin pfs®
5243714|NCT00654732|Adriamycin RDF™|adriamycin rdf™
5243715|NCT00654732|Rituxan|rituxan
5243716|NCT00654732|Rituximab|rituximab
5243717|NCT00654732|Bleomycin|bleomycin
5243718|NCT00654732|Bleomycin sulfate|bleomycin sulfate
5243719|NCT00654732|Blenoxane®|blenoxane®
5243720|NCT00654732|BLM|blm
5243721|NCT00654732|Vinblastine|vinblastine
5243722|NCT00654732|Velban|velban
5243723|NCT00654732|Dacarbazine|dacarbazine
5243724|NCT00654732|DTIC|dtic
5243725|NCT00654732|DTIC-Dome®|dtic-dome®
5243726|NCT00654732|R-ABVD|r-abvd
5243727|NCT00654732|ABVD|abvd
5243728|NCT00654719|Heart failure|heart failure
5243729|NCT00654719|cachexia|cachexia
5243730|NCT00654706|Schizophrenia|schizophrenia
5243731|NCT00654706|Cognition|cognition
5243732|NCT00654706|MATRICS Consensus Cognitive Battery|matrics consensus cognitive battery
5243733|NCT00654693|NTX|ntx
5243734|NCT00654693|Nihon Kohden|nihon kohden
5243735|NCT00654693|mobile monitoring|mobile monitoring
5243736|NCT00654693|monitoring|monitoring
5243737|NCT00654693|nihon|nihon
5243738|NCT00654693|kohden|kohden
5243739|NCT00654693|monitoring device|monitoring device
5243740|NCT00654693|remote monitoring|remote monitoring
5243741|NCT00654693|wireless|wireless
5243742|NCT00654680|Erectile Dysfunction|erectile dysfunction
5243743|NCT00654680|Traumatic spinal cord injury|traumatic spinal cord injury
5243744|NCT00654680|Vardenafil|vardenafil
5243745|NCT00654667|Resveratrol|resveratrol
5243746|NCT00654667|Insulin Resistance|insulin resistance
5243747|NCT00654667|Metabolic Syndrome|metabolic syndrome
5243748|NCT00654667|Sirtuin 1|sirtuin 1
5243749|NCT00654667|IGF-1|igf-1
5243750|NCT00654667|Satiety|satiety
5243751|NCT00654667|Leptin|leptin
5243752|NCT00654667|Adiponectin|adiponectin
5243753|NCT00654641|Surgical Wound Dehiscence|surgical wound dehiscence
5243754|NCT00654641|Wound Infection|wound infection
5243755|NCT00654641|Obesity|obesity
5243756|NCT00654641|Cesarean Delivery|cesarean delivery
5243757|NCT00654641|Wound Closure|wound closure
5243758|NCT00654641|Negative Pressure wound closure|negative pressure wound closure
5243759|NCT00654615|unstable metaphyseal distal radius fractures|unstable metaphyseal distal radius fractures
5243760|NCT00654615|randomized controlled trial|randomized controlled trial
5243761|NCT00654615|surgical fixation|surgical fixation
5243762|NCT00654615|volar plate|volar plate
5243763|NCT00654615|intramedullary distal radius fixation system|intramedullary distal radius fixation system
5243764|NCT00654602|cholesterol|cholesterol
5243765|NCT00654602|low density lipoproteins|low density lipoproteins
5243766|NCT00654602|dyslipidaemia|dyslipidaemia
5243767|NCT00654602|Rosuvastatin|rosuvastatin
5243768|NCT00654602|Crestor|crestor
5243769|NCT00654589|Hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
5243770|NCT00654589|HCT|hct
5243771|NCT00654589|iron overload|iron overload
5243772|NCT00654589|chelators|chelators
5243773|NCT00654589|ICL670|icl670
5243774|NCT00654589|deferasirox|deferasirox
5243775|NCT00654589|serum ferritin|serum ferritin
5243776|NCT00654589|LIC|lic
5243777|NCT00654589|transfusional hemosiderosis|transfusional hemosiderosis
5243778|NCT00654589|blood transfusions|blood transfusions
5243779|NCT00654589|adults|adults
5243780|NCT00654589|iron chelation|iron chelation
5243781|NCT00654589|3-6 months|3-6 months
5243782|NCT00654589|allogeneic hematopoietic stem cell transplantation|allogeneic hematopoietic stem cell transplantation
5243783|NCT00654576|schizophrenia|schizophrenia
5243784|NCT00654576|antipsychotic|antipsychotic
5243785|NCT00654576|outcome|outcome
5243786|NCT00654576|psychosocial intervention|psychosocial intervention
5243787|NCT00654563|Memory Disorders|memory disorders
5243788|NCT00654563|Memory loss|memory loss
5243980|NCT00654004|deficiency|deficiency
5243789|NCT00654563|Age Associated Memory Impairment|age associated memory impairment
5243790|NCT00654550|Photorefractive keratectomy|photorefractive keratectomy
5243791|NCT00654550|Re-epithelialization|re-epithelialization
5243792|NCT00654550|Nexagon|nexagon
5243793|NCT00654550|PRK|prk
5243794|NCT00654550|Coda|coda
5243795|NCT00654537|Cholesterol|cholesterol
5243796|NCT00654537|hypercholesterolemia|hypercholesterolemia
5243797|NCT00654537|low density lipoproteins|low density lipoproteins
5243798|NCT00654524|Endometriosis|endometriosis
5243799|NCT00654524|Recurrence|recurrence
5243800|NCT00654524|Pregnancy Rate|pregnancy rate
5243801|NCT00654524|Laparoscopy|laparoscopy
5243802|NCT00654524|Gonadotropin-Releasing Hormone|gonadotropin-releasing hormone
5243803|NCT00654511|Dexmedetomidine,|dexmedetomidine,
5243804|NCT00654511|fentanyl,|fentanyl,
5243805|NCT00654511|tonsillectomy|tonsillectomy
5243806|NCT00654511|and adenoidectomy,|and adenoidectomy,
5243807|NCT00654485|Cholesterol|cholesterol
5243808|NCT00654485|hypercholesterolemia|hypercholesterolemia
5243809|NCT00654485|low density lipoproteins|low density lipoproteins
5243810|NCT00654485|metabolic syndrome|metabolic syndrome
5243811|NCT00654485|Rosuvastatin|rosuvastatin
5243812|NCT00654472|magnetic resonance imaging, mitral valve area|magnetic resonance imaging, mitral valve area
5243813|NCT00654446|Cholesterol|cholesterol
5243814|NCT00654446|low density lipoproteins|low density lipoproteins
5243815|NCT00654446|dyslipidaemia|dyslipidaemia
5243816|NCT00654446|Rosuvastatin|rosuvastatin
5243817|NCT00654446|Crestor|crestor
5243818|NCT00654446|Simvastatin|simvastatin
5243819|NCT00654446|Zocor|zocor
5243820|NCT00654446|Renal|renal
5243821|NCT00654446|kidney|kidney
5243822|NCT00654433|Hurler Syndrome|hurler syndrome
5243823|NCT00654433|MPS I|mps i
5243824|NCT00654433|Hurler-Scheie Syndrome|hurler-scheie syndrome
5243825|NCT00654433|Hunter Syndrome|hunter syndrome
5243826|NCT00654433|MPS II|mps ii
5243827|NCT00654433|Sanfilippo Syndrome|sanfilippo syndrome
5243828|NCT00654433|MPS III|mps iii
5243829|NCT00654433|Maroteaux-Lamy Syndrome|maroteaux-lamy syndrome
5243830|NCT00654433|MPS VI|mps vi
5243831|NCT00654433|Krabbe Disease|krabbe disease
5243832|NCT00654433|Globoid Leukodystrophy|globoid leukodystrophy
5243833|NCT00654433|Metachromatic Leukodystrophy|metachromatic leukodystrophy
5243834|NCT00654433|MLD|mld
5243835|NCT00654433|Adrenoleukodystrophy|adrenoleukodystrophy
5243836|NCT00654433|ALD|ald
5243837|NCT00654433|Adrenomyeloneuropathy|adrenomyeloneuropathy
5243838|NCT00654433|AMN|amn
5243839|NCT00654433|Sandhoff Disease|sandhoff disease
5243840|NCT00654433|Tay Sachs Disease|tay sachs disease
5243841|NCT00654433|Pelizaeus Merzbacher|pelizaeus merzbacher
5243842|NCT00654433|PMD|pmd
5243843|NCT00654433|Niemann-Pick Disease A|niemann-pick disease a
5243844|NCT00654433|Niemann-Pick Disease B|niemann-pick disease b
5243845|NCT00654433|Alpha-mannosidosis|alpha-mannosidosis
5243846|NCT00654433|Inherited metabolic diseases|inherited metabolic diseases
5243847|NCT00654433|Inborn errors of metabolism|inborn errors of metabolism
5243848|NCT00654433|Lysosomal storage diseases|lysosomal storage diseases
5243849|NCT00654433|Peroxisomal storage diseases|peroxisomal storage diseases
5243850|NCT00654433|Hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
5243851|NCT00654433|Umbilical cord blood transplantation|umbilical cord blood transplantation
5243852|NCT00654433|Mucopolysaccharidosis|mucopolysaccharidosis
5243853|NCT00654433|Mucopolysaccharidosis I|mucopolysaccharidosis i
5243854|NCT00654433|Mucopolysaccharidosis II|mucopolysaccharidosis ii
5243855|NCT00654433|Mucopolysaccharidosis III|mucopolysaccharidosis iii
5243856|NCT00654433|Mucopolysaccharidosis VI|mucopolysaccharidosis vi
5243857|NCT00654433|I Cell disease|i cell disease
5243858|NCT00654433|Fucosidosis|fucosidosis
5243859|NCT00654433|GM1 Gangliosidosis|gm1 gangliosidosis
5243860|NCT00654433|Canavan Disease|canavan disease
5243861|NCT00654407|Cholesterol|cholesterol
5243862|NCT00654407|hypercholesterolemia|hypercholesterolemia
5243863|NCT00654407|Coronary Heart disease|coronary heart disease
5243864|NCT00654407|low density lipoproteins|low density lipoproteins
5243865|NCT00654407|Rosuvastatin|rosuvastatin
5243866|NCT00654407|Atorvastatin|atorvastatin
5243867|NCT00654407|simvastatin|simvastatin
5243868|NCT00654394|Cholesterol|cholesterol
5243869|NCT00654394|Carotid Artery Stenosis|carotid artery stenosis
5243870|NCT00654394|Hypercholesterolemia|hypercholesterolemia
5243871|NCT00654394|Rosuvastatin|rosuvastatin
5243872|NCT00654394|Crestor|crestor
5243873|NCT00654368|Amgen|amgen
5243874|NCT00654355|atopic dermatitis|atopic dermatitis
5243875|NCT00654355|eczema|eczema
5243876|NCT00654342|Sentinel lymph node-colon cancer|sentinel lymph node-colon cancer
5243877|NCT00654329|Dexmedetomidine, transmucosal, myringotomy,|dexmedetomidine, transmucosal, myringotomy,
5243878|NCT00654316|TB|tb
5243879|NCT00654316|Tuberculosis|tuberculosis
5243880|NCT00654316|MVA85A|mva85a
5243881|NCT00654316|Vaccine|vaccine
5243882|NCT00654316|BCG|bcg
5243883|NCT00654303|Cholesterol|cholesterol
5243884|NCT00654303|Hypercholesterolaemia|hypercholesterolaemia
5243885|NCT00654303|Statins|statins
5243886|NCT00654290|Atrial fibrillation|atrial fibrillation
5243887|NCT00654290|coronary bypass|coronary bypass
5243888|NCT00654290|Amiodarone|amiodarone
5243890|NCT00654290|Coronary Artery Bypass Graft (CABG)|coronary artery bypass graft (cabg)
5243891|NCT00654277|bioequivalence|bioequivalence
5243892|NCT00654277|Ondansetron ODT|ondansetron odt
5243893|NCT00654277|Fasting|fasting
5243894|NCT00654277|To determine bioequivalence under fasting conditions|to determine bioequivalence under fasting conditions
5243895|NCT00654251|Spinocerebellar ataxia|spinocerebellar ataxia
5243896|NCT00654251|Machado-Joseph disease|machado-joseph disease
5243897|NCT00654251|Gait monitoring|gait monitoring
5243898|NCT00654251|Functional vision assessment|functional vision assessment
5243899|NCT00654238|Thyroid Cancer|thyroid cancer
5243900|NCT00654238|Anaplastic|anaplastic
5243901|NCT00654238|Medullary|medullary
5243902|NCT00654238|sorafenib|sorafenib
5243903|NCT00654225|Cholesterol|cholesterol
5243904|NCT00654225|low density lipoproteins|low density lipoproteins
5243905|NCT00654225|dyslipidaemia|dyslipidaemia
5243906|NCT00654225|Rosuvastatin|rosuvastatin
5243907|NCT00654225|Crestor|crestor
5243908|NCT00654225|Atorvastatin|atorvastatin
5243909|NCT00654225|Lipitor|lipitor
5243910|NCT00654225|South Asian|south asian
5243911|NCT00654212|stenting, laparoscopic surgery, colon cancer|stenting, laparoscopic surgery, colon cancer
5243912|NCT00654199|CABG|cabg
5243913|NCT00654199|Ventricular Asynchrony|ventricular asynchrony
5243914|NCT00654199|Normal Sinus Rhythm|normal sinus rhythm
5243915|NCT00654186|Androgen Independent Prostate Cancer (AIPC)|androgen independent prostate cancer (aipc)
5243916|NCT00654186|Chemo naive|chemo naive
5243917|NCT00654173|Cholesterol|cholesterol
5243918|NCT00654173|low density lipoproteins|low density lipoproteins
5243919|NCT00654173|dyslipidaemia|dyslipidaemia
5243920|NCT00654173|Rosuvastatin|rosuvastatin
5243921|NCT00654173|Crestor|crestor
5243922|NCT00654173|Atorvastatin|atorvastatin
5243923|NCT00654173|Lipitor|lipitor
5243924|NCT00654173|Zocor|zocor
5243925|NCT00654173|simvastatin|simvastatin
5243926|NCT00654160|stage IIIB anal cancer|stage iiib anal cancer
5243927|NCT00654160|stage IV anal cancer|stage iv anal cancer
5243928|NCT00654160|recurrent anal cancer|recurrent anal cancer
5243929|NCT00654160|carcinoma of the appendix|carcinoma of the appendix
5243930|NCT00654160|stage III colon cancer|stage iii colon cancer
5243931|NCT00654160|stage IV colon cancer|stage iv colon cancer
5243932|NCT00654160|recurrent colon cancer|recurrent colon cancer
5243933|NCT00654160|stage III rectal cancer|stage iii rectal cancer
5243934|NCT00654160|stage IV rectal cancer|stage iv rectal cancer
5243935|NCT00654160|recurrent rectal cancer|recurrent rectal cancer
5243936|NCT00654160|stage III esophageal cancer|stage iii esophageal cancer
5243937|NCT00654160|stage IV esophageal cancer|stage iv esophageal cancer
5243938|NCT00654160|recurrent esophageal cancer|recurrent esophageal cancer
5243939|NCT00654160|recurrent extrahepatic bile duct cancer|recurrent extrahepatic bile duct cancer
5243940|NCT00654160|unresectable extrahepatic bile duct cancer|unresectable extrahepatic bile duct cancer
5243941|NCT00654160|unresectable gallbladder cancer|unresectable gallbladder cancer
5243942|NCT00654160|recurrent gallbladder cancer|recurrent gallbladder cancer
5243943|NCT00654160|stage III gastric cancer|stage iii gastric cancer
5243944|NCT00654160|stage IV gastric cancer|stage iv gastric cancer
5243945|NCT00654160|recurrent gastric cancer|recurrent gastric cancer
5243946|NCT00654160|metastatic gastrointestinal carcinoid tumor|metastatic gastrointestinal carcinoid tumor
5243947|NCT00654160|recurrent gastrointestinal carcinoid tumor|recurrent gastrointestinal carcinoid tumor
5243948|NCT00654160|regional gastrointestinal carcinoid tumor|regional gastrointestinal carcinoid tumor
5243949|NCT00654160|gastrointestinal stromal tumor|gastrointestinal stromal tumor
5243950|NCT00654160|advanced adult primary liver cancer|advanced adult primary liver cancer
5243951|NCT00654160|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
5243952|NCT00654160|recurrent adult primary liver cancer|recurrent adult primary liver cancer
5243953|NCT00654160|stage II pancreatic cancer|stage ii pancreatic cancer
5243954|NCT00654160|stage III pancreatic cancer|stage iii pancreatic cancer
5243955|NCT00654160|stage IV pancreatic cancer|stage iv pancreatic cancer
5243956|NCT00654160|recurrent pancreatic cancer|recurrent pancreatic cancer
5243957|NCT00654160|recurrent small intestine cancer|recurrent small intestine cancer
5243958|NCT00654160|small intestine adenocarcinoma|small intestine adenocarcinoma
5243959|NCT00654160|small intestine leiomyosarcoma|small intestine leiomyosarcoma
5243960|NCT00654160|small intestine lymphoma|small intestine lymphoma
5243962|NCT00654147|antiretroviral therapy naive|antiretroviral therapy naive
5243963|NCT00654147|Integrase inhibitor|integrase inhibitor
5243964|NCT00654147|HIV/AIDS|hiv/aids
5243965|NCT00654147|treatment naïve|treatment naïve
5243966|NCT00654121|prevention|prevention
5243967|NCT00654108|Escherichia coli, cholera, diarrhea, vaccine|escherichia coli, cholera, diarrhea, vaccine
5243968|NCT00654069|Pain|pain
5243969|NCT00654056|Type 2 diabetes|type 2 diabetes
5243970|NCT00654056|Severe insulin resistance|severe insulin resistance
5243971|NCT00654043|Bioequivalence|bioequivalence
5243972|NCT00654043|Torsemide Tablets|torsemide tablets
5243973|NCT00654043|fed|fed
5243974|NCT00654043|To determine bioequivalence under fed conditions.|to determine bioequivalence under fed conditions.
5243975|NCT00654030|Lung Cancer Vaccine|lung cancer vaccine
5243976|NCT00654030|Early Stage Lung Cancer|early stage lung cancer
5243977|NCT00654030|Lung Cancer|lung cancer
5243978|NCT00654004|trifunctional|trifunctional
5243981|NCT00654004|TFP|tfp
5243982|NCT00654004|weight|weight
5243983|NCT00654004|regulation|regulation
5243984|NCT00653991|HIV/AIDS Prevention|hiv/aids prevention
5243985|NCT00653991|Men Who Have Sex With Men (MSM)|men who have sex with men (msm)
5243986|NCT00653991|Risky Sexual Behavior|risky sexual behavior
5243987|NCT00653991|Socially Optimized Learning in a Virtual Environment (SOLVE)|socially optimized learning in a virtual environment (solve)
5243988|NCT00653991|HIV Seronegativity|hiv seronegativity
5243989|NCT00653978|ERCP|ercp
5243990|NCT00653978|cholangiocarcinoma|cholangiocarcinoma
5243991|NCT00653978|hilar stricture|hilar stricture
5243992|NCT00653965|Cholesterol|cholesterol
5243993|NCT00653965|low density lipoproteins|low density lipoproteins
5243994|NCT00653965|dyslipidaemia|dyslipidaemia
5243995|NCT00653965|Rosuvastatin|rosuvastatin
5243996|NCT00653965|Crestor|crestor
5243997|NCT00653965|Atorvastatin|atorvastatin
5243998|NCT00653965|Lipitor|lipitor
5243999|NCT00653965|Hispanic|hispanic
5244000|NCT00653952|Paclitaxel HCl|paclitaxel hcl
5244001|NCT00653952|CAELYX|caelyx
5244002|NCT00653952|DOXIL|doxil
5244003|NCT00653952|Ovarian Carcinoma|ovarian carcinoma
5244004|NCT00653952|Doxorubicin HCl|doxorubicin hcl
5244005|NCT00653939|non-small cell lung cancer|non-small cell lung cancer
5244006|NCT00653939|non-small cell lung carcinoma|non-small cell lung carcinoma
5244007|NCT00653939|neoplasms, lung|neoplasms, lung
5244008|NCT00653939|lung cancer|lung cancer
5244009|NCT00653939|tumors|tumors
5244010|NCT00653939|NSCLC|nsclc
5244011|NCT00653926|Postoperative pain|postoperative pain
5244012|NCT00653926|Local infiltration analgesia|local infiltration analgesia
5244013|NCT00653926|Knee arthroplasty|knee arthroplasty
5244014|NCT00653926|Postoperative pain management following unicompartmental knee arthroplasty|postoperative pain management following unicompartmental knee arthroplasty
5244015|NCT00653900|Verify now|verify now
5244016|NCT00653900|platelet function|platelet function
5244017|NCT00653900|platelet function testing|platelet function testing
5244018|NCT00653900|bleeding risk|bleeding risk
5244019|NCT00653900|periprocedural bleeding|periprocedural bleeding
5244020|NCT00653900|clopidogrel|clopidogrel
5244021|NCT00653900|Our initial goal is to establish if a certain degree of|our initial goal is to establish if a certain degree of
5244022|NCT00653900|platelet function abnormality can predict a higher bleeding|platelet function abnormality can predict a higher bleeding
5244023|NCT00653900|or higher transfusions.|or higher transfusions.
5244024|NCT00653887|Biofeedback|biofeedback
5244025|NCT00653887|anal sphincter|anal sphincter
5244026|NCT00653887|cortical excitability|cortical excitability
5244027|NCT00653887|magnetic stimulation|magnetic stimulation
5244028|NCT00653887|incontinence|incontinence
5244029|NCT00653887|constipation|constipation
5244030|NCT00653874|jaundice|jaundice
5244031|NCT00653874|neonates|neonates
5244032|NCT00653874|transcutaneous bilirubinometry|transcutaneous bilirubinometry
5244033|NCT00653874|clinical assessment of bilirubin|clinical assessment of bilirubin
5244034|NCT00653861|Aesthetic correction|aesthetic correction
5244035|NCT00653848|Adjuvant treatment, high risk, radical radiotherapy|adjuvant treatment, high risk, radical radiotherapy
5244036|NCT00653822|Amevive|amevive
5244037|NCT00653822|alefacept|alefacept
5244038|NCT00653822|pharmacokinetics|pharmacokinetics
5244039|NCT00653822|Japanese|japanese
5244040|NCT00653783|Parkinson disease|parkinson disease
5244041|NCT00653783|Multiple System Atrophy|multiple system atrophy
5244042|NCT00653783|MSA|msa
5244043|NCT00653783|Progressive Supranuclear Palsy|progressive supranuclear palsy
5244044|NCT00653783|PSP|psp
5244045|NCT00653783|observational|observational
5244046|NCT00653783|biomarker|biomarker
5244047|NCT00653757|stage I prostate cancer|stage i prostate cancer
5244048|NCT00653757|stage II prostate cancer|stage ii prostate cancer
5244049|NCT00653757|stage III prostate cancer|stage iii prostate cancer
5244050|NCT00653757|stage IV prostate cancer|stage iv prostate cancer
5244051|NCT00653744|Cholesterol|cholesterol
5244052|NCT00653744|low density lipoproteins|low density lipoproteins
5244053|NCT00653744|dyslipidaemia|dyslipidaemia
5244054|NCT00653744|Rosuvastatin|rosuvastatin
5244055|NCT00653744|Crestor|crestor
5244056|NCT00653744|Atorvastatin|atorvastatin
5244057|NCT00653744|Lipitor|lipitor
5244058|NCT00653744|African American|african american
5244059|NCT00653731|dementia|dementia
5244060|NCT00653731|snoezelen|snoezelen
5244061|NCT00653731|structured reminiscence therapy|structured reminiscence therapy
5244062|NCT00653731|10-minutes activation|10-minutes activation
5244063|NCT00653731|apathy|apathy
5244064|NCT00653718|Pain|pain
5244065|NCT00653718|Characterize musculoskeletal pain|characterize musculoskeletal pain
5244066|NCT00653718|Breast cancer patients treated with aromatase inhibitors|breast cancer patients treated with aromatase inhibitors
5244067|NCT00653705|Probiotics|probiotics
5244068|NCT00653705|Children|children
5244069|NCT00653705|Child Care Center|child care center
5244070|NCT00653705|Nutrition|nutrition
5244071|NCT00653705|Health promotion|health promotion
5244072|NCT00653692|Substance abuse|substance abuse
5244073|NCT00653692|fetal development|fetal development
5244074|NCT00653692|vagal tone|vagal tone
5244075|NCT00653679|exercise|exercise
5244076|NCT00653679|muscle protein signalling|muscle protein signalling
5244077|NCT00653679|protein synthesis|protein synthesis
5244078|NCT00653666|CPT1A|cpt1a
5244079|NCT00653666|steatosis|steatosis
5244080|NCT00653666|deficiency|deficiency
5244081|NCT00653666|metabolic|metabolic
5244082|NCT00653666|response|response
5244083|NCT00653666|fasting|fasting
5244084|NCT00653653|pharmacogenetics|pharmacogenetics
5244085|NCT00653653|pharmacoeconomics|pharmacoeconomics
5244086|NCT00653653|adverse events|adverse events
5244087|NCT00653653|drug metabolism|drug metabolism
5244088|NCT00653640|rehabilitation|rehabilitation
5244089|NCT00653640|head injury|head injury
5244090|NCT00653640|3 months post injury|3 months post injury
5244091|NCT00653640|require manual assistance or walking aids to walk|require manual assistance or walking aids to walk
5244092|NCT00653640|very slow walking speed|very slow walking speed
5244093|NCT00653640|able to follow two step commands|able to follow two step commands
5244094|NCT00653614|Oral contraception|oral contraception
5244096|NCT00653601|glycoprotein IIb/IIIa inhibitor|glycoprotein iib/iiia inhibitor
5244097|NCT00653601|Aggrastat|aggrastat
5244098|NCT00653601|Tirofiban|tirofiban
5244099|NCT00653601|Verify now|verify now
5244100|NCT00653601|platelet function testing|platelet function testing
5244101|NCT00653601|bridge therapy|bridge therapy
5244102|NCT00653588|Cholesterol|cholesterol
5244103|NCT00653588|low density lipoproteins|low density lipoproteins
5244104|NCT00653588|Hypercholesterolemia|hypercholesterolemia
5244105|NCT00653588|Coronary Heart Disease|coronary heart disease
5244106|NCT00653588|Rosuvastatin|rosuvastatin
5244107|NCT00653588|Crestor|crestor
5244108|NCT00653588|Atorvastatin|atorvastatin
5244109|NCT00653588|Lipitor|lipitor
5244110|NCT00653575|Sexual Behavior|sexual behavior
5244111|NCT00653575|HIV|hiv
5244112|NCT00653575|Sexually Transmitted Diseases|sexually transmitted diseases
5244113|NCT00653562|polysomnography|polysomnography
5244114|NCT00653562|zolpidem|zolpidem
5244115|NCT00653562|Sleep disorders|sleep disorders
5244116|NCT00653562|adolescent|adolescent
5244117|NCT00653549|Bioequivalence|bioequivalence
5244118|NCT00653549|Torsemide Tablets|torsemide tablets
5244119|NCT00653549|fasting|fasting
5244120|NCT00653536|stroke|stroke
5244121|NCT00653536|neuroflo|neuroflo
5244122|NCT00653536|device|device
5244123|NCT00653536|failure to recanalize|failure to recanalize
5244124|NCT00653510|Type 2 diabetes|type 2 diabetes
5244125|NCT00653510|Dysregulation|dysregulation
5244126|NCT00653510|Metabolism|metabolism
5244127|NCT00653510|Cardiac output|cardiac output
5244128|NCT00653497|Osteoarthritis|osteoarthritis
5244129|NCT00653484|colon cancer|colon cancer
5244130|NCT00653484|rectal cancer|rectal cancer
5244131|NCT00653484|obesity|obesity
5244132|NCT00653471|obesity|obesity
5244133|NCT00653471|osa|osa
5244134|NCT00653471|capnography|capnography
5244135|NCT00653471|general anesthesia|general anesthesia
5244136|NCT00653458|bioequivalence|bioequivalence
5244137|NCT00653458|Ondansetron ODT|ondansetron odt
5244138|NCT00653458|fed|fed
5244139|NCT00653458|To determine bioequivalence under fed conditions|to determine bioequivalence under fed conditions
5244140|NCT00653445|Low density lipoproteins|low density lipoproteins
5244141|NCT00653445|Hypercholesterolemia|hypercholesterolemia
5244142|NCT00653445|Coronary Heart Disease|coronary heart disease
5244143|NCT00653445|Rosuvastatin|rosuvastatin
5244144|NCT00653445|Crestor|crestor
5244145|NCT00653445|Ezetimibe|ezetimibe
5244146|NCT00653432|Treatment|treatment
5244147|NCT00653432|Osteoarthritis|osteoarthritis
5244148|NCT00653419|bioequivalence|bioequivalence
5244149|NCT00653419|buspirone HCl|buspirone hcl
5244150|NCT00653419|fasting|fasting
5244151|NCT00653406|Schizophrenia|schizophrenia
5244152|NCT00653406|Risperidone|risperidone
5244153|NCT00653406|Intramuscular injection|intramuscular injection
5244154|NCT00653406|Pharmacokinetics|pharmacokinetics
5244155|NCT00653393|bioequivalence, single- dose, fasting|bioequivalence, single- dose, fasting
5244156|NCT00653380|bioequivalence|bioequivalence
5244157|NCT00653380|doxycycline monohydrate|doxycycline monohydrate
5244158|NCT00653380|fasting|fasting
5244159|NCT00653367|Thoracotomy|thoracotomy
5244160|NCT00653367|Nerve section|nerve section
5244161|NCT00653367|QST|qst
5244162|NCT00653367|Quantitative Sensory Test|quantitative sensory test
5244163|NCT00653367|Muscle sparing Posterolateral thoracotomy|muscle sparing posterolateral thoracotomy
5244164|NCT00653367|Chest|chest
5244165|NCT00653367|Wall|wall
5244166|NCT00653367|Surgical|surgical
5244167|NCT00653367|Incision|incision
5244168|NCT00653367|Tumors or cancer of the lung|tumors or cancer of the lung
5244169|NCT00653354|hallux valgus|hallux valgus
5244170|NCT00653341|insulin naive|insulin naive
5244171|NCT00653328|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5244172|NCT00653328|fallopian tube cancer|fallopian tube cancer
5244173|NCT00653328|peritoneal cavity cancer|peritoneal cavity cancer
5244174|NCT00653315|Bioequivalence, Tramadol APAP, fasting|bioequivalence, tramadol apap, fasting
5244175|NCT00653263|methamphetamine|methamphetamine
5244176|NCT00653263|drug abuse|drug abuse
5244177|NCT00653263|withdrawal|withdrawal
5244178|NCT00653250|stage I non-small cell lung cancer|stage i non-small cell lung cancer
5244179|NCT00653250|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
5244180|NCT00653250|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5244181|NCT00653224|levocetirizine|levocetirizine
5244182|NCT00653224|Xyzal|xyzal
5244183|NCT00653224|Seasonal Allergic Rhinitis|seasonal allergic rhinitis
5244184|NCT00653224|total symptom score|total symptom score
5244185|NCT00653224|quality of life|quality of life
5244186|NCT00653198|Rotavirus severe gastroenteritis (RV SGE)|rotavirus severe gastroenteritis (rv sge)
5244187|NCT00653185|Glucose Metabolism Disorder|glucose metabolism disorder
5244188|NCT00653185|Dysmetabolic Syndrome|dysmetabolic syndrome
5244189|NCT00653185|Type II Diabetes|type ii diabetes
5244190|NCT00653185|Diabetes Mellitus, Lipoatrophic|diabetes mellitus, lipoatrophic
5244191|NCT00653185|Dyslipidemia|dyslipidemia
5244192|NCT00653185|Hyperglycemia|hyperglycemia
5244193|NCT00653172|CAP|cap
5244194|NCT00653172|community acquired pneumonia|community acquired pneumonia
5244195|NCT00653159|Intrauterine device, contraception, unplanned pregnancy|intrauterine device, contraception, unplanned pregnancy
5244196|NCT00653146|cervical cancer|cervical cancer
5244197|NCT00653146|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
5244198|NCT00653146|human papilloma virus infection|human papilloma virus infection
5244199|NCT00653146|atypical squamous cells of undetermined significance|atypical squamous cells of undetermined significance
5244200|NCT00653146|low-grade squamous intraepithelial lesion|low-grade squamous intraepithelial lesion
5244201|NCT00653133|ultrasonography|ultrasonography
5244202|NCT00653133|peripheral nerve block|peripheral nerve block
5244203|NCT00653133|peripheral nerve stimulation|peripheral nerve stimulation
5244204|NCT00653120|Bioequivalence, Propranolol ER capsules, fasting|bioequivalence, propranolol er capsules, fasting
5244205|NCT00653107|Palliation|palliation
5244206|NCT00653107|Cancer oesophagus|cancer oesophagus
5244207|NCT00653107|Stent|stent
5244208|NCT00653107|Brachytherapy|brachytherapy
5244209|NCT00653107|Randomized|randomized
5244210|NCT00653094|crohn|crohn
5244211|NCT00653094|fistula|fistula
5244212|NCT00653094|surgery|surgery
5244213|NCT00653094|fibrin glue|fibrin glue
5244214|NCT00653094|seton drainage|seton drainage
5244215|NCT00653081|Shoulder pain|shoulder pain
5244216|NCT00653081|Supervised Exercises|supervised exercises
5244217|NCT00653081|Radial Shock Wave Therapy|radial shock wave therapy
5244218|NCT00653055|Bioequivalence|bioequivalence
5244219|NCT00653055|Cabergoline|cabergoline
5244220|NCT00653055|Fasting|fasting
5244221|NCT00653042|Myocardial Ischemia|myocardial ischemia
5244222|NCT00653042|kidney failure|kidney failure
5244223|NCT00653042|CABG|cabg
5244224|NCT00653042|cardiopulmonary bypass (CPB) pump|cardiopulmonary bypass (cpb) pump
5244225|NCT00653042|Coronary Artery Bypass Surgery|coronary artery bypass surgery
5244226|NCT00653042|heart surgery|heart surgery
5244227|NCT00653042|nesiritide|nesiritide
5244228|NCT00653042|Coronary Heart Disease|coronary heart disease
5244229|NCT00653029|Post concussion syndrome|post concussion syndrome
5244230|NCT00653029|Mild traumatic brain injury|mild traumatic brain injury
5244231|NCT00653029|Effort|effort
5244232|NCT00653029|fmri|fmri
5244233|NCT00653016|Contraception|contraception
5244234|NCT00653016|norelgestromin|norelgestromin
5244235|NCT00653016|ethinyl estradiol|ethinyl estradiol
5244236|NCT00653016|transdermal contraceptive patch|transdermal contraceptive patch
5244237|NCT00653016|EVRA|evra
5244238|NCT00653016|ORTHO EVRA|ortho evra
5244239|NCT00653003|Bioequivalence, Leflunomide, fed|bioequivalence, leflunomide, fed
5244240|NCT00652977|sphincter tears|sphincter tears
5244241|NCT00652977|Ritgen maneuver|ritgen maneuver
5244242|NCT00652977|perineal tears|perineal tears
5244243|NCT00652977|prevention|prevention
5244244|NCT00652977|delivery|delivery
5244245|NCT00652964|sleep apnea, PHOX2B, hypoventilation, polysomnography|sleep apnea, phox2b, hypoventilation, polysomnography
5244246|NCT00652938|Co-administration|co-administration
5244247|NCT00652938|HPV vaccine|hpv vaccine
5244248|NCT00652938|Cervical cancer|cervical cancer
5244249|NCT00652925|arthritis|arthritis
5244250|NCT00652925|juvenile|juvenile
5244251|NCT00652912|bioequivalence, Clonazepam ODT , fasting|bioequivalence, clonazepam odt , fasting
5244252|NCT00652899|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5244253|NCT00652899|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
5244254|NCT00652899|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5244255|NCT00652899|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
5244256|NCT00652899|fallopian tube cancer|fallopian tube cancer
5244257|NCT00652899|peritoneal cavity cancer|peritoneal cavity cancer
5244258|NCT00652886|Bioequivalence, Oxandrolone,fasting|bioequivalence, oxandrolone,fasting
5244259|NCT00652873|Bioequivalence|bioequivalence
5244260|NCT00652873|Cabergoline|cabergoline
5244261|NCT00652873|Fed|fed
5244262|NCT00652860|lung metastases|lung metastases
5244263|NCT00652860|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
5244264|NCT00652834|Renal transplant recipients|renal transplant recipients
5244265|NCT00652834|Gastrointestinal findings in small bowel capsule endoscopy|gastrointestinal findings in small bowel capsule endoscopy
5244266|NCT00652834|Mycophenolic acid|mycophenolic acid
5244267|NCT00652834|Mycophenolate Mofetil|mycophenolate mofetil
5244268|NCT00652834|Mycophenolate Sodium|mycophenolate sodium
5244269|NCT00652821|bioequivalence, single-dose, fed|bioequivalence, single-dose, fed
5244270|NCT00652808|knee, OA patients|knee, oa patients
5244271|NCT00652795|bioequivalence|bioequivalence
5244272|NCT00652795|doxycycline monohydrate|doxycycline monohydrate
5244273|NCT00652795|fasting|fasting
5244274|NCT00652769|Lung|lung
5244275|NCT00652769|Cancer|cancer
5244276|NCT00652769|Staging|staging
5244277|NCT00652769|Endobronchial|endobronchial
5244278|NCT00652769|Ultrasound|ultrasound
5244279|NCT00652769|Endoscopic|endoscopic
5244280|NCT00652756|Respiration, Artificial|respiration, artificial
5244281|NCT00652756|Transportation of Patients|transportation of patients
5244282|NCT00652756|Intubation, Intratracheal|intubation, intratracheal
5244283|NCT00652756|Tracheostomy|tracheostomy
5244284|NCT00652743|immunogenicity|immunogenicity
5244285|NCT00652743|safety|safety
5244286|NCT00652743|GSK pandemic candidate vaccine|gsk pandemic candidate vaccine
5244287|NCT00652730|bioequivalence|bioequivalence
5244288|NCT00652730|buspirone HCl|buspirone hcl
5244289|NCT00652730|fed|fed
5244290|NCT00652704|Bioequivalence|bioequivalence
5244291|NCT00652704|Doxycycline Monohydrate|doxycycline monohydrate
5244292|NCT00652704|Fed|fed
5244293|NCT00652691|peritoneal cavity cancer|peritoneal cavity cancer
5244294|NCT00652691|ovarian clear cell tumor with proliferating activity|ovarian clear cell tumor with proliferating activity
5244295|NCT00652691|ovarian endometrioid adenocarcinoma|ovarian endometrioid adenocarcinoma
5244296|NCT00652691|ovarian mixed epithelial carcinoma|ovarian mixed epithelial carcinoma
5244297|NCT00652691|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5244298|NCT00652691|ovarian mucinous cystadenocarcinoma|ovarian mucinous cystadenocarcinoma
5244299|NCT00652691|ovarian serous cystadenocarcinoma|ovarian serous cystadenocarcinoma
5244300|NCT00652691|ovarian undifferentiated adenocarcinoma|ovarian undifferentiated adenocarcinoma
5244301|NCT00652678|Breast cancer|breast cancer
5244302|NCT00652678|Radiation effects|radiation effects
5244303|NCT00652665|Bioequivalence, single-dose, fasting|bioequivalence, single-dose, fasting
5244304|NCT00652652|Congestive Heart Failure (CHF)|congestive heart failure (chf)
5244305|NCT00652652|Heart Failure|heart failure
5244306|NCT00652652|Chronic Heart Failure|chronic heart failure
5244307|NCT00652652|Dyspnea|dyspnea
5244308|NCT00652652|nesiritide|nesiritide
5244309|NCT00652652|Natrecor|natrecor
5244310|NCT00652639|bioequivalence, Clonazepam tablets, fasting|bioequivalence, clonazepam tablets, fasting
5244311|NCT00652626|MDS|mds
5244312|NCT00652626|AML|aml
5244313|NCT00652626|Solid Tumors|solid tumors
5244314|NCT00652626|Azacitidine|azacitidine
5244315|NCT00652626|PK|pk
5244316|NCT00652626|Pharmacokinetics|pharmacokinetics
5244317|NCT00652626|Renal Impairment|renal impairment
5244318|NCT00652626|Multiple Myeloma|multiple myeloma
5244319|NCT00652626|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
5244320|NCT00652626|Hodgkin's Disease|hodgkin's disease
5244321|NCT00652613|3DCRT|3dcrt
5244322|NCT00652613|IMRT|imrt
5244323|NCT00652613|HNSCC|hnscc
5244324|NCT00652613|Quality of life|quality of life
5244325|NCT00652613|Major salivary gland sparing|major salivary gland sparing
5244326|NCT00652613|Pattern of local and loco-regional recurrence|pattern of local and loco-regional recurrence
5244327|NCT00652613|Disease Free Survival (DFS) & Overall Survival (OAS)|disease free survival (dfs) & overall survival (oas)
5244328|NCT00652613|Dose reduction to normal structures with IMRT|dose reduction to normal structures with imrt
5244329|NCT00652600|Bioequivalence, Propranolol ER capsules, fed|bioequivalence, propranolol er capsules, fed
5244330|NCT00652587|hepatocellular carcinoma|hepatocellular carcinoma
5244331|NCT00652587|hepatectomy|hepatectomy
5244332|NCT00652587|chemoembolization|chemoembolization
5244333|NCT00652587|randomized controlled trial|randomized controlled trial
5244334|NCT00652587|prognosis|prognosis
5244335|NCT00652574|Malignant Pleural Mesothelioma|malignant pleural mesothelioma
5244336|NCT00652574|Dasatinib|dasatinib
5244337|NCT00652574|BMS-354825|bms-354825
5244338|NCT00652574|Sprycel|sprycel
5244339|NCT00652574|MPM|mpm
5244340|NCT00652548|Clavicle|clavicle
5244341|NCT00652548|Fracture|fracture
5244342|NCT00652548|Ultrasound|ultrasound
5244343|NCT00652548|Radiation|radiation
5244344|NCT00652522|AF ablation|af ablation
5244345|NCT00652522|Pulmonary vein isolation(PVI)|pulmonary vein isolation(pvi)
5244346|NCT00652522|reduced LV ejection fraction|reduced lv ejection fraction
5244347|NCT00652522|symptomatic atrial fibrillation|symptomatic atrial fibrillation
5244348|NCT00652522|persistent AF|persistent af
5244349|NCT00652470|infants|infants
5244350|NCT00652470|Hydrocephalus|hydrocephalus
5244351|NCT00652470|Cerebrospinal Fluid Shunt|cerebrospinal fluid shunt
5244352|NCT00652470|Ventriculostomy|ventriculostomy
5244353|NCT00652470|neurosurgery|neurosurgery
5244354|NCT00652418|Magnevist|magnevist
5244355|NCT00652418|Magnetic Resonance Angiography|magnetic resonance angiography
5244356|NCT00652418|Meglumine gadopentetate|meglumine gadopentetate
5244357|NCT00652418|Determination of effective dose in MRA|determination of effective dose in mra
5244358|NCT00652405|cephalic phase reflex|cephalic phase reflex
5244359|NCT00652405|gene expression|gene expression
5244360|NCT00652405|inflammation|inflammation
5244361|NCT00652405|adiponectin|adiponectin
5244362|NCT00652405|pancreatic polypeptide|pancreatic polypeptide
5244363|NCT00652392|asthma|asthma
5244364|NCT00652392|adolescents|adolescents
5244365|NCT00652392|adults|adults
5244366|NCT00652392|Symbicort|symbicort
5244367|NCT00652392|budesonide/formoterol|budesonide/formoterol
5244368|NCT00652392|budesonide|budesonide
5244369|NCT00652379|Acromegaly|acromegaly
5244370|NCT00652379|Insulin sensitivity|insulin sensitivity
5244371|NCT00652379|Glucose tolerance|glucose tolerance
5244372|NCT00652379|Body composition|body composition
5244373|NCT00652379|Growth Hormone|growth hormone
5244374|NCT00652353|Clinical decision rule|clinical decision rule
5244375|NCT00652353|Ottawa Ankle Rule|ottawa ankle rule
5244376|NCT00652353|Ottawa Foot Rule|ottawa foot rule
5244377|NCT00652353|Ankle|ankle
5244378|NCT00652353|Trauma|trauma
5244379|NCT00652353|Education|education
5244380|NCT00652353|Foot Trauma|foot trauma
5244381|NCT00652314|Hemostatic products|hemostatic products
5244382|NCT00652314|Surgical hemostasis|surgical hemostasis
5244383|NCT00652314|Thrombi-gel|thrombi-gel
5244384|NCT00652314|Gelatin Sponge|gelatin sponge
5244385|NCT00652314|Time to hemostasis|time to hemostasis
5244386|NCT00652288|Type I Diabetes Mellitus|type i diabetes mellitus
5244387|NCT00652275|Malaria|malaria
5244388|NCT00652275|vaccine|vaccine
5244389|NCT00652275|Merozoite surface Antigene|merozoite surface antigene
5244390|NCT00652275|Mali|mali
5244391|NCT00652275|Children|children
5244392|NCT00652262|Vardenafil|vardenafil
5244393|NCT00652262|PDE5 inhibitor|pde5 inhibitor
5244394|NCT00652262|Erectile dysfunction|erectile dysfunction
5244395|NCT00652262|Spinal cord injury|spinal cord injury
5244396|NCT00652249|Hydrocephalus|hydrocephalus
5244397|NCT00652249|shunt dysfunction|shunt dysfunction
5244398|NCT00652249|shunt flow|shunt flow
5244399|NCT00652236|Low back pain|low back pain
5244400|NCT00652236|Economics|economics
5244401|NCT00652236|Cost-effectiveness|cost-effectiveness
5244402|NCT00652210|Bladder cancer|bladder cancer
5244403|NCT00652210|prostate cancer|prostate cancer
5244404|NCT00652210|multiphoton microscopy|multiphoton microscopy
5244405|NCT00652197|Hydrocephalus|hydrocephalus
5244406|NCT00652197|shunt dysfunction|shunt dysfunction
5244407|NCT00652197|shunt flow|shunt flow
5244408|NCT00652184|antiviral|antiviral
5244409|NCT00652184|herpes zoster|herpes zoster
5244410|NCT00652184|postherpetic neuralgia|postherpetic neuralgia
5244411|NCT00652184|varicella zoster virus|varicella zoster virus
5244412|NCT00652184|shingles|shingles
5244413|NCT00652171|Treatment|treatment
5244414|NCT00652171|Augmentation|augmentation
5244415|NCT00652171|Resistant depression|resistant depression
5244416|NCT00652171|Lamotrigine|lamotrigine
5244417|NCT00652145|ulcerative colitis|ulcerative colitis
5244418|NCT00652145|inflammatory bowel disease|inflammatory bowel disease
5244419|NCT00652132|ototoxicity|ototoxicity
5244420|NCT00652132|childhood hepatoblastoma|childhood hepatoblastoma
5244421|NCT00652132|stage I childhood liver cancer|stage i childhood liver cancer
5244422|NCT00652132|stage II childhood liver cancer|stage ii childhood liver cancer
5244423|NCT00652132|stage III childhood liver cancer|stage iii childhood liver cancer
5244424|NCT00652119|Ovarian Cancer|ovarian cancer
5244425|NCT00652119|Peritoneal Cancer|peritoneal cancer
5244426|NCT00652119|Fallopian Tube Cancer|fallopian tube cancer
5244427|NCT00652119|Carcinoma of Mullerian Origin|carcinoma of mullerian origin
5244428|NCT00652119|Paclitaxel|paclitaxel
5244429|NCT00652119|Taxol|taxol
5244430|NCT00652119|Carboplatin|carboplatin
5244431|NCT00652119|Paraplatin®|paraplatin®
5244432|NCT00652119|Avastin|avastin
5244433|NCT00652119|Bevacizumab|bevacizumab
5244434|NCT00652119|Anti-VEGF monoclonal antibody|anti-vegf monoclonal antibody
5244435|NCT00652119|rhuMAb-VEGF|rhumab-vegf
5244436|NCT00652067|Mycobacterium avium-intracellulare|mycobacterium avium-intracellulare
5244437|NCT00652041|Multiple Myeloma|multiple myeloma
5244438|NCT00652041|Relapsed|relapsed
5244439|NCT00652041|Refractary|refractary
5244440|NCT00652028|Pharmacokinetics|pharmacokinetics
5244441|NCT00652028|Pharmacodynamics|pharmacodynamics
5244442|NCT00652028|Escalating dose|escalating dose
5244443|NCT00652028|Dexmedotimidine|dexmedotimidine
5244444|NCT00652028|Intubated|intubated
5244445|NCT00652028|Mechanically ventilated|mechanically ventilated
5244446|NCT00652028|Pediatrics|pediatrics
5244447|NCT00652015|in-stent-thrombosis|in-stent-thrombosis
5244448|NCT00652015|CD39|cd39
5244449|NCT00652015|CD73|cd73
5244450|NCT00652015|EPC|epc
5244451|NCT00652002|Asthma|asthma
5244452|NCT00652002|Symbicort|symbicort
5244453|NCT00652002|budesonide/formoterol|budesonide/formoterol
5244454|NCT00652002|budesonide|budesonide
5244455|NCT00652002|formoterol|formoterol
5244456|NCT00651989|optical coherence tomography|optical coherence tomography
5244457|NCT00651989|spectral domain|spectral domain
5244458|NCT00651989|time domain|time domain
5244459|NCT00651976|stage IA breast cancer|stage ia breast cancer
5244460|NCT00651976|stage IB breast cancer|stage ib breast cancer
5244461|NCT00651976|stage II breast cancer|stage ii breast cancer
5244462|NCT00651976|stage III breast cancer|stage iii breast cancer
5244463|NCT00651976|HER2-negative breast cancer|her2-negative breast cancer
5244464|NCT00651976|estrogen receptor-positive breast cancer|estrogen receptor-positive breast cancer
5244465|NCT00651950|Hydrocephalus|hydrocephalus
5244466|NCT00651950|shunt dysfunction|shunt dysfunction
5244467|NCT00651950|shunt flow|shunt flow
5244468|NCT00651937|Multiple Myeloma|multiple myeloma
5244469|NCT00651937|Primary Amyloidosis|primary amyloidosis
5244470|NCT00651937|Cytokine Modulation|cytokine modulation
5244471|NCT00651937|Melphalan|melphalan
5244472|NCT00651937|Alkeran|alkeran
5244473|NCT00651937|Transplant Induced Symptoms|transplant induced symptoms
5244474|NCT00651937|Stem Cell Infusion|stem cell infusion
5244475|NCT00651937|Autologous stem cell transplant|autologous stem cell transplant
5244476|NCT00651937|ASCT|asct
5244477|NCT00651937|Granulocyte-colony stimulating factor|granulocyte-colony stimulating factor
5244478|NCT00651937|G-CSF|g-csf
5244479|NCT00651937|Apheresis|apheresis
5244480|NCT00651924|chronic pain|chronic pain
5244481|NCT00651924|IVR|ivr
5244482|NCT00651924|cognitive-behavior therapy|cognitive-behavior therapy
5244483|NCT00651898|abdominal surgery|abdominal surgery
5244484|NCT00651898|hypothermia|hypothermia
5244485|NCT00651898|circulating water mattress|circulating water mattress
5244486|NCT00651885|UT-15C|ut-15c
5244487|NCT00651885|Peripheral Vascular Disease|peripheral vascular disease
5244488|NCT00651885|Treprostinil|treprostinil
5244489|NCT00651872|Posttraumatic Stress Disorder|posttraumatic stress disorder
5244490|NCT00651872|Functional Impairment|functional impairment
5244491|NCT00651872|Veterans|veterans
5244492|NCT00651872|Military Personnel|military personnel
5244493|NCT00651846|Contraception|contraception
5244494|NCT00651846|Hemostasis|hemostasis
5244495|NCT00651846|Blood Coagulation|blood coagulation
5244496|NCT00651820|wound healing|wound healing
5244497|NCT00651820|scarring|scarring
5244498|NCT00651820|collagenase|collagenase
5244499|NCT00651820|Santyl|santyl
5244500|NCT00651794|Neonatal Resuscitation|neonatal resuscitation
5244501|NCT00651794|Patient Care Team|patient care team
5244502|NCT00651794|Medical Errors|medical errors
5244503|NCT00651781|Acute Myeloid Leukemia|acute myeloid leukemia
5244504|NCT00651781|Relapsed|relapsed
5244505|NCT00651781|Refractory|refractory
5244506|NCT00651768|asthma|asthma
5244507|NCT00651768|adults|adults
5244508|NCT00651768|adolescents|adolescents
5244509|NCT00651768|safety|safety
5244510|NCT00651768|Symbicort|symbicort
5244511|NCT00651768|budesonide/formoterol|budesonide/formoterol
5244512|NCT00651768|budesonide|budesonide
5244513|NCT00651755|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
5244514|NCT00651755|Lymphoma|lymphoma
5244515|NCT00651755|Nausea|nausea
5244516|NCT00651755|Cyclophosphamide|cyclophosphamide
5244517|NCT00651755|Cytoxan|cytoxan
5244518|NCT00651755|Neosar|neosar
5244519|NCT00651755|Doxorubicin|doxorubicin
5244520|NCT00651755|AD|ad
5244521|NCT00651755|Hydroxydaunomycin hydrochloride|hydroxydaunomycin hydrochloride
5244522|NCT00651755|Vincristine|vincristine
5244523|NCT00651755|Prednisone|prednisone
5244524|NCT00651755|Rituximab|rituximab
5244525|NCT00651755|Rituxan|rituxan
5244526|NCT00651755|Aprepitant|aprepitant
5244527|NCT00651755|Emend|emend
5244528|NCT00651755|L754030|l754030
5244529|NCT00651755|MK869|mk869
5244530|NCT00651755|Drug Metabolism|drug metabolism
5244531|NCT00651755|CHOP|chop
5244532|NCT00651755|R-CHOP|r-chop
5244533|NCT00651755|NHL|nhl
5244534|NCT00651716|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5244535|NCT00651716|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5244536|NCT00651716|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5244537|NCT00651716|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5244538|NCT00651716|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5244539|NCT00651716|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5244540|NCT00651716|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5244541|NCT00651716|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5244542|NCT00651716|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5244543|NCT00651716|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5244544|NCT00651716|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5244545|NCT00651716|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5244546|NCT00651716|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5244547|NCT00651716|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5244548|NCT00651716|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5244549|NCT00651716|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5244550|NCT00651716|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5244551|NCT00651716|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5244552|NCT00651716|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5244553|NCT00651716|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5244554|NCT00651716|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5244555|NCT00651716|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5244556|NCT00651716|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5244557|NCT00651716|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5244558|NCT00651716|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5244559|NCT00651716|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5244560|NCT00651716|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5244561|NCT00651716|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5244562|NCT00651716|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5244563|NCT00651716|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5244564|NCT00651716|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5244565|NCT00651716|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5244566|NCT00651716|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5244567|NCT00651716|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5244568|NCT00651716|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5244569|NCT00651716|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5244570|NCT00651716|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5244571|NCT00651716|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5244572|NCT00651716|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5244573|NCT00651716|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5244574|NCT00651716|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5244575|NCT00651716|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5244576|NCT00651716|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5244577|NCT00651716|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5244578|NCT00651716|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
5244579|NCT00651716|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5244580|NCT00651716|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
5244581|NCT00651716|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
5244582|NCT00651716|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
5244583|NCT00651716|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
5244584|NCT00651716|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5244585|NCT00651716|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5244586|NCT00651716|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5244587|NCT00651716|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5244588|NCT00651716|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
5244589|NCT00651716|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
5244590|NCT00651716|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5244591|NCT00651716|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5244592|NCT00651716|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5244593|NCT00651716|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5244594|NCT00651716|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5244595|NCT00651716|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5244596|NCT00651716|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5244597|NCT00651716|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5244598|NCT00651716|atypical chronic myeloid leukemia, BCR-ABL negative|atypical chronic myeloid leukemia, bcr-abl negative
5244599|NCT00651716|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5244600|NCT00651716|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5244601|NCT00651716|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5244602|NCT00651716|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5244603|NCT00651716|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5244604|NCT00651716|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5244605|NCT00651716|refractory hairy cell leukemia|refractory hairy cell leukemia
5244606|NCT00651716|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5244607|NCT00651716|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5244608|NCT00651716|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5244609|NCT00651716|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5244610|NCT00651716|chronic eosinophilic leukemia|chronic eosinophilic leukemia
5244611|NCT00651716|primary myelofibrosis|primary myelofibrosis
5244612|NCT00651716|chronic neutrophilic leukemia|chronic neutrophilic leukemia
5244613|NCT00651716|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5244614|NCT00651716|disseminated neuroblastoma|disseminated neuroblastoma
5244615|NCT00651716|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
5244616|NCT00651716|poor prognosis metastatic gestational trophoblastic tumor|poor prognosis metastatic gestational trophoblastic tumor
5244617|NCT00651716|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5244618|NCT00651716|recurrent neuroblastoma|recurrent neuroblastoma
5244619|NCT00651716|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5244620|NCT00651716|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
5244621|NCT00651716|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
5244622|NCT00651716|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5244623|NCT00651716|stage I multiple myeloma|stage i multiple myeloma
5244624|NCT00651716|stage II multiple myeloma|stage ii multiple myeloma
5244625|NCT00651716|stage III multiple myeloma|stage iii multiple myeloma
5244626|NCT00651716|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
5244627|NCT00651716|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5244628|NCT00651716|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5244629|NCT00651716|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
5244630|NCT00651716|stage IIIA breast cancer|stage iiia breast cancer
5244631|NCT00651716|stage IIIB breast cancer|stage iiib breast cancer
5244632|NCT00651716|stage IIIC breast cancer|stage iiic breast cancer
5244633|NCT00651716|stage IV breast cancer|stage iv breast cancer
5244634|NCT00651716|refractory multiple myeloma|refractory multiple myeloma
5244635|NCT00651677|hand assisted laparoscopy|hand assisted laparoscopy
5244636|NCT00651677|rectal cancer|rectal cancer
5244637|NCT00651677|short term outcomes|short term outcomes
5244638|NCT00651677|straight laparoscopy|straight laparoscopy
5244639|NCT00651651|Asthma|asthma
5244640|NCT00651651|Symbicort|symbicort
5244641|NCT00651651|budesonide/formoterol|budesonide/formoterol
5244642|NCT00651651|budesonide|budesonide
5244643|NCT00651651|formoterol|formoterol
5244644|NCT00651638|PK and safety profile of ARQ 197|pk and safety profile of arq 197
5244645|NCT00651625|arthrocentesis|arthrocentesis
5244646|NCT00651625|injections|injections
5244647|NCT00651625|anesthesia|anesthesia
5244648|NCT00651625|biopsy|biopsy
5244649|NCT00651625|aspiration|aspiration
5244650|NCT00651625|syringe|syringe
5244651|NCT00651625|safety|safety
5244652|NCT00651625|pain|pain
5244653|NCT00651599|Vasomotor symptoms|vasomotor symptoms
5244654|NCT00651599|Vasomotor System|vasomotor system
5244655|NCT00651573|Surgery|surgery
5244656|NCT00651573|Cardiopulmonary bypass|cardiopulmonary bypass
5244657|NCT00651573|Coronary artery bypass graft|coronary artery bypass graft
5244658|NCT00651573|Valve procedure|valve procedure
5244659|NCT00651573|Hematocrit level|hematocrit level
5244660|NCT00651573|Outcomes|outcomes
5244661|NCT00651547|Asthma|asthma
5244662|NCT00651547|Symbicort|symbicort
5244663|NCT00651547|budesonide/formoterol|budesonide/formoterol
5244664|NCT00651547|budesonide|budesonide
5244665|NCT00651547|formoterol|formoterol
5244666|NCT00651547|children|children
5244667|NCT00651534|Formulation Drug Study, healthy postmenopausal|formulation drug study, healthy postmenopausal
5244668|NCT00651521|Angiographic CAD|angiographic cad
5244669|NCT00651521|Chronic kidney disease|chronic kidney disease
5244670|NCT00651521|Left ventricular dysfunction|left ventricular dysfunction
5244671|NCT00651521|Body mass index|body mass index
5244672|NCT00651521|Cardiovascular mortality|cardiovascular mortality
5244673|NCT00651521|Coronary angiography|coronary angiography
5244674|NCT00651508|Patients with Advanced or Metastatic stage IIIB/IV Non-Small Cell Lung Cancer|patients with advanced or metastatic stage iiib/iv non-small cell lung cancer
5244675|NCT00651495|Decision aids|decision aids
5244676|NCT00651495|Seniors|seniors
5244677|NCT00651495|Chronic disease management|chronic disease management
5244678|NCT00651495|Advance directives|advance directives
5244679|NCT00651469|Moderate Acne Vulgaris|moderate acne vulgaris
5244680|NCT00651469|Acne|acne
5244681|NCT00651443|galiximab|galiximab
5244682|NCT00651443|Untreated NHL|untreated nhl
5244683|NCT00651443|antibody|antibody
5244684|NCT00651443|open-label|open-label
5244685|NCT00651430|Balance|balance
5244686|NCT00651430|Voluntary stepping|voluntary stepping
5244687|NCT00651430|function|function
5244688|NCT00651430|disability|disability
5244689|NCT00651430|fear of falls|fear of falls
5244690|NCT00651430|Total Hip Arthroplasty|total hip arthroplasty
5244691|NCT00651417|Organic germanium|organic germanium
5244692|NCT00651417|fatigue|fatigue
5244693|NCT00651417|radiation therapy|radiation therapy
5244694|NCT00651417|breast cancer|breast cancer
5244695|NCT00651417|prostate cancer|prostate cancer
5244696|NCT00651365|Advanced solid tumors|advanced solid tumors
5244697|NCT00651365|Refractory solid tumor|refractory solid tumor
5244698|NCT00651365|Antineoplastic protocol|antineoplastic protocol
5244699|NCT00651365|Drug therapy|drug therapy
5244700|NCT00651365|Pharmacokinetics|pharmacokinetics
5244701|NCT00651365|Met inhibitor|met inhibitor
5244703|NCT00651352|Bioequivalence|bioequivalence
5244704|NCT00651352|Nicotine|nicotine
5244705|NCT00651339|Cerebral Palsy|cerebral palsy
5244706|NCT00651339|Balance|balance
5244707|NCT00651339|Gait|gait
5244708|NCT00651326|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5244709|NCT00651326|stage I prostate cancer|stage i prostate cancer
5244710|NCT00651326|stage II prostate cancer|stage ii prostate cancer
5244711|NCT00651326|stage III prostate cancer|stage iii prostate cancer
5244712|NCT00651326|stage IV prostate cancer|stage iv prostate cancer
5244713|NCT00651313|Dysmenorrhea|dysmenorrhea
5244714|NCT00651313|Periods|periods
5244715|NCT00651313|Menstrual|menstrual
5244716|NCT00651313|Primary dysmenorrhea in women with recurrent dysmenorrhea|primary dysmenorrhea in women with recurrent dysmenorrhea
5244717|NCT00651261|adult acute basophilic leukemia|adult acute basophilic leukemia
5244718|NCT00651261|adult acute eosinophilic leukemia|adult acute eosinophilic leukemia
5244719|NCT00651261|adult acute lymphoblastic leukemia|adult acute lymphoblastic leukemia
5244720|NCT00651261|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
5244721|NCT00651261|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
5244722|NCT00651261|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
5244723|NCT00651261|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
5244724|NCT00651261|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
5244725|NCT00651261|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
5244726|NCT00651261|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5244727|NCT00651261|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5244728|NCT00651261|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5244729|NCT00651261|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5244730|NCT00651261|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
5244731|NCT00651261|adult erythroleukemia (M6a)|adult erythroleukemia (m6a)
5244732|NCT00651261|adult pure erythroid leukemia (M6b)|adult pure erythroid leukemia (m6b)
5244733|NCT00651261|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
5244734|NCT00651248|Saliva|saliva
5244735|NCT00651248|Oral health|oral health
5244736|NCT00651248|Aged|aged
5244737|NCT00651209|Hepatitis B, chronic|hepatitis b, chronic
5244738|NCT00651209|Telbivudine|telbivudine
5244739|NCT00651209|Tenofovir|tenofovir
5244740|NCT00651209|Roadmap Concept|roadmap concept
5244741|NCT00651196|Type 1 diabetes|type 1 diabetes
5244742|NCT00651196|bone|bone
5244743|NCT00651170|Median block nerve|median block nerve
5244744|NCT00651170|Ultrasound|ultrasound
5244745|NCT00651131|post-surgical|post-surgical
5244746|NCT00651131|wound infection|wound infection
5244747|NCT00651131|superficial|superficial
5244748|NCT00651131|deep|deep
5244749|NCT00651131|surgical|surgical
5244750|NCT00651105|Diabetes|diabetes
5244751|NCT00651105|Hyperglycemia|hyperglycemia
5244752|NCT00651105|Healthy|healthy
5244753|NCT00651105|Vildagliptin|vildagliptin
5244754|NCT00651105|Adults|adults
5244755|NCT00651092|turbinectomy|turbinectomy
5244756|NCT00651079|GSK1247303,|gsk1247303,
5244757|NCT00651079|Integrase,|integrase,
5244758|NCT00651079|First Time in Human|first time in human
5244759|NCT00651066|HIV|hiv
5244760|NCT00651066|Tuberculosis|tuberculosis
5244761|NCT00651066|Rifabutin|rifabutin
5244762|NCT00651066|Pharmacokinetics|pharmacokinetics
5244763|NCT00651066|Vietnam|vietnam
5244764|NCT00651040|Polymyositis|polymyositis
5244765|NCT00651040|Dermatomyositis|dermatomyositis
5244766|NCT00651040|Glucocorticoids|glucocorticoids
5244767|NCT00651040|Methotrexate|methotrexate
5244768|NCT00651001|fructose|fructose
5244769|NCT00651001|leptin|leptin
5244770|NCT00651001|metabolic syndrome|metabolic syndrome
5244771|NCT00651001|blood pressure|blood pressure
5244772|NCT00651001|inflammation|inflammation
5244773|NCT00651001|Relationship of fructose intake to leptin levels|relationship of fructose intake to leptin levels
5244774|NCT00651001|Relationship of fructose to metabolic syndrome|relationship of fructose to metabolic syndrome
5244775|NCT00651001|Relationship of fructose to inflammation parameters|relationship of fructose to inflammation parameters
5244776|NCT00651001|Relationship of fructose to blood pressure|relationship of fructose to blood pressure
5244777|NCT00650988|Barrett's Esophagus|barrett's esophagus
5244778|NCT00650988|Cryospray ablation|cryospray ablation
5244779|NCT00650988|High Grade Dysplasia|high grade dysplasia
5244780|NCT00650988|Early Esophageal Cancers|early esophageal cancers
5244781|NCT00650988|Esophageal Neoplasms|esophageal neoplasms
5244782|NCT00650988|Esophageal Intramucosal Cancer (IMCA)|esophageal intramucosal cancer (imca)
5244783|NCT00650988|Esophageal Cancer limited to esophageal wall|esophageal cancer limited to esophageal wall
5244784|NCT00650988|Barretts esophagus High Grade Dysplasia (HGD)|barretts esophagus high grade dysplasia (hgd)
5244785|NCT00650975|STEMI|stemi
5244786|NCT00650975|Laser|laser
5244787|NCT00650975|Thrombus|thrombus
5244788|NCT00650975|Thrombectomy|thrombectomy
5244789|NCT00650962|CPR|cpr
5244790|NCT00650962|Preshock CPR|preshock cpr
5244791|NCT00650962|OHCA|ohca
5244792|NCT00650962|EMS|ems
5244793|NCT00650949|Glioblastoma multiforme|glioblastoma multiforme
5244794|NCT00650949|Glioma|glioma
5244795|NCT00650949|Phase Ib/II|phase ib/ii
5244796|NCT00650949|CYT997|cyt997
5244797|NCT00650936|Atrial|atrial
5244798|NCT00650936|Septal|septal
5244799|NCT00650936|Defect|defect
5244800|NCT00650910|lapatinib|lapatinib
5244801|NCT00650910|Metastatic ErbB2 positive breast cancer|metastatic erbb2 positive breast cancer
5244802|NCT00650910|digoxin|digoxin
5244803|NCT00650897|Efficacy|efficacy
5244804|NCT00650897|Antidepressant|antidepressant
5244805|NCT00650897|Escitalopram|escitalopram
5244806|NCT00650897|Major Depression|major depression
5244807|NCT00650897|Diabetes Mellitus|diabetes mellitus
5244808|NCT00650897|Self Care|self care
5244809|NCT00650884|Dynamic Splinting for low-load, prolonged-duration stretch|dynamic splinting for low-load, prolonged-duration stretch
5244810|NCT00650871|sleep,|sleep,
5244811|NCT00650871|polysomnography.|polysomnography.
5244812|NCT00650871|GW679769,|gw679769,
5244813|NCT00650871|primary insomnia,|primary insomnia,
5244814|NCT00650871|cognitive function,|cognitive function,
5244815|NCT00650858|Intraventricular hemorrhage (IVH)|intraventricular hemorrhage (ivh)
5244816|NCT00650858|rt-PA|rt-pa
5244817|NCT00650845|contrast-induced nephropathy, creatinemia|contrast-induced nephropathy, creatinemia
5244818|NCT00650832|HIV, anti-infectives|hiv, anti-infectives
5244819|NCT00650806|Obesity|obesity
5244820|NCT00650806|Overweight|overweight
5244821|NCT00650806|Weight loss|weight loss
5244822|NCT00650806|Anti-Obesity Agents|anti-obesity agents
5244823|NCT00650806|Human|human
5244824|NCT00650793|Schizophrenia|schizophrenia
5244825|NCT00650793|paliperidone|paliperidone
5244826|NCT00650780|Viatmin D, 25-hydroxyvitamin D, Vitamin D binding protein|viatmin d, 25-hydroxyvitamin d, vitamin d binding protein
5244827|NCT00650754|DHEA|dhea
5244828|NCT00650754|Pregnancy|pregnancy
5244829|NCT00650741|Endothelial Dysfunction|endothelial dysfunction
5244830|NCT00650741|FMD|fmd
5244831|NCT00650728|radiofrequency ablation|radiofrequency ablation
5244832|NCT00650715|Fibromyalgia|fibromyalgia
5244833|NCT00650715|Whole-Body vibration|whole-body vibration
5244834|NCT00650715|Exercise|exercise
5244835|NCT00650715|IGF-1|igf-1
5244836|NCT00650702|glaucoma, ocular hypertension, IOP|glaucoma, ocular hypertension, iop
5244837|NCT00650624|knee osteoarthritis; Japan|knee osteoarthritis; japan
5244838|NCT00650598|anterior cruciate ligament, arthroscopy, knee, post-surgical pain|anterior cruciate ligament, arthroscopy, knee, post-surgical pain
5244839|NCT00650585|smoking|smoking
5244840|NCT00650585|alcohol|alcohol
5244841|NCT00650585|prevention|prevention
5244842|NCT00650585|prevention & control|prevention & control
5244843|NCT00650572|human epidermal growth factor receptor 2|human epidermal growth factor receptor 2
5244844|NCT00650572|epidermal growth factor receptor|epidermal growth factor receptor
5244845|NCT00650572|EGFR|egfr
5244846|NCT00650572|type I receptor tyrosine kinase|type i receptor tyrosine kinase
5244847|NCT00650559|COPD|copd
5244848|NCT00650559|Emphysema|emphysema
5244849|NCT00650559|thorax enlargement|thorax enlargement
5244850|NCT00650559|LVRS|lvrs
5244851|NCT00650546|Non-alcoholic steatohepatitis|non-alcoholic steatohepatitis
5244852|NCT00650546|NASH|nash
5244853|NCT00650507|children|children
5244854|NCT00650507|cardiac surgery|cardiac surgery
5244855|NCT00650507|remote ischemic preconditioning|remote ischemic preconditioning
5244856|NCT00650507|SHAM|sham
5244857|NCT00650507|ischemia-reperfusion|ischemia-reperfusion
5244858|NCT00650468|Renal Transplantation|renal transplantation
5244859|NCT00650468|Prograf|prograf
5244860|NCT00650455|valdecoxib, severe rheumatoid arthritis|valdecoxib, severe rheumatoid arthritis
5244861|NCT00650260|intraoperative warming|intraoperative warming
5244862|NCT00650260|anesthesia|anesthesia
5244863|NCT00650260|hypothermia|hypothermia
5244864|NCT00650260|body temperature|body temperature
5244865|NCT00650182|patch|patch
5244866|NCT00650182|fentanyl|fentanyl
5244867|NCT00650182|chronic pain|chronic pain
5244868|NCT00650143|Stem cell|stem cell
5244869|NCT00650143|Myocardial infarction|myocardial infarction
5244870|NCT00650143|G-CSF|g-csf
5244871|NCT00650143|CD26-inhibition|cd26-inhibition
5244872|NCT00650130|driving under the influence|driving under the influence
5244873|NCT00650130|psychoactive substances|psychoactive substances
5244874|NCT00650130|oral fluid|oral fluid
5244875|NCT00650130|whole blood|whole blood
5244876|NCT00650130|plasma|plasma
5244877|NCT00650130|Ratio of psychoactive substances in whole blood-plasma-oral fluid|ratio of psychoactive substances in whole blood-plasma-oral fluid
5244878|NCT00650130|Prevalence of psychoactive substances in road traffic|prevalence of psychoactive substances in road traffic
5244879|NCT00650104|ropinirole IR|ropinirole ir
5244880|NCT00650104|efficacy|efficacy
5244881|NCT00650104|safety|safety
5244882|NCT00650104|open-label|open-label
5244883|NCT00650104|long term safety; REQUIP|long term safety; requip
5244884|NCT00650104|ropinirole XL|ropinirole xl
5244885|NCT00650104|ropinirole CR|ropinirole cr
5244886|NCT00650104|Parkinson's disease|parkinson's disease
5244887|NCT00650091|Idiopathic Pulmonary Fibrosis|idiopathic pulmonary fibrosis
5244888|NCT00650091|Prednisone|prednisone
5244889|NCT00650091|Azathioprine|azathioprine
5244890|NCT00650091|NAC|nac
5244891|NCT00650091|N-acetylcysteine|n-acetylcysteine
5244892|NCT00650078|Signs and Symptoms|signs and symptoms
5244893|NCT00650078|Autoimmune Diseases|autoimmune diseases
5244894|NCT00650078|Joint Diseases|joint diseases
5244895|NCT00650078|Arthritis|arthritis
5244896|NCT00650078|Connective Tissue Diseases|connective tissue diseases
5244897|NCT00650078|Arthritis, Rheumatoid|arthritis, rheumatoid
5244898|NCT00650078|Rheumatic Diseases|rheumatic diseases
5244899|NCT00650078|Predniso(lo)ne|predniso(lo)ne
5244900|NCT00650039|Post surgical pain|post surgical pain
5244901|NCT00650039|Anterior Cruciate ligament reconstruction|anterior cruciate ligament reconstruction
5244902|NCT00650039|Arthroscopy|arthroscopy
5244903|NCT00650039|Perioperative pain|perioperative pain
5244904|NCT00649961|Premature Birth|premature birth
5244905|NCT00649961|Brain injury|brain injury
5244906|NCT00649961|Neuroprotection|neuroprotection
5244907|NCT00649961|Melatonin|melatonin
5244908|NCT00649961|Pharmacokinetics|pharmacokinetics
5244909|NCT00649922|Vaccines with adalimumab dosing|vaccines with adalimumab dosing
5244910|NCT00649909|Diabetes Mellitus|diabetes mellitus
5244911|NCT00649909|Type II|type ii
5244912|NCT00649909|Aspirin|aspirin
5244913|NCT00649909|Resistance|resistance
5244914|NCT00649883|Influenza|influenza
5244915|NCT00649883|vaccine|vaccine
5244916|NCT00649883|children|children
5244917|NCT00649792|multiple sclerosis|multiple sclerosis
5244918|NCT00649792|MS|ms
5244919|NCT00649792|walking|walking
5244920|NCT00649792|leg strength|leg strength
5244921|NCT00649792|demyelination|demyelination
5244922|NCT00649766|tailored health messages|tailored health messages
5244923|NCT00649766|glaucoma|glaucoma
5244924|NCT00649766|diabetic retinopathy|diabetic retinopathy
5244925|NCT00649766|dilated fundus exams|dilated fundus exams
5244926|NCT00649766|health behavior|health behavior
5244927|NCT00649753|sacroiliac joint dysfunction|sacroiliac joint dysfunction
5244928|NCT00649753|algometer|algometer
5244929|NCT00649753|Chiropractic|chiropractic
5244930|NCT00649753|Manual Therapy|manual therapy
5244931|NCT00649753|indicator points associated with sacroiliac joint dysfunction|indicator points associated with sacroiliac joint dysfunction
5244932|NCT00649701|HIV|hiv
5244933|NCT00649701|Internet|internet
5244934|NCT00649701|MSM|msm
5244935|NCT00649701|Condom Use|condom use
5244936|NCT00649701|Disclosure|disclosure
5244937|NCT00649610|acute low back pain|acute low back pain
5244938|NCT00649584|Antigens, CD30|antigens, cd30
5244939|NCT00649584|Antibody-Drug Conjugate|antibody-drug conjugate
5244940|NCT00649584|Antibodies, Monoclonal|antibodies, monoclonal
5244941|NCT00649584|monomethyl auristatin E|monomethyl auristatin e
5244942|NCT00649584|Combined Modality Therapy|combined modality therapy
5244943|NCT00649584|Drug Therapy|drug therapy
5244944|NCT00649584|Immunotherapy|immunotherapy
5244945|NCT00649584|Lymphoma, Non-Hodgkin|lymphoma, non-hodgkin
5244946|NCT00649584|Disease, Hodgkin|disease, hodgkin
5244947|NCT00649584|Lymphoma, Large-Cell, Anaplastic|lymphoma, large-cell, anaplastic
5244948|NCT00649584|Hematologic Diseases|hematologic diseases
5244949|NCT00649584|Lymphoma|lymphoma
5244950|NCT00649428|Treatment of moderate to severe bilateral nasolabial fold wrinkles|treatment of moderate to severe bilateral nasolabial fold wrinkles
5244951|NCT00649337|mammography|mammography
5244952|NCT00649337|ultrasound|ultrasound
5244953|NCT00649337|breast cancer|breast cancer
5244954|NCT00649337|screening|screening
5244955|NCT00649298|Randomized Controlled Trial|randomized controlled trial
5244956|NCT00649298|Clinical Trial|clinical trial
5244957|NCT00649298|Controlled Clinical Trial|controlled clinical trial
5244958|NCT00649298|Clinical Trial, Phase IV|clinical trial, phase iv
5244959|NCT00649298|Multicenter Study|multicenter study
5244960|NCT00649298|End Stage Kidney Disease|end stage kidney disease
5244961|NCT00649298|Hemodialysis|hemodialysis
5244962|NCT00649298|Renal Dialysis|renal dialysis
5244963|NCT00649298|Renal Replacement Therapy|renal replacement therapy
5244964|NCT00649298|Nocturnal Dialysis|nocturnal dialysis
5244965|NCT00649298|Extended dialysis|extended dialysis
5244966|NCT00649298|Quality of Life|quality of life
5244967|NCT00649298|Quality Adjusted Life Year|quality adjusted life year
5244968|NCT00649298|Hypertrophy, Left Ventricular|hypertrophy, left ventricular
5244969|NCT00649298|Blood Pressure|blood pressure
5244970|NCT00649298|Hypertension|hypertension
5244971|NCT00649298|Anemia|anemia
5244972|NCT00649298|Hematinics|hematinics
5244973|NCT00649298|Erythropoiesis Stimulating Agents|erythropoiesis stimulating agents
5244974|NCT00649298|Cost-utility Analysis|cost-utility analysis
5244975|NCT00649298|Economic Evaluation|economic evaluation
5244976|NCT00649298|Health Care Utilisation|health care utilisation
5244977|NCT00649298|Health Care Costs|health care costs
5244978|NCT00649298|Health Expenditures|health expenditures
5244979|NCT00649298|Hospitalization|hospitalization
5244980|NCT00649298|Cost Analysis|cost analysis
5244981|NCT00649298|Cardiovascular Diseases|cardiovascular diseases
5244982|NCT00649298|Acute Coronary Syndrome|acute coronary syndrome
5244983|NCT00649298|Myocardial Infarction|myocardial infarction
5244984|NCT00649298|Stroke|stroke
5244985|NCT00649298|Cerebrovascular Disorders|cerebrovascular disorders
5244986|NCT00649298|Mortality|mortality
5244987|NCT00649298|Arteriovenous Fistula|arteriovenous fistula
5244988|NCT00649298|Arteriovenous Shunt, Surgical|arteriovenous shunt, surgical
5244989|NCT00649298|Thrombosis|thrombosis
5244990|NCT00649298|Infection|infection
5244991|NCT00649246|genetics|genetics
5244992|NCT00649246|type 1 diabetes|type 1 diabetes
5244993|NCT00649246|biomarkers|biomarkers
5244994|NCT00649246|autoimmunity|autoimmunity
5244995|NCT00649207|WBRT|wbrt
5244996|NCT00649207|Brain Metastases|brain metastases
5244997|NCT00649207|Radiation|radiation
5244998|NCT00649207|ABT-888|abt-888
5244999|NCT00649207|PARP|parp
5245000|NCT00649142|Groin hernia|groin hernia
5245001|NCT00649142|Chronic postsurgical pain|chronic postsurgical pain
5245002|NCT00649142|open mesh repair|open mesh repair
5245003|NCT00649142|laparoscopic mesh glue fixation|laparoscopic mesh glue fixation
5245004|NCT00649142|Sensory changes after groin hernia repair|sensory changes after groin hernia repair
5245005|NCT00649025|Asthma|asthma
5245006|NCT00649025|Asthma Moderate to Severe|asthma moderate to severe
5245007|NCT00648999|Kaletra|kaletra
5245008|NCT00648986|brittle nails|brittle nails
5245009|NCT00648986|Tazarotene|tazarotene
5245010|NCT00648986|Tazorac|tazorac
5245011|NCT00648973|Seasonal Allergic Rhinitis, nasal congestion|seasonal allergic rhinitis, nasal congestion
5245012|NCT00648908|multiple sclerosis|multiple sclerosis
5245013|NCT00648908|MS|ms
5245014|NCT00648908|walking|walking
5245015|NCT00648908|leg strength|leg strength
5245016|NCT00648908|demyelination|demyelination
5245017|NCT00648895|Hypertension|hypertension
5245018|NCT00648895|Blood pressure|blood pressure
5245019|NCT00648895|Nebivolol|nebivolol
5245020|NCT00648895|Bystolic (TM)|bystolic (tm)
5245021|NCT00648895|Metoprolol ER (TM)|metoprolol er (tm)
5245022|NCT00648869|pharmaceutical preparations|pharmaceutical preparations
5245023|NCT00648817|HIV-1|hiv-1
5245024|NCT00648817|tenofovir DF|tenofovir df
5245025|NCT00648739|B-cell Chronic Lymphocytic Leukemia|b-cell chronic lymphocytic leukemia
5245026|NCT00648739|Leukemia|leukemia
5245027|NCT00648739|Multiple Myeloma|multiple myeloma
5245028|NCT00648739|CD200|cd200
5245029|NCT00648739|Anti-CD200|anti-cd200
5245030|NCT00648687|prematurity|prematurity
5245031|NCT00648687|retinopathy of prematurity|retinopathy of prematurity
5245032|NCT00648687|pain|pain
5245033|NCT00648687|very low birth weight infants|very low birth weight infants
5245034|NCT00648635|Rectal Cancer|rectal cancer
5245035|NCT00648635|Recurrent Rectal Adenocarcinoma|recurrent rectal adenocarcinoma
5245036|NCT00648635|Quality of Life|quality of life
5245037|NCT00648635|QOL|qol
5245038|NCT00648635|Questionnaire|questionnaire
5245039|NCT00648635|Survey|survey
5245040|NCT00648609|Community based self management of COPD with palliative care|community based self management of copd with palliative care
5245041|NCT00648479|Fracture Fixation|fracture fixation
5245042|NCT00648453|Fontain II-III stage|fontain ii-iii stage
5245043|NCT00648375|Propanolol|propanolol
5245044|NCT00648375|Beta Blockers|beta blockers
5245045|NCT00648375|Reconsolidation|reconsolidation
5245046|NCT00648375|Cognitive Therapy|cognitive therapy
5245047|NCT00648375|PTSD|ptsd
5245048|NCT00648323|Benign Prostate Hyperplasia|benign prostate hyperplasia
5245049|NCT00648284|Type 2 diabetes|type 2 diabetes
5245050|NCT00648284|CV risk|cv risk
5245051|NCT00648284|rosiglitazone|rosiglitazone
5245052|NCT00648284|AVANDIA|avandia
5245053|NCT00648258|osteoarthritis, knee|osteoarthritis, knee
5245054|NCT00648258|osteoarthritis, hip|osteoarthritis, hip
5245055|NCT00648245|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
5245056|NCT00648245|COPD|copd
5245057|NCT00648245|Chronic bronchitis|chronic bronchitis
5245058|NCT00648232|HIV|hiv
5245059|NCT00648232|AIDS|aids
5245060|NCT00648232|Prevention|prevention
5245061|NCT00648232|VCT|vct
5245062|NCT00648232|Voluntary Counseling and Testing|voluntary counseling and testing
5245063|NCT00648206|driving under the influence|driving under the influence
5245064|NCT00648206|psychoactive substances|psychoactive substances
5245065|NCT00648206|blood samples|blood samples
5245066|NCT00648206|Prevalence of psychoactive substances in road traffic|prevalence of psychoactive substances in road traffic
5245067|NCT00648167|ESRD|esrd
5245068|NCT00648167|end-stage renal disease|end-stage renal disease
5245069|NCT00648167|end stage renal disease|end stage renal disease
5245070|NCT00648167|hemodialysis|hemodialysis
5245071|NCT00648167|dialysis|dialysis
5245072|NCT00648167|kidney failure|kidney failure
5245073|NCT00648167|renal failure|renal failure
5245074|NCT00648167|kidney|kidney
5245075|NCT00648167|renal|renal
5245076|NCT00648167|phosphate binder|phosphate binder
5245077|NCT00648167|phosphorus|phosphorus
5245078|NCT00648115|Veterans|veterans
5245079|NCT00648115|Substance-Related Disorders|substance-related disorders
5245080|NCT00648115|Mental Health|mental health
5245081|NCT00648102|Breast cancer|breast cancer
5245082|NCT00648102|Colorectal cancer|colorectal cancer
5245083|NCT00648102|Pancreatic cancer|pancreatic cancer
5245084|NCT00648102|Bladder cancer|bladder cancer
5245085|NCT00648102|Ovarian cancer|ovarian cancer
5245086|NCT00648102|Metastatic cancer|metastatic cancer
5245087|NCT00648102|Locally advanced cancer|locally advanced cancer
5245088|NCT00648102|Cancer Vaccine|cancer vaccine
5245089|NCT00648102|Vaccine|vaccine
5245090|NCT00648089|Acute ST Elevation Myocardial Infarction|acute st elevation myocardial infarction
5245091|NCT00648037|RITUXIMAB|rituximab
5245092|NCT00648037|Lymphoma|lymphoma
5245093|NCT00647998|Surgical complications|surgical complications
5245094|NCT00647998|Spinal ischemia|spinal ischemia
5245095|NCT00647998|Stroke|stroke
5245096|NCT00647998|Neuroprotection|neuroprotection
5245097|NCT00647946|lipodystrophy|lipodystrophy
5245098|NCT00647933|Females|females
5245099|NCT00647933|Corifollitropin alfa|corifollitropin alfa
5245100|NCT00647933|Antibodies|antibodies
5245101|NCT00647933|Pharmacokinetics|pharmacokinetics
5245102|NCT00647933|Pharmacodynamics|pharmacodynamics
5245103|NCT00647868|pharmacokinetics|pharmacokinetics
5245104|NCT00647868|testosterone|testosterone
5245379|NCT00646529|Symbicort|symbicort
5245105|NCT00647868|hypogonadism|hypogonadism
5245106|NCT00647829|pharyngitis, sore throat|pharyngitis, sore throat
5245107|NCT00647790|PET imaging|pet imaging
5245108|NCT00647790|invasive breast cancer|invasive breast cancer
5245109|NCT00647725|Epidural analgesia|epidural analgesia
5245110|NCT00647725|Latent analgesia|latent analgesia
5245111|NCT00647725|Active analgesia|active analgesia
5245112|NCT00647725|Labor delivery|labor delivery
5245113|NCT00647699|keratoconus|keratoconus
5245114|NCT00647699|cross-linking|cross-linking
5245115|NCT00647699|riboflavin|riboflavin
5245116|NCT00647699|UVA light|uva light
5245117|NCT00647699|cornea|cornea
5245118|NCT00647595|Obesity|obesity
5245119|NCT00647595|Physical activity|physical activity
5245120|NCT00647595|Pregnancy|pregnancy
5245121|NCT00647595|Diabetes mellitus|diabetes mellitus
5245122|NCT00647582|stage I breast cancer|stage i breast cancer
5245123|NCT00647582|stage II breast cancer|stage ii breast cancer
5245124|NCT00647569|vertical rectus abdominis musculocutaneus flap|vertical rectus abdominis musculocutaneus flap
5245125|NCT00647569|mesh repair|mesh repair
5245126|NCT00647569|salvage surgery|salvage surgery
5245127|NCT00647530|adenocarcinoma of the colon|adenocarcinoma of the colon
5245128|NCT00647530|stage I colon cancer|stage i colon cancer
5245129|NCT00647530|stage II colon cancer|stage ii colon cancer
5245130|NCT00647530|stage III colon cancer|stage iii colon cancer
5245131|NCT00647504|stent thrombosis|stent thrombosis
5245132|NCT00647504|stent restenosis|stent restenosis
5245133|NCT00647504|intravascular ultrasound|intravascular ultrasound
5245134|NCT00647478|Insulin-like Growth Factor|insulin-like growth factor
5245135|NCT00647478|Insulin-like Growth Factor binding protein 3|insulin-like growth factor binding protein 3
5245136|NCT00647478|Insulin-like Growth Factor-I system component levels|insulin-like growth factor-i system component levels
5245137|NCT00647478|Insulin-like Growth Factor-I polymorphism|insulin-like growth factor-i polymorphism
5245138|NCT00647478|Alzheimer's disease|alzheimer's disease
5245139|NCT00647478|Mild Cognitive Impairment|mild cognitive impairment
5245140|NCT00647478|Normal cognitive function|normal cognitive function
5245141|NCT00647478|Observational cross sectional study|observational cross sectional study
5245142|NCT00647465|Influenza vaccine|influenza vaccine
5245143|NCT00647465|interferon|interferon
5245144|NCT00647465|adjuvant|adjuvant
5245145|NCT00647465|the elderly|the elderly
5245146|NCT00647452|Lipid metabolism|lipid metabolism
5245147|NCT00647452|VLDL|vldl
5245148|NCT00647452|Exercise|exercise
5245149|NCT00647452|Lipid metabolism in exercise|lipid metabolism in exercise
5245150|NCT00647439|OCULAR INFLAMMATORY DISEASE|ocular inflammatory disease
5245151|NCT00647439|Immune Mediated|immune mediated
5245152|NCT00647439|Gene Expression Patterns|gene expression patterns
5245153|NCT00647439|Diabetic Retinopathy|diabetic retinopathy
5245154|NCT00647439|Age-Related Macular Degeneration|age-related macular degeneration
5245155|NCT00647439|AMD|amd
5245156|NCT00647439|Uveitis|uveitis
5245157|NCT00647426|Stage IIIB/IV|stage iiib/iv
5245158|NCT00647413|smoking|smoking
5245159|NCT00647413|passive smoking|passive smoking
5245160|NCT00647413|exposure to environmental smoke|exposure to environmental smoke
5245161|NCT00647413|home smoking ban|home smoking ban
5245162|NCT00647413|urinary cotinine|urinary cotinine
5245163|NCT00647400|Psoriasis|psoriasis
5245164|NCT00647387|muscular|muscular
5245165|NCT00647387|ventricular|ventricular
5245166|NCT00647387|septal|septal
5245167|NCT00647387|defects|defects
5245168|NCT00647387|VSD|vsd
5245169|NCT00647361|respiratory insufficiency|respiratory insufficiency
5245170|NCT00647361|respiration|respiration
5245171|NCT00647361|ventilators|ventilators
5245172|NCT00647361|diaphragm|diaphragm
5245173|NCT00647361|electromyography|electromyography
5245174|NCT00647361|mechanical ventilation|mechanical ventilation
5245175|NCT00647348|Secondary progressive Multiple Sclerosis|secondary progressive multiple sclerosis
5245176|NCT00647348|Simvastatin|simvastatin
5245177|NCT00647348|MRI|mri
5245178|NCT00647322|Intractable epilepsy, Drug Reduction, Antiepileptic medication|intractable epilepsy, drug reduction, antiepileptic medication
5245179|NCT00647296|ALS|als
5245180|NCT00647296|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
5245181|NCT00647296|Lou Gehrig|lou gehrig
5245182|NCT00647296|Lou Gehrig's|lou gehrig's
5245183|NCT00647296|Lou Gehrig's disease|lou gehrig's disease
5245184|NCT00647296|Motor Neuron Disease|motor neuron disease
5245185|NCT00647296|Nervous System Diseases|nervous system diseases
5245186|NCT00647296|KNS-760704|kns-760704
5245187|NCT00647283|Liver Transplantation|liver transplantation
5245188|NCT00647283|Tolerance|tolerance
5245189|NCT00647283|Allograft tolerance|allograft tolerance
5245190|NCT00647283|Immunosuppression minimization|immunosuppression minimization
5245191|NCT00647283|Immunosuppression weaning|immunosuppression weaning
5245192|NCT00647283|Immunological tolerance|immunological tolerance
5245193|NCT00647257|Sick Sinus Syndrome; Atrial Fibrillation; Pacemaker|sick sinus syndrome; atrial fibrillation; pacemaker
5245194|NCT00647244|Tenofovir|tenofovir
5245195|NCT00647244|Abacavir|abacavir
5245196|NCT00647244|Antiretroviral therapy|antiretroviral therapy
5245197|NCT00647244|HIV|hiv
5245198|NCT00647244|Nucleoside analogue reverse transcriptase inhibitor|nucleoside analogue reverse transcriptase inhibitor
5246723|NCT00640692|Sunitinib|sunitinib
5245199|NCT00647231|Osteoarthritis,Knee,Ketoprofen,Pain,Patch,Analgesic|osteoarthritis,knee,ketoprofen,pain,patch,analgesic
5245200|NCT00647218|stage II breast cancer|stage ii breast cancer
5245201|NCT00647218|stage IIIA breast cancer|stage iiia breast cancer
5245202|NCT00647218|stage IIIB breast cancer|stage iiib breast cancer
5245203|NCT00647218|stage IIIC breast cancer|stage iiic breast cancer
5245204|NCT00647205|Interferon, gamma|interferon, gamma
5245205|NCT00647205|HIV Infections|hiv infections
5245206|NCT00647205|Tuberculosis|tuberculosis
5245207|NCT00647192|atrial fibrillation|atrial fibrillation
5245208|NCT00647192|electrical cardioversion|electrical cardioversion
5245209|NCT00647192|prevention of atrial fibrillation recurrence|prevention of atrial fibrillation recurrence
5245210|NCT00647192|mineralocorticoid receptor blocker|mineralocorticoid receptor blocker
5245211|NCT00647192|eplerenone|eplerenone
5245212|NCT00647192|Recurrence of atrial fibrillation after cardioversion|recurrence of atrial fibrillation after cardioversion
5245213|NCT00647179|Acromegaly|acromegaly
5245214|NCT00647179|Growth Hormone|growth hormone
5245215|NCT00647179|Insulin resistance|insulin resistance
5245216|NCT00647179|Glucose tolerance|glucose tolerance
5245217|NCT00647179|Body Composition|body composition
5245218|NCT00647179|Substrate metabolism|substrate metabolism
5245219|NCT00647166|Vasculitis|vasculitis
5245220|NCT00647166|Polyarteritis nodosa (PAN)|polyarteritis nodosa (pan)
5245221|NCT00647166|Microscopic polyangiitis (MPA)|microscopic polyangiitis (mpa)
5245222|NCT00647166|Eosinophilic granulomatosis with polyangiitis (EGPA)|eosinophilic granulomatosis with polyangiitis (egpa)
5245223|NCT00647166|Churg Strauss syndrome (CSS)|churg strauss syndrome (css)
5245224|NCT00647166|Azathioprine|azathioprine
5245225|NCT00647153|stage I colon cancer|stage i colon cancer
5245226|NCT00647153|stage II colon cancer|stage ii colon cancer
5245227|NCT00647153|stage III colon cancer|stage iii colon cancer
5245228|NCT00647153|stage IV colon cancer|stage iv colon cancer
5245229|NCT00647153|stage I rectal cancer|stage i rectal cancer
5245230|NCT00647153|stage II rectal cancer|stage ii rectal cancer
5245231|NCT00647153|stage III rectal cancer|stage iii rectal cancer
5245232|NCT00647153|stage IV rectal cancer|stage iv rectal cancer
5245233|NCT00647140|Thyroid neoplasm|thyroid neoplasm
5245234|NCT00647140|Thyroid carcinoma|thyroid carcinoma
5245235|NCT00647140|Medullary carcinoma|medullary carcinoma
5245236|NCT00647140|Positron Emission Tomography (PET)|positron emission tomography (pet)
5245237|NCT00647140|18F-L DOPA|18f-l dopa
5245238|NCT00647140|Calcitonin|calcitonin
5245239|NCT00647140|Carcinoembryonic Antibodies|carcinoembryonic antibodies
5245240|NCT00647140|Cervical ultrasonography|cervical ultrasonography
5245241|NCT00647140|Cervical-chest-abdomen tomography|cervical-chest-abdomen tomography
5245242|NCT00647140|Cervical-chest-abdomen magnetic resonance imaging|cervical-chest-abdomen magnetic resonance imaging
5245243|NCT00647140|Osseous radionuclide imaging|osseous radionuclide imaging
5245244|NCT00647140|Post-PET surgery|post-pet surgery
5245245|NCT00647140|Post-PET biopsy|post-pet biopsy
5245246|NCT00647140|Post-PET histology|post-pet histology
5245247|NCT00647127|Buprenorphine|buprenorphine
5245248|NCT00647127|Fentanyl|fentanyl
5245249|NCT00647127|Analgesic effect|analgesic effect
5245250|NCT00647127|Anti-hyperalgesic effect|anti-hyperalgesic effect
5245251|NCT00647127|Experimental pain|experimental pain
5245252|NCT00647114|Cancers expressing HER-2 and/or CEA|cancers expressing her-2 and/or cea
5245253|NCT00647088|Aortic Valve stenosis|aortic valve stenosis
5245254|NCT00647088|Genetic|genetic
5245255|NCT00647088|Mineralisation inhibitors|mineralisation inhibitors
5245256|NCT00647075|Breast cancer|breast cancer
5245257|NCT00647075|undergoing|undergoing
5245258|NCT00647075|adjuvant/neoadjuvant chemotherapy|adjuvant/neoadjuvant chemotherapy
5245259|NCT00647075|symptomatic therapy|symptomatic therapy
5245260|NCT00647036|Parenteral nutrition, Infants, Dipeotiven, Microbial invasion|parenteral nutrition, infants, dipeotiven, microbial invasion
5245261|NCT00646997|atrial fibrillation, left atrium, velocity vector imaging|atrial fibrillation, left atrium, velocity vector imaging
5245262|NCT00646984|Lipodystrophy|lipodystrophy
5245263|NCT00646984|Treatment interruption|treatment interruption
5245264|NCT00646984|HIV|hiv
5245265|NCT00646971|Isoprostane|isoprostane
5245266|NCT00646971|Alkane|alkane
5245267|NCT00646971|Exhaled condensate|exhaled condensate
5245268|NCT00646971|Peripheral arterial tonometry|peripheral arterial tonometry
5245269|NCT00646971|Polysomnography|polysomnography
5245270|NCT00646971|Obstructive Sleep Apnea|obstructive sleep apnea
5245271|NCT00646971|Hypoxia|hypoxia
5245272|NCT00646945|Patient in a oncology unit who has to undergo a painful or invasive procedure|patient in a oncology unit who has to undergo a painful or invasive procedure
5245273|NCT00646906|acetaminophen|acetaminophen
5245274|NCT00646906|low dose aspirin|low dose aspirin
5245275|NCT00646906|cyclooxygenase|cyclooxygenase
5245276|NCT00646906|prostaglandin|prostaglandin
5245277|NCT00646906|drug interaction|drug interaction
5245278|NCT00646906|platelet inhibition|platelet inhibition
5245279|NCT00646906|urinary prostaglandin metabolites|urinary prostaglandin metabolites
5245280|NCT00646906|oxidant stress|oxidant stress
5245281|NCT00646906|smoking|smoking
5245282|NCT00646893|aneuploidy|aneuploidy
5245283|NCT00646893|miscarriage|miscarriage
5245284|NCT00646893|pregnancy loss|pregnancy loss
5245285|NCT00646893|PGD|pgd
5245286|NCT00646893|PGS|pgs
5246724|NCT00640692|Imatinib|imatinib
5245287|NCT00646893|Preimplantation Genetic Diagnosis|preimplantation genetic diagnosis
5245288|NCT00646893|chromosome abnormalities|chromosome abnormalities
5245289|NCT00646893|IVF|ivf
5245290|NCT00646893|ART|art
5245291|NCT00646867|Tetrix cream, contact dermatitis, effect on burning and itching|tetrix cream, contact dermatitis, effect on burning and itching
5245292|NCT00646854|Lymphoma, T-Cell|lymphoma, t-cell
5245293|NCT00646854|Lymphoma, T-Cell, Peripheral|lymphoma, t-cell, peripheral
5245294|NCT00646854|MabCampath|mabcampath
5245295|NCT00646854|Campath|campath
5245296|NCT00646854|CHOP-14|chop-14
5245297|NCT00646854|CD52 expression|cd52 expression
5245298|NCT00646841|Essential hypertension, doxazosin, ambulatory blood pressure monitoring|essential hypertension, doxazosin, ambulatory blood pressure monitoring
5245299|NCT00646828|Pseudohypoaldosteronism type 1|pseudohypoaldosteronism type 1
5245300|NCT00646828|Mineralocorticoid receptor|mineralocorticoid receptor
5245301|NCT00646828|Aldosterone|aldosterone
5245302|NCT00646828|Cardiovascular disease|cardiovascular disease
5245303|NCT00646815|insulin sensitivity|insulin sensitivity
5245304|NCT00646815|substrate metabolism|substrate metabolism
5245305|NCT00646815|fatty liver|fatty liver
5245306|NCT00646815|intramyocellular lipids|intramyocellular lipids
5245307|NCT00646815|growth hormone deficiency|growth hormone deficiency
5245308|NCT00646815|Growth hormone deficiency (Adult)|growth hormone deficiency (adult)
5245309|NCT00646750|Z-BEAM|z-beam
5245310|NCT00646750|Autologous|autologous
5245311|NCT00646750|Lymphoma|lymphoma
5245312|NCT00646750|GELTAMO|geltamo
5245313|NCT00646737|Kidney transplantation|kidney transplantation
5245314|NCT00646737|conversion|conversion
5245315|NCT00646737|mycophenolate mofetil|mycophenolate mofetil
5245316|NCT00646737|mycophenolate sodium,|mycophenolate sodium,
5245317|NCT00646737|tacrolimus|tacrolimus
5245318|NCT00646724|Islets of Langerhans Transplantation|islets of langerhans transplantation
5245319|NCT00646724|Mesenchymal Stem Cells|mesenchymal stem cells
5245320|NCT00646724|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
5245321|NCT00646698|VLDL-TG kinetics|vldl-tg kinetics
5245322|NCT00646698|Obesity|obesity
5245323|NCT00646698|Body composition|body composition
5245324|NCT00646698|Tracers|tracers
5245325|NCT00646698|Tissue biopsies|tissue biopsies
5245326|NCT00646672|ECMO|ecmo
5245327|NCT00646672|Cerebral Perfusion|cerebral perfusion
5245328|NCT00646672|Carotid Artery|carotid artery
5245329|NCT00646672|Aneurysm|aneurysm
5245330|NCT00646672|Cerebral Circulation|cerebral circulation
5245331|NCT00646672|Common Carotid Artery Occlusion|common carotid artery occlusion
5245332|NCT00646659|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
5245333|NCT00646659|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
5245334|NCT00646659|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
5245335|NCT00646659|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
5245336|NCT00646659|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5245337|NCT00646659|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5245338|NCT00646659|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5245339|NCT00646659|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5245340|NCT00646659|untreated metastatic squamous neck cancer with occult primary|untreated metastatic squamous neck cancer with occult primary
5245341|NCT00646646|Sedation|sedation
5245342|NCT00646646|Eye Movements|eye movements
5245343|NCT00646633|Cancer|cancer
5245344|NCT00646633|Acupuncture|acupuncture
5245345|NCT00646620|asthma|asthma
5245346|NCT00646620|bronchodilatation|bronchodilatation
5245347|NCT00646620|Symbicort|symbicort
5245348|NCT00646620|budesonide/formoterol|budesonide/formoterol
5245349|NCT00646620|Advair Diskus|advair diskus
5245350|NCT00646620|Ventolin|ventolin
5245351|NCT00646607|colorectal neoplasm|colorectal neoplasm
5245352|NCT00646607|high risk|high risk
5245353|NCT00646607|stage II/III|stage ii/iii
5245354|NCT00646594|Asthma|asthma
5245355|NCT00646594|inhaled cortocisteroids|inhaled cortocisteroids
5245356|NCT00646594|Symbicort|symbicort
5245357|NCT00646594|budesonide/formoterol|budesonide/formoterol
5245358|NCT00646594|Advair|advair
5245359|NCT00646594|fluticasone/salmeterol|fluticasone/salmeterol
5245360|NCT00646581|Schizophrenia|schizophrenia
5245361|NCT00646581|Memory|memory
5245362|NCT00646581|Concentration|concentration
5245363|NCT00646581|Insulin|insulin
5245364|NCT00646568|IVF|ivf
5245365|NCT00646568|ovarian reserve|ovarian reserve
5245366|NCT00646568|androgens|androgens
5245367|NCT00646568|thecal cells|thecal cells
5245368|NCT00646568|Fertility Agents, Female|fertility agents, female
5245369|NCT00646555|Tissue Samples|tissue samples
5245370|NCT00646555|VEGF Receptors|vegf receptors
5245371|NCT00646555|VEGF|vegf
5245372|NCT00646555|Microvessel Density|microvessel density
5245373|NCT00646555|Hypoxia Inducible Factor|hypoxia inducible factor
5245374|NCT00646555|Inflammatory Breast Cancer|inflammatory breast cancer
5245375|NCT00646555|IBC|ibc
5245376|NCT00646542|Type 2 diabetes, vildagliptin|type 2 diabetes, vildagliptin
5245377|NCT00646529|asthma|asthma
5245378|NCT00646529|children|children
5245380|NCT00646529|budesonide/formoterol|budesonide/formoterol
5245381|NCT00646529|Pulmicort|pulmicort
5245382|NCT00646529|budesonide|budesonide
5245383|NCT00646516|Asthma|asthma
5245384|NCT00646516|inhaled corticosteroids|inhaled corticosteroids
5245385|NCT00646516|Symbicort|symbicort
5245386|NCT00646516|budesonide/formoterol|budesonide/formoterol
5245387|NCT00646516|budesonide|budesonide
5245388|NCT00646503|Hepatitis B, Chronic|hepatitis b, chronic
5245389|NCT00646503|Telbivudine|telbivudine
5245390|NCT00646503|Polymerase Chain reaction|polymerase chain reaction
5245391|NCT00646490|serum, pleural effusion, procalcitonin, pneumonia|serum, pleural effusion, procalcitonin, pneumonia
5245392|NCT00646464|CPT|cpt
5245393|NCT00646464|ADHD|adhd
5245394|NCT00646451|Essential tremor|essential tremor
5245395|NCT00646451|Activities of Daily Living (ADL's)|activities of daily living (adl's)
5245396|NCT00646438|Diabetes|diabetes
5245397|NCT00646438|CABG|cabg
5245398|NCT00646425|Non-infectious uveitis|non-infectious uveitis
5245399|NCT00646412|randomized, controlled, single-blind study|randomized, controlled, single-blind study
5245400|NCT00646412|Adhesion Prophylaxis|adhesion prophylaxis
5245401|NCT00646412|Abdominal Surgery|abdominal surgery
5245402|NCT00646412|Laparotomy, median|laparotomy, median
5245403|NCT00646399|Staphylococcal|staphylococcal
5245404|NCT00646399|Coagulase Negative Staphylococcus|coagulase negative staphylococcus
5245405|NCT00646399|Monoclonal antibodies|monoclonal antibodies
5245406|NCT00646399|Very Low Birth Weight Infants|very low birth weight infants
5245407|NCT00646399|Prophylaxis|prophylaxis
5245408|NCT00646373|Cardiac surgery|cardiac surgery
5245409|NCT00646373|Pump prime|pump prime
5245410|NCT00646373|Blood transfusions|blood transfusions
5245411|NCT00646360|birth size, gestational age, development, child growth,|birth size, gestational age, development, child growth,
5245412|NCT00646360|prenatal nutrition, DHA|prenatal nutrition, dha
5245413|NCT00646347|stroke|stroke
5245414|NCT00646347|upper limb rehabilitation|upper limb rehabilitation
5245415|NCT00646347|treatment|treatment
5245416|NCT00646347|movement recovery from sever paralytic upper limb|movement recovery from sever paralytic upper limb
5245417|NCT00646347|neuro hand orthosis|neuro hand orthosis
5245418|NCT00646347|self practice program|self practice program
5245419|NCT00646347|subacute|subacute
5245420|NCT00646334|Large Pore Size Propylene Mesh|large pore size propylene mesh
5245421|NCT00646334|Incisional Hernia|incisional hernia
5245422|NCT00646334|Randomized Controlled Double-blind Study|randomized controlled double-blind study
5245423|NCT00646321|asthma|asthma
5245424|NCT00646321|children|children
5245425|NCT00646321|adolescents|adolescents
5245426|NCT00646321|Symbicort|symbicort
5245427|NCT00646321|budesonide/ formoterol|budesonide/ formoterol
5245428|NCT00646321|budesonide|budesonide
5245429|NCT00646308|growth hormone deficiency, pituitary tumors|growth hormone deficiency, pituitary tumors
5245430|NCT00646295|TRO|tro
5245431|NCT00646269|Dementia ; Alzheimer's Disease ; Non pharmacological treatments ; cognitive training ; reminiscence therapy ; efficacy assessment|dementia ; alzheimer's disease ; non pharmacological treatments ; cognitive training ; reminiscence therapy ; efficacy assessment
5245432|NCT00646256|schizoaffective|schizoaffective
5245433|NCT00646256|schizotypal|schizotypal
5245434|NCT00646243|Heart failure|heart failure
5245435|NCT00646243|echocardiography|echocardiography
5245436|NCT00646243|cardiac resynchronization therapy|cardiac resynchronization therapy
5245437|NCT00646243|left ventricular dyssynchrony|left ventricular dyssynchrony
5245438|NCT00646230|recurrent neuroblastoma|recurrent neuroblastoma
5245439|NCT00646217|SELF Care Talk|self care talk
5245440|NCT00646217|stroke|stroke
5245441|NCT00646217|caregivers|caregivers
5245442|NCT00646217|Caregiving as experienced by older adults caring for a spouse/partner with a first-ever stroke|caregiving as experienced by older adults caring for a spouse/partner with a first-ever stroke
5245443|NCT00646204|Parkinson's disease|parkinson's disease
5245444|NCT00646204|non-motor symptoms|non-motor symptoms
5245445|NCT00646165|Leukemia, CLL|leukemia, cll
5245446|NCT00646152|Antiviral|antiviral
5245447|NCT00646152|Influenza|influenza
5245448|NCT00646152|Interferon|interferon
5245449|NCT00646152|Prophylaxis|prophylaxis
5245450|NCT00646152|SARS|sars
5245451|NCT00646152|Healthy Volunteer|healthy volunteer
5245452|NCT00646152|HV|hv
5245453|NCT00646139|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5245454|NCT00646139|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
5245455|NCT00646139|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
5245456|NCT00646139|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
5245457|NCT00646139|adult grade III lymphomatoid granulomatosis|adult grade iii lymphomatoid granulomatosis
5245458|NCT00646139|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
5245459|NCT00646139|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5245460|NCT00646139|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
5245461|NCT00646139|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5245462|NCT00646139|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5245463|NCT00646139|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5245464|NCT00646139|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5246725|NCT00640679|Clopidogrel|clopidogrel
5245465|NCT00646139|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5245466|NCT00646139|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5245467|NCT00646139|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5245468|NCT00646139|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5245469|NCT00646139|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5245470|NCT00646139|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5245471|NCT00646139|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
5245472|NCT00646139|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
5245473|NCT00646139|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5245474|NCT00646139|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5245475|NCT00646139|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5245476|NCT00646139|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5245477|NCT00646139|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5245478|NCT00646139|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5245479|NCT00646139|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5245480|NCT00646139|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5245481|NCT00646139|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5245482|NCT00646139|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5245483|NCT00646139|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5245484|NCT00646139|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5245485|NCT00646139|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5245486|NCT00646139|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
5245487|NCT00646139|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
5245488|NCT00646139|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5245489|NCT00646139|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5245490|NCT00646139|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5245491|NCT00646139|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5245492|NCT00646139|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5245493|NCT00646139|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5245494|NCT00646139|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5245495|NCT00646139|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5245496|NCT00646139|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5245497|NCT00646139|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5245498|NCT00646139|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5245499|NCT00646139|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
5245500|NCT00646139|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5245501|NCT00646139|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5245502|NCT00646139|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5245503|NCT00646139|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5245624|NCT00645645|Agenesis of Corpus|agenesis of corpus
5245504|NCT00646139|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5245505|NCT00646139|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5245506|NCT00646139|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5245507|NCT00646139|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5245508|NCT00646139|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5245509|NCT00646139|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5245510|NCT00646139|intraocular lymphoma|intraocular lymphoma
5245511|NCT00646139|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
5245512|NCT00646139|post-transplant lymphoproliferative disorder|post-transplant lymphoproliferative disorder
5245513|NCT00646139|cutaneous B-cell non-Hodgkin lymphoma|cutaneous b-cell non-hodgkin lymphoma
5245514|NCT00646139|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
5245515|NCT00646139|small intestine lymphoma|small intestine lymphoma
5245516|NCT00646100|hepatocellular carcinoma|hepatocellular carcinoma
5245517|NCT00646100|transcatheter arterial chemoembolization|transcatheter arterial chemoembolization
5245518|NCT00646100|prospective control study|prospective control study
5245519|NCT00646100|best support care|best support care
5245520|NCT00646100|survival|survival
5245521|NCT00646074|Caregiver|caregiver
5245522|NCT00646074|Alzheimer's disease|alzheimer's disease
5245523|NCT00646074|Caregiving as experienced by older adults caring for a spouse with Alzheimer's disease or dementia|caregiving as experienced by older adults caring for a spouse with alzheimer's disease or dementia
5245524|NCT00646061|renal colic|renal colic
5245525|NCT00646048|Abdominal Aortic Aneurysm|abdominal aortic aneurysm
5245526|NCT00646048|AAA|aaa
5245527|NCT00646048|TriVascular Stent-Graft System|trivascular stent-graft system
5245528|NCT00646048|Stent-Graft|stent-graft
5245529|NCT00646022|Neuroendocrine|neuroendocrine
5245530|NCT00646022|PET|pet
5245531|NCT00646022|Gastrointestinal|gastrointestinal
5245532|NCT00646022|Serotonin|serotonin
5245533|NCT00646022|Carcinoid Tumor|carcinoid tumor
5245534|NCT00646022|Gastrointestinal Carcinoid Tumor|gastrointestinal carcinoid tumor
5245535|NCT00646022|Familial Cancer Tumor|familial cancer tumor
5245536|NCT00646009|asthma|asthma
5245537|NCT00646009|adults|adults
5245538|NCT00646009|Symbicort|symbicort
5245539|NCT00646009|budesonide/formoterol|budesonide/formoterol
5245540|NCT00646009|Advair Diskus|advair diskus
5245541|NCT00646009|Ventolin|ventolin
5245542|NCT00645996|Probiotics|probiotics
5245543|NCT00645996|vaccines|vaccines
5245544|NCT00645996|Measles|measles
5245545|NCT00645996|Mumps|mumps
5245546|NCT00645996|Rubella|rubella
5245547|NCT00645983|Chamomile|chamomile
5245548|NCT00645983|Anxiety|anxiety
5245549|NCT00645983|Complementary and Alternative Medicine|complementary and alternative medicine
5245550|NCT00645970|chronic pain|chronic pain
5245551|NCT00645970|combat injuries|combat injuries
5245552|NCT00645970|pain assessment|pain assessment
5245553|NCT00645970|multiple traumas|multiple traumas
5245554|NCT00645970|rehabilitation|rehabilitation
5245555|NCT00645957|drainage|drainage
5245556|NCT00645957|irrigation|irrigation
5245557|NCT00645931|Bone Marrow|bone marrow
5245558|NCT00645931|Bone Marrow Transplant|bone marrow transplant
5245559|NCT00645931|Pediatric|pediatric
5245560|NCT00645931|Psychological Impact|psychological impact
5245561|NCT00645931|Psychology|psychology
5245562|NCT00645918|Platelets|platelets
5245563|NCT00645918|Platelet Function Tests|platelet function tests
5245564|NCT00645918|Clopidogrel|clopidogrel
5245565|NCT00645918|Drug Eluting Stents|drug eluting stents
5245566|NCT00645918|Acute Coronary Syndrome|acute coronary syndrome
5245567|NCT00645918|Myocardial Ischemia|myocardial ischemia
5245568|NCT00645918|Stent Thrombosis|stent thrombosis
5245569|NCT00645918|Heart Diseases|heart diseases
5245570|NCT00645918|Coronary Disease|coronary disease
5245571|NCT00645918|Arterial Occlusive Disease|arterial occlusive disease
5245572|NCT00645879|Propionic Acidemia|propionic acidemia
5245573|NCT00645879|hyperammonemia|hyperammonemia
5245574|NCT00645879|hypotonia|hypotonia
5245575|NCT00645879|glutamine|glutamine
5245576|NCT00645879|ornithine alpha ketoglutarate|ornithine alpha ketoglutarate
5245577|NCT00645879|citrate|citrate
5245578|NCT00645866|stage IIIA breast cancer|stage iiia breast cancer
5245579|NCT00645866|stage IIIB breast cancer|stage iiib breast cancer
5245580|NCT00645866|stage IIIC breast cancer|stage iiic breast cancer
5245581|NCT00645840|Type 1 diabetes mellitus|type 1 diabetes mellitus
5245582|NCT00645840|IL1 beta|il1 beta
5245583|NCT00645840|Anakinra|anakinra
5245584|NCT00645827|Insulin|insulin
5245585|NCT00645827|Blood Glucose|blood glucose
5245586|NCT00645801|Routine screening colonoscopy|routine screening colonoscopy
5245587|NCT00645801|Colonoscopy Preparation|colonoscopy preparation
5245588|NCT00645801|Amitiza|amitiza
5245589|NCT00645801|GoLYTELY|golytely
5245590|NCT00645801|Pegylated Electrolytes|pegylated electrolytes
5245591|NCT00645801|Preparation Solution|preparation solution
5245592|NCT00645801|Colonoscopy Solution|colonoscopy solution
5245593|NCT00645788|Ciprofloxacin|ciprofloxacin
5245594|NCT00645788|cystic fibrosis|cystic fibrosis
5245595|NCT00645788|sweat test|sweat test
5245596|NCT00645788|pulmonary function test|pulmonary function test
5245597|NCT00645775|Weight loss|weight loss
5245598|NCT00645775|Antiobesity|antiobesity
5245599|NCT00645775|Metabolic syndrome|metabolic syndrome
5245600|NCT00645775|Leptin|leptin
5245601|NCT00645762|Chronic rhinosinusitis|chronic rhinosinusitis
5245602|NCT00645762|Chronic sinusitis|chronic sinusitis
5245603|NCT00645762|Maxillary sinus|maxillary sinus
5245604|NCT00645762|Anterior ethmoid sinus|anterior ethmoid sinus
5245605|NCT00645762|Ethmoid infundibulum|ethmoid infundibulum
5245606|NCT00645762|Balloon dilation|balloon dilation
5245607|NCT00645762|Endoscopic visualization|endoscopic visualization
5245608|NCT00645762|Local anesthesia|local anesthesia
5245609|NCT00645762|Canine fossa|canine fossa
5245610|NCT00645762|Less invasive|less invasive
5245611|NCT00645736|Chronic Hepatitis B|chronic hepatitis b
5245612|NCT00645723|Acinetobacter baumanii|acinetobacter baumanii
5245613|NCT00645723|Ventilator-associated pneumonia|ventilator-associated pneumonia
5245614|NCT00645697|tuberculosis|tuberculosis
5245615|NCT00645697|Multifocal serpiginous choroiditis|multifocal serpiginous choroiditis
5245616|NCT00645697|histoplasmosis|histoplasmosis
5245617|NCT00645697|Harada toxoplasmosis|harada toxoplasmosis
5245618|NCT00645684|Gastrointestinal Anastomosis|gastrointestinal anastomosis
5245619|NCT00645684|Multicentre|multicentre
5245620|NCT00645684|Randomized controlled single-blind study|randomized controlled single-blind study
5245621|NCT00645684|synthetic, absorbable, braided and coated suture material|synthetic, absorbable, braided and coated suture material
5245622|NCT00645684|Laparotomy|laparotomy
5245623|NCT00645645|Holoprosencephaly|holoprosencephaly
5245625|NCT00645645|Callosum|callosum
5245626|NCT00645645|Genetic Tests|genetic tests
5245627|NCT00645632|localized osteosarcoma|localized osteosarcoma
5245628|NCT00645619|Pneumonia,viral|pneumonia,viral
5245629|NCT00645619|Pneumonia,bacterial|pneumonia,bacterial
5245630|NCT00645619|TREM-1 protein,human|trem-1 protein,human
5245631|NCT00645606|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
5245632|NCT00645606|Maintenance in first-line treatment|maintenance in first-line treatment
5245633|NCT00645606|Elderly patients|elderly patients
5245634|NCT00645593|Bladder Cancer|bladder cancer
5245635|NCT00645567|Biomechanics|biomechanics
5245636|NCT00645567|Ergonomics|ergonomics
5245637|NCT00645567|Spinal Cord Injury|spinal cord injury
5245638|NCT00645567|Pain|pain
5245639|NCT00645567|Shoulder|shoulder
5245640|NCT00645554|Galantamine oral solution|galantamine oral solution
5245641|NCT00645554|Galantamine tablet|galantamine tablet
5245642|NCT00645554|Bioequivalence|bioequivalence
5245643|NCT00645541|Breast Cancer|breast cancer
5245644|NCT00645541|Carcinoma of the Breast|carcinoma of the breast
5245645|NCT00645541|Lymph Nodes|lymph nodes
5245646|NCT00645541|Lymphazurin|lymphazurin
5245647|NCT00645541|Axillary Reverse Mapping|axillary reverse mapping
5245648|NCT00645528|insulin|insulin
5245649|NCT00645528|teaching|teaching
5245650|NCT00645502|Schizophrenia|schizophrenia
5245651|NCT00645502|Risperidone|risperidone
5245652|NCT00645502|Orally-disintegrating tablet|orally-disintegrating tablet
5245653|NCT00645502|Bioequivalence|bioequivalence
5245654|NCT00645489|heart failure intervention|heart failure intervention
5245655|NCT00645450|Stress|stress
5245656|NCT00645450|Posttraumatic|posttraumatic
5245657|NCT00645450|PTSD|ptsd
5245658|NCT00645450|Propranolol|propranolol
5245659|NCT00645450|Treatment|treatment
5245660|NCT00645437|renal diseases|renal diseases
5245661|NCT00645437|levofloxacin|levofloxacin
5245662|NCT00645411|Influenza|influenza
5245663|NCT00645411|Flu|flu
5245664|NCT00645411|Cell Culture-Derived|cell culture-derived
5245665|NCT00645411|Egg-Derived|egg-derived
5245666|NCT00645411|Healthy Children|healthy children
5245667|NCT00645411|Healthy Adolescents|healthy adolescents
5245668|NCT00645411|Safety|safety
5245669|NCT00645411|Immunogenicity|immunogenicity
5245670|NCT00645411|Trivalent|trivalent
5245671|NCT00645411|Inactivated|inactivated
5245672|NCT00645411|Vaccination|vaccination
5245673|NCT00645385|GBM|gbm
5245674|NCT00645385|AA|aa
5245675|NCT00645385|AO|ao
5245676|NCT00645385|Brain|brain
5245677|NCT00645385|Tumors|tumors
5245678|NCT00645385|Malignant|malignant
5245679|NCT00645385|Glioblastoma|glioblastoma
5245680|NCT00645385|Multiforme|multiforme
5245681|NCT00645385|Carmustine|carmustine
5245682|NCT00645385|implant|implant
5245683|NCT00645385|BCNU|bcnu
5245684|NCT00645385|Gliadel|gliadel
5245685|NCT00645385|Wafers|wafers
5245686|NCT00645385|MRS|mrs
5245687|NCT00645385|Spectroscopy|spectroscopy
5245688|NCT00645359|dMRI|dmri
5245689|NCT00645359|diffusion MRI|diffusion mri
5245690|NCT00645359|Diffuse large B-cell lymphoma|diffuse large b-cell lymphoma
5245691|NCT00645359|DLBCL|dlbcl
5245692|NCT00645346|GBS|gbs
5245693|NCT00645333|breast cancer|breast cancer
5245694|NCT00645333|Phase I clinical trial|phase i clinical trial
5245695|NCT00645333|cancer stem cells|cancer stem cells
5245696|NCT00645333|agents with other mechanisms of action|agents with other mechanisms of action
5245697|NCT00645333|Notch inhibitors|notch inhibitors
5245698|NCT00645307|paliperidone|paliperidone
5245699|NCT00645307|Schizophrenia|schizophrenia
5245700|NCT00645294|Hepatitis B|hepatitis b
5245701|NCT00645294|Adefovir dipivoxil|adefovir dipivoxil
5245702|NCT00645294|Children|children
5245703|NCT00645294|Adolescents|adolescents
5245704|NCT00645294|Pharmacokinetics|pharmacokinetics
5245705|NCT00645190|Alzheimer Disease|alzheimer disease
5245706|NCT00645190|galantamine|galantamine
5245707|NCT00645177|Breast Cancer|breast cancer
5245708|NCT00645164|wound healing|wound healing
5245709|NCT00645164|photoallergenicity|photoallergenicity
5245710|NCT00645164|Healthy subjects|healthy subjects
5245711|NCT00645138|breast carcinoma|breast carcinoma
5245712|NCT00645138|breast cancer|breast cancer
5245713|NCT00645138|paravertebral block|paravertebral block
5245714|NCT00645138|comparison of paravertebral block and general anesthesia|comparison of paravertebral block and general anesthesia
5245715|NCT00645138|ultrasound|ultrasound
5245716|NCT00645125|pediatric taste test|pediatric taste test
5245717|NCT00645125|antibiotic taste test|antibiotic taste test
5245718|NCT00645125|cefdinir|cefdinir
5245719|NCT00645125|amoxicillin|amoxicillin
5245720|NCT00645099|Paliperidone ER|paliperidone er
5245721|NCT00645099|Olanzapine|olanzapine
5245722|NCT00645099|Schizophrenia|schizophrenia
5245723|NCT00645073|Acute Bacterial Sinusitis|acute bacterial sinusitis
5245724|NCT00645060|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5245725|NCT00645047|PTSD|ptsd
5245726|NCT00645047|Telemedicine|telemedicine
5245727|NCT00645047|Patient-Centered Care|patient-centered care
5245728|NCT00645047|Professional Patient Relationship|professional patient relationship
5245729|NCT00645047|Psychotherapy|psychotherapy
5245730|NCT00645047|Cognitive Therapy|cognitive therapy
5245731|NCT00645008|Stressors|stressors
5245732|NCT00645008|Patient Satisfaction|patient satisfaction
5245733|NCT00645008|Cardiothoracic-Intensive Care Unit|cardiothoracic-intensive care unit
5245734|NCT00645008|Coronary bypass patient|coronary bypass patient
5245735|NCT00644995|Depression|depression
5245736|NCT00644995|Smoking|smoking
5245737|NCT00644995|Physical Activity|physical activity
5245738|NCT00644930|ARDS,|ards,
5245739|NCT00644930|noninvasive ventilation,|noninvasive ventilation,
5245740|NCT00644930|intubation,|intubation,
5245741|NCT00644930|mortality,|mortality,
5245742|NCT00644930|intensive care|intensive care
5245743|NCT00644917|wound healing|wound healing
5245744|NCT00644917|phototoxicity|phototoxicity
5245745|NCT00644917|Healthy Subjects|healthy subjects
5245746|NCT00644904|Multiple Sclerosis|multiple sclerosis
5245747|NCT00644904|Vitamin D|vitamin d
5245748|NCT00644904|Safety|safety
5245749|NCT00644891|Pediatric taste test|pediatric taste test
5245750|NCT00644891|Antibiotic taste test|antibiotic taste test
5245751|NCT00644891|cefdinir|cefdinir
5245752|NCT00644891|amoxicillin|amoxicillin
5245753|NCT00644878|leukemia|leukemia
5245754|NCT00644878|chronic myelogenous leukemia|chronic myelogenous leukemia
5245755|NCT00644878|chronic phase|chronic phase
5245756|NCT00644878|molecular response|molecular response
5245757|NCT00644878|nilotinib|nilotinib
5245758|NCT00644878|ENABL|enabl
5245759|NCT00644852|Schizophrenia|schizophrenia
5245760|NCT00644852|Schizoaffective disorder|schizoaffective disorder
5245761|NCT00644852|Risperidone long-acting injectable, Long-term evaluation|risperidone long-acting injectable, long-term evaluation
5245762|NCT00644826|randomized controlled trial|randomized controlled trial
5245763|NCT00644826|public health|public health
5245764|NCT00644826|Preventive Health Services|preventive health services
5245765|NCT00644787|Pain|pain
5245766|NCT00644787|Cancer|cancer
5245767|NCT00644787|Fentanyl|fentanyl
5245768|NCT00644787|JNS020QD|jns020qd
5245769|NCT00644787|JNS005|jns005
5245770|NCT00644774|pediatric taste test|pediatric taste test
5245771|NCT00644774|antibiotic taste test|antibiotic taste test
5245772|NCT00644774|cefdinir|cefdinir
5245773|NCT00644774|azithromycin|azithromycin
5245774|NCT00644761|Hepatitis B|hepatitis b
5245775|NCT00644761|Post-Liver Transplantation|post-liver transplantation
5245776|NCT00644761|Adefovir Dipivoxil|adefovir dipivoxil
5245777|NCT00644761|Tacrolimus|tacrolimus
5245778|NCT00644761|Cyclosporine|cyclosporine
5245779|NCT00644735|Erosive Esophagitis|erosive esophagitis
5245780|NCT00644735|Nexium|nexium
5245781|NCT00644735|Esomeprazole|esomeprazole
5245782|NCT00644735|Lansoprazole|lansoprazole
5245783|NCT00644735|Heartburn|heartburn
5245784|NCT00644722|Intubation|intubation
5245785|NCT00644722|Out-of-hospital|out-of-hospital
5245786|NCT00644722|Laryngoscope|laryngoscope
5245787|NCT00644722|Blades|blades
5245788|NCT00644722|Emergency|emergency
5245789|NCT00644696|Neuroblastoma|neuroblastoma
5245790|NCT00644696|Irinotecan|irinotecan
5245791|NCT00644696|Bortezomib|bortezomib
5245792|NCT00644683|premenopausal women with breast cancer|premenopausal women with breast cancer
5245793|NCT00644657|Platelets, platelet aggregation inhibitors|platelets, platelet aggregation inhibitors
5245794|NCT00644644|NTX|ntx
5245795|NCT00644644|Nihon Kohden|nihon kohden
5245796|NCT00644644|mobile monitoring|mobile monitoring
5245797|NCT00644618|pancreatic cancer|pancreatic cancer
5245798|NCT00644618|locally advanced|locally advanced
5245799|NCT00644592|Healthy Volunteers|healthy volunteers
5245800|NCT00644579|wart|wart
5245801|NCT00644579|cutaneous|cutaneous
5245802|NCT00644579|transplant|transplant
5245803|NCT00644579|Cutaneous warts in immune suppressed, kidney transplant patients|cutaneous warts in immune suppressed, kidney transplant patients
5245804|NCT00644566|ADHD|adhd
5245805|NCT00644566|Primary Care|primary care
5245806|NCT00644566|Pediatrics|pediatrics
5245807|NCT00644566|Health services|health services
5245808|NCT00644566|shared care|shared care
5245809|NCT00644566|care manager|care manager
5245810|NCT00644566|screening|screening
5245811|NCT00644540|Influenza|influenza
5245812|NCT00644540|vaccines|vaccines
5245813|NCT00644540|children|children
5245814|NCT00644527|depression|depression
5245815|NCT00644527|music|music
5245816|NCT00644527|sound|sound
5245817|NCT00644527|randomized controlled trial|randomized controlled trial
5245818|NCT00644514|LPS endotoxin|lps endotoxin
5245819|NCT00644514|Asthma|asthma
5245820|NCT00644501|type 1 diabetes|type 1 diabetes
5245821|NCT00644501|beta cells|beta cells
5245822|NCT00644501|immunomodulation|immunomodulation
5245823|NCT00644501|immunointervention|immunointervention
5245824|NCT00644475|Hypertension|hypertension
5245825|NCT00644475|Insulin sensitivity|insulin sensitivity
5245826|NCT00644475|Fibrinolysis|fibrinolysis
5245827|NCT00644462|wheeze detection|wheeze detection
5245828|NCT00644436|tetrix cream|tetrix cream
5245829|NCT00644436|substantivity|substantivity
5245830|NCT00644436|resistance to a gentle wash|resistance to a gentle wash
5245831|NCT00644436|Tetrix Cream remaining on hands after gentle washing with soap and water.|tetrix cream remaining on hands after gentle washing with soap and water.
5245832|NCT00644423|PTSD|ptsd
5245833|NCT00644423|Cognition|cognition
5245834|NCT00644423|Fish Oil|fish oil
5245835|NCT00644423|Omega-3 Fatty Acid|omega-3 fatty acid
5245836|NCT00644410|heart failure|heart failure
5245837|NCT00644410|stem cell|stem cell
5245838|NCT00644410|mesenchymal stromal cell|mesenchymal stromal cell
5245839|NCT00644410|mesenchymal stem cell|mesenchymal stem cell
5245840|NCT00644397|distal femur fracture|distal femur fracture
5245841|NCT00644397|locked plates|locked plates
5245842|NCT00644397|functional outcomes|functional outcomes
5245843|NCT00644397|cost management|cost management
5245844|NCT00644397|femur head|femur head
5245845|NCT00644397|femur neck|femur neck
5245846|NCT00644384|basal cell carcinoma of the skin|basal cell carcinoma of the skin
5245847|NCT00644384|squamous cell carcinoma of the skin|squamous cell carcinoma of the skin
5245848|NCT00644371|Allogeneic|allogeneic
5245849|NCT00644371|Lymphoma|lymphoma
5245850|NCT00644371|GELTAMO|geltamo
5245851|NCT00644371|Z-RIC|z-ric
5245852|NCT00644345|Microvolt T wave alternans|microvolt t wave alternans
5245853|NCT00644345|reproducibility|reproducibility
5245854|NCT00644319|malignant pleural effusion|malignant pleural effusion
5245855|NCT00644306|Multiple Myeloma, very elderly patients, thalidomide|multiple myeloma, very elderly patients, thalidomide
5245856|NCT00644280|Glaucoma,Ahmed Valve|glaucoma,ahmed valve
5245857|NCT00644267|hypertension|hypertension
5245858|NCT00644267|cardiovascular risk|cardiovascular risk
5245859|NCT00644267|risk score|risk score
5245860|NCT00644254|Prognosis|prognosis
5245861|NCT00644254|Extracapsular lymph node involvement|extracapsular lymph node involvement
5245862|NCT00644241|stem cell therapy|stem cell therapy
5245863|NCT00644241|T2DM|t2dm
5245864|NCT00644241|Efficacy Of Autologous Bone Marrow Derived Stem Cell Transplantation In Patients With Type 2 Diabetes Mellitus|efficacy of autologous bone marrow derived stem cell transplantation in patients with type 2 diabetes mellitus
5245865|NCT00644215|injected bleb|injected bleb
5245866|NCT00644215|mitomycin drop|mitomycin drop
5245867|NCT00644215|5-Fu injection|5-fu injection
5245868|NCT00644215|early bleb failure|early bleb failure
5245869|NCT00644202|weight control|weight control
5245870|NCT00644189|clofarabine|clofarabine
5245871|NCT00644189|Clolar|clolar
5245872|NCT00644189|lymphoma|lymphoma
5245873|NCT00644189|NHL|nhl
5245874|NCT00644189|oral chemotherapy|oral chemotherapy
5245875|NCT00644163|HIV|hiv
5245876|NCT00644163|STI|sti
5245877|NCT00644163|Risk Reduction|risk reduction
5245878|NCT00644163|Couples|couples
5245879|NCT00644163|African American|african american
5245880|NCT00644163|HIV Seronegativity|hiv seronegativity
5245881|NCT00644150|Risk Reduction Counseling|risk reduction counseling
5245882|NCT00644150|Anhui, China|anhui, china
5245883|NCT00644150|HIV|hiv
5245884|NCT00644150|STI|sti
5245885|NCT00644137|smoking sensations|smoking sensations
5245886|NCT00644137|no cravings|no cravings
5245887|NCT00644137|desire to smoke|desire to smoke
5245888|NCT00644124|Non-Hodgkin's lymphoma|non-hodgkin's lymphoma
5245889|NCT00644124|angiogenesis inhibitors|angiogenesis inhibitors
5245890|NCT00644124|CHOP protocol|chop protocol
5245891|NCT00644111|Minimally Invasive Decompression and Fusion|minimally invasive decompression and fusion
5245892|NCT00644111|Postoperative analgesia|postoperative analgesia
5245893|NCT00644111|Epidural|epidural
5245894|NCT00644111|Lumbar|lumbar
5245895|NCT00644085|IVF and ICSI|ivf and icsi
5245896|NCT00644072|Hsp90 Inhibitor|hsp90 inhibitor
5245897|NCT00644072|Her2|her2
5245898|NCT00644072|Neoplasms|neoplasms
5245899|NCT00644072|Advanced Cancer|advanced cancer
5245900|NCT00644072|Cancer|cancer
5245901|NCT00644072|Solid Tumor|solid tumor
5245902|NCT00644072|Lymphoma|lymphoma
5245903|NCT00644059|Influenza|influenza
5245904|NCT00644059|vaccine|vaccine
5245905|NCT00644059|children|children
5245906|NCT00644046|Chronic Kidney Disease|chronic kidney disease
5245907|NCT00644046|Prevention|prevention
5245908|NCT00644046|Cardiovascular disease|cardiovascular disease
5245909|NCT00644020|Hepatocellular carcinoma|hepatocellular carcinoma
5245910|NCT00644020|recurrence|recurrence
5245911|NCT00644007|Erectile dysfunction|erectile dysfunction
5245912|NCT00644007|Hypertension|hypertension
5245913|NCT00644007|SK3530|sk3530
5245914|NCT00643994|Prostate Cancer|prostate cancer
5245915|NCT00643994|CyberKnife|cyberknife
5245916|NCT00643994|Stereotactic Radiosurgery|stereotactic radiosurgery
5245917|NCT00643994|Radiotherapy|radiotherapy
5245918|NCT00643994|Radiation|radiation
5245919|NCT00643994|Prostate Tumor|prostate tumor
5245920|NCT00643994|Prostate Surgery|prostate surgery
5245921|NCT00643968|HIV virological control|hiv virological control
5245922|NCT00643968|Lipid profile and morphological fat distribution|lipid profile and morphological fat distribution
5245923|NCT00643968|Treatment Experienced|treatment experienced
5245924|NCT00643955|Evaluation of muscle strength and central activation|evaluation of muscle strength and central activation
5245925|NCT00643929|thrombopoietin receptor agonist|thrombopoietin receptor agonist
5245926|NCT00643929|ocular safety|ocular safety
5245927|NCT00643929|HCV|hcv
5245928|NCT00643929|SB-497115-GR|sb-497115-gr
5245929|NCT00643929|CIT|cit
5245930|NCT00643929|ITP|itp
5245931|NCT00643929|cataract|cataract
5245932|NCT00643929|eltrombopag olamine|eltrombopag olamine
5245933|NCT00643929|lens opacity|lens opacity
5245934|NCT00643916|Meningitis; Meningococcal Infection|meningitis; meningococcal infection
5245935|NCT00643903|Side Effects|side effects
5245936|NCT00643903|Adherence|adherence
5245937|NCT00643903|Coping|coping
5245938|NCT00643903|HIV|hiv
5245939|NCT00643903|AIDS|aids
5245940|NCT00643903|Complementary Therapies|complementary therapies
5245941|NCT00643890|Keywords:|keywords:
5245942|NCT00643890|Parkinson's disease|parkinson's disease
5245943|NCT00643890|Gene transfer|gene transfer
5245944|NCT00643890|Gene therapy|gene therapy
5245945|NCT00643890|Subthalamic nucleus|subthalamic nucleus
5245946|NCT00643890|Adeno-associated virus|adeno-associated virus
5245947|NCT00643890|Study placed in the following topic categories:|study placed in the following topic categories:
5245948|NCT00643890|Ganglion Cysts|ganglion cysts
5245949|NCT00643890|Movement Disorders|movement disorders
5245950|NCT00643890|Parkinson Disease|parkinson disease
5245951|NCT00643890|Basal Ganglia Diseases|basal ganglia diseases
5245952|NCT00643890|Central Nervous System Diseases|central nervous system diseases
5245953|NCT00643890|Parkinsonian Disorders|parkinsonian disorders
5245954|NCT00643890|Neurodegenerative Diseases|neurodegenerative diseases
5245955|NCT00643890|Brain Diseases|brain diseases
5245956|NCT00643890|Additional relevant MeSH terms:|additional relevant mesh terms:
5245957|NCT00643890|Nervous System Diseases|nervous system diseases
5245958|NCT00643877|Colorectal Neoplasms|colorectal neoplasms
5245959|NCT00643877|Regional|regional
5245960|NCT00643877|Liver|liver
5245961|NCT00643877|Neoplasm Metastasis|neoplasm metastasis
5245962|NCT00643864|mirror training|mirror training
5245963|NCT00643864|stroke|stroke
5245964|NCT00643864|hemiparesis|hemiparesis
5245965|NCT00643864|rehabilitation|rehabilitation
5245966|NCT00643825|Temozolomide|temozolomide
5245967|NCT00643825|Phase II|phase ii
5245968|NCT00643825|Chemotherapy|chemotherapy
5245969|NCT00643825|Glioblastoma|glioblastoma
5245970|NCT00643825|Progression-free Survival|progression-free survival
5245971|NCT00643812|Firearm storage|firearm storage
5245972|NCT00643812|Suicide|suicide
5245973|NCT00643812|Unintentional injury|unintentional injury
5245974|NCT00643812|Alaska Native|alaska native
5245975|NCT00643812|Suicide Attempt|suicide attempt
5245976|NCT00643773|Elderly|elderly
5245977|NCT00643760|Peripheral Diabetic Neuropathy (PDN)|peripheral diabetic neuropathy (pdn)
5245978|NCT00643760|Neuropathic Pain|neuropathic pain
5245979|NCT00643747|retinal dystrophy|retinal dystrophy
5245980|NCT00643747|Leber congenital amaurosis|leber congenital amaurosis
5245981|NCT00643747|RPE65|rpe65
5245982|NCT00643747|gene therapy|gene therapy
5245983|NCT00643721|Young healthy athletes|young healthy athletes
5245984|NCT00643708|anovulation|anovulation
5245985|NCT00643708|laser|laser
5245986|NCT00643708|ovarian interstitial|ovarian interstitial
5245987|NCT00643708|polycystic ovary syndrome|polycystic ovary syndrome
5245988|NCT00643708|ultrasound-guided|ultrasound-guided
5245989|NCT00643695|hepatitis C|hepatitis c
5245990|NCT00643695|depression|depression
5245991|NCT00643695|exercise|exercise
5245992|NCT00643682|colonoscopy|colonoscopy
5245993|NCT00643682|bowel preparation|bowel preparation
5245994|NCT00643682|patient education|patient education
5245995|NCT00643682|polyp detection|polyp detection
5245996|NCT00643656|Liver biopsy|liver biopsy
5245997|NCT00643643|HIV|hiv
5245998|NCT00643643|Treatment Naïve|treatment naïve
5245999|NCT00643630|Tetrix crea|tetrix crea
5246000|NCT00643630|skin barrier|skin barrier
5246001|NCT00643630|antigen reaction|antigen reaction
5246002|NCT00643630|prevention|prevention
5246003|NCT00643630|The efficacy of Tetrix Cream to prevent an antigen reaction on the skin.|the efficacy of tetrix cream to prevent an antigen reaction on the skin.
5246004|NCT00643617|Prostate Cancer|prostate cancer
5246005|NCT00643617|CyberKnife|cyberknife
5246006|NCT00643617|Stereotactic Radiosurgery|stereotactic radiosurgery
5246007|NCT00643617|Radiosurgery|radiosurgery
5246008|NCT00643617|Prostate Tumor|prostate tumor
5246009|NCT00643617|Prostate Surgery|prostate surgery
5246010|NCT00643604|Pulmonary arterial hypertension|pulmonary arterial hypertension
5246011|NCT00643604|treatment satisfaction|treatment satisfaction
5246012|NCT00643604|rapid switch|rapid switch
5246013|NCT00643604|remodulin|remodulin
5246014|NCT00643604|Quality of life|quality of life
5246015|NCT00643591|high grade glioma|high grade glioma
5246016|NCT00643591|FDG-PET-CT|fdg-pet-ct
5246017|NCT00643591|blood proteins|blood proteins
5246018|NCT00643591|prognosis|prognosis
5246019|NCT00643578|formoterol|formoterol
5246020|NCT00643578|methacholine challenge|methacholine challenge
5246021|NCT00643552|Muscle Strength|muscle strength
5246022|NCT00643526|Rheumatoid arthritis|rheumatoid arthritis
5246023|NCT00643526|Psoriatic arthritis|psoriatic arthritis
5246024|NCT00643526|Ankylosing spondylitis|ankylosing spondylitis
5246025|NCT00643526|Psoriasis|psoriasis
5246026|NCT00643526|Autoinjector|autoinjector
5246027|NCT00643513|QUALITY OF LIFE|quality of life
5246028|NCT00643513|POSTMENOPAUSAL WOMEN|postmenopausal women
5246029|NCT00643513|HORMONE RECEPTOR POSITIVE DISSEMINATED BREAST CANCER|hormone receptor positive disseminated breast cancer
5246030|NCT00643513|FASLODEX|faslodex
5246031|NCT00643500|Levetiracetam|levetiracetam
5246032|NCT00643500|Keppra|keppra
5246033|NCT00643487|Knee physiology|knee physiology
5246034|NCT00643487|Anterior compartment knee|anterior compartment knee
5246035|NCT00643487|Infrapatellar plica|infrapatellar plica
5246036|NCT00643487|Ligamentum mucosum|ligamentum mucosum
5246037|NCT00643487|Enthesis organ|enthesis organ
5246038|NCT00643487|Fat pad of the knee|fat pad of the knee
5246039|NCT00643487|Patellofemoral kinematics|patellofemoral kinematics
5246040|NCT00643435|self-efficacy|self-efficacy
5246041|NCT00643435|chronic illness|chronic illness
5246042|NCT00643435|health behavior|health behavior
5246043|NCT00643435|education, medical, residency|education, medical, residency
5246044|NCT00643422|normal eyes|normal eyes
5246045|NCT00643396|small cell lung cancer|small cell lung cancer
5246046|NCT00643396|radiotherapy|radiotherapy
5246047|NCT00643370|lung cancer|lung cancer
5246048|NCT00643370|tumor motion|tumor motion
5246049|NCT00643357|children with burns|children with burns
5246050|NCT00643357|Child between 5 and 15 years of age , burned for many days and who has to undergo at least 3 procedures of care|child between 5 and 15 years of age , burned for many days and who has to undergo at least 3 procedures of care
5246051|NCT00643344|obesity|obesity
5246052|NCT00643344|mindfulness based stress reduction|mindfulness based stress reduction
5246053|NCT00643344|diet and exercise|diet and exercise
5246054|NCT00643344|mindful eating|mindful eating
5246055|NCT00643344|stress|stress
5246056|NCT00643331|Osteoporosis|osteoporosis
5246057|NCT00643331|Exercise|exercise
5246058|NCT00643331|Low bone density|low bone density
5246059|NCT00643331|Falls|falls
5246060|NCT00643318|lung cancer|lung cancer
5246061|NCT00643318|lung tumor|lung tumor
5246062|NCT00643318|non-small cell lung cancer|non-small cell lung cancer
5246063|NCT00643318|NSCLC|nsclc
5246064|NCT00643318|CyberKnife|cyberknife
5246065|NCT00643318|radiosurgery|radiosurgery
5246066|NCT00643318|lung surgery|lung surgery
5246067|NCT00643305|HIV|hiv
5246068|NCT00643305|Motivational Interviewing|motivational interviewing
5246069|NCT00643305|Skills|skills
5246070|NCT00643305|Prevention|prevention
5246071|NCT00643305|Mental illness|mental illness
5246072|NCT00643305|Risk reduction|risk reduction
5246073|NCT00643305|HIV/AIDS|hiv/aids
5246074|NCT00643305|HIV Seronegativity|hiv seronegativity
5246075|NCT00643279|implantable hemodynamic monitor|implantable hemodynamic monitor
5246076|NCT00643279|Intracardiac pressures|intracardiac pressures
5246077|NCT00643266|recollection training|recollection training
5246078|NCT00643266|aging|aging
5246079|NCT00643266|amnestic mild cognitive impairment|amnestic mild cognitive impairment
5246080|NCT00643266|fMRI|fmri
5246081|NCT00643253|exclusive breastfeeding|exclusive breastfeeding
5246082|NCT00643253|breastfeeding promotion|breastfeeding promotion
5246083|NCT00643253|health promotion|health promotion
5246084|NCT00643240|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5246085|NCT00643240|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5246086|NCT00643240|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5246087|NCT00643214|Tetrix Cream|tetrix cream
5246088|NCT00643214|Antigen reaction|antigen reaction
5246089|NCT00643214|effect on healing|effect on healing
5246090|NCT00643214|To determine if application of Tetrix Cream to lesions of contact dermatitis interferes with their rate of healing|to determine if application of tetrix cream to lesions of contact dermatitis interferes with their rate of healing
5246091|NCT00643188|Atrial fibrillation|atrial fibrillation
5246092|NCT00643188|Ablation|ablation
5246093|NCT00643188|Heart failure|heart failure
5246094|NCT00643188|Home Monitoring|home monitoring
5246095|NCT00643175|The main objective is to have an endocrinologist treat osteoporosis in patients with fragility hip fractures.|the main objective is to have an endocrinologist treat osteoporosis in patients with fragility hip fractures.
5246096|NCT00643162|Depression|depression
5246097|NCT00643162|Massage|massage
5246098|NCT00643162|Lexapro|lexapro
5246099|NCT00643162|Alternative Therapy|alternative therapy
5246100|NCT00643162|Anti-depressant|anti-depressant
5246101|NCT00643123|Bipolar Disorder|bipolar disorder
5246102|NCT00643123|Mania|mania
5246103|NCT00643123|Mixed mania|mixed mania
5246104|NCT00643123|Allopurinol|allopurinol
5246105|NCT00643123|Treatment-Resistant mania|treatment-resistant mania
5246106|NCT00643110|Hypoglycemia|hypoglycemia
5246107|NCT00643097|adult giant cell glioblastoma|adult giant cell glioblastoma
5246108|NCT00643097|adult gliosarcoma|adult gliosarcoma
5246109|NCT00643097|adult glioblastoma|adult glioblastoma
5246110|NCT00643084|Colorectal|colorectal
5246111|NCT00643084|Bowel preparation|bowel preparation
5246112|NCT00643084|Laparoscopic surgery|laparoscopic surgery
5246113|NCT00643071|Ulcerative colitis|ulcerative colitis
5246114|NCT00643071|Tacrolimus|tacrolimus
5246115|NCT00643071|FK506|fk506
5246116|NCT00643071|Treatment outcome|treatment outcome
5246117|NCT00643058|LPS endotoxin|lps endotoxin
5246118|NCT00643045|Parkinson Disease|parkinson disease
5246119|NCT00643019|Sexually Transmitted Infections|sexually transmitted infections
5246120|NCT00643019|Secondary Prevention|secondary prevention
5246121|NCT00643019|Cognitive Behavioral Intervention|cognitive behavioral intervention
5246122|NCT00643006|Fibromyalgia|fibromyalgia
5246123|NCT00643006|Physical activity|physical activity
5246124|NCT00643006|Function|function
5246125|NCT00643006|Pain|pain
5246126|NCT00643006|Exercise|exercise
5246127|NCT00643006|Inflammation|inflammation
5246128|NCT00642980|Pregnancy|pregnancy
5246129|NCT00642980|Preterm delivery|preterm delivery
5246130|NCT00642980|Bacterial vaginosis|bacterial vaginosis
5246131|NCT00642980|Randomized Clinical Trial|randomized clinical trial
5246132|NCT00642980|Clindamycin|clindamycin
5248434|NCT00633685|Resilience|resilience
5246133|NCT00642928|Excessive Daytime Sleepiness|excessive daytime sleepiness
5246134|NCT00642928|Parkinson's disease|parkinson's disease
5246135|NCT00642902|Relapsing Multiple Sclerosis|relapsing multiple sclerosis
5246136|NCT00642902|Atacicept|atacicept
5246137|NCT00642889|Parkinson's disease|parkinson's disease
5246138|NCT00642863|iron deficiency|iron deficiency
5246139|NCT00642863|iron deficiency anemia|iron deficiency anemia
5246140|NCT00642863|infant|infant
5246141|NCT00642863|development|development
5246142|NCT00642863|behavior|behavior
5246143|NCT00642837|Health-Related Quality of Life|health-related quality of life
5246144|NCT00642837|KEQ-5D|keq-5d
5246145|NCT00642837|Sleep disturbance|sleep disturbance
5246146|NCT00642837|Sleep quality|sleep quality
5246147|NCT00642837|SF-1|sf-1
5246148|NCT00642837|Pain intensity|pain intensity
5246149|NCT00642837|Pain relief|pain relief
5246150|NCT00642837|Tramadol|tramadol
5246151|NCT00642837|Acetaminophen|acetaminophen
5246152|NCT00642811|coronary artery disease (CAD)|coronary artery disease (cad)
5246153|NCT00642811|heart attack|heart attack
5246154|NCT00642811|stable angina|stable angina
5246155|NCT00642785|herpes|herpes
5246156|NCT00642785|HSV|hsv
5246157|NCT00642785|zoster|zoster
5246158|NCT00642785|HZV|hzv
5246159|NCT00642785|shingles|shingles
5246160|NCT00642772|Osteoarthritis|osteoarthritis
5246161|NCT00642772|Veterans|veterans
5246162|NCT00642772|Physical Therapy|physical therapy
5246163|NCT00642772|Health Services Research|health services research
5246164|NCT00642759|NSCLC|nsclc
5246165|NCT00642759|Abraxane|abraxane
5246166|NCT00642759|Carboplatin|carboplatin
5246167|NCT00642759|Bevacizumab|bevacizumab
5246168|NCT00642759|Avastin|avastin
5246169|NCT00642746|Colon|colon
5246170|NCT00642746|Cancer|cancer
5246171|NCT00642746|Metastatic|metastatic
5246172|NCT00642746|Colorectal|colorectal
5246173|NCT00642707|HIV|hiv
5246174|NCT00642707|Treatment Naïve|treatment naïve
5246175|NCT00642694|MDD|mdd
5246176|NCT00642694|Major Depressive Disorder|major depressive disorder
5246177|NCT00642694|Depression|depression
5246178|NCT00642694|Initial Insomnia|initial insomnia
5246179|NCT00642694|sleep|sleep
5246180|NCT00642694|difficulty sleeping|difficulty sleeping
5246181|NCT00642694|down|down
5246182|NCT00642694|sad|sad
5246183|NCT00642694|Major Depressive Disorder(MDD) and initial insomnia|major depressive disorder(mdd) and initial insomnia
5246184|NCT00642655|IVIG|ivig
5246185|NCT00642655|Rituximab|rituximab
5246186|NCT00642655|Highly Sensitized|highly sensitized
5246187|NCT00642655|Kidney Transplantation|kidney transplantation
5246188|NCT00642642|Acne|acne
5246189|NCT00642590|Fertility|fertility
5246190|NCT00642590|Pregnancy|pregnancy
5246191|NCT00642590|Conception|conception
5246192|NCT00642590|Infertility|infertility
5246193|NCT00642590|Behavioral|behavioral
5246194|NCT00642590|Lifestyle|lifestyle
5246195|NCT00642590|Nutrition|nutrition
5246196|NCT00642564|Epilepsy|epilepsy
5246197|NCT00642564|Headache|headache
5246198|NCT00642564|Migraine|migraine
5246199|NCT00642551|vitamin K2|vitamin k2
5246200|NCT00642551|menaquinone-7|menaquinone-7
5246201|NCT00642551|bone health|bone health
5246202|NCT00642551|vascular health|vascular health
5246203|NCT00642538|Diabetic adult male, diabetic postmenopausal women|diabetic adult male, diabetic postmenopausal women
5246204|NCT00642525|detection of anastomotic leakage|detection of anastomotic leakage
5246205|NCT00642525|esophageal resection|esophageal resection
5246206|NCT00642525|diagnostic safety|diagnostic safety
5246207|NCT00642512|CINV|cinv
5246208|NCT00642512|chemotherapy|chemotherapy
5246209|NCT00642512|nausea|nausea
5246210|NCT00642512|vomiting|vomiting
5246211|NCT00642512|retching|retching
5246212|NCT00642499|HIV|hiv
5246213|NCT00642499|AIDS|aids
5246214|NCT00642499|nausea|nausea
5246215|NCT00642499|vomiting|vomiting
5246216|NCT00642499|HAART|haart
5246217|NCT00642499|Treatment Experienced|treatment experienced
5246218|NCT00642499|HIV Infections|hiv infections
5246219|NCT00642486|treatment|treatment
5246220|NCT00642486|positive airway pressure|positive airway pressure
5246221|NCT00642486|compliance|compliance
5246222|NCT00642486|cost effectiveness|cost effectiveness
5246223|NCT00642486|clinical trial|clinical trial
5246224|NCT00642447|noninvasive ventilation|noninvasive ventilation
5246225|NCT00642447|helium|helium
5246226|NCT00642447|oxygen|oxygen
5246227|NCT00642447|sulfur mustard|sulfur mustard
5246228|NCT00642447|chronic bronchitis|chronic bronchitis
5246229|NCT00642447|bronchiolitis|bronchiolitis
5246230|NCT00642434|diabetes blood pressure oxidative stress|diabetes blood pressure oxidative stress
5246231|NCT00642421|Acromegaly|acromegaly
5246232|NCT00642395|Multiple Myeloma|multiple myeloma
5246233|NCT00642395|Autologous Stem Cells Transplantation|autologous stem cells transplantation
5246234|NCT00642395|High Dose Melphalan|high dose melphalan
5246235|NCT00642395|Bortezomib|bortezomib
5246236|NCT00642382|Osteoarthritis|osteoarthritis
5246237|NCT00642382|Hyaluronic Acid|hyaluronic acid
5246238|NCT00642369|Polysomnograph|polysomnograph
5246239|NCT00642356|Idiopathic Parkinson's disease|idiopathic parkinson's disease
5246240|NCT00642356|carbidopa/levodopa/entacapone|carbidopa/levodopa/entacapone
5246241|NCT00642356|non-motor symptoms|non-motor symptoms
5246242|NCT00642356|motor-symptoms|motor-symptoms
5246243|NCT00642343|Balance|balance
5246244|NCT00642343|Severe, Profound deafness|severe, profound deafness
5246245|NCT00642343|Children|children
5246246|NCT00642343|unilateral/bilateral cochlear implants|unilateral/bilateral cochlear implants
5246247|NCT00642343|unilateral cochlear implant|unilateral cochlear implant
5246248|NCT00642343|bilateral cochlear implants|bilateral cochlear implants
5246249|NCT00642330|patent|patent
5246250|NCT00642330|ductus|ductus
5246251|NCT00642330|arteriosus|arteriosus
5246252|NCT00642330|ibuprofen|ibuprofen
5246253|NCT00642330|premature|premature
5246254|NCT00642330|infant|infant
5246255|NCT00642317|Healthy Control|healthy control
5246256|NCT00642317|Tobacco Use|tobacco use
5246257|NCT00642317|Tobacco Initiation|tobacco initiation
5246258|NCT00642317|Smoking|smoking
5246259|NCT00642317|Questionnaire|questionnaire
5246260|NCT00642317|Survey|survey
5246261|NCT00642291|Emtricitabine|emtricitabine
5246262|NCT00642291|Pediatric|pediatric
5246263|NCT00642291|HIV-1|hiv-1
5246264|NCT00642291|Treatment of HIV-1|treatment of hiv-1
5246265|NCT00642278|Type 2 diabetes mellitus|type 2 diabetes mellitus
5246266|NCT00642278|Metformin|metformin
5246267|NCT00642278|Hemoglobin A1c|hemoglobin a1c
5246268|NCT00642252|remineraliation|remineraliation
5246269|NCT00642252|pre-existing white-spot (non-cavitated) enamel lesions|pre-existing white-spot (non-cavitated) enamel lesions
5246270|NCT00642239|Sodium Glycididazole, Radiochemotherapy, Esophageal Carcinoma|sodium glycididazole, radiochemotherapy, esophageal carcinoma
5246271|NCT00642226|Branch Retinal Vein Occlusion|branch retinal vein occlusion
5246272|NCT00642226|BRVO|brvo
5246273|NCT00642226|Macular Edema|macular edema
5246274|NCT00642226|Triamcinolone|triamcinolone
5246275|NCT00642226|Vitrectomy|vitrectomy
5246276|NCT00642213|stroke|stroke
5246277|NCT00642213|ischemic|ischemic
5246278|NCT00642213|TIA|tia
5246279|NCT00642213|hemorrhage|hemorrhage
5246280|NCT00642213|incidence|incidence
5246281|NCT00642213|case-fatality|case-fatality
5246282|NCT00642213|risk factors|risk factors
5246283|NCT00642213|genetic|genetic
5246284|NCT00642187|Asthma|asthma
5246285|NCT00642187|Pulmicort|pulmicort
5246286|NCT00642187|Turbuhaler|turbuhaler
5246287|NCT00642187|Budesonide|budesonide
5246288|NCT00642187|Flexhaler|flexhaler
5246289|NCT00642161|Asthma|asthma
5246290|NCT00642161|Pulmicort|pulmicort
5246291|NCT00642161|Children|children
5246292|NCT00642161|Paediatrics|paediatrics
5246293|NCT00642161|budesonide|budesonide
5246294|NCT00642161|Flexhaler|flexhaler
5246295|NCT00642148|GW856553|gw856553
5246296|NCT00642148|p38 MAPK|p38 mapk
5246297|NCT00642148|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5246298|NCT00642135|premature|premature
5246299|NCT00642135|neonates|neonates
5246300|NCT00642135|infants|infants
5246301|NCT00642135|children|children
5246302|NCT00642135|Mydriasert®|mydriasert®
5246303|NCT00642135|mydriasis|mydriasis
5246304|NCT00642135|fundus|fundus
5246305|NCT00642135|Tropicamide|tropicamide
5246306|NCT00642135|Phenylephrine|phenylephrine
5246307|NCT00642135|clinical trial|clinical trial
5246308|NCT00642135|Infant|infant
5246309|NCT00642135|premature newborns|premature newborns
5246310|NCT00642135|bilateral diagnosis fundus|bilateral diagnosis fundus
5246311|NCT00642122|Asthma|asthma
5246312|NCT00642122|Pulmicort|pulmicort
5246313|NCT00642122|budesonide|budesonide
5246314|NCT00642122|respules|respules
5246315|NCT00642122|turbuhaler|turbuhaler
5246316|NCT00642096|High blood pressure|high blood pressure
5246317|NCT00642096|hypertension|hypertension
5246318|NCT00642096|(TOPROL-XL)|(toprol-xl)
5246319|NCT00642096|metoprolol succinate|metoprolol succinate
5246320|NCT00642096|hydrochlorothiazide|hydrochlorothiazide
5246321|NCT00642083|outflow stenosis|outflow stenosis
5246322|NCT00642083|stentgraft|stentgraft
5246323|NCT00642070|Current symptoms of urinary tract infection|current symptoms of urinary tract infection
5246324|NCT00642057|chorea|chorea
5246325|NCT00642057|dyskinesia|dyskinesia
5246326|NCT00642057|hyperkinetic|hyperkinetic
5246327|NCT00642044|Keratoconus|keratoconus
5246328|NCT00642031|Hematologic Malignancies|hematologic malignancies
5246329|NCT00642031|Leukemia|leukemia
5246330|NCT00642031|Chronic Myelomonocytic Leukemia|chronic myelomonocytic leukemia
5246331|NCT00642031|Acute Lymphocytic Leukemia|acute lymphocytic leukemia
5246332|NCT00642031|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
5246333|NCT00642031|Chronic Myelogenous Leukemia|chronic myelogenous leukemia
5246334|NCT00642031|Agnogenic Myeloid Metaplasia|agnogenic myeloid metaplasia
5246335|NCT00642031|Triciribine Phosphate Monohydrate|triciribine phosphate monohydrate
5246336|NCT00642031|Triciribine|triciribine
5246337|NCT00642031|TCN-PM|tcn-pm
5246338|NCT00642031|VD-0002|vd-0002
5246339|NCT00642018|Hormone Refractory Prostate Cancer|hormone refractory prostate cancer
5246340|NCT00642005|Humidification|humidification
5246341|NCT00642005|Laparoscopy|laparoscopy
5246342|NCT00642005|Colon|colon
5246343|NCT00642005|Hemicolectomy|hemicolectomy
5246344|NCT00642005|Warming|warming
5246345|NCT00641992|amebic liver abscess|amebic liver abscess
5246346|NCT00641992|failure|failure
5246347|NCT00641992|prognosis|prognosis
5246348|NCT00641979|Allergic rhinitis|allergic rhinitis
5246349|NCT00641979|Nasal symptoms|nasal symptoms
5246350|NCT00641979|Congestion|congestion
5246351|NCT00641979|Rhinorrhea|rhinorrhea
5246352|NCT00641979|Sneeze|sneeze
5246353|NCT00641979|budesonide|budesonide
5246354|NCT00641979|Rhinocort AQUA|rhinocort aqua
5246355|NCT00641953|Foot Pain|foot pain
5246356|NCT00641953|Diabetic Neuropathy Pain|diabetic neuropathy pain
5246357|NCT00641953|Diabetic Peripheral Neuropathy foot pain|diabetic peripheral neuropathy foot pain
5246358|NCT00641940|Prevention|prevention
5246359|NCT00641940|Girls|girls
5246360|NCT00641940|Resilience|resilience
5246361|NCT00641927|bipolar disorder|bipolar disorder
5246362|NCT00641927|bipolar type II disorder|bipolar type ii disorder
5246363|NCT00641927|antidepressant|antidepressant
5246364|NCT00641927|mood stabilizer|mood stabilizer
5246365|NCT00641927|venlafaxine|venlafaxine
5246366|NCT00641927|lithium carbonate|lithium carbonate
5246367|NCT00641914|Asthma|asthma
5246368|NCT00641914|Pulmicort|pulmicort
5246369|NCT00641914|budesonide|budesonide
5246370|NCT00641901|gingivitis|gingivitis
5246371|NCT00641901|pregnancy|pregnancy
5246372|NCT00641901|pre-term birth|pre-term birth
5246373|NCT00641888|Cardiovascular risk|cardiovascular risk
5246374|NCT00641888|Inflammatory biomarkers|inflammatory biomarkers
5246375|NCT00641888|Human immunodeficiency virus|human immunodeficiency virus
5246376|NCT00641875|arterial stiffness|arterial stiffness
5246377|NCT00641875|artery|artery
5246378|NCT00641875|aortic pulse wave velocity|aortic pulse wave velocity
5246379|NCT00641875|pulse wave analysis|pulse wave analysis
5246380|NCT00641875|augmentation index|augmentation index
5246381|NCT00641875|end stage renal disease|end stage renal disease
5246382|NCT00641875|nocturnal hemodialysis|nocturnal hemodialysis
5246383|NCT00641875|extended hours of hemodialysis|extended hours of hemodialysis
5246384|NCT00641875|cardiovascular|cardiovascular
5246385|NCT00641875|hemodialysis|hemodialysis
5246386|NCT00641862|Pregnancy|pregnancy
5246387|NCT00641862|Maternal Nutritional Status|maternal nutritional status
5246388|NCT00641862|Vitamin B12|vitamin b12
5246389|NCT00641849|BMI|bmi
5246390|NCT00641849|Physical Activity|physical activity
5246391|NCT00641849|Food|food
5246392|NCT00641849|Nutrition|nutrition
5246393|NCT00641849|Dietary behaviors|dietary behaviors
5246394|NCT00641849|Diet|diet
5246395|NCT00641849|Adult|adult
5246396|NCT00641849|Adults|adults
5246397|NCT00641849|Fat|fat
5246398|NCT00641849|Fats|fats
5246399|NCT00641849|Self monitoring|self monitoring
5246400|NCT00641849|Automated feedback|automated feedback
5246401|NCT00641823|Orthopedic Surgical Procedures|orthopedic surgical procedures
5246402|NCT00641810|Caffeine|caffeine
5246403|NCT00641810|Snoring|snoring
5246404|NCT00641810|Sleep|sleep
5246405|NCT00641797|Canalith Repositioning Technique|canalith repositioning technique
5246406|NCT00641797|Vertigo|vertigo
5246407|NCT00641784|Composite Early neonatal Outcome|composite early neonatal outcome
5246408|NCT00641784|Late Neurological neonatal outcome|late neurological neonatal outcome
5246409|NCT00641758|Coronary Artery Disease|coronary artery disease
5246410|NCT00641758|endothelial dysfunction|endothelial dysfunction
5246411|NCT00641758|Nitric oxide|nitric oxide
5246412|NCT00641745|Lurasidone|lurasidone
5246413|NCT00641745|Schizophrenia|schizophrenia
5246414|NCT00641745|Latuda|latuda
5246415|NCT00641732|venous thromboembolism|venous thromboembolism
5246416|NCT00641732|oral anticoagulant|oral anticoagulant
5246417|NCT00641732|direct factor Xa inhibitor|direct factor xa inhibitor
5246418|NCT00641732|total knee replacement|total knee replacement
5246419|NCT00641732|drug therapy|drug therapy
5246420|NCT00641693|Allergic rhinitis|allergic rhinitis
5246421|NCT00641693|Paediatric|paediatric
5246422|NCT00641693|Nasal symptoms|nasal symptoms
5246423|NCT00641693|Congestion|congestion
5246424|NCT00641693|Rhinorrhea|rhinorrhea
5246425|NCT00641693|Sneeze|sneeze
5246426|NCT00641693|budesonide|budesonide
5246427|NCT00641693|Rhinocort AQUA|rhinocort aqua
5246428|NCT00641680|Seasonal allergic rhinitis|seasonal allergic rhinitis
5246429|NCT00641680|Nasal symptoms|nasal symptoms
5246430|NCT00641680|Congestion|congestion
5246431|NCT00641680|Rhinorrhea|rhinorrhea
5246432|NCT00641680|Sneeze|sneeze
5246433|NCT00641680|budesonide|budesonide
5246434|NCT00641680|Rhinocort AQUA|rhinocort aqua
5246435|NCT00641680|Fluticasone propionate|fluticasone propionate
5246436|NCT00641680|Flonase|flonase
5246437|NCT00641667|Pain|pain
5246438|NCT00641667|Cancer|cancer
5246439|NCT00641667|Fentanyl|fentanyl
5246440|NCT00641667|JNS020QD|jns020qd
5246441|NCT00641654|Chronic hepatitis C|chronic hepatitis c
5246442|NCT00641654|genotype 2 or 3|genotype 2 or 3
5246443|NCT00641654|relapse|relapse
5246444|NCT00641654|pegylated interferon|pegylated interferon
5246445|NCT00641654|ribavirin|ribavirin
5246446|NCT00641641|Viral compartments|viral compartments
5246447|NCT00641641|integrase inhibitor therapy|integrase inhibitor therapy
5246448|NCT00641641|viral species|viral species
5246449|NCT00641628|Nipple sparing mastectomy|nipple sparing mastectomy
5246450|NCT00641628|NAC conservation|nac conservation
5246451|NCT00641602|Erosive Esophagitis|erosive esophagitis
5246452|NCT00641602|Nexium|nexium
5246453|NCT00641602|Heartburn|heartburn
5246454|NCT00641589|Chronic Kidney Disease|chronic kidney disease
5246455|NCT00641589|anemia|anemia
5246456|NCT00641589|epoetin alfa|epoetin alfa
5246457|NCT00641576|Endosseous implants|endosseous implants
5246458|NCT00641563|dexmedetomidine|dexmedetomidine
5246459|NCT00641563|midazolam|midazolam
5246460|NCT00641563|remifentanil|remifentanil
5246461|NCT00641563|Electroencephalography|electroencephalography
5246462|NCT00641563|Event related potentials|event related potentials
5246463|NCT00641563|BIS|bis
5246464|NCT00641563|Bispectral Index|bispectral index
5246465|NCT00641563|Response Entropy|response entropy
5246466|NCT00641563|State Entropy|state entropy
5246467|NCT00641550|physical exercise|physical exercise
5246468|NCT00641550|maternal complications|maternal complications
5246469|NCT00641550|preterm labor|preterm labor
5246470|NCT00641550|birthweight|birthweight
5246471|NCT00641550|Apgar scores|apgar scores
5246472|NCT00641524|Non-alcoholic fatty liver disease|non-alcoholic fatty liver disease
5246473|NCT00641524|liver fibrosis|liver fibrosis
5246474|NCT00641524|metabolic syndrome|metabolic syndrome
5246475|NCT00641524|iron overload|iron overload
5246476|NCT00641524|phlebotomy|phlebotomy
5246477|NCT00641511|PTSD|ptsd
5246478|NCT00641498|suicide|suicide
5246479|NCT00641498|parasuicide|parasuicide
5246480|NCT00641498|prevention|prevention
5246481|NCT00641498|individual supportive psychotherapy|individual supportive psychotherapy
5246482|NCT00641472|Asthma|asthma
5246483|NCT00641472|Pulmicort|pulmicort
5246484|NCT00641472|Children|children
5246485|NCT00641472|paediatrics|paediatrics
5246486|NCT00641472|budesonide|budesonide
5246487|NCT00641459|Behavioral and Psychological Symptoms of Dementia|behavioral and psychological symptoms of dementia
5246488|NCT00641459|BPSD|bpsd
5246489|NCT00641459|NPI|npi
5246490|NCT00641459|CGI|cgi
5246491|NCT00641459|MMSE|mmse
5246492|NCT00641446|Children|children
5246493|NCT00641446|Asthma|asthma
5246494|NCT00641446|Varivax|varivax
5246495|NCT00641446|varicella|varicella
5246496|NCT00641446|Pulmicort|pulmicort
5246497|NCT00641446|budesonide|budesonide
5246498|NCT00641433|chemocautery|chemocautery
5246499|NCT00641420|Acne scarring|acne scarring
5246500|NCT00641420|Post inflammatory hyperpigmentation|post inflammatory hyperpigmentation
5246501|NCT00641407|Bedtime insulins|bedtime insulins
5246502|NCT00641407|Poorly controlled type 2 diabetes|poorly controlled type 2 diabetes
5246503|NCT00641407|Glycemic control|glycemic control
5246504|NCT00641407|HbA1c|hba1c
5246505|NCT00641394|cortisol|cortisol
5246506|NCT00641394|hydrocortisone|hydrocortisone
5246507|NCT00641394|psychotherapy|psychotherapy
5246508|NCT00641394|Emotional Freedom Techniques (EFT)|emotional freedom techniques (eft)
5246509|NCT00641394|Cognitive Behavioral Therapy (CBT)|cognitive behavioral therapy (cbt)
5246510|NCT00641394|depression|depression
5246511|NCT00641394|anxiety|anxiety
5246512|NCT00641381|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5246513|NCT00641381|stage III childhood Hodgkin lymphoma|stage iii childhood hodgkin lymphoma
5246514|NCT00641381|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5246515|NCT00641381|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
5246516|NCT00641381|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
5246517|NCT00641381|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5246518|NCT00641381|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5246519|NCT00641381|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
5246520|NCT00641381|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
5246521|NCT00641381|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5246522|NCT00641381|AIDS-related diffuse large cell lymphoma|aids-related diffuse large cell lymphoma
5246523|NCT00641381|AIDS-related diffuse mixed cell lymphoma|aids-related diffuse mixed cell lymphoma
5246524|NCT00641381|AIDS-related immunoblastic large cell lymphoma|aids-related immunoblastic large cell lymphoma
5246525|NCT00641381|AIDS-related lymphoblastic lymphoma|aids-related lymphoblastic lymphoma
5246526|NCT00641381|AIDS-related small noncleaved cell lymphoma|aids-related small noncleaved cell lymphoma
5246527|NCT00641381|Burkitt lymphoma|burkitt lymphoma
5246528|NCT00641381|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5246529|NCT00641381|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5246530|NCT00641381|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5246531|NCT00641381|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5246532|NCT00641381|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5246533|NCT00641381|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5246534|NCT00641381|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5246535|NCT00641381|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5246536|NCT00641381|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5246537|NCT00641381|stage III childhood lymphoblastic lymphoma|stage iii childhood lymphoblastic lymphoma
5248820|NCT00632099|treatment|treatment
5246538|NCT00641381|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5246539|NCT00641381|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
5246540|NCT00641381|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5246541|NCT00641381|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5246542|NCT00641381|HIV Infections|hiv infections
5246543|NCT00641381|Treatment Experienced|treatment experienced
5246544|NCT00641368|Adolescent|adolescent
5246545|NCT00641368|Child|child
5246546|NCT00641368|Computer|computer
5246547|NCT00641368|Depression|depression
5246548|NCT00641368|Resilience|resilience
5246549|NCT00641342|Parastomal hernia|parastomal hernia
5246550|NCT00641342|Onlay mesh|onlay mesh
5246551|NCT00641342|Sublay mesh|sublay mesh
5246552|NCT00641342|Pain|pain
5246553|NCT00641342|Health questionnaire|health questionnaire
5246554|NCT00641329|ADHD|adhd
5246555|NCT00641329|ADD|add
5246556|NCT00641329|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
5246557|NCT00641329|Attention Deficit|attention deficit
5246558|NCT00641329|Clonidine|clonidine
5246559|NCT00641329|CLONICEL|clonicel
5246560|NCT00641329|Addrenex|addrenex
5246561|NCT00641316|Freeze-dried bone allograft|freeze-dried bone allograft
5246562|NCT00641316|Platelet-rich plasma|platelet-rich plasma
5246563|NCT00641316|Platelet-derived growth factors|platelet-derived growth factors
5246564|NCT00641316|Laser-threaded dental implants|laser-threaded dental implants
5246565|NCT00641316|Resorbable blast textured dental implants|resorbable blast textured dental implants
5246566|NCT00641303|pain|pain
5246567|NCT00641303|fatigue|fatigue
5246568|NCT00641303|hot flashes|hot flashes
5246569|NCT00641303|sleep disorders|sleep disorders
5246570|NCT00641303|depression|depression
5246571|NCT00641303|anxiety disorder|anxiety disorder
5246572|NCT00641303|stage I breast cancer|stage i breast cancer
5246573|NCT00641303|stage II breast cancer|stage ii breast cancer
5246574|NCT00641303|stage IIIA breast cancer|stage iiia breast cancer
5246575|NCT00641303|stage IIIB breast cancer|stage iiib breast cancer
5246576|NCT00641303|stage IIIC breast cancer|stage iiic breast cancer
5246577|NCT00641290|CABG|cabg
5246578|NCT00641290|Valve surgery|valve surgery
5246579|NCT00641277|endosseous dental implants|endosseous dental implants
5246580|NCT00641277|dental aesthetics|dental aesthetics
5246581|NCT00641264|Laryngopharyngeal reflux (LPR)|laryngopharyngeal reflux (lpr)
5246582|NCT00641264|Omeprazole|omeprazole
5246583|NCT00641264|Losec|losec
5246584|NCT00641264|Quality of Life|quality of life
5246585|NCT00641264|Laryngitis|laryngitis
5246586|NCT00641251|T2 Diabetes|t2 diabetes
5246587|NCT00641251|Type 2 diabetes CVD event rates and mortality|type 2 diabetes cvd event rates and mortality
5246588|NCT00641238|NSCLC|nsclc
5246589|NCT00641238|lung cancer|lung cancer
5246590|NCT00641225|Ascending Single Dose|ascending single dose
5246591|NCT00641225|Safety|safety
5246592|NCT00641225|Pharmacokinetics|pharmacokinetics
5246593|NCT00641225|Open-label|open-label
5246594|NCT00641212|Allergic rhinitis|allergic rhinitis
5246595|NCT00641212|Perennial allergic rhinitis|perennial allergic rhinitis
5246596|NCT00641212|Paediatric|paediatric
5246597|NCT00641212|Growth|growth
5246598|NCT00641212|budesonide|budesonide
5246599|NCT00641212|Rhinocort AQUA|rhinocort aqua
5246600|NCT00641199|Antibiotic-associated diarrhea|antibiotic-associated diarrhea
5246601|NCT00641199|Probiotic|probiotic
5246602|NCT00641199|Quality of life|quality of life
5246603|NCT00641199|Antibiotics|antibiotics
5246604|NCT00641186|excessive daytime somnolence|excessive daytime somnolence
5246605|NCT00641186|Parkinson disease|parkinson disease
5246606|NCT00641186|sleep disturbance|sleep disturbance
5246607|NCT00641173|PTSD|ptsd
5246608|NCT00641173|cortisol|cortisol
5246609|NCT00641173|hippocampus|hippocampus
5246610|NCT00641173|memory|memory
5246611|NCT00641160|vinorelbine|vinorelbine
5246612|NCT00641160|metronomic dosing|metronomic dosing
5246613|NCT00641160|oral administration|oral administration
5246614|NCT00641160|nonhematologic malignancies|nonhematologic malignancies
5246615|NCT00641160|pharmacokinetics|pharmacokinetics
5246616|NCT00641134|Cardiac Rehabilitation|cardiac rehabilitation
5246617|NCT00641134|Old age|old age
5246618|NCT00641134|Home physical training|home physical training
5246619|NCT00641108|SPECT Brain Imaging|spect brain imaging
5246620|NCT00641108|Cognitive Therapy|cognitive therapy
5246621|NCT00641108|Serotonin Transporter Binding|serotonin transporter binding
5246622|NCT00641108|Predictive Biomarker|predictive biomarker
5246623|NCT00641095|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
5246624|NCT00641095|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5246625|NCT00641095|stage I mantle cell lymphoma|stage i mantle cell lymphoma
5246626|NCT00641095|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5246627|NCT00641095|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5246628|NCT00641069|Cardiac arrest|cardiac arrest
5246629|NCT00641069|Cardiopulmonary resuscitation|cardiopulmonary resuscitation
5246630|NCT00641056|diabetes|diabetes
5246631|NCT00641056|exenatide|exenatide
5246632|NCT00641056|exenatide once weekly|exenatide once weekly
5246633|NCT00641056|metformin|metformin
5246634|NCT00641056|sulfonylurea|sulfonylurea
5246635|NCT00641056|insulin glargine|insulin glargine
5246636|NCT00641056|Amylin|amylin
5246637|NCT00641056|Lilly|lilly
5246638|NCT00641030|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5246639|NCT00641030|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5246640|NCT00641030|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5246641|NCT00641030|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5246642|NCT00641030|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5246643|NCT00641030|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5246644|NCT00641030|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5246645|NCT00641030|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5246646|NCT00641030|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5246647|NCT00641030|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5246648|NCT00641030|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5246649|NCT00641030|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
5246650|NCT00641030|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5246651|NCT00641030|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5246652|NCT00641030|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
5246653|NCT00641030|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5246654|NCT00641030|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5246655|NCT00641030|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
5246656|NCT00640991|Clinical Trial|clinical trial
5246657|NCT00640991|Insulin|insulin
5246658|NCT00640978|Pancreatic Cancer|pancreatic cancer
5246659|NCT00640978|Advanced Pancreatic Cancer|advanced pancreatic cancer
5246660|NCT00640978|Unresectable|unresectable
5246661|NCT00640978|Metastatic|metastatic
5246662|NCT00640978|RAD001|rad001
5246663|NCT00640978|Everolimus|everolimus
5246664|NCT00640978|Erlotinib|erlotinib
5246665|NCT00640978|OSI-774|osi-774
5246666|NCT00640978|Erlotinib Hydrochloride|erlotinib hydrochloride
5246667|NCT00640978|Tarceva|tarceva
5246668|NCT00640952|Parkinson's disease|parkinson's disease
5246669|NCT00640952|impulse control behaviors|impulse control behaviors
5246670|NCT00640952|dopa-dysregulation|dopa-dysregulation
5246671|NCT00640939|Tendonitis|tendonitis
5246672|NCT00640939|Bursitis|bursitis
5246673|NCT00640913|Defunctioning stoma|defunctioning stoma
5246674|NCT00640913|Low anterior resection|low anterior resection
5246675|NCT00640913|TME surgery|tme surgery
5246676|NCT00640913|Early stoma reversal|early stoma reversal
5246677|NCT00640900|overweight|overweight
5246678|NCT00640900|obesity|obesity
5246679|NCT00640900|weight loss|weight loss
5246680|NCT00640900|commercial weight loss program|commercial weight loss program
5246681|NCT00640887|HIV|hiv
5246682|NCT00640887|Tuberculosis|tuberculosis
5246683|NCT00640887|Rifabutin|rifabutin
5246684|NCT00640887|Pharmacokinetics|pharmacokinetics
5246685|NCT00640887|South Africa|south africa
5246686|NCT00640874|Prophylaxis|prophylaxis
5246687|NCT00640874|pandemic influenza|pandemic influenza
5246688|NCT00640874|influenza A|influenza a
5246689|NCT00640874|H5N1 virus|h5n1 virus
5246690|NCT00640861|stage II breast cancer|stage ii breast cancer
5246691|NCT00640861|stage IIIA breast cancer|stage iiia breast cancer
5246692|NCT00640861|stage IIIB breast cancer|stage iiib breast cancer
5246693|NCT00640861|stage IIIC breast cancer|stage iiic breast cancer
5246694|NCT00640861|stage IA breast cancer|stage ia breast cancer
5246695|NCT00640861|stage IB breast cancer|stage ib breast cancer
5246696|NCT00640861|triple-negative breast cancer|triple-negative breast cancer
5246697|NCT00640861|HER2-positive breast cancer|her2-positive breast cancer
5246698|NCT00640835|Opioid dependence|opioid dependence
5246699|NCT00640809|Bowel Disease|bowel disease
5246700|NCT00640796|Hematologic malignancies, non-B lineage|hematologic malignancies, non-b lineage
5246701|NCT00640796|NK cell expansion|nk cell expansion
5246702|NCT00640796|CliniMACS device|clinimacs device
5246703|NCT00640796|Immunotherapy|immunotherapy
5246704|NCT00640783|Metabolic syndrome|metabolic syndrome
5246705|NCT00640783|Mediterranean diet|mediterranean diet
5246706|NCT00640783|Inflammatory markers|inflammatory markers
5246707|NCT00640783|Endothelial function|endothelial function
5246708|NCT00640757|Methionine|methionine
5246709|NCT00640757|Metabolic syndrome|metabolic syndrome
5246710|NCT00640757|Glucose Metabolism|glucose metabolism
5246711|NCT00640757|Amino acid|amino acid
5246712|NCT00640757|Insulin clamp|insulin clamp
5246713|NCT00640744|Atherogenesis|atherogenesis
5246714|NCT00640744|Atheroma|atheroma
5246715|NCT00640744|Arteriosclerosis|arteriosclerosis
5246716|NCT00640731|DVT|dvt
5246717|NCT00640731|Peripheral Vascular Disease|peripheral vascular disease
5246718|NCT00640731|Venous Thrombosis|venous thrombosis
5246719|NCT00640731|Deep Vein Thrombosis|deep vein thrombosis
5246720|NCT00640718|heart and respiratory monitoring|heart and respiratory monitoring
5246721|NCT00640692|Gastrointestinal stromal tumor|gastrointestinal stromal tumor
5246722|NCT00640692|GIST|gist
5246726|NCT00640679|Drug-eluting Stent|drug-eluting stent
5246727|NCT00640666|Breast cancer|breast cancer
5246728|NCT00640666|Exercise|exercise
5246729|NCT00640666|Biomarkers|biomarkers
5246730|NCT00640653|Sexual Behavior|sexual behavior
5246731|NCT00640653|Abstinence|abstinence
5246732|NCT00640653|Intervention Studies|intervention studies
5246733|NCT00640653|HIV|hiv
5246734|NCT00640653|Sexually Transmitted Infection|sexually transmitted infection
5246735|NCT00640653|Theory of Planned Behavior|theory of planned behavior
5246736|NCT00640653|HIV Seronegativity|hiv seronegativity
5246737|NCT00640640|IOP|iop
5246738|NCT00640640|OPA|opa
5246739|NCT00640640|AMD|amd
5246740|NCT00640640|bevacizumab|bevacizumab
5246741|NCT00640640|ranibizumab|ranibizumab
5246742|NCT00640640|choroidal blood flow|choroidal blood flow
5246743|NCT00640640|DCT|dct
5246744|NCT00640640|Ocular Pulse Amplitude change following anti VEGF|ocular pulse amplitude change following anti vegf
5246745|NCT00640640|Ocular Pulse Amplitude|ocular pulse amplitude
5246746|NCT00640614|Dermatitis, Contact|dermatitis, contact
5246747|NCT00640601|Seroquel|seroquel
5246748|NCT00640601|schizophrenia|schizophrenia
5246749|NCT00640601|Extended Release|extended release
5246750|NCT00640588|Hepatitis B, chronic|hepatitis b, chronic
5246751|NCT00640588|Viral kinetics|viral kinetics
5246752|NCT00640588|Telbivudine|telbivudine
5246753|NCT00640588|Adefovir|adefovir
5246754|NCT00640588|Compliance|compliance
5246755|NCT00640562|Schizophrenia|schizophrenia
5246756|NCT00640562|Depression|depression
5246757|NCT00640562|Quetiapine|quetiapine
5246758|NCT00640549|LDL-subfractions, HDL-subfractions, non insulin dependent diabetes mellitus (NIDDM), hyperlipidemia, atorvastatin|ldl-subfractions, hdl-subfractions, non insulin dependent diabetes mellitus (niddm), hyperlipidemia, atorvastatin
5246759|NCT00640497|acute GVHD|acute gvhd
5246760|NCT00640497|immunotoxin|immunotoxin
5246761|NCT00640497|anti-CD3|anti-cd3
5246762|NCT00640497|anti-CD7|anti-cd7
5246763|NCT00640497|Ricin A|ricin a
5246764|NCT00640471|recurrent colon cancer|recurrent colon cancer
5246765|NCT00640471|stage IV colon cancer|stage iv colon cancer
5246766|NCT00640471|recurrent rectal cancer|recurrent rectal cancer
5246767|NCT00640471|stage IV rectal cancer|stage iv rectal cancer
5246768|NCT00640445|Clinical Trial|clinical trial
5246769|NCT00640445|Combat Disorders|combat disorders
5246770|NCT00640445|PTSD|ptsd
5246771|NCT00640445|Internet-Based Intervention|internet-based intervention
5246772|NCT00640445|Mental Health Services|mental health services
5246773|NCT00640445|Post-deployment Reintegration|post-deployment reintegration
5246774|NCT00640393|Etanercept, UVB, Enbrel, Psoriasis.|etanercept, uvb, enbrel, psoriasis.
5246775|NCT00640380|cervical|cervical
5246776|NCT00640380|paravertebral|paravertebral
5246777|NCT00640380|block|block
5246778|NCT00640367|Acute ischemic stroke|acute ischemic stroke
5246779|NCT00640367|thrombolysis|thrombolysis
5246780|NCT00640367|intra-arterial thrombolysis|intra-arterial thrombolysis
5246781|NCT00640354|Automated External Defibrillator|automated external defibrillator
5246782|NCT00640354|Resuscitation|resuscitation
5246783|NCT00640354|Pediatric|pediatric
5246784|NCT00640328|relapsing forms of multiple sclerosis|relapsing forms of multiple sclerosis
5246785|NCT00640328|ofatumumab|ofatumumab
5246786|NCT00640328|multiple sclerosis|multiple sclerosis
5246787|NCT00640315|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
5246788|NCT00640315|COPD|copd
5246789|NCT00640315|Pulmonary hypertension|pulmonary hypertension
5246790|NCT00640302|Index cases|index cases
5246791|NCT00640302|pandemic influenza|pandemic influenza
5246792|NCT00640302|influenza A|influenza a
5246793|NCT00640302|H5N1 virus|h5n1 virus
5246794|NCT00640289|Factor XIII Deficiency|factor xiii deficiency
5246795|NCT00640289|Rare Bleeding Disorder|rare bleeding disorder
5246796|NCT00640289|Hemophilia|hemophilia
5246797|NCT00640289|Fibrogammin P|fibrogammin p
5246798|NCT00640276|pitavastatin|pitavastatin
5246799|NCT00640276|metabolic syndrome|metabolic syndrome
5246800|NCT00640276|metabolic syndrome risk score|metabolic syndrome risk score
5246801|NCT00640276|hypercholesterolemia|hypercholesterolemia
5246802|NCT00640263|HIV-1|hiv-1
5246803|NCT00640263|Breastfeeding|breastfeeding
5246804|NCT00640263|Prevention|prevention
5246805|NCT00640263|lamivudine|lamivudine
5246806|NCT00640263|lopinavir/ritonavir|lopinavir/ritonavir
5246807|NCT00640250|Dermatitis, Contact, Bronopol, Disperse Blue 106|dermatitis, contact, bronopol, disperse blue 106
5246808|NCT00640237|Vitamine D State|vitamine d state
5246809|NCT00640211|Prophylaxis|prophylaxis
5246810|NCT00640211|pandemic influenza|pandemic influenza
5246811|NCT00640211|influenza A|influenza a
5246812|NCT00640211|H5N1 virus|h5n1 virus
5246813|NCT00640198|Aphasia|aphasia
5246814|NCT00640198|Memantine|memantine
5246815|NCT00640198|Constraint-induced language therapy|constraint-induced language therapy
5246816|NCT00640198|Event-related potentials|event-related potentials
5246817|NCT00640159|Parkinson's disease|parkinson's disease
5246818|NCT00640159|selegiline to Zelapar switch|selegiline to zelapar switch
5246819|NCT00640159|orally disintegrating formulation|orally disintegrating formulation
5246820|NCT00640133|Deep Brain Stimulation|deep brain stimulation
5246821|NCT00640133|Treatment Refractory|treatment refractory
5246822|NCT00640133|Ventral Internal Capsule/Ventral Striatum|ventral internal capsule/ventral striatum
5246823|NCT00640133|Neurosurgery|neurosurgery
5246824|NCT00640133|Neuroimaging|neuroimaging
5246825|NCT00640120|wheeze detection|wheeze detection
5246826|NCT00640107|Magnetic Resonance Imaging|magnetic resonance imaging
5246827|NCT00640094|Melatonin|melatonin
5246828|NCT00640094|Acute myocardial infarction|acute myocardial infarction
5246829|NCT00640094|Primary angioplasty|primary angioplasty
5246830|NCT00640081|adenocarcinoma of the colon|adenocarcinoma of the colon
5246831|NCT00640081|stage IV colon cancer|stage iv colon cancer
5246832|NCT00640081|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5246833|NCT00640081|stage IV rectal cancer|stage iv rectal cancer
5246834|NCT00640081|stage III colon cancer|stage iii colon cancer
5246835|NCT00640081|stage III rectal cancer|stage iii rectal cancer
5246836|NCT00640081|recurrent colon cancer|recurrent colon cancer
5246837|NCT00640081|recurrent rectal cancer|recurrent rectal cancer
5246838|NCT00640068|coronary artery disease|coronary artery disease
5246839|NCT00640068|chest pain|chest pain
5246840|NCT00640068|coronary artery bypass graft|coronary artery bypass graft
5246841|NCT00640068|stress test|stress test
5246842|NCT00640068|Coronary Angiography|coronary angiography
5246843|NCT00640055|verbal autopsy|verbal autopsy
5246844|NCT00640055|stillbirth|stillbirth
5246845|NCT00640055|neonatal death|neonatal death
5246846|NCT00640042|pain|pain
5246847|NCT00640042|opioid|opioid
5246848|NCT00640042|abuse|abuse
5246849|NCT00640042|moderate-severe pain requiring continuous, around-the-clock opioid therapy for an extended period of time|moderate-severe pain requiring continuous, around-the-clock opioid therapy for an extended period of time
5246850|NCT00640029|Arthroplasty|arthroplasty
5246851|NCT00640029|Arthrodesis|arthrodesis
5246852|NCT00640029|Prosthesis|prosthesis
5246853|NCT00640029|Disc replacement|disc replacement
5246854|NCT00640029|Spine|spine
5246855|NCT00640029|Lumbar|lumbar
5246856|NCT00640029|Cervical|cervical
5246857|NCT00640029|Intervertebral disk|intervertebral disk
5246858|NCT00640029|Cervical or lumbar intervertebral disk|cervical or lumbar intervertebral disk
5246859|NCT00640029|Degenerative pathology|degenerative pathology
5246860|NCT00640016|Asthma|asthma
5246861|NCT00640016|CAT-354|cat-354
5246862|NCT00640016|Tralokinumab|tralokinumab
5246864|NCT00640003|Ataxia|ataxia
5246865|NCT00640003|Telangiectasia|telangiectasia
5246866|NCT00639990|Intraabdominal pressure|intraabdominal pressure
5246867|NCT00639977|Intraocular Pressure|intraocular pressure
5246868|NCT00639977|Acupuncture|acupuncture
5246869|NCT00639977|Healthy Volunteers|healthy volunteers
5246870|NCT00639964|diabetes|diabetes
5246871|NCT00639964|pregnancy|pregnancy
5246872|NCT00639964|macrosomia|macrosomia
5246873|NCT00639964|lipidics markers|lipidics markers
5246874|NCT00639964|nutritional factors|nutritional factors
5246875|NCT00639964|placenta|placenta
5246876|NCT00639964|umbilical blood cord|umbilical blood cord
5246877|NCT00639951|Snake Bite|snake bite
5246878|NCT00639951|Antivenin Treatment|antivenin treatment
5246879|NCT00639938|Pregnancy, High-Risk|pregnancy, high-risk
5246880|NCT00639938|HIV Seronegativity|hiv seronegativity
5246881|NCT00639912|contrast induced nephropathy STEMI PCI|contrast induced nephropathy stemi pci
5246882|NCT00639899|Varicocele|varicocele
5246883|NCT00639873|Uncomplicated P. falciparum malaria|uncomplicated p. falciparum malaria
5246884|NCT00639860|extraction|extraction
5246885|NCT00639860|implant|implant
5246886|NCT00639860|alveolar ridge preservation|alveolar ridge preservation
5246887|NCT00639847|Asthma management|asthma management
5246888|NCT00639847|cost|cost
5246889|NCT00639847|disease management|disease management
5246890|NCT00639847|respiratory care|respiratory care
5246891|NCT00639847|nursing|nursing
5246892|NCT00639847|health care utilization|health care utilization
5246893|NCT00639847|health related quality of life|health related quality of life
5246894|NCT00639834|rheumatoid|rheumatoid
5246895|NCT00639834|arthritis|arthritis
5246896|NCT00639834|RA|ra
5246897|NCT00639834|joint inflammation|joint inflammation
5246898|NCT00639834|autoimmune|autoimmune
5246899|NCT00639834|Medarex|medarex
5246900|NCT00639834|Rheumatology|rheumatology
5246901|NCT00639821|Gene expression microarray|gene expression microarray
5246902|NCT00639821|Inflammatory bowel disease|inflammatory bowel disease
5246903|NCT00639821|Infliximab|infliximab
5246904|NCT00639808|delayed gastric emptying|delayed gastric emptying
5246905|NCT00639808|symptomatic gastroparesis|symptomatic gastroparesis
5246906|NCT00639808|diabetes mellitus|diabetes mellitus
5246907|NCT00639795|Thoracic paravertebral block|thoracic paravertebral block
5246908|NCT00639795|Cytokines|cytokines
5246909|NCT00639795|Video assisted thorascopic surgery|video assisted thorascopic surgery
5246910|NCT00639795|Pain|pain
5246911|NCT00639782|thromboembolism|thromboembolism
5246912|NCT00639782|mechanical heart valves|mechanical heart valves
5246913|NCT00639782|randomized|randomized
5246914|NCT00639769|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
5246915|NCT00639769|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5246916|NCT00639769|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5246917|NCT00639769|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
5247004|NCT00639392|Sickle cell disease|sickle cell disease
5246918|NCT00639769|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
5246919|NCT00639769|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
5246920|NCT00639769|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
5246921|NCT00639769|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5246922|NCT00639769|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
5246923|NCT00639769|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
5246924|NCT00639769|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
5246925|NCT00639769|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
5246926|NCT00639769|untreated metastatic squamous neck cancer with occult primary|untreated metastatic squamous neck cancer with occult primary
5246927|NCT00639769|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
5246928|NCT00639769|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
5246929|NCT00639769|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
5246930|NCT00639769|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5246931|NCT00639769|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
5246932|NCT00639769|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
5246933|NCT00639769|recurrent salivary gland cancer|recurrent salivary gland cancer
5246934|NCT00639769|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
5246935|NCT00639769|stage IV salivary gland cancer|stage iv salivary gland cancer
5246936|NCT00639756|Uric acid|uric acid
5246937|NCT00639756|Fructose|fructose
5246938|NCT00639756|Hypertension|hypertension
5246939|NCT00639756|Insulin|insulin
5246940|NCT00639756|Glucose|glucose
5246941|NCT00639756|HOMA|homa
5246942|NCT00639743|Pulmonary embolism|pulmonary embolism
5246943|NCT00639743|Heparin|heparin
5246944|NCT00639743|Thrombolytic therapy|thrombolytic therapy
5246945|NCT00639743|Bleeding|bleeding
5246946|NCT00639730|Epilepsy|epilepsy
5246947|NCT00639717|GVHD|gvhd
5246948|NCT00639704|MRI|mri
5246949|NCT00639704|SPECT|spect
5246950|NCT00639704|Cardiac function|cardiac function
5246951|NCT00639691|Asthma, Anti-immunoglobin E, omalizumab|asthma, anti-immunoglobin e, omalizumab
5246952|NCT00639678|healthy volunteers|healthy volunteers
5246953|NCT00639665|Cocoa, diabetes, polyphenols|cocoa, diabetes, polyphenols
5246954|NCT00639652|Carcinoma, Basal Cell|carcinoma, basal cell
5246955|NCT00639652|3D-histology|3d-histology
5246956|NCT00639652|Micrographic surgery|micrographic surgery
5246957|NCT00639652|Mohs surgery|mohs surgery
5246958|NCT00639652|Shave excision|shave excision
5246959|NCT00639652|Recurrence|recurrence
5246960|NCT00639652|Esthetic outcome|esthetic outcome
5246961|NCT00639639|adult giant cell glioblastoma|adult giant cell glioblastoma
5246962|NCT00639639|adult gliosarcoma|adult gliosarcoma
5246963|NCT00639587|Cetirizine|cetirizine
5246964|NCT00639587|Zyrtec|zyrtec
5246965|NCT00639574|Pain, morphine, nefopam, co analgesia, ureteral calculi, emergency|pain, morphine, nefopam, co analgesia, ureteral calculi, emergency
5246966|NCT00639561|digestive system|digestive system
5246967|NCT00639561|Diet|diet
5246968|NCT00639548|Deep Sedation|deep sedation
5246969|NCT00639548|EEG|eeg
5246970|NCT00639548|Event-Related Potentials|event-related potentials
5246971|NCT00639548|Evoked potentials, auditory|evoked potentials, auditory
5246972|NCT00639548|BIS-Index|bis-index
5246973|NCT00639548|Entropy|entropy
5246974|NCT00639548|ICU|icu
5246975|NCT00639535|Radiology|radiology
5246976|NCT00639535|MRI|mri
5246977|NCT00639535|Positron emission tomography|positron emission tomography
5246978|NCT00639535|Breast Abnormalities|breast abnormalities
5246979|NCT00639535|Dense Breast Tissue|dense breast tissue
5246980|NCT00639522|Liposomal paclitaxel|liposomal paclitaxel
5246981|NCT00639522|Maximum tolerated dose|maximum tolerated dose
5246982|NCT00639522|Pharmacokinetics|pharmacokinetics
5246983|NCT00639522|Gastric carcinoma|gastric carcinoma
5246984|NCT00639496|Idiopathic Pulmonary Fibrosis|idiopathic pulmonary fibrosis
5246985|NCT00639470|Patient Education Handout|patient education handout
5246986|NCT00639470|Parents|parents
5246987|NCT00639470|Patient Education|patient education
5246988|NCT00639457|PPAR-gamma agonist|ppar-gamma agonist
5246989|NCT00639457|glucose metabolism|glucose metabolism
5246990|NCT00639457|inflammation|inflammation
5246991|NCT00639457|adipose tissue distribution|adipose tissue distribution
5246992|NCT00639457|cardiac function|cardiac function
5246993|NCT00639457|vascular function|vascular function
5246994|NCT00639457|mass spectrometry|mass spectrometry
5246995|NCT00639457|Treatment Experienced|treatment experienced
5246996|NCT00639431|phantom limb pain|phantom limb pain
5246997|NCT00639431|limb amputation|limb amputation
5246998|NCT00639431|Amputation|amputation
5246999|NCT00639431|Phantom Limb|phantom limb
5247000|NCT00639431|Pain|pain
5247001|NCT00639405|Parathyroid|parathyroid
5247002|NCT00639405|MRI|mri
5247003|NCT00639405|SPECT|spect
5247005|NCT00639379|toric contact lenses|toric contact lenses
5247006|NCT00639379|vision|vision
5247007|NCT00639379|comfort|comfort
5247008|NCT00639379|toric fit characteristics|toric fit characteristics
5247009|NCT00639379|slit lamp findings|slit lamp findings
5247010|NCT00639366|recurrent breast cancer|recurrent breast cancer
5247011|NCT00639366|stage IIIA breast cancer|stage iiia breast cancer
5247012|NCT00639366|stage IIIB breast cancer|stage iiib breast cancer
5247013|NCT00639366|stage IIIC breast cancer|stage iiic breast cancer
5247014|NCT00639366|stage IV breast cancer|stage iv breast cancer
5247015|NCT00639327|Stomach Neoplasms|stomach neoplasms
5247016|NCT00639327|Second line chemotherapy|second line chemotherapy
5247017|NCT00639327|Refractory to S-1|refractory to s-1
5247018|NCT00639327|irinotecan|irinotecan
5247019|NCT00639327|S-1 and Irinotecan Combination|s-1 and irinotecan combination
5247020|NCT00639327|Phase III study|phase iii study
5247021|NCT00639314|pylorus-preserving pancreaticoduodenectomy|pylorus-preserving pancreaticoduodenectomy
5247022|NCT00639314|pylorus-resecting pancreaticoduodenectomy|pylorus-resecting pancreaticoduodenectomy
5247023|NCT00639314|randomized controlled trial|randomized controlled trial
5247024|NCT00639314|delayed gastric empty|delayed gastric empty
5247025|NCT00639314|quality of life|quality of life
5247026|NCT00639301|Survivor|survivor
5247027|NCT00639301|Quality of Life|quality of life
5247028|NCT00639301|Eye|eye
5247029|NCT00639288|Alcohol Dependence|alcohol dependence
5247030|NCT00639288|PTSD|ptsd
5247031|NCT00639288|CPT-C|cpt-c
5247032|NCT00639262|Sorafenib|sorafenib
5247033|NCT00639262|Radiation Therapy|radiation therapy
5247034|NCT00639262|Radiotherapy|radiotherapy
5247035|NCT00639262|Temozolomide|temozolomide
5247036|NCT00639262|Brain Metastases|brain metastases
5247037|NCT00639262|Brain Tumors|brain tumors
5247038|NCT00639236|COPD|copd
5247039|NCT00639236|Hypertonic saline|hypertonic saline
5247040|NCT00639236|Quality of life|quality of life
5247041|NCT00639236|Dyspnoea.|dyspnoea.
5247042|NCT00639223|Statin related myalgia|statin related myalgia
5247043|NCT00639223|Hyperlipidemia|hyperlipidemia
5247044|NCT00639223|Red yeast rice|red yeast rice
5247045|NCT00639223|Cardiovascular Diseases|cardiovascular diseases
5247046|NCT00639223|Nutritional and Metabolic Diseases|nutritional and metabolic diseases
5247047|NCT00639210|breast cancer|breast cancer
5247048|NCT00639210|exercise|exercise
5247049|NCT00639210|osteoporosis|osteoporosis
5247050|NCT00639210|fracture|fracture
5247051|NCT00639210|quality of life|quality of life
5247052|NCT00639197|Tunneling|tunneling
5247053|NCT00639197|Short term|short term
5247054|NCT00639197|central venous catheters|central venous catheters
5247055|NCT00639197|Ultrasound Guided|ultrasound guided
5247056|NCT00639197|Internal jugular|internal jugular
5247057|NCT00639197|Assess safety and improve technical difficulty|assess safety and improve technical difficulty
5247058|NCT00639184|asphyxia|asphyxia
5247059|NCT00639184|neurodevelopmental outcome|neurodevelopmental outcome
5247060|NCT00639184|home counseling|home counseling
5247061|NCT00639171|breast|breast
5247062|NCT00639171|diagnostic radiology|diagnostic radiology
5247063|NCT00639171|suspicious breast tumors|suspicious breast tumors
5247064|NCT00639171|MRI|mri
5247065|NCT00639145|HIV|hiv
5247066|NCT00639145|Pregnancy|pregnancy
5247067|NCT00639145|Antiretrovirals|antiretrovirals
5247068|NCT00639145|HIV Seronegativity|hiv seronegativity
5247069|NCT00639145|Treatment Experienced|treatment experienced
5247070|NCT00639132|Natural History|natural history
5247071|NCT00639132|Metachromatic Leukodystrophy|metachromatic leukodystrophy
5247072|NCT00639132|Disease Progression|disease progression
5247073|NCT00639106|Breast expander|breast expander
5247074|NCT00639106|Breast reconstruction|breast reconstruction
5247075|NCT00639106|implants|implants
5247076|NCT00639106|08-024|08-024
5247077|NCT00639093|cigarette smoking|cigarette smoking
5247078|NCT00639093|psychoeducational and motivational program|psychoeducational and motivational program
5247079|NCT00639093|virtual reality|virtual reality
5247080|NCT00639080|Type 2 diabetes|type 2 diabetes
5247081|NCT00639080|Dyslipidemia|dyslipidemia
5247082|NCT00639067|Cancer of Lung|cancer of lung
5247083|NCT00639067|Cancer of the Lung|cancer of the lung
5247084|NCT00639067|Lung Cancer|lung cancer
5247085|NCT00639067|Neoplasms, Lung|neoplasms, lung
5247086|NCT00639067|Neoplasms, Pulmonary|neoplasms, pulmonary
5247087|NCT00639067|Pulmonary Cancer|pulmonary cancer
5247088|NCT00639067|Pulmonary Neoplasms|pulmonary neoplasms
5247089|NCT00639054|classification|classification
5247090|NCT00639054|diagnosis|diagnosis
5247091|NCT00639054|genetics|genetics
5247092|NCT00639054|mortality|mortality
5247093|NCT00639054|pathology|pathology
5247094|NCT00639041|n-3 LC-PUFA|n-3 lc-pufa
5247095|NCT00639041|hypertriglyceridemic|hypertriglyceridemic
5247096|NCT00639041|human|human
5247097|NCT00639041|TAG|tag
5247098|NCT00639028|ankle|ankle
5247099|NCT00639028|diagnosis|diagnosis
5247100|NCT00639028|sprain|sprain
5247101|NCT00639028|care|care
5247102|NCT00639028|injury|injury
5247103|NCT00639028|stress radiography|stress radiography
5247104|NCT00639028|ultrasonography|ultrasonography
5247105|NCT00639015|Sepsis|sepsis
5247106|NCT00639015|Septic Shock|septic shock
5247107|NCT00639015|phenylephrine|phenylephrine
5247108|NCT00639015|norepinephrine|norepinephrine
5247109|NCT00639015|catecholamine|catecholamine
5247110|NCT00638989|Asthma|asthma
5247111|NCT00638989|CAT-354|cat-354
5247112|NCT00638989|Tralokinumab|tralokinumab
5247113|NCT00638989|Healthy|healthy
5247114|NCT00638976|Eptifibatide|eptifibatide
5247115|NCT00638976|IV eptifibatide|iv eptifibatide
5247116|NCT00638976|GP IIB/IIIA inhibitors|gp iib/iiia inhibitors
5247117|NCT00638976|DES stent|des stent
5247118|NCT00638950|n-3 LC-PUFA|n-3 lc-pufa
5247119|NCT00638950|Rheumatoid arthritis|rheumatoid arthritis
5247120|NCT00638950|disease activity|disease activity
5247121|NCT00638950|inflammation|inflammation
5247122|NCT00638950|oxidative stress|oxidative stress
5247123|NCT00638950|immune system|immune system
5247124|NCT00638924|healthy sedentary women|healthy sedentary women
5247125|NCT00638885|PTSD|ptsd
5247126|NCT00638885|hippocampus|hippocampus
5247127|NCT00638885|twins|twins
5247128|NCT00638872|diabetes|diabetes
5247129|NCT00638872|foot ulcer|foot ulcer
5247130|NCT00638872|polydeoxyribonucleotide|polydeoxyribonucleotide
5247131|NCT00638859|Community-Acquired pneumonia|community-acquired pneumonia
5247132|NCT00638859|CAP|cap
5247133|NCT00638859|children|children
5247134|NCT00638859|Child|child
5247135|NCT00638846|toric contact lenses|toric contact lenses
5247136|NCT00638846|vision|vision
5247137|NCT00638846|comfort|comfort
5247138|NCT00638846|toric fit characteristics|toric fit characteristics
5247139|NCT00638846|slit lamp findings|slit lamp findings
5247140|NCT00638833|Multiple Sclerosis|multiple sclerosis
5247141|NCT00638820|osteopetrosis|osteopetrosis
5247142|NCT00638794|Myocardial Infarction|myocardial infarction
5247143|NCT00638794|Myocardial Ischemia|myocardial ischemia
5247144|NCT00638781|Acute ischemic stroke|acute ischemic stroke
5247145|NCT00638768|physical therapy|physical therapy
5247146|NCT00638768|rehabilitation|rehabilitation
5247147|NCT00638768|pain|pain
5247148|NCT00638768|osteoporosis|osteoporosis
5247149|NCT00638768|vertebral fracture|vertebral fracture
5247150|NCT00638755|Allergic Rhinitis|allergic rhinitis
5247151|NCT00638755|Perennial Allergic Rhinitis|perennial allergic rhinitis
5247152|NCT00638755|Allergies to perennial allergens|allergies to perennial allergens
5247153|NCT00638755|Allergies to perennial allergens (e.g. dog, cat, dust mites, etc.)|allergies to perennial allergens (e.g. dog, cat, dust mites, etc.)
5247154|NCT00638742|Latanoprost Pediatrics Pharmacokinetics Safety|latanoprost pediatrics pharmacokinetics safety
5247155|NCT00638729|bispectral index|bispectral index
5247156|NCT00638729|sedation|sedation
5247157|NCT00638729|stress hormones|stress hormones
5247158|NCT00638729|cognitive function|cognitive function
5247159|NCT00638716|Type 2 Diabetes Mellitus, incretins, GLP-1, HbA1c, metformin|type 2 diabetes mellitus, incretins, glp-1, hba1c, metformin
5247160|NCT00638703|hyperoxaluria|hyperoxaluria
5247161|NCT00638703|PH|ph
5247162|NCT00638703|oxalate|oxalate
5247163|NCT00638690|Metastatic Castration-Resistant Prostate Cancer|metastatic castration-resistant prostate cancer
5247164|NCT00638690|CRPC|crpc
5247165|NCT00638690|Abiraterone Acetate|abiraterone acetate
5247166|NCT00638690|CB7630|cb7630
5247167|NCT00638677|Oral microbiology|oral microbiology
5247168|NCT00638664|conventional pulse sequences for MR|conventional pulse sequences for mr
5247169|NCT00638664|cardiac chambers and walls|cardiac chambers and walls
5247170|NCT00638664|cardio-thoracic vasculature|cardio-thoracic vasculature
5247171|NCT00638664|the great vessels|the great vessels
5247172|NCT00638664|coronary vasculature|coronary vasculature
5247173|NCT00638664|cardiac|cardiac
5247174|NCT00638664|great vessels|great vessels
5247175|NCT00638651|Tattoos|tattoos
5247176|NCT00638651|Black/blue tattoos|black/blue tattoos
5247177|NCT00638638|Myocardial infarction|myocardial infarction
5247178|NCT00638638|Angioplasty|angioplasty
5247179|NCT00638638|Coronary stenting|coronary stenting
5247180|NCT00638638|Abciximab|abciximab
5247181|NCT00638638|Myocardial reperfusion|myocardial reperfusion
5247182|NCT00638638|Microcirculation|microcirculation
5247183|NCT00638638|EKG|ekg
5247184|NCT00638638|ST elevation myocardial infarction within 6 h of symptom onset|st elevation myocardial infarction within 6 h of symptom onset
5247185|NCT00638625|Needle biopsy|needle biopsy
5247186|NCT00638625|CT Scan|ct scan
5247187|NCT00638625|Lung Tumor|lung tumor
5247188|NCT00638625|Lung Mass|lung mass
5247189|NCT00638612|Immunotherapy|immunotherapy
5247190|NCT00638612|Gene Therapy|gene therapy
5247191|NCT00638612|Cytotoxicity|cytotoxicity
5247192|NCT00638612|Tumor vaccine|tumor vaccine
5247193|NCT00638612|Radiation|radiation
5247194|NCT00638612|Surgery|surgery
5247195|NCT00638612|Chemoradiation|chemoradiation
5247196|NCT00638599|Intubation, intratracheal|intubation, intratracheal
5247197|NCT00638599|Homeostasis|homeostasis
5247198|NCT00638599|Mastectomy, modified radical|mastectomy, modified radical
5247199|NCT00638599|Breast Neoplasms|breast neoplasms
5247200|NCT00638560|PGC-1alpha|pgc-1alpha
5247201|NCT00638560|PPARgamma|ppargamma
5247202|NCT00638560|oxidative stress|oxidative stress
5247203|NCT00638560|training intervention|training intervention
5247204|NCT00638547|Hurler Syndrome|hurler syndrome
5247205|NCT00638547|mucopolysaccharidosis type I|mucopolysaccharidosis type i
5247206|NCT00638547|Iduronidase deficiency|iduronidase deficiency
5247207|NCT00638534|Acute Otitis Media|acute otitis media
5247208|NCT00638534|AOM|aom
5247209|NCT00638534|children|children
5247210|NCT00638534|Child|child
5247211|NCT00638521|lipids|lipids
5247212|NCT00638521|proteins|proteins
5247213|NCT00638521|membrane|membrane
5247214|NCT00638521|lipid raft|lipid raft
5247215|NCT00638482|Dent's disease|dent's disease
5247216|NCT00638482|Nephrolithiasis|nephrolithiasis
5247217|NCT00638482|clinical trial|clinical trial
5247218|NCT00638482|thiazides|thiazides
5247219|NCT00638469|Psoriasis|psoriasis
5247220|NCT00638469|Biologic|biologic
5247221|NCT00638469|adalimumab|adalimumab
5247222|NCT00638469|narrowband UVB|narrowband uvb
5247223|NCT00638469|phototherapy|phototherapy
5247224|NCT00638469|half-side comparison|half-side comparison
5247225|NCT00638456|Eosinophils|eosinophils
5247226|NCT00638456|Esophagitis|esophagitis
5247227|NCT00638456|Microscopy|microscopy
5247228|NCT00638443|Neurogenic claudication, lumbar spinal stenosis, treadmill testing|neurogenic claudication, lumbar spinal stenosis, treadmill testing
5247229|NCT00638430|myopia|myopia
5247230|NCT00638430|Humphery Matrix 30-2 test|humphery matrix 30-2 test
5247231|NCT00638404|Preoperative somatic questions|preoperative somatic questions
5247232|NCT00638404|Preoperative audio tone evaluations|preoperative audio tone evaluations
5247233|NCT00638404|Preoperative anxiety and previous experience with postop pain|preoperative anxiety and previous experience with postop pain
5247234|NCT00638391|Primary early MCa|primary early mca
5247235|NCT00638391|Arimidex|arimidex
5247236|NCT00638378|Prostate Cancer|prostate cancer
5247237|NCT00638365|Cystic Fibrosis, Pseudomonas aeruginosa, Pulmonary CF|cystic fibrosis, pseudomonas aeruginosa, pulmonary cf
5247238|NCT00638352|Core Biopsy|core biopsy
5247239|NCT00638352|Needle Biopsy|needle biopsy
5247240|NCT00638352|Percutaneous Biopsy|percutaneous biopsy
5247241|NCT00638339|Respiration, artificial|respiration, artificial
5247242|NCT00638339|respiratory insufficiency|respiratory insufficiency
5247243|NCT00638339|noninvasive ventilation|noninvasive ventilation
5247244|NCT00638339|sleep deprivation|sleep deprivation
5247245|NCT00638339|intensive care units|intensive care units
5247246|NCT00638326|Clopidogrel, thrombosis, Percutaneous Transluminal Coronary Angioplasty, stents|clopidogrel, thrombosis, percutaneous transluminal coronary angioplasty, stents
5247247|NCT00638313|GLP-1|glp-1
5247248|NCT00638300|hemodialysis|hemodialysis
5247249|NCT00638300|iron|iron
5247250|NCT00638300|inflammation|inflammation
5247251|NCT00638300|atomic absorption|atomic absorption
5247252|NCT00638300|dialysate|dialysate
5247253|NCT00638300|advanced oxidation protein products|advanced oxidation protein products
5247254|NCT00638300|large pore dialysate|large pore dialysate
5247255|NCT00638300|bicarbonate|bicarbonate
5247256|NCT00638300|calcium|calcium
5247257|NCT00638300|citrate|citrate
5247258|NCT00638300|ligand|ligand
5247259|NCT00638287|Subjects with pituitary disease undergoing testing for GH|subjects with pituitary disease undergoing testing for gh
5247260|NCT00638287|deficiency|deficiency
5247261|NCT00638287|Subjects with suspicion for (or diagnosis of) acromegaly|subjects with suspicion for (or diagnosis of) acromegaly
5247262|NCT00638287|undergoing OGTT testing|undergoing ogtt testing
5247263|NCT00638287|Normal controls without evidence of pituitary dysfunction|normal controls without evidence of pituitary dysfunction
5247264|NCT00638274|Quality of pain relief with 2 different methods of identifying epidural space|quality of pain relief with 2 different methods of identifying epidural space
5247265|NCT00638261|Psoriasis|psoriasis
5247266|NCT00638261|Biologic|biologic
5247267|NCT00638261|Adalimumab|adalimumab
5247268|NCT00638261|Narrow-band UVB|narrow-band uvb
5247269|NCT00638261|phototherapy|phototherapy
5247270|NCT00638261|half-side comparison|half-side comparison
5247271|NCT00638248|Acute ischemic stroke|acute ischemic stroke
5247272|NCT00638235|Pelvic floor repair|pelvic floor repair
5247273|NCT00638235|prolapse|prolapse
5247274|NCT00638235|mesh|mesh
5247275|NCT00638222|Carvedilol|carvedilol
5247276|NCT00638222|Heart Disease|heart disease
5247277|NCT00638222|Vascular Disease|vascular disease
5247278|NCT00638222|Kidney|kidney
5247279|NCT00638196|relapsing multiple sclerosis|relapsing multiple sclerosis
5247280|NCT00638196|polyunsaturated fatty acids|polyunsaturated fatty acids
5247281|NCT00638196|omega-6 fatty acids|omega-6 fatty acids
5247282|NCT00638170|Urinary Tract Infections|urinary tract infections
5247283|NCT00638170|Cranberry|cranberry
5247284|NCT00638170|Prevention|prevention
5247285|NCT00638157|Gram-positive bacterial infections|gram-positive bacterial infections
5247286|NCT00638157|Staph Aureus|staph aureus
5247287|NCT00638157|endocarditis|endocarditis
5247288|NCT00638157|bacteremia|bacteremia
5247289|NCT00638157|methicillin-resistant Staphylococcus aureus (MRSA)|methicillin-resistant staphylococcus aureus (mrsa)
5247290|NCT00638144|Hepatitis C|hepatitis c
5247291|NCT00638144|liver transplantation|liver transplantation
5247292|NCT00638144|antibodies mediated neutralization|antibodies mediated neutralization
5247293|NCT00638144|monoclonal antibodies|monoclonal antibodies
5247294|NCT00638092|hypothyroxinemia|hypothyroxinemia
5247295|NCT00638092|preterm infants|preterm infants
5247296|NCT00638092|iodine|iodine
5247297|NCT00638092|neurodevelopmental outcome|neurodevelopmental outcome
5247298|NCT00638092|Iodine supplementation|iodine supplementation
5247299|NCT00638092|Randomised controlled trial|randomised controlled trial
5247300|NCT00638079|Pharmacokinetics|pharmacokinetics
5247301|NCT00638079|Food Effect|food effect
5247302|NCT00638079|Bioavailability|bioavailability
5247303|NCT00638079|Megace ES|megace es
5247304|NCT00638066|vaginismus|vaginismus
5247305|NCT00638066|botulinum toxin A|botulinum toxin a
5247306|NCT00638066|dyspareunia|dyspareunia
5247307|NCT00638066|unconsummated marriage|unconsummated marriage
5247308|NCT00638040|hypoxia|hypoxia
5247309|NCT00638040|lactate|lactate
5247310|NCT00638040|pH|ph
5247311|NCT00638040|tumor microenvironments|tumor microenvironments
5247312|NCT00638040|survival|survival
5247313|NCT00638027|multiple sclerosis|multiple sclerosis
5247314|NCT00638014|Sternal wound closure|sternal wound closure
5247315|NCT00638014|cardiac surgery|cardiac surgery
5247316|NCT00638014|sternal nonunion|sternal nonunion
5247317|NCT00638001|patients with haemophilia A moderate or severe|patients with haemophilia a moderate or severe
5247318|NCT00638001|patients with haemophilia B moderate or severe|patients with haemophilia b moderate or severe
5247319|NCT00637988|Barrett's Esophagus|barrett's esophagus
5247320|NCT00637988|Nexium|nexium
5247321|NCT00637975|neuropathic pain|neuropathic pain
5247322|NCT00637975|oxycodone|oxycodone
5247323|NCT00637975|pregabalin|pregabalin
5247324|NCT00637975|Patients with cancer and presenting a neuropathic pain|patients with cancer and presenting a neuropathic pain
5247325|NCT00637962|HIV|hiv
5247326|NCT00637962|AIDS|aids
5247327|NCT00637962|Vaccine|vaccine
5247328|NCT00637962|intravaginal|intravaginal
5247329|NCT00637962|mucosal|mucosal
5247330|NCT00637962|HIV Seronegativity|hiv seronegativity
5247331|NCT00637949|Osteoarthritis|osteoarthritis
5247332|NCT00637949|lumiracoxib|lumiracoxib
5247333|NCT00637949|rofecoxib|rofecoxib
5247334|NCT00637949|Cox-2|cox-2
5247335|NCT00637949|Osteoarthritis (primary osteoarthritis hip, hand, knee or spine (cervical or lumbar)|osteoarthritis (primary osteoarthritis hip, hand, knee or spine (cervical or lumbar)
5247336|NCT00637936|perioperative oxygen|perioperative oxygen
5247337|NCT00637936|respiratory complications|respiratory complications
5247338|NCT00637923|Hepatitis C, Chronic|hepatitis c, chronic
5247339|NCT00637910|Advanced NSCLC|advanced nsclc
5247340|NCT00637910|EGFR|egfr
5247341|NCT00637910|EGFR copy number|egfr copy number
5247342|NCT00637910|Kras mutations|kras mutations
5247343|NCT00637910|EGRF mutations|egrf mutations
5247344|NCT00637910|Docetaxel|docetaxel
5247345|NCT00637910|Erlotinib|erlotinib
5247346|NCT00637910|Polymorphisms|polymorphisms
5247347|NCT00637897|recurrent breast cancer|recurrent breast cancer
5247348|NCT00637897|stage IV breast cancer|stage iv breast cancer
5247349|NCT00637871|Casodex|casodex
5247350|NCT00637871|bicalutamide|bicalutamide
5247351|NCT00637871|Tamoxifen|tamoxifen
5247352|NCT00637871|Gynaecomastia|gynaecomastia
5247353|NCT00637871|Prostate Cancer|prostate cancer
5247354|NCT00637845|Nexium|nexium
5247355|NCT00637845|Esomeprazole Magnesium|esomeprazole magnesium
5247356|NCT00637845|Gastroesophageal Reflux Disease|gastroesophageal reflux disease
5247357|NCT00637845|Heartburn|heartburn
5247358|NCT00637832|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5247359|NCT00637832|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5247360|NCT00637832|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5247361|NCT00637832|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
5247362|NCT00637832|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
5247363|NCT00637832|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
5247364|NCT00637832|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5247365|NCT00637832|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5247366|NCT00637832|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5247367|NCT00637832|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5247368|NCT00637832|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5247369|NCT00637832|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5247370|NCT00637832|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5247371|NCT00637832|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5247372|NCT00637832|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5247373|NCT00637806|Megestrol acetate|megestrol acetate
5247374|NCT00637806|Anorexia|anorexia
5247375|NCT00637806|Cachexia|cachexia
5247376|NCT00637806|Cancer|cancer
5247377|NCT00637806|Unintended weight loss|unintended weight loss
5247378|NCT00637806|Body weight|body weight
5247379|NCT00637806|Appetite|appetite
5247380|NCT00637806|Megace ES|megace es
5247381|NCT00637793|Xerostomia|xerostomia
5247382|NCT00637793|Sjogren's Syndrome|sjogren's syndrome
5247383|NCT00637780|Sulfasalazine delayed release tablets|sulfasalazine delayed release tablets
5247384|NCT00637780|azulfidine entabs|azulfidine entabs
5247385|NCT00637780|Pharmacokinetics|pharmacokinetics
5247386|NCT00637780|Juvenile Idiopathic Arthritis (JIA)|juvenile idiopathic arthritis (jia)
5247387|NCT00637767|stage I multiple myeloma|stage i multiple myeloma
5247388|NCT00637767|stage II multiple myeloma|stage ii multiple myeloma
5247389|NCT00637767|stage III multiple myeloma|stage iii multiple myeloma
5247390|NCT00637754|ICD|icd
5247391|NCT00637754|Sports|sports
5247392|NCT00637741|Peripheral Vascular Disease|peripheral vascular disease
5247393|NCT00637741|Intermittent claudication|intermittent claudication
5247394|NCT00637741|Critical Limb Ischemia|critical limb ischemia
5247395|NCT00637741|TASC|tasc
5247396|NCT00637728|Megestrol acetate|megestrol acetate
5247397|NCT00637728|Anorexia|anorexia
5247398|NCT00637728|Cachexia|cachexia
5247399|NCT00637728|Lung cancer|lung cancer
5247400|NCT00637728|Pancreatic cancer|pancreatic cancer
5247401|NCT00637728|Unintended weight loss|unintended weight loss
5247402|NCT00637728|Body weight|body weight
5247403|NCT00637728|Appetite|appetite
5247404|NCT00637728|Megace ES|megace es
5247405|NCT00637689|Chronic graft versus host disease|chronic graft versus host disease
5247406|NCT00637689|Allogeneic hematopoietic cell transplantation|allogeneic hematopoietic cell transplantation
5247407|NCT00637689|Biomarkers|biomarkers
5247408|NCT00637689|Response criteria|response criteria
5247409|NCT00637689|Surrogate endpoints|surrogate endpoints
5247410|NCT00637689|Natural history|natural history
5247411|NCT00637676|malignant pleural effusion|malignant pleural effusion
5247412|NCT00637676|subcutaneous tunneled drainage|subcutaneous tunneled drainage
5247413|NCT00637676|talc pleurodesis|talc pleurodesis
5247414|NCT00637663|Chronic hepatitis B|chronic hepatitis b
5247415|NCT00637663|Lamivudine|lamivudine
5247416|NCT00637663|Entecavir|entecavir
5247417|NCT00637637|tumors metastatic to brain|tumors metastatic to brain
5247418|NCT00637637|stage IV adenoid cystic carcinoma of the oral cavity|stage iv adenoid cystic carcinoma of the oral cavity
5247419|NCT00637637|stage IV adrenocortical carcinoma|stage iv adrenocortical carcinoma
5247420|NCT00637637|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5247421|NCT00637637|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5247422|NCT00637637|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5247423|NCT00637637|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5247424|NCT00637637|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5247425|NCT00637637|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5247426|NCT00637637|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5247427|NCT00637637|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
5247428|NCT00637637|stage IV anal cancer|stage iv anal cancer
5247429|NCT00637637|stage IV basal cell carcinoma of the lip|stage iv basal cell carcinoma of the lip
5247430|NCT00637637|stage IV bladder cancer|stage iv bladder cancer
5247431|NCT00637637|stage IV borderline ovarian surface epithelial-stromal tumor|stage iv borderline ovarian surface epithelial-stromal tumor
5247432|NCT00637637|stage IV breast cancer|stage iv breast cancer
5247433|NCT00637637|stage IV childhood anaplastic large cell lymphoma|stage iv childhood anaplastic large cell lymphoma
5247434|NCT00637637|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
5247435|NCT00637637|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
5247436|NCT00637637|stage IV childhood liver cancer|stage iv childhood liver cancer
5247437|NCT00637637|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
5247438|NCT00637637|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
5247439|NCT00637637|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5247440|NCT00637637|stage IV colon cancer|stage iv colon cancer
5247441|NCT00637637|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
5247442|NCT00637637|stage IV esophageal cancer|stage iv esophageal cancer
5247443|NCT00637637|stage IV esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iv esthesioneuroblastoma of the paranasal sinus and nasal cavity
5247444|NCT00637637|stage IV follicular thyroid cancer|stage iv follicular thyroid cancer
5247445|NCT00637637|stage IV gastric cancer|stage iv gastric cancer
5247446|NCT00637637|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5247447|NCT00637637|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5247448|NCT00637637|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5247449|NCT00637637|stage IV hypopharyngeal cancer|stage iv hypopharyngeal cancer
5247450|NCT00637637|stage IV inverted papilloma of the paranasal sinus and nasal cavity|stage iv inverted papilloma of the paranasal sinus and nasal cavity
5247451|NCT00637637|stage IV laryngeal cancer|stage iv laryngeal cancer
5247452|NCT00637637|stage IV lip and oral cavity cancer|stage iv lip and oral cavity cancer
5247453|NCT00637637|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
5247454|NCT00637637|stage IV lymphoepithelioma of the oropharynx|stage iv lymphoepithelioma of the oropharynx
5247455|NCT00637637|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5247456|NCT00637637|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5247457|NCT00637637|stage IV midline lethal granuloma of the paranasal sinus and nasal cavity|stage iv midline lethal granuloma of the paranasal sinus and nasal cavity
5247458|NCT00637637|stage IV mucoepidermoid carcinoma of the oral cavity|stage iv mucoepidermoid carcinoma of the oral cavity
5247459|NCT00637637|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
5247460|NCT00637637|stage IV nasopharyngeal cancer|stage iv nasopharyngeal cancer
5247461|NCT00637637|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5247462|NCT00637637|stage IV oropharyngeal cancer|stage iv oropharyngeal cancer
5247463|NCT00637637|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5247464|NCT00637637|stage IV pancreatic cancer|stage iv pancreatic cancer
5247465|NCT00637637|stage IV papillary thyroid cancer|stage iv papillary thyroid cancer
5247466|NCT00637637|stage IV paranasal sinus and nasal cavity cancer|stage iv paranasal sinus and nasal cavity cancer
5247467|NCT00637637|stage IV penile cancer|stage iv penile cancer
5247468|NCT00637637|stage IV prostate cancer|stage iv prostate cancer
5247469|NCT00637637|stage IV rectal cancer|stage iv rectal cancer
5247470|NCT00637637|stage IV renal cell cancer|stage iv renal cell cancer
5247471|NCT00637637|stage IV salivary gland cancer|stage iv salivary gland cancer
5247472|NCT00637637|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5247473|NCT00637637|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5247474|NCT00637637|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5247475|NCT00637637|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5247476|NCT00637637|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
5247477|NCT00637637|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5247478|NCT00637637|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
5247479|NCT00637637|stage IV endometrial carcinoma|stage iv endometrial carcinoma
5247480|NCT00637637|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
5247481|NCT00637637|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
5247482|NCT00637637|stage IVB vulvar cancer|stage ivb vulvar cancer
5247483|NCT00637637|stage IV Wilms tumor|stage iv wilms tumor
5247484|NCT00637637|stage IVB cervical cancer|stage ivb cervical cancer
5247485|NCT00637637|stage IVB vaginal cancer|stage ivb vaginal cancer
5247486|NCT00637637|metastatic adult malignant fibrous histiocytoma of bone|metastatic adult malignant fibrous histiocytoma of bone
5247487|NCT00637637|metastatic childhood malignant fibrous histiocytoma of bone|metastatic childhood malignant fibrous histiocytoma of bone
5247488|NCT00637637|metastatic gastrointestinal carcinoid tumor|metastatic gastrointestinal carcinoid tumor
5247489|NCT00637637|metastatic parathyroid cancer|metastatic parathyroid cancer
5247490|NCT00637637|metastatic pheochromocytoma|metastatic pheochromocytoma
5247491|NCT00637637|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
5247492|NCT00637637|metastatic squamous neck cancer with occult primary|metastatic squamous neck cancer with occult primary
5247493|NCT00637637|metastatic transitional cell cancer of the renal pelvis and ureter|metastatic transitional cell cancer of the renal pelvis and ureter
5247494|NCT00637637|disseminated neuroblastoma|disseminated neuroblastoma
5247495|NCT00637637|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5247496|NCT00637637|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
5247497|NCT00637637|tongue cancer|tongue cancer
5247498|NCT00637624|Acetylcysteine|acetylcysteine
5247499|NCT00637624|Cisplatin|cisplatin
5247500|NCT00637624|Neuropathy|neuropathy
5247501|NCT00637624|Antioxidants|antioxidants
5247502|NCT00637598|Diagnostic Imaging|diagnostic imaging
5247503|NCT00637598|Mammography|mammography
5247504|NCT00637598|Breast Tomosynthesis|breast tomosynthesis
5247505|NCT00637572|Weight loss|weight loss
5247506|NCT00637572|Cachexia|cachexia
5247507|NCT00637572|Anorexia|anorexia
5247508|NCT00637572|Megestrol acetate oral suspension|megestrol acetate oral suspension
5247509|NCT00637572|Nanocrystal dispersion|nanocrystal dispersion
5247510|NCT00637572|Nanocrystal technology|nanocrystal technology
5247511|NCT00637572|Body weight changes|body weight changes
5247512|NCT00637572|AIDS wasting|aids wasting
5247513|NCT00637572|HIV wasting|hiv wasting
5247514|NCT00637572|Emaciation|emaciation
5247515|NCT00637572|Megace ES|megace es
5247516|NCT00637572|Megace|megace
5247517|NCT00637572|Treatment Experienced|treatment experienced
5247518|NCT00637559|Nexium|nexium
5247519|NCT00637559|Barrett's esophagus|barrett's esophagus
5247520|NCT00637546|Treatment|treatment
5247521|NCT00637546|Efficacy|efficacy
5247522|NCT00637546|Diabetes|diabetes
5247523|NCT00637546|Gait|gait
5247524|NCT00637546|Balance|balance
5247525|NCT00637520|Nonalcoholic Fatty Liver Disease|nonalcoholic fatty liver disease
5247526|NCT00637520|Insulin Resistance|insulin resistance
5247527|NCT00637520|Lipid Metabolism|lipid metabolism
5247528|NCT00637507|High-Frequency Ventilation|high-frequency ventilation
5247529|NCT00637507|Tracheal Gas Insufflation|tracheal gas insufflation
5247530|NCT00637507|Respiration, Artificial|respiration, artificial
5247531|NCT00637507|Respiratory Distress Syndrome|respiratory distress syndrome
5247532|NCT00637507|Adult|adult
5247533|NCT00637494|psychotic depression|psychotic depression
5247534|NCT00637494|major depression with psychotic features|major depression with psychotic features
5247535|NCT00637494|psychosis|psychosis
5247536|NCT00637416|horseness|horseness
5247537|NCT00637403|renal impairment|renal impairment
5247538|NCT00637403|end stage renal disease|end stage renal disease
5247539|NCT00637403|megestrol acetate|megestrol acetate
5247540|NCT00637403|pharmacokinetics|pharmacokinetics
5247541|NCT00637403|hemodialysis|hemodialysis
5247542|NCT00637403|renal dialysis|renal dialysis
5247839|NCT00636129|relaxation|relaxation
5247543|NCT00637403|kidney failure, chronic|kidney failure, chronic
5247544|NCT00637403|renal insufficiency|renal insufficiency
5247545|NCT00637403|Megace ES|megace es
5247546|NCT00637377|Eye diseases|eye diseases
5247547|NCT00637377|Vision Impairment and Blindness|vision impairment and blindness
5247548|NCT00637377|Eyes and Vision|eyes and vision
5247549|NCT00637377|Seniors|seniors
5247550|NCT00637377|Neovascular Age-Related Macular Degeneration (AMD)|neovascular age-related macular degeneration (amd)
5247551|NCT00637377|Retinal Disease|retinal disease
5247552|NCT00637364|pain|pain
5247553|NCT00637364|pancreas|pancreas
5247554|NCT00637364|pancreatic cancer|pancreatic cancer
5247555|NCT00637364|pancreatic adenocarcinoma|pancreatic adenocarcinoma
5247556|NCT00637364|ductal adenocarcinoma|ductal adenocarcinoma
5247557|NCT00637338|Long-acting GLP-1 Diabetes|long-acting glp-1 diabetes
5247558|NCT00637325|trastuzumab optimization in breast cancer|trastuzumab optimization in breast cancer
5247559|NCT00637299|COPD|copd
5247560|NCT00637286|Zolmitriptan|zolmitriptan
5247561|NCT00637286|ZOMIG|zomig
5247562|NCT00637286|migraine|migraine
5247563|NCT00637286|headache response|headache response
5247564|NCT00637286|headache|headache
5247565|NCT00637286|headache pain|headache pain
5247566|NCT00637286|MIDAS|midas
5247567|NCT00637286|HCPC|hcpc
5247568|NCT00637273|diabetes|diabetes
5247569|NCT00637273|exenatide once weekly|exenatide once weekly
5247570|NCT00637273|Byetta|byetta
5247571|NCT00637273|sitagliptin|sitagliptin
5247572|NCT00637273|Januvia|januvia
5247573|NCT00637273|thiazolidinedione|thiazolidinedione
5247574|NCT00637273|Amylin|amylin
5247575|NCT00637273|Lilly|lilly
5247576|NCT00637273|Pioglitazone|pioglitazone
5247577|NCT00637260|motorcortex stimulation|motorcortex stimulation
5247578|NCT00637260|Parkinson's disease|parkinson's disease
5247579|NCT00637260|neuromodulation|neuromodulation
5247580|NCT00637247|pancreatic cancer|pancreatic cancer
5247581|NCT00637247|metastatic|metastatic
5247582|NCT00637247|chemotherapy naive|chemotherapy naive
5247583|NCT00637221|Safety|safety
5247584|NCT00637221|Tolerability|tolerability
5247585|NCT00637208|prostate cancer|prostate cancer
5247586|NCT00637208|venography|venography
5247587|NCT00637208|male patients|male patients
5247588|NCT00637208|Localized microscopic prostate cancer up to Gleason 6 (3+3)|localized microscopic prostate cancer up to gleason 6 (3+3)
5247589|NCT00637208|PSA level <14|psa level <14
5247590|NCT00637208|presence of varicocele|presence of varicocele
5247591|NCT00637195|Human papillomavirus (HPV) vaccine|human papillomavirus (hpv) vaccine
5247592|NCT00637195|Hepatitis B|hepatitis b
5247593|NCT00637195|Cervical cancer|cervical cancer
5247594|NCT00637195|HPV|hpv
5247595|NCT00637195|Papillomavirus|papillomavirus
5247596|NCT00637182|Gynecomastia|gynecomastia
5247597|NCT00637182|Anastrazole|anastrazole
5247598|NCT00637182|Arimidex|arimidex
5247599|NCT00637182|Pubertal|pubertal
5247600|NCT00637182|males|males
5247601|NCT00637182|boys|boys
5247602|NCT00637169|oxygen therapy|oxygen therapy
5247603|NCT00637169|neurodevelopmental impairment|neurodevelopmental impairment
5247604|NCT00637156|Symptomatic DDD at Two Adjacent Levels of cervical spine|symptomatic ddd at two adjacent levels of cervical spine
5247605|NCT00637143|Renal transplant|renal transplant
5247606|NCT00637143|Cyclosporine|cyclosporine
5247607|NCT00637143|Tacrolimus|tacrolimus
5247608|NCT00637143|Intervention|intervention
5247609|NCT00637143|Interstitial Fibrosis Tubular Atrophy|interstitial fibrosis tubular atrophy
5247610|NCT00637143|Chronic Renal Allograft Failure|chronic renal allograft failure
5247611|NCT00637117|Lymphoma, Dendritic, Vaccine, Radiotherapy|lymphoma, dendritic, vaccine, radiotherapy
5247612|NCT00637104|percutaneous transluminal coronary angioplasty|percutaneous transluminal coronary angioplasty
5247613|NCT00637104|stents|stents
5247614|NCT00637104|restenosis|restenosis
5247615|NCT00637104|biocompatible materials|biocompatible materials
5247616|NCT00637104|ceramics|ceramics
5247617|NCT00637078|hypertension|hypertension
5247618|NCT00637078|hypercholesterolemia|hypercholesterolemia
5247619|NCT00637078|family physicians|family physicians
5247620|NCT00637078|fixed dose combination therapy|fixed dose combination therapy
5247621|NCT00637078|cluster randomized controlled trial|cluster randomized controlled trial
5247622|NCT00637065|Pulmonary hypertension|pulmonary hypertension
5247623|NCT00637065|Interstitial lung disease|interstitial lung disease
5247624|NCT00637065|Idiopathic pulmonary fibrosis|idiopathic pulmonary fibrosis
5247625|NCT00637065|Nonspecific interstitial pneumonia|nonspecific interstitial pneumonia
5247626|NCT00637065|Bosentan|bosentan
5247627|NCT00637065|Endothelin receptor antagonists|endothelin receptor antagonists
5247628|NCT00637065|Pulmonary vascular resistance|pulmonary vascular resistance
5247629|NCT00637052|preleukemia|preleukemia
5247630|NCT00637052|dysplasia of myeloid blood cells|dysplasia of myeloid blood cells
5247631|NCT00637039|Advanced cancer|advanced cancer
5247632|NCT00637039|Solid tumour|solid tumour
5247633|NCT00637039|Solid malignancies|solid malignancies
5247634|NCT00637039|Neoplasms|neoplasms
5247635|NCT00637026|Iressa, Gefitinib, Breast Cancer, Surgery|iressa, gefitinib, breast cancer, surgery
5247636|NCT00637013|Subacromial impingement|subacromial impingement
5247637|NCT00637013|Shoulder|shoulder
5247638|NCT00637013|RCT|rct
5247639|NCT00637013|Effectiveness|effectiveness
5247640|NCT00637013|Cost-effectiveness|cost-effectiveness
5247641|NCT00637000|Opioid dependence|opioid dependence
5247642|NCT00637000|Opioid withdrawal symptoms|opioid withdrawal symptoms
5247643|NCT00636987|aortic valve|aortic valve
5247644|NCT00636987|mitral valve|mitral valve
5247645|NCT00636987|heart valve|heart valve
5247646|NCT00636987|tissue valve|tissue valve
5247647|NCT00636987|bioprosthesis|bioprosthesis
5247648|NCT00636987|valve disorder|valve disorder
5247649|NCT00636987|valve disease|valve disease
5247650|NCT00636987|cardiac surgery|cardiac surgery
5247651|NCT00636987|aortic valve regurgitation|aortic valve regurgitation
5247652|NCT00636987|aortic valve stenosis|aortic valve stenosis
5247653|NCT00636987|mitral valve regurgitation|mitral valve regurgitation
5247654|NCT00636987|mitral valve stenosis|mitral valve stenosis
5247655|NCT00636974|Patients who are going to have regional anaesthesia for lower limbs surgery.|patients who are going to have regional anaesthesia for lower limbs surgery.
5247656|NCT00636974|Leg Surgery.|leg surgery.
5247657|NCT00636961|COPD, Indacaterol Maleate, Exercise testing|copd, indacaterol maleate, exercise testing
5247658|NCT00636948|Rectal cancer surgery|rectal cancer surgery
5247659|NCT00636948|Symptomatic anastomotic leakage|symptomatic anastomotic leakage
5247660|NCT00636948|Defunctioning stoma|defunctioning stoma
5247661|NCT00636948|TME surgery|tme surgery
5247662|NCT00636935|Pneumocystis jirovecii Pneumonia|pneumocystis jirovecii pneumonia
5247663|NCT00636935|Corticosteroid Therapy|corticosteroid therapy
5247664|NCT00636935|HIV|hiv
5247665|NCT00636935|Pneumonia|pneumonia
5247666|NCT00636935|Pulmonary Function Testing|pulmonary function testing
5247667|NCT00636935|Antibiotics|antibiotics
5247668|NCT00636935|Prednisone|prednisone
5247669|NCT00636935|Human Immunodeficiency Virus|human immunodeficiency virus
5247670|NCT00636935|CD4|cd4
5247671|NCT00636935|CD8|cd8
5247672|NCT00636935|Viral Load|viral load
5247673|NCT00636935|Bactrim|bactrim
5247674|NCT00636935|Pentamidine|pentamidine
5247675|NCT00636935|Atovaquone|atovaquone
5247676|NCT00636935|Primaquine/Clindamycin|primaquine/clindamycin
5247677|NCT00636935|Trimethoprim/Dapsone|trimethoprim/dapsone
5247678|NCT00636922|Acute Myeloid Leukemia|acute myeloid leukemia
5247679|NCT00636922|Elderly|elderly
5247680|NCT00636922|Unfit|unfit
5247681|NCT00636922|Everolimus|everolimus
5247682|NCT00636922|RAD001|rad001
5247683|NCT00636909|AML|aml
5247684|NCT00636909|ALL|all
5247685|NCT00636909|CML|cml
5247686|NCT00636909|CLL|cll
5247687|NCT00636909|MDS|mds
5247688|NCT00636909|NHL|nhl
5247689|NCT00636909|HODGKIN'S LYMPHOMA|hodgkin's lymphoma
5247690|NCT00636909|APLASTIC ANEMIA|aplastic anemia
5247691|NCT00636909|MULTIPLE MYELOMA|multiple myeloma
5247692|NCT00636909|MYELOPROLIFERATIVE DISORDER|myeloproliferative disorder
5247693|NCT00636909|ALLOGENEIC|allogeneic
5247694|NCT00636909|STEM CELL TRANSPLANT|stem cell transplant
5247695|NCT00636909|HEMATOLOGIC DISORDERS|hematologic disorders
5247696|NCT00636909|CYCLOPHOSPHAMIDE|cyclophosphamide
5247697|NCT00636909|FLUDARABINE|fludarabine
5247698|NCT00636909|CYCLOSPORINE|cyclosporine
5247699|NCT00636909|METHOTREXATE|methotrexate
5247700|NCT00636909|G-CSF|g-csf
5247701|NCT00636909|GVHD|gvhd
5247702|NCT00636909|ENGRAFTMENT|engraftment
5247703|NCT00636909|CHIMERISM|chimerism
5247704|NCT00636896|weight gain|weight gain
5247705|NCT00636896|olanzapine|olanzapine
5247706|NCT00636896|atypical antipsychotic|atypical antipsychotic
5247707|NCT00636883|Pancreatic cancer|pancreatic cancer
5247708|NCT00636857|Water-Electrolyte Imbalance|water-electrolyte imbalance
5247709|NCT00636844|chemotherapy, cardiotoxicity|chemotherapy, cardiotoxicity
5247710|NCT00636831|Prophylactic|prophylactic
5247711|NCT00636831|Antibiotic|antibiotic
5247712|NCT00636831|Infection|infection
5247713|NCT00636831|Primary case|primary case
5247714|NCT00636805|Aloxi|aloxi
5247715|NCT00636805|Brain Neoplasm, Primary|brain neoplasm, primary
5247716|NCT00636805|Brain Neoplasms, Malignant|brain neoplasms, malignant
5247717|NCT00636766|cardiovascular events|cardiovascular events
5247718|NCT00636753|Metabolic and endocrine changes in schizophrenic patients by antipsychotics treatment.|metabolic and endocrine changes in schizophrenic patients by antipsychotics treatment.
5247719|NCT00636740|Prostate cancer, hormone resistant, bisphosphonate|prostate cancer, hormone resistant, bisphosphonate
5247720|NCT00636727|arthrocentesis|arthrocentesis
5247721|NCT00636727|arthroscopy|arthroscopy
5247722|NCT00636727|arthroplasty|arthroplasty
5247723|NCT00636714|intensive insulin therapy|intensive insulin therapy
5247724|NCT00636714|glucose control|glucose control
5247725|NCT00636714|nurse directed|nurse directed
5247726|NCT00636714|nomogram directed|nomogram directed
5247727|NCT00636701|Cerebrovascular Accident|cerebrovascular accident
5247728|NCT00636701|rehabilitation|rehabilitation
5247729|NCT00636688|Obesity|obesity
5247730|NCT00636688|Lifestyle changes|lifestyle changes
5247731|NCT00636675|Accidental falls|accidental falls
5247732|NCT00636649|Eating disorder|eating disorder
5247733|NCT00636636|Postherpetic Neuralgia (PHN), shingles|postherpetic neuralgia (phn), shingles
5247734|NCT00636623|Pilates Exercises|pilates exercises
5247735|NCT00636623|Connective Tissue Massage|connective tissue massage
5247736|NCT00636610|Hedgehog|hedgehog
5247737|NCT00636610|CRC|crc
5247738|NCT00636610|Colorectal Cancer|colorectal cancer
5247739|NCT00636610|Hedgehog Pathway Inhibitor|hedgehog pathway inhibitor
5247740|NCT00636584|sodium nitroprusside|sodium nitroprusside
5247741|NCT00636584|thyroid hormones|thyroid hormones
5247742|NCT00636584|thoracic surgery|thoracic surgery
5247743|NCT00636571|Exercise|exercise
5247744|NCT00636571|Non-Small Cell Lung Cancer|non-small cell lung cancer
5247745|NCT00636571|Cardiopulmonary Fitness|cardiopulmonary fitness
5247746|NCT00636558|coxsackie virus|coxsackie virus
5247747|NCT00636558|melanoma|melanoma
5247748|NCT00636558|breast cancer|breast cancer
5247749|NCT00636558|prostate cancer|prostate cancer
5247750|NCT00636545|Genasense|genasense
5247751|NCT00636545|oblimersen|oblimersen
5247752|NCT00636545|antisense|antisense
5247753|NCT00636545|Bcl-2 antisense|bcl-2 antisense
5247754|NCT00636545|Solid Tumors|solid tumors
5247755|NCT00636519|Botulism Antitoxin,Heptavalent,Bivalent,EDB Muscle,Paralysis|botulism antitoxin,heptavalent,bivalent,edb muscle,paralysis
5247756|NCT00636506|Erectile dysfunction|erectile dysfunction
5247757|NCT00636506|Impotence|impotence
5247758|NCT00636493|retinal vein occlusion|retinal vein occlusion
5247759|NCT00636493|sustained drug delivery implant|sustained drug delivery implant
5247760|NCT00636493|steroid|steroid
5247761|NCT00636493|macular edema|macular edema
5247762|NCT00636480|Antimicrobial|antimicrobial
5247763|NCT00636480|Antisepsis|antisepsis
5247764|NCT00636467|Breast cancer (tumors> 2 cm)|breast cancer (tumors> 2 cm)
5247765|NCT00636467|Detection|detection
5247766|NCT00636467|Axillary sentinel lymph node|axillary sentinel lymph node
5247767|NCT00636454|OA|oa
5247768|NCT00636454|Pain|pain
5247769|NCT00636454|Cognitive Therapy|cognitive therapy
5247770|NCT00636454|Behavior Therapy|behavior therapy
5247771|NCT00636454|Knee OA|knee oa
5247772|NCT00636454|Hip OA|hip oa
5247773|NCT00636441|Early-Stage Breast Cancer|early-stage breast cancer
5247774|NCT00636441|Preoperative systemic chemotherapy (PST)|preoperative systemic chemotherapy (pst)
5247775|NCT00636441|Genomic|genomic
5247776|NCT00636441|Genomic Predictor|genomic predictor
5247777|NCT00636441|Genomic Expression Profiles|genomic expression profiles
5247778|NCT00636441|Randomized|randomized
5247779|NCT00636441|Pathologic complete response (pCR)|pathologic complete response (pcr)
5247780|NCT00636441|HER2 negative|her2 negative
5247781|NCT00636441|Doxorubicin and docetaxel|doxorubicin and docetaxel
5247782|NCT00636441|Doxorubicin and cyclophosphamide|doxorubicin and cyclophosphamide
5247783|NCT00636428|endoscopy|endoscopy
5247784|NCT00636428|Midazolam|midazolam
5247785|NCT00636428|pediatric|pediatric
5247786|NCT00636428|sedation|sedation
5247787|NCT00636428|comfort|comfort
5247788|NCT00636415|Analgesia|analgesia
5247789|NCT00636415|Morphine|morphine
5247790|NCT00636415|Bupivacaine|bupivacaine
5247791|NCT00636415|Osteoarthritis|osteoarthritis
5247792|NCT00636415|Knee|knee
5247793|NCT00636402|Vessel Sealing System|vessel sealing system
5247794|NCT00636402|Cold Knife|cold knife
5247795|NCT00636402|Tonsillectomy|tonsillectomy
5247796|NCT00636402|Pain|pain
5247797|NCT00636402|Postoperative|postoperative
5247798|NCT00636389|Hemodialysis|hemodialysis
5247799|NCT00636389|Dialysis, Renal|dialysis, renal
5247800|NCT00636389|Dialysis, Extracorporeal|dialysis, extracorporeal
5247801|NCT00636389|Extracorporeal Dialysis|extracorporeal dialysis
5247802|NCT00636376|elevated intracranial pressure|elevated intracranial pressure
5247803|NCT00636376|inadequate cerebral perfusion|inadequate cerebral perfusion
5247804|NCT00636376|secondary brain damage|secondary brain damage
5247805|NCT00636350|pepper carotenoids|pepper carotenoids
5247806|NCT00636350|xanthophylls|xanthophylls
5247807|NCT00636350|healthy volunteers|healthy volunteers
5247808|NCT00636337|Pediatric|pediatric
5247809|NCT00636337|Brain Tumor|brain tumor
5247810|NCT00636337|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
5247811|NCT00636337|Inattention|inattention
5247812|NCT00636337|Childhood cancer survivors|childhood cancer survivors
5247813|NCT00636324|Respiratory distress syndrome|respiratory distress syndrome
5247814|NCT00636324|Preterm infants|preterm infants
5247815|NCT00636324|Extubation failure|extubation failure
5247816|NCT00636324|Pneumothorax|pneumothorax
5247817|NCT00636324|Lung injury|lung injury
5247818|NCT00636324|Airway pressure|airway pressure
5247819|NCT00636311|Hodgkin disease|hodgkin disease
5247820|NCT00636311|Salvage therapy|salvage therapy
5247821|NCT00636311|Bortezomib|bortezomib
5247822|NCT00636311|Transplantation|transplantation
5247823|NCT00636298|esophageal carcinoma|esophageal carcinoma
5247824|NCT00636298|cancer of the esophagus|cancer of the esophagus
5247825|NCT00636298|locally advanced or metastatic esophageal cancer|locally advanced or metastatic esophageal cancer
5247826|NCT00636285|A110|a110
5247827|NCT00636285|Safety|safety
5247828|NCT00636272|ICD|icd
5247829|NCT00636272|CRT-D|crt-d
5247830|NCT00636259|Prostate cancer|prostate cancer
5247831|NCT00636259|Casodex|casodex
5247832|NCT00636233|anencephaly|anencephaly
5247833|NCT00636233|acrania|acrania
5247834|NCT00636220|HIV-1 Infections|hiv-1 infections
5247835|NCT00636155|Small Lymphocytic Lymphoma|small lymphocytic lymphoma
5247836|NCT00636155|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
5247837|NCT00636155|EL625|el625
5247838|NCT00636155|cenersen|cenersen
5247840|NCT00636129|relaxation response|relaxation response
5247841|NCT00636129|meditation|meditation
5247842|NCT00636129|nitric oxide|nitric oxide
5247843|NCT00636129|stress management|stress management
5247844|NCT00636129|stress|stress
5247845|NCT00636129|Relaxation Techniques|relaxation techniques
5247846|NCT00636116|snake bite|snake bite
5247847|NCT00636116|antivenin treatment|antivenin treatment
5247848|NCT00636103|Traditional Chinese Medicine|traditional chinese medicine
5247849|NCT00636103|Asthma|asthma
5247850|NCT00636103|Paediatric|paediatric
5247851|NCT00636077|Hemodialysis|hemodialysis
5247852|NCT00636077|Dialysis, Renal|dialysis, renal
5247853|NCT00636051|evidence based practice beliefs|evidence based practice beliefs
5247854|NCT00636051|evidence based practice implementation|evidence based practice implementation
5247855|NCT00636051|evidence based practice dissemination|evidence based practice dissemination
5247856|NCT00636038|beta-carotene|beta-carotene
5247857|NCT00636038|yellow maize|yellow maize
5247858|NCT00636038|vitamin A|vitamin a
5247859|NCT00636012|acupuncture|acupuncture
5247860|NCT00636012|Acupuncture points|acupuncture points
5247861|NCT00635986|Analgesia|analgesia
5247862|NCT00635986|Fentanyl|fentanyl
5247863|NCT00635986|Orthopedic|orthopedic
5247864|NCT00635986|Mechanism of action|mechanism of action
5247865|NCT00635986|Surgery|surgery
5247866|NCT00635973|Iressa|iressa
5247867|NCT00635973|Gefitinib|gefitinib
5247868|NCT00635973|Cancer|cancer
5247869|NCT00635973|Patients diagnosed with cancer who have previously received Iressa in an Iressa clinical trial|patients diagnosed with cancer who have previously received iressa in an iressa clinical trial
5247870|NCT00635960|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
5247871|NCT00635960|ALS|als
5247872|NCT00635960|Growth Hormone|growth hormone
5247873|NCT00635960|IGF-I|igf-i
5247874|NCT00635947|Amniotic fluid index|amniotic fluid index
5247875|NCT00635947|maternal hydration|maternal hydration
5247876|NCT00635947|isotonic solution|isotonic solution
5247877|NCT00635947|Amniotic Fluid|amniotic fluid
5247878|NCT00635934|Lumbar Degenerative Disc Disease at One Level from L4-S1|lumbar degenerative disc disease at one level from l4-s1
5247879|NCT00635921|Borderline Personality Disorder|borderline personality disorder
5247880|NCT00635921|ziprasidone|ziprasidone
5247881|NCT00635895|Fibromyalgia|fibromyalgia
5247882|NCT00635895|Manual Lymphatic Drainage|manual lymphatic drainage
5247883|NCT00635895|Connective Tissue Massage|connective tissue massage
5247884|NCT00635895|Pain|pain
5247885|NCT00635895|Health Related Quality of Life|health related quality of life
5247886|NCT00635895|Randomized Controlled Trial|randomized controlled trial
5247887|NCT00635882|mometasone|mometasone
5247888|NCT00635882|formoterol|formoterol
5247889|NCT00635869|evidence based practice beliefs|evidence based practice beliefs
5247890|NCT00635869|evidence based practice implementation|evidence based practice implementation
5247891|NCT00635869|evidence based practice knowledge|evidence based practice knowledge
5247892|NCT00635869|nurse physician collaboration|nurse physician collaboration
5247893|NCT00635856|Iressa|iressa
5247894|NCT00635856|Gefitinib|gefitinib
5247895|NCT00635856|Prostate Cancer|prostate cancer
5247896|NCT00635856|PSA|psa
5247897|NCT00635843|Lumbar degenerative disc disease at one level from L4-S1|lumbar degenerative disc disease at one level from l4-s1
5247898|NCT00635817|CPP|cpp
5247899|NCT00635817|central precocious puberty|central precocious puberty
5247900|NCT00635817|pediatrics|pediatrics
5247901|NCT00635817|suppression of luteinizing hormone|suppression of luteinizing hormone
5247902|NCT00635817|Lupron|lupron
5247903|NCT00635817|leuprolide acetate|leuprolide acetate
5247904|NCT00635817|depot formulation|depot formulation
5247905|NCT00635817|GnRHa|gnrha
5247906|NCT00635817|GnRH agonist|gnrh agonist
5247907|NCT00635817|GnRH analog|gnrh analog
5247908|NCT00635817|luteinizing hormone|luteinizing hormone
5247909|NCT00635791|Malignant Solid Tumour|malignant solid tumour
5247910|NCT00635791|Renal cell carcinoma|renal cell carcinoma
5247911|NCT00635791|Non small cell lung carcinoma|non small cell lung carcinoma
5247912|NCT00635765|Acromegaly|acromegaly
5247913|NCT00635752|TF-CBT|tf-cbt
5247914|NCT00635752|Effectiveness study|effectiveness study
5247915|NCT00635752|Trauma|trauma
5247916|NCT00635752|Therapy|therapy
5247917|NCT00635739|Whey protein|whey protein
5247918|NCT00635739|Resistance exercise|resistance exercise
5247919|NCT00635739|Physical activity|physical activity
5247920|NCT00635739|Mobility disability|mobility disability
5247921|NCT00635739|Physical function|physical function
5247922|NCT00635739|Muscle mass|muscle mass
5247923|NCT00635739|Muscle strength|muscle strength
5247924|NCT00635739|Older Adults|older adults
5247925|NCT00635739|Mobility-Limited|mobility-limited
5247926|NCT00635726|Bladder Cancer|bladder cancer
5247927|NCT00635713|Advanced breast cancer, FASLODEX, ARIMIDEX, Fulvestrant, Anastrozole, postmenopausal|advanced breast cancer, faslodex, arimidex, fulvestrant, anastrozole, postmenopausal
5247928|NCT00635700|psychosis|psychosis
5247929|NCT00635700|schizophrenia|schizophrenia
5247930|NCT00635700|prodrome|prodrome
5247931|NCT00635700|ziprasidone|ziprasidone
5247932|NCT00635700|placebo|placebo
5247933|NCT00635687|variceal bleeding|variceal bleeding
5247934|NCT00635687|transient elastography|transient elastography
5247935|NCT00635674|sleep apnea|sleep apnea
5247936|NCT00635674|risk factors|risk factors
5247937|NCT00635674|continuous positive airway pressure|continuous positive airway pressure
5247938|NCT00635674|insulin resistance|insulin resistance
5247939|NCT00635674|metabolic syndrome|metabolic syndrome
5247940|NCT00635674|compliance|compliance
5247941|NCT00635661|function|function
5247942|NCT00635661|disability|disability
5247943|NCT00635635|Stress Disorders, Post-Traumatic|stress disorders, post-traumatic
5247944|NCT00635635|Anxiety,|anxiety,
5247945|NCT00635635|Depression,|depression,
5247946|NCT00635635|Guided Imagery|guided imagery
5247947|NCT00635635|Military Sexual Trauma|military sexual trauma
5247948|NCT00635622|Bacterial Vaginosis|bacterial vaginosis
5247949|NCT00635622|BV|bv
5247950|NCT00635622|UCSF|ucsf
5247951|NCT00635622|SFGH|sfgh
5247952|NCT00635596|MT110|mt110
5247953|NCT00635596|solid tumors|solid tumors
5247954|NCT00635596|phase I|phase i
5247955|NCT00635596|BiTE|bite
5247956|NCT00635596|bispecific T-cell engager|bispecific t-cell engager
5247957|NCT00635583|Bone|bone
5247958|NCT00635583|Dairy Intervention|dairy intervention
5247959|NCT00635583|Girls|girls
5247960|NCT00635583|Boys|boys
5247961|NCT00635583|Calcium|calcium
5247962|NCT00635583|Bone Mineralization|bone mineralization
5247963|NCT00635583|Peak Bone Mass|peak bone mass
5247964|NCT00635583|Bone and Bones|bone and bones
5247965|NCT00635583|Female|female
5247966|NCT00635583|Male|male
5247967|NCT00635583|Adolescent|adolescent
5247968|NCT00635583|Healthy|healthy
5247969|NCT00635570|Contraception, Compliance, Acceptability|contraception, compliance, acceptability
5247970|NCT00635557|Recurrent|recurrent
5247971|NCT00635557|Relapsed|relapsed
5247972|NCT00635557|Glioblastoma|glioblastoma
5247973|NCT00635557|Multiforme|multiforme
5247974|NCT00635544|Adolescence|adolescence
5247975|NCT00635544|Overweight|overweight
5247976|NCT00635544|Dietary Fiber|dietary fiber
5247977|NCT00635544|Glycemic Index|glycemic index
5247978|NCT00635544|Healthy lifestyle|healthy lifestyle
5247979|NCT00635518|Health Plan Implementation|health plan implementation
5247980|NCT00635518|Feeding and Eating Disorders of Childhood|feeding and eating disorders of childhood
5247981|NCT00635518|Breast Feeding|breast feeding
5247982|NCT00635518|Overweight|overweight
5247983|NCT00635518|Child|child
5247984|NCT00635518|Infant Nutrition Physiology|infant nutrition physiology
5247985|NCT00635518|Public Health|public health
5247986|NCT00635505|Asthma|asthma
5247987|NCT00635505|albuterol|albuterol
5247988|NCT00635505|HFA|hfa
5247989|NCT00635492|diabetes|diabetes
5247990|NCT00635492|insulin|insulin
5247991|NCT00635492|exenatide|exenatide
5247992|NCT00635492|Byetta|byetta
5247993|NCT00635492|Amylin|amylin
5247994|NCT00635492|Lilly|lilly
5247995|NCT00635479|Fractures|fractures
5247996|NCT00635479|Pelvic bones|pelvic bones
5247997|NCT00635479|Acetabulum|acetabulum
5247998|NCT00635479|Hip bones|hip bones
5247999|NCT00635466|laparoscopic surgery, rectal carcinoma, phase II trial|laparoscopic surgery, rectal carcinoma, phase ii trial
5248000|NCT00635453|Breast Feeding|breast feeding
5248001|NCT00635453|Child|child
5248002|NCT00635453|Infant Nutrition Physiology|infant nutrition physiology
5248003|NCT00635453|Public Health|public health
5248004|NCT00635453|Morbidity|morbidity
5248005|NCT00635453|Health Plan Implementation|health plan implementation
5248006|NCT00635440|skeletal muscle|skeletal muscle
5248007|NCT00635440|ubiquitin|ubiquitin
5248008|NCT00635440|proteasome|proteasome
5248009|NCT00635440|IGF-1|igf-1
5248010|NCT00635440|MGF|mgf
5248011|NCT00635440|protein catabolism|protein catabolism
5248012|NCT00635440|neuromuscular electrical stimulation|neuromuscular electrical stimulation
5248013|NCT00635440|Investigate effect of NMES on muscle metabolism of catabolic patients|investigate effect of nmes on muscle metabolism of catabolic patients
5248014|NCT00635427|VPRIV|vpriv
5248015|NCT00635427|Enzyme Replacement Therapy|enzyme replacement therapy
5248016|NCT00635427|Gaucher disease|gaucher disease
5248017|NCT00635427|glucocerebrosidase|glucocerebrosidase
5248018|NCT00635427|beta-glucocerebrosidase|beta-glucocerebrosidase
5248019|NCT00635427|Acid beta-glucocerebrosidase|acid beta-glucocerebrosidase
5248020|NCT00635427|glucosylceramidase|glucosylceramidase
5248021|NCT00635427|D-glucosyl-N-acylsphingosine glucohydrolase|d-glucosyl-n-acylsphingosine glucohydrolase
5248022|NCT00635427|gene activation|gene activation
5248023|NCT00635427|human|human
5248024|NCT00635414|Gastroesophageal Reflux Disease (GERD), esomeprazole, Nexium|gastroesophageal reflux disease (gerd), esomeprazole, nexium
5248025|NCT00635362|Contraception|contraception
5248026|NCT00635362|Contraceptive Devices|contraceptive devices
5248027|NCT00635362|Intrauterine Devices|intrauterine devices
5248028|NCT00635362|Unplanned Pregnancy|unplanned pregnancy
5248029|NCT00635362|Postpartum Period|postpartum period
5248030|NCT00635349|WOMAC|womac
5248031|NCT00635349|Knee osteoarthritis pain|knee osteoarthritis pain
5248032|NCT00635349|Pain intensity|pain intensity
5248033|NCT00635349|Tramadol|tramadol
5248034|NCT00635349|Acetaminophen|acetaminophen
5248035|NCT00635349|Meloxicam|meloxicam
5248036|NCT00635349|Aceclofenac|aceclofenac
5248037|NCT00635336|Epitope peptide|epitope peptide
5248038|NCT00635336|CTL|ctl
5248039|NCT00635336|Advanced bladder cancer|advanced bladder cancer
5248040|NCT00635336|Vaccination|vaccination
5248041|NCT00635336|advanced bladder cancer which showed resistance for standard treatments|advanced bladder cancer which showed resistance for standard treatments
5248042|NCT00635310|Chronic hepatitis C|chronic hepatitis c
5248043|NCT00635310|Chronic hepatitis B|chronic hepatitis b
5248044|NCT00635310|Liver biopsy|liver biopsy
5248045|NCT00635310|Hemodialysis|hemodialysis
5248046|NCT00635310|1-Deamino-8- D-Arginine Vasopressin|1-deamino-8- d-arginine vasopressin
5248047|NCT00635297|osteoporosis|osteoporosis
5248048|NCT00635297|vertebroplasty|vertebroplasty
5248049|NCT00635297|prophylactic|prophylactic
5248050|NCT00635297|vertebrae|vertebrae
5248051|NCT00635297|fracture|fracture
5248052|NCT00635271|Asthma|asthma
5248053|NCT00635271|Biomarker|biomarker
5248054|NCT00635271|Exhaled Breath Condensate|exhaled breath condensate
5248055|NCT00635271|Cytokine|cytokine
5248056|NCT00635271|Healthy Volunteer|healthy volunteer
5248057|NCT00635271|HV|hv
5248058|NCT00635258|GnRH antagonist|gnrh antagonist
5248059|NCT00635258|oocyte donation|oocyte donation
5248060|NCT00635258|pregnancy|pregnancy
5248061|NCT00635258|implantation|implantation
5248062|NCT00635245|stage IA breast cancer|stage ia breast cancer
5248063|NCT00635245|stage IB breast cancer|stage ib breast cancer
5248064|NCT00635245|stage II breast cancer|stage ii breast cancer
5248065|NCT00635232|Hypertension|hypertension
5248066|NCT00635232|High Blood Pressure|high blood pressure
5248067|NCT00635219|Major depressive disorder|major depressive disorder
5248068|NCT00635219|Placebo-controlled|placebo-controlled
5248069|NCT00635219|Active reference|active reference
5248070|NCT00635219|Multicenter study|multicenter study
5248071|NCT00635219|Randomised study|randomised study
5248072|NCT00635219|Acute treatment|acute treatment
5248073|NCT00635206|OSA|osa
5248074|NCT00635193|Ovarian neoplasms|ovarian neoplasms
5248075|NCT00635193|Angiogenesis inhibitors|angiogenesis inhibitors
5248076|NCT00635193|Angiogenesis|angiogenesis
5248077|NCT00635193|Volociximab|volociximab
5248078|NCT00635193|Ovarian cancer|ovarian cancer
5248079|NCT00635193|Antibody|antibody
5248080|NCT00635193|Monoclonals|monoclonals
5248081|NCT00635180|Isometric exercise|isometric exercise
5248082|NCT00635180|intraocular pressure|intraocular pressure
5248083|NCT00635180|Physiological changes in intraocular pressure during isometric exercise|physiological changes in intraocular pressure during isometric exercise
5248084|NCT00635167|Prostate cancer|prostate cancer
5248085|NCT00635167|prostatic vascularity|prostatic vascularity
5248086|NCT00635167|External Beam Radiation treatment|external beam radiation treatment
5248087|NCT00635167|Contrast Enhanced transrectal Ultrasound|contrast enhanced transrectal ultrasound
5248088|NCT00635154|stage I multiple myeloma|stage i multiple myeloma
5248089|NCT00635154|stage II multiple myeloma|stage ii multiple myeloma
5248090|NCT00635154|stage III multiple myeloma|stage iii multiple myeloma
5248091|NCT00635141|Cystic Fibrosis|cystic fibrosis
5248092|NCT00635141|Lung Clearance Index|lung clearance index
5248093|NCT00635141|Hypertonic Saline|hypertonic saline
5248094|NCT00635141|Pediatrics|pediatrics
5248095|NCT00635128|Diphtheria|diphtheria
5248096|NCT00635128|vaccine|vaccine
5248097|NCT00635128|DTP|dtp
5248098|NCT00635128|Poliomyelitis|poliomyelitis
5248099|NCT00635128|Pertussis|pertussis
5248100|NCT00635128|Booster|booster
5248101|NCT00635128|Tetanus|tetanus
5248102|NCT00635102|Alcohol Dependence, Alcoholism, Glycine, D-Cycloserine|alcohol dependence, alcoholism, glycine, d-cycloserine
5248103|NCT00635089|Eosinophilic Esophagitis|eosinophilic esophagitis
5248104|NCT00635089|Cinquil|cinquil
5248105|NCT00635063|Cancer Breakthrough Pain|cancer breakthrough pain
5248106|NCT00635050|Breast cancer|breast cancer
5248107|NCT00635037|Myofascial pain syndrome|myofascial pain syndrome
5248108|NCT00635037|Acupuncture|acupuncture
5248109|NCT00635037|Nonsteroidal anti-inflammatory agents|nonsteroidal anti-inflammatory agents
5248110|NCT00635037|Muscle relaxants, central|muscle relaxants, central
5248111|NCT00635037|Quality of life.|quality of life.
5248112|NCT00635037|muscle relaxants, analgesia|muscle relaxants, analgesia
5248113|NCT00635024|refractory multiple myeloma|refractory multiple myeloma
5248114|NCT00635024|stage I multiple myeloma|stage i multiple myeloma
5248115|NCT00635024|stage II multiple myeloma|stage ii multiple myeloma
5248116|NCT00635024|stage III multiple myeloma|stage iii multiple myeloma
5248117|NCT00635011|comorbidity|comorbidity
5248118|NCT00635011|Quality of Life|quality of life
5248119|NCT00635011|Body Weight Changes|body weight changes
5248120|NCT00634998|Vitamin C|vitamin c
5248121|NCT00634998|Ascorbic Acid|ascorbic acid
5248122|NCT00634998|Diabetic Neuropathies|diabetic neuropathies
5248123|NCT00634972|Retinopathy of Prematurity|retinopathy of prematurity
5248124|NCT00634972|Premature Infants|premature infants
5248125|NCT00634972|ACULAR|acular
5248126|NCT00634972|Refresh Tears|refresh tears
5248127|NCT00634959|HIV Infections|hiv infections
5248128|NCT00634959|Treatment Naïve|treatment naïve
5248129|NCT00634946|Chemonucleolysis|chemonucleolysis
5248130|NCT00634946|Lumbar Vertebrae|lumbar vertebrae
5248131|NCT00634946|Hernia|hernia
5248132|NCT00634933|active|active
5248133|NCT00634933|rheumatoid|rheumatoid
5248134|NCT00634933|arthritis|arthritis
5248135|NCT00634933|anti CD20|anti cd20
5248136|NCT00634920|De novo renal transplantation|de novo renal transplantation
5248137|NCT00634907|Genotyping|genotyping
5248138|NCT00634907|Warfarin dosing|warfarin dosing
5248139|NCT00634907|arthroplasty|arthroplasty
5248140|NCT00634894|Ovarian Cancer|ovarian cancer
5248141|NCT00634894|Fallopian Tube Cancer|fallopian tube cancer
5248142|NCT00634894|Peritoneal Cancer|peritoneal cancer
5248143|NCT00634894|Femara|femara
5248144|NCT00634894|Letrozole|letrozole
5248145|NCT00634894|Placebo|placebo
5248146|NCT00634881|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
5248147|NCT00634881|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5248148|NCT00634881|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5248149|NCT00634881|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
5248150|NCT00634881|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
5248151|NCT00634868|ulcer wound diabetes|ulcer wound diabetes
5248152|NCT00634855|Endothelial progenitor cells|endothelial progenitor cells
5248153|NCT00634855|Endothelial dysfunction|endothelial dysfunction
5248154|NCT00634777|HNSCC biopsy-proven|hnscc biopsy-proven
5248155|NCT00634777|T1-T4 oral cavity oropharynx hypopharynx larynx|t1-t4 oral cavity oropharynx hypopharynx larynx
5248156|NCT00634777|N+ scheduled for an organ preservation treatment protocol based on concomitant|n+ scheduled for an organ preservation treatment protocol based on concomitant
5248157|NCT00634777|chemoradiation|chemoradiation
5248158|NCT00634764|Maternal weight gain|maternal weight gain
5248159|NCT00634764|Neonatal birth weight|neonatal birth weight
5248160|NCT00634764|Weight gain attitude|weight gain attitude
5248161|NCT00634764|Pregnancy|pregnancy
5248162|NCT00634764|Body fat|body fat
5248163|NCT00634764|Maternal Behavior|maternal behavior
5248164|NCT00634764|Birth outcomes|birth outcomes
5248165|NCT00634751|advanced pancreatic and biliary tract carcinomas|advanced pancreatic and biliary tract carcinomas
5248166|NCT00634738|ischemic compression;carpal tunnel syndrome|ischemic compression;carpal tunnel syndrome
5248167|NCT00634725|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
5248168|NCT00634725|stage III pancreatic cancer|stage iii pancreatic cancer
5248169|NCT00634712|Congestive Heart Failure|congestive heart failure
5248170|NCT00634712|Atacand|atacand
5248171|NCT00634712|Candesartan|candesartan
5248172|NCT00634686|Omega-3 fatty acids|omega-3 fatty acids
5248173|NCT00634686|immune response|immune response
5248174|NCT00634673|Serum Fatty Acids|serum fatty acids
5248175|NCT00634673|FABP2 Gene|fabp2 gene
5248176|NCT00634673|Polymorphism Ala54Thr|polymorphism ala54thr
5248177|NCT00634647|Chemotherapy|chemotherapy
5248178|NCT00634647|Pharmacokinetics|pharmacokinetics
5248179|NCT00634647|Gene Polymorphisms|gene polymorphisms
5248180|NCT00634647|Prostate Cancer|prostate cancer
5248181|NCT00634634|breast cancer|breast cancer
5248182|NCT00634634|Postmenopausal Women with Hormone Receptor-Positive Locally Advanced Breast Cancer|postmenopausal women with hormone receptor-positive locally advanced breast cancer
5248183|NCT00634621|Bladder|bladder
5248184|NCT00634621|Cancer|cancer
5248185|NCT00634621|Cystoscopy|cystoscopy
5248186|NCT00634621|Hexaminolevulinate|hexaminolevulinate
5248187|NCT00634621|Hexvix|hexvix
5248188|NCT00634595|clinical trial|clinical trial
5248189|NCT00634595|randomized|randomized
5248190|NCT00634595|Endostatin|endostatin
5248191|NCT00634595|gene therapy|gene therapy
5248192|NCT00634595|head and neck cancer|head and neck cancer
5248193|NCT00634595|head and neck squamous carcinoma|head and neck squamous carcinoma
5248194|NCT00634582|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5248195|NCT00634582|stage IV prostate cancer|stage iv prostate cancer
5248196|NCT00634582|recurrent prostate cancer|recurrent prostate cancer
5248197|NCT00634582|bone metastases|bone metastases
5248324|NCT00633997|type 2 diabetes|type 2 diabetes
5248198|NCT00634569|CVID, XLA, hyper IgM syndrome, Wiskott-Aldrich Syndrome|cvid, xla, hyper igm syndrome, wiskott-aldrich syndrome
5248199|NCT00634556|Tourette Syndrome|tourette syndrome
5248200|NCT00634556|fMRI|fmri
5248201|NCT00634556|levodopa|levodopa
5248202|NCT00634556|working memory|working memory
5248203|NCT00634556|dopamine|dopamine
5248204|NCT00634543|Diabetic neuropathy|diabetic neuropathy
5248205|NCT00634543|Ultracet|ultracet
5248206|NCT00634543|Tramadol hydrochloride|tramadol hydrochloride
5248207|NCT00634543|Acetaminophen|acetaminophen
5248208|NCT00634543|Gabapentin|gabapentin
5248209|NCT00634530|Pregnancy|pregnancy
5248210|NCT00634530|Prenatal Care|prenatal care
5248211|NCT00634530|Weight|weight
5248212|NCT00634530|Nutritional Status|nutritional status
5248213|NCT00634504|high dose methotrexate|high dose methotrexate
5248214|NCT00634504|Voraxaze|voraxaze
5248215|NCT00634504|leucovorin|leucovorin
5248216|NCT00634504|delayed elimination|delayed elimination
5248217|NCT00634504|methotrexate toxicity|methotrexate toxicity
5248218|NCT00634504|rescue|rescue
5248219|NCT00634504|renal insufficiency|renal insufficiency
5248220|NCT00634478|essential tremor|essential tremor
5248221|NCT00634478|deep brain stimulation|deep brain stimulation
5248222|NCT00634452|Hodgkin's|hodgkin's
5248223|NCT00634452|Cancer|cancer
5248224|NCT00634452|bi-measurable disease|bi-measurable disease
5248225|NCT00634452|Lymphoma|lymphoma
5248226|NCT00634439|cerebrovascular accident|cerebrovascular accident
5248227|NCT00634439|stroke|stroke
5248228|NCT00634439|transient ischemic attack|transient ischemic attack
5248229|NCT00634439|TIA|tia
5248230|NCT00634439|CVA|cva
5248231|NCT00634439|attention deficit hyperactivity disorder|attention deficit hyperactivity disorder
5248232|NCT00634439|ADHD|adhd
5248233|NCT00634426|Spine|spine
5248234|NCT00634426|Neoplasm metastasis|neoplasm metastasis
5248235|NCT00634426|Treatment, surgical|treatment, surgical
5248236|NCT00634426|Treatment, nonoperative|treatment, nonoperative
5248237|NCT00634426|Quality of life|quality of life
5248238|NCT00634413|COPD|copd
5248239|NCT00634400|Congestive Heart Failure|congestive heart failure
5248240|NCT00634400|Atacand|atacand
5248241|NCT00634400|Candesartan|candesartan
5248242|NCT00634374|Rx medibottle|rx medibottle
5248243|NCT00634374|Oral syringe|oral syringe
5248244|NCT00634374|Liquid medication|liquid medication
5248245|NCT00634374|Bitter-tasting|bitter-tasting
5248246|NCT00634374|Infants|infants
5248247|NCT00634322|osteosarcoma|osteosarcoma
5248248|NCT00634322|high dose methotrexate|high dose methotrexate
5248249|NCT00634322|leucovorin|leucovorin
5248250|NCT00634309|Congestive Heart Failure|congestive heart failure
5248251|NCT00634309|Atacand|atacand
5248252|NCT00634309|Candesartan|candesartan
5248253|NCT00634296|Heart failure|heart failure
5248254|NCT00634296|Systolic dysfunction|systolic dysfunction
5248255|NCT00634296|Inspiratory muscle weakness|inspiratory muscle weakness
5248256|NCT00634270|Plexiform, Neurofibromatosis Type 1, Sirolimus, Phase II|plexiform, neurofibromatosis type 1, sirolimus, phase ii
5248257|NCT00634257|Advanced Cancer|advanced cancer
5248258|NCT00634257|Solid Tumors|solid tumors
5248259|NCT00634257|Spirituality|spirituality
5248260|NCT00634257|Religiosity|religiosity
5248261|NCT00634257|Symptom Distress|symptom distress
5248262|NCT00634257|Quality of Life|quality of life
5248263|NCT00634257|Caregivers|caregivers
5248264|NCT00634257|Questionnaire|questionnaire
5248265|NCT00634257|Survey|survey
5248266|NCT00634244|Acute Myelogenous Leukemia (AML), Carboplatin, Topotecan, Flavopiridol, Mitoxantrone, Cytosine Arabinoside, Sirolimus, Etoposide|acute myelogenous leukemia (aml), carboplatin, topotecan, flavopiridol, mitoxantrone, cytosine arabinoside, sirolimus, etoposide
5248267|NCT00634231|Malignant glioma|malignant glioma
5248268|NCT00634231|Glioblastoma multiforme|glioblastoma multiforme
5248269|NCT00634231|Anaplastic astrocytoma|anaplastic astrocytoma
5248270|NCT00634231|Recurrent ependymoma|recurrent ependymoma
5248271|NCT00634231|Gene therapy|gene therapy
5248272|NCT00634231|Immunotherapy|immunotherapy
5248273|NCT00634218|nicotine|nicotine
5248274|NCT00634218|smoking|smoking
5248275|NCT00634218|smoking cessation|smoking cessation
5248276|NCT00634205|Mesothelioma|mesothelioma
5248277|NCT00634205|Valproate|valproate
5248278|NCT00634205|Doxorubicin|doxorubicin
5248279|NCT00634205|Chemotherapy|chemotherapy
5248280|NCT00634205|Phase II|phase ii
5248281|NCT00634192|Chronic infection with P. aeruginosa in Cystic Fibrosis subjects|chronic infection with p. aeruginosa in cystic fibrosis subjects
5248282|NCT00634179|Lymphoma|lymphoma
5248283|NCT00634166|thermal injuries|thermal injuries
5248284|NCT00634166|burns|burns
5248285|NCT00634166|Burn Patients (Subjects with Thermal Injuries Requiring Meshed Autografts)|burn patients (subjects with thermal injuries requiring meshed autografts)
5248286|NCT00634140|gallbladder|gallbladder
5248287|NCT00634140|ezetimibe for 4 to 6 weeks prior to gallbladder removal|ezetimibe for 4 to 6 weeks prior to gallbladder removal
5248288|NCT00634114|Reflux Esophagitis|reflux esophagitis
5248289|NCT00634075|Severe sepsis|severe sepsis
5248290|NCT00634075|Proinflammatory cytokines|proinflammatory cytokines
5248291|NCT00634075|ICU|icu
5248292|NCT00634062|Affective Lability|affective lability
5248293|NCT00634062|Borderline Personality Disorder|borderline personality disorder
5248294|NCT00634062|Pharmacotherapy|pharmacotherapy
5248295|NCT00634049|invasive fungal infections caused by rare molds, rare yeasts|invasive fungal infections caused by rare molds, rare yeasts
5248296|NCT00634049|BAL8557|bal8557
5248297|NCT00634049|Isavuconazole|isavuconazole
5248298|NCT00634049|Aspergillosis|aspergillosis
5248299|NCT00634049|or by dimorphic fungi|or by dimorphic fungi
5248300|NCT00634049|ASP9766|asp9766
5248301|NCT00634036|Asthma|asthma
5248302|NCT00634036|obesity|obesity
5248303|NCT00634036|exacerbation|exacerbation
5248304|NCT00634036|asthmatics|asthmatics
5248305|NCT00634036|fat|fat
5248306|NCT00634036|overweight|overweight
5248307|NCT00634036|adipose tissue|adipose tissue
5248308|NCT00634036|leptin|leptin
5248309|NCT00634036|adiponectin|adiponectin
5248310|NCT00634036|pioglitazone|pioglitazone
5248311|NCT00634036|Actos|actos
5248312|NCT00634036|wheezing|wheezing
5248313|NCT00634036|Pittsburgh|pittsburgh
5248314|NCT00634036|Pennsylvania|pennsylvania
5248315|NCT00634036|pulmonary|pulmonary
5248316|NCT00634036|lung|lung
5248317|NCT00634010|Advanced Cancer|advanced cancer
5248318|NCT00634010|Solid Tumors|solid tumors
5248319|NCT00634010|Cancer Pain|cancer pain
5248320|NCT00634010|Opioid Pain Killer|opioid pain killer
5248321|NCT00634010|Morphine|morphine
5248322|NCT00634010|Methadone|methadone
5248323|NCT00633997|Diabetes mellitus|diabetes mellitus
5248325|NCT00633997|vildagliptin|vildagliptin
5248326|NCT00633997|pharmacokinetics|pharmacokinetics
5248327|NCT00633984|Social Anxiety Disorder|social anxiety disorder
5248328|NCT00633984|Cognitive Behavioral Group Therapy|cognitive behavioral group therapy
5248329|NCT00633984|D-cycloserine|d-cycloserine
5248330|NCT00633971|Post thrombotic syndrome|post thrombotic syndrome
5248331|NCT00633971|Thrombosis|thrombosis
5248332|NCT00633971|Deep vein thrombosis|deep vein thrombosis
5248333|NCT00633971|Venous thrombosis|venous thrombosis
5248334|NCT00633971|Edema|edema
5248335|NCT00633971|stasis ulcers|stasis ulcers
5248336|NCT00633958|18F-FLT|18f-flt
5248338|NCT00633958|PET|pet
5248339|NCT00633958|CNS tumors|cns tumors
5248340|NCT00633958|Newly|newly
5248341|NCT00633958|diagnosed|diagnosed
5248342|NCT00633945|Cutaneous Lupus Erythematosus|cutaneous lupus erythematosus
5248343|NCT00633945|CLE|cle
5248344|NCT00633945|lenalidomide|lenalidomide
5248345|NCT00633945|revlimid|revlimid
5248346|NCT00633945|thalidomide derivative|thalidomide derivative
5248347|NCT00633945|drug|drug
5248348|NCT00633945|lupus|lupus
5248349|NCT00633932|Reflux Esophagitis|reflux esophagitis
5248350|NCT00633919|House dust mites|house dust mites
5248351|NCT00633919|Sublingual immunotherapy|sublingual immunotherapy
5248352|NCT00633919|Allergy|allergy
5248353|NCT00633919|Allergic asthma|allergic asthma
5248354|NCT00633906|HIV|hiv
5248355|NCT00633906|Sexually Transmitted diseases|sexually transmitted diseases
5248356|NCT00633906|Adolescents|adolescents
5248357|NCT00633906|Prevention|prevention
5248358|NCT00633906|HIV Seronegativity|hiv seronegativity
5248359|NCT00633880|NOH|noh
5248360|NCT00633880|Neurogenic Orthostatic Hypotension|neurogenic orthostatic hypotension
5248361|NCT00633880|Orthostatic hypotension|orthostatic hypotension
5248362|NCT00633880|PAF|paf
5248363|NCT00633880|Pure Autonomic Failure|pure autonomic failure
5248364|NCT00633880|MSA|msa
5248365|NCT00633880|Multiple System Atrophy|multiple system atrophy
5248366|NCT00633880|Neuropathy|neuropathy
5248367|NCT00633880|Autonomic Failure|autonomic failure
5248368|NCT00633880|Parkinson|parkinson
5248369|NCT00633880|Dopamine Deficiency|dopamine deficiency
5248370|NCT00633880|Dopamine|dopamine
5248371|NCT00633880|Droxidopa|droxidopa
5248372|NCT00633867|Tracheal intubation|tracheal intubation
5248373|NCT00633867|Laryngoscopy|laryngoscopy
5248374|NCT00633867|videolaryngoscope|videolaryngoscope
5248375|NCT00633867|McGrath|mcgrath
5248376|NCT00633867|success|success
5248377|NCT00633867|time|time
5248378|NCT00633854|annular array ultrasound|annular array ultrasound
5248379|NCT00633854|ophthalmic ultrasound|ophthalmic ultrasound
5248380|NCT00633854|posterior vitreous detachment (PVD)|posterior vitreous detachment (pvd)
5248381|NCT00633841|Alzheimer|alzheimer
5248382|NCT00633841|Morbus Alzheimer|morbus alzheimer
5248383|NCT00633841|Alzheimer Vaccine|alzheimer vaccine
5248384|NCT00633841|Vaccine|vaccine
5248385|NCT00633841|AD|ad
5248386|NCT00633841|Aβ immunotherapy|aβ immunotherapy
5248387|NCT00633828|Bone Density|bone density
5248388|NCT00633828|Bone mass|bone mass
5248389|NCT00633828|Bone mineral density|bone mineral density
5248390|NCT00633828|Bone structure|bone structure
5248391|NCT00633828|Cardiovascular risk factors|cardiovascular risk factors
5248392|NCT00633828|Fat Mass|fat mass
5248393|NCT00633828|Adiposity|adiposity
5248394|NCT00633815|Supine|supine
5248395|NCT00633815|Upright|upright
5248396|NCT00633802|Risperidone|risperidone
5248397|NCT00633802|Borderlone Personality Disorder|borderlone personality disorder
5248398|NCT00633776|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5248399|NCT00633776|COPD|copd
5248400|NCT00633776|Chronic bronchitis|chronic bronchitis
5248401|NCT00633776|Emphysema|emphysema
5248402|NCT00633776|Perforomist|perforomist
5248403|NCT00633776|Foradil|foradil
5248404|NCT00633776|CT|ct
5248405|NCT00633776|lung function|lung function
5248406|NCT00633763|Diagnostic|diagnostic
5248407|NCT00633763|PET/CT imaging of pancreas|pet/ct imaging of pancreas
5248408|NCT00633763|Detecting pancreatic beta cell loss during diabetes|detecting pancreatic beta cell loss during diabetes
5248409|NCT00633750|stage I breast cancer|stage i breast cancer
5248410|NCT00633750|stage II breast cancer|stage ii breast cancer
5248411|NCT00633750|stage IIIA breast cancer|stage iiia breast cancer
5248412|NCT00633750|stage IIIB breast cancer|stage iiib breast cancer
5248413|NCT00633737|Psychology|psychology
5248414|NCT00633737|Laparoscopy|laparoscopy
5248415|NCT00633737|Cholecystectomy|cholecystectomy
5248416|NCT00633737|Psychoneuroimmunology|psychoneuroimmunology
5248417|NCT00633737|Wound healing|wound healing
5248418|NCT00633737|Preparation for surgery|preparation for surgery
5248419|NCT00633737|Stress reduction|stress reduction
5248420|NCT00633737|Stress|stress
5248421|NCT00633737|Relaxation|relaxation
5248422|NCT00633711|OSAS|osas
5248423|NCT00633711|blood pressure|blood pressure
5248424|NCT00633711|sympathetic nervous system|sympathetic nervous system
5248425|NCT00633711|treatment|treatment
5248426|NCT00633711|CPAP|cpap
5248427|NCT00633698|lipoprotein(a)|lipoprotein(a)
5248428|NCT00633698|niacin|niacin
5248429|NCT00633698|placebo|placebo
5248430|NCT00633698|intervention|intervention
5248431|NCT00633685|Posttraumatic Stress Disorder|posttraumatic stress disorder
5248432|NCT00633685|Fluoxetine|fluoxetine
5248433|NCT00633685|Factors predicting response|factors predicting response
5248435|NCT00633685|Pharmacologic augmentation strategies|pharmacologic augmentation strategies
5248436|NCT00633672|NSAID|nsaid
5248437|NCT00633672|Nexium|nexium
5248438|NCT00633672|esomeprazole|esomeprazole
5248439|NCT00633672|Gastric Ulcers|gastric ulcers
5248440|NCT00633659|Hemospan|hemospan
5248441|NCT00633659|Oxygen carriers|oxygen carriers
5248442|NCT00633659|Blood substitutes|blood substitutes
5248443|NCT00633659|Ischemia|ischemia
5248444|NCT00633659|Tissue oxygenation|tissue oxygenation
5248445|NCT00633646|nitrogen balance|nitrogen balance
5248446|NCT00633646|malnutrition|malnutrition
5248447|NCT00633646|chronic kidney disease|chronic kidney disease
5248448|NCT00633646|diet|diet
5248449|NCT00633646|glomerular filtration rate|glomerular filtration rate
5248450|NCT00633633|Heart Failure|heart failure
5248451|NCT00633633|Lifestyle Intervention|lifestyle intervention
5248452|NCT00633633|Exercise|exercise
5248453|NCT00633633|Diet|diet
5248454|NCT00633620|colonoscopy|colonoscopy
5248455|NCT00633620|narrow band imaging|narrow band imaging
5248456|NCT00633620|adenoma|adenoma
5248457|NCT00633620|diagnosis|diagnosis
5248458|NCT00633620|colonoscopic adenoma detection|colonoscopic adenoma detection
5248459|NCT00633594|Mantle Cell Lymphoma|mantle cell lymphoma
5248460|NCT00633594|Rituximab|rituximab
5248461|NCT00633594|Lenalidomide|lenalidomide
5248462|NCT00633594|Bortezomib|bortezomib
5248463|NCT00633594|Phase 1/2|phase 1/2
5248464|NCT00633581|fatigue|fatigue
5248465|NCT00633581|ascorbic acid|ascorbic acid
5248466|NCT00633581|oxidative stress|oxidative stress
5248467|NCT00633568|Non-small cell lung carcinoma|non-small cell lung carcinoma
5248468|NCT00633568|Concomitant radiochemotherapy|concomitant radiochemotherapy
5248469|NCT00633568|Cisplatin|cisplatin
5248470|NCT00633568|Docetaxel|docetaxel
5248471|NCT00633568|Radiotherapy|radiotherapy
5248472|NCT00633568|Chemotherapy|chemotherapy
5248473|NCT00633568|Unresectable stage III non-small cell lung carcinoma|unresectable stage iii non-small cell lung carcinoma
5248474|NCT00633542|thalidomide|thalidomide
5248475|NCT00633542|maintenance|maintenance
5248476|NCT00633542|interferon|interferon
5248477|NCT00633542|dexamethasone|dexamethasone
5248478|NCT00633542|newly diagnosed multiple myeloma|newly diagnosed multiple myeloma
5248479|NCT00633542|relapsed refractory multiple myeloma|relapsed refractory multiple myeloma
5248480|NCT00633529|Phase 1b|phase 1b
5248481|NCT00633529|Non-Small Cell Lung Cancer|non-small cell lung cancer
5248482|NCT00633529|Advanced or Metastatic Disease|advanced or metastatic disease
5248483|NCT00633529|Prior chemotherapy|prior chemotherapy
5248484|NCT00633516|moles|moles
5248485|NCT00633516|melanoma|melanoma
5248486|NCT00633503|free tissue transfer|free tissue transfer
5248487|NCT00633503|pedicle tissue transfer|pedicle tissue transfer
5248488|NCT00633503|complications|complications
5248489|NCT00633503|modulated imaging spectroscopy|modulated imaging spectroscopy
5248490|NCT00633503|observation|observation
5248491|NCT00633503|clinical observation/diagnosis|clinical observation/diagnosis
5248492|NCT00633503|tissue defects requiring free tissue transfer|tissue defects requiring free tissue transfer
5248493|NCT00633503|tissue defects requiring pedicle tissue transfer|tissue defects requiring pedicle tissue transfer
5248494|NCT00633490|Toxicity|toxicity
5248495|NCT00633490|Efficacy|efficacy
5248496|NCT00633477|Systemic Inflammatory Response Syndrome|systemic inflammatory response syndrome
5248497|NCT00633477|Septic Shock|septic shock
5248498|NCT00633477|Septicemia|septicemia
5248499|NCT00633477|Drug Therapy|drug therapy
5248500|NCT00633451|shoulder pain|shoulder pain
5248501|NCT00633451|shoulder impingement syndrome|shoulder impingement syndrome
5248502|NCT00633451|manual therapy|manual therapy
5248503|NCT00633451|rehabilitation|rehabilitation
5248504|NCT00633438|Knee Surgery Arthroscopic Surgery|knee surgery arthroscopic surgery
5248505|NCT00633412|NSAID|nsaid
5248506|NCT00633412|Nexium|nexium
5248507|NCT00633412|esomeprazole|esomeprazole
5248508|NCT00633412|Gastric Ulcers|gastric ulcers
5248509|NCT00633399|Major Depressive Disorder|major depressive disorder
5248510|NCT00633399|Major Depression|major depression
5248511|NCT00633399|Depression|depression
5248512|NCT00633399|Geodon|geodon
5248513|NCT00633399|Ziprasidone|ziprasidone
5248514|NCT00633399|SSRI Augmentation|ssri augmentation
5248515|NCT00633399|Treatment Resistant Depression|treatment resistant depression
5248516|NCT00633386|Knee Surgery|knee surgery
5248517|NCT00633386|Arthroscopic Surgery|arthroscopic surgery
5248518|NCT00633373|lung|lung
5248519|NCT00633373|transplant|transplant
5248520|NCT00633373|transplant rejection|transplant rejection
5248521|NCT00633373|Cyclosporine|cyclosporine
5248522|NCT00633373|bronchiolitis obliterans|bronchiolitis obliterans
5248523|NCT00633373|aerosol|aerosol
5248524|NCT00633360|Women|women
5248525|NCT00633360|PMS|pms
5248526|NCT00633360|Depression|depression
5248527|NCT00633347|oocyte donation|oocyte donation
5248528|NCT00633347|endometrial preparation|endometrial preparation
5248529|NCT00633334|Cancer|cancer
5248530|NCT00633334|GI|gi
5248531|NCT00633334|Tumor|tumor
5248532|NCT00633334|Gastrointestinal|gastrointestinal
5248533|NCT00633334|high risk|high risk
5248534|NCT00633321|smoking cessation|smoking cessation
5248535|NCT00633321|quit smoking|quit smoking
5248536|NCT00633321|smoking vaccine|smoking vaccine
5248537|NCT00633321|nicotine vaccine|nicotine vaccine
5248538|NCT00633321|TA-NIC|ta-nic
5248539|NCT00633321|Aid for smoking cessation in smokers motivated to quit|aid for smoking cessation in smokers motivated to quit
5248540|NCT00633308|hemodialysis|hemodialysis
5248541|NCT00633295|GIST|gist
5248542|NCT00633295|TKI|tki
5248543|NCT00633295|IMATINIB|imatinib
5248544|NCT00633295|NILOTINIB|nilotinib
5248545|NCT00633295|AMN107|amn107
5248546|NCT00633282|Nonalcoholic Fatty Liver Disease|nonalcoholic fatty liver disease
5248547|NCT00633282|Pioglitazone|pioglitazone
5248548|NCT00633282|Berberine|berberine
5248549|NCT00633282|Impaired Glucose Metabolism|impaired glucose metabolism
5248550|NCT00633269|Poly(ADP ribose) polymerases|poly(adp ribose) polymerases
5248551|NCT00633269|Metastatic Solid Tumours|metastatic solid tumours
5248552|NCT00633230|hepatitis C virus|hepatitis c virus
5248553|NCT00633230|complementary and alternative medicine|complementary and alternative medicine
5248554|NCT00633230|peginterferon alfa and ribavirin|peginterferon alfa and ribavirin
5248555|NCT00633217|DISKUS|diskus
5248556|NCT00633217|Salmeterol|salmeterol
5248557|NCT00633217|Fluticasone Propionate|fluticasone propionate
5248558|NCT00633217|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
5248559|NCT00633217|Hydroflouroalkane|hydroflouroalkane
5248560|NCT00633217|COPD|copd
5248561|NCT00633217|HFA MDI|hfa mdi
5248562|NCT00633204|Epitope peptide, CTL, TUR-Bt, Bladder cancer, Vaccination|epitope peptide, ctl, tur-bt, bladder cancer, vaccination
5248563|NCT00633204|Bladder cancer after surgery|bladder cancer after surgery
5248564|NCT00633191|Cystic fibrosis|cystic fibrosis
5248565|NCT00633191|Prevention|prevention
5248566|NCT00633191|Infection|infection
5248567|NCT00633191|Pseudomonas aeruginosa|pseudomonas aeruginosa
5248568|NCT00633191|Gargle|gargle
5248569|NCT00633178|Prenatal Depression|prenatal depression
5248570|NCT00633178|Postpartum Depression|postpartum depression
5248571|NCT00633178|Fetal Development|fetal development
5248572|NCT00633178|Interpersonal Therapy|interpersonal therapy
5248573|NCT00633165|sarcoma|sarcoma
5248574|NCT00633165|myxoid liposarcoma|myxoid liposarcoma
5248575|NCT00633152|complicated skin and skin structure infections|complicated skin and skin structure infections
5248576|NCT00633152|linezolid|linezolid
5248577|NCT00633152|ceftaroline|ceftaroline
5248578|NCT00633152|clinical response|clinical response
5248579|NCT00633152|microbiological response|microbiological response
5248580|NCT00633152|Cellulitis|cellulitis
5248581|NCT00633152|Abscess|abscess
5248582|NCT00633152|Wound infection|wound infection
5248583|NCT00633152|Deeper soft tissue|deeper soft tissue
5248584|NCT00633152|Significant surgical intervention|significant surgical intervention
5248585|NCT00633152|Gram-positive bacterial infection|gram-positive bacterial infection
5248586|NCT00633152|Gram-negative bacterial infection|gram-negative bacterial infection
5248587|NCT00633152|bacterial infection|bacterial infection
5248588|NCT00633152|cephalosporin|cephalosporin
5248589|NCT00633152|broad-spectrum activity|broad-spectrum activity
5248590|NCT00633139|Metazym|metazym
5248591|NCT00633139|Late infantile|late infantile
5248592|NCT00633139|Metachromatic leukodystrophy|metachromatic leukodystrophy
5248593|NCT00633139|Long-term safety|long-term safety
5248594|NCT00633126|PK|pk
5248595|NCT00633126|Pharmacokinetics|pharmacokinetics
5248596|NCT00633113|Total Knee Arthroplasty|total knee arthroplasty
5248597|NCT00633113|Minimally Invasive Knee Replacement|minimally invasive knee replacement
5248598|NCT00633113|Knee Osteoarthritis|knee osteoarthritis
5248599|NCT00633113|Cost effectiveness minimally invasive knee surgery|cost effectiveness minimally invasive knee surgery
5248600|NCT00633074|Influenza|influenza
5248601|NCT00633061|Childhood Cancer|childhood cancer
5248602|NCT00633061|Central Venous Catheter|central venous catheter
5248603|NCT00633061|Deep Vein Thrombosis|deep vein thrombosis
5248604|NCT00633061|Catheter-related Infection|catheter-related infection
5248605|NCT00633061|Catheter-related Occlusion|catheter-related occlusion
5248606|NCT00633048|ascending single-dose study|ascending single-dose study
5248607|NCT00633048|healthy subjects|healthy subjects
5248608|NCT00633035|ulcer|ulcer
5248609|NCT00633035|esomeprazole|esomeprazole
5248610|NCT00633035|famotidine|famotidine
5248611|NCT00633035|Neurosurgery|neurosurgery
5248612|NCT00633022|FDG-PET/CT, atherosclerosis|fdg-pet/ct, atherosclerosis
5248613|NCT00633009|Leishmaniasis|leishmaniasis
5248614|NCT00633009|Delayed-Type Hypersensitivity (DTH)|delayed-type hypersensitivity (dth)
5248615|NCT00633009|Skin Test|skin test
5248616|NCT00633009|Conversion|conversion
5248617|NCT00633009|Prior exposure to Leishmania major|prior exposure to leishmania major
5248618|NCT00632996|shoulder pain|shoulder pain
5248619|NCT00632996|shoulder impingement syndrome|shoulder impingement syndrome
5248620|NCT00632996|manual therapy|manual therapy
5248621|NCT00632996|rehabilitation|rehabilitation
5248622|NCT00632970|Raltegravir|raltegravir
5248623|NCT00632970|Lopinavir|lopinavir
5248624|NCT00632918|Image quality|image quality
5248625|NCT00632918|Dual-source CT|dual-source ct
5248626|NCT00632918|Coronary angiography|coronary angiography
5248627|NCT00632918|Heart rate|heart rate
5248628|NCT00632905|Prostate Cancer|prostate cancer
5248629|NCT00632905|Prostatic adenoma|prostatic adenoma
5248630|NCT00632905|Prostatic neoplasm|prostatic neoplasm
5248631|NCT00632892|oxidative stress markers in urine|oxidative stress markers in urine
5248632|NCT00632892|urine norepinephrine|urine norepinephrine
5248633|NCT00632892|renal tubular enzyme markers|renal tubular enzyme markers
5248634|NCT00632866|auto-immune diseases|auto-immune diseases
5248635|NCT00632866|hydroxychloroquine|hydroxychloroquine
5248636|NCT00632866|primary Sjögren's syndrome|primary sjögren's syndrome
5248637|NCT00632866|inflammatory arthritides|inflammatory arthritides
5248638|NCT00632866|inflammatory rheumatic diseases|inflammatory rheumatic diseases
5248639|NCT00632866|dryness|dryness
5248640|NCT00632866|joint diseases|joint diseases
5248641|NCT00632853|limited stage small cell lung cancer|limited stage small cell lung cancer
5248642|NCT00632814|Kogenate,|kogenate,
5248643|NCT00632814|Children,|children,
5248644|NCT00632814|Factor VIII,|factor viii,
5248645|NCT00632814|Hemophilia A,|hemophilia a,
5248646|NCT00632814|Prophylactic|prophylactic
5248647|NCT00632801|elective laparoscopic colectomy|elective laparoscopic colectomy
5248648|NCT00632801|chewing gum|chewing gum
5248649|NCT00632801|ileus|ileus
5248650|NCT00632801|post-operative care|post-operative care
5248651|NCT00632801|colectomy|colectomy
5248652|NCT00632788|myocardial infarction|myocardial infarction
5248653|NCT00632788|catheterization|catheterization
5248654|NCT00632788|angioplasty|angioplasty
5248655|NCT00632788|door-to-balloon time|door-to-balloon time
5248656|NCT00632775|pediatrics|pediatrics
5248657|NCT00632775|Hyponatremia|hyponatremia
5248658|NCT00632775|Sodium Chloride|sodium chloride
5248659|NCT00632775|maintenance fluids|maintenance fluids
5248660|NCT00632762|Amantadine benefit|amantadine benefit
5248661|NCT00632762|Dyskinesia|dyskinesia
5248662|NCT00632762|Parkinson's disease|parkinson's disease
5248663|NCT00632736|ropinirole XL|ropinirole xl
5248664|NCT00632736|REQUIP|requip
5248665|NCT00632736|Parkinson's disease|parkinson's disease
5248666|NCT00632736|long term safety|long term safety
5248667|NCT00632736|efficacy|efficacy
5248668|NCT00632736|safety|safety
5248669|NCT00632736|ropinirole CR|ropinirole cr
5248670|NCT00632736|ropinirole IR|ropinirole ir
5248671|NCT00632736|open-label|open-label
5248672|NCT00632723|oestrogen receptor|oestrogen receptor
5248673|NCT00632723|ER negative tumours|er negative tumours
5248674|NCT00632723|epidermal growth factor receptor (EGFR)|epidermal growth factor receptor (egfr)
5248675|NCT00632710|rheumatoid arthritis|rheumatoid arthritis
5248676|NCT00632710|hands|hands
5248677|NCT00632710|randomized controlled|randomized controlled
5248678|NCT00632710|low level laser|low level laser
5248679|NCT00632697|endometriosis|endometriosis
5248680|NCT00632697|immunomodulation|immunomodulation
5248681|NCT00632697|infertility|infertility
5248682|NCT00632697|laparoscopic surgery|laparoscopic surgery
5248683|NCT00632697|pentoxifylline|pentoxifylline
5248684|NCT00632684|Family Caregiving|family caregiving
5248685|NCT00632684|Dementia|dementia
5248686|NCT00632671|Obesity cohort|obesity cohort
5248687|NCT00632658|cGVHD|cgvhd
5248688|NCT00632645|Huntington|huntington
5248689|NCT00632645|Neuroleptic|neuroleptic
5248690|NCT00632645|Unified Huntington Disease Rating Scale (UHDRS)|unified huntington disease rating scale (uhdrs)
5248691|NCT00632645|Independence Scale|independence scale
5248692|NCT00632645|Neuroleptic Prescription required|neuroleptic prescription required
5248693|NCT00632632|World Trade Center Victims|world trade center victims
5248694|NCT00632632|Iraq War Veterans|iraq war veterans
5248695|NCT00632632|PTSD|ptsd
5248696|NCT00632619|Subthreshold Manic States in Children|subthreshold manic states in children
5248697|NCT00632619|ADHD|adhd
5248698|NCT00632606|pregnant women|pregnant women
5248699|NCT00632593|Early Complications of both techniques|early complications of both techniques
5248700|NCT00632593|Fistula rate|fistula rate
5248701|NCT00632593|Dehiscence rate|dehiscence rate
5248702|NCT00632593|reoperation rate and cause|reoperation rate and cause
5248703|NCT00632580|Pain, Postoperative|pain, postoperative
5248704|NCT00632567|Anal incontinence|anal incontinence
5248705|NCT00632567|First delivery was traumatic|first delivery was traumatic
5248706|NCT00632567|No anal incontinence|no anal incontinence
5248707|NCT00632528|MEOPA|meopa
5248708|NCT00632528|spasticity|spasticity
5248709|NCT00632528|multilevel surgery|multilevel surgery
5248710|NCT00632528|cerebral palsy|cerebral palsy
5248711|NCT00632528|children|children
5248712|NCT00632515|Colorectal Cancer|colorectal cancer
5248714|NCT00632515|Familial CRC|familial crc
5248715|NCT00632515|Cancer Screening|cancer screening
5248716|NCT00632515|Questionnaire|questionnaire
5248717|NCT00632515|First Degree Relatives|first degree relatives
5248718|NCT00632515|FDRs|fdrs
5248719|NCT00632515|Risk Communication|risk communication
5248720|NCT00632489|Refractory Malignancy|refractory malignancy
5248721|NCT00632489|Breast Cancer|breast cancer
5248722|NCT00632489|LBH589|lbh589
5248723|NCT00632489|Capecitabine|capecitabine
5248724|NCT00632489|Lapatinib|lapatinib
5248725|NCT00632476|Smoking During Pregnancy|smoking during pregnancy
5248726|NCT00632476|Vitamin C|vitamin c
5248727|NCT00632476|Newborn Lung Function|newborn lung function
5248728|NCT00632476|Ascorbic Acid|ascorbic acid
5248729|NCT00632463|Transplant|transplant
5248730|NCT00632463|Immunosuppression|immunosuppression
5248731|NCT00632437|Brain Tumor|brain tumor
5248732|NCT00632437|Craniotomy Surgery|craniotomy surgery
5248733|NCT00632437|Brain Function|brain function
5248734|NCT00632437|Intraoperative Optical Imaging|intraoperative optical imaging
5248735|NCT00632437|Speckle-Contrast Imaging|speckle-contrast imaging
5248736|NCT00632437|Cortical Mapping|cortical mapping
5248737|NCT00632437|Somatosensory Cortex|somatosensory cortex
5248738|NCT00632437|Cerebral blood flow|cerebral blood flow
5248739|NCT00632437|CBF|cbf
5248740|NCT00632437|Laser Speckle Contrast Imaging|laser speckle contrast imaging
5248741|NCT00632437|Multi-Spectral Imaging|multi-spectral imaging
5248742|NCT00632398|massage|massage
5248743|NCT00632398|oncology massage|oncology massage
5248744|NCT00632398|palliative care|palliative care
5248745|NCT00632398|supportive care|supportive care
5248746|NCT00632398|integrative oncology|integrative oncology
5248747|NCT00632398|informal caregiving|informal caregiving
5248748|NCT00632398|spouse caregiving|spouse caregiving
5248749|NCT00632398|family caregiving|family caregiving
5248750|NCT00632398|caregiver education|caregiver education
5248751|NCT00632398|psychosocial oncology|psychosocial oncology
5248752|NCT00632398|caregiver stress|caregiver stress
5248753|NCT00632398|coping with cancer|coping with cancer
5248754|NCT00632398|quality of life|quality of life
5248755|NCT00632398|end of life care|end of life care
5248756|NCT00632359|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
5248757|NCT00632359|CLL|cll
5248758|NCT00632359|Lenalidomide|lenalidomide
5248759|NCT00632359|Revlimid|revlimid
5248760|NCT00632346|childhood abuse|childhood abuse
5248761|NCT00632346|overweight|overweight
5248762|NCT00632346|obesity|obesity
5248763|NCT00632346|BMI as a young adult|bmi as a young adult
5248764|NCT00632346|childhood physical abuse|childhood physical abuse
5248765|NCT00632346|childhood emotional abuse|childhood emotional abuse
5248766|NCT00632346|childhood sexual abuse|childhood sexual abuse
5248767|NCT00632346|childhood physical neglect|childhood physical neglect
5248768|NCT00632346|childhood emotional neglect|childhood emotional neglect
5248769|NCT00632346|childhood witnessing of domestic violence|childhood witnessing of domestic violence
5248770|NCT00632346|parental marital discord|parental marital discord
5248771|NCT00632346|household members with substance abuse|household members with substance abuse
5248772|NCT00632346|household members with mental illness|household members with mental illness
5248773|NCT00632346|household members with criminal behavior|household members with criminal behavior
5248774|NCT00632346|cumulative adverse childhood experiences|cumulative adverse childhood experiences
5248775|NCT00632333|Epitope peptide|epitope peptide
5248776|NCT00632333|Vaccination|vaccination
5248777|NCT00632333|Chemoradiation|chemoradiation
5248778|NCT00632333|Esophageal cancer|esophageal cancer
5248779|NCT00632320|Ventilator, mechanical|ventilator, mechanical
5248780|NCT00632320|Ventilator weaning|ventilator weaning
5248781|NCT00632320|Rapid shallow breathing index|rapid shallow breathing index
5248782|NCT00632320|Continuous positive airway pressure|continuous positive airway pressure
5248783|NCT00632320|Receiver operating characteristic curve|receiver operating characteristic curve
5248784|NCT00632320|COPD|copd
5248785|NCT00632307|lung tumor|lung tumor
5248786|NCT00632307|pleural tumor|pleural tumor
5248787|NCT00632307|interstitial lung disease|interstitial lung disease
5248788|NCT00632307|airway infection|airway infection
5248789|NCT00632307|COPD|copd
5248790|NCT00632307|sleep apnea|sleep apnea
5248791|NCT00632307|ion mobility spectrometry|ion mobility spectrometry
5248792|NCT00632307|breath analysis|breath analysis
5248793|NCT00632294|Bone Cancer|bone cancer
5248794|NCT00632294|Allograft Retrieval|allograft retrieval
5248795|NCT00632294|Allograft Bone|allograft bone
5248796|NCT00632294|Bone Mineral Density|bone mineral density
5248797|NCT00632268|mTOR inhibitor|mtor inhibitor
5248798|NCT00632268|RAD001|rad001
5248799|NCT00632268|everolimus|everolimus
5248800|NCT00632268|chemotherapy|chemotherapy
5248801|NCT00632268|cisplatin|cisplatin
5248802|NCT00632268|high-dose 5-FU|high-dose 5-fu
5248803|NCT00632255|Chronic Myeloid Leukemia|chronic myeloid leukemia
5248804|NCT00632255|Long term Imatinib therapy compliance|long term imatinib therapy compliance
5248805|NCT00632255|Newly diagnosed|newly diagnosed
5248806|NCT00632255|Late side effects|late side effects
5248807|NCT00632229|Obsessive-Compulsive Disorder; Adults; Medication; Treatment|obsessive-compulsive disorder; adults; medication; treatment
5248808|NCT00632190|cervical cancer|cervical cancer
5248809|NCT00632190|cervical intraepithelial neoplasia grade 1|cervical intraepithelial neoplasia grade 1
5248810|NCT00632190|cervical intraepithelial neoplasia grade 2|cervical intraepithelial neoplasia grade 2
5248811|NCT00632190|cervical intraepithelial neoplasia grade 3|cervical intraepithelial neoplasia grade 3
5248812|NCT00632138|sexual dysfunction|sexual dysfunction
5248813|NCT00632138|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
5248814|NCT00632138|prostate cancer|prostate cancer
5248815|NCT00632138|benign prostatic hyperplasia|benign prostatic hyperplasia
5248816|NCT00632138|urinary incontinence|urinary incontinence
5248817|NCT00632125|CKD subjects with or without dialysis treatment|ckd subjects with or without dialysis treatment
5248818|NCT00632112|large volume nebulizer|large volume nebulizer
5248819|NCT00632099|cocaine|cocaine
5248821|NCT00632099|progesterone|progesterone
5248823|NCT00632073|HIV Infections|hiv infections
5248824|NCT00632073|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5248825|NCT00632073|treatment experienced|treatment experienced
5248826|NCT00632060|Low Back Pain|low back pain
5248827|NCT00632060|Manual / Manipulative Therapy|manual / manipulative therapy
5248828|NCT00632047|breast cancer|breast cancer
5248829|NCT00632047|cervical cancer|cervical cancer
5248830|NCT00632034|fracture|fracture
5248831|NCT00632034|tibia|tibia
5248832|NCT00632034|stem cell|stem cell
5248833|NCT00632021|Low Health Literacy|low health literacy
5248834|NCT00632021|Medication Errors|medication errors
5248835|NCT00632021|Cardiovascular Disease|cardiovascular disease
5248836|NCT00632021|Pharmacist|pharmacist
5248837|NCT00632021|Care Transition|care transition
5248838|NCT00631995|Neisseria meningitidis|neisseria meningitidis
5248839|NCT00631982|in vitro maturation oocytes|in vitro maturation oocytes
5248840|NCT00631969|Erectile Dysfunction|erectile dysfunction
5248841|NCT00631917|Hypertension, aliskiren, ramipril, colonoscopy|hypertension, aliskiren, ramipril, colonoscopy
5248842|NCT00631904|Pacemaker|pacemaker
5248843|NCT00631878|Staphylococcal|staphylococcal
5248844|NCT00631878|Monoclonal antibodies|monoclonal antibodies
5248845|NCT00631878|Very Low Birth Weight Infants|very low birth weight infants
5248846|NCT00631878|Prophylaxis|prophylaxis
5248847|NCT00631865|melanocytes|melanocytes
5248848|NCT00631852|Breast Cancer, Biomarkers, Ginseng Root|breast cancer, biomarkers, ginseng root
5248849|NCT00631839|Thoracic Neoplasms|thoracic neoplasms
5248850|NCT00631839|Platinum-based chemotherapy|platinum-based chemotherapy
5248851|NCT00631839|3-D Conformal Radiotherapy|3-d conformal radiotherapy
5248852|NCT00631839|Chemo-radiotherapy induced lung injury|chemo-radiotherapy induced lung injury
5248853|NCT00631839|Chemo-radiotherapy induced esophagus injury|chemo-radiotherapy induced esophagus injury
5248854|NCT00631826|Shoulder|shoulder
5248855|NCT00631826|Injuries|injuries
5248856|NCT00631826|Flexiblity|flexiblity
5248857|NCT00631826|Rotational resistance|rotational resistance
5248858|NCT00631800|Staphylococcal|staphylococcal
5248859|NCT00631800|Monoclonal antibodies|monoclonal antibodies
5248860|NCT00631800|Very Low Birth Weight Infants|very low birth weight infants
5248861|NCT00631800|Prophylaxis|prophylaxis
5248862|NCT00631787|Nitric Oxide|nitric oxide
5248863|NCT00631787|Hemolysis|hemolysis
5248864|NCT00631787|Plasma Hemoglobin|plasma hemoglobin
5248865|NCT00631787|Dimethyl Sulfoxide|dimethyl sulfoxide
5248866|NCT00631787|Organ Dysfuntion|organ dysfuntion
5248867|NCT00631787|Healthy Volunteer|healthy volunteer
5248868|NCT00631787|HV|hv
5248869|NCT00631774|type 2 diabetes|type 2 diabetes
5248870|NCT00631774|meal replacement|meal replacement
5248871|NCT00631774|postprandial response|postprandial response
5248872|NCT00631774|Glucerna SR|glucerna sr
5248873|NCT00631761|urethrocystoscopy|urethrocystoscopy
5248874|NCT00631761|cystoscopy|cystoscopy
5248875|NCT00631761|objective structured assessment of surgical skills (OSATS)|objective structured assessment of surgical skills (osats)
5248876|NCT00631748|cocaine|cocaine
5248877|NCT00631748|quetiapine fumarate|quetiapine fumarate
5248878|NCT00631748|dependence|dependence
5248879|NCT00631748|abuse|abuse
5248880|NCT00631748|addiction|addiction
5248881|NCT00631748|treatment|treatment
5248882|NCT00631735|cancer|cancer
5248883|NCT00631735|qualitative|qualitative
5248884|NCT00631722|PANSS|panss
5248885|NCT00631722|Acute Episode of Schizophrenia|acute episode of schizophrenia
5248886|NCT00631696|Healthy males Human volunteers pregabalin or placebo sperm quality and quantity|healthy males human volunteers pregabalin or placebo sperm quality and quantity
5248887|NCT00631657|placebo controlled|placebo controlled
5248888|NCT00631657|randomized|randomized
5248889|NCT00631657|double blind|double blind
5248890|NCT00631644|Adolescents|adolescents
5248891|NCT00631644|Eating Behavior|eating behavior
5248892|NCT00631644|Eating in the Absence of Hunger|eating in the absence of hunger
5248893|NCT00631644|Disordered Eating|disordered eating
5248894|NCT00631644|Food Intake|food intake
5248895|NCT00631644|Macronutrient Composition|macronutrient composition
5248896|NCT00631644|Obesity|obesity
5248897|NCT00631644|Adolescent|adolescent
5248898|NCT00631644|Healthy Volunteer|healthy volunteer
5248899|NCT00631644|HV|hv
5248900|NCT00631631|Drug Therapy|drug therapy
5248901|NCT00631605|eating disorders|eating disorders
5248902|NCT00631605|ghrelin|ghrelin
5248903|NCT00631605|leptin|leptin
5248904|NCT00631605|BIA|bia
5248905|NCT00631592|GSK1349572,|gsk1349572,
5248906|NCT00631592|healthy volunteers,|healthy volunteers,
5248907|NCT00631592|repeat dose,|repeat dose,
5248908|NCT00631592|relative bioavailability|relative bioavailability
5248909|NCT00631592|Healthy subjects|healthy subjects
5248910|NCT00631566|HIV|hiv
5248911|NCT00631566|Methicillin-resistant Staphylococcus aureus (MRSA)|methicillin-resistant staphylococcus aureus (mrsa)
5248912|NCT00631566|HIV and Staphylococcus aureus infection|hiv and staphylococcus aureus infection
5248913|NCT00631540|renal artery stenosis|renal artery stenosis
5248914|NCT00631540|hypertension|hypertension
5248915|NCT00631540|renovascular|renovascular
5248916|NCT00631540|renal artery blockage|renal artery blockage
5248917|NCT00631540|renal artery disease|renal artery disease
5248918|NCT00631540|renal arteries|renal arteries
5248919|NCT00631540|angioplasty renal artery|angioplasty renal artery
5248920|NCT00631540|renal artery stent|renal artery stent
5248921|NCT00631540|renal artery doppler|renal artery doppler
5248922|NCT00631540|renovascular hypertension|renovascular hypertension
5248923|NCT00631540|kidney stenosis|kidney stenosis
5248924|NCT00631540|renal artery|renal artery
5248925|NCT00631540|stent|stent
5248926|NCT00631540|stenting|stenting
5248927|NCT00631540|kidney disease|kidney disease
5248928|NCT00631540|renal failure|renal failure
5248929|NCT00631540|atherosclerosis|atherosclerosis
5248930|NCT00631540|arterial hypertension|arterial hypertension
5248931|NCT00631540|stenosis|stenosis
5248932|NCT00631527|Prostate Cancer|prostate cancer
5248933|NCT00631527|Radiation Therapy|radiation therapy
5248934|NCT00631527|RT|rt
5248935|NCT00631527|Radiotherapy|radiotherapy
5248936|NCT00631527|Hormone Ablation|hormone ablation
5248937|NCT00631527|Sunitinib Malate|sunitinib malate
5248938|NCT00631527|Leuprolide|leuprolide
5248939|NCT00631527|Lupron|lupron
5248940|NCT00631527|Zoladex|zoladex
5248941|NCT00631527|Goserelin|goserelin
5248942|NCT00631527|Casodex|casodex
5248943|NCT00631527|Bicalutamide|bicalutamide
5248944|NCT00631527|SU011248|su011248
5248945|NCT00631527|Sutent|sutent
5248946|NCT00631527|Angiogenesis inhibitor|angiogenesis inhibitor
5248947|NCT00631514|antihypertensive drugs|antihypertensive drugs
5248948|NCT00631514|non-steroidal anti-inflammatory drugs|non-steroidal anti-inflammatory drugs
5248949|NCT00631514|interaction|interaction
5248950|NCT00631514|family practice|family practice
5248951|NCT00631514|arterial blood pressure|arterial blood pressure
5248952|NCT00631501|tendinopathy|tendinopathy
5248953|NCT00631501|tennis elbow|tennis elbow
5248954|NCT00631501|lateral epicondylitis|lateral epicondylitis
5248955|NCT00631501|lateral epicondylalgia|lateral epicondylalgia
5248956|NCT00631501|MMP-inhibitor|mmp-inhibitor
5248957|NCT00631475|Actelion|actelion
5248958|NCT00631475|Idiopathic Pulmonary Fibrosis|idiopathic pulmonary fibrosis
5248959|NCT00631475|bosentan|bosentan
5248960|NCT00631475|Tracleer|tracleer
5248961|NCT00631475|Interstitial Lung Disease|interstitial lung disease
5248962|NCT00631475|BUILD 3 (NCT00391443)|build 3 (nct00391443)
5248963|NCT00631462|primary myelofibrosis|primary myelofibrosis
5248964|NCT00631462|post-polycythemia vera myelofibrosis|post-polycythemia vera myelofibrosis
5248965|NCT00631462|post-essential thrombocythemia myelofibrosis|post-essential thrombocythemia myelofibrosis
5248966|NCT00631449|HIV|hiv
5248967|NCT00631449|Treatment intensification|treatment intensification
5248968|NCT00631449|Low level viremia|low level viremia
5248969|NCT00631449|Suboptimal CD4+ T cell response|suboptimal cd4+ t cell response
5248970|NCT00631449|treatment experienced|treatment experienced
5248971|NCT00631436|Diffusion Tensor Imaging|diffusion tensor imaging
5248972|NCT00631436|Electroencephalography|electroencephalography
5248973|NCT00631436|Blast Injury|blast injury
5248974|NCT00631436|Traumatic Brain Injury|traumatic brain injury
5248975|NCT00631410|Phase 1|phase 1
5248976|NCT00631410|CRC|crc
5248977|NCT00631410|SU011248|su011248
5248978|NCT00631410|Sunitinib|sunitinib
5248979|NCT00631410|FOLFOX|folfox
5248980|NCT00631410|Colorectal cancer|colorectal cancer
5248981|NCT00631410|metastatic carcinoma of the colon or rectum|metastatic carcinoma of the colon or rectum
5248982|NCT00631397|weakening of the bones|weakening of the bones
5248983|NCT00631384|Voluntary Counseling and Testing|voluntary counseling and testing
5248984|NCT00631384|HIV|hiv
5248985|NCT00631384|HIV seronegativity|hiv seronegativity
5248986|NCT00631371|temsirolimus|temsirolimus
5248987|NCT00631371|renal cell carcinoma|renal cell carcinoma
5248988|NCT00631371|kidney cancer|kidney cancer
5248989|NCT00631371|urogenital cancer|urogenital cancer
5248990|NCT00631358|Ocular inflammation|ocular inflammation
5248991|NCT00631345|prediabetes|prediabetes
5248992|NCT00631345|overweight|overweight
5248993|NCT00631345|obesity|obesity
5248994|NCT00631345|metabolic syndrome|metabolic syndrome
5248995|NCT00631345|community health worker|community health worker
5248996|NCT00631332|women, dementia, cognition.|women, dementia, cognition.
5248997|NCT00631332|non-demented women at least age 65|non-demented women at least age 65
5248998|NCT00631319|OA|oa
5248999|NCT00631319|Chronic Pain|chronic pain
5249000|NCT00631319|Osteoarthritis|osteoarthritis
5249001|NCT00631319|OA Pain|oa pain
5249002|NCT00631319|Osteoarthritis Pain|osteoarthritis pain
5249003|NCT00631319|Pain|pain
5249004|NCT00631319|Hip Pain|hip pain
5249005|NCT00631319|Knee Pain|knee pain
5249006|NCT00631319|Joint Pain|joint pain
5249007|NCT00631293|Healthy volunteers|healthy volunteers
5249008|NCT00631280|Decision Aid|decision aid
5249009|NCT00631280|Informed Choice|informed choice
5249010|NCT00631280|Adherence|adherence
5249011|NCT00631267|reduction|reduction
5249012|NCT00631267|satisfaction|satisfaction
5249013|NCT00631267|visual-analog scale|visual-analog scale
5249014|NCT00631267|complications|complications
5249015|NCT00631267|functional outcome|functional outcome
5249016|NCT00631267|radiological outcome|radiological outcome
5249017|NCT00631241|Cervical Cancer|cervical cancer
5249018|NCT00631241|Parametrial Lymph Nodes|parametrial lymph nodes
5249019|NCT00631241|Sentinel Nodes|sentinel nodes
5249020|NCT00631241|Intraoperative Lymphatic Mapping|intraoperative lymphatic mapping
5249021|NCT00631241|Single Photon Emission Computed Tomography|single photon emission computed tomography
5249022|NCT00631241|SPECT/CT|spect/ct
5249023|NCT00631228|drug eluting stents|drug eluting stents
5249024|NCT00631228|stents|stents
5249025|NCT00631228|Angioplasty|angioplasty
5249026|NCT00631228|coronary artery disease|coronary artery disease
5249027|NCT00631228|total coronary occlusion|total coronary occlusion
5249028|NCT00631228|coronary artery restenosis|coronary artery restenosis
5249029|NCT00631228|stent thrombosis|stent thrombosis
5249030|NCT00631228|vascular disease|vascular disease
5249031|NCT00631228|myocardial ischemia|myocardial ischemia
5249032|NCT00631228|coronary artery stenosis|coronary artery stenosis
5249033|NCT00631215|Hyperbaric|hyperbaric
5249034|NCT00631215|Oxygen|oxygen
5249035|NCT00631215|autism|autism
5249036|NCT00631202|FRDA|frda
5249037|NCT00631202|Erythropoietin|erythropoietin
5249038|NCT00631202|Epoetin alfa|epoetin alfa
5249039|NCT00631189|dyslipidemia|dyslipidemia
5249040|NCT00631176|oral intubation|oral intubation
5249041|NCT00631176|just in time|just in time
5249042|NCT00631176|simulation education|simulation education
5249043|NCT00631176|high fidelity training|high fidelity training
5249044|NCT00631176|intubation training|intubation training
5249045|NCT00631176|intubation success|intubation success
5249046|NCT00631163|Iron Overload,|iron overload,
5249047|NCT00631163|Chelation,|chelation,
5249048|NCT00631163|MDS,|mds,
5249049|NCT00631163|Chronic Anemia,|chronic anemia,
5249050|NCT00631163|Deferasirox,|deferasirox,
5249051|NCT00631163|Transfusional hemosiderosis,|transfusional hemosiderosis,
5249052|NCT00631150|Levetiracetam|levetiracetam
5249053|NCT00631150|Keppra|keppra
5249054|NCT00631137|musculoskeletal complications|musculoskeletal complications
5249055|NCT00631137|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5249056|NCT00631137|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
5249057|NCT00631137|adult giant cell glioblastoma|adult giant cell glioblastoma
5249058|NCT00631137|adult glioblastoma|adult glioblastoma
5249059|NCT00631137|adult gliosarcoma|adult gliosarcoma
5249060|NCT00631124|Contraception|contraception
5249061|NCT00631111|dental pain|dental pain
5249062|NCT00631111|analgesic|analgesic
5249063|NCT00631111|NSAID|nsaid
5249064|NCT00631111|ibuprofen|ibuprofen
5249065|NCT00631111|aspirin|aspirin
5249066|NCT00631098|Resuscitation|resuscitation
5249067|NCT00631098|venous cannulation|venous cannulation
5249068|NCT00631098|external jugular vein|external jugular vein
5249069|NCT00631098|cubital vein|cubital vein
5249070|NCT00631085|healthy nonsmoking nonasthmatic volunteers|healthy nonsmoking nonasthmatic volunteers
5249071|NCT00631072|iNKT|inkt
5249072|NCT00631072|in vitro autologous iNKT|in vitro autologous inkt
5249073|NCT00631059|Hitachi|hitachi
5249074|NCT00631059|Leukemia|leukemia
5249075|NCT00631059|Relapse|relapse
5249076|NCT00631059|Chemotherapy Resistance|chemotherapy resistance
5249077|NCT00631046|n-3 LCPUFA|n-3 lcpufa
5249078|NCT00631046|Fish oil|fish oil
5249079|NCT00631046|essential fatty acids|essential fatty acids
5249080|NCT00631046|infant growth|infant growth
5249081|NCT00631046|obesity|obesity
5249082|NCT00631046|Intestinal microbiota|intestinal microbiota
5249083|NCT00631033|obesity|obesity
5249084|NCT00631033|hyperinsulinism|hyperinsulinism
5249085|NCT00631033|diazoxide|diazoxide
5249086|NCT00631033|metformin|metformin
5249087|NCT00631020|Youth|youth
5249088|NCT00631020|Smoking|smoking
5249089|NCT00631020|Tobacco|tobacco
5249090|NCT00631020|Adolescent|adolescent
5249091|NCT00631020|Dependence|dependence
5249092|NCT00631020|Teen smoking|teen smoking
5249093|NCT00631020|Smoking and youth|smoking and youth
5249094|NCT00631020|Youth and tobacco|youth and tobacco
5249095|NCT00631007|Type 2 diabetes|type 2 diabetes
5249096|NCT00631007|diabetes|diabetes
5249097|NCT00631007|diabetes mellitus|diabetes mellitus
5249098|NCT00631007|diabetes mellitus, type 2|diabetes mellitus, type 2
5249099|NCT00631007|non-TZD|non-tzd
5249100|NCT00631007|thiazolidinedione|thiazolidinedione
5249101|NCT00631007|selective peroxisome proliferator-activated receptor gamma modulator|selective peroxisome proliferator-activated receptor gamma modulator
5249102|NCT00631007|SPPARM|spparm
5249103|NCT00631007|peroxisome proliferator-activated receptor gamma|peroxisome proliferator-activated receptor gamma
5249104|NCT00631007|PPAR gamma|ppar gamma
5249105|NCT00631007|insulin sensitizer|insulin sensitizer
5249106|NCT00631007|glucose control|glucose control
5249107|NCT00631007|endocrinopathy|endocrinopathy
5249108|NCT00631007|hypoglycemic agent|hypoglycemic agent
5249109|NCT00631007|sulfonylurea|sulfonylurea
5249110|NCT00631007|metformin|metformin
5249111|NCT00631007|pioglitazone|pioglitazone
5249112|NCT00631007|nutritional and metabolic diseases|nutritional and metabolic diseases
5249113|NCT00630994|primary myelofibrosis|primary myelofibrosis
5249114|NCT00630994|secondary myelofibrosis|secondary myelofibrosis
5249115|NCT00630994|essential thrombocythemia|essential thrombocythemia
5249116|NCT00630994|polycythemia vera|polycythemia vera
5249117|NCT00630981|dissociative disorders|dissociative disorders
5249118|NCT00630968|Levetiracetam|levetiracetam
5249119|NCT00630968|Keppra|keppra
5249120|NCT00630955|Alcohol Drinking|alcohol drinking
5249121|NCT00630955|Memantine|memantine
5249122|NCT00630942|PSC|psc
5249123|NCT00630916|Aortic valve insufficiency|aortic valve insufficiency
5249124|NCT00630916|Aortic valve|aortic valve
5249125|NCT00630916|Aortic disease|aortic disease
5249126|NCT00630916|Aortic incompetence|aortic incompetence
5249127|NCT00630890|Hilar Cholangiocarcinoma (Klatskin Tumor)|hilar cholangiocarcinoma (klatskin tumor)
5249128|NCT00630890|External Beam Radiation|external beam radiation
5249129|NCT00630890|Cyberknife|cyberknife
5249130|NCT00630890|Capecitabine|capecitabine
5249131|NCT00630864|Transthyretin, TTR, amyloidosis, TTR amyloidosis, polyneuropathy|transthyretin, ttr, amyloidosis, ttr amyloidosis, polyneuropathy
5249132|NCT00630838|Hirschsprung disease|hirschsprung disease
5249133|NCT00630838|enterocolitis|enterocolitis
5249134|NCT00630838|probiotics|probiotics
5249135|NCT00630812|cystic fibrosis|cystic fibrosis
5249136|NCT00630812|mannitol|mannitol
5249137|NCT00630812|mucoactive|mucoactive
5249138|NCT00630799|prostate|prostate
5249139|NCT00630799|cancer|cancer
5249140|NCT00630773|CPR|cpr
5249141|NCT00630773|compression sensor|compression sensor
5249142|NCT00630773|chest compression adjuncts|chest compression adjuncts
5249143|NCT00630747|Hunter syndrome|hunter syndrome
5249144|NCT00630747|hunters syndrome|hunters syndrome
5249145|NCT00630747|hunter's syndrome|hunter's syndrome
5249146|NCT00630747|hunter disease|hunter disease
5249147|NCT00630747|hunters disease|hunters disease
5249148|NCT00630747|hunter's disease|hunter's disease
5249149|NCT00630747|MPS II|mps ii
5249150|NCT00630747|MPSII|mpsii
5249151|NCT00630747|MPS2|mps2
5249152|NCT00630747|MPS 2|mps 2
5249153|NCT00630747|mucopolysaccharides|mucopolysaccharides
5249154|NCT00630747|lysosomal storage disease|lysosomal storage disease
5249155|NCT00630747|lysosomal storage disorder|lysosomal storage disorder
5249156|NCT00630747|chronic ear infection|chronic ear infection
5249157|NCT00630747|enlarged adenoids|enlarged adenoids
5249158|NCT00630747|mps symptoms|mps symptoms
5249159|NCT00630747|mps diagnosis|mps diagnosis
5249160|NCT00630747|mps ii therapy|mps ii therapy
5249161|NCT00630747|MPS II treatment|mps ii treatment
5249162|NCT00630747|ert treatment|ert treatment
5249163|NCT00630747|elaprase|elaprase
5249164|NCT00630747|idursulfase|idursulfase
5249165|NCT00630747|iduronate sulfatase|iduronate sulfatase
5249166|NCT00630747|iduronate 2 sulfatase|iduronate 2 sulfatase
5249167|NCT00630747|enzyme replacement therapy|enzyme replacement therapy
5249168|NCT00630747|hunter syndrome treatment|hunter syndrome treatment
5249169|NCT00630747|hunter's syndrome treatment|hunter's syndrome treatment
5249170|NCT00630747|hunter syndrome therapy|hunter syndrome therapy
5249171|NCT00630747|hunter's disease treatment|hunter's disease treatment
5249172|NCT00630747|mps society|mps society
5249173|NCT00630734|HIV|hiv
5249174|NCT00630734|Pravastatin|pravastatin
5249175|NCT00630734|Darunavir|darunavir
5249176|NCT00630734|Ritonavir|ritonavir
5249177|NCT00630734|Genetic|genetic
5249178|NCT00630708|Renal insufficiency|renal insufficiency
5249179|NCT00630708|Benazepril|benazepril
5249180|NCT00630708|Losartan|losartan
5249181|NCT00630708|combination treatment|combination treatment
5249182|NCT00630708|Safety|safety
5249183|NCT00630695|Axillary lymphocele breast cancer|axillary lymphocele breast cancer
5249184|NCT00630682|Methamphetamine|methamphetamine
5249185|NCT00630682|Drug Abuse|drug abuse
5249186|NCT00630682|Drug Treatment|drug treatment
5249187|NCT00630682|Addiction|addiction
5249188|NCT00630682|Meth|meth
5249189|NCT00630682|Treatment for Methamphetamine Dependence|treatment for methamphetamine dependence
5249190|NCT00630669|Internal hemorrhoids|internal hemorrhoids
5249191|NCT00630669|Rubber band ligation|rubber band ligation
5249192|NCT00630669|Bipolar coagulation|bipolar coagulation
5249193|NCT00630656|sepsis|sepsis
5249194|NCT00630656|talactoferrin|talactoferrin
5249195|NCT00630656|lactoferrin|lactoferrin
5249196|NCT00630656|recombinant human lactoferrin|recombinant human lactoferrin
5249197|NCT00630630|Levetiracetam|levetiracetam
5249198|NCT00630630|Keppra|keppra
5249199|NCT00630617|Obesity|obesity
5249200|NCT00630617|Prevention|prevention
5249201|NCT00630617|Childhood|childhood
5249202|NCT00630617|Children|children
5249203|NCT00630617|Primary care-giver|primary care-giver
5249204|NCT00630604|ultrasonography|ultrasonography
5249205|NCT00630604|knee|knee
5249206|NCT00630604|early degeneration|early degeneration
5249207|NCT00630604|cartilage|cartilage
5249208|NCT00630591|Daughters And MothErS Against Breast Cancer|daughters and mothers against breast cancer
5249209|NCT00630591|DAMES|dames
5249210|NCT00630591|Breast Cancer|breast cancer
5249211|NCT00630591|Weight Loss|weight loss
5249212|NCT00630591|Home-based weight loss|home-based weight loss
5249213|NCT00630591|Quality of Life|quality of life
5249214|NCT00630591|Diet|diet
5249215|NCT00630591|Exercise|exercise
5249216|NCT00630591|Daughter|daughter
5249217|NCT00630591|Mother|mother
5249218|NCT00630591|Cancer Prevention|cancer prevention
5249219|NCT00630591|Prevention|prevention
5249220|NCT00630578|PTSD|ptsd
5249221|NCT00630578|Posttraumatic Stress Disorder|posttraumatic stress disorder
5249222|NCT00630578|Physical Assault|physical assault
5249223|NCT00630578|Physical Abuse|physical abuse
5249224|NCT00630578|Sexual Assault|sexual assault
5249225|NCT00630578|Sexual Abuse|sexual abuse
5249226|NCT00630578|Interpersonal Assault|interpersonal assault
5249227|NCT00630578|Cognitive Processing Therapy|cognitive processing therapy
5249228|NCT00630565|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5249229|NCT00630565|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5249230|NCT00630565|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5249231|NCT00630565|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5249232|NCT00630565|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5249233|NCT00630565|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5249234|NCT00630565|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
5249235|NCT00630552|AMG 479|amg 479
5249236|NCT00630552|Gemcitabine|gemcitabine
5249237|NCT00630552|TR-2|tr-2
5249238|NCT00630552|IGF-1R|igf-1r
5249239|NCT00630552|AMG 655|amg 655
5249240|NCT00630552|Pancreatic cancer|pancreatic cancer
5249241|NCT00630552|Adenocarcinoma of the Pancreas|adenocarcinoma of the pancreas
5249242|NCT00630552|Metastatic Pancreatic Cancer|metastatic pancreatic cancer
5249243|NCT00630539|Menopausal symptoms|menopausal symptoms
5249244|NCT00630539|Urogenital atrophy|urogenital atrophy
5249245|NCT00630539|Vulvar and vaginal atrophy in postmenopausal women|vulvar and vaginal atrophy in postmenopausal women
5249246|NCT00630539|Vaginal atrophy|vaginal atrophy
5249247|NCT00630513|localized community acquired intra-abdominal infection (IAI)|localized community acquired intra-abdominal infection (iai)
5249248|NCT00630513|antibiotics|antibiotics
5249249|NCT00630513|localized peritonitis|localized peritonitis
5249250|NCT00630513|ertapenem|ertapenem
5249251|NCT00630500|Dementia associated with Parkinson's disease|dementia associated with parkinson's disease
5249252|NCT00630500|Dementia with Lewy bodies|dementia with lewy bodies
5249253|NCT00630500|Memantine|memantine
5249254|NCT00630500|Placebo-controlled|placebo-controlled
5249255|NCT00630500|Parallel group|parallel group
5249256|NCT00630474|sleep apnea, rhinitis|sleep apnea, rhinitis
5249257|NCT00630461|mild asthma, mild allergies|mild asthma, mild allergies
5249258|NCT00630435|Premarin®|premarin®
5249259|NCT00630422|Rett Syndrome|rett syndrome
5249260|NCT00630422|Selfcare|selfcare
5249261|NCT00630422|Mobility limitation|mobility limitation
5249262|NCT00630422|Interpersonal relations|interpersonal relations
5249263|NCT00630422|This study avaliated patients with Rett Syndrome|this study avaliated patients with rett syndrome
5249264|NCT00630409|Renal cell carcinoma|renal cell carcinoma
5249265|NCT00630409|Kidney Cancer|kidney cancer
5249266|NCT00630409|Gemcitabine|gemcitabine
5249267|NCT00630409|Doxil|doxil
5249268|NCT00630409|Chemotherapy|chemotherapy
5249269|NCT00630396|stroke|stroke
5249270|NCT00630396|ischemic|ischemic
5249271|NCT00630396|neuroprotection|neuroprotection
5249272|NCT00630396|minocycline|minocycline
5249273|NCT00630396|tissue plasminogen activator (tPA)|tissue plasminogen activator (tpa)
5249274|NCT00630396|biomarkers|biomarkers
5249275|NCT00630396|pharmacokinetics|pharmacokinetics
5249276|NCT00630396|antiapoptotic|antiapoptotic
5249277|NCT00630396|anti-inflammatory|anti-inflammatory
5249278|NCT00630396|treatment|treatment
5249279|NCT00630396|matrix metalloproteinase-9 (MMP-9)|matrix metalloproteinase-9 (mmp-9)
5249280|NCT00630396|thrombolysis|thrombolysis
5249281|NCT00630396|Minocycline to Improve Neurologic Outcome in Stroke (MINOS)|minocycline to improve neurologic outcome in stroke (minos)
5249282|NCT00630396|cerebrovascular stroke|cerebrovascular stroke
5249283|NCT00630396|cerebrovascular accident|cerebrovascular accident
5249284|NCT00630396|cerebral stroke|cerebral stroke
5249285|NCT00630396|cerebrovascular accident (CVA)|cerebrovascular accident (cva)
5249286|NCT00630383|Parasite|parasite
5249287|NCT00630383|Necator|necator
5249288|NCT00630383|immune regulation|immune regulation
5249289|NCT00630383|regulatory T cells|regulatory t cells
5249290|NCT00630383|foxp3|foxp3
5249291|NCT00630383|cytokines|cytokines
5249292|NCT00630383|multiple sclerosis|multiple sclerosis
5249293|NCT00630383|hygiene hypothesis|hygiene hypothesis
5249294|NCT00630357|Levetiracetam|levetiracetam
5249295|NCT00630357|Keppra|keppra
5249296|NCT00630344|RAD001|rad001
5249297|NCT00630344|bicalutamide|bicalutamide
5249298|NCT00630344|androgen independent prostate cancer|androgen independent prostate cancer
5249299|NCT00630331|Influenza|influenza
5249300|NCT00630331|Flu|flu
5249301|NCT00630331|Cell Culture-Derived|cell culture-derived
5249302|NCT00630331|Egg-Derived|egg-derived
5249303|NCT00630331|Healthy Adults|healthy adults
5249304|NCT00630331|Efficacy|efficacy
5249305|NCT00630331|Safety|safety
5249306|NCT00630331|Immunogenicity|immunogenicity
5249307|NCT00630331|Trivalent|trivalent
5249308|NCT00630331|Inactivated|inactivated
5249309|NCT00630331|Influenza-Like Illness|influenza-like illness
5249310|NCT00630331|Vaccination|vaccination
5249311|NCT00630318|MR scanning|mr scanning
5249312|NCT00630305|toric|toric
5249313|NCT00630305|endothelial bleb|endothelial bleb
5249314|NCT00630279|pancreatic exocrine insufficiency|pancreatic exocrine insufficiency
5250248|NCT00626678|Prednisone|prednisone
5249315|NCT00630279|chronic pancreatitis|chronic pancreatitis
5249316|NCT00630266|Heart failure|heart failure
5249317|NCT00630266|left ventricular dilation|left ventricular dilation
5249318|NCT00630266|mitral valve repair|mitral valve repair
5249319|NCT00630266|mitral valve replacement|mitral valve replacement
5249320|NCT00630253|Fanconi anemia|fanconi anemia
5249321|NCT00630240|epirubicin|epirubicin
5249322|NCT00630240|mitomycin C|mitomycin c
5249323|NCT00630240|cisplatin|cisplatin
5249324|NCT00630240|Hepatocellular carcinoma|hepatocellular carcinoma
5249325|NCT00630227|emphysema|emphysema
5249326|NCT00630227|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
5249327|NCT00630227|lung volume reduction|lung volume reduction
5249328|NCT00630214|Total thyroidectomy|total thyroidectomy
5249329|NCT00630214|CND|cnd
5249330|NCT00630214|hypocalcemia|hypocalcemia
5249331|NCT00630214|calcium|calcium
5249332|NCT00630214|vitamin D|vitamin d
5249333|NCT00630201|opioid dependence|opioid dependence
5249334|NCT00630201|opioid addiction|opioid addiction
5249335|NCT00630201|buprenorphine|buprenorphine
5249336|NCT00630201|methadone|methadone
5249337|NCT00630201|heroin|heroin
5249338|NCT00630201|implant|implant
5249339|NCT00630201|opioid withdrawal|opioid withdrawal
5249340|NCT00630201|opioid pain medication|opioid pain medication
5249341|NCT00630201|suboxone|suboxone
5249342|NCT00630188|prostate cancer screening|prostate cancer screening
5249343|NCT00630188|shared decision making|shared decision making
5249344|NCT00630188|prostate-specific antigen|prostate-specific antigen
5249345|NCT00630188|decision making|decision making
5249346|NCT00630188|physician-patient relations|physician-patient relations
5249347|NCT00630175|Insomnia|insomnia
5249348|NCT00630162|protozoa|protozoa
5249349|NCT00630162|Amoeba|amoeba
5249350|NCT00630149|Nasopharyngeal Neoplasms|nasopharyngeal neoplasms
5249351|NCT00630149|Pemetrexed|pemetrexed
5249352|NCT00630110|Non Small Cell Lung|non small cell lung
5249353|NCT00630097|methamphetamine addiction, meth dependence|methamphetamine addiction, meth dependence
5249354|NCT00630084|chronic hepatitis C|chronic hepatitis c
5249355|NCT00630084|sustained virological response|sustained virological response
5249356|NCT00630084|peginterferon|peginterferon
5249357|NCT00630084|ribavirin|ribavirin
5249358|NCT00630084|neoplasms|neoplasms
5249359|NCT00630071|Diagnostic Appendicitis|diagnostic appendicitis
5249360|NCT00630071|Procalcitonin|procalcitonin
5249361|NCT00630058|Chronic Hepatitis C|chronic hepatitis c
5249362|NCT00630058|Protease Inhibitor|protease inhibitor
5249363|NCT00630058|Telaprevir|telaprevir
5249364|NCT00630032|stage II breast cancer|stage ii breast cancer
5249365|NCT00630032|stage IIIA breast cancer|stage iiia breast cancer
5249366|NCT00630032|stage IIIB breast cancer|stage iiib breast cancer
5249367|NCT00630032|stage IIIC breast cancer|stage iiic breast cancer
5249368|NCT00630019|Aqueous humor penetration by anti-infectives|aqueous humor penetration by anti-infectives
5249369|NCT00629993|cervical cancer screening|cervical cancer screening
5249370|NCT00629993|medically underserved women|medically underserved women
5249371|NCT00629993|HPV vaccine|hpv vaccine
5249372|NCT00629967|chronic hepatitis C|chronic hepatitis c
5249373|NCT00629967|genotype 1|genotype 1
5249374|NCT00629967|rapid virological response|rapid virological response
5249375|NCT00629967|sustained virological response|sustained virological response
5249376|NCT00629967|peginterferon|peginterferon
5249377|NCT00629967|ribavirin|ribavirin
5249378|NCT00629967|treatment duration|treatment duration
5249379|NCT00629954|ABUJA HEART STUDY NIGERIA|abuja heart study nigeria
5249380|NCT00629954|CARDIOVASCULAR DISEASES|cardiovascular diseases
5249381|NCT00629928|NSAID, Nexium, esomeprazole, Gastric Ulcers|nsaid, nexium, esomeprazole, gastric ulcers
5249382|NCT00629915|Moyamoya|moyamoya
5249383|NCT00629915|stroke|stroke
5249384|NCT00629902|Heart valve prosthesis|heart valve prosthesis
5249385|NCT00629889|seizure|seizure
5249386|NCT00629889|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5249387|NCT00629889|adult diffuse astrocytoma|adult diffuse astrocytoma
5249388|NCT00629889|adult pineal gland astrocytoma|adult pineal gland astrocytoma
5249389|NCT00629889|adult glioblastoma|adult glioblastoma
5249390|NCT00629889|adult gliosarcoma|adult gliosarcoma
5249391|NCT00629889|adult giant cell glioblastoma|adult giant cell glioblastoma
5249392|NCT00629889|adult brain stem glioma|adult brain stem glioma
5249393|NCT00629889|adult ependymoblastoma|adult ependymoblastoma
5249394|NCT00629889|adult medulloblastoma|adult medulloblastoma
5249395|NCT00629889|adult supratentorial primitive neuroectodermal tumor (PNET)|adult supratentorial primitive neuroectodermal tumor (pnet)
5249396|NCT00629889|adult ependymoma|adult ependymoma
5249397|NCT00629889|adult anaplastic ependymoma|adult anaplastic ependymoma
5249398|NCT00629889|adult anaplastic meningioma|adult anaplastic meningioma
5249399|NCT00629889|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
5249400|NCT00629889|adult oligodendroglioma|adult oligodendroglioma
5249401|NCT00629889|adult pineoblastoma|adult pineoblastoma
5249402|NCT00629889|adult pineocytoma|adult pineocytoma
5249403|NCT00629889|adult mixed glioma|adult mixed glioma
5249404|NCT00629889|adult papillary meningioma|adult papillary meningioma
5249405|NCT00629889|recurrent adult brain tumor|recurrent adult brain tumor
5249406|NCT00629889|adult grade II meningioma|adult grade ii meningioma
5249407|NCT00629876|Chemotherapy|chemotherapy
5249408|NCT00629876|Drug Therapy|drug therapy
5249409|NCT00629863|stage I gastric cancer|stage i gastric cancer
5249410|NCT00629863|stage II gastric cancer|stage ii gastric cancer
5249411|NCT00629863|stage III gastric cancer|stage iii gastric cancer
5249412|NCT00629863|stage I esophageal cancer|stage i esophageal cancer
5249413|NCT00629863|stage II esophageal cancer|stage ii esophageal cancer
5249414|NCT00629863|stage III esophageal cancer|stage iii esophageal cancer
5249415|NCT00629850|spinal cord injury|spinal cord injury
5249416|NCT00629850|respiratory muscle training|respiratory muscle training
5249417|NCT00629850|sleep quality|sleep quality
5249418|NCT00629837|FVIII|fviii
5249419|NCT00629837|Long acting|long acting
5249420|NCT00629837|pk|pk
5249421|NCT00629824|chronic hepatitis C|chronic hepatitis c
5249422|NCT00629824|sustained virological response|sustained virological response
5249423|NCT00629824|rapid virological response|rapid virological response
5249424|NCT00629824|peginterferon|peginterferon
5249425|NCT00629824|ribavirin|ribavirin
5249426|NCT00629824|old age|old age
5249427|NCT00629811|Cicatrix|cicatrix
5249428|NCT00629811|Scar|scar
5249429|NCT00629811|TGFβ3|tgfβ3
5249430|NCT00629811|Avotermin|avotermin
5249431|NCT00629811|Juvista|juvista
5249432|NCT00629811|RN1001|rn1001
5249433|NCT00629798|Busulfan|busulfan
5249434|NCT00629798|Melphalan|melphalan
5249435|NCT00629798|Fludarabine|fludarabine
5249436|NCT00629798|08-008|08-008
5249437|NCT00629785|asthma|asthma
5249438|NCT00629785|pulmonary function tests|pulmonary function tests
5249439|NCT00629785|obesity|obesity
5249440|NCT00629772|Palmoplantar psoriasis|palmoplantar psoriasis
5249441|NCT00629772|Infliximab|infliximab
5249442|NCT00629759|Jennerex|jennerex
5249443|NCT00629759|unresectable liver tumors|unresectable liver tumors
5249444|NCT00629759|primary liver cancer|primary liver cancer
5249445|NCT00629759|metastatic liver cancer|metastatic liver cancer
5249446|NCT00629759|oncolytic virus|oncolytic virus
5249447|NCT00629759|vaccinia virus|vaccinia virus
5249448|NCT00629759|Pexa-Vec|pexa-vec
5249449|NCT00629746|Thyroid|thyroid
5249450|NCT00629746|RLN|rln
5249451|NCT00629746|EMG|emg
5249452|NCT00629733|pharmacokinetics|pharmacokinetics
5249453|NCT00629733|ultra low molecular weight heparin|ultra low molecular weight heparin
5249454|NCT00629720|elevated detrusor leak point pressure|elevated detrusor leak point pressure
5249455|NCT00629707|diabetic ketoacidosis|diabetic ketoacidosis
5249456|NCT00629707|DKA|dka
5249457|NCT00629707|cerebral edema|cerebral edema
5249458|NCT00629707|brain edema|brain edema
5249459|NCT00629694|adenoidectomy, myringotomy, tubes insertion, otitis media, adenoid hyperthophy|adenoidectomy, myringotomy, tubes insertion, otitis media, adenoid hyperthophy
5249460|NCT00629655|fMRI|fmri
5249461|NCT00629655|spinal cord|spinal cord
5249462|NCT00629655|human|human
5249463|NCT00629655|health|health
5249464|NCT00629655|cerebral infarction|cerebral infarction
5249465|NCT00629655|healthy|healthy
5249466|NCT00629642|Neurogenic bladder|neurogenic bladder
5249467|NCT00629642|Vesicare|vesicare
5249468|NCT00629629|Health Plan Implementation|health plan implementation
5249469|NCT00629629|Feeding and Eating Disorders of Childhood|feeding and eating disorders of childhood
5249470|NCT00629629|Breastfeeding|breastfeeding
5249471|NCT00629629|Complementary feeding|complementary feeding
5249472|NCT00629629|Morbidity|morbidity
5249473|NCT00629629|Anemia|anemia
5249474|NCT00629629|Public policy|public policy
5249475|NCT00629616|stage II breast cancer|stage ii breast cancer
5249476|NCT00629616|stage IIIA breast cancer|stage iiia breast cancer
5249477|NCT00629616|stage IIIB breast cancer|stage iiib breast cancer
5249478|NCT00629616|stage IIIC breast cancer|stage iiic breast cancer
5249479|NCT00629603|hepatitis C virus infection|hepatitis c virus infection
5249480|NCT00629603|chronic liver disease|chronic liver disease
5249481|NCT00629603|fibrosis-related cytokine|fibrosis-related cytokine
5249482|NCT00629577|cervical cancer|cervical cancer
5249483|NCT00629577|cervical intraepithelial neoplasia grade 1|cervical intraepithelial neoplasia grade 1
5249484|NCT00629577|cervical intraepithelial neoplasia grade 2|cervical intraepithelial neoplasia grade 2
5249485|NCT00629577|cervical intraepithelial neoplasia grade 3|cervical intraepithelial neoplasia grade 3
5249486|NCT00629564|Gastroesophageal Reflux Disease (GERD), esomeprazole, Nexium|gastroesophageal reflux disease (gerd), esomeprazole, nexium
5249487|NCT00629551|Major Depressive Disorder|major depressive disorder
5249488|NCT00629551|Depression|depression
5249489|NCT00629551|Major Depressive Episode|major depressive episode
5249490|NCT00629551|Antidepressant|antidepressant
5249491|NCT00629538|congestive heart failure|congestive heart failure
5249492|NCT00629538|thoracentesis|thoracentesis
5249493|NCT00629538|transudative pleural effusions|transudative pleural effusions
5249494|NCT00629512|NSAID, Nexium, esomeprazole, Gastric Ulcers|nsaid, nexium, esomeprazole, gastric ulcers
5249495|NCT00629499|Early Stage Breast Cancer|early stage breast cancer
5249496|NCT00629499|Her2-positive|her2-positive
5249497|NCT00629499|nab paclitaxel|nab paclitaxel
5249498|NCT00629499|cyclophosphamide|cyclophosphamide
5249499|NCT00629499|trastuzumab|trastuzumab
5249500|NCT00629486|cytokine gene|cytokine gene
5249501|NCT00629486|hepatitis B|hepatitis b
5249502|NCT00629486|hepatocellular carcinoma|hepatocellular carcinoma
5249503|NCT00629486|chronic liver disease|chronic liver disease
5249504|NCT00629473|multiple myeloma|multiple myeloma
5249505|NCT00629473|leukemias (inc. CLL)|leukemias (inc. cll)
5249506|NCT00629473|lymphomas|lymphomas
5249507|NCT00629473|cutaneous lymphoma|cutaneous lymphoma
5249508|NCT00629473|marginal zone lymphoma|marginal zone lymphoma
5249509|NCT00629473|advanced malignancies without standard treatment options|advanced malignancies without standard treatment options
5249510|NCT00629460|Pulmonary Nodules|pulmonary nodules
5249511|NCT00629447|Primary Brain Tumor|primary brain tumor
5249512|NCT00629447|Venous Thromboembolism|venous thromboembolism
5249513|NCT00629447|Heparin|heparin
5249514|NCT00629434|Diabetes Education|diabetes education
5249515|NCT00629434|Telemedicine|telemedicine
5249516|NCT00629395|pediatric|pediatric
5249517|NCT00629395|brain tumor|brain tumor
5249518|NCT00629395|survivors|survivors
5249519|NCT00629382|abdominal sepsis|abdominal sepsis
5249520|NCT00629382|abdominal surgery|abdominal surgery
5249521|NCT00629382|septic shock|septic shock
5249522|NCT00629382|polymyxin B|polymyxin b
5249523|NCT00629382|hemoperfusion|hemoperfusion
5249524|NCT00629382|Endotoxins|endotoxins
5249525|NCT00629343|Soft Tissue Sarcoma|soft tissue sarcoma
5249526|NCT00629343|Mesothelioma|mesothelioma
5249527|NCT00629343|Azacitidine|azacitidine
5249528|NCT00629343|Temozolomide|temozolomide
5249529|NCT00629343|Temodar|temodar
5249530|NCT00629330|prostate cancer|prostate cancer
5249531|NCT00629330|prostate cancer screening|prostate cancer screening
5249532|NCT00629330|prostate specific antigen|prostate specific antigen
5249533|NCT00629330|African American males|african american males
5249534|NCT00629317|Skin Aging|skin aging
5249535|NCT00629317|Rejuvenation|rejuvenation
5249536|NCT00629317|Photodynamic Therapy|photodynamic therapy
5249537|NCT00629317|Methyl Aminolevulinate|methyl aminolevulinate
5249538|NCT00629304|type 1 diabetes|type 1 diabetes
5249539|NCT00629304|PDA phone (Personal Digital Assistant)|pda phone (personal digital assistant)
5249540|NCT00629304|HbA1c|hba1c
5249541|NCT00629291|iron overload|iron overload
5249542|NCT00629291|Thalassemia|thalassemia
5249543|NCT00629291|Anemia, Sickle Cell|anemia, sickle cell
5249544|NCT00629291|Magnetic Resonance Imaging|magnetic resonance imaging
5249545|NCT00629278|stage IA breast cancer|stage ia breast cancer
5249546|NCT00629278|stage IB breast cancer|stage ib breast cancer
5249547|NCT00629278|stage II breast cancer|stage ii breast cancer
5249548|NCT00629278|stage IIIA breast cancer|stage iiia breast cancer
5249549|NCT00629278|HER2-positive breast cancer|her2-positive breast cancer
5249550|NCT00629265|Dysphagia|dysphagia
5249551|NCT00629265|Neuromuscular Electrical Stimulation (NMES)|neuromuscular electrical stimulation (nmes)
5249552|NCT00629265|Head & Neck Cancer|head & neck cancer
5249553|NCT00629265|Radiation and ChemoTherapy|radiation and chemotherapy
5249554|NCT00629252|Schizophrenia|schizophrenia
5249555|NCT00629252|PPI|ppi
5249556|NCT00629252|P50|p50
5249557|NCT00629252|CANTAB|cantab
5249558|NCT00629252|sensory gating|sensory gating
5249559|NCT00629252|Schizophrenic patients according to DSM-IV|schizophrenic patients according to dsm-iv
5249560|NCT00629239|COPD|copd
5249561|NCT00629239|tolerability|tolerability
5249562|NCT00629239|inhalation|inhalation
5249563|NCT00629226|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5249564|NCT00629226|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5249565|NCT00629226|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5249566|NCT00629226|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5249567|NCT00629226|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
5249568|NCT00629226|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
5249569|NCT00629226|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
5249570|NCT00629226|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
5249571|NCT00629226|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
5249572|NCT00629226|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
5249573|NCT00629226|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
5249574|NCT00629213|prevention,|prevention,
5249575|NCT00629213|type 2 diabetes,|type 2 diabetes,
5249576|NCT00629213|metabolic syndrome,|metabolic syndrome,
5249577|NCT00629213|acarbose treatment|acarbose treatment
5249578|NCT00629200|Advanced Malignancies|advanced malignancies
5249579|NCT00629200|Solid Tumors|solid tumors
5249580|NCT00629200|Melanoma|melanoma
5249581|NCT00629200|Renal Cell Carcinoma|renal cell carcinoma
5249582|NCT00629200|Phase I Studies|phase i studies
5249583|NCT00629200|Sodium Stibogluconate|sodium stibogluconate
5249584|NCT00629200|Interferon Alpha-2b|interferon alpha-2b
5249585|NCT00629200|Intron A|intron a
5249586|NCT00629200|SSG|ssg
5249587|NCT00629187|Lung Neoplasm|lung neoplasm
5249588|NCT00629187|Breast Neoplasm|breast neoplasm
5249589|NCT00629187|Melanoma|melanoma
5249590|NCT00629187|Central Nervous System Neoplasms|central nervous system neoplasms
5249591|NCT00629187|Neoplasm Metastasis|neoplasm metastasis
5250528|NCT00625651|FOLFOX|folfox
5249592|NCT00629187|Neoplasm Second Primary|neoplasm second primary
5249593|NCT00629187|Peripheral Blood Stem Cell Transplantation|peripheral blood stem cell transplantation
5249594|NCT00629174|Cognitive function|cognitive function
5249595|NCT00629174|Elderly|elderly
5249596|NCT00629174|Exercise|exercise
5249597|NCT00629174|Mental activity|mental activity
5249598|NCT00629148|metastasis|metastasis
5249599|NCT00629148|chemotherapy|chemotherapy
5249600|NCT00629148|breast cancer|breast cancer
5249601|NCT00629148|Vinorelbine|vinorelbine
5249602|NCT00629148|Capecitabine|capecitabine
5249603|NCT00629148|sequential chemotherapy|sequential chemotherapy
5249604|NCT00629148|TTF|ttf
5249605|NCT00629135|abscess|abscess
5249606|NCT00629135|intraabdominal abscess|intraabdominal abscess
5249607|NCT00629135|Moxifloxacine|moxifloxacine
5249608|NCT00629135|Moxifloxacin|moxifloxacin
5249609|NCT00629135|Metronidazole|metronidazole
5249610|NCT00629135|Tazobactam|tazobactam
5249611|NCT00629135|Piperacilline|piperacilline
5249612|NCT00629135|Piperacillin|piperacillin
5249613|NCT00629135|Tazobac|tazobac
5249614|NCT00629122|Kidney Transplantation|kidney transplantation
5249615|NCT00629122|Tacrolimus (Prograf)|tacrolimus (prograf)
5249616|NCT00629122|Pharmacokinetics|pharmacokinetics
5249617|NCT00629122|Sublingual administration|sublingual administration
5249618|NCT00629122|Drug interactions (Cytochrome P450 and p-glycoprotein)|drug interactions (cytochrome p450 and p-glycoprotein)
5249619|NCT00629096|Dilated Cardiomyopathy|dilated cardiomyopathy
5249620|NCT00629096|Marrow stem cells|marrow stem cells
5249621|NCT00629096|Myocardial regeneration|myocardial regeneration
5249622|NCT00629096|Mesenchymal stem cells|mesenchymal stem cells
5249623|NCT00629096|Marrow-derived endothelial progenitor cells|marrow-derived endothelial progenitor cells
5249624|NCT00629083|SUI|sui
5249625|NCT00629083|Bulkamid|bulkamid
5249626|NCT00629083|Urinary Incontinence|urinary incontinence
5249627|NCT00629070|cerebral palsy|cerebral palsy
5249628|NCT00629070|muscle strength|muscle strength
5249629|NCT00629070|muscle architecture|muscle architecture
5249630|NCT00629070|ultrasound|ultrasound
5249631|NCT00629070|rehabilitation|rehabilitation
5249632|NCT00629070|rectus femoris|rectus femoris
5249633|NCT00629070|quadriceps muscle|quadriceps muscle
5249634|NCT00629057|androgen-insensitive, non-metastatic, prostate, cancer|androgen-insensitive, non-metastatic, prostate, cancer
5249635|NCT00629031|Visceral leishmaniasis|visceral leishmaniasis
5249636|NCT00629031|Paromomycin|paromomycin
5249637|NCT00629018|Stem Cells|stem cells
5249638|NCT00629018|Heart Failure|heart failure
5249639|NCT00629018|Dilated Cardiomyopathy|dilated cardiomyopathy
5249640|NCT00629005|rehabilitation|rehabilitation
5249641|NCT00629005|upper extremity|upper extremity
5249642|NCT00629005|motor skills|motor skills
5249643|NCT00628992|COPD: chronic obstructive pulmonary disease and acute respiratory failure|copd: chronic obstructive pulmonary disease and acute respiratory failure
5249644|NCT00628966|Heart Attack|heart attack
5249645|NCT00628966|ICD|icd
5249646|NCT00628966|Risk Stratification|risk stratification
5249647|NCT00628966|Arrhythmia|arrhythmia
5249648|NCT00628953|Asthma|asthma
5249649|NCT00628953|Acid Reflux|acid reflux
5249650|NCT00628953|Nexium|nexium
5249651|NCT00628953|Esomeprazole|esomeprazole
5249652|NCT00628914|Major Depressive Disorder|major depressive disorder
5249653|NCT00628914|Insomnia|insomnia
5249654|NCT00628914|Escitalopram|escitalopram
5249655|NCT00628914|Lexapro|lexapro
5249656|NCT00628914|Eszopiclone|eszopiclone
5249657|NCT00628914|Lunesta|lunesta
5249658|NCT00628914|Cordance|cordance
5249659|NCT00628901|Leiomyoma|leiomyoma
5249660|NCT00628901|Uterine Fibroids|uterine fibroids
5249661|NCT00628901|Uterine Fibroid Embolization (UFE)|uterine fibroid embolization (ufe)
5249662|NCT00628901|Uterine Artery Embolization (UAE)|uterine artery embolization (uae)
5249663|NCT00628901|Uterine Neoplasms|uterine neoplasms
5249664|NCT00628901|Menorrhagia|menorrhagia
5249665|NCT00628888|Unipolar Depression|unipolar depression
5249666|NCT00628888|Anxiety|anxiety
5249667|NCT00628888|Adolescent|adolescent
5249668|NCT00628888|Emotion|emotion
5249669|NCT00628888|Cognitive Behavioral|cognitive behavioral
5249670|NCT00628875|mechanical ventilation|mechanical ventilation
5249671|NCT00628875|thoracic impedence|thoracic impedence
5249672|NCT00628875|defibrillator pads|defibrillator pads
5249673|NCT00628875|ventilation detection|ventilation detection
5249674|NCT00628875|pediatric ventilation|pediatric ventilation
5249675|NCT00628862|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5249676|NCT00628862|COPD|copd
5249677|NCT00628849|Mandible|mandible
5249678|NCT00628849|fracture|fracture
5249679|NCT00628849|Champy|champy
5249680|NCT00628849|AO technique|ao technique
5249681|NCT00628836|Neuromuscular stimulator|neuromuscular stimulator
5249682|NCT00628836|Shoulder subluxation|shoulder subluxation
5249683|NCT00628823|Celiac Disease|celiac disease
5249684|NCT00628823|Endomysial antibodies|endomysial antibodies
5249685|NCT00628823|Mild enteropathy|mild enteropathy
5249686|NCT00628823|Treatment|treatment
5249687|NCT00628823|Gluten-free diet|gluten-free diet
5249688|NCT00628810|adenocarcinoma of the colon|adenocarcinoma of the colon
5249689|NCT00628810|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5249690|NCT00628810|stage IV colon cancer|stage iv colon cancer
5249691|NCT00628810|stage IV rectal cancer|stage iv rectal cancer
5249692|NCT00628810|recurrent colon cancer|recurrent colon cancer
5249693|NCT00628810|recurrent rectal cancer|recurrent rectal cancer
5249694|NCT00628797|systemic sclerosis|systemic sclerosis
5249695|NCT00628797|skin fibrosis|skin fibrosis
5249696|NCT00628784|Dysplasia|dysplasia
5249697|NCT00628784|Ablation|ablation
5249698|NCT00628784|Squamous dysplasia|squamous dysplasia
5249699|NCT00628784|Early esophageal adenocarcinoma|early esophageal adenocarcinoma
5249700|NCT00628784|Cryotherapy|cryotherapy
5249701|NCT00628771|HIV Prevention|hiv prevention
5249702|NCT00628771|Teen Pregnancy|teen pregnancy
5249703|NCT00628771|Translational Research|translational research
5249704|NCT00628771|Group Care|group care
5249705|NCT00628771|Prenatal Care|prenatal care
5249706|NCT00628771|STD Prevention|std prevention
5249707|NCT00628771|Gonorrhea|gonorrhea
5249708|NCT00628771|Chlamydia|chlamydia
5249709|NCT00628771|Adolescent Health|adolescent health
5249710|NCT00628771|Community Health Centers|community health centers
5249711|NCT00628771|CenteringPregnancy Plus|centeringpregnancy plus
5249712|NCT00628771|HIV seronegativity|hiv seronegativity
5249713|NCT00628758|Symbicort|symbicort
5249714|NCT00628758|Turbuhaler|turbuhaler
5249715|NCT00628758|Persistent Asthma|persistent asthma
5249716|NCT00628745|TRANSTHYRETIN|transthyretin
5249717|NCT00628745|AMYLOIDOSIS|amyloidosis
5249718|NCT00628745|TRANSTHYRETIN AMYLOIDOSIS|transthyretin amyloidosis
5249719|NCT00628732|Cyclophosphamide|cyclophosphamide
5249720|NCT00628732|Topotecan|topotecan
5249721|NCT00628732|Phase II|phase ii
5249722|NCT00628732|Children|children
5249723|NCT00628732|Relapsed solid tumors|relapsed solid tumors
5249724|NCT00628719|Visceral leishmaniasis|visceral leishmaniasis
5249725|NCT00628719|India|india
5249726|NCT00628719|Liposomal Amphotericin B|liposomal amphotericin b
5249727|NCT00628719|Amphotericin B deoxycholate|amphotericin b deoxycholate
5249728|NCT00628706|tetrahydrocannabinol|tetrahydrocannabinol
5249729|NCT00628706|memory|memory
5249730|NCT00628706|reward|reward
5249731|NCT00628706|magnetic resonance imaging|magnetic resonance imaging
5249732|NCT00628706|endocannabinoids|endocannabinoids
5249733|NCT00628693|CPR|cpr
5249734|NCT00628680|Renal Disease|renal disease
5249735|NCT00628680|Kidney Failure|kidney failure
5249736|NCT00628680|End Stage Renal Disease|end stage renal disease
5249737|NCT00628667|Chronic Posterior Laryngitis|chronic posterior laryngitis
5249738|NCT00628667|CPL|cpl
5249739|NCT00628667|Pharyngeal acid reflux|pharyngeal acid reflux
5249740|NCT00628667|Esomeprazole|esomeprazole
5249741|NCT00628667|Nexium|nexium
5249742|NCT00628654|ovarian germ cell tumor|ovarian germ cell tumor
5249743|NCT00628654|ovarian epithelial cancer|ovarian epithelial cancer
5249744|NCT00628628|Tumor Lysis Syndrome|tumor lysis syndrome
5249745|NCT00628628|TLS|tls
5249746|NCT00628628|hyperuricemia|hyperuricemia
5249747|NCT00628628|Leukemia|leukemia
5249748|NCT00628628|Lymphoma|lymphoma
5249749|NCT00628628|Acute myeloid leukemia|acute myeloid leukemia
5249750|NCT00628628|Chronic myelocytic leukemia|chronic myelocytic leukemia
5249751|NCT00628628|CML|cml
5249752|NCT00628628|lactate dehydrogenase|lactate dehydrogenase
5249753|NCT00628628|LDH|ldh
5249754|NCT00628628|Myelodysplastic Syndrome|myelodysplastic syndrome
5249755|NCT00628628|Rasburicase|rasburicase
5249756|NCT00628628|Elitek™|elitek™
5249757|NCT00628615|Urodynamics|urodynamics
5249758|NCT00628615|Overactive bladder syndrome|overactive bladder syndrome
5249759|NCT00628615|Lower urinary tract symptoms LUTS|lower urinary tract symptoms luts
5249760|NCT00628602|Neuromuscular stimulator|neuromuscular stimulator
5249761|NCT00628602|Pressure ulcer prevention|pressure ulcer prevention
5249762|NCT00628589|schizophrenia, agitation, inhaled loxapine, ADASUVE|schizophrenia, agitation, inhaled loxapine, adasuve
5249763|NCT00628576|Deep Venous Thrombosis|deep venous thrombosis
5249764|NCT00628576|lower extremities|lower extremities
5249765|NCT00628576|Chronic Venous Insufficiency|chronic venous insufficiency
5249766|NCT00628576|Postthrombotic Syndrome|postthrombotic syndrome
5249767|NCT00628576|Heparins|heparins
5249768|NCT00628576|Low-molecular- weight heparin|low-molecular- weight heparin
5249769|NCT00628576|Tinzaparin|tinzaparin
5249770|NCT00628550|cardiac arrest|cardiac arrest
5249771|NCT00628550|cardiopulmonary arrest|cardiopulmonary arrest
5249772|NCT00628550|vasopressin|vasopressin
5249773|NCT00628550|epinephrine|epinephrine
5249774|NCT00628550|pediatrics|pediatrics
5249775|NCT00628550|in hospital cardiopulmonary resuscitation|in hospital cardiopulmonary resuscitation
5249776|NCT00628537|Neuromuscular stimulator|neuromuscular stimulator
5249777|NCT00628537|Flexor deformities of wrist and fingers|flexor deformities of wrist and fingers
5249778|NCT00628498|VOD|vod
5249779|NCT00628485|swallowing function|swallowing function
5249780|NCT00628485|neuromuscular stimulator|neuromuscular stimulator
5249781|NCT00628472|botulinum toxin a|botulinum toxin a
5249782|NCT00628472|botox|botox
5249783|NCT00628472|Decreasing botox injection pain|decreasing botox injection pain
5249784|NCT00628472|injections|injections
5249785|NCT00628459|iron|iron
5249786|NCT00628459|multiple micronutrient|multiple micronutrient
5249787|NCT00628459|malaria|malaria
5249788|NCT00628459|anemia|anemia
5249789|NCT00628459|preschool children|preschool children
5249790|NCT00628446|spinal cord injury|spinal cord injury
5249791|NCT00628446|Coronary artery calcium|coronary artery calcium
5249792|NCT00628446|Dyslipidemia|dyslipidemia
5249793|NCT00628433|phase I/II|phase i/ii
5249794|NCT00628433|ulcerative colitis|ulcerative colitis
5249795|NCT00628433|safety|safety
5249796|NCT00628433|tolerance|tolerance
5249797|NCT00628433|pharmacokinetics|pharmacokinetics
5249798|NCT00628420|Schizophrenia|schizophrenia
5249799|NCT00628420|N-desmethylclozapine|n-desmethylclozapine
5249800|NCT00628420|clozapine|clozapine
5249801|NCT00628420|psychosis|psychosis
5249802|NCT00628420|randomized|randomized
5249803|NCT00628420|placebo studies|placebo studies
5249804|NCT00628407|leaning|leaning
5249805|NCT00628407|CPR|cpr
5249806|NCT00628407|sternal pressure|sternal pressure
5249807|NCT00628407|incomplete release|incomplete release
5249808|NCT00628407|chest compressions|chest compressions
5249809|NCT00628407|pediatric|pediatric
5249810|NCT00628394|Cognition|cognition
5249811|NCT00628394|schizophrenia|schizophrenia
5249812|NCT00628394|Atomoxetine|atomoxetine
5249813|NCT00628394|Strattera|strattera
5249814|NCT00628394|cognitive remediation|cognitive remediation
5249815|NCT00628381|sepsis|sepsis
5249816|NCT00628381|microcirculation|microcirculation
5249817|NCT00628381|nitric oxide|nitric oxide
5249818|NCT00628381|citrulline|citrulline
5249819|NCT00628368|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
5249820|NCT00628368|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
5249821|NCT00628368|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5249822|NCT00628368|recurrent rectal cancer|recurrent rectal cancer
5249823|NCT00628368|stage I rectal cancer|stage i rectal cancer
5249824|NCT00628368|stage II rectal cancer|stage ii rectal cancer
5249825|NCT00628368|stage III rectal cancer|stage iii rectal cancer
5249826|NCT00628368|stage IV rectal cancer|stage iv rectal cancer
5249827|NCT00628368|recurrent esophageal cancer|recurrent esophageal cancer
5249828|NCT00628368|stage I esophageal cancer|stage i esophageal cancer
5249829|NCT00628368|stage II esophageal cancer|stage ii esophageal cancer
5249830|NCT00628368|stage III esophageal cancer|stage iii esophageal cancer
5249831|NCT00628368|stage IV esophageal cancer|stage iv esophageal cancer
5249832|NCT00628355|lidocaine|lidocaine
5249833|NCT00628355|ischemic compression|ischemic compression
5249834|NCT00628355|chronic pelvic pain|chronic pelvic pain
5249835|NCT00628355|myofascial pain syndrome|myofascial pain syndrome
5249836|NCT00628342|Gastroesophageal Reflux Disease|gastroesophageal reflux disease
5249837|NCT00628342|GERD|gerd
5249838|NCT00628342|Esomeprazole|esomeprazole
5249839|NCT00628342|Heartburn|heartburn
5249840|NCT00628342|Nexium|nexium
5249841|NCT00628329|asthma, retinol, cis-retinoic acid|asthma, retinol, cis-retinoic acid
5249842|NCT00628316|tinnitus|tinnitus
5249843|NCT00628316|caffeine|caffeine
5249844|NCT00628303|Good health|good health
5249845|NCT00628277|Obesity|obesity
5249846|NCT00628277|coronary heart disease|coronary heart disease
5249847|NCT00628277|coronary risk factors|coronary risk factors
5249848|NCT00628277|weight loss|weight loss
5249849|NCT00628277|exercise|exercise
5249850|NCT00628264|cardiac surgery|cardiac surgery
5249851|NCT00628264|coronary artery bypass grafting|coronary artery bypass grafting
5249852|NCT00628264|valve surgery|valve surgery
5249853|NCT00628264|acute kidney injury|acute kidney injury
5249854|NCT00628251|Advanced ovarian cancer|advanced ovarian cancer
5249855|NCT00628251|BRCA1 protein|brca1 protein
5249856|NCT00628251|BRCA2 protein|brca2 protein
5249857|NCT00628251|Poly(ADP ribose) polymerases|poly(adp ribose) polymerases
5249858|NCT00628238|Chronic Lymphocytic Leukemia Research Consortium|chronic lymphocytic leukemia research consortium
5249859|NCT00628238|Chronic lymphocytic leukemia|chronic lymphocytic leukemia
5249860|NCT00628238|CLL|cll
5249861|NCT00628238|CLL Research Consortium|cll research consortium
5249862|NCT00628238|CRC|crc
5249863|NCT00628238|Revlimid|revlimid
5249864|NCT00628238|lenalidomide|lenalidomide
5249865|NCT00628238|Rituximab|rituximab
5249866|NCT00628238|Rituxan|rituxan
5249867|NCT00628238|First-line|first-line
5249868|NCT00628238|therapy|therapy
5249869|NCT00628238|untreated|untreated
5249870|NCT00628238|Frontline|frontline
5249871|NCT00628225|Smoking cessation|smoking cessation
5249872|NCT00628212|insulin resistance|insulin resistance
5249873|NCT00628186|pancreaticoduodenectomy|pancreaticoduodenectomy
5249874|NCT00628186|stent|stent
5249875|NCT00628186|pancreaticojejunostomy|pancreaticojejunostomy
5249876|NCT00628186|hospital stay|hospital stay
5249877|NCT00628186|complication|complication
5249878|NCT00628186|pancreatic fistula|pancreatic fistula
5249879|NCT00628160|Septic shock|septic shock
5249880|NCT00628160|Cirrhosis|cirrhosis
5249881|NCT00628160|Survival|survival
5249882|NCT00628147|colonic neoplasms|colonic neoplasms
5249883|NCT00628147|colonoscopy|colonoscopy
5249884|NCT00628147|narrow band imaging|narrow band imaging
5249885|NCT00628147|diagnostic techniques|diagnostic techniques
5249886|NCT00628134|cystic fibrosis|cystic fibrosis
5249887|NCT00628134|surfactant|surfactant
5249888|NCT00628134|aerosol|aerosol
5249889|NCT00628134|inhaled drug|inhaled drug
5249890|NCT00628134|inhaled antibiotic|inhaled antibiotic
5249891|NCT00628121|infertility, menstrual cycle, LH surge|infertility, menstrual cycle, lh surge
5249892|NCT00628108|Xyzal|xyzal
5249893|NCT00628108|Levocetirizine|levocetirizine
5249894|NCT00628108|Allergy|allergy
5249895|NCT00628108|Children|children
5249896|NCT00628108|Seasonal Allergies|seasonal allergies
5249897|NCT00628095|rheumatoid arthritis DMARD methotrexate|rheumatoid arthritis dmard methotrexate
5249898|NCT00628082|Cardiac Energetics|cardiac energetics
5249899|NCT00628082|Dynamic Diastolic filling Assessment|dynamic diastolic filling assessment
5249900|NCT00628082|Heart Failure with Preserved Ejection Fraction|heart failure with preserved ejection fraction
5249901|NCT00628082|Arterial and Ventricular Stiffening|arterial and ventricular stiffening
5249902|NCT00628069|Orthopedics|orthopedics
5249903|NCT00628069|bone fixation|bone fixation
5249904|NCT00628056|Perhexiline|perhexiline
5249905|NCT00628056|diabetes|diabetes
5249906|NCT00628056|diabetic cardiomyopathy|diabetic cardiomyopathy
5249907|NCT00628056|high energy phosphate kinetics|high energy phosphate kinetics
5249908|NCT00628056|magnetic resonance spectroscopy|magnetic resonance spectroscopy
5249909|NCT00628043|Cancer|cancer
5249910|NCT00628043|patients|patients
5249911|NCT00628043|with|with
5249912|NCT00628043|chemotherapy|chemotherapy
5249913|NCT00628043|induced|induced
5249914|NCT00628043|anemia|anemia
5249915|NCT00628030|Behavioral intervention|behavioral intervention
5249916|NCT00628030|Obesity prevention|obesity prevention
5249917|NCT00628017|polyunsaturated fatty acids|polyunsaturated fatty acids
5249918|NCT00628017|Alzheimer's disease|alzheimer's disease
5249919|NCT00628017|mild cognitive impairment|mild cognitive impairment
5249920|NCT00628017|fish oil|fish oil
5249921|NCT00628017|cognition|cognition
5249922|NCT00627978|breast|breast
5249923|NCT00627965|Sildenafil citrate|sildenafil citrate
5249924|NCT00627965|Prevention|prevention
5249925|NCT00627965|High Altitude Pulmonary Edema|high altitude pulmonary edema
5249926|NCT00627965|Acute Mountain Sickness|acute mountain sickness
5249927|NCT00627965|Healthy Lowland Subjects|healthy lowland subjects
5249928|NCT00627965|Pulmonary Artery Systolic Pressure|pulmonary artery systolic pressure
5249929|NCT00627952|hypertension|hypertension
5249930|NCT00627952|intraglomerular pressure|intraglomerular pressure
5249931|NCT00627926|Genotype 1|genotype 1
5249932|NCT00627913|Floppy Iris Syndrome|floppy iris syndrome
5249933|NCT00627900|drug-eluting stents|drug-eluting stents
5249934|NCT00627887|Depressive Disorder, Major|depressive disorder, major
5249935|NCT00627887|Electroconvulsive Therapy|electroconvulsive therapy
5249936|NCT00627887|Lithium Carbonate|lithium carbonate
5249937|NCT00627887|venlafaxine|venlafaxine
5249938|NCT00627848|Alzheimer's disease|alzheimer's disease
5249939|NCT00627848|fmri|fmri
5249940|NCT00627848|face recognition|face recognition
5249941|NCT00627848|rivastigmine|rivastigmine
5249942|NCT00627835|squamous cell carcinoma|squamous cell carcinoma
5249943|NCT00627835|head and neck|head and neck
5249944|NCT00627835|Neoadjuvant Sorafenib and Concurrent Sorafenib, Cisplatin and Radiation|neoadjuvant sorafenib and concurrent sorafenib, cisplatin and radiation
5249945|NCT00627822|Medical students|medical students
5249946|NCT00627822|Medical education|medical education
5249947|NCT00627822|Private hospital|private hospital
5249948|NCT00627822|Patient satisfaction|patient satisfaction
5249949|NCT00627822|Questionnaires|questionnaires
5249950|NCT00627809|coronary microcirculation|coronary microcirculation
5249951|NCT00627809|acut myocardial infarction|acut myocardial infarction
5249952|NCT00627809|infarct size|infarct size
5249953|NCT00627809|streptokinase|streptokinase
5249954|NCT00627809|reperfusion|reperfusion
5249955|NCT00627796|GH|gh
5249956|NCT00627796|IGF-I|igf-i
5249957|NCT00627796|tumor|tumor
5249958|NCT00627796|lanreotide|lanreotide
5249959|NCT00627770|Physical Therapy - Therapeutics - Edema|physical therapy - therapeutics - edema
5249960|NCT00627770|Arthroplasty replacement knee|arthroplasty replacement knee
5249961|NCT00627770|Treatment outcome|treatment outcome
5249962|NCT00627757|metabolic syndrome|metabolic syndrome
5249963|NCT00627757|weight gain|weight gain
5249964|NCT00627757|antipsychotic drugs|antipsychotic drugs
5249965|NCT00627757|Metabolic syndrome and treatment with antipsychotic drugs|metabolic syndrome and treatment with antipsychotic drugs
5249966|NCT00627744|Type 2 diabetes, IGT, Myocardial infarction, Incretins|type 2 diabetes, igt, myocardial infarction, incretins
5249967|NCT00627731|Asthma Patients|asthma patients
5249968|NCT00627718|Age-related macular degeneration|age-related macular degeneration
5249969|NCT00627718|HRT|hrt
5249970|NCT00627718|Macular edema|macular edema
5249971|NCT00627718|Screening for disease|screening for disease
5249972|NCT00627692|Constipation in elderly patients|constipation in elderly patients
5249973|NCT00627679|Pediatric asthma|pediatric asthma
5249974|NCT00627666|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5249975|NCT00627666|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5249976|NCT00627666|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
5249977|NCT00627666|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5249978|NCT00627666|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5249979|NCT00627666|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
5249980|NCT00627666|acute lymphocytic leukemia|acute lymphocytic leukemia
5249981|NCT00627666|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5249982|NCT00627666|acute undifferentiated leukemia|acute undifferentiated leukemia
5249983|NCT00627666|mast cell leukemia|mast cell leukemia
5249984|NCT00627666|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5249985|NCT00627666|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5249986|NCT00627666|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5249987|NCT00627666|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
5249988|NCT00627666|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5249989|NCT00627666|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5249990|NCT00627666|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5249991|NCT00627666|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5249992|NCT00627666|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5249993|NCT00627666|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5249994|NCT00627666|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5249995|NCT00627666|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5249996|NCT00627666|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5249997|NCT00627666|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5249998|NCT00627666|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
5249999|NCT00627666|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
5250000|NCT00627666|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
5250001|NCT00627666|refractory anemia with excess blasts|refractory anemia with excess blasts
5250002|NCT00627653|PPAR|ppar
5250003|NCT00627653|PET study|pet study
5250004|NCT00627653|heart metabolism|heart metabolism
5250005|NCT00627614|stage I breast cancer|stage i breast cancer
5250006|NCT00627614|stage II breast cancer|stage ii breast cancer
5250007|NCT00627614|stage IIIA breast cancer|stage iiia breast cancer
5250008|NCT00627614|stage IIIB breast cancer|stage iiib breast cancer
5250009|NCT00627614|stage IIIC breast cancer|stage iiic breast cancer
5250010|NCT00627614|stage IV breast cancer|stage iv breast cancer
5250011|NCT00627588|ProSavin|prosavin
5250012|NCT00627588|Parkinson's Disease|parkinson's disease
5250013|NCT00627588|Gene Therapy|gene therapy
5250014|NCT00627575|drug interaction|drug interaction
5250015|NCT00627575|pharmacokinetics|pharmacokinetics
5250016|NCT00627575|healthy volunteers|healthy volunteers
5250017|NCT00627562|robotic|robotic
5250018|NCT00627562|robot assisted|robot assisted
5250019|NCT00627562|minimally invasive|minimally invasive
5250020|NCT00627562|tumors of head and neck|tumors of head and neck
5250021|NCT00627549|cystocele, anterior repair, mesh|cystocele, anterior repair, mesh
5250022|NCT00627536|scarring, Juvista, avotermin, transforming growth factor beta 3, TGFB3|scarring, juvista, avotermin, transforming growth factor beta 3, tgfb3
5250023|NCT00627510|Therapeutic Drug Monitoring (TDM)|therapeutic drug monitoring (tdm)
5250024|NCT00627510|Antidepressant|antidepressant
5250025|NCT00627510|Antipsychotic|antipsychotic
5250026|NCT00627510|Treatment adherence|treatment adherence
5250027|NCT00627510|Compliance|compliance
5250028|NCT00627510|Metabolism|metabolism
5250029|NCT00627510|Do patients take their psychiatric medication as prescribed?|do patients take their psychiatric medication as prescribed?
5250030|NCT00627510|Do psychiatric patients metabolize their medication faster than expected?|do psychiatric patients metabolize their medication faster than expected?
5250031|NCT00627510|What are the exact odds that the patient of a physician prescribing antidepressants or antipsychotics has plasma levels that are BELOW those intended?|what are the exact odds that the patient of a physician prescribing antidepressants or antipsychotics has plasma levels that are below those intended?
5250032|NCT00627484|Insulin resistance|insulin resistance
5250033|NCT00627484|Insulin sensitivity|insulin sensitivity
5250034|NCT00627484|bariatric surgery|bariatric surgery
5250035|NCT00627484|diabetes|diabetes
5250036|NCT00627484|calorie restriction|calorie restriction
5250037|NCT00627484|body composition|body composition
5250038|NCT00627458|Hexavalent vaccine|hexavalent vaccine
5250039|NCT00627458|Booster|booster
5250040|NCT00627432|stage III bladder cancer|stage iii bladder cancer
5250041|NCT00627432|stage IV bladder cancer|stage iv bladder cancer
5250042|NCT00627432|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
5250043|NCT00627406|GnRH antagonist|gnrh antagonist
5250044|NCT00627406|GnRH agonist|gnrh agonist
5250045|NCT00627406|hCG|hcg
5250046|NCT00627406|OHSS|ohss
5250047|NCT00627406|In vitro fertilization|in vitro fertilization
5250048|NCT00627406|ovulation induction|ovulation induction
5250049|NCT00627406|Clinical pregnancy rate|clinical pregnancy rate
5250050|NCT00627393|Granulocyte Transfusions|granulocyte transfusions
5250051|NCT00627380|HIV|hiv
5250052|NCT00627380|AIDS|aids
5250053|NCT00627380|insulin resistance|insulin resistance
5250054|NCT00627380|diabetes|diabetes
5250055|NCT00627380|dyslipidemia|dyslipidemia
5250056|NCT00627380|visceral adiposity|visceral adiposity
5250057|NCT00627380|subcutaneous adipose wasting|subcutaneous adipose wasting
5250058|NCT00627380|cardiovascular disease|cardiovascular disease
5250059|NCT00627380|hypertension|hypertension
5250060|NCT00627380|endothelial function|endothelial function
5250061|NCT00627380|quality of life|quality of life
5250062|NCT00627380|Complementary Therapies|complementary therapies
5250063|NCT00627367|Acute Pain, Emergency Department, ED, Hydromorphone, Dilaudid Protocolized Nonprotocolized Usual Care|acute pain, emergency department, ed, hydromorphone, dilaudid protocolized nonprotocolized usual care
5250064|NCT00627354|stage IV prostate cancer|stage iv prostate cancer
5250065|NCT00627354|recurrent prostate cancer|recurrent prostate cancer
5250066|NCT00627354|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5250067|NCT00627341|Exposure Therapy|exposure therapy
5250068|NCT00627341|Relapse Prevention|relapse prevention
5250069|NCT00627341|Anorexia Nervosa|anorexia nervosa
5250070|NCT00627328|Physiologic Pacing|physiologic pacing
5250071|NCT00627328|Dual Chamber Pacing|dual chamber pacing
5250072|NCT00627328|Atrioventricular Block|atrioventricular block
5250073|NCT00627328|Bradycardia|bradycardia
5250074|NCT00627328|Sick Sinus Syndrome|sick sinus syndrome
5250075|NCT00627315|Obesity|obesity
5250076|NCT00627315|Insulin Resistance|insulin resistance
5250077|NCT00627315|Bariatric Surgery|bariatric surgery
5250078|NCT00627315|Gastric Banding|gastric banding
5250079|NCT00627315|Gastric Bypass|gastric bypass
5250080|NCT00627302|Quality of Vision|quality of vision
5250081|NCT00627289|Chronic pain|chronic pain
5250082|NCT00627289|groin hernia|groin hernia
5250083|NCT00627289|neuropathic pain|neuropathic pain
5250084|NCT00627289|chronic postoperative pain|chronic postoperative pain
5250085|NCT00627289|Postherniotomy pain|postherniotomy pain
5250086|NCT00627289|Neuroplastic changes|neuroplastic changes
5250087|NCT00627276|ductal breast carcinoma in situ|ductal breast carcinoma in situ
5250088|NCT00627276|atypical ductal breast hyperplasia|atypical ductal breast hyperplasia
5250089|NCT00627263|ICD|icd
5250090|NCT00627263|Cardiac Arrhythmia|cardiac arrhythmia
5250091|NCT00627263|Arrhythmia|arrhythmia
5250092|NCT00627263|Stress|stress
5250093|NCT00627263|Anger|anger
5250094|NCT00627250|Irritability|irritability
5250095|NCT00627250|Aggression|aggression
5250096|NCT00627250|Brain Injury|brain injury
5250097|NCT00627250|Amantadine|amantadine
5250098|NCT00627250|Irritability and Aggression Due to Traumatic Brain Injury|irritability and aggression due to traumatic brain injury
5250099|NCT00627237|Brain Injuries|brain injuries
5250100|NCT00627237|Cognitive Rehabilitation|cognitive rehabilitation
5250101|NCT00627237|Executive Functioning|executive functioning
5250102|NCT00627211|quality assessment|quality assessment
5250103|NCT00627211|pain reduction|pain reduction
5250104|NCT00627211|gastroscopy|gastroscopy
5250105|NCT00627211|carbondioxide insufflation|carbondioxide insufflation
5250106|NCT00627211|Patient satisfaction|patient satisfaction
5250107|NCT00627185|Tobacco control|tobacco control
5250108|NCT00627185|Tobacco cessation|tobacco cessation
5250109|NCT00627185|Tobacco use|tobacco use
5250110|NCT00627172|Coronary artery disease|coronary artery disease
5250111|NCT00627172|MDCT|mdct
5250112|NCT00627172|Positron emission tomography|positron emission tomography
5250113|NCT00627172|Ultrasound|ultrasound
5250114|NCT00627159|community-based|community-based
5250115|NCT00627159|culturally-sensitive|culturally-sensitive
5250116|NCT00627159|high risk assessment|high risk assessment
5250117|NCT00627159|education classes|education classes
5250118|NCT00627159|cardiovascular risk profile|cardiovascular risk profile
5250119|NCT00627159|Indo-Asian population|indo-asian population
5250120|NCT00627146|Diabetes Mellitus, type 1|diabetes mellitus, type 1
5250121|NCT00627146|ChAgly CD3|chagly cd3
5250122|NCT00627133|Alcohol seizure|alcohol seizure
5250123|NCT00627120|healthy volunteers|healthy volunteers
5250124|NCT00627107|ReWalk, Paraplegia, SCI|rewalk, paraplegia, sci
5250125|NCT00627068|cardiovascular|cardiovascular
5250126|NCT00627068|vasodilation|vasodilation
5250127|NCT00627068|endothelium|endothelium
5250128|NCT00627068|Subjects with high cardiovascular risk|subjects with high cardiovascular risk
5250129|NCT00627055|Second line antiretroviral therapy|second line antiretroviral therapy
5250130|NCT00627055|HIV genotypic resistance|hiv genotypic resistance
5250131|NCT00627055|Kaletra monotherapy|kaletra monotherapy
5250132|NCT00627055|Thailand|thailand
5250133|NCT00627055|48-week efficacy and safety between 2 NRTIs plus lopinavir/ritonavir (LPV/r) and LPV/r monotherapy in patients failing a standard NNRTI-based treatment regimen|48-week efficacy and safety between 2 nrtis plus lopinavir/ritonavir (lpv/r) and lpv/r monotherapy in patients failing a standard nnrti-based treatment regimen
5250134|NCT00627055|treatment experienced|treatment experienced
5250135|NCT00627042|Liver disease|liver disease
5250136|NCT00627042|Neoplasms|neoplasms
5250137|NCT00627042|Liver neoplasms|liver neoplasms
5250138|NCT00627042|Carcinoma, Hepatocellular|carcinoma, hepatocellular
5250139|NCT00627029|Care coordination|care coordination
5250140|NCT00627029|Disease management|disease management
5250141|NCT00627029|Medicare|medicare
5250142|NCT00627029|Fee-for-service|fee-for-service
5250143|NCT00627029|Random assignment|random assignment
5250144|NCT00627029|Elderly|elderly
5250145|NCT00627016|Non-Erosive Gastroesophageal Reflux Disease|non-erosive gastroesophageal reflux disease
5250146|NCT00627016|GERD|gerd
5250147|NCT00627016|heartburn|heartburn
5250148|NCT00627016|sleep disturbance|sleep disturbance
5250149|NCT00627016|nocturnal Reflux|nocturnal reflux
5250150|NCT00626990|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
5250151|NCT00626990|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5250152|NCT00626977|Analgesia|analgesia
5250153|NCT00626977|Obstetrical|obstetrical
5250154|NCT00626977|Anesthesia|anesthesia
5250155|NCT00626977|Epidural|epidural
5250156|NCT00626977|Newborn|newborn
5250157|NCT00626977|Anesthetics, local|anesthetics, local
5250158|NCT00626977|Clonidine|clonidine
5250159|NCT00626977|Pregnant women|pregnant women
5250160|NCT00626977|Infant, newborn|infant, newborn
5250161|NCT00626964|Arterial stiffness|arterial stiffness
5250162|NCT00626964|PulseWave velocity|pulsewave velocity
5250163|NCT00626964|Body composition|body composition
5250164|NCT00626964|Bioimpedance|bioimpedance
5250165|NCT00626964|Morbid Obesity|morbid obesity
5250166|NCT00626964|APO A|apo a
5250167|NCT00626964|APO B|apo b
5250168|NCT00626964|Framingham risk score|framingham risk score
5250169|NCT00626964|Prevention of Coronary Heart Disease|prevention of coronary heart disease
5250170|NCT00626964|Lifestyle Intervention|lifestyle intervention
5250171|NCT00626964|Bariatric Surgery|bariatric surgery
5250172|NCT00626964|Low Energy Diet|low energy diet
5250173|NCT00626951|LMA Supreme|lma supreme
5250174|NCT00626951|LMA ProSeal|lma proseal
5250175|NCT00626951|Laryngeal mask airway|laryngeal mask airway
5250176|NCT00626951|Ventilation|ventilation
5250177|NCT00626938|sarcoidosis|sarcoidosis
5250178|NCT00626938|protein profile|protein profile
5250179|NCT00626938|CYP-450|cyp-450
5250180|NCT00626938|TNF-alpha polymorphisms|tnf-alpha polymorphisms
5250181|NCT00626938|HLA|hla
5250182|NCT00626925|Randomized Trial|randomized trial
5250183|NCT00626925|Medication for Heavy Drinking|medication for heavy drinking
5250184|NCT00626925|Topiramate Treatment|topiramate treatment
5250185|NCT00626912|large aneurysm|large aneurysm
5250186|NCT00626912|recurrence|recurrence
5250187|NCT00626912|hydrocoil|hydrocoil
5250188|NCT00626899|Validation of Cardiac Output measurement in hypothermic patients|validation of cardiac output measurement in hypothermic patients
5250189|NCT00626886|Herniorrhaphy|herniorrhaphy
5250190|NCT00626886|Inguinal Hernia Repair|inguinal hernia repair
5250191|NCT00626886|Postoperative pain|postoperative pain
5250192|NCT00626873|ovarian germ cell tumor|ovarian germ cell tumor
5250193|NCT00626873|ovarian epithelial cancer|ovarian epithelial cancer
5250194|NCT00626860|melanoma|melanoma
5250195|NCT00626847|primary open angle glaucoma|primary open angle glaucoma
5250196|NCT00626847|Nuclear Genetics|nuclear genetics
5250197|NCT00626847|Mitochondrial DNA|mitochondrial dna
5250198|NCT00626847|POAG|poag
5250199|NCT00626834|cocaine addiction|cocaine addiction
5250200|NCT00626834|vigabatrin|vigabatrin
5250201|NCT00626834|ovation pharmaceuticals|ovation pharmaceuticals
5250202|NCT00626834|cocaine|cocaine
5250203|NCT00626834|cocaine related disorders|cocaine related disorders
5250204|NCT00626834|behavior addictive|behavior addictive
5250205|NCT00626834|mental disorders|mental disorders
5250206|NCT00626834|therapeutic uses|therapeutic uses
5250207|NCT00626834|physiologic effects of drugs|physiologic effects of drugs
5250208|NCT00626834|disorder of environmental origin|disorder of environmental origin
5250209|NCT00626834|central nervous system stimulants|central nervous system stimulants
5250210|NCT00626834|central nervous system agents|central nervous system agents
5250211|NCT00626834|pharmacological actions|pharmacological actions
5250212|NCT00626834|substance related disorders|substance related disorders
5250213|NCT00626821|Stoma|stoma
5250214|NCT00626821|Ostomy|ostomy
5250215|NCT00626782|glaucoma|glaucoma
5250216|NCT00626782|glucoma filtering surgery|glucoma filtering surgery
5250217|NCT00626782|ranibizumab|ranibizumab
5250218|NCT00626782|mitomycin C|mitomycin c
5250219|NCT00626782|patients requiring first time glaucoma filtering surgery|patients requiring first time glaucoma filtering surgery
5250220|NCT00626769|Genistein|genistein
5250221|NCT00626769|Bone mineral density|bone mineral density
5250222|NCT00626769|digital mammography|digital mammography
5250223|NCT00626769|safety|safety
5250224|NCT00626756|fluid|fluid
5250225|NCT00626756|Lidco technology|lidco technology
5250226|NCT00626756|guided therapy|guided therapy
5250227|NCT00626756|fluid management guided by Lidco technology|fluid management guided by lidco technology
5250228|NCT00626730|adult grade II meningioma|adult grade ii meningioma
5250229|NCT00626730|adult grade III meningioma|adult grade iii meningioma
5250230|NCT00626717|Keratoconus|keratoconus
5250231|NCT00626717|Cross linking|cross linking
5250232|NCT00626717|Riboflavin|riboflavin
5250233|NCT00626704|Sarcoma|sarcoma
5250234|NCT00626704|Soft Tissue Sarcoma|soft tissue sarcoma
5250235|NCT00626704|Locally Advanced or Metastatic, Unresectable Soft Tissue Sarcoma|locally advanced or metastatic, unresectable soft tissue sarcoma
5250236|NCT00626704|AMG 655|amg 655
5250237|NCT00626704|STS|sts
5250238|NCT00626704|Doxorubicin|doxorubicin
5250239|NCT00626704|Death receptor|death receptor
5250240|NCT00626704|TRAIL receptor|trail receptor
5250241|NCT00626704|Apoptosis|apoptosis
5250242|NCT00626691|antioxidant|antioxidant
5250243|NCT00626691|walnut|walnut
5250244|NCT00626691|nutritional status|nutritional status
5250245|NCT00626691|Antioxidant capacity|antioxidant capacity
5250246|NCT00626678|Pemphigus Vulgaris|pemphigus vulgaris
5250247|NCT00626678|Azathioprine|azathioprine
5250249|NCT00626665|Raynaud disease|raynaud disease
5250250|NCT00626665|Scleroderma|scleroderma
5250251|NCT00626639|palifermin|palifermin
5250252|NCT00626639|Clinical Trial|clinical trial
5250253|NCT00626639|Oncology|oncology
5250254|NCT00626639|Head & Neck|head & neck
5250255|NCT00626626|leukemia|leukemia
5250256|NCT00626626|myelodysplastic syndrome|myelodysplastic syndrome
5250257|NCT00626626|chronic myelogenous leukemia|chronic myelogenous leukemia
5250258|NCT00626626|lymphoma|lymphoma
5250259|NCT00626626|mantle cell lymphoma|mantle cell lymphoma
5250260|NCT00626600|Oxycodone Hydrochloride 50mg/mL|oxycodone hydrochloride 50mg/ml
5250261|NCT00626600|Observational|observational
5250262|NCT00626600|Infusion|infusion
5250263|NCT00626600|Severe cancer pain|severe cancer pain
5250264|NCT00626587|Endobronchial ultrasonography|endobronchial ultrasonography
5250265|NCT00626587|Peripheral pulmonary lesions|peripheral pulmonary lesions
5250266|NCT00626587|Transbronchial needle aspiration|transbronchial needle aspiration
5250267|NCT00626587|Probe location|probe location
5250268|NCT00626587|Diagnostic yield|diagnostic yield
5250269|NCT00626587|EBUS guided TBNA for peripheral pulmonary lesions|ebus guided tbna for peripheral pulmonary lesions
5250270|NCT00626574|Epoetin alfa|epoetin alfa
5250271|NCT00626574|aneurysm|aneurysm
5250272|NCT00626574|subarachnoid hemorrhage|subarachnoid hemorrhage
5250273|NCT00626561|Cervical Cancer|cervical cancer
5250274|NCT00626561|Uterine Cancer|uterine cancer
5250275|NCT00626561|Bevacizumab|bevacizumab
5250276|NCT00626561|Avastin|avastin
5250277|NCT00626561|Anti-VEGF monoclonal antibody|anti-vegf monoclonal antibody
5250278|NCT00626561|rhuMAb-VEGF|rhumab-vegf
5250279|NCT00626561|Paclitaxel|paclitaxel
5250280|NCT00626561|Taxol|taxol
5250409|NCT00625989|allergen challenge|allergen challenge
5250281|NCT00626548|Hormone Resistant Prostate Cancer|hormone resistant prostate cancer
5250282|NCT00626548|Endothelin A Receptor Antagonist|endothelin a receptor antagonist
5250283|NCT00626548|Endothelin A|endothelin a
5250284|NCT00626548|Endothelin A antagonist|endothelin a antagonist
5250285|NCT00626535|Symptomatic Gastroesophageal Reflux Disease (sGERD)|symptomatic gastroesophageal reflux disease (sgerd)
5250286|NCT00626535|Nexium|nexium
5250287|NCT00626535|Esomeprazole|esomeprazole
5250288|NCT00626522|Bronchitis|bronchitis
5250289|NCT00626522|Chronic|chronic
5250290|NCT00626522|Emphysema|emphysema
5250291|NCT00626522|Smokers or ex-Smokers|smokers or ex-smokers
5250292|NCT00626509|stage IV renal cell cancer|stage iv renal cell cancer
5250293|NCT00626483|adult giant cell glioblastoma|adult giant cell glioblastoma
5250294|NCT00626483|adult gliosarcoma|adult gliosarcoma
5250295|NCT00626470|Trochanter|trochanter
5250296|NCT00626470|Femur|femur
5250297|NCT00626470|Fracture|fracture
5250298|NCT00626431|Lupron Depot|lupron depot
5250299|NCT00626431|prostate cancer|prostate cancer
5250300|NCT00626431|leuprolide acetate|leuprolide acetate
5250301|NCT00626405|stage IV melanoma|stage iv melanoma
5250302|NCT00626379|Coronary Heart Disease|coronary heart disease
5250303|NCT00626379|Subclinical Atherosclerosis|subclinical atherosclerosis
5250304|NCT00626379|CVD-Related Markers of Inflammation|cvd-related markers of inflammation
5250305|NCT00626379|Mortality|mortality
5250306|NCT00626366|Nasal Spray|nasal spray
5250307|NCT00626366|Nasal Drop|nasal drop
5250308|NCT00626366|Intranasal Medication|intranasal medication
5250309|NCT00626353|Stroke|stroke
5250310|NCT00626353|rehabilitation|rehabilitation
5250311|NCT00626353|motor recovery|motor recovery
5250312|NCT00626353|cognition|cognition
5250313|NCT00626353|quality of life|quality of life
5250314|NCT00626340|menopause|menopause
5250315|NCT00626340|women|women
5250316|NCT00626340|major depressive disorder|major depressive disorder
5250317|NCT00626340|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
5250318|NCT00626327|vaccine|vaccine
5250319|NCT00626327|toddlers|toddlers
5250320|NCT00626327|healthy|healthy
5250321|NCT00626327|meningitis|meningitis
5250322|NCT00626327|meningococcal|meningococcal
5250323|NCT00626327|measles|measles
5250324|NCT00626327|mumps|mumps
5250325|NCT00626327|rubella|rubella
5250326|NCT00626327|varicella|varicella
5250327|NCT00626327|Prevention of Meningococcal disease types ACWY|prevention of meningococcal disease types acwy
5250328|NCT00626301|efficacy|efficacy
5250329|NCT00626301|safety|safety
5250330|NCT00626301|pharmacokinetics|pharmacokinetics
5250331|NCT00626301|LPV/r monotherapy|lpv/r monotherapy
5250332|NCT00626301|Thai children|thai children
5250333|NCT00626301|efficacy safety LPV/r monotherapy maintenance|efficacy safety lpv/r monotherapy maintenance
5250334|NCT00626301|treatment experienced|treatment experienced
5250335|NCT00626288|Mesalazine in Irritable Bowel Syndrome|mesalazine in irritable bowel syndrome
5250336|NCT00626275|Rheumatoid arthritis|rheumatoid arthritis
5250337|NCT00626275|arthritis|arthritis
5250338|NCT00626262|Gastroesophageal reflux disease|gastroesophageal reflux disease
5250339|NCT00626262|Nexium|nexium
5250340|NCT00626262|Esomeprazole|esomeprazole
5250341|NCT00626262|Administration methods.|administration methods.
5250342|NCT00626249|Nephropathy|nephropathy
5250343|NCT00626249|Kidney Disease|kidney disease
5250344|NCT00626249|Diabetic|diabetic
5250345|NCT00626249|Renal|renal
5250346|NCT00626249|Diabetics|diabetics
5250629|NCT00625313|aphakia|aphakia
5250347|NCT00626236|ADHD and conduct problems|adhd and conduct problems
5250348|NCT00626223|ESRD patients|esrd patients
5250349|NCT00626223|C-reactive protein|c-reactive protein
5250350|NCT00626223|homocysteine|homocysteine
5250351|NCT00626223|5-MTHF|5-mthf
5250352|NCT00626223|survival|survival
5250353|NCT00626223|Hemodialysis patients|hemodialysis patients
5250354|NCT00626210|Mild Cognitive Impairment (MCI)|mild cognitive impairment (mci)
5250355|NCT00626210|Sleep|sleep
5250356|NCT00626210|Fatigue|fatigue
5250357|NCT00626210|Memory|memory
5250358|NCT00626197|SLE|sle
5250359|NCT00626197|Lupus|lupus
5250360|NCT00626197|BELONG|belong
5250361|NCT00626184|Celiac Disease|celiac disease
5250362|NCT00626171|smoking|smoking
5250363|NCT00626171|asthma|asthma
5250364|NCT00626171|sputum|sputum
5250365|NCT00626158|pancreatic cancer|pancreatic cancer
5250366|NCT00626158|biliary cancer|biliary cancer
5250367|NCT00626158|gemcitabine|gemcitabine
5250368|NCT00626158|capecitabine|capecitabine
5250369|NCT00626145|BMMNC|bmmnc
5250370|NCT00626145|STEMI|stemi
5250371|NCT00626145|stem cell|stem cell
5250372|NCT00626145|intracoronary delivery|intracoronary delivery
5250373|NCT00626132|Blood pressure|blood pressure
5250374|NCT00626132|Herbs|herbs
5250375|NCT00626132|Food|food
5250376|NCT00626119|breast cancer|breast cancer
5250377|NCT00626106|postmenopausal|postmenopausal
5250378|NCT00626106|hormone receptor positive|hormone receptor positive
5250379|NCT00626106|locally advanced|locally advanced
5250380|NCT00626106|metastatic|metastatic
5250381|NCT00626080|Insulin|insulin
5250382|NCT00626080|Detemir|detemir
5250383|NCT00626080|Brain|brain
5250384|NCT00626080|Glucose metabolism|glucose metabolism
5250385|NCT00626067|Travatan Dosing Aid|travatan dosing aid
5250386|NCT00626067|compliance monitoring dispenser|compliance monitoring dispenser
5250387|NCT00626054|Colonoscopy|colonoscopy
5250388|NCT00626054|PEG Solution|peg solution
5250389|NCT00626041|Community pharmacies|community pharmacies
5250390|NCT00626041|Primary care networks|primary care networks
5250391|NCT00626041|Global risk assessment|global risk assessment
5250392|NCT00626041|Blood pressure screening|blood pressure screening
5250393|NCT00626028|Pulmonary Vasculature|pulmonary vasculature
5250394|NCT00626028|Nitric Oxide|nitric oxide
5250395|NCT00626028|INOmax®|inomax®
5250396|NCT00626028|Acute Lung Injury|acute lung injury
5250397|NCT00626028|Pulmonary Vasodilator Testing|pulmonary vasodilator testing
5250398|NCT00626028|Idiopathic Pulmonary Arterial Hypertension|idiopathic pulmonary arterial hypertension
5250399|NCT00626028|Congenital Heart Disease|congenital heart disease
5250400|NCT00626028|reversible pulmonary hypertension|reversible pulmonary hypertension
5250401|NCT00626028|vasoreactivity|vasoreactivity
5250402|NCT00626015|adult glioblastoma|adult glioblastoma
5250403|NCT00626015|adult giant cell glioblastoma|adult giant cell glioblastoma
5250404|NCT00626015|adult gliosarcoma|adult gliosarcoma
5250405|NCT00626015|adult high grade glioma|adult high grade glioma
5250406|NCT00626002|Open label|open label
5250407|NCT00625989|asthma|asthma
5250408|NCT00625989|atopy|atopy
5250410|NCT00625989|sputum myeloid and plasmacytoid dendritic cells|sputum myeloid and plasmacytoid dendritic cells
5250411|NCT00625976|Complex regional pain syndrome type I|complex regional pain syndrome type i
5250412|NCT00625976|Graded exposure in vivo|graded exposure in vivo
5250413|NCT00625976|Physiotherapy|physiotherapy
5250414|NCT00625976|Pain-related fear|pain-related fear
5250415|NCT00625963|Pulmonary Hypertension;|pulmonary hypertension;
5250416|NCT00625963|ILD;|ild;
5250417|NCT00625963|CT Imaging;|ct imaging;
5250418|NCT00625963|Echocardiogram;|echocardiogram;
5250419|NCT00625963|Hemodynamic measurements of RHC.|hemodynamic measurements of rhc.
5250420|NCT00625963|Pulmonary Function Tests|pulmonary function tests
5250421|NCT00625950|Hyperprolactinemia|hyperprolactinemia
5250422|NCT00625950|Endometriosis|endometriosis
5250423|NCT00625950|laparoscopy|laparoscopy
5250424|NCT00625950|angiogenesis, VEGF|angiogenesis, vegf
5250425|NCT00625937|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
5250426|NCT00625937|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5250427|NCT00625937|stage III verrucous carcinoma of the oral cavity|stage iii verrucous carcinoma of the oral cavity
5250428|NCT00625937|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
5250429|NCT00625937|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
5250430|NCT00625937|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5250431|NCT00625937|stage III lymphoepithelioma of the nasopharynx|stage iii lymphoepithelioma of the nasopharynx
5250432|NCT00625937|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
5250433|NCT00625937|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
5250434|NCT00625937|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
5250435|NCT00625937|stage III lymphoepithelioma of the oropharynx|stage iii lymphoepithelioma of the oropharynx
5250436|NCT00625937|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
5250437|NCT00625937|stage IV lymphoepithelioma of the oropharynx|stage iv lymphoepithelioma of the oropharynx
5250438|NCT00625937|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5250439|NCT00625937|tongue cancer|tongue cancer
5250440|NCT00625924|Plastic surgery|plastic surgery
5250441|NCT00625924|reconstruction|reconstruction
5250442|NCT00625911|thoracotomy|thoracotomy
5250443|NCT00625911|minimally invasive direct coronary artery bypass|minimally invasive direct coronary artery bypass
5250444|NCT00625911|ketamine|ketamine
5250445|NCT00625911|pain|pain
5250446|NCT00625898|HER2 positive breast cancer|her2 positive breast cancer
5250447|NCT00625898|invasive breast cancer|invasive breast cancer
5250448|NCT00625898|bevacizumab|bevacizumab
5250449|NCT00625898|NSABP|nsabp
5250450|NCT00625898|Roche|roche
5250451|NCT00625898|CIRG|cirg
5250452|NCT00625898|trastuzumab|trastuzumab
5250453|NCT00625898|cyclophosphamide|cyclophosphamide
5250454|NCT00625898|docetaxel|docetaxel
5250455|NCT00625898|carboplatin|carboplatin
5250456|NCT00625898|5-fluorouracil|5-fluorouracil
5250457|NCT00625898|epirubicin|epirubicin
5250458|NCT00625885|Anterior Cruciate Ligament/injuries|anterior cruciate ligament/injuries
5250459|NCT00625885|Anterior Cruciate Ligament/surgery|anterior cruciate ligament/surgery
5250460|NCT00625885|Knee injuries/surgery|knee injuries/surgery
5250461|NCT00625885|Outcomes research|outcomes research
5250462|NCT00625885|Prospective Studies|prospective studies
5250463|NCT00625859|pharmacodynamics|pharmacodynamics
5250464|NCT00625859|Healthy adult male volunteers,|healthy adult male volunteers,
5250465|NCT00625859|pharmacokinetics,|pharmacokinetics,
5250466|NCT00625820|Kidney Disease|kidney disease
5250467|NCT00625820|Albuminuria|albuminuria
5250468|NCT00625820|Glomerular filtration rate|glomerular filtration rate
5250469|NCT00625807|Stress|stress
5250470|NCT00625807|meditation|meditation
5250471|NCT00625807|stress reduction|stress reduction
5250472|NCT00625807|fMRI|fmri
5250473|NCT00625807|behavioral|behavioral
5250474|NCT00625781|Gestational diabetes mellitus|gestational diabetes mellitus
5250475|NCT00625781|Impaired glucose Tolerance|impaired glucose tolerance
5250476|NCT00625781|Pregnancy|pregnancy
5250477|NCT00625781|Fetal macrosomia|fetal macrosomia
5250478|NCT00625781|Treatment|treatment
5250479|NCT00625781|Perinatal morbidity|perinatal morbidity
5250480|NCT00625768|Antibody|antibody
5250481|NCT00625768|safety|safety
5250482|NCT00625768|tolerability|tolerability
5250483|NCT00625768|efficacy|efficacy
5250484|NCT00625768|metastatic renal cell carcinoma|metastatic renal cell carcinoma
5250485|NCT00625768|metastatic malignant melanoma|metastatic malignant melanoma
5250486|NCT00625755|renal cell carcinoma|renal cell carcinoma
5250487|NCT00625755|AJCC Stage IV (primary or relasped) renal cell carcinoma|ajcc stage iv (primary or relasped) renal cell carcinoma
5250488|NCT00625742|Advanced Cancer|advanced cancer
5250489|NCT00625742|Cancer Cachexia|cancer cachexia
5250490|NCT00625742|Cachexia|cachexia
5250491|NCT00625742|Melatonin|melatonin
5250492|NCT00625742|Juven|juven
5250493|NCT00625742|Exercise Training|exercise training
5250494|NCT00625742|Weight Loss|weight loss
5250495|NCT00625729|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
5250496|NCT00625729|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
5250497|NCT00625729|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
5250498|NCT00625729|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5250499|NCT00625729|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5250500|NCT00625729|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5250501|NCT00625729|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5250502|NCT00625729|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5250503|NCT00625729|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5250504|NCT00625729|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5250505|NCT00625729|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5250506|NCT00625729|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5250507|NCT00625729|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5250508|NCT00625729|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5250509|NCT00625729|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5250510|NCT00625729|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5250511|NCT00625703|Pharmacokinetic|pharmacokinetic
5250512|NCT00625690|lung cancer|lung cancer
5250513|NCT00625677|meningococcal serogroup C vaccine|meningococcal serogroup c vaccine
5250514|NCT00625677|reduced dose|reduced dose
5250515|NCT00625677|meningococcal serogroup C conjugate vaccine|meningococcal serogroup c conjugate vaccine
5250516|NCT00625677|pneumococcal conjugate vaccine|pneumococcal conjugate vaccine
5250517|NCT00625664|Cancer|cancer
5250518|NCT00625664|Neoplasms|neoplasms
5250519|NCT00625664|Bladder|bladder
5250520|NCT00625664|Urothelial Tract|urothelial tract
5250521|NCT00625651|Colon Cancer|colon cancer
5250522|NCT00625651|Colorectal Cancer|colorectal cancer
5250523|NCT00625651|Rectal Cancer|rectal cancer
5250524|NCT00625651|AMG 655|amg 655
5250525|NCT00625651|Bevacizumab|bevacizumab
5250526|NCT00625651|Modified FOLFOX6|modified folfox6
5250527|NCT00625651|mFOLFOX6|mfolfox6
5250529|NCT00625638|Advanced Cancer|advanced cancer
5250530|NCT00625638|Caregiver|caregiver
5250531|NCT00625638|Interactive Voice Response|interactive voice response
5250532|NCT00625638|Symptom Control|symptom control
5250533|NCT00625638|IVR System|ivr system
5250534|NCT00625638|Questionnaire|questionnaire
5250535|NCT00625625|stage I colon cancer|stage i colon cancer
5250536|NCT00625625|stage II colon cancer|stage ii colon cancer
5250537|NCT00625625|stage III colon cancer|stage iii colon cancer
5250538|NCT00625625|stage I rectal cancer|stage i rectal cancer
5250539|NCT00625625|stage II rectal cancer|stage ii rectal cancer
5250540|NCT00625625|stage III rectal cancer|stage iii rectal cancer
5250541|NCT00625586|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
5250542|NCT00625586|stage IV pancreatic cancer|stage iv pancreatic cancer
5250543|NCT00625586|recurrent pancreatic cancer|recurrent pancreatic cancer
5250544|NCT00625573|Colon Cancer|colon cancer
5250545|NCT00625573|Abraxis Oncology|abraxis oncology
5250546|NCT00625573|Abraxane|abraxane
5250547|NCT00625573|Phase II|phase ii
5250548|NCT00625573|Colorectal|colorectal
5250549|NCT00625573|Mt. Sinai Medical Center|mt. sinai medical center
5250550|NCT00625573|CCOP|ccop
5250551|NCT00625560|Chronic hepatitis B|chronic hepatitis b
5250552|NCT00625560|Lamivudine|lamivudine
5250553|NCT00625560|Entecavir|entecavir
5250554|NCT00625534|Hernia|hernia
5250555|NCT00625534|Laparoscopy|laparoscopy
5250556|NCT00625534|Pain|pain
5250557|NCT00625534|Sexual|sexual
5250558|NCT00625534|Quality|quality
5250559|NCT00625521|Discoid lupus erythematosus|discoid lupus erythematosus
5250560|NCT00625495|Gastroesophageal reflux disease|gastroesophageal reflux disease
5250561|NCT00625495|Nexium|nexium
5250562|NCT00625495|Esomeprazole|esomeprazole
5250563|NCT00625495|Administration methods.|administration methods.
5250564|NCT00625482|BCG vaccine|bcg vaccine
5250565|NCT00625482|Oral polio vaccine|oral polio vaccine
5250566|NCT00625482|Vitamin A supplementation|vitamin a supplementation
5250567|NCT00625482|Low-birth-weigth|low-birth-weigth
5250568|NCT00625482|Sex-differential|sex-differential
5250569|NCT00625482|Prevention|prevention
5250570|NCT00625482|Immunological parameters|immunological parameters
5250571|NCT00625469|pulmonary arterial hypertension|pulmonary arterial hypertension
5250572|NCT00625469|idiopathic pulmonary fibrosis|idiopathic pulmonary fibrosis
5250573|NCT00625469|bosentan|bosentan
5250574|NCT00625456|phase I|phase i
5250575|NCT00625456|advanced metastatic solid tumors|advanced metastatic solid tumors
5250576|NCT00625456|oncolytic virus|oncolytic virus
5250577|NCT00625456|vaccinia virus|vaccinia virus
5250578|NCT00625456|melanoma|melanoma
5250579|NCT00625456|lung cancer|lung cancer
5250580|NCT00625456|renal cell carcinoma|renal cell carcinoma
5250581|NCT00625456|squamous cell carcinoma of the head and neck|squamous cell carcinoma of the head and neck
5250582|NCT00625456|Pexa-Vec|pexa-vec
5250583|NCT00625443|Idiopathic Thrombocytopenic Purpura|idiopathic thrombocytopenic purpura
5250584|NCT00625443|ITP|itp
5250585|NCT00625443|Chronic Idiopathic Thrombocytopenic Purpura|chronic idiopathic thrombocytopenic purpura
5250586|NCT00625430|Prostate Cancer|prostate cancer
5250587|NCT00625430|Gene Therapy|gene therapy
5250588|NCT00625430|Fludarabine|fludarabine
5250589|NCT00625430|Adenovirus|adenovirus
5250590|NCT00625430|phase I|phase i
5250591|NCT00625417|male breast cancer|male breast cancer
5250592|NCT00625417|stage IA breast cancer|stage ia breast cancer
5250593|NCT00625417|stage IB breast cancer|stage ib breast cancer
5250594|NCT00625417|stage II breast cancer|stage ii breast cancer
5250595|NCT00625417|stage IIIA breast cancer|stage iiia breast cancer
5250596|NCT00625417|stage IIIB breast cancer|stage iiib breast cancer
5250597|NCT00625417|stage IIIC breast cancer|stage iiic breast cancer
5250598|NCT00625417|stage IV breast cancer|stage iv breast cancer
5250599|NCT00625404|Aspartate Aminotransferase (AST)|aspartate aminotransferase (ast)
5250600|NCT00625404|Alanine Aminotransferase (ALT)|alanine aminotransferase (alt)
5250601|NCT00625404|HIV|hiv
5250602|NCT00625404|HIV Prevention|hiv prevention
5250603|NCT00625404|Oral PrEP|oral prep
5250604|NCT00625404|Truvada|truvada
5250605|NCT00625404|women|women
5250606|NCT00625404|Tenofovir|tenofovir
5250607|NCT00625404|TDF|tdf
5250608|NCT00625404|FTC|ftc
5250609|NCT00625404|emtricitabine|emtricitabine
5250610|NCT00625404|hepatitis|hepatitis
5250611|NCT00625404|Pre-exposure Prophylaxis (PrEP)|pre-exposure prophylaxis (prep)
5250612|NCT00625404|HIV Seronegativity|hiv seronegativity
5250613|NCT00625391|postmenopausal, bone, dietary supplement, mind-body exercise|postmenopausal, bone, dietary supplement, mind-body exercise
5250614|NCT00625378|Cancer|cancer
5250615|NCT00625378|Sorafenib|sorafenib
5250616|NCT00625378|Extension program|extension program
5250617|NCT00625365|DEFINITY|definity
5250618|NCT00625365|Safety|safety
5250619|NCT00625365|Survelliance|survelliance
5250620|NCT00625352|Carcinoma, Non-Small-Cell Lung|carcinoma, non-small-cell lung
5250621|NCT00625352|Aged|aged
5250622|NCT00625352|Gemcitabine|gemcitabine
5250623|NCT00625352|UFT|uft
5250624|NCT00625339|Chronic hepatitis B|chronic hepatitis b
5250625|NCT00625339|Lamivudine|lamivudine
5250626|NCT00625339|Entecavir|entecavir
5250627|NCT00625326|psoriasis|psoriasis
5250628|NCT00625313|Cataract|cataract
5250630|NCT00625313|intraocular lens|intraocular lens
5250631|NCT00625313|IOL|iol
5250632|NCT00625313|Optical correction of aphakia|optical correction of aphakia
5250633|NCT00625300|repetitive transcranial stimulation|repetitive transcranial stimulation
5250634|NCT00625300|Parkinson's Disease|parkinson's disease
5250635|NCT00625274|Nexium|nexium
5250636|NCT00625274|esomeprazole|esomeprazole
5250637|NCT00625274|lansoprazole|lansoprazole
5250638|NCT00625274|pantoprazole|pantoprazole
5250639|NCT00625274|Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)|nonsteroidal anti-inflammatory drugs (nsaids)
5250640|NCT00625261|Language delay|language delay
5250641|NCT00625261|Speech and language disorders|speech and language disorders
5250642|NCT00625261|Early language intervention|early language intervention
5250643|NCT00625261|Parent-based language intervention|parent-based language intervention
5250644|NCT00625235|Obesity|obesity
5250645|NCT00625235|Weight loss|weight loss
5250646|NCT00625235|Weight maintenance|weight maintenance
5250647|NCT00625235|VLED|vled
5250648|NCT00625222|Electroencephalography|electroencephalography
5250649|NCT00625222|Seizure frequency|seizure frequency
5250650|NCT00625222|Seizure severity|seizure severity
5250651|NCT00625209|septic shock|septic shock
5250652|NCT00625209|coagulation|coagulation
5250653|NCT00625209|immunomodulation|immunomodulation
5250654|NCT00625209|survival|survival
5250655|NCT00625196|Healthy Japanese volunteers|healthy japanese volunteers
5250656|NCT00625183|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5250657|NCT00625183|stage II rectal cancer|stage ii rectal cancer
5250658|NCT00625183|stage III rectal cancer|stage iii rectal cancer
5250659|NCT00625170|Antipsychotics|antipsychotics
5250660|NCT00625170|Olanzapine|olanzapine
5250661|NCT00625170|Haloperidol|haloperidol
5250662|NCT00625170|Insulin resistance|insulin resistance
5250663|NCT00625170|Dyslipidemia|dyslipidemia
5250664|NCT00625131|Stress Disorders, Posttraumatic|stress disorders, posttraumatic
5250665|NCT00625131|Tobacco Use Disorder|tobacco use disorder
5250666|NCT00625118|Hib conjugate vaccine|hib conjugate vaccine
5250667|NCT00625118|reactogenicity|reactogenicity
5250668|NCT00625118|local reactions|local reactions
5250669|NCT00625118|systemic symptoms|systemic symptoms
5250670|NCT00625092|peritoneal cavity cancer|peritoneal cavity cancer
5250671|NCT00625079|pulmonary hypertension|pulmonary hypertension
5250672|NCT00625079|pulmonary arterial hypertension|pulmonary arterial hypertension
5250673|NCT00625079|interstitial lung disease|interstitial lung disease
5250674|NCT00625079|idiopathic pulmonary fibrosis|idiopathic pulmonary fibrosis
5250675|NCT00625066|precancerous condition|precancerous condition
5250676|NCT00625066|colon cancer|colon cancer
5250677|NCT00625066|rectal cancer|rectal cancer
5250678|NCT00625053|Neuroticism|neuroticism
5250679|NCT00625053|Hernia, ventral|hernia, ventral
5250680|NCT00625053|Laparoscopy|laparoscopy
5250681|NCT00625053|Quality of life|quality of life
5250682|NCT00625040|Incretin effect|incretin effect
5250683|NCT00625040|Gastric banding|gastric banding
5250684|NCT00625040|Glucagon|glucagon
5250685|NCT00625040|Glucagon-Like Peptide 1|glucagon-like peptide 1
5250686|NCT00625040|Gastric Inhibitory Peptide|gastric inhibitory peptide
5250687|NCT00625040|Glucose Intestinal Peptide|glucose intestinal peptide
5250688|NCT00625040|Insulin|insulin
5250689|NCT00625040|C-peptide|c-peptide
5250690|NCT00625027|Emergency Department Visit|emergency department visit
5250691|NCT00625027|Telehealth Ontario|telehealth ontario
5250692|NCT00625027|Triage Levels|triage levels
5250693|NCT00625014|Insulin resistance|insulin resistance
5250694|NCT00625014|Dyslipidemia|dyslipidemia
5250695|NCT00625014|Haloperidol|haloperidol
5250696|NCT00625001|Turner Syndrome|turner syndrome
5250697|NCT00625001|bone mineral density|bone mineral density
5250698|NCT00625001|estrogen replacement therapy|estrogen replacement therapy
5250699|NCT00625001|dual energy x-ray absorptiometry|dual energy x-ray absorptiometry
5250700|NCT00624988|Spinal cord injury|spinal cord injury
5250701|NCT00624988|vibration therapy|vibration therapy
5250702|NCT00624988|bone density|bone density
5250703|NCT00624962|childhood soft tissue sarcoma|childhood soft tissue sarcoma
5250704|NCT00624962|neuroblastoma|neuroblastoma
5250705|NCT00624962|childhood hepatoblastoma|childhood hepatoblastoma
5250706|NCT00624962|childhood cerebellar astrocytoma|childhood cerebellar astrocytoma
5250707|NCT00624962|childhood ependymoma|childhood ependymoma
5250708|NCT00624962|childhood brain stem glioma|childhood brain stem glioma
5250709|NCT00624962|childhood meningioma|childhood meningioma
5250710|NCT00624962|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
5250711|NCT00624962|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
5250712|NCT00624962|childhood acute myeloid leukemia/other myeloid malignancies|childhood acute myeloid leukemia/other myeloid malignancies
5250713|NCT00624962|central nervous system neoplasm|central nervous system neoplasm
5250714|NCT00624962|Wilms tumor and other childhood kidney tumors|wilms tumor and other childhood kidney tumors
5250715|NCT00624962|childhood brain tumor|childhood brain tumor
5250716|NCT00624962|childhood medulloblastoma|childhood medulloblastoma
5250717|NCT00624949|Turner syndrome|turner syndrome
5250718|NCT00624949|aortic dimensions|aortic dimensions
5250719|NCT00624949|blood pressure|blood pressure
5250720|NCT00624949|aortic dilatation|aortic dilatation
5250721|NCT00624949|aortic rupture|aortic rupture
5250722|NCT00624936|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5250723|NCT00624936|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5250724|NCT00624936|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5250725|NCT00624936|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5250726|NCT00624936|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5250727|NCT00624936|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5250728|NCT00624936|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
5250729|NCT00624936|myelodysplastic syndromes|myelodysplastic syndromes
5250730|NCT00624936|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5250731|NCT00624923|Coronary Artery Disease|coronary artery disease
5250732|NCT00624923|Inflammation|inflammation
5250733|NCT00624923|Overweight|overweight
5250734|NCT00624923|Metabolic Syndrome|metabolic syndrome
5250735|NCT00624923|Salsalate|salsalate
5250736|NCT00624910|Post Operative Pain|post operative pain
5250737|NCT00624910|Hysterectomy|hysterectomy
5250738|NCT00624884|Aortic regurgitation,velocity vector imaging|aortic regurgitation,velocity vector imaging
5250739|NCT00624871|Interleukin 1-beta|interleukin 1-beta
5250740|NCT00624871|Interleukin 6|interleukin 6
5250741|NCT00624871|Vitamin C|vitamin c
5250742|NCT00624871|HIE|hie
5250743|NCT00624871|neonates|neonates
5250744|NCT00624858|Depression|depression
5250745|NCT00624858|depressed|depressed
5250746|NCT00624858|overweight|overweight
5250747|NCT00624858|obese|obese
5250748|NCT00624845|Meniscectomy|meniscectomy
5250749|NCT00624832|Asthma|asthma
5250750|NCT00624832|allergen challenge|allergen challenge
5250751|NCT00624832|bronchoprovocation|bronchoprovocation
5250752|NCT00624832|Methacholine challenge|methacholine challenge
5250753|NCT00624832|serum Immunoglobulin E|serum immunoglobulin e
5250754|NCT00624832|Nitric Oxide|nitric oxide
5250755|NCT00624832|skin prick test|skin prick test
5250756|NCT00624819|Streptococcus pneumoniae|streptococcus pneumoniae
5250757|NCT00624819|Haemophilus influenzae|haemophilus influenzae
5250758|NCT00624819|Pneumococcal conjugate vaccine|pneumococcal conjugate vaccine
5250759|NCT00624819|Antibody persistence|antibody persistence
5250760|NCT00624806|Pressure ulcer|pressure ulcer
5250761|NCT00624806|Telemedicine|telemedicine
5250762|NCT00624793|Nausea|nausea
5250763|NCT00624793|Vomiting|vomiting
5250764|NCT00624793|Retching|retching
5250765|NCT00624793|HIV/AIDS|hiv/aids
5250766|NCT00624793|Symptom Management|symptom management
5250767|NCT00624793|Complementary Therapies|complementary therapies
5250768|NCT00624767|insulin|insulin
5250769|NCT00624767|insulin aspart|insulin aspart
5250770|NCT00624767|Type 2 Diabetes|type 2 diabetes
5250771|NCT00624767|diabetes mellitus|diabetes mellitus
5250772|NCT00624754|Obstructive airway disease|obstructive airway disease
5250773|NCT00624754|bronchiolitis obliterans|bronchiolitis obliterans
5250774|NCT00624754|allogeneic hematopoietic stem cell transplantation|allogeneic hematopoietic stem cell transplantation
5250775|NCT00624754|bone marrow transplantation|bone marrow transplantation
5250776|NCT00624754|inhaled treatment|inhaled treatment
5250777|NCT00624754|Budesonide Formoterol|budesonide formoterol
5250778|NCT00624741|Parkinson's disease|parkinson's disease
5250779|NCT00624741|Antiparkinsonian|antiparkinsonian
5250780|NCT00624741|Compassionate use|compassionate use
5250781|NCT00624728|Positron-Emission Tomography|positron-emission tomography
5250782|NCT00624728|Alovudine [Substance Name]|alovudine [substance name]
5250783|NCT00624728|18F-FLT|18f-flt
5250784|NCT00624728|Magnetic Resonance Imaging|magnetic resonance imaging
5250785|NCT00624728|Astrocytoma|astrocytoma
5250786|NCT00624728|Glioblastoma|glioblastoma
5250787|NCT00624702|Asthma, cough, spirometry, maleate, xinafoate, acetate, SDDPI (single dose dry powder inhaler)|asthma, cough, spirometry, maleate, xinafoate, acetate, sddpi (single dose dry powder inhaler)
5250788|NCT00624689|Body composition|body composition
5250789|NCT00624689|Glucose tolerance|glucose tolerance
5250790|NCT00624689|Intima-media thickness|intima-media thickness
5250791|NCT00624689|Visual acuity|visual acuity
5250792|NCT00624689|Neurological development|neurological development
5250793|NCT00624676|Acne|acne
5250794|NCT00624676|lipophilic hydroxy acid|lipophilic hydroxy acid
5250795|NCT00624676|benzoyl peroxide|benzoyl peroxide
5250796|NCT00624663|Rivastigmine, Repeated administration, Healthy Volunteers, organophosphate poisoning, protection, pharmacokinetics, behavioral effects|rivastigmine, repeated administration, healthy volunteers, organophosphate poisoning, protection, pharmacokinetics, behavioral effects
5250797|NCT00624650|Acute Lung Injury|acute lung injury
5250798|NCT00624650|Extravascular Lung Water|extravascular lung water
5250799|NCT00624650|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
5250800|NCT00624637|aromatherapy|aromatherapy
5250801|NCT00624637|massage|massage
5250802|NCT00624637|comfort|comfort
5250803|NCT00624637|postoperative|postoperative
5250804|NCT00624637|infants|infants
5250805|NCT00624637|craniofacial surgery|craniofacial surgery
5250806|NCT00624624|hypogonadotropic hypogonadism|hypogonadotropic hypogonadism
5250807|NCT00624624|bariatric surgery|bariatric surgery
5250808|NCT00624624|serum androgen levels|serum androgen levels
5250809|NCT00624624|bone density|bone density
5250810|NCT00624611|CPB|cpb
5250811|NCT00624611|red blood cell washing|red blood cell washing
5250812|NCT00624585|MDS|mds
5250813|NCT00624585|MDS/MPD|mds/mpd
5250814|NCT00624585|MDS/AML|mds/aml
5250815|NCT00624585|CMML|cmml
5250816|NCT00624585|Excess Marrow Blasts|excess marrow blasts
5250817|NCT00624572|primary teeth|primary teeth
5250818|NCT00624572|chlorexidine|chlorexidine
5250819|NCT00624572|root canal therapy|root canal therapy
5250820|NCT00624572|Pulpectomy|pulpectomy
5250821|NCT00624559|Salt sensitivity of Blood Pressure|salt sensitivity of blood pressure
5250822|NCT00624546|GERD|gerd
5250823|NCT00624546|gastroesophageal reflux|gastroesophageal reflux
5250824|NCT00624546|antireflux surgery|antireflux surgery
5250825|NCT00624546|Barrett's|barrett's
5250826|NCT00624546|Esophagus|esophagus
5250827|NCT00624546|Esophagitis|esophagitis
5250828|NCT00624533|Low back Pain|low back pain
5250829|NCT00624533|Physical Therapy Modalities|physical therapy modalities
5250830|NCT00624533|Exercise Movement Techniques|exercise movement techniques
5250831|NCT00624533|Primary Health Care|primary health care
5250832|NCT00624520|Stress, Psychological|stress, psychological
5250833|NCT00624520|Tachycardia, Ventricular|tachycardia, ventricular
5250834|NCT00624520|Defibrillators, Implantable|defibrillators, implantable
5250835|NCT00624520|Death, Sudden Cardiac|death, sudden cardiac
5250836|NCT00624520|Cognitive Therapy|cognitive therapy
5250837|NCT00624520|Anger|anger
5250838|NCT00624494|venous oxygen saturation|venous oxygen saturation
5250839|NCT00624494|transpulmonary thermodilution|transpulmonary thermodilution
5250840|NCT00624481|osteoporosis|osteoporosis
5250841|NCT00624481|osteopenia|osteopenia
5250842|NCT00624481|bone mineral density|bone mineral density
5250843|NCT00624481|teriparatide|teriparatide
5250844|NCT00624468|atacicept|atacicept
5250845|NCT00624468|neuritis|neuritis
5250846|NCT00624455|Gabapentin|gabapentin
5250847|NCT00624455|tonsillectomy|tonsillectomy
5250848|NCT00624455|post-operative pain|post-operative pain
5250849|NCT00624455|morphine requirements|morphine requirements
5250850|NCT00624455|randomized double blind|randomized double blind
5250851|NCT00624455|adenotonsillectomy|adenotonsillectomy
5250852|NCT00624429|Asthma|asthma
5250853|NCT00624429|Children|children
5250854|NCT00624416|Obesity therapy|obesity therapy
5250855|NCT00624416|fat|fat
5250856|NCT00624416|drug mechanism|drug mechanism
5250857|NCT00624416|adipose tissue|adipose tissue
5250858|NCT00624416|cellular pharmacology|cellular pharmacology
5250859|NCT00624403|Anesthesia|anesthesia
5250860|NCT00624403|Laryngeal mask airway|laryngeal mask airway
5250861|NCT00624351|Lupus|lupus
5250862|NCT00624351|Monoclonal antibody|monoclonal antibody
5250863|NCT00624351|B-Cell immunotherapy|b-cell immunotherapy
5250864|NCT00624338|Atacicept 75 and 150 mg|atacicept 75 and 150 mg
5250865|NCT00624338|Placebo|placebo
5250866|NCT00624325|genotype 1 nonresponders|genotype 1 nonresponders
5250867|NCT00624312|Procrit|procrit
5250868|NCT00624312|Erythropoietin|erythropoietin
5250869|NCT00624312|Patients undergoing major surgical oncology operations|patients undergoing major surgical oncology operations
5250870|NCT00624299|botox|botox
5250871|NCT00624299|limb reconstructions|limb reconstructions
5250872|NCT00624299|limb reconstruction surgery|limb reconstruction surgery
5250873|NCT00624286|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
5250874|NCT00624286|COPD|copd
5250875|NCT00624286|indacaterol|indacaterol
5250876|NCT00624273|digital ulcers,|digital ulcers,
5250877|NCT00624273|systemic sclerosis,|systemic sclerosis,
5250878|NCT00624273|sildenafil,|sildenafil,
5250879|NCT00624273|vasoactive therapies|vasoactive therapies
5250880|NCT00624260|Colorectal cancer|colorectal cancer
5250881|NCT00624260|Recurrence|recurrence
5250882|NCT00624260|Positron Emission Tomography|positron emission tomography
5250883|NCT00624260|Colorectal Cancer with high risk of recurrence stage III|colorectal cancer with high risk of recurrence stage iii
5250884|NCT00624260|Colorectal Cancer with high risk of recurrence stage IV|colorectal cancer with high risk of recurrence stage iv
5250885|NCT00624260|T4N0M0 operated in emergency( because of perforation)|t4n0m0 operated in emergency( because of perforation)
5250886|NCT00624247|routine HIV testing|routine hiv testing
5250887|NCT00624247|jails|jails
5250888|NCT00624247|criminal justice system|criminal justice system
5250889|NCT00624247|substance abuse|substance abuse
5250890|NCT00624247|mental illness|mental illness
5250891|NCT00624247|HIV|hiv
5250892|NCT00624234|neurofibromatosis type 1|neurofibromatosis type 1
5250893|NCT00624234|reading disabilities|reading disabilities
5250894|NCT00624234|NF-1|nf-1
5250895|NCT00624234|learning disabilities|learning disabilities
5250896|NCT00624234|tutoring intervention|tutoring intervention
5250897|NCT00624208|Randomized|randomized
5250898|NCT00624208|double-blind|double-blind
5250899|NCT00624208|4-group clinical interventional study|4-group clinical interventional study
5250900|NCT00624195|HIV Dementia|hiv dementia
5250901|NCT00624195|HAART|haart
5250902|NCT00624195|Cognitive Impairment|cognitive impairment
5250903|NCT00624195|Antiretroviral Regimen|antiretroviral regimen
5250904|NCT00624195|Viral Load|viral load
5250905|NCT00624195|CNS Drug Penetration|cns drug penetration
5250906|NCT00624169|Perforated peptic ulcer|perforated peptic ulcer
5250907|NCT00624169|Mortality|mortality
5250908|NCT00624156|Breast Cancer|breast cancer
5250909|NCT00624143|Antifungal prophylaxis, acute leukemia induction,|antifungal prophylaxis, acute leukemia induction,
5250910|NCT00624130|Contraception,|contraception,
5250911|NCT00624130|Cycle control,|cycle control,
5250912|NCT00624130|Bleeding pattern|bleeding pattern
5250913|NCT00624117|shoulder joint|shoulder joint
5250914|NCT00624117|recovery of function|recovery of function
5250915|NCT00624117|effectiveness of rehabilitation|effectiveness of rehabilitation
5250916|NCT00624117|rehabilitation|rehabilitation
5250917|NCT00624104|VLDL|vldl
5250918|NCT00624104|Kinetics|kinetics
5250919|NCT00624104|Hyperinsulinaemia|hyperinsulinaemia
5250920|NCT00624104|Obesity|obesity
5250921|NCT00624091|Early-surgery, infective endocarditis, in-hospital mortality|early-surgery, infective endocarditis, in-hospital mortality
5250922|NCT00624078|faboterapics|faboterapics
5250923|NCT00624078|treatment|treatment
5250924|NCT00624078|scorpion sting|scorpion sting
5250925|NCT00624078|envenomation|envenomation
5250926|NCT00624065|target blood pressure|target blood pressure
5250927|NCT00624065|hypertension|hypertension
5250928|NCT00624065|COREG CR|coreg cr
5250929|NCT00624065|carvedilol CR|carvedilol cr
5250930|NCT00624065|Stage 1 or 2 essential hypertension|stage 1 or 2 essential hypertension
5250931|NCT00624065|lisinopril|lisinopril
5250932|NCT00624039|presbyopia|presbyopia
5250933|NCT00624013|Diabetes|diabetes
5250934|NCT00624013|Depression|depression
5250935|NCT00624013|diabetes outcomes|diabetes outcomes
5250936|NCT00624013|quality of life|quality of life
5250937|NCT00624000|Ischemic Stroke|ischemic stroke
5250938|NCT00623987|Residual vein thrombosis|residual vein thrombosis
5250939|NCT00623987|Optimal duration|optimal duration
5250940|NCT00623987|Oral anticoagulants|oral anticoagulants
5250941|NCT00623974|Hypocalcemia|hypocalcemia
5250942|NCT00623974|Teriparatide|teriparatide
5250943|NCT00623974|Forteo|forteo
5250944|NCT00623974|Calcium|calcium
5250945|NCT00623974|Calcitriol|calcitriol
5250946|NCT00623974|Rocaltrol|rocaltrol
5250947|NCT00623961|Neuropathic Pain|neuropathic pain
5250948|NCT00623948|Pressure ulcers|pressure ulcers
5250949|NCT00623948|Electrical Stimulation|electrical stimulation
5250950|NCT00623948|Spinal Cord Injury|spinal cord injury
5250951|NCT00623935|AML|aml
5250952|NCT00623922|Patient education|patient education
5250953|NCT00623922|Nurse consultation|nurse consultation
5250954|NCT00623922|Arthritis|arthritis
5250955|NCT00623922|Wellbeing|wellbeing
5250956|NCT00623922|Coping|coping
5250957|NCT00623922|Health related quality of life|health related quality of life
5250958|NCT00623909|Laser Therapy|laser therapy
5250959|NCT00623909|Post Thoracotomy Pain|post thoracotomy pain
5250960|NCT00623909|AvicennaTM laser|avicennatm laser
5250961|NCT00623896|Nehb|nehb
5250962|NCT00623896|ST Elevation Myocardial Infarcton|st elevation myocardial infarcton
5250963|NCT00623896|STEMI|stemi
5250964|NCT00623896|ECG|ecg
5250965|NCT00623883|Human Colonic Aberrant Crypt Foci|human colonic aberrant crypt foci
5250966|NCT00623857|Micronutrients|micronutrients
5250967|NCT00623857|Zinc|zinc
5250968|NCT00623857|Vitamins|vitamins
5250969|NCT00623857|Trace elements|trace elements
5250970|NCT00623857|Minerals|minerals
5250971|NCT00623857|Vitamin A|vitamin a
5250972|NCT00623857|Vitamin B1|vitamin b1
5250973|NCT00623857|Vitamin B2|vitamin b2
5250974|NCT00623857|Niacin|niacin
5250975|NCT00623857|Vitamin B6|vitamin b6
5250976|NCT00623857|Folic acid|folic acid
5250977|NCT00623857|Vitamin B12|vitamin b12
5250978|NCT00623857|Vitamin C|vitamin c
5250979|NCT00623857|Vitamin D|vitamin d
5250980|NCT00623857|Vitamin E|vitamin e
5250981|NCT00623857|Vitamin K|vitamin k
5250982|NCT00623857|Iron|iron
5250983|NCT00623857|Iodine|iodine
5250984|NCT00623857|Copper|copper
5250985|NCT00623857|Selenium|selenium
5250986|NCT00623857|Magnesium|magnesium
5250987|NCT00623857|Calcium|calcium
5250988|NCT00623857|Malaria|malaria
5250989|NCT00623857|Immunity|immunity
5250990|NCT00623857|Anthropometry|anthropometry
5250991|NCT00623844|Prevention|prevention
5250992|NCT00623844|Physical activity|physical activity
5250993|NCT00623844|Obesity|obesity
5250994|NCT00623844|Motor skills|motor skills
5250995|NCT00623844|Kindergarten|kindergarten
5250996|NCT00623831|MBV|mbv
5250997|NCT00623831|Mixed Bacterial Vaccine|mixed bacterial vaccine
5250998|NCT00623831|NY-ESO-1|ny-eso-1
5250999|NCT00623818|Mirror Therapy|mirror therapy
5251000|NCT00623818|Phantom Limb Pain|phantom limb pain
5251001|NCT00623818|Amputee|amputee
5251002|NCT00623818|Healthy Volunteer|healthy volunteer
5251003|NCT00623818|HV|hv
5251004|NCT00623792|Morbid obesity|morbid obesity
5251005|NCT00623792|Diet therapy|diet therapy
5251006|NCT00623792|Bariatric Surgery|bariatric surgery
5251007|NCT00623792|Gastric bypass|gastric bypass
5251008|NCT00623792|Behavior therapy|behavior therapy
5251009|NCT00623792|Randomized controlled trial|randomized controlled trial
5251010|NCT00623792|Weight loss|weight loss
5251011|NCT00623753|Vaccine|vaccine
5251012|NCT00623753|Prevention|prevention
5251013|NCT00623753|HIV|hiv
5251014|NCT00623753|AIDS|aids
5251015|NCT00623753|Human Immunodeficiency Virus|human immunodeficiency virus
5251138|NCT00623129|laryngeal cancer|laryngeal cancer
5251016|NCT00623753|HIV Seronegativity, HIV Preventive Vaccine|hiv seronegativity, hiv preventive vaccine
5251017|NCT00623740|Hydrocortisone|hydrocortisone
5251018|NCT00623740|Very low birth weight|very low birth weight
5251019|NCT00623740|Bronchopulmonary dysplasia|bronchopulmonary dysplasia
5251020|NCT00623740|Prevention Cerebral palsy|prevention cerebral palsy
5251021|NCT00623727|Hemophilia A|hemophilia a
5251022|NCT00623727|FVIII disease|fviii disease
5251023|NCT00623727|rFVIII|rfviii
5251024|NCT00623701|sublingual grass pollen preparation|sublingual grass pollen preparation
5251025|NCT00623701|IgE-mediated Allergic Disease attributed to grass pollen|ige-mediated allergic disease attributed to grass pollen
5251026|NCT00623688|Metered Dose Inhalers|metered dose inhalers
5251027|NCT00623688|Nebulizers|nebulizers
5251028|NCT00623688|Randomized Controlled Trial|randomized controlled trial
5251029|NCT00623675|zeolites|zeolites
5251030|NCT00623675|nutraceuticals|nutraceuticals
5251031|NCT00623675|natural supplements|natural supplements
5251032|NCT00623675|Healthy volunteers|healthy volunteers
5251033|NCT00623662|Glucose infusion|glucose infusion
5251034|NCT00623662|Liver function|liver function
5251035|NCT00623662|Liver resection|liver resection
5251036|NCT00623662|Albumin synthesis|albumin synthesis
5251037|NCT00623662|Stable isotopes|stable isotopes
5251038|NCT00623636|Migraine|migraine
5251039|NCT00623610|Diabetes mellitus, type 1|diabetes mellitus, type 1
5251040|NCT00623610|pancreatic beta cell|pancreatic beta cell
5251041|NCT00623610|transplantation|transplantation
5251042|NCT00623584|penetrating keratoplasty|penetrating keratoplasty
5251043|NCT00623584|corneal transplantation|corneal transplantation
5251044|NCT00623584|corneal grafting|corneal grafting
5251045|NCT00623584|corneal grafts|corneal grafts
5251046|NCT00623584|culture media|culture media
5251047|NCT00623584|corneal culturing|corneal culturing
5251048|NCT00623584|in vitro culturing|in vitro culturing
5251049|NCT00623571|frail elderly|frail elderly
5251050|NCT00623571|hospital at home|hospital at home
5251051|NCT00623571|heart failure|heart failure
5251052|NCT00623571|Acute exacerbation of chronic heart failure|acute exacerbation of chronic heart failure
5251053|NCT00623558|head and neck neoplasm|head and neck neoplasm
5251054|NCT00623558|cetuximab|cetuximab
5251055|NCT00623558|docetaxel|docetaxel
5251056|NCT00623558|cisplatin|cisplatin
5251057|NCT00623558|radiotherapy|radiotherapy
5251058|NCT00623545|Exenatide|exenatide
5251059|NCT00623545|Byetta|byetta
5251060|NCT00623545|weight loss|weight loss
5251061|NCT00623545|energy expenditure|energy expenditure
5251062|NCT00623545|normal volunteers|normal volunteers
5251063|NCT00623532|Tertiary prevention of disability|tertiary prevention of disability
5251064|NCT00623519|Adjuvant postmenopausal breast cancer women|adjuvant postmenopausal breast cancer women
5251066|NCT00623506|Pregnenolone|pregnenolone
5251067|NCT00623506|Cognition|cognition
5251068|NCT00623493|Screening|screening
5251069|NCT00623493|Suicide|suicide
5251070|NCT00623493|Emergency Department|emergency department
5251071|NCT00623493|Children and Adolescents|children and adolescents
5251072|NCT00623493|Suicide Risk|suicide risk
5251073|NCT00623480|Hemophilia A|hemophilia a
5251074|NCT00623467|Central Nervous System Imaging|central nervous system imaging
5251075|NCT00623467|Diagnostic Imaging|diagnostic imaging
5251076|NCT00623454|anxiety|anxiety
5251077|NCT00623454|panic disorder|panic disorder
5251078|NCT00623454|chest pain|chest pain
5251079|NCT00623454|palpitations|palpitations
5251080|NCT00623441|Coronary Artery Disease|coronary artery disease
5251081|NCT00623441|Drug-eluting stent|drug-eluting stent
5251082|NCT00623402|Metastatic melanoma|metastatic melanoma
5251083|NCT00623402|Pegylated interferon|pegylated interferon
5251084|NCT00623402|Protein Kinase Inhibitors|protein kinase inhibitors
5251085|NCT00623402|Sorafenib|sorafenib
5251086|NCT00623402|PegIntron|pegintron
5251087|NCT00623402|Therapeutic Uses|therapeutic uses
5251088|NCT00623402|melanoma (skin)|melanoma (skin)
5251089|NCT00623389|Neurologic disorders|neurologic disorders
5251090|NCT00623389|Rare disease|rare disease
5251091|NCT00623389|Spinal cord injuries|spinal cord injuries
5251092|NCT00623389|Stroke|stroke
5251093|NCT00623389|Paraplegia|paraplegia
5251094|NCT00623389|Tetraplegia|tetraplegia
5251095|NCT00623363|Parkinson's Disease|parkinson's disease
5251096|NCT00623363|motor complications|motor complications
5251097|NCT00623363|dyskinesia|dyskinesia
5251098|NCT00623363|Motor complications associated with Parkinson's|motor complications associated with parkinson's
5251099|NCT00623350|Telemedicine|telemedicine
5251100|NCT00623350|Stroke, Acute|stroke, acute
5251101|NCT00623350|Rural|rural
5251102|NCT00623350|Thrombolysis|thrombolysis
5251103|NCT00623350|Consultation|consultation
5251104|NCT00623337|care seeking|care seeking
5251105|NCT00623337|pregnancy and childbirth|pregnancy and childbirth
5251106|NCT00623337|newborn care practices|newborn care practices
5251107|NCT00623337|low birth weight babies|low birth weight babies
5251108|NCT00623298|Posttraumatic stress disorder|posttraumatic stress disorder
5251109|NCT00623298|depression|depression
5251110|NCT00623298|Narrative Exposure Therapy|narrative exposure therapy
5251111|NCT00623298|Interpersonal Psychotherapy|interpersonal psychotherapy
5251112|NCT00623285|Pain.|pain.
5251113|NCT00623285|Postoperative.|postoperative.
5251114|NCT00623285|CABG.|cabg.
5251115|NCT00623272|The assessment of left ventricular ejection fraction (LVEF)|the assessment of left ventricular ejection fraction (lvef)
5251116|NCT00623246|Obstructive Sleep Apnea|obstructive sleep apnea
5251117|NCT00623246|OSA|osa
5251118|NCT00623246|Adherence|adherence
5251119|NCT00623246|CPAP|cpap
5251120|NCT00623246|Cognition|cognition
5251121|NCT00623233|Breast Neoplasm|breast neoplasm
5251122|NCT00623220|pain, retinopathy of prematurity, infant, premature, eye exam, nitrous oxide|pain, retinopathy of prematurity, infant, premature, eye exam, nitrous oxide
5251123|NCT00623207|Chest Pain Low work Capacity Rate Incompetence|chest pain low work capacity rate incompetence
5251124|NCT00623181|Influenza|influenza
5251125|NCT00623181|Influenza virus|influenza virus
5251126|NCT00623168|Ribavirin|ribavirin
5251127|NCT00623168|Hemorrhagic Fever with Renal Syndrome|hemorrhagic fever with renal syndrome
5251128|NCT00623155|malaria|malaria
5251129|NCT00623155|intermittent preventive treatment|intermittent preventive treatment
5251130|NCT00623155|season|season
5251131|NCT00623155|children|children
5251132|NCT00623142|Myocardial protection|myocardial protection
5251133|NCT00623142|Ischemic Reperfusion Injury|ischemic reperfusion injury
5251134|NCT00623142|Hyperbaric Oxygen|hyperbaric oxygen
5251135|NCT00623142|Preconditioning|preconditioning
5251136|NCT00623129|hypopharyngeal cancer|hypopharyngeal cancer
5251137|NCT00623129|lip and oral cavity cancer|lip and oral cavity cancer
5251139|NCT00623129|nasopharyngeal cancer|nasopharyngeal cancer
5251140|NCT00623129|oropharyngeal cancer|oropharyngeal cancer
5251141|NCT00623129|paranasal sinus and nasal cavity cancer|paranasal sinus and nasal cavity cancer
5251142|NCT00623129|salivary gland cancer|salivary gland cancer
5251143|NCT00623129|xerostomia|xerostomia
5251144|NCT00623129|radiation toxicity|radiation toxicity
5251145|NCT00623116|Kallmann Syndrome|kallmann syndrome
5251146|NCT00623116|hypogonadotropic hypogonadism|hypogonadotropic hypogonadism
5251147|NCT00623103|Parkinson's disease dementia|parkinson's disease dementia
5251148|NCT00623103|cholinesterase inhibitor|cholinesterase inhibitor
5251149|NCT00623103|rivastigmine|rivastigmine
5251150|NCT00623090|prostate cancer screening education|prostate cancer screening education
5251151|NCT00623090|behavioral oncology|behavioral oncology
5251152|NCT00623090|randomized trial|randomized trial
5251153|NCT00623077|metastatic Ewing sarcoma/peripheral primitive neuroectodermal tumor|metastatic ewing sarcoma/peripheral primitive neuroectodermal tumor
5251154|NCT00623077|recurrent Ewing sarcoma/peripheral primitive neuroectodermal tumor|recurrent ewing sarcoma/peripheral primitive neuroectodermal tumor
5251155|NCT00623077|childhood hepatoblastoma|childhood hepatoblastoma
5251156|NCT00623077|recurrent childhood liver cancer|recurrent childhood liver cancer
5251157|NCT00623077|stage IV childhood liver cancer|stage iv childhood liver cancer
5251158|NCT00623077|adult primary liver cancer|adult primary liver cancer
5251159|NCT00623077|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
5251160|NCT00623077|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
5251161|NCT00623077|previously untreated childhood rhabdomyosarcoma|previously untreated childhood rhabdomyosarcoma
5251162|NCT00623077|metastatic childhood soft tissue sarcoma|metastatic childhood soft tissue sarcoma
5251163|NCT00623077|recurrent childhood soft tissue sarcoma|recurrent childhood soft tissue sarcoma
5251164|NCT00623077|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
5251165|NCT00623077|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
5251166|NCT00623077|recurrent Wilms tumor and other childhood kidney tumors|recurrent wilms tumor and other childhood kidney tumors
5251167|NCT00623077|stage IV Wilms tumor|stage iv wilms tumor
5251168|NCT00623077|stage V Wilms tumor|stage v wilms tumor
5251169|NCT00623077|rhabdoid tumor of the kidney|rhabdoid tumor of the kidney
5251170|NCT00623077|stage IV renal cell cancer|stage iv renal cell cancer
5251171|NCT00623077|childhood mixed glioma|childhood mixed glioma
5251172|NCT00623077|recurrent childhood cerebellar astrocytoma|recurrent childhood cerebellar astrocytoma
5251173|NCT00623077|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
5251174|NCT00623077|recurrent childhood ependymoma|recurrent childhood ependymoma
5251175|NCT00623077|recurrent childhood medulloblastoma|recurrent childhood medulloblastoma
5251176|NCT00623077|recurrent childhood pineoblastoma|recurrent childhood pineoblastoma
5251177|NCT00623077|recurrent childhood supratentorial primitive neuroectodermal tumor|recurrent childhood supratentorial primitive neuroectodermal tumor
5251178|NCT00623077|recurrent childhood visual pathway glioma|recurrent childhood visual pathway glioma
5251179|NCT00623077|untreated childhood brain stem glioma|untreated childhood brain stem glioma
5251180|NCT00623077|untreated childhood cerebellar astrocytoma|untreated childhood cerebellar astrocytoma
5251181|NCT00623077|childhood infratentorial ependymoma|childhood infratentorial ependymoma
5251182|NCT00623077|childhood supratentorial ependymoma|childhood supratentorial ependymoma
5251183|NCT00623077|childhood high-grade cerebellar astrocytoma|childhood high-grade cerebellar astrocytoma
5251184|NCT00623077|childhood high-grade cerebral astrocytoma|childhood high-grade cerebral astrocytoma
5251185|NCT00623077|childhood low-grade cerebellar astrocytoma|childhood low-grade cerebellar astrocytoma
5251186|NCT00623077|childhood low-grade cerebral astrocytoma|childhood low-grade cerebral astrocytoma
5251187|NCT00623077|newly diagnosed childhood ependymoma|newly diagnosed childhood ependymoma
5251282|NCT00622791|propofol|propofol
5251188|NCT00623077|childhood atypical teratoid/rhabdoid tumor|childhood atypical teratoid/rhabdoid tumor
5251189|NCT00623077|recurrent retinoblastoma|recurrent retinoblastoma
5251190|NCT00623077|extraocular retinoblastoma|extraocular retinoblastoma
5251191|NCT00623077|intraocular retinoblastoma|intraocular retinoblastoma
5251192|NCT00623077|childhood renal cell carcinoma|childhood renal cell carcinoma
5251193|NCT00623077|clear cell renal cell carcinoma|clear cell renal cell carcinoma
5251194|NCT00623077|recurrent renal cell cancer|recurrent renal cell cancer
5251195|NCT00623077|recurrent childhood visual pathway and hypothalamic glioma|recurrent childhood visual pathway and hypothalamic glioma
5251196|NCT00623077|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5251197|NCT00623077|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
5251198|NCT00623064|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
5251199|NCT00623064|stage IV bladder cancer|stage iv bladder cancer
5251200|NCT00623064|stage III bladder cancer|stage iii bladder cancer
5251201|NCT00623064|metastatic transitional cell cancer of the renal pelvis and ureter|metastatic transitional cell cancer of the renal pelvis and ureter
5251202|NCT00623064|regional transitional cell cancer of the renal pelvis and ureter|regional transitional cell cancer of the renal pelvis and ureter
5251203|NCT00623051|male circumcision|male circumcision
5251204|NCT00623051|HIV|hiv
5251205|NCT00623051|sexual behavior|sexual behavior
5251206|NCT00623051|HIV prevention|hiv prevention
5251207|NCT00623051|HIV Seronegativity|hiv seronegativity
5251208|NCT00623038|Apgar score|apgar score
5251209|NCT00623038|neonatal assessment|neonatal assessment
5251210|NCT00623038|preterm infants|preterm infants
5251211|NCT00623038|resuscitation|resuscitation
5251212|NCT00623025|HIV|hiv
5251213|NCT00623025|Steatorrhea|steatorrhea
5251214|NCT00622999|Malnutrition|malnutrition
5251215|NCT00622999|Colon cancer|colon cancer
5251216|NCT00622999|Colon surgery|colon surgery
5251217|NCT00622999|Outcome|outcome
5251218|NCT00622999|Complication rate|complication rate
5251219|NCT00622973|Prostate cancer|prostate cancer
5251220|NCT00622973|Bladder cancer|bladder cancer
5251221|NCT00622973|Pelvic lymph node metastases|pelvic lymph node metastases
5251222|NCT00622973|Diffusion-weighted MRI|diffusion-weighted mri
5251223|NCT00622973|Sinerem (USPIO)-enhanced MRI|sinerem (uspio)-enhanced mri
5251224|NCT00622973|Imaging influence on surgery|imaging influence on surgery
5251225|NCT00622973|Noninvasive detection of pelvic lymph node metastases|noninvasive detection of pelvic lymph node metastases
5251226|NCT00622973|Influence of imaging protocol on surgical outcome|influence of imaging protocol on surgical outcome
5251227|NCT00622960|obesity|obesity
5251228|NCT00622960|type 2 diabetes|type 2 diabetes
5251229|NCT00622960|weight loss|weight loss
5251230|NCT00622960|monounsaturated fat|monounsaturated fat
5251231|NCT00622960|diet|diet
5251232|NCT00622947|Depression|depression
5251233|NCT00622947|antidepressant effect|antidepressant effect
5251234|NCT00622947|rTMS|rtms
5251235|NCT00622947|sham|sham
5251236|NCT00622947|cognition|cognition
5251237|NCT00622947|saliva cortisol|saliva cortisol
5251238|NCT00622947|brain derived neurotropic factor|brain derived neurotropic factor
5251239|NCT00622934|multiple trauma|multiple trauma
5251240|NCT00622921|PTSD|ptsd
5251241|NCT00622921|alcohol dependence|alcohol dependence
5251242|NCT00622895|scleroderma|scleroderma
5251243|NCT00622895|systemic sclerosis|systemic sclerosis
5251244|NCT00622882|Staphylococcus aureus|staphylococcus aureus
5251245|NCT00622882|Bacteremia|bacteremia
5251246|NCT00622882|Outcome|outcome
5251247|NCT00622882|Mortality|mortality
5251248|NCT00622882|Recurrence|recurrence
5251249|NCT00622882|Infectious Diseases specialists|infectious diseases specialists
5251250|NCT00622869|Liver transplantation|liver transplantation
5251251|NCT00622869|everolimus|everolimus
5251252|NCT00622869|calcineurin inhibitors|calcineurin inhibitors
5251253|NCT00622869|tacrolimus|tacrolimus
5251254|NCT00622869|renal function|renal function
5251255|NCT00622869|MDRD formula|mdrd formula
5251256|NCT00622869|progression of fibrosis|progression of fibrosis
5251257|NCT00622856|diabetes|diabetes
5251258|NCT00622856|adolescents|adolescents
5251259|NCT00622856|psychological therapy|psychological therapy
5251260|NCT00622843|pneumococcal conjugate vaccine|pneumococcal conjugate vaccine
5251261|NCT00622843|polysaccharide vaccine|polysaccharide vaccine
5251262|NCT00622843|PPV|ppv
5251263|NCT00622843|PCV|pcv
5251264|NCT00622843|Streptococcus pneumoniae|streptococcus pneumoniae
5251265|NCT00622843|Prevnar|prevnar
5251266|NCT00622843|Pneumovax|pneumovax
5251267|NCT00622843|HIV|hiv
5251268|NCT00622830|darapladib,|darapladib,
5251269|NCT00622830|SB480848,|sb480848,
5251270|NCT00622830|Japanese healthy volunteers|japanese healthy volunteers
5251271|NCT00622817|Epinephrine|epinephrine
5251272|NCT00622817|Nasal decongestant|nasal decongestant
5251273|NCT00622817|RSV|rsv
5251274|NCT00622817|xylometazoline|xylometazoline
5251275|NCT00622817|Bronchiolitis|bronchiolitis
5251276|NCT00622804|Stomach cancer|stomach cancer
5251277|NCT00622804|Gastrectomy|gastrectomy
5251278|NCT00622804|Postgastrectomy syndrome|postgastrectomy syndrome
5251279|NCT00622791|Cardiopulmonary bypass|cardiopulmonary bypass
5251280|NCT00622791|coronary artery bypass graft|coronary artery bypass graft
5251281|NCT00622791|coronary artery disease|coronary artery disease
5251283|NCT00622791|pharmacokinetics|pharmacokinetics
5251284|NCT00622791|pharmacodynamics|pharmacodynamics
5251285|NCT00622778|intracranial bleeding|intracranial bleeding
5251286|NCT00622778|computed tomography scan|computed tomography scan
5251287|NCT00622765|Obesity, Overweight, Body Weight, Body Size, Nutritional and Metabolic Diseases|obesity, overweight, body weight, body size, nutritional and metabolic diseases
5251288|NCT00622752|Smoking cessation|smoking cessation
5251289|NCT00622752|Craving|craving
5251290|NCT00622752|Smokers|smokers
5251291|NCT00622739|Bipolar Disorder|bipolar disorder
5251292|NCT00622739|Children|children
5251293|NCT00622739|Adolescents|adolescents
5251294|NCT00622739|Treatment|treatment
5251295|NCT00622726|Vascular Endothelial Growth Factor|vascular endothelial growth factor
5251296|NCT00622726|Angiogenesis Inhibitor|angiogenesis inhibitor
5251297|NCT00622726|Premature infants|premature infants
5251298|NCT00622726|Bevacizumab|bevacizumab
5251299|NCT00622726|Zone I or Posterior Zone II ROP|zone i or posterior zone ii rop
5251300|NCT00622726|Aggressive Posterior ROP|aggressive posterior rop
5251301|NCT00622726|Stage 3 ROP|stage 3 rop
5251302|NCT00622726|Neonatal Intensive Care Unit|neonatal intensive care unit
5251303|NCT00622713|Alzheimer's disease|alzheimer's disease
5251304|NCT00622713|cholinesterase inhibitor|cholinesterase inhibitor
5251305|NCT00622713|rivastigmine|rivastigmine
5251306|NCT00622700|MS|ms
5251307|NCT00622700|Clinically Isolated Syndrome|clinically isolated syndrome
5251308|NCT00622700|CIS|cis
5251309|NCT00622700|CDMS|cdms
5251310|NCT00622700|relapses|relapses
5251311|NCT00622687|iloprost|iloprost
5251312|NCT00622687|systemic sclerosis|systemic sclerosis
5251313|NCT00622687|digital ulcers|digital ulcers
5251314|NCT00622687|observational study|observational study
5251315|NCT00622687|randomized|randomized
5251316|NCT00622674|recurrent breast cancer|recurrent breast cancer
5251317|NCT00622674|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5251318|NCT00622674|recurrent small cell lung cancer|recurrent small cell lung cancer
5251319|NCT00622674|recurrent colon cancer|recurrent colon cancer
5251320|NCT00622674|recurrent pancreatic cancer|recurrent pancreatic cancer
5251321|NCT00622674|recurrent head and neck cancer|recurrent head and neck cancer
5251322|NCT00622674|recurrent sarcoma|recurrent sarcoma
5251323|NCT00622674|recurrent kidney cancer|recurrent kidney cancer
5251324|NCT00622674|recurrent renal cell cancer|recurrent renal cell cancer
5251325|NCT00622661|Glycemic response|glycemic response
5251326|NCT00622661|Glycemic index|glycemic index
5251327|NCT00622661|Obesity|obesity
5251328|NCT00622661|Carbohydrates|carbohydrates
5251329|NCT00622661|Insulin|insulin
5251330|NCT00622661|Blood glucose|blood glucose
5251331|NCT00622648|Medical prevention therapy|medical prevention therapy
5251332|NCT00622635|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
5251333|NCT00622635|COPD|copd
5251334|NCT00622635|indacaterol|indacaterol
5251335|NCT00622609|first time in human,|first time in human,
5251336|NCT00622609|MAG|mag
5251337|NCT00622609|monoclonal antibody,|monoclonal antibody,
5251338|NCT00622609|healthy subjects,|healthy subjects,
5251339|NCT00622609|GSK249320,|gsk249320,
5251340|NCT00622596|opiate dependence|opiate dependence
5251341|NCT00622596|buprenorphine|buprenorphine
5251342|NCT00622583|Herniorrhaphy|herniorrhaphy
5251343|NCT00622570|Traumatic brain injury, barbiturate coma|traumatic brain injury, barbiturate coma
5251344|NCT00622544|Microalbuminuria|microalbuminuria
5251345|NCT00622544|Proteinuria|proteinuria
5251346|NCT00622531|heart failure|heart failure
5251347|NCT00622531|BNP|bnp
5251348|NCT00622531|natriuretic peptide|natriuretic peptide
5251349|NCT00622518|otitis media|otitis media
5251350|NCT00622518|children|children
5251351|NCT00622505|Multiple myeloma|multiple myeloma
5251352|NCT00622505|zoledronic acid|zoledronic acid
5251353|NCT00622505|skeletal complications|skeletal complications
5251354|NCT00622505|bone|bone
5251355|NCT00622492|VV-ECMO|vv-ecmo
5251356|NCT00622492|VA-ECMO|va-ecmo
5251357|NCT00622492|PPHN|pphn
5251358|NCT00622492|organ circulation|organ circulation
5251359|NCT00622479|Sorafenib|sorafenib
5251360|NCT00622479|Hypophosphatemia|hypophosphatemia
5251361|NCT00622479|Left ventricular ejection fraction (LVEF)|left ventricular ejection fraction (lvef)
5251362|NCT00622479|Beta-type Natriuretic Peptide (BNP)|beta-type natriuretic peptide (bnp)
5251363|NCT00622466|stage IV breast cancer|stage iv breast cancer
5251364|NCT00622466|male breast cancer|male breast cancer
5251365|NCT00622466|recurrent breast cancer|recurrent breast cancer
5251366|NCT00622466|HER2-negative breast cancer|her2-negative breast cancer
5251367|NCT00622440|HSIL|hsil
5251368|NCT00622440|HGAIN|hgain
5251369|NCT00622440|AIN|ain
5251370|NCT00622440|neoplasia|neoplasia
5251371|NCT00622440|dysplasia|dysplasia
5251373|NCT00622440|Traditional Chinese Medicine|traditional chinese medicine
5251374|NCT00622401|stage IV breast cancer|stage iv breast cancer
5251375|NCT00622401|dendritic cell vaccine|dendritic cell vaccine
5251376|NCT00622401|tumor fusion vaccine|tumor fusion vaccine
5251377|NCT00622401|IL-12|il-12
5251378|NCT00622375|Pharmacokinetic study|pharmacokinetic study
5251379|NCT00622375|Healthy subjects|healthy subjects
5251380|NCT00622362|Immunotherapy|immunotherapy
5251381|NCT00622362|Allergy|allergy
5251382|NCT00622362|Allergoid|allergoid
5251383|NCT00622362|Depigmented|depigmented
5251384|NCT00622362|Polymerized|polymerized
5251385|NCT00622362|Allergen-extract|allergen-extract
5251386|NCT00622362|mites|mites
5251387|NCT00622362|Asthma|asthma
5251388|NCT00622349|Randomised phase III|randomised phase iii
5251389|NCT00622349|Chemotherapy|chemotherapy
5251390|NCT00622349|Advanced non-small cell lung carcinoma|advanced non-small cell lung carcinoma
5251391|NCT00622336|Multiple Myeloma|multiple myeloma
5251392|NCT00622336|Revlimid|revlimid
5251393|NCT00622323|diabetes|diabetes
5251394|NCT00622323|exenatide|exenatide
5251395|NCT00622323|metformin|metformin
5251396|NCT00622323|sulfonylurea|sulfonylurea
5251397|NCT00622323|Byetta|byetta
5251398|NCT00622323|Amylin|amylin
5251399|NCT00622323|Lilly|lilly
5251400|NCT00622271|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
5251401|NCT00622271|Adolescents and Families|adolescents and families
5251402|NCT00622271|Group Therapy Intervention|group therapy intervention
5251403|NCT00622258|everolimus|everolimus
5251404|NCT00622258|mTOR inhibitor|mtor inhibitor
5251405|NCT00622258|non-Hodgkin's lymphoma|non-hodgkin's lymphoma
5251406|NCT00622245|Depression|depression
5251407|NCT00622245|Bipolar disorder|bipolar disorder
5251408|NCT00622245|Placebo-controlled|placebo-controlled
5251409|NCT00622245|Double-blind|double-blind
5251410|NCT00622245|Multicenter|multicenter
5251411|NCT00622245|Clinical study|clinical study
5251412|NCT00622245|Mania|mania
5251413|NCT00622232|HIV-1|hiv-1
5251414|NCT00622232|treatment experienced, complementary therapies|treatment experienced, complementary therapies
5251415|NCT00622219|Alcohol abuse|alcohol abuse
5251416|NCT00622219|Drug abuse|drug abuse
5251417|NCT00622206|Pharmacokinetics|pharmacokinetics
5251418|NCT00622206|ritonavir|ritonavir
5251419|NCT00622206|saquinavir|saquinavir
5251420|NCT00622206|safety and toxicity|safety and toxicity
5251421|NCT00622206|treatment experienced|treatment experienced
5251422|NCT00622193|NSCLC|nsclc
5251423|NCT00622180|Vitiligo|vitiligo
5251424|NCT00622180|Light treatment for vitiligo|light treatment for vitiligo
5251425|NCT00622180|Excilite|excilite
5251426|NCT00622167|Plaque characteristics|plaque characteristics
5251427|NCT00622167|DSCT|dsct
5251428|NCT00622167|IVUS|ivus
5251429|NCT00622141|bioequivalence|bioequivalence
5251430|NCT00622141|ritonavir boosted generic GPO saquinavir|ritonavir boosted generic gpo saquinavir
5251431|NCT00622141|saftey|saftey
5251432|NCT00622141|pharmacokinetics|pharmacokinetics
5251433|NCT00622128|Behavioral Research|behavioral research
5251434|NCT00622128|Dementia|dementia
5251435|NCT00622128|Aggression|aggression
5251436|NCT00622102|warfarin|warfarin
5251437|NCT00622102|adherence|adherence
5251438|NCT00622102|Mechanical heart valves|mechanical heart valves
5251439|NCT00622089|diabetes|diabetes
5251440|NCT00622089|type 2 diabetes|type 2 diabetes
5251441|NCT00622089|cholesterol|cholesterol
5251442|NCT00622076|postoperative|postoperative
5251443|NCT00622076|Catheterization|catheterization
5251444|NCT00622076|colporrhaphy|colporrhaphy
5251445|NCT00622076|cystocele|cystocele
5251446|NCT00622076|cystitis|cystitis
5251447|NCT00622063|cancer, solid tumor|cancer, solid tumor
5251448|NCT00622024|Arrhythmia|arrhythmia
5251449|NCT00622024|Depression|depression
5251450|NCT00622024|Coronary Artery Disease|coronary artery disease
5251451|NCT00621998|Risperidone|risperidone
5251452|NCT00621998|Olanzapine|olanzapine
5251453|NCT00621998|Tardive dyskinesia|tardive dyskinesia
5251454|NCT00621972|acute renal failure|acute renal failure
5251455|NCT00621972|arteriovenous fistula|arteriovenous fistula
5251456|NCT00621972|KIM-1|kim-1
5251457|NCT00621972|chronic kidney disease|chronic kidney disease
5251458|NCT00621959|levocetirizine|levocetirizine
5251459|NCT00621959|Xyzal|xyzal
5251460|NCT00621959|Seasonal Allergic Rhinitis|seasonal allergic rhinitis
5251461|NCT00621959|total symptom score|total symptom score
5251462|NCT00621959|quality of life|quality of life
5251463|NCT00621946|Asthma|asthma
5251464|NCT00621946|Depression|depression
5251465|NCT00621946|Escitalopram|escitalopram
5251466|NCT00621907|randomized|randomized
5251467|NCT00621907|analgesic|analgesic
5251468|NCT00621907|caesarean scars|caesarean scars
5251469|NCT00621907|locoregional anaesthesia|locoregional anaesthesia
5251470|NCT00621907|infiltration|infiltration
5251471|NCT00621907|levobupivacaïne|levobupivacaïne
5251472|NCT00621907|Chirocaïne|chirocaïne
5251473|NCT00621907|caesarian|caesarian
5251474|NCT00621907|unique administration|unique administration
5251475|NCT00621907|post-caesarian analgesic|post-caesarian analgesic
5251476|NCT00621894|Immune thrombocytopenic purpura|immune thrombocytopenic purpura
5251477|NCT00621894|thrombopoietin mimetic|thrombopoietin mimetic
5251478|NCT00621894|ITP|itp
5251479|NCT00621881|hepatic impairment|hepatic impairment
5251480|NCT00621868|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
5251481|NCT00621868|ASP1941|asp1941
5251482|NCT00621842|Geriatric Psychiatry|geriatric psychiatry
5251483|NCT00621842|Aged|aged
5251484|NCT00621842|lamotrigine|lamotrigine
5251485|NCT00621816|nitroprusside|nitroprusside
5251486|NCT00621816|intensive care unit|intensive care unit
5251487|NCT00621816|hypertension|hypertension
5251488|NCT00621816|blood pressure reduction|blood pressure reduction
5251489|NCT00621803|Probiotic|probiotic
5251490|NCT00621803|Pseudomonas aeruginosa|pseudomonas aeruginosa
5251491|NCT00621803|Gastric colonization|gastric colonization
5251492|NCT00621803|Respiratory tract colonization|respiratory tract colonization
5251493|NCT00621803|Ventilator aquired pneumoniae|ventilator aquired pneumoniae
5251494|NCT00621803|determine the effect of oral administration of this probiotic on gastric and respiratory tract colonisation/infection by P. aeruginosa|determine the effect of oral administration of this probiotic on gastric and respiratory tract colonisation/infection by p. aeruginosa
5251495|NCT00621790|fenoldopam|fenoldopam
5251496|NCT00621790|acute renal failure|acute renal failure
5251497|NCT00621790|renal replacement therapy|renal replacement therapy
5251498|NCT00621790|mortality|mortality
5251499|NCT00621790|cardiac surgery|cardiac surgery
5251500|NCT00621790|cardiac anesthesia|cardiac anesthesia
5251501|NCT00621790|intensive care unit|intensive care unit
5251502|NCT00621777|schizophrenia|schizophrenia
5251503|NCT00621777|bipolar disorder|bipolar disorder
5251504|NCT00621777|varenicline|varenicline
5251505|NCT00621777|smoking cessation|smoking cessation
5251506|NCT00621777|relapse prevention|relapse prevention
5251507|NCT00621777|cognitive behavioral therapy|cognitive behavioral therapy
5251508|NCT00621764|Japanese encephalitis (JE)|japanese encephalitis (je)
5251509|NCT00621764|Hepatitis A|hepatitis a
5251510|NCT00621764|Inactivated Mouse-Brain|inactivated mouse-brain
5251511|NCT00621751|Brain Injury|brain injury
5251512|NCT00621751|Irritability|irritability
5251513|NCT00621751|Aggression|aggression
5251514|NCT00621738|mental stress|mental stress
5251515|NCT00621738|cardiovascular risk factor|cardiovascular risk factor
5251516|NCT00621738|platelet adhesion|platelet adhesion
5251517|NCT00621725|Advanced cancer|advanced cancer
5251518|NCT00621725|metastatic|metastatic
5251519|NCT00621725|hepatic impairment|hepatic impairment
5251520|NCT00621712|Renal Dialysis|renal dialysis
5251521|NCT00621712|Dialysis, Extracorporeal|dialysis, extracorporeal
5251522|NCT00621712|Dialysis, Renal|dialysis, renal
5251523|NCT00621712|Extracorporeal Dialysis|extracorporeal dialysis
5251524|NCT00621699|pharmacokinetics|pharmacokinetics
5251525|NCT00621699|drug interactions|drug interactions
5251526|NCT00621699|ezetimibe|ezetimibe
5251527|NCT00621699|tacrolimus|tacrolimus
5251528|NCT00621699|human experimentation|human experimentation
5251529|NCT00621686|adult glioblastoma|adult glioblastoma
5251530|NCT00621686|adult giant cell glioblastoma|adult giant cell glioblastoma
5251531|NCT00621686|adult gliosarcoma|adult gliosarcoma
5251532|NCT00621686|recurrent adult brain tumor|recurrent adult brain tumor
5251533|NCT00621673|Hemophilia A,|hemophilia a,
5251534|NCT00621673|Inhibitor formation,|inhibitor formation,
5251535|NCT00621673|rFVIII|rfviii
5251536|NCT00621660|Acupuncture therapy|acupuncture therapy
5251537|NCT00621660|Cancer|cancer
5251538|NCT00621660|Emesis|emesis
5251539|NCT00621660|Expectations|expectations
5251540|NCT00621660|Placebo|placebo
5251541|NCT00621647|Seroquel|seroquel
5251542|NCT00621647|dementia|dementia
5251543|NCT00621647|agitation symptoms|agitation symptoms
5251544|NCT00621647|Alzheimer's disease|alzheimer's disease
5251545|NCT00621647|vascular dementia|vascular dementia
5251546|NCT00621647|quetiapine fumarate|quetiapine fumarate
5251547|NCT00621634|Tardive dyskinesia|tardive dyskinesia
5251548|NCT00621634|Schizophrenia|schizophrenia
5251549|NCT00621634|Essential fatty acids|essential fatty acids
5251550|NCT00621621|atrioventricular nodal reentrant tachycardia|atrioventricular nodal reentrant tachycardia
5251551|NCT00621621|AVNRT|avnrt
5251552|NCT00621608|Chronic ulcers|chronic ulcers
5251553|NCT00621608|Diabetes|diabetes
5251554|NCT00621608|Hyperbaric Oxygen Therapy|hyperbaric oxygen therapy
5251555|NCT00621595|School Breakfast|school breakfast
5251556|NCT00621595|Diet|diet
5251557|NCT00621595|Nutrition|nutrition
5251558|NCT00621595|Brain Function|brain function
5251559|NCT00621595|Cognition|cognition
5251560|NCT00621595|USDA|usda
5251561|NCT00621595|Healthy Children|healthy children
5251562|NCT00621569|Blood Pressure|blood pressure
5251563|NCT00621569|Dash Diet|dash diet
5251564|NCT00621543|Intrauterine Device|intrauterine device
5251565|NCT00621543|Induced Abortion|induced abortion
5251566|NCT00621543|Medical Abortion|medical abortion
5251567|NCT00621530|Total hip arthroplasty|total hip arthroplasty
5251568|NCT00621530|Total hip replacement|total hip replacement
5251569|NCT00621530|Pain, postoperative|pain, postoperative
5251570|NCT00621530|Ketorolac|ketorolac
5251571|NCT00621530|Patients undergoing unilateral total hip arthroplasty|patients undergoing unilateral total hip arthroplasty
5251572|NCT00621517|Restless Legs Syndrome|restless legs syndrome
5251573|NCT00621517|Bupropion|bupropion
5251574|NCT00621504|ceftaroline|ceftaroline
5251575|NCT00621504|Community-acquired pneumonia|community-acquired pneumonia
5251576|NCT00621504|CAP|cap
5251577|NCT00621504|IV (intravenous)|iv (intravenous)
5251578|NCT00621504|Streptococcus pneumoniae|streptococcus pneumoniae
5251579|NCT00621504|Haemophilus influenzae|haemophilus influenzae
5251580|NCT00621504|Mycoplasma pneumoniae|mycoplasma pneumoniae
5251581|NCT00621504|Chlamydophila spp|chlamydophila spp
5251582|NCT00621504|Legionella spp|legionella spp
5251583|NCT00621504|Multi-drug resistant Streptococcus pneumoniae (MDRSP)|multi-drug resistant streptococcus pneumoniae (mdrsp)
5251584|NCT00621504|antimicrobial resistance|antimicrobial resistance
5251585|NCT00621504|pneumococci|pneumococci
5251586|NCT00621504|Ceftriaxone|ceftriaxone
5251587|NCT00621504|bacteria|bacteria
5251588|NCT00621504|ß-lactam|ß-lactam
5251589|NCT00621504|beta-lactam|beta-lactam
5251590|NCT00621504|antibiotic|antibiotic
5251591|NCT00621491|cardiac pacing|cardiac pacing
5251592|NCT00621491|pacing complication|pacing complication
5251593|NCT00621491|venous thrombosis|venous thrombosis
5251594|NCT00621491|warfarin|warfarin
5251595|NCT00621491|anticoagulation|anticoagulation
5251596|NCT00621491|randomized trial|randomized trial
5251597|NCT00621465|Psychosis|psychosis
5251598|NCT00621465|Homelessness|homelessness
5251599|NCT00621465|Case Management|case management
5251600|NCT00621465|Severe Mental Illness|severe mental illness
5251601|NCT00621439|ocular melanoma|ocular melanoma
5251602|NCT00621426|T wave alternans (TWA)|t wave alternans (twa)
5251603|NCT00621426|dialysis|dialysis
5251604|NCT00621426|end stage renal disease|end stage renal disease
5251605|NCT00621426|sudden cardiac death|sudden cardiac death
5251606|NCT00621426|T-wave alternans|t-wave alternans
5251607|NCT00621426|Cardiac electrical instability|cardiac electrical instability
5251608|NCT00621426|Sympathetic and electrolyte-induced alterations|sympathetic and electrolyte-induced alterations
5251609|NCT00621426|Ventricular repolarization|ventricular repolarization
5251610|NCT00621413|prostate|prostate
5251611|NCT00621413|cancer|cancer
5251612|NCT00621413|intermediate risk|intermediate risk
5251613|NCT00621413|high risk|high risk
5251614|NCT00621413|brachytherapy|brachytherapy
5251615|NCT00621413|Cesium-131|cesium-131
5251616|NCT00621413|seed brachytherapy|seed brachytherapy
5251617|NCT00621413|intermediate and high risk cancer of the prostate|intermediate and high risk cancer of the prostate
5251618|NCT00621400|newly-diagnosed light-chain (AL)-amyloidosis|newly-diagnosed light-chain (al)-amyloidosis
5251619|NCT00621387|reactive arthritis|reactive arthritis
5251620|NCT00621387|antibiotics|antibiotics
5251621|NCT00621374|Pain Management|pain management
5251622|NCT00621374|Cognitive Behavior Therapy|cognitive behavior therapy
5251623|NCT00621374|Hypnosis|hypnosis
5251624|NCT00621361|Lung Cancer|lung cancer
5251625|NCT00621361|AZD2171|azd2171
5251626|NCT00621361|cediranib|cediranib
5251627|NCT00621361|RECENTIN|recentin
5251628|NCT00621361|etoposide|etoposide
5251629|NCT00621361|cisplatin|cisplatin
5251630|NCT00621348|maintenance fluids|maintenance fluids
5251631|NCT00621348|hyponatremia|hyponatremia
5251632|NCT00621348|vasopressin|vasopressin
5251633|NCT00621348|children|children
5251634|NCT00621335|Open angle glaucoma|open angle glaucoma
5251635|NCT00621335|Ocular hypertension|ocular hypertension
5251636|NCT00621335|Parallel comparison|parallel comparison
5251637|NCT00621335|Combigan|combigan
5251638|NCT00621335|Cosopt|cosopt
5251639|NCT00621322|Tuberculosis vaccine|tuberculosis vaccine
5251640|NCT00621309|drug interactions|drug interactions
5251641|NCT00621309|cytochrome P4503A4|cytochrome p4503a4
5251642|NCT00621309|Pregnane X-receptor|pregnane x-receptor
5251643|NCT00621309|induction|induction
5251644|NCT00621309|drug metabolism|drug metabolism
5251645|NCT00621296|Chronic Hepatitis C|chronic hepatitis c
5251646|NCT00621296|Protease Inhibitor|protease inhibitor
5251647|NCT00621270|Major Depression Neurogenesis|major depression neurogenesis
5251648|NCT00621270|Major Depressive Disorder with Concomitant Anxiety|major depressive disorder with concomitant anxiety
5251649|NCT00621257|IBD|ibd
5251650|NCT00621257|Inflammatory Bowel Disease|inflammatory bowel disease
5251651|NCT00621257|Crohn's Disease|crohn's disease
5251652|NCT00621257|Ulcerative Colitis|ulcerative colitis
5251653|NCT00621257|Vitamin D|vitamin d
5251654|NCT00621244|HDAC inhibitor|hdac inhibitor
5251655|NCT00621244|Oral|oral
5251656|NCT00621244|LBH589|lbh589
5251657|NCT00621244|Lymphoma|lymphoma
5251658|NCT00621244|Leukemia|leukemia
5251659|NCT00621244|Multiple myeloma|multiple myeloma
5251660|NCT00621231|Protein Function|protein function
5251661|NCT00621231|normal versus high protein intake|normal versus high protein intake
5251662|NCT00621218|tretinoin, efficacy, safety, rosacea|tretinoin, efficacy, safety, rosacea
5251663|NCT00621205|Insulin resistance, weight reduction, adipose tissue, peripheral|insulin resistance, weight reduction, adipose tissue, peripheral
5251664|NCT00621205|mononuclear cells, gene expression profile, transcriptomics|mononuclear cells, gene expression profile, transcriptomics
5251665|NCT00621192|meropenem|meropenem
5251666|NCT00621192|infants|infants
5251667|NCT00621192|intra-abdominal infection|intra-abdominal infection
5251668|NCT00621192|pharmacokinetics|pharmacokinetics
5251669|NCT00621192|safety|safety
5251670|NCT00621179|Endometriosis,infertility,in vitro fertilization|endometriosis,infertility,in vitro fertilization
5251671|NCT00621166|Generic lopinavir/ritonavir|generic lopinavir/ritonavir
5251672|NCT00621166|Pharmacokinetics|pharmacokinetics
5251673|NCT00621166|Pregnancy|pregnancy
5251674|NCT00621166|Antiviral activity|antiviral activity
5251675|NCT00621166|Safety|safety
5251676|NCT00621153|Candesartan Cilexetil|candesartan cilexetil
5251677|NCT00621153|hydrochlorothiazide|hydrochlorothiazide
5251678|NCT00621153|severe hypertension|severe hypertension
5251679|NCT00621114|Dialysis, Extracorporeal|dialysis, extracorporeal
5251680|NCT00621114|Dialysis, Renal|dialysis, renal
5251681|NCT00621114|Extracorporeal Dialysis|extracorporeal dialysis
5251682|NCT00621114|Hemodialysis|hemodialysis
5251683|NCT00621101|pharmacokinetics|pharmacokinetics
5251684|NCT00621101|drug interactions|drug interactions
5251685|NCT00621101|ezetimibe|ezetimibe
5251686|NCT00621101|sirolimus|sirolimus
5251687|NCT00621101|human experimentation|human experimentation
5251688|NCT00621075|PAH; V/Q SCAN;RHC;Echo;CT Scans; Angiography;PFTs|pah; v/q scan;rhc;echo;ct scans; angiography;pfts
5251689|NCT00621062|varicose|varicose
5251690|NCT00621062|vein|vein
5251691|NCT00621062|ligation|ligation
5251692|NCT00621062|laser|laser
5251693|NCT00621062|foam|foam
5251694|NCT00621062|sclerotherapy|sclerotherapy
5251695|NCT00621062|radiofrequency|radiofrequency
5251696|NCT00621062|duplex|duplex
5251697|NCT00621062|sf36|sf36
5251698|NCT00621062|Aberdeen|aberdeen
5251699|NCT00621062|VCSS|vcss
5251700|NCT00621062|quality|quality
5251701|NCT00621062|recurrence|recurrence
5251702|NCT00621049|Non-Small Cell Lung Cancer|non-small cell lung cancer
5251703|NCT00621049|Resected|resected
5251704|NCT00621049|Carboplatin|carboplatin
5251705|NCT00621049|Docetaxel|docetaxel
5251706|NCT00621049|Bevacizumab|bevacizumab
5251707|NCT00621049|Erlotinib|erlotinib
5251708|NCT00621036|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
5251709|NCT00621036|primary central nervous system Hodgkin lymphoma|primary central nervous system hodgkin lymphoma
5251710|NCT00621036|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
5251711|NCT00621036|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
5251712|NCT00621036|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5251713|NCT00621036|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
5251714|NCT00621036|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5251715|NCT00621036|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5251716|NCT00621036|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5251717|NCT00621036|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5251718|NCT00621036|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5251719|NCT00621036|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5251720|NCT00621036|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5251721|NCT00621036|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5251722|NCT00621036|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
5251723|NCT00621036|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
5251724|NCT00621036|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
5251725|NCT00621036|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
5251726|NCT00621036|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
5251727|NCT00621036|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
5251728|NCT00621036|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5251729|NCT00621036|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5251730|NCT00621036|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5251731|NCT00621036|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5251732|NCT00621036|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5251733|NCT00621036|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5251734|NCT00621036|intraocular lymphoma|intraocular lymphoma
5251735|NCT00621036|post-transplant lymphoproliferative disorder|post-transplant lymphoproliferative disorder
5251736|NCT00621036|cutaneous B-cell non-Hodgkin lymphoma|cutaneous b-cell non-hodgkin lymphoma
5251737|NCT00621036|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
5251738|NCT00621036|small intestine lymphoma|small intestine lymphoma
5251739|NCT00621036|stage IV childhood anaplastic large cell lymphoma|stage iv childhood anaplastic large cell lymphoma
5251740|NCT00621023|Myelodysplastic syndrome|myelodysplastic syndrome
5251742|NCT00620997|cornea|cornea
5251743|NCT00620997|analgesia|analgesia
5251744|NCT00620997|topical|topical
5251745|NCT00620997|anesthetic|anesthetic
5251746|NCT00620984|Staphylococcus aureus|staphylococcus aureus
5251747|NCT00620984|Breastfeeding|breastfeeding
5251748|NCT00620984|Lactational Mastitis|lactational mastitis
5251749|NCT00620984|Polymerase Chain Reaction (PCR) amplification analysis|polymerase chain reaction (pcr) amplification analysis
5251750|NCT00620984|staphylococcal infections|staphylococcal infections
5251751|NCT00620984|staphylococcal Carrier State|staphylococcal carrier state
5251752|NCT00620971|Non Small Cell Lung Cancer|non small cell lung cancer
5251753|NCT00620971|Cisplatin|cisplatin
5251754|NCT00620971|VInorelbine|vinorelbine
5251755|NCT00620971|Docetaxel|docetaxel
5251756|NCT00620971|Gemcitabine|gemcitabine
5251757|NCT00620971|Bevacizumab|bevacizumab
5251758|NCT00620958|Mediation|mediation
5251759|NCT00620958|Outcome|outcome
5251760|NCT00620958|CBT|cbt
5251761|NCT00620958|Child Anxiety Intervention|child anxiety intervention
5251762|NCT00620945|Congenital heart surgery|congenital heart surgery
5251763|NCT00620945|Cardiopulmonary bypass|cardiopulmonary bypass
5251764|NCT00620945|Phenoxybenzamine|phenoxybenzamine
5251765|NCT00620906|manipulation|manipulation
5251766|NCT00620906|manual therapy|manual therapy
5251767|NCT00620906|Sacroiliac joint|sacroiliac joint
5251768|NCT00620906|effects on manipulation on sacroiliac joint|effects on manipulation on sacroiliac joint
5251769|NCT00620893|Dry eye signs and symptoms|dry eye signs and symptoms
5251770|NCT00620893|refractive regression|refractive regression
5251771|NCT00620841|Tacrolimus|tacrolimus
5251772|NCT00620841|Renal Transplantation|renal transplantation
5251773|NCT00620841|genetic polymorphisms|genetic polymorphisms
5251774|NCT00620841|Drug drug interactions|drug drug interactions
5251775|NCT00620815|avian flu|avian flu
5251776|NCT00620815|seasonal influenza vaccine|seasonal influenza vaccine
5251777|NCT00620815|influenza vaccine|influenza vaccine
5251778|NCT00620815|prepandemic vaccine|prepandemic vaccine
5251779|NCT00620815|virus strain with the potential to cause pandemic|virus strain with the potential to cause pandemic
5251780|NCT00620815|tetravalent vaccine|tetravalent vaccine
5251781|NCT00620815|Prophylaxis of influenza|prophylaxis of influenza
5251782|NCT00620802|Platelet function testing|platelet function testing
5251783|NCT00620802|Healthy volunteers|healthy volunteers
5251784|NCT00620789|Insomnia|insomnia
5251785|NCT00620789|Depression|depression
5251786|NCT00620776|Generalized Anxiety Disorder|generalized anxiety disorder
5251787|NCT00620776|Cognitive Behavioral Therapy|cognitive behavioral therapy
5251788|NCT00620776|Psychotherapy plus medication|psychotherapy plus medication
5251789|NCT00620776|Combined treatment|combined treatment
5251790|NCT00620763|Meat protein|meat protein
5251791|NCT00620763|acid load|acid load
5251792|NCT00620763|calcium retention|calcium retention
5251793|NCT00620763|postmenopausal women|postmenopausal women
5251794|NCT00620750|Alcohol dependence|alcohol dependence
5251795|NCT00620711|Hypoxic ischemic encephalopathy|hypoxic ischemic encephalopathy
5251796|NCT00620711|HIE|hie
5251797|NCT00620711|Neonatal encephalopathy|neonatal encephalopathy
5251798|NCT00620711|Cooling|cooling
5251799|NCT00620711|hypothermia|hypothermia
5251800|NCT00620698|amyotrophic lateral sclerosis|amyotrophic lateral sclerosis
5251801|NCT00620698|motor neuron disease|motor neuron disease
5251802|NCT00620698|outcome measure|outcome measure
5251803|NCT00620698|biomarker|biomarker
5251804|NCT00620698|impedance|impedance
5251805|NCT00620685|Arthritis, rheumatoid|arthritis, rheumatoid
5251806|NCT00620672|n-3 supplementation during pregnancy|n-3 supplementation during pregnancy
5251807|NCT00620672|DHA and pregnancy, infant development|dha and pregnancy, infant development
5251808|NCT00620672|n-3 status and gestation|n-3 status and gestation
5251809|NCT00620672|DHA and visual acuity and cognition during infancy|dha and visual acuity and cognition during infancy
5251810|NCT00620646|clopidogrel|clopidogrel
5251811|NCT00620646|platelets|platelets
5251812|NCT00620646|percutaneous coronary intervention|percutaneous coronary intervention
5251813|NCT00620633|Bone Marrow|bone marrow
5251814|NCT00620620|Healthy adult volunteers|healthy adult volunteers
5251815|NCT00620607|gastric|gastric
5251816|NCT00620594|Neoplasms|neoplasms
5251817|NCT00620594|breast neoplasms|breast neoplasms
5251818|NCT00620594|breast diseases|breast diseases
5251819|NCT00620594|solid tumors|solid tumors
5251820|NCT00620594|BEZ235|bez235
5251821|NCT00620594|breast cancer|breast cancer
5251822|NCT00620594|PI3K Inhibitor|pi3k inhibitor
5251823|NCT00620594|Phosphatidylinositol 3|phosphatidylinositol 3
5251824|NCT00620594|kinase|kinase
5251825|NCT00620594|advanced|advanced
5251826|NCT00620568|Safety|safety
5251827|NCT00620568|Tolerability|tolerability
5251828|NCT00620568|Schizophrenia|schizophrenia
5251829|NCT00620542|Coronary artery disease|coronary artery disease
5251830|NCT00620529|polycystic ovary syndrome|polycystic ovary syndrome
5251831|NCT00620529|cardiovascular risk|cardiovascular risk
5251832|NCT00620529|metabolism|metabolism
5251833|NCT00620529|blood pressure|blood pressure
5251834|NCT00620529|liver fat|liver fat
5251835|NCT00620529|heart rate variability|heart rate variability
5251836|NCT00620503|PK|pk
5251837|NCT00620503|Pharmacokinetics|pharmacokinetics
5251838|NCT00620490|Epidural analgesia|epidural analgesia
5251839|NCT00620490|Contraindications|contraindications
5251840|NCT00620490|Paravertebral nerve block analgesia|paravertebral nerve block analgesia
5251841|NCT00620490|ropivacaine|ropivacaine
5251842|NCT00620490|Visual analogical scale|visual analogical scale
5251843|NCT00620490|Morphine|morphine
5251844|NCT00620490|Side effects|side effects
5251845|NCT00620490|Pain and thoracotomy|pain and thoracotomy
5251846|NCT00620451|Treatment|treatment
5251847|NCT00620451|Active|active
5251848|NCT00620451|Celiac|celiac
5251849|NCT00620451|Remission|remission
5251850|NCT00620451|Induction|induction
5251851|NCT00620438|Lumefantrine|lumefantrine
5251852|NCT00620438|Efavirenz|efavirenz
5251853|NCT00620438|Nevirapine|nevirapine
5251854|NCT00620438|Rifampicin|rifampicin
5251855|NCT00620438|HIV|hiv
5251856|NCT00620425|sumatriptan|sumatriptan
5251857|NCT00620425|Intraject|intraject
5251858|NCT00620425|Local Site Reactions|local site reactions
5251859|NCT00620412|influenza|influenza
5251860|NCT00620412|vaccines|vaccines
5251861|NCT00620412|probiotics|probiotics
5251862|NCT00620412|LGG|lgg
5251863|NCT00620399|lumbar fusion|lumbar fusion
5251864|NCT00620386|Intubating conditions|intubating conditions
5251865|NCT00620386|Bonfils intubation fiberscope|bonfils intubation fiberscope
5251866|NCT00620386|Macintosh laryngoscope|macintosh laryngoscope
5251867|NCT00620386|neuromuscular blockade|neuromuscular blockade
5251868|NCT00620373|Dense breast tissue|dense breast tissue
5251869|NCT00620373|Breast Cancer Screening|breast cancer screening
5251870|NCT00620373|Molecular Breast Imaging|molecular breast imaging
5251871|NCT00620373|Breast Cancer|breast cancer
5251872|NCT00620373|Breast|breast
5251873|NCT00620360|dietary fructose|dietary fructose
5251874|NCT00620360|plasma lipids|plasma lipids
5251875|NCT00620360|healthy humans|healthy humans
5251876|NCT00620360|gender differences|gender differences
5251877|NCT00620360|hepatic de novo lipogenesis|hepatic de novo lipogenesis
5251878|NCT00620347|SCLC (small cell lung cancer)|sclc (small cell lung cancer)
5251879|NCT00620347|ED (extensive disease)|ed (extensive disease)
5251880|NCT00620347|RR (response rate)|rr (response rate)
5251881|NCT00620334|ASTHMA|asthma
5251882|NCT00620295|recurrent pancreatic cancer|recurrent pancreatic cancer
5251883|NCT00620295|recurrent breast cancer|recurrent breast cancer
5251884|NCT00620295|recurrent small cell lung cancer|recurrent small cell lung cancer
5251885|NCT00620295|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5251886|NCT00620295|recurrent colon cancer|recurrent colon cancer
5251887|NCT00620295|recurrent prostate cancer|recurrent prostate cancer
5251888|NCT00620295|recurrent head and neck cancer|recurrent head and neck cancer
5251889|NCT00620295|ovarian cancer|ovarian cancer
5251890|NCT00620295|recurrent uterine cancer|recurrent uterine cancer
5251891|NCT00620295|recurrent kidney cancer|recurrent kidney cancer
5251892|NCT00620295|recurrent osteosarcoma|recurrent osteosarcoma
5251893|NCT00620269|NSCLC|nsclc
5251894|NCT00620269|EGFR mutation|egfr mutation
5251895|NCT00620269|Erlotinib|erlotinib
5251896|NCT00620269|IP chemotherapy|ip chemotherapy
5251897|NCT00620269|CCRT|ccrt
5251898|NCT00620256|Glaucoma|glaucoma
5251899|NCT00620256|Hypertension|hypertension
5251900|NCT00620243|Ovarian cancer|ovarian cancer
5251901|NCT00620243|PET|pet
5251902|NCT00620243|CT|ct
5251903|NCT00620243|04-064|04-064
5251904|NCT00620230|Allergic rhinitis, anti-interleukin 4|allergic rhinitis, anti-interleukin 4
5251905|NCT00620217|heart ischemia|heart ischemia
5251906|NCT00620217|coronary artery disease|coronary artery disease
5251907|NCT00620217|plasmid|plasmid
5251908|NCT00620217|VEGF|vegf
5251909|NCT00620217|FGF|fgf
5251910|NCT00620217|percutaneous|percutaneous
5251911|NCT00620217|gene therapy|gene therapy
5251912|NCT00620217|SPECT|spect
5251913|NCT00620217|nuclear magnetic resonance|nuclear magnetic resonance
5251914|NCT00620204|atorvastatin|atorvastatin
5251915|NCT00620204|Angina Pectoris, Variant|angina pectoris, variant
5251916|NCT00620204|endothelial dysfunction|endothelial dysfunction
5251917|NCT00620191|metformin|metformin
5251918|NCT00620191|mild cognitive impairment|mild cognitive impairment
5251919|NCT00620191|alzheimer's disease|alzheimer's disease
5251920|NCT00620191|overweight|overweight
5251921|NCT00620191|insulin|insulin
5251922|NCT00620178|candesartan|candesartan
5251923|NCT00620178|losartan|losartan
5251924|NCT00620178|blood pressure|blood pressure
5251925|NCT00620178|cardiovascular disease|cardiovascular disease
5251926|NCT00620178|health care consumption|health care consumption
5251927|NCT00620165|tremor|tremor
5251928|NCT00620165|writing|writing
5251929|NCT00620165|feeding|feeding
5251930|NCT00620165|pouring|pouring
5251931|NCT00620139|head and neck squamous cell carcinoma|head and neck squamous cell carcinoma
5251932|NCT00620139|chemoradiotherapy|chemoradiotherapy
5251933|NCT00620139|molecular effects|molecular effects
5251934|NCT00620139|05-016|05-016
5251935|NCT00620126|Inflammatory bowel disease|inflammatory bowel disease
5251936|NCT00620126|Ulcerative colitis|ulcerative colitis
5251937|NCT00620126|Telemedicine|telemedicine
5251938|NCT00620126|Telemanagement|telemanagement
5251939|NCT00620126|Chronic disease|chronic disease
5251940|NCT00620087|Atypical lobular hyperplasia|atypical lobular hyperplasia
5251941|NCT00620087|Atypical ductal hyperplasia|atypical ductal hyperplasia
5251942|NCT00620087|Lobular carcinoma in situ|lobular carcinoma in situ
5251943|NCT00620087|Molecular Breast Imaging|molecular breast imaging
5251944|NCT00620074|invasive aspergillosis, opportunistic mold infection|invasive aspergillosis, opportunistic mold infection
5251945|NCT00620048|heart|heart
5251946|NCT00620048|stem Cells|stem cells
5251947|NCT00620048|low EF|low ef
5251948|NCT00620048|heart attack|heart attack
5251949|NCT00620048|cardiomyopathy|cardiomyopathy
5251950|NCT00620048|congestive heart failure|congestive heart failure
5251951|NCT00620048|cardiovascular disease|cardiovascular disease
5251952|NCT00620048|Heart Failure|heart failure
5251953|NCT00620048|Low Ejection Fraction|low ejection fraction
5251954|NCT00620022|indacaterol|indacaterol
5251955|NCT00620022|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
5251956|NCT00620022|exercise endurance|exercise endurance
5251957|NCT00620022|moderate to severe chronic obstructive pulmonary disease|moderate to severe chronic obstructive pulmonary disease
5251958|NCT00620022|COPD|copd
5251959|NCT00620009|Empathy|empathy
5251960|NCT00620009|Feedback|feedback
5251961|NCT00620009|Psychotherapy|psychotherapy
5251962|NCT00619996|Prostate Cancer|prostate cancer
5251963|NCT00619996|Sorafenib|sorafenib
5251964|NCT00619996|Nexavar|nexavar
5251965|NCT00619996|Docetaxel|docetaxel
5251966|NCT00619996|Pisa|pisa
5251967|NCT00619996|Ricci|ricci
5251968|NCT00619983|Asymmetric Diabetic Proximal Motor Neuropathy|asymmetric diabetic proximal motor neuropathy
5251969|NCT00619983|Diabetic Autonomic Neuropathy|diabetic autonomic neuropathy
5251970|NCT00619983|Diabetic Neuralgia|diabetic neuralgia
5251971|NCT00619983|Diabetic Neuropathy, Painful|diabetic neuropathy, painful
5251972|NCT00619983|Neuralgia, Diabetic|neuralgia, diabetic
5251973|NCT00619983|Low back pain, chronic|low back pain, chronic
5251974|NCT00619944|HIV|hiv
5251975|NCT00619944|lumefantrine|lumefantrine
5251976|NCT00619944|lopinavir|lopinavir
5251977|NCT00619944|Africa|africa
5251978|NCT00619944|Antimalarials|antimalarials
5251979|NCT00619944|treatment naïve|treatment naïve
5251980|NCT00619931|Healthy adult volunteers|healthy adult volunteers
5251981|NCT00619918|bronchiolitis|bronchiolitis
5251982|NCT00619918|hypertonic saline|hypertonic saline
5251983|NCT00619905|Rheumatoid Arthritis|rheumatoid arthritis
5251984|NCT00619905|Anti-interleukin-1 beta|anti-interleukin-1 beta
5251985|NCT00619905|ACZ885|acz885
5251986|NCT00619892|SSRI Resistant|ssri resistant
5251987|NCT00619892|Seroquel SR|seroquel sr
5251988|NCT00619892|Seroquel XR|seroquel xr
5251989|NCT00619892|Panic Disorder|panic disorder
5251990|NCT00619892|Comorbid Panic Disorder|comorbid panic disorder
5251991|NCT00619892|Quetiapine SR|quetiapine sr
5251992|NCT00619892|Quetiapine XR|quetiapine xr
5251993|NCT00619879|Leukemia, Myelogenous, Chronic|leukemia, myelogenous, chronic
5251994|NCT00619879|Leukemia, Lymphoblastic, Acute|leukemia, lymphoblastic, acute
5251995|NCT00619879|Leukemia, Myelogenous, Acute|leukemia, myelogenous, acute
5251996|NCT00619879|Myeloproliferative-Myelodysplastic Diseases|myeloproliferative-myelodysplastic diseases
5251997|NCT00619879|Juvenile Myelomonocytic Leukemia|juvenile myelomonocytic leukemia
5251998|NCT00619879|Dysmyelopoietic Syndromes|dysmyelopoietic syndromes
5251999|NCT00619879|Lymphoma, Malignant|lymphoma, malignant
5252000|NCT00619879|Stem Cell Transplantation, Hematopoietic|stem cell transplantation, hematopoietic
5252001|NCT00619879|Allogeneic Transplantation|allogeneic transplantation
5252002|NCT00619879|Human Leukocyte Antigens|human leukocyte antigens
5252003|NCT00619879|Busulfan|busulfan
5252004|NCT00619879|Total Body Irradiation|total body irradiation
5252005|NCT00619879|VP-16|vp-16
5252006|NCT00619879|Etoposide|etoposide
5252007|NCT00619879|Cyclophosphamide|cyclophosphamide
5252008|NCT00619879|Graft-Versus-Host Disease|graft-versus-host disease
5252009|NCT00619866|bone mineral density|bone mineral density
5252010|NCT00619866|NBI-56418|nbi-56418
5252011|NCT00619866|estradiol|estradiol
5252012|NCT00619866|Endometriosis|endometriosis
5252013|NCT00619866|Pelvic Pain|pelvic pain
5252014|NCT00619853|Improving the assisting hand function in children with Hemiplegic Cerebral palsy|improving the assisting hand function in children with hemiplegic cerebral palsy
5252015|NCT00619840|ADHD|adhd
5252016|NCT00619840|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
5252017|NCT00619840|adult|adult
5252018|NCT00619840|methylphenidate hydrochloride|methylphenidate hydrochloride
5252019|NCT00619840|Medikinet retard|medikinet retard
5252020|NCT00619840|long-term observation|long-term observation
5252021|NCT00619840|controlled clinical trial|controlled clinical trial
5252022|NCT00619840|safety|safety
5252023|NCT00619840|randomized, double-blind, placebo-controlled trial|randomized, double-blind, placebo-controlled trial
5252024|NCT00619840|treatment|treatment
5252025|NCT00619840|central nervous system stimulants|central nervous system stimulants
5252026|NCT00619840|therapeutic uses|therapeutic uses
5252027|NCT00619827|Sublingual immunotherapy|sublingual immunotherapy
5252028|NCT00619827|Rhinitis|rhinitis
5252029|NCT00619827|Conjunctivitis|conjunctivitis
5252030|NCT00619827|Allergen challenge|allergen challenge
5252031|NCT00619827|Allergen exposition chamber|allergen exposition chamber
5252032|NCT00619827|Grass pollen tablet|grass pollen tablet
5252033|NCT00619827|Allergic rhinoconjunctivitis|allergic rhinoconjunctivitis
5252034|NCT00619814|Colon polyps|colon polyps
5252035|NCT00619814|Fecal occult blood test|fecal occult blood test
5252036|NCT00619814|Double contrast barium enema|double contrast barium enema
5252037|NCT00619814|Colonoscopy|colonoscopy
5252038|NCT00619801|Xyzal|xyzal
5252039|NCT00619801|Levocetirizine|levocetirizine
5252040|NCT00619801|Allergy|allergy
5252041|NCT00619801|Children|children
5252042|NCT00619801|Seasonal Allergies|seasonal allergies
5252043|NCT00619775|Carotid Artery Disease|carotid artery disease
5252044|NCT00619775|Embolic Protection|embolic protection
5252045|NCT00619762|Breast reconstruction|breast reconstruction
5252046|NCT00619736|Healthy|healthy
5252047|NCT00619710|skin infections|skin infections
5252048|NCT00619710|MERREM|merrem
5252049|NCT00619710|PRIMAXIN IV|primaxin iv
5252050|NCT00619710|complex abscess|complex abscess
5252051|NCT00619710|perirectal abscess|perirectal abscess
5252052|NCT00619710|wound infections|wound infections
5252053|NCT00619710|infected ischemic/diabetic ulcers|infected ischemic/diabetic ulcers
5252054|NCT00619710|cellulitis|cellulitis
5252055|NCT00619710|Meropenem|meropenem
5252056|NCT00619710|Imipenem-cilastatin|imipenem-cilastatin
5252057|NCT00619671|Rituxan|rituxan
5252058|NCT00619671|Rituximab|rituximab
5252059|NCT00619671|Myasthenia Gravis|myasthenia gravis
5252060|NCT00619671|MG|mg
5252061|NCT00619658|telephone follow-up|telephone follow-up
5252062|NCT00619658|medical abortion|medical abortion
5252063|NCT00619658|induced abortion|induced abortion
5252064|NCT00619645|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5252065|NCT00619645|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5252066|NCT00619645|refractory anemia with excess blasts|refractory anemia with excess blasts
5252067|NCT00619645|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
5252068|NCT00619645|refractory anemia|refractory anemia
5252069|NCT00619645|refractory cytopenia with multilineage dysplasia|refractory cytopenia with multilineage dysplasia
5252070|NCT00619645|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5252071|NCT00619645|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5252072|NCT00619645|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5252073|NCT00619645|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5252074|NCT00619645|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5252075|NCT00619645|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5252076|NCT00619645|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5252077|NCT00619645|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5252078|NCT00619645|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5252079|NCT00619645|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5252080|NCT00619645|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5252081|NCT00619645|refractory multiple myeloma|refractory multiple myeloma
5252082|NCT00619645|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5252083|NCT00619645|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5252084|NCT00619645|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5252085|NCT00619645|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5252086|NCT00619645|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5252087|NCT00619645|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5252088|NCT00619645|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5252089|NCT00619645|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5252090|NCT00619645|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5252091|NCT00619645|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5252092|NCT00619645|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5252093|NCT00619645|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5252094|NCT00619645|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5252095|NCT00619645|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5252096|NCT00619645|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5252097|NCT00619645|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5252098|NCT00619645|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5252099|NCT00619645|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5252100|NCT00619645|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5252101|NCT00619645|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5252102|NCT00619645|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5252103|NCT00619645|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5252104|NCT00619645|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5252105|NCT00619645|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5252106|NCT00619645|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5252107|NCT00619645|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5252108|NCT00619645|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5252109|NCT00619645|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5252110|NCT00619645|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5252111|NCT00619645|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5252112|NCT00619645|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5252113|NCT00619645|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5252114|NCT00619645|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5252115|NCT00619645|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5252116|NCT00619645|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5252117|NCT00619645|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5252118|NCT00619645|stage I multiple myeloma|stage i multiple myeloma
5252119|NCT00619645|stage II multiple myeloma|stage ii multiple myeloma
5252120|NCT00619645|stage III multiple myeloma|stage iii multiple myeloma
5252121|NCT00619645|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5252122|NCT00619645|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5252123|NCT00619619|MDD|mdd
5252124|NCT00619619|Child|child
5252125|NCT00619619|Adolescent|adolescent
5252126|NCT00619619|Pharmacokinetic|pharmacokinetic
5252127|NCT00619619|Outpatient|outpatient
5252128|NCT00619619|Pediatrics|pediatrics
5252129|NCT00619619|Depressive Disorder|depressive disorder
5252130|NCT00619619|Major|major
5252131|NCT00619606|prevention of hypoxia|prevention of hypoxia
5252132|NCT00619606|prevention of hypercapnia|prevention of hypercapnia
5252133|NCT00619593|Heart failure|heart failure
5252134|NCT00619593|Ventricular Fibrillation|ventricular fibrillation
5252135|NCT00619593|Sudden cardiac death|sudden cardiac death
5252136|NCT00619593|Hospitalization due to heart failure|hospitalization due to heart failure
5252137|NCT00619593|Implantable cardioverter-defibrillator|implantable cardioverter-defibrillator
5252138|NCT00619593|Risk of 1st heart failure hospitalization|risk of 1st heart failure hospitalization
5252139|NCT00619580|E coli|e coli
5252140|NCT00619567|Cognition|cognition
5252141|NCT00619567|Rehabilitation|rehabilitation
5252142|NCT00619567|Cognitive Stimulation|cognitive stimulation
5252143|NCT00619567|Human Immunodeficiency Virus|human immunodeficiency virus
5252144|NCT00619567|AIDS|aids
5252145|NCT00619554|Healthy volunteers|healthy volunteers
5252146|NCT00619541|HCC|hcc
5252147|NCT00619541|Sorafenib|sorafenib
5252148|NCT00619541|Pisa|pisa
5252149|NCT00619541|Ricci|ricci
5252150|NCT00619541|5-FU|5-fu
5252151|NCT00619541|5FU|5fu
5252152|NCT00619541|5 FU|5 fu
5252153|NCT00619541|Advanced HCC|advanced hcc
5252154|NCT00619528|Transplants|transplants
5252155|NCT00619528|Kidney Transplantation|kidney transplantation
5252156|NCT00619528|Immunosuppression|immunosuppression
5252157|NCT00619528|HLA Antigens|hla antigens
5252158|NCT00619528|Stem Cells|stem cells
5252159|NCT00619528|Bone Marrow|bone marrow
5252160|NCT00619515|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5252161|NCT00619515|stage I prostate cancer|stage i prostate cancer
5252162|NCT00619515|stage II prostate cancer|stage ii prostate cancer
5252163|NCT00619502|Hepatitis B|hepatitis b
5252164|NCT00619502|Polio|polio
5252165|NCT00619502|Diphtheria|diphtheria
5252166|NCT00619502|Pertussis|pertussis
5252167|NCT00619502|H.influenzae type b|h.influenzae type b
5252168|NCT00619476|Neuropathic Pain|neuropathic pain
5252169|NCT00619476|Post-herpetic neuralgia|post-herpetic neuralgia
5252170|NCT00619476|PHN|phn
5252171|NCT00619463|Traumatic Brain Injury|traumatic brain injury
5252172|NCT00619463|Exercise|exercise
5252173|NCT00619463|Cognition|cognition
5252174|NCT00619463|Brain Derived Neurotrophic Factor (BDNF)|brain derived neurotrophic factor (bdnf)
5252175|NCT00619463|peripheral vascular endothelial growth factor (VEGF)|peripheral vascular endothelial growth factor (vegf)
5252176|NCT00619450|atrial fibrillation|atrial fibrillation
5252177|NCT00619450|cardiac pacing|cardiac pacing
5252178|NCT00619450|CAT scanner|cat scanner
5252179|NCT00619437|schizophrenia|schizophrenia
5252180|NCT00619437|genetics|genetics
5252181|NCT00619437|family|family
5252182|NCT00619437|multiplex|multiplex
5252183|NCT00619437|haplotypes|haplotypes
5252184|NCT00619424|erlotinib|erlotinib
5252185|NCT00619424|pharmacokinetics|pharmacokinetics
5252186|NCT00619424|Solid tumors|solid tumors
5252187|NCT00619424|pemetrexed|pemetrexed
5252188|NCT00619424|anti-angiogenesis|anti-angiogenesis
5252189|NCT00619424|pazopanib (GW786034)|pazopanib (gw786034)
5252190|NCT00619424|cytokine and angiogenic factors|cytokine and angiogenic factors
5252191|NCT00619411|Major Depression|major depression
5252192|NCT00619411|Dysthymic Disorder|dysthymic disorder
5252193|NCT00619411|Adjustment Disorder|adjustment disorder
5252194|NCT00619411|With Depressed Mood|with depressed mood
5252195|NCT00619411|Depressive|depressive
5252196|NCT00619411|Disorder Not|disorder not
5252197|NCT00619411|Otherwise|otherwise
5252198|NCT00619411|Specified|specified
5252199|NCT00619411|Adolescent|adolescent
5252200|NCT00619411|Psychotherapy|psychotherapy
5252201|NCT00619398|FK506|fk506
5252202|NCT00619398|tacrolimus|tacrolimus
5252203|NCT00619398|prograf|prograf
5252204|NCT00619398|Liver transplantation|liver transplantation
5252205|NCT00619385|Pharmacokinetics|pharmacokinetics
5252206|NCT00619372|OKT3|okt3
5252207|NCT00619372|beta-glucosylceramide|beta-glucosylceramide
5252208|NCT00619372|oral tolerance|oral tolerance
5252209|NCT00619372|anti-CD3|anti-cd3
5252210|NCT00619372|Safety assessment and healthy volunteers|safety assessment and healthy volunteers
5252211|NCT00619346|Safety|safety
5252212|NCT00619346|Tolerability|tolerability
5252213|NCT00619346|Assessment of potential adverse events and/or laboratory abnormalities|assessment of potential adverse events and/or laboratory abnormalities
5252214|NCT00619320|HIV primary prevention|hiv primary prevention
5252215|NCT00619320|Health promotion|health promotion
5252216|NCT00619320|Health behavior|health behavior
5252217|NCT00619320|Risk reduction behavior|risk reduction behavior
5252218|NCT00619320|Sexual behavior|sexual behavior
5252219|NCT00619320|Safe sex|safe sex
5252220|NCT00619320|Women's health|women's health
5252221|NCT00619320|Minority health|minority health
5252222|NCT00619320|Pregnant Women|pregnant women
5252223|NCT00619320|HIV seronegativity|hiv seronegativity
5252224|NCT00619294|Coronary Vasospasm|coronary vasospasm
5252225|NCT00619294|Endothelium, Vascular|endothelium, vascular
5252226|NCT00619294|Vasodilation|vasodilation
5252227|NCT00619294|Hyperemia|hyperemia
5252228|NCT00619281|Cardiac surgery|cardiac surgery
5252229|NCT00619281|Low cardiac output syndrome|low cardiac output syndrome
5252230|NCT00619281|Mortality|mortality
5252231|NCT00619281|Morbidity|morbidity
5252232|NCT00619268|Temsirolimus|temsirolimus
5252233|NCT00619268|Bevacizumab|bevacizumab
5252234|NCT00619268|Metastatic renal cell carcinoma|metastatic renal cell carcinoma
5252235|NCT00619268|Non-progression|non-progression
5252236|NCT00619255|Adolescents|adolescents
5252237|NCT00619255|Quality Assurance and Improvement|quality assurance and improvement
5252238|NCT00619255|Substance Abuse|substance abuse
5252239|NCT00619255|Posttraumatic Stress|posttraumatic stress
5252240|NCT00619255|Family Centered Care|family centered care
5252241|NCT00619255|Trauma Systems|trauma systems
5252242|NCT00619242|Esophageal cancer|esophageal cancer
5252243|NCT00619229|Alprostadil|alprostadil
5252244|NCT00619229|prostaglandin E1|prostaglandin e1
5252245|NCT00619229|Prostavasin®|prostavasin®
5252246|NCT00619229|macular degeneration|macular degeneration
5252247|NCT00619216|Orthotopic Liver Transplant Recipients with GI disturbance|orthotopic liver transplant recipients with gi disturbance
5252248|NCT00619203|Bacterial meningitis|bacterial meningitis
5252249|NCT00619203|glycerol|glycerol
5252250|NCT00619203|high dose paracetamol|high dose paracetamol
5252251|NCT00619203|children|children
5252252|NCT00619190|open label|open label
5252253|NCT00619190|aripiprazole|aripiprazole
5252254|NCT00619190|children|children
5252255|NCT00619190|adolescents|adolescents
5252256|NCT00619190|autism spectrum disorders|autism spectrum disorders
5252257|NCT00619164|Platelet Aggregation Inhibitors|platelet aggregation inhibitors
5252258|NCT00619164|Coronary Stenosis|coronary stenosis
5252259|NCT00619164|Coronary Thrombosis|coronary thrombosis
5252260|NCT00619151|aortic valve|aortic valve
5252261|NCT00619151|heart valve|heart valve
5252262|NCT00619151|valve replacement|valve replacement
5252263|NCT00619151|Valve disease|valve disease
5252264|NCT00619138|Cognitive therapy|cognitive therapy
5252265|NCT00619138|Stepped care|stepped care
5252266|NCT00619138|Self-help|self-help
5252267|NCT00619138|Internet|internet
5252268|NCT00619138|Anxiety|anxiety
5252269|NCT00619112|adult glioblastoma|adult glioblastoma
5252270|NCT00619112|adult gliosarcoma|adult gliosarcoma
5252271|NCT00619112|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5252272|NCT00619112|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
5252273|NCT00619112|adult mixed glioma|adult mixed glioma
5252274|NCT00619112|recurrent adult brain tumor|recurrent adult brain tumor
5252275|NCT00619099|Myelodysplastic Syndrome|myelodysplastic syndrome
5252276|NCT00619099|Decitabine|decitabine
5252277|NCT00619099|Dacogen|dacogen
5252278|NCT00619099|MGI PHARMA, Inc.|mgi pharma, inc.
5252279|NCT00619086|thyroidectomy|thyroidectomy
5252280|NCT00619086|dexamethasone|dexamethasone
5252281|NCT00619086|steroid|steroid
5252282|NCT00619086|nausea|nausea
5252283|NCT00619073|blood platelets|blood platelets
5252284|NCT00619073|platelet aggregation inhibitors|platelet aggregation inhibitors
5252285|NCT00619073|antiplatelet drugs|antiplatelet drugs
5252286|NCT00619073|clopidogrel|clopidogrel
5252287|NCT00619060|skin cancer|skin cancer
5252288|NCT00619060|healthy, no evidence of disease|healthy, no evidence of disease
5252289|NCT00619021|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5252290|NCT00619021|stage I non-small cell lung cancer|stage i non-small cell lung cancer
5252291|NCT00619021|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
5252292|NCT00619008|obesity|obesity
5252293|NCT00619008|low carbohydrate diet|low carbohydrate diet
5252294|NCT00619008|high complex carbohydrate diet|high complex carbohydrate diet
5252295|NCT00619008|weight regulation hormones|weight regulation hormones
5252296|NCT00619008|hunger|hunger
5252297|NCT00619008|satiety|satiety
5252298|NCT00619008|energy expenditure|energy expenditure
5252299|NCT00619008|body composition|body composition
5252300|NCT00619008|weight loss|weight loss
5252301|NCT00618982|Kidney cancer,|kidney cancer,
5252302|NCT00618982|Sorafenib,|sorafenib,
5252303|NCT00618982|Dose escalation,|dose escalation,
5252304|NCT00618982|No previous treatment|no previous treatment
5252305|NCT00618969|Haploidentical|haploidentical
5252306|NCT00618969|peripheral blood stem cell transplantation|peripheral blood stem cell transplantation
5252307|NCT00618969|leukemia|leukemia
5252308|NCT00618969|myeloma|myeloma
5252309|NCT00618969|Hodgkin's disease|hodgkin's disease
5252310|NCT00618969|non-Hodgkin's lymphoma|non-hodgkin's lymphoma
5252311|NCT00618956|NSRI|nsri
5252312|NCT00618956|milnacipran|milnacipran
5252313|NCT00618956|fibromyalgia|fibromyalgia
5252314|NCT00618956|blood pressure|blood pressure
5252315|NCT00618956|hypertension|hypertension
5252316|NCT00618917|NSCLC|nsclc
5252317|NCT00618917|lung cancer|lung cancer
5252318|NCT00618917|chemotherapy|chemotherapy
5252319|NCT00618917|radiation therapy|radiation therapy
5252320|NCT00618917|radiation toxicity|radiation toxicity
5252321|NCT00618904|Probiotics|probiotics
5252322|NCT00618904|Functional Gastrointestinal Symptoms|functional gastrointestinal symptoms
5252672|NCT00617500|climacteric|climacteric
5252323|NCT00618865|Omega-3 Fatty Acids|omega-3 fatty acids
5252324|NCT00618865|Major Depressive Disorder|major depressive disorder
5252325|NCT00618865|Pregnancy|pregnancy
5252326|NCT00618865|Women during pregnancy and after childbirth are more vulnerable to psychiatric disorders|women during pregnancy and after childbirth are more vulnerable to psychiatric disorders
5252327|NCT00618865|Pharmacotherapy for depression during pregnancy is a clinical dilemma.|pharmacotherapy for depression during pregnancy is a clinical dilemma.
5252328|NCT00618865|Omega-3 polyunsaturated fatty acids (PUFAs) might be a promising alternative of treatment for pregnant women with depression.|omega-3 polyunsaturated fatty acids (pufas) might be a promising alternative of treatment for pregnant women with depression.
5252329|NCT00618852|Pediatrics|pediatrics
5252330|NCT00618852|Erythrocyte Transfusion|erythrocyte transfusion
5252331|NCT00618852|Furosemide|furosemide
5252332|NCT00618852|Fluid Overload|fluid overload
5252333|NCT00618839|Complex skin defects|complex skin defects
5252334|NCT00618839|Burns|burns
5252335|NCT00618839|Wound infection|wound infection
5252336|NCT00618839|Skin trauma|skin trauma
5252337|NCT00618826|Breast cancer|breast cancer
5252338|NCT00618800|Falls|falls
5252339|NCT00618800|Elderly|elderly
5252340|NCT00618800|Injury|injury
5252341|NCT00618800|Medication|medication
5252342|NCT00618800|Pharmacy|pharmacy
5252343|NCT00618800|Pharmacist|pharmacist
5252344|NCT00618761|glucose clamp|glucose clamp
5252345|NCT00618761|beta-cell|beta-cell
5252346|NCT00618748|Bipolar|bipolar
5252347|NCT00618709|Healthy volunteers|healthy volunteers
5252348|NCT00618696|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5252349|NCT00618696|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5252350|NCT00618696|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5252351|NCT00618696|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5252352|NCT00618696|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5252353|NCT00618696|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5252354|NCT00618696|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5252355|NCT00618696|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5252356|NCT00618696|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5252357|NCT00618696|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5252358|NCT00618696|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5252359|NCT00618683|AVNRT|avnrt
5252360|NCT00618683|Atrioventricular|atrioventricular
5252361|NCT00618683|nodal reentrant circuit|nodal reentrant circuit
5252362|NCT00618683|nodal reentrant tachycardia|nodal reentrant tachycardia
5252363|NCT00618683|Paroxysmal supraventricular tachycardia|paroxysmal supraventricular tachycardia
5252364|NCT00618670|aging|aging
5252365|NCT00618670|gait|gait
5252366|NCT00618670|musculoskeletal disorder therapy|musculoskeletal disorder therapy
5252367|NCT00618670|peripheral blood vessel disorder|peripheral blood vessel disorder
5252368|NCT00618670|muscle function|muscle function
5252369|NCT00618670|muscle strength|muscle strength
5252370|NCT00618670|quality of life|quality of life
5252371|NCT00618657|pre-operative|pre-operative
5252372|NCT00618657|neo-adjuvant|neo-adjuvant
5252373|NCT00618657|triple negative|triple negative
5252374|NCT00618657|HER2 positive|her2 positive
5252375|NCT00618657|hormone receptor positive|hormone receptor positive
5252376|NCT00618657|breast|breast
5252377|NCT00618657|Carboplatin|carboplatin
5252378|NCT00618657|Nab-paclitaxel|nab-paclitaxel
5252379|NCT00618657|Trastuzumab|trastuzumab
5252380|NCT00618657|Bevacizumab|bevacizumab
5252381|NCT00618657|Inflammatory|inflammatory
5252382|NCT00618631|Smoking|smoking
5252383|NCT00618631|Nicotine|nicotine
5252384|NCT00618631|Endogenous Opioids|endogenous opioids
5252385|NCT00618631|PET Study|pet study
5252386|NCT00618631|Carfentanil|carfentanil
5252387|NCT00618605|HIV Seronegativity|hiv seronegativity
5252388|NCT00618605|HIV Preventative Vaccine|hiv preventative vaccine
5252389|NCT00618592|carbohydrate supplementation|carbohydrate supplementation
5252390|NCT00618592|cardiac surgery|cardiac surgery
5252391|NCT00618592|spine surgery|spine surgery
5252392|NCT00618592|insulin resistance|insulin resistance
5252393|NCT00618592|insulin sensitivity|insulin sensitivity
5252394|NCT00618592|short insulin tolerance test|short insulin tolerance test
5252395|NCT00618592|HOMA|homa
5252396|NCT00618592|outcomes|outcomes
5252397|NCT00618579|Interaction with LMWH or warfarin|interaction with lmwh or warfarin
5252398|NCT00618566|Women with physical Disabilities|women with physical disabilities
5252399|NCT00618566|Secondary Conditions|secondary conditions
5252400|NCT00618566|Depression|depression
5252401|NCT00618566|Cognitive Behavioral Therapy|cognitive behavioral therapy
5252402|NCT00618566|Consumer Control|consumer control
5252403|NCT00618553|Lung Cancer|lung cancer
5252404|NCT00618553|Pulmonary Rehabilitation|pulmonary rehabilitation
5252405|NCT00618553|Questionnaire|questionnaire
5252406|NCT00618553|Survey|survey
5252407|NCT00618553|Lung Function|lung function
5252408|NCT00618553|Quality of Life|quality of life
5252409|NCT00618540|childhood Langerhans cell histiocytosis|childhood langerhans cell histiocytosis
5252673|NCT00617500|complementary therapy|complementary therapy
5252410|NCT00618527|relapsing remitting multiple sclerosis|relapsing remitting multiple sclerosis
5252411|NCT00618527|multiple sclerosis|multiple sclerosis
5252412|NCT00618514|Varicose Veins|varicose veins
5252413|NCT00618514|Laser Ablation|laser ablation
5252414|NCT00618514|Laser Wire Fibers|laser wire fibers
5252415|NCT00618501|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
5252416|NCT00618488|Probiotics|probiotics
5252417|NCT00618488|BB12|bb12
5252418|NCT00618488|Gastrointestinal Symptoms|gastrointestinal symptoms
5252419|NCT00618475|Depression|depression
5252420|NCT00618475|End Stage Renal Disease|end stage renal disease
5252421|NCT00618475|Kidney Disease|kidney disease
5252422|NCT00618475|Mental Health|mental health
5252423|NCT00618462|Cognitive Behavioral Therapy|cognitive behavioral therapy
5252424|NCT00618462|Pathological Gambling|pathological gambling
5252425|NCT00618449|Trachoma|trachoma
5252426|NCT00618449|Chlamydia trachomatis|chlamydia trachomatis
5252427|NCT00618436|Seizures|seizures
5252428|NCT00618436|Traumatic Brain Injury|traumatic brain injury
5252429|NCT00618436|Subarachnoid Hemorrhage|subarachnoid hemorrhage
5252430|NCT00618423|Neuropathic pain|neuropathic pain
5252431|NCT00618423|Chronic pain|chronic pain
5252432|NCT00618423|Acute postoperative pain|acute postoperative pain
5252433|NCT00618423|Ketamine|ketamine
5252434|NCT00618423|Back surgery|back surgery
5252435|NCT00618423|Anesthesia|anesthesia
5252436|NCT00618423|Perioperative|perioperative
5252437|NCT00618397|ketamine|ketamine
5252438|NCT00618397|pharmacokinetics|pharmacokinetics
5252439|NCT00618397|sedation|sedation
5252440|NCT00618397|critical care|critical care
5252441|NCT00618397|opioid tolerance|opioid tolerance
5252442|NCT00618397|NMDA Antagonist|nmda antagonist
5252443|NCT00618384|TACE|tace
5252444|NCT00618384|hepatocellular carcinoma|hepatocellular carcinoma
5252445|NCT00618371|Intensification|intensification
5252446|NCT00618371|HIV viremia|hiv viremia
5252447|NCT00618371|Human Immunodeficiency Virus|human immunodeficiency virus
5252448|NCT00618345|refractory multiple myeloma|refractory multiple myeloma
5252449|NCT00618293|intraoperative bleeding|intraoperative bleeding
5252450|NCT00618293|aortic-valve replacement|aortic-valve replacement
5252451|NCT00618293|aortic stenosis|aortic stenosis
5252452|NCT00618293|Von Willebrand|von willebrand
5252453|NCT00618293|HEAMATE|heamate
5252454|NCT00618254|Prevention of nausea and vomiting associated with radiation or chemotherapy|prevention of nausea and vomiting associated with radiation or chemotherapy
5252455|NCT00618241|interactions|interactions
5252456|NCT00618241|neuropathic pain|neuropathic pain
5252457|NCT00618241|pharmacokinetics|pharmacokinetics
5252458|NCT00618215|cluster-randomised trial|cluster-randomised trial
5252459|NCT00618215|routine oral examination|routine oral examination
5252460|NCT00618215|implementation research|implementation research
5252461|NCT00618215|practice based research|practice based research
5252462|NCT00618215|CPG|cpg
5252463|NCT00618215|recall interval assignment for routine oral examination|recall interval assignment for routine oral examination
5252464|NCT00618215|prescription bitewing radiographs|prescription bitewing radiographs
5252465|NCT00618215|preventive advice and feed back oral disease|preventive advice and feed back oral disease
5252466|NCT00618176|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5252467|NCT00618176|adverse effects|adverse effects
5252468|NCT00618176|Treatment Outcome|treatment outcome
5252469|NCT00618176|Drug Resistance, Viral|drug resistance, viral
5252470|NCT00618176|treatment naïve|treatment naïve
5252471|NCT00618163|Anti-inflammatory|anti-inflammatory
5252472|NCT00618150|GERD|gerd
5252473|NCT00618150|Dyspepsia|dyspepsia
5252474|NCT00618150|Education|education
5252475|NCT00618150|Information|information
5252476|NCT00618137|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
5252477|NCT00618137|Gene expression profiling|gene expression profiling
5252478|NCT00618137|Inert dusts|inert dusts
5252479|NCT00618137|Natural course|natural course
5252480|NCT00618137|Prospective assessment|prospective assessment
5252481|NCT00618124|solid tumor malignancy, SU011248, sunitinib, capecitabine, Phase 1|solid tumor malignancy, su011248, sunitinib, capecitabine, phase 1
5252482|NCT00618111|Prevention of nausea and vomiting associated with radiation or chemotherapy|prevention of nausea and vomiting associated with radiation or chemotherapy
5252483|NCT00618098|anticoagulant reversal|anticoagulant reversal
5252484|NCT00618098|urgent surgery|urgent surgery
5252485|NCT00618098|invasive procedures|invasive procedures
5252486|NCT00618098|vitamin K|vitamin k
5252487|NCT00618098|prothrombin complex concentrate|prothrombin complex concentrate
5252488|NCT00618072|hyperinsulinemia|hyperinsulinemia
5252489|NCT00618072|insulin resistance|insulin resistance
5252490|NCT00618072|perimenopause|perimenopause
5252491|NCT00618072|obesity|obesity
5252492|NCT00618072|overweight|overweight
5252493|NCT00618072|women|women
5252494|NCT00618033|Hemodialysis|hemodialysis
5252495|NCT00618033|ESRD|esrd
5252496|NCT00618020|CTO|cto
5252497|NCT00618020|Chronic Total Occlusion|chronic total occlusion
5252498|NCT00618020|Revascularization|revascularization
5252499|NCT00617994|psoriasis|psoriasis
5252500|NCT00617981|hepatocellular carcinoma|hepatocellular carcinoma
5252501|NCT00617981|liver cancer|liver cancer
5252502|NCT00617942|Breast Cancer|breast cancer
5252503|NCT00617929|chronic myelogenous leukemia|chronic myelogenous leukemia
5252504|NCT00617929|acute lymphoblastic leukemia|acute lymphoblastic leukemia
5252505|NCT00617929|chronic myeloid leukemia|chronic myeloid leukemia
5252506|NCT00617929|lymphoblastic leukemia|lymphoblastic leukemia
5252507|NCT00617929|acute myeloid leukemia|acute myeloid leukemia
5252508|NCT00617929|chronic eosinophilic leukemia|chronic eosinophilic leukemia
5252509|NCT00617929|primary myelofibrosis|primary myelofibrosis
5252510|NCT00617929|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5252511|NCT00617929|chronic neutrophilic leukemia|chronic neutrophilic leukemia
5252512|NCT00617929|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5252513|NCT00617929|disseminated neuroblastoma|disseminated neuroblastoma
5252514|NCT00617929|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
5252515|NCT00617929|Burkitt lymphoma|burkitt lymphoma
5252516|NCT00617929|rhabdomyosarcoma|rhabdomyosarcoma
5252517|NCT00617929|myelodysplastic syndromes|myelodysplastic syndromes
5252518|NCT00617929|Hodgkin lymphoma|hodgkin lymphoma
5252519|NCT00617929|lymphoblastic lymphoma|lymphoblastic lymphoma
5252520|NCT00617929|breast cancer|breast cancer
5252521|NCT00617929|follicular lymphoma|follicular lymphoma
5252522|NCT00617929|mantle cell lymphoma|mantle cell lymphoma
5252523|NCT00617929|marginal zone lymphoma|marginal zone lymphoma
5252524|NCT00617929|recurrent neuroblastoma|recurrent neuroblastoma
5252525|NCT00617929|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5252526|NCT00617929|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
5252527|NCT00617929|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5252528|NCT00617929|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
5252529|NCT00617929|recurrent Wilms tumor and other childhood kidney tumors|recurrent wilms tumor and other childhood kidney tumors
5252530|NCT00617929|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
5252531|NCT00617929|refractory hairy cell leukemia|refractory hairy cell leukemia
5252532|NCT00617929|refractory multiple myeloma|refractory multiple myeloma
5252533|NCT00617929|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5252534|NCT00617929|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5252535|NCT00617929|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5252536|NCT00617929|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5252537|NCT00617929|stage I multiple myeloma|stage i multiple myeloma
5252538|NCT00617929|stage II multiple myeloma|stage ii multiple myeloma
5252539|NCT00617929|stage III multiple myeloma|stage iii multiple myeloma
5252540|NCT00617929|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
5252541|NCT00617929|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5252542|NCT00617929|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5252543|NCT00617929|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5252544|NCT00617929|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5252545|NCT00617929|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5252546|NCT00617929|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5252547|NCT00617929|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5252548|NCT00617929|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5252549|NCT00617929|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5252550|NCT00617929|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5252551|NCT00617929|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5252552|NCT00617929|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5252553|NCT00617929|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5252554|NCT00617929|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5252555|NCT00617929|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5252556|NCT00617929|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
5252557|NCT00617929|stage IIIA breast cancer|stage iiia breast cancer
5252558|NCT00617929|stage IIIB breast cancer|stage iiib breast cancer
5252559|NCT00617929|stage IIIC breast cancer|stage iiic breast cancer
5252560|NCT00617929|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5252561|NCT00617929|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5252562|NCT00617929|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5252563|NCT00617929|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5252564|NCT00617929|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5252565|NCT00617929|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5252566|NCT00617929|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5252567|NCT00617929|stage IV breast cancer|stage iv breast cancer
5252568|NCT00617929|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5252569|NCT00617929|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5252570|NCT00617929|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5252571|NCT00617929|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5252572|NCT00617929|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5252573|NCT00617929|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5252574|NCT00617929|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5252575|NCT00617929|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5252576|NCT00617929|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5252577|NCT00617916|hyperspectral imaging|hyperspectral imaging
5252578|NCT00617916|tissue oxygenation|tissue oxygenation
5252579|NCT00617916|diabetic foot ulcers|diabetic foot ulcers
5252580|NCT00617916|wound healing|wound healing
5252581|NCT00617916|prevention|prevention
5252582|NCT00617903|rosacea|rosacea
5252583|NCT00617903|papulopustular|papulopustular
5252584|NCT00617903|azelaic acid|azelaic acid
5252585|NCT00617903|foam|foam
5252586|NCT00617890|anti-IGF-1R|anti-igf-1r
5252587|NCT00617851|Influenza|influenza
5252588|NCT00617851|adults|adults
5252589|NCT00617851|different lots|different lots
5252590|NCT00617851|trivalent subunit influenza virus vaccine (IVV)|trivalent subunit influenza virus vaccine (ivv)
5252591|NCT00617851|trivalent subunit influenza vaccine|trivalent subunit influenza vaccine
5252592|NCT00617838|Celiac disease|celiac disease
5252593|NCT00617838|genetic risk|genetic risk
5252594|NCT00617838|gluten introduction|gluten introduction
5252595|NCT00617838|predicting antibodies|predicting antibodies
5252596|NCT00617825|chronic venous disorders|chronic venous disorders
5252597|NCT00617825|cryotherapy|cryotherapy
5252598|NCT00617825|skin microcirculation|skin microcirculation
5252599|NCT00617825|skin temperature|skin temperature
5252600|NCT00617812|Vaccine|vaccine
5252601|NCT00617812|Prevention|prevention
5252602|NCT00617812|Diphtheria|diphtheria
5252603|NCT00617812|Tetanus|tetanus
5252604|NCT00617812|Pertussis|pertussis
5252605|NCT00617812|Hepatitis B|hepatitis b
5252606|NCT00617812|Haemophilus influenzae type b|haemophilus influenzae type b
5252607|NCT00617812|Healthy infants|healthy infants
5252608|NCT00617799|stage IV renal cell cancer|stage iv renal cell cancer
5252609|NCT00617799|stage IV melanoma|stage iv melanoma
5252610|NCT00617786|urinary urgency|urinary urgency
5252611|NCT00617786|urinary frequency|urinary frequency
5252612|NCT00617786|urge incontinence|urge incontinence
5252613|NCT00617786|sacral neuromodulation therapy|sacral neuromodulation therapy
5252614|NCT00617786|urgency|urgency
5252615|NCT00617786|frequency|frequency
5252616|NCT00617773|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5252617|NCT00617773|recurrent fallopian tube cancer|recurrent fallopian tube cancer
5252618|NCT00617773|recurrent primary peritoneal cancer|recurrent primary peritoneal cancer
5252619|NCT00617747|Zolmitriptan|zolmitriptan
5252620|NCT00617747|ZOMIG|zomig
5252621|NCT00617747|migraine|migraine
5252622|NCT00617747|headache response|headache response
5252623|NCT00617747|headache|headache
5252624|NCT00617747|headache pain|headache pain
5252625|NCT00617734|Squamous Cell Carcinoma in Head and Neck|squamous cell carcinoma in head and neck
5252626|NCT00617734|Prior Platinum-based chemotherapy|prior platinum-based chemotherapy
5252627|NCT00617734|Cetuximab|cetuximab
5252628|NCT00617734|Erbitux|erbitux
5252629|NCT00617734|IMC-A12|imc-a12
5252630|NCT00617721|Defective gene(s) in plasma membrane remodelling.|defective gene(s) in plasma membrane remodelling.
5252631|NCT00617721|Scott syndrome,|scott syndrome,
5252632|NCT00617721|Reduced prothrombin consumption,|reduced prothrombin consumption,
5252633|NCT00617721|Circulating biomakers of scott syndrome|circulating biomakers of scott syndrome
5252634|NCT00617695|Zolmitriptan|zolmitriptan
5252635|NCT00617695|ZOMIG|zomig
5252636|NCT00617695|migraine|migraine
5252637|NCT00617695|headache response|headache response
5252638|NCT00617695|headache|headache
5252639|NCT00617695|headache pain|headache pain
5252640|NCT00617682|Maternal immunization|maternal immunization
5252641|NCT00617682|Pneumococcal conjugate vaccine|pneumococcal conjugate vaccine
5252642|NCT00617682|Otitis media|otitis media
5252643|NCT00617669|Hormone Resistant Prostate Cancer|hormone resistant prostate cancer
5252644|NCT00617669|Endothelin A Receptor Antagonist|endothelin a receptor antagonist
5252645|NCT00617669|Endothelin A|endothelin a
5252646|NCT00617669|Endothelin A antagonist|endothelin a antagonist
5252647|NCT00617656|LUNG CANCER|lung cancer
5252648|NCT00617643|Nevirapine|nevirapine
5252649|NCT00617643|Rifampicin|rifampicin
5252650|NCT00617643|Pharmacokinetics|pharmacokinetics
5252651|NCT00617617|isoflavones|isoflavones
5252652|NCT00617617|soy|soy
5252653|NCT00617604|kidney transplant|kidney transplant
5252654|NCT00617604|alefacept|alefacept
5252655|NCT00617591|Lenalidomide|lenalidomide
5252656|NCT00617591|Revlimid|revlimid
5252657|NCT00617591|Pegylated Liposomal Doxorubicin|pegylated liposomal doxorubicin
5252658|NCT00617591|Doxil|doxil
5252659|NCT00617591|Dexamethasone|dexamethasone
5252660|NCT00617591|Decadron|decadron
5252661|NCT00617578|Antitachy pacing|antitachy pacing
5252662|NCT00617578|Implantable cardioverter-defibrillator|implantable cardioverter-defibrillator
5252663|NCT00617552|postoperative ileus|postoperative ileus
5252664|NCT00617552|POI|poi
5252665|NCT00617552|major open abdominal surgery|major open abdominal surgery
5252666|NCT00617539|recurrent breast cancer|recurrent breast cancer
5252667|NCT00617539|stage IV breast cancer|stage iv breast cancer
5252668|NCT00617539|male breast cancer|male breast cancer
5252669|NCT00617539|tumors metastatic to brain|tumors metastatic to brain
5252670|NCT00617526|HIV|hiv
5252671|NCT00617526|treatment naïve|treatment naïve
5252674|NCT00617500|hormonal replacement therapy|hormonal replacement therapy
5252675|NCT00617474|erythropoietin|erythropoietin
5252676|NCT00617474|kidney allograft survival|kidney allograft survival
5252677|NCT00617474|Recombinant Erythropoietin|recombinant erythropoietin
5252678|NCT00617474|erythropoietin (Epo)-induced protein 29, human|erythropoietin (epo)-induced protein 29, human
5252679|NCT00617461|Post-herpetic neuralgia(PHN)|post-herpetic neuralgia(phn)
5252680|NCT00617461|Neuropathic pain|neuropathic pain
5252681|NCT00617448|diathermy hemorrhoids|diathermy hemorrhoids
5252682|NCT00617448|Ligasure|ligasure
5252683|NCT00617448|randomized controlled trial|randomized controlled trial
5252684|NCT00617448|Postoperative pain|postoperative pain
5252685|NCT00617448|Surgical Procedure, Ambulatory|surgical procedure, ambulatory
5252686|NCT00617448|Local Anesthesia|local anesthesia
5252687|NCT00617448|Safety procedure long term|safety procedure long term
5252688|NCT00617448|Day Surgery|day surgery
5252689|NCT00617435|Trans fatty acid|trans fatty acid
5252690|NCT00617435|Insulin resistance|insulin resistance
5252691|NCT00617435|Skeletal muscle|skeletal muscle
5252692|NCT00617435|Adipose tissue|adipose tissue
5252693|NCT00617409|SCLC|sclc
5252694|NCT00617409|vaccine|vaccine
5252695|NCT00617409|immunize|immunize
5252696|NCT00617396|Irritable Bowel Syndrome|irritable bowel syndrome
5252697|NCT00617396|Seroquel|seroquel
5252698|NCT00617396|Abdominal Pain|abdominal pain
5252699|NCT00617383|demyelinating disease|demyelinating disease
5252700|NCT00617383|multiple sclerosis|multiple sclerosis
5252701|NCT00617383|female monozygotic identical twins|female monozygotic identical twins
5252702|NCT00617383|MS|ms
5252703|NCT00617383|non-concordant|non-concordant
5252704|NCT00617383|clinically isolated syndrome - CIS|clinically isolated syndrome - cis
5252705|NCT00617383|brain MRI|brain mri
5252706|NCT00617383|proteomics|proteomics
5252707|NCT00617370|CYCLOPHOSPHAMIDE (CYTOXAN)|cyclophosphamide (cytoxan)
5252708|NCT00617370|EPIRUBICIN|epirubicin
5252709|NCT00617370|PEGFILGRASTIM|pegfilgrastim
5252710|NCT00617370|TAXOL (PACLITAXEL)|taxol (paclitaxel)
5252711|NCT00617357|incisional hernia|incisional hernia
5252712|NCT00617357|abdominal hernia repair|abdominal hernia repair
5252713|NCT00617357|Ventral incisional hernia repair|ventral incisional hernia repair
5252714|NCT00617344|Dengue fever|dengue fever
5252715|NCT00617344|Dengue hemorrhagic fever|dengue hemorrhagic fever
5252716|NCT00617344|Dengue virus|dengue virus
5252717|NCT00617331|vaccine, priming, influenza, flu, A/H9N2|vaccine, priming, influenza, flu, a/h9n2
5252718|NCT00617318|Pomegranate|pomegranate
5252719|NCT00617318|Influenza|influenza
5252720|NCT00617318|Common Cold|common cold
5252721|NCT00617318|Cough|cough
5252722|NCT00617318|Severity|severity
5252723|NCT00617318|Efficacy|efficacy
5252724|NCT00617305|ambrisentan|ambrisentan
5252725|NCT00617305|PAH|pah
5252726|NCT00617305|combination therapy|combination therapy
5252727|NCT00617305|phosphodiesterase type-5 inhibitor (PDE-5i)|phosphodiesterase type-5 inhibitor (pde-5i)
5252728|NCT00617305|cardiovascular|cardiovascular
5252729|NCT00617305|endothelin receptor antagonist|endothelin receptor antagonist
5252730|NCT00617305|ERA|era
5252731|NCT00617292|21-hydroxylase deficiency|21-hydroxylase deficiency
5252732|NCT00617292|21OHD|21ohd
5252733|NCT00617292|CAH|cah
5252734|NCT00617266|tobacco, cessation, BPO, RCT, KAP|tobacco, cessation, bpo, rct, kap
5252735|NCT00617240|antipsychotic|antipsychotic
5252736|NCT00617240|metformin|metformin
5252737|NCT00617240|children|children
5252738|NCT00617240|adolescents|adolescents
5252739|NCT00617227|Enteral vancomycin therapy, serum vancomycin levels, renal failure|enteral vancomycin therapy, serum vancomycin levels, renal failure
5252740|NCT00617214|Schizophrenia|schizophrenia
5252741|NCT00617214|Integrated care program|integrated care program
5252742|NCT00617214|Seroquel|seroquel
5252743|NCT00617201|cocaine|cocaine
5252744|NCT00617201|dependence|dependence
5252745|NCT00617201|stimulants|stimulants
5252746|NCT00617188|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5252747|NCT00617175|Implantable Cardiac Defibrillator|implantable cardiac defibrillator
5252748|NCT00617175|therapies reduction|therapies reduction
5252749|NCT00617175|Shocks|shocks
5252750|NCT00617175|Quality of Life|quality of life
5252751|NCT00617149|exercise,|exercise,
5252752|NCT00617149|excessive weight gain during pregnancy|excessive weight gain during pregnancy
5252753|NCT00617136|Surgery|surgery
5252754|NCT00617136|Anesthesia|anesthesia
5252755|NCT00617136|Hypothermia|hypothermia
5252756|NCT00617136|Temperature|temperature
5252757|NCT00617136|Perioperative|perioperative
5252758|NCT00617136|Temperature Management|temperature management
5252759|NCT00617110|diesel exhaust particles|diesel exhaust particles
5252760|NCT00617110|live attenuated influenza virus vaccine|live attenuated influenza virus vaccine
5252761|NCT00617110|flu vaccine|flu vaccine
5252762|NCT00617097|Pain associated with first trimester surgical abortion|pain associated with first trimester surgical abortion
5252763|NCT00617084|Drug Eluting Stents|drug eluting stents
5252764|NCT00617084|Interventional Cardiology|interventional cardiology
5252765|NCT00617071|colon cancer|colon cancer
5252766|NCT00617071|rectal cancer|rectal cancer
5252767|NCT00617058|antipsychotic|antipsychotic
5252768|NCT00617058|metformin|metformin
5252769|NCT00617058|children|children
5252770|NCT00617058|adolescents|adolescents
5252771|NCT00617045|Post Partum Depression|post partum depression
5252772|NCT00617006|Anesthesia Workspace|anesthesia workspace
5252773|NCT00617006|Hospital Acquired Infections|hospital acquired infections
5252774|NCT00617006|Hand Hygiene|hand hygiene
5252775|NCT00617006|Alcohol Based Cleanser|alcohol based cleanser
5252776|NCT00617006|Bacterial Contamination|bacterial contamination
5252777|NCT00616980|PAD|pad
5252778|NCT00616980|PVD|pvd
5252779|NCT00616980|CLI|cli
5252780|NCT00616980|Stem Cells|stem cells
5252781|NCT00616967|stage II breast cancer|stage ii breast cancer
5252782|NCT00616967|stage IIIA breast cancer|stage iiia breast cancer
5252783|NCT00616967|stage IIIB breast cancer|stage iiib breast cancer
5252784|NCT00616967|stage IIIC breast cancer|stage iiic breast cancer
5252785|NCT00616967|ductal breast carcinoma|ductal breast carcinoma
5252786|NCT00616967|lobular breast carcinoma|lobular breast carcinoma
5252787|NCT00616954|mismatched|mismatched
5252788|NCT00616954|Stem cell transplatation|stem cell transplatation
5252789|NCT00616954|Bone marrow transplantation|bone marrow transplantation
5252790|NCT00616954|T cell depletion|t cell depletion
5252791|NCT00616954|engraftment|engraftment
5252792|NCT00616954|Patients undergoing allogeneic haplo-SCT|patients undergoing allogeneic haplo-sct
5252793|NCT00616941|NY-ESO-1 OLP4|ny-eso-1 olp4
5252794|NCT00616941|Ovarian Cancer|ovarian cancer
5252795|NCT00616941|Cancer Vaccine|cancer vaccine
5252796|NCT00616928|vaccines|vaccines
5252797|NCT00616928|immunogenicity|immunogenicity
5252798|NCT00616928|human|human
5252799|NCT00616928|safety|safety
5252800|NCT00616928|influenza|influenza
5252801|NCT00616915|Wellbutrin SR|wellbutrin sr
5252802|NCT00616902|Zemplar, paricalcitol, PRIMO II|zemplar, paricalcitol, primo ii
5252803|NCT00616876|lactulose|lactulose
5252804|NCT00616876|prebiotic|prebiotic
5252805|NCT00616876|premature infant|premature infant
5252806|NCT00616876|enteral feeding|enteral feeding
5252807|NCT00616876|stools|stools
5252808|NCT00616876|lactobacillus|lactobacillus
5252809|NCT00616876|nutrition|nutrition
5252810|NCT00616876|growth|growth
5252811|NCT00616850|Total Knee Arthroplasty|total knee arthroplasty
5252812|NCT00616850|Intravenous Lidocaine Infusion|intravenous lidocaine infusion
5252813|NCT00616850|Femoral Block Catheter|femoral block catheter
5252814|NCT00616837|Remote consultation/*methods|remote consultation/*methods
5252815|NCT00616837|Orthopaedics methods|orthopaedics methods
5252816|NCT00616837|Telemedicine|telemedicine
5252817|NCT00616837|Follow-up study|follow-up study
5252818|NCT00616837|Ambulatory care|ambulatory care
5252819|NCT00616824|Acellular dermal matrix|acellular dermal matrix
5252820|NCT00616824|breast reconstruction|breast reconstruction
5252821|NCT00616824|tissue expander|tissue expander
5252822|NCT00616824|postoperative pain|postoperative pain
5252823|NCT00616824|complication|complication
5252824|NCT00616824|pain|pain
5252825|NCT00616824|patient satisfaction|patient satisfaction
5252826|NCT00616811|Type 2 diabetes, vildagliptin|type 2 diabetes, vildagliptin
5252827|NCT00616785|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5252828|NCT00616785|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5252829|NCT00616759|Depression|depression
5252830|NCT00616759|Electroconvulsive therapy|electroconvulsive therapy
5252831|NCT00616746|Alcohol, nicotine|alcohol, nicotine
5252832|NCT00616733|Multiple sclerosis, relapsing, secondary progressive, clinically isolated syndrome, MRI|multiple sclerosis, relapsing, secondary progressive, clinically isolated syndrome, mri
5252833|NCT00616720|stage I multiple myeloma|stage i multiple myeloma
5252834|NCT00616720|stage II multiple myeloma|stage ii multiple myeloma
5252835|NCT00616720|stage III multiple myeloma|stage iii multiple myeloma
5252836|NCT00616720|refractory multiple myeloma|refractory multiple myeloma
5252837|NCT00616707|Inflammation|inflammation
5252838|NCT00616707|Oxidative Stress|oxidative stress
5252839|NCT00616707|Microalbuminuria|microalbuminuria
5252840|NCT00616668|Transtibial amputees due to vascular diseases.|transtibial amputees due to vascular diseases.
5252841|NCT00616655|Anxiety|anxiety
5252842|NCT00616642|recurrent pituitary tumor|recurrent pituitary tumor
5252843|NCT00616642|ACTH-producing pituitary tumor|acth-producing pituitary tumor
5252844|NCT00616642|nonfunctioning pituitary tumor|nonfunctioning pituitary tumor
5252845|NCT00616616|appendectomy|appendectomy
5252846|NCT00616616|cholecystectomy|cholecystectomy
5252847|NCT00616616|gastric banding|gastric banding
5252848|NCT00616616|adrenalectomy|adrenalectomy
5252849|NCT00616616|Gastric lap-band placement|gastric lap-band placement
5252850|NCT00616603|Total Knee Arthroplasty.|total knee arthroplasty.
5252851|NCT00616603|Sciatic nerve Blocks.|sciatic nerve blocks.
5252852|NCT00616603|Dexamethasone.|dexamethasone.
5252853|NCT00616590|sleep disorders|sleep disorders
5252854|NCT00616590|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
5252855|NCT00616590|fatigue|fatigue
5252856|NCT00616590|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
5252857|NCT00616590|stage I squamous cell carcinoma of the hypopharynx|stage i squamous cell carcinoma of the hypopharynx
5252858|NCT00616590|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
5252859|NCT00616590|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
5252860|NCT00616590|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5252861|NCT00616590|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
5252862|NCT00616590|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
5252863|NCT00616590|stage I squamous cell carcinoma of the larynx|stage i squamous cell carcinoma of the larynx
5252864|NCT00616590|stage I verrucous carcinoma of the larynx|stage i verrucous carcinoma of the larynx
5252865|NCT00616590|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
5252866|NCT00616590|stage II verrucous carcinoma of the larynx|stage ii verrucous carcinoma of the larynx
5252867|NCT00616590|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
5252868|NCT00616590|stage III verrucous carcinoma of the larynx|stage iii verrucous carcinoma of the larynx
5252869|NCT00616590|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5252870|NCT00616590|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
5252871|NCT00616590|recurrent adenoid cystic carcinoma of the oral cavity|recurrent adenoid cystic carcinoma of the oral cavity
5252872|NCT00616590|recurrent mucoepidermoid carcinoma of the oral cavity|recurrent mucoepidermoid carcinoma of the oral cavity
5252873|NCT00616590|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
5252874|NCT00616590|stage I adenoid cystic carcinoma of the oral cavity|stage i adenoid cystic carcinoma of the oral cavity
5252875|NCT00616590|stage I mucoepidermoid carcinoma of the oral cavity|stage i mucoepidermoid carcinoma of the oral cavity
5252876|NCT00616590|stage I verrucous carcinoma of the oral cavity|stage i verrucous carcinoma of the oral cavity
5252877|NCT00616590|stage II adenoid cystic carcinoma of the oral cavity|stage ii adenoid cystic carcinoma of the oral cavity
5252878|NCT00616590|stage II mucoepidermoid carcinoma of the oral cavity|stage ii mucoepidermoid carcinoma of the oral cavity
5252879|NCT00616590|stage II verrucous carcinoma of the oral cavity|stage ii verrucous carcinoma of the oral cavity
5252880|NCT00616590|stage III adenoid cystic carcinoma of the oral cavity|stage iii adenoid cystic carcinoma of the oral cavity
5252881|NCT00616590|stage III mucoepidermoid carcinoma of the oral cavity|stage iii mucoepidermoid carcinoma of the oral cavity
5252882|NCT00616590|stage III verrucous carcinoma of the oral cavity|stage iii verrucous carcinoma of the oral cavity
5252883|NCT00616590|stage IV adenoid cystic carcinoma of the oral cavity|stage iv adenoid cystic carcinoma of the oral cavity
5252884|NCT00616590|stage IV mucoepidermoid carcinoma of the oral cavity|stage iv mucoepidermoid carcinoma of the oral cavity
5252885|NCT00616590|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
5252886|NCT00616590|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
5252887|NCT00616590|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
5252888|NCT00616590|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
5252889|NCT00616590|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5252890|NCT00616590|recurrent basal cell carcinoma of the lip|recurrent basal cell carcinoma of the lip
5252891|NCT00616590|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
5252892|NCT00616590|stage I basal cell carcinoma of the lip|stage i basal cell carcinoma of the lip
5252893|NCT00616590|stage II basal cell carcinoma of the lip|stage ii basal cell carcinoma of the lip
5252894|NCT00616590|stage III basal cell carcinoma of the lip|stage iii basal cell carcinoma of the lip
5252895|NCT00616590|stage IV basal cell carcinoma of the lip|stage iv basal cell carcinoma of the lip
5252896|NCT00616590|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
5252897|NCT00616590|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
5252898|NCT00616590|recurrent lymphoepithelioma of the nasopharynx|recurrent lymphoepithelioma of the nasopharynx
5252899|NCT00616590|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
5252900|NCT00616590|stage I lymphoepithelioma of the nasopharynx|stage i lymphoepithelioma of the nasopharynx
5252901|NCT00616590|stage I squamous cell carcinoma of the nasopharynx|stage i squamous cell carcinoma of the nasopharynx
5252902|NCT00616590|stage II lymphoepithelioma of the nasopharynx|stage ii lymphoepithelioma of the nasopharynx
5252903|NCT00616590|stage II squamous cell carcinoma of the nasopharynx|stage ii squamous cell carcinoma of the nasopharynx
5252904|NCT00616590|stage III lymphoepithelioma of the nasopharynx|stage iii lymphoepithelioma of the nasopharynx
5252905|NCT00616590|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
5252906|NCT00616590|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
5252907|NCT00616590|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
5252908|NCT00616590|recurrent lymphoepithelioma of the oropharynx|recurrent lymphoepithelioma of the oropharynx
5252909|NCT00616590|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
5252910|NCT00616590|stage I lymphoepithelioma of the oropharynx|stage i lymphoepithelioma of the oropharynx
5252911|NCT00616590|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
5252912|NCT00616590|stage II lymphoepithelioma of the oropharynx|stage ii lymphoepithelioma of the oropharynx
5252913|NCT00616590|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
5252914|NCT00616590|stage III lymphoepithelioma of the oropharynx|stage iii lymphoepithelioma of the oropharynx
5253275|NCT00615004|GH|gh
5252915|NCT00616590|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
5252916|NCT00616590|stage IV lymphoepithelioma of the oropharynx|stage iv lymphoepithelioma of the oropharynx
5252917|NCT00616590|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5252918|NCT00616590|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity
5252919|NCT00616590|recurrent inverted papilloma of the paranasal sinus and nasal cavity|recurrent inverted papilloma of the paranasal sinus and nasal cavity
5252920|NCT00616590|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity
5252921|NCT00616590|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
5252922|NCT00616590|stage I esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage i esthesioneuroblastoma of the paranasal sinus and nasal cavity
5252923|NCT00616590|stage I inverted papilloma of the paranasal sinus and nasal cavity|stage i inverted papilloma of the paranasal sinus and nasal cavity
5252924|NCT00616590|stage I midline lethal granuloma of the paranasal sinus and nasal cavity|stage i midline lethal granuloma of the paranasal sinus and nasal cavity
5252925|NCT00616590|stage I squamous cell carcinoma of the paranasal sinus and nasal cavity|stage i squamous cell carcinoma of the paranasal sinus and nasal cavity
5252926|NCT00616590|stage II esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage ii esthesioneuroblastoma of the paranasal sinus and nasal cavity
5252927|NCT00616590|stage II inverted papilloma of the paranasal sinus and nasal cavity|stage ii inverted papilloma of the paranasal sinus and nasal cavity
5252928|NCT00616590|stage II midline lethal granuloma of the paranasal sinus and nasal cavity|stage ii midline lethal granuloma of the paranasal sinus and nasal cavity
5252929|NCT00616590|stage II squamous cell carcinoma of the paranasal sinus and nasal cavity|stage ii squamous cell carcinoma of the paranasal sinus and nasal cavity
5252930|NCT00616590|stage III esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iii esthesioneuroblastoma of the paranasal sinus and nasal cavity
5252931|NCT00616590|stage III inverted papilloma of the paranasal sinus and nasal cavity|stage iii inverted papilloma of the paranasal sinus and nasal cavity
5252932|NCT00616590|stage III midline lethal granuloma of the paranasal sinus and nasal cavity|stage iii midline lethal granuloma of the paranasal sinus and nasal cavity
5252933|NCT00616590|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
5252934|NCT00616590|stage IV esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iv esthesioneuroblastoma of the paranasal sinus and nasal cavity
5252935|NCT00616590|stage IV inverted papilloma of the paranasal sinus and nasal cavity|stage iv inverted papilloma of the paranasal sinus and nasal cavity
5252936|NCT00616590|stage IV midline lethal granuloma of the paranasal sinus and nasal cavity|stage iv midline lethal granuloma of the paranasal sinus and nasal cavity
5252937|NCT00616590|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
5252938|NCT00616590|recurrent salivary gland cancer|recurrent salivary gland cancer
5252939|NCT00616590|stage I salivary gland cancer|stage i salivary gland cancer
5252940|NCT00616590|stage II salivary gland cancer|stage ii salivary gland cancer
5252941|NCT00616590|stage III salivary gland cancer|stage iii salivary gland cancer
5252942|NCT00616590|stage IV salivary gland cancer|stage iv salivary gland cancer
5252943|NCT00616577|Caudal Epidural Ropivacaine|caudal epidural ropivacaine
5252944|NCT00616564|GM-CSF|gm-csf
5252945|NCT00616564|Interleukin|interleukin
5252946|NCT00616564|IL-2|il-2
5252947|NCT00616564|Sargrostim|sargrostim
5252948|NCT00616551|Acromegaly|acromegaly
5252949|NCT00616538|Atopic|atopic
5252950|NCT00616538|Dermatitis|dermatitis
5252951|NCT00616538|eczema|eczema
5252952|NCT00616538|skin barrier|skin barrier
5252953|NCT00616538|ceramide|ceramide
5252954|NCT00616538|topical|topical
5252955|NCT00616538|inflamation|inflamation
5252956|NCT00616538|steroid|steroid
5252957|NCT00616538|SCORAD|scorad
5252958|NCT00616538|glucocorticoids|glucocorticoids
5252959|NCT00616538|EpiCeram|epiceram
5252960|NCT00616538|Cutivate|cutivate
5252961|NCT00616538|fluticasone|fluticasone
5252962|NCT00616512|Water|water
5252963|NCT00616512|oral care|oral care
5252964|NCT00616512|oral hygiene|oral hygiene
5252965|NCT00616512|dysphagia|dysphagia
5252966|NCT00616512|thin liquid dysphagia|thin liquid dysphagia
5252967|NCT00616512|thickened liquids|thickened liquids
5252968|NCT00616499|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5252969|NCT00616499|adenocarcinoma of the lung|adenocarcinoma of the lung
5252970|NCT00616499|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
5252971|NCT00616499|large cell lung cancer|large cell lung cancer
5252972|NCT00616460|safety|safety
5252973|NCT00616460|efficacy|efficacy
5252974|NCT00616421|vaccine|vaccine
5252975|NCT00616421|children|children
5252976|NCT00616421|healthy|healthy
5252977|NCT00616421|meningitis|meningitis
5252978|NCT00616421|meningococcal|meningococcal
5252979|NCT00616421|prevention of meningococcal disease serogroups ACWY|prevention of meningococcal disease serogroups acwy
5252980|NCT00616421|Menveo|menveo
5252981|NCT00616408|GH|gh
5252982|NCT00616408|IGF-I|igf-i
5252983|NCT00616408|GH-secreting tumors|gh-secreting tumors
5252984|NCT00616408|Octreotide|octreotide
5252985|NCT00616395|Infant Nutrition|infant nutrition
5252986|NCT00616395|Soy Phytochemicals|soy phytochemicals
5252987|NCT00616395|Infant Body Composition|infant body composition
5252988|NCT00616395|Brain Function|brain function
5252989|NCT00616395|Cognition and Development|cognition and development
5252990|NCT00616395|Healthy Infants|healthy infants
5252991|NCT00616382|PDA|pda
5252992|NCT00616382|indomethacin|indomethacin
5252993|NCT00616382|pentoxifylline|pentoxifylline
5252994|NCT00616382|Patent Ductus Arteriosus [PDA] resistant to therapy|patent ductus arteriosus [pda] resistant to therapy
5252995|NCT00616369|pulmonary hypertension|pulmonary hypertension
5252996|NCT00616369|hypertension|hypertension
5252997|NCT00616369|cardiomyopathy|cardiomyopathy
5252998|NCT00616369|arrhythmias|arrhythmias
5252999|NCT00616356|Yellow Fever|yellow fever
5253000|NCT00616343|ET|et
5253001|NCT00616317|Antiphospholipid Syndrome|antiphospholipid syndrome
5253002|NCT00616304|severe falciparum malaria|severe falciparum malaria
5253003|NCT00616291|recurrent prostate cancer|recurrent prostate cancer
5253004|NCT00616291|stage IV prostate cancer|stage iv prostate cancer
5253005|NCT00616278|Growth Failure AND|growth failure and
5253006|NCT00616278|Chronic Renal Insufficiency OR|chronic renal insufficiency or
5253007|NCT00616278|End Stage Renal Disease|end stage renal disease
5253008|NCT00616265|Sleep apnea|sleep apnea
5253009|NCT00616265|Refractory Hypertension|refractory hypertension
5253010|NCT00616265|Difficult-to-treat hypertension|difficult-to-treat hypertension
5253011|NCT00616265|CPAP|cpap
5253012|NCT00616252|Antiretroviral|antiretroviral
5253013|NCT00616252|Pharmacokinetics|pharmacokinetics
5253014|NCT00616252|Pregnancy|pregnancy
5253015|NCT00616239|Melasma|melasma
5253016|NCT00616239|Dark spots on the face|dark spots on the face
5253017|NCT00616213|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5253018|NCT00616200|D-IBS (diarrhea predominant irritable bowel syndrome)|d-ibs (diarrhea predominant irritable bowel syndrome)
5253019|NCT00616174|Cesarean delivery|cesarean delivery
5253020|NCT00616174|Active Warming|active warming
5253021|NCT00616174|Neonatal Temperature|neonatal temperature
5253022|NCT00616161|Acute Heart Failure|acute heart failure
5253023|NCT00616161|Inotropes|inotropes
5253024|NCT00616161|Lusitropic agents|lusitropic agents
5253025|NCT00616161|Istaroxime|istaroxime
5253026|NCT00616161|PST2744|pst2744
5253027|NCT00616148|Epilepsy|epilepsy
5253028|NCT00616148|Seizures|seizures
5253029|NCT00616135|Breast|breast
5253030|NCT00616135|Stem Cell|stem cell
5253031|NCT00616135|Adipose Derived Stem Cells|adipose derived stem cells
5253032|NCT00616135|Adipose Derived Regenerative Cells|adipose derived regenerative cells
5253033|NCT00616135|ADRC|adrc
5253034|NCT00616135|Reconstructive Breast Surgery|reconstructive breast surgery
5253035|NCT00616135|Breast Reconstruction|breast reconstruction
5253036|NCT00616135|Cancer|cancer
5253037|NCT00616135|Carcinoma|carcinoma
5253038|NCT00616135|Autologous fat transplantation|autologous fat transplantation
5253039|NCT00616135|Autologous fat|autologous fat
5253040|NCT00616135|Cosmetic breast deformities|cosmetic breast deformities
5253041|NCT00616135|Functional breast deformity|functional breast deformity
5253042|NCT00616135|Lumpectomy|lumpectomy
5253043|NCT00616135|Segmental mastectomy|segmental mastectomy
5253044|NCT00616135|Quadrantectomy|quadrantectomy
5253045|NCT00616135|breast conservation therapy|breast conservation therapy
5253046|NCT00616122|recurrent breast cancer|recurrent breast cancer
5253047|NCT00616122|stage IV breast cancer|stage iv breast cancer
5253048|NCT00616122|male breast cancer|male breast cancer
5253049|NCT00616096|Serum Immunoglobulin E above 5000 kU/l|serum immunoglobulin e above 5000 ku/l
5253050|NCT00616083|Breast Feeding|breast feeding
5253051|NCT00616083|Body Composition|body composition
5253052|NCT00616083|Body Fat|body fat
5253053|NCT00616083|Infant|infant
5253054|NCT00616083|Diet|diet
5253055|NCT00616083|Healthy Infants|healthy infants
5253056|NCT00616057|fructans supplementation|fructans supplementation
5253057|NCT00616044|Spinal Anesthesia|spinal anesthesia
5253058|NCT00616044|Epidural Anesthesia|epidural anesthesia
5253059|NCT00616044|Orthopedic procedures|orthopedic procedures
5253060|NCT00616031|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5253061|NCT00616031|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5253062|NCT00616018|acetaminophen|acetaminophen
5253063|NCT00616018|protein adducts|protein adducts
5253064|NCT00616018|hepatic function|hepatic function
5253065|NCT00616018|drug safety|drug safety
5253066|NCT00616018|non drinkers|non drinkers
5253067|NCT00616005|Glioblastoma|glioblastoma
5253068|NCT00616005|GBM|gbm
5253069|NCT00616005|Brain tumor|brain tumor
5253070|NCT00616005|Temodar|temodar
5253071|NCT00616005|Temozolomide|temozolomide
5253072|NCT00616005|Irinotecan|irinotecan
5253073|NCT00616005|CPT-11|cpt-11
5253074|NCT00616005|Camptosar|camptosar
5253075|NCT00616005|Malignant glioma|malignant glioma
5253076|NCT00616005|Anaplastic astrocytoma|anaplastic astrocytoma
5253077|NCT00616005|Glioblastoma multiforme|glioblastoma multiforme
5253078|NCT00615979|trauma|trauma
5253079|NCT00615979|portable ultrasound|portable ultrasound
5253080|NCT00615979|telemedicine|telemedicine
5253081|NCT00615979|Department of Defense|department of defense
5253082|NCT00615966|kidney transplantation|kidney transplantation
5253083|NCT00615966|ischemia-reperfusion injury|ischemia-reperfusion injury
5253084|NCT00615966|phosphatidylserine binding|phosphatidylserine binding
5253085|NCT00615940|HER2negative|her2negative
5253086|NCT00615927|Glioblastoma|glioblastoma
5253087|NCT00615927|Gliosarcoma|gliosarcoma
5253088|NCT00615927|glioblastoma multiforme (GBM)|glioblastoma multiforme (gbm)
5253089|NCT00615927|GBM|gbm
5253090|NCT00615927|Imatinib Mesylate|imatinib mesylate
5253091|NCT00615927|Gleevec|gleevec
5253092|NCT00615927|Hydroxyurea|hydroxyurea
5253093|NCT00615927|Droxia|droxia
5253094|NCT00615927|Hydrea|hydrea
5253095|NCT00615927|Hydroxycarbamide|hydroxycarbamide
5253096|NCT00615927|Imatinib|imatinib
5253097|NCT00615927|Brain tumor|brain tumor
5253098|NCT00615927|Malignant brain tumor|malignant brain tumor
5253099|NCT00615927|Recurrent glioblastoma multiforme|recurrent glioblastoma multiforme
5253100|NCT00615927|Progressive glioblastoma multiforme|progressive glioblastoma multiforme
5253101|NCT00615901|cyclophosphamide|cyclophosphamide
5253102|NCT00615901|methotrexate|methotrexate
5253103|NCT00615901|fluorouracil|fluorouracil
5253104|NCT00615901|PEG-filgrastim|peg-filgrastim
5253105|NCT00615888|elective open repair|elective open repair
5253106|NCT00615888|complications|complications
5253107|NCT00615888|morbidity and mortality|morbidity and mortality
5253108|NCT00615888|fast track patient management|fast track patient management
5253109|NCT00615875|naproxen|naproxen
5253110|NCT00615875|acute pain|acute pain
5253111|NCT00615875|postoperative pain|postoperative pain
5253112|NCT00615875|thoracic surgery|thoracic surgery
5253113|NCT00615875|head and neck surgery|head and neck surgery
5253114|NCT00615875|opiate sparing|opiate sparing
5253115|NCT00615862|Sepsis, alcoholism, cortisol, delirium, critical care|sepsis, alcoholism, cortisol, delirium, critical care
5253116|NCT00615849|pneumothorax, thoracoscopy, pleurodesis|pneumothorax, thoracoscopy, pleurodesis
5253117|NCT00615823|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
5253118|NCT00615810|LDL|ldl
5253119|NCT00615810|HDL|hdl
5253120|NCT00615810|triglycerides|triglycerides
5253121|NCT00615810|non HDL cholesterol|non hdl cholesterol
5253122|NCT00615810|cholesterol|cholesterol
5253123|NCT00615810|HIV 1|hiv 1
5253124|NCT00615810|Metabolic parameters|metabolic parameters
5253125|NCT00615810|treatment experienced|treatment experienced
5253126|NCT00615784|Acute Myeloid Leukemia|acute myeloid leukemia
5253127|NCT00615784|AML|aml
5253128|NCT00615784|Bexarotene|bexarotene
5253129|NCT00615758|Erlotinib|erlotinib
5253130|NCT00615758|Biological therapy|biological therapy
5253131|NCT00615758|Tyrosin Kinase Inhibitor therapy|tyrosin kinase inhibitor therapy
5253253|NCT00615186|Anti-tenascin|anti-tenascin
5253132|NCT00615745|Human Immunodeficiency Virus|human immunodeficiency virus
5253133|NCT00615745|treatment experienced|treatment experienced
5253134|NCT00615732|qigong|qigong
5253135|NCT00615732|traditional chinese medicine|traditional chinese medicine
5253136|NCT00615732|exercise therapy|exercise therapy
5253137|NCT00615732|neck pain|neck pain
5253138|NCT00615719|Chest Pain|chest pain
5253139|NCT00615719|Coronary Angiography|coronary angiography
5253140|NCT00615719|Acute Coronary Syndromes|acute coronary syndromes
5253141|NCT00615719|Computed Tomography|computed tomography
5253142|NCT00615706|asthma, inhaled corticosteroids|asthma, inhaled corticosteroids
5253143|NCT00615693|Uveitis|uveitis
5253144|NCT00615693|Macular Edema|macular edema
5253145|NCT00615667|Refractory Nephrotic syndrome|refractory nephrotic syndrome
5253146|NCT00615667|Tacrolimus|tacrolimus
5253147|NCT00615654|Hydrotherapy,|hydrotherapy,
5253148|NCT00615654|RCT,|rct,
5253149|NCT00615641|Children|children
5253150|NCT00615641|Nutrition|nutrition
5253151|NCT00615641|Body Fat|body fat
5253152|NCT00615641|Physical Activity|physical activity
5253153|NCT00615641|Diet|diet
5253154|NCT00615641|Childhood Obesity|childhood obesity
5253155|NCT00615641|Healthy Children|healthy children
5253156|NCT00615628|Inheritance of Osteosarcoma & Paget's Disease through Chromosome 18|inheritance of osteosarcoma & paget's disease through chromosome 18
5253157|NCT00615615|Levetiracetam|levetiracetam
5253158|NCT00615615|Keppra|keppra
5253159|NCT00615602|Early breast cancer|early breast cancer
5253160|NCT00615602|Axillary node positive|axillary node positive
5253161|NCT00615602|HER2 overexpression|her2 overexpression
5253162|NCT00615602|Adjuvant chemotherapy|adjuvant chemotherapy
5253163|NCT00615602|Dose dense|dose dense
5253164|NCT00615602|Docetaxel|docetaxel
5253165|NCT00615602|Trastuzumab|trastuzumab
5253166|NCT00615602|FEC|fec
5253167|NCT00615589|Stage II/III Multiple Myeloma(within 10 months from diagnosis)|stage ii/iii multiple myeloma(within 10 months from diagnosis)
5253168|NCT00615589|high risk|high risk
5253169|NCT00615589|relapse|relapse
5253170|NCT00615589|persistent|persistent
5253171|NCT00615576|Smoker,|smoker,
5253172|NCT00615576|Male,|male,
5253173|NCT00615576|Chronic Obstructive Lung Disease|chronic obstructive lung disease
5253174|NCT00615576|Cystic Fibrosis,|cystic fibrosis,
5253175|NCT00615576|Healthy Volunteer,|healthy volunteer,
5253176|NCT00615550|Preterm|preterm
5253177|NCT00615550|Cervix|cervix
5253178|NCT00615537|Thyroid Nodule|thyroid nodule
5253179|NCT00615537|Thyroid Cancer|thyroid cancer
5253180|NCT00615537|Laser Ablation|laser ablation
5253181|NCT00615537|LITT|litt
5253182|NCT00615537|Nodular Goiter|nodular goiter
5253183|NCT00615537|Thyroid Mass|thyroid mass
5253184|NCT00615524|Breast cancer|breast cancer
5253185|NCT00615524|Advanced|advanced
5253186|NCT00615524|Metastatic|metastatic
5253187|NCT00615524|Pazopanib|pazopanib
5253188|NCT00615524|GW786034|gw786034
5253189|NCT00615524|Exemestane|exemestane
5253190|NCT00615524|Efficacy|efficacy
5253191|NCT00615524|Tolerability|tolerability
5253192|NCT00615524|Health-Related Quality of Life|health-related quality of life
5253193|NCT00615511|schizophrenia|schizophrenia
5253194|NCT00615511|schizoaffective disorder|schizoaffective disorder
5253195|NCT00615511|negative symptoms|negative symptoms
5253196|NCT00615511|cognition|cognition
5253197|NCT00615498|Asthma, obesity, bariatric|asthma, obesity, bariatric
5253198|NCT00615485|Examine the risk of osteoporosis in survivors of solid pediatric cancers|examine the risk of osteoporosis in survivors of solid pediatric cancers
5253199|NCT00615472|Parkinson's Disease|parkinson's disease
5253200|NCT00615472|Deep brain stimulation (DBS)|deep brain stimulation (dbs)
5253201|NCT00615472|Subthalamic Nucleus|subthalamic nucleus
5253202|NCT00615472|Total Intravenous Anesthesia|total intravenous anesthesia
5253203|NCT00615472|Inhalational Anesthesia|inhalational anesthesia
5253204|NCT00615459|Chronic obstructive pulmonary disease, indacaterol, tiotropium, placebo controlled|chronic obstructive pulmonary disease, indacaterol, tiotropium, placebo controlled
5253205|NCT00615446|solid tumor malignancy, SU011248, sunitinib, neoplasms|solid tumor malignancy, su011248, sunitinib, neoplasms
5253206|NCT00615433|Schizophrenia|schizophrenia
5253207|NCT00615433|Latuda|latuda
5253208|NCT00615433|Lurasidone|lurasidone
5253209|NCT00615420|Mucositis|mucositis
5253210|NCT00615420|Radiation|radiation
5253211|NCT00615420|Honey|honey
5253212|NCT00615407|Asthma, alcohol|asthma, alcohol
5253213|NCT00615394|cardiomyopathy, stem cell, cardiac failure|cardiomyopathy, stem cell, cardiac failure
5253214|NCT00615381|Intracranial Aneurysm, Unruptured|intracranial aneurysm, unruptured
5253215|NCT00615381|Craniotomy|craniotomy
5253216|NCT00615381|Insulin|insulin
5253217|NCT00615381|Neuropsychology|neuropsychology
5253218|NCT00615368|Type 1 diabetes|type 1 diabetes
5253219|NCT00615368|Hypoglycaemia|hypoglycaemia
5253220|NCT00615368|Cognitive function|cognitive function
5253221|NCT00615368|Erythropoietin|erythropoietin
5253222|NCT00615355|vitiligo|vitiligo
5253223|NCT00615355|narrow-band UVB|narrow-band uvb
5253224|NCT00615355|ReCell|recell
5253225|NCT00615355|transplantation|transplantation
5253226|NCT00615355|laser|laser
5253227|NCT00615329|Create tumor specific gene profiles to improve diagnostic accuracy|create tumor specific gene profiles to improve diagnostic accuracy
5253228|NCT00615329|Perform gene set validation for diagnostic predictive power|perform gene set validation for diagnostic predictive power
5253229|NCT00615329|Define deviant gene list implicated in pathogenesis|define deviant gene list implicated in pathogenesis
5253230|NCT00615303|Bowel preparation, colonoscopy, simethicone, air bubble|bowel preparation, colonoscopy, simethicone, air bubble
5253231|NCT00615277|Young adults|young adults
5253232|NCT00615277|Long-chain polyunsaturated fatty acids|long-chain polyunsaturated fatty acids
5253233|NCT00615277|Cognitive function|cognitive function
5253234|NCT00615277|Mood|mood
5253235|NCT00615277|Supply with omega-3 fatty acids|supply with omega-3 fatty acids
5253236|NCT00615251|In vitro fertilization|in vitro fertilization
5253237|NCT00615238|overweight, physical activity, body composition, metabolic syndrome|overweight, physical activity, body composition, metabolic syndrome
5253238|NCT00615225|brain death|brain death
5253239|NCT00615225|inflammation|inflammation
5253240|NCT00615225|endotoxin|endotoxin
5253241|NCT00615225|transplantation|transplantation
5253242|NCT00615225|graft|graft
5253243|NCT00615225|apoptosis|apoptosis
5253244|NCT00615225|Systemic inflammatory response|systemic inflammatory response
5253245|NCT00615225|Apoptosis activation|apoptosis activation
5253246|NCT00615225|Graft outcome|graft outcome
5253247|NCT00615212|Healthy Subjects,|healthy subjects,
5253248|NCT00615212|Cytochrome P450 isoenzymes,|cytochrome p450 isoenzymes,
5253249|NCT00615212|Repeat Dose|repeat dose
5253250|NCT00615212|GSK376501,|gsk376501,
5253251|NCT00615186|Neuradiab|neuradiab
5253252|NCT00615186|Locoregional glioblastoma multiforme disease|locoregional glioblastoma multiforme disease
5253254|NCT00615186|Radiolabeled antibody therapy|radiolabeled antibody therapy
5253255|NCT00615186|Survival|survival
5253256|NCT00615173|Tacrolimus|tacrolimus
5253257|NCT00615173|lupus nephritis|lupus nephritis
5253258|NCT00615160|Metastatic melanoma|metastatic melanoma
5253259|NCT00615160|anti angiogenetic treatment|anti angiogenetic treatment
5253260|NCT00615147|Any cancer|any cancer
5253261|NCT00615147|suspected pulmonary embolism|suspected pulmonary embolism
5253262|NCT00615134|treatment experienced|treatment experienced
5253263|NCT00615121|Smoking|smoking
5253264|NCT00615121|Hypertension|hypertension
5253265|NCT00615121|Diabetes|diabetes
5253266|NCT00615121|Cardiovascular disease|cardiovascular disease
5253267|NCT00615121|Renal Failure|renal failure
5253268|NCT00615043|Transurethral resection of bladder tumor|transurethral resection of bladder tumor
5253269|NCT00615043|TURBT|turbt
5253270|NCT00615030|COPD, bronchodilator, long acting beta agonist, LABA|copd, bronchodilator, long acting beta agonist, laba
5253271|NCT00615017|Sepsis|sepsis
5253272|NCT00615017|septic shock|septic shock
5253273|NCT00615017|Systemic Inflammatory Response Syndrome|systemic inflammatory response syndrome
5253274|NCT00615004|Acromegaly|acromegaly
5253276|NCT00615004|IGF-I|igf-i
5253277|NCT00615004|Octreotide-LAR|octreotide-lar
5253278|NCT00615004|Lanreotide|lanreotide
5253279|NCT00615004|Transsphenoidal surgery|transsphenoidal surgery
5253280|NCT00614991|Healthy Subjects|healthy subjects
5253281|NCT00614991|Pharmacokinetics study|pharmacokinetics study
5253282|NCT00614991|Pharmacokinetics of medications|pharmacokinetics of medications
5253283|NCT00614978|HER-2 positive; brain metastases|her-2 positive; brain metastases
5253284|NCT00614965|Cancer|cancer
5253285|NCT00614965|NSCLC|nsclc
5253286|NCT00614965|second-line chemotherapy|second-line chemotherapy
5253287|NCT00614965|irinotecan|irinotecan
5253288|NCT00614965|pemetrexed|pemetrexed
5253289|NCT00614939|DPP-4 inhibitors|dpp-4 inhibitors
5253290|NCT00614939|HbA1c|hba1c
5253291|NCT00614939|incretins|incretins
5253292|NCT00614939|Renal Impairment|renal impairment
5253293|NCT00614926|Fatigue|fatigue
5253294|NCT00614926|low energy|low energy
5253295|NCT00614926|ALS|als
5253296|NCT00614926|treatment|treatment
5253297|NCT00614913|Proton|proton
5253298|NCT00614913|Radiotherapy|radiotherapy
5253299|NCT00614913|Hepatocellular carcinoma|hepatocellular carcinoma
5253300|NCT00614913|Liver Cancer|liver cancer
5253301|NCT00614900|COPD|copd
5253302|NCT00614900|pulmonary hypertension|pulmonary hypertension
5253303|NCT00614900|NT-proBNP|nt-probnp
5253304|NCT00614900|6 minutes walk test|6 minutes walk test
5253305|NCT00614887|Subarachnoid hemorrhage|subarachnoid hemorrhage
5253306|NCT00614887|Pituitary gland|pituitary gland
5253307|NCT00614887|Adrenal gland|adrenal gland
5253308|NCT00614874|Asthma|asthma
5253309|NCT00614874|Avandia|avandia
5253310|NCT00614861|Non-cancer pain|non-cancer pain
5253311|NCT00614861|Pain|pain
5253312|NCT00614848|restenosis|restenosis
5253313|NCT00614835|Gemcitabine|gemcitabine
5253314|NCT00614835|Docetaxel|docetaxel
5253315|NCT00614835|uterine sarcoma|uterine sarcoma
5253316|NCT00614809|gefitinib|gefitinib
5253317|NCT00614809|brain metastasis|brain metastasis
5253318|NCT00614796|COPD|copd
5253319|NCT00614796|Lifestyle|lifestyle
5253320|NCT00614796|Pedometer|pedometer
5253321|NCT00614783|Screening|screening
5253322|NCT00614770|colonoscopy|colonoscopy
5253323|NCT00614744|NICHD Neonatal Research Network|nichd neonatal research network
5253324|NCT00614744|Hypoxic-ischemic encephalopathy (HIE)|hypoxic-ischemic encephalopathy (hie)
5253325|NCT00614744|Hypothermia|hypothermia
5253326|NCT00614744|Neonatal depression|neonatal depression
5253327|NCT00614744|Perinatal asphyxia|perinatal asphyxia
5253328|NCT00614731|Keyhole Limpet Hemocyanin|keyhole limpet hemocyanin
5253329|NCT00614731|KLH|klh
5253330|NCT00614731|atopic dermatitis|atopic dermatitis
5253331|NCT00614731|IgG antibodies|igg antibodies
5253332|NCT00614731|scarification|scarification
5253333|NCT00614718|Implantable cardioverter defibrillator|implantable cardioverter defibrillator
5253334|NCT00614718|lead failure|lead failure
5253335|NCT00614718|pace/sense lead|pace/sense lead
5253336|NCT00614718|ICD complication|icd complication
5253337|NCT00614718|inappropriate therapy|inappropriate therapy
5253338|NCT00614718|Defibrillators|defibrillators
5253339|NCT00614679|biofilm|biofilm
5253340|NCT00614679|catheter lock solution|catheter lock solution
5253341|NCT00614679|catheter salvage|catheter salvage
5253342|NCT00614666|coccidioidomycosis|coccidioidomycosis
5253343|NCT00614666|Valley Fever|valley fever
5253344|NCT00614666|nikkomycin Z|nikkomycin z
5253345|NCT00614653|Pancreatic Cancer|pancreatic cancer
5253346|NCT00614653|Bevacizumab|bevacizumab
5253347|NCT00614653|Avastin™|avastin™
5253348|NCT00614653|Anti-VEGF monoclonal antibody|anti-vegf monoclonal antibody
5253349|NCT00614653|rhuMAb-VEGF|rhumab-vegf
5253350|NCT00614653|Erlotinib|erlotinib
5253351|NCT00614653|Erlotinib Hydrochloride|erlotinib hydrochloride
5253352|NCT00614653|Tarceva|tarceva
5253353|NCT00614653|OSI-774|osi-774
5253354|NCT00614653|Capecitabine|capecitabine
5253355|NCT00614653|Xeloda|xeloda
5253356|NCT00614640|HAART|haart
5253357|NCT00614640|Therapeutic vaccine|therapeutic vaccine
5253358|NCT00614614|Meningococcal disease|meningococcal disease
5253359|NCT00614614|Toddlers|toddlers
5253360|NCT00614614|Neisseria meningitidis|neisseria meningitidis
5253361|NCT00614614|Meningococcal vaccines|meningococcal vaccines
5253362|NCT00614614|Immunogenicity|immunogenicity
5253363|NCT00614614|Human serum bactericidal assay|human serum bactericidal assay
5253364|NCT00614614|Safety|safety
5253365|NCT00614614|Vaccines, conjugate|vaccines, conjugate
5253366|NCT00614614|Booster vaccination|booster vaccination
5253367|NCT00614601|pancreatic cancer|pancreatic cancer
5253368|NCT00614601|vaccine therapy|vaccine therapy
5253369|NCT00614588|temperature|temperature
5253370|NCT00614588|monitor|monitor
5253371|NCT00614588|surgery|surgery
5253372|NCT00614562|critical associated illness polyneuropathy or polymyopathy (CIP/M)|critical associated illness polyneuropathy or polymyopathy (cip/m)
5253373|NCT00614549|Levetiracetam|levetiracetam
5253374|NCT00614549|Keppra|keppra
5253375|NCT00614549|Epilepsy|epilepsy
5253376|NCT00614549|Efficacy|efficacy
5253377|NCT00614549|Safety|safety
5253378|NCT00614536|Reflux Symptom Index|reflux symptom index
5253379|NCT00614536|Reflux Finding Score|reflux finding score
5253380|NCT00614536|Rabeprazole|rabeprazole
5253381|NCT00614536|LaryngoPharyngeal Reflux Disease|laryngopharyngeal reflux disease
5253382|NCT00614536|GastroEsophageal Reflux Disease|gastroesophageal reflux disease
5253383|NCT00614523|MDS|mds
5253384|NCT00614523|Low Risk MDS|low risk mds
5253385|NCT00614523|Intermediate-1 Risk MDS|intermediate-1 risk mds
5253386|NCT00614523|Thrombocytopenia|thrombocytopenia
5253387|NCT00614484|Proton|proton
5253388|NCT00614484|Radiation|radiation
5253389|NCT00614458|latent HIV|latent hiv
5253390|NCT00614458|resting CD4+ T cell|resting cd4+ t cell
5253391|NCT00614458|valproic acid (VPA)|valproic acid (vpa)
5253392|NCT00614458|Raltegravir (MK-0518) intensification|raltegravir (mk-0518) intensification
5253393|NCT00614458|HIV replication|hiv replication
5253394|NCT00614458|treatment experienced|treatment experienced
5253395|NCT00614445|Nausea|nausea
5253396|NCT00614445|Vomiting|vomiting
5253397|NCT00614445|Pregnancy|pregnancy
5253398|NCT00614445|Hyperemesis gravidarum|hyperemesis gravidarum
5253399|NCT00614445|Pregnancy complications|pregnancy complications
5253400|NCT00614432|anticoagulation|anticoagulation
5253401|NCT00614432|surgical abortion|surgical abortion
5253402|NCT00614419|Hernioplasty|hernioplasty
5253403|NCT00614419|polypropylene|polypropylene
5253404|NCT00614419|extracellular matrix|extracellular matrix
5253405|NCT00614419|xenograft|xenograft
5253406|NCT00614406|Celebrex|celebrex
5253407|NCT00614406|prostaglandin inhibitor|prostaglandin inhibitor
5253408|NCT00614406|ovulation|ovulation
5253409|NCT00614406|menstrual cycles|menstrual cycles
5253410|NCT00614367|chromosomal abnormalities in single cells|chromosomal abnormalities in single cells
5253411|NCT00614354|99mTc-glucarate imaging to detect acute coronary syndrome|99mtc-glucarate imaging to detect acute coronary syndrome
5253412|NCT00614341|diabetes mellitus|diabetes mellitus
5253413|NCT00614341|neuropathy|neuropathy
5253414|NCT00614341|distal symmetric polyneuropathy|distal symmetric polyneuropathy
5253415|NCT00614341|pulsed electric fild|pulsed electric fild
5253416|NCT00614328|Alcohol|alcohol
5253417|NCT00614328|Alcohol Abuse|alcohol abuse
5253418|NCT00614328|Alcohol Drinking|alcohol drinking
5253419|NCT00614289|Mild to Moderate Hand Dermatitis|mild to moderate hand dermatitis
5253420|NCT00614289|Hand Eczema|hand eczema
5253421|NCT00614276|Sexual Dysfunction|sexual dysfunction
5253422|NCT00614276|Cancer-related Sexual Dysfunction|cancer-related sexual dysfunction
5253423|NCT00614276|Female Cancer Survivors|female cancer survivors
5253424|NCT00614276|Tendrils|tendrils
5253425|NCT00614276|Website program|website program
5253426|NCT00614276|Self-help tool|self-help tool
5253427|NCT00614276|Sexual counseling|sexual counseling
5253428|NCT00614276|Questionnaires|questionnaires
5253429|NCT00614263|Colonoscopy|colonoscopy
5253430|NCT00614263|Sedation levels|sedation levels
5253431|NCT00614250|Obstructive sleep apnea|obstructive sleep apnea
5253432|NCT00614211|Cervix|cervix
5253433|NCT00614211|Cervical|cervical
5253434|NCT00614211|Cancer|cancer
5253435|NCT00614211|Carcinoma|carcinoma
5253436|NCT00614211|Radical hysterectomy|radical hysterectomy
5253437|NCT00614211|Hysterectomy|hysterectomy
5253438|NCT00614211|Laparoscopy|laparoscopy
5253439|NCT00614211|Laparoscopic|laparoscopic
5253440|NCT00614211|Robotic|robotic
5253441|NCT00614211|Squamous Cell|squamous cell
5253442|NCT00614211|Adenosquamous|adenosquamous
5253443|NCT00614211|Adenocarcinoma|adenocarcinoma
5253444|NCT00614211|Lymphatic Mapping|lymphatic mapping
5253445|NCT00614211|IOLM|iolm
5253446|NCT00614211|SPECT|spect
5253447|NCT00614211|Sentinel Node|sentinel node
5253448|NCT00614211|Uterine cervix|uterine cervix
5253449|NCT00614198|autism|autism
5253450|NCT00614198|autism spectrum disorder|autism spectrum disorder
5253451|NCT00614198|diet|diet
5253452|NCT00614198|gluten|gluten
5253453|NCT00614198|casein|casein
5253454|NCT00614198|intervention|intervention
5253455|NCT00614198|peptide|peptide
5253456|NCT00614198|randomised|randomised
5253457|NCT00614198|controlled|controlled
5253458|NCT00614198|adaptive design|adaptive design
5253459|NCT00614198|Autism Diagnostic Observation Schedule (ADOS)|autism diagnostic observation schedule (ados)
5253460|NCT00614198|Gilliam Autism Rating Scale (GARS)|gilliam autism rating scale (gars)
5253461|NCT00614198|Vineland Adaptive Behaviour Scale (VABS)|vineland adaptive behaviour scale (vabs)
5253462|NCT00614198|Attention-Deficit Hyperactivity Disorder (ADHD)-IV Scale|attention-deficit hyperactivity disorder (adhd)-iv scale
5253463|NCT00614172|Proton|proton
5253464|NCT00614172|Radiation|radiation
5253465|NCT00614172|Breast cancer|breast cancer
5253466|NCT00614159|Child age 1-10 years having a GI Endoscopy with sedation|child age 1-10 years having a gi endoscopy with sedation
5253467|NCT00614146|liver failure, albumin dialysis, liver support|liver failure, albumin dialysis, liver support
5253468|NCT00614133|protein metabolism|protein metabolism
5253469|NCT00614133|surgery|surgery
5253470|NCT00614133|parenteral nutrition|parenteral nutrition
5253471|NCT00614107|Atrial Fibrillation post open heart surgery|atrial fibrillation post open heart surgery
5253472|NCT00614094|placenta, hypoglycemia|placenta, hypoglycemia
5253473|NCT00614081|Glomerular filtration rate measurement|glomerular filtration rate measurement
5253474|NCT00614081|Contrast-enhanced dynamic MR imaging|contrast-enhanced dynamic mr imaging
5253475|NCT00614081|Renal transplant recipients|renal transplant recipients
5253476|NCT00614068|Treatment|treatment
5253477|NCT00614068|PTSD|ptsd
5253478|NCT00614042|CLL|cll
5253479|NCT00614042|NHL|nhl
5253480|NCT00614042|TRU-016|tru-016
5253481|NCT00614042|chronic lymphocytic leukemia|chronic lymphocytic leukemia
5253482|NCT00614042|non-Hodgkin's lymphoma|non-hodgkin's lymphoma
5253483|NCT00614029|sumatriptan|sumatriptan
5253484|NCT00614029|Injections|injections
5253485|NCT00614029|Subcutaneous|subcutaneous
5253486|NCT00614016|healthy volunteers|healthy volunteers
5253487|NCT00614003|decisional conflict;|decisional conflict;
5253488|NCT00614003|decision quality;|decision quality;
5253489|NCT00614003|place of end of life care;|place of end of life care;
5253490|NCT00614003|provider education|provider education
5253491|NCT00613977|fetal lung maturity|fetal lung maturity
5253492|NCT00613977|lamellar body count|lamellar body count
5253493|NCT00613964|Natriuretic Peptides|natriuretic peptides
5253494|NCT00613964|Heart Failure|heart failure
5253495|NCT00613964|Renal Failure|renal failure
5253496|NCT00613938|Acute pain|acute pain
5253497|NCT00613938|bunionectomy|bunionectomy
5253498|NCT00613938|tapentadol|tapentadol
5253499|NCT00613925|endometrial biopsy|endometrial biopsy
5253500|NCT00613925|pain management|pain management
5253501|NCT00613912|Magnetic Resonance Imaging, Magnetic Resonance Spectroscopy, Perfusion, brain|magnetic resonance imaging, magnetic resonance spectroscopy, perfusion, brain
5253502|NCT00613899|home care|home care
5253503|NCT00613899|home rehabilitation|home rehabilitation
5253504|NCT00613899|telemedicine|telemedicine
5253505|NCT00613899|ALS|als
5253506|NCT00613886|NPH|nph
5253507|NCT00613886|Normal Pressure Hydrocephalus|normal pressure hydrocephalus
5253508|NCT00613873|colonoscopy|colonoscopy
5253509|NCT00613860|Endoscopic lung volume reduction, heterogeneous emphysema, interventional bronchoscopy|endoscopic lung volume reduction, heterogeneous emphysema, interventional bronchoscopy
5253510|NCT00613847|PET Scan|pet scan
5253511|NCT00613847|Invasive Solid Tumors|invasive solid tumors
5253512|NCT00613834|Essure sterilization|essure sterilization
5253513|NCT00613834|pain management|pain management
5253514|NCT00613834|intrauterine lidocaine infusion|intrauterine lidocaine infusion
5253515|NCT00613821|surgical abortion|surgical abortion
5253516|NCT00613821|pain management|pain management
5253517|NCT00613808|venous|venous
5253518|NCT00613808|leg|leg
5253519|NCT00613808|ulcer|ulcer
5253520|NCT00613795|pneumonia|pneumonia
5253521|NCT00613795|ventilator associated pneumonia|ventilator associated pneumonia
5253522|NCT00613795|probiotics|probiotics
5253523|NCT00613795|Lactobacillus GG|lactobacillus gg
5253524|NCT00613769|Surgical site infections|surgical site infections
5253525|NCT00613717|iron deficiency anemia|iron deficiency anemia
5253526|NCT00613717|iron deficiency|iron deficiency
5253527|NCT00613717|infant|infant
5253528|NCT00613717|development|development
5253529|NCT00613717|behavior|behavior
5253530|NCT00613691|Refractory|refractory
5253531|NCT00613691|Progressive|progressive
5253532|NCT00613678|pain|pain
5253533|NCT00613678|activities of daily living|activities of daily living
5253534|NCT00613678|symptoms|symptoms
5253535|NCT00613678|self-management|self-management
5253536|NCT00613652|solid tumors|solid tumors
5253537|NCT00613652|solid malignancies|solid malignancies
5253538|NCT00613626|Extensive Stage|extensive stage
5253539|NCT00613626|Untreated|untreated
5253540|NCT00613600|Safety|safety
5253541|NCT00613600|Efficacy|efficacy
5253542|NCT00613600|Glucomannan|glucomannan
5253543|NCT00613600|Dietary fiber|dietary fiber
5253544|NCT00613600|Weight loss|weight loss
5253545|NCT00613587|Interleukin 13|interleukin 13
5253546|NCT00613587|Interleukin 4|interleukin 4
5253547|NCT00613587|Leukotrienes|leukotrienes
5253548|NCT00613587|Basophil Histamine Release|basophil histamine release
5253549|NCT00613561|Patients with the Severe Immunodeficiency diseases|patients with the severe immunodeficiency diseases
5253550|NCT00613561|Severe Immunodeficiency diseases|severe immunodeficiency diseases
5253551|NCT00613548|Moderate|moderate
5253552|NCT00613548|Mitral|mitral
5253553|NCT00613548|Regurgitation|regurgitation
5253554|NCT00613548|CABG|cabg
5253555|NCT00613535|Partial Meniscectomy|partial meniscectomy
5253556|NCT00613535|Partial Thickness Knee Tear|partial thickness knee tear
5253557|NCT00613535|MR Imaging|mr imaging
5253558|NCT00613535|Mechanical Debridement|mechanical debridement
5253559|NCT00613535|Crepitus|crepitus
5253560|NCT00613535|Stability|stability
5253561|NCT00613535|Coblation|coblation
5253562|NCT00613535|Bipolar Radiofrequency|bipolar radiofrequency
5253563|NCT00613535|Debridement|debridement
5253564|NCT00613535|Recurrent Knee Pain|recurrent knee pain
5253565|NCT00613535|meniscectomy|meniscectomy
5253566|NCT00613535|meniscus|meniscus
5253567|NCT00613535|cartilage lesion|cartilage lesion
5253568|NCT00613535|articular cartilage lesion|articular cartilage lesion
5253569|NCT00613535|articular cartilage|articular cartilage
5253570|NCT00613535|knee|knee
5253571|NCT00613522|Sleep apnea, Berlin, Stroke|sleep apnea, berlin, stroke
5253572|NCT00613509|Melanoma, Cancer|melanoma, cancer
5253573|NCT00613496|Atrial Fibrillation|atrial fibrillation
5253574|NCT00613496|irbesartan|irbesartan
5253575|NCT00613496|AT-II-antagonist|at-ii-antagonist
5253576|NCT00613496|Adhesion Molecules|adhesion molecules
5253686|NCT00613093|O6-BG|o6-bg
5253577|NCT00613496|oxidative stress markers|oxidative stress markers
5253578|NCT00613496|hsCRP|hscrp
5253579|NCT00613496|ICAM|icam
5253580|NCT00613496|VCAM|vcam
5253581|NCT00613496|MCP-1|mcp-1
5253582|NCT00613496|vWF|vwf
5253583|NCT00613496|TGFβ1|tgfβ1
5253584|NCT00613496|TNF-α|tnf-α
5253585|NCT00613496|Interleukin-6|interleukin-6
5253586|NCT00613496|8isoProstaglandinF2α|8isoprostaglandinf2α
5253587|NCT00613470|Depression|depression
5253588|NCT00613470|Antidepressants|antidepressants
5253589|NCT00613444|Acne|acne
5253590|NCT00613444|laser|laser
5253591|NCT00613431|pharmacodynamics|pharmacodynamics
5253592|NCT00613405|substance-related disorders|substance-related disorders
5253593|NCT00613392|antioxidant|antioxidant
5253594|NCT00613392|oxidant stress|oxidant stress
5253595|NCT00613392|trauma|trauma
5253596|NCT00613392|free radical|free radical
5253597|NCT00613379|HIV|hiv
5253598|NCT00613379|treatment naïve|treatment naïve
5253599|NCT00613366|intrauterine device|intrauterine device
5253600|NCT00613366|cervical dilation|cervical dilation
5253601|NCT00613366|nulliparous women|nulliparous women
5253602|NCT00613366|pain management|pain management
5253603|NCT00613353|Female|female
5253604|NCT00613340|Cervical pain|cervical pain
5253605|NCT00613340|Zygapophysial joint|zygapophysial joint
5253606|NCT00613340|Specificity|specificity
5253607|NCT00613327|Overactive bladder|overactive bladder
5253608|NCT00613327|Oxybutynin chloride|oxybutynin chloride
5253609|NCT00613327|OROS|oros
5253610|NCT00613288|acute|acute
5253611|NCT00613288|testosterone|testosterone
5253612|NCT00613288|experimental|experimental
5253613|NCT00613288|hypogonadism|hypogonadism
5253614|NCT00613288|lipolysis|lipolysis
5253615|NCT00613288|insulin sensitivity|insulin sensitivity
5253616|NCT00613288|protein|protein
5253617|NCT00613288|metabolism|metabolism
5253618|NCT00613288|Experimental hypogonadism|experimental hypogonadism
5253619|NCT00613288|Testosterone substitution|testosterone substitution
5253620|NCT00613275|PNRP|pnrp
5253621|NCT00613275|Navigation|navigation
5253622|NCT00613275|Navigator|navigator
5253623|NCT00613275|Activation|activation
5253624|NCT00613275|Disparities|disparities
5253625|NCT00613275|Primary Care|primary care
5253626|NCT00613275|Racial and Ethnic Minorities|racial and ethnic minorities
5253627|NCT00613262|Narrow Band Imaging|narrow band imaging
5253628|NCT00613249|HIV-1 Infection|hiv-1 infection
5253629|NCT00613249|HIV Seronegativity|hiv seronegativity
5253630|NCT00613223|Malignant Gliomas|malignant gliomas
5253631|NCT00613223|Etopophos|etopophos
5253632|NCT00613223|Toposar|toposar
5253633|NCT00613223|VePesid|vepesid
5253634|NCT00613223|Etoposide|etoposide
5253635|NCT00613223|Vandetanib|vandetanib
5253636|NCT00613223|Zactima|zactima
5253637|NCT00613223|ZD6474|zd6474
5253638|NCT00613223|VP-16|vp-16
5253639|NCT00613223|Brain Tumor|brain tumor
5253640|NCT00613223|Recurring Malignant Brain Tumor|recurring malignant brain tumor
5253641|NCT00613223|Gliosarcoma|gliosarcoma
5253642|NCT00613223|Glioblastoma|glioblastoma
5253643|NCT00613223|Glioma|glioma
5253644|NCT00613223|Malignant Glioma|malignant glioma
5253645|NCT00613223|GBM|gbm
5253646|NCT00613210|preterm delivery|preterm delivery
5253647|NCT00613210|shory cervix|shory cervix
5253648|NCT00613210|amniotic fluid sludge|amniotic fluid sludge
5253649|NCT00613210|uterine artery doppler|uterine artery doppler
5253650|NCT00613210|singeltone|singeltone
5253651|NCT00613210|normal amniotic fluid index|normal amniotic fluid index
5253652|NCT00613210|without rupter of membranes|without rupter of membranes
5253653|NCT00613210|24-34 weeks of gestation|24-34 weeks of gestation
5253654|NCT00613197|Crohn's Disease|crohn's disease
5253655|NCT00613184|Respiratory Syncytial virus|respiratory syncytial virus
5253656|NCT00613184|Bronchiolitis|bronchiolitis
5253657|NCT00613184|Pediatric|pediatric
5253658|NCT00613171|Systemic sclerosis, scleroderma, fibrosis, STI571, imatinib|systemic sclerosis, scleroderma, fibrosis, sti571, imatinib
5253659|NCT00613158|Subclincal Atherosclerosis|subclincal atherosclerosis
5253660|NCT00613145|Refractory Malignancy|refractory malignancy
5253661|NCT00613145|Phase I|phase i
5253662|NCT00613145|Sorafenib|sorafenib
5253663|NCT00613145|Capecitabine|capecitabine
5253664|NCT00613132|Glioblastoma|glioblastoma
5253665|NCT00613132|Gliosarcoma|gliosarcoma
5253666|NCT00613132|GBM|gbm
5253667|NCT00613132|Brain tumor|brain tumor
5253668|NCT00613132|RAD0001|rad0001
5253669|NCT00613132|Hydroxyurea|hydroxyurea
5253670|NCT00613132|Gleevec|gleevec
5253671|NCT00613132|Imatinib|imatinib
5253672|NCT00613132|Droxia|droxia
5253673|NCT00613132|Everolimus|everolimus
5253674|NCT00613132|Hydrea|hydrea
5253675|NCT00613132|Hydroxycarbamide|hydroxycarbamide
5253676|NCT00613132|Recurrent GBM|recurrent gbm
5253677|NCT00613132|Imatinib mesylate|imatinib mesylate
5253678|NCT00613132|Glioblastoma multiforme|glioblastoma multiforme
5253679|NCT00613119|Inflammation|inflammation
5253680|NCT00613119|Frontotemporal Dementia|frontotemporal dementia
5253681|NCT00613119|Dementia|dementia
5253682|NCT00613119|PBR28|pbr28
5253683|NCT00613119|PET Imaging|pet imaging
5253684|NCT00613093|Temodar|temodar
5253685|NCT00613093|Temozolomide|temozolomide
5253687|NCT00613093|O6-Benzylguanine|o6-benzylguanine
5253688|NCT00613093|NSC 637037|nsc 637037
5253689|NCT00613093|Temodar-Resistant Malignant Glioma|temodar-resistant malignant glioma
5253690|NCT00613093|Brain tumor|brain tumor
5253691|NCT00613093|CNS tumor|cns tumor
5253692|NCT00613093|Cerebral glioblastoma|cerebral glioblastoma
5253693|NCT00613093|Anaplastic astrocytomas|anaplastic astrocytomas
5253694|NCT00613093|Glioma|glioma
5253695|NCT00613080|stage III rectal cancer|stage iii rectal cancer
5253696|NCT00613080|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5253697|NCT00613067|Generalized anxiety disorder|generalized anxiety disorder
5253698|NCT00613067|N100|n100
5253699|NCT00613067|Central serotonergic activity|central serotonergic activity
5253700|NCT00613054|GBM|gbm
5253701|NCT00613054|Brain tumor|brain tumor
5253702|NCT00613054|Zactima|zactima
5253703|NCT00613054|Gleevec|gleevec
5253704|NCT00613054|Hydroxyurea|hydroxyurea
5253705|NCT00613054|Glioblastoma|glioblastoma
5253706|NCT00613054|Gliosarcoma|gliosarcoma
5253707|NCT00613054|Recurrent malignant glioma|recurrent malignant glioma
5253708|NCT00613054|ZD6474|zd6474
5253709|NCT00613054|Malignant glioma|malignant glioma
5253710|NCT00613054|Imatinib|imatinib
5253711|NCT00613054|Droxia|droxia
5253712|NCT00613054|Hydrea|hydrea
5253713|NCT00613054|Hydroxycarbamide|hydroxycarbamide
5253714|NCT00613054|Vandetanib|vandetanib
5253715|NCT00613028|Glioblastoma|glioblastoma
5253716|NCT00613028|Gliosarcoma|gliosarcoma
5253717|NCT00613028|GBM|gbm
5253718|NCT00613028|Bevacizumab|bevacizumab
5253719|NCT00613028|Avastin|avastin
5253720|NCT00613028|Etoposide|etoposide
5253721|NCT00613028|Brain tumor|brain tumor
5253722|NCT00613028|Irinotecan|irinotecan
5253723|NCT00613028|Glioblastoma multiforme|glioblastoma multiforme
5253724|NCT00613028|Temodar|temodar
5253725|NCT00613028|Temozolomide|temozolomide
5253726|NCT00613028|Etopophos|etopophos
5253727|NCT00613028|Toposar|toposar
5253728|NCT00613028|VePesid|vepesid
5253729|NCT00613028|VP-16|vp-16
5253730|NCT00613028|Camptosar|camptosar
5253731|NCT00613015|Cocaine Addiction|cocaine addiction
5253732|NCT00613015|Cocaine Dependence|cocaine dependence
5253733|NCT00613002|hypoactive sexual desire disorder|hypoactive sexual desire disorder
5253734|NCT00613002|testosterone|testosterone
5253735|NCT00613002|menopause|menopause
5253736|NCT00612989|Glioblastoma|glioblastoma
5253737|NCT00612989|Gliosarcoma|gliosarcoma
5253738|NCT00612989|GBM|gbm
5253739|NCT00612989|Temodar|temodar
5253740|NCT00612989|Temozolomide|temozolomide
5253741|NCT00612989|O6-BG|o6-bg
5253742|NCT00612989|O6-Benzylguanine|o6-benzylguanine
5253743|NCT00612989|Recurrent GBM|recurrent gbm
5253744|NCT00612989|Progressive GBM|progressive gbm
5253745|NCT00612989|Brain tumor|brain tumor
5253746|NCT00612989|Malignant glioma|malignant glioma
5253747|NCT00612989|Neulasta|neulasta
5253748|NCT00612989|Pegfilgrastim|pegfilgrastim
5253749|NCT00612976|treatment of COPD|treatment of copd
5253750|NCT00612976|documentation of relevant data|documentation of relevant data
5253751|NCT00612976|related to the budesonide/formoterole therapy in patients with COPD.|related to the budesonide/formoterole therapy in patients with copd.
5253752|NCT00612963|Candidiasis, Oral|candidiasis, oral
5253753|NCT00612963|Thrush|thrush
5253754|NCT00612963|Candidiasis|candidiasis
5253755|NCT00612937|Group B Streptococci|group b streptococci
5253756|NCT00612937|Respiratory Disease|respiratory disease
5253757|NCT00612937|Beta Lactam|beta lactam
5253758|NCT00612937|Newborn|newborn
5253759|NCT00612937|Respiratory Distress|respiratory distress
5253760|NCT00612898|HIV infection|hiv infection
5253761|NCT00612898|Drug resistance|drug resistance
5253762|NCT00612898|Reverse transcriptase inhibitor|reverse transcriptase inhibitor
5253763|NCT00612898|Nucleoside analogue|nucleoside analogue
5253764|NCT00612898|treatment experienced|treatment experienced
5253765|NCT00612859|Levetiracetam|levetiracetam
5253766|NCT00612859|Keppra|keppra
5253767|NCT00612846|Common Bile Duct Calculi|common bile duct calculi
5253768|NCT00612846|Choledocholithiasis|choledocholithiasis
5253769|NCT00612846|Endoscopic sphincterotomy|endoscopic sphincterotomy
5253770|NCT00612846|Cholecystectomy, laparoscopic|cholecystectomy, laparoscopic
5253771|NCT00612846|Laparoscopic bile duct exploration|laparoscopic bile duct exploration
5253772|NCT00612833|Vasectomy|vasectomy
5253773|NCT00612833|Male contraception|male contraception
5253774|NCT00612833|Contraceptive effectiveness|contraceptive effectiveness
5253775|NCT00612833|Semen analysis|semen analysis
5253776|NCT00612833|Surgical techniques|surgical techniques
5253777|NCT00612833|Fascial interposition|fascial interposition
5253778|NCT00612833|Cautery|cautery
5253779|NCT00612833|The relative contraceptive effectiveness of three methods of occluding the vas, in the context of a no-scalpel vasectomy procedure.|the relative contraceptive effectiveness of three methods of occluding the vas, in the context of a no-scalpel vasectomy procedure.
5253780|NCT00612820|Vienna Challenge Chamber|vienna challenge chamber
5253781|NCT00612820|Seasonal Allergic Rhinitis,|seasonal allergic rhinitis,
5253782|NCT00612807|Older Adults|older adults
5253783|NCT00612794|exenatide|exenatide
5253784|NCT00612794|Byetta|byetta
5253785|NCT00612794|diabetes|diabetes
5253786|NCT00612794|Amylin|amylin
5253787|NCT00612794|Lilly|lilly
5253788|NCT00612781|intraocular lens|intraocular lens
5253789|NCT00612781|blue-light filtering intraocular lens|blue-light filtering intraocular lens
5253790|NCT00612781|contrast acuity|contrast acuity
5253791|NCT00612781|color vision|color vision
5253792|NCT00612768|Bioequivalence|bioequivalence
5253793|NCT00612768|Thimerosal|thimerosal
5253794|NCT00612768|Fragrance Mix|fragrance mix
5253795|NCT00612768|PVP formulation|pvp formulation
5253796|NCT00612768|Contact dermatitis|contact dermatitis
5253797|NCT00612755|chronic hepatitis C|chronic hepatitis c
5253798|NCT00612755|co-infection|co-infection
5253799|NCT00612755|extend treatment|extend treatment
5253800|NCT00612755|co-infected HIV-HCV|co-infected hiv-hcv
5253801|NCT00612742|Cardiovascular event|cardiovascular event
5253802|NCT00612742|Breast Cancer|breast cancer
5253803|NCT00612742|Testosterone|testosterone
5253804|NCT00612742|Menopause|menopause
5253805|NCT00612742|Hypoactive Sexual Desire Disorder|hypoactive sexual desire disorder
5253806|NCT00612729|intraocular lens|intraocular lens
5253807|NCT00612729|light filtering intraocular lens|light filtering intraocular lens
5253808|NCT00612729|contrast acuity|contrast acuity
5253809|NCT00612729|color vision|color vision
5253810|NCT00612716|stage I multiple myeloma|stage i multiple myeloma
5253811|NCT00612716|stage II multiple myeloma|stage ii multiple myeloma
5253812|NCT00612716|stage III multiple myeloma|stage iii multiple myeloma
5253813|NCT00612716|refractory multiple myeloma|refractory multiple myeloma
5253814|NCT00612716|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5253815|NCT00612716|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
5253816|NCT00612716|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5253817|NCT00612716|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5253818|NCT00612716|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5253819|NCT00612716|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
5253820|NCT00612716|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
5253821|NCT00612716|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
5253822|NCT00612716|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5253823|NCT00612716|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
5253824|NCT00612716|stage II adult Burkitt lymphoma|stage ii adult burkitt lymphoma
5253825|NCT00612716|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5253826|NCT00612716|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5253827|NCT00612716|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5253828|NCT00612716|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5253829|NCT00612716|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5253830|NCT00612716|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5253831|NCT00612716|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
5253832|NCT00612716|stage II adult immunoblastic large cell lymphoma|stage ii adult immunoblastic large cell lymphoma
5253833|NCT00612716|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5253834|NCT00612716|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5253835|NCT00612716|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5253836|NCT00612716|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
5253837|NCT00612716|stage II adult lymphoblastic lymphoma|stage ii adult lymphoblastic lymphoma
5253838|NCT00612716|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5253839|NCT00612716|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5253840|NCT00612716|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5253841|NCT00612716|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5253842|NCT00612716|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5253843|NCT00612716|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5253844|NCT00612716|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5253845|NCT00612716|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5253846|NCT00612716|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5253847|NCT00612716|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5253848|NCT00612716|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5253849|NCT00612716|recurrent childhood anaplastic large cell lymphoma|recurrent childhood anaplastic large cell lymphoma
5253850|NCT00612716|recurrent childhood grade III lymphomatoid granulomatosis|recurrent childhood grade iii lymphomatoid granulomatosis
5253851|NCT00612716|childhood diffuse large cell lymphoma|childhood diffuse large cell lymphoma
5253852|NCT00612716|childhood immunoblastic large cell lymphoma|childhood immunoblastic large cell lymphoma
5253853|NCT00612716|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
5253854|NCT00612716|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
5253855|NCT00612716|childhood nasal type extranodal NK/T-cell lymphoma|childhood nasal type extranodal nk/t-cell lymphoma
5253856|NCT00612716|Burkitt lymphoma|burkitt lymphoma
5253857|NCT00612716|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
5253858|NCT00612716|stage I childhood small noncleaved cell lymphoma|stage i childhood small noncleaved cell lymphoma
5254151|NCT00611546|TPN|tpn
5253859|NCT00612716|stage II childhood small noncleaved cell lymphoma|stage ii childhood small noncleaved cell lymphoma
5253860|NCT00612716|stage III childhood small noncleaved cell lymphoma|stage iii childhood small noncleaved cell lymphoma
5253861|NCT00612716|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
5253862|NCT00612703|Cancer, oral, erlotinib, tarceva, solid tumor, advanced tumor, phase 1|cancer, oral, erlotinib, tarceva, solid tumor, advanced tumor, phase 1
5253863|NCT00612703|Tumor|tumor
5253864|NCT00612690|Children|children
5253865|NCT00612690|School-Based Mental Health Services|school-based mental health services
5253866|NCT00612690|Urban Poverty|urban poverty
5253867|NCT00612677|recurrent|recurrent
5253868|NCT00612677|non-small cell|non-small cell
5253869|NCT00612651|GBM|gbm
5253870|NCT00612651|Malignant glioma|malignant glioma
5253871|NCT00612651|Brain tumor|brain tumor
5253872|NCT00612651|Temodar|temodar
5253873|NCT00612651|Temozolomide|temozolomide
5253874|NCT00612651|SCH 66336|sch 66336
5253875|NCT00612651|Farnesyl transferase inhibitor|farnesyl transferase inhibitor
5253876|NCT00612651|Glioblastoma multiforme|glioblastoma multiforme
5253877|NCT00612651|Gliosarcoma|gliosarcoma
5253878|NCT00612651|Anaplastic astrocytoma|anaplastic astrocytoma
5253879|NCT00612651|Anaplastic oligodendroglioma|anaplastic oligodendroglioma
5253880|NCT00612651|Anaplastic oligoastrocytoma|anaplastic oligoastrocytoma
5253881|NCT00612638|Temodar|temodar
5253882|NCT00612638|Temozolomide|temozolomide
5253883|NCT00612638|O6-Benzylguanine|o6-benzylguanine
5253884|NCT00612638|O6-BG|o6-bg
5253885|NCT00612638|NSC 637037|nsc 637037
5253886|NCT00612638|Irinotecan|irinotecan
5253887|NCT00612638|CPT-11|cpt-11
5253888|NCT00612638|Recurrent cerebral anaplastic glioma|recurrent cerebral anaplastic glioma
5253889|NCT00612638|Progressive cerebral anaplastic glioma|progressive cerebral anaplastic glioma
5253890|NCT00612638|Malignant glioma|malignant glioma
5253891|NCT00612560|breast neoplasms|breast neoplasms
5253892|NCT00612560|phytoestrogens|phytoestrogens
5253893|NCT00612560|tumor characteristics|tumor characteristics
5253894|NCT00612560|proliferation|proliferation
5253895|NCT00612560|apoptosis|apoptosis
5253896|NCT00612560|estrogen receptor|estrogen receptor
5253897|NCT00612560|HER2|her2
5253898|NCT00612547|Protozoan Infections|protozoan infections
5253899|NCT00612547|Communicable Diseases|communicable diseases
5253900|NCT00612547|Malaria Infection|malaria infection
5253901|NCT00612547|Malaria, falciparum|malaria, falciparum
5253902|NCT00612547|Malaria, vivax|malaria, vivax
5253903|NCT00612547|Artesunate Amodiaquine|artesunate amodiaquine
5253904|NCT00612521|Coronary artery disease|coronary artery disease
5253905|NCT00612521|Coronary artery stenting|coronary artery stenting
5253906|NCT00612521|peri-procedural myonecrosis|peri-procedural myonecrosis
5253907|NCT00612521|Adenosine|adenosine
5253908|NCT00612508|contraception|contraception
5253909|NCT00612508|NuvaRing|nuvaring
5253910|NCT00612508|Desogen|desogen
5253911|NCT00612508|vaginal biopsy|vaginal biopsy
5253912|NCT00612482|Substance abuse|substance abuse
5253913|NCT00612469|dental caries|dental caries
5253914|NCT00612469|vancomycin|vancomycin
5253915|NCT00612469|chlorhexidine|chlorhexidine
5253916|NCT00612469|sodium fluoride|sodium fluoride
5253917|NCT00612469|mutans streptococci|mutans streptococci
5253918|NCT00612456|angiogenesis|angiogenesis
5253919|NCT00612456|pazopanib,|pazopanib,
5253920|NCT00612456|age-related macular degeneration (AMD),|age-related macular degeneration (amd),
5253921|NCT00612456|vascular endothelial growth factor (VEGF),|vascular endothelial growth factor (vegf),
5253922|NCT00612456|choroidal neovascularization (CNV),|choroidal neovascularization (cnv),
5253923|NCT00612443|breast cancer|breast cancer
5253924|NCT00612430|Glioblastoma|glioblastoma
5253925|NCT00612430|Gliosarcoma|gliosarcoma
5253926|NCT00612430|GBM|gbm
5253927|NCT00612430|MG|mg
5253928|NCT00612430|Brain tumor|brain tumor
5253929|NCT00612430|Bevacizumab|bevacizumab
5253930|NCT00612430|Avastin|avastin
5253931|NCT00612430|Etoposide|etoposide
5253932|NCT00612430|VP-16|vp-16
5253933|NCT00612430|Etopophos|etopophos
5253934|NCT00612430|Toposar|toposar
5253935|NCT00612430|VePesid|vepesid
5253936|NCT00612430|Glioblastoma multiforme|glioblastoma multiforme
5253937|NCT00612430|Recurrent GBM|recurrent gbm
5253938|NCT00612430|Anaplastic astrocytoma|anaplastic astrocytoma
5253939|NCT00612430|Malignant glioma|malignant glioma
5253940|NCT00612417|Interaction with recombinant FVIII|interaction with recombinant fviii
5253941|NCT00612404|gastrointestinal disorder|gastrointestinal disorder
5253942|NCT00612404|endoscopy|endoscopy
5253943|NCT00612404|patient with gastrointestinal disorders for whom an endoscopy is performed and who is treated with esomeprazole afterwards.|patient with gastrointestinal disorders for whom an endoscopy is performed and who is treated with esomeprazole afterwards.
5253944|NCT00612391|humerus fracture|humerus fracture
5253945|NCT00612378|Glabellar Furrowing|glabellar furrowing
5253946|NCT00612365|Body Composition|body composition
5253947|NCT00612365|Abdomen|abdomen
5253948|NCT00612365|Atherosclerosis|atherosclerosis
5253949|NCT00612339|Glioma|glioma
5253950|NCT00612339|Temozolomide|temozolomide
5253951|NCT00612339|Temodar|temodar
5253952|NCT00612339|Avastin|avastin
5253953|NCT00612339|Bevacizumab|bevacizumab
5253954|NCT00612339|GBM|gbm
5253955|NCT00612339|Gliosarcoma|gliosarcoma
5253956|NCT00612339|Multifocal GBM|multifocal gbm
5253957|NCT00612339|Brain tumor|brain tumor
5253958|NCT00612339|Unresectable GBM|unresectable gbm
5253959|NCT00612339|Glioblastoma multiforme|glioblastoma multiforme
5253960|NCT00612313|Major Depressive Disorder|major depressive disorder
5253961|NCT00612313|MDD|mdd
5253962|NCT00612313|Children|children
5253963|NCT00612313|Adolescents|adolescents
5253964|NCT00612313|Antidepressant|antidepressant
5253965|NCT00612313|CBT|cbt
5253966|NCT00612300|Ambulatory stroke patients|ambulatory stroke patients
5253967|NCT00612300|Gait training|gait training
5253968|NCT00612300|Lokomat|lokomat
5253969|NCT00612300|Physical therapy|physical therapy
5253970|NCT00612287|Pain|pain
5253971|NCT00612287|Chronic pain|chronic pain
5253972|NCT00612287|Buprenorphine|buprenorphine
5253973|NCT00612287|Drug addiction|drug addiction
5253974|NCT00612274|allogeneic|allogeneic
5253975|NCT00612261|Branch retinal vein occlusion; treatment|branch retinal vein occlusion; treatment
5253976|NCT00612248|Osteoarthritis|osteoarthritis
5253977|NCT00612248|Thumb|thumb
5253978|NCT00612248|Splint|splint
5253979|NCT00612248|Pain|pain
5253980|NCT00612248|Function|function
5253981|NCT00612248|Osteoarthritis of the trapeziometacarpal (TMC) joint|osteoarthritis of the trapeziometacarpal (tmc) joint
5253982|NCT00612235|epilepsy|epilepsy
5253983|NCT00612235|lamotrigine|lamotrigine
5253984|NCT00612235|levetiracetam|levetiracetam
5253985|NCT00612235|carbamazepine|carbamazepine
5253986|NCT00612235|phenytoin|phenytoin
5253987|NCT00612235|lamictal|lamictal
5253988|NCT00612235|keppra|keppra
5253989|NCT00612235|tegretol|tegretol
5253990|NCT00612235|carbatrol|carbatrol
5253991|NCT00612235|dilantin|dilantin
5253992|NCT00612222|Immunotherapy|immunotherapy
5253993|NCT00612222|Metastatic Melanoma|metastatic melanoma
5253994|NCT00612222|Vaccination|vaccination
5253995|NCT00612222|Tumor Regression|tumor regression
5253996|NCT00612222|Skin Cancer|skin cancer
5253997|NCT00612209|ARQ 197, advanced solid tumors, phase 1, dose escalation, pharmacodynamics, safety|arq 197, advanced solid tumors, phase 1, dose escalation, pharmacodynamics, safety
5253998|NCT00612196|Safety and tolerability|safety and tolerability
5253999|NCT00612183|non-Hodgkin's lymphoma|non-hodgkin's lymphoma
5254000|NCT00612183|mantle cell lymphoma|mantle cell lymphoma
5254001|NCT00612170|Phase 3, safety and efficacy study, [S,S[-Reboxetine, Fibromyalgia|phase 3, safety and efficacy study, [s,s[-reboxetine, fibromyalgia
5254002|NCT00612157|Obstructive Sleep Apnea|obstructive sleep apnea
5254003|NCT00612157|Continuous Positive Airway Pressure|continuous positive airway pressure
5254004|NCT00612157|CPAP Compliance|cpap compliance
5254005|NCT00612157|Non-benzodiazepine hypnotics|non-benzodiazepine hypnotics
5254006|NCT00612144|Type 2 DM|type 2 dm
5254007|NCT00612131|medical residents PGY 2 and 3|medical residents pgy 2 and 3
5254008|NCT00612118|Allergic rhinitis,|allergic rhinitis,
5254009|NCT00612118|Vienna Challenge Chamber|vienna challenge chamber
5254010|NCT00612105|Postherpetic Neuralgia, PHN, Shingles,|postherpetic neuralgia, phn, shingles,
5254011|NCT00612092|Coronary CT angiography|coronary ct angiography
5254012|NCT00612092|Radiation dose estimates|radiation dose estimates
5254013|NCT00612079|Sertindole|sertindole
5254014|NCT00612079|sensory gating|sensory gating
5254015|NCT00612079|PPI|ppi
5254016|NCT00612079|P50 suppression|p50 suppression
5254017|NCT00612079|CANTAB|cantab
5254018|NCT00612079|Effect of Sertindole on sensory gating (P50 suppression)|effect of sertindole on sensory gating (p50 suppression)
5254019|NCT00612079|on sensorimotor gating (PPI)|on sensorimotor gating (ppi)
5254020|NCT00612079|and cognition (CANTAB)|and cognition (cantab)
5254021|NCT00612066|ACTH-producing pituitary tumor|acth-producing pituitary tumor
5254022|NCT00612053|cardiovascular disease|cardiovascular disease
5254023|NCT00612053|coronary artery bypass grafting (CABG)|coronary artery bypass grafting (cabg)
5254024|NCT00612053|coronary artery disease (CAD)|coronary artery disease (cad)
5254025|NCT00612053|percutaneous transluminal coronary angioplasty (PCI)|percutaneous transluminal coronary angioplasty (pci)
5254026|NCT00612053|unprotected left main disease|unprotected left main disease
5254027|NCT00612027|gastrointestinal disorder|gastrointestinal disorder
5254028|NCT00612027|acid associated gastrointestinal symptoms.|acid associated gastrointestinal symptoms.
5254029|NCT00612027|esomeprazole therapy in patients with gastrointestinal disorders|esomeprazole therapy in patients with gastrointestinal disorders
5254030|NCT00612027|patients with acid associated gastrointestinal symptoms|patients with acid associated gastrointestinal symptoms
5254031|NCT00612014|delayed gastric emptying|delayed gastric emptying
5254032|NCT00612014|symptomatic gastroparesis|symptomatic gastroparesis
5254033|NCT00612014|diabetes mellitus|diabetes mellitus
5254034|NCT00612001|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5254035|NCT00612001|adult glioblastoma|adult glioblastoma
5254036|NCT00612001|adult giant cell glioblastoma|adult giant cell glioblastoma
5254037|NCT00612001|adult gliosarcoma|adult gliosarcoma
5254038|NCT00612001|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
5254039|NCT00612001|recurrent adult brain tumor|recurrent adult brain tumor
5254040|NCT00612001|adult mixed glioma|adult mixed glioma
5254041|NCT00611988|Walking therapy|walking therapy
5254042|NCT00611988|Diabetes mellitus|diabetes mellitus
5254043|NCT00611988|Peripheral arterial disease|peripheral arterial disease
5254044|NCT00611975|Gonadal Steroid Hormones|gonadal steroid hormones
5254045|NCT00611975|Healthy Volunteers|healthy volunteers
5254046|NCT00611975|Antidepressant Side Effects|antidepressant side effects
5254047|NCT00611975|Fluoxetine|fluoxetine
5254048|NCT00611975|Bupropion|bupropion
5254049|NCT00611975|Prolactin|prolactin
5254050|NCT00611975|Testosterone|testosterone
5254051|NCT00611975|Estradiol|estradiol
5254052|NCT00611975|Progesterone|progesterone
5254053|NCT00611975|Sexual Function|sexual function
5254054|NCT00611975|Serotonin Reuptake Inhibitors|serotonin reuptake inhibitors
5254055|NCT00611975|17-OH Pregnenolone|17-oh pregnenolone
5254056|NCT00611949|Geranium oil|geranium oil
5254057|NCT00611949|Neuropathy|neuropathy
5254058|NCT00611949|Shingles|shingles
5254059|NCT00611949|Herpes zoster|herpes zoster
5254060|NCT00611936|Atomoxetine|atomoxetine
5254061|NCT00611936|Stress|stress
5254062|NCT00611936|d-amphetamine|d-amphetamine
5254063|NCT00611923|Premenstrual Dysphoric Disorder|premenstrual dysphoric disorder
5254064|NCT00611923|PMDD|pmdd
5254065|NCT00611923|PMS|pms
5254066|NCT00611897|NMDA|nmda
5254067|NCT00611897|glutamate|glutamate
5254068|NCT00611897|N-acetylcysteine|n-acetylcysteine
5254069|NCT00611897|P3|p3
5254070|NCT00611858|5-FU|5-fu
5254071|NCT00611858|cetuximab|cetuximab
5254072|NCT00611858|radiation|radiation
5254073|NCT00611858|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5254074|NCT00611858|neoadjuvant therapy|neoadjuvant therapy
5254075|NCT00611845|CABG surgery requiring CPB and at increased risk of bleeding and blood transfusion|cabg surgery requiring cpb and at increased risk of bleeding and blood transfusion
5254076|NCT00611832|behavior problems|behavior problems
5254077|NCT00611832|children|children
5254078|NCT00611832|prevention|prevention
5254079|NCT00611832|television|television
5254080|NCT00611832|media|media
5254081|NCT00611832|parenting|parenting
5254082|NCT00611819|hepatitis|hepatitis
5254083|NCT00611819|co-infection|co-infection
5254084|NCT00611806|Cognition|cognition
5254085|NCT00611806|Folic Acid|folic acid
5254086|NCT00611806|B12|b12
5254087|NCT00611793|Refractory Malignancy|refractory malignancy
5254088|NCT00611793|Advanced Malignancies|advanced malignancies
5254089|NCT00611793|PTK787/ZK222584|ptk787/zk222584
5254090|NCT00611793|Bevacizumab|bevacizumab
5254091|NCT00611780|Coronary CT angiography|coronary ct angiography
5254092|NCT00611780|Radiation dose estimates|radiation dose estimates
5254093|NCT00611767|Thiopental|thiopental
5254094|NCT00611767|Alcohol|alcohol
5254095|NCT00611767|Family History|family history
5254096|NCT00611767|Vulnerability|vulnerability
5254097|NCT00611767|GABA|gaba
5254098|NCT00611741|MRS, glutamate, osmolality|mrs, glutamate, osmolality
5254099|NCT00611728|Glioblastoma|glioblastoma
5254100|NCT00611728|CPT 11|cpt 11
5254101|NCT00611728|Sutent|sutent
5254102|NCT00611728|Sunitinib|sunitinib
5254103|NCT00611728|Sunitinib malate|sunitinib malate
5254104|NCT00611728|Malignant Glioma|malignant glioma
5254105|NCT00611728|GBM|gbm
5254106|NCT00611728|Irinotecan|irinotecan
5254107|NCT00611728|Camptosar|camptosar
5254108|NCT00611728|Anaplastic astrocytoma|anaplastic astrocytoma
5254109|NCT00611728|Anaplastic oligodendroglioma|anaplastic oligodendroglioma
5254110|NCT00611728|Anaplastic oligoastrocytoma|anaplastic oligoastrocytoma
5254111|NCT00611728|SU011248|su011248
5254112|NCT00611728|Brain tumor|brain tumor
5254113|NCT00611728|Recurrent malignant glioma|recurrent malignant glioma
5254114|NCT00611715|recurrent breast cancer|recurrent breast cancer
5254115|NCT00611715|stage IV breast cancer|stage iv breast cancer
5254116|NCT00611702|ELISPOT|elispot
5254117|NCT00611702|RT-PCR|rt-pcr
5254118|NCT00611702|Luminex|luminex
5254119|NCT00611702|Genomics|genomics
5254120|NCT00611689|Refractory Malignancy|refractory malignancy
5254121|NCT00611689|Solid Tumors|solid tumors
5254122|NCT00611689|PTK787|ptk787
5254123|NCT00611689|ZK222584|zk222584
5254124|NCT00611676|osteoarthritis pain|osteoarthritis pain
5254125|NCT00611676|activity limitation|activity limitation
5254126|NCT00611676|antidepressant|antidepressant
5254127|NCT00611676|depression|depression
5254128|NCT00611676|single-blind|single-blind
5254129|NCT00611663|Pneumococcal vaccine|pneumococcal vaccine
5254130|NCT00611663|SLE|sle
5254131|NCT00611663|Vaccination|vaccination
5254132|NCT00611663|Immunosuppression|immunosuppression
5254133|NCT00611663|SLE as defined by the ACR classification|sle as defined by the acr classification
5254134|NCT00611663|Stable SLE|stable sle
5254135|NCT00611663|SLE treated by systemic corticosteroids|sle treated by systemic corticosteroids
5254136|NCT00611650|non-small cell lung cancer|non-small cell lung cancer
5254137|NCT00611650|squamous lung dysplasia|squamous lung dysplasia
5254138|NCT00611650|tobacco use disorder|tobacco use disorder
5254139|NCT00611637|Immunotherapy|immunotherapy
5254140|NCT00611624|MammoSite|mammosite
5254141|NCT00611624|brachytherapy|brachytherapy
5254142|NCT00611572|GABA|gaba
5254143|NCT00611572|glutamate|glutamate
5254144|NCT00611572|NMDA|nmda
5254145|NCT00611572|P300|p300
5254146|NCT00611572|MMN|mmn
5254147|NCT00611559|Infanrix hexa|infanrix hexa
5254148|NCT00611559|combined vaccine|combined vaccine
5254149|NCT00611546|preterm|preterm
5254150|NCT00611546|parenteral nutrition|parenteral nutrition
5254152|NCT00611546|lipid emulsions|lipid emulsions
5254153|NCT00611546|photo-protection|photo-protection
5254154|NCT00611546|oxidative stress|oxidative stress
5254155|NCT00611533|Menopause|menopause
5254156|NCT00611533|Cognition|cognition
5254157|NCT00611520|treatment of COPD|treatment of copd
5254158|NCT00611520|related to the budesonide/formoterole therapy in patients with COPD.|related to the budesonide/formoterole therapy in patients with copd.
5254159|NCT00611494|Drug tolerance|drug tolerance
5254160|NCT00611494|Quality of Life|quality of life
5254161|NCT00611429|Treatment|treatment
5254162|NCT00611429|Adherence|adherence
5254163|NCT00611429|Intervention|intervention
5254164|NCT00611429|Quality of Life|quality of life
5254165|NCT00611416|catechins|catechins
5254166|NCT00611416|caffeine|caffeine
5254167|NCT00611416|energy expenditure|energy expenditure
5254168|NCT00611416|fat oxidation|fat oxidation
5254169|NCT00611416|appetite|appetite
5254170|NCT00611403|LASIK|lasik
5254171|NCT00611390|Viral laryngitis;|viral laryngitis;
5254172|NCT00611390|Viral tracheitis;|viral tracheitis;
5254173|NCT00611390|Herbal medicine;|herbal medicine;
5254174|NCT00611390|Traditional medicine;|traditional medicine;
5254175|NCT00611390|Aromatic essential oils;|aromatic essential oils;
5254176|NCT00611377|delirium|delirium
5254177|NCT00611377|mechanical ventilation|mechanical ventilation
5254178|NCT00611377|age|age
5254179|NCT00611377|severity score|severity score
5254180|NCT00611364|Physical therapy|physical therapy
5254181|NCT00611364|hypertension|hypertension
5254182|NCT00611364|aged|aged
5254183|NCT00611364|exercise|exercise
5254184|NCT00611364|Physical exercise|physical exercise
5254185|NCT00611364|Physical activity|physical activity
5254186|NCT00611351|graft versus host disease|graft versus host disease
5254187|NCT00611351|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5254188|NCT00611351|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5254189|NCT00611351|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5254190|NCT00611351|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5254191|NCT00611351|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5254192|NCT00611351|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5254193|NCT00611351|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
5254194|NCT00611351|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
5254195|NCT00611351|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5254196|NCT00611351|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5254197|NCT00611351|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5254198|NCT00611351|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5254199|NCT00611351|stage III multiple myeloma|stage iii multiple myeloma
5254200|NCT00611351|refractory multiple myeloma|refractory multiple myeloma
5254201|NCT00611351|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5254202|NCT00611351|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
5254203|NCT00611351|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5254204|NCT00611351|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5254205|NCT00611351|secondary myelofibrosis|secondary myelofibrosis
5254206|NCT00611351|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5254207|NCT00611351|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5254208|NCT00611351|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5254209|NCT00611351|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5254210|NCT00611351|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5254211|NCT00611351|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5254212|NCT00611351|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5254213|NCT00611351|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5254214|NCT00611351|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
5254215|NCT00611351|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5254216|NCT00611351|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5254217|NCT00611351|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5254218|NCT00611351|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5254219|NCT00611351|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5254220|NCT00611351|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5254221|NCT00611351|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5254222|NCT00611351|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5254223|NCT00611351|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5254224|NCT00611351|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5254225|NCT00611351|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5254226|NCT00611351|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
5254227|NCT00611351|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5254228|NCT00611351|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5254229|NCT00611351|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
5254230|NCT00611351|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
5254231|NCT00611351|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5254232|NCT00611351|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5254233|NCT00611351|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5254234|NCT00611351|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5254235|NCT00611351|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5254236|NCT00611351|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5254237|NCT00611351|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5254238|NCT00611351|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5254239|NCT00611351|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5254240|NCT00611351|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5254241|NCT00611351|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5254242|NCT00611351|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5254243|NCT00611351|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5254244|NCT00611351|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5254245|NCT00611351|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5254246|NCT00611351|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5254247|NCT00611351|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5254248|NCT00611351|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5254249|NCT00611351|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5254250|NCT00611351|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5254251|NCT00611351|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5254252|NCT00611351|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5254253|NCT00611351|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5254254|NCT00611351|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5254255|NCT00611351|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5254256|NCT00611351|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5254257|NCT00611351|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
5254258|NCT00611351|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
5254259|NCT00611351|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5254260|NCT00611351|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
5254261|NCT00611351|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
5254262|NCT00611351|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
5254263|NCT00611351|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
5254264|NCT00611351|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5254265|NCT00611351|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5254266|NCT00611351|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5254267|NCT00611351|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5254268|NCT00611351|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
5254269|NCT00611351|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
5254270|NCT00611351|refractory hairy cell leukemia|refractory hairy cell leukemia
5254271|NCT00611351|stage I multiple myeloma|stage i multiple myeloma
5254272|NCT00611351|stage II multiple myeloma|stage ii multiple myeloma
5254273|NCT00611338|Complementary Therapies|complementary therapies
5254274|NCT00611325|Glioblastoma|glioblastoma
5254275|NCT00611325|Gliosarcoma|gliosarcoma
5254276|NCT00611325|Glioblastoma multiforme|glioblastoma multiforme
5254277|NCT00611325|Recurrent malignant glioma|recurrent malignant glioma
5254278|NCT00611325|GBM|gbm
5254279|NCT00611325|Recurrent GBM|recurrent gbm
5254280|NCT00611325|Malignant glioma|malignant glioma
5254281|NCT00611325|Brain tumor|brain tumor
5254282|NCT00611325|Avastin|avastin
5254283|NCT00611325|Bevacizumab|bevacizumab
5254284|NCT00611325|Bortezomib|bortezomib
5254285|NCT00611325|Velcade|velcade
5254286|NCT00611312|Alzheimer's disease|alzheimer's disease
5254287|NCT00611312|Cognitive training|cognitive training
5254288|NCT00611299|Probiotics|probiotics
5254289|NCT00611299|Immune response|immune response
5254290|NCT00611299|Blood lipids|blood lipids
5254291|NCT00611299|Intestinal microflora|intestinal microflora
5254292|NCT00611299|Tolerance|tolerance
5254293|NCT00611286|Drug-eluting stent|drug-eluting stent
5254294|NCT00611286|clopidogrel|clopidogrel
5254295|NCT00611286|bare metal stent|bare metal stent
5254296|NCT00611286|landmark analysis|landmark analysis
5254297|NCT00611286|Patients with coronary artery disease|patients with coronary artery disease
5254298|NCT00611273|Glabellar Furrowing|glabellar furrowing
5254299|NCT00611260|Meditation|meditation
5254300|NCT00611260|Congestive Heart Failure|congestive heart failure
5254301|NCT00611260|ICD|icd
5254302|NCT00611260|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
5254303|NCT00611221|massage|massage
5254304|NCT00611221|labour|labour
5254305|NCT00611195|Anesthesia|anesthesia
5254306|NCT00611195|Children|children
5254307|NCT00611195|Larynx|larynx
5254308|NCT00611182|dyspnea|dyspnea
5254309|NCT00611182|pulmonary fibrosis|pulmonary fibrosis
5254310|NCT00611182|interstitial lung disease|interstitial lung disease
5254311|NCT00611182|shortness of breath|shortness of breath
5254312|NCT00611169|Angioplasty, Transluminal, Percutaneous Coronary|angioplasty, transluminal, percutaneous coronary
5254313|NCT00611169|tirofiban|tirofiban
5254314|NCT00611169|Magnetic Resonance Imaging|magnetic resonance imaging
5254315|NCT00611169|Myocardial Infarction|myocardial infarction
5254316|NCT00611156|Thermogenesis|thermogenesis
5254317|NCT00611156|Meal-induced thermogenesis|meal-induced thermogenesis
5254318|NCT00611156|energy expenditure|energy expenditure
5254319|NCT00611156|fat oxidation|fat oxidation
5254320|NCT00611156|bioactive ingredients|bioactive ingredients
5254321|NCT00611156|spices|spices
5254322|NCT00611156|ginger|ginger
5254323|NCT00611156|horseradish|horseradish
5254324|NCT00611156|black pepper|black pepper
5254325|NCT00611156|mustard|mustard
5254326|NCT00611143|Off-pump coronary artery bypass graft|off-pump coronary artery bypass graft
5254327|NCT00611143|Atorvastatin|atorvastatin
5254328|NCT00611143|Postoperative atrial fibrillation|postoperative atrial fibrillation
5254329|NCT00611130|Cocaine|cocaine
5254330|NCT00611130|Addiction|addiction
5254331|NCT00611130|Dependence|dependence
5254332|NCT00611130|Treatment|treatment
5254333|NCT00611117|adaptation to high fat diet|adaptation to high fat diet
5254334|NCT00611117|activity|activity
5254335|NCT00611117|exercise|exercise
5254336|NCT00611104|breast cancer|breast cancer
5254337|NCT00611078|Soft Tissue Sarcoma|soft tissue sarcoma
5254338|NCT00611078|environment|environment
5254339|NCT00611078|pollutants|pollutants
5254340|NCT00611078|04-088|04-088
5254341|NCT00611052|Depressive Disorder|depressive disorder
5254342|NCT00611052|Depressive Disorder, Major|depressive disorder, major
5254343|NCT00611052|Mental Health|mental health
5254344|NCT00611052|Prevention|prevention
5254345|NCT00611039|Darunavir/ritonavir|darunavir/ritonavir
5254346|NCT00611039|virtual inhibitory quotient|virtual inhibitory quotient
5254347|NCT00611039|dose reduction|dose reduction
5254348|NCT00611026|Treatment of overactive bladder|treatment of overactive bladder
5254349|NCT00611013|Development of multi-purpose novel imaging protocols|development of multi-purpose novel imaging protocols
5254350|NCT00611000|colon cancer|colon cancer
5254351|NCT00611000|rectal cancer|rectal cancer
5254352|NCT00610987|Antibiotic Prophylaxis|antibiotic prophylaxis
5254353|NCT00610974|Spinal cord injury|spinal cord injury
5254354|NCT00610974|walking|walking
5254355|NCT00610974|gait training|gait training
5254356|NCT00610974|body-weight supported treadmill training|body-weight supported treadmill training
5254357|NCT00610974|rehabilitation|rehabilitation
5254358|NCT00610961|BK Polyomavirus|bk polyomavirus
5254359|NCT00610961|Transplantation, Kidney|transplantation, kidney
5254360|NCT00610961|Transplantation, Pancreas|transplantation, pancreas
5254361|NCT00610948|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5254362|NCT00610935|Influenza|influenza
5254363|NCT00610935|Subjects with uncomplicated acute influenza|subjects with uncomplicated acute influenza
5254364|NCT00610922|Performance of motor skills|performance of motor skills
5254365|NCT00610909|IBS|ibs
5254366|NCT00610870|Myocardial infarct size|myocardial infarct size
5254367|NCT00610870|Atorvastatin|atorvastatin
5254368|NCT00610870|SPECT|spect
5254369|NCT00610870|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors
5254370|NCT00610844|lung cancer|lung cancer
5254371|NCT00610844|lung metastasis|lung metastasis
5254372|NCT00610844|radiofrequency ablation|radiofrequency ablation
5254373|NCT00610805|SLE|sle
5254374|NCT00610805|lupus|lupus
5254375|NCT00610805|cardiovascular|cardiovascular
5254376|NCT00610805|IMT|imt
5254377|NCT00610805|Systemic Lupus Erythematosus|systemic lupus erythematosus
5254378|NCT00610779|Rhino-sinusitis;|rhino-sinusitis;
5254379|NCT00610779|Herbal medicine;|herbal medicine;
5254380|NCT00610779|Traditional medicine;|traditional medicine;
5254381|NCT00610779|Aromatic essential oils;|aromatic essential oils;
5254382|NCT00610766|coronary CT angiography|coronary ct angiography
5254383|NCT00610766|radiation dose estimates|radiation dose estimates
5254384|NCT00610753|Anorexia nervosa|anorexia nervosa
5254385|NCT00610753|Adolescents|adolescents
5254386|NCT00610753|Family therapy|family therapy
5254387|NCT00610740|recurrent cervical cancer|recurrent cervical cancer
5254388|NCT00610740|cervical cancer|cervical cancer
5254389|NCT00610740|endometrial carcinoma|endometrial carcinoma
5254390|NCT00610740|ovarian epithelial cancer|ovarian epithelial cancer
5254391|NCT00610740|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5254392|NCT00610740|recurrent endometrial carcinoma|recurrent endometrial carcinoma
5254393|NCT00610727|Migraine, Prochlorperazine aerosol|migraine, prochlorperazine aerosol
5254394|NCT00610714|Cancer|cancer
5254395|NCT00610714|Tumour|tumour
5254396|NCT00610714|Ovarian Neoplasms|ovarian neoplasms
5254397|NCT00610714|Ovarian Cancer|ovarian cancer
5254398|NCT00610675|Fifty two weeks|fifty two weeks
5254399|NCT00610675|Open label|open label
5254400|NCT00610675|extension|extension
5254401|NCT00610662|cervical cancer|cervical cancer
5254402|NCT00610662|cervical intraepithelial neoplasia grade 1|cervical intraepithelial neoplasia grade 1
5254403|NCT00610662|cervical intraepithelial neoplasia grade 2|cervical intraepithelial neoplasia grade 2
5254404|NCT00610662|cervical intraepithelial neoplasia grade 3|cervical intraepithelial neoplasia grade 3
5254405|NCT00610649|randomized|randomized
5254406|NCT00610649|placebo controlled|placebo controlled
5254407|NCT00610649|maximum tolerated dose|maximum tolerated dose
5254408|NCT00610636|FOLFOX-4|folfox-4
5254409|NCT00610636|neoadjuvant chemotherapy|neoadjuvant chemotherapy
5254410|NCT00610636|colorectal cancer|colorectal cancer
5254411|NCT00610636|liver metastasis|liver metastasis
5254412|NCT00610636|resectability|resectability
5254413|NCT00610623|Pseudomonas aeruginosa|pseudomonas aeruginosa
5254414|NCT00610623|Pneumonia|pneumonia
5254415|NCT00610623|Ventilator-Associated|ventilator-associated
5254416|NCT00610623|Quorum Sensing|quorum sensing
5254417|NCT00610610|Fibromyalgia|fibromyalgia
5254418|NCT00610610|Paroxetine|paroxetine
5254419|NCT00610597|liver|liver
5254420|NCT00610597|alcohol|alcohol
5254421|NCT00610597|lymphocyte|lymphocyte
5254422|NCT00610584|seasonal allergic rhinitis|seasonal allergic rhinitis
5254423|NCT00610584|acupuncture|acupuncture
5254424|NCT00610584|RCT|rct
5254425|NCT00610584|CAM|cam
5254426|NCT00610571|Temodar|temodar
5254427|NCT00610571|Temozolomide|temozolomide
5254428|NCT00610571|Topotecan|topotecan
5254429|NCT00610571|Hycamtin|hycamtin
5254430|NCT00610571|Malignant Gliomas|malignant gliomas
5254431|NCT00610571|Brain tumor|brain tumor
5254432|NCT00610571|Anaplastic astrocytoma|anaplastic astrocytoma
5254433|NCT00610571|AA|aa
5254434|NCT00610571|GBM|gbm
5254435|NCT00610571|Glioblastoma Multiform|glioblastoma multiform
5254436|NCT00610571|Gliosarcoma|gliosarcoma
5254437|NCT00610545|ATORVASTATIN|atorvastatin
5254438|NCT00610545|VASCULAR SURGERY|vascular surgery
5254439|NCT00610545|CARDIOVASCULAR OUTCOMES|cardiovascular outcomes
5254440|NCT00610532|pharmacoresistance|pharmacoresistance
5254441|NCT00610532|healthy volunteers|healthy volunteers
5254442|NCT00610519|Viral pharyngo-tonsillitis;|viral pharyngo-tonsillitis;
5254443|NCT00610519|Herbal medicine;|herbal medicine;
5254444|NCT00610519|Traditional medicine;|traditional medicine;
5254445|NCT00610519|Aromatic essential oils;|aromatic essential oils;
5254446|NCT00610506|Atypical Depression|atypical depression
5254447|NCT00610493|Advanced Cancer|advanced cancer
5254448|NCT00610493|Bevacizumab|bevacizumab
5254449|NCT00610493|Temsirolimus|temsirolimus
5254450|NCT00610493|Avastin|avastin
5254451|NCT00610493|Torisel|torisel
5254452|NCT00610493|CCI-779|cci-779
5254453|NCT00610493|Anti-VEGF monoclonal antibody|anti-vegf monoclonal antibody
5254454|NCT00610493|rhuMAb-VEGF|rhumab-vegf
5254455|NCT00610493|dynamic contrast-enhanced magnetic resonance imaging|dynamic contrast-enhanced magnetic resonance imaging
5254456|NCT00610493|DCE|dce
5254457|NCT00610493|magnetic resonance imaging|magnetic resonance imaging
5254458|NCT00610493|MRI|mri
5254459|NCT00610480|Dry Eyes|dry eyes
5254460|NCT00610480|Tear Film Stability|tear film stability
5254461|NCT00610454|Levetiracetam|levetiracetam
5254462|NCT00610454|Keppra|keppra
5254463|NCT00610441|randomized|randomized
5254464|NCT00610441|double blind|double blind
5254465|NCT00610441|placebo controlled|placebo controlled
5254466|NCT00610428|Migraine, Staccato Prochlorperazine|migraine, staccato prochlorperazine
5254467|NCT00610428|Migraine headache with or without aura.|migraine headache with or without aura.
5254468|NCT00610376|Handwashing|handwashing
5254469|NCT00610376|Randomized controlled trial|randomized controlled trial
5254470|NCT00610376|Cluster randomization|cluster randomization
5254471|NCT00610376|Community intervention trial|community intervention trial
5254472|NCT00610376|Disease prevention|disease prevention
5254473|NCT00610376|Pediatric communicable disease|pediatric communicable disease
5254474|NCT00610376|Preschool|preschool
5254475|NCT00610376|Illness absenteeism|illness absenteeism
5254476|NCT00610350|Levosimendan|levosimendan
5254477|NCT00610350|pre-conditioning|pre-conditioning
5254478|NCT00610350|cardiac surgery|cardiac surgery
5254479|NCT00610350|myocardial function|myocardial function
5254480|NCT00610350|contractility|contractility
5254481|NCT00610350|heart|heart
5254482|NCT00610350|ischaemia|ischaemia
5254483|NCT00610324|oropharyngeal cleansing|oropharyngeal cleansing
5254484|NCT00610324|oral decontamination|oral decontamination
5254485|NCT00610324|oropharyngeal bacterial flora|oropharyngeal bacterial flora
5254486|NCT00610324|oropharyngeal colonization|oropharyngeal colonization
5254487|NCT00610324|critical illness|critical illness
5254488|NCT00610324|mechanical ventilation|mechanical ventilation
5254489|NCT00610324|tracheal intubation|tracheal intubation
5254490|NCT00610324|prophylaxis|prophylaxis
5254491|NCT00610311|Metastatic Melanoma|metastatic melanoma
5254492|NCT00610311|Immunotherapy|immunotherapy
5254493|NCT00610311|Vaccination|vaccination
5254494|NCT00610311|Tumor Regression|tumor regression
5254495|NCT00610311|Skin Cancer|skin cancer
5254496|NCT00610298|disability affecting strength, balance and coordination|disability affecting strength, balance and coordination
5254497|NCT00610272|single bone metastasis|single bone metastasis
5254498|NCT00610272|multiple bone metastasis|multiple bone metastasis
5254499|NCT00610272|pain relief|pain relief
5254500|NCT00610272|radiotherapy|radiotherapy
5254501|NCT00610259|Depressive disorder|depressive disorder
5254502|NCT00610259|Sleep initiation and maintenance disorder|sleep initiation and maintenance disorder
5254503|NCT00610259|Behavior therapy|behavior therapy
5254504|NCT00610246|Thorax|thorax
5254505|NCT00610246|Abdomen|abdomen
5254506|NCT00610246|Pelvis|pelvis
5254507|NCT00610246|Lesion|lesion
5254508|NCT00610246|Cancer|cancer
5254509|NCT00610246|Radiation|radiation
5254510|NCT00610246|Chemotherapy|chemotherapy
5254511|NCT00610246|Phase 1|phase 1
5254512|NCT00610246|Advanced Cancer|advanced cancer
5254513|NCT00610246|Sorafenib|sorafenib
5254514|NCT00610246|Nexavar|nexavar
5254515|NCT00610246|BAY43-9006|bay43-9006
5254516|NCT00610233|deep brain stimulation|deep brain stimulation
5254517|NCT00610233|urodynamics|urodynamics
5254518|NCT00610220|pediatrics|pediatrics
5254519|NCT00610220|wrist fractures|wrist fractures
5254520|NCT00610220|casting|casting
5254521|NCT00610220|wrist splint|wrist splint
5254522|NCT00610207|Anal fistula|anal fistula
5254523|NCT00610207|fistula in ano|fistula in ano
5254524|NCT00610207|anorectal fistula|anorectal fistula
5254525|NCT00610207|Crohn's Disease|crohn's disease
5254526|NCT00610181|Breast Cancer|breast cancer
5254527|NCT00610181|Breast Carcinoma|breast carcinoma
5254528|NCT00610181|Invasive Lobular Cancer|invasive lobular cancer
5254529|NCT00610181|Mixed Invasive Ductal-lobular Carcinoma|mixed invasive ductal-lobular carcinoma
5254530|NCT00610181|Magnetic Resonance Imaging|magnetic resonance imaging
5254532|NCT00610168|dTpa vaccine|dtpa vaccine
5254533|NCT00610168|pertussis|pertussis
5254534|NCT00610168|Tdap|tdap
5254535|NCT00610168|Boostrix|boostrix
5254536|NCT00610168|booster|booster
5254537|NCT00610168|tetanus|tetanus
5254538|NCT00610168|diphtheria|diphtheria
5254539|NCT00610142|atopic dermatitis|atopic dermatitis
5254540|NCT00610142|pimecrolimus|pimecrolimus
5254541|NCT00610142|hydrocortison|hydrocortison
5254542|NCT00610142|Optical Coherence Tomography|optical coherence tomography
5254543|NCT00610129|MK-0646|mk-0646
5254544|NCT00610090|UNITE|unite
5254545|NCT00610090|AAA|aaa
5254546|NCT00610090|Abdominal Aortic Aneurysms|abdominal aortic aneurysms
5254547|NCT00610090|Stent|stent
5254548|NCT00610090|Graft|graft
5254549|NCT00610077|Letrozole|letrozole
5254550|NCT00610077|Clomiphene citrate|clomiphene citrate
5254551|NCT00610077|Anovulatory infertility|anovulatory infertility
5254552|NCT00610077|Ovulation induction|ovulation induction
5254553|NCT00610064|Refractory lower urinary tract dysfunction|refractory lower urinary tract dysfunction
5254554|NCT00610064|Sacral neuromodulation|sacral neuromodulation
5254555|NCT00610064|Brain effects|brain effects
5254556|NCT00610064|Neuroimaging|neuroimaging
5254557|NCT00610064|Neuromodulation|neuromodulation
5254558|NCT00610051|severe heart failure|severe heart failure
5254559|NCT00610051|transplants|transplants
5254560|NCT00610038|neonatal|neonatal
5254561|NCT00610038|diabetes mellitus|diabetes mellitus
5254562|NCT00610038|mutation|mutation
5254563|NCT00610038|KIR6.2|kir6.2
5254564|NCT00610038|SUR1|sur1
5254565|NCT00610038|Neonatal diabetes mellitus with KIR6.2 or SUR1 mutations|neonatal diabetes mellitus with kir6.2 or sur1 mutations
5254566|NCT00610025|NOTES|notes
5254567|NCT00610025|transgastric endoscopy|transgastric endoscopy
5254568|NCT00610025|obesity surgery|obesity surgery
5254569|NCT00610025|Roux-en-Y surgery|roux-en-y surgery
5254570|NCT00610012|Advanced Renal Cell Carcinoma|advanced renal cell carcinoma
5254571|NCT00610012|MRCC|mrcc
5254572|NCT00610012|Therapy-reality|therapy-reality
5254573|NCT00610012|Observation|observation
5254574|NCT00610012|Registry|registry
5254575|NCT00610012|RCC|rcc
5254576|NCT00610012|ARCC|arcc
5254577|NCT00610012|Germany|germany
5254578|NCT00610012|Metastatic Renal Cell Carcinoma|metastatic renal cell carcinoma
5254579|NCT00610012|Renal Cell Carcinoma|renal cell carcinoma
5254580|NCT00610012|Renal Cell Cancer|renal cell cancer
5254581|NCT00610012|Sorafenib|sorafenib
5254582|NCT00610012|Sunitinib|sunitinib
5254583|NCT00610012|Interferon|interferon
5254584|NCT00610012|Interleukin|interleukin
5254585|NCT00610012|Temsirolimus|temsirolimus
5254586|NCT00610012|Pazopanib|pazopanib
5254587|NCT00610012|Cytokines|cytokines
5254588|NCT00610012|VEGF|vegf
5254589|NCT00609999|Glioblastoma|glioblastoma
5254590|NCT00609999|Gliosarcoma|gliosarcoma
5254591|NCT00609999|GBM|gbm
5254592|NCT00609999|Recurrent MG|recurrent mg
5254593|NCT00609999|Erlotinib|erlotinib
5254594|NCT00609999|Dasatinib|dasatinib
5254595|NCT00609999|Brain tumor|brain tumor
5254596|NCT00609999|Malignant glioma|malignant glioma
5254597|NCT00609999|Tarceva|tarceva
5254598|NCT00609999|Sprycel|sprycel
5254599|NCT00609986|Kidney|kidney
5254600|NCT00609986|Transplantation|transplantation
5254601|NCT00609986|Diabetes|diabetes
5254602|NCT00609986|Hyperglycemia|hyperglycemia
5254603|NCT00609973|Postoperative recurrence, inflammatory bowel disease|postoperative recurrence, inflammatory bowel disease
5255725|NCT00605046|SPECT|spect
5254604|NCT00609960|children anesthesia anxiety clowns|children anesthesia anxiety clowns
5254605|NCT00609934|renal cell carcinoma|renal cell carcinoma
5254606|NCT00609934|kidney cancer|kidney cancer
5254607|NCT00609934|bone metastases|bone metastases
5254608|NCT00609934|RCC|rcc
5254609|NCT00609934|bone pain|bone pain
5254610|NCT00609934|palliative radiotherapy|palliative radiotherapy
5254611|NCT00609934|sorafenib|sorafenib
5254612|NCT00609934|radiation|radiation
5254613|NCT00609934|renal cell|renal cell
5254614|NCT00609882|Nasal CPAP|nasal cpap
5254615|NCT00609882|High flow nasal cannula|high flow nasal cannula
5254616|NCT00609882|Neonate|neonate
5254617|NCT00609843|Bladder cancer|bladder cancer
5254618|NCT00609843|Radiotherapy|radiotherapy
5254619|NCT00609843|Tumour delineation|tumour delineation
5254620|NCT00609843|Markers|markers
5254621|NCT00609830|Glucocorticoids|glucocorticoids
5254622|NCT00609830|Osteoporosis|osteoporosis
5254623|NCT00609830|Rheumatoid Arthritis|rheumatoid arthritis
5254624|NCT00609830|Prevention|prevention
5254625|NCT00609830|GIOP|giop
5254626|NCT00609830|Patient Education|patient education
5254627|NCT00609817|Relapsed Multiple Myeloma|relapsed multiple myeloma
5254628|NCT00609817|Refractory Multiple Myeloma|refractory multiple myeloma
5254629|NCT00609817|GCS 100|gcs 100
5254630|NCT00609804|Non-Small Cell Lung Cancer|non-small cell lung cancer
5254631|NCT00609804|Advanced|advanced
5254632|NCT00609804|Erlotinib|erlotinib
5254633|NCT00609804|Sorafenib|sorafenib
5254634|NCT00609804|Progressing on erlotinib|progressing on erlotinib
5254635|NCT00609791|recurrent breast cancer|recurrent breast cancer
5254636|NCT00609791|stage IV breast cancer|stage iv breast cancer
5254637|NCT00609791|male breast cancer|male breast cancer
5254638|NCT00609778|CPR|cpr
5254639|NCT00609778|Mechanical|mechanical
5254640|NCT00609778|Manual|manual
5254641|NCT00609778|Survival|survival
5254642|NCT00609778|ROSC|rosc
5254643|NCT00609765|advanced|advanced
5254644|NCT00609765|unresectable|unresectable
5254645|NCT00609765|metastatic|metastatic
5254646|NCT00609765|endocrine|endocrine
5254647|NCT00609765|tumors|tumors
5254648|NCT00609752|Crohn Disease|crohn disease
5254649|NCT00609752|Children|children
5254650|NCT00609752|Bone Density|bone density
5254651|NCT00609752|Prednisolone|prednisolone
5254652|NCT00609752|Liquid Diet Therapy|liquid diet therapy
5254653|NCT00609752|Quality of Life|quality of life
5254654|NCT00609752|Metabolic Bone Disease|metabolic bone disease
5254655|NCT00609739|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
5254656|NCT00609726|Endoscopic Ultrasonography|endoscopic ultrasonography
5254657|NCT00609726|Pancreatitis|pancreatitis
5254658|NCT00609726|EUS|eus
5254659|NCT00609713|Child|child
5254660|NCT00609713|Obesity|obesity
5254661|NCT00609700|burn injury|burn injury
5254662|NCT00609700|volume replacement|volume replacement
5254663|NCT00609700|Ringer's Lactate solution|ringer's lactate solution
5254664|NCT00609700|Ringer's Acetate solution|ringer's acetate solution
5254665|NCT00609700|volume replacement with crystalloids|volume replacement with crystalloids
5254666|NCT00609687|sarcoidosis|sarcoidosis
5254667|NCT00609687|diagnostic vitrectomy|diagnostic vitrectomy
5254668|NCT00609687|vitreous biopsy|vitreous biopsy
5254669|NCT00609687|sarcoidosis-associated ocular inflammation|sarcoidosis-associated ocular inflammation
5254670|NCT00609674|Perennial allergic rhinitis; fluticasone furoate nasal spray|perennial allergic rhinitis; fluticasone furoate nasal spray
5254671|NCT00609661|Mesenchymal Stem Cells, Burn|mesenchymal stem cells, burn
5254672|NCT00609648|Dental Anxiety|dental anxiety
5254673|NCT00609648|Dental Phobia|dental phobia
5254674|NCT00609648|Odontophobia|odontophobia
5254675|NCT00609635|Respiratory|respiratory
5254676|NCT00609635|RSV-induced respiratory illness|rsv-induced respiratory illness
5254677|NCT00609622|metastatic colorectal cancer sunitinib (Sutent) bevacizumab (Avastin) randomized study|metastatic colorectal cancer sunitinib (sutent) bevacizumab (avastin) randomized study
5254678|NCT00609609|Allogeneic stem cell grafts|allogeneic stem cell grafts
5254679|NCT00609609|Allogeneic bone marrow graft|allogeneic bone marrow graft
5254680|NCT00609609|Blood and Marrow Transplantation|blood and marrow transplantation
5254681|NCT00609609|Stem cell graft|stem cell graft
5254682|NCT00609609|Graft Versus Host Disease|graft versus host disease
5254683|NCT00609609|GVHD|gvhd
5254684|NCT00609609|Extracorporeal Photopheresis|extracorporeal photopheresis
5254685|NCT00609609|ECP|ecp
5254686|NCT00609609|Photopheresis|photopheresis
5254687|NCT00609609|Methylprednisolone|methylprednisolone
5254688|NCT00609609|Medrol|medrol
5254689|NCT00609609|Depo-Medrol|depo-medrol
5254690|NCT00609609|Solu-Medrol|solu-medrol
5254691|NCT00609596|dutasteride|dutasteride
5254692|NCT00609596|tamsulosin|tamsulosin
5254693|NCT00609596|benign prostatic hyperplasia|benign prostatic hyperplasia
5254694|NCT00609570|hypertension|hypertension
5254695|NCT00609570|supplement|supplement
5254696|NCT00609570|HRV|hrv
5254697|NCT00609557|osteoarthritis pain|osteoarthritis pain
5254698|NCT00609557|activity limitation|activity limitation
5254699|NCT00609557|antidepressant|antidepressant
5254700|NCT00609557|depression|depression
5254701|NCT00609557|single-blind|single-blind
5254702|NCT00609544|Non Dialysis-dependent chronic kidney disease and anemia|non dialysis-dependent chronic kidney disease and anemia
5254703|NCT00609531|Restricted repetitive behaviors|restricted repetitive behaviors
5254704|NCT00609531|restricted interests|restricted interests
5254705|NCT00609531|Aspergers|aspergers
5254706|NCT00609531|Autism|autism
5254707|NCT00609505|Hereditary Breast and Ovarian Cancer syndrome|hereditary breast and ovarian cancer syndrome
5254708|NCT00609505|genetic counseling|genetic counseling
5254709|NCT00609505|breast cancer|breast cancer
5254710|NCT00609505|ovarian cancer|ovarian cancer
5254711|NCT00609505|telemedicine|telemedicine
5254712|NCT00609505|Cancer genetic counseling|cancer genetic counseling
5254713|NCT00609479|Distal radius fracture|distal radius fracture
5254714|NCT00609479|Colle´s fracture|colle´s fracture
5254715|NCT00609479|Internal fixation|internal fixation
5254716|NCT00609479|External fixation|external fixation
5254717|NCT00609479|DASH|dash
5254718|NCT00609479|PRWE|prwe
5254719|NCT00609466|Opioid|opioid
5254720|NCT00609466|Central acting analgesic|central acting analgesic
5254721|NCT00609466|CG5503 IR|cg5503 ir
5254722|NCT00609466|Postoperative pain|postoperative pain
5254723|NCT00609466|Bunionectomy|bunionectomy
5254724|NCT00609466|Morphine|morphine
5254725|NCT00609466|Placebo|placebo
5254726|NCT00609453|Control participants|control participants
5254727|NCT00609440|Morquio's disease; physiotherapy; results|morquio's disease; physiotherapy; results
5254728|NCT00609427|cognitive training|cognitive training
5254729|NCT00609427|cognitive rehabilitation|cognitive rehabilitation
5254730|NCT00609414|Burns|burns
5254731|NCT00609414|Albumin|albumin
5254732|NCT00609414|Fluid Resuscitation|fluid resuscitation
5254733|NCT00609401|Sorafenib|sorafenib
5254735|NCT00609401|Metastatic disease|metastatic disease
5254736|NCT00609375|Sepsis|sepsis
5254737|NCT00609375|Bacteremia|bacteremia
5254738|NCT00609375|Intravenous infusions|intravenous infusions
5254739|NCT00609375|cefepime|cefepime
5254740|NCT00609362|BMD|bmd
5254741|NCT00609362|Rosiglitazone|rosiglitazone
5254742|NCT00609362|Bone marrow fat|bone marrow fat
5254743|NCT00609349|risk factors for pulmonary arterial hypertension|risk factors for pulmonary arterial hypertension
5254744|NCT00609323|Pain|pain
5254745|NCT00609323|postherpetic neuralgia|postherpetic neuralgia
5254746|NCT00609310|clinical trial|clinical trial
5254747|NCT00609310|flavonoid treatment|flavonoid treatment
5254748|NCT00609310|neoplasia recurrence|neoplasia recurrence
5254749|NCT00609310|colorectal cancer|colorectal cancer
5254750|NCT00609310|polypectomy|polypectomy
5254751|NCT00609310|adenoma in Colon|adenoma in colon
5254752|NCT00609310|Neoplasia Recurrence Rates|neoplasia recurrence rates
5254753|NCT00609310|postpolypectomy patients|postpolypectomy patients
5254754|NCT00609297|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5254755|NCT00609297|pain|pain
5254756|NCT00609284|Stage III|stage iii
5254757|NCT00609284|Stage IV|stage iv
5254758|NCT00609284|locally advanced|locally advanced
5254759|NCT00609245|epilepsy|epilepsy
5254760|NCT00609245|photosensitive|photosensitive
5254761|NCT00609245|valproic acid|valproic acid
5254762|NCT00609219|recurrent nasopharyngeal cancer|recurrent nasopharyngeal cancer
5254763|NCT00609219|stage II nasopharyngeal cancer|stage ii nasopharyngeal cancer
5254764|NCT00609219|stage III nasopharyngeal cancer|stage iii nasopharyngeal cancer
5254765|NCT00609219|stage IV nasopharyngeal cancer|stage iv nasopharyngeal cancer
5254766|NCT00609180|Acute Lung Injury|acute lung injury
5254767|NCT00609180|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
5254768|NCT00609180|Feeding|feeding
5254769|NCT00609180|Critical Care|critical care
5254770|NCT00609180|Ventilator|ventilator
5254771|NCT00609180|Omega-3 Fatty Acid|omega-3 fatty acid
5254772|NCT00609180|Antioxidant|antioxidant
5254773|NCT00609167|stage II multiple myeloma|stage ii multiple myeloma
5254774|NCT00609167|stage III multiple myeloma|stage iii multiple myeloma
5254775|NCT00609154|Type 2 diabetes|type 2 diabetes
5254776|NCT00609154|Insulin|insulin
5254777|NCT00609154|biosynthesis|biosynthesis
5254778|NCT00609154|Non diabetic control|non diabetic control
5254779|NCT00609128|tears|tears
5254780|NCT00609128|conjunctival epithelial cells|conjunctival epithelial cells
5254781|NCT00609128|olopatadine|olopatadine
5254782|NCT00609128|impression cytology|impression cytology
5254783|NCT00609115|Sub-acute care|sub-acute care
5254784|NCT00609115|Robotics|robotics
5254785|NCT00609102|Type 2 diabetes|type 2 diabetes
5254786|NCT00609089|Family|family
5254787|NCT00609089|treatment|treatment
5254788|NCT00609089|reinforcement|reinforcement
5254789|NCT00609089|substance|substance
5254790|NCT00609089|trial|trial
5254791|NCT00609089|drug|drug
5254792|NCT00609089|abuse|abuse
5254793|NCT00609089|HIV|hiv
5254794|NCT00609089|risk|risk
5254795|NCT00609063|Statins|statins
5254796|NCT00609063|Myalgia|myalgia
5254797|NCT00609063|Muscle Cramp|muscle cramp
5254798|NCT00609050|cystic fibrosis|cystic fibrosis
5254799|NCT00609050|exercise|exercise
5254800|NCT00609050|perceived exertion|perceived exertion
5254801|NCT00609050|aerobic fitness|aerobic fitness
5254802|NCT00609050|lung function|lung function
5254803|NCT00609050|health related quality of life|health related quality of life
5254804|NCT00609050|self-regulated exercise|self-regulated exercise
5254805|NCT00609037|Gastric Bypass|gastric bypass
5254806|NCT00609037|Body contouring|body contouring
5254807|NCT00609037|Excessive weight loss|excessive weight loss
5254808|NCT00609011|Melanoma|melanoma
5254809|NCT00609011|Metastatic|metastatic
5254810|NCT00608998|Chronic renal failure|chronic renal failure
5254811|NCT00608998|Vasculopathy|vasculopathy
5254812|NCT00608998|Cardiovascular risk|cardiovascular risk
5254813|NCT00608998|Chronic renal failure patients|chronic renal failure patients
5254814|NCT00608985|sleeplessness|sleeplessness
5254815|NCT00608985|orexin receptor antagonist|orexin receptor antagonist
5254816|NCT00608985|almorexant|almorexant
5254817|NCT00608985|insomnia|insomnia
5254818|NCT00608972|negative for a protein called HER2/neu|negative for a protein called her2/neu
5254819|NCT00608972|negative for estrogen receptors (ER) and progesterone receptors (PR).|negative for estrogen receptors (er) and progesterone receptors (pr).
5254820|NCT00608972|breast cancer|breast cancer
5254821|NCT00608959|Skin colonization|skin colonization
5254822|NCT00608959|Catheter colonization|catheter colonization
5254823|NCT00608959|Catheter site infection|catheter site infection
5254824|NCT00608946|efficacy of treatment with copper in patients with mild Alzheimer´s disease|efficacy of treatment with copper in patients with mild alzheimer´s disease
5254825|NCT00608946|cognitive status over time|cognitive status over time
5254826|NCT00608946|CSF and volumetric data over time (1 year)|csf and volumetric data over time (1 year)
5254827|NCT00608933|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5254828|NCT00608933|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
5254829|NCT00608920|SPECT|spect
5254830|NCT00608894|Autoimmune hepatitis|autoimmune hepatitis
5254831|NCT00608894|Chronic active hepatitis|chronic active hepatitis
5254832|NCT00608881|Huntington's disease|huntington's disease
5254833|NCT00608881|Huntington disease|huntington disease
5254834|NCT00608881|HD|hd
5254835|NCT00608881|coenzyme Q10|coenzyme q10
5254836|NCT00608881|CoQ|coq
5254837|NCT00608868|Carcinoma|carcinoma
5254838|NCT00608868|Non Small Cell Lung|non small cell lung
5254839|NCT00608868|EGFR mutation|egfr mutation
5254840|NCT00608868|Gefitinib|gefitinib
5254841|NCT00608855|bone metastases|bone metastases
5254842|NCT00608855|pain|pain
5254843|NCT00608855|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5254844|NCT00608816|epinephrine|epinephrine
5254845|NCT00608790|Tuberculosis, TB, Mycobacterium tuberculosis, children, South Africa|tuberculosis, tb, mycobacterium tuberculosis, children, south africa
5254846|NCT00608777|Localized mild breakthrough|localized mild breakthrough
5254847|NCT00608764|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5254848|NCT00608764|COPD|copd
5254849|NCT00608764|Emphysema|emphysema
5254850|NCT00608764|Chronic Bronchitis|chronic bronchitis
5254851|NCT00608764|Genetics|genetics
5254852|NCT00608764|Association Studies|association studies
5254853|NCT00608764|Computed Tomography|computed tomography
5254854|NCT00608751|Newly Diagnosed head and neck cancer|newly diagnosed head and neck cancer
5254855|NCT00608738|neutropenia|neutropenia
5254856|NCT00608738|infection|infection
5254857|NCT00608738|radiation toxicity|radiation toxicity
5254858|NCT00608738|chemotherapeutic agent toxicity|chemotherapeutic agent toxicity
5254859|NCT00608738|malnutrition|malnutrition
5254860|NCT00608738|musculoskeletal complications|musculoskeletal complications
5254861|NCT00608738|thrombocytopenia|thrombocytopenia
5254862|NCT00608738|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5254863|NCT00608725|heart rate|heart rate
5254864|NCT00608725|blood pressure|blood pressure
5254865|NCT00608725|blood volume|blood volume
5254866|NCT00608725|sympathetic nervous system|sympathetic nervous system
5254867|NCT00608725|orthostatic tachycardia|orthostatic tachycardia
5254868|NCT00608725|orthostatic intolerance|orthostatic intolerance
5254869|NCT00608725|POTS|pots
5254870|NCT00608712|bariatric surgery|bariatric surgery
5254871|NCT00608712|ulcer prevention|ulcer prevention
5254872|NCT00608699|Flushing|flushing
5254873|NCT00608699|GSK256073A,|gsk256073a,
5254874|NCT00608699|Dose Escalation,|dose escalation,
5254875|NCT00608699|Immediate Release Niacin,|immediate release niacin,
5254876|NCT00608686|NIAAA|niaaa
5254877|NCT00608686|Alcohol|alcohol
5254878|NCT00608686|Neurosteroids|neurosteroids
5254879|NCT00608686|Intoxication|intoxication
5254880|NCT00608673|discoid lupus erythematosus|discoid lupus erythematosus
5254881|NCT00608673|pimecrolimus 1% cream|pimecrolimus 1% cream
5254882|NCT00608673|betamethasone valerate 0.1% cream|betamethasone valerate 0.1% cream
5254883|NCT00608660|Peripheral Facial Paralysis|peripheral facial paralysis
5254884|NCT00608660|Acupuncture|acupuncture
5254885|NCT00608660|RCT|rct
5254886|NCT00608634|actinic keratosis|actinic keratosis
5254887|NCT00608621|physostigmine|physostigmine
5254888|NCT00608621|postoperative analgesia|postoperative analgesia
5254889|NCT00608621|pain|pain
5254890|NCT00608621|patient-controlled analgesia|patient-controlled analgesia
5254891|NCT00608621|Opioid consumption|opioid consumption
5254892|NCT00608621|Pain quality (VAS Score)|pain quality (vas score)
5254893|NCT00608621|Hemodynamics|hemodynamics
5254894|NCT00608621|Mobilisation|mobilisation
5254895|NCT00608621|Side effects|side effects
5254896|NCT00608595|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5254897|NCT00608595|recurrent rectal cancer|recurrent rectal cancer
5254898|NCT00608595|stage I rectal cancer|stage i rectal cancer
5254899|NCT00608595|stage II rectal cancer|stage ii rectal cancer
5254900|NCT00608595|stage III rectal cancer|stage iii rectal cancer
5254901|NCT00608582|Transcranial Magnetic Stimulation, Repetitive|transcranial magnetic stimulation, repetitive
5254902|NCT00608582|TMS|tms
5254903|NCT00608582|Treat Naming|treat naming
5254904|NCT00608582|Aphasia|aphasia
5254905|NCT00608582|Chronic Stroke|chronic stroke
5254906|NCT00608582|Randomized, Controlled Trial|randomized, controlled trial
5254907|NCT00608569|Drug Therapy, Combination|drug therapy, combination
5254908|NCT00608569|HIV Non-Nucleoside Reverse Transcriptase Inhibitors|hiv non-nucleoside reverse transcriptase inhibitors
5254909|NCT00608569|HIV Protease Inhibitors|hiv protease inhibitors
5254910|NCT00608569|Viral Load|viral load
5254911|NCT00608569|Virologic Failure|virologic failure
5254912|NCT00608556|Heterotaxy|heterotaxy
5254913|NCT00608556|Primary Ciliary Dyskinesia|primary ciliary dyskinesia
5254914|NCT00608556|Congenital Heart Disease|congenital heart disease
5254915|NCT00608556|Genetic Study|genetic study
5254916|NCT00608556|Situs Inversus|situs inversus
5254917|NCT00608543|cognitive function|cognitive function
5254918|NCT00608543|psychosocial function|psychosocial function
5254919|NCT00608543|augmentation|augmentation
5254920|NCT00608543|treatment refractory depression|treatment refractory depression
5254921|NCT00608530|pain|pain
5254922|NCT00608530|chronic pain|chronic pain
5254923|NCT00608530|chronic back pain|chronic back pain
5254924|NCT00608530|randomized clinical trial|randomized clinical trial
5254925|NCT00608517|graft versus host disease|graft versus host disease
5254926|NCT00608517|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5254927|NCT00608517|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5254928|NCT00608517|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5254929|NCT00608517|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5254930|NCT00608517|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5254931|NCT00608517|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5254932|NCT00608517|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5254933|NCT00608517|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5254934|NCT00608517|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5254935|NCT00608517|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
5254936|NCT00608517|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
5254937|NCT00608517|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
5254938|NCT00608517|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5254939|NCT00608517|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5254940|NCT00608517|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5254941|NCT00608517|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
5254942|NCT00608517|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5254943|NCT00608517|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
5254944|NCT00608517|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5254945|NCT00608517|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
5254946|NCT00608517|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
5254947|NCT00608517|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
5254948|NCT00608517|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
5254949|NCT00608517|noncontiguous stage II adult non-Hodgkin lymphoma|noncontiguous stage ii adult non-hodgkin lymphoma
5254950|NCT00608517|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5254951|NCT00608517|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5254952|NCT00608517|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5254953|NCT00608517|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5254954|NCT00608517|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
5254955|NCT00608517|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
5254956|NCT00608517|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5254957|NCT00608517|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5254958|NCT00608517|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5254959|NCT00608517|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5254960|NCT00608517|stage I multiple myeloma|stage i multiple myeloma
5254961|NCT00608517|stage II multiple myeloma|stage ii multiple myeloma
5254962|NCT00608517|refractory multiple myeloma|refractory multiple myeloma
5254963|NCT00608517|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5254964|NCT00608517|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5254965|NCT00608517|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5254966|NCT00608517|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5254967|NCT00608517|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5254968|NCT00608517|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5254969|NCT00608517|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5254970|NCT00608517|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5254971|NCT00608517|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5254972|NCT00608517|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5254973|NCT00608517|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5254974|NCT00608517|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5254975|NCT00608517|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5254976|NCT00608517|stage III multiple myeloma|stage iii multiple myeloma
5254977|NCT00608517|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5254978|NCT00608517|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5254979|NCT00608517|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5254980|NCT00608517|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5254981|NCT00608517|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5254982|NCT00608517|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5254983|NCT00608517|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5254984|NCT00608517|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5254985|NCT00608517|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5254986|NCT00608517|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5254987|NCT00608517|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5254988|NCT00608517|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5254989|NCT00608517|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5254990|NCT00608517|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5254991|NCT00608517|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5254992|NCT00608517|Philadelphia chromosome positive adult precursor acute lymphoblastic leukemia|philadelphia chromosome positive adult precursor acute lymphoblastic leukemia
5254993|NCT00608517|Philadelphia chromosome positive childhood precursor acute lymphoblastic leukemia|philadelphia chromosome positive childhood precursor acute lymphoblastic leukemia
5254994|NCT00608517|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5254995|NCT00608517|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
5254996|NCT00608517|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
5254997|NCT00608517|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
5254998|NCT00608517|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
5254999|NCT00608517|childhood nasal type extranodal NK/T-cell lymphoma|childhood nasal type extranodal nk/t-cell lymphoma
5255000|NCT00608517|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
5255001|NCT00608517|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
5255002|NCT00608517|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5255003|NCT00608517|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
5255004|NCT00608504|Behavioral Economics|behavioral economics
5255005|NCT00608504|Drug self administration|drug self administration
5255006|NCT00608504|Opioid|opioid
5255007|NCT00608491|Acute Decompensated Heart Failure|acute decompensated heart failure
5255008|NCT00608491|Acute Decompensated Heart Failure With Cardiorenal Syndrome|acute decompensated heart failure with cardiorenal syndrome
5255009|NCT00608491|Cardiorenal Syndrome|cardiorenal syndrome
5255010|NCT00608491|Persistent Congestion|persistent congestion
5255011|NCT00608491|Ultra Filtration|ultra filtration
5255012|NCT00608465|Fibrolytic Dysfunction|fibrolytic dysfunction
5255013|NCT00608465|Obesity|obesity
5255014|NCT00608465|PAI-1|pai-1
5255015|NCT00608452|Lung|lung
5255016|NCT00608452|Ovarian|ovarian
5255017|NCT00608452|Breast|breast
5255018|NCT00608452|Hodgkin's|hodgkin's
5255019|NCT00608439|CAST|cast
5255020|NCT00608439|Centella asiatica|centella asiatica
5255021|NCT00608439|Diabetes|diabetes
5255022|NCT00608439|Diabetic neuropathy|diabetic neuropathy
5255023|NCT00608426|African Americans|african americans
5255024|NCT00608426|telephone counseling|telephone counseling
5255025|NCT00608426|community health planning|community health planning
5255026|NCT00608426|ethnic groups|ethnic groups
5255027|NCT00608400|CLA|cla
5255028|NCT00608400|PTH|pth
5255029|NCT00608400|nutritional supplement|nutritional supplement
5255030|NCT00608374|Waldenström macroglobulinemia|waldenström macroglobulinemia
5255031|NCT00608374|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5255032|NCT00608374|stage I marginal zone lymphoma|stage i marginal zone lymphoma
5255033|NCT00608374|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5255034|NCT00608374|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5255035|NCT00608374|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
5255036|NCT00608374|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
5255037|NCT00608348|exercise|exercise
5255726|NCT00605007|COPD|copd
5255038|NCT00608348|hypoglycemia|hypoglycemia
5255039|NCT00608348|sympathetic nerve activity|sympathetic nerve activity
5255040|NCT00608335|Antifungal|antifungal
5255041|NCT00608335|Micafungin|micafungin
5255042|NCT00608335|Echinocandin|echinocandin
5255043|NCT00608335|Candidiasis|candidiasis
5255044|NCT00608322|Sepsis|sepsis
5255045|NCT00608322|Severe sepsis|severe sepsis
5255046|NCT00608322|Septic shock|septic shock
5255047|NCT00608283|Kidney transplant|kidney transplant
5255048|NCT00608283|Live donor transplant|live donor transplant
5255049|NCT00608244|Tacrolimus|tacrolimus
5255050|NCT00608244|Pharmacokinetics|pharmacokinetics
5255051|NCT00608244|Liver Transplantation|liver transplantation
5255052|NCT00608218|Asthma|asthma
5255053|NCT00608218|ciclesonide|ciclesonide
5255054|NCT00608218|inhaled steroids|inhaled steroids
5255055|NCT00608218|Alvesco|alvesco
5255056|NCT00608205|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
5255057|NCT00608205|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
5255058|NCT00608205|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
5255059|NCT00608205|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
5255060|NCT00608205|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5255061|NCT00608205|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5255062|NCT00608205|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5255063|NCT00608205|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5255064|NCT00608192|HIV|hiv
5255065|NCT00608192|viral hepatitis|viral hepatitis
5255066|NCT00608192|methadone maintenance|methadone maintenance
5255067|NCT00608192|case management|case management
5255068|NCT00608192|costs|costs
5255069|NCT00608192|vaccination|vaccination
5255070|NCT00608192|risk reduction education|risk reduction education
5255071|NCT00608179|epinephrine|epinephrine
5255072|NCT00608179|glucose clamp|glucose clamp
5255073|NCT00608153|essential hypertension|essential hypertension
5255074|NCT00608153|ARB|arb
5255075|NCT00608153|compliance|compliance
5255076|NCT00608153|candesartan|candesartan
5255077|NCT00608140|Advanced Heart Failure|advanced heart failure
5255078|NCT00608140|Non-Ischemic Heart Failure|non-ischemic heart failure
5255079|NCT00608140|Mitral Regurgitation|mitral regurgitation
5255080|NCT00608140|Mitral Valve Replacement|mitral valve replacement
5255081|NCT00608140|Congestive Heart Failure|congestive heart failure
5255082|NCT00608140|Surgical Mitral Valvuloplasty|surgical mitral valvuloplasty
5255083|NCT00608140|Dilated Cardiomyopathy|dilated cardiomyopathy
5255084|NCT00608140|Annular Ring|annular ring
5255085|NCT00608101|hypoglycemia|hypoglycemia
5255086|NCT00608101|exercise|exercise
5255087|NCT00608101|corticosteroids|corticosteroids
5255088|NCT00608088|Breast feeding|breast feeding
5255089|NCT00608088|breastfeeding|breastfeeding
5255090|NCT00608088|randomized clinical trial|randomized clinical trial
5255091|NCT00608088|poverty|poverty
5255092|NCT00608062|endothelial function|endothelial function
5255093|NCT00608062|women|women
5255094|NCT00608062|female|female
5255095|NCT00608062|estrogen deficiency|estrogen deficiency
5255096|NCT00608062|sex hormones|sex hormones
5255097|NCT00608062|adiposity|adiposity
5255098|NCT00608062|oxidative stress|oxidative stress
5255099|NCT00608062|antioxidants|antioxidants
5255100|NCT00608049|Blood Pressure|blood pressure
5255101|NCT00608049|Diabetes|diabetes
5255102|NCT00608049|Nutrition|nutrition
5255103|NCT00608049|Dietary Carbohydrate|dietary carbohydrate
5255104|NCT00608049|Lipoproteins|lipoproteins
5255105|NCT00608049|Insulin Resistance|insulin resistance
5255106|NCT00608036|Adolescents|adolescents
5255107|NCT00608036|Neighborhood|neighborhood
5255108|NCT00608036|Walkability|walkability
5255109|NCT00608036|Physical Activity|physical activity
5255110|NCT00608036|Quality of Life|quality of life
5255111|NCT00608036|Ecological Analysis|ecological analysis
5255112|NCT00608036|Dietary Patterns|dietary patterns
5255113|NCT00608036|Weight Status|weight status
5255114|NCT00608036|Neighborhood Environment|neighborhood environment
5255115|NCT00608036|Food Environment|food environment
5255116|NCT00608036|Recreation Environment|recreation environment
5255117|NCT00608023|HIV|hiv
5255118|NCT00608023|Lipodystrophy|lipodystrophy
5255119|NCT00608023|Abdominal fat accumulation|abdominal fat accumulation
5255120|NCT00608023|Growth hormone releasing hormone|growth hormone releasing hormone
5255121|NCT00608023|HIV-associated lipodystrophy|hiv-associated lipodystrophy
5255122|NCT00608023|Treatment experienced|treatment experienced
5255123|NCT00608010|Preservation of supernumerary embryos in an IVF program|preservation of supernumerary embryos in an ivf program
5255124|NCT00607997|Leukemia|leukemia
5255125|NCT00607997|Myeloid|myeloid
5255126|NCT00607997|Elderly|elderly
5255127|NCT00607997|Hematologic|hematologic
5255128|NCT00607997|Blood|blood
5255129|NCT00607997|Cancer|cancer
5255130|NCT00607997|Malignancy|malignancy
5255131|NCT00607997|SNS-595|sns-595
5255132|NCT00607997|Sunesis|sunesis
5255133|NCT00607997|Hematologic Diseases|hematologic diseases
5255134|NCT00607997|Myelodysplastic Syndromes|myelodysplastic syndromes
5255135|NCT00607997|Older|older
5255136|NCT00607997|voreloxin|voreloxin
5255137|NCT00607997|reveal-1|reveal-1
5255138|NCT00607984|thiotepa|thiotepa
5255139|NCT00607984|melphalan|melphalan
5255140|NCT00607984|brain tumor|brain tumor
5255141|NCT00607984|tumors of central nervous system and other solid tumors|tumors of central nervous system and other solid tumors
5255142|NCT00607971|Constipation predominant irritable bowel syndrome|constipation predominant irritable bowel syndrome
5255143|NCT00607958|Tipranavir|tipranavir
5255144|NCT00607958|ritonavir|ritonavir
5255145|NCT00607958|dose reduction|dose reduction
5255146|NCT00607958|inhibitory quotient|inhibitory quotient
5255147|NCT00607945|Type 2 diabetes mellitus|type 2 diabetes mellitus
5255148|NCT00607945|conjugated linoleic acid|conjugated linoleic acid
5255149|NCT00607945|weight loss|weight loss
5255150|NCT00607945|rosiglitazone|rosiglitazone
5255151|NCT00607945|glucose control|glucose control
5255152|NCT00607945|insulin sensitivity|insulin sensitivity
5255153|NCT00607932|recurrent prostate cancer|recurrent prostate cancer
5255154|NCT00607906|safety|safety
5255155|NCT00607906|pharmacodynamics|pharmacodynamics
5255156|NCT00607906|diabetes|diabetes
5255157|NCT00607906|pharmacokinetics|pharmacokinetics
5255158|NCT00607893|Sleep-Disordered Breathing|sleep-disordered breathing
5255159|NCT00607880|vascular access device complications|vascular access device complications
5255160|NCT00607880|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5255161|NCT00607867|Diabetes Mellitus (type 2)|diabetes mellitus (type 2)
5255162|NCT00607867|Diet|diet
5255163|NCT00607867|Glycohemoglobin|glycohemoglobin
5255164|NCT00607867|Lipids|lipids
5255165|NCT00607867|Kidney Function|kidney function
5255166|NCT00607867|Glycemic Index|glycemic index
5255167|NCT00607867|Dietary Protein|dietary protein
5255168|NCT00607867|Dietary Carbohydrate|dietary carbohydrate
5255169|NCT00607854|Zevalin|zevalin
5255170|NCT00607854|Reduced intensity conditioning|reduced intensity conditioning
5255171|NCT00607854|Allogenic stem cell transplantation|allogenic stem cell transplantation
5255172|NCT00607828|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
5255173|NCT00607828|advanced adult primary liver cancer|advanced adult primary liver cancer
5255174|NCT00607828|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
5255175|NCT00607828|recurrent adult primary liver cancer|recurrent adult primary liver cancer
5255176|NCT00607815|PTSD|ptsd
5255177|NCT00607815|OEF/OIF|oef/oif
5255178|NCT00607815|Combat|combat
5255179|NCT00607815|Treatment|treatment
5255180|NCT00607815|CPT|cpt
5255181|NCT00607815|PCT|pct
5255182|NCT00607815|Cognitive|cognitive
5255183|NCT00607802|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5255184|NCT00607802|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
5255185|NCT00607776|dry, eyes|dry, eyes
5255186|NCT00607776|Amelioration of dry eye symptoms|amelioration of dry eye symptoms
5255187|NCT00607763|Antifungal|antifungal
5255188|NCT00607763|Echinocandin|echinocandin
5255189|NCT00607763|Candidiasis|candidiasis
5255190|NCT00607763|Micafungin|micafungin
5255191|NCT00607750|Wet AMD, Comentis, ATG003, mecamylamine|wet amd, comentis, atg003, mecamylamine
5255192|NCT00607724|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5255193|NCT00607685|Trabeculectomy|trabeculectomy
5255194|NCT00607685|Wound healing|wound healing
5255195|NCT00607685|5 Fluorouracil|5 fluorouracil
5255196|NCT00607685|Hyaluronic acid|hyaluronic acid
5255197|NCT00607685|post-operative scarring|post-operative scarring
5255198|NCT00607672|Angiotensin Converting Enzyme|angiotensin converting enzyme
5255199|NCT00607672|Angiotensin Receptor Blockers|angiotensin receptor blockers
5255200|NCT00607672|Cardiopulmonary Bypass|cardiopulmonary bypass
5255201|NCT00607672|Fibrinolysis|fibrinolysis
5255202|NCT00607672|Inflammation|inflammation
5255203|NCT00607659|Chlamydia|chlamydia
5255204|NCT00607659|Chlamydia trachomatis|chlamydia trachomatis
5255205|NCT00607659|Adolescent Health|adolescent health
5255206|NCT00607659|Female Health|female health
5255207|NCT00607659|Sexually Transmitted Infections|sexually transmitted infections
5255208|NCT00607659|Infertility|infertility
5255209|NCT00607659|Pelvic Inflammatory Disease|pelvic inflammatory disease
5255210|NCT00607646|hypoglycemia|hypoglycemia
5255211|NCT00607646|dehydroepiandrosterone|dehydroepiandrosterone
5255212|NCT00607633|essential hypertension|essential hypertension
5255213|NCT00607633|ARB|arb
5255214|NCT00607633|left ventricular hypertrophy|left ventricular hypertrophy
5255215|NCT00607633|candesartan|candesartan
5255216|NCT00607620|Alcohol Abuse|alcohol abuse
5255217|NCT00607620|Alcohol Dependence|alcohol dependence
5255218|NCT00607620|Alcohol Use Disorder|alcohol use disorder
5255219|NCT00607620|Screening|screening
5255220|NCT00607620|Brief Intervention|brief intervention
5255221|NCT00607620|Motivational Interviewing|motivational interviewing
5255222|NCT00607607|ovarian cancer|ovarian cancer
5255223|NCT00607607|endometrial cancer|endometrial cancer
5255224|NCT00607581|amyloidosis|amyloidosis
5255225|NCT00607581|lenalidomide|lenalidomide
5255226|NCT00607581|cyclophosphamide|cyclophosphamide
5255227|NCT00607581|dexamethasone|dexamethasone
5255228|NCT00607568|physical stress|physical stress
5255229|NCT00607568|psychological stress|psychological stress
5255230|NCT00607555|Infant, premature|infant, premature
5255231|NCT00607555|Infant, very low birth weight|infant, very low birth weight
5255232|NCT00607555|Apnea|apnea
5255233|NCT00607555|Feeding methods|feeding methods
5255234|NCT00607555|Diaphragm|diaphragm
5255235|NCT00607542|spasticity|spasticity
5255236|NCT00607542|cerebral palsy|cerebral palsy
5255237|NCT00607542|baclofen|baclofen
5255238|NCT00607542|pharmacokinetics|pharmacokinetics
5255239|NCT00607542|pharmacodynamics|pharmacodynamics
5255240|NCT00607542|dosing|dosing
5255241|NCT00607542|safety|safety
5255242|NCT00607542|efficacy|efficacy
5255243|NCT00607529|Multiple Diseases|multiple diseases
5255244|NCT00607516|fracture|fracture
5255245|NCT00607516|arthroplasty|arthroplasty
5255246|NCT00607516|wear|wear
5255247|NCT00607516|osteoporosis|osteoporosis
5255248|NCT00607516|bone|bone
5255249|NCT00607490|Vulvodynia|vulvodynia
5255250|NCT00607490|Vulvar pain|vulvar pain
5255251|NCT00607490|Dyspareunia|dyspareunia
5255252|NCT00607490|Sexual dysfunction|sexual dysfunction
5255253|NCT00607490|Vestibulitis|vestibulitis
5255254|NCT00607464|Hypothermia, premature infants, Polyethylene occlusive wrap|hypothermia, premature infants, polyethylene occlusive wrap
5255255|NCT00607438|Locally Advanced or Metastatic|locally advanced or metastatic
5255256|NCT00607425|non-small cell lung cancer|non-small cell lung cancer
5255257|NCT00607425|screening|screening
5255258|NCT00607425|saliva|saliva
5255259|NCT00607425|gene expression|gene expression
5255260|NCT00607425|healthy control subject|healthy control subject
5255261|NCT00607412|PTSD|ptsd
5255262|NCT00607412|substance use disorders|substance use disorders
5255263|NCT00607412|psychotherapy|psychotherapy
5255264|NCT00607399|Solid tumor|solid tumor
5255265|NCT00607399|Advanced Cancer|advanced cancer
5255266|NCT00607399|MET Inhibitor|met inhibitor
5255267|NCT00607399|Receptor Tyrosine Kinase Inhibitor (RTKI)|receptor tyrosine kinase inhibitor (rtki)
5255268|NCT00607386|Hunter syndrome|hunter syndrome
5255269|NCT00607386|hunters syndrome|hunters syndrome
5255270|NCT00607386|hunter's syndrome|hunter's syndrome
5255271|NCT00607386|hunter disease|hunter disease
5255272|NCT00607386|hunters disease|hunters disease
5255273|NCT00607386|hunter's disease|hunter's disease
5255274|NCT00607386|MPS II|mps ii
5255275|NCT00607386|MPSII|mpsii
5255276|NCT00607386|MPS2|mps2
5255277|NCT00607386|MPS 2|mps 2
5255278|NCT00607386|mucopolysaccharides|mucopolysaccharides
5255279|NCT00607386|lysosomal storage disease|lysosomal storage disease
5255280|NCT00607386|lysosomal storage disorder|lysosomal storage disorder
5255281|NCT00607386|chronic ear infection|chronic ear infection
5255282|NCT00607386|enlarged adenoids|enlarged adenoids
5255283|NCT00607386|mps symptoms|mps symptoms
5255284|NCT00607386|mps diagnosis|mps diagnosis
5255285|NCT00607386|mps ii therapy|mps ii therapy
5255286|NCT00607386|MPS II treatment|mps ii treatment
5255287|NCT00607386|ert treatment|ert treatment
5255288|NCT00607386|elaprase|elaprase
5255289|NCT00607386|idursulfase|idursulfase
5255290|NCT00607386|iduronate sulfatase|iduronate sulfatase
5255291|NCT00607386|iduronate 2 sulfatase|iduronate 2 sulfatase
5255292|NCT00607386|enzyme replacement therapy|enzyme replacement therapy
5255293|NCT00607386|hunter syndrome treatment|hunter syndrome treatment
5255294|NCT00607386|hunter's syndrome treatment|hunter's syndrome treatment
5255295|NCT00607386|hunter syndrome therapy|hunter syndrome therapy
5255296|NCT00607386|hunter's disease treatment|hunter's disease treatment
5255297|NCT00607386|mps society|mps society
5255298|NCT00607373|Apolipoprotein B|apolipoprotein b
5255299|NCT00607373|Homozygous Familial Hypercholesterolemia|homozygous familial hypercholesterolemia
5255300|NCT00607373|LDL-receptor gene|ldl-receptor gene
5255301|NCT00607360|cocaine addiction, treatment, contingency management, employment intervention|cocaine addiction, treatment, contingency management, employment intervention
5255302|NCT00607347|Keywords by National Institute of General Medical Sciences|keywords by national institute of general medical sciences
5255303|NCT00607347|Hypertension|hypertension
5255304|NCT00607347|Adverse metabolic effects|adverse metabolic effects
5255305|NCT00607347|Beta blockers|beta blockers
5255306|NCT00607347|Dyslipidemia|dyslipidemia
5255307|NCT00607347|Atenolol|atenolol
5255308|NCT00607347|New onset diabetes|new onset diabetes
5255309|NCT00607347|Pharmacokinetic study|pharmacokinetic study
5255310|NCT00607347|Oral glucose tolerance test|oral glucose tolerance test
5255311|NCT00607334|Child Language|child language
5255312|NCT00607334|Language Therapy|language therapy
5255313|NCT00607334|Vocabulary|vocabulary
5255314|NCT00607321|restenosis|restenosis
5255315|NCT00607321|Coronary Disease|coronary disease
5255316|NCT00607321|Coronary Arteriosclerosis|coronary arteriosclerosis
5255317|NCT00607321|Arterial Occlusive Diseases|arterial occlusive diseases
5255318|NCT00607295|chemotherapy|chemotherapy
5255319|NCT00607295|hormonal therapy|hormonal therapy
5255320|NCT00607295|urogenital atrophy|urogenital atrophy
5255321|NCT00607269|Drug Abuse|drug abuse
5255322|NCT00607269|Contingency management|contingency management
5255323|NCT00607269|Voucher-based Reinforcement Therapy|voucher-based reinforcement therapy
5255324|NCT00607269|Homosexuality|homosexuality
5255325|NCT00607269|Homeless Persons|homeless persons
5255326|NCT00607243|Smallpox vaccine efficacy|smallpox vaccine efficacy
5255327|NCT00607230|type 1 diabetes mellitus|type 1 diabetes mellitus
5255328|NCT00607230|immune modulation|immune modulation
5255329|NCT00607230|cure|cure
5255330|NCT00607230|autoimmunity|autoimmunity
5255331|NCT00607217|Coronary artery diseases|coronary artery diseases
5255332|NCT00607217|Myocardial infarction|myocardial infarction
5255333|NCT00607217|Stable angina|stable angina
5255334|NCT00607217|Influenza|influenza
5255335|NCT00607217|Vaccine|vaccine
5255336|NCT00607204|Basic Research|basic research
5255337|NCT00607204|Individual Sleep Duration|individual sleep duration
5255338|NCT00607204|Melatonin|melatonin
5255339|NCT00607204|Electroencephalogram|electroencephalogram
5255340|NCT00607204|Alertness|alertness
5255341|NCT00607204|Mood|mood
5255342|NCT00607191|Idiopathic talipes equinovarus (ITEV)|idiopathic talipes equinovarus (itev)
5255343|NCT00607178|Influenza|influenza
5255344|NCT00607178|Vaccine|vaccine
5255345|NCT00607126|impaired ambulation|impaired ambulation
5255346|NCT00607113|Neuroendocrine Carcinoma|neuroendocrine carcinoma
5255347|NCT00607113|Avastin|avastin
5255348|NCT00607113|Bevacizumab|bevacizumab
5255349|NCT00607113|RAD001|rad001
5255350|NCT00607113|Everolimus|everolimus
5255351|NCT00607100|High-Resolution Optical Coherence Tomography|high-resolution optical coherence tomography
5255352|NCT00607100|Retinal Nerve Fiber Layer|retinal nerve fiber layer
5255353|NCT00607100|Band Atrophy|band atrophy
5255354|NCT00607061|Glutathione|glutathione
5255355|NCT00607061|Cysteine|cysteine
5255356|NCT00607061|Synthesis rate|synthesis rate
5255357|NCT00607061|Newborns|newborns
5255358|NCT00607061|Low birth weight newborn babies|low birth weight newborn babies
5255359|NCT00607022|dental implant|dental implant
5255360|NCT00607022|early loading|early loading
5255361|NCT00607022|traditional loading|traditional loading
5255362|NCT00607022|anterior|anterior
5255363|NCT00607022|implant stability|implant stability
5255364|NCT00607022|Subjects presenting with one tooth missing in the anterior|subjects presenting with one tooth missing in the anterior
5255365|NCT00607022|incisor/canine) or pre-molar regions of the mandible|incisor/canine) or pre-molar regions of the mandible
5255366|NCT00607022|or maxilla with existing teeth that were healthy|or maxilla with existing teeth that were healthy
5255367|NCT00607022|or adequately restored shall be screened.|or adequately restored shall be screened.
5255368|NCT00606996|Drug Abuse|drug abuse
5255369|NCT00606996|Drug Dependence|drug dependence
5255370|NCT00606996|Alcohol Abuse|alcohol abuse
5255371|NCT00606996|Alcohol Dependence|alcohol dependence
5255372|NCT00606996|Major Depressive Disorder|major depressive disorder
5255373|NCT00606996|Dysthymic Disorder|dysthymic disorder
5255374|NCT00606996|Prisoners|prisoners
5255375|NCT00606996|Women|women
5255376|NCT00606970|Chemotherapy|chemotherapy
5255377|NCT00606970|Breast Cancer|breast cancer
5255378|NCT00606970|Colon Cancer|colon cancer
5255379|NCT00606970|Lung Cancer|lung cancer
5255380|NCT00606957|Obesity|obesity
5255381|NCT00606957|Metabolism|metabolism
5255382|NCT00606944|enhanced recovery program|enhanced recovery program
5255383|NCT00606931|biopsy|biopsy
5255384|NCT00606931|PET|pet
5255385|NCT00606931|image-guidance|image-guidance
5255386|NCT00606931|breast cancer|breast cancer
5255387|NCT00606931|FDG|fdg
5255388|NCT00606931|PEM|pem
5255389|NCT00606918|Strength testing|strength testing
5255390|NCT00606918|Disease progression|disease progression
5255391|NCT00606918|ALS|als
5255392|NCT00606918|Healthy Adults|healthy adults
5255393|NCT00606905|Recurrent miscarriage|recurrent miscarriage
5255394|NCT00606905|Recurrent spontaneous abortion|recurrent spontaneous abortion
5255395|NCT00606905|Habitual abortion|habitual abortion
5255396|NCT00606905|IVIG|ivig
5255397|NCT00606905|Randomized Controlled Trial|randomized controlled trial
5255398|NCT00606892|therapeutic effects|therapeutic effects
5255399|NCT00606879|Solid tumor|solid tumor
5255400|NCT00606879|Advanced Cancer|advanced cancer
5255401|NCT00606879|MET inhibitor|met inhibitor
5255402|NCT00606879|Receptor Tyrosine Kinase Inhibitor (RTKI)|receptor tyrosine kinase inhibitor (rtki)
5255403|NCT00606866|renal, metastatic, carcinoma|renal, metastatic, carcinoma
5255404|NCT00606853|Substance abuse|substance abuse
5255405|NCT00606853|Contingency Management|contingency management
5255406|NCT00606840|overweight|overweight
5255407|NCT00606840|prevention of weight gain|prevention of weight gain
5255408|NCT00606840|young adults|young adults
5255409|NCT00606840|self-regulation|self-regulation
5255410|NCT00606840|daily weighing|daily weighing
5255411|NCT00606840|weight gain prevention|weight gain prevention
5255412|NCT00606827|Contrast-induced nephrophaty|contrast-induced nephrophaty
5255413|NCT00606827|Contrast media|contrast media
5255414|NCT00606827|Angiography|angiography
5255415|NCT00606827|Coronary percutaneous intervention|coronary percutaneous intervention
5255416|NCT00606814|Solid Tumors, IPI-504, docetaxel,cancer|solid tumors, ipi-504, docetaxel,cancer
5255417|NCT00606801|cognitive enhancers|cognitive enhancers
5255418|NCT00606801|Nootropic Agents|nootropic agents
5255419|NCT00606788|randomized clinical trials|randomized clinical trials
5255420|NCT00606788|intensive care|intensive care
5255421|NCT00606788|mechanical ventilation|mechanical ventilation
5255422|NCT00606788|ventilator weaning|ventilator weaning
5255423|NCT00606788|clinical protocols|clinical protocols
5255424|NCT00606788|therapy, computer-assisted|therapy, computer-assisted
5255425|NCT00606788|humans|humans
5255426|NCT00606788|various surgical diseases requiring mechanical ventilation over 24 hours|various surgical diseases requiring mechanical ventilation over 24 hours
5255427|NCT00606775|Adrenergic beta-Antagonists|adrenergic beta-antagonists
5255428|NCT00606775|Duchenne Muscular Dystrophy|duchenne muscular dystrophy
5255429|NCT00606775|Cardiomyopathies|cardiomyopathies
5255430|NCT00606775|Troponin I|troponin i
5255431|NCT00606762|laparoscopic cholecystectomy|laparoscopic cholecystectomy
5255432|NCT00606762|low pressure pneumoperitoneum|low pressure pneumoperitoneum
5255433|NCT00606736|right ventricular outflow tract arrhythmia|right ventricular outflow tract arrhythmia
5255434|NCT00606736|sex hormone level|sex hormone level
5255435|NCT00606736|menstrual cycle|menstrual cycle
5255436|NCT00606736|Gonadal Hormones|gonadal hormones
5255437|NCT00606723|relapsed or refractory AML|relapsed or refractory aml
5255438|NCT00606723|in children, adolescents and young adults|in children, adolescents and young adults
5255439|NCT00606697|Primary Insomnia Adults|primary insomnia adults
5255440|NCT00606684|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
5255441|NCT00606684|COPD|copd
5255442|NCT00606684|GW642444|gw642444
5255443|NCT00606671|polycystic ovary syndrome (PCOS)|polycystic ovary syndrome (pcos)
5255444|NCT00606658|Insomnia|insomnia
5255445|NCT00606658|Ayurveda|ayurveda
5255446|NCT00606658|Shirodhara|shirodhara
5255447|NCT00606658|Quality of Life|quality of life
5255448|NCT00606632|Renal Mass|renal mass
5255449|NCT00606632|Clear Cell Renal Cell Carcinoma|clear cell renal cell carcinoma
5255450|NCT00606632|Cancer of Kidney|cancer of kidney
5255451|NCT00606632|Kidney Cancer|kidney cancer
5255452|NCT00606632|Neoplasms|neoplasms
5255453|NCT00606632|cG250|cg250
5255454|NCT00606632|antibody, monoclonal|antibody, monoclonal
5255455|NCT00606632|Iodine 124|iodine 124
5255456|NCT00606632|Positron-Emission Tomography|positron-emission tomography
5255457|NCT00606632|Kidney|kidney
5255458|NCT00606632|Renal Cancer|renal cancer
5255459|NCT00606632|Renal Neoplasms|renal neoplasms
5255460|NCT00606619|Gastrectomy|gastrectomy
5255461|NCT00606619|Oral feeding|oral feeding
5255462|NCT00606619|Nutrition|nutrition
5255463|NCT00606619|Gastric cancer|gastric cancer
5255464|NCT00606593|insomnia|insomnia
5255465|NCT00606593|elderly|elderly
5255466|NCT00606593|sleeplessness|sleeplessness
5255467|NCT00606580|cutaneous leishmaniasis, topical treatment, Tunisia|cutaneous leishmaniasis, topical treatment, tunisia
5255468|NCT00606567|Defibrillators, Implantable|defibrillators, implantable
5255469|NCT00606554|Respiratory Insufficiency|respiratory insufficiency
5255470|NCT00606554|Ventilators, Mechanical|ventilators, mechanical
5255471|NCT00606554|Ventilator Weaning|ventilator weaning
5255472|NCT00606554|Therapy, Computer-Assisted|therapy, computer-assisted
5255473|NCT00606541|Social Anxiety Disorder|social anxiety disorder
5255474|NCT00606541|Quetiapine XR|quetiapine xr
5255475|NCT00606541|Prevention|prevention
5255476|NCT00606541|tolerability|tolerability
5255477|NCT00606528|Antiviral therapy|antiviral therapy
5255478|NCT00606515|Pharmacokinetics|pharmacokinetics
5255479|NCT00606515|Liposomal paclitaxel|liposomal paclitaxel
5255480|NCT00606502|Stage IIIB/IV non-small cell lung cancer|stage iiib/iv non-small cell lung cancer
5255481|NCT00606502|Non-small cell lung cancer|non-small cell lung cancer
5255482|NCT00606502|NSCLC|nsclc
5255483|NCT00606502|Lung Cancer|lung cancer
5255484|NCT00606502|Pralatrexate|pralatrexate
5255485|NCT00606502|Erlotinib|erlotinib
5255486|NCT00606502|Tarceva|tarceva
5255487|NCT00606502|PDX|pdx
5255488|NCT00606502|Smoking|smoking
5255489|NCT00606502|Smoker|smoker
5255490|NCT00606450|plaque psoriasis|plaque psoriasis
5255491|NCT00606437|Umbilical Cord Blood Graft|umbilical cord blood graft
5255492|NCT00606437|Stem Cell Transplantation|stem cell transplantation
5255493|NCT00606424|head and neck cancer|head and neck cancer
5255494|NCT00606411|Sleep-Related Eating Disorder|sleep-related eating disorder
5255495|NCT00606411|Topiramate|topiramate
5255496|NCT00606411|Parasomnia|parasomnia
5255497|NCT00606398|colorectal metastases|colorectal metastases
5255498|NCT00606385|Recurrence|recurrence
5255499|NCT00606385|Survival|survival
5255500|NCT00606385|Immunology|immunology
5255501|NCT00606385|Laparoscopy|laparoscopy
5255502|NCT00606372|Off-pump|off-pump
5255503|NCT00606372|OPCAB|opcab
5255504|NCT00606372|EuroSCORE|euroscore
5255505|NCT00606372|high-risk patients|high-risk patients
5255506|NCT00606372|Quality of life|quality of life
5255507|NCT00606372|Validity of EuroSCORE|validity of euroscore
5255508|NCT00606359|Influenza|influenza
5255509|NCT00606359|Orthomyxoviridae Infections|orthomyxoviridae infections
5255510|NCT00606359|Renal Transplant|renal transplant
5255511|NCT00606346|Crohn's Disease|crohn's disease
5255512|NCT00606346|Ulcerative Colitis|ulcerative colitis
5255513|NCT00606346|Indeterminate Colitis|indeterminate colitis
5255514|NCT00606346|Inflammatory Bowel Diseases|inflammatory bowel diseases
5255515|NCT00606346|Immunomodulators|immunomodulators
5255516|NCT00606346|infliximab|infliximab
5255517|NCT00606346|TNF-alpha|tnf-alpha
5255727|NCT00605007|Diabetes|diabetes
5255518|NCT00606333|Coronary artery disease|coronary artery disease
5255519|NCT00606333|drug-eluting stents|drug-eluting stents
5255520|NCT00606333|sirolimus-eluting coronary stents|sirolimus-eluting coronary stents
5255521|NCT00606294|Head|head
5255522|NCT00606294|Neck|neck
5255523|NCT00606294|04-070|04-070
5255524|NCT00606268|Antifungal Prophylaxis|antifungal prophylaxis
5255525|NCT00606268|Hematopoietic Stem Cell Transplant|hematopoietic stem cell transplant
5255526|NCT00606268|HSCT|hsct
5255527|NCT00606268|Micafungin|micafungin
5255528|NCT00606255|blood pressure|blood pressure
5255529|NCT00606255|compliance|compliance
5255530|NCT00606255|treatment|treatment
5255531|NCT00606216|MRI|mri
5255532|NCT00606164|Alzheimer's Disease|alzheimer's disease
5255533|NCT00606164|bryostatin 1|bryostatin 1
5255534|NCT00606164|bryostatin|bryostatin
5255535|NCT00606164|safety|safety
5255536|NCT00606164|efficacy|efficacy
5255537|NCT00606164|pharmacokinetics|pharmacokinetics
5255538|NCT00606164|pharmacodynamics|pharmacodynamics
5255539|NCT00606164|protein kinase C|protein kinase c
5255540|NCT00606151|drug eluding stents|drug eluding stents
5255541|NCT00606151|perioperative bridging|perioperative bridging
5255542|NCT00606151|Stents|stents
5255543|NCT00606125|Chemotherapy|chemotherapy
5255544|NCT00606125|Solid Tumors|solid tumors
5255545|NCT00606125|Sorafenib|sorafenib
5255546|NCT00606125|Carboplatin|carboplatin
5255547|NCT00606125|Paclitaxel|paclitaxel
5255548|NCT00606099|Adults|adults
5255549|NCT00606099|compensated chronic hepatitis B|compensated chronic hepatitis b
5255550|NCT00606099|telbivudin|telbivudin
5255551|NCT00606099|aedevofir dipivoxil|aedevofir dipivoxil
5255552|NCT00606086|Hepatitis, HCV, Liver disease, HepC|hepatitis, hcv, liver disease, hepc
5255553|NCT00606060|Hemophilia,|hemophilia,
5255554|NCT00606060|Continuous Infusion|continuous infusion
5255555|NCT00606047|femoroacetabular impingement|femoroacetabular impingement
5255556|NCT00606034|Type 2 diabetes|type 2 diabetes
5255557|NCT00606034|Insulin Resistance|insulin resistance
5255558|NCT00606034|Continuous Subcutaneous Insulin Infusion|continuous subcutaneous insulin infusion
5255559|NCT00606034|U-500 Insulin|u-500 insulin
5255560|NCT00606034|Omnipod|omnipod
5255561|NCT00606008|Sutent|sutent
5255562|NCT00605995|Schizophrenia|schizophrenia
5255563|NCT00605995|Randomized trial|randomized trial
5255564|NCT00605995|Statin|statin
5255565|NCT00605995|Placebo|placebo
5255567|NCT00605969|femoroacetabular, impingement|femoroacetabular, impingement
5255568|NCT00605956|head lice|head lice
5255569|NCT00605956|NatrOVA Creme Rinse - 1% is intended for the treatment of head lice|natrova creme rinse - 1% is intended for the treatment of head lice
5255570|NCT00605943|Retinal Disease|retinal disease
5255571|NCT00605943|Bevacizumab|bevacizumab
5255572|NCT00605943|Ranibizumab|ranibizumab
5255573|NCT00605943|Retinal Eye Disease|retinal eye disease
5255574|NCT00605943|Macular Degeneration|macular degeneration
5255575|NCT00605930|Progressive Supranuclear Palsy|progressive supranuclear palsy
5255576|NCT00605930|PSP|psp
5255577|NCT00605930|Nutriceutical|nutriceutical
5255578|NCT00605930|Pyruvate|pyruvate
5255579|NCT00605930|Creatine|creatine
5255580|NCT00605930|Niacinamide|niacinamide
5255581|NCT00605904|Chemical Stressor|chemical stressor
5255582|NCT00605904|Alcoholism|alcoholism
5255583|NCT00605904|Yohimbine|yohimbine
5255584|NCT00605904|Acamprosate|acamprosate
5255585|NCT00605904|Craving|craving
5255586|NCT00605878|Atopic Dermatitis (Eczema)|atopic dermatitis (eczema)
5255587|NCT00605878|Bacteria|bacteria
5255588|NCT00605878|Filaggrin|filaggrin
5255589|NCT00605878|Skin|skin
5255590|NCT00605878|Microbiome|microbiome
5255591|NCT00605878|Atopic Dermatitis|atopic dermatitis
5255592|NCT00605878|Eczema|eczema
5255593|NCT00605878|Health Volunteer|health volunteer
5255594|NCT00605878|HG|hg
5255595|NCT00605852|Allergic rhinitis|allergic rhinitis
5255596|NCT00605852|first time in human|first time in human
5255597|NCT00605839|mobile technology|mobile technology
5255598|NCT00605839|cell phones|cell phones
5255599|NCT00605839|type 1 diabetes|type 1 diabetes
5255600|NCT00605800|Liver resection|liver resection
5255601|NCT00605774|catecholamines|catecholamines
5255602|NCT00605774|diabetes|diabetes
5255603|NCT00605774|exercise|exercise
5255604|NCT00605761|Cystic Fibrosis|cystic fibrosis
5255605|NCT00605761|Lung function|lung function
5255606|NCT00605761|Anti-Inflammatory|anti-inflammatory
5255607|NCT00605748|catheter ablation|catheter ablation
5255608|NCT00605748|atrial fibrillation|atrial fibrillation
5255609|NCT00605748|pulmonary vein|pulmonary vein
5255610|NCT00605696|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
5255611|NCT00605696|Acute Lung Injury|acute lung injury
5255612|NCT00605657|ALPS|alps
5255613|NCT00605657|Valproic Acid|valproic acid
5255614|NCT00605657|Lymphadenopathy|lymphadenopathy
5255615|NCT00605657|Splenomegaly|splenomegaly
5255616|NCT00605657|Histone Deacytelase (HDAC) Inhibitor|histone deacytelase (hdac) inhibitor
5255617|NCT00605657|Autoimmune Lymphoproliferative Syndrome|autoimmune lymphoproliferative syndrome
5255618|NCT00605631|Pacing|pacing
5255619|NCT00605605|endothelial function|endothelial function
5255620|NCT00605605|atherosclerosis|atherosclerosis
5255621|NCT00605605|smoking|smoking
5255831|NCT00604526|recurrent|recurrent
5255622|NCT00605605|inflammation|inflammation
5255623|NCT00605605|antioxidant|antioxidant
5255624|NCT00605592|Type 1 Diabetes|type 1 diabetes
5255625|NCT00605592|Kidney Transplant|kidney transplant
5255626|NCT00605592|Hypoglycemic Unawareness|hypoglycemic unawareness
5255627|NCT00605592|Islet Transplant|islet transplant
5255628|NCT00605592|Pancreatic Islet Cell Transplantation|pancreatic islet cell transplantation
5255629|NCT00605592|University of Virginia|university of virginia
5255630|NCT00605592|Islet Transplantation|islet transplantation
5255631|NCT00605592|Kidney Transplantation|kidney transplantation
5255632|NCT00605566|Neuroendocrine|neuroendocrine
5255633|NCT00605566|sorafenib|sorafenib
5255634|NCT00605566|cyclophosphamide|cyclophosphamide
5255635|NCT00605566|pharmacodynamic|pharmacodynamic
5255636|NCT00605540|COPD|copd
5255637|NCT00605540|Survival|survival
5255638|NCT00605540|Exacerbation|exacerbation
5255639|NCT00605540|Disease markers|disease markers
5255640|NCT00605527|Acute Lung Injury|acute lung injury
5255641|NCT00605527|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
5255642|NCT00605514|Hemorrhagic Fever|hemorrhagic fever
5255643|NCT00605514|Healthy|healthy
5255644|NCT00605514|Immunity|immunity
5255645|NCT00605514|T-Cells|t-cells
5255646|NCT00605514|Filovirus|filovirus
5255647|NCT00605514|Healthy Volunteer|healthy volunteer
5255648|NCT00605514|HV|hv
5255649|NCT00605488|Pet Scan|pet scan
5255650|NCT00605475|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
5255651|NCT00605475|Canakinumab|canakinumab
5255652|NCT00605475|ACZ885|acz885
5255653|NCT00605475|IL-1B antagonist|il-1b antagonist
5255654|NCT00605475|metformin|metformin
5255655|NCT00605475|glycemic control|glycemic control
5255656|NCT00605475|insulin sensitivity|insulin sensitivity
5255657|NCT00605449|GSK376501|gsk376501
5255658|NCT00605449|Simvastatin|simvastatin
5255659|NCT00605449|Healthy Subjects|healthy subjects
5255660|NCT00605449|Repeat Dose|repeat dose
5255661|NCT00605449|Drug Interaction|drug interaction
5255662|NCT00605449|Randomized|randomized
5255663|NCT00605449|Pharmacokinetics|pharmacokinetics
5255664|NCT00605436|overweight|overweight
5255665|NCT00605436|sedentary|sedentary
5255666|NCT00605436|metabolic syndrome|metabolic syndrome
5255667|NCT00605423|AMD|amd
5255668|NCT00605423|Almera|almera
5255669|NCT00605423|Steroid|steroid
5255670|NCT00605423|Macular|macular
5255671|NCT00605423|ARMD|armd
5255672|NCT00605410|Methacholine bronchoprovocation|methacholine bronchoprovocation
5255673|NCT00605410|Antimuscarinic|antimuscarinic
5255674|NCT00605397|Cu-64 LABELED TRASTUZUMAB|cu-64 labeled trastuzumab
5255675|NCT00605371|Healthy volunteers|healthy volunteers
5255676|NCT00605371|Bioequivalence|bioequivalence
5255677|NCT00605371|Food Effects|food effects
5255678|NCT00605358|geriatric depression|geriatric depression
5255680|NCT00605319|BOO|boo
5255681|NCT00605306|Asthma|asthma
5255682|NCT00605306|spirometry|spirometry
5255683|NCT00605306|lung function|lung function
5255684|NCT00605306|serum cortisol|serum cortisol
5255685|NCT00605306|serum potassium|serum potassium
5255686|NCT00605306|plasma glucose|plasma glucose
5255687|NCT00605280|randomized sham-controlled multicenter macular edema|randomized sham-controlled multicenter macular edema
5255688|NCT00605267|Breast Cancer|breast cancer
5255689|NCT00605267|Breast Neoplasms|breast neoplasms
5255690|NCT00605267|Tumors or cancer of the human BREAST|tumors or cancer of the human breast
5255691|NCT00605267|Tumor or cancer of the human MAMMARY GLAND|tumor or cancer of the human mammary gland
5255692|NCT00605254|P-Glycoprotein|p-glycoprotein
5255693|NCT00605254|Positron Emission Tomography|positron emission tomography
5255694|NCT00605254|Blood Brain Barrier|blood brain barrier
5255695|NCT00605254|Quantitative Imaging|quantitative imaging
5255696|NCT00605254|Multi-Drug Transporter|multi-drug transporter
5255697|NCT00605254|Healthy Volunteer|healthy volunteer
5255698|NCT00605254|HV|hv
5255699|NCT00605241|pharmacodynamics,|pharmacodynamics,
5255700|NCT00605241|pharmacokinetics,|pharmacokinetics,
5255701|NCT00605241|tolerability,|tolerability,
5255702|NCT00605241|Safety,|safety,
5255703|NCT00605241|single dose,|single dose,
5255704|NCT00605241|placebo,|placebo,
5255705|NCT00605241|Nicotine reward|nicotine reward
5255706|NCT00605241|GSK598809|gsk598809
5255707|NCT00605176|Actinic keratosis|actinic keratosis
5255708|NCT00605176|Skin disease|skin disease
5255709|NCT00605163|Parkinson disease, observational, longitudinal|parkinson disease, observational, longitudinal
5255710|NCT00605150|Unresectable HCC|unresectable hcc
5255711|NCT00605124|osteoarthritis|osteoarthritis
5255712|NCT00605124|knee|knee
5255713|NCT00605124|total knee arthroplasty|total knee arthroplasty
5255714|NCT00605124|exercise|exercise
5255715|NCT00605098|HIV|hiv
5255716|NCT00605098|Pregnancy|pregnancy
5255717|NCT00605098|Vertical disease transmission|vertical disease transmission
5255718|NCT00605098|Pharmacokinetics|pharmacokinetics
5255719|NCT00605098|HIV seronegativity|hiv seronegativity
5255720|NCT00605072|cognitive disorders|cognitive disorders
5255721|NCT00605072|angiotensin receptor blockers|angiotensin receptor blockers
5255722|NCT00605059|Alzheimer|alzheimer
5255723|NCT00605059|SPECT|spect
5255724|NCT00605046|Alzheimer|alzheimer
5255728|NCT00605007|Respiratory Disorders|respiratory disorders
5255729|NCT00604994|Lymphoedema|lymphoedema
5255730|NCT00604994|Gynaecology|gynaecology
5255731|NCT00604994|Oncology|oncology
5255732|NCT00604994|Malignant|malignant
5255733|NCT00604994|Benign|benign
5255734|NCT00604994|Incidence|incidence
5255735|NCT00604955|visceral leishmaniasis|visceral leishmaniasis
5255736|NCT00604955|kala-azar|kala-azar
5255737|NCT00604955|Bihar, India|bihar, india
5255738|NCT00604942|Oesophagus|oesophagus
5255739|NCT00604942|Dysphagia|dysphagia
5255740|NCT00604942|Impedance|impedance
5255741|NCT00604942|High Resolution Manometry|high resolution manometry
5255742|NCT00604942|Peristalsis|peristalsis
5255743|NCT00604942|Contractile Pressure|contractile pressure
5255744|NCT00604942|Coordination of contraction|coordination of contraction
5255745|NCT00604942|Bolus transport|bolus transport
5255746|NCT00604929|muscle protein synthesis|muscle protein synthesis
5255747|NCT00604929|whole-body protein breakdown|whole-body protein breakdown
5255748|NCT00604929|nutrition|nutrition
5255749|NCT00604916|oral hygiene|oral hygiene
5255750|NCT00604890|Double-Blind|double-blind
5255751|NCT00604890|Placebo|placebo
5255752|NCT00604890|Topical|topical
5255753|NCT00604890|Treatment|treatment
5255754|NCT00604890|Dose-Ranging|dose-ranging
5255755|NCT00604890|sBCC|sbcc
5255756|NCT00604877|exercise|exercise
5255757|NCT00604877|glucose metabolism|glucose metabolism
5255758|NCT00604877|insulin sensitivity|insulin sensitivity
5255759|NCT00604877|Vascular Function|vascular function
5255760|NCT00604864|deep endometriosis|deep endometriosis
5255761|NCT00604864|pelvic pain|pelvic pain
5255762|NCT00604864|infliximab|infliximab
5255763|NCT00604864|anti TNFa|anti tnfa
5255764|NCT00604838|amniotic fluid leakage|amniotic fluid leakage
5255765|NCT00604838|urinary incontinence|urinary incontinence
5255766|NCT00604838|pregnancy|pregnancy
5255767|NCT00604838|home test|home test
5255768|NCT00604838|vaginal wetness|vaginal wetness
5255769|NCT00604825|menopause|menopause
5255770|NCT00604825|hormone therapy|hormone therapy
5255771|NCT00604825|hot flashes|hot flashes
5255772|NCT00604825|vasomotor symptoms|vasomotor symptoms
5255773|NCT00604786|Basophils|basophils
5255774|NCT00604786|Mast Cells|mast cells
5255775|NCT00604786|IgE|ige
5255776|NCT00604786|IgE receptors|ige receptors
5255777|NCT00604786|omalizumab|omalizumab
5255778|NCT00604773|delirium|delirium
5255779|NCT00604773|critical care|critical care
5255780|NCT00604773|risk factors|risk factors
5255781|NCT00604773|prediction|prediction
5255782|NCT00604747|motor learning|motor learning
5255783|NCT00604747|hemiplegia|hemiplegia
5255784|NCT00604747|stroke|stroke
5255785|NCT00604747|practice|practice
5255786|NCT00604747|physiotherapy|physiotherapy
5255787|NCT00604695|ST-Elevation Myocardial Infarction|st-elevation myocardial infarction
5255788|NCT00604695|Acute Myocardial Infarction|acute myocardial infarction
5255789|NCT00604695|No Reflow|no reflow
5255790|NCT00604682|psoriasis|psoriasis
5255791|NCT00604669|Diabetes|diabetes
5255792|NCT00604669|Nutrition/Dietics|nutrition/dietics
5255793|NCT00604669|clinical outcomes|clinical outcomes
5255794|NCT00604669|total parenteral nutrition|total parenteral nutrition
5255795|NCT00604643|Abdominal Aneurysm|abdominal aneurysm
5255796|NCT00604643|Endovascular Aortic Repair (EVAR)|endovascular aortic repair (evar)
5255797|NCT00604643|Endovascular Stent Graft|endovascular stent graft
5255798|NCT00604643|Endograft|endograft
5255799|NCT00604630|stroke|stroke
5255800|NCT00604630|EPO|epo
5255801|NCT00604630|erythropoietin|erythropoietin
5255802|NCT00604630|ischemia|ischemia
5255803|NCT00604630|hypoxia|hypoxia
5255804|NCT00604630|antiapoptosis|antiapoptosis
5255805|NCT00604630|neuroprotection|neuroprotection
5255806|NCT00604630|rtPA|rtpa
5255807|NCT00604630|thrombolysis|thrombolysis
5255808|NCT00604630|stroke, middle cerebral artery|stroke, middle cerebral artery
5255809|NCT00604630|Ischemic stroke in the middle cerebral artery territory|ischemic stroke in the middle cerebral artery territory
5255810|NCT00604617|Mycobacterium tuberculosis|mycobacterium tuberculosis
5255811|NCT00604617|Tuberculin Test|tuberculin test
5255812|NCT00604617|South Africa|south africa
5255813|NCT00604591|Dementia Treatment|dementia treatment
5255814|NCT00604591|Frontotemporal Dementia|frontotemporal dementia
5255815|NCT00604591|Dopamine|dopamine
5255816|NCT00604591|Frontotemporal Lobar Degeneration|frontotemporal lobar degeneration
5255817|NCT00604578|Pioglitazone|pioglitazone
5255818|NCT00604578|Asthma|asthma
5255819|NCT00604578|Peroxisome Proliferator-Advanced Receptor Gamma|peroxisome proliferator-advanced receptor gamma
5255820|NCT00604578|Airflow Obstruction|airflow obstruction
5255821|NCT00604578|Airway Inflammation|airway inflammation
5255822|NCT00604565|Hemodialysis|hemodialysis
5255823|NCT00604552|Abdominal Aneurysm|abdominal aneurysm
5255824|NCT00604552|Endovascular Aortic Repair (EVAR)|endovascular aortic repair (evar)
5255825|NCT00604552|Endovascular Stent Graft|endovascular stent graft
5255826|NCT00604552|Endograft|endograft
5255827|NCT00604539|Chondroitin sulphate|chondroitin sulphate
5255828|NCT00604539|Synovitis|synovitis
5255829|NCT00604539|Knee osteoarthritis|knee osteoarthritis
5255830|NCT00604539|Magnetic Resonance Imaging|magnetic resonance imaging
5255832|NCT00604487|induction|induction
5255833|NCT00604487|cervix|cervix
5255834|NCT00604487|balloon|balloon
5255835|NCT00604487|Bishop|bishop
5255836|NCT00604474|Deafness|deafness
5255837|NCT00604474|Hearing Loss|hearing loss
5255838|NCT00604474|Cochlear Implants|cochlear implants
5255839|NCT00604474|Advanced Bionics|advanced bionics
5255840|NCT00604474|HiResolution Bionic Ear System|hiresolution bionic ear system
5255841|NCT00604461|Carboplatin|carboplatin
5255842|NCT00604461|Bevacizumab|bevacizumab
5255843|NCT00604461|Avastin|avastin
5255844|NCT00604461|Pemetrexed|pemetrexed
5255845|NCT00604461|Alimta|alimta
5255846|NCT00604448|pulses|pulses
5255847|NCT00604448|beans|beans
5255848|NCT00604448|obesity|obesity
5255849|NCT00604448|overweight|overweight
5255850|NCT00604448|metabolic syndrome|metabolic syndrome
5255851|NCT00604435|breast cancer|breast cancer
5255852|NCT00604435|neoadjuvant chemotherapy|neoadjuvant chemotherapy
5255853|NCT00604435|docetaxel|docetaxel
5255854|NCT00604435|epirubicin|epirubicin
5255855|NCT00604435|recombinant human endostatin (endostar)|recombinant human endostatin (endostar)
5255856|NCT00604435|chemotherapy|chemotherapy
5255857|NCT00604435|endostatin|endostatin
5255858|NCT00604422|Colonic disease|colonic disease
5255859|NCT00604422|Ulcerative colitis|ulcerative colitis
5255860|NCT00604422|suspected or known colonic disease|suspected or known colonic disease
5255861|NCT00604357|CNI free|cni free
5255862|NCT00604357|mTOR inhibition|mtor inhibition
5255863|NCT00604357|induction|induction
5255864|NCT00604357|IL2 receptor antibodies|il2 receptor antibodies
5255865|NCT00604357|renal function|renal function
5255866|NCT00604357|liver transplantation|liver transplantation
5255867|NCT00604331|Pyruvic Acid|pyruvic acid
5255868|NCT00604331|Shock, Cardiogenic|shock, cardiogenic
5255869|NCT00604331|Catecholamines|catecholamines
5255870|NCT00604331|Intra-Aortic Balloon Pumping|intra-aortic balloon pumping
5255871|NCT00604331|Cardiac Output|cardiac output
5255872|NCT00604331|Cardiac Index|cardiac index
5255873|NCT00604331|Cardiac Function|cardiac function
5255874|NCT00604318|quality of life|quality of life
5255875|NCT00604292|Colonic Diseases|colonic diseases
5255876|NCT00604279|Schizophrenia|schizophrenia
5255877|NCT00604279|Paliperidone|paliperidone
5255878|NCT00604279|Paliperidone palmitate|paliperidone palmitate
5255879|NCT00604279|Risperidone|risperidone
5255880|NCT00604279|Risperidone long acting injection|risperidone long acting injection
5255881|NCT00604279|R092670|r092670
5255882|NCT00604266|Potentially resectable hilar cholangiocarcinoma as per initial imaging studies.|potentially resectable hilar cholangiocarcinoma as per initial imaging studies.
5255883|NCT00604266|Able to undergo PET/CT and MRI with Gadolinium|able to undergo pet/ct and mri with gadolinium
5255884|NCT00604240|NICU|nicu
5255885|NCT00604240|caregivers|caregivers
5255886|NCT00604240|discharge instructions|discharge instructions
5255887|NCT00604227|high altitude pulmonary edema|high altitude pulmonary edema
5255888|NCT00604227|pulmonary interstitial fluid|pulmonary interstitial fluid
5255889|NCT00604227|pulmonary function testing|pulmonary function testing
5255890|NCT00604227|hypoxia|hypoxia
5255891|NCT00604227|pulmonary endothelial function|pulmonary endothelial function
5255892|NCT00604227|high altitude exposure without prior acclimatization|high altitude exposure without prior acclimatization
5255893|NCT00604214|Sepsis|sepsis
5255894|NCT00604214|Septic shock|septic shock
5255895|NCT00604201|Myelodyplastic Syndrome (MDS)|myelodyplastic syndrome (mds)
5255896|NCT00604201|Severe Aplastic Anemia (SAA)|severe aplastic anemia (saa)
5255897|NCT00604201|Stem Cell Transplant|stem cell transplant
5255898|NCT00604201|Haploidentical Stem Cells|haploidentical stem cells
5255899|NCT00604201|Umbilical Cord Blood|umbilical cord blood
5255900|NCT00604201|Severe Aplastic Anemia|severe aplastic anemia
5255901|NCT00604201|Myelodysplastic Syndrome|myelodysplastic syndrome
5255903|NCT00604175|HIV|hiv
5255904|NCT00604175|HPV 6|hpv 6
5255905|NCT00604175|HPV 11|hpv 11
5255906|NCT00604175|HPV 16|hpv 16
5255907|NCT00604175|HPV 18|hpv 18
5255908|NCT00604175|Vaccine|vaccine
5255909|NCT00604162|Suspected colonic disease|suspected colonic disease
5255910|NCT00604162|Known colonic disease|known colonic disease
5255911|NCT00604136|melanoma|melanoma
5255912|NCT00604136|tumor infiltrating lymphocytes|tumor infiltrating lymphocytes
5255913|NCT00604136|interleukin-2|interleukin-2
5255914|NCT00604123|JNJ-17166864|jnj-17166864
5255915|NCT00604123|allergic rhinitis|allergic rhinitis
5255916|NCT00604123|pharmacokinetics|pharmacokinetics
5255917|NCT00604123|biomarkers|biomarkers
5255918|NCT00604123|rhinitis symptoms|rhinitis symptoms
5255919|NCT00604123|mountain cedar pollen|mountain cedar pollen
5255920|NCT00604110|Biventricular pacing|biventricular pacing
5255921|NCT00604110|resynchronisation therapy|resynchronisation therapy
5255922|NCT00604110|cardiac surgery|cardiac surgery
5255923|NCT00604110|ejection fraction of less 45%|ejection fraction of less 45%
5255924|NCT00604097|youth suicide|youth suicide
5255925|NCT00604097|family therapy|family therapy
5255926|NCT00604097|primary care|primary care
5255927|NCT00604097|intervention|intervention
5255928|NCT00604084|Scabies|scabies
5255929|NCT00604084|Ivermectin|ivermectin
5255930|NCT00604084|Lindane|lindane
5255931|NCT00604084|Mass Eradication|mass eradication
5255932|NCT00604071|HMP, CNV, PHP, HPHP, AMD|hmp, cnv, php, hphp, amd
5255933|NCT00604058|Poliomyelitis|poliomyelitis
5255934|NCT00604058|intradermal|intradermal
5255935|NCT00604045|post traumatic stress disorder|post traumatic stress disorder
5255936|NCT00604045|cognitive bias|cognitive bias
5255937|NCT00604045|attention|attention
5255938|NCT00604045|combat|combat
5255939|NCT00604045|neuroimaging|neuroimaging
5255940|NCT00604032|Safety when exposed to sunlight|safety when exposed to sunlight
5255941|NCT00604019|sepsis|sepsis
5255942|NCT00604019|septic shock|septic shock
5255943|NCT00604006|Prevention of heart failure in individuals at high risk|prevention of heart failure in individuals at high risk
5255944|NCT00603993|Rheumatoid arthritis|rheumatoid arthritis
5255945|NCT00603967|Breast Cancer|breast cancer
5255946|NCT00603967|Postmenopausal|postmenopausal
5255947|NCT00603967|Aromatase|aromatase
5255948|NCT00603954|Nonmyeloablative conditioning.|nonmyeloablative conditioning.
5255949|NCT00603954|Hematological malignancies.|hematological malignancies.
5255950|NCT00603954|GVHD.|gvhd.
5255951|NCT00603941|Anaplastic Thyroid Cancer|anaplastic thyroid cancer
5255952|NCT00603941|Neoplasm|neoplasm
5255953|NCT00603941|Tumor|tumor
5255954|NCT00603941|Anti-neoplastic Agent|anti-neoplastic agent
5255955|NCT00603941|First-line treatment of advanced Anaplastic thyroid cancer|first-line treatment of advanced anaplastic thyroid cancer
5255956|NCT00603928|attitude|attitude
5255957|NCT00603928|attitude of health personnel|attitude of health personnel
5255958|NCT00603928|ethics|ethics
5255959|NCT00603928|bioethics|bioethics
5255960|NCT00603928|biomedical ethics|biomedical ethics
5255961|NCT00603928|patient care|patient care
5255962|NCT00603928|physicians|physicians
5255963|NCT00603928|placebo effect|placebo effect
5255964|NCT00603928|placebos|placebos
5255965|NCT00603928|questionnaires|questionnaires
5255966|NCT00603928|therapy|therapy
5255967|NCT00603928|general practice|general practice
5255968|NCT00603915|gemcitabine|gemcitabine
5255969|NCT00603915|carboplatin|carboplatin
5255970|NCT00603915|cisplatin|cisplatin
5255971|NCT00603915|erlotinib|erlotinib
5255972|NCT00603915|tarceva|tarceva
5255973|NCT00603915|nasopharyngeal|nasopharyngeal
5255974|NCT00603902|Obesity|obesity
5255975|NCT00603902|Weight loss|weight loss
5255976|NCT00603902|lorcaserin|lorcaserin
5255977|NCT00603902|APD356|apd356
5255978|NCT00603902|BLOSSOM|blossom
5255979|NCT00603902|Hypertension|hypertension
5255980|NCT00603902|Dyslipidemia|dyslipidemia
5255981|NCT00603902|Sleep apnea|sleep apnea
5255982|NCT00603902|glucose tolerance|glucose tolerance
5255983|NCT00603902|cardiovascular disease|cardiovascular disease
5255984|NCT00603902|Arena|arena
5255985|NCT00603889|Hookworm|hookworm
5255986|NCT00603889|Allergy|allergy
5255987|NCT00603889|Vaccine|vaccine
5255988|NCT00603889|Skin test|skin test
5255989|NCT00603863|pancreatic cancer|pancreatic cancer
5255990|NCT00603863|hPAM4|hpam4
5255991|NCT00603863|MUC1 antibody|muc1 antibody
5255992|NCT00603863|cancer of the pancreas|cancer of the pancreas
5255993|NCT00603850|HMP, PHP, AMD, CNV, HPHP|hmp, php, amd, cnv, hphp
5255994|NCT00603837|Hypothermia|hypothermia
5255995|NCT00603837|Prevention|prevention
5255996|NCT00603837|ELGANs(Extremely low gestational age neonates)|elgans(extremely low gestational age neonates)
5255997|NCT00603837|Polyethylene Wrap|polyethylene wrap
5255998|NCT00603837|Sodium Acetate Transport Mattress|sodium acetate transport mattress
5255999|NCT00603824|heparin-Induced thrombocytopenia|heparin-induced thrombocytopenia
5256000|NCT00603824|fondaparinux|fondaparinux
5256001|NCT00603811|Influenza vaccines|influenza vaccines
5256002|NCT00603811|M2e|m2e
5256003|NCT00603798|Actinic keratosis|actinic keratosis
5256004|NCT00603798|Dermatologic disease|dermatologic disease
5256005|NCT00603785|Chronic sinusitis|chronic sinusitis
5256006|NCT00603785|Xolair|xolair
5256007|NCT00603785|Nasal Discharge|nasal discharge
5256008|NCT00603785|Nasal Obstruction|nasal obstruction
5256009|NCT00603785|Facial Pain|facial pain
5256010|NCT00603785|Hyposmia|hyposmia
5256011|NCT00603772|Tretinoin|tretinoin
5256012|NCT00603772|exposure to UV light|exposure to uv light
5256013|NCT00603772|phototoxicity|phototoxicity
5256014|NCT00603772|Safety when exposed to sunlight|safety when exposed to sunlight
5256015|NCT00603759|COX2 inhibitor|cox2 inhibitor
5256016|NCT00603759|head and neck cancer|head and neck cancer
5256017|NCT00603759|chemoradiation|chemoradiation
5256018|NCT00603746|Adolescents|adolescents
5256019|NCT00603746|Adults|adults
5256020|NCT00603746|Asthma|asthma
5256021|NCT00603746|Pharmacokinetics|pharmacokinetics
5256022|NCT00603746|Pharmacogenetics|pharmacogenetics
5256023|NCT00603746|GW685698X|gw685698x
5256024|NCT00603733|Ulcerative Colitis|ulcerative colitis
5256025|NCT00603733|5-Aminosalicylate|5-aminosalicylate
5256026|NCT00603720|PET|pet
5256027|NCT00603720|Heart metabolism|heart metabolism
5256028|NCT00603720|Nitric oxide|nitric oxide
5256029|NCT00603720|Myocardial remodeling|myocardial remodeling
5256030|NCT00603707|capsule|capsule
5256031|NCT00603707|constipation|constipation
5256032|NCT00603707|whole gut transit|whole gut transit
5256033|NCT00603707|colonic transit|colonic transit
5256034|NCT00603707|gastric emptying|gastric emptying
5256035|NCT00603707|small bowel transit|small bowel transit
5256036|NCT00603694|Hippocampus|hippocampus
5256037|NCT00603694|Memory|memory
5256038|NCT00603694|Radiation|radiation
5256039|NCT00603681|constipation|constipation
5256040|NCT00603681|aged|aged
5256041|NCT00603681|polyethylene glycol|polyethylene glycol
5256042|NCT00603668|CLL|cll
5256043|NCT00603655|Diet|diet
5256044|NCT00603655|glycemic load|glycemic load
5256045|NCT00603655|overweight|overweight
5256046|NCT00603655|obesity|obesity
5256047|NCT00603655|hyperlipidemia|hyperlipidemia
5256048|NCT00603642|AMG 531|amg 531
5256049|NCT00603642|Idiopathic Thrombocytopenic Purpura|idiopathic thrombocytopenic purpura
5256050|NCT00603642|ITP|itp
5256051|NCT00603642|Thrombocytopenia|thrombocytopenia
5256052|NCT00603642|Japan|japan
5256053|NCT00603642|Placebo controlled|placebo controlled
5256054|NCT00603642|Phase 3|phase 3
5256055|NCT00603629|Acute Asthma|acute asthma
5256056|NCT00603616|Inflammatory Bowel Disease|inflammatory bowel disease
5256057|NCT00603616|Crohn disease|crohn disease
5256058|NCT00603616|Crohn's disease|crohn's disease
5256059|NCT00603616|Rifaximin|rifaximin
5256060|NCT00603603|C-section|c-section
5256061|NCT00603603|Surg Wound Infect|surg wound infect
5256062|NCT00603590|Cardiovascular disease|cardiovascular disease
5256063|NCT00603590|primary prevention|primary prevention
5256064|NCT00603590|Polypill|polypill
5256065|NCT00603590|efficacy|efficacy
5256066|NCT00603590|safety|safety
5256067|NCT00603590|ADR|adr
5256068|NCT00603590|Diabetes|diabetes
5256069|NCT00603590|Adherence|adherence
5256070|NCT00603590|Compliance|compliance
5256071|NCT00603564|CPAP|cpap
5256072|NCT00603564|community-acquired pneumonia|community-acquired pneumonia
5256073|NCT00603564|acute respiratory failure|acute respiratory failure
5256074|NCT00603564|hypoxemia|hypoxemia
5256075|NCT00603564|Continuous Positive Airway Pressure|continuous positive airway pressure
5256076|NCT00603551|Osteoporosis|osteoporosis
5256077|NCT00603551|Cancer|cancer
5256078|NCT00603551|Chemotherapy|chemotherapy
5256079|NCT00603551|Bone Density|bone density
5256080|NCT00603551|DXA Scan|dxa scan
5256081|NCT00603551|Heel Scan|heel scan
5256082|NCT00603538|CP-751,871, Non-small cell lung cancer, Phase 1|cp-751,871, non-small cell lung cancer, phase 1
5256083|NCT00603512|Phase II MTX add-on study in Japan|phase ii mtx add-on study in japan
5256084|NCT00603499|Diabetes|diabetes
5256085|NCT00603499|Hypertension|hypertension
5256086|NCT00603499|Hypomagnesemia|hypomagnesemia
5256087|NCT00603486|Non-invasive Blood Pressure (NIBP)|non-invasive blood pressure (nibp)
5256088|NCT00603486|GE Dinamap|ge dinamap
5256089|NCT00603486|SuperSTAT|superstat
5256090|NCT00603460|Ovarian Cancer|ovarian cancer
5256091|NCT00603460|Peritoneal Cancer|peritoneal cancer
5256092|NCT00603434|Methamphetamine|methamphetamine
5256093|NCT00603421|borderline personality disorder|borderline personality disorder
5256094|NCT00603421|suicide|suicide
5256095|NCT00603421|suicidality|suicidality
5256096|NCT00603421|suicide attempt|suicide attempt
5256097|NCT00603421|suicidal behavior|suicidal behavior
5256098|NCT00603421|self-injurious behavior|self-injurious behavior
5256099|NCT00603421|self-harm behavior|self-harm behavior
5256100|NCT00603421|suicide prevention center|suicide prevention center
5256101|NCT00603421|telephone intervention|telephone intervention
5256102|NCT00603408|Breast Cancer|breast cancer
5256103|NCT00603408|Locally Advanced|locally advanced
5256104|NCT00603408|Neoadjuvant|neoadjuvant
5256105|NCT00603382|Adults|adults
5256106|NCT00603382|Pharmacokinetics|pharmacokinetics
5256107|NCT00603382|Pharmacogenetics|pharmacogenetics
5256108|NCT00603382|Asthma|asthma
5256109|NCT00603382|Adolescents|adolescents
5256110|NCT00603382|GW685698X|gw685698x
5256111|NCT00603369|HIV prevention|hiv prevention
5256112|NCT00603369|HIV seronegativity|hiv seronegativity
5256113|NCT00603356|GIST|gist
5256114|NCT00603356|Ovarian Cancer|ovarian cancer
5256115|NCT00603356|Mesothelioma|mesothelioma
5256116|NCT00603356|Renal|renal
5256117|NCT00603356|Colorectal Cancer|colorectal cancer
5256118|NCT00603356|Sarcoma|sarcoma
5256119|NCT00603356|NSCLC|nsclc
5256120|NCT00603356|Cancer|cancer
5256121|NCT00603343|antimuscarinics|antimuscarinics
5256122|NCT00603343|children|children
5256123|NCT00603343|overactive bladder|overactive bladder
5256124|NCT00603343|propiverine|propiverine
5256125|NCT00603343|urinary incontinence|urinary incontinence
5256126|NCT00603343|urotherapy|urotherapy
5256127|NCT00603330|Mesenchymal stem cells|mesenchymal stem cells
5256128|NCT00603330|Graft-versus-host disease|graft-versus-host disease
5256129|NCT00603330|Poor graft function|poor graft function
5256130|NCT00603330|Chimerism|chimerism
5256131|NCT00603330|Hematopoietic cell transplantation recipients|hematopoietic cell transplantation recipients
5256132|NCT00603330|Low donor T-cell chimerism|low donor t-cell chimerism
5256133|NCT00603317|Warfarin|warfarin
5256134|NCT00603317|Drug interaction|drug interaction
5256135|NCT00603317|Pharmacogenetics|pharmacogenetics
5256136|NCT00603317|Amoxicillin|amoxicillin
5256137|NCT00603317|Clavulanic acid|clavulanic acid
5256138|NCT00603304|Serenoa repens|serenoa repens
5256139|NCT00603304|Urological symptoms|urological symptoms
5256140|NCT00603304|hyperplasia|hyperplasia
5256141|NCT00603304|BPH|bph
5256142|NCT00603291|obesity|obesity
5256143|NCT00603291|weight loss|weight loss
5256144|NCT00603291|lorcaserin|lorcaserin
5256145|NCT00603291|APD356|apd356
5256146|NCT00603291|BLOOM-DM|bloom-dm
5256147|NCT00603291|hypertension|hypertension
5256148|NCT00603291|dyslipidemia|dyslipidemia
5256149|NCT00603291|sleep apnea|sleep apnea
5256150|NCT00603291|glucose tolerance|glucose tolerance
5256151|NCT00603291|cardiovascular disease|cardiovascular disease
5256152|NCT00603291|Arena|arena
5256153|NCT00603278|Adolescents|adolescents
5256154|NCT00603278|Adults|adults
5256155|NCT00603278|Pharmacokinetics|pharmacokinetics
5256156|NCT00603278|Asthma|asthma
5256157|NCT00603278|GW685698X|gw685698x
5256158|NCT00603278|Pharmacogenetics|pharmacogenetics
5256159|NCT00603265|Diabetic Peripheral Neuropathy|diabetic peripheral neuropathy
5256160|NCT00603265|Neuropathic Pain|neuropathic pain
5256161|NCT00603252|combined hepatitis A and B vaccine|combined hepatitis a and b vaccine
5256162|NCT00603252|risk factors|risk factors
5256163|NCT00603239|diabetes|diabetes
5256164|NCT00603239|exenatide|exenatide
5256165|NCT00603239|metformin|metformin
5256166|NCT00603239|thiazolidinedione|thiazolidinedione
5256167|NCT00603239|Byetta|byetta
5256168|NCT00603239|Amylin|amylin
5256169|NCT00603239|Lilly|lilly
5256170|NCT00603226|Coronary slow flow phenomenon|coronary slow flow phenomenon
5256171|NCT00603226|Coronary angiography|coronary angiography
5256172|NCT00603226|Acute coronary syndrome|acute coronary syndrome
5256173|NCT00603226|Chest pain|chest pain
5256174|NCT00603226|Unstable angina|unstable angina
5256175|NCT00603213|Congestive Heart Failure|congestive heart failure
5256176|NCT00603213|Impedance|impedance
5256177|NCT00603213|Optivol Thoracid Fluid Status monitoring system|optivol thoracid fluid status monitoring system
5256178|NCT00603200|Quality of Life|quality of life
5256179|NCT00603187|Male Contraception|male contraception
5256180|NCT00603187|Acyline|acyline
5256181|NCT00603174|NAVA|nava
5256182|NCT00603174|mechanical ventilation|mechanical ventilation
5256183|NCT00603174|infants|infants
5256184|NCT00603174|pediatric intensive care|pediatric intensive care
5256185|NCT00603174|infant|infant
5256186|NCT00603148|Genetic Polymorphism|genetic polymorphism
5256187|NCT00603148|Integrin alpha2beta1|integrin alpha2beta1
5256188|NCT00603148|Phenotype|phenotype
5256189|NCT00603122|altitude illness|altitude illness
5256190|NCT00603122|hypoxia|hypoxia
5256191|NCT00603109|Body weight, fat mass, growth hormone, ghrelin|body weight, fat mass, growth hormone, ghrelin
5256192|NCT00603083|Hip Arthroplasty|hip arthroplasty
5256193|NCT00603083|Treatment Outcome|treatment outcome
5256194|NCT00603083|Local Anesthesia|local anesthesia
5256195|NCT00603070|Medication Errors|medication errors
5256196|NCT00603070|Adverse Drug Events|adverse drug events
5256197|NCT00603070|Patient Safety|patient safety
5256198|NCT00603070|Electronic Prescribing Systems|electronic prescribing systems
5256199|NCT00603070|Medication Reconciliation|medication reconciliation
5256200|NCT00603057|Non Small Cell Lung Cancer|non small cell lung cancer
5256201|NCT00603018|eating disorders|eating disorders
5256202|NCT00603018|anorexia nervosa|anorexia nervosa
5256203|NCT00603018|anorexia|anorexia
5256204|NCT00603018|PET|pet
5256205|NCT00603018|brain imaging|brain imaging
5256206|NCT00603018|serotonin|serotonin
5256207|NCT00603018|fMRI|fmri
5256208|NCT00603018|Prozac|prozac
5256209|NCT00603018|fluoxetine|fluoxetine
5256210|NCT00603005|Glaucoma|glaucoma
5256211|NCT00603005|Adherence|adherence
5256212|NCT00602992|3T MRI|3t mri
5256213|NCT00602992|Gamma Knife Radiosurgery|gamma knife radiosurgery
5256214|NCT00602979|endotracheal intubation|endotracheal intubation
5256215|NCT00602979|intubation|intubation
5256216|NCT00602979|laryngoscopy|laryngoscopy
5256217|NCT00602979|laryngoscope|laryngoscope
5256218|NCT00602979|surgery|surgery
5256219|NCT00602966|Oocyte cryopreservation|oocyte cryopreservation
5256220|NCT00602966|slow freeze|slow freeze
5256221|NCT00602966|vitrification|vitrification
5256222|NCT00602940|PCOS|pcos
5256223|NCT00602940|ovulation|ovulation
5256224|NCT00602940|hormones|hormones
5256225|NCT00602940|women|women
5256226|NCT00602927|Varenicline, Imaging, fMRI|varenicline, imaging, fmri
5256227|NCT00602914|MicronJet (microneedles)|micronjet (microneedles)
5256228|NCT00602914|Intradermal|intradermal
5256229|NCT00602862|Angiogenesis inhibitors|angiogenesis inhibitors
5256230|NCT00602836|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
5256231|NCT00602836|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
5256232|NCT00602836|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
5256233|NCT00602836|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5256234|NCT00602836|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5256235|NCT00602836|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
5256236|NCT00602836|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
5256237|NCT00602836|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
5256238|NCT00602836|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5256239|NCT00602836|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5256240|NCT00602758|AIDS|aids
5256241|NCT00602758|Adherence|adherence
5256242|NCT00602758|Antiretroviral Therapy|antiretroviral therapy
5256243|NCT00602758|HIV|hiv
5256244|NCT00602745|pancreatic cancer|pancreatic cancer
5256245|NCT00602732|Partner Abuse|partner abuse
5256246|NCT00602732|Preventive Intervention|preventive intervention
5256247|NCT00602732|Postpartum Depression|postpartum depression
5256248|NCT00602732|Postpartum PTSD|postpartum ptsd
5256249|NCT00602706|refractory multiple myeloma|refractory multiple myeloma
5256250|NCT00602706|stage I multiple myeloma|stage i multiple myeloma
5256251|NCT00602706|stage II multiple myeloma|stage ii multiple myeloma
5256252|NCT00602706|stage III multiple myeloma|stage iii multiple myeloma
5256253|NCT00602693|chronic myelogenous leukemia|chronic myelogenous leukemia
5256254|NCT00602693|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5256255|NCT00602693|prolymphocytic leukemia|prolymphocytic leukemia
5256256|NCT00602693|advanced chronic lymphocytic leukemia|advanced chronic lymphocytic leukemia
5256257|NCT00602693|small lymphocytic lymphoma|small lymphocytic lymphoma
5256258|NCT00602693|B-cell lymphoma|b-cell lymphoma
5256259|NCT00602693|follicular lymphoma|follicular lymphoma
5256260|NCT00602693|diffuse large cell lymphoma|diffuse large cell lymphoma
5256261|NCT00602693|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5256262|NCT00602693|Hodgkin lymphoma|hodgkin lymphoma
5256263|NCT00602693|multiple myeloma|multiple myeloma
5256264|NCT00602680|Alzheimer|alzheimer
5256265|NCT00602680|cognitive|cognitive
5256266|NCT00602667|untreated childhood medulloblastoma|untreated childhood medulloblastoma
5256267|NCT00602667|untreated childhood supratentorial primitive neuroectodermal tumor|untreated childhood supratentorial primitive neuroectodermal tumor
5256268|NCT00602667|untreated childhood pineoblastoma|untreated childhood pineoblastoma
5256269|NCT00602667|childhood atypical teratoid/rhabdoid tumor|childhood atypical teratoid/rhabdoid tumor
5256270|NCT00602667|childhood choroid plexus tumor|childhood choroid plexus tumor
5256271|NCT00602667|childhood high grade glioma|childhood high grade glioma
5256272|NCT00602667|newly diagnosed childhood ependymoma|newly diagnosed childhood ependymoma
5256273|NCT00602628|ductal breast carcinoma in situ|ductal breast carcinoma in situ
5256274|NCT00602628|invasive ductal breast carcinoma|invasive ductal breast carcinoma
5256275|NCT00602628|breast cancer in situ|breast cancer in situ
5256276|NCT00602628|stage I breast cancer|stage i breast cancer
5256277|NCT00602628|stage II breast cancer|stage ii breast cancer
5256278|NCT00602628|stage IIIA breast cancer|stage iiia breast cancer
5256279|NCT00602602|stage IV pancreatic cancer|stage iv pancreatic cancer
5256280|NCT00602602|recurrent pancreatic cancer|recurrent pancreatic cancer
5256281|NCT00602589|open-label|open-label
5256282|NCT00602589|randomized|randomized
5256283|NCT00602589|crossover|crossover
5256284|NCT00602589|bioequivalence|bioequivalence
5256285|NCT00602576|recurrent melanoma|recurrent melanoma
5256286|NCT00602576|stage III melanoma|stage iii melanoma
5256287|NCT00602576|stage IV melanoma|stage iv melanoma
5256288|NCT00602563|Generalized Anxiety Disorder|generalized anxiety disorder
5256289|NCT00602563|Information Processing|information processing
5256290|NCT00602550|HIV|hiv
5256291|NCT00602537|Bipolar Type II Disorder|bipolar type ii disorder
5256292|NCT00602537|Hypomania|hypomania
5256293|NCT00602537|Antidepressant|antidepressant
5256294|NCT00602537|Mood Stabilizer|mood stabilizer
5256295|NCT00602537|Venlafaxine|venlafaxine
5256296|NCT00602537|Lithium Carbonate|lithium carbonate
5256297|NCT00602537|Major Depressive Episode|major depressive episode
5256298|NCT00602537|Hypomanic Episodes|hypomanic episodes
5256299|NCT00602537|Prevention of Depression Relapse|prevention of depression relapse
5256300|NCT00602511|Melfalan refractory multiple myeloma|melfalan refractory multiple myeloma
5256301|NCT00602511|Multiple myeloma|multiple myeloma
5256302|NCT00602511|Relapsing|relapsing
5256303|NCT00602511|Refractory|refractory
5256304|NCT00602511|Thalidomide|thalidomide
5256305|NCT00602511|Bortezomib|bortezomib
5256306|NCT00602511|Randomized clinical trial|randomized clinical trial
5256307|NCT00602485|adherence, cardiac rehabilitation|adherence, cardiac rehabilitation
5256308|NCT00602446|iron overload|iron overload
5256309|NCT00602433|advanced nonsmall cell lung cancer|advanced nonsmall cell lung cancer
5256310|NCT00602420|pain|pain
5256311|NCT00602420|musculoskeletal complications|musculoskeletal complications
5256312|NCT00602420|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5256313|NCT00602368|cervical cancer|cervical cancer
5256314|NCT00602368|cervical intraepithelial neoplasia grade 1|cervical intraepithelial neoplasia grade 1
5256315|NCT00602368|cervical intraepithelial neoplasia grade 2|cervical intraepithelial neoplasia grade 2
5256316|NCT00602368|cervical intraepithelial neoplasia grade 3|cervical intraepithelial neoplasia grade 3
5256317|NCT00602355|Postpartum|postpartum
5256318|NCT00602355|Depression|depression
5256319|NCT00602355|Medication Therapy|medication therapy
5256320|NCT00602355|Zoloft|zoloft
5256321|NCT00602355|Sertraline|sertraline
5256322|NCT00602355|Interpersonal Psychotherapy|interpersonal psychotherapy
5256323|NCT00602329|recurrent colon cancer|recurrent colon cancer
5256324|NCT00602329|recurrent rectal cancer|recurrent rectal cancer
5256325|NCT00602329|stage III colon cancer|stage iii colon cancer
5256326|NCT00602329|stage III rectal cancer|stage iii rectal cancer
5256327|NCT00602329|stage IV colon cancer|stage iv colon cancer
5256328|NCT00602329|stage IV rectal cancer|stage iv rectal cancer
5256329|NCT00602329|adenocarcinoma of the colon|adenocarcinoma of the colon
5256330|NCT00602329|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5256331|NCT00602316|invasive ductal breast carcinoma|invasive ductal breast carcinoma
5256332|NCT00602316|stage IA breast cancer|stage ia breast cancer
5256333|NCT00602316|stage IB breast cancer|stage ib breast cancer
5256334|NCT00602316|stage II breast cancer|stage ii breast cancer
5256335|NCT00602316|stage IIIA breast cancer|stage iiia breast cancer
5256336|NCT00602290|Major Depression|major depression
5256337|NCT00602290|Geriatric Major Unipolar Depression|geriatric major unipolar depression
5256338|NCT00602290|Executive Cognitive Dysfunction|executive cognitive dysfunction
5256339|NCT00602290|Elderly|elderly
5256340|NCT00602290|Geriatric|geriatric
5256341|NCT00602290|Executive Cognitive Impairment|executive cognitive impairment
5256342|NCT00602290|Quality of Life|quality of life
5256343|NCT00602290|Disability|disability
5256344|NCT00602290|Comorbidity|comorbidity
5256345|NCT00602290|Medical Burden|medical burden
5256346|NCT00602290|Safety|safety
5256347|NCT00602290|Candidate Genes|candidate genes
5256348|NCT00602264|Anorexia nervosa|anorexia nervosa
5256349|NCT00602264|Adipokines|adipokines
5256350|NCT00602264|Ghrelin|ghrelin
5256351|NCT00602264|Fat mass|fat mass
5256352|NCT00602212|generalized anxiety disorder (GAD)|generalized anxiety disorder (gad)
5256353|NCT00602199|stage IV melanoma|stage iv melanoma
5256354|NCT00602186|female voiding dysfunction|female voiding dysfunction
5256355|NCT00602186|Tamsolusin|tamsolusin
5256356|NCT00602186|prazosin|prazosin
5256357|NCT00602160|Food allergy|food allergy
5256358|NCT00602160|Chinese Herbs|chinese herbs
5256359|NCT00602160|Investigational new drug|investigational new drug
5256360|NCT00602160|Herbs|herbs
5256361|NCT00602160|Therapeutic medicine|therapeutic medicine
5256362|NCT00602160|Traditional Chinese medicine|traditional chinese medicine
5256363|NCT00602147|mucositis|mucositis
5256364|NCT00602147|stage I multiple myeloma|stage i multiple myeloma
5256365|NCT00602147|stage II multiple myeloma|stage ii multiple myeloma
5256366|NCT00602147|stage III multiple myeloma|stage iii multiple myeloma
5256367|NCT00602147|refractory multiple myeloma|refractory multiple myeloma
5256368|NCT00602108|stage I breast cancer|stage i breast cancer
5256369|NCT00602108|stage II breast cancer|stage ii breast cancer
5256370|NCT00602095|Labor induction|labor induction
5256371|NCT00602095|cervical ripening|cervical ripening
5256372|NCT00602095|misoprostol|misoprostol
5256373|NCT00602095|dinoprostone|dinoprostone
5256374|NCT00602095|balloon catheter|balloon catheter
5256375|NCT00602095|prostaglandin|prostaglandin
5256376|NCT00602082|pancreatic alpha cell adenoma|pancreatic alpha cell adenoma
5256377|NCT00602082|pancreatic alpha cell carcinoma|pancreatic alpha cell carcinoma
5256378|NCT00602082|pancreatic beta islet cell adenoma|pancreatic beta islet cell adenoma
5256379|NCT00602082|pancreatic beta islet cell carcinoma|pancreatic beta islet cell carcinoma
5256380|NCT00602082|pancreatic delta cell adenoma|pancreatic delta cell adenoma
5256381|NCT00602082|pancreatic delta cell carcinoma|pancreatic delta cell carcinoma
5256382|NCT00602082|pancreatic G-cell adenoma|pancreatic g-cell adenoma
5256383|NCT00602082|pancreatic G-cell carcinoma|pancreatic g-cell carcinoma
5256384|NCT00602082|gastrinoma|gastrinoma
5256385|NCT00602082|insulinoma|insulinoma
5256386|NCT00602082|glucagonoma|glucagonoma
5256387|NCT00602082|pancreatic polypeptide tumor|pancreatic polypeptide tumor
5256388|NCT00602082|somatostatinoma|somatostatinoma
5256389|NCT00602082|metastatic gastrointestinal carcinoid tumor|metastatic gastrointestinal carcinoid tumor
5256390|NCT00602082|recurrent gastrointestinal carcinoid tumor|recurrent gastrointestinal carcinoid tumor
5256391|NCT00602082|regional gastrointestinal carcinoid tumor|regional gastrointestinal carcinoid tumor
5256392|NCT00602082|islet cell carcinoma|islet cell carcinoma
5256393|NCT00602082|recurrent islet cell carcinoma|recurrent islet cell carcinoma
5256394|NCT00602069|PTSD|ptsd
5256395|NCT00602069|Intimate Partner Violence|intimate partner violence
5256396|NCT00602069|Cognitive Behavioral Therapy|cognitive behavioral therapy
5256397|NCT00602069|Empowerment|empowerment
5256398|NCT00602056|Immunization dropout|immunization dropout
5256399|NCT00602056|Immunization card|immunization card
5256400|NCT00602056|Center based education|center based education
5256401|NCT00602030|lung cancer|lung cancer
5256402|NCT00602030|NSCLC|nsclc
5256403|NCT00602030|lung neoplasms|lung neoplasms
5256404|NCT00602030|respiratory|respiratory
5256405|NCT00602004|Arteriovenous fistula|arteriovenous fistula
5256406|NCT00602004|hypertrophy|hypertrophy
5256407|NCT00602004|losartan|losartan
5256408|NCT00601991|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
5256409|NCT00601991|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5256410|NCT00601978|Parkinson's disease|parkinson's disease
5256411|NCT00601978|carbidopa/levodopa/entacapone|carbidopa/levodopa/entacapone
5256412|NCT00601978|carbidopa/levodopa|carbidopa/levodopa
5256413|NCT00601978|non-motor symptoms|non-motor symptoms
5256414|NCT00601978|event-related potential|event-related potential
5256415|NCT00601978|ERP|erp
5256416|NCT00601978|EEG|eeg
5256417|NCT00601978|electroencephalogram|electroencephalogram
5256418|NCT00601952|post traumatic stress disorder|post traumatic stress disorder
5256419|NCT00601952|cognitive bias|cognitive bias
5256420|NCT00601952|attention|attention
5256421|NCT00601952|combat|combat
5256422|NCT00601939|Abused|abused
5256423|NCT00601939|Female|female
5256424|NCT00601939|African American|african american
5256425|NCT00601939|Group Empowerment Psychoeducational Intervention|group empowerment psychoeducational intervention
5256426|NCT00601939|Enhanced Treatment as Usual|enhanced treatment as usual
5256427|NCT00601926|papillary renal cell carcinoma|papillary renal cell carcinoma
5256428|NCT00601926|stage III renal cell cancer|stage iii renal cell cancer
5256429|NCT00601926|stage IV renal cell cancer|stage iv renal cell cancer
5256430|NCT00601913|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
5256431|NCT00601913|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
5256432|NCT00601913|stage I squamous cell carcinoma of the larynx|stage i squamous cell carcinoma of the larynx
5256433|NCT00601913|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
5256434|NCT00601913|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
5256435|NCT00601913|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
5256436|NCT00601913|stage I squamous cell carcinoma of the hypopharynx|stage i squamous cell carcinoma of the hypopharynx
5256437|NCT00601913|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
5256438|NCT00601913|stage I verrucous carcinoma of the larynx|stage i verrucous carcinoma of the larynx
5256439|NCT00601913|stage I verrucous carcinoma of the oral cavity|stage i verrucous carcinoma of the oral cavity
5256440|NCT00601913|stage II verrucous carcinoma of the oral cavity|stage ii verrucous carcinoma of the oral cavity
5256441|NCT00601887|Anti-inflammatory|anti-inflammatory
5256442|NCT00601848|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5256443|NCT00601848|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5256444|NCT00601848|malignant pleural effusion|malignant pleural effusion
5256445|NCT00601835|Diphtheria|diphtheria
5256446|NCT00601835|Tetanus|tetanus
5256447|NCT00601809|Gastrointestinal|gastrointestinal
5256448|NCT00601809|Adhesive Small Intestine Obstruction|adhesive small intestine obstruction
5256449|NCT00601809|Oral water soluble contrast|oral water soluble contrast
5256450|NCT00601809|Non-operative Conservative Management|non-operative conservative management
5256451|NCT00601809|Operative rate|operative rate
5256452|NCT00601809|Hospital stay|hospital stay
5256453|NCT00601796|adenocarcinoma of the lung|adenocarcinoma of the lung
5256454|NCT00601796|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5256455|NCT00601757|Preventive Intervention|preventive intervention
5256456|NCT00601757|Postpartum Depression|postpartum depression
5256457|NCT00601757|Women on Public Assistance|women on public assistance
5256458|NCT00601744|Orbital Exenteration|orbital exenteration
5256459|NCT00601744|Eye Cancer|eye cancer
5256460|NCT00601744|Social-Psychological Aspects|social-psychological aspects
5256461|NCT00601744|Quality of Life|quality of life
5256462|NCT00601744|Questionnaire|questionnaire
5256463|NCT00601744|Facial Appearance|facial appearance
5256464|NCT00601744|Survey|survey
5256465|NCT00601744|Interview|interview
5256466|NCT00601731|Prevention of Meningococcal disease|prevention of meningococcal disease
5256467|NCT00601705|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
5256468|NCT00601705|adenocarcinoma of the stomach|adenocarcinoma of the stomach
5256469|NCT00601705|stage III esophageal cancer|stage iii esophageal cancer
5256470|NCT00601705|stage IV esophageal cancer|stage iv esophageal cancer
5256471|NCT00601705|stage III gastric cancer|stage iii gastric cancer
5256472|NCT00601705|stage IV gastric cancer|stage iv gastric cancer
5256473|NCT00601705|stage II esophageal cancer|stage ii esophageal cancer
5256474|NCT00601705|stage II gastric cancer|stage ii gastric cancer
5256475|NCT00601692|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
5256476|NCT00601692|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
5256477|NCT00601692|stage II esophageal cancer|stage ii esophageal cancer
5256478|NCT00601692|stage III esophageal cancer|stage iii esophageal cancer
5256479|NCT00601692|stage IV esophageal cancer|stage iv esophageal cancer
5256480|NCT00601679|CHF treatment&prognosis,NT-proBNP testing.|chf treatment&prognosis,nt-probnp testing.
5256481|NCT00601653|Binge Eating Disorder|binge eating disorder
5256482|NCT00601653|BED|bed
5256483|NCT00601653|Nutrition|nutrition
5256484|NCT00601653|Energy Density|energy density
5256485|NCT00601653|Cognitive Behavioral Therapy|cognitive behavioral therapy
5256486|NCT00601653|CBT|cbt
5256487|NCT00601640|skin cancer|skin cancer
5256488|NCT00601627|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
5256489|NCT00601627|stage II pancreatic cancer|stage ii pancreatic cancer
5256490|NCT00601627|stage III pancreatic cancer|stage iii pancreatic cancer
5256491|NCT00601614|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5256492|NCT00601601|stage 0 cervical cancer|stage 0 cervical cancer
5256493|NCT00601601|cervical intraepithelial neoplasia grade 1|cervical intraepithelial neoplasia grade 1
5256494|NCT00601601|cervical intraepithelial neoplasia grade 2|cervical intraepithelial neoplasia grade 2
5256495|NCT00601601|cervical intraepithelial neoplasia grade 3|cervical intraepithelial neoplasia grade 3
5256496|NCT00601562|HIV|hiv
5256497|NCT00601549|Rectal cancer|rectal cancer
5256498|NCT00601549|CCRT|ccrt
5256760|NCT00600691|Finasteride|finasteride
5256499|NCT00601549|Laparoscopic Surgery|laparoscopic surgery
5256500|NCT00601549|rectal cancer can be resected by curative and elective surgery|rectal cancer can be resected by curative and elective surgery
5256501|NCT00601549|rectal adenocarcinoma below peritoneal reflection|rectal adenocarcinoma below peritoneal reflection
5256502|NCT00601549|American Society of Anesthesiology（ASA） classⅠ to Ⅲ lesions|american society of anesthesiology（asa） classⅰ to ⅲ lesions
5256503|NCT00601510|stage III gastric cancer|stage iii gastric cancer
5256504|NCT00601510|stage IV gastric cancer|stage iv gastric cancer
5256505|NCT00601484|Painful Bladder Syndrome, monoclonal antibody|painful bladder syndrome, monoclonal antibody
5256506|NCT00601471|ankle sprain|ankle sprain
5256507|NCT00601471|ankle injuries|ankle injuries
5256508|NCT00601471|sprains and strains|sprains and strains
5256509|NCT00601458|Primary, unilateral, first metatarsal bunionectomy with osteotomy|primary, unilateral, first metatarsal bunionectomy with osteotomy
5256510|NCT00601445|Changes in sleep with aging|changes in sleep with aging
5256511|NCT00601432|open-label|open-label
5256512|NCT00601432|randomized|randomized
5256513|NCT00601432|crossover|crossover
5256514|NCT00601432|food effect|food effect
5256515|NCT00601406|male breast cancer|male breast cancer
5256516|NCT00601406|stage IA breast cancer|stage ia breast cancer
5256517|NCT00601406|stage IB breast cancer|stage ib breast cancer
5256518|NCT00601406|stage II breast cancer|stage ii breast cancer
5256519|NCT00601406|stage I prostate cancer|stage i prostate cancer
5256520|NCT00601406|stage IIB prostate cancer|stage iib prostate cancer
5256521|NCT00601406|stage IIA prostate cancer|stage iia prostate cancer
5256522|NCT00601406|stage III prostate cancer|stage iii prostate cancer
5256523|NCT00601406|stage IA cervical cancer|stage ia cervical cancer
5256524|NCT00601406|stage IB cervical cancer|stage ib cervical cancer
5256525|NCT00601406|stage IIA cervical cancer|stage iia cervical cancer
5256526|NCT00601406|stage IIB cervical cancer|stage iib cervical cancer
5256527|NCT00601406|stage III cervical cancer|stage iii cervical cancer
5256528|NCT00601406|stage IVA cervical cancer|stage iva cervical cancer
5256529|NCT00601406|stage IVB cervical cancer|stage ivb cervical cancer
5256530|NCT00601406|stage I vaginal cancer|stage i vaginal cancer
5256531|NCT00601406|stage II vaginal cancer|stage ii vaginal cancer
5256532|NCT00601406|stage III vaginal cancer|stage iii vaginal cancer
5256533|NCT00601406|stage IVA vaginal cancer|stage iva vaginal cancer
5256534|NCT00601406|stage IVB vaginal cancer|stage ivb vaginal cancer
5256535|NCT00601406|stage IA vulvar cancer|stage ia vulvar cancer
5256536|NCT00601406|stage IB vulvar cancer|stage ib vulvar cancer
5256537|NCT00601406|stage II vulvar cancer|stage ii vulvar cancer
5256538|NCT00601406|stage IIIC vulvar cancer|stage iiic vulvar cancer
5256539|NCT00601406|stage IIIA vulvar cancer|stage iiia vulvar cancer
5256540|NCT00601406|stage IIIB vulvar cancer|stage iiib vulvar cancer
5256541|NCT00601406|stage IVB vulvar cancer|stage ivb vulvar cancer
5256542|NCT00601406|stage IA ovarian epithelial cancer|stage ia ovarian epithelial cancer
5256543|NCT00601406|stage IB ovarian epithelial cancer|stage ib ovarian epithelial cancer
5256544|NCT00601406|stage IC ovarian epithelial cancer|stage ic ovarian epithelial cancer
5256545|NCT00601406|stage IA ovarian germ cell tumor|stage ia ovarian germ cell tumor
5256546|NCT00601406|stage IB ovarian germ cell tumor|stage ib ovarian germ cell tumor
5256547|NCT00601406|stage IC ovarian germ cell tumor|stage ic ovarian germ cell tumor
5256548|NCT00601406|stage IIA ovarian epithelial cancer|stage iia ovarian epithelial cancer
5256549|NCT00601406|stage IIB ovarian epithelial cancer|stage iib ovarian epithelial cancer
5256550|NCT00601406|stage IIC ovarian epithelial cancer|stage iic ovarian epithelial cancer
5256551|NCT00601406|stage IIA ovarian germ cell tumor|stage iia ovarian germ cell tumor
5256552|NCT00601406|stage IIB ovarian germ cell tumor|stage iib ovarian germ cell tumor
5256553|NCT00601406|stage IIC ovarian germ cell tumor|stage iic ovarian germ cell tumor
5256554|NCT00601406|stage IIIA ovarian epithelial cancer|stage iiia ovarian epithelial cancer
5256555|NCT00601406|stage IIIB ovarian epithelial cancer|stage iiib ovarian epithelial cancer
5256556|NCT00601406|stage IIIC ovarian epithelial cancer|stage iiic ovarian epithelial cancer
5256557|NCT00601406|stage IIIA ovarian germ cell tumor|stage iiia ovarian germ cell tumor
5256558|NCT00601406|stage IIIB ovarian germ cell tumor|stage iiib ovarian germ cell tumor
5256559|NCT00601406|stage IIIC ovarian germ cell tumor|stage iiic ovarian germ cell tumor
5256560|NCT00601406|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5256561|NCT00601406|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
5256562|NCT00601406|stage II endometrial carcinoma|stage ii endometrial carcinoma
5256563|NCT00601406|ovarian stromal cancer|ovarian stromal cancer
5256564|NCT00601406|ovarian sarcoma|ovarian sarcoma
5256565|NCT00601406|stage IA fallopian tube cancer|stage ia fallopian tube cancer
5256566|NCT00601406|stage IB fallopian tube cancer|stage ib fallopian tube cancer
5256567|NCT00601406|stage IC fallopian tube cancer|stage ic fallopian tube cancer
5256568|NCT00601406|stage IIA fallopian tube cancer|stage iia fallopian tube cancer
5256569|NCT00601406|stage IIB fallopian tube cancer|stage iib fallopian tube cancer
5256570|NCT00601406|stage IIC fallopian tube cancer|stage iic fallopian tube cancer
5256571|NCT00601406|stage IIIA fallopian tube cancer|stage iiia fallopian tube cancer
5256572|NCT00601406|stage IIIB fallopian tube cancer|stage iiib fallopian tube cancer
5256573|NCT00601406|stage IIIC fallopian tube cancer|stage iiic fallopian tube cancer
5256574|NCT00601406|stage IV fallopian tube cancer|stage iv fallopian tube cancer
5256662|NCT00601107|psoriasis vulgaris|psoriasis vulgaris
5256575|NCT00601406|recurrent primary peritoneal cavity cancer|recurrent primary peritoneal cavity cancer
5256576|NCT00601406|stage IA primary peritoneal cavity cancer|stage ia primary peritoneal cavity cancer
5256577|NCT00601406|stage IB primary peritoneal cavity cancer|stage ib primary peritoneal cavity cancer
5256578|NCT00601406|stage IC primary peritoneal cavity cancer|stage ic primary peritoneal cavity cancer
5256579|NCT00601406|stage IIA primary peritoneal cavity cancer|stage iia primary peritoneal cavity cancer
5256580|NCT00601406|stage IIB primary peritoneal cavity cancer|stage iib primary peritoneal cavity cancer
5256581|NCT00601406|stage IIC primary peritoneal cavity cancer|stage iic primary peritoneal cavity cancer
5256582|NCT00601406|stage IIIA primary peritoneal cavity cancer|stage iiia primary peritoneal cavity cancer
5256583|NCT00601406|stage IIIB primary peritoneal cavity cancer|stage iiib primary peritoneal cavity cancer
5256584|NCT00601406|stage IIIC primary peritoneal cavity cancer|stage iiic primary peritoneal cavity cancer
5256585|NCT00601406|stage IV primary peritoneal cavity cancer|stage iv primary peritoneal cavity cancer
5256586|NCT00601406|stage IA endometrial carcinoma|stage ia endometrial carcinoma
5256587|NCT00601406|stage IB endometrial carcinoma|stage ib endometrial carcinoma
5256588|NCT00601406|stage IIIA endometrial carcinoma|stage iiia endometrial carcinoma
5256589|NCT00601406|stage IIIB endometrial carcinoma|stage iiib endometrial carcinoma
5256590|NCT00601406|stage IIIC endometrial carcinoma|stage iiic endometrial carcinoma
5256591|NCT00601406|stage IVA endometrial carcinoma|stage iva endometrial carcinoma
5256592|NCT00601406|stage IVB endometrial carcinoma|stage ivb endometrial carcinoma
5256593|NCT00601406|stage IA uterine sarcoma|stage ia uterine sarcoma
5256594|NCT00601406|stage IB uterine sarcoma|stage ib uterine sarcoma
5256595|NCT00601406|stage IC uterine sarcoma|stage ic uterine sarcoma
5256596|NCT00601406|stage IIA uterine sarcoma|stage iia uterine sarcoma
5256597|NCT00601406|stage IIB uterine sarcoma|stage iib uterine sarcoma
5256598|NCT00601406|stage IIIA uterine sarcoma|stage iiia uterine sarcoma
5256599|NCT00601406|stage IIIB uterine sarcoma|stage iiib uterine sarcoma
5256600|NCT00601406|stage IIIC uterine sarcoma|stage iiic uterine sarcoma
5256601|NCT00601406|stage IVA uterine sarcoma|stage iva uterine sarcoma
5256602|NCT00601406|stage IVB uterine sarcoma|stage ivb uterine sarcoma
5256603|NCT00601354|Binge Eating|binge eating
5256604|NCT00601354|Orlistat|orlistat
5256605|NCT00601354|Alli|alli
5256606|NCT00601354|Guided Self-Help|guided self-help
5256607|NCT00601341|arthralgia|arthralgia
5256608|NCT00601341|joint pain|joint pain
5256609|NCT00601341|knee injuries|knee injuries
5256610|NCT00601341|knee joint|knee joint
5256611|NCT00601341|low back pain|low back pain
5256612|NCT00601289|pituitary chromophobe adenoma|pituitary chromophobe adenoma
5256613|NCT00601289|recurrent pituitary tumor|recurrent pituitary tumor
5256614|NCT00601289|ACTH-producing pituitary tumor|acth-producing pituitary tumor
5256615|NCT00601289|growth hormone-producing pituitary tumor|growth hormone-producing pituitary tumor
5256616|NCT00601289|prolactin-producing pituitary tumor|prolactin-producing pituitary tumor
5256617|NCT00601289|pituitary basophilic adenoma|pituitary basophilic adenoma
5256618|NCT00601289|pituitary eosinophilic adenoma|pituitary eosinophilic adenoma
5256619|NCT00601289|prolactin secreting adenoma|prolactin secreting adenoma
5256620|NCT00601289|nonfunctioning pituitary tumor|nonfunctioning pituitary tumor
5256621|NCT00601276|pedophilia|pedophilia
5256622|NCT00601276|antiandrogens|antiandrogens
5256623|NCT00601276|gonadotropin releasing hormone agonists|gonadotropin releasing hormone agonists
5256624|NCT00601263|Chinese Herbal Therapy|chinese herbal therapy
5256625|NCT00601263|Asthma|asthma
5256626|NCT00601263|Investigational new drug (IND)|investigational new drug (ind)
5256627|NCT00601263|Complementary and Alternative Medicine|complementary and alternative medicine
5256628|NCT00601237|HIV Prevention|hiv prevention
5256629|NCT00601237|Mobile Phone|mobile phone
5256630|NCT00601237|Technology-Based Intervention|technology-based intervention
5256632|NCT00601237|HIV Seronegativity|hiv seronegativity
5256633|NCT00601224|Social Cognition|social cognition
5256634|NCT00601224|Group Therapy|group therapy
5256635|NCT00601224|Psychosocial Intervention|psychosocial intervention
5256636|NCT00601198|Oxaliplatin-induced Neuropathy|oxaliplatin-induced neuropathy
5256637|NCT00601198|Colon and rectum|colon and rectum
5256638|NCT00601185|06-009|06-009
5256639|NCT00601185|Confocal reflectance microscopy|confocal reflectance microscopy
5256640|NCT00601185|shave-biopsy|shave-biopsy
5256641|NCT00601172|vomiting|vomiting
5256642|NCT00601172|colorectal cancer|colorectal cancer
5256643|NCT00601172|nausea|nausea
5256644|NCT00601172|oxaliplatin|oxaliplatin
5256645|NCT00601159|Metastatic Breast Cancer|metastatic breast cancer
5256646|NCT00601159|triple-negative Breast Cancer|triple-negative breast cancer
5256647|NCT00601159|cisplatin|cisplatin
5256648|NCT00601159|chemotherapy|chemotherapy
5256649|NCT00601146|Hodgkin's disease|hodgkin's disease
5256650|NCT00601146|CT scan|ct scan
5256651|NCT00601133|Solid Tumors|solid tumors
5256652|NCT00601133|Acute Inpatient Rehabilitation|acute inpatient rehabilitation
5256653|NCT00601133|Postural Instability|postural instability
5256654|NCT00601133|Balance|balance
5256655|NCT00601133|Function|function
5256656|NCT00601133|Walking|walking
5256657|NCT00601133|Questionnaire|questionnaire
5256658|NCT00601133|Survey|survey
5256659|NCT00601120|antiangiogenic therapy|antiangiogenic therapy
5256660|NCT00601120|RF ablation|rf ablation
5256661|NCT00601107|psoriasis|psoriasis
5256663|NCT00601107|plaque psoriasis|plaque psoriasis
5256664|NCT00601107|chronic plaque psoriasis|chronic plaque psoriasis
5256665|NCT00601094|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5256666|NCT00601094|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5256667|NCT00601094|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5256668|NCT00601081|Very low birth weight infants|very low birth weight infants
5256669|NCT00601081|HMF|hmf
5256670|NCT00601081|immune system function|immune system function
5256671|NCT00601068|osteonecrosis, jaws, bisphosphonate, fosamax, alendronate|osteonecrosis, jaws, bisphosphonate, fosamax, alendronate
5256672|NCT00601055|COPD|copd
5256673|NCT00601055|Geriatric Depression|geriatric depression
5256674|NCT00601055|Problem-Solving Therapy|problem-solving therapy
5256675|NCT00601055|Treatment Adherence|treatment adherence
5256676|NCT00601042|smoking reduction|smoking reduction
5256677|NCT00601042|smoking cessation|smoking cessation
5256678|NCT00601042|randomized trial|randomized trial
5256679|NCT00601042|Swedish snus|swedish snus
5256680|NCT00601042|smokeless tobacco|smokeless tobacco
5256681|NCT00601029|Exertional Rhabdomyolysis|exertional rhabdomyolysis
5256682|NCT00601016|Infantile hemangioma|infantile hemangioma
5256683|NCT00601016|Hemangioma|hemangioma
5256684|NCT00601016|Hemangioma of Infancy|hemangioma of infancy
5256685|NCT00601016|benign tumors of infancy|benign tumors of infancy
5256686|NCT00601016|Congenital hemangioma|congenital hemangioma
5256687|NCT00601016|Capillary|capillary
5256688|NCT00600990|post-operative nausea and vomiting|post-operative nausea and vomiting
5256689|NCT00600990|PONV|ponv
5256690|NCT00600977|ALL|all
5256691|NCT00600977|Chemotherapy|chemotherapy
5256692|NCT00600977|Pharmacokinetics of doxorubicin (pegylated or not)|pharmacokinetics of doxorubicin (pegylated or not)
5256693|NCT00600977|elderly ALL|elderly all
5256694|NCT00600964|CLL|cll
5256695|NCT00600964|obatoclax|obatoclax
5256696|NCT00600938|iron overload|iron overload
5256697|NCT00600938|cardiac iron|cardiac iron
5256698|NCT00600938|haemosiderosis|haemosiderosis
5256699|NCT00600938|myocardial T2*|myocardial t2*
5256700|NCT00600938|left ventricular ejection fraction|left ventricular ejection fraction
5256701|NCT00600938|LVEF|lvef
5256702|NCT00600938|cardiac dysfunction|cardiac dysfunction
5256703|NCT00600938|thalassaemia|thalassaemia
5256704|NCT00600938|Diamond Blackfan anemia|diamond blackfan anemia
5256705|NCT00600938|DBA|dba
5256706|NCT00600938|sideroblastic anemia|sideroblastic anemia
5256707|NCT00600938|myelodysplastic syndromes|myelodysplastic syndromes
5256708|NCT00600938|MDS (low and INT-1 risk as per the IPSS for MDS)|mds (low and int-1 risk as per the ipss for mds)
5256709|NCT00600938|liver MRI|liver mri
5256710|NCT00600938|deferasirox|deferasirox
5256711|NCT00600938|deferoxamine|deferoxamine
5256712|NCT00600938|ICL670|icl670
5256713|NCT00600938|DFO|dfo
5256714|NCT00600938|cardiovascular magnetic resonance imaging|cardiovascular magnetic resonance imaging
5256715|NCT00600925|Colorectal surgery|colorectal surgery
5256716|NCT00600912|lipid emulsion|lipid emulsion
5256717|NCT00600912|fish oil|fish oil
5256718|NCT00600912|parenteral nutrition|parenteral nutrition
5256719|NCT00600912|leucotriene LTB5|leucotriene ltb5
5256720|NCT00600912|hepatic function|hepatic function
5256721|NCT00600899|Postoperative pain treatment|postoperative pain treatment
5256722|NCT00600886|Acromegaly,|acromegaly,
5256723|NCT00600886|adult,|adult,
5256724|NCT00600886|growth hormone,|growth hormone,
5256725|NCT00600886|insulin-like growth factor I,|insulin-like growth factor i,
5256726|NCT00600886|somatostatin analogue|somatostatin analogue
5256727|NCT00600873|neuroprotection|neuroprotection
5256728|NCT00600873|oxidative stress|oxidative stress
5256729|NCT00600860|MDS (all IPSS subtypes)|mds (all ipss subtypes)
5256730|NCT00600860|Newly diagnosed|newly diagnosed
5256731|NCT00600847|urticaria|urticaria
5256732|NCT00600847|cold urticaria|cold urticaria
5256733|NCT00600847|acquired cold urticaria|acquired cold urticaria
5256734|NCT00600808|SR-hGH, Pharmacokinetics, Pharmacodynamics|sr-hgh, pharmacokinetics, pharmacodynamics
5256735|NCT00600795|NPH|nph
5256736|NCT00600795|TGF-beta|tgf-beta
5256737|NCT00600782|Tuberculosis vaccine|tuberculosis vaccine
5256738|NCT00600769|MAC|mac
5256739|NCT00600769|NTM|ntm
5256740|NCT00600756|schizophrenia|schizophrenia
5256741|NCT00600756|SWNK|swnk
5256742|NCT00600743|Eating|eating
5256743|NCT00600743|Food Intake|food intake
5256744|NCT00600743|Appetite|appetite
5256745|NCT00600730|fMRi|fmri
5256746|NCT00600730|hypoglycemia|hypoglycemia
5256747|NCT00600717|Magnetoencephalography(MEG)|magnetoencephalography(meg)
5256748|NCT00600717|Electroencephalography (EEG)|electroencephalography (eeg)
5256749|NCT00600717|Intracranial recordings (iEEG/ECoG/SEEG)|intracranial recordings (ieeg/ecog/seeg)
5256750|NCT00600717|Functional Mapping|functional mapping
5256751|NCT00600717|Epilepsy|epilepsy
5256752|NCT00600717|Migraine|migraine
5256753|NCT00600717|HFOs|hfos
5256754|NCT00600717|ripples|ripples
5256755|NCT00600717|fast ripples|fast ripples
5256756|NCT00600717|high-gamma|high-gamma
5256757|NCT00600704|Allogenic Blood Use|allogenic blood use
5256758|NCT00600704|Total Blood Loss|total blood loss
5256759|NCT00600704|Reinfusion of Washed Shed Blood|reinfusion of washed shed blood
5256761|NCT00600691|hematuria|hematuria
5256762|NCT00600691|hematospermia|hematospermia
5256763|NCT00600691|prostate biopsy|prostate biopsy
5256764|NCT00600678|food for special medical purposes|food for special medical purposes
5256765|NCT00600665|Sickle Cell Anemia|sickle cell anemia
5256766|NCT00600665|Sickle Cell Disease|sickle cell disease
5256767|NCT00600652|glucocorticoid-receptor|glucocorticoid-receptor
5256768|NCT00600652|flow cytometry|flow cytometry
5256769|NCT00600652|glucocorticoid-resistant|glucocorticoid-resistant
5256770|NCT00600652|prediction|prediction
5256771|NCT00600639|old patients|old patients
5256773|NCT00600639|Intubation|intubation
5256774|NCT00600639|COPD|copd
5256775|NCT00600613|Radiation Therapy|radiation therapy
5256776|NCT00600587|Carcinoma, Non-Small-Cell Lung|carcinoma, non-small-cell lung
5256777|NCT00600587|Genes, erbB-1|genes, erbb-1
5256778|NCT00600587|tyrosine kinase inhibitor|tyrosine kinase inhibitor
5256779|NCT00600587|Neoadjuvant Therapy|neoadjuvant therapy
5256780|NCT00600574|fibromyalgia|fibromyalgia
5256781|NCT00600574|physical therapies|physical therapies
5256782|NCT00600574|stretching|stretching
5256783|NCT00600574|Ai Chi|ai chi
5256784|NCT00600561|meditation|meditation
5256785|NCT00600561|mindfulness|mindfulness
5256786|NCT00600561|HIV|hiv
5256787|NCT00600561|CD4|cd4
5256788|NCT00600561|Complementary Therapies|complementary therapies
5256789|NCT00600548|Cutaneous leishmaniasis|cutaneous leishmaniasis
5256790|NCT00600548|Miltefosine|miltefosine
5256791|NCT00600548|Meglumine antimoniate|meglumine antimoniate
5256792|NCT00600548|L. braziliensis, L. guyanensis|l. braziliensis, l. guyanensis
5256793|NCT00600535|Prostate neoplasms|prostate neoplasms
5256794|NCT00600535|Abiraterone acetate|abiraterone acetate
5256795|NCT00600535|CB7630|cb7630
5256796|NCT00600535|Prostate cancer|prostate cancer
5256797|NCT00600535|Pharmacokinetics|pharmacokinetics
5256798|NCT00600522|intraoperative ultrasonography|intraoperative ultrasonography
5256799|NCT00600522|hepatectomy|hepatectomy
5256800|NCT00600522|colorectal liver metastases|colorectal liver metastases
5256801|NCT00600522|hepatocellular carcinoma|hepatocellular carcinoma
5256802|NCT00600522|contrast enhanced intraoperative ultrasonography.|contrast enhanced intraoperative ultrasonography.
5256803|NCT00600509|Levetiracetam|levetiracetam
5256804|NCT00600509|Keppra|keppra
5256805|NCT00600496|ARRY-142886|arry-142886
5256806|NCT00600496|AZD6244|azd6244
5256807|NCT00600496|Cancer|cancer
5256808|NCT00600496|Colon Cancer|colon cancer
5256809|NCT00600496|Breast Cancer|breast cancer
5256810|NCT00600496|Lung Cancer|lung cancer
5256811|NCT00600496|Melanoma|melanoma
5256812|NCT00600496|Kidney Cancer|kidney cancer
5256813|NCT00600483|obesity|obesity
5256814|NCT00600483|diabetes|diabetes
5256815|NCT00600470|Behavior Problems|behavior problems
5256816|NCT00600470|Behavior Disorders|behavior disorders
5256817|NCT00600457|healing time|healing time
5256818|NCT00600457|pain|pain
5256819|NCT00600457|infection|infection
5256820|NCT00600444|permanent venous access|permanent venous access
5256821|NCT00600444|chemotherapy|chemotherapy
5256822|NCT00600444|parenteral nutrition|parenteral nutrition
5256823|NCT00600444|Patients with a benign and/or malignant diseases which demand a safe and permanent venous access, e.g. for chemotherapy and/or parenteral nutrition|patients with a benign and/or malignant diseases which demand a safe and permanent venous access, e.g. for chemotherapy and/or parenteral nutrition
5256824|NCT00600444|benign diseases|benign diseases
5256825|NCT00600444|malignant diseases|malignant diseases
5256826|NCT00600431|nevus count|nevus count
5256827|NCT00600431|children|children
5256828|NCT00600431|chemotherapy|chemotherapy
5256829|NCT00600418|PTSD|ptsd
5256830|NCT00600418|DYADIC TREATMENT|dyadic treatment
5256831|NCT00600418|WAR AND TERROR|war and terror
5256832|NCT00600418|Posttraumatic symptoms among toddlers|posttraumatic symptoms among toddlers
5256833|NCT00600405|Nephrolithiasis|nephrolithiasis
5256834|NCT00600405|Ureteral Calculi|ureteral calculi
5256835|NCT00600379|stroke chronic gait deficits virtual reality training|stroke chronic gait deficits virtual reality training
5256836|NCT00600353|nausea|nausea
5256837|NCT00600353|cancer|cancer
5256838|NCT00600353|CINV|cinv
5256839|NCT00600327|Stroke|stroke
5256840|NCT00600327|thrombosis|thrombosis
5256841|NCT00600327|thromboembolic|thromboembolic
5256842|NCT00600327|Transient Ischemic Attack|transient ischemic attack
5256843|NCT00600327|TIA|tia
5256844|NCT00600314|Graft-Versus-Host Disease|graft-versus-host disease
5256845|NCT00600314|Transplantation, Allogeneic|transplantation, allogeneic
5256846|NCT00600314|Transplantation, Hematopoietic Stem Cell|transplantation, hematopoietic stem cell
5256847|NCT00600314|Calorimetry, Respiration|calorimetry, respiration
5256848|NCT00600301|Macula|macula
5256849|NCT00600301|Edema|edema
5256850|NCT00600275|BGT226|bgt226
5256851|NCT00600275|Solid tumors|solid tumors
5256852|NCT00600275|Breast cancer|breast cancer
5256853|NCT00600275|Cowden Syndrome|cowden syndrome
5256854|NCT00600275|Phosphatidylinositol 3'-kinase (PI3K) inhibitor|phosphatidylinositol 3'-kinase (pi3k) inhibitor
5256855|NCT00600275|Advanced solid tumors (including sporadic and Cowden Syndrome) (Phase I part)|advanced solid tumors (including sporadic and cowden syndrome) (phase i part)
5256856|NCT00600275|Advanced breast cancer (including sporadic and Cowden Syndrome) (Phase II part)|advanced breast cancer (including sporadic and cowden syndrome) (phase ii part)
5256857|NCT00600262|severe nonproliferative|severe nonproliferative
5256858|NCT00600262|proliferative diabetic retinopathy|proliferative diabetic retinopathy
5256859|NCT00600262|active photocoagulated diabetic retinopathy|active photocoagulated diabetic retinopathy
5256860|NCT00600262|intravitreal bevacizumab|intravitreal bevacizumab
5256861|NCT00600249|Breast cancer.|breast cancer.
5256862|NCT00600249|Triple negative.|triple negative.
5256863|NCT00600249|Neoadjuvant chemotherapy.|neoadjuvant chemotherapy.
5256864|NCT00600249|Targeted therapy.|targeted therapy.
5256865|NCT00600236|Diabetes mellitus type 2 with 10 years of diagnosis and no diabetic retinopathy|diabetes mellitus type 2 with 10 years of diagnosis and no diabetic retinopathy
5256866|NCT00600236|Diabetes mellitus type 2 with 10 years of diagnosis and proliferative diabetic retinopathy|diabetes mellitus type 2 with 10 years of diagnosis and proliferative diabetic retinopathy
5256867|NCT00600184|Stroke|stroke
5256868|NCT00600184|Rehabilitation|rehabilitation
5256869|NCT00600184|Robotics|robotics
5256870|NCT00600171|dose ranging|dose ranging
5256871|NCT00600171|placebo|placebo
5256872|NCT00600171|asthma|asthma
5256873|NCT00600171|safety|safety
5256874|NCT00600171|efficacy|efficacy
5256875|NCT00600171|pharmacokinetics|pharmacokinetics
5256876|NCT00600158|colectomy|colectomy
5256877|NCT00600145|Human volunteers|human volunteers
5256878|NCT00600145|amphetamine dependence|amphetamine dependence
5256879|NCT00600119|NKTR, constipation, opioid, induced, bowel, dysfunction, Naloxol, Naloxone, Narcan, PEG naloxol, OIC, OBD, Nektar|nktr, constipation, opioid, induced, bowel, dysfunction, naloxol, naloxone, narcan, peg naloxol, oic, obd, nektar
5256880|NCT00600093|Amantadine|amantadine
5256881|NCT00600067|Diabetes|diabetes
5256882|NCT00600067|Type 2 Diabetes|type 2 diabetes
5256883|NCT00600067|Diabetes Mellitus|diabetes mellitus
5256884|NCT00600067|Metabolic Diseases|metabolic diseases
5256885|NCT00600067|Glucose Metabolism Disorders|glucose metabolism disorders
5256886|NCT00600067|Glycemic Control|glycemic control
5256887|NCT00600054|Diffuse intrinsic pontine glioma|diffuse intrinsic pontine glioma
5256888|NCT00600054|Common Terminology Criteria|common terminology criteria
5256889|NCT00600054|Epidermal Growth factor receptor|epidermal growth factor receptor
5256890|NCT00600054|Human antihuman antibody|human antihuman antibody
5256891|NCT00600054|pharmacokinetics|pharmacokinetics
5256892|NCT00600054|monoclonal antibody|monoclonal antibody
5256893|NCT00600054|Informed Consent Form|informed consent form
5256894|NCT00600041|Proton Pump Inhibitors|proton pump inhibitors
5256895|NCT00600041|pantoprazole|pantoprazole
5256896|NCT00600041|Cardiac Output|cardiac output
5256897|NCT00600041|Echocardiography|echocardiography
5256898|NCT00600041|adverse effects|adverse effects
5256899|NCT00600028|idiopathic pulmonary fibrosis cough|idiopathic pulmonary fibrosis cough
5256900|NCT00600015|Non-Small Cell Lung Cancer|non-small cell lung cancer
5256901|NCT00600015|Advanced|advanced
5256902|NCT00600015|Sorafenib|sorafenib
5256903|NCT00600015|Erlotinib|erlotinib
5256904|NCT00600015|Double-blind|double-blind
5256905|NCT00600015|Placebo-controlled|placebo-controlled
5256906|NCT00600002|GM-CSF|gm-csf
5256907|NCT00600002|Leukine|leukine
5256908|NCT00599989|long-term effects secondary to cancer therapy in adults|long-term effects secondary to cancer therapy in adults
5256909|NCT00599989|skin reactions secondary to radiation therapy|skin reactions secondary to radiation therapy
5256910|NCT00599989|stage I breast cancer|stage i breast cancer
5256911|NCT00599989|stage II breast cancer|stage ii breast cancer
5256912|NCT00599989|invasive lobular breast carcinoma with predominant in situ component|invasive lobular breast carcinoma with predominant in situ component
5256913|NCT00599989|invasive lobular breast carcinoma|invasive lobular breast carcinoma
5256914|NCT00599989|comedo ductal breast carcinoma|comedo ductal breast carcinoma
5256915|NCT00599989|ductal breast carcinoma in situ|ductal breast carcinoma in situ
5256916|NCT00599989|invasive ductal breast carcinoma|invasive ductal breast carcinoma
5256917|NCT00599989|medullary ductal breast carcinoma with lymphocytic infiltrate|medullary ductal breast carcinoma with lymphocytic infiltrate
5256918|NCT00599989|mucinous ductal breast carcinoma|mucinous ductal breast carcinoma
5256919|NCT00599989|papillary ductal breast carcinoma|papillary ductal breast carcinoma
5256920|NCT00599989|tubular ductal breast carcinoma|tubular ductal breast carcinoma
5256921|NCT00599989|Paget disease of the breast with intraductal carcinoma|paget disease of the breast with intraductal carcinoma
5256922|NCT00599989|Paget disease of the breast with invasive ductal carcinoma|paget disease of the breast with invasive ductal carcinoma
5256923|NCT00599989|breast cancer in situ|breast cancer in situ
5256924|NCT00599950|Mitomycin C|mitomycin c
5256925|NCT00599950|Corneal epithelium|corneal epithelium
5256926|NCT00599950|Photorefractive keratectomy (PRK)|photorefractive keratectomy (prk)
5256927|NCT00599950|Confocal microscope|confocal microscope
5256929|NCT00599924|advanced solid tumors,|advanced solid tumors,
5256930|NCT00599924|colorectal cancer,|colorectal cancer,
5256931|NCT00599924|sunitinib (SUTENT),|sunitinib (sutent),
5256932|NCT00599924|FOLFOX|folfox
5256933|NCT00599911|Drug therapy|drug therapy
5256934|NCT00599911|Depressive disorder|depressive disorder
5256935|NCT00599911|Antidepressive agents|antidepressive agents
5256936|NCT00599911|Depressive symptoms|depressive symptoms
5256937|NCT00599911|Affective disorders|affective disorders
5256938|NCT00599911|Randomized controlled trial|randomized controlled trial
5256939|NCT00599911|Placebo-controlled|placebo-controlled
5256940|NCT00599911|Double-blind|double-blind
5256941|NCT00599911|Active reference|active reference
5256942|NCT00599911|Multicenter study|multicenter study
5256943|NCT00599898|Preterm labor|preterm labor
5256944|NCT00599898|Atosiban|atosiban
5256945|NCT00599898|Nifedipine|nifedipine
5256946|NCT00599872|Allergy|allergy
5256947|NCT00599872|Sublingual Immunotherapy|sublingual immunotherapy
5256948|NCT00599872|Allergic Rhinitis|allergic rhinitis
5256949|NCT00599859|lactase|lactase
5256950|NCT00599859|lactose|lactose
5256951|NCT00599859|microflora|microflora
5256952|NCT00599846|age-related macular degeneration|age-related macular degeneration
5256953|NCT00599846|geographic atrophy|geographic atrophy
5256954|NCT00599833|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
5256955|NCT00599833|stage III pancreatic cancer|stage iii pancreatic cancer
5256956|NCT00599820|Angioid Streaks|angioid streaks
5256957|NCT00599820|Choroidal Neovascularization|choroidal neovascularization
5256958|NCT00599820|Bevacizumab|bevacizumab
5256959|NCT00599794|Sepsis|sepsis
5256960|NCT00599794|Intravascular volume|intravascular volume
5256961|NCT00599794|Ultrasound|ultrasound
5256962|NCT00599794|Noninvasive measurement|noninvasive measurement
5256963|NCT00599781|adenosine deaminase|adenosine deaminase
5256964|NCT00599781|SCID|scid
5256965|NCT00599781|gene therapy|gene therapy
5256966|NCT00599781|retroviral vector|retroviral vector
5256967|NCT00599742|Balance disorder|balance disorder
5256968|NCT00599742|Vestibular disorder|vestibular disorder
5256969|NCT00599742|Generalized anxiety disorder|generalized anxiety disorder
5256970|NCT00599742|Separation anxiety disorder|separation anxiety disorder
5256971|NCT00599742|Children|children
5256972|NCT00599742|Balance training|balance training
5256973|NCT00599716|dry eye syndrome|dry eye syndrome
5256974|NCT00599716|dry eye disease|dry eye disease
5256975|NCT00599716|Vismed|vismed
5256976|NCT00599716|dry eye|dry eye
5256977|NCT00599716|sodium hyaluronate|sodium hyaluronate
5256978|NCT00599716|hyaluronic acid|hyaluronic acid
5256979|NCT00599690|Epi-LASIK-LASIK microkeratome|epi-lasik-lasik microkeratome
5256980|NCT00599690|Corneal thickness|corneal thickness
5256981|NCT00599690|Confocal microscope|confocal microscope
5256982|NCT00599677|acupuncture|acupuncture
5256983|NCT00599677|meridian|meridian
5256984|NCT00599677|acupoint|acupoint
5256985|NCT00599664|Urinary Calculi|urinary calculi
5256986|NCT00599664|Urinary Stones|urinary stones
5256987|NCT00599664|Urinary Tract Stones|urinary tract stones
5256988|NCT00599664|Calculi|calculi
5256989|NCT00599651|Respiratory Distress Syndrome|respiratory distress syndrome
5256990|NCT00599651|Newborn RDS|newborn rds
5256991|NCT00599625|Crohn's Disease|crohn's disease
5256992|NCT00599612|GW856553,|gw856553,
5256993|NCT00599612|radiolabel|radiolabel
5256994|NCT00599612|ADME,|adme,
5256995|NCT00599599|Prolonged Exposure Therapy|prolonged exposure therapy
5256996|NCT00599599|Adherence to HIV Medications|adherence to hiv medications
5256997|NCT00599599|Complementary Therapies|complementary therapies
5256998|NCT00599586|migraine|migraine
5256999|NCT00599586|acupuncture|acupuncture
5257000|NCT00599586|efficacy|efficacy
5257001|NCT00599586|safety|safety
5257002|NCT00599586|meridian|meridian
5257003|NCT00599586|acupoint|acupoint
5257004|NCT00599573|HIV|hiv
5257005|NCT00599573|cocaine dependence|cocaine dependence
5257006|NCT00599573|cocaine abuse|cocaine abuse
5257007|NCT00599573|cocaine addiction|cocaine addiction
5257008|NCT00599573|cocaine users|cocaine users
5257009|NCT00599573|cocaine-related disorders|cocaine-related disorders
5257010|NCT00599573|HIV Infection|hiv infection
5257011|NCT00599560|Meniere's disease|meniere's disease
5257012|NCT00599560|stress|stress
5257013|NCT00599560|vasopressin|vasopressin
5257014|NCT00599560|endolymphatic sac|endolymphatic sac
5257015|NCT00599560|V2 receptor|v2 receptor
5257016|NCT00599560|cyclic AMP|cyclic amp
5257017|NCT00599560|Plasma vasopressin level and V2R mRNA expression level in the endolymphatic sac both were significantly higher in patients with Meniere's disease.|plasma vasopressin level and v2r mrna expression level in the endolymphatic sac both were significantly higher in patients with meniere's disease.
5257018|NCT00599560|In Meniere's disease, there were significant negative co-relationships between vasopressin and V2R.|in meniere's disease, there were significant negative co-relationships between vasopressin and v2r.
5257019|NCT00599560|The cyclic AMP activity was basically up-regulated in the endolymphatic sac in Meniere's disease..|the cyclic amp activity was basically up-regulated in the endolymphatic sac in meniere's disease..
5257020|NCT00599560|The cyclic AMP sensitivity for vasopressin was significantly elevated in the endolymphatic sac in Meniere's disease.|the cyclic amp sensitivity for vasopressin was significantly elevated in the endolymphatic sac in meniere's disease.
5257021|NCT00599547|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
5257022|NCT00599521|Acne Vulgaris|acne vulgaris
5257023|NCT00599521|Adapalene|adapalene
5257024|NCT00599508|memory|memory
5257025|NCT00599508|aging|aging
5257026|NCT00599495|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
5257027|NCT00599495|Multiple Myeloma|multiple myeloma
5257028|NCT00599482|HEMOGLOBIN SC DISEASE|hemoglobin sc disease
5257029|NCT00599482|HEMOGLOBIN C DISEASE|hemoglobin c disease
5257030|NCT00599482|SICKLE CELL TRAIT|sickle cell trait
5257031|NCT00599482|THALASSEMIA|thalassemia
5257032|NCT00599469|Acute Confusional Senile Dementia|acute confusional senile dementia
5257033|NCT00599469|Alzheimer Type Senile Dementia|alzheimer type senile dementia
5257034|NCT00599469|SENILE PLAQUES|senile plaques
5257035|NCT00599469|NEUROFIBRILLARY TANGLES|neurofibrillary tangles
5257036|NCT00599469|NEUROPIL THREADS|neuropil threads
5257037|NCT00599456|Hot flashes|hot flashes
5257038|NCT00599456|Menopause|menopause
5257039|NCT00599456|Omega 3 fatty Acids|omega 3 fatty acids
5257040|NCT00599443|Cell-derived subunit influenza vaccine|cell-derived subunit influenza vaccine
5257041|NCT00599443|Safety|safety
5257042|NCT00599443|Reactogenicity|reactogenicity
5257043|NCT00599430|Probiotic|probiotic
5257044|NCT00599430|Lactobacillus|lactobacillus
5257045|NCT00599430|NCFM|ncfm
5257046|NCT00599430|Bifidobacterium|bifidobacterium
5257047|NCT00599430|Healthy children|healthy children
5257048|NCT00599404|Pharmacokinetics study|pharmacokinetics study
5257049|NCT00599391|KIDNEY FAILURE, ACUTE|kidney failure, acute
5257050|NCT00599391|KIDNEY FAILURE, CHRONIC|kidney failure, chronic
5257051|NCT00599391|RENAL INSUFFICIENCY|renal insufficiency
5257052|NCT00599365|adherence|adherence
5257053|NCT00599365|pharmacist intervention|pharmacist intervention
5257054|NCT00599365|persistence|persistence
5257055|NCT00599365|renal clinic|renal clinic
5257056|NCT00599365|pill count|pill count
5257057|NCT00599352|Hypovitaminosis|hypovitaminosis
5257058|NCT00599352|Chronic liver disease|chronic liver disease
5257059|NCT00599339|Rotigotine|rotigotine
5257060|NCT00599339|Neupro|neupro
5257061|NCT00599326|Exjade PCT Study|exjade pct study
5257062|NCT00599326|PCT Study|pct study
5257063|NCT00599326|Porphyria Cutanea Tarda|porphyria cutanea tarda
5257064|NCT00599287|ICU delirium|icu delirium
5257065|NCT00599287|Hypoactive delirium|hypoactive delirium
5257066|NCT00599287|Haloperidol|haloperidol
5257067|NCT00599287|Methylphenidate|methylphenidate
5257068|NCT00599287|Rivastigmine|rivastigmine
5257069|NCT00599287|Hypoactive ICU delirium|hypoactive icu delirium
5257070|NCT00599274|Multiple Sclerosis|multiple sclerosis
5257071|NCT00599274|Interferon beta 1a|interferon beta 1a
5257072|NCT00599274|Avonex|avonex
5257073|NCT00599261|Cardiac Pacemaker, Artificial|cardiac pacemaker, artificial
5257074|NCT00599248|osteoarthritis, knee|osteoarthritis, knee
5257075|NCT00599235|Hypertension|hypertension
5257076|NCT00599235|Exercise capacity|exercise capacity
5257077|NCT00599235|PDE5 inhibitors|pde5 inhibitors
5257078|NCT00599222|AMD|amd
5257079|NCT00599222|macular degeneration|macular degeneration
5257080|NCT00599222|anti-VEGF|anti-vegf
5257081|NCT00599222|laser treatment|laser treatment
5257082|NCT00599196|Rotigotine|rotigotine
5257083|NCT00599196|Neupro®|neupro®
5257084|NCT00599183|Cervical spine herniation|cervical spine herniation
5257085|NCT00599183|MRI cervical spine|mri cervical spine
5257086|NCT00599183|Diffusion tensor imaging cervical spine|diffusion tensor imaging cervical spine
5257087|NCT00599170|This is a standard phase II trial, in which patients with newly diagnosed diffuse large B cell lymphoma will receive R-CHOP with GM-CSF|this is a standard phase ii trial, in which patients with newly diagnosed diffuse large b cell lymphoma will receive r-chop with gm-csf
5257088|NCT00599144|Cholecystectomy|cholecystectomy
5257089|NCT00599131|Cancer of Larynx|cancer of larynx
5257090|NCT00599118|Atrial Fibrillation|atrial fibrillation
5257091|NCT00599118|Genetics|genetics
5257092|NCT00599092|pituitary tumor|pituitary tumor
5257093|NCT00599092|recurrence|recurrence
5257094|NCT00599079|MAC|mac
5257095|NCT00599066|M-Entropy|m-entropy
5257096|NCT00599053|Ureaplasma|ureaplasma
5257097|NCT00599053|Bronchopulmonary dysplasia|bronchopulmonary dysplasia
5257098|NCT00599053|very low birthweight|very low birthweight
5257099|NCT00599014|Cardiomyopathy, heart failure, DNA,|cardiomyopathy, heart failure, dna,
5257100|NCT00599014|echocardiography, messenger RNA, natural history|echocardiography, messenger rna, natural history
5257101|NCT00599001|healthy volunteer|healthy volunteer
5257102|NCT00599001|research subjects|research subjects
5257103|NCT00599001|Immunostimulatory sequence (ISS)|immunostimulatory sequence (iss)
5257104|NCT00599001|phase 1|phase 1
5257105|NCT00598988|infectious mononucleosis, mono, acupuncture|infectious mononucleosis, mono, acupuncture
5257106|NCT00598975|Phase 2a: Multiple solid tumor types|phase 2a: multiple solid tumor types
5257107|NCT00598975|Phase 2b: Second-Line Colorectal Cancer (CRC)|phase 2b: second-line colorectal cancer (crc)
5257108|NCT00598962|MAC|mac
5257109|NCT00598949|Pituitary|pituitary
5257110|NCT00598949|Adenoma|adenoma
5257111|NCT00598949|Tumor|tumor
5257112|NCT00598949|Acromegaly|acromegaly
5257113|NCT00598949|Prolactinoma|prolactinoma
5257114|NCT00598949|Cushing's|cushing's
5257115|NCT00598936|Hypoxia|hypoxia
5257116|NCT00598936|Cerebral Hypoxia|cerebral hypoxia
5257117|NCT00598923|tbi|tbi
5257118|NCT00598923|traumatic brain injury|traumatic brain injury
5257119|NCT00598923|epilepsy|epilepsy
5257120|NCT00598910|HIV infection|hiv infection
5257121|NCT00598897|MAC|mac
5257122|NCT00598884|Clinical Protocols|clinical protocols
5257123|NCT00598884|Behavioral Research|behavioral research
5257124|NCT00598884|Prevention|prevention
5257125|NCT00598871|Thymosin beta 4|thymosin beta 4
5257126|NCT00598871|Corneal wound healing|corneal wound healing
5257127|NCT00598871|Vitrectomy|vitrectomy
5257128|NCT00598871|Diabetes|diabetes
5257129|NCT00598858|prostate cancer|prostate cancer
5257130|NCT00598858|Prostatectomy|prostatectomy
5257131|NCT00598845|Endometrial cancer|endometrial cancer
5257132|NCT00598845|Molecular markers|molecular markers
5257133|NCT00598845|Lymph node metastasis|lymph node metastasis
5257134|NCT00598845|Prospective study|prospective study
5257135|NCT00598845|Prognosis|prognosis
5257136|NCT00598845|Cancer of Endometrium|cancer of endometrium
5257137|NCT00598845|Tumor Markers, Biological|tumor markers, biological
5257138|NCT00598832|Acne Vulgaris|acne vulgaris
5257139|NCT00598832|Adapalene|adapalene
5257140|NCT00598819|Cerebral Oxygenation|cerebral oxygenation
5257141|NCT00598819|Oxygen Monitoring|oxygen monitoring
5257142|NCT00598806|Noninvasive Bladder Cancer|noninvasive bladder cancer
5257143|NCT00598780|Levocetirizine|levocetirizine
5257144|NCT00598780|Xyzal|xyzal
5257145|NCT00598780|Rhinitis allergic persistent|rhinitis allergic persistent
5257146|NCT00598780|Rhinitis nonseasonal|rhinitis nonseasonal
5257147|NCT00598767|Aortic valve insufficiency|aortic valve insufficiency
5257148|NCT00598767|Aortic valve stenosis|aortic valve stenosis
5257149|NCT00598767|3D echocardiogram|3d echocardiogram
5257150|NCT00598767|3D computed tomography|3d computed tomography
5257151|NCT00598754|Aortic valve stenosis|aortic valve stenosis
5257152|NCT00598754|Aortic valve insufficiency|aortic valve insufficiency
5257153|NCT00598754|Two dimensional echocardiography|two dimensional echocardiography
5257154|NCT00598754|Three dimensional echocardiography|three dimensional echocardiography
5257155|NCT00598741|Bone|bone
5257156|NCT00598741|Sarcoma|sarcoma
5257157|NCT00598741|04-083|04-083
5257158|NCT00598728|Survivors|survivors
5257159|NCT00598728|Quality of Life|quality of life
5257160|NCT00598715|In-stent restenosis|in-stent restenosis
5257161|NCT00598715|In-DES-restenosis|in-des-restenosis
5257162|NCT00598715|paclitaxel|paclitaxel
5257163|NCT00598715|sirolimus|sirolimus
5257164|NCT00598689|LASIK|lasik
5257165|NCT00598689|Ocular Lubricants|ocular lubricants
5257166|NCT00598689|Corneal Epithelium|corneal epithelium
5257167|NCT00598689|Wound Healing|wound healing
5257168|NCT00598663|Type 1 diabetes|type 1 diabetes
5257169|NCT00598650|Lewy Body Disease|lewy body disease
5257170|NCT00598650|Dementia|dementia
5257171|NCT00598650|Clinical Trial|clinical trial
5257172|NCT00598650|Phase II|phase ii
5257173|NCT00598650|E2020|e2020
5257174|NCT00598650|donepezil hydrochloride|donepezil hydrochloride
5257175|NCT00598637|drug eluting stent|drug eluting stent
5257176|NCT00598637|left main disease|left main disease
5257177|NCT00598611|urticaria|urticaria
5257178|NCT00598598|Aortic valve insufficiency|aortic valve insufficiency
5257179|NCT00598598|Aortic valve stenosis|aortic valve stenosis
5257180|NCT00598598|3D echocardiogram|3d echocardiogram
5257181|NCT00598572|Deferoxamine|deferoxamine
5257182|NCT00598572|Safety|safety
5257183|NCT00598572|Intracerebral hemorrhage|intracerebral hemorrhage
5257184|NCT00598559|Acute pain|acute pain
5257185|NCT00598559|Fever|fever
5257186|NCT00598559|IV Acetaminophen|iv acetaminophen
5257187|NCT00598559|Analgesic|analgesic
5257188|NCT00598546|Stomach|stomach
5257189|NCT00598546|Gastric|gastric
5257190|NCT00598546|Stomach Tumor|stomach tumor
5257191|NCT00598546|Stomach Cancer|stomach cancer
5257192|NCT00598507|ZK-EPO|zk-epo
5257193|NCT00598507|ZK219477|zk219477
5257194|NCT00598507|EpothiloneZK|epothilonezk
5257195|NCT00598494|effect of bedrest|effect of bedrest
5257196|NCT00598494|cardiac atrophy|cardiac atrophy
5257197|NCT00598481|SCID|scid
5257198|NCT00598481|gene therapy|gene therapy
5257199|NCT00598481|Adenosine deaminase|adenosine deaminase
5257200|NCT00598481|retroviral vector|retroviral vector
5257201|NCT00598455|angiomyolipomata|angiomyolipomata
5257202|NCT00598455|tuberous sclerosis complex|tuberous sclerosis complex
5257203|NCT00598442|anemia|anemia
5257204|NCT00598442|chronic kidney disease|chronic kidney disease
5257205|NCT00598442|CKD|ckd
5257206|NCT00598442|chronic renal failure|chronic renal failure
5257207|NCT00598442|CRF|crf
5257208|NCT00598442|erythropoietin|erythropoietin
5257209|NCT00598442|EPO|epo
5257210|NCT00598442|erythropoiesis stimulating agent|erythropoiesis stimulating agent
5257211|NCT00598442|ESA|esa
5257212|NCT00598442|Hematide™|hematide™
5257213|NCT00598442|hemoglobin|hemoglobin
5257214|NCT00598442|Hb|hb
5257215|NCT00598442|Hgb|hgb
5257216|NCT00598442|Omontys|omontys
5257217|NCT00598442|peginesatide|peginesatide
5257218|NCT00598442|red blood cell|red blood cell
5257219|NCT00598442|red blood cell production|red blood cell production
5257220|NCT00598429|NICHD Neonatal Research Network|nichd neonatal research network
5257221|NCT00598429|Hypoxemic respiratory failure (HRF)|hypoxemic respiratory failure (hrf)
5257222|NCT00598429|Persistent pulmonary hypertension of the newborn (PPHN)|persistent pulmonary hypertension of the newborn (pphn)
5257223|NCT00598429|Prostaglandin E1 (PGE1)|prostaglandin e1 (pge1)
5257224|NCT00598429|Mechanical ventilation|mechanical ventilation
5257225|NCT00598429|Meconium, aspiration|meconium, aspiration
5257226|NCT00598416|Hepatitis C|hepatitis c
5257227|NCT00598416|Substance Abuse|substance abuse
5257228|NCT00598416|Psychoeducation|psychoeducation
5257229|NCT00598416|Psychiatric functioning|psychiatric functioning
5257230|NCT00598416|Physical Functioning|physical functioning
5257231|NCT00598416|Quality of Life|quality of life
5257232|NCT00598416|NIAAA|niaaa
5257233|NCT00598416|Alcohol|alcohol
5257234|NCT00598403|Cystitis|cystitis
5257235|NCT00598390|Cannabinoid|cannabinoid
5257236|NCT00598390|CB1 Receptor|cb1 receptor
5257237|NCT00598390|Brain Imaging|brain imaging
5257238|NCT00598390|PET Imaging|pet imaging
5257239|NCT00598390|[11C]MePPEP|[11c]meppep
5257240|NCT00598390|Healthy Volunteer|healthy volunteer
5257241|NCT00598390|HV|hv
5257242|NCT00598377|Autosomal dominant polycystic kidney disease|autosomal dominant polycystic kidney disease
5257243|NCT00598377|Adrenal functions|adrenal functions
5257244|NCT00598377|Renal volume|renal volume
5257245|NCT00598377|Glomerular filtration rate|glomerular filtration rate
5257246|NCT00598377|Adrenal Cortex Function Tests|adrenal cortex function tests
5257247|NCT00598364|thyroid|thyroid
5257248|NCT00598364|nodule|nodule
5257249|NCT00598364|genetic|genetic
5257250|NCT00598364|mutation|mutation
5257251|NCT00598364|malignancy|malignancy
5257252|NCT00598351|Meningioma|meningioma
5257253|NCT00598351|Ependymoma|ependymoma
5257254|NCT00598351|Schwannoma|schwannoma
5257255|NCT00598351|Acoustic Neuroma|acoustic neuroma
5257256|NCT00598351|Vestibular Schwannoma|vestibular schwannoma
5257257|NCT00598351|Neurofibromatosis Type 2|neurofibromatosis type 2
5257258|NCT00598351|NF2|nf2
5257259|NCT00598325|Nicotine|nicotine
5257260|NCT00598325|Vaccine|vaccine
5257261|NCT00598325|Immunogenicity|immunogenicity
5257262|NCT00598325|Tobacco|tobacco
5257263|NCT00598325|Habits|habits
5257264|NCT00598299|corneal epithelium|corneal epithelium
5257265|NCT00598286|CB1 Receptor|cb1 receptor
5257266|NCT00598286|PET|pet
5257267|NCT00598286|Cannabinoid|cannabinoid
5257268|NCT00598286|[18F]FMPEP-d2|[18f]fmpep-d2
5257269|NCT00598286|Brain Imaging|brain imaging
5257270|NCT00598286|Healthy Volunteer|healthy volunteer
5257271|NCT00598286|HV|hv
5257272|NCT00598273|anemia|anemia
5257273|NCT00598273|chronic kidney disease|chronic kidney disease
5257274|NCT00598273|CKD|ckd
5257275|NCT00598273|chronic renal failure|chronic renal failure
5257276|NCT00598273|CRF|crf
5257277|NCT00598273|erythropoietin|erythropoietin
5257278|NCT00598273|EPO|epo
5257279|NCT00598273|erythropoiesis stimulating agent|erythropoiesis stimulating agent
5257280|NCT00598273|ESA|esa
5257281|NCT00598273|Hematide™|hematide™
5257282|NCT00598273|hemoglobin|hemoglobin
5257283|NCT00598273|Hb|hb
5257284|NCT00598273|Hgb|hgb
5257285|NCT00598273|Omontys|omontys
5257286|NCT00598273|peginesatide|peginesatide
5257287|NCT00598273|red blood cell|red blood cell
5257288|NCT00598273|red blood cell production|red blood cell production
5257289|NCT00598260|active management|active management
5257290|NCT00598260|induction of labor|induction of labor
5257291|NCT00598260|cesarean delivery|cesarean delivery
5257292|NCT00598260|Cesarean|cesarean
5257293|NCT00598247|Colon Cancer Rectal Colorectal Women|colon cancer rectal colorectal women
5257294|NCT00598208|In-vitro fertilization|in-vitro fertilization
5257295|NCT00598195|Ketamine|ketamine
5257296|NCT00598195|Phamacokinetics|phamacokinetics
5257297|NCT00598195|Cardiopulmonary bypass (CPB)|cardiopulmonary bypass (cpb)
5257298|NCT00598195|ketamine/norketamine pharmacokinetic parameters|ketamine/norketamine pharmacokinetic parameters
5257299|NCT00598182|Attention Deficit Disorder with Hyperactivity|attention deficit disorder with hyperactivity
5257300|NCT00598182|OROS methylphenidate|oros methylphenidate
5257301|NCT00598169|AIDS-related diffuse large cell lymphoma|aids-related diffuse large cell lymphoma
5257302|NCT00598169|AIDS-related diffuse mixed cell lymphoma|aids-related diffuse mixed cell lymphoma
5257303|NCT00598169|AIDS-related diffuse small cleaved cell lymphoma|aids-related diffuse small cleaved cell lymphoma
5257304|NCT00598169|AIDS-related immunoblastic large cell lymphoma|aids-related immunoblastic large cell lymphoma
5257305|NCT00598169|AIDS-related lymphoblastic lymphoma|aids-related lymphoblastic lymphoma
5257306|NCT00598169|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
5257307|NCT00598169|AIDS-related primary CNS lymphoma|aids-related primary cns lymphoma
5257308|NCT00598169|AIDS-related small noncleaved cell lymphoma|aids-related small noncleaved cell lymphoma
5257309|NCT00598130|Patients undergoing elective open partial nephrectomy surgery|patients undergoing elective open partial nephrectomy surgery
5257310|NCT00598130|Excision of a kidney|excision of a kidney
5257311|NCT00598117|Esophageal|esophageal
5257312|NCT00598117|CancerEsophagus|canceresophagus
5257313|NCT00598104|Asthma, interleukin-13|asthma, interleukin-13
5257314|NCT00598091|Solid Tumors|solid tumors
5257315|NCT00598091|Phase I|phase i
5257316|NCT00598091|Expanded Cohort|expanded cohort
5257317|NCT00598091|Pancreatic Cancer|pancreatic cancer
5257318|NCT00598091|Dasatinib|dasatinib
5257319|NCT00598091|Gemcitabine|gemcitabine
5257320|NCT00598065|lung|lung
5257321|NCT00598052|Marijuana dependence withdrawal Escitalopram|marijuana dependence withdrawal escitalopram
5257322|NCT00598026|Tele medicine|tele medicine
5257323|NCT00598026|ICD follow-up|icd follow-up
5257324|NCT00598026|Cost / benefit study|cost / benefit study
5257325|NCT00598013|Kidney Transplantation|kidney transplantation
5257326|NCT00598013|Thiazolidinediones|thiazolidinediones
5257327|NCT00598013|Insulin Resistance|insulin resistance
5257328|NCT00598013|Atherosclerosis|atherosclerosis
5257329|NCT00598000|Lung cancer|lung cancer
5257330|NCT00598000|Quality of Life|quality of life
5257331|NCT00598000|VATS|vats
5257332|NCT00598000|thoracotomy|thoracotomy
5257333|NCT00598000|05-006|05-006
5257334|NCT00597987|BRCA1|brca1
5257335|NCT00597974|carotid artery stenosis|carotid artery stenosis
5257336|NCT00597974|Neuropsychological tests|neuropsychological tests
5257337|NCT00597974|Stroke|stroke
5257338|NCT00597974|Transient ischemia|transient ischemia
5257339|NCT00597974|Stenting|stenting
5257340|NCT00597961|Lung|lung
5257341|NCT00597961|skin|skin
5257342|NCT00597961|melanoma|melanoma
5257343|NCT00597948|mental retardation|mental retardation
5257344|NCT00597948|downs syndrome|downs syndrome
5257345|NCT00597948|autism|autism
5257346|NCT00597948|autism spectrum disorder|autism spectrum disorder
5257347|NCT00597948|cerebral palsy|cerebral palsy
5257348|NCT00597948|developmental disability|developmental disability
5257349|NCT00597948|developmental disabilities|developmental disabilities
5257350|NCT00597948|intellectual disability|intellectual disability
5257351|NCT00597948|intellectual disabilities|intellectual disabilities
5257352|NCT00597948|health promotion|health promotion
5257353|NCT00597948|disease prevention|disease prevention
5257354|NCT00597948|physical health|physical health
5257355|NCT00597948|emotional health|emotional health
5257356|NCT00597948|behavioral health|behavioral health
5257357|NCT00597948|mental health|mental health
5257358|NCT00597948|spiritual health|spiritual health
5257359|NCT00597948|prevention|prevention
5257360|NCT00597935|prolapse|prolapse
5257361|NCT00597935|urinary incontinence|urinary incontinence
5257362|NCT00597935|uterosacral vaginal vault ligament suspension|uterosacral vaginal vault ligament suspension
5257363|NCT00597935|sacrospinous ligament fixation|sacrospinous ligament fixation
5257364|NCT00597935|behavioral therapy|behavioral therapy
5257365|NCT00597935|pelvic muscle training|pelvic muscle training
5257366|NCT00597922|Acute Myocardial Infarction|acute myocardial infarction
5257367|NCT00597922|Heart Attack|heart attack
5257368|NCT00597922|Gender Differences|gender differences
5257369|NCT00597922|Risk Factors|risk factors
5257370|NCT00597922|Quality of Care|quality of care
5257371|NCT00597909|Ammonul®|ammonul®
5257372|NCT00597909|sodium phenylacetate and sodium benzoate|sodium phenylacetate and sodium benzoate
5257373|NCT00597909|hepatic encephalopathy|hepatic encephalopathy
5257374|NCT00597909|Grade 3 or 4 Hepatic Encephalopathy|grade 3 or 4 hepatic encephalopathy
5257375|NCT00597883|carotid endarterectomy|carotid endarterectomy
5257376|NCT00597883|Neuropsychological tests|neuropsychological tests
5257377|NCT00597883|Stroke|stroke
5257378|NCT00597883|Transient ischemia|transient ischemia
5257379|NCT00597870|TAA|taa
5257380|NCT00597844|type I thyroplasty|type i thyroplasty
5257381|NCT00597844|unilateral vocal fold augmentation|unilateral vocal fold augmentation
5257382|NCT00597831|depression|depression
5257383|NCT00597831|electroconvulsive therapy|electroconvulsive therapy
5257384|NCT00597831|Ultrasonography Doppler Transcranial|ultrasonography doppler transcranial
5257385|NCT00597831|intracranial pressure|intracranial pressure
5257386|NCT00597792|Gastroesophageal Reflux Disease (GERD)|gastroesophageal reflux disease (gerd)
5257387|NCT00597792|Plicator|plicator
5257388|NCT00597792|Full-thickness Plication|full-thickness plication
5257389|NCT00597779|intertrochanteric fractures|intertrochanteric fractures
5257390|NCT00597766|CVA|cva
5257391|NCT00597766|Hemiplegia|hemiplegia
5257392|NCT00597766|Hemiplegic shoulder pain|hemiplegic shoulder pain
5257393|NCT00597766|Subacromial steroid injection|subacromial steroid injection
5257394|NCT00597753|anemia|anemia
5257395|NCT00597753|chronic kidney disease|chronic kidney disease
5257396|NCT00597753|CKD|ckd
5257397|NCT00597753|chronic renal failure|chronic renal failure
5257398|NCT00597753|CRF|crf
5257399|NCT00597753|dialysis|dialysis
5257400|NCT00597753|erythropoietin|erythropoietin
5257401|NCT00597753|EPO|epo
5257402|NCT00597753|erythropoiesis stimulating agent|erythropoiesis stimulating agent
5257403|NCT00597753|ESA|esa
5257404|NCT00597753|Hematide™|hematide™
5257405|NCT00597753|hemodialysis|hemodialysis
5257406|NCT00597753|hemoglobin|hemoglobin
5257407|NCT00597753|Hb|hb
5257408|NCT00597753|Hgb|hgb
5257409|NCT00597753|Omontys|omontys
5257410|NCT00597753|peginesatide|peginesatide
5257411|NCT00597753|red blood cell|red blood cell
5257412|NCT00597753|red blood cell production|red blood cell production
5257413|NCT00597727|Peanut Allergy|peanut allergy
5257414|NCT00597727|Sublingual immunotherapy|sublingual immunotherapy
5257415|NCT00597714|Stem Cell Transplantation, Non-myeloablative|stem cell transplantation, non-myeloablative
5257416|NCT00597701|Alcohol withdrawal|alcohol withdrawal
5257417|NCT00597701|Delirium tremors|delirium tremors
5257418|NCT00597675|Peanut allergy|peanut allergy
5257419|NCT00597636|smokers|smokers
5257420|NCT00597623|Osteoarthritis|osteoarthritis
5257421|NCT00597623|Hand|hand
5257422|NCT00597623|Tumor Necrosis Factor-alpha inhibitors|tumor necrosis factor-alpha inhibitors
5257423|NCT00597623|Biological Therapy|biological therapy
5257424|NCT00597610|Rectum|rectum
5257425|NCT00597610|Rectal|rectal
5257426|NCT00597597|Metastatic breast cancer|metastatic breast cancer
5257427|NCT00597597|ER and PR hormone receptor negative|er and pr hormone receptor negative
5257428|NCT00597597|HER2/neu negative|her2/neu negative
5257429|NCT00597597|EGFR positive|egfr positive
5257430|NCT00597584|anemia|anemia
5257431|NCT00597584|chronic kidney disease|chronic kidney disease
5257432|NCT00597584|CKD|ckd
5257433|NCT00597584|chronic renal failure|chronic renal failure
5257434|NCT00597584|CRF|crf
5257435|NCT00597584|dialysis|dialysis
5257436|NCT00597584|erythropoietin|erythropoietin
5257437|NCT00597584|EPO|epo
5257438|NCT00597584|erythropoiesis stimulating agent|erythropoiesis stimulating agent
5257439|NCT00597584|ESA|esa
5257440|NCT00597584|Hematide™|hematide™
5257441|NCT00597584|hemodialysis|hemodialysis
5257442|NCT00597584|hemoglobin|hemoglobin
5257443|NCT00597584|Hb|hb
5257444|NCT00597584|Hgb|hgb
5257445|NCT00597584|Omontys|omontys
5257446|NCT00597584|peginesatide|peginesatide
5257447|NCT00597584|red blood cell|red blood cell
5257448|NCT00597584|red blood cell production|red blood cell production
5257449|NCT00597558|Egg allergy|egg allergy
5257450|NCT00597545|Carotid Endarterectomy|carotid endarterectomy
5257451|NCT00597545|Neuropsychological tests|neuropsychological tests
5257452|NCT00597545|Stroke|stroke
5257453|NCT00597545|Transient ischemia|transient ischemia
5257454|NCT00597545|Hypoperfusion|hypoperfusion
5257455|NCT00597545|Ischemia|ischemia
5257456|NCT00597532|Breast Cancer|breast cancer
5257457|NCT00597532|Soy|soy
5257458|NCT00597532|Milk|milk
5257459|NCT00597532|Supplementation|supplementation
5257460|NCT00597532|02-062|02-062
5257461|NCT00597519|Cancer|cancer
5257462|NCT00597519|Leukemia|leukemia
5257463|NCT00597519|Myelodysplastic Syndrome|myelodysplastic syndrome
5257464|NCT00597519|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
5257465|NCT00597519|Total Body Irradiation|total body irradiation
5257466|NCT00597519|Umbilical Cord Blood Grafts|umbilical cord blood grafts
5257467|NCT00597519|06-014|06-014
5257468|NCT00597506|colorectal|colorectal
5257469|NCT00597506|refractory|refractory
5257470|NCT00597506|adenocarcinoma|adenocarcinoma
5257471|NCT00597506|bevacizumab|bevacizumab
5257472|NCT00597506|everolimus|everolimus
5257473|NCT00597493|Recurrent Glioblastoma Multiforme|recurrent glioblastoma multiforme
5257474|NCT00597493|GBM|gbm
5257475|NCT00597493|Glioblastoma|glioblastoma
5257476|NCT00597493|Sorafenib|sorafenib
5257477|NCT00597493|Temozolomide|temozolomide
5257478|NCT00597493|Brain Tumor|brain tumor
5257479|NCT00597493|Recurrent GBM|recurrent gbm
5257480|NCT00597493|Temodar|temodar
5257481|NCT00597493|Gliosarcoma|gliosarcoma
5257482|NCT00597493|Glioma|glioma
5257483|NCT00597493|Nexavar|nexavar
5257484|NCT00597480|Growth hormone|growth hormone
5257485|NCT00597480|Child|child
5257486|NCT00597480|insulin resistance|insulin resistance
5257487|NCT00597480|metabolic syndrome X|metabolic syndrome x
5257488|NCT00597480|children born small for gestational age|children born small for gestational age
5257489|NCT00597467|myopia|myopia
5257490|NCT00597467|hyperopia|hyperopia
5257491|NCT00597467|extended wear|extended wear
5257492|NCT00597467|ametropia|ametropia
5257493|NCT00597454|Breast|breast
5257494|NCT00597441|unrelated|unrelated
5257495|NCT00597441|umbilical cord blood transplantation|umbilical cord blood transplantation
5257496|NCT00597441|thymus transplantation|thymus transplantation
5257497|NCT00597415|Osteoarthritis|osteoarthritis
5257498|NCT00597415|Knee pain|knee pain
5257499|NCT00597402|Avastin|avastin
5257500|NCT00597402|Bevacizumab|bevacizumab
5257501|NCT00597402|Temozolomide|temozolomide
5257502|NCT00597402|Temodar|temodar
5257503|NCT00597402|Irinotecan|irinotecan
5257504|NCT00597402|Camptosar|camptosar
5257505|NCT00597402|GBM|gbm
5257506|NCT00597402|Glioblastoma Multiforme|glioblastoma multiforme
5257507|NCT00597402|Gliosarcoma|gliosarcoma
5257508|NCT00597402|Brain tumor|brain tumor
5257509|NCT00597402|Glioma|glioma
5257510|NCT00597402|New GBM|new gbm
5257511|NCT00597402|Newly diagnosed GBM or gliosarcoma malignant brain tumor|newly diagnosed gbm or gliosarcoma malignant brain tumor
5257512|NCT00597389|posttraumatic stress disorder|posttraumatic stress disorder
5257513|NCT00597389|propranolol|propranolol
5257514|NCT00597389|inderol|inderol
5257515|NCT00597389|child|child
5257516|NCT00597389|trauma|trauma
5257517|NCT00597389|Posttraumatic stress disorders (PTSD)|posttraumatic stress disorders (ptsd)
5257518|NCT00597376|memory loss|memory loss
5257519|NCT00597363|vascular access site|vascular access site
5257520|NCT00597363|arterial puncture|arterial puncture
5257521|NCT00597363|femoral pseudoaneurysm|femoral pseudoaneurysm
5257522|NCT00597350|Fenugreek|fenugreek
5257523|NCT00597350|Trigonella foenum-graecum|trigonella foenum-graecum
5257524|NCT00597350|Diabetes mellitus|diabetes mellitus
5257525|NCT00597350|Blood sugar|blood sugar
5257526|NCT00597350|Insulin|insulin
5257527|NCT00597350|Glucose|glucose
5257528|NCT00597337|bullying|bullying
5257529|NCT00597337|victimisation|victimisation
5257530|NCT00597337|aggressive behavior|aggressive behavior
5257531|NCT00597324|Allen's test|allen's test
5257532|NCT00597324|lactate|lactate
5257533|NCT00597324|safety|safety
5257534|NCT00597324|radial intervention|radial intervention
5257535|NCT00597324|Patients with coronary artery disease|patients with coronary artery disease
5257536|NCT00597311|rectal cancer|rectal cancer
5257537|NCT00597311|radiotherapy|radiotherapy
5257538|NCT00597311|radiochemotherapy|radiochemotherapy
5257539|NCT00597298|diaphragmatic paralysis|diaphragmatic paralysis
5257540|NCT00597298|cardiac surgery|cardiac surgery
5257541|NCT00597298|respiratory muscle training|respiratory muscle training
5257542|NCT00597285|18-F-Fluoro-2-Deoxy-D-Glucose (FDG)|18-f-fluoro-2-deoxy-d-glucose (fdg)
5257543|NCT00597285|Magnetic Resonance|magnetic resonance
5257544|NCT00597285|Epilepsy|epilepsy
5257545|NCT00597285|HHV-6B|hhv-6b
5257546|NCT00597285|Healthy Volunteer|healthy volunteer
5257547|NCT00597285|HV|hv
5257548|NCT00597272|melanoma|melanoma
5257549|NCT00597272|resected local|resected local
5257550|NCT00597272|systemic metastasis|systemic metastasis
5257551|NCT00597259|hepatitis B, entecavir, pegylated interferon alfa-2a|hepatitis b, entecavir, pegylated interferon alfa-2a
5257552|NCT00597246|Brain|brain
5257553|NCT00597246|CNS|cns
5257554|NCT00597246|Central Nervous System|central nervous system
5257555|NCT00597207|CPR|cpr
5257556|NCT00597207|mechanical|mechanical
5257557|NCT00597207|manual|manual
5257558|NCT00597207|outcome|outcome
5257559|NCT00597207|survival|survival
5257560|NCT00597207|quality|quality
5257561|NCT00597194|inguinal hernia|inguinal hernia
5257562|NCT00597194|laparoscopic repair|laparoscopic repair
5257563|NCT00597194|open repair|open repair
5257564|NCT00597194|randomized|randomized
5257565|NCT00597181|Inflammatory response|inflammatory response
5257566|NCT00597168|Schizophrenia|schizophrenia
5257567|NCT00597168|atypical antipsychotic|atypical antipsychotic
5257568|NCT00597168|quality of life|quality of life
5257569|NCT00597168|ambulatory setting|ambulatory setting
5257570|NCT00597142|renal stent|renal stent
5257571|NCT00597142|stent|stent
5257572|NCT00597142|atherosclerosis|atherosclerosis
5257573|NCT00597142|aortorenal ostium|aortorenal ostium
5257574|NCT00597142|renal|renal
5257575|NCT00597142|renal artery|renal artery
5257576|NCT00597142|PTRA|ptra
5257577|NCT00597129|pancreatic cancer|pancreatic cancer
5257578|NCT00597129|cancer of the pancreas|cancer of the pancreas
5257579|NCT00597129|pancreas cancer|pancreas cancer
5257580|NCT00597116|Mesothelioma|mesothelioma
5257581|NCT00597116|inoperable|inoperable
5257582|NCT00597116|relapsed|relapsed
5257583|NCT00597103|Hemodialysis|hemodialysis
5257584|NCT00597103|Frequent Hemodialysis|frequent hemodialysis
5257585|NCT00597103|Sleep Apnea|sleep apnea
5257586|NCT00597103|Restless Leg Syndrome|restless leg syndrome
5257587|NCT00597103|Cognitive Function|cognitive function
5257588|NCT00597090|Infections|infections
5257589|NCT00597090|lymphoma|lymphoma
5257590|NCT00597064|asthma|asthma
5257591|NCT00597064|asthma control questionnaire|asthma control questionnaire
5257592|NCT00597064|oral corticosteroid|oral corticosteroid
5257593|NCT00597064|air trapping|air trapping
5257594|NCT00597064|AQLQ|aqlq
5257595|NCT00597064|control|control
5257596|NCT00597064|quality of life|quality of life
5257597|NCT00597038|Dasatinib|dasatinib
5257598|NCT00597038|Dacarbazine|dacarbazine
5257599|NCT00597025|Malnutrition|malnutrition
5257600|NCT00597025|Hypoalbuminemia|hypoalbuminemia
5257601|NCT00597025|Dietary Supplements|dietary supplements
5257602|NCT00597025|Hemodialysis|hemodialysis
5257603|NCT00597025|Peritoneal Dialysis|peritoneal dialysis
5257604|NCT00597012|Meniscal Tear|meniscal tear
5257605|NCT00597012|Osteoarthritis|osteoarthritis
5257606|NCT00597012|Arthroscopic Partial Meniscectomy|arthroscopic partial meniscectomy
5257607|NCT00597012|Physical Therapy|physical therapy
5257608|NCT00596999|Myelodysplastic Syndrome (MDS)|myelodysplastic syndrome (mds)
5257609|NCT00596999|Acute myelogenous Leukemia (AML)|acute myelogenous leukemia (aml)
5257610|NCT00596999|Acute Lymphocytic Leukemia (ALL)|acute lymphocytic leukemia (all)
5257611|NCT00596999|Sickle Cell Disease (SCD)|sickle cell disease (scd)
5257612|NCT00596999|Beta Thalassemia|beta thalassemia
5257613|NCT00596999|Inborn Errors of Metabolism|inborn errors of metabolism
5257614|NCT00596999|Severe Combined Immunodeficiency Disease (SCID)|severe combined immunodeficiency disease (scid)
5257615|NCT00596986|Depression|depression
5257616|NCT00596986|Duloxetine|duloxetine
5257617|NCT00596986|Psychotherapy|psychotherapy
5257618|NCT00596986|Magnetic Resonance Imaging|magnetic resonance imaging
5257619|NCT00596960|Alcohol Abuse|alcohol abuse
5257620|NCT00596960|Alcohol Dependence|alcohol dependence
5257621|NCT00596960|Carbohydrate Deficient Transferrin|carbohydrate deficient transferrin
5257622|NCT00596960|Drug Dependence|drug dependence
5257623|NCT00596960|Hepatitis C|hepatitis c
5257624|NCT00596960|Motivation|motivation
5257625|NCT00596947|kidney transplantation|kidney transplantation
5257626|NCT00596947|tacrolimus|tacrolimus
5257627|NCT00596947|Prograf|prograf
5257628|NCT00596947|mycophenolate mofetil|mycophenolate mofetil
5257629|NCT00596947|CellCept|cellcept
5257630|NCT00596947|corticosteroid withdrawal|corticosteroid withdrawal
5257631|NCT00596947|prednisone withdrawal|prednisone withdrawal
5257632|NCT00596947|prednisone maintenance|prednisone maintenance
5257633|NCT00596947|rabbit antithymocyte globulin|rabbit antithymocyte globulin
5257634|NCT00596947|Thymoglobulin|thymoglobulin
5257635|NCT00596934|Nonalcoholic fatty liver disease|nonalcoholic fatty liver disease
5257636|NCT00596934|Insulin resistance|insulin resistance
5257637|NCT00596934|Obesity|obesity
5257638|NCT00596934|Leptin therapy|leptin therapy
5257639|NCT00596934|NASH|nash
5257640|NCT00596921|Ultrasonography|ultrasonography
5257641|NCT00596921|Central Venous Pressure|central venous pressure
5257642|NCT00596921|Noninvasive monitoring|noninvasive monitoring
5257643|NCT00596921|Shock|shock
5257644|NCT00596921|Resuscitation|resuscitation
5257645|NCT00596908|Essential Tremor|essential tremor
5257646|NCT00596908|Parkinsonian Tremor|parkinsonian tremor
5257647|NCT00596908|Parkinson Disease|parkinson disease
5257648|NCT00596908|Upper Extremity Tremor with duration of less than 2 years|upper extremity tremor with duration of less than 2 years
5257649|NCT00596895|Isoflavone, PSA, prostate cancer, recurrent, quality of life|isoflavone, psa, prostate cancer, recurrent, quality of life
5257650|NCT00596882|smoking cessation|smoking cessation
5257651|NCT00596882|nicotine dependence|nicotine dependence
5257652|NCT00596882|message prime|message prime
5257653|NCT00596882|recruitment|recruitment
5257654|NCT00596856|Early childhood caries - ECC|early childhood caries - ecc
5257655|NCT00596856|Referral behavior|referral behavior
5257656|NCT00596856|Oral health risk assessment|oral health risk assessment
5257657|NCT00596856|Guideline development and dissemination|guideline development and dissemination
5257658|NCT00596830|IGF-1R inhibitor|igf-1r inhibitor
5257659|NCT00596830|Non-small-cell lung carcinoma|non-small-cell lung carcinoma
5257660|NCT00596830|CP-751|cp-751
5257661|NCT00596830|871|871
5257662|NCT00596817|Relapse prevention|relapse prevention
5257663|NCT00596817|Antidepressants|antidepressants
5257664|NCT00596817|Placebo-controlled|placebo-controlled
5257665|NCT00596817|Double-blind|double-blind
5257666|NCT00596817|Multicentre study|multicentre study
5257667|NCT00596804|NHL|nhl
5257668|NCT00596804|Non-Hodgkin's lymphoma|non-hodgkin's lymphoma
5257669|NCT00596804|follicular lymphoma|follicular lymphoma
5257670|NCT00596804|B-cell lymphoma|b-cell lymphoma
5257671|NCT00596804|diffuse large cell lymphoma|diffuse large cell lymphoma
5257672|NCT00596804|small lymphoctytic lymphoma|small lymphoctytic lymphoma
5257673|NCT00596804|Mantle cell lymphoma|mantle cell lymphoma
5257674|NCT00596804|MALT|malt
5257675|NCT00596804|marginal zone lymphoma|marginal zone lymphoma
5257676|NCT00596804|High-Grade|high-grade
5257677|NCT00596804|Intermediate-Grade|intermediate-grade
5257678|NCT00596804|Low-Grade|low-grade
5257679|NCT00596804|Mixed|mixed
5257680|NCT00596778|Physical therapy specialty|physical therapy specialty
5257681|NCT00596778|Postoperative period. Abdominal surgery|postoperative period. abdominal surgery
5257682|NCT00596778|Anesthesia recovery period|anesthesia recovery period
5257683|NCT00596778|Spirometry|spirometry
5257684|NCT00596765|Brain Injury|brain injury
5257685|NCT00596765|Neuropsychology|neuropsychology
5257686|NCT00596765|Cognitive Behavioral Therapy|cognitive behavioral therapy
5257687|NCT00596765|Neuropsychological Rehabilitation|neuropsychological rehabilitation
5257688|NCT00596752|Alprostadil|alprostadil
5257689|NCT00596752|Prostavasin|prostavasin
5257690|NCT00596752|PAOD|paod
5257691|NCT00596752|Fontaine Stage IV|fontaine stage iv
5257692|NCT00596739|Bariatric surgery, weight loss surgery, male infertility, Roux-En-Y, gastric banding|bariatric surgery, weight loss surgery, male infertility, roux-en-y, gastric banding
5257693|NCT00596726|All patients presenting for high-risk cardiac surgery and who might post-operatively meet the study inclusion criteria are potential study candidates.|all patients presenting for high-risk cardiac surgery and who might post-operatively meet the study inclusion criteria are potential study candidates.
5257694|NCT00596713|general population|general population
5257695|NCT00596700|Capsule endoscopy|capsule endoscopy
5257696|NCT00596700|Crohn's disease|crohn's disease
5257697|NCT00596700|IBD|ibd
5257698|NCT00596700|Activity score|activity score
5257699|NCT00596700|Small bowel|small bowel
5257700|NCT00596700|Crohn's disease of the small bowel in any stage|crohn's disease of the small bowel in any stage
5257701|NCT00596700|Recruiting|recruiting
5257702|NCT00596687|diabetes|diabetes
5257703|NCT00596687|post-op complications|post-op complications
5257704|NCT00596687|inpatient hyperglycemia|inpatient hyperglycemia
5257705|NCT00596674|Women|women
5257706|NCT00596674|Fibromyalgia Syndrome|fibromyalgia syndrome
5257707|NCT00596674|Health Behaviors|health behaviors
5257708|NCT00596674|Quality of Life|quality of life
5257709|NCT00596661|coronary stent|coronary stent
5257710|NCT00596648|Lung Cancer|lung cancer
5257711|NCT00596648|Non-Small-Cell Lung Cancer|non-small-cell lung cancer
5257712|NCT00596648|NSCLC|nsclc
5257713|NCT00596635|UTI|uti
5257714|NCT00596635|elderly|elderly
5257715|NCT00596635|prevention|prevention
5257716|NCT00596635|cranberry|cranberry
5257717|NCT00596635|E.Coli|e.coli
5257718|NCT00596622|Major Depressive or Manic Episodes|major depressive or manic episodes
5257719|NCT00596622|Bipolar|bipolar
5257720|NCT00596622|Mania|mania
5257721|NCT00596622|Depression|depression
5257722|NCT00596622|Lithium|lithium
5257723|NCT00596622|fMRI|fmri
5257724|NCT00596622|Pictures|pictures
5257725|NCT00596622|Brain Scan|brain scan
5257726|NCT00596609|Injections, intrathecal|injections, intrathecal
5257727|NCT00596609|Transcranial|transcranial
5257728|NCT00596609|Spinal Fusion|spinal fusion
5257729|NCT00596609|Evoked Potentials, Motor|evoked potentials, motor
5257730|NCT00596596|Constipation|constipation
5257731|NCT00596596|prucalopride|prucalopride
5257732|NCT00596570|Atrial fibrillation|atrial fibrillation
5257932|NCT00595517|GI|gi
5257733|NCT00596570|Oral Anticoagulation|oral anticoagulation
5257734|NCT00596570|Percutaneous coronary intervention|percutaneous coronary intervention
5257735|NCT00596557|Renal function, heart transplant, everolimus|renal function, heart transplant, everolimus
5257736|NCT00596544|sexual dysfunction|sexual dysfunction
5257737|NCT00596531|Tinnitus|tinnitus
5257738|NCT00596531|acamprosate|acamprosate
5257739|NCT00596531|clinical trial|clinical trial
5257740|NCT00596505|proliferative diabetic retinopathy|proliferative diabetic retinopathy
5257741|NCT00596505|bevacizumab (Avastin)|bevacizumab (avastin)
5257742|NCT00596505|vitreous hemorrhage|vitreous hemorrhage
5257743|NCT00596505|silicone oil|silicone oil
5257744|NCT00596479|CAD|cad
5257745|NCT00596479|G-CSF|g-csf
5257746|NCT00596479|Collaterals|collaterals
5257747|NCT00596479|CFI|cfi
5257748|NCT00596479|perfusion|perfusion
5257749|NCT00596466|open-label|open-label
5257750|NCT00596466|extension study|extension study
5257751|NCT00596466|pregabalin|pregabalin
5257752|NCT00596466|partial epilepsy|partial epilepsy
5257753|NCT00596453|Prostate Specific Antigen (PSA)|prostate specific antigen (psa)
5257754|NCT00596453|Elevated Prostate Specific Antigen (PSA)|elevated prostate specific antigen (psa)
5257755|NCT00596440|smoking|smoking
5257756|NCT00596440|teachable moment|teachable moment
5257757|NCT00596440|cancer|cancer
5257758|NCT00596427|type two diabetes|type two diabetes
5257759|NCT00596427|gluconeogenesis|gluconeogenesis
5257760|NCT00596427|glucose|glucose
5257761|NCT00596427|lipid synthesis|lipid synthesis
5257762|NCT00596427|hepatic insulin sensitivity|hepatic insulin sensitivity
5257763|NCT00596427|colesevelam HCl|colesevelam hcl
5257764|NCT00596414|liver|liver
5257765|NCT00596414|biopsy|biopsy
5257766|NCT00596388|HMP, AMD, CNV, PHP, HPHP|hmp, amd, cnv, php, hphp
5257767|NCT00596375|Lidocaine|lidocaine
5257768|NCT00596375|Infant|infant
5257769|NCT00596375|Urinary Catheterization|urinary catheterization
5257770|NCT00596375|Emergency Medicine|emergency medicine
5257771|NCT00596375|Analgesia|analgesia
5257772|NCT00596362|Melanoma|melanoma
5257773|NCT00596362|Eye|eye
5257774|NCT00596362|Avastin|avastin
5257775|NCT00596349|epithelial Ovarian Cancer|epithelial ovarian cancer
5257776|NCT00596349|Quality of Life|quality of life
5257777|NCT00596349|Survivorship|survivorship
5257778|NCT00596323|antenna|antenna
5257779|NCT00596323|continuous glucose monitoring|continuous glucose monitoring
5257780|NCT00596323|electromagnetic|electromagnetic
5257781|NCT00596310|Lung cancer|lung cancer
5257782|NCT00596310|screening|screening
5257783|NCT00596297|Diabetic Retinopathy|diabetic retinopathy
5257784|NCT00596297|Vitreous Hemorrhage|vitreous hemorrhage
5257785|NCT00596297|Bevacizumab|bevacizumab
5257786|NCT00596297|pars plana vitrectomy|pars plana vitrectomy
5257787|NCT00596297|preoperative|preoperative
5257788|NCT00596284|Cognitive Behavior Therapy|cognitive behavior therapy
5257789|NCT00596284|Alzheimer's Disease|alzheimer's disease
5257790|NCT00596258|Cervical Intraepithelial Neoplasia (CIN)|cervical intraepithelial neoplasia (cin)
5257791|NCT00596258|High-grade Cervical Intraepithelial Neoplasia|high-grade cervical intraepithelial neoplasia
5257792|NCT00596258|High-grade Squamous Intraepithelial Lesions (HSIL)|high-grade squamous intraepithelial lesions (hsil)
5257793|NCT00596258|Human Papilloma Virus (HPV)|human papilloma virus (hpv)
5257794|NCT00596258|High-Grade Cervical Intraepithelial Lesions (CIN 2/3)|high-grade cervical intraepithelial lesions (cin 2/3)
5257795|NCT00596245|non-smoking healthy volunteers aged 18 - 35|non-smoking healthy volunteers aged 18 - 35
5257796|NCT00596219|HEAD|head
5257797|NCT00596219|NECK|neck
5257798|NCT00596219|SQUAMOUS|squamous
5257799|NCT00596219|CARCINOMA|carcinoma
5257800|NCT00596193|Hyperalgesia|hyperalgesia
5257801|NCT00596193|nociceptors|nociceptors
5257802|NCT00596193|Neurons|neurons
5257803|NCT00596180|carbon monoxide poisoning|carbon monoxide poisoning
5257804|NCT00596180|brain injury|brain injury
5257805|NCT00596167|Short-daily hemodialysis|short-daily hemodialysis
5257806|NCT00596167|pharmacokinetics|pharmacokinetics
5257807|NCT00596167|levofloxacin|levofloxacin
5257808|NCT00596167|gentamicin|gentamicin
5257809|NCT00596167|vancomycin|vancomycin
5257810|NCT00596141|oral periodontal gingival intraoral mucosal mucoperiosteal|oral periodontal gingival intraoral mucosal mucoperiosteal
5257811|NCT00596141|Surgery, Oral|surgery, oral
5257812|NCT00596128|Blood glucose|blood glucose
5257813|NCT00596128|Clinical pathways|clinical pathways
5257814|NCT00596076|Low back pain|low back pain
5257815|NCT00596063|pharmacokinetics|pharmacokinetics
5257816|NCT00596063|pharmacodynamics|pharmacodynamics
5257817|NCT00596063|recombinant human insulin|recombinant human insulin
5257818|NCT00596063|healthy volunteers|healthy volunteers
5257819|NCT00596050|procedural sedation|procedural sedation
5257820|NCT00596050|fracture reduction|fracture reduction
5257821|NCT00596050|pediatric emergency medicine|pediatric emergency medicine
5257822|NCT00596050|etomidate|etomidate
5257823|NCT00596050|ketamine|ketamine
5257824|NCT00596050|analgesia|analgesia
5257825|NCT00596037|Growth hormone Deficiency|growth hormone deficiency
5257826|NCT00596011|prostate cancer|prostate cancer
5257827|NCT00596011|PIN|pin
5257828|NCT00596011|polyphenon E|polyphenon e
5257829|NCT00596011|EGCG|egcg
5257830|NCT00595998|AMD, HMP, PHP|amd, hmp, php
5257831|NCT00595985|Time to Progression|time to progression
5257832|NCT00595985|Toxicity|toxicity
5257833|NCT00595985|Overall survival|overall survival
5257834|NCT00595985|Response rate|response rate
5257835|NCT00595985|Quality of live|quality of live
5257836|NCT00595985|Toxicities|toxicities
5257837|NCT00595972|Time to Progression|time to progression
5257838|NCT00595972|Overall survival|overall survival
5257839|NCT00595972|Response rate|response rate
5257840|NCT00595972|Quality of Live|quality of live
5257841|NCT00595972|Toxicities|toxicities
5257842|NCT00595933|Head and Neck cancer|head and neck cancer
5257843|NCT00595933|Radiation therapy|radiation therapy
5257844|NCT00595933|Dry mouth remedies|dry mouth remedies
5257845|NCT00595933|Dry Mouth|dry mouth
5257846|NCT00595933|Xerostomia|xerostomia
5257847|NCT00595920|Tovaxin|tovaxin
5257848|NCT00595920|Autologous|autologous
5257849|NCT00595920|T-cell vaccine (TCV)|t-cell vaccine (tcv)
5257850|NCT00595907|tuberculosis|tuberculosis
5257851|NCT00595907|interferon gamma release assays|interferon gamma release assays
5257852|NCT00595907|treatment|treatment
5257853|NCT00595894|rheumatoid arthritis|rheumatoid arthritis
5257854|NCT00595894|African Americans|african americans
5257855|NCT00595894|osteopenia|osteopenia
5257856|NCT00595894|osteoporosis|osteoporosis
5257857|NCT00595894|bone mineral density|bone mineral density
5257858|NCT00595881|Bedside emergency ultrasound|bedside emergency ultrasound
5257859|NCT00595881|Abscess|abscess
5257860|NCT00595881|Cellulitis|cellulitis
5257861|NCT00595881|Soft tissue infection|soft tissue infection
5257862|NCT00595881|Methicillin resistant staphylococcus aureus (MRSA)|methicillin resistant staphylococcus aureus (mrsa)
5257863|NCT00595868|Nicotine|nicotine
5257864|NCT00595868|Smoking|smoking
5257865|NCT00595868|Smoking Cessation|smoking cessation
5257866|NCT00595855|glaucoma|glaucoma
5257867|NCT00595855|surgery|surgery
5257868|NCT00595855|non penetrating procedures|non penetrating procedures
5257869|NCT00595855|cataract|cataract
5257870|NCT00595842|Mineral trioxide aggregate|mineral trioxide aggregate
5257871|NCT00595829|Polycythemia Vera|polycythemia vera
5257872|NCT00595829|PV|pv
5257873|NCT00595816|low back pain|low back pain
5257874|NCT00595816|physical fitness|physical fitness
5257875|NCT00595816|injury|injury
5257876|NCT00595816|prevention|prevention
5257877|NCT00595816|conscripts|conscripts
5257878|NCT00595777|Institutional change|institutional change
5257879|NCT00595777|Improved pain management|improved pain management
5257880|NCT00595764|Buprenorphine|buprenorphine
5257881|NCT00595764|Buprenorphine/naloxone|buprenorphine/naloxone
5257882|NCT00595764|Counseling|counseling
5257883|NCT00595764|Primary care|primary care
5257884|NCT00595751|ADHD, Attention Deficit Hyperactivity Disorder|adhd, attention deficit hyperactivity disorder
5257885|NCT00595738|Congestive heart failure|congestive heart failure
5257886|NCT00595738|Cardiac biomarkers|cardiac biomarkers
5257887|NCT00595738|Hemodynamics|hemodynamics
5257888|NCT00595738|Tailored therapy|tailored therapy
5257889|NCT00595725|Cervix|cervix
5257890|NCT00595725|Endometrium|endometrium
5257891|NCT00595725|Cervical Carcinoma|cervical carcinoma
5257892|NCT00595725|Lymphatic Mapping|lymphatic mapping
5257893|NCT00595712|Genovarum|genovarum
5257894|NCT00595712|Medial opening-wedge high tibial osteotomy|medial opening-wedge high tibial osteotomy
5257895|NCT00595712|allograft|allograft
5257896|NCT00595686|Hematologic Malignancies Hsp90 Hematologic Malignancy|hematologic malignancies hsp90 hematologic malignancy
5257897|NCT00595673|Perfusion|perfusion
5257898|NCT00595673|Echocardiograpy|echocardiograpy
5257899|NCT00595673|SPECT|spect
5257900|NCT00595673|angiography|angiography
5257901|NCT00595673|Chest pain|chest pain
5257902|NCT00595660|Palpable Breast Mass|palpable breast mass
5257903|NCT00595660|FNA|fna
5257904|NCT00595660|Cytology|cytology
5257905|NCT00595660|Fine needle aspiration|fine needle aspiration
5257906|NCT00595660|Specimen Adequacy|specimen adequacy
5257907|NCT00595634|Hip|hip
5257908|NCT00595634|Fracture|fracture
5257909|NCT00595634|Intertrochanteric|intertrochanteric
5257910|NCT00595634|intramedullary|intramedullary
5257911|NCT00595608|aftercare|aftercare
5257912|NCT00595608|nasal septum|nasal septum
5257913|NCT00595608|turbinates|turbinates
5257914|NCT00595595|Dental Pulp|dental pulp
5257915|NCT00595595|Regenerative Medicine|regenerative medicine
5257916|NCT00595595|Odontoblasts|odontoblasts
5257917|NCT00595595|Stem Cells|stem cells
5257918|NCT00595595|Growth factor differentiation of stem/progenitor cells|growth factor differentiation of stem/progenitor cells
5257919|NCT00595595|Odontoblast-specific cell phenotypes|odontoblast-specific cell phenotypes
5257920|NCT00595569|flexible insulin therapy|flexible insulin therapy
5257921|NCT00595569|diabetes education|diabetes education
5257922|NCT00595569|diabetes|diabetes
5257923|NCT00595569|insulin|insulin
5257924|NCT00595569|Weekly ambulatory sessions|weekly ambulatory sessions
5257925|NCT00595556|Zonisamide|zonisamide
5257926|NCT00595556|Pharmacotherapy|pharmacotherapy
5257927|NCT00595556|Alcohol dependence|alcohol dependence
5257928|NCT00595556|anticonvulsant|anticonvulsant
5257929|NCT00595530|ketamine|ketamine
5257930|NCT00595530|vasoocclusive pain|vasoocclusive pain
5257931|NCT00595517|gastrointestinal|gastrointestinal
5257933|NCT00595517|NSAID|nsaid
5257934|NCT00595517|Japan|japan
5257935|NCT00595517|Japanese|japanese
5257936|NCT00595517|Gastric ulcer|gastric ulcer
5257937|NCT00595517|duodenal ulcer|duodenal ulcer
5257938|NCT00595504|schizophrenia|schizophrenia
5257939|NCT00595504|metabolism|metabolism
5257940|NCT00595504|antipsychotics|antipsychotics
5257941|NCT00595504|diabetes|diabetes
5257942|NCT00595504|rozerem|rozerem
5257943|NCT00595491|Asthma|asthma
5257944|NCT00595491|Inflammation|inflammation
5257945|NCT00595491|Allergic|allergic
5257946|NCT00595491|Airway|airway
5257947|NCT00595491|Challenge|challenge
5257948|NCT00595491|Chemokines|chemokines
5257949|NCT00595439|Sensory Evoked Potentials (SEPs)|sensory evoked potentials (seps)
5257950|NCT00595439|Electromyogram|electromyogram
5257951|NCT00595439|Transcranial Magnetic Stimulation (TMS)|transcranial magnetic stimulation (tms)
5257952|NCT00595439|Complex Regional Pain Syndrome|complex regional pain syndrome
5257953|NCT00595439|Focal Hand Dystonia|focal hand dystonia
5257954|NCT00595439|Focal Dystonia|focal dystonia
5257955|NCT00595439|Chronic Regional Pain Syndrome|chronic regional pain syndrome
5257956|NCT00595439|CRPS|crps
5257957|NCT00595426|Knee Arthroplasty|knee arthroplasty
5257958|NCT00595426|Factor Xa|factor xa
5257959|NCT00595426|VTE|vte
5257960|NCT00595426|Thrombosis|thrombosis
5257961|NCT00595426|Anticoagulants|anticoagulants
5257962|NCT00595413|Rheumatoid arthritis|rheumatoid arthritis
5257963|NCT00595413|Atacicept|atacicept
5257964|NCT00595413|Adalimumab|adalimumab
5257965|NCT00595413|Humira®|humira®
5257966|NCT00595387|Cognitive Behavioral Therapy|cognitive behavioral therapy
5257967|NCT00595361|asthma|asthma
5257968|NCT00595361|exercise induced asthma|exercise induced asthma
5257969|NCT00595361|exercise induced bronchoconstriction|exercise induced bronchoconstriction
5257970|NCT00595361|long acting beta agonist|long acting beta agonist
5257971|NCT00595361|salmeterol|salmeterol
5257972|NCT00595361|exercise challenge|exercise challenge
5257973|NCT00595361|bronchoprotection|bronchoprotection
5257974|NCT00595361|beta 2 adrenergic receptor polymorphisms|beta 2 adrenergic receptor polymorphisms
5257975|NCT00595361|pharmacogenetics|pharmacogenetics
5257976|NCT00595335|Thyroid-associated ophthalmopathy|thyroid-associated ophthalmopathy
5257977|NCT00595335|Rituximab|rituximab
5257978|NCT00595335|Proptosis|proptosis
5257979|NCT00595322|Bevacizumab|bevacizumab
5257980|NCT00595322|Radiation Treatment|radiation treatment
5257981|NCT00595322|Brain Cancer|brain cancer
5257982|NCT00595296|BreastCancer|breastcancer
5257983|NCT00595296|Sentinel Lymph Nodes|sentinel lymph nodes
5257984|NCT00595296|Metastasis|metastasis
5257985|NCT00595283|Preschool Onset Major Depressive Disorder|preschool onset major depressive disorder
5257986|NCT00595283|Preschool Depression|preschool depression
5257987|NCT00595283|Emotion Development|emotion development
5257988|NCT00595283|Parent Child Interaction|parent child interaction
5257989|NCT00595257|PAD, CLI, Critical Limb Ischemia, bone marrow, stem cell, injection, infusion|pad, cli, critical limb ischemia, bone marrow, stem cell, injection, infusion
5257990|NCT00595244|Perfusion|perfusion
5257991|NCT00595244|Echocardiograpy|echocardiograpy
5257992|NCT00595244|SPECT|spect
5257993|NCT00595244|angiography|angiography
5257994|NCT00595244|Chest pain|chest pain
5257995|NCT00595231|GAD|gad
5257996|NCT00595218|Patient Preferences|patient preferences
5257997|NCT00595218|Patient Satisfaction|patient satisfaction
5257998|NCT00595218|Patient-Doctor Relationship|patient-doctor relationship
5257999|NCT00595205|vaccination|vaccination
5258000|NCT00595205|intussusception|intussusception
5258001|NCT00595205|Rotavirus|rotavirus
5258002|NCT00595205|vaccine|vaccine
5258003|NCT00595179|Infrared|infrared
5258004|NCT00595179|Imaging Techniques|imaging techniques
5258005|NCT00595179|Kidney Reperfusion|kidney reperfusion
5258006|NCT00595179|Pneumoperitoneum|pneumoperitoneum
5258007|NCT00595179|Nephrectomy|nephrectomy
5258008|NCT00595166|Women with excessive vaginal tissue that obstruct the examiner's view of the cervix during a vaginal speculum examination|women with excessive vaginal tissue that obstruct the examiner's view of the cervix during a vaginal speculum examination
5258009|NCT00595140|Acromegaly,|acromegaly,
5258010|NCT00595140|growth hormone receptor antagonist,|growth hormone receptor antagonist,
5258011|NCT00595140|somatostatin analogue,|somatostatin analogue,
5258012|NCT00595140|combined medical treatment,|combined medical treatment,
5258013|NCT00595140|acute effect,|acute effect,
5258014|NCT00595140|endogenous GH|endogenous gh
5258015|NCT00595127|Fanconi|fanconi
5258016|NCT00595127|Anemia|anemia
5258017|NCT00595127|Stem Cell|stem cell
5258018|NCT00595127|Transplant|transplant
5258019|NCT00595114|COPD|copd
5258020|NCT00595114|Airway|airway
5258021|NCT00595114|Inflammation|inflammation
5258022|NCT00595114|Infection|infection
5258023|NCT00595114|Lipid Mediators|lipid mediators
5258024|NCT00595114|Oxidative Stress|oxidative stress
5258025|NCT00595088|Bladder Cancer|bladder cancer
5258026|NCT00595088|Refractory|refractory
5258027|NCT00595075|sleep|sleep
5258028|NCT00595075|performance|performance
5258029|NCT00595075|night shift|night shift
5258030|NCT00595075|Ramelteon|ramelteon
5258031|NCT00595075|Healthy Individuals|healthy individuals
5258032|NCT00595062|Breast|breast
5258033|NCT00595062|Cancer|cancer
5258034|NCT00595049|pulmonary|pulmonary
5258035|NCT00595049|arterial|arterial
5258036|NCT00595049|artery|artery
5258037|NCT00595049|hypertension|hypertension
5258038|NCT00595049|systemic|systemic
5258039|NCT00595049|sclerosis|sclerosis
5258040|NCT00595049|scleroderma|scleroderma
5258041|NCT00595049|remodelling|remodelling
5258042|NCT00595049|bosentan|bosentan
5258043|NCT00595049|tracleer|tracleer
5258044|NCT00595049|intravascular|intravascular
5258045|NCT00595023|Sentinel lymph node|sentinel lymph node
5258046|NCT00595023|Metastasis|metastasis
5258047|NCT00595010|Child Maltreatment|child maltreatment
5258048|NCT00595010|Child Neglect|child neglect
5258049|NCT00595010|Child Physical Abuse|child physical abuse
5258050|NCT00595010|Evidence-Based Practice|evidence-based practice
5258051|NCT00594997|Lyme disease|lyme disease
5258052|NCT00594997|educational intervention for children|educational intervention for children
5258053|NCT00594997|tick borne illness|tick borne illness
5258054|NCT00594997|prophylactic therapy in children|prophylactic therapy in children
5258055|NCT00594997|Self-efficacy|self-efficacy
5258056|NCT00594997|tick prevention|tick prevention
5258057|NCT00594997|tick avoidance|tick avoidance
5258058|NCT00594997|health behavior modification|health behavior modification
5258059|NCT00594971|Health Services Research|health services research
5258060|NCT00594971|Family practice|family practice
5258061|NCT00594932|lupus, arthritis, mycophenolate, biomarkers|lupus, arthritis, mycophenolate, biomarkers
5258062|NCT00594919|acute kidney injury|acute kidney injury
5258063|NCT00594919|ngal|ngal
5258064|NCT00594919|cardiac surgery|cardiac surgery
5258065|NCT00594906|Fracture Healing|fracture healing
5258066|NCT00594906|Teriparatide|teriparatide
5258067|NCT00594906|Forteo|forteo
5258068|NCT00594906|Pelvic Fractures|pelvic fractures
5258070|NCT00594893|Arthroplasty|arthroplasty
5258071|NCT00594893|Minimally Invasive|minimally invasive
5258072|NCT00594880|HIV|hiv
5258073|NCT00594880|HIV-1|hiv-1
5258074|NCT00594880|Pegasys|pegasys
5258075|NCT00594880|Peg-IFN-Alpha-2A|peg-ifn-alpha-2a
5258076|NCT00594880|Viral Suppression|viral suppression
5258077|NCT00594880|ART cessation|art cessation
5258078|NCT00594880|Immune function|immune function
5258079|NCT00594880|Innate Immunity|innate immunity
5258080|NCT00594880|Toxicity|toxicity
5258081|NCT00594880|Immune-based therapy|immune-based therapy
5258082|NCT00594880|Treatment interruption|treatment interruption
5258083|NCT00594867|Healthy|healthy
5258084|NCT00594867|Volunteer|volunteer
5258085|NCT00594854|NSAID|nsaid
5258086|NCT00594854|Gastric Ulcer|gastric ulcer
5258087|NCT00594854|High risk|high risk
5258088|NCT00594854|Arthrotec|arthrotec
5258089|NCT00594854|Vimovo|vimovo
5258090|NCT00594841|Acromioclavicular Joint|acromioclavicular joint
5258091|NCT00594841|Shoulder dislocation|shoulder dislocation
5258092|NCT00594841|AC dislocation|ac dislocation
5258093|NCT00594828|Patient self-testing|patient self-testing
5258094|NCT00594828|Oral anticoagulation therapy|oral anticoagulation therapy
5258095|NCT00594828|Expert Systems|expert systems
5258096|NCT00594828|Point-of-Care Systems|point-of-care systems
5258097|NCT00594828|International Normalized Ratio|international normalized ratio
5258098|NCT00594815|Lymphoma|lymphoma
5258099|NCT00594815|Central Nervous System|central nervous system
5258100|NCT00594802|ALLERGIC REACTION|allergic reaction
5258101|NCT00594789|Osteoporosis|osteoporosis
5258102|NCT00594789|Fractures|fractures
5258103|NCT00594789|Bone densitometry|bone densitometry
5258104|NCT00594789|Dual-energy x-ray absorptiometry|dual-energy x-ray absorptiometry
5258105|NCT00594776|Cone Beam CT|cone beam ct
5258106|NCT00594776|CBCT|cbct
5258107|NCT00594776|Bone Tumors|bone tumors
5258108|NCT00594776|Autographs|autographs
5258109|NCT00594776|Allographs|allographs
5258110|NCT00594763|Turner syndrome|turner syndrome
5258111|NCT00594763|Thromboembolic disease|thromboembolic disease
5258112|NCT00594737|PET|pet
5258113|NCT00594737|frontotemporal dementia|frontotemporal dementia
5258114|NCT00594737|memantine|memantine
5258115|NCT00594737|Pick's disease|pick's disease
5258116|NCT00594724|Tongue|tongue
5258117|NCT00594724|Carcinoma|carcinoma
5258118|NCT00594724|Cancer|cancer
5258119|NCT00594724|02-093|02-093
5258120|NCT00594711|Psychotherapy|psychotherapy
5258121|NCT00594711|depression|depression
5258122|NCT00594698|Perfusion|perfusion
5258123|NCT00594698|Echocardiography|echocardiography
5258124|NCT00594698|Cardiac angiography|cardiac angiography
5258125|NCT00594698|SPECT|spect
5258126|NCT00594685|Heparin|heparin
5258127|NCT00594685|Thromboembolism|thromboembolism
5258128|NCT00594685|Thrombosis|thrombosis
5258129|NCT00594672|Age-Related Macular Degeneration (AMD)|age-related macular degeneration (amd)
5258130|NCT00594672|Cataracts|cataracts
5258131|NCT00594672|Age Related Macular Degeneration|age related macular degeneration
5258132|NCT00594672|AMD|amd
5258133|NCT00594672|Cataract|cataract
5258134|NCT00594659|Marijuana|marijuana
5258135|NCT00594659|Treatment|treatment
5258136|NCT00594659|Behavioral|behavioral
5258137|NCT00594659|Computer|computer
5258138|NCT00594659|Internet|internet
5258625|NCT00592189|Amnion|amnion
5258139|NCT00594646|HIV Prevention|hiv prevention
5258140|NCT00594646|Non-occupational post-exposure prophylaxis|non-occupational post-exposure prophylaxis
5258141|NCT00594646|HIV seronegativity|hiv seronegativity
5258142|NCT00594633|Cognitive dysfunction|cognitive dysfunction
5258143|NCT00594607|clotting|clotting
5258144|NCT00594607|hemodialysis|hemodialysis
5258145|NCT00594607|anticoagulation|anticoagulation
5258146|NCT00594607|bleeding risk|bleeding risk
5258147|NCT00594594|spinal cord injury|spinal cord injury
5258148|NCT00594594|urinary tract infection|urinary tract infection
5258149|NCT00594594|probiotics|probiotics
5258150|NCT00594594|Lactobacilli|lactobacilli
5258151|NCT00594581|cicatrix, scarring, TGF-beta3, avotermin, Juvista|cicatrix, scarring, tgf-beta3, avotermin, juvista
5258152|NCT00594555|Blood disease, bone marrow|blood disease, bone marrow
5258153|NCT00594555|AML|aml
5258154|NCT00594555|CML,Blast Crisis|cml,blast crisis
5258155|NCT00594542|lidocaine|lidocaine
5258156|NCT00594542|local anesthesia|local anesthesia
5258157|NCT00594542|Mohs micrographic surgery|mohs micrographic surgery
5258158|NCT00594529|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
5258159|NCT00594529|Metastatic liver lesions from colorectal cancers|metastatic liver lesions from colorectal cancers
5258160|NCT00594516|Low Back Pain|low back pain
5258161|NCT00594516|Dose Equivalence|dose equivalence
5258162|NCT00594516|Tapentadol (CG5503)|tapentadol (cg5503)
5258163|NCT00594516|Tapentadol-IR|tapentadol-ir
5258164|NCT00594516|Tapentadol-ER|tapentadol-er
5258165|NCT00594503|traumatic brain injury|traumatic brain injury
5258166|NCT00594490|Breast, reconstruction, silicone|breast, reconstruction, silicone
5258167|NCT00594477|IMRT|imrt
5258168|NCT00594477|breast cancer with regional nodal metastasis|breast cancer with regional nodal metastasis
5258169|NCT00594464|Rotigotine|rotigotine
5258170|NCT00594464|NEUPRO®|neupro®
5258171|NCT00594464|Parkinson's Disease (PD)|parkinson's disease (pd)
5258172|NCT00594464|perioperative use|perioperative use
5258173|NCT00594464|anaesthesia,|anaesthesia,
5258174|NCT00594451|rheumatoid arthritis|rheumatoid arthritis
5258175|NCT00594451|cigarette smoking|cigarette smoking
5258176|NCT00594451|gene-environmental interactions|gene-environmental interactions
5258177|NCT00594451|autoimmunity|autoimmunity
5258178|NCT00594451|disease severity|disease severity
5258179|NCT00594438|Synthes Reamer-Irrigator-Aspirator (RIA)|synthes reamer-irrigator-aspirator (ria)
5258180|NCT00594438|Zimmer Sentinal Reamer|zimmer sentinal reamer
5258181|NCT00594438|Transesophageal Echocardiogram (TEE)|transesophageal echocardiogram (tee)
5258182|NCT00594412|1H-Magnetic Resonance Spectroscopy|1h-magnetic resonance spectroscopy
5258183|NCT00594412|Hepatic Steatosis|hepatic steatosis
5258184|NCT00594412|Liver Fat|liver fat
5258185|NCT00594412|Liver Biopsy|liver biopsy
5258186|NCT00594412|Liver|liver
5258187|NCT00594412|Hepatitis|hepatitis
5258188|NCT00594412|Fatty Liver|fatty liver
5258189|NCT00594399|Aging|aging
5258190|NCT00594399|Exercise|exercise
5258191|NCT00594399|Impaired Glucose Tolerance|impaired glucose tolerance
5258192|NCT00594399|Obesity|obesity
5258193|NCT00594399|Functional Status|functional status
5258194|NCT00594399|Disability|disability
5258195|NCT00594399|Health Services Research|health services research
5258196|NCT00594399|Randomized Controlled Trial|randomized controlled trial
5258197|NCT00594399|Diabetes|diabetes
5258198|NCT00594399|Adaptive Randomization Design|adaptive randomization design
5258199|NCT00594386|Rotigotine|rotigotine
5258200|NCT00594386|Neupro|neupro
5258201|NCT00594373|Microbicide|microbicide
5258202|NCT00594373|HIV Seronegativity|hiv seronegativity
5258203|NCT00594360|Exercise Prescription|exercise prescription
5258204|NCT00594360|Self-efficacy|self-efficacy
5258205|NCT00594360|Decisional Balance|decisional balance
5258206|NCT00594360|Readiness to Change|readiness to change
5258207|NCT00594360|Physical Activity|physical activity
5258208|NCT00594347|Streptococcus pneumoniae|streptococcus pneumoniae
5258209|NCT00594334|osteopenia|osteopenia
5258210|NCT00594334|periodontitis|periodontitis
5258211|NCT00594321|spinal fractures|spinal fractures
5258212|NCT00594269|Antidepressants|antidepressants
5258213|NCT00594269|Antipsychotics|antipsychotics
5258214|NCT00594269|Dementia|dementia
5258215|NCT00594269|Discontinuation study|discontinuation study
5258216|NCT00594269|Behavioural- and Psychological Symptoms in Dementia|behavioural- and psychological symptoms in dementia
5258217|NCT00594256|Schizophrenia|schizophrenia
5258218|NCT00594256|Sleep Architecture|sleep architecture
5258219|NCT00594256|Sodium Oxybate|sodium oxybate
5258220|NCT00594256|Insomnia|insomnia
5258221|NCT00594256|Cognition|cognition
5258222|NCT00594230|Myelodysplastic Syndromes (MDS)|myelodysplastic syndromes (mds)
5258223|NCT00594230|Refractory|refractory
5258224|NCT00594230|LBH589|lbh589
5258225|NCT00594217|PCOS|pcos
5258226|NCT00594191|Statins|statins
5258227|NCT00594191|HMG-CoA reductase inhibitors|hmg-coa reductase inhibitors
5258228|NCT00594191|Cirrhosis|cirrhosis
5258229|NCT00594191|Portal hypertension|portal hypertension
5258230|NCT00594191|Variceal bleeding|variceal bleeding
5258231|NCT00594178|spinal cord injury|spinal cord injury
5258232|NCT00594165|Rotigotine|rotigotine
5258233|NCT00594152|Diabetic autonomic neuropathy|diabetic autonomic neuropathy
5258234|NCT00594139|non-neurogenic over active bladder|non-neurogenic over active bladder
5258235|NCT00594139|urge predominant incontinence|urge predominant incontinence
5258236|NCT00594126|Myeloma|myeloma
5258237|NCT00594126|Multiple Myeloma|multiple myeloma
5258238|NCT00594126|Relapsed Multiple Myeloma|relapsed multiple myeloma
5258239|NCT00594126|Refractory Multiple Myeloma|refractory multiple myeloma
5258240|NCT00594126|Relapsed or Refractory Multiple Myeloma|relapsed or refractory multiple myeloma
5258241|NCT00594100|carotid artery stenosis|carotid artery stenosis
5258242|NCT00594100|embolic protection device|embolic protection device
5258243|NCT00594100|GORE Neuro Protection System|gore neuro protection system
5258244|NCT00594100|GORE Flow Reversal System|gore flow reversal system
5258245|NCT00594100|reverse flow|reverse flow
5258246|NCT00594100|proximal occlusion device|proximal occlusion device
5258247|NCT00594100|GNPS|gnps
5258248|NCT00594100|Parodi|parodi
5258249|NCT00594100|EMPiRE|empire
5258250|NCT00594100|distal embolization|distal embolization
5258251|NCT00594100|minimizing risks of CAS|minimizing risks of cas
5258252|NCT00594100|PAES|paes
5258253|NCT00594048|high blood pressure|high blood pressure
5258254|NCT00594035|Spinal procedure|spinal procedure
5258255|NCT00594035|Dura incision|dura incision
5258256|NCT00594022|Electric Stimulation|electric stimulation
5258257|NCT00594022|Latency to Persistent Sleep (LPS)|latency to persistent sleep (lps)
5258258|NCT00594022|Transient Insomnia|transient insomnia
5258259|NCT00594022|Insomnia|insomnia
5258260|NCT00593970|influenza|influenza
5258261|NCT00593970|vaccine|vaccine
5258262|NCT00593970|pregnancy|pregnancy
5258263|NCT00593957|Rett Syndrome|rett syndrome
5258264|NCT00593957|Dextromethorphan|dextromethorphan
5258266|NCT00593944|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
5258267|NCT00593944|B cell|b cell
5258268|NCT00593944|leukemia|leukemia
5258269|NCT00593944|lymphocyte|lymphocyte
5258270|NCT00593944|antibody|antibody
5258271|NCT00593944|monoclonal|monoclonal
5258272|NCT00593944|cancer|cancer
5258273|NCT00593944|blood|blood
5258274|NCT00593931|Brain functional MRI|brain functional mri
5258275|NCT00593918|RSV, asthma, innate immunity, gene, cytokines|rsv, asthma, innate immunity, gene, cytokines
5258276|NCT00593905|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
5258277|NCT00593905|Pulmonary Hypertension|pulmonary hypertension
5258278|NCT00593905|Pharmacogenomics|pharmacogenomics
5258279|NCT00593905|DNA Testing|dna testing
5258280|NCT00593905|sitaxsentan|sitaxsentan
5258281|NCT00593905|bosentan|bosentan
5258282|NCT00593905|ambrisentan|ambrisentan
5258283|NCT00593905|elevated pulmonary artery pressures|elevated pulmonary artery pressures
5258284|NCT00593905|Letairis|letairis
5258285|NCT00593905|Tracleer|tracleer
5258286|NCT00593905|Thelin|thelin
5258287|NCT00593905|Primary Pulmonary Hypertension|primary pulmonary hypertension
5258288|NCT00593905|Pulmonary Artery|pulmonary artery
5258289|NCT00593892|Cytokine Levels|cytokine levels
5258290|NCT00593892|Traumatic Injury|traumatic injury
5258291|NCT00593892|Multisystem Organ Failure|multisystem organ failure
5258292|NCT00593879|MDD|mdd
5258293|NCT00593879|Depression|depression
5258294|NCT00593879|Mecamylamine|mecamylamine
5258295|NCT00593879|Add-on Therapy|add-on therapy
5258296|NCT00593879|Major Depressive Disorder|major depressive disorder
5258297|NCT00593866|Patients who have confirmed cancer arising from the pancreas|patients who have confirmed cancer arising from the pancreas
5258298|NCT00593853|LHRH-agonist related fatigue|lhrh-agonist related fatigue
5258299|NCT00593801|extremely low birth weight infants|extremely low birth weight infants
5258300|NCT00593801|transfusion need|transfusion need
5258301|NCT00593801|erythropoietin|erythropoietin
5258302|NCT00593801|trace elements|trace elements
5258303|NCT00593801|antioxidant enzymes|antioxidant enzymes
5258304|NCT00593801|reduction of the transfusion need by EPO treatment|reduction of the transfusion need by epo treatment
5258305|NCT00593801|trace elements and antioxidant enzymes in blood|trace elements and antioxidant enzymes in blood
5258306|NCT00593788|GIN test|gin test
5258307|NCT00593788|gap detection|gap detection
5258308|NCT00593788|temporal resolution|temporal resolution
5258309|NCT00593788|auditory perception|auditory perception
5258310|NCT00593788|psychoacoustics|psychoacoustics
5258311|NCT00593775|implantation rate|implantation rate
5258312|NCT00593762|Peripheral arterial occlusive disease|peripheral arterial occlusive disease
5258313|NCT00593762|Aspirin|aspirin
5258314|NCT00593762|Clopidogrel|clopidogrel
5258315|NCT00593762|Resistance|resistance
5258316|NCT00593762|Catheter interventional procedure|catheter interventional procedure
5258317|NCT00593762|ASA and clopidogrel resistance|asa and clopidogrel resistance
5258318|NCT00593749|obesity prevention|obesity prevention
5258319|NCT00593749|corner stores|corner stores
5258320|NCT00593749|schools|schools
5258321|NCT00593736|Delayed sleep phase syndrome; drug therapy|delayed sleep phase syndrome; drug therapy
5258322|NCT00593723|IMRT|imrt
5258323|NCT00593710|Randomized|randomized
5258324|NCT00593710|double-blind superiority trial|double-blind superiority trial
5258325|NCT00593697|breast cancer|breast cancer
5258326|NCT00593697|adjuvant therapy|adjuvant therapy
5258327|NCT00593697|trastuzumab|trastuzumab
5258328|NCT00593697|chemotherapy|chemotherapy
5258329|NCT00593684|neonate|neonate
5258330|NCT00593684|central lines|central lines
5258331|NCT00593684|very low birth weight|very low birth weight
5258332|NCT00593684|silver alginate|silver alginate
5258333|NCT00593671|aneuploidies in 7 chromosomes increased with advanced maternal age|aneuploidies in 7 chromosomes increased with advanced maternal age
5258334|NCT00593658|hypoxemia|hypoxemia
5258335|NCT00593658|liver transplantation evaluation|liver transplantation evaluation
5258336|NCT00593658|cirrhosis|cirrhosis
5258337|NCT00593645|Conditioning regimens|conditioning regimens
5258338|NCT00593645|Stem Cell Transplantation|stem cell transplantation
5258339|NCT00593645|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
5258340|NCT00593645|Allogeneic Stem Cell Transplantation|allogeneic stem cell transplantation
5258341|NCT00593645|Nonmyeloablative conditioning|nonmyeloablative conditioning
5258342|NCT00593645|Clofarabine|clofarabine
5258343|NCT00593645|Cytarabine|cytarabine
5258344|NCT00593645|Anti-thymocyte globulin|anti-thymocyte globulin
5258345|NCT00593632|low HDL|low hdl
5258346|NCT00593619|Intravenous Iron|intravenous iron
5258347|NCT00593619|Safety|safety
5258348|NCT00593619|Perioperative|perioperative
5258349|NCT00593619|Iron deficiency|iron deficiency
5258350|NCT00593619|Non hemodialysis population|non hemodialysis population
5258351|NCT00593619|Perioperative blood conservation|perioperative blood conservation
5258352|NCT00593606|Rotigotine|rotigotine
5258353|NCT00593606|NEUPRO|neupro
5258354|NCT00593606|Switching trial from ropinirole to rotigotine,|switching trial from ropinirole to rotigotine,
5258355|NCT00593606|safety and tolerability|safety and tolerability
5258356|NCT00593606|Parkinson disease|parkinson disease
5258357|NCT00593593|benign prostate hyperplasia|benign prostate hyperplasia
5258358|NCT00593593|Dutasteride|dutasteride
5258359|NCT00593593|pharmacovigilance|pharmacovigilance
5258360|NCT00593580|Ovarian cancer|ovarian cancer
5258361|NCT00593580|bone mineral density|bone mineral density
5258362|NCT00593580|bisphosphonates|bisphosphonates
5258363|NCT00593580|chemotherapy|chemotherapy
5258364|NCT00593567|Diabetic Foot Ulcer|diabetic foot ulcer
5258365|NCT00593541|MRI|mri
5258366|NCT00593528|Cirrhosis, STIC TIPS, Portal Hypertension, Transjugular Intrahepatic Portosystemic Shunt , Stents, PTFE|cirrhosis, stic tips, portal hypertension, transjugular intrahepatic portosystemic shunt , stents, ptfe
5258367|NCT00593528|cirrhotic HTP|cirrhotic htp
5258368|NCT00593502|influenza|influenza
5258369|NCT00593502|children|children
5258370|NCT00593502|acute otitis media|acute otitis media
5258371|NCT00593502|oseltamivir|oseltamivir
5258372|NCT00593489|Insulin|insulin
5258373|NCT00593489|Diabetes Mellitus|diabetes mellitus
5258374|NCT00593489|Practice Behaviour|practice behaviour
5258375|NCT00593489|Preceptor|preceptor
5258376|NCT00593489|Pharmacy|pharmacy
5258377|NCT00593476|Type 2 Diabetes|type 2 diabetes
5258378|NCT00593476|Glycemic Control|glycemic control
5258379|NCT00593476|Diabetes Support and Education|diabetes support and education
5258380|NCT00593476|Portion Control|portion control
5258381|NCT00593476|Prepackaged meals|prepackaged meals
5258382|NCT00593463|opioid dependence|opioid dependence
5258383|NCT00593463|methadone|methadone
5258384|NCT00593463|opioid|opioid
5258385|NCT00593450|bevacizumab|bevacizumab
5258386|NCT00593450|ranibizumab|ranibizumab
5258387|NCT00593450|choroidal neovascularization|choroidal neovascularization
5258388|NCT00593437|bone density diagnostic equipment discrepancies|bone density diagnostic equipment discrepancies
5258389|NCT00593411|MD Analyze|md analyze
5258390|NCT00593411|Central Nervous System|central nervous system
5258391|NCT00593411|Spine Disease|spine disease
5258392|NCT00593411|Peripheral Nerve|peripheral nerve
5258393|NCT00593398|Malaria|malaria
5258394|NCT00593398|pregnant women|pregnant women
5258395|NCT00593398|infants|infants
5258396|NCT00593398|Cameroon|cameroon
5258397|NCT00593385|Symptomatic claudication or rest pain and angiographic confirmation of either de novo or restenotic lesions in the common and/or external iliac artery.|symptomatic claudication or rest pain and angiographic confirmation of either de novo or restenotic lesions in the common and/or external iliac artery.
5258398|NCT00593372|Alzheimer's Disease|alzheimer's disease
5258399|NCT00593372|Memory|memory
5258400|NCT00593372|Treatment|treatment
5258401|NCT00593359|Spinal surgery|spinal surgery
5258402|NCT00593359|Prone spinal surgery|prone spinal surgery
5258403|NCT00593333|Femur Fracture|femur fracture
5258404|NCT00593333|Intramedullary Nailing|intramedullary nailing
5258405|NCT00593333|Trochanteric Nailing|trochanteric nailing
5258406|NCT00593333|Piriformis Starting Portal|piriformis starting portal
5258407|NCT00593333|Trochanteric Insertion Portal|trochanteric insertion portal
5258408|NCT00593320|SRS|srs
5258409|NCT00593307|glycemic response|glycemic response
5258410|NCT00593307|hunger|hunger
5258411|NCT00593294|PCOS|pcos
5258412|NCT00593294|oral contraceptives|oral contraceptives
5258413|NCT00593294|physical exercise|physical exercise
5258414|NCT00593294|CVR|cvr
5258415|NCT00593281|Hyaluronidase|hyaluronidase
5258416|NCT00593281|Hylenex|hylenex
5258417|NCT00593281|subcutaneous|subcutaneous
5258418|NCT00593281|morphine|morphine
5258419|NCT00593281|absorption|absorption
5258420|NCT00593281|bioavailability|bioavailability
5258421|NCT00593281|PK study of morphine in patients with pain|pk study of morphine in patients with pain
5258422|NCT00593242|hypoxic-ischemic encephalopathy|hypoxic-ischemic encephalopathy
5258423|NCT00593242|autologous cord blood cells|autologous cord blood cells
5258424|NCT00593242|newborn infants|newborn infants
5258425|NCT00593229|Thrombotic microangiopathy (TMA)|thrombotic microangiopathy (tma)
5258426|NCT00593229|Hemolytic uremic syndrome (HUS)|hemolytic uremic syndrome (hus)
5258427|NCT00593229|Thrombotic thrombocytopenic purpura (TTP)|thrombotic thrombocytopenic purpura (ttp)
5258428|NCT00593216|functional magnetic Resonance Imaging|functional magnetic resonance imaging
5258429|NCT00593216|vertigo|vertigo
5258430|NCT00593216|vestibular|vestibular
5258431|NCT00593177|Plaque psoriasis|plaque psoriasis
5258432|NCT00593177|Psoriasis|psoriasis
5258433|NCT00593164|Hypothermia, Induced|hypothermia, induced
5258434|NCT00593164|Death, Sudden, Cardiac|death, sudden, cardiac
5258435|NCT00593164|Resuscitation|resuscitation
5258436|NCT00593164|Coma|coma
5258437|NCT00593151|Antimetabolites|antimetabolites
5258438|NCT00593151|Virus Diseases|virus diseases
5258439|NCT00593151|Anti-Infective Agents|anti-infective agents
5258440|NCT00593151|RNA Virus Infections|rna virus infections
5258441|NCT00593151|Digestive System Diseases|digestive system diseases
5258442|NCT00593151|Flaviviridae Infections|flaviviridae infections
5258443|NCT00593151|Antineoplastic Agents|antineoplastic agents
5258444|NCT00593151|Therapeutic Uses|therapeutic uses
5258445|NCT00593151|Antiviral Agents|antiviral agents
5258446|NCT00593151|Molecular Mechanisms of Action|molecular mechanisms of action
5258447|NCT00593151|Pharmacologic Actions|pharmacologic actions
5258448|NCT00593138|Focalin XR|focalin xr
5258449|NCT00593138|Adult|adult
5258450|NCT00593138|PET scan|pet scan
5258451|NCT00593125|cocaine|cocaine
5258452|NCT00593125|opioids|opioids
5258453|NCT00593125|heroin|heroin
5258454|NCT00593125|levetiracetam|levetiracetam
5258455|NCT00593112|HMRS Scanning|hmrs scanning
5258456|NCT00593112|ADHD|adhd
5258457|NCT00593112|Child|child
5258458|NCT00593112|Adolescent|adolescent
5258459|NCT00593112|HMRS Scans|hmrs scans
5258460|NCT00593099|Bipolar Disorder|bipolar disorder
5258461|NCT00593099|Nicotine Dependence|nicotine dependence
5258462|NCT00593099|Smoking Cessation|smoking cessation
5258463|NCT00593099|Bupropion, sustained-release|bupropion, sustained-release
5258464|NCT00593086|wound care|wound care
5258465|NCT00593060|Temsirolimus|temsirolimus
5258466|NCT00593060|cetuximab|cetuximab
5258467|NCT00593060|metastatic disease|metastatic disease
5258468|NCT00593047|hypercholesterolemia|hypercholesterolemia
5258469|NCT00593034|Alcohol abuse|alcohol abuse
5258470|NCT00593034|Drug abuse|drug abuse
5258471|NCT00593021|Obscure Gastrointestinal Bleeding|obscure gastrointestinal bleeding
5258472|NCT00593021|Occult Gastrointestinal Bleeding|occult gastrointestinal bleeding
5258473|NCT00593021|Overt Gastrointestinal Bleeding|overt gastrointestinal bleeding
5258474|NCT00593021|Capsule Endoscopy|capsule endoscopy
5258475|NCT00593021|CT Enterography|ct enterography
5258476|NCT00593008|metastatic pancreatic cancer|metastatic pancreatic cancer
5258477|NCT00592943|Adults|adults
5258478|NCT00592943|Healthy Volunteers|healthy volunteers
5258479|NCT00592943|Nuvigil|nuvigil
5258480|NCT00592943|Armodafinil|armodafinil
5258481|NCT00592943|DAT occupancy in healthy volunteers|dat occupancy in healthy volunteers
5258482|NCT00592930|anorexia nervosa, treatment, adolescents, olanzapine|anorexia nervosa, treatment, adolescents, olanzapine
5258483|NCT00592917|osteoporosis|osteoporosis
5258484|NCT00592917|fractures|fractures
5258485|NCT00592917|risk of fracture|risk of fracture
5258486|NCT00592917|vitamin-D|vitamin-d
5258487|NCT00592917|calcium|calcium
5258488|NCT00592917|falls|falls
5258489|NCT00592917|bone mineral density|bone mineral density
5258490|NCT00592917|bone metabolism|bone metabolism
5258491|NCT00592904|Neuralgia|neuralgia
5258492|NCT00592904|neuropathy|neuropathy
5258493|NCT00592891|brain injury|brain injury
5258494|NCT00592891|brain disorders|brain disorders
5258495|NCT00592852|bipolar disorder|bipolar disorder
5258496|NCT00592852|obsessive compulsive disorder|obsessive compulsive disorder
5258497|NCT00592852|Prozac|prozac
5258498|NCT00592839|Nocturnal vasomotor symptoms in postmenopausal women|nocturnal vasomotor symptoms in postmenopausal women
5258499|NCT00592826|PHP|php
5258500|NCT00592826|HMP|hmp
5258501|NCT00592826|HPHP|hphp
5258502|NCT00592826|AMD|amd
5258503|NCT00592826|CNV|cnv
5258504|NCT00592813|rehabilitation|rehabilitation
5258505|NCT00592813|function|function
5258506|NCT00592800|statistics|statistics
5258507|NCT00592800|probability|probability
5258508|NCT00592774|Post-Herpetic Neuralgia|post-herpetic neuralgia
5258509|NCT00592774|PHN)|phn)
5258510|NCT00592761|Deglutition Disorders|deglutition disorders
5258511|NCT00592761|Mendelsohn Maneuver|mendelsohn maneuver
5258512|NCT00592761|SEMG|semg
5258513|NCT00592748|charged particle radiation therapy|charged particle radiation therapy
5258514|NCT00592696|Adolescent depression|adolescent depression
5258515|NCT00592696|Adolescent smoking|adolescent smoking
5258516|NCT00592683|bipolar disorder|bipolar disorder
5258517|NCT00592683|fish oil|fish oil
5258518|NCT00592683|aripiprazole|aripiprazole
5258519|NCT00592683|children|children
5258520|NCT00592657|retrospective chart review|retrospective chart review
5258521|NCT00592657|Jimsonweed ingestion|jimsonweed ingestion
5258522|NCT00592644|ectasia|ectasia
5258523|NCT00592644|vascular lesions|vascular lesions
5258524|NCT00592644|vocal cords|vocal cords
5258525|NCT00592644|voice|voice
5258526|NCT00592644|pulsed dye laser|pulsed dye laser
5258527|NCT00592631|asthma|asthma
5258528|NCT00592631|sleep apnea|sleep apnea
5258529|NCT00592618|ESRD|esrd
5258530|NCT00592618|Hemodialysis|hemodialysis
5258531|NCT00592618|Sleep Apnea|sleep apnea
5258532|NCT00592592|pediatric rhabdomyosarcoma|pediatric rhabdomyosarcoma
5258533|NCT00592592|proton radiation therapy|proton radiation therapy
5258534|NCT00592566|Severe leptospirosis|severe leptospirosis
5258535|NCT00592566|Pulmonary hemorrhage|pulmonary hemorrhage
5258536|NCT00592553|Duchenne muscular dystrophy|duchenne muscular dystrophy
5258537|NCT00592553|Becker muscular dystrophy|becker muscular dystrophy
5258538|NCT00592553|Nonsense mutation|nonsense mutation
5258539|NCT00592553|Premature stop codon|premature stop codon
5258540|NCT00592553|DMD/BMD|dmd/bmd
5258541|NCT00592553|PTC124|ptc124
5258542|NCT00592514|Patients undergoing head and neck surgery that involves the upper aerodigestive tract|patients undergoing head and neck surgery that involves the upper aerodigestive tract
5258543|NCT00592501|proton radiation|proton radiation
5258544|NCT00592501|photon radiation|photon radiation
5258545|NCT00592501|5-FU|5-fu
5258546|NCT00592501|cisplatin|cisplatin
5258547|NCT00592488|Septic shock|septic shock
5258548|NCT00592488|Acetyl-L-carnitine|acetyl-l-carnitine
5258549|NCT00592475|conivaptan|conivaptan
5258550|NCT00592475|Liver Cirrhosis|liver cirrhosis
5258551|NCT00592475|Hypertension, Portal|hypertension, portal
5258552|NCT00592462|Breast Cancer|breast cancer
5258553|NCT00592462|Whole Body MRI|whole body mri
5258554|NCT00592462|Magnetic Resonance Imaging|magnetic resonance imaging
5258555|NCT00592462|Metastases|metastases
5258556|NCT00592449|Insomnia|insomnia
5258557|NCT00592449|Knee pain|knee pain
5258558|NCT00592449|Osteoarthritis|osteoarthritis
5258559|NCT00592449|Arthritis|arthritis
5258560|NCT00592449|Sleep|sleep
5258561|NCT00592436|ADHD|adhd
5258562|NCT00592436|pediatric|pediatric
5258563|NCT00592436|children|children
5258564|NCT00592423|Lateral neck rotation|lateral neck rotation
5258565|NCT00592423|Continuous Positive Airway Pressure|continuous positive airway pressure
5258566|NCT00592397|Dietary Intervention|dietary intervention
5258567|NCT00592397|Nutrigenomics|nutrigenomics
5258568|NCT00592397|Diet, Carbohydrate-Restricted|diet, carbohydrate-restricted
5258569|NCT00592397|Gene Expression|gene expression
5258570|NCT00592397|Gene Expression Profiling|gene expression profiling
5258571|NCT00592397|Oligonucleotide Array Sequence Analysis|oligonucleotide array sequence analysis
5258572|NCT00592397|Biological Markers|biological markers
5258573|NCT00592397|Food|food
5258574|NCT00592397|Obesity|obesity
5258575|NCT00592397|Blood|blood
5258576|NCT00592397|Subcutaneous Fat, Abdominal|subcutaneous fat, abdominal
5258577|NCT00592384|spinal cord injuries|spinal cord injuries
5258578|NCT00592384|major depressive disorder|major depressive disorder
5258579|NCT00592384|dysthymia|dysthymia
5258580|NCT00592384|antidepressant agents|antidepressant agents
5258581|NCT00592384|pain|pain
5258582|NCT00592384|quality of life|quality of life
5258583|NCT00592384|muscle spasticity|muscle spasticity
5258584|NCT00592384|community participation|community participation
5258585|NCT00592384|anxiety|anxiety
5258586|NCT00592358|bipolar disorder|bipolar disorder
5258587|NCT00592358|children|children
5258588|NCT00592358|adolescents|adolescents
5258589|NCT00592358|Invega|invega
5258590|NCT00592345|sarcoma of the thoracic/lumbar/spine/sacrum|sarcoma of the thoracic/lumbar/spine/sacrum
5258591|NCT00592345|paraspinal soft tissues|paraspinal soft tissues
5258592|NCT00592345|proton radiation therapy|proton radiation therapy
5258593|NCT00592345|photon radiation therapy|photon radiation therapy
5258594|NCT00592345|radiation applicator plaque|radiation applicator plaque
5258595|NCT00592319|Papilloma|papilloma
5258596|NCT00592319|pulsed dye laser|pulsed dye laser
5258597|NCT00592319|Celebrex|celebrex
5258598|NCT00592319|voice|voice
5258599|NCT00592306|ATG|atg
5258600|NCT00592306|rabbit thymoglobulin|rabbit thymoglobulin
5258601|NCT00592306|reperfusion lung injury|reperfusion lung injury
5258602|NCT00592306|primary graft dysfunction|primary graft dysfunction
5258603|NCT00592306|lung transplantation|lung transplantation
5258604|NCT00592293|proton beam radiation|proton beam radiation
5258605|NCT00592280|Pancreas transplantation|pancreas transplantation
5258606|NCT00592280|graft pancreatitis|graft pancreatitis
5258607|NCT00592280|Two-layer method|two-layer method
5258608|NCT00592280|organ preservation|organ preservation
5258609|NCT00592267|pediatric|pediatric
5258610|NCT00592267|bipolar disorder|bipolar disorder
5258611|NCT00592254|ADHD|adhd
5258612|NCT00592254|Adults|adults
5258613|NCT00592241|Insulin Pump|insulin pump
5258614|NCT00592228|intermediate lesion|intermediate lesion
5258615|NCT00592228|drug-eluting stent|drug-eluting stent
5258616|NCT00592228|fractional flow reserve|fractional flow reserve
5258617|NCT00592215|Second trimester labor induction|second trimester labor induction
5258618|NCT00592202|Morbid obesity|morbid obesity
5258619|NCT00592202|Adolescents|adolescents
5258620|NCT00592202|Gastric restrictive procedure|gastric restrictive procedure
5258621|NCT00592202|Adjustable gastric band|adjustable gastric band
5258622|NCT00592202|Treatment|treatment
5258623|NCT00592189|Burns|burns
5258624|NCT00592189|Wound healing|wound healing
5258626|NCT00592163|Cancer|cancer
5258627|NCT00592163|Arsenic|arsenic
5258628|NCT00592150|Essential Hypertension|essential hypertension
5258629|NCT00592137|calcium carbonate|calcium carbonate
5258630|NCT00592137|obesity|obesity
5258631|NCT00592137|dairy|dairy
5258632|NCT00592137|energy expenditure|energy expenditure
5258633|NCT00592124|Microbicide|microbicide
5258634|NCT00592124|HIV Seronegativity|hiv seronegativity
5258635|NCT00592111|Pediatric|pediatric
5258636|NCT00592111|Hodgkin's Disease|hodgkin's disease
5258637|NCT00592111|96-016|96-016
5258638|NCT00592098|Lower limb amputation at least 6 months prior to inclusion|lower limb amputation at least 6 months prior to inclusion
5258639|NCT00592098|Presenting with moderate-to-severe pain intensity|presenting with moderate-to-severe pain intensity
5258640|NCT00592098|Outpatients, aged 18 years and above|outpatients, aged 18 years and above
5258641|NCT00592085|Tobacco Use|tobacco use
5258642|NCT00592085|Smoking|smoking
5258643|NCT00592085|Alcohol Use|alcohol use
5258644|NCT00592085|Smoking Cessation|smoking cessation
5258645|NCT00592072|Diabetes Mellitus, Type 1|diabetes mellitus, type 1
5258646|NCT00592072|Medium Chain Fatty Acid|medium chain fatty acid
5258647|NCT00592072|Hypoglycemia|hypoglycemia
5258648|NCT00592046|Phase I|phase i
5258649|NCT00592046|Hematologic Cancers|hematologic cancers
5258650|NCT00592046|Blood Cancers|blood cancers
5258651|NCT00592046|Leukemia|leukemia
5258652|NCT00592046|multiple myeloma|multiple myeloma
5258653|NCT00592046|myelodysplasia (MDS)|myelodysplasia (mds)
5258654|NCT00592046|Relapsed/refractory leukemia or lymphoma|relapsed/refractory leukemia or lymphoma
5258655|NCT00592033|COPD oxygen|copd oxygen
5258656|NCT00592033|COPD rehabilitation|copd rehabilitation
5258657|NCT00592033|exercise|exercise
5258658|NCT00592020|kidney|kidney
5258659|NCT00592020|transplantation|transplantation
5258660|NCT00592020|minimal invasive|minimal invasive
5258661|NCT00592020|short transverse|short transverse
5258662|NCT00592020|hockey stick|hockey stick
5258663|NCT00592020|incision|incision
5258664|NCT00592020|quality of life|quality of life
5258665|NCT00592020|planned kidney transplantation|planned kidney transplantation
5258666|NCT00592007|Non Small Cell Lung Cancer|non small cell lung cancer
5258667|NCT00592007|Stage IIIB|stage iiib
5258668|NCT00592007|Stage IV|stage iv
5258669|NCT00592007|Stable on Erlotinib|stable on erlotinib
5258670|NCT00592007|Exhibit Positivity for Estrogen or Progesterone Receptor|exhibit positivity for estrogen or progesterone receptor
5258671|NCT00591994|tinnitus|tinnitus
5258672|NCT00591994|piribedil|piribedil
5258673|NCT00591994|acoustic otoemissions|acoustic otoemissions
5258674|NCT00591994|ECoG|ecog
5258675|NCT00591981|Geriatric|geriatric
5258676|NCT00591981|Thoracic|thoracic
5258677|NCT00591981|neoplasm|neoplasm
5258678|NCT00591981|(Patients over 70 years of age) Geriatric oncology patients with thoracic neoplasms of the lung, esophagus, pleura and thymus.|(patients over 70 years of age) geriatric oncology patients with thoracic neoplasms of the lung, esophagus, pleura and thymus.
5258679|NCT00591968|ultrasound|ultrasound
5258680|NCT00591968|telediagnosis|telediagnosis
5258681|NCT00591968|teleultrasound|teleultrasound
5258682|NCT00591968|telesonography|telesonography
5258683|NCT00591968|teleultrasonography|teleultrasonography
5258684|NCT00591968|teleradiology|teleradiology
5258685|NCT00591968|telemedicine|telemedicine
5258686|NCT00591968|dominican republic|dominican republic
5258687|NCT00591968|puntacana|puntacana
5258688|NCT00591968|veron|veron
5258689|NCT00591968|store-and-forward|store-and-forward
5258690|NCT00591968|asynchronous|asynchronous
5258691|NCT00591955|geriatric|geriatric
5258692|NCT00591955|sepsis|sepsis
5258693|NCT00591955|outcome assessment(healthcare)|outcome assessment(healthcare)
5258694|NCT00591942|dental cement|dental cement
5258695|NCT00591942|ceramic crowns|ceramic crowns
5258696|NCT00591942|three-unit bridges|three-unit bridges
5258697|NCT00591942|sensitivity|sensitivity
5258698|NCT00591916|burn|burn
5258699|NCT00591916|donor site|donor site
5258700|NCT00591916|grafting|grafting
5258701|NCT00591916|scar|scar
5258702|NCT00591903|Diabetes and Cardiac Proteomics|diabetes and cardiac proteomics
5258703|NCT00591903|Atrial Appendage and Proteomics|atrial appendage and proteomics
5258704|NCT00591903|Diabetic Cardiomyopathy|diabetic cardiomyopathy
5258705|NCT00591903|Tissue Sample|tissue sample
5258706|NCT00591877|GERDCAM: Complementary and alternative medicine|gerdcam: complementary and alternative medicine
5258707|NCT00591877|NERD: non-erosive reflux disease|nerd: non-erosive reflux disease
5258708|NCT00591877|GERD: gastroesophageal reflux disease|gerd: gastroesophageal reflux disease
5258709|NCT00591877|AC: acupuncture|ac: acupuncture
5258710|NCT00591877|SAC: sham acupuncture|sac: sham acupuncture
5258711|NCT00591877|LES: lower esophageal sphincter pressure|les: lower esophageal sphincter pressure
5258712|NCT00591877|TLESR: transient lower esophageal sphincter relaxation|tlesr: transient lower esophageal sphincter relaxation
5258713|NCT00591877|Acupuncture|acupuncture
5258714|NCT00591877|Yoga|yoga
5258715|NCT00591864|Benign breast disease|benign breast disease
5258716|NCT00591864|Breast|breast
5258717|NCT00591864|MRI|mri
5258718|NCT00591864|Mammography|mammography
5258719|NCT00591864|Ultrasound|ultrasound
5258720|NCT00591864|Molecular Breast Imaging|molecular breast imaging
5258721|NCT00591864|Breast Cancer|breast cancer
5258722|NCT00591851|breast cancer|breast cancer
5258723|NCT00591851|adenocarcinoma of the breast|adenocarcinoma of the breast
5258724|NCT00591851|cardiac safety|cardiac safety
5258725|NCT00591851|Breast cancer patients seen at the Memorial Sloan-Kettering Cancer Center|breast cancer patients seen at the memorial sloan-kettering cancer center
5258726|NCT00591838|SBRT|sbrt
5258727|NCT00591773|Blood pressure|blood pressure
5258728|NCT00591773|Blood pressure monitoring, ambulatory|blood pressure monitoring, ambulatory
5258729|NCT00591760|Heart Failure|heart failure
5258730|NCT00591760|Growth Hormone|growth hormone
5258731|NCT00591760|Anabolism|anabolism
5258732|NCT00591760|Anabolic Deficiency|anabolic deficiency
5258733|NCT00591760|Hormone replacement|hormone replacement
5258734|NCT00591747|randomized clinical trial|randomized clinical trial
5258735|NCT00591747|elderly|elderly
5258736|NCT00591747|cancer survivor|cancer survivor
5258737|NCT00591747|bone health|bone health
5258738|NCT00591747|body composition|body composition
5258739|NCT00591747|signs and symptoms|signs and symptoms
5258740|NCT00591734|Metastatic Melanoma|metastatic melanoma
5258741|NCT00591734|Everolimus|everolimus
5258742|NCT00591734|RAD001|rad001
5258743|NCT00591734|Bevacizumab|bevacizumab
5258744|NCT00591721|energy conservation education|energy conservation education
5258745|NCT00591721|occupational therapy intervention|occupational therapy intervention
5258746|NCT00591721|fatigue management|fatigue management
5258747|NCT00591721|psychoeducation|psychoeducation
5258748|NCT00591708|calcium|calcium
5258749|NCT00591708|bone|bone
5258750|NCT00591708|bone density|bone density
5258751|NCT00591708|adolescence|adolescence
5258752|NCT00591695|Malignant Colorectal Obstruction|malignant colorectal obstruction
5258753|NCT00591695|Stent Bridge to Surgery|stent bridge to surgery
5258754|NCT00591669|Inflammatory bowel disease|inflammatory bowel disease
5258755|NCT00591669|Crohn's disease|crohn's disease
5258756|NCT00591643|Adrenal tumors|adrenal tumors
5258757|NCT00591643|Adrenal malignancies|adrenal malignancies
5258758|NCT00591643|abnormal hormonal secretions|abnormal hormonal secretions
5258759|NCT00591643|electrolytes abnormalities|electrolytes abnormalities
5258760|NCT00591643|Imaging|imaging
5258761|NCT00591643|Scanning|scanning
5258762|NCT00591643|tumor localization|tumor localization
5258763|NCT00591630|Diffuse Large Cell Lymphoma|diffuse large cell lymphoma
5258764|NCT00591630|Lymphoma|lymphoma
5258765|NCT00591630|Zevalin|zevalin
5258766|NCT00591630|Ibritumomab|ibritumomab
5258767|NCT00591630|IDEC-Y2B8|idec-y2b8
5258768|NCT00591630|Carmustine|carmustine
5258769|NCT00591630|BCNU|bcnu
5258770|NCT00591630|BiCNU|bicnu
5258771|NCT00591630|Etoposide|etoposide
5258772|NCT00591630|VePesid|vepesid
5258773|NCT00591630|Cytarabine|cytarabine
5258774|NCT00591630|Ara-C|ara-c
5258775|NCT00591630|Cytosar|cytosar
5258776|NCT00591630|DepoCyt|depocyt
5258777|NCT00591630|Cytosine arabinosine hydrochloride|cytosine arabinosine hydrochloride
5258778|NCT00591630|Melphalan|melphalan
5258779|NCT00591630|Rituximab|rituximab
5258780|NCT00591630|Rituxan|rituxan
5258781|NCT00591630|BEAM|beam
5258782|NCT00591617|Opioids|opioids
5258783|NCT00591617|drug dependence|drug dependence
5258784|NCT00591617|drug abuse|drug abuse
5258785|NCT00591617|treatment|treatment
5258786|NCT00591604|burn|burn
5258787|NCT00591604|vitamin D|vitamin d
5258788|NCT00591604|nutrition|nutrition
5258789|NCT00591604|burn recovery|burn recovery
5258790|NCT00591591|Obstructive Sleep Apnea Syndrome|obstructive sleep apnea syndrome
5258791|NCT00591591|sleep disordered breathing|sleep disordered breathing
5258792|NCT00591591|polysomnography (psg)|polysomnography (psg)
5258793|NCT00591591|continuous positive airway pressure (cpap)|continuous positive airway pressure (cpap)
5258794|NCT00591591|brain vascular autoregulation|brain vascular autoregulation
5258795|NCT00591591|brain tissue oxygenation|brain tissue oxygenation
5258796|NCT00591591|near-infrared spectroscopy|near-infrared spectroscopy
5258797|NCT00591591|Obstructive Sleep Apnea|obstructive sleep apnea
5258798|NCT00591578|Blood pressure|blood pressure
5258799|NCT00591578|blood pressure monitoring, ambulatory|blood pressure monitoring, ambulatory
5258800|NCT00591565|Anxiety|anxiety
5258801|NCT00591565|SSRI|ssri
5258802|NCT00591565|SNRI|snri
5258803|NCT00591565|Acamprosate|acamprosate
5258804|NCT00591552|Lung cancer|lung cancer
5258805|NCT00591552|Lymph node dissection|lymph node dissection
5258806|NCT00591539|Carotid Artery Disease|carotid artery disease
5258807|NCT00591539|Intima-Media Thickening|intima-media thickening
5258808|NCT00591539|Carotid Ultrasound|carotid ultrasound
5258809|NCT00591539|Pediatric Cancer Survivors|pediatric cancer survivors
5258810|NCT00591539|Cancer Survivors|cancer survivors
5258811|NCT00591539|Head or Neck Cancer|head or neck cancer
5258812|NCT00591539|Radiation Therapy|radiation therapy
5258814|NCT00591513|burns|burns
5258815|NCT00591513|burn scars|burn scars
5258816|NCT00591513|congenital giant nevi|congenital giant nevi
5258817|NCT00591500|Melanoma|melanoma
5258818|NCT00591500|Skin cancer|skin cancer
5258819|NCT00591500|Genetic Susceptibility|genetic susceptibility
5258820|NCT00591500|polymorphisms|polymorphisms
5258821|NCT00591487|suction|suction
5258822|NCT00591487|assisted|assisted
5258823|NCT00591487|lipectomy|lipectomy
5258824|NCT00591487|liposuction|liposuction
5258825|NCT00591487|contour|contour
5258826|NCT00591487|cosmetic|cosmetic
5258827|NCT00591487|plastic|plastic
5258828|NCT00591487|surgery|surgery
5258829|NCT00591487|Klein|klein
5258830|NCT00591487|tumescent|tumescent
5258831|NCT00591487|technique|technique
5258832|NCT00591487|Healthy women wanting Suction Assisted Lipectomy|healthy women wanting suction assisted lipectomy
5258833|NCT00591474|VRE|vre
5258834|NCT00591474|Probiotics|probiotics
5258835|NCT00591474|colonization|colonization
5258836|NCT00591474|gut health|gut health
5258837|NCT00591461|Barrett's Esophagus|barrett's esophagus
5258838|NCT00591461|Upper Endoscopy|upper endoscopy
5258839|NCT00591461|Esophageal biopsies|esophageal biopsies
5258840|NCT00591461|Accuracy|accuracy
5258841|NCT00591461|Interobserver Agreement|interobserver agreement
5258842|NCT00591448|Thermal injury|thermal injury
5258843|NCT00591435|Anesthesia|anesthesia
5258844|NCT00591435|Surgery|surgery
5258845|NCT00591435|Education|education
5258846|NCT00591435|Economics|economics
5258847|NCT00591422|Arsenic|arsenic
5258848|NCT00591422|Cancer|cancer
5258849|NCT00591383|Cancer|cancer
5258850|NCT00591383|Indibulin|indibulin
5258851|NCT00591383|Erlotinib|erlotinib
5258852|NCT00591370|Memorial Sloan-Kettering Cancer Center patients with measurable, unresectable stage|memorial sloan-kettering cancer center patients with measurable, unresectable stage
5258853|NCT00591370|III or IV melanoma|iii or iv melanoma
5258854|NCT00591357|Antibiotic associated diarrhea|antibiotic associated diarrhea
5258855|NCT00591357|Clostridium difficile|clostridium difficile
5258856|NCT00591357|loperamide|loperamide
5258857|NCT00591344|Parkinson's disease|parkinson's disease
5258858|NCT00591344|exercise|exercise
5258859|NCT00591331|Head Lice|head lice
5258860|NCT00591318|Ceftriaxone|ceftriaxone
5258861|NCT00591318|Psychosis|psychosis
5258862|NCT00591318|Schizophrenia|schizophrenia
5258863|NCT00591318|Schizoaffective Disorder|schizoaffective disorder
5258864|NCT00591305|papilloma|papilloma
5258865|NCT00591305|PDL|pdl
5258866|NCT00591305|diindolylmethane|diindolylmethane
5258867|NCT00591305|recurrence|recurrence
5258868|NCT00591292|cancer|cancer
5258869|NCT00591292|tumor|tumor
5258870|NCT00591292|solid tumor|solid tumor
5258871|NCT00591292|advanced tumor|advanced tumor
5258872|NCT00591279|large bowel cancer|large bowel cancer
5258873|NCT00591279|polyps|polyps
5258874|NCT00591279|colorectal cancer|colorectal cancer
5258875|NCT00591266|Blood pressure|blood pressure
5258876|NCT00591266|blood pressure monitoring ambulatory|blood pressure monitoring ambulatory
5258877|NCT00591266|Drug Therapy|drug therapy
5258878|NCT00591253|Blood pressure|blood pressure
5258879|NCT00591253|blood pressure monitoring ambulatory|blood pressure monitoring ambulatory
5258880|NCT00591253|Drug Therapy|drug therapy
5258881|NCT00591240|RNA, ribosomal, 16S|rna, ribosomal, 16s
5258882|NCT00591240|Biosensing techniques|biosensing techniques
5258883|NCT00591240|Microchip analytical procedures|microchip analytical procedures
5258884|NCT00591214|Chronic Hepatitis C|chronic hepatitis c
5258885|NCT00591214|Protease Inhibitor|protease inhibitor
5258886|NCT00591201|Spondylarthritis|spondylarthritis
5258887|NCT00591201|TNF|tnf
5258888|NCT00591201|Infliximab|infliximab
5258889|NCT00591201|Ankylosing spondylitis|ankylosing spondylitis
5258890|NCT00591201|Juvenile SpA|juvenile spa
5258891|NCT00591201|Juvenile arthritis|juvenile arthritis
5258892|NCT00591188|kidney cancer, capecitabine, interferon|kidney cancer, capecitabine, interferon
5258893|NCT00591162|Bone, Dexa, Parathyroid, Diuretic, Tetracycline|bone, dexa, parathyroid, diuretic, tetracycline
5258894|NCT00591149|cancer|cancer
5258895|NCT00591149|head and neck cancer|head and neck cancer
5258896|NCT00591149|squamous cell cancer|squamous cell cancer
5258897|NCT00591123|Unresectable|unresectable
5258898|NCT00591123|Metastatic|metastatic
5258899|NCT00591123|Esophagus|esophagus
5258900|NCT00591123|Gastric Cardia|gastric cardia
5258901|NCT00591097|urine|urine
5258902|NCT00591097|pediatric|pediatric
5258903|NCT00591097|Normal urine from healthy pediatric population|normal urine from healthy pediatric population
5258904|NCT00591084|randomized trial|randomized trial
5258905|NCT00591084|ischemic stroke|ischemic stroke
5258906|NCT00591084|Ginsenoside-Rd|ginsenoside-rd
5258907|NCT00591071|hyperglycemia|hyperglycemia
5258908|NCT00591071|insulin treatment|insulin treatment
5258909|NCT00591071|intensive care|intensive care
5258910|NCT00591071|hypoglycemia|hypoglycemia
5258911|NCT00591071|mechanical ventilation|mechanical ventilation
5258912|NCT00591071|critically ill patients|critically ill patients
5258913|NCT00591058|recurrent glioma|recurrent glioma
5258914|NCT00591058|Phase I|phase i
5258915|NCT00591058|Multi-Center|multi-center
5258916|NCT00591058|Open label|open label
5258917|NCT00591058|Brain Cancer|brain cancer
5258918|NCT00591058|Brain tumor|brain tumor
5258919|NCT00591058|GBM|gbm
5258920|NCT00591058|Glioma|glioma
5258921|NCT00591058|Glioblastoma multiforme|glioblastoma multiforme
5258922|NCT00591045|gastric adenocarcinoma|gastric adenocarcinoma
5258923|NCT00591045|neoadjuvant chemotherapy|neoadjuvant chemotherapy
5258924|NCT00591045|efficacy|efficacy
5258925|NCT00591045|safety|safety
5258926|NCT00591045|chemotherapy|chemotherapy
5258927|NCT00591032|Critical illness|critical illness
5258928|NCT00591032|Euthyroid sick syndromes|euthyroid sick syndromes
5258929|NCT00591032|Intensive care|intensive care
5258930|NCT00591032|Non-thyroidal illness syndrome|non-thyroidal illness syndrome
5258931|NCT00591032|Low-T3 syndrome|low-t3 syndrome
5258932|NCT00591019|P50, Psychomotor Vigilance Test (PVT), Arousal, Reaction Time|p50, psychomotor vigilance test (pvt), arousal, reaction time
5258933|NCT00591006|Phenytoin|phenytoin
5258934|NCT00591006|Dilantin|dilantin
5258935|NCT00591006|Corticosteroid|corticosteroid
5258936|NCT00591006|Neuroprotection|neuroprotection
5258937|NCT00591006|Mania|mania
5258938|NCT00591006|Cognition|cognition
5258939|NCT00591006|Mood|mood
5258940|NCT00591006|Memory|memory
5258941|NCT00591006|Hydrocortisone|hydrocortisone
5258942|NCT00591006|Healthy Controls|healthy controls
5258943|NCT00591006|MRI|mri
5258944|NCT00591006|hippocampal activation|hippocampal activation
5258945|NCT00590993|MRSI|mrsi
5258946|NCT00590993|MRI|mri
5258947|NCT00590993|Prostate Cancer|prostate cancer
5258948|NCT00590980|Stroke|stroke
5258949|NCT00590980|TIA (transient ischemic attack)|tia (transient ischemic attack)
5258950|NCT00590980|Brain|brain
5258951|NCT00590980|Blood Flow|blood flow
5258952|NCT00590980|Quantitative magnetic resonance angiography (QMRA)|quantitative magnetic resonance angiography (qmra)
5258953|NCT00590967|para-aortic lymph nodes|para-aortic lymph nodes
5258954|NCT00590954|Malignant Gliomas|malignant gliomas
5258955|NCT00590954|CNS|cns
5258956|NCT00590954|Brain Cancer|brain cancer
5258957|NCT00590954|Cancer|cancer
5258958|NCT00590954|Perifosine|perifosine
5258959|NCT00590941|Lymphoma|lymphoma
5258960|NCT00590941|Rituximab|rituximab
5258961|NCT00590941|CHOP|chop
5258962|NCT00590915|ALL|all
5258963|NCT00590902|non small cell lung cancer|non small cell lung cancer
5258964|NCT00590889|artificial heart valve|artificial heart valve
5258965|NCT00590889|mitral heart valve|mitral heart valve
5258966|NCT00590889|aortic heart valve|aortic heart valve
5258967|NCT00590889|endocarditis|endocarditis
5258968|NCT00590889|Aortic valve disease requiring replacement|aortic valve disease requiring replacement
5258969|NCT00590889|Mitral valve disease requiring replacement|mitral valve disease requiring replacement
5258970|NCT00590876|Diabetes Mellitus, Type 1|diabetes mellitus, type 1
5258971|NCT00590876|Hypoglycemia|hypoglycemia
5258972|NCT00590876|Pancreatic Islet Cell Allotransplantation|pancreatic islet cell allotransplantation
5258973|NCT00590863|depression, medication, antidepressant, chronic, recurrent|depression, medication, antidepressant, chronic, recurrent
5258974|NCT00590837|AML|aml
5258975|NCT00590837|Chemotherapy|chemotherapy
5258976|NCT00590837|older|older
5258977|NCT00590837|De novo AML|de novo aml
5258978|NCT00590824|Melanoma|melanoma
5258979|NCT00590824|hu14.18-IL2|hu14.18-il2
5258980|NCT00590811|adolescents|adolescents
5258981|NCT00590811|young adults|young adults
5258982|NCT00590811|dysmenorrhea|dysmenorrhea
5258983|NCT00590811|pelvic pain|pelvic pain
5258984|NCT00590798|Cardiac Catheterization|cardiac catheterization
5258985|NCT00590798|Walk|walk
5258986|NCT00590798|Heart Catheterization|heart catheterization
5258987|NCT00590798|Coronary Disease|coronary disease
5258988|NCT00590798|Heart Disease|heart disease
5258989|NCT00590798|Coronary Artery Disease|coronary artery disease
5258990|NCT00590785|High Risk|high risk
5258991|NCT00590785|Breast Cancer|breast cancer
5258992|NCT00590785|Positive Nodes|positive nodes
5258993|NCT00590785|Cyclophosphamide|cyclophosphamide
5258994|NCT00590785|Doxorubicin|doxorubicin
5258995|NCT00590785|96-041|96-041
5258996|NCT00590772|sleep|sleep
5258997|NCT00590772|somnolence|somnolence
5258998|NCT00590772|allergies|allergies
5258999|NCT00590772|rhinitis|rhinitis
5259000|NCT00590772|fatigue|fatigue
5259001|NCT00590720|Asthma|asthma
5259002|NCT00590720|Bronchitis|bronchitis
5259003|NCT00590707|Hip fractures|hip fractures
5259004|NCT00590707|Femoral neck fractures|femoral neck fractures
5259005|NCT00590707|Trochanteric fractures|trochanteric fractures
5259006|NCT00590707|Intertrochanteric fractures|intertrochanteric fractures
5259007|NCT00590707|Subtrochanteric fractures|subtrochanteric fractures
5259008|NCT00590707|Delirium|delirium
5259009|NCT00590707|Confusion|confusion
5259010|NCT00590694|ranibizumab|ranibizumab
5259011|NCT00590694|Lucentis|lucentis
5259012|NCT00590694|Pigment Epithelial Detachment|pigment epithelial detachment
5259013|NCT00590694|Macular Degeneration|macular degeneration
5259014|NCT00590694|PrONTO|pronto
5259015|NCT00590668|atrial fibrillation|atrial fibrillation
5259016|NCT00590668|pulmonary vein ablation|pulmonary vein ablation
5259017|NCT00590668|pulmonary vein stenosis|pulmonary vein stenosis
5259018|NCT00590655|maintenance therapy|maintenance therapy
5259019|NCT00590642|obsessive compulsive disorder|obsessive compulsive disorder
5259020|NCT00590642|OCD|ocd
5259021|NCT00590642|treatment-resistant|treatment-resistant
5259022|NCT00590642|SSRI|ssri
5259023|NCT00590629|Women with and without CAD|women with and without cad
5259024|NCT00590616|Aortic atheroma|aortic atheroma
5259025|NCT00590603|Multiple myeloma|multiple myeloma
5259026|NCT00590577|Schizophrenia|schizophrenia
5259027|NCT00590577|Long-acting injectable antipsychotic medication|long-acting injectable antipsychotic medication
5259028|NCT00590564|Hepatitis C|hepatitis c
5259029|NCT00590564|Sho-saiko-to|sho-saiko-to
5259030|NCT00590564|SST|sst
5259031|NCT00590564|Interferon Therapy|interferon therapy
5259032|NCT00590551|Skin Breakdown|skin breakdown
5259033|NCT00590551|Skin Damage|skin damage
5259034|NCT00590551|Skin Integrity|skin integrity
5259035|NCT00590551|Pressure|pressure
5259036|NCT00590551|Slings|slings
5259037|NCT00590525|hsCRP|hscrp
5259038|NCT00590512|dietary salt|dietary salt
5259039|NCT00590512|sodium|sodium
5259040|NCT00590512|blood vessels|blood vessels
5259041|NCT00590512|vascular function|vascular function
5259042|NCT00590512|endothelial function|endothelial function
5259043|NCT00590512|heart disease risk|heart disease risk
5259044|NCT00590512|cardiovascular disease risk|cardiovascular disease risk
5259045|NCT00590499|agitation|agitation
5259046|NCT00590499|craniotomy|craniotomy
5259047|NCT00590499|incidence|incidence
5259048|NCT00590499|risk factor|risk factor
5259049|NCT00590499|outcome|outcome
5259050|NCT00590473|Interstitial Cystitis|interstitial cystitis
5259051|NCT00590473|IC|ic
5259052|NCT00590473|Neuromodulation|neuromodulation
5259053|NCT00590473|Interstim Therapy|interstim therapy
5259054|NCT00590460|Allogeneic Stem Cell Transplant|allogeneic stem cell transplant
5259055|NCT00590460|Fanconi Anemia|fanconi anemia
5259056|NCT00590460|Severe Aplastic Anemia|severe aplastic anemia
5259057|NCT00590460|fludarabine|fludarabine
5259058|NCT00590460|campath|campath
5259059|NCT00590460|anti-CD45|anti-cd45
5259060|NCT00590447|1st-line therapy|1st-line therapy
5259061|NCT00590447|single agent rituximab|single agent rituximab
5259062|NCT00590447|CHOP|chop
5259063|NCT00590447|risk stratification|risk stratification
5259064|NCT00590434|CRC - Colorectal cancer|crc - colorectal cancer
5259065|NCT00590434|CVA - Cerebral Vascular Accident|cva - cerebral vascular accident
5259066|NCT00590434|MI - Myocardial Infarction|mi - myocardial infarction
5259067|NCT00590434|CAD - Coronary Artery Disease|cad - coronary artery disease
5259068|NCT00590434|DM - Diabetes Mellitus|dm - diabetes mellitus
5259069|NCT00590434|PVD - Peripheral Vascular Disease|pvd - peripheral vascular disease
5259070|NCT00590434|NSAIDS - Non-Steroidal Anti inflammatory Drugs|nsaids - non-steroidal anti inflammatory drugs
5259071|NCT00590434|screening|screening
5259072|NCT00590434|colonoscopy|colonoscopy
5259073|NCT00590408|coenzyme Q10|coenzyme q10
5259074|NCT00590408|statin|statin
5259075|NCT00590408|myalgia|myalgia
5259076|NCT00590395|Cholecystitis|cholecystitis
5259077|NCT00590395|FDG PET/CT|fdg pet/ct
5259078|NCT00590395|HIDA scan|hida scan
5259079|NCT00590356|Device closure|device closure
5259080|NCT00590304|Asthma, Children, Rural Population, Morbidity, Endotoxin|asthma, children, rural population, morbidity, endotoxin
5259081|NCT00590291|Coronary Artery Disease|coronary artery disease
5259082|NCT00590291|Arteriovenous Malformations|arteriovenous malformations
5259083|NCT00590291|Myocardial Infarction|myocardial infarction
5259084|NCT00590291|CAD|cad
5259085|NCT00590291|MI|mi
5259086|NCT00590291|Heart Attack|heart attack
5259087|NCT00590291|AVM|avm
5259088|NCT00590291|genetic|genetic
5259089|NCT00590291|familial|familial
5259090|NCT00590278|Tomudex|tomudex
5259091|NCT00590278|inoperable rectal cancer|inoperable rectal cancer
5259092|NCT00590278|recurrent rectal cancer|recurrent rectal cancer
5259093|NCT00590265|bipolar type II disorder|bipolar type ii disorder
5259094|NCT00590265|depression|depression
5259095|NCT00590265|remission|remission
5259096|NCT00590265|light-therapy|light-therapy
5259097|NCT00590265|efficacy|efficacy
5259098|NCT00590265|safety|safety
5259099|NCT00590252|Magnetic Resonance|magnetic resonance
5259100|NCT00590252|Imaging|imaging
5259101|NCT00590252|Spectroscopy|spectroscopy
5259102|NCT00590239|Barrett's Esophagus|barrett's esophagus
5259103|NCT00590239|Neoplasia|neoplasia
5259104|NCT00590239|Endoscopic mucosal resection|endoscopic mucosal resection
5259105|NCT00590239|High resolution endoscopy|high resolution endoscopy
5259106|NCT00590239|Chromoendoscopy|chromoendoscopy
5259107|NCT00590226|type 2 diabetes|type 2 diabetes
5259108|NCT00590226|inpatient hyperglycemia|inpatient hyperglycemia
5259109|NCT00590226|SQ insulin|sq insulin
5259110|NCT00590226|Hospitalized patients with type 2 diabetes|hospitalized patients with type 2 diabetes
5259111|NCT00590213|Casodex|casodex
5259112|NCT00590213|Prostate Cancer|prostate cancer
5259113|NCT00590200|CAD|cad
5259114|NCT00590200|Cardiovascular Disease|cardiovascular disease
5259115|NCT00590200|CVD|cvd
5259116|NCT00590200|MI|mi
5259117|NCT00590200|Myocardial Infarction|myocardial infarction
5259118|NCT00590200|Heart Attack|heart attack
5259119|NCT00590200|CABG|cabg
5259120|NCT00590200|Revascularization|revascularization
5259121|NCT00590200|genetic|genetic
5259122|NCT00590174|stent|stent
5259123|NCT00590174|antiplatelet therapy|antiplatelet therapy
5259124|NCT00590161|Fatty Liver|fatty liver
5259125|NCT00590161|Nonalcoholic fatty liver disease (NALFD)|nonalcoholic fatty liver disease (nalfd)
5259126|NCT00590161|NAFLD|nafld
5259127|NCT00590161|Nonalcoholic steatohepatitis (NASH)|nonalcoholic steatohepatitis (nash)
5259128|NCT00590161|NASH|nash
5259129|NCT00590161|pentoxifylline|pentoxifylline
5259130|NCT00590135|calcific aortic valve stenosis|calcific aortic valve stenosis
5259131|NCT00590135|echocardiography, transthoracic|echocardiography, transthoracic
5259132|NCT00590122|Parkinson's disease|parkinson's disease
5259133|NCT00590122|"time to on"|"time to on"
5259134|NCT00590122|delayed on|delayed on
5259135|NCT00590109|Breast Cancer|breast cancer
5259136|NCT00590109|Jewish|jewish
5259137|NCT00590109|BRCA1|brca1
5259138|NCT00590109|BRCA2|brca2
5259139|NCT00590109|97-029|97-029
5259140|NCT00590096|Neuroblastoma|neuroblastoma
5259141|NCT00590096|Pheochromocytoma|pheochromocytoma
5259142|NCT00590096|MIBG|mibg
5259143|NCT00590083|stem cell transplantation|stem cell transplantation
5259144|NCT00590083|adenovirus|adenovirus
5259145|NCT00590083|Cytotoxic T-Lymphocytes|cytotoxic t-lymphocytes
5259146|NCT00590083|prophylaxis|prophylaxis
5259147|NCT00590070|myocardial infarction|myocardial infarction
5259148|NCT00590070|no reflow|no reflow
5259149|NCT00590070|primary PCI|primary pci
5259150|NCT00590070|Coronary no-reflow phenomenon|coronary no-reflow phenomenon
5259151|NCT00590070|primary percutaneous coronary intervention (primary PCI)|primary percutaneous coronary intervention (primary pci)
5259152|NCT00590044|Diabetic ketoacidosis|diabetic ketoacidosis
5259153|NCT00590044|insulin therapy|insulin therapy
5259154|NCT00590044|DKA|dka
5259155|NCT00590031|Esophageal Carcinoma|esophageal carcinoma
5259156|NCT00590031|Cisplatin|cisplatin
5259157|NCT00590031|Irinotecan|irinotecan
5259158|NCT00590031|Radiation Therapy|radiation therapy
5259159|NCT00590031|02-045|02-045
5259160|NCT00590018|Congenital heart disease.|congenital heart disease.
5259161|NCT00590018|Low cardiac output syndrome.|low cardiac output syndrome.
5259162|NCT00590018|Corticosteroids.|corticosteroids.
5259163|NCT00590018|Hydrocortisone.|hydrocortisone.
5259164|NCT00590018|Blood pressure.|blood pressure.
5259165|NCT00590018|Inotropes.|inotropes.
5259166|NCT00590005|severe asthma|severe asthma
5259167|NCT00590005|poorly controlled asthma|poorly controlled asthma
5259168|NCT00589979|Osteoarthritis|osteoarthritis
5259169|NCT00589979|Knee|knee
5259170|NCT00589979|Lidoderm|lidoderm
5259171|NCT00589979|Lidocaine|lidocaine
5259172|NCT00589979|Topical patch|topical patch
5259173|NCT00589979|Adjunct therapy|adjunct therapy
5259174|NCT00589966|prostate cancer treatment|prostate cancer treatment
5259175|NCT00589966|treatment side-effects|treatment side-effects
5259176|NCT00589966|early diagnosis|early diagnosis
5259177|NCT00589966|African American Men|african american men
5259178|NCT00589966|coping skills training|coping skills training
5259179|NCT00589966|quality of life|quality of life
5259180|NCT00589966|Prostate cancer treatment side-effects|prostate cancer treatment side-effects
5259181|NCT00589953|Extreme Prematurity|extreme prematurity
5259182|NCT00589953|Erythropoietin|erythropoietin
5259183|NCT00589953|Perinatal Brain Injury|perinatal brain injury
5259184|NCT00589953|Intraventricular Hemorrhage|intraventricular hemorrhage
5259185|NCT00589953|Periventricular Leukomalacia|periventricular leukomalacia
5259186|NCT00589953|Neurodevelopmental Outcomes|neurodevelopmental outcomes
5259187|NCT00589953|Randomized Clinical Trial|randomized clinical trial
5259188|NCT00589927|stents|stents
5259189|NCT00589927|cilostazol|cilostazol
5259190|NCT00589914|Schizophrenia|schizophrenia
5259191|NCT00589914|long-acting injectable antipsychotic medication|long-acting injectable antipsychotic medication
5259192|NCT00589901|metastatic breast cancer|metastatic breast cancer
5259193|NCT00589901|capecitabine|capecitabine
5259194|NCT00589901|synergistic effect|synergistic effect
5259195|NCT00589901|chemotherapy|chemotherapy
5259196|NCT00589888|hypertension|hypertension
5259197|NCT00589888|metabolic syndrome|metabolic syndrome
5259198|NCT00589888|vascular reactivity|vascular reactivity
5259199|NCT00589888|Elevated blood pressure|elevated blood pressure
5259200|NCT00589888|lipid toxicity|lipid toxicity
5259201|NCT00589875|Immunotherapy|immunotherapy
5259202|NCT00589875|Cytotoxicity|cytotoxicity
5259203|NCT00589875|Tumor vaccine|tumor vaccine
5259204|NCT00589862|Drug Eluting Stents|drug eluting stents
5259205|NCT00589862|Clopidogrel Resistance|clopidogrel resistance
5259206|NCT00589862|Aspirin Resistance|aspirin resistance
5259207|NCT00589849|Myocardial Infarction|myocardial infarction
5259208|NCT00589849|Arrhythmia|arrhythmia
5259209|NCT00589849|T-wave alternans|t-wave alternans
5259210|NCT00589836|HCM|hcm
5259211|NCT00589836|HOCM|hocm
5259212|NCT00589836|hypertrophic cardiomyopathy|hypertrophic cardiomyopathy
5259213|NCT00589836|tissue doppler echocardiography|tissue doppler echocardiography
5259214|NCT00589836|myocardial torsion|myocardial torsion
5259215|NCT00589823|Pain|pain
5259216|NCT00589823|Cancer|cancer
5259217|NCT00589823|Breakthrough|breakthrough
5259218|NCT00589810|ISR|isr
5259219|NCT00589810|in-stent restenosis|in-stent restenosis
5259220|NCT00589810|restenosis|restenosis
5259221|NCT00589810|BMS|bms
5259222|NCT00589810|bare metal stent|bare metal stent
5259223|NCT00589810|revascularization|revascularization
5259224|NCT00589810|genetic|genetic
5259225|NCT00589810|cardiac catheterization|cardiac catheterization
5259226|NCT00589797|Degenerative|degenerative
5259227|NCT00589797|Disc|disc
5259228|NCT00589784|Sunitinib|sunitinib
5259229|NCT00589784|Brain Cancer|brain cancer
5259230|NCT00589784|CNS Cancer|cns cancer
5259231|NCT00589784|meningioma|meningioma
5259232|NCT00589784|intracranial hemangiopericytoma|intracranial hemangiopericytoma
5259233|NCT00589784|hemangioblastoma|hemangioblastoma
5259234|NCT00589784|malignant meningioma|malignant meningioma
5259235|NCT00589784|neurofibromatosis|neurofibromatosis
5259236|NCT00589784|neurofibromatosis type 1|neurofibromatosis type 1
5259237|NCT00589784|neurofibromatosis type 2|neurofibromatosis type 2
5259238|NCT00589784|07-135|07-135
5259239|NCT00589771|IBS|ibs
5259240|NCT00589771|Saccharomyces boulardii|saccharomyces boulardii
5259241|NCT00589771|probiotics|probiotics
5259242|NCT00589771|cytokine|cytokine
5259243|NCT00589771|histology|histology
5259244|NCT00589771|Efficacy|efficacy
5259245|NCT00589758|Right Ventricle|right ventricle
5259246|NCT00589758|Echocardiogram|echocardiogram
5259247|NCT00589758|Evaluation of Heart Failure|evaluation of heart failure
5259248|NCT00589745|Diagnosis|diagnosis
5259249|NCT00589732|stents|stents
5259250|NCT00589732|angiotensin-converting enzyme|angiotensin-converting enzyme
5259251|NCT00589719|Asthma; minority; low-income; African American; Arkansas|asthma; minority; low-income; african american; arkansas
5259252|NCT00589706|high grade gliomas of the brain|high grade gliomas of the brain
5259253|NCT00589706|anti-body treatment|anti-body treatment
5259254|NCT00589706|survival|survival
5259255|NCT00589693|Ventilator-Associated Pneumonia|ventilator-associated pneumonia
5259256|NCT00589693|Pneumonia, hospital-acquired|pneumonia, hospital-acquired
5259257|NCT00589693|Doripenem|doripenem
5259258|NCT00589693|Imipenem-cilastatin|imipenem-cilastatin
5259259|NCT00589680|Acidosis, Diabetic|acidosis, diabetic
5259260|NCT00589680|Diabetic Acidosis|diabetic acidosis
5259261|NCT00589680|Diabetic Ketosis|diabetic ketosis
5259262|NCT00589680|Ketoacidosis, Diabetic|ketoacidosis, diabetic
5259263|NCT00589680|Ketosis, Diabetic|ketosis, diabetic
5259264|NCT00589667|Head and Neck Cancer|head and neck cancer
5259265|NCT00589667|GEMCITABINE|gemcitabine
5259266|NCT00589667|PEMETREXED|pemetrexed
5259267|NCT00589667|ALTIMA|altima
5259268|NCT00589667|epidermoid/squamous cell|epidermoid/squamous cell
5259269|NCT00589667|carcinoma|carcinoma
5259270|NCT00589667|pharynx|pharynx
5259271|NCT00589667|larynx|larynx
5259272|NCT00589667|paranasal sinus|paranasal sinus
5259273|NCT00589667|head/neck squamous cell carcinoma|head/neck squamous cell carcinoma
5259274|NCT00589654|amenorrhea|amenorrhea
5259275|NCT00589654|menstrual cycle|menstrual cycle
5259276|NCT00589654|Breast cancer|breast cancer
5259277|NCT00589654|questionnaire|questionnaire
5259278|NCT00589654|97-127|97-127
5259279|NCT00589641|adolescents|adolescents
5259280|NCT00589641|suicidal ideation and behavior|suicidal ideation and behavior
5259281|NCT00589641|depression|depression
5259282|NCT00589641|substance abuse|substance abuse
5259283|NCT00589628|Childhood|childhood
5259284|NCT00589628|Uveitis|uveitis
5259285|NCT00589615|vitamin D|vitamin d
5259286|NCT00589615|bone density|bone density
5259287|NCT00589602|Adult leukemia|adult leukemia
5259288|NCT00589602|lymphoma|lymphoma
5259289|NCT00589602|myelodysplastic syndromes|myelodysplastic syndromes
5259290|NCT00589602|plasma cell disorders|plasma cell disorders
5259291|NCT00589589|burns|burns
5259292|NCT00589589|hypoglycemia|hypoglycemia
5259293|NCT00589589|hyperglycemia|hyperglycemia
5259294|NCT00589589|glucose monitoring|glucose monitoring
5259295|NCT00589563|graft versus host disease|graft versus host disease
5259296|NCT00589563|infection|infection
5259297|NCT00589563|adult favorable prognosis Hodgkin lymphoma|adult favorable prognosis hodgkin lymphoma
5259298|NCT00589563|adult unfavorable prognosis Hodgkin lymphoma|adult unfavorable prognosis hodgkin lymphoma
5259299|NCT00589563|childhood favorable prognosis Hodgkin lymphoma|childhood favorable prognosis hodgkin lymphoma
5259300|NCT00589563|childhood unfavorable prognosis Hodgkin lymphoma|childhood unfavorable prognosis hodgkin lymphoma
5259301|NCT00589563|cutaneous B-cell non-Hodgkin lymphoma|cutaneous b-cell non-hodgkin lymphoma
5259302|NCT00589563|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5259303|NCT00589563|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5259304|NCT00589563|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
5259305|NCT00589563|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
5259306|NCT00589563|stage I childhood Hodgkin lymphoma|stage i childhood hodgkin lymphoma
5259307|NCT00589563|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
5259308|NCT00589563|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
5259309|NCT00589563|stage II childhood Hodgkin lymphoma|stage ii childhood hodgkin lymphoma
5259310|NCT00589563|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
5259311|NCT00589563|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5259312|NCT00589563|stage III childhood Hodgkin lymphoma|stage iii childhood hodgkin lymphoma
5259313|NCT00589563|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
5259314|NCT00589563|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5259315|NCT00589563|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
5259316|NCT00589563|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
5259317|NCT00589563|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5259318|NCT00589563|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
5259319|NCT00589563|Burkitt lymphoma|burkitt lymphoma
5259320|NCT00589563|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
5259321|NCT00589563|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
5259322|NCT00589563|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
5259323|NCT00589563|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
5259324|NCT00589563|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
5259325|NCT00589563|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
5259326|NCT00589563|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
5259327|NCT00589563|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
5259328|NCT00589563|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
5259329|NCT00589563|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
5259330|NCT00589563|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
5259331|NCT00589563|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
5259332|NCT00589563|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5259333|NCT00589563|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5259334|NCT00589563|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
5259335|NCT00589563|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5259336|NCT00589563|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
5259337|NCT00589563|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
5259338|NCT00589563|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
5259339|NCT00589563|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
5259340|NCT00589563|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5259341|NCT00589563|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5259342|NCT00589563|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5259343|NCT00589563|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5259344|NCT00589563|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
5259345|NCT00589563|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
5259346|NCT00589563|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5259347|NCT00589563|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5259348|NCT00589563|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5259349|NCT00589563|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5259350|NCT00589563|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
5259351|NCT00589563|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5259352|NCT00589563|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5259353|NCT00589563|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
5259684|NCT00588523|TEMOZOLOMIDE|temozolomide
5259354|NCT00589563|recurrent childhood anaplastic large cell lymphoma|recurrent childhood anaplastic large cell lymphoma
5259355|NCT00589563|recurrent childhood grade III lymphomatoid granulomatosis|recurrent childhood grade iii lymphomatoid granulomatosis
5259356|NCT00589563|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
5259357|NCT00589563|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
5259358|NCT00589563|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5259359|NCT00589563|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5259360|NCT00589563|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5259361|NCT00589563|recurrent grade I lymphomatoid granulomatosis|recurrent grade i lymphomatoid granulomatosis
5259362|NCT00589563|recurrent grade II lymphomatoid granulomatosis|recurrent grade ii lymphomatoid granulomatosis
5259363|NCT00589563|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5259364|NCT00589563|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5259365|NCT00589563|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5259366|NCT00589563|small intestine lymphoma|small intestine lymphoma
5259367|NCT00589563|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5259368|NCT00589563|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
5259369|NCT00589563|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
5259370|NCT00589563|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
5259371|NCT00589563|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
5259372|NCT00589563|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
5259373|NCT00589563|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
5259374|NCT00589563|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
5259375|NCT00589563|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5259376|NCT00589563|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5259377|NCT00589563|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5259378|NCT00589563|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5259379|NCT00589563|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5259380|NCT00589563|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5259381|NCT00589563|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
5259382|NCT00589563|stage III childhood anaplastic large cell lymphoma|stage iii childhood anaplastic large cell lymphoma
5259383|NCT00589563|stage III childhood lymphoblastic lymphoma|stage iii childhood lymphoblastic lymphoma
5259384|NCT00589563|stage III childhood small noncleaved cell lymphoma|stage iii childhood small noncleaved cell lymphoma
5259385|NCT00589563|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5259386|NCT00589563|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5259387|NCT00589563|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5259388|NCT00589563|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5259389|NCT00589563|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5259390|NCT00589563|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5259391|NCT00589563|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5259392|NCT00589563|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5259393|NCT00589563|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5259394|NCT00589563|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5259395|NCT00589563|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5259396|NCT00589563|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5259397|NCT00589563|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
5259398|NCT00589563|stage IV childhood anaplastic large cell lymphoma|stage iv childhood anaplastic large cell lymphoma
5259399|NCT00589563|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
5259400|NCT00589563|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
5259401|NCT00589563|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5259402|NCT00589563|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5259403|NCT00589563|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5259404|NCT00589563|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5259405|NCT00589563|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5259406|NCT00589563|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5259407|NCT00589563|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5259408|NCT00589563|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5259409|NCT00589563|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5259410|NCT00589563|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5259411|NCT00589563|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5259412|NCT00589563|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5259413|NCT00589563|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
5259414|NCT00589563|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5259415|NCT00589563|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5259416|NCT00589563|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5259417|NCT00589563|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5259418|NCT00589563|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
5259419|NCT00589563|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5259420|NCT00589563|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5259421|NCT00589563|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5259422|NCT00589563|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5259423|NCT00589563|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5259424|NCT00589563|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5259425|NCT00589563|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
5259426|NCT00589563|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
5259427|NCT00589563|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5259428|NCT00589563|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5259429|NCT00589563|stage I multiple myeloma|stage i multiple myeloma
5259430|NCT00589563|stage II multiple myeloma|stage ii multiple myeloma
5259431|NCT00589563|stage III multiple myeloma|stage iii multiple myeloma
5259432|NCT00589563|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
5259433|NCT00589563|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5259434|NCT00589563|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
5259435|NCT00589563|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5259436|NCT00589563|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5259437|NCT00589563|atypical chronic myeloid leukemia, BCR-ABL negative|atypical chronic myeloid leukemia, bcr-abl negative
5259438|NCT00589563|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5259439|NCT00589563|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
5259440|NCT00589563|primary myelofibrosis|primary myelofibrosis
5259441|NCT00589563|secondary myelofibrosis|secondary myelofibrosis
5259442|NCT00589550|clear cell renal cell carcinoma|clear cell renal cell carcinoma
5259443|NCT00589550|stage III renal cell cancer|stage iii renal cell cancer
5259444|NCT00589550|stage IV renal cell cancer|stage iv renal cell cancer
5259445|NCT00589537|testicular seminoma|testicular seminoma
5259685|NCT00588523|Busulfan|busulfan
5259446|NCT00589537|stage I malignant testicular germ cell tumor|stage i malignant testicular germ cell tumor
5259447|NCT00589524|blocked arteries|blocked arteries
5259448|NCT00589524|narrowing arteries|narrowing arteries
5259449|NCT00589524|IVUS|ivus
5259450|NCT00589524|CT|ct
5259451|NCT00589511|Bilateral severe to profound sensorineural hearing loss|bilateral severe to profound sensorineural hearing loss
5259452|NCT00589459|undiagnosed diabetes|undiagnosed diabetes
5259453|NCT00589459|undiagnosed pre-diabetes|undiagnosed pre-diabetes
5259454|NCT00589459|acute coronary syndrome|acute coronary syndrome
5259455|NCT00589459|undiagnosed pre-diabetes and undiagnosed diabetes|undiagnosed pre-diabetes and undiagnosed diabetes
5259456|NCT00589446|Embryoscopy|embryoscopy
5259457|NCT00589446|recurrent miscarriage|recurrent miscarriage
5259458|NCT00589446|missed abortion|missed abortion
5259459|NCT00589446|Structural anomalies in recurrent miscarriage|structural anomalies in recurrent miscarriage
5259460|NCT00589446|Embryoscopically directed biopsy for karyotyping|embryoscopically directed biopsy for karyotyping
5259461|NCT00589420|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5259462|NCT00589420|recurrent prostate cancer|recurrent prostate cancer
5259463|NCT00589420|stage IV prostate cancer|stage iv prostate cancer
5259464|NCT00589394|pneumococcal vaccine|pneumococcal vaccine
5259465|NCT00589394|normal response|normal response
5259466|NCT00589394|immunodeficiency|immunodeficiency
5259467|NCT00589394|Healthy patients|healthy patients
5259468|NCT00589394|Healthy Volunteers|healthy volunteers
5259469|NCT00589381|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5259470|NCT00589381|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5259471|NCT00589381|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
5259472|NCT00589381|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5259473|NCT00589381|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
5259474|NCT00589381|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5259475|NCT00589381|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5259476|NCT00589381|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
5259477|NCT00589381|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
5259478|NCT00589381|Waldenström macroglobulinemia|waldenström macroglobulinemia
5259479|NCT00589381|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5259480|NCT00589381|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5259481|NCT00589381|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5259482|NCT00589381|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5259483|NCT00589381|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5259484|NCT00589381|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5259485|NCT00589381|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5259486|NCT00589381|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5259487|NCT00589381|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5259488|NCT00589381|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5259489|NCT00589381|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5259490|NCT00589381|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5259491|NCT00589381|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5259492|NCT00589381|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5259493|NCT00589381|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5259494|NCT00589368|Brain Infarction|brain infarction
5259495|NCT00589368|pathology|pathology
5259496|NCT00589368|physiopathology|physiopathology
5259497|NCT00589368|psychology|psychology
5259498|NCT00589368|rehabilitation|rehabilitation
5259499|NCT00589368|Fingers|fingers
5259500|NCT00589368|Grasp|grasp
5259501|NCT00589368|Functional Laterality|functional laterality
5259502|NCT00589368|Hand|hand
5259503|NCT00589368|Strength|strength
5259504|NCT00589368|Neuronal Plasticity|neuronal plasticity
5259505|NCT00589368|Psychomotor Performance|psychomotor performance
5259506|NCT00589368|Biomechanis|biomechanis
5259507|NCT00589368|Touch|touch
5259508|NCT00589368|Weight-Bearing|weight-bearing
5259509|NCT00589355|c-reactive protein|c-reactive protein
5259510|NCT00589355|endothelial dysfunction|endothelial dysfunction
5259511|NCT00589355|glucose intolerance|glucose intolerance
5259512|NCT00589329|Preterm birth|preterm birth
5259513|NCT00589329|antibiotics|antibiotics
5259514|NCT00589329|preterm labor|preterm labor
5259515|NCT00589329|respiratory distress|respiratory distress
5259516|NCT00589329|pergnancy|pergnancy
5259517|NCT00589303|Atrial Fibrillation|atrial fibrillation
5259518|NCT00589303|Heart Failure|heart failure
5259519|NCT00589303|AV Node ablation|av node ablation
5259520|NCT00589303|Cardiac pacemaker|cardiac pacemaker
5259521|NCT00589303|Antiarrhythmic drug|antiarrhythmic drug
5259522|NCT00589290|Histone deacetylase (HDAC) Inhibitors|histone deacetylase (hdac) inhibitors
5259523|NCT00589290|Mediastinal Neoplasm|mediastinal neoplasm
5259524|NCT00589290|Thymic Carcinoma|thymic carcinoma
5259525|NCT00589290|Thymoma|thymoma
5259526|NCT00589277|Smoking|smoking
5259527|NCT00589277|Tobacco|tobacco
5259528|NCT00589277|Message Framing|message framing
5259529|NCT00589264|zinc|zinc
5259530|NCT00589264|iron|iron
5259531|NCT00589264|child development|child development
5259532|NCT00589264|visual attention|visual attention
5259533|NCT00589264|Peru|peru
5259534|NCT00589251|penicillin allergy, penicillin skin test|penicillin allergy, penicillin skin test
5259535|NCT00589238|stage II breast cancer|stage ii breast cancer
5259536|NCT00589238|stage IIIA breast cancer|stage iiia breast cancer
5259537|NCT00589238|stage IIIB breast cancer|stage iiib breast cancer
5259538|NCT00589238|stage IIIC breast cancer|stage iiic breast cancer
5259539|NCT00589225|PH|ph
5259540|NCT00589225|PH type I|ph type i
5259541|NCT00589225|Primary Hyperoxaluria|primary hyperoxaluria
5259542|NCT00589225|Hyperoxaluria|hyperoxaluria
5259543|NCT00589225|Primary Oxalosis|primary oxalosis
5259544|NCT00589225|PH type II|ph type ii
5259545|NCT00589225|PH type III|ph type iii
5259546|NCT00589225|Genetic testing for PH|genetic testing for ph
5259547|NCT00589225|Genetic testing for Primary Hyperoxaluria|genetic testing for primary hyperoxaluria
5259548|NCT00589225|Hereditary study for PH|hereditary study for ph
5259549|NCT00589225|Hereditary study for Primary Hyperoxaluria|hereditary study for primary hyperoxaluria
5259550|NCT00589212|GliaSite|gliasite
5259551|NCT00589212|Brain metastases|brain metastases
5259552|NCT00589212|1-3 METS|1-3 mets
5259553|NCT00589186|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
5259554|NCT00589186|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
5259555|NCT00589186|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
5259556|NCT00589186|recurrent lymphoepithelioma of the nasopharynx|recurrent lymphoepithelioma of the nasopharynx
5259557|NCT00589173|Preventive Care|preventive care
5259558|NCT00589173|Health information technology|health information technology
5259559|NCT00589173|Personal health record|personal health record
5259560|NCT00589121|radiation fibrosis|radiation fibrosis
5259561|NCT00589121|radiation toxicity|radiation toxicity
5259562|NCT00589121|lymphedema|lymphedema
5259563|NCT00589121|musculoskeletal complications|musculoskeletal complications
5259564|NCT00589121|stage I adult soft tissue sarcoma|stage i adult soft tissue sarcoma
5259565|NCT00589121|stage II adult soft tissue sarcoma|stage ii adult soft tissue sarcoma
5259566|NCT00589121|adult extraskeletal chondrosarcoma|adult extraskeletal chondrosarcoma
5259567|NCT00589121|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
5259568|NCT00589108|knee arthroplasty|knee arthroplasty
5259569|NCT00589082|AML|aml
5259570|NCT00589082|elderly|elderly
5259571|NCT00589082|DaunoXome|daunoxome
5259572|NCT00589056|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5259573|NCT00589056|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5259574|NCT00589056|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5259575|NCT00589030|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
5259576|NCT00589030|advanced adult primary liver cancer|advanced adult primary liver cancer
5259577|NCT00589030|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
5259578|NCT00589030|recurrent adult primary liver cancer|recurrent adult primary liver cancer
5259579|NCT00588978|c-reactive protein|c-reactive protein
5259580|NCT00588978|obesity|obesity
5259581|NCT00588978|women's cardiovascular health|women's cardiovascular health
5259582|NCT00588965|QT interval|qt interval
5259583|NCT00588965|beta-blocker|beta-blocker
5259584|NCT00588965|exercise|exercise
5259585|NCT00588965|electrocardiogram|electrocardiogram
5259586|NCT00588965|repolarizaton|repolarizaton
5259587|NCT00588939|reflux|reflux
5259588|NCT00588939|heartburn|heartburn
5259589|NCT00588926|Deep Brain Stimulation|deep brain stimulation
5259590|NCT00588926|Movement Disorders|movement disorders
5259591|NCT00588926|Remifentanil|remifentanil
5259592|NCT00588926|Sedation|sedation
5259593|NCT00588926|Basal Ganglia electrical activity|basal ganglia electrical activity
5259594|NCT00588913|recurrent renal cell cancer|recurrent renal cell cancer
5259595|NCT00588913|stage IV renal cell cancer|stage iv renal cell cancer
5259596|NCT00588913|clear cell renal cell carcinoma|clear cell renal cell carcinoma
5259597|NCT00588913|lung metastases|lung metastases
5259598|NCT00588900|stage IV colon cancer|stage iv colon cancer
5259599|NCT00588900|stage IV rectal cancer|stage iv rectal cancer
5259600|NCT00588900|recurrent colon cancer|recurrent colon cancer
5259601|NCT00588900|recurrent rectal cancer|recurrent rectal cancer
5259602|NCT00588874|male osteoporosis|male osteoporosis
5259603|NCT00588874|male osteopenia|male osteopenia
5259604|NCT00588874|calciotropic hormones|calciotropic hormones
5259605|NCT00588848|Obstructive Sleep Apnea Hypopnea Syndrome|obstructive sleep apnea hypopnea syndrome
5259606|NCT00588848|OSA|osa
5259607|NCT00588848|Postoperative|postoperative
5259608|NCT00588848|CPAP|cpap
5259609|NCT00588835|pharmacokinetics|pharmacokinetics
5260120|NCT00586599|IBD|ibd
5259610|NCT00588835|nausea and vomiting post chemotherapy|nausea and vomiting post chemotherapy
5259611|NCT00588822|monoclonal gammopathy of undetermined significance|monoclonal gammopathy of undetermined significance
5259612|NCT00588796|fibrinogen|fibrinogen
5259613|NCT00588796|burns|burns
5259614|NCT00588796|trauma|trauma
5259615|NCT00588796|metabolism|metabolism
5259616|NCT00588757|IVC filters|ivc filters
5259617|NCT00588757|Trauma|trauma
5259618|NCT00588757|Dwell time|dwell time
5259619|NCT00588718|Necrotizing enterocolitis|necrotizing enterocolitis
5259620|NCT00588718|Progressive necrotizing enterocolitis|progressive necrotizing enterocolitis
5259621|NCT00588718|Proteomics in blood|proteomics in blood
5259622|NCT00588718|Genomics in blood|genomics in blood
5259623|NCT00588718|Multi-center|multi-center
5259624|NCT00588705|Daughters|daughters
5259625|NCT00588705|Communication|communication
5259626|NCT00588705|genetic risk|genetic risk
5259627|NCT00588705|Genetic Counseling|genetic counseling
5259628|NCT00588692|Heart Failure|heart failure
5259629|NCT00588692|Afterload Reduction|afterload reduction
5259630|NCT00588692|Sphygmocor|sphygmocor
5259631|NCT00588679|Prostate Cancer|prostate cancer
5259632|NCT00588679|Cancer|cancer
5259633|NCT00588679|MRI|mri
5259634|NCT00588679|Magnetic Resonance Imaging|magnetic resonance imaging
5259635|NCT00588679|06-035|06-035
5259636|NCT00588666|Myeloproliferative Disorder|myeloproliferative disorder
5259637|NCT00588666|urinary bladder|urinary bladder
5259638|NCT00588666|Cancer|cancer
5259639|NCT00588666|ureter|ureter
5259640|NCT00588666|renal pelvis|renal pelvis
5259641|NCT00588666|chemotherapy|chemotherapy
5259642|NCT00588653|Crohn's disease|crohn's disease
5259643|NCT00588653|capsule endoscopy|capsule endoscopy
5259644|NCT00588653|computed tomography enterography|computed tomography enterography
5259645|NCT00588653|colonoscopy|colonoscopy
5259646|NCT00588653|small bowel follow-through|small bowel follow-through
5259647|NCT00588640|Pain|pain
5259648|NCT00588640|HEENT cancer|heent cancer
5259649|NCT00588627|Chronic cough|chronic cough
5259650|NCT00588627|Post nasal drip|post nasal drip
5259651|NCT00588588|Ventilator associated pneumonia|ventilator associated pneumonia
5259652|NCT00588588|Intensive Care|intensive care
5259653|NCT00588588|Antibiotics|antibiotics
5259654|NCT00588588|Mortality|mortality
5259655|NCT00588588|Length of stay|length of stay
5259656|NCT00588575|Barrett's Esophagus|barrett's esophagus
5259657|NCT00588562|PH|ph
5259658|NCT00588562|PH1|ph1
5259659|NCT00588562|PH2|ph2
5259660|NCT00588562|PH3|ph3
5259661|NCT00588562|PHI|phi
5259662|NCT00588562|PHII|phii
5259663|NCT00588562|PHIII|phiii
5259664|NCT00588562|PH NonI-NonII|ph noni-nonii
5259665|NCT00588562|Primary Hyperoxaluria|primary hyperoxaluria
5259666|NCT00588562|Primary Oxalosis|primary oxalosis
5259667|NCT00588562|Hyperoxaluria|hyperoxaluria
5259668|NCT00588562|Oxalate|oxalate
5259669|NCT00588562|Cystinuria|cystinuria
5259670|NCT00588562|Cystine|cystine
5259671|NCT00588562|APRT|aprt
5259672|NCT00588562|Adenine phosphoribosyl transferase deficiency|adenine phosphoribosyl transferase deficiency
5259673|NCT00588562|Dent disease|dent disease
5259674|NCT00588562|Dent|dent
5259675|NCT00588536|Langerhans Cell Histiocytosis|langerhans cell histiocytosis
5259676|NCT00588536|LCH|lch
5259677|NCT00588536|6-Thioguanine|6-thioguanine
5259678|NCT00588536|6-TG|6-tg
5259679|NCT00588536|Methotrexate|methotrexate
5259680|NCT00588536|MTX|mtx
5259681|NCT00588536|94-132|94-132
5259682|NCT00588523|Brain|brain
5259683|NCT00588523|CNS|cns
5259686|NCT00588523|Thiotepa|thiotepa
5259687|NCT00588510|Sarcoma|sarcoma
5259688|NCT00588510|Bone|bone
5259689|NCT00588497|female sterilization, micro-insert, hysteroscopy|female sterilization, micro-insert, hysteroscopy
5259690|NCT00588484|Carotid artery|carotid artery
5259691|NCT00588484|Common carotid artery|common carotid artery
5259692|NCT00588484|Measurement|measurement
5259693|NCT00588484|Ultrasound|ultrasound
5259694|NCT00588458|Primary sclerosing cholangitis|primary sclerosing cholangitis
5259695|NCT00588458|Computed tomographic cholangiography|computed tomographic cholangiography
5259696|NCT00588458|MELD score|meld score
5259697|NCT00588458|Mayo risk score for PSC|mayo risk score for psc
5259698|NCT00588445|Lung Cancer|lung cancer
5259699|NCT00588445|Non-small cell lung cancer|non-small cell lung cancer
5259700|NCT00588445|Gefitnib|gefitnib
5259701|NCT00588445|Cancer|cancer
5259702|NCT00588445|NSCLC|nsclc
5259703|NCT00588445|bronchioloalveolar cancer|bronchioloalveolar cancer
5259704|NCT00588445|smoker|smoker
5259705|NCT00588432|Stroke|stroke
5259706|NCT00588432|Immobilization|immobilization
5259707|NCT00588432|Myofacial Pain|myofacial pain
5259708|NCT00588432|Hyperthyroid Myopathy|hyperthyroid myopathy
5259709|NCT00588419|Breast Cancer|breast cancer
5259710|NCT00588419|Cancer|cancer
5259711|NCT00588419|Breast Sensation|breast sensation
5259712|NCT00588419|Postmastectomy Breast Reconstruction|postmastectomy breast reconstruction
5259713|NCT00588406|acute, emergency department|acute, emergency department
5259714|NCT00588380|GLP-1|glp-1
5259715|NCT00588380|Insulin Secretion|insulin secretion
5259716|NCT00588367|Inflammation|inflammation
5259717|NCT00588367|Pancreas|pancreas
5259718|NCT00588367|Chronic pancreatitis|chronic pancreatitis
5259719|NCT00588367|Alcoholic pancreatitis|alcoholic pancreatitis
5259720|NCT00588367|Carcinoma, pancreatic ductal|carcinoma, pancreatic ductal
5259721|NCT00588367|Pancreatic neoplasms|pancreatic neoplasms
5259722|NCT00588354|herniated disk|herniated disk
5259723|NCT00588354|radiculopathy|radiculopathy
5259724|NCT00588354|clonidine|clonidine
5259725|NCT00588354|epidural|epidural
5259726|NCT00588354|steroid|steroid
5259727|NCT00588354|corticosteroid|corticosteroid
5259728|NCT00588354|nucleus pulposus|nucleus pulposus
5259729|NCT00588354|transforaminal|transforaminal
5259730|NCT00588341|Melanoma|melanoma
5259731|NCT00588341|Skin Cancer|skin cancer
5259732|NCT00588341|Cancer|cancer
5259733|NCT00588341|Temozolamide|temozolamide
5259734|NCT00588341|TMZ|tmz
5259735|NCT00588302|primary biliary cirrhosis|primary biliary cirrhosis
5259736|NCT00588302|ursodeoxycholic acid|ursodeoxycholic acid
5259737|NCT00588289|Pediatric Cancers|pediatric cancers
5259738|NCT00588289|Oncology|oncology
5259739|NCT00588276|measurable disease|measurable disease
5259740|NCT00588276|locally advanced disease|locally advanced disease
5259741|NCT00588263|Ashkenazi Jewish|ashkenazi jewish
5259742|NCT00588263|Cancer|cancer
5259743|NCT00588263|00-087|00-087
5259744|NCT00588237|ovary|ovary
5259745|NCT00588237|BEVACIZUMAB|bevacizumab
5259746|NCT00588237|CISPLATIN|cisplatin
5259747|NCT00588237|TAXOL|taxol
5259748|NCT00588224|stomach|stomach
5259749|NCT00588224|accommodation|accommodation
5259750|NCT00588224|volume|volume
5259751|NCT00588224|SPECT|spect
5259752|NCT00588224|3 dimensional ultrasonography|3 dimensional ultrasonography
5259753|NCT00588224|healthy volunteers|healthy volunteers
5259754|NCT00588211|Cancer related-Risks|cancer related-risks
5259755|NCT00588211|Risk Perception|risk perception
5259756|NCT00588211|Survey|survey
5259757|NCT00588211|Focus Group|focus group
5259758|NCT00588211|Smoking cessation|smoking cessation
5259759|NCT00588211|tobacco|tobacco
5259760|NCT00588198|histologically confirmed melanoma of any site|histologically confirmed melanoma of any site
5259761|NCT00588185|Progressive Prostate Cancer|progressive prostate cancer
5259762|NCT00588185|[18F]-Fluoro-2-Deoxy-D-Glucose|[18f]-fluoro-2-deoxy-d-glucose
5259763|NCT00588185|[18F] Dihydro-Testosterone|[18f] dihydro-testosterone
5259764|NCT00588185|Pet Imaging|pet imaging
5259765|NCT00588185|Pet scan|pet scan
5259766|NCT00588185|00-095|00-095
5259767|NCT00588172|Metformin|metformin
5259768|NCT00588172|Type 2 diabetes|type 2 diabetes
5259769|NCT00588172|Oct1|oct1
5259770|NCT00588159|Preoperative gabapentin|preoperative gabapentin
5259771|NCT00588159|Acute pain|acute pain
5259772|NCT00588159|Post-thoracotomy pain|post-thoracotomy pain
5259773|NCT00588159|Epidural analgesia|epidural analgesia
5259774|NCT00588146|anemia|anemia
5259775|NCT00588146|HHT|hht
5259776|NCT00588146|Liver disease|liver disease
5259777|NCT00588146|Hypoxemia|hypoxemia
5259778|NCT00588146|Iron deficiency anemia|iron deficiency anemia
5259779|NCT00588146|Liver disease with high cardiac output|liver disease with high cardiac output
5259780|NCT00588146|Diffuse pulmonary AVMs with hypoxemia|diffuse pulmonary avms with hypoxemia
5259781|NCT00588133|antifibrinolytic, bleeding, heart|antifibrinolytic, bleeding, heart
5259782|NCT00588120|Hyperoxaluria|hyperoxaluria
5259783|NCT00588120|Unknown Hyperoxaluria|unknown hyperoxaluria
5259784|NCT00588120|Enteric Hyperoxaluria|enteric hyperoxaluria
5259785|NCT00588120|Oxaluric|oxaluric
5259786|NCT00588120|High Oxalate|high oxalate
5259787|NCT00588120|Oxalate|oxalate
5259788|NCT00588120|C13|c13
5259789|NCT00588120|Oxalate Diet|oxalate diet
5259790|NCT00588107|Cancer|cancer
5259791|NCT00588107|Smoker|smoker
5259792|NCT00588107|Web based intervention|web based intervention
5259793|NCT00588107|Partnership for Health|partnership for health
5259794|NCT00588107|Cancer Survivors|cancer survivors
5259795|NCT00588094|Lymphoma|lymphoma
5259796|NCT00588094|ASCT|asct
5259797|NCT00588094|B-cell non-Hodgkin's lymphoma|b-cell non-hodgkin's lymphoma
5259798|NCT00588094|Cancer|cancer
5259799|NCT00588094|Second line therapy|second line therapy
5259800|NCT00588094|ICE|ice
5259801|NCT00588094|Stem cell transplant|stem cell transplant
5259802|NCT00588081|Vaginal Reconstruction|vaginal reconstruction
5259803|NCT00588068|Adrenal Gland|adrenal gland
5259804|NCT00588068|No stage requirement|no stage requirement
5259805|NCT00588042|Angioplasty, Transluminal, Percutaneous Coronary|angioplasty, transluminal, percutaneous coronary
5259806|NCT00588042|Coronary Artery Disease|coronary artery disease
5259807|NCT00588042|Coronary Occlusion|coronary occlusion
5259808|NCT00588029|Family members|family members
5259809|NCT00588016|Itraconazole|itraconazole
5259810|NCT00588003|Breast|breast
5259811|NCT00588003|ANASTROZOLE|anastrozole
5259812|NCT00587990|Chronic Ischemic Left Ventricular Dysfunction|chronic ischemic left ventricular dysfunction
5259813|NCT00587977|Abdominal aortic aneurysm|abdominal aortic aneurysm
5259814|NCT00587964|Cancer|cancer
5259815|NCT00587964|Brain Metastasis|brain metastasis
5259816|NCT00587964|Radiosurgery|radiosurgery
5259817|NCT00587964|Bladder cancer|bladder cancer
5259818|NCT00587964|Breast cancer|breast cancer
5259819|NCT00587964|Cervical cancer|cervical cancer
5259820|NCT00587964|Colon cancer|colon cancer
5259821|NCT00587964|HEENT cancer|heent cancer
5259822|NCT00587964|Lung cancer|lung cancer
5259823|NCT00587964|Melanoma|melanoma
5259824|NCT00587964|Pancreatic cancer|pancreatic cancer
5259825|NCT00587964|Prostate cancer|prostate cancer
5259826|NCT00587964|Rectal cancer|rectal cancer
5259827|NCT00587964|Sarcoma|sarcoma
5259828|NCT00587964|Testicular cancer|testicular cancer
5259829|NCT00587964|Radiation|radiation
5259830|NCT00587951|Clinical decision-making|clinical decision-making
5259831|NCT00587951|Ictal SPECT|ictal spect
5259832|NCT00587951|Epilepsy surgery|epilepsy surgery
5259833|NCT00587938|congestive heart failure|congestive heart failure
5259834|NCT00587938|Brain naturietic peptide|brain naturietic peptide
5259835|NCT00587938|hospital utilization cost|hospital utilization cost
5259836|NCT00587925|osteoporosis|osteoporosis
5259837|NCT00587912|Kaposi's Sarcoma AIDS Related|kaposi's sarcoma aids related
5259838|NCT00587912|Kaposi's Sarcoma Classical|kaposi's sarcoma classical
5259839|NCT00587912|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
5259840|NCT00587912|HEMATOPOIETIC SYSTEM|hematopoietic system
5259841|NCT00587912|Cancer|cancer
5259842|NCT00587912|AIDS|aids
5259843|NCT00587899|Atrial Fibrillation|atrial fibrillation
5259844|NCT00587899|AF|af
5259845|NCT00587899|A fib|a fib
5259846|NCT00587899|cardiac ablation|cardiac ablation
5259847|NCT00587899|modified maze procedure|modified maze procedure
5259848|NCT00587886|Cancer|cancer
5259849|NCT00587886|Endometrial cancer|endometrial cancer
5259850|NCT00587886|Ovarian cancer|ovarian cancer
5259851|NCT00587886|Corpus Uteri|corpus uteri
5259852|NCT00587886|Endometrium|endometrium
5259853|NCT00587873|Relapsed|relapsed
5259854|NCT00587873|Hodgkin's Disease|hodgkin's disease
5259855|NCT00587873|Methotrexate|methotrexate
5259856|NCT00587873|6-Thioguanine|6-thioguanine
5259857|NCT00587873|94-030|94-030
5259858|NCT00587847|leukemia|leukemia
5259859|NCT00587821|Breast Cancer|breast cancer
5259860|NCT00587821|Breast biopsy|breast biopsy
5259861|NCT00587808|Heart Failure|heart failure
5259862|NCT00587808|Heart Failure, Diastolic|heart failure, diastolic
5259863|NCT00587808|Stroke Volume|stroke volume
5259864|NCT00587769|Smoking|smoking
5259865|NCT00587769|Smoking cessation|smoking cessation
5259866|NCT00587769|Bupropion|bupropion
5259867|NCT00587769|Varenicline|varenicline
5259868|NCT00587769|Tobacco use disorder|tobacco use disorder
5259869|NCT00587756|intraoperative ultrasonography|intraoperative ultrasonography
5259870|NCT00587756|colorectal liver metastases|colorectal liver metastases
5259871|NCT00587756|hepatectomy|hepatectomy
5259872|NCT00587756|portal vein embolization|portal vein embolization
5259873|NCT00587756|Liver|liver
5259874|NCT00587730|heart disease|heart disease
5259875|NCT00587730|cardiac disease|cardiac disease
5259876|NCT00587730|chest pain|chest pain
5259877|NCT00587730|myocardial infarction|myocardial infarction
5259878|NCT00587730|heart attack|heart attack
5259879|NCT00587691|Tovaxin|tovaxin
5259880|NCT00587691|TCV|tcv
5259881|NCT00587691|Autologous|autologous
5259882|NCT00587678|PAD|pad
5259883|NCT00587665|Pain|pain
5259884|NCT00587652|Barrett Esophagus|barrett esophagus
5259885|NCT00587652|Methylene blue|methylene blue
5259886|NCT00587652|Chromoendoscopy|chromoendoscopy
5259887|NCT00587639|Adolescent|adolescent
5259888|NCT00587639|Depression|depression
5259889|NCT00587639|rTMS|rtms
5259890|NCT00587626|neck pain|neck pain
5259891|NCT00587626|shoulder pain|shoulder pain
5259892|NCT00587626|cervical pain|cervical pain
5259893|NCT00587626|chronic|chronic
5259894|NCT00587626|recurrent|recurrent
5259895|NCT00587600|Barrett's Esophagus|barrett's esophagus
5259896|NCT00587600|High Grade Dysplasia|high grade dysplasia
5259897|NCT00587600|Photodynamic Therapy|photodynamic therapy
5259898|NCT00587574|chronic graft-versus-host disease|chronic graft-versus-host disease
5259899|NCT00587561|schizophrenia|schizophrenia
5259900|NCT00587561|social cognition|social cognition
5259901|NCT00587561|cognition|cognition
5259902|NCT00587561|treatment|treatment
5259903|NCT00587561|outcome|outcome
5259904|NCT00587548|locate the ureters during abdominal surgery|locate the ureters during abdominal surgery
5259905|NCT00587535|hemochromatosis|hemochromatosis
5259906|NCT00587535|liver cirrhosis|liver cirrhosis
5259907|NCT00587535|liver diseases|liver diseases
5259908|NCT00587522|Gastroesophageal Reflux Disease (GERD)|gastroesophageal reflux disease (gerd)
5259909|NCT00587522|NDO Full-thickness Plicator|ndo full-thickness plicator
5259910|NCT00587522|Plicator|plicator
5259911|NCT00587522|Endoluminal GERD Therapy|endoluminal gerd therapy
5259912|NCT00587496|HSV DNA|hsv dna
5259913|NCT00587496|volunteers|volunteers
5259914|NCT00587483|cardiopulmonary bypass|cardiopulmonary bypass
5259915|NCT00587483|reperfusion ventricular fibrillation|reperfusion ventricular fibrillation
5259916|NCT00587483|ventricular fibrillation|ventricular fibrillation
5259917|NCT00587483|amiodarone|amiodarone
5259918|NCT00587483|lidocaine|lidocaine
5259919|NCT00587483|cardiac surgery|cardiac surgery
5259920|NCT00587470|valve, mitral, regurgitation|valve, mitral, regurgitation
5259921|NCT00587457|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
5260121|NCT00586599|CD|cd
5259922|NCT00587457|Prolymphocytic Leukemia|prolymphocytic leukemia
5259923|NCT00587457|Small Lymphocytic Lymphoma|small lymphocytic lymphoma
5259924|NCT00587457|Moxetumomab pasudotox|moxetumomab pasudotox
5259925|NCT00587444|heparin management|heparin management
5259926|NCT00587431|Prostate|prostate
5259927|NCT00587431|Cancer|cancer
5259928|NCT00587431|Docetaxel|docetaxel
5259929|NCT00587431|03-076|03-076
5259930|NCT00587405|Watermelon Stomach|watermelon stomach
5259931|NCT00587405|Cryotherapy|cryotherapy
5259932|NCT00587405|Argon Plasma Coagulation|argon plasma coagulation
5259933|NCT00587392|Gastroesophageal Reflux Disease (GERD)|gastroesophageal reflux disease (gerd)
5259934|NCT00587392|Long-term follow-up (LTFU)|long-term follow-up (ltfu)
5259935|NCT00587392|Endoscopic Full-thickness Plication|endoscopic full-thickness plication
5259936|NCT00587392|Plicator|plicator
5259937|NCT00587379|testing for Endothelial Dysfunction and coronary angiography|testing for endothelial dysfunction and coronary angiography
5259938|NCT00587353|tobacco use cessation|tobacco use cessation
5259939|NCT00587353|radiation oncology|radiation oncology
5259940|NCT00587353|smoking|smoking
5259941|NCT00587314|Photodynamic Therapy|photodynamic therapy
5259942|NCT00587314|Barrett's Esophagus|barrett's esophagus
5259943|NCT00587314|Early Esophageal Adenocarcinoma|early esophageal adenocarcinoma
5259944|NCT00587301|Child Obesity|child obesity
5259945|NCT00587288|Cinquil™|cinquil™
5259946|NCT00587288|Reslizumab|reslizumab
5259947|NCT00587275|Gastroesophageal Reflux Disease|gastroesophageal reflux disease
5259948|NCT00587275|GERD|gerd
5259949|NCT00587262|Cochlear|cochlear
5259950|NCT00587262|Hearing|hearing
5259951|NCT00587262|High frequency hearing loss|high frequency hearing loss
5259952|NCT00587249|Malaria, Plasmodium falciparium, Hepatitis B Core Antigen, Circumsporozoite Epitopes|malaria, plasmodium falciparium, hepatitis b core antigen, circumsporozoite epitopes
5259953|NCT00587236|Autofluorescence|autofluorescence
5259954|NCT00587236|Narrow Band|narrow band
5259955|NCT00587236|High definition white light|high definition white light
5259956|NCT00587210|Crohn Disease|crohn disease
5259957|NCT00587210|Inflammatory Bowel Disease|inflammatory bowel disease
5259958|NCT00587197|esophageal varices|esophageal varices
5259959|NCT00587197|portal hypertension|portal hypertension
5259960|NCT00587197|gastric varices|gastric varices
5259961|NCT00587197|cost effectiveness|cost effectiveness
5259962|NCT00587184|Barrett's Esophagus|barrett's esophagus
5259963|NCT00587184|Confocal Microscopy|confocal microscopy
5259964|NCT00587171|Amblyopia|amblyopia
5259965|NCT00587171|Vision Therapy|vision therapy
5259966|NCT00587171|Patching|patching
5259967|NCT00587158|Paricalcitol|paricalcitol
5259968|NCT00587158|Parathyroid Hormone|parathyroid hormone
5259969|NCT00587158|Bone Alkaline Phosphatase|bone alkaline phosphatase
5259970|NCT00587158|Chronic Kidney Disease|chronic kidney disease
5259971|NCT00587158|Glomerular Filtration Rate|glomerular filtration rate
5259972|NCT00587158|Vitamin D Receptor|vitamin d receptor
5259973|NCT00587158|Interstitial Fibrosis and Tubular Atrophy|interstitial fibrosis and tubular atrophy
5259974|NCT00587158|Zemplar®|zemplar®
5259975|NCT00587145|Stomach Neoplasms|stomach neoplasms
5259976|NCT00587145|Secondary|secondary
5259977|NCT00587145|Combination chemotherapy|combination chemotherapy
5259978|NCT00587145|S-1|s-1
5259979|NCT00587145|Docetaxel|docetaxel
5259980|NCT00587145|oxaliplatin|oxaliplatin
5259981|NCT00587132|Diabetes mellitus|diabetes mellitus
5259982|NCT00587132|Peutz-Jeghers syndrome|peutz-jeghers syndrome
5259983|NCT00587119|Urso|urso
5259984|NCT00587119|Budesonide|budesonide
5259985|NCT00587119|PBC|pbc
5259986|NCT00587119|overlap AIH|overlap aih
5259987|NCT00587119|PBC with overlap features of autoimmune hepatitis|pbc with overlap features of autoimmune hepatitis
5259988|NCT00587093|Newly diagnosed|newly diagnosed
5259989|NCT00587093|CA 125|ca 125
5259990|NCT00587093|CT scan|ct scan
5259991|NCT00587093|01-048|01-048
5259992|NCT00587067|FUDR|fudr
5259993|NCT00587067|FLOXORUIDINE|floxoruidine
5259994|NCT00587067|DEXAMETHASONE|dexamethasone
5259995|NCT00587067|Hepatic|hepatic
5259996|NCT00587067|Cancer|cancer
5259997|NCT00587067|02-120|02-120
5259998|NCT00587054|leukemia|leukemia
5259999|NCT00587054|non-Hodgkins|non-hodgkins
5260000|NCT00587054|lymphoblastic lymphoma|lymphoblastic lymphoma
5260001|NCT00587054|myelodysplastic syndrome|myelodysplastic syndrome
5260002|NCT00587054|paroxysmal nocturnal hemoglobinuria (PNH)|paroxysmal nocturnal hemoglobinuria (pnh)
5260003|NCT00587054|cytoreductive regimen|cytoreductive regimen
5260004|NCT00587054|allogeneic stem cell transplant|allogeneic stem cell transplant
5260005|NCT00587041|Synbiotic|synbiotic
5260006|NCT00587041|Urine Oxalate|urine oxalate
5260007|NCT00587041|Probiotic|probiotic
5260008|NCT00587041|Kidney Stone|kidney stone
5260009|NCT00587041|Gastric Bypass|gastric bypass
5260010|NCT00587041|Crohn's|crohn's
5260011|NCT00587041|Stone|stone
5260012|NCT00587041|Hyperoxaluria|hyperoxaluria
5260013|NCT00587041|Enteric Hyperoxaluria|enteric hyperoxaluria
5260014|NCT00587028|Colonography|colonography
5260015|NCT00587028|Colonoscopy|colonoscopy
5260016|NCT00587028|Virtual|virtual
5260017|NCT00587028|Computed Tomographic Colonography|computed tomographic colonography
5260018|NCT00587028|Large intestine|large intestine
5260019|NCT00587028|colon|colon
5260020|NCT00587002|Acute Coronary Syndrome|acute coronary syndrome
5260021|NCT00587002|Women|women
5260022|NCT00586989|Barrett's Esophagus|barrett's esophagus
5260023|NCT00586989|Esophageal Cancer|esophageal cancer
5260024|NCT00586989|High Grade Dysplasia|high grade dysplasia
5260025|NCT00586976|pain, ropivacaine, infusion, sternotomy|pain, ropivacaine, infusion, sternotomy
5260026|NCT00586963|Erosive Esophagitis|erosive esophagitis
5260027|NCT00586963|Reflux Esophagitis|reflux esophagitis
5260028|NCT00586963|GERD|gerd
5260029|NCT00586950|Myocardial Free Fatty Acid metabolism|myocardial free fatty acid metabolism
5260030|NCT00586950|High risk patients|high risk patients
5260031|NCT00586950|End-stage renal failure|end-stage renal failure
5260032|NCT00586950|Cardiovascular events|cardiovascular events
5260033|NCT00586950|prognosis|prognosis
5260034|NCT00586937|Lung Cancer Survivors|lung cancer survivors
5260035|NCT00586911|Nonalcoholic Steatohepatitis|nonalcoholic steatohepatitis
5260036|NCT00586911|NASH|nash
5260037|NCT00586911|Betaine|betaine
5260038|NCT00586898|Prostate|prostate
5260039|NCT00586898|Cancer|cancer
5260040|NCT00586898|Hormones|hormones
5260041|NCT00586898|01-085|01-085
5260042|NCT00586898|ANTIFUNGAL ANTIBIOTICS|antifungal antibiotics
5260043|NCT00586898|ESTROGENS|estrogens
5260044|NCT00586898|LUPRON|lupron
5260045|NCT00586898|TESTOSTERONE|testosterone
5260046|NCT00586898|ZOLADEX|zoladex
5260047|NCT00586885|Nonalcoholic Steatohepatitis|nonalcoholic steatohepatitis
5260048|NCT00586885|NASH|nash
5260049|NCT00586885|L-Alanine|l-alanine
5260050|NCT00586872|Barrett's Esophagus|barrett's esophagus
5260051|NCT00586872|Early Esophageal Adenocarcinoma|early esophageal adenocarcinoma
5260052|NCT00586872|Endoscopic Mucosal Resection|endoscopic mucosal resection
5260053|NCT00586859|Gastroesophageal Reflux Disease (GERD)|gastroesophageal reflux disease (gerd)
5260054|NCT00586859|NDO Full-thickness Plicator|ndo full-thickness plicator
5260055|NCT00586859|Plicator|plicator
5260056|NCT00586859|Endoluminal GERD Therapy|endoluminal gerd therapy
5260057|NCT00586846|Cisplatin|cisplatin
5260058|NCT00586846|Doxorubicin|doxorubicin
5260059|NCT00586846|Methotrexate|methotrexate
5260060|NCT00586846|Osteosarcoma|osteosarcoma
5260061|NCT00586846|03-074|03-074
5260062|NCT00586833|Heart Failure|heart failure
5260063|NCT00586833|Heart Failure, Diastolic|heart failure, diastolic
5260064|NCT00586833|Dyspnea, Paroxysmal|dyspnea, paroxysmal
5260065|NCT00586833|Edema, Cardiac|edema, cardiac
5260066|NCT00586820|Coronary Atherosclerosis|coronary atherosclerosis
5260067|NCT00586820|Microvascular Dysfunction|microvascular dysfunction
5260068|NCT00586820|Non-ST Elevation Myocardial Infarction|non-st elevation myocardial infarction
5260069|NCT00586807|Ulcerative colitis|ulcerative colitis
5260070|NCT00586807|pediatrics|pediatrics
5260071|NCT00586807|UC|uc
5260072|NCT00586807|protein metabolism|protein metabolism
5260073|NCT00586807|energy expenditure|energy expenditure
5260074|NCT00586794|Hypertension|hypertension
5260075|NCT00586794|Eisenmenger|eisenmenger
5260076|NCT00586781|ankle replacement|ankle replacement
5260077|NCT00586781|end-stage arthritis of the ankle|end-stage arthritis of the ankle
5260078|NCT00586781|degenerative ankle disease|degenerative ankle disease
5260079|NCT00586755|Intensive Induction|intensive induction
5260080|NCT00586755|High Dose Chemotherapy|high dose chemotherapy
5260081|NCT00586755|Bone Marrow Transplantation|bone marrow transplantation
5260082|NCT00586755|Mantle Cell Lymphoma|mantle cell lymphoma
5260083|NCT00586742|SLAP lesions|slap lesions
5260084|NCT00586742|labral repair|labral repair
5260085|NCT00586742|bicepstenodesis|bicepstenodesis
5260086|NCT00586742|conservative treatment|conservative treatment
5260087|NCT00586729|Burn|burn
5260088|NCT00586729|Burn wound management|burn wound management
5260089|NCT00586729|Burn graft|burn graft
5260090|NCT00586703|Stem cell transplant|stem cell transplant
5260091|NCT00586703|mismatched donor|mismatched donor
5260092|NCT00586703|NK infusion|nk infusion
5260093|NCT00586690|Stem cell transplant|stem cell transplant
5260094|NCT00586690|matched donor|matched donor
5260095|NCT00586690|NK infusion|nk infusion
5260096|NCT00586677|child abuse|child abuse
5260097|NCT00586677|child neglect|child neglect
5260098|NCT00586677|PCIT|pcit
5260099|NCT00586677|Lutzker|lutzker
5260100|NCT00586677|attachment|attachment
5260101|NCT00586677|parenting|parenting
5260102|NCT00586638|cognition|cognition
5260103|NCT00586638|cognition disorders|cognition disorders
5260104|NCT00586638|executive function|executive function
5260105|NCT00586638|cognitive control|cognitive control
5260106|NCT00586638|attentional control|attentional control
5260107|NCT00586638|biomedical enhancement|biomedical enhancement
5260108|NCT00586638|cognitive enhancement|cognitive enhancement
5260109|NCT00586638|computerized|computerized
5260110|NCT00586638|computer-based|computer-based
5260111|NCT00586638|video game|video game
5260112|NCT00586612|Conjugate vaccine|conjugate vaccine
5260113|NCT00586612|Persistence|persistence
5260114|NCT00586612|Hib vaccine|hib vaccine
5260115|NCT00586612|Combination vaccine|combination vaccine
5260116|NCT00586612|Meningococcal vaccine|meningococcal vaccine
5260117|NCT00586612|Safety|safety
5260118|NCT00586612|Preterm/full-term infants|preterm/full-term infants
5260119|NCT00586612|Immunogenicity|immunogenicity
5260122|NCT00586599|UC|uc
5260123|NCT00586599|Crohn's Disease|crohn's disease
5260124|NCT00586599|Ulcerative Colitis|ulcerative colitis
5260125|NCT00586599|Pediatric|pediatric
5260126|NCT00586599|inflammatory markers|inflammatory markers
5260127|NCT00586573|ADHD|adhd
5260128|NCT00586573|Namenda|namenda
5260129|NCT00586560|solid tumors|solid tumors
5260130|NCT00586547|Haploidentical|haploidentical
5260131|NCT00586547|Stem Cell Transplant|stem cell transplant
5260132|NCT00586547|Graft-Versus-Host disease|graft-versus-host disease
5260133|NCT00586534|crack, cocaine, addiction treatment, virtual reality|crack, cocaine, addiction treatment, virtual reality
5260134|NCT00586521|Coagulation Disorders|coagulation disorders
5260135|NCT00586495|Sorafenib|sorafenib
5260136|NCT00586495|Nexavar|nexavar
5260137|NCT00586495|Metastatic RCC|metastatic rcc
5260138|NCT00586495|Renal Cell Carcinoma|renal cell carcinoma
5260139|NCT00586495|Unresectable RCC|unresectable rcc
5260140|NCT00586482|cigarettes, surgery|cigarettes, surgery
5260141|NCT00586482|Smokers scheduled for elective surgery|smokers scheduled for elective surgery
5260142|NCT00586469|Influenza|influenza
5260143|NCT00586443|solid tumors|solid tumors
5260144|NCT00586443|avastin|avastin
5260145|NCT00586443|Phase I|phase i
5260146|NCT00586443|Phase 1|phase 1
5260147|NCT00586443|combination therapy|combination therapy
5260148|NCT00586443|bevacizumab|bevacizumab
5260149|NCT00586443|RAD001|rad001
5260150|NCT00586443|everolimus|everolimus
5260151|NCT00586443|pantitumumab|pantitumumab
5260152|NCT00586430|apolipoprotein E e4|apolipoprotein e e4
5260153|NCT00586430|Alzheimer's disease|alzheimer's disease
5260154|NCT00586430|somnolence|somnolence
5260155|NCT00586430|Early detection|early detection
5260156|NCT00586417|angiogenesis|angiogenesis
5260157|NCT00586417|tumor angiogenesis|tumor angiogenesis
5260158|NCT00586417|biomarkers|biomarkers
5260159|NCT00586417|healthy volunteers|healthy volunteers
5260160|NCT00586404|Barrett's Esophagus|barrett's esophagus
5260161|NCT00586404|Esophageal neoplasms|esophageal neoplasms
5260162|NCT00586404|gastroesophageal reflux|gastroesophageal reflux
5260163|NCT00586404|gastrointestinal neoplasms|gastrointestinal neoplasms
5260164|NCT00586391|B cell Lymphoma|b cell lymphoma
5260165|NCT00586391|Cancer|cancer
5260166|NCT00586391|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
5260167|NCT00586391|CD19 CHIMERIC RECEPTOR EXPRESSING T LYMPHOCYTES|cd19 chimeric receptor expressing t lymphocytes
5260168|NCT00586391|Acute Lymphocytic Leukemia|acute lymphocytic leukemia
5260169|NCT00586365|complex elbow trauma|complex elbow trauma
5260170|NCT00586365|prevention|prevention
5260171|NCT00586365|complication|complication
5260172|NCT00586365|naproxen|naproxen
5260173|NCT00586365|NSAIDS|nsaids
5260174|NCT00586352|Pediatric|pediatric
5260175|NCT00586352|Crohn's disease|crohn's disease
5260176|NCT00586352|Ulcerative colitis|ulcerative colitis
5260177|NCT00586339|HPV|hpv
5260178|NCT00586339|Human papillomavirus (HPV) vaccine|human papillomavirus (hpv) vaccine
5260179|NCT00586339|Human Immunodeficiency Virus (HIV)|human immunodeficiency virus (hiv)
5260180|NCT00586339|Cervical cancer|cervical cancer
5260181|NCT00586339|Papillomavirus|papillomavirus
5260182|NCT00586326|MammoSite|mammosite
5260183|NCT00586326|DCIS|dcis
5260184|NCT00586313|EUS Biopsy for Non-alcoholic Fatty Liver Disease|eus biopsy for non-alcoholic fatty liver disease
5260185|NCT00586300|Knee pain|knee pain
5260186|NCT00586287|Phenprocoumon|phenprocoumon
5260187|NCT00586287|Dosing algorithm|dosing algorithm
5260188|NCT00586287|loading dose|loading dose
5260189|NCT00586274|Stem Cell Transplant|stem cell transplant
5260190|NCT00586274|Anemia|anemia
5260191|NCT00586274|Fanconi|fanconi
5260192|NCT00586261|Kidney Failure, Chronic|kidney failure, chronic
5260193|NCT00586261|Renal Insufficiency, Chronic|renal insufficiency, chronic
5260194|NCT00586261|Proteinuria|proteinuria
5260195|NCT00586261|Albuminuria|albuminuria
5260196|NCT00586248|Peripheral nerve stimulator, cardiac pacemaker|peripheral nerve stimulator, cardiac pacemaker
5260197|NCT00586235|Fusion|fusion
5260198|NCT00586235|Ultrasound|ultrasound
5260199|NCT00586235|Computed tomography|computed tomography
5260200|NCT00586222|Omega-3 Fatty Acids|omega-3 fatty acids
5260201|NCT00586222|Pediatric Bipolar Disorder|pediatric bipolar disorder
5260202|NCT00586222|Adolescent Bipolar Disorder|adolescent bipolar disorder
5260203|NCT00586222|MRS|mrs
5260204|NCT00586209|sickle cell disease|sickle cell disease
5260205|NCT00586209|sickle cell anemia|sickle cell anemia
5260206|NCT00586209|L-glutamine|l-glutamine
5260207|NCT00586209|Sickle Cell Anemia (homozygous and heterozygous)|sickle cell anemia (homozygous and heterozygous)
5260208|NCT00586209|Sickle ß0-Thalassemia|sickle ß0-thalassemia
5260209|NCT00586196|Delirium|delirium
5260210|NCT00586196|Postoperative confusion|postoperative confusion
5260211|NCT00586196|Hip fracture|hip fracture
5260212|NCT00586196|Long bone fracture|long bone fracture
5260213|NCT00586183|Ventricular Remodeling|ventricular remodeling
5260214|NCT00586170|nonunion|nonunion
5260215|NCT00586170|fracture|fracture
5260216|NCT00586157|ADHD|adhd
5260217|NCT00586157|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
5260218|NCT00586157|Daytrana|daytrana
5260219|NCT00586157|MTS Patch|mts patch
5260220|NCT00586157|Methylphenidate Transdermal System|methylphenidate transdermal system
5260221|NCT00586131|end-stage renal disease|end-stage renal disease
5260222|NCT00586131|automated peritoneal dialysis|automated peritoneal dialysis
5260223|NCT00586131|metabolic acidosis|metabolic acidosis
5260224|NCT00586131|nitrogen balances|nitrogen balances
5260225|NCT00586118|Sedation|sedation
5260226|NCT00586118|Volatile anaesthetic|volatile anaesthetic
5260227|NCT00586118|Sevoflurane|sevoflurane
5260228|NCT00586118|Propofol|propofol
5260229|NCT00586118|Recovery|recovery
5260230|NCT00586105|Sorafenib|sorafenib
5260231|NCT00586105|Nexavar|nexavar
5260232|NCT00586105|Metastatic RCC|metastatic rcc
5260233|NCT00586105|Renal Cell Carcinoma|renal cell carcinoma
5260234|NCT00586105|Unresectable RCC|unresectable rcc
5260235|NCT00586092|Phase I|phase i
5260236|NCT00586092|Phase 1|phase 1
5260237|NCT00586092|avastin|avastin
5260238|NCT00586092|bevacizumab|bevacizumab
5260239|NCT00586092|ABT-510|abt-510
5260240|NCT00586092|solid tumors|solid tumors
5260241|NCT00586092|angiogenesis|angiogenesis
5260242|NCT00586066|Bipolar disorder|bipolar disorder
5260243|NCT00586066|Cognitive dysfunction|cognitive dysfunction
5260244|NCT00586066|Memantine|memantine
5260245|NCT00586066|NMDA antagonist|nmda antagonist
5260246|NCT00586053|Colonic Polyps|colonic polyps
5260247|NCT00586053|Colon|colon
5260248|NCT00586053|Large Intestine|large intestine
5260249|NCT00586053|Cecum|cecum
5260250|NCT00586053|Sigmoid|sigmoid
5260251|NCT00586053|Rectum|rectum
5260252|NCT00586053|Colonoscopy|colonoscopy
5260253|NCT00586053|Virtual Colonoscopy|virtual colonoscopy
5260254|NCT00586053|CT Colonography|ct colonography
5260255|NCT00586053|Computed Tomographic Colonography|computed tomographic colonography
5260256|NCT00586053|Colonography|colonography
5260257|NCT00586040|skin cancer|skin cancer
5260258|NCT00586040|skin excision|skin excision
5260259|NCT00586040|laser|laser
5260260|NCT00586040|superficial sutures|superficial sutures
5260261|NCT00586040|wound healing|wound healing
5260262|NCT00586027|cardiac surgery|cardiac surgery
5260263|NCT00586027|low cardiac output|low cardiac output
5260264|NCT00586027|natriuretic peptide B|natriuretic peptide b
5260265|NCT00586027|mortality|mortality
5260266|NCT00586027|morbidity|morbidity
5260267|NCT00586014|Multiple myeloma|multiple myeloma
5260268|NCT00586014|Autologous Stem Cell Transplant|autologous stem cell transplant
5260269|NCT00586001|Anxiety|anxiety
5260270|NCT00586001|Emotional Disorders|emotional disorders
5260271|NCT00586001|Unified|unified
5260272|NCT00586001|Depression|depression
5260273|NCT00585962|proton beam radiation|proton beam radiation
5260274|NCT00585910|ADHD|adhd
5260275|NCT00585910|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
5260276|NCT00585910|Strattera|strattera
5260277|NCT00585910|Concerta|concerta
5260278|NCT00585910|Atomoxetine|atomoxetine
5260279|NCT00585910|OROS Methylphenidate|oros methylphenidate
5260280|NCT00585897|Diabetes|diabetes
5260281|NCT00585897|Obesity|obesity
5260282|NCT00585884|Reconstruction, Silicone prostheses|reconstruction, silicone prostheses
5260283|NCT00585871|ICD patients with 5 VTs per 3 month period|icd patients with 5 vts per 3 month period
5260284|NCT00585845|Cancer|cancer
5260285|NCT00585845|Ovarian cancer|ovarian cancer
5260286|NCT00585845|Pancreatic cancer|pancreatic cancer
5260287|NCT00585845|Non-small cell lung cancer|non-small cell lung cancer
5260288|NCT00585845|Mesothelioma|mesothelioma
5260289|NCT00585845|Mesothelin|mesothelin
5260290|NCT00585845|Immunotherapy|immunotherapy
5260291|NCT00585832|hypertension|hypertension
5260292|NCT00585832|pre-hypertension|pre-hypertension
5260293|NCT00585832|adolescents|adolescents
5260294|NCT00585832|diet|diet
5260295|NCT00585832|vascular function|vascular function
5260296|NCT00585806|Heart Failure with preserved ejection fraction|heart failure with preserved ejection fraction
5260297|NCT00585793|HIV/AIDS|hiv/aids
5260298|NCT00585767|Hydronephrosis|hydronephrosis
5260299|NCT00585715|Cellulite|cellulite
5260300|NCT00585715|Nd:YAG Laser|nd:yag laser
5260301|NCT00585702|Bipolar Disorder|bipolar disorder
5260302|NCT00585702|Pregnancy|pregnancy
5260303|NCT00585702|Infant Development|infant development
5260304|NCT00585689|Locally advanced urothelial carcinoma of the bladder|locally advanced urothelial carcinoma of the bladder
5260305|NCT00585650|palmoplantar psoriasis|palmoplantar psoriasis
5260306|NCT00585650|etanercept|etanercept
5260307|NCT00585650|Enbrel|enbrel
5260308|NCT00585637|Vitamin D|vitamin d
5260309|NCT00585637|Blacks|blacks
5260310|NCT00585637|cancer|cancer
5260311|NCT00585637|hypertension|hypertension
5260312|NCT00585624|Esophagectomy|esophagectomy
5260313|NCT00585624|Pancreaticoduodenectomy|pancreaticoduodenectomy
5260314|NCT00585624|Whipple|whipple
5260315|NCT00585611|Heart Failure, Congestive|heart failure, congestive
5260316|NCT00585585|Depression|depression
5260317|NCT00585585|Betahistine Dihydrochloride|betahistine dihydrochloride
5260318|NCT00585572|Normal Tissues/Brains|normal tissues/brains
5260319|NCT00585572|Alzheimer|alzheimer
5260320|NCT00585572|Motor Neuron Disease|motor neuron disease
5260321|NCT00585572|Dementia|dementia
5260322|NCT00585572|Healthy Control Volunteers|healthy control volunteers
5260323|NCT00585572|Populations At Risk|populations at risk
5260324|NCT00585572|MCI|mci
5260325|NCT00585559|Lipid|lipid
5260326|NCT00585559|Peroxidation|peroxidation
5260327|NCT00585559|N-Acetylcysteine|n-acetylcysteine
5260328|NCT00585559|Acetaminophen|acetaminophen
5260329|NCT00585559|Vasospasm|vasospasm
5260330|NCT00585546|heart failure|heart failure
5260331|NCT00585546|dilated cardiomyopathy|dilated cardiomyopathy
5260332|NCT00585546|heart assist device|heart assist device
5260333|NCT00585546|clenbuterol|clenbuterol
5260334|NCT00585546|adrenergic beta agonists|adrenergic beta agonists
5260335|NCT00585546|heart transplantation|heart transplantation
5260336|NCT00585507|hormone receptor positive breast cancer|hormone receptor positive breast cancer
5260337|NCT00585507|Fulvestrant|fulvestrant
5260338|NCT00585481|Epidemiological Study|epidemiological study
5260339|NCT00585481|Incidence of severe Respiratory Syncytial Virus|incidence of severe respiratory syncytial virus
5260340|NCT00585481|Preterm Brazilian children|preterm brazilian children
5260341|NCT00585455|vascular endothelium|vascular endothelium
5260342|NCT00585455|nitric oxide|nitric oxide
5260343|NCT00585455|depression|depression
5260344|NCT00585455|heart failure|heart failure
5260345|NCT00585455|vascular biology|vascular biology
5260346|NCT00585416|Prostate Cancer|prostate cancer
5260347|NCT00585416|Hormone Refractory|hormone refractory
5260348|NCT00585416|Metastatic|metastatic
5260349|NCT00585364|Allergic Bronchopulmonary Aspergillosis|allergic bronchopulmonary aspergillosis
5260350|NCT00585364|Aspergillus fumigatus|aspergillus fumigatus
5260351|NCT00585364|cytokine expression|cytokine expression
5260352|NCT00585338|facial telangiectasia,|facial telangiectasia,
5260353|NCT00585338|leg vein telangiectasia|leg vein telangiectasia
5260354|NCT00585338|Port Wine Stain birthmarks|port wine stain birthmarks
5260355|NCT00585312|FAP|fap
5260356|NCT00585299|steatosis|steatosis
5260357|NCT00585299|fatty liver|fatty liver
5260358|NCT00585299|insulin sensitivity|insulin sensitivity
5260359|NCT00585299|fatty liver (steatosis)|fatty liver (steatosis)
5260360|NCT00585286|acne vulgaris|acne vulgaris
5260361|NCT00585286|scarring|scarring
5260362|NCT00585286|laser|laser
5260363|NCT00585260|asthma|asthma
5260364|NCT00585260|bronchoprovocation challenge test|bronchoprovocation challenge test
5260365|NCT00585260|mannitol|mannitol
5260366|NCT00585260|methacholine|methacholine
5260367|NCT00585247|birthmarks|birthmarks
5260368|NCT00585221|Gastrointestinal stromal tumors|gastrointestinal stromal tumors
5260369|NCT00585221|Imatinib|imatinib
5260370|NCT00585221|Peginterferon α-2b|peginterferon α-2b
5260371|NCT00585221|Immunotherapy|immunotherapy
5260372|NCT00585221|Targeted therapy|targeted therapy
5260373|NCT00585208|insomnia|insomnia
5260374|NCT00585208|sleep disturbance|sleep disturbance
5260375|NCT00585208|bipolar disorder|bipolar disorder
5260376|NCT00585195|Crizotinib|crizotinib
5260377|NCT00585195|dose-finding|dose-finding
5260378|NCT00585195|drug-drug interaction|drug-drug interaction
5260379|NCT00585195|ALK rearrangements|alk rearrangements
5260380|NCT00585195|c-Met mutations or amplifications|c-met mutations or amplifications
5260381|NCT00585195|c-Met dependent tumors|c-met dependent tumors
5260382|NCT00585195|ROS1 rearrangements|ros1 rearrangements
5260383|NCT00585195|c-Met exon 14 deletion|c-met exon 14 deletion
5260384|NCT00585195|c-Met exon 14 skipping|c-met exon 14 skipping
5260385|NCT00585195|c-Met exon 14 alterations|c-met exon 14 alterations
5260386|NCT00585182|Obesity|obesity
5260387|NCT00585182|venous thrombosis|venous thrombosis
5260388|NCT00585182|Anticoagulants|anticoagulants
5260389|NCT00585169|Pathological Gambling|pathological gambling
5260390|NCT00585169|Compulsive Gambling|compulsive gambling
5260391|NCT00585169|Gambling Addiction|gambling addiction
5260392|NCT00585169|Gambling|gambling
5260393|NCT00585169|Treatment|treatment
5260394|NCT00585169|Memantine|memantine
5260395|NCT00585169|Pharmacology|pharmacology
5260396|NCT00585156|Celebrex, Bone Ingrowth, Pain relief|celebrex, bone ingrowth, pain relief
5260397|NCT00585143|Dyslipidemia|dyslipidemia
5260398|NCT00585078|capecitabine|capecitabine
5260399|NCT00585078|oxaliplatin|oxaliplatin
5260400|NCT00585052|Ovarian Cancer|ovarian cancer
5260401|NCT00585052|Epithelial Ovarian Cancer|epithelial ovarian cancer
5260402|NCT00585052|Lovastatin|lovastatin
5260403|NCT00585052|Paclitaxel|paclitaxel
5260404|NCT00585039|child|child
5260405|NCT00585039|emergency department|emergency department
5260406|NCT00585026|Refractive error|refractive error
5260407|NCT00585026|Asthenopia|asthenopia
5260408|NCT00585026|Presbyopia|presbyopia
5260409|NCT00585026|Eyeglasses|eyeglasses
5260410|NCT00585026|Productivity|productivity
5260411|NCT00585026|Visual comfort|visual comfort
5260412|NCT00585026|Ergonomics|ergonomics
5260413|NCT00585013|Inhaled Nitric Oxide (NO)|inhaled nitric oxide (no)
5260414|NCT00585013|Anti-inflammatory|anti-inflammatory
5260415|NCT00585013|Anti-reperfusion agent|anti-reperfusion agent
5260416|NCT00584974|Depression|depression
5260417|NCT00584974|Mental Disorders|mental disorders
5260418|NCT00584974|Mood Disorders|mood disorders
5260419|NCT00584974|Depressive Disorder, Major|depressive disorder, major
5260420|NCT00584974|Dysthymic Disorder|dysthymic disorder
5260421|NCT00584961|Metabolic Syndrome, Bipolar Disorder and Cardiovascular Risk Factors|metabolic syndrome, bipolar disorder and cardiovascular risk factors
5260523|NCT00584415|Atrial Fibrillation|atrial fibrillation
5260422|NCT00584948|FXTAS, Fragile X Premutation|fxtas, fragile x premutation
5260423|NCT00584935|Pemphigoid|pemphigoid
5260424|NCT00584935|Blistering Diseases|blistering diseases
5260425|NCT00584935|Blindness|blindness
5260426|NCT00584935|Autoimmune|autoimmune
5260427|NCT00584935|Rituximab|rituximab
5260428|NCT00584922|Esophageal injury|esophageal injury
5260429|NCT00584922|Catheter Ablation|catheter ablation
5260430|NCT00584922|Atrial Fibrillation|atrial fibrillation
5260431|NCT00584896|heart disease|heart disease
5260432|NCT00584896|coronary artery disease|coronary artery disease
5260433|NCT00584896|echocardiogram|echocardiogram
5260434|NCT00584896|ultrasound|ultrasound
5260435|NCT00584896|angiogram|angiogram
5260436|NCT00584896|SPECT|spect
5260437|NCT00584896|chest pain|chest pain
5260438|NCT00584896|perfusion|perfusion
5260439|NCT00584883|Patients who have newly diagnosed brain tumors|patients who have newly diagnosed brain tumors
5260440|NCT00584844|Live Vaccine Strain (LVS), Bacterial Infections, Ulceroglandular, Oculoglandular|live vaccine strain (lvs), bacterial infections, ulceroglandular, oculoglandular
5260441|NCT00584831|astigmatism|astigmatism
5260442|NCT00584831|visual acuity|visual acuity
5260443|NCT00584831|orientation|orientation
5260444|NCT00584831|contact lenses|contact lenses
5260445|NCT00584818|coronary artery disease|coronary artery disease
5260446|NCT00584818|chest pain|chest pain
5260447|NCT00584818|healthy volunteers|healthy volunteers
5260449|NCT00584818|angiogram|angiogram
5260450|NCT00584818|ultrasound|ultrasound
5260451|NCT00584818|echocardiogram|echocardiogram
5260452|NCT00584818|perfusion|perfusion
5260453|NCT00584805|EEE|eee
5260454|NCT00584792|Prostate Cancer|prostate cancer
5260455|NCT00584779|Gabapentin Pharmacokinetics, renal impairment|gabapentin pharmacokinetics, renal impairment
5260456|NCT00584753|Breast cancer|breast cancer
5260457|NCT00584740|Crohn's disease, moderate, severe, active, AIN457|crohn's disease, moderate, severe, active, ain457
5260458|NCT00584727|astigmatism|astigmatism
5260459|NCT00584727|visual acuity|visual acuity
5260460|NCT00584727|fit|fit
5260461|NCT00584727|comfort|comfort
5260462|NCT00584727|satisfaction|satisfaction
5260463|NCT00584727|contact lens|contact lens
5260464|NCT00584714|ultrasound|ultrasound
5260465|NCT00584714|perfusion|perfusion
5260466|NCT00584714|SPECT|spect
5260467|NCT00584714|coronary artery disease|coronary artery disease
5260468|NCT00584714|chest pain|chest pain
5260469|NCT00584714|low probability|low probability
5260470|NCT00584714|angiography|angiography
5260471|NCT00584714|clinical outcomes|clinical outcomes
5260472|NCT00584688|anorexia|anorexia
5260473|NCT00584688|nervosa|nervosa
5260474|NCT00584688|eating|eating
5260475|NCT00584688|disorder|disorder
5260476|NCT00584688|study|study
5260477|NCT00584688|research|research
5260478|NCT00584688|clinical|clinical
5260479|NCT00584688|trial|trial
5260480|NCT00584688|psychiatry|psychiatry
5260481|NCT00584688|psychiatric|psychiatric
5260482|NCT00584675|GERD|gerd
5260483|NCT00584675|laryngopharyngeal reflux disease|laryngopharyngeal reflux disease
5260484|NCT00584662|Rhinitis|rhinitis
5260485|NCT00584649|Inappropriate Sinus Tachycardia|inappropriate sinus tachycardia
5260486|NCT00584649|Inappropiate Tachycardia|inappropiate tachycardia
5260487|NCT00584649|Sinus Tachycardia|sinus tachycardia
5260488|NCT00584649|Palpitations|palpitations
5260489|NCT00584649|Fast Heart rate|fast heart rate
5260490|NCT00584636|child|child
5260491|NCT00584636|emergency department|emergency department
5260492|NCT00584623|dysphagia|dysphagia
5260493|NCT00584623|videofluoroscopy|videofluoroscopy
5260494|NCT00584623|flexible endoscopic evaluation|flexible endoscopic evaluation
5260495|NCT00584610|Women's health|women's health
5260496|NCT00584597|Radiation-Induced Mucositis|radiation-induced mucositis
5260497|NCT00584597|Head and neck cancer|head and neck cancer
5260498|NCT00584597|TRAUMEEL|traumeel
5260499|NCT00584597|Mucositis|mucositis
5260500|NCT00584597|Radiation|radiation
5260501|NCT00584597|Oral cancer|oral cancer
5260502|NCT00584597|Inflammation of the mouth|inflammation of the mouth
5260503|NCT00584597|Homeopathic Medication|homeopathic medication
5260504|NCT00584584|Allergic rhinitis, adults, monoclonal antibody, interleukin-13.|allergic rhinitis, adults, monoclonal antibody, interleukin-13.
5260505|NCT00584558|Arrhythmia|arrhythmia
5260506|NCT00584558|Catheter Ablation|catheter ablation
5260507|NCT00584545|pharyngeal manometry|pharyngeal manometry
5260508|NCT00584545|videofluoroscopy|videofluoroscopy
5260509|NCT00584532|Localized|localized
5260510|NCT00584532|Prostate|prostate
5260511|NCT00584532|Cancer|cancer
5260512|NCT00584519|Schizophrenia, Overweight, Cardiovascular Risk, Obesity|schizophrenia, overweight, cardiovascular risk, obesity
5260513|NCT00584506|orbital fractures|orbital fractures
5260514|NCT00584467|GEM|gem
5260515|NCT00584467|Arteriosclerosis|arteriosclerosis
5260516|NCT00584467|biomarkers|biomarkers
5260517|NCT00584467|Atherosclerosis|atherosclerosis
5260518|NCT00584454|Coxiella burnetti, Bacterial Infections, Rickettsia, Hepatits, Endocarditis|coxiella burnetti, bacterial infections, rickettsia, hepatits, endocarditis
5260519|NCT00584428|Breast Cancer|breast cancer
5260520|NCT00584428|Cancer Treatment|cancer treatment
5260521|NCT00584428|Breast Cancer Treatment|breast cancer treatment
5260522|NCT00584415|Catheter Ablation|catheter ablation
5260524|NCT00584402|liver cancer|liver cancer
5260525|NCT00584389|Obesity|obesity
5260526|NCT00584389|Energy expenditure|energy expenditure
5260527|NCT00584389|Fatty acid|fatty acid
5260528|NCT00584389|Triglyceride|triglyceride
5260529|NCT00584376|Essential tremor|essential tremor
5260530|NCT00584376|tremor|tremor
5260531|NCT00584376|pregabalin|pregabalin
5260532|NCT00584376|lyrica|lyrica
5260533|NCT00584350|coronary angiogram|coronary angiogram
5260534|NCT00584350|percutaneous coronary intervention|percutaneous coronary intervention
5260535|NCT00584337|tomography|tomography
5260536|NCT00584337|coronary artery disease|coronary artery disease
5260537|NCT00584337|Stress Test|stress test
5260538|NCT00584337|Coronary CT Angiography|coronary ct angiography
5260539|NCT00584337|Diagnostic Accuracy|diagnostic accuracy
5260540|NCT00584337|Non invasive testing|non invasive testing
5260541|NCT00584324|elective surgery|elective surgery
5260542|NCT00584324|general anesthesia|general anesthesia
5260543|NCT00584324|implicit memory|implicit memory
5260544|NCT00584298|Barostat|barostat
5260545|NCT00584298|distention|distention
5260546|NCT00584298|IBS|ibs
5260547|NCT00584298|irritable|irritable
5260548|NCT00584298|bowel|bowel
5260549|NCT00584298|syndrome|syndrome
5260550|NCT00584298|colorectal|colorectal
5260551|NCT00584298|sensation|sensation
5260552|NCT00584298|modulation|modulation
5260553|NCT00584298|reproducibility|reproducibility
5260554|NCT00584272|cleft palate|cleft palate
5260555|NCT00584272|suture materials|suture materials
5260556|NCT00584259|GERD|gerd
5260557|NCT00584259|Gastro-Esophageal Disease|gastro-esophageal disease
5260558|NCT00584246|Restless legs syndrome|restless legs syndrome
5260559|NCT00584246|RLS|rls
5260560|NCT00584246|Pregabalin|pregabalin
5260561|NCT00584246|Lyrica|lyrica
5260562|NCT00584233|breast cancer|breast cancer
5260563|NCT00584220|Astigmatism|astigmatism
5260564|NCT00584220|vision|vision
5260565|NCT00584220|comfort|comfort
5260566|NCT00584220|satisfaction|satisfaction
5260567|NCT00584220|contact lenses|contact lenses
5260568|NCT00584207|uterine fibroids|uterine fibroids
5260569|NCT00584194|Hemorrhagic Fever, Viral Infections, Neurologic diseases, Arbovirus Infections, RVF|hemorrhagic fever, viral infections, neurologic diseases, arbovirus infections, rvf
5260570|NCT00584168|UPPP|uppp
5260571|NCT00584168|Dexamethasone|dexamethasone
5260572|NCT00584168|Uvulopalatopharyngoplasty|uvulopalatopharyngoplasty
5260573|NCT00584168|Pain Management|pain management
5260574|NCT00584168|Increasing pain management in patients that have undergone UPPP surgery|increasing pain management in patients that have undergone uppp surgery
5260575|NCT00584155|Cisplatin Ototoxicity|cisplatin ototoxicity
5260576|NCT00584155|Lactated Ringer's|lactated ringer's
5260577|NCT00584155|Ear Cancer|ear cancer
5260578|NCT00584155|Hearing loss|hearing loss
5260579|NCT00584155|Hearing loss due to Cisplatin Ototoxicity|hearing loss due to cisplatin ototoxicity
5260580|NCT00584142|breast cancer|breast cancer
5260581|NCT00584142|survivors|survivors
5260582|NCT00584129|Cancer|cancer
5260583|NCT00584129|Dysphagia|dysphagia
5260584|NCT00584129|Radiation|radiation
5260585|NCT00584129|Patients with H&N cancer who will be receiving chemoradiation|patients with h&n cancer who will be receiving chemoradiation
5260586|NCT00584116|Aortic Valve Replacement|aortic valve replacement
5260587|NCT00584116|AVR|avr
5260588|NCT00584103|transradial amputation|transradial amputation
5260589|NCT00584103|prosthesis|prosthesis
5260590|NCT00584103|prefabricated prosthesis|prefabricated prosthesis
5260591|NCT00584103|inexpensive|inexpensive
5260592|NCT00584103|custom prosthesis|custom prosthesis
5260593|NCT00584103|adult transradial amputation|adult transradial amputation
5260594|NCT00584090|urinary incontinence|urinary incontinence
5260595|NCT00584090|parkinson's disease|parkinson's disease
5260596|NCT00584090|vesicare|vesicare
5260597|NCT00584090|solifenacin succinate|solifenacin succinate
5260598|NCT00584064|patent|patent
5260599|NCT00584064|foramen|foramen
5260600|NCT00584064|ovale|ovale
5260601|NCT00584064|PFO|pfo
5260602|NCT00584051|Control group|control group
5260603|NCT00584038|contraceptive compliance|contraceptive compliance
5260604|NCT00584038|educational intervention|educational intervention
5260605|NCT00584038|oral contraception|oral contraception
5260606|NCT00584025|Parkinson's disease|parkinson's disease
5260607|NCT00584025|dyskinesia|dyskinesia
5260608|NCT00584025|levetiracetam|levetiracetam
5260609|NCT00584025|keppra|keppra
5260610|NCT00584012|Any cancer|any cancer
5260611|NCT00584012|Breast cancer|breast cancer
5260612|NCT00584012|Lovastatin|lovastatin
5260613|NCT00584012|Docetaxel|docetaxel
5260614|NCT00583999|leptin, leptin receptors, adiponectin|leptin, leptin receptors, adiponectin
5260615|NCT00583986|top mounted|top mounted
5260616|NCT00583986|actuation indicator|actuation indicator
5260617|NCT00583986|Asthma|asthma
5260618|NCT00583986|COPD|copd
5260619|NCT00583986|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5260620|NCT00583960|swallowing problems|swallowing problems
5260621|NCT00583960|tracheal stenosis|tracheal stenosis
5260622|NCT00583947|Asthma|asthma
5260623|NCT00583947|Respiratory Tract Diseases|respiratory tract diseases
5260730|NCT00583492|Prostatic Neoplasms|prostatic neoplasms
5260624|NCT00583934|esophageal cancer, head and neck cancer, dysplasia|esophageal cancer, head and neck cancer, dysplasia
5260625|NCT00583921|Atrial Fibrillation|atrial fibrillation
5260626|NCT00583921|ICD|icd
5260627|NCT00583921|BiV ICD|biv icd
5260628|NCT00583921|CHF|chf
5260629|NCT00583921|Congestive Heart Failure|congestive heart failure
5260630|NCT00583921|AF|af
5260631|NCT00583908|astigmatism|astigmatism
5260632|NCT00583908|orientation|orientation
5260633|NCT00583908|visual acuity|visual acuity
5260634|NCT00583908|contact lenses|contact lenses
5260635|NCT00583895|dermatitis|dermatitis
5260636|NCT00583895|atopic|atopic
5260637|NCT00583895|ImCOOH|imcooh
5260638|NCT00583895|safety|safety
5260639|NCT00583895|tolerability|tolerability
5260640|NCT00583895|efficacy|efficacy
5260641|NCT00583895|pharmacokinetics|pharmacokinetics
5260642|NCT00583882|Central Venous Catheter|central venous catheter
5260643|NCT00583882|Guidewire|guidewire
5260644|NCT00583882|Burn|burn
5260645|NCT00583869|Post-operative Pain|post-operative pain
5260646|NCT00583869|Fracture Patients|fracture patients
5260647|NCT00583869|Pregabalin|pregabalin
5260648|NCT00583869|LYRICA|lyrica
5260649|NCT00583856|computer aided design|computer aided design
5260650|NCT00583856|maxillofacial fracture|maxillofacial fracture
5260651|NCT00583856|orbital design|orbital design
5260652|NCT00583843|Lumpectomy|lumpectomy
5260653|NCT00583843|Ultrasonography|ultrasonography
5260654|NCT00583843|Radiotherapy|radiotherapy
5260655|NCT00583830|Lung Cancer|lung cancer
5260656|NCT00583804|Spinal Cord Injury|spinal cord injury
5260657|NCT00583804|Tetraplegia|tetraplegia
5260658|NCT00583804|Functional Electrical Stimulation|functional electrical stimulation
5260659|NCT00583804|Neuroprosthesis|neuroprosthesis
5260660|NCT00583791|muscular|muscular
5260661|NCT00583791|ventricular|ventricular
5260662|NCT00583791|septal|septal
5260663|NCT00583791|defects|defects
5260664|NCT00583791|VSD|vsd
5260665|NCT00583778|Asthma|asthma
5260666|NCT00583778|Bronchodilators|bronchodilators
5260667|NCT00583778|Levalbuterol|levalbuterol
5260668|NCT00583778|Ipratropium|ipratropium
5260669|NCT00583765|Kidney Failure, Acute|kidney failure, acute
5260670|NCT00583765|Hemodialysis|hemodialysis
5260671|NCT00583765|Hemofiltration|hemofiltration
5260672|NCT00583765|Anticoagulation|anticoagulation
5260673|NCT00583765|Citrate|citrate
5260674|NCT00583752|prostate cancer|prostate cancer
5260675|NCT00583752|vaccine|vaccine
5260676|NCT00583752|immunotherapy|immunotherapy
5260677|NCT00583739|Fatigue|fatigue
5260678|NCT00583739|Yoga|yoga
5260679|NCT00583739|Anxiety|anxiety
5260680|NCT00583739|Quality of Life|quality of life
5260681|NCT00583726|chemotherapy|chemotherapy
5260682|NCT00583726|exercise|exercise
5260683|NCT00583726|diet|diet
5260684|NCT00583726|fruit|fruit
5260685|NCT00583726|vegetables|vegetables
5260686|NCT00583726|low-fat|low-fat
5260687|NCT00583700|Breast Neoplasms|breast neoplasms
5260688|NCT00583700|Radiotherapy|radiotherapy
5260689|NCT00583687|Arterial pulse contour cardiac output|arterial pulse contour cardiac output
5260690|NCT00583687|Changing vascular tone|changing vascular tone
5260691|NCT00583687|Tissue Oxymetry|tissue oxymetry
5260692|NCT00583687|Prediction of Fluid Responsiveness|prediction of fluid responsiveness
5260693|NCT00583674|Gastric Cancer|gastric cancer
5260694|NCT00583674|Metastatic Gastric, Gastroesophageal Junction, or Distal Esophageal Adenocarcinoma|metastatic gastric, gastroesophageal junction, or distal esophageal adenocarcinoma
5260695|NCT00583674|AMG 386|amg 386
5260696|NCT00583674|Cisplatin|cisplatin
5260697|NCT00583674|Capecitabine|capecitabine
5260698|NCT00583661|Ventricular Assist Device|ventricular assist device
5260699|NCT00583661|Pediatric Ventricular Assist Device|pediatric ventricular assist device
5260700|NCT00583648|urinary tract infections|urinary tract infections
5260701|NCT00583648|urine|urine
5260702|NCT00583648|urinalysis|urinalysis
5260703|NCT00583648|urine protocols|urine protocols
5260704|NCT00583648|urinalysis protocols|urinalysis protocols
5260705|NCT00583648|nursing protocols|nursing protocols
5260706|NCT00583648|Emergency Department|emergency department
5260707|NCT00583635|Preeclampsia|preeclampsia
5260708|NCT00583635|Prevention|prevention
5260709|NCT00583635|Food Supplement|food supplement
5260710|NCT00583622|Ovarian Cancer|ovarian cancer
5260711|NCT00583622|Epithelial Ovarian Cancer|epithelial ovarian cancer
5260712|NCT00583622|Bevacizumab|bevacizumab
5260713|NCT00583622|Carboplatin|carboplatin
5260714|NCT00583622|Gemcitabine|gemcitabine
5260715|NCT00583622|Docetaxel|docetaxel
5260716|NCT00583622|Melphalan|melphalan
5260717|NCT00583596|patent ductus arteriosus (PDA)|patent ductus arteriosus (pda)
5260718|NCT00583557|Rheumatoid Arthritis|rheumatoid arthritis
5260719|NCT00583557|RA|ra
5260720|NCT00583544|Healthy|healthy
5260721|NCT00583544|Healthy Volunteers|healthy volunteers
5260722|NCT00583531|Antibiotic-refractory Pouchitis|antibiotic-refractory pouchitis
5260723|NCT00583531|Pouchitis|pouchitis
5260724|NCT00583531|Ulcerative Colitis|ulcerative colitis
5260725|NCT00583505|membranous|membranous
5260726|NCT00583505|ventricular|ventricular
5260727|NCT00583505|septal|septal
5260728|NCT00583505|defects|defects
5260729|NCT00583505|VSD|vsd
5261223|NCT00581321|water|water
5260731|NCT00583492|Prostate Cancer|prostate cancer
5260732|NCT00583492|Adenocarinomas|adenocarinomas
5260733|NCT00583492|Tumors of the Prostate|tumors of the prostate
5260734|NCT00583492|Gene Therapy|gene therapy
5260735|NCT00583492|IMRT|imrt
5260736|NCT00583466|submucosal cushion|submucosal cushion
5260737|NCT00583466|polypectomy|polypectomy
5260738|NCT00583466|endoscopic mucosal resection|endoscopic mucosal resection
5260739|NCT00583453|Tonsillectomy|tonsillectomy
5260740|NCT00583453|Analgesia|analgesia
5260741|NCT00583453|Pain measurement|pain measurement
5260742|NCT00583453|Celecoxib|celecoxib
5260743|NCT00583440|12-step|12-step
5260744|NCT00583440|mutual help|mutual help
5260745|NCT00583440|dual diagnosis|dual diagnosis
5260746|NCT00583440|serious mental illness|serious mental illness
5260747|NCT00583401|PFO|pfo
5260748|NCT00583401|stroke|stroke
5260749|NCT00583388|cardiology|cardiology
5260750|NCT00583388|preventive medicine|preventive medicine
5260751|NCT00583388|cardiovascular physiology|cardiovascular physiology
5260752|NCT00583388|healthy subjects|healthy subjects
5260753|NCT00583375|arthritis|arthritis
5260754|NCT00583375|ankle pain|ankle pain
5260755|NCT00583375|foot pain|foot pain
5260756|NCT00583375|hindfoot fracture|hindfoot fracture
5260757|NCT00583375|ankle fracture|ankle fracture
5260758|NCT00583362|SLE|sle
5260759|NCT00583362|Lupus|lupus
5260760|NCT00583349|Bladder Cancer|bladder cancer
5260761|NCT00583349|Chemotherapy|chemotherapy
5260762|NCT00583349|Bladder Neoplasms|bladder neoplasms
5260763|NCT00583310|Prehypertension|prehypertension
5260764|NCT00583297|Arrhythmia|arrhythmia
5260765|NCT00583297|Heart Failure|heart failure
5260766|NCT00583297|T-wave Alternans|t-wave alternans
5260767|NCT00583297|Implanted Cardioverter Defibrillator|implanted cardioverter defibrillator
5260768|NCT00583297|Biological Markers|biological markers
5260769|NCT00583297|Molecular Genetics|molecular genetics
5260770|NCT00583297|Corus CAD|corus cad
5260771|NCT00583297|ASGES|asges
5260772|NCT00583297|Age/Sex/Gene Expression Score|age/sex/gene expression score
5260773|NCT00583297|Gene Expression|gene expression
5260774|NCT00583297|GES|ges
5260775|NCT00583297|CVD|cvd
5260776|NCT00583297|Precision Medicine|precision medicine
5260777|NCT00583297|Sudden Cardiac Death|sudden cardiac death
5260778|NCT00583297|Electrophysiology Study|electrophysiology study
5260779|NCT00583297|Cardiovascular Disease|cardiovascular disease
5260780|NCT00583297|ICD|icd
5260781|NCT00583297|EPS|eps
5260782|NCT00583297|SCD|scd
5260783|NCT00583297|TWA|twa
5260784|NCT00583284|delayed enhancement computed tomography|delayed enhancement computed tomography
5260785|NCT00583284|ventricular tachycardia ablation|ventricular tachycardia ablation
5260786|NCT00583284|ventricular tachycardia|ventricular tachycardia
5260787|NCT00583245|Osteoarthritis|osteoarthritis
5260788|NCT00583245|Gait training|gait training
5260789|NCT00583245|Knee pain|knee pain
5260790|NCT00583245|Rehabilitation|rehabilitation
5260791|NCT00583245|Physical Therapy|physical therapy
5260792|NCT00583232|Pediatric|pediatric
5260793|NCT00583232|Crohn's disease|crohn's disease
5260794|NCT00583232|protein metabolism|protein metabolism
5260795|NCT00583232|energy metabolism|energy metabolism
5260796|NCT00583206|sepsis|sepsis
5260797|NCT00583206|atrophy|atrophy
5260798|NCT00583206|muscle|muscle
5260799|NCT00583206|weakness|weakness
5260800|NCT00583193|Post Traumatic Stress Disorder|post traumatic stress disorder
5260801|NCT00583193|Duloxetine|duloxetine
5260802|NCT00583193|Antidepressants|antidepressants
5260803|NCT00583180|Primary and/or secondary hyperalgesia|primary and/or secondary hyperalgesia
5260804|NCT00583180|hypoesthesia|hypoesthesia
5260805|NCT00583167|HIV|hiv
5260806|NCT00583167|AIDS|aids
5260807|NCT00583167|CNS|cns
5260808|NCT00583167|brain|brain
5260809|NCT00583167|affects|affects
5260810|NCT00583154|constipation|constipation
5260811|NCT00583154|laxative|laxative
5260812|NCT00583128|IBS|ibs
5260813|NCT00583128|Irritable Bowel Syndrome|irritable bowel syndrome
5260814|NCT00583102|Acute Myeloid Leukemia|acute myeloid leukemia
5260815|NCT00583102|AML|aml
5260816|NCT00583102|Lovastatin|lovastatin
5260817|NCT00583102|Cytarabine|cytarabine
5260818|NCT00583076|Pouchitis|pouchitis
5260819|NCT00583076|Active Pouchitis|active pouchitis
5260820|NCT00583076|Safety and Efficacy of AST120|safety and efficacy of ast120
5260821|NCT00583037|Neurally Adjusted Ventilatory Assist|neurally adjusted ventilatory assist
5260822|NCT00583037|Sleep quality|sleep quality
5260823|NCT00583037|Adult|adult
5260824|NCT00583037|Critical Care|critical care
5260825|NCT00583024|prostate cancer|prostate cancer
5260826|NCT00583024|vaccine|vaccine
5260827|NCT00583024|immunotherapy|immunotherapy
5260828|NCT00583011|Amniocentesis|amniocentesis
5260829|NCT00583011|Genetic amniocentesis|genetic amniocentesis
5260830|NCT00583011|Fetal lung maturity|fetal lung maturity
5260831|NCT00583011|Pain control|pain control
5260832|NCT00583011|Pregnancy|pregnancy
5260833|NCT00583011|High risk pregnancy|high risk pregnancy
5260834|NCT00582998|Vacuum Assisted Closure (VAC)|vacuum assisted closure (vac)
5260835|NCT00582998|Calcaneus Fracture|calcaneus fracture
5260836|NCT00582998|Pilon Fracture|pilon fracture
5260837|NCT00582998|Tibial Plateau Fracture|tibial plateau fracture
5260838|NCT00582998|Open Reduction and Internal Fixation|open reduction and internal fixation
5260839|NCT00582985|Tracon|tracon
5260840|NCT00582985|CD105|cd105
5260841|NCT00582985|Anti CD105|anti cd105
5260842|NCT00582985|TRC105|trc105
5260843|NCT00582985|Phase 1|phase 1
5260844|NCT00582985|Cancer|cancer
5260845|NCT00582985|Monoclonal antibody|monoclonal antibody
5260846|NCT00582985|Solid Tumor|solid tumor
5260847|NCT00582972|Calcium Absorption|calcium absorption
5260848|NCT00582972|Fractional Calcium Absorption|fractional calcium absorption
5260849|NCT00582972|Omeprazole|omeprazole
5260850|NCT00582972|Stable Calcium Isotopes|stable calcium isotopes
5260851|NCT00582972|Proton Pump Inhibitor|proton pump inhibitor
5260852|NCT00582972|Intestinal Absorption of Calcium|intestinal absorption of calcium
5260853|NCT00582959|radiology imaging|radiology imaging
5260854|NCT00582959|malignancy|malignancy
5260855|NCT00582959|undergoing radiation therapy|undergoing radiation therapy
5260856|NCT00582946|Hearing Loss, Eardrum, Transducer, Hearing in Noise|hearing loss, eardrum, transducer, hearing in noise
5260857|NCT00582933|Cancer|cancer
5260858|NCT00582933|Donors|donors
5260859|NCT00582933|Leukemia|leukemia
5260860|NCT00582933|Myelodysplastic Syndrome|myelodysplastic syndrome
5260861|NCT00582933|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
5260862|NCT00582933|Lymphoma|lymphoma
5260863|NCT00582933|AML|aml
5260864|NCT00582933|ALL|all
5260865|NCT00582933|CML|cml
5260866|NCT00582933|Allogeneic marrow transplant|allogeneic marrow transplant
5260867|NCT00582933|Bone marrow transplant|bone marrow transplant
5260868|NCT00582920|osseous lesions|osseous lesions
5260869|NCT00582920|breast cancer|breast cancer
5260870|NCT00582920|metastatic breast cancer|metastatic breast cancer
5260871|NCT00582907|FMF|fmf
5260872|NCT00582907|IL1 Trap (Rilonacept)|il1 trap (rilonacept)
5260873|NCT00582907|Periodic fever syndromes|periodic fever syndromes
5260874|NCT00582907|Autoinflammatory syndromes|autoinflammatory syndromes
5260875|NCT00582907|Familial Mediterranean Fever|familial mediterranean fever
5260876|NCT00582907|colchicine|colchicine
5260877|NCT00582894|Allogenic stem cell transplant|allogenic stem cell transplant
5260878|NCT00582894|Hematologic diseases|hematologic diseases
5260879|NCT00582881|Anti-RNP/Sm Autoantibody-Positive|anti-rnp/sm autoantibody-positive
5260880|NCT00582881|MCTD|mctd
5260881|NCT00582881|SLE|sle
5260882|NCT00582868|Subarachnoid hemorrhage|subarachnoid hemorrhage
5260883|NCT00582868|Cerebral Vasospasm|cerebral vasospasm
5260884|NCT00582868|Cleaved-tau protein|cleaved-tau protein
5260885|NCT00582868|Brain oxygen tension level|brain oxygen tension level
5260886|NCT00582855|AQW051|aqw051
5260887|NCT00582855|Mild Alzheimer's disease|mild alzheimer's disease
5260888|NCT00582855|Amnestic Mild Cognitive Impairment|amnestic mild cognitive impairment
5260889|NCT00582842|Early Stage|early stage
5260890|NCT00582842|Localized|localized
5260891|NCT00582829|Colorectal|colorectal
5260892|NCT00582829|Cancer|cancer
5260893|NCT00582829|Screening|screening
5260894|NCT00582829|Intervention|intervention
5260895|NCT00582829|Family|family
5260896|NCT00582816|Recurrent or Refractory Leukemia or Solid Tumors in Pediatrics|recurrent or refractory leukemia or solid tumors in pediatrics
5260897|NCT00582803|breast cancer|breast cancer
5260898|NCT00582803|germline mutation|germline mutation
5260899|NCT00582803|BRCA1|brca1
5260900|NCT00582803|BRCA2|brca2
5260901|NCT00582803|family history|family history
5260902|NCT00582803|genetic testing|genetic testing
5260903|NCT00582803|unaffected women over age 25 who are at elevated risk for|unaffected women over age 25 who are at elevated risk for
5260904|NCT00582803|breast cancer by virtue by a hereditary predisposition|breast cancer by virtue by a hereditary predisposition
5260905|NCT00582790|Renal Cell Cancer|renal cell cancer
5260906|NCT00582790|Metastatic|metastatic
5260907|NCT00582777|nocturnal blood pressure|nocturnal blood pressure
5260908|NCT00582777|chronic renal disease|chronic renal disease
5260909|NCT00582777|hypertensive renal disease|hypertensive renal disease
5260910|NCT00582777|African Americans|african americans
5260911|NCT00582777|ABPM|abpm
5260912|NCT00582764|Breast Lesion|breast lesion
5260913|NCT00582764|Lesion|lesion
5260914|NCT00582764|Breast|breast
5260915|NCT00582764|Cancer|cancer
5260916|NCT00582764|05-091|05-091
5260917|NCT00582751|Volumetric Analysis|volumetric analysis
5260918|NCT00582751|Multiple Diseases|multiple diseases
5260919|NCT00582738|Fibrosis progression|fibrosis progression
5260920|NCT00582738|recurrent hepatitis C|recurrent hepatitis c
5260921|NCT00582738|viral infection|viral infection
5260922|NCT00582738|liver transplant recipients|liver transplant recipients
5260923|NCT00582738|everolimus|everolimus
5260924|NCT00582738|Hepatitis C recurrence after orthotopic liver transplantation (OLT)|hepatitis c recurrence after orthotopic liver transplantation (olt)
5260925|NCT00582725|DLBCL, Elderly|dlbcl, elderly
5260926|NCT00582725|previously untreated DLBCL in the elderly|previously untreated dlbcl in the elderly
5260927|NCT00582712|medullary thyroid cancer|medullary thyroid cancer
5260928|NCT00582712|lithium|lithium
5260929|NCT00582699|Pancreatic Cancer|pancreatic cancer
5260930|NCT00582699|Pancreatic|pancreatic
5260931|NCT00582686|Calcaneus Fractures|calcaneus fractures
5260932|NCT00582686|Iliac Crest Bone Grafting|iliac crest bone grafting
5260933|NCT00582686|Open Reduction & Internal Fixation|open reduction & internal fixation
5260934|NCT00582673|Parkinson's, L-dopa, dyskinesia|parkinson's, l-dopa, dyskinesia
5260935|NCT00582634|non small cell lung cancer|non small cell lung cancer
5260936|NCT00582634|adjuvant|adjuvant
5260937|NCT00582634|cisplatin|cisplatin
5260938|NCT00582634|docetaxel|docetaxel
5260939|NCT00582621|Genetic Studies|genetic studies
5260940|NCT00582621|00-069|00-069
5260941|NCT00582621|blood|blood
5260942|NCT00582621|saliva|saliva
5260943|NCT00582621|buccal cell|buccal cell
5260944|NCT00582582|Metastatic|metastatic
5260945|NCT00582582|Hormone Refractory|hormone refractory
5260946|NCT00582582|Prostate Cancer|prostate cancer
5260947|NCT00582569|Breast lesion|breast lesion
5260948|NCT00582569|Spectroscopy|spectroscopy
5260949|NCT00582569|MRI|mri
5260950|NCT00582556|bone mineral density|bone mineral density
5260951|NCT00582543|Prostate Cancer|prostate cancer
5260952|NCT00582543|Prostate|prostate
5260953|NCT00582530|Prostate Cancer|prostate cancer
5260954|NCT00582530|Early Prostate Cancer|early prostate cancer
5260955|NCT00582530|Radical Prostatectomy|radical prostatectomy
5260956|NCT00582517|Orthopaedic Trauma|orthopaedic trauma
5260957|NCT00582517|Knee Dislocation|knee dislocation
5260958|NCT00582517|Compass Hinge External Fixator|compass hinge external fixator
5260959|NCT00582517|External Brace|external brace
5260960|NCT00582504|Encephalitis,VEE|encephalitis,vee
5260961|NCT00582491|Modafinil|modafinil
5260962|NCT00582491|Sleep|sleep
5260963|NCT00582491|Cognition|cognition
5260964|NCT00582491|Cocaine Dependence|cocaine dependence
5260965|NCT00582478|Breast cancer|breast cancer
5260966|NCT00582478|Quality of Life|quality of life
5260967|NCT00582452|HNPCC|hnpcc
5260968|NCT00582452|prophylactic colectomy|prophylactic colectomy
5260969|NCT00582439|Orthopaedic Trauma Fractures|orthopaedic trauma fractures
5260970|NCT00582439|Orthopaedic Trauma Non-unions|orthopaedic trauma non-unions
5260971|NCT00582439|Reamer-Irrigator-Aspirator (RIA)|reamer-irrigator-aspirator (ria)
5260972|NCT00582439|Bone Graft|bone graft
5260973|NCT00582426|Colorectal cancer|colorectal cancer
5260974|NCT00582426|diarrhea|diarrhea
5260975|NCT00582426|drug therapy|drug therapy
5260976|NCT00582426|octreotide|octreotide
5260977|NCT00582426|fluorouracil|fluorouracil
5260978|NCT00582426|irinotecan|irinotecan
5260979|NCT00582426|capecitabine|capecitabine
5260980|NCT00582426|prevention|prevention
5260981|NCT00582413|Head and Neck Cancer|head and neck cancer
5260982|NCT00582400|livers, hepatocellular carcinoma (HCC)|livers, hepatocellular carcinoma (hcc)
5260983|NCT00582374|Periodontal Disease|periodontal disease
5260984|NCT00582374|Preterm Birth|preterm birth
5260985|NCT00582374|Low Birth Weight|low birth weight
5260986|NCT00582374|Pregnancy|pregnancy
5260987|NCT00582361|Open Fractures|open fractures
5260988|NCT00582361|Vacuum Assisted Closure (VAC) device|vacuum assisted closure (vac) device
5260989|NCT00582361|Irrigation and Debridement|irrigation and debridement
5260990|NCT00582348|Lung Cancer|lung cancer
5260991|NCT00582348|Survivor|survivor
5260992|NCT00582348|Lung|lung
5260993|NCT00582335|Colorectal cancer|colorectal cancer
5260994|NCT00582335|Genetic testing|genetic testing
5260995|NCT00582335|Genetic mutations|genetic mutations
5260996|NCT00582322|Breast Cancer|breast cancer
5260997|NCT00582322|Ovarian Cancer|ovarian cancer
5260998|NCT00582322|Family History|family history
5260999|NCT00582322|Genetic Studies|genetic studies
5261000|NCT00582309|Glycemic Control|glycemic control
5261001|NCT00582309|Intravenous Infusion|intravenous infusion
5261002|NCT00582309|Standard Insulin infusion algorithm|standard insulin infusion algorithm
5261003|NCT00582309|Infusion|infusion
5261004|NCT00582309|Critically Ill|critically ill
5261005|NCT00582296|Lynch syndrome|lynch syndrome
5261006|NCT00582296|04-144|04-144
5261007|NCT00582270|non-hodkin's lymphoma|non-hodkin's lymphoma
5261008|NCT00582270|follicular|follicular
5261009|NCT00582270|non-follicular|non-follicular
5261010|NCT00582270|infectious disease|infectious disease
5261011|NCT00582257|Gastric Cancer|gastric cancer
5261012|NCT00582257|Stomach Cancer|stomach cancer
5261013|NCT00582257|05-118|05-118
5261014|NCT00582244|Menopausal symptoms|menopausal symptoms
5261015|NCT00582244|Quality of Life|quality of life
5261016|NCT00582244|Breast cancer|breast cancer
5261017|NCT00582244|Multicenter trial|multicenter trial
5261018|NCT00582231|Penile injection therapy|penile injection therapy
5261019|NCT00582231|Erectile dysfunction|erectile dysfunction
5261020|NCT00582231|Radical pelvic surgery|radical pelvic surgery
5261021|NCT00582231|Penile Injection Anxiety|penile injection anxiety
5261022|NCT00582218|HIV/AIDS|hiv/aids
5261023|NCT00582218|Access to care|access to care
5261024|NCT00582205|Ovarian Cancer|ovarian cancer
5261025|NCT00582205|Fallopian Tube Cancer|fallopian tube cancer
5261026|NCT00582205|Primary Peritoneal Carcinoma|primary peritoneal carcinoma
5261027|NCT00582205|Uterine Cancer|uterine cancer
5261028|NCT00582205|Intraperitoneal Chemotherapy|intraperitoneal chemotherapy
5261029|NCT00582205|IP Chemotherapy|ip chemotherapy
5261030|NCT00582205|Gynecologic Cancer|gynecologic cancer
5261031|NCT00582205|Women's Cancer|women's cancer
5261032|NCT00582205|Cisplatin|cisplatin
5261033|NCT00582205|Paclitaxel|paclitaxel
5261034|NCT00582205|Recurrent Platinum Sensitive Ovarian Cancer|recurrent platinum sensitive ovarian cancer
5261035|NCT00582192|Phase I trial|phase i trial
5261036|NCT00582192|Oncologists' Communication Styles|oncologists' communication styles
5261037|NCT00582179|Draining Hematoma|draining hematoma
5261038|NCT00582179|Vacuum Assisted Closure (VAC)|vacuum assisted closure (vac)
5261039|NCT00582179|Negative Pressure Wound Therapy (NPWT)|negative pressure wound therapy (npwt)
5261040|NCT00582179|Draining Hematoma following orthopaedic surgery|draining hematoma following orthopaedic surgery
5261041|NCT00582166|Zevalin, High Tumor Burden Indolent Non-Hodgkin's Lymphoma, Ibritumomab Tiuxetan|zevalin, high tumor burden indolent non-hodgkin's lymphoma, ibritumomab tiuxetan
5261042|NCT00582140|Prostate|prostate
5261043|NCT00582140|Cancer|cancer
5261044|NCT00582140|Stage D0|stage d0
5261045|NCT00582140|Non-Metastatic|non-metastatic
5261046|NCT00582140|Rising PSA|rising psa
5261047|NCT00582127|senile|senile
5261048|NCT00582127|dementia|dementia
5261049|NCT00582114|Hemodialysis|hemodialysis
5261050|NCT00582114|Hypertension|hypertension
5261051|NCT00582114|Left ventricular hypertrophy|left ventricular hypertrophy
5261052|NCT00582101|HIV|hiv
5261053|NCT00582101|prevention|prevention
5261054|NCT00582101|families|families
5261055|NCT00582101|Latinos|latinos
5261056|NCT00582101|communication|communication
5261057|NCT00582101|sexuality|sexuality
5261058|NCT00582101|monitoring|monitoring
5261059|NCT00582101|health promotion|health promotion
5261060|NCT00582101|HIV Prevention|hiv prevention
5261061|NCT00582101|HIV Seronegativity|hiv seronegativity
5261062|NCT00582088|Encephalitis, Viral Infections, Neurologic diseases, Alphavirus Infections, VEE|encephalitis, viral infections, neurologic diseases, alphavirus infections, vee
5261063|NCT00582075|Cancer|cancer
5261064|NCT00582075|Brain metastases|brain metastases
5261065|NCT00582075|Gamma Knife Radiosurgery|gamma knife radiosurgery
5261066|NCT00582075|Temodar|temodar
5261067|NCT00582075|Temozolomide|temozolomide
5261068|NCT00582062|Gastric Cancer|gastric cancer
5261069|NCT00582062|Pancreatic cancer|pancreatic cancer
5261070|NCT00582049|Retinoblastoma|retinoblastoma
5261071|NCT00582049|Sporadic heritable retinoblastoma|sporadic heritable retinoblastoma
5261072|NCT00582049|Paternal exposures|paternal exposures
5261073|NCT00582036|Hyperglycemia|hyperglycemia
5261074|NCT00582036|Hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
5261075|NCT00582036|Bone marrow transplant|bone marrow transplant
5261076|NCT00582036|High blood sugar|high blood sugar
5261077|NCT00582023|HIV|hiv
5261078|NCT00582023|coping|coping
5261079|NCT00582023|emotion|emotion
5261080|NCT00582023|affect|affect
5261081|NCT00582023|HIV infection|hiv infection
5261082|NCT00582023|Complimentary therapies|complimentary therapies
5261083|NCT00582010|ischemia-reperfusion|ischemia-reperfusion
5261084|NCT00582010|nitric oxide|nitric oxide
5261085|NCT00582010|inflammation|inflammation
5261086|NCT00582010|cell-death|cell-death
5261087|NCT00582010|Liver-function post transplantation|liver-function post transplantation
5261088|NCT00581997|Pulmonary fibrosis, systemic sclerosis|pulmonary fibrosis, systemic sclerosis
5261089|NCT00581984|breast cancer|breast cancer
5261090|NCT00581984|breast reconstruction|breast reconstruction
5261091|NCT00581984|silicone implants|silicone implants
5261092|NCT00581971|Radiosensitization|radiosensitization
5261093|NCT00581971|COX-2 inhibitor|cox-2 inhibitor
5261094|NCT00581971|Celecoxib|celecoxib
5261095|NCT00581971|Head and Neck Cancer|head and neck cancer
5261096|NCT00581971|Chemoradiation|chemoradiation
5261097|NCT00581958|total body irradiation|total body irradiation
5261098|NCT00581958|Cancer|cancer
5261099|NCT00581958|Hematopoietic System|hematopoietic system
5261100|NCT00581932|clozapine, schizophrenia|clozapine, schizophrenia
5261101|NCT00581919|previously treated multiple myeloma|previously treated multiple myeloma
5261102|NCT00581906|Head and Neck Cancer|head and neck cancer
5261103|NCT00581906|Head Cancer|head cancer
5261104|NCT00581906|Neck Cancer|neck cancer
5261105|NCT00581906|Dynamic Contrast Enhanced MRI|dynamic contrast enhanced mri
5261106|NCT00581906|Magnetic Resonance Spectroscopy (MRS)|magnetic resonance spectroscopy (mrs)
5261107|NCT00581906|Diffusion Weighted MRI (DW-MRI)|diffusion weighted mri (dw-mri)
5261108|NCT00581906|06-007|06-007
5261109|NCT00581893|epilepsy|epilepsy
5261110|NCT00581893|cognitive impairment|cognitive impairment
5261111|NCT00581893|driving simulation|driving simulation
5261112|NCT00581893|cross-over study|cross-over study
5261113|NCT00581880|end stage|end stage
5261114|NCT00581880|Terminally Ill|terminally ill
5261115|NCT00581854|untreated mantle cell lymphoma|untreated mantle cell lymphoma
5261116|NCT00581841|Healthy adult normals|healthy adult normals
5261117|NCT00581828|Calcium Absorption|calcium absorption
5261118|NCT00581828|Intestinal Absorption of Calcium|intestinal absorption of calcium
5261119|NCT00581828|Fractional Calcium Absorption|fractional calcium absorption
5261120|NCT00581828|Stable Calcium Isotopes|stable calcium isotopes
5261121|NCT00581828|Hypovitaminosis D|hypovitaminosis d
5261122|NCT00581828|Vitamin D|vitamin d
5261123|NCT00581828|Bone Mineral Density|bone mineral density
5261124|NCT00581828|Physical Function|physical function
5261125|NCT00581802|CD4-Positive T-Lymphocytes|cd4-positive t-lymphocytes
5261126|NCT00581802|Treatment Naive|treatment naive
5261324|NCT00580840|Cimzia|cimzia
5261127|NCT00581802|Latent HIV Infections|latent hiv infections
5261128|NCT00581789|non small cell lung cancer|non small cell lung cancer
5261129|NCT00581789|sunitinib|sunitinib
5261130|NCT00581789|erlotinib|erlotinib
5261131|NCT00581789|phase 1|phase 1
5261132|NCT00581776|Untreated Mantle Cell Lymphoma|untreated mantle cell lymphoma
5261133|NCT00581750|Biopsy|biopsy
5261134|NCT00581750|Breast|breast
5261135|NCT00581750|01-135|01-135
5261136|NCT00581724|breast cancer|breast cancer
5261137|NCT00581724|Colorectal cancer|colorectal cancer
5261138|NCT00581724|Prostate cancer|prostate cancer
5261139|NCT00581724|Head and Neck cancer|head and neck cancer
5261140|NCT00581724|Lung cancer|lung cancer
5261141|NCT00581724|cancer survivors|cancer survivors
5261142|NCT00581724|07-068|07-068
5261143|NCT00581724|quality of life|quality of life
5261144|NCT00581724|Pain in cancer survivors|pain in cancer survivors
5261145|NCT00581711|Electronic Health Record|electronic health record
5261146|NCT00581711|Clinical Decision Support|clinical decision support
5261147|NCT00581711|Otitis Media|otitis media
5261148|NCT00581698|Melanoma|melanoma
5261149|NCT00581698|Negative regional lymph nodes|negative regional lymph nodes
5261150|NCT00581698|Primary melanomas Clark III and Breslow thickness > 1 mm, or Clark|primary melanomas clark iii and breslow thickness > 1 mm, or clark
5261151|NCT00581698|IV-V and any Breslow thickness, and clinically negative regional nodes|iv-v and any breslow thickness, and clinically negative regional nodes
5261152|NCT00581685|Chronic pain|chronic pain
5261153|NCT00581685|Preemptive analgesia|preemptive analgesia
5261154|NCT00581685|Pregabalin|pregabalin
5261155|NCT00581685|Celecoxib|celecoxib
5261156|NCT00581685|Hip Arthroplasty|hip arthroplasty
5261157|NCT00581685|Osteoarthritis|osteoarthritis
5261158|NCT00581672|Anxiety|anxiety
5261159|NCT00581672|Black men|black men
5261160|NCT00581672|Prostate Cancer|prostate cancer
5261161|NCT00581672|07-125|07-125
5261162|NCT00581633|saline|saline
5261163|NCT00581633|sodium|sodium
5261164|NCT00581633|kidney|kidney
5261165|NCT00581633|tachycardia|tachycardia
5261166|NCT00581620|pneumococcus conjugated vaccine|pneumococcus conjugated vaccine
5261167|NCT00581607|Sarcoidosis|sarcoidosis
5261168|NCT00581594|Pelvic organ prolapse|pelvic organ prolapse
5261169|NCT00581594|Posterior wall defects|posterior wall defects
5261170|NCT00581594|Graft-augmented repair|graft-augmented repair
5261171|NCT00581594|Posterior colporrhaphy|posterior colporrhaphy
5261172|NCT00581581|neonatal encephalopathy|neonatal encephalopathy
5261173|NCT00581581|therapeutic hypothermia|therapeutic hypothermia
5261174|NCT00581581|head cooling|head cooling
5261175|NCT00581581|neonatal asphyxia|neonatal asphyxia
5261176|NCT00581568|Skin cooling during laser treatment|skin cooling during laser treatment
5261177|NCT00581555|Psoriasis|psoriasis
5261178|NCT00581529|breast|breast
5261179|NCT00581516|Prostate Cancer|prostate cancer
5261180|NCT00581516|PCA3|pca3
5261181|NCT00581503|early detection of lung and pleural cancer|early detection of lung and pleural cancer
5261182|NCT00581503|early detection of prostate cancer|early detection of prostate cancer
5261183|NCT00581490|Premature pubarche|premature pubarche
5261184|NCT00581490|Adrenal hyperandrogenism|adrenal hyperandrogenism
5261185|NCT00581490|Metabolic syndrome|metabolic syndrome
5261186|NCT00581477|autonomic nervous system diseases|autonomic nervous system diseases
5261187|NCT00581477|blood pressure|blood pressure
5261188|NCT00581477|congenital|congenital
5261189|NCT00581477|orthostasis|orthostasis
5261190|NCT00581477|catecholamines|catecholamines
5261191|NCT00581464|Smoking cessation|smoking cessation
5261192|NCT00581464|Tobacco dependence|tobacco dependence
5261193|NCT00581464|Mindfulness|mindfulness
5261194|NCT00581464|fMRI|fmri
5261195|NCT00581464|Craving|craving
5261196|NCT00581438|Approach Haemophilia A and B|approach haemophilia a and b
5261198|NCT00581425|Basal Cell Carcinoma|basal cell carcinoma
5261199|NCT00581425|Intron-A|intron-a
5261200|NCT00581425|Aldara|aldara
5261201|NCT00581425|Basal Cell Carcinoma excluding scalp and face|basal cell carcinoma excluding scalp and face
5261202|NCT00581412|Pelvic organ prolapse|pelvic organ prolapse
5261203|NCT00581412|Composite biologic/synthetic graft|composite biologic/synthetic graft
5261204|NCT00581412|Abdominal sacrocolpopexy|abdominal sacrocolpopexy
5261205|NCT00581399|Open heart surgery|open heart surgery
5261206|NCT00581399|Cardiopulmonary Bypass|cardiopulmonary bypass
5261207|NCT00581399|Coronary Artery Bypass Grafting|coronary artery bypass grafting
5261208|NCT00581399|Chest Tube|chest tube
5261209|NCT00581399|Valve Replacement|valve replacement
5261210|NCT00581399|Valve Repair|valve repair
5261211|NCT00581386|Endotracheal Intubation|endotracheal intubation
5261212|NCT00581386|Supraglottic Airway|supraglottic airway
5261213|NCT00581373|water|water
5261214|NCT00581373|orthostatic hypotension|orthostatic hypotension
5261215|NCT00581373|blood pressure|blood pressure
5261216|NCT00581360|Adenoid cystic carcinoma|adenoid cystic carcinoma
5261217|NCT00581360|bortezomib|bortezomib
5261218|NCT00581360|doxorubicin|doxorubicin
5261219|NCT00581334|Pelvic organ prolapse|pelvic organ prolapse
5261220|NCT00581334|Robotic-assisted laparoscopic sacrocolpopexy|robotic-assisted laparoscopic sacrocolpopexy
5261221|NCT00581334|Post hysterectomy prolapse|post hysterectomy prolapse
5261222|NCT00581334|Symptomatic post hysterectomy prolapse of stage II or greater|symptomatic post hysterectomy prolapse of stage ii or greater
5261224|NCT00581321|blood pressure|blood pressure
5261225|NCT00581321|vascular resistance|vascular resistance
5261226|NCT00581321|cardiac transplantation|cardiac transplantation
5261227|NCT00581308|atrial septal defect, septal occluder, HELEX|atrial septal defect, septal occluder, helex
5261228|NCT00581295|internal bleeding|internal bleeding
5261229|NCT00581295|changes in tissue perfusion|changes in tissue perfusion
5261230|NCT00581282|Cocaine abstinence|cocaine abstinence
5261231|NCT00581282|PET scan|pet scan
5261232|NCT00581256|left sided|left sided
5261233|NCT00581243|Safety,Tolerability, Schizophrenia|safety,tolerability, schizophrenia
5261234|NCT00581230|Endotracheal Intubation|endotracheal intubation
5261235|NCT00581230|Rapid Airway Management Positioner|rapid airway management positioner
5261236|NCT00581217|Burn injury|burn injury
5261237|NCT00581217|Skin graft|skin graft
5261238|NCT00581217|Donor site dressing|donor site dressing
5261239|NCT00581217|Outcomes|outcomes
5261240|NCT00581217|Infection rate|infection rate
5261241|NCT00581217|Healing time|healing time
5261242|NCT00581217|Cosmetic Result|cosmetic result
5261243|NCT00581217|Pain|pain
5261244|NCT00581217|Burn injured patients requiring skin grafting|burn injured patients requiring skin grafting
5261245|NCT00581204|trauma situations|trauma situations
5261246|NCT00581204|Lower Body Negative Pressure (LBNP)|lower body negative pressure (lbnp)
5261247|NCT00581191|SAD|sad
5261248|NCT00581191|Healthy|healthy
5261249|NCT00581178|Ureteral Stent|ureteral stent
5261250|NCT00581178|Kidney Stones|kidney stones
5261251|NCT00581152|TBX3|tbx3
5261252|NCT00581126|BENEFIX|benefix
5261253|NCT00581126|Hemophilia B|hemophilia b
5261254|NCT00581113|whole brain radiotherapy|whole brain radiotherapy
5261255|NCT00581113|neural stem cell|neural stem cell
5261256|NCT00581113|brain metastases|brain metastases
5261257|NCT00581113|radiosurgery|radiosurgery
5261258|NCT00581100|Nail Psoriasis|nail psoriasis
5261259|NCT00581100|Plaque Psoriasis|plaque psoriasis
5261260|NCT00581087|Hypertension, pulmonary|hypertension, pulmonary
5261261|NCT00581087|DHEA|dhea
5261262|NCT00581087|six-minute walk test|six-minute walk test
5261263|NCT00581087|pulmonary arterial pressure|pulmonary arterial pressure
5261264|NCT00581074|obesity|obesity
5261265|NCT00581074|diet|diet
5261266|NCT00581074|weight loss|weight loss
5261267|NCT00581074|metabolic syndrome|metabolic syndrome
5261268|NCT00581061|Incontinence|incontinence
5261269|NCT00581061|Robotic Prostatectomy|robotic prostatectomy
5261270|NCT00581048|Asthma|asthma
5261271|NCT00581048|Allergy|allergy
5261272|NCT00581048|Atopy|atopy
5261273|NCT00581048|Vitamin E|vitamin e
5261274|NCT00581048|GSTP1|gstp1
5261275|NCT00581048|Oxidative stress|oxidative stress
5261276|NCT00581035|Meningococcal disease|meningococcal disease
5261277|NCT00581035|pneumococcal disease|pneumococcal disease
5261278|NCT00581035|meningitis|meningitis
5261279|NCT00581022|postural tachycardia syndrome|postural tachycardia syndrome
5261280|NCT00581022|sleep|sleep
5261281|NCT00581022|insomnia|insomnia
5261282|NCT00581009|Sleep deprivation|sleep deprivation
5261283|NCT00581009|antidepressant|antidepressant
5261284|NCT00581009|depression|depression
5261285|NCT00581009|chronobiological|chronobiological
5261286|NCT00580996|water|water
5261287|NCT00580996|orthostatic hypotension|orthostatic hypotension
5261288|NCT00580996|blood pressure|blood pressure
5261289|NCT00580983|Head and Neck cancer|head and neck cancer
5261290|NCT00580970|prostate cancer|prostate cancer
5261291|NCT00580970|radiation therapy|radiation therapy
5261292|NCT00580970|lovastatin|lovastatin
5261293|NCT00580970|rectal injury|rectal injury
5261294|NCT00580957|Obesity|obesity
5261295|NCT00580957|Hypertension|hypertension
5261296|NCT00580957|Autonomic Nervous System|autonomic nervous system
5261297|NCT00580944|Port wine stain|port wine stain
5261298|NCT00580944|progressive malformation of human skin|progressive malformation of human skin
5261299|NCT00580931|nutraceutical, dementia, cognition, HDAC inhibitor|nutraceutical, dementia, cognition, hdac inhibitor
5261300|NCT00580918|Mild Traumatic Brain Injury|mild traumatic brain injury
5261301|NCT00580918|fMRI|fmri
5261302|NCT00580905|Adenosine|adenosine
5261303|NCT00580905|Cytokines|cytokines
5261304|NCT00580905|Inflammation|inflammation
5261305|NCT00580905|VEGF|vegf
5261306|NCT00580879|Anorectal sphincter laceration|anorectal sphincter laceration
5261307|NCT00580879|Pelvic floor dysfunction|pelvic floor dysfunction
5261308|NCT00580879|Sphincter tear|sphincter tear
5261309|NCT00580866|Elbow|elbow
5261310|NCT00580866|Upper Extremity Fractures|upper extremity fractures
5261311|NCT00580866|Distal Humerus|distal humerus
5261312|NCT00580866|Elbow Injuries|elbow injuries
5261313|NCT00580866|Dislocations|dislocations
5261314|NCT00580866|Peri-articular Elbow Injuries|peri-articular elbow injuries
5261315|NCT00580853|smoking lapse behavior|smoking lapse behavior
5261316|NCT00580853|smoking cessation|smoking cessation
5261317|NCT00580853|varenicline|varenicline
5261318|NCT00580853|bupropion|bupropion
5261319|NCT00580853|medication effect on smoking lapse behavior|medication effect on smoking lapse behavior
5261320|NCT00580840|Rheumatoid Arthritis|rheumatoid arthritis
5261321|NCT00580840|Joint Disease|joint disease
5261322|NCT00580840|Arthritis|arthritis
5261323|NCT00580840|Certolizumab pegol|certolizumab pegol
5261325|NCT00580814|Brookhaven|brookhaven
5261326|NCT00580814|ADHD|adhd
5261327|NCT00580814|Dopamine|dopamine
5261328|NCT00580814|methylphenidate|methylphenidate
5261330|NCT00580801|Hepatitis C|hepatitis c
5261331|NCT00580801|Telaprevir|telaprevir
5261332|NCT00580801|Pegylated-interferon-alfa-2a|pegylated-interferon-alfa-2a
5261333|NCT00580801|Pegasys|pegasys
5261334|NCT00580801|Ribavirin|ribavirin
5261335|NCT00580801|Copegus|copegus
5261336|NCT00580788|Endocrine System Diseases|endocrine system diseases
5261337|NCT00580788|MusculoSkeletal System Diseases|musculoskeletal system diseases
5261338|NCT00580788|Hormones|hormones
5261339|NCT00580788|Malignancy|malignancy
5261340|NCT00580788|Postmenopausal Women|postmenopausal women
5261341|NCT00580788|Bone metabolism|bone metabolism
5261342|NCT00580775|Menopause|menopause
5261343|NCT00580775|Hormone Replacement Therapy|hormone replacement therapy
5261344|NCT00580775|Sudden Cardiac Death|sudden cardiac death
5261345|NCT00580749|Pancreatitis|pancreatitis
5261346|NCT00580749|enteral feeding|enteral feeding
5261347|NCT00580749|distal jejunal feeding|distal jejunal feeding
5261348|NCT00580749|naso gastric feeding|naso gastric feeding
5261349|NCT00580749|pancreatic rest|pancreatic rest
5261350|NCT00580736|sebaceous hyperplasia|sebaceous hyperplasia
5261351|NCT00580723|acne|acne
5261352|NCT00580723|rosacea|rosacea
5261353|NCT00580723|acne rosacea|acne rosacea
5261354|NCT00580723|papulopustular rosacea|papulopustular rosacea
5261355|NCT00580723|erythema|erythema
5261356|NCT00580723|telangiectasia|telangiectasia
5261357|NCT00580723|flushing|flushing
5261358|NCT00580710|type 1 diabetes|type 1 diabetes
5261359|NCT00580710|hypoglycemia|hypoglycemia
5261360|NCT00580710|magnetic resonance imaging|magnetic resonance imaging
5261361|NCT00580697|Lower urinary tract symptoms|lower urinary tract symptoms
5261362|NCT00580697|Gynecologic malignancy|gynecologic malignancy
5261363|NCT00580697|Urinary incontinence|urinary incontinence
5261364|NCT00580697|Fecal incontinence|fecal incontinence
5261365|NCT00580697|Frequency|frequency
5261366|NCT00580697|Voiding dysfunction|voiding dysfunction
5261367|NCT00580697|Sexual dysfunction|sexual dysfunction
5261368|NCT00580684|pneumococcus conjugated vaccine 7 valent|pneumococcus conjugated vaccine 7 valent
5261369|NCT00580671|Adolescent Marijuana Abuse|adolescent marijuana abuse
5261370|NCT00580658|Dystonia|dystonia
5261371|NCT00580645|alcohol|alcohol
5261372|NCT00580645|smoking cessation|smoking cessation
5261373|NCT00580645|varenicline|varenicline
5261374|NCT00580645|bupropion|bupropion
5261375|NCT00580645|smoking cessation medications|smoking cessation medications
5261376|NCT00580619|Chronic fatigue syndrome|chronic fatigue syndrome
5261377|NCT00580619|Postural tachycardia syndrome|postural tachycardia syndrome
5261378|NCT00580619|Autonomic nervous system|autonomic nervous system
5261379|NCT00580606|Food Allergy|food allergy
5261380|NCT00580606|Peanut Allergy|peanut allergy
5261381|NCT00580606|Sublingual Immunotherapy|sublingual immunotherapy
5261382|NCT00580593|amyotrophic lateral sclerosis|amyotrophic lateral sclerosis
5261383|NCT00580593|ALS|als
5261384|NCT00580593|nocturnal noninvasive positive pressure ventilation|nocturnal noninvasive positive pressure ventilation
5261385|NCT00580593|NIPPV|nippv
5261386|NCT00580593|forced vital capacity|forced vital capacity
5261387|NCT00580593|FVC|fvc
5261388|NCT00580567|Impulsivity|impulsivity
5261389|NCT00580567|Gambling|gambling
5261390|NCT00580567|Pathological Gamblers|pathological gamblers
5261391|NCT00580567|Problem Gamblers|problem gamblers
5261392|NCT00580567|Non-Pathological Gamblers|non-pathological gamblers
5261393|NCT00580567|Risk-taking|risk-taking
5261394|NCT00580567|Inhibition|inhibition
5261395|NCT00580567|Gambling Severity|gambling severity
5261396|NCT00580515|Cancer|cancer
5261397|NCT00580515|Randomized Controlled Trial|randomized controlled trial
5261398|NCT00580515|Family Therapy intervention|family therapy intervention
5261399|NCT00580502|Obesity, 50 lbs overweight|obesity, 50 lbs overweight
5261400|NCT00580489|helicopter|helicopter
5261401|NCT00580489|aeromedical|aeromedical
5261402|NCT00580489|pain relief|pain relief
5261403|NCT00580489|analgesia|analgesia
5261404|NCT00580489|fentanyl|fentanyl
5261405|NCT00580489|morphine|morphine
5261406|NCT00580489|adverse events|adverse events
5261407|NCT00580476|Breast Cancer|breast cancer
5261408|NCT00580476|Prostate Cancer|prostate cancer
5261409|NCT00580463|central nervous system (CNS) tumor|central nervous system (cns) tumor
5261410|NCT00580463|tissue collection|tissue collection
5261411|NCT00580385|BONE|bone
5261412|NCT00580359|Stomach Neoplasms|stomach neoplasms
5261413|NCT00580359|Secondary|secondary
5261414|NCT00580359|Combination chemotherapy|combination chemotherapy
5261415|NCT00580359|S-1|s-1
5261416|NCT00580359|Capecitabine|capecitabine
5261417|NCT00580346|Aspiration pneumonia|aspiration pneumonia
5261418|NCT00580346|Implanted laryngeal stimulator|implanted laryngeal stimulator
5261419|NCT00580346|Vocal cord closure|vocal cord closure
5261420|NCT00580346|Modified barium swallow|modified barium swallow
5261421|NCT00580333|ER negative|er negative
5261422|NCT00580333|PR negative|pr negative
5261423|NCT00580333|HER2 negative|her2 negative
5261424|NCT00580320|melanoma|melanoma
5261425|NCT00580320|soft tissue sarcoma|soft tissue sarcoma
5261426|NCT00580320|APUD tumor|apud tumor
5261427|NCT00580320|dacarbazine|dacarbazine
5261428|NCT00580320|bortezomib|bortezomib
5261429|NCT00580320|velcade|velcade
5261430|NCT00580307|Headache|headache
5261431|NCT00580307|Rhinogenic|rhinogenic
5261432|NCT00580307|Nose|nose
5261433|NCT00580307|Nasal septum|nasal septum
5261434|NCT00580307|Deviated septum|deviated septum
5261435|NCT00580307|Surgery|surgery
5261436|NCT00580307|Septoplasty|septoplasty
5261437|NCT00580307|Turbinoplasty|turbinoplasty
5261438|NCT00580307|Contact point|contact point
5261439|NCT00580307|HIT-6|hit-6
5261440|NCT00580294|Sciatica|sciatica
5261441|NCT00580294|Diabetic Neuropathies|diabetic neuropathies
5261442|NCT00580294|Complex Regional Pain Syndromes|complex regional pain syndromes
5261443|NCT00580294|Low Back Pain|low back pain
5261444|NCT00580294|Neck Pain|neck pain
5261445|NCT00580294|Headache|headache
5261446|NCT00580294|Back Pain|back pain
5261447|NCT00580294|Arthritis|arthritis
5261448|NCT00580294|Brachial Plexus Injury (stinger/burner)|brachial plexus injury (stinger/burner)
5261449|NCT00580294|Chronic Pain|chronic pain
5261450|NCT00580294|Contractures|contractures
5261451|NCT00580294|Diabetes|diabetes
5261452|NCT00580294|Fibromyalgia|fibromyalgia
5261453|NCT00580294|Foot Pain|foot pain
5261454|NCT00580294|Fracture|fracture
5261455|NCT00580294|Hip|hip
5261456|NCT00580294|Herpes Zoster (shingles)|herpes zoster (shingles)
5261457|NCT00580294|Migraine|migraine
5261458|NCT00580294|Neuropathic Pain|neuropathic pain
5261459|NCT00580294|Osteoarthritis|osteoarthritis
5261460|NCT00580294|Osteoporosis|osteoporosis
5261461|NCT00580294|Rheumatoid Arthritis|rheumatoid arthritis
5261462|NCT00580294|Scoliosis|scoliosis
5261463|NCT00580294|Nerve pain|nerve pain
5261464|NCT00580294|Opana|opana
5261465|NCT00580294|Opioid|opioid
5261466|NCT00580294|Opioid Rotation|opioid rotation
5261467|NCT00580294|Oxymorphone|oxymorphone
5261468|NCT00580294|Morphine|morphine
5261469|NCT00580294|neuropathic|neuropathic
5261470|NCT00580294|oxycodone|oxycodone
5261471|NCT00580281|Gastric cancer|gastric cancer
5261472|NCT00580281|Leukemia|leukemia
5261473|NCT00580281|Chronic Myelogenous Leukemia|chronic myelogenous leukemia
5261474|NCT00580281|Imatinib|imatinib
5261475|NCT00580281|Gleevec|gleevec
5261476|NCT00580255|CHF|chf
5261477|NCT00580255|CRT|crt
5261478|NCT00580255|Atrial Arrhythmias|atrial arrhythmias
5261479|NCT00580255|Ventricular Arrhythmias|ventricular arrhythmias
5261480|NCT00580255|BioZ|bioz
5261481|NCT00580255|Optivol|optivol
5261482|NCT00580242|Myelodysplasia|myelodysplasia
5261483|NCT00580229|Rituxan|rituxan
5261484|NCT00580229|Rituximab|rituximab
5261485|NCT00580216|stroke|stroke
5261486|NCT00580216|systemic thromboembolic events|systemic thromboembolic events
5261487|NCT00580203|HEENT cancers|heent cancers
5261488|NCT00580203|larynx|larynx
5261489|NCT00580203|thyroid|thyroid
5261490|NCT00580203|sarcoma|sarcoma
5261491|NCT00580203|specimen analysis|specimen analysis
5261492|NCT00580177|Inguinal hernia|inguinal hernia
5261493|NCT00580177|Randomized controlled trial|randomized controlled trial
5261494|NCT00580177|Surgery|surgery
5261495|NCT00580177|Complications|complications
5261496|NCT00580177|Surgical mesh|surgical mesh
5261497|NCT00580151|Pain not controled by morphine|pain not controled by morphine
5261498|NCT00580151|Anxiety not controled by lorazepam|anxiety not controled by lorazepam
5261499|NCT00580138|Deglutition Disorders|deglutition disorders
5261500|NCT00580138|Evaluation|evaluation
5261501|NCT00580138|Real-time internet|real-time internet
5261502|NCT00580112|Breast Neoplasms|breast neoplasms
5261503|NCT00580112|Trabectedin|trabectedin
5261504|NCT00580112|Yondelis|yondelis
5261505|NCT00580099|premature infant, body composition, total energy expenditure|premature infant, body composition, total energy expenditure
5261506|NCT00580099|inflammatory growth mediators|inflammatory growth mediators
5261507|NCT00580086|Breast cancer|breast cancer
5261508|NCT00580086|MR spectroscopy|mr spectroscopy
5261509|NCT00580086|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
5261510|NCT00580060|AJCC|ajcc
5261511|NCT00580060|stage|stage
5261512|NCT00580060|IIB|iib
5261513|NCT00580060|IIC|iic
5261514|NCT00580060|III|iii
5261515|NCT00580060|IV|iv
5261516|NCT00580060|Melanoma|melanoma
5261517|NCT00580060|HLA-A2+|hla-a2+
5261518|NCT00580060|Vaccine|vaccine
5261519|NCT00580047|bone density|bone density
5261520|NCT00580047|osteopenia|osteopenia
5261521|NCT00580047|transplant|transplant
5261522|NCT00580047|zoledronic acid|zoledronic acid
5261523|NCT00580047|alendronate|alendronate
5261524|NCT00580034|Allogeneic Stem Cell Transplantation, Campath, HLA-Matched|allogeneic stem cell transplantation, campath, hla-matched
5261525|NCT00580021|Ashkenazi ancestry|ashkenazi ancestry
5261526|NCT00580021|mutations in BRCA1 or BRCA2|mutations in brca1 or brca2
5261527|NCT00580021|Breast Cancer|breast cancer
5261528|NCT00580021|Pancreatic Cancer|pancreatic cancer
5261529|NCT00580008|tomography|tomography
5261530|NCT00580008|coronary artery disease|coronary artery disease
5261531|NCT00580008|coronary artery bypass grafting|coronary artery bypass grafting
5261532|NCT00580008|vein graft|vein graft
5261533|NCT00579982|Mood disorder|mood disorder
5261534|NCT00579943|very low birth weight infant|very low birth weight infant
5261535|NCT00579943|cerebral autoregulation|cerebral autoregulation
5261536|NCT00579943|intraventricular hemorrhage|intraventricular hemorrhage
5261537|NCT00579943|carbon dioxide|carbon dioxide
5261538|NCT00579943|cerebral blood flow velocity|cerebral blood flow velocity
5261539|NCT00579943|ultrasonography, Doppler, transcranial|ultrasonography, doppler, transcranial
5261540|NCT00579943|cerebrovascular circulation|cerebrovascular circulation
5261541|NCT00579930|Bone|bone
5261542|NCT00579930|Soft Tissue|soft tissue
5261543|NCT00579917|Survivor|survivor
5261544|NCT00579917|Behavioral Intervention|behavioral intervention
5261545|NCT00579917|Bone Marrow|bone marrow
5261546|NCT00579917|Stem Cell Transplantation|stem cell transplantation
5261547|NCT00579904|PCOS|pcos
5261548|NCT00579904|polycystic ovary syndrome|polycystic ovary syndrome
5261549|NCT00579904|insulin resistance|insulin resistance
5261550|NCT00579904|fish oil|fish oil
5261551|NCT00579904|walnut-oil|walnut-oil
5261552|NCT00579904|walnuts|walnuts
5261553|NCT00579904|almonds|almonds
5261554|NCT00579904|monounsaturated fats|monounsaturated fats
5261555|NCT00579904|polyunsaturated fats|polyunsaturated fats
5261556|NCT00579904|MUFA|mufa
5261557|NCT00579904|PUFA|pufa
5261558|NCT00579891|colorectal cancer|colorectal cancer
5261559|NCT00579891|tissue collection|tissue collection
5261560|NCT00579865|Quality of Life|quality of life
5261561|NCT00579852|Lung|lung
5261562|NCT00579839|PreTerm Birth|preterm birth
5261563|NCT00579839|PreTerm Neonate|preterm neonate
5261564|NCT00579839|High risk pregnancy|high risk pregnancy
5261565|NCT00579839|Preterm Baby|preterm baby
5261566|NCT00579839|Premature Baby|premature baby
5261567|NCT00579839|Cord Clamping|cord clamping
5261568|NCT00579839|Milking the cord|milking the cord
5261569|NCT00579813|obesity|obesity
5261570|NCT00579813|inflammation|inflammation
5261571|NCT00579813|diabetes|diabetes
5261572|NCT00579800|Vibrant-DE|vibrant-de
5261573|NCT00579800|IDEAL|ideal
5261574|NCT00579800|MRI|mri
5261575|NCT00579800|Breast|breast
5261576|NCT00579800|07-091|07-091
5261577|NCT00579787|cervical cancer|cervical cancer
5261578|NCT00579787|quality of life assessment|quality of life assessment
5261579|NCT00579787|behavioral|behavioral
5261580|NCT00579774|Aging|aging
5261581|NCT00579774|oxidative stress|oxidative stress
5261582|NCT00579774|glycoxidative stress|glycoxidative stress
5261583|NCT00579774|glycation|glycation
5261584|NCT00579774|inflammation|inflammation
5261585|NCT00579774|nutrition|nutrition
5261586|NCT00579774|low AGE intake|low age intake
5261587|NCT00579774|dietary AGEs|dietary ages
5261588|NCT00579761|Endocarditis|endocarditis
5261589|NCT00579761|neurological deficit|neurological deficit
5261590|NCT00579748|OCT imaging|oct imaging
5261591|NCT00579748|Barrett's esophagus|barrett's esophagus
5261592|NCT00579735|Breast cancer|breast cancer
5261593|NCT00579709|Thymus Transplantation|thymus transplantation
5261594|NCT00579709|DiGeorge Anomaly|digeorge anomaly
5261595|NCT00579709|DiGeorge Syndrome|digeorge syndrome
5261596|NCT00579709|Athymia|athymia
5261597|NCT00579709|Low T cell numbers|low t cell numbers
5261598|NCT00579709|Immunoreconstitution|immunoreconstitution
5261599|NCT00579709|Immunodeficiency|immunodeficiency
5261600|NCT00579709|Complete DiGeorge|complete digeorge
5261601|NCT00579709|Typical DiGeorge|typical digeorge
5261602|NCT00579709|Atypical DiGeorge|atypical digeorge
5261603|NCT00579709|Complete DiGeorge Anomaly|complete digeorge anomaly
5261604|NCT00579696|Multiple Diseases|multiple diseases
5261605|NCT00579696|Queens|queens
5261606|NCT00579683|non-small cell lung cancer|non-small cell lung cancer
5261607|NCT00579683|NSCLC|nsclc
5261608|NCT00579683|metastatic disease|metastatic disease
5261609|NCT00579683|resistent disease|resistent disease
5261610|NCT00579683|RNA analysis|rna analysis
5261611|NCT00579683|04-103|04-103
5261612|NCT00579670|Ziprasidone in patients with schizophrenia|ziprasidone in patients with schizophrenia
5261613|NCT00579657|parameters of metabolic syndrome|parameters of metabolic syndrome
5261614|NCT00579631|survivors|survivors
5261615|NCT00579631|adolescent|adolescent
5261616|NCT00579631|pediatric|pediatric
5261617|NCT00579618|non-cancer affected volunteers|non-cancer affected volunteers
5261618|NCT00579618|aged 60 years or older|aged 60 years or older
5261619|NCT00579605|Breastfeeding|breastfeeding
5261620|NCT00579605|Self-efficacy|self-efficacy
5261621|NCT00579605|Motivational Interviewing|motivational interviewing
5261622|NCT00579579|Bowel function|bowel function
5261623|NCT00579579|Bladder function|bladder function
5261624|NCT00579579|Sexual function|sexual function
5261625|NCT00579579|Quality of life|quality of life
5261626|NCT00579566|Biochemical Determinants|biochemical determinants
5261627|NCT00579566|Molecular Determinants|molecular determinants
5261628|NCT00579553|Pre Term|pre term
5261629|NCT00579553|Pre Term Birth|pre term birth
5261630|NCT00579553|Premature Birth|premature birth
5261631|NCT00579553|Premature baby|premature baby
5261632|NCT00579553|High risk pregnancy|high risk pregnancy
5261633|NCT00579553|Progesterone|progesterone
5261634|NCT00579553|IM Progesterone|im progesterone
5261635|NCT00579553|Vaginal Progesterone|vaginal progesterone
5261636|NCT00579527|DiGeorge Anomaly|digeorge anomaly
5261637|NCT00579527|Thymus Transplantation|thymus transplantation
5261638|NCT00579527|DiGeorge Syndrome|digeorge syndrome
5261639|NCT00579527|Athymia|athymia
5261640|NCT00579527|Parathyroid Transplantation|parathyroid transplantation
5261641|NCT00579527|Hypocalcemia|hypocalcemia
5261642|NCT00579527|Hypoparathyroidism|hypoparathyroidism
5261643|NCT00579527|Low T cell numbers|low t cell numbers
5261644|NCT00579527|Immunoreconstitution|immunoreconstitution
5261645|NCT00579527|Immunodeficiency|immunodeficiency
5261646|NCT00579527|Complete DiGeorge Anomaly|complete digeorge anomaly
5261647|NCT00579527|Complete Atypical DiGeorge Anomaly|complete atypical digeorge anomaly
5261648|NCT00579527|Complete DiGeorge Syndrome|complete digeorge syndrome
5261649|NCT00579527|Complete Atypical DiGeorge Syndrome|complete atypical digeorge syndrome
5261650|NCT00579501|Myxoid|myxoid
5261651|NCT00579501|Liposarcoma|liposarcoma
5261652|NCT00579501|Trabectedin|trabectedin
5261653|NCT00579501|Dexamethasone|dexamethasone
5261654|NCT00579475|mifepristone|mifepristone
5261655|NCT00579475|leiomyomas|leiomyomas
5261656|NCT00579475|breast epithelial cell proliferation|breast epithelial cell proliferation
5261657|NCT00579462|Stage III or IV Lung Cancer|stage iii or iv lung cancer
5261658|NCT00579449|child abuse|child abuse
5261659|NCT00579449|child neglect|child neglect
5261660|NCT00579436|inflammation|inflammation
5261661|NCT00579436|obesity|obesity
5261662|NCT00579436|diabetes|diabetes
5261663|NCT00579423|prostate|prostate
5261664|NCT00579423|cancer|cancer
5261665|NCT00579423|vaccine|vaccine
5261666|NCT00579410|gastric acid|gastric acid
5261667|NCT00579410|esophageal reflux|esophageal reflux
5261668|NCT00579410|peptic ulcer|peptic ulcer
5261669|NCT00579410|heartburn|heartburn
5261670|NCT00579397|Markers of Inflammation|markers of inflammation
5261671|NCT00579397|acute graft versus host disease|acute graft versus host disease
5261672|NCT00579397|predicting aGVHD|predicting agvhd
5261673|NCT00579384|Photosensitive epilepsy|photosensitive epilepsy
5261674|NCT00579384|Reflex epilepsy|reflex epilepsy
5261675|NCT00579384|Epilepsy|epilepsy
5261676|NCT00579384|JNJ-26489112|jnj-26489112
5261677|NCT00579371|islet transplantation|islet transplantation
5261678|NCT00579371|type 1 diabetes mellitus|type 1 diabetes mellitus
5261679|NCT00579371|steroid-free immunosuppression|steroid-free immunosuppression
5261680|NCT00579371|rabbit anti-thymocyte globulin|rabbit anti-thymocyte globulin
5261681|NCT00579358|Congenital heart defects|congenital heart defects
5261682|NCT00579332|PSA|psa
5261683|NCT00579332|biochemical failure|biochemical failure
5261684|NCT00579319|breast cancer|breast cancer
5261685|NCT00579306|hypertension|hypertension
5261686|NCT00579306|stroke|stroke
5261687|NCT00579306|cerebrovascular accident|cerebrovascular accident
5261688|NCT00579293|adult survivor of childhood cancer|adult survivor of childhood cancer
5261689|NCT00579293|computer assisted screening of survivors (CASS)|computer assisted screening of survivors (cass)
5261690|NCT00579280|Randomized|randomized
5261691|NCT00579280|Double-Blind|double-blind
5261692|NCT00579280|Placebo-Controlled|placebo-controlled
5261693|NCT00579280|Quetiapine|quetiapine
5261694|NCT00579280|DivalproexSodiumER|divalproexsodiumer
5261695|NCT00579280|Bipolar|bipolar
5261696|NCT00579280|Anxiety|anxiety
5261697|NCT00579280|Panic|panic
5261698|NCT00579280|GAD|gad
5261699|NCT00579267|MINI-KID|mini-kid
5261700|NCT00579267|structured diagnostic interview|structured diagnostic interview
5261701|NCT00579267|reliability and validity|reliability and validity
5261702|NCT00579267|K-SADS|k-sads
5261703|NCT00579267|Sheehan Disability Scale|sheehan disability scale
5261704|NCT00579254|Efficacy,safety & tolerability of Caduet In Patients With Cardiovascular Risk Factors|efficacy,safety & tolerability of caduet in patients with cardiovascular risk factors
5261705|NCT00579228|Diabetes|diabetes
5261706|NCT00579228|Vascular risk|vascular risk
5261707|NCT00579228|Inflammation|inflammation
5261708|NCT00579215|Cancer|cancer
5261709|NCT00579215|Enhanced Care|enhanced care
5261710|NCT00579215|Decision-Making|decision-making
5261711|NCT00579215|Advance Lung Cancer|advance lung cancer
5261712|NCT00579215|Questionaires|questionaires
5261713|NCT00579215|Stage III Lung Cancer|stage iii lung cancer
5261714|NCT00579215|Stage IV Lung Cancer|stage iv lung cancer
5261715|NCT00579202|Dialyzer|dialyzer
5261716|NCT00579189|ear tubes|ear tubes
5261717|NCT00579189|ear drainage|ear drainage
5261718|NCT00579189|ear infection|ear infection
5261719|NCT00579189|ear drops|ear drops
5261720|NCT00579163|Blood|blood
5261721|NCT00579163|Salvia|salvia
5261722|NCT00579163|Tissue|tissue
5261723|NCT00579150|Birth Defects|birth defects
5261724|NCT00579150|High Risk Pregnancy|high risk pregnancy
5261725|NCT00579150|Type 2 Diabetes|type 2 diabetes
5261726|NCT00579137|Severe Combined Immunodeficiency Disease|severe combined immunodeficiency disease
5261727|NCT00579137|Severe Primary Immunodeficiency Disorder|severe primary immunodeficiency disorder
5261728|NCT00579137|Undefined T cell Deficiency Disorder|undefined t cell deficiency disorder
5261729|NCT00579137|Wiskott-Aldrick Syndrome|wiskott-aldrick syndrome
5261730|NCT00579137|Allogeneic stem cell transplant|allogeneic stem cell transplant
5261731|NCT00579137|Fludarabine|fludarabine
5261732|NCT00579137|monoclonal antibodies|monoclonal antibodies
5261733|NCT00579124|Blood and Marrow Transplant|blood and marrow transplant
5261734|NCT00579124|T cell Depletion|t cell depletion
5261735|NCT00579124|Unrelated|unrelated
5261736|NCT00579124|Related|related
5261737|NCT00579124|Donor|donor
5261738|NCT00579111|Myelodysplastic and Myeloproliferative Disorders|myelodysplastic and myeloproliferative disorders
5261739|NCT00579111|Acute Myelogenous Leukemia|acute myelogenous leukemia
5261740|NCT00579111|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
5261741|NCT00579111|Chronic Myelogenous Leukemia|chronic myelogenous leukemia
5261742|NCT00579111|Multiple Myeloma|multiple myeloma
5261743|NCT00579111|Plasma Cell dyscrasia|plasma cell dyscrasia
5261744|NCT00579111|Lymphoproliferative disorders|lymphoproliferative disorders
5261745|NCT00579111|Hematologic Diseases|hematologic diseases
5261746|NCT00579111|Fludarabine|fludarabine
5261747|NCT00579111|Busulfan|busulfan
5261748|NCT00579111|Campath|campath
5261749|NCT00579111|Alemtuzumab|alemtuzumab
5261750|NCT00579111|allogeneic stem cell transplant|allogeneic stem cell transplant
5261751|NCT00579098|Atrial Fibrillation|atrial fibrillation
5261752|NCT00579098|Arrhythmia|arrhythmia
5261753|NCT00579098|Pulmonary Vein Isolation|pulmonary vein isolation
5261754|NCT00579098|Left atrial catheter ablation|left atrial catheter ablation
5261755|NCT00579098|Inflammation|inflammation
5261756|NCT00579098|Endothelial dysfunction|endothelial dysfunction
5261757|NCT00579072|Prostate|prostate
5261758|NCT00579072|cognitive effects|cognitive effects
5261759|NCT00579072|06-084|06-084
5261760|NCT00579046|Anemia|anemia
5261761|NCT00579046|Chronic obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5261762|NCT00579046|Erythropoietin|erythropoietin
5261763|NCT00579046|6-minute walk test|6-minute walk test
5261764|NCT00579033|somatosensory|somatosensory
5261765|NCT00579033|cortex|cortex
5261766|NCT00579033|neuroimaging|neuroimaging
5261767|NCT00579033|tactile|tactile
5261768|NCT00579033|cortical plasticity|cortical plasticity
5261769|NCT00579033|dystonia|dystonia
5261770|NCT00579020|cornea|cornea
5261771|NCT00579020|inflammation|inflammation
5261772|NCT00579020|blepharitis|blepharitis
5261773|NCT00579020|lid infection|lid infection
5261774|NCT00579007|Prophylactic Mastectomy|prophylactic mastectomy
5261775|NCT00579007|Prophylactic Oophorectomy|prophylactic oophorectomy
5261776|NCT00578994|Unicompartmental Knee|unicompartmental knee
5261777|NCT00578994|Partial Knee|partial knee
5261778|NCT00578994|Knee arthroplasty|knee arthroplasty
5261779|NCT00578981|Osteoporosis, age-related|osteoporosis, age-related
5261780|NCT00578981|Osteoporosis, Postmenopausal|osteoporosis, postmenopausal
5261781|NCT00578981|Bone Loss|bone loss
5261782|NCT00578981|Low Bone Density|low bone density
5261783|NCT00578968|COPD|copd
5261784|NCT00578968|Tiotropium|tiotropium
5261785|NCT00578968|Spiriva|spiriva
5261786|NCT00578955|Blepharoconjunctivitis, Ophthalmology|blepharoconjunctivitis, ophthalmology
5261787|NCT00578942|Allogeneic Stem Cell Transplantation, Campath, HLA-Matched|allogeneic stem cell transplantation, campath, hla-matched
5261788|NCT00578929|allergic rhinitis|allergic rhinitis
5261789|NCT00578929|allergies|allergies
5261790|NCT00578929|seasonal allergies|seasonal allergies
5261791|NCT00578903|Severe Aplastic Anemia|severe aplastic anemia
5261792|NCT00578903|Severe|severe
5261793|NCT00578890|diabetic foot|diabetic foot
5261794|NCT00578890|osteomyelitis|osteomyelitis
5261795|NCT00578877|Contraception|contraception
5261796|NCT00578877|SILCS Diaphragm|silcs diaphragm
5261797|NCT00578877|Contraceptive Gel|contraceptive gel
5261798|NCT00578864|Neuroblastoma|neuroblastoma
5261799|NCT00578864|Etoposide|etoposide
5261800|NCT00578864|Cisplatin|cisplatin
5261801|NCT00578864|Adriamycin|adriamycin
5261802|NCT00578864|Cyclophosphamide|cyclophosphamide
5261803|NCT00578864|Cytoxan|cytoxan
5261804|NCT00578851|Hip Arthroplasty|hip arthroplasty
5261805|NCT00578851|Hip Arthritis|hip arthritis
5261806|NCT00578825|Severe acute respiratory syndrome|severe acute respiratory syndrome
5261807|NCT00578799|ulcerative colitis|ulcerative colitis
5261808|NCT00578773|ear tubes|ear tubes
5261809|NCT00578773|ear infection|ear infection
5261810|NCT00578773|ear drops|ear drops
5261811|NCT00578773|ear tube surgery|ear tube surgery
5261812|NCT00578773|acute otitis media|acute otitis media
5261813|NCT00578760|hearing loss|hearing loss
5261814|NCT00578760|ototoxicity|ototoxicity
5261815|NCT00578760|cisplatin|cisplatin
5261816|NCT00578747|Breast Cancer|breast cancer
5261817|NCT00578747|Breast Neoplasms|breast neoplasms
5261818|NCT00578747|Targeted Radiotherapy|targeted radiotherapy
5261819|NCT00578747|Mastectomy|mastectomy
5261820|NCT00578747|Seroma|seroma
5261821|NCT00578721|Colorectal cancer|colorectal cancer
5261822|NCT00578721|aspirin|aspirin
5261823|NCT00578708|membranous|membranous
5261824|NCT00578708|ventricular|ventricular
5261825|NCT00578708|septal|septal
5261826|NCT00578708|defect|defect
5261827|NCT00578708|VSD|vsd
5261828|NCT00578695|Hyponatremia|hyponatremia
5261829|NCT00578695|Serum Sodium|serum sodium
5261830|NCT00578695|Fluid Overload|fluid overload
5261831|NCT00578695|Heart Failure|heart failure
5261832|NCT00578695|Acute Heart Failure|acute heart failure
5261833|NCT00578695|Vasopressin Antagonist|vasopressin antagonist
5261834|NCT00578669|Smoking Cessation|smoking cessation
5261835|NCT00578669|Tobacco Use Cessation|tobacco use cessation
5261836|NCT00578669|Antidepressants|antidepressants
5261837|NCT00578656|Food Allergy|food allergy
5261838|NCT00578656|Milk Allergy|milk allergy
5261839|NCT00578643|Stem Cell Transplant|stem cell transplant
5261840|NCT00578643|Chronic Granulomatous Disease|chronic granulomatous disease
5261841|NCT00578643|Fludarabine|fludarabine
5261842|NCT00578643|Busulfan|busulfan
5261843|NCT00578643|Cyclophosphamide|cyclophosphamide
5261844|NCT00578630|pediatric tumors|pediatric tumors
5261845|NCT00578630|genetic test development|genetic test development
5261846|NCT00578630|All Pediatric patients with a histologically proven tumor.|all pediatric patients with a histologically proven tumor.
5261847|NCT00578617|Atrial fibrillation|atrial fibrillation
5261848|NCT00578617|Left Atrial Ablation|left atrial ablation
5261849|NCT00578617|Pulmonary Vein Isolation|pulmonary vein isolation
5261850|NCT00578617|Catheter Ablation|catheter ablation
5261851|NCT00578617|Antiarrhythmic Drug Therapy|antiarrhythmic drug therapy
5261852|NCT00578591|Graft Versus Host Disease|graft versus host disease
5261853|NCT00578591|GVHD|gvhd
5261854|NCT00578591|allogeneic hematopoietic transplant|allogeneic hematopoietic transplant
5261855|NCT00578591|AHT|aht
5261856|NCT00578591|posttransplant|posttransplant
5261857|NCT00578591|Rituximab|rituximab
5261858|NCT00578578|Omega3 fatty acids|omega3 fatty acids
5261859|NCT00578578|hsCRP|hscrp
5261860|NCT00578578|CAD|cad
5261861|NCT00578565|Rheumatoid Arthritis|rheumatoid arthritis
5261862|NCT00578565|Interstitial Pneumonia|interstitial pneumonia
5261863|NCT00578565|Rheumatology|rheumatology
5261864|NCT00578565|Rituximab|rituximab
5261865|NCT00578552|tobacco|tobacco
5261866|NCT00578552|smoking|smoking
5261867|NCT00578552|gabapentin|gabapentin
5261868|NCT00578552|abstinence|abstinence
5261869|NCT00578539|Stem Cell Transplantation|stem cell transplantation
5261870|NCT00578526|urothelial cancer|urothelial cancer
5261871|NCT00578526|targeted therapy|targeted therapy
5261872|NCT00578526|antiangiogenesis therapy|antiangiogenesis therapy
5261873|NCT00578526|SU011248|su011248
5261874|NCT00578526|clinical trial|clinical trial
5261875|NCT00578500|chemotherapy, female, fertility preservation, gonadotoxicity|chemotherapy, female, fertility preservation, gonadotoxicity
5261876|NCT00578500|oophorectomy, in vitro maturation, ovarian cryopreservation,|oophorectomy, in vitro maturation, ovarian cryopreservation,
5261877|NCT00578500|oocyte cryopreservation, ovarian transplantation|oocyte cryopreservation, ovarian transplantation
5261878|NCT00578474|Acute otitis media|acute otitis media
5261879|NCT00578474|Tympanostomy tubes|tympanostomy tubes
5261880|NCT00578461|Stem Cell Transplant|stem cell transplant
5261881|NCT00578461|myeloproliferative disease|myeloproliferative disease
5261882|NCT00578461|myelodsyplastic disease|myelodsyplastic disease
5261883|NCT00578461|Leukemia|leukemia
5261884|NCT00578461|Cancer|cancer
5261885|NCT00578461|Lymphoma|lymphoma
5261886|NCT00578461|Lymphoma, Hodgkin|lymphoma, hodgkin
5261887|NCT00578461|Lymphoma, non-Hodgkin|lymphoma, non-hodgkin
5261888|NCT00578435|ERYTHROPOIESIS|erythropoiesis
5261889|NCT00578435|Genetic Disorders|genetic disorders
5261890|NCT00578435|Sickle Cell Anemia|sickle cell anemia
5261891|NCT00578435|Thalassemia|thalassemia
5261892|NCT00578435|Diamond Blackfan Anemia|diamond blackfan anemia
5261893|NCT00578422|PAD|pad
5261894|NCT00578422|Peripheral Artery Disease|peripheral artery disease
5261895|NCT00578422|IVUS|ivus
5261896|NCT00578422|Plaque|plaque
5261897|NCT00578409|castration resistant prostate cancer|castration resistant prostate cancer
5261898|NCT00578409|progressive castrate metastatic prostate cancer|progressive castrate metastatic prostate cancer
5261899|NCT00578396|Grapes and colon cancer prevention|grapes and colon cancer prevention
5261900|NCT00578383|Depression|depression
5261901|NCT00578383|Major depression|major depression
5261902|NCT00578383|Bipolar Disorder|bipolar disorder
5261903|NCT00578383|Bipolar depression|bipolar depression
5261904|NCT00578383|LFMS|lfms
5261905|NCT00578383|low field magnetic stimulation|low field magnetic stimulation
5261906|NCT00578383|mood disorders|mood disorders
5261907|NCT00578383|affective disorders|affective disorders
5261908|NCT00578370|Ciclosporin|ciclosporin
5261909|NCT00578370|Plaque type psoriasis|plaque type psoriasis
5261910|NCT00578370|Psoriasis plaque test|psoriasis plaque test
5261911|NCT00578370|Sonography|sonography
5261912|NCT00578370|Cyclosporin|cyclosporin
5261913|NCT00578370|Psoriasis|psoriasis
5261914|NCT00578357|problem gambling|problem gambling
5261915|NCT00578357|personalized feedback|personalized feedback
5261916|NCT00578357|gambling addiction|gambling addiction
5261917|NCT00578344|Sickle Cell Disease|sickle cell disease
5261918|NCT00578344|SCD|scd
5261919|NCT00578344|Hemoglobin SS|hemoglobin ss
5261920|NCT00578344|Hemoglobin SC|hemoglobin sc
5261921|NCT00578344|Hemoglobin Sb0/+|hemoglobin sb0/+
5261922|NCT00578344|HLA genotype|hla genotype
5261923|NCT00578344|Severe anemia|severe anemia
5261924|NCT00578344|Transfusion therapy|transfusion therapy
5261925|NCT00578331|rhinitis|rhinitis
5261926|NCT00578331|perennial allergic rhinitis|perennial allergic rhinitis
5261927|NCT00578331|allergic rhinitis|allergic rhinitis
5261928|NCT00578292|transfusion-dependent|transfusion-dependent
5262344|NCT00576823|neuropathic|neuropathic
5261929|NCT00578292|homozygous b0/+-thalassemia|homozygous b0/+-thalassemia
5261930|NCT00578292|severe variants of b0/+-thalassemia|severe variants of b0/+-thalassemia
5261931|NCT00578292|chronic transfusion therapy|chronic transfusion therapy
5261932|NCT00578292|iron chelating agents|iron chelating agents
5261933|NCT00578292|severe|severe
5261934|NCT00578292|transfusion-dependent homozygous b0/+-thalassemia or severe variants of b0/+-thalassemia|transfusion-dependent homozygous b0/+-thalassemia or severe variants of b0/+-thalassemia
5261935|NCT00578266|Severe Aplastic Anemia (SAA)|severe aplastic anemia (saa)
5261936|NCT00578266|Transplant for Severe Aplastic Anemia (SAA)|transplant for severe aplastic anemia (saa)
5261937|NCT00578240|benign|benign
5261938|NCT00578240|Rising PSA|rising psa
5261939|NCT00578240|Clinical Metastases|clinical metastases
5261940|NCT00578240|90-040|90-040
5261941|NCT00578227|Human papillomavirus infection,|human papillomavirus infection,
5261942|NCT00578227|cervical cancer|cervical cancer
5261943|NCT00578227|HPV vaccine,|hpv vaccine,
5261944|NCT00578214|mohs micrographic surgery|mohs micrographic surgery
5261945|NCT00578214|skin cancer|skin cancer
5261946|NCT00578214|anxiety|anxiety
5261947|NCT00578214|basal cell carcinoma|basal cell carcinoma
5261948|NCT00578214|squamous cell carcinoma|squamous cell carcinoma
5261949|NCT00578214|midazolam|midazolam
5261950|NCT00578214|versed|versed
5261951|NCT00578201|Esophageal neoplasms|esophageal neoplasms
5261952|NCT00578201|Cetuximab|cetuximab
5261953|NCT00578201|Oxaliplatin|oxaliplatin
5261954|NCT00578201|Fluorouracil|fluorouracil
5261955|NCT00578201|radiotherapy|radiotherapy
5261956|NCT00578188|Adolescent Health|adolescent health
5261957|NCT00578188|Sexually transmitted infection|sexually transmitted infection
5261958|NCT00578188|Women's Health|women's health
5261959|NCT00578175|Vaccines|vaccines
5261960|NCT00578175|Rubella|rubella
5261961|NCT00578175|Varicella Vaccine|varicella vaccine
5261962|NCT00578175|Children|children
5261963|NCT00578175|Humans|humans
5261964|NCT00578175|Mumps|mumps
5261965|NCT00578175|Immunogenicity|immunogenicity
5261966|NCT00578175|Safety|safety
5261967|NCT00578175|Measles|measles
5261968|NCT00578175|Combined Vaccine|combined vaccine
5261969|NCT00578162|Cancer|cancer
5261970|NCT00578162|Survivors|survivors
5261971|NCT00578149|chemoradiotherapy|chemoradiotherapy
5261972|NCT00578149|Lung cancer|lung cancer
5261973|NCT00578136|Rectus Sheath|rectus sheath
5261974|NCT00578136|Local infiltration|local infiltration
5261975|NCT00578136|Pain Control|pain control
5261976|NCT00578123|Prostate|prostate
5261977|NCT00578123|Cancer|cancer
5261978|NCT00578123|Quality of Life|quality of life
5261979|NCT00578123|Questionaires|questionaires
5261980|NCT00578123|04-094|04-094
5261981|NCT00578110|glaucoma VEP detection device diagnosis vision|glaucoma vep detection device diagnosis vision
5261982|NCT00578071|esophageal cancer|esophageal cancer
5261983|NCT00578032|head|head
5261984|NCT00578032|neck|neck
5261985|NCT00578032|cancer|cancer
5261986|NCT00578032|reconstruction|reconstruction
5261987|NCT00578032|quality of life|quality of life
5261988|NCT00578032|07-150|07-150
5261989|NCT00578019|Comparative|comparative
5261990|NCT00578019|Supracondylar Femur Fracture|supracondylar femur fracture
5261991|NCT00578019|Intramedullary nailing|intramedullary nailing
5261992|NCT00578019|Less Invasive Stabilization System (LISS) Plating|less invasive stabilization system (liss) plating
5261993|NCT00578006|toxicity related symptoms|toxicity related symptoms
5261994|NCT00578006|04-020|04-020
5261995|NCT00577993|Lymphoma|lymphoma
5261996|NCT00577993|Follicular Lymphoma|follicular lymphoma
5261997|NCT00577993|Indolent Lymphoma|indolent lymphoma
5261998|NCT00577993|Fludarabine|fludarabine
5261999|NCT00577993|Novantrone|novantrone
5262000|NCT00577993|Mitoxantrone|mitoxantrone
5262001|NCT00577993|Decadron|decadron
5262002|NCT00577993|Dexamethasone|dexamethasone
5262003|NCT00577993|Rituximab|rituximab
5262004|NCT00577993|Anti-CD20|anti-cd20
5262005|NCT00577993|IDEC-C2B8|idec-c2b8
5262006|NCT00577993|Chimeric Anti-CD20 Antibody|chimeric anti-cd20 antibody
5262007|NCT00577993|Interferon|interferon
5262008|NCT00577993|Interferon Alpha-2b|interferon alpha-2b
5262009|NCT00577993|IFN|ifn
5262010|NCT00577993|Doxorubicin|doxorubicin
5262011|NCT00577993|Vincristine|vincristine
5262012|NCT00577993|Bleomycin|bleomycin
5262013|NCT00577993|Cyclophosphamide|cyclophosphamide
5262014|NCT00577993|Etoposide|etoposide
5262015|NCT00577993|Cisplatin|cisplatin
5262016|NCT00577993|Ara-C|ara-c
5262017|NCT00577993|Methyl-Prednisolone|methyl-prednisolone
5262018|NCT00577993|Procarbazine|procarbazine
5262019|NCT00577993|Prednisone|prednisone
5262020|NCT00577993|FND|fnd
5262021|NCT00577980|Prostate Cancer|prostate cancer
5262022|NCT00577980|Castration-Resistant Prostate Cancer|castration-resistant prostate cancer
5262023|NCT00577980|Testosterone Replacement Therapy|testosterone replacement therapy
5262024|NCT00577980|Testosterone|testosterone
5262025|NCT00577980|CRPC|crpc
5262026|NCT00577980|TRT|trt
5262027|NCT00577967|Uremic pruritis|uremic pruritis
5262028|NCT00577954|Coma|coma
5262029|NCT00577954|TBI|tbi
5262030|NCT00577954|Stroke|stroke
5262031|NCT00577954|SAH|sah
5262032|NCT00577954|Cerebral Anoxia|cerebral anoxia
5262033|NCT00577954|Multimodal MRI|multimodal mri
5262034|NCT00577915|Breast cancer|breast cancer
5262035|NCT00577915|MRI spectroscopy|mri spectroscopy
5262036|NCT00577915|Diagnostic radiology|diagnostic radiology
5262037|NCT00577902|head and neck cancer|head and neck cancer
5262038|NCT00577824|diabetes|diabetes
5262039|NCT00577824|exenatide|exenatide
5262040|NCT00577824|LY2148568|ly2148568
5262041|NCT00577824|Byetta|byetta
5262042|NCT00577824|Lilly|lilly
5262043|NCT00577824|Amylin|amylin
5262044|NCT00577811|Special Need Plans|special need plans
5262045|NCT00577811|Fee for Services|fee for services
5262046|NCT00577811|Access to Care|access to care
5262047|NCT00577811|Medicaid|medicaid
5262048|NCT00577798|chemotherapeutic agent toxicity|chemotherapeutic agent toxicity
5262049|NCT00577798|cardiac toxicity|cardiac toxicity
5262050|NCT00577798|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
5262051|NCT00577798|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
5262052|NCT00577798|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5262053|NCT00577798|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5262054|NCT00577798|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
5262055|NCT00577798|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
5262056|NCT00577798|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
5262057|NCT00577798|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
5262058|NCT00577798|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5262059|NCT00577798|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
5262060|NCT00577798|cutaneous B-cell non-Hodgkin lymphoma|cutaneous b-cell non-hodgkin lymphoma
5262061|NCT00577798|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
5262062|NCT00577798|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
5262063|NCT00577798|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
5262064|NCT00577798|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
5262065|NCT00577798|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
5262066|NCT00577798|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
5262067|NCT00577798|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
5262068|NCT00577798|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
5262069|NCT00577798|adult grade III lymphomatoid granulomatosis|adult grade iii lymphomatoid granulomatosis
5262070|NCT00577798|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
5262071|NCT00577798|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
5262072|NCT00577798|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
5262073|NCT00577798|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
5262074|NCT00577798|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
5262075|NCT00577798|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5262076|NCT00577798|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5262177|NCT00577525|LATENT VIRAL INFECTION|latent viral infection
5262077|NCT00577798|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
5262078|NCT00577798|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5262079|NCT00577798|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
5262080|NCT00577798|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5262081|NCT00577798|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5262082|NCT00577798|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
5262083|NCT00577798|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
5262084|NCT00577798|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
5262085|NCT00577798|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5262086|NCT00577798|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5262087|NCT00577798|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
5262088|NCT00577798|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
5262089|NCT00577798|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
5262090|NCT00577798|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5262091|NCT00577798|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5262092|NCT00577798|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
5262093|NCT00577798|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
5262094|NCT00577798|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
5262095|NCT00577798|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5262096|NCT00577798|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5262097|NCT00577798|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
5262098|NCT00577798|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
5262178|NCT00577525|GENOME HYBRIDIZATION|genome hybridization
5262099|NCT00577798|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
5262100|NCT00577798|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5262101|NCT00577798|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5262102|NCT00577798|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
5262103|NCT00577798|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5262104|NCT00577798|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
5262105|NCT00577798|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5262106|NCT00577798|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5262107|NCT00577798|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
5262108|NCT00577798|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5262109|NCT00577798|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
5262110|NCT00577798|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5262111|NCT00577798|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5262112|NCT00577798|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
5262113|NCT00577798|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5262114|NCT00577798|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
5262115|NCT00577798|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5262116|NCT00577798|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5262117|NCT00577798|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
5262118|NCT00577798|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5262119|NCT00577798|stage I mantle cell lymphoma|stage i mantle cell lymphoma
5262120|NCT00577798|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5262121|NCT00577798|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5262122|NCT00577798|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5262123|NCT00577798|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5262124|NCT00577798|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5262125|NCT00577798|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
5262126|NCT00577798|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
5262127|NCT00577798|stage I marginal zone lymphoma|stage i marginal zone lymphoma
5262128|NCT00577798|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5262129|NCT00577798|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5262130|NCT00577798|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
5262131|NCT00577798|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
5262132|NCT00577798|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
5262133|NCT00577798|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5262134|NCT00577798|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5262135|NCT00577785|cystectomy|cystectomy
5262136|NCT00577772|SmartPill Capsule|smartpill capsule
5262137|NCT00577772|Digestive System Diseases|digestive system diseases
5262138|NCT00577772|Small Bowel Bacterial Overgrowth|small bowel bacterial overgrowth
5262139|NCT00577772|Gastrointestinal Device|gastrointestinal device
5262140|NCT00577772|Oro-cecal|oro-cecal
5262141|NCT00577759|Quality assurance, health care|quality assurance, health care
5262142|NCT00577759|primary health care|primary health care
5262143|NCT00577759|community health services|community health services
5262144|NCT00577759|referral and consultation|referral and consultation
5262145|NCT00577759|exercise|exercise
5262146|NCT00577759|diet|diet
5262147|NCT00577759|tobacco|tobacco
5262148|NCT00577746|Non Small Cell Lung|non small cell lung
5262149|NCT00577733|Pulmonary function test|pulmonary function test
5262150|NCT00577733|Methacholine challenge|methacholine challenge
5262151|NCT00577733|Breathing variability|breathing variability
5262152|NCT00577733|Polygraphy|polygraphy
5262153|NCT00577707|Lung Cancer|lung cancer
5262154|NCT00577707|Erlotinib|erlotinib
5262155|NCT00577707|clinical stage IB-IIIA|clinical stage ib-iiia
5262156|NCT00577694|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5262157|NCT00577681|HIV|hiv
5262158|NCT00577681|Lipoproteins|lipoproteins
5262159|NCT00577681|Inflammatory Markers|inflammatory markers
5262160|NCT00577681|Coagulation Markers|coagulation markers
5262161|NCT00577681|Treatment Experienced|treatment experienced
5262162|NCT00577655|Pediatric, asthma, albuterol-HFA and Placebo|pediatric, asthma, albuterol-hfa and placebo
5262163|NCT00577642|aminobisphosphonates|aminobisphosphonates
5262164|NCT00577629|high risk non-hodgkins lymphoma|high risk non-hodgkins lymphoma
5262165|NCT00577629|NHL|nhl
5262166|NCT00577629|Bexxar|bexxar
5262167|NCT00577629|high dose chemotherapy|high dose chemotherapy
5262168|NCT00577616|Endovascular repair|endovascular repair
5262169|NCT00577616|Ruptured aorta-iliac aneurysms|ruptured aorta-iliac aneurysms
5262170|NCT00577616|Mortality at 30 days|mortality at 30 days
5262171|NCT00577603|stoma, hernia, mesh|stoma, hernia, mesh
5262172|NCT00577590|Type II Diabetes Mellitus|type ii diabetes mellitus
5262173|NCT00577590|Diabetes|diabetes
5262174|NCT00577590|PET|pet
5262175|NCT00577590|Heart Metabolism|heart metabolism
5262176|NCT00577590|Lovaza|lovaza
5262179|NCT00577525|HERPES VIRUS|herpes virus
5262180|NCT00577525|ADENOVIRUS|adenovirus
5262181|NCT00577499|cystic fibrosis|cystic fibrosis
5262182|NCT00577499|constipation|constipation
5262183|NCT00577499|lubiprostone|lubiprostone
5262184|NCT00577499|nutrition|nutrition
5262185|NCT00577499|pulmonary function|pulmonary function
5262186|NCT00577447|autism|autism
5262187|NCT00577447|omega-3 fatty acids|omega-3 fatty acids
5262188|NCT00577447|docosahexaenoic acid|docosahexaenoic acid
5262189|NCT00577434|Procedural sedation|procedural sedation
5262190|NCT00577434|Sedation for diagnostic imaging|sedation for diagnostic imaging
5262191|NCT00577408|Opiate Dependence|opiate dependence
5262192|NCT00577408|Heroin Dependence|heroin dependence
5262193|NCT00577408|Naltrexone|naltrexone
5262194|NCT00577382|Sutent|sutent
5262195|NCT00577382|malignant melanoma|malignant melanoma
5262196|NCT00577369|arterial line|arterial line
5262197|NCT00577369|end-expiratory desflurane|end-expiratory desflurane
5262198|NCT00577304|Raynaud's|raynaud's
5262199|NCT00577304|Nitroglycerin|nitroglycerin
5262200|NCT00577304|Scleroderma|scleroderma
5262201|NCT00577278|graft versus host disease|graft versus host disease
5262202|NCT00577278|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
5262203|NCT00577278|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
5262204|NCT00577278|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
5262205|NCT00577278|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5262206|NCT00577278|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5262207|NCT00577278|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5262208|NCT00577278|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5262209|NCT00577278|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5262210|NCT00577278|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5262211|NCT00577278|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
5262212|NCT00577278|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
5262213|NCT00577278|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
5262214|NCT00577278|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5262215|NCT00577278|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5262216|NCT00577278|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5262217|NCT00577278|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5262218|NCT00577278|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5262219|NCT00577278|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5262220|NCT00577278|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
5262221|NCT00577278|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5262222|NCT00577278|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5262223|NCT00577278|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
5262224|NCT00577278|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5262225|NCT00577278|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5262226|NCT00577278|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
5262227|NCT00577278|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
5262228|NCT00577278|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5262229|NCT00577278|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5262230|NCT00577278|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
5262231|NCT00577278|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5262232|NCT00577278|stage I marginal zone lymphoma|stage i marginal zone lymphoma
5262233|NCT00577278|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5262234|NCT00577278|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5262235|NCT00577278|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
5262236|NCT00577278|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5262237|NCT00577278|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
5262238|NCT00577278|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
5262239|NCT00577278|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5262240|NCT00577278|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5262241|NCT00577278|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
5262242|NCT00577278|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5262243|NCT00577278|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5262244|NCT00577278|stage I mantle cell lymphoma|stage i mantle cell lymphoma
5262245|NCT00577278|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5262246|NCT00577278|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5262247|NCT00577278|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
5262248|NCT00577278|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
5262249|NCT00577278|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5262250|NCT00577278|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
5262251|NCT00577278|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5262252|NCT00577278|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5262253|NCT00577278|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
5262254|NCT00577278|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
5262255|NCT00577278|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5262256|NCT00577278|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
5262257|NCT00577278|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5262258|NCT00577278|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5262259|NCT00577265|Asthma Control|asthma control
5262260|NCT00577252|Cystic fibrosis|cystic fibrosis
5262261|NCT00577252|Adolescents|adolescents
5262262|NCT00577252|Coping Compliance|coping compliance
5262263|NCT00577252|Adjustment|adjustment
5262264|NCT00577226|scoliosis, immature spine|scoliosis, immature spine
5262265|NCT00577213|Diagnosis|diagnosis
5262266|NCT00577213|Hemangiomas|hemangiomas
5262267|NCT00577213|Vascular Malformations|vascular malformations
5262268|NCT00577213|Venular Malformations|venular malformations
5262269|NCT00577213|Venous Malformations|venous malformations
5262270|NCT00577213|Lymphatic Malformations|lymphatic malformations
5262271|NCT00577213|Arteriovenous Malformations|arteriovenous malformations
5262272|NCT00577174|Children|children
5262273|NCT00577174|Obesity|obesity
5262274|NCT00577174|Insulin resistance|insulin resistance
5262275|NCT00577174|Diabetes|diabetes
5262276|NCT00577174|Mitochondrial Function|mitochondrial function
5262277|NCT00577161|pixantrone|pixantrone
5262278|NCT00577161|NHL|nhl
5262279|NCT00577161|rituximab|rituximab
5262280|NCT00577161|fludarabine|fludarabine
5262281|NCT00577148|NASH|nash
5262282|NCT00577148|chronic liver disease|chronic liver disease
5262283|NCT00577135|Loop Diuretics|loop diuretics
5262284|NCT00577135|Furosemide|furosemide
5262285|NCT00577135|Fluid Overload|fluid overload
5262286|NCT00577135|Cardio Renal Failure|cardio renal failure
5262287|NCT00577122|Medroxyprogesterone progesterone acetate (MPA)|medroxyprogesterone progesterone acetate (mpa)
5262288|NCT00577122|Cyclophosphamide plus Methotrexate|cyclophosphamide plus methotrexate
5262289|NCT00577096|multiple myeloma|multiple myeloma
5262290|NCT00577096|polysomnography|polysomnography
5262291|NCT00577096|quality of life|quality of life
5262292|NCT00577096|exercise|exercise
5262293|NCT00577083|miss rates|miss rates
5262294|NCT00577057|Nasopharyngeal Carcinoma|nasopharyngeal carcinoma
5262295|NCT00577057|Stage III - IVB|stage iii - ivb
5262296|NCT00577044|NAFLD|nafld
5262297|NCT00577005|GABAergic|gabaergic
5262298|NCT00577005|levetiracetam|levetiracetam
5262299|NCT00576992|Barrett's Esophagus|barrett's esophagus
5262300|NCT00576992|Demographics|demographics
5262301|NCT00576992|Questionnaire|questionnaire
5262302|NCT00576992|Heartburn|heartburn
5262303|NCT00576979|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5262304|NCT00576979|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5262305|NCT00576940|enteral nutrition, immunomodulating nutrition|enteral nutrition, immunomodulating nutrition
5262306|NCT00576927|Sleep hygiene|sleep hygiene
5262307|NCT00576927|Sleep latency|sleep latency
5262308|NCT00576927|Elderly sleep|elderly sleep
5262309|NCT00576927|Nursing Home sleep|nursing home sleep
5262310|NCT00576914|adjuvant therapy|adjuvant therapy
5262311|NCT00576914|non-small cell lung cancer|non-small cell lung cancer
5262312|NCT00576914|vinorelbine|vinorelbine
5262313|NCT00576914|cisplatin|cisplatin
5262314|NCT00576914|recombinant human endostatin(endostar)|recombinant human endostatin(endostar)
5262315|NCT00576888|Multifocal lymphangioendoltheliomatosis with thrombocytopenia|multifocal lymphangioendoltheliomatosis with thrombocytopenia
5262316|NCT00576888|Cutaneovisceral angiomatosis with thrombocytopenia|cutaneovisceral angiomatosis with thrombocytopenia
5262317|NCT00576888|Thrombocytopenia|thrombocytopenia
5262318|NCT00576888|Hemangiomas|hemangiomas
5262319|NCT00576888|Hemangiomatosis|hemangiomatosis
5262320|NCT00576888|Lymphatic malformation|lymphatic malformation
5262321|NCT00576888|Kasabach-Merritt|kasabach-merritt
5262322|NCT00576888|Blue-rubber bleb nevus|blue-rubber bleb nevus
5262323|NCT00576888|Angiomatosis|angiomatosis
5262324|NCT00576875|Depression|depression
5262325|NCT00576875|Elderly|elderly
5262326|NCT00576875|Neuroimaging|neuroimaging
5262327|NCT00576875|Postmortem|postmortem
5262328|NCT00576875|Knockout mouse|knockout mouse
5262329|NCT00576836|Thymus Transplantation|thymus transplantation
5262330|NCT00576836|DiGeorge Syndrome|digeorge syndrome
5262331|NCT00576836|DiGeorge Anomaly|digeorge anomaly
5262332|NCT00576836|Athymia|athymia
5262333|NCT00576836|Parathyroid Transplantation|parathyroid transplantation
5262334|NCT00576836|Hypocalcemia|hypocalcemia
5262335|NCT00576836|Hypoparathyroidism|hypoparathyroidism
5262336|NCT00576836|Low T cell numbers|low t cell numbers
5262337|NCT00576836|Immunoreconstitution|immunoreconstitution
5262338|NCT00576836|Immunodeficiency|immunodeficiency
5262339|NCT00576836|Complete DiGeorge|complete digeorge
5262340|NCT00576836|Complete DiGeorge Anomaly|complete digeorge anomaly
5262341|NCT00576836|Typical DiGeorge|typical digeorge
5262342|NCT00576823|child|child
5262343|NCT00576823|bladder|bladder
5262345|NCT00576823|alpha blockers|alpha blockers
5262346|NCT00576797|vaginal|vaginal
5262347|NCT00576797|bacteria|bacteria
5262348|NCT00576797|microflora|microflora
5262349|NCT00576797|bacterial DNA|bacterial dna
5262350|NCT00576797|To determine the normal bacteria in the vagina|to determine the normal bacteria in the vagina
5262351|NCT00576784|type 2 diabetes|type 2 diabetes
5262352|NCT00576784|insulin treatment|insulin treatment
5262353|NCT00576784|ß-cell function|ß-cell function
5262354|NCT00576745|Sutures|sutures
5262355|NCT00576732|Irritability|irritability
5262356|NCT00576732|Risperidone|risperidone
5262357|NCT00576732|Antipsychotic agent|antipsychotic agent
5262358|NCT00576732|Autism|autism
5262359|NCT00576732|Adolescents|adolescents
5262360|NCT00576732|Children|children
5262361|NCT00576706|Patients with rheumatoid arthritis, osteoarthritis, and ankylosing spondylitis or any other arthritis-like disease requiring continuous NSAIDs therapy|patients with rheumatoid arthritis, osteoarthritis, and ankylosing spondylitis or any other arthritis-like disease requiring continuous nsaids therapy
5262362|NCT00576693|ischemic stroke|ischemic stroke
5262363|NCT00576693|intracranial stenting|intracranial stenting
5262364|NCT00576693|vascular risk factor management|vascular risk factor management
5262365|NCT00576680|RAD001|rad001
5262366|NCT00576680|temozolomide|temozolomide
5262367|NCT00576667|NASH|nash
5262368|NCT00576667|chronic liver disease|chronic liver disease
5262369|NCT00576615|healthy volunteers|healthy volunteers
5262370|NCT00576615|amnesic effects|amnesic effects
5262371|NCT00576589|Safety in patients with Asymptomatic cholelithiasis/gallstones.|safety in patients with asymptomatic cholelithiasis/gallstones.
5262372|NCT00576576|Atherosclerosis, vulnerable plaque, IVUS, shear stress|atherosclerosis, vulnerable plaque, ivus, shear stress
5262373|NCT00576563|rectal cancer|rectal cancer
5262374|NCT00576563|blood proteins|blood proteins
5262375|NCT00576563|irradiation|irradiation
5262376|NCT00576563|FDG-PET-CT|fdg-pet-ct
5262377|NCT00576550|Hand eczema|hand eczema
5262378|NCT00576550|Prevention|prevention
5262379|NCT00576537|New/Recurrent Glioblastoma|new/recurrent glioblastoma
5262380|NCT00576524|Hypotension during dialysis|hypotension during dialysis
5262381|NCT00576524|End Stage Renal Disease|end stage renal disease
5262382|NCT00576524|Decrease complications during dialysis|decrease complications during dialysis
5262383|NCT00576524|Low Blood Pressure|low blood pressure
5262384|NCT00576511|Constipation|constipation
5262385|NCT00576511|Prucalopride|prucalopride
5262386|NCT00576511|Colonic Transit Time|colonic transit time
5262387|NCT00576498|GERD|gerd
5262388|NCT00576498|NBI|nbi
5262389|NCT00576498|AFI|afi
5262390|NCT00576498|IM|im
5262391|NCT00576498|SSBE|ssbe
5262392|NCT00576498|LSBE|lsbe
5262393|NCT00576498|LGD|lgd
5262394|NCT00576498|HGD|hgd
5262395|NCT00576485|Cataract|cataract
5262396|NCT00576485|Intraocular lens|intraocular lens
5262397|NCT00576485|Spherical aberration|spherical aberration
5262398|NCT00576485|Contrast sensitivity|contrast sensitivity
5262399|NCT00576472|Brain Tumor, Acute Lymphoblastic Leukemia, Methylphenidate, Cognitive Late Effects|brain tumor, acute lymphoblastic leukemia, methylphenidate, cognitive late effects
5262400|NCT00576407|Thymus Transplantation|thymus transplantation
5262401|NCT00576407|DiGeorge Syndrome|digeorge syndrome
5262402|NCT00576407|Athymia|athymia
5262403|NCT00576407|Low T cell numbers|low t cell numbers
5262404|NCT00576407|Immunoreconstitution|immunoreconstitution
5262405|NCT00576407|Primary immunodeficiency|primary immunodeficiency
5262406|NCT00576407|DiGeorge Anomaly|digeorge anomaly
5262407|NCT00576407|Complete DiGeorge|complete digeorge
5262408|NCT00576407|Typical DiGeorge|typical digeorge
5262409|NCT00576394|Glucose, Insulin|glucose, insulin
5262410|NCT00576381|Precedex|precedex
5262411|NCT00576381|Open Heart Surgery|open heart surgery
5262412|NCT00576381|Dexmedetomidine|dexmedetomidine
5262413|NCT00576381|Sedation|sedation
5262414|NCT00576355|Adolescent|adolescent
5262415|NCT00576355|Psychopathology|psychopathology
5262416|NCT00576355|Interpersonal Therapy|interpersonal therapy
5262417|NCT00576355|Interpersonal and Social Rhythm Therapy|interpersonal and social rhythm therapy
5262418|NCT00576329|vitreoretinal surgery, ketorolac, Acular, mydriasis|vitreoretinal surgery, ketorolac, acular, mydriasis
5262419|NCT00576316|Asthma|asthma
5262420|NCT00576264|open abdominal surgery|open abdominal surgery
5262421|NCT00576264|abdominal laparoscopic surgery|abdominal laparoscopic surgery
5262422|NCT00576264|peritoneal stem cells|peritoneal stem cells
5262423|NCT00576264|patients scheduled for any type of elective intra-abdominal surgery at Cedars-Sinai Medical Center with designated surgeons|patients scheduled for any type of elective intra-abdominal surgery at cedars-sinai medical center with designated surgeons
5262424|NCT00576251|Ocular inflammation|ocular inflammation
5262425|NCT00576251|blepharaconjunctivitis|blepharaconjunctivitis
5262426|NCT00576238|Atopic eczema|atopic eczema
5262427|NCT00576238|Topical corticosteroid|topical corticosteroid
5262428|NCT00576225|NSCLC|nsclc
5262429|NCT00576225|women|women
5262430|NCT00576225|CT-2103|ct-2103
5262431|NCT00576225|paclitaxel|paclitaxel
5262432|NCT00576225|carboplatin|carboplatin
5262433|NCT00576212|termination fetal anomaly|termination fetal anomaly
5262434|NCT00576212|psychological sequelae pregnancy termination for anomalies|psychological sequelae pregnancy termination for anomalies
5262435|NCT00576212|supportive follow-up pregnancy termination anomalies|supportive follow-up pregnancy termination anomalies
5262436|NCT00576173|Cancer pain|cancer pain
5262437|NCT00576173|Breakthrough pain|breakthrough pain
5262438|NCT00576173|acetaminophen|acetaminophen
5262439|NCT00576173|tramadol hydrochloride|tramadol hydrochloride
5262440|NCT00576173|Ultracet|ultracet
5262441|NCT00576160|medication adherence|medication adherence
5262443|NCT00576147|NIRS|nirs
5262444|NCT00576147|Hematoma|hematoma
5262445|NCT00576134|Larynx, tracheotomy, titanium beads|larynx, tracheotomy, titanium beads
5262446|NCT00576082|Lyme borreliosis|lyme borreliosis
5262447|NCT00576082|Erythema migrans|erythema migrans
5262448|NCT00576082|Borrelial lymphocytoma|borrelial lymphocytoma
5262449|NCT00576082|Acrodermatitis chronica atrophicans|acrodermatitis chronica atrophicans
5262450|NCT00576082|Borrelia burgdorferi|borrelia burgdorferi
5262451|NCT00576082|Borrelia afzelii|borrelia afzelii
5262452|NCT00576082|Borrelia garinii|borrelia garinii
5262453|NCT00576069|asthma|asthma
5262454|NCT00576069|lung function|lung function
5262455|NCT00576069|inflammation|inflammation
5262456|NCT00576056|Hepatocellular|hepatocellular
5262457|NCT00576056|Carcinoma|carcinoma
5262458|NCT00576056|TACE|tace
5262459|NCT00576056|Sorafenib|sorafenib
5262460|NCT00576056|Transcatheter Arterial Chemoembolization|transcatheter arterial chemoembolization
5262461|NCT00576056|Nexavar|nexavar
5262462|NCT00576056|Unresectable|unresectable
5262463|NCT00576043|training|training
5262464|NCT00576043|Patient satisfaction|patient satisfaction
5262465|NCT00576043|endoscopy|endoscopy
5262466|NCT00576043|simulator|simulator
5262467|NCT00576043|Safety|safety
5262468|NCT00576017|Cancer pain treatment|cancer pain treatment
5262469|NCT00576017|Fentanyl TTS|fentanyl tts
5262470|NCT00576017|Dihydrocodeine|dihydrocodeine
5262471|NCT00576017|Tramadol|tramadol
5262472|NCT00576017|Cancer pain|cancer pain
5262473|NCT00576017|Durogesic|durogesic
5262474|NCT00576017|Ultram|ultram
5262475|NCT00576004|Pelvic organ prolapse, Urinary incontinence, Burch colposuspension, surgery|pelvic organ prolapse, urinary incontinence, burch colposuspension, surgery
5262476|NCT00575991|conjugated linoleic acid, body fat, children, overweight|conjugated linoleic acid, body fat, children, overweight
5262477|NCT00575978|breast cancer|breast cancer
5262478|NCT00575965|simvastatin|simvastatin
5262479|NCT00575939|HIV|hiv
5262480|NCT00575939|IMT|imt
5262481|NCT00575939|coronary|coronary
5262482|NCT00575939|Treatment Naive|treatment naive
5262483|NCT00575926|Randomized controlled trial|randomized controlled trial
5262484|NCT00575926|Lingzhi|lingzhi
5262485|NCT00575926|Immune functions|immune functions
5262486|NCT00575926|Quality of life|quality of life
5262487|NCT00575926|Survival|survival
5262488|NCT00575900|Adolescent obesity,|adolescent obesity,
5262489|NCT00575900|low carbohydrate diets|low carbohydrate diets
5262490|NCT00575900|metabolic risk factors|metabolic risk factors
5262491|NCT00575900|BMI|bmi
5262492|NCT00575887|Temozolomide|temozolomide
5262493|NCT00575887|Brain Tumor, Recurrent|brain tumor, recurrent
5262494|NCT00575887|Chemotherapy|chemotherapy
5262495|NCT00575874|rivoglitazone HCl|rivoglitazone hcl
5262496|NCT00575874|pioglitazone HCl|pioglitazone hcl
5262497|NCT00575874|thiazolidinedione|thiazolidinedione
5262498|NCT00575874|peroxisome proliferator-activated receptor gamma (PPAR gamma)|peroxisome proliferator-activated receptor gamma (ppar gamma)
5262499|NCT00575874|type 2 diabetes mellitus|type 2 diabetes mellitus
5262500|NCT00575861|asthma|asthma
5262501|NCT00575861|nitric oxide gas exchange|nitric oxide gas exchange
5262502|NCT00575861|lung function|lung function
5262503|NCT00575848|Schizophrenia|schizophrenia
5262504|NCT00575848|Glycine|glycine
5262505|NCT00575848|Magnetic Resonance Spectroscopy (MRS)|magnetic resonance spectroscopy (mrs)
5262506|NCT00575835|vitamin D|vitamin d
5262507|NCT00575835|seasonal variation|seasonal variation
5262508|NCT00575835|PTH|pth
5262509|NCT00575835|bone markers|bone markers
5262510|NCT00575822|GERD|gerd
5262511|NCT00575822|Sham|sham
5262512|NCT00575822|Randomized Controlled Study|randomized controlled study
5262513|NCT00575822|Endoscopic Full-thickness Plication|endoscopic full-thickness plication
5262514|NCT00575822|Plicator|plicator
5262515|NCT00575809|Mucositis, hematopoietic stem cell transplantation, chemotherapy|mucositis, hematopoietic stem cell transplantation, chemotherapy
5262516|NCT00575796|pediatrics|pediatrics
5262517|NCT00575796|Low Grade Glioma|low grade glioma
5262518|NCT00575796|Vinblastine|vinblastine
5262519|NCT00575783|type 1 diabetes|type 1 diabetes
5262520|NCT00575783|hypoglycemia|hypoglycemia
5262521|NCT00575783|magnetic resonance imaging|magnetic resonance imaging
5262522|NCT00575757|Steatosis|steatosis
5262523|NCT00575757|NASH|nash
5262524|NCT00575744|Sentinel Lymph Node Biopsy|sentinel lymph node biopsy
5262525|NCT00575744|Axillary Node Dissection|axillary node dissection
5262526|NCT00575744|Intraoperative Injection|intraoperative injection
5262527|NCT00575744|Lumpectomy|lumpectomy
5262528|NCT00575744|Mastectomy|mastectomy
5262529|NCT00575718|Quitting tobacco|quitting tobacco
5262530|NCT00575718|tobacco use|tobacco use
5262531|NCT00575679|Automobile driving|automobile driving
5262532|NCT00575679|Driving under the influence|driving under the influence
5262533|NCT00575679|Interview, psychological|interview, psychological
5262534|NCT00575679|Brief intervention|brief intervention
5262535|NCT00575679|Brief motivational interview|brief motivational interview
5262536|NCT00575666|cognition, psychopathology|cognition, psychopathology
5262537|NCT00575653|Guillain-Barre Syndrome|guillain-barre syndrome
5262538|NCT00575653|Meningococcal vaccines|meningococcal vaccines
5262539|NCT00575653|Tetravalent Meningococcal Vaccine|tetravalent meningococcal vaccine
5262540|NCT00575653|Vaccination|vaccination
5262541|NCT00575653|Vaccines|vaccines
5262542|NCT00575653|Vaccines, Conjugate|vaccines, conjugate
5262543|NCT00575627|Hepatitis C|hepatitis c
5262544|NCT00575627|persistently normal ALT|persistently normal alt
5262545|NCT00575627|pNNALT|pnnalt
5262546|NCT00575627|Theraphy for Hepatitis C|theraphy for hepatitis c
5262547|NCT00575627|Pegylated Interferon|pegylated interferon
5262548|NCT00575627|Combined therapy|combined therapy
5262549|NCT00575614|Constipation|constipation
5262550|NCT00575614|Prucalopride|prucalopride
5262551|NCT00575614|Ano-rectal physiology|ano-rectal physiology
5262552|NCT00575614|Oro-caecal transit time|oro-caecal transit time
5262554|NCT00575601|pco|pco
5262555|NCT00575601|simvastatin|simvastatin
5262556|NCT00575601|ivf|ivf
5262557|NCT00575601|embryo transfer|embryo transfer
5262558|NCT00575588|DPP-4 Inhibitors|dpp-4 inhibitors
5262559|NCT00575588|HbA1c|hba1c
5262560|NCT00575588|incretins|incretins
5262561|NCT00575575|Suicidal ideation|suicidal ideation
5262562|NCT00575575|cognitive behavior therapy|cognitive behavior therapy
5262563|NCT00575536|spasticity|spasticity
5262564|NCT00575536|rhizotomy|rhizotomy
5262565|NCT00575536|surgery|surgery
5262566|NCT00575523|atropine|atropine
5262567|NCT00575523|percutaneous ethanol instillation|percutaneous ethanol instillation
5262568|NCT00575523|hepatoma|hepatoma
5262569|NCT00575523|bradycardia|bradycardia
5262570|NCT00575523|arrhythmia|arrhythmia
5262571|NCT00575510|unified theory of behavior|unified theory of behavior
5262572|NCT00575510|Pap test|pap test
5262573|NCT00575510|cervical dysplasia|cervical dysplasia
5262574|NCT00575510|women's health|women's health
5262575|NCT00575497|Hemodialysis|hemodialysis
5262576|NCT00575497|Adequacy|adequacy
5262577|NCT00575497|Frequency|frequency
5262578|NCT00575484|Congestive Heart Failure|congestive heart failure
5262579|NCT00575484|Renal Insufficiency|renal insufficiency
5262580|NCT00575484|Hypertonic Saline Solution|hypertonic saline solution
5262581|NCT00575484|Diuretic Resistance|diuretic resistance
5262582|NCT00575484|Cardiorenal Syndrome|cardiorenal syndrome
5262583|NCT00575471|rivoglitazone HCl|rivoglitazone hcl
5262584|NCT00575471|thiazolidinedione|thiazolidinedione
5262585|NCT00575471|peroxisome proliferator-activated receptor gamma (PPARgamma)|peroxisome proliferator-activated receptor gamma (ppargamma)
5262586|NCT00575471|diabetes mellitus, type 2|diabetes mellitus, type 2
5262587|NCT00575432|magnetic resonance imaging|magnetic resonance imaging
5262588|NCT00575432|renal function|renal function
5262589|NCT00575432|renal transplant|renal transplant
5262590|NCT00575432|urinary calculi|urinary calculi
5262591|NCT00575432|healthy controls|healthy controls
5262592|NCT00575432|kidney|kidney
5262593|NCT00575419|Contrast Induced Nephropathy|contrast induced nephropathy
5262594|NCT00575393|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5262595|NCT00575393|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5262596|NCT00575393|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5262597|NCT00575354|Sevoflurane|sevoflurane
5262598|NCT00575354|Isoflurane|isoflurane
5262599|NCT00575354|Breast tumor|breast tumor
5262600|NCT00575354|Anesthesia|anesthesia
5262601|NCT00575341|Central Adrenal Insufficiency|central adrenal insufficiency
5262602|NCT00575341|DHEA|dhea
5262603|NCT00575341|Pubes|pubes
5262604|NCT00575328|Sexual Dysfunction|sexual dysfunction
5262605|NCT00575328|Bipolar Disorder|bipolar disorder
5262606|NCT00575315|HIV-HCV Coinfection|hiv-hcv coinfection
5262607|NCT00575315|HIV|hiv
5262608|NCT00575315|Histology|histology
5262609|NCT00575302|IVF|ivf
5262610|NCT00575302|poor responder|poor responder
5262611|NCT00575302|recFSH|recfsh
5262612|NCT00575302|Fertilization in Vitro|fertilization in vitro
5262613|NCT00575302|Poor responders|poor responders
5262614|NCT00575276|Pain, Cholecystectomy, Cytokines, Sex Differences|pain, cholecystectomy, cytokines, sex differences
5262615|NCT00575263|Pain, Sodium Channel, Dental pulp|pain, sodium channel, dental pulp
5262616|NCT00575250|Osteoporosis/prevention & control|osteoporosis/prevention & control
5262617|NCT00575250|Osteoporosis Prevention and Self-Management Course|osteoporosis prevention and self-management course
5262618|NCT00575250|Patient Education/*trends//Questionnaires|patient education/*trends//questionnaires
5262619|NCT00575250|Adult//Aged//Middle Aged|adult//aged//middle aged
5262620|NCT00575250|Life Style//|life style//
5262621|NCT00575237|Laparoscopic Surgery|laparoscopic surgery
5262622|NCT00575237|Shoulder pain|shoulder pain
5262623|NCT00575237|PDNV|pdnv
5262624|NCT00575237|Anesthesia|anesthesia
5262625|NCT00575237|Residual CO2|residual co2
5262626|NCT00575237|Postoperative Pain|postoperative pain
5262627|NCT00575237|Female ASA 1 and 2 outpatients who were scheduled for elective gynecologic laparoscopic surgery|female asa 1 and 2 outpatients who were scheduled for elective gynecologic laparoscopic surgery
5262628|NCT00575224|Hepatitis C|hepatitis c
5262629|NCT00575224|Genotype 6|genotype 6
5262630|NCT00575224|Novel genoytpe|novel genoytpe
5262631|NCT00575224|HCV|hcv
5262632|NCT00575224|Treatment|treatment
5262633|NCT00575211|New onset cardiomyopathy|new onset cardiomyopathy
5262634|NCT00575211|Onset of symptoms less than 6 months|onset of symptoms less than 6 months
5262635|NCT00575211|LVEF < 40%|lvef < 40%
5262636|NCT00575198|Chest tubes|chest tubes
5262637|NCT00575198|Trauma|trauma
5262638|NCT00575185|Mono|mono
5262639|NCT00575185|Mononucleosis|mononucleosis
5262640|NCT00575185|Epstein-Barr virus|epstein-barr virus
5262641|NCT00575172|type2 diabetes mellitus|type2 diabetes mellitus
5262642|NCT00575172|cardiovascular disease|cardiovascular disease
5262643|NCT00575172|macrovascular event|macrovascular event
5262644|NCT00575159|type 1 Diabetes mellitus, pharmacokinetics,|type 1 diabetes mellitus, pharmacokinetics,
5262645|NCT00575159|pharmacodynamics|pharmacodynamics
5262646|NCT00575159|Adult male and females,|adult male and females,
5262647|NCT00575146|glioblastoma|glioblastoma
5262648|NCT00575146|ketogenic diet|ketogenic diet
5262649|NCT00575120|Endothelial Function, MRI, Vascular Biology|endothelial function, mri, vascular biology
5262650|NCT00575081|Physiological Brain Atlas, Brain registry, Brain database|physiological brain atlas, brain registry, brain database
5262651|NCT00575042|PBC|pbc
5262652|NCT00575042|Primary Biliary Cirrhosis|primary biliary cirrhosis
5262653|NCT00575042|Fenofibrate|fenofibrate
5262654|NCT00575042|Triglide|triglide
5262655|NCT00575029|megestrol acetate|megestrol acetate
5262656|NCT00575029|adrenal insufficiency|adrenal insufficiency
5262657|NCT00575029|adrenal suppression|adrenal suppression
5262658|NCT00574990|Interdisciplinary Communication|interdisciplinary communication
5262659|NCT00574990|Safety Management|safety management
5262660|NCT00574990|Management, Medication Therapy|management, medication therapy
5262661|NCT00574990|Cooperative Behavior|cooperative behavior
5262662|NCT00574990|Drug Therapy Management|drug therapy management
5262663|NCT00574990|Physician Nurse Relationships|physician nurse relationships
5262664|NCT00574990|Side Effects|side effects
5262665|NCT00574990|Hospital Information Systems|hospital information systems
5262666|NCT00574990|Documentation|documentation
5262667|NCT00574990|Quality Assurance, Health Care|quality assurance, health care
5262668|NCT00574977|vaccinia|vaccinia
5262669|NCT00574977|virus|virus
5262670|NCT00574977|tumor|tumor
5262671|NCT00574977|melanoma|melanoma
5262672|NCT00574977|breast cancer|breast cancer
5262673|NCT00574977|squamous cell cancer|squamous cell cancer
5262674|NCT00574977|colorectal|colorectal
5262675|NCT00574977|liver|liver
5262676|NCT00574977|pancreatic|pancreatic
5262677|NCT00574977|adenocarcinoma|adenocarcinoma
5262678|NCT00574951|fallopian tube cancer|fallopian tube cancer
5262679|NCT00574951|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5262680|NCT00574951|primary peritoneal cavity cancer|primary peritoneal cavity cancer
5262681|NCT00574925|H. pylori|h. pylori
5262682|NCT00574912|Type 2 diabetes|type 2 diabetes
5262683|NCT00574912|Insulin Glargine|insulin glargine
5262684|NCT00574912|Endogenous Glucose Production|endogenous glucose production
5262685|NCT00574899|Prostate|prostate
5262686|NCT00574873|Bosutinib|bosutinib
5262687|NCT00574873|imatinib|imatinib
5262688|NCT00574873|CML|cml
5262689|NCT00574860|Oral Mucositis|oral mucositis
5262690|NCT00574860|Chemoradiation therapy|chemoradiation therapy
5262691|NCT00574860|Head and neck cancer|head and neck cancer
5262692|NCT00574847|ischemic heart disease|ischemic heart disease
5262693|NCT00574847|mental stress-induced myocardial ischemia|mental stress-induced myocardial ischemia
5262694|NCT00574847|escitalopram|escitalopram
5262695|NCT00574821|Hypertrophic Cardiomyopathy(HCM)|hypertrophic cardiomyopathy(hcm)
5262696|NCT00574821|Magnetocardiography (MCG)|magnetocardiography (mcg)
5262697|NCT00574808|Primary care|primary care
5262698|NCT00574808|Prevention of Cardiovascular Disease|prevention of cardiovascular disease
5262699|NCT00574808|Chronic Disease Management|chronic disease management
5262700|NCT00574808|Chronic Disease Prevention|chronic disease prevention
5262701|NCT00574808|Chronic Care Model|chronic care model
5262702|NCT00574808|Outreach Facilitation|outreach facilitation
5262703|NCT00574782|cholesterol, coronary heart disease|cholesterol, coronary heart disease
5262704|NCT00574782|rosuvastatin|rosuvastatin
5262705|NCT00574782|LDL-C goal|ldl-c goal
5262706|NCT00574782|hypercholesterolemia|hypercholesterolemia
5262707|NCT00574769|RAD001|rad001
5262708|NCT00574769|mTOR inhibition|mtor inhibition
5262709|NCT00574769|docetaxel|docetaxel
5262710|NCT00574769|bevacizumab|bevacizumab
5262711|NCT00574769|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5262712|NCT00574769|recurrent prostate cancer|recurrent prostate cancer
5262713|NCT00574769|stage IV prostate cancer|stage iv prostate cancer
5262714|NCT00574769|prostate cancer|prostate cancer
5262715|NCT00574769|Metastatic, androgen independent prostate cancer|metastatic, androgen independent prostate cancer
5262716|NCT00574743|ERL080A, Heart Transplantation, Mycophenolate, EC-MPS|erl080a, heart transplantation, mycophenolate, ec-mps
5262717|NCT00574717|hyperopia|hyperopia
5262718|NCT00574717|ocular refraction|ocular refraction
5262719|NCT00574717|infant|infant
5262720|NCT00574717|vision|vision
5262721|NCT00574691|Closure Device|closure device
5262722|NCT00574691|Angiography|angiography
5262723|NCT00574691|Angioplasty|angioplasty
5262724|NCT00574691|Hemostasis|hemostasis
5262725|NCT00574691|Heart Catheterization|heart catheterization
5262726|NCT00574691|Coronary Angiography|coronary angiography
5262727|NCT00574678|Screening tool for cancer|screening tool for cancer
5262728|NCT00574665|Type 2 Diabetes|type 2 diabetes
5262729|NCT00574665|Endothelial Function|endothelial function
5262730|NCT00574665|Fibrinolytic Balance|fibrinolytic balance
5262731|NCT00574652|HCV+|hcv+
5262732|NCT00574652|cryoglobulinemia|cryoglobulinemia
5262733|NCT00574652|Vasculitis|vasculitis
5262734|NCT00574652|IL-2 treatment|il-2 treatment
5262735|NCT00574652|safety and efficacy|safety and efficacy
5262736|NCT00574639|Type 1 Diabetes|type 1 diabetes
5262737|NCT00574639|Alprazolam|alprazolam
5262738|NCT00574639|Exercise|exercise
5262739|NCT00574626|NHL|nhl
5262740|NCT00574626|Non Hodgkins Lymphoma|non hodgkins lymphoma
5262741|NCT00574626|BMT|bmt
5262742|NCT00574626|Bone Marrow Transplant|bone marrow transplant
5262743|NCT00574626|PBSCT|pbsct
5262744|NCT00574626|Peripheral Blood Stem Cell Transplant|peripheral blood stem cell transplant
5262745|NCT00574626|PSCT|psct
5262746|NCT00574613|Skin fibrosis|skin fibrosis
5262747|NCT00574613|systemic scleroderma|systemic scleroderma
5262748|NCT00574613|systemic sclerosis|systemic sclerosis
5262749|NCT00574613|P144|p144
5262750|NCT00574613|orphan drug|orphan drug
5262751|NCT00574613|soluble collagen|soluble collagen
5262752|NCT00574613|durometer|durometer
5262753|NCT00574613|skin fibrosis in systemic sclerosis|skin fibrosis in systemic sclerosis
5262754|NCT00574600|HIV Seronegativity|hiv seronegativity
5262755|NCT00574600|HIV Preventive Vaccine|hiv preventive vaccine
5262756|NCT00574587|Vorinostat|vorinostat
5262757|NCT00574587|Neoadjuvant Chemotherapy|neoadjuvant chemotherapy
5262758|NCT00574574|cardiovascular disease|cardiovascular disease
5262759|NCT00574574|CVD|cvd
5262760|NCT00574574|skin health|skin health
5262761|NCT00574574|postmenopausal women|postmenopausal women
5262762|NCT00574574|anthocyanin|anthocyanin
5262763|NCT00574574|inflammation|inflammation
5262764|NCT00574561|CT angiography (CTA)|ct angiography (cta)
5262765|NCT00574561|Magnetocardiography (MCG)|magnetocardiography (mcg)
5262766|NCT00574561|heart disease|heart disease
5262767|NCT00574548|Vaccines, Pneumococcal Conjugate Vaccine|vaccines, pneumococcal conjugate vaccine
5262768|NCT00574535|Reproductive Hormones|reproductive hormones
5262769|NCT00574522|HIV|hiv
5262770|NCT00574522|AIDS|aids
5262771|NCT00574522|Radiation|radiation
5262772|NCT00574522|Far infrared|far infrared
5262773|NCT00574522|Treatment|treatment
5262774|NCT00574522|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5262775|NCT00574522|Complimentary therapies|complimentary therapies
5262776|NCT00574509|NHL|nhl
5262777|NCT00574509|Non Hodgkins Lymphoma|non hodgkins lymphoma
5262778|NCT00574509|131Iodine-Anti-B1 Radioimmunotherapy|131iodine-anti-b1 radioimmunotherapy
5262779|NCT00574509|Autologous Hematopoietic Stem Cell Transplant|autologous hematopoietic stem cell transplant
5262780|NCT00574509|AHSCT|ahsct
5262781|NCT00574496|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5262782|NCT00574496|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
5262783|NCT00574496|adult lymphocyte depletion Hodgkin lymphoma|adult lymphocyte depletion hodgkin lymphoma
5262784|NCT00574496|adult nodular sclerosis Hodgkin lymphoma|adult nodular sclerosis hodgkin lymphoma
5262785|NCT00574496|adult mixed cellularity Hodgkin lymphoma|adult mixed cellularity hodgkin lymphoma
5262786|NCT00574496|childhood lymphocyte depletion Hodgkin lymphoma|childhood lymphocyte depletion hodgkin lymphoma
5262787|NCT00574496|childhood mixed cellularity Hodgkin lymphoma|childhood mixed cellularity hodgkin lymphoma
5262788|NCT00574496|childhood nodular sclerosis Hodgkin lymphoma|childhood nodular sclerosis hodgkin lymphoma
5262789|NCT00574496|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5262790|NCT00574496|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5262791|NCT00574496|stage III childhood Hodgkin lymphoma|stage iii childhood hodgkin lymphoma
5262792|NCT00574496|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
5262793|NCT00574483|Renal cell carcinoma|renal cell carcinoma
5262794|NCT00574457|Atherosclerosis|atherosclerosis
5262795|NCT00574457|Cardiovascular Risk Prevention|cardiovascular risk prevention
5262796|NCT00574457|Carotid Ultrasound|carotid ultrasound
5262797|NCT00574457|Handheld ultrasound|handheld ultrasound
5262798|NCT00574457|Office Practice|office practice
5262799|NCT00574457|Carotid Intima Media Thickness|carotid intima media thickness
5262800|NCT00574457|Carotid Plaque|carotid plaque
5262801|NCT00574444|transvaginal peritoneoscopy|transvaginal peritoneoscopy
5262802|NCT00574431|Critical care|critical care
5262803|NCT00574431|Intensive care unit|intensive care unit
5262804|NCT00574431|Early enteral nutrition|early enteral nutrition
5262805|NCT00574431|Nutritional management protocol|nutritional management protocol
5262806|NCT00574418|Fibroid Tumor|fibroid tumor
5262807|NCT00574418|Fibroid Uterus|fibroid uterus
5262808|NCT00574418|Fibroids, Uterine|fibroids, uterine
5262809|NCT00574418|Fibromyoma|fibromyoma
5262810|NCT00574418|Uterine Neoplasms|uterine neoplasms
5262811|NCT00574405|Insulin pump|insulin pump
5262812|NCT00574405|Beta cell|beta cell
5262813|NCT00574392|skin disorders|skin disorders
5262814|NCT00574379|Allergic Rhinitis|allergic rhinitis
5262815|NCT00574379|Mountain Cedar Pollen|mountain cedar pollen
5262816|NCT00574379|Pollen Allergy|pollen allergy
5262817|NCT00574379|Rhinoconjunctivitis|rhinoconjunctivitis
5262818|NCT00574366|recurrent breast cancer|recurrent breast cancer
5262819|NCT00574366|stage IV breast cancer|stage iv breast cancer
5262820|NCT00574366|male breast cancer|male breast cancer
5262821|NCT00574353|colorectal cancer|colorectal cancer
5262822|NCT00574353|07-151|07-151
5262823|NCT00574340|Type 2 Diabetes|type 2 diabetes
5262824|NCT00574340|Endothelial Function|endothelial function
5262825|NCT00574340|Fibrinolytic Balance|fibrinolytic balance
5262826|NCT00574340|Hypoglycemia|hypoglycemia
5262827|NCT00574327|Role|role
5262828|NCT00574327|Registry|registry
5262829|NCT00574327|Barrett's Esophagus|barrett's esophagus
5262830|NCT00574314|women|women
5262831|NCT00574314|Registry|registry
5262832|NCT00574301|Image Guided Vacuum Assisted Biopsy|image guided vacuum assisted biopsy
5262833|NCT00574301|Radiofrequency Ablation|radiofrequency ablation
5262834|NCT00574301|Breast Conservation Therapy|breast conservation therapy
5262835|NCT00574301|Mastectomy|mastectomy
5262836|NCT00574301|MRI|mri
5262837|NCT00574288|Multiple Myeloma|multiple myeloma
5262838|NCT00574288|Daratumumab|daratumumab
5262839|NCT00574288|Safety|safety
5262840|NCT00574288|HuMax-CD38|humax-cd38
5262841|NCT00574288|Dose-escalation|dose-escalation
5262842|NCT00574275|metastatic pancreatic cancer|metastatic pancreatic cancer
5262843|NCT00574275|angiogenesis inhibitor|angiogenesis inhibitor
5262844|NCT00574275|gemcitabine|gemcitabine
5262845|NCT00574262|acute ischemic stroke|acute ischemic stroke
5262846|NCT00574262|clinical pathway|clinical pathway
5262847|NCT00574262|quality of care|quality of care
5262848|NCT00574262|secondary prevention|secondary prevention
5262849|NCT00574249|Psoriasis|psoriasis
5262850|NCT00574249|Moderate Psoriasis|moderate psoriasis
5262851|NCT00574249|Severe Psoriasis|severe psoriasis
5262852|NCT00574249|Chronic Plaque Psoriasis|chronic plaque psoriasis
5262853|NCT00574249|Severe Chronic Plaque Psoriasis|severe chronic plaque psoriasis
5262854|NCT00574210|Seasonal Allergic Rhinitis (SAR)|seasonal allergic rhinitis (sar)
5262855|NCT00574210|Environmental Exposure Chamber (EEC)|environmental exposure chamber (eec)
5262856|NCT00574210|Therapeutic Uses|therapeutic uses
5262857|NCT00574210|Antihistamine Drug|antihistamine drug
5262858|NCT00574210|Ragweed Pollen|ragweed pollen
5262859|NCT00574197|Heart Transplant|heart transplant
5262860|NCT00574197|gastrointestinal|gastrointestinal
5262861|NCT00574197|Cellcept|cellcept
5262862|NCT00574197|Myfortic|myfortic
5262863|NCT00574197|GI|gi
5262864|NCT00574197|GI symptoms with Mycophenolate Mofetil after heart transplant|gi symptoms with mycophenolate mofetil after heart transplant
5262865|NCT00574184|ED|ed
5262866|NCT00574184|Erectile Dysfunction|erectile dysfunction
5262867|NCT00574158|ozone|ozone
5262868|NCT00574158|inflammatory airway disease|inflammatory airway disease
5262869|NCT00574158|polymorphisms|polymorphisms
5262870|NCT00574145|fatigue|fatigue
5262871|NCT00574145|depression|depression
5262872|NCT00574145|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
5262873|NCT00574145|stage I breast cancer|stage i breast cancer
5262874|NCT00574145|stage II breast cancer|stage ii breast cancer
5262875|NCT00574145|stage IIIA breast cancer|stage iiia breast cancer
5262876|NCT00574145|stage IIIB breast cancer|stage iiib breast cancer
5262877|NCT00574145|stage IIIC breast cancer|stage iiic breast cancer
5262878|NCT00574145|recurrent breast cancer|recurrent breast cancer
5262879|NCT00574119|heart failure|heart failure
5262880|NCT00574119|positron emission tomography|positron emission tomography
5262881|NCT00574119|magnetic resonance imaging|magnetic resonance imaging
5262882|NCT00574119|myocardial energetics|myocardial energetics
5262883|NCT00574119|myocardial perfusion|myocardial perfusion
5262884|NCT00574106|Cancer|cancer
5262885|NCT00574106|Tumors|tumors
5262886|NCT00574093|combination therapy|combination therapy
5262887|NCT00574093|Lucentis|lucentis
5262888|NCT00574093|Visudyne|visudyne
5262889|NCT00574054|Familial Dementia|familial dementia
5262890|NCT00574054|Semantic Dementia|semantic dementia
5262891|NCT00574054|Senile Paranoid Dementia|senile paranoid dementia
5262892|NCT00574041|Multiple Sclerosis|multiple sclerosis
5262893|NCT00574041|Avonex|avonex
5262894|NCT00574041|side effects|side effects
5262895|NCT00574041|flu like symptoms|flu like symptoms
5262896|NCT00574028|IBD Study|ibd study
5262897|NCT00574015|toothache|toothache
5262898|NCT00574015|regional anesthesia|regional anesthesia
5262899|NCT00574015|emergency department|emergency department
5262900|NCT00573989|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
5262901|NCT00573989|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
5262902|NCT00573989|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
5262903|NCT00573989|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
5262904|NCT00573989|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
5262905|NCT00573989|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
5262906|NCT00573989|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
5263003|NCT00573573|PARATHYROID NEOPLASMS|parathyroid neoplasms
5262907|NCT00573989|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
5262908|NCT00573976|SCIM|scim
5262909|NCT00573976|SCIM III|scim iii
5262910|NCT00573976|Multi-Center|multi-center
5262911|NCT00573976|United States|united states
5262912|NCT00573963|Cesarean section|cesarean section
5262913|NCT00573950|cilostazol|cilostazol
5262914|NCT00573950|Type 2 Diabetes mellitus|type 2 diabetes mellitus
5262915|NCT00573950|Metabolic Syndrome|metabolic syndrome
5262916|NCT00573950|adipocytokines|adipocytokines
5262917|NCT00573950|arterial stiffness|arterial stiffness
5262918|NCT00573950|Pulse wave velocity|pulse wave velocity
5262919|NCT00573937|Neoplasms|neoplasms
5262920|NCT00573937|Pain|pain
5262921|NCT00573937|Methadone|methadone
5262922|NCT00573937|Morphine|morphine
5262923|NCT00573911|Barrett's esophagus|barrett's esophagus
5262924|NCT00573911|GERD|gerd
5262925|NCT00573898|daptomycin|daptomycin
5262926|NCT00573885|non-small cell lung cancer|non-small cell lung cancer
5262927|NCT00573885|small cell lung cancer|small cell lung cancer
5262928|NCT00573885|tobacco use disorder|tobacco use disorder
5262929|NCT00573872|Radiosurgery|radiosurgery
5262930|NCT00573872|Phase II|phase ii
5262931|NCT00573872|Cancer|cancer
5262932|NCT00573872|Spinal|spinal
5262933|NCT00573872|AVM|avm
5262934|NCT00573859|Smoking|smoking
5262935|NCT00573859|ADHD|adhd
5262936|NCT00573859|Stimulant medication|stimulant medication
5262937|NCT00573846|IBD|ibd
5262938|NCT00573833|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5262939|NCT00573833|stage IIB prostate cancer|stage iib prostate cancer
5262940|NCT00573833|stage IIA prostate cancer|stage iia prostate cancer
5262941|NCT00573820|Tumors or cancer of the prostate|tumors or cancer of the prostate
5262942|NCT00573820|Cancer of Prostate|cancer of prostate
5262943|NCT00573820|Cancer of the Prostate|cancer of the prostate
5262944|NCT00573820|Neoplasms, Prostate|neoplasms, prostate
5262945|NCT00573820|Neoplasms, Prostatic|neoplasms, prostatic
5262946|NCT00573820|Prostate Cancer|prostate cancer
5262947|NCT00573820|Prostate Neoplasms|prostate neoplasms
5262948|NCT00573820|Prostatic Cancer|prostatic cancer
5262949|NCT00573807|Neuralgia, Sciatic|neuralgia, sciatic
5262950|NCT00573807|Sciatic Neuralgia|sciatic neuralgia
5262951|NCT00573807|Sciatica, Bilateral|sciatica, bilateral
5262952|NCT00573807|Lower back pain|lower back pain
5262953|NCT00573794|Ulcerative Colitis|ulcerative colitis
5262954|NCT00573781|Systems biology|systems biology
5262955|NCT00573781|Nutrigenomics|nutrigenomics
5262956|NCT00573781|Metabolomics|metabolomics
5262957|NCT00573781|Gene expression|gene expression
5262958|NCT00573781|Fat tissue|fat tissue
5262959|NCT00573781|Peripheral mononuclear cells|peripheral mononuclear cells
5262960|NCT00573781|Gene clusters|gene clusters
5262961|NCT00573781|Gene expression profiles|gene expression profiles
5262962|NCT00573781|Personal diets|personal diets
5262963|NCT00573781|Metabolic syndrome|metabolic syndrome
5262964|NCT00573781|Type 2 Diabetes|type 2 diabetes
5262965|NCT00573781|Atherosclerosis|atherosclerosis
5262966|NCT00573768|Ankle, sprain, diclofenac diethylamine|ankle, sprain, diclofenac diethylamine
5262967|NCT00573755|stage IV breast cancer|stage iv breast cancer
5262968|NCT00573755|recurrent breast cancer|recurrent breast cancer
5262969|NCT00573742|hypertension|hypertension
5262970|NCT00573729|vascular malformation|vascular malformation
5262971|NCT00573716|bone mineral content|bone mineral content
5262972|NCT00573716|aripiprazole monotherapy|aripiprazole monotherapy
5262973|NCT00573716|risperidone monotherapy|risperidone monotherapy
5262974|NCT00573703|Laparoscopic Burch colposuspension|laparoscopic burch colposuspension
5262975|NCT00573703|Stress incontinence|stress incontinence
5262976|NCT00573703|Surgery|surgery
5262977|NCT00573703|TOT|tot
5262978|NCT00573703|Treatment|treatment
5262979|NCT00573703|Predominant or genuine stress urinary incontinence|predominant or genuine stress urinary incontinence
5262980|NCT00573690|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5262981|NCT00573664|Cesarean section|cesarean section
5262982|NCT00573664|Gabapentin|gabapentin
5262983|NCT00573651|JIA|jia
5262984|NCT00573651|SEA syndrome|sea syndrome
5262985|NCT00573651|AS|as
5262986|NCT00573651|psoriatic arthritis|psoriatic arthritis
5262987|NCT00573651|HPV vaccine|hpv vaccine
5262988|NCT00573638|glaucoma|glaucoma
5262989|NCT00573638|compliance|compliance
5262990|NCT00573638|eye drops|eye drops
5262991|NCT00573638|deliver aid|deliver aid
5262992|NCT00573638|Patients could range anywhere from 40 to 80 years old|patients could range anywhere from 40 to 80 years old
5262993|NCT00573638|Patients must have diagnosis requiring treatment with Xalatan.|patients must have diagnosis requiring treatment with xalatan.
5262994|NCT00573638|Patients will be male or female and from any racial/ethnic background.|patients will be male or female and from any racial/ethnic background.
5262995|NCT00573612|Fibromyalgia|fibromyalgia
5262996|NCT00573612|Fibromyalgia patients|fibromyalgia patients
5262997|NCT00573599|Migraine|migraine
5262998|NCT00573599|Emergency|emergency
5262999|NCT00573599|imitrex|imitrex
5263000|NCT00573599|prochlorperazine|prochlorperazine
5263001|NCT00573599|Acute Migraine Headache in the Emergency Department|acute migraine headache in the emergency department
5263002|NCT00573573|PRIMARY HYPERPARATHYROIDISM|primary hyperparathyroidism
5263004|NCT00573573|SECONDARY HYPERPARATHYROIDISM|secondary hyperparathyroidism
5263005|NCT00573573|HYPOCALCEMIA|hypocalcemia
5263006|NCT00573560|Heart failure|heart failure
5263007|NCT00573560|percutaneous|percutaneous
5263008|NCT00573560|interventional cardiology|interventional cardiology
5263009|NCT00573560|apical remodeling|apical remodeling
5263010|NCT00573560|LV dilatation|lv dilatation
5263011|NCT00573560|akinesis|akinesis
5263012|NCT00573560|dyskinesis|dyskinesis
5263013|NCT00573547|depression|depression
5263014|NCT00573547|chronic renal failures|chronic renal failures
5263015|NCT00573547|end stage renal disease|end stage renal disease
5263016|NCT00573534|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
5263017|NCT00573534|ADHD|adhd
5263018|NCT00573534|ADD|add
5263019|NCT00573534|Prevention|prevention
5263020|NCT00573534|Substance use|substance use
5263021|NCT00573534|Adolescent|adolescent
5263022|NCT00573521|ESBL positive cultures|esbl positive cultures
5263023|NCT00573508|Overactive Bladder|overactive bladder
5263024|NCT00573495|Advanced breast cancer|advanced breast cancer
5263025|NCT00573482|weight gain prevention|weight gain prevention
5263026|NCT00573482|obesity|obesity
5263027|NCT00573482|overweight|overweight
5263028|NCT00573482|food environment|food environment
5263029|NCT00573482|The intervention group received the education in REDE techniques|the intervention group received the education in rede techniques
5263030|NCT00573482|The control group received no intervention at all.|the control group received no intervention at all.
5263031|NCT00573482|Both groups were exposed to the food labels and the new lower ED foods.|both groups were exposed to the food labels and the new lower ed foods.
5263032|NCT00573482|Only the intervention group received the education sessions and only they were eligible for the price reductions.|only the intervention group received the education sessions and only they were eligible for the price reductions.
5263033|NCT00573469|gastrointestinal|gastrointestinal
5263034|NCT00573469|GI|gi
5263035|NCT00573469|Crohn's disease|crohn's disease
5263036|NCT00573469|Japan|japan
5263037|NCT00573469|Japanese|japanese
5263038|NCT00573456|Thye 1 Diabetes|thye 1 diabetes
5263039|NCT00573456|Type 2 Diabetes|type 2 diabetes
5263040|NCT00573443|Amyotrophic Lateral Sclerosis (Lou Gehrig's disease, ALS)|amyotrophic lateral sclerosis (lou gehrig's disease, als)
5263041|NCT00573443|Multiple Sclerosis (MS)|multiple sclerosis (ms)
5263042|NCT00573430|Candesartan Cilexetil|candesartan cilexetil
5263043|NCT00573430|Non-diabetic Nephropathy|non-diabetic nephropathy
5263044|NCT00573430|hypertension|hypertension
5263045|NCT00573430|urine protein creatinine ratio|urine protein creatinine ratio
5263046|NCT00573417|Schizophrenia|schizophrenia
5263047|NCT00573417|Clozapine|clozapine
5263048|NCT00573417|Cognition|cognition
5263049|NCT00573417|Metabolic Syndrome|metabolic syndrome
5263050|NCT00573417|Negative Symptoms|negative symptoms
5263051|NCT00573417|Wakefulness|wakefulness
5263052|NCT00573417|Fatigue|fatigue
5263053|NCT00573404|gastrointestinal stromal tumor|gastrointestinal stromal tumor
5263054|NCT00573378|CML|cml
5263055|NCT00573365|dermatitis|dermatitis
5263056|NCT00573365|skin|skin
5263057|NCT00573365|radiation|radiation
5263058|NCT00573365|light|light
5263059|NCT00573365|LED photomodulation|led photomodulation
5263060|NCT00573365|Gentlewaves|gentlewaves
5263061|NCT00573352|Arthritis, Degenerative|arthritis, degenerative
5263062|NCT00573352|Osteoarthrosis|osteoarthrosis
5263063|NCT00573352|Osteoarthrosis Deformans|osteoarthrosis deformans
5263064|NCT00573339|Cardiac|cardiac
5263065|NCT00573339|MRI|mri
5263066|NCT00573339|normal controls|normal controls
5263067|NCT00573313|Alcoholic Liver Disease (ALD)|alcoholic liver disease (ald)
5263068|NCT00573313|S-adenosylmethionine|s-adenosylmethionine
5263069|NCT00573313|SAMe|same
5263070|NCT00573300|Schizophrenia|schizophrenia
5263071|NCT00573300|Immune System|immune system
5263072|NCT00573300|Kynurenate|kynurenate
5263073|NCT00573300|tryptophan metabolism|tryptophan metabolism
5263074|NCT00573300|NMDA receptor|nmda receptor
5263075|NCT00573300|indolamine 2,3-deoxygenase (IDO)|indolamine 2,3-deoxygenase (ido)
5263076|NCT00573287|Clozapine, risperidone, first episode,|clozapine, risperidone, first episode,
5263077|NCT00573274|Cesarean section|cesarean section
5263078|NCT00573274|Cardiac Output|cardiac output
5263079|NCT00573274|Physioflow|physioflow
5263080|NCT00573274|Cardiography, Impedance|cardiography, impedance
5263081|NCT00573261|Diabetic neuropathy|diabetic neuropathy
5263082|NCT00573261|Pregabalin|pregabalin
5263083|NCT00573261|Lyrica|lyrica
5263084|NCT00573248|Nicotine|nicotine
5263085|NCT00573248|ADHD|adhd
5263086|NCT00573248|Gender|gender
5263087|NCT00573235|isolates|isolates
5263088|NCT00573235|infection|infection
5263089|NCT00573235|E coli isolates|e coli isolates
5263090|NCT00573222|Asthma|asthma
5263091|NCT00573209|Impotence|impotence
5263092|NCT00573209|Male Impotence|male impotence
5263093|NCT00573209|Male Sexual Impotence|male sexual impotence
5263094|NCT00573196|Affective Psychosis, Bipolar|affective psychosis, bipolar
5263095|NCT00573196|Depression, Bipolar|depression, bipolar
5263096|NCT00573196|Mania|mania
5263097|NCT00573196|Manic Disorder|manic disorder
5263098|NCT00573196|Manic State|manic state
5263099|NCT00573196|Manic-Depressive Psychosis|manic-depressive psychosis
5263854|NCT00569790|S-1|s-1
5263100|NCT00573196|Psychoses, Manic-Depressive|psychoses, manic-depressive
5263101|NCT00573196|Psychosis, Manic-Depressive|psychosis, manic-depressive
5263102|NCT00573183|Cocaine, methamphetamine, amphetamine, other stimulant drugs|cocaine, methamphetamine, amphetamine, other stimulant drugs
5263103|NCT00573170|Migraine, acute|migraine, acute
5263104|NCT00573170|Migraine|migraine
5263105|NCT00573170|Butalbital-containing Combination Medication (BCM)|butalbital-containing combination medication (bcm)
5263106|NCT00573170|Naproxen sodium|naproxen sodium
5263107|NCT00573170|Sumatriptan succinate|sumatriptan succinate
5263108|NCT00573170|TREXIMET®|treximet®
5263109|NCT00573157|nephritis|nephritis
5263110|NCT00573157|atacicept|atacicept
5263111|NCT00573131|Esophageal cancer|esophageal cancer
5263112|NCT00573131|Localized esophageal cancer|localized esophageal cancer
5263113|NCT00573131|Operable esophageal cancer|operable esophageal cancer
5263114|NCT00573131|Loco-regional esophageal cancer|loco-regional esophageal cancer
5263115|NCT00573131|Esophagectomy|esophagectomy
5263116|NCT00573131|Phase 2|phase 2
5263117|NCT00573131|Paclitaxel|paclitaxel
5263118|NCT00573131|Tumor|tumor
5263119|NCT00573131|Local|local
5263120|NCT00573131|Chemotherapy|chemotherapy
5263121|NCT00573131|radiation therapy|radiation therapy
5263122|NCT00573131|surgery|surgery
5263123|NCT00573131|OncoGel|oncogel
5263124|NCT00573131|Squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
5263125|NCT00573118|Pregnancy complications: preeclampsia , severe IUGR , IUFD or placental abruption (n = 5).|pregnancy complications: preeclampsia , severe iugr , iufd or placental abruption (n = 5).
5263126|NCT00573092|Cardiovascular Epidemiology|cardiovascular epidemiology
5263127|NCT00573092|Genomics|genomics
5263128|NCT00573092|Genome-Wide Association Study|genome-wide association study
5263129|NCT00573079|Kidney|kidney
5263130|NCT00573079|Infants|infants
5263131|NCT00573066|Postoperative from cardiac surgery|postoperative from cardiac surgery
5263132|NCT00573066|Dexmedetomidine|dexmedetomidine
5263133|NCT00573053|hypercapneic response|hypercapneic response
5263134|NCT00573053|hyperoxic response|hyperoxic response
5263135|NCT00573053|breathing pattern|breathing pattern
5263136|NCT00573053|periodic breathing|periodic breathing
5263137|NCT00573053|sighs|sighs
5263138|NCT00573040|Radiotherapy|radiotherapy
5263139|NCT00573040|NSCLC|nsclc
5263140|NCT00573040|Stage III non-small cell lung cancer|stage iii non-small cell lung cancer
5263141|NCT00573027|microvascular dysfunction|microvascular dysfunction
5263142|NCT00573027|Microvascular|microvascular
5263143|NCT00573014|Obtunded blunt trauma patients|obtunded blunt trauma patients
5263144|NCT00573001|naive|naive
5263145|NCT00573001|HIV-1|hiv-1
5263146|NCT00573001|simplified treatment|simplified treatment
5263147|NCT00573001|Treatment Experienced|treatment experienced
5263148|NCT00572988|symptom management|symptom management
5263149|NCT00572988|function status|function status
5263150|NCT00572988|physical activity|physical activity
5263151|NCT00572988|health care utilization|health care utilization
5263152|NCT00572975|New diagnostic test for Cystic Fibrosis.|new diagnostic test for cystic fibrosis.
5263153|NCT00572949|heart disease|heart disease
5263154|NCT00572949|chest pain|chest pain
5263155|NCT00572949|coronary artery disease|coronary artery disease
5263156|NCT00572949|atherosclerosis|atherosclerosis
5263157|NCT00572936|Glaucoma|glaucoma
5263158|NCT00572936|Ocular Hypertension|ocular hypertension
5263159|NCT00572936|Timolol®, Latanoprost® and Dorzolamide®|timolol®, latanoprost® and dorzolamide®
5263160|NCT00572923|radiotherapy|radiotherapy
5263161|NCT00572923|LD-SCLC|ld-sclc
5263162|NCT00572923|stage I-III small cell lung cancer|stage i-iii small cell lung cancer
5263163|NCT00572897|Myelofibrosis|myelofibrosis
5263164|NCT00572897|Myeloproliferative disease|myeloproliferative disease
5263165|NCT00572897|Stem Cell Transplant|stem cell transplant
5263166|NCT00572897|Allogeneic Transplant|allogeneic transplant
5263167|NCT00572897|Conditioning Regimen|conditioning regimen
5263168|NCT00572897|Reduced Intensity Regimen|reduced intensity regimen
5263169|NCT00572897|Fludarabine|fludarabine
5263170|NCT00572897|Melphalan|melphalan
5263171|NCT00572897|ATG|atg
5263172|NCT00572884|permethrin|permethrin
5263173|NCT00572884|pyrethroid|pyrethroid
5263174|NCT00572884|pharmacokinetics|pharmacokinetics
5263175|NCT00572884|metabolism|metabolism
5263176|NCT00572884|accelerator mass spectrometry|accelerator mass spectrometry
5263177|NCT00572884|human exposure|human exposure
5263178|NCT00572858|Hypo E|hypo e
5263179|NCT00572845|Basal Energy Expenditure|basal energy expenditure
5263180|NCT00572845|Spasticity|spasticity
5263181|NCT00572845|Modified Ashworth Scale|modified ashworth scale
5263182|NCT00572845|Penn Spasm Frequency Score|penn spasm frequency score
5263183|NCT00572832|Human Papillomavirus Vaccine|human papillomavirus vaccine
5263184|NCT00572819|Hysteroscopy|hysteroscopy
5263185|NCT00572819|Misoprostol|misoprostol
5263186|NCT00572819|Postmenopausal women|postmenopausal women
5263187|NCT00572819|Cervical ripening|cervical ripening
5263188|NCT00572819|Dilatation|dilatation
5263189|NCT00572819|Sequential trial|sequential trial
5263190|NCT00572819|Estradiol|estradiol
5263191|NCT00572780|Crohn's Disease|crohn's disease
5263192|NCT00572780|CT Enteroclysis|ct enteroclysis
5263193|NCT00572767|randomised-controlled trial|randomised-controlled trial
5263194|NCT00572767|ischemic stroke|ischemic stroke
5263195|NCT00572767|motor recovery|motor recovery
5263196|NCT00572767|amphetamine|amphetamine
5263197|NCT00572767|motor recovery of patients after a first-ever ischemic stroke|motor recovery of patients after a first-ever ischemic stroke
5263198|NCT00572741|Autism|autism
5263199|NCT00572741|vitamin B 12|vitamin b 12
5263200|NCT00572741|glutathione|glutathione
5263201|NCT00572715|kidney|kidney
5263202|NCT00572715|neonates|neonates
5263203|NCT00572702|Biocompatible Materials|biocompatible materials
5263204|NCT00572702|Female|female
5263205|NCT00572702|Humans|humans
5263206|NCT00572702|Pelvic Floor|pelvic floor
5263207|NCT00572702|Polypropylenes|polypropylenes
5263208|NCT00572702|Prostheses and Implants|prostheses and implants
5263209|NCT00572702|Surgical Mesh|surgical mesh
5263210|NCT00572702|Uterine Prolapse/*therapy|uterine prolapse/*therapy
5263211|NCT00572689|Exenatide|exenatide
5263212|NCT00572689|TCF7L2 polymorphism|tcf7l2 polymorphism
5263213|NCT00572689|Pharmacodynamics|pharmacodynamics
5263214|NCT00572689|Pharmacokinetics|pharmacokinetics
5263215|NCT00572663|Proteinuria|proteinuria
5263216|NCT00572663|Antioxidant|antioxidant
5263217|NCT00572663|N-acetylcysteine|n-acetylcysteine
5263218|NCT00572650|Type-2 diabetes, DPP-4 inhibitor, vildagliptin|type-2 diabetes, dpp-4 inhibitor, vildagliptin
5263219|NCT00572624|Heart Metabolism|heart metabolism
5263220|NCT00572624|Obesity|obesity
5263221|NCT00572624|Weight loss|weight loss
5263222|NCT00572624|Gastric bypass surgery|gastric bypass surgery
5263223|NCT00572624|Diet and exercise|diet and exercise
5263224|NCT00572611|Mass Balance|mass balance
5263225|NCT00572611|Metabolism|metabolism
5263226|NCT00572611|Absorption|absorption
5263227|NCT00572611|Excretion|excretion
5263228|NCT00572611|Pharmacokinetics|pharmacokinetics
5263229|NCT00572598|PET|pet
5263230|NCT00572598|multidrug resistance|multidrug resistance
5263231|NCT00572598|fluoropaclitaxel|fluoropaclitaxel
5263232|NCT00572598|paclitaxel|paclitaxel
5263233|NCT00572598|breast cancer|breast cancer
5263234|NCT00572598|dosimetry|dosimetry
5263235|NCT00572598|imaging feasibility|imaging feasibility
5263236|NCT00572585|Ulcerative colitis|ulcerative colitis
5263237|NCT00572585|immunosuppressive therapy|immunosuppressive therapy
5263238|NCT00572585|AEB071|aeb071
5263239|NCT00572585|Modified Baron score|modified baron score
5263240|NCT00572585|Partial Mayo score|partial mayo score
5263241|NCT00572533|End-Stage Renal Disease|end-stage renal disease
5263242|NCT00572533|Chronic Hemodialysis|chronic hemodialysis
5263243|NCT00572520|Depressive Disorder|depressive disorder
5263244|NCT00572520|Weight Loss|weight loss
5263245|NCT00572520|Behavioral Treatment|behavioral treatment
5263246|NCT00572520|Behavior Therapy|behavior therapy
5263247|NCT00572520|Randomized Clinical Trial|randomized clinical trial
5263248|NCT00572507|Absorbable Monofilament Suture Material|absorbable monofilament suture material
5263249|NCT00572507|Safety and Efficacy|safety and efficacy
5263250|NCT00572507|Abdominal Wall/ Fascia|abdominal wall/ fascia
5263251|NCT00572507|Laparotomy|laparotomy
5263252|NCT00572494|Tibial arteries|tibial arteries
5263253|NCT00572494|Absorbable implants|absorbable implants
5263254|NCT00572494|Stents|stents
5263255|NCT00572494|Limb salvage|limb salvage
5263256|NCT00572481|Sentinel Lymph Node Biopsy|sentinel lymph node biopsy
5263257|NCT00572481|Axillary Node Dissection|axillary node dissection
5263258|NCT00572481|Prevention of lymphedema|prevention of lymphedema
5263259|NCT00572481|Prevention of neuroma|prevention of neuroma
5263260|NCT00572481|Prevention of seroma|prevention of seroma
5263261|NCT00572468|cancer|cancer
5263262|NCT00572468|pre-operative surgery|pre-operative surgery
5263263|NCT00572468|prostate|prostate
5263264|NCT00572468|prostatectomy|prostatectomy
5263265|NCT00572468|radiation|radiation
5263266|NCT00572455|Open-Angle Glaucoma|open-angle glaucoma
5263267|NCT00572455|Ocular Hypertension|ocular hypertension
5263268|NCT00572442|Non-invasive heart scan|non-invasive heart scan
5263269|NCT00572442|MCG|mcg
5263270|NCT00572442|Cardiac Risk Factors|cardiac risk factors
5263271|NCT00572442|healthy volunteers|healthy volunteers
5263272|NCT00572429|HIV/AIDS|hiv/aids
5263273|NCT00572429|HAART|haart
5263274|NCT00572429|high cholesterol|high cholesterol
5263275|NCT00572429|exercise|exercise
5263276|NCT00572429|L-carnitine|l-carnitine
5263277|NCT00572429|Complimentary therapies|complimentary therapies
5263278|NCT00572416|fatigue|fatigue
5263279|NCT00572416|activity-rest|activity-rest
5263280|NCT00572416|sleep-wake|sleep-wake
5263281|NCT00572416|psychological distress|psychological distress
5263282|NCT00572416|symptom management|symptom management
5263283|NCT00572403|microalbuminuria|microalbuminuria
5263284|NCT00572403|risk factors|risk factors
5263285|NCT00572377|Sexual|sexual
5263286|NCT00572377|Arousal|arousal
5263287|NCT00572377|Female|female
5263288|NCT00572364|Cancer|cancer
5263289|NCT00572364|Advanced solid malignancies|advanced solid malignancies
5263290|NCT00572351|Wine|wine
5263291|NCT00572325|radiotherapy|radiotherapy
5263292|NCT00572325|NSCLC|nsclc
5263293|NCT00572325|stage III non-small cell lung cancer|stage iii non-small cell lung cancer
5263294|NCT00572312|Proteinuria,|proteinuria,
5263295|NCT00572312|atorvastatin|atorvastatin
5263385|NCT00571909|Chronic Kidney Pain|chronic kidney pain
5263296|NCT00572299|glucocorticoids, prednisone, alendronate,osteoclasts|glucocorticoids, prednisone, alendronate,osteoclasts
5263297|NCT00572286|heart transplant|heart transplant
5263298|NCT00572286|advanced heart failure|advanced heart failure
5263299|NCT00572286|orthotropic heart transplantation|orthotropic heart transplantation
5263300|NCT00572286|(MCG) magnetocardiograph|(mcg) magnetocardiograph
5263301|NCT00572286|echocardiogram|echocardiogram
5263302|NCT00572260|MRSA|mrsa
5263303|NCT00572260|Increased risk for infection|increased risk for infection
5263304|NCT00572234|Methamphetamine|methamphetamine
5263305|NCT00572234|Bupropion SR|bupropion sr
5263306|NCT00572221|CQI|cqi
5263307|NCT00572221|QA|qa
5263308|NCT00572221|Best Practice|best practice
5263309|NCT00572221|Quality Improvement|quality improvement
5263310|NCT00572221|Nursing Facilities|nursing facilities
5263311|NCT00572221|Nursing Homes|nursing homes
5263312|NCT00572221|Care|care
5263313|NCT00572195|Epilepsy|epilepsy
5263314|NCT00572195|Responsive neurostimulation|responsive neurostimulation
5263315|NCT00572195|RNS System|rns system
5263316|NCT00572195|NeuroPace|neuropace
5263317|NCT00572195|Brain stimulation|brain stimulation
5263318|NCT00572195|Seizures|seizures
5263319|NCT00572182|recurrent childhood brain stem glioma|recurrent childhood brain stem glioma
5263320|NCT00572182|childhood central nervous system germ cell tumor|childhood central nervous system germ cell tumor
5263321|NCT00572182|recurrent childhood cerebellar astrocytoma|recurrent childhood cerebellar astrocytoma
5263322|NCT00572182|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
5263323|NCT00572182|childhood high-grade cerebral astrocytoma|childhood high-grade cerebral astrocytoma
5263324|NCT00572182|childhood choroid plexus tumor|childhood choroid plexus tumor
5263325|NCT00572182|childhood craniopharyngioma|childhood craniopharyngioma
5263326|NCT00572182|recurrent childhood ependymoma|recurrent childhood ependymoma
5263327|NCT00572182|recurrent childhood medulloblastoma|recurrent childhood medulloblastoma
5263328|NCT00572182|childhood oligodendroglioma|childhood oligodendroglioma
5263329|NCT00572182|recurrent childhood pineoblastoma|recurrent childhood pineoblastoma
5263330|NCT00572182|recurrent childhood supratentorial primitive neuroectodermal tumor|recurrent childhood supratentorial primitive neuroectodermal tumor
5263331|NCT00572182|childhood atypical teratoid/rhabdoid tumor|childhood atypical teratoid/rhabdoid tumor
5263332|NCT00572182|childhood spinal cord neoplasm|childhood spinal cord neoplasm
5263333|NCT00572182|childhood infratentorial ependymoma|childhood infratentorial ependymoma
5263334|NCT00572182|childhood supratentorial ependymoma|childhood supratentorial ependymoma
5263335|NCT00572182|recurrent childhood visual pathway and hypothalamic glioma|recurrent childhood visual pathway and hypothalamic glioma
5263336|NCT00572182|childhood grade III meningioma|childhood grade iii meningioma
5263337|NCT00572156|IGF-1 Deficiency|igf-1 deficiency
5263338|NCT00572156|growth|growth
5263339|NCT00572156|ISS|iss
5263340|NCT00572156|Constitutional growth delay|constitutional growth delay
5263341|NCT00572156|Primary IGFD|primary igfd
5263342|NCT00572156|Primary IGF Deficiency|primary igf deficiency
5263343|NCT00572143|Colonic Neoplasms/surgery*|colonic neoplasms/surgery*
5263344|NCT00572143|Continuity of Patient Care*|continuity of patient care*
5263345|NCT00572143|Follow-Up Studies|follow-up studies
5263346|NCT00572143|Quality of Life|quality of life
5263347|NCT00572143|Patient Satisfaction|patient satisfaction
5263348|NCT00572130|Tumor-targeted gene medicine|tumor-targeted gene medicine
5263349|NCT00572130|Cyclin G1 gene|cyclin g1 gene
5263350|NCT00572130|Osteosarcoma|osteosarcoma
5263351|NCT00572117|Bipolar Disorder|bipolar disorder
5263352|NCT00572117|Manic Disorder|manic disorder
5263353|NCT00572117|Alcoholism|alcoholism
5263354|NCT00572117|Alcohol Abuse|alcohol abuse
5263355|NCT00572117|Alcohol Dependence|alcohol dependence
5263356|NCT00572117|Clinical Trial|clinical trial
5263357|NCT00572117|Evaluation Trial|evaluation trial
5263358|NCT00572117|Intervention Trial|intervention trial
5263359|NCT00572117|Validation Studies|validation studies
5263360|NCT00572091|Heart Failure|heart failure
5263361|NCT00572091|Mitral Regurgitation|mitral regurgitation
5263362|NCT00572078|solid tumor|solid tumor
5263363|NCT00572039|Age-Related Macular Degeneration|age-related macular degeneration
5263364|NCT00572039|AMD|amd
5263365|NCT00572039|Vision Function|vision function
5263366|NCT00572039|Problem Solving Treatment|problem solving treatment
5263367|NCT00572039|PST|pst
5263368|NCT00572026|Attention deficit|attention deficit
5263369|NCT00572026|Hyperactivity|hyperactivity
5263370|NCT00572026|Attention deficit hyperactivity disorder|attention deficit hyperactivity disorder
5263371|NCT00571987|Breast cancer|breast cancer
5263372|NCT00571987|Lumpectomy|lumpectomy
5263373|NCT00571987|Radiofrequency Ablation|radiofrequency ablation
5263374|NCT00571987|Negative margins|negative margins
5263375|NCT00571987|Breast Conserving Surgery|breast conserving surgery
5263377|NCT00571961|Pharmacokinetics|pharmacokinetics
5263378|NCT00571961|Buprenorphine|buprenorphine
5263379|NCT00571961|Kaletra|kaletra
5263380|NCT00571961|HIV Seronegativity|hiv seronegativity
5263381|NCT00571948|infant, complementary food, iron, meat, LC-PUFA, omega-3,|infant, complementary food, iron, meat, lc-pufa, omega-3,
5263382|NCT00571948|rapeseed oil, diet|rapeseed oil, diet
5263383|NCT00571922|methamphetamine, crystal, treatment|methamphetamine, crystal, treatment
5263384|NCT00571909|Polycystic Kidney Disease|polycystic kidney disease
5263386|NCT00571909|Autosomal Dominant Polycystic Kidney|autosomal dominant polycystic kidney
5263387|NCT00571909|Kidney Cyst|kidney cyst
5263388|NCT00571909|VSPL|vspl
5263389|NCT00571909|video thoracoscopic splanchnicectomy|video thoracoscopic splanchnicectomy
5263390|NCT00571896|constipation|constipation
5263391|NCT00571896|SennaS|sennas
5263392|NCT00571883|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
5263393|NCT00571883|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
5263394|NCT00571883|tongue cancer|tongue cancer
5263395|NCT00571844|High Blood Pressure|high blood pressure
5263396|NCT00571844|Exercise|exercise
5263397|NCT00571844|Diet|diet
5263398|NCT00571844|Biomarkers|biomarkers
5263399|NCT00571831|macula edema|macula edema
5263400|NCT00571831|intraocular lens|intraocular lens
5263401|NCT00571831|prospective randomized parallel clinical design|prospective randomized parallel clinical design
5263402|NCT00571818|euglycemic|euglycemic
5263403|NCT00571818|transplant|transplant
5263404|NCT00571818|pancreas|pancreas
5263405|NCT00571818|hyperglycemic|hyperglycemic
5263406|NCT00571818|kidney|kidney
5263407|NCT00571805|cigarette|cigarette
5263408|NCT00571805|craving|craving
5263409|NCT00571805|reward|reward
5263410|NCT00571792|COPD|copd
5263411|NCT00571792|The cohort will be comprised of normal non-smoking individuals, those individuals|the cohort will be comprised of normal non-smoking individuals, those individuals
5263412|NCT00571792|who smoke who do not exhibit symptoms of COPD and individuals who smoke who do demonstrate|who smoke who do not exhibit symptoms of copd and individuals who smoke who do demonstrate
5263413|NCT00571792|symptoms of COPD|symptoms of copd
5263414|NCT00571766|chronic hypertension in pregnancy|chronic hypertension in pregnancy
5263415|NCT00571766|chronic Hypertension|chronic hypertension
5263416|NCT00571753|pulmonary tuberculosis|pulmonary tuberculosis
5263417|NCT00571753|NAT2 genotyping|nat2 genotyping
5263418|NCT00571753|hepatotoxicity of isoniazid|hepatotoxicity of isoniazid
5263419|NCT00571740|stage IV colon cancer|stage iv colon cancer
5263420|NCT00571740|stage IV rectal cancer|stage iv rectal cancer
5263421|NCT00571740|recurrent colon cancer|recurrent colon cancer
5263422|NCT00571740|recurrent rectal cancer|recurrent rectal cancer
5263423|NCT00571727|growth|growth
5263424|NCT00571727|insulin like growth factor|insulin like growth factor
5263425|NCT00571727|Larons syndrome|larons syndrome
5263426|NCT00571714|Chronic hepatitis C|chronic hepatitis c
5263427|NCT00571714|Pilot Comparison|pilot comparison
5263428|NCT00571714|Peginterferon alph-2a|peginterferon alph-2a
5263429|NCT00571714|Ribavirin|ribavirin
5263430|NCT00571714|Betaine|betaine
5263431|NCT00571714|Genotype 1|genotype 1
5263432|NCT00571714|Treatment naive|treatment naive
5263433|NCT00571701|HPV|hpv
5263434|NCT00571701|RRP|rrp
5263435|NCT00571688|Bipolar Disorder|bipolar disorder
5263436|NCT00571688|Depression, Bipolar|depression, bipolar
5263437|NCT00571688|Mania|mania
5263438|NCT00571675|Prostate Cancer|prostate cancer
5263439|NCT00571675|Hormone Refractory Prostate Cancer|hormone refractory prostate cancer
5263440|NCT00571675|HRPC|hrpc
5263441|NCT00571675|Docetaxel|docetaxel
5263442|NCT00571675|Taxotere|taxotere
5263443|NCT00571675|Prednisone|prednisone
5263444|NCT00571675|Metastatic (Stage IV) Disease|metastatic (stage iv) disease
5263445|NCT00571675|Chemotherapy-naïve metastatic Hormone Refractory Prostate Cancer (HRPC)|chemotherapy-naïve metastatic hormone refractory prostate cancer (hrpc)
5263446|NCT00571649|Acute medical illnesses with increased risk for VTE.|acute medical illnesses with increased risk for vte.
5263447|NCT00571649|Deep vein thrombosis (DVT)|deep vein thrombosis (dvt)
5263448|NCT00571649|Pulmonary embolism (PE),|pulmonary embolism (pe),
5263449|NCT00571649|Venous Thromboembolic disease (VTE),|venous thromboembolic disease (vte),
5263450|NCT00571649|Medical illness|medical illness
5263451|NCT00571636|Opioids infusion|opioids infusion
5263452|NCT00571636|mechanical ventilation|mechanical ventilation
5263453|NCT00571623|Brain Injury|brain injury
5263454|NCT00571623|Intracranial hypertension|intracranial hypertension
5263455|NCT00571623|Human subjects|human subjects
5263456|NCT00571623|Nursing care|nursing care
5263457|NCT00571610|Heart Failure|heart failure
5263458|NCT00571610|Mitral Regurgitation|mitral regurgitation
5263459|NCT00571597|surgery|surgery
5263460|NCT00571597|ablation|ablation
5263461|NCT00571597|radiofrequency|radiofrequency
5263462|NCT00571597|minimaze|minimaze
5263463|NCT00571597|transtelephonic monitoring|transtelephonic monitoring
5263464|NCT00571571|Identity difussion|identity difussion
5263465|NCT00571571|Adolescent psychotherapy|adolescent psychotherapy
5263466|NCT00571571|Transference Focused Psychotherapy for Adolescents|transference focused psychotherapy for adolescents
5263467|NCT00571571|Identity|identity
5263468|NCT00571571|Identity crisis|identity crisis
5263469|NCT00571571|Identity pathology|identity pathology
5263470|NCT00571545|Traumatic brain injury|traumatic brain injury
5263471|NCT00571545|Depression|depression
5263472|NCT00571545|Exercise|exercise
5263473|NCT00571506|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
5263474|NCT00571506|Vascular Diseases|vascular diseases
5263475|NCT00571506|Thiazolidinediones|thiazolidinediones
5263476|NCT00571506|Platelet Aggregation|platelet aggregation
5263477|NCT00571493|non-hodgkin's lymphoma|non-hodgkin's lymphoma
5263478|NCT00571493|mantle cell lymphoma|mantle cell lymphoma
5263479|NCT00571493|BEAM|beam
5263480|NCT00571493|Velcade|velcade
5263481|NCT00571480|auricular acupuncture|auricular acupuncture
5263482|NCT00571480|pregnancy related low back pain|pregnancy related low back pain
5263483|NCT00571480|acupuncture|acupuncture
5263484|NCT00571467|Autoimmune Diseases|autoimmune diseases
5263485|NCT00571467|Bleeding Disorders|bleeding disorders
5263486|NCT00571467|Blood and Blood Disorders|blood and blood disorders
5263487|NCT00571454|depression|depression
5263488|NCT00571454|primary care|primary care
5263489|NCT00571454|Latino|latino
5263490|NCT00571454|telephone|telephone
5263491|NCT00571454|care management|care management
5263492|NCT00571441|stroke|stroke
5263493|NCT00571441|Brain injury|brain injury
5263494|NCT00571441|nursing|nursing
5263495|NCT00571441|Critical care|critical care
5263496|NCT00571428|COPD|copd
5263497|NCT00571428|Chronic Bronchitis|chronic bronchitis
5263498|NCT00571428|Emphysema|emphysema
5263499|NCT00571415|Image guided adaptive radiotherapy|image guided adaptive radiotherapy
5263500|NCT00571402|Family Treatment|family treatment
5263501|NCT00571402|Pharmacotherapy|pharmacotherapy
5263502|NCT00571389|Stage IV|stage iv
5263503|NCT00571389|Advanced Stage III|advanced stage iii
5263504|NCT00571376|Quality of health care|quality of health care
5263505|NCT00571376|Health care costs|health care costs
5263506|NCT00571350|Cystocele|cystocele
5263507|NCT00571350|tension free vaginal tapes|tension free vaginal tapes
5263508|NCT00571350|urinary incontinence|urinary incontinence
5263509|NCT00571337|Stop infliximab.|stop infliximab.
5263510|NCT00571324|hyperinsulinism|hyperinsulinism
5263511|NCT00571324|hypoglycemia|hypoglycemia
5263512|NCT00571324|KATP channel|katp channel
5263513|NCT00571324|Kir6.2|kir6.2
5263514|NCT00571311|Assent|assent
5263515|NCT00571311|Adolescent|adolescent
5263516|NCT00571311|Informed Consent|informed consent
5263517|NCT00571298|Extrapleural pneumonectomy|extrapleural pneumonectomy
5263518|NCT00571298|Pleurectomy Decortication|pleurectomy decortication
5263519|NCT00571298|Mesothelioma|mesothelioma
5263520|NCT00571298|cisplatin|cisplatin
5263521|NCT00571298|gemcitabine|gemcitabine
5263522|NCT00571298|amifostine|amifostine
5263523|NCT00571298|sodium thiosulfate|sodium thiosulfate
5263524|NCT00571285|Parkinson's disease|parkinson's disease
5263525|NCT00571285|Nutrition|nutrition
5263526|NCT00571285|Vitamin supplement|vitamin supplement
5263527|NCT00571285|Motor function|motor function
5263528|NCT00571285|Non-motor function|non-motor function
5263529|NCT00571272|Cholestatic Liver Disease|cholestatic liver disease
5263530|NCT00571272|Cholestasis|cholestasis
5263531|NCT00571272|Childhood Diseases|childhood diseases
5263532|NCT00571272|Genetic Diseases|genetic diseases
5263533|NCT00571272|Bile Acid Synthesis and Metabolism Defects|bile acid synthesis and metabolism defects
5263534|NCT00571272|Progressive Familial Intrahepatic Cholestasis|progressive familial intrahepatic cholestasis
5263535|NCT00571259|Sodium citrate|sodium citrate
5263536|NCT00571259|Gentamicin|gentamicin
5263537|NCT00571259|Prophylaxis|prophylaxis
5263538|NCT00571259|Hemodialysis|hemodialysis
5263539|NCT00571259|Central venous catheter|central venous catheter
5263540|NCT00571246|treatment|treatment
5263541|NCT00571246|Lamotrigine|lamotrigine
5263542|NCT00571246|Topiramate|topiramate
5263543|NCT00571246|alcohol dependence|alcohol dependence
5263544|NCT00571246|post traumatic stress disorder|post traumatic stress disorder
5263545|NCT00571233|Single Ventricle|single ventricle
5263546|NCT00571233|Congenital Heart Disease|congenital heart disease
5263547|NCT00571233|Children|children
5263548|NCT00571233|Fontan|fontan
5263549|NCT00571233|Tricuspid Atresia|tricuspid atresia
5263550|NCT00571233|Hypoplastic Left Heart Syndrome|hypoplastic left heart syndrome
5263551|NCT00571233|Heart Failure|heart failure
5263552|NCT00571233|Biomarkers|biomarkers
5263553|NCT00571233|Single ventricle physiology such as:|single ventricle physiology such as:
5263554|NCT00571233|unbalanced AV canal|unbalanced av canal
5263555|NCT00571233|Interested in patients both before and after Fontan Surgery|interested in patients both before and after fontan surgery
5263556|NCT00571220|gastric bypass|gastric bypass
5263557|NCT00571220|diabetes|diabetes
5263558|NCT00571220|obesity|obesity
5263559|NCT00571220|diet-induced weight loss|diet-induced weight loss
5263560|NCT00571220|incretin levels (GLP-1,GIP)|incretin levels (glp-1,gip)
5263561|NCT00571220|incretin effect|incretin effect
5263562|NCT00571207|driving under the influence of drugs|driving under the influence of drugs
5263563|NCT00571207|on-site oral fluid screening devices|on-site oral fluid screening devices
5263564|NCT00571207|checklist|checklist
5263565|NCT00571194|pravastatin, peritoneal dialysis, pediatric patients|pravastatin, peritoneal dialysis, pediatric patients
5263566|NCT00571181|Algorithms|algorithms
5263567|NCT00571181|Anesthesia, General/*methods|anesthesia, general/*methods
5263568|NCT00571181|Anesthetics, Intravenous/*administration & dosage|anesthetics, intravenous/*administration & dosage
5263569|NCT00571181|Drug Delivery Systems/*methods/statistics & numerical data|drug delivery systems/*methods/statistics & numerical data
5263570|NCT00571181|Electroencephalography/drug effects/*methods/|electroencephalography/drug effects/*methods/
5263571|NCT00571181|Feasibility Studies|feasibility studies
5263666|NCT00570791|Pneumatonometer|pneumatonometer
5263572|NCT00571181|Propofol/*administration & dosage|propofol/*administration & dosage
5263573|NCT00571181|Remifentanil/*administration & dosage|remifentanil/*administration & dosage
5263574|NCT00571181|Bronchoscopy/*methods|bronchoscopy/*methods
5263575|NCT00571181|Prospective Studies|prospective studies
5263576|NCT00571181|Software|software
5263577|NCT00571168|chemotherapy induced nausea and vomiting|chemotherapy induced nausea and vomiting
5263578|NCT00571168|autologous peripheral blood stemcell transplantation|autologous peripheral blood stemcell transplantation
5263579|NCT00571168|high dose chemotherapy|high dose chemotherapy
5263580|NCT00571142|edema|edema
5263581|NCT00571142|retinal thickness|retinal thickness
5263582|NCT00571142|diabetic retinopathy|diabetic retinopathy
5263583|NCT00571129|Primary,silicone tube,revision,mitomycin C,endoscopic DCR|primary,silicone tube,revision,mitomycin c,endoscopic dcr
5263584|NCT00571116|Metastatic Melanoma|metastatic melanoma
5263585|NCT00571116|Disulfiram|disulfiram
5263586|NCT00571116|Arsenic Trioxide|arsenic trioxide
5263587|NCT00571116|Metastatic Melanoma and at Least One Prior Systemic Therapy|metastatic melanoma and at least one prior systemic therapy
5263588|NCT00571103|acamprosate, impulse-control disorders|acamprosate, impulse-control disorders
5263589|NCT00571090|Thyroid nodule|thyroid nodule
5263590|NCT00571090|Biopsy, Fine-Needle|biopsy, fine-needle
5263591|NCT00571077|Thyroid neoplasms|thyroid neoplasms
5263592|NCT00571077|thyroid nodules|thyroid nodules
5263593|NCT00571077|electrical impedance scanning|electrical impedance scanning
5263594|NCT00571051|MEG, mindfulness, tactile perception|meg, mindfulness, tactile perception
5263595|NCT00571038|Hypertension|hypertension
5263596|NCT00571038|Self-help groups|self-help groups
5263597|NCT00571038|Community health networks|community health networks
5263598|NCT00571038|Health knowledge, attitudes, practice|health knowledge, attitudes, practice
5263599|NCT00571038|Patient participation|patient participation
5263600|NCT00571038|Randomized clinical trial|randomized clinical trial
5263601|NCT00571025|Mild Cognitive Impairment|mild cognitive impairment
5263602|NCT00571025|disease/disorder proneness/risk|disease/disorder proneness/risk
5263603|NCT00571025|family genetics|family genetics
5263604|NCT00571025|genetic counseling|genetic counseling
5263605|NCT00571025|genetic marker|genetic marker
5263606|NCT00571025|genetic polymorphism|genetic polymorphism
5263607|NCT00571025|genetic susceptibility|genetic susceptibility
5263608|NCT00571012|glaucoma|glaucoma
5263609|NCT00571012|outflow facility|outflow facility
5263610|NCT00571012|Healthy eye function|healthy eye function
5263855|NCT00569790|Irinotecan|irinotecan
5263611|NCT00570999|Peripheral blood stem cell transplantation|peripheral blood stem cell transplantation
5263612|NCT00570999|Palifermin|palifermin
5263613|NCT00570999|Kepivance|kepivance
5263614|NCT00570999|Prevenar|prevenar
5263616|NCT00570986|Plaque Psoriasis|plaque psoriasis
5263617|NCT00570973|Variceal Bleeding|variceal bleeding
5263618|NCT00570973|Cirrhosis|cirrhosis
5263619|NCT00570973|Encephalopathy|encephalopathy
5263620|NCT00570973|Endoscopic band ligation|endoscopic band ligation
5263621|NCT00570973|TIPS|tips
5263622|NCT00570960|Peritonitis|peritonitis
5263623|NCT00570947|CPR Anytime|cpr anytime
5263624|NCT00570921|Breast cancer|breast cancer
5263625|NCT00570921|Fulvestrant|fulvestrant
5263626|NCT00570921|Everolimus|everolimus
5263627|NCT00570908|brain metastasis|brain metastasis
5263628|NCT00570908|breast cancer|breast cancer
5263629|NCT00570908|metastatic breast cancer|metastatic breast cancer
5263630|NCT00570895|Iron|iron
5263631|NCT00570895|Absorption|absorption
5263632|NCT00570895|Ascorbic Acid|ascorbic acid
5263633|NCT00570895|Ferrous Fumarate|ferrous fumarate
5263634|NCT00570882|Renal cell carcinoma|renal cell carcinoma
5263635|NCT00570882|Sunitinib|sunitinib
5263636|NCT00570882|phase II study|phase ii study
5263637|NCT00570882|Randomized study|randomized study
5263638|NCT00570869|Infant CPR|infant cpr
5263639|NCT00570856|Folic Acid|folic acid
5263640|NCT00570856|Homocysteine|homocysteine
5263641|NCT00570856|intima-media thickness|intima-media thickness
5263642|NCT00570817|Methotrexate|methotrexate
5263643|NCT00570817|Nephrotoxicity|nephrotoxicity
5263644|NCT00570817|Hydration|hydration
5263645|NCT00570817|Acute lymphoblastic leukemia|acute lymphoblastic leukemia
5263646|NCT00570817|Non-Hodgkin's lymphoma|non-hodgkin's lymphoma
5263647|NCT00570817|Medulloblastoma|medulloblastoma
5263648|NCT00570817|Ependymoma|ependymoma
5263649|NCT00570817|Prolonged elimination time of methotrexate|prolonged elimination time of methotrexate
5263650|NCT00570804|Smoking Cessation|smoking cessation
5263651|NCT00570804|Puerto Rico Quitline|puerto rico quitline
5263652|NCT00570804|Motivational Relapse Prevention|motivational relapse prevention
5263653|NCT00570804|Oral Cancer|oral cancer
5263654|NCT00570804|Risk Reduction|risk reduction
5263655|NCT00570804|Tobacco Use|tobacco use
5263656|NCT00570804|Alcohol Use|alcohol use
5263657|NCT00570804|MAPS|maps
5263658|NCT00570804|Motivation and Problem-Solving|motivation and problem-solving
5263659|NCT00570804|Telephone Interview|telephone interview
5263660|NCT00570804|Counseling|counseling
5263661|NCT00570791|Cornea|cornea
5263662|NCT00570791|Tonometers|tonometers
5263663|NCT00570791|Goldmann applanation|goldmann applanation
5263664|NCT00570791|Tonopen|tonopen
5263665|NCT00570791|Shiotz|shiotz
5263667|NCT00570778|QVA, Indacaterol, Glycopyrrolate, Concept1, COPD, cross over study, safety and efficacy, trough FEV1|qva, indacaterol, glycopyrrolate, concept1, copd, cross over study, safety and efficacy, trough fev1
5263668|NCT00570739|Colesevelam|colesevelam
5263669|NCT00570739|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
5263670|NCT00570739|Pre-diabetes|pre-diabetes
5263671|NCT00570739|Metformin|metformin
5263672|NCT00570700|prostate|prostate
5263673|NCT00570687|Inhaled Insulin|inhaled insulin
5263674|NCT00570674|SSCHN|sschn
5263675|NCT00570674|Abraxane|abraxane
5263676|NCT00570674|IMRT|imrt
5263677|NCT00570648|Corneal transplantation|corneal transplantation
5263678|NCT00570635|GIST|gist
5263679|NCT00570635|Gastrointestinal Cancer|gastrointestinal cancer
5263680|NCT00570622|Cirrhosis|cirrhosis
5263681|NCT00570622|oxidative stress|oxidative stress
5263682|NCT00570622|pioglitazone|pioglitazone
5263683|NCT00570609|CPR|cpr
5263684|NCT00570583|Depression|depression
5263685|NCT00570583|Cognitive impairment|cognitive impairment
5263686|NCT00570583|Dementia|dementia
5263687|NCT00570583|Neuroimaging|neuroimaging
5263688|NCT00570583|Genetics|genetics
5263689|NCT00570570|stroke|stroke
5263690|NCT00570570|hemiplegia|hemiplegia
5263691|NCT00570570|gait|gait
5263692|NCT00570570|Strengthening|strengthening
5263693|NCT00570570|Physiotherapy|physiotherapy
5263694|NCT00570557|Skill Maintenance|skill maintenance
5263695|NCT00570557|Skill Decay|skill decay
5263696|NCT00570557|Screening|screening
5263697|NCT00570544|copd|copd
5263698|NCT00570544|emphysema|emphysema
5263699|NCT00570544|tiotropium|tiotropium
5263700|NCT00570544|lung function|lung function
5263701|NCT00570544|dynamic hyperinflation|dynamic hyperinflation
5263702|NCT00570518|driving under the influence|driving under the influence
5263703|NCT00570518|psychoactive substances|psychoactive substances
5263704|NCT00570518|roadside surveys|roadside surveys
5263705|NCT00570518|hospital surveys|hospital surveys
5263706|NCT00570518|accident involvement risk estimation|accident involvement risk estimation
5263707|NCT00570492|allergic rhinitis|allergic rhinitis
5263708|NCT00570492|fluticasone furoate nasal spray|fluticasone furoate nasal spray
5263709|NCT00570492|growth|growth
5263710|NCT00570479|Retisert|retisert
5263711|NCT00570479|Uveitis|uveitis
5263712|NCT00570479|glaucoma|glaucoma
5263713|NCT00570466|Type 2 Diabetes|type 2 diabetes
5263714|NCT00570466|Prevention|prevention
5263715|NCT00570466|Children|children
5263716|NCT00570466|Diet|diet
5263717|NCT00570466|Physical Activity|physical activity
5263718|NCT00570440|AE adverse event|ae adverse event
5263719|NCT00570440|AIDS acquired immunodeficiency syndrome|aids acquired immunodeficiency syndrome
5263720|NCT00570440|ALT (SGPT) alanine aminotransferase|alt (sgpt) alanine aminotransferase
5263721|NCT00570440|ART antiretroviral therapy|art antiretroviral therapy
5263722|NCT00570440|AST (SGOT) aspartate aminotransferase|ast (sgot) aspartate aminotransferase
5263723|NCT00570440|DCF data collection forms|dcf data collection forms
5263724|NCT00570440|DMC Data Monitoring Committee|dmc data monitoring committee
5263725|NCT00570440|FDA (U.S.) Food and Drug Administration|fda (u.s.) food and drug administration
5263726|NCT00570440|GCP Good Clinical Practice guidelines|gcp good clinical practice guidelines
5263727|NCT00570440|HB sAg Hepatitis B surface antigen|hb sag hepatitis b surface antigen
5263728|NCT00570440|ICH International Conference of Harmonisation|ich international conference of harmonisation
5263729|NCT00570440|IND Investigational New Drug Application|ind investigational new drug application
5263730|NCT00570440|IRB Institutional Review Board|irb institutional review board
5263731|NCT00570440|IU international units|iu international units
5263732|NCT00570440|mg milligram(s)|mg milligram(s)
5263733|NCT00570440|mm3 cubic millimeter(s)|mm3 cubic millimeter(s)
5263734|NCT00570440|PCR polymerase chain reaction|pcr polymerase chain reaction
5263735|NCT00570440|SAE serious adverse event|sae serious adverse event
5263736|NCT00570440|µg microgram|µg microgram
5263737|NCT00570440|ULN upper limit of the normal range|uln upper limit of the normal range
5263738|NCT00570440|WB Western Blot|wb western blot
5263739|NCT00570427|psychotherapy|psychotherapy
5263740|NCT00570427|behavior therapy|behavior therapy
5263741|NCT00570427|counseling|counseling
5263742|NCT00570427|aging|aging
5263743|NCT00570427|medically underserved population|medically underserved population
5263744|NCT00570401|adenocarcinoma of the lung|adenocarcinoma of the lung
5263745|NCT00570401|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5263746|NCT00570401|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5263747|NCT00570401|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5263748|NCT00570401|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5263749|NCT00570388|Neurocognitive|neurocognitive
5263750|NCT00570388|Alcohol Dependence|alcohol dependence
5263751|NCT00570388|Prometa|prometa
5263752|NCT00570388|Prometa Protocol|prometa protocol
5263753|NCT00570388|Starosta|starosta
5263754|NCT00570375|Blood disease, bone marrow|blood disease, bone marrow
5263755|NCT00570362|Normal tension glaucoma|normal tension glaucoma
5263756|NCT00570362|Glutathione|glutathione
5263757|NCT00570362|Antioxidant|antioxidant
5263758|NCT00570349|Inhaled Nitric oxide|inhaled nitric oxide
5263759|NCT00570349|Cystic Fibrosis|cystic fibrosis
5263760|NCT00570336|HCV|hcv
5263761|NCT00570336|HCV treatment failure|hcv treatment failure
5263762|NCT00570336|Elevated aminotransferases|elevated aminotransferases
5263763|NCT00570323|Breast Cancer|breast cancer
5263764|NCT00570323|HORMONE RECEPTOR POSITIVE BREAST CANCER|hormone receptor positive breast cancer
5263765|NCT00570297|Pediatric|pediatric
5263766|NCT00570297|Polymorphism, Genetic|polymorphism, genetic
5263767|NCT00570297|Adrenergic beta-Agonists|adrenergic beta-agonists
5263768|NCT00570284|Cancer|cancer
5263769|NCT00570284|solid tumor|solid tumor
5263770|NCT00570284|food effect|food effect
5263771|NCT00570284|HDAC inhibitor|hdac inhibitor
5263772|NCT00570284|oral|oral
5263773|NCT00570284|LBH589|lbh589
5263774|NCT00570271|placebo effect|placebo effect
5263775|NCT00570271|blood pressure|blood pressure
5263776|NCT00570271|autonomic nervous system|autonomic nervous system
5263777|NCT00570271|prestige|prestige
5263778|NCT00570271|basic research on physiological placebo effects|basic research on physiological placebo effects
5263779|NCT00570245|Lung transplantation|lung transplantation
5263780|NCT00570232|Resectable, recurrent head and neck cancer|resectable, recurrent head and neck cancer
5263781|NCT00570206|Probation|probation
5263782|NCT00570206|Motivational|motivational
5263783|NCT00570180|newly diagnosed|newly diagnosed
5263784|NCT00570167|Osteoarthritis|osteoarthritis
5263785|NCT00570167|Hip|hip
5263786|NCT00570167|Artroplasty|artroplasty
5263787|NCT00570167|Resurfacing|resurfacing
5263788|NCT00570154|Mitochondrial Function in Monocytes|mitochondrial function in monocytes
5263789|NCT00570154|Macrophages and Diabetes or Insulin Resistance|macrophages and diabetes or insulin resistance
5263790|NCT00570154|Peripheral Blood Mononuclear Cells|peripheral blood mononuclear cells
5263791|NCT00570154|Diabetes|diabetes
5263792|NCT00570154|Monocyte|monocyte
5263793|NCT00570154|Macrophages|macrophages
5263794|NCT00570154|Proteome|proteome
5263795|NCT00570154|Type 2 Diabetes|type 2 diabetes
5263796|NCT00570154|Insulin Resistance|insulin resistance
5263797|NCT00570154|Insulin Sensitivity|insulin sensitivity
5263798|NCT00570154|Pre-Diabetes|pre-diabetes
5263799|NCT00570154|Healthy Volunteer|healthy volunteer
5263800|NCT00570154|HV|hv
5263801|NCT00570128|Down Syndrome|down syndrome
5263802|NCT00570128|trisomy 21|trisomy 21
5263803|NCT00570115|Sleep Apnea Syndromes diastolic disfunction left atrium|sleep apnea syndromes diastolic disfunction left atrium
5263804|NCT00570102|dietary manipulation|dietary manipulation
5263805|NCT00570102|infants|infants
5263806|NCT00570102|feasibility|feasibility
5263807|NCT00570102|Type 1 Diabetes Mellitus, Beta-cell Autoimmunity|type 1 diabetes mellitus, beta-cell autoimmunity
5263808|NCT00570089|Ranolazine|ranolazine
5263809|NCT00570089|Myocardial ischemia|myocardial ischemia
5263810|NCT00570089|Double blinded|double blinded
5263811|NCT00570089|Placebo controlled|placebo controlled
5263812|NCT00570063|Schizophrenia|schizophrenia
5263813|NCT00570063|acute exacerbation|acute exacerbation
5263814|NCT00570063|and PF-02545920|and pf-02545920
5263815|NCT00570050|Major Depressive Disorder, Memory, Executive function|major depressive disorder, memory, executive function
5263816|NCT00570037|Influenza|influenza
5263817|NCT00570037|Vaccine|vaccine
5263818|NCT00570037|Children|children
5263819|NCT00570024|Acupuncture|acupuncture
5263820|NCT00570024|Coronary Artery Disease|coronary artery disease
5263821|NCT00569985|AIDS-related diffuse large cell lymphoma|aids-related diffuse large cell lymphoma
5263822|NCT00569985|AIDS-related diffuse mixed cell lymphoma|aids-related diffuse mixed cell lymphoma
5263823|NCT00569985|AIDS-related diffuse small cleaved cell lymphoma|aids-related diffuse small cleaved cell lymphoma
5263824|NCT00569985|AIDS-related immunoblastic large cell lymphoma|aids-related immunoblastic large cell lymphoma
5263825|NCT00569985|AIDS-related small noncleaved cell lymphoma|aids-related small noncleaved cell lymphoma
5263826|NCT00569985|HIV-associated Hodgkin lymphoma|hiv-associated hodgkin lymphoma
5263827|NCT00569985|Treatment Experienced|treatment experienced
5263828|NCT00569959|fasting lipid measures|fasting lipid measures
5263829|NCT00569959|non-fasting lipid measures|non-fasting lipid measures
5263830|NCT00569959|clinical decision-making|clinical decision-making
5263831|NCT00569959|LDL-Cholesterol|ldl-cholesterol
5263832|NCT00569946|AG-013736|ag-013736
5263833|NCT00569946|RCC|rcc
5263834|NCT00569946|Phase 2|phase 2
5263835|NCT00569933|Hip Surgery|hip surgery
5263836|NCT00569933|Perioperative|perioperative
5263837|NCT00569933|suggestions/imagery|suggestions/imagery
5263838|NCT00569907|type 2 diabetes|type 2 diabetes
5263839|NCT00569907|continuous glucose monitoring|continuous glucose monitoring
5263840|NCT00569907|exenatide|exenatide
5263841|NCT00569907|exenatide use|exenatide use
5263842|NCT00569881|Epithelium|epithelium
5263843|NCT00569881|Wound Healing|wound healing
5263844|NCT00569881|PRK|prk
5263845|NCT00569868|PLASMACYTOMA|plasmacytoma
5263846|NCT00569829|cognitive behavioral therapy|cognitive behavioral therapy
5263847|NCT00569829|anxiety disorders|anxiety disorders
5263848|NCT00569829|school-based intervention|school-based intervention
5263849|NCT00569829|randomized, controlled trial|randomized, controlled trial
5263850|NCT00569816|myocardial protection|myocardial protection
5263851|NCT00569816|pharmacological preconditioning|pharmacological preconditioning
5263852|NCT00569816|volatile anesthetics|volatile anesthetics
5263853|NCT00569816|myocardial injury following CABG surgery|myocardial injury following cabg surgery
5263856|NCT00569790|Bevacizumab|bevacizumab
5263857|NCT00569764|schizophrenia|schizophrenia
5263858|NCT00569764|metabolic syndrome|metabolic syndrome
5263859|NCT00569764|aripiprazole|aripiprazole
5263860|NCT00569751|de novo|de novo
5263861|NCT00569751|coronary|coronary
5263862|NCT00569751|coronary artery disease|coronary artery disease
5263863|NCT00569751|coronary disease|coronary disease
5263864|NCT00569738|neuroendocrine tumor|neuroendocrine tumor
5263865|NCT00569738|somatostatin analog|somatostatin analog
5263866|NCT00569738|Gallium 68|gallium 68
5263867|NCT00569738|PET|pet
5263868|NCT00569712|non-small cell lung cancer|non-small cell lung cancer
5263869|NCT00569712|precancerous condition|precancerous condition
5263870|NCT00569699|S-1|s-1
5263871|NCT00569699|Bevacizumab|bevacizumab
5263872|NCT00569686|PAD|pad
5263873|NCT00569686|peripheral artery disease|peripheral artery disease
5263874|NCT00569673|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5263875|NCT00569673|fallopian tube cancer|fallopian tube cancer
5263876|NCT00569673|primary peritoneal cavity cancer|primary peritoneal cavity cancer
5263877|NCT00569660|Myelofibrosis|myelofibrosis
5263878|NCT00569660|MF|mf
5263879|NCT00569660|Leukemia|leukemia
5263880|NCT00569660|Azacitidine|azacitidine
5263881|NCT00569660|Vidaza|vidaza
5263882|NCT00569647|preoperative anxiety|preoperative anxiety
5263883|NCT00569647|burn reconstruction|burn reconstruction
5263884|NCT00569634|Venous blood gas|venous blood gas
5263885|NCT00569634|Arterial blood gas|arterial blood gas
5263886|NCT00569634|pH|ph
5263887|NCT00569634|pCO2|pco2
5263888|NCT00569634|Bicarbonate|bicarbonate
5263889|NCT00569608|Parental stress|parental stress
5263890|NCT00569608|Early discharge|early discharge
5263891|NCT00569608|Anxiety|anxiety
5263892|NCT00569608|Depression|depression
5263893|NCT00569608|Neonatal Intensive Care Unit|neonatal intensive care unit
5263894|NCT00569595|Prevention of Diabetes and other chronic diseases|prevention of diabetes and other chronic diseases
5263895|NCT00569582|Cushing's Disease|cushing's disease
5263896|NCT00569582|Cushing's Syndrome|cushing's syndrome
5263897|NCT00569582|Cushings|cushings
5263898|NCT00569582|Pituitary|pituitary
5263899|NCT00569582|ACTH|acth
5263900|NCT00569582|Adrenocorticotropic hormone|adrenocorticotropic hormone
5263901|NCT00569582|Ectopic|ectopic
5263902|NCT00569582|Adrenal adenoma|adrenal adenoma
5263903|NCT00569582|Adrenal carcinoma|adrenal carcinoma
5263904|NCT00569582|Adrenal autonomy|adrenal autonomy
5263905|NCT00569582|Cortisol|cortisol
5263906|NCT00569582|Hypercortisolemia|hypercortisolemia
5263907|NCT00569582|Cushingoid|cushingoid
5263908|NCT00569582|Moon facies|moon facies
5263909|NCT00569582|Dorsocervical fat|dorsocervical fat
5263910|NCT00569582|Plethora|plethora
5263911|NCT00569582|Hirsutism|hirsutism
5263912|NCT00569582|Violaceous striae|violaceous striae
5263913|NCT00569582|Hormone|hormone
5263914|NCT00569582|Contraceptive|contraceptive
5263915|NCT00569582|Endocrine|endocrine
5263916|NCT00569582|Cushing Syndrome|cushing syndrome
5263917|NCT00569582|Ectopic ACTH Secretion|ectopic acth secretion
5263918|NCT00569556|Diabetes Mellitus|diabetes mellitus
5263919|NCT00569556|Chronic Care Model|chronic care model
5263920|NCT00569556|Case Management|case management
5263921|NCT00569543|breast cancer in situ|breast cancer in situ
5263922|NCT00569543|ductal breast carcinoma in situ|ductal breast carcinoma in situ
5263923|NCT00569543|stage I breast cancer|stage i breast cancer
5263924|NCT00569543|stage II breast cancer|stage ii breast cancer
5263925|NCT00569543|stage IIIA breast cancer|stage iiia breast cancer
5263926|NCT00569543|stage IIIB breast cancer|stage iiib breast cancer
5263927|NCT00569543|stage IIIC breast cancer|stage iiic breast cancer
5263928|NCT00569543|stage IV breast cancer|stage iv breast cancer
5263929|NCT00569530|nitric oxide|nitric oxide
5263930|NCT00569530|surfactant|surfactant
5263931|NCT00569530|bronchopulmonary dysplasia|bronchopulmonary dysplasia
5263932|NCT00569530|prematurity|prematurity
5263933|NCT00569530|neonates|neonates
5263934|NCT00569530|iNO|ino
5263935|NCT00569530|Infasurf|infasurf
5263936|NCT00569530|lung function|lung function
5263937|NCT00569530|ventilated infants|ventilated infants
5263938|NCT00569517|obesity|obesity
5263939|NCT00569517|CBT|cbt
5263940|NCT00569517|Atypical antipsychotics|atypical antipsychotics
5263941|NCT00569517|metabolic syndrome|metabolic syndrome
5263942|NCT00569504|schizophrenia|schizophrenia
5263943|NCT00569504|antipsychotics|antipsychotics
5263944|NCT00569504|metabolic syndrome|metabolic syndrome
5263945|NCT00569504|prevalence|prevalence
5263946|NCT00569478|ICD|icd
5263947|NCT00569478|Rehabilitation|rehabilitation
5263948|NCT00569465|nitric oxide|nitric oxide
5263949|NCT00569465|oxidative stress|oxidative stress
5263950|NCT00569465|diabetes|diabetes
5263951|NCT00569465|hypertension|hypertension
5263952|NCT00569465|endothelial dysfunction|endothelial dysfunction
5263953|NCT00569439|Labor|labor
5263954|NCT00569439|Carbohydrate|carbohydrate
5263955|NCT00569439|Dystocia|dystocia
5263956|NCT00569413|Sex|sex
5263957|NCT00569413|brain imaging|brain imaging
5263958|NCT00569413|dopamine|dopamine
5263959|NCT00569413|sexual disorder|sexual disorder
5265245|NCT00563875|Aspirin|aspirin
5263960|NCT00569387|pancreatic cancer|pancreatic cancer
5263961|NCT00569387|vaccine|vaccine
5263962|NCT00569361|allergic rhinitis to dust mite|allergic rhinitis to dust mite
5263963|NCT00569361|allergic rhinitis associated with bronchial hyperreactivity|allergic rhinitis associated with bronchial hyperreactivity
5263964|NCT00569361|allergic rhinitis associated with asthma|allergic rhinitis associated with asthma
5263965|NCT00569335|S-1, Bevacizumab, Irinotecan|s-1, bevacizumab, irinotecan
5263966|NCT00569322|ICU|icu
5263967|NCT00569322|Admission|admission
5263968|NCT00569322|BG|bg
5263969|NCT00569309|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
5263970|NCT00569309|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5263971|NCT00569309|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5263972|NCT00569309|stage I mantle cell lymphoma|stage i mantle cell lymphoma
5263973|NCT00569309|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5263974|NCT00569309|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5263975|NCT00569309|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5263976|NCT00569309|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5263977|NCT00569309|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5263978|NCT00569309|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
5263979|NCT00569309|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
5263980|NCT00569309|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
5263981|NCT00569309|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5263982|NCT00569309|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5263983|NCT00569309|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5263984|NCT00569309|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5263985|NCT00569309|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5263986|NCT00569309|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5263987|NCT00569309|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
5263988|NCT00569309|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
5263989|NCT00569309|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
5263990|NCT00569309|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5263991|NCT00569309|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5263992|NCT00569309|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5263993|NCT00569309|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5263994|NCT00569309|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5263995|NCT00569309|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5263996|NCT00569309|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5263997|NCT00569309|stage I multiple myeloma|stage i multiple myeloma
5263998|NCT00569309|stage II multiple myeloma|stage ii multiple myeloma
5263999|NCT00569309|stage III multiple myeloma|stage iii multiple myeloma
5264000|NCT00569309|refractory multiple myeloma|refractory multiple myeloma
5264001|NCT00569309|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
5264002|NCT00569309|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5264003|NCT00569309|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
5264004|NCT00569309|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
5264005|NCT00569309|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
5264006|NCT00569309|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5264007|NCT00569309|small intestine lymphoma|small intestine lymphoma
5264008|NCT00569296|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5264009|NCT00569296|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5264010|NCT00569283|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5264011|NCT00569283|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5264012|NCT00569283|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5264013|NCT00569283|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5264014|NCT00569283|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5264015|NCT00569283|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5264016|NCT00569283|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5264017|NCT00569283|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5264018|NCT00569283|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
5264019|NCT00569283|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5264020|NCT00569283|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
5264021|NCT00569283|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
5264022|NCT00569283|chronic eosinophilic leukemia|chronic eosinophilic leukemia
5264023|NCT00569283|primary myelofibrosis|primary myelofibrosis
5264024|NCT00569283|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5264025|NCT00569283|chronic neutrophilic leukemia|chronic neutrophilic leukemia
5265342|NCT00563446|Anemia|anemia
5264026|NCT00569283|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5264027|NCT00569283|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5264028|NCT00569283|disseminated neuroblastoma|disseminated neuroblastoma
5264029|NCT00569283|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5264030|NCT00569283|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
5264031|NCT00569283|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
5264032|NCT00569283|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5264033|NCT00569283|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
5264034|NCT00569283|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5264035|NCT00569283|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
5264036|NCT00569283|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
5264037|NCT00569283|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
5264038|NCT00569283|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
5264039|NCT00569283|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5264040|NCT00569283|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5264041|NCT00569283|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5264042|NCT00569283|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5264043|NCT00569283|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
5264044|NCT00569283|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
5264045|NCT00569283|high risk metastatic gestational trophoblastic tumor|high risk metastatic gestational trophoblastic tumor
5264046|NCT00569283|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
5264047|NCT00569283|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5264048|NCT00569283|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5264049|NCT00569283|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5264050|NCT00569283|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5264051|NCT00569283|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5264052|NCT00569283|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5264053|NCT00569283|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5264054|NCT00569283|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5264055|NCT00569283|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5264056|NCT00569283|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5264057|NCT00569283|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
5264058|NCT00569283|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5264059|NCT00569283|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5264060|NCT00569283|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
5264061|NCT00569283|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
5264062|NCT00569283|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
5264063|NCT00569283|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
5264064|NCT00569283|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5264065|NCT00569283|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5264066|NCT00569283|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5264067|NCT00569283|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5264068|NCT00569283|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5264177|NCT00568971|Toxicity|toxicity
5264069|NCT00569283|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5264070|NCT00569283|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5264071|NCT00569283|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5264072|NCT00569283|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5264073|NCT00569283|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5264074|NCT00569283|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5264075|NCT00569283|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5264076|NCT00569283|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5264077|NCT00569283|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5264078|NCT00569283|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5264079|NCT00569283|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5264080|NCT00569283|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5264081|NCT00569283|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5264082|NCT00569283|recurrent neuroblastoma|recurrent neuroblastoma
5264083|NCT00569283|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5264084|NCT00569283|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
5264085|NCT00569283|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5264086|NCT00569283|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5264087|NCT00569283|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5264088|NCT00569283|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
5264089|NCT00569283|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
5264090|NCT00569283|childhood malignant ovarian germ cell tumor|childhood malignant ovarian germ cell tumor
5264091|NCT00569283|childhood malignant testicular germ cell tumor|childhood malignant testicular germ cell tumor
5264092|NCT00569283|recurrent Wilms tumor and other childhood kidney tumors|recurrent wilms tumor and other childhood kidney tumors
5264093|NCT00569283|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5264094|NCT00569283|refractory hairy cell leukemia|refractory hairy cell leukemia
5264095|NCT00569283|refractory multiple myeloma|refractory multiple myeloma
5264096|NCT00569283|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5264097|NCT00569283|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5264098|NCT00569283|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5264099|NCT00569283|stage I multiple myeloma|stage i multiple myeloma
5264100|NCT00569283|stage II multiple myeloma|stage ii multiple myeloma
5264101|NCT00569283|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
5264102|NCT00569283|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5264103|NCT00569283|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5264104|NCT00569283|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5264105|NCT00569283|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5264106|NCT00569283|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5264107|NCT00569283|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5264108|NCT00569283|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5264109|NCT00569283|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5264110|NCT00569283|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5264111|NCT00569283|stage III multiple myeloma|stage iii multiple myeloma
5264112|NCT00569283|stage IIIA breast cancer|stage iiia breast cancer
5264113|NCT00569283|stage IIIB breast cancer|stage iiib breast cancer
5264114|NCT00569283|stage IIIC breast cancer|stage iiic breast cancer
5264115|NCT00569283|stage IV breast cancer|stage iv breast cancer
5264116|NCT00569283|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5264117|NCT00569283|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5264118|NCT00569283|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5264119|NCT00569283|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5264120|NCT00569283|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5264121|NCT00569283|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5264122|NCT00569283|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5264123|NCT00569283|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5264124|NCT00569283|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5264125|NCT00569257|LHRH receptor|lhrh receptor
5264126|NCT00569257|receptor positive tumors|receptor positive tumors
5264127|NCT00569257|platinum resistant ovarian cancer|platinum resistant ovarian cancer
5264128|NCT00569244|Primary Dysmenorrhea|primary dysmenorrhea
5264129|NCT00569244|Menstrual Pain|menstrual pain
5264130|NCT00569244|Oral Contraception|oral contraception
5264131|NCT00569231|Warts|warts
5264132|NCT00569231|Candida|candida
5264133|NCT00569231|HPV|hpv
5264134|NCT00569231|Injections, Intralesional|injections, intralesional
5264135|NCT00569231|Immune System|immune system
5264136|NCT00569192|asthmatic children|asthmatic children
5264137|NCT00569179|Myeloid Malignancies|myeloid malignancies
5264138|NCT00569179|Bone Marrow Transplant|bone marrow transplant
5264139|NCT00569179|AML|aml
5264140|NCT00569179|ALL|all
5264141|NCT00569179|MDS|mds
5264142|NCT00569179|CML|cml
5264143|NCT00569166|fatigue|fatigue
5264144|NCT00569166|sleep disorders|sleep disorders
5264145|NCT00569166|ductal breast carcinoma in situ|ductal breast carcinoma in situ
5264146|NCT00569166|lobular breast carcinoma in situ|lobular breast carcinoma in situ
5264147|NCT00569166|breast cancer|breast cancer
5264148|NCT00569166|hot flashes|hot flashes
5264149|NCT00569153|Androgen-independent prostate cancer, metastatic|androgen-independent prostate cancer, metastatic
5264150|NCT00569088|hemorrhagic stroke|hemorrhagic stroke
5264151|NCT00569088|Chinese Medicine|chinese medicine
5264152|NCT00569088|pathogenesis|pathogenesis
5264153|NCT00569088|YURE|yure
5264154|NCT00569075|Apoptic biomarkers|apoptic biomarkers
5264155|NCT00569075|Early detection periodontitis|early detection periodontitis
5264156|NCT00569075|Gingival crevicular fluid|gingival crevicular fluid
5264157|NCT00569075|Healthy subjects|healthy subjects
5264158|NCT00569062|Psychomotor retardation|psychomotor retardation
5264159|NCT00569062|cytokines|cytokines
5264160|NCT00569062|GW856553|gw856553
5264161|NCT00569062|Major Depressive Disorder (MDD)|major depressive disorder (mdd)
5264162|NCT00569036|Advanced or Metastatic Solid Tumors or Neoplasms|advanced or metastatic solid tumors or neoplasms
5264163|NCT00569023|Beta Carotene|beta carotene
5264164|NCT00569023|visual functions|visual functions
5264165|NCT00569023|Fundus albipunctatus|fundus albipunctatus
5264166|NCT00569023|Night Blindness|night blindness
5264167|NCT00569010|Acute Myelogenous Leukemia|acute myelogenous leukemia
5264168|NCT00569010|AML|aml
5264169|NCT00569010|Myelodysplastic Syndrome|myelodysplastic syndrome
5264170|NCT00569010|MDS|mds
5264171|NCT00569010|Leukemia|leukemia
5264172|NCT00568997|Atopic dermatitis eczema pediatric pimecrolimus malignancy|atopic dermatitis eczema pediatric pimecrolimus malignancy
5264173|NCT00568971|DCF|dcf
5264174|NCT00568971|Advanced gastric cancer|advanced gastric cancer
5264175|NCT00568971|Phase II study|phase ii study
5264176|NCT00568971|Efficacy|efficacy
5264178|NCT00568958|heavy episodic drinking|heavy episodic drinking
5264179|NCT00568958|young adults|young adults
5264180|NCT00568958|naltrexone|naltrexone
5264181|NCT00568958|BASICS counseling|basics counseling
5264182|NCT00568958|alcohol-related consequences|alcohol-related consequences
5264183|NCT00568958|double-blind trial|double-blind trial
5264184|NCT00568958|randomized clinical trial|randomized clinical trial
5264185|NCT00568945|Atrial Fibrillation|atrial fibrillation
5264186|NCT00568945|Capadenoson|capadenoson
5264187|NCT00568880|stage I multiple myeloma|stage i multiple myeloma
5264188|NCT00568880|stage II multiple myeloma|stage ii multiple myeloma
5264189|NCT00568880|stage III multiple myeloma|stage iii multiple myeloma
5264190|NCT00568880|refractory multiple myeloma|refractory multiple myeloma
5264191|NCT00568841|advanced Non-Small-Cell Lung Cancer|advanced non-small-cell lung cancer
5264192|NCT00568841|erlotinib|erlotinib
5264193|NCT00568841|FDG-PET|fdg-pet
5264194|NCT00568841|FLT-PET|flt-pet
5264195|NCT00568828|Macular Teleangiectasia|macular teleangiectasia
5264196|NCT00568828|Macular Pigment|macular pigment
5264197|NCT00568815|DLBCL|dlbcl
5264198|NCT00568815|Rituximab|rituximab
5264199|NCT00568815|ESHAP|eshap
5264200|NCT00568815|Efficacy|efficacy
5264201|NCT00568815|Toxicity|toxicity
5264202|NCT00568789|Insomnia|insomnia
5264203|NCT00568789|Aged|aged
5264204|NCT00568789|Postural Balance|postural balance
5264205|NCT00568789|Drug Therapy|drug therapy
5264206|NCT00568763|stage IV melanoma|stage iv melanoma
5264207|NCT00568763|recurrent melanoma|recurrent melanoma
5264208|NCT00568750|gastrointestinal stromal tumor|gastrointestinal stromal tumor
5264209|NCT00568737|Severe Sepsis|severe sepsis
5264210|NCT00568724|Hydronephrosis|hydronephrosis
5264211|NCT00568724|Ureteral obstruction|ureteral obstruction
5264212|NCT00568711|Doxycycline,|doxycycline,
5264213|NCT00568711|Rifampin|rifampin
5264214|NCT00568711|Scrub typhus.|scrub typhus.
5264215|NCT00568672|Major Depression|major depression
5264216|NCT00568672|Olanzapine|olanzapine
5264217|NCT00568672|add-on therapy|add-on therapy
5264218|NCT00568672|antidepressant|antidepressant
5264219|NCT00568672|atypical antipsychotic|atypical antipsychotic
5264220|NCT00568659|Gas exchange|gas exchange
5264221|NCT00568659|Respiratory mechanics|respiratory mechanics
5264222|NCT00568659|Ventilator Induced Lung Injury|ventilator induced lung injury
5264223|NCT00568607|NK/T cell lymphoma|nk/t cell lymphoma
5264224|NCT00568607|Response Rate|response rate
5264225|NCT00568607|TTP|ttp
5264226|NCT00568607|OS|os
5264227|NCT00568607|Toxicities|toxicities
5264228|NCT00568594|Apolipoprotein A-I,|apolipoprotein a-i,
5264229|NCT00568594|Atherosclerosis,|atherosclerosis,
5264230|NCT00568594|HDL,|hdl,
5264231|NCT00568594|Inflammation,|inflammation,
5264232|NCT00568568|Growth Hormone|growth hormone
5264233|NCT00568568|GH signaling|gh signaling
5264234|NCT00568568|Insulin resistance|insulin resistance
5264235|NCT00568568|Insulin Signaling|insulin signaling
5264236|NCT00568542|cardiomyopathy|cardiomyopathy
5264237|NCT00568542|ischemia|ischemia
5264238|NCT00568542|percutaneous coronary intervention|percutaneous coronary intervention
5264239|NCT00568542|remodeling|remodeling
5264240|NCT00568529|Advanced gastric cancer|advanced gastric cancer
5264241|NCT00568529|Response rate|response rate
5264242|NCT00568529|Side effects|side effects
5264243|NCT00568529|time to progression|time to progression
5264244|NCT00568529|overall survival|overall survival
5264245|NCT00568516|ASP3550|asp3550
5264246|NCT00568516|Degarelix|degarelix
5264247|NCT00568516|Prostate cancer|prostate cancer
5264248|NCT00568516|Prostatic neoplasms|prostatic neoplasms
5264249|NCT00568503|COPD/TIOTROPIUM/QAX028|copd/tiotropium/qax028
5264250|NCT00568477|Rituximab, Heemannn|rituximab, heemannn
5264251|NCT00568464|ESFT (Ewing's sarcoma family of tumors)|esft (ewing's sarcoma family of tumors)
5264252|NCT00568464|Response rate|response rate
5264253|NCT00568464|TTP|ttp
5264254|NCT00568464|OS|os
5264255|NCT00568464|Toxicity|toxicity
5264256|NCT00568451|stage IV melanoma|stage iv melanoma
5264257|NCT00568451|recurrent melanoma|recurrent melanoma
5264258|NCT00568412|atopic dermatitis|atopic dermatitis
5264259|NCT00568399|Coronary|coronary
5264260|NCT00568399|Calcification|calcification
5264261|NCT00568399|Dialysis|dialysis
5264262|NCT00568399|Thiosulfate|thiosulfate
5264263|NCT00568399|Cardiovascular|cardiovascular
5264264|NCT00568386|Dry eye|dry eye
5264265|NCT00568373|Gastroparesis|gastroparesis
5264266|NCT00568373|Gastric electrical stimulator|gastric electrical stimulator
5264267|NCT00568347|chronic airflow obstruction|chronic airflow obstruction
5264268|NCT00568334|chickenpox|chickenpox
5264269|NCT00568334|varicella|varicella
5264270|NCT00568334|two-dose schedule|two-dose schedule
5264271|NCT00568334|second year of life|second year of life
5264272|NCT00568321|monoclonal antibody|monoclonal antibody
5264273|NCT00568308|Hepatocellular Carcinoma|hepatocellular carcinoma
5264274|NCT00568308|PI-88|pi-88
5264275|NCT00568308|Phase III|phase iii
5264276|NCT00568308|Adjuvant Therapy|adjuvant therapy
5264277|NCT00568308|Hepatoma|hepatoma
5264278|NCT00568308|Liver Cancer|liver cancer
5264279|NCT00568269|Recurrence rate after inguinal hernia repair on primary inguinal herina.|recurrence rate after inguinal hernia repair on primary inguinal herina.
5264280|NCT00568256|Ulcerative Colitis|ulcerative colitis
5264281|NCT00568256|IBD Flare-Up|ibd flare-up
5264282|NCT00568256|Stress|stress
5264283|NCT00568243|Visuomotor Integration|visuomotor integration
5264284|NCT00568243|Visual Attention|visual attention
5264285|NCT00568243|Healthy Volunteer|healthy volunteer
5264286|NCT00568243|HV|hv
5264287|NCT00568230|heart failure|heart failure
5264288|NCT00568230|mitral regurgitation|mitral regurgitation
5264289|NCT00568204|pruritus, itching, mexyn-a, clearitch, magicool-plus|pruritus, itching, mexyn-a, clearitch, magicool-plus
5264290|NCT00568191|Age-related macular degeneration|age-related macular degeneration
5264291|NCT00568191|choroidal neovascularization|choroidal neovascularization
5264292|NCT00568191|Stratus OCT|stratus oct
5264293|NCT00568191|Cirrus OCT|cirrus oct
5264294|NCT00568165|Heart failure, congestive|heart failure, congestive
5264295|NCT00568165|Echocardiography|echocardiography
5264296|NCT00568165|Patient care team|patient care team
5264297|NCT00568152|Apples|apples
5264298|NCT00568152|Dietary intervention|dietary intervention
5264299|NCT00568152|Procyanidins|procyanidins
5264300|NCT00568139|adrenal cancer|adrenal cancer
5264301|NCT00568139|mitotane (Lysodren)|mitotane (lysodren)
5264302|NCT00568139|adverse events|adverse events
5264431|NCT00567489|APD|apd
5264303|NCT00568126|Antidepressant Induced Sexual Dysfunction|antidepressant induced sexual dysfunction
5264304|NCT00568126|Depression|depression
5264305|NCT00568126|Sexual Dysfunction|sexual dysfunction
5264306|NCT00568113|preterm labour|preterm labour
5264307|NCT00568113|n acetyl cysteine|n acetyl cysteine
5264308|NCT00568113|bacterial vaginosis|bacterial vaginosis
5264309|NCT00568100|gas exchange|gas exchange
5264310|NCT00568100|pressure support ventilation|pressure support ventilation
5264311|NCT00568100|respiratory mechanics|respiratory mechanics
5264312|NCT00568100|COPD|copd
5264313|NCT00568100|NAVA|nava
5264314|NCT00568087|N-acetylcysteine|n-acetylcysteine
5264315|NCT00568087|Alcoholism|alcoholism
5264316|NCT00568087|Treatment|treatment
5264317|NCT00568061|INOT44|inot44
5264318|NCT00568061|NOMI|nomi
5264319|NCT00568048|stage IV melanoma|stage iv melanoma
5264320|NCT00568048|recurrent melanoma|recurrent melanoma
5264321|NCT00568035|diabetic|diabetic
5264322|NCT00568035|peripheral|peripheral
5264323|NCT00568035|neuropathy|neuropathy
5264324|NCT00568009|Congestive Heart Failure|congestive heart failure
5264325|NCT00568009|Impaired Renal Function|impaired renal function
5264326|NCT00567996|Chronic obstructive pulmonary disease, indacaterol, salmeterol, placebo controlled|chronic obstructive pulmonary disease, indacaterol, salmeterol, placebo controlled
5264327|NCT00567970|liver metastases|liver metastases
5264328|NCT00567957|pre-eclampsia|pre-eclampsia
5264329|NCT00567957|remifentanil|remifentanil
5264330|NCT00567957|anesthesia, general|anesthesia, general
5264331|NCT00567957|analgesics, opioid|analgesics, opioid
5264332|NCT00567957|anesthetics, intravenous|anesthetics, intravenous
5264333|NCT00567957|Cesarean section|cesarean section
5264334|NCT00567957|newborn|newborn
5264335|NCT00567957|maternal haemodynamic|maternal haemodynamic
5264336|NCT00567944|Physical Therapy Modalities|physical therapy modalities
5264337|NCT00567944|Electric Stimulation|electric stimulation
5264338|NCT00567944|Postural Balance|postural balance
5264339|NCT00567918|Keratoconjunctivitis|keratoconjunctivitis
5264340|NCT00567918|Vernal keratoconjunctivitis|vernal keratoconjunctivitis
5264341|NCT00567918|FK506|fk506
5264342|NCT00567918|Tacrolimus|tacrolimus
5264343|NCT00567905|Type 2 Diabetes|type 2 diabetes
5264344|NCT00567905|Green tea extract|green tea extract
5264345|NCT00567905|overweight|overweight
5264346|NCT00567892|tinnitus|tinnitus
5264347|NCT00567892|subjective tinnitus|subjective tinnitus
5264348|NCT00567892|therapy|therapy
5264349|NCT00567892|repetitive transcranial magnetic stimulation|repetitive transcranial magnetic stimulation
5264350|NCT00567892|clinical trial|clinical trial
5264351|NCT00567879|Breast Cancer|breast cancer
5264352|NCT00567879|HER2 positive|her2 positive
5264353|NCT00567879|adult-female|adult-female
5264354|NCT00567879|LBH589|lbh589
5264355|NCT00567879|HDAC inhibitor|hdac inhibitor
5264356|NCT00567879|panobinostat|panobinostat
5264357|NCT00567853|mitral valve regurgitation|mitral valve regurgitation
5264358|NCT00567853|mitral valve disease|mitral valve disease
5264359|NCT00567853|mitral valve repair|mitral valve repair
5264360|NCT00567853|mitral valve dysfunction|mitral valve dysfunction
5264361|NCT00567853|heart valve|heart valve
5264362|NCT00567853|valve disease|valve disease
5264363|NCT00567853|cardiac surgery|cardiac surgery
5264364|NCT00567840|Early Bactericidal Activity|early bactericidal activity
5264365|NCT00567840|EBA|eba
5264366|NCT00567840|pulmonary tuberculosis|pulmonary tuberculosis
5264367|NCT00567840|PA-824|pa-824
5264368|NCT00567840|Pretomanid|pretomanid
5264369|NCT00567840|CL-007|cl-007
5264370|NCT00567827|Pneumonia|pneumonia
5264371|NCT00567814|Cocaine|cocaine
5264372|NCT00567814|Dependence|dependence
5264373|NCT00567814|Addiction|addiction
5264374|NCT00567814|Cortisol|cortisol
5264375|NCT00567814|GABA|gaba
5264376|NCT00567801|Lower Extremity|lower extremity
5264377|NCT00567801|Ischemia|ischemia
5264378|NCT00567788|Glaucoma, angle-closure|glaucoma, angle-closure
5264379|NCT00567762|Keratoconjunctivitis|keratoconjunctivitis
5264380|NCT00567762|vernal keratoconjunctivitis|vernal keratoconjunctivitis
5264381|NCT00567762|FK506|fk506
5264382|NCT00567762|Tacrolimus|tacrolimus
5264383|NCT00567749|HIV-1 Infections|hiv-1 infections
5264384|NCT00567736|low back pain|low back pain
5264385|NCT00567736|complementary therapies|complementary therapies
5264386|NCT00567697|ranibizumab|ranibizumab
5264387|NCT00567697|CRVO|crvo
5264388|NCT00567697|macular edema|macular edema
5264389|NCT00567697|sham|sham
5264390|NCT00567684|Transitional Cell Carcinoma|transitional cell carcinoma
5264391|NCT00567684|Urothelial Cancer|urothelial cancer
5264392|NCT00567684|Bladder Cancer|bladder cancer
5264393|NCT00567684|Computed Tomography Urography|computed tomography urography
5264394|NCT00567684|CTU|ctu
5264395|NCT00567684|Intravenous Urography|intravenous urography
5264396|NCT00567684|IVU|ivu
5264397|NCT00567684|TCC|tcc
5264398|NCT00567684|transitional cell carcinomas|transitional cell carcinomas
5264399|NCT00567671|keratoconus|keratoconus
5264400|NCT00567671|ectasia|ectasia
5264401|NCT00567671|cross-linking|cross-linking
5264402|NCT00567671|riboflavin|riboflavin
5264403|NCT00567671|UVA light|uva light
5264404|NCT00567671|cornea|cornea
5264405|NCT00567632|Pneumococci|pneumococci
5264406|NCT00567632|Antibody|antibody
5264407|NCT00567632|Standard laboratory values|standard laboratory values
5264408|NCT00567619|GERD|gerd
5264409|NCT00567619|NIS|nis
5264410|NCT00567580|stage IIB prostate cancer|stage iib prostate cancer
5264411|NCT00567580|stage IIA prostate cancer|stage iia prostate cancer
5264412|NCT00567580|stage III prostate cancer|stage iii prostate cancer
5264413|NCT00567580|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5264414|NCT00567554|breast cancer|breast cancer
5264415|NCT00567554|primary systemic therapy|primary systemic therapy
5264416|NCT00567554|pCR Rates|pcr rates
5264417|NCT00567554|Bevacizumab|bevacizumab
5264418|NCT00567554|Trastuzumab|trastuzumab
5264419|NCT00567554|Lapatinib|lapatinib
5264420|NCT00567554|Everolimus|everolimus
5264421|NCT00567541|shoulder|shoulder
5264422|NCT00567541|pain|pain
5264423|NCT00567541|stroke|stroke
5264424|NCT00567541|subluxation|subluxation
5264425|NCT00567528|Soft tissue injuries|soft tissue injuries
5264426|NCT00567528|Topical ibuprofen|topical ibuprofen
5264427|NCT00567528|Adolescent athletes|adolescent athletes
5264428|NCT00567489|ESRD|esrd
5264429|NCT00567489|Diabetes|diabetes
5264430|NCT00567489|CAPD|capd
5264432|NCT00567476|Asthma, anti-immunoglobulin E, omalizumab|asthma, anti-immunoglobulin e, omalizumab
5264434|NCT00567463|Bronchial hyperresponsiveness|bronchial hyperresponsiveness
5264435|NCT00567463|Methacholine|methacholine
5264436|NCT00567463|Induced sputum|induced sputum
5264437|NCT00567463|bronchial biopsies|bronchial biopsies
5264438|NCT00567450|sciatic block|sciatic block
5264439|NCT00567450|ropivacaine|ropivacaine
5264440|NCT00567450|mepivacaine|mepivacaine
5264441|NCT00567450|locoregional anesthesia|locoregional anesthesia
5264442|NCT00567437|aortic stenosis|aortic stenosis
5264443|NCT00567437|prognosis|prognosis
5264444|NCT00567437|brain natriuretic peptide|brain natriuretic peptide
5264445|NCT00567424|epilepsy|epilepsy
5264446|NCT00567424|refractory|refractory
5264447|NCT00567424|seizure|seizure
5264448|NCT00567424|drug interactions|drug interactions
5264449|NCT00567424|pharmacokinetics|pharmacokinetics
5264450|NCT00567411|Glaucoma|glaucoma
5264451|NCT00567411|Laser|laser
5264452|NCT00567411|laser trabeculoplasty|laser trabeculoplasty
5264453|NCT00567411|selective laser trabeculoplasty|selective laser trabeculoplasty
5264454|NCT00567411|intraocular pressure|intraocular pressure
5264455|NCT00567398|ESRD|esrd
5264456|NCT00567398|Diabetes|diabetes
5264457|NCT00567398|CAPD|capd
5264458|NCT00567398|APD|apd
5264459|NCT00567372|Diffuse diabetic macular edema|diffuse diabetic macular edema
5264460|NCT00567372|sub-tenon|sub-tenon
5264461|NCT00567372|Bevacizumab|bevacizumab
5264462|NCT00567359|NSCLC|nsclc
5264463|NCT00567359|erlotinib|erlotinib
5264464|NCT00567359|epidermal growth factor receptor|epidermal growth factor receptor
5264465|NCT00567359|EGFR|egfr
5264466|NCT00567346|randomised|randomised
5264467|NCT00567346|double-blind|double-blind
5264468|NCT00567346|placebo-controlled|placebo-controlled
5264469|NCT00567346|efficacy and safety|efficacy and safety
5264470|NCT00567346|Oralgen® Grass Pollen|oralgen® grass pollen
5264471|NCT00567346|allergic rhinoconjunctivitis|allergic rhinoconjunctivitis
5264472|NCT00567346|Allergy|allergy
5264473|NCT00567346|Rhinoconjunctivitis|rhinoconjunctivitis
5265438|NCT00562991|asthma|asthma
5264474|NCT00567346|Immunotherapy|immunotherapy
5264475|NCT00567346|Grass pollen extract|grass pollen extract
5264476|NCT00567320|varenicline|varenicline
5264477|NCT00567294|Osteoporosis|osteoporosis
5264478|NCT00567294|Medication adherence|medication adherence
5264479|NCT00567294|Telephonic education|telephonic education
5264480|NCT00567294|Motivational interviewing|motivational interviewing
5264481|NCT00567281|Schizoaffective disorder|schizoaffective disorder
5264482|NCT00567281|Auditory Hallucinations|auditory hallucinations
5264483|NCT00567281|Voices|voices
5264484|NCT00567281|Repetitive Transcranial Magnetic Stimulation|repetitive transcranial magnetic stimulation
5264485|NCT00567281|rTMS|rtms
5264486|NCT00567281|Wernicke's Area|wernicke's area
5264487|NCT00567281|Middle Temporal Cortex|middle temporal cortex
5264488|NCT00567281|Persistent Auditory Hallucinations|persistent auditory hallucinations
5264489|NCT00567281|"Previously Participated in Parent rTMS Protocol"|"previously participated in parent rtms protocol"
5264490|NCT00567268|Post-Marketing surveillance|post-marketing surveillance
5264491|NCT00567255|Obesity|obesity
5264492|NCT00567242|aphasia|aphasia
5264493|NCT00567242|therapies, investigational|therapies, investigational
5264494|NCT00567242|rehabilitation of speech and language disorders|rehabilitation of speech and language disorders
5264495|NCT00567242|magnetic resonance imaging, functional|magnetic resonance imaging, functional
5264496|NCT00567242|language|language
5264497|NCT00567229|refractory multiple myeloma|refractory multiple myeloma
5264498|NCT00567190|Herceptin|herceptin
5264499|NCT00567190|Breast cancer|breast cancer
5264500|NCT00567190|MBC|mbc
5264501|NCT00567190|Taxotere|taxotere
5264502|NCT00567190|HER2|her2
5264503|NCT00567190|HER2 positive breast cancer|her2 positive breast cancer
5264504|NCT00567190|HER2 + breast cancer|her2 + breast cancer
5264505|NCT00567190|HER2-positive|her2-positive
5264506|NCT00567190|HER2-positive metastatic breast cancer|her2-positive metastatic breast cancer
5264507|NCT00567164|Oral Contraception|oral contraception
5264508|NCT00567164|Birth Control pill|birth control pill
5264509|NCT00567164|Healthy women requesting oral contraception|healthy women requesting oral contraception
5264510|NCT00567164|Contraceptive efficacy|contraceptive efficacy
5264511|NCT00567125|low-pressure pneumoperitoneum|low-pressure pneumoperitoneum
5264512|NCT00567125|laparoscopy|laparoscopy
5264513|NCT00567125|cytokines|cytokines
5264514|NCT00567125|VEGF-A|vegf-a
5264515|NCT00567125|endostatin|endostatin
5264516|NCT00567099|Psychiatry|psychiatry
5264517|NCT00567099|Antipsychotic|antipsychotic
5264518|NCT00567099|Psychopharmacology|psychopharmacology
5264519|NCT00567099|Clinical Trial|clinical trial
5264520|NCT00567099|Open Label|open label
5264521|NCT00567099|Schizophrenia|schizophrenia
5264522|NCT00567099|Sensory Gating|sensory gating
5264523|NCT00567099|Attention|attention
5264524|NCT00567099|Memory|memory
5264525|NCT00567086|Migraine|migraine
5264526|NCT00567073|Glycogen Storage Disease Type II (GSD-II)|glycogen storage disease type ii (gsd-ii)
5264527|NCT00567073|GSD-II|gsd-ii
5264528|NCT00567073|Pompe Disease|pompe disease
5264529|NCT00567073|Pompe Disease (Late-Onset)|pompe disease (late-onset)
5264530|NCT00567073|Acid Maltase Deficiency Disease|acid maltase deficiency disease
5264531|NCT00567073|Glycogenosis II|glycogenosis ii
5264532|NCT00567060|Piracetam|piracetam
5264533|NCT00567060|Nootropil|nootropil
5264534|NCT00567034|Zyprexa|zyprexa
5264535|NCT00567034|naltrexone|naltrexone
5264536|NCT00567034|schizophrenia|schizophrenia
5264537|NCT00567034|Metabolic Syndrome|metabolic syndrome
5264538|NCT00567034|pain|pain
5264539|NCT00567021|reflux|reflux
5264540|NCT00567021|NSAR treatment|nsar treatment
5264541|NCT00567021|Patients with reflux symptoms or gastrointestinal symptoms after NSAR Treatment|patients with reflux symptoms or gastrointestinal symptoms after nsar treatment
5264542|NCT00567008|cocaine|cocaine
5264543|NCT00567008|crack cocaine|crack cocaine
5264544|NCT00567008|cocaine-related disorders|cocaine-related disorders
5264545|NCT00567008|substance-related disorders|substance-related disorders
5264546|NCT00567008|alpha4beta2 nicotinic acetylcholine receptor|alpha4beta2 nicotinic acetylcholine receptor
5264547|NCT00566995|Kidney Tumors|kidney tumors
5264548|NCT00566995|Clear Cell Renal Cancer|clear cell renal cancer
5264549|NCT00566995|VEGFR Inhibitor|vegfr inhibitor
5264550|NCT00566995|EGFR Inhibitor|egfr inhibitor
5264551|NCT00566995|VHL|vhl
5264552|NCT00566995|Von Hippel Lindau|von hippel lindau
5264553|NCT00566995|Kidney Tumor|kidney tumor
5264554|NCT00566982|Urogenital atrophy|urogenital atrophy
5264555|NCT00566982|Menopausal symptoms|menopausal symptoms
5264556|NCT00566982|Vulvar and vaginal atrophy in postmenopausal women|vulvar and vaginal atrophy in postmenopausal women
5264557|NCT00566982|Vaginal atrophy|vaginal atrophy
5264558|NCT00566969|cocaine, opiate, methadone, carvedilol|cocaine, opiate, methadone, carvedilol
5264559|NCT00566956|Hydrosalpinx/IVF/Reproductive outcome.|hydrosalpinx/ivf/reproductive outcome.
5264560|NCT00566956|Hydrosalpinx|hydrosalpinx
5264561|NCT00566943|Staple Line Reinforcement, Buttress|staple line reinforcement, buttress
5264563|NCT00566917|Prolapse|prolapse
5264564|NCT00566917|Anterior vaginal wall prolapse|anterior vaginal wall prolapse
5264565|NCT00566904|Post-herpetic Neuralgia|post-herpetic neuralgia
5264566|NCT00566904|Pain after Shingles|pain after shingles
5264567|NCT00566904|Shingles|shingles
5264568|NCT00566904|PHN|phn
5264569|NCT00566891|percutaneous coronary angioplasty|percutaneous coronary angioplasty
5264570|NCT00566891|pci|pci
5264571|NCT00566891|tirofiban|tirofiban
5264572|NCT00566891|side effects|side effects
5264573|NCT00566878|Glycogen Storage Disease|glycogen storage disease
5264574|NCT00566878|GSD-II|gsd-ii
5264575|NCT00566878|Pompe Disease|pompe disease
5264576|NCT00566878|Pompe Disease (Late-Onset)|pompe disease (late-onset)
5264577|NCT00566878|Acid Maltase Deficiency Disease|acid maltase deficiency disease
5264578|NCT00566878|Glycogenosis II|glycogenosis ii
5264579|NCT00566852|cognitive/functional effects|cognitive/functional effects
5264580|NCT00566852|neurotoxicity|neurotoxicity
5264581|NCT00566852|tumors metastatic to brain|tumors metastatic to brain
5264582|NCT00566852|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5264583|NCT00566839|COPD|copd
5264584|NCT00566839|LVRS|lvrs
5264585|NCT00566839|Awake surgery|awake surgery
5264586|NCT00566839|Thoracic epidural anesthesia|thoracic epidural anesthesia
5264587|NCT00566839|One-lung ventilation|one-lung ventilation
5264588|NCT00566839|Emphysema|emphysema
5264589|NCT00566839|VATS|vats
5264590|NCT00566839|Lung surgery|lung surgery
5264591|NCT00566826|Physical Function|physical function
5264592|NCT00566826|Total Knee Replacement|total knee replacement
5264593|NCT00566826|Physical Activity|physical activity
5264594|NCT00566826|Behavioral Support|behavioral support
5264595|NCT00566826|Arthroplasty|arthroplasty
5264596|NCT00566826|Function|function
5264597|NCT00566826|Self-Care|self-care
5264598|NCT00566813|Diabetes Mellitus, Type 1|diabetes mellitus, type 1
5264599|NCT00566813|Islets of Langerhans Transplantation|islets of langerhans transplantation
5264600|NCT00566813|Exenatide|exenatide
5264601|NCT00566813|Soluble tumor necrosis factor receptor|soluble tumor necrosis factor receptor
5264602|NCT00566800|esophageal cancer|esophageal cancer
5264603|NCT00566800|Barrett esophagus|barrett esophagus
5264604|NCT00566787|AF|af
5264605|NCT00566787|Atrial Fibrillation|atrial fibrillation
5264606|NCT00566787|afib|afib
5264607|NCT00566787|racing heart|racing heart
5264608|NCT00566787|cabg|cabg
5264609|NCT00566787|valve|valve
5264610|NCT00566787|ablation|ablation
5264611|NCT00566787|bipolar|bipolar
5264612|NCT00566787|radiofrequency|radiofrequency
5264613|NCT00566787|rf|rf
5264614|NCT00566774|myocardial infarction|myocardial infarction
5264615|NCT00566774|secondary prevention|secondary prevention
5264616|NCT00566774|health insurance|health insurance
5264617|NCT00566774|cost-sharing|cost-sharing
5264618|NCT00566761|Macular edema|macular edema
5264619|NCT00566761|central retinal vein occlusion|central retinal vein occlusion
5264620|NCT00566761|bevacizumab|bevacizumab
5264621|NCT00566761|triamcinolone|triamcinolone
5264622|NCT00566709|transfusion|transfusion
5264623|NCT00566709|NIRS|nirs
5264624|NCT00566709|cerebral oxygenation|cerebral oxygenation
5264625|NCT00566709|red blood cell|red blood cell
5264626|NCT00566709|near infrared spectroscopy|near infrared spectroscopy
5264627|NCT00566696|Haploidentical stem cell transplant|haploidentical stem cell transplant
5264628|NCT00566696|Allogeneic stem cell transplant|allogeneic stem cell transplant
5264629|NCT00566696|Mismatched family member stem cell donor transplant|mismatched family member stem cell donor transplant
5264630|NCT00566696|Bone marrow transplant|bone marrow transplant
5264631|NCT00566696|High risk hematologic malignancies|high risk hematologic malignancies
5264632|NCT00566696|T cell depletion methodology|t cell depletion methodology
5264633|NCT00566696|Miltenyi Biotec CliniMACS stem cell selection device|miltenyi biotec clinimacs stem cell selection device
5264634|NCT00566696|Campath-1H intravenous|campath-1h intravenous
5264635|NCT00566683|Propofol|propofol
5264636|NCT00566683|colonoscopy|colonoscopy
5264637|NCT00566683|sedation|sedation
5264638|NCT00566683|pain|pain
5264639|NCT00566683|compare NAPS versus diazemuls in outpatient colonoscopy|compare naps versus diazemuls in outpatient colonoscopy
5264640|NCT00566670|Hemodialysis|hemodialysis
5264641|NCT00566657|Critical Limb Ischemia|critical limb ischemia
5264642|NCT00566657|Peripheral Artery Disease|peripheral artery disease
5264643|NCT00566657|Plasmid based gene therapy|plasmid based gene therapy
5264644|NCT00566644|endometrial cancer|endometrial cancer
5264645|NCT00566644|hereditary non-polyposis colon cancer (hMSH2, hMLH1, hPMS1, hPMS2)|hereditary non-polyposis colon cancer (hmsh2, hmlh1, hpms1, hpms2)
5264646|NCT00566631|Schizophrenia|schizophrenia
5264647|NCT00566631|Paliperidone Extended Release (ER)|paliperidone extended release (er)
5264648|NCT00566631|Invega|invega
5264649|NCT00566618|Breast Cancer|breast cancer
5264650|NCT00566618|Bone Metastases|bone metastases
5264651|NCT00566618|Breast Cancer with Bone Metastases|breast cancer with bone metastases
5264652|NCT00566618|Breast Cancer with Metastases to Bone|breast cancer with metastases to bone
5264653|NCT00566618|Dasatinib|dasatinib
5264654|NCT00566618|Zometa|zometa
5264655|NCT00566618|Zoledronic Acid|zoledronic acid
5264656|NCT00566618|Zoledronate|zoledronate
5264657|NCT00566618|BMS-345825|bms-345825
5264658|NCT00566618|Sprycel®|sprycel®
5264659|NCT00566579|Human papillomavirus|human papillomavirus
5264660|NCT00566579|Clearance|clearance
5264661|NCT00566579|Cryotherapy|cryotherapy
5264662|NCT00566566|adipocytokines|adipocytokines
5264663|NCT00566566|inflammatory markers|inflammatory markers
5264664|NCT00566566|cardiovascular disease|cardiovascular disease
5264665|NCT00566566|diabetes mellitus|diabetes mellitus
5264666|NCT00566566|Leptin|leptin
5264667|NCT00566553|Grape Seed Extract|grape seed extract
5264668|NCT00566553|Breast Cancer|breast cancer
5264669|NCT00566553|Estrogen Levels|estrogen levels
5264670|NCT00566553|Aromatase Inhibitor|aromatase inhibitor
5264671|NCT00566540|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
5264672|NCT00566540|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5264673|NCT00566540|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
5264674|NCT00566540|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5264675|NCT00566540|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
5264676|NCT00566540|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5264677|NCT00566540|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
5264678|NCT00566514|fibromyalgia|fibromyalgia
5264679|NCT00566514|ribose|ribose
5264680|NCT00566514|d-ribose|d-ribose
5264681|NCT00566514|dextrose|dextrose
5264682|NCT00566501|Moderate-to-severe|moderate-to-severe
5264683|NCT00566501|Alzheimer's|alzheimer's
5264684|NCT00566501|Disease|disease
5264685|NCT00566488|Thymus Transplantation|thymus transplantation
5264686|NCT00566488|Parathyroid Transplantation|parathyroid transplantation
5264687|NCT00566488|DiGeorge Syndrome|digeorge syndrome
5264688|NCT00566488|Hypoparathyroidism|hypoparathyroidism
5264689|NCT00566488|Athymia|athymia
5264690|NCT00566449|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
5264691|NCT00566449|ADHD|adhd
5264692|NCT00566449|JNJ-31001074|jnj-31001074
5264693|NCT00566436|Peripheral Arterial Occlusive Disease|peripheral arterial occlusive disease
5264694|NCT00566436|Superficial Femoral Artery|superficial femoral artery
5264695|NCT00566436|Remote Endarterectomy|remote endarterectomy
5264696|NCT00566436|Suprageniculate Bypass Surgery|suprageniculate bypass surgery
5264697|NCT00566436|Blood Vessel Prosthesis Implantation|blood vessel prosthesis implantation
5264698|NCT00566436|Vascular Patency|vascular patency
5264699|NCT00566423|PAH|pah
5264700|NCT00566423|Biomarkers|biomarkers
5264701|NCT00566423|MIF|mif
5264702|NCT00566423|BNP|bnp
5264703|NCT00566423|6 Minute Walk (6MW)|6 minute walk (6mw)
5264704|NCT00566410|DCA|dca
5264705|NCT00566410|Phase I|phase i
5264706|NCT00566410|Dose Escalation|dose escalation
5264707|NCT00566410|Solid Tumours|solid tumours
5264708|NCT00566410|Dichloroacetate|dichloroacetate
5264709|NCT00566410|Pharmacokinetic|pharmacokinetic
5264710|NCT00566397|RI RI Study Rage Inhibitors|ri ri study rage inhibitors
5264711|NCT00566384|Loss of libido|loss of libido
5264712|NCT00566384|Acquired, oral contraceptive -associated female sexual dysfunction|acquired, oral contraceptive -associated female sexual dysfunction
5264713|NCT00566371|attention deficit hyperactivity disorder|attention deficit hyperactivity disorder
5264714|NCT00566371|insomnia|insomnia
5264715|NCT00566371|atomoxetine|atomoxetine
5264716|NCT00566358|diabetes mellitus, type 2|diabetes mellitus, type 2
5264717|NCT00566358|duodenal exclusion|duodenal exclusion
5264718|NCT00566358|bariatric surgery|bariatric surgery
5264719|NCT00566358|Glucagon-Like Peptide 1|glucagon-like peptide 1
5264720|NCT00566358|Gastric Inhibitory Polypeptide|gastric inhibitory polypeptide
5264721|NCT00566358|insulin|insulin
5264722|NCT00566358|glucagon|glucagon
5264723|NCT00566358|ghrelin|ghrelin
5264724|NCT00566332|Waldenström Macroglobulinemia|waldenström macroglobulinemia
5264725|NCT00566332|Lymphoplasmacytic lymphoma|lymphoplasmacytic lymphoma
5264726|NCT00566332|Splenic Marginal Zone Lymphoma|splenic marginal zone lymphoma
5264727|NCT00566332|Fludarabine|fludarabine
5264728|NCT00566332|Chlorambucil|chlorambucil
5264729|NCT00566319|Exercise|exercise
5264730|NCT00566306|Clostridium difficile|clostridium difficile
5264731|NCT00566306|disinfectant|disinfectant
5264732|NCT00566280|MBI|mbi
5264733|NCT00566280|Mammogram|mammogram
5264734|NCT00566280|Breast Cancer|breast cancer
5264735|NCT00566280|Breast Ultrasound|breast ultrasound
5264736|NCT00566280|Bloody Nipple Discharge|bloody nipple discharge
5264737|NCT00566280|Molecular Breast Imaging|molecular breast imaging
5264738|NCT00566254|Epilepsy|epilepsy
5264739|NCT00566254|paediatric|paediatric
5264740|NCT00566254|partial onset seizures|partial onset seizures
5264741|NCT00566241|Body weight|body weight
5264742|NCT00566241|Body composition|body composition
5264743|NCT00566241|Pulmonary function|pulmonary function
5264744|NCT00566241|Carbohydrate tolerance|carbohydrate tolerance
5264745|NCT00566228|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5264746|NCT00566228|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5264747|NCT00566228|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5264748|NCT00566228|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5264749|NCT00566215|diabetes mellitus, type 2|diabetes mellitus, type 2
5264750|NCT00566215|Insulin resistance|insulin resistance
5264751|NCT00566215|Intra-Abdominal Fat|intra-abdominal fat
5264752|NCT00566215|Omentum|omentum
5264753|NCT00566215|duodenal exclusion|duodenal exclusion
5264754|NCT00566215|bariatric surgery|bariatric surgery
5264755|NCT00566215|Glucagon-Like Peptide 1|glucagon-like peptide 1
5264756|NCT00566215|Gastric Inhibitory Polypeptide|gastric inhibitory polypeptide
5264757|NCT00566215|insulin|insulin
5264758|NCT00566215|glucagon|glucagon
5264759|NCT00566215|ghrelin|ghrelin
5264760|NCT00566215|adiponectin|adiponectin
5264761|NCT00566215|Cytokines|cytokines
5264762|NCT00566202|Major Depressive Disorder|major depressive disorder
5264763|NCT00566202|Depression|depression
5264764|NCT00566202|JNJ-18038683|jnj-18038683
5264765|NCT00566202|Escitalopram|escitalopram
5264766|NCT00566189|diabetes mellitus, type 2|diabetes mellitus, type 2
5264767|NCT00566189|Insulin resistance|insulin resistance
5264768|NCT00566189|Intra-Abdominal Fat|intra-abdominal fat
5264769|NCT00566189|Omentum|omentum
5264770|NCT00566189|duodenal exclusion|duodenal exclusion
5264771|NCT00566189|bariatric surgery|bariatric surgery
5264772|NCT00566189|Glucagon-Like Peptide 1|glucagon-like peptide 1
5264773|NCT00566189|Gastric Inhibitory Polypeptide|gastric inhibitory polypeptide
5264774|NCT00566189|insulin|insulin
5264775|NCT00566189|glucagon|glucagon
5264776|NCT00566189|ghrelin|ghrelin
5264777|NCT00566189|adiponectin|adiponectin
5264778|NCT00566189|Cytokines|cytokines
5264779|NCT00566176|Atrial Fibrillation|atrial fibrillation
5264780|NCT00566176|AF|af
5264781|NCT00566176|AFIB|afib
5264782|NCT00566176|racing heart|racing heart
5264783|NCT00566176|pulmonary vein isolation|pulmonary vein isolation
5264784|NCT00566176|pvi|pvi
5264785|NCT00566176|mini maze|mini maze
5264786|NCT00566176|maze|maze
5264787|NCT00566150|Keppra|keppra
5264788|NCT00566150|Levetiracetam|levetiracetam
5264789|NCT00566150|Anticonvulsant|anticonvulsant
5264790|NCT00566150|Depression|depression
5264791|NCT00566150|Bipolar Disorder|bipolar disorder
5264792|NCT00566150|Affective Disorders|affective disorders
5264793|NCT00566150|Mood Disorders|mood disorders
5264794|NCT00566150|Double Blind|double blind
5264795|NCT00566150|Acute Antidepressant Effects|acute antidepressant effects
5264796|NCT00566137|Scleroderma|scleroderma
5264797|NCT00566137|Pulmonary Hypertension|pulmonary hypertension
5264798|NCT00566124|Levemir, Lantus, Insulatard, Pharmacodynamics, Healthy humans|levemir, lantus, insulatard, pharmacodynamics, healthy humans
5264799|NCT00566111|Ceftriaxone|ceftriaxone
5264800|NCT00566111|Acute Antidepressant Effects|acute antidepressant effects
5264801|NCT00566111|Glutamatergic System|glutamatergic system
5264802|NCT00566111|Double-Blind|double-blind
5264803|NCT00566111|Mood Disorders|mood disorders
5264804|NCT00566111|Bipolar Disorder|bipolar disorder
5264805|NCT00566111|Depression|depression
5264806|NCT00566111|Affective Disorders|affective disorders
5264807|NCT00566098|stage II multiple myeloma|stage ii multiple myeloma
5264808|NCT00566098|stage III multiple myeloma|stage iii multiple myeloma
5264810|NCT00566085|Breast Cancer|breast cancer
5264811|NCT00566085|Neoadjuvant Therapy|neoadjuvant therapy
5264812|NCT00566085|Molecular Breast Imaging|molecular breast imaging
5264813|NCT00566072|the effect of information on compliance of medication|the effect of information on compliance of medication
5264814|NCT00566059|therapeutic advice|therapeutic advice
5264815|NCT00566033|AUDIT|audit
5264816|NCT00566033|Chronic kidney disease|chronic kidney disease
5264817|NCT00566033|Clinical trial|clinical trial
5264818|NCT00566033|Creatinine|creatinine
5264819|NCT00566033|Multiple intervents|multiple intervents
5264820|NCT00566033|Nephrology guidelines.|nephrology guidelines.
5264821|NCT00566020|Open-label extension|open-label extension
5264822|NCT00566020|Tolerability|tolerability
5264823|NCT00566020|Lamotrigine|lamotrigine
5264824|NCT00566020|Safety|safety
5264825|NCT00566020|Bipolar I disorder|bipolar i disorder
5264826|NCT00566007|disc herniation|disc herniation
5264827|NCT00566007|lumbar|lumbar
5264828|NCT00566007|ozone therapy|ozone therapy
5264829|NCT00565994|hemodialysis|hemodialysis
5264830|NCT00565994|Vascular access|vascular access
5264831|NCT00565994|arteriovenous fistula|arteriovenous fistula
5264832|NCT00565994|indwelling percutaneous catheters|indwelling percutaneous catheters
5264833|NCT00565994|arteriovenous grafts|arteriovenous grafts
5264834|NCT00565981|B-CLL|b-cll
5264835|NCT00565981|refractory|refractory
5264836|NCT00565981|molecular profiling|molecular profiling
5264837|NCT00565981|alemtuzumab|alemtuzumab
5264838|NCT00565981|fludarabinephosphate|fludarabinephosphate
5264839|NCT00565968|stage IIIB melanoma|stage iiib melanoma
5264840|NCT00565968|stage IIIC melanoma|stage iiic melanoma
5264841|NCT00565968|recurrent melanoma|recurrent melanoma
5264842|NCT00565955|Montelukast|montelukast
5264843|NCT00565955|Acute Asthma|acute asthma
5264844|NCT00565942|Integrative medicine|integrative medicine
5264845|NCT00565942|Primary care|primary care
5264846|NCT00565942|Swedish massage therapy|swedish massage therapy
5264847|NCT00565942|Manual therapy|manual therapy
5264848|NCT00565942|Naprapathy|naprapathy
5264849|NCT00565942|Shiatsu|shiatsu
5264850|NCT00565942|Acupuncture/TCM|acupuncture/tcm
5264851|NCT00565942|Qigong|qigong
5264852|NCT00565942|Pragmatic RCT|pragmatic rct
5264853|NCT00565942|Health services research|health services research
5264854|NCT00565929|Variola major, smallpox, vaccine, hematopoietic stem cell transplant|variola major, smallpox, vaccine, hematopoietic stem cell transplant
5264855|NCT00565916|Post-Menopausal|post-menopausal
5264856|NCT00565916|PET|pet
5264857|NCT00565916|Estrogen|estrogen
5264858|NCT00565916|Progesterone|progesterone
5264859|NCT00565916|Heart Metabolism|heart metabolism
5264860|NCT00565916|Cardiovascular Disease|cardiovascular disease
5264861|NCT00565903|pleuropulmonary blastoma|pleuropulmonary blastoma
5264862|NCT00565903|PPB|ppb
5264863|NCT00565903|cystic nephroma|cystic nephroma
5264864|NCT00565903|DICER1|dicer1
5264865|NCT00565903|miRNA|mirna
5264866|NCT00565890|very low birth weight infant|very low birth weight infant
5264867|NCT00565890|hypothyroxinemia|hypothyroxinemia
5264868|NCT00565890|outcomes|outcomes
5264869|NCT00565877|Catheter|catheter
5264870|NCT00565877|Peripherally inserted central catheter|peripherally inserted central catheter
5264871|NCT00565877|ultrasound|ultrasound
5264872|NCT00565877|malposition|malposition
5264873|NCT00565864|Hypothyroidism|hypothyroidism
5264874|NCT00565864|Cognition|cognition
5264875|NCT00565864|Metabolism|metabolism
5264876|NCT00565838|Randomized study|randomized study
5264877|NCT00565838|surgical treatment|surgical treatment
5264878|NCT00565838|autologous fascial sling|autologous fascial sling
5264879|NCT00565838|TVT|tvt
5264880|NCT00565838|stress urinary incontinence.|stress urinary incontinence.
5264881|NCT00565812|knee Osteoarthritis Disease Modifying Osteoarthritis Drug|knee osteoarthritis disease modifying osteoarthritis drug
5264882|NCT00565799|DM|dm
5264883|NCT00565760|Acute|acute
5264884|NCT00565760|Pain|pain
5264885|NCT00565747|GM-CSF|gm-csf
5264886|NCT00565747|infertility|infertility
5264887|NCT00565721|Static PET imaging|static pet imaging
5264888|NCT00565721|Dynamic PET imaging|dynamic pet imaging
5264889|NCT00565721|Angiogenesis|angiogenesis
5264890|NCT00565721|αvβ3 integrins|αvβ3 integrins
5264891|NCT00565721|oncology imaging|oncology imaging
5264892|NCT00565708|stage II colon cancer|stage ii colon cancer
5264893|NCT00565708|stage III colon cancer|stage iii colon cancer
5264894|NCT00565708|stage II rectal cancer|stage ii rectal cancer
5264895|NCT00565708|stage III rectal cancer|stage iii rectal cancer
5264896|NCT00565695|Visual Outcomes|visual outcomes
5264897|NCT00565695|Patient Satisfaction|patient satisfaction
5264898|NCT00565695|Cataract Extraction|cataract extraction
5264899|NCT00565669|Treatment|treatment
5264900|NCT00565669|Dry Eye|dry eye
5264901|NCT00565656|Myelodysplastic syndromes (int-1, int-2 and high risk according to IPSS) with excess of marrow blasts including CMML with leucocytes<10 000/mm3|myelodysplastic syndromes (int-1, int-2 and high risk according to ipss) with excess of marrow blasts including cmml with leucocytes<10 000/mm3
5264902|NCT00565643|Adhesion|adhesion
5264903|NCT00565643|Seprafilm|seprafilm
5264904|NCT00565643|Cesarean section|cesarean section
5264905|NCT00565617|depression|depression
5264906|NCT00565617|epidural|epidural
5264907|NCT00565617|cortical stimulation|cortical stimulation
5264908|NCT00565617|brain stimulation|brain stimulation
5264909|NCT00565617|treatment-resistant|treatment-resistant
5264910|NCT00565617|deep brain stimulation|deep brain stimulation
5264911|NCT00565617|TMS|tms
5264912|NCT00565617|DBS|dbs
5264913|NCT00565617|ECS|ecs
5264914|NCT00565604|Perforator Veins|perforator veins
5264915|NCT00565604|Incompetent Veins|incompetent veins
5264916|NCT00565604|Varicose Veins|varicose veins
5264917|NCT00565591|asthma|asthma
5264918|NCT00565591|inhaler device|inhaler device
5264919|NCT00565591|albuterol sulfate|albuterol sulfate
5264920|NCT00565565|Biventriular chronic heart failure, Pulmonary hypertension|biventriular chronic heart failure, pulmonary hypertension
5264921|NCT00565552|silicone gel|silicone gel
5264922|NCT00565552|cicatrix|cicatrix
5264923|NCT00565552|wound healing|wound healing
5264924|NCT00565552|scar|scar
5264925|NCT00565552|keloid|keloid
5264926|NCT00565539|PEGylated recombinant interleukin 29|pegylated recombinant interleukin 29
5264927|NCT00565539|interferon lambda|interferon lambda
5264928|NCT00565539|interleukin 29|interleukin 29
5264929|NCT00565539|hepatitis C|hepatitis c
5264930|NCT00565539|virus|virus
5264931|NCT00565539|infection|infection
5264932|NCT00565539|liver|liver
5264933|NCT00565526|Autonomic Nervous System|autonomic nervous system
5264934|NCT00565526|Sjogren's Syndrome|sjogren's syndrome
5264935|NCT00565526|Pathogenesis|pathogenesis
5264936|NCT00565526|Cholinergic|cholinergic
5264937|NCT00565526|Parasympathetic|parasympathetic
5264938|NCT00565526|Sjogren Syndrome|sjogren syndrome
5264939|NCT00565487|Radiotherapy|radiotherapy
5264940|NCT00565487|Non-operable pancreatic cancer|non-operable pancreatic cancer
5264941|NCT00565487|locally advanced pancreatic cancer|locally advanced pancreatic cancer
5264942|NCT00565474|Renal transplantation|renal transplantation
5264943|NCT00565474|fluvastatin|fluvastatin
5264944|NCT00565448|Nasopharyngeal carcinoma|nasopharyngeal carcinoma
5264945|NCT00565435|Chiari I Malformation|chiari i malformation
5264946|NCT00565422|Internet addiction|internet addiction
5264947|NCT00565422|Problematic internet use|problematic internet use
5264948|NCT00565422|Escitalopram|escitalopram
5264949|NCT00565422|Lexapro|lexapro
5264950|NCT00565409|Active Rheumatoid Arthritis|active rheumatoid arthritis
5264951|NCT00565383|Pregnancy|pregnancy
5264952|NCT00565383|37 Weeks Gestation|37 weeks gestation
5264953|NCT00565383|Breech Presentation|breech presentation
5264954|NCT00565383|Version Procedure|version procedure
5264955|NCT00565383|Pain Control|pain control
5264956|NCT00565383|Neuraxial analgesia|neuraxial analgesia
5264957|NCT00565370|Gastric cancer|gastric cancer
5264958|NCT00565370|capecitabine|capecitabine
5264959|NCT00565370|cisplatin|cisplatin
5264960|NCT00565370|sorafenib|sorafenib
5264961|NCT00565370|phase I|phase i
5264962|NCT00565370|phase II|phase ii
5264963|NCT00565357|Postnatal Growth|postnatal growth
5264964|NCT00565357|Postnatal Development|postnatal development
5264965|NCT00565357|Noise|noise
5264966|NCT00565357|Neonatal Intensive Care Unit|neonatal intensive care unit
5264967|NCT00565344|Medicaid|medicaid
5264968|NCT00565344|Disenrollment|disenrollment
5264969|NCT00565318|Benfotiamine|benfotiamine
5264970|NCT00565318|Diabetes|diabetes
5264971|NCT00565318|Nephropathy|nephropathy
5264972|NCT00565305|Healing Touch|healing touch
5264973|NCT00565305|NK cytotoxicity|nk cytotoxicity
5264974|NCT00565305|cytokines|cytokines
5264975|NCT00565305|fatigue|fatigue
5264976|NCT00565279|Seborrhoeic dermatitis|seborrhoeic dermatitis
5264977|NCT00565253|pulmonary embolism|pulmonary embolism
5264978|NCT00565253|inhaled nitric oxide|inhaled nitric oxide
5264979|NCT00565240|ovarian synchronization|ovarian synchronization
5264980|NCT00565240|folliculogenesis|folliculogenesis
5264981|NCT00565214|vitamin supplements|vitamin supplements
5264982|NCT00565214|healthy smokers|healthy smokers
5264983|NCT00565214|epithelial lung tissue|epithelial lung tissue
5264984|NCT00565214|bronchoscopy|bronchoscopy
5264985|NCT00565214|antioxidant levels|antioxidant levels
5264986|NCT00565201|Stroke, Cerebrovascular accident, Spasticity, Arm, Hand|stroke, cerebrovascular accident, spasticity, arm, hand
5264987|NCT00565175|Treatment resistant|treatment resistant
5264988|NCT00565175|Chronic|chronic
5264989|NCT00565136|Device study|device study
5264990|NCT00565136|Pelvic floor weakness|pelvic floor weakness
5264991|NCT00565136|Fecal incontinence|fecal incontinence
5264992|NCT00565123|bacterial conjunctivitis levofloxacin fluoroquinolone|bacterial conjunctivitis levofloxacin fluoroquinolone
5264993|NCT00565097|Polycystic Liver Disease|polycystic liver disease
5264994|NCT00565097|Autosomal Dominant Polycystic Kidney Disease|autosomal dominant polycystic kidney disease
5264995|NCT00565097|Liver cyst|liver cyst
5264996|NCT00565097|Lanreotide|lanreotide
5264997|NCT00565071|Cost-effectiveness|cost-effectiveness
5264998|NCT00565071|Diagnosis|diagnosis
5264999|NCT00565071|Treatment|treatment
5265000|NCT00565071|Malaria|malaria
5265001|NCT00565045|hand|hand
5265002|NCT00565045|stroke|stroke
5265003|NCT00565045|hemiplegia|hemiplegia
5265004|NCT00565045|electrical stimulation|electrical stimulation
5265005|NCT00565045|recovery|recovery
5265006|NCT00565032|postpartum depression|postpartum depression
5265007|NCT00565032|thyroxine|thyroxine
5265008|NCT00565032|thyroid antibodies|thyroid antibodies
5265009|NCT00565032|thyroid stimulating hormone|thyroid stimulating hormone
5265010|NCT00565032|Edinburgh Postnatal Depression Scale (EPDS)|edinburgh postnatal depression scale (epds)
5265011|NCT00564980|Randomized|randomized
5265012|NCT00564980|Prospective|prospective
5265013|NCT00564980|Procedure / Surgery|procedure / surgery
5265014|NCT00564954|ADHD|adhd
5265015|NCT00564954|children|children
5265016|NCT00564954|laboratory classroom|laboratory classroom
5265017|NCT00564954|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
5265018|NCT00564941|Myelodysplastic Syndromes|myelodysplastic syndromes
5265019|NCT00564941|beta-Thalassemia|beta-thalassemia
5265020|NCT00564941|Iron Overload|iron overload
5265021|NCT00564941|Iron Chelating Agents|iron chelating agents
5265022|NCT00564941|deferasirox|deferasirox
5265023|NCT00564928|Hormone resistant prostate cancer|hormone resistant prostate cancer
5265024|NCT00564928|castrate resistant prostate cancer|castrate resistant prostate cancer
5265025|NCT00564928|HRPC|hrpc
5265026|NCT00564928|CRPC|crpc
5265027|NCT00564915|Epilepsy|epilepsy
5265028|NCT00564902|Macular Pigment Optical Density|macular pigment optical density
5265029|NCT00564902|Skin Carotenoids|skin carotenoids
5265030|NCT00564902|Lipofuscin|lipofuscin
5265031|NCT00564902|Photostress (Glare Recovery)|photostress (glare recovery)
5265032|NCT00564902|Visual Field Progression|visual field progression
5265033|NCT00564902|Contrast Sensitivity|contrast sensitivity
5265034|NCT00564902|Color Vision|color vision
5265035|NCT00564902|Cognitive Function|cognitive function
5265036|NCT00564889|primary systemic amyloidosis|primary systemic amyloidosis
5265037|NCT00564876|Non Small Cell Lung Cancer (NSCLC)|non small cell lung cancer (nsclc)
5265038|NCT00564876|carcinoma|carcinoma
5265039|NCT00564876|dasatinib|dasatinib
5265040|NCT00564876|neoadjuvant|neoadjuvant
5265041|NCT00564876|adjuvant|adjuvant
5265042|NCT00564876|resection|resection
5265043|NCT00564876|genomic signature|genomic signature
5265044|NCT00564876|predictor|predictor
5265045|NCT00564876|microarray|microarray
5265046|NCT00564863|Diarrhea|diarrhea
5265047|NCT00564863|ETEC|etec
5265048|NCT00564837|Anterior cruciate ligament|anterior cruciate ligament
5265049|NCT00564837|Reconstruction|reconstruction
5265050|NCT00564837|Rehabilitation|rehabilitation
5265051|NCT00564837|Home-based|home-based
5265052|NCT00564824|coronary disease|coronary disease
5265053|NCT00564824|atherosclerosis|atherosclerosis
5265054|NCT00564824|endothelial function|endothelial function
5265055|NCT00564824|caffeine|caffeine
5265056|NCT00564824|cerebrovascular disease|cerebrovascular disease
5265057|NCT00564824|prevention|prevention
5265058|NCT00564811|Agaricus blazei (Murrill) ss. Heinemann,|agaricus blazei (murrill) ss. heinemann,
5265059|NCT00564811|Hepatitis C|hepatitis c
5265060|NCT00564811|Nutritional status|nutritional status
5265061|NCT00564811|Liver Function Tests|liver function tests
5265062|NCT00564811|Antiviral Agents|antiviral agents
5265063|NCT00564798|protocoladolescents|protocoladolescents
5265064|NCT00564798|children|children
5265065|NCT00564798|health behaviours/attitudes|health behaviours/attitudes
5265066|NCT00564798|weight loss/management|weight loss/management
5265067|NCT00564798|program evaluation|program evaluation
5265068|NCT00564772|raltegravir|raltegravir
5265069|NCT00564772|lopinavir|lopinavir
5265070|NCT00564772|ritonavir|ritonavir
5265071|NCT00564772|pharmacokinetics|pharmacokinetics
5265072|NCT00564759|CGD|cgd
5265073|NCT00564746|SB-681323,|sb-681323,
5265074|NCT00564746|ADME,|adme,
5265075|NCT00564746|radiolabel|radiolabel
5265076|NCT00564694|adenocarcinoma of the colon|adenocarcinoma of the colon
5265077|NCT00564694|recurrent colon cancer|recurrent colon cancer
5265078|NCT00564694|stage I colon cancer|stage i colon cancer
5265079|NCT00564694|stage II colon cancer|stage ii colon cancer
5265080|NCT00564694|stage III colon cancer|stage iii colon cancer
5265081|NCT00564694|stage IV colon cancer|stage iv colon cancer
5265082|NCT00564694|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5265083|NCT00564694|recurrent rectal cancer|recurrent rectal cancer
5265084|NCT00564694|stage I rectal cancer|stage i rectal cancer
5265085|NCT00564694|stage II rectal cancer|stage ii rectal cancer
5265086|NCT00564694|stage III rectal cancer|stage iii rectal cancer
5265087|NCT00564694|stage IV rectal cancer|stage iv rectal cancer
5265088|NCT00564655|pediatrics|pediatrics
5265089|NCT00564655|Gastric Tube Insertion|gastric tube insertion
5265090|NCT00564655|Anesthesia|anesthesia
5265091|NCT00564655|Regional Anesthetic|regional anesthetic
5265092|NCT00564655|Transversus Abdominal Plane|transversus abdominal plane
5265093|NCT00564616|cardiac arrest|cardiac arrest
5265094|NCT00564616|video cell phone|video cell phone
5265095|NCT00564616|dispatcher-assisted CPR|dispatcher-assisted cpr
5265096|NCT00564603|Glucocorticoid|glucocorticoid
5265097|NCT00564603|Opioids|opioids
5265098|NCT00564603|Balanced analgesia|balanced analgesia
5265099|NCT00564577|Diarrhea ETEC|diarrhea etec
5265100|NCT00564564|obsessive compulsive disorder|obsessive compulsive disorder
5265101|NCT00564564|pharmacological treatment|pharmacological treatment
5265102|NCT00564564|quetiapine|quetiapine
5265103|NCT00564564|clomipramine|clomipramine
5265104|NCT00564564|SSRI|ssri
5265105|NCT00564551|Prediabetes|prediabetes
5265106|NCT00564551|Type 2 diabetes|type 2 diabetes
5265107|NCT00564551|Metabolic syndrome|metabolic syndrome
5265108|NCT00564551|Insulin resistance syndrome|insulin resistance syndrome
5265109|NCT00564551|Weight loss|weight loss
5265110|NCT00564551|Milk products|milk products
5265111|NCT00564551|Calcium|calcium
5265112|NCT00564538|liver transplant|liver transplant
5265113|NCT00564525|children|children
5265114|NCT00564525|abdominal pain|abdominal pain
5265115|NCT00564525|amitriptyline|amitriptyline
5265116|NCT00564512|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
5265117|NCT00564512|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
5265118|NCT00564512|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
5265119|NCT00564512|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5265120|NCT00564512|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5265121|NCT00564499|COPD|copd
5265122|NCT00564499|Symbicort|symbicort
5265123|NCT00564499|General Practitioners|general practitioners
5265124|NCT00564486|Abdominal Laparoscopic Surgery|abdominal laparoscopic surgery
5265125|NCT00564473|internal medicine|internal medicine
5265126|NCT00564473|herbal medicine|herbal medicine
5265127|NCT00564473|prevalence|prevalence
5265128|NCT00564473|attitudes|attitudes
5265129|NCT00564473|herb-drug interaction|herb-drug interaction
5265130|NCT00564434|delirium|delirium
5265131|NCT00564434|pathophysiology|pathophysiology
5265132|NCT00564434|risk factors|risk factors
5265133|NCT00564434|pain|pain
5265134|NCT00564434|dementia|dementia
5265135|NCT00564395|blood sugar|blood sugar
5265136|NCT00564395|glycemic|glycemic
5265137|NCT00564382|Acute coronary syndrome|acute coronary syndrome
5265138|NCT00564382|Cardiac Magnetic Resonance Imaging|cardiac magnetic resonance imaging
5265139|NCT00564382|Contrast agents|contrast agents
5265140|NCT00564382|Gadolinium|gadolinium
5265141|NCT00564369|HIV testing|hiv testing
5265142|NCT00564369|HIV Seronegativity|hiv seronegativity
5265143|NCT00564356|cataract, phacoemulsification, coumadin, antiaggregants|cataract, phacoemulsification, coumadin, antiaggregants
5265144|NCT00564343|Balance|balance
5265145|NCT00564343|Water based training|water based training
5265146|NCT00564343|Physical functioning|physical functioning
5265147|NCT00564343|stepping behavior|stepping behavior
5265148|NCT00564330|dental erosion|dental erosion
5265149|NCT00564330|OCT|oct
5265439|NCT00562991|child|child
5265150|NCT00564330|proton pump inhibitor|proton pump inhibitor
5265151|NCT00564317|PTSD|ptsd
5265152|NCT00564317|Depression|depression
5265153|NCT00564317|Suicidality|suicidality
5265154|NCT00564317|trauma-focussed treatment|trauma-focussed treatment
5265155|NCT00564317|KIDNET|kidnet
5265156|NCT00564317|Narrative Exposure Therapy for Children|narrative exposure therapy for children
5265157|NCT00564317|Meditation|meditation
5265158|NCT00564317|Relaxation|relaxation
5265159|NCT00564317|War|war
5265160|NCT00564304|Nasal Potential Difference|nasal potential difference
5265161|NCT00564291|OCT|oct
5265162|NCT00564278|Hispanic Americans|hispanic americans
5265163|NCT00564278|Major Depressive Disorder|major depressive disorder
5265164|NCT00564278|Antidepressant Therapy|antidepressant therapy
5265165|NCT00564278|Motivational Interviewing|motivational interviewing
5265166|NCT00564278|Treatment Retention|treatment retention
5265167|NCT00564278|Treatment Adherence|treatment adherence
5265168|NCT00564265|GIST|gist
5265169|NCT00564226|urge urinary incontinence|urge urinary incontinence
5265170|NCT00564213|Myopia|myopia
5265171|NCT00564213|Mitomycin|mitomycin
5265172|NCT00564200|Multiple Myeloma, transplant|multiple myeloma, transplant
5265173|NCT00564174|recurrent pregnancy loss|recurrent pregnancy loss
5265174|NCT00564174|lupus anticoagulant|lupus anticoagulant
5265175|NCT00564174|anti cardiolipin antibodies|anti cardiolipin antibodies
5265176|NCT00564174|thrombophilia|thrombophilia
5265177|NCT00564174|low molecular weight heparin|low molecular weight heparin
5265179|NCT00564174|randomized clinical trial|randomized clinical trial
5265180|NCT00564148|antiVEGF therapy|antivegf therapy
5265181|NCT00564135|hysterectomy|hysterectomy
5265182|NCT00564135|laparoscopy|laparoscopy
5265183|NCT00564135|urinary retention|urinary retention
5265184|NCT00564135|urinary tract infection|urinary tract infection
5265185|NCT00564135|catheterization|catheterization
5265186|NCT00564122|Murmur|murmur
5265187|NCT00564122|Artificial-Intelligence|artificial-intelligence
5265188|NCT00564122|Stethoscope|stethoscope
5265189|NCT00564122|Congenital Heart Disease|congenital heart disease
5265190|NCT00564122|Structural Heart Disease|structural heart disease
5265191|NCT00564083|Compare the relative differences between the organic and sythentic materials for sacryl colpopexy.|compare the relative differences between the organic and sythentic materials for sacryl colpopexy.
5265192|NCT00564070|Depression|depression
5265193|NCT00564070|Diabetes|diabetes
5265194|NCT00564070|Adherence|adherence
5265195|NCT00564057|HIV|hiv
5265196|NCT00564057|blood pressure|blood pressure
5265197|NCT00564057|left ventricle|left ventricle
5265198|NCT00564057|metabolic profile|metabolic profile
5265199|NCT00564057|treatment experienced|treatment experienced
5265200|NCT00564044|biofilm-infection-related immune hyperreactivity|biofilm-infection-related immune hyperreactivity
5265201|NCT00564044|mesh extrusion|mesh extrusion
5265202|NCT00564044|mid-urethral sling|mid-urethral sling
5265203|NCT00564044|determine the immune reactivity of biofilms in mesh erosion|determine the immune reactivity of biofilms in mesh erosion
5265204|NCT00564031|hormone replacement therapy; endothelial function;|hormone replacement therapy; endothelial function;
5265205|NCT00564018|type 1 diabetes, basal-bolus, honeymoon, C-peptide|type 1 diabetes, basal-bolus, honeymoon, c-peptide
5265206|NCT00564005|stroke rehabilitation|stroke rehabilitation
5265207|NCT00564005|cortical reorganization|cortical reorganization
5265208|NCT00564005|kinematic analysis|kinematic analysis
5265209|NCT00563979|age related macular degeneration|age related macular degeneration
5265210|NCT00563979|supplementation|supplementation
5265211|NCT00563979|macular pigment|macular pigment
5265212|NCT00563966|smoking pregnancy behaviour polymorphisms|smoking pregnancy behaviour polymorphisms
5265213|NCT00563953|Breast|breast
5265214|NCT00563953|Cancer|cancer
5265215|NCT00563953|Anthracyclines|anthracyclines
5265216|NCT00563953|Cardiopathy|cardiopathy
5265217|NCT00563940|diabetic macular edema|diabetic macular edema
5265218|NCT00563940|OCT|oct
5265219|NCT00563927|Nasopharyngeal Carcinoma|nasopharyngeal carcinoma
5265220|NCT00563927|T1-4N2-3M0|t1-4n2-3m0
5265221|NCT00563914|Malaria|malaria
5265222|NCT00563901|CHD|chd
5265223|NCT00563901|Combined CHD|combined chd
5265224|NCT00563901|Stroke|stroke
5265225|NCT00563901|Combined Cardiovascular Disease (CVD)|combined cardiovascular disease (cvd)
5265226|NCT00563901|Pharmacogenetics|pharmacogenetics
5265227|NCT00563901|End-Stage Renal Disease|end-stage renal disease
5265228|NCT00563901|Heart Failure|heart failure
5265229|NCT00563901|Hospitalized/Fatal Heart Failure|hospitalized/fatal heart failure
5265230|NCT00563901|Angina|angina
5265231|NCT00563901|Coronary Revascularizations|coronary revascularizations
5265232|NCT00563901|CHD Mortality|chd mortality
5265233|NCT00563901|Lisinopril|lisinopril
5265234|NCT00563901|Chlorthalidone|chlorthalidone
5265235|NCT00563901|Amlodipine|amlodipine
5265236|NCT00563901|Doxazosin|doxazosin
5265237|NCT00563888|PTSD|ptsd
5265238|NCT00563888|torture survivors|torture survivors
5265239|NCT00563888|Narrative Exposure Therapy|narrative exposure therapy
5265240|NCT00563888|trauma-related memory processes|trauma-related memory processes
5265241|NCT00563888|steady state visual evoked fields|steady state visual evoked fields
5265242|NCT00563875|Platelets|platelets
5265243|NCT00563875|Platelet aggregation|platelet aggregation
5265244|NCT00563875|Drug resistance|drug resistance
5265246|NCT00563875|Diabetes mellitus|diabetes mellitus
5265247|NCT00563862|Nasopharyngeal Carcinoma|nasopharyngeal carcinoma
5265248|NCT00563862|T3-4N0-1M0|t3-4n0-1m0
5265249|NCT00563836|ovarian cancer|ovarian cancer
5265250|NCT00563836|catumaxomab|catumaxomab
5265251|NCT00563836|phase II|phase ii
5265252|NCT00563836|intraoperative|intraoperative
5265253|NCT00563836|adjuvant|adjuvant
5265254|NCT00563836|trifunctional antibody|trifunctional antibody
5265255|NCT00563823|stage IV melanoma|stage iv melanoma
5265256|NCT00563823|recurrent melanoma|recurrent melanoma
5265257|NCT00563810|Adult|adult
5265258|NCT00563810|Aged|aged
5265259|NCT00563797|treatment|treatment
5265260|NCT00563797|alcohol dependence|alcohol dependence
5265261|NCT00563797|depression|depression
5265262|NCT00563797|mecamylamine|mecamylamine
5265263|NCT00563784|Non-Small Cell Lung Cancer|non-small cell lung cancer
5265264|NCT00563784|Lung Cancer|lung cancer
5265265|NCT00563784|Squamous Cell Carcinoma|squamous cell carcinoma
5265266|NCT00563784|Adenocarcinoma|adenocarcinoma
5265267|NCT00563784|Bronchoalveolar Cell Carcinoma|bronchoalveolar cell carcinoma
5265268|NCT00563784|Large Cell Anaplastic Carcinoma|large cell anaplastic carcinoma
5265269|NCT00563784|Giant Cell Carcinoma|giant cell carcinoma
5265270|NCT00563784|Clear Cell Carcinoma|clear cell carcinoma
5265271|NCT00563784|Erlotinib|erlotinib
5265272|NCT00563784|Erlotinib Hydrocholoride|erlotinib hydrocholoride
5265273|NCT00563784|OSI-774|osi-774
5265274|NCT00563784|Tarceva|tarceva
5265275|NCT00563784|Carboplatin|carboplatin
5265276|NCT00563784|Paraplatin|paraplatin
5265277|NCT00563784|Paclitaxel|paclitaxel
5265278|NCT00563784|Taxol|taxol
5265279|NCT00563784|NSCLC|nsclc
5265280|NCT00563758|Chronic constipation|chronic constipation
5265281|NCT00563745|COPD|copd
5265282|NCT00563745|ALS|als
5265283|NCT00563745|Telemedicine|telemedicine
5265284|NCT00563745|mechanical ventilation|mechanical ventilation
5265285|NCT00563745|Integrated care|integrated care
5265286|NCT00563745|strict follow up|strict follow up
5265287|NCT00563745|impact and costs on health care resources|impact and costs on health care resources
5265288|NCT00563745|telemedicine programme|telemedicine programme
5265289|NCT00563745|home mechanical ventilation (HMV)|home mechanical ventilation (hmv)
5265290|NCT00563745|frail patients|frail patients
5265291|NCT00563745|chronic respiratory failure (CRF)|chronic respiratory failure (crf)
5265292|NCT00563693|heart failure|heart failure
5265293|NCT00563693|cheyne stokes respiration|cheyne stokes respiration
5265294|NCT00563693|adaptive servo ventilator|adaptive servo ventilator
5265295|NCT00563680|AMG 479|amg 479
5265296|NCT00563680|IGF-1R|igf-1r
5265297|NCT00563680|Insulin-like growth factor|insulin-like growth factor
5265298|NCT00563680|Insulin-like growth factor receptor|insulin-like growth factor receptor
5265299|NCT00563680|Ewing's|ewing's
5265300|NCT00563680|Sarcoma|sarcoma
5265301|NCT00563667|Pterygium|pterygium
5265302|NCT00563667|Cataract|cataract
5265303|NCT00563667|Astigmatism|astigmatism
5265304|NCT00563654|Benign Prostatic Hyperplasia (BPH)|benign prostatic hyperplasia (bph)
5265305|NCT00563654|Acute Retention of Urine (AUR)|acute retention of urine (aur)
5265306|NCT00563641|NCPAP|ncpap
5265307|NCT00563641|Very early surfactant|very early surfactant
5265308|NCT00563628|Pattern Scan Laser.|pattern scan laser.
5265309|NCT00563628|Photocoagulation.|photocoagulation.
5265310|NCT00563628|Diabetic retinopathy treatment.|diabetic retinopathy treatment.
5265311|NCT00563628|Laser treatment|laser treatment
5265312|NCT00563615|Constipation (idiopathic)|constipation (idiopathic)
5265313|NCT00563602|Portal hypertension|portal hypertension
5265314|NCT00563602|Prevention of rebleeding|prevention of rebleeding
5265315|NCT00563602|Complications of cirrhosis|complications of cirrhosis
5265316|NCT00563602|Portal hemodynamic|portal hemodynamic
5265317|NCT00563602|Prazosine|prazosine
5265318|NCT00563602|Nadolol|nadolol
5265319|NCT00563602|isosorbide mononitrate|isosorbide mononitrate
5265320|NCT00563589|Acute graft-versus-host disease post high risk allogeneic stem cell transplantation|acute graft-versus-host disease post high risk allogeneic stem cell transplantation
5265321|NCT00563576|Depo-Provera|depo-provera
5265322|NCT00563576|Medroxyprogesterone Acetate|medroxyprogesterone acetate
5265323|NCT00563576|Metrorrhagia|metrorrhagia
5265324|NCT00563576|Irregular Bleeding|irregular bleeding
5265325|NCT00563563|Nicotine-dependence in overweight and obese subjects|nicotine-dependence in overweight and obese subjects
5265326|NCT00563537|neurology|neurology
5265327|NCT00563537|sclerosis|sclerosis
5265328|NCT00563537|imaging|imaging
5265329|NCT00563537|tomography|tomography
5265330|NCT00563511|smoking cessation|smoking cessation
5265331|NCT00563498|Veno-occlusive disease|veno-occlusive disease
5265332|NCT00563498|Mucositis|mucositis
5265333|NCT00563485|Benign Prostatic Hyperplasia (BPH)|benign prostatic hyperplasia (bph)
5265334|NCT00563485|Acute Retention of Urine (AUR)|acute retention of urine (aur)
5265335|NCT00563472|Healthy female volunteers will participate in this study|healthy female volunteers will participate in this study
5265336|NCT00563459|Epilepsy, seizures|epilepsy, seizures
5265337|NCT00563459|partial onset seizures|partial onset seizures
5265338|NCT00563459|anti-epileptic drugs (AED)|anti-epileptic drugs (aed)
5265339|NCT00563459|carisbamate|carisbamate
5265340|NCT00563459|topiramate|topiramate
5265341|NCT00563459|levetiracetam|levetiracetam
5265343|NCT00563446|End-stage renal failure|end-stage renal failure
5265344|NCT00563446|Continuous ambulatory peritoneal dialysis|continuous ambulatory peritoneal dialysis
5265345|NCT00563433|diabetic|diabetic
5265346|NCT00563433|diabetes mellitus|diabetes mellitus
5265347|NCT00563433|foot|foot
5265348|NCT00563433|ulcers|ulcers
5265349|NCT00563433|Floxin|floxin
5265350|NCT00563433|oral antibiotic|oral antibiotic
5265351|NCT00563433|topical cream|topical cream
5265352|NCT00563420|Lung cancer|lung cancer
5265353|NCT00563407|skin toxicity prediction|skin toxicity prediction
5265354|NCT00563407|cardiac toxicity prediction|cardiac toxicity prediction
5265355|NCT00563394|diabetic|diabetic
5265356|NCT00563394|diabetes mellitus|diabetes mellitus
5265357|NCT00563394|foot|foot
5265358|NCT00563394|ulcers|ulcers
5265359|NCT00563394|Floxin|floxin
5265360|NCT00563394|oral antibiotic|oral antibiotic
5265361|NCT00563394|topical cream|topical cream
5265362|NCT00563355|chronic kidney disease|chronic kidney disease
5265363|NCT00563355|cardiovascular disease|cardiovascular disease
5265364|NCT00563342|Ethanol, lock solution, infection|ethanol, lock solution, infection
5265365|NCT00563329|Smokers who are not willing to quit in the near future but intend to reduce smoking|smokers who are not willing to quit in the near future but intend to reduce smoking
5265366|NCT00563316|colorectal cancer|colorectal cancer
5265367|NCT00563316|chemotherapy|chemotherapy
5265368|NCT00563316|cancer|cancer
5265369|NCT00563316|metastatic|metastatic
5265370|NCT00563316|irinotecan|irinotecan
5265371|NCT00563316|EGFr|egfr
5265372|NCT00563316|epidermal growth factor|epidermal growth factor
5265373|NCT00563277|Pterygium|pterygium
5265374|NCT00563277|Cataract|cataract
5265375|NCT00563277|Intraocular lens power calculation accuracy|intraocular lens power calculation accuracy
5265376|NCT00563264|obesity|obesity
5265377|NCT00563264|parenting|parenting
5265378|NCT00563264|postpartum period|postpartum period
5265379|NCT00563264|family research|family research
5265380|NCT00563251|Bronchiolitis obliterans in bone marrow transplant recipients|bronchiolitis obliterans in bone marrow transplant recipients
5265381|NCT00563238|Extubation|extubation
5265382|NCT00563212|Lung Diseases, Interstitial|lung diseases, interstitial
5265383|NCT00563212|Fibrosis|fibrosis
5265384|NCT00563212|Interferons|interferons
5265385|NCT00563212|Pulmonary Fibrosis|pulmonary fibrosis
5265386|NCT00563212|Pathologic Processes|pathologic processes
5265387|NCT00563212|Lung Diseases|lung diseases
5265388|NCT00563212|Fibrosing alveolitis|fibrosing alveolitis
5265389|NCT00563212|Interferon-gamma, Recombinant|interferon-gamma, recombinant
5265390|NCT00563212|Aerosols|aerosols
5265391|NCT00563199|smoking cessation|smoking cessation
5265392|NCT00563199|smoking behaviors|smoking behaviors
5265393|NCT00563186|infection control|infection control
5265394|NCT00563186|nosocomial infection|nosocomial infection
5265395|NCT00563186|hospital design|hospital design
5265396|NCT00563186|physical plant design|physical plant design
5265397|NCT00563186|antibiotic resistant organisms|antibiotic resistant organisms
5265398|NCT00563160|lung cancer|lung cancer
5265399|NCT00563147|tivozanib|tivozanib
5265400|NCT00563147|AV-951|av-951
5265401|NCT00563134|Suspected or confirmed severe Gram-negative sepsis|suspected or confirmed severe gram-negative sepsis
5265402|NCT00563121|Retinopathy of Prematurity|retinopathy of prematurity
5265403|NCT00563121|ROP|rop
5265404|NCT00563121|Vascular Endothelial Growth Factor|vascular endothelial growth factor
5265405|NCT00563121|VEGF|vegf
5265406|NCT00563121|Vitreous|vitreous
5265407|NCT00563121|Subretinal Fluid|subretinal fluid
5265408|NCT00563121|ELISA|elisa
5265409|NCT00563121|VEGF levels in Aqueous, Vitreous and subretinal Fluid|vegf levels in aqueous, vitreous and subretinal fluid
5265410|NCT00563108|Acute graft-versus-host disease post allogeneic stem cell transplantation|acute graft-versus-host disease post allogeneic stem cell transplantation
5265411|NCT00563095|Hepatocellular carcinoma|hepatocellular carcinoma
5265412|NCT00563082|SLE|sle
5265413|NCT00563082|Genetics|genetics
5265414|NCT00563069|diagnostic and therapeutic rigid cystoscopy|diagnostic and therapeutic rigid cystoscopy
5265415|NCT00563056|Formoterol|formoterol
5265416|NCT00563056|Fluticasone|fluticasone
5265417|NCT00563056|Asthma|asthma
5265418|NCT00563043|Pattern Scan Laser.|pattern scan laser.
5265419|NCT00563043|Photocoagulation.|photocoagulation.
5265420|NCT00563043|Diabetic retinopathy treatment.|diabetic retinopathy treatment.
5265421|NCT00563043|Laser treatment.|laser treatment.
5265422|NCT00563043|Electroretinogram.|electroretinogram.
5265423|NCT00563043|a wave.|a wave.
5265424|NCT00563043|b wave.|b wave.
5265425|NCT00563043|Implicit time.|implicit time.
5265426|NCT00563030|Cardiopulmonary bypass|cardiopulmonary bypass
5265427|NCT00563030|Neutrophils|neutrophils
5265428|NCT00563030|Coronary artery bypass graft surgery|coronary artery bypass graft surgery
5265429|NCT00563017|Catatonic Schizophrenia|catatonic schizophrenia
5265430|NCT00563017|Disorganized Schizophrenia|disorganized schizophrenia
5265431|NCT00563017|Paranoid Schizophrenia|paranoid schizophrenia
5265432|NCT00563017|Undifferentiated Schizophrenia|undifferentiated schizophrenia
5265433|NCT00563017|Schizo-affective disorders|schizo-affective disorders
5265434|NCT00563004|Diabetes mellitus|diabetes mellitus
5265435|NCT00563004|Herbal treatment|herbal treatment
5265436|NCT00563004|Food supplement|food supplement
5265437|NCT00562991|exhaled NO|exhaled no
5265440|NCT00562978|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5265441|NCT00562978|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5265442|NCT00562978|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5265443|NCT00562978|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5265444|NCT00562978|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5265445|NCT00562978|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5265446|NCT00562978|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5265447|NCT00562978|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5265448|NCT00562978|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5265449|NCT00562978|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5265450|NCT00562978|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5265451|NCT00562978|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5265452|NCT00562978|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5265453|NCT00562978|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5265454|NCT00562978|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5265455|NCT00562978|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5265456|NCT00562978|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5265457|NCT00562978|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5265458|NCT00562978|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5265459|NCT00562978|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5265460|NCT00562978|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5265461|NCT00562978|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5265462|NCT00562978|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5265463|NCT00562978|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5265464|NCT00562952|Natriuretic peptide|natriuretic peptide
5265465|NCT00562952|Prognosis|prognosis
5265466|NCT00562952|Diabetes|diabetes
5265467|NCT00562952|Heart failure|heart failure
5265468|NCT00562952|Heart disease|heart disease
5265469|NCT00562939|Antibody Formation|antibody formation
5265470|NCT00562939|Antibody Affinity|antibody affinity
5265471|NCT00562939|Immunity|immunity
5265472|NCT00562939|Pneumococcal Vaccines|pneumococcal vaccines
5265473|NCT00562939|Oligodeoxyribonucleotides|oligodeoxyribonucleotides
5265474|NCT00562926|Schizophrenia|schizophrenia
5265475|NCT00562926|Schizophrenia spectrum disorder|schizophrenia spectrum disorder
5265476|NCT00562913|Cancer|cancer
5265477|NCT00562913|Sorafenib|sorafenib
5265478|NCT00562913|Cyclophosphamide|cyclophosphamide
5265479|NCT00562913|Doxorubicin|doxorubicin
5265480|NCT00562887|Crohn's Disease|crohn's disease
5265481|NCT00562874|HIV|hiv
5265482|NCT00562874|AIDS|aids
5265483|NCT00562874|WOMEN|women
5265484|NCT00562874|KENYA|kenya
5265485|NCT00562874|NUTRITION|nutrition
5265486|NCT00562874|HIV/AIDS|hiv/aids
5265487|NCT00562874|treatment naive|treatment naive
5265488|NCT00562861|Bipolar Disorder|bipolar disorder
5265489|NCT00562861|Bipolar Depression|bipolar depression
5265490|NCT00562861|Clinical Trials, Phase II|clinical trials, phase ii
5265491|NCT00562861|Clinical Pharmacology|clinical pharmacology
5265492|NCT00562848|gastric emptying|gastric emptying
5265493|NCT00562848|pharmacokinetic|pharmacokinetic
5265494|NCT00562848|tolerability|tolerability
5265495|NCT00562848|safety|safety
5265496|NCT00562848|GSK962040|gsk962040
5265497|NCT00562848|gut motility|gut motility
5265498|NCT00562848|First Time in Human|first time in human
5265499|NCT00562835|ARDS|ards
5265500|NCT00562835|Adult|adult
5265501|NCT00562835|Methylprednisolone|methylprednisolone
5265502|NCT00562796|Growth Hormone Deficiency|growth hormone deficiency
5265503|NCT00562796|Cardiovascular Disease|cardiovascular disease
5265504|NCT00562796|Intra-abdominal Fat|intra-abdominal fat
5265505|NCT00562796|Insulin Resistance|insulin resistance
5265506|NCT00562783|HBV|hbv
5265507|NCT00562783|HCV|hcv
5265508|NCT00562783|Liver cirrhosis|liver cirrhosis
5265509|NCT00562770|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
5265510|NCT00562770|CLL|cll
5265511|NCT00562770|Leukemia|leukemia
5265512|NCT00562757|Wedensky modulation|wedensky modulation
5265513|NCT00562757|Risk stratification|risk stratification
5265514|NCT00562757|Electrophysiology|electrophysiology
5265515|NCT00562757|Noninvasive|noninvasive
5265516|NCT00562757|Ischemic heart disease|ischemic heart disease
5265517|NCT00562757|ICD guidelines|icd guidelines
5265518|NCT00562757|Myocardial infarction|myocardial infarction
5265519|NCT00562718|stage II breast cancer|stage ii breast cancer
5265520|NCT00562718|stage IIIA breast cancer|stage iiia breast cancer
5265521|NCT00562718|stage IIIB breast cancer|stage iiib breast cancer
5265522|NCT00562718|male breast cancer|male breast cancer
5265523|NCT00562718|recurrent breast cancer|recurrent breast cancer
5265524|NCT00562705|growth hormone|growth hormone
5265525|NCT00562705|eating regulation|eating regulation
5265526|NCT00562705|nutritional intervention|nutritional intervention
5265527|NCT00562705|short stature|short stature
5265528|NCT00562705|ISS|iss
5265529|NCT00562705|SGA|sga
5265530|NCT00562705|IGHD|ighd
5265531|NCT00562705|MPHD|mphd
5265532|NCT00562692|Heart failure|heart failure
5265533|NCT00562692|OAD|oad
5265534|NCT00562692|BNP|bnp
5265535|NCT00562692|Heart Failure patients who present to the emergency department|heart failure patients who present to the emergency department
5265536|NCT00562679|Patients with coronary artery disease|patients with coronary artery disease
5265537|NCT00562666|cell therapy|cell therapy
5265538|NCT00562666|T lymphocytes|t lymphocytes
5265539|NCT00562666|hepatic intra-arterial injection|hepatic intra-arterial injection
5265540|NCT00562653|profile autoantibodies|profile autoantibodies
5265541|NCT00562653|clinical symptoms|clinical symptoms
5265542|NCT00562640|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5265543|NCT00562640|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5265544|NCT00562640|recurrent primary peritoneal cavity cancer|recurrent primary peritoneal cavity cancer
5265545|NCT00562640|stage IIIA primary peritoneal cavity cancer|stage iiia primary peritoneal cavity cancer
5265546|NCT00562640|stage IIIB primary peritoneal cavity cancer|stage iiib primary peritoneal cavity cancer
5265547|NCT00562640|stage IIIC primary peritoneal cavity cancer|stage iiic primary peritoneal cavity cancer
5265548|NCT00562640|stage IV primary peritoneal cavity cancer|stage iv primary peritoneal cavity cancer
5265549|NCT00562640|recurrent fallopian tube cancer|recurrent fallopian tube cancer
5265550|NCT00562640|stage IIIA fallopian tube cancer|stage iiia fallopian tube cancer
5265551|NCT00562640|stage IIIB fallopian tube cancer|stage iiib fallopian tube cancer
5265552|NCT00562640|stage IIIC fallopian tube cancer|stage iiic fallopian tube cancer
5265553|NCT00562640|stage IV fallopian tube cancer|stage iv fallopian tube cancer
5265554|NCT00562640|stage IIIA ovarian epithelial cancer|stage iiia ovarian epithelial cancer
5265555|NCT00562640|stage IIIB ovarian epithelial cancer|stage iiib ovarian epithelial cancer
5265556|NCT00562640|stage IIIC ovarian epithelial cancer|stage iiic ovarian epithelial cancer
5265557|NCT00562640|06-155|06-155
5265558|NCT00562627|osteoarthritis|osteoarthritis
5265559|NCT00562627|knee arthroplasty|knee arthroplasty
5265560|NCT00562627|local infiltration analgesia|local infiltration analgesia
5265561|NCT00562627|TKA|tka
5265562|NCT00562627|epidural analgesia|epidural analgesia
5265563|NCT00562627|operation|operation
5265564|NCT00562627|surgery|surgery
5265565|NCT00562601|Leukapheresis|leukapheresis
5265566|NCT00562601|Plasmapheresis|plasmapheresis
5265567|NCT00562601|Lymphocytes|lymphocytes
5265568|NCT00562601|Neutrophils|neutrophils
5265569|NCT00562536|Umbilical cord clamping|umbilical cord clamping
5265570|NCT00562536|Preterm infants|preterm infants
5265571|NCT00562536|Randomized controlled trial|randomized controlled trial
5265572|NCT00562536|For women giving birth to singleton infants 32 weeks gestational age or less|for women giving birth to singleton infants 32 weeks gestational age or less
5265573|NCT00562523|Cancer|cancer
5265574|NCT00562523|Docetaxel|docetaxel
5265575|NCT00562523|Sorafenib|sorafenib
5265576|NCT00562510|HIV-1 infection|hiv-1 infection
5265577|NCT00562510|raltegravir|raltegravir
5265578|NCT00562510|immune discordance|immune discordance
5265579|NCT00562510|treatment experienced|treatment experienced
5265580|NCT00562497|Acute GVHD|acute gvhd
5265581|NCT00562497|Acute Graft Versus Host Disease|acute graft versus host disease
5265582|NCT00562471|adhesions|adhesions
5265583|NCT00562471|gynecologic surgery|gynecologic surgery
5265584|NCT00562471|laparoscopy|laparoscopy
5265585|NCT00562471|laparotomy|laparotomy
5265586|NCT00562471|polyethylene glycol|polyethylene glycol
5265587|NCT00562471|hydrogel|hydrogel
5265588|NCT00562471|Adhesions following gynecologic surgery to remove myomas|adhesions following gynecologic surgery to remove myomas
5265589|NCT00562458|Advanced breast cancer|advanced breast cancer
5265590|NCT00562458|Advanced breast cancer in postmenopausal women|advanced breast cancer in postmenopausal women
5265591|NCT00562445|Adrenal insufficiency|adrenal insufficiency
5265592|NCT00562445|GI bleeding|gi bleeding
5265593|NCT00562445|Portal hypertension|portal hypertension
5265594|NCT00562445|Acute pancreatitis|acute pancreatitis
5265595|NCT00562445|Critical emergencies in digestive diseases|critical emergencies in digestive diseases
5265596|NCT00562445|Severe acute pancreatitis|severe acute pancreatitis
5265597|NCT00562432|atrial fibrillation|atrial fibrillation
5265598|NCT00562432|CABG|cabg
5265599|NCT00562432|ganglionated plexi|ganglionated plexi
5265600|NCT00562406|Macular edema secondary to branch retinal vein occlusion|macular edema secondary to branch retinal vein occlusion
5265601|NCT00562380|cutaneous B-cell non-Hodgkin lymphoma|cutaneous b-cell non-hodgkin lymphoma
5265602|NCT00562380|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
5265603|NCT00562380|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
5265604|NCT00562380|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
5265605|NCT00562380|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5265606|NCT00562380|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5265607|NCT00562380|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5265608|NCT00562380|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5265609|NCT00562380|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5265610|NCT00562380|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5265611|NCT00562380|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5265612|NCT00562380|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
5265613|NCT00562380|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5265614|NCT00562380|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5265615|NCT00562380|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5265616|NCT00562380|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5265617|NCT00562380|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5265618|NCT00562380|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5265619|NCT00562380|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5265620|NCT00562380|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5265621|NCT00562380|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5265622|NCT00562380|small intestine lymphoma|small intestine lymphoma
5265623|NCT00562380|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5265624|NCT00562380|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5265625|NCT00562380|recurrent Ewing sarcoma/peripheral primitive neuroectodermal tumor|recurrent ewing sarcoma/peripheral primitive neuroectodermal tumor
5265626|NCT00562380|adult desmoplastic small round cell tumor|adult desmoplastic small round cell tumor
5265627|NCT00562380|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
5265628|NCT00562380|recurrent prostate cancer|recurrent prostate cancer
5265629|NCT00562354|Vaccines, Pneumococcal Conjugate Vaccine|vaccines, pneumococcal conjugate vaccine
5265630|NCT00562341|obesity|obesity
5265631|NCT00562341|psa|psa
5265632|NCT00562341|prostate cancer|prostate cancer
5265633|NCT00562328|stage 0 chronic lymphocytic leukemia|stage 0 chronic lymphocytic leukemia
5265634|NCT00562328|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
5265635|NCT00562328|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
5265636|NCT00562302|lung biopsy|lung biopsy
5265637|NCT00562289|Stroke|stroke
5265638|NCT00562289|Patent Foramen Ovale|patent foramen ovale
5265639|NCT00562289|Atrial septal aneurysm|atrial septal aneurysm
5265640|NCT00562289|Antiplatelet therapy|antiplatelet therapy
5265641|NCT00562289|Oral anticoagulants|oral anticoagulants
5265642|NCT00562289|Transcatheter closure|transcatheter closure
5265643|NCT00562289|Migraine|migraine
5265645|NCT00562276|insertion timing|insertion timing
5265646|NCT00562263|overweight|overweight
5265647|NCT00562263|obesity|obesity
5265648|NCT00562263|adolescent|adolescent
5265649|NCT00562263|insulin resistance|insulin resistance
5265650|NCT00562263|treatment|treatment
5265651|NCT00562237|immunogenicity|immunogenicity
5265652|NCT00562237|safety|safety
5265653|NCT00562237|adjuvanted pandemic vaccine|adjuvanted pandemic vaccine
5265654|NCT00562224|PCI-24781|pci-24781
5265655|NCT00562224|Neoplasms by site|neoplasms by site
5265656|NCT00562224|Lymphoma, non-hodgkin|lymphoma, non-hodgkin
5265657|NCT00562224|Hodgkin disease|hodgkin disease
5265658|NCT00562224|Multiple myeloma|multiple myeloma
5265659|NCT00562224|Leukemia, lymphocytic, chronic|leukemia, lymphocytic, chronic
5265660|NCT00562211|children|children
5265661|NCT00562185|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5265662|NCT00562185|ovarian sarcoma|ovarian sarcoma
5265663|NCT00562185|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
5265664|NCT00562185|ovarian stromal cancer|ovarian stromal cancer
5265665|NCT00562159|rhinoconjunctivitis|rhinoconjunctivitis
5265666|NCT00562159|rhinitis|rhinitis
5265667|NCT00562159|conjunctivitis|conjunctivitis
5265668|NCT00562159|allergy|allergy
5265669|NCT00562159|allergen|allergen
5265670|NCT00562159|immunotherapy|immunotherapy
5265671|NCT00562146|nutrition|nutrition
5265672|NCT00562146|enteral access|enteral access
5265673|NCT00562107|Minimized ventricular pacing, clinical outcome, SafeR, AAIsafeR, dual chamber pacemaker therapy, % of ventricular pacing, hospitalizations, symptomatic AF|minimized ventricular pacing, clinical outcome, safer, aaisafer, dual chamber pacemaker therapy, % of ventricular pacing, hospitalizations, symptomatic af
5265674|NCT00562094|Pantoprazole|pantoprazole
5265675|NCT00562094|eGERD (Erosive Gastroesophageal Reflux Disease)|egerd (erosive gastroesophageal reflux disease)
5265676|NCT00562094|NERD (Non-Erosive Reflux Disease)|nerd (non-erosive reflux disease)
5265677|NCT00562094|sleep disorders|sleep disorders
5265678|NCT00562081|asthma|asthma
5265679|NCT00562081|Virtual Asthma Clinic|virtual asthma clinic
5265680|NCT00562081|metabolites|metabolites
5265681|NCT00562081|asthma education|asthma education
5265682|NCT00562068|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
5265683|NCT00562068|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
5265684|NCT00562068|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
5265685|NCT00562068|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
5265686|NCT00562068|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
5265687|NCT00562068|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5265688|NCT00562068|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
5265689|NCT00562068|small intestine lymphoma|small intestine lymphoma
5265690|NCT00562068|peripheral T-cell lymphoma|peripheral t-cell lymphoma
5265691|NCT00562042|pulmonary embolism|pulmonary embolism
5265692|NCT00562042|risk stratification|risk stratification
5265693|NCT00562042|prognosis|prognosis
5265694|NCT00562042|troponin|troponin
5265695|NCT00562042|Brain natriuretic peptide|brain natriuretic peptide
5265696|NCT00562042|echocardiogram|echocardiogram
5265697|NCT00562029|Diabetes Mellitus|diabetes mellitus
5265698|NCT00562029|Surgery|surgery
5265699|NCT00562029|Duodenal Bypass|duodenal bypass
5265700|NCT00562029|Resolution|resolution
5265701|NCT00562029|Surgical Procedures|surgical procedures
5265702|NCT00562016|Patient undergoing scheduled PCI|patient undergoing scheduled pci
5265703|NCT00562003|Ovarian cancer study|ovarian cancer study
5265704|NCT00561990|pancreatic cancer|pancreatic cancer
5265705|NCT00561977|Nutrition|nutrition
5265706|NCT00561977|Dietary Quality|dietary quality
5265707|NCT00561977|Weight loss|weight loss
5265708|NCT00561938|Confocal laser endomicroscopy|confocal laser endomicroscopy
5265709|NCT00561938|cancerous and non-cancerous conditions|cancerous and non-cancerous conditions
5265710|NCT00561938|tolerance|tolerance
5265711|NCT00561938|intravenous fluorescein|intravenous fluorescein
5265712|NCT00561938|Digestive symptoms or disease requiring an endoscopy procedure (upper GI endoscopy or colonoscopy) performed under general anaesthesia|digestive symptoms or disease requiring an endoscopy procedure (upper gi endoscopy or colonoscopy) performed under general anaesthesia
5265713|NCT00561912|Renal Cell Carcinoma|renal cell carcinoma
5265714|NCT00561912|Renal Cell Cancer|renal cell cancer
5265715|NCT00561912|Clear Cell|clear cell
5265716|NCT00561912|Kidney|kidney
5265717|NCT00561912|Decitabine|decitabine
5265718|NCT00561912|Dacogen|dacogen
5265719|NCT00561912|5-Aza-Deoxycytidine|5-aza-deoxycytidine
5265720|NCT00561912|Interferon Alfa-2b|interferon alfa-2b
5265721|NCT00561912|Intron A®|intron a®
5265722|NCT00561912|RCC|rcc
5265723|NCT00561899|safety|safety
5265724|NCT00561899|tolerability|tolerability
5265725|NCT00561899|efficacy|efficacy
5265726|NCT00561899|intermittent prevetive treatment|intermittent prevetive treatment
5265727|NCT00561899|children|children
5265728|NCT00561886|COPD|copd
5265729|NCT00561886|lung function|lung function
5265730|NCT00561886|dysnpea|dysnpea
5265731|NCT00561873|astrocytoma, glioblastoma, intrinsic pontine glioma|astrocytoma, glioblastoma, intrinsic pontine glioma
5265732|NCT00561860|Obstructive sleep apnea-hypopnea|obstructive sleep apnea-hypopnea
5265733|NCT00561860|Telemedicine|telemedicine
5265734|NCT00561834|non-arteritic ischemic optic neuropathy|non-arteritic ischemic optic neuropathy
5265735|NCT00561834|ranibizumab|ranibizumab
5265736|NCT00561834|naion|naion
5265737|NCT00561821|elderly|elderly
5265738|NCT00561821|randomized|randomized
5265739|NCT00561821|placebo controlled|placebo controlled
5265740|NCT00561808|PCO/PCOD|pco/pcod
5265741|NCT00561808|IVM|ivm
5265742|NCT00561808|Immature Oocytes|immature oocytes
5265743|NCT00561795|AGO|ago
5265744|NCT00561795|Advanced,|advanced,
5265745|NCT00561795|Gynaecologic cancer(s),|gynaecologic cancer(s),
5265746|NCT00561795|Genetics|genetics
5265747|NCT00561795|GW786034,|gw786034,
5265748|NCT00561795|Pazopanib,|pazopanib,
5265749|NCT00561782|Spinal Cord Injury Pain|spinal cord injury pain
5265750|NCT00561782|Chronic Neuropathic Pain|chronic neuropathic pain
5265751|NCT00561782|SCI Pain|sci pain
5265752|NCT00561782|Pain, Chronic Neuropathic|pain, chronic neuropathic
5265753|NCT00561782|Spectroscopy, Magnetic Resonance|spectroscopy, magnetic resonance
5265754|NCT00561782|MRS|mrs
5265755|NCT00561782|Traumatic Brain Injury Pain|traumatic brain injury pain
5265756|NCT00561769|poor responder|poor responder
5265757|NCT00561769|growth hormone|growth hormone
5265758|NCT00561769|luteal|luteal
5265759|NCT00561756|cutaneous B-cell non-Hodgkin lymphoma|cutaneous b-cell non-hodgkin lymphoma
5265760|NCT00561756|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5265761|NCT00561756|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5265762|NCT00561756|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5265763|NCT00561756|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5265764|NCT00561756|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5265765|NCT00561756|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5265766|NCT00561756|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5265767|NCT00561756|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5265768|NCT00561743|Multiple myeloma|multiple myeloma
5265769|NCT00561743|response rate|response rate
5265770|NCT00561743|peripheral stem cell transplant|peripheral stem cell transplant
5265771|NCT00561743|safety|safety
5265772|NCT00561743|tolerability|tolerability
5265773|NCT00561730|PPI (Proton Pump Inhibitor) therapy|ppi (proton pump inhibitor) therapy
5265774|NCT00561730|Pantoprazole|pantoprazole
5265775|NCT00561730|eGERD (Erosive Gastroesophageal Reflux Disease)|egerd (erosive gastroesophageal reflux disease)
5265776|NCT00561730|NERD (Non-Erosive Reflux Disease)|nerd (non-erosive reflux disease)
5265777|NCT00561717|Seasonal Allergic Rhinitis|seasonal allergic rhinitis
5265778|NCT00561717|Ragweed|ragweed
5265779|NCT00561717|Pollen|pollen
5265780|NCT00561717|Allergy|allergy
5265781|NCT00561704|obese female|obese female
5265782|NCT00561704|Type 2 Diabetes|type 2 diabetes
5265783|NCT00561704|Diabetic Nephropathy|diabetic nephropathy
5265784|NCT00561704|Glucose Metabolism|glucose metabolism
5265785|NCT00561704|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers
5265786|NCT00561704|Adiponectin|adiponectin
5265787|NCT00561691|diffuse instrinsic ponitine glioma, brainstem|diffuse instrinsic ponitine glioma, brainstem
5265788|NCT00561678|Postoperative Confusion|postoperative confusion
5265789|NCT00561678|Postoperative Delirium|postoperative delirium
5265790|NCT00561678|PD|pd
5265791|NCT00561678|Postoperative Cognitive Dysfunction|postoperative cognitive dysfunction
5265792|NCT00561678|POCD|pocd
5265793|NCT00561652|Low back pain|low back pain
5265794|NCT00561652|Chiropractic|chiropractic
5265795|NCT00561652|Exercise|exercise
5265796|NCT00561652|Veterans|veterans
5265797|NCT00561639|sepsis|sepsis
5265798|NCT00561639|immunosuppressed|immunosuppressed
5265799|NCT00561639|multiplex PCR|multiplex pcr
5265800|NCT00561639|diagnosis|diagnosis
5265801|NCT00561639|therapeutic|therapeutic
5265802|NCT00561613|Diaphragm|diaphragm
5265803|NCT00561613|postcoital test|postcoital test
5265804|NCT00561613|SILCS|silcs
5265805|NCT00561613|nonoxynol-9|nonoxynol-9
5265806|NCT00561600|Hip arthroplasty|hip arthroplasty
5265807|NCT00561600|Acetabular cup replacement|acetabular cup replacement
5265808|NCT00561600|Acetabulum arthroplasty|acetabulum arthroplasty
5265809|NCT00561587|novel antipsychotic|novel antipsychotic
5265810|NCT00561587|quetiapine|quetiapine
5265811|NCT00561587|depression|depression
5265812|NCT00561587|psychopathology|psychopathology
5265813|NCT00561574|elderly|elderly
5265814|NCT00561574|randomized|randomized
5265815|NCT00561574|double blind|double blind
5265816|NCT00561561|Schizophrenia|schizophrenia
5265817|NCT00561561|Prepulse Inhibition|prepulse inhibition
5265818|NCT00561561|Acoustic Startle|acoustic startle
5265819|NCT00561535|IBS|ibs
5265820|NCT00561535|Diarrhea|diarrhea
5265821|NCT00561535|Rome III|rome iii
5265822|NCT00561522|Recurrence|recurrence
5265823|NCT00561522|Metastasis|metastasis
5265824|NCT00561522|Hepatocellular Carcinoma|hepatocellular carcinoma
5265825|NCT00561522|Radical Hepatic Resection|radical hepatic resection
5265826|NCT00561522|Drug Prevention|drug prevention
5265827|NCT00561522|Capecitabine|capecitabine
5265828|NCT00561522|Surgery|surgery
5265829|NCT00561496|HIV prevention|hiv prevention
5265830|NCT00561496|Microbicides|microbicides
5265831|NCT00561496|Pharmacokinetics|pharmacokinetics
5265832|NCT00561496|vaginal biopsies|vaginal biopsies
5265833|NCT00561483|Acute heart failure|acute heart failure
5265834|NCT00561483|cystatin C|cystatin c
5265835|NCT00561483|renal failure|renal failure
5265836|NCT00561483|biomarker|biomarker
5265837|NCT00561470|colorectal cancer|colorectal cancer
5265838|NCT00561470|metastatic|metastatic
5265839|NCT00561470|anti-angiogenic|anti-angiogenic
5265840|NCT00561470|irinotecan|irinotecan
5265841|NCT00561470|5-FU|5-fu
5265842|NCT00561470|FOLFIRI|folfiri
5265843|NCT00561457|Iliac|iliac
5265844|NCT00561457|Artery|artery
5265845|NCT00561457|Occlusive|occlusive
5265846|NCT00561457|Stenosis|stenosis
5265847|NCT00561444|Prostate Cancer|prostate cancer
5265848|NCT00561444|Radical retropubic prostatectomy|radical retropubic prostatectomy
5265849|NCT00561444|Robotic prostatectomy|robotic prostatectomy
5265850|NCT00561444|Photon external beam radiation|photon external beam radiation
5265851|NCT00561444|Photon external beam radiation with hormone therapy|photon external beam radiation with hormone therapy
5265852|NCT00561444|Proton radiation|proton radiation
5265853|NCT00561444|Radioisotopic implant|radioisotopic implant
5265854|NCT00561444|Cryotherapy|cryotherapy
5265855|NCT00561444|Quality of Life|quality of life
5265856|NCT00561444|Questionnaire|questionnaire
5265857|NCT00561444|Survey|survey
5265858|NCT00561444|QOL|qol
5265859|NCT00561431|CVVHDF Dose Study|cvvhdf dose study
5265860|NCT00561418|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5265861|NCT00561418|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5265862|NCT00561418|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5265863|NCT00561418|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5265864|NCT00561418|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5265865|NCT00561418|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5265866|NCT00561418|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
5265867|NCT00561418|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
5265868|NCT00561418|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
5265869|NCT00561418|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
5265870|NCT00561418|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
5265871|NCT00561418|small intestine lymphoma|small intestine lymphoma
5265872|NCT00561418|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5265873|NCT00561405|Stroke|stroke
5265874|NCT00561405|Walking|walking
5265875|NCT00561405|Motor learning|motor learning
5265876|NCT00561405|Skill acquisition|skill acquisition
5265877|NCT00561392|Alzheimer's Disease|alzheimer's disease
5265878|NCT00561392|Rivastigmine|rivastigmine
5265879|NCT00561392|Patch|patch
5265880|NCT00561379|Diffuse Large B Cell Lymphoma|diffuse large b cell lymphoma
5265881|NCT00561379|not previously treated|not previously treated
5265882|NCT00561366|ALS|als
5265883|NCT00561366|Lou Gehrig's disease|lou gehrig's disease
5265884|NCT00561353|Hepatitis C, Chronic|hepatitis c, chronic
5265885|NCT00561353|Tibotec|tibotec
5265886|NCT00561353|TMC435350-TiDP16-C201|tmc435350-tidp16-c201
5265887|NCT00561353|TMC435350-C201|tmc435350-c201
5265888|NCT00561353|TMC435|tmc435
5265889|NCT00561353|PEGASYS (peginterferon alpha-2a, PegIFNα-2a)|pegasys (peginterferon alpha-2a, pegifnα-2a)
5265890|NCT00561353|COPEGUS (ribavirin)|copegus (ribavirin)
5265891|NCT00561340|ADHD|adhd
5265892|NCT00561340|Growth|growth
5265893|NCT00561340|Atomoxetine|atomoxetine
5265894|NCT00561340|Pediasure|pediasure
5265895|NCT00561327|hypertension|hypertension
5265896|NCT00561327|angiotensin receptor blockers|angiotensin receptor blockers
5265897|NCT00561327|peroxisome proliferator activated receptor gamma|peroxisome proliferator activated receptor gamma
5265898|NCT00561314|sexual dysfunction|sexual dysfunction
5265899|NCT00561314|urinary incontinence|urinary incontinence
5265900|NCT00561314|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5265901|NCT00561314|stage I prostate cancer|stage i prostate cancer
5265902|NCT00561314|stage IIB prostate cancer|stage iib prostate cancer
5265903|NCT00561314|stage IIA prostate cancer|stage iia prostate cancer
5265904|NCT00561288|Acetaminophen|acetaminophen
5265905|NCT00561288|Social Psychology|social psychology
5265906|NCT00561288|Affect|affect
5265907|NCT00561288|Interpersonal Rejection|interpersonal rejection
5265908|NCT00561262|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5265909|NCT00561262|stage I prostate cancer|stage i prostate cancer
5265910|NCT00561262|stage IIB prostate cancer|stage iib prostate cancer
5265911|NCT00561262|stage IIA prostate cancer|stage iia prostate cancer
5265912|NCT00561262|stage III prostate cancer|stage iii prostate cancer
5265913|NCT00561223|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
5265914|NCT00561223|pulmonary hypertension|pulmonary hypertension
5265915|NCT00561210|infections|infections
5265916|NCT00561184|H5N1 Pandemic|h5n1 pandemic
5265917|NCT00561145|Anorexia of ageing|anorexia of ageing
5265918|NCT00561145|Anorexia of aging|anorexia of aging
5265919|NCT00561145|Energy balance|energy balance
5265920|NCT00561145|Elderly|elderly
5265921|NCT00561132|vanadium|vanadium
5265922|NCT00561132|insulin sensitivity|insulin sensitivity
5265923|NCT00561132|impaired glucose tolerance|impaired glucose tolerance
5265924|NCT00561132|triglycerides|triglycerides
5265925|NCT00561119|maintenance chemotherapy|maintenance chemotherapy
5265926|NCT00561119|metastatic or recurrent breast cancer|metastatic or recurrent breast cancer
5265927|NCT00561119|gemcitabine|gemcitabine
5265928|NCT00561119|paclitaxel(GP)|paclitaxel(gp)
5265929|NCT00561106|Bell´s palsy|bell´s palsy
5265930|NCT00561106|prednisone|prednisone
5265931|NCT00561106|valacyclovir|valacyclovir
5265932|NCT00561093|Hypoalbuminemia|hypoalbuminemia
5265933|NCT00561093|Protein-energy malnutrition|protein-energy malnutrition
5265934|NCT00561093|Inflammation|inflammation
5265935|NCT00561093|Oxidative stress|oxidative stress
5265936|NCT00561093|Chronic Kidney disease (CKD) stage 5|chronic kidney disease (ckd) stage 5
5265937|NCT00561093|maintenance hemodialysis|maintenance hemodialysis
5265938|NCT00561067|Spinal cord injury|spinal cord injury
5265939|NCT00561067|spinal shock|spinal shock
5265940|NCT00561067|erythropoietin|erythropoietin
5265941|NCT00561054|Coimbra|coimbra
5265942|NCT00561054|NSCLC|nsclc
5265943|NCT00561054|CETUXIMAB|cetuximab
5265944|NCT00561041|alcohol|alcohol
5265945|NCT00561041|alcohol use disorder|alcohol use disorder
5265946|NCT00561041|cognitive-behavioral therapy|cognitive-behavioral therapy
5265947|NCT00561041|brief phone aftercare intervention|brief phone aftercare intervention
5265948|NCT00561041|individual aftercare therapy|individual aftercare therapy
5265949|NCT00561028|Atherosclerosis|atherosclerosis
5265950|NCT00561028|Coronary artery disease|coronary artery disease
5265951|NCT00561028|Chlamydia pneumoniae|chlamydia pneumoniae
5265952|NCT00561028|Mycoplasma pneumoniae|mycoplasma pneumoniae
5265953|NCT00561015|Hepatitis C, Chronic|hepatitis c, chronic
5265954|NCT00561015|Genotype 2|genotype 2
5265955|NCT00561015|Genotype 3|genotype 3
5265956|NCT00561015|Telaprevir|telaprevir
5265957|NCT00561002|Influenza Vaccine|influenza vaccine
5265958|NCT00561002|Influenza Virus|influenza virus
5265959|NCT00561002|Orthomyxoviridae Infections|orthomyxoviridae infections
5265960|NCT00561002|Fluzone®|fluzone®
5265961|NCT00560989|Chronic Beryllium Disease|chronic beryllium disease
5265962|NCT00560989|CBD|cbd
5265963|NCT00560989|Beryllium|beryllium
5265964|NCT00560989|Genetic|genetic
5265965|NCT00560989|Environmental|environmental
5265966|NCT00560976|neutrophil gelatinase associated lipocalin|neutrophil gelatinase associated lipocalin
5265967|NCT00560976|hemodialysis|hemodialysis
5265968|NCT00560976|iron|iron
5265969|NCT00560976|inflammation|inflammation
5265970|NCT00560976|Oxidative Stress|oxidative stress
5265971|NCT00560963|Advanced or metastatic pancreas carcinoma|advanced or metastatic pancreas carcinoma
5265972|NCT00560963|gemcitabine|gemcitabine
5265973|NCT00560963|everolimus|everolimus
5265974|NCT00560937|Schizophrenia|schizophrenia
5265975|NCT00560937|Pregnenolone|pregnenolone
5265976|NCT00560937|Cognition|cognition
5265977|NCT00560937|Negative Symptoms|negative symptoms
5265978|NCT00560911|oral anticoagulation|oral anticoagulation
5265979|NCT00560911|self-management|self-management
5265980|NCT00560911|elderly patients|elderly patients
5265981|NCT00560911|randomised controlled trial|randomised controlled trial
5265982|NCT00560898|staining|staining
5265983|NCT00560898|epithelial barrier function|epithelial barrier function
5265984|NCT00560885|atrial fibrillation|atrial fibrillation
5265985|NCT00560885|af|af
5265986|NCT00560885|ablation|ablation
5265987|NCT00560885|arrhythmia|arrhythmia
5265988|NCT00560885|racing heart|racing heart
5265989|NCT00560885|afib|afib
5265990|NCT00560885|surgical ablation|surgical ablation
5265991|NCT00560872|atrial flutter|atrial flutter
5265992|NCT00560872|ablation|ablation
5265993|NCT00560872|navigation|navigation
5265994|NCT00560859|Sleep disordered breathing|sleep disordered breathing
5265995|NCT00560859|Sleep apnea|sleep apnea
5265996|NCT00560859|Tonsillectomy|tonsillectomy
5265997|NCT00560859|Adenoidectomy|adenoidectomy
5265998|NCT00560859|Snoring|snoring
5265999|NCT00560859|Neurobehavioral Manifestations|neurobehavioral manifestations
5266000|NCT00560859|Obstructive Sleep Apnea Syndrome|obstructive sleep apnea syndrome
5266001|NCT00560846|Gastric cancer|gastric cancer
5266002|NCT00560846|Esophageal cancer|esophageal cancer
5266003|NCT00560846|Surgical complications|surgical complications
5266004|NCT00560846|Immunonutrition|immunonutrition
5266005|NCT00560820|β-thalassemia|β-thalassemia
5266006|NCT00560820|transfusional iron overload|transfusional iron overload
5266007|NCT00560820|renal function|renal function
5266008|NCT00560820|renal biomarkers|renal biomarkers
5266009|NCT00560820|deferasirox|deferasirox
5266010|NCT00560807|WAD II|wad ii
5266011|NCT00560807|WAD III|wad iii
5266012|NCT00560807|mobilization|mobilization
5266013|NCT00560807|dosage|dosage
5266014|NCT00560807|acute whiplash associated disorders (WAD) II and III (113) with a symptom duration of less than 30 days|acute whiplash associated disorders (wad) ii and iii (113) with a symptom duration of less than 30 days
5266015|NCT00560807|neck pain|neck pain
5266016|NCT00560794|Minimal Residual Disease|minimal residual disease
5266017|NCT00560794|adult ALL|adult all
5266018|NCT00560794|immunotherapeutic treatment|immunotherapeutic treatment
5266019|NCT00560794|anti-CD19 bispecific antibody derivative|anti-cd19 bispecific antibody derivative
5266020|NCT00560794|Blinatumomab|blinatumomab
5266021|NCT00560794|MT103|mt103
5266022|NCT00560781|PTSD|ptsd
5266023|NCT00560781|Pregnenolone|pregnenolone
5266024|NCT00560781|Cognition|cognition
5266025|NCT00560768|Risk stratification method, negative predictive value, fast ventricular arrhythmias, ICD|risk stratification method, negative predictive value, fast ventricular arrhythmias, icd
5266026|NCT00560768|The negative predictive value of the T amplitude variance as a method for risk stratification for patients with an increased risk for SCD.|the negative predictive value of the t amplitude variance as a method for risk stratification for patients with an increased risk for scd.
5266027|NCT00560755|Prevention of: measles, mumps, rubella and varicella|prevention of: measles, mumps, rubella and varicella
5266028|NCT00560729|elderly people|elderly people
5266029|NCT00560690|Hepatitis C|hepatitis c
5266030|NCT00560690|metformin|metformin
5266031|NCT00560690|Insulin Resistance|insulin resistance
5266032|NCT00560677|Schizophrenia|schizophrenia
5266033|NCT00560677|PTSD|ptsd
5266034|NCT00560677|Cognition|cognition
5266035|NCT00560664|knee|knee
5266036|NCT00560664|chondral defect|chondral defect
5266037|NCT00560664|osteochondral defect|osteochondral defect
5266038|NCT00560651|keratoconus|keratoconus
5266039|NCT00560651|cornea|cornea
5266040|NCT00560651|cross linking|cross linking
5266041|NCT00560651|UV-light|uv-light
5266042|NCT00560651|riboflavin|riboflavin
5266043|NCT00560612|PTSD|ptsd
5266044|NCT00560612|Paroxetine|paroxetine
5266045|NCT00560612|Subthreshold|subthreshold
5266046|NCT00560599|MRSA|mrsa
5266047|NCT00560599|Methicillin Resistant Staphylococcus aureus|methicillin resistant staphylococcus aureus
5266048|NCT00560599|Staphylococcus aureus|staphylococcus aureus
5266049|NCT00560599|Skin Infections|skin infections
5266050|NCT00560599|Body Decolonization|body decolonization
5266051|NCT00560599|Environmental Decolonization|environmental decolonization
5266052|NCT00560586|sleep fragmentation|sleep fragmentation
5266053|NCT00560586|apnea|apnea
5266054|NCT00560586|hypoxia|hypoxia
5266055|NCT00560560|Refractory Colorectal|refractory colorectal
5266056|NCT00560560|Single arm|single arm
5266057|NCT00560560|Phase 2|phase 2
5266058|NCT00560534|Magnetic resonance|magnetic resonance
5266059|NCT00560534|whole body|whole body
5266060|NCT00560534|angiography|angiography
5266061|NCT00560534|venous compression|venous compression
5266062|NCT00560534|MRI|mri
5266063|NCT00560521|CPAP|cpap
5266064|NCT00560521|Tuberculosis|tuberculosis
5266065|NCT00560521|Pleural effusion|pleural effusion
5266066|NCT00560521|Physiotherapy|physiotherapy
5266067|NCT00560495|stage I non-small cell lung cancer|stage i non-small cell lung cancer
5266068|NCT00560495|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
5266069|NCT00560495|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5266070|NCT00560495|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5266071|NCT00560495|adenocarcinoma of the lung|adenocarcinoma of the lung
5266072|NCT00560495|adenosquamous cell lung cancer|adenosquamous cell lung cancer
5266073|NCT00560495|large cell lung cancer|large cell lung cancer
5266074|NCT00560495|squamous cell lung cancer|squamous cell lung cancer
5266075|NCT00560482|prostate|prostate
5266076|NCT00560482|cancer|cancer
5266077|NCT00560482|prostatic cancer|prostatic cancer
5266078|NCT00560482|castrate-resistant prostate cancer (CRPC)|castrate-resistant prostate cancer (crpc)
5266079|NCT00560469|Adipokines|adipokines
5266080|NCT00560469|Inflammation|inflammation
5266081|NCT00560469|Metabolic syndrome|metabolic syndrome
5266082|NCT00560456|Age, Snoring, Driving simulator, Sleep deprivation, chronic sleep restriction, objective and subjective sleepiness|age, snoring, driving simulator, sleep deprivation, chronic sleep restriction, objective and subjective sleepiness
5266083|NCT00560443|bone fracture|bone fracture
5266084|NCT00560443|ketorolac|ketorolac
5266085|NCT00560443|tramadol|tramadol
5266086|NCT00560378|Tacrolimus|tacrolimus
5266087|NCT00560378|Administration, topical|administration, topical
5266088|NCT00560378|Drug safety|drug safety
5266089|NCT00560378|Adults|adults
5266090|NCT00560378|Children|children
5266091|NCT00560365|stage I colon cancer|stage i colon cancer
5266092|NCT00560365|stage II colon cancer|stage ii colon cancer
5266093|NCT00560365|stage III colon cancer|stage iii colon cancer
5266094|NCT00560365|stage I rectal cancer|stage i rectal cancer
5266095|NCT00560365|stage II rectal cancer|stage ii rectal cancer
5266096|NCT00560365|stage III rectal cancer|stage iii rectal cancer
5266097|NCT00560339|Congestive Heart Failure|congestive heart failure
5266098|NCT00560339|Implantable Defibrillators|implantable defibrillators
5266099|NCT00560339|Intrathoracic Impedance|intrathoracic impedance
5266100|NCT00560326|Paediatric patients|paediatric patients
5266101|NCT00560326|Tacrolimus|tacrolimus
5266102|NCT00560326|Dermatitis, Atopic|dermatitis, atopic
5266103|NCT00560313|Meningococcal disease|meningococcal disease
5266104|NCT00560313|prevention|prevention
5266105|NCT00560313|vaccination|vaccination
5266106|NCT00560287|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
5266107|NCT00560287|Non-invasive ventilation|non-invasive ventilation
5266108|NCT00560287|Chronic Respiratory Failure|chronic respiratory failure
5266109|NCT00560261|Sickle cell disease;|sickle cell disease;
5266110|NCT00560261|Lung capillary blood volume;|lung capillary blood volume;
5266111|NCT00560261|Children|children
5266112|NCT00560248|Chest Pain|chest pain
5266113|NCT00560248|STEMI|stemi
5266114|NCT00560248|UA/NSTEMI|ua/nstemi
5266115|NCT00560248|ACS|acs
5266116|NCT00560248|Emergency Department|emergency department
5266117|NCT00560222|randomized controlled trial|randomized controlled trial
5266118|NCT00560222|lactoferrin|lactoferrin
5266119|NCT00560222|children|children
5266120|NCT00560222|diarrhea|diarrhea
5266121|NCT00560222|malnutrition|malnutrition
5266122|NCT00560222|growth|growth
5266123|NCT00560209|ONO-1101|ono-1101
5266124|NCT00560209|Coronary Artery Disease|coronary artery disease
5266125|NCT00560209|Multi-slice CT|multi-slice ct
5266126|NCT00560196|Neuropathic pain|neuropathic pain
5266127|NCT00560196|Chronic pain|chronic pain
5266128|NCT00560196|Depression|depression
5266129|NCT00560196|Anxiety|anxiety
5266130|NCT00560183|Acute|acute
5266131|NCT00560183|Bunionectomy|bunionectomy
5266132|NCT00560170|HMG-CoA Reductase Inhibitors|hmg-coa reductase inhibitors
5266133|NCT00560170|endothelial function|endothelial function
5266134|NCT00560170|HMG-CoA Reductase Inhibitors on vascular protection|hmg-coa reductase inhibitors on vascular protection
5266135|NCT00560157|ICU patients|icu patients
5266136|NCT00560118|recurrent melanoma|recurrent melanoma
5266137|NCT00560118|stage IV melanoma|stage iv melanoma
5266138|NCT00560105|COPD|copd
5266139|NCT00560092|Magnesium|magnesium
5266140|NCT00560092|Pain|pain
5266141|NCT00560092|Morphine|morphine
5266142|NCT00560092|Intrathecal|intrathecal
5266143|NCT00560092|NMDA|nmda
5266144|NCT00560092|Elective total hip replacement under intrathecal anesthesia|elective total hip replacement under intrathecal anesthesia
5266145|NCT00560066|influenza|influenza
5266146|NCT00560066|vaccine|vaccine
5266147|NCT00560053|Multiple Myeloma|multiple myeloma
5266148|NCT00560053|Alternating chemotherapy|alternating chemotherapy
5266149|NCT00560053|Transplantation|transplantation
5266150|NCT00560040|Troponin|troponin
5266151|NCT00560040|Natriuretic Peptide, Brain|natriuretic peptide, brain
5266152|NCT00560040|Exercise|exercise
5266153|NCT00560040|Echocardiography|echocardiography
5266154|NCT00560027|postpartum depression|postpartum depression
5266155|NCT00560027|intimate partner violence|intimate partner violence
5266156|NCT00560001|frail elderly|frail elderly
5266157|NCT00560001|medication errors|medication errors
5266158|NCT00560001|patient compliance & attitudes|patient compliance & attitudes
5266159|NCT00560001|guideline adherence|guideline adherence
5266160|NCT00559988|Implanted Cardioverter Defibrillator|implanted cardioverter defibrillator
5266161|NCT00559988|Cardiac Resynchronization Therapy Defibrillator|cardiac resynchronization therapy defibrillator
5266162|NCT00559988|Home Monitoring|home monitoring
5266163|NCT00559988|Oral Anticoagulation|oral anticoagulation
5266164|NCT00559975|Adjuvanted Influenza Vaccine|adjuvanted influenza vaccine
5266165|NCT00559962|LDL|ldl
5266166|NCT00559962|hepatic fat|hepatic fat
5266167|NCT00559897|bone metastases|bone metastases
5266168|NCT00559897|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5266169|NCT00559897|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5266170|NCT00559897|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5266171|NCT00559884|pharmacokinetics,|pharmacokinetics,
5266172|NCT00559884|healthy male and females,|healthy male and females,
5266173|NCT00559884|pharmacodynamics|pharmacodynamics
5266174|NCT00559871|dyskinesia|dyskinesia
5266175|NCT00559871|movement disorders|movement disorders
5266176|NCT00559871|basal ganglia diseases|basal ganglia diseases
5266177|NCT00559871|JP-1730|jp-1730
5266178|NCT00559871|Parkinson|parkinson
5266179|NCT00559871|end-of-dose wearing off|end-of-dose wearing off
5266180|NCT00559871|fluctuations|fluctuations
5266181|NCT00559858|palmar-plantar erythrodysesthesia|palmar-plantar erythrodysesthesia
5266182|NCT00559858|breast cancer|breast cancer
5266183|NCT00559858|male breast cancer|male breast cancer
5266184|NCT00559858|colon cancer|colon cancer
5266185|NCT00559858|rectal cancer|rectal cancer
5266186|NCT00559832|acute mountain sickness|acute mountain sickness
5266187|NCT00559832|intermittent hypoxia|intermittent hypoxia
5266188|NCT00559832|acclimatization|acclimatization
5266189|NCT00559819|Alcohol|alcohol
5266190|NCT00559819|Driving|driving
5266191|NCT00559819|Impairment|impairment
5266192|NCT00559806|immobilisation|immobilisation
5266193|NCT00559806|aging|aging
5266194|NCT00559806|resistance training|resistance training
5266195|NCT00559806|atrophy|atrophy
5266196|NCT00559806|The effect of immobilisation in elderly compared to young individuals|the effect of immobilisation in elderly compared to young individuals
5266197|NCT00559780|Resistance training|resistance training
5266198|NCT00559780|Aging|aging
5266199|NCT00559780|hip-surgery|hip-surgery
5266200|NCT00559767|Kidney Function|kidney function
5266201|NCT00559767|Genes|genes
5266202|NCT00559767|Association Analysis|association analysis
5266203|NCT00559767|Polymorphisms|polymorphisms
5266204|NCT00559767|Diabetes|diabetes
5266205|NCT00559741|stage IV colon cancer|stage iv colon cancer
5266206|NCT00559741|recurrent colon cancer|recurrent colon cancer
5266207|NCT00559741|stage IV rectal cancer|stage iv rectal cancer
5266208|NCT00559741|recurrent rectal cancer|recurrent rectal cancer
5266209|NCT00559715|bevacizumab|bevacizumab
5266210|NCT00559715|ranibizumab|ranibizumab
5266211|NCT00559715|macular degeneration|macular degeneration
5266212|NCT00559715|age-related|age-related
5266213|NCT00559715|neovascular|neovascular
5266214|NCT00559715|intravitreal injection|intravitreal injection
5266215|NCT00559715|vision loss|vision loss
5266216|NCT00559715|outpatient setting|outpatient setting
5266217|NCT00559702|natalizumab|natalizumab
5266218|NCT00559702|multiple sclerosis|multiple sclerosis
5266219|NCT00559702|Tysabri ®|tysabri ®
5266220|NCT00559689|asthma patients|asthma patients
5266221|NCT00559689|well-controlled|well-controlled
5266222|NCT00559676|recurrent colon cancer|recurrent colon cancer
5266223|NCT00559676|stage IV colon cancer|stage iv colon cancer
5266224|NCT00559676|recurrent rectal cancer|recurrent rectal cancer
5266225|NCT00559676|stage IV rectal cancer|stage iv rectal cancer
5266226|NCT00559663|Flavonoid|flavonoid
5266227|NCT00559663|hsCRP|hscrp
5266228|NCT00559663|HDL|hdl
5266229|NCT00559663|LDL|ldl
5266230|NCT00559663|platelet reactivity|platelet reactivity
5266231|NCT00559650|Acute decompensated heart failure|acute decompensated heart failure
5266232|NCT00559650|Double blind study,|double blind study,
5266233|NCT00559650|BAY58-2667|bay58-2667
5266234|NCT00559650|Soluble guanylate cyclase activator|soluble guanylate cyclase activator
5266235|NCT00559624|safety|safety
5266236|NCT00559624|tolerability|tolerability
5266237|NCT00559624|dose-escalation|dose-escalation
5266238|NCT00559611|Non-Small Lung Cancer|non-small lung cancer
5266239|NCT00559611|Lung Cancer|lung cancer
5266240|NCT00559611|Endobronchial Ultrasound|endobronchial ultrasound
5266241|NCT00559611|Fine Needle Aspiration|fine needle aspiration
5266242|NCT00559611|Mediastinoscopy|mediastinoscopy
5266243|NCT00559611|EBUS-FNA|ebus-fna
5266244|NCT00559611|EBUS|ebus
5266245|NCT00559611|Needle Biopsy|needle biopsy
5266246|NCT00559611|NSCLC|nsclc
5266247|NCT00559598|pancreatic cancer|pancreatic cancer
5266248|NCT00559598|extrahepatic bile duct cancer|extrahepatic bile duct cancer
5266249|NCT00559572|Exercise|exercise
5266250|NCT00559572|Group Counseling|group counseling
5266251|NCT00559572|Obesity|obesity
5266252|NCT00559559|Primary and secondary prevention for ventricular tachycardia|primary and secondary prevention for ventricular tachycardia
5266253|NCT00559520|Patients|patients
5266254|NCT00559520|Suffering|suffering
5266255|NCT00559520|Undernutrition|undernutrition
5266256|NCT00559520|Requiring|requiring
5266257|NCT00559520|Vascular|vascular
5266258|NCT00559520|Surgery|surgery
5266259|NCT00559494|complete spinal cord injury|complete spinal cord injury
5266260|NCT00559494|incomplete spinal cord injury|incomplete spinal cord injury
5266261|NCT00559494|central cord spinal cord injury|central cord spinal cord injury
5266262|NCT00559494|traumatic|traumatic
5266263|NCT00559481|recurrent prostate cancer|recurrent prostate cancer
5266264|NCT00559442|high altitude pulmonary edema|high altitude pulmonary edema
5266265|NCT00559442|hypoxic pulmonary vasoconstriction|hypoxic pulmonary vasoconstriction
5266266|NCT00559442|right ventricular function|right ventricular function
5266267|NCT00559442|hypoxia|hypoxia
5266268|NCT00559429|Prostate Cancer|prostate cancer
5266269|NCT00559416|HIV/AIDS|hiv/aids
5266270|NCT00559416|HLA-B*57|hla-b*57
5266271|NCT00559416|Cell Transfer|cell transfer
5266272|NCT00559416|HIV|hiv
5266273|NCT00559416|treatment experienced|treatment experienced
5266274|NCT00559403|Human immunodeficiency virus|human immunodeficiency virus
5266275|NCT00559403|South Africa|south africa
5266276|NCT00559403|Intervention Studies|intervention studies
5266277|NCT00559403|Sexual Behavior|sexual behavior
5266278|NCT00559403|Adolescents|adolescents
5266279|NCT00559403|STD|std
5266280|NCT00559403|HIV Seronegativity|hiv seronegativity
5266281|NCT00559390|Polycystic Ovary Syndrome|polycystic ovary syndrome
5266282|NCT00559390|Metabolic Syndrome|metabolic syndrome
5266283|NCT00559390|PCOS|pcos
5266284|NCT00559390|children|children
5266285|NCT00559390|girls|girls
5266286|NCT00559390|daughters|daughters
5266287|NCT00559390|sisters|sisters
5266288|NCT00559390|irregular periods|irregular periods
5266289|NCT00559351|esophagectomy|esophagectomy
5266290|NCT00559351|chemotherapy|chemotherapy
5266291|NCT00559351|chemoradiotherapy|chemoradiotherapy
5266292|NCT00559351|combined modality therapy|combined modality therapy
5266293|NCT00559338|CHF|chf
5266294|NCT00559338|Heart Failure|heart failure
5266295|NCT00559338|Dyspnea|dyspnea
5266296|NCT00559338|Cardiomyopathy|cardiomyopathy
5266297|NCT00559312|mild COPD|mild copd
5266298|NCT00559312|dyspnea|dyspnea
5266299|NCT00559312|exercise|exercise
5266300|NCT00559312|combination therapy|combination therapy
5266301|NCT00559299|163090|163090
5266302|NCT00559299|placebo-controlled|placebo-controlled
5266303|NCT00559299|MDD|mdd
5266304|NCT00559299|Depression|depression
5266305|NCT00559299|Tolerability|tolerability
5266306|NCT00559299|MDE|mde
5266307|NCT00559286|perfusion|perfusion
5266308|NCT00559286|microcirculation|microcirculation
5266309|NCT00559286|RBC function|rbc function
5266310|NCT00559286|NO metabolism|no metabolism
5266311|NCT00559286|AT receptor blocker|at receptor blocker
5266312|NCT00559234|Optic Nerve|optic nerve
5266313|NCT00559234|Retina|retina
5266314|NCT00559234|Cornea|cornea
5266315|NCT00559234|Lens|lens
5266316|NCT00559234|Ocular Genetic Diseases|ocular genetic diseases
5266317|NCT00559234|Inherited Eye Disease|inherited eye disease
5266318|NCT00559234|Genetic Eye Disease|genetic eye disease
5266319|NCT00559221|AML|aml
5266320|NCT00559208|Children and Youth|children and youth
5266321|NCT00559208|Families|families
5266322|NCT00559208|Differential Response|differential response
5266323|NCT00559195|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5266324|NCT00559195|anemia|anemia
5266325|NCT00559195|fatigue|fatigue
5266326|NCT00559169|epilepsy|epilepsy
5266327|NCT00559169|seizures|seizures
5266328|NCT00559169|menstrual cycle|menstrual cycle
5266329|NCT00559156|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
5266330|NCT00559156|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
5266331|NCT00559156|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5266332|NCT00559156|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
5266333|NCT00559156|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5266334|NCT00559156|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
5266335|NCT00559156|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
5266336|NCT00559156|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
5266337|NCT00559156|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5266338|NCT00559156|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
5266339|NCT00559156|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
5266340|NCT00559156|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
5266341|NCT00559156|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
5266342|NCT00559156|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
5266343|NCT00559156|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
5266344|NCT00559156|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
5266345|NCT00559156|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5266346|NCT00559156|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
5266347|NCT00559156|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
5266348|NCT00559156|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
5266349|NCT00559156|recurrent salivary gland cancer|recurrent salivary gland cancer
5266350|NCT00559156|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
5266351|NCT00559156|stage III salivary gland cancer|stage iii salivary gland cancer
5266352|NCT00559156|stage IV salivary gland cancer|stage iv salivary gland cancer
5266353|NCT00559143|AV conduction disturbances|av conduction disturbances
5266354|NCT00559143|LV function|lv function
5266355|NCT00559143|Biventricular Pacing|biventricular pacing
5266356|NCT00559143|Conductance Catheters|conductance catheters
5266357|NCT00559130|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
5266358|NCT00559130|Acute Lung Injury|acute lung injury
5266359|NCT00559130|Sepsis|sepsis
5266360|NCT00559130|Hemoperfusion|hemoperfusion
5266361|NCT00559104|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5266362|NCT00559104|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5266363|NCT00559104|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5266364|NCT00559104|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5266365|NCT00559104|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5266366|NCT00559104|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5266367|NCT00559104|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5266368|NCT00559104|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5266369|NCT00559104|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5266370|NCT00559104|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5266372|NCT00559091|Acute myelocytic leukemia|acute myelocytic leukemia
5266373|NCT00559091|leukemia|leukemia
5266374|NCT00559091|relapsed|relapsed
5266375|NCT00559091|refractory|refractory
5266376|NCT00559091|M4|m4
5266377|NCT00559091|M5|m5
5266378|NCT00559078|Adrenal Hyperplasia, Congenital|adrenal hyperplasia, congenital
5266379|NCT00559078|Psychosexual Development|psychosexual development
5266380|NCT00559078|Sexual Development|sexual development
5266381|NCT00559078|Intersex|intersex
5266382|NCT00559078|Qualitative|qualitative
5266383|NCT00559078|CAH|cah
5266384|NCT00559078|Interview|interview
5266385|NCT00559078|Disorder of Sex Development|disorder of sex development
5266386|NCT00559078|Telephone|telephone
5266387|NCT00559078|Quality of Life|quality of life
5266388|NCT00559078|Mental Health|mental health
5266389|NCT00559078|Counseling|counseling
5266390|NCT00559065|Case-Cohort Study|case-cohort study
5266391|NCT00559065|Leukemia|leukemia
5266392|NCT00559065|Lymphoma|lymphoma
5266393|NCT00559065|Benzene|benzene
5266394|NCT00559065|Blood Disorders|blood disorders
5266395|NCT00559065|Solvent Exposure|solvent exposure
5266396|NCT00559065|Cancer Risk|cancer risk
5266397|NCT00559052|Enzymes|enzymes
5266398|NCT00559052|VIOKASE|viokase
5266399|NCT00559052|Bioavailability|bioavailability
5266400|NCT00559039|breast cancer|breast cancer
5266401|NCT00559039|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5266402|NCT00559013|Staple line reinforcement|staple line reinforcement
5266403|NCT00559013|Staple line buttress|staple line buttress
5266404|NCT00559013|Anastomotic reinforcement|anastomotic reinforcement
5266405|NCT00559000|PTSD|ptsd
5266406|NCT00559000|Children|children
5266407|NCT00559000|trauma-focused Treatment|trauma-focused treatment
5266408|NCT00559000|KIDNET|kidnet
5266409|NCT00559000|Narrative Exposure Therapy for Children|narrative exposure therapy for children
5266410|NCT00558987|Discipline|discipline
5266411|NCT00558987|Parenting|parenting
5266412|NCT00558987|Primary Care|primary care
5266413|NCT00558987|Videos|videos
5266414|NCT00558961|CLL|cll
5266415|NCT00558961|chronic lymphocytic leukemia|chronic lymphocytic leukemia
5266416|NCT00558961|leukemia|leukemia
5266417|NCT00558961|gleevec|gleevec
5266418|NCT00558961|chlorambucil|chlorambucil
5266419|NCT00558948|Bone Marrow Transplant|bone marrow transplant
5266420|NCT00558948|Bone Mineral Density|bone mineral density
5266421|NCT00558948|Survivors|survivors
5266422|NCT00558948|Muscle Strength|muscle strength
5266423|NCT00558922|Lung|lung
5266424|NCT00558922|Non small cell|non small cell
5266425|NCT00558922|antisense|antisense
5266426|NCT00558922|oligonucleotide|oligonucleotide
5266427|NCT00558922|paclitaxel|paclitaxel
5266428|NCT00558922|carboplatin|carboplatin
5266429|NCT00558896|stage II multiple myeloma|stage ii multiple myeloma
5266430|NCT00558896|stage III multiple myeloma|stage iii multiple myeloma
5266431|NCT00558896|refractory multiple myeloma|refractory multiple myeloma
5266432|NCT00558870|Solid Tumors|solid tumors
5266433|NCT00558870|Morphine|morphine
5266434|NCT00558870|Methadone|methadone
5266435|NCT00558870|Co-Opioid Analgesic|co-opioid analgesic
5266436|NCT00558870|Pain|pain
5266437|NCT00558844|Cystic Fibrosis|cystic fibrosis
5266438|NCT00558844|Respiratory Infections|respiratory infections
5266439|NCT00558844|Pulmonary Cystic Fibrosis|pulmonary cystic fibrosis
5266440|NCT00558844|CFTR|cftr
5266441|NCT00558831|Acne|acne
5266442|NCT00558779|Coronary artery bypass|coronary artery bypass
5266443|NCT00558779|off pump coronary artery bypass grafting (OPCAB)|off pump coronary artery bypass grafting (opcab)
5266444|NCT00558766|Disruptive Behavior Disorders|disruptive behavior disorders
5266445|NCT00558766|Behavior|behavior
5266446|NCT00558766|Gambling|gambling
5266447|NCT00558766|Dopaminergic Mechanisms|dopaminergic mechanisms
5266448|NCT00558766|Dopamine|dopamine
5266449|NCT00558766|Parkinson Disease|parkinson disease
5266450|NCT00558766|PD|pd
5266451|NCT00558740|Dietary protein|dietary protein
5266452|NCT00558740|Fructose|fructose
5266453|NCT00558740|VLDL-triglycerides|vldl-triglycerides
5266454|NCT00558740|Hepatic de novo lipogenesis|hepatic de novo lipogenesis
5266455|NCT00558740|Lipid oxidation|lipid oxidation
5266456|NCT00558727|Advanced Solid Tumors|advanced solid tumors
5266457|NCT00558727|Solid Tumors|solid tumors
5266458|NCT00558727|Tumor|tumor
5266459|NCT00558727|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
5266460|NCT00558727|Chemotherapy|chemotherapy
5266461|NCT00558727|Benzoquinone|benzoquinone
5266462|NCT00558701|burns|burns
5266463|NCT00558701|donor site|donor site
5266464|NCT00558701|healing|healing
5266465|NCT00558701|microcurrent|microcurrent
5266466|NCT00558675|Non-Hodgkins Lymphoma|non-hodgkins lymphoma
5266467|NCT00558675|Hodgkins Lymphoma|hodgkins lymphoma
5266468|NCT00558675|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
5266469|NCT00558675|Chronic Myeloid Leukemia|chronic myeloid leukemia
5266470|NCT00558675|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
5266471|NCT00558675|Multiple Myeloma|multiple myeloma
5266472|NCT00558675|Immunotherapy|immunotherapy
5266473|NCT00558675|Allogeneic Cell Therapy|allogeneic cell therapy
5266474|NCT00558662|compression therapy|compression therapy
5266475|NCT00558662|venous leg ulcer|venous leg ulcer
5266476|NCT00558662|sub bandage pressure|sub bandage pressure
5266477|NCT00558636|NSCLC|nsclc
5266478|NCT00558623|lead, blood|lead, blood
5266479|NCT00558623|pregnancy|pregnancy
5266480|NCT00558623|calcium|calcium
5266481|NCT00558623|randomized trial|randomized trial
5266482|NCT00558623|dietary supplementation|dietary supplementation
5266483|NCT00558623|bone resorption|bone resorption
5266484|NCT00558597|Proteomics|proteomics
5266485|NCT00558597|Lung Transplantation|lung transplantation
5266486|NCT00558584|dilated cardiomyopathy|dilated cardiomyopathy
5266487|NCT00558584|immunoadsorption|immunoadsorption
5266488|NCT00558584|immunoglobulin G|immunoglobulin g
5266489|NCT00558558|Solid Tumors|solid tumors
5266490|NCT00558558|Cancer-Associated Anorexia|cancer-associated anorexia
5266491|NCT00558558|Weight Loss|weight loss
5266492|NCT00558558|Haelan|haelan
5266493|NCT00558558|Fermented Soy Product|fermented soy product
5266494|NCT00558558|Nutrition|nutrition
5266495|NCT00558558|Cachexia|cachexia
5266496|NCT00558545|Breast|breast
5266497|NCT00558545|paclitaxel|paclitaxel
5266498|NCT00558545|antisense|antisense
5266499|NCT00558545|oligonucleotide|oligonucleotide
5266500|NCT00558532|Morbid obesity|morbid obesity
5266501|NCT00558532|Omega-3 fatty acid levels|omega-3 fatty acid levels
5266502|NCT00558519|B-cell adult acute lymphoblastic leukemia|b-cell adult acute lymphoblastic leukemia
5266503|NCT00558519|T-cell adult acute lymphoblastic leukemia|t-cell adult acute lymphoblastic leukemia
5266504|NCT00558519|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
5266505|NCT00558506|Ankylosing spondylitis|ankylosing spondylitis
5266506|NCT00558506|activity|activity
5266507|NCT00558506|treatment|treatment
5266508|NCT00558506|clinical trial|clinical trial
5266509|NCT00558454|Iron supplements|iron supplements
5266510|NCT00558454|Infant|infant
5266511|NCT00558454|Low birth weight|low birth weight
5266512|NCT00558454|Prevention of iron deficiency and its physiological consequences|prevention of iron deficiency and its physiological consequences
5266513|NCT00558454|Safety|safety
5266514|NCT00558376|Colonoscopy|colonoscopy
5266515|NCT00558363|Prostate Cancer|prostate cancer
5266516|NCT00558363|AVODART|avodart
5266517|NCT00558363|PSA|psa
5266518|NCT00558363|dutasteride|dutasteride
5266519|NCT00558363|PSADT|psadt
5266520|NCT00558363|Prostate specific antigen|prostate specific antigen
5266521|NCT00558363|radical therapy|radical therapy
5266522|NCT00558363|doubling time|doubling time
5266523|NCT00558350|lobectomy|lobectomy
5266524|NCT00558350|inflammatory reaction|inflammatory reaction
5266525|NCT00558350|intrapulmonary|intrapulmonary
5266526|NCT00558350|intrapleural|intrapleural
5266527|NCT00558337|Treatment of Parkinson's Disease|treatment of parkinson's disease
5266528|NCT00558324|LASIK|lasik
5266529|NCT00558324|Confocal microscopy|confocal microscopy
5266530|NCT00558324|Flap|flap
5266531|NCT00558311|Aneurysmal|aneurysmal
5266532|NCT00558311|Subarachnoid|subarachnoid
5266533|NCT00558311|Hemorrhage|hemorrhage
5266534|NCT00558311|vasospasm|vasospasm
5266535|NCT00558311|clazosentan|clazosentan
5266536|NCT00558311|PIVLAZ|pivlaz
5266537|NCT00558311|Actelion|actelion
5266538|NCT00558311|surgical clipping|surgical clipping
5266539|NCT00558298|schizophrenia|schizophrenia
5266540|NCT00558298|schizoaffective disorder|schizoaffective disorder
5266541|NCT00558298|risperidone|risperidone
5266542|NCT00558298|intramuscular injection|intramuscular injection
5266543|NCT00558298|long-acting injectable|long-acting injectable
5266544|NCT00558285|COPD|copd
5266545|NCT00558285|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5266546|NCT00558285|Indacaterol|indacaterol
5266547|NCT00558285|QVA149|qva149
5266548|NCT00558272|breast cancer|breast cancer
5266549|NCT00558272|prostate cancer|prostate cancer
5266550|NCT00558272|metastatic bone disease|metastatic bone disease
5266551|NCT00558272|Subjects with breast cancer or prostate cancer with metastatic bone disease|subjects with breast cancer or prostate cancer with metastatic bone disease
5266552|NCT00558246|Breast Lift|breast lift
5266553|NCT00558246|Breast Reduction|breast reduction
5266554|NCT00558246|Breast Reconstruction|breast reconstruction
5266555|NCT00558246|Plastic Surgery|plastic surgery
5266556|NCT00558246|Skin Closure|skin closure
5266557|NCT00558246|Wound Healing|wound healing
5266558|NCT00558246|Dermabond|dermabond
5266559|NCT00558233|Colorectal cancer|colorectal cancer
5266560|NCT00558233|Screening|screening
5266561|NCT00558233|Health literacy|health literacy
5266562|NCT00558233|Patient education|patient education
5266563|NCT00558233|Computer assisted instruction|computer assisted instruction
5266564|NCT00558220|Lymphoma, B-cell|lymphoma, b-cell
5266565|NCT00558220|Immunotherapy, passive|immunotherapy, passive
5266566|NCT00558220|Remission induction|remission induction
5266567|NCT00558220|Autologous transplantation|autologous transplantation
5266568|NCT00558207|Pancreatic cancer|pancreatic cancer
5266569|NCT00558207|pancreas cancer|pancreas cancer
5266570|NCT00558207|Locally advanced or metastatic pancreatic adenocarcioma|locally advanced or metastatic pancreatic adenocarcioma
5266571|NCT00558194|Weight loss|weight loss
5266572|NCT00558181|B CLL|b cll
5266573|NCT00558181|Chronic B Lymphocytic Leukemia|chronic b lymphocytic leukemia
5266574|NCT00558181|Methylprednisolone|methylprednisolone
5266575|NCT00558181|Rituximab|rituximab
5266576|NCT00558168|Anastrazole|anastrazole
5266577|NCT00558168|safety|safety
5266578|NCT00558168|early breast cancer|early breast cancer
5266579|NCT00558155|immunonutrition|immunonutrition
5266580|NCT00558155|enteral nutrition|enteral nutrition
5266581|NCT00558155|parenteral nutrition|parenteral nutrition
5266582|NCT00558155|surgery|surgery
5266583|NCT00558142|contrast nephropathy|contrast nephropathy
5266584|NCT00558142|radiocontrast-induced nephropathy|radiocontrast-induced nephropathy
5266585|NCT00558142|chronic kidney disease|chronic kidney disease
5266586|NCT00558142|acetylcysteine|acetylcysteine
5266587|NCT00558142|clinical study|clinical study
5266588|NCT00558129|Lumbar Spinal Stenosis|lumbar spinal stenosis
5266589|NCT00558129|X-STOP® IPD|x-stop® ipd
5266590|NCT00558129|Interspinous process decompression|interspinous process decompression
5266591|NCT00558129|Neurogenic Intermittent Claudication|neurogenic intermittent claudication
5266592|NCT00558116|Carpal Tunnel Syndrome|carpal tunnel syndrome
5266593|NCT00558116|Dynamic Splinting|dynamic splinting
5266594|NCT00558116|Nerve Conduction Studies|nerve conduction studies
5266595|NCT00558116|Splinting|splinting
5266596|NCT00558116|Levine Katz Survey|levine katz survey
5266597|NCT00558103|GW572016|gw572016
5266598|NCT00558103|Breast Cancer|breast cancer
5266599|NCT00558103|RECIST|recist
5266600|NCT00558103|Inflammatory Breast Cancer|inflammatory breast cancer
5266601|NCT00558103|Pazopanib|pazopanib
5266602|NCT00558103|ErbB2|erbb2
5266603|NCT00558103|Cutaneous Disease|cutaneous disease
5266604|NCT00558103|Tykerb|tykerb
5266605|NCT00558103|Inflammatory|inflammatory
5266606|NCT00558103|Skin|skin
5266607|NCT00558103|Her2|her2
5266608|NCT00558103|Lapatinib|lapatinib
5266609|NCT00558103|GW786034|gw786034
5266610|NCT00558090|pain|pain
5266611|NCT00558090|Intensive Care Unit|intensive care unit
5266612|NCT00558090|morphine|morphine
5266613|NCT00558090|pKpD|pkpd
5266614|NCT00558090|numerical rating scale|numerical rating scale
5266615|NCT00558090|critically ill patients|critically ill patients
5266616|NCT00558077|Anovulation|anovulation
5266617|NCT00558077|Clomiphene citrate|clomiphene citrate
5266618|NCT00558077|Fertility|fertility
5266619|NCT00558077|Metformin|metformin
5266620|NCT00558077|Ovulation induction|ovulation induction
5266621|NCT00558077|PCOS|pcos
5266622|NCT00558077|Sterility|sterility
5266623|NCT00558077|Treatment|treatment
5266624|NCT00558077|Clomiphene citrate-resistance|clomiphene citrate-resistance
5266625|NCT00558051|Colorectal Cancer|colorectal cancer
5266626|NCT00558051|Colorectal Carcinoma|colorectal carcinoma
5266627|NCT00558051|Colorectal Tumors|colorectal tumors
5266628|NCT00558051|Neoplasms, Colorectal|neoplasms, colorectal
5266629|NCT00558038|Hepatic|hepatic
5266630|NCT00558038|Encephalopathy|encephalopathy
5266631|NCT00558038|Liver|liver
5266632|NCT00558038|Liver Disease|liver disease
5266633|NCT00558038|Liver Failure|liver failure
5266634|NCT00558038|Lactulose|lactulose
5266635|NCT00558038|AST-120|ast-120
5266636|NCT00558012|Osteoporosis|osteoporosis
5266637|NCT00558012|Bone loss|bone loss
5266638|NCT00558012|Frail Geriatric Women|frail geriatric women
5266639|NCT00558012|Nursing Home Patients|nursing home patients
5266640|NCT00558012|Fragility Fractures|fragility fractures
5266641|NCT00557999|Cardiology|cardiology
5266642|NCT00557999|Mechanical ventilation|mechanical ventilation
5266643|NCT00557999|Intensive care|intensive care
5266644|NCT00557986|1-Metastatic breast cancer|1-metastatic breast cancer
5266645|NCT00557986|2-Surgery|2-surgery
5266646|NCT00557986|3-Survival|3-survival
5266647|NCT00557947|Abdominoplasty|abdominoplasty
5266648|NCT00557947|Body Lift|body lift
5266649|NCT00557947|Plastic Surgery|plastic surgery
5267052|NCT00556088|Carboplatin|carboplatin
5266650|NCT00557947|Skin Closure|skin closure
5266651|NCT00557947|Wound Healing|wound healing
5266652|NCT00557947|Dermabond|dermabond
5266653|NCT00557934|tetralogy of Fallot|tetralogy of fallot
5266654|NCT00557934|right ventricular dysfunction|right ventricular dysfunction
5266655|NCT00557934|pulmonary insufficiency|pulmonary insufficiency
5266656|NCT00557934|pulmonary valve replacement|pulmonary valve replacement
5266657|NCT00557934|pressure-volume loops|pressure-volume loops
5266658|NCT00557934|long-term follow-up in tetralogy of Fallot|long-term follow-up in tetralogy of fallot
5266659|NCT00557921|ACS|acs
5266660|NCT00557921|CAD|cad
5266661|NCT00557921|MI|mi
5266662|NCT00557921|PCI|pci
5266663|NCT00557921|PTCA|ptca
5266664|NCT00557921|NSTEMI|nstemi
5266665|NCT00557921|STEMI|stemi
5266666|NCT00557921|acute coronary syndrome|acute coronary syndrome
5266667|NCT00557921|cerebrovascular disorders|cerebrovascular disorders
5266668|NCT00557921|coronary artery stent placement|coronary artery stent placement
5266669|NCT00557921|coronary thrombosis|coronary thrombosis
5266670|NCT00557921|myocardial infarction|myocardial infarction
5266671|NCT00557921|myocardial ischemia|myocardial ischemia
5266672|NCT00557921|percutaneous coronary intervention|percutaneous coronary intervention
5266673|NCT00557921|percutaneous transluminal coronary angioplasty|percutaneous transluminal coronary angioplasty
5266674|NCT00557921|peripheral vascular diseases|peripheral vascular diseases
5266675|NCT00557921|duodenal obstruction|duodenal obstruction
5266676|NCT00557921|duodenal ulcer|duodenal ulcer
5266677|NCT00557921|dyspepsia|dyspepsia
5266678|NCT00557921|esophagitis, peptic|esophagitis, peptic
5266679|NCT00557921|gastric outlet obstruction|gastric outlet obstruction
5266680|NCT00557921|gastroduodenal ulcer|gastroduodenal ulcer
5266681|NCT00557921|gastroesophageal reflux disease|gastroesophageal reflux disease
5266682|NCT00557921|gastrointestinal hemorrhage|gastrointestinal hemorrhage
5266683|NCT00557921|peptic ulcer|peptic ulcer
5266684|NCT00557921|peptic ulcer perforation|peptic ulcer perforation
5266685|NCT00557908|Von Willebrand Disease|von willebrand disease
5266686|NCT00557908|VWD|vwd
5266687|NCT00557908|prophylaxis|prophylaxis
5266688|NCT00557895|Asthma|asthma
5266689|NCT00557895|Hypersensitivity|hypersensitivity
5266690|NCT00557895|Peanut Allergy|peanut allergy
5266691|NCT00557895|Eosinophilic Esophagitis|eosinophilic esophagitis
5266692|NCT00557895|Eosinophilic Gastroenteritis|eosinophilic gastroenteritis
5266693|NCT00557882|prolapse|prolapse
5266694|NCT00557882|uterus|uterus
5266695|NCT00557882|mesh|mesh
5266696|NCT00557882|bladder|bladder
5266697|NCT00557856|Solid Tumors Transforming Growth Factor Beta Activin Receptor-like Kinase 1|solid tumors transforming growth factor beta activin receptor-like kinase 1
5266698|NCT00557843|Bupivacaine|bupivacaine
5266699|NCT00557843|Colon|colon
5266700|NCT00557843|Surgery|surgery
5266701|NCT00557843|Oxygenation|oxygenation
5266702|NCT00557830|Renal Cell Carcinoma|renal cell carcinoma
5266703|NCT00557830|Kidney Cancer|kidney cancer
5266704|NCT00557817|HCT|hct
5266705|NCT00557817|autologous|autologous
5266706|NCT00557817|erythropoiesis|erythropoiesis
5266707|NCT00557817|iron saccharate|iron saccharate
5266708|NCT00557817|erythropoietin|erythropoietin
5266709|NCT00557817|darbepoetin alpha|darbepoetin alpha
5266710|NCT00557804|Congestive Heart Failure|congestive heart failure
5266711|NCT00557791|AMD|amd
5266712|NCT00557791|ARMD|armd
5266713|NCT00557791|Exudative Macular Degeneration|exudative macular degeneration
5266714|NCT00557791|Bevasiranib|bevasiranib
5266715|NCT00557791|siRNA|sirna
5266716|NCT00557778|prevention|prevention
5266717|NCT00557778|dyslipidemia|dyslipidemia
5266718|NCT00557765|Tuberculosis|tuberculosis
5266719|NCT00557765|Latent tuberculosis infection|latent tuberculosis infection
5266720|NCT00557765|Interferon gamma release assay|interferon gamma release assay
5266721|NCT00557765|Contact tracing|contact tracing
5266722|NCT00557739|CRx-191|crx-191
5266723|NCT00557739|Plaque|plaque
5266724|NCT00557739|Psoriasis|psoriasis
5266725|NCT00557739|nortriptyline hydrochloride|nortriptyline hydrochloride
5266726|NCT00557739|mometasone furoate|mometasone furoate
5266727|NCT00557739|psoriatic infiltrate|psoriatic infiltrate
5266728|NCT00557726|Inflammation|inflammation
5266729|NCT00557726|Infection|infection
5266730|NCT00557726|Fever|fever
5266731|NCT00557700|Mild to moderate asthma|mild to moderate asthma
5266732|NCT00557687|IVF|ivf
5266733|NCT00557687|ovarian reserve|ovarian reserve
5266734|NCT00557687|poor response|poor response
5266735|NCT00557661|Heart failure|heart failure
5266736|NCT00557661|CD-NP|cd-np
5266737|NCT00557648|Anxiety|anxiety
5266738|NCT00557648|Children|children
5266739|NCT00557648|Cognitive-Behavioral Therapy|cognitive-behavioral therapy
5266740|NCT00557648|School-Based Interventions|school-based interventions
5266741|NCT00557635|pseudo-arthrosis, osseous matrix, cell therapy|pseudo-arthrosis, osseous matrix, cell therapy
5266742|NCT00557622|PTSD (Posttraumatic Stress Disorder)|ptsd (posttraumatic stress disorder)
5266743|NCT00557622|CAPS|caps
5266744|NCT00557622|fMRI|fmri
5266745|NCT00557622|Paroxetine|paroxetine
5266746|NCT00557609|Microphthalmia transcription (MiT) factor associated tumors|microphthalmia transcription (mit) factor associated tumors
5266747|NCT00557609|Alveolar soft part sarcoma (ASPS)|alveolar soft part sarcoma (asps)
5266748|NCT00557609|Clear cell sarcoma (CCS)|clear cell sarcoma (ccs)
5266749|NCT00557609|Renal cell carcinoma (RCC)|renal cell carcinoma (rcc)
5266750|NCT00557596|Pancreatic|pancreatic
5266751|NCT00557596|antisense|antisense
5266752|NCT00557596|oligonucleotide|oligonucleotide
5266753|NCT00557596|gemcitabine|gemcitabine
5266754|NCT00557583|VBY-376 Hepatitis C pharmacokinetics safety|vby-376 hepatitis c pharmacokinetics safety
5266755|NCT00557570|Antiretroviral|antiretroviral
5266756|NCT00557570|Opportunistic Infection|opportunistic infection
5266757|NCT00557570|treatment experienced|treatment experienced
5266758|NCT00557570|treatment naive|treatment naive
5266759|NCT00557557|Colorectal|colorectal
5266760|NCT00557557|liver|liver
5266761|NCT00557557|cancer|cancer
5266762|NCT00557557|metastases|metastases
5266763|NCT00557544|migraine|migraine
5266764|NCT00557544|metoclopramide|metoclopramide
5266765|NCT00557544|ketoprofen|ketoprofen
5266766|NCT00557544|child|child
5266767|NCT00557492|pancreas|pancreas
5266768|NCT00557492|pancreatic|pancreatic
5266769|NCT00557492|cancer|cancer
5266770|NCT00557492|resectable|resectable
5266771|NCT00557466|QMF|qmf
5266772|NCT00557466|indacaterol|indacaterol
5266773|NCT00557466|TWISTHALER® device|twisthaler® device
5266774|NCT00557440|Asthma|asthma
5266775|NCT00557440|QMF|qmf
5266776|NCT00557440|Indacaterol|indacaterol
5266777|NCT00557440|Mometasone|mometasone
5266778|NCT00557427|mild to moderate depression according to the DSM-IV scale|mild to moderate depression according to the dsm-iv scale
5266779|NCT00557414|acute respiratory distress syndrome|acute respiratory distress syndrome
5266780|NCT00557414|soluble triggering receptor expressed on myeloid cells-1|soluble triggering receptor expressed on myeloid cells-1
5266781|NCT00557414|prognosis|prognosis
5266782|NCT00557388|muscle loss|muscle loss
5266783|NCT00557388|aging|aging
5266784|NCT00557388|protein|protein
5266785|NCT00557388|amino acids|amino acids
5266786|NCT00557388|exercise|exercise
5266787|NCT00557388|protein synthesis|protein synthesis
5266788|NCT00557375|Brain Tumors|brain tumors
5266789|NCT00557375|Survey|survey
5266790|NCT00557362|Keratitis|keratitis
5266791|NCT00557362|Eye Infection, Fungal|eye infection, fungal
5266792|NCT00557362|Fungal Eye Infection|fungal eye infection
5266793|NCT00557362|Ocular Infection, Fungal|ocular infection, fungal
5266794|NCT00557362|Fungal Keratitis|fungal keratitis
5266795|NCT00557362|Mycotic Infections, Ocular|mycotic infections, ocular
5266796|NCT00557362|Voriconazole|voriconazole
5266797|NCT00557362|Natamycin|natamycin
5266798|NCT00557349|gastric bypass surgery|gastric bypass surgery
5266799|NCT00557349|anastomosis, Roux-en-Y|anastomosis, roux-en-y
5266800|NCT00557349|Complication, Postoperative|complication, postoperative
5266801|NCT00557310|osteoporosis, teriparatide, postmenopausal, MRI, finite element analysis|osteoporosis, teriparatide, postmenopausal, mri, finite element analysis
5266802|NCT00557297|asthma|asthma
5266803|NCT00557297|SMART|smart
5266804|NCT00557297|inhaled|inhaled
5266805|NCT00557297|glucocorticosteroid|glucocorticosteroid
5266806|NCT00557297|reliever|reliever
5266807|NCT00557297|maintenance|maintenance
5266808|NCT00557297|single inhaler|single inhaler
5266809|NCT00557284|Atopic Dermatitis (Eczema) associated with food allergies|atopic dermatitis (eczema) associated with food allergies
5266810|NCT00557245|HIV infection|hiv infection
5266811|NCT00557245|HIV uninfected partners|hiv uninfected partners
5266812|NCT00557245|Double Blind|double blind
5266813|NCT00557245|Placebo|placebo
5266814|NCT00557245|Seroconversion|seroconversion
5266815|NCT00557245|TDF|tdf
5266816|NCT00557245|FTC TDF|ftc tdf
5266817|NCT00557245|Safety|safety
5266818|NCT00557245|HIV Seronegativity|hiv seronegativity
5266819|NCT00557232|bevacizumab|bevacizumab
5266820|NCT00557232|rubeosis iridis|rubeosis iridis
5266821|NCT00557232|glaucoma|glaucoma
5266822|NCT00557219|cardiac surgery|cardiac surgery
5266823|NCT00557219|fenoldopam|fenoldopam
5266824|NCT00557219|ketanserin|ketanserin
5266825|NCT00557219|renal replacement therapy|renal replacement therapy
5266826|NCT00557206|Recurrent Disease|recurrent disease
5266827|NCT00557206|Metastatic Disease|metastatic disease
5266828|NCT00557206|Squamous Cell Carcinoma|squamous cell carcinoma
5266829|NCT00557206|Multicenter|multicenter
5266830|NCT00557206|Phase II|phase ii
5266831|NCT00557180|Steroid Resistance|steroid resistance
5266832|NCT00557180|Inflammation|inflammation
5266833|NCT00557154|Pediatrics|pediatrics
5266834|NCT00557154|Venous access|venous access
5266835|NCT00557154|Emergency|emergency
5266836|NCT00557141|Single arm observational retrospective and prospective study|single arm observational retrospective and prospective study
5266837|NCT00557128|COREG CR,|coreg cr,
5266838|NCT00557128|lisinopril,|lisinopril,
5266839|NCT00557128|hypertension,|hypertension,
5266840|NCT00557128|dose proportionality,|dose proportionality,
5266841|NCT00557128|fixed dose combination (FDC)|fixed dose combination (fdc)
5266842|NCT00557115|Quality of life|quality of life
5266843|NCT00557115|Quadriceps|quadriceps
5266844|NCT00557115|Muscle|muscle
5266845|NCT00557115|Exacerbation|exacerbation
5266846|NCT00557102|liver metastases|liver metastases
5266847|NCT00557102|lung metastases|lung metastases
5266848|NCT00557102|recurrent rectal cancer|recurrent rectal cancer
5267053|NCT00556088|Bevacizumab|bevacizumab
5266849|NCT00557102|stage IV rectal cancer|stage iv rectal cancer
5266850|NCT00557102|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5266851|NCT00557102|adenocarcinoma of the colon|adenocarcinoma of the colon
5266852|NCT00557102|recurrent colon cancer|recurrent colon cancer
5266853|NCT00557102|stage IV colon cancer|stage iv colon cancer
5266854|NCT00557089|Pediatrics|pediatrics
5266855|NCT00557089|Cystic Fibrosis|cystic fibrosis
5266856|NCT00557089|Lung Clearance Index|lung clearance index
5266857|NCT00557089|rhDNAse|rhdnase
5266858|NCT00557076|Randomized Clinical Trial|randomized clinical trial
5266859|NCT00557076|Auditory Stimulation|auditory stimulation
5266860|NCT00557050|Hamstring|hamstring
5266861|NCT00557050|Muscle|muscle
5266862|NCT00557050|Injury|injury
5266863|NCT00557050|Prevention|prevention
5266865|NCT00557037|Castrate and Non-Castrate Prostate Cancer|castrate and non-castrate prostate cancer
5266866|NCT00557024|hepatocellular carcinoma|hepatocellular carcinoma
5266867|NCT00557024|liver cancer|liver cancer
5266868|NCT00557024|radiofrequency ablation|radiofrequency ablation
5266869|NCT00557024|radiotherapy|radiotherapy
5266870|NCT00557024|adjuvant therapy|adjuvant therapy
5266871|NCT00556998|pharmacokinetics and safety data of voriconazole in immunocompromised adolescents|pharmacokinetics and safety data of voriconazole in immunocompromised adolescents
5266872|NCT00556959|ADHD|adhd
5266873|NCT00556959|Clonidine|clonidine
5266874|NCT00556959|Attention Deficit|attention deficit
5266875|NCT00556959|Hyperactivity|hyperactivity
5266876|NCT00556959|CLONICEL|clonicel
5266877|NCT00556959|Addrenex|addrenex
5266878|NCT00556946|Vascular Malformation|vascular malformation
5266879|NCT00556933|Induction|induction
5266880|NCT00556933|rATG|ratg
5266881|NCT00556933|Calcineurin-inhibitor withdrawal|calcineurin-inhibitor withdrawal
5266882|NCT00556920|Coreg CR|coreg cr
5266883|NCT00556907|DCIS|dcis
5266884|NCT00556907|To evaluate Preoperative mammagraphy and MRI to select candiates with DCIS for IORT|to evaluate preoperative mammagraphy and mri to select candiates with dcis for iort
5266885|NCT00556868|High school students|high school students
5266886|NCT00556868|Boarding school|boarding school
5266887|NCT00556868|Breakfast|breakfast
5266888|NCT00556868|Fasting|fasting
5266889|NCT00556868|Memory|memory
5266890|NCT00556868|Attention|attention
5266891|NCT00556868|Mood|mood
5266892|NCT00556855|chronic hand dermatitis|chronic hand dermatitis
5266893|NCT00556855|research study|research study
5266894|NCT00556855|E-do|e-do
5266895|NCT00556855|HK-03|hk-03
5266896|NCT00556842|Hemi-Arthroplasty|hemi-arthroplasty
5266897|NCT00556842|Total Hip Arthroplasty|total hip arthroplasty
5266898|NCT00556816|COPD|copd
5266899|NCT00556816|outpatient on demand clinic|outpatient on demand clinic
5266900|NCT00556803|hepatocellular carcinoma|hepatocellular carcinoma
5266901|NCT00556803|liver cancer|liver cancer
5266902|NCT00556803|radiofrequency ablation|radiofrequency ablation
5266903|NCT00556803|transcatheter arterial chemoembolization|transcatheter arterial chemoembolization
5266904|NCT00556803|adjuvant therapy|adjuvant therapy
5266905|NCT00556777|stage I breast cancer|stage i breast cancer
5266906|NCT00556764|ANAM|anam
5266907|NCT00556764|Parkinson's|parkinson's
5266908|NCT00556751|Electrocardiogram|electrocardiogram
5266909|NCT00556751|Electrocardiography|electrocardiography
5266910|NCT00556751|Cardiovascular Risk Factors|cardiovascular risk factors
5266911|NCT00556751|Cholesterol|cholesterol
5266912|NCT00556751|Blood Pressure|blood pressure
5266913|NCT00556751|Diabetes|diabetes
5266914|NCT00556738|HFPV|hfpv
5266915|NCT00556738|neonatal respiratory distress|neonatal respiratory distress
5266916|NCT00556699|NHL|nhl
5266917|NCT00556699|Rituxan|rituxan
5266918|NCT00556699|anti-CD40|anti-cd40
5266919|NCT00556673|Asthma, QMF149, fixed combination of indacaterol and mometasone furoate|asthma, qmf149, fixed combination of indacaterol and mometasone furoate
5266920|NCT00556660|Alzheimer|alzheimer
5266921|NCT00556660|SPECT|spect
5266922|NCT00556647|fast-track diagnosis|fast-track diagnosis
5266923|NCT00556647|PET-CT|pet-ct
5266924|NCT00556647|endoscopic techniques|endoscopic techniques
5266925|NCT00556647|lung cancer|lung cancer
5266926|NCT00556634|HIV|hiv
5266927|NCT00556634|efavirenz|efavirenz
5266928|NCT00556634|central nervous system|central nervous system
5266929|NCT00556634|adverse effects|adverse effects
5266930|NCT00556621|stage II bladder cancer|stage ii bladder cancer
5266931|NCT00556621|stage III bladder cancer|stage iii bladder cancer
5266932|NCT00556621|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
5266933|NCT00556595|atrial fibrillation|atrial fibrillation
5266934|NCT00556595|paroxysmal|paroxysmal
5266935|NCT00556595|symptomatic|symptomatic
5266936|NCT00556595|drug-refractory|drug-refractory
5266937|NCT00556569|Physical activity|physical activity
5266938|NCT00556569|Obesity|obesity
5266939|NCT00556543|Rib Fracture|rib fracture
5266940|NCT00556543|Rib Fracture Repair|rib fracture repair
5266941|NCT00556543|Rib Fracture ORIF|rib fracture orif
5266942|NCT00556543|Flail Chest|flail chest
5266943|NCT00556543|Implant|implant
5266944|NCT00556543|Prosthesis|prosthesis
5266945|NCT00556543|Rib fracture non-union|rib fracture non-union
5266946|NCT00556543|Chest wall deformity|chest wall deformity
5266947|NCT00556530|Congenital Heart Defects|congenital heart defects
5266948|NCT00556530|Single Nucleotide Polymorphisms|single nucleotide polymorphisms
5266949|NCT00556530|Copy Number Variations|copy number variations
5266950|NCT00556530|Whole Genome Association Study|whole genome association study
5266951|NCT00556517|Hamstring|hamstring
5266952|NCT00556517|Strain|strain
5266953|NCT00556517|Rehabilitation|rehabilitation
5266954|NCT00556517|muscles|muscles
5266955|NCT00556504|add-on treatment|add-on treatment
5266956|NCT00556504|botanical drug|botanical drug
5266957|NCT00556504|HCV genotype 1|hcv genotype 1
5266958|NCT00556504|TCM-700C|tcm-700c
5266959|NCT00556504|genotype I|genotype i
5266960|NCT00556491|renal|renal
5266961|NCT00556491|kidney|kidney
5266962|NCT00556491|injury|injury
5266963|NCT00556491|acute|acute
5266964|NCT00556491|bypass|bypass
5266965|NCT00556491|cardiac|cardiac
5266966|NCT00556491|minocycline|minocycline
5266967|NCT00556491|prevention|prevention
5266968|NCT00556491|Acute Kidney Failure|acute kidney failure
5266969|NCT00556478|Premature Ejaculation|premature ejaculation
5266970|NCT00556478|Lidocaine|lidocaine
5266971|NCT00556478|Prilocaine|prilocaine
5266972|NCT00556478|EMLA® cream|emla® cream
5266973|NCT00556478|topical anesthetics|topical anesthetics
5266974|NCT00556465|diabetic nephropathy|diabetic nephropathy
5266975|NCT00556465|proteinuria|proteinuria
5266976|NCT00556465|antioxidant|antioxidant
5266977|NCT00556439|Vasculitis|vasculitis
5266978|NCT00556439|Arteritis|arteritis
5266979|NCT00556439|Takayasu's|takayasu's
5266980|NCT00556439|Temporal Arteritis|temporal arteritis
5266981|NCT00556439|Abatacept|abatacept
5266982|NCT00556426|Venous Thromboembolic Disease|venous thromboembolic disease
5266983|NCT00556426|IVC Filter|ivc filter
5266984|NCT00556426|Pulmonary Embolism|pulmonary embolism
5266985|NCT00556413|stage IV colon cancer|stage iv colon cancer
5266986|NCT00556413|stage IV rectal cancer|stage iv rectal cancer
5266987|NCT00556413|recurrent colon cancer|recurrent colon cancer
5266988|NCT00556413|recurrent rectal cancer|recurrent rectal cancer
5266989|NCT00556400|Uterine Bleeding|uterine bleeding
5266990|NCT00556400|Thrombocytopenia|thrombocytopenia
5266991|NCT00556400|Aplastic Anemia|aplastic anemia
5266992|NCT00556400|Oral Contraceptive Pills|oral contraceptive pills
5266993|NCT00556400|Menorrhagia|menorrhagia
5266994|NCT00556387|traumatic brain injury|traumatic brain injury
5266995|NCT00556374|confirmed adenocarcinoma|confirmed adenocarcinoma
5266996|NCT00556374|non-metastatic breast cancer|non-metastatic breast cancer
5266997|NCT00556374|estrogen receptor positive|estrogen receptor positive
5266998|NCT00556374|progesterone receptor positive|progesterone receptor positive
5266999|NCT00556374|non-steroidal aromatase|non-steroidal aromatase
5267000|NCT00556374|aromatase inhibitor therapy|aromatase inhibitor therapy
5267001|NCT00556374|postmenopausal woman|postmenopausal woman
5267002|NCT00556374|adjuvant chemotherapy|adjuvant chemotherapy
5267003|NCT00556374|neoadjuvant chemotherapy|neoadjuvant chemotherapy
5267004|NCT00556348|bevacizumab|bevacizumab
5267005|NCT00556348|AMD|amd
5267006|NCT00556348|Complications|complications
5267007|NCT00556348|Visual acuity|visual acuity
5267008|NCT00556348|OCt|oct
5267009|NCT00556348|Age Macular Degeneration|age macular degeneration
5267010|NCT00556335|manual aspiration|manual aspiration
5267011|NCT00556335|conventional|conventional
5267012|NCT00556335|length of stay|length of stay
5267013|NCT00556283|outlet obstruction|outlet obstruction
5267014|NCT00556283|rectocele|rectocele
5267015|NCT00556270|pain|pain
5267016|NCT00556270|fentanyl|fentanyl
5267017|NCT00556270|transdermal patch|transdermal patch
5267018|NCT00556257|Immunosuppression, JAK3 inhibitor, kidney transplantation|immunosuppression, jak3 inhibitor, kidney transplantation
5267019|NCT00556231|NIRS|nirs
5267020|NCT00556231|cardiac output|cardiac output
5267021|NCT00556231|anaerobic threshold|anaerobic threshold
5267022|NCT00556231|exercise stress|exercise stress
5267023|NCT00556231|congenital heart defect|congenital heart defect
5267024|NCT00556218|Breast Cancer|breast cancer
5267025|NCT00556218|Tibetan Meditation|tibetan meditation
5267026|NCT00556218|Quality of Life|quality of life
5267027|NCT00556218|Cognitive Function|cognitive function
5267028|NCT00556218|QOL|qol
5267029|NCT00556205|mRCC|mrcc
5267030|NCT00556205|sunitinib|sunitinib
5267031|NCT00556205|bevacizumab|bevacizumab
5267032|NCT00556192|SLE|sle
5267033|NCT00556192|Rituximab|rituximab
5267034|NCT00556192|Methylprednisolone|methylprednisolone
5267035|NCT00556192|Cyclophosphamide|cyclophosphamide
5267036|NCT00556166|Enterra therapy|enterra therapy
5267037|NCT00556166|Gastric Simulation System|gastric simulation system
5267038|NCT00556153|brain tumors, children|brain tumors, children
5267039|NCT00556127|Large B-cell Lymphoma|large b-cell lymphoma
5267040|NCT00556127|Rituximab|rituximab
5267041|NCT00556127|ASCT|asct
5267042|NCT00556114|eye exam|eye exam
5267043|NCT00556114|Retina|retina
5267044|NCT00556101|Magnetic resonance|magnetic resonance
5267045|NCT00556101|whole body|whole body
5267046|NCT00556101|angiography|angiography
5267047|NCT00556101|questionnaire|questionnaire
5267048|NCT00556088|LBH589|lbh589
5267049|NCT00556088|Phase I|phase i
5267050|NCT00556088|Solid Tumors|solid tumors
5267051|NCT00556088|Paclitaxel|paclitaxel
5267054|NCT00556088|Dose escalation|dose escalation
5267055|NCT00556075|Endometriosis|endometriosis
5267056|NCT00556075|Pelvic pain|pelvic pain
5267057|NCT00556075|Oral progesterone blocker|oral progesterone blocker
5267058|NCT00556049|mRCC|mrcc
5267059|NCT00556049|sunitinib|sunitinib
5267060|NCT00556049|gemcitabine|gemcitabine
5267061|NCT00556036|healthy|healthy
5267062|NCT00556036|overweight|overweight
5267063|NCT00556036|obese|obese
5267064|NCT00556036|anorexia nervosa|anorexia nervosa
5267065|NCT00556036|weight|weight
5267066|NCT00556036|cortisol|cortisol
5267067|NCT00556036|hormone|hormone
5267068|NCT00556036|bone density|bone density
5267069|NCT00556036|bone|bone
5267070|NCT00556036|osteopenia|osteopenia
5267071|NCT00556036|osteoporosis|osteoporosis
5267072|NCT00556036|amenorrhea|amenorrhea
5267073|NCT00556036|menses|menses
5267074|NCT00556036|irregular|irregular
5267075|NCT00556036|stress|stress
5267076|NCT00556036|depression|depression
5267077|NCT00556036|exercise|exercise
5267078|NCT00556036|diet|diet
5267079|NCT00556023|interventional|interventional
5267080|NCT00556023|dose-finding|dose-finding
5267081|NCT00555997|Major Depressive Disorder|major depressive disorder
5267082|NCT00555997|Major Depression|major depression
5267083|NCT00555997|Depression|depression
5267084|NCT00555997|Geodon|geodon
5267085|NCT00555997|Ziprasidone|ziprasidone
5267086|NCT00555984|Intracranial tumors|intracranial tumors
5267087|NCT00555984|Inflammatory markers|inflammatory markers
5267088|NCT00555984|Craniotomy|craniotomy
5267089|NCT00555984|Postoperative complications|postoperative complications
5267090|NCT00555958|Obesity|obesity
5267091|NCT00555958|Bariatric surgery|bariatric surgery
5267092|NCT00555958|Excess weight loss|excess weight loss
5267093|NCT00555958|Vagus nerve|vagus nerve
5267094|NCT00555958|Vagal blocking|vagal blocking
5267095|NCT00555958|VBLOC(TM) therapy|vbloc(tm) therapy
5267096|NCT00555945|Intertrochanteric fracture|intertrochanteric fracture
5267097|NCT00555945|Gamma3 intramedullary nail|gamma3 intramedullary nail
5267098|NCT00555945|Sliding hip screw|sliding hip screw
5267099|NCT00555932|Intracranial Thrombosis|intracranial thrombosis
5267100|NCT00555932|Cerebral Sinovenous Thrombosis|cerebral sinovenous thrombosis
5267101|NCT00555932|Pediatrics|pediatrics
5267102|NCT00555932|Cranial Ultrasound|cranial ultrasound
5267103|NCT00555919|Metastatic breast cancer stage IV|metastatic breast cancer stage iv
5267104|NCT00555919|Metastatic breast cancer|metastatic breast cancer
5267105|NCT00555919|mBC|mbc
5267106|NCT00555919|Stage IV breast cancer|stage iv breast cancer
5267107|NCT00555919|Hormone receptor positive breast cancer|hormone receptor positive breast cancer
5267108|NCT00555893|randomized|randomized
5267109|NCT00555893|blinded|blinded
5267110|NCT00555893|controlled|controlled
5267111|NCT00555893|efficacy|efficacy
5267112|NCT00555867|hormone-receptor positive primary breast cancer|hormone-receptor positive primary breast cancer
5267113|NCT00555867|compliance|compliance
5267114|NCT00555867|Postmenopausal women|postmenopausal women
5267115|NCT00555854|Motivational interviewing,|motivational interviewing,
5267116|NCT00555854|Multidisciplinary|multidisciplinary
5267117|NCT00555854|Life style changes|life style changes
5267118|NCT00555854|Prevention|prevention
5267119|NCT00555854|Compliance|compliance
5267120|NCT00555854|Self Care|self care
5267121|NCT00555854|Behaviour|behaviour
5267122|NCT00555841|breast cancer|breast cancer
5267123|NCT00555828|Myocardial Infarction|myocardial infarction
5267124|NCT00555828|Myocardial infarct|myocardial infarct
5267125|NCT00555828|Infarction|infarction
5267126|NCT00555802|Low Back Pain|low back pain
5267127|NCT00555802|Motor Control Exercise|motor control exercise
5267128|NCT00555802|General exercise|general exercise
5267129|NCT00555802|Ultrasonography, Multifidus|ultrasonography, multifidus
5267130|NCT00555802|Transversus abdominis|transversus abdominis
5267131|NCT00555802|Randomized Controlled trial.|randomized controlled trial.
5267132|NCT00555789|kidney transplantation|kidney transplantation
5267133|NCT00555789|rejection|rejection
5267134|NCT00555789|AEB071|aeb071
5267135|NCT00555789|tacrolimus|tacrolimus
5267136|NCT00555789|mycophenolic acid|mycophenolic acid
5267137|NCT00555789|immunosuppression|immunosuppression
5267138|NCT00555776|tinnitus|tinnitus
5267139|NCT00555776|gabapentin|gabapentin
5267140|NCT00555763|Intraocular pressure|intraocular pressure
5267141|NCT00555763|Goldmann tonometry|goldmann tonometry
5267142|NCT00555763|applanation tonometry|applanation tonometry
5267143|NCT00555763|Tonometry, Ocular|tonometry, ocular
5267144|NCT00555750|sleep|sleep
5267145|NCT00555750|metabolism|metabolism
5267146|NCT00555750|insulin|insulin
5267147|NCT00555750|glucose|glucose
5267148|NCT00555750|actigraphy|actigraphy
5267149|NCT00555750|diary|diary
5267150|NCT00555750|volumetry|volumetry
5267151|NCT00555750|GABA|gaba
5267152|NCT00555737|Celiac Disease|celiac disease
5267153|NCT00555737|Capsule Endoscopy|capsule endoscopy
5267154|NCT00555737|small Bowel Disease|small bowel disease
5267155|NCT00555724|Relapsed|relapsed
5267156|NCT00555724|refractory|refractory
5267157|NCT00555724|solid tumor|solid tumor
5267158|NCT00555711|Brain tumor|brain tumor
5267160|NCT00555698|Depression|depression
5267161|NCT00555685|Heart Failure|heart failure
5267162|NCT00555685|Renal failure|renal failure
5267163|NCT00555685|Hyponatremia|hyponatremia
5267164|NCT00555659|Degeneration|degeneration
5267165|NCT00555659|Spondylosis|spondylosis
5267166|NCT00555659|Spondylolisthesis|spondylolisthesis
5267167|NCT00555659|Stenosis|stenosis
5267168|NCT00555633|Photoprotection|photoprotection
5267169|NCT00555633|Sunscreen|sunscreen
5267170|NCT00555633|After-sun-lotion|after-sun-lotion
5267171|NCT00555633|DNA repair enzymes|dna repair enzymes
5267172|NCT00555633|liposomes|liposomes
5267173|NCT00555633|skin cancer|skin cancer
5267174|NCT00555633|Xeroderma pigmentosum|xeroderma pigmentosum
5267175|NCT00555633|Basal cell nevus syndrome|basal cell nevus syndrome
5267176|NCT00555607|asthma|asthma
5267177|NCT00555607|COPD|copd
5267178|NCT00555607|severe|severe
5267179|NCT00555607|controlled|controlled
5267180|NCT00555607|mild|mild
5267181|NCT00555607|biomarker|biomarker
5267182|NCT00555607|exacerbation|exacerbation
5267183|NCT00555594|corneal neovascularization|corneal neovascularization
5267184|NCT00555594|Bevacizumab (Avastin)|bevacizumab (avastin)
5267185|NCT00555594|Immunologic rejection|immunologic rejection
5267186|NCT00555594|vascular endothelial growth factor|vascular endothelial growth factor
5267187|NCT00555581|Systemic Sclerosis|systemic sclerosis
5267188|NCT00555568|mental health|mental health
5267189|NCT00555568|group processes|group processes
5267190|NCT00555555|Factor VIII deficiency|factor viii deficiency
5267191|NCT00555555|Von Willebrand disease|von willebrand disease
5267192|NCT00555555|FVIII/VWF concentrate|fviii/vwf concentrate
5267193|NCT00555555|Bleeding disorders|bleeding disorders
5267194|NCT00555555|Blood disorders|blood disorders
5267195|NCT00555542|B-cell|b-cell
5267196|NCT00555542|rituximab|rituximab
5267197|NCT00555542|Rheumatoid Arthritis|rheumatoid arthritis
5267198|NCT00555529|COPD|copd
5267199|NCT00555529|exhaled breath condensate|exhaled breath condensate
5267200|NCT00555529|applanation tonometry|applanation tonometry
5267201|NCT00555529|induced sputum|induced sputum
5267202|NCT00555529|smokers|smokers
5267203|NCT00555529|healthy control|healthy control
5267204|NCT00555516|Breast Cancer、 Chemotherapy、 Neutropenia、WBC|breast cancer、 chemotherapy、 neutropenia、wbc
5267205|NCT00555503|prospective study|prospective study
5267206|NCT00555503|registry|registry
5267207|NCT00555503|quality of life|quality of life
5267208|NCT00555503|mastectomy|mastectomy
5267209|NCT00555503|reconstructive surgical procedures|reconstructive surgical procedures
5267210|NCT00555503|BrCa1|brca1
5267211|NCT00555503|BrCa2|brca2
5267212|NCT00555503|breast cancer prevention|breast cancer prevention
5267213|NCT00555490|Soy|soy
5267214|NCT00555490|Diabetes|diabetes
5267215|NCT00555490|Nephropathy|nephropathy
5267216|NCT00555477|premenopausal breast cancer with chemotherapy-induced ovarian failure|premenopausal breast cancer with chemotherapy-induced ovarian failure
5267217|NCT00555464|hemangioma, steroid, prednisolone, vincristine|hemangioma, steroid, prednisolone, vincristine
5267218|NCT00555451|phase I|phase i
5267219|NCT00555451|safety|safety
5267220|NCT00555451|tolerance|tolerance
5267221|NCT00555451|insulin resistance|insulin resistance
5267222|NCT00555451|obese|obese
5267223|NCT00555451|pharmacokinetics|pharmacokinetics
5267224|NCT00555438|major orthopaedic surgery|major orthopaedic surgery
5267225|NCT00555438|venous thromboembolic events prevention|venous thromboembolic events prevention
5267226|NCT00555438|renal impairment|renal impairment
5267227|NCT00555438|Arixtra|arixtra
5267228|NCT00555438|anti-Xa activity|anti-xa activity
5267229|NCT00555425|Buprenorphine|buprenorphine
5267230|NCT00555425|Buprenorphine/naloxone|buprenorphine/naloxone
5267231|NCT00555425|Counseling|counseling
5267232|NCT00555425|Primary care|primary care
5267233|NCT00555412|pharmacokinetic|pharmacokinetic
5267234|NCT00555412|multidose|multidose
5267235|NCT00555412|Staccato Loxapine|staccato loxapine
5267236|NCT00555399|Glioblastoma Multiforme|glioblastoma multiforme
5267237|NCT00555399|Anaplastic Glioma|anaplastic glioma
5267238|NCT00555399|Vorinostat|vorinostat
5267239|NCT00555399|Suberoylanilide Hydroxamic Acid|suberoylanilide hydroxamic acid
5267240|NCT00555399|SAHA|saha
5267241|NCT00555399|MSK-390|msk-390
5267242|NCT00555399|Zolinza|zolinza
5267243|NCT00555399|Isotretinoin|isotretinoin
5267244|NCT00555399|Accutane|accutane
5267245|NCT00555399|13-cis-Retinoic Acid|13-cis-retinoic acid
5267246|NCT00555399|Carboplatin|carboplatin
5267247|NCT00555399|Paraplatin|paraplatin
5267248|NCT00555399|CBT|cbt
5267249|NCT00555399|Temozolomide|temozolomide
5267250|NCT00555399|Temodar|temodar
5267251|NCT00555386|Selenium|selenium
5267252|NCT00555386|Soy|soy
5267253|NCT00555386|Breast Cancer Risk|breast cancer risk
5267254|NCT00555373|Pediatric|pediatric
5267255|NCT00555373|Renal|renal
5267256|NCT00555373|Transplant|transplant
5267257|NCT00555360|Health Information Technology|health information technology
5267258|NCT00555360|Patient Care Management|patient care management
5267259|NCT00555360|Self Care|self care
5267260|NCT00555360|Quality of Life|quality of life
5267261|NCT00555360|Family or non-Family Informal Caregivers|family or non-family informal caregivers
5267262|NCT00555347|Sarcoidosis|sarcoidosis
5267263|NCT00555347|Fatigue|fatigue
5267264|NCT00555334|hepatocellular carcinoma|hepatocellular carcinoma
5267265|NCT00555334|liver cancer|liver cancer
5267266|NCT00555334|radiofrequency ablation|radiofrequency ablation
5267267|NCT00555334|lamivudine|lamivudine
5267268|NCT00555308|urolithiasis|urolithiasis
5267269|NCT00555308|ultrasound|ultrasound
5267270|NCT00555308|hydronephrosis|hydronephrosis
5267271|NCT00555282|central venous catheter|central venous catheter
5267272|NCT00555282|cvc|cvc
5267273|NCT00555282|coated catheter|coated catheter
5267274|NCT00555282|bacteriaemia|bacteriaemia
5267275|NCT00555282|bloodstream infection|bloodstream infection
5267276|NCT00555269|Macular pucker|macular pucker
5267277|NCT00555269|Macular hole|macular hole
5267278|NCT00555269|Membrane Blue|membrane blue
5267279|NCT00555269|Infracyanine Green|infracyanine green
5267280|NCT00555269|Peripheral Visual Field|peripheral visual field
5267281|NCT00555256|NSCLC|nsclc
5267282|NCT00555243|Laparoscopic Surgical Simulation|laparoscopic surgical simulation
5267283|NCT00555230|HMG-CoA reductase inhibitors|hmg-coa reductase inhibitors
5267284|NCT00555230|Crestor|crestor
5267285|NCT00555230|Rosuvastatin|rosuvastatin
5267286|NCT00555217|kidney disease|kidney disease
5267287|NCT00555217|nephropathy|nephropathy
5267288|NCT00555217|type 2 diabetes|type 2 diabetes
5267289|NCT00555217|hyperkalemia|hyperkalemia
5267290|NCT00555217|acute kidney injury|acute kidney injury
5267291|NCT00555204|mild to moderate Alzheimer's disease, memory, cognition, dementia|mild to moderate alzheimer's disease, memory, cognition, dementia
5267292|NCT00555191|fructose|fructose
5267293|NCT00555191|Irritable bowel syndrome|irritable bowel syndrome
5267294|NCT00555191|malabsorption|malabsorption
5267295|NCT00555191|Glut5 transporter gene|glut5 transporter gene
5267296|NCT00555178|Polymorphic light eruption|polymorphic light eruption
5267297|NCT00555178|Regulatory T cells (Tregs)|regulatory t cells (tregs)
5267298|NCT00555178|Seasonal fluctuation|seasonal fluctuation
5267299|NCT00555178|UV radiation|uv radiation
5267300|NCT00555178|Phototherapy|phototherapy
5267301|NCT00555165|Macular Degeneration|macular degeneration
5267302|NCT00555165|Visual Impairment|visual impairment
5267303|NCT00555165|Quality of Life|quality of life
5267304|NCT00555165|Implantable Telescope|implantable telescope
5267305|NCT00555139|anxiety,|anxiety,
5267306|NCT00555139|depression,|depression,
5267307|NCT00555139|fMRI|fmri
5267308|NCT00555139|CRF-1 antagonists,|crf-1 antagonists,
5267309|NCT00555126|Polytrauma|polytrauma
5267310|NCT00555126|Hypothermia|hypothermia
5267311|NCT00555126|Wound Infection|wound infection
5267312|NCT00555126|Blood Loss|blood loss
5267313|NCT00555126|Combined perioperative morbidity|combined perioperative morbidity
5267314|NCT00555113|pseudoxanthoma elasticum|pseudoxanthoma elasticum
5267315|NCT00555113|Visual acuity|visual acuity
5267316|NCT00555113|Choroidal neovascularization|choroidal neovascularization
5267317|NCT00555113|angioid streaks|angioid streaks
5267318|NCT00555087|Erectile dysfunction|erectile dysfunction
5267319|NCT00555087|Hypogonadotrophic males|hypogonadotrophic males
5267320|NCT00555061|SID|sid
5267321|NCT00555061|impetigo|impetigo
5267322|NCT00555061|pharmacokinetics|pharmacokinetics
5267323|NCT00555061|Retapamulin ointment, 1%|retapamulin ointment, 1%
5267324|NCT00555061|Skin abnormalities|skin abnormalities
5267325|NCT00555061|Dermatoses|dermatoses
5267326|NCT00555061|pediatric|pediatric
5267327|NCT00555061|infection|infection
5267328|NCT00555061|SITL|sitl
5267329|NCT00555048|graft versus host disease|graft versus host disease
5267330|NCT00555048|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
5267331|NCT00555048|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
5267332|NCT00555048|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
5267333|NCT00555048|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
5267334|NCT00555048|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
5267335|NCT00555048|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5267336|NCT00555048|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
5267337|NCT00555048|adult acute promyelocytic leukemia (M3)|adult acute promyelocytic leukemia (m3)
5267338|NCT00555048|adult erythroleukemia (M6a)|adult erythroleukemia (m6a)
5267339|NCT00555048|adult pure erythroid leukemia (M6b)|adult pure erythroid leukemia (m6b)
5267340|NCT00555048|childhood acute megakaryocytic leukemia (M7)|childhood acute megakaryocytic leukemia (m7)
5267341|NCT00555048|childhood acute monoblastic leukemia (M5a)|childhood acute monoblastic leukemia (m5a)
5267342|NCT00555048|childhood acute monocytic leukemia (M5b)|childhood acute monocytic leukemia (m5b)
5267343|NCT00555048|childhood acute myeloblastic leukemia with maturation (M2)|childhood acute myeloblastic leukemia with maturation (m2)
5267344|NCT00555048|childhood acute myeloblastic leukemia without maturation (M1)|childhood acute myeloblastic leukemia without maturation (m1)
5267345|NCT00555048|childhood acute myelomonocytic leukemia (M4)|childhood acute myelomonocytic leukemia (m4)
5267346|NCT00555048|childhood acute promyelocytic leukemia (M3)|childhood acute promyelocytic leukemia (m3)
5267347|NCT00555048|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5267348|NCT00555048|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5267349|NCT00555048|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5267350|NCT00555048|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5267351|NCT00555048|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5267352|NCT00555048|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5267353|NCT00555048|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5267354|NCT00555048|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5267355|NCT00555048|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
5267356|NCT00555048|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
5267357|NCT00555048|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
5267479|NCT00554528|prosthesis|prosthesis
5267358|NCT00555048|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5267359|NCT00555048|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5267360|NCT00555048|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5267361|NCT00555048|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5267362|NCT00555048|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5267363|NCT00555048|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5267364|NCT00555048|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5267365|NCT00555048|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
5267366|NCT00555048|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5267367|NCT00555048|myelodysplastic/myeloproliferative diseases|myelodysplastic/myeloproliferative diseases
5267368|NCT00555048|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5267369|NCT00555035|GSK1349572,|gsk1349572,
5267370|NCT00555035|healthy volunteers|healthy volunteers
5267371|NCT00555022|Anticholinergic,|anticholinergic,
5267372|NCT00555022|FTIH,|ftih,
5267373|NCT00555022|Muscarinic Receptor Antagonist,|muscarinic receptor antagonist,
5267374|NCT00555022|Plethysmography|plethysmography
5267375|NCT00555022|COPD,|copd,
5267376|NCT00555009|traumatic brain Injury, cognitive function|traumatic brain injury, cognitive function
5267377|NCT00554996|urinary tract infection|urinary tract infection
5267378|NCT00554996|urinary catheter|urinary catheter
5267379|NCT00554996|Escherichia coli|escherichia coli
5267380|NCT00554996|biofilm|biofilm
5267381|NCT00554983|Recombinant birch pollen allergy|recombinant birch pollen allergy
5267382|NCT00554983|IgE-mediated allergic disease attributed to birch pollen|ige-mediated allergic disease attributed to birch pollen
5267383|NCT00554970|Adult Asthmatics|adult asthmatics
5267384|NCT00554944|Fluid Management|fluid management
5267385|NCT00554944|surgery|surgery
5267386|NCT00554944|Obesity|obesity
5267387|NCT00554918|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5267388|NCT00554918|recurrent prostate cancer|recurrent prostate cancer
5267389|NCT00554918|stage IV prostate cancer|stage iv prostate cancer
5267390|NCT00554918|bone metastases|bone metastases
5267391|NCT00554905|ablation|ablation
5267392|NCT00554905|catheter|catheter
5267393|NCT00554905|Carcinoma, Hepatocellular|carcinoma, hepatocellular
5267394|NCT00554905|therapy|therapy
5267395|NCT00554905|Chemoembolization, Therapeutic|chemoembolization, therapeutic
5267396|NCT00554905|Humans|humans
5267397|NCT00554905|Liver Neoplasms|liver neoplasms
5267398|NCT00554892|Rectal cancer|rectal cancer
5267399|NCT00554892|Sphincter preservation|sphincter preservation
5267400|NCT00554892|Mechanical bowel preparation|mechanical bowel preparation
5267401|NCT00554892|Post operative morbidity|post operative morbidity
5267402|NCT00554892|Anastomotic leakage|anastomotic leakage
5267403|NCT00554827|Relapsed or Refractory Cutaneous T-cell Lymphoma|relapsed or refractory cutaneous t-cell lymphoma
5267404|NCT00554827|Lymphoma|lymphoma
5267405|NCT00554827|Cutaneous T-cell Lymphoma|cutaneous t-cell lymphoma
5267406|NCT00554827|T-cell Lymphoma|t-cell lymphoma
5267407|NCT00554827|Mycosis fungoides|mycosis fungoides
5267408|NCT00554827|Sézary syndrome|sézary syndrome
5267409|NCT00554827|Primary cutaneous anaplastic large cell|primary cutaneous anaplastic large cell
5267410|NCT00554814|Iron deficiency|iron deficiency
5267411|NCT00554814|Ferritin|ferritin
5267412|NCT00554814|Encapsulated iron|encapsulated iron
5267413|NCT00554814|Infant formula|infant formula
5267414|NCT00554801|Central Auditory Processing|central auditory processing
5267415|NCT00554801|Traumatic Brain Injury|traumatic brain injury
5267416|NCT00554801|Hearing Loss|hearing loss
5267417|NCT00554775|tumors metastatic to brain|tumors metastatic to brain
5267418|NCT00554775|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5267419|NCT00554775|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5267420|NCT00554762|mechanical pain,|mechanical pain,
5267421|NCT00554762|heat pain,|heat pain,
5267422|NCT00554762|dose,|dose,
5267423|NCT00554762|efficacy|efficacy
5267424|NCT00554762|dose response,|dose response,
5267425|NCT00554762|GW842166,|gw842166,
5267426|NCT00554762|Single,|single,
5267427|NCT00554762|pharmacodynamics,|pharmacodynamics,
5267428|NCT00554762|repeat dose,|repeat dose,
5267429|NCT00554749|Selective mutism|selective mutism
5267430|NCT00554749|Children|children
5267431|NCT00554749|Treatment|treatment
5267432|NCT00554736|Pollen Allergy|pollen allergy
5267433|NCT00554736|Allergy|allergy
5267434|NCT00554723|Stroke|stroke
5267435|NCT00554723|Cerebral infarct|cerebral infarct
5267436|NCT00554723|Recovery|recovery
5267437|NCT00554723|Double blind|double blind
5267438|NCT00554723|Randomized|randomized
5267439|NCT00554723|Placebo|placebo
5267440|NCT00554723|Traditional Chinese Medicine|traditional chinese medicine
5267441|NCT00554723|Neuroaid|neuroaid
5267442|NCT00554710|Crohn's disease|crohn's disease
5267443|NCT00554710|immunomodulators|immunomodulators
5267444|NCT00554710|biologicals|biologicals
5267445|NCT00554697|tissue oxygenation|tissue oxygenation
5267446|NCT00554697|perioperative|perioperative
5267447|NCT00554697|outcome|outcome
5267448|NCT00554684|Outcome|outcome
5267449|NCT00554684|Elderly|elderly
5267450|NCT00554684|ICU|icu
5267451|NCT00554684|Quality of Life|quality of life
5267452|NCT00554671|Diabetes Mellitus|diabetes mellitus
5267453|NCT00554671|Clinical pharmacists|clinical pharmacists
5267454|NCT00554671|guideline adherence|guideline adherence
5267455|NCT00554671|group medical visits|group medical visits
5267456|NCT00554671|behavioral modification|behavioral modification
5267457|NCT00554671|pharmacotherapy|pharmacotherapy
5267458|NCT00554645|obesity|obesity
5267459|NCT00554645|children|children
5267460|NCT00554645|psychological intervention|psychological intervention
5267461|NCT00554632|Contraceptive|contraceptive
5267462|NCT00554632|Venous thrombosis|venous thrombosis
5267463|NCT00554632|Coagulation parameter|coagulation parameter
5267464|NCT00554619|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
5267465|NCT00554619|Ambrisentan|ambrisentan
5267466|NCT00554606|Rheumatoid Arthritis|rheumatoid arthritis
5267467|NCT00554606|Anit-interleukin-1 beta|anit-interleukin-1 beta
5267468|NCT00554606|ACZ885|acz885
5267469|NCT00554580|continuous positive airway pressure|continuous positive airway pressure
5267470|NCT00554580|outcome measure|outcome measure
5267471|NCT00554580|clinical trial|clinical trial
5267472|NCT00554567|HIV/AIDS|hiv/aids
5267473|NCT00554567|Voluntary Counseling and Testing|voluntary counseling and testing
5267474|NCT00554567|Rural India|rural india
5267475|NCT00554567|HIV Care|hiv care
5267476|NCT00554567|Health Services Research|health services research
5267477|NCT00554528|Cervical|cervical
5267478|NCT00554528|disc|disc
5267480|NCT00554528|adjacent|adjacent
5267481|NCT00554528|disease|disease
5267482|NCT00554528|randomized|randomized
5267483|NCT00554528|prospective|prospective
5267484|NCT00554528|study|study
5267485|NCT00554515|Kidney|kidney
5267486|NCT00554515|Renal Cell|renal cell
5267487|NCT00554515|Metastatic|metastatic
5267488|NCT00554515|interleukin-2|interleukin-2
5267489|NCT00554515|select|select
5267490|NCT00554489|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5267491|NCT00554489|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5267492|NCT00554489|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5267493|NCT00554489|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5267494|NCT00554489|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5267495|NCT00554489|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5267496|NCT00554476|Lateral Epicondylitis|lateral epicondylitis
5267497|NCT00554476|Treatment|treatment
5267498|NCT00554476|Corticosteroid|corticosteroid
5267499|NCT00554476|Elbow Cast|elbow cast
5267500|NCT00554476|Icing|icing
5267501|NCT00554476|NSAIDs|nsaids
5267502|NCT00554463|limited stage small cell lung cancer|limited stage small cell lung cancer
5267503|NCT00554437|Accidental Falls|accidental falls
5267504|NCT00554437|RCT|rct
5267505|NCT00554437|Age 65 and older|age 65 and older
5267506|NCT00554437|noninstitualized populations|noninstitualized populations
5267507|NCT00554424|oocyte retrieval|oocyte retrieval
5267508|NCT00554424|pain relief|pain relief
5267509|NCT00554424|Local anaesthetic|local anaesthetic
5267510|NCT00554411|Travatan Z|travatan z
5267511|NCT00554411|glaucoma|glaucoma
5267512|NCT00554411|tear film break up time|tear film break up time
5267513|NCT00554398|Raltegravir|raltegravir
5267514|NCT00554398|MK-0518|mk-0518
5267515|NCT00554398|Treatment intensification|treatment intensification
5267516|NCT00554398|HIV-1 latency|hiv-1 latency
5267517|NCT00554398|HIV eradication|hiv eradication
5267518|NCT00554398|treatment experienced|treatment experienced
5267519|NCT00554372|Jennerex|jennerex
5267520|NCT00554372|HCC|hcc
5267521|NCT00554372|unresectable primary hepatocellular carcinoma|unresectable primary hepatocellular carcinoma
5267522|NCT00554372|hepatocellular carcinoma|hepatocellular carcinoma
5267523|NCT00554372|liver cancer|liver cancer
5267524|NCT00554372|Phase 2|phase 2
5267525|NCT00554372|oncolytic virus|oncolytic virus
5267526|NCT00554372|Pexa-Vec|pexa-vec
5267527|NCT00554359|Acute Kidney Injury|acute kidney injury
5267528|NCT00554359|Acute Renal Failure|acute renal failure
5267529|NCT00554346|COX-2; post-operative ; sports injury; surgical pain|cox-2; post-operative ; sports injury; surgical pain
5267530|NCT00554320|vulvodynia|vulvodynia
5267531|NCT00554320|painful bladder syndrome|painful bladder syndrome
5267532|NCT00554320|myofascial pain syndrome|myofascial pain syndrome
5267533|NCT00554320|pelvic floor tension myalgia|pelvic floor tension myalgia
5267534|NCT00554307|patent ductus arteriosus|patent ductus arteriosus
5267535|NCT00554307|indomethacin|indomethacin
5267536|NCT00554307|neoprofen|neoprofen
5267537|NCT00554307|blood flow|blood flow
5267538|NCT00554294|children|children
5267539|NCT00554294|primary prevention|primary prevention
5267540|NCT00554294|environmental change|environmental change
5267541|NCT00554294|behavioural change|behavioural change
5267542|NCT00554294|school setting|school setting
5267543|NCT00554294|changing of drinking habits|changing of drinking habits
5267544|NCT00554294|promotion of drinking tap water|promotion of drinking tap water
5267545|NCT00554281|Type 1 diabetes|type 1 diabetes
5267546|NCT00554281|Hypoglycemia|hypoglycemia
5267547|NCT00554281|Glucose sensor|glucose sensor
5267548|NCT00554268|Advanced Cancers|advanced cancers
5267549|NCT00554268|Solid Tumors|solid tumors
5267550|NCT00554268|PBI-05204|pbi-05204
5267551|NCT00554255|Pharmacodynamics|pharmacodynamics
5267552|NCT00554255|Japanese|japanese
5267553|NCT00554255|safety|safety
5267554|NCT00554255|Pharmacokinetics|pharmacokinetics
5267555|NCT00554242|endothelium|endothelium
5267556|NCT00554242|antioxidants|antioxidants
5267557|NCT00554242|flavonoids|flavonoids
5267558|NCT00554229|Hormone Resistant Prostate Cancer|hormone resistant prostate cancer
5267559|NCT00554229|Endothelin A Receptor Antagonist|endothelin a receptor antagonist
5267560|NCT00554229|Endothelin A|endothelin a
5267561|NCT00554229|Endothelin A antagonist|endothelin a antagonist
5267562|NCT00554216|Obesity, morbid obesity|obesity, morbid obesity
5267563|NCT00554190|rhinosinusitis, ethmoid|rhinosinusitis, ethmoid
5267564|NCT00554177|sexual|sexual
5267565|NCT00554177|combat|combat
5267566|NCT00554177|PTSD|ptsd
5267567|NCT00554177|Clinical trial|clinical trial
5267568|NCT00554177|Trauma|trauma
5267569|NCT00554177|PTSD treatment|ptsd treatment
5267570|NCT00554177|PTSD medication|ptsd medication
5267571|NCT00554177|Post traumatic stress disorder|post traumatic stress disorder
5267572|NCT00554164|Aggressive non-Hodgkin's lymphoma|aggressive non-hodgkin's lymphoma
5267573|NCT00554164|Positron emission tomography|positron emission tomography
5267574|NCT00554164|Chemotherapy|chemotherapy
5267575|NCT00554138|rosuvastatin|rosuvastatin
5267576|NCT00554138|dipyridamole|dipyridamole
5267577|NCT00554138|caffeine|caffeine
5267578|NCT00554125|Sirolimus; Orthotopic liver transplantation; HCC|sirolimus; orthotopic liver transplantation; hcc
5267579|NCT00554112|Exercise Training|exercise training
5267580|NCT00554112|Glucose Intolerance|glucose intolerance
5267581|NCT00554112|Human Aging|human aging
5267582|NCT00554112|Insulin Secretion|insulin secretion
5267583|NCT00554073|Magnetic resonance|magnetic resonance
5267584|NCT00554073|whole body|whole body
5267585|NCT00554073|angiography|angiography
5267586|NCT00554073|vasovist|vasovist
5267587|NCT00554073|gadofosveset|gadofosveset
5267588|NCT00554073|blood pool agent|blood pool agent
5267589|NCT00554073|3T|3t
5267590|NCT00554073|1.5T|1.5t
5267591|NCT00554073|Field strength|field strength
5267592|NCT00554047|Dementia|dementia
5267593|NCT00554047|Caregivers|caregivers
5267594|NCT00554047|Costs and cost analysis|costs and cost analysis
5267595|NCT00554047|Multicenter study|multicenter study
5267596|NCT00554047|Randomized controlled trial|randomized controlled trial
5267597|NCT00554047|Quality Adjusted Life Years|quality adjusted life years
5267598|NCT00554047|Quality of life|quality of life
5267599|NCT00554047|Technology assessment, biomedical; Methods|technology assessment, biomedical; methods
5267600|NCT00554034|gingivitis, localized treatment|gingivitis, localized treatment
5267601|NCT00554021|Central venous catheter|central venous catheter
5267602|NCT00554021|nosocomial infection|nosocomial infection
5267603|NCT00554008|Appendicitis|appendicitis
5267604|NCT00554008|laparoscopy|laparoscopy
5267605|NCT00554008|randomized trial|randomized trial
5267606|NCT00554008|children|children
5267607|NCT00554008|pediatric|pediatric
5267608|NCT00553982|Replacement|replacement
5267609|NCT00553982|Knee|knee
5267610|NCT00553982|Patella|patella
5267611|NCT00553982|Arthroplasty|arthroplasty
5267612|NCT00553969|cardiovascular disease prevention|cardiovascular disease prevention
5267613|NCT00553943|lymphoma|lymphoma
5267614|NCT00553943|cerebral lymphoma|cerebral lymphoma
5267615|NCT00553943|central nervous system|central nervous system
5267616|NCT00553943|cytarabine|cytarabine
5267617|NCT00553943|rituximab|rituximab
5267618|NCT00553943|Diffuse large B-cell lymphomas, with cerebral or neuromeningeal involvement|diffuse large b-cell lymphomas, with cerebral or neuromeningeal involvement
5267619|NCT00553930|HCV/HIV-coinfected patients|hcv/hiv-coinfected patients
5267620|NCT00553930|Peginterferon alfa-2a|peginterferon alfa-2a
5267621|NCT00553917|Pregnancy|pregnancy
5267622|NCT00553917|Depression|depression
5267623|NCT00553917|Antidepressants|antidepressants
5267624|NCT00553852|Very Severe Obesity|very severe obesity
5267625|NCT00553852|Body Composition|body composition
5267626|NCT00553852|GH deficiency|gh deficiency
5267627|NCT00553852|IGF-I|igf-i
5267628|NCT00553852|LASGB|lasgb
5267629|NCT00553852|GH therapy|gh therapy
5267630|NCT00553839|anesthesia|anesthesia
5267631|NCT00553839|children|children
5267632|NCT00553839|ketamine|ketamine
5267633|NCT00553839|pharmacokinetics|pharmacokinetics
5267634|NCT00553813|Unresectable|unresectable
5267635|NCT00553813|Gemcitabine|gemcitabine
5267636|NCT00553813|Taxane|taxane
5267637|NCT00553813|TPI 287|tpi 287
5267638|NCT00553787|Obesity, Type 2 diabetes|obesity, type 2 diabetes
5267639|NCT00553774|CAD Patients on Optimal Treatment|cad patients on optimal treatment
5267640|NCT00553761|Band atrophy|band atrophy
5267641|NCT00553761|Pattern electroretinogram|pattern electroretinogram
5267642|NCT00553761|Chiasmal compression|chiasmal compression
5267643|NCT00553761|Neural loss|neural loss
5267644|NCT00553761|Electrophysiological tests|electrophysiological tests
5267645|NCT00553735|Dry Eye|dry eye
5267646|NCT00553735|Graft versus Host Disease|graft versus host disease
5267647|NCT00553735|GVHD|gvhd
5267648|NCT00553722|hypertension|hypertension
5267649|NCT00553722|dialysis|dialysis
5267650|NCT00553722|hyperaldosteronism|hyperaldosteronism
5267651|NCT00553709|nausea|nausea
5267652|NCT00553709|vomiting|vomiting
5267653|NCT00553709|retching|retching
5267654|NCT00553709|emesis|emesis
5267655|NCT00553709|surgery|surgery
5267656|NCT00553709|anesthesia|anesthesia
5267657|NCT00553696|chemotherapy|chemotherapy
5267658|NCT00553696|combination|combination
5267659|NCT00553683|stage IV pancreatic cancer|stage iv pancreatic cancer
5267660|NCT00553683|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
5267661|NCT00553683|advanced adult primary liver cancer|advanced adult primary liver cancer
5267662|NCT00553683|recurrent adult primary liver cancer|recurrent adult primary liver cancer
5267663|NCT00553683|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
5267664|NCT00553683|recurrent pancreatic cancer|recurrent pancreatic cancer
5267665|NCT00553683|recurrent colon cancer|recurrent colon cancer
5267666|NCT00553683|recurrent breast cancer|recurrent breast cancer
5267667|NCT00553683|recurrent gastric cancer|recurrent gastric cancer
5267668|NCT00553683|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5267669|NCT00553683|recurrent melanoma|recurrent melanoma
5267670|NCT00553683|stage IV breast cancer|stage iv breast cancer
5267671|NCT00553683|stage IV gastric cancer|stage iv gastric cancer
5267672|NCT00553683|stage IV colon cancer|stage iv colon cancer
5267673|NCT00553683|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5267674|NCT00553683|stage IV melanoma|stage iv melanoma
5267675|NCT00553683|liver metastases|liver metastases
5267676|NCT00553670|coronary artery|coronary artery
5267677|NCT00553670|bifurcation|bifurcation
5267678|NCT00553670|stent|stent
5267679|NCT00553670|intravascular ultrasound|intravascular ultrasound
5267680|NCT00553670|fractional flow reserve|fractional flow reserve
5267681|NCT00553657|Experimental Medicine|experimental medicine
5267682|NCT00553631|Enzyme Replacement Therapy|enzyme replacement therapy
5267683|NCT00553631|Gaucher disease|gaucher disease
5267684|NCT00553631|glucocerebrosidase|glucocerebrosidase
5267685|NCT00553631|beta-glucocerebrosidase|beta-glucocerebrosidase
5267686|NCT00553631|Acid beta-glucocerebrosidase|acid beta-glucocerebrosidase
5267687|NCT00553631|glucosylceramidase|glucosylceramidase
5267688|NCT00553631|D-glucosyl-N-acylsphingosine glucohydrolase|d-glucosyl-n-acylsphingosine glucohydrolase
5267689|NCT00553631|gene activation|gene activation
5267690|NCT00553631|human|human
5267691|NCT00553618|Interleukin 2|interleukin 2
5267692|NCT00553618|Proleukin|proleukin
5267693|NCT00553618|DTIC|dtic
5267694|NCT00553618|Dacarbazine|dacarbazine
5267695|NCT00553618|metastatic melanoma|metastatic melanoma
5267696|NCT00553618|adjuvant|adjuvant
5267697|NCT00553605|Renal Colic Pain Urinary Tract Colic|renal colic pain urinary tract colic
5267698|NCT00553579|contrast sensitivity, retention time|contrast sensitivity, retention time
5267699|NCT00553566|stage 0 bladder cancer|stage 0 bladder cancer
5267700|NCT00553566|stage I bladder cancer|stage i bladder cancer
5267701|NCT00553566|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
5267702|NCT00553553|Intrathecal morphine ITM intravenous morphine remifentanil hepatic resection|intrathecal morphine itm intravenous morphine remifentanil hepatic resection
5267703|NCT00553553|Adult|adult
5267704|NCT00553553|ASA I-III (stable)|asa i-iii (stable)
5267705|NCT00553553|Liver dysfunction requiring primary parenchymal resection|liver dysfunction requiring primary parenchymal resection
5267706|NCT00553540|backache|backache
5267707|NCT00553540|low backpain|low backpain
5267708|NCT00553540|sciatica|sciatica
5267709|NCT00553514|Infertility|infertility
5267710|NCT00553514|Oligo-anovulation|oligo-anovulation
5267711|NCT00553514|GONAL-f®|gonal-f®
5267712|NCT00553514|AS900672-Enriched|as900672-enriched
5267713|NCT00553514|hyperglycosylated recombinant human follicle stimulating hormone (r-hFSH)|hyperglycosylated recombinant human follicle stimulating hormone (r-hfsh)
5267714|NCT00553501|stage II grade 1 follicular lymphoma|stage ii grade 1 follicular lymphoma
5267715|NCT00553501|stage II grade 2 follicular lymphoma|stage ii grade 2 follicular lymphoma
5267716|NCT00553501|stage II grade 3 follicular lymphoma|stage ii grade 3 follicular lymphoma
5267717|NCT00553501|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5267718|NCT00553501|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5267719|NCT00553501|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5267720|NCT00553501|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5268095|NCT00551967|survivorship|survivorship
5267721|NCT00553501|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5267722|NCT00553501|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5267723|NCT00553488|diabetes|diabetes
5267724|NCT00553488|insulin|insulin
5267725|NCT00553488|subcutaneous|subcutaneous
5267726|NCT00553488|intra-dermal|intra-dermal
5267727|NCT00553488|blood glucose|blood glucose
5267728|NCT00553462|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5267729|NCT00553462|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5267730|NCT00553462|adenocarcinoma of the lung|adenocarcinoma of the lung
5267731|NCT00553462|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
5267732|NCT00553462|large cell lung cancer|large cell lung cancer
5267733|NCT00553462|squamous cell lung cancer|squamous cell lung cancer
5267734|NCT00553449|nocturnal heartburn|nocturnal heartburn
5267735|NCT00553449|day-time heartburn|day-time heartburn
5267736|NCT00553449|rabeprazole|rabeprazole
5267737|NCT00553449|GERD|gerd
5267738|NCT00553436|colon|colon
5267739|NCT00553436|rectum|rectum
5267740|NCT00553436|polyp|polyp
5267741|NCT00553436|EMR|emr
5267742|NCT00553436|Established indication for a procedure greater than colonoscopy and colonic polypectomy|established indication for a procedure greater than colonoscopy and colonic polypectomy
5267743|NCT00553410|stage IA breast cancer|stage ia breast cancer
5267744|NCT00553410|stage IB breast cancer|stage ib breast cancer
5267745|NCT00553410|stage II breast cancer|stage ii breast cancer
5267746|NCT00553410|stage IIIA breast cancer|stage iiia breast cancer
5267747|NCT00553397|Living donor lung transplant|living donor lung transplant
5267748|NCT00553397|End stage lung disease|end stage lung disease
5267749|NCT00553384|smell|smell
5267750|NCT00553384|olfaction|olfaction
5267751|NCT00553384|androstadienone|androstadienone
5267752|NCT00553384|women|women
5267753|NCT00553384|pheromones|pheromones
5267754|NCT00553384|Healthy Volunteers|healthy volunteers
5267755|NCT00553384|Physiological Effects of Androstadienone Exposure|physiological effects of androstadienone exposure
5267756|NCT00553371|stage II malignant testicular germ cell tumor|stage ii malignant testicular germ cell tumor
5267757|NCT00553371|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
5267758|NCT00553358|Lapatinib|lapatinib
5267759|NCT00553358|ErbB2+|erbb2+
5267760|NCT00553358|Early Breast Cancer|early breast cancer
5267761|NCT00553358|Neoadjuvant|neoadjuvant
5267762|NCT00553345|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
5267763|NCT00553345|stage 0 bladder cancer|stage 0 bladder cancer
5267764|NCT00553345|stage I bladder cancer|stage i bladder cancer
5267765|NCT00553319|ADHD|adhd
5267766|NCT00553319|Cocaine|cocaine
5267767|NCT00553319|Treatment|treatment
5267768|NCT00553293|infertility|infertility
5267769|NCT00553293|in vitro fertilization|in vitro fertilization
5267770|NCT00553293|LH supplementation|lh supplementation
5267771|NCT00553293|Benefits|benefits
5267772|NCT00553241|TIA|tia
5267773|NCT00553241|prognosis|prognosis
5267774|NCT00553241|evaluation|evaluation
5267775|NCT00553241|management|management
5267776|NCT00553228|maternal immunization|maternal immunization
5267777|NCT00553228|whooping cough|whooping cough
5267778|NCT00553228|pertussis|pertussis
5267779|NCT00553215|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
5267780|NCT00553215|stage 0 bladder cancer|stage 0 bladder cancer
5267781|NCT00553215|stage I bladder cancer|stage i bladder cancer
5267782|NCT00553215|stage II bladder cancer|stage ii bladder cancer
5267783|NCT00553202|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5267784|NCT00553202|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
5267785|NCT00553189|PARP Inhibitor|parp inhibitor
5267786|NCT00553189|Advanced Cancer|advanced cancer
5267787|NCT00553189|Combination Therapy|combination therapy
5267788|NCT00553189|Early Trial|early trial
5267789|NCT00553189|DNA Damage Repair|dna damage repair
5267790|NCT00553189|Topotecan|topotecan
5267791|NCT00553189|Cancer|cancer
5267792|NCT00553189|Solid Tumor|solid tumor
5267793|NCT00553189|Lymphoma|lymphoma
5267794|NCT00553176|Infliximab|infliximab
5267795|NCT00553176|Immune disorder|immune disorder
5267796|NCT00553176|Remicade|remicade
5267797|NCT00553176|Registry|registry
5267798|NCT00553176|Crohn's Disease|crohn's disease
5267799|NCT00553163|Hypnotherapy|hypnotherapy
5267800|NCT00553163|Prevention of relapse|prevention of relapse
5267801|NCT00553163|ulcerative colitis|ulcerative colitis
5267802|NCT00553150|adult gliosarcoma|adult gliosarcoma
5267803|NCT00553150|adult giant cell glioblastoma|adult giant cell glioblastoma
5267804|NCT00553150|adult glioblastoma|adult glioblastoma
5267805|NCT00553150|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5267806|NCT00553150|adult diffuse astrocytoma|adult diffuse astrocytoma
5267807|NCT00553150|adult pilocytic astrocytoma|adult pilocytic astrocytoma
5267808|NCT00553150|adult subependymal giant cell astrocytoma|adult subependymal giant cell astrocytoma
5267809|NCT00553137|oropharyngeal candidiasis|oropharyngeal candidiasis
5267810|NCT00553124|stage 0 bladder cancer|stage 0 bladder cancer
5267811|NCT00553124|stage I bladder cancer|stage i bladder cancer
5267812|NCT00553124|stage II bladder cancer|stage ii bladder cancer
5267813|NCT00553124|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
5267814|NCT00553111|syphilis|syphilis
5267815|NCT00553111|video education|video education
5267816|NCT00553111|knowledge|knowledge
5267817|NCT00553111|black|black
5267818|NCT00553111|hispanic|hispanic
5267819|NCT00553085|anxiety disorders|anxiety disorders
5267820|NCT00553085|children|children
5267821|NCT00553085|neurodevelopmental disorder|neurodevelopmental disorder
5267822|NCT00553085|neurodevelopmental delay|neurodevelopmental delay
5267823|NCT00553085|temperament|temperament
5267824|NCT00553072|Asphyxia|asphyxia
5267825|NCT00553072|perinatal|perinatal
5267826|NCT00553072|magnesium sulphate|magnesium sulphate
5267827|NCT00553059|nausea and vomiting|nausea and vomiting
5267828|NCT00553059|unspecified adult solid tumor|unspecified adult solid tumor
5267829|NCT00553059|Palonosetron|palonosetron
5267830|NCT00553059|Dexamethasone|dexamethasone
5267831|NCT00553046|ethics|ethics
5267832|NCT00553046|COPD|copd
5267833|NCT00553046|end of life|end of life
5267834|NCT00553046|mechanical ventilation|mechanical ventilation
5267835|NCT00553046|CRF home ventilated patients|crf home ventilated patients
5267836|NCT00553033|Patients must be candidable to liver resection|patients must be candidable to liver resection
5267837|NCT00553007|Periodontal disease|periodontal disease
5267838|NCT00553007|Metabolic Syndrome|metabolic syndrome
5267839|NCT00552994|Drug eluting stent|drug eluting stent
5267840|NCT00552994|Diabetics|diabetics
5267841|NCT00552994|Intravascular ultrasound|intravascular ultrasound
5267842|NCT00552994|Pathophysiologic (neointimal hyperplasia and peri-stent remodeling)|pathophysiologic (neointimal hyperplasia and peri-stent remodeling)
5267843|NCT00552981|common cold|common cold
5267844|NCT00552981|Finnish sauna|finnish sauna
5267845|NCT00552981|rct|rct
5267846|NCT00552968|trauma|trauma
5267847|NCT00552968|pain|pain
5267848|NCT00552955|Lymphangioleiomyomatosis|lymphangioleiomyomatosis
5267849|NCT00552955|Abdominal Lymphangioleiomyomas|abdominal lymphangioleiomyomas
5267850|NCT00552955|Chyle|chyle
5267851|NCT00552955|Ascites|ascites
5267852|NCT00552955|Tuberous Sclerosis Complex|tuberous sclerosis complex
5267853|NCT00552955|LAM|lam
5267854|NCT00552942|obesity|obesity
5267855|NCT00552942|diabetes|diabetes
5267856|NCT00552942|cytokines|cytokines
5267857|NCT00552890|obesity|obesity
5267858|NCT00552890|atkins|atkins
5267859|NCT00552890|weight reduction|weight reduction
5267860|NCT00552890|kidney function|kidney function
5267861|NCT00552877|PCI|pci
5267862|NCT00552877|Drug-eluting stent|drug-eluting stent
5267863|NCT00552851|acromegaly|acromegaly
5267864|NCT00552851|heart failure|heart failure
5267865|NCT00552851|hypertrophy|hypertrophy
5267866|NCT00552851|cardiomegaly|cardiomegaly
5267867|NCT00552838|Antimicrobial prescribing|antimicrobial prescribing
5267868|NCT00552838|Antimicrobial utilization|antimicrobial utilization
5267869|NCT00552825|acute lymphoblastic leukemia|acute lymphoblastic leukemia
5267870|NCT00552825|long-term lung function|long-term lung function
5267871|NCT00552812|Aortic Coarctation|aortic coarctation
5267872|NCT00552812|Heart Defects, Congenital|heart defects, congenital
5267873|NCT00552812|Stents|stents
5267874|NCT00552812|Heart Catheterization|heart catheterization
5267875|NCT00552799|cellulitis|cellulitis
5267876|NCT00552799|lymphoedema|lymphoedema
5267877|NCT00552799|penicillin|penicillin
5267878|NCT00552799|clinical trial|clinical trial
5267879|NCT00552786|noise|noise
5267880|NCT00552786|hearing loss|hearing loss
5267881|NCT00552786|temporary threshold shift|temporary threshold shift
5267882|NCT00552773|SINUSITIS|sinusitis
5267883|NCT00552773|CYCLAMEN|cyclamen
5267884|NCT00552747|fenofibrate|fenofibrate
5267885|NCT00552747|coronary heart disease|coronary heart disease
5267886|NCT00552747|mixed hyperlipidemia|mixed hyperlipidemia
5267887|NCT00552734|Type 1 diabetes|type 1 diabetes
5267888|NCT00552734|Improved glycemic control|improved glycemic control
5267889|NCT00552734|Glucose excursions|glucose excursions
5267890|NCT00552734|Target range glucose levels|target range glucose levels
5267891|NCT00552734|Insulin guidance software|insulin guidance software
5267892|NCT00552734|Advisor|advisor
5267893|NCT00552721|Motor control|motor control
5267894|NCT00552721|Spasticity|spasticity
5267895|NCT00552708|COREG CR|coreg cr
5267896|NCT00552695|intravenous catheter|intravenous catheter
5267897|NCT00552695|emergency department|emergency department
5267898|NCT00552695|pain|pain
5267899|NCT00552682|HIV|hiv
5267900|NCT00552682|fibromialgy|fibromialgy
5267901|NCT00552682|chronic fatigue syndrome|chronic fatigue syndrome
5267902|NCT00552682|duloxetine|duloxetine
5267903|NCT00552682|pain|pain
5267904|NCT00552682|treatment experienced|treatment experienced
5267905|NCT00552682|Fibromialgy in patients with HIV-1 infection|fibromialgy in patients with hiv-1 infection
5267906|NCT00552669|Drug Eluting Stents|drug eluting stents
5267907|NCT00552669|Stents Bare Metal|stents bare metal
5267908|NCT00552669|Stent Thrombosis|stent thrombosis
5267909|NCT00552669|Coronary revascularization|coronary revascularization
5267910|NCT00552669|Survival|survival
5267911|NCT00552656|Angioplasty, Transluminal, Percutaneous Coronary|angioplasty, transluminal, percutaneous coronary
5267912|NCT00552656|Drug-eluting stents|drug-eluting stents
5267913|NCT00552656|Treatment Outcome|treatment outcome
5267914|NCT00552643|Recalcitrant ulcers|recalcitrant ulcers
5267915|NCT00552643|Chronic wounds|chronic wounds
5267916|NCT00552643|Venous insufficiency wounds|venous insufficiency wounds
5267917|NCT00552643|Ulcers|ulcers
5267918|NCT00552643|Exposed bones|exposed bones
5267919|NCT00552643|Exposed Tendons|exposed tendons
5267920|NCT00552643|Granulation tissue|granulation tissue
5267921|NCT00552643|Polyheal 1|polyheal 1
5267922|NCT00552643|Wound care|wound care
5267923|NCT00552643|Wound healing|wound healing
5267924|NCT00552643|Diabetic wounds healing|diabetic wounds healing
5267925|NCT00552643|Post trauma|post trauma
5267926|NCT00552643|Post surgery complication|post surgery complication
5267927|NCT00552643|Recalcitrant wounds including venous, post-operative and post-traumatic chronic wounds with different etiologies including wounds with exposed bone and tendon.|recalcitrant wounds including venous, post-operative and post-traumatic chronic wounds with different etiologies including wounds with exposed bone and tendon.
5267928|NCT00552630|lead poisoning|lead poisoning
5267929|NCT00552630|chelation|chelation
5267930|NCT00552604|multiple sclerosis|multiple sclerosis
5267931|NCT00552604|muscle stiffness|muscle stiffness
5267932|NCT00552604|spasticity|spasticity
5267933|NCT00552604|pain|pain
5267934|NCT00552604|treatment|treatment
5267935|NCT00552604|cannabinoids|cannabinoids
5267936|NCT00552591|family risk|family risk
5267937|NCT00552591|behavior modification|behavior modification
5267938|NCT00552591|lifestyle change|lifestyle change
5267939|NCT00552591|prevention of CHD|prevention of chd
5267940|NCT00552591|health care costs|health care costs
5267941|NCT00552578|drug dependence|drug dependence
5267942|NCT00552578|substance abuse|substance abuse
5267943|NCT00552578|substance use disorders|substance use disorders
5267944|NCT00552578|myofascial pain syndrome|myofascial pain syndrome
5267945|NCT00552578|neuralgia|neuralgia
5267946|NCT00552578|back pain|back pain
5267947|NCT00552565|IBS, IBS-D, R-verapamil, Arverpamil, Rezular|ibs, ibs-d, r-verapamil, arverpamil, rezular
5267948|NCT00552552|cancer-related fatigue|cancer-related fatigue
5267949|NCT00552552|self-management|self-management
5267950|NCT00552552|patient education|patient education
5267951|NCT00552552|cancer survivors|cancer survivors
5267952|NCT00552552|chronic disease|chronic disease
5267953|NCT00552539|syphilis|syphilis
5267954|NCT00552539|educational video|educational video
5267955|NCT00552539|knowledge|knowledge
5267956|NCT00552539|black|black
5267957|NCT00552539|Hispanic|hispanic
5267958|NCT00552526|Epilepsy|epilepsy
5267959|NCT00552526|Children|children
5267960|NCT00552526|Mental retardation|mental retardation
5267961|NCT00552526|Ketogenic diet|ketogenic diet
5267962|NCT00552526|Diet|diet
5267963|NCT00552513|timing|timing
5267964|NCT00552513|intervention|intervention
5267965|NCT00552513|early|early
5267966|NCT00552513|delayed|delayed
5267967|NCT00552513|acute coronary syndromes|acute coronary syndromes
5267968|NCT00552513|PCI|pci
5267969|NCT00552513|angiography|angiography
5267970|NCT00552513|Non ST-segment elevation myocardial infarction|non st-segment elevation myocardial infarction
5267971|NCT00552513|unstable angina|unstable angina
5267972|NCT00552487|isolated ACTH deficiency|isolated acth deficiency
5267973|NCT00552487|Hashimoto disease|hashimoto disease
5267974|NCT00552487|Hashimoto thyroiditis|hashimoto thyroiditis
5267975|NCT00552487|autoimmune thyroiditis|autoimmune thyroiditis
5267976|NCT00552474|Parkinson disease|parkinson disease
5267977|NCT00552474|Movement disorders|movement disorders
5267978|NCT00552474|Deep Brain Stimulation|deep brain stimulation
5267979|NCT00552474|Libra|libra
5267980|NCT00552474|l-dopa|l-dopa
5267981|NCT00552474|levodopa|levodopa
5267982|NCT00552474|neuromodulation|neuromodulation
5267983|NCT00552474|neurostimulation|neurostimulation
5267984|NCT00552474|Electrical stimulation of the brain|electrical stimulation of the brain
5267985|NCT00552474|STN|stn
5267986|NCT00552474|Subthalamic nucleus|subthalamic nucleus
5267987|NCT00552461|Pulmonary alveolar proteinosis|pulmonary alveolar proteinosis
5267988|NCT00552461|Primary Pulmonary alveolar proteinosis|primary pulmonary alveolar proteinosis
5267989|NCT00552461|Rituximab|rituximab
5267990|NCT00552461|Idiopathic|idiopathic
5267991|NCT00552461|Symptomatic|symptomatic
5267992|NCT00552461|GM-CSF Antibody|gm-csf antibody
5267993|NCT00552448|Pediatric, asthma, pediatric ICU|pediatric, asthma, pediatric icu
5267994|NCT00552422|gastroparesis|gastroparesis
5267995|NCT00552422|gastroesophageal reflux|gastroesophageal reflux
5267996|NCT00552409|Diabetes mellitus|diabetes mellitus
5267997|NCT00552409|Type 2 diabetes|type 2 diabetes
5267998|NCT00552409|Chronic kidney disease|chronic kidney disease
5267999|NCT00552409|Diabetic kidney disease|diabetic kidney disease
5268000|NCT00552409|Microalbuminuria|microalbuminuria
5268001|NCT00552409|Albuminuria|albuminuria
5268002|NCT00552409|Vitamin D|vitamin d
5268003|NCT00552409|Cholecalciferol|cholecalciferol
5268004|NCT00552409|Kidney|kidney
5268005|NCT00552409|Renal|renal
5268006|NCT00552409|Cardiovascular|cardiovascular
5268007|NCT00552409|Clinical trial|clinical trial
5268008|NCT00552409|Placebo|placebo
5268009|NCT00552396|multiple myeloma|multiple myeloma
5268010|NCT00552396|Anti-KIR (1-7F9)|anti-kir (1-7f9)
5268011|NCT00552383|Preterm Infant|preterm infant
5268012|NCT00552383|Behaviour|behaviour
5268013|NCT00552383|Developmental Care|developmental care
5268014|NCT00552383|NIDCAP|nidcap
5268015|NCT00552383|Family Centred Care|family centred care
5268016|NCT00552383|Neurodevelopmental Outcome, preterm infant|neurodevelopmental outcome, preterm infant
5268017|NCT00552344|CDP 870|cdp 870
5268018|NCT00552344|Certolizumab Pegol|certolizumab pegol
5268019|NCT00552344|CIMZIA|cimzia
5268020|NCT00552344|Crohn's Disease|crohn's disease
5268021|NCT00552344|Crohn Disease|crohn disease
5268022|NCT00552344|CD Induction|cd induction
5268023|NCT00552344|Induction|induction
5268024|NCT00552344|Clinical response|clinical response
5268025|NCT00552344|Clinical remission|clinical remission
5268026|NCT00552292|metabolic syndrome|metabolic syndrome
5268027|NCT00552292|hypertension|hypertension
5268028|NCT00552292|obesity|obesity
5268029|NCT00552292|dyslipidemia|dyslipidemia
5268030|NCT00552292|hyperglycemia|hyperglycemia
5268031|NCT00552292|cardiovascular complications|cardiovascular complications
5268032|NCT00552279|HPV|hpv
5268033|NCT00552279|cervical cancer|cervical cancer
5268034|NCT00552279|papillomavirus|papillomavirus
5268035|NCT00552279|Human papillomavirus (HPV) vaccine|human papillomavirus (hpv) vaccine
5268036|NCT00552266|Methylphenidate|methylphenidate
5268037|NCT00552266|Trichotillomania|trichotillomania
5268038|NCT00552266|Attention deficit|attention deficit
5268039|NCT00552214|Nucleic acid test|nucleic acid test
5268040|NCT00552214|HIV-1|hiv-1
5268041|NCT00552214|hepatitis|hepatitis
5268042|NCT00552214|HBV|hbv
5268043|NCT00552214|HCV|hcv
5268044|NCT00552214|TMA|tma
5268045|NCT00552214|HIV Seronegativity|hiv seronegativity
5268046|NCT00552201|kidney transplantation|kidney transplantation
5268047|NCT00552201|Tacrolimus|tacrolimus
5268048|NCT00552201|P450 3A5 cytochrome|p450 3a5 cytochrome
5268049|NCT00552201|genotype|genotype
5268050|NCT00552188|Atherosclerosis|atherosclerosis
5268051|NCT00552084|Fish Oil|fish oil
5268052|NCT00552071|Acromegaly|acromegaly
5268053|NCT00552071|Octreotide LAR|octreotide lar
5268054|NCT00552071|Ultrasound guidance|ultrasound guidance
5268055|NCT00552058|CDP 870|cdp 870
5268056|NCT00552058|Certolizumab Pegol|certolizumab pegol
5268057|NCT00552058|CIMZIA ®|cimzia ®
5268058|NCT00552058|Crohn's disease|crohn's disease
5268059|NCT00552058|Induction|induction
5268060|NCT00552058|Clinical remission|clinical remission
5268061|NCT00552058|Clinical response|clinical response
5268062|NCT00552045|epilepsy|epilepsy
5268063|NCT00552045|localization-related epilepsy|localization-related epilepsy
5268064|NCT00552045|idiopathic generalized epilepsy|idiopathic generalized epilepsy
5268065|NCT00552045|infantile spasms|infantile spasms
5268066|NCT00552045|Lennox-Gastaut syndrome|lennox-gastaut syndrome
5268067|NCT00552045|polymicrogyria|polymicrogyria
5268068|NCT00552045|periventricular heterotopias|periventricular heterotopias
5268069|NCT00552045|malformations of cortical development|malformations of cortical development
5268070|NCT00552045|phenome|phenome
5268071|NCT00552045|genome|genome
5268072|NCT00552045|genotype|genotype
5268073|NCT00552045|phenotype|phenotype
5268074|NCT00552006|PTSD|ptsd
5268075|NCT00552006|Treatment|treatment
5268076|NCT00552006|Randomized Controlled Clinical Trial|randomized controlled clinical trial
5268077|NCT00552006|Combat|combat
5268078|NCT00552006|Child Soldiers|child soldiers
5268079|NCT00552006|Dissemination|dissemination
5268080|NCT00552006|Narrative Exposure Therapy|narrative exposure therapy
5268081|NCT00552006|Africa|africa
5268082|NCT00551993|laparoscopy|laparoscopy
5268083|NCT00551993|robot|robot
5268084|NCT00551993|vaginal prolapse|vaginal prolapse
5268085|NCT00551993|sacrocolpopexy|sacrocolpopexy
5268086|NCT00551993|sacral colpopexy|sacral colpopexy
5268087|NCT00551980|Headache|headache
5268088|NCT00551980|Cervical Pain|cervical pain
5268089|NCT00551980|Cognitive treatment|cognitive treatment
5268090|NCT00551980|Relaxation|relaxation
5268091|NCT00551980|Exercise|exercise
5268092|NCT00551967|clinical outcomes|clinical outcomes
5268093|NCT00551967|radiographic outcomes|radiographic outcomes
5268094|NCT00551967|total hip arthroplasty|total hip arthroplasty
5268096|NCT00551928|Multiple Myeloma|multiple myeloma
5268097|NCT00551928|Lenalidomide|lenalidomide
5268098|NCT00551928|High dose Melphalan|high dose melphalan
5268099|NCT00551928|Mobilization|mobilization
5268101|NCT00551902|Glaucoma|glaucoma
5268102|NCT00551902|trabeculectomy|trabeculectomy
5268103|NCT00551902|anterior chamber maintainer|anterior chamber maintainer
5268104|NCT00551902|anterior chamber infusion|anterior chamber infusion
5268105|NCT00551889|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5268106|NCT00551863|alcohol, drugs, aggression, substance use disorder treatment|alcohol, drugs, aggression, substance use disorder treatment
5268107|NCT00551850|epidermal growth factor inhibitor|epidermal growth factor inhibitor
5268108|NCT00551850|solid tumors|solid tumors
5268109|NCT00551850|advanced cancer|advanced cancer
5268110|NCT00551837|Lung Transplantation|lung transplantation
5268111|NCT00551837|Kidney Transplnatation|kidney transplnatation
5268112|NCT00551837|Chroinic Kidney Disease|chroinic kidney disease
5268113|NCT00551837|Influenza|influenza
5268114|NCT00551824|esophageal stricture|esophageal stricture
5268115|NCT00551811|SB-656933-AAA,|sb-656933-aaa,
5268116|NCT00551811|ozone challenge|ozone challenge
5268117|NCT00551811|single dose,|single dose,
5268118|NCT00551798|Hodgkin's Disease|hodgkin's disease
5268119|NCT00551798|Malignant lymphomas high grade|malignant lymphomas high grade
5268120|NCT00551798|Chemoresistance|chemoresistance
5268121|NCT00551798|MIBI|mibi
5268122|NCT00551798|PGP|pgp
5268123|NCT00551798|MRP1|mrp1
5268124|NCT00551798|Tumor response|tumor response
5268125|NCT00551785|Hypoactive Sexual Desire Disorder|hypoactive sexual desire disorder
5268126|NCT00551785|Menopause|menopause
5268127|NCT00551785|Androgen|androgen
5268128|NCT00551772|Bio-availability, healthy elderly volunteers|bio-availability, healthy elderly volunteers
5268129|NCT00551759|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
5268130|NCT00551759|chemoradiotherapy|chemoradiotherapy
5268131|NCT00551759|oxaliplatin|oxaliplatin
5268132|NCT00551759|cetuximab|cetuximab
5268133|NCT00551759|docetaxel|docetaxel
5268134|NCT00551746|purple grape juice|purple grape juice
5268135|NCT00551746|antioxidants|antioxidants
5268136|NCT00551746|platelet aggregation|platelet aggregation
5268137|NCT00551746|anti-thrombotic|anti-thrombotic
5268138|NCT00551733|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5268139|NCT00551733|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5268140|NCT00551733|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5268141|NCT00551720|HIV|hiv
5268142|NCT00551720|HIV positive|hiv positive
5268143|NCT00551720|AIDS|aids
5268144|NCT00551720|smoking cessation|smoking cessation
5268145|NCT00551720|smoking|smoking
5268146|NCT00551720|smoking counseling|smoking counseling
5268147|NCT00551707|CombinatoRx|combinatorx
5268148|NCT00551707|CRx-102|crx-102
5268149|NCT00551707|Rheumatoid Arthritis|rheumatoid arthritis
5268150|NCT00551707|Prednisolone|prednisolone
5268151|NCT00551707|Dipyridamole|dipyridamole
5268152|NCT00551707|ACR20|acr20
5268153|NCT00551694|GSK256073A|gsk256073a
5268154|NCT00551681|cardiac resynchronisation therapy|cardiac resynchronisation therapy
5268155|NCT00551681|epicardial lead|epicardial lead
5268156|NCT00551681|coronary sinus|coronary sinus
5268157|NCT00551655|Human Immunodeficiency Viruses|human immunodeficiency viruses
5268158|NCT00551655|Glomerular Filtration Rate|glomerular filtration rate
5268159|NCT00551655|Tenofovir|tenofovir
5268160|NCT00551655|Treatment Experienced|treatment experienced
5268161|NCT00551642|Preemie, Inhaled Nitric Oxide|preemie, inhaled nitric oxide
5268162|NCT00551603|epoetinum beta once-weekly|epoetinum beta once-weekly
5268163|NCT00551603|darbepoetinum once-fortnightly|darbepoetinum once-fortnightly
5268164|NCT00551603|anemia correction|anemia correction
5268165|NCT00551603|hemoglobin stability|hemoglobin stability
5268166|NCT00551590|diabetes mellitus|diabetes mellitus
5268167|NCT00551590|DPP-4 inhibitor|dpp-4 inhibitor
5268168|NCT00551590|sitagliptin|sitagliptin
5268169|NCT00551590|exendin(9-39)|exendin(9-39)
5268170|NCT00551590|GLP-1|glp-1
5268171|NCT00551577|Ovarian neoplasms,|ovarian neoplasms,
5268172|NCT00551577|Neoadjuvant Therapy,|neoadjuvant therapy,
5268173|NCT00551577|Docetaxel,|docetaxel,
5268174|NCT00551577|Neoplasm, Residual|neoplasm, residual
5268175|NCT00551564|total body water|total body water
5268176|NCT00551564|T2DM,|t2dm,
5268177|NCT00551564|Healthy Obese,|healthy obese,
5268178|NCT00551564|Insulin Resistance,|insulin resistance,
5268179|NCT00551564|Rosiglitazone maleate,|rosiglitazone maleate,
5268180|NCT00551564|Glucose Disposal,|glucose disposal,
5268181|NCT00551564|hyperinsulinemic-euglycemic clamp,|hyperinsulinemic-euglycemic clamp,
5268182|NCT00551551|Pelvic floor|pelvic floor
5268183|NCT00551551|Kegel exercises|kegel exercises
5268184|NCT00551551|Quality of Life|quality of life
5268185|NCT00551551|Pelvic Pain|pelvic pain
5268186|NCT00551538|Diabetes|diabetes
5268187|NCT00551538|Diabetic|diabetic
5268188|NCT00551538|Insulin|insulin
5268189|NCT00551538|Glargine|glargine
5268190|NCT00551538|Lispro|lispro
5268191|NCT00551525|stage IIB prostate cancer|stage iib prostate cancer
5268192|NCT00551525|stage IIA prostate cancer|stage iia prostate cancer
5268193|NCT00551525|stage III prostate cancer|stage iii prostate cancer
5268194|NCT00551525|stage IV prostate cancer|stage iv prostate cancer
5268195|NCT00551512|cancer|cancer
5268196|NCT00551512|solid tumors|solid tumors
5268197|NCT00551499|Sleep Apnea, CRT|sleep apnea, crt
5268198|NCT00551486|Pyrosequencing|pyrosequencing
5268199|NCT00551486|BRAFV600E mutation|brafv600e mutation
5268200|NCT00551486|Thyroid incidentaloma|thyroid incidentaloma
5268201|NCT00551486|Ultrasound-guided fine-needle aspiration biopsy|ultrasound-guided fine-needle aspiration biopsy
5268202|NCT00551473|pharmacodynamics,|pharmacodynamics,
5268203|NCT00551473|tolerance|tolerance
5268204|NCT00551473|H2 antagonist,|h2 antagonist,
5268205|NCT00551473|AH23844,|ah23844,
5268206|NCT00551473|lavoltidine,|lavoltidine,
5268207|NCT00551473|gastroesophageal reflux disease (GERD), pharmacokinetics,|gastroesophageal reflux disease (gerd), pharmacokinetics,
5268208|NCT00551460|adult acute promyelocytic leukemia (M3)|adult acute promyelocytic leukemia (m3)
5268209|NCT00551460|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5268851|NCT00548366|cirrhosis|cirrhosis
5268210|NCT00551460|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5268211|NCT00551460|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5268212|NCT00551460|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
5268213|NCT00551395|glaucoma|glaucoma
5268214|NCT00551395|laser|laser
5268215|NCT00551395|trabeculoplasty|trabeculoplasty
5268216|NCT00551382|Montelukast|montelukast
5268217|NCT00551382|Upper respiratory tract infection|upper respiratory tract infection
5268218|NCT00551382|leukotriene|leukotriene
5268219|NCT00551382|Children|children
5268220|NCT00551369|stage I non-small cell lung cancer|stage i non-small cell lung cancer
5268221|NCT00551369|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
5268222|NCT00551369|adenocarcinoma of the lung|adenocarcinoma of the lung
5268223|NCT00551369|large cell lung cancer|large cell lung cancer
5268224|NCT00551369|squamous cell lung cancer|squamous cell lung cancer
5268225|NCT00551369|adenosquamous cell lung cancer|adenosquamous cell lung cancer
5268226|NCT00551356|Diabetes|diabetes
5268227|NCT00551356|Diabetic|diabetic
5268229|NCT00551356|Humalog|humalog
5268230|NCT00551356|Lantus|lantus
5268231|NCT00551356|Glargine|glargine
5268232|NCT00551356|Lispro|lispro
5268233|NCT00551330|Treatment Experienced|treatment experienced
5268234|NCT00551317|SB480848,|sb480848,
5268235|NCT00551317|Japanese healthy volunteers|japanese healthy volunteers
5268236|NCT00551317|darapladib,|darapladib,
5268237|NCT00551278|sentinel lymph node|sentinel lymph node
5268238|NCT00551278|metastasis|metastasis
5268239|NCT00551278|molecular pathology|molecular pathology
5268240|NCT00551239|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
5268241|NCT00551239|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
5268242|NCT00551239|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5268243|NCT00551239|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5268244|NCT00551239|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5268245|NCT00551239|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5268246|NCT00551239|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5268247|NCT00551239|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5268248|NCT00551239|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5268249|NCT00551239|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
5268250|NCT00551239|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
5268251|NCT00551239|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5268252|NCT00551239|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5268253|NCT00551239|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5268254|NCT00551239|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5268255|NCT00551239|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
5268256|NCT00551239|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
5268257|NCT00551239|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5268258|NCT00551239|stage I marginal zone lymphoma|stage i marginal zone lymphoma
5268259|NCT00551239|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5268260|NCT00551239|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5268261|NCT00551239|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
5268262|NCT00551239|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
5268263|NCT00551239|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5268264|NCT00551239|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
5268265|NCT00551239|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5268266|NCT00551239|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5268267|NCT00551239|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5268268|NCT00551239|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
5268269|NCT00551239|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
5268270|NCT00551239|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5268271|NCT00551239|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5268272|NCT00551226|TB|tb
5268273|NCT00551226|Patients with tuberculosis|patients with tuberculosis
5268274|NCT00551213|anti-IGF-1R|anti-igf-1r
5268275|NCT00551200|Buphenyl|buphenyl
5268276|NCT00551200|Sodium Phenylbutyrate|sodium phenylbutyrate
5268277|NCT00551200|Urea Cycle Disorder|urea cycle disorder
5268278|NCT00551200|UCD|ucd
5268279|NCT00551161|Alzheimer disease|alzheimer disease
5268280|NCT00551161|memantine|memantine
5268281|NCT00551161|cholinesterase inhibitors|cholinesterase inhibitors
5268282|NCT00551161|magnetic resonance spectroscopy|magnetic resonance spectroscopy
5268283|NCT00551161|N-acetylaspartate|n-acetylaspartate
5268284|NCT00551161|inositol|inositol
5268285|NCT00551161|cerebrospinal fluid|cerebrospinal fluid
5268286|NCT00551161|tau proteins|tau proteins
5268287|NCT00551161|amyloid beta-protein|amyloid beta-protein
5268288|NCT00551135|postoperative pain chronic pain|postoperative pain chronic pain
5268289|NCT00551122|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
5268290|NCT00551122|testicular seminoma|testicular seminoma
5268291|NCT00551122|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
5268292|NCT00551122|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
5268293|NCT00551122|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
5268294|NCT00551122|testicular choriocarcinoma and seminoma|testicular choriocarcinoma and seminoma
5268295|NCT00551122|testicular embryonal carcinoma and seminoma|testicular embryonal carcinoma and seminoma
5268296|NCT00551122|testicular embryonal carcinoma and teratoma with seminoma|testicular embryonal carcinoma and teratoma with seminoma
5268297|NCT00551122|testicular embryonal carcinoma and yolk sac tumor with seminoma|testicular embryonal carcinoma and yolk sac tumor with seminoma
5268298|NCT00551122|testicular yolk sac tumor and teratoma with seminoma|testicular yolk sac tumor and teratoma with seminoma
5268299|NCT00551122|recurrent extragonadal non-seminomatous germ cell tumor|recurrent extragonadal non-seminomatous germ cell tumor
5268300|NCT00551122|recurrent extragonadal seminoma|recurrent extragonadal seminoma
5268301|NCT00551122|stage IV extragonadal non-seminomatous germ cell tumor|stage iv extragonadal non-seminomatous germ cell tumor
5268302|NCT00551122|stage IV extragonadal seminoma|stage iv extragonadal seminoma
5268303|NCT00551122|recurrent extragonadal germ cell tumor|recurrent extragonadal germ cell tumor
5268304|NCT00551122|ovarian mixed germ cell tumor|ovarian mixed germ cell tumor
5268305|NCT00551122|adult central nervous system germ cell tumor|adult central nervous system germ cell tumor
5268306|NCT00551096|Advanced Solid Tumors|advanced solid tumors
5268307|NCT00551096|Biliary or Pancreatic Malignancies|biliary or pancreatic malignancies
5268308|NCT00551044|prostatic neoplasms|prostatic neoplasms
5268309|NCT00551044|bicalutamide|bicalutamide
5268310|NCT00551044|quality of life|quality of life
5268311|NCT00551044|osteoporosis|osteoporosis
5268312|NCT00551031|Influenza|influenza
5268313|NCT00551031|Orthomyxoviruses|orthomyxoviruses
5268314|NCT00551031|Myxovirus Infection|myxovirus infection
5268315|NCT00551031|Inactivated Split-virion influenza vaccine|inactivated split-virion influenza vaccine
5268316|NCT00551031|Elderly|elderly
5268317|NCT00551018|Treatment Naive|treatment naive
5268318|NCT00551005|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5268319|NCT00550992|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
5268320|NCT00550992|T-cell childhood acute lymphoblastic leukemia|t-cell childhood acute lymphoblastic leukemia
5268321|NCT00550992|acute undifferentiated leukemia|acute undifferentiated leukemia
5268322|NCT00550979|gestational diabetes mellitus|gestational diabetes mellitus
5268323|NCT00550979|cardiovascular disease risk|cardiovascular disease risk
5268324|NCT00550979|heart disease risk|heart disease risk
5268325|NCT00550966|Fibromyalgia|fibromyalgia
5268326|NCT00550966|Quality of life|quality of life
5268327|NCT00550966|Primary Care|primary care
5268328|NCT00550966|Non-pharmacological treatment|non-pharmacological treatment
5268329|NCT00550966|Cost / Cost-efficacy|cost / cost-efficacy
5268330|NCT00550940|epilepsy|epilepsy
5268331|NCT00550940|attention|attention
5268332|NCT00550940|emotion|emotion
5268333|NCT00550940|behavior problems|behavior problems
5268334|NCT00550940|child|child
5268335|NCT00550940|adolescent|adolescent
5268336|NCT00550927|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5268337|NCT00550914|Papilloma, Papillomatosis, Laser, Laser Surgery|papilloma, papillomatosis, laser, laser surgery
5268338|NCT00550901|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5268339|NCT00550888|uterus|uterus
5268340|NCT00550888|abdominal delivery|abdominal delivery
5268341|NCT00550888|suture techniques|suture techniques
5268342|NCT00550875|Allergic rhinoconjunctivitis,|allergic rhinoconjunctivitis,
5268343|NCT00550875|Immunotherapy|immunotherapy
5268344|NCT00550862|PBC, Primary Biliary Cirrhosis, Liver,|pbc, primary biliary cirrhosis, liver,
5268345|NCT00550836|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
5268346|NCT00550836|duct cell adenocarcinoma of the pancreas|duct cell adenocarcinoma of the pancreas
5268347|NCT00550836|stage IV pancreatic cancer|stage iv pancreatic cancer
5268348|NCT00550810|Sutent|sutent
5268349|NCT00550797|Steroid-naive, non-smokers|steroid-naive, non-smokers
5268350|NCT00550797|Mild to moderate allergic asthmatic adults|mild to moderate allergic asthmatic adults
5268351|NCT00550784|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5268352|NCT00550784|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5268353|NCT00550784|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5268354|NCT00550784|fallopian tube cancer|fallopian tube cancer
5268355|NCT00550784|peritoneal cavity cancer|peritoneal cavity cancer
5268356|NCT00550758|Methacholine challenge; Spirometry, Early childhood|methacholine challenge; spirometry, early childhood
5268357|NCT00550732|Triazoles|triazoles
5268358|NCT00550706|Prescription point prevalence|prescription point prevalence
5268359|NCT00550706|Drug utilization|drug utilization
5268360|NCT00550706|Define Daily Dose|define daily dose
5268361|NCT00550693|bloodstream infections|bloodstream infections
5268362|NCT00550693|hemodialysis catheter|hemodialysis catheter
5268363|NCT00550667|Attention-deficit hyperactivity disorder|attention-deficit hyperactivity disorder
5268364|NCT00550667|adult|adult
5268365|NCT00550667|diagnostic validity|diagnostic validity
5268366|NCT00550667|neuropsychological functions|neuropsychological functions
5268367|NCT00550667|social functioning|social functioning
5268947|NCT00547911|Entacapone|entacapone
5268368|NCT00550654|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5268369|NCT00550654|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
5268370|NCT00550654|recurrent melanoma|recurrent melanoma
5268371|NCT00550654|recurrent osteosarcoma|recurrent osteosarcoma
5268372|NCT00550654|recurrent renal cell cancer|recurrent renal cell cancer
5268373|NCT00550654|recurrent uterine sarcoma|recurrent uterine sarcoma
5268374|NCT00550654|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
5268375|NCT00550654|stage IV melanoma|stage iv melanoma
5268376|NCT00550654|stage IV uterine sarcoma|stage iv uterine sarcoma
5268377|NCT00550654|ovarian sarcoma|ovarian sarcoma
5268378|NCT00550654|chondrosarcoma|chondrosarcoma
5268379|NCT00550654|metastatic osteosarcoma|metastatic osteosarcoma
5268380|NCT00550654|stage IV renal cell cancer|stage iv renal cell cancer
5268381|NCT00550654|lung metastases|lung metastases
5268382|NCT00550654|liver metastases|liver metastases
5268383|NCT00550654|bone metastases|bone metastases
5268384|NCT00550641|fibromyalgia|fibromyalgia
5268385|NCT00550641|pool-based exercise|pool-based exercise
5268386|NCT00550628|neoplasm of uncertain malignant potential|neoplasm of uncertain malignant potential
5268387|NCT00550628|colon cancer|colon cancer
5268388|NCT00550615|Non-Hodgkins Lymphoma|non-hodgkins lymphoma
5268389|NCT00550615|Relapsed Non Hodgkins Lymphoma|relapsed non hodgkins lymphoma
5268390|NCT00550615|Refractory Non Hodgkins Lymphoma|refractory non hodgkins lymphoma
5268391|NCT00550615|Dasatinib|dasatinib
5268392|NCT00550602|Tracheomalacia|tracheomalacia
5268393|NCT00550602|Tracheobronchomalacia|tracheobronchomalacia
5268394|NCT00550602|Airway Stabilization|airway stabilization
5268395|NCT00550602|Bronchoscopy|bronchoscopy
5268396|NCT00550602|Stent Placement|stent placement
5268397|NCT00550602|Tracheobronchoplasty|tracheobronchoplasty
5268398|NCT00550602|COPD|copd
5268399|NCT00550589|high-grade squamous intraepithelial lesion|high-grade squamous intraepithelial lesion
5268400|NCT00550589|stage 0 anal cancer|stage 0 anal cancer
5268401|NCT00550576|Digoxin Antibodies|digoxin antibodies
5268402|NCT00550576|Bipolar Disorder|bipolar disorder
5268403|NCT00550563|recurrent colon cancer|recurrent colon cancer
5268404|NCT00550563|stage I colon cancer|stage i colon cancer
5268405|NCT00550563|stage II colon cancer|stage ii colon cancer
5268406|NCT00550563|stage III colon cancer|stage iii colon cancer
5268407|NCT00550563|stage IV colon cancer|stage iv colon cancer
5268408|NCT00550563|recurrent rectal cancer|recurrent rectal cancer
5268409|NCT00550563|stage I rectal cancer|stage i rectal cancer
5268410|NCT00550563|stage II rectal cancer|stage ii rectal cancer
5268411|NCT00550563|stage III rectal cancer|stage iii rectal cancer
5268412|NCT00550563|stage IV rectal cancer|stage iv rectal cancer
5268413|NCT00550550|rhinoconjunctivitis|rhinoconjunctivitis
5268414|NCT00550550|rhinitis|rhinitis
5268415|NCT00550550|conjunctivitis|conjunctivitis
5268416|NCT00550550|allergy|allergy
5268417|NCT00550550|allergen|allergen
5268418|NCT00550550|immunotherapy|immunotherapy
5268419|NCT00550537|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5268420|NCT00550537|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5268421|NCT00550537|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5268422|NCT00550537|squamous cell lung cancer|squamous cell lung cancer
5268423|NCT00550537|adenosquamous cell lung cancer|adenosquamous cell lung cancer
5268424|NCT00550537|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
5268425|NCT00550537|large cell lung cancer|large cell lung cancer
5268426|NCT00550537|adenocarcinoma of the lung|adenocarcinoma of the lung
5268427|NCT00550524|Knee osteoarthritis|knee osteoarthritis
5268428|NCT00550511|Abdominal pain|abdominal pain
5268429|NCT00550511|ultrasound|ultrasound
5268430|NCT00550511|surgery|surgery
5268431|NCT00550511|emergency department|emergency department
5268432|NCT00550511|diagnostic accuracy|diagnostic accuracy
5268433|NCT00550498|Retinal Vasculitis|retinal vasculitis
5268434|NCT00550498|Retinal Edema|retinal edema
5268435|NCT00550498|Behcet's Disease|behcet's disease
5268436|NCT00550472|probiotics|probiotics
5268437|NCT00550472|atopic dermatitis|atopic dermatitis
5268438|NCT00550472|immune system|immune system
5268439|NCT00550472|human|human
5268440|NCT00550472|Lactobacillus|lactobacillus
5268441|NCT00550472|Bifidobacterium|bifidobacterium
5268442|NCT00550472|healthy subjects|healthy subjects
5268443|NCT00550459|Hyponatremia|hyponatremia
5268444|NCT00550459|Cognitive|cognitive
5268445|NCT00550459|Neurological Function|neurological function
5268446|NCT00550459|Elderly|elderly
5268447|NCT00550446|Janus Kinase 3 Clinical Trial|janus kinase 3 clinical trial
5268448|NCT00550420|open-label extension|open-label extension
5268449|NCT00550420|tolerability|tolerability
5268450|NCT00550420|Alzheimer's disease|alzheimer's disease
5268451|NCT00550420|Rosiglitazone extended-release (XR)|rosiglitazone extended-release (xr)
5268452|NCT00550420|safety|safety
5268453|NCT00550420|cognition|cognition
5268454|NCT00550420|BRL-049653|brl-049653
5268455|NCT00550407|Lamotrigine|lamotrigine
5268456|NCT00550407|Prevention of relapse or recurrence of a mood episode|prevention of relapse or recurrence of a mood episode
5268457|NCT00550407|Bipolar I disorder|bipolar i disorder
5268458|NCT00550394|Adolescents|adolescents
5268459|NCT00550381|healthy subjects|healthy subjects
5268460|NCT00550342|Focal segmental glomerulosclerosis|focal segmental glomerulosclerosis
5268461|NCT00550342|FSGS|fsgs
5268462|NCT00550342|Proteinuria|proteinuria
5268463|NCT00550342|rituximab|rituximab
5268464|NCT00550342|B cell|b cell
5268465|NCT00550342|autoimmune|autoimmune
5268466|NCT00550342|CD20|cd20
5268467|NCT00550342|treatment|treatment
5268468|NCT00550342|children|children
5268469|NCT00550290|vulvectomy|vulvectomy
5268470|NCT00550290|wound infection|wound infection
5268471|NCT00550290|wound complication|wound complication
5268472|NCT00550290|prophylactic antibiotic|prophylactic antibiotic
5268473|NCT00550290|Post-operative wound complications following vulvectomy|post-operative wound complications following vulvectomy
5268474|NCT00550277|Renal Cell Carcinoma|renal cell carcinoma
5268475|NCT00550277|Refractory|refractory
5268476|NCT00550277|LBH589|lbh589
5268477|NCT00550264|Hospital Readmission|hospital readmission
5268478|NCT00550264|Continuity of Care|continuity of care
5268479|NCT00550264|Quality of Health Care|quality of health care
5268480|NCT00550251|Nausea|nausea
5268481|NCT00550251|Vomiting|vomiting
5268482|NCT00550251|Emesis|emesis
5268483|NCT00550251|Palliative|palliative
5268484|NCT00550251|Terminal|terminal
5268485|NCT00550251|Cancer|cancer
5268486|NCT00550238|Parkinson's Disease Psychosis|parkinson's disease psychosis
5268487|NCT00550225|succinate|succinate
5268488|NCT00550225|anti-muscarinic|anti-muscarinic
5268489|NCT00550225|b-agonist|b-agonist
5268490|NCT00550212|healthy subjects|healthy subjects
5268491|NCT00550199|Solid Tumors|solid tumors
5268492|NCT00550199|Phase I|phase i
5268493|NCT00550199|LBH589|lbh589
5268494|NCT00550199|Gemcitabine|gemcitabine
5268495|NCT00550186|spinal anesthesia|spinal anesthesia
5268496|NCT00550186|preload|preload
5268497|NCT00550186|diuresis|diuresis
5268498|NCT00550186|bladder retention|bladder retention
5268499|NCT00550147|ADHD-Combined TypeDisruptive behavior Disorder|adhd-combined typedisruptive behavior disorder
5268500|NCT00550134|Breast Cancer|breast cancer
5268501|NCT00550134|Quality of life|quality of life
5268502|NCT00550108|pancreatic cyst|pancreatic cyst
5268503|NCT00550108|ethanol injection|ethanol injection
5268504|NCT00550095|Microalbuminuria/proteinuria|microalbuminuria/proteinuria
5268505|NCT00550095|hypertensive patients with type 2 diabetes|hypertensive patients with type 2 diabetes
5268506|NCT00550095|Valsartan|valsartan
5268507|NCT00550095|microalbuminuria/proteinuria in hypertensive patients with type 2 diabetes|microalbuminuria/proteinuria in hypertensive patients with type 2 diabetes
5268508|NCT00550082|Anticoagulation|anticoagulation
5268509|NCT00550082|High-Risk|high-risk
5268510|NCT00550082|Deep Vein Thrombosis|deep vein thrombosis
5268511|NCT00550082|Pulmonary Embolism|pulmonary embolism
5268512|NCT00550082|Surgery|surgery
5268513|NCT00550069|late preterm infants|late preterm infants
5268514|NCT00550069|near term infants|near term infants
5268515|NCT00550069|outcome|outcome
5268516|NCT00550056|PTSD, Posttraumatic Stress Disorder, refugees, war|ptsd, posttraumatic stress disorder, refugees, war
5268517|NCT00550043|Rheumatoid arthritis|rheumatoid arthritis
5268518|NCT00550030|Psoriasis|psoriasis
5268519|NCT00550030|UVB radiation|uvb radiation
5268520|NCT00550030|Biologics|biologics
5268521|NCT00550030|Etanercept|etanercept
5268522|NCT00550030|PASI|pasi
5268523|NCT00550004|Unresectable|unresectable
5268524|NCT00550004|locally advanced|locally advanced
5268525|NCT00550004|metastatic pancreatic adenocarcinoma|metastatic pancreatic adenocarcinoma
5268526|NCT00550004|Stage III|stage iii
5268527|NCT00550004|Stage IV|stage iv
5268528|NCT00549991|High Blood Pressure|high blood pressure
5268529|NCT00549978|Safety and Pharmacokinetics in healthy subjects|safety and pharmacokinetics in healthy subjects
5268530|NCT00549939|child|child
5268531|NCT00549939|bladder|bladder
5268532|NCT00549939|neuropathic|neuropathic
5268533|NCT00549939|alpha blockers|alpha blockers
5268534|NCT00549913|adjacent vertebral levels between L1 and S1|adjacent vertebral levels between l1 and s1
5268535|NCT00549900|HPV vaccine,|hpv vaccine,
5268536|NCT00549900|Cervical cancer|cervical cancer
5268537|NCT00549900|Human papillomavirus infection,|human papillomavirus infection,
5268538|NCT00549874|insulin resistance|insulin resistance
5268539|NCT00549874|type 2 diabetes|type 2 diabetes
5268540|NCT00549874|myocardial perfusion|myocardial perfusion
5268541|NCT00549874|nitrosative stress|nitrosative stress
5268542|NCT00549874|thiazolidinediones|thiazolidinediones
5268543|NCT00549861|Cardiac Magnetic Resonance Imaging|cardiac magnetic resonance imaging
5268544|NCT00549861|Contrast agents|contrast agents
5268545|NCT00549861|Gadobutrol|gadobutrol
5268546|NCT00549861|Fibrosis|fibrosis
5268547|NCT00549861|Prognosis|prognosis
5268548|NCT00549861|Magnetic Resonance|magnetic resonance
5268549|NCT00549861|Gadolinium|gadolinium
5268550|NCT00549848|Leukemia|leukemia
5268551|NCT00549835|mucositis pain|mucositis pain
5268552|NCT00549835|cancer|cancer
5268553|NCT00549835|pain|pain
5268554|NCT00549835|acupuncture|acupuncture
5268555|NCT00549835|mucositis|mucositis
5268556|NCT00549835|cancer pain|cancer pain
5268557|NCT00549822|aromatase inhibitor|aromatase inhibitor
5268558|NCT00549822|CA 15-3|ca 15-3
5268559|NCT00549822|Hormone receptor positive|hormone receptor positive
5268948|NCT00547911|Carbidopa|carbidopa
5268560|NCT00549809|mechanical ventilation; respiratory failure|mechanical ventilation; respiratory failure
5268561|NCT00549796|coronary artery disease|coronary artery disease
5268562|NCT00549796|angioplasty|angioplasty
5268563|NCT00549796|stent|stent
5268564|NCT00549796|percutaneous coronary intervention|percutaneous coronary intervention
5268565|NCT00549796|on-site cardiac surgery|on-site cardiac surgery
5268566|NCT00549796|randomized trial|randomized trial
5268567|NCT00549770|Hypertension, valsartan, LCZ696|hypertension, valsartan, lcz696
5268568|NCT00549757|Type 2 diabetes mellitus|type 2 diabetes mellitus
5268569|NCT00549757|renal morbidity and mortality|renal morbidity and mortality
5268570|NCT00549757|cardiovascular disease|cardiovascular disease
5268571|NCT00549757|micro-albuminuria|micro-albuminuria
5268572|NCT00549757|macro-albuminuria|macro-albuminuria
5268573|NCT00549757|RAAS|raas
5268574|NCT00549757|renin inhibitor|renin inhibitor
5268575|NCT00549757|Reduced estimated glomerular filtration rate|reduced estimated glomerular filtration rate
5268576|NCT00549744|ASTHMA|asthma
5268577|NCT00549744|CLINICAL ENDPOINT,|clinical endpoint,
5268578|NCT00549731|autism|autism
5268579|NCT00549731|autistic|autistic
5268580|NCT00549731|language|language
5268581|NCT00549731|development|development
5268582|NCT00549731|developmental|developmental
5268583|NCT00549731|assessment|assessment
5268584|NCT00549718|Schizophrenia|schizophrenia
5268585|NCT00549718|SM-13496|sm-13496
5268586|NCT00549718|Latuda|latuda
5268587|NCT00549718|Lurasidone|lurasidone
5268588|NCT00549705|Anticoagulation|anticoagulation
5268589|NCT00549705|Thrombosis|thrombosis
5268590|NCT00549705|Bleeding|bleeding
5268591|NCT00549705|Clotting|clotting
5268592|NCT00549705|Pulmonary Embolism|pulmonary embolism
5268593|NCT00549705|Deep Vein Thrombosis|deep vein thrombosis
5268594|NCT00549679|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
5268595|NCT00549679|COPD|copd
5268596|NCT00549679|Repeat Dose|repeat dose
5268597|NCT00549679|GSK256066|gsk256066
5268598|NCT00549666|OC DDI|oc ddi
5268599|NCT00549666|lurasidone|lurasidone
5268600|NCT00549666|Latuda|latuda
5268601|NCT00549666|schizophenia|schizophenia
5268602|NCT00549653|GW856553,|gw856553,
5268603|NCT00549653|drug-drug interactions,|drug-drug interactions,
5268604|NCT00549653|rosuvastatin|rosuvastatin
5268605|NCT00549640|nicotine dependence|nicotine dependence
5268606|NCT00549640|tobacco dependence|tobacco dependence
5268607|NCT00549614|heart failure|heart failure
5268608|NCT00549601|Alzheimer's|alzheimer's
5268609|NCT00549601|rivastigmine|rivastigmine
5268610|NCT00549601|transdermal|transdermal
5268611|NCT00549601|safety|safety
5268612|NCT00549601|randomized|randomized
5268613|NCT00549601|switch|switch
5268614|NCT00549601|patch|patch
5268615|NCT00549588|Polymorphic light eruption|polymorphic light eruption
5268616|NCT00549588|UV radiation|uv radiation
5268617|NCT00549588|photoprotection|photoprotection
5268618|NCT00549588|sunscreen|sunscreen
5268619|NCT00549588|DNA repair enzymes|dna repair enzymes
5268620|NCT00549588|after-sun-lotion|after-sun-lotion
5268621|NCT00549575|Severe Intra uterine growth retardation below the third centile with abnormal uterine doppler|severe intra uterine growth retardation below the third centile with abnormal uterine doppler
5268622|NCT00549575|Severe growth retardation with pathologic uterine Doppler|severe growth retardation with pathologic uterine doppler
5268623|NCT00549575|L-Arginine|l-arginine
5268624|NCT00549575|Nitric Oxide Donor|nitric oxide donor
5268625|NCT00549562|Autistic Disorder|autistic disorder
5268626|NCT00549536|calcium supplementation|calcium supplementation
5268627|NCT00549536|intracellular ions|intracellular ions
5268628|NCT00549536|sodium/hydrogen exchange activity|sodium/hydrogen exchange activity
5268629|NCT00549523|HIV|hiv
5268630|NCT00549523|Alternative Medicine|alternative medicine
5268631|NCT00549523|Complementary Medicine|complementary medicine
5268632|NCT00549510|COREG CR,|coreg cr,
5268633|NCT00549510|lisinopril,|lisinopril,
5268634|NCT00549510|hypertension,|hypertension,
5268635|NCT00549510|dose proportionality,|dose proportionality,
5268636|NCT00549510|fixed dose combination (FDC)|fixed dose combination (fdc)
5268637|NCT00549497|GW870086X, inhaled, asthma, cortisol, pharmacokinetics, osteocalcin|gw870086x, inhaled, asthma, cortisol, pharmacokinetics, osteocalcin
5268638|NCT00549484|Thrombocytopenia|thrombocytopenia
5268639|NCT00549484|Thrombopoietin|thrombopoietin
5268640|NCT00549484|Platelet Transfusion|platelet transfusion
5268641|NCT00549484|Platelet Factor 4|platelet factor 4
5268642|NCT00549471|children with cerebral palsy ages eight to eleven.|children with cerebral palsy ages eight to eleven.
5268643|NCT00549458|Week pelvic floor muscle in females|week pelvic floor muscle in females
5268644|NCT00549445|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5268645|NCT00549445|COPD|copd
5268646|NCT00549445|Exacerbation|exacerbation
5268647|NCT00549445|Macrolide|macrolide
5268648|NCT00549406|Vision|vision
5268649|NCT00549406|Visual attention|visual attention
5268650|NCT00549406|Postural balance|postural balance
5268651|NCT00549406|Geriatrics|geriatrics
5268652|NCT00549393|intensive care unit|intensive care unit
5268653|NCT00549393|Healthcare associated infections (HAI)|healthcare associated infections (hai)
5268654|NCT00549393|pediatric|pediatric
5268755|NCT00548834|Certolizumab Pegol|certolizumab pegol
5268655|NCT00549380|Aneurysmal Disease in Thorax, Abdominal or Extremity|aneurysmal disease in thorax, abdominal or extremity
5268656|NCT00549367|Nutritional status|nutritional status
5268657|NCT00549367|Nutrition counselling|nutrition counselling
5268658|NCT00549367|Nutrition assessment|nutrition assessment
5268659|NCT00549367|HIV|hiv
5268660|NCT00549367|Alternative Medicine|alternative medicine
5268661|NCT00549367|Complementary Medicine|complementary medicine
5268662|NCT00549354|Abdominal Infrarenal Aortic|abdominal infrarenal aortic
5268663|NCT00549354|Aorto-Iliac Aneurysms|aorto-iliac aneurysms
5268664|NCT00549341|Torticollis|torticollis
5268665|NCT00549341|Cervical Dystonia|cervical dystonia
5268666|NCT00549328|anti-angiogenesis|anti-angiogenesis
5268667|NCT00549328|Non-small cell lung cancer,|non-small cell lung cancer,
5268668|NCT00549328|pazopanib (GW786034)|pazopanib (gw786034)
5268669|NCT00549263|Safety|safety
5268670|NCT00549263|Pharmacokinetics|pharmacokinetics
5268671|NCT00549263|Bioequivalence|bioequivalence
5268672|NCT00549250|Human papillomavirus 6/11|human papillomavirus 6/11
5268673|NCT00549250|Neonates|neonates
5268674|NCT00549250|Human papillomavirus 6 or 11 infection|human papillomavirus 6 or 11 infection
5268675|NCT00549237|RYGBP|rygbp
5268676|NCT00549237|Early nutrition|early nutrition
5268677|NCT00549237|Lean body mass|lean body mass
5268678|NCT00549237|Length of stay|length of stay
5268679|NCT00549237|Body Composition|body composition
5268680|NCT00549211|Healthy Subjects,|healthy subjects,
5268681|NCT00549211|Safety,|safety,
5268682|NCT00549211|Tolerability,|tolerability,
5268683|NCT00549211|Pharmacokinetics|pharmacokinetics
5268684|NCT00549198|tenofovir|tenofovir
5268685|NCT00549198|HIV|hiv
5268686|NCT00549198|efavirenz|efavirenz
5268687|NCT00549198|naive|naive
5268688|NCT00549198|lamivudine|lamivudine
5268689|NCT00549198|abacavir|abacavir
5268690|NCT00549198|emtricitabine|emtricitabine
5268691|NCT00549198|renal|renal
5268692|NCT00549172|Osteoarthritis, Knee|osteoarthritis, knee
5268693|NCT00549172|Arthroscopic Surgery|arthroscopic surgery
5268694|NCT00549172|Menisci, Medial|menisci, medial
5268695|NCT00549172|Placebo Effect|placebo effect
5268696|NCT00549172|Treatment Efficacy|treatment efficacy
5268697|NCT00549159|menorrhagia|menorrhagia
5268698|NCT00549159|dysfunctional uterine bleeding|dysfunctional uterine bleeding
5268699|NCT00549159|endometrial ablation|endometrial ablation
5268700|NCT00549146|reversibility|reversibility
5268701|NCT00549146|COPD|copd
5268702|NCT00549146|lung function|lung function
5268703|NCT00549133|Microalbuminaria in hypertensive patients with type II diabetes mellitus|microalbuminaria in hypertensive patients with type ii diabetes mellitus
5268704|NCT00549120|Healthy Subjects|healthy subjects
5268705|NCT00549120|muscarinic receptor antagonist|muscarinic receptor antagonist
5268706|NCT00549120|propranolol|propranolol
5268707|NCT00549120|beta-blocker|beta-blocker
5268708|NCT00549120|beta-agonist|beta-agonist
5268709|NCT00549107|low cardiac output syndrome|low cardiac output syndrome
5268710|NCT00549107|open heart surgery|open heart surgery
5268711|NCT00549107|infants|infants
5268712|NCT00549107|Low cardiac output syndrome in infants undergoing corrective open heart surgery|low cardiac output syndrome in infants undergoing corrective open heart surgery
5268713|NCT00549081|DHEA|dhea
5268715|NCT00549081|low ovarian response|low ovarian response
5268716|NCT00549055|Macugen Age-related macular degeneration (AMD) Observational study|macugen age-related macular degeneration (amd) observational study
5268717|NCT00549042|Back Pain|back pain
5268718|NCT00549042|Chronic Low Back Pain|chronic low back pain
5268719|NCT00549042|Chronic Back Pain|chronic back pain
5268720|NCT00549042|Pain|pain
5268721|NCT00549042|Chronic Pain|chronic pain
5268722|NCT00549029|muscle disorder|muscle disorder
5268723|NCT00549029|statins|statins
5268724|NCT00549029|creatine kinase|creatine kinase
5268725|NCT00549016|Aneurysm Exclusion|aneurysm exclusion
5268726|NCT00548977|spermatogenesis defect|spermatogenesis defect
5268727|NCT00548977|male infertility|male infertility
5268728|NCT00548977|azoospermia|azoospermia
5268729|NCT00548977|oligozoospermia|oligozoospermia
5268730|NCT00548977|Y chromosome markers|y chromosome markers
5268731|NCT00548977|estrogen gene|estrogen gene
5268732|NCT00548964|Ketamine|ketamine
5268733|NCT00548964|glutamate|glutamate
5268734|NCT00548964|N-methyl-D-aspartate|n-methyl-d-aspartate
5268735|NCT00548964|treatment resistant|treatment resistant
5268736|NCT00548964|major depressive disorder|major depressive disorder
5268737|NCT00548964|lithium|lithium
5268738|NCT00548951|Dementia|dementia
5268739|NCT00548938|Brain Tumor|brain tumor
5268740|NCT00548938|GBM|gbm
5268741|NCT00548938|Glioblastoma Multiforme|glioblastoma multiforme
5268742|NCT00548938|Giladel|giladel
5268743|NCT00548938|Temozolomide|temozolomide
5268744|NCT00548912|Kidney Failure, Chronic|kidney failure, chronic
5268745|NCT00548912|Hemodialysis|hemodialysis
5268746|NCT00548912|Spironolactone|spironolactone
5268747|NCT00548899|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
5268748|NCT00548899|Targeted therapy|targeted therapy
5268749|NCT00548886|QT Prolongation|qt prolongation
5268750|NCT00548886|QT Interval|qt interval
5268751|NCT00548886|Epinephrine|epinephrine
5268752|NCT00548886|Stress test|stress test
5268753|NCT00548847|Leukemia|leukemia
5268754|NCT00548834|CDP870|cdp870
5268756|NCT00548795|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
5268757|NCT00548795|ARDS|ards
5268758|NCT00548795|Neutrophil|neutrophil
5268759|NCT00548769|PK,|pk,
5268760|NCT00548769|SB-683699,|sb-683699,
5268761|NCT00548769|multiple sclerosis|multiple sclerosis
5268762|NCT00548769|firategrast,|firategrast,
5268763|NCT00548769|surface area,|surface area,
5268764|NCT00548756|Brain Cancer|brain cancer
5268765|NCT00548756|Whole Brain Radiation Therapy|whole brain radiation therapy
5268766|NCT00548756|Quality of Life|quality of life
5268767|NCT00548756|QOL|qol
5268768|NCT00548756|Questionnaire|questionnaire
5268769|NCT00548756|Survey|survey
5268770|NCT00548756|WBRT|wbrt
5268771|NCT00548743|Depression|depression
5268772|NCT00548743|Postpartum|postpartum
5268773|NCT00548743|Dyad satisfaction|dyad satisfaction
5268774|NCT00548743|Parenting comfort|parenting comfort
5268775|NCT00548743|Screening|screening
5268776|NCT00548743|Management|management
5268777|NCT00548743|Follow up|follow up
5268778|NCT00548743|Primary care|primary care
5268779|NCT00548743|Practice based research|practice based research
5268780|NCT00548730|Bronchoscopy|bronchoscopy
5268781|NCT00548730|Endoscopy|endoscopy
5268782|NCT00548730|Image Enhancement|image enhancement
5268783|NCT00548730|Autofluorescence|autofluorescence
5268784|NCT00548730|Narrow Band Image|narrow band image
5268785|NCT00548717|GVHD|gvhd
5268786|NCT00548717|Stem cell transplantation|stem cell transplantation
5268787|NCT00548717|Sirolimus|sirolimus
5268788|NCT00548704|Extravasation|extravasation
5268789|NCT00548704|Anthracyclines|anthracyclines
5268790|NCT00548678|diclofenac, platelet aggregation, ketorolac, aspirin|diclofenac, platelet aggregation, ketorolac, aspirin
5268791|NCT00548665|Atherosclerosis|atherosclerosis
5268792|NCT00548665|Smoking cessation|smoking cessation
5268793|NCT00548665|Diagnostic techniques, cardiovascular|diagnostic techniques, cardiovascular
5268794|NCT00548665|Ultrasonography|ultrasonography
5268795|NCT00548665|Health behavior|health behavior
5268796|NCT00548652|apathy|apathy
5268797|NCT00548652|obesity|obesity
5268798|NCT00548652|methylphenidate|methylphenidate
5268799|NCT00548652|MOVE|move
5268800|NCT00548652|medical crisis counselling|medical crisis counselling
5268801|NCT00548626|Pancreatic Cancer|pancreatic cancer
5268802|NCT00548626|Endoscopic Ultrasonography|endoscopic ultrasonography
5268803|NCT00548626|Fine-Needle Aspiration|fine-needle aspiration
5268804|NCT00548626|Cytopathology|cytopathology
5268805|NCT00548613|Myocardial Infarction|myocardial infarction
5268806|NCT00548613|Heart Attack|heart attack
5268807|NCT00548613|Coronary Artery Bypass Grafting|coronary artery bypass grafting
5268808|NCT00548600|Prostate Cancer|prostate cancer
5268809|NCT00548600|Iridium|iridium
5268810|NCT00548600|Implant|implant
5268811|NCT00548600|Radiotherapy|radiotherapy
5268812|NCT00548587|Acute Coronary Syndrome|acute coronary syndrome
5268813|NCT00548561|extravasation|extravasation
5268814|NCT00548561|anthracyclines|anthracyclines
5268815|NCT00548548|Avastin|avastin
5268816|NCT00548548|Metastatic Adenocarcinoma|metastatic adenocarcinoma
5268817|NCT00548548|AVAGAST|avagast
5268818|NCT00548522|Type 1 Diabetes|type 1 diabetes
5268819|NCT00548522|Pregnancy|pregnancy
5268820|NCT00548522|Islet Mass|islet mass
5268821|NCT00548522|C-peptide|c-peptide
5268822|NCT00548496|fractured wrist|fractured wrist
5268823|NCT00548496|Distal radial fracture,|distal radial fracture,
5268824|NCT00548483|Endotracheal intubation|endotracheal intubation
5268825|NCT00548483|Laryngeal edema|laryngeal edema
5268826|NCT00548483|Cuff-leak test|cuff-leak test
5268827|NCT00548483|Corticosteroids|corticosteroids
5268828|NCT00548483|This study was to ascertain whether administration of dexamethasone to critically intubated patients prevent postextubation airway obstruction.|this study was to ascertain whether administration of dexamethasone to critically intubated patients prevent postextubation airway obstruction.
5268829|NCT00548483|This study was to compare high dose and low dose dexamethasone in preventing noninvasive ventilation or reintubation among critically ill intubated patients|this study was to compare high dose and low dose dexamethasone in preventing noninvasive ventilation or reintubation among critically ill intubated patients
5268830|NCT00548470|schizophrenia|schizophrenia
5268831|NCT00548470|varenicline|varenicline
5268832|NCT00548470|cognition|cognition
5268833|NCT00548470|cigarette smoking|cigarette smoking
5268834|NCT00548457|the function of the endothelium of the arteries in patients suffering from ectatic coronary arteries|the function of the endothelium of the arteries in patients suffering from ectatic coronary arteries
5268835|NCT00548444|Tuberculosis|tuberculosis
5268836|NCT00548444|Lymphocyte kinetics|lymphocyte kinetics
5268837|NCT00548444|MVA85A|mva85a
5268838|NCT00548444|Deuterium|deuterium
5268839|NCT00548431|Leukemia, Lymphocytic, Acute [C04.557.337.428.511]|leukemia, lymphocytic, acute [c04.557.337.428.511]
5268840|NCT00548431|6-mercaptopurine|6-mercaptopurine
5268841|NCT00548431|methotrexate|methotrexate
5268842|NCT00548431|asparaginase|asparaginase
5268843|NCT00548405|Multiple Sclerosis|multiple sclerosis
5268844|NCT00548392|breast|breast
5268845|NCT00548392|cancer|cancer
5268846|NCT00548392|ultrasound|ultrasound
5268847|NCT00548392|high risk|high risk
5268848|NCT00548392|marker clip|marker clip
5268849|NCT00548379|vitamin D|vitamin d
5268850|NCT00548379|pneumonia|pneumonia
5268852|NCT00548366|portal hypertension|portal hypertension
5268853|NCT00548366|ascites|ascites
5268854|NCT00548366|sodium restriction|sodium restriction
5268855|NCT00548327|Genes|genes
5268856|NCT00548327|Dorsolateral Prefrontal Cortex|dorsolateral prefrontal cortex
5268857|NCT00548327|Dopamine|dopamine
5268858|NCT00548327|Functional Magnetic Resonance Imaging|functional magnetic resonance imaging
5268859|NCT00548327|Neuropsychological Testing|neuropsychological testing
5268860|NCT00548327|Schizophrenia|schizophrenia
5268861|NCT00548327|Atomoxetine|atomoxetine
5268862|NCT00548327|Cognitive Study|cognitive study
5268863|NCT00548327|Pharmacogenetics|pharmacogenetics
5268864|NCT00548327|Normal Volunteers|normal volunteers
5268865|NCT00548327|Catechol-O-Methyltransferase|catechol-o-methyltransferase
5268866|NCT00548327|Healthy Volunteer|healthy volunteer
5268867|NCT00548314|Matriderm|matriderm
5268868|NCT00548314|Dermal matrix|dermal matrix
5268869|NCT00548314|VAC therapy|vac therapy
5268870|NCT00548314|Split skin graft|split skin graft
5268871|NCT00548314|Burns|burns
5268872|NCT00548314|Scar quality|scar quality
5268873|NCT00548275|Buprenorphine|buprenorphine
5268874|NCT00548275|Drug counseling|drug counseling
5268875|NCT00548275|HIV risk reduction counseling|hiv risk reduction counseling
5268876|NCT00548275|HIV Seronegativity|hiv seronegativity
5268877|NCT00548275|HIV risk behaviors|hiv risk behaviors
5268878|NCT00548262|Open-label|open-label
5268879|NCT00548262|non-comparative study to evaluate short course of IV anidulafungin|non-comparative study to evaluate short course of iv anidulafungin
5268880|NCT00548262|followed by oral voriconazole|followed by oral voriconazole
5268881|NCT00548262|for tx of candidemia/invasive candidiasis.|for tx of candidemia/invasive candidiasis.
5268882|NCT00548249|Subjects with ESRD receiving chronic Hemodialysis|subjects with esrd receiving chronic hemodialysis
5268883|NCT00548236|exercise intervention|exercise intervention
5268884|NCT00548236|AACT|aact
5268885|NCT00548223|recurrence of stroke|recurrence of stroke
5268886|NCT00548223|Dengzhan Shengmai Capsule|dengzhan shengmai capsule
5268887|NCT00548223|Traditional Chinese Medicine|traditional chinese medicine
5268888|NCT00548210|Hypertrophy|hypertrophy
5268889|NCT00548210|scarring|scarring
5268890|NCT00548210|scar treatment|scar treatment
5268891|NCT00548210|silicone|silicone
5268892|NCT00548197|Intravitreal Bevacizumab injection|intravitreal bevacizumab injection
5268893|NCT00548197|Pars plana vitrectomy|pars plana vitrectomy
5268894|NCT00548197|tractional retinal detachment|tractional retinal detachment
5268895|NCT00548197|Diabetic retinopathy|diabetic retinopathy
5268896|NCT00548184|primary breast cancers|primary breast cancers
5268897|NCT00548184|Locally advanced breast cancers|locally advanced breast cancers
5268898|NCT00548158|diabetes|diabetes
5268899|NCT00548145|Pitavastatin|pitavastatin
5268900|NCT00548145|Statins|statins
5268901|NCT00548145|Donepezil|donepezil
5268902|NCT00548145|Alzheimer's Disease|alzheimer's disease
5268903|NCT00548145|Hypercholesterolemia|hypercholesterolemia
5268904|NCT00548145|ADAS-Jcog|adas-jcog
5268905|NCT00548145|Alzheimer Disease (MMSE 15-23 and CDR1 or 2)|alzheimer disease (mmse 15-23 and cdr1 or 2)
5268906|NCT00548106|infant formula, milk allergy, hydrolized whey|infant formula, milk allergy, hydrolized whey
5268907|NCT00548093|non-small cell lung cancer|non-small cell lung cancer
5268908|NCT00548093|advanced|advanced
5268909|NCT00548093|previously treated|previously treated
5268910|NCT00548067|High blood pressure, hypertension, drug interaction, steady state, valsartan, hydrochlorothiazide, amlodipine|high blood pressure, hypertension, drug interaction, steady state, valsartan, hydrochlorothiazide, amlodipine
5268911|NCT00548054|cholera|cholera
5268912|NCT00548054|vaccine|vaccine
5268913|NCT00548054|Kolkata|kolkata
5268914|NCT00548054|West Bengal|west bengal
5268915|NCT00548054|India|india
5268916|NCT00548054|immunogenicity|immunogenicity
5268917|NCT00548054|safety|safety
5268918|NCT00548054|infants|infants
5268919|NCT00548054|expanded programme on immunization|expanded programme on immunization
5268920|NCT00548041|HIV|hiv
5268921|NCT00548041|Emergency Department|emergency department
5268922|NCT00548041|HIV Seronegativity|hiv seronegativity
5268923|NCT00548002|Staphylococcus aureus|staphylococcus aureus
5268924|NCT00548002|bacteremia|bacteremia
5268925|NCT00548002|endocarditis|endocarditis
5268926|NCT00548002|sepsis|sepsis
5268927|NCT00548002|fluoroquinolone|fluoroquinolone
5268928|NCT00548002|rifampin|rifampin
5268929|NCT00548002|levofloxacin|levofloxacin
5268930|NCT00548002|trovafloxacin|trovafloxacin
5268931|NCT00547989|ASA class I and II|asa class i and ii
5268932|NCT00547976|Inflammation|inflammation
5268933|NCT00547976|Unstable Plaque|unstable plaque
5268934|NCT00547976|Macrophage|macrophage
5268935|NCT00547976|Thrombosis|thrombosis
5268936|NCT00547976|Autoradiography|autoradiography
5268937|NCT00547976|Atherosclerosis|atherosclerosis
5268938|NCT00547976|Vasculitis|vasculitis
5268939|NCT00547963|Alcohol Drinking|alcohol drinking
5268940|NCT00547963|Marijuana Smoking|marijuana smoking
5268941|NCT00547963|Substance Use|substance use
5268942|NCT00547963|Emergency Department (ED)|emergency department (ed)
5268943|NCT00547937|Sleep Apnea|sleep apnea
5268944|NCT00547937|Oxidative Stress|oxidative stress
5268945|NCT00547937|Nitric oxide|nitric oxide
5268946|NCT00547937|Cardiovascular disease|cardiovascular disease
5268949|NCT00547911|Locus Ceruleus/Norepinephrine-Autonomic System|locus ceruleus/norepinephrine-autonomic system
5268950|NCT00547911|Norepinephrine|norepinephrine
5268951|NCT00547911|Adrenergic Nervous System|adrenergic nervous system
5268952|NCT00547898|HIV|hiv
5268953|NCT00547898|AIDS|aids
5268954|NCT00547898|Diarrhea|diarrhea
5268955|NCT00547898|HIV Associated Diarrhea|hiv associated diarrhea
5268956|NCT00547885|dihydrocodeine|dihydrocodeine
5268957|NCT00547885|opioids, long acting|opioids, long acting
5268958|NCT00547885|opioids, short acting|opioids, short acting
5268959|NCT00547885|Chronic pain|chronic pain
5268960|NCT00547885|non-malignant pain|non-malignant pain
5268961|NCT00547859|microcirculation|microcirculation
5268962|NCT00547859|cardiac surgery|cardiac surgery
5268963|NCT00547859|metabolism|metabolism
5268964|NCT00547859|capnometry|capnometry
5268965|NCT00547846|Cough|cough
5268966|NCT00547846|Antitussive|antitussive
5268967|NCT00547846|PDC-748|pdc-748
5268968|NCT00547846|PhytoHealth|phytohealth
5268969|NCT00547833|language disorders|language disorders
5268970|NCT00547833|language learning disabilities|language learning disabilities
5268971|NCT00547833|vocabulary|vocabulary
5268972|NCT00547833|reading|reading
5268973|NCT00547820|radiation dose|radiation dose
5268974|NCT00547820|VCUG|vcug
5268975|NCT00547820|pediatric patients|pediatric patients
5268976|NCT00547807|Pain, neonate, nursing care|pain, neonate, nursing care
5268977|NCT00547729|Heart Failure|heart failure
5268978|NCT00547729|Left Atrial Pressure Monitoring|left atrial pressure monitoring
5268979|NCT00547716|Hepatitis C|hepatitis c
5268980|NCT00547716|Omega 3 fatty acids|omega 3 fatty acids
5268981|NCT00547716|Omacor|omacor
5268982|NCT00547716|Interferon|interferon
5268983|NCT00547703|Nonulcer dyspepsia|nonulcer dyspepsia
5268984|NCT00547703|Functional dyspepsia|functional dyspepsia
5268985|NCT00547703|Antidepressant use in dyspepsia|antidepressant use in dyspepsia
5268986|NCT00547703|Nortriptyline|nortriptyline
5268987|NCT00547703|Tricyclic antidepressants|tricyclic antidepressants
5268988|NCT00547677|liver metastases|liver metastases
5268989|NCT00547677|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5268990|NCT00547664|Hylenex, time tagged pain pain reduction, hospice population|hylenex, time tagged pain pain reduction, hospice population
5268991|NCT00547651|Small Cell Lung Cancer|small cell lung cancer
5268992|NCT00547651|Lung Cancer|lung cancer
5268993|NCT00547651|Limited Disease Sensitive Small Cell Lung Cancer|limited disease sensitive small cell lung cancer
5268994|NCT00547651|Extensive Disease Sensitive Small Cell Lung Cancer|extensive disease sensitive small cell lung cancer
5268995|NCT00547651|Limited Disease Refractory Small Cell Lung Cancer|limited disease refractory small cell lung cancer
5268996|NCT00547651|Extensive Disease Refractory Small Cell Lung Cancer|extensive disease refractory small cell lung cancer
5268997|NCT00547651|Refractory Small Cell Lung Cancer|refractory small cell lung cancer
5268998|NCT00547651|Sensitive Small Cell Lung Cancer|sensitive small cell lung cancer
5268999|NCT00547638|laceration/wound closure|laceration/wound closure
5269000|NCT00547638|topical skin adhesive|topical skin adhesive
5269001|NCT00547612|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
5269002|NCT00547612|stage I pancreatic cancer|stage i pancreatic cancer
5269003|NCT00547612|stage II pancreatic cancer|stage ii pancreatic cancer
5269004|NCT00547612|stage III pancreatic cancer|stage iii pancreatic cancer
5269005|NCT00547612|stage IV pancreatic cancer|stage iv pancreatic cancer
5269006|NCT00547612|recurrent pancreatic cancer|recurrent pancreatic cancer
5269007|NCT00547560|Alzheimer Disease|alzheimer disease
5269008|NCT00547547|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5269009|NCT00547534|Bortezomib|bortezomib
5269010|NCT00547534|Bendamustine|bendamustine
5269011|NCT00547534|Rituximab|rituximab
5269012|NCT00547534|Relapsed|relapsed
5269013|NCT00547534|Refractory|refractory
5269014|NCT00547534|Mantle Cell|mantle cell
5269015|NCT00547534|Indolent|indolent
5269016|NCT00547482|Type 2 Diabetes|type 2 diabetes
5269017|NCT00547482|Overweight|overweight
5269018|NCT00547482|Obese|obese
5269019|NCT00547469|Irritable Bowel Syndrome|irritable bowel syndrome
5269020|NCT00547469|IBS-c|ibs-c
5269021|NCT00547469|IBS constipation|ibs constipation
5269022|NCT00547469|women with IBS|women with ibs
5269023|NCT00547469|women with constipation|women with constipation
5269024|NCT00547443|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5269025|NCT00547443|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5269026|NCT00547443|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5269027|NCT00547443|adenocarcinoma of the lung|adenocarcinoma of the lung
5269028|NCT00547443|squamous cell lung cancer|squamous cell lung cancer
5269029|NCT00547443|large cell lung cancer|large cell lung cancer
5269030|NCT00547443|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
5269031|NCT00547443|adenosquamous cell lung cancer|adenosquamous cell lung cancer
5269032|NCT00547391|adults|adults
5269033|NCT00547391|children|children
5269034|NCT00547391|tonsillectomy|tonsillectomy
5269035|NCT00547378|overactive bladder, urinary incontinence, incontinence,Urgency-frequency|overactive bladder, urinary incontinence, incontinence,urgency-frequency
5269036|NCT00547365|primary systemic amyloidosis|primary systemic amyloidosis
5269037|NCT00547339|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5269038|NCT00547339|stage I prostate cancer|stage i prostate cancer
5269039|NCT00547339|stage IIB prostate cancer|stage iib prostate cancer
5269040|NCT00547339|stage IIA prostate cancer|stage iia prostate cancer
5269041|NCT00547300|Hypertension|hypertension
5269042|NCT00547300|Nebivolol|nebivolol
5269043|NCT00547300|Beta blocker|beta blocker
5269044|NCT00547300|Tolerability|tolerability
5269045|NCT00547261|solid tumor|solid tumor
5269046|NCT00547261|antimitotic|antimitotic
5269047|NCT00547261|tubulin binder|tubulin binder
5269048|NCT00547248|Booster vaccination.|booster vaccination.
5269049|NCT00547248|Immunogenicity|immunogenicity
5269050|NCT00547248|Pneumococcal vaccine|pneumococcal vaccine
5269051|NCT00547248|Safety|safety
5269052|NCT00547248|Pneumococcal disease|pneumococcal disease
5269053|NCT00547235|infection|infection
5269054|NCT00547235|precancerous/nonmalignant condition|precancerous/nonmalignant condition
5269055|NCT00547196|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5269056|NCT00547196|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5269057|NCT00547196|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5269058|NCT00547196|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5269059|NCT00547196|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5269060|NCT00547196|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5269061|NCT00547196|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5269062|NCT00547196|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5269063|NCT00547196|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5269064|NCT00547196|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5269065|NCT00547196|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5269066|NCT00547196|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5269067|NCT00547196|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5269068|NCT00547196|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5269069|NCT00547196|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5269070|NCT00547196|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5269071|NCT00547196|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5269072|NCT00547196|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5269073|NCT00547196|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5269074|NCT00547196|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
5269075|NCT00547196|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5269076|NCT00547196|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5269077|NCT00547196|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5269078|NCT00547196|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5269079|NCT00547196|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5269080|NCT00547196|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5269081|NCT00547196|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5269082|NCT00547196|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5269083|NCT00547196|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5269084|NCT00547196|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5269085|NCT00547196|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5269086|NCT00547196|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5269087|NCT00547196|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5269088|NCT00547196|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5269089|NCT00547170|pelvic infection|pelvic infection
5269090|NCT00547170|abortion|abortion
5269091|NCT00547170|doxycycline|doxycycline
5269092|NCT00547157|head and neck|head and neck
5269093|NCT00547157|squamous cell carcinoma|squamous cell carcinoma
5269094|NCT00547157|radiotherapy|radiotherapy
5269095|NCT00547157|chemoradiotherapy|chemoradiotherapy
5269096|NCT00547157|panitumumab|panitumumab
5269097|NCT00547157|locally advanced head & neck cancer|locally advanced head & neck cancer
5269098|NCT00547157|EGFr|egfr
5269099|NCT00547157|epidermal growth factor receptor|epidermal growth factor receptor
5269100|NCT00547157|SCCHN|scchn
5269101|NCT00547157|locally advanced SCCHN|locally advanced scchn
5269102|NCT00547157|HNC|hnc
5269103|NCT00547157|epidermal growth factor|epidermal growth factor
5269104|NCT00547131|tumors metastatic to brain|tumors metastatic to brain
5269105|NCT00547131|recurrent adult brain tumor|recurrent adult brain tumor
5269106|NCT00547118|Metabolic abnormalities|metabolic abnormalities
5269107|NCT00547118|Safety|safety
5269108|NCT00547118|Satiety|satiety
5269109|NCT00547105|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5269110|NCT00547105|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5269111|NCT00547105|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5269112|NCT00547105|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5269113|NCT00547066|ITP|itp
5269114|NCT00547066|hA20|ha20
5269115|NCT00547066|Treatment|treatment
5269116|NCT00547040|calcification|calcification
5269117|NCT00547040|bone lesions|bone lesions
5269118|NCT00547027|diabetes|diabetes
5269119|NCT00547027|physical activity|physical activity
5269120|NCT00547027|print-based intervention|print-based intervention
5269121|NCT00547027|tailored intervention|tailored intervention
5269122|NCT00547014|treatment, parallel assignment, double blind, randomized, placebo control, safety study,SLE (Systemic Lupus Erythematosus)|treatment, parallel assignment, double blind, randomized, placebo control, safety study,sle (systemic lupus erythematosus)
5269123|NCT00547001|Menopause|menopause
5269124|NCT00547001|Hot flashes|hot flashes
5269125|NCT00547001|vasomotor symptoms|vasomotor symptoms
5269126|NCT00547001|tapering regimen|tapering regimen
5269127|NCT00547001|hormonal therapy|hormonal therapy
5269128|NCT00547001|Other menopausal symptoms including mood changes|other menopausal symptoms including mood changes
5269129|NCT00546988|primary treatment|primary treatment
5269130|NCT00546988|allogeneic stem-cell transplantation|allogeneic stem-cell transplantation
5269131|NCT00546988|high-dose therapy|high-dose therapy
5269132|NCT00546988|cytogenetics|cytogenetics
5269133|NCT00546975|gastrointestinal surgery|gastrointestinal surgery
5269134|NCT00546975|nutritional intervention|nutritional intervention
5269135|NCT00546975|functional status|functional status
5269136|NCT00546975|quality of life|quality of life
5269137|NCT00546949|Decompression, Surgical|decompression, surgical
5269138|NCT00546949|x-stop|x-stop
5269139|NCT00546949|lumbar decompression|lumbar decompression
5269140|NCT00546949|spinal stenosis|spinal stenosis
5269141|NCT00546949|radiculopathy|radiculopathy
5269142|NCT00546936|Histoplasmosis|histoplasmosis
5269143|NCT00546884|End of Life|end of life
5269144|NCT00546884|Advance Directives|advance directives
5269145|NCT00546884|Randomized controlled trial|randomized controlled trial
5269146|NCT00546884|End of life care|end of life care
5269147|NCT00546884|End of life advance care planning|end of life advance care planning
5269148|NCT00546858|Pelvic pain|pelvic pain
5269149|NCT00546858|Vulvar pain|vulvar pain
5269150|NCT00546806|Rehabilitation,|rehabilitation,
5269151|NCT00546806|Treatment outcome,|treatment outcome,
5269152|NCT00546806|Whiplash injuries,|whiplash injuries,
5269153|NCT00546806|Randomized Clinical Trials|randomized clinical trials
5269154|NCT00546793|humanized anti-CD20 veltuzumab (IMMU-106) administered subcutaneously|humanized anti-cd20 veltuzumab (immu-106) administered subcutaneously
5269155|NCT00546780|Multiple Myeloma|multiple myeloma
5269156|NCT00546780|Heat Shock Protein 90|heat shock protein 90
5269157|NCT00546780|Hsp90|hsp90
5269158|NCT00546780|KOS-953|kos-953
5269159|NCT00546780|17-AAG|17-aag
5269160|NCT00546780|bortezomib|bortezomib
5269161|NCT00546780|first relapse|first relapse
5269162|NCT00546780|tanespimycin|tanespimycin
5269163|NCT00546780|TIME-1|time-1
5269164|NCT00546741|Diabetes,NOS|diabetes,nos
5269165|NCT00546689|HIV|hiv
5269166|NCT00546689|aids|aids
5269167|NCT00546689|intestinal parasites|intestinal parasites
5269168|NCT00546689|eosinophils|eosinophils
5269169|NCT00546689|immunoglobulins|immunoglobulins
5269170|NCT00546689|HIV/aids|hiv/aids
5269171|NCT00546689|Treatment Experienced|treatment experienced
5269172|NCT00546663|Cystic Fibrosis, hypertonic saline|cystic fibrosis, hypertonic saline
5269173|NCT00546650|Focus of study is to compare pharmacokinetics|focus of study is to compare pharmacokinetics
5269174|NCT00546611|PEP005|pep005
5269175|NCT00546611|Common Wart(s)|common wart(s)
5269176|NCT00546611|Common warts (verruca[e] vulgaris)|common warts (verruca[e] vulgaris)
5269177|NCT00546598|Total hip replacement, Total hip arthroplasty|total hip replacement, total hip arthroplasty
5269178|NCT00546585|influenza, inactivated influenza A/H7N7 vaccine, parent protocol|influenza, inactivated influenza a/h7n7 vaccine, parent protocol
5269179|NCT00546559|Lipophilic statins|lipophilic statins
5269180|NCT00546559|Insulin resistance|insulin resistance
5269181|NCT00546559|simvastatin and pravastatin may have differential metabolic effects in hypercholesterolemic patients.|simvastatin and pravastatin may have differential metabolic effects in hypercholesterolemic patients.
5269182|NCT00546546|Crohn|crohn
5269183|NCT00546546|immunosuppressants|immunosuppressants
5269184|NCT00546546|natural history|natural history
5269185|NCT00546546|steroids|steroids
5269186|NCT00546520|Asthma|asthma
5269187|NCT00546520|Ciclesonide|ciclesonide
5269188|NCT00546520|Airway hyperresponsiveness|airway hyperresponsiveness
5269189|NCT00546520|Sputum|sputum
5269190|NCT00546520|Nitric oxide|nitric oxide
5269191|NCT00546468|stomach cancer|stomach cancer
5269192|NCT00546468|laparoscopy|laparoscopy
5269193|NCT00546468|gastrectomy|gastrectomy
5269194|NCT00546468|QOL|qol
5269195|NCT00546468|survival|survival
5269196|NCT00546468|clinical study|clinical study
5269197|NCT00546455|Obesity|obesity
5269198|NCT00546455|insulin resistance|insulin resistance
5269199|NCT00546442|insulin resistance|insulin resistance
5269200|NCT00546442|chronic hepatitis C|chronic hepatitis c
5269201|NCT00546442|genotype 1|genotype 1
5269202|NCT00546429|Proximal femoral fracture|proximal femoral fracture
5269203|NCT00546429|Trochanteric fracture|trochanteric fracture
5269204|NCT00546429|Intramedullary nailing|intramedullary nailing
5269205|NCT00546403|Excessive Daytime Sleepiness|excessive daytime sleepiness
5269206|NCT00546377|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
5269207|NCT00546377|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
5269208|NCT00546377|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5269209|NCT00546377|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5269210|NCT00546377|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5269211|NCT00546377|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5269212|NCT00546377|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5269213|NCT00546377|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5269214|NCT00546377|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5269215|NCT00546351|Lacosamide|lacosamide
5269216|NCT00546299|Ambulatory oxygen therapy|ambulatory oxygen therapy
5269217|NCT00546299|COPD|copd
5269218|NCT00546299|exertional hypoxemia|exertional hypoxemia
5269219|NCT00546273|LTBI (Latent tuberculosis infection)|ltbi (latent tuberculosis infection)
5269220|NCT00546273|TB(Tuberculosis)|tb(tuberculosis)
5269221|NCT00546273|Vaccine|vaccine
5269222|NCT00546260|STEMI|stemi
5269223|NCT00546260|ACS|acs
5269224|NCT00546234|asthma|asthma
5269225|NCT00546234|tiotropium|tiotropium
5269226|NCT00546234|smoking|smoking
5269227|NCT00546234|eNO|eno
5269228|NCT00546234|metabolites|metabolites
5269229|NCT00546234|Virtual Asthma Clinic|virtual asthma clinic
5269230|NCT00546221|Depression|depression
5269231|NCT00546221|Mental health|mental health
5269232|NCT00546221|Exercise|exercise
5269233|NCT00546221|Prescribed exercise|prescribed exercise
5269234|NCT00546221|Physical health|physical health
5269235|NCT00546221|Social wellbeing|social wellbeing
5269236|NCT00546208|bladder function|bladder function
5269237|NCT00546208|cutaneous ureterostomy|cutaneous ureterostomy
5269238|NCT00546208|hydronephrosis|hydronephrosis
5269239|NCT00546195|Cord Blood|cord blood
5269240|NCT00546195|Neutrophils|neutrophils
5269241|NCT00546195|Polysaccharide|polysaccharide
5269242|NCT00546195|Gene Expression|gene expression
5269243|NCT00546182|Lipophilic statins|lipophilic statins
5269244|NCT00546182|Insulin resistance|insulin resistance
5269245|NCT00546182|hypercholesterolemic patients|hypercholesterolemic patients
5269246|NCT00546169|Patients undergoing elective or acute cholecystectomy|patients undergoing elective or acute cholecystectomy
5269247|NCT00546156|ER positive|er positive
5269248|NCT00546156|PR positive|pr positive
5269249|NCT00546143|Asthma, anti-immunoglobulin E, omalizumab|asthma, anti-immunoglobulin e, omalizumab
5269250|NCT00546130|ED-SCLC|ed-sclc
5269251|NCT00546130|small cell lung cancer|small cell lung cancer
5269252|NCT00546130|CPT-11|cpt-11
5269253|NCT00546130|irinotecan hydrochloride|irinotecan hydrochloride
5269254|NCT00546130|CDDP|cddp
5269255|NCT00546130|cisplatin|cisplatin
5269256|NCT00546130|PSK|psk
5269257|NCT00546130|Krestin|krestin
5269258|NCT00546117|otitis media with effusion|otitis media with effusion
5269259|NCT00546117|gastroesophageal reflux|gastroesophageal reflux
5269260|NCT00546117|ear infection|ear infection
5269261|NCT00546117|proton pump inhibitor|proton pump inhibitor
5269262|NCT00546104|Advanced Breast Cancer|advanced breast cancer
5269263|NCT00546104|Breast cancer|breast cancer
5269264|NCT00546104|Dasatinib|dasatinib
5269265|NCT00546104|Inoperable Stage III Breast Cancer|inoperable stage iii breast cancer
5269266|NCT00546104|Metastatic Breast Cancer|metastatic breast cancer
5269267|NCT00546104|Stage IV Breast Cancer|stage iv breast cancer
5269268|NCT00546091|Imaging|imaging
5269269|NCT00546091|Multi-Spectral Imaging|multi-spectral imaging
5269270|NCT00546091|Thermography|thermography
5269271|NCT00546091|Laser Doppler Imaging|laser doppler imaging
5269272|NCT00546091|Vasculature|vasculature
5269273|NCT00546091|Healthy Volunteer|healthy volunteer
5269274|NCT00546091|HV|hv
5269275|NCT00546078|HPV vaccine|hpv vaccine
5269276|NCT00546078|Cervical cancer|cervical cancer
5269277|NCT00546078|Human papillomavirus infection|human papillomavirus infection
5269278|NCT00546065|Barrett's esophagus|barrett's esophagus
5269279|NCT00546065|ablation|ablation
5269280|NCT00546065|esomeprazole|esomeprazole
5269281|NCT00546065|Barrett's cancer|barrett's cancer
5269282|NCT00546065|Ablation of Barrett's esophagus|ablation of barrett's esophagus
5269283|NCT00546065|Surveillance of Barrett's esophagus after endoscopic resection of Barrett's cancer|surveillance of barrett's esophagus after endoscopic resection of barrett's cancer
5269284|NCT00546065|Recurrence of Barrett's cancer|recurrence of barrett's cancer
5269285|NCT00546039|Prostate cancer|prostate cancer
5269286|NCT00546039|Localized prostatectomy|localized prostatectomy
5269287|NCT00546039|Laparoscopic prostatectomy|laparoscopic prostatectomy
5269288|NCT00546039|Chemoprevention|chemoprevention
5269289|NCT00546039|Genistein|genistein
5269290|NCT00546039|BONISTEIN™|bonistein™
5269291|NCT00546026|placental function|placental function
5269292|NCT00546026|high-risk pregnancies|high-risk pregnancies
5269293|NCT00546026|psychological distress|psychological distress
5269294|NCT00546013|abdominal aortic aneurysms|abdominal aortic aneurysms
5269295|NCT00546013|pseudoexfoliation syndrome|pseudoexfoliation syndrome
5269296|NCT00546013|glaucoma|glaucoma
5269297|NCT00545987|HIV vaccine|hiv vaccine
5269299|NCT00545987|AIDS|aids
5269300|NCT00545987|prevention|prevention
5269301|NCT00545987|HIV/AIDS|hiv/aids
5269302|NCT00545987|HIV Preventative Vaccine|hiv preventative vaccine
5269303|NCT00545987|HIV Seronegativity|hiv seronegativity
5269304|NCT00545974|Randomized|randomized
5269305|NCT00545974|Double-Blind|double-blind
5269306|NCT00545974|Placebo-Controlled|placebo-controlled
5269307|NCT00545974|memantine|memantine
5269308|NCT00545974|Namenda|namenda
5269309|NCT00545974|Frontotemporal Dementia|frontotemporal dementia
5269310|NCT00545974|Semantic Dementia|semantic dementia
5269311|NCT00545974|FTD|ftd
5269312|NCT00545974|SD|sd
5269313|NCT00545974|dementia|dementia
5269314|NCT00545974|behavioral decline|behavioral decline
5269315|NCT00545974|cognitive decline|cognitive decline
5269316|NCT00545961|respiratory infection|respiratory infection
5269317|NCT00545961|sinusitis|sinusitis
5269318|NCT00545961|rhinosinusitis|rhinosinusitis
5269319|NCT00545961|children|children
5269320|NCT00545961|middle meatal specimens|middle meatal specimens
5269321|NCT00545961|respiratory track bacteria|respiratory track bacteria
5269322|NCT00545961|amoxicillin-clavulanate|amoxicillin-clavulanate
5269323|NCT00545961|pneumococci|pneumococci
5269324|NCT00545961|haemophilus|haemophilus
5269325|NCT00545961|moraxella|moraxella
5269326|NCT00545948|Non-Small-Cell Lung Cancer|non-small-cell lung cancer
5269327|NCT00545948|NSCLC|nsclc
5269328|NCT00545948|Non-Squamous|non-squamous
5269329|NCT00545948|Genomics|genomics
5269330|NCT00545948|Guided Therapy|guided therapy
5269331|NCT00545948|Directed Therapy|directed therapy
5269332|NCT00545948|Genomic Expression Profiles|genomic expression profiles
5269333|NCT00545948|Chemotherapy Sensitivity|chemotherapy sensitivity
5269334|NCT00545922|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
5269335|NCT00545922|anxiety|anxiety
5269336|NCT00545922|depression|depression
5269337|NCT00545922|cognitive behavioral therapy|cognitive behavioral therapy
5269338|NCT00545883|GERD|gerd
5269339|NCT00545883|esophagitis|esophagitis
5269340|NCT00545883|PPI|ppi
5269341|NCT00545857|Type 1 diabetes|type 1 diabetes
5269342|NCT00545857|Insulin dependent diabetes|insulin dependent diabetes
5269343|NCT00545857|Juvenile onset diabetes|juvenile onset diabetes
5269344|NCT00545857|pioglitazone|pioglitazone
5269345|NCT00545831|Home Parenteral Nutrition|home parenteral nutrition
5269346|NCT00545831|Sepsis Prevention|sepsis prevention
5269347|NCT00545831|Central Venous Catheters|central venous catheters
5269348|NCT00545831|Taurolidine|taurolidine
5269349|NCT00545805|Insulin resistance|insulin resistance
5269350|NCT00545805|Metabolic syndrome X|metabolic syndrome x
5269351|NCT00545805|Obesity|obesity
5269352|NCT00545805|Intra-Abdominal Fat|intra-abdominal fat
5269353|NCT00545805|Omentum|omentum
5269354|NCT00545805|Bariatric surgery|bariatric surgery
5269355|NCT00545805|Glucose Clamp Technique|glucose clamp technique
5269356|NCT00545805|Intravenous Glucose Tolerance Test|intravenous glucose tolerance test
5269357|NCT00545805|Adiponectin|adiponectin
5269358|NCT00545805|Cytokines|cytokines
5269359|NCT00545792|Recurrent Endometrial cancer|recurrent endometrial cancer
5269360|NCT00545792|Recurrent Cervical cancer|recurrent cervical cancer
5269361|NCT00545792|Recurrent Ovarian cancer|recurrent ovarian cancer
5269362|NCT00545792|Recurrent Vaginal cancer|recurrent vaginal cancer
5269363|NCT00545792|Recurrent Vulvar cancer|recurrent vulvar cancer
5269364|NCT00545792|Vaginal recurrence|vaginal recurrence
5269365|NCT00545792|Brachytherapy|brachytherapy
5269366|NCT00545792|Radiation Treatment|radiation treatment
5269367|NCT00545792|External Beam Radiation|external beam radiation
5269368|NCT00545792|Avastin|avastin
5269369|NCT00545792|Bevacizumab|bevacizumab
5269370|NCT00545766|Prostate Cancer|prostate cancer
5269371|NCT00545766|Hormone Refractory|hormone refractory
5269372|NCT00545766|Vinflunine|vinflunine
5269373|NCT00545766|Salvage Chemotherapy|salvage chemotherapy
5269374|NCT00545753|Human Head lice|human head lice
5269375|NCT00545727|Diabetes|diabetes
5269376|NCT00545727|Children|children
5269377|NCT00545727|Adolescents|adolescents
5269378|NCT00545727|Diet|diet
5269379|NCT00545727|Glycemic index|glycemic index
5269380|NCT00545701|Influenza|influenza
5269381|NCT00545701|A/H5N1 strain|a/h5n1 strain
5269382|NCT00545701|Orthomyxoviridae Infections|orthomyxoviridae infections
5269383|NCT00545701|Influenza Pandemics|influenza pandemics
5269384|NCT00545662|traumatic brain injury|traumatic brain injury
5269385|NCT00545662|cognition|cognition
5269386|NCT00545662|behavioral outcome|behavioral outcome
5269387|NCT00545662|functional outcome|functional outcome
5269388|NCT00545662|treatment|treatment
5269389|NCT00545662|early intervention|early intervention
5269390|NCT00545662|citicoline|citicoline
5269391|NCT00545649|Fibromyalgia|fibromyalgia
5269392|NCT00545649|chronic pain|chronic pain
5269393|NCT00545649|physical|physical
5269394|NCT00545649|exercise|exercise
5269395|NCT00545649|activity|activity
5269396|NCT00545649|education|education
5269397|NCT00545623|HIV/AIDS|hiv/aids
5269398|NCT00545623|Alternative Medicine|alternative medicine
5269399|NCT00545623|Complementary Medicine|complementary medicine
5269400|NCT00545597|adrenoleukodystrophy|adrenoleukodystrophy
5269401|NCT00545597|adrenomyeloneuropathy|adrenomyeloneuropathy
5269402|NCT00545558|Antiretroviral Therapy, Highly Active|antiretroviral therapy, highly active
5269403|NCT00545558|Coinfection|coinfection
5269404|NCT00545558|Treatment Naive|treatment naive
5269405|NCT00545545|Colorectal|colorectal
5269406|NCT00545545|Carcinoma|carcinoma
5269407|NCT00545545|Recurrent|recurrent
5269408|NCT00545545|Progressive|progressive
5269409|NCT00545545|Cetuximab|cetuximab
5269410|NCT00545545|Irinotecan|irinotecan
5269411|NCT00545545|5-Fluorouracil|5-fluorouracil
5269412|NCT00545519|Multiple Myeloma|multiple myeloma
5269413|NCT00545519|Thymoglobulin|thymoglobulin
5269414|NCT00545506|wound infection|wound infection
5269415|NCT00545506|tissue oxygen tension|tissue oxygen tension
5269416|NCT00545506|local warming|local warming
5269417|NCT00545493|Rasmussen encephalitis|rasmussen encephalitis
5269418|NCT00545493|Chronic encephalitis|chronic encephalitis
5269419|NCT00545493|Cerebral hemiatrophy|cerebral hemiatrophy
5269420|NCT00545493|Hemiparesis|hemiparesis
5269421|NCT00545493|Epilepsy|epilepsy
5269422|NCT00545467|Aripiprazole|aripiprazole
5269423|NCT00545467|schizophrenia|schizophrenia
5269424|NCT00545467|antipsychotics|antipsychotics
5269425|NCT00545467|pharmacogenomics|pharmacogenomics
5269426|NCT00545467|cytochrome P450 enzyme|cytochrome p450 enzyme
5269427|NCT00545454|Inflammation|inflammation
5269428|NCT00545454|anti-cytokine|anti-cytokine
5269429|NCT00545454|anti-chemokine|anti-chemokine
5269430|NCT00545441|Anal fistula|anal fistula
5269431|NCT00545441|fistula in ano|fistula in ano
5269432|NCT00545441|anorectal fistula|anorectal fistula
5269433|NCT00545428|Nasal acquired diseases|nasal acquired diseases
5269434|NCT00545428|Nasal congenital diseases|nasal congenital diseases
5269435|NCT00545428|Rhinoplasty|rhinoplasty
5269436|NCT00545428|Grafts|grafts
5269437|NCT00545415|fruit|fruit
5269438|NCT00545415|antioxidant|antioxidant
5269439|NCT00545415|Healthy subjects|healthy subjects
5269440|NCT00545350|Prevention|prevention
5269441|NCT00545350|Falls, accidental falls|falls, accidental falls
5269442|NCT00545350|Fractures|fractures
5269443|NCT00545350|Physical injuries|physical injuries
5269444|NCT00545350|Women|women
5269445|NCT00545350|Elderly|elderly
5269446|NCT00545350|Physical exercise|physical exercise
5269447|NCT00545350|Balance exercise|balance exercise
5269448|NCT00545311|multiple inhaled, NVA237, COPD|multiple inhaled, nva237, copd
5269449|NCT00545298|Nitric Oxide|nitric oxide
5269450|NCT00545298|Venous Leg Ulcers|venous leg ulcers
5269451|NCT00545285|clinical outcomes|clinical outcomes
5269452|NCT00545285|radiographic outcomes|radiographic outcomes
5269453|NCT00545285|total hip arthroplasty|total hip arthroplasty
5269454|NCT00545285|survivorship|survivorship
5269455|NCT00545272|QMF|qmf
5269456|NCT00545272|indacaterol|indacaterol
5269457|NCT00545272|Twisthaler®|twisthaler®
5269458|NCT00545259|Organ transplant, liver, pharmacokinetics, AEB071, immunosuppression|organ transplant, liver, pharmacokinetics, aeb071, immunosuppression
5269459|NCT00545246|VEGF Trap|vegf trap
5269460|NCT00545194|Prostaglandin E2|prostaglandin e2
5269461|NCT00545194|Intravaginal gel|intravaginal gel
5269462|NCT00545194|Bishop score|bishop score
5269463|NCT00545194|Induction of labor|induction of labor
5269464|NCT00545194|randomized trial|randomized trial
5269465|NCT00545194|Vaginal insert|vaginal insert
5269466|NCT00545181|bacterial vaginosis|bacterial vaginosis
5269467|NCT00545181|vaginal acidifying gel|vaginal acidifying gel
5269468|NCT00545181|recurrence|recurrence
5269469|NCT00545168|head lice|head lice
5269470|NCT00545025|Influenza|influenza
5269471|NCT00545025|Influenza vaccine|influenza vaccine
5269472|NCT00545012|Levetiracetam|levetiracetam
5269473|NCT00545012|Keppra|keppra
5269474|NCT00544999|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5269475|NCT00544999|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5269476|NCT00544999|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
5269477|NCT00544999|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
5269478|NCT00544999|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
5269479|NCT00544999|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
5269480|NCT00544999|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
5269481|NCT00544999|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
5269482|NCT00544999|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5269483|NCT00544999|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5269484|NCT00544999|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5269485|NCT00544999|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5269486|NCT00544986|breast cancer|breast cancer
5269487|NCT00544986|post menopausal women|post menopausal women
5269488|NCT00544986|Post menopausal women with hormone sensitive advanced breast cancer|post menopausal women with hormone sensitive advanced breast cancer
5269489|NCT00544960|AT101|at101
5269490|NCT00544960|AT-101|at-101
5269491|NCT00544960|cancer|cancer
5269492|NCT00544960|lung|lung
5269493|NCT00544960|non-small cell|non-small cell
5269494|NCT00544960|docetaxel|docetaxel
5269495|NCT00544960|bcl|bcl
5269496|NCT00544947|Respiratory Depression|respiratory depression
5269497|NCT00544947|Caesarean Section|caesarean section
5269498|NCT00544947|Diamorphine|diamorphine
5269499|NCT00544947|Fentanyl|fentanyl
5269500|NCT00544908|stage IV pancreatic cancer|stage iv pancreatic cancer
5269501|NCT00544869|Vasopressin antagonist , Cardiac Edema ,Diuretics|vasopressin antagonist , cardiac edema ,diuretics
5269502|NCT00544856|mild Alzheimer's disease|mild alzheimer's disease
5269503|NCT00544856|mild cognitive impairment|mild cognitive impairment
5269504|NCT00544830|stage IV prostate cancer|stage iv prostate cancer
5269505|NCT00544830|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5269506|NCT00544830|recurrent prostate cancer|recurrent prostate cancer
5269507|NCT00544817|Concurrent Radiation Therapy|concurrent radiation therapy
5269508|NCT00544817|Temozolomide|temozolomide
5269509|NCT00544817|Sorafenib|sorafenib
5269510|NCT00544817|First-line|first-line
5269511|NCT00544817|Glioblastoma Multiforme|glioblastoma multiforme
5269512|NCT00544817|Phase II|phase ii
5269513|NCT00544804|recurrent breast cancer|recurrent breast cancer
5269514|NCT00544804|stage IIIA breast cancer|stage iiia breast cancer
5269515|NCT00544804|stage IIIB breast cancer|stage iiib breast cancer
5269516|NCT00544804|stage IIIC breast cancer|stage iiic breast cancer
5269517|NCT00544804|stage IV breast cancer|stage iv breast cancer
5269518|NCT00544804|bone metastases|bone metastases
5269519|NCT00544791|Mild Cognitive Impairment|mild cognitive impairment
5269520|NCT00544791|Melatonin|melatonin
5269521|NCT00544791|Antioxidant|antioxidant
5269522|NCT00544791|Memory|memory
5269523|NCT00544791|Alzheimer|alzheimer
5269524|NCT00544778|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
5269525|NCT00544778|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
5269526|NCT00544778|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
5269527|NCT00544778|metastatic osteosarcoma|metastatic osteosarcoma
5269528|NCT00544778|recurrent osteosarcoma|recurrent osteosarcoma
5269529|NCT00544778|metastatic Ewing sarcoma/peripheral primitive neuroectodermal tumor|metastatic ewing sarcoma/peripheral primitive neuroectodermal tumor
5269530|NCT00544778|recurrent Ewing sarcoma/peripheral primitive neuroectodermal tumor|recurrent ewing sarcoma/peripheral primitive neuroectodermal tumor
5269531|NCT00544778|Ewing sarcoma of bone|ewing sarcoma of bone
5269532|NCT00544765|Breast cancer|breast cancer
5269533|NCT00544765|neoadjuvant therapy|neoadjuvant therapy
5269534|NCT00544765|pCR rates|pcr rates
5269535|NCT00544752|sleep apnea syndromes, ambient indoor temperature|sleep apnea syndromes, ambient indoor temperature
5269536|NCT00544739|Coronary Artery Disease|coronary artery disease
5269537|NCT00544739|Premature|premature
5269538|NCT00544739|Female|female
5269539|NCT00544726|Rehabilitation|rehabilitation
5269540|NCT00544700|stage IV colon cancer|stage iv colon cancer
5269541|NCT00544700|stage IV rectal cancer|stage iv rectal cancer
5269542|NCT00544687|Skin|skin
5269543|NCT00544687|Atrophy|atrophy
5269544|NCT00544687|CRX-191|crx-191
5269545|NCT00544687|mometasone furoate|mometasone furoate
5269546|NCT00544687|nortriptyline hydrochloride|nortriptyline hydrochloride
5269547|NCT00544687|Skin Thickness in Normal Healthy Volunteers|skin thickness in normal healthy volunteers
5269548|NCT00544674|extensive stage small cell lung cancer|extensive stage small cell lung cancer
5269549|NCT00544674|limited stage small cell lung cancer|limited stage small cell lung cancer
5269550|NCT00544674|recurrent small cell lung cancer|recurrent small cell lung cancer
5269551|NCT00544648|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5269552|NCT00544648|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5269553|NCT00544622|Stroke treatment|stroke treatment
5269554|NCT00544622|Rehabilitation|rehabilitation
5269555|NCT00544622|Stroke chain|stroke chain
5269556|NCT00544622|Stroke unit|stroke unit
5269557|NCT00544609|Bladder|bladder
5269558|NCT00544609|Sorafenib|sorafenib
5269559|NCT00544609|Radiotherapy|radiotherapy
5269560|NCT00544583|Abdominal wall|abdominal wall
5269561|NCT00544570|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5269562|NCT00544570|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
5269563|NCT00544544|Bipolar|bipolar
5269564|NCT00544544|depression|depression
5269565|NCT00544531|MI oocytes, FISH,chromosomal aberrations|mi oocytes, fish,chromosomal aberrations
5269566|NCT00544518|type 2 diabetes|type 2 diabetes
5269567|NCT00544518|Benfluorex|benfluorex
5269568|NCT00544518|Metformin|metformin
5269569|NCT00544518|insulin secretion|insulin secretion
5269570|NCT00544518|glucose control|glucose control
5269571|NCT00544492|arteriovenous fistula|arteriovenous fistula
5269572|NCT00544492|dialysis access|dialysis access
5269573|NCT00544492|pain|pain
5269574|NCT00544492|anxiety|anxiety
5269575|NCT00544492|fistula related complications|fistula related complications
5269576|NCT00544492|aneurysm|aneurysm
5269577|NCT00544466|acute myeloid leukemia with multilineage dysplasia following myelodysplastic syndrome|acute myeloid leukemia with multilineage dysplasia following myelodysplastic syndrome
5269578|NCT00544466|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5269579|NCT00544466|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5269580|NCT00544466|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5269581|NCT00544466|adult acute myeloid leukemia with del(5q)|adult acute myeloid leukemia with del(5q)
5269582|NCT00544466|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5269583|NCT00544466|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5269584|NCT00544466|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5269585|NCT00544466|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5269586|NCT00544466|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
5269587|NCT00544466|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5269588|NCT00544466|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
5269589|NCT00544466|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5269590|NCT00544466|untreated childhood acute myeloid leukemia and other myeloid malignancies|untreated childhood acute myeloid leukemia and other myeloid malignancies
5269591|NCT00544466|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5269592|NCT00544466|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5269593|NCT00544466|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5269594|NCT00544466|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5269595|NCT00544466|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
5269596|NCT00544466|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5269597|NCT00544466|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5269598|NCT00544466|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
5269599|NCT00544466|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
5269600|NCT00544466|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
5269601|NCT00544453|SPECT|spect
5269602|NCT00544453|Alzheimer disease|alzheimer disease
5269603|NCT00544440|Prostate neoplasms|prostate neoplasms
5269604|NCT00544440|Prostate cancer|prostate cancer
5269605|NCT00544440|Castration-resistant prostate cancer|castration-resistant prostate cancer
5269606|NCT00544440|Abiraterone acetate|abiraterone acetate
5269607|NCT00544440|CB7630|cb7630
5269608|NCT00544440|Prednisone|prednisone
5269609|NCT00544440|Testosterone|testosterone
5269610|NCT00544440|Bone marrow|bone marrow
5269611|NCT00544427|Upper Areo-Digestive tract|upper areo-digestive tract
5269612|NCT00544414|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
5269613|NCT00544414|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5269614|NCT00544414|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
5269615|NCT00544414|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
5269616|NCT00544414|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5269617|NCT00544414|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5269618|NCT00544414|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
5269619|NCT00544414|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5269620|NCT00544414|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
5269621|NCT00544414|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
5269622|NCT00544414|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
5269623|NCT00544401|infertility|infertility
5269624|NCT00544401|in vitro fertilization|in vitro fertilization
5269625|NCT00544401|intracytoplasmic sperm implantation|intracytoplasmic sperm implantation
5269626|NCT00544401|acupuncture|acupuncture
5269627|NCT00544401|hypnosis|hypnosis
5269628|NCT00544401|hypnopuncture|hypnopuncture
5269629|NCT00544388|Levocetirizine dihydrochloride|levocetirizine dihydrochloride
5269630|NCT00544388|Xyzal tablet|xyzal tablet
5269631|NCT00544362|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
5269632|NCT00544362|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
5269633|NCT00544362|stage IIIA esophageal cancer|stage iiia esophageal cancer
5269634|NCT00544362|stage IIIB esophageal cancer|stage iiib esophageal cancer
5269635|NCT00544362|stage IIIC esophageal cancer|stage iiic esophageal cancer
5269636|NCT00544362|stage IV esophageal cancer|stage iv esophageal cancer
5269637|NCT00544349|stage IV colon cancer|stage iv colon cancer
5269638|NCT00544349|recurrent colon cancer|recurrent colon cancer
5269639|NCT00544349|stage IV rectal cancer|stage iv rectal cancer
5269640|NCT00544349|recurrent rectal cancer|recurrent rectal cancer
5269641|NCT00544349|liver metastases|liver metastases
5269642|NCT00544336|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5269643|NCT00544336|recurrent breast cancer|recurrent breast cancer
5269644|NCT00544336|stage I breast cancer|stage i breast cancer
5269645|NCT00544336|stage II breast cancer|stage ii breast cancer
5269646|NCT00544336|stage IIIA breast cancer|stage iiia breast cancer
5269647|NCT00544336|stage IIIB breast cancer|stage iiib breast cancer
5269648|NCT00544336|stage IIIC breast cancer|stage iiic breast cancer
5269649|NCT00544336|stage IV breast cancer|stage iv breast cancer
5269650|NCT00544336|recurrent prostate cancer|recurrent prostate cancer
5269651|NCT00544336|stage I prostate cancer|stage i prostate cancer
5269652|NCT00544336|stage II prostate cancer|stage ii prostate cancer
5269653|NCT00544336|stage III prostate cancer|stage iii prostate cancer
5269654|NCT00544336|stage IV prostate cancer|stage iv prostate cancer
5269655|NCT00544336|extensive stage small cell lung cancer|extensive stage small cell lung cancer
5269656|NCT00544336|limited stage small cell lung cancer|limited stage small cell lung cancer
5269657|NCT00544336|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5269658|NCT00544336|recurrent small cell lung cancer|recurrent small cell lung cancer
5269659|NCT00544336|stage I non-small cell lung cancer|stage i non-small cell lung cancer
5269660|NCT00544336|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
5269661|NCT00544336|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5269662|NCT00544336|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5269663|NCT00544336|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5269664|NCT00544336|recurrent colon cancer|recurrent colon cancer
5269665|NCT00544336|stage I colon cancer|stage i colon cancer
5269666|NCT00544336|stage II colon cancer|stage ii colon cancer
5269667|NCT00544336|stage III colon cancer|stage iii colon cancer
5269668|NCT00544336|stage IV colon cancer|stage iv colon cancer
5269669|NCT00544336|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
5269670|NCT00544336|stage I squamous cell carcinoma of the hypopharynx|stage i squamous cell carcinoma of the hypopharynx
5269671|NCT00544336|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
5269672|NCT00544336|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
5269673|NCT00544336|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5269674|NCT00544336|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
5269675|NCT00544336|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
5269676|NCT00544336|stage I squamous cell carcinoma of the larynx|stage i squamous cell carcinoma of the larynx
5269677|NCT00544336|stage I verrucous carcinoma of the larynx|stage i verrucous carcinoma of the larynx
5269678|NCT00544336|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
5269679|NCT00544336|stage II verrucous carcinoma of the larynx|stage ii verrucous carcinoma of the larynx
5269680|NCT00544336|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
5269681|NCT00544336|stage III verrucous carcinoma of the larynx|stage iii verrucous carcinoma of the larynx
5269682|NCT00544336|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5269683|NCT00544336|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
5269684|NCT00544336|recurrent adenoid cystic carcinoma of the oral cavity|recurrent adenoid cystic carcinoma of the oral cavity
5269685|NCT00544336|recurrent mucoepidermoid carcinoma of the oral cavity|recurrent mucoepidermoid carcinoma of the oral cavity
5269686|NCT00544336|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
5269687|NCT00544336|stage I adenoid cystic carcinoma of the oral cavity|stage i adenoid cystic carcinoma of the oral cavity
5269688|NCT00544336|stage I mucoepidermoid carcinoma of the oral cavity|stage i mucoepidermoid carcinoma of the oral cavity
5269689|NCT00544336|stage I verrucous carcinoma of the oral cavity|stage i verrucous carcinoma of the oral cavity
5269690|NCT00544336|stage II adenoid cystic carcinoma of the oral cavity|stage ii adenoid cystic carcinoma of the oral cavity
5269691|NCT00544336|stage II mucoepidermoid carcinoma of the oral cavity|stage ii mucoepidermoid carcinoma of the oral cavity
5269692|NCT00544336|stage II verrucous carcinoma of the oral cavity|stage ii verrucous carcinoma of the oral cavity
5269693|NCT00544336|stage III adenoid cystic carcinoma of the oral cavity|stage iii adenoid cystic carcinoma of the oral cavity
5269694|NCT00544336|stage III mucoepidermoid carcinoma of the oral cavity|stage iii mucoepidermoid carcinoma of the oral cavity
5269695|NCT00544336|stage III verrucous carcinoma of the oral cavity|stage iii verrucous carcinoma of the oral cavity
5269696|NCT00544336|stage IV adenoid cystic carcinoma of the oral cavity|stage iv adenoid cystic carcinoma of the oral cavity
5269697|NCT00544336|stage IV mucoepidermoid carcinoma of the oral cavity|stage iv mucoepidermoid carcinoma of the oral cavity
5269698|NCT00544336|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
5269699|NCT00544336|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
5269700|NCT00544336|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
5269701|NCT00544336|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
5269702|NCT00544336|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5269703|NCT00544336|recurrent basal cell carcinoma of the lip|recurrent basal cell carcinoma of the lip
5269704|NCT00544336|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
5269705|NCT00544336|stage I basal cell carcinoma of the lip|stage i basal cell carcinoma of the lip
5269706|NCT00544336|stage II basal cell carcinoma of the lip|stage ii basal cell carcinoma of the lip
5269707|NCT00544336|stage III basal cell carcinoma of the lip|stage iii basal cell carcinoma of the lip
5269708|NCT00544336|stage IV basal cell carcinoma of the lip|stage iv basal cell carcinoma of the lip
5269709|NCT00544336|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
5269710|NCT00544336|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
5269711|NCT00544336|untreated metastatic squamous neck cancer with occult primary|untreated metastatic squamous neck cancer with occult primary
5269712|NCT00544336|recurrent lymphoepithelioma of the nasopharynx|recurrent lymphoepithelioma of the nasopharynx
5270005|NCT00543686|Montelukast|montelukast
5269713|NCT00544336|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
5269714|NCT00544336|stage I lymphoepithelioma of the nasopharynx|stage i lymphoepithelioma of the nasopharynx
5269715|NCT00544336|stage I squamous cell carcinoma of the nasopharynx|stage i squamous cell carcinoma of the nasopharynx
5269716|NCT00544336|stage II lymphoepithelioma of the nasopharynx|stage ii lymphoepithelioma of the nasopharynx
5269717|NCT00544336|stage II squamous cell carcinoma of the nasopharynx|stage ii squamous cell carcinoma of the nasopharynx
5269718|NCT00544336|stage III lymphoepithelioma of the nasopharynx|stage iii lymphoepithelioma of the nasopharynx
5269719|NCT00544336|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
5269720|NCT00544336|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
5269721|NCT00544336|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
5269722|NCT00544336|recurrent lymphoepithelioma of the oropharynx|recurrent lymphoepithelioma of the oropharynx
5269817|NCT00544245|weight loss|weight loss
5269723|NCT00544336|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
5269724|NCT00544336|stage I lymphoepithelioma of the oropharynx|stage i lymphoepithelioma of the oropharynx
5269725|NCT00544336|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
5269726|NCT00544336|stage II lymphoepithelioma of the oropharynx|stage ii lymphoepithelioma of the oropharynx
5269727|NCT00544336|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
5269728|NCT00544336|stage III lymphoepithelioma of the oropharynx|stage iii lymphoepithelioma of the oropharynx
5269729|NCT00544336|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
5269730|NCT00544336|stage IV lymphoepithelioma of the oropharynx|stage iv lymphoepithelioma of the oropharynx
5269731|NCT00544336|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5269732|NCT00544336|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity
5269733|NCT00544336|recurrent inverted papilloma of the paranasal sinus and nasal cavity|recurrent inverted papilloma of the paranasal sinus and nasal cavity
5269734|NCT00544336|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity
5269735|NCT00544336|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
5269736|NCT00544336|stage I esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage i esthesioneuroblastoma of the paranasal sinus and nasal cavity
5269737|NCT00544336|stage I inverted papilloma of the paranasal sinus and nasal cavity|stage i inverted papilloma of the paranasal sinus and nasal cavity
5269738|NCT00544336|stage I midline lethal granuloma of the paranasal sinus and nasal cavity|stage i midline lethal granuloma of the paranasal sinus and nasal cavity
5269739|NCT00544336|stage I squamous cell carcinoma of the paranasal sinus and nasal cavity|stage i squamous cell carcinoma of the paranasal sinus and nasal cavity
5269740|NCT00544336|stage II esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage ii esthesioneuroblastoma of the paranasal sinus and nasal cavity
5269741|NCT00544336|stage II inverted papilloma of the paranasal sinus and nasal cavity|stage ii inverted papilloma of the paranasal sinus and nasal cavity
5269742|NCT00544336|stage II midline lethal granuloma of the paranasal sinus and nasal cavity|stage ii midline lethal granuloma of the paranasal sinus and nasal cavity
5269743|NCT00544336|stage II squamous cell carcinoma of the paranasal sinus and nasal cavity|stage ii squamous cell carcinoma of the paranasal sinus and nasal cavity
5269744|NCT00544336|stage III esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iii esthesioneuroblastoma of the paranasal sinus and nasal cavity
5269745|NCT00544336|stage III inverted papilloma of the paranasal sinus and nasal cavity|stage iii inverted papilloma of the paranasal sinus and nasal cavity
5269746|NCT00544336|stage III midline lethal granuloma of the paranasal sinus and nasal cavity|stage iii midline lethal granuloma of the paranasal sinus and nasal cavity
5269747|NCT00544336|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
5269748|NCT00544336|stage IV esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iv esthesioneuroblastoma of the paranasal sinus and nasal cavity
5269749|NCT00544336|stage IV inverted papilloma of the paranasal sinus and nasal cavity|stage iv inverted papilloma of the paranasal sinus and nasal cavity
5269750|NCT00544336|stage IV midline lethal granuloma of the paranasal sinus and nasal cavity|stage iv midline lethal granuloma of the paranasal sinus and nasal cavity
5269751|NCT00544336|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
5269752|NCT00544336|high-grade salivary gland mucoepidermoid carcinoma|high-grade salivary gland mucoepidermoid carcinoma
5269753|NCT00544336|low-grade salivary gland mucoepidermoid carcinoma|low-grade salivary gland mucoepidermoid carcinoma
5269754|NCT00544336|recurrent salivary gland cancer|recurrent salivary gland cancer
5269755|NCT00544336|salivary gland acinic cell tumor|salivary gland acinic cell tumor
5269756|NCT00544336|salivary gland adenocarcinoma|salivary gland adenocarcinoma
5269757|NCT00544336|salivary gland adenoid cystic carcinoma|salivary gland adenoid cystic carcinoma
5269758|NCT00544336|salivary gland anaplastic carcinoma|salivary gland anaplastic carcinoma
5269759|NCT00544336|salivary gland malignant mixed cell type tumor|salivary gland malignant mixed cell type tumor
5269760|NCT00544336|salivary gland poorly differentiated carcinoma|salivary gland poorly differentiated carcinoma
5269761|NCT00544336|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
5269762|NCT00544336|stage I salivary gland cancer|stage i salivary gland cancer
5269763|NCT00544336|stage II salivary gland cancer|stage ii salivary gland cancer
5269764|NCT00544336|stage III salivary gland cancer|stage iii salivary gland cancer
5269765|NCT00544336|stage IV salivary gland cancer|stage iv salivary gland cancer
5269766|NCT00544323|alveolar bone|alveolar bone
5269767|NCT00544323|radiographic alveolar bone changes around oral implants of various designs 12 m post loading|radiographic alveolar bone changes around oral implants of various designs 12 m post loading
5269768|NCT00544297|Actinic Keratosis|actinic keratosis
5269769|NCT00544297|Topical|topical
5269770|NCT00544297|Dermatology|dermatology
5269771|NCT00544297|Hand|hand
5269772|NCT00544284|adult glioblastoma|adult glioblastoma
5269773|NCT00544284|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5269774|NCT00544284|adult giant cell glioblastoma|adult giant cell glioblastoma
5269775|NCT00544284|recurrent adult brain tumor|recurrent adult brain tumor
5269776|NCT00544284|adult gliosarcoma|adult gliosarcoma
5269777|NCT00544284|adult mixed glioma|adult mixed glioma
5269778|NCT00544284|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
5269779|NCT00544284|primary central nervous system lymphoma|primary central nervous system lymphoma
5269780|NCT00544284|adult diffuse astrocytoma|adult diffuse astrocytoma
5269781|NCT00544284|adult brain stem glioma|adult brain stem glioma
5269782|NCT00544284|adult central nervous system germ cell tumor|adult central nervous system germ cell tumor
5269783|NCT00544284|adult choroid plexus tumor|adult choroid plexus tumor
5269784|NCT00544284|adult craniopharyngioma|adult craniopharyngioma
5269785|NCT00544284|adult ependymoblastoma|adult ependymoblastoma
5269786|NCT00544284|adult medulloblastoma|adult medulloblastoma
5269787|NCT00544284|adult supratentorial primitive neuroectodermal tumor (PNET)|adult supratentorial primitive neuroectodermal tumor (pnet)
5269788|NCT00544284|adult anaplastic ependymoma|adult anaplastic ependymoma
5269789|NCT00544284|adult ependymoma|adult ependymoma
5269790|NCT00544284|adult myxopapillary ependymoma|adult myxopapillary ependymoma
5269791|NCT00544284|adult subependymoma|adult subependymoma
5269792|NCT00544284|adult anaplastic meningioma|adult anaplastic meningioma
5269793|NCT00544284|adult melanocytic lesion|adult melanocytic lesion
5269794|NCT00544284|adult meningeal hemangiopericytoma|adult meningeal hemangiopericytoma
5269795|NCT00544284|adult grade I meningioma|adult grade i meningioma
5269796|NCT00544284|adult grade II meningioma|adult grade ii meningioma
5269797|NCT00544284|adult grade III meningioma|adult grade iii meningioma
5269798|NCT00544284|adult papillary meningioma|adult papillary meningioma
5269799|NCT00544284|adult oligodendroglioma|adult oligodendroglioma
5269800|NCT00544284|adult pineoblastoma|adult pineoblastoma
5269801|NCT00544284|adult pineocytoma|adult pineocytoma
5269802|NCT00544284|tumors metastatic to brain|tumors metastatic to brain
5269803|NCT00544284|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5269804|NCT00544284|adult pilocytic astrocytoma|adult pilocytic astrocytoma
5269805|NCT00544284|adult subependymal giant cell astrocytoma|adult subependymal giant cell astrocytoma
5269806|NCT00544271|BOOSTRIX|boostrix
5269807|NCT00544271|INFANRIX|infanrix
5269808|NCT00544258|Pharmacokinetic study|pharmacokinetic study
5269809|NCT00544258|Actinic Keratosis|actinic keratosis
5269810|NCT00544258|Topical|topical
5269811|NCT00544258|Dermatology|dermatology
5269812|NCT00544245|overweight|overweight
5269813|NCT00544245|obesity|obesity
5269814|NCT00544245|accelerometer|accelerometer
5269815|NCT00544245|pedometer|pedometer
5269816|NCT00544245|energy balance|energy balance
5269818|NCT00544245|weight maintenance|weight maintenance
5269819|NCT00544232|Breast Cancer|breast cancer
5269820|NCT00544232|neoadjuvant therapy|neoadjuvant therapy
5269821|NCT00544232|pCR rates|pcr rates
5269822|NCT00544219|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
5269823|NCT00544219|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5269824|NCT00544219|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
5269825|NCT00544219|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5269826|NCT00544219|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5269827|NCT00544193|adenocarcinoma of the extrahepatic bile duct|adenocarcinoma of the extrahepatic bile duct
5269828|NCT00544193|adenocarcinoma of the gallbladder|adenocarcinoma of the gallbladder
5269829|NCT00544193|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
5269830|NCT00544193|adenocarcinoma of the stomach|adenocarcinoma of the stomach
5269831|NCT00544193|stage I pancreatic cancer|stage i pancreatic cancer
5269832|NCT00544193|stage II pancreatic cancer|stage ii pancreatic cancer
5269833|NCT00544193|stage III pancreatic cancer|stage iii pancreatic cancer
5269834|NCT00544193|localized extrahepatic bile duct cancer|localized extrahepatic bile duct cancer
5269835|NCT00544193|recurrent extrahepatic bile duct cancer|recurrent extrahepatic bile duct cancer
5269836|NCT00544193|unresectable extrahepatic bile duct cancer|unresectable extrahepatic bile duct cancer
5269837|NCT00544193|localized gallbladder cancer|localized gallbladder cancer
5269838|NCT00544193|recurrent gallbladder cancer|recurrent gallbladder cancer
5269839|NCT00544193|unresectable gallbladder cancer|unresectable gallbladder cancer
5269840|NCT00544193|recurrent gastric cancer|recurrent gastric cancer
5269841|NCT00544193|stage II gastric cancer|stage ii gastric cancer
5269842|NCT00544193|stage III gastric cancer|stage iii gastric cancer
5269843|NCT00544193|stage IV gastric cancer|stage iv gastric cancer
5269844|NCT00544193|stage I gastric cancer|stage i gastric cancer
5270006|NCT00543686|Leukotriene|leukotriene
5269845|NCT00544193|recurrent pancreatic cancer|recurrent pancreatic cancer
5269846|NCT00544193|small intestine adenocarcinoma|small intestine adenocarcinoma
5269847|NCT00544193|stage IV pancreatic cancer|stage iv pancreatic cancer
5269848|NCT00544167|Breast Cancer|breast cancer
5269849|NCT00544167|Early Stage|early stage
5269850|NCT00544167|High Risk|high risk
5269851|NCT00544167|Node Positive|node positive
5269852|NCT00544167|Doxorubicin|doxorubicin
5269853|NCT00544167|Cyclophosphamide|cyclophosphamide
5269854|NCT00544167|Paclitaxel|paclitaxel
5269855|NCT00544167|Sorafenib|sorafenib
5269856|NCT00544154|CDP870|cdp870
5269857|NCT00544154|Certolizumab pegol|certolizumab pegol
5269858|NCT00544141|Temperature measurement|temperature measurement
5269859|NCT00544128|HIV|hiv
5269860|NCT00544128|initial therapy|initial therapy
5269861|NCT00544128|once daily|once daily
5269862|NCT00544128|randomized trial|randomized trial
5269863|NCT00544128|non inferiority|non inferiority
5269864|NCT00544128|Treatment Naive|treatment naive
5269865|NCT00544115|graft versus host disease|graft versus host disease
5269866|NCT00544115|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5269867|NCT00544115|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5269868|NCT00544115|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
5269869|NCT00544115|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
5269870|NCT00544115|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5269871|NCT00544115|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5269872|NCT00544115|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5269873|NCT00544115|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
5269874|NCT00544115|refractory anemia with excess blasts|refractory anemia with excess blasts
5269875|NCT00544115|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
5269876|NCT00544115|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5269877|NCT00544115|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
5269878|NCT00544115|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
5269879|NCT00544115|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5269880|NCT00544115|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5269881|NCT00544115|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5269882|NCT00544115|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
5269883|NCT00544115|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5269884|NCT00544115|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5269885|NCT00544115|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5269886|NCT00544115|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5269887|NCT00544115|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5269888|NCT00544115|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5269889|NCT00544115|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5269890|NCT00544115|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5269891|NCT00544115|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
5269892|NCT00544115|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5269893|NCT00544115|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5269894|NCT00544115|chronic eosinophilic leukemia|chronic eosinophilic leukemia
5269895|NCT00544115|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
5269896|NCT00544115|chronic neutrophilic leukemia|chronic neutrophilic leukemia
5269897|NCT00544115|essential thrombocythemia|essential thrombocythemia
5269898|NCT00544115|polycythemia vera|polycythemia vera
5269899|NCT00544115|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
5269900|NCT00544115|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5269901|NCT00544115|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5269902|NCT00544115|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5269903|NCT00544115|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5269904|NCT00544115|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5269905|NCT00544115|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5269906|NCT00544115|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5269907|NCT00544115|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5269908|NCT00544115|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5269909|NCT00544115|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5269910|NCT00544115|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5269911|NCT00544115|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5269912|NCT00544115|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5269913|NCT00544115|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5269914|NCT00544115|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5270003|NCT00543686|Responder Profiles|responder profiles
5270004|NCT00543686|Fluticasone|fluticasone
5269915|NCT00544115|recurrent childhood grade III lymphomatoid granulomatosis|recurrent childhood grade iii lymphomatoid granulomatosis
5269916|NCT00544115|childhood nasal type extranodal NK/T-cell lymphoma|childhood nasal type extranodal nk/t-cell lymphoma
5269917|NCT00544115|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
5269918|NCT00544115|childhood diffuse large cell lymphoma|childhood diffuse large cell lymphoma
5269919|NCT00544115|childhood immunoblastic large cell lymphoma|childhood immunoblastic large cell lymphoma
5269920|NCT00544115|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
5269921|NCT00544115|Burkitt lymphoma|burkitt lymphoma
5269922|NCT00544115|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
5269923|NCT00544115|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5269924|NCT00544115|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
5269925|NCT00544115|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
5269926|NCT00544115|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
5269927|NCT00544115|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
5269928|NCT00544115|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5269929|NCT00544115|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
5269930|NCT00544115|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5269931|NCT00544115|refractory multiple myeloma|refractory multiple myeloma
5269932|NCT00544115|stage III multiple myeloma|stage iii multiple myeloma
5269933|NCT00544115|aplastic anemia|aplastic anemia
5269934|NCT00544115|paroxysmal nocturnal hemoglobinuria|paroxysmal nocturnal hemoglobinuria
5269935|NCT00544115|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5269936|NCT00544115|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
5269937|NCT00544115|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5269938|NCT00544115|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5269939|NCT00544115|stage II multiple myeloma|stage ii multiple myeloma
5269940|NCT00544102|Insulin Resistance|insulin resistance
5269941|NCT00544102|Systemic Lupus Erythematosus|systemic lupus erythematosus
5269942|NCT00544102|Atherosclerosis|atherosclerosis
5269943|NCT00544102|Lupus|lupus
5269945|NCT00544089|azoospermia FISH IL-18 TESTICULAR BIOPSY|azoospermia fish il-18 testicular biopsy
5269946|NCT00544063|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5269947|NCT00544050|Levetiracetam|levetiracetam
5269948|NCT00544050|Keppra|keppra
5269949|NCT00544024|Mefloquine|mefloquine
5269950|NCT00544011|stage IV colon cancer|stage iv colon cancer
5269951|NCT00544011|stage IV rectal cancer|stage iv rectal cancer
5269952|NCT00544011|adenocarcinoma of the colon|adenocarcinoma of the colon
5269953|NCT00544011|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5269954|NCT00543998|Sinusitis|sinusitis
5269955|NCT00543985|metabolic syndrome|metabolic syndrome
5269956|NCT00543985|obesity|obesity
5269957|NCT00543985|exercise|exercise
5269958|NCT00543907|breast reconstruction|breast reconstruction
5269959|NCT00543907|DIEP flap|diep flap
5269960|NCT00543894|Antibiotic, ICU, hospital acquired infection.|antibiotic, icu, hospital acquired infection.
5269961|NCT00543881|telemedicine|telemedicine
5269962|NCT00543881|remote patient monitoring|remote patient monitoring
5269963|NCT00543881|chronic heart failure|chronic heart failure
5269964|NCT00543881|mortality|mortality
5269965|NCT00543881|health economics|health economics
5269966|NCT00543855|Lewy Body Disease|lewy body disease
5269967|NCT00543855|Dementia|dementia
5269968|NCT00543855|Clinical Trial|clinical trial
5269969|NCT00543855|Phase II|phase ii
5269970|NCT00543855|E2020|e2020
5269971|NCT00543855|donepezil hydrochloride|donepezil hydrochloride
5269972|NCT00543842|Rectal Cancer|rectal cancer
5269973|NCT00543842|Bevacizumab|bevacizumab
5269974|NCT00543842|Erlotinib|erlotinib
5269975|NCT00543842|Capecitabine|capecitabine
5269976|NCT00543829|breast cancer|breast cancer
5269977|NCT00543829|doxorubicin|doxorubicin
5269978|NCT00543829|docetaxel|docetaxel
5269979|NCT00543829|tamoxifen|tamoxifen
5269980|NCT00543777|Liver Cancer|liver cancer
5269981|NCT00543777|Magnetic Resonance Elastography|magnetic resonance elastography
5269982|NCT00543777|2-Point Dixon Magnetic Resonance Imaging|2-point dixon magnetic resonance imaging
5269983|NCT00543777|Liver Disease|liver disease
5269984|NCT00543777|Fatty Liver|fatty liver
5269985|NCT00543777|Liver Fibrosis|liver fibrosis
5269986|NCT00543777|Liver Cirrhosis|liver cirrhosis
5269987|NCT00543777|MRE|mre
5269988|NCT00543777|2PD MRI|2pd mri
5269989|NCT00543777|phase correction algorithm|phase correction algorithm
5269990|NCT00543764|Intraoperative Pathway|intraoperative pathway
5269991|NCT00543764|Breast Reconstruction|breast reconstruction
5269992|NCT00543764|DIEP flap|diep flap
5269993|NCT00543725|Antiretroviral|antiretroviral
5269994|NCT00543725|HIV-1|hiv-1
5269995|NCT00543725|AIDS|aids
5269996|NCT00543725|TMC278-C215|tmc278-c215
5269997|NCT00543725|TMC278-TiDP6-C215|tmc278-tidp6-c215
5269998|NCT00543725|Treatment Naive|treatment naive
5269999|NCT00543712|Sarcoma|sarcoma
5270000|NCT00543712|synovial sarcoma|synovial sarcoma
5270001|NCT00543712|APM4171g|apm4171g
5270002|NCT00543686|Pre-School Asthma|pre-school asthma
5270007|NCT00543686|Children with Pre-School Asthma|children with pre-school asthma
5270008|NCT00543673|Healthy term infants|healthy term infants
5270009|NCT00543660|Corneal transplantation, Descemet membrane, endothelium|corneal transplantation, descemet membrane, endothelium
5270010|NCT00543647|Fenofibrate|fenofibrate
5270011|NCT00543647|Glomerular filtration rate|glomerular filtration rate
5270012|NCT00543647|inulin clearance|inulin clearance
5270013|NCT00543647|creatinine|creatinine
5270014|NCT00543647|healthy volunteers|healthy volunteers
5270015|NCT00543647|cross-over|cross-over
5270016|NCT00543608|pneumonia|pneumonia
5270017|NCT00543608|nosocomial pneumonia|nosocomial pneumonia
5270018|NCT00543569|kidney transplant|kidney transplant
5270019|NCT00543569|alefacept|alefacept
5270020|NCT00543530|HIV|hiv
5270021|NCT00543530|Treatment Experienced|treatment experienced
5270022|NCT00543504|Advanced Cancer|advanced cancer
5270023|NCT00543504|Bevacizumab|bevacizumab
5270024|NCT00543504|Avastin|avastin
5270025|NCT00543504|Sorafenib|sorafenib
5270026|NCT00543504|BAY 43-9006|bay 43-9006
5270027|NCT00543504|Erlotinib|erlotinib
5270028|NCT00543504|OSI-774|osi-774
5270029|NCT00543504|Tarceva|tarceva
5270030|NCT00543504|Trastuzumab|trastuzumab
5270031|NCT00543504|Herceptin|herceptin
5270032|NCT00543504|Sunitinib|sunitinib
5270033|NCT00543504|SU011248|su011248
5270034|NCT00543504|Sutent|sutent
5270035|NCT00543504|Cetuximab|cetuximab
5270036|NCT00543504|Lapatinib|lapatinib
5270037|NCT00543504|Tykerb|tykerb
5270038|NCT00543504|Anti-VEGF monoclonal antibody|anti-vegf monoclonal antibody
5270039|NCT00543504|rhuMAb-VEGF|rhumab-vegf
5270040|NCT00543504|Erlotinib hydrochloride|erlotinib hydrochloride
5270041|NCT00543504|GW572016|gw572016
5270042|NCT00543504|Sunitinib Malate|sunitinib malate
5270043|NCT00543478|Irritable bowel syndrome|irritable bowel syndrome
5270044|NCT00543478|Diarrhea|diarrhea
5270045|NCT00543478|Probiotics|probiotics
5270046|NCT00543426|Fuzheng Huayu Tablets|fuzheng huayu tablets
5270047|NCT00543426|Multicenter clinical study|multicenter clinical study
5270048|NCT00543400|Percutaneous Coronary Intervention (PCI)|percutaneous coronary intervention (pci)
5270049|NCT00543348|BALLOON ANGIOPLASTY|balloon angioplasty
5270050|NCT00543348|AUTOGENOUS FISTULA|autogenous fistula
5270051|NCT00543335|Non-Small Cell Lung Cancer|non-small cell lung cancer
5270052|NCT00543335|Lung Cancer|lung cancer
5270053|NCT00543335|NSCLC|nsclc
5270054|NCT00543335|Radiation Therapy|radiation therapy
5270055|NCT00543335|Sorafenib|sorafenib
5270056|NCT00543335|BAY 43-9006|bay 43-9006
5270057|NCT00543335|Thoracic Radiation|thoracic radiation
5270058|NCT00543309|Fontan Operation|fontan operation
5270059|NCT00543309|Cardiopulmonary Bypass|cardiopulmonary bypass
5270060|NCT00543309|Heart Defects, Congenital|heart defects, congenital
5270061|NCT00543309|Milrinone|milrinone
5270062|NCT00543309|Natriuretic peptide, brain|natriuretic peptide, brain
5270063|NCT00543296|uveitis|uveitis
5270064|NCT00543296|Cystoid Macular Edema (CME)|cystoid macular edema (cme)
5270065|NCT00543296|fluocinolone acetonide|fluocinolone acetonide
5270066|NCT00543296|non-infectious uveitis affecting the posterior segment|non-infectious uveitis affecting the posterior segment
5270067|NCT00543270|EVAR|evar
5270068|NCT00543270|AAA|aaa
5270069|NCT00543270|Aneurysm|aneurysm
5270070|NCT00543270|Powerlink|powerlink
5270071|NCT00543244|Chronic hepatitis C|chronic hepatitis c
5270072|NCT00543244|Pegylated interferon|pegylated interferon
5270073|NCT00543244|Ribavirin|ribavirin
5270074|NCT00543244|Virokinetics|virokinetics
5270075|NCT00543231|ECOG|ecog
5270076|NCT00543231|MRT|mrt
5270077|NCT00543231|NCI CTC|nci ctc
5270078|NCT00543231|SAE|sae
5270079|NCT00543231|Short Intravenous Infusion to Patients with Solid Tumors|short intravenous infusion to patients with solid tumors
5270080|NCT00543192|Endometrial Cancer|endometrial cancer
5270081|NCT00543192|Sexual Function|sexual function
5270082|NCT00543166|Sjögren's syndrome|sjögren's syndrome
5270083|NCT00543166|fatigue|fatigue
5270084|NCT00543166|salivary gland|salivary gland
5270085|NCT00543166|dehydroepiandrosterone|dehydroepiandrosterone
5270086|NCT00543153|Advanced Cancer|advanced cancer
5270087|NCT00543153|Exceptional Patient|exceptional patient
5270088|NCT00543153|Cancer Care|cancer care
5270089|NCT00543153|Interview|interview
5270090|NCT00543140|Obesity|obesity
5270091|NCT00543140|Morbid Obesity|morbid obesity
5270092|NCT00543114|CLL|cll
5270093|NCT00543114|SLL|sll
5270094|NCT00543114|Revlimid|revlimid
5270095|NCT00543114|lenalidomide|lenalidomide
5270096|NCT00543101|HIV/AIDS|hiv/aids
5270097|NCT00543101|darunavir|darunavir
5270098|NCT00543101|Protease inhibitors|protease inhibitors
5270099|NCT00543101|Dual boosted|dual boosted
5270100|NCT00543101|Treatment experienced|treatment experienced
5270101|NCT00543088|Schizophrenia|schizophrenia
5270102|NCT00543088|Bipolar Disorder|bipolar disorder
5270103|NCT00543088|manic episode|manic episode
5270104|NCT00543088|atypical antipsychotic|atypical antipsychotic
5270105|NCT00543088|Schizophrenia or Bipolar Disorder (currently in a manic episode)|schizophrenia or bipolar disorder (currently in a manic episode)
5270106|NCT00543075|Renal Function|renal function
5270107|NCT00543075|Adult|adult
5270108|NCT00543075|Genasense|genasense
5270109|NCT00543075|oblimersen|oblimersen
5270110|NCT00543075|G3139|g3139
5270111|NCT00543075|Genta|genta
5270112|NCT00543075|Pharmacokinetics|pharmacokinetics
5270113|NCT00543049|platinum refractory|platinum refractory
5270114|NCT00543049|epithelial ovarian cancer|epithelial ovarian cancer
5270115|NCT00543049|primary cancer of the peritoneum|primary cancer of the peritoneum
5270116|NCT00543049|cancer of the fallopian tube|cancer of the fallopian tube
5270117|NCT00543036|Cannabis|cannabis
5270118|NCT00543036|Addiction|addiction
5270119|NCT00543036|Craving|craving
5270120|NCT00543036|TMS|tms
5270121|NCT00542997|Subcutaneous immune globulin|subcutaneous immune globulin
5270122|NCT00542997|SCIG|scig
5270123|NCT00542971|Leukemia|leukemia
5270124|NCT00542971|AML|aml
5270125|NCT00542971|High-Risk MDS|high-risk mds
5270126|NCT00542971|Acute Myeloid Leukemia|acute myeloid leukemia
5270127|NCT00542971|High-Risk Myelodysplastic Disorder|high-risk myelodysplastic disorder
5270128|NCT00542971|Idarubicin|idarubicin
5270129|NCT00542971|Ara-C|ara-c
5270130|NCT00542971|Cytarabine|cytarabine
5270131|NCT00542971|Sorafenib|sorafenib
5270132|NCT00542971|BAY43-9006|bay43-9006
5270133|NCT00542958|Cancer|cancer
5270134|NCT00542958|Refractory solid tumor|refractory solid tumor
5270135|NCT00542945|Heart Failure|heart failure
5270136|NCT00542945|ICD|icd
5270137|NCT00542945|Dilated cardiomyopathy|dilated cardiomyopathy
5270138|NCT00542932|COPD|copd
5270139|NCT00542932|Exercise|exercise
5270140|NCT00542932|Home|home
5270141|NCT00542906|healthy volunteers|healthy volunteers
5270142|NCT00542906|Somatosensory stimuli|somatosensory stimuli
5270143|NCT00542906|fMRI|fmri
5270144|NCT00542906|second somatosensory area|second somatosensory area
5270145|NCT00542906|insular cortex|insular cortex
5270146|NCT00542906|functional anatomy|functional anatomy
5270147|NCT00542893|bcl-2|bcl-2
5270148|NCT00542893|CFR|cfr
5270149|NCT00542893|DTIC|dtic
5270150|NCT00542893|ECOG|ecog
5270151|NCT00542893|EMEA|emea
5270152|NCT00542893|MedDRA|meddra
5270153|NCT00542893|NCI CTC|nci ctc
5270154|NCT00542893|SAE|sae
5270155|NCT00542880|COPD|copd
5270156|NCT00542880|Symbicort|symbicort
5270157|NCT00542880|Seretide|seretide
5270158|NCT00542867|Hypercholesterolemia|hypercholesterolemia
5270159|NCT00542867|Third Joint European Task Force guidelines|third joint european task force guidelines
5270160|NCT00542867|Survey|survey
5270161|NCT00542854|arrhythmia|arrhythmia
5270162|NCT00542854|pacemaker|pacemaker
5270163|NCT00542854|defibrillator|defibrillator
5270164|NCT00542854|electromagnetic interference|electromagnetic interference
5270165|NCT00542841|Adrenal Hyperplasia, Congenital|adrenal hyperplasia, congenital
5270291|NCT00542334|CGMS|cgms
5270166|NCT00542841|Steroid Biosynthesis Disorders|steroid biosynthesis disorders
5270167|NCT00542815|Chronic Kidney Disease|chronic kidney disease
5270168|NCT00542815|Dialysis|dialysis
5270169|NCT00542815|Hyperphosphatemia|hyperphosphatemia
5270170|NCT00542802|post stroke epileptic late onset seizures|post stroke epileptic late onset seizures
5270171|NCT00542789|gastrointestinal|gastrointestinal
5270172|NCT00542789|GI|gi
5270173|NCT00542789|NSAID|nsaid
5270174|NCT00542789|Japan|japan
5270175|NCT00542789|Japanese|japanese
5270176|NCT00542789|Gastric ulcer|gastric ulcer
5270177|NCT00542789|duodenal ulcer|duodenal ulcer
5270178|NCT00542776|inflammatory bowel disease (IBD)|inflammatory bowel disease (ibd)
5270179|NCT00542776|immunosuppressed or non-immunosuppressed|immunosuppressed or non-immunosuppressed
5270180|NCT00542776|influenza vaccine|influenza vaccine
5270181|NCT00542776|antibody titers|antibody titers
5270182|NCT00542776|seroprotective titers|seroprotective titers
5270183|NCT00542776|vaccine-associated adverse events|vaccine-associated adverse events
5270184|NCT00542763|Sjogren's syndrome|sjogren's syndrome
5270185|NCT00542763|Mycophenolate sodium|mycophenolate sodium
5270186|NCT00542750|Cannabis|cannabis
5270187|NCT00542750|Marijuana|marijuana
5270188|NCT00542750|Pharmacotherapy|pharmacotherapy
5270189|NCT00542750|Adolescent|adolescent
5270190|NCT00542737|Acute Lung Injury|acute lung injury
5270191|NCT00542737|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
5270192|NCT00542737|Acute Respiratory Failure|acute respiratory failure
5270193|NCT00542737|Web-Based Intervention|web-based intervention
5270194|NCT00542737|Lung Preventive Ventilation|lung preventive ventilation
5270195|NCT00542724|Insulin|insulin
5270196|NCT00542724|Diabetes Mellitus type I|diabetes mellitus type i
5270197|NCT00542724|Juvenile diabetes|juvenile diabetes
5270198|NCT00542711|Curcumin|curcumin
5270199|NCT00542711|Bioavilability|bioavilability
5270200|NCT00542711|Healthy subjects|healthy subjects
5270201|NCT00542698|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
5270202|NCT00542698|Glucose Monitor graphs|glucose monitor graphs
5270203|NCT00542698|Physical Activity|physical activity
5270204|NCT00542672|Mexican American|mexican american
5270205|NCT00542672|Dietary Intake|dietary intake
5270206|NCT00542672|Child-Feeding Practices|child-feeding practices
5270207|NCT00542672|Weight|weight
5270208|NCT00542672|Cultural Values|cultural values
5270209|NCT00542659|Atrial fibrillation|atrial fibrillation
5270210|NCT00542659|Maze procedure|maze procedure
5270863|NCT00539500|ClinicMACS|clinicmacs
5270211|NCT00542633|Diabetes mellitus type 2|diabetes mellitus type 2
5270212|NCT00542633|Diabetes|diabetes
5270213|NCT00542633|Insulin|insulin
5270214|NCT00542633|NIDDM|niddm
5270215|NCT00542633|Rapid acting|rapid acting
5270216|NCT00542607|Levocetirizine dihydrochloride|levocetirizine dihydrochloride
5270217|NCT00542607|Xyzal tablets|xyzal tablets
5270218|NCT00542594|breast cancer|breast cancer
5270219|NCT00542594|anastrozole|anastrozole
5270220|NCT00542581|Visual Outcomes|visual outcomes
5270221|NCT00542581|Patient Satisfaction|patient satisfaction
5270222|NCT00542581|Ophthalmology|ophthalmology
5270223|NCT00542581|Cataractous Lens|cataractous lens
5270224|NCT00542542|Breast Cancer|breast cancer
5270225|NCT00542542|Reconstructive Surgery|reconstructive surgery
5270226|NCT00542542|Paravertebral Block|paravertebral block
5270227|NCT00542542|Anesthesia|anesthesia
5270228|NCT00542542|Propofol|propofol
5270229|NCT00542542|Fentanyl|fentanyl
5270230|NCT00542542|Ropivacaine|ropivacaine
5270231|NCT00542542|Midazolam|midazolam
5270232|NCT00542529|Healthy Subjects|healthy subjects
5270233|NCT00542516|Hip Replacement Arthroplasty|hip replacement arthroplasty
5270234|NCT00542516|Hydroxyethyl Starch|hydroxyethyl starch
5270235|NCT00542516|Hemodilution|hemodilution
5270236|NCT00542516|Hetastarch|hetastarch
5270237|NCT00542516|Colloids|colloids
5270238|NCT00542503|Cardiac Outcomes|cardiac outcomes
5270239|NCT00542503|MRI|mri
5270240|NCT00542503|Cardiac Stress Testing|cardiac stress testing
5270241|NCT00542490|Endometrial cancer|endometrial cancer
5270242|NCT00542490|Gynecologic Cancer|gynecologic cancer
5270243|NCT00542490|Vaginal Cuff Brachytherapy|vaginal cuff brachytherapy
5270244|NCT00542490|Vaginal radiation|vaginal radiation
5270245|NCT00542464|Safety in Healthy Adult Subjects|safety in healthy adult subjects
5270246|NCT00542451|node-negative breast cancer|node-negative breast cancer
5270247|NCT00542451|HER-2 positive|her-2 positive
5270248|NCT00542438|Cardiovascular Disease|cardiovascular disease
5270249|NCT00542438|Cancer Prevention|cancer prevention
5270250|NCT00542438|Physical Activity|physical activity
5270251|NCT00542438|Body Composition|body composition
5270252|NCT00542438|Environment|environment
5270253|NCT00542438|Exercise|exercise
5270254|NCT00542425|osteoporosis|osteoporosis
5270255|NCT00542425|postmenopausal|postmenopausal
5270256|NCT00542425|bone loss|bone loss
5270257|NCT00542399|levemir|levemir
5270258|NCT00542399|type 1 diabetes|type 1 diabetes
5270259|NCT00542386|Chronic Kidney Disease|chronic kidney disease
5270260|NCT00542386|Dialysis|dialysis
5270261|NCT00542386|Hyperphosphatemia|hyperphosphatemia
5270262|NCT00542386|Dyslipidemia|dyslipidemia
5270263|NCT00542386|Phosphate binder|phosphate binder
5270264|NCT00542373|Oral Cancer|oral cancer
5270265|NCT00542373|Oral Cavity Mucosa|oral cavity mucosa
5270266|NCT00542373|Leukoplakia|leukoplakia
5270267|NCT00542373|Erythroplakia|erythroplakia
5270268|NCT00542373|Fluorescence Imaging|fluorescence imaging
5270269|NCT00542373|Reflectance Imaging|reflectance imaging
5270270|NCT00542373|Multispectral Digital Microscope|multispectral digital microscope
5270271|NCT00542373|Portable Spectroscopy System|portable spectroscopy system
5270272|NCT00542373|Fast Excitation-Emission Matrix|fast excitation-emission matrix
5270273|NCT00542373|PS2|ps2
5270274|NCT00542373|MDM|mdm
5270275|NCT00542373|Fast EEM4|fast eem4
5270276|NCT00542360|Accidental Falls|accidental falls
5270277|NCT00542360|Aged|aged
5270278|NCT00542360|Social Marketing|social marketing
5270279|NCT00542360|Exercise|exercise
5270280|NCT00542360|Accident Prevention|accident prevention
5270281|NCT00542360|Religion|religion
5270282|NCT00542360|Randomized Controlled Trial|randomized controlled trial
5270283|NCT00542347|gastric acid|gastric acid
5270284|NCT00542347|proton pump inhibitors|proton pump inhibitors
5270285|NCT00542347|omeprazole|omeprazole
5270286|NCT00542347|esomeprazole|esomeprazole
5270287|NCT00542334|Nocturnal Hypoglycemia|nocturnal hypoglycemia
5270288|NCT00542334|Type 1 diabetes|type 1 diabetes
5270289|NCT00542334|Children|children
5270290|NCT00542334|Adolescents|adolescents
5270292|NCT00542321|lateral rotation|lateral rotation
5270293|NCT00542321|kinetic therapy|kinetic therapy
5270294|NCT00542321|mechanical ventilation|mechanical ventilation
5270295|NCT00542321|pulmonary complications|pulmonary complications
5270296|NCT00542282|lung sounds,|lung sounds,
5270297|NCT00542282|airway obstruction,|airway obstruction,
5270298|NCT00542282|asthma,|asthma,
5270299|NCT00542282|auscultation|auscultation
5270300|NCT00542269|Hypertension|hypertension
5270301|NCT00542269|Metabolic Syndrome|metabolic syndrome
5270302|NCT00542269|Dual combination therapy|dual combination therapy
5270303|NCT00542269|Triple combination therapy|triple combination therapy
5270304|NCT00542269|Aliskiren|aliskiren
5270305|NCT00542269|Direct Renin inhibitor|direct renin inhibitor
5270306|NCT00542256|Apoplexy|apoplexy
5270307|NCT00542256|Cerebral Stroke|cerebral stroke
5270308|NCT00542256|Cerebrovascular Accident, Acute|cerebrovascular accident, acute
5270309|NCT00542256|Cerebrovascular Apoplexy|cerebrovascular apoplexy
5270310|NCT00542256|Cerebrovascular Stroke|cerebrovascular stroke
5270311|NCT00542256|CVA (Cerebrovascular Accident)|cva (cerebrovascular accident)
5270312|NCT00542256|Stroke|stroke
5270313|NCT00542256|Stroke, Acute|stroke, acute
5270314|NCT00542256|Vascular Accident, Brain|vascular accident, brain
5270315|NCT00542243|enlarged prostate|enlarged prostate
5270316|NCT00542243|finasteride|finasteride
5270317|NCT00542230|Erythrocytes|erythrocytes
5270318|NCT00542230|Drug Screen|drug screen
5270319|NCT00542230|Sickle Cell Trait|sickle cell trait
5270320|NCT00542230|Sickle Cell Disease|sickle cell disease
5270321|NCT00542217|Healthy Volunteers|healthy volunteers
5270322|NCT00542204|Diabetes|diabetes
5270323|NCT00542204|Blood Glucose Self-Monitoring|blood glucose self-monitoring
5270324|NCT00542204|Home Blood Glucose Monitoring|home blood glucose monitoring
5270325|NCT00542204|Internet|internet
5270326|NCT00542204|Personal Health Record (PHR)|personal health record (phr)
5270327|NCT00542204|Health Information Technology (HIT)|health information technology (hit)
5270328|NCT00542204|Care management|care management
5270329|NCT00542204|Disease Management|disease management
5270330|NCT00542204|Diabetes self-management|diabetes self-management
5270331|NCT00542204|Consumer Health Information|consumer health information
5270332|NCT00542204|Medical Records Systems, Computerized|medical records systems, computerized
5270333|NCT00542204|Computerized Medical Records System|computerized medical records system
5270334|NCT00542204|Automated Medical Records System|automated medical records system
5270335|NCT00542204|Electronic Health Record (EHR)|electronic health record (ehr)
5270336|NCT00542204|Remote patient monitoring|remote patient monitoring
5270337|NCT00542191|Triple negative (ER/PR negative; HER2 negative)|triple negative (er/pr negative; her2 negative)
5270338|NCT00542178|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
5270339|NCT00542178|Cardiovascular Diseases|cardiovascular diseases
5270340|NCT00542152|IBD|ibd
5270341|NCT00542152|Ulcerative colitis|ulcerative colitis
5270342|NCT00542152|refractory to steroids|refractory to steroids
5270343|NCT00542139|Osteoarthritis|osteoarthritis
5270344|NCT00542139|Knee arthroplasty|knee arthroplasty
5270345|NCT00542139|Steroid injection|steroid injection
5270346|NCT00542139|Rehabilitation|rehabilitation
5270347|NCT00542126|GnRH analog, IVF, infertility, frozen-thawed embryos|gnrh analog, ivf, infertility, frozen-thawed embryos
5270348|NCT00542113|Parental|parental
5270349|NCT00542113|Parents|parents
5270350|NCT00542113|Prevention|prevention
5270351|NCT00542113|Energy balance|energy balance
5270352|NCT00542113|Glucose regulation|glucose regulation
5270353|NCT00542113|Healthy lifestyles|healthy lifestyles
5270354|NCT00542113|Healthy families|healthy families
5270355|NCT00542113|Active living|active living
5270356|NCT00542074|Bacterial vaginosis|bacterial vaginosis
5270357|NCT00542074|recurrence|recurrence
5270358|NCT00542074|male factor|male factor
5270359|NCT00542061|COPD|copd
5270360|NCT00542061|Asthma|asthma
5270361|NCT00542061|Lung function|lung function
5270362|NCT00542061|Monitoring|monitoring
5270363|NCT00542061|Primary Care|primary care
5270364|NCT00542048|Hepatic metastases|hepatic metastases
5270365|NCT00542048|Angiogenesis|angiogenesis
5270366|NCT00542048|EndoTAG-1|endotag-1
5270367|NCT00542048|Pharmacokinetics|pharmacokinetics
5270368|NCT00542048|Pharmacodynamics|pharmacodynamics
5270369|NCT00542048|Metastases of the liver|metastases of the liver
5270370|NCT00542035|Analgesia|analgesia
5270371|NCT00542009|Phase 2A, safety and efficacy trial with CE-326,597 in patients with T2DM.|phase 2a, safety and efficacy trial with ce-326,597 in patients with t2dm.
5270372|NCT00541983|Diabetes|diabetes
5270373|NCT00541983|Type 2|type 2
5270374|NCT00541983|Mellitus|mellitus
5270375|NCT00541970|viral infections|viral infections
5270376|NCT00541970|Human Papillomavirus (HPV) vaccine|human papillomavirus (hpv) vaccine
5270377|NCT00541970|safety|safety
5270378|NCT00541970|vaccine|vaccine
5270379|NCT00541970|immunogenicity|immunogenicity
5270380|NCT00541970|cervical cancer|cervical cancer
5270381|NCT00541957|Major depression|major depression
5270382|NCT00541957|Primary care|primary care
5270383|NCT00541944|hyponatremia|hyponatremia
5270384|NCT00541944|diagnosis and treatment of hyponatremia|diagnosis and treatment of hyponatremia
5270385|NCT00541944|classification of hyponatremia|classification of hyponatremia
5270386|NCT00541918|sevoflurane,|sevoflurane,
5270387|NCT00541918|propofol,|propofol,
5270388|NCT00541918|heart surgery,|heart surgery,
5270389|NCT00541918|cardiopulmonary bypass,|cardiopulmonary bypass,
5270390|NCT00541918|memory disorders,|memory disorders,
5270391|NCT00541892|Cell Culture Techniques|cell culture techniques
5270392|NCT00541879|Childhood|childhood
5270393|NCT00541879|Prevention|prevention
5270394|NCT00541879|Energy balance|energy balance
5270395|NCT00541879|Glucose regulation|glucose regulation
5270396|NCT00541879|Healthy lifestyle|healthy lifestyle
5270397|NCT00541879|Healthy eating|healthy eating
5270398|NCT00541879|Active living|active living
5270399|NCT00541866|Leukemia|leukemia
5270400|NCT00541866|Acute Myeloid|acute myeloid
5270401|NCT00541866|Relapsed|relapsed
5270402|NCT00541866|Refractory|refractory
5270403|NCT00541866|Cancer|cancer
5270404|NCT00541866|AML|aml
5270405|NCT00541866|Cytarabine|cytarabine
5270406|NCT00541866|SNS-595|sns-595
5270407|NCT00541866|Phase 1|phase 1
5270408|NCT00541866|Voreloxin|voreloxin
5270409|NCT00541853|Autosomal Dominant Polycystic Kidney Disease|autosomal dominant polycystic kidney disease
5270410|NCT00541853|Hypertension|hypertension
5270411|NCT00541853|Angiotensin-2 Receptor Blocker|angiotensin-2 receptor blocker
5270412|NCT00541853|Calcium Channel Blocker|calcium channel blocker
5270413|NCT00541853|Kidney Volume|kidney volume
5270414|NCT00541840|Sarcoma|sarcoma
5270415|NCT00541840|Sorafenib|sorafenib
5270416|NCT00541840|GEIS|geis
5270417|NCT00541827|Sepsis. Shock, septic. Mitochondria.|sepsis. shock, septic. mitochondria.
5270418|NCT00541814|Renal Transplantation|renal transplantation
5270419|NCT00541814|Calcineurin Inhibitor|calcineurin inhibitor
5270420|NCT00541814|Cyclosporine|cyclosporine
5270421|NCT00541814|Withdrawal|withdrawal
5270422|NCT00541814|Minimisation|minimisation
5270423|NCT00541762|Neurotensin|neurotensin
5270424|NCT00541762|Human|human
5270425|NCT00541762|Physiology of neurotensin|physiology of neurotensin
5270426|NCT00541762|fat perfusion|fat perfusion
5270427|NCT00541762|healthy subjects|healthy subjects
5270428|NCT00541749|SLE|sle
5270429|NCT00541736|Familial Hemiplegic Migraine|familial hemiplegic migraine
5270430|NCT00541710|menopause|menopause
5270431|NCT00541710|genistein|genistein
5270432|NCT00541710|pre-diabetes|pre-diabetes
5270433|NCT00541671|Narcotics|narcotics
5270434|NCT00541671|Nausea|nausea
5270435|NCT00541619|hypertension|hypertension
5270436|NCT00541619|sympathetic activity|sympathetic activity
5270437|NCT00541619|early renal damage|early renal damage
5270438|NCT00541606|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
5270439|NCT00541606|Pharmaceutical Care|pharmaceutical care
5270440|NCT00541606|Collaborative Practice|collaborative practice
5270441|NCT00541593|Pancreatic pseudocyst|pancreatic pseudocyst
5270442|NCT00541593|NOTES|notes
5270443|NCT00541567|Wheight management in T2D|wheight management in t2d
5270444|NCT00541515|Type 1 diabetes|type 1 diabetes
5270445|NCT00541515|Artificial pancreas|artificial pancreas
5270446|NCT00541515|Insulin Pump|insulin pump
5270447|NCT00541502|evaluate the effectiveness of improving cognitive function of aripiprazole in treating adolescents and young adults with psychotic disorder in Taiwan|evaluate the effectiveness of improving cognitive function of aripiprazole in treating adolescents and young adults with psychotic disorder in taiwan
5270448|NCT00541489|Osteoarthritis|osteoarthritis
5270449|NCT00541489|Osteoarthritis, Hip|osteoarthritis, hip
5270450|NCT00541463|HIV|hiv
5270451|NCT00541463|Treatment Experienced|treatment experienced
5270452|NCT00541437|Change from baseline of HbA1c after 16 weeks of treatment|change from baseline of hba1c after 16 weeks of treatment
5270453|NCT00541437|Change from baseline of FPG after 16 weeks of treatment|change from baseline of fpg after 16 weeks of treatment
5270454|NCT00541437|Change from baseline of diabetes self-care scale by patient on drug administration after 16 weeks of treatment|change from baseline of diabetes self-care scale by patient on drug administration after 16 weeks of treatment
5270455|NCT00541424|Mantle Cell Lymphoma|mantle cell lymphoma
5270456|NCT00541424|Lymphoma|lymphoma
5270457|NCT00541424|CT Colonography|ct colonography
5270458|NCT00541424|PET Scan|pet scan
5270459|NCT00541424|PET/CT Scan|pet/ct scan
5270460|NCT00541424|Gas Insufflation|gas insufflation
5270461|NCT00541398|Antipsychotic polypharmacy|antipsychotic polypharmacy
5270462|NCT00541398|Schizophrenia|schizophrenia
5270463|NCT00541398|Implementation of clinical guidelines|implementation of clinical guidelines
5270464|NCT00541385|malaria|malaria
5270465|NCT00541385|pediatric|pediatric
5270466|NCT00541385|Africa|africa
5270467|NCT00541385|Phillipines|phillipines
5270468|NCT00541385|Coartem|coartem
5270469|NCT00541385|Artesunate|artesunate
5270470|NCT00541385|lumefantrine|lumefantrine
5270471|NCT00541385|Arthemeter|arthemeter
5270472|NCT00541385|pyronaridine|pyronaridine
5270473|NCT00541385|Pyramax|pyramax
5270474|NCT00541346|Autism|autism
5270475|NCT00541346|Autism Spectrum Disorders|autism spectrum disorders
5270476|NCT00541346|ADHD|adhd
5270477|NCT00541333|Dry Age Related Macular Degeneration|dry age related macular degeneration
5270478|NCT00541333|Dry AMD|dry amd
5270479|NCT00541320|Anti-thrombolytic direct Factor Xa inhibitor|anti-thrombolytic direct factor xa inhibitor
5270480|NCT00541307|Peripheral Arterial Disease|peripheral arterial disease
5270481|NCT00541307|Peripheral Vascular Disease|peripheral vascular disease
5270482|NCT00541294|Tuberculosis|tuberculosis
5270483|NCT00541294|HIV|hiv
5270484|NCT00541294|Diagnostics|diagnostics
5270485|NCT00541294|Pediatrics|pediatrics
5270486|NCT00541281|prostate cancer|prostate cancer
5270487|NCT00541281|hormone resistant|hormone resistant
5270488|NCT00541281|metastatic|metastatic
5270489|NCT00541281|estramustine combine to docetaxel|estramustine combine to docetaxel
5270490|NCT00541281|randomized study|randomized study
5270491|NCT00541268|Heart Failure|heart failure
5270492|NCT00541268|ICD|icd
5270493|NCT00541268|Dilated cardiomyopathy|dilated cardiomyopathy
5270494|NCT00541255|Bronchial Asthma|bronchial asthma
5270495|NCT00541255|Food Allergy|food allergy
5270496|NCT00541255|Bronchial Hyperresponsiveness|bronchial hyperresponsiveness
5270497|NCT00541216|congenital myasthenia|congenital myasthenia
5270498|NCT00541216|ephedrine|ephedrine
5270499|NCT00541203|tomography|tomography
5270500|NCT00541203|coronary artery disease|coronary artery disease
5270501|NCT00541203|Stress Test|stress test
5270502|NCT00541203|Coronary Angiography|coronary angiography
5270503|NCT00541190|cystic fibrosis|cystic fibrosis
5270504|NCT00541190|mucociliary clearance|mucociliary clearance
5270505|NCT00541190|outcome measures|outcome measures
5270506|NCT00541177|prevention myopia|prevention myopia
5270507|NCT00541164|CMT|cmt
5270508|NCT00541164|Charcot-Marie Tooth|charcot-marie tooth
5270509|NCT00541164|CoQ10|coq10
5270510|NCT00541164|Coenzyme Q10|coenzyme q10
5270511|NCT00541151|Stress urinary incontinence in Women|stress urinary incontinence in women
5270512|NCT00541138|tumors metastatic to brain|tumors metastatic to brain
5270513|NCT00541138|recurrent adult brain tumor|recurrent adult brain tumor
5270514|NCT00541138|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5270515|NCT00541138|adult diffuse astrocytoma|adult diffuse astrocytoma
5270516|NCT00541138|adult giant cell glioblastoma|adult giant cell glioblastoma
5270517|NCT00541138|adult gliosarcoma|adult gliosarcoma
5270518|NCT00541138|adult pilocytic astrocytoma|adult pilocytic astrocytoma
5270519|NCT00541138|adult pineal gland astrocytoma|adult pineal gland astrocytoma
5270520|NCT00541138|adult subependymal giant cell astrocytoma|adult subependymal giant cell astrocytoma
5270521|NCT00541138|adult brain stem glioma|adult brain stem glioma
5270522|NCT00541138|adult anaplastic ependymoma|adult anaplastic ependymoma
5270523|NCT00541138|adult ependymoma|adult ependymoma
5270524|NCT00541138|adult myxopapillary ependymoma|adult myxopapillary ependymoma
5270525|NCT00541138|adult subependymoma|adult subependymoma
5270526|NCT00541138|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
5270527|NCT00541138|adult oligodendroglioma|adult oligodendroglioma
5270528|NCT00541138|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5270529|NCT00541138|adult mixed glioma|adult mixed glioma
5270530|NCT00541125|recurrent colon cancer|recurrent colon cancer
5270531|NCT00541125|stage IV colon cancer|stage iv colon cancer
5270532|NCT00541125|recurrent rectal cancer|recurrent rectal cancer
5270533|NCT00541125|stage IV rectal cancer|stage iv rectal cancer
5270534|NCT00541125|adenocarcinoma of the colon|adenocarcinoma of the colon
5270535|NCT00541125|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5270536|NCT00541112|stage III rectal cancer|stage iii rectal cancer
5270537|NCT00541112|stage IV rectal cancer|stage iv rectal cancer
5270538|NCT00541112|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5270539|NCT00541099|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5270540|NCT00541099|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5270541|NCT00541099|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5270542|NCT00541086|stage IA breast cancer|stage ia breast cancer
5270543|NCT00541086|stage IB breast cancer|stage ib breast cancer
5270544|NCT00541086|stage II breast cancer|stage ii breast cancer
5270545|NCT00541086|stage IIIA breast cancer|stage iiia breast cancer
5270546|NCT00541086|stage IIIB breast cancer|stage iiib breast cancer
5270547|NCT00541086|stage IIIC breast cancer|stage iiic breast cancer
5270548|NCT00541086|estrogen receptor-positive breast cancer|estrogen receptor-positive breast cancer
5270549|NCT00541086|progesterone receptor-positive breast cancer|progesterone receptor-positive breast cancer
5270550|NCT00541073|advanced malignant mesothelioma|advanced malignant mesothelioma
5270551|NCT00541073|recurrent malignant mesothelioma|recurrent malignant mesothelioma
5270552|NCT00541060|caries susceptibility,enamel matrix,candidate genes,mutation|caries susceptibility,enamel matrix,candidate genes,mutation
5270553|NCT00541047|sexual dysfunction|sexual dysfunction
5270554|NCT00541047|urinary complications|urinary complications
5270555|NCT00541047|gastrointestinal complications|gastrointestinal complications
5270556|NCT00541047|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5270557|NCT00541047|stage I prostate cancer|stage i prostate cancer
5270558|NCT00541047|stage IIB prostate cancer|stage iib prostate cancer
5270559|NCT00541047|stage IIA prostate cancer|stage iia prostate cancer
5270560|NCT00541047|stage III prostate cancer|stage iii prostate cancer
5270561|NCT00541034|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
5270562|NCT00541034|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
5270563|NCT00541034|stage II small lymphocytic lymphoma|stage ii small lymphocytic lymphoma
5270564|NCT00541034|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5270565|NCT00541034|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5270566|NCT00541034|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
5270567|NCT00541034|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
5270568|NCT00541034|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5270569|NCT00541034|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5270570|NCT00541021|stage III pancreatic cancer|stage iii pancreatic cancer
5270571|NCT00541021|stage IV pancreatic cancer|stage iv pancreatic cancer
5270572|NCT00541021|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
5270573|NCT00541021|recurrent pancreatic cancer|recurrent pancreatic cancer
5270574|NCT00541008|type 1 papillary renal cell carcinoma|type 1 papillary renal cell carcinoma
5270575|NCT00541008|type 2 papillary renal cell carcinoma|type 2 papillary renal cell carcinoma
5270576|NCT00541008|stage IV renal cell cancer|stage iv renal cell cancer
5270577|NCT00541008|stage III renal cell cancer|stage iii renal cell cancer
5270578|NCT00540982|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5270579|NCT00540982|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5270580|NCT00540982|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5270864|NCT00539500|CliniMACS|clinimacs
5270581|NCT00540982|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5270582|NCT00540982|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5270583|NCT00540969|bone metastases|bone metastases
5270584|NCT00540969|pain|pain
5270585|NCT00540969|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5270586|NCT00540969|stage IV melanoma|stage iv melanoma
5270587|NCT00540969|stage IV renal cell cancer|stage iv renal cell cancer
5270588|NCT00540956|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
5270589|NCT00540956|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
5270590|NCT00540956|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
5270591|NCT00540956|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
5270592|NCT00540956|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
5270593|NCT00540956|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
5270594|NCT00540956|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
5270595|NCT00540956|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
5270596|NCT00540956|adult erythroleukemia (M6a)|adult erythroleukemia (m6a)
5270597|NCT00540956|adult pure erythroid leukemia (M6b)|adult pure erythroid leukemia (m6b)
5270598|NCT00540956|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5270599|NCT00540956|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5270600|NCT00540956|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5270601|NCT00540956|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5270602|NCT00540943|cetuximab|cetuximab
5270603|NCT00540943|irinotecan,|irinotecan,
5270604|NCT00540943|pazopanib,|pazopanib,
5270605|NCT00540943|Colorectal cancer,|colorectal cancer,
5270606|NCT00540904|contrast|contrast
5270607|NCT00540904|nephropathy|nephropathy
5270608|NCT00540904|bicarbonate|bicarbonate
5270609|NCT00540904|prevention|prevention
5270610|NCT00540878|Formulation Drug Study|formulation drug study
5270611|NCT00540865|Homebound Persons|homebound persons
5270612|NCT00540865|Case Management|case management
5270613|NCT00540865|Problem Solving Therapy|problem solving therapy
5270614|NCT00540852|Breast cancer receiving chemotherapy|breast cancer receiving chemotherapy
5270615|NCT00540813|bifurcation stenosis|bifurcation stenosis
5270616|NCT00540813|Patients with documented ischemia due to a de-novo bifurcation stenosis|patients with documented ischemia due to a de-novo bifurcation stenosis
5270617|NCT00540800|anthracycline pre-treated|anthracycline pre-treated
5270618|NCT00540800|chemotherapy|chemotherapy
5270619|NCT00540800|first-line|first-line
5270620|NCT00540800|metastatic breast cancer|metastatic breast cancer
5270621|NCT00540800|locally advanced breast cancer|locally advanced breast cancer
5270622|NCT00540774|oral cancer|oral cancer
5270623|NCT00540774|oral mucositis|oral mucositis
5270624|NCT00540774|oral stomatitis|oral stomatitis
5270625|NCT00540774|Dry mouth|dry mouth
5270626|NCT00540774|Gingivitis|gingivitis
5270627|NCT00540761|Coronary Artery Disease|coronary artery disease
5270628|NCT00540761|Atherosclerosis|atherosclerosis
5270629|NCT00540748|first trimester abortion|first trimester abortion
5270630|NCT00540748|oxytocin|oxytocin
5270631|NCT00540696|Anemia|anemia
5270632|NCT00540696|Non-Myeloid Malignancies|non-myeloid malignancies
5270633|NCT00540696|darbepoetin alfa|darbepoetin alfa
5270634|NCT00540696|chemotherapy|chemotherapy
5270635|NCT00540670|Coronary artery disease|coronary artery disease
5270636|NCT00540644|Multiple Myeloma|multiple myeloma
5270637|NCT00540644|Revlimid|revlimid
5270638|NCT00540631|House Dust Mite Allergen|house dust mite allergen
5270639|NCT00540631|Aluminium hydroxide-adsorbed|aluminium hydroxide-adsorbed
5270640|NCT00540605|Microbicide|microbicide
5270641|NCT00540605|Pregnancy|pregnancy
5270642|NCT00540605|HIV Seronegativity|hiv seronegativity
5270643|NCT00540592|Influenza vaccine GSK576389A|influenza vaccine gsk576389a
5270644|NCT00540592|Influenza infection|influenza infection
5270645|NCT00540592|Fluarix|fluarix
5270646|NCT00540579|Pancreas|pancreas
5270647|NCT00540579|Untreated|untreated
5270648|NCT00540579|Advanced|advanced
5270649|NCT00540579|Gemcitabine|gemcitabine
5270650|NCT00540579|CC-4047|cc-4047
5270651|NCT00540553|SARM,|sarm,
5270652|NCT00540553|FTIH,|ftih,
5270653|NCT00540553|pharmacokinetics|pharmacokinetics
5270654|NCT00540527|acute ischemic stroke;thrombolysis;intraarterial thrombolysis|acute ischemic stroke;thrombolysis;intraarterial thrombolysis
5270655|NCT00540514|Advanced Non-Small Cell Lung Cancer|advanced non-small cell lung cancer
5270656|NCT00540501|zanamivir,|zanamivir,
5270657|NCT00540501|influenza virus,|influenza virus,
5270658|NCT00540501|healthy volunteer,|healthy volunteer,
5270659|NCT00540501|PK, drug interaction,|pk, drug interaction,
5270660|NCT00540501|IV, and oseltamivir.|iv, and oseltamivir.
5270661|NCT00540475|Idiopathic Pulmonary Fibrosis|idiopathic pulmonary fibrosis
5270662|NCT00540475|Interstitial Lung Disease|interstitial lung disease
5270663|NCT00540462|Type II Diabetes Mellitus|type ii diabetes mellitus
5270664|NCT00540462|Gastric bypass|gastric bypass
5270665|NCT00540462|Obese-related diabetes mellitus|obese-related diabetes mellitus
5270666|NCT00540462|Sugar control|sugar control
5270667|NCT00540462|treatment of obesity related diabetes mellitus|treatment of obesity related diabetes mellitus
5270668|NCT00540449|TMC278-C209|tmc278-c209
5270669|NCT00540449|Antiretroviral|antiretroviral
5270670|NCT00540449|Non-nucleoside reverse transcriptase inhibitor|non-nucleoside reverse transcriptase inhibitor
5270671|NCT00540449|HIV-1|hiv-1
5270672|NCT00540449|AIDS|aids
5270673|NCT00540449|TMC278-TiDP6-C209|tmc278-tidp6-c209
5270674|NCT00540449|Treatment Naive|treatment naive
5270675|NCT00540436|Ambrisentan|ambrisentan
5270676|NCT00540436|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
5270677|NCT00540436|6MWD|6mwd
5270678|NCT00540423|thrombopoietin,|thrombopoietin,
5270679|NCT00540423|immunosuppressive therapy,|immunosuppressive therapy,
5270680|NCT00540423|eltrombopag,|eltrombopag,
5270681|NCT00540423|idiopathic thrombocytopenic purpura,|idiopathic thrombocytopenic purpura,
5270682|NCT00540423|blood platelet,|blood platelet,
5270683|NCT00540423|splenectomy|splenectomy
5270684|NCT00540384|Anemia|anemia
5270685|NCT00540384|Solid tumors|solid tumors
5270686|NCT00540384|Multicycle chemotherapy|multicycle chemotherapy
5270687|NCT00540384|NESP|nesp
5270688|NCT00540371|Port Wine Stain|port wine stain
5270689|NCT00540358|Triple negative breast cancer|triple negative breast cancer
5270690|NCT00540345|chronic hepatitis C|chronic hepatitis c
5270691|NCT00540345|genotype 2|genotype 2
5270692|NCT00540345|rapid virological response|rapid virological response
5270693|NCT00540345|sustained virological response|sustained virological response
5270694|NCT00540345|peginterferon|peginterferon
5270695|NCT00540345|ribavirin|ribavirin
5270696|NCT00540345|treatment duration|treatment duration
5270697|NCT00540332|Oncology|oncology
5270698|NCT00540332|KGF|kgf
5270699|NCT00540332|HNC|hnc
5270700|NCT00540332|head and neck|head and neck
5270701|NCT00540332|oral mucositis|oral mucositis
5270702|NCT00540332|OM|om
5270703|NCT00540332|proteinurea|proteinurea
5270704|NCT00540332|palifermin|palifermin
5270705|NCT00540332|clinical trial|clinical trial
5270706|NCT00540319|Risky behaviors|risky behaviors
5270707|NCT00540319|Prenatal care|prenatal care
5270708|NCT00540319|Substance use|substance use
5270709|NCT00540319|Domestic violence|domestic violence
5270710|NCT00540306|breast tissue|breast tissue
5270711|NCT00540280|NSCLC|nsclc
5270712|NCT00540267|Schizophrenia|schizophrenia
5270713|NCT00540267|Alcohol Abuse|alcohol abuse
5270714|NCT00540267|Bone Density|bone density
5270715|NCT00540254|Chronic Fatigue|chronic fatigue
5270716|NCT00540254|Insomnia|insomnia
5270717|NCT00540254|Cognitive Behavioral Therapy|cognitive behavioral therapy
5270718|NCT00540228|Influenza|influenza
5270719|NCT00540228|Influenza Vaccine|influenza vaccine
5270720|NCT00540202|Effectiveness|effectiveness
5270721|NCT00540202|Oral quinine|oral quinine
5270722|NCT00540202|Coartem|coartem
5270723|NCT00540202|Uncomplicated malaria|uncomplicated malaria
5270724|NCT00540202|Children|children
5270725|NCT00540189|appendicitis, perforated, children|appendicitis, perforated, children
5270726|NCT00540176|Dichloroacetate|dichloroacetate
5270727|NCT00540176|Glioblastoma Multiforme|glioblastoma multiforme
5270728|NCT00540176|Glioma|glioma
5270729|NCT00540150|Immunotherapy|immunotherapy
5270730|NCT00540150|Mite|mite
5270731|NCT00540150|Asthma|asthma
5270732|NCT00540150|bronchial provocation|bronchial provocation
5270733|NCT00540150|SIT|sit
5270734|NCT00540150|specific immunotherapy|specific immunotherapy
5270735|NCT00540137|Antiretroviral therapy|antiretroviral therapy
5270736|NCT00540137|Neurocognitive function|neurocognitive function
5270737|NCT00540137|Magnetic resonance spectroscopy|magnetic resonance spectroscopy
5270738|NCT00540137|HIV disease|hiv disease
5270739|NCT00540137|Treatment Naive|treatment naive
5270740|NCT00540111|Soluble fiber|soluble fiber
5270741|NCT00540111|HIV/aids|hiv/aids
5270742|NCT00540111|Hypertriglyceridemia|hypertriglyceridemia
5270743|NCT00540111|Cytokines|cytokines
5270744|NCT00540111|Alternative Medicine|alternative medicine
5270745|NCT00540111|Complementary Medicine|complementary medicine
5270746|NCT00540098|panic disorder|panic disorder
5270747|NCT00540098|pharmacotherapy|pharmacotherapy
5270748|NCT00540098|non-pharmacological treatment|non-pharmacological treatment
5270749|NCT00540098|SSRI|ssri
5270750|NCT00540098|paroxetine|paroxetine
5270751|NCT00540098|exercise|exercise
5270752|NCT00540072|Moderate to Severe Community-Acquired Acute Bacterial Pneumonia Due to S. Pneumoniae|moderate to severe community-acquired acute bacterial pneumonia due to s. pneumoniae
5270753|NCT00540059|Prostate carcinoma|prostate carcinoma
5270754|NCT00540059|LHRH|lhrh
5270755|NCT00540059|Zoladex|zoladex
5270756|NCT00540046|IUD|iud
5270757|NCT00540046|Second trimester termination|second trimester termination
5270758|NCT00540046|Contraception|contraception
5270759|NCT00540033|probiotics|probiotics
5270760|NCT00540033|necrotizing enterocolitis|necrotizing enterocolitis
5270761|NCT00540033|preterm very low birth weight infants (VLBW)|preterm very low birth weight infants (vlbw)
5270762|NCT00540020|Brain Injuries|brain injuries
5270763|NCT00540020|Cognition|cognition
5270764|NCT00540020|Randomized Trials|randomized trials
5270765|NCT00540020|Rehabilitation|rehabilitation
5270766|NCT00540020|Treatment Outcome|treatment outcome
5270767|NCT00540007|Hodgkin Lymphoma|hodgkin lymphoma
5270768|NCT00540007|Lenalidomide|lenalidomide
5270769|NCT00540007|Anti-neoplastic agents|anti-neoplastic agents
5270770|NCT00540007|Thalidomide|thalidomide
5270772|NCT00539994|SB-275833|sb-275833
5270773|NCT00539994|retapamulin|retapamulin
5270774|NCT00539994|nasal colonization|nasal colonization
5270775|NCT00539994|PK|pk
5270776|NCT00539994|tolerability|tolerability
5270777|NCT00539994|safety|safety
5270778|NCT00539994|efficacy|efficacy
5270779|NCT00539981|Influenza|influenza
5270780|NCT00539955|intimate partner violence|intimate partner violence
5270781|NCT00539955|alcohol use|alcohol use
5270782|NCT00539955|substance use|substance use
5270783|NCT00539942|Randomized Clinical Trials|randomized clinical trials
5270784|NCT00539942|Randomized Controlled Trial|randomized controlled trial
5270785|NCT00539942|Venous thrombosis|venous thrombosis
5270786|NCT00539942|Anticoagulant Drugs|anticoagulant drugs
5270787|NCT00539942|Doppler Ultrasound|doppler ultrasound
5270788|NCT00539942|Postoperative complications|postoperative complications
5270789|NCT00539903|Activity Level|activity level
5270790|NCT00539877|Gstric cancer|gstric cancer
5270791|NCT00539877|Pritoneal seeding|pritoneal seeding
5270792|NCT00539877|Intraperitoneal chemotherapy|intraperitoneal chemotherapy
5270793|NCT00539877|Irinotecan|irinotecan
5270794|NCT00539864|Influenza|influenza
5270795|NCT00539851|Allogenic Stem Cell Transplantation|allogenic stem cell transplantation
5270796|NCT00539851|Diabetes Mellitus|diabetes mellitus
5270797|NCT00539838|SLE|sle
5270798|NCT00539825|Anticholinergic,|anticholinergic,
5270799|NCT00539825|Plethysmography|plethysmography
5270800|NCT00539825|Muscarinic Receptor Antagonist,|muscarinic receptor antagonist,
5270801|NCT00539825|COPD,|copd,
5270802|NCT00539825|FTIH,|ftih,
5270803|NCT00539812|Intimate partner violence|intimate partner violence
5270804|NCT00539812|alcohol use|alcohol use
5270805|NCT00539812|substance use|substance use
5270806|NCT00539799|systemic lupus erythematosus|systemic lupus erythematosus
5270807|NCT00539799|lupus nephritis|lupus nephritis
5270808|NCT00539786|Patients with extraesophageal manifestation of gastroesophageal reflux disease|patients with extraesophageal manifestation of gastroesophageal reflux disease
5270809|NCT00539760|domain antibody|domain antibody
5270810|NCT00539760|Rheumatoid Arthritis,|rheumatoid arthritis,
5270811|NCT00539747|Presymptomatic|presymptomatic
5270812|NCT00539747|Huntington Disease|huntington disease
5270813|NCT00539747|Meaning Making|meaning making
5270814|NCT00539747|Genetic Testing|genetic testing
5270815|NCT00539747|HD|hd
5270816|NCT00539734|age-related macular degeneration (AMD)|age-related macular degeneration (amd)
5270817|NCT00539734|choroidal neovascularization membrane(CNVM)|choroidal neovascularization membrane(cnvm)
5270818|NCT00539734|ranibizumab|ranibizumab
5270819|NCT00539734|anti-vascular endothelial growth factor|anti-vascular endothelial growth factor
5270820|NCT00539734|electrophysiology|electrophysiology
5270821|NCT00539734|electroretinography|electroretinography
5270822|NCT00539721|Nausea|nausea
5270823|NCT00539721|Vomiting|vomiting
5270824|NCT00539708|Non-invasive ventilation|non-invasive ventilation
5270825|NCT00539708|Hypercapnic respiratory failure|hypercapnic respiratory failure
5270826|NCT00539708|Mechanical ventilation|mechanical ventilation
5270827|NCT00539708|Respiratory failure after extubation|respiratory failure after extubation
5270828|NCT00539695|Stem Cell transplant|stem cell transplant
5270829|NCT00539695|Graft verus host disease|graft verus host disease
5270830|NCT00539695|IL-2|il-2
5270831|NCT00539695|acute lymphoblastic leukemia|acute lymphoblastic leukemia
5270832|NCT00539695|ALL|all
5270833|NCT00539695|acute myelogenous leukemia|acute myelogenous leukemia
5270834|NCT00539695|AML|aml
5270835|NCT00539695|chronic myelogenous leukemia|chronic myelogenous leukemia
5270836|NCT00539695|myelodysplastic syndrome|myelodysplastic syndrome
5270837|NCT00539695|myeloproliferative disorder|myeloproliferative disorder
5270838|NCT00539695|Hodgkin lymphoma|hodgkin lymphoma
5270839|NCT00539695|non-Hodgkin lymphoma|non-hodgkin lymphoma
5270840|NCT00539695|non-malignant diseases requiring allogeneic HSCT|non-malignant diseases requiring allogeneic hsct
5270841|NCT00539656|Cord blood stem cell transplantation|cord blood stem cell transplantation
5270842|NCT00539656|Ex vivo expansion|ex vivo expansion
5270843|NCT00539656|Alternative donor|alternative donor
5270844|NCT00539643|Liver Cancer|liver cancer
5270845|NCT00539643|Hepatoma|hepatoma
5270846|NCT00539643|07-099|07-099
5270847|NCT00539617|metastatic esophageal cancer|metastatic esophageal cancer
5270848|NCT00539617|erlotinib|erlotinib
5270849|NCT00539617|folfox|folfox
5270850|NCT00539617|advanced esophageal cancer|advanced esophageal cancer
5270851|NCT00539617|unresectable esophageal cancer|unresectable esophageal cancer
5270852|NCT00539604|Comparison study between MDCT and coronary angiography|comparison study between mdct and coronary angiography
5270853|NCT00539591|Cutaneous Melanoma|cutaneous melanoma
5270854|NCT00539565|biliary atresia|biliary atresia
5270855|NCT00539565|Kasai portoenterostomy|kasai portoenterostomy
5270856|NCT00539565|corticosteroids|corticosteroids
5270857|NCT00539513|obsessive-compulsive disorder|obsessive-compulsive disorder
5270858|NCT00539513|OCD|ocd
5270859|NCT00539513|glutamate|glutamate
5270860|NCT00539513|N-Acetylcysteine|n-acetylcysteine
5270861|NCT00539513|augmentation|augmentation
5270862|NCT00539500|Neuroblastoma|neuroblastoma
5270865|NCT00539500|Stem Cell Transplantation|stem cell transplantation
5270866|NCT00539500|Blood And Marrow Transplantation|blood and marrow transplantation
5270867|NCT00539500|Pediatric|pediatric
5270868|NCT00539500|Solid Tumors|solid tumors
5270869|NCT00539500|Carboplatin|carboplatin
5270870|NCT00539500|Paraplatin|paraplatin
5270871|NCT00539500|Etoposide|etoposide
5270872|NCT00539500|VePesid|vepesid
5270873|NCT00539500|Melphalan|melphalan
5270874|NCT00539500|Alkeran|alkeran
5270875|NCT00539500|CD133+ Cells|cd133+ cells
5270876|NCT00539474|ROLL trial|roll trial
5270877|NCT00539474|Minimally invasive surgery|minimally invasive surgery
5270878|NCT00539474|Non palpable breast cancer|non palpable breast cancer
5270879|NCT00539435|Diabetes Mellitus|diabetes mellitus
5270880|NCT00539435|Pulsatile Intravenous Insulin Therapy|pulsatile intravenous insulin therapy
5270881|NCT00539435|Diabetic Cardiac Quality of Life|diabetic cardiac quality of life
5270882|NCT00539435|Cardiac Disease|cardiac disease
5270883|NCT00539422|breast cancer|breast cancer
5270884|NCT00539422|cytochrome 450|cytochrome 450
5270885|NCT00539422|CYP2D6*4|cyp2d6*4
5270886|NCT00539422|Ferritin|ferritin
5270887|NCT00539422|oxidative stress|oxidative stress
5270888|NCT00539422|cancer|cancer
5270889|NCT00539422|cancer breast|cancer breast
5270890|NCT00539409|Diabetes Mellitus|diabetes mellitus
5270891|NCT00539409|Pulsatile Intravenous Insulin Therapy|pulsatile intravenous insulin therapy
5270892|NCT00539409|Diabetic Quality of Life|diabetic quality of life
5270893|NCT00539409|Orthostatic Hypotension|orthostatic hypotension
5270894|NCT00539409|Brittle or Labile diabetes|brittle or labile diabetes
5270895|NCT00539383|Lung cancer|lung cancer
5270896|NCT00539383|Breast cancer|breast cancer
5270897|NCT00539383|Melanoma|melanoma
5270898|NCT00539383|Hepatocellular carcinoma|hepatocellular carcinoma
5270899|NCT00539383|Brain metastases|brain metastases
5270900|NCT00539370|Scleritis|scleritis
5270901|NCT00539370|Intermediate Uveitis|intermediate uveitis
5270902|NCT00539370|Posterior Uveitis|posterior uveitis
5270903|NCT00539370|Intraocular Inflammatory Disease|intraocular inflammatory disease
5270904|NCT00539370|Data Analysis|data analysis
5270905|NCT00539370|Data Collection|data collection
5270906|NCT00539370|Sample Analysis|sample analysis
5270907|NCT00539357|Cranial Electrostimulation Therapy|cranial electrostimulation therapy
5270908|NCT00539344|Glioblastoma multiforme|glioblastoma multiforme
5270909|NCT00539344|Anaplastic astrocytoma|anaplastic astrocytoma
5270910|NCT00539344|Anaplastic oligodendroglioma|anaplastic oligodendroglioma
5270911|NCT00539331|Non-small Cell Lung Cancer|non-small cell lung cancer
5270912|NCT00539331|NSCLC|nsclc
5270913|NCT00539331|AZD2171|azd2171
5270914|NCT00539331|Paclitaxel/Carboplatin|paclitaxel/carboplatin
5270915|NCT00539331|Non-small Cell Lung Cancer (NSCLC)|non-small cell lung cancer (nsclc)
5270916|NCT00539305|selective androgen receptor modulators (SARMs)|selective androgen receptor modulators (sarms)
5270917|NCT00539305|hormone replacement therapy|hormone replacement therapy
5270918|NCT00539305|age-associated cognitive decline|age-associated cognitive decline
5270919|NCT00539305|testosterone supplementation|testosterone supplementation
5270920|NCT00539292|pediatrics|pediatrics
5270921|NCT00539292|gastroschisis|gastroschisis
5270922|NCT00539292|silastic spring-loaded silo|silastic spring-loaded silo
5270923|NCT00539279|Cognitive- Behavior Therapy|cognitive- behavior therapy
5270924|NCT00539279|Combat Disorders|combat disorders
5270925|NCT00539279|Elderly|elderly
5270926|NCT00539279|Geriatrics|geriatrics
5270927|NCT00539279|Implosive therapy|implosive therapy
5270928|NCT00539279|Neuropsychological Test|neuropsychological test
5270929|NCT00539279|Post-traumatic Stress Disorder|post-traumatic stress disorder
5270930|NCT00539279|Psychotherapy|psychotherapy
5270931|NCT00539279|Randomized Controlled Trial|randomized controlled trial
5270932|NCT00539279|Relaxation techniques|relaxation techniques
5270933|NCT00539266|Claudication|claudication
5270934|NCT00539266|Critical limb ischemia|critical limb ischemia
5270935|NCT00539266|Cell therapy|cell therapy
5270936|NCT00539266|Bone marrow|bone marrow
5270937|NCT00539253|liver cancer|liver cancer
5270938|NCT00539253|transarterial chemoembolization|transarterial chemoembolization
5270939|NCT00539240|acid reflux|acid reflux
5270940|NCT00539240|acid regurgitation|acid regurgitation
5270941|NCT00539240|esophagitis|esophagitis
5270942|NCT00539240|GERD|gerd
5270943|NCT00539240|heartburn|heartburn
5270944|NCT00539240|pain|pain
5270945|NCT00539240|peptic|peptic
5270946|NCT00539227|Breast Cancer|breast cancer
5270947|NCT00539227|Nipple-Areolar Complex|nipple-areolar complex
5270948|NCT00539227|Mastectomy|mastectomy
5270949|NCT00539227|Prophylactic mastectomy|prophylactic mastectomy
5270950|NCT00539227|Immediate reconstruction|immediate reconstruction
5270951|NCT00539227|Reconstructive surgery|reconstructive surgery
5270952|NCT00539227|Questionnaire|questionnaire
5270953|NCT00539227|Survey|survey
5270954|NCT00539227|NAC|nac
5270955|NCT00539201|GSK706769,|gsk706769,
5270956|NCT00539201|CCR5 inhibitor,|ccr5 inhibitor,
5270957|NCT00539201|HIV|hiv
5270958|NCT00539188|Borderline Personality Disorder(BPD)|borderline personality disorder(bpd)
5270959|NCT00539188|Dialectical Behavioral Therapy (DBT)|dialectical behavioral therapy (dbt)
5270960|NCT00539188|glutamate|glutamate
5270961|NCT00539188|N-Acetylcysteine|n-acetylcysteine
5270962|NCT00539188|Borderline Personality Disorder with Self-Injurious Behavior|borderline personality disorder with self-injurious behavior
5270963|NCT00539175|diabetes mellitus|diabetes mellitus
5270964|NCT00539175|neuropathy|neuropathy
5270965|NCT00539175|diabetic neuropathy|diabetic neuropathy
5270966|NCT00539162|Ovarian Cancer|ovarian cancer
5270967|NCT00539162|CA 125 Algorithm|ca 125 algorithm
5270968|NCT00539162|Cancer Detection|cancer detection
5270969|NCT00539162|Questionnaire|questionnaire
5270970|NCT00539162|Survey|survey
5270971|NCT00539149|Acute otitis media|acute otitis media
5270972|NCT00539149|Otitis media with effusion|otitis media with effusion
5270973|NCT00539149|Tympanic membrane perforation|tympanic membrane perforation
5270974|NCT00539136|GSK561679,|gsk561679,
5270975|NCT00539136|Pharmacokinetic,|pharmacokinetic,
5270976|NCT00539136|healthy volunteers,|healthy volunteers,
5270977|NCT00539136|Gamma Scintigraphy,|gamma scintigraphy,
5270978|NCT00539136|PillCam™,|pillcam™,
5270979|NCT00539136|acoustic vest|acoustic vest
5270980|NCT00539123|buprenorphine|buprenorphine
5270981|NCT00539123|drug counseling|drug counseling
5270982|NCT00539123|HIV risk reduction counseling|hiv risk reduction counseling
5270983|NCT00539097|pediatrics|pediatrics
5270984|NCT00539084|microneedles|microneedles
5270985|NCT00539084|microneedle|microneedle
5270986|NCT00539084|intradermal|intradermal
5270987|NCT00539071|schizophrenia|schizophrenia
5270988|NCT00539071|schizoaffective disorder|schizoaffective disorder
5270989|NCT00539071|long acting injectable|long acting injectable
5270990|NCT00539071|treatment resistant|treatment resistant
5270991|NCT00539045|myocardial infarction, thrombus|myocardial infarction, thrombus
5270992|NCT00539032|N. meningitidis|n. meningitidis
5270993|NCT00539032|Meningitis|meningitis
5270994|NCT00539032|Meningococcemia|meningococcemia
5270995|NCT00539019|nutrition assessment|nutrition assessment
5270996|NCT00539019|pediatric|pediatric
5270997|NCT00539006|fluticasone propionate|fluticasone propionate
5270998|NCT00539006|seasonal allergic rhinitis|seasonal allergic rhinitis
5270999|NCT00539006|fluticasone furoate|fluticasone furoate
5271000|NCT00539006|experience|experience
5271001|NCT00539006|GW685698X|gw685698x
5271002|NCT00539006|preference|preference
5271003|NCT00538980|Polycythemia Vera|polycythemia vera
5271004|NCT00538980|PV|pv
5271005|NCT00538980|P Vera|p vera
5271006|NCT00538967|Collagenases|collagenases
5271007|NCT00538967|MMP|mmp
5271008|NCT00538967|Cathepsins|cathepsins
5271009|NCT00538967|Doxycycline|doxycycline
5271010|NCT00538967|Aneurysm|aneurysm
5271011|NCT00538954|Perioperative|perioperative
5271012|NCT00538954|recovery|recovery
5271013|NCT00538954|nutrition|nutrition
5271014|NCT00538954|enhanced|enhanced
5271015|NCT00538954|laxative|laxative
5271016|NCT00538941|chocolate,|chocolate,
5271017|NCT00538941|heart failure,|heart failure,
5271018|NCT00538941|endothelial function,|endothelial function,
5271019|NCT00538941|platelet adhesion,|platelet adhesion,
5271020|NCT00538941|oxidative stress,|oxidative stress,
5271021|NCT00538941|baroreceptor function,|baroreceptor function,
5271022|NCT00538928|acute respiratory distress syndrome|acute respiratory distress syndrome
5271023|NCT00538928|extracorporeal lung support|extracorporeal lung support
5271024|NCT00538928|hypoxia|hypoxia
5271025|NCT00538928|hypercapnia|hypercapnia
5271026|NCT00538928|acute respiratory distress syndrome (ARDS)|acute respiratory distress syndrome (ards)
5271027|NCT00538915|immunodeficiency|immunodeficiency
5271028|NCT00538915|humoral immunity|humoral immunity
5271029|NCT00538915|antibody deficiency|antibody deficiency
5271031|NCT00538915|PIDD|pidd
5271032|NCT00538902|Humira, methotrexate|humira, methotrexate
5271033|NCT00538889|Adult|adult
5271034|NCT00538850|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5271035|NCT00538850|pain|pain
5271036|NCT00538850|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5271037|NCT00538850|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5271038|NCT00538850|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5271039|NCT00538850|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5271040|NCT00538850|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5271041|NCT00538850|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5271042|NCT00538850|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5271043|NCT00538850|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5271044|NCT00538850|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5271045|NCT00538850|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5271046|NCT00538850|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
5271047|NCT00538850|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5271048|NCT00538850|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
5271049|NCT00538850|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
5271050|NCT00538850|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
5271051|NCT00538850|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
5271052|NCT00538850|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
5271053|NCT00538850|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
5271054|NCT00538850|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5271055|NCT00538850|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5271056|NCT00538850|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5271057|NCT00538850|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5271058|NCT00538850|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5271059|NCT00538850|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5271060|NCT00538850|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5271061|NCT00538850|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5271062|NCT00538850|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5271063|NCT00538850|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5271064|NCT00538850|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5271065|NCT00538850|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5271066|NCT00538850|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5271067|NCT00538850|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5271068|NCT00538850|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5271069|NCT00538850|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5271070|NCT00538850|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5271071|NCT00538850|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5271072|NCT00538850|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5271073|NCT00538850|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5271074|NCT00538850|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5271075|NCT00538850|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5271076|NCT00538850|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5271077|NCT00538850|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5271078|NCT00538850|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5271079|NCT00538850|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5271080|NCT00538850|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5271081|NCT00538850|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5271082|NCT00538850|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5271083|NCT00538850|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5271084|NCT00538850|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5271085|NCT00538850|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5271086|NCT00538850|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5271087|NCT00538850|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5271088|NCT00538850|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5271089|NCT00538850|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5271090|NCT00538850|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5271091|NCT00538850|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5271092|NCT00538850|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5271093|NCT00538850|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5271094|NCT00538850|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5271095|NCT00538850|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5271096|NCT00538850|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5271097|NCT00538850|stage I multiple myeloma|stage i multiple myeloma
5271098|NCT00538850|stage II multiple myeloma|stage ii multiple myeloma
5271099|NCT00538850|stage III multiple myeloma|stage iii multiple myeloma
5271100|NCT00538850|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5271101|NCT00538850|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
5271102|NCT00538850|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5271103|NCT00538850|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5271104|NCT00538850|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
5271105|NCT00538850|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
5271106|NCT00538850|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5271107|NCT00538850|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5271108|NCT00538850|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
5271109|NCT00538850|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
5271110|NCT00538850|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
5271111|NCT00538850|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
5271112|NCT00538850|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
5271113|NCT00538850|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
5271114|NCT00538850|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
5271115|NCT00538850|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
5271116|NCT00538850|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
5271117|NCT00538850|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
5271118|NCT00538850|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
5271119|NCT00538850|stage I marginal zone lymphoma|stage i marginal zone lymphoma
5271120|NCT00538850|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
5271121|NCT00538850|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
5271122|NCT00538850|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
5271123|NCT00538850|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
5271124|NCT00538850|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
5271125|NCT00538850|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
5271126|NCT00538850|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
5271127|NCT00538850|stage I mantle cell lymphoma|stage i mantle cell lymphoma
5271128|NCT00538850|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
5271129|NCT00538850|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
5271130|NCT00538850|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
5271131|NCT00538850|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
5271132|NCT00538850|refractory multiple myeloma|refractory multiple myeloma
5271133|NCT00538850|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5271134|NCT00538850|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
5271135|NCT00538850|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
5271136|NCT00538850|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
5271137|NCT00538850|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
5271138|NCT00538850|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
5271139|NCT00538850|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
5271140|NCT00538850|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
5271141|NCT00538850|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
5271142|NCT00538850|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
5271143|NCT00538850|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
5271144|NCT00538850|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
5271145|NCT00538850|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
5271146|NCT00538850|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
5271147|NCT00538850|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
5271148|NCT00538850|chronic eosinophilic leukemia|chronic eosinophilic leukemia
5271149|NCT00538850|primary myelofibrosis|primary myelofibrosis
5271150|NCT00538850|chronic neutrophilic leukemia|chronic neutrophilic leukemia
5271151|NCT00538850|essential thrombocythemia|essential thrombocythemia
5271152|NCT00538850|polycythemia vera|polycythemia vera
5271153|NCT00538850|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5271154|NCT00538850|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
5271155|NCT00538850|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5271156|NCT00538850|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5271157|NCT00538850|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
5271158|NCT00538850|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
5271159|NCT00538850|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5271160|NCT00538850|acute undifferentiated leukemia|acute undifferentiated leukemia
5271161|NCT00538850|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5271162|NCT00538850|stage 0 chronic lymphocytic leukemia|stage 0 chronic lymphocytic leukemia
5271163|NCT00538850|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
5271164|NCT00538850|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
5271165|NCT00538850|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5271166|NCT00538850|refractory hairy cell leukemia|refractory hairy cell leukemia
5271167|NCT00538850|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
5271168|NCT00538850|prolymphocytic leukemia|prolymphocytic leukemia
5271169|NCT00538850|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
5271170|NCT00538850|Waldenström macroglobulinemia|waldenström macroglobulinemia
5271171|NCT00538850|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5271172|NCT00538850|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5271173|NCT00538850|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5271174|NCT00538850|post-transplant lymphoproliferative disorder|post-transplant lymphoproliferative disorder
5271175|NCT00538850|extramedullary plasmacytoma|extramedullary plasmacytoma
5271176|NCT00538850|isolated plasmacytoma of bone|isolated plasmacytoma of bone
5271177|NCT00538850|monoclonal gammopathy of undetermined significance|monoclonal gammopathy of undetermined significance
5271178|NCT00538850|primary systemic amyloidosis|primary systemic amyloidosis
5271179|NCT00538850|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5271180|NCT00538850|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5271181|NCT00538850|adult grade III lymphomatoid granulomatosis|adult grade iii lymphomatoid granulomatosis
5271182|NCT00538850|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
5271183|NCT00538850|AIDS-related primary CNS lymphoma|aids-related primary cns lymphoma
5271184|NCT00538850|intraocular lymphoma|intraocular lymphoma
5271185|NCT00538850|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
5271186|NCT00538850|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
5271187|NCT00538850|primary central nervous system Hodgkin lymphoma|primary central nervous system hodgkin lymphoma
5271188|NCT00538850|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
5271189|NCT00538850|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
5271190|NCT00538850|stage I squamous cell carcinoma of the hypopharynx|stage i squamous cell carcinoma of the hypopharynx
5271191|NCT00538850|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
5271192|NCT00538850|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
5271193|NCT00538850|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5271194|NCT00538850|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
5271195|NCT00538850|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
5271196|NCT00538850|stage I squamous cell carcinoma of the larynx|stage i squamous cell carcinoma of the larynx
5271197|NCT00538850|stage I verrucous carcinoma of the larynx|stage i verrucous carcinoma of the larynx
5271198|NCT00538850|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
5271199|NCT00538850|stage II verrucous carcinoma of the larynx|stage ii verrucous carcinoma of the larynx
5271200|NCT00538850|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
5271201|NCT00538850|stage III verrucous carcinoma of the larynx|stage iii verrucous carcinoma of the larynx
5271202|NCT00538850|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5271203|NCT00538850|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
5271204|NCT00538850|recurrent adenoid cystic carcinoma of the oral cavity|recurrent adenoid cystic carcinoma of the oral cavity
5271205|NCT00538850|recurrent mucoepidermoid carcinoma of the oral cavity|recurrent mucoepidermoid carcinoma of the oral cavity
5271206|NCT00538850|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
5271207|NCT00538850|stage I adenoid cystic carcinoma of the oral cavity|stage i adenoid cystic carcinoma of the oral cavity
5271208|NCT00538850|stage I mucoepidermoid carcinoma of the oral cavity|stage i mucoepidermoid carcinoma of the oral cavity
5271209|NCT00538850|stage I verrucous carcinoma of the oral cavity|stage i verrucous carcinoma of the oral cavity
5271210|NCT00538850|stage II adenoid cystic carcinoma of the oral cavity|stage ii adenoid cystic carcinoma of the oral cavity
5271211|NCT00538850|stage II mucoepidermoid carcinoma of the oral cavity|stage ii mucoepidermoid carcinoma of the oral cavity
5271212|NCT00538850|stage II verrucous carcinoma of the oral cavity|stage ii verrucous carcinoma of the oral cavity
5271213|NCT00538850|stage III adenoid cystic carcinoma of the oral cavity|stage iii adenoid cystic carcinoma of the oral cavity
5271214|NCT00538850|stage III mucoepidermoid carcinoma of the oral cavity|stage iii mucoepidermoid carcinoma of the oral cavity
5271215|NCT00538850|stage III verrucous carcinoma of the oral cavity|stage iii verrucous carcinoma of the oral cavity
5271216|NCT00538850|stage IV adenoid cystic carcinoma of the oral cavity|stage iv adenoid cystic carcinoma of the oral cavity
5271217|NCT00538850|stage IV mucoepidermoid carcinoma of the oral cavity|stage iv mucoepidermoid carcinoma of the oral cavity
5271218|NCT00538850|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
5271219|NCT00538850|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
5271220|NCT00538850|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
5271221|NCT00538850|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
5271222|NCT00538850|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5271223|NCT00538850|recurrent basal cell carcinoma of the lip|recurrent basal cell carcinoma of the lip
5271224|NCT00538850|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
5271225|NCT00538850|stage I basal cell carcinoma of the lip|stage i basal cell carcinoma of the lip
5271226|NCT00538850|stage II basal cell carcinoma of the lip|stage ii basal cell carcinoma of the lip
5271227|NCT00538850|stage III basal cell carcinoma of the lip|stage iii basal cell carcinoma of the lip
5271228|NCT00538850|stage IV basal cell carcinoma of the lip|stage iv basal cell carcinoma of the lip
5271229|NCT00538850|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
5271230|NCT00538850|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
5271231|NCT00538850|untreated metastatic squamous neck cancer with occult primary|untreated metastatic squamous neck cancer with occult primary
5271232|NCT00538850|recurrent lymphoepithelioma of the nasopharynx|recurrent lymphoepithelioma of the nasopharynx
5271233|NCT00538850|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
5271234|NCT00538850|stage I lymphoepithelioma of the nasopharynx|stage i lymphoepithelioma of the nasopharynx
5271235|NCT00538850|stage I squamous cell carcinoma of the nasopharynx|stage i squamous cell carcinoma of the nasopharynx
5271236|NCT00538850|stage II lymphoepithelioma of the nasopharynx|stage ii lymphoepithelioma of the nasopharynx
5271237|NCT00538850|stage II squamous cell carcinoma of the nasopharynx|stage ii squamous cell carcinoma of the nasopharynx
5271238|NCT00538850|stage III lymphoepithelioma of the nasopharynx|stage iii lymphoepithelioma of the nasopharynx
5271239|NCT00538850|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
5271240|NCT00538850|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
5271241|NCT00538850|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
5271242|NCT00538850|recurrent lymphoepithelioma of the oropharynx|recurrent lymphoepithelioma of the oropharynx
5271243|NCT00538850|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
5271244|NCT00538850|stage I lymphoepithelioma of the oropharynx|stage i lymphoepithelioma of the oropharynx
5271245|NCT00538850|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
5271246|NCT00538850|stage II lymphoepithelioma of the oropharynx|stage ii lymphoepithelioma of the oropharynx
5271247|NCT00538850|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
5271248|NCT00538850|stage III lymphoepithelioma of the oropharynx|stage iii lymphoepithelioma of the oropharynx
5271249|NCT00538850|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
5271250|NCT00538850|stage IV lymphoepithelioma of the oropharynx|stage iv lymphoepithelioma of the oropharynx
5271251|NCT00538850|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5271252|NCT00538850|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity
5271253|NCT00538850|recurrent inverted papilloma of the paranasal sinus and nasal cavity|recurrent inverted papilloma of the paranasal sinus and nasal cavity
5271254|NCT00538850|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity
5271255|NCT00538850|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
5271256|NCT00538850|stage I esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage i esthesioneuroblastoma of the paranasal sinus and nasal cavity
5271257|NCT00538850|stage I inverted papilloma of the paranasal sinus and nasal cavity|stage i inverted papilloma of the paranasal sinus and nasal cavity
5271258|NCT00538850|stage I midline lethal granuloma of the paranasal sinus and nasal cavity|stage i midline lethal granuloma of the paranasal sinus and nasal cavity
5271259|NCT00538850|stage I squamous cell carcinoma of the paranasal sinus and nasal cavity|stage i squamous cell carcinoma of the paranasal sinus and nasal cavity
5271260|NCT00538850|stage II esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage ii esthesioneuroblastoma of the paranasal sinus and nasal cavity
5271261|NCT00538850|stage II inverted papilloma of the paranasal sinus and nasal cavity|stage ii inverted papilloma of the paranasal sinus and nasal cavity
5271262|NCT00538850|stage II midline lethal granuloma of the paranasal sinus and nasal cavity|stage ii midline lethal granuloma of the paranasal sinus and nasal cavity
5271263|NCT00538850|stage II squamous cell carcinoma of the paranasal sinus and nasal cavity|stage ii squamous cell carcinoma of the paranasal sinus and nasal cavity
5271264|NCT00538850|stage III esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iii esthesioneuroblastoma of the paranasal sinus and nasal cavity
5271265|NCT00538850|stage III inverted papilloma of the paranasal sinus and nasal cavity|stage iii inverted papilloma of the paranasal sinus and nasal cavity
5271266|NCT00538850|stage III midline lethal granuloma of the paranasal sinus and nasal cavity|stage iii midline lethal granuloma of the paranasal sinus and nasal cavity
5271267|NCT00538850|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
5271268|NCT00538850|stage IV esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iv esthesioneuroblastoma of the paranasal sinus and nasal cavity
5271269|NCT00538850|stage IV inverted papilloma of the paranasal sinus and nasal cavity|stage iv inverted papilloma of the paranasal sinus and nasal cavity
5271270|NCT00538850|stage IV midline lethal granuloma of the paranasal sinus and nasal cavity|stage iv midline lethal granuloma of the paranasal sinus and nasal cavity
5271271|NCT00538850|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
5271272|NCT00538850|high-grade salivary gland mucoepidermoid carcinoma|high-grade salivary gland mucoepidermoid carcinoma
5271273|NCT00538850|low-grade salivary gland mucoepidermoid carcinoma|low-grade salivary gland mucoepidermoid carcinoma
5271274|NCT00538850|recurrent salivary gland cancer|recurrent salivary gland cancer
5271275|NCT00538850|salivary gland acinic cell tumor|salivary gland acinic cell tumor
5271276|NCT00538850|salivary gland adenocarcinoma|salivary gland adenocarcinoma
5271277|NCT00538850|salivary gland adenoid cystic carcinoma|salivary gland adenoid cystic carcinoma
5271278|NCT00538850|salivary gland anaplastic carcinoma|salivary gland anaplastic carcinoma
5271279|NCT00538850|salivary gland malignant mixed cell type tumor|salivary gland malignant mixed cell type tumor
5271280|NCT00538850|salivary gland poorly differentiated carcinoma|salivary gland poorly differentiated carcinoma
5271491|NCT00538850|stage IIIA anal cancer|stage iiia anal cancer
5271281|NCT00538850|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
5271282|NCT00538850|stage I salivary gland cancer|stage i salivary gland cancer
5271283|NCT00538850|stage II salivary gland cancer|stage ii salivary gland cancer
5271284|NCT00538850|stage III salivary gland cancer|stage iii salivary gland cancer
5271285|NCT00538850|stage IV salivary gland cancer|stage iv salivary gland cancer
5271286|NCT00538850|adult grade I meningioma|adult grade i meningioma
5271287|NCT00538850|adult choroid plexus tumor|adult choroid plexus tumor
5271288|NCT00538850|adult craniopharyngioma|adult craniopharyngioma
5271289|NCT00538850|adult myxopapillary ependymoma|adult myxopapillary ependymoma
5271290|NCT00538850|adult diffuse astrocytoma|adult diffuse astrocytoma
5271291|NCT00538850|adult pilocytic astrocytoma|adult pilocytic astrocytoma
5271292|NCT00538850|adult pineocytoma|adult pineocytoma
5271293|NCT00538850|adult ependymoma|adult ependymoma
5271294|NCT00538850|adult subependymoma|adult subependymoma
5271295|NCT00538850|adult oligodendroglioma|adult oligodendroglioma
5271296|NCT00538850|adult subependymal giant cell astrocytoma|adult subependymal giant cell astrocytoma
5271297|NCT00538850|meningeal melanocytoma|meningeal melanocytoma
5271298|NCT00538850|adult meningeal hemangiopericytoma|adult meningeal hemangiopericytoma
5271299|NCT00538850|adult pineal gland astrocytoma|adult pineal gland astrocytoma
5271300|NCT00538850|adult central nervous system germ cell tumor|adult central nervous system germ cell tumor
5271301|NCT00538850|adult medulloblastoma|adult medulloblastoma
5271302|NCT00538850|adult supratentorial primitive neuroectodermal tumor (PNET)|adult supratentorial primitive neuroectodermal tumor (pnet)
5271303|NCT00538850|adult ependymoblastoma|adult ependymoblastoma
5271304|NCT00538850|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5271305|NCT00538850|adult anaplastic ependymoma|adult anaplastic ependymoma
5271306|NCT00538850|adult glioblastoma|adult glioblastoma
5271307|NCT00538850|adult gliosarcoma|adult gliosarcoma
5271308|NCT00538850|adult giant cell glioblastoma|adult giant cell glioblastoma
5271309|NCT00538850|adult grade III meningioma|adult grade iii meningioma
5271310|NCT00538850|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
5271311|NCT00538850|adult pineoblastoma|adult pineoblastoma
5271312|NCT00538850|adult mixed glioma|adult mixed glioma
5271313|NCT00538850|recurrent adult brain tumor|recurrent adult brain tumor
5271314|NCT00538850|adult anaplastic meningioma|adult anaplastic meningioma
5271315|NCT00538850|adult papillary meningioma|adult papillary meningioma
5271316|NCT00538850|adult brain stem glioma|adult brain stem glioma
5271317|NCT00538850|stage IA cervical cancer|stage ia cervical cancer
5271318|NCT00538850|stage IB cervical cancer|stage ib cervical cancer
5271319|NCT00538850|stage IIA cervical cancer|stage iia cervical cancer
5271320|NCT00538850|stage IIB cervical cancer|stage iib cervical cancer
5271321|NCT00538850|stage III cervical cancer|stage iii cervical cancer
5271322|NCT00538850|stage IVA cervical cancer|stage iva cervical cancer
5271323|NCT00538850|stage IVB cervical cancer|stage ivb cervical cancer
5271324|NCT00538850|recurrent cervical cancer|recurrent cervical cancer
5271325|NCT00538850|recurrent endometrial carcinoma|recurrent endometrial carcinoma
5271326|NCT00538850|stage I endometrial carcinoma|stage i endometrial carcinoma
5271327|NCT00538850|stage II endometrial carcinoma|stage ii endometrial carcinoma
5271328|NCT00538850|stage III endometrial carcinoma|stage iii endometrial carcinoma
5271329|NCT00538850|stage IV endometrial carcinoma|stage iv endometrial carcinoma
5271330|NCT00538850|fallopian tube cancer|fallopian tube cancer
5271331|NCT00538850|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5271332|NCT00538850|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
5271333|NCT00538850|stage I ovarian epithelial cancer|stage i ovarian epithelial cancer
5271334|NCT00538850|stage I ovarian germ cell tumor|stage i ovarian germ cell tumor
5271335|NCT00538850|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
5271336|NCT00538850|stage II ovarian germ cell tumor|stage ii ovarian germ cell tumor
5271337|NCT00538850|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5271338|NCT00538850|stage III ovarian germ cell tumor|stage iii ovarian germ cell tumor
5271339|NCT00538850|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5271340|NCT00538850|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
5271341|NCT00538850|ovarian sarcoma|ovarian sarcoma
5271342|NCT00538850|ovarian stromal cancer|ovarian stromal cancer
5271343|NCT00538850|recurrent uterine sarcoma|recurrent uterine sarcoma
5271344|NCT00538850|stage I uterine sarcoma|stage i uterine sarcoma
5271345|NCT00538850|stage II uterine sarcoma|stage ii uterine sarcoma
5271346|NCT00538850|stage III uterine sarcoma|stage iii uterine sarcoma
5271347|NCT00538850|stage IV uterine sarcoma|stage iv uterine sarcoma
5271348|NCT00538850|recurrent colon cancer|recurrent colon cancer
5271349|NCT00538850|stage I colon cancer|stage i colon cancer
5271350|NCT00538850|stage II colon cancer|stage ii colon cancer
5271351|NCT00538850|stage III colon cancer|stage iii colon cancer
5271352|NCT00538850|stage IV colon cancer|stage iv colon cancer
5271353|NCT00538850|recurrent bladder cancer|recurrent bladder cancer
5271354|NCT00538850|recurrent gallbladder cancer|recurrent gallbladder cancer
5271355|NCT00538850|stage I bladder cancer|stage i bladder cancer
5271356|NCT00538850|stage II bladder cancer|stage ii bladder cancer
5271357|NCT00538850|stage III bladder cancer|stage iii bladder cancer
5271358|NCT00538850|stage IV bladder cancer|stage iv bladder cancer
5271359|NCT00538850|recurrent gastric cancer|recurrent gastric cancer
5271360|NCT00538850|stage I gastric cancer|stage i gastric cancer
5271361|NCT00538850|stage II gastric cancer|stage ii gastric cancer
5271362|NCT00538850|stage III gastric cancer|stage iii gastric cancer
5271363|NCT00538850|stage IV gastric cancer|stage iv gastric cancer
5271364|NCT00538850|advanced adult primary liver cancer|advanced adult primary liver cancer
5271365|NCT00538850|recurrent small intestine cancer|recurrent small intestine cancer
5271438|NCT00538850|male breast cancer|male breast cancer
5271366|NCT00538850|localized transitional cell cancer of the renal pelvis and ureter|localized transitional cell cancer of the renal pelvis and ureter
5271367|NCT00538850|metastatic transitional cell cancer of the renal pelvis and ureter|metastatic transitional cell cancer of the renal pelvis and ureter
5271368|NCT00538850|recurrent renal cell cancer|recurrent renal cell cancer
5271369|NCT00538850|recurrent transitional cell cancer of the renal pelvis and ureter|recurrent transitional cell cancer of the renal pelvis and ureter
5271370|NCT00538850|regional transitional cell cancer of the renal pelvis and ureter|regional transitional cell cancer of the renal pelvis and ureter
5271371|NCT00538850|stage I renal cell cancer|stage i renal cell cancer
5271372|NCT00538850|stage II renal cell cancer|stage ii renal cell cancer
5271373|NCT00538850|stage III renal cell cancer|stage iii renal cell cancer
5271374|NCT00538850|stage IV renal cell cancer|stage iv renal cell cancer
5271375|NCT00538850|distal urethral cancer|distal urethral cancer
5271376|NCT00538850|proximal urethral cancer|proximal urethral cancer
5271377|NCT00538850|recurrent urethral cancer|recurrent urethral cancer
5271378|NCT00538850|urethral cancer associated with invasive bladder cancer|urethral cancer associated with invasive bladder cancer
5271379|NCT00538850|stage I adrenocortical carcinoma|stage i adrenocortical carcinoma
5271380|NCT00538850|stage II adrenocortical carcinoma|stage ii adrenocortical carcinoma
5271381|NCT00538850|stage III adrenocortical carcinoma|stage iii adrenocortical carcinoma
5271382|NCT00538850|stage IV adrenocortical carcinoma|stage iv adrenocortical carcinoma
5271383|NCT00538850|recurrent adrenocortical carcinoma|recurrent adrenocortical carcinoma
5271384|NCT00538850|extragonadal germ cell tumor|extragonadal germ cell tumor
5271385|NCT00538850|localized gastrointestinal carcinoid tumor|localized gastrointestinal carcinoid tumor
5271386|NCT00538850|metastatic gastrointestinal carcinoid tumor|metastatic gastrointestinal carcinoid tumor
5271387|NCT00538850|recurrent gastrointestinal carcinoid tumor|recurrent gastrointestinal carcinoid tumor
5271388|NCT00538850|regional gastrointestinal carcinoid tumor|regional gastrointestinal carcinoid tumor
5271389|NCT00538850|gastrinoma|gastrinoma
5271390|NCT00538850|insulinoma|insulinoma
5271391|NCT00538850|WDHA syndrome|wdha syndrome
5271392|NCT00538850|glucagonoma|glucagonoma
5271393|NCT00538850|pancreatic polypeptide tumor|pancreatic polypeptide tumor
5271394|NCT00538850|somatostatinoma|somatostatinoma
5271395|NCT00538850|recurrent islet cell carcinoma|recurrent islet cell carcinoma
5271396|NCT00538850|carcinoma of the appendix|carcinoma of the appendix
5271397|NCT00538850|localized extrahepatic bile duct cancer|localized extrahepatic bile duct cancer
5271398|NCT00538850|recurrent extrahepatic bile duct cancer|recurrent extrahepatic bile duct cancer
5271399|NCT00538850|unresectable extrahepatic bile duct cancer|unresectable extrahepatic bile duct cancer
5271400|NCT00538850|localized gallbladder cancer|localized gallbladder cancer
5271401|NCT00538850|unresectable gallbladder cancer|unresectable gallbladder cancer
5271402|NCT00538850|gastrointestinal stromal tumor|gastrointestinal stromal tumor
5271403|NCT00538850|localized resectable adult primary liver cancer|localized resectable adult primary liver cancer
5271404|NCT00538850|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
5271405|NCT00538850|recurrent adult primary liver cancer|recurrent adult primary liver cancer
5271406|NCT00538850|stage I pancreatic cancer|stage i pancreatic cancer
5271407|NCT00538850|stage II pancreatic cancer|stage ii pancreatic cancer
5271408|NCT00538850|stage III pancreatic cancer|stage iii pancreatic cancer
5271409|NCT00538850|stage IV pancreatic cancer|stage iv pancreatic cancer
5271410|NCT00538850|recurrent pancreatic cancer|recurrent pancreatic cancer
5271411|NCT00538850|small intestine adenocarcinoma|small intestine adenocarcinoma
5271412|NCT00538850|small intestine leiomyosarcoma|small intestine leiomyosarcoma
5271413|NCT00538850|small intestine lymphoma|small intestine lymphoma
5271414|NCT00538850|stage I non-small cell lung cancer|stage i non-small cell lung cancer
5271415|NCT00538850|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
5271416|NCT00538850|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5271417|NCT00538850|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5271418|NCT00538850|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5271419|NCT00538850|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5271420|NCT00538850|pulmonary carcinoid tumor|pulmonary carcinoid tumor
5271421|NCT00538850|extensive stage small cell lung cancer|extensive stage small cell lung cancer
5271422|NCT00538850|limited stage small cell lung cancer|limited stage small cell lung cancer
5271423|NCT00538850|recurrent small cell lung cancer|recurrent small cell lung cancer
5271424|NCT00538850|liver metastases|liver metastases
5271425|NCT00538850|lung metastases|lung metastases
5271426|NCT00538850|primary peritoneal cavity cancer|primary peritoneal cavity cancer
5271427|NCT00538850|lung papilloma|lung papilloma
5271428|NCT00538850|peripheral primitive neuroectodermal tumor of the kidney|peripheral primitive neuroectodermal tumor of the kidney
5271429|NCT00538850|clear cell sarcoma of the kidney|clear cell sarcoma of the kidney
5271430|NCT00538850|rhabdoid tumor of the kidney|rhabdoid tumor of the kidney
5271431|NCT00538850|congenital mesoblastic nephroma|congenital mesoblastic nephroma
5271432|NCT00538850|stage II breast cancer|stage ii breast cancer
5271433|NCT00538850|stage IIIA breast cancer|stage iiia breast cancer
5271434|NCT00538850|stage IIIB breast cancer|stage iiib breast cancer
5271435|NCT00538850|stage IIIC breast cancer|stage iiic breast cancer
5271436|NCT00538850|stage IV breast cancer|stage iv breast cancer
5271437|NCT00538850|recurrent breast cancer|recurrent breast cancer
5271902|NCT00536978|Leukemia|leukemia
5271439|NCT00538850|breast cancer in situ|breast cancer in situ
5271440|NCT00538850|localized osteosarcoma|localized osteosarcoma
5271441|NCT00538850|metastatic osteosarcoma|metastatic osteosarcoma
5271442|NCT00538850|recurrent osteosarcoma|recurrent osteosarcoma
5271443|NCT00538850|localized Ewing sarcoma/peripheral primitive neuroectodermal tumor|localized ewing sarcoma/peripheral primitive neuroectodermal tumor
5271444|NCT00538850|metastatic Ewing sarcoma/peripheral primitive neuroectodermal tumor|metastatic ewing sarcoma/peripheral primitive neuroectodermal tumor
5271445|NCT00538850|recurrent Ewing sarcoma/peripheral primitive neuroectodermal tumor|recurrent ewing sarcoma/peripheral primitive neuroectodermal tumor
5271446|NCT00538850|chondrosarcoma|chondrosarcoma
5271447|NCT00538850|malignant giant cell tumor of bone|malignant giant cell tumor of bone
5271448|NCT00538850|desmoid tumor|desmoid tumor
5271449|NCT00538850|stage I adult soft tissue sarcoma|stage i adult soft tissue sarcoma
5271450|NCT00538850|stage II adult soft tissue sarcoma|stage ii adult soft tissue sarcoma
5271451|NCT00538850|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
5271452|NCT00538850|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
5271453|NCT00538850|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
5271454|NCT00538850|recurrent thymoma and thymic carcinoma|recurrent thymoma and thymic carcinoma
5271455|NCT00538850|advanced malignant mesothelioma|advanced malignant mesothelioma
5271456|NCT00538850|localized malignant mesothelioma|localized malignant mesothelioma
5271457|NCT00538850|recurrent malignant mesothelioma|recurrent malignant mesothelioma
5271458|NCT00538850|phosphaturic mesenchymal tumor|phosphaturic mesenchymal tumor
5271459|NCT00538850|stage I malignant testicular germ cell tumor|stage i malignant testicular germ cell tumor
5271460|NCT00538850|stage II malignant testicular germ cell tumor|stage ii malignant testicular germ cell tumor
5271461|NCT00538850|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
5271462|NCT00538850|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
5271463|NCT00538850|stage 0 penile cancer|stage 0 penile cancer
5271464|NCT00538850|stage I penile cancer|stage i penile cancer
5271465|NCT00538850|stage II penile cancer|stage ii penile cancer
5271466|NCT00538850|stage III penile cancer|stage iii penile cancer
5271467|NCT00538850|stage IV penile cancer|stage iv penile cancer
5271468|NCT00538850|recurrent penile cancer|recurrent penile cancer
5271469|NCT00538850|stage I prostate cancer|stage i prostate cancer
5271470|NCT00538850|stage IIB prostate cancer|stage iib prostate cancer
5271471|NCT00538850|stage IIA prostate cancer|stage iia prostate cancer
5271472|NCT00538850|stage III prostate cancer|stage iii prostate cancer
5271473|NCT00538850|stage IV prostate cancer|stage iv prostate cancer
5271474|NCT00538850|recurrent prostate cancer|recurrent prostate cancer
5271475|NCT00538850|stage 0 vaginal cancer|stage 0 vaginal cancer
5271476|NCT00538850|stage I vaginal cancer|stage i vaginal cancer
5271477|NCT00538850|stage II vaginal cancer|stage ii vaginal cancer
5271478|NCT00538850|stage III vaginal cancer|stage iii vaginal cancer
5271479|NCT00538850|stage IVA vaginal cancer|stage iva vaginal cancer
5271480|NCT00538850|stage IVB vaginal cancer|stage ivb vaginal cancer
5271481|NCT00538850|recurrent vaginal cancer|recurrent vaginal cancer
5271482|NCT00538850|stage 0 vulvar cancer|stage 0 vulvar cancer
5271483|NCT00538850|stage I vulvar cancer|stage i vulvar cancer
5271484|NCT00538850|stage II vulvar cancer|stage ii vulvar cancer
5271485|NCT00538850|stage III vulvar cancer|stage iii vulvar cancer
5271486|NCT00538850|stage IVB vulvar cancer|stage ivb vulvar cancer
5271487|NCT00538850|recurrent vulvar cancer|recurrent vulvar cancer
5271488|NCT00538850|stage 0 anal cancer|stage 0 anal cancer
5271489|NCT00538850|stage I anal cancer|stage i anal cancer
5271490|NCT00538850|stage II anal cancer|stage ii anal cancer
5271492|NCT00538850|stage IIIB anal cancer|stage iiib anal cancer
5271493|NCT00538850|stage IV anal cancer|stage iv anal cancer
5271494|NCT00538850|recurrent anal cancer|recurrent anal cancer
5271495|NCT00538850|stage 0 rectal cancer|stage 0 rectal cancer
5271496|NCT00538850|stage I rectal cancer|stage i rectal cancer
5271497|NCT00538850|stage II rectal cancer|stage ii rectal cancer
5271498|NCT00538850|stage III rectal cancer|stage iii rectal cancer
5271499|NCT00538850|stage IV rectal cancer|stage iv rectal cancer
5271500|NCT00538850|recurrent rectal cancer|recurrent rectal cancer
5271501|NCT00538850|stage 0 esophageal cancer|stage 0 esophageal cancer
5271502|NCT00538850|stage I esophageal cancer|stage i esophageal cancer
5271503|NCT00538850|stage II esophageal cancer|stage ii esophageal cancer
5271504|NCT00538850|stage III esophageal cancer|stage iii esophageal cancer
5271505|NCT00538850|stage IV esophageal cancer|stage iv esophageal cancer
5271506|NCT00538850|recurrent esophageal cancer|recurrent esophageal cancer
5271507|NCT00538850|stage I thymoma|stage i thymoma
5271508|NCT00538850|stage II thymoma|stage ii thymoma
5271509|NCT00538850|stage III thymoma|stage iii thymoma
5271510|NCT00538850|stage IVA thymoma|stage iva thymoma
5271511|NCT00538850|stage IVB thymoma|stage ivb thymoma
5271512|NCT00538850|recurrent melanoma|recurrent melanoma
5271513|NCT00538850|stage 0 melanoma|stage 0 melanoma
5271514|NCT00538850|stage IA melanoma|stage ia melanoma
5271515|NCT00538850|stage IB melanoma|stage ib melanoma
5271516|NCT00538850|stage IIA melanoma|stage iia melanoma
5271517|NCT00538850|stage IIB melanoma|stage iib melanoma
5271518|NCT00538850|stage IIC melanoma|stage iic melanoma
5271519|NCT00538850|stage IIIA melanoma|stage iiia melanoma
5271520|NCT00538850|stage IIIB melanoma|stage iiib melanoma
5271521|NCT00538850|stage IIIC melanoma|stage iiic melanoma
5271522|NCT00538850|stage IV melanoma|stage iv melanoma
5271523|NCT00538824|myeloma|myeloma
5271524|NCT00538824|relapsed or refractory multiple myeloma|relapsed or refractory multiple myeloma
5271525|NCT00538798|Pharmacokinetics|pharmacokinetics
5271526|NCT00538798|Binding Potential|binding potential
5271527|NCT00538798|Glutamate|glutamate
5271528|NCT00538798|Positron Emission Tomography|positron emission tomography
5271529|NCT00538798|Metabolic Glutamate Receptors|metabolic glutamate receptors
5271530|NCT00538798|Healthy Volunteer|healthy volunteer
5271531|NCT00538798|HV|hv
5271532|NCT00538785|Synagis, motavizumab, palivizumab, children, MEDI-524, RSV, congenital hear disease|synagis, motavizumab, palivizumab, children, medi-524, rsv, congenital hear disease
5271533|NCT00538772|Metastatic Renal Cell Carcinoma|metastatic renal cell carcinoma
5271534|NCT00538772|Biomarkers|biomarkers
5271535|NCT00538772|Biomarkers in patients with Metastatic Renal Cell Carcinoma Who Have Progressed After Sunitinib Therapy|biomarkers in patients with metastatic renal cell carcinoma who have progressed after sunitinib therapy
5271536|NCT00538759|Aortic valve stenosis|aortic valve stenosis
5271537|NCT00538759|Balloon aortic valvuloplasty|balloon aortic valvuloplasty
5271538|NCT00538759|Aortic valve restenosis|aortic valve restenosis
5271539|NCT00538733|myeloma|myeloma
5271540|NCT00538733|newly diagnosed multiple myeloma|newly diagnosed multiple myeloma
5271541|NCT00538720|Primary Hyperparathyroidism|primary hyperparathyroidism
5271542|NCT00538720|PHPT|phpt
5271543|NCT00538720|Parathyroid glands|parathyroid glands
5271544|NCT00538720|Vitamin D deficiency|vitamin d deficiency
5271545|NCT00538720|Vitamin D|vitamin d
5271546|NCT00538720|Ergocalciferol|ergocalciferol
5271547|NCT00538707|mental stress|mental stress
5271548|NCT00538707|platelet adhesion|platelet adhesion
5271549|NCT00538707|platelet function|platelet function
5271550|NCT00538707|catecholamines|catecholamines
5271551|NCT00538694|Moderate to severe community-acquired acute bacterial pneumonia due to S. Pneumoniae|moderate to severe community-acquired acute bacterial pneumonia due to s. pneumoniae
5271552|NCT00538668|Prostate|prostate
5271553|NCT00538668|Prostate Cancer|prostate cancer
5271554|NCT00538668|Prostate Ca|prostate ca
5271555|NCT00538655|amphetamine|amphetamine
5271556|NCT00538655|methamphetamine|methamphetamine
5271557|NCT00538655|addition|addition
5271558|NCT00538655|treatment study|treatment study
5271559|NCT00538655|drug use|drug use
5271560|NCT00538655|modafinil|modafinil
5271561|NCT00538642|schizophrenia|schizophrenia
5271562|NCT00538642|antipsychotics|antipsychotics
5271563|NCT00538642|diabetes|diabetes
5271564|NCT00538642|bipolar disorder|bipolar disorder
5271565|NCT00538616|Brain Injury|brain injury
5271566|NCT00538590|ologen|ologen
5271567|NCT00538590|collagen matrix|collagen matrix
5271568|NCT00538590|glaucoma|glaucoma
5271569|NCT00538590|trabeculectomy|trabeculectomy
5271570|NCT00538590|Mitomycin-C|mitomycin-c
5271571|NCT00538577|Necrotizing fasciitis|necrotizing fasciitis
5271572|NCT00538564|prolonged, painful erection|prolonged, painful erection
5271573|NCT00538564|priapism|priapism
5271574|NCT00538564|sickle cell anemia|sickle cell anemia
5271575|NCT00538551|HD|hd
5271576|NCT00538551|NHL|nhl
5271577|NCT00538538|Macular Degeneration|macular degeneration
5271578|NCT00538538|AMD|amd
5271579|NCT00538538|Hemorrhage|hemorrhage
5271580|NCT00538538|Wet AMD|wet amd
5271581|NCT00538512|Influenza|influenza
5271582|NCT00538512|Live attenuated influenza vaccine|live attenuated influenza vaccine
5271583|NCT00538512|Inactivated influenza vaccine|inactivated influenza vaccine
5271584|NCT00538512|Vaccine Efficacy|vaccine efficacy
5271585|NCT00538499|pain|pain
5271586|NCT00538499|perioperative/postoperative complications|perioperative/postoperative complications
5271587|NCT00538486|Hypertension|hypertension
5271588|NCT00538486|Abdominal obesity|abdominal obesity
5271589|NCT00538486|Treatment|treatment
5271590|NCT00538473|GSK Bio's influenza vaccine GSK576389A|gsk bio's influenza vaccine gsk576389a
5271591|NCT00538473|Influenza Infection|influenza infection
5271592|NCT00538473|Fluarix|fluarix
5271593|NCT00538460|tomography|tomography
5271594|NCT00538460|coronary artery disease|coronary artery disease
5271595|NCT00538460|magnetic resonance imaging|magnetic resonance imaging
5271596|NCT00538447|CML|cml
5271597|NCT00538434|Eosinophilic Esophagitis|eosinophilic esophagitis
5271598|NCT00538434|GERD|gerd
5271599|NCT00538434|EE|ee
5271600|NCT00538434|Reslizumab|reslizumab
5271601|NCT00538434|IL-5|il-5
5271602|NCT00538434|Interleukin-5|interleukin-5
5271603|NCT00538434|Cinquil|cinquil
5271604|NCT00538421|propofol|propofol
5271605|NCT00538421|Anaesthesia|anaesthesia
5271606|NCT00538421|Sevoflurane|sevoflurane
5271607|NCT00538421|Abdominal|abdominal
5271608|NCT00538421|Aortic|aortic
5271609|NCT00538421|Aneurysm|aneurysm
5271610|NCT00538408|Magnetic resonance|magnetic resonance
5271611|NCT00538408|whole body|whole body
5271612|NCT00538408|angiography|angiography
5271613|NCT00538408|vasovist|vasovist
5271614|NCT00538408|gadofosveset|gadofosveset
5271615|NCT00538408|dotarem|dotarem
5271616|NCT00538408|blood pool agent|blood pool agent
5271617|NCT00538382|Malaria|malaria
5271618|NCT00538382|Pregnancy|pregnancy
5271619|NCT00538382|Artesunate|artesunate
5271620|NCT00538382|Pharmacokinetics|pharmacokinetics
5271621|NCT00538382|Pharmacodynamics|pharmacodynamics
5271622|NCT00538382|Democratic Republic of Congo|democratic republic of congo
5271623|NCT00538369|Nursing|nursing
5271624|NCT00538369|critical care|critical care
5271625|NCT00538369|sedation assessment|sedation assessment
5271626|NCT00538369|Bispectral index|bispectral index
5271627|NCT00538356|Heart failure|heart failure
5271628|NCT00538356|Rehospitalization:|rehospitalization:
5271629|NCT00538356|Packer composite score|packer composite score
5271630|NCT00538356|Home Monitoring|home monitoring
5271631|NCT00538356|Cardiac resynchronization therapy|cardiac resynchronization therapy
5271632|NCT00538356|Implantable cardioverter-defibrillator|implantable cardioverter-defibrillator
5271633|NCT00538343|brain metastases|brain metastases
5271634|NCT00538343|breast cancer|breast cancer
5271635|NCT00538317|Acute myocardial infarction,|acute myocardial infarction,
5271636|NCT00538317|GPIIbIIIa inhibitors,|gpiibiiia inhibitors,
5271637|NCT00538317|primary angioplasty,|primary angioplasty,
5271638|NCT00538317|tirofiban|tirofiban
5271639|NCT00538291|recurrent colon cancer|recurrent colon cancer
5271640|NCT00538291|stage IV colon cancer|stage iv colon cancer
5271641|NCT00538291|recurrent rectal cancer|recurrent rectal cancer
5271642|NCT00538291|stage IV rectal cancer|stage iv rectal cancer
5271644|NCT00538265|liver transplantation, hepatitis C virus, immunoprophylaxis|liver transplantation, hepatitis c virus, immunoprophylaxis
5271645|NCT00538252|drug use, antisocial behavior, early intervention, prevention|drug use, antisocial behavior, early intervention, prevention
5271646|NCT00538213|Influenza vaccine GSK576389A|influenza vaccine gsk576389a
5271647|NCT00538213|Fluarix|fluarix
5271648|NCT00538213|Influenza infection|influenza infection
5271649|NCT00538200|Nutrition|nutrition
5271650|NCT00538200|COPD|copd
5271651|NCT00538161|Acute lung injury|acute lung injury
5271652|NCT00538161|cardiac surgery|cardiac surgery
5271653|NCT00538161|The incidence of ARDS after elective cardiac surgery is 1-3%|the incidence of ards after elective cardiac surgery is 1-3%
5271654|NCT00538161|The impairment of lung function and oxygenation may occur in 20-80% of patients undergoing surgery.|the impairment of lung function and oxygenation may occur in 20-80% of patients undergoing surgery.
5271655|NCT00538161|The purpose of this study is to assess the efficacy of low tidal volume ventilation.|the purpose of this study is to assess the efficacy of low tidal volume ventilation.
5271656|NCT00538161|Reducing interleukin and cytokine production may prevent or reduce the incidence of acute lung injury.|reducing interleukin and cytokine production may prevent or reduce the incidence of acute lung injury.
5271657|NCT00538135|randomised controlled trial|randomised controlled trial
5271658|NCT00538135|borderline personality disorder|borderline personality disorder
5271659|NCT00538135|cognitive behavioural therapy|cognitive behavioural therapy
5271660|NCT00538135|treatment as usual|treatment as usual
5271661|NCT00538122|schizophrenia|schizophrenia
5271662|NCT00538122|schizoaffective disorder|schizoaffective disorder
5271663|NCT00538122|bipolar disorder|bipolar disorder
5271664|NCT00538122|antipsychotic drug treatment|antipsychotic drug treatment
5271665|NCT00538122|safety|safety
5271666|NCT00538122|arrythmias|arrythmias
5271667|NCT00538109|CML in Blast Crisis|cml in blast crisis
5271668|NCT00538109|Accelerated Phase oe Chronic Phase|accelerated phase oe chronic phase
5271669|NCT00538096|B-cell Non-Hodgkin's Lymphoma|b-cell non-hodgkin's lymphoma
5271670|NCT00538083|Cocoa|cocoa
5271671|NCT00538083|Overweight adults|overweight adults
5271672|NCT00538083|Endothelial function|endothelial function
5271673|NCT00538083|Blood pressure|blood pressure
5271674|NCT00538083|Cardiovascular disease risk|cardiovascular disease risk
5271675|NCT00538083|Dark chocolate|dark chocolate
5271676|NCT00538083|Sugar|sugar
5271677|NCT00538070|Sarcosine|sarcosine
5271678|NCT00538070|Glycine|glycine
5271679|NCT00538070|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
5271680|NCT00538070|Schizophrenia|schizophrenia
5271681|NCT00538057|Healthy volunteers|healthy volunteers
5271682|NCT00538044|pulmonary hypertension|pulmonary hypertension
5271683|NCT00538044|simvastatin|simvastatin
5271684|NCT00538044|advanced pulmonary hypertension secondary to congenital heart disease|advanced pulmonary hypertension secondary to congenital heart disease
5271685|NCT00538044|advanced pulmonary hypertension secondary to chronic pulmonary embolism|advanced pulmonary hypertension secondary to chronic pulmonary embolism
5271686|NCT00538005|recurrent melanoma|recurrent melanoma
5271687|NCT00538005|stage IV melanoma|stage iv melanoma
5271688|NCT00537992|combined surgery,|combined surgery,
5271689|NCT00537992|cataract surgery,|cataract surgery,
5271690|NCT00537992|vitrectomy,|vitrectomy,
5271691|NCT00537992|blue light-filter iols|blue light-filter iols
5271692|NCT00537979|Dialysis|dialysis
5271693|NCT00537979|Hyperparathyroidism|hyperparathyroidism
5271694|NCT00537979|Zemplar|zemplar
5271695|NCT00537966|Primary HIV Infection|primary hiv infection
5271696|NCT00537953|Leishmaniasis|leishmaniasis
5271697|NCT00537953|Cutaneous leishmaniasis|cutaneous leishmaniasis
5271698|NCT00537953|Miltefosine|miltefosine
5271699|NCT00537953|Glucantime|glucantime
5271700|NCT00537953|Antimony|antimony
5271701|NCT00537953|Pentavalent antimonials|pentavalent antimonials
5271702|NCT00537953|Combination therapy|combination therapy
5271703|NCT00537927|laparoscopic correction|laparoscopic correction
5271704|NCT00537927|ventral and incisional hernia|ventral and incisional hernia
5271705|NCT00537927|mesh fixation|mesh fixation
5271706|NCT00537927|postoperative pain|postoperative pain
5271707|NCT00537914|Small for Gestational Age, Omnitrope®/Somatropin, rhGH,SGA|small for gestational age, omnitrope®/somatropin, rhgh,sga
5271708|NCT00537901|Colon and Rectum Cancer|colon and rectum cancer
5271709|NCT00537862|Kidney Transplant Patients|kidney transplant patients
5271710|NCT00537862|Immunosuppresion|immunosuppresion
5271711|NCT00537862|Enteric-coated mycophenolate sodium|enteric-coated mycophenolate sodium
5271712|NCT00537836|Hot flushes|hot flushes
5271713|NCT00537836|Therapy of hot flushes|therapy of hot flushes
5271714|NCT00537836|17ß-estradiol (E2)|17ß-estradiol (e2)
5271715|NCT00537836|Hormone replacement therapy|hormone replacement therapy
5271716|NCT00537823|Colorectal Cancer|colorectal cancer
5271717|NCT00537823|Metastasis|metastasis
5271718|NCT00537823|Neoadjuvant Therapy|neoadjuvant therapy
5271719|NCT00537810|Obesity|obesity
5271720|NCT00537810|Binge eating|binge eating
5271721|NCT00537810|Sibutramine|sibutramine
5271722|NCT00537810|Self-help|self-help
5271723|NCT00537810|Primary care|primary care
5271724|NCT00537797|Thyroid Neoplasms|thyroid neoplasms
5271725|NCT00537797|Positron Emission Tomography|positron emission tomography
5271726|NCT00537797|18FDG|18fdg
5271727|NCT00537784|platelets tendon ligament|platelets tendon ligament
5271728|NCT00537771|Early Breast cancer|early breast cancer
5271729|NCT00537771|adjuvant therapy|adjuvant therapy
5271730|NCT00537771|hormone receptor|hormone receptor
5271731|NCT00537771|hormonal therapy|hormonal therapy
5271732|NCT00537771|anastrozole|anastrozole
5271733|NCT00537771|tamoxifen|tamoxifen
5271734|NCT00537758|binge eating disorder|binge eating disorder
5271735|NCT00537758|cognitive behavior therapy|cognitive behavior therapy
5271736|NCT00537758|combination therapy|combination therapy
5271737|NCT00537758|obesity|obesity
5271738|NCT00537758|weight loss|weight loss
5271739|NCT00537758|body weight|body weight
5271740|NCT00537758|clinical trial|clinical trial
5271741|NCT00537758|dietary restriction|dietary restriction
5271742|NCT00537758|overeating|overeating
5271743|NCT00537758|weight control|weight control
5271744|NCT00537732|gastro-oesophageal reflux disease|gastro-oesophageal reflux disease
5271745|NCT00537719|healthy|healthy
5271746|NCT00537719|pharmacodynamics|pharmacodynamics
5271747|NCT00537719|glucagon-like peptide 1|glucagon-like peptide 1
5271748|NCT00537719|pharmacokinetics|pharmacokinetics
5271749|NCT00537719|scintigraphy|scintigraphy
5271750|NCT00537719|radiation|radiation
5271751|NCT00537719|albiglutide|albiglutide
5271752|NCT00537706|Socioeconomic Determinants|socioeconomic determinants
5271753|NCT00537706|Health Status|health status
5271754|NCT00537706|Low-income|low-income
5271755|NCT00537706|Priority-setting|priority-setting
5271756|NCT00537706|Group Discussion|group discussion
5271757|NCT00537693|Continuous Renal Replacement Therapy (CRRT)|continuous renal replacement therapy (crrt)
5271758|NCT00537693|Sepsis|sepsis
5271759|NCT00537693|Convection|convection
5271760|NCT00537693|Diffusion|diffusion
5271761|NCT00537680|Friedreich's Ataxia|friedreich's ataxia
5271762|NCT00537680|Idebenone|idebenone
5271763|NCT00537680|ICARS|icars
5271764|NCT00537667|IL-1ra|il-1ra
5271765|NCT00537667|PEG sTNF-RI|peg stnf-ri
5271766|NCT00537667|Synovial biopsy|synovial biopsy
5271767|NCT00537667|Inflammation|inflammation
5271768|NCT00537667|Bone and Cartilage Destruction|bone and cartilage destruction
5271769|NCT00537667|Rheumatoid Arthritis|rheumatoid arthritis
5271770|NCT00537654|benign prostatic hyperplasia,|benign prostatic hyperplasia,
5271771|NCT00537654|AVODART,|avodart,
5271772|NCT00537654|FLOMAX|flomax
5271773|NCT00537641|noninvasive ventilation|noninvasive ventilation
5271774|NCT00537602|cystic fibrosis|cystic fibrosis
5271775|NCT00537602|miglustat|miglustat
5271776|NCT00537602|Zavesca|zavesca
5271777|NCT00537602|Actelion|actelion
5271778|NCT00537602|nasal potential difference|nasal potential difference
5271779|NCT00537602|transmembrane conductance regulator (CFTR)|transmembrane conductance regulator (cftr)
5271780|NCT00537589|arthrocentesis|arthrocentesis
5271781|NCT00537589|ultrasound|ultrasound
5271782|NCT00537589|emergency|emergency
5271783|NCT00537550|ALL|all
5271784|NCT00537550|Adult|adult
5271785|NCT00537537|Hepatitis B, Chronic, Hepatitis B e Antigen positive, Adults, Telbivudine, Adefovir|hepatitis b, chronic, hepatitis b e antigen positive, adults, telbivudine, adefovir
5271786|NCT00537524|Bird flu|bird flu
5271787|NCT00537524|seasonal influenza vaccine|seasonal influenza vaccine
5271788|NCT00537524|influenza vaccine|influenza vaccine
5271789|NCT00537524|prepandemic vaccine|prepandemic vaccine
5271790|NCT00537524|virus strain with the potential to cause pandemic|virus strain with the potential to cause pandemic
5271791|NCT00537524|toddlers|toddlers
5271792|NCT00537524|children|children
5271793|NCT00537524|adolescents|adolescents
5271794|NCT00537498|urokinase, diabetes, wound healing, major amputation|urokinase, diabetes, wound healing, major amputation
5271795|NCT00537485|SPM 962|spm 962
5271796|NCT00537485|rotigotine|rotigotine
5271797|NCT00537485|Parkinson's disease|parkinson's disease
5271798|NCT00537485|monotherapy|monotherapy
5271799|NCT00537472|Bupivacaine|bupivacaine
5271800|NCT00537472|spinal anesthesia|spinal anesthesia
5271801|NCT00537472|total knee arthroplasty|total knee arthroplasty
5271802|NCT00537459|Premature ejaculation (PE) ejaculatory latency time (ELT)|premature ejaculation (pe) ejaculatory latency time (elt)
5271803|NCT00537446|noninvasive ventilation|noninvasive ventilation
5271804|NCT00537433|Medication errors|medication errors
5271805|NCT00537433|Patient nonadherence|patient nonadherence
5271806|NCT00537433|Literacy|literacy
5271807|NCT00537433|Communication|communication
5271808|NCT00537420|weight loss|weight loss
5271809|NCT00537420|dieting|dieting
5271810|NCT00537407|Hepatitis|hepatitis
5271811|NCT00537407|Hepatitis C|hepatitis c
5271812|NCT00537394|Treatment Experienced|treatment experienced
5271813|NCT00537381|Prostatic neoplasms|prostatic neoplasms
5271814|NCT00537381|CNTO 95|cnto 95
5271815|NCT00537381|Intetumumab|intetumumab
5271816|NCT00537381|Docetaxel|docetaxel
5271817|NCT00537381|Prednisone|prednisone
5271818|NCT00537368|infusion|infusion
5271819|NCT00537368|CNTO 888|cnto 888
5271820|NCT00537368|Phase 1|phase 1
5271821|NCT00537368|solid tumor|solid tumor
5271822|NCT00537368|cancer|cancer
5271823|NCT00537355|ragweed|ragweed
5271824|NCT00537355|ragweed allergy|ragweed allergy
5271825|NCT00537355|allergy|allergy
5271826|NCT00537355|allergies|allergies
5271827|NCT00537355|allergic|allergic
5271828|NCT00537355|seasonal allergic rhinitis|seasonal allergic rhinitis
5271829|NCT00537355|allergic rhinitis|allergic rhinitis
5271830|NCT00537342|Immunotherapy|immunotherapy
5271831|NCT00537342|Allergoid|allergoid
5271832|NCT00537342|Depigmented|depigmented
5271833|NCT00537342|Polymerized|polymerized
5271834|NCT00537342|Allergen-extract|allergen-extract
5271835|NCT00537342|Rhinoconjunctivitis|rhinoconjunctivitis
5271836|NCT00537290|antiphospholipid syndrome|antiphospholipid syndrome
5271837|NCT00537264|health-related quality of life|health-related quality of life
5271838|NCT00537264|primary care|primary care
5271839|NCT00537264|computer-assisted instruction|computer-assisted instruction
5271840|NCT00537238|Epilepsies partial|epilepsies partial
5271841|NCT00537238|Partial Seizure Disorder|partial seizure disorder
5271842|NCT00537238|Complex Partial Seizure Disorder|complex partial seizure disorder
5271843|NCT00537238|Epilepsy|epilepsy
5271844|NCT00537225|peripheral arterial disease|peripheral arterial disease
5271845|NCT00537225|walking time|walking time
5271846|NCT00537225|lifestyle modification|lifestyle modification
5271847|NCT00537225|cardiovascular risk reduction|cardiovascular risk reduction
5271848|NCT00537225|exercise|exercise
5271849|NCT00537225|diet|diet
5271850|NCT00537225|claudication|claudication
5271851|NCT00537212|Psoriasis|psoriasis
5271852|NCT00537212|Weight loss|weight loss
5271853|NCT00537212|diet|diet
5271854|NCT00537199|Head And Neck|head and neck
5271855|NCT00537199|Oropharynx|oropharynx
5271856|NCT00537199|Oral Cancer|oral cancer
5271857|NCT00537199|OraTest|oratest
5271858|NCT00537199|OraTest Dye|oratest dye
5271859|NCT00537199|Rinse Staining Procedure|rinse staining procedure
5271860|NCT00537199|Visual Examination|visual examination
5271861|NCT00537186|Congestive heart failure|congestive heart failure
5271862|NCT00537186|Anaemia|anaemia
5271863|NCT00537186|Iron oligosaccharide|iron oligosaccharide
5271864|NCT00537160|Pediatrics|pediatrics
5271865|NCT00537147|Chimeric West Nile Virus|chimeric west nile virus
5271866|NCT00537147|West Nile Virus|west nile virus
5271867|NCT00537147|Dengue Virus|dengue virus
5271868|NCT00537134|Aneurysm|aneurysm
5271869|NCT00537134|Brain|brain
5271870|NCT00537134|Unruptured|unruptured
5271871|NCT00537134|observation|observation
5271872|NCT00537134|treatment|treatment
5271873|NCT00537134|Endovascular|endovascular
5271874|NCT00537121|recurrent gastric cancer|recurrent gastric cancer
5271875|NCT00537121|stage IV gastric cancer|stage iv gastric cancer
5271876|NCT00537121|recurrent esophageal cancer|recurrent esophageal cancer
5271877|NCT00537121|stage IV esophageal cancer|stage iv esophageal cancer
5271878|NCT00537121|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
5271879|NCT00537121|adenocarcinoma of the stomach|adenocarcinoma of the stomach
5271880|NCT00537121|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
5271881|NCT00537121|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
5271882|NCT00537121|stage III gastric cancer|stage iii gastric cancer
5271883|NCT00537121|stage III esophageal cancer|stage iii esophageal cancer
5271884|NCT00537121|advanced adult primary liver cancer|advanced adult primary liver cancer
5271885|NCT00537121|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
5271886|NCT00537121|recurrent adult primary liver cancer|recurrent adult primary liver cancer
5271887|NCT00537108|Pregnancy in adolescence|pregnancy in adolescence
5271888|NCT00537095|follicular|follicular
5271889|NCT00537095|papillary|papillary
5271890|NCT00537082|FTY720,|fty720,
5271891|NCT00537082|MS|ms
5271892|NCT00537043|hypertension,|hypertension,
5271893|NCT00537043|carvedilol,|carvedilol,
5271894|NCT00537043|repeat-dosing|repeat-dosing
5271895|NCT00537004|primary progressive aphasia|primary progressive aphasia
5271896|NCT00537004|frontotemporal dementia|frontotemporal dementia
5271897|NCT00537004|semantic dementia|semantic dementia
5271898|NCT00537004|progressive nonfluent aphasia|progressive nonfluent aphasia
5271899|NCT00537004|progressive aphasia|progressive aphasia
5271900|NCT00537004|frontotemporal lobar degeneration|frontotemporal lobar degeneration
5271901|NCT00536978|Lymphoma|lymphoma
5271903|NCT00536978|B-Cell Lymphoid Malignancies|b-cell lymphoid malignancies
5271904|NCT00536978|CLL|cll
5271905|NCT00536978|Cll/Small Lymphocytic Lymphoma|cll/small lymphocytic lymphoma
5271906|NCT00536978|Follicular Lymphoma|follicular lymphoma
5271907|NCT00536978|Mantle Cell Lymphoma|mantle cell lymphoma
5271908|NCT00536978|Diffuse Large Cell Lymphoma|diffuse large cell lymphoma
5271909|NCT00536978|Splenic Lymphoma|splenic lymphoma
5271910|NCT00536978|MALT|malt
5271911|NCT00536978|Lymphoplasmacytic Lymphoma|lymphoplasmacytic lymphoma
5271912|NCT00536978|Burkitt's Lymphoma|burkitt's lymphoma
5271913|NCT00536978|ARA-C|ara-c
5271914|NCT00536978|BCNU|bcnu
5271915|NCT00536978|Campath-1H|campath-1h
5271916|NCT00536978|Cytoxan|cytoxan
5271917|NCT00536978|Etoposide|etoposide
5271918|NCT00536978|Fludarabine|fludarabine
5271919|NCT00536978|Melphalan|melphalan
5271920|NCT00536978|Rituximab|rituximab
5271921|NCT00536978|Allogeneic Stem Cell Transplant|allogeneic stem cell transplant
5271922|NCT00536978|T-Cell Cell Adback|t-cell cell adback
5271923|NCT00536978|Natural Killer (NK) Cell Adback|natural killer (nk) cell adback
5271924|NCT00536965|Hyperlipidemia|hyperlipidemia
5271925|NCT00536965|Need-to-treat|need-to-treat
5271926|NCT00536965|NIS|nis
5271927|NCT00536965|Secondary prevention patients with hyperlipidemia and atherosclerosis (coronary heart disease, carotid stenosis, PVD, etc.) and/or diabetes|secondary prevention patients with hyperlipidemia and atherosclerosis (coronary heart disease, carotid stenosis, pvd, etc.) and/or diabetes
5271928|NCT00536952|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
5271929|NCT00536952|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
5271930|NCT00536952|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5271931|NCT00536952|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
5271932|NCT00536952|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5271933|NCT00536952|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
5271934|NCT00536952|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
5271935|NCT00536952|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
5271936|NCT00536952|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5271937|NCT00536952|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
5271938|NCT00536952|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
5271939|NCT00536952|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
5271940|NCT00536952|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
5271941|NCT00536952|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
5271942|NCT00536952|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5271943|NCT00536926|telemedicine|telemedicine
5271944|NCT00536926|lung transplantation|lung transplantation
5271945|NCT00536926|home spirometry|home spirometry
5271946|NCT00536913|Symbicort pMDI|symbicort pmdi
5271947|NCT00536913|spacer|spacer
5271948|NCT00536913|children|children
5271949|NCT00536900|Substance abuse|substance abuse
5271950|NCT00536900|Behavior therapy|behavior therapy
5271951|NCT00536900|representative payee|representative payee
5271952|NCT00536900|cocaine abuse|cocaine abuse
5271953|NCT00536900|alcohol abuse|alcohol abuse
5271954|NCT00536900|case management|case management
5271955|NCT00536900|dual diagnosis|dual diagnosis
5271956|NCT00536874|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
5271957|NCT00536874|stage IA pancreatic cancer|stage ia pancreatic cancer
5271958|NCT00536874|stage IB pancreatic cancer|stage ib pancreatic cancer
5271959|NCT00536874|stage IIA pancreatic cancer|stage iia pancreatic cancer
5271960|NCT00536874|stage IIB pancreatic cancer|stage iib pancreatic cancer
5271961|NCT00536874|stage III pancreatic cancer|stage iii pancreatic cancer
5271962|NCT00536861|erlotinib|erlotinib
5271963|NCT00536861|cranial radiotherapy|cranial radiotherapy
5271964|NCT00536848|Probiotics|probiotics
5271965|NCT00536848|HIV|hiv
5271966|NCT00536848|AIDS|aids
5271967|NCT00536848|Diarrhea|diarrhea
5271968|NCT00536848|Lactobacillus rhamnosus GR-1|lactobacillus rhamnosus gr-1
5272091|NCT00536302|Nutritional supplement|nutritional supplement
5271969|NCT00536848|Lactobacillus reuteri RC-14|lactobacillus reuteri rc-14
5271970|NCT00536848|Immune system|immune system
5271971|NCT00536848|Infectious Diseases|infectious diseases
5271972|NCT00536848|Complementary Therapies|complementary therapies
5271973|NCT00536848|Treatment Naive|treatment naive
5271974|NCT00536835|Non-Hodgkins Lymphoma|non-hodgkins lymphoma
5271975|NCT00536835|Cancer|cancer
5271976|NCT00536835|First time in human|first time in human
5271977|NCT00536835|PLK1 inhibitor|plk1 inhibitor
5271978|NCT00536835|Advanced Solid Tumor|advanced solid tumor
5271979|NCT00536835|GSK461364|gsk461364
5271980|NCT00536822|rehabilitation|rehabilitation
5271981|NCT00536822|pediatrics|pediatrics
5271982|NCT00536809|Metastatic Colorectal Cancer|metastatic colorectal cancer
5271983|NCT00536809|oxaliplatin|oxaliplatin
5271984|NCT00536809|fluoropyrimidines cancers|fluoropyrimidines cancers
5271985|NCT00536809|Advanced Colorectal Cancer|advanced colorectal cancer
5271986|NCT00536809|capecitabine|capecitabine
5271987|NCT00536809|lapatinib|lapatinib
5271988|NCT00536796|Hyperlipidemia|hyperlipidemia
5271989|NCT00536796|Need-to-treat|need-to-treat
5271991|NCT00536796|Secondary prevention patients with hyperlipidemia and atherosclerosis (coronary heart disease, carotid stenosis, PVD, etc.) and/or diabetes|secondary prevention patients with hyperlipidemia and atherosclerosis (coronary heart disease, carotid stenosis, pvd, etc.) and/or diabetes
5271992|NCT00536783|Psychiatry|psychiatry
5271993|NCT00536783|Antipsychotic|antipsychotic
5271994|NCT00536783|Psychopharmacology|psychopharmacology
5271995|NCT00536783|Clinical Trial|clinical trial
5271996|NCT00536783|Open Label|open label
5271997|NCT00536783|Schizophrenia|schizophrenia
5271998|NCT00536783|Sensory Gating|sensory gating
5271999|NCT00536783|Attention|attention
5272000|NCT00536783|Memory|memory
5272001|NCT00536731|Asthma|asthma
5272002|NCT00536731|Symbicort|symbicort
5272003|NCT00536718|invasive lobular breast carcinoma with predominant in situ component|invasive lobular breast carcinoma with predominant in situ component
5272004|NCT00536718|invasive lobular breast carcinoma|invasive lobular breast carcinoma
5272005|NCT00536718|lobular breast carcinoma in situ|lobular breast carcinoma in situ
5272006|NCT00536705|asthma|asthma
5272007|NCT00536705|child|child
5272008|NCT00536705|transforming growth factor beta(TGF-β)|transforming growth factor beta(tgf-β)
5272009|NCT00536705|Leukotriene Antagonists(Montelukast)|leukotriene antagonists(montelukast)
5272010|NCT00536692|macular edema|macular edema
5272011|NCT00536692|DME|dme
5272012|NCT00536692|diabetic|diabetic
5272013|NCT00536692|mecamylamine|mecamylamine
5272014|NCT00536692|Comentis|comentis
5272015|NCT00536679|Relative Bioavailability|relative bioavailability
5272016|NCT00536679|Randomised|randomised
5272017|NCT00536679|GSK163090|gsk163090
5272018|NCT00536679|Food Effect|food effect
5272019|NCT00536666|Chronic kidney disease|chronic kidney disease
5272020|NCT00536666|Aneamia|aneamia
5272021|NCT00536666|Iron oligosaccharide|iron oligosaccharide
5272022|NCT00536666|Chronic kidney disease patients|chronic kidney disease patients
5272023|NCT00536653|prostate cancer|prostate cancer
5272024|NCT00536653|bone density|bone density
5272025|NCT00536653|osteoporosis|osteoporosis
5272026|NCT00536653|androgen antagonists|androgen antagonists
5272027|NCT00536640|Non Small Cell Lung Carcinoma (NSCLC Stage III an IV)|non small cell lung carcinoma (nsclc stage iii an iv)
5272028|NCT00536627|DNA vaccine|dna vaccine
5272029|NCT00536614|pancreatic cancer|pancreatic cancer
5272030|NCT00536614|metastatic|metastatic
5272031|NCT00536614|EGFR|egfr
5272032|NCT00536614|locally advanced pancreatic cancer|locally advanced pancreatic cancer
5272033|NCT00536575|Multiple Myeloma|multiple myeloma
5272034|NCT00536575|Relapsed|relapsed
5272035|NCT00536575|Refractory|refractory
5272036|NCT00536575|Sorafenib|sorafenib
5272037|NCT00536575|Bortezomib|bortezomib
5272038|NCT00536562|Comprehensive Cardiac Rehabilitation|comprehensive cardiac rehabilitation
5272039|NCT00536562|Randomized Controlled Trial|randomized controlled trial
5272040|NCT00536562|TIA (Transient Ischemic Attack)|tia (transient ischemic attack)
5272041|NCT00536562|Mild Non-Disabling Stroke|mild non-disabling stroke
5272042|NCT00536562|Vascular Protection|vascular protection
5272043|NCT00536549|Glucose monitoring system|glucose monitoring system
5272044|NCT00536549|life style intervention|life style intervention
5272045|NCT00536536|Childhood|childhood
5272046|NCT00536536|Obesity|obesity
5272047|NCT00536536|Primary Care|primary care
5272048|NCT00536523|constipation, impaction, and bowel obstruction|constipation, impaction, and bowel obstruction
5272049|NCT00536523|ovarian epithelial cancer|ovarian epithelial cancer
5272050|NCT00536523|peritoneal cavity cancer|peritoneal cavity cancer
5272051|NCT00536523|fallopian tube cancer|fallopian tube cancer
5272052|NCT00536510|High Cholesterol|high cholesterol
5272053|NCT00536510|Excess lipids|excess lipids
5272054|NCT00536497|GW842166,|gw842166,
5272055|NCT00536497|Healthy volunteers,|healthy volunteers,
5272056|NCT00536497|Inflammatory Pain.|inflammatory pain.
5272057|NCT00536484|Overactive Bladder|overactive bladder
5272058|NCT00536458|localized low grade lymphoma|localized low grade lymphoma
5272059|NCT00536458|Chemotherapy|chemotherapy
5272060|NCT00536458|Radiotherapy|radiotherapy
5272061|NCT00536458|Molecular analyses|molecular analyses
5272062|NCT00536458|primary|primary
5272063|NCT00536445|NAVA|nava
5272064|NCT00536445|Preterm|preterm
5272065|NCT00536445|Case study|case study
5272066|NCT00536406|Geriatric|geriatric
5272067|NCT00536406|Nursing Homes|nursing homes
5272068|NCT00536393|diffuse larg cells lymphoma|diffuse larg cells lymphoma
5272069|NCT00536393|chemotherapy|chemotherapy
5272070|NCT00536393|toxicity|toxicity
5272071|NCT00536393|diffuse high grade lymphoma|diffuse high grade lymphoma
5272072|NCT00536367|Heart Failure, Congestive|heart failure, congestive
5272073|NCT00536367|Mortality Prediction Model|mortality prediction model
5272074|NCT00536341|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
5272075|NCT00536341|untreated|untreated
5272076|NCT00536341|minimally treated|minimally treated
5272077|NCT00536341|fludarabine|fludarabine
5272078|NCT00536341|rituximab|rituximab
5272079|NCT00536341|lenalidomide|lenalidomide
5272080|NCT00536328|Reflux Impact Scale (RIS)|reflux impact scale (ris)
5272182|NCT00535990|Surgical|surgical
5272081|NCT00536328|predictive value|predictive value
5272082|NCT00536328|treatment success|treatment success
5272083|NCT00536328|patient satisfaction|patient satisfaction
5272084|NCT00536328|proton pump inhibitor|proton pump inhibitor
5272085|NCT00536328|gastro-esophageal reflux disease|gastro-esophageal reflux disease
5272086|NCT00536328|PPU|ppu
5272087|NCT00536315|COPD|copd
5272088|NCT00536302|OA|oa
5272089|NCT00536302|Knee arthritis|knee arthritis
5272090|NCT00536302|Osteoarthritis|osteoarthritis
5272092|NCT00536302|CAM|cam
5272093|NCT00536302|MRI|mri
5272094|NCT00536289|Blunt needles|blunt needles
5272095|NCT00536289|obstetric lacerations|obstetric lacerations
5272096|NCT00536289|Needlestick injuries|needlestick injuries
5272097|NCT00536289|Needlestick injuries to physicians|needlestick injuries to physicians
5272098|NCT00536276|vitamin D|vitamin d
5272099|NCT00536250|Pre-Diabetes|pre-diabetes
5272100|NCT00536250|Childhood Obesity|childhood obesity
5272101|NCT00536250|Metabolic Syndrome|metabolic syndrome
5272102|NCT00536250|insulin resistance|insulin resistance
5272103|NCT00536250|Impaired Glucose Tolerance|impaired glucose tolerance
5272104|NCT00536250|Non Alcoholic Fatty Liver Disease|non alcoholic fatty liver disease
5272105|NCT00536250|High Molecular Weight Adiponectin|high molecular weight adiponectin
5272106|NCT00536250|Hypoadiponectinemia|hypoadiponectinemia
5272107|NCT00536224|Health promotion|health promotion
5272108|NCT00536224|Emergency Medical Services|emergency medical services
5272109|NCT00536224|Randomized controlled trial|randomized controlled trial
5272110|NCT00536224|Chest pain observation unit|chest pain observation unit
5272111|NCT00536224|Cardiovascular risk factors|cardiovascular risk factors
5272112|NCT00536211|Exercise|exercise
5272113|NCT00536211|Physical Activity|physical activity
5272114|NCT00536211|Metformin|metformin
5272115|NCT00536211|Hyperinsulinemic-Euglycemic Clamp|hyperinsulinemic-euglycemic clamp
5272116|NCT00536211|Muscle Biopsy|muscle biopsy
5272117|NCT00536211|Fatty Acid Oxidation|fatty acid oxidation
5272118|NCT00536211|Peroxisome proliferator-activated receptor gamma|peroxisome proliferator-activated receptor gamma
5272119|NCT00536211|Detraining|detraining
5272120|NCT00536211|Inactivity|inactivity
5272121|NCT00536211|Skeletal muscle|skeletal muscle
5272122|NCT00536198|Premenstrual Syndrome|premenstrual syndrome
5272123|NCT00536185|ALOX5|alox5
5272124|NCT00536185|5-lipoxygenase|5-lipoxygenase
5272125|NCT00536185|Heart Disease|heart disease
5272126|NCT00536185|Blacks|blacks
5272127|NCT00536172|Antidepressant|antidepressant
5272128|NCT00536172|Major depression|major depression
5272129|NCT00536172|Prevention|prevention
5272130|NCT00536172|Head and neck cancer|head and neck cancer
5272131|NCT00536159|nurse-community health worker team|nurse-community health worker team
5272132|NCT00536159|perinatal depression|perinatal depression
5272133|NCT00536159|stress|stress
5272134|NCT00536159|Medicaid enhanced prenatal programs|medicaid enhanced prenatal programs
5272135|NCT00536146|Glucocorticoid|glucocorticoid
5272136|NCT00536146|Steroids|steroids
5272137|NCT00536146|Dose-Responsive Curve|dose-responsive curve
5272138|NCT00536146|EC50|ec50
5272139|NCT00536146|Stress Response|stress response
5272140|NCT00536146|Alcoholism|alcoholism
5272141|NCT00536133|zinc|zinc
5272142|NCT00536133|aute lower respiratory infections|aute lower respiratory infections
5272143|NCT00536120|MS|ms
5272144|NCT00536120|Multiple sclerosis|multiple sclerosis
5272145|NCT00536120|Relapsing forms of Multiple Sclerosis|relapsing forms of multiple sclerosis
5272146|NCT00536107|Non-Small Cell Lung Cancer|non-small cell lung cancer
5272147|NCT00536107|Locally Advanced or Metastatic NSCL Cancer|locally advanced or metastatic nscl cancer
5272148|NCT00536094|Cognitive behavioral therapy|cognitive behavioral therapy
5272149|NCT00536094|Youth|youth
5272150|NCT00536094|School|school
5272151|NCT00536094|African American|african american
5272152|NCT00536081|Breast cancer|breast cancer
5272153|NCT00536081|Adjuvant|adjuvant
5272154|NCT00536081|Advanced|advanced
5272155|NCT00536081|Chemotherapy|chemotherapy
5272156|NCT00536081|G-CSF|g-csf
5272157|NCT00536081|Pegfilgrastim|pegfilgrastim
5272158|NCT00536081|Prevention|prevention
5272159|NCT00536081|Febrile neutropenia|febrile neutropenia
5272160|NCT00536068|platelet|platelet
5272161|NCT00536068|aggregation|aggregation
5272162|NCT00536068|aspirin|aspirin
5272163|NCT00536055|breast cancer|breast cancer
5272164|NCT00536055|prostate cancer|prostate cancer
5272165|NCT00536055|dyadic coping|dyadic coping
5272166|NCT00536042|minocycline|minocycline
5272167|NCT00536042|asthma|asthma
5272168|NCT00536042|oral steroids|oral steroids
5272169|NCT00536042|IgE|ige
5272170|NCT00536029|Melanoma|melanoma
5272171|NCT00536029|SIAscope|siascope
5272172|NCT00536029|pigmented skin lesions|pigmented skin lesions
5272173|NCT00536016|AMD|amd
5272174|NCT00536016|Neovascular Age-Related Macular Degeneration|neovascular age-related macular degeneration
5272175|NCT00536003|preterm delivery|preterm delivery
5272176|NCT00536003|preterm labor|preterm labor
5272177|NCT00536003|perinatal morbidity|perinatal morbidity
5272178|NCT00536003|perinatal mortality|perinatal mortality
5272179|NCT00535990|Cholecystectomy|cholecystectomy
5272180|NCT00535990|Appendectomy|appendectomy
5272181|NCT00535990|Esophageal|esophageal
5272183|NCT00535990|Procedures|procedures
5272184|NCT00535990|Surgery|surgery
5272185|NCT00535990|Gastric|gastric
5272186|NCT00535990|bypass|bypass
5272187|NCT00535977|Gene expression|gene expression
5272188|NCT00535977|Prostate|prostate
5272189|NCT00535977|Broccoli|broccoli
5272190|NCT00535977|Cancer|cancer
5272191|NCT00535977|Men diagnosed with high-grade Prostatic Intraepithelia Neoplasia|men diagnosed with high-grade prostatic intraepithelia neoplasia
5272192|NCT00535964|Cigarette Smoking|cigarette smoking
5272193|NCT00535964|Tobacco Use|tobacco use
5272194|NCT00535964|Adolescents|adolescents
5272195|NCT00535964|Anxiety Sensitivity (AS)|anxiety sensitivity (as)
5272196|NCT00535951|Non-small cell lung cancer|non-small cell lung cancer
5272197|NCT00535951|NSCLC|nsclc
5272198|NCT00535951|lung cancer|lung cancer
5272199|NCT00535951|pleural mesothelioma|pleural mesothelioma
5272200|NCT00535951|malignant|malignant
5272201|NCT00535951|advanced stage|advanced stage
5272202|NCT00535951|mesothelioma|mesothelioma
5272203|NCT00535951|phase I|phase i
5272204|NCT00535951|LBH589|lbh589
5272205|NCT00535951|dextromethorphan|dextromethorphan
5272206|NCT00535951|CYP2D6|cyp2d6
5272207|NCT00535951|oral|oral
5272208|NCT00535925|type 2 diabetes|type 2 diabetes
5272209|NCT00535925|nephropathy|nephropathy
5272210|NCT00535925|CV events|cv events
5272211|NCT00535912|CLL|cll
5272212|NCT00535899|Aortic stenosis|aortic stenosis
5272213|NCT00535899|Speckle tracking imaging|speckle tracking imaging
5272214|NCT00535899|Low ejection fraction|low ejection fraction
5272215|NCT00535899|Aortic valve replacement|aortic valve replacement
5272216|NCT00535899|Strain|strain
5272217|NCT00535886|Trans Fatty Acids|trans fatty acids
5272218|NCT00535886|conjugated linoleic acid|conjugated linoleic acid
5272219|NCT00535886|vaccenic acid|vaccenic acid
5272220|NCT00535886|High Density Lipoprotein Cholesterol|high density lipoprotein cholesterol
5272221|NCT00535886|Low Density Lipoprotein Cholesterol|low density lipoprotein cholesterol
5272222|NCT00535886|Beef|beef
5272223|NCT00535873|Leukemia|leukemia
5272224|NCT00535873|CLL|cll
5272225|NCT00535873|chronic lymphocytic leukemia|chronic lymphocytic leukemia
5272226|NCT00535873|SLL|sll
5272227|NCT00535873|small lymphocytic lymphoma|small lymphocytic lymphoma
5272228|NCT00535873|Untreated CLL|untreated cll
5272229|NCT00535873|Lenalidomide|lenalidomide
5272230|NCT00535873|CC-5013|cc-5013
5272231|NCT00535873|Revlimid|revlimid
5272232|NCT00535873|Oral|oral
5272233|NCT00535860|Osteoporosis|osteoporosis
5272234|NCT00535860|Transdermal|transdermal
5272235|NCT00535860|hPTH(1-34)|hpth(1-34)
5272236|NCT00535847|Genotype 1|genotype 1
5272237|NCT00535834|stage I prostate cancer|stage i prostate cancer
5272238|NCT00535834|stage II prostate cancer|stage ii prostate cancer
5272239|NCT00535834|stage III prostate cancer|stage iii prostate cancer
5272240|NCT00535834|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5272241|NCT00535821|Emergency Department|emergency department
5272242|NCT00535821|Hemodynamic Optimization|hemodynamic optimization
5272243|NCT00535821|Esophageal Doppler monitoring|esophageal doppler monitoring
5272244|NCT00535821|Early Goal-Directed Therapy|early goal-directed therapy
5272245|NCT00535769|topical|topical
5272246|NCT00535769|medication adherence|medication adherence
5272247|NCT00535769|adherence|adherence
5272248|NCT00535769|compliance|compliance
5272249|NCT00535769|medication compliance|medication compliance
5272250|NCT00535769|sunscreen|sunscreen
5272251|NCT00535769|reminder|reminder
5272252|NCT00535756|Pancreatic Exocrine Insufficiency After Pancreatic Surgery|pancreatic exocrine insufficiency after pancreatic surgery
5272253|NCT00535717|Urethral stricture|urethral stricture
5272254|NCT00535717|Ayurvedic treatment|ayurvedic treatment
5272255|NCT00535717|mutra marg sankoch|mutra marg sankoch
5272256|NCT00535717|uttarbasti|uttarbasti
5272257|NCT00535717|Sesame oil|sesame oil
5272258|NCT00535717|Honey|honey
5272259|NCT00535717|Rock salt|rock salt
5272260|NCT00535678|Mammography|mammography
5272261|NCT00535678|mammogram|mammogram
5272262|NCT00535678|breast|breast
5272263|NCT00535678|Abnormal and normal breast tissue|abnormal and normal breast tissue
5272264|NCT00535639|Tolerability of ALK Tree Tablet in patients with birch pollen induced allergy|tolerability of alk tree tablet in patients with birch pollen induced allergy
5272265|NCT00535600|Bariatric Surgery|bariatric surgery
5272266|NCT00535600|Insulin Action|insulin action
5272267|NCT00535600|Insulin Secretion|insulin secretion
5272268|NCT00535600|Insulin Resistance|insulin resistance
5272269|NCT00535600|Gut Hormones|gut hormones
5272270|NCT00535600|Obesity|obesity
5272271|NCT00535587|Fibromyalgia|fibromyalgia
5272272|NCT00535587|Exercise|exercise
5272273|NCT00535587|Mestinon|mestinon
5272274|NCT00535574|retinoids|retinoids
5272275|NCT00535574|bexarotene|bexarotene
5272276|NCT00535574|schizophrenia|schizophrenia
5272277|NCT00535574|PANSS|panss
5272278|NCT00535574|Positive and negative symptoms of schizophrenia|positive and negative symptoms of schizophrenia
5272279|NCT00535561|iron deficiency anemia|iron deficiency anemia
5272280|NCT00535561|anemia|anemia
5272281|NCT00535561|hypothyroidism|hypothyroidism
5272282|NCT00535561|subclinical hypothyroidism|subclinical hypothyroidism
5272283|NCT00535548|Chronic wounds|chronic wounds
5272284|NCT00535548|Pressure sores|pressure sores
5272285|NCT00535548|Hematopoietic stem cells|hematopoietic stem cells
5272286|NCT00535548|Wound healing|wound healing
5272287|NCT00535535|Elevated triglycerides|elevated triglycerides
5272288|NCT00535535|Diabetes|diabetes
5272289|NCT00535535|Cardiovascular disease|cardiovascular disease
5272290|NCT00535522|Pharmacokinetics|pharmacokinetics
5272291|NCT00535522|pharmacodynamics|pharmacodynamics
5272292|NCT00535522|maximal tolerated dose|maximal tolerated dose
5272293|NCT00535483|blood microdialysis|blood microdialysis
5272294|NCT00535483|glucose monitoring|glucose monitoring
5272295|NCT00535483|glucose control|glucose control
5272296|NCT00535483|automated blood sampling|automated blood sampling
5272297|NCT00535483|online-sensor|online-sensor
5272298|NCT00535483|algorithm|algorithm
5272299|NCT00535483|type 1 diabetes|type 1 diabetes
5272300|NCT00535457|anxiety|anxiety
5272301|NCT00535457|maladaptive behavior|maladaptive behavior
5272302|NCT00535457|anesthesia|anesthesia
5272303|NCT00535457|Anxiety before anesthesia and maladaptive behavior after anesthesia.|anxiety before anesthesia and maladaptive behavior after anesthesia.
5272304|NCT00535444|Hypertension|hypertension
5272305|NCT00535444|parish nurse|parish nurse
5272306|NCT00535431|Asthma|asthma
5272307|NCT00535431|allergy|allergy
5272308|NCT00535431|interleukin-4|interleukin-4
5272309|NCT00535431|interleukin-13|interleukin-13
5272310|NCT00535431|IL-4|il-4
5272311|NCT00535431|IL-13|il-13
5272312|NCT00535418|Breast cancer|breast cancer
5272313|NCT00535418|neoadjuvant treatment|neoadjuvant treatment
5272314|NCT00535418|treatment duration|treatment duration
5272315|NCT00535418|Primary hormone receptor positive|primary hormone receptor positive
5272316|NCT00535418|breast cancer in postmenopausal women|breast cancer in postmenopausal women
5272317|NCT00535405|High Cholesterol|high cholesterol
5272318|NCT00535392|Epilepsy|epilepsy
5272319|NCT00535392|Child|child
5272320|NCT00535392|Levetiracetam|levetiracetam
5272321|NCT00535392|Keppra®|keppra®
5272322|NCT00535392|Infusion|infusion
5272323|NCT00535392|Intravenous|intravenous
5272324|NCT00535379|glioblastoma multiforme|glioblastoma multiforme
5272325|NCT00535379|sunitinib|sunitinib
5272326|NCT00535379|recurrent|recurrent
5272327|NCT00535379|progressive|progressive
5272328|NCT00535353|recurrent colon cancer|recurrent colon cancer
5272329|NCT00535353|stage IV colon cancer|stage iv colon cancer
5272330|NCT00535353|recurrent rectal cancer|recurrent rectal cancer
5272331|NCT00535353|stage IV rectal cancer|stage iv rectal cancer
5272332|NCT00535353|stage III rectal cancer|stage iii rectal cancer
5272333|NCT00535353|stage III colon cancer|stage iii colon cancer
5272334|NCT00535340|Anxiety|anxiety
5272335|NCT00535340|Anti-Anxiety Agents|anti-anxiety agents
5272336|NCT00535327|Mammography|mammography
5272337|NCT00535327|mammogram|mammogram
5272338|NCT00535327|breast|breast
5272339|NCT00535327|Abnormal and normal breast tissue|abnormal and normal breast tissue
5272340|NCT00535314|Melanoma|melanoma
5272341|NCT00535301|cystocele|cystocele
5272342|NCT00535301|uterine prolapse|uterine prolapse
5272343|NCT00535301|urinary incontinence|urinary incontinence
5272344|NCT00535275|NSCLC relapse after adjuvant chemotherapy|nsclc relapse after adjuvant chemotherapy
5272346|NCT00535262|depression|depression
5272347|NCT00535236|Prevention of herpes zoster and HZ-related complications|prevention of herpes zoster and hz-related complications
5272348|NCT00535223|Cognitive Behavior Therapy|cognitive behavior therapy
5272349|NCT00535223|Group therapy|group therapy
5272350|NCT00535223|Posttraumatic Stress Disorder|posttraumatic stress disorder
5272351|NCT00535223|Randomized Controlled Trial|randomized controlled trial
5272352|NCT00535223|Treatment outcome|treatment outcome
5272353|NCT00535223|Veterans|veterans
5272354|NCT00535223|War|war
5272355|NCT00535210|spinal cord injury|spinal cord injury
5272356|NCT00535210|exercise rehabilitation|exercise rehabilitation
5272357|NCT00535210|inpatient|inpatient
5272358|NCT00535210|RCT|rct
5272359|NCT00535210|physical function|physical function
5272360|NCT00535184|Mammography|mammography
5272361|NCT00535184|mammogram|mammogram
5272362|NCT00535184|breast|breast
5272363|NCT00535184|Abnormal and normal breast tissue|abnormal and normal breast tissue
5272364|NCT00535158|Chronic Kidney disease|chronic kidney disease
5272365|NCT00535158|Dialysis|dialysis
5272366|NCT00535158|Vitamin D|vitamin d
5272367|NCT00535158|Chronic kidney disease is associated with impaired muscle strength, pain and fractures.|chronic kidney disease is associated with impaired muscle strength, pain and fractures.
5272368|NCT00535145|antipsychotic|antipsychotic
5272369|NCT00535145|paliperidone ER|paliperidone er
5272370|NCT00535145|liver disease|liver disease
5272371|NCT00535145|Schizophrenia|schizophrenia
5272372|NCT00535145|Schizoaffective Disorder|schizoaffective disorder
5272373|NCT00535145|Invega|invega
5272374|NCT00535132|schizophrenia|schizophrenia
5272375|NCT00535132|medication satisfaction, Invega|medication satisfaction, invega
5272376|NCT00535106|Ventricular fibrillation|ventricular fibrillation
5272377|NCT00535106|Cardiac arrest|cardiac arrest
5272378|NCT00535106|Automated external defibrillator|automated external defibrillator
5272379|NCT00535106|AED|aed
5272380|NCT00535106|Waveform based algorithms|waveform based algorithms
5272381|NCT00535106|VF waveform analysis|vf waveform analysis
5272382|NCT00535093|Pharyngitis|pharyngitis
5272383|NCT00535093|Community infections|community infections
5272384|NCT00535093|Rapid Testing|rapid testing
5272385|NCT00535093|Group A Streptococcus|group a streptococcus
5272386|NCT00535080|actinic|actinic
5272387|NCT00535080|keratoses|keratoses
5272388|NCT00535080|superficial|superficial
5272389|NCT00535080|basal|basal
5272390|NCT00535080|carcinomas|carcinomas
5272391|NCT00535080|Bowen's|bowen's
5272392|NCT00535080|large or multiple superficial Basal Carcinomas|large or multiple superficial basal carcinomas
5272393|NCT00535067|Breast Cancer|breast cancer
5272394|NCT00535067|Questionnaire|questionnaire
5272395|NCT00535067|Survey|survey
5272396|NCT00535067|Neuropathic Pain|neuropathic pain
5272397|NCT00535067|Cancer Survivors|cancer survivors
5272398|NCT00535067|Quality of Life|quality of life
5272399|NCT00535067|QOL|qol
5272400|NCT00535054|Dry Eye Syndrome|dry eye syndrome
5272401|NCT00535041|Pilot trial of pre-operative chemo/RT using Xeloda and external beam RT followed by definite surgery in patients with localized rectal CA|pilot trial of pre-operative chemo/rt using xeloda and external beam rt followed by definite surgery in patients with localized rectal ca
5272402|NCT00535028|asthma|asthma
5272403|NCT00535028|allergy|allergy
5272404|NCT00535028|interleukin-4|interleukin-4
5272405|NCT00535028|interleukin-13|interleukin-13
5272406|NCT00535028|IL-4|il-4
5272407|NCT00535028|IL-13|il-13
5272408|NCT00535028|atopic|atopic
5272409|NCT00535028|late asthmatic response|late asthmatic response
5272410|NCT00535028|inflammation|inflammation
5272411|NCT00535002|Cocaine Addiction|cocaine addiction
5272412|NCT00535002|Cocaine Dependence|cocaine dependence
5272413|NCT00534989|NHL and HD|nhl and hd
5272414|NCT00534963|sonohysterography, catheter placement|sonohysterography, catheter placement
5272415|NCT00534950|Randomized multicenter study of 5 vs 6 weekly fraction of RT in the treatment of SCC of the head and neck|randomized multicenter study of 5 vs 6 weekly fraction of rt in the treatment of scc of the head and neck
5272416|NCT00534937|Venous stasis ulcer|venous stasis ulcer
5272417|NCT00534937|Compression pump|compression pump
5272418|NCT00534937|Randomized trial|randomized trial
5272419|NCT00534937|Flexitouch compression|flexitouch compression
5272420|NCT00534924|IR injury|ir injury
5272421|NCT00534924|MRI|mri
5272422|NCT00534924|Vitamin C|vitamin c
5272423|NCT00534924|Postconditioning|postconditioning
5272424|NCT00534911|Depression|depression
5272425|NCT00534911|Physical Illness|physical illness
5272426|NCT00534911|Inflammatory Bowel Disease|inflammatory bowel disease
5272427|NCT00534911|Cognitive Behavioral Therapy|cognitive behavioral therapy
5272428|NCT00534885|inactivated hepatitis A vaccine|inactivated hepatitis a vaccine
5272429|NCT00534885|Healive|healive
5272430|NCT00534885|safety|safety
5272431|NCT00534885|immunogenicity|immunogenicity
5272432|NCT00534885|immune persistence|immune persistence
5272433|NCT00534872|4 Parallel cohorts|4 parallel cohorts
5272434|NCT00534872|Healthy Female|healthy female
5272435|NCT00534872|Healthy Elderly|healthy elderly
5272436|NCT00534872|Pharmacokinetic|pharmacokinetic
5272437|NCT00534872|Safety and Tolerability|safety and tolerability
5272438|NCT00534846|premenstrual syndrome|premenstrual syndrome
5272439|NCT00534846|mastalgia|mastalgia
5272440|NCT00534846|toremifene|toremifene
5272441|NCT00534846|selective estrogen receptor modulators|selective estrogen receptor modulators
5272442|NCT00534833|Diphtheria|diphtheria
5272443|NCT00534833|Tetanus|tetanus
5272444|NCT00534833|Pertussis|pertussis
5272445|NCT00534833|Hepatitis B Hansenula (HB)|hepatitis b hansenula (hb)
5272446|NCT00534833|Haemophilus influenzae type b|haemophilus influenzae type b
5272447|NCT00534820|Cytogenetic Analysis of Bone Marrow Specimen in Non-Hodgkin's Lymphoma or Hodgkin's Disease|cytogenetic analysis of bone marrow specimen in non-hodgkin's lymphoma or hodgkin's disease
5272448|NCT00534781|Achilles|achilles
5272449|NCT00534781|Tendinosis|tendinosis
5272450|NCT00534781|Tendinitis|tendinitis
5272451|NCT00534781|Achilles Tendinosis|achilles tendinosis
5272452|NCT00534781|Achilles Tendinitis|achilles tendinitis
5272453|NCT00534781|Coblation|coblation
5272454|NCT00534781|Bipolar Radiofrequency|bipolar radiofrequency
5272455|NCT00534781|Surgical Debridement|surgical debridement
5272456|NCT00534781|Debridement|debridement
5272457|NCT00534781|Heel Pain|heel pain
5272458|NCT00534781|Achilles Pain|achilles pain
5272459|NCT00534742|Siblings|siblings
5272460|NCT00534729|Organ Preservation|organ preservation
5272461|NCT00534729|Carboplatin|carboplatin
5272462|NCT00534729|Taxol|taxol
5272463|NCT00534729|RT|rt
5272464|NCT00534729|laryngeal & Hypopharyngeal CA|laryngeal & hypopharyngeal ca
5272465|NCT00534729|Locally advanced laryngeal & Hypopharyngeal CA|locally advanced laryngeal & hypopharyngeal ca
5272466|NCT00534716|Cannabis|cannabis
5272467|NCT00534716|doping|doping
5272468|NCT00534716|THC|thc
5272469|NCT00534716|GC/MS|gc/ms
5272470|NCT00534716|Pharmacokinetics|pharmacokinetics
5272471|NCT00534716|Volunteers|volunteers
5272472|NCT00534690|Pulmonary disease|pulmonary disease
5272473|NCT00534690|Intubation, Intratracheal|intubation, intratracheal
5272474|NCT00534690|Positive-pressure ventilation|positive-pressure ventilation
5272475|NCT00534677|Variceal bleed|variceal bleed
5272476|NCT00534677|Cirrhosis|cirrhosis
5272477|NCT00534677|Vasoactive agents|vasoactive agents
5272804|NCT00533585|rhuMAb-VEGF|rhumab-vegf
5272478|NCT00534677|Terlipressin|terlipressin
5272479|NCT00534677|Octreotide|octreotide
5272480|NCT00534677|Safety & Efficacy|safety & efficacy
5272481|NCT00534638|HPV vaccine|hpv vaccine
5272482|NCT00534638|Healthy adolescents|healthy adolescents
5272483|NCT00534638|Cervical cancer|cervical cancer
5272484|NCT00534638|Safety|safety
5272485|NCT00534638|Immunogenicity|immunogenicity
5272486|NCT00534638|Cervarix|cervarix
5272487|NCT00534625|Asthma, exacerbation, pulmonary function|asthma, exacerbation, pulmonary function
5272488|NCT00534612|Parotid gland neoplasms|parotid gland neoplasms
5272489|NCT00534599|Generalized anxiety disorders|generalized anxiety disorders
5272490|NCT00534599|anxiety|anxiety
5272491|NCT00534599|adjunct treatment in anxiety|adjunct treatment in anxiety
5272492|NCT00534599|anxiety disorder|anxiety disorder
5272493|NCT00534599|partial or non-responder in anxiety|partial or non-responder in anxiety
5272494|NCT00534586|Pain|pain
5272495|NCT00534586|SSEP|ssep
5272496|NCT00534586|CHEPS|cheps
5272497|NCT00534586|Propofol|propofol
5272498|NCT00534586|Sevoflurane|sevoflurane
5272499|NCT00534586|S-Ketamine|s-ketamine
5272500|NCT00534586|Remifentanil|remifentanil
5272501|NCT00534586|Healthy volunteers|healthy volunteers
5272502|NCT00534534|Pancreatitis|pancreatitis
5272503|NCT00534534|acute|acute
5272504|NCT00534534|alcoholic|alcoholic
5272505|NCT00534534|recurrence|recurrence
5272506|NCT00534534|alcoholism|alcoholism
5272507|NCT00534534|treatment|treatment
5272508|NCT00534534|Acute alcoholic pancreatitis|acute alcoholic pancreatitis
5272509|NCT00534521|overactive bladder|overactive bladder
5272510|NCT00534521|posterior tibial nerve stimulation|posterior tibial nerve stimulation
5272511|NCT00534508|Skin|skin
5272512|NCT00534508|Pharmacokinetics|pharmacokinetics
5272513|NCT00534508|Tacrolimus|tacrolimus
5272514|NCT00534508|dermatitis, atopic|dermatitis, atopic
5272515|NCT00534495|Systemic Juvenile Idiopathic Arthritis|systemic juvenile idiopathic arthritis
5272516|NCT00534495|Juvenile Rheumatoid Arthritis|juvenile rheumatoid arthritis
5272517|NCT00534495|Systemic Juvenile Rheumatoid Arthritis|systemic juvenile rheumatoid arthritis
5272518|NCT00534482|fitness|fitness
5272519|NCT00534469|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5272520|NCT00534469|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5272521|NCT00534469|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5272522|NCT00534469|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5272523|NCT00534469|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5272524|NCT00534469|adult acute basophilic leukemia|adult acute basophilic leukemia
5272525|NCT00534469|adult acute eosinophilic leukemia|adult acute eosinophilic leukemia
5272526|NCT00534469|adult erythroleukemia (M6a)|adult erythroleukemia (m6a)
5272527|NCT00534469|adult pure erythroid leukemia (M6b)|adult pure erythroid leukemia (m6b)
5272528|NCT00534469|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
5272529|NCT00534469|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
5272530|NCT00534469|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
5272531|NCT00534469|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
5272532|NCT00534469|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
5272533|NCT00534469|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
5272534|NCT00534469|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
5272535|NCT00534456|exploratory study|exploratory study
5272536|NCT00534456|anemia|anemia
5272537|NCT00534456|pharmacogenetics testing|pharmacogenetics testing
5272538|NCT00534456|biomarkers|biomarkers
5272539|NCT00534456|echocardiography|echocardiography
5272540|NCT00534443|peptic ulcer|peptic ulcer
5272541|NCT00534443|gastritis|gastritis
5272542|NCT00534443|sTREM-1|strem-1
5272543|NCT00534443|cytokines|cytokines
5272544|NCT00534443|Changes of inflammatory status in gastric mucosa|changes of inflammatory status in gastric mucosa
5272545|NCT00534443|sTREM-1 as a disease marker|strem-1 as a disease marker
5272546|NCT00534430|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5272547|NCT00534430|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5272548|NCT00534430|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5272549|NCT00534430|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5272550|NCT00534430|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5272551|NCT00534430|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5272552|NCT00534430|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5272553|NCT00534430|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5272554|NCT00534430|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5272555|NCT00534430|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5272556|NCT00534430|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5272557|NCT00534430|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
5272558|NCT00534430|refractory anemia with excess blasts|refractory anemia with excess blasts
5272559|NCT00534430|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5272560|NCT00534430|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5272561|NCT00534417|Hormone|hormone
5272562|NCT00534417|Receptor|receptor
5272563|NCT00534417|Positive|positive
5272564|NCT00534417|Metastatic|metastatic
5272565|NCT00534417|Breast|breast
5272566|NCT00534417|Cancer|cancer
5272567|NCT00534404|Internet-Assisted Tobacco Treatments|internet-assisted tobacco treatments
5272568|NCT00534404|Online Smoking Cessation Programs|online smoking cessation programs
5272569|NCT00534404|Nicotine Patches|nicotine patches
5272570|NCT00534404|Telephone Counseling|telephone counseling
5272571|NCT00534404|Smoking Abstinence|smoking abstinence
5272572|NCT00534391|Antibiotics|antibiotics
5272573|NCT00534391|hordeolum|hordeolum
5272574|NCT00534378|Nerve agent|nerve agent
5272575|NCT00534378|Midazolam|midazolam
5272576|NCT00534378|Seizures|seizures
5272577|NCT00534378|Severe recurrent convulsive seizures induced by nerve agent exposure|severe recurrent convulsive seizures induced by nerve agent exposure
5272578|NCT00534365|stress urinary incontinence|stress urinary incontinence
5272579|NCT00534365|sling procedures|sling procedures
5272580|NCT00534365|tension-free vaginal tape|tension-free vaginal tape
5272582|NCT00534352|AIDS|aids
5272583|NCT00534352|Immunodeficiency Virus, Human|immunodeficiency virus, human
5272584|NCT00534352|PREZISTA|prezista
5272585|NCT00534352|darunavir|darunavir
5272586|NCT00534352|TMC114|tmc114
5272587|NCT00534352|TMC125|tmc125
5272588|NCT00534352|Protease Inhibitor|protease inhibitor
5272589|NCT00534352|Non-Nucleoside Reverse Transcriptase Inhibitor|non-nucleoside reverse transcriptase inhibitor
5272590|NCT00534352|Truvada|truvada
5272591|NCT00534352|Treatment Naive|treatment naive
5272592|NCT00534300|ICD-pacemaker|icd-pacemaker
5272593|NCT00534287|sepsis|sepsis
5272594|NCT00534287|antibiotics|antibiotics
5272595|NCT00534287|carbapenems|carbapenems
5272596|NCT00534287|fluoroquinolones|fluoroquinolones
5272597|NCT00534287|Severe sepsis and septic shock|severe sepsis and septic shock
5272598|NCT00534274|stage II breast cancer|stage ii breast cancer
5272599|NCT00534274|stage IIIA breast cancer|stage iiia breast cancer
5272600|NCT00534261|Multiple Sclerosis|multiple sclerosis
5272601|NCT00534261|Avonex|avonex
5272602|NCT00534261|Interferon beta-1a|interferon beta-1a
5272603|NCT00534222|Patients with a manic episode|patients with a manic episode
5272604|NCT00534222|Patients diagnosed w/schizophrenia, who start a treatment with an atypical antipsychotic & who are at least scored as moderately ill on the CGI at baseline|patients diagnosed w/schizophrenia, who start a treatment with an atypical antipsychotic & who are at least scored as moderately ill on the cgi at baseline
5272605|NCT00534209|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5272606|NCT00534209|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5272607|NCT00534196|recurrent prostate cancer|recurrent prostate cancer
5272608|NCT00534196|stage I prostate cancer|stage i prostate cancer
5272609|NCT00534196|stage IIB prostate cancer|stage iib prostate cancer
5272610|NCT00534196|stage IIA prostate cancer|stage iia prostate cancer
5272611|NCT00534196|stage III prostate cancer|stage iii prostate cancer
5272612|NCT00534183|Metabolic syndrome|metabolic syndrome
5272613|NCT00534183|Obesity|obesity
5272614|NCT00534183|Diabetes|diabetes
5272615|NCT00534170|Probiotic|probiotic
5272616|NCT00534170|Prevention of diarrhoea|prevention of diarrhoea
5272617|NCT00534170|Nutritional status|nutritional status
5272618|NCT00534157|intracranial pressure|intracranial pressure
5272619|NCT00534157|intraocular pressure|intraocular pressure
5272620|NCT00534157|tonometry|tonometry
5272621|NCT00534118|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5272622|NCT00534118|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5272623|NCT00534118|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5272624|NCT00534118|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
5272625|NCT00534118|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5272626|NCT00534118|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5272627|NCT00534118|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5272628|NCT00534118|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5272629|NCT00534118|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5272630|NCT00534118|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5272631|NCT00534118|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5272632|NCT00534118|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5272633|NCT00534118|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5272634|NCT00534118|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5272635|NCT00534118|stage I multiple myeloma|stage i multiple myeloma
5272636|NCT00534118|stage II multiple myeloma|stage ii multiple myeloma
5272637|NCT00534118|stage III multiple myeloma|stage iii multiple myeloma
5272638|NCT00534118|refractory multiple myeloma|refractory multiple myeloma
5272639|NCT00534118|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5272640|NCT00534118|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
5272641|NCT00534118|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5272642|NCT00534118|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5272643|NCT00534118|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5272644|NCT00534118|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5272645|NCT00534118|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5272646|NCT00534118|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5272647|NCT00534118|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5272648|NCT00534118|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5272649|NCT00534118|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5272650|NCT00534118|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5272651|NCT00534118|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5272652|NCT00534118|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5272653|NCT00534118|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
5272654|NCT00534118|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
5272655|NCT00534118|recurrent childhood grade III lymphomatoid granulomatosis|recurrent childhood grade iii lymphomatoid granulomatosis
5272656|NCT00534118|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
5272657|NCT00534118|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
5272658|NCT00534118|childhood diffuse large cell lymphoma|childhood diffuse large cell lymphoma
5272659|NCT00534118|childhood immunoblastic large cell lymphoma|childhood immunoblastic large cell lymphoma
5272660|NCT00534118|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
5272661|NCT00534118|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5272662|NCT00534118|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5272663|NCT00534118|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5272664|NCT00534118|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5272665|NCT00534118|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5272666|NCT00534118|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5272667|NCT00534118|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5272668|NCT00534118|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5272669|NCT00534118|cutaneous B-cell non-Hodgkin lymphoma|cutaneous b-cell non-hodgkin lymphoma
5272670|NCT00534105|Pregnancy|pregnancy
5272671|NCT00534105|Gestational diabetes|gestational diabetes
5272672|NCT00534105|Hyperlipidemia|hyperlipidemia
5272673|NCT00534092|Lumbar Spinal Stenosis|lumbar spinal stenosis
5272674|NCT00534092|X STOP|x stop
5272675|NCT00534079|Cystic Fibrosis and chronic rhinosinusitis|cystic fibrosis and chronic rhinosinusitis
5272676|NCT00534066|Natriuretic Peptide, Brain|natriuretic peptide, brain
5272677|NCT00534053|colon cancer screening|colon cancer screening
5272678|NCT00534053|mail reminders|mail reminders
5272679|NCT00534053|fecal occult blood test|fecal occult blood test
5272680|NCT00534053|compliance|compliance
5272681|NCT00534027|NSCLC|nsclc
5272682|NCT00534027|Non-Small Cell Lung Cancer|non-small cell lung cancer
5272683|NCT00534027|Paclitaxel|paclitaxel
5272684|NCT00534027|Carboplatin|carboplatin
5272685|NCT00534027|AMG 655|amg 655
5272686|NCT00534001|bladder cancer|bladder cancer
5272687|NCT00534001|cervical cancer|cervical cancer
5272688|NCT00534001|esophageal cancer|esophageal cancer
5272689|NCT00534001|gastric cancer|gastric cancer
5272690|NCT00534001|renal cell carcinoma|renal cell carcinoma
5272691|NCT00534001|adult primary liver cancer|adult primary liver cancer
5272692|NCT00534001|non-small cell lung cancer|non-small cell lung cancer
5272693|NCT00534001|small cell lung cancer|small cell lung cancer
5272694|NCT00534001|pancreatic cancer|pancreatic cancer
5272695|NCT00534001|hypopharyngeal cancer|hypopharyngeal cancer
5272696|NCT00534001|laryngeal cancer|laryngeal cancer
5272697|NCT00534001|lip and oral cavity cancer|lip and oral cavity cancer
5272698|NCT00534001|nasopharyngeal cancer|nasopharyngeal cancer
5272699|NCT00534001|oropharyngeal cancer|oropharyngeal cancer
5272700|NCT00534001|paranasal sinus and nasal cavity cancer|paranasal sinus and nasal cavity cancer
5272701|NCT00534001|adult acute myeloid leukemia|adult acute myeloid leukemia
5272702|NCT00534001|tobacco use disorder|tobacco use disorder
5272703|NCT00533988|Central venous catheters|central venous catheters
5272704|NCT00533988|Antimicrobial impregnated catheters|antimicrobial impregnated catheters
5272705|NCT00533988|Duration of catheter use|duration of catheter use
5272706|NCT00533988|Catheter-related infection|catheter-related infection
5272707|NCT00533988|Insertion site|insertion site
5272708|NCT00533988|Parenteral nutrition|parenteral nutrition
5272709|NCT00533988|Critically ill patients (multidisciplinary)|critically ill patients (multidisciplinary)
5272710|NCT00533975|Colon Cancer screening|colon cancer screening
5272711|NCT00533975|immunofecal occult blood test|immunofecal occult blood test
5272712|NCT00533975|colonoscopy|colonoscopy
5272713|NCT00533975|diagnostic validity|diagnostic validity
5272714|NCT00533962|Glaucoma|glaucoma
5272715|NCT00533962|Anecortave Acetate|anecortave acetate
5272716|NCT00533962|Intraocular pressure|intraocular pressure
5272903|NCT00533117|fluoxetine|fluoxetine
5272717|NCT00533962|Advanced glaucoma cases with uncontrolled IOP|advanced glaucoma cases with uncontrolled iop
5272718|NCT00533949|radiation toxicity|radiation toxicity
5272719|NCT00533949|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5272720|NCT00533949|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5272721|NCT00533936|stage II breast cancer|stage ii breast cancer
5272722|NCT00533936|stage IIIA breast cancer|stage iiia breast cancer
5272723|NCT00533936|stage IIIB breast cancer|stage iiib breast cancer
5272724|NCT00533936|stage IIIC breast cancer|stage iiic breast cancer
5272725|NCT00533923|Nonmyeloablative Allogeneic Stem Cell Transplantation|nonmyeloablative allogeneic stem cell transplantation
5272726|NCT00533923|mini-transplant|mini-transplant
5272727|NCT00533923|AML|aml
5272728|NCT00533923|ALL|all
5272729|NCT00533923|CML|cml
5272730|NCT00533923|CLL|cll
5272731|NCT00533923|Myelodysplastic syndrome|myelodysplastic syndrome
5272732|NCT00533923|Relapsed non-Hodgkin's or Hodgkin's lymphoma|relapsed non-hodgkin's or hodgkin's lymphoma
5272733|NCT00533923|Relapsed multiple myeloma|relapsed multiple myeloma
5272734|NCT00533923|Aplastic anemia|aplastic anemia
5272735|NCT00533923|Myeloproliferative disorder|myeloproliferative disorder
5272736|NCT00533923|GM-CSF|gm-csf
5272737|NCT00533923|Cyclosporin|cyclosporin
5272738|NCT00533923|Fludarabine (FLUDARA)|fludarabine (fludara)
5272739|NCT00533923|Cyclophosphamide|cyclophosphamide
5272740|NCT00533923|CAMPATH-1H|campath-1h
5272741|NCT00533923|GVHD|gvhd
5272742|NCT00533923|CMV|cmv
5272743|NCT00533923|AML in first remission, first relapse or subsequent remission|aml in first remission, first relapse or subsequent remission
5272744|NCT00533923|ALL in first relapse, second or subsequent remission|all in first relapse, second or subsequent remission
5272745|NCT00533923|ALL in first remission, in a high-risk category|all in first remission, in a high-risk category
5272746|NCT00533923|Aplastic anemia characterized by ANC< 1000 and/or platelets < 30 without transfusional support|aplastic anemia characterized by anc< 1000 and/or platelets < 30 without transfusional support
5272747|NCT00533923|Myeloproliferative disorder (P Vera, CMML, ET)|myeloproliferative disorder (p vera, cmml, et)
5272748|NCT00533910|Minimal hepatic encephalopathy|minimal hepatic encephalopathy
5272749|NCT00533897|Rheumatoid Arthritis (RA)|rheumatoid arthritis (ra)
5272750|NCT00533884|delirium|delirium
5272751|NCT00533884|cognitive/functional effects|cognitive/functional effects
5272752|NCT00533884|hypopharyngeal cancer|hypopharyngeal cancer
5272753|NCT00533884|laryngeal cancer|laryngeal cancer
5272754|NCT00533884|lip and oral cavity cancer|lip and oral cavity cancer
5272755|NCT00533884|metastatic squamous neck cancer with occult primary|metastatic squamous neck cancer with occult primary
5272756|NCT00533884|nasopharyngeal cancer|nasopharyngeal cancer
5272757|NCT00533884|oropharyngeal cancer|oropharyngeal cancer
5272758|NCT00533884|paranasal sinus and nasal cavity cancer|paranasal sinus and nasal cavity cancer
5272759|NCT00533884|salivary gland cancer|salivary gland cancer
5272760|NCT00533884|esophageal cancer|esophageal cancer
5272761|NCT00533884|non-small cell lung cancer|non-small cell lung cancer
5272762|NCT00533884|small cell lung cancer|small cell lung cancer
5272763|NCT00533871|Natriuretic Peptide Brain|natriuretic peptide brain
5272764|NCT00533858|Systolic hypertension|systolic hypertension
5272765|NCT00533832|depression|depression
5272766|NCT00533832|vagus nerve stimulation|vagus nerve stimulation
5272767|NCT00533819|Exercise intervention|exercise intervention
5272768|NCT00533819|Maths Scores|maths scores
5272769|NCT00533819|Blood pressure|blood pressure
5272770|NCT00533819|Female school children|female school children
5272771|NCT00533819|Body mass index|body mass index
5272772|NCT00533806|Cognitive Behavior Therapy|cognitive behavior therapy
5272773|NCT00533806|Active Control|active control
5272774|NCT00533806|Relaxation Therapy|relaxation therapy
5272775|NCT00533806|Young Children|young children
5272776|NCT00533793|bone, tibial shaft fracture|bone, tibial shaft fracture
5272777|NCT00533767|Hantavirus cardiopulmonary syndrome, Andes virus, Chile|hantavirus cardiopulmonary syndrome, andes virus, chile
5272778|NCT00533754|age-related macular degeneration, genetics|age-related macular degeneration, genetics
5272779|NCT00533741|Severe Acute Respiratory Syndrome, Coronavirus, vaccine|severe acute respiratory syndrome, coronavirus, vaccine
5272780|NCT00533715|Inspiratory Spirometry; Preschool Children; Computer games|inspiratory spirometry; preschool children; computer games
5272781|NCT00533715|Health|health
5272782|NCT00533702|Phase II|phase ii
5272783|NCT00533702|Melanoma|melanoma
5272784|NCT00533702|IMC-1121B|imc-1121b
5272785|NCT00533702|ImClone|imclone
5272786|NCT00533637|Allergic rhinitis|allergic rhinitis
5272787|NCT00533637|Nasal spray|nasal spray
5272788|NCT00533637|Anti-histamine|anti-histamine
5272789|NCT00533637|Tolerability|tolerability
5272790|NCT00533624|Gastrointestinal toxicity|gastrointestinal toxicity
5272791|NCT00533585|Non-Small Cell Lung Cancer|non-small cell lung cancer
5272792|NCT00533585|Lung Cancer|lung cancer
5272793|NCT00533585|NSCLC|nsclc
5272794|NCT00533585|malignant pleural effusions|malignant pleural effusions
5272795|NCT00533585|Sorafenib|sorafenib
5272796|NCT00533585|Paclitaxel|paclitaxel
5272797|NCT00533585|Taxol|taxol
5272798|NCT00533585|Carboplatin|carboplatin
5272799|NCT00533585|Paraplatin|paraplatin
5272800|NCT00533585|Bevacizumab|bevacizumab
5272801|NCT00533585|Avastin|avastin
5272802|NCT00533585|BAY 43-9006|bay 43-9006
5272803|NCT00533585|Anti-VEGF monoclonal antibody|anti-vegf monoclonal antibody
5272805|NCT00533559|type 2 diabetes|type 2 diabetes
5272806|NCT00533559|free fatty acids|free fatty acids
5272807|NCT00533559|insulin resistance|insulin resistance
5272808|NCT00533559|beta cell lipotoxic effect|beta cell lipotoxic effect
5272809|NCT00533546|Acute Ischemic Stroke|acute ischemic stroke
5272810|NCT00533533|Docetaxel,Oxaliplatin|docetaxel,oxaliplatin
5272811|NCT00533533|Phase I/II study|phase i/ii study
5272812|NCT00533533|Advanced gastric cancer|advanced gastric cancer
5272813|NCT00533533|First line treatment|first line treatment
5272814|NCT00533533|Advanced gastric cancer with measurable disease|advanced gastric cancer with measurable disease
5272815|NCT00533507|Pneumococcal vaccine.|pneumococcal vaccine.
5272816|NCT00533507|Pneumococcal disease|pneumococcal disease
5272817|NCT00533507|Safety|safety
5272818|NCT00533507|Immunogenicity|immunogenicity
5272819|NCT00533507|Primary vaccination|primary vaccination
5272820|NCT00533468|pain|pain
5272821|NCT00533468|lumbar puncture|lumbar puncture
5272822|NCT00533468|neonates|neonates
5272823|NCT00533468|infants|infants
5272824|NCT00533468|emergency department|emergency department
5272825|NCT00533468|topical anesthesia|topical anesthesia
5272826|NCT00533468|LMX4|lmx4
5272827|NCT00533455|Antipsychotics, tremor|antipsychotics, tremor
5272828|NCT00533442|Rapamycin|rapamycin
5272829|NCT00533442|Mycophenolate Mofetil (MMF)|mycophenolate mofetil (mmf)
5272830|NCT00533442|Kidney-Pancreas Transplant|kidney-pancreas transplant
5272831|NCT00533416|Myelodyplastic Syndrome (MDS)|myelodyplastic syndrome (mds)
5272832|NCT00533416|Selective Mitotic Inhibitor|selective mitotic inhibitor
5272833|NCT00533416|Targeted Therapy|targeted therapy
5272834|NCT00533416|Myelodysplastic Syndrome|myelodysplastic syndrome
5272835|NCT00533416|MDS|mds
5272836|NCT00533390|efavirenz|efavirenz
5272837|NCT00533390|tuberculosis|tuberculosis
5272838|NCT00533390|AIDS|aids
5272839|NCT00533390|rifampicin|rifampicin
5272840|NCT00533390|efficacy|efficacy
5272841|NCT00533390|safety|safety
5272842|NCT00533390|Treatment Naive|treatment naive
5272843|NCT00533338|Breast Cancer|breast cancer
5272844|NCT00533338|Cancer Survivors|cancer survivors
5272845|NCT00533338|Weight Gain Prevention|weight gain prevention
5272846|NCT00533338|Diet|diet
5272847|NCT00533338|Exercise|exercise
5272848|NCT00533338|Questionnaire|questionnaire
5272849|NCT00533338|Survey|survey
5272850|NCT00533299|Epigenetics, hydralazine, valproate, ovarian cancer|epigenetics, hydralazine, valproate, ovarian cancer
5272851|NCT00533286|physiotherapy|physiotherapy
5272852|NCT00533286|Tuebingen concept|tuebingen concept
5272853|NCT00533286|benzodiazepines|benzodiazepines
5272854|NCT00533286|muscle relaxants|muscle relaxants
5272855|NCT00533286|disc herniation|disc herniation
5272856|NCT00533260|Patients with a manic episode or patients diagnosed with schizophrenia , patients who are being treated with quetiapine and are on a stable dosing regime|patients with a manic episode or patients diagnosed with schizophrenia , patients who are being treated with quetiapine and are on a stable dosing regime
5272857|NCT00533247|Cox-2 Inhibitor|cox-2 inhibitor
5272858|NCT00533247|Pre-emptive Pain|pre-emptive pain
5272859|NCT00533247|Preoperative Pain|preoperative pain
5272860|NCT00533247|Pain Prophylaxis|pain prophylaxis
5272861|NCT00533247|Celebrex|celebrex
5272862|NCT00533247|Celecoxib|celecoxib
5272863|NCT00533234|Elbow fracture|elbow fracture
5272864|NCT00533234|Elbow dislocation|elbow dislocation
5272865|NCT00533234|Radial head fracture|radial head fracture
5272866|NCT00533234|Radial neck fracture|radial neck fracture
5272867|NCT00533221|growth hormone|growth hormone
5272868|NCT00533221|strength|strength
5272869|NCT00533221|Spinal muscular atrophy type II and III|spinal muscular atrophy type ii and iii
5272870|NCT00533195|UVA1|uva1
5272871|NCT00533195|PUVA|puva
5272872|NCT00533195|atopic dermatitis|atopic dermatitis
5272873|NCT00533182|Influenza Infection|influenza infection
5272874|NCT00533182|Immunocompromised Host|immunocompromised host
5272875|NCT00533182|Resistance Mutations|resistance mutations
5272876|NCT00533182|Prolonged Infection|prolonged infection
5272877|NCT00533169|Neuroblastoma|neuroblastoma
5272878|NCT00533169|ZD6474|zd6474
5272879|NCT00533169|Zactima|zactima
5272880|NCT00533169|Isotretinoin|isotretinoin
5272881|NCT00533169|13-Cis Retinoic Acid|13-cis retinoic acid
5272882|NCT00533169|Accutane|accutane
5272883|NCT00533169|Pediatric Neuroblastoma|pediatric neuroblastoma
5272884|NCT00533156|Closure Device|closure device
5272885|NCT00533156|Angiography|angiography
5272886|NCT00533156|Angioplasty|angioplasty
5272887|NCT00533156|Hemostasis|hemostasis
5272888|NCT00533156|Heart Catheterization|heart catheterization
5272889|NCT00533156|Vascular Closure|vascular closure
5272890|NCT00533156|Peripheral Closure|peripheral closure
5272891|NCT00533156|Coronary Angiography|coronary angiography
5272892|NCT00533143|Solid cancer patient|solid cancer patient
5272893|NCT00533143|Non-invasive ventilation|non-invasive ventilation
5272894|NCT00533143|Acute Respiratory Failure|acute respiratory failure
5272895|NCT00533130|AO|ao
5272896|NCT00533130|Pediatric|pediatric
5272897|NCT00533130|Classification|classification
5272898|NCT00533130|Long Bones|long bones
5272899|NCT00533130|fractures|fractures
5272900|NCT00533130|bones|bones
5272901|NCT00533117|suicide|suicide
5272902|NCT00533117|self-mutilation|self-mutilation
5272904|NCT00533117|placebo|placebo
5272905|NCT00533117|dialectical behavior therapy|dialectical behavior therapy
5272906|NCT00533117|supportive therapy|supportive therapy
5272907|NCT00533104|Limb ischemia|limb ischemia
5272908|NCT00533104|Cell Therapy|cell therapy
5272909|NCT00533078|omega3 fatty acid|omega3 fatty acid
5272910|NCT00533078|parenteral nutrition|parenteral nutrition
5272911|NCT00533078|chemotherapy|chemotherapy
5272912|NCT00533078|infection|infection
5272913|NCT00533078|neutropenia|neutropenia
5272914|NCT00533065|Aging|aging
5272915|NCT00533052|Behavioral weight loss|behavioral weight loss
5272916|NCT00532974|HIV|hiv
5272917|NCT00532974|Human Immunodeficiency Virus|human immunodeficiency virus
5272918|NCT00532974|Vaccines|vaccines
5272919|NCT00532974|HIV Vaccines|hiv vaccines
5272920|NCT00532974|Peptide|peptide
5272921|NCT00532974|Peptide Vaccines|peptide vaccines
5272922|NCT00532974|HIV 1|hiv 1
5272923|NCT00532883|Sickle Cell Disease|sickle cell disease
5272924|NCT00532883|Vaso-occlusive Event|vaso-occlusive event
5272925|NCT00532883|Painful Crises|painful crises
5272926|NCT00532883|Acute Chest Syndrome|acute chest syndrome
5272927|NCT00532870|laparoscopy|laparoscopy
5272928|NCT00532870|ventral hernia|ventral hernia
5272929|NCT00532870|mesh|mesh
5272930|NCT00532870|Ventral hernias are the second most common type of abdominal hernias after inguinal hernias.|ventral hernias are the second most common type of abdominal hernias after inguinal hernias.
5272931|NCT00532870|The majority of ventral hernias are incisional hernias that develop in 11% to 20% of patients who undergo Laparotomy .|the majority of ventral hernias are incisional hernias that develop in 11% to 20% of patients who undergo laparotomy .
5272932|NCT00532870|Surgeons have struggled to reduce the morbidity from incarceration (6% to 15% of cases) and strangulation (2%) of these hernias.|surgeons have struggled to reduce the morbidity from incarceration (6% to 15% of cases) and strangulation (2%) of these hernias.
5272933|NCT00532857|Patients with HER2 + stage II/III breast cancer|patients with her2 + stage ii/iii breast cancer
5272934|NCT00532844|6R-BH4|6r-bh4
5272935|NCT00532844|BH4|bh4
5272936|NCT00532844|BH4 deficiency|bh4 deficiency
5272937|NCT00532844|sapropterin dihydrochloride|sapropterin dihydrochloride
5272938|NCT00532844|endothelial dysfunction|endothelial dysfunction
5272939|NCT00532844|NO|no
5272940|NCT00532844|Hypertension|hypertension
5272941|NCT00532844|Nitric Oxide|nitric oxide
5272942|NCT00532844|Vitamin C|vitamin c
5272943|NCT00532818|Epigenetic therapy|epigenetic therapy
5272944|NCT00532818|Hydralazine|hydralazine
5272945|NCT00532818|Valproate|valproate
5272946|NCT00532818|Cervical cancer|cervical cancer
5272947|NCT00532818|Randomized|randomized
5272948|NCT00532818|Phase III|phase iii
5272949|NCT00532805|Alpha 1-Antitrypsin Deficiency|alpha 1-antitrypsin deficiency
5272950|NCT00532792|Avian|avian
5272951|NCT00532792|Pandemic|pandemic
5272952|NCT00532792|Influenza|influenza
5272953|NCT00532792|A/H5N1|a/h5n1
5272954|NCT00532779|Obesity|obesity
5272955|NCT00532779|Antiobesity agents|antiobesity agents
5272956|NCT00532779|Antiobesity drugs|antiobesity drugs
5272957|NCT00532779|Overweight drug therapy|overweight drug therapy
5272958|NCT00532779|Obese drug therapy|obese drug therapy
5272959|NCT00532779|Weight loss drug effects|weight loss drug effects
5272960|NCT00532779|Bupropion administration and dosage|bupropion administration and dosage
5272961|NCT00532779|Naltrexone administration and dosage|naltrexone administration and dosage
5272962|NCT00532779|Double blind method|double blind method
5272963|NCT00532779|Combination drug therapy|combination drug therapy
5272964|NCT00532779|Delayed action preparations|delayed action preparations
5272965|NCT00532766|Healthy subjects|healthy subjects
5272966|NCT00532753|empowerment|empowerment
5272967|NCT00532753|health|health
5272968|NCT00532753|education|education
5272969|NCT00532740|liver metastases|liver metastases
5272970|NCT00532740|advanced adult primary liver cancer|advanced adult primary liver cancer
5272971|NCT00532727|Breast Cancer|breast cancer
5272972|NCT00532727|Triple Negative|triple negative
5272973|NCT00532701|Chronic hepatitis C|chronic hepatitis c
5272974|NCT00532701|Genotype|genotype
5272975|NCT00532701|Interferon|interferon
5272976|NCT00532701|Ribavirin|ribavirin
5272977|NCT00532701|Genotype 2|genotype 2
5272978|NCT00532701|Peginterferon|peginterferon
5272979|NCT00532688|acetylcysteine|acetylcysteine
5272980|NCT00532688|N-acetylcysteine|n-acetylcysteine
5272981|NCT00532688|heart failure|heart failure
5272982|NCT00532688|renal failure|renal failure
5272983|NCT00532675|Myeloma|myeloma
5272984|NCT00532675|Multiple Myeloma|multiple myeloma
5272985|NCT00532675|Lenalidomide|lenalidomide
5272986|NCT00532675|Revlimid|revlimid
5272987|NCT00532675|Dexamethasone|dexamethasone
5272988|NCT00532675|LBH589|lbh589
5272989|NCT00532675|Combination|combination
5272990|NCT00532662|Epidural|epidural
5272991|NCT00532662|Intravenous|intravenous
5272992|NCT00532662|Ketamine|ketamine
5272993|NCT00532662|Analgesia|analgesia
5272994|NCT00532662|Caudal|caudal
5272995|NCT00532662|Pediatric|pediatric
5272996|NCT00532662|Regional|regional
5272997|NCT00532662|Local Anesthetics|local anesthetics
5272998|NCT00532636|Airway|airway
5272999|NCT00532636|Airway obstruction|airway obstruction
5273000|NCT00532636|Mouth-to-mask resuscitation|mouth-to-mask resuscitation
5273001|NCT00532636|Respiration artificial|respiration artificial
5273002|NCT00532636|Ventilation|ventilation
5273003|NCT00532636|Ventilation of an unprotected airway|ventilation of an unprotected airway
5273004|NCT00532636|Safety and efficiency of mask ventilation|safety and efficiency of mask ventilation
5273005|NCT00532636|Avoidance of stomach inflation|avoidance of stomach inflation
5273006|NCT00532610|Diabetes,|diabetes,
5273007|NCT00532610|ECG,|ecg,
5273008|NCT00532610|Healthy Volunteers|healthy volunteers
5273009|NCT00532610|GSK189075,|gsk189075,
5273010|NCT00532597|Vascular Endothelium-Dependent Relaxation|vascular endothelium-dependent relaxation
5273011|NCT00532597|Hemodialysis|hemodialysis
5273012|NCT00532597|Hemodiafiltration|hemodiafiltration
5273013|NCT00532584|COPD|copd
5273014|NCT00532584|inhaled steroids|inhaled steroids
5273015|NCT00532584|bronchodilator|bronchodilator
5273016|NCT00532584|gene expression|gene expression
5273017|NCT00532584|smoker's lungs|smoker's lungs
5273018|NCT00532571|CoQ10|coq10
5273019|NCT00532571|PSP|psp
5273020|NCT00532571|CBD|cbd
5273021|NCT00532558|Hyperlipidemia|hyperlipidemia
5273022|NCT00532558|Drug Therapy|drug therapy
5273023|NCT00532532|Multiple sclerosis|multiple sclerosis
5273024|NCT00532493|Combat Trauma|combat trauma
5273025|NCT00532493|Post traumatic stress disorder|post traumatic stress disorder
5273026|NCT00532493|PTSD|ptsd
5273027|NCT00532493|Sleep Disturbance|sleep disturbance
5273028|NCT00532493|Trauma-Related Nightmares|trauma-related nightmares
5273029|NCT00532480|Depression|depression
5273030|NCT00532480|Duloxetine|duloxetine
5273031|NCT00532480|fMRI|fmri
5273032|NCT00532480|pictures|pictures
5273033|NCT00532467|healthy volunteers|healthy volunteers
5273034|NCT00532415|Vitrectomy|vitrectomy
5273035|NCT00532415|Visualization|visualization
5273036|NCT00532402|Monitoring|monitoring
5273037|NCT00532402|Breathing Gas|breathing gas
5273038|NCT00532402|Propofol|propofol
5273039|NCT00532389|Myeloma|myeloma
5273040|NCT00532389|Multiple Myeloma|multiple myeloma
5273041|NCT00532389|Bortezomib|bortezomib
5273042|NCT00532389|LBH589|lbh589
5273043|NCT00532389|Combination|combination
5273044|NCT00532376|epilepsy|epilepsy
5273045|NCT00532376|depression|depression
5273046|NCT00532376|fMRI|fmri
5273047|NCT00532376|emotion|emotion
5273048|NCT00532350|COPD|copd
5273049|NCT00532350|pharmacokinetics|pharmacokinetics
5273050|NCT00532350|plethysmography|plethysmography
5273051|NCT00532350|cycle ergometry|cycle ergometry
5273052|NCT00532350|exercise testing|exercise testing
5273053|NCT00532350|spirometry|spirometry
5273054|NCT00532337|ONO-5334|ono-5334
5273055|NCT00532337|osteoporosis|osteoporosis
5273056|NCT00532337|osteopenia|osteopenia
5273057|NCT00532324|Methicillin resistant Staphylococcus aureus|methicillin resistant staphylococcus aureus
5273058|NCT00532324|Staphylococcus aureus|staphylococcus aureus
5273059|NCT00532324|Healthy term and near term neonates|healthy term and near term neonates
5273060|NCT00532324|Prevention|prevention
5273061|NCT00532324|Nasal and Vaginal Colonization rates|nasal and vaginal colonization rates
5273062|NCT00532324|Pregnant women|pregnant women
5273063|NCT00532311|Hyperlipidemia|hyperlipidemia
5273064|NCT00532311|Drug Therapy|drug therapy
5273065|NCT00532298|Fluarix|fluarix
5273066|NCT00532298|Influenza Infection|influenza infection
5273067|NCT00532298|GSK Biologicals' influenza vaccine GSK576389A|gsk biologicals' influenza vaccine gsk576389a
5273068|NCT00532259|Lymphoma, Large B-Cell, Diffuse|lymphoma, large b-cell, diffuse
5273069|NCT00532259|Transformed Follicular Lymphoma|transformed follicular lymphoma
5273070|NCT00532259|Stem cell transplantation|stem cell transplantation
5273071|NCT00532259|Relapsed|relapsed
5273072|NCT00532259|Refractory|refractory
5273073|NCT00532233|Idiopathic Pulmonary Fibrosis|idiopathic pulmonary fibrosis
5273074|NCT00532220|osteonecrosis|osteonecrosis
5273075|NCT00532220|bone marrow edema|bone marrow edema
5273076|NCT00532220|ibandronate|ibandronate
5273077|NCT00532220|bisphosphonate|bisphosphonate
5273078|NCT00532220|knee|knee
5273079|NCT00532194|ovarian cancer|ovarian cancer
5273080|NCT00532194|fallopian tube cancer|fallopian tube cancer
5273081|NCT00532194|primary serous peritoneal cancer|primary serous peritoneal cancer
5273082|NCT00532194|gynaecological carcinoma|gynaecological carcinoma
5273083|NCT00532194|randomised controlled trial|randomised controlled trial
5273084|NCT00532194|Cediranib|cediranib
5273085|NCT00532194|AZD2171|azd2171
5273086|NCT00532194|efficacy|efficacy
5273087|NCT00532181|Health insurance|health insurance
5273088|NCT00532181|Health utilization rates|health utilization rates
5273089|NCT00532181|Saving Behavior|saving behavior
5273090|NCT00532181|Risk aversion|risk aversion
5273091|NCT00532168|advanced HIV-infected patients|advanced hiv-infected patients
5273092|NCT00532168|late presenters|late presenters
5273093|NCT00532168|antiretroviral therapy|antiretroviral therapy
5273094|NCT00532168|immune reconstitution|immune reconstitution
5273095|NCT00532168|Treatment Naive|treatment naive
5273096|NCT00532155|lung cancer|lung cancer
5273097|NCT00532155|angiogenesis inhibitor|angiogenesis inhibitor
5273098|NCT00532155|chemotherapy|chemotherapy
5273099|NCT00532116|Healthy|healthy
5273100|NCT00532116|Elderly|elderly
5273101|NCT00532116|Non Elderly|non elderly
5273102|NCT00532116|Healthy Volunteers|healthy volunteers
5273103|NCT00532103|Suicidal Ideation|suicidal ideation
5273104|NCT00532103|Major Depressive Disorder|major depressive disorder
5273105|NCT00532103|Suicide Risk|suicide risk
5273106|NCT00532103|Antidepressant Medication|antidepressant medication
5273107|NCT00532077|renal,|renal,
5273108|NCT00532077|pharmacology,|pharmacology,
5273109|NCT00532077|Osteoporosis|osteoporosis
5273110|NCT00532064|Advanced Cancers|advanced cancers
5273111|NCT00532064|Cardiotoxicity Detection|cardiotoxicity detection
5273112|NCT00532064|Heart Damage|heart damage
5273113|NCT00532064|Troponin 1 Blood Test|troponin 1 blood test
5273114|NCT00532064|B-type Natriuretic Peptide Blood Test|b-type natriuretic peptide blood test
5273115|NCT00532064|Questionnaire|questionnaire
5273116|NCT00532064|Survey|survey
5273117|NCT00532064|BNP|bnp
5273118|NCT00532051|cataract, lasik, laser refractive surgery|cataract, lasik, laser refractive surgery
5273119|NCT00532038|Osteoarthritis|osteoarthritis
5273120|NCT00532038|Pain|pain
5273121|NCT00532025|Sorafenib|sorafenib
5273122|NCT00532025|NSCLC|nsclc
5273123|NCT00532025|Adjuvant Treatment|adjuvant treatment
5273124|NCT00532025|resected Non-Small Cell Lung Carcinoma|resected non-small cell lung carcinoma
5273125|NCT00532012|Rheumatoid Arthritis|rheumatoid arthritis
5273126|NCT00532012|RhuDex®|rhudex®
5273127|NCT00532012|Meglumine|meglumine
5273128|NCT00532012|Oral Bioavailability|oral bioavailability
5273129|NCT00531999|Raltegravir|raltegravir
5273130|NCT00531999|Euglycaemic clamp|euglycaemic clamp
5273131|NCT00531999|healthy volunteer|healthy volunteer
5273132|NCT00531986|Monotherapy|monotherapy
5273133|NCT00531986|Neuropsychological tests|neuropsychological tests
5273134|NCT00531986|HIV viral load in ZNS|hiv viral load in zns
5273135|NCT00531986|HIV viral load in genital|hiv viral load in genital
5273136|NCT00531986|Lumbar puncture and HIV viral load in ZNS|lumbar puncture and hiv viral load in zns
5273137|NCT00531986|Monotherapy and compartment failure (ZNS and genital)|monotherapy and compartment failure (zns and genital)
5273138|NCT00531986|ZNS viral load under monotherapy|zns viral load under monotherapy
5273139|NCT00531986|Genital viral load under monotherapy|genital viral load under monotherapy
5273140|NCT00531986|Neuropsychological tests (HIV Dementia)|neuropsychological tests (hiv dementia)
5273141|NCT00531986|Treatment Experienced|treatment experienced
5273142|NCT00531973|breast cancer|breast cancer
5273143|NCT00531973|echocardiography|echocardiography
5273144|NCT00531973|neoplasia|neoplasia
5273145|NCT00531947|Mental Health|mental health
5273146|NCT00531947|Adolescents|adolescents
5273147|NCT00531947|Major Depressive Disorder|major depressive disorder
5273148|NCT00531947|Depression|depression
5273149|NCT00531947|Adolescent Depression|adolescent depression
5273150|NCT00531947|Pediatric Depression|pediatric depression
5273151|NCT00531921|Heart Diseases|heart diseases
5273152|NCT00531921|Kidney Diseases|kidney diseases
5273153|NCT00531921|Liver Diseases|liver diseases
5273154|NCT00531921|Liver Failure|liver failure
5273155|NCT00531921|Lung Diseases|lung diseases
5273156|NCT00531921|Transplant|transplant
5273157|NCT00531921|Transplantation, Homologous|transplantation, homologous
5273158|NCT00531921|Rejection|rejection
5273159|NCT00531921|Kidney Failure|kidney failure
5273160|NCT00531908|Growth Hormone|growth hormone
5273161|NCT00531908|Epithelial sodium channel|epithelial sodium channel
5273162|NCT00531908|Hypertension|hypertension
5273163|NCT00531908|A Furosemide|a furosemide
5273164|NCT00531908|Nasal Mucosa|nasal mucosa
5273165|NCT00531895|major depression|major depression
5273166|NCT00531895|chronic headache|chronic headache
5273167|NCT00531895|antidepressant|antidepressant
5273168|NCT00531895|duloxetine|duloxetine
5273169|NCT00531882|healthy volunteers|healthy volunteers
5273170|NCT00531882|neutrophil migration|neutrophil migration
5273171|NCT00531882|anti inflammatory non-steroidal agent|anti inflammatory non-steroidal agent
5273172|NCT00531882|simvastatin|simvastatin
5273173|NCT00531882|pioglitazone|pioglitazone
5273174|NCT00531869|safewater|safewater
5273175|NCT00531869|randomized|randomized
5273176|NCT00531856|Kidney Transplant, Carbon Monoxide|kidney transplant, carbon monoxide
5273177|NCT00531843|deep vein thrombosis|deep vein thrombosis
5273178|NCT00531843|venous thromboembolism|venous thromboembolism
5273179|NCT00531843|pulmonary embolism|pulmonary embolism
5273180|NCT00531830|children with PDD|children with pdd
5273181|NCT00531791|COPD|copd
5273182|NCT00531791|exacerbation|exacerbation
5273183|NCT00531791|fluticasone|fluticasone
5273184|NCT00531791|salmeterol|salmeterol
5273185|NCT00531791|steroid|steroid
5273186|NCT00531778|Women with increased risk for developing ovarian cancer|women with increased risk for developing ovarian cancer
5273187|NCT00531778|early detection|early detection
5273188|NCT00531778|biomarker for ovarian cancer|biomarker for ovarian cancer
5273189|NCT00531765|contrast-induced-nephropathy,|contrast-induced-nephropathy,
5273190|NCT00531765|cardiac cath|cardiac cath
5273191|NCT00531765|creatinine|creatinine
5273192|NCT00531765|contrast|contrast
5273193|NCT00531765|nephropathy|nephropathy
5273194|NCT00531739|Surgery|surgery
5273195|NCT00531739|Colectomy|colectomy
5273196|NCT00531739|Proctocolectomy|proctocolectomy
5273197|NCT00531739|Adhesions|adhesions
5273382|NCT00530803|pediatric|pediatric
5273198|NCT00531713|hypothyroidism, quality og life, depression|hypothyroidism, quality og life, depression
5273199|NCT00531700|influenza|influenza
5273200|NCT00531700|risk behaviors|risk behaviors
5273201|NCT00531700|immunization|immunization
5273202|NCT00531700|knowledge attitudes behaviors|knowledge attitudes behaviors
5273203|NCT00531700|personally controlled health record|personally controlled health record
5273204|NCT00531700|Indivo|indivo
5273205|NCT00531687|relapse|relapse
5273206|NCT00531674|Efficacy of public health intervention (nutrition)|efficacy of public health intervention (nutrition)
5273207|NCT00531648|Toddlers that having feeding disorders and SPD|toddlers that having feeding disorders and spd
5273208|NCT00531635|Mixed hemopoietic chimerism, Fludarabine, TBI, PBSC, immunosuppression, Mycophenolate Mofetil|mixed hemopoietic chimerism, fludarabine, tbi, pbsc, immunosuppression, mycophenolate mofetil
5273209|NCT00531622|Depression|depression
5273210|NCT00531622|Major Depressive Episode|major depressive episode
5273211|NCT00531622|Antidepressant|antidepressant
5273212|NCT00531596|Elderly|elderly
5273213|NCT00531596|Non Elderly|non elderly
5273214|NCT00531596|Healthy Volunteers|healthy volunteers
5273215|NCT00531583|AML in 1st & 2nd complete remission w/no HLA matched related donor|aml in 1st & 2nd complete remission w/no hla matched related donor
5273216|NCT00531570|Women with ultrasound defined complex pelvic masses|women with ultrasound defined complex pelvic masses
5273217|NCT00531557|Darunavir|darunavir
5273218|NCT00531557|Euglycaemic clamp|euglycaemic clamp
5273220|NCT00531557|Treatment Experienced|treatment experienced
5273221|NCT00531531|pulmonary infection|pulmonary infection
5273222|NCT00531531|transmission|transmission
5273223|NCT00531531|P.Aeruginosa|p.aeruginosa
5273224|NCT00531531|surfaces|surfaces
5273225|NCT00531518|Schizophrenia|schizophrenia
5273226|NCT00531518|Bipolar disorder|bipolar disorder
5273227|NCT00531518|Psychosis|psychosis
5273228|NCT00531518|Prodromal psychosis|prodromal psychosis
5273229|NCT00531518|Family psychoeducation|family psychoeducation
5273230|NCT00531518|Supported education|supported education
5273231|NCT00531518|Supported employment|supported employment
5273232|NCT00531518|Ulra-high-risk for psychosis|ulra-high-risk for psychosis
5273233|NCT00531518|Major depression|major depression
5273234|NCT00531518|Bipolar disorder, with psychotic features|bipolar disorder, with psychotic features
5273235|NCT00531518|Major depression, with psychotic features|major depression, with psychotic features
5273236|NCT00531518|Attenuated, prodromal psychotic symptoms|attenuated, prodromal psychotic symptoms
5273237|NCT00531505|Obesity|obesity
5273238|NCT00531492|Maternal and child health|maternal and child health
5273239|NCT00531492|Developing country|developing country
5273240|NCT00531492|Skin to skin care|skin to skin care
5273241|NCT00531492|Newly born low birth weight infants and their mothers|newly born low birth weight infants and their mothers
5273242|NCT00531492|(Delivery at University Hospital Center, Mahajanga, Madagascar)|(delivery at university hospital center, mahajanga, madagascar)
5273243|NCT00531466|Spinal cord injury|spinal cord injury
5273244|NCT00531440|Renal transplantation, everolimus, Immunosuppressants|renal transplantation, everolimus, immunosuppressants
5273245|NCT00531427|Chronic pain,|chronic pain,
5273246|NCT00531427|OA of the knee,|oa of the knee,
5273247|NCT00531427|opioid,|opioid,
5273248|NCT00531427|transdermal|transdermal
5273249|NCT00531414|Asthmatic|asthmatic
5273250|NCT00531414|healthy|healthy
5273251|NCT00531401|Non-Small-Cell Lung|non-small-cell lung
5273252|NCT00531362|Atherosclerosis|atherosclerosis
5273253|NCT00531362|Aspirin|aspirin
5273254|NCT00531362|Resistance,|resistance,
5273255|NCT00531362|Acute coronary syndromes|acute coronary syndromes
5273256|NCT00531349|Endometrial Cancer|endometrial cancer
5273257|NCT00531349|Anesthesia; regional|anesthesia; regional
5273258|NCT00531349|cancer recurrence|cancer recurrence
5273259|NCT00531349|Analgesia; opioid|analgesia; opioid
5273260|NCT00531336|age-related Macular degeneration|age-related macular degeneration
5273261|NCT00531336|Macugen|macugen
5273262|NCT00531336|Avastin|avastin
5273263|NCT00531323|Pharmacokinetic|pharmacokinetic
5273264|NCT00531323|TMC125|tmc125
5273265|NCT00531323|Healthy volunteers|healthy volunteers
5273266|NCT00531323|Efavarinz|efavarinz
5273267|NCT00531310|CML|cml
5273268|NCT00531310|allogeneic SCT|allogeneic sct
5273269|NCT00531310|matched family donor|matched family donor
5273270|NCT00531310|unrelated donor|unrelated donor
5273271|NCT00531310|cord blood donor|cord blood donor
5273272|NCT00531310|persistent disease|persistent disease
5273273|NCT00531284|Non-small cell lung carcinoma|non-small cell lung carcinoma
5273274|NCT00531284|Small-cell lung carcinoma|small-cell lung carcinoma
5273275|NCT00531284|Ovarian Cancer|ovarian cancer
5273276|NCT00531284|Renal Cancer|renal cancer
5273277|NCT00531284|Other solid tumors|other solid tumors
5273278|NCT00531284|multiple myeloma|multiple myeloma
5273279|NCT00531284|lymphoma|lymphoma
5273280|NCT00531258|Depression|depression
5273281|NCT00531258|TBI|tbi
5273282|NCT00531258|TMS|tms
5273283|NCT00531258|Major Depression resulting from a mild to moderate closed head injury|major depression resulting from a mild to moderate closed head injury
5273284|NCT00531245|TS-1 and oxaliplatin|ts-1 and oxaliplatin
5273285|NCT00531245|Phase I/II study|phase i/ii study
5273286|NCT00531245|Colorectal cancer|colorectal cancer
5273287|NCT00531245|First line treatment|first line treatment
5273381|NCT00530803|Synera patch|synera patch
5273288|NCT00531232|Previously treated Myelodysplastic Syndromes (MDS)|previously treated myelodysplastic syndromes (mds)
5273289|NCT00531232|oral clofarabine|oral clofarabine
5273290|NCT00531232|Intermediate-1, Intermediate-2 and High Risk Myelodysplastic Syndromes (MDS)|intermediate-1, intermediate-2 and high risk myelodysplastic syndromes (mds)
5273291|NCT00531232|secondary AML (with history of MDS)|secondary aml (with history of mds)
5273292|NCT00531219|appendicitis|appendicitis
5273293|NCT00531219|cholelithiasis|cholelithiasis
5273294|NCT00531219|gallstones|gallstones
5273295|NCT00531193|Healthy male volunteers|healthy male volunteers
5273296|NCT00531180|Esophageal Cancer|esophageal cancer
5273297|NCT00531180|Lung Cancer|lung cancer
5273298|NCT00531180|Thoracic Malignancies|thoracic malignancies
5273299|NCT00531180|4D CT scans|4d ct scans
5273300|NCT00531180|Lung Function|lung function
5273301|NCT00531167|lamivudine resistant mutations|lamivudine resistant mutations
5273302|NCT00531167|rescue therapy|rescue therapy
5273303|NCT00531141|age-related macular degeneration|age-related macular degeneration
5273304|NCT00531141|optical coherence tomography|optical coherence tomography
5273305|NCT00531141|retinal thickness|retinal thickness
5273306|NCT00531141|exudative age-related macular degeneration|exudative age-related macular degeneration
5273307|NCT00531128|Sitosterol|sitosterol
5273308|NCT00531128|Nutrigenomics|nutrigenomics
5273309|NCT00531128|Gene Expression|gene expression
5273310|NCT00531128|Insulin Resistance|insulin resistance
5273311|NCT00531128|Sitosterolemia|sitosterolemia
5273312|NCT00531115|metastatic colorectal cancer|metastatic colorectal cancer
5273313|NCT00531115|elderly patients|elderly patients
5273314|NCT00531115|cetuximab, oxaliplatin, capecitabine|cetuximab, oxaliplatin, capecitabine
5273315|NCT00531102|oxygen|oxygen
5273316|NCT00531102|continuous positive airway pressure|continuous positive airway pressure
5273317|NCT00531102|infant, newborn|infant, newborn
5273318|NCT00531102|resuscitation|resuscitation
5273319|NCT00531089|TTP|ttp
5273320|NCT00531089|thrombotic thrombocytopenic purpura|thrombotic thrombocytopenic purpura
5273321|NCT00531089|HUS|hus
5273322|NCT00531089|hemolytic uremic syndrome|hemolytic uremic syndrome
5273323|NCT00531089|plasma exchange|plasma exchange
5273324|NCT00531076|bevacizumab|bevacizumab
5273325|NCT00531076|thoracic radiotherapy|thoracic radiotherapy
5273326|NCT00531076|locally-advanced non-small cell lung cancer|locally-advanced non-small cell lung cancer
5273327|NCT00531063|Renal transplantation, everolimus, Immunosuppressants|renal transplantation, everolimus, immunosuppressants
5273328|NCT00531050|COPD|copd
5273329|NCT00531050|cycle ergometry|cycle ergometry
5273330|NCT00531050|exercise testing|exercise testing
5273331|NCT00531050|spirometry|spirometry
5273332|NCT00531050|cardiovascular|cardiovascular
5273333|NCT00531050|salbutamol|salbutamol
5273334|NCT00531050|indacaterol|indacaterol
5273335|NCT00531050|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
5273336|NCT00531037|AV block, SND, BTS, AAIsafeR, SafeR, PM implanted|av block, snd, bts, aaisafer, safer, pm implanted
5273337|NCT00531024|Exudative Neovascular|exudative neovascular
5273338|NCT00531024|AMD|amd
5273339|NCT00531024|Avastin|avastin
5273340|NCT00531024|Systemic|systemic
5273341|NCT00531024|Exudative Age-Related Macular Degeneration|exudative age-related macular degeneration
5273342|NCT00531011|Stents|stents
5273343|NCT00531011|Drug-eluting Stent|drug-eluting stent
5273344|NCT00531011|Angioplasty|angioplasty
5273345|NCT00531011|Coronary Artery stenosis|coronary artery stenosis
5273346|NCT00531011|Coronary Artery Stent Restenosis|coronary artery stent restenosis
5273347|NCT00531011|Stent Thrombosis|stent thrombosis
5273348|NCT00530998|appendicitis|appendicitis
5273349|NCT00530998|cholelithiasis|cholelithiasis
5273350|NCT00530998|Gallstones|gallstones
5273351|NCT00530985|disability|disability
5273352|NCT00530985|substance abuse|substance abuse
5273353|NCT00530985|vocational rehabilitation|vocational rehabilitation
5273354|NCT00530985|case management|case management
5273355|NCT00530972|co-infected HCV/HIV|co-infected hcv/hiv
5273356|NCT00530972|relapsers|relapsers
5273357|NCT00530907|Advanced Cancer|advanced cancer
5273358|NCT00530907|Valproic Acid|valproic acid
5273359|NCT00530907|Depakene|depakene
5273360|NCT00530907|Bevacizumab|bevacizumab
5273361|NCT00530907|Avastin|avastin
5273362|NCT00530907|Anti-VEGF monoclonal antibody|anti-vegf monoclonal antibody
5273363|NCT00530907|rhuMAb-VEGF|rhumab-vegf
5273364|NCT00530894|Valvular Heart Disease|valvular heart disease
5273365|NCT00530894|Critical/Severe Aortic Stenosis|critical/severe aortic stenosis
5273366|NCT00530894|High risk symptomatic patients|high risk symptomatic patients
5273367|NCT00530868|Hormonal and antibody therapy for breast cancer|hormonal and antibody therapy for breast cancer
5273368|NCT00530868|Hormonal therapy for breast cancer|hormonal therapy for breast cancer
5273369|NCT00530868|Antibody therapy for breast cancer|antibody therapy for breast cancer
5273370|NCT00530855|Epilepsy|epilepsy
5273371|NCT00530855|Partial-onset Seizures|partial-onset seizures
5273372|NCT00530855|Lacosamide|lacosamide
5273373|NCT00530855|Monotherapy|monotherapy
5273374|NCT00530855|Vimpat|vimpat
5273375|NCT00530829|diarrhea|diarrhea
5273376|NCT00530829|zinc|zinc
5273377|NCT00530829|oral rehydration therapy|oral rehydration therapy
5273378|NCT00530803|EMLA|emla
5273379|NCT00530803|venipuncture|venipuncture
5273380|NCT00530803|children|children
5273383|NCT00530803|Lidocaine/prilocaine|lidocaine/prilocaine
5273384|NCT00530790|Restless Legs Syndrome|restless legs syndrome
5273385|NCT00530777|Disease Transmission, Vertical|disease transmission, vertical
5273386|NCT00530777|valacyclovir|valacyclovir
5273387|NCT00530777|Randomized Controlled Trials|randomized controlled trials
5273388|NCT00530777|HIV|hiv
5273389|NCT00530777|herpes|herpes
5273390|NCT00530777|Herpesvirus 2, Human|herpesvirus 2, human
5273391|NCT00530777|HIV Seronegativity|hiv seronegativity
5273392|NCT00530764|Pain|pain
5273393|NCT00530764|Cancer|cancer
5273394|NCT00530764|Palliative|palliative
5273395|NCT00530751|breast cancer|breast cancer
5273396|NCT00530738|HPN|hpn
5273397|NCT00530738|lipid emulsion|lipid emulsion
5273398|NCT00530738|long term|long term
5273399|NCT00530738|insufficient enteral resorption capacity|insufficient enteral resorption capacity
5273400|NCT00530725|occult pneumothorax|occult pneumothorax
5273401|NCT00530725|mechanical ventilation|mechanical ventilation
5273402|NCT00530725|critical care|critical care
5273403|NCT00530725|pneumothorax|pneumothorax
5273404|NCT00530725|thoracostomy|thoracostomy
5273405|NCT00530712|SFA|sfa
5273406|NCT00530712|Popliteal|popliteal
5273407|NCT00530712|Stent|stent
5273408|NCT00530712|EverFlex|everflex
5273409|NCT00530699|Acute Myeloid Leukaemia|acute myeloid leukaemia
5273410|NCT00530699|Phase 1|phase 1
5273411|NCT00530699|AZD1152|azd1152
5273412|NCT00530686|Diabetes Mellitus|diabetes mellitus
5273413|NCT00530686|Hypoglycemia|hypoglycemia
5273414|NCT00530686|Hyperglycemia|hyperglycemia
5273415|NCT00530686|Type 1 Diabetes|type 1 diabetes
5273416|NCT00530686|Islet cell transplantation|islet cell transplantation
5273417|NCT00530660|Pandemic influenza|pandemic influenza
5273418|NCT00530647|Brain motor network, Plasticity, functional MRI, Stroke|brain motor network, plasticity, functional mri, stroke
5273419|NCT00530634|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
5273420|NCT00530634|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5273421|NCT00530634|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5273422|NCT00530595|hemodialysis|hemodialysis
5273423|NCT00530582|progesterone, postmenopause, sleep-EEG|progesterone, postmenopause, sleep-eeg
5273424|NCT00530569|Breast Cancer|breast cancer
5273425|NCT00530569|Herceptin Therapy|herceptin therapy
5273426|NCT00530543|Robot|robot
5273427|NCT00530543|Gait|gait
5273428|NCT00530543|Stroke|stroke
5273429|NCT00530530|ASP8825|asp8825
5273430|NCT00530530|Restless legs Syndrome|restless legs syndrome
5273431|NCT00530530|XP13512|xp13512
5273432|NCT00530517|migraine|migraine
5273433|NCT00530517|sumatripatan|sumatripatan
5273434|NCT00530504|Carotid Artery Disease|carotid artery disease
5273435|NCT00530504|Embolic Protection|embolic protection
5273436|NCT00530491|lung resection|lung resection
5273437|NCT00530491|reduced pulmonary function|reduced pulmonary function
5273438|NCT00530478|Donepezil|donepezil
5273439|NCT00530478|Stroke|stroke
5273440|NCT00530478|Cognitive function|cognitive function
5273441|NCT00530478|Cognitive neural network|cognitive neural network
5273442|NCT00530452|COX-2|cox-2
5273443|NCT00530452|carbonic anhydrase|carbonic anhydrase
5273444|NCT00530452|osteoarthritis|osteoarthritis
5273445|NCT00530452|anti-inflammatory|anti-inflammatory
5273446|NCT00530452|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors
5273447|NCT00530426|Heart Failure, Congestive|heart failure, congestive
5273448|NCT00530426|Registry|registry
5273449|NCT00530426|Acute Decompensated Heart Failure|acute decompensated heart failure
5273450|NCT00530426|Dyspnea|dyspnea
5273451|NCT00530400|Antibiotic prophylaxis|antibiotic prophylaxis
5273452|NCT00530400|Bacterial Infections / prevention & control|bacterial infections / prevention & control
5273453|NCT00530400|Surgical wound infection / prevention & control|surgical wound infection / prevention & control
5273454|NCT00530400|Neurosurgery|neurosurgery
5273455|NCT00530400|Postoperative Complications / prevention & control|postoperative complications / prevention & control
5273456|NCT00530400|Clinical trial [publication type]|clinical trial [publication type]
5273457|NCT00530387|Photocontact|photocontact
5273458|NCT00530387|Dermatitis|dermatitis
5273459|NCT00530387|NSAID|nsaid
5273460|NCT00530387|Sunscreen|sunscreen
5273461|NCT00530387|Photopatch|photopatch
5273462|NCT00530374|Pediatrics|pediatrics
5273463|NCT00530374|Malnutrition|malnutrition
5273464|NCT00530374|Iron Deficiency|iron deficiency
5273465|NCT00530374|Sprinkles|sprinkles
5273466|NCT00530374|Oral Iron Supplementation|oral iron supplementation
5273467|NCT00530361|Myocardial Ischemia|myocardial ischemia
5273468|NCT00530361|Kidney failure|kidney failure
5273469|NCT00530361|CABG|cabg
5273470|NCT00530361|Cardiopulmonary bypass (CPB) pump|cardiopulmonary bypass (cpb) pump
5273471|NCT00530361|Coronary Artery Bypass Surgery|coronary artery bypass surgery
5273472|NCT00530361|Heart surgery|heart surgery
5273473|NCT00530361|Nesiritide|nesiritide
5273474|NCT00530361|Coronary Heart Disease|coronary heart disease
5273475|NCT00530348|Multiple Sclerosis|multiple sclerosis
5273476|NCT00530322|Adhesions|adhesions
5273477|NCT00530322|Laparoscopy|laparoscopy
5273478|NCT00530322|Colorectal surgery|colorectal surgery
5273479|NCT00530322|Colorectal disease|colorectal disease
5273480|NCT00530309|GLP-1|glp-1
5273481|NCT00530309|type 2 diabeted mellitus|type 2 diabeted mellitus
5273482|NCT00530309|safety|safety
5273483|NCT00530309|GSK716155|gsk716155
5273484|NCT00530309|GLP-1 receptor agonist|glp-1 receptor agonist
5273485|NCT00530309|tolerability|tolerability
5273486|NCT00530309|pharmacokinetics|pharmacokinetics
5273487|NCT00530309|pharmacodynamics|pharmacodynamics
5273488|NCT00530296|Depression|depression
5273489|NCT00530296|End stage renal disease|end stage renal disease
5273490|NCT00530296|Quality of Life|quality of life
5273491|NCT00530296|Cognitive Behavioral Therapy|cognitive behavioral therapy
5273492|NCT00530283|Squamous|squamous
5273493|NCT00530283|Unknown Primary|unknown primary
5273494|NCT00530283|Patients with Squamous cell cancer neck nodes|patients with squamous cell cancer neck nodes
5273495|NCT00530270|Sickle Cell Disease|sickle cell disease
5273496|NCT00530270|ACS|acs
5273497|NCT00530270|Acute Chest Syndrome|acute chest syndrome
5273498|NCT00530270|Hgb SS|hgb ss
5273499|NCT00530270|Hgb Sβ0|hgb sβ0
5273500|NCT00530270|Dexamethasone|dexamethasone
5273501|NCT00530257|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
5273502|NCT00530257|Methylphenidate|methylphenidate
5273503|NCT00530257|Attention|attention
5273504|NCT00530257|Working Memory|working memory
5273505|NCT00530244|cystic fibrosis|cystic fibrosis
5273506|NCT00530244|fatty acids|fatty acids
5273507|NCT00530244|docosahexaenoic acid|docosahexaenoic acid
5273508|NCT00530244|infant formula|infant formula
5273509|NCT00530244|growth|growth
5273510|NCT00530244|pancreatic function|pancreatic function
5273511|NCT00530231|Capsule endoscopy|capsule endoscopy
5273512|NCT00530231|Missing rate|missing rate
5273513|NCT00530205|weight changes|weight changes
5273514|NCT00530205|malnutrition|malnutrition
5273515|NCT00530205|stage III non-small cell lung cancer|stage iii non-small cell lung cancer
5273516|NCT00530192|Refractory Cancer|refractory cancer
5273517|NCT00530192|Molecular Profile|molecular profile
5273518|NCT00530179|Diffuse Large B-Cell Lymphoma|diffuse large b-cell lymphoma
5273519|NCT00530179|Positron Emission Tomography|positron emission tomography
5273520|NCT00530179|CHOP Chemotherapy protocol|chop chemotherapy protocol
5273521|NCT00530179|Stem Cell Transplantation|stem cell transplantation
5273522|NCT00530179|Fluorodeoxyglucose F18|fluorodeoxyglucose f18
5273523|NCT00530166|Asthma|asthma
5273524|NCT00530166|persistant asthma|persistant asthma
5273525|NCT00530166|controller medications|controller medications
5273526|NCT00530166|FEV1|fev1
5273527|NCT00530153|Eating|eating
5273528|NCT00530153|Food Habits|food habits
5273529|NCT00530153|Adolescent|adolescent
5273530|NCT00530153|Dental Research|dental research
5273531|NCT00530140|Follicular Lymphoma|follicular lymphoma
5273532|NCT00530140|Idiotype vaccine|idiotype vaccine
5273533|NCT00530127|Friedreich's ataxia|friedreich's ataxia
5273771|NCT00529217|TMS|tms
5273534|NCT00530088|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
5273535|NCT00530088|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
5273536|NCT00530088|stage I squamous cell carcinoma of the larynx|stage i squamous cell carcinoma of the larynx
5273537|NCT00530088|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
5273538|NCT00530088|stage 0 laryngeal cancer|stage 0 laryngeal cancer
5273539|NCT00530088|stage 0 lip and oral cavity cancer|stage 0 lip and oral cavity cancer
5273540|NCT00530075|Wegener Granulomatosis|wegener granulomatosis
5273541|NCT00530075|Vasculitis|vasculitis
5273542|NCT00530075|Gusperimus|gusperimus
5273543|NCT00530075|Immunosuppression|immunosuppression
5273544|NCT00530062|Asthma and Poor Coordinators of Asthma Inhalers|asthma and poor coordinators of asthma inhalers
5273545|NCT00530049|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
5273546|NCT00530049|hypopharyngeal cancer|hypopharyngeal cancer
5273547|NCT00530049|laryngeal cancer|laryngeal cancer
5273548|NCT00530049|lip and oral cavity cancer|lip and oral cavity cancer
5273549|NCT00530049|metastatic squamous neck cancer with occult primary|metastatic squamous neck cancer with occult primary
5273550|NCT00530049|nasopharyngeal cancer|nasopharyngeal cancer
5273551|NCT00530049|oropharyngeal cancer|oropharyngeal cancer
5273552|NCT00530049|paranasal sinus and nasal cavity cancer|paranasal sinus and nasal cavity cancer
5273553|NCT00530049|salivary gland cancer|salivary gland cancer
5273554|NCT00530049|tongue cancer|tongue cancer
5273555|NCT00530049|07-098|07-098
5273556|NCT00530036|Mortality|mortality
5273557|NCT00530036|Patient readmission|patient readmission
5273558|NCT00530036|Institutionalization|institutionalization
5273559|NCT00530010|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
5273560|NCT00530010|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
5273561|NCT00530010|advanced adult primary liver cancer|advanced adult primary liver cancer
5273562|NCT00529997|Lumbar Spine|lumbar spine
5273563|NCT00529997|Lumbar Spinal Stenosis|lumbar spinal stenosis
5273564|NCT00529997|Spondylolisthesis|spondylolisthesis
5273565|NCT00529997|Dynamic Stabilization|dynamic stabilization
5273566|NCT00529997|Motion Preserving|motion preserving
5273567|NCT00529997|Arthroplasty|arthroplasty
5273568|NCT00529997|Randomized|randomized
5273569|NCT00529997|Investigational|investigational
5273570|NCT00529997|Back Pain|back pain
5273571|NCT00529997|Leg Pain|leg pain
5273572|NCT00529984|CEA|cea
5273573|NCT00529984|CEA-expressing malignancies|cea-expressing malignancies
5273574|NCT00529984|Metastatic malignancies|metastatic malignancies
5273575|NCT00529984|VRP Vaccine|vrp vaccine
5273576|NCT00529984|Alphavirus replicons|alphavirus replicons
5273577|NCT00529984|Molecular therapeutics|molecular therapeutics
5273578|NCT00529984|Stage III colon cancer|stage iii colon cancer
5273579|NCT00529971|Mindfulness|mindfulness
5273580|NCT00529971|HIV|hiv
5273581|NCT00529971|Male|male
5273582|NCT00529971|Living with HIV|living with hiv
5273583|NCT00529971|18-70 years of age|18-70 years of age
5273584|NCT00529971|live within one hour of hospital|live within one hour of hospital
5273585|NCT00529971|fluent in English|fluent in english
5273586|NCT00529971|Complementary Therapies|complementary therapies
5273587|NCT00529971|HIV Therapeutic Vaccine|hiv therapeutic vaccine
5273588|NCT00529958|Anterior Cruciate Ligament (ACL) Reconstruction|anterior cruciate ligament (acl) reconstruction
5273589|NCT00529958|Patellar Tendon|patellar tendon
5273590|NCT00529958|Hamstring Tendon|hamstring tendon
5273591|NCT00529958|Double-Bundle|double-bundle
5273592|NCT00529958|Autograft|autograft
5273593|NCT00529945|PFO|pfo
5273594|NCT00529945|Stroke|stroke
5273595|NCT00529945|Transient Ischemic Attack|transient ischemic attack
5273596|NCT00529945|Migraine|migraine
5273597|NCT00529945|Decompression Illness|decompression illness
5273598|NCT00529932|Acute Myocardial Infarction|acute myocardial infarction
5273599|NCT00529932|Celltherapy|celltherapy
5273600|NCT00529932|Bone Marrow|bone marrow
5273601|NCT00529919|Overweight|overweight
5273602|NCT00529919|Obesity|obesity
5273603|NCT00529919|Weight loss|weight loss
5273604|NCT00529919|Medium chain triglycerides|medium chain triglycerides
5273605|NCT00529919|Cardiovascular disease risk|cardiovascular disease risk
5273606|NCT00529906|attention deficit hyperactivity disorder|attention deficit hyperactivity disorder
5273607|NCT00529906|neuropsychological deficits|neuropsychological deficits
5273608|NCT00529906|endophenotype|endophenotype
5273609|NCT00529906|molecular genetics|molecular genetics
5273610|NCT00529906|candidate gene|candidate gene
5273611|NCT00529906|family-based association study|family-based association study
5273612|NCT00529893|Attention-deficit/Hyperactivity Disorder|attention-deficit/hyperactivity disorder
5273613|NCT00529893|neuropsychological functioning|neuropsychological functioning
5273614|NCT00529893|Atomoxetine|atomoxetine
5273615|NCT00529880|AML|aml
5273616|NCT00529867|Artemether/Lumefantrine suspension|artemether/lumefantrine suspension
5273617|NCT00529867|P. falciparum malaria|p. falciparum malaria
5273618|NCT00529867|children|children
5273619|NCT00529867|uncomplicated Plasmodium falciparum malaria|uncomplicated plasmodium falciparum malaria
5273620|NCT00529854|Intensive care unit|intensive care unit
5273621|NCT00529854|medical documentation|medical documentation
5273622|NCT00529854|medical billing|medical billing
5273623|NCT00529841|Salt Wasting Congenital Adrenal Hyperplasia|salt wasting congenital adrenal hyperplasia
5273624|NCT00529841|Subcutaneous Hydrocortisone|subcutaneous hydrocortisone
5273625|NCT00529828|CLA|cla
5273626|NCT00529828|Industrial trans fatty acids|industrial trans fatty acids
5273627|NCT00529828|Oleic acid|oleic acid
5273628|NCT00529828|Controlled dietary trial|controlled dietary trial
5273629|NCT00529815|Continuous|continuous
5273630|NCT00529815|blood|blood
5273631|NCT00529815|glucose|glucose
5273632|NCT00529815|monitoring|monitoring
5273633|NCT00529815|diabetes|diabetes
5273634|NCT00529815|type2|type2
5273635|NCT00529802|metastatic|metastatic
5273636|NCT00529802|renal|renal
5273637|NCT00529802|cell|cell
5273638|NCT00529802|carcinoma|carcinoma
5273639|NCT00529802|cancer|cancer
5273640|NCT00529776|Prevention of ventilator associated pneumonia|prevention of ventilator associated pneumonia
5273641|NCT00529763|Chronic Phase, Advanced Phase chronic myeloid leukemia|chronic phase, advanced phase chronic myeloid leukemia
5273642|NCT00529763|Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia|philadelphia chromosome positive acute lymphoblastic leukemia
5273643|NCT00529737|Breast Cancer|breast cancer
5273644|NCT00529737|Marker Clip Migration|marker clip migration
5273645|NCT00529737|Vacuum-Assisted Biopsy|vacuum-assisted biopsy
5273646|NCT00529737|Postprocedure Mammogram|postprocedure mammogram
5273647|NCT00529737|Breast Biopsy|breast biopsy
5273648|NCT00529724|Energy metabolism, metabolic syndrome, by chronic bilateral subthalamic stimulation, Parkinson's disease|energy metabolism, metabolic syndrome, by chronic bilateral subthalamic stimulation, parkinson's disease
5273770|NCT00529217|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
5273649|NCT00529724|Patients with Parkinson's disease and will be treated by chronic bilateral subthalamic stimulation.|patients with parkinson's disease and will be treated by chronic bilateral subthalamic stimulation.
5273650|NCT00529711|coronary|coronary
5273651|NCT00529711|artery|artery
5273652|NCT00529711|bypass|bypass
5273653|NCT00529711|grafting|grafting
5273654|NCT00529711|IV|iv
5273655|NCT00529711|cardiac output|cardiac output
5273656|NCT00529698|HIV|hiv
5273657|NCT00529698|Tat protein|tat protein
5273658|NCT00529698|Preventative vaccine|preventative vaccine
5273659|NCT00529698|Healthy volunteers|healthy volunteers
5273660|NCT00529698|HIV-1/2 uninfected|hiv-1/2 uninfected
5273661|NCT00529698|HIV Preventive Vaccine|hiv preventive vaccine
5273662|NCT00529672|endovenous laser therapy|endovenous laser therapy
5273663|NCT00529672|sclerotherapy|sclerotherapy
5273664|NCT00529672|crossectomy and stripping|crossectomy and stripping
5273665|NCT00529672|surgery|surgery
5273666|NCT00529672|treatment|treatment
5273667|NCT00529672|varicose veins|varicose veins
5273668|NCT00529659|Sarcopenia (loss of muscle mass)|sarcopenia (loss of muscle mass)
5273669|NCT00529646|Healthy adult volunteers|healthy adult volunteers
5273670|NCT00529633|Inflammation|inflammation
5273671|NCT00529633|albumin|albumin
5273672|NCT00529620|Malaria|malaria
5273673|NCT00529620|IPT|ipt
5273674|NCT00529620|preventive treatment|preventive treatment
5273675|NCT00529607|myocardial infarction, reperfusion injury, echocardiography, magnetic resonance imaging, inflammation, nitric oxide|myocardial infarction, reperfusion injury, echocardiography, magnetic resonance imaging, inflammation, nitric oxide
5273676|NCT00529594|Laser Photocoagulation|laser photocoagulation
5273677|NCT00529594|Pain relief|pain relief
5273678|NCT00529581|multiple sclerosis|multiple sclerosis
5273679|NCT00529581|cognitive impairment|cognitive impairment
5273680|NCT00529581|cognitive dysfunction|cognitive dysfunction
5273681|NCT00529581|Cognitive Dysfunction associated with Multiple Sclerosis|cognitive dysfunction associated with multiple sclerosis
5273682|NCT00529568|hepatitis C|hepatitis c
5273683|NCT00529568|ribavirin|ribavirin
5273684|NCT00529568|Hepatitis C-related thrombocytopenia|hepatitis c-related thrombocytopenia
5273685|NCT00529568|thrombopoietin|thrombopoietin
5273686|NCT00529568|peginterferon alfa-2b|peginterferon alfa-2b
5273687|NCT00529568|platelets|platelets
5273688|NCT00529542|Polycystic Ovary Syndrome|polycystic ovary syndrome
5273689|NCT00529529|asthma|asthma
5273690|NCT00529529|QAB149|qab149
5273691|NCT00529529|indacaterol|indacaterol
5273692|NCT00529516|Fluarix|fluarix
5273693|NCT00529516|GSK Bio's influenza vaccine GSK576389A|gsk bio's influenza vaccine gsk576389a
5273694|NCT00529516|Influenza infection|influenza infection
5273695|NCT00529503|Lymphoproliferative Disorders|lymphoproliferative disorders
5273696|NCT00529503|Lymphoma|lymphoma
5273697|NCT00529503|Antigens, CD40|antigens, cd40
5273698|NCT00529503|Antibody, Monoclonal|antibody, monoclonal
5273699|NCT00529503|Combined Modality Therapy|combined modality therapy
5273700|NCT00529503|Lymphoma, Large B-Cell, Diffuse|lymphoma, large b-cell, diffuse
5273701|NCT00529503|Lymphoma, Non-Hodgkin|lymphoma, non-hodgkin
5273702|NCT00529503|Hematologic Diseases|hematologic diseases
5273703|NCT00529503|Immunoproliferative Disorders|immunoproliferative disorders
5273704|NCT00529503|Lymphatic Diseases|lymphatic diseases
5273705|NCT00529490|coronary|coronary
5273706|NCT00529490|artery|artery
5273707|NCT00529490|bypass|bypass
5273708|NCT00529490|grafting|grafting
5273709|NCT00529490|I.V.|i.v.
5273710|NCT00529490|cardiac output|cardiac output
5273711|NCT00529464|Cervical Intraepithelial Neoplasia|cervical intraepithelial neoplasia
5273712|NCT00529464|Cervical Dysplasia|cervical dysplasia
5273713|NCT00529464|Cervical Cancer|cervical cancer
5273714|NCT00529464|Fluorescence Spectroscopy|fluorescence spectroscopy
5273715|NCT00529464|Colposcopy|colposcopy
5273716|NCT00529464|Loop Electrical Excision Procedure|loop electrical excision procedure
5273717|NCT00529464|LEEP|leep
5273718|NCT00529451|Hypertension, Aliskiren, Ramipril|hypertension, aliskiren, ramipril
5273719|NCT00529425|Femoral neck fracture|femoral neck fracture
5273720|NCT00529425|Hip fracture|hip fracture
5273721|NCT00529399|immune tolerance|immune tolerance
5273722|NCT00529399|immunotherapy|immunotherapy
5273723|NCT00529399|antigen-specific tolerance|antigen-specific tolerance
5273724|NCT00529399|vaccine induced tolerance|vaccine induced tolerance
5273725|NCT00529399|Beta-cell function|beta-cell function
5273726|NCT00529399|T-cells|t-cells
5273727|NCT00529399|DPT-1|dpt-1
5273728|NCT00529399|treatment of type 1 diabetes|treatment of type 1 diabetes
5273729|NCT00529399|new onset type 1 diabetes|new onset type 1 diabetes
5273730|NCT00529399|juvenile diabetes|juvenile diabetes
5273731|NCT00529399|T1D|t1d
5273732|NCT00529399|diabetes mellitus|diabetes mellitus
5273733|NCT00529399|Type 1 diabetes TrialNet|type 1 diabetes trialnet
5273734|NCT00529399|TrialNet|trialnet
5273735|NCT00529386|prostatitis|prostatitis
5273736|NCT00529386|Botox|botox
5273737|NCT00529360|Acute Leukemia|acute leukemia
5273738|NCT00529360|Allogeneic Stem Cell Transplant|allogeneic stem cell transplant
5273739|NCT00529360|Clofarabine|clofarabine
5273740|NCT00529360|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
5273741|NCT00529360|Acute Myelogenous Leukemia|acute myelogenous leukemia
5273742|NCT00529334|Breast Cancer|breast cancer
5273743|NCT00529334|Partial breast irradiation|partial breast irradiation
5273744|NCT00529334|Radiosurgery|radiosurgery
5273745|NCT00529334|CyberKnife|cyberknife
5273746|NCT00529334|Radiotherapy|radiotherapy
5273747|NCT00529334|PBI|pbi
5273748|NCT00529308|Tourette|tourette
5273749|NCT00529308|Tourette's|tourette's
5273750|NCT00529295|misoprostol|misoprostol
5273751|NCT00529295|labor induction|labor induction
5273752|NCT00529282|Low numbers of neutrophils in the blood|low numbers of neutrophils in the blood
5273753|NCT00529282|increased body temperature|increased body temperature
5273754|NCT00529282|cancer chemotherapy|cancer chemotherapy
5273755|NCT00529282|ceftobiprole|ceftobiprole
5273756|NCT00529282|pseudomonas infections|pseudomonas infections
5273858|NCT00528879|Endocrine System Diseases|endocrine system diseases
5273757|NCT00529269|Renal Transplant Patients, GI symptom, Enteric-coated mycophenolate sodium|renal transplant patients, gi symptom, enteric-coated mycophenolate sodium
5273758|NCT00529256|Adult smokers|adult smokers
5273759|NCT00529243|Treatment Experience|treatment experience
5273760|NCT00529243|On enfuvirtide|on enfuvirtide
5273761|NCT00529230|Advanced Cancer|advanced cancer
5273762|NCT00529230|Chronic Opioid Therapy|chronic opioid therapy
5273763|NCT00529230|Secondary Hypogonadism|secondary hypogonadism
5273764|NCT00529230|Cancer-Related Pain Syndromes|cancer-related pain syndromes
5273765|NCT00529230|Questionnaire|questionnaire
5273766|NCT00529217|Dissociative|dissociative
5273767|NCT00529217|Dissociation|dissociation
5273768|NCT00529217|Depersonalization|depersonalization
5273769|NCT00529217|Depersonalization Disorder|depersonalization disorder
5273772|NCT00529217|Depersonalization Disorder (DPD)|depersonalization disorder (dpd)
5273773|NCT00529217|rTMS|rtms
5273774|NCT00529204|Fatty Liver|fatty liver
5273775|NCT00529204|Nonalcoholic fatty liver disease|nonalcoholic fatty liver disease
5273776|NCT00529204|NAFDL|nafdl
5273777|NCT00529204|Diabetes|diabetes
5273778|NCT00529204|ALT|alt
5273779|NCT00529204|exenatide|exenatide
5273780|NCT00529191|Type I Diabetes (T1DM)|type i diabetes (t1dm)
5273781|NCT00529191|Atorvastatin (Lipitor)|atorvastatin (lipitor)
5273782|NCT00529191|Insulin|insulin
5273783|NCT00529191|Pancreas|pancreas
5273784|NCT00529191|Beta Cells|beta cells
5273785|NCT00529165|injection to meal time|injection to meal time
5273786|NCT00529165|human insulin|human insulin
5273787|NCT00529152|Iron Overload|iron overload
5273788|NCT00529139|Extended dialysis|extended dialysis
5273789|NCT00529139|Acute kidney injury|acute kidney injury
5273790|NCT00529139|Intensive care unit|intensive care unit
5273791|NCT00529139|Renal replacement therapy|renal replacement therapy
5273792|NCT00529139|Survival|survival
5273793|NCT00529139|Dialysis|dialysis
5273794|NCT00529126|hemorrhoidectomy|hemorrhoidectomy
5273795|NCT00529126|pain|pain
5273796|NCT00529126|Postoperative|postoperative
5273797|NCT00529126|analgesia|analgesia
5273798|NCT00529113|pancreatic cancer|pancreatic cancer
5273799|NCT00529113|gemcitabine|gemcitabine
5273800|NCT00529087|Opioid-Induced Constipation|opioid-induced constipation
5273801|NCT00529074|Epidural Analgesia|epidural analgesia
5273802|NCT00529061|Sickle Cell Disease|sickle cell disease
5273803|NCT00529061|Sickle Cell Anemia|sickle cell anemia
5273804|NCT00529048|Type 2 diabetes mellitus|type 2 diabetes mellitus
5273805|NCT00529048|Incretin effect|incretin effect
5273806|NCT00529048|Glucagon-Like Peptide 1|glucagon-like peptide 1
5273807|NCT00529048|Gastric Inhibitory Polypeptide|gastric inhibitory polypeptide
5273808|NCT00529035|Chronic GVHD|chronic gvhd
5273809|NCT00529035|Steroid refractory GVHD|steroid refractory gvhd
5273810|NCT00529035|allogeneic stem cell transplantation|allogeneic stem cell transplantation
5273811|NCT00529022|Advanced Cancer|advanced cancer
5273812|NCT00529022|Solid Tumors|solid tumors
5273813|NCT00529022|Ovarian Cancer|ovarian cancer
5273814|NCT00529022|Fallopian Tube Cancer|fallopian tube cancer
5273815|NCT00529022|Peritoneal Cancer|peritoneal cancer
5273816|NCT00529022|Azacitidine|azacitidine
5273817|NCT00529022|5-Azacitidine|5-azacitidine
5273818|NCT00529022|5-Aza|5-aza
5273819|NCT00529022|Vidaza™|vidaza™
5273820|NCT00529022|5-AZC|5-azc
5273821|NCT00529022|AZA-CR|aza-cr
5273822|NCT00529022|Ladakamycin|ladakamycin
5273823|NCT00529022|NSC-102816|nsc-102816
5273824|NCT00529022|Vidaza|vidaza
5273825|NCT00529022|Valproic Acid|valproic acid
5273826|NCT00529022|Depakene|depakene
5273827|NCT00529022|Carboplatin|carboplatin
5273828|NCT00529022|Paraplatin|paraplatin
5273829|NCT00529009|PK analysis|pk analysis
5273830|NCT00528983|Myelodysplastic Syndromes MDS|myelodysplastic syndromes mds
5273831|NCT00528983|Acute Myelogenous Leukemia AML|acute myelogenous leukemia aml
5273832|NCT00528983|Chronic Myelomonocytic Leukemia CMML|chronic myelomonocytic leukemia cmml
5273833|NCT00528970|POI|poi
5273834|NCT00528970|Hernia|hernia
5273835|NCT00528970|Ventral Wall Hernia Repair|ventral wall hernia repair
5273836|NCT00528970|Post Operative Ileus|post operative ileus
5273837|NCT00528957|Phase 3|phase 3
5273838|NCT00528957|Randomized, Open-Label|randomized, open-label
5273839|NCT00528957|Treatment-Experienced|treatment-experienced
5273840|NCT00528957|Highly Active Antiretroviral Therapy|highly active antiretroviral therapy
5273841|NCT00528957|HIV|hiv
5273842|NCT00528957|Tenofovir DF|tenofovir df
5273843|NCT00528957|Pediatrics|pediatrics
5273844|NCT00528944|alveolar volume|alveolar volume
5273845|NCT00528944|pulmonary function testing|pulmonary function testing
5273846|NCT00528944|emphysema|emphysema
5273847|NCT00528931|Assessment of AUX I and/or AUX II in human plasma|assessment of aux i and/or aux ii in human plasma
5273848|NCT00528918|diabetes|diabetes
5273849|NCT00528918|hyperglycemia|hyperglycemia
5273850|NCT00528918|insulin|insulin
5273851|NCT00528918|Apidra|apidra
5273852|NCT00528918|Glargine|glargine
5273853|NCT00528905|Schizophrenia|schizophrenia
5273854|NCT00528905|Cognitive Deficits|cognitive deficits
5273855|NCT00528892|Treatment Experienced|treatment experienced
5273856|NCT00528879|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
5273857|NCT00528879|Diabetes Mellitus|diabetes mellitus
5273859|NCT00528879|Glucose Metabolism Disorders|glucose metabolism disorders
5273860|NCT00528879|Metabolic Diseases|metabolic diseases
5273861|NCT00528879|Metformin|metformin
5273862|NCT00528879|Hypoglycemic Agents|hypoglycemic agents
5273863|NCT00528879|Pharmacologic Actions|pharmacologic actions
5273864|NCT00528879|Physiological Effects of Drugs|physiological effects of drugs
5273865|NCT00528866|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5273866|NCT00528866|stage IIB prostate cancer|stage iib prostate cancer
5273867|NCT00528866|stage IIA prostate cancer|stage iia prostate cancer
5273868|NCT00528866|stage III prostate cancer|stage iii prostate cancer
5273869|NCT00528866|stage IV prostate cancer|stage iv prostate cancer
5273870|NCT00528853|Bronchiolitis Obliterans Syndrome|bronchiolitis obliterans syndrome
5273871|NCT00528827|Hypertension, High Blood Pressure, Pediatric Hypertension, High blood pressure in children|hypertension, high blood pressure, pediatric hypertension, high blood pressure in children
5273872|NCT00528814|Hand Sanitizer|hand sanitizer
5273873|NCT00528814|Respiratory Infection|respiratory infection
5273874|NCT00528801|Sickle Cell Disease|sickle cell disease
5273875|NCT00528801|Sickle Cell Anemia|sickle cell anemia
5273876|NCT00528801|Hemoglobin SS|hemoglobin ss
5273877|NCT00528801|Hemoglobin SB0|hemoglobin sb0
5273878|NCT00528775|adenocarcinoma of the lung|adenocarcinoma of the lung
5273879|NCT00528775|large cell lung cancer|large cell lung cancer
5273880|NCT00528775|squamous cell lung cancer|squamous cell lung cancer
5273881|NCT00528775|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5273882|NCT00528775|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5273883|NCT00528775|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5273884|NCT00528775|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5273885|NCT00528762|Epidemiology|epidemiology
5273886|NCT00528762|Puberty|puberty
5273887|NCT00528762|Body Weight|body weight
5273888|NCT00528762|Body Image|body image
5273889|NCT00528762|Focus Group|focus group
5273890|NCT00528749|Respiratory effort|respiratory effort
5273891|NCT00528749|Upper Airway Resistance Syndrome|upper airway resistance syndrome
5273892|NCT00528736|preterm infants < 28 weeks|preterm infants < 28 weeks
5273893|NCT00528736|B-type natriuretic peptide|b-type natriuretic peptide
5273894|NCT00528736|prediction|prediction
5273895|NCT00528736|ductus intervention|ductus intervention
5273896|NCT00528723|beclomethasone|beclomethasone
5273897|NCT00528723|as needed|as needed
5273898|NCT00528723|salbutamol|salbutamol
5273899|NCT00528723|wheezing|wheezing
5273900|NCT00528710|S-Adenosylmethionine|s-adenosylmethionine
5273901|NCT00528684|Oncolytics Biotech|oncolytics biotech
5273902|NCT00528684|cancer alternative therapies|cancer alternative therapies
5273903|NCT00528684|malignant glioma|malignant glioma
5273904|NCT00528684|glioblastoma multiforme|glioblastoma multiforme
5273905|NCT00528684|oncolytic virus|oncolytic virus
5273906|NCT00528684|reovirus|reovirus
5273907|NCT00528684|REOLYSIN|reolysin
5273908|NCT00528671|phenprocoumon|phenprocoumon
5273909|NCT00528671|INR self-management|inr self-management
5273910|NCT00528671|mechanical heart valve replacement|mechanical heart valve replacement
5273911|NCT00528671|bleeding|bleeding
5273912|NCT00528671|thromboembolism|thromboembolism
5273913|NCT00528658|Soft Tissue Injuries|soft tissue injuries
5273914|NCT00528632|Gallstones|gallstones
5273915|NCT00528632|Gallbladder|gallbladder
5273916|NCT00528632|Cholesterolosis|cholesterolosis
5273917|NCT00528632|Serum cholesterol|serum cholesterol
5273918|NCT00528632|triglycerides|triglycerides
5273919|NCT00528632|Body Mass Index|body mass index
5273920|NCT00528619|Solid tumor malignancy|solid tumor malignancy
5273921|NCT00528619|non-small cell lung cancer|non-small cell lung cancer
5273922|NCT00528619|sunitinib|sunitinib
5273923|NCT00528619|pemetrexed|pemetrexed
5273925|NCT00528619|Mesothelioma|mesothelioma
5273926|NCT00528593|HIV|hiv
5273927|NCT00528593|AIDS|aids
5273928|NCT00528593|neuropathy|neuropathy
5273929|NCT00528593|Procrit|procrit
5273930|NCT00528593|epoetin alfa|epoetin alfa
5273931|NCT00528593|erythropoetin|erythropoetin
5273932|NCT00528593|Treatment Experienced|treatment experienced
5273933|NCT00528580|Sepsis|sepsis
5273934|NCT00528580|Statin|statin
5273935|NCT00528580|Infection|infection
5273936|NCT00528580|Immunomodulatory|immunomodulatory
5273937|NCT00528554|CINV|cinv
5273938|NCT00528554|chemotherapy induced nausea and vomiting (CINV)|chemotherapy induced nausea and vomiting (cinv)
5273939|NCT00528528|Chronic Hepatitis C|chronic hepatitis c
5273940|NCT00528528|Genotype 1|genotype 1
5273941|NCT00528528|Telaprevir|telaprevir
5273942|NCT00528528|Treatment-naïve|treatment-naïve
5273943|NCT00528528|VX-950-C208|vx-950-c208
5273944|NCT00528528|VX-950-TiDP24-C208|vx-950-tidp24-c208
5273945|NCT00528515|anesthesia intravenous|anesthesia intravenous
5273946|NCT00528515|propofol|propofol
5273947|NCT00528515|anesthesia inhalation|anesthesia inhalation
5273948|NCT00528515|desflurane|desflurane
5273949|NCT00528515|heart surgery|heart surgery
5273950|NCT00528515|coronary artery by-pass off-pump|coronary artery by-pass off-pump
5273951|NCT00528515|hemodynamic processes|hemodynamic processes
5273952|NCT00528515|anesthesia|anesthesia
5273953|NCT00528502|Parathyroid Disease|parathyroid disease
5273954|NCT00528502|Minimal Invasive Parathyroid Surgery|minimal invasive parathyroid surgery
5273955|NCT00528502|MIPS|mips
5273956|NCT00528502|Laryngeal Reflexes|laryngeal reflexes
5273957|NCT00528502|Lidocaine|lidocaine
5273958|NCT00528502|Saline|saline
5273959|NCT00528489|HIV Seronegativity|hiv seronegativity
5273960|NCT00528489|DNA Plasmid Vaccine|dna plasmid vaccine
5273961|NCT00528489|HIV Preventive Vaccine|hiv preventive vaccine
5273962|NCT00528476|pyelonephritis|pyelonephritis
5273963|NCT00528476|cystitis|cystitis
5273964|NCT00528476|risk factor|risk factor
5273965|NCT00528476|children|children
5273966|NCT00528476|urodynamics|urodynamics
5273967|NCT00528463|Pre-emptive analgesia|pre-emptive analgesia
5273968|NCT00528463|Peripheral nerve block (sciatic)|peripheral nerve block (sciatic)
5273969|NCT00528463|phantom lomb pain|phantom lomb pain
5273970|NCT00528450|adult acute promyelocytic leukemia (M3)|adult acute promyelocytic leukemia (m3)
5273971|NCT00528450|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5273972|NCT00528450|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
5273973|NCT00528437|Recurrent or refractory medulloblastoma/PNET|recurrent or refractory medulloblastoma/pnet
5273974|NCT00528437|CNS germ cell tumors|cns germ cell tumors
5273975|NCT00528437|Ependymomas|ependymomas
5273976|NCT00528437|AT/RT|at/rt
5273977|NCT00528437|High grade glioma|high grade glioma
5273978|NCT00528437|Other malignant brain tumors|other malignant brain tumors
5273979|NCT00528411|Coronary artery disease|coronary artery disease
5273980|NCT00528411|CAD|cad
5273981|NCT00528411|heart attack|heart attack
5273982|NCT00528411|stable angina|stable angina
5273983|NCT00528411|Stable coronary artery disease|stable coronary artery disease
5273984|NCT00528398|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
5273985|NCT00528398|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
5273986|NCT00528398|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
5273987|NCT00528398|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
5273988|NCT00528398|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
5273989|NCT00528398|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
5273990|NCT00528398|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
5273991|NCT00528398|adult erythroleukemia (M6a)|adult erythroleukemia (m6a)
5273992|NCT00528398|adult pure erythroid leukemia (M6b)|adult pure erythroid leukemia (m6b)
5273993|NCT00528398|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5273994|NCT00528398|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5273995|NCT00528398|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5273996|NCT00528398|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5273997|NCT00528398|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5273998|NCT00528398|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
5273999|NCT00528385|Proteinuria|proteinuria
5274000|NCT00528385|Renin-Angiotensin-Aldosterone System|renin-angiotensin-aldosterone system
5274001|NCT00528385|Aldosterone Antagonists|aldosterone antagonists
5274002|NCT00528359|antipsychotic drugs|antipsychotic drugs
5274003|NCT00528359|schizophrenia|schizophrenia
5274004|NCT00528359|β-cell function|β-cell function
5274005|NCT00528359|insulin resistance|insulin resistance
5274006|NCT00528346|chronic pain|chronic pain
5274007|NCT00528346|functional magnetic resonance imaging|functional magnetic resonance imaging
5274008|NCT00528346|fMRI|fmri
5274009|NCT00528346|cognitive training|cognitive training
5274010|NCT00528333|Lintuzumab|lintuzumab
5274011|NCT00528333|Antigens, CD33|antigens, cd33
5274012|NCT00528333|Antibodies, Monoclonal|antibodies, monoclonal
5274013|NCT00528333|Leukemia, Myeloid, Acute|leukemia, myeloid, acute
5274014|NCT00528333|Hematologic Diseases|hematologic diseases
5274015|NCT00528333|Leukemia|leukemia
5274016|NCT00528320|Congestive Heart Failure|congestive heart failure
5274017|NCT00528320|Heart Failure|heart failure
5274018|NCT00528320|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
5274019|NCT00528320|ICD|icd
5274020|NCT00528320|Implantable Cardioverter-Defibrillator|implantable cardioverter-defibrillator
5274021|NCT00528320|Defibrillator|defibrillator
5274022|NCT00528307|myocardial perfusion|myocardial perfusion
5274023|NCT00528307|His ablation|his ablation
5274024|NCT00528307|biventricular pacing|biventricular pacing
5274025|NCT00528307|His bundle ablation for atrial fibrillation|his bundle ablation for atrial fibrillation
5274026|NCT00528294|Recurrent head and neck tumors|recurrent head and neck tumors
5274027|NCT00528281|Non Small Cell Lung Cancer (NSCLC)|non small cell lung cancer (nsclc)
5274028|NCT00528281|Pemetrexed,|pemetrexed,
5274029|NCT00528281|Lapatinib (GW572016),|lapatinib (gw572016),
5274030|NCT00528268|Spinal Muscular Atrophy|spinal muscular atrophy
5274031|NCT00528268|SMA|sma
5274032|NCT00528268|Sodium Phenylbutyrate|sodium phenylbutyrate
5274033|NCT00528255|cervical ripening|cervical ripening
5274034|NCT00528255|induction of labor|induction of labor
5274035|NCT00528216|Analgesics|analgesics
5274036|NCT00528216|Capsaicin|capsaicin
5274037|NCT00528203|Sickle Cell Disease|sickle cell disease
5274038|NCT00528203|Sickle Cell Anemia|sickle cell anemia
5274039|NCT00528203|DNA|dna
5274040|NCT00528190|Cystic Fibrosis|cystic fibrosis
5274041|NCT00528190|Aspergillus Fumigatus|aspergillus fumigatus
5274042|NCT00528190|randomized controlled clinical trials|randomized controlled clinical trials
5274043|NCT00528177|kappa-opioid receptor|kappa-opioid receptor
5274044|NCT00528177|my-opioid receptor|my-opioid receptor
5274045|NCT00528177|oxycodone|oxycodone
5274046|NCT00528177|morphine|morphine
5274047|NCT00528177|postoperative pain|postoperative pain
5274048|NCT00528164|children|children
5274049|NCT00528164|overweight|overweight
5274050|NCT00528164|obesity|obesity
5274051|NCT00528164|family|family
5274052|NCT00528164|intervention|intervention
5274053|NCT00528164|control|control
5274054|NCT00528164|randomized|randomized
5274055|NCT00528164|physical activity|physical activity
5274056|NCT00528164|diet|diet
5274057|NCT00528164|nutrition|nutrition
5274058|NCT00528164|behavior|behavior
5274059|NCT00528164|body mass index|body mass index
5274060|NCT00528151|Curcumin, LHON, antioxidant, visual outcome|curcumin, lhon, antioxidant, visual outcome
5274061|NCT00528138|Appendicitis|appendicitis
5274062|NCT00528138|Hyperbilirubinemia|hyperbilirubinemia
5274063|NCT00528138|CRP|crp
5274064|NCT00528138|Values of bilirubin|values of bilirubin
5274065|NCT00528138|Values of liver function test|values of liver function test
5274066|NCT00528138|Values of white blood cells|values of white blood cells
5274067|NCT00528138|Values of CRP|values of crp
5274068|NCT00528125|pain prevention|pain prevention
5274069|NCT00528125|neonatal pain|neonatal pain
5274070|NCT00528125|laser acupuncture|laser acupuncture
5274071|NCT00528125|complementary and alternative medicine|complementary and alternative medicine
5274072|NCT00528112|Contraception|contraception
5274073|NCT00528112|Intrauterine|intrauterine
5274074|NCT00528112|IUD|iud
5274075|NCT00528112|IUS|ius
5274076|NCT00528086|Group visits|group visits
5274077|NCT00528073|Rifaximin-EIR|rifaximin-eir
5274078|NCT00528073|Crohn's disease|crohn's disease
5274079|NCT00528073|remission|remission
5274080|NCT00528060|HIV infections|hiv infections
5274081|NCT00528060|atazanavir|atazanavir
5274082|NCT00528060|Pharmacokinetics|pharmacokinetics
5274083|NCT00528060|Treatment Naive|treatment naive
5274084|NCT00528047|Cancer|cancer
5274085|NCT00528047|Solid Tumor|solid tumor
5274086|NCT00528047|Metastatic|metastatic
5274087|NCT00528047|Neoplasm, Malignant|neoplasm, malignant
5274088|NCT00528034|Vaginal Cancer|vaginal cancer
5274089|NCT00528034|Lymphoscintigraphy|lymphoscintigraphy
5274090|NCT00528034|Lymphatic Mapping|lymphatic mapping
5274091|NCT00528034|Sentinel Lymph Node|sentinel lymph node
5274092|NCT00528034|Isosulfan Blue|isosulfan blue
5274093|NCT00528034|Lymph|lymph
5274094|NCT00528021|Head Lice|head lice
5274095|NCT00528021|Lice Infestation|lice infestation
5274096|NCT00528021|Pediculosis|pediculosis
5274097|NCT00528021|Pediculosis Capitis|pediculosis capitis
5274098|NCT00528008|infection|infection
5274099|NCT00528008|sepsis|sepsis
5274100|NCT00528008|povidone-iodine|povidone-iodine
5274101|NCT00528008|chlorhexidine gluconate|chlorhexidine gluconate
5274102|NCT00528008|fever|fever
5274103|NCT00528008|erythema|erythema
5274104|NCT00528008|leukocytosis|leukocytosis
5274105|NCT00528008|drainage|drainage
5274106|NCT00528008|vaginal discharge|vaginal discharge
5274107|NCT00528008|elective cesarean section|elective cesarean section
5274108|NCT00527982|Head and Neck Cancer|head and neck cancer
5274109|NCT00527982|Lung Cancer|lung cancer
5274110|NCT00527982|Non-Small Cell Lung Cancer|non-small cell lung cancer
5274111|NCT00527982|Celecoxib|celecoxib
5274112|NCT00527982|Celebrex|celebrex
5274113|NCT00527969|American ginseng extract|american ginseng extract
5274114|NCT00527969|Panax quinquefolius|panax quinquefolius
5274115|NCT00527969|Memory enhancement|memory enhancement
5274116|NCT00527969|Cognitive function|cognitive function
5274117|NCT00527969|Working memory|working memory
5274118|NCT00527969|Declarative memory|declarative memory
5274119|NCT00527969|Psychomotor speed|psychomotor speed
5274120|NCT00527969|Executive skills|executive skills
5274121|NCT00527969|Psychosocial adaptation|psychosocial adaptation
5274122|NCT00527956|Breastfeeding premature infants|breastfeeding premature infants
5274123|NCT00527930|Breast Neoplasms|breast neoplasms
5274124|NCT00527930|Oxaliplatin|oxaliplatin
5274125|NCT00527930|S1|s1
5274126|NCT00527917|IC/PBS|ic/pbs
5274127|NCT00527917|Interstitial Cystitis/Painful Bladder Syndrome|interstitial cystitis/painful bladder syndrome
5274128|NCT00527904|osteoarthritis|osteoarthritis
5274129|NCT00527904|rheumatoid arthritis|rheumatoid arthritis
5274130|NCT00527904|ankylosing spondylisit|ankylosing spondylisit
5274131|NCT00527904|NSAIDS|nsaids
5274132|NCT00527891|Liver Cancer|liver cancer
5274133|NCT00527891|Magnetic Resonance Imaging|magnetic resonance imaging
5274134|NCT00527891|Signa Excite 3.0T MRI Scan|signa excite 3.0t mri scan
5274135|NCT00527878|Hyper-IgE Recurrent Infection Syndrome|hyper-ige recurrent infection syndrome
5274136|NCT00527878|Ranitidine Therapy|ranitidine therapy
5274137|NCT00527878|Job's Syndrome|job's syndrome
5274138|NCT00527878|Cross-Over Study|cross-over study
5274139|NCT00527878|Double-Blind Placebo Controlled|double-blind placebo controlled
5274140|NCT00527878|Hyper-IgE Syndrome|hyper-ige syndrome
5274141|NCT00527878|Job Syndrome|job syndrome
5274142|NCT00527878|Immune Deficiency|immune deficiency
5274143|NCT00527865|Influenza, Flu, DAS181, Fludase|influenza, flu, das181, fludase
5274144|NCT00527852|Flocked swab|flocked swab
5274145|NCT00527852|Group A streptococcus pharyngitis|group a streptococcus pharyngitis
5274146|NCT00527826|Severe and very severe COPD (GOLD stage III / IV) exacerbations|severe and very severe copd (gold stage iii / iv) exacerbations
5274147|NCT00527826|health care utilisation|health care utilisation
5274148|NCT00527826|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
5274149|NCT00527826|quality of life|quality of life
5274150|NCT00527826|compliance|compliance
5274151|NCT00527826|salmeterol/fluticasone combination|salmeterol/fluticasone combination
5274152|NCT00527813|acute respiratory distress syndrome|acute respiratory distress syndrome
5274153|NCT00527813|prone position|prone position
5274154|NCT00527813|Acute respiratory distress syndrome (ARDS)|acute respiratory distress syndrome (ards)
5274155|NCT00527800|Malaria|malaria
5274156|NCT00527800|HIV|hiv
5274157|NCT00527800|Trimethoprim-sulfamethoxazole|trimethoprim-sulfamethoxazole
5274158|NCT00527800|Artemether-lumefantrine|artemether-lumefantrine
5274159|NCT00527800|Dihydroartemisinin-piperaquine|dihydroartemisinin-piperaquine
5274160|NCT00527800|Acute Infection|acute infection
5274161|NCT00527787|NSAID|nsaid
5274162|NCT00527787|gastric ulcers|gastric ulcers
5274163|NCT00527787|Vimovo|vimovo
5274164|NCT00527787|Naproxen|naproxen
5274165|NCT00527787|Esomeprazole|esomeprazole
5274166|NCT00527774|Hepatitis C|hepatitis c
5274167|NCT00527774|malnutrition-inflammation complex syndrome (MICS)|malnutrition-inflammation complex syndrome (mics)
5274168|NCT00527774|dialysis|dialysis
5274169|NCT00527774|mortality|mortality
5274170|NCT00527774|hospitalization|hospitalization
5274171|NCT00527774|health-related quality of life (HRQOL)|health-related quality of life (hrqol)
5274172|NCT00527774|peripheral arterial occlusive disease (PAOD)|peripheral arterial occlusive disease (paod)
5274173|NCT00527761|Metastatic Melanoma|metastatic melanoma
5274174|NCT00527761|Temozolomide|temozolomide
5274175|NCT00527761|Temodar|temodar
5274176|NCT00527761|Taxotere|taxotere
5274177|NCT00527761|Cisplatin|cisplatin
5274178|NCT00527761|TTC|ttc
5274179|NCT00527748|Range of Motion|range of motion
5274180|NCT00527748|Ankle Fractures|ankle fractures
5274181|NCT00527748|Elderly patients|elderly patients
5274182|NCT00527735|Non Small Cell Lung Cancer (NSCLC)|non small cell lung cancer (nsclc)
5274183|NCT00527735|Small Cell Lung Cancer (SCLC)|small cell lung cancer (sclc)
5274184|NCT00527722|Lung Cancer|lung cancer
5274185|NCT00527722|Bio-Seal Track Plug|bio-seal track plug
5274186|NCT00527722|Lung Biopsy|lung biopsy
5274187|NCT00527722|Lung Plug|lung plug
5274188|NCT00527722|Air Leaks|air leaks
5274189|NCT00527683|vigabatrin|vigabatrin
5274190|NCT00527683|GVG|gvg
5274191|NCT00527683|addiction|addiction
5274192|NCT00527683|treatment|treatment
5274193|NCT00527683|cocaine dependence|cocaine dependence
5274194|NCT00527670|Genomics|genomics
5274195|NCT00527657|Brain Neoplasms|brain neoplasms
5274196|NCT00527657|Melanoma|melanoma
5274197|NCT00527657|Metastatic Melanoma|metastatic melanoma
5274198|NCT00527657|Brain Metastasis|brain metastasis
5274199|NCT00527657|Temozolomide|temozolomide
5274200|NCT00527657|Temodar|temodar
5274201|NCT00527657|Thalidomide|thalidomide
5274202|NCT00527657|Thalomid|thalomid
5274203|NCT00527657|Lomustine|lomustine
5274204|NCT00527657|CCNU|ccnu
5274205|NCT00527657|CeeNU|ceenu
5274206|NCT00527644|biliary leaks after laparoscopic cholecystectomy|biliary leaks after laparoscopic cholecystectomy
5274207|NCT00527631|advanced ovarian cancer|advanced ovarian cancer
5274208|NCT00527631|whole abdominal irradiation|whole abdominal irradiation
5274209|NCT00527631|intensity modulated radiotherapy|intensity modulated radiotherapy
5274210|NCT00527631|ovarian cancer stage FIGO III|ovarian cancer stage figo iii
5274211|NCT00527618|Herpes Simplex Virus Type 2|herpes simplex virus type 2
5274212|NCT00527618|Human Immunodeficiency Virus|human immunodeficiency virus
5274213|NCT00527618|Treatment Naive|treatment naive
5274214|NCT00527605|placebo control|placebo control
5274215|NCT00527605|Chinese|chinese
5274216|NCT00527605|Dutasteride|dutasteride
5274217|NCT00527605|Randomized|randomized
5274218|NCT00527605|Benign Prostatic Hyperplasia|benign prostatic hyperplasia
5274219|NCT00527605|Double blind|double blind
5274220|NCT00527592|Comfort|comfort
5274221|NCT00527579|Epilepsy|epilepsy
5274222|NCT00527579|Taenia Solium|taenia solium
5274223|NCT00527579|Microglia|microglia
5274224|NCT00527579|Neuroinflammation|neuroinflammation
5274225|NCT00527579|Compartment Model|compartment model
5274226|NCT00527579|Neurocysticercosis|neurocysticercosis
5274227|NCT00527579|Healthy Volunteer|healthy volunteer
5274228|NCT00527579|HV|hv
5274229|NCT00527566|Churg Strauss Syndrome|churg strauss syndrome
5274230|NCT00527553|Macular pigment|macular pigment
5274231|NCT00527553|AMD|amd
5274232|NCT00527553|ARM|arm
5274233|NCT00527514|Hypertension|hypertension
5274234|NCT00527514|Angiotensin Receptor Blocker|angiotensin receptor blocker
5274235|NCT00527514|Calcium Channel Blocker|calcium channel blocker
5274236|NCT00527514|Stage I and II Hypertension|stage i and ii hypertension
5274237|NCT00527501|Open-angle glaucoma|open-angle glaucoma
5274238|NCT00527501|ocular hypertension|ocular hypertension
5274613|NCT00526110|Esophagus|esophagus
5274239|NCT00527488|Benign Prostate Hyperplasia|benign prostate hyperplasia
5274240|NCT00527488|BPH|bph
5274241|NCT00527488|PK/PD|pk/pd
5274242|NCT00527488|GnRH antagonist|gnrh antagonist
5274243|NCT00527475|Anti-VEGF therapy|anti-vegf therapy
5274244|NCT00527475|photodynamic therapy|photodynamic therapy
5274245|NCT00527475|neovascularization|neovascularization
5274246|NCT00527462|Asthma GINA 1|asthma gina 1
5274247|NCT00527423|VEGF Trap-Eye|vegf trap-eye
5274248|NCT00527423|Macular Degeneration|macular degeneration
5274249|NCT00527423|AMD|amd
5274250|NCT00527423|Neovascular Age-Related Macular Degeneration|neovascular age-related macular degeneration
5274251|NCT00527397|Diabetes Mellitus|diabetes mellitus
5274252|NCT00527384|Stress|stress
5274253|NCT00527371|Benign hyperplasia of the prostate|benign hyperplasia of the prostate
5274254|NCT00527358|violence|violence
5274255|NCT00527345|Asthma|asthma
5274256|NCT00527345|Diesel exhaust|diesel exhaust
5274257|NCT00527332|Hospitalization|hospitalization
5274258|NCT00527332|Postoperative care|postoperative care
5274259|NCT00527332|Quality of Life|quality of life
5274260|NCT00527332|Health economy|health economy
5274261|NCT00527332|Anesthesia. Spinal|anesthesia. spinal
5274262|NCT00527332|Anesthesia, General|anesthesia, general
5274263|NCT00527319|NSCLC|nsclc
5274264|NCT00527319|anorexia|anorexia
5274265|NCT00527319|cachexia|cachexia
5274266|NCT00527319|grip strength|grip strength
5274267|NCT00527319|lean body mass|lean body mass
5274268|NCT00527306|aphthous stomatitis|aphthous stomatitis
5274269|NCT00527306|canker sores|canker sores
5274270|NCT00527306|multivitamins|multivitamins
5274271|NCT00527306|vitamin deficiency|vitamin deficiency
5274272|NCT00527293|stage I breast cancer|stage i breast cancer
5274273|NCT00527293|stage II breast cancer|stage ii breast cancer
5274274|NCT00527293|invasive ductal breast carcinoma|invasive ductal breast carcinoma
5274275|NCT00527293|medullary ductal breast carcinoma with lymphocytic infiltrate|medullary ductal breast carcinoma with lymphocytic infiltrate
5274276|NCT00527293|mucinous ductal breast carcinoma|mucinous ductal breast carcinoma
5274277|NCT00527293|tubular ductal breast carcinoma|tubular ductal breast carcinoma
5274278|NCT00527293|papillary ductal breast carcinoma|papillary ductal breast carcinoma
5274279|NCT00527280|Allotransplantation:composite tissue|allotransplantation:composite tissue
5274280|NCT00527280|Face transplantation|face transplantation
5274281|NCT00527241|partner violence, spouse abuse|partner violence, spouse abuse
5274282|NCT00527228|Muscular dystrophy|muscular dystrophy
5274283|NCT00527228|therapy|therapy
5274284|NCT00527228|steroids|steroids
5274285|NCT00527228|deflazacort|deflazacort
5274286|NCT00527228|dysferlinopathy|dysferlinopathy
5274287|NCT00527228|LGMD|lgmd
5274288|NCT00527228|MM|mm
5274289|NCT00527189|Arthritis|arthritis
5274290|NCT00527189|Exercise|exercise
5274291|NCT00527189|Balance - Postural Control|balance - postural control
5274292|NCT00527176|Systemic Lupus Erythematosus|systemic lupus erythematosus
5274293|NCT00527176|Corticosteroid|corticosteroid
5274294|NCT00527176|Pulse therapy|pulse therapy
5274295|NCT00527176|Diffusion weighted imaging|diffusion weighted imaging
5274296|NCT00527176|q Space Imaging|q space imaging
5274297|NCT00527163|Echocardiogram|echocardiogram
5274298|NCT00527163|Endothelial Dysfunction|endothelial dysfunction
5274299|NCT00527163|Malaria|malaria
5274300|NCT00527163|Mali|mali
5274301|NCT00527163|Screening|screening
5274302|NCT00527098|Trauma Resuscitation|trauma resuscitation
5274303|NCT00527072|plaque psoriasis|plaque psoriasis
5274304|NCT00527072|psoriasis|psoriasis
5274305|NCT00527072|infliximab|infliximab
5274306|NCT00527072|remicade|remicade
5274307|NCT00527072|etanercept|etanercept
5274308|NCT00527072|enbrel|enbrel
5274309|NCT00527072|psunrise|psunrise
5274310|NCT00527072|C0168Z04|c0168z04
5274311|NCT00527059|Cardiorenal syndrome|cardiorenal syndrome
5274312|NCT00527033|YM178|ym178
5274313|NCT00527033|Urinary Bladder, Overactive|urinary bladder, overactive
5274314|NCT00527020|qEEG,|qeeg,
5274315|NCT00527020|GlyT-1 inhibitor,|glyt-1 inhibitor,
5274316|NCT00527020|ERP|erp
5274317|NCT00527020|GSK1018921,|gsk1018921,
5274318|NCT00527020|FTIH,|ftih,
5274319|NCT00527020|schizophrenia,|schizophrenia,
5274320|NCT00527020|single-dose,|single-dose,
5274321|NCT00527020|healthy volunteers,|healthy volunteers,
5274322|NCT00527020|MMN,|mmn,
5274323|NCT00527007|Vasopressor|vasopressor
5274324|NCT00527007|Epinephrine|epinephrine
5274325|NCT00527007|Norepinephrine|norepinephrine
5274326|NCT00527007|Cooling|cooling
5274327|NCT00527007|Fever|fever
5274328|NCT00527007|ICU|icu
5274329|NCT00526994|intimate partner violence|intimate partner violence
5274330|NCT00526994|domestic violence|domestic violence
5274331|NCT00526994|spouse abuse|spouse abuse
5274332|NCT00526994|screening|screening
5274333|NCT00526955|Manual muscle testing|manual muscle testing
5274334|NCT00526942|ACRD|acrd
5274335|NCT00526942|Visual Memory|visual memory
5274336|NCT00526942|Visual Perception|visual perception
5274337|NCT00526942|Speed|speed
5274338|NCT00526942|Computerized|computerized
5274339|NCT00526942|SAAGE|saage
5274340|NCT00526942|Cognitive Decline|cognitive decline
5274341|NCT00526916|Epilepsy|epilepsy
5274342|NCT00526916|Taenia Solium|taenia solium
5274343|NCT00526916|Microglia|microglia
5274344|NCT00526916|Neuroinflammation|neuroinflammation
5274345|NCT00526916|Compartment Model|compartment model
5274346|NCT00526916|Neurocysticercosis|neurocysticercosis
5274347|NCT00526916|Healthy Volunteer|healthy volunteer
5274348|NCT00526916|HV|hv
5274349|NCT00526903|IBS|ibs
5274350|NCT00526903|abdominal pain|abdominal pain
5274351|NCT00526903|recurrent abdominal pain|recurrent abdominal pain
5274352|NCT00526903|irritable bowel syndrome|irritable bowel syndrome
5274353|NCT00526903|diarrhea|diarrhea
5274354|NCT00526903|constipation|constipation
5274355|NCT00526903|bloating|bloating
5274356|NCT00526890|squamous cell lung cancer|squamous cell lung cancer
5274357|NCT00526890|adenocarcinoma of the lung|adenocarcinoma of the lung
5274358|NCT00526890|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
5274359|NCT00526890|large cell lung cancer|large cell lung cancer
5274360|NCT00526890|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5274361|NCT00526890|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5274362|NCT00526890|adenosquamous cell lung cancer|adenosquamous cell lung cancer
5274363|NCT00526877|Schizophrenia|schizophrenia
5274364|NCT00526877|Schizoaffective disorders|schizoaffective disorders
5274365|NCT00526877|Risperidone|risperidone
5274366|NCT00526877|Risperdal Consta|risperdal consta
5274367|NCT00526864|Burden of Illness for Herpes zoster in Thailand.|burden of illness for herpes zoster in thailand.
5274368|NCT00526851|lip and oral cavity cancer|lip and oral cavity cancer
5274369|NCT00526851|oropharyngeal cancer|oropharyngeal cancer
5274370|NCT00526838|Solid Tumor|solid tumor
5274371|NCT00526838|Multiple Myeloma|multiple myeloma
5274372|NCT00526786|Low Grade Dysplasia|low grade dysplasia
5274373|NCT00526786|High Grade Dysplasia|high grade dysplasia
5274374|NCT00526786|Barrett's Esophagus|barrett's esophagus
5274375|NCT00526786|Cryospray ablation|cryospray ablation
5274376|NCT00526786|ICE|ice
5274377|NCT00526786|Cryotherapy|cryotherapy
5274378|NCT00526786|Cryo|cryo
5274379|NCT00526786|CryoSpray|cryospray
5274380|NCT00526773|motivational therapy|motivational therapy
5274381|NCT00526760|Dexmedetomidine, Sedation, Long-term, Phase 3|dexmedetomidine, sedation, long-term, phase 3
5274382|NCT00526734|stage I multiple myeloma|stage i multiple myeloma
5274383|NCT00526734|stage II multiple myeloma|stage ii multiple myeloma
5274384|NCT00526734|stage III multiple myeloma|stage iii multiple myeloma
5274385|NCT00526721|Hypercholesterolemia|hypercholesterolemia
5274386|NCT00526721|Crestor|crestor
5274387|NCT00526721|LDL target goal|ldl target goal
5274388|NCT00526721|high risk patients|high risk patients
5274389|NCT00526721|Naturalistic|naturalistic
5274390|NCT00526721|Observational|observational
5274391|NCT00526708|dyslipidemia|dyslipidemia
5274392|NCT00526708|hypertension|hypertension
5274393|NCT00526708|rosuvastatin|rosuvastatin
5274394|NCT00526708|efficacy|efficacy
5274395|NCT00526708|Naturalistic|naturalistic
5274396|NCT00526708|Observational|observational
5274397|NCT00526695|Ischemia/Reperfusion|ischemia/reperfusion
5274398|NCT00526695|Organ Protection|organ protection
5274399|NCT00526695|Anesthetics|anesthetics
5274400|NCT00526682|Antiobesity|antiobesity
5274401|NCT00526682|Weight loss|weight loss
5274402|NCT00526669|tumor biopsy|tumor biopsy
5274403|NCT00526669|capecitabine|capecitabine
5274404|NCT00526669|first line|first line
5274405|NCT00526669|Gastro Esophageal (GE) Junction Cancer|gastro esophageal (ge) junction cancer
5274406|NCT00526669|Gastric cancer|gastric cancer
5274407|NCT00526669|newly diagnosed|newly diagnosed
5274408|NCT00526669|GE junction|ge junction
5274409|NCT00526669|lapatinib|lapatinib
5274410|NCT00526669|metastatic or unresectable|metastatic or unresectable
5274411|NCT00526656|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
5274412|NCT00526656|stage II bladder cancer|stage ii bladder cancer
5274413|NCT00526656|stage III bladder cancer|stage iii bladder cancer
5274414|NCT00526656|stage IV bladder cancer|stage iv bladder cancer
5274415|NCT00526643|stage IIIB|stage iiib
5274416|NCT00526643|Stage IV|stage iv
5274417|NCT00526643|chemotherapy|chemotherapy
5274418|NCT00526643|monotherapy|monotherapy
5274419|NCT00526643|combination chemotherapy|combination chemotherapy
5274420|NCT00526643|poor performance status|poor performance status
5274421|NCT00526630|freezing|freezing
5274422|NCT00526630|gait|gait
5274423|NCT00526630|festination|festination
5274424|NCT00526630|shuffling|shuffling
5274425|NCT00526630|balance|balance
5274426|NCT00526617|Solid Tumor|solid tumor
5274427|NCT00526617|Melanoma|melanoma
5274428|NCT00526617|Breast cancer|breast cancer
5274429|NCT00526617|Ovarian cancer|ovarian cancer
5274430|NCT00526617|Primary peritoneal cancer|primary peritoneal cancer
5274431|NCT00526617|Fallopian tube cancer|fallopian tube cancer
5274432|NCT00526617|Hepatocellular carcinoma|hepatocellular carcinoma
5274433|NCT00526617|HCC|hcc
5274434|NCT00526617|BRCA deficient|brca deficient
5274435|NCT00526617|BRCA mutation|brca mutation
5274436|NCT00526617|Temozolomide|temozolomide
5274437|NCT00526617|Temodar|temodar
5274438|NCT00526617|TMZ|tmz
5274439|NCT00526617|ABT-888|abt-888
5274440|NCT00526617|PARP inhibitor|parp inhibitor
5274441|NCT00526604|return to work|return to work
5274442|NCT00526604|low back pain|low back pain
5274443|NCT00526604|work related rehabilitation|work related rehabilitation
5274444|NCT00526591|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5274445|NCT00526591|stage I prostate cancer|stage i prostate cancer
5274446|NCT00526591|stage II prostate cancer|stage ii prostate cancer
5274447|NCT00526591|stage III prostate cancer|stage iii prostate cancer
5274448|NCT00526578|Pancreatic Cancer|pancreatic cancer
5274449|NCT00526578|Pancreatic Cancer Genetic Epidemiology|pancreatic cancer genetic epidemiology
5274450|NCT00526578|PACGENE|pacgene
5274451|NCT00526578|Healthy Control|healthy control
5274452|NCT00526578|Familial Pancreatic Cancer|familial pancreatic cancer
5274453|NCT00526578|FPC|fpc
5274454|NCT00526578|Questionnaire|questionnaire
5274455|NCT00526552|dyslipidemia|dyslipidemia
5274456|NCT00526552|rosuvastatin|rosuvastatin
5274457|NCT00526552|diabetes|diabetes
5274458|NCT00526552|cholesterol|cholesterol
5274459|NCT00526552|Naturalistic|naturalistic
5274460|NCT00526552|Observational|observational
5274461|NCT00526539|THR|thr
5274462|NCT00526539|reversed hybrid|reversed hybrid
5274463|NCT00526539|wear|wear
5274464|NCT00526500|Severe Traumatic Brain Injury|severe traumatic brain injury
5274465|NCT00526500|Subarachnoid Hemorrhage|subarachnoid hemorrhage
5274466|NCT00526500|Anoxic Brain Injury|anoxic brain injury
5274467|NCT00526500|Passive Gait Training|passive gait training
5274468|NCT00526500|Tilt Table With Integrated Stepping System|tilt table with integrated stepping system
5274469|NCT00526500|Electroencephalogram|electroencephalogram
5274470|NCT00526500|Event Related Potentials|event related potentials
5274471|NCT00526487|Thoracic Dissection|thoracic dissection
5274472|NCT00526487|Dissection|dissection
5274473|NCT00526487|Endovascular|endovascular
5274474|NCT00526461|stage 0 non-small cell lung cancer|stage 0 non-small cell lung cancer
5274475|NCT00526461|adenocarcinoma of the lung|adenocarcinoma of the lung
5274476|NCT00526461|squamous cell lung cancer|squamous cell lung cancer
5274477|NCT00526461|large cell lung cancer|large cell lung cancer
5274478|NCT00526448|high dose of ribavirin|high dose of ribavirin
5274479|NCT00526448|extend treatment duration|extend treatment duration
5274480|NCT00526448|tailoring treatment|tailoring treatment
5274481|NCT00526435|Arthritis|arthritis
5274482|NCT00526435|osteoarthritis|osteoarthritis
5274483|NCT00526435|rheumatoid arthritis|rheumatoid arthritis
5274484|NCT00526435|fibromyalgia|fibromyalgia
5274485|NCT00526435|lupus|lupus
5274486|NCT00526422|Questionnaire, dental caries, diagnosis,treatment|questionnaire, dental caries, diagnosis,treatment
5274487|NCT00526409|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
5274488|NCT00526396|chemotherapy|chemotherapy
5274489|NCT00526396|toxicity adjusted dose|toxicity adjusted dose
5274490|NCT00526383|Major depressive disorder|major depressive disorder
5274491|NCT00526383|Antidepressants|antidepressants
5274492|NCT00526383|Weight gain|weight gain
5274493|NCT00526383|Metabolic syndromes|metabolic syndromes
5274494|NCT00526370|self test|self test
5274495|NCT00526370|PAP smear|pap smear
5274496|NCT00526370|tampon test|tampon test
5274497|NCT00526370|E6/E7|e6/e7
5274498|NCT00526370|mRNA|mrna
5274499|NCT00526370|HPV|hpv
5274500|NCT00526357|omega-3 fatty acids|omega-3 fatty acids
5274501|NCT00526357|asthma|asthma
5274502|NCT00526357|airway hyperresponsiveness|airway hyperresponsiveness
5274503|NCT00526357|inflammation|inflammation
5274504|NCT00526344|remission of asthma|remission of asthma
5274505|NCT00526331|Perioperative Therapy|perioperative therapy
5274506|NCT00526331|Perioperative Hydration|perioperative hydration
5274507|NCT00526331|Arterial Pressure Based Cardiac Output|arterial pressure based cardiac output
5274508|NCT00526331|Vigileo Monitor|vigileo monitor
5274509|NCT00526331|FloTrac Sensor|flotrac sensor
5274510|NCT00526331|Fluid Volume|fluid volume
5274511|NCT00526331|APCO|apco
5274512|NCT00526318|localized resectable neuroblastoma|localized resectable neuroblastoma
5274513|NCT00526318|localized unresectable neuroblastoma|localized unresectable neuroblastoma
5274514|NCT00526318|regional neuroblastoma|regional neuroblastoma
5274515|NCT00526318|stage 4S neuroblastoma|stage 4s neuroblastoma
5274516|NCT00526318|disseminated neuroblastoma|disseminated neuroblastoma
5274517|NCT00526305|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
5274518|NCT00526305|Chromosome Philadelphia positive|chromosome philadelphia positive
5274519|NCT00526292|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5274520|NCT00526292|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5274521|NCT00526292|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5274522|NCT00526292|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5274523|NCT00526292|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
5274524|NCT00526292|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5274525|NCT00526292|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5274526|NCT00526292|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
5274527|NCT00526292|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5274528|NCT00526292|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5274614|NCT00526084|ALL|all
5274529|NCT00526292|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5274530|NCT00526292|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5274531|NCT00526292|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5274532|NCT00526292|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5274533|NCT00526279|Hypertension|hypertension
5274534|NCT00526279|Atacand/Atacand plus|atacand/atacand plus
5274535|NCT00526279|COMBAT|combat
5274536|NCT00526279|Compliance|compliance
5274537|NCT00526279|Naturalistic|naturalistic
5274538|NCT00526279|Observational|observational
5274539|NCT00526253|Congestive Heart Failure|congestive heart failure
5274540|NCT00526253|CHF|chf
5274541|NCT00526253|Heart Disease|heart disease
5274542|NCT00526253|Heart Attack|heart attack
5274543|NCT00526253|Stem Cell|stem cell
5274544|NCT00526253|Myoblast|myoblast
5274545|NCT00526253|Bioheart|bioheart
5274546|NCT00526214|Spontaneous intracerebral hemorrhage|spontaneous intracerebral hemorrhage
5274547|NCT00526214|Acute Spontaneous, Supratentorial intracerebral hemorrhage|acute spontaneous, supratentorial intracerebral hemorrhage
5274548|NCT00526201|Arthritis|arthritis
5274549|NCT00526201|Osteoarthritis|osteoarthritis
5274550|NCT00526201|Rheumatoid Arthritis|rheumatoid arthritis
5274551|NCT00526201|Fibromyalgia|fibromyalgia
5274552|NCT00526201|Lupus|lupus
5274553|NCT00526188|Primovist|primovist
5274554|NCT00526188|Chinese patients|chinese patients
5274555|NCT00526188|Liver MRI|liver mri
5274556|NCT00526175|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
5274557|NCT00526175|Minimal Residual Disease|minimal residual disease
5274558|NCT00526149|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
5274559|NCT00526149|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
5274560|NCT00526149|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
5274561|NCT00526149|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
5274562|NCT00526149|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
5274563|NCT00526149|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
5274564|NCT00526149|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
5274565|NCT00526149|recurrent breast cancer|recurrent breast cancer
5274566|NCT00526149|stage IV breast cancer|stage iv breast cancer
5274567|NCT00526149|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5274568|NCT00526149|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5274569|NCT00526149|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5274570|NCT00526149|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
5274571|NCT00526149|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
5274572|NCT00526149|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
5274573|NCT00526149|adult leiomyosarcoma|adult leiomyosarcoma
5274574|NCT00526149|uterine leiomyosarcoma|uterine leiomyosarcoma
5274575|NCT00526149|adult alveolar soft-part sarcoma|adult alveolar soft-part sarcoma
5274576|NCT00526149|adult angiosarcoma|adult angiosarcoma
5274577|NCT00526149|adult desmoplastic small round cell tumor|adult desmoplastic small round cell tumor
5274578|NCT00526149|adult epithelioid sarcoma|adult epithelioid sarcoma
5274579|NCT00526149|adult fibrosarcoma|adult fibrosarcoma
5274580|NCT00526149|adult liposarcoma|adult liposarcoma
5274581|NCT00526149|adult malignant fibrous histiocytoma|adult malignant fibrous histiocytoma
5274582|NCT00526149|adult malignant mesenchymoma|adult malignant mesenchymoma
5274583|NCT00526149|adult neurofibrosarcoma|adult neurofibrosarcoma
5274584|NCT00526149|adult rhabdomyosarcoma|adult rhabdomyosarcoma
5274585|NCT00526149|adult synovial sarcoma|adult synovial sarcoma
5274586|NCT00526149|endometrial stromal sarcoma|endometrial stromal sarcoma
5274587|NCT00526149|ovarian carcinosarcoma|ovarian carcinosarcoma
5274588|NCT00526149|ovarian sarcoma|ovarian sarcoma
5274589|NCT00526149|recurrent uterine sarcoma|recurrent uterine sarcoma
5274590|NCT00526149|stage IV uterine sarcoma|stage iv uterine sarcoma
5274591|NCT00526149|recurrent melanoma|recurrent melanoma
5274592|NCT00526149|stage IV melanoma|stage iv melanoma
5274593|NCT00526136|Atrial Fibrillation|atrial fibrillation
5274594|NCT00526123|Dialysis|dialysis
5274595|NCT00526123|Dialysis Catheter|dialysis catheter
5274596|NCT00526123|Kidney Disease|kidney disease
5274597|NCT00526123|Dialysis Clinic|dialysis clinic
5274598|NCT00526123|Chronic Catheter|chronic catheter
5274599|NCT00526123|Catheter|catheter
5274600|NCT00526123|Kidney|kidney
5274601|NCT00526110|Gastrointestinal Diseases|gastrointestinal diseases
5274602|NCT00526110|Adenocarcinoma of the Stomach|adenocarcinoma of the stomach
5274603|NCT00526110|Gastroesophageal Junction Cancer|gastroesophageal junction cancer
5274604|NCT00526110|Cancer of the Stomach|cancer of the stomach
5274605|NCT00526110|5-Fluorouracil|5-fluorouracil
5274606|NCT00526110|5-FU|5-fu
5274607|NCT00526110|Adrucil|adrucil
5274608|NCT00526110|Efudex|efudex
5274609|NCT00526110|Docetaxel|docetaxel
5274610|NCT00526110|Oxaliplatin|oxaliplatin
5274611|NCT00526110|Eloxatin|eloxatin
5274612|NCT00526110|Taxotere|taxotere
5274615|NCT00526084|Healthy subjects|healthy subjects
5274616|NCT00526071|Fabry Disease|fabry disease
5274617|NCT00526071|Lysosomal Storage Disorder|lysosomal storage disorder
5274618|NCT00526058|Heparin|heparin
5274619|NCT00526058|Extracorporeal|extracorporeal
5274620|NCT00526058|Low Density Lipo-Protein (LDL) Cholesterol|low density lipo-protein (ldl) cholesterol
5274621|NCT00526058|Apheresis|apheresis
5274622|NCT00526058|Device|device
5274623|NCT00526045|AUY922|auy922
5274624|NCT00526045|Solid tumors|solid tumors
5274625|NCT00526045|Breast Cancer|breast cancer
5274626|NCT00526045|Phase I/II|phase i/ii
5274627|NCT00526045|Advanced Solid malignancies (Phase I)|advanced solid malignancies (phase i)
5274628|NCT00526045|Breast Cancer ( Phase II )|breast cancer ( phase ii )
5274629|NCT00526045|HER2+|her2+
5274630|NCT00526045|ER+|er+
5274631|NCT00526045|HSP90|hsp90
5274632|NCT00526032|Skin Cancer|skin cancer
5274633|NCT00526032|Cancerous skin lesions|cancerous skin lesions
5274634|NCT00526032|Melanoma Detection|melanoma detection
5274635|NCT00526032|Spectroscopic Oblique-Incidence Reflectometry|spectroscopic oblique-incidence reflectometry
5274636|NCT00526032|OIR Imaging Probe|oir imaging probe
5274637|NCT00526019|remission of asthma|remission of asthma
5274638|NCT00526006|Clinical significance of the acid rebound phenomenon after withdrawal of treatment with a PPI|clinical significance of the acid rebound phenomenon after withdrawal of treatment with a ppi
5274639|NCT00525993|sports|sports
5274640|NCT00525993|ankle|ankle
5274641|NCT00525993|sprain|sprain
5274642|NCT00525993|etoricoxib|etoricoxib
5274643|NCT00525993|antiinflammatory|antiinflammatory
5274644|NCT00525993|treatment outcome|treatment outcome
5274645|NCT00525980|Breast Cancer|breast cancer
5274646|NCT00525980|Cancer Risk|cancer risk
5274647|NCT00525980|CD-ROM|cd-rom
5274648|NCT00525980|Focus Group|focus group
5274649|NCT00525980|Cancer Genetics|cancer genetics
5274650|NCT00525967|Cancer Pain|cancer pain
5274651|NCT00525967|Methadone|methadone
5274652|NCT00525967|Morphine|morphine
5274653|NCT00525967|Acetaminophen|acetaminophen
5274654|NCT00525967|Palliative Care|palliative care
5274655|NCT00525954|Coronary|coronary
5274656|NCT00525954|Artery|artery
5274657|NCT00525954|Artheroschlerosis|artheroschlerosis
5274658|NCT00525954|Phospholipase|phospholipase
5274659|NCT00525954|CAD|cad
5274660|NCT00525954|Coronary Artery Disease (CAD)|coronary artery disease (cad)
5274661|NCT00525928|craving|craving
5274662|NCT00525928|smoking|smoking
5274663|NCT00525928|depression|depression
5274664|NCT00525915|Esophageal Cancer|esophageal cancer
5274665|NCT00525915|Gastroesophageal Cancer|gastroesophageal cancer
5274666|NCT00525915|Gastroesophageal Junction|gastroesophageal junction
5274667|NCT00525915|Radiation Therapy|radiation therapy
5274668|NCT00525915|5-Fluorouracil|5-fluorouracil
5274669|NCT00525915|5-FU|5-fu
5274670|NCT00525915|Adrucil|adrucil
5274671|NCT00525915|Efudex|efudex
5274672|NCT00525915|Oxaliplatin|oxaliplatin
5274673|NCT00525889|diabetes|diabetes
5274674|NCT00525889|juvenile diabetes|juvenile diabetes
5274675|NCT00525889|type 1 diabetes|type 1 diabetes
5274676|NCT00525889|diabetes mellitus|diabetes mellitus
5274677|NCT00525889|recent onset|recent onset
5274678|NCT00525889|new onset|new onset
5274679|NCT00525876|Mantle Cell Lymphoma|mantle cell lymphoma
5274680|NCT00525876|Lymphoma|lymphoma
5274681|NCT00525876|Allogeneic Stem Cell Transplant|allogeneic stem cell transplant
5274682|NCT00525876|Rituximab|rituximab
5274683|NCT00525876|Cyclophosphamide|cyclophosphamide
5274684|NCT00525876|Neosar|neosar
5274685|NCT00525876|Cytoxan|cytoxan
5274686|NCT00525876|Fludarabine|fludarabine
5274687|NCT00525876|Fludara|fludara
5274688|NCT00525876|Fludarabine phosphate|fludarabine phosphate
5274689|NCT00525876|Rituxan|rituxan
5274690|NCT00525876|Alemtuzumab|alemtuzumab
5274691|NCT00525876|CAMPATH-1H|campath-1h
5274692|NCT00525876|Campath|campath
5274693|NCT00525876|Total Body Irradiation|total body irradiation
5274694|NCT00525876|TBI|tbi
5274695|NCT00525863|schizophrenia|schizophrenia
5274696|NCT00525863|oxygen therapy|oxygen therapy
5274697|NCT00525850|cardiovascular disease|cardiovascular disease
5274698|NCT00525850|weight loss|weight loss
5274699|NCT00525837|varenicline|varenicline
5274700|NCT00525837|depression|depression
5274701|NCT00525837|anhedonia|anhedonia
5274702|NCT00525837|smoking|smoking
5274703|NCT00525824|Hypercholesterolaemia|hypercholesterolaemia
5274704|NCT00525824|Coronary Heart Disease (CHD)|coronary heart disease (chd)
5274705|NCT00525824|Atherosclerosis|atherosclerosis
5274706|NCT00525798|Osteoporosis, oral salmon calcitonin, treatment, efficacy, tolerability|osteoporosis, oral salmon calcitonin, treatment, efficacy, tolerability
5274707|NCT00525785|Stomach Cancer|stomach cancer
5274708|NCT00525785|Gastric Cancer|gastric cancer
5274709|NCT00525785|Adenocarcinoma of the Stomach|adenocarcinoma of the stomach
5274710|NCT00525785|Gastroesophageal Junction|gastroesophageal junction
5274711|NCT00525785|Esophageal|esophageal
5274712|NCT00525785|Gastric|gastric
5274713|NCT00525785|5-Fluorouracil|5-fluorouracil
5274714|NCT00525785|5-FU|5-fu
5274715|NCT00525785|Adrucil|adrucil
5274716|NCT00525785|Efudex|efudex
5274717|NCT00525785|Folinic Acid|folinic acid
5274718|NCT00525785|Oxaliplatin|oxaliplatin
5274719|NCT00525785|Eloxatin|eloxatin
5274720|NCT00525785|Chemoradiotherapy|chemoradiotherapy
5274721|NCT00525785|Radiation|radiation
5274722|NCT00525785|Radiotherapy|radiotherapy
5274723|NCT00525785|XRT|xrt
5274724|NCT00525772|asthma|asthma
5274725|NCT00525772|exercise induced bronchoconstriction|exercise induced bronchoconstriction
5274726|NCT00525772|sputum eosinophils|sputum eosinophils
5274727|NCT00525759|Breast cancer|breast cancer
5274728|NCT00525759|Zoledronic acid|zoledronic acid
5274729|NCT00525759|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
5274730|NCT00525759|Synergy|synergy
5274731|NCT00525759|Apoptosis|apoptosis
5274732|NCT00525746|Acute Myeloid Leukemia|acute myeloid leukemia
5274733|NCT00525746|Myelodysplastic Syndrome|myelodysplastic syndrome
5274734|NCT00525746|Leukemia|leukemia
5274735|NCT00525746|MDS|mds
5274736|NCT00525746|AML|aml
5274737|NCT00525746|Malignancy|malignancy
5274738|NCT00525746|Molecular Epidemiology|molecular epidemiology
5274739|NCT00525746|Epidemiologic markers|epidemiologic markers
5274740|NCT00525746|Clinical markers|clinical markers
5274741|NCT00525746|Constitutional genetic markers|constitutional genetic markers
5274742|NCT00525746|Case-comparison study|case-comparison study
5274743|NCT00525733|HIV-1|hiv-1
5274744|NCT00525733|Acute Infection|acute infection
5274745|NCT00525733|Treatment Naive|treatment naive
5274746|NCT00525720|Prostate Cancer|prostate cancer
5274747|NCT00525720|Prostatic Carcinoma|prostatic carcinoma
5274748|NCT00525720|Intermediate prostate cancer|intermediate prostate cancer
5274749|NCT00525720|Transperineal Interstitial Permanent Brachytherapy|transperineal interstitial permanent brachytherapy
5274750|NCT00525720|Brachytherapy|brachytherapy
5274751|NCT00525720|Prostate brachytherapy|prostate brachytherapy
5274752|NCT00525720|Prostate implant|prostate implant
5274753|NCT00525720|Prostate|prostate
5274754|NCT00525720|Questionnaire|questionnaire
5274755|NCT00525720|Survey|survey
5274756|NCT00525707|acute heart failure|acute heart failure
5274757|NCT00525707|Actelion|actelion
5274758|NCT00525707|tezosentan|tezosentan
5274759|NCT00525707|acute decompensation of chronic heart failure|acute decompensation of chronic heart failure
5274760|NCT00525707|New onset of heart failure|new onset of heart failure
5274761|NCT00525681|Obese|obese
5274762|NCT00525681|Calcineurine inhibitor|calcineurine inhibitor
5274763|NCT00525681|Pharmacokinetics|pharmacokinetics
5274764|NCT00525681|Interaction|interaction
5274765|NCT00525668|multiple sclerosis|multiple sclerosis
5274766|NCT00525668|inflammation|inflammation
5274767|NCT00525668|neurodegeneration|neurodegeneration
5274768|NCT00525668|neuroprotection|neuroprotection
5274769|NCT00525655|Familial Adenomatous Polyposis|familial adenomatous polyposis
5274770|NCT00525655|Colorectal Cancer|colorectal cancer
5274771|NCT00525655|Multimedia Intervention|multimedia intervention
5274772|NCT00525655|Questionnaire|questionnaire
5274773|NCT00525655|Survey|survey
5274774|NCT00525655|FAP|fap
5274775|NCT00525642|Breast-adjuvant|breast-adjuvant
5274776|NCT00525642|Breast-chemotherapy|breast-chemotherapy
5274777|NCT00525642|Combination chemotherapy regimens|combination chemotherapy regimens
5274778|NCT00525616|bullous pemphigoid|bullous pemphigoid
5274779|NCT00525616|mabthera|mabthera
5274780|NCT00525603|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
5274781|NCT00525603|CML|cml
5274782|NCT00525603|Leukemia|leukemia
5274783|NCT00525603|Cyclophosphamide|cyclophosphamide
5274784|NCT00525603|Fludarabine|fludarabine
5274785|NCT00525603|Alemtuzumab|alemtuzumab
5274786|NCT00525603|Rituximab|rituximab
5274787|NCT00525603|CFAR|cfar
5274788|NCT00525590|Gliadel|gliadel
5274789|NCT00525577|Type 2 diabetes, glycemic control|type 2 diabetes, glycemic control
5274790|NCT00525564|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
5274791|NCT00525564|Exercise|exercise
5274792|NCT00525564|Endurance shuttle walking test|endurance shuttle walking test
5274793|NCT00525564|Bronchodilation|bronchodilation
5274794|NCT00525564|Salmeterol|salmeterol
5274795|NCT00525525|Glioblastoma|glioblastoma
5274796|NCT00525525|Gliosarcoma|gliosarcoma
5274797|NCT00525525|Bevacizumab|bevacizumab
5274798|NCT00525525|Avastin|avastin
5274799|NCT00525525|Erlotinib|erlotinib
5274800|NCT00525525|Tarceva|tarceva
5274801|NCT00525525|Temozolomide|temozolomide
5274802|NCT00525525|Temodar|temodar
5274803|NCT00525499|acne|acne
5274804|NCT00525486|Nifedipine|nifedipine
5274805|NCT00525486|Tocolysis|tocolysis
5274806|NCT00525486|Maintenance|maintenance
5274807|NCT00525486|Preterm delivery|preterm delivery
5274808|NCT00525486|extended release nifedipine|extended release nifedipine
5274809|NCT00525486|PTL|ptl
5274810|NCT00525460|fertility|fertility
5274811|NCT00525460|stage I ovarian cancer|stage i ovarian cancer
5274812|NCT00525460|stage II ovarian cancer|stage ii ovarian cancer
5274813|NCT00525460|fertility sparing|fertility sparing
5274814|NCT00525447|Antigens, CD40|antigens, cd40
5274815|NCT00525447|Antibodies, Monoclonal|antibodies, monoclonal
5274816|NCT00525447|Combined Modality Therapy|combined modality therapy
5274817|NCT00525447|Multiple Myeloma|multiple myeloma
5274818|NCT00525447|Blood Coagulation Disorders|blood coagulation disorders
5274819|NCT00525447|Hematologic Diseases|hematologic diseases
5275020|NCT00524745|Gardasil|gardasil
5274820|NCT00525447|Hemorrhagic Disorders|hemorrhagic disorders
5274821|NCT00525447|Hemostatic Disorders|hemostatic disorders
5274822|NCT00525447|Immunoproliferative Disorders|immunoproliferative disorders
5274823|NCT00525447|Lymphoproliferative Disorders|lymphoproliferative disorders
5274824|NCT00525447|Paraproteinemias|paraproteinemias
5274825|NCT00525447|Vascular Diseases|vascular diseases
5274826|NCT00525447|Antibody-Dependent Cell Cytotoxicity|antibody-dependent cell cytotoxicity
5274827|NCT00525434|Laser bonding soft tissue albumin|laser bonding soft tissue albumin
5274828|NCT00525421|curcuminoids|curcuminoids
5274829|NCT00525421|oral lichen planus|oral lichen planus
5274830|NCT00525421|c reactive protein|c reactive protein
5274831|NCT00525421|interleukin 6|interleukin 6
5274832|NCT00525408|HRPC|hrpc
5274833|NCT00525408|Metastatic Hormone Refractory Prostate Cancer|metastatic hormone refractory prostate cancer
5274834|NCT00525408|Docetaxel|docetaxel
5274835|NCT00525408|Mycobacterium w|mycobacterium w
5274836|NCT00525395|Phototherapy|phototherapy
5274837|NCT00525395|Vitiligo scoring system|vitiligo scoring system
5274838|NCT00525382|Levocetirizine dihydrochloride|levocetirizine dihydrochloride
5274839|NCT00525382|Xyzal tablets|xyzal tablets
5274840|NCT00525356|Aorta|aorta
5274841|NCT00525356|Dissection|dissection
5274842|NCT00525356|Thoracic|thoracic
5274843|NCT00525343|Avonex pivotal trial|avonex pivotal trial
5274844|NCT00525343|Avonex|avonex
5274845|NCT00525343|Avonex long term follow-up|avonex long term follow-up
5274846|NCT00525343|Avonex outcomes|avonex outcomes
5274847|NCT00525317|Pregnancy|pregnancy
5274848|NCT00525317|Magnesium|magnesium
5274849|NCT00525317|Leg Pain|leg pain
5274850|NCT00525304|medical co-morbidity|medical co-morbidity
5274851|NCT00525304|diabetes|diabetes
5274852|NCT00525304|heart disease|heart disease
5274853|NCT00525304|respiratory illness|respiratory illness
5274854|NCT00525291|Exercise Therapy|exercise therapy
5274855|NCT00525291|Biofeedback (Psychology)|biofeedback (psychology)
5274856|NCT00525291|Adult|adult
5274857|NCT00525291|Fecal Incontinence/*therapy|fecal incontinence/*therapy
5274858|NCT00525291|EMG - Biofeedback|emg - biofeedback
5274859|NCT00525291|EMG - Triggered Stimulation|emg - triggered stimulation
5274860|NCT00525291|Augmented biofeedback|augmented biofeedback
5274861|NCT00525278|Levocetirizine dihydrochloride|levocetirizine dihydrochloride
5274862|NCT00525278|Xyzal tablets|xyzal tablets
5274863|NCT00525265|Vasopressin antagonist|vasopressin antagonist
5274864|NCT00525265|Cardiac Edema|cardiac edema
5274865|NCT00525265|Diuretics|diuretics
5274866|NCT00525252|Liver cirrhosis|liver cirrhosis
5274867|NCT00525252|Alcoholism|alcoholism
5274868|NCT00525252|Craving|craving
5274869|NCT00525239|Lipids|lipids
5274870|NCT00525239|lipoproteins|lipoproteins
5274871|NCT00525239|VLDL|vldl
5274872|NCT00525239|triglycerides|triglycerides
5274873|NCT00525239|apo B100|apo b100
5274874|NCT00525239|HDL|hdl
5274875|NCT00525239|apo A1|apo a1
5274876|NCT00525239|endothelial dysfunction|endothelial dysfunction
5274877|NCT00525239|insulin secretion|insulin secretion
5274878|NCT00525239|hyperglycemic clamp|hyperglycemic clamp
5274879|NCT00525239|HIV-seronegative Volunteers|hiv-seronegative volunteers
5274880|NCT00525239|HIV-infected subjects starting an efavirenz-based regimen|hiv-infected subjects starting an efavirenz-based regimen
5274881|NCT00525239|Treatment Experienced|treatment experienced
5274882|NCT00525226|Psychiatry|psychiatry
5274883|NCT00525226|Psychology|psychology
5274884|NCT00525226|Pregnancy|pregnancy
5274885|NCT00525226|Stress|stress
5274886|NCT00525226|Anxiety|anxiety
5274887|NCT00525213|Rheumatoid Arthritis|rheumatoid arthritis
5274888|NCT00525200|predictive marker|predictive marker
5274889|NCT00525200|personalized therapy|personalized therapy
5274890|NCT00525200|response assessment|response assessment
5274891|NCT00525200|p53 genotype|p53 genotype
5274892|NCT00525187|onychomycosis|onychomycosis
5274893|NCT00525187|diabetic neuropathic patients|diabetic neuropathic patients
5274894|NCT00525187|reliability of the diagnostic of onychomycosis|reliability of the diagnostic of onychomycosis
5274895|NCT00525174|Amblyopia|amblyopia
5274896|NCT00525174|Patching|patching
5274897|NCT00525174|Bangerter filters|bangerter filters
5274898|NCT00525161|breast cancer|breast cancer
5274899|NCT00525161|Sorafenib|sorafenib
5274900|NCT00525161|Nexavar|nexavar
5274901|NCT00525161|Endocrine Therapy|endocrine therapy
5274902|NCT00525122|hyperthyroidism|hyperthyroidism
5274903|NCT00525122|radioactive iodine|radioactive iodine
5274904|NCT00525122|antithyroid drugs|antithyroid drugs
5274905|NCT00525122|Hyperthyroidism, treatment with radioactive iodine without antithyroid drugs|hyperthyroidism, treatment with radioactive iodine without antithyroid drugs
5274906|NCT00525109|Cholesterol|cholesterol
5274907|NCT00525109|Hyperlipidemia|hyperlipidemia
5274908|NCT00525109|Gene array|gene array
5274909|NCT00525083|hyperlipidemia|hyperlipidemia
5274910|NCT00525083|HDL-C|hdl-c
5274911|NCT00525083|low density lipoprotein|low density lipoprotein
5274912|NCT00525057|Bone Cancer|bone cancer
5274913|NCT00525057|Orthopaedic Oncology|orthopaedic oncology
5274914|NCT00525057|Orthopaedics|orthopaedics
5274915|NCT00525057|Myeloma|myeloma
5274916|NCT00525057|Lymphoma|lymphoma
5274917|NCT00525057|Deep Venous Thrombosis|deep venous thrombosis
5274918|NCT00525057|DVT Prophylaxis|dvt prophylaxis
5274919|NCT00525057|Thromboembolic disease|thromboembolic disease
5274920|NCT00525057|Blood clots|blood clots
5274921|NCT00525057|Dalteparin|dalteparin
5274922|NCT00525057|Fragmin|fragmin
5274923|NCT00525057|Surgery|surgery
5274924|NCT00525057|Bone Tumor|bone tumor
5274925|NCT00525057|Tumor of soft tissue|tumor of soft tissue
5274926|NCT00525057|Lower extremity|lower extremity
5274928|NCT00525057|TED hose|ted hose
5274929|NCT00525057|Mechanical compression stocking|mechanical compression stocking
5274930|NCT00525031|Melanoma|melanoma
5274931|NCT00525031|Temozolomide|temozolomide
5274932|NCT00525031|Temodar|temodar
5274933|NCT00525031|Pegylated Interferon Alpha-2b|pegylated interferon alpha-2b
5274934|NCT00525031|PEG-Intron|peg-intron
5274935|NCT00525031|PGI|pgi
5274936|NCT00525031|Resectable metastatic melanoma|resectable metastatic melanoma
5274937|NCT00525031|Surgery|surgery
5274938|NCT00525018|Pain|pain
5274939|NCT00525018|Functional neuroimaging|functional neuroimaging
5274940|NCT00525018|Neuropathy|neuropathy
5274941|NCT00525018|Thermal sensation|thermal sensation
5274942|NCT00525005|Stomach Neoplasm|stomach neoplasm
5274943|NCT00525005|Docetaxel|docetaxel
5274944|NCT00525005|Oxaliplatin|oxaliplatin
5274945|NCT00525005|S-1|s-1
5274946|NCT00524992|Focal Segmental Glomerulosclerosis|focal segmental glomerulosclerosis
5274947|NCT00524992|Collapsing Glomerulopathy|collapsing glomerulopathy
5274948|NCT00524992|Anti-Retroviral Toxicity|anti-retroviral toxicity
5274949|NCT00524992|Lipodystrophy|lipodystrophy
5274950|NCT00524992|Metabolic Syndrome|metabolic syndrome
5274951|NCT00524992|Tubular Injury|tubular injury
5274952|NCT00524992|Renal Biopsy|renal biopsy
5274953|NCT00524992|Proteinuria|proteinuria
5274954|NCT00524992|Tenofovir Toxicity|tenofovir toxicity
5274955|NCT00524992|HAART Toxicity|haart toxicity
5274956|NCT00524992|HIV Positive|hiv positive
5274957|NCT00524992|HIV-Associated Focal Segmental Glomerulosclerosis|hiv-associated focal segmental glomerulosclerosis
5274958|NCT00524953|allogeneic bone marrow transplantation|allogeneic bone marrow transplantation
5274959|NCT00524953|non-T-cell depleted|non-t-cell depleted
5274960|NCT00524953|UV-c|uv-c
5274961|NCT00524953|GVHD|gvhd
5274962|NCT00524940|Influenza|influenza
5274963|NCT00524940|Orthomyxoviruses|orthomyxoviruses
5274964|NCT00524940|Inactivated Split-virion influenza vaccine|inactivated split-virion influenza vaccine
5274965|NCT00524927|Incident Pain|incident pain
5274966|NCT00524927|Bone Marrow Biopsy|bone marrow biopsy
5274967|NCT00524914|Parkinson's disease|parkinson's disease
5274968|NCT00524914|Pain|pain
5274969|NCT00524914|Nociceptive threshold|nociceptive threshold
5274970|NCT00524914|Functional imaging|functional imaging
5274971|NCT00524914|Cerebral activity|cerebral activity
5274972|NCT00524914|Dopamine agonist.|dopamine agonist.
5274973|NCT00524901|Apoptosis|apoptosis
5274974|NCT00524901|CABG|cabg
5274975|NCT00524901|Coronary Artery Disease|coronary artery disease
5274976|NCT00524901|Three Vessel Disease|three vessel disease
5274977|NCT00524901|Erythropoietin|erythropoietin
5274978|NCT00524901|EPO-receptor signaling|epo-receptor signaling
5274979|NCT00524888|Hand|hand
5274980|NCT00524888|Laceration|laceration
5274981|NCT00524888|bioadhesive|bioadhesive
5274982|NCT00524888|ER|er
5274983|NCT00524888|Hand laceration distal to the volar wrist crease|hand laceration distal to the volar wrist crease
5274984|NCT00524875|Proliferative diabetic retinopathy|proliferative diabetic retinopathy
5274985|NCT00524875|Bevacizumab|bevacizumab
5274986|NCT00524875|Early post-vitrectomy vitreous hemorrhage|early post-vitrectomy vitreous hemorrhage
5274987|NCT00524862|Implantable Cardioverter Defibrillator|implantable cardioverter defibrillator
5274988|NCT00524862|Ejection Fraction|ejection fraction
5274989|NCT00524862|QRS duration|qrs duration
5274990|NCT00524849|Breast cancer|breast cancer
5274991|NCT00524849|Bone metastasis|bone metastasis
5274992|NCT00524849|Circulating VEGF|circulating vegf
5274993|NCT00524849|Zoledronic acid|zoledronic acid
5274994|NCT00524849|Angiogenesis|angiogenesis
5274995|NCT00524836|levocetirizine dihydrochloride|levocetirizine dihydrochloride
5274996|NCT00524836|Xyzal tablets|xyzal tablets
5274997|NCT00524823|Prostate Cancer|prostate cancer
5274998|NCT00524823|Hyperplasia - BPH|hyperplasia - bph
5274999|NCT00524823|FACS|facs
5275000|NCT00524823|Prostate Cancer, Hyperplasia - BPH, Malignancy|prostate cancer, hyperplasia - bph, malignancy
5275001|NCT00524797|Myelosuppression,|myelosuppression,
5275002|NCT00524797|chemotherapeutic agents,|chemotherapeutic agents,
5275003|NCT00524797|leucopenia,|leucopenia,
5275004|NCT00524797|thrombocytopenia,|thrombocytopenia,
5275005|NCT00524797|Profonycia|profonycia
5275006|NCT00524784|GVHD|gvhd
5275007|NCT00524784|HSCT|hsct
5275008|NCT00524784|BMT|bmt
5275009|NCT00524784|APOPTOTIC CELLS|apoptotic cells
5275010|NCT00524771|Contraception|contraception
5275011|NCT00524771|Contraceptive Vaginal Ring|contraceptive vaginal ring
5275012|NCT00524758|ologen|ologen
5275013|NCT00524758|oculusgen|oculusgen
5275014|NCT00524758|collagen matrix|collagen matrix
5275015|NCT00524758|trabeculectomy|trabeculectomy
5275016|NCT00524758|filtering surgery|filtering surgery
5275017|NCT00524758|mitomycin-C|mitomycin-c
5275018|NCT00524758|MMC|mmc
5275019|NCT00524758|Aeon Astron|aeon astron
5275021|NCT00524745|Human Papillomavirus|human papillomavirus
5275022|NCT00524745|HPV vaccine|hpv vaccine
5275023|NCT00524745|Cervical cancer|cervical cancer
5275024|NCT00524732|Pertussis|pertussis
5275025|NCT00524732|Tetanus|tetanus
5275026|NCT00524732|Diphtheria|diphtheria
5275027|NCT00524706|S-1|s-1
5275028|NCT00524706|oral fluoropyrimidine|oral fluoropyrimidine
5275029|NCT00524706|tegafur|tegafur
5275030|NCT00524706|Gimeracil|gimeracil
5275031|NCT00524706|Oteracil Potassium|oteracil potassium
5275032|NCT00524706|Leucovorin|leucovorin
5275033|NCT00524706|Calcium Folinate|calcium folinate
5275034|NCT00524706|Oxaliplatin|oxaliplatin
5275035|NCT00524706|L-OHP|l-ohp
5275036|NCT00524706|colorectal cancer|colorectal cancer
5275037|NCT00524693|Bronchiolitis|bronchiolitis
5275038|NCT00524693|controlled clinical trial|controlled clinical trial
5275039|NCT00524693|pediatrics|pediatrics
5275040|NCT00524693|Infants|infants
5275041|NCT00524693|montelukast|montelukast
5275042|NCT00524693|Respiratory syncytial virus|respiratory syncytial virus
5275043|NCT00524680|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5275044|NCT00524680|recurrent prostate cancer|recurrent prostate cancer
5275045|NCT00524680|stage I prostate cancer|stage i prostate cancer
5275046|NCT00524680|stage II prostate cancer|stage ii prostate cancer
5275047|NCT00524680|stage III prostate cancer|stage iii prostate cancer
5275048|NCT00524680|stage IV prostate cancer|stage iv prostate cancer
5275049|NCT00524667|Active CLL|active cll
5275050|NCT00524654|To determine the effects of cervical spine manipulation on postural control.|to determine the effects of cervical spine manipulation on postural control.
5275051|NCT00524641|Asthma|asthma
5275052|NCT00524641|Symbicort|symbicort
5275053|NCT00524641|NIS|nis
5275054|NCT00524615|resistant hypertension treatment|resistant hypertension treatment
5275055|NCT00524615|spironolactone|spironolactone
5275056|NCT00524615|aldosterone antagonists|aldosterone antagonists
5275057|NCT00524615|resistant arterial hypertension|resistant arterial hypertension
5275058|NCT00524615|refractory arterial hypertension|refractory arterial hypertension
5275059|NCT00524602|Stereotaxis|stereotaxis
5275060|NCT00524602|Arrythmia|arrythmia
5275061|NCT00524602|Catheter ablation|catheter ablation
5275062|NCT00524602|Heart|heart
5275063|NCT00524589|recurrent prostate cancer|recurrent prostate cancer
5275064|NCT00524576|Hepatitis B|hepatitis b
5275065|NCT00524576|Persistence|persistence
5275066|NCT00524576|Challenge dose|challenge dose
5275067|NCT00524563|Acinetobacter|acinetobacter
5275068|NCT00524563|bloodstream infection|bloodstream infection
5275069|NCT00524563|Isolate|isolate
5275070|NCT00524550|Moderate alcohol consumption|moderate alcohol consumption
5275071|NCT00524550|insulin secretion|insulin secretion
5275072|NCT00524550|insulin sensitivity|insulin sensitivity
5275073|NCT00524550|Beta-cell function|beta-cell function
5275074|NCT00524550|Adiponectin|adiponectin
5275075|NCT00524550|Appetite|appetite
5275076|NCT00524550|Satiety|satiety
5275077|NCT00524550|Alcohol-induced gene expression|alcohol-induced gene expression
5275078|NCT00524550|Endocannabinoids|endocannabinoids
5275079|NCT00524550|Glucose metabolism|glucose metabolism
5275080|NCT00524550|Lipid metabolism|lipid metabolism
5275081|NCT00524550|Ratio HMW/total adiponectin|ratio hmw/total adiponectin
5275082|NCT00524550|Appetite regulation|appetite regulation
5275083|NCT00524550|Alcohol-induced adiponectin increase|alcohol-induced adiponectin increase
5275084|NCT00524537|Crohn's Disease|crohn's disease
5275085|NCT00524524|solid tumors|solid tumors
5275086|NCT00524524|biopsy|biopsy
5275087|NCT00524511|cesarean|cesarean
5275088|NCT00524511|wound|wound
5275089|NCT00524511|Dermabond|dermabond
5275090|NCT00524511|superglue|superglue
5275091|NCT00524511|staples|staples
5275092|NCT00524511|wound complications|wound complications
5275093|NCT00524498|OPC-18|opc-18
5275094|NCT00524498|Interferon-alpha|interferon-alpha
5275095|NCT00524498|Fluorouracil|fluorouracil
5275096|NCT00524485|actinic keratosis|actinic keratosis
5275097|NCT00524472|Hyperinsulinemic glucose control|hyperinsulinemic glucose control
5275098|NCT00524472|cardiac surgery|cardiac surgery
5275099|NCT00524472|Outcome|outcome
5275100|NCT00524459|stage IIIA breast cancer|stage iiia breast cancer
5275101|NCT00524459|stage IIIB breast cancer|stage iiib breast cancer
5275102|NCT00524446|Infant|infant
5275103|NCT00524446|Sub-Saharan Africa|sub-saharan africa
5275104|NCT00524446|Complementary feeding|complementary feeding
5275105|NCT00524446|Fortified spread|fortified spread
5275106|NCT00524446|Lipid-based nutrient supplement|lipid-based nutrient supplement
5275107|NCT00524446|Malnutrition|malnutrition
5275108|NCT00524446|Stunting|stunting
5275109|NCT00524446|Growth|growth
5275110|NCT00524446|Morbidity|morbidity
5275111|NCT00524446|Development|development
5275112|NCT00524446|Haemoglobin|haemoglobin
5275113|NCT00524433|acute heart failure|acute heart failure
5275114|NCT00524433|acute decompensation of chronic heart failure|acute decompensation of chronic heart failure
5275115|NCT00524433|new onset of heart failure|new onset of heart failure
5275116|NCT00524433|tezosentan|tezosentan
5275117|NCT00524433|Actelion|actelion
5275118|NCT00524420|Pain|pain
5275119|NCT00524420|Fatigue|fatigue
5275120|NCT00524420|Chronic Fatigue Syndrome|chronic fatigue syndrome
5275121|NCT00524420|Chronic Fatigue-Fibromyalgia Syndrome|chronic fatigue-fibromyalgia syndrome
5275122|NCT00524420|Depression|depression
5275123|NCT00524420|Major Depressive Disorder|major depressive disorder
5275124|NCT00524407|Anemia|anemia
5275125|NCT00524407|hemoglobin|hemoglobin
5275126|NCT00524407|chemotherapy|chemotherapy
5275127|NCT00524407|hematologic response|hematologic response
5275128|NCT00524407|subcutaneous injection|subcutaneous injection
5275129|NCT00524407|Epoetin alfa|epoetin alfa
5275130|NCT00524407|FACT-An|fact-an
5275131|NCT00524407|LASA|lasa
5275132|NCT00524407|PROCRIT|procrit
5275133|NCT00524394|VLBW|vlbw
5275134|NCT00524394|sepsis|sepsis
5275135|NCT00524394|diagnosis|diagnosis
5275136|NCT00524394|suspected sepsis|suspected sepsis
5275137|NCT00524368|Human immunodeficiency virus - type 1|human immunodeficiency virus - type 1
5275138|NCT00524368|HIV-1 Infection|hiv-1 infection
5275139|NCT00524368|TMC-114|tmc-114
5275140|NCT00524368|Darunavir|darunavir
5275141|NCT00524368|Ritonavir|ritonavir
5275142|NCT00524355|GERD|gerd
5275143|NCT00524355|GIS|gis
5275144|NCT00524355|heartburn|heartburn
5275145|NCT00524355|NIS|nis
5275146|NCT00524355|PPI|ppi
5275147|NCT00524342|IL-11|il-11
5275148|NCT00524342|von Willebrand disease|von willebrand disease
5275149|NCT00524342|von Willebrand factor|von willebrand factor
5275150|NCT00524342|VWFmRNA|vwfmrna
5275151|NCT00524342|menorrhagia|menorrhagia
5275152|NCT00524329|upper GI-symptoms|upper gi-symptoms
5275153|NCT00524329|heartburn|heartburn
5275154|NCT00524329|NSAID|nsaid
5275155|NCT00524329|risk|risk
5275156|NCT00524329|PPI|ppi
5275157|NCT00524329|Bloating|bloating
5275158|NCT00524329|Regurgitation|regurgitation
5275159|NCT00524316|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
5275160|NCT00524316|advanced adult primary liver cancer|advanced adult primary liver cancer
5275161|NCT00524316|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
5275162|NCT00524316|recurrent adult primary liver cancer|recurrent adult primary liver cancer
5275163|NCT00524303|ErbB2 Overexpressing|erbb2 overexpressing
5275164|NCT00524303|ErbB2 Positive|erbb2 positive
5275165|NCT00524303|Lapatinib|lapatinib
5275166|NCT00524303|Invasive Breast Cancer|invasive breast cancer
5275167|NCT00524290|Acinetobacter|acinetobacter
5275168|NCT00524290|infection|infection
5275169|NCT00524290|isolate|isolate
5275170|NCT00524277|stage I breast cancer|stage i breast cancer
5275171|NCT00524277|stage II breast cancer|stage ii breast cancer
5275172|NCT00524277|stage IIIA breast cancer|stage iiia breast cancer
5275173|NCT00524277|stage IIIB breast cancer|stage iiib breast cancer
5275174|NCT00524277|stage IIIC breast cancer|stage iiic breast cancer
5275175|NCT00524277|male breast cancer|male breast cancer
5275176|NCT00524251|Patients with reflux complaints|patients with reflux complaints
5275177|NCT00524251|GERD|gerd
5275178|NCT00524251|quality of life|quality of life
5275179|NCT00524251|lifestyle adjustments|lifestyle adjustments
5275180|NCT00524238|hypothyroidism|hypothyroidism
5275181|NCT00524238|glucose turnover|glucose turnover
5275182|NCT00524238|clamp|clamp
5275183|NCT00524238|insulin resistance|insulin resistance
5275184|NCT00524238|lipid turnover|lipid turnover
5275185|NCT00524238|amino acid turnover|amino acid turnover
5275186|NCT00524225|IL-11|il-11
5275187|NCT00524225|von Willebrand disease|von willebrand disease
5275188|NCT00524225|von Willebrand factor|von willebrand factor
5275189|NCT00524225|VWFmRNA|vwfmrna
5275190|NCT00524225|surgery|surgery
5275191|NCT00524199|homocysteine|homocysteine
5275192|NCT00524199|hemodialysis|hemodialysis
5275193|NCT00524199|mesna|mesna
5275194|NCT00524186|stage III gastric cancer|stage iii gastric cancer
5275195|NCT00524186|stage IV gastric cancer|stage iv gastric cancer
5275196|NCT00524186|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
5275197|NCT00524186|stage IV esophageal cancer|stage iv esophageal cancer
5275198|NCT00524186|recurrent gastric cancer|recurrent gastric cancer
5275199|NCT00524186|recurrent esophageal cancer|recurrent esophageal cancer
5275200|NCT00524186|adenocarcinoma of the stomach|adenocarcinoma of the stomach
5275201|NCT00524173|Emtricitabine|emtricitabine
5275202|NCT00524173|Tenofovir|tenofovir
5275203|NCT00524173|Antiviral Therapy|antiviral therapy
5275204|NCT00524173|Hepatitis B|hepatitis b
5275205|NCT00524173|HBV|hbv
5275206|NCT00524160|Fentanyl|fentanyl
5275207|NCT00524160|opioid analgesics|opioid analgesics
5275208|NCT00524160|arthritis|arthritis
5275209|NCT00524160|osteoarthritis|osteoarthritis
5275210|NCT00524160|rheumatoid arthritis|rheumatoid arthritis
5275211|NCT00524160|transdermal administration|transdermal administration
5275212|NCT00524147|loculated pleural effusion|loculated pleural effusion
5275213|NCT00524147|pigtail drainage|pigtail drainage
5275214|NCT00524147|pleural effusion|pleural effusion
5275215|NCT00524147|pleural thickening|pleural thickening
5275216|NCT00524147|tuberculosis|tuberculosis
5275217|NCT00524134|Epilepsy|epilepsy
5275218|NCT00524134|Seizure|seizure
5275219|NCT00524134|p-glycoprotein|p-glycoprotein
5275220|NCT00524121|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
5275221|NCT00524121|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
5275222|NCT00524121|stage I esophageal cancer|stage i esophageal cancer
5275223|NCT00524121|stage II esophageal cancer|stage ii esophageal cancer
5275224|NCT00524121|stage III esophageal cancer|stage iii esophageal cancer
5275225|NCT00524121|stage IV esophageal cancer|stage iv esophageal cancer
5275226|NCT00524108|shunt|shunt
5275227|NCT00524108|internal ventriculoperitoneal|internal ventriculoperitoneal
5275228|NCT00524095|prophylaxis|prophylaxis
5275229|NCT00524095|Antibiotic|antibiotic
5275230|NCT00524095|inhaled steroids|inhaled steroids
5275231|NCT00524095|bronchiectasis|bronchiectasis
5275232|NCT00524095|prevalence|prevalence
5275233|NCT00524095|chronic bronchitis|chronic bronchitis
5275234|NCT00524069|stage I pancreatic cancer|stage i pancreatic cancer
5275235|NCT00524069|stage II pancreatic cancer|stage ii pancreatic cancer
5275236|NCT00524069|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
5275237|NCT00524056|Essential Tremor|essential tremor
5275238|NCT00524056|Tremor|tremor
5275239|NCT00524056|Anti-epileptic drug (AED)|anti-epileptic drug (aed)
5275240|NCT00524043|Schizophrenia|schizophrenia
5275241|NCT00524030|Epilepsy|epilepsy
5275242|NCT00524030|partial seizures|partial seizures
5275243|NCT00524030|pregabalin monotherapy|pregabalin monotherapy
5275244|NCT00524030|double-blind and randomized trial|double-blind and randomized trial
5275245|NCT00524017|hypopharyngeal cancer|hypopharyngeal cancer
5275246|NCT00524017|laryngeal cancer|laryngeal cancer
5275247|NCT00524017|lip and oral cavity cancer|lip and oral cavity cancer
5275248|NCT00524017|nasopharyngeal cancer|nasopharyngeal cancer
5275249|NCT00524017|oropharyngeal cancer|oropharyngeal cancer
5275250|NCT00524017|paranasal sinus and nasal cavity cancer|paranasal sinus and nasal cavity cancer
5275251|NCT00524017|salivary gland cancer|salivary gland cancer
5275252|NCT00524017|precancerous condition|precancerous condition
5275253|NCT00524004|Passive immunization, Bovine Milk Immunoglobulin|passive immunization, bovine milk immunoglobulin
5275254|NCT00523978|Atrial Fibrillation|atrial fibrillation
5275255|NCT00523965|Kala-azar|kala-azar
5275256|NCT00523965|miltefosine|miltefosine
5275257|NCT00523965|liposomal amphotericin B|liposomal amphotericin b
5275258|NCT00523952|dermatitis, atopic|dermatitis, atopic
5275259|NCT00523952|tacrolimus|tacrolimus
5275260|NCT00523952|adult|adult
5275261|NCT00523939|Lymphoma|lymphoma
5275262|NCT00523939|Leukemia|leukemia
5275263|NCT00523939|Leukemic Meningitis|leukemic meningitis
5275264|NCT00523939|Lymphomatous Meningitis|lymphomatous meningitis
5275265|NCT00523926|Tuberculosis|tuberculosis
5275266|NCT00523913|type 2 diabetes mellitus;|type 2 diabetes mellitus;
5275267|NCT00523913|diabetes;|diabetes;
5275268|NCT00523913|rosiglitazone|rosiglitazone
5275269|NCT00523913|Avandia;|avandia;
5275270|NCT00523900|malnutrition|malnutrition
5275271|NCT00523900|underweight|underweight
5275272|NCT00523900|low body weight|low body weight
5275273|NCT00523900|BMI under 19|bmi under 19
5275274|NCT00523900|under nourished|under nourished
5275275|NCT00523900|malnourished|malnourished
5275276|NCT00523887|Radiation pain|radiation pain
5275277|NCT00523887|Duragesic|duragesic
5275278|NCT00523887|Fentanyl|fentanyl
5275279|NCT00523887|Pain|pain
5275280|NCT00523861|Glucose|glucose
5275281|NCT00523861|Insulin sensitivity|insulin sensitivity
5275282|NCT00523861|Glucose metabolism|glucose metabolism
5275283|NCT00523861|Appetite|appetite
5275284|NCT00523861|Satiety|satiety
5275285|NCT00523848|stage I multiple myeloma|stage i multiple myeloma
5275286|NCT00523848|stage II multiple myeloma|stage ii multiple myeloma
5275287|NCT00523848|stage III multiple myeloma|stage iii multiple myeloma
5275288|NCT00523822|This study seeks to determine if the correction of a sacroiliac lesion can produce a functional change in cervical spine.|this study seeks to determine if the correction of a sacroiliac lesion can produce a functional change in cervical spine.
5275289|NCT00523809|Breast Cancer|breast cancer
5275290|NCT00523809|Ovarian Cancer|ovarian cancer
5275291|NCT00523809|Stem Cell Transplantation|stem cell transplantation
5275292|NCT00523809|Bevacizumab|bevacizumab
5275293|NCT00523809|Fludarabine|fludarabine
5275294|NCT00523809|Melphalan|melphalan
5275295|NCT00523809|Avastin|avastin
5275296|NCT00523809|Thymoglobulin|thymoglobulin
5275297|NCT00523809|ATG|atg
5275298|NCT00523809|Antithymocyte Globulin|antithymocyte globulin
5275299|NCT00523809|Allogeneic Hematopoietic Stem Cell Transplantation|allogeneic hematopoietic stem cell transplantation
5275300|NCT00523809|AHSCT|ahsct
5275301|NCT00523796|dyslipidemia|dyslipidemia
5275302|NCT00523796|in practice survey|in practice survey
5275303|NCT00523796|Vietnam|vietnam
5275304|NCT00523783|Schizophrenia|schizophrenia
5275305|NCT00523783|Schizoaffective|schizoaffective
5275306|NCT00523783|quetiapine|quetiapine
5275307|NCT00523783|long-term efficacy|long-term efficacy
5275308|NCT00523783|Naturalistic|naturalistic
5275309|NCT00523783|Observational|observational
5275310|NCT00523770|Invasive Pneumococcal Diseases|invasive pneumococcal diseases
5275311|NCT00523770|Pneumonia|pneumonia
5275312|NCT00523757|heart failure|heart failure
5275313|NCT00523757|collagen|collagen
5275314|NCT00523757|diastolic function|diastolic function
5275315|NCT00523744|hypertension, valsartan, amlodipine|hypertension, valsartan, amlodipine
5275316|NCT00523731|Stem cells|stem cells
5275317|NCT00523731|Rest pain|rest pain
5275521|NCT00522964|normal|normal
5275318|NCT00523731|claudication|claudication
5275319|NCT00523731|chronic ischemic or non-healing ulcers|chronic ischemic or non-healing ulcers
5275320|NCT00523731|Angiogenesis|angiogenesis
5275321|NCT00523731|no-option cases|no-option cases
5275322|NCT00523718|obsessive-compulsive disorder|obsessive-compulsive disorder
5275323|NCT00523718|OCD|ocd
5275324|NCT00523718|glutamate|glutamate
5275325|NCT00523718|riluzole|riluzole
5275326|NCT00523718|augmentation|augmentation
5275327|NCT00523718|treatment|treatment
5275328|NCT00523705|premenstrual syndrome|premenstrual syndrome
5275329|NCT00523705|PMS|pms
5275330|NCT00523705|PMDD|pmdd
5275331|NCT00523705|treatment|treatment
5275332|NCT00523705|SSRI|ssri
5275333|NCT00523692|Early arthritis|early arthritis
5275334|NCT00523692|Rheumatoid arthritis|rheumatoid arthritis
5275335|NCT00523692|Rheumatoid factor|rheumatoid factor
5275336|NCT00523692|Anti CCP antibody|anti ccp antibody
5275337|NCT00523692|Remission|remission
5275338|NCT00523692|Anti-TNF therapy|anti-tnf therapy
5275339|NCT00523692|methotrexate|methotrexate
5275340|NCT00523679|Asthma|asthma
5275341|NCT00523679|Symbicort|symbicort
5275342|NCT00523679|SMART|smart
5275343|NCT00523679|inhaler|inhaler
5275344|NCT00523679|compliance|compliance
5275345|NCT00523679|Naturalistic|naturalistic
5275346|NCT00523679|Observational|observational
5275347|NCT00523666|Alzheimer's disease|alzheimer's disease
5275348|NCT00523666|diffusion tensor imaging|diffusion tensor imaging
5275349|NCT00523640|metastatic|metastatic
5275350|NCT00523640|renal cell|renal cell
5275351|NCT00523640|kidney|kidney
5275352|NCT00523640|neoplasm|neoplasm
5275353|NCT00523627|Energy Expenditure|energy expenditure
5275354|NCT00523627|Adaptive Thermogenesis|adaptive thermogenesis
5275355|NCT00523627|Low-protein Overfeeding|low-protein overfeeding
5275356|NCT00523627|Fasting|fasting
5275357|NCT00523627|Weight Gain|weight gain
5275358|NCT00523614|venous thromboembolism|venous thromboembolism
5275359|NCT00523601|Bipolar depression|bipolar depression
5275360|NCT00523601|quetiapine|quetiapine
5275361|NCT00523601|observational|observational
5275362|NCT00523601|Naturalistic|naturalistic
5275363|NCT00523588|Cutaneous lupus erythematosus|cutaneous lupus erythematosus
5275364|NCT00523588|Pulsed dye laser|pulsed dye laser
5275365|NCT00523575|Elderly|elderly
5275366|NCT00523575|Osteoporosis|osteoporosis
5275367|NCT00523575|hip fracture|hip fracture
5275368|NCT00523575|malnutrition|malnutrition
5275369|NCT00523575|nutritional support|nutritional support
5275370|NCT00523562|fructose|fructose
5275371|NCT00523562|dietary lipids|dietary lipids
5275372|NCT00523562|dietary proteins|dietary proteins
5275373|NCT00523562|hepatic steatosis|hepatic steatosis
5275374|NCT00523562|insulin resistance|insulin resistance
5275375|NCT00523562|Healthy humans|healthy humans
5275376|NCT00523562|overweight humans|overweight humans
5275377|NCT00523562|obese humans|obese humans
5275378|NCT00523549|Hypertension|hypertension
5275379|NCT00523549|systolic blood pressure|systolic blood pressure
5275380|NCT00523549|diastolic dysfunction|diastolic dysfunction
5275381|NCT00523549|valsartan|valsartan
5275382|NCT00523549|amlodipine|amlodipine
5275383|NCT00523536|High Blood Pressure|high blood pressure
5275384|NCT00523536|Cardiovascular|cardiovascular
5275385|NCT00523523|Rehabilitation|rehabilitation
5275386|NCT00523523|hemiplegia|hemiplegia
5275387|NCT00523523|stroke|stroke
5275388|NCT00523523|upper extremity|upper extremity
5275389|NCT00523523|motor skills|motor skills
5275390|NCT00523523|therapy|therapy
5275391|NCT00523510|breastmilk|breastmilk
5275392|NCT00523510|perinatal HIV|perinatal hiv
5275393|NCT00523510|infant feeding|infant feeding
5275394|NCT00523510|flash heat|flash heat
5275395|NCT00523510|pasteurization|pasteurization
5275396|NCT00523510|pmtct|pmtct
5275397|NCT00523510|HIV|hiv
5275398|NCT00523510|HIV Seronegativity|hiv seronegativity
5275399|NCT00523510|Treatment Naive|treatment naive
5275400|NCT00523497|Severe community-acquired pneumonia|severe community-acquired pneumonia
5275401|NCT00523497|Noninvasive mechanical ventilation|noninvasive mechanical ventilation
5275402|NCT00523497|Acute hypoxemic respiratory failure.|acute hypoxemic respiratory failure.
5275403|NCT00523484|Beck Anxiety Inventory|beck anxiety inventory
5275404|NCT00523484|Prostate Cancer|prostate cancer
5275405|NCT00523484|Prostate Specific Antigen|prostate specific antigen
5275406|NCT00523484|Naturalistic|naturalistic
5275407|NCT00523484|Observational|observational
5275408|NCT00523471|prostate cancer|prostate cancer
5275409|NCT00523471|gamma H2AX|gamma h2ax
5275410|NCT00523471|radiosensitivity|radiosensitivity
5275411|NCT00523458|Co-infection|co-infection
5275412|NCT00523458|Tuberculosis|tuberculosis
5275413|NCT00523458|HIV|hiv
5275414|NCT00523458|Drug interactions|drug interactions
5275415|NCT00523458|Non nucleoside reverse transcriptase inhibitors|non nucleoside reverse transcriptase inhibitors
5275416|NCT00523458|Therapy|therapy
5275417|NCT00523458|Treatment Naive|treatment naive
5275418|NCT00523445|Schizophrenia|schizophrenia
5275419|NCT00523445|Cognition|cognition
5275420|NCT00523445|Varenicline|varenicline
5275421|NCT00523432|ovarian cancer|ovarian cancer
5275422|NCT00523432|cervical cancer|cervical cancer
5275423|NCT00523432|uterine cancer|uterine cancer
5275424|NCT00523432|fallopian tube cancer|fallopian tube cancer
5275425|NCT00523432|endometrial cancer|endometrial cancer
5275426|NCT00523432|vaginal cancer|vaginal cancer
5275427|NCT00523432|peritoneal cancer|peritoneal cancer
5275428|NCT00523432|reproductive cancer|reproductive cancer
5275429|NCT00523406|choroidal neovascularisation,|choroidal neovascularisation,
5275430|NCT00523406|vision,|vision,
5275431|NCT00523406|macula,|macula,
5275432|NCT00523406|macular degeneration|macular degeneration
5275433|NCT00523406|optical coherence tomography|optical coherence tomography
5275434|NCT00523406|neovascular age related macular degeneration|neovascular age related macular degeneration
5275435|NCT00523367|Gastro Esophageal Reflux Disease (GERD)|gastro esophageal reflux disease (gerd)
5275436|NCT00523367|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
5275437|NCT00523354|Eosinophilic Esophagitis|eosinophilic esophagitis
5275438|NCT00523354|TNF-alpha|tnf-alpha
5275439|NCT00523354|TNF-alpha Blockade|tnf-alpha blockade
5275440|NCT00523354|Infliximab|infliximab
5275441|NCT00523341|postmenopausal osteoporosis|postmenopausal osteoporosis
5275442|NCT00523341|low bone density|low bone density
5275443|NCT00523341|fractures|fractures
5275444|NCT00523341|low bone mass|low bone mass
5275445|NCT00523328|Rheumatoid Arthritis|rheumatoid arthritis
5275446|NCT00523328|Arthritis|arthritis
5275447|NCT00523328|BG9924|bg9924
5275448|NCT00523328|methotrexate|methotrexate
5275449|NCT00523315|Aromatase Inhibitor|aromatase inhibitor
5275450|NCT00523315|Breast Cancer|breast cancer
5275451|NCT00523315|compliance|compliance
5275452|NCT00523315|Naturalistic|naturalistic
5275453|NCT00523315|Observational|observational
5275454|NCT00523302|Major Depression|major depression
5275455|NCT00523302|Fibromyalgia|fibromyalgia
5275456|NCT00523302|TMS|tms
5275457|NCT00523289|Ropivacaine|ropivacaine
5275458|NCT00523289|Bupivacaine|bupivacaine
5275459|NCT00523289|Upper Extremity|upper extremity
5275460|NCT00523289|Local anesthetic|local anesthetic
5275461|NCT00523276|Severe acute respiratory syndrome, SARS, China|severe acute respiratory syndrome, sars, china
5275462|NCT00523250|Glaucoma|glaucoma
5275463|NCT00523224|Stem cells|stem cells
5275464|NCT00523224|Coronary Artery Bypass grafting|coronary artery bypass grafting
5275465|NCT00523224|Congestive Heart Failure|congestive heart failure
5275466|NCT00523224|Coronary Artery Disease|coronary artery disease
5275467|NCT00523224|Angiogenesis|angiogenesis
5275468|NCT00523211|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5275469|NCT00523211|Treatment Experienced|treatment experienced
5275470|NCT00523198|Cortisol|cortisol
5275471|NCT00523185|alcohol withdrawal|alcohol withdrawal
5275472|NCT00523185|lorazepam|lorazepam
5275473|NCT00523185|diazepam|diazepam
5275474|NCT00523172|Chiropractic Manipulation|chiropractic manipulation
5275475|NCT00523159|clear cell renal cell carcinoma|clear cell renal cell carcinoma
5275476|NCT00523146|primary dysmenorrhea|primary dysmenorrhea
5275477|NCT00523146|Herbal remedy|herbal remedy
5275478|NCT00523133|alcoholism|alcoholism
5275479|NCT00523133|naltrexone|naltrexone
5275480|NCT00523133|motivational enhancement therapy|motivational enhancement therapy
5275481|NCT00523107|Fatigue|fatigue
5275482|NCT00523107|Standard Palliative Care|standard palliative care
5275483|NCT00523107|PG2|pg2
5275484|NCT00523107|QLQ-C30|qlq-c30
5275485|NCT00523107|Compassionate|compassionate
5275486|NCT00523081|adolescent depression treatment, cognitive behavioral therapy,|adolescent depression treatment, cognitive behavioral therapy,
5275487|NCT00523081|collaborative care|collaborative care
5275488|NCT00523068|overactive bladder|overactive bladder
5275489|NCT00523068|stress urinary incontinence|stress urinary incontinence
5275490|NCT00523068|detrusor overactivity|detrusor overactivity
5275491|NCT00523068|urodynamics|urodynamics
5275492|NCT00523055|Pain|pain
5275493|NCT00523055|Brachial Plexus Anesthesia|brachial plexus anesthesia
5275494|NCT00523055|Plasma Lidocaine Levels|plasma lidocaine levels
5275495|NCT00523055|Ultrasound|ultrasound
5275496|NCT00523029|Self-management programs|self-management programs
5275497|NCT00523029|Chronic medical illness|chronic medical illness
5275498|NCT00523016|acupuncture|acupuncture
5275499|NCT00523016|electroacupuncture|electroacupuncture
5275500|NCT00523016|sham acupuncture|sham acupuncture
5275501|NCT00523016|spinal cord injury|spinal cord injury
5275502|NCT00523016|neuropathic pain|neuropathic pain
5275503|NCT00523016|burning pain|burning pain
5275504|NCT00523003|weight loss|weight loss
5275505|NCT00523003|obesity|obesity
5275506|NCT00523003|high protein|high protein
5275507|NCT00523003|meal replacement|meal replacement
5275508|NCT00522977|Myocardial strain|myocardial strain
5275509|NCT00522977|Myocardial function|myocardial function
5275510|NCT00522977|Pregnancy|pregnancy
5275511|NCT00522977|Postpartum|postpartum
5275512|NCT00522977|Echocardiography|echocardiography
5275513|NCT00522977|Myocardial adaptation to pregnancy|myocardial adaptation to pregnancy
5275514|NCT00522977|Systolic function|systolic function
5275515|NCT00522977|Diastolic function|diastolic function
5275516|NCT00522964|Chinese-American|chinese-american
5275517|NCT00522964|Children|children
5275519|NCT00522964|health behaviors|health behaviors
5275520|NCT00522964|Behavioral intervention|behavioral intervention
5275522|NCT00522951|MRI|mri
5275523|NCT00522951|Brain Metastasis|brain metastasis
5275524|NCT00522951|Gadolinium|gadolinium
5275525|NCT00522951|Imaging|imaging
5275526|NCT00522951|Diagnostic Agent|diagnostic agent
5275527|NCT00522938|Lung|lung
5275528|NCT00522938|Cancer|cancer
5275529|NCT00522938|Non-small|non-small
5275530|NCT00522938|Lung Cancer|lung cancer
5275531|NCT00522938|NSCLC|nsclc
5275532|NCT00522938|erlotinib|erlotinib
5275533|NCT00522938|oral|oral
5275534|NCT00522938|Locally Advanced Non-small Cell Lung Cancer|locally advanced non-small cell lung cancer
5275535|NCT00522938|Metastatic Non-small Cell Lung Cancer|metastatic non-small cell lung cancer
5275536|NCT00522925|hypertension|hypertension
5275537|NCT00522925|high blood pressure|high blood pressure
5275538|NCT00522912|Trachoma|trachoma
5275539|NCT00522912|Trichiasis|trichiasis
5275540|NCT00522912|Surgery|surgery
5275541|NCT00522912|Epilation|epilation
5275542|NCT00522912|Ethiopia|ethiopia
5275543|NCT00522899|aged|aged
5275544|NCT00522899|exercise|exercise
5275545|NCT00522899|cognitive therapy|cognitive therapy
5275546|NCT00522899|dementia|dementia
5275547|NCT00522899|prevention|prevention
5275548|NCT00522886|cetuximab|cetuximab
5275549|NCT00522886|concurrent|concurrent
5275550|NCT00522886|iso-toxic|iso-toxic
5275551|NCT00522886|NSCLC|nsclc
5275552|NCT00522873|Postmenopausal Symptoms e.g.|postmenopausal symptoms e.g.
5275553|NCT00522873|Hot flushes|hot flushes
5275554|NCT00522873|Sweating episodes|sweating episodes
5275555|NCT00522873|Vaginal dryness|vaginal dryness
5275556|NCT00522860|Trichiasis|trichiasis
5275557|NCT00522860|Trachoma|trachoma
5275558|NCT00522860|Surgery|surgery
5275559|NCT00522860|Suture|suture
5275560|NCT00522860|Ethiopia|ethiopia
5275561|NCT00522847|Postmenopausal|postmenopausal
5275562|NCT00522847|non dry eye|non dry eye
5275563|NCT00522834|melanoma|melanoma
5275564|NCT00522834|oncology|oncology
5275565|NCT00522834|Stage IV Metastatic Melanoma|stage iv metastatic melanoma
5275566|NCT00522821|IgG subclass deficiency|igg subclass deficiency
5275567|NCT00522821|Anti-polysaccharide deficiency|anti-polysaccharide deficiency
5275568|NCT00522821|therapy|therapy
5275569|NCT00522821|Immunoglobulins, Intravenous|immunoglobulins, intravenous
5275570|NCT00522821|co-trimoxazole|co-trimoxazole
5275571|NCT00522808|HCV|hcv
5275572|NCT00522808|antiviral|antiviral
5275573|NCT00522808|PK|pk
5275574|NCT00522808|Safety|safety
5275575|NCT00522795|Esophageal Cancer|esophageal cancer
5275576|NCT00522769|binge eating|binge eating
5275577|NCT00522769|adolescent girls|adolescent girls
5275578|NCT00522769|cognitive behavioral therapy|cognitive behavioral therapy
5275579|NCT00522756|Kidney Failure, Acute|kidney failure, acute
5275580|NCT00522756|Cardiac Surgical Procedures|cardiac surgical procedures
5275581|NCT00522756|Sodium Bicarbonate|sodium bicarbonate
5275582|NCT00522756|Sodium Chloride|sodium chloride
5275583|NCT00522756|Prevention and control|prevention and control
5275584|NCT00522743|SGA|sga
5275585|NCT00522743|GH|gh
5275586|NCT00522743|GnRHa|gnrha
5275587|NCT00522743|IGF-1|igf-1
5275588|NCT00522730|Liver failure|liver failure
5275589|NCT00522730|Liver cirrhosis|liver cirrhosis
5275590|NCT00522730|Parenteral nutrition|parenteral nutrition
5275591|NCT00522730|Enteral nutrition|enteral nutrition
5275592|NCT00522730|Lipids|lipids
5275593|NCT00522730|Safety|safety
5275594|NCT00522730|Drug tolerance|drug tolerance
5275595|NCT00522704|Arteriovenous fistula|arteriovenous fistula
5275596|NCT00522704|Access blood flow|access blood flow
5275597|NCT00522704|Extracorporeal blood flow|extracorporeal blood flow
5275598|NCT00522704|Dynamic arterial line pressure|dynamic arterial line pressure
5275599|NCT00522704|Hemodialysis treatment|hemodialysis treatment
5275600|NCT00522691|Fecal incontinence|fecal incontinence
5275601|NCT00522691|sacral nerve stimulation|sacral nerve stimulation
5275602|NCT00522678|Healthy Volunteers|healthy volunteers
5275603|NCT00522652|cancer|cancer
5275604|NCT00522652|advanced cancer|advanced cancer
5275605|NCT00522652|lymphoma|lymphoma
5275606|NCT00522639|lung cancer|lung cancer
5275607|NCT00522639|FDG-PET-CT|fdg-pet-ct
5275608|NCT00522639|blood proteins|blood proteins
5275609|NCT00522639|prognose|prognose
5275610|NCT00522626|Fetus|fetus
5275611|NCT00522626|Drug abuse|drug abuse
5275612|NCT00522626|Fetal development|fetal development
5275613|NCT00522626|Substance abuse|substance abuse
5275614|NCT00522626|Opioids|opioids
5275615|NCT00522626|Methadone|methadone
5275616|NCT00522613|recovery|recovery
5275617|NCT00522613|serious mental illness|serious mental illness
5275618|NCT00522613|bipolar disorder|bipolar disorder
5275619|NCT00522613|schizophrenia|schizophrenia
5275620|NCT00522613|schizoaffective disorder|schizoaffective disorder
5275621|NCT00522600|eyedrops|eyedrops
5275622|NCT00522600|compliance|compliance
5275623|NCT00522600|glaucoma medications|glaucoma medications
5275624|NCT00522600|adherence|adherence
5275625|NCT00522574|Myeloproliferative Disorders|myeloproliferative disorders
5275626|NCT00522561|Healthy volunteers|healthy volunteers
5275627|NCT00522561|running|running
5275628|NCT00522561|energetic cost|energetic cost
5275629|NCT00522561|limb mechanical characteristics|limb mechanical characteristics
5275630|NCT00522561|contractile components|contractile components
5275631|NCT00522561|elastic components|elastic components
5275632|NCT00522561|healthy men doing regularly physical activities|healthy men doing regularly physical activities
5275633|NCT00522548|African American|african american
5275634|NCT00522548|Kidney Transplant|kidney transplant
5275635|NCT00522535|AAA|aaa
5275636|NCT00522535|Abdominal Aortic Aneurysms|abdominal aortic aneurysms
5275637|NCT00522535|Endovascular|endovascular
5275639|NCT00522535|Aorta|aorta
5275640|NCT00522535|Stent Graft|stent graft
5275641|NCT00522535|Stent|stent
5275642|NCT00522535|Tortuous|tortuous
5275643|NCT00522535|High Angle|high angle
5275644|NCT00522535|Angled Necks|angled necks
5275645|NCT00522522|Naturalistic, retrospective, utilization of care services, diagnosis, epilepsy|naturalistic, retrospective, utilization of care services, diagnosis, epilepsy
5275646|NCT00522496|Craniocerebral trauma|craniocerebral trauma
5275647|NCT00522496|matrix metalloproteinase|matrix metalloproteinase
5275648|NCT00522496|microdialysis|microdialysis
5275649|NCT00522457|Breast Cancer|breast cancer
5275650|NCT00522457|investigational drug|investigational drug
5275651|NCT00522457|drug therapy|drug therapy
5275652|NCT00522457|Antineoplastic Protocols|antineoplastic protocols
5275653|NCT00522457|Immunotherapy|immunotherapy
5275654|NCT00522457|Metastatic breast cancer|metastatic breast cancer
5275655|NCT00522457|Advanced breast cancer|advanced breast cancer
5275656|NCT00522457|Stage IV breast cancer|stage iv breast cancer
5275657|NCT00522457|Her-2/neu expressing breast cancer|her-2/neu expressing breast cancer
5275658|NCT00522457|Her-2/neu|her-2/neu
5275659|NCT00522457|Trastuzumab refractory|trastuzumab refractory
5275660|NCT00522431|Hypogonadism|hypogonadism
5275661|NCT00522418|Epilepsy|epilepsy
5275662|NCT00522418|VNS Therapy|vns therapy
5275663|NCT00522405|Transarterial chemoembolisation|transarterial chemoembolisation
5275664|NCT00522405|Thalidomide|thalidomide
5275665|NCT00522405|Capecitabine|capecitabine
5275666|NCT00522405|Treatment|treatment
5275667|NCT00522392|Consolidation therapy|consolidation therapy
5275668|NCT00522392|First-line therapy|first-line therapy
5275669|NCT00522392|Proteasome inhibitor|proteasome inhibitor
5275670|NCT00522392|Thalidomide analogue|thalidomide analogue
5275671|NCT00522392|Quality of life|quality of life
5275672|NCT00522379|Parkinson's disease|parkinson's disease
5275673|NCT00522379|rotigotine|rotigotine
5275674|NCT00522379|patch|patch
5275675|NCT00522379|transdermal|transdermal
5275676|NCT00522379|dopamine agonist|dopamine agonist
5275677|NCT00522379|off time|off time
5275678|NCT00522379|Neupro|neupro
5275679|NCT00522353|obesity|obesity
5275680|NCT00522353|weight loss|weight loss
5275681|NCT00522353|satiety hormones|satiety hormones
5275682|NCT00522353|body composition|body composition
5275683|NCT00522353|appetite ratings|appetite ratings
5275684|NCT00522340|Implantable Cardioverter Defibrillators|implantable cardioverter defibrillators
5275685|NCT00522340|ICD|icd
5275686|NCT00522340|Exercise|exercise
5275687|NCT00522340|Cardiac|cardiac
5275688|NCT00522340|Inflammation|inflammation
5275689|NCT00522327|Immigrant|immigrant
5275690|NCT00522327|Interpreting|interpreting
5275691|NCT00522314|Non-invasive ventilation|non-invasive ventilation
5275692|NCT00522314|Airway clearance|airway clearance
5275693|NCT00522314|Bronchiectasis|bronchiectasis
5275694|NCT00522301|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5275695|NCT00522301|fallopian tube cancer|fallopian tube cancer
5275696|NCT00522301|primary peritoneal cavity cancer|primary peritoneal cavity cancer
5275697|NCT00522301|stage I ovarian epithelial cancer|stage i ovarian epithelial cancer
5275698|NCT00522301|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
5275699|NCT00522301|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5275700|NCT00522301|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5275701|NCT00522288|Myopia|myopia
5275702|NCT00522288|Self-Perception|self-perception
5275703|NCT00522288|Contact Lenses|contact lenses
5275704|NCT00522288|Glasses|glasses
5275705|NCT00522288|Randomized|randomized
5275706|NCT00522288|Children|children
5275707|NCT00522288|Self-esteem|self-esteem
5275708|NCT00522275|Adjunctive treatment in epilepsy|adjunctive treatment in epilepsy
5275709|NCT00522275|add-on treatment for epilepsy|add-on treatment for epilepsy
5275710|NCT00522275|partial seizures|partial seizures
5275711|NCT00522275|AEDs|aeds
5275712|NCT00522275|antiepileptic drugs|antiepileptic drugs
5275713|NCT00522275|seizures|seizures
5275714|NCT00522262|Breast Neoplasms|breast neoplasms
5275715|NCT00522262|Exercise|exercise
5275716|NCT00522262|Physical activity|physical activity
5275717|NCT00522262|Estrone|estrone
5275718|NCT00522262|Estradiol|estradiol
5275719|NCT00522262|Adiposity|adiposity
5275720|NCT00522262|Breast density|breast density
5275721|NCT00522262|Mammographic density|mammographic density
5275722|NCT00522262|Insulin-Like Growth Factor I|insulin-like growth factor i
5275723|NCT00522262|Insulin Resistance|insulin resistance
5275724|NCT00522262|Women|women
5275725|NCT00522262|Postmenopause|postmenopause
5275726|NCT00522249|Metastatic Renal Cell Carcinoma|metastatic renal cell carcinoma
5275727|NCT00522249|RCC|rcc
5275728|NCT00522249|M3thodist|m3thodist
5275729|NCT00522249|Pegylated Alfa Interferon|pegylated alfa interferon
5275730|NCT00522249|Sunitinib|sunitinib
5275731|NCT00522249|Tarceva|tarceva
5275732|NCT00522249|Peg IFN|peg ifn
5275733|NCT00522236|Adjuvanted Influenza Vaccine|adjuvanted influenza vaccine
5275734|NCT00522223|Cervical Cancer|cervical cancer
5275735|NCT00522223|Cancer Survivors|cancer survivors
5275736|NCT00522223|Cervix Cancer|cervix cancer
5275737|NCT00522223|Sexual Functioning|sexual functioning
5275738|NCT00522223|Quality Of Life|quality of life
5275739|NCT00522223|Questionnaire|questionnaire
5275740|NCT00522223|Radiation Therapy|radiation therapy
5275741|NCT00522223|Radical Hysterectomy|radical hysterectomy
5275742|NCT00522210|type 1 diabetes|type 1 diabetes
5275743|NCT00522210|children|children
5275744|NCT00522210|long acting insulin analogue|long acting insulin analogue
5275745|NCT00522210|hemoglobin A1c|hemoglobin a1c
5275746|NCT00522197|non-small cell lung cancer|non-small cell lung cancer
5275747|NCT00522197|small cell lung cancer|small cell lung cancer
5275748|NCT00522197|squamous lung dysplasia|squamous lung dysplasia
5275749|NCT00522184|intra-articular injection|intra-articular injection
5275750|NCT00522184|acute synovitis|acute synovitis
5275751|NCT00522184|etanercept|etanercept
5275752|NCT00522171|Harmonic|harmonic
5275753|NCT00522171|Massive Weight Loss|massive weight loss
5275754|NCT00522171|Electro Surgery|electro surgery
5275755|NCT00522171|Skin and Fat Redundancy after massive weight loss|skin and fat redundancy after massive weight loss
5275756|NCT00522171|Obesity|obesity
5275757|NCT00522145|Non-Small-Cell Lung Cancer|non-small-cell lung cancer
5275758|NCT00522132|intravenous artesunate|intravenous artesunate
5275759|NCT00522132|severe malaria|severe malaria
5275760|NCT00522132|Plasmodium falciparum|plasmodium falciparum
5275761|NCT00522132|Africa|africa
5275762|NCT00522132|Severe Plasmodium falciparum Malaria|severe plasmodium falciparum malaria
5275763|NCT00522119|Essential Hypertension|essential hypertension
5275764|NCT00522119|High Blood Pressure|high blood pressure
5275765|NCT00522106|Behavioral graded activity|behavioral graded activity
5275766|NCT00522106|Hip|hip
5275767|NCT00522106|Knee|knee
5275768|NCT00522106|Physical therapy|physical therapy
5275769|NCT00522106|Exercise therapy|exercise therapy
5275770|NCT00522093|constipation|constipation
5275771|NCT00522067|influenza|influenza
5275772|NCT00522067|influenza vaccine|influenza vaccine
5275773|NCT00522067|adjuvanted influenza vaccine|adjuvanted influenza vaccine
5275774|NCT00522067|subunit influenza vaccine|subunit influenza vaccine
5275775|NCT00522067|surface antigen|surface antigen
5275776|NCT00522054|Exercise|exercise
5275777|NCT00522054|Physical function|physical function
5275778|NCT00522054|Rheumatoid arthritis|rheumatoid arthritis
5275779|NCT00522054|Tai Chi|tai chi
5275780|NCT00522041|Pain associated with chronic anal fissure|pain associated with chronic anal fissure
5275781|NCT00522028|QoL|qol
5275782|NCT00522028|Osteodensitometry|osteodensitometry
5275783|NCT00522028|Arterial pressure|arterial pressure
5275784|NCT00522028|PTH|pth
5275785|NCT00522015|PSP|psp
5275786|NCT00522015|dementia|dementia
5275787|NCT00522015|neuropsychology|neuropsychology
5275788|NCT00522015|treatment|treatment
5275789|NCT00522002|Connective tissue diseases|connective tissue diseases
5275790|NCT00522002|Blood coagulation disorders|blood coagulation disorders
5275791|NCT00522002|Leg ulcers|leg ulcers
5275792|NCT00522002|Rheumatoid Arthritis|rheumatoid arthritis
5275793|NCT00522002|Systemic Lupus Erythematosus|systemic lupus erythematosus
5275794|NCT00522002|Systemic Scleroderma|systemic scleroderma
5275795|NCT00522002|Mixed Connective Tissue Disease|mixed connective tissue disease
5275796|NCT00521989|Osteoarthritis|osteoarthritis
5275797|NCT00521989|Knee|knee
5275798|NCT00521989|CRx-102|crx-102
5275799|NCT00521989|prednisolone|prednisolone
5275800|NCT00521989|dipyridamole|dipyridamole
5275801|NCT00521989|CombinatoRx|combinatorx
5275802|NCT00521989|WOMAC|womac
5275803|NCT00521976|Risk assessment|risk assessment
5275804|NCT00521976|Chest pain|chest pain
5275805|NCT00521976|Coronary Artery Disease|coronary artery disease
5275806|NCT00521976|Acute coronary syndromes|acute coronary syndromes
5275807|NCT00521976|Factor XIIa|factor xiia
5275808|NCT00521976|B-type natriuretic peptide (BNP)|b-type natriuretic peptide (bnp)
5275809|NCT00521976|high-sensitive C-reactive protein (hsCRP)|high-sensitive c-reactive protein (hscrp)
5275810|NCT00521976|Omega-3|omega-3
5275811|NCT00521963|Intraarticular injection|intraarticular injection
5275812|NCT00521963|Infliximab|infliximab
5275813|NCT00521950|Pharmacogenetics|pharmacogenetics
5275814|NCT00521950|Cost Effectiveness|cost effectiveness
5275815|NCT00521950|Inflammatory Bowel Diseases|inflammatory bowel diseases
5275816|NCT00521950|Crohn Disease|crohn disease
5275817|NCT00521950|Ulcerative Colitis|ulcerative colitis
5275818|NCT00521950|Randomized Controlled Trials|randomized controlled trials
5275819|NCT00521911|Intervention Studies|intervention studies
5275820|NCT00521911|Randomized Controlled Trials|randomized controlled trials
5275821|NCT00521911|Cognitive Therapy|cognitive therapy
5275822|NCT00521911|Hospitals, General|hospitals, general
5275823|NCT00521911|Prevalence|prevalence
5275824|NCT00521898|Corneal transplantation, Descemet membrane|corneal transplantation, descemet membrane
5275825|NCT00521885|Bleeding rates|bleeding rates
5275826|NCT00521885|Prophylaxis for deep vein thrombosis|prophylaxis for deep vein thrombosis
5275827|NCT00521872|surgery (STARR operation)|surgery (starr operation)
5275828|NCT00521859|Hematologic Malignancies|hematologic malignancies
5275829|NCT00521859|Leukemia|leukemia
5275830|NCT00521859|Lymphoma|lymphoma
5275831|NCT00521859|Myeloma|myeloma
5275832|NCT00521859|Hodgkin's Disease|hodgkin's disease
5275833|NCT00521859|Hematopoietic Cell Transplantation|hematopoietic cell transplantation
5275834|NCT00521859|Cloretazine|cloretazine
5275835|NCT00521859|VNP40101M|vnp40101m
5275836|NCT00521859|Fludarabine|fludarabine
5275837|NCT00521859|Fludarabine Phosphate|fludarabine phosphate
5275838|NCT00521859|Fludara|fludara
5275839|NCT00521859|ATG|atg
5275840|NCT00521859|Antithymocyte|antithymocyte
5275841|NCT00521859|Thymoglobulin|thymoglobulin
5275842|NCT00521833|Kataract|kataract
5275843|NCT00521833|Astigmatism|astigmatism
5275844|NCT00521833|phacoemulsification|phacoemulsification
5275845|NCT00521820|Glucose Metabolism Disorder|glucose metabolism disorder
5275846|NCT00521820|Dysmetabolic Syndrome|dysmetabolic syndrome
5275847|NCT00521820|Type II Diabetes|type ii diabetes
5275848|NCT00521820|Diabetes Mellitus, Lipoatrophic|diabetes mellitus, lipoatrophic
5275849|NCT00521820|Dyslipidemia|dyslipidemia
5275850|NCT00521820|Drug Therapy|drug therapy
5275851|NCT00521807|Hypnosis,|hypnosis,
5275852|NCT00521807|Chronic widespread pain,|chronic widespread pain,
5275853|NCT00521807|CWP,|cwp,
5275854|NCT00521807|General Practice|general practice
5275855|NCT00521794|Arrhythmia|arrhythmia
5275856|NCT00521794|Muscle Weakness|muscle weakness
5275857|NCT00521794|Periodic Paralysis|periodic paralysis
5275858|NCT00521794|Channelopathy|channelopathy
5275859|NCT00521781|Unresectable or Metastatic Adenocarcinoma Prostate Cancer|unresectable or metastatic adenocarcinoma prostate cancer
5275860|NCT00521781|Hormonal Therapy|hormonal therapy
5275861|NCT00521781|Abraxane|abraxane
5275862|NCT00521781|M3thodist|m3thodist
5275863|NCT00521768|Post traumatic stress disorder|post traumatic stress disorder
5275864|NCT00521768|Anxiety disorder|anxiety disorder
5275865|NCT00521768|Comunity base intervention|comunity base intervention
5275866|NCT00521768|Education|education
5275867|NCT00521768|Behavioural treatment|behavioural treatment
5275868|NCT00521755|Laser bonding soft tissue albumin|laser bonding soft tissue albumin
5275869|NCT00521742|Glucose Metabolism Disorder|glucose metabolism disorder
5275870|NCT00521742|Dysmetabolic Syndrome|dysmetabolic syndrome
5275871|NCT00521742|Type II Diabetes|type ii diabetes
5275872|NCT00521742|Diabetes Mellitus, Lipoatrophic|diabetes mellitus, lipoatrophic
5275873|NCT00521742|Dyslipidemia|dyslipidemia
5275874|NCT00521742|Drug Therapy|drug therapy
5275875|NCT00521729|Thyroid|thyroid
5275876|NCT00521729|Thermoregulation|thermoregulation
5275877|NCT00521729|Catecholamines|catecholamines
5275878|NCT00521729|Energy Expenditure|energy expenditure
5275879|NCT00521729|Obesity|obesity
5275880|NCT00521729|Healthy Volunteer|healthy volunteer
5275881|NCT00521729|HV|hv
5275882|NCT00521716|Hip Prosthesis Implantation|hip prosthesis implantation
5275883|NCT00521703|endoscopy, gastrointestinal|endoscopy, gastrointestinal
5275884|NCT00521703|lidocaine|lidocaine
5275885|NCT00521703|propofol|propofol
5275886|NCT00521703|child|child
5275887|NCT00521703|adolescent|adolescent
5275888|NCT00521677|VAP|vap
5275889|NCT00521677|Oral care|oral care
5275890|NCT00521677|Acquired pneumonia|acquired pneumonia
5275891|NCT00521677|Mortality|mortality
5275892|NCT00521677|LOS in ICU|los in icu
5275893|NCT00521677|LOS in hospital|los in hospital
5275894|NCT00521677|All patients on ventilator in the ICU|all patients on ventilator in the icu
5275895|NCT00521664|proof of safety and cost effectiveness of the new therapeutic platelet transfusion strategy|proof of safety and cost effectiveness of the new therapeutic platelet transfusion strategy
5275896|NCT00521651|Physical Activity|physical activity
5275897|NCT00521651|Cancer Risk|cancer risk
5275898|NCT00521612|sevoflurane|sevoflurane
5275899|NCT00521612|isoflurane|isoflurane
5275900|NCT00521612|anaesthesia|anaesthesia
5275901|NCT00521586|Pneumococcal Conjugate Vaccine|pneumococcal conjugate vaccine
5275902|NCT00521560|High-Dose Radio-Immuno- and Chemotherapy|high-dose radio-immuno- and chemotherapy
5275903|NCT00521560|stem cell transplantation|stem cell transplantation
5275904|NCT00521560|90Y-Ibritumomab-Tiuxetan|90y-ibritumomab-tiuxetan
5275905|NCT00521547|Acupuncture|acupuncture
5275906|NCT00521547|Analgesia|analgesia
5275907|NCT00521547|Functional magnetic resonance imaging (fMRI)|functional magnetic resonance imaging (fmri)
5275908|NCT00521547|Neuronal Mechanisms|neuronal mechanisms
5275909|NCT00521547|Quantitative Peripheral Sensory Testings|quantitative peripheral sensory testings
5275910|NCT00521547|Normal Volunteers|normal volunteers
5275911|NCT00521534|Sleep related Breathing Disorder|sleep related breathing disorder
5275912|NCT00521534|Congestive Heart Failure|congestive heart failure
5275913|NCT00521534|Atrial Overdrive Pacing|atrial overdrive pacing
5275914|NCT00521534|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
5275915|NCT00521508|IgA|iga
5275916|NCT00521508|kidney|kidney
5275917|NCT00521508|Berger'disease|berger'disease
5275918|NCT00521508|regulatory T cells|regulatory t cells
5275919|NCT00521508|pathogenesis of Berger's disease|pathogenesis of berger's disease
5275920|NCT00521495|static magnetic field|static magnetic field
5275921|NCT00521495|permanent magnet|permanent magnet
5275922|NCT00521495|carpal tunnel syndrome|carpal tunnel syndrome
5275923|NCT00521495|median nerve|median nerve
5275924|NCT00521482|recurrent|recurrent
5275925|NCT00521482|after standard therapy|after standard therapy
5275926|NCT00521469|Disequilibrium|disequilibrium
5275927|NCT00521469|Spinal Manipulation|spinal manipulation
5275928|NCT00521469|Postural control|postural control
5275929|NCT00521430|recurrent childhood grade III lymphomatoid granulomatosis|recurrent childhood grade iii lymphomatoid granulomatosis
5275930|NCT00521430|childhood diffuse large cell lymphoma|childhood diffuse large cell lymphoma
5275931|NCT00521430|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
5275932|NCT00521430|childhood immunoblastic large cell lymphoma|childhood immunoblastic large cell lymphoma
5275933|NCT00521430|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
5275934|NCT00521430|childhood nasal type extranodal NK/T-cell lymphoma|childhood nasal type extranodal nk/t-cell lymphoma
5275935|NCT00521430|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
5275936|NCT00521430|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5275937|NCT00521430|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5275938|NCT00521430|aplastic anemia|aplastic anemia
5275939|NCT00521430|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5275940|NCT00521430|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
5275941|NCT00521430|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
5275942|NCT00521430|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5275943|NCT00521430|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5275944|NCT00521430|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5275945|NCT00521430|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5275946|NCT00521430|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5275947|NCT00521430|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
5275948|NCT00521430|refractory anemia with excess blasts|refractory anemia with excess blasts
5275949|NCT00521430|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
5275950|NCT00521430|refractory anemia|refractory anemia
5275951|NCT00521430|refractory multiple myeloma|refractory multiple myeloma
5275952|NCT00521430|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5275953|NCT00521430|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5275954|NCT00521430|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5275955|NCT00521430|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5275956|NCT00521430|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5275957|NCT00521430|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5275958|NCT00521430|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
5275959|NCT00521430|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5275960|NCT00521430|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
5275961|NCT00521430|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5275962|NCT00521430|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5275963|NCT00521430|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
5275964|NCT00521430|Waldenström macroglobulinemia|waldenström macroglobulinemia
5275965|NCT00521430|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5275966|NCT00521430|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5275967|NCT00521430|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5275968|NCT00521430|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5275969|NCT00521430|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
5275970|NCT00521430|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5275971|NCT00521430|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5275972|NCT00521430|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5275973|NCT00521430|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5275974|NCT00521430|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5275975|NCT00521430|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5275976|NCT00521430|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5275977|NCT00521430|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5275978|NCT00521430|stage I multiple myeloma|stage i multiple myeloma
5275979|NCT00521430|stage II multiple myeloma|stage ii multiple myeloma
5275980|NCT00521430|stage III multiple myeloma|stage iii multiple myeloma
5275981|NCT00521430|cutaneous B-cell non-Hodgkin lymphoma|cutaneous b-cell non-hodgkin lymphoma
5275982|NCT00521430|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5275983|NCT00521430|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
5276101|NCT00521105|Telemedicine|telemedicine
5275984|NCT00521430|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5275985|NCT00521430|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5275986|NCT00521430|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5275987|NCT00521430|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5275988|NCT00521430|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5275989|NCT00521430|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5275990|NCT00521430|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
5275991|NCT00521430|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5275992|NCT00521430|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5275993|NCT00521430|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5275994|NCT00521417|RCT|rct
5275995|NCT00521404|Pancreatic cancer|pancreatic cancer
5275996|NCT00521404|chemotherapy naive|chemotherapy naive
5275997|NCT00521404|unresectable or metastatic pancreatic cancer|unresectable or metastatic pancreatic cancer
5275998|NCT00521404|CS1008|cs1008
5275999|NCT00521404|Gemcitabine|gemcitabine
5276000|NCT00521404|Gemzar|gemzar
5276001|NCT00521391|smoking cessation|smoking cessation
5276002|NCT00521391|nicotine|nicotine
5276003|NCT00521391|physical activity|physical activity
5276004|NCT00521378|Diabetes|diabetes
5276005|NCT00521378|Type 1 and Type 2 Diabetes|type 1 and type 2 diabetes
5276006|NCT00521365|Bipolar Disorder|bipolar disorder
5276007|NCT00521365|Bipolar Affective Psychosis|bipolar affective psychosis
5276008|NCT00521365|Mania|mania
5276009|NCT00521365|Manic Disorder|manic disorder
5276010|NCT00521365|Manic State|manic state
5276011|NCT00521352|TMS|tms
5276012|NCT00521352|Dorsolateral Prefrontal Cortex|dorsolateral prefrontal cortex
5276013|NCT00521339|Apremilast,|apremilast,
5276014|NCT00521339|Psoriasis,|psoriasis,
5276015|NCT00521339|PASI-75,|pasi-75,
5276016|NCT00521339|sPGA|spga
5276017|NCT00521326|doppler|doppler
5276018|NCT00521326|coronary stenosis|coronary stenosis
5276019|NCT00521326|non-invasive testing|non-invasive testing
5276020|NCT00521326|A prospective study of a new diagnostic method.|a prospective study of a new diagnostic method.
5276021|NCT00521326|Study consists of a transthoracic doppler of LAD.|study consists of a transthoracic doppler of lad.
5276022|NCT00521326|Doppler to be performed prior to coronary angiography.|doppler to be performed prior to coronary angiography.
5276023|NCT00521326|F/U doppler examination for those who undergo PCI.|f/u doppler examination for those who undergo pci.
5276024|NCT00521326|Doppler results will be compared with coronary angiography.|doppler results will be compared with coronary angiography.
5276025|NCT00521300|Acromegaly|acromegaly
5276026|NCT00521287|Immunologic Surveillance|immunologic surveillance
5276027|NCT00521287|Vaccination|vaccination
5276028|NCT00521287|Immunotherapy|immunotherapy
5276029|NCT00521287|Dendritic Cells|dendritic cells
5276030|NCT00521274|Progressive Hormone Refractory Prostate Cancer|progressive hormone refractory prostate cancer
5276031|NCT00521274|HRPC|hrpc
5276032|NCT00521274|MVA 5T4|mva 5t4
5276033|NCT00521274|Trovax®|trovax®
5276034|NCT00521274|Docetaxel|docetaxel
5276035|NCT00521274|M3thodist|m3thodist
5276036|NCT00521261|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5276037|NCT00521261|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5276038|NCT00521261|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5276039|NCT00521261|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5276040|NCT00521261|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5276041|NCT00521261|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5276042|NCT00521261|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
5276043|NCT00521261|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5276044|NCT00521261|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5276045|NCT00521261|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5276046|NCT00521261|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5276047|NCT00521261|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5276048|NCT00521261|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5276049|NCT00521261|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5276050|NCT00521261|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
5276051|NCT00521261|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
5276052|NCT00521261|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
5276053|NCT00521261|cutaneous B-cell non-Hodgkin lymphoma|cutaneous b-cell non-hodgkin lymphoma
5276054|NCT00521248|Neonatal Abstinence Syndrome|neonatal abstinence syndrome
5276055|NCT00521248|buprenorphine|buprenorphine
5276056|NCT00521248|neonatal|neonatal
5276057|NCT00521248|opioid withdrawal|opioid withdrawal
5276058|NCT00521235|risk factors|risk factors
5276059|NCT00521235|metabolic syndrome|metabolic syndrome
5276060|NCT00521235|dentists|dentists
5276061|NCT00521235|trainers|trainers
5276062|NCT00521235|Healthy subjects|healthy subjects
5276063|NCT00521235|students|students
5276064|NCT00521235|seniors|seniors
5276065|NCT00521222|asthma|asthma
5276066|NCT00521222|beta agonist|beta agonist
5276067|NCT00521222|bronchodilator|bronchodilator
5276068|NCT00521222|pulmonary|pulmonary
5276069|NCT00521222|genotype|genotype
5276070|NCT00521222|pharmacogenomics|pharmacogenomics
5276071|NCT00521222|corticosteroid|corticosteroid
5276072|NCT00521222|allergy|allergy
5276073|NCT00521222|immunology|immunology
5276074|NCT00521209|Impoverished Population|impoverished population
5276075|NCT00521196|migraine|migraine
5276076|NCT00521196|headache|headache
5276077|NCT00521196|chronic|chronic
5276078|NCT00521196|pain|pain
5276079|NCT00521196|brain|brain
5276080|NCT00521196|neurology|neurology
5276081|NCT00521196|stimulation|stimulation
5276082|NCT00521196|noninvasive|noninvasive
5276083|NCT00521196|transcranial|transcranial
5276084|NCT00521196|direct|direct
5276085|NCT00521196|current|current
5276086|NCT00521196|tDCS|tdcs
5276087|NCT00521196|tms|tms
5276088|NCT00521196|rTMS|rtms
5276089|NCT00521196|BIDMC|bidmc
5276090|NCT00521183|adult tumors metastatic to brain|adult tumors metastatic to brain
5276091|NCT00521170|Levocetirizine|levocetirizine
5276092|NCT00521170|Wheal and flare|wheal and flare
5276093|NCT00521170|Allergic|allergic
5276094|NCT00521157|Substance abuse|substance abuse
5276095|NCT00521157|Opiate dependency|opiate dependency
5276096|NCT00521157|Treatment|treatment
5276097|NCT00521157|Relapse prevention|relapse prevention
5276098|NCT00521131|Levocetirizine dihydrochloride|levocetirizine dihydrochloride
5276099|NCT00521131|Xyzal tablets|xyzal tablets
5276100|NCT00521105|Type 1 Diabetes|type 1 diabetes
5276102|NCT00521105|Children|children
5276103|NCT00521092|Treatment Experienced|treatment experienced
5276104|NCT00521079|Obesity|obesity
5276105|NCT00521079|Bariatric surgery|bariatric surgery
5276106|NCT00521079|Excess weight loss|excess weight loss
5276107|NCT00521079|Vagus nerve|vagus nerve
5276108|NCT00521079|Vagal blocking|vagal blocking
5276109|NCT00521079|vBloc(TM) therapy|vbloc(tm) therapy
5276110|NCT00521053|immune|immune
5276111|NCT00521053|vaccine|vaccine
5276112|NCT00521053|systemic|systemic
5276113|NCT00521053|Metastatic Melanoma (AJCC Stage III or IV)|metastatic melanoma (ajcc stage iii or iv)
5276114|NCT00521040|Levocetirizine dihydrochloride|levocetirizine dihydrochloride
5276115|NCT00521040|Xyzal tablets|xyzal tablets
5276116|NCT00521027|Debridement|debridement
5276117|NCT00521027|hydrosurgery|hydrosurgery
5276118|NCT00521027|Versajet|versajet
5276119|NCT00521027|leg ulcer|leg ulcer
5276120|NCT00521014|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5276121|NCT00521014|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5276122|NCT00521014|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5276123|NCT00521001|stage IV melanoma|stage iv melanoma
5276124|NCT00520988|hypertension|hypertension
5276125|NCT00520988|intervention|intervention
5276126|NCT00520988|disease management|disease management
5276127|NCT00520988|telephone-based|telephone-based
5276128|NCT00520988|Hypertension: diagnosed but uncontrolled|hypertension: diagnosed but uncontrolled
5276129|NCT00520975|Trastuzumab|trastuzumab
5276130|NCT00520975|Bevacizumab|bevacizumab
5276131|NCT00520975|Metastatic Breast Cancer|metastatic breast cancer
5276132|NCT00520975|HER2/NEU|her2/neu
5276133|NCT00520962|cardiovascular disease|cardiovascular disease
5276134|NCT00520962|glucose intolerance|glucose intolerance
5276135|NCT00520962|type 2 diabetes|type 2 diabetes
5276136|NCT00520962|endothelial dysfunction|endothelial dysfunction
5276137|NCT00520962|inflammation|inflammation
5276138|NCT00520962|Age> 30 years, male and female|age> 30 years, male and female
5276139|NCT00520962|Fasting glucose below 126 mg/dl|fasting glucose below 126 mg/dl
5276140|NCT00520949|H.pylori|h.pylori
5276141|NCT00520949|Triple therapy failure|triple therapy failure
5276142|NCT00520949|Quadruple therapy|quadruple therapy
5276143|NCT00520910|Polypodium leucotomos, Ultraviolet Rays, Heliocare, calaguala, anapsos|polypodium leucotomos, ultraviolet rays, heliocare, calaguala, anapsos
5276144|NCT00520910|Skin Aging and Damage|skin aging and damage
5276145|NCT00520897|chronic HIV infection|chronic hiv infection
5276146|NCT00520897|Human Immunodeficiency Virus|human immunodeficiency virus
5276147|NCT00520897|Treatment Experienced|treatment experienced
5276148|NCT00520884|frailty|frailty
5276149|NCT00520884|ghrelin|ghrelin
5276150|NCT00520884|appetite|appetite
5276151|NCT00520884|weight loss|weight loss
5276152|NCT00520871|Cardiovascular disease|cardiovascular disease
5276153|NCT00520871|Blueberruy|blueberruy
5276154|NCT00520871|Antioxidants|antioxidants
5276155|NCT00520871|Oxidative stress|oxidative stress
5276156|NCT00520871|Inflammation|inflammation
5276157|NCT00520845|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5276158|NCT00520845|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5276159|NCT00520845|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5276160|NCT00520845|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5276161|NCT00520832|Primary Insomnia|primary insomnia
5276162|NCT00520832|Microcurrent Therapy|microcurrent therapy
5276163|NCT00520832|Sleep Surveys|sleep surveys
5276164|NCT00520819|Antioxidants|antioxidants
5276165|NCT00520819|Phytochemicals|phytochemicals
5276166|NCT00520819|Oxidative stress|oxidative stress
5276167|NCT00520819|Inflammation|inflammation
5276168|NCT00520819|Endothelial function|endothelial function
5276169|NCT00520806|Heart failure|heart failure
5276170|NCT00520806|Renal dysfunction|renal dysfunction
5276171|NCT00520806|Relaxin|relaxin
5276172|NCT00520806|Vasodilator|vasodilator
5276173|NCT00520780|Chronic Heart Failure|chronic heart failure
5276174|NCT00520780|Iron deficiency|iron deficiency
5276175|NCT00520780|Iron deficiency anaemia|iron deficiency anaemia
5276176|NCT00520780|Anaemia|anaemia
5276177|NCT00520780|Heart disease|heart disease
5276178|NCT00520767|primary systemic amyloidosis|primary systemic amyloidosis
5276179|NCT00520767|light chain deposition disease|light chain deposition disease
5276180|NCT00520754|levocetirizine dihydrochloride Xyzal tablets|levocetirizine dihydrochloride xyzal tablets
5276181|NCT00520741|Epilepsy|epilepsy
5276182|NCT00520741|Partial Onset Seizures|partial onset seizures
5276183|NCT00520741|Lacosamide|lacosamide
5276184|NCT00520741|Monotherapy|monotherapy
5276185|NCT00520741|Vimpat|vimpat
5276186|NCT00520728|Schizophrenia|schizophrenia
5276187|NCT00520728|Psychosis|psychosis
5276188|NCT00520728|Occupational Disengagement|occupational disengagement
5276189|NCT00520728|Occupational Imbalance|occupational imbalance
5276190|NCT00520715|fluoroquinolone resistance|fluoroquinolone resistance
5276191|NCT00520715|commensal flora|commensal flora
5276192|NCT00520715|carriage|carriage
5276193|NCT00520702|Non-Small Cell Lung Cancer|non-small cell lung cancer
5276194|NCT00520702|Lung Cancer|lung cancer
5276195|NCT00520702|3-Dimensional Conformal Radiation Therapy|3-dimensional conformal radiation therapy
5276196|NCT00520702|Intensity Modulated Radiation Therapy|intensity modulated radiation therapy
5276197|NCT00520702|3D CRT|3d crt
5276198|NCT00520702|IMRT|imrt
5276199|NCT00520702|NSCLC|nsclc
5276201|NCT00520702|Treatment related pneumonitis|treatment related pneumonitis
5276202|NCT00520663|Distribution,|distribution,
5276203|NCT00520663|SB-649868,|sb-649868,
5276204|NCT00520663|Healthy,|healthy,
5276205|NCT00520663|Excretion,|excretion,
5276206|NCT00520663|Sleep disturbances|sleep disturbances
5276207|NCT00520663|Volunteer,|volunteer,
5276208|NCT00520663|Metabolism,|metabolism,
5276209|NCT00520663|Absorption,|absorption,
5276210|NCT00520624|EIL|eil
5276211|NCT00520611|Obesity|obesity
5276212|NCT00520611|Weight Loss|weight loss
5276213|NCT00520611|Financial Incentives|financial incentives
5276214|NCT00520611|Lottery|lottery
5276215|NCT00520611|Deposit|deposit
5276216|NCT00520585|atorvastatin|atorvastatin
5276217|NCT00520585|repolarisation|repolarisation
5276218|NCT00520585|cardiomyocytes|cardiomyocytes
5276219|NCT00520572|Rheumatoid Arthritis|rheumatoid arthritis
5276220|NCT00520546|PET|pet
5276221|NCT00520546|MRI|mri
5276222|NCT00520546|Choline|choline
5276223|NCT00520546|FEC|fec
5276224|NCT00520546|prostate cancer|prostate cancer
5276225|NCT00520533|Clinical trials|clinical trials
5276226|NCT00520533|cG250 mAb|cg250 mab
5276227|NCT00520533|monoclonal antibody G250|monoclonal antibody g250
5276228|NCT00520533|sunitinib|sunitinib
5276229|NCT00520533|angiogenesis inhibitors|angiogenesis inhibitors
5276230|NCT00520533|Positron-Emission Tomography|positron-emission tomography
5276231|NCT00520533|Pharmacokinetics|pharmacokinetics
5276232|NCT00520533|Pharmacodynamics|pharmacodynamics
5276233|NCT00520520|post resuscitation|post resuscitation
5276234|NCT00520520|post ventricular fibrillation|post ventricular fibrillation
5276235|NCT00520520|patients receiving mild therapeutic hypothermia|patients receiving mild therapeutic hypothermia
5276236|NCT00520507|Depression|depression
5276237|NCT00520507|Bipolar Disorder|bipolar disorder
5276238|NCT00520507|Major|major
5276239|NCT00520494|Previously Untreated Patient (PUP)|previously untreated patient (pup)
5276240|NCT00520494|Primary Immunodeficiency (PID)|primary immunodeficiency (pid)
5276241|NCT00520494|CVID|cvid
5276242|NCT00520494|XLA|xla
5276243|NCT00520494|Subcutaneous immunoglobulin (SCIG)|subcutaneous immunoglobulin (scig)
5276244|NCT00520494|IgG trough level|igg trough level
5276245|NCT00520494|Quality of life|quality of life
5276246|NCT00520494|Common variable immunodeficiency (CVID)|common variable immunodeficiency (cvid)
5276247|NCT00520494|X-linked agammaglobulinemia (XLA)|x-linked agammaglobulinemia (xla)
5276248|NCT00520481|prostate cancer|prostate cancer
5276249|NCT00520468|Myelodysplastic Syndrome|myelodysplastic syndrome
5276250|NCT00520468|MDS|mds
5276251|NCT00520468|Erythropoietin|erythropoietin
5276252|NCT00520468|Darbepoetin alfa|darbepoetin alfa
5276253|NCT00520468|Aranesp|aranesp
5276254|NCT00520468|Erythropoiesis stimulating protein|erythropoiesis stimulating protein
5276255|NCT00520468|G-CSF|g-csf
5276256|NCT00520468|Filgrastim|filgrastim
5276257|NCT00520468|Neupogen|neupogen
5276258|NCT00520468|Prednisone|prednisone
5276259|NCT00520468|Cyclosporin A|cyclosporin a
5276260|NCT00520468|Sandimmune|sandimmune
5276261|NCT00520468|CYA|cya
5276262|NCT00520468|Cyclosporine|cyclosporine
5276263|NCT00520442|fracture|fracture
5276264|NCT00520429|Depression|depression
5276265|NCT00520429|Anxiety|anxiety
5276266|NCT00520429|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
5276267|NCT00520429|Heart Failure, Congestive|heart failure, congestive
5276268|NCT00520377|Sinus Lift Surgery|sinus lift surgery
5276269|NCT00520377|Sinus Floor Augmentation|sinus floor augmentation
5276270|NCT00520377|Insufficient Bone Height|insufficient bone height
5276271|NCT00520338|celecoxib|celecoxib
5276272|NCT00520338|postoperative pain|postoperative pain
5276273|NCT00520338|thyroidectomy|thyroidectomy
5276274|NCT00520325|MBL deficient oncologic hematologic pediatric fever neutropenia|mbl deficient oncologic hematologic pediatric fever neutropenia
5276275|NCT00520312|Peripheral Arterial Disease|peripheral arterial disease
5276276|NCT00520312|PAD|pad
5276277|NCT00520312|Functional Impairment|functional impairment
5276278|NCT00520312|Magnetic Resonance Imaging|magnetic resonance imaging
5276279|NCT00520299|metastatic melanoma|metastatic melanoma
5276280|NCT00520299|ADI|adi
5276281|NCT00520299|ADI-PEG 20|adi-peg 20
5276282|NCT00520299|ADI SS PEG 20,000mw|adi ss peg 20,000mw
5276283|NCT00520299|arginine|arginine
5276284|NCT00520299|enzyme therapy|enzyme therapy
5276285|NCT00520286|Methamphetamine Dependence|methamphetamine dependence
5276286|NCT00520247|enalapril|enalapril
5276287|NCT00520247|folic acid|folic acid
5276288|NCT00520247|hyperglycemia|hyperglycemia
5276289|NCT00520247|hypertension|hypertension
5276290|NCT00520247|fasting plasma glucose|fasting plasma glucose
5276291|NCT00520234|Candida|candida
5276292|NCT00520234|Prophylaxis|prophylaxis
5276293|NCT00520234|High risk adults|high risk adults
5276294|NCT00520234|Intensive care unit (ICU)|intensive care unit (icu)
5276295|NCT00520221|minocycline|minocycline
5276296|NCT00520221|pleurodesis|pleurodesis
5276297|NCT00520221|aspiration|aspiration
5276298|NCT00520221|pneumothorax|pneumothorax
5276299|NCT00520221|Primary spontaneous pneumothorax|primary spontaneous pneumothorax
5276300|NCT00520221|First attack|first attack
5276301|NCT00520221|Successful aspiration|successful aspiration
5276302|NCT00520208|ATRA|atra
5276303|NCT00520208|Trisenox|trisenox
5276304|NCT00520208|Arsenic|arsenic
5276305|NCT00520208|Arsenic Trioxide|arsenic trioxide
5276306|NCT00520208|APL|apl
5276307|NCT00520169|bioavailability|bioavailability
5276308|NCT00520143|GSD-II, Pompe Disease, Glycogen Storage Disease II|gsd-ii, pompe disease, glycogen storage disease ii
5276309|NCT00520130|Unrelated Donors|unrelated donors
5276310|NCT00520130|Reduced Intensity Stem Cell Transplant|reduced intensity stem cell transplant
5276311|NCT00520130|Leukemia|leukemia
5276312|NCT00520130|Lymphoma|lymphoma
5276313|NCT00520130|Allogeneic Stem Cell Transplant|allogeneic stem cell transplant
5276314|NCT00520130|Myelodysplastic Syndrome|myelodysplastic syndrome
5276315|NCT00520130|Multiple Myeloma|multiple myeloma
5276316|NCT00520091|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
5276317|NCT00520091|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
5276318|NCT00520091|stage II esophageal cancer|stage ii esophageal cancer
5276319|NCT00520091|stage III esophageal cancer|stage iii esophageal cancer
5276320|NCT00520091|stage IV esophageal cancer|stage iv esophageal cancer
5276321|NCT00520052|bisphosphonates, prostate cancer, bone density, osteoporosis|bisphosphonates, prostate cancer, bone density, osteoporosis
5276322|NCT00520039|Otitis Media|otitis media
5276323|NCT00520039|Effusion|effusion
5276324|NCT00520039|OMM|omm
5276325|NCT00520039|OMT|omt
5276326|NCT00520039|Resolution|resolution
5276327|NCT00520026|suicide|suicide
5276328|NCT00520026|prevention|prevention
5276329|NCT00520026|lithium|lithium
5276330|NCT00520026|suicidality|suicidality
5276331|NCT00520000|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5276332|NCT00519987|pharmacokinetics|pharmacokinetics
5276333|NCT00519974|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
5276334|NCT00519974|stage I breast cancer|stage i breast cancer
5276335|NCT00519974|stage II breast cancer|stage ii breast cancer
5276336|NCT00519974|stage IIIA breast cancer|stage iiia breast cancer
5276337|NCT00519974|stage IIIB breast cancer|stage iiib breast cancer
5276338|NCT00519974|stage IIIC breast cancer|stage iiic breast cancer
5276339|NCT00519974|stage IV breast cancer|stage iv breast cancer
5276340|NCT00519974|recurrent breast cancer|recurrent breast cancer
5276341|NCT00519935|Insulin Dependent Diabetes Mellitus|insulin dependent diabetes mellitus
5276342|NCT00519935|family therapy|family therapy
5276343|NCT00519935|adolescents|adolescents
5276344|NCT00519909|dairy products, calcium, fat excretion, energy excretion|dairy products, calcium, fat excretion, energy excretion
5276345|NCT00519883|Anastrozole|anastrozole
5276346|NCT00519883|Exercise|exercise
5276347|NCT00519870|Pulmonary hypertension|pulmonary hypertension
5276348|NCT00519870|Angiotensin receptor blocker|angiotensin receptor blocker
5276349|NCT00519870|Calcium channel blocker|calcium channel blocker
5276350|NCT00519831|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5276351|NCT00519831|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5276352|NCT00519831|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5276353|NCT00519818|Congenital Adrenal Hyperplasia|congenital adrenal hyperplasia
5276354|NCT00519818|Hydrocortisone|hydrocortisone
5276355|NCT00519818|Pharmacokinetic|pharmacokinetic
5276356|NCT00519818|Pharmacodynamic|pharmacodynamic
5276357|NCT00519805|thromboembolism|thromboembolism
5276358|NCT00519805|extensive stage small cell lung cancer|extensive stage small cell lung cancer
5276359|NCT00519805|limited stage small cell lung cancer|limited stage small cell lung cancer
5276360|NCT00519805|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5276361|NCT00519805|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
5276362|NCT00519805|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5276363|NCT00519805|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5276364|NCT00519805|stage I non-small cell lung cancer|stage i non-small cell lung cancer
5276365|NCT00519792|Relapse|relapse
5276366|NCT00519792|HCV|hcv
5276367|NCT00519792|Hepatitis C|hepatitis c
5276368|NCT00519792|Interferon|interferon
5276369|NCT00519792|Ribavirin|ribavirin
5276370|NCT00519779|affect|affect
5276371|NCT00519779|inflammation|inflammation
5276372|NCT00519766|Ratio of 3-Hydroxycotinine to Cotinine|ratio of 3-hydroxycotinine to cotinine
5276373|NCT00519766|Nicotine Metabolism|nicotine metabolism
5276374|NCT00519766|Pregnancy|pregnancy
5276375|NCT00519753|Glaucoma|glaucoma
5276376|NCT00519740|grass-pollen|grass-pollen
5276377|NCT00519740|allergy|allergy
5276378|NCT00519740|bronchial hyperreactivity|bronchial hyperreactivity
5276379|NCT00519740|asthma|asthma
5276380|NCT00519727|diabetes|diabetes
5276381|NCT00519701|sickle cell anemia|sickle cell anemia
5276382|NCT00519701|hydroxyurea|hydroxyurea
5276383|NCT00519688|tegafur|tegafur
5276384|NCT00519688|thalidomide|thalidomide
5276385|NCT00519688|advanced hepatocellular carcinoma|advanced hepatocellular carcinoma
5276386|NCT00519675|Chronic hand eczema|chronic hand eczema
5276387|NCT00519675|Chronic hand dermatitis|chronic hand dermatitis
5276388|NCT00519675|Patients with chronic hand eczema, who are refractory to topical corticosteroids|patients with chronic hand eczema, who are refractory to topical corticosteroids
5276389|NCT00519662|Solid|solid
5276390|NCT00519662|Tumors|tumors
5276391|NCT00519662|Advanced|advanced
5276392|NCT00519649|Hepatitis B vaccine|hepatitis b vaccine
5276393|NCT00519649|Challenge dose|challenge dose
5276394|NCT00519636|experience|experience
5276395|NCT00519636|GW685698X|gw685698x
5276396|NCT00519636|fluticasone furoate|fluticasone furoate
5276397|NCT00519636|preference|preference
5276398|NCT00519636|seasonal allergic rhinitis|seasonal allergic rhinitis
5276399|NCT00519636|fluticasone propionate|fluticasone propionate
5276400|NCT00519623|diabetes|diabetes
5276401|NCT00519623|insulin|insulin
5276402|NCT00519623|blood sugar|blood sugar
5276403|NCT00519623|type 1 diabetes|type 1 diabetes
5276404|NCT00519623|insulin dependent diabetes|insulin dependent diabetes
5276405|NCT00519623|transdermal|transdermal
5276406|NCT00519610|portal hypertension, H-graft shunt|portal hypertension, h-graft shunt
5276407|NCT00519597|Coronary Artery Disease|coronary artery disease
5276408|NCT00519597|Sleep Apnea|sleep apnea
5276409|NCT00519597|CPAP|cpap
5276410|NCT00519597|Revascularization|revascularization
5276411|NCT00519597|Mortality|mortality
5276412|NCT00519584|Interscalene nerve block|interscalene nerve block
5276413|NCT00519584|Dexamethasone|dexamethasone
5276414|NCT00519584|Ropivacaine|ropivacaine
5276415|NCT00519571|Dental Implantation, Endosseous|dental implantation, endosseous
5276416|NCT00519545|breast|breast
5276417|NCT00519545|cancer|cancer
5276418|NCT00519545|stage|stage
5276419|NCT00519545|one|one
5276420|NCT00519545|four|four
5276421|NCT00519532|Neupro®|neupro®
5276422|NCT00519532|Rotigotine|rotigotine
5276423|NCT00519532|Parkinson's Disease|parkinson's disease
5276424|NCT00519519|Rebleeding after endoscopic therapy|rebleeding after endoscopic therapy
5276425|NCT00519506|Pulmonary Embolism|pulmonary embolism
5276426|NCT00519506|PE|pe
5276427|NCT00519493|Clozex|clozex
5276428|NCT00519493|Sutures|sutures
5276429|NCT00519480|Tolerability|tolerability
5276430|NCT00519480|GSK189075,|gsk189075,
5276431|NCT00519480|Metformin,|metformin,
5276432|NCT00519480|Safety,|safety,
5276433|NCT00519480|Diabetes,|diabetes,
5276434|NCT00519467|dose-ranging study|dose-ranging study
5276435|NCT00519467|SB-714703|sb-714703
5276436|NCT00519467|artesunate,|artesunate,
5276437|NCT00519467|malaria|malaria
5276438|NCT00519467|CDA,|cda,
5276439|NCT00519467|chlorproguanil,|chlorproguanil,
5276440|NCT00519467|dapsone,|dapsone,
5276441|NCT00519454|Systemic Lupus Erythematosus|systemic lupus erythematosus
5276442|NCT00519454|Estrogen receptors|estrogen receptors
5276443|NCT00519454|T cells|t cells
5276444|NCT00519454|Hormones|hormones
5276445|NCT00519454|Female adult SLE|female adult sle
5276446|NCT00519441|laparoscopic Heller myotomy, achalasia, reflux|laparoscopic heller myotomy, achalasia, reflux
5276447|NCT00519428|depression|depression
5276448|NCT00519428|Major Depressive Disorder|major depressive disorder
5276449|NCT00519415|Tongue plate|tongue plate
5276450|NCT00519415|Facemask|facemask
5276451|NCT00519415|class III maxillary deficiency|class iii maxillary deficiency
5276452|NCT00519415|orthodontic angle class three|orthodontic angle class three
5276453|NCT00519402|partial tonsillectomy|partial tonsillectomy
5276454|NCT00519402|complete tonsillectomy|complete tonsillectomy
5276455|NCT00519402|tonsillectomy|tonsillectomy
5276456|NCT00519402|obstruction sleep disordered breathing OSDB|obstruction sleep disordered breathing osdb
5276457|NCT00519402|apnea|apnea
5276458|NCT00519376|pharmacodynamics,|pharmacodynamics,
5276459|NCT00519376|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
5276460|NCT00519376|safety,|safety,
5276461|NCT00519376|COPD patients|copd patients
5276462|NCT00519376|pharmacokinetics,|pharmacokinetics,
5276463|NCT00519376|tolerability,|tolerability,
5276464|NCT00519376|GW642444,|gw642444,
5276465|NCT00519363|Lupus|lupus
5276466|NCT00519363|TLR's|tlr's
5276467|NCT00519363|Hyperlipidemia|hyperlipidemia
5276468|NCT00519363|age eighteen to sixty|age eighteen to sixty
5276469|NCT00519363|female with SLE|female with sle
5276470|NCT00519363|SLEDAI, greater than four|sledai, greater than four
5276595|NCT00518895|antisense|antisense
5276471|NCT00519363|LDL cholesterol elevated|ldl cholesterol elevated
5276472|NCT00519350|SIRS, sepsis and related syndromes|sirs, sepsis and related syndromes
5276473|NCT00519337|Atrial Fibrillation|atrial fibrillation
5276474|NCT00519337|cardiac surgery|cardiac surgery
5276475|NCT00519337|ascorbic acid|ascorbic acid
5276476|NCT00519337|vitamin-c|vitamin-c
5276477|NCT00519337|inflammation|inflammation
5276478|NCT00519324|Gastric Cancer|gastric cancer
5276479|NCT00519324|RAD001|rad001
5276480|NCT00519324|mTOR|mtor
5276481|NCT00519311|Intellectual disability|intellectual disability
5276482|NCT00519311|Health promotion|health promotion
5276484|NCT00519298|Alzheimer Disease|alzheimer disease
5276485|NCT00519285|metastatic|metastatic
5276486|NCT00519285|prostate|prostate
5276487|NCT00519285|cancer|cancer
5276488|NCT00519272|Cervical Cancer|cervical cancer
5276489|NCT00519272|Cervix|cervix
5276490|NCT00519272|Precancerous Lesions|precancerous lesions
5276491|NCT00519272|Cervical carcinoma in situ|cervical carcinoma in situ
5276492|NCT00519272|CIS|cis
5276493|NCT00519272|Early cervical cancer detection and treatment|early cervical cancer detection and treatment
5276494|NCT00519272|Barriers to Care|barriers to care
5276495|NCT00519272|Harris County|harris county
5276496|NCT00519272|Questionnaire|questionnaire
5276497|NCT00519246|Breast Neoplasms|breast neoplasms
5276498|NCT00519246|Non-Steroidal Anti-Inflammatory Agents|non-steroidal anti-inflammatory agents
5276499|NCT00519246|Analgesia|analgesia
5276500|NCT00519233|HRPC|hrpc
5276501|NCT00519233|Advanced hormone refractory prostate cancer|advanced hormone refractory prostate cancer
5276502|NCT00519220|achalasia, Heller myotomy|achalasia, heller myotomy
5276503|NCT00519207|pediatrics|pediatrics
5276504|NCT00519207|pain|pain
5276505|NCT00519207|infants|infants
5276506|NCT00519207|newborn screening|newborn screening
5276507|NCT00519207|venipuncture|venipuncture
5276508|NCT00519207|lidocaine|lidocaine
5276509|NCT00519207|sucrose|sucrose
5276510|NCT00519194|Arrhythmia|arrhythmia
5276511|NCT00519194|Atrial Fibrillation|atrial fibrillation
5276512|NCT00519181|HTLV|htlv
5276513|NCT00519181|HAM/TSP|ham/tsp
5276514|NCT00519181|VALPROIC ACID|valproic acid
5276515|NCT00519181|PROVIRAL LOAD|proviral load
5276516|NCT00519129|Pain|pain
5276517|NCT00519129|Patient satisfaction|patient satisfaction
5276518|NCT00519103|microarray|microarray
5276519|NCT00519103|Inflammtion|inflammtion
5276520|NCT00519103|fibrosis|fibrosis
5276521|NCT00519090|leukemia|leukemia
5276522|NCT00519090|bone marrow|bone marrow
5276523|NCT00519090|leukemia symptoms|leukemia symptoms
5276524|NCT00519090|cml|cml
5276525|NCT00519090|complete blood count|complete blood count
5276526|NCT00519090|lymphocyte|lymphocyte
5276527|NCT00519090|blood cancer|blood cancer
5276528|NCT00519090|leukocytes|leukocytes
5276529|NCT00519090|chronic leukemia|chronic leukemia
5276530|NCT00519090|bone marrow biopsy|bone marrow biopsy
5276531|NCT00519090|leukemia research|leukemia research
5276532|NCT00519090|leukemia cells|leukemia cells
5276533|NCT00519090|bone marrow disease|bone marrow disease
5276534|NCT00519090|chronic myeloid leukemia|chronic myeloid leukemia
5276535|NCT00519090|blood cancer symptoms|blood cancer symptoms
5276536|NCT00519090|white blood cell diseases|white blood cell diseases
5276537|NCT00519090|chronic myelogenous leukemia|chronic myelogenous leukemia
5276538|NCT00519090|leukemia treatment|leukemia treatment
5276539|NCT00519090|leukemia facts|leukemia facts
5276540|NCT00519090|leucemia|leucemia
5276541|NCT00519090|facts about leukemia|facts about leukemia
5276542|NCT00519090|myelogenous leukemia|myelogenous leukemia
5276543|NCT00519090|newly diagnosed CML|newly diagnosed cml
5276544|NCT00519090|suboptimal response|suboptimal response
5276545|NCT00519090|Philadelphia chromosome positive (Ph+)|philadelphia chromosome positive (ph+)
5276546|NCT00519090|chronic myelogenous leukemia in chronic phase (CML-CP)|chronic myelogenous leukemia in chronic phase (cml-cp)
5276547|NCT00519077|cancer|cancer
5276548|NCT00519077|squamous cell|squamous cell
5276549|NCT00519077|carcinoma|carcinoma
5276550|NCT00519077|head|head
5276551|NCT00519077|neck|neck
5276552|NCT00519064|influenza|influenza
5276553|NCT00519064|influenza vaccine|influenza vaccine
5276554|NCT00519064|adjuvanted influenza vaccine|adjuvanted influenza vaccine
5276555|NCT00519064|H5N1 influenza antigen|h5n1 influenza antigen
5276556|NCT00519051|depression|depression
5276557|NCT00519051|primary care|primary care
5276558|NCT00519051|pharmacotherapy|pharmacotherapy
5276559|NCT00519038|Critical Pathways|critical pathways
5276560|NCT00519038|Congestive Heart Failure|congestive heart failure
5276561|NCT00519038|Randomized Controlled Trial|randomized controlled trial
5276562|NCT00519038|Effectiveness|effectiveness
5276563|NCT00519025|Linezolid|linezolid
5276564|NCT00519025|Staphylococcus Aureus|staphylococcus aureus
5276565|NCT00519025|Infections|infections
5276566|NCT00519012|early nonresponse|early nonresponse
5276567|NCT00518999|cognition, attention, memory, executive functions, illness-awareness, insight.|cognition, attention, memory, executive functions, illness-awareness, insight.
5276568|NCT00518986|Obstructive Sleep Apnea/Hypopnea Syndrome|obstructive sleep apnea/hypopnea syndrome
5276569|NCT00518986|Excessive Sleepiness|excessive sleepiness
5276570|NCT00518960|ProAlgaZyme|proalgazyme
5276571|NCT00518960|Algae|algae
5276572|NCT00518960|High density lipoprotein; HDL|high density lipoprotein; hdl
5276573|NCT00518960|C-Reactive Protein; CRP|c-reactive protein; crp
5276574|NCT00518960|Hyperlipidemia|hyperlipidemia
5276575|NCT00518960|Metabolic Syndrome|metabolic syndrome
5276576|NCT00518947|Bipolar Disorder|bipolar disorder
5276577|NCT00518947|Mania|mania
5276578|NCT00518947|Antimanic|antimanic
5276579|NCT00518947|Verapamil|verapamil
5276580|NCT00518947|Lithium|lithium
5276581|NCT00518934|Safety and efficiency of angiogenesis for patients with limb|safety and efficiency of angiogenesis for patients with limb
5276582|NCT00518934|ischemia by transplantation of human cord blood mononuclear|ischemia by transplantation of human cord blood mononuclear
5276583|NCT00518934|cells|cells
5276584|NCT00518921|adenosin agonist|adenosin agonist
5276585|NCT00518921|chronic stable angina|chronic stable angina
5276586|NCT00518908|Ischemia reperfusion injury|ischemia reperfusion injury
5276587|NCT00518908|Organ protection|organ protection
5276588|NCT00518895|Melanoma|melanoma
5276589|NCT00518895|Advanced Melanoma|advanced melanoma
5276590|NCT00518895|Malignant Melanoma|malignant melanoma
5276591|NCT00518895|Metastatic Melanoma|metastatic melanoma
5276592|NCT00518895|Skin Cancer|skin cancer
5276593|NCT00518895|Genasense|genasense
5276594|NCT00518895|oblimersen|oblimersen
5276596|NCT00518895|Bcl-2 antisense|bcl-2 antisense
5276597|NCT00518895|G3139|g3139
5276598|NCT00518895|dacarbazine|dacarbazine
5276599|NCT00518869|Non-Small Cell Lung Cancer (NSCLC)|non-small cell lung cancer (nsclc)
5276600|NCT00518869|Complementary and Alternative Medicine (CAM)|complementary and alternative medicine (cam)
5276601|NCT00518869|Chemotherapy|chemotherapy
5276602|NCT00518869|Myelosuppression|myelosuppression
5276603|NCT00518869|Quality of Life|quality of life
5276604|NCT00518869|Fatigue|fatigue
5276605|NCT00518869|EORTC QLQ-C30 and LC13|eortc qlq-c30 and lc13
5276606|NCT00518856|birth asphyxia|birth asphyxia
5276607|NCT00518856|neonatal sepsis|neonatal sepsis
5276608|NCT00518856|maternal to child transmission of HIV|maternal to child transmission of hiv
5276609|NCT00518843|binge eating|binge eating
5276610|NCT00518843|purging|purging
5276611|NCT00518830|postnatal depression|postnatal depression
5276612|NCT00518830|primary care|primary care
5276613|NCT00518830|depressed women|depressed women
5276614|NCT00518817|Dystrophy|dystrophy
5276615|NCT00518817|Cardiomyopathy|cardiomyopathy
5276616|NCT00518791|Integrated health care system|integrated health care system
5276617|NCT00518791|Treatment effectiveness|treatment effectiveness
5276618|NCT00518791|Cost effectiveness|cost effectiveness
5276619|NCT00518791|Program evaluation|program evaluation
5276620|NCT00518778|fusariosis|fusariosis
5276621|NCT00518778|solid organ transplants|solid organ transplants
5276622|NCT00518765|aliskiren, renal hemodynamics, hormonal response, renin pathway, RAAS biomarkers|aliskiren, renal hemodynamics, hormonal response, renin pathway, raas biomarkers
5276623|NCT00518752|Ventilator Acquired Pneumonia|ventilator acquired pneumonia
5276624|NCT00518752|Oral Hygiene|oral hygiene
5276625|NCT00518752|Oral Care|oral care
5276626|NCT00518752|Xerostomia|xerostomia
5276627|NCT00518726|Adjuvanted Influenza Vaccine|adjuvanted influenza vaccine
5276628|NCT00518713|Epilepsy|epilepsy
5276629|NCT00518713|Lennox-Gastaut Syndrome|lennox-gastaut syndrome
5276630|NCT00518713|Drop seizures|drop seizures
5276631|NCT00518713|Clobazam|clobazam
5276632|NCT00518674|pain|pain
5276633|NCT00518674|local infiltration analgesia|local infiltration analgesia
5276634|NCT00518661|quinolone resistance|quinolone resistance
5276635|NCT00518661|ESBL|esbl
5276636|NCT00518661|Klebsiella species|klebsiella species
5276637|NCT00518661|Infection|infection
5276638|NCT00518648|Accidental falls|accidental falls
5276639|NCT00518648|Prevention|prevention
5276640|NCT00518648|Treatment effectiveness|treatment effectiveness
5276641|NCT00518635|Growth hormone|growth hormone
5276642|NCT00518635|Insulin sensitivity|insulin sensitivity
5276643|NCT00518635|Polycystic ovary|polycystic ovary
5276644|NCT00518609|Neonatal|neonatal
5276645|NCT00518609|Sepsis|sepsis
5276646|NCT00518609|Global Network|global network
5276647|NCT00518609|Antibiotics|antibiotics
5276648|NCT00518609|India|india
5276649|NCT00518609|International|international
5276650|NCT00518609|Maternal and child health|maternal and child health
5276651|NCT00518596|Neonatal|neonatal
5276652|NCT00518596|Sepsis|sepsis
5276653|NCT00518596|Global Network|global network
5276654|NCT00518596|Probiotics|probiotics
5276655|NCT00518596|India|india
5276656|NCT00518596|International|international
5276657|NCT00518596|Maternal and child health|maternal and child health
5276658|NCT00518583|Breast cancer|breast cancer
5276659|NCT00518583|Over-expressing Her2-neu|over-expressing her2-neu
5276660|NCT00518570|PMDD|pmdd
5276661|NCT00518570|PMS|pms
5276662|NCT00518570|Levetiracetam|levetiracetam
5276663|NCT00518557|liver cancer|liver cancer
5276664|NCT00518557|interventional radiology|interventional radiology
5276665|NCT00518557|Chemoembolization|chemoembolization
5276666|NCT00518557|Safety|safety
5276667|NCT00518557|Effectiveness|effectiveness
5276668|NCT00518544|hydroxyethyl starch, blood type, coagulation|hydroxyethyl starch, blood type, coagulation
5276669|NCT00518531|osteoporosis|osteoporosis
5276670|NCT00518531|low bone mineral density|low bone mineral density
5276671|NCT00518531|alendronate|alendronate
5276672|NCT00518531|denosumab|denosumab
5276673|NCT00518531|adherence|adherence
5276674|NCT00518531|preference|preference
5276675|NCT00518531|satisfaction|satisfaction
5276676|NCT00518531|postmenopausal|postmenopausal
5276677|NCT00518531|women|women
5276678|NCT00518518|Asthma|asthma
5276679|NCT00518518|Sublingual immunotherapy|sublingual immunotherapy
5276680|NCT00518518|Children|children
5276681|NCT00518505|GERD, laparoscopic surgery|gerd, laparoscopic surgery
5276682|NCT00518479|Hypertension|hypertension
5276683|NCT00518479|Left Ventricular Hypertrophy|left ventricular hypertrophy
5276684|NCT00518466|Obesity|obesity
5276685|NCT00518453|Influenza vaccine|influenza vaccine
5276686|NCT00518440|Liver disease|liver disease
5276687|NCT00518440|Liver injury|liver injury
5276688|NCT00518414|infant, formula, LC PUFA|infant, formula, lc pufa
5276689|NCT00518401|A hypoperfusion of the blood through a leg|a hypoperfusion of the blood through a leg
5276690|NCT00518401|Stem cells|stem cells
5276691|NCT00518401|Stem cell transplantation|stem cell transplantation
5276692|NCT00518401|Stem cell autologous transplantation|stem cell autologous transplantation
5276693|NCT00518388|Epidemiology|epidemiology
5276694|NCT00518388|Cervical Cancer|cervical cancer
5276695|NCT00518388|Human Papillomavirus|human papillomavirus
5276696|NCT00518388|Focus Group|focus group
5276697|NCT00518388|Questionnaire|questionnaire
5276698|NCT00518388|Survey|survey
5276699|NCT00518388|HPV|hpv
5276700|NCT00518362|TW|tw
5276701|NCT00518362|Valsartan|valsartan
5276702|NCT00518362|treatment|treatment
5276703|NCT00518362|diabetic nephropathy|diabetic nephropathy
5276704|NCT00518362|Proteinuria|proteinuria
5276705|NCT00518323|Schizophrenia|schizophrenia
5276706|NCT00518323|Antipsychotic|antipsychotic
5276707|NCT00518310|Interstitial lung disease|interstitial lung disease
5276708|NCT00518310|Idiopathic pulmonary fibrosis|idiopathic pulmonary fibrosis
5276709|NCT00518310|Usual interstitial pneumonia|usual interstitial pneumonia
5276710|NCT00518310|Cryptogenic fibrosing alveolitis|cryptogenic fibrosing alveolitis
5276711|NCT00518310|Therapy|therapy
5276712|NCT00518310|Azathioprine|azathioprine
5276713|NCT00518310|Steroids|steroids
5276714|NCT00518310|Glucocorticoids|glucocorticoids
5276715|NCT00518310|Corticosteroids|corticosteroids
5276716|NCT00518310|Prednisone|prednisone
5276717|NCT00518297|Antivirals / HIV|antivirals / hiv
5276718|NCT00518284|Restenosis|restenosis
5276719|NCT00518284|Superficial Femoral Artery|superficial femoral artery
5276720|NCT00518284|Prevention of restenosis|prevention of restenosis
5276721|NCT00518284|Revascularization of the superficial Femoral Artery|revascularization of the superficial femoral artery
5276722|NCT00518258|Parkinson's Disease|parkinson's disease
5276723|NCT00518258|Magnetic Resonance Imaging (MRI)|magnetic resonance imaging (mri)
5276724|NCT00518258|neuropsychological assessment|neuropsychological assessment
5276725|NCT00518245|unstable angina|unstable angina
5276726|NCT00518245|drug therapy|drug therapy
5276727|NCT00518245|myocardial ischemia|myocardial ischemia
5276728|NCT00518245|myocardial infarction|myocardial infarction
5276729|NCT00518245|hemorrhage|hemorrhage
5276730|NCT00518232|Methylphenidate|methylphenidate
5276731|NCT00518232|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
5276733|NCT00518219|Valsartan|valsartan
5276734|NCT00518219|treatment|treatment
5276735|NCT00518219|membranous nephropathy|membranous nephropathy
5276736|NCT00518219|proteinuria|proteinuria
5276737|NCT00518206|Clinical Trial|clinical trial
5276738|NCT00518206|Phase 2|phase 2
5276739|NCT00518206|Cancer Vaccine|cancer vaccine
5276740|NCT00518206|NY-ESO-1 protein, human|ny-eso-1 protein, human
5276741|NCT00518206|ISCOMATRIX, immunological adjuvant|iscomatrix, immunological adjuvant
5276742|NCT00518206|Cyclophosphamide|cyclophosphamide
5276743|NCT00518206|T-Cells, Regulatory|t-cells, regulatory
5276744|NCT00518180|Meningococcal|meningococcal
5276745|NCT00518180|meningitis|meningitis
5276746|NCT00518180|vaccine|vaccine
5276747|NCT00518180|adolescents|adolescents
5276748|NCT00518167|Type 2 diabetes|type 2 diabetes
5276749|NCT00518167|primary prevention|primary prevention
5276750|NCT00518167|diet|diet
5276751|NCT00518167|physical activity|physical activity
5276752|NCT00518167|intervention|intervention
5276753|NCT00518167|impaired glucose tolerance|impaired glucose tolerance
5276754|NCT00518167|lifestyle|lifestyle
5276755|NCT00518167|randomized controlled study|randomized controlled study
5276756|NCT00518154|AIDS|aids
5276757|NCT00518154|Immunological non-responders|immunological non-responders
5276758|NCT00518154|Neuroimmune modulation|neuroimmune modulation
5276759|NCT00518154|Pyridostigmine|pyridostigmine
5276760|NCT00518154|Treatment Experienced|treatment experienced
5276761|NCT00518128|Obstructive Sleep Apnea|obstructive sleep apnea
5276762|NCT00518128|Leptin|leptin
5276763|NCT00518128|Homocysteine|homocysteine
5276764|NCT00518128|C-reactive protein|c-reactive protein
5276765|NCT00518115|GLP-1,|glp-1,
5276766|NCT00518115|Type 2 Diabetes,|type 2 diabetes,
5276767|NCT00518115|pharmacokinetics,|pharmacokinetics,
5276768|NCT00518115|pharmacodynamics,|pharmacodynamics,
5276769|NCT00518115|GSK716155,|gsk716155,
5276770|NCT00518115|metformin,|metformin,
5276771|NCT00518115|exenatide|exenatide
5276772|NCT00518115|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
5276773|NCT00518102|REGRANEX (becaplermin)|regranex (becaplermin)
5276774|NCT00518102|Platelet-derived growth factor BB|platelet-derived growth factor bb
5276775|NCT00518102|Cancer|cancer
5276776|NCT00518102|Cancer incidence|cancer incidence
5276777|NCT00518102|Cancer mortality|cancer mortality
5276778|NCT00518076|Staphylococcus aureus carriers students nursing|staphylococcus aureus carriers students nursing
5276779|NCT00518050|Health Behaviors|health behaviors
5276780|NCT00518050|Surveillance|surveillance
5276781|NCT00518050|06-128|06-128
5276782|NCT00518024|tinnitus|tinnitus
5276783|NCT00518024|transcranial magnetic stimulation|transcranial magnetic stimulation
5276784|NCT00518024|treatment|treatment
5276785|NCT00518024|cortex|cortex
5276786|NCT00517998|Lung volume reduction|lung volume reduction
5276787|NCT00517998|Bronchoscopy|bronchoscopy
5276788|NCT00517998|Emphysema|emphysema
5276789|NCT00517998|COPD|copd
5276790|NCT00517998|NETT|nett
5276791|NCT00517998|Lung disease|lung disease
5276792|NCT00517998|COLD|cold
5276793|NCT00517998|BLVR|blvr
5276794|NCT00517985|perimenopausal depression|perimenopausal depression
5276795|NCT00517985|duloxetine|duloxetine
5276796|NCT00517985|cymbalta|cymbalta
5276797|NCT00517985|major depressive disorder|major depressive disorder
5276798|NCT00517985|women|women
5276799|NCT00517972|perimenopausal depression|perimenopausal depression
5276800|NCT00517972|omacor|omacor
5276801|NCT00517972|major depressive disorder|major depressive disorder
5276802|NCT00517972|women|women
5276803|NCT00517959|Stereotactic radiotherapy|stereotactic radiotherapy
5276804|NCT00517959|conformal radiotherapy|conformal radiotherapy
5276805|NCT00517959|late sequelae|late sequelae
5276806|NCT00517959|cognition|cognition
5276807|NCT00517959|endocrine dysfunction|endocrine dysfunction
5276808|NCT00517946|anti-allergy.|anti-allergy.
5276809|NCT00517946|seasonal allergic rhinitis (SAR),|seasonal allergic rhinitis (sar),
5276810|NCT00517946|intranasal allergen challenge,|intranasal allergen challenge,
5276811|NCT00517946|MRI,|mri,
5276812|NCT00517933|Idiopathic Pulmonary Fibrosis|idiopathic pulmonary fibrosis
5276813|NCT00517933|Pulmonary Hypertension|pulmonary hypertension
5276814|NCT00517894|lymphoma|lymphoma
5276815|NCT00517894|aggressive|aggressive
5276816|NCT00517894|chemotherapy|chemotherapy
5276817|NCT00517894|dose-dense|dose-dense
5276818|NCT00517868|bladder|bladder
5276819|NCT00517868|pain|pain
5276820|NCT00517868|urgency|urgency
5276821|NCT00517868|frequency|frequency
5276822|NCT00517842|Parkinson's disease|parkinson's disease
5276823|NCT00517829|metastatic gastric or adenocarcinoma of the GE junction|metastatic gastric or adenocarcinoma of the ge junction
5276824|NCT00517803|micronutrients|micronutrients
5276825|NCT00517803|immunodeficiency|immunodeficiency
5276826|NCT00517803|probiotics|probiotics
5276827|NCT00517803|yogurt|yogurt
5276828|NCT00517803|Healthy|healthy
5276829|NCT00517803|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5276830|NCT00517803|Complementary Therapies|complementary therapies
5276831|NCT00517790|Refractory|refractory
5276832|NCT00517790|Metastatic|metastatic
5276833|NCT00517777|sleep apnea syndrome|sleep apnea syndrome
5276834|NCT00517777|metabolic syndrome|metabolic syndrome
5276835|NCT00517777|cardiac remodelling|cardiac remodelling
5276836|NCT00517777|continuous positive airway pressure ventilation|continuous positive airway pressure ventilation
5276837|NCT00517764|major depressive disorder|major depressive disorder
5276838|NCT00517764|MDD|mdd
5276839|NCT00517764|escitalopram|escitalopram
5276840|NCT00517764|open-label|open-label
5276841|NCT00517764|major depression|major depression
5276842|NCT00517764|serotonin transporter|serotonin transporter
5276843|NCT00517764|brain-derived neurotrophic factor|brain-derived neurotrophic factor
5276844|NCT00517751|Lumbar Spinal Stenosis|lumbar spinal stenosis
5276845|NCT00517751|X-STOP Spacer|x-stop spacer
5276846|NCT00517751|Interspinous process decompression|interspinous process decompression
5276847|NCT00517751|Neurogenic Intermittent Claudication|neurogenic intermittent claudication
5276848|NCT00517725|exercise|exercise
5276849|NCT00517725|lung diffusion|lung diffusion
5276850|NCT00517725|hypoxia|hypoxia
5276851|NCT00517725|chemoreceptor|chemoreceptor
5276852|NCT00517725|beta-blockers|beta-blockers
5276853|NCT00517725|heart failure|heart failure
5276854|NCT00517712|Acute promyelocytic leukemia|acute promyelocytic leukemia
5276855|NCT00517712|Arsenic trioxide|arsenic trioxide
5276856|NCT00517712|Molecular remission|molecular remission
5276857|NCT00517712|Toxicity profile|toxicity profile
5276858|NCT00517712|Maintenance therapy|maintenance therapy
5276859|NCT00517686|Poor risk factor control|poor risk factor control
5276860|NCT00517686|Treatment intensification|treatment intensification
5276861|NCT00517686|Medication adherence|medication adherence
5276862|NCT00517686|Cardiovascular disease (CVD)|cardiovascular disease (cvd)
5276863|NCT00517673|Healthy Volunteer|healthy volunteer
5276864|NCT00517660|Healthy subjects|healthy subjects
5276865|NCT00517660|Lower Respiratory Tract Infections|lower respiratory tract infections
5276866|NCT00517660|Upper Respiratory Tract Infections|upper respiratory tract infections
5276867|NCT00517647|ADHD|adhd
5276868|NCT00517647|atomoxetine|atomoxetine
5276869|NCT00517647|preschool children|preschool children
5276870|NCT00517647|efficacy|efficacy
5276871|NCT00517647|safety|safety
5276872|NCT00517634|asthma|asthma
5276873|NCT00517634|allergen challenge|allergen challenge
5276874|NCT00517634|IL-5|il-5
5276875|NCT00517634|eosinophils|eosinophils
5276876|NCT00517621|Peritoneal cancer|peritoneal cancer
5276877|NCT00517621|Relapse or progression|relapse or progression
5276878|NCT00517595|Non-Small Cell Lung Cancer|non-small cell lung cancer
5276879|NCT00517582|ACE Inhibitor|ace inhibitor
5276880|NCT00517582|Angioedema|angioedema
5276881|NCT00517582|Bradykinin|bradykinin
5276882|NCT00517582|Swelling|swelling
5276883|NCT00517569|Gene Therapy|gene therapy
5276884|NCT00517569|GX-12|gx-12
5276885|NCT00517569|HIV-1|hiv-1
5276886|NCT00517569|Interleukin|interleukin
5276887|NCT00517569|AIDS|aids
5276888|NCT00517569|HIV-1 type B infection|hiv-1 type b infection
5276889|NCT00517569|Treatment Naive|treatment naive
5276890|NCT00517556|Dysmenorrhea|dysmenorrhea
5276891|NCT00517556|continuous OCP|continuous ocp
5276892|NCT00517543|inflammation|inflammation
5276893|NCT00517517|Pandemic influenza|pandemic influenza
5276894|NCT00517504|methylphenidate|methylphenidate
5276895|NCT00517504|ritalin|ritalin
5276896|NCT00517504|attention deficit hyperactivity disorder|attention deficit hyperactivity disorder
5276897|NCT00517504|developmental disorder|developmental disorder
5276898|NCT00517504|preschool children|preschool children
5276899|NCT00517426|heart failure,|heart failure,
5276900|NCT00517426|exercise|exercise
5276901|NCT00517426|periodic breathing,|periodic breathing,
5276902|NCT00517426|acetazolamide|acetazolamide
5276903|NCT00517400|PTSD|ptsd
5276904|NCT00517387|Depression|depression
5276905|NCT00517387|SSRI|ssri
5276906|NCT00517387|Atypical Antipsychotic|atypical antipsychotic
5276907|NCT00517387|Cognition|cognition
5276908|NCT00517387|Mood|mood
5276909|NCT00517387|Quality of Life|quality of life
5276910|NCT00517348|Adult|adult
5276911|NCT00517335|anorexia nervosa|anorexia nervosa
5276912|NCT00517335|bulimia nervosa|bulimia nervosa
5276913|NCT00517322|left atrial volume|left atrial volume
5276914|NCT00517322|hypertension|hypertension
5276915|NCT00517322|ramipril|ramipril
5276916|NCT00517322|irbesartan|irbesartan
5276917|NCT00517322|diastolic function|diastolic function
5276918|NCT00517283|diabetes|diabetes
5276919|NCT00517283|gastric emptying|gastric emptying
5276920|NCT00517283|exenatide|exenatide
5276921|NCT00517283|Byetta|byetta
5276922|NCT00517283|Amylin|amylin
5276923|NCT00517283|Lilly|lilly
5276924|NCT00517270|Non-cardiac chest pain|non-cardiac chest pain
5276925|NCT00517257|Retinal vein occlusion|retinal vein occlusion
5276926|NCT00517257|Retinal vein thrombosis|retinal vein thrombosis
5276927|NCT00517257|Central retinal vein occlusion|central retinal vein occlusion
5276928|NCT00517257|Branch retinal vein occlusion|branch retinal vein occlusion
5276929|NCT00517257|Visual loss|visual loss
5276930|NCT00517257|Atorvastatin|atorvastatin
5276931|NCT00517257|Statin|statin
5276932|NCT00517257|Neovascularization|neovascularization
5276933|NCT00517257|Thrombosis|thrombosis
5276934|NCT00517244|Children|children
5276935|NCT00517244|Healthy Controls|healthy controls
5276936|NCT00517244|Assessment|assessment
5276937|NCT00517231|Pulmonary tuberculosis|pulmonary tuberculosis
5276938|NCT00517231|Mycobacterium tuberculosis|mycobacterium tuberculosis
5276939|NCT00517231|Cytokines|cytokines
5276940|NCT00517231|Acute Phase Response|acute phase response
5276941|NCT00517231|Treatment|treatment
5276942|NCT00517218|Evaluate the Effect of Genasense on the Efficacy/Safety of Rituximab/Fludarabine Treatment in Untreated Subjects With Chronic Lymphocyctic Leukemia|evaluate the effect of genasense on the efficacy/safety of rituximab/fludarabine treatment in untreated subjects with chronic lymphocyctic leukemia
5276943|NCT00517205|upper ureteric stone|upper ureteric stone
5276944|NCT00517179|Benign Prostatic Hyperplasia (BPH)|benign prostatic hyperplasia (bph)
5276945|NCT00517179|Erectile Dysfunction (ED)|erectile dysfunction (ed)
5276946|NCT00517166|tourniquet|tourniquet
5276947|NCT00517166|extremity injury|extremity injury
5276948|NCT00517166|hemostatic device|hemostatic device
5276949|NCT00517153|Zavesca|zavesca
5276950|NCT00517153|miglustat|miglustat
5276951|NCT00517153|Niemann-Pick Type C|niemann-pick type c
5276952|NCT00517153|Actelion|actelion
5276953|NCT00517140|Pregnancy women with a scarred uterus due to previous caesarean section|pregnancy women with a scarred uterus due to previous caesarean section
5276954|NCT00517127|Intraoperative care|intraoperative care
5276955|NCT00517127|Ringer's lactate|ringer's lactate
5276956|NCT00517127|Voluven|voluven
5276957|NCT00517127|Cardiovascular diagnostic technique|cardiovascular diagnostic technique
5277237|NCT00515970|Excision|excision
5276958|NCT00517127|Doppler effect|doppler effect
5276959|NCT00517114|Reflux laryngitis|reflux laryngitis
5276960|NCT00517101|spondyloarthropathy|spondyloarthropathy
5276961|NCT00517101|inflammatory bowel disease|inflammatory bowel disease
5276962|NCT00517101|antibodies|antibodies
5276963|NCT00517088|Physical Activity|physical activity
5276964|NCT00517088|Breast Cancer|breast cancer
5276965|NCT00517075|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
5276966|NCT00517075|Repetitive Transcranial Magnetic Stimulation|repetitive transcranial magnetic stimulation
5276967|NCT00517075|Schizophrenia|schizophrenia
5276968|NCT00517075|Schizoaffective Disorder|schizoaffective disorder
5276969|NCT00517075|Treatment|treatment
5276970|NCT00517075|Negative Symptoms|negative symptoms
5276971|NCT00517075|Social Dysfunction|social dysfunction
5276972|NCT00517075|TMS|tms
5276973|NCT00517075|rTMS|rtms
5276974|NCT00517062|Growth hormone|growth hormone
5276975|NCT00517062|insulin sensitivity|insulin sensitivity
5276976|NCT00517062|cortisol|cortisol
5276977|NCT00517049|NHL|nhl
5276978|NCT00517049|Rituxan|rituxan
5276979|NCT00517049|Lymphoma|lymphoma
5276980|NCT00517049|CD20-positive|cd20-positive
5276981|NCT00517049|B-Cell|b-cell
5276982|NCT00517049|APM4083g|apm4083g
5276983|NCT00517036|Major Depression|major depression
5276984|NCT00517036|Omega-3|omega-3
5276985|NCT00517036|Major Depressive Disorder|major depressive disorder
5276986|NCT00517023|Implantable Loop Recorder|implantable loop recorder
5276987|NCT00517023|Home monitoring|home monitoring
5276988|NCT00517023|Syncope/ Falls Clinic|syncope/ falls clinic
5276989|NCT00517010|Age-related macular degeneration|age-related macular degeneration
5276990|NCT00517010|Exudative age-related macular degeneration|exudative age-related macular degeneration
5276991|NCT00517010|Wet macular degeneration|wet macular degeneration
5276992|NCT00517010|Intravitreal injection|intravitreal injection
5276993|NCT00517010|Proton beam irradiation|proton beam irradiation
5276994|NCT00517010|Lucentis|lucentis
5276995|NCT00517010|Ranibizumab|ranibizumab
5276996|NCT00516984|Relationship between Osteopathic Manipulative Therapy (OMT) and the autonomic nervous system|relationship between osteopathic manipulative therapy (omt) and the autonomic nervous system
5276997|NCT00516984|LF/HF ratio|lf/hf ratio
5276998|NCT00516971|Non-erosive reflux disease|non-erosive reflux disease
5276999|NCT00516958|diabetic|diabetic
5277000|NCT00516958|ulcer|ulcer
5277001|NCT00516958|infection|infection
5277002|NCT00516958|topical|topical
5277003|NCT00516958|wound|wound
5277004|NCT00516945|hepatitis B during cancer chemotherapy|hepatitis b during cancer chemotherapy
5277005|NCT00516932|Suicidal Event|suicidal event
5277006|NCT00516932|Behavioral Activation|behavioral activation
5277007|NCT00516919|Obesity|obesity
5277008|NCT00516919|Binge Eating|binge eating
5277009|NCT00516919|Monolingual Hispanic Persons|monolingual hispanic persons
5277010|NCT00516919|Orlistat|orlistat
5277011|NCT00516919|Behavioral Weight Loss Treatment|behavioral weight loss treatment
5277012|NCT00516893|natalizumab|natalizumab
5277013|NCT00516893|Tysabri|tysabri
5277014|NCT00516893|Multiple Sclerosis|multiple sclerosis
5277015|NCT00516893|Relapsing Forms of Multiple Sclerosis|relapsing forms of multiple sclerosis
5277016|NCT00516880|chronic kidney disease|chronic kidney disease
5277017|NCT00516880|cardiovascular disease|cardiovascular disease
5277018|NCT00516854|Non-cardiac chest pain|non-cardiac chest pain
5277019|NCT00516841|epithelial ovarian cancer|epithelial ovarian cancer
5277020|NCT00516841|peritoneal cancer|peritoneal cancer
5277021|NCT00516841|platinum-resistant ovarian cancer|platinum-resistant ovarian cancer
5277022|NCT00516841|Platinum-Resistant Advanced Epithelial Ovarian Cancer or Primary Peritoneal Cancer|platinum-resistant advanced epithelial ovarian cancer or primary peritoneal cancer
5277023|NCT00516828|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5277024|NCT00516828|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5277025|NCT00516828|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5277026|NCT00516828|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5277027|NCT00516828|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5277028|NCT00516828|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
5277029|NCT00516828|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5277030|NCT00516828|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5277031|NCT00516828|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5277032|NCT00516802|Poly(ADP ribose) polymerases|poly(adp ribose) polymerases
5277033|NCT00516802|dacarbazine|dacarbazine
5277034|NCT00516750|recurrent bladder cancer|recurrent bladder cancer
5277035|NCT00516750|stage II bladder cancer|stage ii bladder cancer
5277036|NCT00516750|stage III bladder cancer|stage iii bladder cancer
5277037|NCT00516750|stage IV bladder cancer|stage iv bladder cancer
5277038|NCT00516724|malignant solid tumours|malignant solid tumours
5277039|NCT00516724|Poly(ADP ribose) polymerases|poly(adp ribose) polymerases
5277040|NCT00516711|Surgery with Pringle maneuver needed for liver resection|surgery with pringle maneuver needed for liver resection
5277041|NCT00516698|stage I breast cancer|stage i breast cancer
5277042|NCT00516698|stage II breast cancer|stage ii breast cancer
5277043|NCT00516698|stage IIIA breast cancer|stage iiia breast cancer
5277044|NCT00516698|stage IIIC breast cancer|stage iiic breast cancer
5277045|NCT00516685|LUNG CANCER|lung cancer
5277046|NCT00516685|NSCLC|nsclc
5277047|NCT00516685|EGF|egf
5277048|NCT00516685|CANCER VACCINE|cancer vaccine
5277049|NCT00516685|IMMUNOTHERAPY|immunotherapy
5277050|NCT00516672|lapatinib,|lapatinib,
5277051|NCT00516672|cancer|cancer
5277052|NCT00516672|pharmacokinetics,|pharmacokinetics,
5277053|NCT00516672|safety,|safety,
5277054|NCT00516672|pazopanib,|pazopanib,
5277055|NCT00516672|Japanese patients,|japanese patients,
5277056|NCT00516659|ETEC|etec
5277057|NCT00516659|Traveler's diarrhea|traveler's diarrhea
5277058|NCT00516659|TCI|tci
5277059|NCT00516659|patch vaccine|patch vaccine
5277060|NCT00516659|diarrhea prevention|diarrhea prevention
5277061|NCT00516659|epidemiology ETEC|epidemiology etec
5277062|NCT00516659|Escherichia coli|escherichia coli
5277063|NCT00516646|Advanced Glycation End-products (AGEs)|advanced glycation end-products (ages)
5277064|NCT00516646|Alegebrium|alegebrium
5277065|NCT00516633|Asthma|asthma
5277066|NCT00516633|Adherence|adherence
5277067|NCT00516633|Burden of asthma|burden of asthma
5277068|NCT00516633|Quality of life|quality of life
5277069|NCT00516633|Questionnaires|questionnaires
5277070|NCT00516620|Body Weight|body weight
5277071|NCT00516607|recurrent adult brain tumor|recurrent adult brain tumor
5277072|NCT00516607|adult mixed glioma|adult mixed glioma
5277073|NCT00516607|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5277074|NCT00516607|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
5277075|NCT00516607|adult glioblastoma|adult glioblastoma
5277076|NCT00516607|adult anaplastic ependymoma|adult anaplastic ependymoma
5277077|NCT00516607|adult giant cell glioblastoma|adult giant cell glioblastoma
5277078|NCT00516607|adult gliosarcoma|adult gliosarcoma
5277079|NCT00516607|adult pineal gland astrocytoma|adult pineal gland astrocytoma
5277080|NCT00516581|Pneumocystis Pneumonia|pneumocystis pneumonia
5277081|NCT00516581|Acquired Immune Deficiency Syndrome|acquired immune deficiency syndrome
5277082|NCT00516581|Highly Active Antiretroviral Therapy|highly active antiretroviral therapy
5277083|NCT00516581|Treatment Experienced|treatment experienced
5277084|NCT00516581|Treatment Naive|treatment naive
5277085|NCT00516555|Breech Presentation|breech presentation
5277086|NCT00516555|External Cephalic version|external cephalic version
5277087|NCT00516555|Thyroid Function Tests|thyroid function tests
5277088|NCT00516542|stage IV breast cancer|stage iv breast cancer
5277089|NCT00516542|recurrent breast cancer|recurrent breast cancer
5277090|NCT00516542|male breast cancer|male breast cancer
5277091|NCT00516516|muscle cramp|muscle cramp
5277092|NCT00516516|pregnancy|pregnancy
5277093|NCT00516516|carnitine|carnitine
5277094|NCT00516516|randomized controlled clinical trials|randomized controlled clinical trials
5277095|NCT00516490|GnRH agonist|gnrh agonist
5277096|NCT00516490|IVF/ICSI outcome|ivf/icsi outcome
5277097|NCT00516490|luteal phase|luteal phase
5277098|NCT00516477|Adeno-Associated Virus (AAV)|adeno-associated virus (aav)
5277099|NCT00516477|Leber Congenital Amaurosis|leber congenital amaurosis
5277100|NCT00516477|Gene transfer|gene transfer
5277101|NCT00516464|Proliferative Diabetic Retinopathy|proliferative diabetic retinopathy
5277102|NCT00516464|Vitrectomy|vitrectomy
5277103|NCT00516464|Ranibizumab|ranibizumab
5277104|NCT00516438|malignant solid tumours|malignant solid tumours
5277105|NCT00516438|Poly(ADP ribose)|poly(adp ribose)
5277106|NCT00516438|polymerases|polymerases
5277107|NCT00516425|stage IA breast cancer|stage ia breast cancer
5277108|NCT00516425|stage IB breast cancer|stage ib breast cancer
5277109|NCT00516425|stage II breast cancer|stage ii breast cancer
5277110|NCT00516425|stage IIIA breast cancer|stage iiia breast cancer
5277111|NCT00516412|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
5277112|NCT00516412|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5277113|NCT00516412|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5277114|NCT00516412|stage I mantle cell lymphoma|stage i mantle cell lymphoma
5277115|NCT00516412|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5277116|NCT00516412|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5277117|NCT00516399|Fungal keratitis|fungal keratitis
5277118|NCT00516399|povidone iodine|povidone iodine
5277119|NCT00516399|childhood blindness|childhood blindness
5277120|NCT00516399|povidone-iodine|povidone-iodine
5277121|NCT00516386|Adolescents|adolescents
5277122|NCT00516386|Anorexia nervosa (AN)|anorexia nervosa (an)
5277123|NCT00516386|Bone formation markers|bone formation markers
5277124|NCT00516386|Insulin like growth factor-1 (IGF-I)|insulin like growth factor-1 (igf-i)
5277125|NCT00516373|advanced ovarian cancer|advanced ovarian cancer
5277126|NCT00516373|BRCA 1 protein|brca 1 protein
5277127|NCT00516373|BRCA 2 protein|brca 2 protein
5277128|NCT00516373|Poly(ADP ribose)polymerases|poly(adp ribose)polymerases
5277129|NCT00516360|Catheter related bloodstream infections|catheter related bloodstream infections
5277130|NCT00516360|Infant, Newborn|infant, newborn
5277131|NCT00516360|Intensive Care Units, Neonatal|intensive care units, neonatal
5277132|NCT00516360|Neonatal Central Line Infections|neonatal central line infections
5277133|NCT00516347|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
5277134|NCT00516347|esophageal cancer|esophageal cancer
5277135|NCT00516347|Barrett esophagus|barrett esophagus
5277136|NCT00516334|brain|brain
5277137|NCT00516334|electroencephalography|electroencephalography
5277138|NCT00516334|premature infant|premature infant
5277139|NCT00516334|neurodevelopment|neurodevelopment
5277140|NCT00516321|thrombopoietin|thrombopoietin
5277141|NCT00516321|hepatitis C|hepatitis c
5277142|NCT00516321|ribavirin|ribavirin
5277143|NCT00516321|platelets|platelets
5277144|NCT00516321|Hepatitis C-related thrombocytopenia|hepatitis c-related thrombocytopenia
5277145|NCT00516321|peginterferon alfa-2a|peginterferon alfa-2a
5277146|NCT00516308|CLI|cli
5277147|NCT00516308|Critical Limb Ischemia|critical limb ischemia
5277148|NCT00516308|PAD|pad
5277149|NCT00516308|Paripheral Arterial Disease|paripheral arterial disease
5277150|NCT00516308|Artherosclerosis|artherosclerosis
5277151|NCT00516308|Leg pain|leg pain
5277152|NCT00516308|Cardiovascular|cardiovascular
5277153|NCT00516308|Atherectomy|atherectomy
5277154|NCT00516308|NightHawk|nighthawk
5277155|NCT00516282|adult glioblastoma|adult glioblastoma
5277156|NCT00516282|adult giant cell glioblastoma|adult giant cell glioblastoma
5277157|NCT00516282|adult gliosarcoma|adult gliosarcoma
5277158|NCT00516282|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5277159|NCT00516282|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
5277160|NCT00516282|adult mixed glioma|adult mixed glioma
5277161|NCT00516269|Breast Cancer|breast cancer
5277162|NCT00516269|Gastrointestinal Cancer|gastrointestinal cancer
5277163|NCT00516269|GI Cancer|gi cancer
5277164|NCT00516269|Fatigue|fatigue
5277165|NCT00516269|OROS Methylphenidate HCl|oros methylphenidate hcl
5277166|NCT00516269|Methylphenidate|methylphenidate
5277167|NCT00516269|Methylphenidate Hydrochloride|methylphenidate hydrochloride
5277168|NCT00516269|Concerta|concerta
5277169|NCT00516269|Ritalin|ritalin
5277170|NCT00516269|Placebo|placebo
5277171|NCT00516256|Prostate Cancer|prostate cancer
5277172|NCT00516256|Quality of Life|quality of life
5277173|NCT00516256|Cancer Information Mentor|cancer information mentor
5277174|NCT00516256|CHESS|chess
5277175|NCT00516256|the Comprehensive Health Enhancement Support System|the comprehensive health enhancement support system
5277176|NCT00516256|Social support|social support
5277177|NCT00516256|Skill-building tools|skill-building tools
5277178|NCT00516230|Colonic Neoplasms|colonic neoplasms
5277179|NCT00516230|Lynch syndrome|lynch syndrome
5277180|NCT00516217|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5277181|NCT00516217|adult lymphocyte predominant Hodgkin lymphoma|adult lymphocyte predominant hodgkin lymphoma
5277182|NCT00516204|Hyperlipidemia|hyperlipidemia
5277183|NCT00516204|Diabetics|diabetics
5277184|NCT00516204|NIS|nis
5277185|NCT00516204|Diabetics with hyperlipidemia and atherosclerosis (coronary heart disease, carotid stenosis, PAVK, etc.)|diabetics with hyperlipidemia and atherosclerosis (coronary heart disease, carotid stenosis, pavk, etc.)
5277186|NCT00516191|Multiple Myeloma|multiple myeloma
5277187|NCT00516191|Velcade|velcade
5277188|NCT00516191|Doxil|doxil
5277189|NCT00516191|Melphalan|melphalan
5277190|NCT00516178|Fish oil supplement|fish oil supplement
5277191|NCT00516178|n-3 PUFA|n-3 pufa
5277192|NCT00516178|Cardiac function|cardiac function
5277193|NCT00516178|Membrane incorporation|membrane incorporation
5277194|NCT00516178|Inflammation|inflammation
5277195|NCT00516178|Clinical outcome|clinical outcome
5277196|NCT00516165|liver cancer|liver cancer
5277197|NCT00516165|RAD001|rad001
5277198|NCT00516152|Matched Unrelated Donor|matched unrelated donor
5277199|NCT00516152|Stem Cell Transplantation|stem cell transplantation
5277200|NCT00516152|Busulfan|busulfan
5277201|NCT00516152|fludarabine|fludarabine
5277202|NCT00516152|Hematopoietic Disorder|hematopoietic disorder
5277203|NCT00516139|Epilepsy elderly seizure|epilepsy elderly seizure
5277204|NCT00516126|hemostasis monitoring|hemostasis monitoring
5277205|NCT00516126|perioperative blood loss|perioperative blood loss
5277206|NCT00516113|paroxetine|paroxetine
5277207|NCT00516113|onset of action|onset of action
5277208|NCT00516113|serotonin reuptake inhibitors|serotonin reuptake inhibitors
5277209|NCT00516100|NSCLC|nsclc
5277210|NCT00516087|Nasopharyngeal Carcinoma|nasopharyngeal carcinoma
5277211|NCT00516074|exenatide|exenatide
5277212|NCT00516074|Byetta|byetta
5277213|NCT00516074|type 2 diabetes|type 2 diabetes
5277214|NCT00516074|heart rate|heart rate
5277215|NCT00516074|Amylin|amylin
5277216|NCT00516074|Lilly|lilly
5277217|NCT00516048|exenatide|exenatide
5277218|NCT00516048|Byetta|byetta
5277219|NCT00516048|antibodies|antibodies
5277220|NCT00516048|Amylin|amylin
5277221|NCT00516048|Lilly|lilly
5277222|NCT00516035|Bird Flu|bird flu
5277223|NCT00516009|RADICULAR PAIN|radicular pain
5277224|NCT00516009|DISC HERNIATION|disc herniation
5277225|NCT00516009|DEXAMETHASONE|dexamethasone
5277226|NCT00516009|VAS|vas
5277227|NCT00515996|panic disorder|panic disorder
5277228|NCT00515996|paroxetine|paroxetine
5277229|NCT00515996|genetic polymorphism|genetic polymorphism
5277230|NCT00515996|serotonin|serotonin
5277231|NCT00515983|melanoma|melanoma
5277232|NCT00515983|dendritic cells|dendritic cells
5277233|NCT00515983|apoptotic/necrotic cells|apoptotic/necrotic cells
5277234|NCT00515983|therapeutic vaccine|therapeutic vaccine
5277235|NCT00515970|Carcinoma, Basal Cell|carcinoma, basal cell
5277236|NCT00515970|Curettage|curettage
5277238|NCT00515970|Recurrence|recurrence
5277239|NCT00515970|Complication|complication
5277240|NCT00515970|Esthetic outcome|esthetic outcome
5277241|NCT00515944|No condition|no condition
5277242|NCT00515944|healthy volunteers|healthy volunteers
5277243|NCT00515931|Gastrointestinal stromal tumor|gastrointestinal stromal tumor
5277244|NCT00515931|GIST|gist
5277245|NCT00515931|Sarcoma|sarcoma
5277246|NCT00515931|Radiation therapy|radiation therapy
5277247|NCT00515931|Radiotherapy|radiotherapy
5277248|NCT00515918|Iron deficiency|iron deficiency
5277249|NCT00515918|brain|brain
5277250|NCT00515918|cognition|cognition
5277251|NCT00515918|behavior|behavior
5277252|NCT00515879|Generalized subtype|generalized subtype
5277253|NCT00515866|Advanced pancreatic cancer|advanced pancreatic cancer
5277254|NCT00515866|Poly (ADP ribose) polymerases|poly (adp ribose) polymerases
5277255|NCT00515866|Advanced Solid Tumours|advanced solid tumours
5277256|NCT00515853|Rectal neoplasms|rectal neoplasms
5277257|NCT00515853|Biofeedback (Psychology)|biofeedback (psychology)
5277258|NCT00515853|Fecal Incontinence|fecal incontinence
5277259|NCT00515853|Aged|aged
5277260|NCT00515853|Anterior resection|anterior resection
5277261|NCT00515827|Treatment Experienced|treatment experienced
5277262|NCT00515814|Legal blindness|legal blindness
5277263|NCT00515814|Retinopathy pigmentosa|retinopathy pigmentosa
5277264|NCT00515814|Hereditary condition|hereditary condition
5277265|NCT00515814|Photo-receptor degeneration|photo-receptor degeneration
5277266|NCT00515814|Retina implant|retina implant
5277267|NCT00515814|Subretinal implant|subretinal implant
5277268|NCT00515801|diabetes mellitus type 1|diabetes mellitus type 1
5277269|NCT00515801|hypoglycemia|hypoglycemia
5277270|NCT00515801|sulfonylurea|sulfonylurea
5277271|NCT00515801|glucagon|glucagon
5277272|NCT00515788|Neoplastic Meningitis|neoplastic meningitis
5277273|NCT00515788|Leptomeningeal Disease|leptomeningeal disease
5277274|NCT00515788|Temozolomide|temozolomide
5277275|NCT00515788|Temodar|temodar
5277276|NCT00515788|DepoCyt|depocyt
5277277|NCT00515788|Liposomal Cytarabine|liposomal cytarabine
5277278|NCT00515788|Liposomal ara-C|liposomal ara-c
5277279|NCT00515762|persistent alopecia|persistent alopecia
5277280|NCT00515762|docetaxel|docetaxel
5277281|NCT00515762|breast cancer|breast cancer
5277282|NCT00515736|selenium|selenium
5277283|NCT00515736|oxidative stress|oxidative stress
5277284|NCT00515736|glutathione peroxidase|glutathione peroxidase
5277285|NCT00515736|critically ill|critically ill
5277286|NCT00515736|outcome|outcome
5277287|NCT00515736|supplementation|supplementation
5277288|NCT00515723|control|control
5277289|NCT00515723|risperidone|risperidone
5277290|NCT00515723|olanzapine|olanzapine
5277291|NCT00515723|quetiapine|quetiapine
5277292|NCT00515723|ziprasidone|ziprasidone
5277293|NCT00515710|Hemophilia B|hemophilia b
5277294|NCT00515710|Gene Transfer|gene transfer
5277295|NCT00515710|Adeno-Associated Virus (AAV)|adeno-associated virus (aav)
5277296|NCT00515710|Coagulation Factor IX|coagulation factor ix
5277297|NCT00515710|Long-term Follow-up|long-term follow-up
5277298|NCT00515710|Delayed Adverse Events|delayed adverse events
5277299|NCT00515671|self-management|self-management
5277300|NCT00515671|recovery|recovery
5277301|NCT00515671|severe mental illness|severe mental illness
5277302|NCT00515658|Major depression|major depression
5277303|NCT00515658|Theta-burst rTMS|theta-burst rtms
5277304|NCT00515658|Cortical excitability|cortical excitability
5277305|NCT00515658|Hamilton depression rating scale|hamilton depression rating scale
5277306|NCT00515645|Autonomic nervous system|autonomic nervous system
5277307|NCT00515645|Immersion|immersion
5277308|NCT00515645|Heart rate variability|heart rate variability
5277309|NCT00515645|Head-down tilt|head-down tilt
5277310|NCT00515645|Healthy volunteers|healthy volunteers
5277311|NCT00515632|Type 2 diabetes mellitus on Stable insulin therapy|type 2 diabetes mellitus on stable insulin therapy
5277312|NCT00515632|Balaglitazone|balaglitazone
5277313|NCT00515632|Pioglitazone (Actos®)|pioglitazone (actos®)
5277314|NCT00515632|HbA1c|hba1c
5277315|NCT00515632|Weight gain|weight gain
5277316|NCT00515632|Oedema|oedema
5277317|NCT00515632|Fasting blood glucose|fasting blood glucose
5277318|NCT00515593|osteoporosis|osteoporosis
5277319|NCT00515593|postmenopausal women|postmenopausal women
5277320|NCT00515593|Severe postmenopausal osteoporosis|severe postmenopausal osteoporosis
5277321|NCT00515580|obstructive sleep apnea|obstructive sleep apnea
5277322|NCT00515580|upper airway resistance syndrome|upper airway resistance syndrome
5277323|NCT00515580|tongue suture|tongue suture
5277324|NCT00515580|retrolingual tongue collapse|retrolingual tongue collapse
5277325|NCT00515580|minimally invasive|minimally invasive
5277326|NCT00515567|explanted lungs|explanted lungs
5277327|NCT00515567|pulmonary fibrosis|pulmonary fibrosis
5277328|NCT00515554|Hodgkin lymphoma|hodgkin lymphoma
5277329|NCT00515554|PET|pet
5277330|NCT00515554|advances stages|advances stages
5277331|NCT00515554|Rituximab|rituximab
5277332|NCT00515541|Platelet|platelet
5277333|NCT00515541|Cardiovascular|cardiovascular
5277334|NCT00515541|Lipid|lipid
5277335|NCT00515541|Fish Oil|fish oil
5277336|NCT00515541|Omega 3|omega 3
5277337|NCT00515541|DHA|dha
5277338|NCT00515541|EPA|epa
5277339|NCT00515541|Bleeding|bleeding
5277340|NCT00515541|Clotting|clotting
5277341|NCT00515541|platelet function|platelet function
5277342|NCT00515541|Lipid profile|lipid profile
5277343|NCT00515541|Weight and Bleeding risk|weight and bleeding risk
5277344|NCT00515528|metastatic melanoma|metastatic melanoma
5277345|NCT00515502|chronic obstructive pulmonary disease,|chronic obstructive pulmonary disease,
5277346|NCT00515502|GSK573719,|gsk573719,
5277347|NCT00515502|muscarinic receptor antagonist|muscarinic receptor antagonist
5277348|NCT00515489|Schizophrenia|schizophrenia
5277349|NCT00515489|Schizoaffective Disorder|schizoaffective disorder
5277350|NCT00515489|Schizophreniform Disorders|schizophreniform disorders
5277351|NCT00515476|metabolic syndrome|metabolic syndrome
5277352|NCT00515476|HDL-Cholesterol|hdl-cholesterol
5277353|NCT00515476|EPC|epc
5277354|NCT00515476|endothelial function|endothelial function
5277355|NCT00515476|reduced blood HDL-Cholesterol level|reduced blood hdl-cholesterol level
5277356|NCT00515463|Osteopenia|osteopenia
5277357|NCT00515463|Osteoporosis|osteoporosis
5277358|NCT00515463|AMG 162|amg 162
5277359|NCT00515463|Postmenopausal|postmenopausal
5277360|NCT00515463|Pre-filled syringe|pre-filled syringe
5277361|NCT00515450|Myasthenia Gravis|myasthenia gravis
5277362|NCT00515437|Sialorrhea|sialorrhea
5277363|NCT00515424|Glaucoma|glaucoma
5277364|NCT00515424|Ocular Hypertension|ocular hypertension
5277365|NCT00515424|RKI983|rki983
5277366|NCT00515424|Primary Open Angle Glaucoma and Ocular Hypertension|primary open angle glaucoma and ocular hypertension
5277367|NCT00515411|gastroesophageal junction|gastroesophageal junction
5277368|NCT00515411|gastric cancer|gastric cancer
5277369|NCT00515411|adenocarcinoma|adenocarcinoma
5277370|NCT00515411|unresectable gastric cancer|unresectable gastric cancer
5277371|NCT00515411|metastatic gastric|metastatic gastric
5277372|NCT00515385|Randomized|randomized
5277373|NCT00515385|Double-Blind|double-blind
5277374|NCT00515385|Dose-Escalation|dose-escalation
5277375|NCT00515385|Cohort Study|cohort study
5277376|NCT00515372|Ovarian Cancer|ovarian cancer
5277377|NCT00515372|Peritoneal Cancer|peritoneal cancer
5277378|NCT00515372|Fallopian Tube Cancer|fallopian tube cancer
5277379|NCT00515372|Depression|depression
5277380|NCT00515372|Telephone Counseling|telephone counseling
5277381|NCT00515372|Quality of Life|quality of life
5277382|NCT00515359|Sedation|sedation
5277383|NCT00515359|MRI|mri
5277384|NCT00515359|pediatric|pediatric
5277385|NCT00515359|propofol|propofol
5277386|NCT00515359|brain|brain
5277387|NCT00515359|spine|spine
5277388|NCT00515359|quality of MRI|quality of mri
5277389|NCT00515359|Continuous propofol dosing|continuous propofol dosing
5277390|NCT00515359|continuous propofol administration|continuous propofol administration
5277391|NCT00515359|Intermittent propofol dosing|intermittent propofol dosing
5277392|NCT00515359|intermittent propofol administration|intermittent propofol administration
5277393|NCT00515359|Sedative agent|sedative agent
5277394|NCT00515359|propofol continuous infusions|propofol continuous infusions
5277395|NCT00515359|Recovery time|recovery time
5277396|NCT00515359|Complications of sedation|complications of sedation
5277397|NCT00515359|bolus dosing|bolus dosing
5277398|NCT00515346|CLI|cli
5277399|NCT00515346|Critical Limb Ischemia|critical limb ischemia
5277400|NCT00515333|Alzheimer|alzheimer
5277401|NCT00515333|Dementia|dementia
5277402|NCT00515320|Autism|autism
5277403|NCT00515320|children|children
5277404|NCT00515320|adolescent|adolescent
5277405|NCT00515320|Fluoxetine|fluoxetine
5277406|NCT00515320|Autistic Disorder|autistic disorder
5277407|NCT00515320|Repetitive behavior|repetitive behavior
5277408|NCT00515320|SSRI|ssri
5277409|NCT00515320|Selective Serotonin Reuptake Inhibitor|selective serotonin reuptake inhibitor
5277410|NCT00515307|Hypercholesterolemia, Familial|hypercholesterolemia, familial
5277411|NCT00515307|Bone marrow|bone marrow
5277412|NCT00515307|Mesenchymal stem cell|mesenchymal stem cell
5277413|NCT00515307|Hepatocyte|hepatocyte
5277414|NCT00515294|Caffeine|caffeine
5277415|NCT00515294|Alcohol|alcohol
5277416|NCT00515294|Alcohol Consumption|alcohol consumption
5277417|NCT00515294|Residual Effects|residual effects
5277418|NCT00515294|Family History|family history
5277419|NCT00515294|Psychomotor Vigilance Test|psychomotor vigilance test
5277420|NCT00515294|Driving Simulation|driving simulation
5277421|NCT00515294|Reaction Time|reaction time
5277422|NCT00515281|prematurity|prematurity
5277423|NCT00515281|nitric oxide|nitric oxide
5277424|NCT00515281|bronchopulmonary dysplasia|bronchopulmonary dysplasia
5277425|NCT00515281|intraventricular hemorrhage|intraventricular hemorrhage
5277426|NCT00515281|periventricular leukomalacia|periventricular leukomalacia
5277427|NCT00515281|neurodevelopment|neurodevelopment
5277428|NCT00515268|LPS challenge,|lps challenge,
5277429|NCT00515268|Healthy volunteers|healthy volunteers
5277430|NCT00515255|Obsessive Compulsive Disorder|obsessive compulsive disorder
5277431|NCT00515255|Neuropharm|neuropharm
5277432|NCT00515255|NPL-2003|npl-2003
5277433|NCT00515242|massage therapy|massage therapy
5277434|NCT00515242|relaxation treatments|relaxation treatments
5277435|NCT00515229|cystic fibrosis|cystic fibrosis
5277436|NCT00515229|ceramide|ceramide
5277437|NCT00515229|amitriptyline|amitriptyline
5277638|NCT00514410|Depression|depression
5277438|NCT00515229|Pseudomonas aeruginosa|pseudomonas aeruginosa
5277439|NCT00515229|lung function|lung function
5277440|NCT00515216|Phase II|phase ii
5277441|NCT00515216|Gastric cancer|gastric cancer
5277442|NCT00515216|Gastroesophageal cancer|gastroesophageal cancer
5277443|NCT00515216|Metastatic|metastatic
5277444|NCT00515216|FOLFOX|folfox
5277445|NCT00515216|Thymidylate synthase|thymidylate synthase
5277446|NCT00515216|Pharmacogenomic|pharmacogenomic
5277447|NCT00515203|Immune (Idiopathic) Thrombocytopenic Purpura|immune (idiopathic) thrombocytopenic purpura
5277448|NCT00515203|Pediatric Idiopathic Thrombocytopenic Purpura|pediatric idiopathic thrombocytopenic purpura
5277449|NCT00515190|Stomach Neoplasms|stomach neoplasms
5277450|NCT00515190|Secondary|secondary
5277451|NCT00515190|Combination chemotherapy|combination chemotherapy
5277452|NCT00515190|S-1|s-1
5277453|NCT00515190|oxaliplatin|oxaliplatin
5277454|NCT00515177|mindfulness|mindfulness
5277455|NCT00515177|meditation|meditation
5277456|NCT00515177|MBSR|mbsr
5277457|NCT00515177|mindfulness meditation|mindfulness meditation
5277458|NCT00515177|sleep|sleep
5277459|NCT00515177|insomnia|insomnia
5277460|NCT00515177|chronic insomnia|chronic insomnia
5277461|NCT00515177|primary insomnia|primary insomnia
5277462|NCT00515177|Minnesota|minnesota
5277463|NCT00515164|lung volume reduction|lung volume reduction
5277464|NCT00515164|emphysema|emphysema
5277465|NCT00515164|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
5277466|NCT00515151|Bloodstream Infection|bloodstream infection
5277467|NCT00515151|Bacteremia|bacteremia
5277468|NCT00515151|Central Venous Catheter|central venous catheter
5277469|NCT00515151|Alcohol|alcohol
5277470|NCT00515151|Disinfection|disinfection
5277471|NCT00515151|Octenidine Dihydrochloride|octenidine dihydrochloride
5277472|NCT00515138|B-Cell NHL|b-cell nhl
5277473|NCT00515138|Autologous Stem Cell Transplant|autologous stem cell transplant
5277474|NCT00515138|RICE|rice
5277475|NCT00515125|Quality of life|quality of life
5277476|NCT00515125|Supplement|supplement
5277477|NCT00515125|Care home|care home
5277478|NCT00515125|Elderly|elderly
5277479|NCT00515125|Malnutrition|malnutrition
5277480|NCT00515112|prostate|prostate
5277481|NCT00515112|cancer|cancer
5277482|NCT00515112|testosterone replacement|testosterone replacement
5277483|NCT00515112|AndroGel|androgel
5277484|NCT00515112|prostatic cancer|prostatic cancer
5277485|NCT00515112|prostatic neoplasms|prostatic neoplasms
5277486|NCT00515099|New-onset Type 1 Diabetes Mellitus|new-onset type 1 diabetes mellitus
5277487|NCT00515099|New-onset T1DM|new-onset t1dm
5277488|NCT00515099|New-onset Type 1 Diabetes|new-onset type 1 diabetes
5277489|NCT00515099|New-onset T1D|new-onset t1d
5277490|NCT00515099|Newly Diagnosed Type 1 Diabetes Mellitus|newly diagnosed type 1 diabetes mellitus
5277491|NCT00515099|Autoimmune diabetes|autoimmune diabetes
5277492|NCT00515099|Thymoglobulin|thymoglobulin
5277493|NCT00515099|ATG|atg
5277494|NCT00515099|Rabbit antithymocyte globulin|rabbit antithymocyte globulin
5277495|NCT00515086|Glioblastoma Multiforme, GBM, RAD001, RAD|glioblastoma multiforme, gbm, rad001, rad
5277496|NCT00515073|Endometrial Cancer|endometrial cancer
5277497|NCT00515073|Papillary Serous Carcinoma|papillary serous carcinoma
5277498|NCT00515073|Pelvic Radiation Therapy|pelvic radiation therapy
5277499|NCT00515073|Paclitaxel|paclitaxel
5277500|NCT00515073|Taxol|taxol
5277501|NCT00515060|Advanced Cancer|advanced cancer
5277502|NCT00515060|Therapy-Induced Pain|therapy-induced pain
5277503|NCT00515060|Pain Threshold|pain threshold
5277504|NCT00515060|Sensory Tests|sensory tests
5277505|NCT00515060|Stimuli|stimuli
5277506|NCT00515060|Pain|pain
5277507|NCT00515047|Atopic Dermatitis|atopic dermatitis
5277508|NCT00515047|Eczema|eczema
5277509|NCT00515047|Eczema Herpeticum|eczema herpeticum
5277510|NCT00515047|Molluscum Contagiousum|molluscum contagiousum
5277511|NCT00515047|Herpes Simplex|herpes simplex
5277512|NCT00515047|Vaccinia|vaccinia
5277513|NCT00515034|Doripenem|doripenem
5277514|NCT00515034|Imipenem|imipenem
5277515|NCT00515034|Cilastatin|cilastatin
5277516|NCT00515034|Vancomycin|vancomycin
5277517|NCT00515034|DORIBAX, DORIPREX, FINIBAX, DURAPTA, PRIMAXIN, Anti Bacterial Agents|doribax, doriprex, finibax, durapta, primaxin, anti bacterial agents
5277518|NCT00515034|Ileus|ileus
5277519|NCT00515034|Hospitalized|hospitalized
5277520|NCT00515034|Fever|fever
5277521|NCT00515021|Metabolic syndrome|metabolic syndrome
5277522|NCT00515021|Aldosterone inhibitor|aldosterone inhibitor
5277523|NCT00515021|Diurnal drug regimen|diurnal drug regimen
5277524|NCT00515021|PAI-1 levels|pai-1 levels
5277525|NCT00514982|Hermansky-Pudlak Syndrome|hermansky-pudlak syndrome
5277526|NCT00514982|Colitis|colitis
5277527|NCT00514982|Medical Therapy|medical therapy
5277528|NCT00514982|Immunopathogenesis|immunopathogenesis
5277529|NCT00514982|Cytokine|cytokine
5277530|NCT00514982|Hermansky-Pudlak Syndrome Associated Colitis|hermansky-pudlak syndrome associated colitis
5277531|NCT00514982|HPS|hps
5277532|NCT00514969|accelerated and blastic phase|accelerated and blastic phase
5277533|NCT00514969|STI571|sti571
5277534|NCT00514956|Post-Traumatic Stress Syndrome (PTSD)|post-traumatic stress syndrome (ptsd)
5277535|NCT00514930|radiofrequency ablation|radiofrequency ablation
5277536|NCT00514930|liver cancer|liver cancer
5277537|NCT00514930|complications|complications
5277538|NCT00514930|liver tumors|liver tumors
5277539|NCT00514904|safety|safety
5277540|NCT00514904|meningococcal vaccine|meningococcal vaccine
5277541|NCT00514904|immunogenicity|immunogenicity
5277542|NCT00514878|nausea|nausea
5277543|NCT00514878|postoperative nausea and vomiting|postoperative nausea and vomiting
5277544|NCT00514878|postoperative pain|postoperative pain
5277545|NCT00514865|ONO-2333Ms|ono-2333ms
5277546|NCT00514865|Major Depressive Disorder|major depressive disorder
5277547|NCT00514839|Prescription drug use disorder|prescription drug use disorder
5277548|NCT00514839|Brief intervention|brief intervention
5277549|NCT00514839|General hospital|general hospital
5277550|NCT00514839|Motivational Interviewing|motivational interviewing
5277551|NCT00514800|Home monitoring|home monitoring
5277552|NCT00514800|Primary care|primary care
5277553|NCT00514800|Hypertension|hypertension
5277554|NCT00514800|TIA|tia
5277555|NCT00514787|Asthma|asthma
5277556|NCT00514787|NIS|nis
5277557|NCT00514774|Huntington chorea|huntington chorea
5277558|NCT00514774|chorea|chorea
5277559|NCT00514774|hereditary|hereditary
5277560|NCT00514774|tauroursodeoxycholic acid|tauroursodeoxycholic acid
5277561|NCT00514774|ursodeoxycholic acid|ursodeoxycholic acid
5277562|NCT00514774|TUDCA|tudca
5277563|NCT00514774|UDCA|udca
5277564|NCT00514761|colorectal cancer|colorectal cancer
5277565|NCT00514761|AZD6244|azd6244
5277566|NCT00514748|breast reconstruction|breast reconstruction
5277567|NCT00514748|DIEP|diep
5277568|NCT00514748|vessel pedicle|vessel pedicle
5277569|NCT00514735|atrial fibrillation|atrial fibrillation
5277570|NCT00514722|Hematopoietic malignancies|hematopoietic malignancies
5277571|NCT00514722|Umbilical cord blood transplantation|umbilical cord blood transplantation
5277572|NCT00514722|Lymphoma: diffuse large cell, mantle cell, peripheral T-cell, T-NK cell, or Hodgkin's|lymphoma: diffuse large cell, mantle cell, peripheral t-cell, t-nk cell, or hodgkin's
5277573|NCT00514709|Diphtheria|diphtheria
5277574|NCT00514709|Tetanus|tetanus
5277575|NCT00514709|Pertussis|pertussis
5277576|NCT00514709|Hepatitis B Hansenula (HB)|hepatitis b hansenula (hb)
5277577|NCT00514709|Haemophilus influenzae type b|haemophilus influenzae type b
5277578|NCT00514696|Cancer|cancer
5277579|NCT00514696|Leukemia|leukemia
5277580|NCT00514696|GCS-100|gcs-100
5277581|NCT00514696|CLL|cll
5277582|NCT00514670|Prevention of gastrointestinal and respiratory illness|prevention of gastrointestinal and respiratory illness
5277583|NCT00514644|Panorama|panorama
5277584|NCT00514644|Carotid stenoses|carotid stenoses
5277585|NCT00514618|Term Pregnancy|term pregnancy
5277586|NCT00514618|Diabetes|diabetes
5277587|NCT00514618|Cervical Ripening|cervical ripening
5277588|NCT00514618|Induction|induction
5277589|NCT00514618|misoprostol|misoprostol
5277590|NCT00514618|Term Gestational Diabetics|term gestational diabetics
5277591|NCT00514605|HIV 1|hiv 1
5277592|NCT00514605|AIDS|aids
5277593|NCT00514605|Assay|assay
5277594|NCT00514605|Rapid Test|rapid test
5277595|NCT00514605|HIV-1|hiv-1
5277596|NCT00514605|HIV Seronegativity|hiv seronegativity
5277597|NCT00514592|Carotid stenosis|carotid stenosis
5277598|NCT00514592|Carotid endarterectomy|carotid endarterectomy
5277599|NCT00514579|Cord Blood Stem Cell Transplantation|cord blood stem cell transplantation
5277600|NCT00514579|Hematologic Malignancies|hematologic malignancies
5277601|NCT00514579|Leukemia|leukemia
5277602|NCT00514579|Myelodysplastic Syndrome|myelodysplastic syndrome
5277603|NCT00514566|Polyamide|polyamide
5277604|NCT00514566|Polydioxanone|polydioxanone
5277605|NCT00514566|Midline|midline
5277606|NCT00514566|Abdominal|abdominal
5277607|NCT00514566|Closure|closure
5277608|NCT00514553|Prenatal Testing|prenatal testing
5277609|NCT00514553|Test Decision-Making|test decision-making
5277610|NCT00514553|Decision-Making Intervention|decision-making intervention
5277611|NCT00514553|Theory of Unconscious Thought|theory of unconscious thought
5277612|NCT00514553|Informed Choice|informed choice
5277613|NCT00514553|Decision Making|decision making
5277614|NCT00514553|Counseling|counseling
5277615|NCT00514540|Prostate Cancer|prostate cancer
5277616|NCT00514540|Anaplastic Prostate Cancer|anaplastic prostate cancer
5277617|NCT00514540|Carboplatin|carboplatin
5277618|NCT00514540|Docetaxel|docetaxel
5277619|NCT00514540|Taxotere|taxotere
5277620|NCT00514540|Paraplatin|paraplatin
5277621|NCT00514514|Everolimus|everolimus
5277622|NCT00514514|mycophenolate|mycophenolate
5277623|NCT00514514|CNI-free|cni-free
5277624|NCT00514514|kidney transplantation|kidney transplantation
5277625|NCT00514488|chronic myeloid leukemia|chronic myeloid leukemia
5277626|NCT00514488|STI 571|sti 571
5277627|NCT00514488|CML022|cml022
5277628|NCT00514475|Mantle cell lymphoma|mantle cell lymphoma
5277629|NCT00514475|Zevalin|zevalin
5277630|NCT00514475|90Y-ibritumomab tiuxetan|90y-ibritumomab tiuxetan
5277631|NCT00514475|Radioimmunotherapy|radioimmunotherapy
5277632|NCT00514475|High-dose therapy|high-dose therapy
5277633|NCT00514475|First line|first line
5277634|NCT00514436|Asthma|asthma
5277635|NCT00514436|children|children
5277636|NCT00514436|low-income, underserved|low-income, underserved
5277637|NCT00514436|Reduction in hospitalization|reduction in hospitalization
5277639|NCT00514410|Folate|folate
5277640|NCT00514410|Folic acid|folic acid
5277641|NCT00514410|Antidepressants|antidepressants
5277642|NCT00514397|untreated childhood brain stem glioma|untreated childhood brain stem glioma
5277643|NCT00514371|Multiple Myeloma|multiple myeloma
5277644|NCT00514371|Heat Shock Protein 90|heat shock protein 90
5277645|NCT00514371|Hsp90|hsp90
5277646|NCT00514371|KOS-953|kos-953
5277647|NCT00514371|17-AAG|17-aag
5277648|NCT00514371|bortezomib|bortezomib
5277649|NCT00514371|relapsed-refractory|relapsed-refractory
5277650|NCT00514371|tanespimycin|tanespimycin
5277651|NCT00514358|Fungal|fungal
5277652|NCT00514358|Infection|infection
5277653|NCT00514358|sepsis|sepsis
5277654|NCT00514358|pharmacokinetics|pharmacokinetics
5277655|NCT00514345|chemotherapeutic agent toxicity|chemotherapeutic agent toxicity
5277656|NCT00514345|localized Ewing sarcoma/peripheral primitive neuroectodermal tumor|localized ewing sarcoma/peripheral primitive neuroectodermal tumor
5277657|NCT00514345|metastatic Ewing sarcoma/peripheral primitive neuroectodermal tumor|metastatic ewing sarcoma/peripheral primitive neuroectodermal tumor
5277658|NCT00514345|nonmetastatic childhood soft tissue sarcoma|nonmetastatic childhood soft tissue sarcoma
5277659|NCT00514345|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
5277660|NCT00514345|recurrent Ewing sarcoma/peripheral primitive neuroectodermal tumor|recurrent ewing sarcoma/peripheral primitive neuroectodermal tumor
5277661|NCT00514345|metastatic childhood soft tissue sarcoma|metastatic childhood soft tissue sarcoma
5277662|NCT00514345|recurrent childhood soft tissue sarcoma|recurrent childhood soft tissue sarcoma
5277663|NCT00514345|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
5277664|NCT00514345|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
5277665|NCT00514332|colorectal stents|colorectal stents
5277666|NCT00514332|colonic obstruction|colonic obstruction
5277667|NCT00514332|colonic adenocarcinoma|colonic adenocarcinoma
5277668|NCT00514332|colorectal surgery|colorectal surgery
5277669|NCT00514306|Advanced Cancer|advanced cancer
5277670|NCT00514306|Breast cancer|breast cancer
5277671|NCT00514306|Renal cancer|renal cancer
5277672|NCT00514306|Ovarian Cancer|ovarian cancer
5277673|NCT00514306|Metastatic Cancer|metastatic cancer
5277674|NCT00514306|Non-small cell lung cancer|non-small cell lung cancer
5277675|NCT00514306|Colorectal cancer|colorectal cancer
5277676|NCT00514293|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5277677|NCT00514293|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5277678|NCT00514293|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5277679|NCT00514280|Lead and Smoke Study in D.C.|lead and smoke study in d.c.
5277680|NCT00514280|Birth Weight|birth weight
5277681|NCT00514280|Gestational Age|gestational age
5277682|NCT00514280|Lead|lead
5277683|NCT00514280|Tobacco Smoke|tobacco smoke
5277684|NCT00514267|Prostate Cancer|prostate cancer
5277685|NCT00514267|HRPC|hrpc
5277686|NCT00514267|Hormone Refractory Prostate Cancer|hormone refractory prostate cancer
5277687|NCT00514267|YM155|ym155
5277688|NCT00514267|Treatment Outcome|treatment outcome
5277689|NCT00514267|Solid Tumors|solid tumors
5277690|NCT00514254|endometrial cancer|endometrial cancer
5277691|NCT00514254|risk factors|risk factors
5277692|NCT00514254|questionnaire|questionnaire
5277693|NCT00514254|07-093|07-093
5277694|NCT00514228|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
5277695|NCT00514228|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
5277696|NCT00514228|advanced adult primary liver cancer|advanced adult primary liver cancer
5277697|NCT00514228|recurrent adult primary liver cancer|recurrent adult primary liver cancer
5277698|NCT00514215|lung metastases|lung metastases
5277699|NCT00514215|stage I non-small cell lung cancer|stage i non-small cell lung cancer
5277700|NCT00514215|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
5277701|NCT00514215|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5277702|NCT00514215|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5277703|NCT00514215|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5277704|NCT00514215|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5277705|NCT00514215|recurrent renal cell cancer|recurrent renal cell cancer
5277706|NCT00514215|stage IV renal cell cancer|stage iv renal cell cancer
5277707|NCT00514215|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5277708|NCT00514202|cocaine|cocaine
5277709|NCT00514202|ADHD|adhd
5277710|NCT00514202|attention|attention
5277711|NCT00514202|hyperactivity|hyperactivity
5277712|NCT00514202|drug|drug
5277713|NCT00514202|dependence|dependence
5277714|NCT00514189|Acute Myelogenous Leukemia|acute myelogenous leukemia
5277715|NCT00514189|Leukemia|leukemia
5277716|NCT00514189|Autologous Dendritic Cells|autologous dendritic cells
5277717|NCT00514189|Vaccine|vaccine
5277718|NCT00514189|AML|aml
5277719|NCT00514189|mRNA|mrna
5277720|NCT00514163|pancreatic carcinoma|pancreatic carcinoma
5277721|NCT00514163|gemcitabine|gemcitabine
5277722|NCT00514163|S-1|s-1
5277723|NCT00514163|phaseⅡstudy|phaseⅱstudy
5277724|NCT00514150|angiography|angiography
5277725|NCT00514150|complications|complications
5277726|NCT00514150|contrast media|contrast media
5277727|NCT00514150|kidney|kidney
5277728|NCT00514150|prevention|prevention
5277729|NCT00514098|Microbicide|microbicide
5277730|NCT00514098|Seroconversion|seroconversion
5277731|NCT00514098|Treatment Experienced|treatment experienced
5277732|NCT00514098|Treatment Naive|treatment naive
5277733|NCT00514085|recurrent melanoma|recurrent melanoma
5277734|NCT00514085|stage IV melanoma|stage iv melanoma
5277735|NCT00514072|stage IV prostate cancer|stage iv prostate cancer
5277736|NCT00514072|recurrent prostate cancer|recurrent prostate cancer
5277737|NCT00514059|Diphteria-tetanus-pertussis-polio vaccine|diphteria-tetanus-pertussis-polio vaccine
5277738|NCT00514059|Booster immunization|booster immunization
5277739|NCT00514059|Vaccine effect (Diphtheria-tetanus-acellular pertussis-polio)|vaccine effect (diphtheria-tetanus-acellular pertussis-polio)
5277740|NCT00514059|Immunity|immunity
5277741|NCT00514059|Safety|safety
5277742|NCT00514046|Multiple Endocrine Neoplasia (MEN)|multiple endocrine neoplasia (men)
5277743|NCT00514046|Medullary Thyroid Carcinoma|medullary thyroid carcinoma
5277744|NCT00514046|Molecularly-Targeted Therapy|molecularly-targeted therapy
5277745|NCT00514046|Pediatric|pediatric
5277746|NCT00514046|Pharmacokinetics|pharmacokinetics
5277747|NCT00514046|MTC|mtc
5277748|NCT00514046|Multiple Endocrine Neoplasia|multiple endocrine neoplasia
5277749|NCT00514046|MEN|men
5277750|NCT00514020|adenocarcinoma of the stomach|adenocarcinoma of the stomach
5277751|NCT00514020|stage IV gastric cancer|stage iv gastric cancer
5277752|NCT00514020|recurrent gastric cancer|recurrent gastric cancer
5277753|NCT00514007|Non-small cell lung cancer|non-small cell lung cancer
5277754|NCT00514007|Ovarian cancer|ovarian cancer
5277755|NCT00514007|Renal cancer|renal cancer
5277756|NCT00514007|Advanced Cancer|advanced cancer
5277757|NCT00514007|Metastatic cancer|metastatic cancer
5277758|NCT00514007|Breast cancer|breast cancer
5277759|NCT00514007|Colorectal cancer|colorectal cancer
5277760|NCT00513994|Pharmacokinetics|pharmacokinetics
5277761|NCT00513994|Nitroglycerin|nitroglycerin
5277762|NCT00513994|pharmacokinetics study of nitroglycerin containing treatments|pharmacokinetics study of nitroglycerin containing treatments
5277763|NCT00513981|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
5277764|NCT00513981|recurrent osteosarcoma|recurrent osteosarcoma
5277765|NCT00513981|recurrent childhood soft tissue sarcoma|recurrent childhood soft tissue sarcoma
5277766|NCT00513981|recurrent childhood ependymoma|recurrent childhood ependymoma
5277767|NCT00513981|untreated childhood brain stem glioma|untreated childhood brain stem glioma
5277768|NCT00513981|recurrent childhood brain stem glioma|recurrent childhood brain stem glioma
5277769|NCT00513955|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5277770|NCT00513942|Fetal Movement|fetal movement
5277771|NCT00513942|Maternal-Fetal-Attachment|maternal-fetal-attachment
5277772|NCT00513942|Fetus|fetus
5277773|NCT00513929|Severe Pneumonia|severe pneumonia
5277774|NCT00513929|Zinc|zinc
5277775|NCT00513929|Associated pathogens|associated pathogens
5277776|NCT00513929|Severe Pneumonia by type of associated pathogens|severe pneumonia by type of associated pathogens
5277777|NCT00513929|Severe Pneumonia by basal plasma zinc status|severe pneumonia by basal plasma zinc status
5277778|NCT00513916|breast cancer|breast cancer
5277779|NCT00513916|healthy, no evidence of disease|healthy, no evidence of disease
5277780|NCT00513903|Pulmonary Diseases|pulmonary diseases
5277781|NCT00513903|Continuity of Pharmacy Care|continuity of pharmacy care
5277782|NCT00513890|Bronchiolitis|bronchiolitis
5277783|NCT00513890|Esophageal pressure mesurement|esophageal pressure mesurement
5277784|NCT00513890|Clinical score|clinical score
5277785|NCT00513890|Citical care|citical care
5277786|NCT00513890|Infant|infant
5277787|NCT00513877|recurrent malignant mesothelioma|recurrent malignant mesothelioma
5277788|NCT00513877|stage IA malignant mesothelioma|stage ia malignant mesothelioma
5277789|NCT00513877|stage IB malignant mesothelioma|stage ib malignant mesothelioma
5277790|NCT00513877|stage II malignant mesothelioma|stage ii malignant mesothelioma
5277791|NCT00513877|stage III malignant mesothelioma|stage iii malignant mesothelioma
5277792|NCT00513877|stage IV malignant mesothelioma|stage iv malignant mesothelioma
5277793|NCT00513864|Opioid Analgesics|opioid analgesics
5277794|NCT00513864|Morphine|morphine
5277795|NCT00513864|Codeine|codeine
5277796|NCT00513864|Sickle Cell Disease|sickle cell disease
5277797|NCT00513851|Advanced Cancer|advanced cancer
5277798|NCT00513851|Non-small cell lung cancer|non-small cell lung cancer
5277799|NCT00513851|Small cell lung cancer|small cell lung cancer
5277800|NCT00513851|Uterine cancer|uterine cancer
5277801|NCT00513851|Ovarian cancer|ovarian cancer
5277802|NCT00513851|Renal cancer|renal cancer
5277803|NCT00513851|Head and neck cancer|head and neck cancer
5277804|NCT00513851|Cervical cancer|cervical cancer
5277805|NCT00513851|Metastatic cancer|metastatic cancer
5277806|NCT00513851|Colorectal cancer|colorectal cancer
5277807|NCT00513851|Gastrointestinal stromal tumors|gastrointestinal stromal tumors
5277808|NCT00513825|Contrast Nephropathy|contrast nephropathy
5277809|NCT00513825|Sodium Bicarbonate|sodium bicarbonate
5277810|NCT00513825|Prevention|prevention
5277811|NCT00513786|Endometrial Cancer|endometrial cancer
5277812|NCT00513786|Advanced Stage Endometrial Cancer|advanced stage endometrial cancer
5277813|NCT00513786|Stage 3 or 4 endometrial cancer|stage 3 or 4 endometrial cancer
5277814|NCT00513786|Cancer treatment|cancer treatment
5277815|NCT00513786|gyn cancer|gyn cancer
5277816|NCT00513773|Abdominal Aortic Aneurysm,|abdominal aortic aneurysm,
5277817|NCT00513773|Inflammation and Risk Prediction|inflammation and risk prediction
5277818|NCT00513773|Diagnostic Tool Efficacy|diagnostic tool efficacy
5277819|NCT00513760|Pharmacogenetics|pharmacogenetics
5277820|NCT00513760|Singulair|singulair
5277821|NCT00513760|montelukast|montelukast
5277822|NCT00513760|Leukotriene Antagonists|leukotriene antagonists
5277823|NCT00513760|Anti-Asthmatic Agents|anti-asthmatic agents
5277824|NCT00513760|Intestinal Absorption|intestinal absorption
5277825|NCT00513760|pharmacokinetics|pharmacokinetics
5277826|NCT00513760|absorption|absorption
5277827|NCT00513760|biochemical transport|biochemical transport
5277828|NCT00513760|Membrane Transport Proteins|membrane transport proteins
5277829|NCT00513760|Drug Interactions|drug interactions
5277830|NCT00513747|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
5277831|NCT00513747|stage 0 chronic lymphocytic leukemia|stage 0 chronic lymphocytic leukemia
5277832|NCT00513747|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
5277833|NCT00513734|keratopathy|keratopathy
5277834|NCT00513734|exposure|exposure
5277835|NCT00513734|intensive care|intensive care
5277836|NCT00513734|eye|eye
5277837|NCT00513734|ulcer|ulcer
5277838|NCT00513734|Corneal|corneal
5277839|NCT00513721|prostate|prostate
5277840|NCT00513721|prostate cancer|prostate cancer
5277841|NCT00513721|surgical margins|surgical margins
5277842|NCT00513721|gleason score|gleason score
5277843|NCT00513721|positive lateral biopsies|positive lateral biopsies
5277844|NCT00513708|Detoxification|detoxification
5277845|NCT00513708|Treatment|treatment
5277846|NCT00513682|Cystic Fibrosis|cystic fibrosis
5277847|NCT00513682|Pancreatic insufficiency|pancreatic insufficiency
5277848|NCT00513682|Steatorrhea|steatorrhea
5277849|NCT00513682|Children 7 to 11 years|children 7 to 11 years
5277850|NCT00513682|Pancreatic enzyme|pancreatic enzyme
5277851|NCT00513669|Malaria|malaria
5277852|NCT00513669|Vaccine|vaccine
5277853|NCT00513669|Falciparum|falciparum
5277854|NCT00513669|Trial|trial
5277855|NCT00513669|Phase I|phase i
5277856|NCT00513669|Safety|safety
5277857|NCT00513669|Immunogenicity|immunogenicity
5277858|NCT00513656|Efficacy|efficacy
5277859|NCT00513656|chronic|chronic
5277860|NCT00513656|cancer|cancer
5277861|NCT00513656|pain|pain
5277862|NCT00513656|constipation|constipation
5277863|NCT00513656|oxycodone|oxycodone
5277864|NCT00513656|naloxone|naloxone
5277865|NCT00513656|Moderate to severe chronic cancer pain|moderate to severe chronic cancer pain
5277866|NCT00513643|euglycaemic glucose clamp|euglycaemic glucose clamp
5277867|NCT00513643|duration of action|duration of action
5277868|NCT00513643|late metabolic activity|late metabolic activity
5277869|NCT00513643|hypoglycaemia|hypoglycaemia
5277870|NCT00513617|Sickle Cell Disease|sickle cell disease
5277871|NCT00513617|Anemia|anemia
5277872|NCT00513617|Nitric Oxide|nitric oxide
5277873|NCT00513617|Vaso Occlusive Events|vaso occlusive events
5277874|NCT00513617|Arginine Supplementation|arginine supplementation
5277875|NCT00513604|Clinical Response|clinical response
5277876|NCT00513604|Immunotherapy|immunotherapy
5277877|NCT00513604|Cancer|cancer
5277878|NCT00513604|Cytokines|cytokines
5277879|NCT00513604|Adoptive Cell Therapy|adoptive cell therapy
5277880|NCT00513604|Melanoma|melanoma
5277881|NCT00513604|Skin Cancer|skin cancer
5277882|NCT00513604|Malignant Melanoma|malignant melanoma
5277883|NCT00513591|Pregnancy|pregnancy
5277884|NCT00513591|Lupus (systemic lupus erythematosus or cutaneous lupus)|lupus (systemic lupus erythematosus or cutaneous lupus)
5277885|NCT00513591|Rheumatoid Arthritis|rheumatoid arthritis
5277886|NCT00513591|Sjogren's Syndrome|sjogren's syndrome
5277887|NCT00513591|Scleroderma|scleroderma
5277888|NCT00513578|refractory anemia with excess blasts|refractory anemia with excess blasts
5277889|NCT00513578|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
5277890|NCT00513578|refractory anemia|refractory anemia
5277891|NCT00513578|refractory cytopenia with multilineage dysplasia|refractory cytopenia with multilineage dysplasia
5277892|NCT00513578|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5277893|NCT00513578|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5277894|NCT00513565|GSK561679,|gsk561679,
5277895|NCT00513565|single,|single,
5277896|NCT00513565|dose,|dose,
5277897|NCT00513565|lorazepam,|lorazepam,
5277898|NCT00513565|fMRI,|fmri,
5277899|NCT00513565|BOLD,|bold,
5277900|NCT00513565|healthy volunteers|healthy volunteers
5277901|NCT00513539|unresectable gallbladder cancer|unresectable gallbladder cancer
5277902|NCT00513539|recurrent gallbladder cancer|recurrent gallbladder cancer
5277903|NCT00513539|metastatic gallbladder cancer|metastatic gallbladder cancer
5277904|NCT00513539|cholangiocarcinoma of the gallbladder|cholangiocarcinoma of the gallbladder
5277905|NCT00513539|unresectable extrahepatic bile duct cancer|unresectable extrahepatic bile duct cancer
5277906|NCT00513539|recurrent extrahepatic bile duct cancer|recurrent extrahepatic bile duct cancer
5277907|NCT00513539|metastatic extrahepatic bile duct cancer|metastatic extrahepatic bile duct cancer
5277908|NCT00513539|cholangiocarcinoma of the extrahepatic bile duct|cholangiocarcinoma of the extrahepatic bile duct
5277909|NCT00513526|infection|infection
5277983|NCT00513422|Chondroitin|chondroitin
5277910|NCT00513526|low-grade squamous intraepithelial lesion|low-grade squamous intraepithelial lesion
5277911|NCT00513526|atypical squamous cells of undetermined significance|atypical squamous cells of undetermined significance
5277912|NCT00513513|HIV|hiv
5277913|NCT00513513|AIDS|aids
5277914|NCT00513513|TMC114|tmc114
5277915|NCT00513513|Protease inhibitor|protease inhibitor
5277916|NCT00513513|Darunavir|darunavir
5277917|NCT00513513|Antiretroviral agents|antiretroviral agents
5277918|NCT00513513|Treatment Naive|treatment naive
5277919|NCT00513500|community health care|community health care
5277920|NCT00513500|community health worker|community health worker
5277921|NCT00513500|malaria|malaria
5277922|NCT00513500|pneumonia|pneumonia
5277923|NCT00513500|rapid diagnostic test|rapid diagnostic test
5277924|NCT00513487|Allergic Rhinitis|allergic rhinitis
5277925|NCT00513487|dust mites|dust mites
5277926|NCT00513487|IgE|ige
5277927|NCT00513487|IL-13|il-13
5277928|NCT00513487|nasal|nasal
5277929|NCT00513487|inflammation|inflammation
5277930|NCT00513474|graft versus host disease|graft versus host disease
5277931|NCT00513474|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5277932|NCT00513474|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
5277933|NCT00513474|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5277934|NCT00513474|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5277935|NCT00513474|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5277936|NCT00513474|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5277937|NCT00513474|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5277938|NCT00513474|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5277939|NCT00513474|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5277940|NCT00513474|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5277941|NCT00513474|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5277942|NCT00513474|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
5278181|NCT00512785|Imidafenacin|imidafenacin
5277943|NCT00513474|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5277944|NCT00513474|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5277945|NCT00513474|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5277946|NCT00513474|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5277947|NCT00513474|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5277948|NCT00513474|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5277949|NCT00513474|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5277950|NCT00513474|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5277951|NCT00513474|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5277952|NCT00513474|Waldenström macroglobulinemia|waldenström macroglobulinemia
5277953|NCT00513474|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5277954|NCT00513474|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5277955|NCT00513474|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5277956|NCT00513474|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5277957|NCT00513474|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5277958|NCT00513474|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5277959|NCT00513474|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5277960|NCT00513474|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5277961|NCT00513474|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5277962|NCT00513474|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5277963|NCT00513474|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5277964|NCT00513474|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5277965|NCT00513474|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5277966|NCT00513474|primary myelofibrosis|primary myelofibrosis
5277967|NCT00513474|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
5277968|NCT00513474|chronic eosinophilic leukemia|chronic eosinophilic leukemia
5277969|NCT00513474|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5277970|NCT00513474|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5277971|NCT00513474|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
5277972|NCT00513474|refractory hairy cell leukemia|refractory hairy cell leukemia
5277973|NCT00513474|refractory multiple myeloma|refractory multiple myeloma
5277974|NCT00513474|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5277975|NCT00513474|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5277976|NCT00513448|Chronic Disabling Condition|chronic disabling condition
5277977|NCT00513448|Comparative Evaluation|comparative evaluation
5277978|NCT00513448|Physical Activity|physical activity
5277979|NCT00513448|Physical Therapy|physical therapy
5277980|NCT00513448|Rehabilitation|rehabilitation
5277981|NCT00513422|Osteoarthritis, knee|osteoarthritis, knee
5277982|NCT00513422|Glucosamine|glucosamine
5277984|NCT00513422|Disease progression|disease progression
5277985|NCT00513422|NSAIDs|nsaids
5277986|NCT00513409|Immunogenicity|immunogenicity
5277987|NCT00513409|Pneumococcal disease|pneumococcal disease
5277988|NCT00513409|Safety|safety
5277989|NCT00513409|Booster vaccination|booster vaccination
5277990|NCT00513409|Pneumococcal vaccine|pneumococcal vaccine
5277991|NCT00513396|Randomized control trial|randomized control trial
5277992|NCT00513396|multidrug resistant tuberculosis|multidrug resistant tuberculosis
5277993|NCT00513396|isoniazid|isoniazid
5277994|NCT00513396|standardized regimen|standardized regimen
5277995|NCT00513396|adjuvant therapy|adjuvant therapy
5277996|NCT00513383|basaloid squamous cell carcinoma|basaloid squamous cell carcinoma
5277997|NCT00513383|undifferentiated carcinoma|undifferentiated carcinoma
5277998|NCT00513383|adenosquamous cell carcinoma|adenosquamous cell carcinoma
5277999|NCT00513370|Psoriasis|psoriasis
5278000|NCT00513370|adalimumab|adalimumab
5278001|NCT00513357|Gastrointestinal Cancer|gastrointestinal cancer
5278002|NCT00513357|Lung Cancer|lung cancer
5278003|NCT00513357|Cachexia|cachexia
5278004|NCT00513357|Melatonin|melatonin
5278005|NCT00513357|Placebo|placebo
5278006|NCT00513357|Anorexia|anorexia
5278007|NCT00513357|Weight Loss|weight loss
5278008|NCT00513344|Endothelial function|endothelial function
5278009|NCT00513344|Arterial stiffness|arterial stiffness
5278010|NCT00513344|Dark chocolate|dark chocolate
5278011|NCT00513344|Milk chocolate|milk chocolate
5278012|NCT00513344|Polyphenols|polyphenols
5278013|NCT00513331|Barrett's Esophagus|barrett's esophagus
5278014|NCT00513331|GERD|gerd
5278015|NCT00513331|Carcinoma|carcinoma
5278016|NCT00513318|Umbilical cord blood transplantation|umbilical cord blood transplantation
5278017|NCT00513318|hematopoietic malignancies|hematopoietic malignancies
5278018|NCT00513305|acute myeloid leukemia, cytarabine, arsenic trioxide.|acute myeloid leukemia, cytarabine, arsenic trioxide.
5278019|NCT00513279|Safety,|safety,
5278020|NCT00513279|GSK618334|gsk618334
5278021|NCT00513279|pharmacokinetics,|pharmacokinetics,
5278022|NCT00513279|repeat dose,|repeat dose,
5278023|NCT00513279|tolerability,|tolerability,
5278024|NCT00513279|pharmacodynamics,|pharmacodynamics,
5278025|NCT00513279|placebo,|placebo,
5278026|NCT00513266|recurrent rectal cancer|recurrent rectal cancer
5278027|NCT00513266|stage IV rectal cancer|stage iv rectal cancer
5278028|NCT00513266|recurrent colon cancer|recurrent colon cancer
5278029|NCT00513266|stage IV colon cancer|stage iv colon cancer
5278030|NCT00513266|adenocarcinoma of the colon|adenocarcinoma of the colon
5278031|NCT00513266|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5278032|NCT00513266|liver metastases|liver metastases
5278033|NCT00513266|lung metastases|lung metastases
5278034|NCT00513253|lapatinib|lapatinib
5278035|NCT00513253|Healthy Adult Volunteer|healthy adult volunteer
5278036|NCT00513240|erythropoetin|erythropoetin
5278037|NCT00513240|neuroprotection|neuroprotection
5278038|NCT00513240|neonate|neonate
5278039|NCT00513240|cardiac|cardiac
5278040|NCT00513240|magnetic resonance imaging|magnetic resonance imaging
5278041|NCT00513240|brain magnetic resonance imaging|brain magnetic resonance imaging
5278042|NCT00513240|electroencephalogram|electroencephalogram
5278043|NCT00513214|Diabetes|diabetes
5278044|NCT00513214|Type 2|type 2
5278045|NCT00513214|Mellitus|mellitus
5278046|NCT00513201|lyspro|lyspro
5278047|NCT00513201|regular insulin|regular insulin
5278048|NCT00513201|cirrhotic patients|cirrhotic patients
5278049|NCT00513188|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
5278050|NCT00513188|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5278051|NCT00513188|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
5278052|NCT00513188|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
5278053|NCT00513188|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
5278054|NCT00513175|Allogeneic SCT|allogeneic sct
5278055|NCT00513175|Matched unrelated donors|matched unrelated donors
5278056|NCT00513175|hematologic malignancies|hematologic malignancies
5278057|NCT00513175|renal cell carcinoma|renal cell carcinoma
5278058|NCT00513175|aplastic anemia|aplastic anemia
5278059|NCT00513162|Advanced Cancers|advanced cancers
5278060|NCT00513162|Brain|brain
5278061|NCT00513162|CNS|cns
5278062|NCT00513162|Neural|neural
5278063|NCT00513162|Pediatrics|pediatrics
5278064|NCT00513162|Spinal|spinal
5278065|NCT00513162|Neuroectodermal Tumor|neuroectodermal tumor
5278066|NCT00513162|Brain Metastases|brain metastases
5278067|NCT00513162|Valproate|valproate
5278068|NCT00513162|Valproic Acid|valproic acid
5278069|NCT00513162|Depakene|depakene
5278070|NCT00513162|Etoposide|etoposide
5278071|NCT00513162|VePesid|vepesid
5278072|NCT00513149|angioplasty|angioplasty
5278073|NCT00513149|clopidogrel|clopidogrel
5278074|NCT00513149|coronary artery disease|coronary artery disease
5278075|NCT00513149|PFA|pfa
5278076|NCT00513136|Fatigue|fatigue
5278077|NCT00513136|Breast Cancer|breast cancer
5278078|NCT00513136|Behavioral Research|behavioral research
5278079|NCT00513136|Quality of Life|quality of life
5278080|NCT00513123|Digital Colposcopy for Fluorescence|digital colposcopy for fluorescence
5278081|NCT00513123|DCF|dcf
5278882|NCT00510185|elderly|elderly
5278082|NCT00513123|Fluorescence Spectroscopy|fluorescence spectroscopy
5278083|NCT00513123|Digital Colposcopy|digital colposcopy
5278084|NCT00513123|DC|dc
5278085|NCT00513123|Cervical Intraepithelial Neoplasia|cervical intraepithelial neoplasia
5278086|NCT00513123|Cervical Cancer|cervical cancer
5278087|NCT00513123|Cervix|cervix
5278088|NCT00513123|Vagina|vagina
5278089|NCT00513123|Lesions of the cervix|lesions of the cervix
5278090|NCT00513123|Precancerous lesions|precancerous lesions
5278091|NCT00513110|Endotoxin|endotoxin
5278092|NCT00513110|Adenosine|adenosine
5278093|NCT00513110|Caffeine|caffeine
5278094|NCT00513110|AMPD1 polymorphism|ampd1 polymorphism
5278095|NCT00513097|Epidemiology|epidemiology
5278096|NCT00513097|Cancer Prevention|cancer prevention
5278097|NCT00513097|Smoking Cessation|smoking cessation
5278098|NCT00513097|Smoking Prevention|smoking prevention
5278099|NCT00513097|Focus Groups|focus groups
5278100|NCT00513084|Behavioral,|behavioral,
5278101|NCT00513084|Self-Determination Theory,|self-determination theory,
5278102|NCT00513084|Motivational Interviewing,|motivational interviewing,
5278103|NCT00513084|Exercise, Physical Activity,|exercise, physical activity,
5278104|NCT00513084|Motivation,|motivation,
5278105|NCT00513084|Moderators,|moderators,
5278106|NCT00513084|Mediators,|mediators,
5278107|NCT00513084|Predictors,|predictors,
5278108|NCT00513084|Weight|weight
5278109|NCT00513058|metastatic breast cancer|metastatic breast cancer
5278110|NCT00513058|advanced breast cancer|advanced breast cancer
5278111|NCT00513045|Nightmares|nightmares
5278112|NCT00513045|treatment|treatment
5278113|NCT00513045|self-help|self-help
5278114|NCT00513032|propofol|propofol
5278115|NCT00513032|anaesthesia induction|anaesthesia induction
5278116|NCT00513032|parathyroidectomy|parathyroidectomy
5278117|NCT00513032|methylene blue|methylene blue
5278118|NCT00513032|General anesthesia|general anesthesia
5278119|NCT00513019|Neurotic Excoriation|neurotic excoriation
5278120|NCT00513019|Pathologic Skin Picking|pathologic skin picking
5278121|NCT00513019|Psychogenic Excoriation|psychogenic excoriation
5278122|NCT00512993|Postoperative treatment with zoledronic acid|postoperative treatment with zoledronic acid
5278123|NCT00512993|Preoperative anthracycline/taxane containing chemotherapy|preoperative anthracycline/taxane containing chemotherapy
5278124|NCT00512980|intermediate stages|intermediate stages
5278125|NCT00512967|oxidative stress|oxidative stress
5278126|NCT00512967|antioxidants|antioxidants
5278127|NCT00512967|inflammation|inflammation
5278128|NCT00512967|quercetin|quercetin
5278129|NCT00512954|airway inflammation|airway inflammation
5278130|NCT00512954|susceptibility to infections|susceptibility to infections
5278131|NCT00512954|inflammatory response in blood and urine|inflammatory response in blood and urine
5278132|NCT00512954|infective exacerbations|infective exacerbations
5278133|NCT00512954|asthma|asthma
5278134|NCT00512954|COPD|copd
5278135|NCT00512928|vitamin K2|vitamin k2
5278136|NCT00512928|oral anticoagulation|oral anticoagulation
5278137|NCT00512928|interference|interference
5278138|NCT00512928|level of anticoagulation|level of anticoagulation
5278139|NCT00512928|carboxylation level of osteocalcin and matrix-gla protein|carboxylation level of osteocalcin and matrix-gla protein
5278140|NCT00512915|Farfield Sensing|farfield sensing
5278141|NCT00512915|Pacing lead|pacing lead
5278142|NCT00512915|Postventricular atrial blanking|postventricular atrial blanking
5278143|NCT00512915|Bradycardia|bradycardia
5278144|NCT00512902|active alveolitis in systemic sclerosis|active alveolitis in systemic sclerosis
5278145|NCT00512889|CTL|ctl
5278146|NCT00512889|MART-1|mart-1
5278147|NCT00512889|Melan-A|melan-a
5278148|NCT00512889|artificial APC|artificial apc
5278149|NCT00512889|melanoma|melanoma
5278150|NCT00512889|metastatic melanoma|metastatic melanoma
5278151|NCT00512889|adoptive immunotherapy|adoptive immunotherapy
5278152|NCT00512889|adoptive cell transfer|adoptive cell transfer
5278153|NCT00512889|immunotherapy|immunotherapy
5278154|NCT00512850|Folic acid|folic acid
5278155|NCT00512850|Adenoma of Large Intestine|adenoma of large intestine
5278156|NCT00512837|Telemedicine|telemedicine
5278157|NCT00512837|clinical management|clinical management
5278158|NCT00512837|empowerment|empowerment
5278159|NCT00512837|engagement|engagement
5278160|NCT00512837|education|education
5278161|NCT00512824|calcium|calcium
5278162|NCT00512824|probiotics|probiotics
5278163|NCT00512824|diarrhea|diarrhea
5278164|NCT00512824|children|children
5278165|NCT00512824|Indonesia|indonesia
5278166|NCT00512824|Healthy children|healthy children
5278167|NCT00512824|acute diarrhea|acute diarrhea
5278168|NCT00512811|furosemide|furosemide
5278169|NCT00512811|inhalation|inhalation
5278170|NCT00512811|dyspnea|dyspnea
5278171|NCT00512811|spirometry|spirometry
5278172|NCT00512811|mustard gas|mustard gas
5278173|NCT00512811|bronchiolitis|bronchiolitis
5278174|NCT00512811|sulfur mustard|sulfur mustard
5278175|NCT00512798|stage III melanoma|stage iii melanoma
5278176|NCT00512798|stage IV melanoma|stage iv melanoma
5278177|NCT00512798|recurrent melanoma|recurrent melanoma
5278178|NCT00512798|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5278179|NCT00512798|recurrent adult brain tumor|recurrent adult brain tumor
5278180|NCT00512798|melanoma (skin)|melanoma (skin)
5278182|NCT00512785|KRP-197/ONO-8025|krp-197/ono-8025
5278183|NCT00512785|overactive bladder|overactive bladder
5278184|NCT00512785|antimuscarinic|antimuscarinic
5278185|NCT00512772|Time series|time series
5278186|NCT00512772|Implementation|implementation
5278187|NCT00512746|small cell lung cancer|small cell lung cancer
5278188|NCT00512746|non-small cell lung cancer|non-small cell lung cancer
5278189|NCT00512746|precancerous condition|precancerous condition
5278190|NCT00512733|Healthy volunteers|healthy volunteers
5278191|NCT00512720|PAD|pad
5278192|NCT00512720|Peripheral Artery Disease|peripheral artery disease
5278193|NCT00512720|PVD|pvd
5278194|NCT00512720|Peripheral Vascular Disease|peripheral vascular disease
5278195|NCT00512720|Leg Blockage|leg blockage
5278196|NCT00512720|Angioplasty|angioplasty
5278197|NCT00512720|Stent|stent
5278198|NCT00512720|Claudication|claudication
5278199|NCT00512707|testosterone|testosterone
5278200|NCT00512707|erectile dysfunction|erectile dysfunction
5278201|NCT00512707|sildenafil|sildenafil
5278202|NCT00512694|Lupus|lupus
5278203|NCT00512694|Systemic Lupus Erythematosus|systemic lupus erythematosus
5278204|NCT00512694|Cutaneous Lupus|cutaneous lupus
5278205|NCT00512681|Stomach Neoplasms|stomach neoplasms
5278206|NCT00512681|Secondary|secondary
5278207|NCT00512681|Combination chemotherapy|combination chemotherapy
5278208|NCT00512681|S-1|s-1
5278209|NCT00512681|irinotecan|irinotecan
5278210|NCT00512681|oxaliplatin|oxaliplatin
5278211|NCT00512655|Fear of falling|fear of falling
5278212|NCT00512655|Intraindividual variability|intraindividual variability
5278213|NCT00512655|Cognition|cognition
5278214|NCT00512655|Fall prevention|fall prevention
5278215|NCT00512655|Fear|fear
5278216|NCT00512655|Frail elderly|frail elderly
5278217|NCT00512655|Intervention|intervention
5278218|NCT00512642|Non-Small Cell Lung Cancer|non-small cell lung cancer
5278219|NCT00512642|p53|p53
5278220|NCT00512642|Smoking|smoking
5278221|NCT00512642|Carcinogenesis|carcinogenesis
5278222|NCT00512642|Loss of Heterozygosity|loss of heterozygosity
5278223|NCT00512629|PN|pn
5278224|NCT00512629|cholestasis|cholestasis
5278225|NCT00512629|gastrointestinal disease in infants|gastrointestinal disease in infants
5278226|NCT00512629|short bowel syndrome|short bowel syndrome
5278227|NCT00512616|Ceftriaxone|ceftriaxone
5278228|NCT00512616|Acute Antidepressant Effects|acute antidepressant effects
5278229|NCT00512616|Glutamatergic System|glutamatergic system
5278230|NCT00512616|Double-Blind|double-blind
5278231|NCT00512616|Mood Disorders|mood disorders
5278232|NCT00512616|Bipolar Disorder|bipolar disorder
5278233|NCT00512616|Depression|depression
5278234|NCT00512603|cerebro vascular event|cerebro vascular event
5278235|NCT00512590|fibromyalgia|fibromyalgia
5278236|NCT00512590|relaxation|relaxation
5278237|NCT00512590|imagery|imagery
5278238|NCT00512590|pain|pain
5278239|NCT00512590|functional status|functional status
5278240|NCT00512590|self efficacy|self efficacy
5278241|NCT00512590|minority health|minority health
5278242|NCT00512577|sickle cell disease|sickle cell disease
5278243|NCT00512577|pre-operative transfusion|pre-operative transfusion
5278244|NCT00512577|blood transfusion|blood transfusion
5278245|NCT00512564|Sickle Cell Anemia|sickle cell anemia
5278246|NCT00512564|Sickle Cell Thalassemia|sickle cell thalassemia
5278247|NCT00512564|Iron overload|iron overload
5278248|NCT00512564|Non transferrin binding iron|non transferrin binding iron
5278249|NCT00512564|Hepcidin|hepcidin
5278250|NCT00512551|Cervical Cancer|cervical cancer
5278251|NCT00512551|DNA Array Analysis|dna array analysis
5278252|NCT00512551|Gene Expression|gene expression
5278253|NCT00512551|DNA|dna
5278254|NCT00512538|Diabetic foot|diabetic foot
5278255|NCT00512512|transoral|transoral
5278256|NCT00512512|transluminal|transluminal
5278257|NCT00512512|endoscopic|endoscopic
5278258|NCT00512512|laparoscopic|laparoscopic
5278259|NCT00512512|liver|liver
5278260|NCT00512512|biopsy|biopsy
5278261|NCT00512499|Osteoporosis|osteoporosis
5278262|NCT00512499|Fragility fractures|fragility fractures
5278263|NCT00512499|Fracture clinics|fracture clinics
5278264|NCT00512499|Orthopedic surgeons|orthopedic surgeons
5278265|NCT00512473|GH, GH receptor blockade, GH signaling, insulin resistance|gh, gh receptor blockade, gh signaling, insulin resistance
5278266|NCT00512460|Neoplastic Meningitis|neoplastic meningitis
5278267|NCT00512460|Leptomeningeal Disease|leptomeningeal disease
5278268|NCT00512460|Solid Tumor|solid tumor
5278269|NCT00512460|Lymphoma|lymphoma
5278270|NCT00512460|Leukemia|leukemia
5278271|NCT00512460|Brain Tumor|brain tumor
5278272|NCT00512460|RTA 744|rta 744
5278273|NCT00512447|Aging|aging
5278274|NCT00512434|tibial|tibial
5278275|NCT00512434|shaft|shaft
5278276|NCT00512434|fracture|fracture
5278277|NCT00512434|open|open
5278278|NCT00512434|bone-marrow|bone-marrow
5278279|NCT00512434|graft|graft
5278280|NCT00512434|injection|injection
5278281|NCT00512434|mesenchymal stem cell|mesenchymal stem cell
5278282|NCT00512408|To assess the effect of a 12 week testosterone administration on maximal exercise capacity, muscle strength and insulin resistance in elderly CHF patients|to assess the effect of a 12 week testosterone administration on maximal exercise capacity, muscle strength and insulin resistance in elderly chf patients
5278883|NCT00510172|Headache|headache
5278283|NCT00512395|laparoscopic colorectal surgery|laparoscopic colorectal surgery
5278284|NCT00512395|epidural analgesia|epidural analgesia
5278285|NCT00512395|pain score|pain score
5278286|NCT00512395|postoperative ileus|postoperative ileus
5278287|NCT00512382|GER Gastrointestinal reflux|ger gastrointestinal reflux
5278288|NCT00512382|Aspiration|aspiration
5278289|NCT00512382|ASHTMA|ashtma
5278290|NCT00512382|COUGH|cough
5278291|NCT00512382|WHEEZE|wheeze
5278292|NCT00512382|PH-IMPEDANCE|ph-impedance
5278293|NCT00512382|WEEM Wheezy Monitor|weem wheezy monitor
5278294|NCT00512369|Metabolic pathways|metabolic pathways
5278295|NCT00512369|Atherosclerosis|atherosclerosis
5278296|NCT00512369|Monocyte Function|monocyte function
5278297|NCT00512343|Synovial Fluid|synovial fluid
5278298|NCT00512343|Arthritis|arthritis
5278299|NCT00512343|Paired serum/synovial fluid samples|paired serum/synovial fluid samples
5278300|NCT00512330|childhood|childhood
5278301|NCT00512330|tuberculosis|tuberculosis
5278302|NCT00512330|diagnostic|diagnostic
5278303|NCT00512330|lipoarabinomannan|lipoarabinomannan
5278304|NCT00512330|ELISA|elisa
5278305|NCT00512330|Tuberculosis in Childhood|tuberculosis in childhood
5278306|NCT00512317|partial onset epilepsy|partial onset epilepsy
5278307|NCT00512317|adult epilepsy|adult epilepsy
5278308|NCT00512317|partial seizures|partial seizures
5278309|NCT00512317|anticonvulsant|anticonvulsant
5278310|NCT00512317|catamenial epilepsy|catamenial epilepsy
5278311|NCT00512317|adult partial onset epilepsy|adult partial onset epilepsy
5278312|NCT00512291|Advanced Cancer|advanced cancer
5278313|NCT00512291|Hyperactive Delirium|hyperactive delirium
5278314|NCT00512291|Mixed Delirium|mixed delirium
5278315|NCT00512291|Olanzapine|olanzapine
5278316|NCT00512278|Hepatitis|hepatitis
5278317|NCT00512278|HCV|hcv
5278318|NCT00512278|Hepatitis C|hepatitis c
5278319|NCT00512265|n-acetylcysteine|n-acetylcysteine
5278320|NCT00512265|esophagectomy|esophagectomy
5278321|NCT00512265|inflammatory reaction|inflammatory reaction
5278322|NCT00512265|pulmonary morbidity|pulmonary morbidity
5278323|NCT00512252|Plerixafor|plerixafor
5278324|NCT00512252|CXCR4|cxcr4
5278325|NCT00512252|Chemosensitization|chemosensitization
5278326|NCT00512239|Early Rheumatoid Arthritis|early rheumatoid arthritis
5278327|NCT00512239|Early inflammatory arthritis|early inflammatory arthritis
5278328|NCT00512239|Biomarkers|biomarkers
5278329|NCT00512239|Autoantibodies|autoantibodies
5278330|NCT00512239|Anti-Sa antibodies|anti-sa antibodies
5278331|NCT00512239|Anti-CCP antibodies|anti-ccp antibodies
5278332|NCT00512226|Sickle Cell Anemia|sickle cell anemia
5278333|NCT00512226|Sickle Cell Thalassemia|sickle cell thalassemia
5278334|NCT00512226|Iron Overload|iron overload
5278335|NCT00512226|MRI|mri
5278336|NCT00512213|preoperative Immunonutrition|preoperative immunonutrition
5278337|NCT00512213|major abdominal surgery|major abdominal surgery
5278338|NCT00512213|complication|complication
5278339|NCT00512174|Portable Ultrasound Scanner|portable ultrasound scanner
5278340|NCT00512174|Non Invasive Bladder Volume Measurement|non invasive bladder volume measurement
5278341|NCT00512174|Radical Cystectomy|radical cystectomy
5278342|NCT00512174|Bladder Reconstruction|bladder reconstruction
5278343|NCT00512161|Any patient undergoing elective cardiac surgery|any patient undergoing elective cardiac surgery
5278344|NCT00512122|early parenteral nutrition|early parenteral nutrition
5278345|NCT00512122|critical illness|critical illness
5278346|NCT00512122|respiratory failure|respiratory failure
5278347|NCT00512122|kidney failure|kidney failure
5278348|NCT00512122|hepatic failure|hepatic failure
5278349|NCT00512122|muscle strength|muscle strength
5278350|NCT00512122|rehabilitation|rehabilitation
5278351|NCT00512122|overfeeding|overfeeding
5278352|NCT00512122|Reduced Oral Intake|reduced oral intake
5278353|NCT00512109|vascular risk|vascular risk
5278354|NCT00512109|perioperative|perioperative
5278355|NCT00512109|vascular events|vascular events
5278356|NCT00512109|cohort study|cohort study
5278357|NCT00512109|surgery|surgery
5278358|NCT00512096|Genitourinary|genitourinary
5278359|NCT00512096|Penile Cancer|penile cancer
5278360|NCT00512096|Neoadjuvant Chemotherapy|neoadjuvant chemotherapy
5278361|NCT00512096|Extirpative Surgery|extirpative surgery
5278362|NCT00512096|TanyN2-3M0 Squamous Cell Carcinoma of the Penis|tanyn2-3m0 squamous cell carcinoma of the penis
5278363|NCT00512096|Cisplatin|cisplatin
5278364|NCT00512096|Platinol-AQ|platinol-aq
5278365|NCT00512096|Platinol|platinol
5278366|NCT00512096|CDDP|cddp
5278367|NCT00512096|Ifosfamide|ifosfamide
5278368|NCT00512096|Ifex|ifex
5278369|NCT00512096|Paclitaxel|paclitaxel
5278370|NCT00512096|Taxol|taxol
5278371|NCT00512083|Leukemia, Myeloid + Acute Disease|leukemia, myeloid + acute disease
5278372|NCT00512070|schizophrenia|schizophrenia
5278373|NCT00512070|schizoaffective disorder|schizoaffective disorder
5278374|NCT00512070|bipolar disorder|bipolar disorder
5278375|NCT00512070|olanzapine|olanzapine
5278376|NCT00512070|melatonin|melatonin
5278377|NCT00512070|obesity|obesity
5278378|NCT00512070|metabolic syndrome|metabolic syndrome
5278379|NCT00512057|cardiac syndrome X|cardiac syndrome x
5278380|NCT00512057|endothelial function|endothelial function
5278381|NCT00512044|anesthesia, Longo, mucosectomy, hemorrhoids|anesthesia, longo, mucosectomy, hemorrhoids
5278382|NCT00512031|atherosclerosis|atherosclerosis
5278383|NCT00512031|metabolic pathways|metabolic pathways
5278384|NCT00512031|monocyte adhesion,|monocyte adhesion,
5278385|NCT00512018|Electric Stimulation|electric stimulation
5278386|NCT00512018|Quadriceps Muscle|quadriceps muscle
5278387|NCT00512018|Muscle Strength|muscle strength
5278388|NCT00512018|Neuromuscular Properties|neuromuscular properties
5278389|NCT00512018|Tension-Length Relationship|tension-length relationship
5278390|NCT00512018|Healthy young adults|healthy young adults
5278391|NCT00512005|Functional Mitral Regurgitation (FMR)|functional mitral regurgitation (fmr)
5278392|NCT00512005|Ischemic Mitral Regurgitation|ischemic mitral regurgitation
5278393|NCT00512005|Less invasive repair|less invasive repair
5278394|NCT00512005|Percutaneous MV repair|percutaneous mv repair
5278395|NCT00512005|Mitral Valve Repair|mitral valve repair
5278396|NCT00512005|Heart Failure|heart failure
5278397|NCT00512005|Left Ventricular Dysfunction|left ventricular dysfunction
5278398|NCT00511992|Ovarian Cancer|ovarian cancer
5278399|NCT00511992|Gynecologic Cancer|gynecologic cancer
5278400|NCT00511992|Ovarian Carcinoma|ovarian carcinoma
5278401|NCT00511992|Peritoneal Carcinoma|peritoneal carcinoma
5278402|NCT00511992|IP chemotherapy|ip chemotherapy
5278403|NCT00511992|Intraperitoneal|intraperitoneal
5278404|NCT00511992|Avastin|avastin
5278405|NCT00511992|Bevacizumab|bevacizumab
5278406|NCT00511979|Healthy Patients|healthy patients
5278407|NCT00511966|Gastroesophageal Reflux|gastroesophageal reflux
5278408|NCT00511966|Rabeprazole|rabeprazole
5278409|NCT00511953|Hot flashes|hot flashes
5278410|NCT00511953|Hot flushes|hot flushes
5278411|NCT00511953|Postmenopausal symptoms|postmenopausal symptoms
5278412|NCT00511927|heart|heart
5278413|NCT00511927|failure|failure
5278414|NCT00511927|growth|growth
5278415|NCT00511927|hormone|hormone
5278416|NCT00511927|igf|igf
5278417|NCT00511927|dilative|dilative
5278418|NCT00511927|cardiomyopathy|cardiomyopathy
5278419|NCT00511914|Influenza vaccine|influenza vaccine
5278420|NCT00511901|anemia|anemia
5278421|NCT00511901|function|function
5278422|NCT00511901|rehabilitation|rehabilitation
5278423|NCT00511888|chronic heart failure|chronic heart failure
5278424|NCT00511888|hypertension|hypertension
5278425|NCT00511888|beta blockers|beta blockers
5278426|NCT00511875|diabetic retinopathy|diabetic retinopathy
5278427|NCT00511875|diabetes|diabetes
5278428|NCT00511875|diabetic eye studies|diabetic eye studies
5278429|NCT00511875|neovascularization|neovascularization
5278430|NCT00511862|TheraSphere|therasphere
5278431|NCT00511862|radioactive microspheres|radioactive microspheres
5278432|NCT00511862|Yttrium-90|yttrium-90
5278433|NCT00511862|Yttrium glass microspheres|yttrium glass microspheres
5278434|NCT00511836|alcoholism|alcoholism
5278435|NCT00511836|addiction|addiction
5278436|NCT00511836|alcohol detoxification|alcohol detoxification
5278437|NCT00511823|drug-drug interaction,|drug-drug interaction,
5278438|NCT00511823|rosiglitazone,|rosiglitazone,
5278439|NCT00511823|safety|safety
5278440|NCT00511823|CYP2C8,|cyp2c8,
5278441|NCT00511823|pharmacokinetics,|pharmacokinetics,
5278442|NCT00511823|CYP3A4,|cyp3a4,
5278443|NCT00511823|granisetron,|granisetron,
5278444|NCT00511823|dolasetron,|dolasetron,
5278445|NCT00511823|CYP2D6,|cyp2d6,
5278446|NCT00511823|casopitant,|casopitant,
5278447|NCT00511810|Sadness|sadness
5278448|NCT00511810|Insomnia|insomnia
5278449|NCT00511810|Loss of appetite|loss of appetite
5278450|NCT00511810|Fatigue|fatigue
5278451|NCT00511810|Trouble thinking|trouble thinking
5278452|NCT00511797|Dysmenorrhea|dysmenorrhea
5278453|NCT00511797|Dysmenorrheal score|dysmenorrheal score
5278454|NCT00511797|Drospirenone|drospirenone
5278455|NCT00511797|DRSP|drsp
5278456|NCT00511797|Ethinylestradiol|ethinylestradiol
5278457|NCT00511784|Contraception|contraception
5278458|NCT00511784|Hormonal contraception|hormonal contraception
5278459|NCT00511784|Oral contraception|oral contraception
5278460|NCT00511784|Ethinyl estradiol, Levonorgestrel, Contraception|ethinyl estradiol, levonorgestrel, contraception
5278461|NCT00511784|Transdermal|transdermal
5278462|NCT00511784|Venous thromboembolism|venous thromboembolism
5278463|NCT00511784|Norelgestromin|norelgestromin
5278464|NCT00511771|Tegaserod, treatment IND, irritable bowel syndrome with constipation, IBS-C, chronic idiopathic constipation, CIC, chronic constipation, CC|tegaserod, treatment ind, irritable bowel syndrome with constipation, ibs-c, chronic idiopathic constipation, cic, chronic constipation, cc
5278465|NCT00511758|Cervical Dysplasia|cervical dysplasia
5278466|NCT00511758|Digital Imaging|digital imaging
5278467|NCT00511758|Colposcopy|colposcopy
5278468|NCT00511758|Cervix|cervix
5278469|NCT00511745|Interactions|interactions
5278470|NCT00511745|Adjusted doses|adjusted doses
5278471|NCT00511745|Duodenal Ulcer|duodenal ulcer
5278472|NCT00511745|Gastric Ulcer|gastric ulcer
5278473|NCT00511745|Erosive or ulcerate Gastroesophageal Reflux|erosive or ulcerate gastroesophageal reflux
5278474|NCT00511745|Rabeprazole|rabeprazole
5278475|NCT00511745|Gastroesophageal reflux|gastroesophageal reflux
5278476|NCT00511693|fragility fracture|fragility fracture
5278477|NCT00511693|management of osteoporosis|management of osteoporosis
5278478|NCT00511693|osteoporosis coordinator|osteoporosis coordinator
5278479|NCT00511693|small volume hospitals|small volume hospitals
5278480|NCT00511654|depression|depression
5278884|NCT00510172|Migraine|migraine
5278481|NCT00511654|NK1 receptor antagonists,|nk1 receptor antagonists,
5278482|NCT00511641|Ovarian Cancer|ovarian cancer
5278483|NCT00511641|Cancer Screening|cancer screening
5278484|NCT00511641|Quality of Life|quality of life
5278485|NCT00511641|Questionnaire|questionnaire
5278486|NCT00511641|Screening|screening
5278487|NCT00511641|Survey|survey
5278488|NCT00511628|Schizophrenia|schizophrenia
5278489|NCT00511628|Risperidone|risperidone
5278490|NCT00511628|Schizoaffective disorder|schizoaffective disorder
5278491|NCT00511628|Schizophreniform disorder|schizophreniform disorder
5278492|NCT00511628|Weight gain|weight gain
5278493|NCT00511615|Cervical Intraepithelial Neoplasia|cervical intraepithelial neoplasia
5278494|NCT00511615|Loop Electrosurgical Excision Procedure|loop electrosurgical excision procedure
5278495|NCT00511615|Cervical Cancer|cervical cancer
5278496|NCT00511615|Colposcopy|colposcopy
5278497|NCT00511615|Molecular Imaging|molecular imaging
5278498|NCT00511615|LEEP|leep
5278499|NCT00511576|Advanced or Metastatic Breast Cancer|advanced or metastatic breast cancer
5278500|NCT00511576|Breast Cancer|breast cancer
5278501|NCT00511576|Advanced or Metastatic Non-Small-Cell Lung Cancer (NSCLC)|advanced or metastatic non-small-cell lung cancer (nsclc)
5278502|NCT00511576|Hormone Refractory Prostate Cancer|hormone refractory prostate cancer
5278503|NCT00511576|Prostate Cancer|prostate cancer
5278504|NCT00511576|Gastric Cancer|gastric cancer
5278505|NCT00511576|Advanced Gastric Adenocarcinoma|advanced gastric adenocarcinoma
5278506|NCT00511576|HDAC Inhibitor|hdac inhibitor
5278507|NCT00511576|Taxotere|taxotere
5278508|NCT00511576|Docetaxel|docetaxel
5278509|NCT00511563|Cortisol,|cortisol,
5278510|NCT00511563|stress,|stress,
5278511|NCT00511563|response,|response,
5278512|NCT00511563|Irritable Bowel Syndrome,|irritable bowel syndrome,
5278513|NCT00511563|cytokine.|cytokine.
5278514|NCT00511550|peripheral blood stem cells|peripheral blood stem cells
5278515|NCT00511550|filgrastim-mobilized|filgrastim-mobilized
5278516|NCT00511550|allogeneic transplantation|allogeneic transplantation
5278517|NCT00511550|Unrelated Donors for allogeneic transplantation|unrelated donors for allogeneic transplantation
5278518|NCT00511537|AML|aml
5278519|NCT00511537|ALL|all
5278520|NCT00511537|CML|cml
5278521|NCT00511537|Lymphoma|lymphoma
5278522|NCT00511537|Myelodysplasia|myelodysplasia
5278523|NCT00511537|Unrelated stem cell transplantation|unrelated stem cell transplantation
5278524|NCT00511537|Hematopoietic disorders|hematopoietic disorders
5278525|NCT00511524|brain,|brain,
5278526|NCT00511524|inflammation,|inflammation,
5278527|NCT00511524|CB2,|cb2,
5278528|NCT00511524|PET|pet
5278529|NCT00511524|analgesia,|analgesia,
5278530|NCT00511511|hypertension|hypertension
5278531|NCT00511511|angiogenesis inhibitors|angiogenesis inhibitors
5278532|NCT00511511|tyrosine kinase inhibitor|tyrosine kinase inhibitor
5278533|NCT00511511|Sunitinib|sunitinib
5278534|NCT00511498|Laparoscopic Radical Prostatectomy|laparoscopic radical prostatectomy
5278535|NCT00511498|Nightly sildenafil|nightly sildenafil
5278536|NCT00511485|Cancer|cancer
5278537|NCT00511485|Adenocarcinoma|adenocarcinoma
5278538|NCT00511485|Phase II|phase ii
5278539|NCT00511485|Lung|lung
5278540|NCT00511485|Non-small cell lung cancer|non-small cell lung cancer
5278541|NCT00511485|NSCLC|nsclc
5278542|NCT00511485|EC145|ec145
5278543|NCT00511485|EC20|ec20
5278544|NCT00511459|Randomized|randomized
5278545|NCT00511459|4-Arm|4-arm
5278546|NCT00511459|Placebo controlled|placebo controlled
5278547|NCT00511459|Phase 2 Trial|phase 2 trial
5278548|NCT00511459|AMG 386|amg 386
5278549|NCT00511459|Paclitaxel|paclitaxel
5278550|NCT00511459|Bevacizumab|bevacizumab
5278551|NCT00511459|First-line Therapy|first-line therapy
5278552|NCT00511459|Her-2 Negative|her-2 negative
5278553|NCT00511459|Metastatic or Locally Recurrent Breast Cancer|metastatic or locally recurrent breast cancer
5278554|NCT00511446|Stomach neoplasms|stomach neoplasms
5278555|NCT00511446|docetaxel|docetaxel
5278556|NCT00511446|oxaliplatin|oxaliplatin
5278557|NCT00511446|capecitabine|capecitabine
5278558|NCT00511420|cocoa|cocoa
5278559|NCT00511420|cardiovascular disease|cardiovascular disease
5278560|NCT00511420|blood pressure|blood pressure
5278561|NCT00511407|Acute renal failure|acute renal failure
5278562|NCT00511407|Bioartificial kidney|bioartificial kidney
5278563|NCT00511407|Cell therapy|cell therapy
5278564|NCT00511407|Hemofiltration|hemofiltration
5278565|NCT00511407|Septic shock|septic shock
5278566|NCT00511394|Decompensated Cirrhosis with Ascites|decompensated cirrhosis with ascites
5278567|NCT00511381|Hearing Loss|hearing loss
5278568|NCT00511381|Late-Onset Hearing Loss|late-onset hearing loss
5278569|NCT00511381|Deafness|deafness
5278570|NCT00511368|HIV|hiv
5278571|NCT00511368|treatment experienced|treatment experienced
5278572|NCT00511368|AIDS|aids
5278573|NCT00511329|growth hormone|growth hormone
5278574|NCT00511329|short stature|short stature
5278575|NCT00511329|growth failure|growth failure
5278576|NCT00511329|chronic illness|chronic illness
5278577|NCT00511303|Philadelphia chromosome|philadelphia chromosome
5278578|NCT00511303|protein-tyrosine kinases|protein-tyrosine kinases
5278681|NCT00510861|male age, assisted reproduction, sperm, pregnancy outcome|male age, assisted reproduction, sperm, pregnancy outcome
5278682|NCT00510835|septic shock|septic shock
5278579|NCT00511290|Primary disease or condition being studied: Asthma -COPD-Interstitial Lung Diseases-Occupational Lung Diseases|primary disease or condition being studied: asthma -copd-interstitial lung diseases-occupational lung diseases
5278580|NCT00511277|quetiapine|quetiapine
5278581|NCT00511277|schizophrenia|schizophrenia
5278582|NCT00511277|first-episode psychosis|first-episode psychosis
5278583|NCT00511277|depression|depression
5278584|NCT00511277|psychopathology|psychopathology
5278585|NCT00511264|Laparoscopy|laparoscopy
5278586|NCT00511264|Ultrasound|ultrasound
5278587|NCT00511264|Cancer|cancer
5278588|NCT00511264|Biopsy|biopsy
5278589|NCT00511251|IS-SEM|is-sem
5278590|NCT00511238|Onyx|onyx
5278591|NCT00511238|PR171|pr171
5278592|NCT00511238|carfilzomib|carfilzomib
5278593|NCT00511238|multiple myeloma|multiple myeloma
5278594|NCT00511238|relapsed|relapsed
5278595|NCT00511238|refractory|refractory
5278596|NCT00511225|dialysis|dialysis
5278597|NCT00511225|Vitamin D|vitamin d
5278598|NCT00511212|severe peritonitis|severe peritonitis
5278599|NCT00511212|SSI|ssi
5278600|NCT00511212|lower digestive tract surgery|lower digestive tract surgery
5278601|NCT00511212|Severe peritonitis after lower digestive tract surgery|severe peritonitis after lower digestive tract surgery
5278602|NCT00511186|Sepsis|sepsis
5278603|NCT00511186|Alkaline Phosphatase|alkaline phosphatase
5278604|NCT00511186|inflammation|inflammation
5278605|NCT00511186|infection|infection
5278606|NCT00511186|renal failure|renal failure
5278607|NCT00511173|mechanical valve|mechanical valve
5278608|NCT00511160|myocarditis|myocarditis
5278609|NCT00511160|parvovirus B19 (PVB19)|parvovirus b19 (pvb19)
5278610|NCT00511160|human herpes virus 6 (HHV6)|human herpes virus 6 (hhv6)
5278611|NCT00511160|cardiac magnetic resonance tomography (CMR)|cardiac magnetic resonance tomography (cmr)
5278612|NCT00511147|IVIG|ivig
5278613|NCT00511147|ITP|itp
5278614|NCT00511134|insomnia|insomnia
5278615|NCT00511134|nicotine dependence|nicotine dependence
5278616|NCT00511134|smoking|smoking
5278617|NCT00511134|smoking cessation|smoking cessation
5278618|NCT00511134|zyban|zyban
5278619|NCT00511121|chronic myeloid leukemia|chronic myeloid leukemia
5278620|NCT00511121|tyrosine kinase|tyrosine kinase
5278621|NCT00511108|Type 2 Diabetes Mellitus (T2DM)|type 2 diabetes mellitus (t2dm)
5278622|NCT00511095|Hepatitis B vaccine|hepatitis b vaccine
5278623|NCT00511095|HBV vaccine|hbv vaccine
5278624|NCT00511095|Hepatitis B|hepatitis b
5278625|NCT00511095|Hepatitis|hepatitis
5278626|NCT00511095|HBV|hbv
5278627|NCT00511069|Bortezomib|bortezomib
5278628|NCT00511069|CML033|cml033
5278629|NCT00511056|HIV|hiv
5278630|NCT00511056|Adherence|adherence
5278631|NCT00511056|Compliance|compliance
5278632|NCT00511056|Highly Active Antiretroviral Therapy (HAART)|highly active antiretroviral therapy (haart)
5278633|NCT00511056|ARV|arv
5278634|NCT00511056|ART|art
5278635|NCT00511056|Sexual Risk Behavior|sexual risk behavior
5278636|NCT00511056|Unsafe|unsafe
5278637|NCT00511056|Transmission|transmission
5278638|NCT00511043|PTK787|ptk787
5278639|NCT00511043|DLCL|dlcl
5278640|NCT00511043|Diffuse large cell lymphoma|diffuse large cell lymphoma
5278641|NCT00511030|Diabetes|diabetes
5278642|NCT00511017|Solid Tumors|solid tumors
5278643|NCT00511017|Doxercalciferol|doxercalciferol
5278644|NCT00511017|Pediatric Cancer|pediatric cancer
5278645|NCT00511017|Recurrent Pediatric Solid Tumors|recurrent pediatric solid tumors
5278646|NCT00511017|Calcium|calcium
5278647|NCT00511017|Vitamin D|vitamin d
5278648|NCT00511004|Brugia Malayi|brugia malayi
5278649|NCT00511004|Lymphatic Filariasis|lymphatic filariasis
5278650|NCT00511004|Albendazole|albendazole
5278651|NCT00511004|Diethylcarbamazine|diethylcarbamazine
5278652|NCT00510991|ASTHMA|asthma
5278653|NCT00510978|Inflammatory Bowel Disease IBD|inflammatory bowel disease ibd
5278654|NCT00510978|Ulcerative Colitis|ulcerative colitis
5278655|NCT00510978|Crohn's disease|crohn's disease
5278656|NCT00510978|Probiotics|probiotics
5278657|NCT00510978|Gastrointestinal|gastrointestinal
5278658|NCT00510965|choroidal neovascularization|choroidal neovascularization
5278659|NCT00510965|angioid streaks|angioid streaks
5278660|NCT00510965|pseudoxanthoma elasticum|pseudoxanthoma elasticum
5278661|NCT00510965|Groenblad-Strandberg-Syndrome|groenblad-strandberg-syndrome
5278662|NCT00510965|therapy|therapy
5278663|NCT00510965|ranibizumab|ranibizumab
5278664|NCT00510965|lucentis|lucentis
5278665|NCT00510965|Choroidal neovascularization in patients with PXE|choroidal neovascularization in patients with pxe
5278666|NCT00510952|diabetes|diabetes
5278667|NCT00510952|type 2|type 2
5278668|NCT00510939|Acute myeloid leukemia|acute myeloid leukemia
5278669|NCT00510939|NFkB activity and leukemia|nfkb activity and leukemia
5278670|NCT00510939|expression of NFkB|expression of nfkb
5278671|NCT00510913|Treatment efficacy|treatment efficacy
5278672|NCT00510913|Transplantation rejection|transplantation rejection
5278673|NCT00510913|Kidney transplantation|kidney transplantation
5278674|NCT00510913|Cyclosporine|cyclosporine
5278675|NCT00510913|tacrolimus|tacrolimus
5278676|NCT00510887|follicular lymphoma|follicular lymphoma
5278677|NCT00510887|Velcade|velcade
5278678|NCT00510887|VR-FND|vr-fnd
5278679|NCT00510874|Influenza|influenza
5278680|NCT00510874|GSK 1557484A vaccine|gsk 1557484a vaccine
5278683|NCT00510835|resuscitation|resuscitation
5278684|NCT00510835|sepsis|sepsis
5278685|NCT00510835|cost-effectiveness|cost-effectiveness
5278686|NCT00510835|sepsis-induced organ dysfunction|sepsis-induced organ dysfunction
5278687|NCT00510835|early goal directed therapy|early goal directed therapy
5278688|NCT00510835|emergency medicine|emergency medicine
5278689|NCT00510835|critical care medicine|critical care medicine
5278690|NCT00510822|Cimicoxib|cimicoxib
5278691|NCT00510822|Cox-2 inhibitor|cox-2 inhibitor
5278692|NCT00510822|Sertraline|sertraline
5278693|NCT00510796|Hereditary Non-Polyposis Colon Cancer|hereditary non-polyposis colon cancer
5278694|NCT00510796|Colon Cancer|colon cancer
5278695|NCT00510796|Endometrial Cancer|endometrial cancer
5278696|NCT00510796|Cancer Screening|cancer screening
5278697|NCT00510796|Interview|interview
5278698|NCT00510796|HNPCC|hnpcc
5278699|NCT00510783|tonic-clonic seizure|tonic-clonic seizure
5278700|NCT00510783|emergency department|emergency department
5278701|NCT00510783|IV levetiracetam|iv levetiracetam
5278702|NCT00510783|Keppra|keppra
5278703|NCT00510783|seizures|seizures
5278704|NCT00510783|phenytoin|phenytoin
5278705|NCT00510783|Dilantin|dilantin
5278706|NCT00510783|Grand Mal seizure|grand mal seizure
5278707|NCT00510770|CPAP|cpap
5278708|NCT00510770|Post-opreative|post-opreative
5278709|NCT00510770|ARF|arf
5278710|NCT00510770|liver transplant|liver transplant
5278711|NCT00510770|Post-operative hypoxemia in liver transplant|post-operative hypoxemia in liver transplant
5278712|NCT00510744|obesity, bariatric surgery, pancreatic secretion|obesity, bariatric surgery, pancreatic secretion
5278713|NCT00510731|Ventricular Tachycardia|ventricular tachycardia
5278714|NCT00510731|Cardiac Sudden Death|cardiac sudden death
5278715|NCT00510731|Ventricular Fibrillation|ventricular fibrillation
5278716|NCT00510731|Heart Rate Variability|heart rate variability
5278717|NCT00510718|Prostate|prostate
5278718|NCT00510718|Cancer|cancer
5278719|NCT00510718|Hormone|hormone
5278720|NCT00510718|Refractory|refractory
5278721|NCT00510718|Castration|castration
5278722|NCT00510705|adiposity|adiposity
5278723|NCT00510692|Eicosapentaenoic Acid|eicosapentaenoic acid
5278724|NCT00510692|EPA|epa
5278725|NCT00510692|EPA 99%|epa 99%
5278726|NCT00510692|Fatty acid|fatty acid
5278727|NCT00510692|omega-3|omega-3
5278728|NCT00510692|apoptosis|apoptosis
5278729|NCT00510692|cell proliferation|cell proliferation
5278730|NCT00510692|colonic mucosa|colonic mucosa
5278731|NCT00510692|polyp|polyp
5278732|NCT00510692|Familial Adenomatous Polyposis Coli|familial adenomatous polyposis coli
5278733|NCT00510692|FAP|fap
5278734|NCT00510692|resolvin|resolvin
5278735|NCT00510692|Ileo-rectal anastomosis|ileo-rectal anastomosis
5278736|NCT00510692|IRA|ira
5278737|NCT00510692|PUFA|pufa
5278738|NCT00510692|Endoscopy|endoscopy
5278739|NCT00510679|Benin|benin
5278740|NCT00510679|child health|child health
5278741|NCT00510679|developing country|developing country
5278742|NCT00510679|health services research|health services research
5278743|NCT00510679|health worker performance|health worker performance
5278744|NCT00510679|Integrated Management of Childhood Illness|integrated management of childhood illness
5278745|NCT00510666|Pain, Postoperative|pain, postoperative
5278746|NCT00510666|Analgesics, Opioid|analgesics, opioid
5278747|NCT00510666|Analgesia, Patient-Controlled|analgesia, patient-controlled
5278748|NCT00510666|Pain Measurement|pain measurement
5278749|NCT00510653|Ovarian Cancer|ovarian cancer
5278750|NCT00510653|Primary Peritoneal Cancer|primary peritoneal cancer
5278751|NCT00510653|Fallopian Tube Cancer|fallopian tube cancer
5278752|NCT00510653|Recurrent Platinum-Resistant|recurrent platinum-resistant
5278753|NCT00510653|Taxane-Resistant|taxane-resistant
5278754|NCT00510653|Epithelial Ovarian Cancer|epithelial ovarian cancer
5278755|NCT00510653|Imatinib Mesylate|imatinib mesylate
5278756|NCT00510653|Gleevec|gleevec
5278757|NCT00510653|STI571|sti571
5278758|NCT00510653|Protein tyrosine kinase inhibitor|protein tyrosine kinase inhibitor
5278759|NCT00510640|thyroid carcinoma|thyroid carcinoma
5278760|NCT00510640|Sunitinib|sunitinib
5278761|NCT00510640|RECIST guidelines|recist guidelines
5278762|NCT00510627|Metastatic Liver Cancer|metastatic liver cancer
5278763|NCT00510627|Colorectal Cancer|colorectal cancer
5278764|NCT00510627|Radiofrequency Ablation|radiofrequency ablation
5278765|NCT00510627|Chemotherapy|chemotherapy
5278766|NCT00510614|Bacterial Vaginosis|bacterial vaginosis
5278767|NCT00510614|Recurrent Bacterial Vaginosis|recurrent bacterial vaginosis
5278768|NCT00510588|adiposity|adiposity
5278769|NCT00510575|Juvenile Scoliosis|juvenile scoliosis
5278770|NCT00510575|Adolescent Scoliosis|adolescent scoliosis
5278771|NCT00510575|Scoliosis Management|scoliosis management
5278772|NCT00510575|Spinal Fusion|spinal fusion
5278773|NCT00510575|Scoliosis instrumentation|scoliosis instrumentation
5278774|NCT00510575|Juvenile or Adolescent Idiopathic Scoliosis|juvenile or adolescent idiopathic scoliosis
5278775|NCT00510562|Cranial manipulation|cranial manipulation
5278776|NCT00510562|Visual function|visual function
5278777|NCT00510536|Psoriasis, arthritis, arthralgia|psoriasis, arthritis, arthralgia
5278778|NCT00510523|MS|ms
5278779|NCT00510523|Balance|balance
5278780|NCT00510523|Multiple Sclerosis|multiple sclerosis
5278781|NCT00510510|COPD|copd
5278782|NCT00510510|glycopyrronium bromide|glycopyrronium bromide
5278783|NCT00510510|antimuscarinic|antimuscarinic
5278784|NCT00510497|dendritic cell|dendritic cell
5278785|NCT00510497|therapeutic vaccine|therapeutic vaccine
5278786|NCT00510497|HIV-1|hiv-1
5278787|NCT00510497|apoptotic cells|apoptotic cells
5278788|NCT00510497|Phase I/II|phase i/ii
5278789|NCT00510484|Pancreatic exocrine insufficiency|pancreatic exocrine insufficiency
5278790|NCT00510484|Cystic Fibrosis|cystic fibrosis
5278791|NCT00510445|Non Small Cell Lung Cancer|non small cell lung cancer
5278792|NCT00510445|Advanced Non Small Cell Lung Cancer|advanced non small cell lung cancer
5278793|NCT00510445|Metastatic Non Small Cell Lung Cancer|metastatic non small cell lung cancer
5278794|NCT00510432|heparin|heparin
5278795|NCT00510432|heparin-induced thrombocytopenia|heparin-induced thrombocytopenia
5278796|NCT00510432|HIT|hit
5278797|NCT00510432|allergy|allergy
5278798|NCT00510432|skin|skin
5278799|NCT00510432|dermatology|dermatology
5278800|NCT00510432|DTH|dth
5278801|NCT00510432|delayed-type hypersensitivity|delayed-type hypersensitivity
5278802|NCT00510432|histology|histology
5278803|NCT00510432|Patients receiving sc heparin therapy|patients receiving sc heparin therapy
5278804|NCT00510432|Age over 18 years|age over 18 years
5278805|NCT00510432|Recruitment will stop when 20 patients with skin lesions are included|recruitment will stop when 20 patients with skin lesions are included
5278806|NCT00510419|Migraine|migraine
5278807|NCT00510406|Lower Urinary Tract Symptoms|lower urinary tract symptoms
5278808|NCT00510406|Treatment|treatment
5278809|NCT00510406|Solifenacin succinate|solifenacin succinate
5278810|NCT00510406|Tamsulosin hydrochloride|tamsulosin hydrochloride
5278811|NCT00510406|Prostatic Hyperplasia|prostatic hyperplasia
5278812|NCT00510393|Critical Limb Ischemia|critical limb ischemia
5278813|NCT00510393|CLI|cli
5278814|NCT00510393|Drug Eluting Stent|drug eluting stent
5278815|NCT00510393|DES|des
5278816|NCT00510393|Bare Metal Stent|bare metal stent
5278817|NCT00510393|BMS|bms
5278818|NCT00510367|Breast Cancer|breast cancer
5278819|NCT00510367|FAC|fac
5278820|NCT00510367|Doxorubicin|doxorubicin
5278821|NCT00510367|Adriamycin|adriamycin
5278822|NCT00510367|Rubex|rubex
5278823|NCT00510367|5-Fluorouracil|5-fluorouracil
5278824|NCT00510367|5-FU|5-fu
5278825|NCT00510367|Adrucil|adrucil
5278826|NCT00510367|Efudex|efudex
5278827|NCT00510367|Cyclophosphamide|cyclophosphamide
5278828|NCT00510367|Cytoxan|cytoxan
5278829|NCT00510367|Neosar|neosar
5278830|NCT00510367|Pregnancy|pregnancy
5278831|NCT00510354|Progressive GIST|progressive gist
5278832|NCT00510354|Resistance to Imatinib mesylate|resistance to imatinib mesylate
5278833|NCT00510341|Behavior Change Counseling|behavior change counseling
5278834|NCT00510341|Motivational Interviewing|motivational interviewing
5278835|NCT00510341|Chronic Care Model|chronic care model
5278836|NCT00510341|Communication|communication
5278837|NCT00510341|Residency Training|residency training
5278838|NCT00510341|Skill Assessment|skill assessment
5278839|NCT00510328|whole body vibration|whole body vibration
5278840|NCT00510328|muscle physiology|muscle physiology
5278841|NCT00510315|leukemia|leukemia
5278842|NCT00510315|survivors|survivors
5278843|NCT00510315|women|women
5278844|NCT00510315|leukemia survivors|leukemia survivors
5278845|NCT00510315|cancer or a related illness|cancer or a related illness
5278846|NCT00510315|Hodgkin's Lymphoma|hodgkin's lymphoma
5278847|NCT00510315|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
5278848|NCT00510315|myelodysplastic syndrome|myelodysplastic syndrome
5278849|NCT00510315|aplastic anemia|aplastic anemia
5278850|NCT00510315|treated with total body irradiation|treated with total body irradiation
5278851|NCT00510315|followed by an allogeneic or autologous stem cell transplant|followed by an allogeneic or autologous stem cell transplant
5278852|NCT00510302|Ultraviolet Radiation|ultraviolet radiation
5278853|NCT00510302|Melanoma|melanoma
5278854|NCT00510302|Questionnaire|questionnaire
5278855|NCT00510302|Survey|survey
5278856|NCT00510302|First Degree Relative|first degree relative
5278857|NCT00510302|Interview|interview
5278858|NCT00510289|Sorafenib|sorafenib
5278859|NCT00510289|Myelodysplastic Syndromes|myelodysplastic syndromes
5278860|NCT00510289|MDS|mds
5278861|NCT00510263|Prednisolone|prednisolone
5278862|NCT00510263|Valacyclovir|valacyclovir
5278863|NCT00510250|Cervix Cancer|cervix cancer
5278864|NCT00510250|Cervical Cancer|cervical cancer
5278865|NCT00510250|Sorafenib|sorafenib
5278866|NCT00510250|Cisplatin|cisplatin
5278867|NCT00510250|Radiation|radiation
5278868|NCT00510250|Radiotherapy|radiotherapy
5278869|NCT00510250|Phase I|phase i
5278870|NCT00510250|Phase II|phase ii
5278871|NCT00510250|Carcinoma|carcinoma
5278872|NCT00510250|Cancer|cancer
5278873|NCT00510250|Cervix|cervix
5278874|NCT00510237|HIV|hiv
5278875|NCT00510237|Adolescents newly diagnosed with HIV|adolescents newly diagnosed with hiv
5278876|NCT00510198|Heart Disease|heart disease
5278877|NCT00510198|Congestive Heart Failure|congestive heart failure
5278878|NCT00510198|Thoracic Fluid Monitoring|thoracic fluid monitoring
5278879|NCT00510185|coronary artery disease|coronary artery disease
5278880|NCT00510185|coronary angioplasty|coronary angioplasty
5278881|NCT00510185|coronary artery bypass surgery|coronary artery bypass surgery
5278885|NCT00510172|Vasodilatation|vasodilatation
5278886|NCT00510159|Schistosoma haematobium|schistosoma haematobium
5278887|NCT00510159|Praziquantel|praziquantel
5278888|NCT00510159|Artesunate + Sulfamethoxypyrazine/pyrimethamine|artesunate + sulfamethoxypyrazine/pyrimethamine
5278889|NCT00510159|Randomized double blind placebo controlled clinical trial|randomized double blind placebo controlled clinical trial
5278890|NCT00510120|Attention Deficit and Disruptive Behavior Disorders|attention deficit and disruptive behavior disorders
5278891|NCT00510120|Conduct Disorder|conduct disorder
5278892|NCT00510120|Behavior Problems in Youth|behavior problems in youth
5278893|NCT00510120|Argumentativeness|argumentativeness
5278894|NCT00510120|Children|children
5278895|NCT00510120|Therapy|therapy
5278896|NCT00510120|Attention Deficit Disorder|attention deficit disorder
5278897|NCT00510094|Social Skills|social skills
5278898|NCT00510094|Anger Management|anger management
5278899|NCT00510094|Relational Aggression|relational aggression
5278900|NCT00510068|Phase III|phase iii
5278901|NCT00510068|Advanced Neuroendocrine Tumor in adults|advanced neuroendocrine tumor in adults
5278902|NCT00510068|RAD001|rad001
5278903|NCT00510068|NET|net
5278904|NCT00510068|everolimus|everolimus
5278905|NCT00510068|mTOr|mtor
5278906|NCT00510068|islet cell|islet cell
5278907|NCT00510068|neuroendocrine|neuroendocrine
5278908|NCT00510042|von Willebrand disease|von willebrand disease
5278909|NCT00510042|von Willebrand factor|von willebrand factor
5278910|NCT00510042|national study|national study
5278911|NCT00510042|bleeding disorder|bleeding disorder
5278912|NCT00510042|quality of life|quality of life
5278913|NCT00510016|infants|infants
5278914|NCT00510016|opioid withdrawal|opioid withdrawal
5278915|NCT00510016|abstinence syndrome|abstinence syndrome
5278916|NCT00510016|methadone|methadone
5278917|NCT00510016|heroin|heroin
5278918|NCT00510003|Atopic dermatitis, children, pimecrolimus, eczema|atopic dermatitis, children, pimecrolimus, eczema
5278919|NCT00509990|Atopic dermatitis, pimecrolimus, children|atopic dermatitis, pimecrolimus, children
5278920|NCT00509951|Neuroses|neuroses
5278921|NCT00509951|Evidence-Based Treatment|evidence-based treatment
5278922|NCT00509951|Clinical Investigation|clinical investigation
5278923|NCT00509951|Young Patients|young patients
5278924|NCT00509951|Phobic Disorders|phobic disorders
5278925|NCT00509951|Fear|fear
5278926|NCT00509951|Phobias|phobias
5278927|NCT00509938|immunocompromized|immunocompromized
5278928|NCT00509938|hLF1-11|hlf1-11
5278929|NCT00509938|antimicrobial|antimicrobial
5278930|NCT00509938|peptide|peptide
5278931|NCT00509938|lactoferrin|lactoferrin
5278932|NCT00509860|Advanced Sarcomas|advanced sarcomas
5278933|NCT00509860|Irinotecan|irinotecan
5278934|NCT00509860|Camptosar|camptosar
5278935|NCT00509860|CPT-11|cpt-11
5278936|NCT00509847|S. epidermidis|s. epidermidis
5278937|NCT00509847|Staphylococcus|staphylococcus
5278938|NCT00509847|Lactoferrin|lactoferrin
5278939|NCT00509847|hLF1-11|hlf1-11
5278940|NCT00509847|Bacteraemia|bacteraemia
5278941|NCT00509834|hLF1-11|hlf1-11
5278942|NCT00509834|Candida|candida
5278943|NCT00509834|candidaemia|candidaemia
5278944|NCT00509834|lactoferrin|lactoferrin
5278945|NCT00509782|Solid Tumors|solid tumors
5278946|NCT00509782|Anti-Tumor Effects|anti-tumor effects
5278947|NCT00509782|ZIO-101|zio-101
5278948|NCT00509769|Trastuzumab emtansine|trastuzumab emtansine
5278949|NCT00509769|MBC|mbc
5278950|NCT00509769|Breast cancer|breast cancer
5278951|NCT00509769|HER2-positive breast cancer|her2-positive breast cancer
5278952|NCT00509769|HER2|her2
5278953|NCT00509756|healthy subjects|healthy subjects
5278954|NCT00509743|Adult volunteers|adult volunteers
5278955|NCT00509730|stress urinary incontinence|stress urinary incontinence
5278956|NCT00509730|urodynamics|urodynamics
5278957|NCT00509730|randomized clinical trial|randomized clinical trial
5278958|NCT00509730|surgery|surgery
5278959|NCT00509717|quality of health care|quality of health care
5278960|NCT00509717|prescriptions, drug|prescriptions, drug
5278961|NCT00509717|anticholesteremic agents|anticholesteremic agents
5278962|NCT00509717|community pharmacy services|community pharmacy services
5278963|NCT00509704|Sutent|sutent
5278964|NCT00509704|tumor necrosis|tumor necrosis
5278965|NCT00509704|DCE-MRI (Dynamic enhanced magnetic resonance imaging)|dce-mri (dynamic enhanced magnetic resonance imaging)
5278966|NCT00509691|infection|infection
5278967|NCT00509691|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5278968|NCT00509691|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5278969|NCT00509691|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5278970|NCT00509691|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5278971|NCT00509691|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5278972|NCT00509691|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5278973|NCT00509691|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5278974|NCT00509691|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5278975|NCT00509691|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
5278976|NCT00509691|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5278977|NCT00509691|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
5278978|NCT00509691|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
5278979|NCT00509691|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
5278980|NCT00509691|chronic eosinophilic leukemia|chronic eosinophilic leukemia
5278981|NCT00509691|primary myelofibrosis|primary myelofibrosis
5278982|NCT00509691|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5278983|NCT00509691|chronic neutrophilic leukemia|chronic neutrophilic leukemia
5278984|NCT00509691|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5278985|NCT00509691|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5278986|NCT00509691|disseminated neuroblastoma|disseminated neuroblastoma
5278987|NCT00509691|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5278988|NCT00509691|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
5278989|NCT00509691|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
5278990|NCT00509691|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5278991|NCT00509691|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
5278992|NCT00509691|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5278993|NCT00509691|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
5278994|NCT00509691|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
5278995|NCT00509691|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
5278996|NCT00509691|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
5278997|NCT00509691|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5278998|NCT00509691|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5278999|NCT00509691|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5279000|NCT00509691|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5279001|NCT00509691|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
5279002|NCT00509691|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
5279003|NCT00509691|high risk metastatic gestational trophoblastic tumor|high risk metastatic gestational trophoblastic tumor
5279004|NCT00509691|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
5279005|NCT00509691|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5279006|NCT00509691|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5279007|NCT00509691|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5279008|NCT00509691|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5279009|NCT00509691|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5279010|NCT00509691|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5279011|NCT00509691|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5279012|NCT00509691|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5279013|NCT00509691|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5279014|NCT00509691|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5279015|NCT00509691|recurrent breast cancer|recurrent breast cancer
5279016|NCT00509691|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
5279017|NCT00509691|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5279018|NCT00509691|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5279019|NCT00509691|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
5279020|NCT00509691|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
5279021|NCT00509691|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
5279022|NCT00509691|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
5279023|NCT00509691|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5279024|NCT00509691|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5279025|NCT00509691|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5279026|NCT00509691|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5279027|NCT00509691|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5279028|NCT00509691|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5279029|NCT00509691|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5279030|NCT00509691|recurrent neuroblastoma|recurrent neuroblastoma
5279031|NCT00509691|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5279032|NCT00509691|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
5279033|NCT00509691|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5279034|NCT00509691|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
5279253|NCT00509106|beta-lactam|beta-lactam
5279035|NCT00509691|recurrent Wilms tumor and other childhood kidney tumors|recurrent wilms tumor and other childhood kidney tumors
5279036|NCT00509691|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5279275|NCT00509080|NT-proBNP|nt-probnp
5279037|NCT00509691|refractory hairy cell leukemia|refractory hairy cell leukemia
5279038|NCT00509691|refractory multiple myeloma|refractory multiple myeloma
5279039|NCT00509691|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5279040|NCT00509691|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5279041|NCT00509691|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5279042|NCT00509691|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5279043|NCT00509691|stage I multiple myeloma|stage i multiple myeloma
5279044|NCT00509691|stage II multiple myeloma|stage ii multiple myeloma
5279045|NCT00509691|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5279046|NCT00509691|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5279047|NCT00509691|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5279048|NCT00509691|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5279049|NCT00509691|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5279050|NCT00509691|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5279051|NCT00509691|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5279052|NCT00509691|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5279053|NCT00509691|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5279054|NCT00509691|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5279055|NCT00509691|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5279056|NCT00509691|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5279057|NCT00509691|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5279058|NCT00509691|stage III multiple myeloma|stage iii multiple myeloma
5279059|NCT00509691|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5279060|NCT00509691|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
5279061|NCT00509691|stage IIIA breast cancer|stage iiia breast cancer
5279062|NCT00509691|stage IIIB breast cancer|stage iiib breast cancer
5279063|NCT00509691|stage IIIC breast cancer|stage iiic breast cancer
5279064|NCT00509691|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5279065|NCT00509691|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5279066|NCT00509691|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5279067|NCT00509691|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5279068|NCT00509691|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5279069|NCT00509691|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5279070|NCT00509691|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5279071|NCT00509691|stage IV breast cancer|stage iv breast cancer
5279072|NCT00509691|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5279073|NCT00509691|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5279074|NCT00509691|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5279075|NCT00509691|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5279076|NCT00509691|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5279077|NCT00509691|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5279078|NCT00509691|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5279079|NCT00509691|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5279080|NCT00509691|stage IIA ovarian epithelial cancer|stage iia ovarian epithelial cancer
5279081|NCT00509691|stage IIA ovarian germ cell tumor|stage iia ovarian germ cell tumor
5279082|NCT00509691|stage IIB ovarian epithelial cancer|stage iib ovarian epithelial cancer
5279083|NCT00509691|stage IIB ovarian germ cell tumor|stage iib ovarian germ cell tumor
5279084|NCT00509691|stage IIC ovarian epithelial cancer|stage iic ovarian epithelial cancer
5279085|NCT00509691|stage IIC ovarian germ cell tumor|stage iic ovarian germ cell tumor
5279086|NCT00509691|stage IIIA ovarian epithelial cancer|stage iiia ovarian epithelial cancer
5279087|NCT00509691|stage IIIA ovarian germ cell tumor|stage iiia ovarian germ cell tumor
5279088|NCT00509691|stage IIIB ovarian epithelial cancer|stage iiib ovarian epithelial cancer
5279089|NCT00509691|stage IIIB ovarian germ cell tumor|stage iiib ovarian germ cell tumor
5279090|NCT00509691|stage IIIC ovarian epithelial cancer|stage iiic ovarian epithelial cancer
5279091|NCT00509691|stage IIIC ovarian germ cell tumor|stage iiic ovarian germ cell tumor
5279092|NCT00509691|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
5279093|NCT00509678|Rituximab|rituximab
5279094|NCT00509678|Rituxan|rituxan
5279095|NCT00509678|Psoriatic Arthritis|psoriatic arthritis
5279096|NCT00509678|Arthritis|arthritis
5279097|NCT00509665|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
5279098|NCT00509665|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
5279099|NCT00509665|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
5279100|NCT00509665|recurrent adenoid cystic carcinoma of the oral cavity|recurrent adenoid cystic carcinoma of the oral cavity
5279101|NCT00509665|recurrent basal cell carcinoma of the lip|recurrent basal cell carcinoma of the lip
5279102|NCT00509665|recurrent mucoepidermoid carcinoma of the oral cavity|recurrent mucoepidermoid carcinoma of the oral cavity
5279103|NCT00509665|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
5279104|NCT00509665|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
5279105|NCT00509665|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
5279106|NCT00509665|recurrent lymphoepithelioma of the nasopharynx|recurrent lymphoepithelioma of the nasopharynx
5279107|NCT00509665|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
5279108|NCT00509665|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity
5279109|NCT00509665|recurrent inverted papilloma of the paranasal sinus and nasal cavity|recurrent inverted papilloma of the paranasal sinus and nasal cavity
5279110|NCT00509665|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity
5279111|NCT00509665|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
5279112|NCT00509665|recurrent salivary gland cancer|recurrent salivary gland cancer
5279113|NCT00509665|recurrent lymphoepithelioma of the oropharynx|recurrent lymphoepithelioma of the oropharynx
5279114|NCT00509665|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
5279115|NCT00509652|Hemochromatosis|hemochromatosis
5279116|NCT00509652|Primary hemochromatosis|primary hemochromatosis
5279117|NCT00509652|Hereditary hemochromatosis|hereditary hemochromatosis
5279118|NCT00509652|Therapy|therapy
5279119|NCT00509652|Erythrocyte apheresis|erythrocyte apheresis
5279120|NCT00509652|Phlebotomy|phlebotomy
5279121|NCT00509652|Apheresis|apheresis
5279122|NCT00509652|Efficacy|efficacy
5279123|NCT00509626|fatigue|fatigue
5279124|NCT00509626|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
5279125|NCT00509626|weight changes|weight changes
5279126|NCT00509626|depression|depression
5279127|NCT00509626|stage I breast cancer|stage i breast cancer
5279128|NCT00509626|stage II breast cancer|stage ii breast cancer
5279129|NCT00509600|Juvenile Myelomonocytic Leukemia|juvenile myelomonocytic leukemia
5279130|NCT00509600|JMML|jmml
5279131|NCT00509600|Leukemia|leukemia
5279132|NCT00509600|Etanercept|etanercept
5279133|NCT00509600|Enbrel|enbrel
5279134|NCT00509574|Single Nucleotide Polymorphism|single nucleotide polymorphism
5279135|NCT00509574|statins|statins
5279136|NCT00509574|hyperlipidemia|hyperlipidemia
5279137|NCT00509561|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
5279138|NCT00509561|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
5279139|NCT00509561|stage IA esophageal cancer|stage ia esophageal cancer
5279140|NCT00509561|stage IB esophageal cancer|stage ib esophageal cancer
5279141|NCT00509561|stage IIA esophageal cancer|stage iia esophageal cancer
5279142|NCT00509561|stage IIB esophageal cancer|stage iib esophageal cancer
5279143|NCT00509561|stage IIIA esophageal cancer|stage iiia esophageal cancer
5279144|NCT00509561|stage IIIB esophageal cancer|stage iiib esophageal cancer
5279145|NCT00509561|stage IIIC esophageal cancer|stage iiic esophageal cancer
5279146|NCT00509535|Vitreoscilla filiformis extract|vitreoscilla filiformis extract
5279147|NCT00509535|SCORAD|scorad
5279148|NCT00509535|pruritus|pruritus
5279149|NCT00509535|microflora|microflora
5279150|NCT00509535|TEWL|tewl
5279151|NCT00509509|Hereditary Breast Cancer (BRCA1, BRCA2)|hereditary breast cancer (brca1, brca2)
5279152|NCT00509496|Refractory|refractory
5279153|NCT00509496|Gene Therapy|gene therapy
5279154|NCT00509496|HLA-A2 Positive|hla-a2 positive
5279155|NCT00509496|Stage IV Melanoma|stage iv melanoma
5279156|NCT00509496|Melanoma|melanoma
5279157|NCT00509496|Skin Cancer|skin cancer
5279158|NCT00509496|Malignant Melanoma|malignant melanoma
5279159|NCT00509483|multinodular|multinodular
5279160|NCT00509483|goitre|goitre
5279161|NCT00509483|recombinant human TSH|recombinant human tsh
5279162|NCT00509457|NSCLC, vaccination|nsclc, vaccination
5279163|NCT00509457|Inoperable NSCLC stage IIIA/B in good performance status|inoperable nsclc stage iiia/b in good performance status
5279164|NCT00509431|adult giant cell glioblastoma|adult giant cell glioblastoma
5279165|NCT00509431|adult gliosarcoma|adult gliosarcoma
5279166|NCT00509431|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5279167|NCT00509431|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
5279168|NCT00509431|adult mixed glioma|adult mixed glioma
5279169|NCT00509431|recurrent adult brain tumor|recurrent adult brain tumor
5279170|NCT00509431|adult glioblastoma|adult glioblastoma
5279171|NCT00509431|adult pilocytic astrocytoma|adult pilocytic astrocytoma
5279172|NCT00509431|adult diffuse astrocytoma|adult diffuse astrocytoma
5279173|NCT00509431|adult subependymal giant cell astrocytoma|adult subependymal giant cell astrocytoma
5279174|NCT00509431|adult oligodendroglioma|adult oligodendroglioma
5279175|NCT00509418|Nonalcoholic steatohepatitis|nonalcoholic steatohepatitis
5279176|NCT00509418|Nonalcoholic Fatty Liver|nonalcoholic fatty liver
5279177|NCT00509418|Nutritional supplement|nutritional supplement
5279178|NCT00509418|Diet|diet
5279179|NCT00509418|Exercise|exercise
5279180|NCT00509405|Endogenous acid production|endogenous acid production
5279181|NCT00509405|metabolic acidosis|metabolic acidosis
5279182|NCT00509405|potassium citrate|potassium citrate
5279183|NCT00509405|osteoporosis|osteoporosis
5279184|NCT00509405|sarcopenia|sarcopenia
5279185|NCT00509405|hypertension|hypertension
5279186|NCT00509405|Effect of potassium citrate on bone mineral density and bone mass|effect of potassium citrate on bone mineral density and bone mass
5279276|NCT00509080|natriuretic peptides|natriuretic peptides
5279187|NCT00509392|Varicose veins, venous reflux, GSV disease|varicose veins, venous reflux, gsv disease
5279188|NCT00509379|Relapsed/refractory indolent lymphoma|relapsed/refractory indolent lymphoma
5279189|NCT00509379|Non-follicular Lymphoma|non-follicular lymphoma
5279190|NCT00509379|Mantle cell non-Hodgkin Lymphoma|mantle cell non-hodgkin lymphoma
5279191|NCT00509379|Patients naïve or sensitive to rituximab|patients naïve or sensitive to rituximab
5279192|NCT00509379|Patients not eligible for high dose chemotherapy with ASCT|patients not eligible for high dose chemotherapy with asct
5279193|NCT00509366|genomics|genomics
5279194|NCT00509366|genomics predictor|genomics predictor
5279195|NCT00509366|genomics analysis|genomics analysis
5279196|NCT00509366|squamous|squamous
5279197|NCT00509366|non-squamous|non-squamous
5279198|NCT00509353|recurrent neuroblastoma|recurrent neuroblastoma
5279199|NCT00509340|antiretroviral|antiretroviral
5279200|NCT00509340|adherence|adherence
5279201|NCT00509340|poor antiretroviral adherence|poor antiretroviral adherence
5279202|NCT00509327|postoperative ileus|postoperative ileus
5279203|NCT00509327|colorectal surgery|colorectal surgery
5279204|NCT00509327|bisacodyl|bisacodyl
5279205|NCT00509327|laxatives|laxatives
5279206|NCT00509301|brain cancer|brain cancer
5279207|NCT00509301|Cotara|cotara
5279208|NCT00509301|radioactive isotope|radioactive isotope
5279209|NCT00509301|monoclonal antibody|monoclonal antibody
5279210|NCT00509301|radiation distribution|radiation distribution
5279211|NCT00509288|Refractory|refractory
5279212|NCT00509288|Gene Therapy|gene therapy
5279213|NCT00509288|HLA-A2 Positive|hla-a2 positive
5279214|NCT00509288|Stage IV Melanoma|stage iv melanoma
5279215|NCT00509288|Melanoma|melanoma
5279216|NCT00509288|Skin Cancer|skin cancer
5279217|NCT00509288|Malignant Melanoma|malignant melanoma
5279218|NCT00509223|Type 2 diabetes|type 2 diabetes
5279219|NCT00509223|Obstructive sleep apnea|obstructive sleep apnea
5279220|NCT00509223|Glycemic control|glycemic control
5279221|NCT00509223|Insulin resistance|insulin resistance
5279222|NCT00509223|Sleep disordered breathing|sleep disordered breathing
5279223|NCT00509210|Liver Disease|liver disease
5279224|NCT00509197|Asthma|asthma
5279225|NCT00509197|Non-eosinophilic Asthma|non-eosinophilic asthma
5279226|NCT00509197|sputum eosinophils|sputum eosinophils
5279227|NCT00509197|Inhaled Corticosteroids|inhaled corticosteroids
5279228|NCT00509184|untreated|untreated
5279229|NCT00509171|embolism|embolism
5279230|NCT00509171|femur fracture|femur fracture
5279231|NCT00509171|lavage|lavage
5279232|NCT00509171|TEE|tee
5279233|NCT00509171|reamer|reamer
5279234|NCT00509171|IM nail|im nail
5279235|NCT00509158|safety|safety
5279236|NCT00509158|immunogenicity|immunogenicity
5279237|NCT00509158|efficacy|efficacy
5279238|NCT00509145|Relapsing|relapsing
5279239|NCT00509145|Remitting|remitting
5279240|NCT00509119|apoplexia|apoplexia
5279241|NCT00509119|Intracranial and intraarterial pressure curves in acute apoplectic patients|intracranial and intraarterial pressure curves in acute apoplectic patients
5279242|NCT00509106|ceftaroline|ceftaroline
5279243|NCT00509106|Community-acquired pneumonia|community-acquired pneumonia
5279244|NCT00509106|CAP|cap
5279245|NCT00509106|Streptococcus pneumoniae|streptococcus pneumoniae
5279246|NCT00509106|Haemophilus influenzae|haemophilus influenzae
5279247|NCT00509106|Mycoplasma pneumoniae|mycoplasma pneumoniae
5279248|NCT00509106|Chlamydophila spp|chlamydophila spp
5279249|NCT00509106|Legionella ssp|legionella ssp
5279250|NCT00509106|multi-drug resistant Streptococcus pneumoniae (MDRSP)|multi-drug resistant streptococcus pneumoniae (mdrsp)
5279251|NCT00509106|antimicrobial resistance|antimicrobial resistance
5279252|NCT00509106|pneumococci|pneumococci
5279254|NCT00509106|ceftaroline fosamil|ceftaroline fosamil
5279255|NCT00509106|ceftriaxone|ceftriaxone
5279256|NCT00509106|antibiotic|antibiotic
5279257|NCT00509093|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
5279258|NCT00509093|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
5279259|NCT00509093|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
5279260|NCT00509093|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5279261|NCT00509093|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5279262|NCT00509093|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5279263|NCT00509093|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5279264|NCT00509093|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
5279265|NCT00509093|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
5279266|NCT00509093|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
5279267|NCT00509093|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
5279268|NCT00509093|adult erythroleukemia (M6a)|adult erythroleukemia (m6a)
5279269|NCT00509093|adult pure erythroid leukemia (M6b)|adult pure erythroid leukemia (m6b)
5279270|NCT00509093|adult acute basophilic leukemia|adult acute basophilic leukemia
5279271|NCT00509093|adult acute eosinophilic leukemia|adult acute eosinophilic leukemia
5279272|NCT00509093|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5279273|NCT00509080|mitral regurgitation|mitral regurgitation
5279274|NCT00509080|BNP|bnp
5279277|NCT00509080|valvular heart disease|valvular heart disease
5279278|NCT00509067|Schizoaffective Disorder|schizoaffective disorder
5279279|NCT00509067|Acetylcholine|acetylcholine
5279280|NCT00509067|Nicotinic Receptors|nicotinic receptors
5279281|NCT00509067|Nicotine|nicotine
5279282|NCT00509067|Galantamine|galantamine
5279283|NCT00509067|negative symptoms|negative symptoms
5279284|NCT00509054|Parastomal hernia, wound infection, stoma care.|parastomal hernia, wound infection, stoma care.
5279285|NCT00509041|advanced malignant mesothelioma|advanced malignant mesothelioma
5279286|NCT00509041|epithelial mesothelioma|epithelial mesothelioma
5279287|NCT00509041|recurrent malignant mesothelioma|recurrent malignant mesothelioma
5279288|NCT00509041|sarcomatous mesothelioma|sarcomatous mesothelioma
5279289|NCT00509028|Asthma|asthma
5279290|NCT00509028|Bronchial|bronchial
5279291|NCT00509015|antimalarials|antimalarials
5279292|NCT00509015|malaria transmission|malaria transmission
5279293|NCT00509015|mass drug administration|mass drug administration
5279294|NCT00509015|artemisinin-based combination therapy|artemisinin-based combination therapy
5279295|NCT00509015|primaquine|primaquine
5279296|NCT00509015|gametocytes|gametocytes
5279297|NCT00509015|QT-NASBA|qt-nasba
5279298|NCT00509002|Salivary Gland Cancer|salivary gland cancer
5279299|NCT00509002|Iressa|iressa
5279300|NCT00509002|ZD1839|zd1839
5279301|NCT00508989|Acetylcholine|acetylcholine
5279302|NCT00508989|Forearm Blood Flow|forearm blood flow
5279303|NCT00508989|HDL|hdl
5279304|NCT00508989|L-NMMA|l-nmma
5279305|NCT00508989|Sickle Cell Anemia|sickle cell anemia
5279306|NCT00508989|Sickle Cell Disease|sickle cell disease
5279307|NCT00508976|bupivacaine|bupivacaine
5279308|NCT00508976|marcaine|marcaine
5279309|NCT00508976|lidocaine|lidocaine
5279310|NCT00508976|normal saline|normal saline
5279311|NCT00508976|narcotics|narcotics
5279312|NCT00508976|analog pain scale|analog pain scale
5279313|NCT00508976|postoperative pain|postoperative pain
5279314|NCT00508976|preemptive|preemptive
5279315|NCT00508976|aerosolization|aerosolization
5279316|NCT00508976|streamed|streamed
5279317|NCT00508963|New World Cutaneous or Mucocutaneous Leishmaniasis|new world cutaneous or mucocutaneous leishmaniasis
5279318|NCT00508950|Vaccines|vaccines
5279319|NCT00508950|Pneumococcal Conjugate Vaccine|pneumococcal conjugate vaccine
5279320|NCT00508950|Adult|adult
5279321|NCT00508937|Diet|diet
5279322|NCT00508937|Protein|protein
5279323|NCT00508937|Glucose|glucose
5279324|NCT00508937|Insulin|insulin
5279325|NCT00508937|Cholesterol|cholesterol
5279326|NCT00508937|Triglycerides|triglycerides
5279327|NCT00508937|LDL subclasses|ldl subclasses
5279328|NCT00508924|Argatroban|argatroban
5279329|NCT00508924|Direct thrombin inhibitor|direct thrombin inhibitor
5279330|NCT00508924|Percutaneous coronary intervention|percutaneous coronary intervention
5279331|NCT00508924|Activated clotting time|activated clotting time
5279332|NCT00508924|PCI|pci
5279333|NCT00508924|ACT|act
5279334|NCT00508911|open-label,|open-label,
5279335|NCT00508911|oral contraceptive,|oral contraceptive,
5279336|NCT00508911|Combine Oral Contraceptives,|combine oral contraceptives,
5279337|NCT00508911|single-sequence,|single-sequence,
5279338|NCT00508911|volunteers|volunteers
5279339|NCT00508911|GW876008,|gw876008,
5279340|NCT00508911|repeat-dose,|repeat-dose,
5279341|NCT00508911|female,|female,
5279342|NCT00508911|pharmacokinetics,|pharmacokinetics,
5279343|NCT00508898|lupus nephritis|lupus nephritis
5279344|NCT00508898|proteinuria|proteinuria
5279345|NCT00508898|chronic kidney diseases|chronic kidney diseases
5279346|NCT00508898|SLE|sle
5279347|NCT00508885|hyperphosphatemia|hyperphosphatemia
5279348|NCT00508885|niacinamide|niacinamide
5279349|NCT00508885|ESRD|esrd
5279350|NCT00508885|peritoneal dialysis|peritoneal dialysis
5279351|NCT00508885|renal osteodystrophy|renal osteodystrophy
5279352|NCT00508872|Colorectal Liver Metastases|colorectal liver metastases
5279353|NCT00508872|Oxaliplatin|oxaliplatin
5279354|NCT00508872|Eloxatin|eloxatin
5279355|NCT00508872|Fluorouracil|fluorouracil
5279356|NCT00508872|Leucovorin|leucovorin
5279357|NCT00508872|Bevacizumab|bevacizumab
5279358|NCT00508872|Anti-VEGF monoclonal antibody|anti-vegf monoclonal antibody
5279359|NCT00508872|rhuMAb-VEGF|rhumab-vegf
5279360|NCT00508872|Folfox-B|folfox-b
5279361|NCT00508872|5-FU|5-fu
5279362|NCT00508872|Avastin|avastin
5279363|NCT00508859|depression|depression
5279364|NCT00508859|adolescents|adolescents
5279365|NCT00508859|maintenance treatment|maintenance treatment
5279366|NCT00508859|antidepressant|antidepressant
5279367|NCT00508846|Hereditary Non-Polyposis Colon Cancer|hereditary non-polyposis colon cancer
5279368|NCT00508846|Gynecologic Cancers|gynecologic cancers
5279369|NCT00508846|Genetic Counseling|genetic counseling
5279370|NCT00508846|Questionnaire|questionnaire
5279371|NCT00508846|Survey|survey
5279372|NCT00508846|HNPCC|hnpcc
5279373|NCT00508833|Adjuvants|adjuvants
5279374|NCT00508833|HBsAg|hbsag
5279375|NCT00508820|Platelet|platelet
5279376|NCT00508820|AMG 531|amg 531
5279377|NCT00508820|Thrombopoietin|thrombopoietin
5279378|NCT00508820|blood disorder|blood disorder
5279379|NCT00508820|bleeding disorder|bleeding disorder
5279380|NCT00508820|immune thrombocytopenic purpura|immune thrombocytopenic purpura
5279381|NCT00508820|idiopathic thrombocytopenic purpura|idiopathic thrombocytopenic purpura
5279382|NCT00508820|immune (idiopathic) thrombocytopenic purpura|immune (idiopathic) thrombocytopenic purpura
5279383|NCT00508820|TPO|tpo
5279384|NCT00508820|thrombopoietic protein|thrombopoietic protein
5279385|NCT00508807|Lymphoid Malignancies|lymphoid malignancies
5279386|NCT00508807|Solid Tumors|solid tumors
5279387|NCT00508807|RTA 402|rta 402
5279388|NCT00508794|Breast Cancer|breast cancer
5279389|NCT00508794|Tibetan Yoga|tibetan yoga
5279390|NCT00508794|Stretching Program|stretching program
5279391|NCT00508794|Yoga|yoga
5279392|NCT00508794|Quality of Life|quality of life
5279393|NCT00508794|Questionnaire|questionnaire
5279394|NCT00508794|Survey|survey
5279395|NCT00508768|Rheumatoid Arthritis|rheumatoid arthritis
5279396|NCT00508768|Methotrexate|methotrexate
5279397|NCT00508755|cerebrovascular accident|cerebrovascular accident
5279398|NCT00508755|electrical stimulation|electrical stimulation
5279399|NCT00508755|gait training|gait training
5279400|NCT00508755|motor learning|motor learning
5279401|NCT00508742|Nasopharyngeal Colonization|nasopharyngeal colonization
5279402|NCT00508742|Streptococcus pneumoniae|streptococcus pneumoniae
5279403|NCT00508742|Healthy Infants|healthy infants
5279404|NCT00508742|Vaccines|vaccines
5279405|NCT00508742|Pneumococcal Conjugate Vaccine|pneumococcal conjugate vaccine
5279406|NCT00508716|Congestive Heart Failure|congestive heart failure
5279407|NCT00508716|Health Literacy|health literacy
5279408|NCT00508716|Health Education|health education
5279409|NCT00508716|Congestive Heart Failure (inpatients)|congestive heart failure (inpatients)
5279410|NCT00508703|Uterine Cancer|uterine cancer
5279411|NCT00508703|Cervical Cancer|cervical cancer
5279412|NCT00508703|Endometrial Cancer|endometrial cancer
5279413|NCT00508703|Intensity Modulated Radiotherapy|intensity modulated radiotherapy
5279414|NCT00508703|IMRT|imrt
5279415|NCT00508703|Computed Tomography|computed tomography
5279416|NCT00508703|CT|ct
5279417|NCT00508703|CT Scan|ct scan
5279418|NCT00508690|Antibiotic Prophylaxis|antibiotic prophylaxis
5279419|NCT00508690|Colorectal Surgery|colorectal surgery
5279420|NCT00508690|Laparoscopy|laparoscopy
5279421|NCT00508677|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
5279422|NCT00508677|Mazindol|mazindol
5279423|NCT00508664|by laryngectomy operable carcinoma of the larynx and the hypopharynx|by laryngectomy operable carcinoma of the larynx and the hypopharynx
5279424|NCT00508651|parainfluenza virus, children, vaccine|parainfluenza virus, children, vaccine
5279425|NCT00508638|Heart Failure|heart failure
5279426|NCT00508612|Blood Pressure|blood pressure
5279427|NCT00508612|Systolic Blood Pressure|systolic blood pressure
5279428|NCT00508612|Diastolic Blood Pressure|diastolic blood pressure
5279429|NCT00508612|Ambulatory Blood Pressure Monitoring|ambulatory blood pressure monitoring
5279430|NCT00508612|Relaxation|relaxation
5279431|NCT00508612|Meditation|meditation
5279432|NCT00508612|Coping Skills|coping skills
5279433|NCT00508612|Adolescents|adolescents
5279434|NCT00508599|type 2 diabetes|type 2 diabetes
5279435|NCT00508599|bed rest|bed rest
5279436|NCT00508599|insulin resistance|insulin resistance
5279437|NCT00508599|insulin|insulin
5279438|NCT00508599|glucose|glucose
5279439|NCT00508599|orthostatic response|orthostatic response
5279440|NCT00508586|Breast cancer|breast cancer
5279441|NCT00508586|PTC299|ptc299
5279442|NCT00508586|VEGF|vegf
5279443|NCT00508586|Angiogenesis|angiogenesis
5279444|NCT00508586|Post-transcriptional control|post-transcriptional control
5279445|NCT00508586|Aromatase inhibitors|aromatase inhibitors
5279446|NCT00508573|Hereditary Nonpolyposis Colorectal Cancer|hereditary nonpolyposis colorectal cancer
5279447|NCT00508573|Lynch Syndrome|lynch syndrome
5279448|NCT00508573|HNPCC|hnpcc
5279449|NCT00508573|Syndrome Registry|syndrome registry
5279450|NCT00508573|Questionnaire|questionnaire
5279451|NCT00508573|Endometrial cancer|endometrial cancer
5279452|NCT00508573|Ovarian cancer|ovarian cancer
5279453|NCT00508560|Contingency management|contingency management
5279454|NCT00508560|Smoking cessation|smoking cessation
5279455|NCT00508560|Psychotic disorders|psychotic disorders
5279456|NCT00508560|Veterans|veterans
5279457|NCT00508547|Methotrexate|methotrexate
5279458|NCT00508547|Acitretin|acitretin
5279459|NCT00508547|Cyclosporine|cyclosporine
5279460|NCT00508547|Systemic PUVA|systemic puva
5279461|NCT00508547|Infliximab|infliximab
5279462|NCT00508547|Adalimumab|adalimumab
5279463|NCT00508547|Alefacept|alefacept
5279464|NCT00508547|Efalizumab|efalizumab
5279465|NCT00508547|Etanercept|etanercept
5279466|NCT00508547|Psoriasis|psoriasis
5279467|NCT00508547|Psoriatic arthritis|psoriatic arthritis
5279468|NCT00508547|Skin disease|skin disease
5279469|NCT00508547|Cosentyx|cosentyx
5279470|NCT00508534|pharmacokinetic study,|pharmacokinetic study,
5279471|NCT00508534|gastric pH|gastric ph
5279472|NCT00508521|cerebrovascular accident|cerebrovascular accident
5279473|NCT00508521|electrical stimulation|electrical stimulation
5279474|NCT00508521|motor learning|motor learning
5279475|NCT00508521|upper extremity rehabilitation|upper extremity rehabilitation
5279476|NCT00508508|Heart Failure|heart failure
5279477|NCT00508508|Peer Support|peer support
5279478|NCT00508508|Self Management|self management
5279479|NCT00508495|pain, postoperative|pain, postoperative
5279480|NCT00508495|replacement, total hip|replacement, total hip
5279481|NCT00508495|total hip replacement|total hip replacement
5279482|NCT00508495|arthroplasty, replacement, hip|arthroplasty, replacement, hip
5279483|NCT00508482|Acupuncture|acupuncture
5279484|NCT00508482|Functional constipation|functional constipation
5279485|NCT00508469|Intraocular pressure|intraocular pressure
5279486|NCT00508469|Open-angle glaucoma|open-angle glaucoma
5279487|NCT00508469|Ocular hypertension|ocular hypertension
5279488|NCT00508469|Adherence|adherence
5279489|NCT00508469|Compliance|compliance
5279490|NCT00508456|Glioblastoma Multiforme|glioblastoma multiforme
5279491|NCT00508456|Methionine Restriction|methionine restriction
5279492|NCT00508456|Hominex-2|hominex-2
5279493|NCT00508456|Methionine Restriction Diet|methionine restriction diet
5279494|NCT00508456|Hominex-2 Amino Acid-Modified Medical Food|hominex-2 amino acid-modified medical food
5279495|NCT00508456|Temozolomide|temozolomide
5279496|NCT00508456|Temodar|temodar
5279497|NCT00508443|Stereotactic Spine Radiotherapy System|stereotactic spine radiotherapy system
5279498|NCT00508443|SSRS|ssrs
5279499|NCT00508443|CT-on-Rails|ct-on-rails
5279500|NCT00508443|Metastatic Spine Disease|metastatic spine disease
5279501|NCT00508443|Spinal Neoplasms|spinal neoplasms
5279502|NCT00508443|Radiation Therapy|radiation therapy
5279503|NCT00508443|Trilogy|trilogy
5279504|NCT00508443|Cancer|cancer
5279505|NCT00508443|Breast Cancer|breast cancer
5279506|NCT00508443|Gastrointestinal Cancer|gastrointestinal cancer
5279507|NCT00508443|Genitourinary Disease|genitourinary disease
5279508|NCT00508443|Lung Cancer|lung cancer
5279509|NCT00508443|Lymphoma|lymphoma
5279510|NCT00508443|Melanoma|melanoma
5279511|NCT00508443|Sarcoma|sarcoma
5279512|NCT00508443|Spinal Cancer|spinal cancer
5279513|NCT00508430|ASP8825|asp8825
5279514|NCT00508430|Diabetic Neuropathies|diabetic neuropathies
5279515|NCT00508430|Pain|pain
5279516|NCT00508417|Malaria Incidence|malaria incidence
5279517|NCT00508417|Anemia|anemia
5279518|NCT00508417|Clinical Malaria|clinical malaria
5279519|NCT00508378|Ovarian Cancer|ovarian cancer
5279520|NCT00508378|Quality of Life|quality of life
5279521|NCT00508378|Chemotherapy Side-Effects|chemotherapy side-effects
5279522|NCT00508378|Interview|interview
5279523|NCT00508378|Questionnaire|questionnaire
5279524|NCT00508378|Caregivers|caregivers
5279525|NCT00508365|lisinopril|lisinopril
5279526|NCT00508365|carvedilol|carvedilol
5279527|NCT00508365|hypertension|hypertension
5279528|NCT00508352|breast|breast
5279529|NCT00508352|cancer|cancer
5279530|NCT00508352|locoregional|locoregional
5279531|NCT00508352|IMRT|imrt
5279532|NCT00508352|tomotherapy|tomotherapy
5279533|NCT00508339|Soft Tissue Sarcoma|soft tissue sarcoma
5279534|NCT00508339|Limb Sparing Surgery|limb sparing surgery
5279535|NCT00508339|Toronto Extremity Salvage Score|toronto extremity salvage score
5279536|NCT00508339|Radiotherapy|radiotherapy
5279537|NCT00508339|Quality of Life|quality of life
5279538|NCT00508339|Questionnaire|questionnaire
5279539|NCT00508339|Survey|survey
5279540|NCT00508339|TESS|tess
5279541|NCT00508326|Advanced Cancer|advanced cancer
5279542|NCT00508326|Solid Tumor|solid tumor
5279543|NCT00508326|Liver Metastasis|liver metastasis
5279544|NCT00508326|Hepatic Artery Infusion|hepatic artery infusion
5279545|NCT00508326|Liver|liver
5279546|NCT00508326|Paclitaxel|paclitaxel
5279547|NCT00508326|Taxol|taxol
5279548|NCT00508313|Lung Cancer|lung cancer
5279549|NCT00508313|Healthy Control|healthy control
5279550|NCT00508313|Thermal Imaging|thermal imaging
5279551|NCT00508313|Thermal Signatures|thermal signatures
5279552|NCT00508313|Radiation Therapy|radiation therapy
5279553|NCT00508313|Chemoradiation Therapy|chemoradiation therapy
5279554|NCT00508300|laparoscopic|laparoscopic
5279555|NCT00508300|colectomy|colectomy
5279556|NCT00508300|Fast Track|fast track
5279557|NCT00508300|epidural|epidural
5279558|NCT00508274|Advanced Metastatic Breast Cancer|advanced metastatic breast cancer
5279559|NCT00508274|breast cancer|breast cancer
5279560|NCT00508274|lapatinib|lapatinib
5279561|NCT00508274|HER2+ positive|her2+ positive
5279562|NCT00508274|TYVERB|tyverb
5279563|NCT00508274|TYKERB|tykerb
5279564|NCT00508261|Meningococcal vaccine|meningococcal vaccine
5279565|NCT00508261|Immunogenicity|immunogenicity
5279566|NCT00508261|Routine infancy vaccination|routine infancy vaccination
5279567|NCT00508261|Safety|safety
5279568|NCT00508248|omega 3fatty acids|omega 3fatty acids
5279569|NCT00508235|Neurofibromatosis|neurofibromatosis
5279570|NCT00508235|Quality of Friendships|quality of friendships
5279571|NCT00508235|Disease Severity|disease severity
5279572|NCT00508235|Questionnaire|questionnaire
5279573|NCT00508235|NF-1|nf-1
5279575|NCT00508222|HCV|hcv
5279576|NCT00508222|HIV/HCV Co-infection|hiv/hcv co-infection
5279577|NCT00508222|Kaletra Monotherapy|kaletra monotherapy
5279578|NCT00508222|Treatment Experienced|treatment experienced
5279579|NCT00508209|high-dose melphalan|high-dose melphalan
5279580|NCT00508209|bortezomib|bortezomib
5279581|NCT00508209|response|response
5279582|NCT00508209|toxicity|toxicity
5279583|NCT00508209|relapse|relapse
5279584|NCT00508196|right ventricular pacing|right ventricular pacing
5279585|NCT00508196|endothelial function|endothelial function
5279586|NCT00508196|cardiac output|cardiac output
5279587|NCT00508183|full thickness rotator cuff tear|full thickness rotator cuff tear
5279588|NCT00508170|Head and Neck Cancer|head and neck cancer
5279589|NCT00508170|Human Papillomavirus Infection|human papillomavirus infection
5279590|NCT00508170|Oropharyngeal Patients|oropharyngeal patients
5279591|NCT00508170|Sexual Behavior|sexual behavior
5279592|NCT00508170|Questionnaire|questionnaire
5279593|NCT00508144|Non-Small Cell Lung Cancer|non-small cell lung cancer
5279594|NCT00508144|Lung Cancer|lung cancer
5279595|NCT00508144|NSCLC|nsclc
5279596|NCT00508144|Malignant pleural effusion|malignant pleural effusion
5279597|NCT00508144|Pericardial effusion|pericardial effusion
5279598|NCT00508144|Pemetrexed|pemetrexed
5279599|NCT00508144|Alimta|alimta
5279600|NCT00508144|LY231514|ly231514
5279601|NCT00508144|Poor Performance Status|poor performance status
5279602|NCT00508144|Asymptomatic Brain Metastases|asymptomatic brain metastases
5279603|NCT00508131|Milk fortification|milk fortification
5279604|NCT00508131|Effectivness evaluation|effectivness evaluation
5279605|NCT00508131|Iron deficiency anemia|iron deficiency anemia
5279606|NCT00508131|Stunting|stunting
5279607|NCT00508131|Zinc deficiency|zinc deficiency
5279608|NCT00508118|Aortic Arch Reconstruction Surgery|aortic arch reconstruction surgery
5279609|NCT00508105|Osteoarthritis|osteoarthritis
5279610|NCT00508105|Shoulder|shoulder
5279611|NCT00508105|tenotomy|tenotomy
5279612|NCT00508105|ostotomy|ostotomy
5279613|NCT00508092|appendicectomy|appendicectomy
5279614|NCT00508092|pain|pain
5279615|NCT00508092|local anaesthetic|local anaesthetic
5279616|NCT00508092|nerve block|nerve block
5279617|NCT00508092|Post operative pain following appendicectomy|post operative pain following appendicectomy
5279618|NCT00508079|Venous Disease|venous disease
5279619|NCT00508079|Varicose Veins|varicose veins
5279620|NCT00508079|Chronic Venous Insufficiency|chronic venous insufficiency
5279621|NCT00508079|PAD|pad
5279622|NCT00508066|Congenital Scoliosis|congenital scoliosis
5279623|NCT00508066|Idiopathic Scoliosis|idiopathic scoliosis
5279624|NCT00508066|Spinal Fusion|spinal fusion
5279625|NCT00508066|Post-Operative Pain Management|post-operative pain management
5279626|NCT00508066|Infusion Catheter|infusion catheter
5279627|NCT00508053|wound infection|wound infection
5279628|NCT00508053|incisional hernia|incisional hernia
5279629|NCT00508053|wound dehiscence|wound dehiscence
5279630|NCT00508053|wound healing|wound healing
5279631|NCT00508053|postoperative complications|postoperative complications
5279632|NCT00508053|surgical techniques|surgical techniques
5279633|NCT00508040|Birdshot Retine choroidopathy|birdshot retine choroidopathy
5279634|NCT00508040|Macular edema|macular edema
5279635|NCT00508040|Prednisone|prednisone
5279636|NCT00508040|Interferon alpha 2a|interferon alpha 2a
5279637|NCT00508040|Associated with Cystoid macular edema|associated with cystoid macular edema
5279638|NCT00508040|With Visual acuity loss|with visual acuity loss
5279639|NCT00508027|sickle cell disease|sickle cell disease
5279640|NCT00508027|simvastatin|simvastatin
5279641|NCT00508027|statin drugs|statin drugs
5279642|NCT00508027|nitric oxide donors|nitric oxide donors
5279643|NCT00508027|vascular injury|vascular injury
5279644|NCT00508014|Cardiovascular disease|cardiovascular disease
5279645|NCT00508014|Diabetes|diabetes
5279646|NCT00508014|Quality improvement|quality improvement
5279647|NCT00508014|Peer review|peer review
5279648|NCT00508001|Hepatocellular carcinoma|hepatocellular carcinoma
5279649|NCT00508001|Advanced solid, malignant tumour|advanced solid, malignant tumour
5279650|NCT00507988|Cognitive Training|cognitive training
5279651|NCT00507988|Complex Problem Solving|complex problem solving
5279652|NCT00507988|Goal Management|goal management
5279653|NCT00507988|Planning|planning
5279654|NCT00507975|Smoking|smoking
5279655|NCT00507975|pregnancy|pregnancy
5279656|NCT00507975|newborn|newborn
5279657|NCT00507975|birth weight|birth weight
5279658|NCT00507975|nicotine patch|nicotine patch
5279659|NCT00507975|birth|birth
5279660|NCT00507962|Advanced Cancer|advanced cancer
5279661|NCT00507962|Dominant Liver Involvement|dominant liver involvement
5279662|NCT00507962|Hepatic Intraarterial Cisplatin|hepatic intraarterial cisplatin
5279663|NCT00507962|Cisplatin|cisplatin
5279664|NCT00507962|Liposomal Doxorubicin|liposomal doxorubicin
5279665|NCT00507962|Platinol-AQ|platinol-aq
5279666|NCT00507962|Platinol|platinol
5279667|NCT00507962|CDDP|cddp
5279668|NCT00507962|Doxil|doxil
5279669|NCT00507962|Liposomal|liposomal
5279670|NCT00507962|Doxorubicin Hydrochloride|doxorubicin hydrochloride
5279671|NCT00507949|COPD|copd
5279672|NCT00507949|body weight|body weight
5279673|NCT00507949|megestrol acetate|megestrol acetate
5279674|NCT00507949|cytokines|cytokines
5279675|NCT00507936|Diabetic Neuropathy|diabetic neuropathy
5279676|NCT00507936|Painful|painful
5279677|NCT00507936|Diabetic Polyneuropathy|diabetic polyneuropathy
5279678|NCT00507936|Neuralgia|neuralgia
5279679|NCT00507936|Diabetic|diabetic
5279680|NCT00507936|Diabetic Neuropathies|diabetic neuropathies
5279681|NCT00507936|Diabetic Neuralgia|diabetic neuralgia
5279682|NCT00507923|Breast Cancer|breast cancer
5279683|NCT00507923|Tibetan Yoga|tibetan yoga
5279684|NCT00507923|Stretching|stretching
5279685|NCT00507923|Yoga|yoga
5279686|NCT00507923|Fatigue|fatigue
5279687|NCT00507923|Sleep|sleep
5279688|NCT00507923|Questionnaire|questionnaire
5279689|NCT00507923|Survey|survey
5279690|NCT00507910|ankle fracture|ankle fracture
5279691|NCT00507910|pes planus|pes planus
5279692|NCT00507897|thyroid nodules, blood pressure, thyroid hormones|thyroid nodules, blood pressure, thyroid hormones
5279693|NCT00507884|Kidney Neoplasms|kidney neoplasms
5279694|NCT00507884|Renal Tumors|renal tumors
5279695|NCT00507884|Magnetic Resonance Imaging|magnetic resonance imaging
5279696|NCT00507884|3 Tesla MRI|3 tesla mri
5279697|NCT00507884|MRI|mri
5279698|NCT00507871|cryptosporidiosis, Cryptosporidium, Uganda, diarrhea|cryptosporidiosis, cryptosporidium, uganda, diarrhea
5279699|NCT00507858|Head and Neck Cancer|head and neck cancer
5279700|NCT00507858|Squamous Cell Cancer|squamous cell cancer
5279701|NCT00507858|Alimta|alimta
5279702|NCT00507858|Pemetrexed|pemetrexed
5279703|NCT00507858|Dexamethasone|dexamethasone
5279704|NCT00507858|HNSCC|hnscc
5279705|NCT00507858|Decadron|decadron
5279706|NCT00507832|Prurigo nodularis|prurigo nodularis
5279707|NCT00507819|Other Single Ventricle Anatomy|other single ventricle anatomy
5279708|NCT00507819|Hypoplastic Left Heart Syndrome|hypoplastic left heart syndrome
5279709|NCT00507819|Tricuspid Atresia|tricuspid atresia
5279710|NCT00507806|Acute Ischemic Stroke|acute ischemic stroke
5279711|NCT00507806|Microbubbles|microbubbles
5279712|NCT00507806|Transcranial Doppler ultrasound|transcranial doppler ultrasound
5279713|NCT00507806|TIBI|tibi
5279714|NCT00507806|Symptomatic Intracranial Hemorrhage|symptomatic intracranial hemorrhage
5279715|NCT00507806|modified Rankin Scale|modified rankin scale
5279716|NCT00507806|Recanalization|recanalization
5279717|NCT00507806|Perflutren|perflutren
5279718|NCT00507780|GnRH Antagonist|gnrh antagonist
5279719|NCT00507780|Premature Ovarian Failure|premature ovarian failure
5279720|NCT00507780|Fertility|fertility
5279721|NCT00507780|Chemotherapy|chemotherapy
5279722|NCT00507780|POF|pof
5279723|NCT00507754|Advanced Cancer|advanced cancer
5279724|NCT00507754|Solid Tumors|solid tumors
5279725|NCT00507754|Latent Mycobacterium Tuberculosis|latent mycobacterium tuberculosis
5279726|NCT00507754|Tuberculin Skin Test|tuberculin skin test
5279727|NCT00507754|Tuberculosis|tuberculosis
5279728|NCT00507754|T-SPOT TB test|t-spot tb test
5279729|NCT00507754|TB|tb
5279730|NCT00507741|Cancer|cancer
5279731|NCT00507741|Ovarian|ovarian
5279732|NCT00507741|Endometrial|endometrial
5279733|NCT00507741|Phase II|phase ii
5279734|NCT00507741|EC145|ec145
5279735|NCT00507741|EC20|ec20
5279736|NCT00507728|Pharmacogenetics|pharmacogenetics
5279737|NCT00507728|Emotional Reactivity|emotional reactivity
5279738|NCT00507728|Smoking Cessation Counseling|smoking cessation counseling
5279739|NCT00507728|Smoking|smoking
5279740|NCT00507728|Bupropion|bupropion
5279741|NCT00507728|Wellbutrin|wellbutrin
5279742|NCT00507728|Wellbutrin SR|wellbutrin sr
5279743|NCT00507728|Zyban|zyban
5279744|NCT00507728|Varenicline|varenicline
5279745|NCT00507728|Chantix|chantix
5279746|NCT00507728|Placebo|placebo
5279747|NCT00507715|Parkinson's Disease, Idiopathic|parkinson's disease, idiopathic
5279748|NCT00507715|l-dopa levels|l-dopa levels
5279749|NCT00507715|plantago ovata husk|plantago ovata husk
5279750|NCT00507689|Truvada|truvada
5279751|NCT00507689|HBIg|hbig
5279752|NCT00507689|Chronic Hepatitis B Recurrence|chronic hepatitis b recurrence
5279753|NCT00507689|Post Orthotopic Liver Transplant|post orthotopic liver transplant
5279754|NCT00507676|Asthma|asthma
5279755|NCT00507676|Wheezing|wheezing
5279756|NCT00507676|Infant|infant
5279757|NCT00507663|beta blocker|beta blocker
5279758|NCT00507663|functional recovery|functional recovery
5279759|NCT00507650|Pressure ulcers|pressure ulcers
5279760|NCT00507650|Geriatrics|geriatrics
5279761|NCT00507650|Nursing home|nursing home
5279762|NCT00507650|Fluid balance|fluid balance
5279763|NCT00507650|Collagen deposition|collagen deposition
5279764|NCT00507611|breast|breast
5279765|NCT00507611|sentinel lymph node|sentinel lymph node
5279766|NCT00507611|node mapping|node mapping
5279767|NCT00507598|colorectal cancer|colorectal cancer
5279768|NCT00507598|metabolomics|metabolomics
5279769|NCT00507585|Liver Cancer|liver cancer
5279770|NCT00507585|Liver metastases|liver metastases
5279771|NCT00507585|Metastatic advanced solid tumors|metastatic advanced solid tumors
5279772|NCT00507585|Advanced solid tumors metastatic to the liver|advanced solid tumors metastatic to the liver
5279773|NCT00507585|Hepatic Arterial Infusion|hepatic arterial infusion
5279774|NCT00507585|Intra-arterial hepatic oxaliplatin|intra-arterial hepatic oxaliplatin
5279775|NCT00507585|Fluorouracil|fluorouracil
5279776|NCT00507585|5-FU|5-fu
5279777|NCT00507585|Adrucil|adrucil
5279778|NCT00507585|Efudex|efudex
5279779|NCT00507585|5-fluorouracil|5-fluorouracil
5279780|NCT00507585|Avastin|avastin
5279781|NCT00507585|Leucovorin|leucovorin
5279782|NCT00507585|Oxaliplatin|oxaliplatin
5279783|NCT00507585|Bevacizumab|bevacizumab
5279784|NCT00507572|Solid Tumors|solid tumors
5279785|NCT00507572|Pregnancy|pregnancy
5279786|NCT00507572|Data Collection|data collection
5279787|NCT00507546|sleep|sleep
5279788|NCT00507546|melatonin|melatonin
5279789|NCT00507546|spinal cord injury|spinal cord injury
5279790|NCT00507546|insomnia|insomnia
5279791|NCT00507546|tetraplegia|tetraplegia
5279792|NCT00507533|CPAP|cpap
5279793|NCT00507533|Hematologic|hematologic
5279794|NCT00507533|Neutropenic|neutropenic
5279795|NCT00507533|ARF|arf
5279796|NCT00507520|RCT|rct
5279797|NCT00507520|Almonds|almonds
5279798|NCT00507520|Hyperlipidemia|hyperlipidemia
5279799|NCT00507520|Blood Lipids|blood lipids
5279800|NCT00507507|tenofovir|tenofovir
5279801|NCT00507507|monotherapy|monotherapy
5279802|NCT00507507|emtricitabine|emtricitabine
5279803|NCT00507507|combination|combination
5279804|NCT00507507|hepatitis B|hepatitis b
5279805|NCT00507494|posttransplant diabetes mellitus|posttransplant diabetes mellitus
5279806|NCT00507494|kidney transplantation|kidney transplantation
5279807|NCT00507494|filtration fraction|filtration fraction
5279808|NCT00507494|proteinuria|proteinuria
5279809|NCT00507481|Sleep|sleep
5279810|NCT00507481|ICU|icu
5279811|NCT00507481|Delirium|delirium
5279812|NCT00507481|Post surgical ventilated patients|post surgical ventilated patients
5279813|NCT00507481|ICU patients|icu patients
5279814|NCT00507468|bone marrow|bone marrow
5279815|NCT00507468|autologous|autologous
5279816|NCT00507468|ejection fraction|ejection fraction
5279817|NCT00507468|left ventricle|left ventricle
5279818|NCT00507468|heart attack|heart attack
5279819|NCT00507468|myocardial infarction|myocardial infarction
5279820|NCT00507468|left ventricular dysfunction post myocardial infarction|left ventricular dysfunction post myocardial infarction
5279821|NCT00507455|Lower Urinary Tract Symptoms|lower urinary tract symptoms
5279822|NCT00507455|Bladder Outlet Obstruction|bladder outlet obstruction
5279823|NCT00507455|Treatment|treatment
5279824|NCT00507455|Solifenacin Succinate|solifenacin succinate
5279825|NCT00507455|Tamsulosin hydrochloride|tamsulosin hydrochloride
5279826|NCT00507442|Treatment for patients with multiple myeloma|treatment for patients with multiple myeloma
5279827|NCT00507442|who have received no prior treatment|who have received no prior treatment
5279828|NCT00507429|thyroid neoplasms|thyroid neoplasms
5279829|NCT00507429|thyroid cancer|thyroid cancer
5279830|NCT00507429|thyroid carcinoma|thyroid carcinoma
5279831|NCT00507390|fish oils|fish oils
5279832|NCT00507377|Esophageal Benign Disease|esophageal benign disease
5279833|NCT00507377|Gastroesophageal Reflux Disease|gastroesophageal reflux disease
5279834|NCT00507377|Hiatal Hernia|hiatal hernia
5279835|NCT00507377|Antireflux Surgery|antireflux surgery
5279836|NCT00507377|Short Esophagus|short esophagus
5279837|NCT00507351|Breast Cancer|breast cancer
5279838|NCT00507351|Colorectal Cancer|colorectal cancer
5279839|NCT00507351|Lung Cancer|lung cancer
5279840|NCT00507351|Prostate Cancer|prostate cancer
5279841|NCT00507351|Pain Management|pain management
5279842|NCT00507351|Questionnaire|questionnaire
5279843|NCT00507351|Survey|survey
5279844|NCT00507338|percutaneous coronary intervention|percutaneous coronary intervention
5279845|NCT00507325|Malignant Melanoma|malignant melanoma
5279846|NCT00507325|Blood Sample|blood sample
5279847|NCT00507325|Tumor Sample|tumor sample
5279848|NCT00507325|Long-term storage|long-term storage
5279849|NCT00507325|Sample Collection|sample collection
5279850|NCT00507312|To assess two new diagnostic devices for detecting early Heart Failure.|to assess two new diagnostic devices for detecting early heart failure.
5279851|NCT00507299|Child maltreatment|child maltreatment
5279852|NCT00507299|Physician education|physician education
5279853|NCT00507299|Prevention|prevention
5279854|NCT00507273|Gastrointestinal Stromal Tumors|gastrointestinal stromal tumors
5279855|NCT00507273|Gastrointestinal Cancer|gastrointestinal cancer
5279856|NCT00507273|GISTs|gists
5279857|NCT00507273|GIST Registry|gist registry
5279858|NCT00507273|Registry|registry
5279859|NCT00507260|Leukemia|leukemia
5279860|NCT00507260|Lymphoma|lymphoma
5279861|NCT00507260|Post-Allogeneic Blood and Marrow Transplantation|post-allogeneic blood and marrow transplantation
5279862|NCT00507260|Blood and Marrow Transplantation|blood and marrow transplantation
5279863|NCT00507260|BMT|bmt
5279864|NCT00507260|Cancer-Related Fatigue|cancer-related fatigue
5279865|NCT00507260|Fatigue|fatigue
5279866|NCT00507260|Nutritional Assessment|nutritional assessment
5279867|NCT00507260|Nutritional Intervention|nutritional intervention
5279868|NCT00507260|Malnutrition|malnutrition
5279869|NCT00507247|Catheter-Related Infection|catheter-related infection
5279870|NCT00507247|Bloodstream Infections|bloodstream infections
5279871|NCT00507247|Staphylococcus Aureus|staphylococcus aureus
5279872|NCT00507247|Daptomycin|daptomycin
5279873|NCT00507234|COPD|copd
5279874|NCT00507221|HIV|hiv
5279875|NCT00507221|Helminthiasis|helminthiasis
5279876|NCT00507221|Co-infection|co-infection
5279877|NCT00507221|Treatment Naive|treatment naive
5279878|NCT00507208|trismus|trismus
5279879|NCT00507208|head and neck cancer|head and neck cancer
5279880|NCT00507195|Postanethesia cognitive recovery|postanethesia cognitive recovery
5279881|NCT00507195|Postoperative delirium|postoperative delirium
5279882|NCT00507195|hypnotics|hypnotics
5279883|NCT00507195|propofol|propofol
5279884|NCT00507195|sevoflurane|sevoflurane
5279885|NCT00507195|desflurane|desflurane
5279886|NCT00507195|postoperative cognitive recovery|postoperative cognitive recovery
5280190|NCT00506051|phase 1|phase 1
5279887|NCT00507182|Oral Mucosa Lesions|oral mucosa lesions
5279888|NCT00507182|Oral Cancer|oral cancer
5279889|NCT00507182|Neoplasia and Dysplasia in oral cavity mucosa|neoplasia and dysplasia in oral cavity mucosa
5279890|NCT00507182|Fluorescence Spectroscopy|fluorescence spectroscopy
5279891|NCT00507182|Reflectance Spectroscopy|reflectance spectroscopy
5279892|NCT00507182|Pre-cancerous lesions|pre-cancerous lesions
5279893|NCT00507182|Cancerous lesions|cancerous lesions
5279894|NCT00507182|Mouth|mouth
5279895|NCT00507143|Colorectal neoplasms|colorectal neoplasms
5279896|NCT00507143|Secondary|secondary
5279897|NCT00507143|irinotecan|irinotecan
5279898|NCT00507143|Pharmacokinetics|pharmacokinetics
5279899|NCT00507143|Pharmacodynamics|pharmacodynamics
5279900|NCT00507143|SLCO1B1|slco1b1
5279901|NCT00507143|PXR|pxr
5279902|NCT00507117|Obstructive Sleep Apnea|obstructive sleep apnea
5279903|NCT00507117|Polysomnography|polysomnography
5279904|NCT00507117|Non-benzodiazepine hypnotics|non-benzodiazepine hypnotics
5279905|NCT00507104|traumatic brain injury|traumatic brain injury
5279906|NCT00507104|Subarachnoid Hemorrhage|subarachnoid hemorrhage
5279907|NCT00507104|Hypopituitarism|hypopituitarism
5279908|NCT00507091|ZD6474|zd6474
5279909|NCT00507091|Irinotecan|irinotecan
5279910|NCT00507091|5-Fluorouracil|5-fluorouracil
5279911|NCT00507091|Leucovorin|leucovorin
5279912|NCT00507091|colorectal|colorectal
5279913|NCT00507078|Obstructive Sleep Apnea|obstructive sleep apnea
5279914|NCT00507078|Leptin|leptin
5279915|NCT00507078|Homocysteine|homocysteine
5279916|NCT00507078|C-reactive Protein|c-reactive protein
5279917|NCT00507052|Hemodialysis|hemodialysis
5279918|NCT00507052|Residual Renal Function|residual renal function
5279919|NCT00507039|PD20 FEV1|pd20 fev1
5279920|NCT00507039|grass pollen|grass pollen
5279921|NCT00507039|one-step|one-step
5279922|NCT00507013|vascular closure device|vascular closure device
5279923|NCT00506974|sleep|sleep
5279924|NCT00506974|normal sleepers|normal sleepers
5279925|NCT00506948|Hematological Malignancies|hematological malignancies
5279926|NCT00506948|Myelodysplastic Syndrome|myelodysplastic syndrome
5279927|NCT00506948|Graft Versus Host Disease|graft versus host disease
5279928|NCT00506948|GVHD|gvhd
5279929|NCT00506948|Allogeneic Hematopoietic Stem Cell Transplantation|allogeneic hematopoietic stem cell transplantation
5279930|NCT00506948|AHSCT|ahsct
5279931|NCT00506948|Leukemia|leukemia
5279932|NCT00506948|Lymphoma|lymphoma
5279933|NCT00506948|T-Cells|t-cells
5279934|NCT00506948|Thymoglobulin|thymoglobulin
5279935|NCT00506948|ATG|atg
5279936|NCT00506948|rATG|ratg
5279937|NCT00506948|Rabbit Antithymocyte Globulin|rabbit antithymocyte globulin
5279938|NCT00506948|Rapamune|rapamune
5279939|NCT00506948|Sirolimus|sirolimus
5279940|NCT00506948|Mycophenolate Mofetil|mycophenolate mofetil
5279941|NCT00506948|Cellcept|cellcept
5279942|NCT00506948|MMF|mmf
5279943|NCT00506935|methamphetamine|methamphetamine
5279944|NCT00506935|GVG|gvg
5279945|NCT00506935|vigabatrin|vigabatrin
5279946|NCT00506935|stimulant|stimulant
5279947|NCT00506922|Graft-Versus-Host Disease|graft-versus-host disease
5279948|NCT00506922|GVHD Prevention|gvhd prevention
5279949|NCT00506922|Hodgkin's Disease|hodgkin's disease
5279950|NCT00506922|Leukemia|leukemia
5279951|NCT00506922|Lymphoma|lymphoma
5279952|NCT00506922|Methotrexate|methotrexate
5279953|NCT00506922|Tacrolimus|tacrolimus
5279954|NCT00506922|Pentostatin|pentostatin
5279955|NCT00506909|oxytocin|oxytocin
5279956|NCT00506896|Rheumatoid Arthritis|rheumatoid arthritis
5279957|NCT00506896|glucocorticoid|glucocorticoid
5279958|NCT00506896|intraarticular injection|intraarticular injection
5279959|NCT00506896|arthritis|arthritis
5279960|NCT00506870|Heart Valve Prosthesis Implantation|heart valve prosthesis implantation
5279961|NCT00506870|INR self monitoring|inr self monitoring
5279962|NCT00506870|cost benefit evaluation|cost benefit evaluation
5279963|NCT00506857|Hematologic Malignancies|hematologic malignancies
5279964|NCT00506857|Blood And Marrow Transplantation|blood and marrow transplantation
5279965|NCT00506857|Leukemia|leukemia
5279966|NCT00506857|MDS|mds
5279967|NCT00506857|Lymphoma|lymphoma
5279968|NCT00506857|Myeloma|myeloma
5279969|NCT00506857|Fludarabine|fludarabine
5279970|NCT00506857|Fludara|fludara
5279971|NCT00506857|Fludarabine Phosphate|fludarabine phosphate
5279972|NCT00506857|Busulfan|busulfan
5279973|NCT00506857|Busulfex|busulfex
5279974|NCT00506857|Myleran|myleran
5279975|NCT00506857|Progenitor Cell Transplantation|progenitor cell transplantation
5279976|NCT00506857|Granulocyte colony stimulating factor|granulocyte colony stimulating factor
5279977|NCT00506857|G-CSF|g-csf
5279978|NCT00506857|Apheresis|apheresis
5279979|NCT00506857|Blood cell infusion|blood cell infusion
5279980|NCT00506844|Rectal neoplasms|rectal neoplasms
5279981|NCT00506844|Neoadjuvant treatment|neoadjuvant treatment
5279982|NCT00506844|Cetuximab|cetuximab
5279983|NCT00506844|Irinotecan|irinotecan
5279984|NCT00506844|Capecitabine|capecitabine
5279985|NCT00506844|Radiotherapy|radiotherapy
5279986|NCT00506844|Combination chemotherapy|combination chemotherapy
5279987|NCT00506818|emotional symptoms|emotional symptoms
5279988|NCT00506818|vascular risk-factors|vascular risk-factors
5280294|NCT00505635|Velban|velban
5279989|NCT00506805|solid tumor malignancy; Hsp90|solid tumor malignancy; hsp90
5279990|NCT00506792|Cystic fibrosis, QAU145, nasal potential difference|cystic fibrosis, qau145, nasal potential difference
5279991|NCT00506779|Uterine Papillary Serous Carcinoma|uterine papillary serous carcinoma
5279992|NCT00506779|Uterine Cancer|uterine cancer
5279993|NCT00506779|UPSC|upsc
5279994|NCT00506779|Taxol|taxol
5279995|NCT00506779|Paclitaxel|paclitaxel
5279996|NCT00506779|Gleevec|gleevec
5279997|NCT00506779|Imatinib Mesylate|imatinib mesylate
5279998|NCT00506779|STI571|sti571
5279999|NCT00506766|Urinary Incontinence|urinary incontinence
5280000|NCT00506766|Self efficacy|self efficacy
5280001|NCT00506766|Pelvic floor muscle training|pelvic floor muscle training
5280002|NCT00506766|Bladder training|bladder training
5280003|NCT00506753|substance abuse|substance abuse
5280004|NCT00506714|Osteoarthritis|osteoarthritis
5280005|NCT00506714|Walking Sticks|walking sticks
5280006|NCT00506714|Canes|canes
5280007|NCT00506675|Amblyopia|amblyopia
5280008|NCT00506675|Atropine|atropine
5280009|NCT00506675|Patching|patching
5280010|NCT00506649|protocol|protocol
5280011|NCT00506649|analgesia|analgesia
5280012|NCT00506649|sedation|sedation
5280013|NCT00506649|delirium|delirium
5280014|NCT00506649|coma|coma
5280015|NCT00506623|Rectal neoplasm|rectal neoplasm
5280016|NCT00506623|Neoadjuvant therapy|neoadjuvant therapy
5280017|NCT00506623|Radiotherapy|radiotherapy
5280018|NCT00506623|Combination chemotherapy|combination chemotherapy
5280019|NCT00506623|Irinotecan|irinotecan
5280020|NCT00506623|Capecitabine|capecitabine
5280021|NCT00506610|Pain|pain
5280022|NCT00506610|Postherpetic Neuralgia|postherpetic neuralgia
5280023|NCT00506610|Neuralgia, Postherpetic|neuralgia, postherpetic
5280024|NCT00506610|Shingles|shingles
5280025|NCT00506610|Herpes Zoster|herpes zoster
5280026|NCT00506610|Neuropathic Pain|neuropathic pain
5280027|NCT00506597|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
5280028|NCT00506597|Leukemia|leukemia
5280029|NCT00506597|Erwinia L-Asparaginase|erwinia l-asparaginase
5280030|NCT00506597|Erwinase|erwinase
5280031|NCT00506584|Human milk nutritional intervention|human milk nutritional intervention
5280032|NCT00506584|Pre-term, very low birth weight|pre-term, very low birth weight
5280033|NCT00506584|Fortification of human breast milk|fortification of human breast milk
5280034|NCT00506571|colorectal neoplasms|colorectal neoplasms
5280035|NCT00506571|secondary|secondary
5280036|NCT00506571|Combination chemotherapy|combination chemotherapy
5280037|NCT00506571|S-1|s-1
5280038|NCT00506571|irinotecan|irinotecan
5280039|NCT00506571|oxaliplatin|oxaliplatin
5280040|NCT00506558|cervical spondylotic myelopathy|cervical spondylotic myelopathy
5280041|NCT00506558|degenerative cervical spondylosis|degenerative cervical spondylosis
5280042|NCT00506558|spinal fusion|spinal fusion
5280043|NCT00506532|Pulmonary Surfactants|pulmonary surfactants
5280044|NCT00506532|Lung transplantation|lung transplantation
5280045|NCT00506532|Primary Graft Dysfunction|primary graft dysfunction
5280046|NCT00506519|DIC associated with severe sepsis|dic associated with severe sepsis
5280047|NCT00506506|N-acetylcysteine|n-acetylcysteine
5280048|NCT00506506|Chronic kidney disease|chronic kidney disease
5280049|NCT00506506|eGFR|egfr
5280050|NCT00506506|Cystatin C|cystatin c
5280051|NCT00506506|proteinuria|proteinuria
5280052|NCT00506506|Stage 3 chronic kidney disease|stage 3 chronic kidney disease
5280053|NCT00506493|Persistent Atrial Fibrillation Surgical RF Ablation|persistent atrial fibrillation surgical rf ablation
5280054|NCT00506493|Perisistent Atrial Fibrillation|perisistent atrial fibrillation
5280055|NCT00506493|Surgical Ablation|surgical ablation
5280056|NCT00506480|Embryo Implantation|embryo implantation
5280057|NCT00506480|Endometrium|endometrium
5280058|NCT00506480|endometrial implantation|endometrial implantation
5280059|NCT00506480|Oocyte Donation|oocyte donation
5280060|NCT00506480|in vitro fertilization|in vitro fertilization
5280061|NCT00506480|endometrial sampling|endometrial sampling
5280062|NCT00506467|Intrathoracic Malignancy|intrathoracic malignancy
5280063|NCT00506467|Lung Cancer|lung cancer
5280064|NCT00506467|Vibration Response Imaging|vibration response imaging
5280065|NCT00506467|VRI|vri
5280066|NCT00506454|Fatigue|fatigue
5280067|NCT00506454|Hemodialysis|hemodialysis
5280068|NCT00506454|Endotoxemia|endotoxemia
5280069|NCT00506454|Phospholipid|phospholipid
5280070|NCT00506454|Emulsion|emulsion
5280071|NCT00506441|Chronic Kidney Disease|chronic kidney disease
5280072|NCT00506441|Dialysis|dialysis
5280073|NCT00506441|Hyperphosphatemia|hyperphosphatemia
5280074|NCT00506441|Phosphate binder|phosphate binder
5280075|NCT00506428|aging|aging
5280076|NCT00506428|sleep|sleep
5280077|NCT00506428|sleep deprivation|sleep deprivation
5280078|NCT00506428|performance|performance
5280079|NCT00506428|memory|memory
5280080|NCT00506428|metabolism|metabolism
5280081|NCT00506415|Alzheimer's|alzheimer's
5280082|NCT00506415|Patch|patch
5280083|NCT00506415|Cognitive|cognitive
5280084|NCT00506415|Decline|decline
5280085|NCT00506402|Adult patients with refractory leukemias, MDS or AMM|adult patients with refractory leukemias, mds or amm
5280186|NCT00506051|Non-small cell lung cancer|non-small cell lung cancer
5280187|NCT00506051|lung cancer|lung cancer
5280188|NCT00506051|alimta|alimta
5280086|NCT00506389|Sleep Initiation and Maintenance Disorders, Sleep Disorders, Intrinsic Dyssomnias, Sleep Disorders, Nervous System Diseases, Mental Disorders|sleep initiation and maintenance disorders, sleep disorders, intrinsic dyssomnias, sleep disorders, nervous system diseases, mental disorders
5280087|NCT00506376|Cervical Cancer|cervical cancer
5280088|NCT00506376|Hysterectomy|hysterectomy
5280089|NCT00506376|Interview|interview
5280090|NCT00506363|scar|scar
5280091|NCT00506363|surgery|surgery
5280092|NCT00506363|lasers|lasers
5280093|NCT00506324|Intensity Modulated Radiotherapy|intensity modulated radiotherapy
5280094|NCT00506324|Chemotherapy|chemotherapy
5280095|NCT00506324|Head and Neck Neoplasms|head and neck neoplasms
5280096|NCT00506324|Dysphagia|dysphagia
5280097|NCT00506311|Superficial Groin Dissection|superficial groin dissection
5280098|NCT00506311|Melanoma|melanoma
5280099|NCT00506311|Fibrin Tissue Adhesive|fibrin tissue adhesive
5280100|NCT00506311|Fibrin Sealant|fibrin sealant
5280101|NCT00506311|Tisseel|tisseel
5280102|NCT00506311|Seroma|seroma
5280103|NCT00506298|Diabetes|diabetes
5280104|NCT00506298|CRx-401|crx-401
5280105|NCT00506298|Bezafibrate|bezafibrate
5280106|NCT00506298|Diflunisal|diflunisal
5280107|NCT00506298|Metformin|metformin
5280108|NCT00506298|plasma glucose|plasma glucose
5280109|NCT00506285|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
5280110|NCT00506285|ADHD|adhd
5280111|NCT00506285|Adult|adult
5280112|NCT00506285|Methylphenidate Transdermal System|methylphenidate transdermal system
5280113|NCT00506285|Daytrana|daytrana
5280114|NCT00506272|diabetes mellitus|diabetes mellitus
5280115|NCT00506272|hyperglycemia|hyperglycemia
5280116|NCT00506272|hypoglycemia|hypoglycemia
5280117|NCT00506272|self care|self care
5280118|NCT00506259|Deletion 17p11.2|deletion 17p11.2
5280119|NCT00506259|Melatonin|melatonin
5280120|NCT00506259|Phototherapy|phototherapy
5280121|NCT00506259|Behavioral Phenotype|behavioral phenotype
5280122|NCT00506259|Developmental Delay/MR|developmental delay/mr
5280123|NCT00506259|Smith-Magenis Syndrome|smith-magenis syndrome
5280124|NCT00506259|Sleep Disturbance|sleep disturbance
5280125|NCT00506259|SMS|sms
5280126|NCT00506259|Sleep Disorder|sleep disorder
5280127|NCT00506246|anaesthesia|anaesthesia
5280128|NCT00506233|Graft-Versus-Host Disease|graft-versus-host disease
5280129|NCT00506233|GVHD|gvhd
5280130|NCT00506233|Questionnaire|questionnaire
5280131|NCT00506207|Gastrointestinal neoplasms|gastrointestinal neoplasms
5280132|NCT00506207|Combination chemotherapy|combination chemotherapy
5280133|NCT00506207|S-1|s-1
5280134|NCT00506207|Irinotecan|irinotecan
5280135|NCT00506207|Oxaliplatin|oxaliplatin
5280136|NCT00506194|type 2 diabetes|type 2 diabetes
5280137|NCT00506194|oral glucose tolerance test|oral glucose tolerance test
5280138|NCT00506194|insulin|insulin
5280139|NCT00506194|oral anti-diabetic drug|oral anti-diabetic drug
5280140|NCT00506194|ß-cell function|ß-cell function
5280141|NCT00506168|Colorectal neoplasms|colorectal neoplasms
5280142|NCT00506168|Secondary|secondary
5280143|NCT00506168|Drug therapy, combination|drug therapy, combination
5280144|NCT00506168|Irinotecan|irinotecan
5280145|NCT00506168|Capecitabine|capecitabine
5280146|NCT00506155|Bladder Cancer|bladder cancer
5280147|NCT00506155|Urothelial Cancer|urothelial cancer
5280148|NCT00506155|Avastin|avastin
5280149|NCT00506155|Bevacizumab|bevacizumab
5280150|NCT00506155|Cisplatin|cisplatin
5280151|NCT00506155|Doxorubicin|doxorubicin
5280152|NCT00506155|Methotrexate|methotrexate
5280153|NCT00506155|Vinblastine|vinblastine
5280154|NCT00506155|M-VAC|m-vac
5280155|NCT00506129|Cutaneous T-Cell Lymphoma|cutaneous t-cell lymphoma
5280156|NCT00506129|CTCL|ctcl
5280157|NCT00506129|Allogeneic Transplantation|allogeneic transplantation
5280158|NCT00506129|Lymphoma|lymphoma
5280159|NCT00506129|Allogeneic peripheral blood progenitor cell|allogeneic peripheral blood progenitor cell
5280160|NCT00506129|PBPC|pbpc
5280161|NCT00506129|Bone Marrow transplantation|bone marrow transplantation
5280162|NCT00506129|Stem Cell Transplant|stem cell transplant
5280163|NCT00506129|SCT|sct
5280164|NCT00506129|Fludarabine|fludarabine
5280165|NCT00506129|Fludarabine Phosphate|fludarabine phosphate
5280166|NCT00506129|Fludara|fludara
5280167|NCT00506129|Melphalan|melphalan
5280168|NCT00506116|Pelvic floor muscle training|pelvic floor muscle training
5280169|NCT00506116|Self-directed pushing|self-directed pushing
5280170|NCT00506116|Antenatal perineal massage|antenatal perineal massage
5280171|NCT00506103|Thyroidectomy|thyroidectomy
5280172|NCT00506103|Central neck dissection|central neck dissection
5280173|NCT00506103|Harmonic scalpel|harmonic scalpel
5280174|NCT00506103|Perioperative complications|perioperative complications
5280175|NCT00506090|scar|scar
5280176|NCT00506090|surgery|surgery
5280177|NCT00506090|lasers|lasers
5280178|NCT00506077|Undifferentiated schizophrenia|undifferentiated schizophrenia
5280179|NCT00506077|residual schizophrenia|residual schizophrenia
5280180|NCT00506064|Breast Cancer|breast cancer
5280181|NCT00506064|Sleep|sleep
5280182|NCT00506064|Melatonin|melatonin
5280183|NCT00506064|Placebo|placebo
5280184|NCT00506064|Survey|survey
5280185|NCT00506064|Postoperative Srejic Sleep SAT Survey|postoperative srejic sleep sat survey
5280189|NCT00506051|vandetanib|vandetanib
5280191|NCT00506038|Calcific Tendinitis|calcific tendinitis
5280192|NCT00506025|Pregnancy|pregnancy
5280193|NCT00506025|Cranberry|cranberry
5280194|NCT00506025|Asymptomatic Bacteruria|asymptomatic bacteruria
5280195|NCT00506012|Myoclonus Dystonia|myoclonus dystonia
5280196|NCT00506012|Essential Myoclonus|essential myoclonus
5280197|NCT00506012|Inherited Myoclonus|inherited myoclonus
5280198|NCT00506012|Dyskinesia|dyskinesia
5280199|NCT00506012|Movement Disorder|movement disorder
5280200|NCT00505999|Multiple Myeloma|multiple myeloma
5280201|NCT00505999|Etiology|etiology
5280202|NCT00505999|Risk Factors|risk factors
5280203|NCT00505999|Healthy Controls|healthy controls
5280204|NCT00505999|Questionnaire|questionnaire
5280205|NCT00505999|Survey|survey
5280206|NCT00505947|macular edema|macular edema
5280207|NCT00505947|diabetes mellitus|diabetes mellitus
5280208|NCT00505947|visual loss|visual loss
5280209|NCT00505947|diabetic retinopathy|diabetic retinopathy
5280210|NCT00505947|macula|macula
5280211|NCT00505947|maculopathy|maculopathy
5280212|NCT00505947|infliximab|infliximab
5280213|NCT00505934|Epilepsy|epilepsy
5280214|NCT00505934|Child|child
5280215|NCT00505934|Levetiracetam|levetiracetam
5280216|NCT00505934|Keppra®|keppra®
5280217|NCT00505934|Infusion|infusion
5280218|NCT00505934|Intravenous|intravenous
5280219|NCT00505921|T-Cell Lymphoma|t-cell lymphoma
5280220|NCT00505921|Lymphoma|lymphoma
5280221|NCT00505921|Campath-1H|campath-1h
5280222|NCT00505921|Allogenic Transplantation|allogenic transplantation
5280223|NCT00505921|Stem Cell Transplant|stem cell transplant
5280224|NCT00505921|Alemtuzumab|alemtuzumab
5280225|NCT00505895|Multiple Myeloma|multiple myeloma
5280226|NCT00505895|Fludarabine|fludarabine
5280227|NCT00505895|Fludara|fludara
5280228|NCT00505895|Fludarabine Phosphate|fludarabine phosphate
5280229|NCT00505895|Melphalan|melphalan
5280230|NCT00505895|Alkeran|alkeran
5280231|NCT00505895|Stem Cell Infusion|stem cell infusion
5280232|NCT00505895|Stem Cell Transfusion|stem cell transfusion
5280233|NCT00505895|SCT|sct
5280234|NCT00505895|Allogeneic Peripheral Blood Stem Cell Transfusion|allogeneic peripheral blood stem cell transfusion
5280235|NCT00505895|APBSCT|apbsct
5280236|NCT00505895|Bone Marrow Transplantation|bone marrow transplantation
5280237|NCT00505895|BMT|bmt
5280238|NCT00505895|Rituxan|rituxan
5280239|NCT00505895|Rituximab|rituximab
5280240|NCT00505895|FM140|fm140
5280241|NCT00505895|FM100|fm100
5280242|NCT00505882|Type 1 diabetes|type 1 diabetes
5280243|NCT00505882|Pramlintide|pramlintide
5280244|NCT00505882|Weight gain|weight gain
5280245|NCT00505882|Intensive insulin therapy|intensive insulin therapy
5280246|NCT00505882|Beta cell|beta cell
5280247|NCT00505869|Pregnant Smokers|pregnant smokers
5280248|NCT00505869|Mood Management Intervention|mood management intervention
5280249|NCT00505869|Health & Wellness Intervention|health & wellness intervention
5280250|NCT00505869|Smoking Cessation|smoking cessation
5280251|NCT00505869|Questionnaire|questionnaire
5280252|NCT00505869|Survey|survey
5280253|NCT00505830|Asperger Syndrom|asperger syndrom
5280254|NCT00505830|Autism Quotient|autism quotient
5280255|NCT00505830|French version|french version
5280256|NCT00505830|screening|screening
5280257|NCT00505830|diagnostic test|diagnostic test
5280258|NCT00505830|accuracy|accuracy
5280259|NCT00505804|dexmedetomidine|dexmedetomidine
5280260|NCT00505804|haloperidol|haloperidol
5280261|NCT00505791|Acute decompensated heart failure|acute decompensated heart failure
5280262|NCT00505791|Normal left ventricular ejection fraction|normal left ventricular ejection fraction
5280263|NCT00505791|Vasodilator therapy|vasodilator therapy
5280264|NCT00505765|Cognition|cognition
5280265|NCT00505765|Schizophrenia|schizophrenia
5280266|NCT00505752|Assisted reproductive technology, follicle stimulating hormone|assisted reproductive technology, follicle stimulating hormone
5280267|NCT00505739|Endometrial Cancer|endometrial cancer
5280268|NCT00505739|Low Grade Endometrial Stromal Sarcoma|low grade endometrial stromal sarcoma
5280269|NCT00505739|RU-486|ru-486
5280270|NCT00505739|Mifepristone|mifepristone
5280271|NCT00505739|LGESS|lgess
5280272|NCT00505726|Cervical Intraepithelial Neoplasia|cervical intraepithelial neoplasia
5280273|NCT00505726|Cervical Cancer|cervical cancer
5280274|NCT00505726|Reflectance Confocal Imaging|reflectance confocal imaging
5280275|NCT00505726|Colposcopy|colposcopy
5280276|NCT00505713|Sarcoma|sarcoma
5280277|NCT00505713|Rexin-G|rexin-g
5280278|NCT00505713|Gene Therapy|gene therapy
5280279|NCT00505700|acute myeloid leukemia|acute myeloid leukemia
5280280|NCT00505687|Rotigotine|rotigotine
5280281|NCT00505687|Neupro®|neupro®
5280282|NCT00505661|Ovarian Cancer|ovarian cancer
5280283|NCT00505661|Fallopian Tube Cancer|fallopian tube cancer
5280284|NCT00505661|Peritoneal Cancer|peritoneal cancer
5280285|NCT00505661|Letrozole|letrozole
5280286|NCT00505661|Femara|femara
5280287|NCT00505648|Hypersensitivity|hypersensitivity
5280288|NCT00505648|Syndrome|syndrome
5280289|NCT00505648|Tegeline|tegeline
5280290|NCT00505635|advanced stage IV melanoma|advanced stage iv melanoma
5280291|NCT00505635|unresectable stage III melanoma|unresectable stage iii melanoma
5280292|NCT00505635|Melanoma|melanoma
5280293|NCT00505635|Temozolomide|temozolomide
5280295|NCT00505635|Vinblastine|vinblastine
5280296|NCT00505635|Cisplatin|cisplatin
5280297|NCT00505635|Interleukin-2|interleukin-2
5280298|NCT00505635|Intron-A|intron-a
5280299|NCT00505635|Interferon Alpha-2b|interferon alpha-2b
5280300|NCT00505635|Thalidomide|thalidomide
5280301|NCT00505635|Thalomid|thalomid
5280302|NCT00505635|Temodar|temodar
5280303|NCT00505635|Proleukin|proleukin
5280304|NCT00505609|fertility awareness-based method|fertility awareness-based method
5280305|NCT00505609|family planning|family planning
5280306|NCT00505609|Standard Days Method|standard days method
5280307|NCT00505609|Institute for Reproductive Health|institute for reproductive health
5280308|NCT00505609|Efficacy|efficacy
5280309|NCT00505609|CycleBeads|cyclebeads
5280310|NCT00505596|Prenatal testing|prenatal testing
5280311|NCT00505596|Decisionmaking|decisionmaking
5280312|NCT00505596|Decision aid|decision aid
5280313|NCT00505596|Informed choice|informed choice
5280314|NCT00505570|Migraine|migraine
5280315|NCT00505570|Migraine with aura|migraine with aura
5280316|NCT00505570|Patent foramen ovale|patent foramen ovale
5280317|NCT00505570|PFO|pfo
5280318|NCT00505557|augmentation mammoplasty|augmentation mammoplasty
5280319|NCT00505557|Dual plane|dual plane
5280320|NCT00505557|Endoscope|endoscope
5280321|NCT00505557|Transaxillary incision|transaxillary incision
5280322|NCT00505544|Advanced Cancer|advanced cancer
5280323|NCT00505544|Questionnaire|questionnaire
5280324|NCT00505544|Survey|survey
5280325|NCT00505544|Sleep Disturbance|sleep disturbance
5280326|NCT00505544|Sleep Quality|sleep quality
5280327|NCT00505531|Pain|pain
5280328|NCT00505518|Major Depressive Disorder|major depressive disorder
5280329|NCT00505518|Telepsychiatry|telepsychiatry
5280330|NCT00505518|Chinese American|chinese american
5280331|NCT00505518|Nursing Home|nursing home
5280332|NCT00505505|Neurointensive care|neurointensive care
5280333|NCT00505505|Intensive insulin infusion|intensive insulin infusion
5280334|NCT00505505|Hypoglycemia|hypoglycemia
5280335|NCT00505505|Postoperative Mortality|postoperative mortality
5280336|NCT00505505|Postoperative Morbidity|postoperative morbidity
5280337|NCT00505505|Neurologic outcome|neurologic outcome
5280338|NCT00505492|Malignant Mixed Mesodermal Tumor|malignant mixed mesodermal tumor
5280339|NCT00505492|MMMT|mmmt
5280340|NCT00505492|Uterine Neoplasms|uterine neoplasms
5280341|NCT00505492|Radiation Therapy|radiation therapy
5280342|NCT00505492|Paclitaxel|paclitaxel
5280343|NCT00505492|Carboplatin|carboplatin
5280344|NCT00505492|Cisplatin|cisplatin
5280345|NCT00505492|Taxol|taxol
5280346|NCT00505479|Congenital Hypothyroidism|congenital hypothyroidism
5280347|NCT00505479|pregnancy|pregnancy
5280348|NCT00505479|iodine|iodine
5280349|NCT00505479|deficiency|deficiency
5280350|NCT00505466|Human Genetics|human genetics
5280351|NCT00505466|Genetic Counseling|genetic counseling
5280352|NCT00505466|Genetic Testing|genetic testing
5280353|NCT00505466|p53 Mutation|p53 mutation
5280354|NCT00505466|Genetics|genetics
5280355|NCT00505453|Influenza|influenza
5280356|NCT00505427|PCOS|pcos
5280357|NCT00505427|polycystic ovary syndrome|polycystic ovary syndrome
5280358|NCT00505427|polycystic ovarian syndrome|polycystic ovarian syndrome
5280359|NCT00505427|alpha lipoic acid|alpha lipoic acid
5280360|NCT00505427|insulin resistance|insulin resistance
5280361|NCT00505427|oxidative stress|oxidative stress
5280362|NCT00505414|Chronic Tumor Related Pain|chronic tumor related pain
5280363|NCT00505414|Analgesic|analgesic
5280364|NCT00505414|Tapentadol Extended Release|tapentadol extended release
5280365|NCT00505414|Morphine Sulfate Controlled Release|morphine sulfate controlled release
5280366|NCT00505414|Pain assessment|pain assessment
5280367|NCT00505414|Placebo|placebo
5280368|NCT00505401|HIV|hiv
5280369|NCT00505401|Tat protein|tat protein
5280370|NCT00505401|HIV Therapeutic Vaccine|hiv therapeutic vaccine
5280371|NCT00505388|asthma|asthma
5280372|NCT00505388|bronchial|bronchial
5280373|NCT00505388|Symbicort|symbicort
5280374|NCT00505375|CTLA4-Ig|ctla4-ig
5280375|NCT00505375|Abatacept|abatacept
5280376|NCT00505375|Beta-cell function|beta-cell function
5280377|NCT00505375|T-cells|t-cells
5280378|NCT00505375|DPT-1|dpt-1
5280379|NCT00505375|treatment|treatment
5280380|NCT00505375|treatment of type 1 diabetes|treatment of type 1 diabetes
5280381|NCT00505375|new onset type 1 diabetes|new onset type 1 diabetes
5280382|NCT00505375|juvenile diabetes|juvenile diabetes
5280383|NCT00505375|T1D|t1d
5280384|NCT00505375|diabetes mellitus|diabetes mellitus
5280385|NCT00505375|Type 1 diabetes TrialNet|type 1 diabetes trialnet
5280386|NCT00505375|TrialNet|trialnet
5280387|NCT00505349|neurotrophic factors|neurotrophic factors
5280388|NCT00505349|cognitive status|cognitive status
5280389|NCT00505349|young adults|young adults
5280390|NCT00505349|mature adults|mature adults
5280391|NCT00505349|cognitive training|cognitive training
5280392|NCT00505336|Diastolic heart failure|diastolic heart failure
5280393|NCT00505336|Markers of collagen turnover|markers of collagen turnover
5280394|NCT00505336|Statins|statins
5280395|NCT00505336|Aldosterone receptor blockers|aldosterone receptor blockers
5280396|NCT00505323|Cortex stimulation|cortex stimulation
5280397|NCT00505323|Focal secondary Dystonia|focal secondary dystonia
5280398|NCT00505323|Effectiveness|effectiveness
5280399|NCT00505323|Quality of life improvement|quality of life improvement
5280400|NCT00505323|Focal dystonias secondary to central grey nuclei lesions|focal dystonias secondary to central grey nuclei lesions
5280401|NCT00505310|Kidney Cancer|kidney cancer
5280402|NCT00505310|Renal Cell Carcinoma|renal cell carcinoma
5280403|NCT00505310|Emotional Expression|emotional expression
5280404|NCT00505310|Writing|writing
5280405|NCT00505310|Questionnaire|questionnaire
5280406|NCT00505310|Survey|survey
5280407|NCT00505297|Osteoarthritis (OA)|osteoarthritis (oa)
5280408|NCT00505297|Magnetic Resonance Imaging (MRI)|magnetic resonance imaging (mri)
5280409|NCT00505297|delayed Gadolinium Enhanced MRI of cartilage (dGEMRIC)|delayed gadolinium enhanced mri of cartilage (dgemric)
5280410|NCT00505297|disease modifying osteoarthritis drug (DMOAD)|disease modifying osteoarthritis drug (dmoad)
5280411|NCT00505297|Potentially rapidly progressing osteoarthritis|potentially rapidly progressing osteoarthritis
5280412|NCT00505297|MRI measurement of cartilage|mri measurement of cartilage
5280413|NCT00505284|Diabetic neuropathy|diabetic neuropathy
5280414|NCT00505271|Breast Cancer|breast cancer
5280415|NCT00505271|Rexin-G|rexin-g
5280416|NCT00505271|Gene Therapy|gene therapy
5280417|NCT00505258|Bacteremia|bacteremia
5280418|NCT00505258|Bloodstream infection|bloodstream infection
5280419|NCT00505258|Staphylococcus aureus|staphylococcus aureus
5280420|NCT00505258|Staphylococcal Infections|staphylococcal infections
5280421|NCT00505258|MRSA|mrsa
5280422|NCT00505258|MSSA|mssa
5280423|NCT00505245|Advanced Cancer|advanced cancer
5280424|NCT00505245|Symptom Distress|symptom distress
5280425|NCT00505245|MDASI|mdasi
5280426|NCT00505245|M.D. Anderson Symptom Inventory|m.d. anderson symptom inventory
5280427|NCT00505245|Quality of Life|quality of life
5280428|NCT00505245|Questionnaire|questionnaire
5280429|NCT00505245|Interactive voice response telephone system|interactive voice response telephone system
5280431|NCT00505232|Y-90 Ibritumomab tiuxetan|y-90 ibritumomab tiuxetan
5280432|NCT00505232|Rituximab|rituximab
5280433|NCT00505232|Hyper-CVAD|hyper-cvad
5280434|NCT00505232|Mantle Cell Lymphoma Patients|mantle cell lymphoma patients
5280435|NCT00505232|Zevalin(R)|zevalin(r)
5280436|NCT00505219|Osteonecrosis|osteonecrosis
5280437|NCT00505180|Hemodialysis|hemodialysis
5280438|NCT00505180|Mortality|mortality
5280439|NCT00505167|Alzheimer's disease|alzheimer's disease
5280440|NCT00505167|Memantine|memantine
5280441|NCT00505167|Donepezil|donepezil
5280442|NCT00505167|Magnetic resonance Spectroscopy|magnetic resonance spectroscopy
5280443|NCT00505167|randomized trial|randomized trial
5280444|NCT00505154|Heart failure|heart failure
5280445|NCT00505154|inflammation|inflammation
5280446|NCT00505154|cytokines|cytokines
5280447|NCT00505141|Childhood Brain Cancer|childhood brain cancer
5280448|NCT00505141|Childhood Acute Lymphoblastic Leukemia|childhood acute lymphoblastic leukemia
5280449|NCT00505128|Biliary pancreatitis|biliary pancreatitis
5280450|NCT00505128|Bile duct stones|bile duct stones
5280451|NCT00505128|EUS Endoscopic UltraSonography|eus endoscopic ultrasonography
5280452|NCT00505128|Endoscopic sphincterotomy|endoscopic sphincterotomy
5280453|NCT00505128|ERCP|ercp
5280454|NCT00505102|Kidney Diseases|kidney diseases
5280455|NCT00505102|Heart Transplantation|heart transplantation
5280456|NCT00505102|Everolimus|everolimus
5280457|NCT00505102|Cyclosporine Toxicity|cyclosporine toxicity
5280458|NCT00505089|pharmacokinetic, pharmacodynamic, subcutaneous, intravenous, ACZ885, patients, rheumatoid, arthritis.|pharmacokinetic, pharmacodynamic, subcutaneous, intravenous, acz885, patients, rheumatoid, arthritis.
5280459|NCT00505076|Cognition|cognition
5280460|NCT00505076|Schizophrenia|schizophrenia
5280461|NCT00505063|vaccine|vaccine
5280462|NCT00505063|childhood|childhood
5280463|NCT00505063|cancer|cancer
5280464|NCT00505050|heart failure, disease program management, treatment, education|heart failure, disease program management, treatment, education
5280465|NCT00505037|ASP1585|asp1585
5280466|NCT00505037|Renal Dialysis|renal dialysis
5280467|NCT00505037|Chronic Kidney Disease|chronic kidney disease
5280468|NCT00505037|Hyperphosphatemia|hyperphosphatemia
5280469|NCT00505024|Non-Small Cell Lung Cancer|non-small cell lung cancer
5280470|NCT00505024|Esophageal Cancer|esophageal cancer
5280471|NCT00505024|Lung Cancer|lung cancer
5280472|NCT00505024|Interactive Voice Response System|interactive voice response system
5280473|NCT00505024|IVRS|ivrs
5280474|NCT00505011|susceptibility|susceptibility
5280475|NCT00505011|genes|genes
5280476|NCT00505011|environment|environment
5280477|NCT00505011|ophthalmopathy|ophthalmopathy
5280478|NCT00505011|outcome|outcome
5280479|NCT00504998|Pancreatic cancer|pancreatic cancer
5280480|NCT00504998|Rexin-G|rexin-g
5280481|NCT00504998|Treatment|treatment
5280482|NCT00504985|Advanced Cancer|advanced cancer
5280483|NCT00504985|Hematologic Malignancy|hematologic malignancy
5280484|NCT00504985|Fatigue|fatigue
5280485|NCT00504985|Emergency Center|emergency center
5280486|NCT00504985|Survey|survey
5280487|NCT00504959|Age-related macular degeneration (AMD),|age-related macular degeneration (amd),
5280488|NCT00504959|choroidal neovascularization (CNV),|choroidal neovascularization (cnv),
5280489|NCT00504959|vascular endothelial growth factor (VEGF)|vascular endothelial growth factor (vegf)
5280490|NCT00504946|allergen immunotherapy premedication|allergen immunotherapy premedication
5280491|NCT00504933|Rhinitis|rhinitis
5280492|NCT00504933|Allergic|allergic
5280493|NCT00504933|Seasonal|seasonal
5280494|NCT00504933|Hay Fever|hay fever
5280495|NCT00504933|Pollen Allergy|pollen allergy
5280496|NCT00504933|Pollinosis|pollinosis
5280497|NCT00504933|Rhinoconjunctivitis|rhinoconjunctivitis
5280498|NCT00504920|Leukemia|leukemia
5280499|NCT00504920|Myelodysplastic Syndrome|myelodysplastic syndrome
5280500|NCT00504920|Acute Myeloblastic Leukemia|acute myeloblastic leukemia
5280501|NCT00504920|Symptom-Related Cytokines|symptom-related cytokines
5280502|NCT00504920|Blood or Marrow Transplantation|blood or marrow transplantation
5280503|NCT00504920|Questionnaire|questionnaire
5280504|NCT00504907|RSV|rsv
5280505|NCT00504894|N/A healthy volunteers|n/a healthy volunteers
5280506|NCT00504881|Epilepsy|epilepsy
5280507|NCT00504881|Brivaracetam|brivaracetam
5280508|NCT00504881|Partial Onset Seizures|partial onset seizures
5280509|NCT00504855|Pressure ulcer|pressure ulcer
5280510|NCT00504855|Waterproof|waterproof
5280511|NCT00504855|Gortex|gortex
5280512|NCT00504855|Cast padding|cast padding
5280513|NCT00504855|Pediatric|pediatric
5280514|NCT00504855|Heel|heel
5280515|NCT00504842|Acute Ischemic Stroke|acute ischemic stroke
5280516|NCT00504842|Microbubbles|microbubbles
5280517|NCT00504842|Transcranial Doppler ultrasound|transcranial doppler ultrasound
5280518|NCT00504842|TIBI|tibi
5280519|NCT00504842|Symptomatic Intracranial Hemorrhage|symptomatic intracranial hemorrhage
5280520|NCT00504842|modified Rankin Scale|modified rankin scale
5280521|NCT00504842|Recanalization|recanalization
5280522|NCT00504842|Perflutren|perflutren
5280523|NCT00504829|LCP-AtorFen|lcp-atorfen
5280524|NCT00504829|Non-HDL cholesterol|non-hdl cholesterol
5280525|NCT00504829|Triglycerides|triglycerides
5280526|NCT00504829|HDL cholesterol|hdl cholesterol
5280527|NCT00504829|LDL cholesterol|ldl cholesterol
5280528|NCT00504829|Atorvastatin|atorvastatin
5280529|NCT00504829|Fenofibrate|fenofibrate
5280530|NCT00504816|healthy female,|healthy female,
5280531|NCT00504816|pharmacokinetics,|pharmacokinetics,
5280532|NCT00504816|pharmacodynamics|pharmacodynamics
5280533|NCT00504816|drug interaction,|drug interaction,
5280534|NCT00504803|HCT, nonmyeloablative, mesenchymal stem cells, GVHD|hct, nonmyeloablative, mesenchymal stem cells, gvhd
5280535|NCT00504790|GSK923295,|gsk923295,
5280536|NCT00504790|First Time in Human,|first time in human,
5280537|NCT00504790|pharmacodynamics|pharmacodynamics
5280538|NCT00504790|cancer,|cancer,
5280539|NCT00504790|maximally tolerated dose, pharmacokinetics,|maximally tolerated dose, pharmacokinetics,
5280540|NCT00504790|Refractory Cancer|refractory cancer
5280541|NCT00504790|CENPE,|cenpe,
5280542|NCT00504790|Phase I,|phase i,
5280543|NCT00504764|Relapsed Acute Promyelocytic Leukemia|relapsed acute promyelocytic leukemia
5280544|NCT00504764|Arsenic Trioxide|arsenic trioxide
5280545|NCT00504751|diffuse large b cell|diffuse large b cell
5280546|NCT00504738|lung disease|lung disease
5280547|NCT00504738|chronic obstructive pulmonary disease (COPD)|chronic obstructive pulmonary disease (copd)
5280548|NCT00504738|asthma|asthma
5280549|NCT00504738|smokers|smokers
5280550|NCT00504738|non-smokers|non-smokers
5280551|NCT00504725|Lobectomy|lobectomy
5280552|NCT00504725|VATS|vats
5280553|NCT00504712|Testosterone|testosterone
5280554|NCT00504712|Hypogonadism|hypogonadism
5280555|NCT00504712|Diabetes|diabetes
5280556|NCT00504712|PVD|pvd
5280557|NCT00504712|RCT|rct
5280558|NCT00504699|breast cancer|breast cancer
5280559|NCT00504699|ovarian stimulation|ovarian stimulation
5280560|NCT00504699|aromatase inhibitors|aromatase inhibitors
5280561|NCT00504699|letrozole|letrozole
5280562|NCT00504699|fertility preservation|fertility preservation
5280563|NCT00504699|recurrence|recurrence
5280564|NCT00504660|Anaplastic Glioma|anaplastic glioma
5280565|NCT00504660|Glioblastoma Multiforme|glioblastoma multiforme
5280566|NCT00504660|Brain Cancer|brain cancer
5280567|NCT00504660|6-Thioguanine|6-thioguanine
5280568|NCT00504660|Capecitabine|capecitabine
5280569|NCT00504660|Celecoxib|celecoxib
5280570|NCT00504660|Temozolomide|temozolomide
5280571|NCT00504660|Xeloda|xeloda
5280572|NCT00504660|Temodar|temodar
5280573|NCT00504660|TMZ|tmz
5280574|NCT00504660|CCNU|ccnu
5280575|NCT00504660|6-TG|6-tg
5280576|NCT00504647|Hypertrophic|hypertrophic
5280577|NCT00504647|Cardiomyopathy|cardiomyopathy
5280578|NCT00504647|Diastolic|diastolic
5280579|NCT00504647|Ventricular|ventricular
5280580|NCT00504647|Interaction|interaction
5280581|NCT00504647|Biventricular|biventricular
5280582|NCT00504647|Pacemaker|pacemaker
5280583|NCT00504634|Multiple Myeloma|multiple myeloma
5280584|NCT00504634|Post Allogeneic Transplantation|post allogeneic transplantation
5280585|NCT00504634|Bortezomib|bortezomib
5280586|NCT00504634|Velcade|velcade
5280587|NCT00504634|PS-341|ps-341
5280588|NCT00504621|personality|personality
5280589|NCT00504621|fatigue|fatigue
5280590|NCT00504621|quality of life|quality of life
5280591|NCT00504621|health care consumption|health care consumption
5280592|NCT00504595|Rheumatoid Arthritis|rheumatoid arthritis
5280593|NCT00504582|Axillary Node Dissection|axillary node dissection
5280594|NCT00504582|Fibrin Sealant|fibrin sealant
5280595|NCT00504582|Tisseel|tisseel
5280596|NCT00504582|Melanoma|melanoma
5280597|NCT00504582|Seroma|seroma
5280598|NCT00504556|Anti-coagulant|anti-coagulant
5280599|NCT00504556|Non-valvular|non-valvular
5280600|NCT00504556|Venous Thromboembolism|venous thromboembolism
5280601|NCT00504556|Prevention of Blood Clots|prevention of blood clots
5280602|NCT00504556|Atrial Fibrillation|atrial fibrillation
5280603|NCT00504556|Non-valvular atrial fibrillation|non-valvular atrial fibrillation
5280604|NCT00504543|Kidney transplant, AEB071|kidney transplant, aeb071
5280605|NCT00504517|Outpatient continuity training|outpatient continuity training
5280606|NCT00504517|Relevant, Patient-centered curriculum|relevant, patient-centered curriculum
5280607|NCT00504517|Evaluation|evaluation
5280608|NCT00504517|New graduation requirements|new graduation requirements
5280609|NCT00504504|Hodgkin's Disease|hodgkin's disease
5280610|NCT00504504|Lymphoma|lymphoma
5280611|NCT00504504|Rituximab|rituximab
5280612|NCT00504504|Rituxan|rituxan
5280613|NCT00504504|Adriamycin|adriamycin
5280614|NCT00504504|Doxorubicin|doxorubicin
5280615|NCT00504504|Rubex|rubex
5280616|NCT00504504|Bleomycin|bleomycin
5280617|NCT00504504|Bleomycin sulfate|bleomycin sulfate
5280618|NCT00504504|Blenoxane|blenoxane
5280619|NCT00504504|BLM|blm
5280620|NCT00504504|Dacarbazine|dacarbazine
5280621|NCT00504504|DTIC|dtic
5280622|NCT00504504|DTIC-Dome|dtic-dome
5280623|NCT00504504|Vincristine|vincristine
5280624|NCT00504504|Vinblastine|vinblastine
5280625|NCT00504504|Vinblastine Sulfate|vinblastine sulfate
5280626|NCT00504504|ABVD|abvd
5280627|NCT00504504|ABVD Chemotherapy Treatment|abvd chemotherapy treatment
5280628|NCT00504491|Rituximab-CHOP|rituximab-chop
5280629|NCT00504491|Alemtuzumab|alemtuzumab
5280630|NCT00504491|Chronic lymphocytic leukaemia|chronic lymphocytic leukaemia
5280631|NCT00504478|Inflammation|inflammation
5280632|NCT00504478|carbohydrates|carbohydrates
5280633|NCT00504478|omega-3|omega-3
5280634|NCT00504478|overweight|overweight
5280635|NCT00504478|diet|diet
5280636|NCT00504465|Labor|labor
5280637|NCT00504465|Labor induction|labor induction
5280638|NCT00504465|Cervical ripening|cervical ripening
5280639|NCT00504465|Dinoprostone|dinoprostone
5280640|NCT00504465|Fetal safety|fetal safety
5280641|NCT00504465|Oxytocin|oxytocin
5280642|NCT00504465|Cesarean delivery|cesarean delivery
5280643|NCT00504452|HIV|hiv
5280644|NCT00504452|viral|viral
5280645|NCT00504452|Viral decay acceleration|viral decay acceleration
5280646|NCT00504452|ART|art
5280647|NCT00504452|HAART|haart
5280648|NCT00504452|Treatment Experienced|treatment experienced
5280649|NCT00504439|COPD,|copd,
5280650|NCT00504439|CD11b,|cd11b,
5280651|NCT00504439|CXCR2,|cxcr2,
5280652|NCT00504439|safety,|safety,
5280653|NCT00504439|repeat dose,|repeat dose,
5280654|NCT00504439|tolerability.|tolerability.
5280655|NCT00504439|SB-656933,|sb-656933,
5280656|NCT00504413|Metabolic Networks and Pathways|metabolic networks and pathways
5280657|NCT00504413|Methadone|methadone
5280658|NCT00504413|Polymorphism, genetic|polymorphism, genetic
5280659|NCT00504413|Cytochrome P-450 Enzyme System|cytochrome p-450 enzyme system
5280660|NCT00504400|macular telangiectasia|macular telangiectasia
5280661|NCT00504400|parafoveal telangiectasis|parafoveal telangiectasis
5280662|NCT00504400|nonproliferative|nonproliferative
5280663|NCT00504400|therapy|therapy
5280664|NCT00504400|intravitreal injection|intravitreal injection
5280665|NCT00504400|ranibizumab|ranibizumab
5280666|NCT00504400|lucentis|lucentis
5280667|NCT00504387|Burning mouth disorder|burning mouth disorder
5280668|NCT00504387|Taste disorder|taste disorder
5280669|NCT00504387|Quantitative sensory testing|quantitative sensory testing
5280670|NCT00504387|Gustatory testing|gustatory testing
5280671|NCT00504387|Neuropathic orofacial pain|neuropathic orofacial pain
5280672|NCT00504387|Oral burning|oral burning
5280673|NCT00504374|Lung Cancer|lung cancer
5280674|NCT00504374|Epidemiology|epidemiology
5280675|NCT00504374|Symptoms|symptoms
5280676|NCT00504374|Gene Polymorphisms|gene polymorphisms
5280677|NCT00504374|Questionnaire|questionnaire
5280678|NCT00504374|Survey|survey
5280679|NCT00504361|Asthma|asthma
5280680|NCT00504361|COPD|copd
5280681|NCT00504361|Interstitial Lung Disease|interstitial lung disease
5280682|NCT00504361|Cystic Fibrosis|cystic fibrosis
5280683|NCT00504361|Lung Cancer|lung cancer
5280684|NCT00504361|smokers|smokers
5280685|NCT00504361|non-smokers|non-smokers
5280686|NCT00504348|Interstitial pneumonitis|interstitial pneumonitis
5280687|NCT00504348|Polymyositis|polymyositis
5280688|NCT00504348|Dermatomyositis|dermatomyositis
5280689|NCT00504348|Tacrolimus|tacrolimus
5280690|NCT00504348|Corticosteroids|corticosteroids
5280691|NCT00504335|Acute Radiation Syndrome|acute radiation syndrome
5280692|NCT00504335|Hematopoietic Syndrome|hematopoietic syndrome
5280693|NCT00504335|Radiation Injury|radiation injury
5280694|NCT00504335|BIO 300|bio 300
5280695|NCT00504322|Esophageal Neoplasms|esophageal neoplasms
5280696|NCT00504309|triglycerides|triglycerides
5280697|NCT00504309|hypertriglyceridemia|hypertriglyceridemia
5280698|NCT00504309|omega-3|omega-3
5280699|NCT00504309|n-3|n-3
5280700|NCT00504309|eicosapentaenoic acid|eicosapentaenoic acid
5280701|NCT00504309|EPA|epa
5280702|NCT00504309|docosahexaenoic acid|docosahexaenoic acid
5280703|NCT00504309|DHA|dha
5280704|NCT00504309|flow mediated dilation|flow mediated dilation
5280705|NCT00504309|fish|fish
5280706|NCT00504309|Moderate hypertriglyceridemia|moderate hypertriglyceridemia
5280707|NCT00504296|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5280708|NCT00504283|Renal colic, pain, protocol, emergency department|renal colic, pain, protocol, emergency department
5280709|NCT00504257|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5280710|NCT00504257|recurrent primary peritoneal cavity cancer|recurrent primary peritoneal cavity cancer
5280711|NCT00504257|recurrent fallopian tube cancer|recurrent fallopian tube cancer
5280712|NCT00504244|SLE|sle
5280713|NCT00504244|SLEDAI|sledai
5280714|NCT00504244|Azathioprine|azathioprine
5280715|NCT00504244|Myfortic|myfortic
5280716|NCT00504231|influenza|influenza
5280717|NCT00504231|prevention|prevention
5280718|NCT00504231|intradermal|intradermal
5280719|NCT00504231|vaccine|vaccine
5280720|NCT00504231|delivery|delivery
5280721|NCT00504231|elderly|elderly
5280722|NCT00504218|Growth Factor|growth factor
5280723|NCT00504218|Hypothalamic-Pituitary Dysfunction|hypothalamic-pituitary dysfunction
5280724|NCT00504218|Primary Disorders of the Thyroid|primary disorders of the thyroid
5280725|NCT00504218|Decreased Bone Mineral Density|decreased bone mineral density
5280726|NCT00504218|Endocrine Side Effects Related to Cancer Therapy|endocrine side effects related to cancer therapy
5280727|NCT00504218|Primary Gonadal Dysfunction|primary gonadal dysfunction
5280728|NCT00504218|Obesity|obesity
5280729|NCT00504218|Impaired Glucose Tolerance|impaired glucose tolerance
5280730|NCT00504218|Thyroid Disorder|thyroid disorder
5280731|NCT00504218|Cancer Therapy Endocrine Side Effects|cancer therapy endocrine side effects
5280732|NCT00504218|Pituitary Dysfunction|pituitary dysfunction
5280733|NCT00504218|Childhood Cancer Survivors|childhood cancer survivors
5280734|NCT00504205|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5280735|NCT00504205|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5280736|NCT00504205|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
5280737|NCT00504205|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5280738|NCT00504205|intraocular lymphoma|intraocular lymphoma
5280739|NCT00504205|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5280740|NCT00504205|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5280741|NCT00504205|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5280742|NCT00504205|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5280743|NCT00504205|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5280744|NCT00504205|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5280745|NCT00504205|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5280746|NCT00504205|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5280747|NCT00504205|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5280748|NCT00504205|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5280749|NCT00504205|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5280750|NCT00504205|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5280751|NCT00504205|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5280752|NCT00504205|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5280753|NCT00504205|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5280754|NCT00504205|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5280755|NCT00504205|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5280756|NCT00504205|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5280757|NCT00504205|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5280758|NCT00504205|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5280759|NCT00504205|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5280760|NCT00504205|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5280761|NCT00504205|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5280762|NCT00504205|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5280763|NCT00504205|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
5280764|NCT00504205|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
5280765|NCT00504205|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5280766|NCT00504205|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5280767|NCT00504205|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5280768|NCT00504205|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5280769|NCT00504205|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5280770|NCT00504205|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
5280771|NCT00504205|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5280772|NCT00504205|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5280773|NCT00504205|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5280774|NCT00504205|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5281020|NCT00503594|Procarbazine|procarbazine
5280775|NCT00504205|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5280776|NCT00504205|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5280777|NCT00504205|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5280778|NCT00504205|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5280779|NCT00504205|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
5280780|NCT00504205|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
5280781|NCT00504205|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5280782|NCT00504205|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5280783|NCT00504205|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5280784|NCT00504205|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5280785|NCT00504205|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5280786|NCT00504205|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
5280787|NCT00504205|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5280788|NCT00504205|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
5280789|NCT00504205|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
5280790|NCT00504179|coronary artery bypass graft|coronary artery bypass graft
5280791|NCT00504179|osteopathic manipulative treatment|osteopathic manipulative treatment
5280792|NCT00504179|cardiovascular disease|cardiovascular disease
5280793|NCT00504140|Osteosarcoma|osteosarcoma
5280794|NCT00504140|Interferon Alpha|interferon alpha
5280795|NCT00504140|IFN-|ifn-
5280796|NCT00504140|Roferon|roferon
5280797|NCT00504140|Recombinant Interferon Alpha|recombinant interferon alpha
5280798|NCT00504140|Etoposide|etoposide
5280799|NCT00504140|VP-16|vp-16
5280800|NCT00504127|Arthritis|arthritis
5280801|NCT00504127|Degenerative|degenerative
5280802|NCT00504114|Osteoarthritis, knee|osteoarthritis, knee
5280803|NCT00504114|anterior cruciate ligament|anterior cruciate ligament
5280804|NCT00504114|Magnetic Resonance Imaging|magnetic resonance imaging
5280805|NCT00504101|stage I multiple myeloma|stage i multiple myeloma
5280806|NCT00504101|stage II multiple myeloma|stage ii multiple myeloma
5280807|NCT00504101|stage III multiple myeloma|stage iii multiple myeloma
5280808|NCT00504088|CLI|cli
5280809|NCT00504088|Critical Limb Ischemia|critical limb ischemia
5280810|NCT00504088|PAD|pad
5280811|NCT00504088|Peripheral Arterial Disease|peripheral arterial disease
5280812|NCT00504088|Artherosclerosis|artherosclerosis
5280813|NCT00504088|Leg Pain|leg pain
5280814|NCT00504088|Cardiovascular|cardiovascular
5280815|NCT00504088|Artherectomy|artherectomy
5280816|NCT00504088|Bypass|bypass
5280817|NCT00504088|Peripheral Bypass|peripheral bypass
5280818|NCT00504088|PROOF|proof
5280819|NCT00504075|Idiopathic Thrombocytopenic Purpura|idiopathic thrombocytopenic purpura
5280820|NCT00504075|Bleeding disorders|bleeding disorders
5280821|NCT00504075|Immune System and Disorders|immune system and disorders
5280822|NCT00504062|asthma|asthma
5280823|NCT00504062|bronchial|bronchial
5280824|NCT00504049|Cerebral Palsy|cerebral palsy
5280825|NCT00504049|Electromyography|electromyography
5280826|NCT00504049|Wavelet Analysis|wavelet analysis
5280827|NCT00504036|Obesity|obesity
5280828|NCT00504036|Morbid obesity|morbid obesity
5280829|NCT00504036|Gastric balloon|gastric balloon
5280830|NCT00504036|Gastric by-pass|gastric by-pass
5280831|NCT00504036|Morbid obesity with BMI > 45 kg/m²|morbid obesity with bmi > 45 kg/m²
5280832|NCT00504023|Paget disease of the vulva|paget disease of the vulva
5280833|NCT00504023|recurrent vulvar cancer|recurrent vulvar cancer
5280834|NCT00504023|stage 0 vulvar cancer|stage 0 vulvar cancer
5280835|NCT00504023|stage I vulvar cancer|stage i vulvar cancer
5280836|NCT00504023|stage II vulvar cancer|stage ii vulvar cancer
5280837|NCT00504023|stage III vulvar cancer|stage iii vulvar cancer
5280838|NCT00504023|imiquimod|imiquimod
5280839|NCT00504023|07-029|07-029
5280840|NCT00504010|arnica|arnica
5280841|NCT00504010|muscle soreness|muscle soreness
5280842|NCT00504010|exercise|exercise
5280843|NCT00504010|eccentric|eccentric
5280844|NCT00503997|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
5280845|NCT00503997|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
5280846|NCT00503997|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
5280847|NCT00503997|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
5280848|NCT00503997|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
5280849|NCT00503997|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5280850|NCT00503997|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5280851|NCT00503997|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5280852|NCT00503997|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5280853|NCT00503997|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
5280854|NCT00503997|untreated metastatic squamous neck cancer with occult primary|untreated metastatic squamous neck cancer with occult primary
5281021|NCT00503594|Vincristine|vincristine
5280855|NCT00503984|Adenocarcinoma of the prostate|adenocarcinoma of the prostate
5280856|NCT00503984|Recurrent prostate cancer|recurrent prostate cancer
5280857|NCT00503984|Stage IV prostate cancer|stage iv prostate cancer
5280858|NCT00503984|Pain|pain
5280859|NCT00503971|Vorinostat|vorinostat
5280860|NCT00503971|NSCLC|nsclc
5280861|NCT00503971|EGFR|egfr
5280862|NCT00503971|Erlotinib|erlotinib
5280863|NCT00503958|non-small cell lung cancer|non-small cell lung cancer
5280864|NCT00503958|small cell lung cancer|small cell lung cancer
5280865|NCT00503958|health status unknown|health status unknown
5280866|NCT00503945|sleep apnea|sleep apnea
5280867|NCT00503945|continuous positive airway pressure|continuous positive airway pressure
5280868|NCT00503945|echocardiography|echocardiography
5280869|NCT00503945|Natriuretic peptide|natriuretic peptide
5280870|NCT00503932|Rectal Cancer|rectal cancer
5280871|NCT00503932|Capecitabine|capecitabine
5280872|NCT00503932|Proton Therapy|proton therapy
5280873|NCT00503932|Adenocarcinoma of the rectum|adenocarcinoma of the rectum
5280874|NCT00503932|Gastrointestinal|gastrointestinal
5280875|NCT00503932|Proton Radiotherapy|proton radiotherapy
5280876|NCT00503919|Cervix|cervix
5280877|NCT00503919|Cervical dysplasia|cervical dysplasia
5280878|NCT00503919|Cervical neoplasia|cervical neoplasia
5280879|NCT00503919|Cervical intraepithelial neoplasia|cervical intraepithelial neoplasia
5280880|NCT00503919|Multi-spectral Digital Colposcopy|multi-spectral digital colposcopy
5280881|NCT00503919|MDC|mdc
5280882|NCT00503919|Acetic acid|acetic acid
5280883|NCT00503919|Colposcopy|colposcopy
5280884|NCT00503919|Spectroscopy|spectroscopy
5280885|NCT00503919|Fluorescence Spectroscopy|fluorescence spectroscopy
5280886|NCT00503919|Abnormal Pap Smear|abnormal pap smear
5280887|NCT00503906|stage IV breast cancer|stage iv breast cancer
5280888|NCT00503906|recurrent breast cancer|recurrent breast cancer
5280889|NCT00503893|Wilms' Tumor|wilms' tumor
5280890|NCT00503893|Genitourinary Anomalies|genitourinary anomalies
5280891|NCT00503893|Beckwith-Wiedemann Hemihypertrophy|beckwith-wiedemann hemihypertrophy
5280892|NCT00503893|Aniridia|aniridia
5280893|NCT00503893|Questionnaire|questionnaire
5280894|NCT00503880|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5280895|NCT00503880|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5280896|NCT00503880|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5280897|NCT00503867|unresectable hepatocellular carcinoma|unresectable hepatocellular carcinoma
5280898|NCT00503867|HCC|hcc
5280899|NCT00503867|SIR-Spheres|sir-spheres
5280900|NCT00503867|Y-90 Microspheres|y-90 microspheres
5280901|NCT00503867|brachytherapy|brachytherapy
5280902|NCT00503867|SIRT|sirt
5280903|NCT00503867|liver cancer|liver cancer
5280904|NCT00503854|Solid Tumors|solid tumors
5280905|NCT00503854|Febrile Neutropenia|febrile neutropenia
5280906|NCT00503854|Fatigue|fatigue
5280907|NCT00503854|Symptom Burden|symptom burden
5280908|NCT00503854|Questionnaire|questionnaire
5280909|NCT00503854|Survey|survey
5280910|NCT00503841|stage I breast cancer|stage i breast cancer
5280911|NCT00503841|recurrent breast cancer|recurrent breast cancer
5280912|NCT00503841|stage II breast cancer|stage ii breast cancer
5280913|NCT00503841|stage IIIA breast cancer|stage iiia breast cancer
5280914|NCT00503841|stage IIIB breast cancer|stage iiib breast cancer
5280915|NCT00503841|stage IIIC breast cancer|stage iiic breast cancer
5280916|NCT00503828|Derris Scandens Benth extract|derris scandens benth extract
5280917|NCT00503828|Osteoarthritis|osteoarthritis
5280918|NCT00503828|WOMAC|womac
5280919|NCT00503828|6-minute walk|6-minute walk
5280920|NCT00503815|colonoscopy|colonoscopy
5280921|NCT00503815|bowel preparation|bowel preparation
5280922|NCT00503815|prep|prep
5280923|NCT00503802|Sleep Apnea|sleep apnea
5280924|NCT00503802|Sleep disordered breathing|sleep disordered breathing
5280925|NCT00503802|Nasal Obstruction|nasal obstruction
5280926|NCT00503802|Turbinate|turbinate
5280927|NCT00503802|Radiofrequency|radiofrequency
5280928|NCT00503802|Continuous positive airway pressure|continuous positive airway pressure
5280929|NCT00503802|CPAP|cpap
5280930|NCT00503802|Sleep surgery|sleep surgery
5280931|NCT00503789|Healthy infants|healthy infants
5280932|NCT00503776|xerostomia|xerostomia
5280933|NCT00503776|mucositis|mucositis
5280934|NCT00503776|dysphagia|dysphagia
5280935|NCT00503776|radiation toxicity|radiation toxicity
5280936|NCT00503776|chemotherapeutic agent toxicity|chemotherapeutic agent toxicity
5280937|NCT00503776|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
5280938|NCT00503776|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5280939|NCT00503776|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
5280940|NCT00503776|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
5280941|NCT00503776|stage III verrucous carcinoma of the larynx|stage iii verrucous carcinoma of the larynx
5280942|NCT00503776|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5280943|NCT00503776|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
5280944|NCT00503776|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
5280945|NCT00503776|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
5280946|NCT00503776|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
5280947|NCT00503776|stage III verrucous carcinoma of the oral cavity|stage iii verrucous carcinoma of the oral cavity
5280948|NCT00503776|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5280949|NCT00503776|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
5280950|NCT00503776|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
5280951|NCT00503776|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
5280952|NCT00503776|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
5280953|NCT00503776|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
5280954|NCT00503776|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
5280955|NCT00503776|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
5280956|NCT00503776|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5280957|NCT00503776|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
5280958|NCT00503776|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
5280959|NCT00503776|stage III salivary gland cancer|stage iii salivary gland cancer
5280960|NCT00503776|stage IV salivary gland cancer|stage iv salivary gland cancer
5280961|NCT00503776|recurrent salivary gland cancer|recurrent salivary gland cancer
5280962|NCT00503763|Smoldering multiple myeloma|smoldering multiple myeloma
5280963|NCT00503763|Simvastatin|simvastatin
5280964|NCT00503763|Paraprotein|paraprotein
5280965|NCT00503750|Breast Cancer|breast cancer
5280966|NCT00503737|colorectal cancer screening|colorectal cancer screening
5280967|NCT00503737|National Colorectal Cancer Roundtable Toolbox|national colorectal cancer roundtable toolbox
5280968|NCT00503724|recurrent childhood brain stem glioma|recurrent childhood brain stem glioma
5280969|NCT00503724|childhood central nervous system germ cell tumor|childhood central nervous system germ cell tumor
5280970|NCT00503724|recurrent childhood cerebellar astrocytoma|recurrent childhood cerebellar astrocytoma
5280971|NCT00503724|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
5280972|NCT00503724|childhood choroid plexus tumor|childhood choroid plexus tumor
5280973|NCT00503724|childhood craniopharyngioma|childhood craniopharyngioma
5280974|NCT00503724|childhood infratentorial ependymoma|childhood infratentorial ependymoma
5280975|NCT00503724|childhood supratentorial ependymoma|childhood supratentorial ependymoma
5280976|NCT00503724|recurrent childhood ependymoma|recurrent childhood ependymoma
5280977|NCT00503724|recurrent childhood medulloblastoma|recurrent childhood medulloblastoma
5280978|NCT00503724|childhood oligodendroglioma|childhood oligodendroglioma
5280979|NCT00503724|recurrent childhood supratentorial primitive neuroectodermal tumor|recurrent childhood supratentorial primitive neuroectodermal tumor
5280980|NCT00503724|recurrent childhood visual pathway and hypothalamic glioma|recurrent childhood visual pathway and hypothalamic glioma
5280981|NCT00503724|recurrent childhood visual pathway glioma|recurrent childhood visual pathway glioma
5280982|NCT00503724|childhood grade I meningioma|childhood grade i meningioma
5280983|NCT00503724|childhood grade II meningioma|childhood grade ii meningioma
5280984|NCT00503724|childhood grade III meningioma|childhood grade iii meningioma
5280985|NCT00503724|recurrent childhood subependymal giant cell astrocytoma|recurrent childhood subependymal giant cell astrocytoma
5280986|NCT00503724|recurrent childhood pineoblastoma|recurrent childhood pineoblastoma
5280987|NCT00503724|recurrent childhood brain tumor|recurrent childhood brain tumor
5280988|NCT00503724|disseminated neuroblastoma|disseminated neuroblastoma
5280989|NCT00503724|recurrent neuroblastoma|recurrent neuroblastoma
5280990|NCT00503711|ZD6474 PK|zd6474 pk
5280991|NCT00503685|Metastatic Colorectal Cancer with Disease Progression|metastatic colorectal cancer with disease progression
5280992|NCT00503685|Failed prior to Anti-EGFr Therapy|failed prior to anti-egfr therapy
5280993|NCT00503672|Motor Activity|motor activity
5280994|NCT00503672|Pregnancy|pregnancy
5280995|NCT00503672|Accelerometer|accelerometer
5280996|NCT00503659|PC20 FEV1|pc20 fev1
5280997|NCT00503659|PD20FEV1|pd20fev1
5280998|NCT00503659|bronchial hyperreactivity|bronchial hyperreactivity
5280999|NCT00503659|bronchial asthma|bronchial asthma
5281000|NCT00503646|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
5281001|NCT00503646|sexual dysfunction and infertility|sexual dysfunction and infertility
5281002|NCT00503646|sexuality and reproductive issues|sexuality and reproductive issues
5281003|NCT00503646|stage IIB prostate cancer|stage iib prostate cancer
5281004|NCT00503646|stage IIA prostate cancer|stage iia prostate cancer
5281005|NCT00503646|stage I prostate cancer|stage i prostate cancer
5281006|NCT00503633|sleep disorders|sleep disorders
5281007|NCT00503633|genetics|genetics
5281008|NCT00503620|Cerebral Palsy|cerebral palsy
5281009|NCT00503620|Botulinum Toxin|botulinum toxin
5281010|NCT00503620|Neuromuscular Function|neuromuscular function
5281011|NCT00503607|colonoscopy|colonoscopy
5281012|NCT00503607|bowel preparation|bowel preparation
5281013|NCT00503607|prep|prep
5281014|NCT00503594|Primary central nervous system lymphoma|primary central nervous system lymphoma
5281015|NCT00503594|Brain lymphoma|brain lymphoma
5281016|NCT00503594|Elderly|elderly
5281017|NCT00503594|Chemotherapy|chemotherapy
5281018|NCT00503594|Methotrexate|methotrexate
5281019|NCT00503594|Temozolomide|temozolomide
5281022|NCT00503594|Cytarabine|cytarabine
5281023|NCT00503568|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5281024|NCT00503568|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5281025|NCT00503568|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5281026|NCT00503555|Primary Health Care|primary health care
5281027|NCT00503555|Hispanic Americans|hispanic americans
5281028|NCT00503542|Vaginitis|vaginitis
5281029|NCT00503542|Bacterial Vaginosis|bacterial vaginosis
5281030|NCT00503542|Vaginal trichomoniasis|vaginal trichomoniasis
5281031|NCT00503542|Vulvovaginal candidiasis|vulvovaginal candidiasis
5281032|NCT00503516|weight loss, appetite, dementia, megestrol acetate|weight loss, appetite, dementia, megestrol acetate
5281033|NCT00503477|Japan|japan
5281034|NCT00503477|Phase I|phase i
5281035|NCT00503477|solid tumor|solid tumor
5281036|NCT00503477|AZD2171|azd2171
5281037|NCT00503464|guideline|guideline
5281038|NCT00503464|adherence|adherence
5281039|NCT00503451|Advanced cancer|advanced cancer
5281040|NCT00503451|solid tumors|solid tumors
5281041|NCT00503451|lymphoma|lymphoma
5281042|NCT00503451|HDAC|hdac
5281043|NCT00503451|LBH589|lbh589
5281044|NCT00503451|adults|adults
5281045|NCT00503451|non-Hodgkin's lymphoma|non-hodgkin's lymphoma
5281046|NCT00503438|Arthritis|arthritis
5281047|NCT00503438|Osteoarthritis|osteoarthritis
5281048|NCT00503438|Arthroplasty|arthroplasty
5281049|NCT00503412|phase I|phase i
5281050|NCT00503412|AZD2171|azd2171
5281051|NCT00503412|solid tumor|solid tumor
5281052|NCT00503412|metastatic tumor|metastatic tumor
5281053|NCT00503399|Glucocorticoid Induced|glucocorticoid induced
5281054|NCT00503386|chemotherapy-induced nausea and vomiting|chemotherapy-induced nausea and vomiting
5281055|NCT00503386|acute|acute
5281056|NCT00503386|delayed|delayed
5281057|NCT00503386|emesis|emesis
5281058|NCT00503386|antiemetics|antiemetics
5281059|NCT00503386|5-HT3 receptor antagonist|5-ht3 receptor antagonist
5281060|NCT00503386|granisetron|granisetron
5281061|NCT00503386|palonosetron|palonosetron
5281062|NCT00503360|Ocular Hypertension|ocular hypertension
5281063|NCT00503360|SAD448|sad448
5281064|NCT00503347|coinfection with chronic hepatitis C virus and HIV|coinfection with chronic hepatitis c virus and hiv
5281065|NCT00503347|Treatment Naive|treatment naive
5281066|NCT00503321|gastric cancer, TS-1, PSK|gastric cancer, ts-1, psk
5281067|NCT00503308|HIV Seronegativity|hiv seronegativity
5281068|NCT00503295|reovirus|reovirus
5281069|NCT00503295|oncolytic virus|oncolytic virus
5281070|NCT00503295|sarcoma|sarcoma
5281071|NCT00503295|REOLYSIN|reolysin
5281072|NCT00503295|Oncolytics Biotech|oncolytics biotech
5281073|NCT00503269|Haemorrhoidectomy|haemorrhoidectomy
5281074|NCT00503269|Local anaesthesia|local anaesthesia
5281075|NCT00503256|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
5281076|NCT00503256|Leukemia|leukemia
5281077|NCT00503256|Lymphoma|lymphoma
5281078|NCT00503256|Questionnaire|questionnaire
5281079|NCT00503256|Survey|survey
5281080|NCT00503256|CLL|cll
5281081|NCT00503230|tobacco|tobacco
5281082|NCT00503230|smoking|smoking
5281083|NCT00503230|HIV|hiv
5281084|NCT00503230|Latino|latino
5281085|NCT00503217|intrauterine insemination|intrauterine insemination
5281086|NCT00503217|GnRH agonist|gnrh agonist
5281087|NCT00503217|implantation|implantation
5281088|NCT00503204|cancer|cancer
5281089|NCT00503204|tumor|tumor
5281090|NCT00503204|advance solid tumour|advance solid tumour
5281091|NCT00503204|glioblastoma|glioblastoma
5281092|NCT00503204|malignant brain tumour|malignant brain tumour
5281093|NCT00503191|Autism|autism
5281094|NCT00503191|Neurodevelopmental disorder|neurodevelopmental disorder
5281095|NCT00503165|Menitorix|menitorix
5281096|NCT00503165|vaccine|vaccine
5281097|NCT00503126|pediatrics|pediatrics
5281098|NCT00503126|bivalirudin|bivalirudin
5281099|NCT00503100|Pain|pain
5281100|NCT00503100|Preterm-Born Adolescents|preterm-born adolescents
5281101|NCT00503087|Injections|injections
5281102|NCT00503087|Vacuum|vacuum
5281103|NCT00503087|Pain|pain
5281104|NCT00503087|Pneumatic Skin Flattening|pneumatic skin flattening
5281105|NCT00503087|PSF|psf
5281106|NCT00503074|Diet, reducing|diet, reducing
5281107|NCT00503074|Television|television
5281108|NCT00503074|Child Behavior|child behavior
5281109|NCT00503061|pharmaceopidemiological|pharmaceopidemiological
5281110|NCT00503061|Symbicort SMART|symbicort smart
5281111|NCT00503061|GPRD|gprd
5281112|NCT00503048|atopy|atopy
5281113|NCT00503048|atopic diseases|atopic diseases
5281114|NCT00503048|children|children
5281115|NCT00503048|orphanages|orphanages
5281116|NCT00503035|Familial Adenomatous Polyposis|familial adenomatous polyposis
5281117|NCT00503035|Colorectal Tumors|colorectal tumors
5281118|NCT00503035|Molecular Targeting|molecular targeting
5281119|NCT00503035|Celecoxib|celecoxib
5281120|NCT00503035|Celebrex|celebrex
5281121|NCT00503035|SC-58635|sc-58635
5281122|NCT00503035|Apoptosis Induction|apoptosis induction
5281123|NCT00503035|Colon|colon
5281124|NCT00503035|Rectum|rectum
5281125|NCT00503035|colonoscopy|colonoscopy
5281126|NCT00503035|Biopsy|biopsy
5281127|NCT00503022|Wet age-related macular degeneration|wet age-related macular degeneration
5281128|NCT00503022|ACZ885|acz885
5281129|NCT00503009|Rhinovirus|rhinovirus
5281130|NCT00503009|Asthma|asthma
5281131|NCT00502983|Acute Myelogenous Leukemia|acute myelogenous leukemia
5281132|NCT00502983|Epidemiology|epidemiology
5281133|NCT00502983|Leukemia|leukemia
5281134|NCT00502983|Healthy Control|healthy control
5281135|NCT00502983|Lifestyle Factors|lifestyle factors
5281136|NCT00502983|Genetic Susceptibility|genetic susceptibility
5281137|NCT00502983|Interview|interview
5281138|NCT00502983|AML|aml
5281139|NCT00502970|Chronic HCV|chronic hcv
5281140|NCT00502970|Treatment|treatment
5281141|NCT00502957|biofeedback|biofeedback
5281142|NCT00502957|constipation|constipation
5281143|NCT00502944|HIV|hiv
5281144|NCT00502944|Testing|testing
5281145|NCT00502944|HIV Seronegativity|hiv seronegativity
5281146|NCT00502905|Acute Myeloid Leukemia|acute myeloid leukemia
5281147|NCT00502905|Myelodysplastic Syndromes|myelodysplastic syndromes
5281148|NCT00502905|Busulfan|busulfan
5281149|NCT00502905|Busulfex|busulfex
5281150|NCT00502905|Myleran|myleran
5281151|NCT00502905|Fludarabine|fludarabine
5281152|NCT00502905|Fludarabine Phosphate|fludarabine phosphate
5281153|NCT00502905|Fludara|fludara
5281154|NCT00502892|Solid Tumors|solid tumors
5281155|NCT00502892|Topotecan|topotecan
5281156|NCT00502892|Hycamtin|hycamtin
5281157|NCT00502892|Ifosfamide|ifosfamide
5281158|NCT00502892|Ifex|ifex
5281159|NCT00502892|Carboplatin|carboplatin
5281160|NCT00502892|Paraplatin|paraplatin
5281161|NCT00502892|Pediatric|pediatric
5281162|NCT00502892|Children|children
5281163|NCT00502892|Young Adults|young adults
5281164|NCT00502866|breastfeeding|breastfeeding
5281165|NCT00502866|vitamin D supplementation|vitamin d supplementation
5281166|NCT00502866|rickets|rickets
5281167|NCT00502827|Human Immunodeficiency Virus|human immunodeficiency virus
5281168|NCT00502827|HIV positive|hiv positive
5281169|NCT00502827|HIV Positive Smokers|hiv positive smokers
5281170|NCT00502827|AIDS|aids
5281171|NCT00502827|Cell Phone Intervention|cell phone intervention
5281172|NCT00502827|CPI|cpi
5281173|NCT00502827|Smoking Cessation|smoking cessation
5281174|NCT00502827|Interview|interview
5281175|NCT00502814|Breast Cancer|breast cancer
5281176|NCT00502814|3-D Optical Surface Scan|3-d optical surface scan
5281177|NCT00502814|Soft Tissue Biomechanics|soft tissue biomechanics
5281178|NCT00502814|Mechanical Testing|mechanical testing
5281179|NCT00502814|Skin Ultrasound|skin ultrasound
5281180|NCT00502814|Magnetic Resonance Imaging|magnetic resonance imaging
5281181|NCT00502814|CT Scan|ct scan
5281182|NCT00502801|Pneumonia|pneumonia
5281183|NCT00502801|Lung Infection|lung infection
5281184|NCT00502801|Bacterial Infection|bacterial infection
5281185|NCT00502801|Hospital-Acquired Infection|hospital-acquired infection
5281186|NCT00502801|Ventilator Infection|ventilator infection
5281187|NCT00502801|Antibiotic Therapy|antibiotic therapy
5281188|NCT00502775|ragweed|ragweed
5281189|NCT00502775|once daily|once daily
5281190|NCT00502775|fexofenadine|fexofenadine
5281191|NCT00502775|fluticasone furoate|fluticasone furoate
5281192|NCT00502775|allergic rhinitis|allergic rhinitis
5281193|NCT00502762|small-cell lung cancer|small-cell lung cancer
5281194|NCT00502762|refractory|refractory
5281195|NCT00502762|topotecan|topotecan
5281196|NCT00502749|Leukemia|leukemia
5281197|NCT00502749|Lymphoma|lymphoma
5281198|NCT00502749|Exercise|exercise
5281199|NCT00502749|Quality of Life|quality of life
5281200|NCT00502749|Questionnaire|questionnaire
5281201|NCT00502749|Survey|survey
5281202|NCT00502723|Retropubic Prostatectomy|retropubic prostatectomy
5281203|NCT00502723|Surgical Procedures|surgical procedures
5281204|NCT00502723|Laparoscopic|laparoscopic
5281205|NCT00502697|preterm|preterm
5281206|NCT00502697|prematurity|prematurity
5281207|NCT00502697|home visitation|home visitation
5281208|NCT00502697|system of care|system of care
5281209|NCT00502684|breast cancer|breast cancer
5281210|NCT00502684|surgery|surgery
5281211|NCT00502684|immune suppression|immune suppression
5281212|NCT00502684|beta blockers|beta blockers
5281213|NCT00502684|COX2 inhibitors|cox2 inhibitors
5281214|NCT00502658|Overweight|overweight
5281215|NCT00502658|Obese|obese
5281216|NCT00502658|Dietary Supplements|dietary supplements
5281217|NCT00502658|Shakes|shakes
5281218|NCT00502658|Nutrition|nutrition
5281219|NCT00502658|Overweight and Obese Adults (BMI 25-35)|overweight and obese adults (bmi 25-35)
5281220|NCT00502645|algorithm|algorithm
5281221|NCT00502645|cs-1 decision support system|cs-1 decision support system
5281222|NCT00502645|insulin|insulin
5281223|NCT00502645|hyperglycemia|hyperglycemia
5281224|NCT00502645|tight glycemic control|tight glycemic control
5281225|NCT00502645|intensive care|intensive care
5281226|NCT00502645|adults|adults
5281227|NCT00502632|Pleural empyema|pleural empyema
5281228|NCT00502632|Pleural effusion|pleural effusion
5281229|NCT00502632|Dornase alfa|dornase alfa
5281230|NCT00502632|Urokinase|urokinase
5281231|NCT00502632|Children|children
5281232|NCT00502619|Low back pain|low back pain
5281233|NCT00502619|acupuncture|acupuncture
5281234|NCT00502619|treadmill exercise|treadmill exercise
5281235|NCT00502606|provisional restoration|provisional restoration
5281236|NCT00502606|antibacterial nanoparticles|antibacterial nanoparticles
5281237|NCT00502606|cement|cement
5281238|NCT00502606|biofilm|biofilm
5281239|NCT00502606|bacteria|bacteria
5281240|NCT00502606|flora|flora
5281241|NCT00502606|plaque|plaque
5281242|NCT00502606|dental|dental
5281243|NCT00502606|prosthesis|prosthesis
5281244|NCT00502593|Influenza|influenza
5281245|NCT00502593|Pandemic Influenza Vaccine (GSK1562902A)|pandemic influenza vaccine (gsk1562902a)
5281246|NCT00502580|Oral Cancer|oral cancer
5281247|NCT00502580|Multispectral Digital Microscope|multispectral digital microscope
5281248|NCT00502580|Multispectral Digital Imaging|multispectral digital imaging
5281249|NCT00502580|Interview|interview
5281250|NCT00502580|MDM|mdm
5281251|NCT00502567|advanced solid tumors|advanced solid tumors
5281252|NCT00502567|AZD2171|azd2171
5281253|NCT00502567|Phase I|phase i
5281254|NCT00502554|lung function|lung function
5281255|NCT00502554|FEV1|fev1
5281256|NCT00502528|Infarction|infarction
5281257|NCT00502528|Endothelin|endothelin
5281258|NCT00502528|Perfusion|perfusion
5281259|NCT00502515|Diabetes|diabetes
5281260|NCT00502515|Neuropathy|neuropathy
5281261|NCT00502502|Anal Cancer|anal cancer
5281262|NCT00502502|Colorectal Cancer|colorectal cancer
5281263|NCT00502502|Esophageal Cancer|esophageal cancer
5281264|NCT00502502|Gastric Cancer|gastric cancer
5281265|NCT00502502|Lung Cancer|lung cancer
5281266|NCT00502502|Questionnaire|questionnaire
5281267|NCT00502502|Survey|survey
5281268|NCT00502502|Chemoradiation Therapy|chemoradiation therapy
5281269|NCT00502502|Symptoms|symptoms
5281270|NCT00502502|Cytokines|cytokines
5281271|NCT00502489|prolonged mechanical ventilation; weaning;rehabilitation|prolonged mechanical ventilation; weaning;rehabilitation
5281272|NCT00502476|MRSA|mrsa
5281273|NCT00502476|VRE|vre
5281274|NCT00502476|BSI|bsi
5281275|NCT00502463|head and neck cancer, stage III/IV|head and neck cancer, stage iii/iv
5281276|NCT00502463|no prior radiotherapy of head and neck region|no prior radiotherapy of head and neck region
5281277|NCT00502450|Acute mastoiditis|acute mastoiditis
5281278|NCT00502450|Hearing loss|hearing loss
5281279|NCT00502450|Mastoidectomy|mastoidectomy
5281280|NCT00502450|Audiogram|audiogram
5281281|NCT00502424|Rheumatoid Arthritis|rheumatoid arthritis
5281282|NCT00502424|Hand|hand
5281283|NCT00502424|Splint|splint
5281284|NCT00502424|Occupational Therapy|occupational therapy
5281285|NCT00502411|Soft Tissue Sarcoma|soft tissue sarcoma
5281286|NCT00502411|External Beam Radiotherapy|external beam radiotherapy
5281287|NCT00502411|Radiation Therapy|radiation therapy
5281288|NCT00502411|Extremity and Trunk|extremity and trunk
5281289|NCT00502411|EBRT|ebrt
5281290|NCT00502411|Sarcoma|sarcoma
5281291|NCT00502411|Doxorubicin|doxorubicin
5281292|NCT00502411|AD|ad
5281293|NCT00502411|Hydroxydaunomycin hydrochloride|hydroxydaunomycin hydrochloride
5281294|NCT00502411|XRT|xrt
5281295|NCT00502411|RT|rt
5281296|NCT00502411|Radiotherapy|radiotherapy
5281297|NCT00502385|Phase I|phase i
5281298|NCT00502385|AML|aml
5281299|NCT00502385|de novo or secondary AML|de novo or secondary aml
5281300|NCT00502385|AZD2171|azd2171
5281301|NCT00502359|Gestational diabetes, screening, glucose monitoring|gestational diabetes, screening, glucose monitoring
5281302|NCT00502346|Pharmacodynamics|pharmacodynamics
5281303|NCT00502333|back pain|back pain
5281304|NCT00502333|neck pain|neck pain
5281305|NCT00502333|prognosis|prognosis
5281306|NCT00502333|catastrophizing|catastrophizing
5281307|NCT00502333|coping strategies|coping strategies
5281308|NCT00502333|disability|disability
5281309|NCT00502333|Prognosis for back and neck pain|prognosis for back and neck pain
5281310|NCT00502320|Seasonal Affective Disorder|seasonal affective disorder
5281311|NCT00502320|Ramelteon|ramelteon
5281312|NCT00502320|Psychiatry|psychiatry
5281313|NCT00502320|Randomized Controlled Trial|randomized controlled trial
5281314|NCT00502320|Hamilton Depression Rating Scale- SAD Version|hamilton depression rating scale- sad version
5281315|NCT00502320|Circadian Rhythm|circadian rhythm
5281316|NCT00502307|Renal Cell Carcinoma|renal cell carcinoma
5281317|NCT00502307|AV-951|av-951
5281318|NCT00502307|tivozanib|tivozanib
5281319|NCT00502294|Ulcerative Colitis, UC, Intravenous Steroid-Refractory Ulcerative Colitis, IVSR-UC|ulcerative colitis, uc, intravenous steroid-refractory ulcerative colitis, ivsr-uc
5281320|NCT00502281|Gonadotropins|gonadotropins
5281321|NCT00502281|Infertility|infertility
5281322|NCT00502281|Intrauterine insemination|intrauterine insemination
5281323|NCT00502281|PCOS|pcos
5281324|NCT00502281|Timed intercourse|timed intercourse
5281325|NCT00502281|Treatment|treatment
5281326|NCT00502268|Coronary Calcification|coronary calcification
5281327|NCT00502268|Endstage Renal Disease|endstage renal disease
5281328|NCT00502268|Parathyroid hormone|parathyroid hormone
5281329|NCT00502255|Telemonitoring|telemonitoring
5281330|NCT00502255|Cost-effectiveness|cost-effectiveness
5281331|NCT00502255|Heart failure|heart failure
5281332|NCT00502255|Case management|case management
5281333|NCT00502229|Clomiphene citrate|clomiphene citrate
5281334|NCT00502229|Controlled overian stimulation|controlled overian stimulation
5281335|NCT00502229|Infertility|infertility
5281336|NCT00502229|Metformin|metformin
5281337|NCT00502229|Polycystic ovary syndrome|polycystic ovary syndrome
5281338|NCT00502229|Treatment|treatment
5281339|NCT00502216|Tobacco|tobacco
5281340|NCT00502216|Smoking|smoking
5281341|NCT00502216|Weight|weight
5281342|NCT00502216|Naltrexone|naltrexone
5281343|NCT00502216|Varenicline|varenicline
5281344|NCT00502203|Uterine Neoplasms|uterine neoplasms
5281345|NCT00502203|Endometrial Cancer|endometrial cancer
5281346|NCT00502203|Paclitaxel|paclitaxel
5281347|NCT00502203|Taxol|taxol
5281348|NCT00502203|Carboplatin|carboplatin
5281349|NCT00502203|Paraplatin|paraplatin
5281350|NCT00502203|Malignant Mixed Mullerian Tumors|malignant mixed mullerian tumors
5281351|NCT00502203|MMMT|mmmt
5281352|NCT00502203|Immunohistochemical markers|immunohistochemical markers
5281353|NCT00502190|pessary|pessary
5281354|NCT00502190|extending pregnancy|extending pregnancy
5281355|NCT00502177|Continuous Hyperthermic Peritoneal Perfusion|continuous hyperthermic peritoneal perfusion
5281356|NCT00502177|Peritoneal Neoplasms|peritoneal neoplasms
5281357|NCT00502177|Quality of Life|quality of life
5281358|NCT00502177|Questionnaire|questionnaire
5281359|NCT00502177|Survey|survey
5281360|NCT00502177|CHPP|chpp
5281361|NCT00502164|Advanced Prostate Cancer|advanced prostate cancer
5281362|NCT00502138|diabetes|diabetes
5281363|NCT00502138|insulin|insulin
5281364|NCT00502138|pramlintide|pramlintide
5281365|NCT00502138|IDDM|iddm
5281366|NCT00502125|Reflectance Confocal Imaging|reflectance confocal imaging
5281367|NCT00502125|Oral Mucosal Lesions|oral mucosal lesions
5281368|NCT00502125|Oral Mucosa Disease|oral mucosa disease
5281369|NCT00502125|Neoplasia Detection|neoplasia detection
5281370|NCT00502112|Lintuzumab|lintuzumab
5281371|NCT00502112|Antigens, CD33|antigens, cd33
5281372|NCT00502112|Antibodies, Monoclonal|antibodies, monoclonal
5281373|NCT00502112|Combined Modality Therapy|combined modality therapy
5281374|NCT00502112|Myelodysplastic Syndromes|myelodysplastic syndromes
5281375|NCT00502112|Hematologic Diseases|hematologic diseases
5281376|NCT00502112|Preleukemia|preleukemia
5281377|NCT00502099|Chronic hepatitis C|chronic hepatitis c
5281378|NCT00502099|pegylated interferon alfa-2a|pegylated interferon alfa-2a
5281379|NCT00502099|ribavirin, rapid virologic response|ribavirin, rapid virologic response
5281380|NCT00502099|early virologic response|early virologic response
5281381|NCT00502099|sustained virologic response|sustained virologic response
5281382|NCT00502086|Chronic hepatitis C|chronic hepatitis c
5281383|NCT00502086|Cirrhosis of the liver|cirrhosis of the liver
5281384|NCT00502086|Mortality|mortality
5281385|NCT00502086|Complications|complications
5281386|NCT00502086|Health-related quality of live|health-related quality of live
5281387|NCT00502086|Hepatocellular carcinoma|hepatocellular carcinoma
5281388|NCT00502086|Nutritional supplement|nutritional supplement
5281389|NCT00502060|Phase I|phase i
5281390|NCT00502060|AZD2171|azd2171
5281391|NCT00502060|ZD1839|zd1839
5281392|NCT00502060|solid tumor|solid tumor
5281393|NCT00502047|plantago ovata husk|plantago ovata husk
5281394|NCT00502047|soluble fibre|soluble fibre
5281395|NCT00502047|hypercholesterolemia|hypercholesterolemia
5281396|NCT00502047|cardiovascular risk factor|cardiovascular risk factor
5281397|NCT00502034|Carcinoma, Renal Cell|carcinoma, renal cell
5281398|NCT00502034|Low-dose Interleukin|low-dose interleukin
5281399|NCT00502034|Adjuvant Immunotherapy|adjuvant immunotherapy
5281400|NCT00502021|obesity|obesity
5281401|NCT00502021|alpha linolenic acid|alpha linolenic acid
5281402|NCT00502021|flaxseed|flaxseed
5281403|NCT00502021|C-reactive protein|c-reactive protein
5281404|NCT00502021|inflammation|inflammation
5281405|NCT00502008|Diabetes|diabetes
5281406|NCT00502008|India|india
5281407|NCT00502008|Coccinia Cordifolia|coccinia cordifolia
5281408|NCT00502008|Coccinia indica|coccinia indica
5281409|NCT00502008|Blood glucose levels|blood glucose levels
5281410|NCT00501995|High Dose Cyclophosphamide|high dose cyclophosphamide
5281411|NCT00501995|Systemic Sclerosis|systemic sclerosis
5281412|NCT00501995|Scleroderma|scleroderma
5281413|NCT00501995|immunoablation|immunoablation
5281414|NCT00501982|surfactant|surfactant
5281416|NCT00501982|nCPAP|ncpap
5281417|NCT00501982|Mechanical Ventilation|mechanical ventilation
5281418|NCT00501982|Premature Infants|premature infants
5281419|NCT00501982|Neonatal Respiratory Distress Syndrome (nRDS)|neonatal respiratory distress syndrome (nrds)
5281420|NCT00501969|Rotigotine|rotigotine
5281421|NCT00501969|Neupro®|neupro®
5281422|NCT00501956|chronic renal replacement therapy|chronic renal replacement therapy
5281423|NCT00501956|malnutrition anorexia|malnutrition anorexia
5281424|NCT00501956|parenteral nutrition|parenteral nutrition
5281425|NCT00501930|Dose Escalation;|dose escalation;
5281426|NCT00501930|Supratherapeutic;|supratherapeutic;
5281427|NCT00501930|GSK189075;|gsk189075;
5281428|NCT00501930|Diabetes|diabetes
5281429|NCT00501917|acute myocardial infarction|acute myocardial infarction
5281430|NCT00501904|Anovulation|anovulation
5281431|NCT00501904|Infertility|infertility
5281432|NCT00501904|Metformin|metformin
5281433|NCT00501904|PCOS|pcos
5281434|NCT00501904|Treatment|treatment
5281435|NCT00501891|Glioblastoma Multiforme|glioblastoma multiforme
5281436|NCT00501891|Brain and Central Nervous System Tumors|brain and central nervous system tumors
5281437|NCT00501891|Recurrent Malignant Glioma|recurrent malignant glioma
5282058|NCT00499889|Leukemia|leukemia
5281438|NCT00501891|Recurrent Glioblastoma Multiforme|recurrent glioblastoma multiforme
5281439|NCT00501891|Avastin|avastin
5281440|NCT00501891|Bevacizumab|bevacizumab
5281441|NCT00501891|Temodar|temodar
5281442|NCT00501891|Temozolomide|temozolomide
5281443|NCT00501878|phenylephrine|phenylephrine
5281444|NCT00501878|mydriasis|mydriasis
5281445|NCT00501878|diabetes mellitus|diabetes mellitus
5281446|NCT00501865|healthy volunteers|healthy volunteers
5281447|NCT00501865|food effect,|food effect,
5281448|NCT00501865|quantitative pharmacokinetic analysis,|quantitative pharmacokinetic analysis,
5281449|NCT00501865|GW273225,|gw273225,
5281450|NCT00501852|COPD, Age≥40 yrs, Glycopyrronium Bromide|copd, age≥40 yrs, glycopyrronium bromide
5281451|NCT00501839|Anovulation|anovulation
5281452|NCT00501839|Clomiphene citrate|clomiphene citrate
5281453|NCT00501839|Infertility|infertility
5281454|NCT00501839|PCOS|pcos
5281455|NCT00501839|Treatment|treatment
5281456|NCT00501826|Leukemia|leukemia
5281457|NCT00501826|ALL|all
5281458|NCT00501826|T-cell ALL|t-cell all
5281459|NCT00501826|Lymphoblastic Lymphoma|lymphoblastic lymphoma
5281460|NCT00501826|Hyper-CVAD|hyper-cvad
5281461|NCT00501826|Doxorubicin|doxorubicin
5281462|NCT00501826|Cyclophosphamide|cyclophosphamide
5281463|NCT00501826|Cytarabine|cytarabine
5281464|NCT00501826|Dexamethasone|dexamethasone
5281465|NCT00501826|Methotrexate|methotrexate
5281466|NCT00501826|Vincristine|vincristine
5281467|NCT00501826|Nelarabine|nelarabine
5281468|NCT00501813|Hepatocellular carcinoma|hepatocellular carcinoma
5281469|NCT00501813|Intrahepatic vessels invasion|intrahepatic vessels invasion
5281470|NCT00501813|Hepatectomy|hepatectomy
5281471|NCT00501813|Transcatheter arterial chemoembolization|transcatheter arterial chemoembolization
5281472|NCT00501813|Local regional treatment|local regional treatment
5281473|NCT00501800|Reproductive Health|reproductive health
5281474|NCT00501800|Fertility|fertility
5281475|NCT00501800|Infertility|infertility
5281476|NCT00501800|Genetics|genetics
5281477|NCT00501800|Continental Population Groups|continental population groups
5281478|NCT00501800|Epidemiology|epidemiology
5281479|NCT00501800|Aging|aging
5281480|NCT00501800|Health|health
5281481|NCT00501787|Anovulation|anovulation
5281482|NCT00501787|metformin|metformin
5281483|NCT00501787|PCOS|pcos
5281484|NCT00501787|treatment|treatment
5281485|NCT00501774|Localized vulvodynia|localized vulvodynia
5281486|NCT00501774|Helicobacter pylori|helicobacter pylori
5281487|NCT00501774|peptic disease|peptic disease
5281488|NCT00501774|omeprazole|omeprazole
5281489|NCT00501761|Endometrial Cancer|endometrial cancer
5281490|NCT00501761|Healthy Controls|healthy controls
5281491|NCT00501761|Social Cognitive Theory|social cognitive theory
5281492|NCT00501761|Behavioral Intervention|behavioral intervention
5281493|NCT00501761|Physical Activity|physical activity
5281494|NCT00501761|Exercise Program|exercise program
5281495|NCT00501761|Questionnaire|questionnaire
5281496|NCT00501748|Neuromyelitis Optica|neuromyelitis optica
5281497|NCT00501748|acute transverse myelitis|acute transverse myelitis
5281498|NCT00501735|T-Cell|t-cell
5281499|NCT00501735|Lymphoma|lymphoma
5281500|NCT00501735|Forodesine|forodesine
5281501|NCT00501735|Mycosis Fungoides|mycosis fungoides
5281502|NCT00501722|cirrhotic ascites|cirrhotic ascites
5281503|NCT00501722|hyponatraemia|hyponatraemia
5281504|NCT00501683|metabolite profiling|metabolite profiling
5281505|NCT00501683|excretion,|excretion,
5281506|NCT00501683|radioactivity,|radioactivity,
5281507|NCT00501683|pharmacokinetic,|pharmacokinetic,
5281508|NCT00501683|mass balance,|mass balance,
5281509|NCT00501670|Herpes zoster|herpes zoster
5281510|NCT00501670|PCR|pcr
5281511|NCT00501670|Varicella zoster Virus (VZV)|varicella zoster virus (vzv)
5281512|NCT00501670|Shingles|shingles
5281513|NCT00501670|GSK Biologicals|gsk biologicals
5281514|NCT00501657|gastric emptying|gastric emptying
5281515|NCT00501657|glycemia|glycemia
5281516|NCT00501657|appetite|appetite
5281517|NCT00501657|incretin hormones|incretin hormones
5281518|NCT00501644|Müllerian Carcinomas|müllerian carcinomas
5281519|NCT00501644|Ovarian Cancer|ovarian cancer
5281520|NCT00501644|Fallopian Tube Cancer|fallopian tube cancer
5281521|NCT00501644|Peritoneal Cancer|peritoneal cancer
5281522|NCT00501644|Epithelial Ovarian|epithelial ovarian
5281523|NCT00501644|Peritoneal|peritoneal
5281524|NCT00501644|Fallopian Tube|fallopian tube
5281525|NCT00501644|Chemoimmunotherapy|chemoimmunotherapy
5281526|NCT00501644|Platinum Sensitive Müllerian|platinum sensitive müllerian
5281527|NCT00501644|Carboplatin|carboplatin
5281528|NCT00501644|Paraplatin|paraplatin
5281529|NCT00501644|GM-CSF|gm-csf
5281530|NCT00501644|Sargramostim|sargramostim
5281531|NCT00501644|Interferon Gamma|interferon gamma
5281532|NCT00501644|Quality of Life|quality of life
5281533|NCT00501644|QOL|qol
5281534|NCT00501631|Addiction|addiction
5281535|NCT00501631|Alcoholism|alcoholism
5281536|NCT00501631|Inpatient detoxification|inpatient detoxification
5281537|NCT00501618|Schizophrenia|schizophrenia
5281538|NCT00501618|Schizoaffective Disorder|schizoaffective disorder
5281539|NCT00501618|Orally dissolving clozapine|orally dissolving clozapine
5281540|NCT00501618|orally disintegrating clozapine|orally disintegrating clozapine
5281541|NCT00501618|bio-equivalence|bio-equivalence
5281542|NCT00501618|desmethylclozapine|desmethylclozapine
5281543|NCT00501618|clozapine plasma level|clozapine plasma level
5281544|NCT00501618|equivalence|equivalence
5281545|NCT00501618|fazaclo|fazaclo
5281546|NCT00501618|generic clozapine|generic clozapine
5281547|NCT00501605|Phase I|phase i
5281548|NCT00501605|AZD2171|azd2171
5281549|NCT00501605|advanced solid tumors|advanced solid tumors
5281550|NCT00501592|Farnesoid X receptor agonist|farnesoid x receptor agonist
5281551|NCT00501592|Metabolic Disorder|metabolic disorder
5281552|NCT00501592|Diabetes|diabetes
5281553|NCT00501592|NAFLD|nafld
5281554|NCT00501566|cirrhotic ascites|cirrhotic ascites
5281555|NCT00501553|Heart Failure,|heart failure,
5281556|NCT00501553|Vitamin D status,|vitamin d status,
5281557|NCT00501553|NT-proBNP|nt-probnp
5281558|NCT00501540|low-grade neuroendocrine tumors|low-grade neuroendocrine tumors
5281559|NCT00501540|lithium|lithium
5281560|NCT00501527|Allergoid|allergoid
5281561|NCT00501527|Depigmented|depigmented
5281562|NCT00501527|Polymerized|polymerized
5281563|NCT00501527|Allergen-extract|allergen-extract
5281564|NCT00501527|Rhinoconjunctivitis|rhinoconjunctivitis
5281565|NCT00501527|Asthma|asthma
5281566|NCT00501514|chronic heart failure|chronic heart failure
5281567|NCT00501514|cardiopulmonary exercise|cardiopulmonary exercise
5281568|NCT00501514|oxygen consumption|oxygen consumption
5281569|NCT00501514|growth hormone|growth hormone
5281570|NCT00501501|Rehospitalization|rehospitalization
5281571|NCT00501501|Cesarean|cesarean
5281572|NCT00501501|Vaginal delivery|vaginal delivery
5281573|NCT00501488|pharmacodynamics|pharmacodynamics
5281574|NCT00501488|insulin resistance|insulin resistance
5281575|NCT00501488|therapy|therapy
5281576|NCT00501488|volunteer|volunteer
5281577|NCT00501475|N-acetylcysteine|n-acetylcysteine
5281578|NCT00501475|nephropathy|nephropathy
5281579|NCT00501475|bicarbonate|bicarbonate
5281580|NCT00501462|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
5281581|NCT00501462|renal insufficiency|renal insufficiency
5281582|NCT00501449|Multiple Endocrine Neoplasia|multiple endocrine neoplasia
5281583|NCT00501449|Questionnaire|questionnaire
5281584|NCT00501449|Psychosocial|psychosocial
5281585|NCT00501449|Surveillance Behaviors|surveillance behaviors
5281586|NCT00501449|MEN Syndromes|men syndromes
5281587|NCT00501423|antiplatelet drug|antiplatelet drug
5281588|NCT00501423|resistance|resistance
5281589|NCT00501423|atherothrombosis|atherothrombosis
5281590|NCT00501410|Colorectal Cancer|colorectal cancer
5281591|NCT00501410|Dual Inhibition of EGFR|dual inhibition of egfr
5281592|NCT00501410|FOLFOX Chemotherapy|folfox chemotherapy
5281593|NCT00501410|5-FU|5-fu
5281594|NCT00501410|Cetuximab|cetuximab
5281595|NCT00501410|Dasatinib|dasatinib
5281596|NCT00501410|Leucovorin|leucovorin
5281597|NCT00501410|Oxaliplatin|oxaliplatin
5281598|NCT00501410|5-Fluorouracil|5-fluorouracil
5281599|NCT00501410|BMS-354825|bms-354825
5281600|NCT00501410|Eloxatin|eloxatin
5281601|NCT00501410|Sprycel|sprycel
5281602|NCT00501410|C225|c225
5281603|NCT00501410|Erbitux|erbitux
5281604|NCT00501410|IMC-C225|imc-c225
5281605|NCT00501410|Adrucil|adrucil
5281606|NCT00501410|Efudex|efudex
5281607|NCT00501410|Folinic Acid|folinic acid
5281608|NCT00501397|ketoconazole,|ketoconazole,
5281609|NCT00501397|drug interaction,|drug interaction,
5281610|NCT00501397|pharmacokinetics|pharmacokinetics
5281611|NCT00501397|T2DM,|t2dm,
5281612|NCT00501384|cirrhotic ascites|cirrhotic ascites
5281613|NCT00501371|Benign Prostatic Hyperplasia|benign prostatic hyperplasia
5281614|NCT00501371|MCS|mcs
5281615|NCT00501371|Lower Urinary Tract Symptoms|lower urinary tract symptoms
5281616|NCT00501371|International prostate symptom score|international prostate symptom score
5281617|NCT00501371|Voiding|voiding
5281618|NCT00501371|Alpha-blockers|alpha-blockers
5281619|NCT00501358|SLEEP APNEA|sleep apnea
5281620|NCT00501358|venous thromboembolism|venous thromboembolism
5281621|NCT00501358|COAGULABILITY|coagulability
5281622|NCT00501358|COAGULATION FACTORS|coagulation factors
5281623|NCT00501358|HYPOXIA|hypoxia
5281624|NCT00501345|Thrombocytopenia|thrombocytopenia
5281625|NCT00501345|Platelet Function|platelet function
5281626|NCT00501345|Acute Coronary Syndrome|acute coronary syndrome
5281627|NCT00501345|Myocardial Infarction|myocardial infarction
5281628|NCT00501345|Heart Attack|heart attack
5281629|NCT00501345|Aspirin|aspirin
5281630|NCT00501332|neutropenia|neutropenia
5281631|NCT00501332|breast|breast
5281632|NCT00501332|cancer|cancer
5281633|NCT00501332|chemotherapy|chemotherapy
5281634|NCT00501319|Interactive Voice Response Telephone System|interactive voice response telephone system
5281635|NCT00501319|Non-Small Cell Lung Cancer|non-small cell lung cancer
5281636|NCT00501319|Lung Cancer|lung cancer
5281637|NCT00501319|Questionnaire|questionnaire
5281638|NCT00501319|Survey|survey
5281639|NCT00501319|NSCLC|nsclc
5281640|NCT00501319|IVR|ivr
5281641|NCT00501306|Condyloma Accuminata|condyloma accuminata
5281642|NCT00501306|Low Grade Squamous Intraepithelial Lesion|low grade squamous intraepithelial lesion
5281643|NCT00501306|High Grade Squamous Intraepithelial Lesion|high grade squamous intraepithelial lesion
5281644|NCT00501306|Anal Cancer Screening|anal cancer screening
5281645|NCT00501280|Epidemiology|epidemiology
5281646|NCT00501280|Genetic Susceptibility|genetic susceptibility
5281647|NCT00501280|Migrant Farmworker Children|migrant farmworker children
5281648|NCT00501280|Migrant Education Program|migrant education program
5281649|NCT00501280|Interview|interview
5281650|NCT00501280|Questionnaire|questionnaire
5281651|NCT00501267|solabegron,|solabegron,
5281652|NCT00501267|oxybutynin,|oxybutynin,
5281653|NCT00501267|healthy adults,|healthy adults,
5281654|NCT00501267|drug interaction|drug interaction
5281655|NCT00501254|Slow release ASA|slow release asa
5281656|NCT00501254|Platelet functionalism|platelet functionalism
5281657|NCT00501254|Secondary cardiovascular prevention|secondary cardiovascular prevention
5281658|NCT00501228|Graft-Versus-Host Disease|graft-versus-host disease
5281659|NCT00501228|Stem Cell Transplantation|stem cell transplantation
5281660|NCT00501228|Tissue Repair|tissue repair
5281661|NCT00501228|Organ-Specific Tissue Damage|organ-specific tissue damage
5281662|NCT00501228|Filgrastim|filgrastim
5281663|NCT00501228|RhG-CSF|rhg-csf
5281664|NCT00501215|Primary Hyperparathyroidism|primary hyperparathyroidism
5281665|NCT00501215|PHPT|phpt
5281666|NCT00501215|Parathyroidectomy|parathyroidectomy
5281667|NCT00501215|Polysomnogram|polysomnogram
5281668|NCT00501215|PSG|psg
5281669|NCT00501215|Sleep Quality|sleep quality
5281670|NCT00501215|Interview|interview
5281671|NCT00501202|diabetes mellitus|diabetes mellitus
5281672|NCT00501202|diabetic microvascular injury|diabetic microvascular injury
5281673|NCT00501202|painful polyneuropathy.|painful polyneuropathy.
5281674|NCT00501189|Gardasil|gardasil
5281675|NCT00501189|Human Papilloma Virus|human papilloma virus
5281676|NCT00501189|Papanicolaou Smear|papanicolaou smear
5281677|NCT00501189|ASCUS|ascus
5281678|NCT00501189|LGSIL|lgsil
5281679|NCT00501189|Human Papilloma Virus Vaccine|human papilloma virus vaccine
5281680|NCT00501189|Human Papillomavirus Infection|human papillomavirus infection
5281681|NCT00501176|Pancreas|pancreas
5281682|NCT00501176|cancer|cancer
5281683|NCT00501176|SEMS|sems
5281684|NCT00501176|Plastic|plastic
5281685|NCT00501176|stent|stent
5281686|NCT00501176|Whipple|whipple
5281687|NCT00501176|Jaundicie|jaundicie
5281688|NCT00501163|Schizophrenia|schizophrenia
5281689|NCT00501163|Cardiovascular|cardiovascular
5281690|NCT00501163|Risk|risk
5281691|NCT00501150|linezolid|linezolid
5281692|NCT00501150|vancomycin|vancomycin
5281693|NCT00501150|glycopeptides|glycopeptides
5281694|NCT00501150|methicillin resistant staphylococcus aureus|methicillin resistant staphylococcus aureus
5281695|NCT00501150|resistant gram positive infections|resistant gram positive infections
5281696|NCT00501137|HPV|hpv
5281697|NCT00501137|HPV vaccine|hpv vaccine
5281698|NCT00501137|Gardasil|gardasil
5281699|NCT00501137|Human Papillomavirus|human papillomavirus
5281700|NCT00501137|vaccine|vaccine
5281701|NCT00501137|2 dose versus 3|2 dose versus 3
5281702|NCT00501111|Dementia|dementia
5281703|NCT00501111|Alzheimer Type|alzheimer type
5281704|NCT00501111|Alzheimer Disease|alzheimer disease
5281705|NCT00501098|Leukemia|leukemia
5281706|NCT00501098|Prophylaxis|prophylaxis
5281707|NCT00501098|Fungal Infections|fungal infections
5281708|NCT00501098|Caspofungin|caspofungin
5281709|NCT00501072|hyperglycemia|hyperglycemia
5281710|NCT00501072|hypoglycemia|hypoglycemia
5281711|NCT00501072|glucose variability|glucose variability
5281712|NCT00501072|insulin infusion system; implantable insulin pump|insulin infusion system; implantable insulin pump
5281713|NCT00501072|continuous glucose monitoring|continuous glucose monitoring
5281714|NCT00501059|Primary prevention of coronary heart disease|primary prevention of coronary heart disease
5281715|NCT00501059|Stroke and cardiovascular death|stroke and cardiovascular death
5281716|NCT00501059|Aspirin|aspirin
5281717|NCT00501046|Kidney Diseases|kidney diseases
5281718|NCT00501033|Induction of labor|induction of labor
5281719|NCT00501033|Cesarean|cesarean
5281720|NCT00501033|Endometritis|endometritis
5281721|NCT00501033|Foley|foley
5281722|NCT00501033|Infections|infections
5281723|NCT00501020|Type 2 Diabetes|type 2 diabetes
5281724|NCT00501020|metformin|metformin
5281725|NCT00501020|rosiglitazone|rosiglitazone
5281726|NCT00500994|Conversion Disorder|conversion disorder
5281727|NCT00500994|Psychogenic Movement Disorders|psychogenic movement disorders
5281728|NCT00500994|Non-Epileptic Seizure|non-epileptic seizure
5281729|NCT00500994|Functional Magnetic Resonance Imaging (fMRI)|functional magnetic resonance imaging (fmri)
5281730|NCT00500994|Genetic Polymorphisms|genetic polymorphisms
5281731|NCT00500994|Psychogenic Movement Disorder|psychogenic movement disorder
5281732|NCT00500994|PMD|pmd
5281733|NCT00500994|NES|nes
5281734|NCT00500994|Healthy Volunteer|healthy volunteer
5281735|NCT00500994|HV|hv
5281736|NCT00500981|Fluid responsiveness|fluid responsiveness
5281737|NCT00500968|Pancreas|pancreas
5281738|NCT00500968|Leakage|leakage
5281739|NCT00500968|Fistula|fistula
5281740|NCT00500968|tail|tail
5281741|NCT00500955|microalbuminuria,|microalbuminuria,
5281742|NCT00500955|Type 2 Diabetes|type 2 diabetes
5281743|NCT00500955|rosiglitazone,|rosiglitazone,
5281744|NCT00500942|Interventional Radiology|interventional radiology
5281745|NCT00500942|Pain Quantification|pain quantification
5281746|NCT00500942|Pain Management|pain management
5281747|NCT00500942|Patient Satisfaction|patient satisfaction
5281748|NCT00500942|Questionnaire|questionnaire
5281749|NCT00500942|Survey|survey
5281750|NCT00500929|OHSP|ohsp
5281751|NCT00500929|High risk|high risk
5281752|NCT00500929|Geriatrics|geriatrics
5281753|NCT00500903|Advanced malignancies|advanced malignancies
5281754|NCT00500890|Choroid Plexus Tumors|choroid plexus tumors
5281755|NCT00500890|Carboplatin|carboplatin
5281756|NCT00500890|Cyclophosphamide|cyclophosphamide
5281757|NCT00500890|Etoposide|etoposide
5281758|NCT00500890|Vincristine|vincristine
5281759|NCT00500890|Paraplatin|paraplatin
5281760|NCT00500890|Cytoxan|cytoxan
5281761|NCT00500890|Neosar|neosar
5281762|NCT00500877|Smoking cessation|smoking cessation
5281763|NCT00500877|Phone Counseling|phone counseling
5281764|NCT00500864|COPD|copd
5281765|NCT00500864|Magnesium|magnesium
5281766|NCT00500864|Pulmonary function|pulmonary function
5281767|NCT00500864|Exercise Physiology|exercise physiology
5281768|NCT00500851|critical illness|critical illness
5281769|NCT00500851|enteral nutrition|enteral nutrition
5281770|NCT00500851|gastrointestinal intubation|gastrointestinal intubation
5281771|NCT00500838|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
5281772|NCT00500838|Transthoracic Impedance|transthoracic impedance
5281773|NCT00500825|Cardiopulmonary resuscitation|cardiopulmonary resuscitation
5281774|NCT00500825|Therapeutic hypothermia|therapeutic hypothermia
5281775|NCT00500825|resting energy expenditure|resting energy expenditure
5281776|NCT00500812|biologic drug|biologic drug
5281777|NCT00500812|transport sequence|transport sequence
5281779|NCT00500812|spinal cord injury|spinal cord injury
5281780|NCT00500812|paralysis|paralysis
5281781|NCT00500812|paraplegia|paraplegia
5281782|NCT00500812|tetraplegia|tetraplegia
5281783|NCT00500812|quadraplegia|quadraplegia
5281784|NCT00500812|trauma|trauma
5281785|NCT00500812|nervous system|nervous system
5281786|NCT00500812|fibrin sealant|fibrin sealant
5281787|NCT00500812|neurosurgery|neurosurgery
5281788|NCT00500799|Transcranial Magnetic Stimulation (TMS)|transcranial magnetic stimulation (tms)
5281789|NCT00500799|Blink Reflex|blink reflex
5281790|NCT00500799|Blepharospasm|blepharospasm
5281791|NCT00500799|Healthy Volunteer|healthy volunteer
5281792|NCT00500799|HV|hv
5281793|NCT00500773|cardiovascular risc factors|cardiovascular risc factors
5281794|NCT00500773|inflammation|inflammation
5281795|NCT00500773|aerobic and exertional exercise|aerobic and exertional exercise
5281796|NCT00500760|Head and Neck Cancer|head and neck cancer
5281797|NCT00500760|panitumumab|panitumumab
5281798|NCT00500747|hepatitis C, HCV, vaccine, recombinant vaccine, adjuvant|hepatitis c, hcv, vaccine, recombinant vaccine, adjuvant
5281799|NCT00500734|Cardiomyopathy|cardiomyopathy
5281800|NCT00500734|Tissue Bank|tissue bank
5281801|NCT00500734|Heart Disease|heart disease
5281802|NCT00500734|Heart Failure|heart failure
5281803|NCT00500734|Congestive Heart Failure|congestive heart failure
5281804|NCT00500721|healthy subjects|healthy subjects
5281805|NCT00500708|Heart failure|heart failure
5281806|NCT00500708|Implanted Cardioverter Defibrillator|implanted cardioverter defibrillator
5281807|NCT00500708|Biological Markers|biological markers
5281808|NCT00500708|Molecular Genetics|molecular genetics
5281809|NCT00500708|Coronary Heart Disease|coronary heart disease
5281810|NCT00500708|Gene Expression|gene expression
5281811|NCT00500708|GES|ges
5281812|NCT00500708|CVD|cvd
5281813|NCT00500708|CHD|chd
5281814|NCT00500708|Precision Medicine|precision medicine
5281815|NCT00500708|Genome-wide association study|genome-wide association study
5281816|NCT00500708|Cardiovascular Disease|cardiovascular disease
5281817|NCT00500708|CAD|cad
5281818|NCT00500708|GWAS|gwas
5281819|NCT00500708|DISCERN|discern
5281820|NCT00500682|Kidney Diseases|kidney diseases
5281821|NCT00500669|Varicose veins|varicose veins
5281822|NCT00500669|wound infection|wound infection
5281823|NCT00500669|recurrence|recurrence
5281824|NCT00500617|Atherosclerosis|atherosclerosis
5281825|NCT00500617|Biological Markers|biological markers
5281826|NCT00500617|Molecular Genetics|molecular genetics
5281827|NCT00500617|Gene Expression|gene expression
5281828|NCT00500617|GES|ges
5281829|NCT00500617|CAD|cad
5281830|NCT00500617|CVD|cvd
5281831|NCT00500617|CHD|chd
5281832|NCT00500617|Clinical Validity|clinical validity
5281833|NCT00500617|Precision Medicine|precision medicine
5281834|NCT00500617|ASGES|asges
5281835|NCT00500617|CT Angiography|ct angiography
5281836|NCT00500617|Corus CAD|corus cad
5281837|NCT00500617|Coronary angiorgram|coronary angiorgram
5281838|NCT00500617|Age/Sex/Gene expression Score|age/sex/gene expression score
5281839|NCT00500617|Coronary Artery Disease|coronary artery disease
5281840|NCT00500617|Angina Pectoris|angina pectoris
5281841|NCT00500617|Chest Pain|chest pain
5281842|NCT00500617|Cardiovascular Disease|cardiovascular disease
5281843|NCT00500617|Coronary Heart Disease|coronary heart disease
5281844|NCT00500617|CTA|cta
5281845|NCT00500617|PREDICT|predict
5281846|NCT00500591|Endometrial Abnormalities|endometrial abnormalities
5281847|NCT00500591|Endometrial Cancer|endometrial cancer
5281848|NCT00500591|Obesity|obesity
5281849|NCT00500591|Survey|survey
5281850|NCT00500591|Questionnaire|questionnaire
5281851|NCT00500578|Hematological Malignancies|hematological malignancies
5281852|NCT00500578|Respiratory Infection|respiratory infection
5281853|NCT00500578|Respiratory Syncytial Virus|respiratory syncytial virus
5281854|NCT00500578|RSV|rsv
5281855|NCT00500578|Ribavirin|ribavirin
5281856|NCT00500578|Virazole|virazole
5281857|NCT00500565|Breast Cancer|breast cancer
5281858|NCT00500565|On-Q Pain Relief System|on-q pain relief system
5281859|NCT00500565|Transverse Rectus Abdominous Myocutaneous|transverse rectus abdominous myocutaneous
5281860|NCT00500565|Breast Reconstruction|breast reconstruction
5281861|NCT00500565|TRAM flap|tram flap
5281862|NCT00500565|Bupivicaine|bupivicaine
5281863|NCT00500565|Pain Management|pain management
5281864|NCT00500552|Perhexiline|perhexiline
5281865|NCT00500552|Hypertrophic Cardiomyopathy|hypertrophic cardiomyopathy
5281866|NCT00500539|Asthma|asthma
5281867|NCT00500539|omalizumab|omalizumab
5281868|NCT00500539|safety|safety
5281869|NCT00500539|allergic asthma|allergic asthma
5281870|NCT00500539|adolescents|adolescents
5281871|NCT00500526|COPD|copd
5281872|NCT00500526|Pulmonary function|pulmonary function
5281873|NCT00500526|Respiratory muscle|respiratory muscle
5281874|NCT00500526|Dyspnea|dyspnea
5281875|NCT00500526|Quality of life|quality of life
5281876|NCT00500513|Lung Cancer|lung cancer
5281877|NCT00500513|Respiratory-Induced Tumor Motion|respiratory-induced tumor motion
5281878|NCT00500513|Tumor Motion|tumor motion
5281879|NCT00500513|Pulmonary Function|pulmonary function
5281880|NCT00500513|Fiducial Marker|fiducial marker
5281881|NCT00500487|HIV prevention|hiv prevention
5281882|NCT00500487|HIV seronegativity|hiv seronegativity
5281883|NCT00500474|Meniere's disease|meniere's disease
5281884|NCT00500474|inner ear|inner ear
5281885|NCT00500474|endolymphatic sac drainage|endolymphatic sac drainage
5281886|NCT00500474|steroids|steroids
5281887|NCT00500474|declined surgery|declined surgery
5281888|NCT00500474|natural course|natural course
5281889|NCT00500474|Efficacy of steroids via endolymphatic sac|efficacy of steroids via endolymphatic sac
5281890|NCT00500474|for intractable Meniere's disease|for intractable meniere's disease
5281891|NCT00500461|Muscarinic Receptor Antagonist,|muscarinic receptor antagonist,
5281892|NCT00500461|intravenous infusion,|intravenous infusion,
5281893|NCT00500461|pharmacokinetics|pharmacokinetics
5281894|NCT00500461|healthy subjects,|healthy subjects,
5281895|NCT00500461|safety,|safety,
5281896|NCT00500461|tolerability,|tolerability,
5281897|NCT00500461|Anticholinergic,|anticholinergic,
5281898|NCT00500461|oral dosing,|oral dosing,
5281899|NCT00500448|Arthritis, Knee, Quadriceps, Electrical Stimulation, Women|arthritis, knee, quadriceps, electrical stimulation, women
5281900|NCT00500435|Cervical Cancer|cervical cancer
5281901|NCT00500435|Laparoscopy|laparoscopy
5281902|NCT00500435|Lymph Node Dissection|lymph node dissection
5281903|NCT00500435|Extraperitoneal Laparoscopic Lymphadenectomy|extraperitoneal laparoscopic lymphadenectomy
5281904|NCT00500422|Solid Tumors|solid tumors
5281905|NCT00500422|Doxil|doxil
5281906|NCT00500422|Adriamycin|adriamycin
5281907|NCT00500422|Pegylated Liposomal Doxorubicin|pegylated liposomal doxorubicin
5281908|NCT00500422|Liposomal Doxorubicin|liposomal doxorubicin
5281909|NCT00500422|Doxorubicin Hydrochloride|doxorubicin hydrochloride
5281910|NCT00500422|Gemcitabine|gemcitabine
5281911|NCT00500422|Gemzar|gemzar
5281912|NCT00500422|Bortezomib|bortezomib
5281913|NCT00500422|Velcade|velcade
5281914|NCT00500422|PS341|ps341
5281915|NCT00500422|PS-341|ps-341
5281916|NCT00500422|LDP-341|ldp-341
5281917|NCT00500422|MLN341|mln341
5281918|NCT00500409|rhPTH(1-34)|rhpth(1-34)
5281919|NCT00500409|Osteoporosis|osteoporosis
5281920|NCT00500396|Retinopathy of Prematurity.|retinopathy of prematurity.
5281921|NCT00500396|ROP.|rop.
5281922|NCT00500396|Vascular Endothelial Growth Factor.|vascular endothelial growth factor.
5281923|NCT00500396|VEGF.|vegf.
5281924|NCT00500396|Vitreous.|vitreous.
5281925|NCT00500396|Subretinal Fluid.|subretinal fluid.
5281926|NCT00500396|ELISA.|elisa.
5281927|NCT00500383|Breast Cancer Risk|breast cancer risk
5281928|NCT00500383|BRCA1|brca1
5281929|NCT00500383|BRCA2|brca2
5281930|NCT00500383|Breast Cancer Susceptibility gene|breast cancer susceptibility gene
5281931|NCT00500383|Optical Transillumination Spectroscopy|optical transillumination spectroscopy
5281932|NCT00500383|Transillumination Breast Spectroscopy|transillumination breast spectroscopy
5281933|NCT00500370|exenatide|exenatide
5281934|NCT00500370|obesity|obesity
5281935|NCT00500370|diabetes|diabetes
5281936|NCT00500370|Amylin|amylin
5281937|NCT00500370|Lilly|lilly
5281938|NCT00500344|Age-related Macular Degeneration|age-related macular degeneration
5281939|NCT00500344|Choroidal Neovascularization|choroidal neovascularization
5281940|NCT00500344|Electroretinography|electroretinography
5281941|NCT00500344|Retinal Function|retinal function
5281942|NCT00500331|Pioglitazone|pioglitazone
5281943|NCT00500331|HbA1c|hba1c
5281944|NCT00500331|Diabetes mellitus|diabetes mellitus
5281945|NCT00500318|Bronchitis, Chronic; Emphysema|bronchitis, chronic; emphysema
5281946|NCT00500305|indomethacin therapy|indomethacin therapy
5281947|NCT00500305|patent ductus arteriosus|patent ductus arteriosus
5281948|NCT00500292|colorectal|colorectal
5281949|NCT00500292|cancer|cancer
5281950|NCT00500292|zactima|zactima
5281951|NCT00500279|Drug-eluting stent|drug-eluting stent
5281952|NCT00500279|Restenosis|restenosis
5281953|NCT00500279|Celecoxib|celecoxib
5281954|NCT00500253|exhaled nitric oxide|exhaled nitric oxide
5281955|NCT00500253|asthma|asthma
5281956|NCT00500253|children|children
5281957|NCT00500253|inhaled glucocorticosteroids|inhaled glucocorticosteroids
5281958|NCT00500240|Acute Lymphocytic Leukemia|acute lymphocytic leukemia
5281959|NCT00500240|Leukemia|leukemia
5281960|NCT00500240|Lymphoma|lymphoma
5281961|NCT00500240|Burkitts Lymphoma|burkitts lymphoma
5281962|NCT00500240|Lymphoblastic Leukemia|lymphoblastic leukemia
5281963|NCT00500240|Blood Sugar|blood sugar
5281964|NCT00500240|Hyperglycemia|hyperglycemia
5281965|NCT00500240|Insulin Aspart|insulin aspart
5281966|NCT00500240|Insulin Glargine|insulin glargine
5281967|NCT00500240|Hyper-CVAD|hyper-cvad
5281968|NCT00500214|inguinal hernia|inguinal hernia
5281969|NCT00500214|herniorrhaphy|herniorrhaphy
5281970|NCT00500214|mesh repair|mesh repair
5281971|NCT00500214|ilioinguinal neurectomy|ilioinguinal neurectomy
5281972|NCT00500214|postoperative pain in cases and controls during one year.|postoperative pain in cases and controls during one year.
5281973|NCT00500214|postoperative hyposthesia in cases and controls during one year.|postoperative hyposthesia in cases and controls during one year.
5281974|NCT00500201|Healthy Volunteer|healthy volunteer
5281975|NCT00500188|Gastrointestinal Stromal Tumors|gastrointestinal stromal tumors
5281976|NCT00500188|GIST|gist
5281977|NCT00500188|Kit expression|kit expression
5281978|NCT00500188|Resectable|resectable
5281979|NCT00500188|Imatinib Mesylate|imatinib mesylate
5281980|NCT00500188|Gleevec|gleevec
5281981|NCT00500188|STI-571|sti-571
5281982|NCT00500188|Imatinib|imatinib
5281983|NCT00500188|NSC-716051|nsc-716051
5281984|NCT00500175|diabetes|diabetes
5281985|NCT00500175|ulceration|ulceration
5281986|NCT00500175|amputation|amputation
5281987|NCT00500175|pressure sores|pressure sores
5281988|NCT00500175|shear friction|shear friction
5281989|NCT00500136|bias|bias
5281990|NCT00500123|alpha-1|alpha-1
5281991|NCT00500123|antitrypsin|antitrypsin
5281993|NCT00500123|genetic testing|genetic testing
5281994|NCT00500123|alpha-1 antitrypsin deficiency|alpha-1 antitrypsin deficiency
5281995|NCT00500123|AATD|aatd
5281996|NCT00500110|Prostate Cancer|prostate cancer
5281997|NCT00500110|Hormonal Ablation|hormonal ablation
5281998|NCT00500110|Docetaxel|docetaxel
5281999|NCT00500110|Imatinib Mesylate|imatinib mesylate
5282000|NCT00500110|STI571|sti571
5282001|NCT00500110|Gleevec|gleevec
5282002|NCT00500110|Taxotere|taxotere
5282003|NCT00500110|Goserelin Acetate|goserelin acetate
5282004|NCT00500110|Zoladex|zoladex
5282005|NCT00500110|Leuprolide|leuprolide
5282006|NCT00500110|Lupron|lupron
5282007|NCT00500084|Chronic Pancreatitis|chronic pancreatitis
5282008|NCT00500084|Pancreatectomy|pancreatectomy
5282009|NCT00500058|Rituximab,|rituximab,
5282010|NCT00500058|oncology|oncology
5282011|NCT00500058|IL-18,|il-18,
5282012|NCT00500058|combination study,|combination study,
5282013|NCT00500058|cytokine,|cytokine,
5282014|NCT00500045|CRVO|crvo
5282015|NCT00500045|HRVO|hrvo
5282016|NCT00500045|BRVO|brvo
5282017|NCT00500032|Adult|adult
5282018|NCT00499980|Breast cancer|breast cancer
5282019|NCT00499980|Spectroscopy, Near-Infrared|spectroscopy, near-infrared
5282020|NCT00499980|Oximetry|oximetry
5282021|NCT00499967|genital warts|genital warts
5282022|NCT00499967|venereal warts|venereal warts
5282023|NCT00499967|human papilloma virus|human papilloma virus
5282024|NCT00499954|microdialysis|microdialysis
5282025|NCT00499954|subcutaneous adipose tissue|subcutaneous adipose tissue
5282026|NCT00499954|glucose sensor|glucose sensor
5282027|NCT00499954|glucose monitoring|glucose monitoring
5282028|NCT00499954|type 1 diabetes|type 1 diabetes
5282029|NCT00499954|Guardian RT|guardian rt
5282030|NCT00499954|Glucoday S|glucoday s
5282031|NCT00499941|Alpha 1-Antitrypsin Deficiency|alpha 1-antitrypsin deficiency
5282032|NCT00499928|SB-751689|sb-751689
5282033|NCT00499928|osteoporosis|osteoporosis
5282034|NCT00499928|metabolism|metabolism
5282035|NCT00499928|excretion|excretion
5282036|NCT00499902|AIS|ais
5282037|NCT00499902|acute ischemic stroke|acute ischemic stroke
5282038|NCT00499902|stroke|stroke
5282039|NCT00499902|alfimeprase|alfimeprase
5282040|NCT00499902|blood clot|blood clot
5282041|NCT00499902|brain|brain
5282042|NCT00499902|thrombus|thrombus
5282043|NCT00499902|thrombolytic|thrombolytic
5282044|NCT00499902|thrombosis|thrombosis
5282045|NCT00499902|plasminogen activator|plasminogen activator
5282046|NCT00499902|arterial flow|arterial flow
5282047|NCT00499902|neurology|neurology
5282048|NCT00499902|intra-arterial|intra-arterial
5282049|NCT00499902|intra-thrombus|intra-thrombus
5282050|NCT00499902|catheter-directed|catheter-directed
5282051|NCT00499902|symptomatic ICH|symptomatic ich
5282052|NCT00499902|ICH|ich
5282053|NCT00499902|AOL|aol
5282054|NCT00499902|arterial occlusive lesion|arterial occlusive lesion
5282055|NCT00499902|recanalization|recanalization
5282056|NCT00499889|Chronic Myelogenous Leukemia|chronic myelogenous leukemia
5282057|NCT00499889|Allogeneic Stem Cell Transplantation|allogeneic stem cell transplantation
5282059|NCT00499889|Imatinib Mesylate|imatinib mesylate
5282060|NCT00499889|Gleevec|gleevec
5282061|NCT00499889|Busulfan|busulfan
5282062|NCT00499889|Busulfex|busulfex
5282063|NCT00499889|Myleran|myleran
5282064|NCT00499889|Fludarabine|fludarabine
5282065|NCT00499889|ATG|atg
5282066|NCT00499889|STI571|sti571
5282067|NCT00499889|Antithymocyte Globulin|antithymocyte globulin
5282068|NCT00499889|Thymoglobulin|thymoglobulin
5282069|NCT00499876|Human immune deficiency virus|human immune deficiency virus
5282070|NCT00499876|Acquired immune deficiency syndrome|acquired immune deficiency syndrome
5282071|NCT00499876|malaria|malaria
5282072|NCT00499876|mefloquine|mefloquine
5282073|NCT00499876|prophylaxis|prophylaxis
5282074|NCT00499876|HIV/AIDS|hiv/aids
5282075|NCT00499876|Treatment Naive|treatment naive
5282076|NCT00499850|ZD6474|zd6474
5282077|NCT00499850|FOLFOX|folfox
5282078|NCT00499850|colorectal|colorectal
5282079|NCT00499850|adenocarcinoma|adenocarcinoma
5282080|NCT00500266|pneumococcal conjugate vaccine|pneumococcal conjugate vaccine
5282081|NCT00500266|vaccine|vaccine
5282082|NCT00499824|Diabetes|diabetes
5282083|NCT00499824|Management guidelines|management guidelines
5282084|NCT00499824|Efficacy|efficacy
5282085|NCT00499798|infertility|infertility
5282086|NCT00499798|chemotherapeutic agent toxicity|chemotherapeutic agent toxicity
5282087|NCT00499798|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5282088|NCT00499798|adult diffuse astrocytoma|adult diffuse astrocytoma
5282089|NCT00499798|adult giant cell glioblastoma|adult giant cell glioblastoma
5282090|NCT00499798|adult gliosarcoma|adult gliosarcoma
5282091|NCT00499798|adult pilocytic astrocytoma|adult pilocytic astrocytoma
5282092|NCT00499798|adult brain stem glioma|adult brain stem glioma
5282093|NCT00499798|adult central nervous system germ cell tumor|adult central nervous system germ cell tumor
5282094|NCT00499798|adult choroid plexus tumor|adult choroid plexus tumor
5282095|NCT00499798|adult craniopharyngioma|adult craniopharyngioma
5282096|NCT00499798|adult ependymoblastoma|adult ependymoblastoma
5282097|NCT00499798|adult medulloblastoma|adult medulloblastoma
5282098|NCT00499798|adult supratentorial primitive neuroectodermal tumor (PNET)|adult supratentorial primitive neuroectodermal tumor (pnet)
5282099|NCT00499798|adult anaplastic ependymoma|adult anaplastic ependymoma
5282100|NCT00499798|adult ependymoma|adult ependymoma
5282101|NCT00499798|adult myxopapillary ependymoma|adult myxopapillary ependymoma
5282102|NCT00499798|adult subependymoma|adult subependymoma
5282103|NCT00499798|adult anaplastic meningioma|adult anaplastic meningioma
5282104|NCT00499798|meningeal melanocytoma|meningeal melanocytoma
5282105|NCT00499798|adult meningeal hemangiopericytoma|adult meningeal hemangiopericytoma
5282106|NCT00499798|adult papillary meningioma|adult papillary meningioma
5282107|NCT00499798|adult grade I meningioma|adult grade i meningioma
5282108|NCT00499798|adult grade II meningioma|adult grade ii meningioma
5282109|NCT00499798|adult grade III meningioma|adult grade iii meningioma
5282110|NCT00499798|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
5282111|NCT00499798|adult oligodendroglioma|adult oligodendroglioma
5282112|NCT00499798|adult pineoblastoma|adult pineoblastoma
5282113|NCT00499798|adult pineocytoma|adult pineocytoma
5282114|NCT00499798|adult mixed glioma|adult mixed glioma
5282115|NCT00499798|recurrent adult brain tumor|recurrent adult brain tumor
5282116|NCT00499798|adult subependymal giant cell astrocytoma|adult subependymal giant cell astrocytoma
5282117|NCT00499785|depression|depression
5282118|NCT00499785|cognitive/functional effects|cognitive/functional effects
5282119|NCT00499785|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
5282120|NCT00499785|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5282121|NCT00499785|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5282122|NCT00499785|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5282123|NCT00499785|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5282124|NCT00499785|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5282125|NCT00499759|fatigue|fatigue
5282126|NCT00499759|depression|depression
5282127|NCT00499759|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
5282128|NCT00499759|musculoskeletal complications|musculoskeletal complications
5282129|NCT00499759|acute undifferentiated leukemia|acute undifferentiated leukemia
5282130|NCT00499759|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5282131|NCT00499759|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5282132|NCT00499759|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5282133|NCT00499759|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5282134|NCT00499759|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5282135|NCT00499759|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
5282136|NCT00499759|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
5282137|NCT00499759|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5282138|NCT00499759|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5282139|NCT00499759|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5282140|NCT00499746|drug discrimination|drug discrimination
5282141|NCT00499746|opioid pharmacology|opioid pharmacology
5282142|NCT00499746|behavioral pharmacology|behavioral pharmacology
5282143|NCT00499746|human research|human research
5282144|NCT00499733|carcinoma of unknown primary|carcinoma of unknown primary
5282145|NCT00499733|recurrent carcinoma of unknown primary|recurrent carcinoma of unknown primary
5282146|NCT00499733|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5282147|NCT00499733|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5282148|NCT00499733|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5282149|NCT00499733|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5282150|NCT00499733|extensive stage small cell lung cancer|extensive stage small cell lung cancer
5282151|NCT00499733|recurrent small cell lung cancer|recurrent small cell lung cancer
5282152|NCT00499733|stage III renal cell cancer|stage iii renal cell cancer
5282153|NCT00499733|stage IV renal cell cancer|stage iv renal cell cancer
5282154|NCT00499733|recurrent renal cell cancer|recurrent renal cell cancer
5282155|NCT00499733|stage III prostate cancer|stage iii prostate cancer
5282156|NCT00499733|stage IV prostate cancer|stage iv prostate cancer
5282157|NCT00499733|recurrent prostate cancer|recurrent prostate cancer
5282158|NCT00499733|male breast cancer|male breast cancer
5282159|NCT00499733|recurrent breast cancer|recurrent breast cancer
5282160|NCT00499733|stage IIIA breast cancer|stage iiia breast cancer
5282161|NCT00499733|stage IIIB breast cancer|stage iiib breast cancer
5282162|NCT00499733|stage IIIC breast cancer|stage iiic breast cancer
5282163|NCT00499733|stage IV breast cancer|stage iv breast cancer
5282164|NCT00499733|chondrosarcoma|chondrosarcoma
5282165|NCT00499733|metastatic osteosarcoma|metastatic osteosarcoma
5282166|NCT00499733|recurrent osteosarcoma|recurrent osteosarcoma
5282167|NCT00499733|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
5282168|NCT00499733|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
5282169|NCT00499733|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
5282170|NCT00499733|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
5282171|NCT00499733|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
5282172|NCT00499733|metastatic childhood soft tissue sarcoma|metastatic childhood soft tissue sarcoma
5282173|NCT00499733|recurrent childhood soft tissue sarcoma|recurrent childhood soft tissue sarcoma
5282174|NCT00499733|ovarian sarcoma|ovarian sarcoma
5282175|NCT00499733|stage III uterine sarcoma|stage iii uterine sarcoma
5282176|NCT00499733|stage IV uterine sarcoma|stage iv uterine sarcoma
5282177|NCT00499733|recurrent Kaposi sarcoma|recurrent kaposi sarcoma
5282178|NCT00499733|classic Kaposi sarcoma|classic kaposi sarcoma
5282179|NCT00499733|metastatic Ewing sarcoma/peripheral primitive neuroectodermal tumor|metastatic ewing sarcoma/peripheral primitive neuroectodermal tumor
5282180|NCT00499733|recurrent Ewing sarcoma/peripheral primitive neuroectodermal tumor|recurrent ewing sarcoma/peripheral primitive neuroectodermal tumor
5282181|NCT00499733|stage III colon cancer|stage iii colon cancer
5282182|NCT00499733|stage IV colon cancer|stage iv colon cancer
5282183|NCT00499733|recurrent colon cancer|recurrent colon cancer
5282184|NCT00499733|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
5282185|NCT00499733|recurrent adult primary liver cancer|recurrent adult primary liver cancer
5282186|NCT00499733|recurrent childhood liver cancer|recurrent childhood liver cancer
5282187|NCT00499733|stage III childhood liver cancer|stage iii childhood liver cancer
5282188|NCT00499733|stage IV childhood liver cancer|stage iv childhood liver cancer
5282189|NCT00499733|stage III pancreatic cancer|stage iii pancreatic cancer
5282190|NCT00499733|localized osteosarcoma|localized osteosarcoma
5282191|NCT00499733|malignant giant cell tumor of bone|malignant giant cell tumor of bone
5282192|NCT00499733|stage IV melanoma|stage iv melanoma
5282193|NCT00499733|recurrent melanoma|recurrent melanoma
5282194|NCT00499733|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
5282195|NCT00499733|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5282196|NCT00499733|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
5282197|NCT00499733|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
5282198|NCT00499733|stage III verrucous carcinoma of the larynx|stage iii verrucous carcinoma of the larynx
5282199|NCT00499733|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5282200|NCT00499733|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
5282201|NCT00499733|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
5282202|NCT00499733|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
5282203|NCT00499733|stage III basal cell carcinoma of the lip|stage iii basal cell carcinoma of the lip
5282204|NCT00499733|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
5282205|NCT00499733|stage III verrucous carcinoma of the oral cavity|stage iii verrucous carcinoma of the oral cavity
5282206|NCT00499733|stage IV adenoid cystic carcinoma of the oral cavity|stage iv adenoid cystic carcinoma of the oral cavity
5282207|NCT00499733|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5282208|NCT00499733|recurrent adenoid cystic carcinoma of the oral cavity|recurrent adenoid cystic carcinoma of the oral cavity
5282209|NCT00499733|recurrent mucoepidermoid carcinoma of the oral cavity|recurrent mucoepidermoid carcinoma of the oral cavity
5282277|NCT00499668|mast cell leukemia|mast cell leukemia
5282210|NCT00499733|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
5282211|NCT00499733|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
5282212|NCT00499733|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
5282213|NCT00499733|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
5282214|NCT00499733|untreated metastatic squamous neck cancer with occult primary|untreated metastatic squamous neck cancer with occult primary
5282215|NCT00499733|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
5282216|NCT00499733|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
5282217|NCT00499733|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
5282218|NCT00499733|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
5282219|NCT00499733|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5282220|NCT00499733|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
5282221|NCT00499733|stage III esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iii esthesioneuroblastoma of the paranasal sinus and nasal cavity
5282222|NCT00499733|stage III inverted papilloma of the paranasal sinus and nasal cavity|stage iii inverted papilloma of the paranasal sinus and nasal cavity
5282223|NCT00499733|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
5282224|NCT00499733|stage IV esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iv esthesioneuroblastoma of the paranasal sinus and nasal cavity
5282225|NCT00499733|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
5282226|NCT00499733|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
5282227|NCT00499733|high-grade salivary gland mucoepidermoid carcinoma|high-grade salivary gland mucoepidermoid carcinoma
5282228|NCT00499733|salivary gland adenocarcinoma|salivary gland adenocarcinoma
5282229|NCT00499733|salivary gland adenoid cystic carcinoma|salivary gland adenoid cystic carcinoma
5282230|NCT00499733|salivary gland anaplastic carcinoma|salivary gland anaplastic carcinoma
5282231|NCT00499733|salivary gland malignant mixed cell type tumor|salivary gland malignant mixed cell type tumor
5282232|NCT00499733|salivary gland poorly differentiated carcinoma|salivary gland poorly differentiated carcinoma
5282233|NCT00499733|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
5282234|NCT00499733|low-grade salivary gland mucoepidermoid carcinoma|low-grade salivary gland mucoepidermoid carcinoma
5282235|NCT00499733|salivary gland acinic cell tumor|salivary gland acinic cell tumor
5282236|NCT00499733|stage III salivary gland cancer|stage iii salivary gland cancer
5282237|NCT00499733|stage IV salivary gland cancer|stage iv salivary gland cancer
5282238|NCT00499733|recurrent salivary gland cancer|recurrent salivary gland cancer
5282239|NCT00499733|intraocular lymphoma|intraocular lymphoma
5282240|NCT00499733|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
5282241|NCT00499733|recurrent pancreatic cancer|recurrent pancreatic cancer
5282242|NCT00499733|recurrent uterine sarcoma|recurrent uterine sarcoma
5282243|NCT00499733|newly diagnosed carcinoma of unknown primary|newly diagnosed carcinoma of unknown primary
5282244|NCT00499733|advanced adult primary liver cancer|advanced adult primary liver cancer
5282245|NCT00499733|ciliary body and choroid melanoma, medium/large size|ciliary body and choroid melanoma, medium/large size
5282246|NCT00499733|conjunctival melanoma|conjunctival melanoma
5282247|NCT00499733|stage IV pancreatic cancer|stage iv pancreatic cancer
5282248|NCT00499733|stage IIIA melanoma|stage iiia melanoma
5282249|NCT00499733|stage IIIB melanoma|stage iiib melanoma
5282250|NCT00499733|stage IIIC melanoma|stage iiic melanoma
5282251|NCT00499733|tongue cancer|tongue cancer
5282252|NCT00499720|Cystic Fibrosis|cystic fibrosis
5282253|NCT00499720|Pseudomonas aeruginosa|pseudomonas aeruginosa
5282254|NCT00499720|airway infection|airway infection
5282255|NCT00499720|Aztreonam Lysine for Inhalation|aztreonam lysine for inhalation
5282257|NCT00499707|Drug-naive|drug-naive
5282258|NCT00499707|type 2 diabetes|type 2 diabetes
5282259|NCT00499694|stage IV prostate cancer|stage iv prostate cancer
5282260|NCT00499694|recurrent prostate cancer|recurrent prostate cancer
5282261|NCT00499694|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5282262|NCT00499681|stage I breast cancer|stage i breast cancer
5282263|NCT00499681|stage II breast cancer|stage ii breast cancer
5282264|NCT00499681|stage IIIA breast cancer|stage iiia breast cancer
5282265|NCT00499681|stage IIIB breast cancer|stage iiib breast cancer
5282266|NCT00499668|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5282267|NCT00499668|nausea and vomiting|nausea and vomiting
5282268|NCT00499668|chronic myelogenous leukemia|chronic myelogenous leukemia
5282269|NCT00499668|chronic eosinophilic leukemia|chronic eosinophilic leukemia
5282270|NCT00499668|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
5282271|NCT00499668|chronic neutrophilic leukemia|chronic neutrophilic leukemia
5282272|NCT00499668|essential thrombocythemia|essential thrombocythemia
5282273|NCT00499668|polycythemia vera|polycythemia vera
5282274|NCT00499668|adult acute lymphoblastic leukemia|adult acute lymphoblastic leukemia
5282275|NCT00499668|adult acute myeloid leukemia|adult acute myeloid leukemia
5282276|NCT00499668|acute undifferentiated leukemia|acute undifferentiated leukemia
5282278|NCT00499668|adult T-cell leukemia/lymphoma|adult t-cell leukemia/lymphoma
5282279|NCT00499668|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
5282280|NCT00499668|chronic lymphocytic leukemia|chronic lymphocytic leukemia
5282281|NCT00499668|hairy cell leukemia|hairy cell leukemia
5282282|NCT00499668|prolymphocytic leukemia|prolymphocytic leukemia
5282283|NCT00499668|AIDS-related lymphoma|aids-related lymphoma
5282284|NCT00499668|adult Hodgkin lymphoma|adult hodgkin lymphoma
5282285|NCT00499668|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5282286|NCT00499668|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
5282287|NCT00499668|cutaneous B-cell non-Hodgkin lymphoma|cutaneous b-cell non-hodgkin lymphoma
5282288|NCT00499668|cutaneous T-cell non-Hodgkin lymphoma|cutaneous t-cell non-hodgkin lymphoma
5282289|NCT00499668|mycosis fungoides/Sezary syndrome|mycosis fungoides/sezary syndrome
5282290|NCT00499668|adult grade III lymphomatoid granulomatosis|adult grade iii lymphomatoid granulomatosis
5282291|NCT00499668|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
5282292|NCT00499668|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
5282293|NCT00499668|adult Burkitt lymphoma|adult burkitt lymphoma
5282294|NCT00499668|adult diffuse large cell lymphoma|adult diffuse large cell lymphoma
5282295|NCT00499668|adult diffuse mixed cell lymphoma|adult diffuse mixed cell lymphoma
5282296|NCT00499668|adult diffuse small cleaved cell lymphoma|adult diffuse small cleaved cell lymphoma
5282297|NCT00499668|adult immunoblastic large cell lymphoma|adult immunoblastic large cell lymphoma
5282298|NCT00499668|adult lymphoblastic lymphoma|adult lymphoblastic lymphoma
5282299|NCT00499668|grade 1 follicular lymphoma|grade 1 follicular lymphoma
5282300|NCT00499668|grade 2 follicular lymphoma|grade 2 follicular lymphoma
5282301|NCT00499668|grade 3 follicular lymphoma|grade 3 follicular lymphoma
5282302|NCT00499668|mantle cell lymphoma|mantle cell lymphoma
5282303|NCT00499668|marginal zone lymphoma|marginal zone lymphoma
5282304|NCT00499668|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5282305|NCT00499668|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5282306|NCT00499668|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5282307|NCT00499668|small lymphocytic lymphoma|small lymphocytic lymphoma
5282308|NCT00499668|intraocular lymphoma|intraocular lymphoma
5282309|NCT00499668|primary central nervous system lymphoma|primary central nervous system lymphoma
5282310|NCT00499668|post-transplant lymphoproliferative disorder|post-transplant lymphoproliferative disorder
5282311|NCT00499668|multiple myeloma and other plasma cell neoplasms|multiple myeloma and other plasma cell neoplasms
5282312|NCT00499668|myelodysplastic syndromes|myelodysplastic syndromes
5282313|NCT00499668|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
5282314|NCT00499668|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5282315|NCT00499668|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
5282316|NCT00499668|chronic myeloproliferative disorders|chronic myeloproliferative disorders
5282317|NCT00499668|myelodysplastic/myeloproliferative diseases|myelodysplastic/myeloproliferative diseases
5282318|NCT00499642|Healthy Subjects|healthy subjects
5282319|NCT00499629|healthy subjects|healthy subjects
5282320|NCT00499616|regional neuroblastoma|regional neuroblastoma
5282321|NCT00499616|disseminated neuroblastoma|disseminated neuroblastoma
5282322|NCT00499616|stage 4S neuroblastoma|stage 4s neuroblastoma
5282323|NCT00499616|localized unresectable neuroblastoma|localized unresectable neuroblastoma
5282324|NCT00499616|localized resectable neuroblastoma|localized resectable neuroblastoma
5282325|NCT00499603|Breast Cancer|breast cancer
5282326|NCT00499603|ER negative|er negative
5282327|NCT00499603|PR negative|pr negative
5282328|NCT00499603|HER2neu negative|her2neu negative
5282329|NCT00499603|Tumor Triple Negative Receptors|tumor triple negative receptors
5282330|NCT00499603|Paclitaxel|paclitaxel
5282331|NCT00499603|Taxol|taxol
5282332|NCT00499603|RAD001|rad001
5282333|NCT00499603|FEC|fec
5282334|NCT00499603|5-Fluorouracil|5-fluorouracil
5282335|NCT00499603|5-FU|5-fu
5282336|NCT00499603|Adrucil|adrucil
5282337|NCT00499603|Efudex|efudex
5282338|NCT00499603|Epirubicin|epirubicin
5282339|NCT00499603|Cyclophosphamide|cyclophosphamide
5282340|NCT00499590|AMD|amd
5282341|NCT00499590|Macular Degeneration|macular degeneration
5282342|NCT00499590|bevasiranib|bevasiranib
5282343|NCT00499590|COBALT study|cobalt study
5282344|NCT00499590|age related macular degeneration|age related macular degeneration
5282345|NCT00499590|wet AMD|wet amd
5282346|NCT00499590|wet age related macular degeneration|wet age related macular degeneration
5282347|NCT00499577|stage I multiple myeloma|stage i multiple myeloma
5282348|NCT00499577|stage II multiple myeloma|stage ii multiple myeloma
5282349|NCT00499577|stage III multiple myeloma|stage iii multiple myeloma
5282350|NCT00499577|refractory multiple myeloma|refractory multiple myeloma
5282351|NCT00499551|Anterior Uveitis|anterior uveitis
5282352|NCT00499551|Posterior Uveitis|posterior uveitis
5282353|NCT00499551|Intermediate Uveitis|intermediate uveitis
5282354|NCT00499551|Panuveitis|panuveitis
5282355|NCT00499551|Iontophoresis|iontophoresis
5282356|NCT00499551|Dexamethasone|dexamethasone
5282357|NCT00499538|healthy subjects|healthy subjects
5282358|NCT00499525|male breast cancer|male breast cancer
5282359|NCT00499525|recurrent breast cancer|recurrent breast cancer
5282714|NCT00498537|proteinuria|proteinuria
5282360|NCT00499525|stage IIIB breast cancer|stage iiib breast cancer
5282361|NCT00499525|stage IIIC breast cancer|stage iiic breast cancer
5282362|NCT00499525|stage IV breast cancer|stage iv breast cancer
5282363|NCT00499525|stage IIIA breast cancer|stage iiia breast cancer
5282364|NCT00499512|Ovarian Cancer|ovarian cancer
5282365|NCT00499512|Peritoneal Cancer|peritoneal cancer
5282366|NCT00499512|Fallopian Tube Cancer|fallopian tube cancer
5282367|NCT00499512|Spirituality|spirituality
5282368|NCT00499512|Religion|religion
5282369|NCT00499512|Quality of Life|quality of life
5282370|NCT00499512|Questionnaire|questionnaire
5282371|NCT00499512|Survey|survey
5282372|NCT00499499|Cancer|cancer
5282373|NCT00499499|solid tumors|solid tumors
5282374|NCT00499486|recurrent pancreatic cancer|recurrent pancreatic cancer
5282375|NCT00499486|stage III pancreatic cancer|stage iii pancreatic cancer
5282376|NCT00499486|stage IV pancreatic cancer|stage iv pancreatic cancer
5282377|NCT00499486|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
5282378|NCT00499460|Healthy, No Evidence of Disease|healthy, no evidence of disease
5282379|NCT00499447|stage I non-small cell lung cancer|stage i non-small cell lung cancer
5282380|NCT00499447|adenocarcinoma of the lung|adenocarcinoma of the lung
5282381|NCT00499447|adenosquamous cell lung cancer|adenosquamous cell lung cancer
5282382|NCT00499447|large cell lung cancer|large cell lung cancer
5282383|NCT00499447|squamous cell lung cancer|squamous cell lung cancer
5282384|NCT00499434|aids|aids
5282385|NCT00499421|Prostate Cancer|prostate cancer
5282386|NCT00499421|External Beam Radiation Therapy|external beam radiation therapy
5282387|NCT00499421|Fiducial Markers|fiducial markers
5282388|NCT00499421|Acculoc System|acculoc system
5282389|NCT00499421|Center Of Mass|center of mass
5282390|NCT00499421|EBRT|ebrt
5282391|NCT00499408|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5282392|NCT00499408|stage I prostate cancer|stage i prostate cancer
5282393|NCT00499408|stage II prostate cancer|stage ii prostate cancer
5282394|NCT00499408|stage III prostate cancer|stage iii prostate cancer
5282395|NCT00499395|stage IV colon cancer|stage iv colon cancer
5282396|NCT00499395|stage IV rectal cancer|stage iv rectal cancer
5282397|NCT00499395|recurrent colon cancer|recurrent colon cancer
5282398|NCT00499395|recurrent rectal cancer|recurrent rectal cancer
5282399|NCT00499395|liver metastases|liver metastases
5282400|NCT00499382|Advanced Cancers|advanced cancers
5282401|NCT00499382|Cardiac Function|cardiac function
5282402|NCT00499382|Nuclear Medicine Cardiac Scan|nuclear medicine cardiac scan
5282403|NCT00499382|Positron Emission Tomography|positron emission tomography
5282404|NCT00499382|Radionuclide Ventriculography|radionuclide ventriculography
5282405|NCT00499382|Ventricular Ejection Fraction|ventricular ejection fraction
5282406|NCT00499382|PET/CT|pet/ct
5282407|NCT00499382|RNV|rnv
5282408|NCT00499356|friction|friction
5282409|NCT00499356|pressure|pressure
5282410|NCT00499356|insole|insole
5282411|NCT00499356|ulcer|ulcer
5282412|NCT00499356|prevention|prevention
5282413|NCT00499343|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
5282414|NCT00499343|Lymphoma|lymphoma
5282415|NCT00499343|Etoposide|etoposide
5282416|NCT00499343|G-CSF|g-csf
5282417|NCT00499343|GM-CSF|gm-csf
5282418|NCT00499343|Isophosphamide|isophosphamide
5282419|NCT00499343|Rituximab|rituximab
5282420|NCT00499343|Ifosfamide|ifosfamide
5282421|NCT00499343|Sargramostim|sargramostim
5282422|NCT00499343|Leukine|leukine
5282423|NCT00499343|Filgrastim|filgrastim
5282424|NCT00499343|Neupogen|neupogen
5282425|NCT00499343|Apheresis|apheresis
5282426|NCT00499343|Stem Cell Collection|stem cell collection
5282427|NCT00499330|stage IA non-small cell lung cancer|stage ia non-small cell lung cancer
5282428|NCT00499330|adenocarcinoma of the lung|adenocarcinoma of the lung
5282429|NCT00499330|squamous cell lung cancer|squamous cell lung cancer
5282430|NCT00499330|large cell lung cancer|large cell lung cancer
5282431|NCT00499330|adenosquamous cell lung cancer|adenosquamous cell lung cancer
5282432|NCT00499330|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
5282433|NCT00499317|Urgency|urgency
5282434|NCT00499317|Frequency|frequency
5282435|NCT00499317|Pelvic pain|pelvic pain
5282436|NCT00499317|Sexual dysfunction|sexual dysfunction
5282437|NCT00499317|Erectile dysfunction|erectile dysfunction
5282438|NCT00499317|Painful intercourse|painful intercourse
5282439|NCT00499304|Forced oscillation Technique (FOT)|forced oscillation technique (fot)
5282440|NCT00499304|Expiratory flow limitation (EFL)|expiratory flow limitation (efl)
5282441|NCT00499304|Breathing artifacts|breathing artifacts
5282442|NCT00499304|COPD|copd
5282443|NCT00499291|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5282444|NCT00499291|recurrent breast cancer|recurrent breast cancer
5282445|NCT00499291|stage IIIA breast cancer|stage iiia breast cancer
5282446|NCT00499291|stage IIIB breast cancer|stage iiib breast cancer
5282447|NCT00499291|stage IIIC breast cancer|stage iiic breast cancer
5282448|NCT00499291|recurrent prostate cancer|recurrent prostate cancer
5282449|NCT00499291|stage III prostate cancer|stage iii prostate cancer
5282450|NCT00499291|stage IV prostate cancer|stage iv prostate cancer
5282451|NCT00499291|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5282452|NCT00499291|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5282453|NCT00499291|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5282454|NCT00499291|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5282455|NCT00499291|extensive stage small cell lung cancer|extensive stage small cell lung cancer
5282456|NCT00499291|recurrent small cell lung cancer|recurrent small cell lung cancer
5282457|NCT00499291|recurrent bladder cancer|recurrent bladder cancer
5282458|NCT00499291|stage III bladder cancer|stage iii bladder cancer
5282459|NCT00499291|stage IV bladder cancer|stage iv bladder cancer
5282460|NCT00499291|recurrent renal cell cancer|recurrent renal cell cancer
5282461|NCT00499291|stage III renal cell cancer|stage iii renal cell cancer
5282462|NCT00499291|stage IV renal cell cancer|stage iv renal cell cancer
5282463|NCT00499291|clear cell sarcoma of the kidney|clear cell sarcoma of the kidney
5282464|NCT00499291|rhabdoid tumor of the kidney|rhabdoid tumor of the kidney
5282465|NCT00499291|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
5282466|NCT00499291|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
5282467|NCT00499291|recurrent cervical cancer|recurrent cervical cancer
5282468|NCT00499291|stage III cervical cancer|stage iii cervical cancer
5282469|NCT00499291|stage IVA cervical cancer|stage iva cervical cancer
5282470|NCT00499291|stage IVB cervical cancer|stage ivb cervical cancer
5282471|NCT00499291|recurrent endometrial carcinoma|recurrent endometrial carcinoma
5282472|NCT00499291|stage III endometrial carcinoma|stage iii endometrial carcinoma
5282473|NCT00499291|stage IV endometrial carcinoma|stage iv endometrial carcinoma
5282474|NCT00499291|fallopian tube cancer|fallopian tube cancer
5282475|NCT00499291|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5282476|NCT00499291|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5282477|NCT00499291|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5282478|NCT00499291|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
5282479|NCT00499291|stage III ovarian germ cell tumor|stage iii ovarian germ cell tumor
5282480|NCT00499291|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
5282481|NCT00499291|ovarian sarcoma|ovarian sarcoma
5282482|NCT00499291|ovarian stromal cancer|ovarian stromal cancer
5282483|NCT00499291|recurrent uterine sarcoma|recurrent uterine sarcoma
5282484|NCT00499291|stage III uterine sarcoma|stage iii uterine sarcoma
5282485|NCT00499291|stage IV uterine sarcoma|stage iv uterine sarcoma
5282486|NCT00499291|recurrent hypopharyngeal cancer|recurrent hypopharyngeal cancer
5282487|NCT00499291|stage III hypopharyngeal cancer|stage iii hypopharyngeal cancer
5282488|NCT00499291|stage IV hypopharyngeal cancer|stage iv hypopharyngeal cancer
5282489|NCT00499291|recurrent laryngeal cancer|recurrent laryngeal cancer
5282490|NCT00499291|stage III laryngeal cancer|stage iii laryngeal cancer
5282491|NCT00499291|stage IV laryngeal cancer|stage iv laryngeal cancer
5282492|NCT00499291|recurrent lip and oral cavity cancer|recurrent lip and oral cavity cancer
5282493|NCT00499291|stage III lip and oral cavity cancer|stage iii lip and oral cavity cancer
5282494|NCT00499291|stage IV lip and oral cavity cancer|stage iv lip and oral cavity cancer
5282495|NCT00499291|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
5282496|NCT00499291|untreated metastatic squamous neck cancer with occult primary|untreated metastatic squamous neck cancer with occult primary
5282497|NCT00499291|recurrent nasopharyngeal cancer|recurrent nasopharyngeal cancer
5282498|NCT00499291|stage III nasopharyngeal cancer|stage iii nasopharyngeal cancer
5282499|NCT00499291|stage IV nasopharyngeal cancer|stage iv nasopharyngeal cancer
5282500|NCT00499291|recurrent oropharyngeal cancer|recurrent oropharyngeal cancer
5282501|NCT00499291|stage III oropharyngeal cancer|stage iii oropharyngeal cancer
5282502|NCT00499291|stage IV oropharyngeal cancer|stage iv oropharyngeal cancer
5282503|NCT00499291|recurrent paranasal sinus and nasal cavity cancer|recurrent paranasal sinus and nasal cavity cancer
5282504|NCT00499291|stage III paranasal sinus and nasal cavity cancer|stage iii paranasal sinus and nasal cavity cancer
5282505|NCT00499291|stage IV paranasal sinus and nasal cavity cancer|stage iv paranasal sinus and nasal cavity cancer
5282506|NCT00499291|recurrent salivary gland cancer|recurrent salivary gland cancer
5282507|NCT00499291|stage III salivary gland cancer|stage iii salivary gland cancer
5282508|NCT00499291|stage IV salivary gland cancer|stage iv salivary gland cancer
5282509|NCT00499291|recurrent esophageal cancer|recurrent esophageal cancer
5282510|NCT00499291|stage III esophageal cancer|stage iii esophageal cancer
5282511|NCT00499291|stage IV esophageal cancer|stage iv esophageal cancer
5282512|NCT00499291|recurrent gastric cancer|recurrent gastric cancer
5282513|NCT00499291|stage III gastric cancer|stage iii gastric cancer
5282514|NCT00499291|stage IV gastric cancer|stage iv gastric cancer
5282515|NCT00499291|adult central nervous system germ cell tumor|adult central nervous system germ cell tumor
5282516|NCT00499291|adult teratoma|adult teratoma
5282517|NCT00499291|ovarian teratoma|ovarian teratoma
5282518|NCT00499291|testicular teratoma|testicular teratoma
5282519|NCT00499291|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
5282520|NCT00499291|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
5282521|NCT00499291|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
5282522|NCT00499291|recurrent carcinoma of unknown primary|recurrent carcinoma of unknown primary
5282523|NCT00499278|Osteoarthritis|osteoarthritis
5282524|NCT00499278|joint|joint
5282525|NCT00499278|knee|knee
5282527|NCT00499278|surgery|surgery
5282528|NCT00499265|recurrent pancreatic cancer|recurrent pancreatic cancer
5282529|NCT00499265|stage III pancreatic cancer|stage iii pancreatic cancer
5282530|NCT00499265|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
5282531|NCT00499239|Hematologic Malignancies|hematologic malignancies
5282532|NCT00499239|CLL|cll
5282533|NCT00499239|NHL|nhl
5282534|NCT00499239|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
5282535|NCT00499239|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
5282536|NCT00499239|CLL and NHL|cll and nhl
5282537|NCT00499239|Multiple Myeloma|multiple myeloma
5282538|NCT00499239|MM|mm
5282539|NCT00499187|Fanconi|fanconi
5282540|NCT00499187|Kidney|kidney
5282541|NCT00499187|Renal|renal
5282542|NCT00499187|HIV|hiv
5282543|NCT00499187|HIV-1|hiv-1
5282544|NCT00499187|Treatment Experienced|treatment experienced
5282545|NCT00499174|stage II prostate cancer|stage ii prostate cancer
5282546|NCT00499174|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5282547|NCT00499161|Individualized care|individualized care
5282548|NCT00499161|Relationship based care|relationship based care
5282549|NCT00499161|Negotiated care|negotiated care
5282550|NCT00499161|Patient focused care|patient focused care
5282551|NCT00499122|stage II breast cancer|stage ii breast cancer
5282552|NCT00499122|stage IIIC breast cancer|stage iiic breast cancer
5282553|NCT00499122|inflammatory breast cancer|inflammatory breast cancer
5282554|NCT00499109|RRM1|rrm1
5282555|NCT00499109|ERCC1|ercc1
5282556|NCT00499109|Customized Chemotherapy|customized chemotherapy
5282557|NCT00499096|Chronic Illness|chronic illness
5282558|NCT00499096|Disease management|disease management
5282559|NCT00499096|Health Behaviors|health behaviors
5282560|NCT00499096|Mood Disorders-Bipolar|mood disorders-bipolar
5282561|NCT00499083|stage II breast cancer|stage ii breast cancer
5282562|NCT00499083|stage IIIA breast cancer|stage iiia breast cancer
5282563|NCT00499083|stage IIIB breast cancer|stage iiib breast cancer
5282564|NCT00499083|stage IIIC breast cancer|stage iiic breast cancer
5282565|NCT00499070|refractory cytopenia with multilineage dysplasia|refractory cytopenia with multilineage dysplasia
5282566|NCT00499070|aplastic anemia|aplastic anemia
5282567|NCT00499070|Fanconi anemia|fanconi anemia
5282568|NCT00499070|dyskeratosis congenita|dyskeratosis congenita
5282569|NCT00499070|Shwachman-Diamond syndrome|shwachman-diamond syndrome
5282570|NCT00499070|Pearson marrow-pancreas syndrome|pearson marrow-pancreas syndrome
5282571|NCT00499057|early stage breast cancer|early stage breast cancer
5282572|NCT00499044|cognition|cognition
5282573|NCT00499044|attention|attention
5282574|NCT00499044|memory|memory
5282575|NCT00499044|concentration|concentration
5282576|NCT00499044|schizophrenia|schizophrenia
5282577|NCT00499018|Large B-Cell Lymphoma|large b-cell lymphoma
5282578|NCT00499018|Rituximab|rituximab
5282579|NCT00499018|Autologous Stem Cell Transplantation|autologous stem cell transplantation
5282580|NCT00498992|dermatologic complications|dermatologic complications
5282581|NCT00498992|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5282582|NCT00498979|stage IV melanoma|stage iv melanoma
5282583|NCT00498979|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5282584|NCT00498979|adult diffuse astrocytoma|adult diffuse astrocytoma
5282585|NCT00498979|adult glioblastoma|adult glioblastoma
5282586|NCT00498979|adult giant cell glioblastoma|adult giant cell glioblastoma
5282587|NCT00498979|adult pilocytic astrocytoma|adult pilocytic astrocytoma
5282588|NCT00498979|adult brain stem glioma|adult brain stem glioma
5282589|NCT00498979|adult anaplastic ependymoma|adult anaplastic ependymoma
5282590|NCT00498979|adult ependymoma|adult ependymoma
5282591|NCT00498979|adult myxopapillary ependymoma|adult myxopapillary ependymoma
5282592|NCT00498979|adult subependymoma|adult subependymoma
5282593|NCT00498979|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
5282594|NCT00498979|adult oligodendroglioma|adult oligodendroglioma
5282595|NCT00498979|mixed gliomas|mixed gliomas
5282596|NCT00498979|recurrent adult brain tumor|recurrent adult brain tumor
5282597|NCT00498979|recurrent melanoma|recurrent melanoma
5282598|NCT00498979|adult gliosarcoma|adult gliosarcoma
5282599|NCT00498979|adult subependymal giant cell astrocytoma|adult subependymal giant cell astrocytoma
5282600|NCT00498979|adult pineal gland astrocytoma|adult pineal gland astrocytoma
5282601|NCT00498966|Kidney|kidney
5282602|NCT00498966|perifosine|perifosine
5282603|NCT00498966|Progression on treatment with sunitinib or sorafenib|progression on treatment with sunitinib or sorafenib
5282604|NCT00498953|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
5282605|NCT00498953|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
5282606|NCT00498953|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5282607|NCT00498953|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
5282608|NCT00498953|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5282609|NCT00498940|LV function, Compliance, wall motion, echocardiography|lv function, compliance, wall motion, echocardiography
5282610|NCT00498927|recurrent adult brain tumor|recurrent adult brain tumor
5282611|NCT00498927|adult giant cell glioblastoma|adult giant cell glioblastoma
5282612|NCT00498927|adult glioblastoma|adult glioblastoma
5282613|NCT00498927|adult gliosarcoma|adult gliosarcoma
5282614|NCT00498927|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5282924|NCT00497809|High risk|high risk
5282615|NCT00498927|adult diffuse astrocytoma|adult diffuse astrocytoma
5282616|NCT00498927|adult pilocytic astrocytoma|adult pilocytic astrocytoma
5282617|NCT00498927|adult subependymal giant cell astrocytoma|adult subependymal giant cell astrocytoma
5282618|NCT00498927|adult anaplastic ependymoma|adult anaplastic ependymoma
5282619|NCT00498927|adult ependymoma|adult ependymoma
5282620|NCT00498927|adult myxopapillary ependymoma|adult myxopapillary ependymoma
5282621|NCT00498927|adult subependymoma|adult subependymoma
5282622|NCT00498927|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
5282623|NCT00498927|adult oligodendroglioma|adult oligodendroglioma
5282624|NCT00498927|adult brain stem glioma|adult brain stem glioma
5282625|NCT00498927|adult mixed glioma|adult mixed glioma
5282626|NCT00498927|adult pineal gland astrocytoma|adult pineal gland astrocytoma
5282627|NCT00498914|Lymphoma, Large-Cell, Diffuse|lymphoma, large-cell, diffuse
5282628|NCT00498914|Lymphoma, B-Cell|lymphoma, b-cell
5282629|NCT00498914|YM155|ym155
5282630|NCT00498914|Treatment outcomes|treatment outcomes
5282631|NCT00498914|Refractory|refractory
5282632|NCT00498901|stage IV breast cancer|stage iv breast cancer
5282633|NCT00498901|recurrent breast cancer|recurrent breast cancer
5282634|NCT00498888|urge urinary incontinence|urge urinary incontinence
5282635|NCT00498888|rehabilitation|rehabilitation
5282636|NCT00498888|anticholinergic|anticholinergic
5282637|NCT00498875|Oropharyngeal Cancer|oropharyngeal cancer
5282638|NCT00498875|Head and Neck Cancer|head and neck cancer
5282639|NCT00498875|Depression|depression
5282640|NCT00498875|Questionnaire|questionnaire
5282641|NCT00498875|Survey|survey
5282642|NCT00498875|Interview|interview
5282643|NCT00498849|Sleep apnea|sleep apnea
5282644|NCT00498849|Continuous positive airway pressure|continuous positive airway pressure
5282645|NCT00498849|Microarray|microarray
5282646|NCT00498849|Polysomnography|polysomnography
5282647|NCT00498836|CP-4055|cp-4055
5282648|NCT00498836|Elacyt|elacyt
5282649|NCT00498836|Cancer|cancer
5282650|NCT00498836|Metastatic|metastatic
5282651|NCT00498836|Malignant melanoma|malignant melanoma
5282652|NCT00498836|Combination treatment|combination treatment
5282653|NCT00498836|Sorafenib|sorafenib
5282654|NCT00498836|Nexavar|nexavar
5282655|NCT00498797|prostate cancer|prostate cancer
5282656|NCT00498797|zactima|zactima
5282657|NCT00498797|vandetanib|vandetanib
5282658|NCT00498797|metastatic|metastatic
5282659|NCT00498784|Intra-uterine contraception|intra-uterine contraception
5282660|NCT00498784|Intrauterine Devices|intrauterine devices
5282661|NCT00498771|Lymphedema|lymphedema
5282662|NCT00498771|Aquatic Exercise|aquatic exercise
5282663|NCT00498771|Breast Cancer|breast cancer
5282664|NCT00498758|Parkinson's disease|parkinson's disease
5282665|NCT00498758|Gait Disturbances|gait disturbances
5282666|NCT00498758|Mobility|mobility
5282667|NCT00498758|Quality of life|quality of life
5282668|NCT00498732|Obstructive sleep apnea syndrome; CPAP, microarray|obstructive sleep apnea syndrome; cpap, microarray
5282669|NCT00498719|Leukemia|leukemia
5282670|NCT00498719|Lymphoma|lymphoma
5282671|NCT00498719|Brain Tumor|brain tumor
5282672|NCT00498719|Attention Deficit|attention deficit
5282673|NCT00498719|Cognitive Training Program|cognitive training program
5282674|NCT00498719|Central Nervous System|central nervous system
5282675|NCT00498719|CNS|cns
5282676|NCT00498719|CTP|ctp
5282677|NCT00498706|Depressive Disorder, Major|depressive disorder, major
5282678|NCT00498706|Cognitive Behavioral Therapy|cognitive behavioral therapy
5282679|NCT00498706|Psychotherapy|psychotherapy
5282680|NCT00498706|Telemedicine|telemedicine
5282681|NCT00498706|Primary Care|primary care
5282682|NCT00498680|Erectile Dysfunction|erectile dysfunction
5282683|NCT00498680|Treatment|treatment
5282684|NCT00498680|PDE5i|pde5i
5282685|NCT00498667|PET/CT|pet/ct
5282686|NCT00498667|Aggressive non-Hodgkin Lymphoma|aggressive non-hodgkin lymphoma
5282687|NCT00498654|Prevention of Typhoid Fever in Adult Travelers|prevention of typhoid fever in adult travelers
5282688|NCT00498641|perceptual learning|perceptual learning
5282689|NCT00498641|occlusion therapy|occlusion therapy
5282690|NCT00498628|Alcoholism|alcoholism
5282691|NCT00498628|Alcohol dependence|alcohol dependence
5282692|NCT00498628|Quetiapine|quetiapine
5282693|NCT00498615|scleroderma|scleroderma
5282694|NCT00498615|Raynaud's phenomenon|raynaud's phenomenon
5282695|NCT00498615|Rho-kinase inhibitor|rho-kinase inhibitor
5282696|NCT00498576|hypertension|hypertension
5282697|NCT00498576|kidney transplant|kidney transplant
5282698|NCT00498576|melatonin|melatonin
5282699|NCT00498576|adiponectin|adiponectin
5282700|NCT00498563|high altitude|high altitude
5282701|NCT00498563|sleep|sleep
5282702|NCT00498563|altitude illness|altitude illness
5282703|NCT00498563|neurobehavioral manifestations|neurobehavioral manifestations
5282704|NCT00498563|psychomotor performance|psychomotor performance
5282705|NCT00498563|mood states|mood states
5282706|NCT00498550|Clozapine|clozapine
5282707|NCT00498550|Schizophrenia|schizophrenia
5282708|NCT00498550|Dual Diagnosis|dual diagnosis
5282709|NCT00498550|Substance Abuse|substance abuse
5282710|NCT00498550|Cannabis Abuse|cannabis abuse
5282711|NCT00498537|spironolactone|spironolactone
5282712|NCT00498537|aldosterone|aldosterone
5282713|NCT00498537|diabetic nephropathy|diabetic nephropathy
5282715|NCT00498537|hyperkalemia|hyperkalemia
5282716|NCT00498537|albuminuria|albuminuria
5282717|NCT00498537|renal failure|renal failure
5282718|NCT00498524|implantable cardioverter-defibrillator|implantable cardioverter-defibrillator
5282719|NCT00498524|ischemic cardiomyopathy|ischemic cardiomyopathy
5282720|NCT00498524|ventricular arrhythmias|ventricular arrhythmias
5282721|NCT00498524|sibling concordance|sibling concordance
5282722|NCT00498511|Anemia, Iron-Deficiency|anemia, iron-deficiency
5282723|NCT00498511|Endoscopy, Gastrointestinal|endoscopy, gastrointestinal
5282724|NCT00498511|Male, aged 18 to 40|male, aged 18 to 40
5282725|NCT00498498|severe head injury|severe head injury
5282726|NCT00498498|Endothelin|endothelin
5282727|NCT00498498|CSF|csf
5282728|NCT00498498|Plasma|plasma
5282729|NCT00498498|Cellular Apoptosis|cellular apoptosis
5282730|NCT00498485|chronic|chronic
5282731|NCT00498485|fatigue|fatigue
5282732|NCT00498485|pain|pain
5282733|NCT00498485|sleep|sleep
5282734|NCT00498485|xyrem|xyrem
5282735|NCT00498485|must have chronic fatigue syndrome|must have chronic fatigue syndrome
5282736|NCT00498485|no hypertension|no hypertension
5282737|NCT00498485|no sleep apnea|no sleep apnea
5282738|NCT00498472|BNP|bnp
5282739|NCT00498472|heart failure|heart failure
5282740|NCT00498459|Physical activity|physical activity
5282741|NCT00498459|Randomised trial|randomised trial
5282742|NCT00498459|Prevention|prevention
5282743|NCT00498459|Adolescents|adolescents
5282744|NCT00498459|Obesity|obesity
5282745|NCT00498459|Cardiovascular risk factors|cardiovascular risk factors
5282746|NCT00498433|Aliskiren|aliskiren
5282747|NCT00498433|Renin-Angiotensin System (RAS)|renin-angiotensin system (ras)
5282748|NCT00498433|Hypertension|hypertension
5282749|NCT00498433|Abdominal obesity|abdominal obesity
5282750|NCT00498420|HUE-MAN|hue-man
5282751|NCT00498420|Rare disorder|rare disorder
5282752|NCT00498420|Hepatosplenomegaly|hepatosplenomegaly
5282753|NCT00498420|Dysostosis|dysostosis
5282754|NCT00498407|CP-4055|cp-4055
5282755|NCT00498407|ELACYT(TM)|elacyt(tm)
5282756|NCT00498407|Cancer|cancer
5282757|NCT00498407|Colorectal cancer|colorectal cancer
5282758|NCT00498407|CRC|crc
5282759|NCT00498407|Second line therapy|second line therapy
5282760|NCT00498394|Obesity|obesity
5282761|NCT00498394|Weight loss|weight loss
5282762|NCT00498394|Diet fads|diet fads
5282763|NCT00498368|Estimated glomerular filtration rate (GFR)|estimated glomerular filtration rate (gfr)
5282764|NCT00498368|Proteinuria|proteinuria
5282765|NCT00498368|Renal Fibrosis|renal fibrosis
5282766|NCT00498355|uveitis|uveitis
5282767|NCT00498355|cytoid macular edema|cytoid macular edema
5282768|NCT00498355|steroid|steroid
5282769|NCT00498355|Lucentis|lucentis
5282770|NCT00498329|fMRI|fmri
5282771|NCT00498329|Electroencephalogram (EEG)|electroencephalogram (eeg)
5282772|NCT00498329|Attention|attention
5282773|NCT00498329|Sensorimotor Integration|sensorimotor integration
5282774|NCT00498329|Human Brain|human brain
5282775|NCT00498329|Healthy Volunteer|healthy volunteer
5282776|NCT00498329|HV|hv
5282777|NCT00498316|Myelodysplastic Syndrome|myelodysplastic syndrome
5282778|NCT00498316|Leukemia|leukemia
5282779|NCT00498316|Cord Blood Expansion|cord blood expansion
5282780|NCT00498316|Umbilical Cord Blood|umbilical cord blood
5282781|NCT00498316|Mesenchymal Stem Cells|mesenchymal stem cells
5282782|NCT00498316|Acute Myelogenous Leukemia|acute myelogenous leukemia
5282783|NCT00498316|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
5282784|NCT00498316|ALL|all
5282785|NCT00498316|AML|aml
5282786|NCT00498316|MDS|mds
5282787|NCT00498303|influenza vaccine|influenza vaccine
5282788|NCT00498290|Enhanced Recovery After Surgery Protocol(ERAS)|enhanced recovery after surgery protocol(eras)
5282789|NCT00498290|Colorectal Surgery|colorectal surgery
5282790|NCT00498277|Osteoporosis|osteoporosis
5282791|NCT00498277|Magnetic Resonance Imaging|magnetic resonance imaging
5282792|NCT00498277|Vertebral Fractures|vertebral fractures
5282793|NCT00498277|Quantitative Diffusion|quantitative diffusion
5282794|NCT00498277|Fat Imaging|fat imaging
5282795|NCT00498277|Spine|spine
5282796|NCT00498264|Exercise|exercise
5282797|NCT00498264|Rehabilitation|rehabilitation
5282798|NCT00498264|Strength exercise|strength exercise
5282799|NCT00498264|Aerobic exercise|aerobic exercise
5282800|NCT00498264|Pain|pain
5282801|NCT00498251|lung injury, acute|lung injury, acute
5282802|NCT00498251|thoracic surgical procedures|thoracic surgical procedures
5282803|NCT00498251|lung cancer|lung cancer
5282804|NCT00498251|salbutamol|salbutamol
5282805|NCT00498238|Arterial stiffness, Augmentation index, Subclinical Hypothyroidism|arterial stiffness, augmentation index, subclinical hypothyroidism
5282806|NCT00498225|Pancreatic Cancer|pancreatic cancer
5282807|NCT00498212|Heplisav|heplisav
5282808|NCT00498212|Hepatitis B|hepatitis b
5282809|NCT00498212|Hepatitis|hepatitis
5282810|NCT00498212|HBV|hbv
5282811|NCT00498212|Hepatitis B vaccine|hepatitis b vaccine
5282812|NCT00498212|kidney disease|kidney disease
5282813|NCT00498212|renal disease|renal disease
5282814|NCT00498212|kidney failure|kidney failure
5282815|NCT00498212|renal failure|renal failure
5282816|NCT00498199|Multiples sclerosis|multiples sclerosis
5282817|NCT00498199|oscillopsia|oscillopsia
5282818|NCT00498199|eye movements|eye movements
5282819|NCT00498199|motion detection|motion detection
5282820|NCT00498199|retinal slip|retinal slip
5282821|NCT00498199|nystagmus|nystagmus
5282822|NCT00498186|Rotigotine|rotigotine
5282823|NCT00498186|Neupro®|neupro®
5282824|NCT00498173|Autistic Disorder|autistic disorder
5282825|NCT00498173|Autism Spectrum Disorder|autism spectrum disorder
5282826|NCT00498160|Kidney transplant|kidney transplant
5282827|NCT00498160|Tolerance|tolerance
5282828|NCT00498160|Marrow/stem cell transplant|marrow/stem cell transplant
5282829|NCT00498147|amputation|amputation
5282830|NCT00498147|angina|angina
5282831|NCT00498147|angiography|angiography
5282832|NCT00498147|angioplasty|angioplasty
5282833|NCT00498147|arterial disease|arterial disease
5282834|NCT00498147|artery disease|artery disease
5282835|NCT00498147|bypass|bypass
5282836|NCT00498147|CABG|cabg
5282837|NCT00498147|cad|cad
5282838|NCT00498147|carotid|carotid
5282839|NCT00498147|cerebral accident|cerebral accident
5282840|NCT00498147|CHF|chf
5282841|NCT00498147|CRF|crf
5282842|NCT00498147|CVA|cva
5282843|NCT00498147|endarterectomy|endarterectomy
5282844|NCT00498147|heart attack|heart attack
5282845|NCT00498147|heart failure|heart failure
5282846|NCT00498147|infarct|infarct
5282847|NCT00498147|kidney disease|kidney disease
5282848|NCT00498147|kidney failure|kidney failure
5282849|NCT00498147|laser|laser
5282850|NCT00498147|nephropathy|nephropathy
5282851|NCT00498147|neuropathy|neuropathy
5282852|NCT00498147|pad|pad
5282853|NCT00498147|PCI|pci
5282854|NCT00498147|percutaneous coronary|percutaneous coronary
5282855|NCT00498147|percutaneous transluminal|percutaneous transluminal
5282856|NCT00498147|pvd|pvd
5282857|NCT00498147|renal failure|renal failure
5282858|NCT00498147|retinopathy|retinopathy
5282859|NCT00498147|revascularization|revascularization
5282860|NCT00498147|schemia|schemia
5282861|NCT00498147|stenosis|stenosis
5282862|NCT00498147|stent|stent
5282863|NCT00498147|stroke|stroke
5282864|NCT00498147|transient|transient
5282865|NCT00498147|ulcer|ulcer
5282866|NCT00498147|vascular disease|vascular disease
5282867|NCT00498134|Gastric cancer|gastric cancer
5282868|NCT00498121|Ventilator associated pneumonia.|ventilator associated pneumonia.
5282869|NCT00498121|Procalcitonin.|procalcitonin.
5282870|NCT00498108|Rotigotine|rotigotine
5282871|NCT00498108|Restless Legs Syndrome|restless legs syndrome
5282872|NCT00498095|Delayed renal graft function|delayed renal graft function
5282873|NCT00498095|Acute renal allograft dysfunction|acute renal allograft dysfunction
5282874|NCT00498069|Critical limb ischemia due to peripheral arterial occlusive disease|critical limb ischemia due to peripheral arterial occlusive disease
5282875|NCT00498069|Autologous bone marrow concentrate|autologous bone marrow concentrate
5282876|NCT00498056|HIV Seronegativity|hiv seronegativity
5282877|NCT00498056|HIV Preventive Vaccine|hiv preventive vaccine
5282878|NCT00498043|Lymphoma|lymphoma
5282879|NCT00498043|PET|pet
5282880|NCT00498043|Chemotherapy|chemotherapy
5282881|NCT00498043|Rituximab|rituximab
5282882|NCT00498030|Insulin Resistance|insulin resistance
5282883|NCT00498030|Stress, Psychological|stress, psychological
5282884|NCT00498017|Infections|infections
5282885|NCT00498004|Quality of Life|quality of life
5282886|NCT00498004|Schizophrenia|schizophrenia
5282887|NCT00498004|Quetiapine|quetiapine
5282888|NCT00498004|Risperidone|risperidone
5282889|NCT00497991|AML|aml
5282890|NCT00497991|phase I/II|phase i/ii
5282891|NCT00497991|AZD1152|azd1152
5282892|NCT00497991|Acute Myeloid Leukaemia|acute myeloid leukaemia
5282893|NCT00497965|Balance|balance
5282894|NCT00497965|Chiropractic|chiropractic
5282895|NCT00497965|Older Adults|older adults
5282896|NCT00497952|Relapsing-remitting multiple sclerosis|relapsing-remitting multiple sclerosis
5282897|NCT00497952|Marrow/Stem cell transplant|marrow/stem cell transplant
5282898|NCT00497939|Benign Prostatic Hyperplasia (BPH)|benign prostatic hyperplasia (bph)
5282899|NCT00497939|Currently on alpha blocker|currently on alpha blocker
5282900|NCT00497926|Kidney transplant|kidney transplant
5282901|NCT00497926|Tolerance|tolerance
5282902|NCT00497926|Marrow/Enriched Hematopoetic Stem Cell Transplant|marrow/enriched hematopoetic stem cell transplant
5282903|NCT00497913|Tennis Elbow|tennis elbow
5282904|NCT00497913|Botulinum Toxin|botulinum toxin
5282905|NCT00497874|depression|depression
5282906|NCT00497874|stage of change|stage of change
5282907|NCT00497874|intervention|intervention
5282908|NCT00497874|randomized clinical trial|randomized clinical trial
5282909|NCT00497874|population-based|population-based
5282910|NCT00497874|expert system|expert system
5282911|NCT00497861|Low back pain|low back pain
5282912|NCT00497861|Chiropractic|chiropractic
5282913|NCT00497861|Spinal manipulation|spinal manipulation
5282914|NCT00497861|Activator Methods Chiropractic Technique|activator methods chiropractic technique
5282915|NCT00497835|motor seizures|motor seizures
5282916|NCT00497835|accelerometer|accelerometer
5282917|NCT00497835|algorithm|algorithm
5282918|NCT00497835|detection|detection
5282919|NCT00497835|alert|alert
5282920|NCT00497822|Dementia|dementia
5282921|NCT00497809|Breast Cancer|breast cancer
5282922|NCT00497809|Neutropenia|neutropenia
5282923|NCT00497809|Chemotherapy|chemotherapy
5282925|NCT00497796|cytomegalovirus|cytomegalovirus
5282926|NCT00497796|CMV|cmv
5282927|NCT00497796|prophylaxis|prophylaxis
5282928|NCT00497796|liver|liver
5282929|NCT00497796|liver transplant|liver transplant
5282930|NCT00497757|Marrow/hematopoietic stem cell transplant|marrow/hematopoietic stem cell transplant
5282931|NCT00497744|CAPD peritonitis|capd peritonitis
5282932|NCT00497744|Peritoneal Dialysis, Continuous Ambulatory|peritoneal dialysis, continuous ambulatory
5282933|NCT00497731|Advanced solid tumors|advanced solid tumors
5282934|NCT00497705|Ebsteins Anomaly|ebsteins anomaly
5282935|NCT00497705|Heart Septal Defects, Ventricle|heart septal defects, ventricle
5282936|NCT00497705|Heart Defects, Congenital|heart defects, congenital
5282937|NCT00497705|Double Outlet Right Ventricle|double outlet right ventricle
5282938|NCT00497705|Truncus Arteriosus Persistant|truncus arteriosus persistant
5282939|NCT00497705|Ebstein's Anomaly|ebstein's anomaly
5282940|NCT00497705|Congenital Heart Disease|congenital heart disease
5282941|NCT00497705|Heart Defects|heart defects
5282942|NCT00497679|advanced solid tumours|advanced solid tumours
5282943|NCT00497666|Diabetes|diabetes
5282944|NCT00497666|Diabetic nephropathy|diabetic nephropathy
5282945|NCT00497666|renal protection|renal protection
5282946|NCT00497640|sleep apnea, titration, CPAP, neural network|sleep apnea, titration, cpap, neural network
5282947|NCT00497614|Rheumatoid arthritis|rheumatoid arthritis
5282948|NCT00497614|Positron emission tomodensitometry|positron emission tomodensitometry
5282949|NCT00497614|Tumor necrosis factor alpha inhibitor|tumor necrosis factor alpha inhibitor
5282950|NCT00497601|Visceral Leishmaniasis|visceral leishmaniasis
5282951|NCT00497601|Amphotericin B|amphotericin b
5282952|NCT00497601|Fat emulsion|fat emulsion
5282953|NCT00497588|laryngeal cancer|laryngeal cancer
5282954|NCT00497588|RADIOTHERAPY|radiotherapy
5282955|NCT00497588|Voice Quality|voice quality
5282956|NCT00497575|Congenital Hypothyroidism|congenital hypothyroidism
5282957|NCT00497575|diagnosis|diagnosis
5282958|NCT00497575|L-thyroxine|l-thyroxine
5282959|NCT00497575|newborn screening|newborn screening
5282960|NCT00497562|Fibromyalgia|fibromyalgia
5282961|NCT00497562|growth hormone|growth hormone
5282962|NCT00497562|IGF-1|igf-1
5282963|NCT00497562|FIQ|fiq
5282964|NCT00497549|Esophagectomy|esophagectomy
5282965|NCT00497549|hand sewn anastomosis|hand sewn anastomosis
5282966|NCT00497549|side-to-side stapled|side-to-side stapled
5282967|NCT00497536|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
5282968|NCT00497536|Continuous Subcutaneous Insulin Infusion (CSII)|continuous subcutaneous insulin infusion (csii)
5282969|NCT00497523|Asthma|asthma
5282970|NCT00497523|Young Children|young children
5282971|NCT00497523|Corticosteroids|corticosteroids
5282972|NCT00497523|Beclomethasone|beclomethasone
5282973|NCT00497523|Salbutamol|salbutamol
5282974|NCT00497523|Beclomethasone/Salbutamol fixed combination|beclomethasone/salbutamol fixed combination
5282975|NCT00497523|Suspension for nebulisation|suspension for nebulisation
5282976|NCT00497510|Balance|balance
5282977|NCT00497510|Chiropractic|chiropractic
5282978|NCT00497510|Older Adults|older adults
5282979|NCT00497497|CRC|crc
5282980|NCT00497497|Colon cancer|colon cancer
5282981|NCT00497497|Avastin|avastin
5282982|NCT00497497|APM4187g|apm4187g
5282983|NCT00497471|Plasmodium Falciparum|plasmodium falciparum
5282984|NCT00497471|Antimlarial chemoprophylaxis|antimlarial chemoprophylaxis
5282985|NCT00497471|Iron supplementation|iron supplementation
5282986|NCT00497471|Tanzania|tanzania
5282987|NCT00497458|breast|breast
5282988|NCT00497458|neoplasms|neoplasms
5282989|NCT00497458|anastrazole|anastrazole
5282990|NCT00497458|testosterone|testosterone
5282991|NCT00497445|Peripheral arterial disease|peripheral arterial disease
5282992|NCT00497445|Exercise therapy|exercise therapy
5282993|NCT00497445|Angioplasty|angioplasty
5282994|NCT00497445|Bypass surgery|bypass surgery
5282995|NCT00497432|Hyperbaric Oxygen|hyperbaric oxygen
5282996|NCT00497419|STEMI|stemi
5282997|NCT00497419|ST elevation myocardial infarction|st elevation myocardial infarction
5282998|NCT00497406|submandibular salivary gland transfer|submandibular salivary gland transfer
5282999|NCT00497406|intensity-modulated radiation therapy|intensity-modulated radiation therapy
5283000|NCT00497406|helical tomotherapy|helical tomotherapy
5283001|NCT00497406|reduction of xerostomia|reduction of xerostomia
5283002|NCT00497393|Emergency department, administration, overcrowding|emergency department, administration, overcrowding
5283003|NCT00497367|safety|safety
5283004|NCT00497367|feasibility|feasibility
5283005|NCT00497367|bifurcation|bifurcation
5283006|NCT00497367|lesion|lesion
5283007|NCT00497367|de novo|de novo
5283008|NCT00497367|intervention|intervention
5283009|NCT00497354|Ultrasound, Complications, Regional Anesthesia|ultrasound, complications, regional anesthesia
5283010|NCT00497341|infection after total knee arthroplasty|infection after total knee arthroplasty
5283011|NCT00497328|contrast induced nephropathy|contrast induced nephropathy
5283012|NCT00497315|Non-Small Cell Lung Cancer|non-small cell lung cancer
5283013|NCT00497315|NSCLC|nsclc
5283014|NCT00497315|Chemoradiation|chemoradiation
5283015|NCT00497315|locally advanced NSCLC|locally advanced nsclc
5283016|NCT00497315|pemetrexed|pemetrexed
5283017|NCT00497315|lung cancer|lung cancer
5283018|NCT00497302|cocaine|cocaine
5283019|NCT00497302|opiate|opiate
5283020|NCT00497302|pregnancy|pregnancy
5283021|NCT00497302|post-partum|post-partum
5283022|NCT00497302|neonatal abstinence syndrome|neonatal abstinence syndrome
5283023|NCT00497302|contingency management|contingency management
5283024|NCT00497302|Reinforcement Based Treatment|reinforcement based treatment
5283025|NCT00497302|women|women
5283026|NCT00497289|n-3 PUFA|n-3 pufa
5283027|NCT00497289|parenteral nutrition|parenteral nutrition
5283028|NCT00497289|preterm infant|preterm infant
5283029|NCT00497276|Adults|adults
5283030|NCT00497276|Anesthesia recovery period|anesthesia recovery period
5283031|NCT00497276|Comparative study|comparative study
5283032|NCT00497276|Electric stimulation|electric stimulation
5283033|NCT00497276|Humans|humans
5283034|NCT00497276|Nerve blocks/methods/indications|nerve blocks/methods/indications
5283035|NCT00497276|Patient satisfaction|patient satisfaction
5283036|NCT00497276|Peripheral nerves|peripheral nerves
5283037|NCT00497276|Sciatic nerve/ultrasonography|sciatic nerve/ultrasonography
5283038|NCT00497276|Ultrasonography|ultrasonography
5283039|NCT00497276|Treatment outcome|treatment outcome
5283040|NCT00497276|Nerve blocks/economics|nerve blocks/economics
5283041|NCT00497250|Phase 1 Clinical Trials|phase 1 clinical trials
5283042|NCT00497250|Iressa|iressa
5283043|NCT00497250|radiation therapy|radiation therapy
5283044|NCT00497250|Chinese|chinese
5283045|NCT00497250|NSCLC|nsclc
5283046|NCT00497250|chemotherapy|chemotherapy
5283047|NCT00497237|Asthma|asthma
5283048|NCT00497237|Stepdown|stepdown
5283049|NCT00497237|Beclomethasone|beclomethasone
5283050|NCT00497237|Formoterol|formoterol
5283051|NCT00497237|Corticosteroids|corticosteroids
5283052|NCT00497224|Pancreatic Cancer|pancreatic cancer
5283053|NCT00497224|Pancreatic Carcinoma|pancreatic carcinoma
5283054|NCT00497224|Pancreas|pancreas
5283055|NCT00497224|Adenocarcinoma|adenocarcinoma
5283056|NCT00497224|Erlotinib|erlotinib
5283057|NCT00497224|Tarceva|tarceva
5283058|NCT00497224|OSI-774|osi-774
5283059|NCT00497224|Phase II|phase ii
5283060|NCT00497211|First large acute myocardial infarction|first large acute myocardial infarction
5283061|NCT00497198|Type 2 Diabetes|type 2 diabetes
5283062|NCT00497198|anion-exchange resin|anion-exchange resin
5283063|NCT00497185|Mindfulness-Based Cognitive Therapy|mindfulness-based cognitive therapy
5283064|NCT00497185|Somatization Disorder|somatization disorder
5283065|NCT00497185|Medically Unexplained Symptoms|medically unexplained symptoms
5283066|NCT00497185|Functional Somatic Symptoms|functional somatic symptoms
5283067|NCT00497185|SF-36|sf-36
5283068|NCT00497159|Trial of Dimebon to treat patients with mild-to-moderate Huntington's disease.|trial of dimebon to treat patients with mild-to-moderate huntington's disease.
5283069|NCT00497146|paricalcitol|paricalcitol
5283070|NCT00497146|Zemplar|zemplar
5283071|NCT00497146|PRIMO|primo
5283072|NCT00497146|Chronic Kidney Disease Stage 3B/4|chronic kidney disease stage 3b/4
5283073|NCT00497133|glucoseintolerance|glucoseintolerance
5283074|NCT00497120|sleep apnea|sleep apnea
5283075|NCT00497120|snoring|snoring
5283076|NCT00497120|acetazolamide|acetazolamide
5283077|NCT00497120|uvulopalatopharyngoplasty|uvulopalatopharyngoplasty
5283078|NCT00497120|daytime sleepiness|daytime sleepiness
5283079|NCT00497120|upper airway|upper airway
5283080|NCT00497107|UFT/LV|uft/lv
5283081|NCT00497107|PSK|psk
5283082|NCT00497107|Colorectal cancer|colorectal cancer
5283083|NCT00497107|Adjuvant therapy|adjuvant therapy
5283084|NCT00497094|carotid artery stenting|carotid artery stenting
5283085|NCT00497094|atherosclerosis|atherosclerosis
5283086|NCT00497094|cerebrovascular|cerebrovascular
5283087|NCT00497094|stroke|stroke
5283088|NCT00497081|Methamphetamine|methamphetamine
5283089|NCT00497081|HIV|hiv
5283090|NCT00497081|MSM|msm
5283091|NCT00497081|HIV Seronegativity|hiv seronegativity
5283092|NCT00497068|smoking|smoking
5283093|NCT00497068|pregnancy|pregnancy
5283094|NCT00497068|neonatal abstinence syndrome|neonatal abstinence syndrome
5283095|NCT00497055|Methamphetamine|methamphetamine
5283096|NCT00497055|HIV|hiv
5283097|NCT00497055|MSM|msm
5283098|NCT00497055|HIV Seronegativity|hiv seronegativity
5283099|NCT00497029|dental caries|dental caries
5283100|NCT00497029|early childhood caries|early childhood caries
5283101|NCT00497029|caries prevention|caries prevention
5283102|NCT00497029|infants|infants
5283103|NCT00497016|hypertension|hypertension
5283104|NCT00497016|statin|statin
5283105|NCT00497016|sympathetic|sympathetic
5283106|NCT00497003|Endothelial function|endothelial function
5283107|NCT00497003|Beta blocker|beta blocker
5283108|NCT00497003|Type 2 diabetes|type 2 diabetes
5283109|NCT00497003|Chronic heart failure|chronic heart failure
5283110|NCT00496990|male|male
5283111|NCT00496990|female|female
5283112|NCT00496990|couple|couple
5283113|NCT00496990|cocaine|cocaine
5283114|NCT00496990|opiate|opiate
5283115|NCT00496990|methadone|methadone
5283116|NCT00496990|detoxification|detoxification
5283117|NCT00496990|pregnancy|pregnancy
5283118|NCT00496977|lung cancer|lung cancer
5283119|NCT00496977|CT scan|ct scan
5283120|NCT00496977|screening|screening
5283121|NCT00496964|Botulinum toxin type A|botulinum toxin type a
5283122|NCT00496964|Patellofemoral pain syndrome|patellofemoral pain syndrome
5283123|NCT00496964|Knee Injuries|knee injuries
5283124|NCT00496964|Exercise Therapy|exercise therapy
5283125|NCT00496951|Neonatal abstinence syndrome|neonatal abstinence syndrome
5283126|NCT00496951|Methadone|methadone
5283127|NCT00496951|Vagal tone|vagal tone
5283128|NCT00496938|Stents|stents
5283129|NCT00496938|Angioplasty|angioplasty
5283130|NCT00496938|Total coronary occlusions|total coronary occlusions
5283131|NCT00496938|Coronary restenosis|coronary restenosis
5283132|NCT00496938|Stent thrombosis|stent thrombosis
5283133|NCT00496938|Everolimus|everolimus
5283134|NCT00496899|Labor|labor
5283135|NCT00496899|Obstetric|obstetric
5283136|NCT00496899|cervical dilatation|cervical dilatation
5283137|NCT00496886|Pain|pain
5283138|NCT00496886|Nociception|nociception
5283139|NCT00496873|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
5283140|NCT00496873|NHL|nhl
5283141|NCT00496873|Lymphoma|lymphoma
5283142|NCT00496873|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
5283143|NCT00496873|SLL|sll
5283144|NCT00496873|Small Lymphocytic Lymphoma|small lymphocytic lymphoma
5283145|NCT00496873|Lymphoplasmacytic lymphoma/immunocytoma|lymphoplasmacytic lymphoma/immunocytoma
5283146|NCT00496873|Follicular lymphoma|follicular lymphoma
5283147|NCT00496873|Extranodal marginal zone B-cell lymphoma of MALT type|extranodal marginal zone b-cell lymphoma of malt type
5283148|NCT00496873|Nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5283149|NCT00496873|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
5283150|NCT00496873|CLL|cll
5283151|NCT00496873|Bulky Lymphoma|bulky lymphoma
5283152|NCT00496873|Nipent|nipent
5283153|NCT00496873|Cytoxan|cytoxan
5283154|NCT00496873|Rituxan|rituxan
5283155|NCT00496873|Cyclophosphamide|cyclophosphamide
5283156|NCT00496873|Rituximab|rituximab
5283157|NCT00496873|Pentostatin|pentostatin
5283158|NCT00496860|cancer|cancer
5283159|NCT00496860|p53|p53
5283160|NCT00496860|immunotherapy|immunotherapy
5283161|NCT00496860|targeted|targeted
5283162|NCT00496860|metastatic|metastatic
5283163|NCT00496860|malignancy|malignancy
5283164|NCT00496860|malignancies|malignancies
5283165|NCT00496860|interleukin-2|interleukin-2
5283166|NCT00496860|IL-2|il-2
5283167|NCT00496860|fusion protein|fusion protein
5283168|NCT00496860|antitumor|antitumor
5283169|NCT00496860|melanoma|melanoma
5283170|NCT00496860|renal cancer|renal cancer
5283171|NCT00496860|lung cancer|lung cancer
5283172|NCT00496860|kidney cancer|kidney cancer
5283173|NCT00496860|breast cancer|breast cancer
5283174|NCT00496860|colorectal cancer|colorectal cancer
5283175|NCT00496860|colon cancer|colon cancer
5283176|NCT00496860|renal cell carcinoma|renal cell carcinoma
5283177|NCT00496860|advanced cancer|advanced cancer
5283178|NCT00496860|head and neck cancer|head and neck cancer
5283179|NCT00496860|breast tumors|breast tumors
5283180|NCT00496860|cancer of head and neck|cancer of head and neck
5283181|NCT00496860|esophagus cancer|esophagus cancer
5283182|NCT00496860|lymphoma|lymphoma
5283183|NCT00496860|ovarian cancer|ovarian cancer
5283184|NCT00496860|ovary cancer|ovary cancer
5283185|NCT00496860|bladder cancer|bladder cancer
5283186|NCT00496860|stomach cancer|stomach cancer
5283187|NCT00496860|TCR|tcr
5283188|NCT00496860|T-cell receptor|t-cell receptor
5283189|NCT00496860|P53 gene|p53 gene
5283190|NCT00496860|p53 tumor suppressor protein|p53 tumor suppressor protein
5283191|NCT00496847|rhPDGF,|rhpdgf,
5283192|NCT00496847|periodontal disease|periodontal disease
5283193|NCT00496821|Respiratory Syncytial Virus|respiratory syncytial virus
5283194|NCT00496808|Ductal Carcinoma In Situ|ductal carcinoma in situ
5283195|NCT00496808|Breast Cancer|breast cancer
5283196|NCT00496808|Herceptin|herceptin
5283197|NCT00496808|Trastuzumab|trastuzumab
5283198|NCT00496808|DCIS|dcis
5283199|NCT00496795|Breast cancer, chemoresistance, predictive markers.|breast cancer, chemoresistance, predictive markers.
5283200|NCT00496782|Treatment Experienced|treatment experienced
5283201|NCT00496756|clear cell renal cell carcinoma|clear cell renal cell carcinoma
5283202|NCT00496756|stage III renal cell cancer|stage iii renal cell cancer
5283203|NCT00496756|stage IV renal cell cancer|stage iv renal cell cancer
5283204|NCT00496756|recurrent renal cell cancer|recurrent renal cell cancer
5283205|NCT00496730|Metabolic Disorder|metabolic disorder
5283206|NCT00496717|Calcium scoring/aorta/ cardiovascular risk factor/scann|calcium scoring/aorta/ cardiovascular risk factor/scann
5283207|NCT00496717|Patients with at least one cardiovascular risk factor|patients with at least one cardiovascular risk factor
5283208|NCT00496704|adenocarcinoma of the colon|adenocarcinoma of the colon
5283209|NCT00496704|recurrent colon cancer|recurrent colon cancer
5283210|NCT00496704|stage III colon cancer|stage iii colon cancer
5283211|NCT00496704|stage IV colon cancer|stage iv colon cancer
5283212|NCT00496704|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5283213|NCT00496704|recurrent rectal cancer|recurrent rectal cancer
5283214|NCT00496704|stage III rectal cancer|stage iii rectal cancer
5283215|NCT00496704|stage IV rectal cancer|stage iv rectal cancer
5283216|NCT00496691|HIV prevention|hiv prevention
5283217|NCT00496691|HIV Seronegativity|hiv seronegativity
5283218|NCT00496678|PNRP|pnrp
5283219|NCT00496678|navigation|navigation
5283220|NCT00496678|navigator|navigator
5283221|NCT00496678|activation|activation
5283222|NCT00496678|disparities|disparities
5283523|NCT00495521|Pediatrics|pediatrics
5283223|NCT00496678|randomized control trial|randomized control trial
5283224|NCT00496678|primary care|primary care
5283225|NCT00496678|racial and ethnic minorities|racial and ethnic minorities
5283226|NCT00496665|Stage IV breast cancer|stage iv breast cancer
5283227|NCT00496665|metronomic chemotherapy|metronomic chemotherapy
5283228|NCT00496652|Squamous Cell Carcinomas of the Head and Neck|squamous cell carcinomas of the head and neck
5283229|NCT00496652|Epidermal Growth Factor receptor|epidermal growth factor receptor
5283230|NCT00496652|Antibody|antibody
5283231|NCT00496652|Radiotherapy|radiotherapy
5283232|NCT00496639|hemodialysis|hemodialysis
5283233|NCT00496639|arterio-venous grafts|arterio-venous grafts
5283234|NCT00496639|angioplasty|angioplasty
5283235|NCT00496639|stents|stents
5283236|NCT00496639|mechanical thrombectomy|mechanical thrombectomy
5283237|NCT00496626|HPV infections|hpv infections
5283238|NCT00496613|Breast cancer|breast cancer
5283239|NCT00496613|survivor|survivor
5283240|NCT00496587|Genitourinary|genitourinary
5283241|NCT00496587|Kidney Cancer|kidney cancer
5283242|NCT00496587|Sarcomatoid Renal Cell Carcinoma|sarcomatoid renal cell carcinoma
5283243|NCT00496587|Renal Cell Carcinoma|renal cell carcinoma
5283244|NCT00496587|RCC|rcc
5283245|NCT00496587|Sarcomatoid Carcinoma of the Kidney|sarcomatoid carcinoma of the kidney
5283246|NCT00496587|Unresectable renal cell carcinoma|unresectable renal cell carcinoma
5283247|NCT00496587|Capecitabine|capecitabine
5283248|NCT00496587|Xeloda|xeloda
5283249|NCT00496587|Gemcitabine|gemcitabine
5283250|NCT00496587|Gemzar|gemzar
5283251|NCT00496587|Bevacizumab|bevacizumab
5283252|NCT00496587|Anti-VEGF monoclonal antibody|anti-vegf monoclonal antibody
5283253|NCT00496587|rhuMAb-VEGF|rhumab-vegf
5283254|NCT00496587|Avastin|avastin
5283255|NCT00496587|Vascular Endothelial Growth Factor|vascular endothelial growth factor
5283256|NCT00496587|VEGF|vegf
5283257|NCT00496574|asthma|asthma
5283258|NCT00496574|immunotherapy|immunotherapy
5283259|NCT00496574|efficacy|efficacy
5283260|NCT00496574|children|children
5283261|NCT00496574|symptoms score|symptoms score
5283262|NCT00496574|quality of life|quality of life
5283263|NCT00496574|spirometry|spirometry
5283264|NCT00496574|PC20M|pc20m
5283265|NCT00496561|asthma|asthma
5283266|NCT00496561|immunotherapy|immunotherapy
5283267|NCT00496561|children|children
5283268|NCT00496561|regulatory T cells|regulatory t cells
5283269|NCT00496561|ECP|ecp
5283270|NCT00496561|PC20M|pc20m
5283271|NCT00496561|Quality of Life|quality of life
5283272|NCT00496561|Symptoms score|symptoms score
5283273|NCT00496561|Spirometry|spirometry
5283274|NCT00496548|Crohn's Disease|crohn's disease
5283275|NCT00496535|head|head
5283276|NCT00496535|neck|neck
5283277|NCT00496535|cancer|cancer
5283278|NCT00496535|neoplasm|neoplasm
5283279|NCT00496522|Skull Base Chondrosarcoma|skull base chondrosarcoma
5283280|NCT00496522|Proton Beam Therapy|proton beam therapy
5283281|NCT00496522|Chondrosarcoma|chondrosarcoma
5283282|NCT00496522|CNS|cns
5283283|NCT00496509|ZD6474|zd6474
5283284|NCT00496509|Colorectal Cancer|colorectal cancer
5283285|NCT00496509|Liver Metastases|liver metastases
5283286|NCT00496509|Biomarkers|biomarkers
5283287|NCT00496483|Tacrolimus|tacrolimus
5283288|NCT00496483|Pharmacokinetics|pharmacokinetics
5283289|NCT00496483|Kidney Transplantation|kidney transplantation
5283290|NCT00496470|Chronic Obstructive Pulmonary Disease, COPD|chronic obstructive pulmonary disease, copd
5283291|NCT00496457|Diabetic Neuropathy|diabetic neuropathy
5283292|NCT00496457|Painful Peripheral Diabetic Neuropathy|painful peripheral diabetic neuropathy
5283293|NCT00496457|TRO19622|tro19622
5283294|NCT00496457|Trophos|trophos
5283295|NCT00496444|Advanced Cancers|advanced cancers
5283296|NCT00496444|Azacytidine|azacytidine
5283297|NCT00496444|5-Azacitidine|5-azacitidine
5283298|NCT00496444|5-aza|5-aza
5283299|NCT00496444|Vidaza|vidaza
5283300|NCT00496444|5-AZC|5-azc
5283301|NCT00496444|AZA-CR|aza-cr
5283302|NCT00496444|Ladakamycin|ladakamycin
5283303|NCT00496444|NSC-102816|nsc-102816
5283304|NCT00496444|Valproic Acid|valproic acid
5283305|NCT00496444|Depakene|depakene
5283306|NCT00496418|colostomy|colostomy
5283307|NCT00496418|parastomal|parastomal
5283308|NCT00496418|peristomal|peristomal
5283309|NCT00496418|hernia|hernia
5283310|NCT00496418|mesh|mesh
5283311|NCT00496418|surgery|surgery
5283312|NCT00496418|Indication for permanent end colostomy|indication for permanent end colostomy
5283313|NCT00496405|Vascular endothelial growth factor.|vascular endothelial growth factor.
5283314|NCT00496405|Retinal Thickness|retinal thickness
5283315|NCT00496405|Diabetic Macular Edema|diabetic macular edema
5283316|NCT00496405|Optical Coherent Tomography|optical coherent tomography
5283317|NCT00496392|breakthrough pain in patients with cancer|breakthrough pain in patients with cancer
5283318|NCT00496379|metastatic breast cancer|metastatic breast cancer
5283319|NCT00496379|invasive breast cancer|invasive breast cancer
5283320|NCT00496379|brain metastases|brain metastases
5283321|NCT00496379|ZK-EPO|zk-epo
5283322|NCT00496353|Neoplasm Malignant|neoplasm malignant
5283323|NCT00496340|Pentostatin|pentostatin
5283324|NCT00496340|Busulfan|busulfan
5283325|NCT00496340|Rituxan|rituxan
5283524|NCT00495521|Ileo-cecal|ileo-cecal
5283326|NCT00496340|Allogeneic Hematopoietic Stem Cell Transplantation|allogeneic hematopoietic stem cell transplantation
5283327|NCT00496301|renal|renal
5283328|NCT00496301|sorafenib|sorafenib
5283329|NCT00496301|Unresectable and/or metastatic renal cell cancer|unresectable and/or metastatic renal cell cancer
5283330|NCT00496288|BRCA mutation|brca mutation
5283331|NCT00496288|Breast cancer|breast cancer
5283332|NCT00496288|Prophylactic breast irradiation|prophylactic breast irradiation
5283333|NCT00496288|Prevention of contralateral breast cancer|prevention of contralateral breast cancer
5283334|NCT00496275|NSCLC|nsclc
5283335|NCT00496275|ZACTIMA|zactima
5283336|NCT00496262|Congenital fibrinogen deficiency|congenital fibrinogen deficiency
5283337|NCT00496262|Fibrinogen concentrate|fibrinogen concentrate
5283338|NCT00496262|Pharmacokinetics|pharmacokinetics
5283339|NCT00496262|Thrombelastography|thrombelastography
5283340|NCT00496249|Prostate|prostate
5283341|NCT00496249|cancer|cancer
5283342|NCT00496249|brachytherapy|brachytherapy
5283343|NCT00496249|radiation|radiation
5283344|NCT00496249|semen|semen
5283345|NCT00496249|fertility|fertility
5283346|NCT00496236|head|head
5283347|NCT00496236|neck|neck
5283348|NCT00496236|cancer|cancer
5283349|NCT00496236|neoplasm|neoplasm
5283350|NCT00496223|Sunitinib|sunitinib
5283351|NCT00496223|Dacarbazine|dacarbazine
5283352|NCT00496223|Melanoma|melanoma
5283353|NCT00496210|Adaptation|adaptation
5283354|NCT00496210|Pervasive Developmental Disorder|pervasive developmental disorder
5283355|NCT00496210|Autism Spectrum Disorders|autism spectrum disorders
5283356|NCT00496210|Pervasive Developmental Disorders|pervasive developmental disorders
5283357|NCT00496210|Caregiver Adaptation|caregiver adaptation
5283358|NCT00496197|candidemia|candidemia
5283359|NCT00496197|invasive candidiasis|invasive candidiasis
5283360|NCT00496197|fungal bloodstream infection|fungal bloodstream infection
5283361|NCT00496184|Nifedipine treatment|nifedipine treatment
5283362|NCT00496184|Vestibulitis|vestibulitis
5283363|NCT00496184|Placebo|placebo
5283364|NCT00496158|Nucleoside Treatment-Naïve Patients with HBeAg Negative Chronic Hepatitis due to Hepatitis B Virus|nucleoside treatment-naïve patients with hbeag negative chronic hepatitis due to hepatitis b virus
5283365|NCT00496158|hepatitis b virus|hepatitis b virus
5283366|NCT00496145|diabetes|diabetes
5283367|NCT00496145|self management|self management
5283368|NCT00496145|patient education|patient education
5283369|NCT00496145|telephone reinforcement|telephone reinforcement
5283370|NCT00496145|Spanish Diabetes|spanish diabetes
5283371|NCT00496145|Tomando Control de su Diabetes|tomando control de su diabetes
5283373|NCT00496132|Leukemia|leukemia
5283374|NCT00496132|Lymph|lymph
5283375|NCT00496119|Proton Beam Therapy|proton beam therapy
5283376|NCT00496119|Skull Base Chordoma|skull base chordoma
5283377|NCT00496119|Chordoma of the Skull Base|chordoma of the skull base
5283378|NCT00496119|Chordoma|chordoma
5283379|NCT00496080|Menorrhagia associated with Uterine Fibroids|menorrhagia associated with uterine fibroids
5283380|NCT00496067|Fibroids|fibroids
5283381|NCT00496067|Menorrhagia|menorrhagia
5283382|NCT00496067|Menorrhagia associated with uterine fibroids|menorrhagia associated with uterine fibroids
5283383|NCT00496041|Stenosis (> 75%) or occlusion of the superficial femoral artery|stenosis (> 75%) or occlusion of the superficial femoral artery
5283384|NCT00496028|Solid tumors|solid tumors
5283385|NCT00496028|locally advanced or Metastatic Cancer suitable for treatment with carboplatin and/or paclitaxel|locally advanced or metastatic cancer suitable for treatment with carboplatin and/or paclitaxel
5283386|NCT00496015|Streptococcus Pneumoniae Vaccines|streptococcus pneumoniae vaccines
5283387|NCT00496015|Meningococcal disease|meningococcal disease
5283388|NCT00496015|Carriage|carriage
5283389|NCT00496015|Prophylactic antipyretic|prophylactic antipyretic
5283390|NCT00496015|Safety|safety
5283391|NCT00496015|Pneumococcal vaccine|pneumococcal vaccine
5283392|NCT00496015|Fever|fever
5283393|NCT00496015|Pneumococcal disease|pneumococcal disease
5283394|NCT00496015|Immunogenicity|immunogenicity
5283395|NCT00496015|Meningococcal vaccine|meningococcal vaccine
5283396|NCT00496015|Booster vaccination|booster vaccination
5283397|NCT00496002|Hepatitis B virus|hepatitis b virus
5283398|NCT00496002|Nucleoside Treatment-Naïve Patients with HBeAg Positive|nucleoside treatment-naïve patients with hbeag positive
5283399|NCT00495989|Handicapped individuals|handicapped individuals
5283400|NCT00495976|common cold|common cold
5283401|NCT00495976|flu|flu
5283402|NCT00495976|influenza|influenza
5283403|NCT00495963|Mechanical ventilation, Ventilator- associated pneumonia, Bronchoalveolar lavage, Pediatric intensive care unit, Flexible bronchoscopy, Critical care|mechanical ventilation, ventilator- associated pneumonia, bronchoalveolar lavage, pediatric intensive care unit, flexible bronchoscopy, critical care
5283404|NCT00495950|Melanoma|melanoma
5283405|NCT00495950|Lymphedema|lymphedema
5283406|NCT00495950|Limb Swelling|limb swelling
5283407|NCT00495950|Questionnaire|questionnaire
5283408|NCT00495950|Quality of Life|quality of life
5283409|NCT00495950|Physical Function|physical function
5283410|NCT00495950|Survey|survey
5283411|NCT00495885|Sleep problems|sleep problems
5283412|NCT00495885|insomnia|insomnia
5283413|NCT00495885|sleeplessness|sleeplessness
5283414|NCT00495885|primary insomnia|primary insomnia
5283415|NCT00495885|insomnia disorder|insomnia disorder
5283416|NCT00495872|Solid Tumors|solid tumors
5283417|NCT00495872|Advanced Cancer|advanced cancer
5283418|NCT00495872|Dasatinib|dasatinib
5283419|NCT00495872|Erlotinib|erlotinib
5283420|NCT00495872|Lapatinib|lapatinib
5283421|NCT00495872|Lenalidomide|lenalidomide
5283422|NCT00495872|Sorafenib|sorafenib
5283423|NCT00495872|Erlotinib Hydrochloride|erlotinib hydrochloride
5283424|NCT00495872|Sunitinib Malate|sunitinib malate
5283425|NCT00495872|Sunitinib|sunitinib
5283426|NCT00495872|Valproic Acid|valproic acid
5283427|NCT00495872|SU011248|su011248
5283428|NCT00495859|Immunonutrition|immunonutrition
5283429|NCT00495859|immune enhancing diets|immune enhancing diets
5283430|NCT00495859|arginine|arginine
5283431|NCT00495859|ω-3 fatty acids|ω-3 fatty acids
5283432|NCT00495859|nucleotides|nucleotides
5283433|NCT00495859|liver transplantation|liver transplantation
5283434|NCT00495859|clinical trial|clinical trial
5283435|NCT00495846|Hepatocellular carcinoma|hepatocellular carcinoma
5283436|NCT00495846|Somatostatin analogues|somatostatin analogues
5283437|NCT00495846|Somatostatin receptors|somatostatin receptors
5283438|NCT00495846|Octreotide|octreotide
5283439|NCT00495846|Lanreotide|lanreotide
5283440|NCT00495846|IGF-I|igf-i
5283441|NCT00495846|IGF-II|igf-ii
5283442|NCT00495833|Hypertension|hypertension
5283443|NCT00495820|Alzheimer's Disease|alzheimer's disease
5283444|NCT00495820|Apathy|apathy
5283445|NCT00495820|Dementia|dementia
5283446|NCT00495820|Methylphenidate|methylphenidate
5283447|NCT00495807|Psychological Tests|psychological tests
5283448|NCT00495807|Pain, Postoperative|pain, postoperative
5283449|NCT00495807|Nurses|nurses
5283450|NCT00495794|diabetes|diabetes
5283451|NCT00495794|hypertension|hypertension
5283452|NCT00495794|adherence|adherence
5283453|NCT00495794|implementation|implementation
5283454|NCT00495794|medications|medications
5283455|NCT00495794|organization of care|organization of care
5283456|NCT00495781|functional iron deficiency|functional iron deficiency
5283457|NCT00495781|renal anemia|renal anemia
5283458|NCT00495781|dialysis|dialysis
5283459|NCT00495781|erythropoietin|erythropoietin
5283460|NCT00495781|darbepoetin|darbepoetin
5283461|NCT00495768|Hepatitis C|hepatitis c
5283462|NCT00495768|HCV|hcv
5283463|NCT00495768|Depression|depression
5283464|NCT00495768|Interferons|interferons
5283465|NCT00495768|Ribavirin|ribavirin
5283466|NCT00495755|Chronic Graft-vs-Host Disease|chronic graft-vs-host disease
5283467|NCT00495729|SB-649868,|sb-649868,
5283468|NCT00495729|Simvastatin|simvastatin
5283469|NCT00495729|Repeated dose,|repeated dose,
5283470|NCT00495703|Cancer survivors|cancer survivors
5283471|NCT00495703|Chemotherapy|chemotherapy
5283472|NCT00495703|Cognitive function|cognitive function
5283473|NCT00495703|Exercise|exercise
5283474|NCT00495703|Physical Activity|physical activity
5283475|NCT00495690|Zinc recipients|zinc recipients
5283476|NCT00495690|Placebo recipients|placebo recipients
5283477|NCT00495677|Treatment Experienced|treatment experienced
5283478|NCT00495677|Treatment Naive|treatment naive
5283479|NCT00495664|titanium|titanium
5283480|NCT00495664|paclitaxel|paclitaxel
5283481|NCT00495664|stent|stent
5283482|NCT00495664|myocardial infarction|myocardial infarction
5283483|NCT00495664|angioplasty|angioplasty
5283484|NCT00495664|PCI|pci
5283485|NCT00495651|HIV|hiv
5283486|NCT00495651|HAART|haart
5283487|NCT00495651|Early Intervention|early intervention
5283488|NCT00495651|Naive patients|naive patients
5283489|NCT00495638|6-Minute Walk|6-minute walk
5283490|NCT00495638|Chuvash Polycythemia|chuvash polycythemia
5283491|NCT00495638|Echocardiogram|echocardiogram
5283492|NCT00495638|Sickle Cell Anemia|sickle cell anemia
5283493|NCT00495638|Pulmonary Function Tests|pulmonary function tests
5283494|NCT00495638|Sickle Cell Disease|sickle cell disease
5283495|NCT00495638|SCD|scd
5283496|NCT00495638|Pulmonary Hypertension|pulmonary hypertension
5283497|NCT00495625|Hepatocellular cancer (HCC)|hepatocellular cancer (hcc)
5283498|NCT00495625|Sunitinib malate|sunitinib malate
5283499|NCT00495625|Vascular endothelial growth factor (VEGF)|vascular endothelial growth factor (vegf)
5283500|NCT00495625|Platelet-derived growth factor (PDGF)|platelet-derived growth factor (pdgf)
5283501|NCT00495625|Tyrosine kinases|tyrosine kinases
5283502|NCT00495625|Liver|liver
5283503|NCT00495612|Xolair|xolair
5283504|NCT00495612|Allergic asthma|allergic asthma
5283505|NCT00495612|Cat allergy|cat allergy
5283506|NCT00495599|Obese|obese
5283507|NCT00495599|Adipose Tissue|adipose tissue
5283508|NCT00495599|Visfatin|visfatin
5283509|NCT00495599|Gastric Bypass Surgery|gastric bypass surgery
5283510|NCT00495586|COPD|copd
5283511|NCT00495586|Antibiotics|antibiotics
5283512|NCT00495560|induction|induction
5283513|NCT00495560|abortion|abortion
5283514|NCT00495560|injection, intra-amniotic|injection, intra-amniotic
5283515|NCT00495560|misoprostol|misoprostol
5283516|NCT00495547|Myelodysplastic Syndrome|myelodysplastic syndrome
5283517|NCT00495547|Red Cell transfusion dependent|red cell transfusion dependent
5283518|NCT00495521|Crohn's|crohn's
5283519|NCT00495521|Crohn's Disease|crohn's disease
5283520|NCT00495521|Acute Flare|acute flare
5283521|NCT00495521|Mild to Moderate Crohn's Disease|mild to moderate crohn's disease
5283522|NCT00495521|Children|children
5283525|NCT00495521|Pediatric Crohn's Disease|pediatric crohn's disease
5283526|NCT00495521|New Onset Crohn's Disease|new onset crohn's disease
5283527|NCT00495521|Recently diagnosed Crohn's Disease|recently diagnosed crohn's disease
5283528|NCT00495508|Quinine|quinine
5283529|NCT00495508|Artemether|artemether
5283530|NCT00495508|Lumefantrine|lumefantrine
5283531|NCT00495508|malaria|malaria
5283532|NCT00495508|Uganda|uganda
5283533|NCT00495508|Artemisinin- based combination therapy|artemisinin- based combination therapy
5283534|NCT00495508|pregnancy|pregnancy
5283535|NCT00495508|Malaria In Pregnancy|malaria in pregnancy
5283536|NCT00495482|Euthanasia|euthanasia
5283537|NCT00495482|Assisted Suicide|assisted suicide
5283538|NCT00495482|Assisted Dying|assisted dying
5283539|NCT00495482|Palliative Care Medicine|palliative care medicine
5283540|NCT00495469|Diabetes mellitus HbA1c|diabetes mellitus hba1c
5283541|NCT00495456|cardiovascular|cardiovascular
5283542|NCT00495456|risk|risk
5283543|NCT00495456|longitudinal|longitudinal
5283544|NCT00495456|prospective|prospective
5283545|NCT00495430|Healthy|healthy
5283546|NCT00495430|Lung sounds|lung sounds
5283547|NCT00495430|Breath sounds|breath sounds
5283548|NCT00495417|Alzheimer|alzheimer
5283549|NCT00495417|Morbus Alzheimer|morbus alzheimer
5283550|NCT00495417|Alzheimer Vaccine|alzheimer vaccine
5283551|NCT00495417|Vaccine|vaccine
5283552|NCT00495417|AD|ad
5283553|NCT00495417|Aβ immunotherapy|aβ immunotherapy
5283554|NCT00495404|chronic non-malignant pain|chronic non-malignant pain
5283555|NCT00495404|opiates|opiates
5283556|NCT00495404|prescriptions|prescriptions
5283557|NCT00495404|addiction|addiction
5283558|NCT00495391|Hepatitis C, Chronic|hepatitis c, chronic
5283559|NCT00495378|PROCRIT|procrit
5283560|NCT00495378|Epoetin alfa|epoetin alfa
5283561|NCT00495378|chemotherapy related anemia|chemotherapy related anemia
5283562|NCT00495365|Anemia|anemia
5283563|NCT00495365|low blood count|low blood count
5283564|NCT00495365|chronic kidney disease|chronic kidney disease
5283565|NCT00495365|chronic kidney failure|chronic kidney failure
5283566|NCT00495365|darbepoetin alfa|darbepoetin alfa
5283567|NCT00495365|epoetin alfa|epoetin alfa
5283568|NCT00495365|recombinant human erythropoietin|recombinant human erythropoietin
5283569|NCT00495352|Schizophrenia|schizophrenia
5283570|NCT00495352|NRT|nrt
5283571|NCT00495352|Bupropion|bupropion
5283572|NCT00495352|Stages of change|stages of change
5283573|NCT00495326|drug interactions|drug interactions
5283574|NCT00495326|Treatment Naive|treatment naive
5283575|NCT00495313|Rosacea|rosacea
5283576|NCT00495300|HSC/MUD Transplant|hsc/mud transplant
5283577|NCT00495300|NMDP|nmdp
5283578|NCT00495300|NMDP Data Collection|nmdp data collection
5283579|NCT00495300|NMDP Samples|nmdp samples
5283580|NCT00495300|BMT|bmt
5283581|NCT00495300|Samples|samples
5283582|NCT00495287|Acute myelogenous leukemia|acute myelogenous leukemia
5283583|NCT00495287|Adult patients|adult patients
5283584|NCT00495287|Cytogenetic risk class|cytogenetic risk class
5283585|NCT00495287|Clinico-cytogenetic risk model|clinico-cytogenetic risk model
5283586|NCT00495287|Risk-oriented therapy|risk-oriented therapy
5283587|NCT00495274|Bioequivalent|bioequivalent
5283588|NCT00495274|pharmacodynamic|pharmacodynamic
5283589|NCT00495274|Reference formulation|reference formulation
5283590|NCT00495274|5 new formulation|5 new formulation
5283591|NCT00495274|Food effect|food effect
5283592|NCT00495274|Pharmacokinetics|pharmacokinetics
5283593|NCT00495261|Gambling|gambling
5283594|NCT00495261|Mindfulness|mindfulness
5283595|NCT00495261|Cognitive Behavioural Therapy|cognitive behavioural therapy
5283596|NCT00495248|group intervention|group intervention
5283597|NCT00495248|stroke|stroke
5283598|NCT00495248|senior centres|senior centres
5283599|NCT00495248|health promotion|health promotion
5283600|NCT00495235|Endometrial Cancer|endometrial cancer
5283601|NCT00495235|Polycystic Ovarian Syndrome|polycystic ovarian syndrome
5283602|NCT00495235|Insulin Resistance|insulin resistance
5283603|NCT00495235|Pre-diabetes|pre-diabetes
5283604|NCT00495235|Harris County|harris county
5283605|NCT00495235|PCOS|pcos
5283606|NCT00495235|Uterus|uterus
5283607|NCT00495235|Questionnaire|questionnaire
5283608|NCT00495235|Body mass index|body mass index
5283609|NCT00495235|BMI|bmi
5283610|NCT00495222|gastrojejunostomy|gastrojejunostomy
5283611|NCT00495222|stoma|stoma
5283612|NCT00495209|Complementary and Alternative Medicine|complementary and alternative medicine
5283613|NCT00495209|Breast Cancer|breast cancer
5283614|NCT00495209|Qigong|qigong
5283615|NCT00495209|Medical Qigong|medical qigong
5283616|NCT00495209|External Qi Therapy|external qi therapy
5283617|NCT00495209|EQT|eqt
5283618|NCT00495183|cocaine dependence|cocaine dependence
5283619|NCT00495183|cocaine use|cocaine use
5283620|NCT00495183|CNS stimulants|cns stimulants
5283621|NCT00495183|caffeine|caffeine
5283622|NCT00495183|biperiden|biperiden
5283623|NCT00495183|placebo|placebo
5283624|NCT00495170|Non-Small Cell Lung Cancer|non-small cell lung cancer
5283625|NCT00495170|Lung Cancer|lung cancer
5283626|NCT00495170|Proton Radiotherapy|proton radiotherapy
5283627|NCT00495170|Proton Beam|proton beam
5283628|NCT00495170|Paclitaxel|paclitaxel
5283629|NCT00495170|Taxol|taxol
5283630|NCT00495170|Carboplatin|carboplatin
5283631|NCT00495170|Paraplatin|paraplatin
5283632|NCT00495170|NSCLC|nsclc
5283633|NCT00495144|Phase I|phase i
5283634|NCT00495144|Advanced Solid Tumors|advanced solid tumors
5283635|NCT00495144|Hypoxia|hypoxia
5283636|NCT00495144|Prodrug|prodrug
5283637|NCT00495144|Multi-Center|multi-center
5283638|NCT00495144|Open-Label|open-label
5283639|NCT00495144|Dose-Escalation|dose-escalation
5283640|NCT00495131|Chronic hepatitis C|chronic hepatitis c
5283641|NCT00495131|Genotype 1|genotype 1
5283642|NCT00495131|Interferon|interferon
5283643|NCT00495131|Ribavirin|ribavirin
5283644|NCT00495118|schizophrenia|schizophrenia
5283645|NCT00495118|schizoaffective disorder|schizoaffective disorder
5283646|NCT00495118|risperidone|risperidone
5283647|NCT00495118|intramuscular injection|intramuscular injection
5283648|NCT00495118|long-acting injectable|long-acting injectable
5283649|NCT00495092|cocaine dependence|cocaine dependence
5283650|NCT00495092|cocaine use|cocaine use
5283651|NCT00495092|cocaine craving|cocaine craving
5283652|NCT00495079|acute|acute
5283653|NCT00495079|lymphoblastic|lymphoblastic
5283654|NCT00495079|lymphocytic|lymphocytic
5283655|NCT00495079|leukemia|leukemia
5283656|NCT00495079|leukaemia|leukaemia
5283657|NCT00495079|lukemia|lukemia
5283658|NCT00495079|leukimia|leukimia
5283659|NCT00495079|ALL|all
5283660|NCT00495079|Marqibo|marqibo
5283661|NCT00495079|Hana Biosciences|hana biosciences
5283662|NCT00495079|vincristine|vincristine
5283663|NCT00495079|liposomal|liposomal
5283664|NCT00495079|liposome|liposome
5283665|NCT00495079|optisome|optisome
5283666|NCT00495079|hematology|hematology
5283667|NCT00495079|malignancy|malignancy
5283668|NCT00495079|hematological|hematological
5283669|NCT00495079|relapsed|relapsed
5283670|NCT00495079|anti-leukemia|anti-leukemia
5283671|NCT00495079|adult|adult
5283672|NCT00495079|chemotherapy|chemotherapy
5283673|NCT00495053|overactive bladder, urinary urgency|overactive bladder, urinary urgency
5283674|NCT00495040|Non-Small Cell Lung Cancer|non-small cell lung cancer
5283675|NCT00495040|Lung Cancer|lung cancer
5283676|NCT00495040|Proton Radiotherapy|proton radiotherapy
5283677|NCT00495040|Proton Beam|proton beam
5283678|NCT00495040|NSCLC|nsclc
5283679|NCT00495027|PTSD|ptsd
5283680|NCT00495027|prevention|prevention
5283681|NCT00495027|World Wide Web|world wide web
5283682|NCT00495027|Behavior Therapy|behavior therapy
5283683|NCT00495014|GSK376501,|gsk376501,
5283684|NCT00495014|Single Dose,|single dose,
5283685|NCT00495014|Dose Escalation,|dose escalation,
5283686|NCT00495014|Healthy Overweight/Obese Volunteer|healthy overweight/obese volunteer
5283687|NCT00494949|Anesthesia, spinal|anesthesia, spinal
5283688|NCT00494949|Blood substitutes|blood substitutes
5283689|NCT00494949|Oxygen therapeutics|oxygen therapeutics
5283690|NCT00494949|Orthopedic surgery|orthopedic surgery
5283691|NCT00494949|Plasma expanders|plasma expanders
5283692|NCT00494949|Vasoconstriction|vasoconstriction
5283693|NCT00494949|Hemospan|hemospan
5283694|NCT00494936|HIV|hiv
5283695|NCT00494936|HCV|hcv
5283696|NCT00494936|Treatment Naive|treatment naive
5283697|NCT00494936|Treatment Experienced|treatment experienced
5283698|NCT00494936|HIV and HCV Coinfection|hiv and hcv coinfection
5283699|NCT00494910|Palliative Care|palliative care
5283700|NCT00494910|Terminally Ill|terminally ill
5283701|NCT00494910|Group Therapy|group therapy
5283702|NCT00494910|07-094|07-094
5283703|NCT00494884|Type 2 diabetes|type 2 diabetes
5283704|NCT00494884|vildagliptin|vildagliptin
5283705|NCT00494884|metformin combination|metformin combination
5283706|NCT00494871|BAY59-7939|bay59-7939
5283707|NCT00494871|Rivaroxaban|rivaroxaban
5283708|NCT00494871|Non-Valvular Atrial Fibrillation|non-valvular atrial fibrillation
5283709|NCT00494871|Japanese Patients|japanese patients
5283710|NCT00494871|Phase III|phase iii
5283711|NCT00494871|12620|12620
5283712|NCT00494858|Bulimia nervosa|bulimia nervosa
5283713|NCT00494858|Cognitive Behavioral Therapy|cognitive behavioral therapy
5283714|NCT00494858|Personality Disorders|personality disorders
5283715|NCT00494845|Mindfulness|mindfulness
5283716|NCT00494845|Elderly|elderly
5283717|NCT00494845|Chronic Illness|chronic illness
5283718|NCT00494845|Back Pain|back pain
5283719|NCT00494845|Chronic Low Back Pain|chronic low back pain
5283720|NCT00494845|Older adults over the age of sixty-five|older adults over the age of sixty-five
5283721|NCT00494845|MMSE score of over 23|mmse score of over 23
5283722|NCT00494845|Speaks English|speaks english
5283723|NCT00494832|Dexmedetomidine|dexmedetomidine
5283724|NCT00494832|Evoked potentials|evoked potentials
5283725|NCT00494832|Spine surgery|spine surgery
5283726|NCT00494819|ADHD, subtype, methylphenidate, neuropsychological measures|adhd, subtype, methylphenidate, neuropsychological measures
5283727|NCT00494806|Postoperative Ileus (POI)|postoperative ileus (poi)
5283728|NCT00494806|Rocking Chair|rocking chair
5283729|NCT00494806|Abdominal Cancer|abdominal cancer
5283730|NCT00494793|Open abdomen|open abdomen
5283731|NCT00494793|Fascial closure|fascial closure
5283732|NCT00494793|Vacuum assisted wound closure|vacuum assisted wound closure
5283733|NCT00494793|Mesh|mesh
5283734|NCT00494793|Abdominal compartment syndrome|abdominal compartment syndrome
5283735|NCT00494793|Intraabdominal pressure|intraabdominal pressure
5283736|NCT00494793|Incisional hernia|incisional hernia
5283737|NCT00494780|CHOP (cyclophosphamide,doxorubicin,vincristine,prednisolone)|chop (cyclophosphamide,doxorubicin,vincristine,prednisolone)
5283738|NCT00494780|ofatumumab|ofatumumab
5283739|NCT00494767|body composition|body composition
5283740|NCT00494767|obesity|obesity
5283741|NCT00494767|4C model|4c model
5283742|NCT00494767|hunger|hunger
5283743|NCT00494767|weight loss|weight loss
5283744|NCT00494754|autism spectrum disorder|autism spectrum disorder
5283745|NCT00494754|family genetic study|family genetic study
5283746|NCT00494754|gene|gene
5283747|NCT00494754|phenotype|phenotype
5283748|NCT00494754|endophenotype|endophenotype
5283749|NCT00494728|Smoking|smoking
5283750|NCT00494728|Depression|depression
5283751|NCT00494728|Major Depressive Disorder|major depressive disorder
5283752|NCT00494728|Cognitive Behavioral Analysis System of Psychotherapy|cognitive behavioral analysis system of psychotherapy
5283753|NCT00494728|Smoking Cessation Treatment|smoking cessation treatment
5283754|NCT00494728|Nicotine Replacement Therapy|nicotine replacement therapy
5283755|NCT00494728|Nicotine Patch|nicotine patch
5283756|NCT00494728|CBASP|cbasp
5283757|NCT00494728|MDD|mdd
5283758|NCT00494702|Asphyxia|asphyxia
5283759|NCT00494702|Resuscitation|resuscitation
5283760|NCT00494702|Oxidative stress|oxidative stress
5283761|NCT00494702|Prematurity|prematurity
5283762|NCT00494702|Follow up|follow up
5283763|NCT00494689|transcranial sonolysis or monitoring|transcranial sonolysis or monitoring
5283764|NCT00494689|rapid magnetic stimulation|rapid magnetic stimulation
5283765|NCT00494689|cerebral ischemia|cerebral ischemia
5283766|NCT00494689|hydrocephalus|hydrocephalus
5283767|NCT00494689|Barthel's index|barthel's index
5283768|NCT00494676|Hemianopia|hemianopia
5283769|NCT00494676|Mobility|mobility
5283770|NCT00494676|Rehabilitation|rehabilitation
5283771|NCT00494676|Low vision|low vision
5283772|NCT00494663|diabetes|diabetes
5283773|NCT00494663|type 2 diabetes|type 2 diabetes
5283774|NCT00494663|cholesterol|cholesterol
5283775|NCT00494650|PTSD|ptsd
5283776|NCT00494650|Schizophrenia|schizophrenia
5283777|NCT00494650|Schizoaffective Disorder|schizoaffective disorder
5283778|NCT00494650|Bipolar Disorder|bipolar disorder
5283779|NCT00494650|Major Depression|major depression
5283780|NCT00494624|Wheezing|wheezing
5283781|NCT00494624|virus|virus
5283782|NCT00494624|child|child
5283783|NCT00494598|opioids, cerebral perfusion, arterial pharmacokinetics|opioids, cerebral perfusion, arterial pharmacokinetics
5283784|NCT00494585|CEP-701|cep-701
5283785|NCT00494585|Leukemia|leukemia
5283786|NCT00494585|Myelofibrosis|myelofibrosis
5283787|NCT00494585|MF|mf
5283788|NCT00494585|JAK2|jak2
5283789|NCT00494585|Tyrosine Kinase Inhibitor|tyrosine kinase inhibitor
5283790|NCT00494585|Lestaurtinib|lestaurtinib
5283791|NCT00494585|Chronic Idiopathic Myelofibrosis|chronic idiopathic myelofibrosis
5283792|NCT00494585|CIMF|cimf
5283793|NCT00494572|Montelukast|montelukast
5283794|NCT00494572|Albuterol|albuterol
5283795|NCT00494572|Status Asthmaticus|status asthmaticus
5283796|NCT00494572|Asthma|asthma
5283797|NCT00494559|Type 2 Diabetes|type 2 diabetes
5283798|NCT00494559|Pioglitazone|pioglitazone
5283799|NCT00494559|restenosis|restenosis
5283800|NCT00494546|prostate|prostate
5283801|NCT00494546|brachytherapy|brachytherapy
5283802|NCT00494533|pulmonary arterial hypertension|pulmonary arterial hypertension
5283803|NCT00494533|prostacyclin analogue|prostacyclin analogue
5283804|NCT00494533|intravenous|intravenous
5283805|NCT00494520|Anomia|anomia
5283806|NCT00494520|Aphasia|aphasia
5283807|NCT00494520|Traumatic Brain Injury|traumatic brain injury
5283808|NCT00494520|Cerebrovascular Accident|cerebrovascular accident
5283809|NCT00494507|periodic paralysis|periodic paralysis
5283810|NCT00494507|dichlorphenamide|dichlorphenamide
5283811|NCT00494494|cystoid macular edema|cystoid macular edema
5283812|NCT00494494|cataract|cataract
5283813|NCT00494494|nonsteroidal antiinflammatory drugs|nonsteroidal antiinflammatory drugs
5283814|NCT00494494|optical coherence tomography|optical coherence tomography
5283815|NCT00494481|Zactima|zactima
5283816|NCT00494468|Insomnia|insomnia
5283817|NCT00494468|Sleep Disorder|sleep disorder
5283818|NCT00494468|Sleep Deprivation|sleep deprivation
5283819|NCT00494455|critical illness|critical illness
5283820|NCT00494455|hyperglycemia|hyperglycemia
5283821|NCT00494455|intensive insulin therapy|intensive insulin therapy
5283822|NCT00494455|glucose monitoring|glucose monitoring
5283823|NCT00494455|shock|shock
5283824|NCT00494442|Advanced ovarian cancer|advanced ovarian cancer
5283825|NCT00494442|Poly(ADP ribose) polymerases|poly(adp ribose) polymerases
5283826|NCT00494442|KU-0059436|ku-0059436
5283827|NCT00494442|AZD2281|azd2281
5283828|NCT00494442|BRCA1 protein|brca1 protein
5283829|NCT00494442|BRCA2 protein|brca2 protein
5283830|NCT00494429|Preterm Neonates|preterm neonates
5283831|NCT00494429|Morphine|morphine
5283832|NCT00494429|Critically ill|critically ill
5283833|NCT00494403|sprain proprioception|sprain proprioception
5283834|NCT00494390|Biometry|biometry
5283835|NCT00494390|corneal opacity|corneal opacity
5283836|NCT00494390|astigmatism|astigmatism
5283837|NCT00494390|refraction|refraction
5283838|NCT00494364|ear disease|ear disease
5283839|NCT00494364|otitis|otitis
5283840|NCT00494364|Eustachian tube|eustachian tube
5283841|NCT00494364|mastoid air cells|mastoid air cells
5283842|NCT00494364|Normal healthy volunteers|normal healthy volunteers
5283843|NCT00494351|Hidradenitis Suppurativa|hidradenitis suppurativa
5283844|NCT00494351|Nd:YAG laser|nd:yag laser
5283845|NCT00494338|Metastatic Androgen Independent Prostate Cancer (MAIPC)|metastatic androgen independent prostate cancer (maipc)
5283846|NCT00494325|age related maculopathy, macular pigment|age related maculopathy, macular pigment
5283847|NCT00494312|Glucose Metabolism Disorder|glucose metabolism disorder
5283848|NCT00494312|Dysmetabolic Syndrome|dysmetabolic syndrome
5283849|NCT00494312|Type II Diabetes|type ii diabetes
5283850|NCT00494312|Diabetes Mellitus|diabetes mellitus
5283851|NCT00494312|Lipoatrophic|lipoatrophic
5283852|NCT00494312|Dyslipidemia|dyslipidemia
5283853|NCT00494312|Liver|liver
5283854|NCT00494312|Drug Therapy|drug therapy
5283855|NCT00494299|HCC|hcc
5283856|NCT00494299|Cancer|cancer
5283857|NCT00494299|Liver Cancer|liver cancer
5283858|NCT00494299|TACE|tace
5283859|NCT00494286|Abuse Focused Cognitive Behavioral Therapy|abuse focused cognitive behavioral therapy
5283860|NCT00494286|Treatment Effectiveness Research|treatment effectiveness research
5283861|NCT00494286|Treatment Dissemination|treatment dissemination
5283862|NCT00494273|Haitian American Adolescents|haitian american adolescents
5283863|NCT00494273|HIV Prevention|hiv prevention
5283864|NCT00494273|Cognitive Behavioral Intervention|cognitive behavioral intervention
5283865|NCT00494260|recurrent abdominal pain|recurrent abdominal pain
5283866|NCT00494260|illness behavior|illness behavior
5283867|NCT00494260|social learning|social learning
5283868|NCT00494260|cognitive behavioral therapy|cognitive behavioral therapy
5283869|NCT00494247|acute coronary syndromes|acute coronary syndromes
5283870|NCT00494247|endothelial progenitor cells|endothelial progenitor cells
5283871|NCT00494247|coronary stent|coronary stent
5283872|NCT00494234|Advanced breast cancer|advanced breast cancer
5283873|NCT00494234|Poly(ADP ribose) polymerases|poly(adp ribose) polymerases
5283874|NCT00494234|AZD2281,KU-0059436 (olaparib)|azd2281,ku-0059436 (olaparib)
5283875|NCT00494234|BRCA1 protein|brca1 protein
5283876|NCT00494234|BRCA2 protein|brca2 protein
5283877|NCT00494221|Colorectal cancer|colorectal cancer
5283878|NCT00494221|Recentin|recentin
5283879|NCT00494221|Metastatic Cancer|metastatic cancer
5283880|NCT00494221|FOLFOX|folfox
5283881|NCT00494208|androgens|androgens
5283882|NCT00494208|testosterone|testosterone
5283883|NCT00494208|testosterone deficiency|testosterone deficiency
5283884|NCT00494208|women|women
5283885|NCT00494208|menopause|menopause
5283886|NCT00494208|surgical Menopause|surgical menopause
5283887|NCT00494208|hysterectomy|hysterectomy
5283888|NCT00494208|oophorectomy|oophorectomy
5283889|NCT00494208|ovariectomy|ovariectomy
5283890|NCT00494208|sexual dysfunction|sexual dysfunction
5283891|NCT00494208|sexual function|sexual function
5283892|NCT00494208|muscle function|muscle function
5283893|NCT00494208|insulin sensitivity|insulin sensitivity
5283894|NCT00494208|body composition|body composition
5283895|NCT00494195|limb girdle muscular dystrophy type 2D|limb girdle muscular dystrophy type 2d
5283896|NCT00494195|alpha-sarcoglycanopathy|alpha-sarcoglycanopathy
5283897|NCT00494195|LGMD|lgmd
5283898|NCT00494195|LGMD2D|lgmd2d
5283899|NCT00494195|gene therapy|gene therapy
5283900|NCT00494195|gene transfer|gene transfer
5283901|NCT00494195|muscular dystrophy|muscular dystrophy
5283902|NCT00494195|SGCA|sgca
5283903|NCT00494195|sarcoglycan|sarcoglycan
5283904|NCT00494195|limb girdle|limb girdle
5283905|NCT00494195|adeno-associated virus|adeno-associated virus
5283906|NCT00494195|AAV|aav
5283907|NCT00494195|AAV1|aav1
5283908|NCT00494182|Head and Neck Cancer|head and neck cancer
5283909|NCT00494182|Squamous Cell Carcinoma|squamous cell carcinoma
5283910|NCT00494182|Sorafenib|sorafenib
5283911|NCT00494182|BAY 43-9006|bay 43-9006
5283912|NCT00494182|Carboplatin|carboplatin
5283913|NCT00494182|Paclitaxel|paclitaxel
5283914|NCT00494182|SCCHN|scchn
5283915|NCT00494169|Idiopathic Hypogonadotropic Hypogonadism|idiopathic hypogonadotropic hypogonadism
5283916|NCT00494169|Kallmann Syndrome|kallmann syndrome
5283917|NCT00494169|Puberty|puberty
5283918|NCT00494169|Pituitary Abnormalities|pituitary abnormalities
5283919|NCT00494169|Hypothalamus|hypothalamus
5283920|NCT00494169|anosmia|anosmia
5283921|NCT00494169|GnRH deficiency|gnrh deficiency
5283922|NCT00494143|Amputee|amputee
5283923|NCT00494143|Economy|economy
5283924|NCT00494143|Efficiency|efficiency
5283925|NCT00494143|Foot|foot
5283926|NCT00494143|Gait|gait
5283927|NCT00494143|Kinematics|kinematics
5283928|NCT00494143|Kinetics|kinetics
5283929|NCT00494143|Prosthesis|prosthesis
5283930|NCT00494104|vitamin D deficiency|vitamin d deficiency
5283931|NCT00494104|breastfed infant|breastfed infant
5283932|NCT00494104|northern latitude|northern latitude
5283933|NCT00494104|infant|infant
5283934|NCT00494104|breastfed|breastfed
5283935|NCT00494104|winter|winter
5283936|NCT00494104|vitamin D status|vitamin d status
5283937|NCT00494078|critical illness|critical illness
5283938|NCT00494078|hyperglycemia|hyperglycemia
5283939|NCT00494078|intensive insulin therapy|intensive insulin therapy
5283940|NCT00494078|glucose monitoring|glucose monitoring
5283941|NCT00494052|Coronary Heart Disease|coronary heart disease
5283942|NCT00494052|Choice Behavior|choice behavior
5283943|NCT00494052|Risk Factors|risk factors
5283944|NCT00494052|Risk Assessment|risk assessment
5283945|NCT00494052|Primary Prevention|primary prevention
5283946|NCT00494052|Decision Making|decision making
5283947|NCT00494052|Decision Aids|decision aids
5283948|NCT00494052|Patient Compliance|patient compliance
5283949|NCT00494039|prostate|prostate
5283950|NCT00494039|cancer|cancer
5283951|NCT00494039|radiation|radiation
5283952|NCT00494039|brachytherapy|brachytherapy
5283953|NCT00494013|diabetes|diabetes
5283954|NCT00494013|type 2|type 2
5283955|NCT00493987|Testosterone|testosterone
5283956|NCT00493987|Androgens|androgens
5283957|NCT00493987|Dihydrotestosterone|dihydrotestosterone
5283958|NCT00493987|5-alpha reductase|5-alpha reductase
5283959|NCT00493987|Body Composition|body composition
5283960|NCT00493987|Muscle|muscle
5283961|NCT00493987|Sexual function|sexual function
5283962|NCT00493987|Men|men
5283963|NCT00493987|Healthy Men|healthy men
5283964|NCT00493974|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5283965|NCT00493974|COPD|copd
5283966|NCT00493974|Exacerbation|exacerbation
5283967|NCT00493974|Anti-leukotriene|anti-leukotriene
5283968|NCT00493974|Length of Stay|length of stay
5283969|NCT00493974|LOS|los
5283970|NCT00493961|Kallmann Syndrome|kallmann syndrome
5283971|NCT00493961|Idiopathic Hypogonadotropic Hypogonadism|idiopathic hypogonadotropic hypogonadism
5283972|NCT00493961|GnRH deficiency|gnrh deficiency
5283973|NCT00493935|bedtime snack|bedtime snack
5283974|NCT00493935|hypoglycemia|hypoglycemia
5283975|NCT00493935|Diabetes Mellitus, Type I|diabetes mellitus, type i
5283976|NCT00493935|glucose monitoring|glucose monitoring
5283977|NCT00493922|Malaria|malaria
5283978|NCT00493922|Diagnosis|diagnosis
5283979|NCT00493922|Rapid diagnostic tests|rapid diagnostic tests
5283980|NCT00493922|Microscopy|microscopy
5283981|NCT00493922|Clinical diagnosis|clinical diagnosis
5283982|NCT00493922|Africa|africa
5283983|NCT00493909|thoracotomy|thoracotomy
5283984|NCT00493909|pain therapy|pain therapy
5283985|NCT00493909|thoracic paravertebral blockade|thoracic paravertebral blockade
5283986|NCT00493909|intrathecal opioids|intrathecal opioids
5283987|NCT00493909|thoracic epidural analgesia|thoracic epidural analgesia
5283988|NCT00493909|Analgesia after thoracotomy|analgesia after thoracotomy
5283989|NCT00493896|Venous Thromboembolism Prophylaxis|venous thromboembolism prophylaxis
5283990|NCT00493896|VTE prophylaxis|vte prophylaxis
5283991|NCT00493883|Therasphere|therasphere
5283992|NCT00493883|Yttrium|yttrium
5283993|NCT00493883|liver|liver
5283994|NCT00493883|cancer|cancer
5283995|NCT00493883|radiation|radiation
5283996|NCT00493857|Colorectal cancer|colorectal cancer
5283997|NCT00493857|Monoclonal antibody|monoclonal antibody
5283998|NCT00493857|Anti-EGFR|anti-egfr
5283999|NCT00493844|Chest pain|chest pain
5284000|NCT00493844|Unstable angina|unstable angina
5284001|NCT00493844|NT-proBNP|nt-probnp
5284002|NCT00493844|Exercise test.|exercise test.
5284003|NCT00493831|smoking reduction|smoking reduction
5284004|NCT00493831|inflammation|inflammation
5284005|NCT00493831|harm reduction|harm reduction
5284006|NCT00493831|lipid biomarkers|lipid biomarkers
5284007|NCT00493818|GSK690693,|gsk690693,
5284008|NCT00493818|Solid Tumors,|solid tumors,
5284009|NCT00493818|Lymphoma,|lymphoma,
5284010|NCT00493818|AKT|akt
5284011|NCT00493805|homeostasis model assessment of insulin resistance|homeostasis model assessment of insulin resistance
5284012|NCT00493766|LBH589|lbh589
5284013|NCT00493766|Prostate Cancer|prostate cancer
5284014|NCT00493766|HRPC|hrpc
5284015|NCT00493766|Hormone Refractory Prostate Cancer|hormone refractory prostate cancer
5284016|NCT00493740|Cephalic phase, oncology patients|cephalic phase, oncology patients
5284017|NCT00493727|Oxidative stress|oxidative stress
5284018|NCT00493727|N-acetylcysteine|n-acetylcysteine
5284019|NCT00493727|NAC|nac
5284020|NCT00493727|Isoprostane|isoprostane
5284021|NCT00493727|Proteinuria|proteinuria
5284022|NCT00493727|Diabetes|diabetes
5284023|NCT00493727|Mucomyst|mucomyst
5284024|NCT00493727|albuminuria|albuminuria
5284025|NCT00493714|Advanced Cancer|advanced cancer
5284026|NCT00493714|Delirium|delirium
5284027|NCT00493714|Restlessness|restlessness
5284028|NCT00493714|Confusion|confusion
5284029|NCT00493714|Caregivers|caregivers
5284030|NCT00493714|Questionnaire|questionnaire
5284031|NCT00493688|Abdominal Cancer|abdominal cancer
5284032|NCT00493688|Pelvic Cancer|pelvic cancer
5284033|NCT00493688|Perioperative Energy Dynamics|perioperative energy dynamics
5284034|NCT00493688|Cardiopulmonary Exercise Testing|cardiopulmonary exercise testing
5284035|NCT00493688|CPET|cpet
5284036|NCT00493675|Cystic duct leakage|cystic duct leakage
5284037|NCT00493636|Breast Cancer|breast cancer
5284038|NCT00493610|Oxidant stress|oxidant stress
5284039|NCT00493610|N-acetylcysteine|n-acetylcysteine
5284040|NCT00493610|Hepatitis C|hepatitis c
5284041|NCT00493610|Liver disease|liver disease
5284042|NCT00493610|Mucomyst|mucomyst
5284043|NCT00493610|Isoprostane|isoprostane
5284044|NCT00493597|Atherosclerosis|atherosclerosis
5284045|NCT00493597|Restenosis|restenosis
5284046|NCT00493597|EPC|epc
5284047|NCT00493597|DC|dc
5284048|NCT00493584|Myocardial Infarction|myocardial infarction
5284049|NCT00493584|Myocardial Ischemia|myocardial ischemia
5284050|NCT00493584|Myocardial Revascularization|myocardial revascularization
5284051|NCT00493584|Telemedicine|telemedicine
5284052|NCT00493584|Percutaneous Transluminal Coronary Angioplasty|percutaneous transluminal coronary angioplasty
5284053|NCT00493571|Myelodysplastic Syndromes|myelodysplastic syndromes
5284054|NCT00493571|MDS|mds
5284055|NCT00493571|Gimatecan|gimatecan
5284056|NCT00493571|Leukemia|leukemia
5284057|NCT00493558|Roentgen Stereophotogrammetric Analysis|roentgen stereophotogrammetric analysis
5284058|NCT00493558|Trabecular Metal Posterior Lumbar Interbody Cage|trabecular metal posterior lumbar interbody cage
5284059|NCT00493558|Posterior Lumbar Interbody Fusion Cage|posterior lumbar interbody fusion cage
5284060|NCT00493558|Posterior Lumbar spine fusion surgery|posterior lumbar spine fusion surgery
5284061|NCT00493545|Multicenter|multicenter
5284062|NCT00493545|Open-Label|open-label
5284063|NCT00493545|Nonrandomized|nonrandomized
5284064|NCT00493545|Safety|safety
5284065|NCT00493519|Cephalic phase|cephalic phase
5284066|NCT00493519|Anorexia nervosa|anorexia nervosa
5284067|NCT00493519|Bulimia nervosa|bulimia nervosa
5284068|NCT00493519|obese binge eaters|obese binge eaters
5284069|NCT00493519|VAS|vas
5284070|NCT00493519|EDI|edi
5284071|NCT00493519|shame-feed procedure|shame-feed procedure
5284072|NCT00493506|ProAlgaZyme|proalgazyme
5284073|NCT00493506|HIV|hiv
5284074|NCT00493506|HAART|haart
5284075|NCT00493506|hsCRP|hscrp
5284076|NCT00493506|Oxidative stress|oxidative stress
5284077|NCT00493506|CD4+ lymphocytes|cd4+ lymphocytes
5284078|NCT00493506|Algae|algae
5284079|NCT00493506|HAART adverse effects|haart adverse effects
5284080|NCT00493506|HBV|hbv
5284081|NCT00493493|Cymetra|cymetra
5284082|NCT00493467|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
5284083|NCT00493467|Lymphoma|lymphoma
5284084|NCT00493467|Indolent Lymphomas|indolent lymphomas
5284085|NCT00493467|Ibritumomab Tiuxetan|ibritumomab tiuxetan
5284086|NCT00493467|Zevalin|zevalin
5284087|NCT00493454|Indolent Lymphoma|indolent lymphoma
5284088|NCT00493454|Extranodal Marginal|extranodal marginal
5284089|NCT00493454|Nodal Marginal Zone|nodal marginal zone
5284090|NCT00493454|Splenic Marginal|splenic marginal
5284091|NCT00493454|MALT Type|malt type
5284092|NCT00493454|Zevalin|zevalin
5284093|NCT00493454|Ibritumomab Tiuxetan|ibritumomab tiuxetan
5284094|NCT00493454|Rituximab|rituximab
5284095|NCT00493428|Hepatocellular Carcinoma|hepatocellular carcinoma
5284096|NCT00493428|GABAergic Activity|gabaergic activity
5284097|NCT00493428|Baclofen|baclofen
5284098|NCT00493415|microcirculation|microcirculation
5284099|NCT00493415|sepsis|sepsis
5284100|NCT00493415|nitroglycerine|nitroglycerine
5284101|NCT00493415|SDF imaging|sdf imaging
5284102|NCT00493402|Antineoplastic Agents|antineoplastic agents
5284103|NCT00493402|administration & dosage|administration & dosage
5284104|NCT00493402|Carcinoma, Hepatocellular|carcinoma, hepatocellular
5284105|NCT00493402|Chemoembolization, Therapeutic|chemoembolization, therapeutic
5284106|NCT00493402|Humans|humans
5284107|NCT00493402|Liver Neoplasms|liver neoplasms
5284108|NCT00493402|therapy|therapy
5284109|NCT00493389|ACTH stimulation test|acth stimulation test
5284110|NCT00493389|cortisol|cortisol
5284111|NCT00493389|stress|stress
5284112|NCT00493376|tirapazamine|tirapazamine
5284113|NCT00493376|DNA damage|dna damage
5284114|NCT00493376|comet assay|comet assay
5284115|NCT00493363|falciparum malaria|falciparum malaria
5284116|NCT00493363|artemisinins|artemisinins
5284117|NCT00493363|artesunate|artesunate
5284118|NCT00493363|resistance|resistance
5284119|NCT00493350|Breast Cancer|breast cancer
5284120|NCT00493350|Circulating Tumor Cells|circulating tumor cells
5284121|NCT00493350|Gene Profiling|gene profiling
5284122|NCT00493350|International Stage Stratification Study|international stage stratification study
5284123|NCT00493350|Blood Sample|blood sample
5284124|NCT00493350|ISSS|isss
5284125|NCT00493337|Adherence|adherence
5284126|NCT00493337|Compliance|compliance
5284127|NCT00493337|Statins|statins
5284128|NCT00493337|Intervention|intervention
5284129|NCT00493337|Hypercholesterolemia|hypercholesterolemia
5284130|NCT00493324|psoriasis|psoriasis
5284131|NCT00493324|alefacept|alefacept
5284132|NCT00493324|polyvalent pneumococcal vaccine|polyvalent pneumococcal vaccine
5284133|NCT00493324|Immunization|immunization
5284134|NCT00493298|disease progression|disease progression
5284135|NCT00493298|Multiple Sclerosis|multiple sclerosis
5284136|NCT00493298|disease activity|disease activity
5284137|NCT00493298|Tysabri|tysabri
5284138|NCT00493298|natalizumab|natalizumab
5284139|NCT00493298|long-term safety|long-term safety
5284140|NCT00493285|Lower Respiratory Tract Illness|lower respiratory tract illness
5284141|NCT00493285|RSV and PIV3 infection|rsv and piv3 infection
5284142|NCT00493272|Blood coagulation disorder, acquired|blood coagulation disorder, acquired
5284143|NCT00493272|Hemodilution|hemodilution
5284144|NCT00493272|Fibrinogen|fibrinogen
5284145|NCT00493272|Hemostasis|hemostasis
5284146|NCT00493272|HES|hes
5284147|NCT00493259|Health-Related Quality of Life|health-related quality of life
5284148|NCT00493233|schizophrenia|schizophrenia
5284149|NCT00493233|antipsychotics|antipsychotics
5284150|NCT00493233|polypharmacy|polypharmacy
5284151|NCT00493233|double-blind|double-blind
5284152|NCT00493233|randomized|randomized
5284153|NCT00493220|ceftriaxone|ceftriaxone
5284154|NCT00493220|cephalosporins|cephalosporins
5284155|NCT00493220|pharmacokinetics|pharmacokinetics
5284156|NCT00493220|subcutaneous|subcutaneous
5284157|NCT00493220|hyaluronoglucosaminidase|hyaluronoglucosaminidase
5284158|NCT00493220|hyaluronidase|hyaluronidase
5284159|NCT00493220|hyaluronan|hyaluronan
5284160|NCT00493220|rHuPH20|rhuph20
5284161|NCT00493194|Cyclosporine toxicity|cyclosporine toxicity
5284162|NCT00493194|Interstitial Fibrosis|interstitial fibrosis
5284163|NCT00493194|Chronic allograft nephropathy|chronic allograft nephropathy
5284164|NCT00493194|Sirolimus|sirolimus
5284165|NCT00493181|oprelvekin|oprelvekin
5284166|NCT00493181|tyrosine kinase inhibitor|tyrosine kinase inhibitor
5284167|NCT00493181|Chronic Myelogenous Leukemia|chronic myelogenous leukemia
5284168|NCT00493181|Leukemia|leukemia
5284169|NCT00493181|CML|cml
5284170|NCT00493181|Thrombocytopenia|thrombocytopenia
5284171|NCT00493181|Imatinib|imatinib
5284172|NCT00493181|IL-11|il-11
5284173|NCT00493181|Interleukin 11|interleukin 11
5284174|NCT00493181|Neumega|neumega
5284175|NCT00493129|Systemic Mastocytosis|systemic mastocytosis
5284176|NCT00493129|SM|sm
5284177|NCT00493129|Mast Cell Leukemia|mast cell leukemia
5284178|NCT00493129|Leukemia|leukemia
5284179|NCT00493129|Denileukin Diftitox|denileukin diftitox
5284180|NCT00493129|Ontak|ontak
5284181|NCT00493116|recovery of efficacy|recovery of efficacy
5284182|NCT00493116|MxA protein|mxa protein
5284183|NCT00493116|neutralizing antibodies|neutralizing antibodies
5284184|NCT00493116|Multiple sclerosis|multiple sclerosis
5284185|NCT00493103|thyroglobulin gene|thyroglobulin gene
5284186|NCT00493103|congenital hypothyroidism|congenital hypothyroidism
5284187|NCT00493103|gene mutations|gene mutations
5284188|NCT00493103|fetal goiter|fetal goiter
5284189|NCT00493103|iodine nutrition|iodine nutrition
5284190|NCT00493090|Professional|professional
5284191|NCT00493090|patient partnership|patient partnership
5284192|NCT00493090|patient satisfaction|patient satisfaction
5284193|NCT00493090|professional training|professional training
5284194|NCT00493077|Multiple Sclerosis|multiple sclerosis
5284195|NCT00493077|Neutralizing antibodies|neutralizing antibodies
5284196|NCT00493077|Safety|safety
5284197|NCT00493077|Low immunogenicity|low immunogenicity
5284198|NCT00493077|interferon|interferon
5284199|NCT00493077|interferon-beta-1a|interferon-beta-1a
5284200|NCT00493051|diabetes|diabetes
5284201|NCT00493051|nonhealing|nonhealing
5284202|NCT00493051|ulcers|ulcers
5284203|NCT00493051|neuropathic|neuropathic
5284204|NCT00493038|Treatment of acute bacterial rhinosinusitis|treatment of acute bacterial rhinosinusitis
5284205|NCT00493025|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
5284206|NCT00493025|stage II esophageal cancer|stage ii esophageal cancer
5284207|NCT00493025|stage III esophageal cancer|stage iii esophageal cancer
5284208|NCT00493025|stage IV esophageal cancer|stage iv esophageal cancer
5284209|NCT00493012|body weight|body weight
5284210|NCT00493012|body compostion|body compostion
5284211|NCT00493012|vitamin D|vitamin d
5284212|NCT00493012|blood pressure|blood pressure
5284213|NCT00492999|recurrent colon cancer|recurrent colon cancer
5284214|NCT00492999|stage IV colon cancer|stage iv colon cancer
5284215|NCT00492999|recurrent rectal cancer|recurrent rectal cancer
5284216|NCT00492999|stage IV rectal cancer|stage iv rectal cancer
5284217|NCT00492999|adenocarcinoma of the colon|adenocarcinoma of the colon
5284218|NCT00492999|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5284219|NCT00492999|liver metastases|liver metastases
5284220|NCT00492986|Renal Cell Cancer (RCC)|renal cell cancer (rcc)
5284221|NCT00492986|Cancer|cancer
5284222|NCT00492973|arthroplasty|arthroplasty
5284223|NCT00492973|replacement|replacement
5284224|NCT00492973|knee|knee
5284225|NCT00492960|larazotide acetate|larazotide acetate
5284226|NCT00492947|Phase I|phase i
5284227|NCT00492947|dendritic cell|dendritic cell
5284228|NCT00492947|vaccine|vaccine
5284229|NCT00492947|intra tumoral|intra tumoral
5284230|NCT00492947|squamous cell carcinoma|squamous cell carcinoma
5284231|NCT00492934|subfertility|subfertility
5284232|NCT00492934|endometrium thickness|endometrium thickness
5284233|NCT00492934|implantation rate|implantation rate
5284234|NCT00492934|embryo cryopreservation|embryo cryopreservation
5284235|NCT00492934|embryo transfer|embryo transfer
5284236|NCT00492921|graft versus host disease|graft versus host disease
5284237|NCT00492908|Coronary Revascularization|coronary revascularization
5284238|NCT00492908|Titanium-Nitride-Oxide Coated Stent|titanium-nitride-oxide coated stent
5284239|NCT00492908|Zotarolimus-Eluting Stent|zotarolimus-eluting stent
5284240|NCT00492882|Polycystic Ovary Syndrome|polycystic ovary syndrome
5284241|NCT00492882|Follicular Arrest|follicular arrest
5284242|NCT00492882|Anti-Mullerian Hormone|anti-mullerian hormone
5284243|NCT00492882|FSH|fsh
5284244|NCT00492869|kidney transplantation|kidney transplantation
5284245|NCT00492869|rejection|rejection
5284246|NCT00492869|AEB071|aeb071
5284247|NCT00492869|tacrolimus|tacrolimus
5284248|NCT00492869|mycophenolic|mycophenolic
5284249|NCT00492869|basiliximab|basiliximab
5284250|NCT00492869|immunosuppression|immunosuppression
5284251|NCT00492856|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5284252|NCT00492856|adult acute promyelocytic leukemia (M3)|adult acute promyelocytic leukemia (m3)
5284253|NCT00492856|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
5284254|NCT00492843|Ibandronate, Lung cancer, bone metastasis|ibandronate, lung cancer, bone metastasis
5284255|NCT00492830|Phase 1|phase 1
5284256|NCT00492830|TRC093|trc093
5284257|NCT00492830|denatured collagen|denatured collagen
5284258|NCT00492830|solid tumor|solid tumor
5284259|NCT00492830|antibody|antibody
5284260|NCT00492830|TRACON|tracon
5284261|NCT00492830|Locally advanced solid tumors|locally advanced solid tumors
5284262|NCT00492830|Metastatic solid tumors|metastatic solid tumors
5284263|NCT00492817|Spinal Neoplasms|spinal neoplasms
5284264|NCT00492817|Paraspinal Metastases|paraspinal metastases
5284265|NCT00492817|Stereotactic Body Radiotherapy|stereotactic body radiotherapy
5284266|NCT00492817|CT-on-Rails|ct-on-rails
5284267|NCT00492817|Spinal Cord|spinal cord
5284268|NCT00492817|SBRT|sbrt
5284269|NCT00492804|inguinal hernia|inguinal hernia
5284270|NCT00492804|chronic pain|chronic pain
5284271|NCT00492804|neurectomy|neurectomy
5284272|NCT00492804|hypesthesia|hypesthesia
5284273|NCT00492791|crohn's disease|crohn's disease
5284274|NCT00492791|capsule endoscopes|capsule endoscopes
5284275|NCT00492765|Combination therapy|combination therapy
5284276|NCT00492765|Simvastatin|simvastatin
5284277|NCT00492765|Multiple Sclerosis|multiple sclerosis
5284278|NCT00492765|Interferon-beta-1a|interferon-beta-1a
5284279|NCT00492739|Orthotopic liver transplantation|orthotopic liver transplantation
5284280|NCT00492739|Pediatric|pediatric
5284281|NCT00492739|Immunosuppression|immunosuppression
5284282|NCT00492739|Varicella vaccine|varicella vaccine
5284283|NCT00492739|B cell response|b cell response
5284284|NCT00492739|T cell response|t cell response
5284285|NCT00492739|Antibodies|antibodies
5284286|NCT00492739|Varicella|varicella
5284287|NCT00492739|Chickenpox|chickenpox
5284288|NCT00492739|transplantation|transplantation
5284289|NCT00492726|Complicated Intra-Abdominal Infections|complicated intra-abdominal infections
5284290|NCT00492713|Bioavailability|bioavailability
5284291|NCT00492713|Dark Chocolate|dark chocolate
5284292|NCT00492713|Milk Chocolate|milk chocolate
5284293|NCT00492713|Polyphenols|polyphenols
5284294|NCT00492700|steatosis,|steatosis,
5284295|NCT00492700|fibrosis,|fibrosis,
5284296|NCT00492700|diabetes,|diabetes,
5284297|NCT00492700|obesity|obesity
5284298|NCT00492687|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5284299|NCT00492687|adult giant cell glioblastoma|adult giant cell glioblastoma
5284300|NCT00492687|adult gliosarcoma|adult gliosarcoma
5284301|NCT00492687|adult glioblastoma|adult glioblastoma
5284302|NCT00492674|TKA|tka
5284303|NCT00492674|Arthroplasty|arthroplasty
5284304|NCT00492674|Knee|knee
5284305|NCT00492674|Osteoarthritis|osteoarthritis
5284306|NCT00492674|Rehabilitation|rehabilitation
5284307|NCT00492661|Tacrolimus|tacrolimus
5284308|NCT00492661|Prograf|prograf
5284309|NCT00492661|PRIDE|pride
5284310|NCT00492648|GSK Biologicals|gsk biologicals
5284311|NCT00492648|Varicella Zoster Virus (VZV)|varicella zoster virus (vzv)
5284312|NCT00492648|Intracellular cytokine staining (ICS)|intracellular cytokine staining (ics)
5284313|NCT00492648|Vaccine|vaccine
5284314|NCT00492648|Cell mediated immunity (CMI)|cell mediated immunity (cmi)
5284315|NCT00492648|Herpes Zoster (HZ)|herpes zoster (hz)
5284316|NCT00492648|Shingles|shingles
5284317|NCT00492622|Gastroparesis|gastroparesis
5284318|NCT00492622|Gastroesophageal reflux disease|gastroesophageal reflux disease
5284319|NCT00492622|heartburn|heartburn
5284320|NCT00492609|Surgery|surgery
5284321|NCT00492609|Navigation|navigation
5284322|NCT00492609|ACL|acl
5284323|NCT00492609|IKDC|ikdc
5284324|NCT00492609|comparative study|comparative study
5284325|NCT00492583|probiotic|probiotic
5284326|NCT00492583|health|health
5284327|NCT00492583|bifidobacterium lactis|bifidobacterium lactis
5284328|NCT00492583|BB-12|bb-12
5284329|NCT00492570|Multiple Sclerosis|multiple sclerosis
5284330|NCT00492570|Cognitive Dysfunction in Multiple sclerosis|cognitive dysfunction in multiple sclerosis
5284331|NCT00492570|early treatment|early treatment
5284332|NCT00492570|Avonex|avonex
5284333|NCT00492570|interferon beta 1a|interferon beta 1a
5284334|NCT00492570|Cognitive Dysfunction|cognitive dysfunction
5284335|NCT00492557|Pneumococcal Disease|pneumococcal disease
5284336|NCT00492557|Pneumococcal Conjugate Vaccine|pneumococcal conjugate vaccine
5284337|NCT00492544|Human Papillomavirus (HPV) vaccine|human papillomavirus (hpv) vaccine
5284338|NCT00492544|safety|safety
5284339|NCT00492544|cervical cancer|cervical cancer
5284340|NCT00492544|immunogenicity|immunogenicity
5284341|NCT00492544|vaccine|vaccine
5284342|NCT00492544|viral infections|viral infections
5284343|NCT00492544|pre-adolescent and adolescent females|pre-adolescent and adolescent females
5284344|NCT00492531|Interventional Study|interventional study
5284345|NCT00492531|6-Minute Walk|6-minute walk
5284346|NCT00492531|Sickle Cell Anemia|sickle cell anemia
5284347|NCT00492531|Sildenafil/Viagra|sildenafil/viagra
5284348|NCT00492531|Tricuspid Regurgitant Velocity|tricuspid regurgitant velocity
5284349|NCT00492531|Sickle Cell Disease|sickle cell disease
5284350|NCT00492531|Pulmonary Hypertension|pulmonary hypertension
5284351|NCT00492518|Contrast Induced Nephropathy|contrast induced nephropathy
5284352|NCT00492518|Prophylaxis|prophylaxis
5284353|NCT00492518|Theophylline|theophylline
5284354|NCT00492518|Acetylcysteine|acetylcysteine
5284355|NCT00492518|Coronary angiography|coronary angiography
5284356|NCT00492505|stage IIIA melanoma|stage iiia melanoma
5284357|NCT00492505|stage IIIB melanoma|stage iiib melanoma
5284358|NCT00492505|stage IIIC melanoma|stage iiic melanoma
5284359|NCT00492492|radius,|radius,
5284360|NCT00492492|pinning,|pinning,
5284361|NCT00492492|fixed-angle plate,|fixed-angle plate,
5284362|NCT00492492|quick-DASH,|quick-dash,
5284363|NCT00492492|HERZBERG-score.|herzberg-score.
5284364|NCT00492466|Multiple Sclerosis|multiple sclerosis
5284365|NCT00492466|antibody|antibody
5284366|NCT00492466|Neutralizing antibody|neutralizing antibody
5284367|NCT00492466|Binding antibody|binding antibody
5284368|NCT00492466|MxA protein|mxa protein
5284369|NCT00492440|recurrent renal cell cancer|recurrent renal cell cancer
5284370|NCT00492440|stage IV renal cell cancer|stage iv renal cell cancer
5284371|NCT00492440|stage III renal cell cancer|stage iii renal cell cancer
5284372|NCT00492440|recurrent melanoma|recurrent melanoma
5284373|NCT00492440|stage IV melanoma|stage iv melanoma
5284374|NCT00492414|Panic disorder (PD)|panic disorder (pd)
5284375|NCT00492388|breakthrough|breakthrough
5284376|NCT00492388|pain|pain
5284377|NCT00492388|cancer|cancer
5284378|NCT00492362|hemodialysis|hemodialysis
5284379|NCT00492362|exercise|exercise
5284380|NCT00492362|physical fitness|physical fitness
5284381|NCT00492362|dialysis adequacy|dialysis adequacy
5284382|NCT00492349|Varenicline|varenicline
5284383|NCT00492349|Neurobiology|neurobiology
5284384|NCT00492349|clinical trial|clinical trial
5284385|NCT00492349|cognitive deficits|cognitive deficits
5284386|NCT00492349|Schizophreniform Disorder|schizophreniform disorder
5284387|NCT00492336|Cognitive impairments|cognitive impairments
5284388|NCT00492336|Negative symptoms|negative symptoms
5284389|NCT00492323|pain following the healing of rashes and blisters|pain following the healing of rashes and blisters
5284390|NCT00492323|herpes virus|herpes virus
5284391|NCT00492323|rash|rash
5284392|NCT00492323|varicella-zoster virus|varicella-zoster virus
5284393|NCT00492323|shingles.|shingles.
5284394|NCT00492310|Smoking|smoking
5284395|NCT00492310|tobacco|tobacco
5284396|NCT00492310|women|women
5284397|NCT00492310|yoga|yoga
5284398|NCT00492284|Macular Degeneration|macular degeneration
5284399|NCT00492284|AMD|amd
5284400|NCT00492284|CNV|cnv
5284401|NCT00492284|Choroidal neovascularization|choroidal neovascularization
5284402|NCT00492284|Photodynamic therapy|photodynamic therapy
5284403|NCT00492284|CNV Secondary to Age Related Macular Degeneration|cnv secondary to age related macular degeneration
5284404|NCT00492271|Friulimicin B|friulimicin b
5284405|NCT00492271|Lipopeptide Antibiotic|lipopeptide antibiotic
5284406|NCT00492271|First in Man|first in man
5284407|NCT00492258|stage II renal cell cancer|stage ii renal cell cancer
5284408|NCT00492258|stage III renal cell cancer|stage iii renal cell cancer
5284409|NCT00492258|stage IV renal cell cancer|stage iv renal cell cancer
5284410|NCT00492258|stage I renal cell cancer|stage i renal cell cancer
5284411|NCT00492258|clear cell renal cell carcinoma|clear cell renal cell carcinoma
5284412|NCT00492258|papillary renal cell carcinoma|papillary renal cell carcinoma
5284413|NCT00492245|PTK|ptk
5284414|NCT00492245|corneal opacity|corneal opacity
5284415|NCT00492245|mitomycin|mitomycin
5284416|NCT00492232|Chronic Insomnia|chronic insomnia
5284417|NCT00492232|Sleep Initiation and Maintenance Disorder|sleep initiation and maintenance disorder
5284418|NCT00492232|Drug Therapy|drug therapy
5284419|NCT00492219|arthroplasty|arthroplasty
5284420|NCT00492219|replacement|replacement
5284421|NCT00492219|knee|knee
5284422|NCT00492219|prosthesis|prosthesis
5284423|NCT00492206|Non Small Cell Lung Cancer|non small cell lung cancer
5284424|NCT00492206|NSCLC|nsclc
5284425|NCT00492206|EGFR Inhibitor|egfr inhibitor
5284426|NCT00492206|Radiation Therapy|radiation therapy
5284427|NCT00492193|Hand assist laparoscopic partial large bowel resection|hand assist laparoscopic partial large bowel resection
5284428|NCT00492193|Laparoscopic partial large bowel resection|laparoscopic partial large bowel resection
5284429|NCT00492167|recurrent neuroblastoma|recurrent neuroblastoma
5284430|NCT00492167|regional neuroblastoma|regional neuroblastoma
5284431|NCT00492167|stage 4S neuroblastoma|stage 4s neuroblastoma
5284432|NCT00492167|disseminated neuroblastoma|disseminated neuroblastoma
5284433|NCT00492154|FRACTURE OF DISTAL RADIUS|fracture of distal radius
5284434|NCT00492141|Ewing's Sarcoma|ewing's sarcoma
5284435|NCT00492141|Lung Involvement|lung involvement
5284436|NCT00492141|Temozolomide|temozolomide
5284437|NCT00492141|Temodar|temodar
5284438|NCT00492141|Aerosol Liposomal 9-Nitro-20(S)-Camptothecin|aerosol liposomal 9-nitro-20(s)-camptothecin
5284439|NCT00492141|Aerosol L9-NC|aerosol l9-nc
5284441|NCT00492128|hypertension|hypertension
5284442|NCT00492128|angiotensin receptor blocker|angiotensin receptor blocker
5284443|NCT00492128|diuretic|diuretic
5284444|NCT00492128|combination therapy|combination therapy
5284445|NCT00492115|sleep|sleep
5284446|NCT00492115|dementia|dementia
5284447|NCT00492115|apnea|apnea
5284448|NCT00492115|memory|memory
5284449|NCT00492115|Parkinson's disease|parkinson's disease
5284450|NCT00492102|pharmacokinetics|pharmacokinetics
5284451|NCT00492102|Montelukast|montelukast
5284452|NCT00492102|bronchopulmonary dysplasia|bronchopulmonary dysplasia
5284453|NCT00492102|Pharmacokinetics of Montelukast|pharmacokinetics of montelukast
5284454|NCT00492076|Specific immunotherapy|specific immunotherapy
5284455|NCT00492076|Mite|mite
5284456|NCT00492076|Asthma|asthma
5284457|NCT00492063|safety|safety
5284458|NCT00492063|immunogenicity|immunogenicity
5284459|NCT00492063|non-inferiority|non-inferiority
5284460|NCT00492063|MDCK|mdck
5284461|NCT00492063|cell culture-derived|cell culture-derived
5284462|NCT00492063|subunit influenza vaccine|subunit influenza vaccine
5284463|NCT00492063|influenza prevention|influenza prevention
5284464|NCT00492050|Waldenstrom's Macroglobulinemia|waldenstrom's macroglobulinemia
5284465|NCT00492050|Macroglobulinemic Lymphoma|macroglobulinemic lymphoma
5284466|NCT00492050|Stem Cell Collection|stem cell collection
5284467|NCT00492050|Bortezomib|bortezomib
5284468|NCT00492050|LDP-341|ldp-341
5284469|NCT00492050|MLN341|mln341
5284470|NCT00492050|PS-341|ps-341
5284471|NCT00492050|Velcade|velcade
5284472|NCT00492050|Rituximab|rituximab
5284473|NCT00492050|Rituxan|rituxan
5284474|NCT00492037|hyponatremia|hyponatremia
5284475|NCT00492037|hypervolemic|hypervolemic
5284476|NCT00492037|euvolemic|euvolemic
5284477|NCT00492037|conivaptan|conivaptan
5284478|NCT00492024|Respiratory Tract Infection|respiratory tract infection
5284479|NCT00492024|Bacterial Sinusitis|bacterial sinusitis
5284480|NCT00492011|Circadian Rhythm Disorders|circadian rhythm disorders
5284481|NCT00492011|Biological Clock Disturbances|biological clock disturbances
5284482|NCT00492011|Jet Lag Syndrome|jet lag syndrome
5284483|NCT00492011|Time Zone Change Syndrome|time zone change syndrome
5284484|NCT00492011|Drug Therapy|drug therapy
5284485|NCT00491985|Influenza A/H5N1 Virus|influenza a/h5n1 virus
5284486|NCT00491985|Influenza Pandemic|influenza pandemic
5284487|NCT00491985|Orthomyxoviridae Infections|orthomyxoviridae infections
5284488|NCT00491959|oral mucosa|oral mucosa
5284489|NCT00491959|limbal insufficiency|limbal insufficiency
5284490|NCT00491959|transplantation|transplantation
5284491|NCT00491959|cornea|cornea
5284492|NCT00491959|ocular surface|ocular surface
5284493|NCT00491946|Cancer|cancer
5284494|NCT00491946|Actinomycin|actinomycin
5284495|NCT00491946|Vincristine|vincristine
5284496|NCT00491920|osteoporosis|osteoporosis
5284497|NCT00491920|bone mineral density|bone mineral density
5284498|NCT00491920|vitamin D|vitamin d
5284499|NCT00491907|folic acid|folic acid
5284500|NCT00491907|endothelial function|endothelial function
5284501|NCT00491907|baroreceptor function|baroreceptor function
5284502|NCT00491907|heart failure|heart failure
5284503|NCT00491894|Mental Retardation|mental retardation
5284504|NCT00491894|Neurological Impairment|neurological impairment
5284505|NCT00491894|Cerebral Palsy|cerebral palsy
5284506|NCT00491894|Drooling|drooling
5284507|NCT00491894|Neurological Conditions|neurological conditions
5284508|NCT00491881|blood pressure|blood pressure
5284509|NCT00491881|No added salt diet|no added salt diet
5284510|NCT00491881|urinary sodium|urinary sodium
5284511|NCT00491855|Advanced Peritoneal Carcinomatosis|advanced peritoneal carcinomatosis
5284512|NCT00491855|Peritoneal Cancer|peritoneal cancer
5284513|NCT00491855|Bevacizumab|bevacizumab
5284514|NCT00491855|Avastin|avastin
5284515|NCT00491855|vascular endothelial growth factor|vascular endothelial growth factor
5284516|NCT00491855|Anti-VEGF monoclonal antibody|anti-vegf monoclonal antibody
5284517|NCT00491855|rhuMAb-VEGF|rhumab-vegf
5284518|NCT00491855|Oxaliplatin|oxaliplatin
5284519|NCT00491855|Eloxatin|eloxatin
5284520|NCT00491855|Paclitaxel|paclitaxel
5284521|NCT00491855|Taxol|taxol
5284522|NCT00491842|Huntington's Disease|huntington's disease
5284523|NCT00491842|Disclosure|disclosure
5284524|NCT00491842|Adaptation|adaptation
5284525|NCT00491842|Communication About Huntington's Disease|communication about huntington's disease
5284526|NCT00491842|Huntington Disease|huntington disease
5284527|NCT00491842|HD|hd
5284528|NCT00491842|Phone Interview|phone interview
5284529|NCT00491816|breast|breast
5284530|NCT00491816|cancer|cancer
5284531|NCT00491816|breast cancer|breast cancer
5284532|NCT00491803|COPD|copd
5284533|NCT00491790|montelukast|montelukast
5284534|NCT00491790|Albuterol|albuterol
5284535|NCT00491790|Status Asthmaticus|status asthmaticus
5284536|NCT00491790|Asthma|asthma
5284537|NCT00491777|Noninvasive|noninvasive
5284538|NCT00491777|Hemodynamic|hemodynamic
5284539|NCT00491777|Monitoring|monitoring
5284540|NCT00491777|Critical Care|critical care
5284541|NCT00491777|Swan-Ganz|swan-ganz
5284542|NCT00491751|endothelium|endothelium
5284543|NCT00491751|nitric oxide|nitric oxide
5284544|NCT00491751|statins|statins
5284545|NCT00491751|ascorbic acid|ascorbic acid
5284546|NCT00491738|RCC|rcc
5284547|NCT00491738|Renal cell cancer|renal cell cancer
5284548|NCT00491738|Avastin|avastin
5284549|NCT00491738|Sutent|sutent
5284550|NCT00491712|Glaucoma|glaucoma
5284551|NCT00491712|Neovascular Glaucoma|neovascular glaucoma
5284552|NCT00491712|Drainage implant devices|drainage implant devices
5284553|NCT00491712|Silicone Ahmed Tube|silicone ahmed tube
5284554|NCT00491712|Triamcinolone|triamcinolone
5284555|NCT00491699|NSCLC|nsclc
5284556|NCT00491686|Long-term depression|long-term depression
5284557|NCT00491673|Fracture|fracture
5284558|NCT00491673|Femoral neck|femoral neck
5284559|NCT00491673|Arthroplasty|arthroplasty
5284560|NCT00491660|Gravity|gravity
5284561|NCT00491660|Mechanical ventilation|mechanical ventilation
5284562|NCT00491660|Infants|infants
5284563|NCT00491660|Ventilator-associated pneumonia|ventilator-associated pneumonia
5284564|NCT00491660|Types of bacterial colonies in subjects at 2-5 days of mechanical ventilation|types of bacterial colonies in subjects at 2-5 days of mechanical ventilation
5284565|NCT00491660|Colony count of an organism was cultured|colony count of an organism was cultured
5284566|NCT00491647|ADHD, time perception, treatments|adhd, time perception, treatments
5284567|NCT00491634|acute myeloid leukemia|acute myeloid leukemia
5284568|NCT00491634|myelodysplastic syndrome|myelodysplastic syndrome
5284569|NCT00491634|allogeneic stem cell transplantation|allogeneic stem cell transplantation
5284570|NCT00491634|reduced-intensity conditioning|reduced-intensity conditioning
5284571|NCT00491634|treosulfan|treosulfan
5284572|NCT00491621|kidney|kidney
5284573|NCT00491621|tumor|tumor
5284574|NCT00491621|Molecular Markers|molecular markers
5284575|NCT00491621|Cytology|cytology
5284576|NCT00491621|Histology|histology
5284577|NCT00491621|Cystic kidney tumor|cystic kidney tumor
5284578|NCT00491608|Phase 3b|phase 3b
5284579|NCT00491608|rThrombin|rthrombin
5284580|NCT00491608|spine surgery|spine surgery
5284581|NCT00491608|vascular surgery|vascular surgery
5284582|NCT00491608|hemostasis|hemostasis
5284583|NCT00491608|immunogenicity|immunogenicity
5284584|NCT00491608|safety|safety
5284585|NCT00491595|Soy isoflavones|soy isoflavones
5284586|NCT00491595|Genotoxicity|genotoxicity
5284587|NCT00491595|Apoptosis|apoptosis
5284588|NCT00491595|Estrogenic effects|estrogenic effects
5284589|NCT00491569|Schizophrenia|schizophrenia
5284590|NCT00491569|sarcosine|sarcosine
5284591|NCT00491569|D-serine|d-serine
5284592|NCT00491569|NMDA|nmda
5284593|NCT00491556|Atazanavir/Ritonavir (ATV/r)|atazanavir/ritonavir (atv/r)
5284594|NCT00491556|highly-active antiretroviral therapy (HAART)|highly-active antiretroviral therapy (haart)
5284595|NCT00491556|Treatment Naive|treatment naive
5284596|NCT00491491|non-Hodgkin's lymphoma|non-hodgkin's lymphoma
5284597|NCT00491491|autologous stem cell transplantation|autologous stem cell transplantation
5284598|NCT00491491|radioimmunotherapy|radioimmunotherapy
5284599|NCT00491491|zevalin|zevalin
5284600|NCT00491478|Repetitive behavior disorder|repetitive behavior disorder
5284601|NCT00491478|Stereotypy|stereotypy
5284602|NCT00491478|Sertraline|sertraline
5284603|NCT00491465|Type 1 Diabetes, physical activity, pediatric, metabolic control|type 1 diabetes, physical activity, pediatric, metabolic control
5284604|NCT00491452|Ischemic MR|ischemic mr
5284605|NCT00491452|Annuloplasty|annuloplasty
5284606|NCT00491439|in vivo confocal microscopy|in vivo confocal microscopy
5284607|NCT00491439|vitrectomy|vitrectomy
5284608|NCT00491439|corneal transplantation|corneal transplantation
5284609|NCT00491439|Epi-LASIK|epi-lasik
5284610|NCT00491439|wound healing|wound healing
5284611|NCT00491426|Infection|infection
5284612|NCT00491426|Anti-Infective Agents|anti-infective agents
5284613|NCT00491426|Antifungal Agents|antifungal agents
5284614|NCT00491426|Proteomics|proteomics
5284615|NCT00491413|neurodevelopmental outcomes|neurodevelopmental outcomes
5284616|NCT00491400|endothelium|endothelium
5284617|NCT00491400|obesity|obesity
5284618|NCT00491400|diabetes mellitus|diabetes mellitus
5284619|NCT00491400|dyslipidemia|dyslipidemia
5284620|NCT00491387|hypertension|hypertension
5284621|NCT00491387|sympathetic nervous system|sympathetic nervous system
5284622|NCT00491361|ADHD, SNAP-IV, SDQ, ASRS, reliability, validity|adhd, snap-iv, sdq, asrs, reliability, validity
5284623|NCT00491348|Generalized anxiety disorder|generalized anxiety disorder
5284624|NCT00491348|fMRI|fmri
5284625|NCT00491348|Worry|worry
5284626|NCT00491335|AIDS|aids
5284627|NCT00491335|Lung Cancer|lung cancer
5284628|NCT00491335|Emphysema|emphysema
5284629|NCT00491335|Nicotine|nicotine
5284630|NCT00491335|HIV Infection|hiv infection
5284631|NCT00491335|Smoking|smoking
5284632|NCT00491322|Vitamin D|vitamin d
5284633|NCT00491322|Vitamin D deficiency|vitamin d deficiency
5284634|NCT00491322|Insulin resistance|insulin resistance
5284635|NCT00491322|Diabetes|diabetes
5284636|NCT00491322|Diabetes mellitus|diabetes mellitus
5284637|NCT00491322|FGF-23|fgf-23
5284638|NCT00491322|FGF23|fgf23
5284639|NCT00491322|Phosphate|phosphate
5284640|NCT00491296|S/P Transuretral resection of bladder tumor|s/p transuretral resection of bladder tumor
5284641|NCT00491296|Recurrent tumor after BCG Treatment|recurrent tumor after bcg treatment
5284642|NCT00491270|Vaginosis, Bacterial|vaginosis, bacterial
5284643|NCT00491270|Abortion, Spontaneous|abortion, spontaneous
5284644|NCT00491270|Premature Birth|premature birth
5284645|NCT00491257|Influenza|influenza
5284946|NCT00490022|Androgen|androgen
5284646|NCT00491257|Orthomyxoviridae Infections|orthomyxoviridae infections
5284647|NCT00491257|Orthomyxoviruses|orthomyxoviruses
5284648|NCT00491257|Split-virion influenza vaccine|split-virion influenza vaccine
5284649|NCT00491244|Chronic hepatitis C|chronic hepatitis c
5284650|NCT00491244|Hemodialysis|hemodialysis
5284651|NCT00491244|Interferon|interferon
5284652|NCT00491244|Ribavirin|ribavirin
5284653|NCT00491231|orthostatic hypotension|orthostatic hypotension
5284654|NCT00491231|ambulatory blood pressure monitoring|ambulatory blood pressure monitoring
5284655|NCT00491218|impact of cardiac computed tomography on outpatient angina evaluation|impact of cardiac computed tomography on outpatient angina evaluation
5284656|NCT00491218|downstream resource utilization|downstream resource utilization
5284657|NCT00491192|Fever|fever
5284658|NCT00491192|Acute cerebral damage|acute cerebral damage
5284659|NCT00491192|Normothermia|normothermia
5284660|NCT00491192|Diclofenac|diclofenac
5284661|NCT00491192|ICU|icu
5284662|NCT00491192|Outcome|outcome
5284663|NCT00491192|Intracranial pressure|intracranial pressure
5284664|NCT00491192|Cerebral perfusion pressure|cerebral perfusion pressure
5284665|NCT00491192|Traumatic brain injury|traumatic brain injury
5284666|NCT00491192|Subarachnoid hemorrhage|subarachnoid hemorrhage
5284667|NCT00491179|Chronic hepatitis C|chronic hepatitis c
5284668|NCT00491179|hemodialysis|hemodialysis
5284669|NCT00491179|interferon|interferon
5284670|NCT00491179|ribavirin|ribavirin
5284671|NCT00491166|diabetic macular edema|diabetic macular edema
5284672|NCT00491166|bromfenac ophthalmic solution|bromfenac ophthalmic solution
5284673|NCT00491153|asthma|asthma
5284674|NCT00491153|airway hyperresponsiveness|airway hyperresponsiveness
5284675|NCT00491153|dry powder mannitol inhalation|dry powder mannitol inhalation
5284676|NCT00491153|methacholine|methacholine
5284677|NCT00491140|EGFR|egfr
5284678|NCT00491140|KRAS|kras
5284679|NCT00491140|BRAF|braf
5284680|NCT00491140|MET|met
5284681|NCT00491140|IGFR1|igfr1
5284682|NCT00491101|Asthma Control|asthma control
5284683|NCT00491101|Quality of Life|quality of life
5284684|NCT00491101|Children|children
5284685|NCT00491101|Polish Version of PAQLQ(S) by Juniper|polish version of paqlq(s) by juniper
5284686|NCT00491075|Renal Cell Carcinoma|renal cell carcinoma
5284687|NCT00491075|Non-Clear Cell|non-clear cell
5284688|NCT00491075|Pemetrexed|pemetrexed
5284689|NCT00491075|Gemcitabine|gemcitabine
5284690|NCT00491075|LY231514|ly231514
5284691|NCT00491075|Alimta|alimta
5284692|NCT00491075|MTA|mta
5284693|NCT00491075|Multitargeted Antifolate|multitargeted antifolate
5284694|NCT00491075|NSC-698037|nsc-698037
5284695|NCT00491075|Gemcitabine Hydrochloride|gemcitabine hydrochloride
5284696|NCT00491075|Gemzar|gemzar
5284698|NCT00491062|Parkinson's disease|parkinson's disease
5284699|NCT00491062|enteric nervous system|enteric nervous system
5284700|NCT00491049|prophylaxis|prophylaxis
5284701|NCT00491049|intraocular surgery|intraocular surgery
5284702|NCT00491049|endophthalmitis|endophthalmitis
5284703|NCT00491049|antibiotic|antibiotic
5284704|NCT00491036|Acute myocardial infarction|acute myocardial infarction
5284705|NCT00491036|cardiogenic shock|cardiogenic shock
5284706|NCT00491036|percutaneous coronary intervention|percutaneous coronary intervention
5284707|NCT00491036|intraaortic balloon counterpulsation|intraaortic balloon counterpulsation
5284708|NCT00491036|Acute myocardial infarction - cardiogenic shock|acute myocardial infarction - cardiogenic shock
5284709|NCT00491010|atrial flutter|atrial flutter
5284710|NCT00491010|ablation|ablation
5284711|NCT00491010|voltage targeted|voltage targeted
5284712|NCT00490997|ketamine|ketamine
5284713|NCT00490997|propofol|propofol
5284714|NCT00490997|sedation|sedation
5284715|NCT00490997|pediatric|pediatric
5284716|NCT00490997|emergency department|emergency department
5284717|NCT00490997|fracture|fracture
5284718|NCT00490984|obstructive sleep apena|obstructive sleep apena
5284719|NCT00490984|tongue|tongue
5284720|NCT00490984|surgery|surgery
5284721|NCT00490971|Bipolar Disorder|bipolar disorder
5284722|NCT00490971|Mania|mania
5284723|NCT00490971|Depression|depression
5284724|NCT00490971|Manic-Depressive Disorder|manic-depressive disorder
5284725|NCT00490958|heart Failure|heart failure
5284726|NCT00490958|haemodialysis|haemodialysis
5284727|NCT00490958|telmisartan|telmisartan
5284728|NCT00490958|angiotensin converting enzyme inhibitor|angiotensin converting enzyme inhibitor
5284729|NCT00490932|Watery diarrhea|watery diarrhea
5284730|NCT00490932|Bloody diarrhea|bloody diarrhea
5284731|NCT00490919|Chronic pain|chronic pain
5284732|NCT00490919|opioid|opioid
5284733|NCT00490919|transdermal|transdermal
5284734|NCT00490919|Moderate to severe chronic low back pain|moderate to severe chronic low back pain
5284735|NCT00490906|MS (Multiple Sclerosis)|ms (multiple sclerosis)
5284736|NCT00490893|counterregulation|counterregulation
5284737|NCT00490893|hypoglycemia unawareness|hypoglycemia unawareness
5284738|NCT00490893|insulin therapy|insulin therapy
5284739|NCT00490828|Cardiac surgery|cardiac surgery
5284740|NCT00490828|systemic inflammatory response syndrome|systemic inflammatory response syndrome
5284741|NCT00490828|health-related quality of life|health-related quality of life
5284742|NCT00490802|Autism|autism
5284743|NCT00490802|Treatment|treatment
5284744|NCT00490802|Oxytocin|oxytocin
5284745|NCT00490802|Adults|adults
5284746|NCT00490802|Autism Spectrum Disorder|autism spectrum disorder
5284747|NCT00490789|tuberous sclerosis|tuberous sclerosis
5284748|NCT00490789|lymphangioleiomyomatosis|lymphangioleiomyomatosis
5284749|NCT00490789|sirolimus|sirolimus
5284750|NCT00490789|angiomyolioma|angiomyolioma
5284751|NCT00490789|rapamycin|rapamycin
5284752|NCT00490789|mTOR|mtor
5284753|NCT00490776|Cutaneous T-Cell Lymphoma|cutaneous t-cell lymphoma
5284754|NCT00490776|adults|adults
5284755|NCT00490776|Mycosis Fungoides|mycosis fungoides
5284756|NCT00490776|Sézary Syndrome|sézary syndrome
5284757|NCT00490776|CTCL|ctcl
5284758|NCT00490763|Prostate Cancer|prostate cancer
5284759|NCT00490763|Active Surveillance|active surveillance
5284760|NCT00490763|Prostate Specific Antigen|prostate specific antigen
5284761|NCT00490763|Questionnaire|questionnaire
5284762|NCT00490763|Survey|survey
5284763|NCT00490750|Heller Dor|heller dor
5284764|NCT00490750|Heller Toupet|heller toupet
5284765|NCT00490750|Myotomy|myotomy
5284766|NCT00490737|ESRD|esrd
5284767|NCT00490737|dialysis|dialysis
5284768|NCT00490737|hemodialysis|hemodialysis
5284769|NCT00490737|continuous ambulatory peritoneal dialysis|continuous ambulatory peritoneal dialysis
5284770|NCT00490724|Heart failure, congestive|heart failure, congestive
5284771|NCT00490724|Nesiritide and|nesiritide and
5284772|NCT00490724|JNS004|jns004
5284773|NCT00490698|Kidney Cancer|kidney cancer
5284774|NCT00490698|Renal Cell Carcinoma|renal cell carcinoma
5284775|NCT00490698|Bone-Targeted Therapy|bone-targeted therapy
5284776|NCT00490698|Zoledronate|zoledronate
5284777|NCT00490698|Zometa|zometa
5284778|NCT00490698|Atorvastatin|atorvastatin
5284779|NCT00490698|Lipitor|lipitor
5284780|NCT00490698|RCC|rcc
5284781|NCT00490672|Hypertension|hypertension
5284782|NCT00490672|Diabetes Mellitus|diabetes mellitus
5284783|NCT00490672|Hyperlipidaemia|hyperlipidaemia
5284784|NCT00490672|Primary Care|primary care
5284785|NCT00490672|Community Care|community care
5284786|NCT00490672|Multiple Risk Factors Interventional Strategies|multiple risk factors interventional strategies
5284787|NCT00490646|Locally advanced and/or metastatic breast cancer|locally advanced and/or metastatic breast cancer
5284788|NCT00490633|Influenza|influenza
5284789|NCT00490633|Non Pharmaceutical Intervention|non pharmaceutical intervention
5284790|NCT00490633|Face Mask|face mask
5284791|NCT00490633|Hand Hygiene|hand hygiene
5284792|NCT00490620|primary biliary cirrhosis C06.552.630.400|primary biliary cirrhosis c06.552.630.400
5284793|NCT00490620|retroviral infection C02.782.815|retroviral infection c02.782.815
5284794|NCT00490607|Hemagiomas of infancy|hemagiomas of infancy
5284795|NCT00490594|ACL|acl
5284796|NCT00490594|ligament|ligament
5284797|NCT00490594|ACL injury|acl injury
5284798|NCT00490581|Early housing after hospitalization|early housing after hospitalization
5284799|NCT00490568|cognition|cognition
5284800|NCT00490568|Alzheimer's disease|alzheimer's disease
5284801|NCT00490568|Rosiglitazone extended-release (XR)|rosiglitazone extended-release (xr)
5284802|NCT00490568|safety|safety
5284803|NCT00490568|adjunctive therapy|adjunctive therapy
5284804|NCT00490568|BRL-049653|brl-049653
5284805|NCT00490568|tolerability|tolerability
5284806|NCT00490568|open-label extension|open-label extension
5284807|NCT00490555|Male Contraception|male contraception
5284808|NCT00490555|Testosterone|testosterone
5284809|NCT00490555|Testis|testis
5284810|NCT00490555|Contraception|contraception
5284811|NCT00490555|Prostate|prostate
5284812|NCT00490542|Bipolar Disorder|bipolar disorder
5284813|NCT00490542|Major Depression|major depression
5284814|NCT00490542|Clinical pharmacology|clinical pharmacology
5284815|NCT00490542|Clinical Trial|clinical trial
5284816|NCT00490516|Schizophrenia, psychotic disorders|schizophrenia, psychotic disorders
5284817|NCT00490503|Breast Cancer|breast cancer
5284818|NCT00490503|Magnetic Resonance Imaging|magnetic resonance imaging
5284819|NCT00490503|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
5284821|NCT00490503|DW-MRI|dw-mri
5284822|NCT00490503|MRS|mrs
5284823|NCT00490503|MRI|mri
5284824|NCT00490477|acute renal failure|acute renal failure
5284825|NCT00490477|lipopolysaccharide|lipopolysaccharide
5284826|NCT00490477|tubular apoptosis|tubular apoptosis
5284827|NCT00490477|Polymyxin-B fiber|polymyxin-b fiber
5284828|NCT00490477|Severe sepsis from gram negative infection|severe sepsis from gram negative infection
5284829|NCT00490464|Patients with SAH or ICH|patients with sah or ich
5284830|NCT00490438|perineometry|perineometry
5284831|NCT00490438|Modified Oxford Score|modified oxford score
5284832|NCT00490438|pelvic muscles evaluation|pelvic muscles evaluation
5284833|NCT00490438|urinary incontinence|urinary incontinence
5284834|NCT00490438|vaginal palpation|vaginal palpation
5284835|NCT00490425|probiotics|probiotics
5284836|NCT00490425|LGG|lgg
5284837|NCT00490425|praevention|praevention
5284838|NCT00490425|allergic asthma|allergic asthma
5284839|NCT00490425|children|children
5284840|NCT00490412|Vitamin D|vitamin d
5284841|NCT00490412|Treatment Experienced|treatment experienced
5284842|NCT00490386|Retrospective|retrospective
5284843|NCT00490386|Length of Stay|length of stay
5284844|NCT00490386|Helicobacter pylori|helicobacter pylori
5284845|NCT00490347|VentrAssistTM|ventrassisttm
5284846|NCT00490347|LVAD|lvad
5284847|NCT00490347|End-stage heart failure|end-stage heart failure
5284848|NCT00490347|Cardiomyopathy|cardiomyopathy
5284849|NCT00490334|Carcinomas|carcinomas
5284850|NCT00490334|Squamous Cel|squamous cel
5284851|NCT00490334|Adenocarcinoma|adenocarcinoma
5284852|NCT00490334|Acute Lymphocytic Leukemia|acute lymphocytic leukemia
5284853|NCT00490321|VentrAssistTM|ventrassisttm
5284854|NCT00490321|LVAD|lvad
5284855|NCT00490321|End-stage heart failure|end-stage heart failure
5284856|NCT00490321|Cardiomyopathy|cardiomyopathy
5284857|NCT00490308|luteal|luteal
5284858|NCT00490308|phase|phase
5284859|NCT00490308|estradiol|estradiol
5284860|NCT00490308|pregnancy|pregnancy
5284861|NCT00490308|rate|rate
5284862|NCT00490295|biomarkers|biomarkers
5284863|NCT00490295|brain ischemia|brain ischemia
5284864|NCT00490295|neonates|neonates
5284865|NCT00490295|cardiac surgery|cardiac surgery
5284866|NCT00490295|congenital heart disease|congenital heart disease
5284867|NCT00490282|Head and Neck Cancer|head and neck cancer
5284868|NCT00490282|Oropharyngeal Cancer|oropharyngeal cancer
5284869|NCT00490282|Adaptive Radiotherapy|adaptive radiotherapy
5284870|NCT00490282|Intensity Modulated Radiation Therapy|intensity modulated radiation therapy
5284871|NCT00490282|IMRT|imrt
5284872|NCT00490282|ART|art
5284873|NCT00490269|Marijuana dependence|marijuana dependence
5284874|NCT00490256|Selective Cerebral Perfusion|selective cerebral perfusion
5284875|NCT00490256|Renal Complications|renal complications
5284876|NCT00490256|Gastrointestinal Complications|gastrointestinal complications
5284877|NCT00490256|Aortic Arch Reconstruction|aortic arch reconstruction
5284878|NCT00490256|Modified Perfusion|modified perfusion
5284879|NCT00490256|Cardiopulmonary Bypass|cardiopulmonary bypass
5284880|NCT00490256|Pediatrics|pediatrics
5284881|NCT00490256|Cardiac Defects|cardiac defects
5284882|NCT00490256|intestinal ischemia|intestinal ischemia
5284883|NCT00490256|necrotizing entercolitis|necrotizing entercolitis
5284884|NCT00490256|Near Infra-red spectroscopy|near infra-red spectroscopy
5284885|NCT00490256|Creatinine|creatinine
5284886|NCT00490256|C-reactive protein levels|c-reactive protein levels
5284887|NCT00490243|Asthma|asthma
5284888|NCT00490243|Children|children
5284889|NCT00490243|Exercise|exercise
5284890|NCT00490243|Pulmonary Function|pulmonary function
5284891|NCT00490243|Budesonide|budesonide
5284892|NCT00490243|Montelukast|montelukast
5284893|NCT00490243|Formoterol|formoterol
5284894|NCT00490230|Paromomycin|paromomycin
5284895|NCT00490230|Gentamicin|gentamicin
5284896|NCT00490217|Spontaneous bacterial peritonitis|spontaneous bacterial peritonitis
5284897|NCT00490217|incidence|incidence
5284898|NCT00490217|Finland|finland
5284899|NCT00490217|etiology|etiology
5284900|NCT00490217|liver cirrhosis|liver cirrhosis
5284901|NCT00490204|Perennial Allergic Rhinitis|perennial allergic rhinitis
5284902|NCT00490204|Placebo control|placebo control
5284903|NCT00490204|anti-histamine|anti-histamine
5284904|NCT00490204|Cetirizine|cetirizine
5284905|NCT00490178|Type II diabetes|type ii diabetes
5284906|NCT00490178|dyslipidemia|dyslipidemia
5284907|NCT00490178|metformin|metformin
5284908|NCT00490178|fenofibrate|fenofibrate
5284909|NCT00490178|synordia|synordia
5284910|NCT00490152|HIV|hiv
5284911|NCT00490152|Microbicide Gel|microbicide gel
5284912|NCT00490152|HIV Seronegativity|hiv seronegativity
5284913|NCT00490139|Adjuvant|adjuvant
5284914|NCT00490139|ErbB2-overexpressing|erbb2-overexpressing
5284915|NCT00490139|Early stage breast cancer|early stage breast cancer
5284916|NCT00490139|HER2/neu gene amplified|her2/neu gene amplified
5284917|NCT00490126|Laparoscopic Surgery|laparoscopic surgery
5284918|NCT00490126|Laparoscopy|laparoscopy
5284919|NCT00490126|Gynecology|gynecology
5284920|NCT00490126|Demographics|demographics
5284921|NCT00490126|Perioperative Care|perioperative care
5284922|NCT00490100|X-Linked Severe Combined Immune Deficiency (XSCID)|x-linked severe combined immune deficiency (xscid)
5284923|NCT00490100|Growth Hormone|growth hormone
5284924|NCT00490100|Insulin-Like Growth Factor 1 (IGF)-1|insulin-like growth factor 1 (igf)-1
5284925|NCT00490100|Bone Age|bone age
5284926|NCT00490100|Growth Failure|growth failure
5284927|NCT00490100|XSCID|xscid
5284928|NCT00490100|X-Linked Severe Combined Immunodeficiency|x-linked severe combined immunodeficiency
5284929|NCT00490087|Atypical endometrial polyps|atypical endometrial polyps
5284930|NCT00490087|Atypical Endometrial Hyperplasia|atypical endometrial hyperplasia
5284931|NCT00490087|Hysteroscopic resection|hysteroscopic resection
5284932|NCT00490087|Conservative treatment|conservative treatment
5284933|NCT00490087|Fertile women|fertile women
5284934|NCT00490074|AIDS Vaccines|aids vaccines
5284935|NCT00490074|Vaccines, DNA|vaccines, dna
5284936|NCT00490074|HIV Preventive Vaccine|hiv preventive vaccine
5284937|NCT00490074|HIV Seronegativity|hiv seronegativity
5284938|NCT00490048|Ulcerative colits|ulcerative colits
5284939|NCT00490048|lung|lung
5284940|NCT00490048|Induced sputum|induced sputum
5284941|NCT00490048|Our aim to evaluate lung involvement in Ulcerative colitis patients by induced sputum|our aim to evaluate lung involvement in ulcerative colitis patients by induced sputum
5284942|NCT00490035|Epilepsy|epilepsy
5284943|NCT00490035|Brivaracetam|brivaracetam
5284944|NCT00490035|Partial Onset Seizures|partial onset seizures
5284945|NCT00490022|Dihydrotestosterone|dihydrotestosterone
5284947|NCT00490022|Prostate|prostate
5284948|NCT00489970|Persistence|persistence
5284949|NCT00489970|immunogenicity|immunogenicity
5284950|NCT00489957|congenital cardiac disorders|congenital cardiac disorders
5284951|NCT00489957|echocardiography|echocardiography
5284952|NCT00489944|ciliary body and choroid melanoma, medium/large size|ciliary body and choroid melanoma, medium/large size
5284953|NCT00489944|extraocular extension melanoma|extraocular extension melanoma
5284954|NCT00489944|iris melanoma|iris melanoma
5284955|NCT00489944|epithelioid cell intraocular melanoma|epithelioid cell intraocular melanoma
5284956|NCT00489944|stage IIB intraocular melanoma|stage iib intraocular melanoma
5284957|NCT00489944|stage IIIA intraocular melanoma|stage iiia intraocular melanoma
5284958|NCT00489944|stage IIIB intraocular melanoma|stage iiib intraocular melanoma
5284959|NCT00489944|stage IIIC intraocular melanoma|stage iiic intraocular melanoma
5284960|NCT00489944|stage IV intraocular melanoma|stage iv intraocular melanoma
5284961|NCT00489931|Avian Influenza|avian influenza
5284962|NCT00489931|Healthy|healthy
5284963|NCT00489931|Immunity|immunity
5284964|NCT00489931|Preventive|preventive
5284965|NCT00489931|Bird Flu|bird flu
5284966|NCT00489931|Healthy Volunteer|healthy volunteer
5284967|NCT00489931|HV|hv
5284968|NCT00489905|prostate cancer|prostate cancer
5284969|NCT00489905|bone mineral density|bone mineral density
5284970|NCT00489892|traumatic brain injury|traumatic brain injury
5284971|NCT00489892|TBI|tbi
5284972|NCT00489892|working memory|working memory
5284973|NCT00489892|modafinil|modafinil
5284974|NCT00489892|fMRI|fmri
5284975|NCT00489892|MRI|mri
5284976|NCT00489879|Mobile Health Units|mobile health units
5284977|NCT00489879|Chronic Disease|chronic disease
5284978|NCT00489866|PTSD|ptsd
5284979|NCT00489866|Antidepressant|antidepressant
5284980|NCT00489866|Aripiprazole|aripiprazole
5284981|NCT00489866|OEF|oef
5284982|NCT00489866|OIF|oif
5284983|NCT00489853|COPD|copd
5284984|NCT00489840|Chronic Central Serous Chorioretinopathy|chronic central serous chorioretinopathy
5284985|NCT00489827|Coronary Artery Bypass|coronary artery bypass
5284986|NCT00489827|Myocardial Protection|myocardial protection
5284987|NCT00489827|Angina, Unstable|angina, unstable
5284988|NCT00489827|Myocardial Ischemia|myocardial ischemia
5284989|NCT00489827|Myocardial Infarction|myocardial infarction
5284990|NCT00489827|Unstable Coronary Artery Disease|unstable coronary artery disease
5284991|NCT00489827|Glutamate|glutamate
5284992|NCT00489814|Prostate Cancer|prostate cancer
5284993|NCT00489814|Prostate Proton Therapy|prostate proton therapy
5284994|NCT00489814|Proton Radiation Therapy|proton radiation therapy
5284995|NCT00489814|Proton Radiotherapy|proton radiotherapy
5284996|NCT00489814|Quality of Life|quality of life
5284997|NCT00489814|QOL|qol
5284998|NCT00489814|Questionnaire|questionnaire
5284999|NCT00489801|Cardiac Rehabilitation|cardiac rehabilitation
5285000|NCT00489801|Exercise|exercise
5285001|NCT00489801|Heart failure|heart failure
5285002|NCT00489801|Coronary heart disease|coronary heart disease
5285003|NCT00489788|MRI|mri
5285004|NCT00489788|Ventricular Strain|ventricular strain
5285005|NCT00489788|Pulmonary Valve Replacement|pulmonary valve replacement
5285006|NCT00489788|Post Tetralogy of Fallot|post tetralogy of fallot
5285007|NCT00489762|Childhood|childhood
5285008|NCT00489762|Asthma|asthma
5285009|NCT00489762|Heating|heating
5285010|NCT00489762|Insulation|insulation
5285011|NCT00489762|Respiratory symptoms|respiratory symptoms
5285012|NCT00489749|Achilles tendon rupture|achilles tendon rupture
5285013|NCT00489749|Open surgical repair|open surgical repair
5285014|NCT00489749|Early functional mobilization|early functional mobilization
5285015|NCT00489749|Weightbearing|weightbearing
5285016|NCT00489749|Rehabilitation|rehabilitation
5285017|NCT00489736|Atrial Fibrillation|atrial fibrillation
5285018|NCT00489736|sinus rhythm|sinus rhythm
5285019|NCT00489736|amiodarone|amiodarone
5285020|NCT00489723|size of stone 1-2 cm|size of stone 1-2 cm
5285021|NCT00489723|Pt. with no use of alfa bloker prior ESWL|pt. with no use of alfa bloker prior eswl
5285022|NCT00489723|Pt. without internal stent|pt. without internal stent
5285023|NCT00489710|stage IV renal cell cancer|stage iv renal cell cancer
5285024|NCT00489710|recurrent renal cell cancer|recurrent renal cell cancer
5285025|NCT00489697|colorectal cancer|colorectal cancer
5285026|NCT00489697|hepatic metastases|hepatic metastases
5285027|NCT00489697|bevacizumab|bevacizumab
5285028|NCT00489697|anti-angiogenic agent|anti-angiogenic agent
5285029|NCT00489697|chemotherapy regimens|chemotherapy regimens
5285030|NCT00489697|tumor vascularity|tumor vascularity
5285031|NCT00489697|Contrast-enhanced ultrasound|contrast-enhanced ultrasound
5285032|NCT00489671|pancreatic cancer|pancreatic cancer
5285033|NCT00489671|precancerous condition|precancerous condition
5285034|NCT00489658|Human African trypanosomiasis|human african trypanosomiasis
5285035|NCT00489658|sleeping sickness|sleeping sickness
5285036|NCT00489658|Trypanosoma brucei gambiense|trypanosoma brucei gambiense
5285037|NCT00489658|combination|combination
5285038|NCT00489658|eflornithine|eflornithine
5285039|NCT00489658|nifurtimox|nifurtimox
5285040|NCT00489658|Human African trypanosomiasis (sleeping sickness) due to Trypanosoma brucei gambiense in the late stage (stage 2 or meningo-encephalitic)|human african trypanosomiasis (sleeping sickness) due to trypanosoma brucei gambiense in the late stage (stage 2 or meningo-encephalitic)
5285041|NCT00489645|pramlintide|pramlintide
5285042|NCT00489645|gastric emptying|gastric emptying
5285043|NCT00489645|T1DM|t1dm
5285044|NCT00489645|postprandial|postprandial
5285045|NCT00489632|Leukemia|leukemia
5285046|NCT00489632|Pediatrics|pediatrics
5285047|NCT00489632|Cancer|cancer
5285048|NCT00489632|Coping|coping
5285049|NCT00489632|Caregiver|caregiver
5285050|NCT00489632|Questionnaire|questionnaire
5285051|NCT00489632|Children|children
5285052|NCT00489632|Resiliency|resiliency
5285053|NCT00489632|Adjustment|adjustment
5285054|NCT00489632|Illness-related factors|illness-related factors
5285055|NCT00489619|Infectious diseases|infectious diseases
5285056|NCT00489619|Democratic Republic of Congo|democratic republic of congo
5285057|NCT00489619|Malaria|malaria
5285058|NCT00489619|International|international
5285059|NCT00489619|Maternal and child health|maternal and child health
5285060|NCT00489619|Women's Health|women's health
5285061|NCT00489619|Global Network|global network
5285062|NCT00489619|Sexually transmitted infections (STIs)|sexually transmitted infections (stis)
5285063|NCT00489606|SK3530|sk3530
5285064|NCT00489606|tamsulosin|tamsulosin
5285065|NCT00489606|hemodynamic interaction|hemodynamic interaction
5285066|NCT00489606|safety|safety
5285067|NCT00489593|Advanced Cancer|advanced cancer
5285068|NCT00489593|Weight Loss|weight loss
5285069|NCT00489593|Cachexia|cachexia
5285070|NCT00489593|Olanzapine|olanzapine
5285071|NCT00489593|Zyprexa|zyprexa
5285072|NCT00489593|Fluoxetine|fluoxetine
5285073|NCT00489593|Symbyax|symbyax
5285074|NCT00489580|stroke|stroke
5285075|NCT00489580|weakness|weakness
5285076|NCT00489580|motor recovery|motor recovery
5285077|NCT00489567|Rotavirus gastroenteritis|rotavirus gastroenteritis
5285078|NCT00489554|Primary vaccination|primary vaccination
5285079|NCT00489554|Safety|safety
5285080|NCT00489554|Pneumococcal vaccine.|pneumococcal vaccine.
5285081|NCT00489554|Pneumococcal disease|pneumococcal disease
5285082|NCT00489554|Immunogenicity|immunogenicity
5285083|NCT00489541|paclitaxel-eluting stent|paclitaxel-eluting stent
5285084|NCT00489541|PES|pes
5285085|NCT00489528|serostim|serostim
5285086|NCT00489528|Dose-Response Relationship, Drug|dose-response relationship, drug
5285087|NCT00489528|Body Composition|body composition
5285088|NCT00489515|adenocarcinoma of the gallbladder|adenocarcinoma of the gallbladder
5285089|NCT00489515|stage I pancreatic cancer|stage i pancreatic cancer
5285090|NCT00489515|stage II pancreatic cancer|stage ii pancreatic cancer
5285091|NCT00489515|stage III pancreatic cancer|stage iii pancreatic cancer
5285092|NCT00489515|stage IV pancreatic cancer|stage iv pancreatic cancer
5285093|NCT00489515|stage I colon cancer|stage i colon cancer
5285094|NCT00489515|stage II colon cancer|stage ii colon cancer
5285095|NCT00489515|stage III colon cancer|stage iii colon cancer
5285096|NCT00489515|stage IV colon cancer|stage iv colon cancer
5285097|NCT00489515|stage I gastric cancer|stage i gastric cancer
5285098|NCT00489515|stage II gastric cancer|stage ii gastric cancer
5285099|NCT00489515|stage III gastric cancer|stage iii gastric cancer
5285100|NCT00489515|stage IV gastric cancer|stage iv gastric cancer
5285101|NCT00489515|localized gallbladder cancer|localized gallbladder cancer
5285102|NCT00489515|small intestine adenocarcinoma|small intestine adenocarcinoma
5285103|NCT00489515|adenocarcinoma of the colon|adenocarcinoma of the colon
5285104|NCT00489515|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
5285105|NCT00489515|adenocarcinoma of the stomach|adenocarcinoma of the stomach
5285106|NCT00489489|MS|ms
5285107|NCT00489489|interferon-beta|interferon-beta
5285108|NCT00489489|adjunctive therapy|adjunctive therapy
5285109|NCT00489489|relapses|relapses
5285110|NCT00489476|Staccato® Loxapine, Migraine|staccato® loxapine, migraine
5285111|NCT00489463|LNG-IUS|lng-ius
5285112|NCT00489463|TCu 380A|tcu 380a
5285113|NCT00489463|Ultrasonography|ultrasonography
5285114|NCT00489463|Doppler color|doppler color
5285115|NCT00489463|power Doppler|power doppler
5285116|NCT00489463|female|female
5285117|NCT00489463|Volunteers|volunteers
5285118|NCT00489450|SK3530|sk3530
5285119|NCT00489450|alcohol|alcohol
5285120|NCT00489450|pharmacokinetics|pharmacokinetics
5285121|NCT00489450|safety|safety
5285122|NCT00489437|diagnosis|diagnosis
5285123|NCT00489424|zoledronic acid|zoledronic acid
5285124|NCT00489424|post dose symptoms|post dose symptoms
5285125|NCT00489424|transient|transient
5285126|NCT00489424|acetaminophen|acetaminophen
5285127|NCT00489424|fluvastatin|fluvastatin
5285128|NCT00489411|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5285129|NCT00489411|neurotoxicity|neurotoxicity
5285130|NCT00489411|pain|pain
5285131|NCT00489411|peripheral neuropathy|peripheral neuropathy
5285132|NCT00489385|Fibrosis|fibrosis
5285133|NCT00489385|Viral Kinetics|viral kinetics
5285134|NCT00489385|Hepatotoxicity|hepatotoxicity
5285135|NCT00489385|Immunity|immunity
5285136|NCT00489385|HIV Infection|hiv infection
5285137|NCT00489385|Hepatitis C|hepatitis c
5285138|NCT00489385|HCV|hcv
5285139|NCT00489385|Treatment Experienced|treatment experienced
5285140|NCT00489385|Treatment Naive|treatment naive
5285141|NCT00489333|ProAlgaZyme|proalgazyme
5285142|NCT00489333|Metabolic syndrome|metabolic syndrome
5285143|NCT00489333|Inflammation|inflammation
5285144|NCT00489333|Cardiovascular|cardiovascular
5285145|NCT00489333|hsCRP|hscrp
5285146|NCT00489333|Lipids|lipids
5285147|NCT00489333|Algae|algae
5285148|NCT00489320|Coronary disease|coronary disease
5285149|NCT00489320|Arteries|arteries
5285150|NCT00489320|Atherosclerosis|atherosclerosis
5285151|NCT00489320|Arteriosclerosis|arteriosclerosis
5285152|NCT00489307|Advanced Cancer|advanced cancer
5285153|NCT00489307|Solid Tumors|solid tumors
5285154|NCT00489307|Fatigue|fatigue
5285155|NCT00489307|Pain|pain
5285156|NCT00489307|Nausea|nausea
5285157|NCT00489307|Anorexia|anorexia
5285158|NCT00489307|Dexamethasone|dexamethasone
5285159|NCT00489307|Decadron|decadron
5285160|NCT00489307|Placebo|placebo
5285161|NCT00489294|Human growth hormone|human growth hormone
5285162|NCT00489294|idiopathic short stature|idiopathic short stature
5285163|NCT00489294|short stature|short stature
5285164|NCT00489281|sickle cell disease|sickle cell disease
5285165|NCT00489268|Barrett's Esophagus|barrett's esophagus
5285166|NCT00489268|Intestinal Metaplasia|intestinal metaplasia
5285167|NCT00489268|Radiofrequency Ablation|radiofrequency ablation
5285168|NCT00489255|Parkinson's disease|parkinson's disease
5285169|NCT00489255|Anti-emetic|anti-emetic
5285170|NCT00489255|Nausea|nausea
5285171|NCT00489255|Vomiting|vomiting
5285172|NCT00489229|Rosiglitazone|rosiglitazone
5285173|NCT00489229|Ramipril|ramipril
5285174|NCT00489229|Impaired glucose tolerance|impaired glucose tolerance
5285175|NCT00489229|Arterial stiffness|arterial stiffness
5285176|NCT00489229|Diabetic vasculopathy|diabetic vasculopathy
5285177|NCT00489216|Graft Versus Host Disease|graft versus host disease
5285178|NCT00489216|GVHD|gvhd
5285179|NCT00489216|Efalizumab|efalizumab
5285180|NCT00489216|Raptiva|raptiva
5285181|NCT00489216|Steroid|steroid
5285182|NCT00489216|Refractory|refractory
5285183|NCT00489216|Skin|skin
5285184|NCT00489216|Liver|liver
5285185|NCT00489216|Lineberger|lineberger
5285186|NCT00489216|University of North Carolina|university of north carolina
5285187|NCT00489177|cardiac resynchronization therapy|cardiac resynchronization therapy
5285188|NCT00489177|response|response
5285189|NCT00489177|Defibrillators|defibrillators
5285190|NCT00489164|DIABETIC PATIENTS WITH NATIVE CORONARY ARTERY LESIONS|diabetic patients with native coronary artery lesions
5285191|NCT00489151|HBV|hbv
5285192|NCT00489125|long-term effects secondary to cancer therapy in adults|long-term effects secondary to cancer therapy in adults
5285193|NCT00489125|recurrent breast cancer|recurrent breast cancer
5285194|NCT00489125|stage I breast cancer|stage i breast cancer
5285195|NCT00489125|stage II breast cancer|stage ii breast cancer
5285196|NCT00489125|stage IIIA breast cancer|stage iiia breast cancer
5285197|NCT00489125|stage IIIB breast cancer|stage iiib breast cancer
5285198|NCT00489125|stage IIIC breast cancer|stage iiic breast cancer
5285199|NCT00489125|stage IV breast cancer|stage iv breast cancer
5285200|NCT00489086|nevoid basal cell carcinoma syndrome|nevoid basal cell carcinoma syndrome
5285201|NCT00489086|basal cell carcinoma of the skin|basal cell carcinoma of the skin
5285202|NCT00489060|Cryoablation|cryoablation
5285203|NCT00489060|Radiation|radiation
5285204|NCT00489060|Prostate Cancer|prostate cancer
5285206|NCT00489034|adolescent females|adolescent females
5285207|NCT00489034|adherence|adherence
5285208|NCT00489034|clinical care|clinical care
5285209|NCT00489034|risk behaviors|risk behaviors
5285210|NCT00489021|Subacute care|subacute care
5285211|NCT00489021|Activities of Daily Living|activities of daily living
5285212|NCT00489021|Cognition assessment|cognition assessment
5285213|NCT00489021|Mood assessment|mood assessment
5285214|NCT00489021|Incontinence control|incontinence control
5285215|NCT00489008|Lung Cancer|lung cancer
5285216|NCT00489008|Non-Small Cell|non-small cell
5285217|NCT00489008|Stereotactic Body Radiation Therapy|stereotactic body radiation therapy
5285218|NCT00489008|SBRT|sbrt
5285219|NCT00489008|NSCLC|nsclc
5285220|NCT00488995|HIV Therapeutic Vaccine|hiv therapeutic vaccine
5285221|NCT00488982|Metastatic Hormone Refractory Prostate Cancer|metastatic hormone refractory prostate cancer
5285222|NCT00488969|Morphine|morphine
5285223|NCT00488969|Chronic Pain|chronic pain
5285224|NCT00488969|Spinal Cord Injury|spinal cord injury
5285225|NCT00488969|Neuropathic Pain|neuropathic pain
5285226|NCT00488956|foot|foot
5285227|NCT00488956|ankle|ankle
5285228|NCT00488956|edema|edema
5285229|NCT00488943|Stent-Graft|stent-graft
5285230|NCT00488943|AAA|aaa
5285231|NCT00488943|Abdominal Aortic Anuerysm|abdominal aortic anuerysm
5285232|NCT00488943|Zenith|zenith
5285233|NCT00488943|Endovascular|endovascular
5285234|NCT00488943|Treatment with Zenith Aortic Stent-Graft for repair Abdominal Aortic Aneurysm|treatment with zenith aortic stent-graft for repair abdominal aortic aneurysm
5285235|NCT00488930|Obesity|obesity
5285236|NCT00488930|Hyperglycemia|hyperglycemia
5285237|NCT00488930|Diabetes Mellitus Type I|diabetes mellitus type i
5285238|NCT00488930|Diabetes Mellitus Type II|diabetes mellitus type ii
5285239|NCT00488917|Liver cirrhosis|liver cirrhosis
5285240|NCT00488917|acute liver failure|acute liver failure
5285241|NCT00488917|liver transplantation|liver transplantation
5285242|NCT00488917|sepsis, infection|sepsis, infection
5285243|NCT00488917|endothelium|endothelium
5285244|NCT00488917|lipids|lipids
5285245|NCT00488917|diagnosis|diagnosis
5285246|NCT00488917|prognosis|prognosis
5285247|NCT00488904|infection|infection
5285248|NCT00488904|colorectalcancer|colorectalcancer
5285249|NCT00488904|omega-3 fedtsyre|omega-3 fedtsyre
5285250|NCT00488904|complications|complications
5285251|NCT00488891|Schizophrenia|schizophrenia
5285252|NCT00488891|Paliperdone ER|paliperdone er
5285253|NCT00488891|Invega|invega
5285254|NCT00488891|Observational|observational
5285255|NCT00488891|Antipsychotic agents|antipsychotic agents
5285256|NCT00488878|Ovarian Cancer|ovarian cancer
5285257|NCT00488878|Ovarian Carcinoma|ovarian carcinoma
5285258|NCT00488878|Low-Grade Serous Carcinoma|low-grade serous carcinoma
5285259|NCT00488878|Low Malignant Potential|low malignant potential
5285260|NCT00488878|Peritoneum Tumors|peritoneum tumors
5285261|NCT00488878|Psammocarcinoma|psammocarcinoma
5285262|NCT00488878|Data Collection|data collection
5285263|NCT00488878|Research Database|research database
5285264|NCT00488865|increased risk for PE require caval interruption|increased risk for pe require caval interruption
5285265|NCT00488839|Spasticity|spasticity
5285266|NCT00488839|Multiple Sclerosis|multiple sclerosis
5285267|NCT00488826|Vaccines, Pneumococcal Conjugate Vaccine|vaccines, pneumococcal conjugate vaccine
5285268|NCT00488813|Tzh-Chi ESBL study|tzh-chi esbl study
5285269|NCT00488800|Pneumococcal Infections/PC (Prevention & Control)|pneumococcal infections/pc (prevention & control)
5285270|NCT00488787|dental|dental
5285271|NCT00488787|surgery|surgery
5285272|NCT00488787|analgesia|analgesia
5285273|NCT00488787|2-4 impacted third molars|2-4 impacted third molars
5285274|NCT00488774|Colitis, ulcerative|colitis, ulcerative
5285275|NCT00488774|Golimumab|golimumab
5285276|NCT00488774|CNTO 148|cnto 148
5285277|NCT00488761|Tigecycline|tigecycline
5285278|NCT00488761|cSSSI|csssi
5285279|NCT00488761|complicated skin and skin structure infections|complicated skin and skin structure infections
5285280|NCT00488748|MST|mst
5285281|NCT00488748|Magnetic Seizure Therapy|magnetic seizure therapy
5285282|NCT00488748|ECT|ect
5285283|NCT00488748|Electroconvulsive Therapy|electroconvulsive therapy
5285284|NCT00488748|Depression|depression
5285285|NCT00488748|Magnetic|magnetic
5285286|NCT00488735|Randomized controlled trial|randomized controlled trial
5285287|NCT00488735|Back pain|back pain
5285288|NCT00488735|Neck pain|neck pain
5285289|NCT00488735|Rehabilitation|rehabilitation
5285290|NCT00488735|Cognitive-behavioral|cognitive-behavioral
5285291|NCT00488735|Primary care|primary care
5285292|NCT00488735|Sick-listing|sick-listing
5285293|NCT00488735|Health-care utilization.|health-care utilization.
5285294|NCT00488722|To observe the biological changes under concurrent Zoladex and CEF as neoadjuvant regimen with respect to the ER,PR,cerbB-2 status before and after therapy|to observe the biological changes under concurrent zoladex and cef as neoadjuvant regimen with respect to the er,pr,cerbb-2 status before and after therapy
5285295|NCT00488709|Acute Myeloid Leukemia|acute myeloid leukemia
5285296|NCT00488709|Multi Drug Resistance|multi drug resistance
5285297|NCT00488696|Aneurysm|aneurysm
5285298|NCT00488696|Aortic Arch|aortic arch
5285299|NCT00488696|Endovascular|endovascular
5285300|NCT00488696|Stent-Graft|stent-graft
5285301|NCT00488683|Meningococcal disease|meningococcal disease
5285302|NCT00488683|Prevention|prevention
5285303|NCT00488683|Vaccination|vaccination
5285304|NCT00488670|Alzheimer's disease|alzheimer's disease
5285305|NCT00488670|elderly|elderly
5285306|NCT00488670|open-label|open-label
5285307|NCT00488670|escitalopram|escitalopram
5285308|NCT00488657|speech|speech
5285309|NCT00488657|Parkinson's disease|parkinson's disease
5285310|NCT00488657|treatment|treatment
5285311|NCT00488657|speech intelligibility|speech intelligibility
5285312|NCT00488657|speaking rate|speaking rate
5285313|NCT00488644|Hypothyroidism|hypothyroidism
5285314|NCT00488644|Brain Tumor|brain tumor
5285315|NCT00488644|Levothyroxine|levothyroxine
5285316|NCT00488644|Liothyronine|liothyronine
5285317|NCT00488644|Synthroid|synthroid
5285318|NCT00488644|Cytomel|cytomel
5285319|NCT00488631|Colitis, Ulcerative|colitis, ulcerative
5285320|NCT00488631|Golimumab|golimumab
5285321|NCT00488631|CNTO 148|cnto 148
5285322|NCT00488618|Mania|mania
5285323|NCT00488618|Bipolar I Disorder|bipolar i disorder
5285324|NCT00488618|Acute Mania Associated with Bipolar I Disorder|acute mania associated with bipolar i disorder
5285325|NCT00488592|Myelodysplastic Syndrome (MDS)|myelodysplastic syndrome (mds)
5285326|NCT00488592|Acute Myeloid Leukemia (AML)|acute myeloid leukemia (aml)
5285327|NCT00488592|Chronic Myeloid Leukemia (CML)|chronic myeloid leukemia (cml)
5285328|NCT00488592|Wilm's Tumor-1|wilm's tumor-1
5285329|NCT00488592|Proteinase-3|proteinase-3
5285330|NCT00488592|Myelodysplastic Syndrome|myelodysplastic syndrome
5285332|NCT00488592|Acute Myeloid Leukemia|acute myeloid leukemia
5285333|NCT00488592|AML|aml
5285334|NCT00488592|Chronic Myeloid Leukemia|chronic myeloid leukemia
5285335|NCT00488592|CML|cml
5285336|NCT00488579|iron prophylaxis|iron prophylaxis
5285337|NCT00488579|pregnancy|pregnancy
5285338|NCT00488579|birth weight|birth weight
5285339|NCT00488579|prematurity|prematurity
5285340|NCT00488579|perinatal mortality|perinatal mortality
5285341|NCT00488566|bipolar disorder,|bipolar disorder,
5285342|NCT00488566|single doses,|single doses,
5285343|NCT00488566|resting motor threshold|resting motor threshold
5285344|NCT00488566|TMS,|tms,
5285345|NCT00488553|Lymphoma|lymphoma
5285346|NCT00488553|Epidemiology|epidemiology
5285347|NCT00488553|Lifestyle Factors|lifestyle factors
5285348|NCT00488553|Questionnaire|questionnaire
5285349|NCT00488553|Survey|survey
5285350|NCT00488540|newborn|newborn
5285351|NCT00488540|infant|infant
5285352|NCT00488540|pain|pain
5285353|NCT00488540|acetaminophen|acetaminophen
5285354|NCT00488540|paracetamol|paracetamol
5285355|NCT00488540|mode of delivery|mode of delivery
5285356|NCT00488540|vacuum extraction|vacuum extraction
5285357|NCT00488540|forceps extraction|forceps extraction
5285358|NCT00488540|cesarean section|cesarean section
5285359|NCT00488540|EDIN scale|edin scale
5285360|NCT00488540|Bernese Pain Scale for Neonates|bernese pain scale for neonates
5285361|NCT00488540|pain after different modes of delivery in newborn infants|pain after different modes of delivery in newborn infants
5285362|NCT00488540|efficacy of acetaminophen as analgesia for newborn infants|efficacy of acetaminophen as analgesia for newborn infants
5285363|NCT00488514|Long-term Safety|long-term safety
5285364|NCT00488514|Migraine|migraine
5285365|NCT00488514|Adolescent Migraine Headache|adolescent migraine headache
5285366|NCT00488514|sumatriptan succinate|sumatriptan succinate
5285367|NCT00488514|naproxen sodium|naproxen sodium
5285368|NCT00488501|intrathoracic impedance|intrathoracic impedance
5285369|NCT00488501|cardiac resynchronization therapy|cardiac resynchronization therapy
5285370|NCT00488501|heart failure|heart failure
5285371|NCT00488462|obstetric hemorrhage|obstetric hemorrhage
5285372|NCT00488462|hypovolemic shock|hypovolemic shock
5285373|NCT00488462|non-pneumatic anti-shock garment|non-pneumatic anti-shock garment
5285374|NCT00488462|safe motherhood|safe motherhood
5285375|NCT00488462|maternal mortality|maternal mortality
5285376|NCT00488462|maternal morbidity|maternal morbidity
5285377|NCT00488449|Dose Escalation|dose escalation
5285378|NCT00488449|GSK256073A,|gsk256073a,
5285379|NCT00488436|Myelodysplastic Syndrome|myelodysplastic syndrome
5285380|NCT00488436|Antithymocyte Globulin|antithymocyte globulin
5285381|NCT00488436|Cyclosporine|cyclosporine
5285382|NCT00488423|diabetes|diabetes
5285383|NCT00488423|MIDAS|midas
5285384|NCT00488423|gut hormones|gut hormones
5285385|NCT00488423|gastric bypass|gastric bypass
5285386|NCT00488423|lap band|lap band
5285387|NCT00488410|Chronic heart failure|chronic heart failure
5285388|NCT00488410|real time three-dimensional echocardiography|real time three-dimensional echocardiography
5285389|NCT00488410|cardiac resynchronization therapy|cardiac resynchronization therapy
5285390|NCT00488410|ventricular asynchrony|ventricular asynchrony
5285391|NCT00488410|systolic dysynchrony index|systolic dysynchrony index
5285392|NCT00488397|Tygacil|tygacil
5285393|NCT00488397|microdilution method|microdilution method
5285394|NCT00488397|Tigecycline|tigecycline
5285395|NCT00488397|In-Vitro|in-vitro
5285396|NCT00488384|Squamous cell carcinoma of the skin under hemodialysis|squamous cell carcinoma of the skin under hemodialysis
5285397|NCT00488371|Streptococcus pneumoniae nasopharyngeal carriage|streptococcus pneumoniae nasopharyngeal carriage
5285398|NCT00488358|abdominal|abdominal
5285399|NCT00488358|aortic|aortic
5285400|NCT00488358|aneurysm|aneurysm
5285401|NCT00488358|Zenith|zenith
5285402|NCT00488358|blood pressure|blood pressure
5285403|NCT00488345|cIAI|ciai
5285404|NCT00488345|cSSSI|csssi
5285405|NCT00488345|CAP|cap
5285406|NCT00488345|Child|child
5285407|NCT00488332|Head and Neck Cancer|head and neck cancer
5285408|NCT00488332|Oral Mucositis|oral mucositis
5285409|NCT00488332|Optical Coherence Tomography|optical coherence tomography
5285410|NCT00488332|Fluorescence Spectroscopy|fluorescence spectroscopy
5285411|NCT00488332|Optical Assessment|optical assessment
5285412|NCT00488319|Schizophrenia|schizophrenia
5285413|NCT00488319|Adolescent|adolescent
5285414|NCT00488319|Paliperidone|paliperidone
5285415|NCT00488319|Antipsychotic agents|antipsychotic agents
5285416|NCT00488319|Antipsychotic drugs|antipsychotic drugs
5285417|NCT00488319|Psychosis.|psychosis.
5285418|NCT00488306|Tigecycline|tigecycline
5285419|NCT00488306|Complicated intra-abdominal infections|complicated intra-abdominal infections
5285420|NCT00488306|cIAI|ciai
5285421|NCT00488293|Telemedicine|telemedicine
5285422|NCT00488293|Skin diseases|skin diseases
5285423|NCT00488293|Dermatology|dermatology
5285424|NCT00488293|Quality of life|quality of life
5285425|NCT00488293|Economics|economics
5285426|NCT00488280|walking|walking
5285427|NCT00488280|walking recovery|walking recovery
5285428|NCT00488280|physical therapy|physical therapy
5285429|NCT00488280|locomotor training|locomotor training
5285430|NCT00488280|body weight support|body weight support
5285431|NCT00488280|neuroplasticity|neuroplasticity
5285432|NCT00488280|step|step
5285433|NCT00488280|treadmill|treadmill
5285434|NCT00488280|treadmill training|treadmill training
5285435|NCT00488280|locomotion|locomotion
5285436|NCT00488267|Osteoarthritis|osteoarthritis
5285437|NCT00488267|Pain|pain
5285438|NCT00488254|Long QT Syndrome|long qt syndrome
5285439|NCT00488254|Romano Ward|romano ward
5285440|NCT00488254|Jervell-Lange Nielson Syndrome|jervell-lange nielson syndrome
5285441|NCT00488241|Eczema|eczema
5285442|NCT00488241|Medical device|medical device
5285443|NCT00488215|constipation|constipation
5285444|NCT00488215|prucalopride|prucalopride
5285445|NCT00488215|MTD|mtd
5285446|NCT00488215|cardiovascular safety|cardiovascular safety
5285447|NCT00488202|Advanced Ovarian Cancer|advanced ovarian cancer
5285448|NCT00488202|Sexual Function|sexual function
5285449|NCT00488176|seasonal allergic rhinitis|seasonal allergic rhinitis
5285450|NCT00488176|children|children
5285451|NCT00488176|montelukast|montelukast
5285452|NCT00488176|cetirizine|cetirizine
5285453|NCT00488163|schizophrenia|schizophrenia
5285454|NCT00488163|cognition|cognition
5285455|NCT00488163|atomoxetine|atomoxetine
5285456|NCT00488163|norepinephrine|norepinephrine
5285457|NCT00488163|dopamine|dopamine
5285458|NCT00488137|constipation|constipation
5285459|NCT00488137|prucalopride|prucalopride
5285460|NCT00488137|QOL|qol
5285461|NCT00488137|SCBM|scbm
5285462|NCT00488137|PAC-SYM|pac-sym
5285463|NCT00488124|short stature|short stature
5285464|NCT00488111|Regional anesthesia|regional anesthesia
5285465|NCT00488111|Fluid Therapy|fluid therapy
5285466|NCT00488111|Hemostasis, Surgical|hemostasis, surgical
5285467|NCT00488098|Healthy Bioequivalence|healthy bioequivalence
5285468|NCT00488085|Crohn’s disease, obesity, REE, body composition, fat absorption|crohn’s disease, obesity, ree, body composition, fat absorption
5285469|NCT00488072|Advanced Cancer|advanced cancer
5285470|NCT00488072|Anorexia|anorexia
5285471|NCT00488072|Weight Loss|weight loss
5285472|NCT00488072|Insomnia|insomnia
5285473|NCT00488072|Appetite|appetite
5285474|NCT00488072|Mirtazapine|mirtazapine
5285475|NCT00488072|Placebo|placebo
5285476|NCT00488059|Treatment Experienced|treatment experienced
5285477|NCT00488046|Bird Flu|bird flu
5285478|NCT00488033|Coronary Artery Disease|coronary artery disease
5285479|NCT00488033|Diabetes|diabetes
5285480|NCT00488033|CT Angiography|ct angiography
5285481|NCT00488020|rest pain|rest pain
5285482|NCT00488020|ischemic ulcers|ischemic ulcers
5285483|NCT00488007|Alzheimer disease|alzheimer disease
5285484|NCT00488007|Cognitive impairment|cognitive impairment
5285485|NCT00488007|Sensorineural hearing loss|sensorineural hearing loss
5285486|NCT00488007|Hearing aids|hearing aids
5285487|NCT00487994|Hypercholesterolemia|hypercholesterolemia
5285488|NCT00487994|Hyperlipidemia|hyperlipidemia
5285489|NCT00487994|Drug Therapy|drug therapy
5285490|NCT00487981|Pain|pain
5285491|NCT00487981|Implantable stimulation device|implantable stimulation device
5285492|NCT00487981|Neuropathy|neuropathy
5285493|NCT00487968|healthy adult volunteers|healthy adult volunteers
5285494|NCT00487968|eltrombopag|eltrombopag
5285495|NCT00487955|gastritis|gastritis
5285496|NCT00487955|helicobacter pylori|helicobacter pylori
5285497|NCT00487955|REE|ree
5285498|NCT00487955|patients with gastritis that refers to helicobacter pylori treatment|patients with gastritis that refers to helicobacter pylori treatment
5285499|NCT00487929|sleep apnea|sleep apnea
5285500|NCT00487929|morbidity|morbidity
5285501|NCT00487929|cardiovascular|cardiovascular
5285502|NCT00487929|cpap|cpap
5285503|NCT00487929|oxidative stress|oxidative stress
5285504|NCT00487916|Blood Stage|blood stage
5285505|NCT00487916|Investigational|investigational
5285506|NCT00487916|Vaccine|vaccine
5285507|NCT00487916|Malaria|malaria
5285508|NCT00487916|Healthy Volunteer|healthy volunteer
5285509|NCT00487916|HV|hv
5285510|NCT00487903|Coronary Artery Disease|coronary artery disease
5285511|NCT00487903|Echocardiogram|echocardiogram
5285512|NCT00487903|Contrast|contrast
5285513|NCT00487903|Perfusion|perfusion
5285514|NCT00487903|Ultrasound|ultrasound
5285515|NCT00487903|Normal volunteers|normal volunteers
5285516|NCT00487890|Geriatric|geriatric
5285517|NCT00487890|Abdominal|abdominal
5285518|NCT00487890|Surgery|surgery
5285519|NCT00487890|gastrointestinal surgery|gastrointestinal surgery
5285520|NCT00487890|intrabdominal surgery|intrabdominal surgery
5285521|NCT00487877|metabolism, temperature changing, skin, heart rate|metabolism, temperature changing, skin, heart rate
5285522|NCT00487851|Pancreatic|pancreatic
5285523|NCT00487851|cancer|cancer
5285524|NCT00487851|Periampullay|periampullay
5285525|NCT00487851|Neoplasms|neoplasms
5285526|NCT00487851|Biliary|biliary
5285527|NCT00487851|Duodenal|duodenal
5285528|NCT00487851|Jaundice|jaundice
5285529|NCT00487851|obstruction|obstruction
5285530|NCT00487851|pancreas cancer|pancreas cancer
5285531|NCT00487851|Pancreatic cancer|pancreatic cancer
5285532|NCT00487838|Autofluorescence Imaging|autofluorescence imaging
5285533|NCT00487838|Early Age-Related Maculopathy|early age-related maculopathy
5285534|NCT00487838|Photochemical Changes|photochemical changes
5285535|NCT00487838|Colored Sunglasses|colored sunglasses
5285536|NCT00487838|Pseudophakes|pseudophakes
5285537|NCT00487838|Fundus Camera|fundus camera
5285538|NCT00487838|Confocal Scanning Laser Ophthalmoscope|confocal scanning laser ophthalmoscope
5285539|NCT00487838|Molecular Imaging within Retina|molecular imaging within retina
5285540|NCT00487838|Spectral Balance among Photochemical Processes|spectral balance among photochemical processes
5285541|NCT00487838|Noninvasive Autofluorescence Imaging|noninvasive autofluorescence imaging
5285748|NCT00487253|Leishmania Viannia|leishmania viannia
5285542|NCT00487838|Age-Related Maculopathy (AMD)|age-related maculopathy (amd)
5285543|NCT00487838|Age-Related Macular Degeneration|age-related macular degeneration
5285544|NCT00487838|AMD|amd
5285545|NCT00487838|Age-Related Macular Changes|age-related macular changes
5285546|NCT00487838|Early Age-Related Macular Changes|early age-related macular changes
5285547|NCT00487825|ACR20, ACR50, ACZ885 (anti-interleukin-1beta monoclonal antibody), rheumatoid arthritis, methotrexate|acr20, acr50, acz885 (anti-interleukin-1beta monoclonal antibody), rheumatoid arthritis, methotrexate
5285548|NCT00487812|Acute myocardial infarction|acute myocardial infarction
5285549|NCT00487812|left ventricular remodelling|left ventricular remodelling
5285550|NCT00487812|SPECT imaging|spect imaging
5285551|NCT00487799|Acute Decompensated Heart Failure|acute decompensated heart failure
5285552|NCT00487799|ADHF|adhf
5285553|NCT00487799|Heart Failure|heart failure
5285554|NCT00487786|Antisense|antisense
5285555|NCT00487786|Heat Shock Protein|heat shock protein
5285556|NCT00487773|asthma|asthma
5285557|NCT00487773|children|children
5285558|NCT00487773|inhaled glucocorticosteroids|inhaled glucocorticosteroids
5285559|NCT00487773|bone metabolism|bone metabolism
5285560|NCT00487760|Lung Cancer|lung cancer
5285561|NCT00487760|African-American Families|african-american families
5285562|NCT00487760|Genetic Risk Communication|genetic risk communication
5285563|NCT00487760|Interest in Genetic Testing and Genetics Research|interest in genetic testing and genetics research
5285564|NCT00487760|Health Disparities|health disparities
5285565|NCT00487760|Smoking Cessation|smoking cessation
5285566|NCT00487734|Metabolic Syndrome|metabolic syndrome
5285567|NCT00487734|Hypogonadism|hypogonadism
5285568|NCT00487734|Insulin Resistance|insulin resistance
5285569|NCT00487721|Prostate cancer|prostate cancer
5285570|NCT00487708|ACZ885|acz885
5285571|NCT00487708|NALP3 mutations|nalp3 mutations
5285572|NCT00487708|Interleukin-1beta|interleukin-1beta
5285573|NCT00487708|Muckle-Wells Syndrome|muckle-wells syndrome
5285574|NCT00487695|Barrett's esophagus|barrett's esophagus
5285575|NCT00487695|Esophageal adenocarcinoma|esophageal adenocarcinoma
5285576|NCT00487695|Endoscopy|endoscopy
5285577|NCT00487695|Confocal laser endomicroscopy|confocal laser endomicroscopy
5285578|NCT00487682|herpes zoster|herpes zoster
5285579|NCT00487682|ASP2151|asp2151
5285580|NCT00487682|Valacyclovir hydrochloride|valacyclovir hydrochloride
5285581|NCT00487669|paclitaxel poliglumex|paclitaxel poliglumex
5285582|NCT00487669|xyotax|xyotax
5285583|NCT00487669|alimta|alimta
5285584|NCT00487669|advanced non-small cell lung cancer|advanced non-small cell lung cancer
5285585|NCT00487643|Lacritin|lacritin
5285586|NCT00487630|Heterozygous females|heterozygous females
5285587|NCT00487630|Cardiomyopathy|cardiomyopathy
5285588|NCT00487617|Arteriopathy|arteriopathy
5285589|NCT00487617|endothelial function|endothelial function
5285590|NCT00487617|fruit juice|fruit juice
5285591|NCT00487604|Coronary Artery Disease|coronary artery disease
5285592|NCT00487604|Drug Eluting Stent|drug eluting stent
5285593|NCT00487604|Bare Metal Stent|bare metal stent
5285594|NCT00487604|Subacute thrombosis|subacute thrombosis
5285595|NCT00487604|Bleeding|bleeding
5285596|NCT00487604|Economic|economic
5285597|NCT00487591|cholesterol|cholesterol
5285598|NCT00487591|dyslipidemia|dyslipidemia
5285599|NCT00487591|omega 3|omega 3
5285600|NCT00487578|Post traumatic headache|post traumatic headache
5285601|NCT00487578|Head trauma|head trauma
5285602|NCT00487578|Head injury|head injury
5285603|NCT00487578|Headache|headache
5285604|NCT00487578|Naratriptan|naratriptan
5285605|NCT00487565|Total knee replacement|total knee replacement
5285606|NCT00487565|Total knee arthroplasty|total knee arthroplasty
5285607|NCT00487565|Osteoarthritis|osteoarthritis
5285608|NCT00487565|Rheumatoid or other inflammatory arthritis|rheumatoid or other inflammatory arthritis
5285609|NCT00487565|Post-traumatic or juvenile arthritis|post-traumatic or juvenile arthritis
5285610|NCT00487552|endoscopy|endoscopy
5285611|NCT00487552|esophagogastroduodenoscopy|esophagogastroduodenoscopy
5285612|NCT00487552|gastric outlet obstruction|gastric outlet obstruction
5285613|NCT00487552|gastro-jejunostomy|gastro-jejunostomy
5285614|NCT00487552|gastric malignancy|gastric malignancy
5285615|NCT00487552|duodenal stent|duodenal stent
5285616|NCT00487552|Malignant Gastric Outlet Obstruction|malignant gastric outlet obstruction
5285617|NCT00487539|Colitis, Ulcerative|colitis, ulcerative
5285618|NCT00487539|Golimumab|golimumab
5285619|NCT00487539|CNTO 148|cnto 148
5285620|NCT00487526|Bypass|bypass
5285621|NCT00487526|Duodenal jejunal|duodenal jejunal
5285622|NCT00487526|type 2 diabetes|type 2 diabetes
5285623|NCT00487526|non-obese adults|non-obese adults
5285624|NCT00487513|Follicular B Cell lymphoma|follicular b cell lymphoma
5285625|NCT00487513|vaccination|vaccination
5285626|NCT00487500|Major Depressive Disorder|major depressive disorder
5285627|NCT00487500|Electroconvulsive Therapy|electroconvulsive therapy
5285628|NCT00487487|Candidates for this study are survivors of paralytic poliomyelitis|candidates for this study are survivors of paralytic poliomyelitis
5285629|NCT00487461|SAH|sah
5285630|NCT00487461|Vasospasm|vasospasm
5285631|NCT00487448|Myelodysplastic Syndrome|myelodysplastic syndrome
5285632|NCT00487448|Chemotherapy|chemotherapy
5285633|NCT00487448|Peripheral blood stem cells transplantation|peripheral blood stem cells transplantation
5285634|NCT00487448|Bone marrow transplantation|bone marrow transplantation
5285635|NCT00487448|Secondary Acute Myeloblastic Leukemia|secondary acute myeloblastic leukemia
5285636|NCT00487435|CG5503|cg5503
5285637|NCT00487435|Tapentadol|tapentadol
5285638|NCT00487435|chronic non-malignant pain|chronic non-malignant pain
5285639|NCT00487435|osteoarthritis|osteoarthritis
5285640|NCT00487435|lower back pain|lower back pain
5285641|NCT00487435|analgesic|analgesic
5285642|NCT00487435|opioid|opioid
5285643|NCT00487422|constipation|constipation
5285644|NCT00487422|prucalopride|prucalopride
5285645|NCT00487422|QOL|qol
5285646|NCT00487422|SCBM|scbm
5285647|NCT00487422|PAC-SYM|pac-sym
5285648|NCT00487409|Ulcerative colitis|ulcerative colitis
5285649|NCT00487409|Crohn's disease|crohn's disease
5285650|NCT00487409|Colorectal polyps|colorectal polyps
5285651|NCT00487409|Colorectal malignancy|colorectal malignancy
5285652|NCT00487409|Endometriosis|endometriosis
5285653|NCT00487409|Diverticulitis|diverticulitis
5285654|NCT00487409|Colonic inertia|colonic inertia
5285655|NCT00487396|capsule endoscopy|capsule endoscopy
5285656|NCT00487396|Crohn's disease|crohn's disease
5285657|NCT00487396|small bowel disease|small bowel disease
5285658|NCT00487396|inflammatory bowel disease|inflammatory bowel disease
5285659|NCT00487396|Patients with suspected small bowel Crohn's disease|patients with suspected small bowel crohn's disease
5285660|NCT00487383|Cerebellum|cerebellum
5285661|NCT00487383|Transcranial Magnetic Stimulation (TMS)|transcranial magnetic stimulation (tms)
5285662|NCT00487383|Blepharospasm|blepharospasm
5285663|NCT00487383|DYT-1 Generalized Dystonia|dyt-1 generalized dystonia
5285664|NCT00487383|Focal Dystonia|focal dystonia
5285665|NCT00487383|Dystonia|dystonia
5285666|NCT00487383|Healthy Volunteer|healthy volunteer
5285667|NCT00487383|HV|hv
5285668|NCT00487370|Acupuncture|acupuncture
5285669|NCT00487370|Gold implantation|gold implantation
5285670|NCT00487370|Osteoarthritis|osteoarthritis
5285671|NCT00487370|Knee osteoarthritis|knee osteoarthritis
5285672|NCT00487370|Double-blind, randomized controlled trial|double-blind, randomized controlled trial
5285673|NCT00487370|Intervention|intervention
5285674|NCT00487370|Family practice|family practice
5285675|NCT00487357|Epidemiology|epidemiology
5285676|NCT00487357|Cancer Prevention|cancer prevention
5285677|NCT00487357|Questionnaire|questionnaire
5285678|NCT00487357|MATCh|match
5285679|NCT00487357|Survey|survey
5285680|NCT00487344|medicaid|medicaid
5285681|NCT00487344|insurance|insurance
5285682|NCT00487344|education|education
5285683|NCT00487344|clinical|clinical
5285684|NCT00487344|trial|trial
5285685|NCT00487344|healthcare|healthcare
5285686|NCT00487344|reimburse|reimburse
5285687|NCT00487344|pay|pay
5285688|NCT00487344|free|free
5285689|NCT00487344|assist|assist
5285690|NCT00487344|study|study
5285691|NCT00487344|oklahoma|oklahoma
5285692|NCT00487344|edmond|edmond
5285693|NCT00487344|Oklahoma City|oklahoma city
5285694|NCT00487344|diet|diet
5285695|NCT00487344|nutrition|nutrition
5285696|NCT00487344|weight loss|weight loss
5285697|NCT00487344|body|body
5285698|NCT00487344|fat|fat
5285699|NCT00487344|obese|obese
5285700|NCT00487344|overweight|overweight
5285701|NCT00487344|health|health
5285702|NCT00487344|medical|medical
5285703|NCT00487344|therapy|therapy
5285704|NCT00487344|meal plan|meal plan
5285705|NCT00487344|jenny craig|jenny craig
5285706|NCT00487344|weight watcher|weight watcher
5285707|NCT00487344|LA Weightloss|la weightloss
5285708|NCT00487344|Bryan Attebery|bryan attebery
5285709|NCT00487344|Results|results
5285710|NCT00487344|YMCA|ymca
5285711|NCT00487344|UCO|uco
5285712|NCT00487344|OSU|osu
5285713|NCT00487344|OU|ou
5285714|NCT00487344|clinics|clinics
5285715|NCT00487344|physicians|physicians
5285716|NCT00487344|surgery|surgery
5285717|NCT00487344|pills|pills
5285718|NCT00487344|financial|financial
5285719|NCT00487344|money|money
5285720|NCT00487331|Solid Tumors|solid tumors
5285721|NCT00487331|Acupuncture|acupuncture
5285722|NCT00487331|Uncontrolled Pain|uncontrolled pain
5285723|NCT00487331|Pain|pain
5285724|NCT00487318|fluvastatin|fluvastatin
5285725|NCT00487318|hepatitis C|hepatitis c
5285726|NCT00487318|chronic hepatitis C|chronic hepatitis c
5285727|NCT00487318|not previously treated with pegylated interferon and ribavirin|not previously treated with pegylated interferon and ribavirin
5285728|NCT00487305|GM-CSF|gm-csf
5285729|NCT00487305|vaccine|vaccine
5285730|NCT00487305|K562|k562
5285731|NCT00487292|accidents|accidents
5285732|NCT00487292|shift work|shift work
5285733|NCT00487292|sleepiness|sleepiness
5285734|NCT00487292|naps|naps
5285735|NCT00487292|bright light pulses|bright light pulses
5285736|NCT00487292|sleep|sleep
5285737|NCT00487279|Coronary|coronary
5285738|NCT00487279|Artery|artery
5285739|NCT00487279|Disease|disease
5285740|NCT00487279|Sudden|sudden
5285741|NCT00487279|Cardiac|cardiac
5285742|NCT00487279|Death|death
5285743|NCT00487279|ICD|icd
5285744|NCT00487266|Acupuncture|acupuncture
5285745|NCT00487266|Torque|torque
5285746|NCT00487266|Force Decay|force decay
5285747|NCT00487253|Cutaneous Leishmaniasis|cutaneous leishmaniasis
5285749|NCT00487253|Pediatric|pediatric
5285750|NCT00487253|Miltefosine|miltefosine
5285751|NCT00487253|Randomized|randomized
5285752|NCT00487253|Colombia|colombia
5285753|NCT00487240|diabetes|diabetes
5285754|NCT00487240|type 1|type 1
5285755|NCT00487227|caffeine|caffeine
5285756|NCT00487227|coffee|coffee
5285757|NCT00487227|decaffeinated|decaffeinated
5285758|NCT00487227|cognition|cognition
5285759|NCT00487227|mood|mood
5285760|NCT00487227|autonomic|autonomic
5285761|NCT00487201|liver transplantation|liver transplantation
5285762|NCT00487201|biliary strictures|biliary strictures
5285763|NCT00487201|ERCP|ercp
5285764|NCT00487175|Pain|pain
5285765|NCT00487175|sensitization|sensitization
5285766|NCT00487175|analgesia|analgesia
5285767|NCT00487175|Healthy volunteers and pain|healthy volunteers and pain
5285768|NCT00487162|glycemic control, diabetes, obesity, comorbidities|glycemic control, diabetes, obesity, comorbidities
5285769|NCT00487149|Repeatability|repeatability
5285770|NCT00487149|Respiratory Muscle Strength|respiratory muscle strength
5285771|NCT00487136|Drug Interaction|drug interaction
5285772|NCT00487136|Pharmacokinetics|pharmacokinetics
5285773|NCT00487136|Pharmacodynamics|pharmacodynamics
5285774|NCT00487123|Hypertension, compliance, Valsartan, hydrochlorothiazide (HCTZ)|hypertension, compliance, valsartan, hydrochlorothiazide (hctz)
5285775|NCT00487110|Pain|pain
5285776|NCT00487110|serotonin|serotonin
5285777|NCT00487110|interaction|interaction
5285778|NCT00487110|Patients with postsurgical pain, after ear surgery|patients with postsurgical pain, after ear surgery
5285779|NCT00487097|intensive care|intensive care
5285780|NCT00487097|critically ill|critically ill
5285781|NCT00487097|fish oil|fish oil
5285782|NCT00487097|pressure sores|pressure sores
5285783|NCT00487084|analgesia|analgesia
5285784|NCT00487084|tubal ligation|tubal ligation
5285785|NCT00487084|chloroprocaine|chloroprocaine
5285786|NCT00487071|Anal fistula|anal fistula
5285787|NCT00487071|High-type|high-type
5285788|NCT00487071|Anal fistula plug|anal fistula plug
5285789|NCT00487071|Efficacy|efficacy
5285790|NCT00487071|Recurrence|recurrence
5285791|NCT00487058|Gimatecan|gimatecan
5285792|NCT00487058|topoisomerase I inhibitor|topoisomerase i inhibitor
5285793|NCT00487058|advanced solid tumors|advanced solid tumors
5285794|NCT00487045|Hemorrhoids|hemorrhoids
5285795|NCT00487045|Thrombosed External Hemorrhoids (TEH)|thrombosed external hemorrhoids (teh)
5285796|NCT00487045|Reduction|reduction
5285797|NCT00487045|Prevention|prevention
5285798|NCT00487045|Stabilizer Device|stabilizer device
5285799|NCT00487045|Pregnant|pregnant
5285800|NCT00487045|Vaginal Birth|vaginal birth
5285801|NCT00487045|Single Birth|single birth
5285802|NCT00487045|Asymptomatic Hemorrhoids|asymptomatic hemorrhoids
5285803|NCT00487032|allergic rhinitis|allergic rhinitis
5285804|NCT00487032|rhinitis medicamentosa|rhinitis medicamentosa
5285805|NCT00487032|imidazolines|imidazolines
5285806|NCT00487032|corticosteroid|corticosteroid
5285807|NCT00487019|ampicillin|ampicillin
5285808|NCT00487019|penicillin G|penicillin g
5285809|NCT00487019|gentamicin|gentamicin
5285810|NCT00487019|neonatal sepsis|neonatal sepsis
5285811|NCT00487019|empiric therapy|empiric therapy
5285812|NCT00486993|Diet|diet
5285813|NCT00486993|Exercise|exercise
5285814|NCT00486993|Smoking|smoking
5285815|NCT00486993|Stress|stress
5285816|NCT00486993|Polyphenols|polyphenols
5285817|NCT00486980|influenza|influenza
5285818|NCT00486967|Insulin resistance, heart failure, congestive heart failure,|insulin resistance, heart failure, congestive heart failure,
5285819|NCT00486967|Peak VO2, Endothelial Function, Leptin, TNF.|peak vo2, endothelial function, leptin, tnf.
5285820|NCT00486954|lapatinib|lapatinib
5285821|NCT00486954|paclitaxel|paclitaxel
5285822|NCT00486954|ErbB2|erbb2
5285823|NCT00486954|Gastric cancer|gastric cancer
5285824|NCT00486954|Advanced gastric cancer|advanced gastric cancer
5285825|NCT00486941|Primary Prevention|primary prevention
5285826|NCT00486941|Health Promotion|health promotion
5285827|NCT00486941|Diet|diet
5285828|NCT00486941|Exercise|exercise
5285829|NCT00486941|Risk Factors|risk factors
5285830|NCT00486941|Randomized Controlled Trial|randomized controlled trial
5285831|NCT00486928|Valves, heart disease, prosthesis.|valves, heart disease, prosthesis.
5285832|NCT00486915|Atrial Fibrillation|atrial fibrillation
5285833|NCT00486915|Left Atrial Appendage|left atrial appendage
5285834|NCT00486915|Surgical Ligation|surgical ligation
5285835|NCT00486915|Thromboembolism|thromboembolism
5285836|NCT00486915|Cerebrovascular Accident|cerebrovascular accident
5285837|NCT00486902|Ketamine|ketamine
5285838|NCT00486902|Spinal Anesthesia|spinal anesthesia
5285839|NCT00486902|C-section|c-section
5285840|NCT00486889|Glycogenesis 2|glycogenesis 2
5285841|NCT00486876|Irritable bowel syndrome|irritable bowel syndrome
5285842|NCT00486876|Diarrhea predominant Irritable Bowel Syndrome|diarrhea predominant irritable bowel syndrome
5285843|NCT00486876|Alternating Irritable Bowel Syndrome|alternating irritable bowel syndrome
5285844|NCT00486863|Philippines, Schistosoma japonicum, Schistosomiasis, pregnant women, fetuses, 08-0049|philippines, schistosoma japonicum, schistosomiasis, pregnant women, fetuses, 08-0049
5285845|NCT00486850|RDS|rds
5285846|NCT00486850|Preterm|preterm
5285847|NCT00486850|SIMV|simv
5285848|NCT00486850|NIPPV|nippv
5285849|NCT00486811|Osteoarthritis|osteoarthritis
5285850|NCT00486811|Knee|knee
5285851|NCT00486811|Pain Assessment|pain assessment
5285852|NCT00486811|CG5503 PR|cg5503 pr
5285853|NCT00486811|Centrally acting analgesic|centrally acting analgesic
5285854|NCT00486811|Placebo|placebo
5285855|NCT00486811|Oxycodone|oxycodone
5285856|NCT00486811|Chronic Pain due to knee Osteoarthritis|chronic pain due to knee osteoarthritis
5285857|NCT00486811|Tapentadol|tapentadol
5285858|NCT00486798|acute schizophrenia|acute schizophrenia
5285859|NCT00486798|schizoaffective disorder|schizoaffective disorder
5285860|NCT00486798|psychosis Not Otherwise Specified (NOS)|psychosis not otherwise specified (nos)
5285861|NCT00486798|bipolar mania with psychotic symptoms|bipolar mania with psychotic symptoms
5285862|NCT00486772|This study was designed to investigate whether the suggested beneficial effects of sevelamer on VC were related to fetuin-A levels in patients with CKD.|this study was designed to investigate whether the suggested beneficial effects of sevelamer on vc were related to fetuin-a levels in patients with ckd.
5285863|NCT00486746|sleep apnea|sleep apnea
5285864|NCT00486746|lifestyle intervention|lifestyle intervention
5285865|NCT00486746|cardiovascular|cardiovascular
5285866|NCT00486733|extracorporeal shock wave therapy|extracorporeal shock wave therapy
5285867|NCT00486733|soft tissue wounds|soft tissue wounds
5285868|NCT00486707|Ovarian Cancer|ovarian cancer
5285869|NCT00486707|Questionnaire|questionnaire
5285870|NCT00486707|Genetic Testing|genetic testing
5285871|NCT00486707|Survey|survey
5285872|NCT00486694|Malaria, vivax|malaria, vivax
5285873|NCT00486694|Afghanistan|afghanistan
5285874|NCT00486694|Sulfadoxine-pyrimethamine|sulfadoxine-pyrimethamine
5285875|NCT00486694|drug resistance|drug resistance
5285876|NCT00486681|Glucose monitoring|glucose monitoring
5285877|NCT00486681|Diabetes management|diabetes management
5285878|NCT00486681|Information system|information system
5285879|NCT00486681|In-patient glycemic control|in-patient glycemic control
5285880|NCT00486668|HER2 positive breast cancer|her2 positive breast cancer
5285881|NCT00486668|invasive breast cancer|invasive breast cancer
5285882|NCT00486668|lapatinib|lapatinib
5285883|NCT00486668|neoadjuvant|neoadjuvant
5285884|NCT00486668|NSABP|nsabp
5285885|NCT00486668|paclitaxel|paclitaxel
5285886|NCT00486668|trastuzumab|trastuzumab
5285887|NCT00486668|doxorubicin|doxorubicin
5285888|NCT00486668|cyclophosphamide|cyclophosphamide
5285889|NCT00486655|Cholecystectomy|cholecystectomy
5285890|NCT00486655|NOTES|notes
5285891|NCT00486655|Transgastric|transgastric
5285892|NCT00486629|Exercise|exercise
5285893|NCT00486629|Diet|diet
5285894|NCT00486629|Pregnancy|pregnancy
5285895|NCT00486629|Obesity|obesity
5285896|NCT00486629|Macrosomia|macrosomia
5285897|NCT00486603|adult glioblastoma|adult glioblastoma
5285898|NCT00486603|adult gliosarcoma|adult gliosarcoma
5285899|NCT00486603|adult giant cell glioblastoma|adult giant cell glioblastoma
5285900|NCT00486590|Human milk fortification|human milk fortification
5285901|NCT00486590|Premature neonate|premature neonate
5285902|NCT00486590|Very low birth weight|very low birth weight
5285903|NCT00486577|Hearing Disorders, Hearing Loss, Hyperacusis, Tinnitus, chronic cortical stimulation, functional magnetic resonance imaging|hearing disorders, hearing loss, hyperacusis, tinnitus, chronic cortical stimulation, functional magnetic resonance imaging
5285904|NCT00486564|Treatment|treatment
5285905|NCT00486564|Refractory or Relapsed|refractory or relapsed
5285906|NCT00486551|Anger control training|anger control training
5285907|NCT00486551|Cognitive behavioral therapy|cognitive behavioral therapy
5285908|NCT00486551|Behavior therapy|behavior therapy
5285909|NCT00486551|Tourette Syndrome|tourette syndrome
5285910|NCT00486551|Randomized trial|randomized trial
5285911|NCT00486551|Anger|anger
5285912|NCT00486551|Aggression|aggression
5285913|NCT00486525|fatigue|fatigue
5285914|NCT00486525|depression|depression
5285915|NCT00486525|pain|pain
5285916|NCT00486525|cancer survivor|cancer survivor
5285917|NCT00486525|stage IA breast cancer|stage ia breast cancer
5285918|NCT00486525|stage IB breast cancer|stage ib breast cancer
5285919|NCT00486525|stage II breast cancer|stage ii breast cancer
5285920|NCT00486525|stage IIIA breast cancer|stage iiia breast cancer
5285921|NCT00486525|breast cancer in situ|breast cancer in situ
5285922|NCT00486512|colorectal, adenomas, prevention|colorectal, adenomas, prevention
5285923|NCT00486499|radiation|radiation
5285924|NCT00486499|brachytherapy|brachytherapy
5285925|NCT00486499|prostate|prostate
5285926|NCT00486499|cancer|cancer
5285927|NCT00486486|24-hour IOP control|24-hour iop control
5285928|NCT00486460|Locally advanced or metastatic adenocarcinoma of the|locally advanced or metastatic adenocarcinoma of the
5285929|NCT00486460|pancreas|pancreas
5285930|NCT00486460|confirmed by histology or cytology|confirmed by histology or cytology
5285931|NCT00486460|Inoperatable|inoperatable
5285932|NCT00486434|Osteoarthritis, oral salmon calcitonin, treatment, efficacy, tolerability|osteoarthritis, oral salmon calcitonin, treatment, efficacy, tolerability
5285933|NCT00486421|idiopathic thrombocytopenic purpura|idiopathic thrombocytopenic purpura
5285934|NCT00486408|HIV Seronegativity|hiv seronegativity
5285935|NCT00486408|HIV Preventive Vaccine|hiv preventive vaccine
5285936|NCT00486408|Adenovirus|adenovirus
5285937|NCT00486395|prematurity|prematurity
5285938|NCT00486395|randomized trial|randomized trial
5285939|NCT00486395|RDS|rds
5285940|NCT00486395|surfactant|surfactant
5285941|NCT00486395|CPAP|cpap
5285942|NCT00486395|ventilation|ventilation
5285943|NCT00486382|visceral leishmaniasis|visceral leishmaniasis
5285944|NCT00486382|vaccine|vaccine
5285945|NCT00486369|Osteoarthritis, oral salmon calcitonin, tolerability, biomarkers|osteoarthritis, oral salmon calcitonin, tolerability, biomarkers
5285946|NCT00486356|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5285947|NCT00486356|recurrent gastric cancer|recurrent gastric cancer
5285948|NCT00486356|stage IV gastric cancer|stage iv gastric cancer
5285949|NCT00486356|advanced adult primary liver cancer|advanced adult primary liver cancer
5285950|NCT00486356|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
5285951|NCT00486356|recurrent adult primary liver cancer|recurrent adult primary liver cancer
5285952|NCT00486356|recurrent extrahepatic bile duct cancer|recurrent extrahepatic bile duct cancer
5285953|NCT00486356|unresectable extrahepatic bile duct cancer|unresectable extrahepatic bile duct cancer
5285954|NCT00486356|recurrent gallbladder cancer|recurrent gallbladder cancer
5285955|NCT00486356|unresectable gallbladder cancer|unresectable gallbladder cancer
5285956|NCT00486343|Asthma|asthma
5285957|NCT00486343|ICS|ics
5285958|NCT00486343|5-LO Inhibition|5-lo inhibition
5285959|NCT00486343|Leukotrienes|leukotrienes
5285960|NCT00486343|Asthma control|asthma control
5285961|NCT00486343|Asthma exacerbations|asthma exacerbations
5285962|NCT00486330|HIV|hiv
5285963|NCT00486330|Pharmacokinetics|pharmacokinetics
5285964|NCT00486330|Buprenorphine|buprenorphine
5285965|NCT00486330|Tipranavir|tipranavir
5285966|NCT00486330|HIV Seronegativity|hiv seronegativity
5285967|NCT00486317|Osteoarthritis, oral salmon calcitonin, tolerability, biomarkers|osteoarthritis, oral salmon calcitonin, tolerability, biomarkers
5285968|NCT00486304|cachexia|cachexia
5285969|NCT00486304|weight changes|weight changes
5285970|NCT00486304|recurrent oropharyngeal cancer|recurrent oropharyngeal cancer
5285971|NCT00486304|stage I oropharyngeal cancer|stage i oropharyngeal cancer
5285972|NCT00486304|stage II oropharyngeal cancer|stage ii oropharyngeal cancer
5285973|NCT00486304|stage III oropharyngeal cancer|stage iii oropharyngeal cancer
5285974|NCT00486304|stage IV oropharyngeal cancer|stage iv oropharyngeal cancer
5285975|NCT00486291|Diabetes, Obese diabetics|diabetes, obese diabetics
5285976|NCT00486265|Phase I|phase i
5285977|NCT00486265|Phase II|phase ii
5285978|NCT00486265|acute myelogenous leukemia|acute myelogenous leukemia
5285979|NCT00486265|AML|aml
5285980|NCT00486265|cancer|cancer
5285981|NCT00486239|Epilepsy|epilepsy
5285982|NCT00486239|memory|memory
5285983|NCT00486239|emotion|emotion
5285984|NCT00486213|dermatologic complications|dermatologic complications
5285985|NCT00486213|chemotherapeutic agent toxicity|chemotherapeutic agent toxicity
5285986|NCT00486213|palmar-plantar erythrodysesthesia|palmar-plantar erythrodysesthesia
5285987|NCT00486213|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5285988|NCT00486200|ASP2151|asp2151
5285989|NCT00486200|Herpes Genitalis|herpes genitalis
5285990|NCT00486200|Sexually Transmitted Disease|sexually transmitted disease
5285991|NCT00486200|Herpes Simplex Virus Genital Infection|herpes simplex virus genital infection
5285992|NCT00486200|Treatment Outcome|treatment outcome
5285993|NCT00486200|Genital Herpes|genital herpes
5285994|NCT00486187|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
5285995|NCT00486187|Thiazolidinediones|thiazolidinediones
5285996|NCT00486187|Rosiglitazone|rosiglitazone
5285997|NCT00486187|Adipokine|adipokine
5285998|NCT00486187|Inflammation|inflammation
5285999|NCT00486187|Cardiometabolic risk|cardiometabolic risk
5286000|NCT00486187|Angiotensin receptor blocker|angiotensin receptor blocker
5286001|NCT00486174|Sepsis|sepsis
5286002|NCT00486174|Methylene Blue|methylene blue
5286003|NCT00486174|Norepinephrine|norepinephrine
5286004|NCT00486161|Obesity|obesity
5286005|NCT00486161|Ghrelin|ghrelin
5286006|NCT00486161|Non-esterified fatty acids|non-esterified fatty acids
5286007|NCT00486161|Growth hormone|growth hormone
5286008|NCT00486161|Insulin|insulin
5286009|NCT00486161|Cycloergometer exercise|cycloergometer exercise
5286010|NCT00486148|Formula|formula
5286011|NCT00486148|Feeding|feeding
5286012|NCT00486148|Healthy|healthy
5286013|NCT00486148|Full|full
5286014|NCT00486148|Term|term
5286015|NCT00486148|Infants|infants
5286016|NCT00486135|Cancer|cancer
5286017|NCT00486135|Solid tumors|solid tumors
5286018|NCT00486135|Lymphoma|lymphoma
5286019|NCT00486109|Diabetes|diabetes
5286020|NCT00486096|cannulation|cannulation
5286021|NCT00486096|infant|infant
5286022|NCT00486096|femoral arterial|femoral arterial
5286023|NCT00486070|cardiac anomaly|cardiac anomaly
5286024|NCT00486070|pulmonary veins|pulmonary veins
5286025|NCT00486070|cyanosis|cyanosis
5286026|NCT00486070|flow reversal|flow reversal
5286027|NCT00486070|TAPAVC|tapavc
5286028|NCT00486057|Daclizumab|daclizumab
5286029|NCT00486057|Immuno-suppression protocol|immuno-suppression protocol
5286030|NCT00486057|Heart Transplant|heart transplant
5286031|NCT00486057|Rejection|rejection
5286032|NCT00486044|amyloid protein|amyloid protein
5286033|NCT00486044|apolipoprotein|apolipoprotein
5286034|NCT00486044|cerebrospinal fluid|cerebrospinal fluid
5286035|NCT00486044|cerebrovascular circulation|cerebrovascular circulation
5286036|NCT00486044|inflammation|inflammation
5286037|NCT00486044|magnetic resonance imaging|magnetic resonance imaging
5286038|NCT00486044|prevention & control|prevention & control
5286039|NCT00486031|IBD|ibd
5286040|NCT00486031|UC|uc
5286041|NCT00486031|Ulcerative Colitis|ulcerative colitis
5286042|NCT00486031|Inflammatory Bowel Disease|inflammatory bowel disease
5286043|NCT00486018|Lucentis|lucentis
5286044|NCT00486018|RVO|rvo
5286045|NCT00486018|BRVO|brvo
5286046|NCT00486018|Edema|edema
5286047|NCT00485992|blood stream infection|blood stream infection
5286048|NCT00485992|CICU|cicu
5286049|NCT00485992|pediatric|pediatric
5286050|NCT00485992|chlorhexidine swabs|chlorhexidine swabs
5286051|NCT00485979|Breast Cancer|breast cancer
5286052|NCT00485979|Neoadjuvant therapy|neoadjuvant therapy
5286053|NCT00485966|Adult Leukemia|adult leukemia
5286054|NCT00485966|CLL|cll
5286055|NCT00485966|B-CLL|b-cll
5286056|NCT00485966|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
5286057|NCT00485966|B-cell CLL|b-cell cll
5286058|NCT00485953|Osteoporosis|osteoporosis
5286059|NCT00485953|breast cancer|breast cancer
5286060|NCT00485953|aromatase inhibitors|aromatase inhibitors
5286061|NCT00485953|bone loss|bone loss
5286062|NCT00485953|bone mineral density|bone mineral density
5286063|NCT00485940|constipation|constipation
5286064|NCT00485940|prucalopride|prucalopride
5286065|NCT00485940|QOL|qol
5286066|NCT00485940|SCBM|scbm
5286067|NCT00485940|PAC-SYM|pac-sym
5286068|NCT00485927|Trauma|trauma
5286069|NCT00485927|Stress|stress
5286070|NCT00485927|Simulation|simulation
5286071|NCT00485914|employment|employment
5286072|NCT00485914|work|work
5286074|NCT00485836|RVO|rvo
5286075|NCT00485836|Lucentis|lucentis
5286076|NCT00485836|Edema|edema
5286077|NCT00485797|attention deficit hyperactivity disorder (ADHD)|attention deficit hyperactivity disorder (adhd)
5286078|NCT00485797|Dual tasking|dual tasking
5286079|NCT00485797|Postural Control|postural control
5286080|NCT00485797|Methylphenidate (Ritalin)|methylphenidate (ritalin)
5286081|NCT00485797|The focus of the study is To explore the effects of Ritalin on postural control in ADHD Children, during single and dual task conditions.|the focus of the study is to explore the effects of ritalin on postural control in adhd children, during single and dual task conditions.
5286082|NCT00485784|Identify in a population of patients with a PE, an IUGR and a FD a modification of circulating endothelial biomarkers compared with normal pregnancy.|identify in a population of patients with a pe, an iugr and a fd a modification of circulating endothelial biomarkers compared with normal pregnancy.
5286083|NCT00485745|surgery|surgery
5286084|NCT00485745|repeat sternotomy|repeat sternotomy
5286085|NCT00485745|pediatrics|pediatrics
5286086|NCT00485732|Cervical neoplasia|cervical neoplasia
5286087|NCT00485732|AS04|as04
5286088|NCT00485732|Randomized|randomized
5286089|NCT00485732|Cervical cancer|cervical cancer
5286090|NCT00485732|HPV-16/18 L1 VLP AS04|hpv-16/18 l1 vlp as04
5286091|NCT00485732|Phase IIIb|phase iiib
5286092|NCT00485732|Korea|korea
5286093|NCT00485732|HPV|hpv
5286094|NCT00485732|Double-blind|double-blind
5286095|NCT00485732|Controlled|controlled
5286096|NCT00485719|Cancer|cancer
5286097|NCT00485719|Solid Tumors|solid tumors
5286098|NCT00485706|dialysis|dialysis
5286099|NCT00485706|vascular calcification|vascular calcification
5286100|NCT00485706|bone mineralism|bone mineralism
5286101|NCT00485706|arterial stiffness|arterial stiffness
5286102|NCT00485706|bone metabolism|bone metabolism
5286103|NCT00485706|chronic kidney disease|chronic kidney disease
5286104|NCT00485693|pain|pain
5286105|NCT00485693|postoperative|postoperative
5286106|NCT00485693|total knee arthroplasty|total knee arthroplasty
5286107|NCT00485693|analgesia|analgesia
5286108|NCT00485667|pain|pain
5286109|NCT00485667|postoperative|postoperative
5286110|NCT00485654|Heterotaxy Syndrome|heterotaxy syndrome
5286111|NCT00485654|Intestinal Malrotation|intestinal malrotation
5286112|NCT00485654|Functional Asplenia|functional asplenia
5286113|NCT00485654|Complex Cyanotic heart disease|complex cyanotic heart disease
5286114|NCT00485641|Stroke|stroke
5286115|NCT00485641|SaeboFlex|saeboflex
5286116|NCT00485641|Hand function|hand function
5286117|NCT00485615|eicosapentaenoic acid|eicosapentaenoic acid
5286118|NCT00485615|fish oil|fish oil
5286119|NCT00485615|Omega 3|omega 3
5286120|NCT00485615|Social Anxiety Disorder|social anxiety disorder
5286121|NCT00485602|malocclusion|malocclusion
5286122|NCT00485602|aligner|aligner
5286123|NCT00485602|crowding|crowding
5286124|NCT00485602|expansion|expansion
5286125|NCT00485602|orthodontic treatment|orthodontic treatment
5286126|NCT00485589|FILM|film
5286127|NCT00485589|RA|ra
5286128|NCT00485589|anti-CD20|anti-cd20
5286129|NCT00485589|CD20|cd20
5286130|NCT00485563|Cancer|cancer
5286131|NCT00485563|Vaccine|vaccine
5286132|NCT00485563|Phase 2|phase 2
5286133|NCT00485563|folate-hapten conjugate|folate-hapten conjugate
5286134|NCT00485563|Progressive|progressive
5286135|NCT00485563|Metastatic|metastatic
5286136|NCT00485563|Experimental|experimental
5286137|NCT00485537|GnRH antagonist|gnrh antagonist
5286138|NCT00485537|GnRH agonist|gnrh agonist
5286139|NCT00485537|ICSI|icsi
5286330|NCT00484757|Narcolepsy|narcolepsy
5286140|NCT00485537|miscarriage rate|miscarriage rate
5286141|NCT00485537|pregnancy outcome|pregnancy outcome
5286142|NCT00485524|Near Infrared Spectroscopy|near infrared spectroscopy
5286143|NCT00485524|Serum Lactate Levels|serum lactate levels
5286144|NCT00485524|post operative outcomes|post operative outcomes
5286145|NCT00485485|Head and Neck Cancer|head and neck cancer
5286146|NCT00485485|Squamous Cell Cancer|squamous cell cancer
5286147|NCT00485485|Imatinib Mesylate|imatinib mesylate
5286148|NCT00485485|Gleevec|gleevec
5286149|NCT00485485|Imatinib|imatinib
5286150|NCT00485485|STI571|sti571
5286151|NCT00485485|Docetaxel|docetaxel
5286152|NCT00485485|Taxotere|taxotere
5286153|NCT00485472|Osteoarthritis|osteoarthritis
5286154|NCT00485472|lacosamide|lacosamide
5286155|NCT00485472|VIMPAT|vimpat
5286156|NCT00485433|hernia|hernia
5286157|NCT00485433|unilateral|unilateral
5286158|NCT00485433|postoperative|postoperative
5286159|NCT00485433|analgesia|analgesia
5286160|NCT00485420|Internet based disease management program|internet based disease management program
5286161|NCT00485394|AMD|amd
5286162|NCT00485394|age-related macular degeneration|age-related macular degeneration
5286163|NCT00485394|geographic atrophy|geographic atrophy
5286164|NCT00485394|GA|ga
5286165|NCT00485368|marfan syndrome|marfan syndrome
5286166|NCT00485368|aortic root diameter|aortic root diameter
5286167|NCT00485355|hysterectomy|hysterectomy
5286168|NCT00485355|Laparoscopy|laparoscopy
5286169|NCT00485355|robotics|robotics
5286170|NCT00485342|Chronic hepatitis C,Genotype1,Naïf,bitherapy,Ribavirin adaptation,ribavirin AUC|chronic hepatitis c,genotype1,naïf,bitherapy,ribavirin adaptation,ribavirin auc
5286171|NCT00485329|Chronic Wounds, Venous Ulcers, Papain, Debridement, Continuous streaming|chronic wounds, venous ulcers, papain, debridement, continuous streaming
5286172|NCT00485329|DermaStream-EnzyStream|dermastream-enzystream
5286173|NCT00485316|Colorectal carcinoma|colorectal carcinoma
5286174|NCT00485316|Rectal carcinoma|rectal carcinoma
5286175|NCT00485316|Laparoscopy|laparoscopy
5286176|NCT00485316|Laparoscopic surgery|laparoscopic surgery
5286177|NCT00485316|Open surgery|open surgery
5286178|NCT00485316|Randomized trial|randomized trial
5286179|NCT00485303|Prostatic Neoplasms|prostatic neoplasms
5286180|NCT00485303|Prostate cancer|prostate cancer
5286181|NCT00485303|Abiraterone acetate|abiraterone acetate
5286182|NCT00485303|CB7630|cb7630
5286183|NCT00485303|Prednisone|prednisone
5286184|NCT00485290|cirrhosis, Portal Hypertension, Esophageal Varices, Meal|cirrhosis, portal hypertension, esophageal varices, meal
5286185|NCT00485277|Breast cancer|breast cancer
5286186|NCT00485277|Vaccine|vaccine
5286187|NCT00485277|Metastatic|metastatic
5286188|NCT00485277|HER-2-positive|her-2-positive
5286189|NCT00485277|Phase I|phase i
5286190|NCT00485277|HER-2 Positive Metastatic Breast Cancer|her-2 positive metastatic breast cancer
5286191|NCT00485251|operation time in minutes|operation time in minutes
5286192|NCT00485251|pain score from 1-10|pain score from 1-10
5286193|NCT00485251|recurrence|recurrence
5286194|NCT00485251|survival|survival
5286195|NCT00485238|glaucoma|glaucoma
5286196|NCT00485212|postoperative pain|postoperative pain
5286197|NCT00485199|Pneumatic Retinopexy|pneumatic retinopexy
5286198|NCT00485199|vitrectomy|vitrectomy
5286199|NCT00485199|retinal detachment|retinal detachment
5286200|NCT00485199|macular hole|macular hole
5286201|NCT00485199|treatment|treatment
5286202|NCT00485199|multi-center|multi-center
5286203|NCT00485199|Retinal Detachment due to Myopic Macular hole|retinal detachment due to myopic macular hole
5286204|NCT00485160|Patent Ductus Arteriosus|patent ductus arteriosus
5286205|NCT00485160|Indomethacin|indomethacin
5286206|NCT00485160|Ibuprofen|ibuprofen
5286207|NCT00485160|Renal effects|renal effects
5286208|NCT00485147|Claudication|claudication
5286209|NCT00485147|peripheral arterial disease|peripheral arterial disease
5286210|NCT00485147|Diagnosis|diagnosis
5286211|NCT00485147|Exercise|exercise
5286212|NCT00485147|Walking impairment|walking impairment
5286213|NCT00485147|Disability|disability
5286214|NCT00485121|Ezetimibe|ezetimibe
5286215|NCT00485121|Statin|statin
5286216|NCT00485121|Low- density lipoprotein cholesterol|low- density lipoprotein cholesterol
5286217|NCT00485121|Adipokine|adipokine
5286218|NCT00485121|Adiponectin|adiponectin
5286219|NCT00485121|C-reactive protein|c-reactive protein
5286220|NCT00485121|Coronary artery disease|coronary artery disease
5286221|NCT00485121|Metabolic Syndrome|metabolic syndrome
5286222|NCT00485121|Obesity|obesity
5286223|NCT00485108|primary open angle glaucoma|primary open angle glaucoma
5286224|NCT00485108|pseudoexfoliation glaucoma|pseudoexfoliation glaucoma
5286225|NCT00485108|selective laser trabeculoplasty|selective laser trabeculoplasty
5286226|NCT00485108|intra ocular pressure|intra ocular pressure
5286227|NCT00485108|anti-inflammatory therapy|anti-inflammatory therapy
5286228|NCT00485108|prednisolone acetate 1%|prednisolone acetate 1%
5286229|NCT00485108|ketorolac tromethamine 0.5%|ketorolac tromethamine 0.5%
5286230|NCT00485082|Cystic Fibrosis|cystic fibrosis
5286231|NCT00485082|Disclosure|disclosure
5286232|NCT00485082|Dating Partner|dating partner
5286233|NCT00485082|Phone Interview|phone interview
5286234|NCT00485069|Ropinirole hydrochloride|ropinirole hydrochloride
5286235|NCT00485069|L-dopa|l-dopa
5286236|NCT00485069|Parkinson's Disease|parkinson's disease
5286237|NCT00485069|Dopamine agonist|dopamine agonist
5286238|NCT00485056|Diabetes|diabetes
5286239|NCT00485056|Tissue doppler imaging|tissue doppler imaging
5286240|NCT00485056|Wave intensity analysis.|wave intensity analysis.
5286241|NCT00485043|T'ai Chi|t'ai chi
5286242|NCT00485043|Osteoarthritis|osteoarthritis
5286243|NCT00485043|Exercise|exercise
5286244|NCT00485043|Older adults|older adults
5286245|NCT00485030|coronary artery disease|coronary artery disease
5286246|NCT00485030|stent|stent
5286247|NCT00485030|angioplasty|angioplasty
5286248|NCT00485017|Obesity|obesity
5286249|NCT00485017|Weight Loss|weight loss
5286250|NCT00485004|Coronary artery disease|coronary artery disease
5286251|NCT00485004|Stent|stent
5286252|NCT00485004|Angioplasty|angioplasty
5286253|NCT00484991|Phenylketonuria|phenylketonuria
5286254|NCT00484991|PKU|pku
5286255|NCT00484991|Phenylketonurias|phenylketonurias
5286256|NCT00484991|Hyperphenylalaninaemia|hyperphenylalaninaemia
5286257|NCT00484991|Hydroxylase Deficiency|hydroxylase deficiency
5286258|NCT00484978|Stereotactic Radiosurgery|stereotactic radiosurgery
5286259|NCT00484978|Surgery|surgery
5286260|NCT00484978|Metastatic tumor to brain|metastatic tumor to brain
5286261|NCT00484978|radiation|radiation
5286262|NCT00484978|Brain Metastases of all pathologies|brain metastases of all pathologies
5286263|NCT00484965|Coronary stent|coronary stent
5286264|NCT00484965|Inflammation|inflammation
5286265|NCT00484965|Atherosclerosis|atherosclerosis
5286266|NCT00484965|Immunosuppressive|immunosuppressive
5286267|NCT00484952|rotavirus|rotavirus
5286268|NCT00484952|diarrheal diseases|diarrheal diseases
5286269|NCT00484952|hospitalizations|hospitalizations
5286270|NCT00484952|multicenter|multicenter
5286271|NCT00484952|children|children
5286272|NCT00484952|under five year old|under five year old
5286273|NCT00484952|Hospitalization due to diarhheal diseases|hospitalization due to diarhheal diseases
5286274|NCT00484952|Hospitalization due to rotavirus gastroenteritis|hospitalization due to rotavirus gastroenteritis
5286275|NCT00484952|Nosocomial rotavirus infections|nosocomial rotavirus infections
5286276|NCT00484926|coronary disease|coronary disease
5286277|NCT00484926|stents|stents
5286278|NCT00484926|antiplatelet drugs|antiplatelet drugs
5286279|NCT00484926|drug-eluting stents|drug-eluting stents
5286280|NCT00484913|healthy subjects|healthy subjects
5286281|NCT00484900|Open randomized multi-centre clinical trial in Africa|open randomized multi-centre clinical trial in africa
5286282|NCT00484900|Uncomplicated P. falciparum malaria|uncomplicated p. falciparum malaria
5286283|NCT00484900|Artemisinin-based Combination Therapy|artemisinin-based combination therapy
5286284|NCT00484900|Artesunate + sulfalene + pyrimethamine|artesunate + sulfalene + pyrimethamine
5286285|NCT00484900|24 hour treatment|24 hour treatment
5286286|NCT00484900|Artemether + lumefantrine|artemether + lumefantrine
5286287|NCT00484887|Hernia mesh|hernia mesh
5286288|NCT00484887|Implanted mesh material|implanted mesh material
5286289|NCT00484887|Explanted mesh material|explanted mesh material
5286290|NCT00484874|Hodgkin's lymphoma|hodgkin's lymphoma
5286291|NCT00484874|Radioimmunotherapy|radioimmunotherapy
5286292|NCT00484874|Bexxar|bexxar
5286293|NCT00484874|I-131 Tositumomab|i-131 tositumomab
5286294|NCT00484874|Safety|safety
5286295|NCT00484874|Efficacy|efficacy
5286296|NCT00484874|Nuclear Medicine|nuclear medicine
5286297|NCT00484874|Monoclonal antibody|monoclonal antibody
5286298|NCT00484874|Radiolabeled|radiolabeled
5286299|NCT00484861|Women|women
5286300|NCT00484861|Healthy Volunteers|healthy volunteers
5286301|NCT00484861|Triglyceride|triglyceride
5286302|NCT00484861|Healthy Volunteer|healthy volunteer
5286303|NCT00484861|HV|hv
5286304|NCT00484848|oncology, medical|oncology, medical
5286305|NCT00484848|implantable catheter|implantable catheter
5286306|NCT00484848|vascular access ports|vascular access ports
5286307|NCT00484848|persistent withdrawal occlusion|persistent withdrawal occlusion
5286308|NCT00484848|Vortex®|vortex®
5286309|NCT00484848|Celsite®|celsite®
5286310|NCT00484848|Vacutainer®|vacutainer®
5286311|NCT00484848|venous cut-down|venous cut-down
5286312|NCT00484835|Abdominal|abdominal
5286313|NCT00484835|Hysterectomy|hysterectomy
5286314|NCT00484835|Electrocoagulation forceps|electrocoagulation forceps
5286315|NCT00484835|Electrosurgery|electrosurgery
5286316|NCT00484835|Gyrus plasma open seal forceps|gyrus plasma open seal forceps
5286317|NCT00484835|Patients undergoing abdominal hysterectomy for various reasons|patients undergoing abdominal hysterectomy for various reasons
5286318|NCT00484809|rheumatoid arthritis|rheumatoid arthritis
5286319|NCT00484809|juvenile rheumatoid arthritis|juvenile rheumatoid arthritis
5286320|NCT00484796|Carotid Surgery|carotid surgery
5286321|NCT00484796|Cerebral Ischemia|cerebral ischemia
5286322|NCT00484796|Cognitive Deficits|cognitive deficits
5286323|NCT00484796|Somatosensory-evoked Potentials|somatosensory-evoked potentials
5286324|NCT00484796|Neuromonitoring|neuromonitoring
5286325|NCT00484783|Laparoscopic Surgical Procedures|laparoscopic surgical procedures
5286326|NCT00484783|Endoscopic Surgical Procedures|endoscopic surgical procedures
5286327|NCT00484783|Laparoscopic & endoscopic procedures with a gastrotomy|laparoscopic & endoscopic procedures with a gastrotomy
5286328|NCT00484783|or opening in bladder or urethra|or opening in bladder or urethra
5286329|NCT00484770|heart failure, brain natriuretic peptide|heart failure, brain natriuretic peptide
5286331|NCT00484757|Orexines|orexines
5286332|NCT00484757|sleep|sleep
5286333|NCT00484757|cognition|cognition
5286334|NCT00484757|cytokines|cytokines
5286335|NCT00484744|pain|pain
5286336|NCT00484744|orthodontic|orthodontic
5286337|NCT00484744|acetaminophen|acetaminophen
5286338|NCT00484744|ibuprofen|ibuprofen
5286339|NCT00484744|separator|separator
5286340|NCT00484705|Androgens|androgens
5286341|NCT00484705|Menstrual pattern|menstrual pattern
5286342|NCT00484705|Insulin resistance|insulin resistance
5286343|NCT00484705|Adipocytes|adipocytes
5286344|NCT00484705|Obesity|obesity
5286345|NCT00484705|Stress|stress
5286346|NCT00484705|Muscle sympathetic nerve activity|muscle sympathetic nerve activity
5286347|NCT00484705|Psychological distress and quality of life|psychological distress and quality of life
5286348|NCT00484692|randomized controlled trial|randomized controlled trial
5286349|NCT00484692|smoking cessation|smoking cessation
5286350|NCT00484692|nicotine dependence|nicotine dependence
5286351|NCT00484692|sustained-release bupropion|sustained-release bupropion
5286352|NCT00484692|psychotherapy|psychotherapy
5286353|NCT00484692|psychodynamic model training|psychodynamic model training
5286354|NCT00484666|recurrent|recurrent
5286355|NCT00484666|platinum|platinum
5286356|NCT00484666|resistant|resistant
5286357|NCT00484666|ovarian|ovarian
5286358|NCT00484666|primary|primary
5286359|NCT00484666|peritoneal|peritoneal
5286360|NCT00484666|cancer|cancer
5286361|NCT00484653|To achieve a quality and quantitative molecular biology assay for vaginal flora abnormalities|to achieve a quality and quantitative molecular biology assay for vaginal flora abnormalities
5286362|NCT00484627|Exercise|exercise
5286363|NCT00484627|HIV|hiv
5286364|NCT00484627|Creatine|creatine
5286365|NCT00484627|Muscle|muscle
5286366|NCT00484614|Breast Cancer, breast conserving surgery|breast cancer, breast conserving surgery
5286367|NCT00484588|VAP|vap
5286368|NCT00484575|Sevoflurane|sevoflurane
5286369|NCT00484575|CABG|cabg
5286370|NCT00484575|cardioprotection|cardioprotection
5286371|NCT00484575|AnaConDa|anaconda
5286372|NCT00484562|oxygen|oxygen
5286373|NCT00484562|COPD|copd
5286374|NCT00484562|exercise|exercise
5286375|NCT00484549|Fabry disease, Screening, Ischemic stroke|fabry disease, screening, ischemic stroke
5286376|NCT00484536|CDP323|cdp323
5286377|NCT00484536|Relapsing Multiple Sclerosis|relapsing multiple sclerosis
5286378|NCT00484536|Magnetic Resonance Imaging|magnetic resonance imaging
5286379|NCT00484536|Oral Compound|oral compound
5286380|NCT00484536|MS|ms
5286381|NCT00484523|To constitute a standardized database of multimode neural imaging.|to constitute a standardized database of multimode neural imaging.
5286382|NCT00484510|Ascorbic Acid|ascorbic acid
5286383|NCT00484510|Vitamin C|vitamin c
5286384|NCT00484510|Charcot Marie Tooth|charcot marie tooth
5286385|NCT00484510|CMT|cmt
5286386|NCT00484510|CMT1a|cmt1a
5286387|NCT00484497|Sleep quality|sleep quality
5286388|NCT00484497|food supplement|food supplement
5286389|NCT00484497|randomized controlled trial|randomized controlled trial
5286390|NCT00484497|actigraphy|actigraphy
5286391|NCT00484497|Leeds|leeds
5286392|NCT00484497|Volunteers presenting moderate primary insomnia|volunteers presenting moderate primary insomnia
5286393|NCT00484484|Cancer|cancer
5286394|NCT00484484|Refractory pain|refractory pain
5286395|NCT00484484|Uncontrolled pain|uncontrolled pain
5286396|NCT00484484|Ketamine|ketamine
5286397|NCT00484484|Uncontrolled cancer pain|uncontrolled cancer pain
5286398|NCT00484458|Degenerative Disc Disease|degenerative disc disease
5286399|NCT00484458|Total Disc Replacement|total disc replacement
5286400|NCT00484445|Chronic critical illness|chronic critical illness
5286401|NCT00484445|Functional status|functional status
5286402|NCT00484445|Outcomes|outcomes
5286403|NCT00484445|Post-ICU|post-icu
5286404|NCT00484432|NGR-hTNF|ngr-htnf
5286405|NCT00484432|Ovarian cancer|ovarian cancer
5286406|NCT00484432|Doxorubicin|doxorubicin
5286407|NCT00484419|Colesevelam HCl,|colesevelam hcl,
5286408|NCT00484419|rosiglitazone|rosiglitazone
5286409|NCT00484419|sitagliptin|sitagliptin
5286410|NCT00484419|Type 2 diabetes|type 2 diabetes
5286411|NCT00484419|metformin|metformin
5286412|NCT00484406|Matrix Metalloproteinases|matrix metalloproteinases
5286413|NCT00484406|Atherosclerosis|atherosclerosis
5286414|NCT00484406|Genetic polymorphism|genetic polymorphism
5286415|NCT00484406|Acute coronary syndromes|acute coronary syndromes
5286416|NCT00484380|Valvular surgery|valvular surgery
5286417|NCT00484380|Diagnostic accuracy of coronary angiography|diagnostic accuracy of coronary angiography
5286418|NCT00484380|Coronary stenosis|coronary stenosis
5286419|NCT00484380|Coronary revascularisation|coronary revascularisation
5286420|NCT00484367|Alcohol abuse|alcohol abuse
5286421|NCT00484367|Substance abuse|substance abuse
5286422|NCT00484367|Cannabis abuse|cannabis abuse
5286423|NCT00484367|Adolescents|adolescents
5286424|NCT00484367|Group therapy|group therapy
5286425|NCT00484367|Family therapy|family therapy
5286426|NCT00484354|Acute Renal Failure|acute renal failure
5286427|NCT00484354|Cardiac Surgery|cardiac surgery
5286428|NCT00484354|Sodium Bicarbonate|sodium bicarbonate
5286429|NCT00484354|Length of Stay|length of stay
5286430|NCT00484354|Mortality|mortality
5286431|NCT00484341|NGR-hTNF|ngr-htnf
5286432|NCT00484341|Doxorubicin|doxorubicin
5286433|NCT00484341|Soft Tissue Sarcoma|soft tissue sarcoma
5286434|NCT00484328|hepatitis C|hepatitis c
5286435|NCT00484328|Ribavirin|ribavirin
5286436|NCT00484328|Dosage|dosage
5286437|NCT00484328|Pharmacokinetics|pharmacokinetics
5286438|NCT00484315|drug-eluting stent|drug-eluting stent
5286439|NCT00484315|paclitaxel-eluting stent|paclitaxel-eluting stent
5286440|NCT00484315|DES|des
5286441|NCT00484302|Marijuana Abuse|marijuana abuse
5286442|NCT00484302|Psychotic Disorders|psychotic disorders
5286443|NCT00484302|Schizophrenia|schizophrenia
5286444|NCT00484276|NGR-hTNF|ngr-htnf
5286445|NCT00484276|malignant pleural mesothelioma|malignant pleural mesothelioma
5286446|NCT00484250|Oral Lichen Planus|oral lichen planus
5286447|NCT00484250|Metronidazole|metronidazole
5286448|NCT00484250|Doxycycline|doxycycline
5286449|NCT00484237|Rheumatoid Arthritis|rheumatoid arthritis
5286450|NCT00484211|NGR-hTNF, Hepatocellular Carcinoma (HCC)|ngr-htnf, hepatocellular carcinoma (hcc)
5286451|NCT00484185|Hemophilia B|hemophilia b
5286452|NCT00484185|BeneFIX|benefix
5286453|NCT00484185|Safety|safety
5286454|NCT00484185|Efficacy|efficacy
5286455|NCT00484172|Obesity|obesity
5286456|NCT00484159|Low back pain of suspected lumbar zygapophysial etiology|low back pain of suspected lumbar zygapophysial etiology
5286457|NCT00484146|Sepsis|sepsis
5286458|NCT00484146|Early Stage|early stage
5286459|NCT00484146|Immune System|immune system
5286460|NCT00484146|Receptors|receptors
5286461|NCT00484146|Cytokines|cytokines
5286462|NCT00484133|sepsis|sepsis
5286463|NCT00484133|severe sepsis|severe sepsis
5286464|NCT00484133|microcirculation|microcirculation
5286465|NCT00484133|Orthogonal polarisation spectral|orthogonal polarisation spectral
5286466|NCT00484120|Osteoarthritis|osteoarthritis
5286467|NCT00484120|Diclofenac|diclofenac
5286468|NCT00484120|Nano-emulsion|nano-emulsion
5286469|NCT00484094|Rapamune|rapamune
5286470|NCT00484094|Safety|safety
5286471|NCT00484094|Efficacy|efficacy
5286472|NCT00484094|Kidney Transplantation|kidney transplantation
5286473|NCT00484081|TESE|tese
5286474|NCT00484081|NON-OBSTRUCTIVE|non-obstructive
5286475|NCT00484081|MICRODISSECTION|microdissection
5286476|NCT00484081|AZOOSPERMIA|azoospermia
5286477|NCT00484081|ICSI|icsi
5286478|NCT00484068|type 2 diabetes|type 2 diabetes
5286479|NCT00484068|microalbuminuria|microalbuminuria
5286480|NCT00484068|chicken-based diet|chicken-based diet
5286481|NCT00484068|ACE inhibitor|ace inhibitor
5286482|NCT00484055|Antibiotic Prophylaxis|antibiotic prophylaxis
5286483|NCT00484042|pancreatitis|pancreatitis
5286484|NCT00484042|polyamine|polyamine
5286485|NCT00484042|cytokine|cytokine
5286486|NCT00484029|Temporomandibular Disorders|temporomandibular disorders
5286488|NCT00484029|TMJ/TMD|tmj/tmd
5286489|NCT00484029|Pain Management|pain management
5286490|NCT00484029|Pain|pain
5286491|NCT00484029|Headaches|headaches
5286492|NCT00484016|adjuvant|adjuvant
5286493|NCT00484016|chemotherapy|chemotherapy
5286494|NCT00484016|observation|observation
5286495|NCT00484016|resected|resected
5286496|NCT00484016|cancers|cancers
5286497|NCT00484003|Atopic eczema|atopic eczema
5286498|NCT00484003|Pimecrolimus|pimecrolimus
5286499|NCT00484003|Children|children
5286500|NCT00484003|Quality of life|quality of life
5286501|NCT00484003|Safety|safety
5286502|NCT00484003|Atopic dermatitis|atopic dermatitis
5286503|NCT00483990|Phase I Study in healthy subjects|phase i study in healthy subjects
5286504|NCT00483964|Schizophrenia|schizophrenia
5286505|NCT00483964|Herbal extracts|herbal extracts
5286506|NCT00483964|Randomized|randomized
5286507|NCT00483964|Controlled|controlled
5286508|NCT00483964|Clinical Trial|clinical trial
5286509|NCT00483951|Transthoracic echocardiography|transthoracic echocardiography
5286510|NCT00483951|Ischemia|ischemia
5286511|NCT00483951|Cardiovascular Disease|cardiovascular disease
5286512|NCT00483951|Heart Disease|heart disease
5286513|NCT00483951|Congenital Heart Disease|congenital heart disease
5286514|NCT00483951|Heart Valve Disease|heart valve disease
5286515|NCT00483951|Atherosclerosis|atherosclerosis
5286516|NCT00483925|Langerhans cell histiocytosis|langerhans cell histiocytosis
5286517|NCT00483925|flow mediated dilatation|flow mediated dilatation
5286518|NCT00483925|intima media thickness|intima media thickness
5286519|NCT00483925|insulin resistance|insulin resistance
5286520|NCT00483925|hypopituitarism|hypopituitarism
5286521|NCT00483925|glucose and lipid metabolism,|glucose and lipid metabolism,
5286522|NCT00483925|structural arterial and functional endothelial properties in patients with multisystem LCH|structural arterial and functional endothelial properties in patients with multisystem lch
5286523|NCT00483912|pancreatitis, MARS|pancreatitis, mars
5286524|NCT00483912|severe acute pancreatitis with early multiple organ failure|severe acute pancreatitis with early multiple organ failure
5286525|NCT00483899|GW870086X Asthma Crossover repeat dose inhaled|gw870086x asthma crossover repeat dose inhaled
5286526|NCT00483886|constipation|constipation
5286527|NCT00483886|prucalopride|prucalopride
5286528|NCT00483886|QOL|qol
5286529|NCT00483886|SCBM|scbm
5286530|NCT00483886|PAC-SYM|pac-sym
5286531|NCT00483873|Cardiac Arrest, Neurological Recovery, EEG, Quantitative EEG|cardiac arrest, neurological recovery, eeg, quantitative eeg
5286532|NCT00483860|Cancer|cancer
5286533|NCT00483860|Solid tumor,|solid tumor,
5286534|NCT00483860|normal renal function|normal renal function
5286535|NCT00483860|renal impairment,|renal impairment,
5286536|NCT00483860|prior platinum-based chemotherapy,|prior platinum-based chemotherapy,
5286537|NCT00483847|TYGRIS - Rest of World (ROW)|tygris - rest of world (row)
5286538|NCT00483847|TYSABRI|tysabri
5286539|NCT00483847|natalizumab|natalizumab
5286540|NCT00483847|Multiple Sclerosis|multiple sclerosis
5286541|NCT00483834|Bevacizumab|bevacizumab
5286542|NCT00483834|Avastin|avastin
5286543|NCT00483834|CPT-11|cpt-11
5286544|NCT00483834|Irinotecan|irinotecan
5286545|NCT00483834|Camptothecin-11|camptothecin-11
5286546|NCT00483834|Capecitabine|capecitabine
5286547|NCT00483834|Xeloda|xeloda
5286548|NCT00483834|Metastatic|metastatic
5286549|NCT00483834|Colorectal|colorectal
5286550|NCT00483834|Colon|colon
5286551|NCT00483834|Rectal|rectal
5286552|NCT00483821|stage I squamous cell carcinoma of the hypopharynx|stage i squamous cell carcinoma of the hypopharynx
5286553|NCT00483821|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
5286554|NCT00483821|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
5286555|NCT00483821|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5286556|NCT00483821|stage I squamous cell carcinoma of the larynx|stage i squamous cell carcinoma of the larynx
5286557|NCT00483821|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
5286558|NCT00483821|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
5286559|NCT00483821|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5286560|NCT00483821|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
5286561|NCT00483821|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
5286562|NCT00483821|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
5286563|NCT00483821|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5286564|NCT00483821|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
5286565|NCT00483821|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
5286566|NCT00483821|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
5286567|NCT00483821|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5286568|NCT00483821|stage I verrucous carcinoma of the larynx|stage i verrucous carcinoma of the larynx
5286569|NCT00483821|stage II verrucous carcinoma of the larynx|stage ii verrucous carcinoma of the larynx
5286570|NCT00483821|stage III verrucous carcinoma of the larynx|stage iii verrucous carcinoma of the larynx
5286571|NCT00483821|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
5286572|NCT00483821|stage I verrucous carcinoma of the oral cavity|stage i verrucous carcinoma of the oral cavity
5286573|NCT00483821|stage II verrucous carcinoma of the oral cavity|stage ii verrucous carcinoma of the oral cavity
5286574|NCT00483821|stage III verrucous carcinoma of the oral cavity|stage iii verrucous carcinoma of the oral cavity
5286575|NCT00483821|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
5286576|NCT00483782|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5286577|NCT00483782|Brenner tumor|brenner tumor
5286578|NCT00483782|ovarian carcinosarcoma|ovarian carcinosarcoma
5286579|NCT00483782|ovarian clear cell cystadenocarcinoma|ovarian clear cell cystadenocarcinoma
5286580|NCT00483782|ovarian endometrioid adenocarcinoma|ovarian endometrioid adenocarcinoma
5286581|NCT00483782|ovarian mixed epithelial carcinoma|ovarian mixed epithelial carcinoma
5286582|NCT00483782|ovarian mucinous cystadenocarcinoma|ovarian mucinous cystadenocarcinoma
5286583|NCT00483782|ovarian serous cystadenocarcinoma|ovarian serous cystadenocarcinoma
5286584|NCT00483782|ovarian undifferentiated adenocarcinoma|ovarian undifferentiated adenocarcinoma
5286585|NCT00483782|stage IA ovarian epithelial cancer|stage ia ovarian epithelial cancer
5286586|NCT00483782|stage IB ovarian epithelial cancer|stage ib ovarian epithelial cancer
5286587|NCT00483782|stage IC ovarian epithelial cancer|stage ic ovarian epithelial cancer
5286588|NCT00483782|stage IIA ovarian epithelial cancer|stage iia ovarian epithelial cancer
5286589|NCT00483782|stage IIB ovarian epithelial cancer|stage iib ovarian epithelial cancer
5286590|NCT00483782|stage IIC ovarian epithelial cancer|stage iic ovarian epithelial cancer
5286591|NCT00483782|stage IIIA ovarian epithelial cancer|stage iiia ovarian epithelial cancer
5286592|NCT00483782|stage IIIB ovarian epithelial cancer|stage iiib ovarian epithelial cancer
5286593|NCT00483782|stage IIIC ovarian epithelial cancer|stage iiic ovarian epithelial cancer
5286594|NCT00483782|stage IA fallopian tube cancer|stage ia fallopian tube cancer
5286595|NCT00483782|stage IB fallopian tube cancer|stage ib fallopian tube cancer
5286596|NCT00483782|stage IC fallopian tube cancer|stage ic fallopian tube cancer
5286597|NCT00483782|stage IIA fallopian tube cancer|stage iia fallopian tube cancer
5286598|NCT00483782|stage IIB fallopian tube cancer|stage iib fallopian tube cancer
5286599|NCT00483782|stage IIC fallopian tube cancer|stage iic fallopian tube cancer
5286600|NCT00483782|stage IIIA fallopian tube cancer|stage iiia fallopian tube cancer
5286601|NCT00483782|stage IIIB fallopian tube cancer|stage iiib fallopian tube cancer
5286602|NCT00483782|stage IIIC fallopian tube cancer|stage iiic fallopian tube cancer
5286603|NCT00483782|stage IV fallopian tube cancer|stage iv fallopian tube cancer
5287016|NCT00482261|elderly|elderly
5286604|NCT00483782|stage IA primary peritoneal cavity cancer|stage ia primary peritoneal cavity cancer
5286605|NCT00483782|stage IB primary peritoneal cavity cancer|stage ib primary peritoneal cavity cancer
5286606|NCT00483782|stage IC primary peritoneal cavity cancer|stage ic primary peritoneal cavity cancer
5286607|NCT00483782|stage IIA primary peritoneal cavity cancer|stage iia primary peritoneal cavity cancer
5286608|NCT00483782|stage IIB primary peritoneal cavity cancer|stage iib primary peritoneal cavity cancer
5286609|NCT00483782|stage IIC primary peritoneal cavity cancer|stage iic primary peritoneal cavity cancer
5286610|NCT00483782|stage IIIA primary peritoneal cavity cancer|stage iiia primary peritoneal cavity cancer
5286611|NCT00483782|stage IIIB primary peritoneal cavity cancer|stage iiib primary peritoneal cavity cancer
5286612|NCT00483782|stage IIIC primary peritoneal cavity cancer|stage iiic primary peritoneal cavity cancer
5286613|NCT00483782|stage IV primary peritoneal cavity cancer|stage iv primary peritoneal cavity cancer
5286614|NCT00483769|Cystis Fibrosis|cystis fibrosis
5286615|NCT00483769|Glucose intolerance|glucose intolerance
5286616|NCT00483769|Glargine|glargine
5286618|NCT00483756|Immunosuppression|immunosuppression
5286619|NCT00483756|JAK3 inhibitor|jak3 inhibitor
5286620|NCT00483756|kidney transplantation.|kidney transplantation.
5286621|NCT00483717|Migraine|migraine
5286622|NCT00483717|Ketorolac|ketorolac
5286623|NCT00483704|multiple attacks of moderate to severe migraine headaches|multiple attacks of moderate to severe migraine headaches
5286624|NCT00483691|Intervention|intervention
5286625|NCT00483691|Home Visit|home visit
5286626|NCT00483691|Growth|growth
5286627|NCT00483691|Child Development|child development
5286628|NCT00483678|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
5286629|NCT00483678|sexual dysfunction|sexual dysfunction
5286630|NCT00483678|sexuality and reproductive issues|sexuality and reproductive issues
5286631|NCT00483678|recurrent prostate cancer|recurrent prostate cancer
5286632|NCT00483678|stage III prostate cancer|stage iii prostate cancer
5286633|NCT00483678|stage IV prostate cancer|stage iv prostate cancer
5286634|NCT00483665|endoleak|endoleak
5286635|NCT00483652|multiple sclerosis|multiple sclerosis
5286636|NCT00483652|MS|ms
5286637|NCT00483652|walking|walking
5286638|NCT00483652|leg strength|leg strength
5286639|NCT00483652|demyelination|demyelination
5286640|NCT00483639|anxiety disorder|anxiety disorder
5286641|NCT00483639|long-term effects secondary to cancer therapy in adults|long-term effects secondary to cancer therapy in adults
5286642|NCT00483639|head and neck cancer|head and neck cancer
5286643|NCT00483639|non-small cell lung cancer|non-small cell lung cancer
5286644|NCT00483639|small cell lung cancer|small cell lung cancer
5286645|NCT00483626|hemodynamic|hemodynamic
5286646|NCT00483626|pulmonary hypertension|pulmonary hypertension
5286647|NCT00483626|sildenafil|sildenafil
5286648|NCT00483613|Daily stress|daily stress
5286649|NCT00483613|Cognitive-behavioral therapy|cognitive-behavioral therapy
5286650|NCT00483613|Quality of life|quality of life
5286651|NCT00483613|SLEDAI|sledai
5286652|NCT00483600|Fondaparinux|fondaparinux
5286653|NCT00483600|Pharmacokinetic|pharmacokinetic
5286654|NCT00483587|NSTEMI|nstemi
5286655|NCT00483587|Acute coronary syndrome|acute coronary syndrome
5286656|NCT00483587|Heme arginate|heme arginate
5286657|NCT00483587|HO-1|ho-1
5286658|NCT00483587|Heme oxygenase-1|heme oxygenase-1
5286659|NCT00483574|Menactra® vaccine|menactra® vaccine
5286660|NCT00483574|Meningococcal meningitis|meningococcal meningitis
5286661|NCT00483574|Measles|measles
5286662|NCT00483574|Mumps|mumps
5286663|NCT00483574|Rubella|rubella
5286664|NCT00483574|Varicella virus|varicella virus
5286665|NCT00483574|Haemophilus influenzae type b|haemophilus influenzae type b
5286666|NCT00483574|Pneumococcal conjugate vaccine|pneumococcal conjugate vaccine
5286667|NCT00483561|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5286668|NCT00483561|recurrent prostate cancer|recurrent prostate cancer
5286669|NCT00483561|stage III prostate cancer|stage iii prostate cancer
5286670|NCT00483561|stage IV prostate cancer|stage iv prostate cancer
5286671|NCT00483535|Gw273225, Oral Contraceptive Interaction|gw273225, oral contraceptive interaction
5286672|NCT00483522|Rehabilitation|rehabilitation
5286673|NCT00483522|Directive counseling|directive counseling
5286674|NCT00483522|Brain injuries|brain injuries
5286675|NCT00483509|NGR-hTNF|ngr-htnf
5286677|NCT00483483|HIV|hiv
5286678|NCT00483483|Unsafe sex|unsafe sex
5286679|NCT00483483|High-risk sex|high-risk sex
5286680|NCT00483483|Needle sharing|needle sharing
5286681|NCT00483483|STDs|stds
5286682|NCT00483470|Hepatitis A|hepatitis a
5286683|NCT00483457|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5286684|NCT00483444|Rehabilitation|rehabilitation
5286685|NCT00483444|Brain injuries|brain injuries
5286686|NCT00483444|Directive counseling|directive counseling
5286687|NCT00483431|vitamin K2|vitamin k2
5286688|NCT00483431|dosis-response|dosis-response
5286689|NCT00483431|osteocalcin|osteocalcin
5286690|NCT00483431|matrix-gla protein|matrix-gla protein
5286691|NCT00483418|male|male
5286692|NCT00483418|cancer|cancer
5286693|NCT00483405|advanced adult primary liver cancer|advanced adult primary liver cancer
5286694|NCT00483405|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
5286695|NCT00483405|recurrent adult primary liver cancer|recurrent adult primary liver cancer
5286696|NCT00483405|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
5286697|NCT00483392|insulin|insulin
5286698|NCT00483392|rosiglitazone|rosiglitazone
5286699|NCT00483392|metformin|metformin
5286700|NCT00483392|hiv|hiv
5286701|NCT00483392|protease inhibitors|protease inhibitors
5286702|NCT00483366|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5286703|NCT00483327|Well|well
5286704|NCT00483327|Moderately|moderately
5286705|NCT00483327|Differentiated|differentiated
5286706|NCT00483301|Melanoma|melanoma
5286707|NCT00483301|Abraxane|abraxane
5286708|NCT00483301|Sorafenib|sorafenib
5286709|NCT00483301|BAY 43-9006|bay 43-9006
5286710|NCT00483301|Abraxis|abraxis
5286711|NCT00483288|cervical cancer|cervical cancer
5286712|NCT00483275|Accidental Falls|accidental falls
5286713|NCT00483275|Accident Prevention|accident prevention
5286714|NCT00483275|Patient Education|patient education
5286715|NCT00483275|Exercise Training|exercise training
5286716|NCT00483275|Alfacalcidol|alfacalcidol
5286717|NCT00483262|Temsirolimus|temsirolimus
5286718|NCT00483262|Bortezomib|bortezomib
5286719|NCT00483249|Thoracoabdominal|thoracoabdominal
5286720|NCT00483249|Paravisceral|paravisceral
5286721|NCT00483249|Aneurysm|aneurysm
5286722|NCT00483249|Endovascular|endovascular
5286723|NCT00483249|Stent-Graft|stent-graft
5286724|NCT00483249|Aorta|aorta
5286725|NCT00483236|Non-Ischaemic Cardiomyopathy|non-ischaemic cardiomyopathy
5286726|NCT00483223|ER negative|er negative
5286727|NCT00483223|PgR negative|pgr negative
5286728|NCT00483223|HER2 negative|her2 negative
5286729|NCT00483223|cisplatin|cisplatin
5286730|NCT00483223|carboplatinum|carboplatinum
5286731|NCT00483223|platinum|platinum
5286732|NCT00483223|p63|p63
5286733|NCT00483223|p73|p73
5286734|NCT00483197|VentrAssistTM|ventrassisttm
5286735|NCT00483197|LVAD|lvad
5286736|NCT00483197|End-stage heart failure|end-stage heart failure
5286737|NCT00483197|Cardiomyopathy|cardiomyopathy
5286738|NCT00483158|Helicobacter pylori|helicobacter pylori
5286739|NCT00483158|Fluoroquinolones|fluoroquinolones
5286740|NCT00483158|First in Man|first in man
5286741|NCT00483119|pemphigus vulgaris|pemphigus vulgaris
5286742|NCT00483119|IVIg|ivig
5286743|NCT00483119|cyclophosphamide|cyclophosphamide
5286744|NCT00483119|treatment|treatment
5286745|NCT00483119|pemphigus antibodies|pemphigus antibodies
5286746|NCT00483106|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
5286747|NCT00483106|Genetics|genetics
5286748|NCT00483106|Pharmacogenetics|pharmacogenetics
5286749|NCT00483093|NGR-hTNF|ngr-htnf
5286750|NCT00483093|cisplatin|cisplatin
5286751|NCT00483093|solid tumors|solid tumors
5286752|NCT00483080|NGR-hTNF|ngr-htnf
5286753|NCT00483080|CRC|crc
5286754|NCT00483067|Idiopathic Hypereosinophilic Syndrome|idiopathic hypereosinophilic syndrome
5286755|NCT00483067|Leukemia|leukemia
5286756|NCT00483067|2-Chlorodeoxyadenosine|2-chlorodeoxyadenosine
5286757|NCT00483067|Cladribine|cladribine
5286758|NCT00483067|Cytarabine|cytarabine
5286759|NCT00483067|Ara-C|ara-c
5286760|NCT00483067|2-CdA|2-cda
5286761|NCT00483067|G-CSF|g-csf
5286762|NCT00483067|HES|hes
5286763|NCT00483054|HIV|hiv
5286764|NCT00483054|tuberculosis|tuberculosis
5286765|NCT00483054|efavirenz|efavirenz
5286766|NCT00483054|nevirapine|nevirapine
5286767|NCT00483054|rifampicin|rifampicin
5286768|NCT00483054|co-infected HIV and tuberculosis patients|co-infected hiv and tuberculosis patients
5286769|NCT00483015|presentation|presentation
5286770|NCT00483015|outcome|outcome
5286771|NCT00483015|response|response
5286772|NCT00483015|never- smokers|never- smokers
5286773|NCT00483002|A prospective and observational program to monitor use in real practice including efficacy of Varenicline in Korea.|a prospective and observational program to monitor use in real practice including efficacy of varenicline in korea.
5286774|NCT00482963|HIV|hiv
5286775|NCT00482963|Contraception|contraception
5286776|NCT00482963|Antiretroviral agents|antiretroviral agents
5286777|NCT00482963|Pharmacokinetics|pharmacokinetics
5286778|NCT00482937|Safety|safety
5286779|NCT00482937|Heart Failure|heart failure
5286780|NCT00482924|obesity|obesity
5286781|NCT00482924|cardiovascular risk profiles|cardiovascular risk profiles
5286782|NCT00482924|adipokines|adipokines
5286783|NCT00482924|preatherosclerosis|preatherosclerosis
5286784|NCT00482924|low grade inflammation|low grade inflammation
5286785|NCT00482924|dyslipidemia|dyslipidemia
5286786|NCT00482924|insulin resistance|insulin resistance
5286787|NCT00482924|brown adipose tissue|brown adipose tissue
5286788|NCT00482924|white adipose tissue|white adipose tissue
5286789|NCT00482911|recurrent intraocular melanoma|recurrent intraocular melanoma
5286790|NCT00482911|metastatic intraocular melanoma|metastatic intraocular melanoma
5286791|NCT00482911|ciliary body and choroid melanoma, medium/large size|ciliary body and choroid melanoma, medium/large size
5286792|NCT00482911|extraocular extension melanoma|extraocular extension melanoma
5286793|NCT00482911|iris melanoma|iris melanoma
5286794|NCT00482911|conjunctival melanoma|conjunctival melanoma
5286795|NCT00482885|Esophagus|esophagus
5286796|NCT00482885|Peristalsis|peristalsis
5286797|NCT00482885|Contractile Pressure|contractile pressure
5286798|NCT00482885|Coordination of contraction|coordination of contraction
5286799|NCT00482885|Bolus transport|bolus transport
5286800|NCT00482885|Esophageal function|esophageal function
5286801|NCT00482872|stage I squamous cell carcinoma of the hypopharynx|stage i squamous cell carcinoma of the hypopharynx
5286802|NCT00482872|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
5286803|NCT00482872|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
5286804|NCT00482872|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5286805|NCT00482872|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
5286806|NCT00482872|stage I squamous cell carcinoma of the larynx|stage i squamous cell carcinoma of the larynx
5286807|NCT00482872|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
5286808|NCT00482872|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
5286809|NCT00482872|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5286810|NCT00482872|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
5286811|NCT00482872|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
5286812|NCT00482872|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
5286813|NCT00482872|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
5286814|NCT00482872|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5286815|NCT00482872|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
5286816|NCT00482872|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
5286817|NCT00482872|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
5286818|NCT00482872|untreated metastatic squamous neck cancer with occult primary|untreated metastatic squamous neck cancer with occult primary
5286819|NCT00482872|stage I squamous cell carcinoma of the nasopharynx|stage i squamous cell carcinoma of the nasopharynx
5286820|NCT00482872|stage II squamous cell carcinoma of the nasopharynx|stage ii squamous cell carcinoma of the nasopharynx
5286821|NCT00482872|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
5286822|NCT00482872|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
5286823|NCT00482872|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
5286824|NCT00482872|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
5286825|NCT00482872|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
5286826|NCT00482872|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
5286827|NCT00482872|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5286828|NCT00482872|stage I squamous cell carcinoma of the paranasal sinus and nasal cavity|stage i squamous cell carcinoma of the paranasal sinus and nasal cavity
5286829|NCT00482872|stage II squamous cell carcinoma of the paranasal sinus and nasal cavity|stage ii squamous cell carcinoma of the paranasal sinus and nasal cavity
5286830|NCT00482872|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
5286831|NCT00482872|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
5286832|NCT00482872|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
5286833|NCT00482872|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
5286834|NCT00482872|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
5286835|NCT00482872|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
5286836|NCT00482872|stage I verrucous carcinoma of the larynx|stage i verrucous carcinoma of the larynx
5286837|NCT00482872|stage I verrucous carcinoma of the oral cavity|stage i verrucous carcinoma of the oral cavity
5286838|NCT00482872|stage II verrucous carcinoma of the larynx|stage ii verrucous carcinoma of the larynx
5286839|NCT00482872|stage II verrucous carcinoma of the oral cavity|stage ii verrucous carcinoma of the oral cavity
5286840|NCT00482872|stage III verrucous carcinoma of the larynx|stage iii verrucous carcinoma of the larynx
5286841|NCT00482872|stage III verrucous carcinoma of the oral cavity|stage iii verrucous carcinoma of the oral cavity
5286842|NCT00482872|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
5286843|NCT00482872|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
5286844|NCT00482872|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
5286845|NCT00482859|Fibromyalgia Syndrome|fibromyalgia syndrome
5286846|NCT00482846|mucositis|mucositis
5286847|NCT00482846|drug/agent toxicity by tissue/organ|drug/agent toxicity by tissue/organ
5286848|NCT00482846|stage II multiple myeloma|stage ii multiple myeloma
5286849|NCT00482846|stage III multiple myeloma|stage iii multiple myeloma
5286850|NCT00482846|refractory multiple myeloma|refractory multiple myeloma
5286851|NCT00482833|adult acute promyelocytic leukemia (M3)|adult acute promyelocytic leukemia (m3)
5286852|NCT00482833|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5286853|NCT00482833|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
5286854|NCT00482820|anxiety|anxiety
5287112|NCT00481871|Gemcitabine|gemcitabine
5286855|NCT00482820|attention-biases|attention-biases
5286856|NCT00482820|children|children
5286857|NCT00482807|stage I prostate cancer|stage i prostate cancer
5286858|NCT00482807|stage II prostate cancer|stage ii prostate cancer
5286859|NCT00482807|stage III prostate cancer|stage iii prostate cancer
5286860|NCT00482807|stage IV prostate cancer|stage iv prostate cancer
5286861|NCT00482807|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5286862|NCT00482807|recurrent prostate cancer|recurrent prostate cancer
5286863|NCT00482794|Antiphospholipid Antibody Syndrome|antiphospholipid antibody syndrome
5286864|NCT00482781|Apnea|apnea
5286865|NCT00482781|Bradycardia|bradycardia
5286866|NCT00482781|Preterm Infant|preterm infant
5286867|NCT00482781|Immunization|immunization
5286868|NCT00482781|DTaP|dtap
5286869|NCT00482768|Diabetes, type II; Primary Health Care; Outpatient Care|diabetes, type ii; primary health care; outpatient care
5286870|NCT00482755|male breast cancer|male breast cancer
5286871|NCT00482755|stage II breast cancer|stage ii breast cancer
5286872|NCT00482755|stage IIIA breast cancer|stage iiia breast cancer
5286873|NCT00482742|Chronic Total Occlusion|chronic total occlusion
5286874|NCT00482716|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5286875|NCT00482716|refractory multiple myeloma|refractory multiple myeloma
5286876|NCT00482716|stage I multiple myeloma|stage i multiple myeloma
5286877|NCT00482716|stage II multiple myeloma|stage ii multiple myeloma
5286878|NCT00482716|stage III multiple myeloma|stage iii multiple myeloma
5286879|NCT00482716|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
5286880|NCT00482716|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5286881|NCT00482716|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5286882|NCT00482716|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
5286883|NCT00482716|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
5286884|NCT00482716|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
5286885|NCT00482716|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
5286886|NCT00482716|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
5286887|NCT00482716|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
5286888|NCT00482716|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
5286889|NCT00482716|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
5286890|NCT00482716|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5286891|NCT00482716|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5286892|NCT00482716|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
5286893|NCT00482716|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
5286894|NCT00482716|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5286895|NCT00482716|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5286896|NCT00482716|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5286897|NCT00482716|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5286898|NCT00482716|stage I marginal zone lymphoma|stage i marginal zone lymphoma
5286899|NCT00482716|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5286900|NCT00482716|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5286901|NCT00482716|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
5286902|NCT00482716|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5286903|NCT00482716|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5286904|NCT00482716|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5286905|NCT00482716|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5286906|NCT00482716|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5286907|NCT00482716|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5286908|NCT00482716|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5286909|NCT00482716|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5286910|NCT00482716|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5286911|NCT00482716|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5286912|NCT00482716|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
5286913|NCT00482716|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
5286914|NCT00482716|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5286915|NCT00482716|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5286916|NCT00482716|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5286917|NCT00482716|anemia|anemia
5286918|NCT00482703|Imatinib resistant or intolerant chronic phase CML|imatinib resistant or intolerant chronic phase cml
5286919|NCT00482690|Smoking cessation|smoking cessation
5286920|NCT00482690|Biomarkers|biomarkers
5286921|NCT00482690|Aldehydes|aldehydes
5286922|NCT00482690|Exhaled breath|exhaled breath
5286923|NCT00482690|Harm Reduction|harm reduction
5286924|NCT00482690|Cigarette smoking|cigarette smoking
5286925|NCT00482690|cessation|cessation
5286926|NCT00482690|reduction|reduction
5286927|NCT00482677|adult glioblastoma|adult glioblastoma
5286928|NCT00482677|adult giant cell glioblastoma|adult giant cell glioblastoma
5286929|NCT00482677|adult gliosarcoma|adult gliosarcoma
5286930|NCT00482586|adult primary liver cancer|adult primary liver cancer
5286931|NCT00482586|liver metastases|liver metastases
5286932|NCT00482573|Electrocardiography, ambulatory/methods|electrocardiography, ambulatory/methods
5286933|NCT00482573|Blood Pressure monitoring, ambulatory/methods|blood pressure monitoring, ambulatory/methods
5286934|NCT00482573|Cardiotocography/methods|cardiotocography/methods
5286935|NCT00482573|Dental restoration, permanent|dental restoration, permanent
5286936|NCT00482573|Anesthesia, local /methods|anesthesia, local /methods
5286937|NCT00482573|Lidocaine|lidocaine
5286938|NCT00482573|Vasoconstrictor Agents|vasoconstrictor agents
5286939|NCT00482573|Epinephrine|epinephrine
5286940|NCT00482573|Pregnancy|pregnancy
5286941|NCT00482573|Rheumatic Heart Disease|rheumatic heart disease
5286942|NCT00482560|Sucrose|sucrose
5286943|NCT00482560|Breastfeeding|breastfeeding
5286944|NCT00482560|Heel lance|heel lance
5286945|NCT00482547|urinary tract infection|urinary tract infection
5286946|NCT00482547|urinary catheter|urinary catheter
5286947|NCT00482521|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5286948|NCT00482508|Asthma|asthma
5286949|NCT00482508|anti immunoglobulin E|anti immunoglobulin e
5286950|NCT00482508|omalizumab|omalizumab
5286951|NCT00482495|refractory multiple myeloma|refractory multiple myeloma
5286952|NCT00482495|stage I multiple myeloma|stage i multiple myeloma
5286953|NCT00482495|stage II multiple myeloma|stage ii multiple myeloma
5286954|NCT00482495|stage III multiple myeloma|stage iii multiple myeloma
5286955|NCT00482482|Yoga|yoga
5286956|NCT00482482|Bipolar disorder|bipolar disorder
5286957|NCT00482482|Major depression|major depression
5286958|NCT00482482|Dysthymia|dysthymia
5286959|NCT00482482|Randomized|randomized
5286960|NCT00482469|ischemia-reperfusion|ischemia-reperfusion
5286961|NCT00482469|ischemia|ischemia
5286962|NCT00482469|reperfusion|reperfusion
5286963|NCT00482469|DIEP-flap|diep-flap
5286964|NCT00482469|flap|flap
5286965|NCT00482456|Nitrous oxide|nitrous oxide
5286966|NCT00482456|Homocysteine|homocysteine
5286967|NCT00482456|folate|folate
5286968|NCT00482456|vitamin B12|vitamin b12
5286969|NCT00482430|Undifferentiated schizophrenia|undifferentiated schizophrenia
5286970|NCT00482430|Residual schizophrenia|residual schizophrenia
5286971|NCT00482391|recurrent breast cancer|recurrent breast cancer
5286972|NCT00482391|stage I breast cancer|stage i breast cancer
5286973|NCT00482391|stage II breast cancer|stage ii breast cancer
5286974|NCT00482391|stage IIIA breast cancer|stage iiia breast cancer
5286975|NCT00482391|stage IIIB breast cancer|stage iiib breast cancer
5286976|NCT00482391|stage IIIC breast cancer|stage iiic breast cancer
5286977|NCT00482391|male breast cancer|male breast cancer
5286978|NCT00482378|stage I multiple myeloma|stage i multiple myeloma
5286979|NCT00482378|stage II multiple myeloma|stage ii multiple myeloma
5286980|NCT00482378|stage III multiple myeloma|stage iii multiple myeloma
5286981|NCT00482378|refractory multiple myeloma|refractory multiple myeloma
5286982|NCT00482378|pain|pain
5286983|NCT00482365|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
5286984|NCT00482365|advanced adult primary liver cancer|advanced adult primary liver cancer
5286985|NCT00482365|localized resectable adult primary liver cancer|localized resectable adult primary liver cancer
5286986|NCT00482365|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
5286987|NCT00482365|recurrent adult primary liver cancer|recurrent adult primary liver cancer
5286988|NCT00482339|bacterial contamination|bacterial contamination
5286989|NCT00482339|platelet concentrates|platelet concentrates
5286990|NCT00482339|blood donation|blood donation
5286991|NCT00482339|looxster|looxster
5286992|NCT00482339|pureprove|pureprove
5286993|NCT00482339|bacterial genomic DNA|bacterial genomic dna
5286994|NCT00482339|bacterial contamination of platelet concentrates|bacterial contamination of platelet concentrates
5286995|NCT00482339|"Preparation of bacterial DNA in blood"|"preparation of bacterial dna in blood"
5286996|NCT00482339|comparison of blood culture versus NAT|comparison of blood culture versus nat
5286997|NCT00482313|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
5286998|NCT00482313|ADHD|adhd
5286999|NCT00482313|Prison|prison
5287000|NCT00482313|Treatment|treatment
5287001|NCT00482313|Randomized|randomized
5287002|NCT00482313|Double-Blind|double-blind
5287003|NCT00482313|Placebo Control|placebo control
5287004|NCT00482313|Parallel Assignment|parallel assignment
5287005|NCT00482313|Efficacy Study|efficacy study
5287006|NCT00482300|Histologically proved endometrial carcinoma preoperatively supposed stage I-II|histologically proved endometrial carcinoma preoperatively supposed stage i-ii
5287007|NCT00482274|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5287008|NCT00482274|recurrent prostate cancer|recurrent prostate cancer
5287009|NCT00482274|stage I prostate cancer|stage i prostate cancer
5287010|NCT00482274|stage II prostate cancer|stage ii prostate cancer
5287011|NCT00482274|stage III prostate cancer|stage iii prostate cancer
5287012|NCT00482274|stage IV prostate cancer|stage iv prostate cancer
5287013|NCT00482261|myeloma|myeloma
5287014|NCT00482261|relapse|relapse
5287015|NCT00482261|refractory|refractory
5287017|NCT00482261|lenalidomide|lenalidomide
5287018|NCT00482248|Asthma|asthma
5287019|NCT00482248|anti-immunoglobulin E|anti-immunoglobulin e
5287020|NCT00482248|omalizumab|omalizumab
5287021|NCT00482248|allergic asthma|allergic asthma
5287022|NCT00482222|adenocarcinoma of the colon|adenocarcinoma of the colon
5287023|NCT00482222|stage IV colon cancer|stage iv colon cancer
5287024|NCT00482222|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5287025|NCT00482222|stage IV rectal cancer|stage iv rectal cancer
5287026|NCT00482222|liver metastases|liver metastases
5287027|NCT00482222|recurrent colon cancer|recurrent colon cancer
5287028|NCT00482222|recurrent rectal cancer|recurrent rectal cancer
5287029|NCT00482209|mifepristone, misoprostol, medical abortion|mifepristone, misoprostol, medical abortion
5287030|NCT00482183|Bare metal stent|bare metal stent
5287031|NCT00482183|Major adverse cardiac events|major adverse cardiac events
5287032|NCT00482183|Pioglitazone|pioglitazone
5287033|NCT00482183|Restenosis|restenosis
5287034|NCT00482183|Sirolimus eluting stent|sirolimus eluting stent
5287035|NCT00482144|Pulsed-Dye Laser|pulsed-dye laser
5287036|NCT00482118|Air Pollution|air pollution
5287037|NCT00482118|Tumor Markers|tumor markers
5287038|NCT00482118|Genetic Polymorphisms|genetic polymorphisms
5287039|NCT00482118|Molecular Epidemiology|molecular epidemiology
5287040|NCT00482118|Environmental Epidemiology|environmental epidemiology
5287041|NCT00482118|Lung Cancer|lung cancer
5287042|NCT00482105|melanoma|melanoma
5287043|NCT00482092|Crohn's disease|crohn's disease
5287044|NCT00482092|adult stem cell therapy|adult stem cell therapy
5287045|NCT00482066|Wegener's granulomatosis|wegener's granulomatosis
5287046|NCT00482066|Microscopic polyangiitis|microscopic polyangiitis
5287047|NCT00482066|Churg Strauss Syndrome|churg strauss syndrome
5287048|NCT00482066|ANCA|anca
5287049|NCT00482040|CPAP|cpap
5287050|NCT00482040|Preterm|preterm
5287051|NCT00482040|Prematurity|prematurity
5287052|NCT00482040|Apnea of prematurity|apnea of prematurity
5287053|NCT00482027|HIV vaccine|hiv vaccine
5287054|NCT00482027|Adeno-associated virus vactored vaccine|adeno-associated virus vactored vaccine
5287055|NCT00482027|HIV-1 subtype C|hiv-1 subtype c
5287056|NCT00482027|Safety|safety
5287057|NCT00482027|Immunogenicity|immunogenicity
5287058|NCT00482027|Biodistribution|biodistribution
5287059|NCT00482027|HIV prevention|hiv prevention
5287060|NCT00482001|Donepezil|donepezil
5287061|NCT00482001|Driving|driving
5287062|NCT00482001|Cholinesterase Inhibitors|cholinesterase inhibitors
5287063|NCT00482001|Geriatric Psychiatry|geriatric psychiatry
5287064|NCT00482001|Psychopharmacology|psychopharmacology
5287065|NCT00482001|Aricept|aricept
5287066|NCT00481988|depression|depression
5287067|NCT00481988|transcranial direct current stimulation|transcranial direct current stimulation
5287068|NCT00481988|direct current stimulation|direct current stimulation
5287069|NCT00481988|tdcs|tdcs
5287070|NCT00481975|binge eating|binge eating
5287071|NCT00481975|eating disorders|eating disorders
5287072|NCT00481975|obesity|obesity
5287073|NCT00481949|Gastro-oesophageal reflux disease|gastro-oesophageal reflux disease
5287074|NCT00481949|pH measurement|ph measurement
5287075|NCT00481949|symptom association|symptom association
5287076|NCT00481949|wireless pH monitoring system|wireless ph monitoring system
5287077|NCT00481949|Functional Heartburn|functional heartburn
5287078|NCT00481949|Gastro-esophageal reflux disease|gastro-esophageal reflux disease
5287079|NCT00481936|Neoplasms|neoplasms
5287080|NCT00481936|Neoplasm, Epithelial|neoplasm, epithelial
5287081|NCT00481936|Neoplasm, Glandular|neoplasm, glandular
5287082|NCT00481923|hypocaloric diet|hypocaloric diet
5287083|NCT00481923|energy intake|energy intake
5287084|NCT00481897|overweight|overweight
5287085|NCT00481897|obesity|obesity
5287086|NCT00481897|type 2 diabetes|type 2 diabetes
5287087|NCT00481897|diabetes|diabetes
5287088|NCT00481897|worksite cost|worksite cost
5287089|NCT00481897|nutrition|nutrition
5287090|NCT00481884|Breast Cancer|breast cancer
5287091|NCT00481884|Radiation Dermatitis|radiation dermatitis
5287092|NCT00481884|RadiaPlexRx Gel|radiaplexrx gel
5287093|NCT00481884|Aquaphor|aquaphor
5287094|NCT00481871|Lymphoproliferative malignancies|lymphoproliferative malignancies
5287095|NCT00481871|Lymphoma|lymphoma
5287096|NCT00481871|Hodgkin's lymphoma (HL)|hodgkin's lymphoma (hl)
5287097|NCT00481871|Non-Hodgkin's lymphoma (NHL)|non-hodgkin's lymphoma (nhl)
5287098|NCT00481871|PTCL|ptcl
5287099|NCT00481871|T/NK-cell leukemia/lymphoma|t/nk-cell leukemia/lymphoma
5287100|NCT00481871|T-cell lymphoma/leukemia (HTLV 1+)|t-cell lymphoma/leukemia (htlv 1+)
5287101|NCT00481871|Angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
5287102|NCT00481871|Blastic NK lymphoma|blastic nk lymphoma
5287103|NCT00481871|Anaplastic large cell lymphoma|anaplastic large cell lymphoma
5287104|NCT00481871|T/NK-cell lymphoma|t/nk-cell lymphoma
5287105|NCT00481871|Enteropathy-type intestinal lymphoma|enteropathy-type intestinal lymphoma
5287106|NCT00481871|Hepatosplenic T-cell lymphoma|hepatosplenic t-cell lymphoma
5287107|NCT00481871|Extranodal peripheral T/NK-cell lymphoma|extranodal peripheral t/nk-cell lymphoma
5287108|NCT00481871|Subcutaneous panniculitis T-cell lymphoma|subcutaneous panniculitis t-cell lymphoma
5287109|NCT00481871|Transformed mycosis fungoides|transformed mycosis fungoides
5287110|NCT00481871|PDX|pdx
5287111|NCT00481871|Pralatrexate|pralatrexate
5287113|NCT00481871|Gemzar|gemzar
5287114|NCT00481871|Vitamin B12|vitamin b12
5287115|NCT00481871|Folic acid|folic acid
5287116|NCT00481858|chronic lymphocytic leukemia|chronic lymphocytic leukemia
5287117|NCT00481858|biomarker|biomarker
5287118|NCT00481858|prognosis|prognosis
5287119|NCT00481858|apoptosis|apoptosis
5287120|NCT00481858|neoplasm/cancer diagnosis|neoplasm/cancer diagnosis
5287121|NCT00481858|stable isotope|stable isotope
5287122|NCT00481858|diagnosis evaluation|diagnosis evaluation
5287123|NCT00481858|outcomes|outcomes
5287124|NCT00481858|CD19|cd19
5287125|NCT00481858|CD5|cd5
5287126|NCT00481819|Kidney Transplantation|kidney transplantation
5287127|NCT00481819|Tacrolimus|tacrolimus
5287128|NCT00481819|Methylprednisolone|methylprednisolone
5287129|NCT00481819|Prednisolone|prednisolone
5287130|NCT00481819|Mycophenolate Mofetil|mycophenolate mofetil
5287131|NCT00481806|Virchow's Triad|virchow's triad
5287132|NCT00481806|Thrombin|thrombin
5287133|NCT00481806|Graft Failure|graft failure
5287134|NCT00481793|Plutonium|plutonium
5287135|NCT00481793|Ionizing Radiation|ionizing radiation
5287136|NCT00481793|Polymorphism|polymorphism
5287137|NCT00481793|Biological Marker|biological marker
5287138|NCT00481793|Russia|russia
5287139|NCT00481767|Safety|safety
5287140|NCT00481767|Immunogenicity|immunogenicity
5287141|NCT00481767|Human Papillomavirus (HPV) vaccine|human papillomavirus (hpv) vaccine
5287142|NCT00481754|Endometrium|endometrium
5287143|NCT00481754|PTEN|pten
5287144|NCT00481754|Hormones|hormones
5287145|NCT00481754|Carcinogenesis|carcinogenesis
5287146|NCT00481754|Etiology|etiology
5287147|NCT00481754|Tissue Evaluation|tissue evaluation
5287148|NCT00481754|Questionnaire|questionnaire
5287149|NCT00481741|Angioplasty, Percutaneous TransluminalCoronary|angioplasty, percutaneous transluminalcoronary
5287150|NCT00481715|Web-Based Weight Loss Program|web-based weight loss program
5287151|NCT00481715|Cash Incentive Weight Loss Program|cash incentive weight loss program
5287152|NCT00481715|North Carolina|north carolina
5287153|NCT00481689|Cipro|cipro
5287154|NCT00481689|Complicated UTI|complicated uti
5287155|NCT00481689|Pseudomonas aeruginosa|pseudomonas aeruginosa
5287156|NCT00481676|Chronic urticaria, omalizumab, thyroperoxidase, IgE|chronic urticaria, omalizumab, thyroperoxidase, ige
5287157|NCT00481637|paraneoplastic; autoimmunity;|paraneoplastic; autoimmunity;
5287158|NCT00481624|advanced lung cancer|advanced lung cancer
5287159|NCT00481624|Procrit|procrit
5287160|NCT00481624|Epoetin Alfa|epoetin alfa
5287161|NCT00481624|Ferric Gluconate|ferric gluconate
5287162|NCT00481624|iron supplementation|iron supplementation
5287163|NCT00481611|Industry Hygiene|industry hygiene
5287164|NCT00481611|Molecular Epidemiology|molecular epidemiology
5287165|NCT00481611|Cancer Susceptibility|cancer susceptibility
5287166|NCT00481611|Genotoxicity|genotoxicity
5287167|NCT00481611|Immune Function|immune function
5287168|NCT00481611|Cancer Susceptability|cancer susceptability
5287169|NCT00481585|claudin|claudin
5287170|NCT00481585|electrophysiology|electrophysiology
5287171|NCT00481585|breast|breast
5287172|NCT00481585|screening|screening
5287173|NCT00481572|Sepsis|sepsis
5287174|NCT00481572|Septic Shock|septic shock
5287175|NCT00481572|vasopressin|vasopressin
5287176|NCT00481572|terlipressin|terlipressin
5287177|NCT00481559|Voraxaze|voraxaze
5287178|NCT00481559|glucarpidase|glucarpidase
5287179|NCT00481559|carboxypeptidase|carboxypeptidase
5287180|NCT00481559|cancer|cancer
5287181|NCT00481559|lymphoma|lymphoma
5287182|NCT00481559|leukemia|leukemia
5287183|NCT00481559|osteosarcoma|osteosarcoma
5287184|NCT00481559|methotrexate|methotrexate
5287185|NCT00481559|delayed elimination|delayed elimination
5287186|NCT00481559|renal insufficiency|renal insufficiency
5287187|NCT00481559|toxicity|toxicity
5287188|NCT00481546|Leber congenital amaurosis|leber congenital amaurosis
5287189|NCT00481546|LCA|lca
5287190|NCT00481546|RPE65|rpe65
5287191|NCT00481546|Retinal disease due to RPE65 mutations|retinal disease due to rpe65 mutations
5287192|NCT00481546|RPE65-associated Leber congenital amaurosis|rpe65-associated leber congenital amaurosis
5287193|NCT00481533|Cesarean Delivery|cesarean delivery
5287194|NCT00481533|Uterine Contractility|uterine contractility
5287195|NCT00481507|Probiotic|probiotic
5287196|NCT00481507|Cultured dairy drink|cultured dairy drink
5287197|NCT00481507|Health|health
5287198|NCT00481507|10 day antibiotic|10 day antibiotic
5287199|NCT00481507|Otherwise healthy|otherwise healthy
5287200|NCT00481494|Glaucoma|glaucoma
5287201|NCT00481494|Drug compliance|drug compliance
5287202|NCT00481494|Personality|personality
5287203|NCT00481481|Tacrolimus, Kidney Transplantation|tacrolimus, kidney transplantation
5287204|NCT00481468|Coronary artery disease|coronary artery disease
5287205|NCT00481468|chest pain|chest pain
5287206|NCT00481455|Glioblastoma Multiforme|glioblastoma multiforme
5287207|NCT00481455|temozolomide|temozolomide
5287208|NCT00481442|Septic shock|septic shock
5287209|NCT00481442|Sepsis|sepsis
5287210|NCT00481442|Norepinephrine|norepinephrine
5287211|NCT00481442|Phenylephrine|phenylephrine
5287212|NCT00481429|Biomarker|biomarker
5287213|NCT00481429|Glitazone|glitazone
5287214|NCT00481429|Diabetes|diabetes
5287316|NCT00481052|Nilotinib|nilotinib
5287215|NCT00481416|Esophageal Varices|esophageal varices
5287216|NCT00481416|PillCam Eso|pillcam eso
5287217|NCT00481416|Capsule Endoscopy|capsule endoscopy
5287218|NCT00481416|Given Imaging|given imaging
5287219|NCT00481416|Inscope|inscope
5287220|NCT00481403|Sperm, male fertility, microarrays|sperm, male fertility, microarrays
5287221|NCT00481390|HIV|hiv
5287222|NCT00481390|HLA-B*5701|hla-b*5701
5287223|NCT00481390|prevalence|prevalence
5287224|NCT00481390|Treatment Experienced|treatment experienced
5287225|NCT00481390|Treatment Naive|treatment naive
5287226|NCT00481377|Ablation|ablation
5287227|NCT00481377|Ventricular tachycardia|ventricular tachycardia
5287228|NCT00481377|coronary artery disease|coronary artery disease
5287229|NCT00481377|Implantable cardioverter defibrillator interventions|implantable cardioverter defibrillator interventions
5287230|NCT00481364|hemodialysis|hemodialysis
5287231|NCT00481364|endothelial function|endothelial function
5287232|NCT00481364|coronary artery calcification|coronary artery calcification
5287233|NCT00481364|atherosclerosis|atherosclerosis
5287234|NCT00481364|statin|statin
5287235|NCT00481351|artificial chilomicrons kinetics|artificial chilomicrons kinetics
5287236|NCT00481351|ezetimibe plus statin|ezetimibe plus statin
5287237|NCT00481351|lipid lowering therapy|lipid lowering therapy
5287238|NCT00481338|Cohort|cohort
5287239|NCT00481338|Quality of life|quality of life
5287240|NCT00481338|Health resource use|health resource use
5287241|NCT00481338|Disability|disability
5287242|NCT00481338|Prognosis|prognosis
5287243|NCT00481312|Initial Sedation|initial sedation
5287244|NCT00481312|Mechanical ventilation|mechanical ventilation
5287245|NCT00481299|Insulin|insulin
5287246|NCT00481299|glucose|glucose
5287247|NCT00481299|lipids|lipids
5287248|NCT00481299|prolactinoma|prolactinoma
5287249|NCT00481299|hyperprolactinemia|hyperprolactinemia
5287250|NCT00481286|Group clinics|group clinics
5287251|NCT00481286|Goal setting|goal setting
5287252|NCT00481286|Diabetes|diabetes
5287253|NCT00481286|Hypertension|hypertension
5287254|NCT00481286|Age 50+|age 50+
5287255|NCT00481273|MDS|mds
5287256|NCT00481260|Hgb C|hgb c
5287257|NCT00481260|Screening|screening
5287258|NCT00481247|Chronic Phase Philadelphia Chromosome Positive Chronic Myeloid Leukemia|chronic phase philadelphia chromosome positive chronic myeloid leukemia
5287259|NCT00481234|Anesthesia, General|anesthesia, general
5287260|NCT00481234|Abnormalities, Cardiovascular|abnormalities, cardiovascular
5287261|NCT00481234|Heart Rate|heart rate
5287262|NCT00481234|Forecasting|forecasting
5287263|NCT00481221|Thalassemia|thalassemia
5287264|NCT00481221|Iron Deficiency|iron deficiency
5287265|NCT00481221|Carrier screening|carrier screening
5287266|NCT00481208|open-angle glaucoma|open-angle glaucoma
5287267|NCT00481208|diurnal fluctuation|diurnal fluctuation
5287268|NCT00481208|intraocular pressure|intraocular pressure
5287269|NCT00481208|peripapillary retinal blood flow|peripapillary retinal blood flow
5287270|NCT00481208|latent asymmetric intraocular pressure|latent asymmetric intraocular pressure
5287271|NCT00481182|PK|pk
5287272|NCT00481182|PD|pd
5287273|NCT00481182|FPV|fpv
5287274|NCT00481182|RTV|rtv
5287275|NCT00481182|APV|apv
5287276|NCT00481182|ritonavir|ritonavir
5287277|NCT00481182|fosamprenavir|fosamprenavir
5287278|NCT00481182|amprenavir|amprenavir
5287279|NCT00481182|methadone|methadone
5287280|NCT00481182|pharmacokinetics|pharmacokinetics
5287281|NCT00481182|pharmacodynamics|pharmacodynamics
5287282|NCT00481169|Postmenopausal Osteoporosis|postmenopausal osteoporosis
5287283|NCT00481143|Myelodysplastic Syndrome|myelodysplastic syndrome
5287284|NCT00481143|MDS|mds
5287285|NCT00481143|iron overload|iron overload
5287286|NCT00481143|chelation|chelation
5287287|NCT00481143|chelators|chelators
5287288|NCT00481143|ICL670|icl670
5287289|NCT00481143|Deferasirox|deferasirox
5287290|NCT00481143|serum ferritin|serum ferritin
5287291|NCT00481143|LIC|lic
5287292|NCT00481143|transfusional hemosiderosis|transfusional hemosiderosis
5287293|NCT00481143|Refractory Anemia|refractory anemia
5287294|NCT00481143|RA|ra
5287295|NCT00481143|Refractory Anemia with Ringed Sideroblasts|refractory anemia with ringed sideroblasts
5287296|NCT00481143|RARS|rars
5287297|NCT00481143|blood transfusions|blood transfusions
5287298|NCT00481143|Mydelodysplastic Syndrome(s)|mydelodysplastic syndrome(s)
5287299|NCT00481130|Alport Syndrome|alport syndrome
5287300|NCT00481130|x linked|x linked
5287301|NCT00481130|autosomal dominant Alport syndrome|autosomal dominant alport syndrome
5287302|NCT00481130|glomerular basement membrane|glomerular basement membrane
5287303|NCT00481130|hereditary nephritis|hereditary nephritis
5287304|NCT00481130|familial benign haematuria|familial benign haematuria
5287305|NCT00481130|type IV collagen|type iv collagen
5287306|NCT00481130|hereditary nephritis with neurosensory deafness|hereditary nephritis with neurosensory deafness
5287307|NCT00481130|vison loss|vison loss
5287308|NCT00481104|Obesity|obesity
5287309|NCT00481065|Bird flu|bird flu
5287310|NCT00481065|influenza vaccine|influenza vaccine
5287311|NCT00481065|Seasonal influenza vaccine|seasonal influenza vaccine
5287312|NCT00481065|Prepandemic vaccine|prepandemic vaccine
5287313|NCT00481052|Adult|adult
5287314|NCT00481052|CML|cml
5287315|NCT00481052|Philadelphia positive|philadelphia positive
5287317|NCT00481052|early chronic phase|early chronic phase
5287318|NCT00481052|untreated or treated only with Hydroxyurea or Anagrelide|untreated or treated only with hydroxyurea or anagrelide
5287319|NCT00481052|Chronic Myeloid Leukemia|chronic myeloid leukemia
5287320|NCT00481039|Sickle cell disease|sickle cell disease
5287321|NCT00481039|Sickle cell thalassemia|sickle cell thalassemia
5287322|NCT00481039|Population screening|population screening
5287323|NCT00481013|Spinal Muscular Atrophy|spinal muscular atrophy
5287324|NCT00481013|Adult|adult
5287325|NCT00481000|Dialectical Cognitive Therapy|dialectical cognitive therapy
5287326|NCT00481000|Clinical Psychology|clinical psychology
5287327|NCT00480987|High-Risk Myelodysplastic Syndromes|high-risk myelodysplastic syndromes
5287328|NCT00480987|Acute Myeloid Leukemia|acute myeloid leukemia
5287329|NCT00480987|Leukemia|leukemia
5287330|NCT00480987|Oxaliplatin|oxaliplatin
5287331|NCT00480987|Fludarabine|fludarabine
5287332|NCT00480987|Cytarabine|cytarabine
5287333|NCT00480987|AML|aml
5287334|NCT00480987|MDS|mds
5287335|NCT00480974|Sickle cell anemia|sickle cell anemia
5287336|NCT00480974|Sickle cell thalassemia|sickle cell thalassemia
5287337|NCT00480974|Hydroxyurea|hydroxyurea
5287338|NCT00480948|infant|infant
5287339|NCT00480948|infant formula|infant formula
5287340|NCT00480948|fatty acids|fatty acids
5287341|NCT00480948|palmitic acid|palmitic acid
5287342|NCT00480948|stool|stool
5287343|NCT00480948|calcium|calcium
5287344|NCT00480935|Localized|localized
5287345|NCT00480935|Renal Cell Carcinoma|renal cell carcinoma
5287346|NCT00480935|Neoadjuvant|neoadjuvant
5287347|NCT00480935|Sunitinib Malate (Sutent)|sunitinib malate (sutent)
5287348|NCT00480922|non-alcoholic fatty liver disease|non-alcoholic fatty liver disease
5287349|NCT00480922|steatohepatitis|steatohepatitis
5287350|NCT00480922|overweight|overweight
5287351|NCT00480922|insulin resistance|insulin resistance
5287352|NCT00480896|Dermatitis, atopic|dermatitis, atopic
5287353|NCT00480896|Tacrolimus|tacrolimus
5287354|NCT00480896|Child|child
5287355|NCT00480896|treatment outcomes|treatment outcomes
5287356|NCT00480883|cutaneous leishmaniasis of the old world|cutaneous leishmaniasis of the old world
5287357|NCT00480870|Alzheimer|alzheimer
5287358|NCT00480870|polysomnography|polysomnography
5287359|NCT00480870|REM sleep|rem sleep
5287360|NCT00480870|donepezil|donepezil
5287361|NCT00480870|sleep apnea|sleep apnea
5287362|NCT00480870|oxygen saturation|oxygen saturation
5287363|NCT00480857|Prostate|prostate
5287364|NCT00480857|Radiation|radiation
5287365|NCT00480844|schizophrenia|schizophrenia
5287366|NCT00480844|Sertindole|sertindole
5287367|NCT00480844|Risperidone|risperidone
5287368|NCT00480844|cognitive impairment|cognitive impairment
5287369|NCT00480831|NSCLC|nsclc
5287370|NCT00480831|Cancer|cancer
5287371|NCT00480831|Avastin|avastin
5287372|NCT00480831|APM4074g|apm4074g
5287373|NCT00480792|Hepatitis B vaccination|hepatitis b vaccination
5287374|NCT00480792|GenHevac-B Pasteur|genhevac-b pasteur
5287375|NCT00480792|HIV Infections|hiv infections
5287376|NCT00480779|Prediabetes|prediabetes
5287377|NCT00480779|Metabolic syndrome|metabolic syndrome
5287378|NCT00480779|Prevention|prevention
5287379|NCT00480779|Lifestyle intervention|lifestyle intervention
5287380|NCT00480766|Glucocorticoid|glucocorticoid
5287381|NCT00480753|Raynaud's phenomenon|raynaud's phenomenon
5287382|NCT00480753|Raynaud's Disease|raynaud's disease
5287383|NCT00480753|Raynaud's disease secondary to scleroderma|raynaud's disease secondary to scleroderma
5287384|NCT00480753|Raynaud's phenomenon secondary to autoimmune disease|raynaud's phenomenon secondary to autoimmune disease
5287385|NCT00480740|Dexmedetomidine|dexmedetomidine
5287386|NCT00480740|Congenital heart disease|congenital heart disease
5287387|NCT00480740|pharmacokinetics|pharmacokinetics
5287388|NCT00480740|pharmacodynamics|pharmacodynamics
5287389|NCT00480740|pediatric|pediatric
5287390|NCT00480740|Bidirectional cavopulmonary anastomosis|bidirectional cavopulmonary anastomosis
5287391|NCT00480740|Fontan physiology|fontan physiology
5287392|NCT00480740|Cardiac transplant|cardiac transplant
5287393|NCT00480727|Halo Thoracic Orthosis|halo thoracic orthosis
5287394|NCT00480727|Re-tension|re-tension
5287395|NCT00480727|Pin loosening|pin loosening
5287396|NCT00480714|TB|tb
5287397|NCT00480714|Vaccine|vaccine
5287398|NCT00480714|BCG|bcg
5287399|NCT00480701|Alzheimer|alzheimer
5287400|NCT00480701|Parkinson|parkinson
5287401|NCT00480701|dementia|dementia
5287402|NCT00480701|neurologic|neurologic
5287403|NCT00480688|TB|tb
5287404|NCT00480688|BCG|bcg
5287405|NCT00480675|bursitis|bursitis
5287406|NCT00480675|injection|injection
5287407|NCT00480675|fluoroscopy|fluoroscopy
5287408|NCT00480662|Paget's bone disease|paget's bone disease
5287409|NCT00480649|SERETIDE|seretide
5287410|NCT00480649|asthma|asthma
5287411|NCT00480649|Korean|korean
5287412|NCT00480649|ACT|act
5287413|NCT00480623|Prostate Cancer|prostate cancer
5287414|NCT00480623|Biochemical Failure|biochemical failure
5287415|NCT00480623|Radical Prostatectomy|radical prostatectomy
5287416|NCT00480610|Dermatitis, atopic|dermatitis, atopic
5287417|NCT00480610|Tacrolimus|tacrolimus
5287418|NCT00480610|Adult|adult
5287419|NCT00480610|treatment outcomes|treatment outcomes
5287420|NCT00480597|gemcitabine|gemcitabine
5287421|NCT00480597|vinorelbine|vinorelbine
5287422|NCT00480597|cisplatin|cisplatin
5287423|NCT00480597|capecitabine|capecitabine
5287424|NCT00480597|pretreated metastatic breast cancer|pretreated metastatic breast cancer
5287425|NCT00480584|pancreatic|pancreatic
5287426|NCT00480584|gemcitabine|gemcitabine
5287427|NCT00480584|erlotinib (HER1/epidermal growth factor receptor [EGFR] tyrosine kinase inhibitor)|erlotinib (her1/epidermal growth factor receptor [egfr] tyrosine kinase inhibitor)
5287428|NCT00480584|capecitabine|capecitabine
5287429|NCT00480571|chronic schizophrenia or schizo-affective disorder|chronic schizophrenia or schizo-affective disorder
5287430|NCT00480558|HIV|hiv
5287431|NCT00480558|MVA85A|mva85a
5287432|NCT00480558|TB|tb
5287433|NCT00480558|Tuberculosis|tuberculosis
5287434|NCT00480558|Human Immunodeficiency Virus|human immunodeficiency virus
5287435|NCT00480558|Safety|safety
5287436|NCT00480558|Immunogenicity|immunogenicity
5287437|NCT00480558|Efficacy|efficacy
5287438|NCT00480558|Treatment Naive|treatment naive
5287439|NCT00480545|Women with bleeding disorders|women with bleeding disorders
5287440|NCT00480545|Menstrual cycle|menstrual cycle
5287441|NCT00480545|Women|women
5287442|NCT00480545|Healthy volunteers|healthy volunteers
5287443|NCT00480532|birth control|birth control
5287444|NCT00480532|continuous contraception|continuous contraception
5287445|NCT00480532|break-through bleeding|break-through bleeding
5287446|NCT00480519|meatotomy|meatotomy
5287447|NCT00480519|meatal stenosis|meatal stenosis
5287448|NCT00480519|local anaesthesia|local anaesthesia
5287449|NCT00480519|feasibility|feasibility
5287450|NCT00480519|pain control|pain control
5287451|NCT00480506|chimerism|chimerism
5287452|NCT00480506|allogenic hematopoietic transplantation|allogenic hematopoietic transplantation
5287453|NCT00480506|assay|assay
5287454|NCT00480480|Trauma|trauma
5287455|NCT00480480|Grief|grief
5287456|NCT00480480|Depression|depression
5287457|NCT00480480|Adolescent|adolescent
5287458|NCT00480480|War|war
5287459|NCT00480480|Group|group
5287460|NCT00480480|Therapy|therapy
5287461|NCT00480480|Treatment|treatment
5287462|NCT00480480|Intervention|intervention
5287463|NCT00480480|School|school
5287464|NCT00480480|Development|development
5287465|NCT00480454|TB|tb
5287466|NCT00480454|Tuberculosis|tuberculosis
5287467|NCT00480454|Infants|infants
5287468|NCT00480454|EPI|epi
5287469|NCT00480441|Marijuana|marijuana
5287470|NCT00480441|Addiction|addiction
5287471|NCT00480441|Substance Withdrawal Syndrome|substance withdrawal syndrome
5287472|NCT00480441|Clinical Trial|clinical trial
5287473|NCT00480441|Dronabinol|dronabinol
5287474|NCT00480441|Behavioral Therapy|behavioral therapy
5287475|NCT00480441|Adults|adults
5287476|NCT00480441|Neuroimaging|neuroimaging
5287477|NCT00480441|Neuropsychological Testing|neuropsychological testing
5287478|NCT00480441|Neurocognitive Testing|neurocognitive testing
5287479|NCT00480441|Behavioral Probes|behavioral probes
5287480|NCT00480428|Radioactive Fallout|radioactive fallout
5287481|NCT00480428|Childhood Exposures|childhood exposures
5287482|NCT00480428|External Radiation Dose|external radiation dose
5287483|NCT00480428|Internal Radiation Dose to Thyroid Gland|internal radiation dose to thyroid gland
5287484|NCT00480428|Pasture-Dairy Animal- Milk- Thyroid Pathway|pasture-dairy animal- milk- thyroid pathway
5287485|NCT00480402|preterm birth|preterm birth
5287486|NCT00480402|progesterone|progesterone
5287487|NCT00480402|twins|twins
5287488|NCT00480402|Preterm birth in twin gestations|preterm birth in twin gestations
5287489|NCT00480389|Clear cell Renal cell carcinoma|clear cell renal cell carcinoma
5287490|NCT00480389|Metastatic|metastatic
5287491|NCT00480389|Sorafenib tosylate|sorafenib tosylate
5287492|NCT00480389|Preoperative treatment|preoperative treatment
5287493|NCT00480376|transrectal biopsy|transrectal biopsy
5287494|NCT00480376|prostate|prostate
5287495|NCT00480376|prophylaxis antibiotic|prophylaxis antibiotic
5287496|NCT00480363|Smoldering Multiple Myeloma|smoldering multiple myeloma
5287497|NCT00480363|PETHEMA|pethema
5287498|NCT00480363|Smoldering|smoldering
5287499|NCT00480350|HIV|hiv
5287500|NCT00480350|virological response|virological response
5287501|NCT00480350|CD4|cd4
5287502|NCT00480350|food supplement|food supplement
5287503|NCT00480350|Human Immunodeficiency Virus|human immunodeficiency virus
5287504|NCT00480350|Complementary Therapies|complementary therapies
5287505|NCT00480337|PCOS|pcos
5287506|NCT00480337|Fertility Preservation|fertility preservation
5287507|NCT00480337|Repeated IVF Failure|repeated ivf failure
5287508|NCT00480337|S/P Hyperstimulation|s/p hyperstimulation
5287509|NCT00480311|symptomatic|symptomatic
5287510|NCT00480311|lumbar spinal stenosis|lumbar spinal stenosis
5287511|NCT00480311|disability|disability
5287512|NCT00480311|fear avoidance beliefs|fear avoidance beliefs
5287513|NCT00480311|quality of life|quality of life
5287514|NCT00480285|Gastroesophageal reflux disease|gastroesophageal reflux disease
5287515|NCT00480285|Laparoscopic Nissen Fundoplication|laparoscopic nissen fundoplication
5287516|NCT00480285|Laparoscopic anterior partial fundoplication|laparoscopic anterior partial fundoplication
5287517|NCT00480272|rheumatoid arthritis|rheumatoid arthritis
5287518|NCT00480272|clinical remission|clinical remission
5287519|NCT00480259|blood urea nitrogen|blood urea nitrogen
5287520|NCT00480259|nitrogen balance|nitrogen balance
5287521|NCT00480259|nutrition|nutrition
5287522|NCT00480259|intensive care|intensive care
5287523|NCT00480246|receptor oocupancy|receptor oocupancy
5287524|NCT00480233|depression|depression
5287525|NCT00480233|screening|screening
5287526|NCT00480233|primary care|primary care
5287527|NCT00480233|validity|validity
5287528|NCT00480233|Hebrew|hebrew
5287529|NCT00480233|Primary care and general medical patients|primary care and general medical patients
5287530|NCT00480220|specific care|specific care
5287531|NCT00480220|assistance plan|assistance plan
5287532|NCT00480220|Alzheimer's disease|alzheimer's disease
5287533|NCT00480181|Neuropathic pain|neuropathic pain
5287534|NCT00480181|Multiple Sclerosis|multiple sclerosis
5287535|NCT00480181|Nabilone|nabilone
5287536|NCT00480181|Gabapentin|gabapentin
5287537|NCT00480168|child|child
5287538|NCT00480168|adolescent|adolescent
5287539|NCT00480168|weight gain|weight gain
5287540|NCT00480168|endocrine disruptors|endocrine disruptors
5287541|NCT00480129|grass allergies,|grass allergies,
5287542|NCT00480129|ragweed allergies,|ragweed allergies,
5287543|NCT00480129|probiotics, lactobacillus,|probiotics, lactobacillus,
5287544|NCT00480129|bifidobacterium,|bifidobacterium,
5287545|NCT00480129|functional foods,|functional foods,
5287546|NCT00480129|yogurt,|yogurt,
5287547|NCT00480129|inflammatory cytokines|inflammatory cytokines
5287548|NCT00480116|Consistency|consistency
5287549|NCT00480116|Immunogenicity|immunogenicity
5287550|NCT00480103|Embryo morphological and chromosomal features|embryo morphological and chromosomal features
5287551|NCT00480103|Implantation and pregnancy rate|implantation and pregnancy rate
5287552|NCT00480090|Prostate|prostate
5287553|NCT00480090|Androgen independent|androgen independent
5287554|NCT00480090|Phase II|phase ii
5287555|NCT00480090|Second line|second line
5287556|NCT00480090|Androgen-independent prostate cancer|androgen-independent prostate cancer
5287557|NCT00480077|Heart Failure, randomized, OptiVol® Fluid status monitoring|heart failure, randomized, optivol® fluid status monitoring
5287558|NCT00480064|AML|aml
5287559|NCT00480064|older patients|older patients
5287560|NCT00480064|lomustine|lomustine
5287561|NCT00480051|Cardiac Failure|cardiac failure
5287562|NCT00480051|Pacemaker|pacemaker
5287563|NCT00480051|Dyssynchrony|dyssynchrony
5287564|NCT00480051|Cardiac Magnetic Resonance|cardiac magnetic resonance
5287565|NCT00480051|Narrow QRS|narrow qrs
5287566|NCT00480038|symptomatic|symptomatic
5287567|NCT00480038|lumbar disc herniation|lumbar disc herniation
5287568|NCT00480038|disability|disability
5287569|NCT00480038|fear avoidance beliefs|fear avoidance beliefs
5287570|NCT00480038|quality of life|quality of life
5287571|NCT00480025|ASCI|asci
5287572|NCT00480025|Immunotherapeutic|immunotherapeutic
5287573|NCT00480025|MAGRIT|magrit
5287574|NCT00480025|Tumor antigen|tumor antigen
5287575|NCT00480025|Non-small-cell lung cancer|non-small-cell lung cancer
5287576|NCT00480025|Adjuvant cancer therapy|adjuvant cancer therapy
5287577|NCT00480012|healthy subjects|healthy subjects
5287578|NCT00479999|HIV-Negative|hiv-negative
5287579|NCT00479999|Healthy|healthy
5287580|NCT00479999|Immunity|immunity
5287581|NCT00479999|Preventive|preventive
5287582|NCT00479999|Virus|virus
5287583|NCT00479999|Healthy Volunteer|healthy volunteer
5287584|NCT00479999|HV|hv
5287585|NCT00479999|HIV Preventive Vaccine|hiv preventive vaccine
5287586|NCT00479986|diabetes mellitus|diabetes mellitus
5287587|NCT00479986|monocyte activation|monocyte activation
5287588|NCT00479986|cardiovascular risk|cardiovascular risk
5287589|NCT00479973|diabetes|diabetes
5287590|NCT00479973|non-insulin dependant diabetes|non-insulin dependant diabetes
5287591|NCT00479973|type 2 diabetes|type 2 diabetes
5287592|NCT00479973|cinnamon|cinnamon
5287593|NCT00479973|natural health product|natural health product
5287594|NCT00479973|hypercholesterolemia|hypercholesterolemia
5287595|NCT00479973|dyslipidemia|dyslipidemia
5287596|NCT00479973|elevated cholesterol|elevated cholesterol
5287597|NCT00479960|Asthenozoospermia|asthenozoospermia
5287598|NCT00479960|Azoospermia|azoospermia
5287599|NCT00479960|Oligospermia|oligospermia
5287600|NCT00479960|Omega-3|omega-3
5287601|NCT00479960|Fatty Acids|fatty acids
5287602|NCT00479947|Yeast vaginitis|yeast vaginitis
5287603|NCT00479947|Probiotics|probiotics
5287604|NCT00479947|Lactobacilli|lactobacilli
5287605|NCT00479947|Fluconazole|fluconazole
5287606|NCT00479934|scleroderma|scleroderma
5287607|NCT00479934|imatinib|imatinib
5287608|NCT00479934|PDGFR|pdgfr
5287609|NCT00479934|Rodnan|rodnan
5287610|NCT00479921|Influenza|influenza
5287611|NCT00479921|Vaccine|vaccine
5287612|NCT00479921|CHMP criteria|chmp criteria
5287613|NCT00479908|Blood pressure|blood pressure
5287614|NCT00479908|Angina|angina
5287615|NCT00479908|Sildenafil|sildenafil
5287616|NCT00479908|Phosphodiesterase type 5|phosphodiesterase type 5
5287617|NCT00479908|Organic nitrate|organic nitrate
5287618|NCT00479908|Glyceryl trinitrate|glyceryl trinitrate
5287619|NCT00479908|Drug interaction|drug interaction
5287620|NCT00479895|Percutaneous Coronary Intervention|percutaneous coronary intervention
5287621|NCT00479895|Myocardial Ischemia|myocardial ischemia
5287622|NCT00479895|Balloon Occlusion|balloon occlusion
5287623|NCT00479895|Catheter Lab|catheter lab
5287624|NCT00479856|ErbB1|erbb1
5287625|NCT00479856|ErbB2|erbb2
5287626|NCT00479856|GW572016|gw572016
5287627|NCT00479856|lapatinib|lapatinib
5287628|NCT00479856|Relapsed breast cancer|relapsed breast cancer
5287629|NCT00479856|dual tyrosine kinase inhibitor|dual tyrosine kinase inhibitor
5287630|NCT00479856|MBC|mbc
5287631|NCT00479856|EGFR|egfr
5287632|NCT00479856|Her-2/neu|her-2/neu
5287633|NCT00479856|FISH amplification|fish amplification
5287634|NCT00479843|Alzheimer Disease|alzheimer disease
5287635|NCT00479843|Dementia|dementia
5287636|NCT00479843|Elderly|elderly
5287637|NCT00479843|Nutrition|nutrition
5287638|NCT00479843|Malnutrition|malnutrition
5287639|NCT00479843|Weight Loss|weight loss
5287640|NCT00479830|Epidemiology|epidemiology
5287641|NCT00479830|Health Risks|health risks
5287642|NCT00479830|Questionnaire|questionnaire
5287643|NCT00479830|Interview|interview
5287644|NCT00479830|South Asian|south asian
5287645|NCT00479830|Asian Indian|asian indian
5287646|NCT00479830|Bangladeshi|bangladeshi
5287647|NCT00479830|Pakistani|pakistani
5287648|NCT00479830|Sri Lankan|sri lankan
5287649|NCT00479817|Advanced Recurrent Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer|advanced recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer
5287650|NCT00479804|indication for CMR|indication for cmr
5287651|NCT00479791|Type 2 diabetes mellitus|type 2 diabetes mellitus
5287652|NCT00479791|Fatty acids|fatty acids
5287653|NCT00479791|Postprandial response|postprandial response
5287654|NCT00479791|Insulin|insulin
5287655|NCT00479791|Glucose|glucose
5287656|NCT00479791|Triglycerides|triglycerides
5287657|NCT00479778|Postmenopause|postmenopause
5287658|NCT00479765|glioblastoma multiforme|glioblastoma multiforme
5287659|NCT00479765|recurrent|recurrent
5287660|NCT00479765|Phase 1|phase 1
5287661|NCT00479765|Phase 2|phase 2
5287662|NCT00479765|Phase I|phase i
5287663|NCT00479765|Phase II|phase ii
5287664|NCT00479765|brain|brain
5287665|NCT00479765|cancer|cancer
5287666|NCT00479765|paclitaxel|paclitaxel
5287667|NCT00479765|intracranial|intracranial
5287668|NCT00479765|tumor|tumor
5287669|NCT00479765|local|local
5287670|NCT00479765|chemotherapy|chemotherapy
5287671|NCT00479765|brain tumor|brain tumor
5287672|NCT00479765|brain cancer|brain cancer
5287673|NCT00479765|glioma|glioma
5287674|NCT00479765|OncoGel|oncogel
5287675|NCT00479739|formoterol/budesonide|formoterol/budesonide
5287676|NCT00479739|exacerbations|exacerbations
5287677|NCT00479739|Salmeterol/fluticasone propionate|salmeterol/fluticasone propionate
5287678|NCT00479739|adjustable maintenance dosing|adjustable maintenance dosing
5287679|NCT00479739|asthma control|asthma control
5287680|NCT00479713|High Cholesterol|high cholesterol
5287681|NCT00479687|Osteoarthritis|osteoarthritis
5287682|NCT00479687|Shoulder|shoulder
5287683|NCT00479687|HA|ha
5287684|NCT00479674|Metastatic Breast Cancer|metastatic breast cancer
5287685|NCT00479674|Advanced Breast Cancer|advanced breast cancer
5287686|NCT00479674|Hormone Receptor AND Her2/neu Negative|hormone receptor and her2/neu negative
5287687|NCT00479674|Triple Negative|triple negative
5287688|NCT00479674|Triple Negative Breast Cancer|triple negative breast cancer
5287689|NCT00479674|Stage IV or Inoperable Stage III Breast Cancer|stage iv or inoperable stage iii breast cancer
5287690|NCT00479661|initial sedation|initial sedation
5287691|NCT00479661|mechanical ventilation|mechanical ventilation
5287692|NCT00479635|HRPC|hrpc
5287693|NCT00479635|TPI 287|tpi 287
5287694|NCT00479635|Taxane|taxane
5287695|NCT00479635|MDR|mdr
5287696|NCT00479635|Hormone Refractory Prostate Cancer|hormone refractory prostate cancer
5287697|NCT00479622|Membranous Nephropathy|membranous nephropathy
5287698|NCT00479622|Systemic Lupus Erythematosus|systemic lupus erythematosus
5287699|NCT00479609|Insulin resistance|insulin resistance
5287700|NCT00479609|Glucose tolerance|glucose tolerance
5287701|NCT00479609|Type 2 diabetes|type 2 diabetes
5287702|NCT00479609|Androgen sensitivity|androgen sensitivity
5287703|NCT00479596|Overactive Bladder|overactive bladder
5287704|NCT00479596|OAB|oab
5287705|NCT00479596|Refractory OAB|refractory oab
5287706|NCT00479596|Botox|botox
5287707|NCT00479596|Bladder|bladder
5287708|NCT00479583|Cancer (solid tumors)|cancer (solid tumors)
5287709|NCT00479557|Alzheimer's Disease|alzheimer's disease
5287710|NCT00479557|active immunization|active immunization
5287711|NCT00479531|Restless Legs Syndrome|restless legs syndrome
5287712|NCT00479531|Sequential Compression Device|sequential compression device
5287713|NCT00479531|Sleep Quality|sleep quality
5287714|NCT00479531|Quality of Life|quality of life
5287715|NCT00479518|stroke|stroke
5287716|NCT00479518|transient ischemic attack|transient ischemic attack
5287717|NCT00479518|albuminuria|albuminuria
5287718|NCT00479518|BNP|bnp
5287719|NCT00479518|Cystatin C|cystatin c
5287720|NCT00479492|Obesity, weight loss|obesity, weight loss
5287721|NCT00479479|cobalamin|cobalamin
5287722|NCT00479479|methylmalonic acid|methylmalonic acid
5287723|NCT00479479|homocysteine|homocysteine
5287724|NCT00479479|folate|folate
5287725|NCT00479479|newborns|newborns
5287726|NCT00479479|infants|infants
5287727|NCT00479479|Deficiency Disease|deficiency disease
5287728|NCT00479479|Breastfeeding|breastfeeding
5287729|NCT00479479|Infant|infant
5287730|NCT00479427|osteoarthritis pain assessments|osteoarthritis pain assessments
5287731|NCT00479375|screening|screening
5287732|NCT00479375|human papillomavirus|human papillomavirus
5287733|NCT00479362|Pacemaker|pacemaker
5287734|NCT00479362|Cardioverter-defibrillator|cardioverter-defibrillator
5287735|NCT00479362|Hemorrhage|hemorrhage
5287736|NCT00479362|Hematoma|hematoma
5287737|NCT00479362|Thrombosis|thrombosis
5287738|NCT00479362|Embolism|embolism
5287739|NCT00479336|OPC-41061|opc-41061
5287740|NCT00479336|Tolvaptan|tolvaptan
5287741|NCT00479336|ascites|ascites
5287742|NCT00479336|Cirrhosis|cirrhosis
5287743|NCT00479323|pneumococcal vaccine, Pneumovax, reference sera, serum 89SF|pneumococcal vaccine, pneumovax, reference sera, serum 89sf
5287744|NCT00479284|Non-invasive ventilation|non-invasive ventilation
5287745|NCT00479284|Polysomnography|polysomnography
5287746|NCT00479284|Average volume assured pressure support|average volume assured pressure support
5287747|NCT00479271|RCT|rct
5287748|NCT00479271|Dementia|dementia
5287749|NCT00479271|community trial|community trial
5287750|NCT00479271|Homebased care|homebased care
5287751|NCT00479271|caregiver burden|caregiver burden
5287752|NCT00479271|Behavioural problems|behavioural problems
5287753|NCT00479271|Dementia in subjects|dementia in subjects
5287754|NCT00479271|behavioral problems in subjects|behavioral problems in subjects
5287755|NCT00479271|Mental health of carers|mental health of carers
5287756|NCT00479245|nonspecific low back pain|nonspecific low back pain
5287757|NCT00479245|disability|disability
5287758|NCT00479245|fear avoidance beliefs|fear avoidance beliefs
5287759|NCT00479245|quality of life|quality of life
5287760|NCT00479232|Leukemia|leukemia
5287761|NCT00479232|Myelocytic|myelocytic
5287762|NCT00479232|Acute Myelodysplastic Syndromes|acute myelodysplastic syndromes
5287763|NCT00479206|artesuante|artesuante
5287764|NCT00479206|falciparum malaria|falciparum malaria
5287765|NCT00479206|Cambodia|cambodia
5287766|NCT00479206|Artemisinin resistance|artemisinin resistance
5287767|NCT00479193|Burns|burns
5287768|NCT00479193|Dressing change|dressing change
5287769|NCT00479180|Hemodialysis access|hemodialysis access
5287770|NCT00479180|Arteriovenous graft|arteriovenous graft
5287771|NCT00479180|Arteriovenous fistula|arteriovenous fistula
5287772|NCT00479180|End stage renal disease|end stage renal disease
5287773|NCT00479167|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
5287774|NCT00479167|Follicular Non-Hodgkin's Lymphoma|follicular non-hodgkin's lymphoma
5287775|NCT00479167|Lymphoma|lymphoma
5287776|NCT00479154|Restless Leg Syndrome|restless leg syndrome
5287777|NCT00479154|Botulinum Toxin|botulinum toxin
5287778|NCT00479154|RLS|rls
5287779|NCT00479141|Treatment Naive|treatment naive
5287780|NCT00479141|Treatment Experienced|treatment experienced
5287781|NCT00479141|Complementary Therapies|complementary therapies
5287782|NCT00479128|Solid Tumor|solid tumor
5287783|NCT00479128|Bladder Cancer|bladder cancer
5287784|NCT00479128|Ureteral Cancer|ureteral cancer
5287785|NCT00479128|Urothelial Cancer|urothelial cancer
5287786|NCT00479128|Urethral Cancer|urethral cancer
5287787|NCT00479128|Renal Pelvis Tumor|renal pelvis tumor
5287788|NCT00479128|Bortezomib|bortezomib
5287789|NCT00479128|Gemcitabine|gemcitabine
5287790|NCT00479128|Doxorubicin|doxorubicin
5287791|NCT00479128|Gemzar|gemzar
5287792|NCT00479128|Adriamycin|adriamycin
5287793|NCT00479128|Velcade|velcade
5287794|NCT00479128|LDP-341|ldp-341
5287795|NCT00479128|MLN341|mln341
5287796|NCT00479128|PS-341|ps-341
5287797|NCT00479128|Gemcitabine Hydrochloride|gemcitabine hydrochloride
5287798|NCT00479128|AD|ad
5287799|NCT00479128|Hydroxydaunomycin hydrochloride|hydroxydaunomycin hydrochloride
5287800|NCT00479102|Iron supplementation|iron supplementation
5287801|NCT00479102|Babies|babies
5287802|NCT00479102|Prevention|prevention
5287803|NCT00479089|Transitional Cell Carcinoma|transitional cell carcinoma
5287804|NCT00479089|Urothelium|urothelium
5287805|NCT00479089|Urothelial Cancer|urothelial cancer
5287806|NCT00479089|Bladder Cancer|bladder cancer
5287807|NCT00479089|Docetaxel|docetaxel
5287808|NCT00479089|Taxotere|taxotere
5287809|NCT00479089|ZD1839|zd1839
5287810|NCT00479089|Gefitinib|gefitinib
5287811|NCT00479089|Iressa|iressa
5287812|NCT00479089|Consolidation Therapy|consolidation therapy
5287813|NCT00479076|antineoplastic agents|antineoplastic agents
5287814|NCT00479076|VEGF Trap|vegf trap
5287815|NCT00479063|MODIC changes|modic changes
5287816|NCT00479063|chronic low back pain|chronic low back pain
5287817|NCT00479063|magnetic resonance imaging (MRI)|magnetic resonance imaging (mri)
5287818|NCT00479063|vertebrae|vertebrae
5287819|NCT00479063|intervertebral disc|intervertebral disc
5287820|NCT00479050|Hepatocellular carcinoma,treatment|hepatocellular carcinoma,treatment
5287821|NCT00479037|postmenopausal women with primary osteoporosis|postmenopausal women with primary osteoporosis
5287822|NCT00479011|fluid management|fluid management
5287823|NCT00479011|arterial pulse pressure variation|arterial pulse pressure variation
5287824|NCT00479011|high-risk surgery|high-risk surgery
5287825|NCT00478998|expulsion therapy|expulsion therapy
5287826|NCT00478998|tamsulosin|tamsulosin
5287827|NCT00478998|ureterolithiasis|ureterolithiasis
5287828|NCT00478998|stents|stents
5287829|NCT00478985|Leukemia|leukemia
5287830|NCT00478985|Adult Chronic|adult chronic
5287831|NCT00478985|Myeloid|myeloid
5287832|NCT00478972|obese|obese
5287833|NCT00478972|diabetes|diabetes
5287834|NCT00478972|cannabinoid-1 receptor|cannabinoid-1 receptor
5287835|NCT00478959|Lenalidomide|lenalidomide
5287836|NCT00478959|Revlimid|revlimid
5287837|NCT00478959|Hodgkin's|hodgkin's
5287838|NCT00478959|Hodgkin|hodgkin
5287839|NCT00478959|Hodgkin's Lymphoma|hodgkin's lymphoma
5287840|NCT00478959|Hodgkin's Disease|hodgkin's disease
5287841|NCT00478959|Lymphoma|lymphoma
5287842|NCT00478946|colorectal cancer|colorectal cancer
5287843|NCT00478946|picoplatin|picoplatin
5287844|NCT00478946|FOLFOX|folfox
5287845|NCT00478946|FOLPI|folpi
5287846|NCT00478946|chemotherapy|chemotherapy
5287847|NCT00478933|Arrhythmia|arrhythmia
5287848|NCT00478933|Ventricular|ventricular
5287849|NCT00478933|Atrial|atrial
5287850|NCT00478933|Tachycardia|tachycardia
5287851|NCT00478933|Fibrillation|fibrillation
5287852|NCT00478933|Flutter|flutter
5287853|NCT00478933|GNB3|gnb3
5287854|NCT00478933|GNAS|gnas
5287855|NCT00478933|GNAQ|gnaq
5287856|NCT00478907|oculocardiac reflex; strabismus surgery;|oculocardiac reflex; strabismus surgery;
5287857|NCT00478894|Anterior cruciate ligament / injuries|anterior cruciate ligament / injuries
5287858|NCT00478894|Anterior cruciate ligament / surgery|anterior cruciate ligament / surgery
5287859|NCT00478894|knee injuries / surgery|knee injuries / surgery
5287860|NCT00478894|outcomes research|outcomes research
5287861|NCT00478894|prospective studies|prospective studies
5287862|NCT00478894|osteoarthritis|osteoarthritis
5287863|NCT00478868|MODIC changes|modic changes
5287864|NCT00478868|chronic low back pain|chronic low back pain
5287865|NCT00478868|magnetic resonance imaging (MRI)|magnetic resonance imaging (mri)
5287866|NCT00478868|vertebrae|vertebrae
5287867|NCT00478868|intervertebral disc|intervertebral disc
5287868|NCT00478842|Gilles de la Tourette syndrome|gilles de la tourette syndrome
5287869|NCT00478842|Deep brain stimulation|deep brain stimulation
5287870|NCT00478842|Globus PALLIDUS|globus pallidus
5287871|NCT00478816|Bird flu|bird flu
5287872|NCT00478816|influenza vaccine|influenza vaccine
5287873|NCT00478816|prepandemic vaccine|prepandemic vaccine
5287874|NCT00478803|Standardized surgical procedure|standardized surgical procedure
5287875|NCT00478803|Aortic root aneurysm|aortic root aneurysm
5287876|NCT00478803|Dystrophic aortic insufficiency|dystrophic aortic insufficiency
5287877|NCT00478803|Conservative aortic valve surgery|conservative aortic valve surgery
5287878|NCT00478803|Aortic annuloplasty|aortic annuloplasty
5287879|NCT00478803|Mechanical aortic valve replacement|mechanical aortic valve replacement
5287880|NCT00478803|Sinus of Valsalva|sinus of valsalva
5287881|NCT00478803|Cardiac Surgical Procedures|cardiac surgical procedures
5287882|NCT00478790|Glaucoma|glaucoma
5287883|NCT00478790|Pterygium|pterygium
5287884|NCT00478790|collagen matrix|collagen matrix
5287885|NCT00478790|OculusGen|oculusgen
5287886|NCT00478790|trabeculectomy|trabeculectomy
5287887|NCT00478790|Anti scarring|anti scarring
5287888|NCT00478790|pterygium recurrence|pterygium recurrence
5287889|NCT00478790|tissue engineering|tissue engineering
5287890|NCT00478790|ologen|ologen
5287891|NCT00478790|Aeon Astron|aeon astron
5287892|NCT00478777|CC-5013|cc-5013
5287893|NCT00478777|Revlimid|revlimid
5287894|NCT00478777|Lenalidomide|lenalidomide
5287895|NCT00478777|Celgene|celgene
5287896|NCT00478777|Multiple Myeloma|multiple myeloma
5287897|NCT00478764|intraocular|intraocular
5287898|NCT00478764|triamcinolone|triamcinolone
5287899|NCT00478764|gatifloxicin|gatifloxicin
5287900|NCT00478764|inflammation|inflammation
5287901|NCT00478764|visual acuity|visual acuity
5287902|NCT00478751|Visible light, Long UVA,Pigmentation|visible light, long uva,pigmentation
5287903|NCT00478751|Normal healthy volunteers with dark skin type.|normal healthy volunteers with dark skin type.
5287904|NCT00478738|b-agonist,|b-agonist,
5287905|NCT00478738|COPD.|copd.
5287906|NCT00478738|pharmacodynamic,|pharmacodynamic,
5287907|NCT00478738|pharmacokinetic,|pharmacokinetic,
5287908|NCT00478738|anti muscarinic,|anti muscarinic,
5287909|NCT00478725|Metastatic Cancer|metastatic cancer
5287910|NCT00478725|Advanced Cancer|advanced cancer
5287911|NCT00478712|Hirschsprung|hirschsprung
5287912|NCT00478699|SCAT|scat
5287913|NCT00478699|BRCA1|brca1
5287914|NCT00478699|BRCA1 mRNA Levels|brca1 mrna levels
5287915|NCT00478699|ADJUVANT|adjuvant
5287916|NCT00478699|LUNG|lung
5287917|NCT00478699|GECP-SCAT|gecp-scat
5287918|NCT00478686|Breast Cancer|breast cancer
5287919|NCT00478686|Dihydropyrimidine Dehydrogenase|dihydropyrimidine dehydrogenase
5287920|NCT00478686|DPYD|dpyd
5287921|NCT00478686|DPYD Variants|dpyd variants
5287922|NCT00478686|Toxicity|toxicity
5287923|NCT00478686|Capecitabine|capecitabine
5287924|NCT00478686|Xeloda|xeloda
5287925|NCT00478673|NexStent|nexstent
5287926|NCT00478673|FilterWire EZ|filterwire ez
5287927|NCT00478673|Boston Scientific|boston scientific
5287928|NCT00478673|Carotid Artery|carotid artery
5287929|NCT00478673|Carotid Endarterectomy|carotid endarterectomy
5287930|NCT00478673|Carotid Revascularization|carotid revascularization
5287931|NCT00478647|Enzyme Replacement Therapy|enzyme replacement therapy
5287932|NCT00478647|Gaucher disease|gaucher disease
5287933|NCT00478647|glucocerebrosidase|glucocerebrosidase
5287934|NCT00478647|beta-glucocerebrosidase|beta-glucocerebrosidase
5287935|NCT00478647|Acid beta-glucocerebrosidase|acid beta-glucocerebrosidase
5287936|NCT00478647|glucosylceramidase|glucosylceramidase
5287937|NCT00478647|D-glucosyl-N-acylsphingosine glucohydrolase|d-glucosyl-n-acylsphingosine glucohydrolase
5287938|NCT00478647|gene activation|gene activation
5287939|NCT00478647|human|human
5287940|NCT00478634|Colorectal Cancer|colorectal cancer
5287941|NCT00478634|Colorectal Carcinoma|colorectal carcinoma
5287942|NCT00478634|Colorectal Tumors|colorectal tumors
5287943|NCT00478634|Neoplasms, Colorectal|neoplasms, colorectal
5287944|NCT00478621|HPV|hpv
5287945|NCT00478595|obese|obese
5287946|NCT00478595|diabetes|diabetes
5287947|NCT00478595|cannabinoid-1 receptor|cannabinoid-1 receptor
5287948|NCT00478582|Anemia|anemia
5287949|NCT00478582|Visual scale|visual scale
5287950|NCT00478582|nephrological patients|nephrological patients
5287951|NCT00478582|Anemia in nephrological patients|anemia in nephrological patients
5287952|NCT00478556|CT scan|ct scan
5287953|NCT00478556|oral contrast|oral contrast
5287954|NCT00478543|Loop diuretics|loop diuretics
5287955|NCT00478543|Chronic Kidney Disease|chronic kidney disease
5287956|NCT00478543|Hypertension|hypertension
5287957|NCT00478543|Blood pressure control|blood pressure control
5287958|NCT00478543|Left ventricular mass|left ventricular mass
5287959|NCT00478517|Spinal trauma|spinal trauma
5287960|NCT00478517|erythropoietin|erythropoietin
5287961|NCT00478517|dose escalation study|dose escalation study
5287962|NCT00478504|anovulation|anovulation
5287963|NCT00478504|ovulation induction,|ovulation induction,
5287964|NCT00478504|polycystic ovarian syndrome|polycystic ovarian syndrome
5287965|NCT00478504|clomifene citrate|clomifene citrate
5287966|NCT00478504|letrozole|letrozole
5287967|NCT00478478|Stroke|stroke
5287968|NCT00478478|Ischemic|ischemic
5287969|NCT00478478|Thrombus|thrombus
5287970|NCT00478478|Embolectomy|embolectomy
5287971|NCT00478478|Thrombectomy|thrombectomy
5287972|NCT00478478|Merci|merci
5287973|NCT00478478|Concentric|concentric
5287974|NCT00478478|Embolus|embolus
5287975|NCT00478478|Embolism|embolism
5287976|NCT00478478|Mechanical|mechanical
5287977|NCT00478465|chronic fatigue syndrome|chronic fatigue syndrome
5287978|NCT00478465|fatigue|fatigue
5287979|NCT00478465|valganciclovir|valganciclovir
5287980|NCT00478465|valcyte|valcyte
5287981|NCT00478465|Epstein-Barr virus|epstein-barr virus
5287982|NCT00478465|EBV|ebv
5287983|NCT00478465|Human herpes virus 6|human herpes virus 6
5287984|NCT00478465|HHV 6|hhv 6
5287985|NCT00478465|herpes viruses|herpes viruses
5287986|NCT00478465|herpes|herpes
5287987|NCT00478439|aging|aging
5287988|NCT00478439|age-related macular degeneration|age-related macular degeneration
5287989|NCT00478439|macular pigment|macular pigment
5287990|NCT00478439|dark adaptation|dark adaptation
5287991|NCT00478400|Recovery|recovery
5287992|NCT00478400|Magnetic resonance imaging|magnetic resonance imaging
5287993|NCT00478400|Awareness|awareness
5287994|NCT00478400|Neurologic deficits|neurologic deficits
5287995|NCT00478387|Advanced Ovarian and Primary Peritoneal Cancer in Remission|advanced ovarian and primary peritoneal cancer in remission
5287996|NCT00478348|Postoperative Complications|postoperative complications
5287997|NCT00478348|Drainage|drainage
5287998|NCT00478348|Infection|infection
5287999|NCT00478348|Seroma|seroma
5288000|NCT00478348|Hematoma|hematoma
5288001|NCT00478348|Recurrence|recurrence
5288002|NCT00478348|Abdominal Wall|abdominal wall
5288003|NCT00478348|Hernia|hernia
5288004|NCT00478348|Surgical Mesh|surgical mesh
5288005|NCT00478335|congenital nephrogenic diabetes insipidus|congenital nephrogenic diabetes insipidus
5288006|NCT00478335|polyuria|polyuria
5288007|NCT00478335|urine osmolality|urine osmolality
5288008|NCT00478335|aquaporin-2|aquaporin-2
5288009|NCT00478335|vasopressin V2 receptor|vasopressin v2 receptor
5288010|NCT00478322|Diabetes;|diabetes;
5288011|NCT00478322|Type II diabetes;|type ii diabetes;
5288012|NCT00478322|Non-insulin dependent diabetes;|non-insulin dependent diabetes;
5288013|NCT00478322|Obesity|obesity
5288014|NCT00478309|colon cancer|colon cancer
5288015|NCT00478309|rectal cancer|rectal cancer
5288016|NCT00478309|healthy, no evidence of disease|healthy, no evidence of disease
5288017|NCT00478296|Pulmonary hypertension|pulmonary hypertension
5288018|NCT00478296|Sildenafil|sildenafil
5288019|NCT00478296|Bosentan|bosentan
5288020|NCT00478296|Trisomy 21|trisomy 21
5288021|NCT00478296|Atrial septal defect|atrial septal defect
5288022|NCT00478283|breast cancer|breast cancer
5288023|NCT00478257|fatigue|fatigue
5288024|NCT00478257|sleep|sleep
5288025|NCT00478257|quality of life|quality of life
5288026|NCT00478257|light|light
5288027|NCT00478257|cancer|cancer
5288028|NCT00478244|epidermolysis bullosa|epidermolysis bullosa
5288029|NCT00478244|dystrophic epidermolysis bullosa|dystrophic epidermolysis bullosa
5288030|NCT00478231|Multicenter|multicenter
5288031|NCT00478231|Open Label|open label
5288032|NCT00478231|Non-Comparative Safety Study Of Maraviroc|non-comparative safety study of maraviroc
5288033|NCT00478231|Treatment Experienced|treatment experienced
5288034|NCT00478218|stage I multiple myeloma|stage i multiple myeloma
5288035|NCT00478218|stage II multiple myeloma|stage ii multiple myeloma
5288036|NCT00478218|stage III multiple myeloma|stage iii multiple myeloma
5288037|NCT00478205|Moderate to Severe Alzheimer's Disease|moderate to severe alzheimer's disease
5288038|NCT00478192|hyponatremia|hyponatremia
5288039|NCT00478192|hypervolemic|hypervolemic
5288040|NCT00478192|euvolemic|euvolemic
5288041|NCT00478192|edematous|edematous
5288042|NCT00478192|conivaptan|conivaptan
5288043|NCT00478179|herpes zoster|herpes zoster
5288044|NCT00478179|shingles|shingles
5288045|NCT00478179|PHN|phn
5288046|NCT00478179|post herpetic neuralgia|post herpetic neuralgia
5288047|NCT00478179|neuropathic pain|neuropathic pain
5288048|NCT00478114|Renal Cell Carcinoma|renal cell carcinoma
5288049|NCT00478114|Sorafenib|sorafenib
5288050|NCT00478101|Pain|pain
5288051|NCT00478088|Single Level|single level
5288052|NCT00478088|Cervical Disc Disease|cervical disc disease
5288053|NCT00478075|stage I multiple myeloma|stage i multiple myeloma
5288054|NCT00478075|stage II multiple myeloma|stage ii multiple myeloma
5288055|NCT00478075|stage III multiple myeloma|stage iii multiple myeloma
5288056|NCT00478075|refractory multiple myeloma|refractory multiple myeloma
5288057|NCT00478062|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
5288058|NCT00478062|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
5288059|NCT00478062|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5288060|NCT00478062|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5288061|NCT00478049|Non-Small Cell Lung Cancer|non-small cell lung cancer
5288062|NCT00478036|glaucoma|glaucoma
5288063|NCT00478036|selective laser trabeculoplasty|selective laser trabeculoplasty
5288064|NCT00478036|anterior chamber flare|anterior chamber flare
5288065|NCT00478023|Opioid|opioid
5288066|NCT00478023|Central acting analgesic|central acting analgesic
5288067|NCT00478023|Pain postoperative|pain postoperative
5288068|NCT00478023|Abdomen acute|abdomen acute
5288069|NCT00478023|CG5503 IR|cg5503 ir
5288070|NCT00478023|Morphine|morphine
5288071|NCT00478023|Placebo|placebo
5288072|NCT00478010|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
5288073|NCT00478010|stage III colon cancer|stage iii colon cancer
5288074|NCT00478010|stage IV colon cancer|stage iv colon cancer
5288075|NCT00478010|stage III rectal cancer|stage iii rectal cancer
5288076|NCT00478010|stage IV rectal cancer|stage iv rectal cancer
5288077|NCT00478010|stage II pancreatic cancer|stage ii pancreatic cancer
5288078|NCT00478010|stage III pancreatic cancer|stage iii pancreatic cancer
5288079|NCT00478010|stage IV pancreatic cancer|stage iv pancreatic cancer
5288080|NCT00477997|Growth Hormone|growth hormone
5288081|NCT00477997|Insulin Signaling|insulin signaling
5288082|NCT00477997|GH signaling|gh signaling
5288083|NCT00477984|Alcohol|alcohol
5288084|NCT00477984|Driving|driving
5288085|NCT00477984|Multitasking|multitasking
5288086|NCT00477984|ERP|erp
5288087|NCT00477984|social drinkers|social drinkers
5288088|NCT00477971|primary systemic amyloidosis|primary systemic amyloidosis
5288089|NCT00477958|cognitive/functional effects|cognitive/functional effects
5288090|NCT00477958|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
5288091|NCT00477958|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5288092|NCT00477945|Non Hodgkin's Lymphoma|non hodgkin's lymphoma
5288093|NCT00477945|High Risk or Refractory Non Hodgkin's Lymphoma|high risk or refractory non hodgkin's lymphoma
5288094|NCT00477945|APBSCT|apbsct
5288095|NCT00477945|clofarabine|clofarabine
5288096|NCT00477932|Pentalogy of Cantrell|pentalogy of cantrell
5288097|NCT00477932|mutations|mutations
5288098|NCT00477932|DNA|dna
5288099|NCT00477932|RNA|rna
5288100|NCT00477919|stage IV melanoma|stage iv melanoma
5288101|NCT00477919|stage IV renal cell cancer|stage iv renal cell cancer
5288102|NCT00477919|unresectable extrahepatic bile duct cancer|unresectable extrahepatic bile duct cancer
5288103|NCT00477919|advanced malignant mesothelioma|advanced malignant mesothelioma
5288104|NCT00477919|stage IV prostate cancer|stage iv prostate cancer
5288105|NCT00477919|adult giant cell glioblastoma|adult giant cell glioblastoma
5288106|NCT00477919|adult gliosarcoma|adult gliosarcoma
5288107|NCT00477919|extensive stage small cell lung cancer|extensive stage small cell lung cancer
5288108|NCT00477919|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5288109|NCT00477919|stage IV colon cancer|stage iv colon cancer
5288110|NCT00477919|stage IV gastric cancer|stage iv gastric cancer
5288111|NCT00477919|stage IV esophageal cancer|stage iv esophageal cancer
5288112|NCT00477919|stage IV bladder cancer|stage iv bladder cancer
5288113|NCT00477919|male breast cancer|male breast cancer
5288114|NCT00477919|stage IV breast cancer|stage iv breast cancer
5288115|NCT00477919|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5288116|NCT00477919|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
5288117|NCT00477919|ovarian sarcoma|ovarian sarcoma
5288118|NCT00477919|ovarian stromal cancer|ovarian stromal cancer
5288119|NCT00477919|fatigue|fatigue
5288120|NCT00477919|anorexia|anorexia
5288121|NCT00477919|cachexia|cachexia
5288122|NCT00477919|pain|pain
5288123|NCT00477919|weight changes|weight changes
5288124|NCT00477919|depression|depression
5288420|NCT00476944|Heparin|heparin
5288125|NCT00477919|poor performance status|poor performance status
5288126|NCT00477919|recurrent adult brain tumor|recurrent adult brain tumor
5288127|NCT00477919|clear cell sarcoma of the kidney|clear cell sarcoma of the kidney
5288128|NCT00477919|advanced adult primary liver cancer|advanced adult primary liver cancer
5288129|NCT00477919|recurrent adult primary liver cancer|recurrent adult primary liver cancer
5288130|NCT00477919|recurrent small cell lung cancer|recurrent small cell lung cancer
5288131|NCT00477919|recurrent bladder cancer|recurrent bladder cancer
5288132|NCT00477919|recurrent breast cancer|recurrent breast cancer
5288133|NCT00477919|recurrent colon cancer|recurrent colon cancer
5288134|NCT00477919|recurrent esophageal cancer|recurrent esophageal cancer
5288135|NCT00477919|recurrent gastric cancer|recurrent gastric cancer
5288136|NCT00477919|recurrent melanoma|recurrent melanoma
5288137|NCT00477919|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5288138|NCT00477919|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5288139|NCT00477919|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
5288140|NCT00477919|stage IV pancreatic cancer|stage iv pancreatic cancer
5288141|NCT00477919|recurrent prostate cancer|recurrent prostate cancer
5288142|NCT00477919|recurrent renal cell cancer|recurrent renal cell cancer
5288143|NCT00477919|recurrent pancreatic cancer|recurrent pancreatic cancer
5288144|NCT00477919|stage IV rectal cancer|stage iv rectal cancer
5288145|NCT00477919|recurrent rectal cancer|recurrent rectal cancer
5288146|NCT00477919|recurrent malignant mesothelioma|recurrent malignant mesothelioma
5288147|NCT00477919|recurrent carcinoma of unknown primary|recurrent carcinoma of unknown primary
5288148|NCT00477919|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
5288149|NCT00477919|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
5288150|NCT00477919|stage IV uterine sarcoma|stage iv uterine sarcoma
5288151|NCT00477919|recurrent uterine sarcoma|recurrent uterine sarcoma
5288152|NCT00477919|recurrent extrahepatic bile duct cancer|recurrent extrahepatic bile duct cancer
5288153|NCT00477919|unresectable gallbladder cancer|unresectable gallbladder cancer
5288154|NCT00477919|recurrent gallbladder cancer|recurrent gallbladder cancer
5288155|NCT00477919|adult glioblastoma|adult glioblastoma
5288156|NCT00477906|melanoma|melanoma
5288157|NCT00477906|vaccine|vaccine
5288158|NCT00477906|metastatic|metastatic
5288159|NCT00477906|autologous|autologous
5288160|NCT00477880|gastric cancer|gastric cancer
5288161|NCT00477880|giant hypertrophic gastritis|giant hypertrophic gastritis
5288162|NCT00477867|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5288163|NCT00477841|esophageal Cancer|esophageal cancer
5288164|NCT00477841|Dysphagia|dysphagia
5288165|NCT00477841|Stent|stent
5288166|NCT00477841|interstitial brachytherapy|interstitial brachytherapy
5288167|NCT00477828|sleep apnea|sleep apnea
5288168|NCT00477828|dementia|dementia
5288169|NCT00477828|excessive sleepiness|excessive sleepiness
5288170|NCT00477828|cognition|cognition
5288171|NCT00477815|stage I multiple myeloma|stage i multiple myeloma
5288172|NCT00477815|refractory multiple myeloma|refractory multiple myeloma
5288173|NCT00477815|stage II multiple myeloma|stage ii multiple myeloma
5288174|NCT00477815|stage III multiple myeloma|stage iii multiple myeloma
5288175|NCT00477802|Parkinson's disease|parkinson's disease
5288176|NCT00477802|levodopa-induced cervical dyskinesias|levodopa-induced cervical dyskinesias
5288177|NCT00477789|chronic heart failure|chronic heart failure
5288178|NCT00477789|diastolic dysfunction|diastolic dysfunction
5288179|NCT00477789|uric acid|uric acid
5288180|NCT00477776|Beginning of breastfeeding|beginning of breastfeeding
5288181|NCT00477750|stage I multiple myeloma|stage i multiple myeloma
5288182|NCT00477750|stage II multiple myeloma|stage ii multiple myeloma
5288183|NCT00477750|stage III multiple myeloma|stage iii multiple myeloma
5288184|NCT00477737|cardioprotection|cardioprotection
5288185|NCT00477737|sevoflurane|sevoflurane
5288186|NCT00477737|esophageal Doppler|esophageal doppler
5288187|NCT00477737|thermodilution|thermodilution
5288188|NCT00477737|coronary artery bypass|coronary artery bypass
5288189|NCT00477724|latent|latent
5288190|NCT00477711|Cetuximab|cetuximab
5288191|NCT00477711|cisplatin|cisplatin
5288192|NCT00477711|capecitabine|capecitabine
5288193|NCT00477711|first line treatment|first line treatment
5288194|NCT00477685|Glaucoma|glaucoma
5288195|NCT00477685|Collagen matrix|collagen matrix
5288196|NCT00477685|OculusGen|oculusgen
5288197|NCT00477685|Phacotrabeculectomy|phacotrabeculectomy
5288198|NCT00477685|anti scarring|anti scarring
5288199|NCT00477685|tissue engineering|tissue engineering
5288200|NCT00477685|ologen|ologen
5288201|NCT00477685|Aeon Astron|aeon astron
5288202|NCT00477672|Parkinson's disease, psychotic disorders|parkinson's disease, psychotic disorders
5288203|NCT00477659|fMRI study; open-label donepezil|fmri study; open-label donepezil
5288204|NCT00477646|colon cancer|colon cancer
5288205|NCT00477646|rectal cancer|rectal cancer
5288206|NCT00477646|breast cancer|breast cancer
5288207|NCT00477646|cervical cancer|cervical cancer
5288208|NCT00477633|Contraception|contraception
5288209|NCT00477620|Myopia|myopia
5288210|NCT00477620|Prevention|prevention
5288211|NCT00477594|Familial Hypercholesterolemia|familial hypercholesterolemia
5288212|NCT00477594|Heterozygous Familial Hypercholesterolemia|heterozygous familial hypercholesterolemia
5288315|NCT00477256|Questionnaire|questionnaire
5288213|NCT00477594|Homozygous Familial Hypercholesterolemia|homozygous familial hypercholesterolemia
5288214|NCT00477594|ISIS 301012|isis 301012
5288215|NCT00477594|mipomersen|mipomersen
5288216|NCT00477594|Open Label Extension|open label extension
5288217|NCT00477581|diabetes|diabetes
5288218|NCT00477581|exenatide|exenatide
5288219|NCT00477581|sitagliptin|sitagliptin
5288220|NCT00477581|Amylin|amylin
5288221|NCT00477581|Lilly|lilly
5288222|NCT00477568|Wheelchair users|wheelchair users
5288223|NCT00477568|Back pain|back pain
5288224|NCT00477568|Prevalence|prevalence
5288225|NCT00477568|Risk factors|risk factors
5288226|NCT00477555|aortic valve|aortic valve
5288227|NCT00477555|concomitant procedures|concomitant procedures
5288228|NCT00477555|porcine bioprosthesis|porcine bioprosthesis
5288229|NCT00477555|stented valve|stented valve
5288230|NCT00477542|Clofarabine|clofarabine
5288231|NCT00477542|allogeneic HSCT|allogeneic hsct
5288232|NCT00477542|refractory malignancies|refractory malignancies
5288233|NCT00477503|Central Nervous System Tumors|central nervous system tumors
5288234|NCT00477503|Brain Tumors|brain tumors
5288235|NCT00477503|Leptomeningeal Metastasis|leptomeningeal metastasis
5288236|NCT00477503|Cerebral Spinal Fluid|cerebral spinal fluid
5288237|NCT00477503|Human CSF Flow|human csf flow
5288238|NCT00477503|Nuclear Imaging|nuclear imaging
5288239|NCT00477503|Gallium-67 Citrate|gallium-67 citrate
5288240|NCT00477503|In-111 DTPA|in-111 dtpa
5288241|NCT00477477|overweight|overweight
5288242|NCT00477477|metabolic syndrome|metabolic syndrome
5288243|NCT00477477|adolescent|adolescent
5288244|NCT00477477|cardiovascular|cardiovascular
5288245|NCT00477477|risk factors|risk factors
5288246|NCT00477477|hypertension|hypertension
5288247|NCT00477477|dyslipidemia|dyslipidemia
5288248|NCT00477477|inflammation|inflammation
5288249|NCT00477477|coagulopathy|coagulopathy
5288250|NCT00477464|dual kinase inhibitor,|dual kinase inhibitor,
5288251|NCT00477464|EGFR/ErbB1,|egfr/erbb1,
5288252|NCT00477464|ErbB2-overexpressing,|erbb2-overexpressing,
5288253|NCT00477464|GW572016,|gw572016,
5288254|NCT00477464|advanced/metastatic breast cancer, Lapatinib,|advanced/metastatic breast cancer, lapatinib,
5288255|NCT00477464|HER-2/new,|her-2/new,
5288256|NCT00477464|pharmacokinetics|pharmacokinetics
5288257|NCT00477451|Staccato™ Alprazolam, Panic Attack, Inhaled alprazolam|staccato™ alprazolam, panic attack, inhaled alprazolam
5288258|NCT00477425|Avastin|avastin
5288259|NCT00477412|Mantle Cell Lymphoma|mantle cell lymphoma
5288260|NCT00477412|Lymphoma|lymphoma
5288261|NCT00477412|Bortezomib|bortezomib
5288262|NCT00477412|LDP-341|ldp-341
5288263|NCT00477412|MLN341|mln341
5288264|NCT00477412|Velcade|velcade
5288265|NCT00477412|Cyclophosphamide|cyclophosphamide
5288266|NCT00477412|Neosar|neosar
5288267|NCT00477412|Cytoxan|cytoxan
5288268|NCT00477412|Doxorubicin|doxorubicin
5288269|NCT00477412|Adriamycin|adriamycin
5288270|NCT00477412|Rubex|rubex
5288271|NCT00477412|Rituximab|rituximab
5288272|NCT00477412|Vincristine|vincristine
5288273|NCT00477412|Methotrexate|methotrexate
5288274|NCT00477412|Cytarabine|cytarabine
5288275|NCT00477412|Cytosar|cytosar
5288276|NCT00477412|DepoCyt|depocyt
5288277|NCT00477412|Cytosine arabinosine hydrochloride|cytosine arabinosine hydrochloride
5288278|NCT00477412|Mesna|mesna
5288279|NCT00477412|Dexamethasone|dexamethasone
5288280|NCT00477399|Obesity|obesity
5288281|NCT00477399|Weight loss maintenance|weight loss maintenance
5288282|NCT00477399|QOL|qol
5288283|NCT00477399|Life Style|life style
5288284|NCT00477399|Follow Up|follow up
5288285|NCT00477386|recurrent ovarian cancer|recurrent ovarian cancer
5288286|NCT00477386|platinum resistant|platinum resistant
5288287|NCT00477386|decitabine|decitabine
5288288|NCT00477347|Liver Transplantation|liver transplantation
5288289|NCT00477347|Anesthesia, general|anesthesia, general
5288290|NCT00477347|Closed-loop|closed-loop
5288291|NCT00477334|Recurrent genital herpes|recurrent genital herpes
5288292|NCT00477334|Black population|black population
5288293|NCT00477321|Interleukin 7|interleukin 7
5288294|NCT00477321|Immune Reconstitution|immune reconstitution
5288295|NCT00477321|T Cell Turnover|t cell turnover
5288296|NCT00477321|CD4 Lymphenia|cd4 lymphenia
5288297|NCT00477321|Immune-Based Therapies|immune-based therapies
5288298|NCT00477321|HIV Infection|hiv infection
5288299|NCT00477308|HIV children|hiv children
5288300|NCT00477308|genotypic resistance|genotypic resistance
5288301|NCT00477308|dual NRTIs|dual nrtis
5288302|NCT00477308|Salvage therapy|salvage therapy
5288303|NCT00477308|treatment outcome|treatment outcome
5288304|NCT00477308|Salvage therapy based on genotyping results|salvage therapy based on genotyping results
5288305|NCT00477308|Treatment Failure|treatment failure
5288306|NCT00477295|Epilepsy|epilepsy
5288307|NCT00477282|Ovarian|ovarian
5288308|NCT00477282|Cancer|cancer
5288309|NCT00477282|Advanced Ovarian Cancer|advanced ovarian cancer
5288310|NCT00477269|Pulmonary Arterial Hypertension, tyrosine kinase inhibitor, STI571|pulmonary arterial hypertension, tyrosine kinase inhibitor, sti571
5288311|NCT00477256|Pediatric Cancer|pediatric cancer
5288312|NCT00477256|Child Adjustment|child adjustment
5288313|NCT00477256|School Reintegration|school reintegration
5288314|NCT00477256|Caregiver|caregiver
5288316|NCT00477256|Quality of Life|quality of life
5288317|NCT00477256|Survey|survey
5288318|NCT00477243|Advanced Cancer|advanced cancer
5288319|NCT00477243|Palliative Care Patients|palliative care patients
5288320|NCT00477243|Spirituality|spirituality
5288321|NCT00477243|Locus of Control|locus of control
5288322|NCT00477243|Questionnaire|questionnaire
5288323|NCT00477230|AF|af
5288324|NCT00477230|PAF|paf
5288325|NCT00477230|paroxysmal atrial fibrillation|paroxysmal atrial fibrillation
5288326|NCT00477230|ablation|ablation
5288327|NCT00477230|failed drugs|failed drugs
5288328|NCT00477217|Osteonecrosis|osteonecrosis
5288329|NCT00477217|zoledronic acid|zoledronic acid
5288330|NCT00477217|knee|knee
5288331|NCT00477204|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
5288332|NCT00477204|dyslipidemia|dyslipidemia
5288333|NCT00477204|adolescents|adolescents
5288334|NCT00477191|psoriasis|psoriasis
5288335|NCT00477191|metabolic syndrome|metabolic syndrome
5288336|NCT00477191|Syndrome X|syndrome x
5288337|NCT00477191|diabetes|diabetes
5288338|NCT00477191|insulin resistance|insulin resistance
5288339|NCT00477191|obesity|obesity
5288340|NCT00477191|hypertension|hypertension
5288341|NCT00477191|hyperlipidemia|hyperlipidemia
5288342|NCT00477191|hypercholesterolemia|hypercholesterolemia
5288343|NCT00477178|possible problems using codeine when driving|possible problems using codeine when driving
5288344|NCT00477165|Irritable bowel syndrome|irritable bowel syndrome
5288345|NCT00477165|Antidepressant|antidepressant
5288346|NCT00477165|IBS|ibs
5288347|NCT00477165|Serotonin-reuptake inhibitor|serotonin-reuptake inhibitor
5288348|NCT00477165|SSRI|ssri
5288349|NCT00477165|Visceral sensitivity|visceral sensitivity
5288350|NCT00477165|Barostat|barostat
5288351|NCT00477165|Quality of life|quality of life
5288352|NCT00477165|Depression|depression
5288353|NCT00477152|dehydration|dehydration
5288354|NCT00477152|fluid therapy|fluid therapy
5288355|NCT00477152|pediatrics|pediatrics
5288356|NCT00477152|emergency medicine|emergency medicine
5288357|NCT00477152|hyaluronoglucosaminidase|hyaluronoglucosaminidase
5288358|NCT00477152|hyaluronidase|hyaluronidase
5288359|NCT00477152|hypodermoclysis|hypodermoclysis
5288360|NCT00477152|clysis|clysis
5288361|NCT00477152|subcutaneous hydration|subcutaneous hydration
5288362|NCT00477152|subcutaneous rehydration|subcutaneous rehydration
5288363|NCT00477152|hyaluronan|hyaluronan
5288364|NCT00477152|rHuPH20|rhuph20
5288365|NCT00477126|ritonavir generic capsule|ritonavir generic capsule
5288366|NCT00477126|Norvir®|norvir®
5288367|NCT00477126|Thailand|thailand
5288368|NCT00477126|Determine bioequivalence between Norvir and GPO ritonavir|determine bioequivalence between norvir and gpo ritonavir
5288369|NCT00477113|natalizumab|natalizumab
5288370|NCT00477113|MS|ms
5288371|NCT00477113|Tysabri|tysabri
5288372|NCT00477113|Multiple Sclerosis|multiple sclerosis
5288373|NCT00477113|TYGRIS|tygris
5288374|NCT00477100|Inflammatory Breast Cancer|inflammatory breast cancer
5288375|NCT00477100|Cancer Registry|cancer registry
5288376|NCT00477100|Core Biopsy|core biopsy
5288377|NCT00477100|Skin Biopsy|skin biopsy
5288378|NCT00477100|IBC|ibc
5288379|NCT00477074|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
5288380|NCT00477074|emphysema|emphysema
5288381|NCT00477074|inflammation|inflammation
5288382|NCT00477074|repair|repair
5288383|NCT00477061|MORPHINE|morphine
5288384|NCT00477061|ANALGESIA|analgesia
5288385|NCT00477061|ACUTE APPENDICITS|acute appendicits
5288386|NCT00477048|IDV nephrotoxicity|idv nephrotoxicity
5288387|NCT00477022|Diabetic Foot Ulcer|diabetic foot ulcer
5288388|NCT00477022|Vacuum compression therapy|vacuum compression therapy
5288389|NCT00477022|Stereology|stereology
5288390|NCT00477022|Ulcer Area|ulcer area
5288391|NCT00477022|Vasotrain|vasotrain
5288392|NCT00477022|Random Controlled Trial.|random controlled trial.
5288393|NCT00477009|Sleep apnea syndromes|sleep apnea syndromes
5288394|NCT00477009|Snoring|snoring
5288395|NCT00477009|Mandibular advancement|mandibular advancement
5288396|NCT00477009|Activator appliances|activator appliances
5288397|NCT00477009|Disorders of excessive somnolence|disorders of excessive somnolence
5288398|NCT00477009|Blood pressure|blood pressure
5288399|NCT00477009|Inflammation|inflammation
5288400|NCT00477009|Oxidative stress|oxidative stress
5288401|NCT00477009|Hormones|hormones
5288402|NCT00477009|Markers of Metabolic Syndrome X|markers of metabolic syndrome x
5288403|NCT00476996|RA|ra
5288404|NCT00476996|SCRIPT|script
5288405|NCT00476996|anti-CD20|anti-cd20
5288406|NCT00476996|CD20|cd20
5288407|NCT00476983|saquinavir/ritonavir 1500/100 mg once daily|saquinavir/ritonavir 1500/100 mg once daily
5288408|NCT00476970|Colorectal Cancer|colorectal cancer
5288409|NCT00476970|Cancer Screening|cancer screening
5288410|NCT00476970|Patient Navigation|patient navigation
5288411|NCT00476970|Low English Proficiency|low english proficiency
5288412|NCT00476957|Drug Eluting Stents|drug eluting stents
5288413|NCT00476957|Interventional Cardiology|interventional cardiology
5288414|NCT00476944|CAD|cad
5288415|NCT00476944|Coronary Artery Disease|coronary artery disease
5288416|NCT00476944|Angiomax|angiomax
5288417|NCT00476944|Bivalirudin|bivalirudin
5288418|NCT00476944|PCI|pci
5288419|NCT00476944|MAVE|mave
5288421|NCT00476931|Diabetic neuropathy|diabetic neuropathy
5288422|NCT00476931|Diabetes Type 1 or 2|diabetes type 1 or 2
5288423|NCT00476931|Moderate to severe sensorimotor diabetic polyneuropathy|moderate to severe sensorimotor diabetic polyneuropathy
5288424|NCT00476931|Unmeasurable nerve conduction velocity|unmeasurable nerve conduction velocity
5288425|NCT00476918|diabetic macular edema|diabetic macular edema
5288426|NCT00476918|triamcinolone acetonide|triamcinolone acetonide
5288427|NCT00476918|intravitreal|intravitreal
5288428|NCT00476918|steroid|steroid
5288429|NCT00476905|Basal Cell Carcinoma|basal cell carcinoma
5288430|NCT00476905|Squamous Cell Carcinoma|squamous cell carcinoma
5288431|NCT00476905|Pre-Cancer Lesions|pre-cancer lesions
5288432|NCT00476905|Pigmented Lesions|pigmented lesions
5288433|NCT00476905|Benign Lesions|benign lesions
5288434|NCT00476905|Skin Cancer|skin cancer
5288435|NCT00476905|Spectral Diagnosis|spectral diagnosis
5288436|NCT00476905|Optical Spectroscopy|optical spectroscopy
5288437|NCT00476892|Pelvic organ prolapse|pelvic organ prolapse
5288438|NCT00476892|Pelvic floor muscle training|pelvic floor muscle training
5288439|NCT00476892|Prolapse symptoms|prolapse symptoms
5288440|NCT00476892|Urinary symptoms|urinary symptoms
5288441|NCT00476892|Sexual function|sexual function
5288442|NCT00476892|randomised controlled trial|randomised controlled trial
5288443|NCT00476879|Growth hormone|growth hormone
5288444|NCT00476879|Fasting|fasting
5288445|NCT00476879|Signaltransduction|signaltransduction
5288446|NCT00476879|fatty liver|fatty liver
5288447|NCT00476879|insulin sensitivity|insulin sensitivity
5288448|NCT00476879|forearm model|forearm model
5288449|NCT00476879|protein metabolism|protein metabolism
5288450|NCT00476879|respiratory quotient|respiratory quotient
5288451|NCT00476866|Paraplegia|paraplegia
5288452|NCT00476866|tetraplegia|tetraplegia
5288453|NCT00476866|lung compliance|lung compliance
5288454|NCT00476866|work of breathing|work of breathing
5288455|NCT00476866|hyperinflation|hyperinflation
5288456|NCT00476866|rehabilitation|rehabilitation
5288457|NCT00476853|HIV-TB|hiv-tb
5288458|NCT00476853|nevirapine based HAART with rifampin treated TB|nevirapine based haart with rifampin treated tb
5288459|NCT00476853|Compare PK profile, efficacy, safety and tolerability of HAART containing nevirapine 400mg/day versus 600 mg/day in HIV/TB co-infected patients|compare pk profile, efficacy, safety and tolerability of haart containing nevirapine 400mg/day versus 600 mg/day in hiv/tb co-infected patients
5288460|NCT00476853|Treatment Naive|treatment naive
5288461|NCT00476827|Breast Cancer|breast cancer
5288462|NCT00476827|Metastatic|metastatic
5288463|NCT00476827|Brain|brain
5288464|NCT00476827|Anti-angiogenesis|anti-angiogenesis
5288465|NCT00476814|cystic fibrosis,|cystic fibrosis,
5288466|NCT00476814|nasal potential difference,|nasal potential difference,
5288467|NCT00476814|primary sclerosing cholangitis|primary sclerosing cholangitis
5288468|NCT00476801|UVA1|uva1
5288469|NCT00476801|scleroderma|scleroderma
5288470|NCT00476801|keloids|keloids
5288471|NCT00476801|light therapy|light therapy
5288472|NCT00476801|morphea|morphea
5288473|NCT00476788|pediatrics|pediatrics
5288474|NCT00476788|CSII|csii
5288475|NCT00476788|diabetes|diabetes
5288476|NCT00476788|C-peptide|c-peptide
5288477|NCT00476788|adverse events|adverse events
5288478|NCT00476775|obesity|obesity
5288479|NCT00476775|prevention|prevention
5288480|NCT00476775|girls|girls
5288481|NCT00476775|Latina/Hispanic|latina/hispanic
5288482|NCT00476775|Dance|dance
5288483|NCT00476775|television|television
5288484|NCT00476775|screen time|screen time
5288485|NCT00476736|COPD|copd
5288486|NCT00476736|Pulmonary function|pulmonary function
5288487|NCT00476736|Air trapping|air trapping
5288488|NCT00476736|Acetyl cystein|acetyl cystein
5288489|NCT00476723|HIV infection|hiv infection
5288490|NCT00476723|Hepatitis coinfection|hepatitis coinfection
5288491|NCT00476710|Type 2 diabetes mellitus|type 2 diabetes mellitus
5288492|NCT00476710|Bile acid|bile acid
5288493|NCT00476710|Stable isotope|stable isotope
5288494|NCT00476710|Colesevelam HCl|colesevelam hcl
5288495|NCT00476710|Impaired Glucose Tolerance|impaired glucose tolerance
5288496|NCT00476697|UVA1|uva1
5288497|NCT00476697|scleroderma|scleroderma
5288498|NCT00476697|keloids|keloids
5288499|NCT00476697|morphea|morphea
5288500|NCT00476697|light therapy|light therapy
5288501|NCT00476684|radiofrequency|radiofrequency
5288502|NCT00476671|neuropsychiatric|neuropsychiatric
5288503|NCT00476671|neurocognitive|neurocognitive
5288504|NCT00476671|psychiatric|psychiatric
5288505|NCT00476671|HIV related dementia|hiv related dementia
5288506|NCT00476671|MCMD|mcmd
5288507|NCT00476671|HIV-1|hiv-1
5288633|NCT00476294|Disease-Free Survival|disease-free survival
5288634|NCT00476294|AMD3100|amd3100
5288635|NCT00476294|G-CSF|g-csf
5288508|NCT00476671|Prevalence, risk factors of neurocognitive impairment and psychiatric comorbidities in HIV-1 infected patients with undetectable viral load in the HAART era.|prevalence, risk factors of neurocognitive impairment and psychiatric comorbidities in hiv-1 infected patients with undetectable viral load in the haart era.
5288509|NCT00476671|Treatment Experienced|treatment experienced
5288510|NCT00476658|Obesity|obesity
5288511|NCT00476658|macrophage infiltration|macrophage infiltration
5288512|NCT00476658|insulinoresistance|insulinoresistance
5288513|NCT00476658|inflammation|inflammation
5288931|NCT00475228|IUD|iud
5288514|NCT00476632|Epidemiology|epidemiology
5288515|NCT00476632|Questionnaire|questionnaire
5288516|NCT00476632|Controls|controls
5288517|NCT00476619|Contrast|contrast
5288518|NCT00476619|Nephropathy|nephropathy
5288519|NCT00476619|acute renal failure|acute renal failure
5288520|NCT00476619|Erythropoietin|erythropoietin
5288521|NCT00476619|CT scan|ct scan
5288522|NCT00476606|HIV children|hiv children
5288523|NCT00476606|HAART|haart
5288524|NCT00476606|ARV|arv
5288525|NCT00476606|Second line HAART|second line haart
5288526|NCT00476606|Viral Load|viral load
5288527|NCT00476606|Combination drug|combination drug
5288528|NCT00476606|Treatment Experienced|treatment experienced
5288529|NCT00476606|Treatment Naive|treatment naive
5288530|NCT00476593|Uveitis|uveitis
5288531|NCT00476593|Iritis|iritis
5288532|NCT00476593|Macular Thickness|macular thickness
5288533|NCT00476593|HLA-B27 related|hla-b27 related
5288534|NCT00476593|Macular edema|macular edema
5288535|NCT00476593|Macular thickening|macular thickening
5288536|NCT00476593|OCT|oct
5288537|NCT00476593|mfERG|mferg
5288538|NCT00476593|Eye drops|eye drops
5288539|NCT00476593|Dexamethosone|dexamethosone
5288540|NCT00476593|Diclofenac|diclofenac
5288541|NCT00476593|Retinal aging|retinal aging
5288542|NCT00476580|Sri Lankan Sinhalese|sri lankan sinhalese
5288543|NCT00476580|Epidemiology|epidemiology
5288544|NCT00476580|Cancer Risk|cancer risk
5288545|NCT00476580|US Migrant|us migrant
5288546|NCT00476580|Questionnaire|questionnaire
5288547|NCT00476580|Survey|survey
5288548|NCT00476580|Acculturation|acculturation
5288549|NCT00476580|Health and Cancer Risks|health and cancer risks
5288550|NCT00476580|Health Habits|health habits
5288551|NCT00476567|exercise|exercise
5288552|NCT00476567|pregnancy|pregnancy
5288553|NCT00476567|prevention|prevention
5288554|NCT00476567|pregnancy-related diseases|pregnancy-related diseases
5288555|NCT00476567|labor|labor
5288556|NCT00476567|complications|complications
5288557|NCT00476567|physiotherapy|physiotherapy
5288558|NCT00476554|CTCL|ctcl
5288559|NCT00476541|AML|aml
5288560|NCT00476541|Children|children
5288561|NCT00476541|Gemtuzumab ozogamicin|gemtuzumab ozogamicin
5288562|NCT00476541|Stem cell transplantation|stem cell transplantation
5288563|NCT00476528|Posttraumatic amnesia|posttraumatic amnesia
5288564|NCT00476528|Early intervention|early intervention
5288565|NCT00476528|A systematic nursing programme in the ICU|a systematic nursing programme in the icu
5288566|NCT00476528|Early identification of patients with posttraumatic amnesia|early identification of patients with posttraumatic amnesia
5288567|NCT00476515|Kidney transplantation|kidney transplantation
5288568|NCT00476515|Donor specific antibodies|donor specific antibodies
5288569|NCT00476515|Positive cross match|positive cross match
5288570|NCT00476502|genetic polymorphism|genetic polymorphism
5288571|NCT00476502|CYP 3A|cyp 3a
5288572|NCT00476502|MDR-1|mdr-1
5288573|NCT00476502|Thai|thai
5288574|NCT00476502|HIV|hiv
5288575|NCT00476502|Treatment Experienced|treatment experienced
5288576|NCT00476489|secondary adrenal insuffiency|secondary adrenal insuffiency
5288577|NCT00476489|hypothalamus-pituitary-adrenal axis impairement|hypothalamus-pituitary-adrenal axis impairement
5288578|NCT00476489|topical steroids|topical steroids
5288579|NCT00476476|Tarceva|tarceva
5288580|NCT00476476|erlotinib|erlotinib
5288581|NCT00476476|squamous cell carcinoma of the vulvar|squamous cell carcinoma of the vulvar
5288582|NCT00476463|TDF+FTC|tdf+ftc
5288583|NCT00476463|FTC|ftc
5288584|NCT00476463|HIV/HBV|hiv/hbv
5288585|NCT00476463|TDF compared to TDF+FTC in HIV/HBV|tdf compared to tdf+ftc in hiv/hbv
5288586|NCT00476463|Treatment Naive|treatment naive
5288587|NCT00476450|Oral Microbial Flora|oral microbial flora
5288588|NCT00476450|Hematopoietic Stem Cell Transplant|hematopoietic stem cell transplant
5288589|NCT00476450|Allogeneic Stem Cell Transplant|allogeneic stem cell transplant
5288590|NCT00476424|once daily Efavirenz 400 mg|once daily efavirenz 400 mg
5288591|NCT00476424|PK once daily Efavirenz 400 mg versus 600 mg|pk once daily efavirenz 400 mg versus 600 mg
5288592|NCT00476424|Treatment Experienced|treatment experienced
5288593|NCT00476411|isolated HBc|isolated hbc
5288594|NCT00476411|HBV vaccine response|hbv vaccine response
5288595|NCT00476411|occult HBV in isolated antiHBC compared HIV to non HIV|occult hbv in isolated antihbc compared hiv to non hiv
5288596|NCT00476398|Capsule endoscopy|capsule endoscopy
5288597|NCT00476398|Wireless imaging|wireless imaging
5288598|NCT00476398|esophagus|esophagus
5288599|NCT00476398|stomach|stomach
5288600|NCT00476372|neuropsychology|neuropsychology
5288601|NCT00476372|cognitive impairment|cognitive impairment
5288602|NCT00476372|motor disorder|motor disorder
5288603|NCT00476372|parkinson's disease|parkinson's disease
5288604|NCT00476359|Lopinavir/r|lopinavir/r
5288605|NCT00476359|Saquinavir|saquinavir
5288606|NCT00476359|Dual boosted PIs|dual boosted pis
5288607|NCT00476359|Pharmacokinetics|pharmacokinetics
5288608|NCT00476359|HIV children|hiv children
5288609|NCT00476359|C min|c min
5288610|NCT00476359|Second line HAART|second line haart
5288611|NCT00476359|ARV|arv
5288612|NCT00476359|VL failure|vl failure
5288613|NCT00476359|Dosage|dosage
5288614|NCT00476359|To evaluate treatment response|to evaluate treatment response
5288615|NCT00476359|Treatment Experienced|treatment experienced
5288616|NCT00476346|physical training|physical training
5288617|NCT00476346|military training|military training
5288618|NCT00476346|bone|bone
5288619|NCT00476346|fracture prevention|fracture prevention
5288620|NCT00476346|young adult|young adult
5288621|NCT00476333|EMG|emg
5288622|NCT00476333|Kinetics|kinetics
5288623|NCT00476333|Kinematics|kinematics
5288624|NCT00476333|Perturbation|perturbation
5288625|NCT00476333|Footwear|footwear
5288626|NCT00476320|echocardiography|echocardiography
5288627|NCT00476320|myocardial infarction|myocardial infarction
5288628|NCT00476320|magnetic resonance imaging|magnetic resonance imaging
5288629|NCT00476320|revascularization|revascularization
5288630|NCT00476320|viability|viability
5288631|NCT00476307|Flu vaccine|flu vaccine
5288632|NCT00476294|Multiple Myeloma|multiple myeloma
5288636|NCT00476294|Autologous Transplantation|autologous transplantation
5288637|NCT00476255|child safety restraint|child safety restraint
5288638|NCT00476255|injury prevention|injury prevention
5288639|NCT00476255|automotive|automotive
5288640|NCT00476242|heroin abuse|heroin abuse
5288641|NCT00476242|opiate abuse|opiate abuse
5288642|NCT00476242|opioid dependence|opioid dependence
5288643|NCT00476242|naltrexone|naltrexone
5288644|NCT00476242|memantine|memantine
5288645|NCT00476229|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
5288646|NCT00476229|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
5288647|NCT00476229|Hodgkin's Lymphoma|hodgkin's lymphoma
5288648|NCT00476229|Lymphoma|lymphoma
5288649|NCT00476229|Leukemia|leukemia
5288650|NCT00476229|Mycophenolate Mofetil|mycophenolate mofetil
5288651|NCT00476229|Tacrolimus|tacrolimus
5288652|NCT00476229|Thymoglobulin|thymoglobulin
5288653|NCT00476229|Total Lymphoid Irradiation|total lymphoid irradiation
5288654|NCT00476216|Non-Small Cell Lung Cancer|non-small cell lung cancer
5288655|NCT00476216|Venous Thromboembolism|venous thromboembolism
5288657|NCT00476216|Arixtra|arixtra
5288658|NCT00476203|Breast Cancer|breast cancer
5288659|NCT00476203|Yoga|yoga
5288660|NCT00476203|Quality of Life|quality of life
5288661|NCT00476203|Obesity|obesity
5288662|NCT00476203|Fatigue|fatigue
5288663|NCT00476203|Weight|weight
5288664|NCT00476190|ALL|all
5288665|NCT00476177|DC|dc
5288666|NCT00476177|DLI|dli
5288667|NCT00476177|graft vs. host disease|graft vs. host disease
5288668|NCT00476177|GVHD|gvhd
5288669|NCT00476164|chronic allograft nephropathy|chronic allograft nephropathy
5288670|NCT00476164|C4d|c4d
5288671|NCT00476164|Anti-CD20|anti-cd20
5288672|NCT00476164|B cells|b cells
5288673|NCT00476164|Antibody|antibody
5288674|NCT00476151|DPN|dpn
5288675|NCT00476151|Diabetic|diabetic
5288676|NCT00476151|Nerve Pain|nerve pain
5288677|NCT00476138|Epigallocatechin-Gallate|epigallocatechin-gallate
5288678|NCT00476138|Glaucoma|glaucoma
5288679|NCT00476138|Optic Nerve|optic nerve
5288680|NCT00476138|Pattern Electroretinogram|pattern electroretinogram
5288681|NCT00476138|Retinal Ganglion Cells|retinal ganglion cells
5288682|NCT00476112|Atrial flutter|atrial flutter
5288683|NCT00476112|RSD1235|rsd1235
5288684|NCT00476086|oxaliplatin|oxaliplatin
5288685|NCT00476086|gemcitabine|gemcitabine
5288686|NCT00476086|MMMT|mmmt
5288687|NCT00476060|Cirrhosis|cirrhosis
5288688|NCT00476060|Bone marrow|bone marrow
5288689|NCT00476060|Mesenchymal stem cell|mesenchymal stem cell
5288690|NCT00476060|MELD score|meld score
5288691|NCT00476060|Quality of life|quality of life
5288692|NCT00476034|Osteoarthritis|osteoarthritis
5288693|NCT00476034|lumiracoxib|lumiracoxib
5288694|NCT00476034|celecoxib|celecoxib
5288695|NCT00476034|Cox-2|cox-2
5288696|NCT00476034|knee|knee
5288697|NCT00476021|postpartum|postpartum
5288698|NCT00476021|contraception|contraception
5288699|NCT00476021|postplacental IUD|postplacental iud
5288700|NCT00476021|intrauterine devices|intrauterine devices
5288701|NCT00476008|Alzheimer's Disease|alzheimer's disease
5288702|NCT00476008|Mild Alzheimer's Disease|mild alzheimer's disease
5288703|NCT00476008|Driving|driving
5288704|NCT00476008|Driving Impairment|driving impairment
5288705|NCT00475982|Diet|diet
5288706|NCT00475982|Insulin-like Growth Factor|insulin-like growth factor
5288707|NCT00475982|Weight Loss|weight loss
5288708|NCT00475956|Cancer|cancer
5288709|NCT00475956|Tumour|tumour
5288710|NCT00475956|Advanced Solid Tumour|advanced solid tumour
5288711|NCT00475956|Lung Cancer|lung cancer
5288712|NCT00475956|Breast Cancer|breast cancer
5288713|NCT00475956|Cholangiocarcinoma|cholangiocarcinoma
5288714|NCT00475956|Colon Cancer|colon cancer
5288715|NCT00475956|Gastric Cancer|gastric cancer
5288716|NCT00475956|Choriocarcinoma|choriocarcinoma
5288717|NCT00475956|Liver Cancer|liver cancer
5288718|NCT00475956|Myeloma|myeloma
5288719|NCT00475956|Ovarian Cancer|ovarian cancer
5288720|NCT00475956|Pancreatic Cancer|pancreatic cancer
5288721|NCT00475956|Peritoneal Cancer|peritoneal cancer
5288722|NCT00475943|Swallowing Disorders|swallowing disorders
5288723|NCT00475943|Swallowing|swallowing
5288724|NCT00475943|Videofluoroscopy|videofluoroscopy
5288725|NCT00475943|Dysphagia|dysphagia
5288726|NCT00475943|Epiglottis|epiglottis
5288727|NCT00475943|Healthy Volunteer|healthy volunteer
5288728|NCT00475943|HV|hv
5288729|NCT00475930|MRSA|mrsa
5288730|NCT00475930|Staphylococcus aureus|staphylococcus aureus
5288731|NCT00475917|Advanced malignancies|advanced malignancies
5288732|NCT00475917|Solid tumor|solid tumor
5288733|NCT00475904|Post Herpetic Neuralgia|post herpetic neuralgia
5288734|NCT00475904|PHN|phn
5288735|NCT00475904|Neuropathy|neuropathy
5288736|NCT00475904|Nerve Pain|nerve pain
5288737|NCT00475904|Topical|topical
5288738|NCT00475891|isolate|isolate
5288739|NCT00475891|infection|infection
5288740|NCT00475891|linezolid|linezolid
5288741|NCT00475878|opiate use|opiate use
5288742|NCT00475878|depression|depression
5288743|NCT00475878|buprenorphine|buprenorphine
5288744|NCT00475878|escitalopram|escitalopram
5288745|NCT00475865|MS|ms
5288746|NCT00475865|glatiramer acetate|glatiramer acetate
5288747|NCT00475865|adjunctive therapy|adjunctive therapy
5288748|NCT00475865|relapses|relapses
5288749|NCT00475852|Heart Decompensation|heart decompensation
5288750|NCT00475852|Dyspnea|dyspnea
5288751|NCT00475852|Heart failure|heart failure
5288752|NCT00475852|Nesiritide|nesiritide
5288753|NCT00475852|Decompensated|decompensated
5288754|NCT00475852|ADHF|adhf
5288755|NCT00475839|stress urinary incontinence|stress urinary incontinence
5288756|NCT00475839|sling procedures|sling procedures
5288757|NCT00475839|tension-free vaginal tape|tension-free vaginal tape
5288758|NCT00475839|transobturator|transobturator
5288759|NCT00475826|Heterozigous Familial Hypercholesterolemia|heterozigous familial hypercholesterolemia
5288760|NCT00475826|Sub-clinical atherosclerosis|sub-clinical atherosclerosis
5288761|NCT00475826|Chylomicrons metabolism|chylomicrons metabolism
5288762|NCT00475826|Statin plus ezetimibe|statin plus ezetimibe
5288763|NCT00475826|Coronary artery calcification|coronary artery calcification
5288764|NCT00475813|Paediatric subjects with asthma|paediatric subjects with asthma
5288765|NCT00475800|Osteoarthritis|osteoarthritis
5288766|NCT00475800|lumiracoxib|lumiracoxib
5288767|NCT00475800|celecoxib|celecoxib
5288768|NCT00475800|Cox-2|cox-2
5288769|NCT00475800|knee|knee
5288770|NCT00475787|Older Adults|older adults
5288771|NCT00475787|Patient Education|patient education
5288772|NCT00475787|Randomized Controlled Trial|randomized controlled trial
5288773|NCT00475787|Sham procedure|sham procedure
5288774|NCT00475787|Spinal Manipulation|spinal manipulation
5288775|NCT00475787|Veterans|veterans
5288776|NCT00475761|Breast biopsy|breast biopsy
5288777|NCT00475761|Breast imaging|breast imaging
5288778|NCT00475761|Breast Cancer|breast cancer
5288779|NCT00475761|Mammographic Density|mammographic density
5288780|NCT00475761|Breast|breast
5288781|NCT00475748|cervical spine|cervical spine
5288782|NCT00475748|spinal cord|spinal cord
5288783|NCT00475748|trauma|trauma
5288784|NCT00475748|spinal cord injury|spinal cord injury
5288785|NCT00475748|central cord syndrome|central cord syndrome
5288786|NCT00475722|cancer|cancer
5288787|NCT00475722|colon|colon
5288788|NCT00475722|prevention|prevention
5288789|NCT00475722|healthy eating|healthy eating
5288790|NCT00475722|Mediterranean diet|mediterranean diet
5288791|NCT00475722|PGE2|pge2
5288792|NCT00475722|cyclooxygenase|cyclooxygenase
5288793|NCT00475722|lipoxygenase|lipoxygenase
5288794|NCT00475722|Healthy People 2010 diet|healthy people 2010 diet
5288795|NCT00475722|dietary prevention of colon cancer|dietary prevention of colon cancer
5288796|NCT00475709|aortic valve|aortic valve
5288797|NCT00475709|heart valve|heart valve
5288798|NCT00475709|tissue valve|tissue valve
5288799|NCT00475709|bioprosthesis|bioprosthesis
5288800|NCT00475709|valve disorder|valve disorder
5288801|NCT00475709|valve disease|valve disease
5288802|NCT00475709|cardiac surgery|cardiac surgery
5288803|NCT00475709|aortic valve stenosis|aortic valve stenosis
5288804|NCT00475709|aortic valve regurgitation|aortic valve regurgitation
5288805|NCT00475683|Doxorubicin|doxorubicin
5288806|NCT00475683|Mucositis|mucositis
5288807|NCT00475683|Prevention|prevention
5288808|NCT00475683|Curcumin|curcumin
5288809|NCT00475631|Clubfoot|clubfoot
5288810|NCT00475631|Chart review|chart review
5288811|NCT00475618|Early chilhood caries|early chilhood caries
5288812|NCT00475618|Prevention|prevention
5288813|NCT00475618|Fluoride varnish|fluoride varnish
5288814|NCT00475618|fluoride toothpaste|fluoride toothpaste
5288815|NCT00475618|non fluoride tooth paste|non fluoride tooth paste
5288816|NCT00475618|Professional cleaning|professional cleaning
5288817|NCT00475605|atopic dermatitis|atopic dermatitis
5288818|NCT00475605|child|child
5288819|NCT00475605|tacrolimus ointment|tacrolimus ointment
5288820|NCT00475605|Protopic Ointment|protopic ointment
5288821|NCT00475592|Esophageal Varices|esophageal varices
5288822|NCT00475592|Gastric Varices|gastric varices
5288823|NCT00475592|Capsule Endoscopy|capsule endoscopy
5288824|NCT00475592|Portal Hypertension|portal hypertension
5288825|NCT00475592|Cirrhosis|cirrhosis
5288826|NCT00475592|Gastrointestinal Hemorrhage|gastrointestinal hemorrhage
5288827|NCT00475579|ventilator-associated pneumonia|ventilator-associated pneumonia
5288828|NCT00475579|endotracheal tube|endotracheal tube
5288829|NCT00475579|polyurethane cuff|polyurethane cuff
5288830|NCT00475579|polyvinyl cuff|polyvinyl cuff
5288831|NCT00475579|subglottic secretion drainage|subglottic secretion drainage
5288832|NCT00475553|spotting|spotting
5288833|NCT00475553|PMS|pms
5288834|NCT00475553|nuvaring|nuvaring
5288835|NCT00475553|birth control|birth control
5288836|NCT00475553|pelvic pain|pelvic pain
5288837|NCT00475553|headache|headache
5288838|NCT00475553|mood swings|mood swings
5288839|NCT00475553|continuous use|continuous use
5288840|NCT00475540|prolapse|prolapse
5288841|NCT00475540|uterus|uterus
5288842|NCT00475540|pelvic organ|pelvic organ
5288843|NCT00475540|vaginal prolpase|vaginal prolpase
5288844|NCT00475514|Menstrually-related Migraine Headache|menstrually-related migraine headache
5288845|NCT00475514|'Difficult to Treat' as specified in protocol|'difficult to treat' as specified in protocol
5288846|NCT00475501|anabolic effects|anabolic effects
5288847|NCT00475501|finasteride|finasteride
5288848|NCT00475501|male hypogonadism|male hypogonadism
5288849|NCT00475501|sarcopenia|sarcopenia
5288850|NCT00475501|testosterone|testosterone
5288851|NCT00475488|radial artery|radial artery
5288852|NCT00475488|right internal thoracic artery|right internal thoracic artery
5288853|NCT00475488|saphenous vein|saphenous vein
5288854|NCT00475488|grafts|grafts
5288855|NCT00475488|coronary bypass surgery|coronary bypass surgery
5288856|NCT00475475|Overweight|overweight
5288857|NCT00475475|Obesity|obesity
5288858|NCT00475475|Appetite|appetite
5288859|NCT00475475|Dietary sugars|dietary sugars
5288860|NCT00475475|Fructose|fructose
5288861|NCT00475475|Glucose|glucose
5288862|NCT00475475|Leptin|leptin
5288863|NCT00475475|Insulin|insulin
5288864|NCT00475475|Ghrelin|ghrelin
5288865|NCT00475462|Metoprolol and Syncope|metoprolol and syncope
5288866|NCT00475449|percutaneous coronary intervention|percutaneous coronary intervention
5288867|NCT00475449|Stent|stent
5288868|NCT00475449|coronary artery bypass grafting|coronary artery bypass grafting
5288869|NCT00475436|muscarinic receptor antagonist|muscarinic receptor antagonist
5288870|NCT00475436|GSK573719,|gsk573719,
5288871|NCT00475436|chronic obstructive pulmonary disease,|chronic obstructive pulmonary disease,
5288872|NCT00475410|Autologous adipose-derived stem cells|autologous adipose-derived stem cells
5288873|NCT00475410|Complex perianal fistula|complex perianal fistula
5288874|NCT00475410|Inflammatory Bowel Disease|inflammatory bowel disease
5288875|NCT00475410|Advanced cell therapy|advanced cell therapy
5288876|NCT00475410|Fibrin glue|fibrin glue
5288877|NCT00475384|Acute Myelogenous Leukemia|acute myelogenous leukemia
5288878|NCT00475384|Acute Lymphocytic Leukemia|acute lymphocytic leukemia
5288879|NCT00475384|Myelodysplastic Syndrome|myelodysplastic syndrome
5288880|NCT00475384|Stem Cell Transplant|stem cell transplant
5288881|NCT00475384|Haploidentical Donor|haploidentical donor
5288882|NCT00475384|Leukemia|leukemia
5288883|NCT00475384|Fludarabine|fludarabine
5288884|NCT00475384|Total Body Irradiation|total body irradiation
5288885|NCT00475384|Thiotepa|thiotepa
5288886|NCT00475371|Healthy|healthy
5288887|NCT00475371|Diabetes Mellitus: Type II|diabetes mellitus: type ii
5288888|NCT00475345|Nocturnal hypoglycemia|nocturnal hypoglycemia
5288889|NCT00475345|Bedtime snacks|bedtime snacks
5288890|NCT00475345|Continuous glucose monitoring|continuous glucose monitoring
5288891|NCT00475345|Continuous subcutaneous insulin infusion|continuous subcutaneous insulin infusion
5288892|NCT00475345|CSII|csii
5288893|NCT00475345|Intensive therapy|intensive therapy
5288894|NCT00475319|Dry Eye Syndromes|dry eye syndromes
5288895|NCT00475319|OPC-12759|opc-12759
5288896|NCT00475306|Metoclopramide|metoclopramide
5288897|NCT00475306|Nausea|nausea
5288898|NCT00475306|Akathisia|akathisia
5288899|NCT00475306|Emergency department|emergency department
5288900|NCT00475293|metastatic colorectal cancer|metastatic colorectal cancer
5288901|NCT00475293|2nd-line Therapy|2nd-line therapy
5288902|NCT00475293|panitumumab|panitumumab
5288903|NCT00475293|irinotecan|irinotecan
5288904|NCT00475280|geriatric assessment adapted therapy|geriatric assessment adapted therapy
5288905|NCT00475280|Leukemia, Lymphoblastic, Acute|leukemia, lymphoblastic, acute
5288906|NCT00475280|Older patients|older patients
5288907|NCT00475280|> 60 years old|> 60 years old
5288908|NCT00475280|Ph negative|ph negative
5288909|NCT00475267|aortic valve|aortic valve
5288910|NCT00475267|heart valve|heart valve
5288911|NCT00475267|tissue valve|tissue valve
5288912|NCT00475267|bioprosthesis|bioprosthesis
5288913|NCT00475267|valve disorder|valve disorder
5288914|NCT00475267|valve disease|valve disease
5288915|NCT00475267|cardiac surgery|cardiac surgery
5288916|NCT00475267|aortic valve stenosis|aortic valve stenosis
5288917|NCT00475267|aortic valve regurgitation|aortic valve regurgitation
5288918|NCT00475254|Retinitis Pigmentosa|retinitis pigmentosa
5288919|NCT00475254|stress|stress
5288920|NCT00475254|sleepiness|sleepiness
5288921|NCT00475254|low vision|low vision
5288922|NCT00475254|mind-body|mind-body
5288923|NCT00475241|Combat Disorders|combat disorders
5288924|NCT00475241|Cortisol|cortisol
5288925|NCT00475241|Posttraumatic Stress Disorder (PTSD)|posttraumatic stress disorder (ptsd)
5288926|NCT00475241|Psychophysiology|psychophysiology
5288927|NCT00475241|Therapy|therapy
5288928|NCT00475241|Treatment|treatment
5288929|NCT00475241|Veterans|veterans
5288930|NCT00475228|levonorgestrel IUD|levonorgestrel iud
5288932|NCT00475228|dilation and evacuation|dilation and evacuation
5288933|NCT00475228|contraception|contraception
5288934|NCT00475189|birth control|birth control
5288935|NCT00475189|PMS|pms
5288936|NCT00475189|headaches|headaches
5288937|NCT00475189|mood swings|mood swings
5288938|NCT00475189|pelvic pain|pelvic pain
5288939|NCT00475176|Hepatitis C Virus Genotype 1|hepatitis c virus genotype 1
5288940|NCT00475176|Non-Responders|non-responders
5288941|NCT00475176|SAMe|same
5288942|NCT00475176|Natural Killer Cells|natural killer cells
5288943|NCT00475176|Interferon Signaling|interferon signaling
5288944|NCT00475176|Ribavirin|ribavirin
5288945|NCT00475176|Peginterferon|peginterferon
5288946|NCT00475176|Hemolysis|hemolysis
5288947|NCT00475176|STAT|stat
5288948|NCT00475176|Hepatitis C|hepatitis c
5288949|NCT00475163|Obesity|obesity
5288950|NCT00475163|Mentoring|mentoring
5288951|NCT00475163|Fitness|fitness
5288952|NCT00475163|Self-esteem|self-esteem
5288953|NCT00475137|Bipolar II Disorder|bipolar ii disorder
5288954|NCT00475137|depression|depression
5288955|NCT00475137|Lamotrigine|lamotrigine
5288956|NCT00475137|Add On antidepressant|add on antidepressant
5288957|NCT00475137|randomized|randomized
5288958|NCT00475137|single blind|single blind
5288959|NCT00475137|parallel group|parallel group
5288960|NCT00475124|Pacemaker follow-up|pacemaker follow-up
5288961|NCT00475124|Telecardiology|telecardiology
5288962|NCT00475124|Home Monitoring|home monitoring
5288963|NCT00475111|Cognitive Behavioral Intervention|cognitive behavioral intervention
5288964|NCT00475111|Emotion Regulation|emotion regulation
5288965|NCT00475111|Pain Management|pain management
5288966|NCT00475111|Psychological Adaptation|psychological adaptation
5288967|NCT00475111|Coping Efficacy|coping efficacy
5288968|NCT00475111|Markers of Disease Activity|markers of disease activity
5288969|NCT00475098|Low molecular weight heparin|low molecular weight heparin
5288970|NCT00475098|Lung cancer|lung cancer
5288971|NCT00475098|Non small cell lung cancer|non small cell lung cancer
5288972|NCT00475098|Adjuvant therapy|adjuvant therapy
5288973|NCT00475098|Anticoagulants|anticoagulants
5288974|NCT00475098|Heparin|heparin
5288975|NCT00475085|nausea and vomiting|nausea and vomiting
5288976|NCT00475085|recurrent breast cancer|recurrent breast cancer
5288977|NCT00475085|stage I breast cancer|stage i breast cancer
5288978|NCT00475085|stage II breast cancer|stage ii breast cancer
5288979|NCT00475085|stage IIIA breast cancer|stage iiia breast cancer
5288980|NCT00475085|stage IIIB breast cancer|stage iiib breast cancer
5288981|NCT00475085|stage IIIC breast cancer|stage iiic breast cancer
5288982|NCT00475085|stage IV breast cancer|stage iv breast cancer
5288983|NCT00475085|inflammatory breast cancer|inflammatory breast cancer
5288984|NCT00475085|male breast cancer|male breast cancer
5288985|NCT00475059|kidney transplantation|kidney transplantation
5288986|NCT00475059|Glomerular filtration rate|glomerular filtration rate
5288987|NCT00475059|inulin clearance|inulin clearance
5288988|NCT00475059|MDRD equation|mdrd equation
5288989|NCT00475059|cystatin C|cystatin c
5288990|NCT00475059|cimetidine|cimetidine
5288991|NCT00475046|smoking|smoking
5288992|NCT00475046|post partum|post partum
5288993|NCT00475046|relapse prevention|relapse prevention
5288994|NCT00475046|motivational interviewing|motivational interviewing
5288995|NCT00475046|TTM|ttm
5288996|NCT00475046|implement motivational enhancement interventions in pediatric practices|implement motivational enhancement interventions in pediatric practices
5288997|NCT00475046|examine the effectiveness of the intervention|examine the effectiveness of the intervention
5288998|NCT00475046|develop measurements appropriate to tailor interventions|develop measurements appropriate to tailor interventions
5288999|NCT00475046|analyze further unfavorable and favorable factors outlined by previous research|analyze further unfavorable and favorable factors outlined by previous research
5289000|NCT00475020|Idiopathic Myelofibrosis|idiopathic myelofibrosis
5289001|NCT00475020|Myelofibrosis|myelofibrosis
5289002|NCT00475020|Essential Thrombocythemia|essential thrombocythemia
5289003|NCT00475020|Polycythemia Vera|polycythemia vera
5289004|NCT00475020|Busulfan|busulfan
5289005|NCT00475020|Antithymocyte Globulin|antithymocyte globulin
5289006|NCT00475020|ATG|atg
5289007|NCT00475020|Fludarabine|fludarabine
5289008|NCT00475020|Thymoglobulin|thymoglobulin
5289009|NCT00475007|Emphysema|emphysema
5289010|NCT00475007|IBV® Valve|ibv® valve
5289011|NCT00475007|COPD|copd
5289012|NCT00475007|Shortness of Breath|shortness of breath
5289013|NCT00475007|Spiration|spiration
5289014|NCT00474994|chondrosarcoma|chondrosarcoma
5289015|NCT00474994|recurrent osteosarcoma|recurrent osteosarcoma
5289016|NCT00474994|localized adult malignant fibrous histiocytoma of bone|localized adult malignant fibrous histiocytoma of bone
5289017|NCT00474994|metastatic adult malignant fibrous histiocytoma of bone|metastatic adult malignant fibrous histiocytoma of bone
5289018|NCT00474994|recurrent adult malignant fibrous histiocytoma of bone|recurrent adult malignant fibrous histiocytoma of bone
5289019|NCT00474994|recurrent Ewing sarcoma/peripheral primitive neuroectodermal tumor|recurrent ewing sarcoma/peripheral primitive neuroectodermal tumor
5289020|NCT00474994|recurrent Kaposi sarcoma|recurrent kaposi sarcoma
5289021|NCT00474994|recurrent uterine sarcoma|recurrent uterine sarcoma
5289022|NCT00474994|adult leiomyosarcoma|adult leiomyosarcoma
5289023|NCT00474994|adult malignant fibrous histiocytoma|adult malignant fibrous histiocytoma
5289024|NCT00474994|adult rhabdomyosarcoma|adult rhabdomyosarcoma
5289025|NCT00474994|dermatofibrosarcoma protuberans|dermatofibrosarcoma protuberans
5289026|NCT00474994|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
5289027|NCT00474994|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
5289028|NCT00474994|ovarian sarcoma|ovarian sarcoma
5289029|NCT00474994|uterine leiomyosarcoma|uterine leiomyosarcoma
5289030|NCT00474994|stage III uterine sarcoma|stage iii uterine sarcoma
5289031|NCT00474994|stage IV uterine sarcoma|stage iv uterine sarcoma
5289032|NCT00474994|desmoid tumor|desmoid tumor
5289033|NCT00474994|adult angiosarcoma|adult angiosarcoma
5289034|NCT00474994|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
5289035|NCT00474994|uterine carcinosarcoma|uterine carcinosarcoma
5289036|NCT00474994|endometrial stromal sarcoma|endometrial stromal sarcoma
5289037|NCT00474994|fibrosarcomatous osteosarcoma|fibrosarcomatous osteosarcoma
5289038|NCT00474994|chondrosarcomatous osteosarcoma|chondrosarcomatous osteosarcoma
5289039|NCT00474994|adult alveolar soft-part sarcoma|adult alveolar soft-part sarcoma
5289040|NCT00474994|adult epithelioid sarcoma|adult epithelioid sarcoma
5289041|NCT00474994|adult extraskeletal chondrosarcoma|adult extraskeletal chondrosarcoma
5289042|NCT00474994|adult extraskeletal osteosarcoma|adult extraskeletal osteosarcoma
5289043|NCT00474994|adult fibrosarcoma|adult fibrosarcoma
5289044|NCT00474994|adult malignant hemangiopericytoma|adult malignant hemangiopericytoma
5289045|NCT00474994|adult malignant mesenchymoma|adult malignant mesenchymoma
5289046|NCT00474994|adult neurofibrosarcoma|adult neurofibrosarcoma
5289047|NCT00474994|adult synovial sarcoma|adult synovial sarcoma
5289048|NCT00474994|adult desmoplastic small round cell tumor|adult desmoplastic small round cell tumor
5289049|NCT00474994|adult liposarcoma|adult liposarcoma
5289050|NCT00474994|anaplastic osteosarcoma|anaplastic osteosarcoma
5289051|NCT00474994|mixed osteosarcoma|mixed osteosarcoma
5289052|NCT00474994|small intestine leiomyosarcoma|small intestine leiomyosarcoma
5289053|NCT00474994|osteoblastic osteosarcoma|osteoblastic osteosarcoma
5289054|NCT00474994|telangiectatic osteosarcoma|telangiectatic osteosarcoma
5289055|NCT00474994|classic Kaposi sarcoma|classic kaposi sarcoma
5289056|NCT00474994|immunosuppressive treatment related Kaposi sarcoma|immunosuppressive treatment related kaposi sarcoma
5289057|NCT00474994|AIDS-related Kaposi sarcoma|aids-related kaposi sarcoma
5289058|NCT00474981|neonatal mortality|neonatal mortality
5289059|NCT00474981|infant mortality|infant mortality
5289060|NCT00474981|newborn caring practices|newborn caring practices
5289061|NCT00474942|Hypertension|hypertension
5289062|NCT00474942|Metabolic Alkalosis|metabolic alkalosis
5289063|NCT00474942|Hypokalemia|hypokalemia
5289064|NCT00474929|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5289065|NCT00474929|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5289066|NCT00474929|stage III multiple myeloma|stage iii multiple myeloma
5289067|NCT00474929|refractory multiple myeloma|refractory multiple myeloma
5289068|NCT00474929|Waldenström macroglobulinemia|waldenström macroglobulinemia
5289069|NCT00474929|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5289070|NCT00474929|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5289071|NCT00474929|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5289072|NCT00474929|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5289073|NCT00474929|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5289074|NCT00474929|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5289075|NCT00474929|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5289076|NCT00474929|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5289077|NCT00474929|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5289078|NCT00474929|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5289079|NCT00474929|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5289080|NCT00474929|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5289081|NCT00474929|cutaneous B-cell non-Hodgkin lymphoma|cutaneous b-cell non-hodgkin lymphoma
5289082|NCT00474929|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5289083|NCT00474929|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5289084|NCT00474929|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5289085|NCT00474929|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5289086|NCT00474929|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
5289087|NCT00474916|Neuropathic pain|neuropathic pain
5289088|NCT00474916|Cancer|cancer
5289089|NCT00474890|Seasonal allergic rhinitis|seasonal allergic rhinitis
5289090|NCT00474877|Clinical|clinical
5289091|NCT00474877|Splints|splints
5289092|NCT00474877|Rheumatoid|rheumatoid
5289093|NCT00474864|Endothelial Function,|endothelial function,
5289094|NCT00474864|vascular compliance,|vascular compliance,
5289095|NCT00474864|atherosclerosis|atherosclerosis
5289096|NCT00474851|Endometriosis|endometriosis
5289097|NCT00474851|Adolescents|adolescents
5289098|NCT00474851|Bone density|bone density
5289099|NCT00474851|GnRH Agonist|gnrh agonist
5289100|NCT00474851|Add-back therapy|add-back therapy
5289101|NCT00474838|type 2 diabetes mellitus|type 2 diabetes mellitus
5289102|NCT00474838|intensive insulin therapy|intensive insulin therapy
5289103|NCT00474786|Metastatic or Advanced Renal Cell Carcinoma|metastatic or advanced renal cell carcinoma
5289104|NCT00474747|Severe Aplastic Anemia|severe aplastic anemia
5289105|NCT00474747|Total Body Irradiation|total body irradiation
5289106|NCT00474747|Antithymocyte Globulin|antithymocyte globulin
5289107|NCT00474747|Cyclophosphamide|cyclophosphamide
5289108|NCT00474747|Cytoxan|cytoxan
5289109|NCT00474747|Neosar|neosar
5289110|NCT00474747|Fludarabine|fludarabine
5289111|NCT00474747|Fludara|fludara
5289112|NCT00474747|Fludarabine Phosphate|fludarabine phosphate
5289113|NCT00474747|Thymoglobulin|thymoglobulin
5289114|NCT00474747|ATG|atg
5289115|NCT00474747|TBI|tbi
5289116|NCT00474747|Cyclosporine|cyclosporine
5289117|NCT00474747|Tacrolimus|tacrolimus
5289118|NCT00474734|hepatocellular carcinoma|hepatocellular carcinoma
5289119|NCT00474734|liver transplantation|liver transplantation
5289120|NCT00474734|staging|staging
5289121|NCT00474734|intravascular ultrasound|intravascular ultrasound
5289122|NCT00474721|child|child
5289123|NCT00474721|pain|pain
5289124|NCT00474721|analgesics|analgesics
5289125|NCT00474695|Exudative age-related macular degeneration|exudative age-related macular degeneration
5289126|NCT00474682|ferric pyrophosphate, iron bioavailability, fortification,|ferric pyrophosphate, iron bioavailability, fortification,
5289127|NCT00474669|Ovarian Carcinoma|ovarian carcinoma
5289128|NCT00474656|high frequency oscillation|high frequency oscillation
5289129|NCT00474656|lung-protective ventilation|lung-protective ventilation
5289130|NCT00474656|ARDS|ards
5289131|NCT00474656|ventilator-induced lung injury|ventilator-induced lung injury
5289132|NCT00474630|Obesity|obesity
5289133|NCT00474630|Overweight|overweight
5289134|NCT00474630|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
5289135|NCT00474604|breast cancer|breast cancer
5289136|NCT00474591|Coronary artery bypass surgery, fondaparinux, graft patency, graft occlusion, graft failure, anticoagulation|coronary artery bypass surgery, fondaparinux, graft patency, graft occlusion, graft failure, anticoagulation
5289137|NCT00474565|Catheter,|catheter,
5289138|NCT00474565|Aortic root injection,|aortic root injection,
5289139|NCT00474565|low dose contrast injection,|low dose contrast injection,
5289140|NCT00474565|coronary artery angiogarm and|coronary artery angiogarm and
5289141|NCT00474565|coronary artery bypass graft imaging.|coronary artery bypass graft imaging.
5289142|NCT00474539|Vaccine|vaccine
5289143|NCT00474526|Meningococcal|meningococcal
5289144|NCT00474526|meningitis|meningitis
5289145|NCT00474526|vaccine|vaccine
5289146|NCT00474526|infants|infants
5289147|NCT00474526|Meningococcal meningitis|meningococcal meningitis
5289148|NCT00474526|Meningococcal disease|meningococcal disease
5289149|NCT00474513|AD, H3, Brain, Cognitive Impairment|ad, h3, brain, cognitive impairment
5289150|NCT00474500|Iron absorption|iron absorption
5289151|NCT00474500|Coca-Cola|coca-cola
5289152|NCT00474487|Meningococcal|meningococcal
5289153|NCT00474487|meningitis|meningitis
5289154|NCT00474487|vaccine|vaccine
5289155|NCT00474487|adolescents|adolescents
5289156|NCT00474487|adults|adults
5289157|NCT00474474|virtual patient|virtual patient
5289158|NCT00474474|therapeutic decision making|therapeutic decision making
5289159|NCT00474461|coronary artery disease|coronary artery disease
5289160|NCT00474461|Heart Attack|heart attack
5289161|NCT00474461|Heart failure|heart failure
5289162|NCT00474461|Cardiac Stem Cells|cardiac stem cells
5289163|NCT00474461|Coronary Artery Bypass|coronary artery bypass
5289164|NCT00474448|Hereditary Multiple Exostoses|hereditary multiple exostoses
5289165|NCT00474448|Survey|survey
5289166|NCT00474448|Quality of Life|quality of life
5289167|NCT00474448|Hereditary Multiple Exostoses,|hereditary multiple exostoses,
5289168|NCT00474448|also known as Multiple Hereditary Exostoses,|also known as multiple hereditary exostoses,
5289169|NCT00474448|also known as Hereditary Multiple Osteochondromas|also known as hereditary multiple osteochondromas
5289170|NCT00474435|Tuberculosis|tuberculosis
5289171|NCT00474435|HIV|hiv
5289172|NCT00474435|Coinfection|coinfection
5289173|NCT00474435|Pharmacokinetics|pharmacokinetics
5289174|NCT00474435|Emtricitabine|emtricitabine
5289175|NCT00474435|Tenofovir|tenofovir
5289176|NCT00474435|Rifampin|rifampin
5289177|NCT00474435|Efavirenz|efavirenz
5289178|NCT00474435|Treatment Naive|treatment naive
5289179|NCT00474422|breastfeeding|breastfeeding
5289180|NCT00474422|support|support
5289181|NCT00474409|Vertigo|vertigo
5289182|NCT00474409|Posterior circulation infarction|posterior circulation infarction
5289183|NCT00474396|Uric acid|uric acid
5289184|NCT00474396|Dairy|dairy
5289185|NCT00474396|Diet|diet
5289186|NCT00474383|Prostate neoplasms|prostate neoplasms
5289187|NCT00474383|CB7630|cb7630
5289188|NCT00474383|Abiraterone acetate|abiraterone acetate
5289189|NCT00474383|Glucocorticoid|glucocorticoid
5289190|NCT00474383|Prednisone|prednisone
5289191|NCT00474383|Prednisolone|prednisolone
5289192|NCT00474370|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5289193|NCT00474357|Bipolar affective disorder|bipolar affective disorder
5289194|NCT00474357|myths|myths
5289195|NCT00474357|preconceived notions|preconceived notions
5289196|NCT00474357|stigma|stigma
5289197|NCT00474357|hope|hope
5289198|NCT00474344|Genetics|genetics
5289199|NCT00474344|Clubfoot|clubfoot
5289200|NCT00474344|DNA|dna
5289201|NCT00474344|Idiopathic Talipes Equinovarus also known as Clubfoot|idiopathic talipes equinovarus also known as clubfoot
5289202|NCT00474331|DNA sequencing|dna sequencing
5289203|NCT00474331|EXT genes|ext genes
5289204|NCT00474331|Hereditary Multiple Exostoses,|hereditary multiple exostoses,
5289205|NCT00474331|also known as Multiple Hereditary Exostoses,|also known as multiple hereditary exostoses,
5289206|NCT00474331|also known as Hereditary Multiple Osteochondromas|also known as hereditary multiple osteochondromas
5289207|NCT00474318|Adolescents|adolescents
5289208|NCT00474318|Obesity|obesity
5289209|NCT00474318|Bariatrics|bariatrics
5289210|NCT00474318|Surgery for Weight Loss|surgery for weight loss
5289211|NCT00474318|Teen-LABS|teen-labs
5289212|NCT00474305|PTSD|ptsd
5289213|NCT00474305|Prolonged Exposure|prolonged exposure
5289214|NCT00474305|Virtual Reality|virtual reality
5289215|NCT00474292|Stroke|stroke
5289216|NCT00474292|Rehabilitation|rehabilitation
5289217|NCT00474292|Plasticity|plasticity
5289218|NCT00474292|fMRI|fmri
5289219|NCT00474292|Reorganization|reorganization
5289220|NCT00474279|Growth hormone secretagogue|growth hormone secretagogue
5289221|NCT00474279|Body composition|body composition
5289222|NCT00474279|Functional ability|functional ability
5289223|NCT00474279|Aging|aging
5289224|NCT00474279|Sarcopenia|sarcopenia
5289225|NCT00474266|MMRV vaccine|mmrv vaccine
5289226|NCT00474266|co-administration|co-administration
5289227|NCT00474266|immunogenicity|immunogenicity
5289228|NCT00474266|meningococcal vaccine|meningococcal vaccine
5289229|NCT00474266|conjugate vaccine|conjugate vaccine
5289230|NCT00474240|cholesterol|cholesterol
5289231|NCT00474227|obesity|obesity
5289232|NCT00474227|weight gain|weight gain
5289233|NCT00474227|schizophrenia|schizophrenia
5289234|NCT00474227|schizoaffective disorder|schizoaffective disorder
5289235|NCT00474227|antipsychotic induced weight gain|antipsychotic induced weight gain
5289236|NCT00474214|STEMI|stemi
5289237|NCT00474214|Primary PCI|primary pci
5289238|NCT00474214|Length of Stay|length of stay
5289239|NCT00474214|Early Discharge|early discharge
5289240|NCT00474201|Pharmacokinetic|pharmacokinetic
5289241|NCT00474201|HIV|hiv
5289242|NCT00474201|Drug-Drug Interaction|drug-drug interaction
5289243|NCT00474201|Lopinavir/Ritonavir|lopinavir/ritonavir
5289244|NCT00474201|Gemfibrozil|gemfibrozil
5289245|NCT00474201|Healthy Volunteer|healthy volunteer
5289246|NCT00474201|HV|hv
5289247|NCT00474188|Celgene|celgene
5289248|NCT00474188|Revlimid|revlimid
5289249|NCT00474188|Lenalidomide|lenalidomide
5289250|NCT00474188|Diffuse Large B-cell lymphoma|diffuse large b-cell lymphoma
5289251|NCT00474188|Non-Hodgkins lymphoma|non-hodgkins lymphoma
5289252|NCT00474188|CC-5013|cc-5013
5289253|NCT00474188|Response Rate|response rate
5289254|NCT00474188|Tumor Control Rate|tumor control rate
5289255|NCT00474188|Duration of Response|duration of response
5289256|NCT00474188|Time to Progression|time to progression
5289257|NCT00474188|Progression-free survival and safety|progression-free survival and safety
5289258|NCT00474162|Cesarean section|cesarean section
5289259|NCT00474162|coagulation changes|coagulation changes
5289260|NCT00474123|angina|angina
5289261|NCT00474123|atherosclerosis|atherosclerosis
5289262|NCT00474123|simvastatin|simvastatin
5289263|NCT00474123|ezetimibe|ezetimibe
5289264|NCT00474123|inflammation|inflammation
5289265|NCT00474110|Ketamine|ketamine
5289266|NCT00474110|hydromorphone|hydromorphone
5289267|NCT00474110|pediatric mucositis|pediatric mucositis
5289268|NCT00474097|Colorectal Neoplasms|colorectal neoplasms
5289269|NCT00474097|Colitis, Ulcerative|colitis, ulcerative
5289270|NCT00474097|Diverticulitis|diverticulitis
5289271|NCT00474097|Colonic Polyps|colonic polyps
5289272|NCT00474097|Crohn Disease|crohn disease
5289273|NCT00474084|Stent|stent
5289274|NCT00474084|Hydroxyapatite|hydroxyapatite
5289275|NCT00474084|Coronary Artery Stenosis|coronary artery stenosis
5289276|NCT00474084|Angioplasty|angioplasty
5289277|NCT00474071|Remifentanil|remifentanil
5289278|NCT00474071|endotracheal intubation|endotracheal intubation
5289279|NCT00474071|pediatrics|pediatrics
5289280|NCT00474058|rotigotine|rotigotine
5289281|NCT00474058|Neupro®|neupro®
5289282|NCT00474058|Parkinson's Disease|parkinson's disease
5289283|NCT00474032|Idiopathic clubfoot|idiopathic clubfoot
5289284|NCT00474032|Botox injection|botox injection
5289285|NCT00474032|Idiopathic Talipes Equinovarus, also known as Idiopathic clubfoot|idiopathic talipes equinovarus, also known as idiopathic clubfoot
5289286|NCT00474019|pediatrics|pediatrics
5289287|NCT00474019|neonates|neonates
5289288|NCT00473993|Hepatitis C|hepatitis c
5289289|NCT00473993|Opioid Maintenance Treatment|opioid maintenance treatment
5289290|NCT00473993|Methadone|methadone
5289291|NCT00473993|Buprenorphine|buprenorphine
5289292|NCT00473993|Heroin|heroin
5289293|NCT00473993|Interferon, pegylated|interferon, pegylated
5289294|NCT00473980|MHC|mhc
5289295|NCT00473980|CTLs|ctls
5289296|NCT00473980|Colon carcinoma|colon carcinoma
5289297|NCT00473980|NSAID|nsaid
5289298|NCT00473980|Survival|survival
5289299|NCT00473967|Vaccine|vaccine
5289300|NCT00473967|Hookworm|hookworm
5289301|NCT00473967|Phase 1|phase 1
5289302|NCT00473967|Na-ASP-2|na-asp-2
5289303|NCT00473941|colorectal cancer|colorectal cancer
5289304|NCT00473941|colon cancer|colon cancer
5289305|NCT00473941|rectal cancer|rectal cancer
5289306|NCT00473928|Macular|macular
5289307|NCT00473928|degeration|degeration
5289308|NCT00473928|Complement|complement
5289309|NCT00473876|Chronic Heart Failure|chronic heart failure
5289310|NCT00473876|Insulin Resistance|insulin resistance
5289311|NCT00473876|Metformin|metformin
5289312|NCT00473876|Peak VO2|peak vo2
5289313|NCT00473863|Acute coronary syndrome|acute coronary syndrome
5289314|NCT00473863|Acute myocardial infarction|acute myocardial infarction
5289315|NCT00473863|Unstable angina|unstable angina
5289316|NCT00473863|Coronary computed tomographic angiography|coronary computed tomographic angiography
5289317|NCT00473863|Coronary Angiography|coronary angiography
5289318|NCT00473863|Tomography, X-Ray Computed|tomography, x-ray computed
5289319|NCT00473863|Tomography, Spiral Computed|tomography, spiral computed
5289320|NCT00473850|DNA sequencing|dna sequencing
5289321|NCT00473850|EXT genes|ext genes
5289322|NCT00473850|Hereditary Multiple Exostoses,|hereditary multiple exostoses,
5289323|NCT00473850|also known as Multiple Hereditary Exostoses,|also known as multiple hereditary exostoses,
5289324|NCT00473850|also known as Hereditary Multiple Osteochondromas|also known as hereditary multiple osteochondromas
5289325|NCT00473837|malaria|malaria
5289326|NCT00473837|anaemia|anaemia
5289327|NCT00473837|chloroquine|chloroquine
5289328|NCT00473837|iron delocalisation|iron delocalisation
5289329|NCT00473837|macrophages|macrophages
5289330|NCT00473824|hepatitis C|hepatitis c
5289331|NCT00473824|liver transplantation|liver transplantation
5289332|NCT00473824|immune globulin|immune globulin
5289333|NCT00473811|Glycemic index|glycemic index
5289334|NCT00473811|carbohydrates|carbohydrates
5289335|NCT00473811|diabetes mellitus, type 2|diabetes mellitus, type 2
5289336|NCT00473811|randomized clinical trial|randomized clinical trial
5289337|NCT00473798|Patient Satisfaction|patient satisfaction
5289338|NCT00473798|Quality of Life|quality of life
5289339|NCT00473798|Psychological Distress|psychological distress
5289340|NCT00473798|Cervical Cancer|cervical cancer
5289341|NCT00473798|Cervical Cancer Screening|cervical cancer screening
5289342|NCT00473798|Questionnaire|questionnaire
5289343|NCT00473785|Cardiovascular disease|cardiovascular disease
5289344|NCT00473785|Prevention|prevention
5289345|NCT00473785|Lifestyle|lifestyle
5289346|NCT00473772|cobalt chromium stent|cobalt chromium stent
5289347|NCT00473772|paclitaxel coated balloon catheter|paclitaxel coated balloon catheter
5289348|NCT00473772|DEBlue|deblue
5289349|NCT00473772|drug eluting balloon|drug eluting balloon
5289350|NCT00473746|Prostate neoplasms|prostate neoplasms
5289351|NCT00473746|Hormone refractory prostate cancer|hormone refractory prostate cancer
5289352|NCT00473746|Abiraterone acetate|abiraterone acetate
5289353|NCT00473746|CB7630|cb7630
5289354|NCT00473733|PATIENTS WITH DIABETES MELLITUS TYPE 2|patients with diabetes mellitus type 2
5289355|NCT00473733|UNDERGO UPPER ENDOSCOPY|undergo upper endoscopy
5289356|NCT00473733|BIOPSIES FOR GLP RECEPTORS EXPRESSION|biopsies for glp receptors expression
5289357|NCT00473733|PCR ANALYSIS|pcr analysis
5289358|NCT00473707|Third stage of labor|third stage of labor
5289359|NCT00473668|Hepatitis B|hepatitis b
5289360|NCT00473668|Tetanus|tetanus
5289361|NCT00473668|Diphtheria|diphtheria
5289362|NCT00473668|Pertussis|pertussis
5289363|NCT00473668|Haemophilus influenzae type b Vaccines|haemophilus influenzae type b vaccines
5289364|NCT00473655|Triglycerides|triglycerides
5289365|NCT00473655|hypertriglyceridemia|hypertriglyceridemia
5289366|NCT00473655|statins|statins
5289367|NCT00473655|rosuvastatin|rosuvastatin
5289368|NCT00473655|hyperlipoproteinemia|hyperlipoproteinemia
5289369|NCT00473655|Fredrickson Type IIb or IV|fredrickson type iib or iv
5289370|NCT00473642|Ranibizumab|ranibizumab
5289371|NCT00473642|Lucentis|lucentis
5289372|NCT00473642|Verteporfin|verteporfin
5289373|NCT00473642|Visudyne|visudyne
5289374|NCT00473642|Photodynamic therapy|photodynamic therapy
5289375|NCT00473616|Phase I|phase i
5289376|NCT00473616|solid tumors|solid tumors
5289377|NCT00473616|solid malignancies|solid malignancies
5289378|NCT00473616|cancer Eligibility|cancer eligibility
5289379|NCT00473603|androgens|androgens
5289380|NCT00473603|fatty acids|fatty acids
5289381|NCT00473590|Avastin|avastin
5289382|NCT00473590|AMBER|amber
5289383|NCT00473590|Myeloma|myeloma
5289384|NCT00473590|Velcade|velcade
5289385|NCT00473564|Lesions|lesions
5289386|NCT00473564|Biopsy|biopsy
5289387|NCT00473564|Surgery|surgery
5289388|NCT00473551|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
5289389|NCT00473551|Lymphoma|lymphoma
5289390|NCT00473551|Myeloma|myeloma
5289391|NCT00473551|Leukemia|leukemia
5289392|NCT00473551|Anti-Third Party Cytolytic Lymphocytes|anti-third party cytolytic lymphocytes
5289393|NCT00473551|Indolent Lymphoid Malignancies|indolent lymphoid malignancies
5289394|NCT00473551|Fludarabine|fludarabine
5289395|NCT00473551|Fludara|fludara
5289396|NCT00473551|Rituximab|rituximab
5289397|NCT00473551|Rituxan|rituxan
5289398|NCT00473551|Cyclophosphamide|cyclophosphamide
5289399|NCT00473551|Cytoxan®|cytoxan®
5289400|NCT00473551|Neosar®|neosar®
5289401|NCT00473551|Stem Cell Transplantation|stem cell transplantation
5289402|NCT00473551|T-lymphocytes|t-lymphocytes
5289403|NCT00473551|Miltenyi CliniMACS System|miltenyi clinimacs system
5289404|NCT00473551|Graft vs. Host Disease|graft vs. host disease
5289405|NCT00473551|GVHD|gvhd
5289406|NCT00473551|Allogenic Transplant|allogenic transplant
5289407|NCT00473551|Sirolimus|sirolimus
5289408|NCT00473551|Rapamycin|rapamycin
5289409|NCT00473538|Structured exercise training program|structured exercise training program
5289410|NCT00473538|Infertility|infertility
5289411|NCT00473538|Menstrual cycle|menstrual cycle
5289412|NCT00473538|PCOS|pcos
5289413|NCT00473538|Treatment|treatment
5289414|NCT00473512|Abiraterone acetate|abiraterone acetate
5289415|NCT00473512|CB7630|cb7630
5289416|NCT00473512|Prostatic neoplasms|prostatic neoplasms
5289417|NCT00473512|Hormone refractory prostate cancer|hormone refractory prostate cancer
5289418|NCT00473512|Castration resistant prostate cancer|castration resistant prostate cancer
5289419|NCT00473512|Castration refractory prostate cancer|castration refractory prostate cancer
5289420|NCT00473499|drug eluting balloon|drug eluting balloon
5289421|NCT00473499|drug eluting stent|drug eluting stent
5289422|NCT00473499|stem cells|stem cells
5289423|NCT00473473|homeopathy|homeopathy
5289424|NCT00473473|Traumeel|traumeel
5289425|NCT00473473|mechanical ventilation|mechanical ventilation
5289426|NCT00473473|secretions|secretions
5289427|NCT00473460|Chronic bronchitis|chronic bronchitis
5289428|NCT00473460|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
5289429|NCT00473460|Acute exacerbation of chronic bronchitis|acute exacerbation of chronic bronchitis
5289430|NCT00473460|Prevention therapy|prevention therapy
5289431|NCT00473460|Antibiotics|antibiotics
5289432|NCT00473460|Fluoroquinolone|fluoroquinolone
5289433|NCT00473460|Moxifloxacin|moxifloxacin
5289434|NCT00473460|AECB|aecb
5289435|NCT00473447|Rehabilitation|rehabilitation
5289436|NCT00473447|Children|children
5289437|NCT00473447|Cerebral Palsy|cerebral palsy
5289438|NCT00473447|Arm|arm
5289439|NCT00473447|Paresis|paresis
5289440|NCT00473434|Schizophrenia|schizophrenia
5289441|NCT00473434|Drug Therapy|drug therapy
5289442|NCT00473434|Treatment Outcome|treatment outcome
5289443|NCT00473408|Glioma|glioma
5289444|NCT00473408|DCE-MRI|dce-mri
5289445|NCT00473408|Angiogenesis|angiogenesis
5289446|NCT00473408|Cancer stem cells|cancer stem cells
5289447|NCT00473408|Tumor vasculature|tumor vasculature
5289448|NCT00473382|Lucentis|lucentis
5289449|NCT00473382|DME|dme
5289450|NCT00473382|Diabetes|diabetes
5289451|NCT00473382|Vision loss|vision loss
5289452|NCT00473369|atypical adenoma|atypical adenoma
5289453|NCT00473369|Ki-67|ki-67
5289454|NCT00473369|p53|p53
5289455|NCT00473369|pituitary|pituitary
5289456|NCT00473369|prognosis|prognosis
5289457|NCT00473356|Morbid obesity|morbid obesity
5289458|NCT00473356|Lean body mass|lean body mass
5289459|NCT00473356|amino acid supplement|amino acid supplement
5289460|NCT00473356|laparoscopic gastric bypass|laparoscopic gastric bypass
5289461|NCT00473343|Photodynamic therapy (PDT)|photodynamic therapy (pdt)
5289462|NCT00473343|PDT with Metvix cream|pdt with metvix cream
5289463|NCT00473343|"High risk BCC"|"high risk bcc"
5289464|NCT00473343|Basal Cell carcinoma|basal cell carcinoma
5289465|NCT00473343|Histologically confirmed complete response|histologically confirmed complete response
5289466|NCT00473330|Lucentis|lucentis
5289467|NCT00473330|DME|dme
5289468|NCT00473330|Diabetes|diabetes
5289469|NCT00473330|Vision loss|vision loss
5289470|NCT00473317|sunlight|sunlight
5289471|NCT00473317|UVB|uvb
5289472|NCT00473317|Vitamin D|vitamin d
5289473|NCT00473304|Safety|safety
5289474|NCT00473304|Efficacy|efficacy
5289475|NCT00473304|Adaptation|adaptation
5289476|NCT00473304|myopia and contact lens wear in children|myopia and contact lens wear in children
5289477|NCT00473291|pleural effusion|pleural effusion
5289478|NCT00473291|lung sounds|lung sounds
5289479|NCT00473291|acoustic monitoring|acoustic monitoring
5289480|NCT00473278|tear protein|tear protein
5289481|NCT00473252|aspergillus infections|aspergillus infections
5289482|NCT00473252|immunosuppression|immunosuppression
5289483|NCT00473252|kidney transplantation|kidney transplantation
5289484|NCT00473252|hemodialysis|hemodialysis
5289485|NCT00473252|galactomannan test|galactomannan test
5289486|NCT00473252|fine dust|fine dust
5289487|NCT00473252|construction activity|construction activity
5289488|NCT00473252|airborne aspergillus spores|airborne aspergillus spores
5289489|NCT00473239|vitamin D|vitamin d
5289490|NCT00473239|cholecalciferol|cholecalciferol
5289491|NCT00473239|25-hydroxyvitamin D|25-hydroxyvitamin d
5289492|NCT00473213|Multiple Sclerosis|multiple sclerosis
5289493|NCT00473213|Interferon|interferon
5289494|NCT00473213|Magnetic Resonance|magnetic resonance
5289495|NCT00473200|hyperhomocysteinemia|hyperhomocysteinemia
5289496|NCT00473200|homocysteine|homocysteine
5289497|NCT00473200|S-adenosylmethionine|s-adenosylmethionine
5289498|NCT00473200|SAMe|same
5289499|NCT00473200|Asymmetric dimethylagrinine (ADMA)|asymmetric dimethylagrinine (adma)
5289500|NCT00473187|X-linked dominant hypophosphatemic rickets|x-linked dominant hypophosphatemic rickets
5289501|NCT00473187|growth disorders|growth disorders
5289502|NCT00473187|anthropometry|anthropometry
5289503|NCT00473187|human growth hormone|human growth hormone
5289504|NCT00473174|Ramipril|ramipril
5289606|NCT00472745|arthritis|arthritis
5289505|NCT00473174|Ambulatory blood pressure monitoring|ambulatory blood pressure monitoring
5289506|NCT00473174|Chronotherapy|chronotherapy
5289507|NCT00473174|Circadian|circadian
5289508|NCT00473174|Non-dipper|non-dipper
5289509|NCT00473161|movement disorders|movement disorders
5289510|NCT00473161|childhood|childhood
5289511|NCT00473148|Duration of weaning from invasive ventilation|duration of weaning from invasive ventilation
5289512|NCT00473148|Mechanical ventilation|mechanical ventilation
5289513|NCT00473148|Weaning|weaning
5289514|NCT00473148|B-type natriuretic peptide|b-type natriuretic peptide
5289515|NCT00473148|Fluid balance|fluid balance
5289516|NCT00473148|Diuretics|diuretics
5289517|NCT00473148|Intubated patient receiving mechanical ventilation|intubated patient receiving mechanical ventilation
5289518|NCT00473148|for at least 24 hours|for at least 24 hours
5289519|NCT00473148|Respiratory insufficiency|respiratory insufficiency
5289520|NCT00473135|Dengue Fever|dengue fever
5289521|NCT00473135|Dengue Vaccine|dengue vaccine
5289522|NCT00473135|Dengue Virus|dengue virus
5289523|NCT00473135|Dengue Hemorrhagic Fever|dengue hemorrhagic fever
5289524|NCT00473135|Dengue Shock Syndrome|dengue shock syndrome
5289525|NCT00473122|Breast Cancer|breast cancer
5289526|NCT00473122|Breast Reconstruction|breast reconstruction
5289527|NCT00473122|Delayed-Immediate Reconstruction|delayed-immediate reconstruction
5289528|NCT00473122|Postmastectomy Radiation Therapy|postmastectomy radiation therapy
5289529|NCT00473122|Mastectomy|mastectomy
5289530|NCT00473122|XRT|xrt
5289531|NCT00473109|Hemodialysis|hemodialysis
5289532|NCT00473109|Heparin|heparin
5289533|NCT00473109|Clotting|clotting
5289534|NCT00473096|Decision making|decision making
5289535|NCT00473096|Patient Education|patient education
5289536|NCT00473096|Indigency|indigency
5289537|NCT00473096|Minority group|minority group
5289538|NCT00473083|Rash|rash
5289539|NCT00473083|Erlotinib|erlotinib
5289540|NCT00473083|Lung Cancer|lung cancer
5289541|NCT00473057|acute stroke|acute stroke
5289542|NCT00473057|middle cerebral artery|middle cerebral artery
5289543|NCT00473057|autologous transplantation|autologous transplantation
5289544|NCT00473057|bone marrow cells|bone marrow cells
5289545|NCT00473057|stem cells|stem cells
5289546|NCT00473057|cell therapy|cell therapy
5289547|NCT00473031|bone mass|bone mass
5289548|NCT00473031|calcium absorption|calcium absorption
5289549|NCT00473031|bone quality|bone quality
5289550|NCT00473031|fracture risk|fracture risk
5289551|NCT00473018|postexposure prophylaxis|postexposure prophylaxis
5289552|NCT00473018|HIV Seronegativity|hiv seronegativity
5289553|NCT00472992|Pregnancy|pregnancy
5289554|NCT00472992|TYSABRI|tysabri
5289555|NCT00472940|Cancer|cancer
5289556|NCT00472940|Hypogonadism|hypogonadism
5289557|NCT00472940|testosterone|testosterone
5289558|NCT00472940|cachexia|cachexia
5289559|NCT00472914|Hypertonia|hypertonia
5289560|NCT00472914|Childhood|childhood
5289561|NCT00472901|Polymorphic Light Eruption (PLE)|polymorphic light eruption (ple)
5289562|NCT00472901|Afamelanotide|afamelanotide
5289563|NCT00472901|CUV1647|cuv1647
5289564|NCT00472901|photoprotection|photoprotection
5289565|NCT00472901|sun poisoning|sun poisoning
5289566|NCT00472888|Alpha-adrenergic blockers|alpha-adrenergic blockers
5289567|NCT00472888|cataract surgery|cataract surgery
5289568|NCT00472888|pseudoexfoliation syndrome|pseudoexfoliation syndrome
5289569|NCT00472888|diabetes mellitus|diabetes mellitus
5289570|NCT00472888|hypertension|hypertension
5289571|NCT00472888|pupil|pupil
5289572|NCT00472875|hypoglycaemia|hypoglycaemia
5289573|NCT00472875|type 1 diabetes mellitus|type 1 diabetes mellitus
5289574|NCT00472849|OFAR 2|ofar 2
5289575|NCT00472849|Oxaliplatin|oxaliplatin
5289576|NCT00472849|Fludarabine|fludarabine
5289577|NCT00472849|Cytarabine|cytarabine
5289578|NCT00472849|Ara-C|ara-c
5289579|NCT00472849|Rituximab|rituximab
5289580|NCT00472849|Richter's Transformation|richter's transformation
5289581|NCT00472849|Prolymphocytic Leukemia|prolymphocytic leukemia
5289582|NCT00472849|B-Cell Chronic Lymphocytic Leukemia|b-cell chronic lymphocytic leukemia
5289583|NCT00472849|Leukemia|leukemia
5289584|NCT00472849|CLL|cll
5289585|NCT00472823|cholecalciferol|cholecalciferol
5289586|NCT00472823|vitamin D deficiency|vitamin d deficiency
5289587|NCT00472823|bone density|bone density
5289588|NCT00472823|dietary calcium|dietary calcium
5289589|NCT00472823|hypercalcemia|hypercalcemia
5289590|NCT00472823|hypercalciuria|hypercalciuria
5289591|NCT00472810|Glaucoma|glaucoma
5289592|NCT00472810|Collagen matrix|collagen matrix
5289593|NCT00472810|ologen|ologen
5289594|NCT00472810|OculusGen|oculusgen
5289595|NCT00472810|Antifibrotic|antifibrotic
5289596|NCT00472810|Trabeculectomy|trabeculectomy
5289597|NCT00472810|anti scarring|anti scarring
5289598|NCT00472810|tissue engineering|tissue engineering
5289599|NCT00472810|high risk patient for trabeculectomy|high risk patient for trabeculectomy
5289600|NCT00472810|Aeon Astron|aeon astron
5289601|NCT00472771|Recurrent extensive small cell lung cancer|recurrent extensive small cell lung cancer
5289602|NCT00472745|bone mass|bone mass
5289603|NCT00472745|calcium absorption|calcium absorption
5289604|NCT00472745|bone quality|bone quality
5289605|NCT00472745|fracture risk|fracture risk
5289607|NCT00472745|osteoporosis|osteoporosis
5289608|NCT00472732|UCD|ucd
5289609|NCT00472732|OTCD|otcd
5289610|NCT00472732|Ammonia|ammonia
5289611|NCT00472732|Urea Metabolism|urea metabolism
5289612|NCT00472732|Inborn Errors|inborn errors
5289613|NCT00472719|HIV Seronegativity|hiv seronegativity
5289614|NCT00472719|HIV Preventive Vaccine|hiv preventive vaccine
5289615|NCT00472719|Adenovirus|adenovirus
5289616|NCT00472706|Treatment|treatment
5289617|NCT00472706|Excision|excision
5289618|NCT00472706|Photodynamic therapy|photodynamic therapy
5289619|NCT00472706|Recurrence rate|recurrence rate
5289620|NCT00472706|Cosmetic outcome|cosmetic outcome
5289621|NCT00472693|Breast cancer|breast cancer
5289622|NCT00472693|Metastatic breast cancer|metastatic breast cancer
5289623|NCT00472693|Second-Line Therapy|second-line therapy
5289624|NCT00472693|Triple Negative|triple negative
5289625|NCT00472693|Her-2 negative|her-2 negative
5289626|NCT00472693|Hormone receptor negative|hormone receptor negative
5289627|NCT00472693|Abraxane|abraxane
5289628|NCT00472693|Bevacizumab|bevacizumab
5289629|NCT00472680|bone mass|bone mass
5289630|NCT00472680|calcium absorption|calcium absorption
5289631|NCT00472680|bone quality|bone quality
5289632|NCT00472680|fracture risk|fracture risk
5289633|NCT00472667|Bacterial infections|bacterial infections
5289634|NCT00472667|Procalcitonin|procalcitonin
5289635|NCT00472667|Intensive care unit|intensive care unit
5289636|NCT00472667|Antibiotic therapy|antibiotic therapy
5289637|NCT00472667|Suspicion of bacterial infection or proven|suspicion of bacterial infection or proven
5289638|NCT00472654|bone mass|bone mass
5289639|NCT00472654|calcium absorption|calcium absorption
5289640|NCT00472654|bone quality|bone quality
5289641|NCT00472654|fracture risk|fracture risk
5289642|NCT00472615|Bipolar Disorder|bipolar disorder
5289643|NCT00472615|Menstrual Cycle|menstrual cycle
5289644|NCT00472615|Depression|depression
5289645|NCT00472615|Mania or Hypomania|mania or hypomania
5289646|NCT00472615|Predictor|predictor
5289647|NCT00472602|Opisthorchis viverrini, liver fluke, Thailand, cancer|opisthorchis viverrini, liver fluke, thailand, cancer
5289648|NCT00472576|NMDA Receptor|nmda receptor
5289649|NCT00472576|Depression Treatment|depression treatment
5289650|NCT00472576|Unipolar Depression|unipolar depression
5289651|NCT00472576|Treatment Resistant|treatment resistant
5289652|NCT00472576|Glutamatergic|glutamatergic
5289653|NCT00472576|Depression|depression
5289654|NCT00472576|Major Depression|major depression
5289655|NCT00472563|bicarbonate|bicarbonate
5289656|NCT00472563|nephropathy|nephropathy
5289657|NCT00472563|contrast|contrast
5289658|NCT00472550|esomeprazole, gastric emptying, reflux|esomeprazole, gastric emptying, reflux
5289659|NCT00472537|Ventral hernia|ventral hernia
5289660|NCT00472537|Incisional hernia|incisional hernia
5289661|NCT00472498|Cardiac Arrest|cardiac arrest
5289662|NCT00472498|Biphasic Defibrillator|biphasic defibrillator
5289663|NCT00472472|restenosis|restenosis
5289664|NCT00472472|peripheral arterial disease|peripheral arterial disease
5289665|NCT00472472|paccocath|paccocath
5289666|NCT00472472|drug-coated balloon|drug-coated balloon
5289667|NCT00472459|Non-melanoma skin cancer|non-melanoma skin cancer
5289668|NCT00472459|Organ transplant recipients|organ transplant recipients
5289669|NCT00472459|Photodynamic therapy|photodynamic therapy
5289670|NCT00472459|Actinic keratosis|actinic keratosis
5289671|NCT00472446|Surgery|surgery
5289672|NCT00472446|Thyroid gland|thyroid gland
5289673|NCT00472446|cervical block|cervical block
5289674|NCT00472446|Pain, Postoperative|pain, postoperative
5289675|NCT00472433|Alemtuzumab in autoimmune cytopenias|alemtuzumab in autoimmune cytopenias
5289676|NCT00472407|Normal|normal
5289677|NCT00472394|Medical abortion|medical abortion
5289678|NCT00472394|Preferences|preferences
5289679|NCT00472394|Willingness to Pay|willingness to pay
5289680|NCT00472381|Acute Ischemic Stroke|acute ischemic stroke
5289681|NCT00472381|Post-Stroke Hyperglycaemia|post-stroke hyperglycaemia
5289682|NCT00472381|Insulin treatment|insulin treatment
5289683|NCT00472381|Insulin|insulin
5289684|NCT00472381|DWI|dwi
5289685|NCT00472381|MRI|mri
5289686|NCT00472368|Advanced cancer|advanced cancer
5289687|NCT00472368|lymphoma|lymphoma
5289688|NCT00472368|chronic hematological malignancies|chronic hematological malignancies
5289689|NCT00472368|adult|adult
5289690|NCT00472355|Parkinson's disease|parkinson's disease
5289691|NCT00472355|PD|pd
5289692|NCT00472355|apomorphine|apomorphine
5289693|NCT00472342|impaired glucose tolerance|impaired glucose tolerance
5289694|NCT00472342|impaired fasting glucose|impaired fasting glucose
5289695|NCT00472342|diabetes|diabetes
5289696|NCT00472342|adipokine|adipokine
5289697|NCT00472342|adiponectin|adiponectin
5289698|NCT00472342|RBP-4|rbp-4
5289699|NCT00472342|adrenomedullin|adrenomedullin
5289700|NCT00472303|Opioid|opioid
5289701|NCT00472303|Central acting analgesic|central acting analgesic
5289702|NCT00472303|CG5503 PR|cg5503 pr
5289703|NCT00472303|Tumor related pain|tumor related pain
5289704|NCT00472303|Cancer related pain|cancer related pain
5289705|NCT00472303|Morphine|morphine
5289706|NCT00472303|Pain assessment|pain assessment
5289707|NCT00472303|Placebo|placebo
5289708|NCT00472290|Hematology|hematology
5289709|NCT00472290|MDS|mds
5289710|NCT00472290|Myelodysplastic Syndromes|myelodysplastic syndromes
5289711|NCT00472290|Thrombocytopenia|thrombocytopenia
5289712|NCT00472264|methodology study, PET Imaging, COPD patients|methodology study, pet imaging, copd patients
5289713|NCT00472251|dutasteride|dutasteride
5289714|NCT00472251|body mass index|body mass index
5289715|NCT00472251|testosterone|testosterone
5289716|NCT00472225|Chronic graft-versus-host disease|chronic graft-versus-host disease
5289717|NCT00472225|rituximab|rituximab
5289718|NCT00472186|Tonsillectomy|tonsillectomy
5289719|NCT00472186|Pain|pain
5289720|NCT00472173|Apexification|apexification
5289721|NCT00472173|Pulp necrosis|pulp necrosis
5289722|NCT00472173|Calcium hydroxide|calcium hydroxide
5289723|NCT00472173|MTA|mta
5289724|NCT00472173|pulp necrosis of an anterior immature tooth|pulp necrosis of an anterior immature tooth
5289725|NCT00472160|Preoxygenation|preoxygenation
5289726|NCT00472160|Non Invasive Ventilation|non invasive ventilation
5289727|NCT00472160|Continuous Positive Airway Pressure,|continuous positive airway pressure,
5289728|NCT00472160|Intubation,|intubation,
5289729|NCT00472160|Organ failure|organ failure
5289730|NCT00472134|Hernia|hernia
5289731|NCT00472134|Ventral|ventral
5289732|NCT00472134|Laparoscopic Hernia Repair|laparoscopic hernia repair
5289733|NCT00472108|Nodular Basal Cell Carcinoma|nodular basal cell carcinoma
5289734|NCT00472108|Basal Cell Carcinoma|basal cell carcinoma
5289735|NCT00472108|PDT with Metvix 160 mg/g cream|pdt with metvix 160 mg/g cream
5289736|NCT00472108|PDT with placebo cream|pdt with placebo cream
5289737|NCT00472108|Histological verification|histological verification
5289738|NCT00472095|diabetes|diabetes
5289739|NCT00472095|fotonovela|fotonovela
5289740|NCT00472095|Latino|latino
5289741|NCT00472082|Immunosuppression|immunosuppression
5289742|NCT00472082|Renal Transplantation|renal transplantation
5289743|NCT00472069|Stress Urinary Incontinence|stress urinary incontinence
5289744|NCT00472069|striated urethral sphincter insufficiency|striated urethral sphincter insufficiency
5289745|NCT00472069|myofibers|myofibers
5289746|NCT00472069|satellite cells|satellite cells
5289747|NCT00472069|myotubes|myotubes
5289748|NCT00472069|urethral|urethral
5289749|NCT00472069|Muscle fibres|muscle fibres
5289750|NCT00472056|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
5289751|NCT00472056|Lymphoid Malignancies|lymphoid malignancies
5289752|NCT00472056|Lymphoma|lymphoma
5289753|NCT00472056|BEAM Chemotherapy|beam chemotherapy
5289754|NCT00472056|Carmustine|carmustine
5289755|NCT00472056|BCNU|bcnu
5289756|NCT00472056|BiCNU|bicnu
5289757|NCT00472056|Etoposide|etoposide
5289758|NCT00472056|VePesid|vepesid
5289759|NCT00472056|Cytarabine|cytarabine
5289760|NCT00472056|Cytosar|cytosar
5289761|NCT00472056|DepoCyt|depocyt
5289762|NCT00472056|Cytosine arabinosine hydrochloride|cytosine arabinosine hydrochloride
5289763|NCT00472056|Ara-C|ara-c
5289764|NCT00472056|Melphalan|melphalan
5289765|NCT00472056|Rituximab|rituximab
5289766|NCT00472056|Rituxan|rituxan
5289767|NCT00472043|Nodular Basal Cell Carcinoma|nodular basal cell carcinoma
5289768|NCT00472043|Basal Cell Carcinoma|basal cell carcinoma
5289769|NCT00472043|Photodynamic therapy (PDT)|photodynamic therapy (pdt)
5289770|NCT00472043|Metvix|metvix
5289771|NCT00472043|Histological verification|histological verification
5289772|NCT00472043|PDT with Metvix cream|pdt with metvix cream
5289773|NCT00472043|PDT with Placebo cream|pdt with placebo cream
5289774|NCT00472030|bullous pemphigoid|bullous pemphigoid
5289775|NCT00472030|omalizumab|omalizumab
5289776|NCT00472030|xolair|xolair
5289777|NCT00472030|IgE|ige
5289778|NCT00472030|autoimmunity|autoimmunity
5289779|NCT00472030|skin disease|skin disease
5289780|NCT00472017|untreated childhood brain stem glioma|untreated childhood brain stem glioma
5289781|NCT00471991|Oral contraceptive|oral contraceptive
5289782|NCT00471991|ovulation inhibitory effect|ovulation inhibitory effect
5289783|NCT00471978|non-small cell lung cancer|non-small cell lung cancer
5289784|NCT00471978|small cell lung cancer|small cell lung cancer
5289785|NCT00471978|pulmonary carcinoid tumor|pulmonary carcinoid tumor
5289786|NCT00471952|Migraine|migraine
5289787|NCT00471939|Burn, Meshed skin graft, PDGF|burn, meshed skin graft, pdgf
5289788|NCT00471939|deep partial thickness or full thickness burns|deep partial thickness or full thickness burns
5289789|NCT00471926|Diabetes Care|diabetes care
5289790|NCT00471913|Femur|femur
5289791|NCT00471913|Fracture|fracture
5289792|NCT00471913|Antegrade|antegrade
5289793|NCT00471913|Nailing|nailing
5289794|NCT00471913|Shaft|shaft
5289795|NCT00471913|Abductor|abductor
5289796|NCT00471887|stage III melanoma|stage iii melanoma
5289797|NCT00471887|stage IV melanoma|stage iv melanoma
5289798|NCT00471887|recurrent melanoma|recurrent melanoma
5289799|NCT00471861|Inflammatory Markers|inflammatory markers
5289800|NCT00471861|Migraine|migraine
5289801|NCT00471848|Thymoglobuline|thymoglobuline
5289802|NCT00471848|Rabbit ATG|rabbit atg
5289803|NCT00471848|Ciclosporin|ciclosporin
5289804|NCT00471848|Aplastic Anemia|aplastic anemia
5289805|NCT00471835|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
5289806|NCT00471835|stage I non-small cell lung cancer|stage i non-small cell lung cancer
5289807|NCT00471835|adenocarcinoma of the lung|adenocarcinoma of the lung
5289902|NCT00471523|Metformin|metformin
5289808|NCT00471835|adenosquamous cell lung cancer|adenosquamous cell lung cancer
5289809|NCT00471835|large cell lung cancer|large cell lung cancer
5289810|NCT00471835|squamous cell lung cancer|squamous cell lung cancer
5289811|NCT00471822|Streptococcus pneumoniae nasopharyngeal carriage|streptococcus pneumoniae nasopharyngeal carriage
5289812|NCT00471796|Patients with functional chest pain and functional heartburns|patients with functional chest pain and functional heartburns
5289813|NCT00471783|gingivitis|gingivitis
5289814|NCT00471783|chlorhexidine|chlorhexidine
5289815|NCT00471783|dental floss|dental floss
5289816|NCT00471783|RCT|rct
5289817|NCT00471783|bleeding on probing|bleeding on probing
5289818|NCT00471783|gingival and plaque indices|gingival and plaque indices
5289819|NCT00471757|pnuemonia|pnuemonia
5289820|NCT00471757|influenca|influenca
5289821|NCT00471744|benign epilepsy|benign epilepsy
5289822|NCT00471744|pediatrics|pediatrics
5289823|NCT00471744|children|children
5289824|NCT00471744|rolandic epilepsy|rolandic epilepsy
5289825|NCT00471744|levetiracetam|levetiracetam
5289826|NCT00471744|sulthiame|sulthiame
5289827|NCT00471731|Ocular Surface Disease|ocular surface disease
5289828|NCT00471731|Imprinting|imprinting
5289829|NCT00471731|Eye Abnormalities|eye abnormalities
5289830|NCT00471731|Ovarian Insufficiency|ovarian insufficiency
5289831|NCT00471731|Women's Eye Health and Disease|women's eye health and disease
5289832|NCT00471731|Turner Syndrome|turner syndrome
5289833|NCT00471731|TS|ts
5289834|NCT00471731|Premature Ovarian Failure|premature ovarian failure
5289835|NCT00471731|POF|pof
5289836|NCT00471731|Healthy Volunteer|healthy volunteer
5289837|NCT00471731|HV|hv
5289838|NCT00471718|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5289839|NCT00471718|stage IV prostate cancer|stage iv prostate cancer
5289840|NCT00471718|recurrent prostate cancer|recurrent prostate cancer
5289841|NCT00471705|Miltefosine|miltefosine
5289842|NCT00471705|Leishmaniasis|leishmaniasis
5289843|NCT00471705|Glucantime|glucantime
5289844|NCT00471705|Thermotherapy|thermotherapy
5289845|NCT00471705|Colombia|colombia
5289846|NCT00471679|disseminated neuroblastoma|disseminated neuroblastoma
5289847|NCT00471679|localized unresectable neuroblastoma|localized unresectable neuroblastoma
5289848|NCT00471679|recurrent neuroblastoma|recurrent neuroblastoma
5289849|NCT00471679|regional neuroblastoma|regional neuroblastoma
5289850|NCT00471679|stage 4S neuroblastoma|stage 4s neuroblastoma
5289851|NCT00471666|Malaria|malaria
5289852|NCT00471666|Filariasis|filariasis
5289853|NCT00471666|Coinfection|coinfection
5289854|NCT00471666|Co-Infection|co-infection
5289855|NCT00471653|thrombocytopenia|thrombocytopenia
5289856|NCT00471653|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
5289857|NCT00471653|adult brain stem glioma|adult brain stem glioma
5289858|NCT00471653|adult mixed glioma|adult mixed glioma
5289859|NCT00471653|adult giant cell glioblastoma|adult giant cell glioblastoma
5289860|NCT00471653|adult gliosarcoma|adult gliosarcoma
5289861|NCT00471653|adult glioblastoma|adult glioblastoma
5289862|NCT00471653|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5289863|NCT00471653|adult anaplastic ependymoma|adult anaplastic ependymoma
5289864|NCT00471653|adult pineal gland astrocytoma|adult pineal gland astrocytoma
5289865|NCT00471640|pneumonia|pneumonia
5289866|NCT00471640|dexamethasone|dexamethasone
5289867|NCT00471640|community-acquired pneumonia|community-acquired pneumonia
5289868|NCT00471614|HIV|hiv
5289869|NCT00471614|AIDS|aids
5289870|NCT00471614|uridine|uridine
5289871|NCT00471614|mitochondria|mitochondria
5289872|NCT00471614|insulin resistance|insulin resistance
5289873|NCT00471614|Treatment Experienced|treatment experienced
5289874|NCT00471601|recurrent breast cancer|recurrent breast cancer
5289875|NCT00471601|stage IA breast cancer|stage ia breast cancer
5289876|NCT00471601|stage IB breast cancer|stage ib breast cancer
5289877|NCT00471601|stage II breast cancer|stage ii breast cancer
5289878|NCT00471601|stage IIIA breast cancer|stage iiia breast cancer
5289879|NCT00471601|stage IIIB breast cancer|stage iiib breast cancer
5289880|NCT00471601|stage IIIC breast cancer|stage iiic breast cancer
5289881|NCT00471601|stage IV breast cancer|stage iv breast cancer
5289882|NCT00471588|Dopamine|dopamine
5289883|NCT00471588|OCD|ocd
5289884|NCT00471588|MRI|mri
5289885|NCT00471588|stimulant users|stimulant users
5289886|NCT00471575|fatty liver|fatty liver
5289887|NCT00471575|pregnancy|pregnancy
5289888|NCT00471575|ultra sound|ultra sound
5289889|NCT00471575|Pregnant women at the end of pregnancy or immediately after birth.|pregnant women at the end of pregnancy or immediately after birth.
5289890|NCT00471575|controls-women with normal liver|controls-women with normal liver
5289891|NCT00471575|correlation between ultrasonography and nutritional, obsthetric and laboratory data.|correlation between ultrasonography and nutritional, obsthetric and laboratory data.
5289892|NCT00471562|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5289893|NCT00471549|Diabetes|diabetes
5289894|NCT00471549|Dyslipidaemia|dyslipidaemia
5289895|NCT00471549|Atherosclerosis|atherosclerosis
5289896|NCT00471549|Osteoprotegerin|osteoprotegerin
5289897|NCT00471549|Adhesion molecules|adhesion molecules
5289898|NCT00471549|Simvastatin|simvastatin
5289899|NCT00471523|Anovulation|anovulation
5289900|NCT00471523|Clomiphene citrate|clomiphene citrate
5289901|NCT00471523|Infertility|infertility
5289903|NCT00471523|PCOS|pcos
5289904|NCT00471523|Treatment|treatment
5289905|NCT00471510|androgenetic alopecia|androgenetic alopecia
5289906|NCT00471510|male pattern hair loss|male pattern hair loss
5289907|NCT00471510|male pattern baldness|male pattern baldness
5289908|NCT00471510|androgenetic alopecia or male pattern hair loss|androgenetic alopecia or male pattern hair loss
5289909|NCT00471497|leukemia|leukemia
5289910|NCT00471497|bone marrow|bone marrow
5289911|NCT00471497|leukemia symptoms|leukemia symptoms
5289912|NCT00471497|lukemia|lukemia
5289913|NCT00471497|cml|cml
5289914|NCT00471497|complete blood count|complete blood count
5289915|NCT00471497|lymphocyte|lymphocyte
5289916|NCT00471497|blood cancer|blood cancer
5289917|NCT00471497|leukocytes|leukocytes
5289918|NCT00471497|chronic leukemia|chronic leukemia
5289919|NCT00471497|bone marrow biopsy|bone marrow biopsy
5289920|NCT00471497|leukemia research|leukemia research
5289921|NCT00471497|leukemia cells|leukemia cells
5289922|NCT00471497|bone marrow disease|bone marrow disease
5289923|NCT00471497|chronic myeloid leukemia|chronic myeloid leukemia
5289924|NCT00471497|blood cancer symptoms|blood cancer symptoms
5289925|NCT00471497|white blood cell diseases|white blood cell diseases
5289926|NCT00471497|chronic myelogenous leukemia|chronic myelogenous leukemia
5289927|NCT00471497|leukemia treatment|leukemia treatment
5289928|NCT00471497|leukemia facts|leukemia facts
5289929|NCT00471497|leucemia|leucemia
5289930|NCT00471497|facts about leukemia|facts about leukemia
5289931|NCT00471497|myelogenous leukemia|myelogenous leukemia
5289932|NCT00471497|newly diagnosed CML|newly diagnosed cml
5289933|NCT00471497|newly diagnosed Philadelphia chromosome positive (Ph+) chronic myelogenous leukemia in chronic phase (CML-CP)|newly diagnosed philadelphia chromosome positive (ph+) chronic myelogenous leukemia in chronic phase (cml-cp)
5289934|NCT00471484|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
5289935|NCT00471484|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
5289936|NCT00471484|advanced adult primary liver cancer|advanced adult primary liver cancer
5289937|NCT00471484|childhood hepatocellular carcinoma|childhood hepatocellular carcinoma
5289938|NCT00471484|stage III childhood liver cancer|stage iii childhood liver cancer
5289939|NCT00471484|stage IV childhood liver cancer|stage iv childhood liver cancer
5289940|NCT00471471|recurrent melanoma|recurrent melanoma
5289941|NCT00471471|stage IV melanoma|stage iv melanoma
5289942|NCT00471471|ciliary body and choroid melanoma, medium/large size|ciliary body and choroid melanoma, medium/large size
5289943|NCT00471471|extraocular extension melanoma|extraocular extension melanoma
5289944|NCT00471471|iris melanoma|iris melanoma
5289945|NCT00471471|recurrent intraocular melanoma|recurrent intraocular melanoma
5289946|NCT00471471|metastatic intraocular melanoma|metastatic intraocular melanoma
5289947|NCT00471471|conjunctival melanoma|conjunctival melanoma
5289948|NCT00471471|stage IIIA melanoma|stage iiia melanoma
5289949|NCT00471471|stage IIIB melanoma|stage iiib melanoma
5289950|NCT00471471|stage IIIC melanoma|stage iiic melanoma
5289951|NCT00471458|Radioiodine|radioiodine
5289952|NCT00471458|Hyperthyroidism|hyperthyroidism
5289953|NCT00471458|Morbidity|morbidity
5289954|NCT00471458|Cardiovascular diseases|cardiovascular diseases
5289955|NCT00471445|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5289956|NCT00471445|pain|pain
5289957|NCT00471445|neurotoxicity|neurotoxicity
5289958|NCT00471445|peripheral neuropathy|peripheral neuropathy
5289959|NCT00471432|recurrent prostate cancer|recurrent prostate cancer
5289960|NCT00471432|stage IV prostate cancer|stage iv prostate cancer
5289961|NCT00471432|recurrent renal cell cancer|recurrent renal cell cancer
5289962|NCT00471432|stage IV renal cell cancer|stage iv renal cell cancer
5289963|NCT00471432|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5289964|NCT00471432|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5289965|NCT00471432|recurrent bladder cancer|recurrent bladder cancer
5289966|NCT00471432|stage IV bladder cancer|stage iv bladder cancer
5289967|NCT00471432|recurrent breast cancer|recurrent breast cancer
5289968|NCT00471432|stage IV breast cancer|stage iv breast cancer
5289969|NCT00471432|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5289970|NCT00471432|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5289971|NCT00471432|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5289972|NCT00471432|male breast cancer|male breast cancer
5289973|NCT00471393|TMJ|tmj
5289974|NCT00471393|Osteoarthritis|osteoarthritis
5289975|NCT00471393|Degenerative Joint disease|degenerative joint disease
5289976|NCT00471367|Phase I|phase i
5289977|NCT00471367|AZD4877|azd4877
5289978|NCT00471367|Lymphoma|lymphoma
5289979|NCT00471367|B-cell non-Hodgkin lymphoma|b-cell non-hodgkin lymphoma
5289980|NCT00471341|arteriosclerosis|arteriosclerosis
5289981|NCT00471341|coronary disease|coronary disease
5289982|NCT00471341|inflammation|inflammation
5289983|NCT00471341|COX-2 inhibition|cox-2 inhibition
5289984|NCT00471341|hypertension|hypertension
5289985|NCT00471328|GIST|gist
5289986|NCT00471328|adults|adults
5289987|NCT00471328|imatinib resistant|imatinib resistant
5289988|NCT00471328|sunitinib resistant|sunitinib resistant
5289989|NCT00471328|AMN107|amn107
5289990|NCT00471328|nilotinib|nilotinib
5289991|NCT00471328|treatment|treatment
5289992|NCT00471328|Gastrointestinal stromal tumor (GIST)|gastrointestinal stromal tumor (gist)
5289993|NCT00471315|SOD|sod
5289994|NCT00471315|Common Bile Duct Diseases|common bile duct diseases
5289995|NCT00471315|Sphincterotomy|sphincterotomy
5289996|NCT00471315|Cholangiopancreatography, Endoscopic Retrograde|cholangiopancreatography, endoscopic retrograde
5289997|NCT00471302|Healthy Volunteers|healthy volunteers
5289998|NCT00471302|Immunological Parameters|immunological parameters
5289999|NCT00471302|Mali|mali
5290000|NCT00471302|B Lymphocyte|b lymphocyte
5290002|NCT00471302|Healthy Volunteer|healthy volunteer
5290003|NCT00471289|Critical Limb Ischemia|critical limb ischemia
5290004|NCT00471289|Stents|stents
5290005|NCT00471289|Drug Eluting Stents|drug eluting stents
5290006|NCT00471289|Peripheral arterial disease|peripheral arterial disease
5290007|NCT00471289|PAD|pad
5290008|NCT00471289|Paclitaxel|paclitaxel
5290009|NCT00471289|TAXUS|taxus
5290010|NCT00471289|Infrapopliteal|infrapopliteal
5290011|NCT00471289|Infragenicular|infragenicular
5290012|NCT00471289|Interventional Radiology|interventional radiology
5290013|NCT00471289|CLI|cli
5290014|NCT00471289|DES|des
5290015|NCT00471276|Metastatic Breast Cancer|metastatic breast cancer
5290016|NCT00471250|Bronchoscopy|bronchoscopy
5290017|NCT00471250|Bronchoalveolar Lavage|bronchoalveolar lavage
5290018|NCT00471250|Nasal Mucosal Biopsy|nasal mucosal biopsy
5290019|NCT00471250|Research Procedures|research procedures
5290020|NCT00471250|Infection Susceptibility|infection susceptibility
5290021|NCT00471250|Lung Infection Susceptibility|lung infection susceptibility
5290022|NCT00471250|Healthy Volunteer|healthy volunteer
5290023|NCT00471250|HV|hv
5290024|NCT00471237|bone mineral density,|bone mineral density,
5290025|NCT00471237|Ronacaleret|ronacaleret
5290026|NCT00471237|teriparatide|teriparatide
5290027|NCT00471237|alendronate,|alendronate,
5290028|NCT00471237|Post-menopausal women,|post-menopausal women,
5290029|NCT00471237|osteoporosis,|osteoporosis,
5290030|NCT00471237|SB-751689|sb-751689
5290031|NCT00471185|Male Contraception|male contraception
5290032|NCT00471185|Acyline|acyline
5290033|NCT00471146|Randomized Study Of Gemcitabine Plus AG-013736 Versus Gemcitabine Plus Placebo For Advanced Pancreatic Cancer.|randomized study of gemcitabine plus ag-013736 versus gemcitabine plus placebo for advanced pancreatic cancer.
5290034|NCT00471133|melanoma|melanoma
5290035|NCT00471133|DNA vaccine|dna vaccine
5290036|NCT00471133|tyrosinase|tyrosinase
5290037|NCT00471133|electroporation|electroporation
5290038|NCT00471107|Frontal Lobe|frontal lobe
5290039|NCT00471107|Language|language
5290040|NCT00471107|Dementia|dementia
5290041|NCT00471107|Healthy Volunteer|healthy volunteer
5290042|NCT00471107|HV|hv
5290043|NCT00471094|heartburn|heartburn
5290044|NCT00471094|erosive esophagitis|erosive esophagitis
5290045|NCT00471094|healing|healing
5290046|NCT00471094|population pharmacokinetics|population pharmacokinetics
5290047|NCT00471094|Quality of Life (QoL)|quality of life (qol)
5290048|NCT00471081|Neisseria meningitidis;|neisseria meningitidis;
5290049|NCT00471081|Humans;|humans;
5290050|NCT00471081|Meningococcal vaccines;|meningococcal vaccines;
5290051|NCT00471081|Safety|safety
5290052|NCT00471081|Vaccines, conjugate;|vaccines, conjugate;
5290053|NCT00471081|Toddlers;|toddlers;
5290054|NCT00471081|Immunogenicity;|immunogenicity;
5290055|NCT00471055|osteoarthritis|osteoarthritis
5290056|NCT00471055|knee|knee
5290057|NCT00471055|capsaicin gel|capsaicin gel
5290058|NCT00471055|capsicum|capsicum
5290059|NCT00471042|Heroin Dependence|heroin dependence
5290060|NCT00471042|Opioid Dependence|opioid dependence
5290061|NCT00471042|Primary Care|primary care
5290062|NCT00471042|Buprenorphine|buprenorphine
5290063|NCT00471029|pH study, peptic ulcer, proton pump inhibitor|ph study, peptic ulcer, proton pump inhibitor
5290064|NCT00471003|Hypertension|hypertension
5290065|NCT00470990|IHH|ihh
5290066|NCT00470990|Kallmann syndrome|kallmann syndrome
5290067|NCT00470990|hypogonadism|hypogonadism
5290068|NCT00470964|laser trabeculoplasty, glaucoma, argon, titanium-sapphire|laser trabeculoplasty, glaucoma, argon, titanium-sapphire
5290069|NCT00470964|IOP lowering effect|iop lowering effect
5290070|NCT00470964|Adverse effects|adverse effects
5290071|NCT00470964|IOP spikes|iop spikes
5290072|NCT00470951|rectal cancer|rectal cancer
5290073|NCT00470951|laparoscopic assisted resection|laparoscopic assisted resection
5290074|NCT00470951|open resection|open resection
5290075|NCT00470951|preoperative chemoradiation|preoperative chemoradiation
5290076|NCT00470951|randomized trial|randomized trial
5290077|NCT00470925|Neurological|neurological
5290078|NCT00470925|Dopamine|dopamine
5290079|NCT00470912|cutaneous lupus erythemaosus|cutaneous lupus erythemaosus
5290080|NCT00470912|photoprotection|photoprotection
5290081|NCT00470912|photoprovocation|photoprovocation
5290082|NCT00470912|Sunscreen RV 2547C|sunscreen rv 2547c
5290083|NCT00470899|Feto-maternal transfusion|feto-maternal transfusion
5290084|NCT00470899|Kleihauer-Betke|kleihauer-betke
5290085|NCT00470847|Herceptin|herceptin
5290086|NCT00470847|breast cancer|breast cancer
5290087|NCT00470847|radiation therapy|radiation therapy
5290088|NCT00470847|stereotactic radiosurgery|stereotactic radiosurgery
5290089|NCT00470847|SRS|srs
5290090|NCT00470847|whole brain radiation|whole brain radiation
5290091|NCT00470847|WBRT|wbrt
5290092|NCT00470834|prostate cancer|prostate cancer
5290093|NCT00470834|androgen deprivation therapy|androgen deprivation therapy
5290094|NCT00470821|melatonin|melatonin
5290095|NCT00470821|actigraphy|actigraphy
5290096|NCT00470821|sedation|sedation
5290097|NCT00470821|critical patients|critical patients
5290098|NCT00470821|ICU|icu
5290099|NCT00470808|Minors|minors
5290100|NCT00470808|Enrollment in another study|enrollment in another study
5290101|NCT00470808|Males|males
5290102|NCT00470808|HBA1C greater than 7|hba1c greater than 7
5290103|NCT00470808|Drug therapy for DM|drug therapy for dm
5290104|NCT00470795|diabetes|diabetes
5290105|NCT00470795|gastroparesis|gastroparesis
5290106|NCT00470795|acupuncture|acupuncture
5290107|NCT00470795|symptoms|symptoms
5290108|NCT00470795|gastric emptying|gastric emptying
5290109|NCT00470782|colonic neoplasms|colonic neoplasms
5290110|NCT00470782|exercise|exercise
5290111|NCT00470782|body composition|body composition
5290112|NCT00470782|anthropometry|anthropometry
5290113|NCT00470769|Color-Doppler Ultrasonography|color-doppler ultrasonography
5290114|NCT00470769|Renal scintigraphy|renal scintigraphy
5290115|NCT00470769|Kidney failure|kidney failure
5290116|NCT00470769|GFR|gfr
5290117|NCT00470743|Ibuprofen|ibuprofen
5290118|NCT00470743|Indomethacin|indomethacin
5290119|NCT00470743|Infant, very low birth weight|infant, very low birth weight
5290120|NCT00470743|Prematurity|prematurity
5290121|NCT00470743|Ductus Arteriosus, patent|ductus arteriosus, patent
5290122|NCT00470717|late preterm infant|late preterm infant
5290123|NCT00470717|breastfeeding|breastfeeding
5290124|NCT00470717|formula feeding|formula feeding
5290125|NCT00470717|rehospitalization|rehospitalization
5290126|NCT00470717|telephone|telephone
5290127|NCT00470704|HER2-positive breast cancer|her2-positive breast cancer
5290128|NCT00470704|Herceptin|herceptin
5290129|NCT00470704|trastuzumab|trastuzumab
5290130|NCT00470678|Age-related|age-related
5290131|NCT00470678|macular|macular
5290132|NCT00470678|degeneration|degeneration
5290133|NCT00470678|AMD|amd
5290134|NCT00470678|Ranibizumab|ranibizumab
5290135|NCT00470678|Anti-VEGF|anti-vegf
5290136|NCT00470678|choroidal|choroidal
5290137|NCT00470678|neovascularization|neovascularization
5290138|NCT00470678|CNV|cnv
5290139|NCT00470678|Asian patients|asian patients
5290140|NCT00470678|Korea|korea
5290141|NCT00470678|Taiwan|taiwan
5290142|NCT00470678|associated|associated
5290143|NCT00470652|pain|pain
5290144|NCT00470652|Pain Measurement|pain measurement
5290145|NCT00470652|Decision Making, Computer-Assisted|decision making, computer-assisted
5290146|NCT00470652|Informatics|informatics
5290147|NCT00470639|TMS|tms
5290148|NCT00470639|Treatment|treatment
5290149|NCT00470639|Bipolar|bipolar
5290150|NCT00470639|Efficacy|efficacy
5290151|NCT00470626|Pulmonary Embolism|pulmonary embolism
5290152|NCT00470626|Venous Thromboembolism|venous thromboembolism
5290153|NCT00470626|Inferior Vena Cava Filter|inferior vena cava filter
5290154|NCT00470626|IVC|ivc
5290155|NCT00470626|PE|pe
5290156|NCT00470613|Neoplasm|neoplasm
5290157|NCT00470587|chest pain|chest pain
5290158|NCT00470587|myocardial infarction|myocardial infarction
5290159|NCT00470587|unstable angina|unstable angina
5290160|NCT00470574|recurrent breast cancer|recurrent breast cancer
5290161|NCT00470574|stage IV breast cancer|stage iv breast cancer
5290162|NCT00470574|male breast cancer|male breast cancer
5290163|NCT00470561|mammographic breast density aspirin|mammographic breast density aspirin
5290164|NCT00470548|male breast cancer|male breast cancer
5290165|NCT00470548|recurrent breast cancer|recurrent breast cancer
5290166|NCT00470548|stage IIIA breast cancer|stage iiia breast cancer
5290167|NCT00470548|stage IIIB breast cancer|stage iiib breast cancer
5290168|NCT00470548|stage IIIC breast cancer|stage iiic breast cancer
5290169|NCT00470548|stage IV breast cancer|stage iv breast cancer
5290170|NCT00470548|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5290171|NCT00470548|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5290172|NCT00470548|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5290173|NCT00470548|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5290174|NCT00470548|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5290175|NCT00470535|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
5290176|NCT00470535|recurrent pancreatic cancer|recurrent pancreatic cancer
5290177|NCT00470535|stage III pancreatic cancer|stage iii pancreatic cancer
5290178|NCT00470535|stage IV pancreatic cancer|stage iv pancreatic cancer
5290179|NCT00470522|methotrexate|methotrexate
5290180|NCT00470522|folic acid|folic acid
5290181|NCT00470522|systemic lupus erythematosus|systemic lupus erythematosus
5290182|NCT00470522|steroid|steroid
5290183|NCT00470483|PET|pet
5290184|NCT00470483|Social Anxiety Disorder|social anxiety disorder
5290185|NCT00470483|fRMI|frmi
5290186|NCT00470444|Cardiac Surgery|cardiac surgery
5290187|NCT00470444|Transfusion Medicine|transfusion medicine
5290188|NCT00470444|Cardiac Anesthesia Risk Evaluation (CARE) Score of 3 or 4|cardiac anesthesia risk evaluation (care) score of 3 or 4
5290189|NCT00470444|(Dupuis J-Y et al, Anesthesiology 2001;94: 194-204)|(dupuis j-y et al, anesthesiology 2001;94: 194-204)
5290190|NCT00470418|Alzheimer Disease|alzheimer disease
5290191|NCT00470418|Alzheimer Type Senile Dementia|alzheimer type senile dementia
5290192|NCT00470418|Alzheimer's Disease|alzheimer's disease
5290193|NCT00470418|clinical trial|clinical trial
5290194|NCT00470418|dementia|dementia
5290195|NCT00470418|diabetes|diabetes
5290196|NCT00470418|dietary supplements|dietary supplements
5290197|NCT00470418|Senile Dementia, Alzheimer Type|senile dementia, alzheimer type
5290198|NCT00470418|Therapeutics|therapeutics
5290199|NCT00470405|adult solid tumor|adult solid tumor
5290200|NCT00470405|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5290201|NCT00470405|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5290202|NCT00470405|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5290203|NCT00470405|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
5290204|NCT00470405|cutaneous B-cell non-Hodgkin lymphoma|cutaneous b-cell non-hodgkin lymphoma
5290205|NCT00470405|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
5290206|NCT00470405|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
5290207|NCT00470405|adult grade III lymphomatoid granulomatosis|adult grade iii lymphomatoid granulomatosis
5290208|NCT00470405|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
5290209|NCT00470405|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5290210|NCT00470405|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5290211|NCT00470405|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5290212|NCT00470405|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5290213|NCT00470405|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5290214|NCT00470405|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5290215|NCT00470405|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5290216|NCT00470405|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5290217|NCT00470405|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5290218|NCT00470405|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5290219|NCT00470405|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5290220|NCT00470405|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5290221|NCT00470405|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5290222|NCT00470405|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5290223|NCT00470405|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
5290224|NCT00470405|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5290225|NCT00470405|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5290226|NCT00470405|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5290227|NCT00470405|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5290228|NCT00470405|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5290229|NCT00470405|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5290230|NCT00470405|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5290231|NCT00470405|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5290232|NCT00470405|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5290233|NCT00470405|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5290234|NCT00470405|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5290235|NCT00470405|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5290236|NCT00470405|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5290237|NCT00470405|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5290238|NCT00470405|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5290239|NCT00470405|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5290240|NCT00470405|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
5290241|NCT00470392|Erythema|erythema
5290242|NCT00470392|optimization|optimization
5290243|NCT00470392|Papule|papule
5290244|NCT00470392|Plaque|plaque
5290245|NCT00470392|pretreatment|pretreatment
5290246|NCT00470392|T cells|t cells
5290247|NCT00470392|UVB laser light|uvb laser light
5290248|NCT00470392|psoriasis|psoriasis
5290249|NCT00470392|topical administration|topical administration
5290250|NCT00470379|stage II melanoma|stage ii melanoma
5290251|NCT00470379|stage III melanoma|stage iii melanoma
5290252|NCT00470379|stage IV melanoma|stage iv melanoma
5290253|NCT00470366|stage II malignant testicular germ cell tumor|stage ii malignant testicular germ cell tumor
5290254|NCT00470366|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
5290255|NCT00470366|testicular choriocarcinoma and embryonal carcinoma|testicular choriocarcinoma and embryonal carcinoma
5290256|NCT00470366|testicular choriocarcinoma and seminoma|testicular choriocarcinoma and seminoma
5290257|NCT00470366|testicular choriocarcinoma and teratoma|testicular choriocarcinoma and teratoma
5290258|NCT00470366|testicular choriocarcinoma and yolk sac tumor|testicular choriocarcinoma and yolk sac tumor
5290259|NCT00470366|testicular choriocarcinoma|testicular choriocarcinoma
5290260|NCT00470366|testicular embryonal carcinoma and seminoma|testicular embryonal carcinoma and seminoma
5290261|NCT00470366|testicular embryonal carcinoma and teratoma with seminoma|testicular embryonal carcinoma and teratoma with seminoma
5290513|NCT00469651|Malaria|malaria
5290262|NCT00470366|testicular embryonal carcinoma and teratoma|testicular embryonal carcinoma and teratoma
5290263|NCT00470366|testicular embryonal carcinoma and yolk sac tumor with seminoma|testicular embryonal carcinoma and yolk sac tumor with seminoma
5290264|NCT00470366|testicular embryonal carcinoma and yolk sac tumor|testicular embryonal carcinoma and yolk sac tumor
5290265|NCT00470366|testicular embryonal carcinoma|testicular embryonal carcinoma
5290266|NCT00470366|testicular seminoma|testicular seminoma
5290267|NCT00470366|testicular yolk sac tumor and teratoma with seminoma|testicular yolk sac tumor and teratoma with seminoma
5290268|NCT00470366|testicular yolk sac tumor and teratoma|testicular yolk sac tumor and teratoma
5290269|NCT00470366|testicular yolk sac tumor|testicular yolk sac tumor
5290270|NCT00470366|stage I malignant testicular germ cell tumor|stage i malignant testicular germ cell tumor
5290271|NCT00470366|adult central nervous system germ cell tumor|adult central nervous system germ cell tumor
5290272|NCT00470366|ovarian choriocarcinoma|ovarian choriocarcinoma
5290273|NCT00470366|ovarian dysgerminoma|ovarian dysgerminoma
5290274|NCT00470366|ovarian embryonal carcinoma|ovarian embryonal carcinoma
5290275|NCT00470366|ovarian yolk sac tumor|ovarian yolk sac tumor
5290276|NCT00470366|ovarian immature teratoma|ovarian immature teratoma
5290277|NCT00470366|ovarian mature teratoma|ovarian mature teratoma
5290278|NCT00470366|ovarian monodermal and highly specialized teratoma|ovarian monodermal and highly specialized teratoma
5290279|NCT00470366|ovarian polyembryoma|ovarian polyembryoma
5290280|NCT00470366|ovarian mixed germ cell tumor|ovarian mixed germ cell tumor
5290281|NCT00470366|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
5290282|NCT00470366|stage IV extragonadal seminoma|stage iv extragonadal seminoma
5290283|NCT00470366|stage I extragonadal non-seminomatous germ cell tumor|stage i extragonadal non-seminomatous germ cell tumor
5290284|NCT00470366|stage II extragonadal non-seminomatous germ cell tumor|stage ii extragonadal non-seminomatous germ cell tumor
5290285|NCT00470366|stage III extragonadal non-seminomatous germ cell tumor|stage iii extragonadal non-seminomatous germ cell tumor
5290286|NCT00470366|stage IV extragonadal non-seminomatous germ cell tumor|stage iv extragonadal non-seminomatous germ cell tumor
5290287|NCT00470366|adult teratoma|adult teratoma
5290288|NCT00470366|testicular immature teratoma|testicular immature teratoma
5290289|NCT00470366|testicular mature teratoma|testicular mature teratoma
5290290|NCT00470366|stage IA ovarian germ cell tumor|stage ia ovarian germ cell tumor
5290291|NCT00470366|stage IB ovarian germ cell tumor|stage ib ovarian germ cell tumor
5290292|NCT00470366|stage IC ovarian germ cell tumor|stage ic ovarian germ cell tumor
5290293|NCT00470366|stage IIA ovarian germ cell tumor|stage iia ovarian germ cell tumor
5290294|NCT00470366|stage IIB ovarian germ cell tumor|stage iib ovarian germ cell tumor
5290295|NCT00470366|stage IIC ovarian germ cell tumor|stage iic ovarian germ cell tumor
5290296|NCT00470366|stage IIIA ovarian germ cell tumor|stage iiia ovarian germ cell tumor
5290297|NCT00470366|stage IIIB ovarian germ cell tumor|stage iiib ovarian germ cell tumor
5290298|NCT00470366|stage IIIC ovarian germ cell tumor|stage iiic ovarian germ cell tumor
5290299|NCT00470353|recurrent colon cancer|recurrent colon cancer
5290300|NCT00470353|stage I colon cancer|stage i colon cancer
5290301|NCT00470353|stage II colon cancer|stage ii colon cancer
5290302|NCT00470353|stage III colon cancer|stage iii colon cancer
5290303|NCT00470340|Recurrence|recurrence
5290304|NCT00470340|Neoplasm Recurrence, Local|neoplasm recurrence, local
5290305|NCT00470340|Liver|liver
5290306|NCT00470340|Liver Neoplasms|liver neoplasms
5290307|NCT00470340|Liver Cirrhosis|liver cirrhosis
5290308|NCT00470340|Carcinoma, Hepatocellular|carcinoma, hepatocellular
5290309|NCT00470340|Iodized Oil|iodized oil
5290310|NCT00470340|gemcitabine [Substance Name]|gemcitabine [substance name]
5290311|NCT00470340|oxaliplatin [Substance Name]|oxaliplatin [substance name]
5290312|NCT00470340|gemcitabine-oxaliplatin regimen [Substance Name]|gemcitabine-oxaliplatin regimen [substance name]
5290313|NCT00470340|Randomized Controlled Trials|randomized controlled trials
5290314|NCT00470340|Multicenter Studies|multicenter studies
5290315|NCT00470340|Cisplatin|cisplatin
5290316|NCT00470340|Injections, Intra-Arterial|injections, intra-arterial
5290317|NCT00470340|Injections, Intravenous|injections, intravenous
5290318|NCT00470340|Chemotherapy, Adjuvant|chemotherapy, adjuvant
5290319|NCT00470327|Interstitial lung diseases|interstitial lung diseases
5290320|NCT00470327|idiopathic pulmonary fibrosis|idiopathic pulmonary fibrosis
5290321|NCT00470327|Sarcoidosis|sarcoidosis
5290322|NCT00470327|mRNA and cytokine expression|mrna and cytokine expression
5290323|NCT00470314|Acute liver failure|acute liver failure
5290324|NCT00470314|Ornithine Aspartate|ornithine aspartate
5290325|NCT00470314|Ammonia|ammonia
5290326|NCT00470314|Encephalopathy|encephalopathy
5290327|NCT00470288|cesarean delivery|cesarean delivery
5290328|NCT00470288|bladder flaps|bladder flaps
5290329|NCT00470275|recurrent Ewing sarcoma/peripheral primitive neuroectodermal tumor|recurrent ewing sarcoma/peripheral primitive neuroectodermal tumor
5290330|NCT00470262|fatty acid oxidation complex|fatty acid oxidation complex
5290331|NCT00470262|fenofibrate|fenofibrate
5290332|NCT00470262|Inflammation|inflammation
5290333|NCT00470262|Peroxisome Proliferator-Activated Receptors|peroxisome proliferator-activated receptors
5290334|NCT00470262|pioglitazone|pioglitazone
5290335|NCT00470262|Prediabetic State|prediabetic state
5290336|NCT00470262|insulin resistance|insulin resistance
5290337|NCT00470249|stage IIIB breast cancer|stage iiib breast cancer
5290338|NCT00470249|stage IIIC breast cancer|stage iiic breast cancer
5290339|NCT00470249|stage IV breast cancer|stage iv breast cancer
5290340|NCT00470249|recurrent breast cancer|recurrent breast cancer
5290341|NCT00470249|male breast cancer|male breast cancer
5290342|NCT00470249|stage IIIA breast cancer|stage iiia breast cancer
5290343|NCT00470236|Ductal carcinoma in-situ|ductal carcinoma in-situ
5290344|NCT00470236|Breast conserving therapy|breast conserving therapy
5290345|NCT00470236|Whole breast radiation therapy|whole breast radiation therapy
5290346|NCT00470236|Tumour bed boost|tumour bed boost
5290347|NCT00470236|Fractionation schedules|fractionation schedules
5290348|NCT00470236|Completely excised non-low risk DCIS|completely excised non-low risk dcis
5290349|NCT00470223|localized osteosarcoma|localized osteosarcoma
5290350|NCT00470223|metastatic osteosarcoma|metastatic osteosarcoma
5290351|NCT00470210|Ribavirin|ribavirin
5290352|NCT00470210|non-responders|non-responders
5290353|NCT00470210|HCV co-infected patients|hcv co-infected patients
5290354|NCT00470210|sustained virological response|sustained virological response
5290355|NCT00470210|Treatment Experienced|treatment experienced
5290356|NCT00470184|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
5290357|NCT00470184|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
5290358|NCT00470184|stage II esophageal cancer|stage ii esophageal cancer
5290359|NCT00470184|stage III esophageal cancer|stage iii esophageal cancer
5290360|NCT00470184|stage IV esophageal cancer|stage iv esophageal cancer
5290361|NCT00470158|zinc|zinc
5290362|NCT00470158|iron|iron
5290363|NCT00470158|interaction|interaction
5290364|NCT00470158|diarrhea|diarrhea
5290365|NCT00470158|delivery|delivery
5290366|NCT00470145|unmilled formulation,|unmilled formulation,
5290367|NCT00470145|micronised formulation|micronised formulation
5290368|NCT00470145|relative bioavailability,|relative bioavailability,
5290369|NCT00470132|ventricular shunt|ventricular shunt
5290370|NCT00470119|breast cancer|breast cancer
5290371|NCT00470119|obesity|obesity
5290372|NCT00470119|weight changes|weight changes
5290373|NCT00470106|Cognition|cognition
5290374|NCT00470106|Remediation|remediation
5290375|NCT00470106|Schizophrenia|schizophrenia
5290376|NCT00470106|Social Cognition|social cognition
5290377|NCT00470093|refractory multiple myeloma|refractory multiple myeloma
5290378|NCT00470093|stage I multiple myeloma|stage i multiple myeloma
5290379|NCT00470093|stage II multiple myeloma|stage ii multiple myeloma
5290380|NCT00470093|stage III multiple myeloma|stage iii multiple myeloma
5290381|NCT00470080|Venepuncture|venepuncture
5290382|NCT00470080|Pain|pain
5290383|NCT00470080|Emla cream|emla cream
5290384|NCT00470080|Oral sucrose solution|oral sucrose solution
5290385|NCT00470080|Premature infant|premature infant
5290386|NCT00470080|Premature infant admitted to the care baby unit were|premature infant admitted to the care baby unit were
5290387|NCT00470080|included in the study.|included in the study.
5290388|NCT00470080|Programed venepuncture is performed with analgesia.|programed venepuncture is performed with analgesia.
5290389|NCT00470067|recurrent endometrial carcinoma|recurrent endometrial carcinoma
5290390|NCT00470067|stage III endometrial carcinoma|stage iii endometrial carcinoma
5290391|NCT00470067|stage IV endometrial carcinoma|stage iv endometrial carcinoma
5290392|NCT00470041|Healthy volunteers|healthy volunteers
5290394|NCT00470028|Treatment|treatment
5290395|NCT00470028|Adolescents|adolescents
5290396|NCT00470028|Safety|safety
5290397|NCT00470028|Efficacy|efficacy
5290398|NCT00470015|stage II melanoma|stage ii melanoma
5290399|NCT00470015|stage III melanoma|stage iii melanoma
5290400|NCT00470015|stage IV melanoma|stage iv melanoma
5290401|NCT00470015|recurrent melanoma|recurrent melanoma
5290402|NCT00470002|growth hormone|growth hormone
5290403|NCT00470002|nitric oxide|nitric oxide
5290404|NCT00470002|nitrate|nitrate
5290405|NCT00470002|cyclic guanosine monophosphate|cyclic guanosine monophosphate
5290406|NCT00470002|insulin-like growth factor-1|insulin-like growth factor-1
5290407|NCT00470002|asymmetric dimethylarginine|asymmetric dimethylarginine
5290408|NCT00470002|blood pressure|blood pressure
5290409|NCT00470002|endothelial progenitor cells|endothelial progenitor cells
5290410|NCT00469989|immune system|immune system
5290411|NCT00469989|allergy|allergy
5290412|NCT00469989|hookworm infection|hookworm infection
5290413|NCT00469989|parasite infection|parasite infection
5290414|NCT00469989|asthma|asthma
5290415|NCT00469976|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5290416|NCT00469976|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5290417|NCT00469976|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5290418|NCT00469963|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
5290419|NCT00469963|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
5290420|NCT00469963|recurrent adult primary liver cancer|recurrent adult primary liver cancer
5290421|NCT00469963|advanced adult primary liver cancer|advanced adult primary liver cancer
5290422|NCT00469950|PCI|pci
5290423|NCT00469950|stent|stent
5290424|NCT00469950|training|training
5290425|NCT00469950|endothelial function|endothelial function
5290426|NCT00469950|restenosis|restenosis
5290427|NCT00469950|late luminal loss|late luminal loss
5290428|NCT00469950|heart rate variability|heart rate variability
5290429|NCT00469950|oxygen uptake capacity|oxygen uptake capacity
5290430|NCT00469950|inflammatory markers|inflammatory markers
5290514|NCT00469651|vaccine|vaccine
5290431|NCT00469937|radiation toxicity|radiation toxicity
5290432|NCT00469937|neurotoxicity|neurotoxicity
5290433|NCT00469937|cognitive/functional effects|cognitive/functional effects
5290434|NCT00469937|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5290435|NCT00469937|adult tumors metastatic to brain|adult tumors metastatic to brain
5290436|NCT00469924|Informatics|informatics
5290437|NCT00469924|Clinical Laboratory Information Systems|clinical laboratory information systems
5290438|NCT00469924|Hospital Communication Systems|hospital communication systems
5290439|NCT00469924|Laboratory Techniques and Procedures|laboratory techniques and procedures
5290440|NCT00469924|Point-of-Care Systems|point-of-care systems
5290441|NCT00469924|Therapy, Computer-Assisted|therapy, computer-assisted
5290442|NCT00469911|Heart|heart
5290443|NCT00469911|Transplant|transplant
5290444|NCT00469911|MRS|mrs
5290445|NCT00469911|MRI|mri
5290446|NCT00469911|Spectroscopy|spectroscopy
5290447|NCT00469898|extensive stage small cell lung cancer|extensive stage small cell lung cancer
5290448|NCT00469885|Smoking cessation|smoking cessation
5290449|NCT00469885|cardiovascular disease|cardiovascular disease
5290450|NCT00469885|smoking reduction|smoking reduction
5290451|NCT00469885|nicotine replacement|nicotine replacement
5290452|NCT00469859|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5290453|NCT00469859|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5290454|NCT00469859|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5290455|NCT00469859|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5290456|NCT00469859|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5290457|NCT00469859|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5290458|NCT00469859|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5290459|NCT00469859|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5290460|NCT00469846|Pre-Eclampsia|pre-eclampsia
5290461|NCT00469846|Hypertension,pregnancy-induced|hypertension,pregnancy-induced
5290462|NCT00469846|Preterm labor|preterm labor
5290463|NCT00469833|Diabetes|diabetes
5290464|NCT00469833|Glucose Tolerance|glucose tolerance
5290465|NCT00469833|Incretin|incretin
5290466|NCT00469833|Insulin|insulin
5290467|NCT00469820|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5290468|NCT00469820|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5290469|NCT00469820|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5290470|NCT00469820|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5290471|NCT00469820|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5290472|NCT00469820|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5290473|NCT00469820|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5290474|NCT00469820|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5290475|NCT00469820|stage III multiple myeloma|stage iii multiple myeloma
5290476|NCT00469820|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
5290477|NCT00469820|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
5290478|NCT00469820|stage I multiple myeloma|stage i multiple myeloma
5290479|NCT00469820|stage II multiple myeloma|stage ii multiple myeloma
5290480|NCT00469820|refractory multiple myeloma|refractory multiple myeloma
5290481|NCT00469807|Ghrelin|ghrelin
5290482|NCT00469807|Pregnancy outcome|pregnancy outcome
5290483|NCT00469794|arrhythmias|arrhythmias
5290484|NCT00469794|Athletes|athletes
5290485|NCT00469794|exercise|exercise
5290486|NCT00469768|HIV-1 infection|hiv-1 infection
5290487|NCT00469768|HIV Seronegativity|hiv seronegativity
5290488|NCT00469742|Cardiology|cardiology
5290489|NCT00469742|Pediatrics|pediatrics
5290490|NCT00469742|Cardiac Defects|cardiac defects
5290491|NCT00469742|Cardiopulmonary Bypass Surgery|cardiopulmonary bypass surgery
5290492|NCT00469742|Aprotinin|aprotinin
5290493|NCT00469742|thrombosis|thrombosis
5290494|NCT00469742|renal dysfunction|renal dysfunction
5290495|NCT00469729|Tetraethylenepentamine|tetraethylenepentamine
5290496|NCT00469729|Umbilical Cord Blood Stem Cell Transplantation|umbilical cord blood stem cell transplantation
5290497|NCT00469729|Hematological Malignancies|hematological malignancies
5290498|NCT00469729|Acute Lymphoid Leukemia|acute lymphoid leukemia
5290499|NCT00469729|Subjects with high-risk hematologic malignancies who are candidates for allogeneic stem cell transplantation|subjects with high-risk hematologic malignancies who are candidates for allogeneic stem cell transplantation
5290500|NCT00469716|Fluid balance|fluid balance
5290501|NCT00469716|respiratory function|respiratory function
5290502|NCT00469716|cardiac function|cardiac function
5290503|NCT00469716|inflammation|inflammation
5290504|NCT00469716|Cardiopulmonary bypass|cardiopulmonary bypass
5290505|NCT00469703|Pancreatitis|pancreatitis
5290506|NCT00469664|Schizophrenia|schizophrenia
5290507|NCT00469664|Schizoaffective|schizoaffective
5290508|NCT00469664|Cognitive Impairment|cognitive impairment
5290509|NCT00469664|Cognition|cognition
5290510|NCT00469664|Memory|memory
5290511|NCT00469664|Attention|attention
5290512|NCT00469664|Concentration|concentration
5290515|NCT00469651|MSP3LSP|msp3lsp
5290516|NCT00469651|Safety|safety
5290517|NCT00469651|children|children
5290518|NCT00469651|Tanzania|tanzania
5290519|NCT00469638|atrial fibrillation|atrial fibrillation
5290520|NCT00469638|paroxysmal|paroxysmal
5290521|NCT00469638|persistent|persistent
5290522|NCT00469638|symptomatic|symptomatic
5290523|NCT00469638|ablation|ablation
5290524|NCT00469638|catheter|catheter
5290525|NCT00469638|introducer|introducer
5290526|NCT00469638|Agilis NxT|agilis nxt
5290527|NCT00469638|sinus rhythm|sinus rhythm
5290528|NCT00469638|paroxysmal atrial fibrillation|paroxysmal atrial fibrillation
5290529|NCT00469638|persistent atrial fibrillation|persistent atrial fibrillation
5290530|NCT00469638|symptomatic atrial fibrillation|symptomatic atrial fibrillation
5290531|NCT00469612|Myopia|myopia
5290532|NCT00469612|NeuroVision|neurovision
5290533|NCT00469612|Visual acuity|visual acuity
5290534|NCT00469612|Contrast sensitivity|contrast sensitivity
5290535|NCT00469599|Hyperparathyroidism, Secondary|hyperparathyroidism, secondary
5290536|NCT00469599|Kidney Failure, Chronic|kidney failure, chronic
5290537|NCT00469599|Renal Insufficiency, Chronic|renal insufficiency, chronic
5290538|NCT00469599|Vitamin D Deficiency|vitamin d deficiency
5290539|NCT00469599|Renal Osteodystrophy|renal osteodystrophy
5290540|NCT00469599|Hemodialysis|hemodialysis
5290541|NCT00469560|MDS|mds
5290542|NCT00469560|Chronic transfusional hemosiderosis|chronic transfusional hemosiderosis
5290543|NCT00469560|Deferasirox|deferasirox
5290544|NCT00469547|ethanol, microbicide, sexually transmitted, Kenya, males|ethanol, microbicide, sexually transmitted, kenya, males
5290545|NCT00469547|HIV Seronegativity|hiv seronegativity
5290546|NCT00469534|minimized time to beam|minimized time to beam
5290547|NCT00469534|hypofractionated 3D CRT plus IMRT|hypofractionated 3d crt plus imrt
5290548|NCT00469534|PET-scan|pet-scan
5290549|NCT00469508|Methamphetamine|methamphetamine
5290550|NCT00469508|Modafinil|modafinil
5290551|NCT00469508|Medication|medication
5290552|NCT00469508|Contingency Management|contingency management
5290553|NCT00469508|Crystal meth|crystal meth
5290554|NCT00469508|Los Angeles|los angeles
5290555|NCT00469508|Addiction|addiction
5290556|NCT00469508|Meth|meth
5290557|NCT00469482|Delirium|delirium
5290558|NCT00469482|Cognitive Impairment|cognitive impairment
5290559|NCT00469482|Sleep|sleep
5290560|NCT00469482|Polysomnography|polysomnography
5290561|NCT00469482|Sedation|sedation
5290562|NCT00469482|Mechanical Ventilation|mechanical ventilation
5290563|NCT00469482|Critical Illness|critical illness
5290564|NCT00469469|Adrenal Cortex|adrenal cortex
5290565|NCT00469469|ACC|acc
5290566|NCT00469456|memantine|memantine
5290567|NCT00469456|Alzheimer's Disease|alzheimer's disease
5290568|NCT00469456|communication|communication
5290569|NCT00469443|Metastatic colorectal cancer|metastatic colorectal cancer
5290570|NCT00469443|Irinotecan|irinotecan
5290571|NCT00469443|Capecitabine|capecitabine
5290572|NCT00469443|Bevacizumab|bevacizumab
5290573|NCT00469430|appendicitis|appendicitis
5290574|NCT00469430|treatment|treatment
5290575|NCT00469430|antibiotics|antibiotics
5290576|NCT00469417|Methyl aminolevulinate|methyl aminolevulinate
5290577|NCT00469417|Photodynamic therapy|photodynamic therapy
5290578|NCT00469417|Primary Superficial Basal Cell Carcinoma|primary superficial basal cell carcinoma
5290579|NCT00469404|Transdermal patch|transdermal patch
5290580|NCT00469404|Centrally acting analgesic|centrally acting analgesic
5290581|NCT00469404|Plasma level|plasma level
5290582|NCT00469404|Healthy volunteers|healthy volunteers
5290583|NCT00469391|Weight Reduction|weight reduction
5290584|NCT00469378|firategrast|firategrast
5290585|NCT00469378|lymphocytes|lymphocytes
5290586|NCT00469378|leukocytes|leukocytes
5290587|NCT00469378|SB-683699|sb-683699
5290588|NCT00469378|cerebrospinal fluid|cerebrospinal fluid
5290589|NCT00469378|relapsing forms of multiple sclerosis|relapsing forms of multiple sclerosis
5290590|NCT00469365|clinical trial, medication adherence, pharmacy intervention|clinical trial, medication adherence, pharmacy intervention
5290591|NCT00469365|Patients with specific chronic diseases|patients with specific chronic diseases
5290592|NCT00469352|Pharmacogenetics|pharmacogenetics
5290593|NCT00469352|Genetics|genetics
5290594|NCT00469352|Treatment response|treatment response
5290596|NCT00469352|Wet AMD|wet amd
5290597|NCT00469352|Age-related macular degeneration|age-related macular degeneration
5290598|NCT00469339|Breast Cancer|breast cancer
5290599|NCT00469339|Diabetes|diabetes
5290600|NCT00469339|Colon Cancer|colon cancer
5290601|NCT00469339|Cardiovascular Disease|cardiovascular disease
5290602|NCT00469326|coronary artery disease|coronary artery disease
5290603|NCT00469326|percutaneous coronary intervention|percutaneous coronary intervention
5290604|NCT00469326|atorvastatin|atorvastatin
5290605|NCT00469313|copd|copd
5290606|NCT00469313|inspiratory muscle training|inspiratory muscle training
5290607|NCT00469313|IF|if
5290608|NCT00469300|herpes labialis|herpes labialis
5290609|NCT00469300|cold sore|cold sore
5290610|NCT00469300|acyclovir|acyclovir
5290611|NCT00469300|iontophoresis|iontophoresis
5290612|NCT00469300|topical|topical
5290613|NCT00469287|diabetes mellitus|diabetes mellitus
5290614|NCT00469287|blood sugar|blood sugar
5290615|NCT00469287|overweight|overweight
5290616|NCT00469287|obesity|obesity
5290617|NCT00469287|Traditional Chinese medicine|traditional chinese medicine
5290618|NCT00469274|Pertussis|pertussis
5290619|NCT00469274|Healthcare worker|healthcare worker
5290620|NCT00469274|Post-exposure prophylaxis|post-exposure prophylaxis
5290621|NCT00469274|Vaccination|vaccination
5290622|NCT00469274|Pertussis in healthcare workers following occupational|pertussis in healthcare workers following occupational
5290623|NCT00469274|exposure to pertussis|exposure to pertussis
5290624|NCT00469261|Myocardial infarction|myocardial infarction
5290625|NCT00469261|Ventricular remodeling|ventricular remodeling
5290626|NCT00469261|Matrix metalloproteinases|matrix metalloproteinases
5290627|NCT00469261|Doxycycline|doxycycline
5290628|NCT00469248|Myocardial infarction|myocardial infarction
5290629|NCT00469248|Cardiogenic shock|cardiogenic shock
5290630|NCT00469248|Systemic inflammatory response syndrome|systemic inflammatory response syndrome
5290631|NCT00469248|Percutaneous coronary intervention|percutaneous coronary intervention
5290632|NCT00469248|aortic balloon counterpulsation|aortic balloon counterpulsation
5290633|NCT00469222|small cell lung cancer|small cell lung cancer
5290634|NCT00469222|radiotherapy dose escalation|radiotherapy dose escalation
5290635|NCT00469209|Multiple Myeloma|multiple myeloma
5290636|NCT00469209|Melphalan|melphalan
5290637|NCT00469209|Trisenox|trisenox
5290638|NCT00469209|Arsenic Trioxide|arsenic trioxide
5290639|NCT00469209|Ascorbic Acid|ascorbic acid
5290640|NCT00469209|Vitamin C|vitamin c
5290641|NCT00469209|Velcade|velcade
5290642|NCT00469209|Bortezomib|bortezomib
5290643|NCT00469196|mesothelioma|mesothelioma
5290644|NCT00469196|tomotherapy|tomotherapy
5290645|NCT00469170|HIV-1|hiv-1
5290646|NCT00469170|HIV seronegativity|hiv seronegativity
5290647|NCT00469157|compatibility of Optive after PRK or LASIK|compatibility of optive after prk or lasik
5290648|NCT00469144|Stem Cell Transplantation|stem cell transplantation
5290649|NCT00469144|Leukemia|leukemia
5290650|NCT00469144|Busulfan|busulfan
5290651|NCT00469144|Fludarabine|fludarabine
5290652|NCT00469144|MDS|mds
5290653|NCT00469144|AML|aml
5290654|NCT00469131|liver transplantation,|liver transplantation,
5290655|NCT00469131|HCV recurrence,|hcv recurrence,
5290656|NCT00469131|immunosuppression|immunosuppression
5290657|NCT00469105|Type 2 Diabetes|type 2 diabetes
5290658|NCT00469105|Diabetes Education|diabetes education
5290659|NCT00469105|Health Literacy|health literacy
5290660|NCT00469079|Biomarkers|biomarkers
5290661|NCT00469079|Smoking|smoking
5290662|NCT00469079|Tobacco|tobacco
5290663|NCT00469079|Cessation|cessation
5290664|NCT00469066|small cell lung cancer|small cell lung cancer
5290665|NCT00469066|bladder cancer|bladder cancer
5290666|NCT00469066|conformal radiotherapy|conformal radiotherapy
5290667|NCT00469053|Transdermal patch|transdermal patch
5290668|NCT00469053|multidose|multidose
5290669|NCT00469053|Centrally acting analgesic|centrally acting analgesic
5290670|NCT00469053|Plasma level|plasma level
5290671|NCT00469053|Healthy volunteers|healthy volunteers
5290672|NCT00469040|GW642444,|gw642444,
5290673|NCT00469040|healthy subjects|healthy subjects
5290674|NCT00469040|magnesium stearate,|magnesium stearate,
5290675|NCT00469027|Pulmonary Arterial Hypertension (PAH)|pulmonary arterial hypertension (pah)
5290676|NCT00469014|Acute Myeloid Leukemia|acute myeloid leukemia
5290677|NCT00469014|AML|aml
5290678|NCT00469014|Myelodysplastic Syndrome|myelodysplastic syndrome
5290679|NCT00469014|MDS|mds
5290680|NCT00469014|Chronic Myeloid Leukemia|chronic myeloid leukemia
5290681|NCT00469014|CML|cml
5290682|NCT00469014|Busulfan|busulfan
5290683|NCT00469014|Busulfex|busulfex
5290684|NCT00469014|Myleran|myleran
5290685|NCT00469014|Fludarabine|fludarabine
5290686|NCT00469014|Fludara|fludara
5290687|NCT00469014|Fludarabine Phosphate|fludarabine phosphate
5290688|NCT00469014|Clofarabine|clofarabine
5290689|NCT00469014|Clofarex|clofarex
5290690|NCT00469014|Clolar|clolar
5290691|NCT00469014|Allogeneic stem cell transplantation|allogeneic stem cell transplantation
5290692|NCT00469014|ASCT|asct
5290693|NCT00469014|Stem Cell|stem cell
5290694|NCT00469014|Gleevec|gleevec
5290695|NCT00469014|Imatinib Mesylate|imatinib mesylate
5290696|NCT00469001|Hospitalization and death from exacerbation CHF.|hospitalization and death from exacerbation chf.
5290697|NCT00468949|Health-Related Quality of Life|health-related quality of life
5290698|NCT00468949|Dupuytren's Disease|dupuytren's disease
5290699|NCT00468949|Health Utilities Index|health utilities index
5290700|NCT00468949|Short Form-36;|short form-36;
5290701|NCT00468949|Michigan Hand Outcomes Questionnaire|michigan hand outcomes questionnaire
5290702|NCT00468936|anti-rejection|anti-rejection
5290703|NCT00468936|GI side effects|gi side effects
5290704|NCT00468936|heart transplant patients|heart transplant patients
5290705|NCT00468923|Primary prevention|primary prevention
5290706|NCT00468923|Cholesterol lowering|cholesterol lowering
5290707|NCT00468923|Blood pressure lowering|blood pressure lowering
5290708|NCT00468923|Cardiovascular disease prevention|cardiovascular disease prevention
5290709|NCT00468897|Alzheimers Disease|alzheimers disease
5290710|NCT00468897|healthy volunteers|healthy volunteers
5290711|NCT00468897|bioequivalence|bioequivalence
5290712|NCT00468884|Kinetics of GLP-1 and PYY3-36; increasing oral doses|kinetics of glp-1 and pyy3-36; increasing oral doses
5290713|NCT00468858|Dengue|dengue
5290714|NCT00468858|Virus|virus
5290715|NCT00468858|Live-attenuated|live-attenuated
5290716|NCT00468858|Vaccine|vaccine
5290717|NCT00468858|Dengue viral infection|dengue viral infection
5290718|NCT00468858|Dengue Vaccine|dengue vaccine
5290719|NCT00468845|pain after hysterectomy|pain after hysterectomy
5290720|NCT00468845|amount of opioids used|amount of opioids used
5290721|NCT00468819|Contrast-enhanced MRI|contrast-enhanced mri
5290722|NCT00468819|MR angiography (MRA) Children 2-17 years|mr angiography (mra) children 2-17 years
5290723|NCT00468806|PET scan|pet scan
5290724|NCT00468806|Health Males|health males
5290725|NCT00468793|central venous saturation|central venous saturation
5290726|NCT00468793|bowel surgery|bowel surgery
5290727|NCT00468793|morbidity|morbidity
5290728|NCT00468793|intravenous infusions|intravenous infusions
5290729|NCT00468780|Canadian Triage Acuity Scale|canadian triage acuity scale
5290730|NCT00468780|paramedics|paramedics
5290731|NCT00468780|triage nurse|triage nurse
5290732|NCT00468780|triage levels|triage levels
5290733|NCT00468780|inter-rater reliability|inter-rater reliability
5290734|NCT00468780|health services outcomes|health services outcomes
5290735|NCT00468767|Atrial fibrillation|atrial fibrillation
5290736|NCT00468767|RSD1235|rsd1235
5290737|NCT00468767|Atrial fibrillation of 3 hours to 7 days duration.|atrial fibrillation of 3 hours to 7 days duration.
5290738|NCT00468767|Atrial fibrillation of 3 hours to 45 days duration.|atrial fibrillation of 3 hours to 45 days duration.
5290739|NCT00468741|Breast Cancer|breast cancer
5290740|NCT00468741|Internet|internet
5290741|NCT00468741|Computer|computer
5290742|NCT00468741|Support|support
5290743|NCT00468741|Information|information
5290744|NCT00468741|Education|education
5290745|NCT00468741|Control Group: Usual care and Internet access|control group: usual care and internet access
5290746|NCT00468741|CHESS Information Services only|chess information services only
5290747|NCT00468741|CHESS Social Support & Information Services|chess social support & information services
5290748|NCT00468741|CHESS Information, Social Support & Skills Services|chess information, social support & skills services
5290749|NCT00468728|CDAD, Clostridium difficile, diarrhea|cdad, clostridium difficile, diarrhea
5290750|NCT00468728|Clostridium difficile-Associated Diarrhea|clostridium difficile-associated diarrhea
5290751|NCT00468715|stage IV breast cancer|stage iv breast cancer
5290752|NCT00468715|recurrent breast cancer|recurrent breast cancer
5290753|NCT00468715|male breast cancer|male breast cancer
5290754|NCT00468689|SB-751689,|sb-751689,
5290755|NCT00468689|Calcium-sensing receptor antagonist (CaR),|calcium-sensing receptor antagonist (car),
5290756|NCT00468689|Osteoporosis,|osteoporosis,
5290757|NCT00468689|Parathyroid hormone (PTH),|parathyroid hormone (pth),
5290758|NCT00468689|Oral dose|oral dose
5290759|NCT00468676|major Depressive Disorder|major depressive disorder
5290760|NCT00468676|Diabetes|diabetes
5290761|NCT00468676|Heart Disease|heart disease
5290762|NCT00468663|preeclampsia|preeclampsia
5290763|NCT00468663|preterm delivery|preterm delivery
5290764|NCT00468663|lipid peroxidation|lipid peroxidation
5290765|NCT00468663|inflammation|inflammation
5290766|NCT00468637|heart failure|heart failure
5290767|NCT00468637|cardiovascular high risk|cardiovascular high risk
5290768|NCT00468637|erectile dysfunction|erectile dysfunction
5290769|NCT00468637|cardiovascular disease|cardiovascular disease
5290770|NCT00468624|Growth hormone|growth hormone
5290771|NCT00468624|insulin-like growth factor 1|insulin-like growth factor 1
5290772|NCT00468624|pegvisomant|pegvisomant
5290773|NCT00468611|Secondary Progressive Multiple Sclerosis|secondary progressive multiple sclerosis
5290774|NCT00468611|Multiple Sclerosis|multiple sclerosis
5290775|NCT00468598|troponin|troponin
5290776|NCT00468598|long-term outcome|long-term outcome
5290777|NCT00468598|on-pump cardiac surgery|on-pump cardiac surgery
5290778|NCT00468585|Breast cancer|breast cancer
5290779|NCT00468585|Metastatic breast cancer|metastatic breast cancer
5290780|NCT00468585|Breast|breast
5290781|NCT00468585|Metastatic|metastatic
5290782|NCT00468572|Emotion|emotion
5290783|NCT00468572|Oxytocin|oxytocin
5290784|NCT00468572|Cortisol|cortisol
5290785|NCT00468559|pediatrics|pediatrics
5290786|NCT00468559|neonates|neonates
5290787|NCT00468533|Arupiprazole, prolacin, PANSS, CGI, AIMS|arupiprazole, prolacin, panss, cgi, aims
5290788|NCT00468520|induction of labor|induction of labor
5290789|NCT00468520|cervical ripening|cervical ripening
5290790|NCT00468520|Foley catheter|foley catheter
5290791|NCT00468520|oxytocin|oxytocin
5290792|NCT00468507|CCK release|cck release
5290793|NCT00468494|non diabetic|non diabetic
5290794|NCT00468494|catabolic energy state|catabolic energy state
5290795|NCT00468481|Healthy women requesting contraception|healthy women requesting contraception
5290796|NCT00468481|Folic Acid|folic acid
5290797|NCT00468468|breast cancer|breast cancer
5290798|NCT00468468|Internet|internet
5290799|NCT00468468|computer|computer
5290800|NCT00468468|support|support
5290801|NCT00468468|information|information
5290802|NCT00468468|education|education
5290803|NCT00468455|Colorectal Surgery|colorectal surgery
5290804|NCT00468455|Abdominal Surgery|abdominal surgery
5290805|NCT00468455|Diverticulitis|diverticulitis
5290806|NCT00468455|Colon Cancer|colon cancer
5290807|NCT00468455|Rectal Cancer|rectal cancer
5290808|NCT00468455|Colon Polyp|colon polyp
5290809|NCT00468455|Rectal Polyp|rectal polyp
5290810|NCT00468455|Crohn's Disease|crohn's disease
5290811|NCT00468442|Insulin dependence|insulin dependence
5290812|NCT00468442|Hypoglycemia|hypoglycemia
5290813|NCT00468442|Hypoglycemia unawareness|hypoglycemia unawareness
5290814|NCT00468429|Glaucoma|glaucoma
5290815|NCT00468429|Bevacizumab|bevacizumab
5290816|NCT00468429|Glaucoma Filtration Surgery|glaucoma filtration surgery
5290817|NCT00468429|Mitomycin C|mitomycin c
5290818|NCT00468429|Intraocular Pressure|intraocular pressure
5290819|NCT00468403|Insulin dependence|insulin dependence
5290820|NCT00468403|Hypoglycemia|hypoglycemia
5290821|NCT00468403|Hypoglycemia unawareness|hypoglycemia unawareness
5290822|NCT00468364|Hypoglycemia, bedtime insulin, long-acting insulin|hypoglycemia, bedtime insulin, long-acting insulin
5290823|NCT00468351|bevacizumab|bevacizumab
5290824|NCT00468351|diabetes|diabetes
5290825|NCT00468351|intravitreal|intravitreal
5290826|NCT00468351|macular edema|macular edema
5290827|NCT00468351|triamcinolone|triamcinolone
5290828|NCT00468351|VEGF|vegf
5290829|NCT00468338|general anesthesia|general anesthesia
5290830|NCT00468338|dental rehabilitation|dental rehabilitation
5290831|NCT00468338|mental retardation|mental retardation
5290832|NCT00468325|coronary artery disease|coronary artery disease
5290833|NCT00468325|chest pain|chest pain
5290834|NCT00468325|emergency room|emergency room
5290835|NCT00468299|early|early
5290836|NCT00468299|pregnancy|pregnancy
5290837|NCT00468299|failure|failure
5290838|NCT00468299|mifepristone|mifepristone
5290839|NCT00468299|misoprostol|misoprostol
5290840|NCT00468299|buccal|buccal
5290841|NCT00468299|miscarriage|miscarriage
5290842|NCT00468299|fetal|fetal
5290843|NCT00468299|demise|demise
5290844|NCT00468299|anembryonic|anembryonic
5290845|NCT00468299|progesterone|progesterone
5290846|NCT00468286|Prostate Cancer|prostate cancer
5290847|NCT00468273|Deficiency Syndromes, Antibody|deficiency syndromes, antibody
5290848|NCT00468273|Antibody Deficiency Syndrome|antibody deficiency syndrome
5290849|NCT00468273|Bruton's agammaglobulinemia|bruton's agammaglobulinemia
5290850|NCT00468273|Common Variable Immune Deficiency|common variable immune deficiency
5290851|NCT00468273|Hyper IgM syndromes|hyper igm syndromes
5290852|NCT00468260|Cancer|cancer
5290853|NCT00468260|EPO906|epo906
5290854|NCT00468260|Patupilone|patupilone
5290855|NCT00468247|mean systemic pressure|mean systemic pressure
5290856|NCT00468247|fluid therapy|fluid therapy
5290857|NCT00468247|closed loop control|closed loop control
5290858|NCT00468247|circulation modelling|circulation modelling
5290859|NCT00468234|smoking cessation|smoking cessation
5290860|NCT00468234|harm reduction|harm reduction
5290861|NCT00468234|biomarker|biomarker
5290862|NCT00468234|exhaled breath condensate|exhaled breath condensate
5290863|NCT00468221|Ozone|ozone
5290864|NCT00468221|Healthy Adults|healthy adults
5290865|NCT00468208|Vasculitis|vasculitis
5290866|NCT00468208|Relapse|relapse
5290867|NCT00468208|Wegener's|wegener's
5290868|NCT00468208|Treatment|treatment
5290869|NCT00468195|tomography|tomography
5290870|NCT00468195|coronary artery disease|coronary artery disease
5290871|NCT00468195|obesity|obesity
5290872|NCT00468182|Multiple sclerosis|multiple sclerosis
5290873|NCT00468182|Interferon beta|interferon beta
5290874|NCT00468182|plasmacytoid dendritic cells|plasmacytoid dendritic cells
5290875|NCT00468169|Cetuximab|cetuximab
5290876|NCT00468169|Erbitux|erbitux
5290877|NCT00468169|locally|locally
5290878|NCT00468169|advanced|advanced
5290879|NCT00468169|head|head
5290880|NCT00468169|neck|neck
5290881|NCT00468169|cancer|cancer
5290882|NCT00468169|neoplasms|neoplasms
5290883|NCT00468169|squamous|squamous
5290884|NCT00468169|carcinoma|carcinoma
5290885|NCT00468169|lymphoepithelioma|lymphoepithelioma
5290886|NCT00468156|fruit|fruit
5290887|NCT00468156|vegetables|vegetables
5290888|NCT00468156|prevention|prevention
5290889|NCT00468156|cancer|cancer
5290890|NCT00468156|counseling|counseling
5290891|NCT00468156|cancer risk|cancer risk
5290892|NCT00468130|Aggression|aggression
5290893|NCT00468130|Irritability|irritability
5290894|NCT00468130|Global autism severity|global autism severity
5290895|NCT00468117|Hypoglycemia|hypoglycemia
5290896|NCT00468117|Kidney Transplant|kidney transplant
5290897|NCT00468117|Insulin independence|insulin independence
5290898|NCT00468117|Islet Transplantation|islet transplantation
5290899|NCT00468117|Intensive Insulin Therapy|intensive insulin therapy
5290900|NCT00468104|parapneumonic pleural effusion|parapneumonic pleural effusion
5290901|NCT00468104|empyema|empyema
5290902|NCT00468104|TPA (Activase, Alteplase)|tpa (activase, alteplase)
5290903|NCT00468091|GLP-1|glp-1
5290904|NCT00468091|exendin(9-39)|exendin(9-39)
5290905|NCT00468091|atropine|atropine
5290906|NCT00468091|human|human
5290907|NCT00468091|motility|motility
5290908|NCT00468078|Parkinson's disease|parkinson's disease
5290909|NCT00468078|Essential tremor|essential tremor
5290910|NCT00468078|F-18 FPCIT|f-18 fpcit
5290911|NCT00468078|PET|pet
5290912|NCT00468065|intravenous|intravenous
5290913|NCT00468065|catheter|catheter
5290914|NCT00468065|IV|iv
5290915|NCT00468052|obstructive sleep apnea|obstructive sleep apnea
5290916|NCT00468052|tonsillectomy|tonsillectomy
5290917|NCT00468052|adenoidectomy|adenoidectomy
5290918|NCT00468039|metformin|metformin
5290919|NCT00468039|vildagliptin|vildagliptin
5290920|NCT00468039|initial combination|initial combination
5290921|NCT00468026|BPH|bph
5290922|NCT00468026|Prostate|prostate
5290923|NCT00468026|Stent|stent
5290924|NCT00468026|Benign prostatic hyperplasia (BPH)|benign prostatic hyperplasia (bph)
5290925|NCT00468013|Fibromyalgia|fibromyalgia
5290926|NCT00468013|Irritable Bowel|irritable bowel
5290927|NCT00468013|Chronic Fatigue|chronic fatigue
5290928|NCT00468013|Medically Unexplained Symptoms|medically unexplained symptoms
5290929|NCT00468013|Resilience Building Exercises|resilience building exercises
5290930|NCT00468013|Depression|depression
5290931|NCT00468013|Well-Being|well-being
5290932|NCT00468000|Peripheral Arterial Disease|peripheral arterial disease
5290933|NCT00468000|Critical Limb Ischemia|critical limb ischemia
5290934|NCT00468000|Ischemia|ischemia
5290935|NCT00468000|Peripheral Vascular Disease|peripheral vascular disease
5290936|NCT00468000|ixmyelocel-T|ixmyelocel-t
5290937|NCT00467961|CML (Chronic Myelogenous Leukemia)|cml (chronic myelogenous leukemia)
5290938|NCT00467961|CLL (Chronic Lymphocytic Leukemia)|cll (chronic lymphocytic leukemia)
5290939|NCT00467961|AML (Acute Myelogenous Leukemia)|aml (acute myelogenous leukemia)
5290940|NCT00467961|Leukemia|leukemia
5290941|NCT00467961|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
5290942|NCT00467961|CLL|cll
5290943|NCT00467961|Chronic Myelogenous Leukemia|chronic myelogenous leukemia
5290944|NCT00467961|CML|cml
5290945|NCT00467961|Acute Myelogenous Leukemia|acute myelogenous leukemia
5290946|NCT00467961|AML|aml
5290947|NCT00467961|Acute B-Lymphoblastic Leukemia|acute b-lymphoblastic leukemia
5290948|NCT00467961|ALL|all
5290949|NCT00467961|Myelodysplastic Syndrome|myelodysplastic syndrome
5290950|NCT00467961|MDS|mds
5290951|NCT00467948|clean contaminated, laryngectomy, wound infection|clean contaminated, laryngectomy, wound infection
5290952|NCT00467935|amd|amd
5290953|NCT00467935|disciform|disciform
5290954|NCT00467935|fibrosis|fibrosis
5290955|NCT00467935|Lucentis|lucentis
5290956|NCT00467935|scotoma|scotoma
5290957|NCT00467922|Hand-assisted colorectal surgery|hand-assisted colorectal surgery
5290958|NCT00467922|colorectal disease|colorectal disease
5290959|NCT00467922|Crohn's|crohn's
5290960|NCT00467922|diverticulitis|diverticulitis
5290961|NCT00467922|Colorectal resections|colorectal resections
5290962|NCT00467909|micronutrients|micronutrients
5290963|NCT00467909|cognition|cognition
5290964|NCT00467909|DHA|dha
5290965|NCT00467909|healthy children|healthy children
5290966|NCT00467896|PAH|pah
5290967|NCT00467896|iloprost|iloprost
5290968|NCT00467896|Ventavis|ventavis
5290969|NCT00467896|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
5290970|NCT00467896|Actelion Pharmaceuticals|actelion pharmaceuticals
5290971|NCT00467896|Cotherix|cotherix
5290972|NCT00467883|Zygomycosis|zygomycosis
5290973|NCT00467883|High dose liposomal amphotericin B|high dose liposomal amphotericin b
5290974|NCT00467870|investigational|investigational
5290975|NCT00467870|testosterone|testosterone
5290976|NCT00467870|testosterone undecanoate|testosterone undecanoate
5290977|NCT00467870|TU|tu
5290978|NCT00467870|Hypogonadism|hypogonadism
5290979|NCT00467870|primary hypogonadism|primary hypogonadism
5290980|NCT00467870|secondary hypogonadism|secondary hypogonadism
5290981|NCT00467857|cyanoacrylates|cyanoacrylates
5290982|NCT00467857|microbial sealants|microbial sealants
5290983|NCT00467857|skin flora contamination|skin flora contamination
5290984|NCT00467857|surgery|surgery
5290985|NCT00467844|Cachexia|cachexia
5290986|NCT00467844|Muscle Wasting|muscle wasting
5290987|NCT00467844|Non-Small Cell Lung Cancer|non-small cell lung cancer
5290988|NCT00467844|Colorectal Cancer|colorectal cancer
5290989|NCT00467844|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
5290990|NCT00467844|Stage 3 or 4 Breast Cancer|stage 3 or 4 breast cancer
5290991|NCT00467844|Chronis Lymphocytic Leukemia|chronis lymphocytic leukemia
5290992|NCT00467831|Restrictive Lung Disease|restrictive lung disease
5290993|NCT00467831|Pulmonary Fibrosis|pulmonary fibrosis
5290994|NCT00467831|Albinism|albinism
5290995|NCT00467831|Platelet Storage Pool Deficiency|platelet storage pool deficiency
5290996|NCT00467831|Metabolic Disease|metabolic disease
5290997|NCT00467831|Hermansky-Pudlak Syndrome|hermansky-pudlak syndrome
5290998|NCT00467831|HPS|hps
5290999|NCT00467831|Lung Disease|lung disease
5291000|NCT00467818|Aggression|aggression
5291001|NCT00467818|Irritability|irritability
5291002|NCT00467818|Global severity|global severity
5291003|NCT00467805|Light exposure|light exposure
5291004|NCT00467805|light spectrum|light spectrum
5291005|NCT00467805|reproductive hormones|reproductive hormones
5291006|NCT00467805|women|women
5291007|NCT00467792|urticaria pigmentosa|urticaria pigmentosa
5291008|NCT00467792|mastocytosis|mastocytosis
5291009|NCT00467792|mastocytomas|mastocytomas
5291010|NCT00467766|dementia|dementia
5291011|NCT00467766|Counseling|counseling
5291012|NCT00467753|Irritability|irritability
5291013|NCT00467753|Functional Ability|functional ability
5291014|NCT00467753|Aggression|aggression
5291015|NCT00467753|Mood Instability|mood instability
5291016|NCT00467727|Diagnostic Mammography|diagnostic mammography
5291017|NCT00467727|Breast Imaging|breast imaging
5291018|NCT00467727|Phase Contrast Mammography|phase contrast mammography
5291019|NCT00467727|X-Ray Mammography|x-ray mammography
5291020|NCT00467714|RHINOPLASTY ,ESTHETIC SURGERY|rhinoplasty ,esthetic surgery
5291021|NCT00467701|pneumonia|pneumonia
5291022|NCT00467701|Legionnaires disease|legionnaires disease
5291023|NCT00467701|risk factors|risk factors
5291024|NCT00467688|type 1 diabetes|type 1 diabetes
5291025|NCT00467688|glucose excursion|glucose excursion
5291026|NCT00467688|hypoglycemia awareness|hypoglycemia awareness
5291027|NCT00467688|continuous glucose monitoring|continuous glucose monitoring
5291028|NCT00467675|NonDiabetes|nondiabetes
5291029|NCT00467675|CGM|cgm
5291030|NCT00467649|Symlin|symlin
5291031|NCT00467649|Amylin|amylin
5291032|NCT00467649|insulin|insulin
5291033|NCT00467649|Humalog|humalog
5291034|NCT00467649|Novolog|novolog
5291035|NCT00467649|Apidra|apidra
5291036|NCT00467636|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5291037|NCT00467636|Corticosteroid induced hyperglycaemia|corticosteroid induced hyperglycaemia
5291038|NCT00467636|Insulin|insulin
5291039|NCT00467623|Pregnancy|pregnancy
5291040|NCT00467623|holotranscobalamin|holotranscobalamin
5291041|NCT00467623|cobalamin|cobalamin
5291042|NCT00467623|vitamin B12 analogues|vitamin b12 analogues
5291043|NCT00467623|reference interval|reference interval
5291044|NCT00467610|myelodysplastic|myelodysplastic
5291045|NCT00467610|MDS|mds
5291046|NCT00467610|Panhematin|panhematin
5291047|NCT00467610|Hemin|hemin
5291048|NCT00467597|Dyskinesia|dyskinesia
5291049|NCT00467597|Levodopa|levodopa
5291050|NCT00467597|Movement Disorders|movement disorders
5291051|NCT00467597|Parkinson Disease|parkinson disease
5291052|NCT00467571|chronic idiopathic thrombocytopenic purpura|chronic idiopathic thrombocytopenic purpura
5291053|NCT00467571|Helicobacter pylori infection|helicobacter pylori infection
5291054|NCT00467571|platelet|platelet
5291055|NCT00467558|Impulse Control Disorder|impulse control disorder
5291056|NCT00467558|Compulsive Sexual Behavior|compulsive sexual behavior
5291057|NCT00467545|HBeAg-positive|hbeag-positive
5291058|NCT00467545|chronic hepatitis B|chronic hepatitis b
5291059|NCT00467545|telbivudine|telbivudine
5291060|NCT00467519|Tetanus; Diphtheria; Pertussis; ADACEL; DAPTACEL|tetanus; diphtheria; pertussis; adacel; daptacel
5291061|NCT00467506|Recurrence of medullary thyroid carcinoma: abnormal calcitonin level and biomarkers doubling time lower than 5 years after initial surgery|recurrence of medullary thyroid carcinoma: abnormal calcitonin level and biomarkers doubling time lower than 5 years after initial surgery
5291062|NCT00467454|Pyromania|pyromania
5291063|NCT00467454|Fire Setting|fire setting
5291064|NCT00467454|Compulsive Fire Setting|compulsive fire setting
5291065|NCT00467428|ADHD|adhd
5291066|NCT00467415|Walking|walking
5291067|NCT00467415|Treadmill|treadmill
5291068|NCT00467415|Partial Weightbearing|partial weightbearing
5291069|NCT00467402|agomelatine, Major Depressive Disorder, MDD, depression|agomelatine, major depressive disorder, mdd, depression
5291070|NCT00467389|Acetylcholine|acetylcholine
5291071|NCT00467389|Acetylcholinesterase|acetylcholinesterase
5291072|NCT00467389|Butyrylcholinesterase|butyrylcholinesterase
5291073|NCT00467389|Cholinesterase Inhibitor|cholinesterase inhibitor
5291074|NCT00467350|constipation|constipation
5291075|NCT00467350|treatment|treatment
5291076|NCT00467350|fecal impaction|fecal impaction
5291077|NCT00467350|pediatric|pediatric
5291078|NCT00467337|insole|insole
5291079|NCT00467337|osteoarthritis|osteoarthritis
5291080|NCT00467337|pain|pain
5291081|NCT00467337|valgus knee|valgus knee
5291082|NCT00467324|obstructive sleep apnea|obstructive sleep apnea
5291083|NCT00467324|surgery|surgery
5291084|NCT00467324|tongue|tongue
5291085|NCT00467311|Contrast-induced nephropathy|contrast-induced nephropathy
5291086|NCT00467311|Cystatin C|cystatin c
5291087|NCT00467311|Contrast media|contrast media
5291088|NCT00467311|Creatinine|creatinine
5291089|NCT00467311|Cardiac Catheterization|cardiac catheterization
5291090|NCT00467298|Exercise|exercise
5291091|NCT00467298|heart failure|heart failure
5291092|NCT00467298|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
5291093|NCT00467298|patient education|patient education
5291094|NCT00467298|costs|costs
5291095|NCT00467298|quality of life|quality of life
5291096|NCT00467285|Bone Density|bone density
5291097|NCT00467285|C-telopeptide|c-telopeptide
5291098|NCT00467285|Dual-Energy X-Ray Absorptiometry|dual-energy x-ray absorptiometry
5291099|NCT00467285|N-telopeptide|n-telopeptide
5291100|NCT00467285|Osteocalcin|osteocalcin
5291101|NCT00467285|Osteoporosis|osteoporosis
5291102|NCT00467285|Thiazolidinediones|thiazolidinediones
5291103|NCT00467285|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
5291104|NCT00467272|Catheter-Related Bloodstream Infections|catheter-related bloodstream infections
5291105|NCT00467272|Bloodstream Infection|bloodstream infection
5291106|NCT00467272|Daptomycin|daptomycin
5291107|NCT00467272|Cubicin|cubicin
5291108|NCT00467272|CRBSI|crbsi
5291109|NCT00467259|Natural Menopause|natural menopause
5291110|NCT00467246|Diabetes emergencies|diabetes emergencies
5291111|NCT00467220|Calorie restriction|calorie restriction
5291112|NCT00467220|alternate day fasting|alternate day fasting
5291113|NCT00467220|calorie intake|calorie intake
5291114|NCT00467194|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
5291115|NCT00467194|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
5291116|NCT00467194|recurrent adult primary liver cancer|recurrent adult primary liver cancer
5291117|NCT00467194|advanced adult primary liver cancer|advanced adult primary liver cancer
5291118|NCT00467181|cardiac surgery|cardiac surgery
5291119|NCT00467181|renal dysfunction|renal dysfunction
5291120|NCT00467168|dietary fatty acid composition|dietary fatty acid composition
5291121|NCT00467168|postprandial|postprandial
5291122|NCT00467168|triglyceride-rich lipoprotein|triglyceride-rich lipoprotein
5291123|NCT00467168|type 2 diabetes|type 2 diabetes
5291124|NCT00467155|Helicobacter pylori, children, infants, Gambia|helicobacter pylori, children, infants, gambia
5291125|NCT00467142|stage IV colon cancer|stage iv colon cancer
5291126|NCT00467142|stage IV rectal cancer|stage iv rectal cancer
5291127|NCT00467142|adenocarcinoma of the colon|adenocarcinoma of the colon
5291128|NCT00467142|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5291129|NCT00467142|recurrent colon cancer|recurrent colon cancer
5291130|NCT00467142|recurrent rectal cancer|recurrent rectal cancer
5291131|NCT00467129|stage IV colon cancer|stage iv colon cancer
5291132|NCT00467129|stage IV rectal cancer|stage iv rectal cancer
5291133|NCT00467116|stage III pancreatic cancer|stage iii pancreatic cancer
5291134|NCT00467116|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
5291135|NCT00467116|stage II pancreatic cancer|stage ii pancreatic cancer
5291136|NCT00467116|recurrent pancreatic cancer|recurrent pancreatic cancer
5291137|NCT00467103|Adult Aphasia|adult aphasia
5291138|NCT00467103|Diffusion Tensor Imaging|diffusion tensor imaging
5291139|NCT00467103|functional Magnetic Resonance Imaging|functional magnetic resonance imaging
5291140|NCT00467103|Language Recovery|language recovery
5291141|NCT00467103|Left Middle Cerebral Artery Stroke|left middle cerebral artery stroke
5291142|NCT00467103|Nonfluent Aphasia|nonfluent aphasia
5291143|NCT00467090|Parkinson's Disease|parkinson's disease
5291144|NCT00467090|Gene|gene
5291145|NCT00467090|Genetic|genetic
5291146|NCT00467090|Family Studies|family studies
5291147|NCT00467090|LRRK-2|lrrk-2
5291148|NCT00467090|Parkinson Disease|parkinson disease
5291150|NCT00467077|recurrent renal cell cancer|recurrent renal cell cancer
5291151|NCT00467077|stage IV renal cell cancer|stage iv renal cell cancer
5291152|NCT00467077|stage III renal cell cancer|stage iii renal cell cancer
5291153|NCT00467064|Disease self-management|disease self-management
5291154|NCT00467064|Community programs|community programs
5291155|NCT00467038|affect|affect
5291156|NCT00467038|aggression|aggression
5291157|NCT00467038|anger|anger
5291158|NCT00467038|behavior therapy|behavior therapy
5291159|NCT00467038|borderline personality disorder|borderline personality disorder
5291160|NCT00467038|MRI, functional|mri, functional
5291161|NCT00467025|Metastatic clear cell carcinoma of the kidney|metastatic clear cell carcinoma of the kidney
5291162|NCT00467025|RCC|rcc
5291163|NCT00467012|Inoperable metastatic breast cancer|inoperable metastatic breast cancer
5291164|NCT00466999|misoprostol|misoprostol
5291165|NCT00466999|incomplete abortion|incomplete abortion
5291166|NCT00466999|PAC|pac
5291167|NCT00466986|recurrent|recurrent
5291168|NCT00466986|ovarian|ovarian
5291169|NCT00466986|cancer|cancer
5291170|NCT00466986|platinum sensitive|platinum sensitive
5291171|NCT00466973|Atrial fibrillation|atrial fibrillation
5291172|NCT00466973|ablation device comparison|ablation device comparison
5291173|NCT00466973|ablation in right atria|ablation in right atria
5291174|NCT00466947|Otitis media|otitis media
5291175|NCT00466947|Pneumonia|pneumonia
5291176|NCT00466947|Community acquired pneumonia (CAP)|community acquired pneumonia (cap)
5291177|NCT00466947|Pneumococcal disease|pneumococcal disease
5291178|NCT00466947|Booster vaccination|booster vaccination
5291179|NCT00466947|Immunogenicity|immunogenicity
5291180|NCT00466947|Pneumococcal vaccine|pneumococcal vaccine
5291181|NCT00466947|Safety|safety
5291182|NCT00466947|Efficacy|efficacy
5291183|NCT00466947|Carriage|carriage
5291184|NCT00466934|Cerebral Blood Flow|cerebral blood flow
5291185|NCT00466934|Cerebral Cortex|cerebral cortex
5291186|NCT00466934|Cognition|cognition
5291187|NCT00466934|Optical Imaging|optical imaging
5291188|NCT00466934|Healthy Volunteer|healthy volunteer
5291189|NCT00466934|HV|hv
5291190|NCT00466921|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5291191|NCT00466921|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
5291192|NCT00466921|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
5291193|NCT00466921|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
5291194|NCT00466921|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
5291195|NCT00466895|Leukemia|leukemia
5291196|NCT00466895|Lenalidomide|lenalidomide
5291197|NCT00466882|obese|obese
5291198|NCT00466882|renal failure|renal failure
5291199|NCT00466882|renal transplant candidate|renal transplant candidate
5291200|NCT00466882|Hemodialysis BMI between 36 and 42|hemodialysis bmi between 36 and 42
5291201|NCT00466856|neoplastic syndrome|neoplastic syndrome
5291202|NCT00466856|metastatic gastrointestinal carcinoid tumor|metastatic gastrointestinal carcinoid tumor
5291203|NCT00466856|recurrent gastrointestinal carcinoid tumor|recurrent gastrointestinal carcinoid tumor
5291204|NCT00466856|thyroid gland medullary carcinoma|thyroid gland medullary carcinoma
5291205|NCT00466856|metastatic pheochromocytoma|metastatic pheochromocytoma
5291206|NCT00466856|recurrent islet cell carcinoma|recurrent islet cell carcinoma
5291207|NCT00466856|liver metastases|liver metastases
5291208|NCT00466856|recurrent pheochromocytoma|recurrent pheochromocytoma
5291209|NCT00466856|gastrinoma|gastrinoma
5291210|NCT00466856|insulinoma|insulinoma
5291211|NCT00466856|WDHA syndrome|wdha syndrome
5291212|NCT00466856|glucagonoma|glucagonoma
5291213|NCT00466856|pancreatic polypeptide tumor|pancreatic polypeptide tumor
5291214|NCT00466856|somatostatinoma|somatostatinoma
5291215|NCT00466843|Abnormal hematopoiesis|abnormal hematopoiesis
5291216|NCT00466843|Leukemia|leukemia
5291217|NCT00466843|Autoimmune Disease|autoimmune disease
5291218|NCT00466830|pain|pain
5291219|NCT00466830|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
5291220|NCT00466830|stage IIIA breast cancer|stage iiia breast cancer
5291221|NCT00466830|stage IIIB breast cancer|stage iiib breast cancer
5291222|NCT00466830|stage I breast cancer|stage i breast cancer
5291223|NCT00466830|stage II breast cancer|stage ii breast cancer
5291224|NCT00466830|stage IIIC breast cancer|stage iiic breast cancer
5291225|NCT00466817|Cytomegalovirus, congenital, infants|cytomegalovirus, congenital, infants
5291226|NCT00466804|heart transplant recipients|heart transplant recipients
5291227|NCT00466804|organ transplantation|organ transplantation
5291228|NCT00466804|immune biomarkers|immune biomarkers
5291229|NCT00466804|transplant rejection|transplant rejection
5291230|NCT00466765|Fat Grafting|fat grafting
5291231|NCT00466765|Breast Augmentation|breast augmentation
5291232|NCT00466765|Liposuctioned Fat Transfer|liposuctioned fat transfer
5291233|NCT00466765|Lumpectomy|lumpectomy
5291234|NCT00466765|Mastectomy|mastectomy
5291235|NCT00466765|Micromastia|micromastia
5291236|NCT00466765|Asymmetry|asymmetry
5291237|NCT00466765|Post Lumpectomy Filling Defects|post lumpectomy filling defects
5291238|NCT00466765|Post implant removal filling defect|post implant removal filling defect
5291239|NCT00466765|Post Mastectomy|post mastectomy
5291240|NCT00466765|Autologous Fat Transfer|autologous fat transfer
5291241|NCT00466765|Tubular breasts|tubular breasts
5291242|NCT00466765|Tuberous breasts|tuberous breasts
5291243|NCT00466765|Constricted breasts|constricted breasts
5291244|NCT00466726|chronic myelogenous leukemia, BCR-ABL1 positive|chronic myelogenous leukemia, bcr-abl1 positive
5291245|NCT00466726|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5291246|NCT00466726|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5291247|NCT00466726|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5291248|NCT00466726|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5291249|NCT00466713|Nonischemic dilated cardiomyopathy|nonischemic dilated cardiomyopathy
5291250|NCT00466700|Helicobacter pylori, Gambia, endoscopy, Africa|helicobacter pylori, gambia, endoscopy, africa
5291251|NCT00466687|stage IV melanoma|stage iv melanoma
5291252|NCT00466687|recurrent melanoma|recurrent melanoma
5291253|NCT00466674|Myeloma|myeloma
5291254|NCT00466674|RICT|rict
5291255|NCT00466674|conditioning|conditioning
5291256|NCT00466674|allograft|allograft
5291257|NCT00466661|Acamprosate|acamprosate
5291258|NCT00466661|Alcoholism|alcoholism
5291259|NCT00466661|Bipolar disorder|bipolar disorder
5291260|NCT00466661|Comorbidity|comorbidity
5291261|NCT00466661|Craving|craving
5291262|NCT00466661|Depression|depression
5291263|NCT00466661|GABA|gaba
5291264|NCT00466661|Glutamate|glutamate
5291265|NCT00466661|Mania|mania
5291266|NCT00466661|Pharmacotherapy|pharmacotherapy
5291267|NCT00466661|Withdrawal|withdrawal
5291268|NCT00466648|laparoscopy, port site, closure, Dermabond|laparoscopy, port site, closure, dermabond
5291269|NCT00466635|Clostridium difficile Disease|clostridium difficile disease
5291270|NCT00466635|Infectious diarrhea|infectious diarrhea
5291271|NCT00466635|C. difficile|c. difficile
5291272|NCT00466635|CDAD|cdad
5291273|NCT00466635|Clostridium difficile-associated diarrhea|clostridium difficile-associated diarrhea
5291274|NCT00466635|Clostridium difficile diarrhea|clostridium difficile diarrhea
5291275|NCT00466635|Antibiotic-Associated Colitis|antibiotic-associated colitis
5291276|NCT00466635|Clostridium Enterocolitis|clostridium enterocolitis
5291277|NCT00466635|Antibiotic-Associated Diarrhea|antibiotic-associated diarrhea
5291278|NCT00466635|Pseudomembranous Colitis|pseudomembranous colitis
5291279|NCT00466635|Clostridium difficile|clostridium difficile
5291280|NCT00466622|PCOS|pcos
5291281|NCT00466622|pregnancy|pregnancy
5291282|NCT00466622|metformin|metformin
5291283|NCT00466622|blood flow|blood flow
5291284|NCT00466622|Pulsatility index|pulsatility index
5291285|NCT00466609|clomipramine|clomipramine
5291286|NCT00466609|quetiapine|quetiapine
5291287|NCT00466609|fluoxetine|fluoxetine
5291288|NCT00466609|placebo|placebo
5291289|NCT00466609|augmentation|augmentation
5291290|NCT00466609|obsessive compulsive disorder|obsessive compulsive disorder
5291291|NCT00466596|allergic rhinitis|allergic rhinitis
5291292|NCT00466596|mild asthma|mild asthma
5291293|NCT00466596|dust mite allergy|dust mite allergy
5291294|NCT00466596|gamma tocopherol|gamma tocopherol
5291295|NCT00466583|Carcinoma, Lymphoma|carcinoma, lymphoma
5291296|NCT00466557|Malaria, Plasmodium falciparum, mosquito, Africa, Anopheles|malaria, plasmodium falciparum, mosquito, africa, anopheles
5291297|NCT00466544|Chronic tonsillitis|chronic tonsillitis
5291298|NCT00466544|Recurrent tonsillitis|recurrent tonsillitis
5291299|NCT00466531|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5291300|NCT00466531|06-138|06-138
5291301|NCT00466518|Kidney transplant|kidney transplant
5291302|NCT00466518|type 2 diabetes|type 2 diabetes
5291303|NCT00466518|sitagliptin|sitagliptin
5291304|NCT00466505|recurrent colon cancer|recurrent colon cancer
5291305|NCT00466505|stage IV colon cancer|stage iv colon cancer
5291306|NCT00466505|recurrent rectal cancer|recurrent rectal cancer
5291307|NCT00466505|stage IV rectal cancer|stage iv rectal cancer
5291308|NCT00466492|Drug Administration Schedule|drug administration schedule
5291309|NCT00466492|Intensive Care Units|intensive care units
5291310|NCT00466492|Length of Stay|length of stay
5291311|NCT00466492|Respiration, Artificial|respiration, artificial
5291312|NCT00466492|Stress Disorders, Post-Traumatic/etiology/*psychology|stress disorders, post-traumatic/etiology/*psychology
5291313|NCT00466492|Critical Illness/*psychology|critical illness/*psychology
5291314|NCT00466492|Pneumonia/prevention & control|pneumonia/prevention & control
5291315|NCT00466492|Hypnotics and Sedatives/*administration & dosage|hypnotics and sedatives/*administration & dosage
5291316|NCT00466479|neuroprotection|neuroprotection
5291317|NCT00466479|alpha one agonists|alpha one agonists
5291318|NCT00466479|glaucoma|glaucoma
5291319|NCT00466479|visual field|visual field
5291320|NCT00466466|Small-Cell Lung Cancer|small-cell lung cancer
5291321|NCT00466466|SCLC|sclc
5291322|NCT00466466|Advanced Lung Cancer|advanced lung cancer
5291323|NCT00466466|RAD|rad
5291324|NCT00466466|RAD001|rad001
5291325|NCT00466466|Chemotherapy|chemotherapy
5291326|NCT00466466|Cisplatin|cisplatin
5291327|NCT00466466|Etoposide|etoposide
5291328|NCT00466375|hemangioma|hemangioma
5291329|NCT00466375|vascular anomaly|vascular anomaly
5291330|NCT00466375|infantile hemangioma|infantile hemangioma
5291331|NCT00466362|Obesity|obesity
5291332|NCT00466362|Diabetes|diabetes
5291333|NCT00466362|Weight|weight
5291334|NCT00466362|Lifestyle|lifestyle
5291335|NCT00466362|Follow up|follow up
5291336|NCT00466349|SMA Type I|sma type i
5291337|NCT00466349|SMA Type II|sma type ii
5291338|NCT00466349|SMA Type III|sma type iii
5291339|NCT00466349|SMN|smn
5291340|NCT00466349|Werdnig-Hoffman Disease|werdnig-hoffman disease
5291341|NCT00466349|Spinal Muscular Atrophy|spinal muscular atrophy
5291342|NCT00466349|Registry|registry
5291343|NCT00466349|SMA Type IV|sma type iv
5291344|NCT00466336|Chronic hepatitis C|chronic hepatitis c
5291345|NCT00466336|Non-invasive diagnosis|non-invasive diagnosis
5291346|NCT00466336|Duplex Doppler ultrasonography|duplex doppler ultrasonography
5291347|NCT00466336|Biochemical indices|biochemical indices
5291348|NCT00466336|Hepatic fibrosis|hepatic fibrosis
5291349|NCT00466336|Cirrhosis|cirrhosis
5291350|NCT00466323|Mental Illness|mental illness
5291351|NCT00466323|Schizophrenia|schizophrenia
5291352|NCT00466323|Education|education
5291353|NCT00466323|Family member treatment|family member treatment
5291354|NCT00466323|Active psychoses|active psychoses
5291355|NCT00466310|Schizophrenia|schizophrenia
5291356|NCT00466310|Metabolomics|metabolomics
5291357|NCT00466297|Interprofessional|interprofessional
5291358|NCT00466297|Collaboration|collaboration
5291359|NCT00466297|Teamwork|teamwork
5291360|NCT00466297|General internal medicine|general internal medicine
5291361|NCT00466297|Cluster randomized|cluster randomized
5291362|NCT00466271|Chronic hepatitis C|chronic hepatitis c
5291363|NCT00466271|Persistently normal alanine aminotransferase levels|persistently normal alanine aminotransferase levels
5291364|NCT00466271|Hepatic fibrosis|hepatic fibrosis
5291365|NCT00466271|Non-invasive diagnosis|non-invasive diagnosis
5291366|NCT00466271|Splenic arterial pulsatility index|splenic arterial pulsatility index
5291367|NCT00466258|Diffuse large B cell lymphoma|diffuse large b cell lymphoma
5291368|NCT00466258|HIV|hiv
5291369|NCT00466258|R-CHOP|r-chop
5291370|NCT00466258|Highly active antiretroviral therapy|highly active antiretroviral therapy
5291371|NCT00466258|Treatment Experienced|treatment experienced
5291372|NCT00466245|MVA Vaccine|mva vaccine
5291373|NCT00466232|Small Cell|small cell
5291374|NCT00466232|Lung Cancer|lung cancer
5291375|NCT00466232|Treatment|treatment
5291376|NCT00466219|Presence of HCV RNA in serum|presence of hcv rna in serum
5291377|NCT00466219|Absence of graft rejection|absence of graft rejection
5291378|NCT00466219|Recurrent hepatitis C after liver transplantation|recurrent hepatitis c after liver transplantation
5291379|NCT00466206|pectus excavatum|pectus excavatum
5291380|NCT00466206|magnetic alteration|magnetic alteration
5291381|NCT00466206|chest wall deformity|chest wall deformity
5291382|NCT00466193|Insomnia|insomnia
5291383|NCT00466180|Once-a-day|once-a-day
5291384|NCT00466180|Adherence|adherence
5291385|NCT00466180|Nevirapine|nevirapine
5291386|NCT00466180|Patient noncompliance|patient noncompliance
5291387|NCT00466180|Administration and dosage|administration and dosage
5291388|NCT00466180|Treatment Experienced|treatment experienced
5291389|NCT00466154|Aspirin resistance|aspirin resistance
5291390|NCT00466154|Platelet activation|platelet activation
5291391|NCT00466154|Hypercholesterolemia|hypercholesterolemia
5291392|NCT00466128|fetal membranes, preterm rupture|fetal membranes, preterm rupture
5291393|NCT00466128|preterm rupture|preterm rupture
5291394|NCT00466128|PPROM|pprom
5291395|NCT00466102|Breast Cancer|breast cancer
5291396|NCT00466102|Bone metastases as only metastatic site|bone metastases as only metastatic site
5291397|NCT00466102|Breast cancer, HER2 negative|breast cancer, her2 negative
5291398|NCT00466102|Bone metastasis as only metastatic site|bone metastasis as only metastatic site
5291399|NCT00466102|Pretreated with endocrine therapy|pretreated with endocrine therapy
5291400|NCT00466102|Up to one previous chemotherapy|up to one previous chemotherapy
5291401|NCT00466102|Previous treatment with bisphosphonates allowed|previous treatment with bisphosphonates allowed
5291402|NCT00466089|NSCLC, lung cancer|nsclc, lung cancer
5291403|NCT00466089|Patients with localized-unresectable (IA-IIIB) non-small cell lung cancer non susceptible for chemotherapy treatment.|patients with localized-unresectable (ia-iiib) non-small cell lung cancer non susceptible for chemotherapy treatment.
5291404|NCT00466076|Drusen|drusen
5291405|NCT00466076|AMD|amd
5291406|NCT00466076|Dry form of Age related Macular Degeneration|dry form of age related macular degeneration
5291407|NCT00466063|Iron overload|iron overload
5291408|NCT00466063|children|children
5291409|NCT00466063|deferasirox|deferasirox
5291410|NCT00466063|Transfusion-dependent anemia|transfusion-dependent anemia
5291411|NCT00466050|plaque rupture,|plaque rupture,
5291412|NCT00466050|acute coronary thrombose,|acute coronary thrombose,
5291413|NCT00466050|coronary angiography,|coronary angiography,
5291414|NCT00466050|IVUS|ivus
5291415|NCT00466037|Rheumatoid|rheumatoid
5291416|NCT00466037|rituximab|rituximab
5291417|NCT00466037|influenza|influenza
5291418|NCT00466024|Asthma|asthma
5291419|NCT00466024|persistent|persistent
5291420|NCT00466024|children|children
5291421|NCT00466024|particulates|particulates
5291422|NCT00466024|ETS|ets
5291423|NCT00465998|Ultrasound|ultrasound
5291424|NCT00465998|Induced labor|induced labor
5291425|NCT00465998|Cervical length|cervical length
5291426|NCT00465998|Engagement of fetal head|engagement of fetal head
5291427|NCT00465998|Occiput posterior|occiput posterior
5291428|NCT00465998|Outcome of labor|outcome of labor
5291429|NCT00465985|Muckle-Wells Syndrome|muckle-wells syndrome
5291430|NCT00465985|children|children
5291431|NCT00465985|systemic autoinflammatory disease|systemic autoinflammatory disease
5291432|NCT00465985|CIAS-1 gene|cias-1 gene
5291433|NCT00465985|NALP-3|nalp-3
5291434|NCT00465985|ACZ885|acz885
5291435|NCT00465985|human monoclonal anti-human interleukin-1beta (IL-1beta)|human monoclonal anti-human interleukin-1beta (il-1beta)
5291436|NCT00465985|antibody|antibody
5291437|NCT00465985|autosomal dominant|autosomal dominant
5291562|NCT00465491|refractory|refractory
5291438|NCT00465985|familial autoinflammatory syndrome|familial autoinflammatory syndrome
5291439|NCT00465972|HIV|hiv
5291440|NCT00465972|Insomnia|insomnia
5291441|NCT00465972|Cytokines|cytokines
5291442|NCT00465972|Adherence|adherence
5291443|NCT00465959|COPD|copd
5291444|NCT00465946|Salt supplementation|salt supplementation
5291445|NCT00465946|Vasovagal syncope|vasovagal syncope
5291446|NCT00465946|Orthostatic tolerance|orthostatic tolerance
5291447|NCT00465946|Healthy volunteers|healthy volunteers
5291448|NCT00465933|Acute Promyelocytic Leukemia|acute promyelocytic leukemia
5291449|NCT00465933|AIDA|aida
5291450|NCT00465920|schizophrenia|schizophrenia
5291451|NCT00465920|cognitive behavioural therapy|cognitive behavioural therapy
5291452|NCT00465920|early onset psychosis|early onset psychosis
5291453|NCT00465920|Psychotic disorders (schizophrenia, schizoaffective disorder, delusional disorder, schizophreniform disorder according to DSM IV) in adolescents|psychotic disorders (schizophrenia, schizoaffective disorder, delusional disorder, schizophreniform disorder according to dsm iv) in adolescents
5291454|NCT00465907|lung cancer with malignant pleural effusion|lung cancer with malignant pleural effusion
5291455|NCT00465894|overactive bladder|overactive bladder
5291456|NCT00465894|urge leakage|urge leakage
5291457|NCT00465894|nightime urination|nightime urination
5291458|NCT00465894|incontinence|incontinence
5291459|NCT00465894|urinary frequency|urinary frequency
5291460|NCT00465881|Diabetes|diabetes
5291461|NCT00465881|CGM|cgm
5291462|NCT00465868|Acute Myocardial Infarction|acute myocardial infarction
5291463|NCT00465868|Coronary Revascularization|coronary revascularization
5291464|NCT00465868|Microvascular Obstruction|microvascular obstruction
5291465|NCT00465868|Cardiac MR|cardiac mr
5291466|NCT00465868|Collagen Turnover|collagen turnover
5291467|NCT00465868|Heart failure, post-mi|heart failure, post-mi
5291468|NCT00465855|Carbon monoxide poisoning|carbon monoxide poisoning
5291469|NCT00465855|Hyperbaric oxygen therapy|hyperbaric oxygen therapy
5291470|NCT00465855|Randomized controlled trial|randomized controlled trial
5291471|NCT00465855|Clinical investigation|clinical investigation
5291472|NCT00465842|Hepatitis|hepatitis
5291473|NCT00465842|Liver Cirrhosis|liver cirrhosis
5291474|NCT00465842|HCC|hcc
5291475|NCT00465829|Obesity|obesity
5291476|NCT00465816|non-inferiority|non-inferiority
5291477|NCT00465816|adolescents|adolescents
5291478|NCT00465816|meningococcal vaccine|meningococcal vaccine
5291479|NCT00465803|Open-angle glaucoma or ocular hypertension|open-angle glaucoma or ocular hypertension
5291480|NCT00465790|biomarkers|biomarkers
5291481|NCT00465790|neuroimaging|neuroimaging
5291482|NCT00465790|genetics|genetics
5291483|NCT00465790|PET|pet
5291484|NCT00465790|Genetic and Idiopathic Parkinson|genetic and idiopathic parkinson
5291485|NCT00465790|Multiple Systemic Atrophy|multiple systemic atrophy
5291486|NCT00465790|Huntington|huntington
5291487|NCT00465790|Dopa Responsive Dystonia|dopa responsive dystonia
5291488|NCT00465777|malaria|malaria
5291489|NCT00465777|mortality|mortality
5291490|NCT00465777|hospital|hospital
5291491|NCT00465777|incentive|incentive
5291492|NCT00465777|personnel|personnel
5291493|NCT00465777|paediatric|paediatric
5291494|NCT00465764|healthy infants|healthy infants
5291495|NCT00465725|Picoplatin|picoplatin
5291496|NCT00465725|tumor|tumor
5291497|NCT00465725|cancer|cancer
5291498|NCT00465725|sarcoma|sarcoma
5291499|NCT00465725|neoplasm|neoplasm
5291500|NCT00465725|advanced|advanced
5291501|NCT00465725|platinum|platinum
5291502|NCT00465725|chemotherapy|chemotherapy
5291503|NCT00465725|Solid Tumor|solid tumor
5291504|NCT00465712|transabdominal amnioinfusion|transabdominal amnioinfusion
5291505|NCT00465712|external cephalic version|external cephalic version
5291506|NCT00465712|breech presentation|breech presentation
5291507|NCT00465699|Eczema|eczema
5291508|NCT00465699|Pediatric|pediatric
5291509|NCT00465699|Vitamin B12|vitamin b12
5291510|NCT00465686|handwriting|handwriting
5291511|NCT00465686|child|child
5291512|NCT00465686|primary school|primary school
5291513|NCT00465686|posture|posture
5291514|NCT00465686|assistive device|assistive device
5291515|NCT00465673|breast cancer|breast cancer
5291516|NCT00465673|brain metastatsis|brain metastatsis
5291517|NCT00465673|Lipo-Dox|lipo-dox
5291518|NCT00465660|Osteoarthritis|osteoarthritis
5291519|NCT00465660|Cartilage|cartilage
5291520|NCT00465660|Exercise|exercise
5291521|NCT00465660|Progressive Resistance Training|progressive resistance training
5291522|NCT00465647|Postoperative pain|postoperative pain
5291523|NCT00465647|Hydromorphone oral solution|hydromorphone oral solution
5291524|NCT00465647|opioid|opioid
5291525|NCT00465647|pharmacokinetics|pharmacokinetics
5291526|NCT00465647|pharmacodynamics|pharmacodynamics
5291527|NCT00465634|Screening|screening
5291528|NCT00465634|uterine artery Doppler|uterine artery doppler
5291529|NCT00465634|HELLP syndrome|hellp syndrome
5291530|NCT00465634|abruption|abruption
5291531|NCT00465621|Open-angle glaucoma|open-angle glaucoma
5291532|NCT00465621|ocular hypertension|ocular hypertension
5291533|NCT00465608|adults|adults
5291534|NCT00465608|PTSD|ptsd
5291535|NCT00465608|trauma|trauma
5291536|NCT00465608|AZF|azf
5291537|NCT00465608|propranolol|propranolol
5291538|NCT00465608|reconsolidation|reconsolidation
5291539|NCT00465608|Post traumatic stress disorder|post traumatic stress disorder
5291540|NCT00465608|chronic form|chronic form
5291541|NCT00465608|PTSD (Post-Traumatic Stress Disorder)|ptsd (post-traumatic stress disorder)
5291542|NCT00465582|carriage|carriage
5291543|NCT00465582|Neisseria meningitidis|neisseria meningitidis
5291544|NCT00465582|risk factors|risk factors
5291545|NCT00465569|Food Allergy|food allergy
5291546|NCT00465569|Oral Immunotherapy|oral immunotherapy
5291547|NCT00465569|Immunoglobulin E|immunoglobulin e
5291548|NCT00465543|Nasal polyposis|nasal polyposis
5291549|NCT00465543|Mint tea|mint tea
5291550|NCT00465543|Double-blind|double-blind
5291551|NCT00465543|Placebo-controlled|placebo-controlled
5291552|NCT00465543|Crossover|crossover
5291553|NCT00465517|Partial onset seizures|partial onset seizures
5291554|NCT00465517|Complex-partial seizures|complex-partial seizures
5291555|NCT00465517|Anticonvulsant|anticonvulsant
5291556|NCT00465517|Partial seizures|partial seizures
5291557|NCT00465517|Catamenial epilepsy|catamenial epilepsy
5291558|NCT00465504|local analgesia|local analgesia
5291559|NCT00465504|intra-articular corticosteroid injection|intra-articular corticosteroid injection
5291560|NCT00465504|iontophoresis|iontophoresis
5291561|NCT00465504|Local analgesia for intra-articular corticosteroid injection|local analgesia for intra-articular corticosteroid injection
5291563|NCT00465491|chemotherapy|chemotherapy
5291564|NCT00465491|progressed|progressed
5291565|NCT00465491|second-line treatment|second-line treatment
5291566|NCT00465491|small cell lung cancer|small cell lung cancer
5291567|NCT00465491|best supportive care|best supportive care
5291568|NCT00465491|picoplatin|picoplatin
5291569|NCT00465478|Diabetes Mellitus|diabetes mellitus
5291570|NCT00465478|Bone Marros Mononuclear Cells|bone marros mononuclear cells
5291571|NCT00465478|Transplantation|transplantation
5291572|NCT00465465|Tuberculosis|tuberculosis
5291573|NCT00465465|TB|tb
5291574|NCT00465465|MVA 85A|mva 85a
5291575|NCT00465465|BCG|bcg
5291576|NCT00465439|femoral artery sheath|femoral artery sheath
5291577|NCT00465439|vasovagal reaction|vasovagal reaction
5291578|NCT00465439|pain|pain
5291579|NCT00465439|perception|perception
5291580|NCT00465426|HIV Infection|hiv infection
5291581|NCT00465426|Cardiovascular Disease|cardiovascular disease
5291582|NCT00465426|Antiretroviral Therapy|antiretroviral therapy
5291583|NCT00465426|Inflammatory Markers|inflammatory markers
5291584|NCT00465426|Treatment Experienced|treatment experienced
5291960|NCT00464126|cardiac|cardiac
5291585|NCT00465413|metered-dose inhalers (MDI)|metered-dose inhalers (mdi)
5291586|NCT00465413|forced expiratory volume in 1 second (FEV1)|forced expiratory volume in 1 second (fev1)
5291587|NCT00465413|forced expiratory flow rate (FEF25-75%)|forced expiratory flow rate (fef25-75%)
5291588|NCT00465400|exudative age-related macular degeneration (AMD)|exudative age-related macular degeneration (amd)
5291589|NCT00465400|non-exudative age-related macular degeneration (AMD)|non-exudative age-related macular degeneration (amd)
5291590|NCT00465400|oxidative stress|oxidative stress
5291591|NCT00465400|photodynamic therapy|photodynamic therapy
5291592|NCT00465374|ARDS|ards
5291593|NCT00465374|Pressure/time curve|pressure/time curve
5291594|NCT00465374|Stress Index|stress index
5291595|NCT00465361|Growth and Development|growth and development
5291596|NCT00465361|Child Development|child development
5291597|NCT00465361|Developmental Surveillance|developmental surveillance
5291598|NCT00465361|Medical Education|medical education
5291599|NCT00465361|Internship and Residency|internship and residency
5291600|NCT00465348|normal tension glaucoma|normal tension glaucoma
5291601|NCT00465348|vascular dysregulation|vascular dysregulation
5291602|NCT00465335|computed tomography|computed tomography
5291603|NCT00465335|stress test|stress test
5291604|NCT00465335|equivocal|equivocal
5291605|NCT00465335|catheterization|catheterization
5291606|NCT00465309|Respiratory Insufficiency|respiratory insufficiency
5291607|NCT00465309|CO2 removal|co2 removal
5291608|NCT00465309|protective ventilation|protective ventilation
5291609|NCT00465309|ARDS|ards
5291610|NCT00466388|dry mouth|dry mouth
5291611|NCT00465283|Donepezil, ECT, Memory Disfunction|donepezil, ect, memory disfunction
5291612|NCT00465270|Cryptogenic|cryptogenic
5291613|NCT00465270|Stroke|stroke
5291614|NCT00465270|PFO|pfo
5291615|NCT00465244|Prehospital and ED seizures|prehospital and ed seizures
5291616|NCT00465231|Induction of labour|induction of labour
5291617|NCT00465231|Bupivacaine consumption|bupivacaine consumption
5291618|NCT00465231|Prevention|prevention
5291619|NCT00465218|Bioprosthesis|bioprosthesis
5291620|NCT00465218|Thrombosis|thrombosis
5291621|NCT00465218|Cerebral emboli|cerebral emboli
5291622|NCT00465218|Transcranial Doppler|transcranial doppler
5291623|NCT00465218|Platelet function tests|platelet function tests
5291624|NCT00465205|HIV infection|hiv infection
5291625|NCT00465205|HIV Shedding|hiv shedding
5291626|NCT00465205|HSV suppression|hsv suppression
5291627|NCT00465205|Co-infected|co-infected
5291628|NCT00465205|Women|women
5291629|NCT00465205|Reactivation|reactivation
5291630|NCT00465205|Valacyclovir|valacyclovir
5291631|NCT00465205|Treatment Naive|treatment naive
5291632|NCT00465179|Non-Clear Cell Renal Carcinoma|non-clear cell renal carcinoma
5291633|NCT00465179|Non-clear cell renal cell cancer|non-clear cell renal cell cancer
5291634|NCT00465179|Renal Cell Cancer|renal cell cancer
5291635|NCT00465179|Kidney Cancer|kidney cancer
5291636|NCT00465179|Papillary|papillary
5291637|NCT00465179|Chromophobe|chromophobe
5291638|NCT00465179|Collecting duct carcinoma|collecting duct carcinoma
5291639|NCT00465179|CDC|cdc
5291640|NCT00465179|Renal medullary carcinoma|renal medullary carcinoma
5291641|NCT00465179|RMC|rmc
5291642|NCT00465179|Sunitinib Malate|sunitinib malate
5291643|NCT00465179|Sutent|sutent
5291644|NCT00465179|SU011248|su011248
5291645|NCT00465166|Accidental dural puncture|accidental dural puncture
5291646|NCT00465166|Labour epidural|labour epidural
5291647|NCT00465166|Ultrasound|ultrasound
5291648|NCT00465166|Ligamentum flavum|ligamentum flavum
5291649|NCT00465153|Inflammation|inflammation
5291650|NCT00465153|cytokines|cytokines
5291651|NCT00465153|sarcopenia|sarcopenia
5291652|NCT00465153|strength|strength
5291653|NCT00465153|muscle|muscle
5291654|NCT00465153|aging|aging
5291655|NCT00465153|exercise|exercise
5291656|NCT00465114|Preeclampsia|preeclampsia
5291657|NCT00465114|Hemodynamic monitoring|hemodynamic monitoring
5291658|NCT00465101|Benign Prostatic Hyperplasia|benign prostatic hyperplasia
5291659|NCT00465101|Transurethral resection of the prostate|transurethral resection of the prostate
5291660|NCT00465101|Lower urinary tract symptoms|lower urinary tract symptoms
5291661|NCT00465101|GreenLight|greenlight
5291662|NCT00465101|Laserscope|laserscope
5291663|NCT00465101|Photoselective vaporization of the prostate|photoselective vaporization of the prostate
5291664|NCT00465101|enlarged prostate|enlarged prostate
5291665|NCT00465062|Lysosomal Disease|lysosomal disease
5291666|NCT00465062|Lipids|lipids
5291667|NCT00465062|B Lymphocytes|b lymphocytes
5291668|NCT00465062|Brain Damage|brain damage
5291669|NCT00465062|Gaucher Disease|gaucher disease
5291670|NCT00465062|GD|gd
5291671|NCT00465049|abscess, primary closure, secondary closure|abscess, primary closure, secondary closure
5291672|NCT00465036|fat absorption|fat absorption
5291673|NCT00465036|fibres|fibres
5291674|NCT00465023|proton beam irradiation|proton beam irradiation
5291675|NCT00465023|liver cancer|liver cancer
5291676|NCT00465010|Adolescence|adolescence
5291677|NCT00465010|Sexual health|sexual health
5291678|NCT00465010|Communication|communication
5291679|NCT00465010|Parenting|parenting
5291680|NCT00464997|methotrexate aspirin pharmacokinetics|methotrexate aspirin pharmacokinetics
5291681|NCT00464984|Weight loss|weight loss
5291682|NCT00464984|Physical fitness|physical fitness
5291683|NCT00464984|Quality of life|quality of life
5291684|NCT00464958|Fatigue|fatigue
5291685|NCT00464958|Spasticity|spasticity
5291686|NCT00464958|Sublingual Tizanidine|sublingual tizanidine
5291687|NCT00464958|Epworth Sleepiness Scale|epworth sleepiness scale
5291688|NCT00464958|Fatigue Severity Scale|fatigue severity scale
5291689|NCT00464932|COPD|copd
5291690|NCT00464932|Vasoactive Intestinal Peptide|vasoactive intestinal peptide
5291691|NCT00464932|Lung Function|lung function
5291692|NCT00464919|Advance, hepatocellular carcinoma|advance, hepatocellular carcinoma
5291693|NCT00464893|gastric cancer|gastric cancer
5291694|NCT00464893|catumaxomab|catumaxomab
5291695|NCT00464893|neoadjuvant chemotherapy|neoadjuvant chemotherapy
5291696|NCT00464893|phase II|phase ii
5291697|NCT00464893|interoperative|interoperative
5291698|NCT00464893|trifunctional antibody|trifunctional antibody
5291699|NCT00464880|Placebo-controlled study|placebo-controlled study
5291700|NCT00464880|assess the renoprotective effect of renin inhibition|assess the renoprotective effect of renin inhibition
5291701|NCT00464880|Aliskiren as an alternative to irbesartan|aliskiren as an alternative to irbesartan
5291702|NCT00464880|Type 2 diabetes patients|type 2 diabetes patients
5291703|NCT00464880|incipient/overt diabetic nephropathy|incipient/overt diabetic nephropathy
5291704|NCT00464867|Bifidobacterium breve|bifidobacterium breve
5291705|NCT00464867|oral whole cell cholera vaccine|oral whole cell cholera vaccine
5291706|NCT00464867|immunogenicity|immunogenicity
5291707|NCT00464867|Supplementation with probiotic improves vibriocidal antibody response in 2-5 year old childern given the killed oral cholera vaccine|supplementation with probiotic improves vibriocidal antibody response in 2-5 year old childern given the killed oral cholera vaccine
5291708|NCT00464867|Supplementation with probiotics results in improving the ASC responses to CT and LPS of V. cholerae O1|supplementation with probiotics results in improving the asc responses to ct and lps of v. cholerae o1
5291709|NCT00464854|Glucose control|glucose control
5291710|NCT00464854|Subcutaneous insulin treatment|subcutaneous insulin treatment
5291711|NCT00464854|Multiple daily injections|multiple daily injections
5291712|NCT00464841|Tsui Test|tsui test
5291713|NCT00464841|Combined Spinal Epidural|combined spinal epidural
5291714|NCT00464841|Labour|labour
5291715|NCT00464828|Central venous cannulation|central venous cannulation
5291716|NCT00464828|Internal jugular vein|internal jugular vein
5291717|NCT00464828|Ultrasound|ultrasound
5291718|NCT00464828|Obstetrics|obstetrics
5291719|NCT00464815|immunogenicity|immunogenicity
5291720|NCT00464815|safety|safety
5291721|NCT00464815|meningococcal vaccine|meningococcal vaccine
5291722|NCT00464802|healthy|healthy
5291723|NCT00464802|safety|safety
5291724|NCT00464789|Postmenopausal|postmenopausal
5291725|NCT00464776|Randomized|randomized
5291726|NCT00464776|double-blind|double-blind
5291727|NCT00464776|cross-over|cross-over
5291728|NCT00464776|4-period|4-period
5291729|NCT00464776|4 treatment|4 treatment
5291730|NCT00464776|within-subject placebo-controlled study|within-subject placebo-controlled study
5291731|NCT00464776|assess optimal renoprotective dose of Aliskiren|assess optimal renoprotective dose of aliskiren
5291732|NCT00464776|hypertensive type 2 diabetes patients|hypertensive type 2 diabetes patients
5291733|NCT00464776|incipient or overt nephropathy|incipient or overt nephropathy
5291734|NCT00464763|Mental Health|mental health
5291735|NCT00464763|Neurological Disease|neurological disease
5291736|NCT00464763|Heart Valve Repair Surgery|heart valve repair surgery
5291737|NCT00464750|Cardiac output|cardiac output
5291738|NCT00464750|Thermodilution|thermodilution
5291739|NCT00464737|Fibromyalgia Syndrome|fibromyalgia syndrome
5291740|NCT00464737|Rotigotine|rotigotine
5291741|NCT00464737|Neupro|neupro
5291742|NCT00464724|Prostate Cancer|prostate cancer
5291743|NCT00464724|Magnetic Resonance Spectroscopic Imaging|magnetic resonance spectroscopic imaging
5291744|NCT00464724|Perfluorocarbon Compound|perfluorocarbon compound
5291745|NCT00464724|AIR-MRSI|air-mrsi
5291746|NCT00464724|PFC-MRSI|pfc-mrsi
5291747|NCT00464724|3 Tesla|3 tesla
5291748|NCT00464724|MRSI|mrsi
5291749|NCT00464724|PFC|pfc
5291750|NCT00464711|depression|depression
5291751|NCT00464711|biology|biology
5291752|NCT00464698|OCD|ocd
5291753|NCT00464698|Obsessive Compulsive Disorder|obsessive compulsive disorder
5291754|NCT00464698|Obsessions|obsessions
5291755|NCT00464698|Compulsions|compulsions
5291756|NCT00464698|Duloxetine|duloxetine
5291757|NCT00464698|Cymbalta|cymbalta
5291758|NCT00464672|Influenza, Egg-Derived, Healthy Children, Healthy Adolescents, Healthy Adults, Safety, Immunogenicity, Trivalent, Inactivated, Vaccination|influenza, egg-derived, healthy children, healthy adolescents, healthy adults, safety, immunogenicity, trivalent, inactivated, vaccination
5291759|NCT00464659|Sleep apnea obstructive syndrome (SAOS)|sleep apnea obstructive syndrome (saos)
5291760|NCT00464659|memory deficit|memory deficit
5291761|NCT00464659|Continuous Positive Airway Pression (CPAP)|continuous positive airway pression (cpap)
5291762|NCT00464659|Sham CPAP|sham cpap
5291763|NCT00464646|NSABP|nsabp
5291764|NCT00464646|Epirubicin|epirubicin
5291765|NCT00464646|Cyclophosphamide|cyclophosphamide
5291766|NCT00464646|Docetaxel|docetaxel
5291767|NCT00464646|Trastuzumab|trastuzumab
5291768|NCT00464646|Bevacizumab|bevacizumab
5291769|NCT00464646|Neoadjuvant Therapy|neoadjuvant therapy
5291770|NCT00464646|HER2|her2
5291771|NCT00464646|Locally Advanced Breast Cancer|locally advanced breast cancer
5291772|NCT00464646|Adjuvant Therapy|adjuvant therapy
5291773|NCT00464646|Pathologic Stage III Breast Cancer|pathologic stage iii breast cancer
5291774|NCT00464646|Inflammatory Breast Cancer|inflammatory breast cancer
5291775|NCT00464633|CLL|cll
5291776|NCT00464633|PLL|pll
5291777|NCT00464633|flavopiridol|flavopiridol
5291778|NCT00464620|Dasatinib|dasatinib
5291779|NCT00464620|Rhabdomyosarcoma|rhabdomyosarcoma
5291780|NCT00464620|Malignant peripheral nerve sheath tumor|malignant peripheral nerve sheath tumor
5291781|NCT00464620|Chondrosarcoma|chondrosarcoma
5291782|NCT00464620|Ewing's|ewing's
5291783|NCT00464620|Alveolar soft part sarcoma (ASPS)|alveolar soft part sarcoma (asps)
5291784|NCT00464620|Chordoma|chordoma
5291785|NCT00464620|Epithelioid sarcoma|epithelioid sarcoma
5291786|NCT00464620|Giant cell tumor of bone|giant cell tumor of bone
5291787|NCT00464620|Hemangiopericytoma/solitary fibrous tumor|hemangiopericytoma/solitary fibrous tumor
5291788|NCT00464620|Gastrointestinal Stromal Tumor (GIST)|gastrointestinal stromal tumor (gist)
5291789|NCT00464594|Japan Early Diabetes Intervention Study|japan early diabetes intervention study
5291790|NCT00464581|non-ischemic retinopathy|non-ischemic retinopathy
5291791|NCT00464568|Seasonal allergic rhinitis,|seasonal allergic rhinitis,
5291792|NCT00464568|hayfever|hayfever
5291793|NCT00464555|Allogeneic Islets|allogeneic islets
5291794|NCT00464555|Allogeneic Islet Transplantation|allogeneic islet transplantation
5291795|NCT00464555|Type 1 diabetes mellitus|type 1 diabetes mellitus
5291796|NCT00464555|Type 1 diabetes|type 1 diabetes
5291797|NCT00464555|T1D|t1d
5291798|NCT00464555|T1DM|t1dm
5291799|NCT00464555|Insulin dependence|insulin dependence
5291800|NCT00464555|Hypoglycemia unawareness in T1D|hypoglycemia unawareness in t1d
5291801|NCT00464555|Islet transplant|islet transplant
5291802|NCT00464555|Islet transplantation|islet transplantation
5291803|NCT00464555|Islet graft|islet graft
5291804|NCT00464542|herpes simplex virus|herpes simplex virus
5291805|NCT00464529|blood glucose|blood glucose
5291806|NCT00464529|hyperglycemia|hyperglycemia
5291807|NCT00464529|hypoglycemia|hypoglycemia
5291808|NCT00464529|Perioperative care|perioperative care
5291809|NCT00464529|inpatient|inpatient
5291810|NCT00464516|Breast cancer (Estrogen Receptor positive)|breast cancer (estrogen receptor positive)
5291811|NCT00464503|statins|statins
5291812|NCT00464503|proteinuria|proteinuria
5291813|NCT00464503|proteomic analysis|proteomic analysis
5291814|NCT00464503|healthy volunteers|healthy volunteers
5291815|NCT00464490|Weaning|weaning
5291816|NCT00464490|Extuvation|extuvation
5291817|NCT00464490|Dexmedetomidine|dexmedetomidine
5291818|NCT00464477|Autism|autism
5291819|NCT00464477|Autistic disorder|autistic disorder
5291820|NCT00464477|Pervasive developmental disorder|pervasive developmental disorder
5291821|NCT00464477|Asperger syndrome|asperger syndrome
5291822|NCT00464477|Childhood disintegrative disorder|childhood disintegrative disorder
5291823|NCT00464477|Rett syndrome|rett syndrome
5291824|NCT00464464|Parkinson's disease|parkinson's disease
5291825|NCT00464464|PD|pd
5291826|NCT00464464|depression|depression
5291827|NCT00464464|cognitive-behavioral therapy|cognitive-behavioral therapy
5291828|NCT00464464|social support|social support
5291829|NCT00464425|Electroacupuncture|electroacupuncture
5291830|NCT00464425|Postoperative ileus|postoperative ileus
5291831|NCT00464425|Colorectal surgery|colorectal surgery
5291832|NCT00464425|Laparoscopic surgery|laparoscopic surgery
5291833|NCT00464425|Randomised trial|randomised trial
5291834|NCT00464412|Osteoporosis|osteoporosis
5291835|NCT00464412|Knowledge|knowledge
5291836|NCT00464412|Beliefs|beliefs
5291837|NCT00464412|Education|education
5291838|NCT00464412|Women|women
5291839|NCT00464399|De novo renal transplantation|de novo renal transplantation
5291840|NCT00464399|CNI-free protocol|cni-free protocol
5291841|NCT00464399|adults|adults
5291842|NCT00464399|everolimus|everolimus
5291843|NCT00464399|rejections|rejections
5291844|NCT00464386|Severe burns|severe burns
5291845|NCT00464386|Severe Trauma|severe trauma
5291846|NCT00464386|Closed loop insulin|closed loop insulin
5291847|NCT00464386|continuous glucose monitoring|continuous glucose monitoring
5291848|NCT00464373|Prostatitis|prostatitis
5291849|NCT00464373|Chronic Prostatitis with Chronic Pelvic Pain Syndrome|chronic prostatitis with chronic pelvic pain syndrome
5291850|NCT00464373|Botulinum Toxin Type A|botulinum toxin type a
5291851|NCT00464373|Drug therapy|drug therapy
5291852|NCT00464373|Injections, intramuscular|injections, intramuscular
5291853|NCT00464347|AMD|amd
5291854|NCT00464347|wet AMD|wet amd
5291855|NCT00464347|verteporfin PDT|verteporfin pdt
5291856|NCT00464347|Avastin|avastin
5291857|NCT00464347|TAC-PF|tac-pf
5291858|NCT00464308|Gastroesophageal Reflux|gastroesophageal reflux
5291859|NCT00464308|Heartburn|heartburn
5291860|NCT00464308|Proton pump inhibitor|proton pump inhibitor
5291861|NCT00464308|GORD|gord
5291862|NCT00464295|Hepatocellular Carcinoma|hepatocellular carcinoma
5291863|NCT00464295|Phase 2 Trial|phase 2 trial
5291864|NCT00464295|Capecitabine|capecitabine
5291865|NCT00464295|Treatment Efficacy|treatment efficacy
5291866|NCT00464282|Fluorine–18-α–methyltyrosine,|fluorine–18-α–methyltyrosine,
5291867|NCT00464282|Positron emission tomography,|positron emission tomography,
5291868|NCT00464282|Fluorodeoxyglucose|fluorodeoxyglucose
5291869|NCT00464282|Lung cancer,|lung cancer,
5291870|NCT00464282|Amino acid transportor 1,|amino acid transportor 1,
5291871|NCT00464282|Ki-67|ki-67
5291872|NCT00464282|Proven or suspected non-small cell lung cancer were enrolled in the study|proven or suspected non-small cell lung cancer were enrolled in the study
5291873|NCT00464269|Epilepsy|epilepsy
5291874|NCT00464269|Brivaracetam|brivaracetam
5291875|NCT00464269|Partial Onset Seizures, Adolescents & Adults|partial onset seizures, adolescents & adults
5291876|NCT00464256|abstinence|abstinence
5291877|NCT00464243|Sleep problems|sleep problems
5291878|NCT00464243|Insomnia|insomnia
5291879|NCT00464243|Sleeplessness|sleeplessness
5291880|NCT00464243|Polysomnographic|polysomnographic
5291881|NCT00464230|Displaced Femoral Neck Fractures|displaced femoral neck fractures
5291882|NCT00464230|Treatment|treatment
5291883|NCT00464230|Function|function
5291884|NCT00464230|Pain|pain
5291885|NCT00464230|Quality of life|quality of life
5291886|NCT00464230|Complications|complications
5291887|NCT00464230|Reoperations|reoperations
5291888|NCT00464230|Internal Fixation|internal fixation
5291889|NCT00464230|Hemiarthroplasty|hemiarthroplasty
5291890|NCT00464230|Activities of Daily Living|activities of daily living
5291891|NCT00464217|Acute Myeloblastic Leukaemia|acute myeloblastic leukaemia
5291892|NCT00464191|bipolar depression|bipolar depression
5291893|NCT00464191|SSRI|ssri
5291894|NCT00464191|escitalopram|escitalopram
5291895|NCT00464191|bipolar disorder|bipolar disorder
5291896|NCT00464191|antidepressant|antidepressant
5291897|NCT00464191|treatment trial|treatment trial
5291898|NCT00464191|RCT|rct
5291899|NCT00464178|multiple myeloma|multiple myeloma
5291900|NCT00464178|myeloma|myeloma
5291901|NCT00464178|relapsed myeloma|relapsed myeloma
5291902|NCT00464178|refractory myeloma|refractory myeloma
5291903|NCT00464178|relapsed, refractory myeloma|relapsed, refractory myeloma
5291904|NCT00464178|relapsed, refractory multiple myeloma|relapsed, refractory multiple myeloma
5291905|NCT00464178|refractory multiple myeloma|refractory multiple myeloma
5291906|NCT00464178|relapsed multiple myeloma|relapsed multiple myeloma
5291907|NCT00464178|B lymphoid malignancies|b lymphoid malignancies
5291908|NCT00464178|Myeloma, Plasma-Cell|myeloma, plasma-cell
5291909|NCT00464178|Myeloma Proteins|myeloma proteins
5291910|NCT00464178|hnRNP A1|hnrnp a1
5291911|NCT00464178|myeloma helix-destabilizing protein, mouse|myeloma helix-destabilizing protein, mouse
5291912|NCT00464178|IgC3kappa Jir protein, human|igc3kappa jir protein, human
5291913|NCT00464178|gamma 3 myeloma protein Jir, human|gamma 3 myeloma protein jir, human
5291914|NCT00464178|M-proteins (Myeloma)|m-proteins (myeloma)
5291915|NCT00464178|M315 myeloma protein, mouse|m315 myeloma protein, mouse
5291916|NCT00464178|myeloma protein M 315, mouse|myeloma protein m 315, mouse
5291917|NCT00464178|McPC603 antibody|mcpc603 antibody
5291918|NCT00464178|myeloma protein McPC603 antibody|myeloma protein mcpc603 antibody
5291919|NCT00464178|multiple myeloma M-proteins|multiple myeloma m-proteins
5291920|NCT00464178|M protein, multiple myeloma|m protein, multiple myeloma
5291921|NCT00464178|myeloma cell activator|myeloma cell activator
5291922|NCT00464178|myeloma immunoglobulins|myeloma immunoglobulins
5291923|NCT00464178|myeloma immunoglobulin M603|myeloma immunoglobulin m603
5291924|NCT00464178|myeloma immunoglobulin S15|myeloma immunoglobulin s15
5291925|NCT00464178|myeloma protein A48, mouse|myeloma protein a48, mouse
5291926|NCT00464178|A48 myeloma protein, mouse|a48 myeloma protein, mouse
5291927|NCT00464178|ABPC48 myeloma protein, mouse|abpc48 myeloma protein, mouse
5291928|NCT00464178|myeloma protein A 48, mouse|myeloma protein a 48, mouse
5291929|NCT00464178|myeloma protein Dob|myeloma protein dob
5291930|NCT00464178|myeloma protein M 467|myeloma protein m 467
5291931|NCT00464178|myeloma protein M467|myeloma protein m467
5291932|NCT00464178|myeloma protein MOPC 141, mouse|myeloma protein mopc 141, mouse
5291933|NCT00464178|MOPC141 myeloma protein, mouse|mopc141 myeloma protein, mouse
5291934|NCT00464178|myeloma protein MOPC 173|myeloma protein mopc 173
5291935|NCT00464178|myeloma protein Rou|myeloma protein rou
5291936|NCT00464178|IgA2 myeloma protein Rou|iga2 myeloma protein rou
5291937|NCT00464178|myeloma protein TEPC15|myeloma protein tepc15
5291938|NCT00464178|myeloma protein T15|myeloma protein t15
5291939|NCT00464178|myeloma protein TEPC 15|myeloma protein tepc 15
5291940|NCT00464178|myeloma protein W3129|myeloma protein w3129
5291941|NCT00464178|myeloma protein WIE|myeloma protein wie
5291942|NCT00464178|myeloma-associated membrane antigen KMA|myeloma-associated membrane antigen kma
5291943|NCT00464178|myeloma antigen KMA|myeloma antigen kma
5291944|NCT00464178|MYEOV protein, human|myeov protein, human
5291945|NCT00464178|protein 460|protein 460
5291946|NCT00464178|myeloma protein MOPC 460|myeloma protein mopc 460
5291947|NCT00464178|TRAPPC1 protein, human|trappc1 protein, human
5291948|NCT00464178|multiple myeloma protein 2, human|multiple myeloma protein 2, human
5291949|NCT00464178|Wis heavy-chain disease protein, human|wis heavy-chain disease protein, human
5291950|NCT00464178|myeloma protein Wis, human|myeloma protein wis, human
5291951|NCT00464165|abstinence|abstinence
5291952|NCT00464139|endometriosis|endometriosis
5291953|NCT00464139|prevalence|prevalence
5291954|NCT00464139|fertility|fertility
5291955|NCT00464139|pain|pain
5291956|NCT00464139|ultrasound|ultrasound
5291957|NCT00464126|crystalloid|crystalloid
5291958|NCT00464126|colloid|colloid
5291959|NCT00464126|pediatric|pediatric
5291961|NCT00464126|resuscitation|resuscitation
5291962|NCT00464126|Postoperative|postoperative
5291963|NCT00464113|Myeloid Leukemia|myeloid leukemia
5291964|NCT00464113|Lymphocytic Leukemia|lymphocytic leukemia
5291965|NCT00464113|Ph+ ALL|ph+ all
5291966|NCT00464100|Neurodevelopmental outcomes|neurodevelopmental outcomes
5291967|NCT00464100|congenital heart disease|congenital heart disease
5291968|NCT00464100|NIRS monitoring|nirs monitoring
5291969|NCT00464100|hypoxia|hypoxia
5291970|NCT00464074|fatigue|fatigue
5291971|NCT00464074|Tysabri|tysabri
5291972|NCT00464074|cognition|cognition
5291973|NCT00464061|Sleep problems|sleep problems
5291974|NCT00464061|Insomnia|insomnia
5291975|NCT00464061|Sleeplessness|sleeplessness
5291976|NCT00464061|Primary insomnia|primary insomnia
5291977|NCT00464061|Insomnia disorder|insomnia disorder
5291978|NCT00464035|Obesity|obesity
5291979|NCT00464035|Calcium|calcium
5291980|NCT00464035|Fat absorption|fat absorption
5291981|NCT00464035|Postprandial lipid profile|postprandial lipid profile
5291982|NCT00464035|appetite|appetite
5291983|NCT00464022|pain, endoscopy|pain, endoscopy
5291984|NCT00464022|Pain, endoscopy, randomised trial|pain, endoscopy, randomised trial
5291985|NCT00464009|Early childhood caries - ECC|early childhood caries - ecc
5291986|NCT00464009|Prevention|prevention
5291987|NCT00464009|Continuing medical education|continuing medical education
5291988|NCT00464009|Randomized controlled trial|randomized controlled trial
5291989|NCT00463996|Ovarian cancer|ovarian cancer
5291990|NCT00463996|MRI|mri
5291991|NCT00463996|Contrast agent|contrast agent
5291992|NCT00463970|Chronic low back pain|chronic low back pain
5291993|NCT00463970|Brief cognitive intervention|brief cognitive intervention
5291994|NCT00463970|Cognitive behavior therapy|cognitive behavior therapy
5291995|NCT00463970|Seal oil|seal oil
5291996|NCT00463957|sildenafil|sildenafil
5291997|NCT00463957|tadalafil|tadalafil
5291998|NCT00463957|phosphodiesterase|phosphodiesterase
5291999|NCT00463957|visual persistence|visual persistence
5292000|NCT00463957|reaction time|reaction time
5292001|NCT00463944|Electronic voting system|electronic voting system
5292002|NCT00463931|Schistosomiasis|schistosomiasis
5292003|NCT00463931|Soiltransmitted helminthiasis|soiltransmitted helminthiasis
5292004|NCT00463931|Community-based volunteer|community-based volunteer
5292005|NCT00463931|School based treatment approach|school based treatment approach
5292006|NCT00463905|osteoporosis|osteoporosis
5292007|NCT00463905|vertebral fractures|vertebral fractures
5292008|NCT00463905|randomised controlled trial|randomised controlled trial
5292009|NCT00463905|screening|screening
5292010|NCT00463892|melanoma|melanoma
5292011|NCT00463892|lymph nodes|lymph nodes
5292012|NCT00463892|magnetic resonance imaging|magnetic resonance imaging
5292013|NCT00463892|screening|screening
5292014|NCT00463892|detection|detection
5292015|NCT00463879|Schizophrenia|schizophrenia
5292016|NCT00463879|Cognition|cognition
5292017|NCT00463879|Smoking|smoking
5292018|NCT00463879|Galantamine|galantamine
5292019|NCT00463879|Nicotine|nicotine
5292020|NCT00463879|Cognitive Deficits|cognitive deficits
5292021|NCT00463866|Asthma|asthma
5292022|NCT00463853|Bone Marrow Cells|bone marrow cells
5292023|NCT00463853|Cardiovascular Surgery|cardiovascular surgery
5292024|NCT00463853|Coronary Artery Bypass Graft|coronary artery bypass graft
5292025|NCT00463853|Phase I Study|phase i study
5292026|NCT00463853|Stem Cells|stem cells
5292027|NCT00463840|Locally advanced pancreatic cancer|locally advanced pancreatic cancer
5292028|NCT00463840|oxaliplatin|oxaliplatin
5292029|NCT00463840|chemoradiation|chemoradiation
5292030|NCT00463840|5FU|5fu
5292031|NCT00463827|asthma|asthma
5292032|NCT00463827|smokers|smokers
5292033|NCT00463827|statin|statin
5292034|NCT00463827|atorvastatin|atorvastatin
5292035|NCT00463827|randomised|randomised
5292036|NCT00463827|placebo|placebo
5292037|NCT00463827|cigarette|cigarette
5292038|NCT00463827|blind|blind
5292039|NCT00463827|COPD|copd
5292040|NCT00463814|Advanced Malignancy|advanced malignancy
5292041|NCT00463814|Cancer Eligibility|cancer eligibility
5292042|NCT00463814|Malignancy|malignancy
5292043|NCT00463801|Complicated Skin and Skin-Structure Infections, Daptomycin, MRSA, Diabetic Foot, Abscess, Cellulitis|complicated skin and skin-structure infections, daptomycin, mrsa, diabetic foot, abscess, cellulitis
5292044|NCT00463801|Complicated skin and skin-structure infections|complicated skin and skin-structure infections
5292045|NCT00463788|cancer|cancer
5292046|NCT00463788|breast|breast
5292047|NCT00463788|metastatic|metastatic
5292048|NCT00463788|triple negative|triple negative
5292049|NCT00463775|Treatment|treatment
5292050|NCT00463775|Topiramate|topiramate
5292051|NCT00463775|Alcohol Dependence|alcohol dependence
5292052|NCT00463775|Borderline Personality Disorder|borderline personality disorder
5292053|NCT00463749|primary PCI|primary pci
5292054|NCT00463749|nephropathy|nephropathy
5292055|NCT00463749|infarct size|infarct size
5292056|NCT00463749|infarction|infarction
5292057|NCT00463749|ST-elevation myocardial infarction|st-elevation myocardial infarction
5292058|NCT00463736|short term tocolysis|short term tocolysis
5292059|NCT00463736|preterm premature rupture of membranes|preterm premature rupture of membranes
5292060|NCT00463723|penetrating keratoplasty|penetrating keratoplasty
5292061|NCT00463723|graft rejection|graft rejection
5292062|NCT00463723|immunosuppression|immunosuppression
5292063|NCT00463710|MTI, DWI, Avonex, MRI|mti, dwi, avonex, mri
5292064|NCT00463697|GW642444,|gw642444,
5292065|NCT00463697|magnesium stearate,|magnesium stearate,
5292066|NCT00463697|asthmatic patients|asthmatic patients
5292067|NCT00463658|Falls|falls
5292068|NCT00463658|Home Care|home care
5292069|NCT00463658|Aging Population|aging population
5292070|NCT00463658|Clinical Effectiveness|clinical effectiveness
5292071|NCT00463658|Health Economics|health economics
5292072|NCT00463632|schistosomiasis|schistosomiasis
5292073|NCT00463632|anaemia|anaemia
5292074|NCT00463632|pregnancy|pregnancy
5292075|NCT00463593|schistosomiasis|schistosomiasis
5292076|NCT00463593|helminthes|helminthes
5292077|NCT00463593|anaemia|anaemia
5292078|NCT00463580|depression|depression
5292079|NCT00463580|TNF-alpha antagonist|tnf-alpha antagonist
5292080|NCT00463580|infliximab|infliximab
5292081|NCT00463580|treatment resistant depression|treatment resistant depression
5292082|NCT00463580|major depressive disorder (MDD)|major depressive disorder (mdd)
5292083|NCT00463580|bipolar I disorder|bipolar i disorder
5292084|NCT00463580|bipolar II disorder|bipolar ii disorder
5292085|NCT00463567|indacaterol|indacaterol
5292086|NCT00463567|long acting beta-2 agonist|long acting beta-2 agonist
5292087|NCT00463554|Incontinence|incontinence
5292088|NCT00463554|Stress Urinary|stress urinary
5292089|NCT00463541|Urinary Bladder, Overactive|urinary bladder, overactive
5292090|NCT00463541|Urgency|urgency
5292091|NCT00463541|VESIcare®|vesicare®
5292092|NCT00463541|Solifenacin succinate|solifenacin succinate
5292093|NCT00463528|schistosomiasis|schistosomiasis
5292094|NCT00463528|gender perspectives|gender perspectives
5292095|NCT00463515|Non-Small Cell Lung Cancer|non-small cell lung cancer
5292096|NCT00463515|NSCLC|nsclc
5292097|NCT00463515|Chemoradiation|chemoradiation
5292098|NCT00463515|lung cancer|lung cancer
5292099|NCT00463515|induction chemotherapy|induction chemotherapy
5292100|NCT00463515|chemo-radiotherapy|chemo-radiotherapy
5292101|NCT00463502|The purpose of study was investigated the effect of|the purpose of study was investigated the effect of
5292102|NCT00463502|metformin on thyroid hormone metabolism in euthyroid patients|metformin on thyroid hormone metabolism in euthyroid patients
5292103|NCT00463502|with type 2 DM. The results revealed significant decreases|with type 2 dm. the results revealed significant decreases
5292104|NCT00463502|in TSH and fT4|in tsh and ft4
5292105|NCT00463489|lifestyle intervention|lifestyle intervention
5292106|NCT00463489|breast|breast
5292107|NCT00463489|cancer|cancer
5292108|NCT00463489|adjuvant|adjuvant
5292109|NCT00463489|letrozole|letrozole
5292110|NCT00463489|weight loss|weight loss
5292111|NCT00463489|BMI|bmi
5292112|NCT00463489|post-menopausal|post-menopausal
5292113|NCT00463489|estrogen receptor positive|estrogen receptor positive
5292114|NCT00463489|progesterone receptor positive|progesterone receptor positive
5292115|NCT00463450|Hormone Replacement Therapy|hormone replacement therapy
5292116|NCT00463450|Impaired well-being, mood and sexuality|impaired well-being, mood and sexuality
5292117|NCT00463437|Fever.|fever.
5292118|NCT00463437|Meningococcal disease.|meningococcal disease.
5292119|NCT00463437|Pneumococcal disease.|pneumococcal disease.
5292120|NCT00463437|Meningococcal vaccine.|meningococcal vaccine.
5292121|NCT00463437|Pneumococcal vaccine.|pneumococcal vaccine.
5292122|NCT00463437|Immunogenicity.|immunogenicity.
5292123|NCT00463437|Booster vaccination.|booster vaccination.
5292124|NCT00463437|Safety.|safety.
5292125|NCT00463424|Metacarpophalangeal Joint|metacarpophalangeal joint
5292126|NCT00463424|Arthroplasty, Replacement|arthroplasty, replacement
5292127|NCT00463424|Range of Motion, Articular|range of motion, articular
5292128|NCT00463424|Randomized Controlled Trials|randomized controlled trials
5292129|NCT00463424|Swanson|swanson
5292130|NCT00463424|NeuFlex|neuflex
5292131|NCT00463411|osteoporosis|osteoporosis
5292132|NCT00463411|male|male
5292133|NCT00463411|fracture risk|fracture risk
5292134|NCT00463411|genetical epidemiology|genetical epidemiology
5292135|NCT00463398|Endometriosis|endometriosis
5292136|NCT00463398|Fertility Surgery|fertility surgery
5292137|NCT00463398|Quality of Life|quality of life
5292138|NCT00463398|Pain|pain
5292139|NCT00463398|Sexual Function|sexual function
5292140|NCT00463398|Health economics|health economics
5292141|NCT00463398|Recurrence|recurrence
5292142|NCT00463398|Pregnancy|pregnancy
5292143|NCT00463385|Celgene|celgene
5292144|NCT00463385|CC-4047|cc-4047
5292145|NCT00463385|Myelofibrosis|myelofibrosis
5292146|NCT00463385|myelofibrosis with myeloid metaplasia|myelofibrosis with myeloid metaplasia
5292147|NCT00463385|myeloid metaplasia|myeloid metaplasia
5292148|NCT00463385|JAK2|jak2
5292149|NCT00463385|CC-4047-MMM-001|cc-4047-mmm-001
5292150|NCT00463385|Prednisone|prednisone
5292151|NCT00463385|Phase II|phase ii
5292152|NCT00463385|pomalidomide|pomalidomide
5292153|NCT00463385|bone marrow histology|bone marrow histology
5292154|NCT00463385|imids|imids
5292155|NCT00463385|MMM|mmm
5292156|NCT00463385|Ashkenazi Jewish Population|ashkenazi jewish population
5292157|NCT00463385|exposure to Thorotrast|exposure to thorotrast
5292158|NCT00463385|exposure to solvents (benzene and toluene)|exposure to solvents (benzene and toluene)
5292349|NCT00462761|refractory|refractory
5292159|NCT00463385|acute megakaryocytic leukemia|acute megakaryocytic leukemia
5292160|NCT00463385|history of polycythemia vera|history of polycythemia vera
5292161|NCT00463359|basal cell carcinoma|basal cell carcinoma
5292162|NCT00463359|curettage|curettage
5292163|NCT00463359|Imiquimod|imiquimod
5292164|NCT00463359|treatment|treatment
5292165|NCT00463346|Treatment|treatment
5292166|NCT00463346|Alcohol Dependence|alcohol dependence
5292167|NCT00463346|Schizophrenia|schizophrenia
5292168|NCT00463333|postoperative delirium|postoperative delirium
5292169|NCT00463333|psychometric testing|psychometric testing
5292170|NCT00463333|EEG|eeg
5292171|NCT00463333|serum markers|serum markers
5292172|NCT00463320|Age-related macular degeneration (AMD),|age-related macular degeneration (amd),
5292173|NCT00463320|vascular endothelial growth factor (VEGF)receptor (VEGFR)|vascular endothelial growth factor (vegf)receptor (vegfr)
5292174|NCT00463320|choroidal neovascularization,|choroidal neovascularization,
5292175|NCT00463307|schistosomiasis|schistosomiasis
5292176|NCT00463307|Schistosoma mansoni|schistosoma mansoni
5292177|NCT00463307|Circulating cathodic antigen urine dipstick|circulating cathodic antigen urine dipstick
5292178|NCT00463294|CABG|cabg
5292179|NCT00463294|On-pump|on-pump
5292180|NCT00463294|Off-pump|off-pump
5292181|NCT00463281|stroke, ischemic|stroke, ischemic
5292182|NCT00463281|computed tomography|computed tomography
5292183|NCT00463281|thrombolysis|thrombolysis
5292184|NCT00463268|osteopenia|osteopenia
5292185|NCT00463268|osteoporosis prevention|osteoporosis prevention
5292186|NCT00463268|alendronate|alendronate
5292187|NCT00463255|Diet|diet
5292188|NCT00463255|elderly|elderly
5292189|NCT00463255|age-related diseases|age-related diseases
5292190|NCT00463255|prevention|prevention
5292191|NCT00463255|cognitive decline|cognitive decline
5292192|NCT00463255|Clinical study|clinical study
5292193|NCT00463242|agomelatine, Major Depressive Disorder, MDD, depression|agomelatine, major depressive disorder, mdd, depression
5292194|NCT00463229|stroke|stroke
5292195|NCT00463229|rehabilitation|rehabilitation
5292196|NCT00463229|home care services|home care services
5292197|NCT00463229|effectiveness|effectiveness
5292198|NCT00463229|quantitative research|quantitative research
5292199|NCT00463229|interdisciplinary|interdisciplinary
5292200|NCT00463229|cost|cost
5292201|NCT00463229|health services research, integrated|health services research, integrated
5292202|NCT00463216|back, neck, pain, sick leave|back, neck, pain, sick leave
5292203|NCT00463203|primary malignant brain tumor|primary malignant brain tumor
5292204|NCT00463203|grade II glioma|grade ii glioma
5292205|NCT00463203|meningeoma|meningeoma
5292206|NCT00463203|ependymoma|ependymoma
5292207|NCT00463203|Recurrence or progression after standard treatment|recurrence or progression after standard treatment
5292208|NCT00463190|Probiotics|probiotics
5292209|NCT00463190|Diarrhea|diarrhea
5292210|NCT00463190|Enterocolitis|enterocolitis
5292211|NCT00463177|Pain|pain
5292212|NCT00463177|Chronic pain|chronic pain
5292213|NCT00463177|Pain disorder|pain disorder
5292214|NCT00463177|Functional MRI|functional mri
5292215|NCT00463177|Sensitization|sensitization
5292216|NCT00463164|functional MRI|functional mri
5292217|NCT00463151|Rebamipide|rebamipide
5292218|NCT00463151|Enema|enema
5292219|NCT00463151|Ulcerative Colitis|ulcerative colitis
5292220|NCT00463138|perceived increase or decrease in symptoms post treatment|perceived increase or decrease in symptoms post treatment
5292221|NCT00463138|Satisfaction with the treatment|satisfaction with the treatment
5292222|NCT00463125|Scleroderma, systemic|scleroderma, systemic
5292223|NCT00463125|therapeutic|therapeutic
5292224|NCT00463125|platelet gel|platelet gel
5292225|NCT00463112|Obesity|obesity
5292226|NCT00463112|Polycystic Ovary Syndrome|polycystic ovary syndrome
5292227|NCT00463112|weight loss|weight loss
5292228|NCT00463112|Hyperadrogonemia|hyperadrogonemia
5292229|NCT00463112|Sibutramine|sibutramine
5292230|NCT00463099|Anterior Cruciate Ligament/injuries|anterior cruciate ligament/injuries
5292231|NCT00463099|Anterior Cruciate Ligament/surgery|anterior cruciate ligament/surgery
5292232|NCT00463099|Knee injuries/surgery|knee injuries/surgery
5292233|NCT00463099|Outcomes research|outcomes research
5292234|NCT00463099|Prospective Studies|prospective studies
5292235|NCT00463086|Tuberculosis|tuberculosis
5292236|NCT00463086|TB|tb
5292237|NCT00463086|Mycobacteria|mycobacteria
5292238|NCT00463086|HIV|hiv
5292239|NCT00463086|Human immunodeficiency virus|human immunodeficiency virus
5292240|NCT00463086|Latent tuberculosis infection|latent tuberculosis infection
5292241|NCT00463086|HAART|haart
5292242|NCT00463086|Highly active anti-retroviral therapy|highly active anti-retroviral therapy
5292243|NCT00463086|Isoniazid preventive therapy|isoniazid preventive therapy
5292244|NCT00463086|INH|inh
5292245|NCT00463086|Opportunistic infections|opportunistic infections
5292246|NCT00463086|HIV-1|hiv-1
5292247|NCT00463086|Treatment Experienced|treatment experienced
5292248|NCT00463086|AIDS|aids
5292249|NCT00463086|Mycobacterium Tuberculosis|mycobacterium tuberculosis
5292250|NCT00463073|Progressive primary Glioblastoma multiforme|progressive primary glioblastoma multiforme
5292251|NCT00463060|erlotinib|erlotinib
5292252|NCT00463060|celecoxib|celecoxib
5292253|NCT00463060|radiation|radiation
5292254|NCT00463060|progression-free survival|progression-free survival
5292255|NCT00463047|Breakthrough pain|breakthrough pain
5292256|NCT00463047|Opioid-tolerant|opioid-tolerant
5292257|NCT00463047|Chronic pain|chronic pain
5292258|NCT00463034|stage IV breast cancer|stage iv breast cancer
5292259|NCT00463034|stage I breast cancer|stage i breast cancer
5292260|NCT00463034|stage II breast cancer|stage ii breast cancer
5292261|NCT00463034|stage IIIA breast cancer|stage iiia breast cancer
5292262|NCT00463034|stage IIIB breast cancer|stage iiib breast cancer
5292263|NCT00463034|stage IIIC breast cancer|stage iiic breast cancer
5292264|NCT00463021|Hectorol (doxercalciferol capsules)|hectorol (doxercalciferol capsules)
5292265|NCT00463021|Zemplar (paricalcitol injection)|zemplar (paricalcitol injection)
5292266|NCT00463008|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5292267|NCT00463008|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
5292268|NCT00463008|adult glioblastoma|adult glioblastoma
5292269|NCT00463008|recurrent adult brain tumor|recurrent adult brain tumor
5292270|NCT00463008|adult gliosarcoma|adult gliosarcoma
5292271|NCT00463008|adult giant cell glioblastoma|adult giant cell glioblastoma
5292272|NCT00462995|Non Small Cell Lung Cancer|non small cell lung cancer
5292273|NCT00462995|Lung Cancer|lung cancer
5292274|NCT00462995|Erlotinib|erlotinib
5292275|NCT00462995|Neoadjuvant Treatment|neoadjuvant treatment
5292276|NCT00462982|stage IV melanoma|stage iv melanoma
5292277|NCT00462982|tumors metastatic to brain|tumors metastatic to brain
5292278|NCT00462982|stage IV renal cell cancer|stage iv renal cell cancer
5292279|NCT00462982|recurrent melanoma|recurrent melanoma
5292280|NCT00462982|recurrent renal cell cancer|recurrent renal cell cancer
5292281|NCT00462969|Endometrial cancer|endometrial cancer
5292282|NCT00462969|Sonohysterography|sonohysterography
5292283|NCT00462956|lapatinib|lapatinib
5292284|NCT00462956|metastatic breast cancer|metastatic breast cancer
5292285|NCT00462956|trastuzumab (Herceptin)|trastuzumab (herceptin)
5292286|NCT00462956|Stage IV breast cancer|stage iv breast cancer
5292287|NCT00462956|ErbB2|erbb2
5292288|NCT00462956|ErbB1|erbb1
5292289|NCT00462943|CML|cml
5292290|NCT00462943|HHT|hht
5292291|NCT00462943|Homoharringtonine|homoharringtonine
5292292|NCT00462943|Omacetaxine|omacetaxine
5292293|NCT00462917|disease /disorder proneness /risk|disease /disorder proneness /risk
5292294|NCT00462917|family genetics|family genetics
5292295|NCT00462917|genetic counseling|genetic counseling
5292296|NCT00462917|genetic marker|genetic marker
5292297|NCT00462917|genetic polymorphism|genetic polymorphism
5292298|NCT00462917|genetic screening|genetic screening
5292299|NCT00462917|genetic susceptibility|genetic susceptibility
5292300|NCT00462891|breast cancer|breast cancer
5292301|NCT00462878|Febrile neutropenia|febrile neutropenia
5292302|NCT00462865|breast cancer|breast cancer
5292303|NCT00462865|neoadjuvant chemotherapy|neoadjuvant chemotherapy
5292304|NCT00462865|adjuvant treatment|adjuvant treatment
5292305|NCT00462865|consolidation therapy|consolidation therapy
5292306|NCT00462865|anti-angiogenesis therapy|anti-angiogenesis therapy
5292307|NCT00462852|thromboembolism|thromboembolism
5292308|NCT00462852|stage III pancreatic cancer|stage iii pancreatic cancer
5292309|NCT00462852|stage IV pancreatic cancer|stage iv pancreatic cancer
5292310|NCT00462852|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
5292311|NCT00462852|recurrent pancreatic cancer|recurrent pancreatic cancer
5292312|NCT00462852|stage II pancreatic cancer|stage ii pancreatic cancer
5292313|NCT00462839|Estimated Blood Loss|estimated blood loss
5292314|NCT00462839|Obstetrics|obstetrics
5292315|NCT00462839|postpartum hemorrhage|postpartum hemorrhage
5292316|NCT00462813|cervical cancer|cervical cancer
5292317|NCT00462813|cervical intraepithelial neoplasia grade 2|cervical intraepithelial neoplasia grade 2
5292318|NCT00462813|cervical intraepithelial neoplasia grade 3|cervical intraepithelial neoplasia grade 3
5292319|NCT00462813|cervical intraepithelial neoplasia grade 1|cervical intraepithelial neoplasia grade 1
5292320|NCT00462787|acute undifferentiated leukemia|acute undifferentiated leukemia
5292321|NCT00462787|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5292322|NCT00462787|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5292323|NCT00462787|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5292324|NCT00462787|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5292325|NCT00462774|Myocardial infarction|myocardial infarction
5292326|NCT00462774|Heart failure|heart failure
5292327|NCT00462774|Cell therapy|cell therapy
5292328|NCT00462774|Bone marrow|bone marrow
5292329|NCT00462774|CD133|cd133
5292330|NCT00462774|Bypass surgery|bypass surgery
5292331|NCT00462774|Stem cells|stem cells
5292333|NCT00462761|kinase|kinase
5292334|NCT00462761|inhibitor|inhibitor
5292335|NCT00462761|tyrosine|tyrosine
5292336|NCT00462761|acute|acute
5292337|NCT00462761|FLT3|flt3
5292338|NCT00462761|AC220|ac220
5292339|NCT00462761|pharmacokinetic|pharmacokinetic
5292340|NCT00462761|pharmacokinetics|pharmacokinetics
5292341|NCT00462761|PK|pk
5292342|NCT00462761|pharmacodynamic|pharmacodynamic
5292343|NCT00462761|pharmacodynamics|pharmacodynamics
5292344|NCT00462761|mutations|mutations
5292345|NCT00462761|PD|pd
5292346|NCT00462761|receptor|receptor
5292347|NCT00462761|class III|class iii
5292348|NCT00462761|relapsed|relapsed
5292350|NCT00462761|t(8;21)|t(8;21)
5292351|NCT00462761|q22;q22|q22;q22
5292352|NCT00462761|AML1/ETO|aml1/eto
5292353|NCT00462761|t(16;16|t(16;16
5292354|NCT00462761|p13;q22|p13;q22
5292355|NCT00462761|CBFbeta/MYH11|cbfbeta/myh11
5292356|NCT00462761|inv(16)|inv(16)
5292357|NCT00462761|p13q22|p13q22
5292358|NCT00462761|11q23|11q23
5292359|NCT00462761|dysplasia|dysplasia
5292360|NCT00462761|myeloid|myeloid
5292361|NCT00462761|myelomonocytic|myelomonocytic
5292362|NCT00462761|monoblastic|monoblastic
5292363|NCT00462761|monocytic|monocytic
5292364|NCT00462761|erythroid|erythroid
5292365|NCT00462761|erythroleukemia|erythroleukemia
5292366|NCT00462761|megakaryoblastic|megakaryoblastic
5292367|NCT00462761|basophilic|basophilic
5292368|NCT00462761|panmyelosis|panmyelosis
5292369|NCT00462761|myelofibrosis|myelofibrosis
5292370|NCT00462735|Cancer of the Nasal Cavity|cancer of the nasal cavity
5292371|NCT00462722|body composition|body composition
5292372|NCT00462722|bone density|bone density
5292373|NCT00462722|cyclooxygenase inhibitor|cyclooxygenase inhibitor
5292374|NCT00462722|bone metabolism|bone metabolism
5292375|NCT00462722|muscle function|muscle function
5292376|NCT00462722|muscle strength|muscle strength
5292377|NCT00462709|Hereditary angioedema|hereditary angioedema
5292378|NCT00462709|C1 esterase inhibitor (human)|c1 esterase inhibitor (human)
5292379|NCT00462696|stage II breast cancer|stage ii breast cancer
5292380|NCT00462696|stage IIIA breast cancer|stage iiia breast cancer
5292381|NCT00462696|stage IIIB breast cancer|stage iiib breast cancer
5292382|NCT00462696|stage IIIC breast cancer|stage iiic breast cancer
5292383|NCT00462683|Stroke|stroke
5292384|NCT00462683|Anoxia|anoxia
5292385|NCT00462683|Brain Injury|brain injury
5292386|NCT00462683|Rehabilitation|rehabilitation
5292387|NCT00462683|Osteoporosis|osteoporosis
5292388|NCT00462683|Osteopenia|osteopenia
5292389|NCT00462670|Cardiac edema|cardiac edema
5292390|NCT00462670|OPC-41061|opc-41061
5292391|NCT00462670|Vasopressin antagonist|vasopressin antagonist
5292392|NCT00462657|infection|infection
5292393|NCT00462657|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5292394|NCT00462657|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5292395|NCT00462657|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5292396|NCT00462657|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5292397|NCT00462657|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5292398|NCT00462657|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5292399|NCT00462657|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5292400|NCT00462657|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5292401|NCT00462657|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
5292402|NCT00462657|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5292403|NCT00462657|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5292404|NCT00462657|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5292405|NCT00462657|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5292406|NCT00462657|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5292407|NCT00462657|graft versus host disease|graft versus host disease
5292408|NCT00462644|adrenal insufficiency|adrenal insufficiency
5292409|NCT00462644|etomidate|etomidate
5292410|NCT00462644|rapid sequence induction|rapid sequence induction
5292411|NCT00462631|coronary artery|coronary artery
5292412|NCT00462631|Diabetes|diabetes
5292413|NCT00462618|Insomnia|insomnia
5292414|NCT00462618|Elderly|elderly
5292415|NCT00462618|Affective disorders|affective disorders
5292416|NCT00462592|exercise-induced bronchoconstriction (EIB)|exercise-induced bronchoconstriction (eib)
5292417|NCT00462592|airway inflammation|airway inflammation
5292418|NCT00462579|carbapenem-resistant acinetobacter baumannii|carbapenem-resistant acinetobacter baumannii
5292419|NCT00462579|positive culture|positive culture
5292420|NCT00462579|positive culture for carbapenem-resistant acinetobacter|positive culture for carbapenem-resistant acinetobacter
5292421|NCT00462566|Motor cortex stimulation|motor cortex stimulation
5292422|NCT00462566|neuropathic|neuropathic
5292423|NCT00462566|pain|pain
5292424|NCT00462566|complex regional pain syndrome|complex regional pain syndrome
5292425|NCT00462566|deafferentation facial pain|deafferentation facial pain
5292426|NCT00462540|COPD|copd
5292427|NCT00462540|Formoterol|formoterol
5292428|NCT00462540|Ipratropium|ipratropium
5292429|NCT00462540|Crossover|crossover
5292430|NCT00462527|Cystatin C|cystatin c
5292431|NCT00462527|Acute renal failure|acute renal failure
5292432|NCT00462527|Gastroenteritis|gastroenteritis
5292433|NCT00462527|Dehydration|dehydration
5292434|NCT00462501|stage II rectal cancer|stage ii rectal cancer
5292435|NCT00462501|stage III rectal cancer|stage iii rectal cancer
5292436|NCT00462501|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5292437|NCT00462475|GH|gh
5292438|NCT00462475|IGF-I|igf-i
5292439|NCT00462475|GH deficiency|gh deficiency
5292440|NCT00462475|Atherosclerosis|atherosclerosis
5292441|NCT00462475|Insulin resistance syndrome|insulin resistance syndrome
5292442|NCT00462449|Botulinum Toxin|botulinum toxin
5292443|NCT00462449|Ness H200|ness h200
5292444|NCT00462449|Functional Electrical Stimulation|functional electrical stimulation
5292445|NCT00462449|Repetitive Task Practice|repetitive task practice
5292446|NCT00462436|functional foods|functional foods
5292447|NCT00462436|soy|soy
5292448|NCT00462436|nuts|nuts
5292449|NCT00462436|LDL cholesterol|ldl cholesterol
5292450|NCT00462436|fibre|fibre
5292451|NCT00462436|secondary prevention|secondary prevention
5292452|NCT00462436|risk reduction|risk reduction
5292453|NCT00462436|endothelial function|endothelial function
5292454|NCT00462436|endothelial progenitor cells|endothelial progenitor cells
5292455|NCT00462436|inflammation|inflammation
5292456|NCT00462436|glycemic control|glycemic control
5292457|NCT00462436|HOMA|homa
5292458|NCT00462423|Metastatic malignant melanoma|metastatic malignant melanoma
5292459|NCT00462423|First-line therapy|first-line therapy
5292460|NCT00462410|recurrent breast cancer|recurrent breast cancer
5292461|NCT00462410|stage I breast cancer|stage i breast cancer
5292462|NCT00462410|stage II breast cancer|stage ii breast cancer
5292463|NCT00462410|stage IIIA breast cancer|stage iiia breast cancer
5292464|NCT00462410|stage IIIB breast cancer|stage iiib breast cancer
5292465|NCT00462410|stage IIIC breast cancer|stage iiic breast cancer
5292466|NCT00462410|stage IV breast cancer|stage iv breast cancer
5292467|NCT00462397|cervical adenocarcinoma|cervical adenocarcinoma
5292468|NCT00462397|cervical adenosquamous cell carcinoma|cervical adenosquamous cell carcinoma
5292469|NCT00462397|cervical squamous cell carcinoma|cervical squamous cell carcinoma
5292470|NCT00462397|stage IB cervical cancer|stage ib cervical cancer
5292471|NCT00462397|stage IIA cervical cancer|stage iia cervical cancer
5292472|NCT00462397|stage IIB cervical cancer|stage iib cervical cancer
5292473|NCT00462397|stage III cervical cancer|stage iii cervical cancer
5292474|NCT00462397|stage IVA cervical cancer|stage iva cervical cancer
5292475|NCT00462397|recurrent cervical cancer|recurrent cervical cancer
5292476|NCT00462371|quality of life|quality of life
5292477|NCT00462371|child diabetes mellitus type 1|child diabetes mellitus type 1
5292478|NCT00462371|Continuous subcutaneous insulin infusion(CSII)|continuous subcutaneous insulin infusion(csii)
5292479|NCT00462371|metabolic control|metabolic control
5292480|NCT00462332|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5292481|NCT00462332|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5292482|NCT00462306|Obstructive Sleep Apnea|obstructive sleep apnea
5292483|NCT00462306|Pregnancy|pregnancy
5292484|NCT00462306|Berlin Questionnaire|berlin questionnaire
5292485|NCT00462267|Nutrition|nutrition
5292486|NCT00462267|Exercise|exercise
5292487|NCT00462267|Body mass index|body mass index
5292488|NCT00462267|Lifestyle change|lifestyle change
5292489|NCT00462267|Obesity|obesity
5292490|NCT00462267|Overweight|overweight
5292491|NCT00462267|Adolescents|adolescents
5292492|NCT00462267|Teens|teens
5292493|NCT00462254|Ramelteon|ramelteon
5292494|NCT00462254|Parkinson's disease|parkinson's disease
5292495|NCT00462254|Sleep disturbances|sleep disturbances
5292496|NCT00462241|Chest pain|chest pain
5292497|NCT00462241|Chest wall|chest wall
5292498|NCT00462241|Atypical chest pain|atypical chest pain
5292499|NCT00462241|Non-cardiac chest pain|non-cardiac chest pain
5292500|NCT00462241|Undiagnosed chest pain|undiagnosed chest pain
5292501|NCT00462241|Physical examination|physical examination
5292502|NCT00462241|Randomized controlled trial|randomized controlled trial
5292503|NCT00462241|Treatment study|treatment study
5292504|NCT00462241|Chiropractor|chiropractor
5292505|NCT00462228|traumatic brain injury|traumatic brain injury
5292506|NCT00462228|memory|memory
5292507|NCT00462228|attention|attention
5292508|NCT00462202|Diabetes|diabetes
5292509|NCT00462202|Microalbuminuria|microalbuminuria
5292510|NCT00462202|Proteinuria|proteinuria
5292511|NCT00462202|Albuminuria|albuminuria
5292512|NCT00462202|KRX-101|krx-101
5292513|NCT00462202|Sulodexide|sulodexide
5292514|NCT00462202|Nephropathy|nephropathy
5292515|NCT00462202|Keryx|keryx
5292516|NCT00462202|Collaborative Study Group|collaborative study group
5292517|NCT00462202|Diabetic nephropathy with persistent microalbuminuria|diabetic nephropathy with persistent microalbuminuria
5292518|NCT00462189|CAT-8015|cat-8015
5292519|NCT00462189|HA22|ha22
5292520|NCT00462189|HCL|hcl
5292521|NCT00462189|Relapse|relapse
5292522|NCT00462189|Refractory|refractory
5292523|NCT00462189|immunotherapy|immunotherapy
5292524|NCT00462189|immunotoxin|immunotoxin
5292525|NCT00462176|colorectal endometriosis|colorectal endometriosis
5292526|NCT00462176|deep infiltrating endometriosis|deep infiltrating endometriosis
5292527|NCT00462176|dysmenorroe|dysmenorroe
5292528|NCT00462176|dyspareunia|dyspareunia
5292529|NCT00462176|quality of life|quality of life
5292530|NCT00462150|arthritis, rheumatoid|arthritis, rheumatoid
5292531|NCT00462150|expressed emotion|expressed emotion
5292532|NCT00462150|randomized controlled trial|randomized controlled trial
5292533|NCT00462150|affect|affect
5292534|NCT00462150|blood sedimentation|blood sedimentation
5292535|NCT00462150|psychophysiology|psychophysiology
5292536|NCT00462150|feasibility studies|feasibility studies
5292537|NCT00462150|intervention studies|intervention studies
5292538|NCT00462150|time management|time management
5292539|NCT00462137|GERD|gerd
5292540|NCT00462137|Gastroesphageal Reflux Disease (GERD)|gastroesphageal reflux disease (gerd)
5292541|NCT00462124|Prostate|prostate
5292542|NCT00462124|cancer|cancer
5292543|NCT00462124|radiation|radiation
5292544|NCT00462124|biodegradable implantable balloon|biodegradable implantable balloon
5292545|NCT00462124|intrarectal balloon|intrarectal balloon
5292546|NCT00462111|indometacin|indometacin
5292547|NCT00462111|reaction time|reaction time
5292548|NCT00462111|postural balance|postural balance
5292549|NCT00462111|obstacle avoidance|obstacle avoidance
5292550|NCT00462111|accidental falls|accidental falls
5292551|NCT00462098|Osteonecrosis of the jaw|osteonecrosis of the jaw
5292552|NCT00462098|hyperbaric oxygen|hyperbaric oxygen
5292553|NCT00462098|bisphosphonates|bisphosphonates
5292554|NCT00462085|cerebral palsy|cerebral palsy
5292555|NCT00462085|ankle foot orthosis|ankle foot orthosis
5292557|NCT00462085|surface electromyography|surface electromyography
5292558|NCT00462085|gait analysis|gait analysis
5292559|NCT00462059|Transition of care|transition of care
5292560|NCT00462059|Continuity of care|continuity of care
5292561|NCT00462046|Berberine|berberine
5292562|NCT00462046|Type 2 diabetes|type 2 diabetes
5292563|NCT00462046|Dyslipidemia|dyslipidemia
5292564|NCT00462020|appendicitis, perforation, abscess, treatment|appendicitis, perforation, abscess, treatment
5292565|NCT00461994|OBESITY|obesity
5292566|NCT00461994|CHILDREN|children
5292567|NCT00461994|METABOLIC PARAMETERS|metabolic parameters
5292568|NCT00461994|DIET|diet
5292569|NCT00461994|EXERCISE|exercise
5292570|NCT00461981|Live, attenuated influenza virus vaccine (LAIV)|live, attenuated influenza virus vaccine (laiv)
5292571|NCT00461981|Trivalent inactivated influenza virus vaccine (TIV)|trivalent inactivated influenza virus vaccine (tiv)
5292572|NCT00461981|FluMist|flumist
5292573|NCT00461968|Cholesterol|cholesterol
5292574|NCT00461968|LDL|ldl
5292575|NCT00461968|Ezetimibe|ezetimibe
5292576|NCT00461968|Statin|statin
5292577|NCT00461968|Zetia|zetia
5292578|NCT00461968|Zocor|zocor
5292579|NCT00461968|Simvastin|simvastin
5292580|NCT00461955|Symptomatic Multiple Myeloma|symptomatic multiple myeloma
5292581|NCT00461955|first line treatment|first line treatment
5292582|NCT00461955|first autologous Stem Cell Transplantation|first autologous stem cell transplantation
5292583|NCT00461955|ex vivo amplified autologous peripheral blood stem cells|ex vivo amplified autologous peripheral blood stem cells
5292584|NCT00461942|Health Food;|health food;
5292585|NCT00461942|Green Tea;|green tea;
5292586|NCT00461942|Neuroprotection|neuroprotection
5292587|NCT00461929|chronic myeloid leukemia|chronic myeloid leukemia
5292588|NCT00461929|gastrointestinal stromal cell tumors|gastrointestinal stromal cell tumors
5292589|NCT00461929|chromosome abnormality|chromosome abnormality
5292590|NCT00461929|imatinib|imatinib
5292591|NCT00461929|bone marrow aspiration|bone marrow aspiration
5292592|NCT00461916|half-dose depot triptorelin|half-dose depot triptorelin
5292593|NCT00461916|reduced-dose daily buserelin|reduced-dose daily buserelin
5292594|NCT00461916|controlled ovarian stimulation|controlled ovarian stimulation
5292595|NCT00461916|long protocol|long protocol
5292596|NCT00461916|ICSI|icsi
5292597|NCT00461903|essential hypertension|essential hypertension
5292598|NCT00461903|symptomatic paroxysmal or persistent atrial fibrillation|symptomatic paroxysmal or persistent atrial fibrillation
5292599|NCT00461890|Alcohol|alcohol
5292600|NCT00461890|Veterans|veterans
5292601|NCT00461890|Primary Care|primary care
5292602|NCT00461890|Naltrexone|naltrexone
5292603|NCT00461864|fracture|fracture
5292604|NCT00461864|occult|occult
5292605|NCT00461864|hip|hip
5292606|NCT00461851|Advanced/Metastatic Bladder Carcinoma|advanced/metastatic bladder carcinoma
5292607|NCT00461838|colorectal endometriosis|colorectal endometriosis
5292608|NCT00461838|deep infiltrating endometriosis|deep infiltrating endometriosis
5292609|NCT00461838|dysmenorroe|dysmenorroe
5292610|NCT00461838|dyspareunia|dyspareunia
5292611|NCT00461838|quality of life|quality of life
5292612|NCT00461825|Immunosuppression|immunosuppression
5292613|NCT00461825|Kidney transplantation|kidney transplantation
5292614|NCT00461825|multicenter study|multicenter study
5292615|NCT00461799|Crigler-Najjar disease.|crigler-najjar disease.
5292616|NCT00461799|Bilirubin.|bilirubin.
5292617|NCT00461799|Phototherapy.|phototherapy.
5292618|NCT00461799|Orlistat.|orlistat.
5292619|NCT00461799|Unconjugated hyperbilirubinemia.|unconjugated hyperbilirubinemia.
5292620|NCT00461773|Neoadjuvant treatment|neoadjuvant treatment
5292621|NCT00461760|HPV Screening/Testing for cervical cancer screening|hpv screening/testing for cervical cancer screening
5292622|NCT00461747|Untreated|untreated
5292623|NCT00461747|Transplant|transplant
5292624|NCT00461747|Younger|younger
5292625|NCT00461734|Right Ventricular High Septal Pacing|right ventricular high septal pacing
5292626|NCT00461734|Right Ventricular Apical Pacing|right ventricular apical pacing
5292627|NCT00461734|Left Ventricular Dysfunction|left ventricular dysfunction
5292628|NCT00461734|Heart Block|heart block
5292629|NCT00461734|Pacemaker|pacemaker
5292630|NCT00461734|Atrial Fibrillation|atrial fibrillation
5292631|NCT00461734|Ejection Fraction|ejection fraction
5292632|NCT00461695|Cytomegalovirus (CMV)|cytomegalovirus (cmv)
5292633|NCT00461695|Tick-borne encephalitis virus (TBEV)|tick-borne encephalitis virus (tbev)
5292634|NCT00461695|Ageing|ageing
5292635|NCT00461695|Vaccine|vaccine
5292636|NCT00461695|Immunity|immunity
5292637|NCT00461682|TRPV1 antagonist|trpv1 antagonist
5292638|NCT00461682|Fecal Urgency|fecal urgency
5292639|NCT00461682|rectal pain|rectal pain
5292640|NCT00461682|IBS|ibs
5292641|NCT00461669|hip|hip
5292642|NCT00461669|fracture|fracture
5292643|NCT00461669|ultrasound|ultrasound
5292644|NCT00461656|Antiseptic|antiseptic
5292645|NCT00461656|Povidone-Iodine|povidone-iodine
5292646|NCT00461643|Anovulation|anovulation
5292647|NCT00461643|Clomiphene citrate|clomiphene citrate
5292648|NCT00461643|Infertility|infertility
5292649|NCT00461643|Metformin|metformin
5292650|NCT00461643|PCOS|pcos
5292651|NCT00461643|RCT|rct
5292652|NCT00461643|Treatment|treatment
5292653|NCT00461630|coronary heart disease|coronary heart disease
5292654|NCT00461630|cardiovascular disease|cardiovascular disease
5292655|NCT00461630|stroke|stroke
5292656|NCT00461630|peripheral arterial disease|peripheral arterial disease
5292657|NCT00461630|diabetes mellitus|diabetes mellitus
5292658|NCT00461630|cholesterol|cholesterol
5292659|NCT00461630|HDL cholesterol|hdl cholesterol
5292660|NCT00461630|simvastatin|simvastatin
5292661|NCT00461630|ezetimibe|ezetimibe
5292662|NCT00461630|ER niacin|er niacin
5292663|NCT00461630|laropiprant|laropiprant
5292664|NCT00461617|diabetes|diabetes
5292665|NCT00461617|rapid and short acting insulin secretagogue|rapid and short acting insulin secretagogue
5292666|NCT00461617|α-glucosidase inhibitor|α-glucosidase inhibitor
5292667|NCT00461617|HbA1C|hba1c
5292668|NCT00461617|insulin|insulin
5292669|NCT00461604|gastroesophageal reflux disease|gastroesophageal reflux disease
5292670|NCT00461604|baclofen|baclofen
5292671|NCT00461604|impedance|impedance
5292672|NCT00461591|Noninvasive Bladder Cancer|noninvasive bladder cancer
5292673|NCT00461578|P.falciparum|p.falciparum
5292674|NCT00461578|malaria|malaria
5292675|NCT00461578|lapdap+artesunate|lapdap+artesunate
5292676|NCT00461578|safety|safety
5292677|NCT00461578|efficay|efficay
5292678|NCT00461565|Retina|retina
5292679|NCT00461565|PDE-5|pde-5
5292680|NCT00461565|Levitra|levitra
5292681|NCT00461565|Viagra|viagra
5292682|NCT00461565|Normal healthy volunteers for evaluation of retinal function|normal healthy volunteers for evaluation of retinal function
5292683|NCT00461552|Lipodystrophy|lipodystrophy
5292684|NCT00461552|HIV|hiv
5292685|NCT00461552|HAART|haart
5292686|NCT00461552|HIV Lipodystrophy Syndrome|hiv lipodystrophy syndrome
5292687|NCT00461552|Lipodystrophy syndrome|lipodystrophy syndrome
5292688|NCT00461552|HIV-Associated Lipodystrophy|hiv-associated lipodystrophy
5292689|NCT00461552|HIV-Associated Lipodystrophy Syndrome|hiv-associated lipodystrophy syndrome
5292690|NCT00461552|Treatment Experienced|treatment experienced
5292691|NCT00461539|Tobacco Use|tobacco use
5292692|NCT00461539|Alcohol and Drug Use|alcohol and drug use
5292693|NCT00461539|Obesity|obesity
5292694|NCT00461539|Risky Sexual Behavior|risky sexual behavior
5292695|NCT00461526|IBS|ibs
5292696|NCT00461526|d-IBS|d-ibs
5292697|NCT00461526|Irritable Bowel Syndrome|irritable bowel syndrome
5292698|NCT00461513|Heart Failure, Congestive|heart failure, congestive
5292699|NCT00461513|Disease Management|disease management
5292700|NCT00461513|Health Status|health status
5292701|NCT00461513|Quality of Life|quality of life
5292702|NCT00461513|Telemedicine|telemedicine
5292703|NCT00461513|Depression|depression
5292704|NCT00461500|persistent|persistent
5292705|NCT00461500|moderate|moderate
5292706|NCT00461500|asthma|asthma
5292707|NCT00461500|adults|adults
5292708|NCT00461500|Initial|initial
5292709|NCT00461500|Maintenance|maintenance
5292710|NCT00461500|Therapy|therapy
5292711|NCT00461487|Adolescent Behavior|adolescent behavior
5292712|NCT00461487|Communication|communication
5292713|NCT00461487|Health Behavior|health behavior
5292714|NCT00461487|Risk-Taking|risk-taking
5292715|NCT00461487|Sexual Behavior|sexual behavior
5292716|NCT00461474|Shoulder pain|shoulder pain
5292717|NCT00461474|Chronic Spinal Cord Injury|chronic spinal cord injury
5292718|NCT00461474|Exercise|exercise
5292719|NCT00461474|Physical therapy techniques|physical therapy techniques
5292720|NCT00461474|Motor performance|motor performance
5292721|NCT00461448|Potassium supplement|potassium supplement
5292722|NCT00461448|Rheumatoid Arthritis|rheumatoid arthritis
5292723|NCT00461448|Pain|pain
5292724|NCT00461448|Disease Activity|disease activity
5292725|NCT00461422|IVF|ivf
5292726|NCT00461422|GnRH antagonist|gnrh antagonist
5292727|NCT00461409|Neonatal Seizures|neonatal seizures
5292728|NCT00461409|Treatment|treatment
5292729|NCT00461409|Anticonvulsant|anticonvulsant
5292730|NCT00461409|Levetiracetam|levetiracetam
5292731|NCT00461396|Relapsing-Remitting Multiple Sclerosis|relapsing-remitting multiple sclerosis
5292732|NCT00461396|First demyelinating event|first demyelinating event
5292733|NCT00461396|MRI features consistent with MS|mri features consistent with ms
5292734|NCT00461370|safety|safety
5292735|NCT00461370|Phase 1|phase 1
5292736|NCT00461370|pharmacokinetics|pharmacokinetics
5292737|NCT00461370|SRX251|srx251
5292738|NCT00461370|Azevan|azevan
5292739|NCT00461370|safety in healthy volunteers|safety in healthy volunteers
5292740|NCT00461357|Old for Old|old for old
5292741|NCT00461357|Eurotransplant Senior Program|eurotransplant senior program
5292742|NCT00461357|Glomerular Filtration Rate|glomerular filtration rate
5292743|NCT00461344|Breast|breast
5292744|NCT00461331|Type 1 diabetes mellitus|type 1 diabetes mellitus
5292745|NCT00461331|Glycemic control|glycemic control
5292746|NCT00461331|Continuous subcutaneous insulin infusion|continuous subcutaneous insulin infusion
5292747|NCT00461331|Continuous glucose monitoring system|continuous glucose monitoring system
5292748|NCT00461318|vocational rehabilitation|vocational rehabilitation
5292749|NCT00461318|psychosis|psychosis
5292750|NCT00461318|cross country comparison|cross country comparison
5292751|NCT00461305|Dysmenorrhea|dysmenorrhea
5292752|NCT00461305|Intracyclic bleeding|intracyclic bleeding
5292753|NCT00461305|Drospirenone (DRSP)|drospirenone (drsp)
5292754|NCT00461305|Ethinylestradiol|ethinylestradiol
5292755|NCT00461279|attachment|attachment
5292756|NCT00461279|depression|depression
5292757|NCT00461279|IPT|ipt
5292758|NCT00461279|CBT|cbt
5292759|NCT00461279|pharmacotherapy|pharmacotherapy
5292760|NCT00461266|Treatment Experienced|treatment experienced
5292761|NCT00461253|breast cancer|breast cancer
5292762|NCT00461240|heart|heart
5292763|NCT00461240|MRS|mrs
5292764|NCT00461240|acromegaly|acromegaly
5292765|NCT00461240|growth hormone|growth hormone
5292766|NCT00461227|Puerto Rican|puerto rican
5292767|NCT00461227|Allergies|allergies
5292768|NCT00461214|laparoscopy|laparoscopy
5292769|NCT00461214|surgery|surgery
5292770|NCT00461214|technical skills|technical skills
5292771|NCT00461214|outcomes|outcomes
5292772|NCT00461214|resident training|resident training
5292773|NCT00461201|Health Services Research|health services research
5292774|NCT00461201|Nurse Practitioners|nurse practitioners
5292775|NCT00461201|Outcome and Process Assessment (Health Care)|outcome and process assessment (health care)
5292776|NCT00461201|Patient Acceptance of Health Care|patient acceptance of health care
5292777|NCT00461201|Patient Satisfaction|patient satisfaction
5292778|NCT00461201|Primary Health Care|primary health care
5292779|NCT00461201|Professional Autonomy|professional autonomy
5292780|NCT00461188|acromegaly|acromegaly
5292781|NCT00461188|gigantism|gigantism
5292782|NCT00461188|familial pituitary adenoma|familial pituitary adenoma
5292783|NCT00461188|Familial acromegaly|familial acromegaly
5292784|NCT00461188|Familial Isolated Pituitary Adenoma|familial isolated pituitary adenoma
5292785|NCT00461188|FIPA|fipa
5292786|NCT00461188|Pituitary adenoma predisposition|pituitary adenoma predisposition
5292787|NCT00461188|PAP|pap
5292788|NCT00461175|Uterine Perforation|uterine perforation
5292789|NCT00461149|Acromegaly|acromegaly
5292790|NCT00461149|GH|gh
5292791|NCT00461149|IGF-I|igf-i
5292792|NCT00461149|Pituitary tumors|pituitary tumors
5292793|NCT00461149|Octreotide|octreotide
5292794|NCT00461136|Time course|time course
5292795|NCT00461136|antiproteinuric|antiproteinuric
5292796|NCT00461136|blood pressure|blood pressure
5292797|NCT00461136|lowering effect|lowering effect
5292798|NCT00461136|initiation of renin inhibition|initiation of renin inhibition
5292799|NCT00461136|Aliskiren in Type 2 diabetes|aliskiren in type 2 diabetes
5292800|NCT00461136|incipient and/or established nephropathy|incipient and/or established nephropathy
5292801|NCT00461097|Egg Allergy|egg allergy
5292802|NCT00461097|Egg Oral Immunotherapy (OIT)|egg oral immunotherapy (oit)
5292803|NCT00461097|Food Allergy|food allergy
5292804|NCT00461084|Lymphoma|lymphoma
5292805|NCT00461084|Advanced Stage|advanced stage
5292806|NCT00461084|Untreated|untreated
5292807|NCT00461084|Advanced Stage Lymphoma|advanced stage lymphoma
5292808|NCT00461084|Untreated Lymphoma|untreated lymphoma
5292809|NCT00461084|07-038|07-038
5292810|NCT00461071|Bulimia nervosa|bulimia nervosa
5292811|NCT00461071|Guided Self-help|guided self-help
5292812|NCT00461071|Psycho-education|psycho-education
5292813|NCT00461045|multiple myeloma|multiple myeloma
5292814|NCT00461045|proteasome inhibitor|proteasome inhibitor
5292815|NCT00461045|relapsed|relapsed
5292816|NCT00461045|refractory|refractory
5292817|NCT00460993|Aging|aging
5292818|NCT00460993|Sleep|sleep
5292819|NCT00460993|Nursing Home|nursing home
5292820|NCT00460993|Sleep in nursing homes|sleep in nursing homes
5292821|NCT00460980|resident training|resident training
5292822|NCT00460980|laparoscopic skills|laparoscopic skills
5292823|NCT00460980|surgical skills assessment|surgical skills assessment
5292824|NCT00460967|non-Exudative (Dry) Age-Related Macular Degeneration|non-exudative (dry) age-related macular degeneration
5292825|NCT00460928|congenital heart block|congenital heart block
5292826|NCT00460928|neonatal lupus|neonatal lupus
5292827|NCT00460928|systemic lupus erythematosus|systemic lupus erythematosus
5292828|NCT00460928|Sjogren syndrome|sjogren syndrome
5292829|NCT00460928|autoantibodies|autoantibodies
5292830|NCT00460928|SSA/Ro|ssa/ro
5292831|NCT00460928|SSB/La|ssb/la
5292832|NCT00460928|autoimmunity|autoimmunity
5292833|NCT00460928|pregnancy|pregnancy
5292834|NCT00460928|intravenous immune globulin|intravenous immune globulin
5292835|NCT00460928|IVIG|ivig
5292836|NCT00460928|immunoglobulin|immunoglobulin
5292837|NCT00460915|Lacidipine|lacidipine
5292838|NCT00460915|Amlodipine|amlodipine
5292839|NCT00460902|TMS|tms
5293602|NCT00458159|RCMD-RS|rcmd-rs
5292840|NCT00460902|drug resistant depression|drug resistant depression
5292841|NCT00460889|hand assist|hand assist
5292842|NCT00460889|laparoscopy|laparoscopy
5292843|NCT00460889|renal donor|renal donor
5292844|NCT00460889|outcomes|outcomes
5292845|NCT00460876|topotecan|topotecan
5292846|NCT00460876|periocular|periocular
5292847|NCT00460876|chemotherapy|chemotherapy
5292848|NCT00460863|sleep|sleep
5292849|NCT00460863|hemodialysis|hemodialysis
5292850|NCT00460863|daytime sleepiness|daytime sleepiness
5292851|NCT00460863|temperature|temperature
5292852|NCT00460837|colorectal cancer|colorectal cancer
5292853|NCT00460837|bowel preparation regimen|bowel preparation regimen
5292854|NCT00460837|patients with symptoms attributable to colorectal cancer|patients with symptoms attributable to colorectal cancer
5292855|NCT00460824|transplant|transplant
5292856|NCT00460824|HLA antibodies matching|hla antibodies matching
5292857|NCT00460824|immunologic mismatching|immunologic mismatching
5292858|NCT00460811|Irritable Bowel Syndrome with Constipation|irritable bowel syndrome with constipation
5292859|NCT00460811|IBS|ibs
5292860|NCT00460811|Irritable Bowel Syndrome|irritable bowel syndrome
5292861|NCT00460811|linaclotide acetate|linaclotide acetate
5292862|NCT00460811|linaclotide|linaclotide
5292863|NCT00460811|MD-1100|md-1100
5292864|NCT00460798|Sunitinib|sunitinib
5292865|NCT00460798|kidney diseases|kidney diseases
5292866|NCT00460798|urogenital neoplasms|urogenital neoplasms
5292867|NCT00460798|kidney cancer|kidney cancer
5292868|NCT00460759|Mycobacterium tuberculosis, rifapentine, moxifloxacin|mycobacterium tuberculosis, rifapentine, moxifloxacin
5292869|NCT00460746|HIV|hiv
5292870|NCT00460746|AIDS|aids
5292871|NCT00460746|Immunodeficiency Virus, Human|immunodeficiency virus, human
5292872|NCT00460746|PREZISTA|prezista
5292873|NCT00460746|darunavir|darunavir
5292874|NCT00460746|TMC114|tmc114
5292875|NCT00460746|TMC125|tmc125
5292876|NCT00460746|Protease Inhibitor|protease inhibitor
5292877|NCT00460746|Non-Nucleoside Reverse Transcriptase Inhibitor|non-nucleoside reverse transcriptase inhibitor
5292878|NCT00460746|enfuvirtide|enfuvirtide
5292879|NCT00460746|Treatment Experienced|treatment experienced
5292880|NCT00460720|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
5292881|NCT00460720|ADHD|adhd
5292882|NCT00460720|Methylphenidate|methylphenidate
5292883|NCT00460720|MPH|mph
5292884|NCT00460720|Extended-Release Methylphenidate|extended-release methylphenidate
5292885|NCT00460707|GW679769|gw679769
5292886|NCT00460707|healthy adult subjects|healthy adult subjects
5292887|NCT00460707|casopitant|casopitant
5292888|NCT00460707|ketoconazole|ketoconazole
5292889|NCT00460694|allogeneic transplant|allogeneic transplant
5292890|NCT00460694|haematological malignancies|haematological malignancies
5292891|NCT00460694|allogeneic CIK cells|allogeneic cik cells
5292892|NCT00460681|Hepatocellular Carcinoma|hepatocellular carcinoma
5292893|NCT00460681|Thymopentin|thymopentin
5292894|NCT00460681|Recurrence|recurrence
5292895|NCT00460681|Resection|resection
5292896|NCT00460668|elective thoracotomy|elective thoracotomy
5292897|NCT00460668|pulmonary rehabilitation|pulmonary rehabilitation
5292898|NCT00460668|quality of life|quality of life
5292899|NCT00460655|Post-Stroke|post-stroke
5292900|NCT00460655|Lower Limb|lower limb
5292901|NCT00460655|botulinum toxin type A|botulinum toxin type a
5292902|NCT00460655|Spasticity|spasticity
5292903|NCT00460642|Frozen embryo transfers (FET).|frozen embryo transfers (fet).
5292904|NCT00460642|Egg donation (ED).|egg donation (ed).
5292905|NCT00460642|IVF.|ivf.
5292906|NCT00460642|ART.|art.
5292907|NCT00460642|Implantation.|implantation.
5292908|NCT00460642|GnRH antagonist.|gnrh antagonist.
5292909|NCT00460642|Cetrotide.|cetrotide.
5292910|NCT00460642|Endometrial response.|endometrial response.
5292911|NCT00460642|Infertility treatments:|infertility treatments:
5292912|NCT00460642|Transfer of embryos from egg donation (ED) to recipients.|transfer of embryos from egg donation (ed) to recipients.
5292913|NCT00460629|Adoptive immunotherapy|adoptive immunotherapy
5292914|NCT00460629|BCR-ABL reactive T cells|bcr-abl reactive t cells
5293167|NCT00459719|Prednisolone|prednisolone
5292915|NCT00460629|Allogeneic Transplantation|allogeneic transplantation
5292916|NCT00460616|Prolactin|prolactin
5292917|NCT00460616|Prolactinomas|prolactinomas
5292918|NCT00460616|Dopamine-Agonists|dopamine-agonists
5292919|NCT00460616|Cabergoline|cabergoline
5292920|NCT00460616|Cardiac valve disease|cardiac valve disease
5292921|NCT00460603|GI neoplasms (phase 1)|gi neoplasms (phase 1)
5292922|NCT00460590|Tuberculosis|tuberculosis
5292923|NCT00460590|TB|tb
5292924|NCT00460590|MVA 85A|mva 85a
5292925|NCT00460577|Asthma, Formoterol, Bronchial Obstruction, Children|asthma, formoterol, bronchial obstruction, children
5292926|NCT00460564|Spasticity|spasticity
5292927|NCT00460564|Post-Stroke|post-stroke
5292928|NCT00460564|botulinum toxin type A|botulinum toxin type a
5292929|NCT00460564|Upper Limb|upper limb
5292930|NCT00460538|Seasonal allergic rhinitis|seasonal allergic rhinitis
5292931|NCT00460538|lectranal|lectranal
5292932|NCT00460538|allergy|allergy
5292933|NCT00460525|malaria, Mali, children, Plasmodium falciparum, vaccine|malaria, mali, children, plasmodium falciparum, vaccine
5292934|NCT00460512|Schizophrenia|schizophrenia
5292935|NCT00460512|Flexible dosing|flexible dosing
5293603|NCT00458159|RARS|rars
5292936|NCT00460512|Non-acute patients|non-acute patients
5292937|NCT00460512|Antipsychotic|antipsychotic
5292938|NCT00460512|Atypical|atypical
5292939|NCT00460512|INVEGA|invega
5292940|NCT00460499|Diabetes|diabetes
5292941|NCT00460473|Mental Health|mental health
5292942|NCT00460473|Neurological Disease|neurological disease
5292943|NCT00460473|Hip Injuries and Disorders|hip injuries and disorders
5292944|NCT00460460|Phase I|phase i
5292945|NCT00460460|cancer|cancer
5292946|NCT00460460|lymphoma|lymphoma
5292947|NCT00460460|leukemia|leukemia
5292948|NCT00460460|myeloma|myeloma
5292949|NCT00460460|AML|aml
5292950|NCT00460460|ALL|all
5292951|NCT00460460|NHL|nhl
5292952|NCT00460460|MM|mm
5292953|NCT00460447|anti-CD33|anti-cd33
5292954|NCT00460447|Immunotoxin|immunotoxin
5292955|NCT00460447|Acute myeloid leukemia|acute myeloid leukemia
5292956|NCT00460434|Prolapse|prolapse
5292957|NCT00460434|Urinary incontinence|urinary incontinence
5292958|NCT00460434|TVT|tvt
5292959|NCT00460421|Oral Mucositis|oral mucositis
5292960|NCT00460421|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
5292961|NCT00460421|Acute Myeloid Leukemia|acute myeloid leukemia
5292962|NCT00460421|Palifermin|palifermin
5292963|NCT00460421|Kepivance|kepivance
5292964|NCT00460408|Macular degeneration|macular degeneration
5292965|NCT00460408|Safety|safety
5292966|NCT00460408|Non-interventional|non-interventional
5292967|NCT00460408|Non-randomized|non-randomized
5292968|NCT00460395|Brain Metastasis|brain metastasis
5292969|NCT00460395|Cerebral Metastases|cerebral metastases
5292970|NCT00460395|Brain Cancer|brain cancer
5292971|NCT00460395|Stereotactic Radiosurgery|stereotactic radiosurgery
5292972|NCT00460395|Craniotomy|craniotomy
5292973|NCT00460382|HIV infections|hiv infections
5292974|NCT00460382|HIV integrase inhibitor|hiv integrase inhibitor
5292975|NCT00460382|etravirine|etravirine
5292976|NCT00460382|darunavir|darunavir
5292977|NCT00460382|MK 0518|mk 0518
5292978|NCT00460382|raltegravir|raltegravir
5292979|NCT00460382|Treatment Experienced|treatment experienced
5292980|NCT00460382|Antiviral drug resistance|antiviral drug resistance
5292981|NCT00460369|uncomplicated malaria|uncomplicated malaria
5292982|NCT00460369|children|children
5292983|NCT00460369|treatment|treatment
5292984|NCT00460369|effectiveness|effectiveness
5292985|NCT00460343|patient non-adherence|patient non-adherence
5292986|NCT00460343|antihypertensive agents|antihypertensive agents
5292987|NCT00460343|community pharmacy services|community pharmacy services
5292988|NCT00460343|professional roles|professional roles
5292989|NCT00460330|diagnosis|diagnosis
5292990|NCT00460330|galactomannan|galactomannan
5292991|NCT00460330|glucan|glucan
5292992|NCT00460330|real-time PCR|real-time pcr
5292993|NCT00460330|invasive fungal infection|invasive fungal infection
5292994|NCT00460330|aspergillosis|aspergillosis
5292995|NCT00460330|Chinese patients|chinese patients
5292996|NCT00460317|lung|lung
5292997|NCT00460317|cancer|cancer
5292998|NCT00460317|chemotherapy|chemotherapy
5292999|NCT00460317|paclitaxel|paclitaxel
5293000|NCT00460317|carboplatin|carboplatin
5293001|NCT00460317|placebo|placebo
5293002|NCT00460317|angiogenesis|angiogenesis
5293003|NCT00460317|VEGF|vegf
5293004|NCT00460317|multi kinase inhibitor|multi kinase inhibitor
5293005|NCT00460304|Type I diabetes|type i diabetes
5293006|NCT00460304|Insulin pump|insulin pump
5293007|NCT00460304|Continuous glucose monitoring|continuous glucose monitoring
5293008|NCT00460304|Insulin to carbohydrate ratio|insulin to carbohydrate ratio
5293009|NCT00460304|Correction factor|correction factor
5293010|NCT00460304|Pramlintide|pramlintide
5293011|NCT00460291|PAD|pad
5293012|NCT00460291|vein bypass|vein bypass
5293013|NCT00460291|supported varicose veins|supported varicose veins
5293014|NCT00460278|Cancer|cancer
5293015|NCT00460278|Solid Tumors|solid tumors
5293016|NCT00460265|Squamous Cell Carcinoma|squamous cell carcinoma
5293017|NCT00460265|Epidermal Growth Factor|epidermal growth factor
5293018|NCT00460265|Epidermal Growth Factor Receptor|epidermal growth factor receptor
5293019|NCT00460265|SCCHN|scchn
5293020|NCT00460265|Metastatic Head and Neck Cancer|metastatic head and neck cancer
5293021|NCT00460265|EGFr|egfr
5293022|NCT00460265|Head and Neck Cancer|head and neck cancer
5293023|NCT00460265|Recurrent Head and Neck Cancer|recurrent head and neck cancer
5293024|NCT00460252|algorithm|algorithm
5293025|NCT00460252|insulin|insulin
5293026|NCT00460252|hyperglycemia|hyperglycemia
5293027|NCT00460252|tight glycemic control|tight glycemic control
5293028|NCT00460252|intensive care|intensive care
5293029|NCT00460252|adults|adults
5293030|NCT00460239|Opioid addiction|opioid addiction
5293031|NCT00460239|Opioid dependence|opioid dependence
5293032|NCT00460239|Buprenorphine|buprenorphine
5293033|NCT00460226|Korean|korean
5293034|NCT00460226|Bipolar I disorder|bipolar i disorder
5293035|NCT00460226|Non-serious rash|non-serious rash
5293036|NCT00460226|Lamotrigine|lamotrigine
5293037|NCT00460213|home blood pressure|home blood pressure
5293038|NCT00460200|depression|depression
5293039|NCT00460200|fatigue|fatigue
5293040|NCT00460200|sleep disorders|sleep disorders
5293137|NCT00459810|recurrent prostate cancer|recurrent prostate cancer
5293041|NCT00460200|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
5293042|NCT00460200|ovarian epithelial cancer|ovarian epithelial cancer
5293168|NCT00459706|Rheumatoid Arthritis|rheumatoid arthritis
5293043|NCT00460187|carotid artery, distal protection device, carotid stenting|carotid artery, distal protection device, carotid stenting
5293044|NCT00460174|stage I pancreatic cancer|stage i pancreatic cancer
5293045|NCT00460174|stage II pancreatic cancer|stage ii pancreatic cancer
5293046|NCT00460174|stage III pancreatic cancer|stage iii pancreatic cancer
5293047|NCT00460161|acupuncture|acupuncture
5293048|NCT00460161|amputation|amputation
5293049|NCT00460161|phantom limb pain|phantom limb pain
5293050|NCT00460148|ropinirole PR/CR,|ropinirole pr/cr,
5293051|NCT00460148|pharmacokinetic,|pharmacokinetic,
5293052|NCT00460148|formulation,|formulation,
5293053|NCT00460148|food effect,|food effect,
5293054|NCT00460148|SK&F101468,|sk&f101468,
5293055|NCT00460148|PD|pd
5293056|NCT00460135|Resistance|resistance
5293057|NCT00460135|Training|training
5293058|NCT00460135|Obesity|obesity
5293059|NCT00460135|Children|children
5293060|NCT00460122|Human Leukocyte Antigens (HLA)|human leukocyte antigens (hla)
5293061|NCT00460122|Transfusion Reactions|transfusion reactions
5293062|NCT00460122|Platelet Donors|platelet donors
5293063|NCT00460109|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5293064|NCT00460109|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5293065|NCT00460109|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5293066|NCT00460109|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5293067|NCT00460096|Pulmonary Emphysema|pulmonary emphysema
5293068|NCT00460083|Atopic Dermatitis|atopic dermatitis
5293069|NCT00460083|eczema|eczema
5293070|NCT00460083|dermatitis|dermatitis
5293071|NCT00460083|skin barrier|skin barrier
5293072|NCT00460083|barrier repair|barrier repair
5293073|NCT00460083|ceramide|ceramide
5293074|NCT00460083|physiologic lipid|physiologic lipid
5293075|NCT00460083|pruritus|pruritus
5293076|NCT00460083|Elidel|elidel
5293077|NCT00460083|Epiceram|epiceram
5293078|NCT00460083|topical steroid|topical steroid
5293079|NCT00460057|osteoporosis|osteoporosis
5293080|NCT00460057|alendronate|alendronate
5293081|NCT00460057|bone marker|bone marker
5293082|NCT00460044|ADMA|adma
5293083|NCT00460044|Preterms|preterms
5293084|NCT00460044|infants|infants
5293085|NCT00460044|mechanical ventilation|mechanical ventilation
5293086|NCT00460044|Preterm infants|preterm infants
5293087|NCT00460031|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5293088|NCT00460031|stage III prostate cancer|stage iii prostate cancer
5293089|NCT00460031|stage IV prostate cancer|stage iv prostate cancer
5293090|NCT00460031|recurrent prostate cancer|recurrent prostate cancer
5293091|NCT00460018|Gestational Diabetes Mellitus|gestational diabetes mellitus
5293092|NCT00460018|Weight Loss|weight loss
5293093|NCT00460018|Physical Activity|physical activity
5293094|NCT00460018|Breastfeeding|breastfeeding
5293095|NCT00460018|Pregnancy|pregnancy
5293096|NCT00460018|Postpartum|postpartum
5293097|NCT00460018|Intervention|intervention
5293098|NCT00460018|Prevention|prevention
5293099|NCT00460005|Migraine|migraine
5293100|NCT00460005|headache|headache
5293101|NCT00460005|observational|observational
5293102|NCT00459992|Obesity|obesity
5293103|NCT00459992|Weight Gain|weight gain
5293104|NCT00459992|Adult|adult
5293105|NCT00459992|Histamine|histamine
5293106|NCT00459992|Metabolism|metabolism
5293107|NCT00459992|Overweight|overweight
5293108|NCT00459979|clear cell renal cell carcinoma|clear cell renal cell carcinoma
5293109|NCT00459979|stage III renal cell cancer|stage iii renal cell cancer
5293110|NCT00459979|stage IV renal cell cancer|stage iv renal cell cancer
5293111|NCT00459979|papillary renal cell carcinoma|papillary renal cell carcinoma
5293112|NCT00459940|Growth hormone|growth hormone
5293113|NCT00459940|Lipolysis|lipolysis
5293114|NCT00459940|Insulin resistance|insulin resistance
5293115|NCT00459940|Pioglitazone|pioglitazone
5293116|NCT00459940|Growth hormone replaced growth hormone deficient adults|growth hormone replaced growth hormone deficient adults
5293117|NCT00459927|Adenotonsillectomy|adenotonsillectomy
5293118|NCT00459927|Coblation tonsillectomy|coblation tonsillectomy
5293119|NCT00459927|Floseal|floseal
5293120|NCT00459914|sleep apnea|sleep apnea
5293121|NCT00459914|refractory hypertension|refractory hypertension
5293122|NCT00459914|continuous positive airway pressure|continuous positive airway pressure
5293123|NCT00459901|Metastatic Colorectal Cancer|metastatic colorectal cancer
5293124|NCT00459888|CLI|cli
5293125|NCT00459888|Critical Limb Ischemia|critical limb ischemia
5293126|NCT00459888|Infrapopliteal|infrapopliteal
5293127|NCT00459888|Cryoplasty|cryoplasty
5293128|NCT00459875|recurrent renal cell cancer|recurrent renal cell cancer
5293129|NCT00459875|stage IV renal cell cancer|stage iv renal cell cancer
5293130|NCT00459849|Melanoma|melanoma
5293131|NCT00459849|Brachytherapy|brachytherapy
5293132|NCT00459849|Ultrasonography|ultrasonography
5293133|NCT00459836|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5293134|NCT00459823|Cancer|cancer
5293135|NCT00459823|solid tumors|solid tumors
5293136|NCT00459810|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5293138|NCT00459810|stage IV prostate cancer|stage iv prostate cancer
5293139|NCT00459797|GlideScope|glidescope
5293140|NCT00459797|cobalt|cobalt
5293141|NCT00459797|single-use|single-use
5293142|NCT00459797|intubation|intubation
5293143|NCT00459797|airway|airway
5293144|NCT00459797|Elective surgical patients requiring orotracheal intubation|elective surgical patients requiring orotracheal intubation
5293145|NCT00459784|Improvement|improvement
5293146|NCT00459784|Dementia early diagnosis|dementia early diagnosis
5293147|NCT00459784|Dementia management|dementia management
5293148|NCT00459784|Primary care|primary care
5293149|NCT00459771|angiotensin II-receptor (AT1) blocker|angiotensin ii-receptor (at1) blocker
5293150|NCT00459771|prevention|prevention
5293151|NCT00459771|trastuzumab|trastuzumab
5293152|NCT00459771|cardiotoxicity|cardiotoxicity
5293153|NCT00459758|hypertension|hypertension
5293154|NCT00459758|Hans|hans
5293155|NCT00459758|Electrical stimulation|electrical stimulation
5293156|NCT00459745|Cardiovascular Disease|cardiovascular disease
5293157|NCT00459745|Fenofibrate|fenofibrate
5293158|NCT00459745|LDL cholesterol|ldl cholesterol
5293159|NCT00459745|HDL cholesterol|hdl cholesterol
5293160|NCT00459745|Hyperlipidemia|hyperlipidemia
5293161|NCT00459745|Pravastatin|pravastatin
5293162|NCT00459745|Triglycerides|triglycerides
5293163|NCT00459732|zinc, thalassemia, bone mineral density|zinc, thalassemia, bone mineral density
5293164|NCT00459719|Liver Transplantation|liver transplantation
5293165|NCT00459719|Tacrolimus|tacrolimus
5293166|NCT00459719|Methylprednisolone|methylprednisolone
5293169|NCT00459693|HIV-Dementia|hiv-dementia
5293170|NCT00459693|Brain|brain
5293171|NCT00459693|PET|pet
5293172|NCT00459693|PBR28|pbr28
5293173|NCT00459693|MCMD|mcmd
5293174|NCT00459693|HIV Positive|hiv positive
5293175|NCT00459693|HIV Dementia|hiv dementia
5293176|NCT00459693|AIDS Related Dementia|aids related dementia
5293177|NCT00459693|Minor Cognitive Motor Disorder|minor cognitive motor disorder
5293178|NCT00459693|Healthy Volunteer|healthy volunteer
5293179|NCT00459693|HV|hv
5293180|NCT00459680|hypertension|hypertension
5293181|NCT00459680|acupuncture|acupuncture
5293182|NCT00459680|laser|laser
5293183|NCT00459667|Relapsing multiple sclerosis|relapsing multiple sclerosis
5293184|NCT00459667|interferon beta 1b|interferon beta 1b
5293185|NCT00459667|Betaferon|betaferon
5293186|NCT00459667|Betaseron|betaseron
5293187|NCT00459654|HRPC|hrpc
5293188|NCT00459654|Recurrent Prostate Cancer|recurrent prostate cancer
5293189|NCT00459654|Metastatic Cancer|metastatic cancer
5293190|NCT00459641|Osteogenic Gel|osteogenic gel
5293191|NCT00459641|Solitary Bone Cysts|solitary bone cysts
5293192|NCT00459628|early breast cancer|early breast cancer
5293193|NCT00459628|post-operative radiation treatment|post-operative radiation treatment
5293194|NCT00459602|laparoscopic surgery|laparoscopic surgery
5293195|NCT00459589|Cancer|cancer
5293196|NCT00459589|elderly|elderly
5293197|NCT00459589|malnutrition|malnutrition
5293198|NCT00459589|chemotherapy|chemotherapy
5293199|NCT00459589|survival|survival
5293200|NCT00459589|comprehensive geriatric assessment|comprehensive geriatric assessment
5293201|NCT00459589|morbidity|morbidity
5293202|NCT00459576|Asthma|asthma
5293203|NCT00459576|Eczema|eczema
5293204|NCT00459576|Dermatitis, Atopic|dermatitis, atopic
5293205|NCT00459576|Infant|infant
5293206|NCT00459563|vitamin D|vitamin d
5293207|NCT00459563|blood pressure|blood pressure
5293208|NCT00459563|hypertension|hypertension
5293209|NCT00459563|Vitamin D insufficient|vitamin d insufficient
5293210|NCT00459563|Systolic blood pressure between 130 and 150 mmHg|systolic blood pressure between 130 and 150 mmhg
5293211|NCT00459550|Alzheimer's Disease|alzheimer's disease
5293212|NCT00459550|First Time in Human (FTIH) Study|first time in human (ftih) study
5293213|NCT00459537|Toenail fungus|toenail fungus
5293214|NCT00459537|Onychomycosis|onychomycosis
5293215|NCT00459537|Nail fungus|nail fungus
5293216|NCT00459537|Toenail fungal infection|toenail fungal infection
5293217|NCT00459537|Tinea unguium|tinea unguium
5293218|NCT00459537|Dermatophytes|dermatophytes
5293219|NCT00459537|Foot dermatoses|foot dermatoses
5293220|NCT00459524|Acute Myelogenous Leukemia|acute myelogenous leukemia
5293221|NCT00459524|Myelodysplastic Syndrome|myelodysplastic syndrome
5293222|NCT00459524|Leukemia|leukemia
5293223|NCT00459524|Quality of Life|quality of life
5293224|NCT00459524|Questionnaire|questionnaire
5293225|NCT00459524|Survey|survey
5293226|NCT00459524|Neurocognitive Function|neurocognitive function
5293227|NCT00459524|AML|aml
5293228|NCT00459524|MDS|mds
5293229|NCT00459524|QOL|qol
5293230|NCT00459511|Adrenomedullin|adrenomedullin
5293231|NCT00459511|Glucose|glucose
5293232|NCT00459511|Insulin|insulin
5293233|NCT00459511|Systemic Inflammatory response Syndrome|systemic inflammatory response syndrome
5293234|NCT00459511|Pediatric|pediatric
5293235|NCT00459511|Cortisol|cortisol
5293236|NCT00459511|ACTH|acth
5293237|NCT00459498|NIS|nis
5293238|NCT00459498|thyroid adenoma|thyroid adenoma
5293239|NCT00459498|thyroid cancer|thyroid cancer
5293240|NCT00459498|Iodine uptake|iodine uptake
5293241|NCT00459498|expression|expression
5293242|NCT00459485|Plasm zinc concentration|plasm zinc concentration
5293600|NCT00458159|MDS|mds
5293243|NCT00459485|Zinc supplementation|zinc supplementation
5293244|NCT00459485|Assessment of zinc status|assessment of zinc status
5293245|NCT00459485|Plasma zinc concentration|plasma zinc concentration
5293246|NCT00459472|resident training|resident training
5293247|NCT00459472|laparoscopy|laparoscopy
5293248|NCT00459472|virtual reality|virtual reality
5293249|NCT00459472|surgical education|surgical education
5293250|NCT00459446|Magnetic Resonance Imaging|magnetic resonance imaging
5293251|NCT00459446|Gadolinium Contrast|gadolinium contrast
5293252|NCT00459446|Gadofosveset|gadofosveset
5293253|NCT00459446|Atherosclerosis|atherosclerosis
5293254|NCT00459446|Chronic Total Arterial Occlusions|chronic total arterial occlusions
5293255|NCT00459446|Cardiovascular Disease|cardiovascular disease
5293256|NCT00459446|Blocked Arteries|blocked arteries
5293257|NCT00459446|Peripheral Artery Disease|peripheral artery disease
5293258|NCT00459446|PAD|pad
5293259|NCT00459446|Intermittent Claudication|intermittent claudication
5293260|NCT00459446|Chronic Total Arterial Occlusion|chronic total arterial occlusion
5293261|NCT00459433|Low back pain|low back pain
5293262|NCT00459433|Return to work|return to work
5293263|NCT00459433|Biopsychosocial|biopsychosocial
5293264|NCT00459433|Screening|screening
5293265|NCT00459433|SMS|sms
5293266|NCT00459433|Non specific low back pain|non specific low back pain
5293267|NCT00459420|Parkinson's disease|parkinson's disease
5293268|NCT00459420|Excessive Daytime Somnolence|excessive daytime somnolence
5293269|NCT00459420|Caffeine|caffeine
5293270|NCT00459420|Disease-Modifying|disease-modifying
5293271|NCT00459368|asthma|asthma
5293272|NCT00459368|patient compliance|patient compliance
5293273|NCT00459368|metered dose inhalers|metered dose inhalers
5293274|NCT00459368|corticosteroids|corticosteroids
5293275|NCT00459368|health behaviour|health behaviour
5293276|NCT00459368|prevention & control|prevention & control
5293277|NCT00459355|Alzheimer's disease|alzheimer's disease
5293278|NCT00459355|Dementia|dementia
5293279|NCT00459355|Safety|safety
5293280|NCT00459355|Home Care Services|home care services
5293281|NCT00459329|Depression|depression
5293282|NCT00459329|Epilepsy|epilepsy
5293283|NCT00459329|Problem-Solving Therapy|problem-solving therapy
5293284|NCT00459329|Mental Health|mental health
5293285|NCT00459329|Neurology|neurology
5293286|NCT00459329|Home-based health care|home-based health care
5293287|NCT00459329|Community-based program|community-based program
5293288|NCT00459329|Collaborative care|collaborative care
5293289|NCT00459303|cataract|cataract
5293290|NCT00459303|aspherical intraocular lenses|aspherical intraocular lenses
5293291|NCT00459303|functional vision|functional vision
5293292|NCT00459290|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5293293|NCT00459290|primary peritoneal cavity cancer|primary peritoneal cavity cancer
5293294|NCT00459290|fallopian tube cancer|fallopian tube cancer
5293295|NCT00459277|Pain|pain
5293296|NCT00459277|Cancer|cancer
5293297|NCT00459264|Folic Acid|folic acid
5293298|NCT00459264|Prevention|prevention
5293299|NCT00459264|Depression|depression
5293300|NCT00459264|Bipolar Disorder|bipolar disorder
5293301|NCT00459264|Teenagers|teenagers
5293302|NCT00459251|N-acetyltransferase|n-acetyltransferase
5293303|NCT00459251|Pharmacogenetics|pharmacogenetics
5293304|NCT00459238|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
5293305|NCT00459225|Pediatrics|pediatrics
5293306|NCT00459225|Cardiac Defect|cardiac defect
5293307|NCT00459225|Cardiac Surgery|cardiac surgery
5293308|NCT00459225|Single Ventricle|single ventricle
5293309|NCT00459225|Anemia|anemia
5293310|NCT00459225|blood transfusions|blood transfusions
5293311|NCT00459225|red cell volume|red cell volume
5293312|NCT00459225|red cell distribution|red cell distribution
5293313|NCT00459225|oral iron|oral iron
5293314|NCT00459225|ferrous sulfate|ferrous sulfate
5293315|NCT00459225|Congenital Cardiac Defects|congenital cardiac defects
5293316|NCT00459225|Hemoglobin|hemoglobin
5293317|NCT00459225|Iron Deficiency|iron deficiency
5293318|NCT00459186|prostate cancer|prostate cancer
5293319|NCT00459186|RAD001|rad001
5293320|NCT00459186|mTOR inhibition|mtor inhibition
5293321|NCT00459186|docetaxel|docetaxel
5293322|NCT00459173|abstinence|abstinence
5293323|NCT00459173|maintenance|maintenance
5293324|NCT00459160|Hypotensive Resuscitation|hypotensive resuscitation
5293325|NCT00459160|Hypotensive Anesthesia|hypotensive anesthesia
5293326|NCT00459160|Hemorrhagic Shock|hemorrhagic shock
5293327|NCT00459160|Penetrating Trauma|penetrating trauma
5293328|NCT00459134|sexual dysfunction|sexual dysfunction
5293329|NCT00459134|sexuality and reproductive issues|sexuality and reproductive issues
5293330|NCT00459134|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5293331|NCT00459121|stage I non-small cell lung cancer|stage i non-small cell lung cancer
5293332|NCT00459121|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
5293333|NCT00459121|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5293334|NCT00459082|Dexmedetomine|dexmedetomine
5293335|NCT00459082|Post-operative cardiac surgery|post-operative cardiac surgery
5293336|NCT00459069|tumor vaccine|tumor vaccine
5293337|NCT00459069|GM-CSF|gm-csf
5293338|NCT00459043|SCCHN|scchn
5293339|NCT00459030|colon cancer|colon cancer
5293340|NCT00459030|rectal cancer|rectal cancer
5293341|NCT00459017|24 hour ambulatory blood pressure measurement|24 hour ambulatory blood pressure measurement
5293342|NCT00459017|Mean blood pressure|mean blood pressure
5293343|NCT00459017|Wrist manometer|wrist manometer
5293344|NCT00459017|Frequent measurement|frequent measurement
5293345|NCT00459004|weight loss|weight loss
5293346|NCT00458991|Recombinant Human Growth Hormone|recombinant human growth hormone
5293347|NCT00458991|growth hormone deficiency|growth hormone deficiency
5293348|NCT00458991|short stature|short stature
5293349|NCT00458991|phenotyping|phenotyping
5293350|NCT00458952|MIBG|mibg
5293351|NCT00458952|iobenguane|iobenguane
5293352|NCT00458952|iodine|iodine
5293353|NCT00458952|I 131|i 131
5293354|NCT00458952|radiotherapy|radiotherapy
5293355|NCT00458952|radiopharmaceutical|radiopharmaceutical
5293356|NCT00458952|dosimetry|dosimetry
5293357|NCT00458952|neuroendocrine tumor|neuroendocrine tumor
5293358|NCT00458952|Ultratrace|ultratrace
5293359|NCT00458952|no carrier added|no carrier added
5293360|NCT00458952|metaiodobenzyl-guanidine|metaiodobenzyl-guanidine
5293361|NCT00458926|ventilation, mechanical|ventilation, mechanical
5293362|NCT00458926|intubation, endotracheal|intubation, endotracheal
5293363|NCT00458926|respiratory insufficiency|respiratory insufficiency
5293364|NCT00458913|localized malignant mesothelioma|localized malignant mesothelioma
5293365|NCT00458913|recurrent malignant mesothelioma|recurrent malignant mesothelioma
5293366|NCT00458913|advanced malignant mesothelioma|advanced malignant mesothelioma
5293367|NCT00458887|ototoxicity|ototoxicity
5293368|NCT00458887|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
5293369|NCT00458874|CV risk factors|cv risk factors
5293370|NCT00458874|subclinical atherosclerosis|subclinical atherosclerosis
5293371|NCT00458874|lifestyle intervention|lifestyle intervention
5293372|NCT00458874|motivation|motivation
5293373|NCT00458861|Active Rheumatoid Arthritis (RA)|active rheumatoid arthritis (ra)
5293374|NCT00458848|B-cell adult acute lymphoblastic leukemia|b-cell adult acute lymphoblastic leukemia
5293375|NCT00458848|T-cell adult acute lymphoblastic leukemia|t-cell adult acute lymphoblastic leukemia
5293376|NCT00458848|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
5293377|NCT00458848|L1 adult acute lymphoblastic leukemia|l1 adult acute lymphoblastic leukemia
5293378|NCT00458848|L2 adult acute lymphoblastic leukemia|l2 adult acute lymphoblastic leukemia
5293379|NCT00458848|TdT positive adult acute lymphoblastic leukemia|tdt positive adult acute lymphoblastic leukemia
5293380|NCT00458835|Allergic rhinitis|allergic rhinitis
5293381|NCT00458822|primary systemic amyloidosis|primary systemic amyloidosis
5293382|NCT00458809|recurrent colon cancer|recurrent colon cancer
5293383|NCT00458809|stage IV colon cancer|stage iv colon cancer
5293384|NCT00458809|carcinoma of the appendix|carcinoma of the appendix
5293385|NCT00458809|recurrent rectal cancer|recurrent rectal cancer
5293386|NCT00458809|stage IV rectal cancer|stage iv rectal cancer
5293387|NCT00458809|primary peritoneal cavity cancer|primary peritoneal cavity cancer
5293388|NCT00458796|hypercalcemia of malignancy|hypercalcemia of malignancy
5293389|NCT00458796|musculoskeletal complications|musculoskeletal complications
5293390|NCT00458796|pain|pain
5293391|NCT00458796|stage IV breast cancer|stage iv breast cancer
5293392|NCT00458796|male breast cancer|male breast cancer
5293393|NCT00458796|recurrent breast cancer|recurrent breast cancer
5293394|NCT00458796|bone metastases|bone metastases
5293395|NCT00458783|Transfusion|transfusion
5293396|NCT00458783|Cardiac|cardiac
5293397|NCT00458783|Blood storage duration|blood storage duration
5293398|NCT00458770|Comparison of a spontaneous acute cluster headache attack and rest (no pain) in ten patients with cluster headache defined with IHS criteria|comparison of a spontaneous acute cluster headache attack and rest (no pain) in ten patients with cluster headache defined with ihs criteria
5293399|NCT00458757|Amputees|amputees
5293400|NCT00458757|Affordance|affordance
5293401|NCT00458757|Peripersonal space|peripersonal space
5293402|NCT00458757|Pseudo neglect|pseudo neglect
5293403|NCT00458757|Reaching|reaching
5293404|NCT00458757|Spatial|spatial
5293405|NCT00458757|visual|visual
5293406|NCT00458744|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
5293407|NCT00458744|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5293408|NCT00458744|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
5293409|NCT00458744|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
5293410|NCT00458744|childhood acute promyelocytic leukemia (M3)|childhood acute promyelocytic leukemia (m3)
5293411|NCT00458744|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5293412|NCT00458744|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5293413|NCT00458744|childhood central nervous system germ cell tumor|childhood central nervous system germ cell tumor
5293414|NCT00458744|childhood choroid plexus tumor|childhood choroid plexus tumor
5293415|NCT00458744|childhood craniopharyngioma|childhood craniopharyngioma
5293416|NCT00458744|childhood infratentorial ependymoma|childhood infratentorial ependymoma
5293417|NCT00458744|childhood grade I meningioma|childhood grade i meningioma
5293418|NCT00458744|childhood grade II meningioma|childhood grade ii meningioma
5293419|NCT00458744|childhood grade III meningioma|childhood grade iii meningioma
5293420|NCT00458744|childhood supratentorial ependymoma|childhood supratentorial ependymoma
5293601|NCT00458159|Celgene|celgene
5293421|NCT00458744|recurrent childhood brain stem glioma|recurrent childhood brain stem glioma
5293422|NCT00458744|recurrent childhood cerebellar astrocytoma|recurrent childhood cerebellar astrocytoma
5293423|NCT00458744|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
5293424|NCT00458744|recurrent childhood ependymoma|recurrent childhood ependymoma
5293425|NCT00458744|recurrent childhood medulloblastoma|recurrent childhood medulloblastoma
5293426|NCT00458744|recurrent childhood supratentorial primitive neuroectodermal tumors|recurrent childhood supratentorial primitive neuroectodermal tumors
5293427|NCT00458744|recurrent childhood visual pathway and hypothalamic glioma|recurrent childhood visual pathway and hypothalamic glioma
5293428|NCT00458744|recurrent childhood visual pathway glioma|recurrent childhood visual pathway glioma
5293429|NCT00458744|high-grade childhood cerebral astrocytoma|high-grade childhood cerebral astrocytoma
5293430|NCT00458744|low-grade childhood cerebral astrocytoma|low-grade childhood cerebral astrocytoma
5293431|NCT00458744|recurrent childhood brain tumor|recurrent childhood brain tumor
5293432|NCT00458744|childhood spinal cord tumor|childhood spinal cord tumor
5293433|NCT00458744|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
5293434|NCT00458744|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
5293435|NCT00458744|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
5293436|NCT00458744|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
5293437|NCT00458744|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
5293438|NCT00458744|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
5293439|NCT00458744|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
5293440|NCT00458744|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
5293441|NCT00458744|childhood grade III lymphomatoid granulomatosis|childhood grade iii lymphomatoid granulomatosis
5293442|NCT00458744|childhood nasal type extranodal NK/T-cell lymphoma|childhood nasal type extranodal nk/t-cell lymphoma
5293443|NCT00458744|recurrent childhood grade III lymphomatoid granulomatosis|recurrent childhood grade iii lymphomatoid granulomatosis
5293444|NCT00458744|recurrent childhood pineoblastoma|recurrent childhood pineoblastoma
5293445|NCT00458718|abstinence|abstinence
5293446|NCT00458718|nicotine patch|nicotine patch
5293447|NCT00458705|stage I multiple myeloma|stage i multiple myeloma
5293448|NCT00458705|stage II multiple myeloma|stage ii multiple myeloma
5293449|NCT00458705|stage III multiple myeloma|stage iii multiple myeloma
5293450|NCT00458705|refractory multiple myeloma|refractory multiple myeloma
5293451|NCT00458679|CHRONIC LYMPHOCYTIC LEUKEMIA (B-CLL)|chronic lymphocytic leukemia (b-cll)
5293452|NCT00458679|CD40 LIGAND AND IL-2-EXPRESSING TUMOR CELLS|cd40 ligand and il-2-expressing tumor cells
5293453|NCT00458666|Amniotic fluid|amniotic fluid
5293454|NCT00458666|D-dimer|d-dimer
5293455|NCT00458666|coagulation|coagulation
5293456|NCT00458666|factor X activation|factor x activation
5293457|NCT00458653|DC/tumor cell fusions|dc/tumor cell fusions
5293458|NCT00458653|GM-CSF|gm-csf
5293459|NCT00458653|high dose chemotherapy|high dose chemotherapy
5293460|NCT00458627|Plethysmograpy|plethysmograpy
5293461|NCT00458627|preschool|preschool
5293462|NCT00458627|methacholine challenge|methacholine challenge
5293463|NCT00458627|spirometry|spirometry
5293464|NCT00458627|asthma|asthma
5293465|NCT00458614|Cystic Fibrosis|cystic fibrosis
5293466|NCT00458601|EGFRvIII vaccinetemozolomidecancer vaccineimmunotherapy|egfrviii vaccinetemozolomidecancer vaccineimmunotherapy
5293467|NCT00458588|breast cancer|breast cancer
5293468|NCT00458575|Retinitis Pigmentosa|retinitis pigmentosa
5293469|NCT00458575|Advanced retinitis pigmentosa (RP)|advanced retinitis pigmentosa (rp)
5293470|NCT00458575|CNTO 2476|cnto 2476
5293471|NCT00458575|Subretinal|subretinal
5293472|NCT00458575|Human umbilical tissue-derived cells (hUTC)|human umbilical tissue-derived cells (hutc)
5293473|NCT00458575|Light perception (LP)|light perception (lp)
5293474|NCT00458575|Hand motion (HM)|hand motion (hm)
5293475|NCT00458562|cervical cancer|cervical cancer
5293476|NCT00458562|atypical squamous cells of undetermined significance|atypical squamous cells of undetermined significance
5293477|NCT00458562|stage 0 cervical cancer|stage 0 cervical cancer
5293478|NCT00458562|cervical intraepithelial neoplasia grade 1|cervical intraepithelial neoplasia grade 1
5293479|NCT00458562|cervical intraepithelial neoplasia grade 2|cervical intraepithelial neoplasia grade 2
5293480|NCT00458562|cervical intraepithelial neoplasia grade 3|cervical intraepithelial neoplasia grade 3
5293481|NCT00458549|stage I prostate cancer|stage i prostate cancer
5293482|NCT00458549|stage II prostate cancer|stage ii prostate cancer
5293483|NCT00458549|stage III prostate cancer|stage iii prostate cancer
5293484|NCT00458549|stage IV prostate cancer|stage iv prostate cancer
5293485|NCT00458536|GM-CSF|gm-csf
5293486|NCT00458536|vaccine|vaccine
5293487|NCT00458536|debulking nephrectomy|debulking nephrectomy
5293488|NCT00458536|dendritic cells|dendritic cells
5293489|NCT00458523|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
5293490|NCT00458523|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
5293491|NCT00458523|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
5293492|NCT00458523|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5293493|NCT00458523|stage 0 chronic lymphocytic leukemia|stage 0 chronic lymphocytic leukemia
5293494|NCT00458523|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5293495|NCT00458510|Pain|pain
5293496|NCT00458510|Cancer|cancer
5293497|NCT00458510|Breakthrough|breakthrough
5293498|NCT00458497|Holofiber|holofiber
5293499|NCT00458497|chronic foot pain|chronic foot pain
5293500|NCT00458497|sleep quality|sleep quality
5293501|NCT00458484|stage I renal cell cancer|stage i renal cell cancer
5293502|NCT00458484|stage II renal cell cancer|stage ii renal cell cancer
5293503|NCT00458484|stage III renal cell cancer|stage iii renal cell cancer
5293504|NCT00458484|stage IV renal cell cancer|stage iv renal cell cancer
5293505|NCT00458471|Urinary Catheter|urinary catheter
5293506|NCT00458471|Spinal Cord Injury|spinal cord injury
5293507|NCT00458471|Escherichia Coli|escherichia coli
5293508|NCT00458471|Urinary Tract Infection|urinary tract infection
5293509|NCT00458458|Endometriosis|endometriosis
5293510|NCT00458458|Dysmenorrhea|dysmenorrhea
5293511|NCT00458458|Pelvic Pain|pelvic pain
5293512|NCT00458458|Period Pain|period pain
5293513|NCT00458458|Menstrual Cramps|menstrual cramps
5293514|NCT00458458|Dyspareunia|dyspareunia
5293515|NCT00458458|Norethindrone Acetate|norethindrone acetate
5293516|NCT00458458|Lupron Depot|lupron depot
5293517|NCT00458458|Bone Density|bone density
5293518|NCT00458458|Lipid Profile|lipid profile
5293519|NCT00458445|Attention-Deficit Hyperactivity Disorder (ADHD)|attention-deficit hyperactivity disorder (adhd)
5293520|NCT00458432|fMRI|fmri
5293521|NCT00458432|Pavlovian Conditioning|pavlovian conditioning
5293522|NCT00458432|Functional Activity|functional activity
5293523|NCT00458432|Brain|brain
5293524|NCT00458432|Fear|fear
5293525|NCT00458432|Healthy Volunteer|healthy volunteer
5293526|NCT00458432|HV|hv
5293527|NCT00458419|dyspnea; leg discomfort; exercise duration|dyspnea; leg discomfort; exercise duration
5293528|NCT00458406|obstructive sleep apnea|obstructive sleep apnea
5293529|NCT00458406|child|child
5293530|NCT00458406|CPAP|cpap
5293531|NCT00458393|HIV|hiv
5293532|NCT00458393|Chemoprophylaxis|chemoprophylaxis
5293533|NCT00458393|Hepatitis|hepatitis
5293534|NCT00458393|Viral human hepatitis|viral human hepatitis
5293535|NCT00458393|HIV Seronegativity|hiv seronegativity
5293536|NCT00458380|Doppler ultrasonography|doppler ultrasonography
5293537|NCT00458380|Embryos|embryos
5293538|NCT00458380|Infertility|infertility
5293539|NCT00458380|IVF|ivf
5293540|NCT00458380|Oocytes|oocytes
5293541|NCT00458380|Tubal factor|tubal factor
5293542|NCT00458380|unexplained infertility|unexplained infertility
5293543|NCT00458367|PASS|pass
5293544|NCT00458367|Safety Assessment|safety assessment
5293545|NCT00458367|Efficacy Assessment|efficacy assessment
5293546|NCT00458367|long-acting injectable risperidone|long-acting injectable risperidone
5293547|NCT00458354|Spinal Sealant|spinal sealant
5293548|NCT00458354|Spinal Sealant System|spinal sealant system
5293549|NCT00458354|Dural Repair|dural repair
5293550|NCT00458354|Spinal Surgery|spinal surgery
5293551|NCT00458341|Cystic fibrosis|cystic fibrosis
5293552|NCT00458341|Nonsense mutation|nonsense mutation
5293553|NCT00458341|Premature stop codon|premature stop codon
5293554|NCT00458302|HIV|hiv
5293555|NCT00458302|Monotherapy|monotherapy
5293556|NCT00458302|Darunavir|darunavir
5293557|NCT00458302|Protease inhibitor|protease inhibitor
5293558|NCT00458302|Early pre-treated|early pre-treated
5293559|NCT00458302|Undetectable|undetectable
5293560|NCT00458302|Treatment Experienced|treatment experienced
5293561|NCT00458276|Left sided heart disease|left sided heart disease
5293562|NCT00458276|Elevated pulmonary arterial pressure|elevated pulmonary arterial pressure
5293563|NCT00458276|Right ventricular failure|right ventricular failure
5293564|NCT00458276|Cardiac surgery|cardiac surgery
5293565|NCT00458276|heart-lung machine|heart-lung machine
5293566|NCT00458276|cardiopulmonary bypass|cardiopulmonary bypass
5293567|NCT00458276|tezosentan|tezosentan
5293568|NCT00458276|Actelion|actelion
5293569|NCT00458263|Growth Hormone treatment|growth hormone treatment
5293570|NCT00458263|ISS|iss
5293571|NCT00458263|Biochemical markers|biochemical markers
5293572|NCT00458263|Growth response|growth response
5293573|NCT00458250|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
5293574|NCT00458250|Haploidentical|haploidentical
5293575|NCT00458250|Hematologic Neoplasms|hematologic neoplasms
5293576|NCT00458250|human, Bone Marrow|human, bone marrow
5293577|NCT00458250|Granulocyte Colony-stimulating Factor|granulocyte colony-stimulating factor
5293578|NCT00458250|CAMPATH|campath
5293579|NCT00458250|Alemtuzumab|alemtuzumab
5293580|NCT00458250|AML|aml
5293581|NCT00458250|ALL|all
5293582|NCT00458250|10. Eligibility|10. eligibility
5293583|NCT00458237|HER2 positive|her2 positive
5293584|NCT00458237|metastatic breast cancer|metastatic breast cancer
5293585|NCT00458237|RAD001|rad001
5293586|NCT00458237|Herceptin|herceptin
5293587|NCT00458224|overweight|overweight
5293588|NCT00458224|obesity|obesity
5293589|NCT00458224|child|child
5293590|NCT00458211|Schizophrenia|schizophrenia
5293591|NCT00458211|Ziprasidone|ziprasidone
5293592|NCT00458198|Selective Mutism|selective mutism
5293593|NCT00458172|lay theories|lay theories
5293594|NCT00458172|health concepts|health concepts
5293595|NCT00458172|survey|survey
5293596|NCT00458172|internet research|internet research
5293597|NCT00458172|Ideas about health|ideas about health
5293598|NCT00458159|CC-11006|cc-11006
5293599|NCT00458159|RA|ra
5293604|NCT00458159|RAEB-1|raeb-1
5293605|NCT00458159|Low-or Intermediate-1-Risk Myelodysplastic Syndrome (MDS)|low-or intermediate-1-risk myelodysplastic syndrome (mds)
5293606|NCT00458133|aerobic exercise|aerobic exercise
5293607|NCT00458133|resistance exercise|resistance exercise
5293608|NCT00458133|type 2 diabetes|type 2 diabetes
5293609|NCT00458133|hemoglobin A1C|hemoglobin a1c
5293610|NCT00458133|exercise|exercise
5293611|NCT00458120|Dengue Fever|dengue fever
5293612|NCT00458120|Dengue Hemorrhagic Fever|dengue hemorrhagic fever
5293613|NCT00458120|Dengue Vaccination|dengue vaccination
5293614|NCT00458107|Pharmacokinetics|pharmacokinetics
5293615|NCT00458107|Pharmacodynamics|pharmacodynamics
5293616|NCT00458094|Exercise|exercise
5293617|NCT00458094|Mental Illness|mental illness
5293618|NCT00458094|Community Psychiatry|community psychiatry
5293619|NCT00458094|Peer Support|peer support
5293620|NCT00458094|Mental Disorders|mental disorders
5293621|NCT00458068|preterm infant|preterm infant
5293622|NCT00458068|iron supplementation|iron supplementation
5293623|NCT00458068|iron deficiency|iron deficiency
5293624|NCT00458068|blood transfusion|blood transfusion
5293625|NCT00458055|Lipid lowering agents|lipid lowering agents
5293626|NCT00458055|Drug treatment|drug treatment
5293627|NCT00458055|Statin|statin
5293628|NCT00458055|Fibrate|fibrate
5293629|NCT00458055|Niacin|niacin
5293630|NCT00458055|Cellular cholesterol efflux|cellular cholesterol efflux
5293631|NCT00458042|Ventavis|ventavis
5293632|NCT00458042|iloporst|iloporst
5293633|NCT00458042|Remodulin|remodulin
5293634|NCT00458042|treprostinil|treprostinil
5293635|NCT00458042|PAH|pah
5293636|NCT00458042|prostacyclin|prostacyclin
5293637|NCT00458029|type 2 diabetes risk factors|type 2 diabetes risk factors
5293638|NCT00458029|obesity|obesity
5293639|NCT00458029|prevention|prevention
5293640|NCT00458029|adolescence|adolescence
5293641|NCT00458029|school based|school based
5293642|NCT00458003|Preeclampsia|preeclampsia
5293643|NCT00458003|Spinal Anesthesia|spinal anesthesia
5293644|NCT00458003|Hypotension|hypotension
5293645|NCT00458003|Cesarean Delivery|cesarean delivery
5293646|NCT00458003|Phenylephrine|phenylephrine
5293647|NCT00458003|Ephedrine|ephedrine
5293648|NCT00457990|Neurocognitive outcome|neurocognitive outcome
5293649|NCT00457990|preterm infant|preterm infant
5293650|NCT00457990|very low birth weight|very low birth weight
5293651|NCT00457990|iron deficiency|iron deficiency
5293652|NCT00457990|iron supplementation|iron supplementation
5293653|NCT00457977|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5293654|NCT00457977|COPD|copd
5293655|NCT00457977|Pneumococcal|pneumococcal
5293656|NCT00457977|Vaccine|vaccine
5293657|NCT00457977|Opsonization|opsonization
5293658|NCT00457977|Antibodies|antibodies
5293659|NCT00457964|Tuberous Sclerosis Complex (TSC)|tuberous sclerosis complex (tsc)
5293660|NCT00457964|Lymyphangioleiomyomatosis|lymyphangioleiomyomatosis
5293661|NCT00457964|Mammalian Target of Rapamycin (mTOR)|mammalian target of rapamycin (mtor)
5293662|NCT00457964|RAD001|rad001
5293663|NCT00457964|Angiomyolipmas|angiomyolipmas
5293664|NCT00457951|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5293665|NCT00457951|COPD|copd
5293666|NCT00457951|Heparin|heparin
5293667|NCT00457951|ODSH|odsh
5293668|NCT00457951|Exacerbations of COPD|exacerbations of copd
5293669|NCT00457938|lipodystrophy|lipodystrophy
5293670|NCT00457925|absorption,|absorption,
5293671|NCT00457925|metabolism,|metabolism,
5293672|NCT00457925|excretion|excretion
5293673|NCT00457925|distribution,|distribution,
5293674|NCT00457899|schizophrenia|schizophrenia
5293675|NCT00457899|schizoaffective disorder|schizoaffective disorder
5293676|NCT00457899|quetiapine|quetiapine
5293677|NCT00457899|seroquel|seroquel
5293678|NCT00457899|titration|titration
5293679|NCT00457873|surgery|surgery
5293680|NCT00457860|CLL|cll
5293681|NCT00457860|PLL|pll
5293682|NCT00457860|SLL|sll
5293683|NCT00457860|Relapse|relapse
5293684|NCT00457860|Refractory|refractory
5293685|NCT00457860|immunotoxin|immunotoxin
5293686|NCT00457860|HA22|ha22
5293687|NCT00457860|CAT-8015|cat-8015
5293688|NCT00457860|immunotherapy|immunotherapy
5293689|NCT00457847|PGD|pgd
5293690|NCT00457834|Heart failure|heart failure
5293691|NCT00457834|Dyssynchrony|dyssynchrony
5293692|NCT00457834|Cardiac resynchronization therapy|cardiac resynchronization therapy
5293693|NCT00457834|Atrial fibrillation|atrial fibrillation
5293694|NCT00457834|RVOT|rvot
5293695|NCT00457834|RVapex|rvapex
5293696|NCT00457821|G551D mutation|g551d mutation
5293697|NCT00457821|Fibrosis|fibrosis
5293698|NCT00457821|Pancreatic Diseases|pancreatic diseases
5293699|NCT00457821|Digestive System Diseases|digestive system diseases
5293700|NCT00457821|Lung Diseases|lung diseases
5293701|NCT00457821|Respiratory Tract Diseases|respiratory tract diseases
5293702|NCT00457821|Genetic Diseases, Inborn|genetic diseases, inborn
5293703|NCT00457821|Infant, Newborn, Diseases|infant, newborn, diseases
5293704|NCT00457821|Pathologic Processes|pathologic processes
5293705|NCT00457808|TSC and LAM|tsc and lam
5293706|NCT00457808|Tuberous Sclerosis Complex and sporadic LAM|tuberous sclerosis complex and sporadic lam
5293707|NCT00457782|Cancer|cancer
5293708|NCT00457782|Blood disorders|blood disorders
5293709|NCT00457782|Leukaemia, Adult Chronic|leukaemia, adult chronic
5293710|NCT00457782|Lymphoma|lymphoma
5293711|NCT00457782|Multiple Myeloma|multiple myeloma
5293712|NCT00457769|Aricept|aricept
5293713|NCT00457769|Donepezil|donepezil
5293714|NCT00457769|Memory|memory
5293715|NCT00457769|vascular dementia|vascular dementia
5293716|NCT00457769|stroke|stroke
5293717|NCT00457769|functional tasks|functional tasks
5293718|NCT00457769|self-generation|self-generation
5293719|NCT00457756|LDL cholesterol|ldl cholesterol
5293720|NCT00457756|HDL cholesterol|hdl cholesterol
5293721|NCT00457756|natural supplement|natural supplement
5293722|NCT00457756|guar gum|guar gum
5293723|NCT00457756|phytosterols|phytosterols
5293724|NCT00457756|policosanol|policosanol
5293725|NCT00457756|chrysanthemum|chrysanthemum
5293726|NCT00457743|Evaluate of RTD for Japanese GIST patients|evaluate of rtd for japanese gist patients
5293727|NCT00457730|Multiple Sclerosis|multiple sclerosis
5293728|NCT00457730|Duloxetine|duloxetine
5293729|NCT00457730|Pain|pain
5293730|NCT00457717|myopia, auricular acupoint, atropine, RCT|myopia, auricular acupoint, atropine, rct
5293731|NCT00457704|MRSA|mrsa
5293732|NCT00457704|Home Care|home care
5293733|NCT00457704|Risk factors|risk factors
5293734|NCT00457704|transmissions|transmissions
5293735|NCT00457704|observational study|observational study
5293736|NCT00457691|colorectal neoplasms|colorectal neoplasms
5293737|NCT00457678|Vision loss|vision loss
5293738|NCT00457678|Retina|retina
5293739|NCT00457678|VEG-F|veg-f
5293740|NCT00457678|Fovea|fovea
5293741|NCT00457678|AMD|amd
5293742|NCT00457665|HIV|hiv
5293743|NCT00457665|Lipodystrophy|lipodystrophy
5293744|NCT00457665|Treatment Experienced|treatment experienced
5293745|NCT00457652|Rosuvastatin|rosuvastatin
5293746|NCT00457652|Caffeine|caffeine
5293747|NCT00457652|Ischemia|ischemia
5293748|NCT00457652|Reperfusion|reperfusion
5293749|NCT00457639|lipodystrophy|lipodystrophy
5293750|NCT00457626|Children|children
5293751|NCT00457626|pediatrics|pediatrics
5293752|NCT00457626|High Blood Pressure|high blood pressure
5293753|NCT00457626|Hypertension|hypertension
5293754|NCT00457626|Valsartan|valsartan
5293755|NCT00457613|alkaline phosphatase|alkaline phosphatase
5293756|NCT00457613|sepsis|sepsis
5293757|NCT00457613|kidney function|kidney function
5293758|NCT00457600|information technology|information technology
5293759|NCT00457600|emergency department|emergency department
5293760|NCT00457600|medication error|medication error
5293761|NCT00457600|quality of care|quality of care
5293762|NCT00457600|patient-centered care|patient-centered care
5293763|NCT00457561|The relationship between all-cause mortality in patients introduced hemodialysis and recombinant human erythropoietin dose and serum adiponectin level|the relationship between all-cause mortality in patients introduced hemodialysis and recombinant human erythropoietin dose and serum adiponectin level
5293764|NCT00457548|Alcohol use|alcohol use
5293765|NCT00457548|Brief Interventions|brief interventions
5293766|NCT00457548|Injuries|injuries
5293767|NCT00457548|Emergency Department Patients|emergency department patients
5293768|NCT00457548|Harmful and hazardous alcohol use among ED injured patients|harmful and hazardous alcohol use among ed injured patients
5293769|NCT00457535|recombinant human erythropoietin|recombinant human erythropoietin
5293770|NCT00457535|adiponectin|adiponectin
5293771|NCT00457535|mortality|mortality
5293772|NCT00457522|intimate partner violence|intimate partner violence
5293773|NCT00457522|depression|depression
5293774|NCT00457522|PTSD|ptsd
5293775|NCT00457522|fatigue|fatigue
5293776|NCT00457509|Pandemic influenza|pandemic influenza
5293777|NCT00457509|Avian influenza|avian influenza
5293778|NCT00457509|Orthomyxoviridae Infections|orthomyxoviridae infections
5293779|NCT00457509|A/H5N1|a/h5n1
5293780|NCT00457496|Behavior Therapy|behavior therapy
5293781|NCT00457496|Relaxation Techniques|relaxation techniques
5293782|NCT00457496|Cognitive Therapy|cognitive therapy
5293783|NCT00457496|Exercise Movement Techniques|exercise movement techniques
5293784|NCT00457483|hypertension|hypertension
5293785|NCT00457483|diuretic|diuretic
5293786|NCT00457483|angiotensin receptor blockers|angiotensin receptor blockers
5293787|NCT00457483|prediction|prediction
5293788|NCT00457457|With or without erectile dysfunction|with or without erectile dysfunction
5293789|NCT00457431|in-hospital cardiac arrest|in-hospital cardiac arrest
5293790|NCT00457431|resuscitation|resuscitation
5293791|NCT00457431|mild therapeutic hypothermia|mild therapeutic hypothermia
5293792|NCT00457405|ischemia-reperfusion injury|ischemia-reperfusion injury
5293793|NCT00457405|atherosclerosis|atherosclerosis
5293794|NCT00457405|dipyridamole|dipyridamole
5293795|NCT00457405|annexin A5 targeting|annexin a5 targeting
5293796|NCT00457392|Non-small cell lung cancer|non-small cell lung cancer
5293797|NCT00457392|sunitinib|sunitinib
5293798|NCT00457392|erlotinib|erlotinib
5293799|NCT00457392|Phase 3|phase 3
5293800|NCT00457379|Coronary artery disease|coronary artery disease
5293801|NCT00457379|HDL-Cholesterol|hdl-cholesterol
5293802|NCT00457379|Endothelial Function|endothelial function
5293803|NCT00457379|Endothelial Progenitor Cells|endothelial progenitor cells
5293804|NCT00457379|normal blood HDL-Cholesterol level|normal blood hdl-cholesterol level
5293805|NCT00457340|Tachycardia, Ventricular|tachycardia, ventricular
5293806|NCT00457340|Ventricular Fibrillation|ventricular fibrillation
5293807|NCT00457327|protective ileostomy|protective ileostomy
5293808|NCT00457327|rectal cancer|rectal cancer
5293809|NCT00457327|low anterior resection|low anterior resection
5293810|NCT00457314|single-large scale deletions|single-large scale deletions
5293811|NCT00457314|point mutations in mtDNA|point mutations in mtdna
5293812|NCT00457301|Lung transplantation, health-related quality of life.|lung transplantation, health-related quality of life.
5293813|NCT00457288|Cutaneous Mastocytosis|cutaneous mastocytosis
5293814|NCT00457288|Topical treatment|topical treatment
5293815|NCT00457262|paraoxonase1 activity|paraoxonase1 activity
5293817|NCT00457262|HDL|hdl
5293818|NCT00457262|postmenopausal women|postmenopausal women
5293819|NCT00457262|postmenopausal women and hyperlipidemia|postmenopausal women and hyperlipidemia
5293820|NCT00457249|Pertussis|pertussis
5293821|NCT00457249|Tetanus|tetanus
5293822|NCT00457249|Diphtheria|diphtheria
5293823|NCT00457249|Tdap|tdap
5293824|NCT00457236|Clopidogrel|clopidogrel
5293825|NCT00457236|Coronary Artery Disease|coronary artery disease
5293826|NCT00457236|Dose-Response Relationship, Drug|dose-response relationship, drug
5293827|NCT00457236|Drug Resistance|drug resistance
5293828|NCT00457236|PCI|pci
5293829|NCT00457223|pterygium|pterygium
5293830|NCT00457223|pterygia|pterygia
5293831|NCT00457223|excision|excision
5293832|NCT00457223|amniotic membrane transplantation|amniotic membrane transplantation
5293833|NCT00457223|fibrin glue|fibrin glue
5293834|NCT00457223|suture|suture
5293835|NCT00457210|Psychology|psychology
5293836|NCT00457197|bipolar disorder|bipolar disorder
5293837|NCT00457197|alcohol dependence|alcohol dependence
5293838|NCT00457197|mania|mania
5293839|NCT00457197|manic disorder|manic disorder
5293840|NCT00457197|depression|depression
5293841|NCT00457184|Migraine|migraine
5293842|NCT00457184|Thrombosis|thrombosis
5293843|NCT00457184|Thrombophilia|thrombophilia
5293844|NCT00457171|GI-270384 colitis patients ECAM oral|gi-270384 colitis patients ecam oral
5293845|NCT00457158|pulmonary embolism|pulmonary embolism
5293846|NCT00457158|inferior vena cava filters|inferior vena cava filters
5293847|NCT00457158|venous thrombosis|venous thrombosis
5293848|NCT00457158|randomized controlled trial|randomized controlled trial
5293849|NCT00457145|Hyperfluorescence on Fluorescein|hyperfluorescence on fluorescein
5293850|NCT00457145|Idiopathic Juxtafoveal Telangiectasia|idiopathic juxtafoveal telangiectasia
5293851|NCT00457145|Retinal Edema/Thinning|retinal edema/thinning
5293852|NCT00457145|Vascular Endothelial Growth Factor|vascular endothelial growth factor
5293853|NCT00457145|Macular Telangiectasia|macular telangiectasia
5293854|NCT00457132|Knee|knee
5293855|NCT00457132|Osteoarthritis|osteoarthritis
5293856|NCT00457132|WOMAC|womac
5293857|NCT00457132|ALF|alf
5293858|NCT00457132|Wedging|wedging
5293859|NCT00457119|Non Small Cell Lung Cancer|non small cell lung cancer
5293860|NCT00457119|NSCLC|nsclc
5293861|NCT00457119|Advanced Lung Cancer|advanced lung cancer
5293862|NCT00457119|RAD|rad
5293863|NCT00457119|RAD001|rad001
5293864|NCT00457119|chemotherapy|chemotherapy
5293865|NCT00457119|carboplatin|carboplatin
5293866|NCT00457119|paclitaxel|paclitaxel
5293867|NCT00457119|bevacizumab|bevacizumab
5293868|NCT00457106|panic|panic
5293869|NCT00457093|Type 2 Diabetes|type 2 diabetes
5293870|NCT00457093|continuous glucose monitoring|continuous glucose monitoring
5293871|NCT00457093|basal insulin|basal insulin
5293872|NCT00457080|capnography|capnography
5293873|NCT00457080|safety|safety
5293874|NCT00457080|opioids|opioids
5293875|NCT00457080|respiratory depression|respiratory depression
5293876|NCT00457080|postoperative|postoperative
5293877|NCT00457080|orthopedic|orthopedic
5293878|NCT00457080|OSA|osa
5293879|NCT00457080|apnea|apnea
5293880|NCT00457067|Hyperfluorescence on Fluorescein|hyperfluorescence on fluorescein
5293881|NCT00457067|Idiopathic Juxtafoveal Telangiectasia|idiopathic juxtafoveal telangiectasia
5293882|NCT00457067|Retinal Edema/Thinning|retinal edema/thinning
5293883|NCT00457067|Vascular Endothelial Growth Factor|vascular endothelial growth factor
5293884|NCT00457067|Macular Telangiectasia|macular telangiectasia
5293885|NCT00457054|Mood Regulating Circuit|mood regulating circuit
5293886|NCT00457054|Lithium|lithium
5293887|NCT00457054|fMRI|fmri
5293888|NCT00457041|Trust|trust
5293889|NCT00457041|Decision Making|decision making
5293890|NCT00457041|Vulnerability|vulnerability
5293891|NCT00457041|Survey|survey
5293892|NCT00457028|Obsessive Compulsive Disorder|obsessive compulsive disorder
5293893|NCT00457028|Anxiety|anxiety
5293894|NCT00457028|Treatment efficacy|treatment efficacy
5293895|NCT00457002|Prevention of deep vein thrombosis and pulmonary embolism with acutely ill hospitalized patients|prevention of deep vein thrombosis and pulmonary embolism with acutely ill hospitalized patients
5293896|NCT00456989|Androgen Independent|androgen independent
5293897|NCT00456989|Prostate Cancer|prostate cancer
5293898|NCT00456989|Taxotere|taxotere
5293899|NCT00456989|Doxil|doxil
5293900|NCT00456989|AIPC|aipc
5293901|NCT00456989|Advanced Androgen-Independent Prostate Cancer|advanced androgen-independent prostate cancer
5293902|NCT00456976|Seligiline|seligiline
5293903|NCT00456976|Negative symptoms|negative symptoms
5293904|NCT00456976|Schizopherenia|schizopherenia
5293905|NCT00456963|angiotensin converting enzyme inhibitors|angiotensin converting enzyme inhibitors
5293906|NCT00456963|angiotensin receptor blockers|angiotensin receptor blockers
5293907|NCT00456963|diabetes|diabetes
5293908|NCT00456963|hypertension|hypertension
5293909|NCT00456963|therapeutic strategies|therapeutic strategies
5293910|NCT00456950|coronary atherosclerosis|coronary atherosclerosis
5293911|NCT00456950|magnetic resonance imaging|magnetic resonance imaging
5293912|NCT00456950|vulnerable plaque|vulnerable plaque
5293913|NCT00456924|progesterone receptor modulator|progesterone receptor modulator
5293914|NCT00456911|obesity|obesity
5293915|NCT00456911|prevention|prevention
5293916|NCT00456911|children|children
5293917|NCT00456911|adults|adults
5293918|NCT00456911|family|family
5293919|NCT00456911|dietary|dietary
5293920|NCT00456911|coaching|coaching
5293921|NCT00456911|body mass index|body mass index
5293922|NCT00456911|fat mass|fat mass
5293923|NCT00456885|obesity|obesity
5293924|NCT00456885|double blind|double blind
5293925|NCT00456885|placebo controlled|placebo controlled
5293926|NCT00456885|weight loss|weight loss
5293927|NCT00456885|appetite|appetite
5293928|NCT00456885|energy expenditure|energy expenditure
5293929|NCT00456872|Pain during injection of the pre-procedure anesthetic|pain during injection of the pre-procedure anesthetic
5293930|NCT00456859|chronic kidney disease|chronic kidney disease
5293931|NCT00456859|oral carbonaceous adsorbent|oral carbonaceous adsorbent
5293932|NCT00456859|randomized clinical trial|randomized clinical trial
5293933|NCT00456859|composite endpoint|composite endpoint
5293934|NCT00456846|Metastatic Breast Cancer, ABI-007, Abraxane|metastatic breast cancer, abi-007, abraxane
5293935|NCT00456833|Non Small Cell Lung Cancer|non small cell lung cancer
5293936|NCT00456833|NSCLC|nsclc
5293937|NCT00456833|Advanced lung cancer|advanced lung cancer
5293938|NCT00456833|RAD|rad
5293939|NCT00456833|RAD001|rad001
5293940|NCT00456833|erlotinib|erlotinib
5293941|NCT00456820|Mood Regulating Circuit|mood regulating circuit
5293942|NCT00456820|SSRI|ssri
5293943|NCT00456820|fMRI|fmri
5293944|NCT00456807|Human Papillomavirus|human papillomavirus
5293945|NCT00456794|Parkinson's disease|parkinson's disease
5293946|NCT00456794|Levodopa|levodopa
5293947|NCT00456794|End of dose wearing off|end of dose wearing off
5293948|NCT00456794|OFF time|off time
5293949|NCT00456781|rotator cuff|rotator cuff
5293950|NCT00456781|randomized clinical trial|randomized clinical trial
5293951|NCT00456768|Panic Disorder|panic disorder
5293952|NCT00456768|Anxiety|anxiety
5293953|NCT00456768|Treatment efficacy|treatment efficacy
5293954|NCT00456755|Perennial Allergic rhinitis|perennial allergic rhinitis
5293955|NCT00456755|Traditional Chinese Medicine|traditional chinese medicine
5293956|NCT00456742|Generalized Anxiety Disorder|generalized anxiety disorder
5293957|NCT00456742|Anxiety|anxiety
5293958|NCT00456742|Treatment efficacy|treatment efficacy
5293959|NCT00456729|Iron deficiency|iron deficiency
5293960|NCT00456729|Malabsorption|malabsorption
5293961|NCT00456729|Giardiasis|giardiasis
5293962|NCT00456716|BAC lung cancer|bac lung cancer
5293963|NCT00456716|adenocarcinoma of the lung|adenocarcinoma of the lung
5293964|NCT00456703|fluids,|fluids,
5293965|NCT00456703|restriction,|restriction,
5293966|NCT00456703|infection,|infection,
5293967|NCT00456703|bowel surgery,|bowel surgery,
5293968|NCT00456703|open abdominal|open abdominal
5293969|NCT00456690|Thalassemia|thalassemia
5293970|NCT00456690|Nutrition|nutrition
5293971|NCT00456690|Endocrine|endocrine
5293972|NCT00456690|BMI|bmi
5293973|NCT00456677|minocycline|minocycline
5293974|NCT00456677|asthma|asthma
5293975|NCT00456677|oral corticosteroids|oral corticosteroids
5293976|NCT00456664|CMV|cmv
5293977|NCT00456664|IRIS|iris
5293978|NCT00456651|Sleep Apnea|sleep apnea
5293979|NCT00456651|Obesity|obesity
5293980|NCT00456651|Neuropeptides|neuropeptides
5293981|NCT00456651|Hormones|hormones
5293982|NCT00456638|OP-CABG|op-cabg
5293983|NCT00456638|Depodur traditional drug|depodur traditional drug
5293984|NCT00456625|Hepatitis B vaccine|hepatitis b vaccine
5293985|NCT00456625|Challenge dose|challenge dose
5293986|NCT00456586|Parkinson's disease|parkinson's disease
5293987|NCT00456586|Levodopa therapy|levodopa therapy
5293988|NCT00456586|End of dose wearing off|end of dose wearing off
5293989|NCT00456586|Off time|off time
5293990|NCT00456573|Pediatric Obstructive sleep apnea syndrome|pediatric obstructive sleep apnea syndrome
5293991|NCT00456547|Cesarean hysterectomy|cesarean hysterectomy
5293992|NCT00456547|Postpartum hemorrhage|postpartum hemorrhage
5293993|NCT00456547|Coagulation|coagulation
5293994|NCT00456534|Smoking|smoking
5293995|NCT00456521|Obesity|obesity
5293996|NCT00456521|Behavior Modification|behavior modification
5293997|NCT00456469|TB|tb
5293998|NCT00456469|latent|latent
5293999|NCT00456469|infection|infection
5294000|NCT00456469|Ethiopia|ethiopia
5294001|NCT00456443|Thalassemia|thalassemia
5294002|NCT00456443|Sickle cell anemia|sickle cell anemia
5294003|NCT00456443|Splenectomy|splenectomy
5294004|NCT00456443|Infections|infections
5294005|NCT00456443|Streptococcal Pneumonia|streptococcal pneumonia
5294006|NCT00456417|Neurological|neurological
5294007|NCT00456417|Alzheimers|alzheimers
5294008|NCT00456404|peppermint water|peppermint water
5294009|NCT00456404|nipple crack|nipple crack
5294010|NCT00456404|lactating women|lactating women
5294011|NCT00456391|Brain CT scan|brain ct scan
5294012|NCT00456391|Pediatric emergency room|pediatric emergency room
5294013|NCT00456365|Autosomal dominant polycystic kidney disease|autosomal dominant polycystic kidney disease
5294014|NCT00456365|Cystic kidney disease|cystic kidney disease
5294015|NCT00456365|High blood pressure|high blood pressure
5294016|NCT00456365|Statin|statin
5294017|NCT00456339|Obstructive sleep apnea syndrome (OSAS) in children|obstructive sleep apnea syndrome (osas) in children
5294018|NCT00456326|Heparin|heparin
5294019|NCT00456326|Unfractionated Heparin|unfractionated heparin
5294020|NCT00456326|Low Molecular Weight Heparin|low molecular weight heparin
5294021|NCT00456326|Anticoagulation|anticoagulation
5294022|NCT00456326|Thrombocytopenia|thrombocytopenia
5294023|NCT00456326|Thrombosis|thrombosis
5294024|NCT00456326|Venous Thrombosis|venous thrombosis
5294025|NCT00456326|Pulmonary Embolism|pulmonary embolism
5294026|NCT00456313|asthma|asthma
5294027|NCT00456313|fluticasone propionate|fluticasone propionate
5294028|NCT00456313|salmeterol/fluticasone propionate|salmeterol/fluticasone propionate
5294029|NCT00456313|combination product|combination product
5294030|NCT00456313|innate immune response|innate immune response
5294031|NCT00456313|neutrophil priming|neutrophil priming
5294032|NCT00456300|Type 1 Diabetes|type 1 diabetes
5294033|NCT00456300|Hyperglycemia|hyperglycemia
5294034|NCT00456300|Hypoglycemia|hypoglycemia
5294035|NCT00456287|Sleep Apnea|sleep apnea
5294036|NCT00456287|Clotting- fibrinolysis patterns|clotting- fibrinolysis patterns
5294037|NCT00456287|Platelet function markers|platelet function markers
5294038|NCT00456287|Endothelial dysfunction|endothelial dysfunction
5294039|NCT00456274|Hypothalamic Amenorrhea|hypothalamic amenorrhea
5294040|NCT00456274|Idiopathic hypogonadotropic hypogonadism|idiopathic hypogonadotropic hypogonadism
5294041|NCT00456274|Acquired hypogonadotropic hypogonadism|acquired hypogonadotropic hypogonadism
5294042|NCT00456274|Kallmann's Syndrome|kallmann's syndrome
5294043|NCT00456274|Amenorrhea|amenorrhea
5294044|NCT00456274|Gonadotropin Releasing Hormone|gonadotropin releasing hormone
5294045|NCT00456261|Non Small Cell Lung Cancer|non small cell lung cancer
5294046|NCT00456248|Chronic Hepatitis C|chronic hepatitis c
5294047|NCT00456248|Liver|liver
5294048|NCT00456248|Pegylated|pegylated
5294049|NCT00456248|Interferon|interferon
5294050|NCT00456248|Ribavirin|ribavirin
5294051|NCT00456248|Combination|combination
5294052|NCT00456248|Nonresponder|nonresponder
5294053|NCT00456248|Relapser|relapser
5294054|NCT00456248|HCV|hcv
5294055|NCT00456248|Infergen|infergen
5294056|NCT00456248|SVR|svr
5294057|NCT00456222|Sleep|sleep
5294058|NCT00456222|Circadian rhythms|circadian rhythms
5294059|NCT00456222|Menstrual cycle|menstrual cycle
5294060|NCT00456209|Lived Experiences|lived experiences
5294061|NCT00456209|Adolescents|adolescents
5294062|NCT00456209|Cancer Treatment|cancer treatment
5294063|NCT00456209|Occupations|occupations
5294064|NCT00456196|COPD|copd
5294065|NCT00456196|Thrombosis|thrombosis
5294066|NCT00456196|Cancer|cancer
5294067|NCT00456196|Renal|renal
5294068|NCT00456196|Elderly|elderly
5294069|NCT00456196|Surgery|surgery
5294070|NCT00456196|Orthopedic Surgery|orthopedic surgery
5294071|NCT00456196|Medically Ill|medically ill
5294072|NCT00456196|Deep Vein Thrombosis|deep vein thrombosis
5294073|NCT00456196|Pulmonary Embolism|pulmonary embolism
5294074|NCT00456196|Anticoagulation|anticoagulation
5294075|NCT00456183|Tuberculosis|tuberculosis
5294076|NCT00456183|Latent|latent
5294077|NCT00456183|TB|tb
5294078|NCT00456183|Vaccine|vaccine
5294079|NCT00456183|MVA 85A|mva 85a
5294080|NCT00456170|Vaginal|vaginal
5294081|NCT00456170|Hysterectomy|hysterectomy
5294082|NCT00456170|Harmonic|harmonic
5294083|NCT00456170|Ligasure|ligasure
5294084|NCT00456170|Sutures|sutures
5294085|NCT00456170|Modern|modern
5294086|NCT00456170|Patients undergoing vaginal hysterectomy for various reasons|patients undergoing vaginal hysterectomy for various reasons
5294087|NCT00456157|Osteoarthritis|osteoarthritis
5294088|NCT00456157|Osteophytes|osteophytes
5294089|NCT00456157|Knee|knee
5294090|NCT00456157|Intra-articular|intra-articular
5294091|NCT00456157|OP-1|op-1
5294092|NCT00456144|GnRH|gnrh
5294093|NCT00456144|Insulin sensitivity|insulin sensitivity
5294094|NCT00456118|recurrent pregnancy losses|recurrent pregnancy losses
5294095|NCT00456118|preeclampsia|preeclampsia
5294096|NCT00456118|intervillositis|intervillositis
5294097|NCT00456118|maternofetal alloimmunization|maternofetal alloimmunization
5294098|NCT00456105|Type 2 diabetes|type 2 diabetes
5294099|NCT00456105|Post-op dysglycemia|post-op dysglycemia
5294100|NCT00456105|Peripheral vascular disease|peripheral vascular disease
5294101|NCT00456105|Infrainguinal bypass surgery|infrainguinal bypass surgery
5294102|NCT00456092|psoriatic arthritis|psoriatic arthritis
5294103|NCT00456092|ACR|acr
5294104|NCT00456092|PASI|pasi
5294105|NCT00456092|DAS|das
5294106|NCT00456092|pharmacokinetic|pharmacokinetic
5294107|NCT00456092|biopsy|biopsy
5294108|NCT00456066|Acute myocardial infarction|acute myocardial infarction
5294109|NCT00456066|Thromboaspiration|thromboaspiration
5294110|NCT00456066|Infarct size|infarct size
5294111|NCT00456066|Left ventricular remodelling|left ventricular remodelling
5294112|NCT00456053|Renal Anemia|renal anemia
5294113|NCT00456053|Renal Failure|renal failure
5294114|NCT00456053|Kidney Disease|kidney disease
5294115|NCT00456053|Human EPO|human epo
5294116|NCT00456040|amyloidosis|amyloidosis
5294117|NCT00456040|heart failure|heart failure
5294118|NCT00456040|heart transplant|heart transplant
5294119|NCT00456040|stem cell transplant|stem cell transplant
5294120|NCT00456027|Type 2 Diabetes|type 2 diabetes
5294121|NCT00456027|LADA|lada
5294122|NCT00456027|Latent Autoimmune Diabetes in Adult|latent autoimmune diabetes in adult
5294123|NCT00456027|Autoimmunity|autoimmunity
5294124|NCT00456027|HbA1c|hba1c
5294125|NCT00456027|C-peptide|c-peptide
5294126|NCT00456014|Major Depression|major depression
5294127|NCT00456014|Antidepressants|antidepressants
5294128|NCT00456001|heparin|heparin
5294129|NCT00456001|low molecular weight heparin|low molecular weight heparin
5294130|NCT00456001|enoxaparin|enoxaparin
5294131|NCT00456001|anticoagulation|anticoagulation
5294132|NCT00456001|thrombosis|thrombosis
5294133|NCT00456001|venous thrombosis|venous thrombosis
5294134|NCT00456001|thromboembolism|thromboembolism
5294135|NCT00456001|pulmonary embolism|pulmonary embolism
5294136|NCT00456001|medication|medication
5294137|NCT00455988|questionnaire developement|questionnaire developement
5294138|NCT00455988|regularity|regularity
5294139|NCT00455988|lifestyle|lifestyle
5294140|NCT00455988|type 2 diabetes|type 2 diabetes
5294141|NCT00455975|Kidney Cancer|kidney cancer
5294142|NCT00455975|Renal Cancer|renal cancer
5294143|NCT00455975|Clear Cell Carcinoma|clear cell carcinoma
5294144|NCT00455962|estrogen|estrogen
5294145|NCT00455962|progesterone|progesterone
5294146|NCT00455962|African-American|african-american
5294147|NCT00455962|Caucasian|caucasian
5294148|NCT00455962|infusion|infusion
5294149|NCT00455962|gonadotropins|gonadotropins
5294150|NCT00455962|healthy|healthy
5294151|NCT00455936|Adenocarcinoma|adenocarcinoma
5294152|NCT00455936|NSCLC|nsclc
5294153|NCT00455936|gemcitabine|gemcitabine
5294154|NCT00455936|Cisplatin|cisplatin
5294155|NCT00455936|Gefitinib|gefitinib
5294156|NCT00455936|Never smoker|never smoker
5294157|NCT00455923|asthma|asthma
5294158|NCT00455923|exacerbation|exacerbation
5294159|NCT00455923|persistent|persistent
5294160|NCT00455923|bronchial hyperresponsiveness|bronchial hyperresponsiveness
5294162|NCT00455923|GINAII|ginaii
5294163|NCT00455910|Low risk myelodysplastic syndromes|low risk myelodysplastic syndromes
5294164|NCT00455910|MDS|mds
5294165|NCT00455910|Bone marrow diseases|bone marrow diseases
5294166|NCT00455910|Thalidomide|thalidomide
5294167|NCT00455910|Cytopenias|cytopenias
5294168|NCT00455910|Anemia|anemia
5294169|NCT00455897|granulocyte monocyte colony stimulating factor|granulocyte monocyte colony stimulating factor
5294170|NCT00455897|Leukine|leukine
5294171|NCT00455897|Sargramostim|sargramostim
5294172|NCT00455897|Diffuse large B cell lymphoma|diffuse large b cell lymphoma
5294173|NCT00455897|non-Hodgkin's lymphoma|non-hodgkin's lymphoma
5294174|NCT00455871|macular degeneration|macular degeneration
5294175|NCT00455845|Endometriosis|endometriosis
5294176|NCT00455845|Lng IUD|lng iud
5294177|NCT00455832|sperm chromatin structure integrity|sperm chromatin structure integrity
5294178|NCT00455832|sperm concentration|sperm concentration
5294179|NCT00455832|sperm motility|sperm motility
5294180|NCT00455832|sperm morphology|sperm morphology
5294181|NCT00455832|peginterferon|peginterferon
5294182|NCT00455832|ribavirin|ribavirin
5294183|NCT00455832|hepatitis C|hepatitis c
5294184|NCT00455819|pulmonary embolism|pulmonary embolism
5294185|NCT00455819|pro-BNP|pro-bnp
5294186|NCT00455819|home treatment|home treatment
5294187|NCT00455806|Helicobacter pylori|helicobacter pylori
5294188|NCT00455806|rescue therapy|rescue therapy
5294189|NCT00455806|eradication therapy|eradication therapy
5294190|NCT00455806|esomeprazole|esomeprazole
5294191|NCT00455806|moxifloxacin|moxifloxacin
5294192|NCT00455806|resistance|resistance
5294193|NCT00455793|HIV|hiv
5294194|NCT00455793|atherosclerosis|atherosclerosis
5294195|NCT00455780|Eating|eating
5294196|NCT00455780|Dieting|dieting
5294197|NCT00455780|Meal replacements|meal replacements
5294198|NCT00455780|Energy Density|energy density
5294199|NCT00455780|Weight Loss Maintenance|weight loss maintenance
5294200|NCT00455767|persistent ARDS|persistent ards
5294201|NCT00455767|alveolar inflammation|alveolar inflammation
5294202|NCT00455767|early pulmonary fibrosis|early pulmonary fibrosis
5294203|NCT00455767|mechanichal ventilation|mechanichal ventilation
5294204|NCT00455767|P/V curve|p/v curve
5294205|NCT00455767|Static compliance|static compliance
5294206|NCT00455767|elastase activity|elastase activity
5294207|NCT00455767|inhibitor of Human Neutrophil Elastase|inhibitor of human neutrophil elastase
5294208|NCT00455741|menopause|menopause
5294209|NCT00455741|estrogen|estrogen
5294210|NCT00455741|progesterone|progesterone
5294211|NCT00455741|hormone replacement|hormone replacement
5294212|NCT00455741|aging|aging
5294213|NCT00455741|PET|pet
5294214|NCT00455715|Schizophrenia|schizophrenia
5294215|NCT00455715|Cognition|cognition
5294216|NCT00455715|Sildenafil|sildenafil
5294217|NCT00455715|PDE5 Inhibitor|pde5 inhibitor
5294218|NCT00455702|schizophrenia|schizophrenia
5294219|NCT00455702|cognition|cognition
5294220|NCT00455702|d-cycloserine|d-cycloserine
5294221|NCT00455702|memory|memory
5294222|NCT00455689|Lupron|lupron
5294223|NCT00455689|Premenopausal|premenopausal
5294224|NCT00455689|Hot flashes|hot flashes
5294225|NCT00455676|Scarf Osteotomy|scarf osteotomy
5294226|NCT00455676|Chevron Osteotomy|chevron osteotomy
5294227|NCT00455676|Comparison|comparison
5294228|NCT00455663|Schizoaffective Disorder|schizoaffective disorder
5294229|NCT00455663|Medication Adherence|medication adherence
5294230|NCT00455650|schizophrenia|schizophrenia
5294231|NCT00455650|cognition|cognition
5294232|NCT00455650|nicotinic receptors|nicotinic receptors
5294233|NCT00455650|mecamylamine|mecamylamine
5294234|NCT00455650|varenicline|varenicline
5294235|NCT00455624|androgen deprivation therapy|androgen deprivation therapy
5294236|NCT00455624|insulin resistance|insulin resistance
5294237|NCT00455611|Heart Failure, Congestive|heart failure, congestive
5294238|NCT00455611|Continuous Positive Airway Pressure|continuous positive airway pressure
5294239|NCT00455611|Baroreflex|baroreflex
5294240|NCT00455611|Echocardiography|echocardiography
5294241|NCT00455598|Diabetes|diabetes
5294242|NCT00455585|Pharmacokinetics|pharmacokinetics
5294243|NCT00455585|Antiretrovirals|antiretrovirals
5294244|NCT00455585|Uganda|uganda
5294245|NCT00455585|HIV|hiv
5294246|NCT00455585|Treatment Experienced|treatment experienced
5294247|NCT00455572|Immunotherapeutic|immunotherapeutic
5294248|NCT00455572|Adjuvant cancer therapy|adjuvant cancer therapy
5294249|NCT00455572|Non-small-cell lung cancer|non-small-cell lung cancer
5294250|NCT00455572|ASCI|asci
5294251|NCT00455559|Resistant Gastrointestinal Stromal Tumor|resistant gastrointestinal stromal tumor
5294252|NCT00455559|GIST|gist
5294253|NCT00455559|Perifosine|perifosine
5294254|NCT00455559|Gleevec|gleevec
5294255|NCT00455546|Coronary|coronary
5294256|NCT00455546|Artery|artery
5294257|NCT00455546|Atherosclerosis|atherosclerosis
5294258|NCT00455546|Phospholipase|phospholipase
5294259|NCT00455546|CAD|cad
5294260|NCT00455533|Early Breast Cancer|early breast cancer
5294261|NCT00455520|Diabetic neuropathy|diabetic neuropathy
5294262|NCT00455520|Painful Diabetic Polyneuropathy|painful diabetic polyneuropathy
5294263|NCT00455520|Polyneuropathy|polyneuropathy
5294264|NCT00455520|Peripheral neuropathy|peripheral neuropathy
5294265|NCT00455507|Parkinson's disease|parkinson's disease
5294266|NCT00455507|levodopa|levodopa
5294267|NCT00455507|end of dose wearing off|end of dose wearing off
5294268|NCT00455507|OFF time|off time
5294269|NCT00455494|Drug-resistant malaria|drug-resistant malaria
5294270|NCT00455494|Bioavailability|bioavailability
5294271|NCT00455494|Food-effect study|food-effect study
5294272|NCT00455468|Severe pneumonia|severe pneumonia
5294273|NCT00455468|children|children
5294274|NCT00455468|day care management|day care management
5294275|NCT00455468|hospitalized management|hospitalized management
5294276|NCT00455468|Randomized controlled trial|randomized controlled trial
5294277|NCT00455468|Under five children|under five children
5294278|NCT00455429|Atopic Dermatitis|atopic dermatitis
5294279|NCT00455429|JNJ-26113100|jnj-26113100
5294280|NCT00455416|Low grade lymphoma|low grade lymphoma
5294281|NCT00455416|Diet|diet
5294282|NCT00455416|Antioxidants|antioxidants
5294283|NCT00455416|Non Hodgkin Lymphoma - Follicular Lymphoma grade 1&2 stage III/IV|non hodgkin lymphoma - follicular lymphoma grade 1&2 stage iii/iv
5294284|NCT00455403|Metabolic Syndrome|metabolic syndrome
5294285|NCT00455403|Atherosclerosis|atherosclerosis
5294286|NCT00455390|Post immediate Psychotherapeutic Intervention|post immediate psychotherapeutic intervention
5294287|NCT00455390|Psychotraumatic disorders|psychotraumatic disorders
5294288|NCT00455390|PTSD post traumatic syndrome disorder|ptsd post traumatic syndrome disorder
5294289|NCT00455390|CUMP Cellules d’Urgence Médico Psychologique|cump cellules d’urgence médico psychologique
5294290|NCT00455377|Cement dust exposure|cement dust exposure
5294291|NCT00455377|Induced sputum|induced sputum
5294292|NCT00455377|Airway inflammation|airway inflammation
5294293|NCT00455377|Peripheral blood inflammation markers|peripheral blood inflammation markers
5294294|NCT00455364|Fungal infection prophylaxis|fungal infection prophylaxis
5294295|NCT00455364|Lung transplant|lung transplant
5294296|NCT00455364|Fungal infection post lung transplant|fungal infection post lung transplant
5294297|NCT00455351|Palliative treatment|palliative treatment
5294298|NCT00455351|Max. tolerable dose|max. tolerable dose
5294299|NCT00455338|meal|meal
5294300|NCT00455338|composition|composition
5294301|NCT00455338|postprandial|postprandial
5294302|NCT00455338|PCOS|pcos
5294303|NCT00455338|androgen|androgen
5294304|NCT00455325|Insulin Resistance|insulin resistance
5294305|NCT00455325|Atherosclerosis|atherosclerosis
5294306|NCT00455325|Metabolic Syndrome|metabolic syndrome
5294307|NCT00455312|Dyskeratosis Congenita|dyskeratosis congenita
5294308|NCT00455312|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
5294309|NCT00455312|Severe Aplastic Anemia|severe aplastic anemia
5294310|NCT00455299|Laparoscopy, ventral, hernia, repair, surgery|laparoscopy, ventral, hernia, repair, surgery
5294311|NCT00455286|CNS Lymphoma|cns lymphoma
5294312|NCT00455273|Breast Cancer|breast cancer
5294313|NCT00455273|DCE MRI|dce mri
5294314|NCT00455234|Aggression|aggression
5294315|NCT00455234|Violent behaviour in people with psychotic illness|violent behaviour in people with psychotic illness
5294316|NCT00455221|CML|cml
5294317|NCT00455221|Imatinib|imatinib
5294318|NCT00455221|vaccine|vaccine
5294319|NCT00455221|peptide|peptide
5294320|NCT00455221|gene|gene
5294321|NCT00455221|MRD|mrd
5294322|NCT00455221|DNA|dna
5294323|NCT00455182|Acupuncture|acupuncture
5294324|NCT00455182|Hip Arthroplasty|hip arthroplasty
5294325|NCT00455182|Knee Arthroplasty|knee arthroplasty
5294326|NCT00455182|Pain Management|pain management
5294327|NCT00455169|Influenza|influenza
5294328|NCT00455169|Infant, Premature|infant, premature
5294329|NCT00455169|Immunization|immunization
5294330|NCT00455169|Vaccination|vaccination
5294331|NCT00455156|Contraception|contraception
5294332|NCT00455156|Vaginal Ring|vaginal ring
5294333|NCT00455143|Postoperative delirium|postoperative delirium
5294334|NCT00455143|PD|pd
5294335|NCT00455143|Postoperative cognitive dysfunction|postoperative cognitive dysfunction
5294336|NCT00455143|POCD|pocd
5294337|NCT00455130|mannitol|mannitol
5294338|NCT00455130|cystic fibrosis|cystic fibrosis
5294339|NCT00455130|mucolytic|mucolytic
5294340|NCT00455130|mucoactive|mucoactive
5294341|NCT00455117|analgesia|analgesia
5294342|NCT00455117|pain|pain
5294343|NCT00455117|neurosurgery|neurosurgery
5294344|NCT00455117|NSAIDS|nsaids
5294345|NCT00455117|parecoxib|parecoxib
5294346|NCT00455117|morphine consumption|morphine consumption
5294347|NCT00455104|Fabry Disease|fabry disease
5294348|NCT00455104|National Registry|national registry
5294349|NCT00455091|Post-operative Hepatocellular Carcinoma.|post-operative hepatocellular carcinoma.
5294350|NCT00455078|Gastric reflux|gastric reflux
5294351|NCT00455078|Lung transplant|lung transplant
5294352|NCT00455078|chronic rejection|chronic rejection
5294353|NCT00455078|Gastric reflux in lung transplant as it relates to chronic rejection|gastric reflux in lung transplant as it relates to chronic rejection
5294354|NCT00455065|whole grain|whole grain
5294355|NCT00455065|metabolic syndrome|metabolic syndrome
5294356|NCT00455065|weight loss|weight loss
5294357|NCT00455052|XMT-1001|xmt-1001
5294358|NCT00455052|cancer|cancer
5294359|NCT00455052|tumor|tumor
5294360|NCT00455052|camptothecin|camptothecin
5294361|NCT00455052|Fleximer|fleximer
5294362|NCT00455052|polymer|polymer
5294363|NCT00455052|Phase 1|phase 1
5294364|NCT00455052|safety|safety
5294365|NCT00455052|pharmacokinetics|pharmacokinetics
5294366|NCT00455052|maximum tolerated dose|maximum tolerated dose
5294367|NCT00455052|NSCLC|nsclc
5294368|NCT00455052|non-small cell lung cancer|non-small cell lung cancer
5294369|NCT00455052|SCLC|sclc
5294370|NCT00455052|small cell lung cancer|small cell lung cancer
5294371|NCT00455039|neoadjuvant, HER2, Breast,GSK,lapatinib|neoadjuvant, her2, breast,gsk,lapatinib
5294372|NCT00455013|Kidney transplant|kidney transplant
5294373|NCT00454987|antibody persistence|antibody persistence
5294374|NCT00454987|Meningococcal serogroup C vaccine|meningococcal serogroup c vaccine
5294375|NCT00454987|conjugate vaccine|conjugate vaccine
5294376|NCT00454987|Haemophilus influenzae type b vaccine|haemophilus influenzae type b vaccine
5294377|NCT00454974|end stage renal failure|end stage renal failure
5294378|NCT00454974|dialysis|dialysis
5294379|NCT00454974|wearable artificial kidney|wearable artificial kidney
5294380|NCT00454961|Malaria|malaria
5294381|NCT00454961|Plasmodium falciparum|plasmodium falciparum
5294382|NCT00454961|artemether-lumefantrine|artemether-lumefantrine
5294383|NCT00454961|effectiveness|effectiveness
5294384|NCT00454948|Obesity prevention|obesity prevention
5294385|NCT00454948|Dietary intake|dietary intake
5294386|NCT00454948|Physical activity|physical activity
5294387|NCT00454948|Mexican American|mexican american
5294388|NCT00454948|Family Characteristics|family characteristics
5294389|NCT00454935|epilepsy|epilepsy
5294390|NCT00454935|glioma|glioma
5294391|NCT00454922|glaucoma|glaucoma
5294392|NCT00454922|patient educator|patient educator
5294393|NCT00454909|Meningococcal Serogroups A, C, W-135 and/or Y Disease|meningococcal serogroups a, c, w-135 and/or y disease
5294394|NCT00454896|Urinary Bladder, Overactive|urinary bladder, overactive
5294395|NCT00454896|Urgency|urgency
5294396|NCT00454896|VESIcare®|vesicare®
5294397|NCT00454896|Solifenacin succinate|solifenacin succinate
5294398|NCT00454883|Safety of ziprasidone, efficacy of ziprasidone, manic episodes in bipolar disorder, mixed episodes in bipolar disorder, schizoaffective disorder.|safety of ziprasidone, efficacy of ziprasidone, manic episodes in bipolar disorder, mixed episodes in bipolar disorder, schizoaffective disorder.
5294399|NCT00454870|Alzheimer's Disease|alzheimer's disease
5294400|NCT00454870|Cognition|cognition
5294401|NCT00454870|Cognitive impairment|cognitive impairment
5294402|NCT00454857|Thrombocytopenia|thrombocytopenia
5294403|NCT00454857|Chart Review|chart review
5294404|NCT00454857|Platelet|platelet
5294405|NCT00454857|Retrospective|retrospective
5294406|NCT00454857|Prospective|prospective
5294407|NCT00454857|Non-interventional|non-interventional
5294641|NCT00453986|lot-to-lot consistency|lot-to-lot consistency
5294408|NCT00454857|Health Resource Utilization (HRU)|health resource utilization (hru)
5294409|NCT00454857|Quality of Life (QOL)|quality of life (qol)
5294410|NCT00454857|Immune Thrombocytopenic Purpura (ITP)|immune thrombocytopenic purpura (itp)
5294411|NCT00454857|Idiopathic Thrombocytopenic Purpura (ITP)|idiopathic thrombocytopenic purpura (itp)
5294412|NCT00454857|Immune (Idiopathic) Thrombocytopenic Purpura (ITP)|immune (idiopathic) thrombocytopenic purpura (itp)
5294413|NCT00454857|Observational|observational
5294414|NCT00454831|Hypercholesterolemia|hypercholesterolemia
5294415|NCT00454831|LDL-cholesterol|ldl-cholesterol
5294416|NCT00454831|chitosan|chitosan
5294417|NCT00454831|HEP-40|hep-40
5294418|NCT00454805|Advanced Breast Cancer|advanced breast cancer
5294419|NCT00454792|Low back pain|low back pain
5294420|NCT00454792|Modic changes|modic changes
5294421|NCT00454779|SCCHNC|scchnc
5294422|NCT00454779|Metastatic|metastatic
5294423|NCT00454779|Recurrent|recurrent
5294424|NCT00454766|Patient Education|patient education
5294425|NCT00454766|Cervical Dysplasia|cervical dysplasia
5294426|NCT00454766|Questionnaire|questionnaire
5294427|NCT00454753|Myeloid, Chronic|myeloid, chronic
5294428|NCT00454753|Lymphocytic, Acute|lymphocytic, acute
5294429|NCT00454740|Urinary Bladder, Overactive|urinary bladder, overactive
5294430|NCT00454740|Urgency|urgency
5294431|NCT00454740|VESIcare®|vesicare®
5294432|NCT00454740|Solifenacin succinate|solifenacin succinate
5294433|NCT00454701|Psoriasis|psoriasis
5294434|NCT00454701|Alefacept|alefacept
5294435|NCT00454701|Amevive®|amevive®
5294436|NCT00454701|Drug exposure|drug exposure
5294437|NCT00454688|Irritable Bowel Syndrome|irritable bowel syndrome
5294438|NCT00454688|Asimadoline|asimadoline
5294439|NCT00454675|Smokers|smokers
5294440|NCT00454675|Chronic Bronchitis|chronic bronchitis
5294441|NCT00454675|Pulmonary Function Test Abnormalities|pulmonary function test abnormalities
5294442|NCT00454675|COPD|copd
5294443|NCT00454662|Elderly|elderly
5294444|NCT00454662|Hypertension|hypertension
5294445|NCT00454662|Cardiovascular Diseases|cardiovascular diseases
5294446|NCT00454662|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers
5294447|NCT00454662|Calcium Channel Blockers|calcium channel blockers
5294448|NCT00454662|Diuretics|diuretics
5294449|NCT00454662|Combination Drug Therapy|combination drug therapy
5294450|NCT00454662|Diabetes|diabetes
5294451|NCT00454649|axitinib|axitinib
5294452|NCT00454649|chemotherapy|chemotherapy
5294453|NCT00454649|anti-angiogenesis|anti-angiogenesis
5294454|NCT00454649|VEGF inhibition|vegf inhibition
5294455|NCT00454623|Adiponectin|adiponectin
5294456|NCT00454623|diabetes|diabetes
5294457|NCT00454623|metabolism|metabolism
5294458|NCT00454623|Adiponectin levels|adiponectin levels
5294459|NCT00454610|Pediatric|pediatric
5294460|NCT00454610|Overweight|overweight
5294461|NCT00454610|Obesity|obesity
5294462|NCT00454610|Intervention|intervention
5294463|NCT00454610|Prevention|prevention
5294464|NCT00454610|Mexican American|mexican american
5294465|NCT00454584|Psoriasis|psoriasis
5294466|NCT00454584|CNTO 1275|cnto 1275
5294467|NCT00454584|Etanercept|etanercept
5294468|NCT00454584|Immune diorder|immune diorder
5294469|NCT00454584|Skin disorder|skin disorder
5294470|NCT00454558|Pulmonary Arterial Hypertension (PAH)|pulmonary arterial hypertension (pah)
5294471|NCT00454558|Chronic Thromboembolic Pulmonary Hypertension (CTEPH)|chronic thromboembolic pulmonary hypertension (cteph)
5294472|NCT00454532|Breast Cancer|breast cancer
5294473|NCT00454532|Bionovo|bionovo
5294474|NCT00454532|BZL101|bzl101
5294475|NCT00454532|Chinese Herbs|chinese herbs
5294476|NCT00454519|peritoneal carcinomatosis|peritoneal carcinomatosis
5294477|NCT00454519|cisplatin|cisplatin
5294478|NCT00454519|mitomycin|mitomycin
5294479|NCT00454519|gastric cancer|gastric cancer
5294480|NCT00454519|colorectal cancer|colorectal cancer
5294481|NCT00454493|omacor|omacor
5294482|NCT00454493|fish oil|fish oil
5294483|NCT00454493|omega 3|omega 3
5294484|NCT00454493|fatty acids|fatty acids
5294485|NCT00454493|coronary artery disease|coronary artery disease
5294486|NCT00454493|endothelial function|endothelial function
5294487|NCT00454493|heart rate variability|heart rate variability
5294488|NCT00454493|carotid intimal media thickness|carotid intimal media thickness
5294489|NCT00454493|QT dispersion|qt dispersion
5294490|NCT00454480|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
5294491|NCT00454480|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5294492|NCT00454480|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5294493|NCT00454480|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5294494|NCT00454480|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5294495|NCT00454480|refractory anemia with excess blasts|refractory anemia with excess blasts
5294496|NCT00454480|adult acute basophilic leukemia|adult acute basophilic leukemia
5294497|NCT00454480|adult acute eosinophilic leukemia|adult acute eosinophilic leukemia
5294498|NCT00454480|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
5294499|NCT00454480|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
5294500|NCT00454480|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
5294501|NCT00454480|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
5294867|NCT00453323|Esophageal Cancer|esophageal cancer
5294502|NCT00454480|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
5294503|NCT00454480|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
5294504|NCT00454480|adult erythroleukemia (M6a)|adult erythroleukemia (m6a)
5294505|NCT00454480|adult pure erythroid leukemia (M6b)|adult pure erythroid leukemia (m6b)
5294506|NCT00454480|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5294507|NCT00454480|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5294508|NCT00454480|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5294509|NCT00454480|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5294510|NCT00454480|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
5294511|NCT00454480|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
5294512|NCT00454454|memory|memory
5294513|NCT00454454|display enhanced testing|display enhanced testing
5294514|NCT00454441|Sleep Quality|sleep quality
5294515|NCT00454441|Menopausal Symptoms|menopausal symptoms
5294516|NCT00454441|Actigraph|actigraph
5294517|NCT00454441|Bionovo|bionovo
5294518|NCT00454441|MF101|mf101
5294519|NCT00454428|Bypass Surgery|bypass surgery
5294520|NCT00454428|Coronary Artery|coronary artery
5294521|NCT00454415|Diet|diet
5294522|NCT00454415|Body Mass Index|body mass index
5294523|NCT00454415|BMI|bmi
5294524|NCT00454389|Macular|macular
5294525|NCT00454389|Degeneration|degeneration
5294526|NCT00454389|AMD|amd
5294527|NCT00454389|Wet Age-Related macular degeneration|wet age-related macular degeneration
5294528|NCT00454376|metastatic gastrointestinal carcinoid tumor|metastatic gastrointestinal carcinoid tumor
5294529|NCT00454376|recurrent gastrointestinal carcinoid tumor|recurrent gastrointestinal carcinoid tumor
5294530|NCT00454376|pulmonary carcinoid tumor|pulmonary carcinoid tumor
5294531|NCT00454376|gastrinoma|gastrinoma
5294532|NCT00454376|insulinoma|insulinoma
5294533|NCT00454376|WDHA syndrome|wdha syndrome
5294534|NCT00454376|pancreatic polypeptide tumor|pancreatic polypeptide tumor
5294535|NCT00454376|somatostatinoma|somatostatinoma
5294536|NCT00454376|glucagonoma|glucagonoma
5294537|NCT00454376|liver metastases|liver metastases
5294538|NCT00454350|Hectorol (doxercalciferol injection)|hectorol (doxercalciferol injection)
5294539|NCT00454350|Zemplar (paricalcitol injection)|zemplar (paricalcitol injection)
5294540|NCT00454337|HIV-1 infection|hiv-1 infection
5294541|NCT00454337|enfuvirtide|enfuvirtide
5294542|NCT00454337|raltegravir|raltegravir
5294543|NCT00454337|treatment experienced|treatment experienced
5294544|NCT00454324|Lung cancer|lung cancer
5294545|NCT00454324|Small cell lung cancer|small cell lung cancer
5294546|NCT00454324|Abraxane|abraxane
5294547|NCT00454324|Paclitaxel|paclitaxel
5294548|NCT00454324|Carboplatin|carboplatin
5294549|NCT00454324|Phase II|phase ii
5294550|NCT00454324|Randomized|randomized
5294551|NCT00454324|Lineberger|lineberger
5294552|NCT00454324|LCCC|lccc
5294553|NCT00454311|Pregnancy and implantation rates|pregnancy and implantation rates
5294554|NCT00454311|Efficiency and accuracy of the genetic testing|efficiency and accuracy of the genetic testing
5294555|NCT00454298|Severe Osteoarthritis|severe osteoarthritis
5294556|NCT00454298|Arthritis|arthritis
5294557|NCT00454285|bacteremia,cultures, infective endocarditis, prophylaxis|bacteremia,cultures, infective endocarditis, prophylaxis
5294558|NCT00454272|febrile|febrile
5294559|NCT00454272|neutropenia|neutropenia
5294560|NCT00454272|cancer|cancer
5294561|NCT00454272|Gram positive infection|gram positive infection
5294562|NCT00454259|Postoperative Hyperalgesia|postoperative hyperalgesia
5294563|NCT00454259|Human volunteer|human volunteer
5294564|NCT00454259|Fentanyl|fentanyl
5294565|NCT00454259|Randomized Controlled Trial|randomized controlled trial
5294566|NCT00454259|Pain chronicisation|pain chronicisation
5294567|NCT00454259|Predictive test|predictive test
5294568|NCT00454233|Diabetes Mellitus Type 2|diabetes mellitus type 2
5294569|NCT00454233|YM543|ym543
5294570|NCT00454233|Treatment|treatment
5294571|NCT00454233|Safety|safety
5294572|NCT00454233|efficacy|efficacy
5294573|NCT00454207|Pulmonary Arterial Hypertension, PAH|pulmonary arterial hypertension, pah
5294574|NCT00454194|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5294575|NCT00454194|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5294576|NCT00454194|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5294577|NCT00454194|adenosquamous cell lung cancer|adenosquamous cell lung cancer
5294578|NCT00454194|adenocarcinoma of the lung|adenocarcinoma of the lung
5294579|NCT00454181|human immunodeficiency virus|human immunodeficiency virus
5294580|NCT00454181|human papilloma virus|human papilloma virus
5294581|NCT00454181|warts, oral|warts, oral
5294582|NCT00454181|papillomatosis|papillomatosis
5294583|NCT00454181|treatment experienced|treatment experienced
5294584|NCT00454168|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
5294585|NCT00454168|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
5294586|NCT00454168|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
5294587|NCT00454168|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5294588|NCT00454168|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5294589|NCT00454168|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5294590|NCT00454168|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5294591|NCT00454168|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5294592|NCT00454168|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5294593|NCT00454168|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
5294594|NCT00454168|adult acute promyelocytic leukemia (M3)|adult acute promyelocytic leukemia (m3)
5294595|NCT00454168|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5294596|NCT00454168|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
5294597|NCT00454168|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
5294598|NCT00454168|adult erythroleukemia (M6a)|adult erythroleukemia (m6a)
5294599|NCT00454168|adult pure erythroid leukemia (M6b)|adult pure erythroid leukemia (m6b)
5294600|NCT00454168|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
5294601|NCT00454155|HSCT|hsct
5294602|NCT00454155|AGVHD|agvhd
5294603|NCT00454155|Myeloablative|myeloablative
5294604|NCT00454155|Allogeneic|allogeneic
5294605|NCT00454155|Hematopoietic|hematopoietic
5294606|NCT00454155|Stem|stem
5294607|NCT00454155|Cell|cell
5294608|NCT00454155|Transplantation|transplantation
5294609|NCT00454129|Feasibilty of cholangiography via double-balloon enteroscopy|feasibilty of cholangiography via double-balloon enteroscopy
5294610|NCT00454116|Colon Cancer|colon cancer
5294611|NCT00454116|Rectal Cancer|rectal cancer
5294612|NCT00454103|adrenocortical carcinoma (ACC)|adrenocortical carcinoma (acc)
5294613|NCT00454103|adrenal tumor|adrenal tumor
5294614|NCT00454103|metastastic adrenocortical carcinoma|metastastic adrenocortical carcinoma
5294615|NCT00454090|Advanced Malignancies|advanced malignancies
5294616|NCT00454077|thyroid cancer; rhTSH; thyroid ablation|thyroid cancer; rhtsh; thyroid ablation
5294617|NCT00454064|cognitive-behavioral therapy|cognitive-behavioral therapy
5294618|NCT00454064|back pain|back pain
5294619|NCT00454064|low back pain|low back pain
5294620|NCT00454064|biofeedback|biofeedback
5294621|NCT00454064|randomized controlled study|randomized controlled study
5294622|NCT00454064|EMG biofeedback|emg biofeedback
5294623|NCT00454051|Asthma, anti-immunoglobulin E, omalizumab, IgE receptors|asthma, anti-immunoglobulin e, omalizumab, ige receptors
5294624|NCT00454038|cystectomy|cystectomy
5294625|NCT00454038|augmentation|augmentation
5294626|NCT00454038|sinus|sinus
5294627|NCT00454038|amputation|amputation
5294628|NCT00454038|implant|implant
5294629|NCT00454025|glaucoma|glaucoma
5294630|NCT00454025|intraocular pressure|intraocular pressure
5294631|NCT00454025|postural changes|postural changes
5294632|NCT00454012|non reassuring fetal heart rate tracing|non reassuring fetal heart rate tracing
5294633|NCT00454012|biophysical profile|biophysical profile
5294634|NCT00454012|assessing fetal wellbeing|assessing fetal wellbeing
5294635|NCT00453999|influenza|influenza
5294636|NCT00453999|flu|flu
5294637|NCT00453986|immunogenicity|immunogenicity
5294638|NCT00453986|Meningococcal serogroups A, C, W-135 and/or Y disease|meningococcal serogroups a, c, w-135 and/or y disease
5294639|NCT00453986|co-administration|co-administration
5294640|NCT00453986|meningococcal vaccine|meningococcal vaccine
5294642|NCT00453986|conjugate vaccine|conjugate vaccine
5294643|NCT00453973|anemia|anemia
5294644|NCT00453973|chronic kidney disease|chronic kidney disease
5294646|NCT00453973|chronic renal failure|chronic renal failure
5294647|NCT00453973|CRF|crf
5294648|NCT00453973|dialysis|dialysis
5294649|NCT00453973|erythropoietin|erythropoietin
5294650|NCT00453973|EPO|epo
5294651|NCT00453973|erythropoiesis stimulating agent|erythropoiesis stimulating agent
5294652|NCT00453973|ESA|esa
5294653|NCT00453973|Hematide™|hematide™
5294654|NCT00453973|hemodialysis|hemodialysis
5294655|NCT00453973|hemoglobin|hemoglobin
5294656|NCT00453973|Hb|hb
5294657|NCT00453973|Hgb|hgb
5294658|NCT00453973|Omontys|omontys
5294659|NCT00453973|peginesatide|peginesatide
5294660|NCT00453973|red blood cell|red blood cell
5294661|NCT00453973|red blood cell production|red blood cell production
5294662|NCT00453960|Endometrial hyperplasia|endometrial hyperplasia
5294663|NCT00453960|Genistein|genistein
5294664|NCT00453960|Isoflavones|isoflavones
5294665|NCT00453960|dysfunctional uterine bleeding|dysfunctional uterine bleeding
5294666|NCT00453934|Diabetes|diabetes
5294667|NCT00453934|Type 1 Diabetes|type 1 diabetes
5294668|NCT00453934|Type 2 Diabetes|type 2 diabetes
5294669|NCT00453934|Physiologic Insulin|physiologic insulin
5294670|NCT00453934|Basal Insulin|basal insulin
5294671|NCT00453934|Bolus Insulin|bolus insulin
5294672|NCT00453934|Mealtime insulin|mealtime insulin
5294673|NCT00453934|Insulin patch|insulin patch
5294674|NCT00453934|Multiple daily injections|multiple daily injections
5294675|NCT00453921|TBI|tbi
5294676|NCT00453921|Memory|memory
5294677|NCT00453921|Methylphenidate|methylphenidate
5294678|NCT00453921|Ritalin|ritalin
5294679|NCT00453921|Memory and Attention Training|memory and attention training
5294680|NCT00453895|Adrenal cancer refractory to cytotoxic therapy|adrenal cancer refractory to cytotoxic therapy
5294681|NCT00453895|Sunitinib|sunitinib
5294682|NCT00453895|Multitargeted tyrosine-kinase inhibitor|multitargeted tyrosine-kinase inhibitor
5294683|NCT00453869|Liver fibrosis|liver fibrosis
5294684|NCT00453869|Hepatitis B virus and C virus|hepatitis b virus and c virus
5294685|NCT00453869|FibroMeter|fibrometer
5294686|NCT00453869|FibroScan®|fibroscan®
5294687|NCT00453856|Malaria|malaria
5294688|NCT00453856|Sulfadoxine|sulfadoxine
5294689|NCT00453856|Pyrimethamine|pyrimethamine
5294690|NCT00453856|Resistance|resistance
5294691|NCT00453856|Gabon|gabon
5294692|NCT00453843|Stroke|stroke
5294693|NCT00453843|movement therapy|movement therapy
5294694|NCT00453843|robotics|robotics
5294695|NCT00453843|rehabilitation robotics|rehabilitation robotics
5294696|NCT00453843|shoulder, elbow, wrist|shoulder, elbow, wrist
5294697|NCT00453830|Diverticulitis; laparoscopy; short term outcome|diverticulitis; laparoscopy; short term outcome
5294698|NCT00453817|islet transplantation|islet transplantation
5294699|NCT00453817|imaging|imaging
5294700|NCT00453817|graft monitoring|graft monitoring
5294701|NCT00453817|magnetic resonance imaging|magnetic resonance imaging
5294702|NCT00453804|Alcohol dependence|alcohol dependence
5294703|NCT00453804|Major Mental Illness|major mental illness
5294704|NCT00453804|Injectable naltrexone|injectable naltrexone
5294705|NCT00453791|GW805858|gw805858
5294706|NCT00453791|MDI|mdi
5294707|NCT00453791|asthma|asthma
5294708|NCT00453791|surfactant|surfactant
5294709|NCT00453778|mild asthma|mild asthma
5294710|NCT00453778|FLIXOTIDE|flixotide
5294711|NCT00453778|methacholine|methacholine
5294712|NCT00453778|bronchial challenge|bronchial challenge
5294713|NCT00453778|leukotriene D4|leukotriene d4
5294714|NCT00453765|cough|cough
5294715|NCT00453765|hyperreactivity|hyperreactivity
5294716|NCT00453765|montelukast|montelukast
5294717|NCT00453752|systemic sclerosis|systemic sclerosis
5294718|NCT00453752|pulmonary hypertension|pulmonary hypertension
5294719|NCT00453752|echocardiography|echocardiography
5294720|NCT00453752|N-Terminal proBNP|n-terminal probnp
5294721|NCT00453726|Natriuretic peptide brain|natriuretic peptide brain
5294722|NCT00453726|Continuous positive airway pressure|continuous positive airway pressure
5294723|NCT00453726|Intermittent positive pressure breathing|intermittent positive pressure breathing
5294724|NCT00453726|Respiratory insufficiency|respiratory insufficiency
5294725|NCT00453713|Idiopathic pulmonary fibrosis|idiopathic pulmonary fibrosis
5294726|NCT00453713|Interstitial lung disease|interstitial lung disease
5294727|NCT00453713|Diffuse parenchymal lung disease|diffuse parenchymal lung disease
5294728|NCT00453713|Health disparities|health disparities
5294729|NCT00453700|chagas|chagas
5294730|NCT00453700|trypanosoma cruzi|trypanosoma cruzi
5294731|NCT00453687|COPD|copd
5294732|NCT00453687|GSK233705,|gsk233705,
5294733|NCT00453687|Magnesium Stearate,|magnesium stearate,
5294734|NCT00453674|Adrenal cancer|adrenal cancer
5294735|NCT00453674|Treatment|treatment
5294736|NCT00453674|Surgery|surgery
5294737|NCT00453674|Mitotane|mitotane
5294738|NCT00453661|Breast Cancer|breast cancer
5294739|NCT00453661|Cervical Cancer|cervical cancer
5294740|NCT00453661|Prostate Cancer|prostate cancer
5294741|NCT00453661|Colorectal Cancer|colorectal cancer
5294742|NCT00453661|Lung Cancer|lung cancer
5294743|NCT00453661|Cancer Prevention|cancer prevention
5294744|NCT00453661|Treatment Demonstration for Ethnic and Racial Minorities|treatment demonstration for ethnic and racial minorities
5294745|NCT00453661|Centers for Medicare and Medicaid Services|centers for medicare and medicaid services
5294746|NCT00453661|CMS|cms
5294747|NCT00453661|Hispanic American|hispanic american
5294748|NCT00453661|Cancer Screening Assessment|cancer screening assessment
5294749|NCT00453661|Annual Questionnaire|annual questionnaire
5294750|NCT00453661|Patient Navigator|patient navigator
5294751|NCT00453661|Educational Materials|educational materials
5294752|NCT00453648|stable isotopes|stable isotopes
5294753|NCT00453648|vitamin A|vitamin a
5294754|NCT00453648|beta-carotene|beta-carotene
5294755|NCT00453648|orange-fleshed sweet potatoes|orange-fleshed sweet potatoes
5294756|NCT00453648|iron|iron
5294757|NCT00453648|zinc|zinc
5294758|NCT00453648|absorption|absorption
5294759|NCT00453648|bioavailability|bioavailability
5294760|NCT00453648|vitamin A equivalency|vitamin a equivalency
5294761|NCT00453648|Bangladesh|bangladesh
5294762|NCT00453648|women|women
5294763|NCT00453635|Cancer|cancer
5294764|NCT00453635|Breast cancer|breast cancer
5294765|NCT00453635|First line treatment|first line treatment
5294766|NCT00453635|Docetaxel|docetaxel
5294767|NCT00453635|Carboplatin|carboplatin
5294768|NCT00453635|Herceptin|herceptin
5294769|NCT00453635|Vinorelbine|vinorelbine
5294770|NCT00453622|Heart Failure|heart failure
5294771|NCT00453622|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
5294772|NCT00453622|Risk stratification|risk stratification
5294773|NCT00453622|Prediction|prediction
5294774|NCT00453622|Proteomics|proteomics
5294775|NCT00453622|Chemokine|chemokine
5294776|NCT00453622|cardiac enzymes|cardiac enzymes
5294777|NCT00453622|Brain Natriuretic Peptide|brain natriuretic peptide
5294778|NCT00453609|Bipolar Disorders|bipolar disorders
5294779|NCT00453609|Schizophrenia|schizophrenia
5294780|NCT00453609|Schizoaffective Disorders|schizoaffective disorders
5294781|NCT00453609|Alcohol Dependence|alcohol dependence
5294782|NCT00453609|Long-lasting injectable naltrexone|long-lasting injectable naltrexone
5294783|NCT00453596|infertile women|infertile women
5294784|NCT00453596|thin endometrial thickness|thin endometrial thickness
5294785|NCT00453596|implantation failure|implantation failure
5294786|NCT00453583|Pediatric|pediatric
5294787|NCT00453583|Allergies|allergies
5294788|NCT00453583|Antihistamines|antihistamines
5294789|NCT00453583|Non-interventional|non-interventional
5294790|NCT00453570|Diphteria|diphteria
5294791|NCT00453570|Tetanus|tetanus
5294792|NCT00453570|Haemophilus influenzae type b|haemophilus influenzae type b
5294793|NCT00453570|Poliomyelitis|poliomyelitis
5294794|NCT00453570|Pertussis|pertussis
5294795|NCT00453557|growth hormone, obesity, visceral adiposity|growth hormone, obesity, visceral adiposity
5294796|NCT00453544|computer assisted instruction|computer assisted instruction
5294797|NCT00453544|decision making|decision making
5294798|NCT00453544|educational resource design /development|educational resource design /development
5294799|NCT00453544|executive function|executive function
5294800|NCT00453531|Forearm Ischemia|forearm ischemia
5294801|NCT00453531|Endothelial Function|endothelial function
5294802|NCT00453531|Acetyicholine Vasodilation|acetyicholine vasodilation
5294803|NCT00453531|Venous Plethysmography|venous plethysmography
5294804|NCT00453531|Healthy Volunteer|healthy volunteer
5294805|NCT00453531|HV|hv
5294806|NCT00453518|SVG|svg
5294807|NCT00453518|Saphenous Vein Graft|saphenous vein graft
5294808|NCT00453518|Embolic Protection|embolic protection
5294809|NCT00453518|Distal Protection|distal protection
5294810|NCT00453518|EPD|epd
5294811|NCT00453518|FiberNet|fibernet
5294812|NCT00453518|Saphenous Vein Graft intervention|saphenous vein graft intervention
5294813|NCT00453505|Transcranial Direct Current Stimulation (TDCS)|transcranial direct current stimulation (tdcs)
5294814|NCT00453505|Transcranial Magnetic Stimulation (TMS)|transcranial magnetic stimulation (tms)
5294815|NCT00453505|Peripheral Nerve Stimulation|peripheral nerve stimulation
5294816|NCT00453505|Primary Motor Cortex|primary motor cortex
5294817|NCT00453505|Corticomotor Excitability|corticomotor excitability
5294818|NCT00453505|Healthy Volunteer|healthy volunteer
5294819|NCT00453505|HV|hv
5294820|NCT00453479|muscarinic receptor,|muscarinic receptor,
5294821|NCT00453479|bronchodilators|bronchodilators
5294822|NCT00453479|Chronic obstructive pulmonary disease,|chronic obstructive pulmonary disease,
5294823|NCT00453466|women experiencing domestic violence|women experiencing domestic violence
5294824|NCT00453453|Congestive heart failure|congestive heart failure
5294825|NCT00453453|observation unit|observation unit
5294826|NCT00453453|nesiritide|nesiritide
5294827|NCT00453440|HIV|hiv
5294828|NCT00453440|HLA-B*5701|hla-b*5701
5294829|NCT00453440|Abacavir hypersensitivity reaction|abacavir hypersensitivity reaction
5294830|NCT00453440|HIV Infection|hiv infection
5294831|NCT00453427|PTL NOS|ptl nos
5294832|NCT00453427|AILD|aild
5294833|NCT00453427|NHL|nhl
5294834|NCT00453427|CHOP|chop
5294835|NCT00453414|PAH|pah
5294836|NCT00453414|Pediatric|pediatric
5294837|NCT00453414|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
5294838|NCT00453401|cold sore|cold sore
5294839|NCT00453375|Diabetic|diabetic
5294840|NCT00453375|Diabetes|diabetes
5294841|NCT00453375|Type 1 Diabetes|type 1 diabetes
5294842|NCT00453375|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
5294843|NCT00453375|autoimmune disease|autoimmune disease
5294844|NCT00453362|NSCLC|nsclc
5294845|NCT00453362|Tarceva|tarceva
5294846|NCT00453362|Positron emission technology|positron emission technology
5294847|NCT00453362|PET|pet
5294848|NCT00453362|Computerized tomography|computerized tomography
5294849|NCT00453362|CT|ct
5294850|NCT00453349|Uncomplicated pelvic inflammatory disease|uncomplicated pelvic inflammatory disease
5294851|NCT00453336|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
5294852|NCT00453336|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
5294853|NCT00453336|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
5294854|NCT00453336|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5294855|NCT00453336|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
5294856|NCT00453336|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
5294857|NCT00453336|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
5294858|NCT00453336|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5294859|NCT00453336|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
5294860|NCT00453336|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
5294861|NCT00453336|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
5294862|NCT00453336|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5294863|NCT00453336|stage I squamous cell carcinoma of the larynx|stage i squamous cell carcinoma of the larynx
5294864|NCT00453336|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
5294865|NCT00453336|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
5294866|NCT00453336|oral leukoplakia|oral leukoplakia
5294868|NCT00453323|Phase II|phase ii
5294869|NCT00453323|Metastatic esophageal cancer|metastatic esophageal cancer
5294870|NCT00453323|Recurrent esophageal cancer|recurrent esophageal cancer
5294871|NCT00453310|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
5294872|NCT00453310|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
5294873|NCT00453310|ovarian choriocarcinoma|ovarian choriocarcinoma
5294874|NCT00453310|ovarian immature teratoma|ovarian immature teratoma
5294875|NCT00453310|ovarian mature teratoma|ovarian mature teratoma
5294876|NCT00453310|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
5294877|NCT00453310|testicular choriocarcinoma|testicular choriocarcinoma
5294878|NCT00453310|testicular seminoma|testicular seminoma
5294879|NCT00453310|testicular yolk sac tumor|testicular yolk sac tumor
5294880|NCT00453310|ovarian dysgerminoma|ovarian dysgerminoma
5294881|NCT00453310|ovarian embryonal carcinoma|ovarian embryonal carcinoma
5294882|NCT00453310|ovarian yolk sac tumor|ovarian yolk sac tumor
5294883|NCT00453310|ovarian monodermal and highly specialized teratoma|ovarian monodermal and highly specialized teratoma
5294884|NCT00453310|ovarian polyembryoma|ovarian polyembryoma
5294885|NCT00453310|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
5294886|NCT00453310|ovarian mixed germ cell tumor|ovarian mixed germ cell tumor
5294887|NCT00453310|testicular choriocarcinoma and embryonal carcinoma|testicular choriocarcinoma and embryonal carcinoma
5294888|NCT00453310|testicular choriocarcinoma and seminoma|testicular choriocarcinoma and seminoma
5294889|NCT00453310|testicular choriocarcinoma and teratoma|testicular choriocarcinoma and teratoma
5294890|NCT00453310|testicular choriocarcinoma and yolk sac tumor|testicular choriocarcinoma and yolk sac tumor
5294891|NCT00453310|testicular embryonal carcinoma and seminoma|testicular embryonal carcinoma and seminoma
5294892|NCT00453310|testicular embryonal carcinoma and teratoma with seminoma|testicular embryonal carcinoma and teratoma with seminoma
5294893|NCT00453310|testicular embryonal carcinoma and teratoma|testicular embryonal carcinoma and teratoma
5294894|NCT00453310|testicular embryonal carcinoma and yolk sac tumor with seminoma|testicular embryonal carcinoma and yolk sac tumor with seminoma
5294895|NCT00453310|testicular embryonal carcinoma and yolk sac tumor|testicular embryonal carcinoma and yolk sac tumor
5294896|NCT00453310|testicular yolk sac tumor and teratoma with seminoma|testicular yolk sac tumor and teratoma with seminoma
5294897|NCT00453310|testicular yolk sac tumor and teratoma|testicular yolk sac tumor and teratoma
5294898|NCT00453310|testicular embryonal carcinoma|testicular embryonal carcinoma
5294899|NCT00453310|recurrent extragonadal non-seminomatous germ cell tumor|recurrent extragonadal non-seminomatous germ cell tumor
5294900|NCT00453310|recurrent extragonadal seminoma|recurrent extragonadal seminoma
5294901|NCT00453310|stage IV extragonadal non-seminomatous germ cell tumor|stage iv extragonadal non-seminomatous germ cell tumor
5294902|NCT00453310|stage IV extragonadal seminoma|stage iv extragonadal seminoma
5294903|NCT00453310|recurrent extragonadal germ cell tumor|recurrent extragonadal germ cell tumor
5294904|NCT00453310|testicular immature teratoma|testicular immature teratoma
5294905|NCT00453310|testicular mature teratoma|testicular mature teratoma
5294906|NCT00453310|adult teratoma|adult teratoma
5294907|NCT00453297|Bionovo|bionovo
5294908|NCT00453297|MF101|mf101
5294909|NCT00453297|Herbs|herbs
5294910|NCT00453297|The primary goal of this study is to identify the highest safe oral dose of MF101 that is well tolerated in humans.|the primary goal of this study is to identify the highest safe oral dose of mf101 that is well tolerated in humans.
5294911|NCT00453271|chronic persistent infection of the nail bed or plate|chronic persistent infection of the nail bed or plate
5294912|NCT00453258|ocular proteomics|ocular proteomics
5294913|NCT00453258|eye disease|eye disease
5294914|NCT00453258|proteomics|proteomics
5294915|NCT00453232|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
5294916|NCT00453232|testicular choriocarcinoma and seminoma|testicular choriocarcinoma and seminoma
5294917|NCT00453232|testicular embryonal carcinoma and seminoma|testicular embryonal carcinoma and seminoma
5294918|NCT00453232|testicular choriocarcinoma and embryonal carcinoma|testicular choriocarcinoma and embryonal carcinoma
5294919|NCT00453232|testicular choriocarcinoma and teratoma|testicular choriocarcinoma and teratoma
5294920|NCT00453232|testicular choriocarcinoma|testicular choriocarcinoma
5294921|NCT00453232|testicular choriocarcinoma and yolk sac tumor|testicular choriocarcinoma and yolk sac tumor
5294922|NCT00453232|testicular embryonal carcinoma and teratoma with seminoma|testicular embryonal carcinoma and teratoma with seminoma
5294923|NCT00453232|testicular embryonal carcinoma and teratoma|testicular embryonal carcinoma and teratoma
5294924|NCT00453232|testicular embryonal carcinoma and yolk sac tumor with seminoma|testicular embryonal carcinoma and yolk sac tumor with seminoma
5294925|NCT00453232|testicular embryonal carcinoma and yolk sac tumor|testicular embryonal carcinoma and yolk sac tumor
5294926|NCT00453232|testicular embryonal carcinoma|testicular embryonal carcinoma
5294927|NCT00453232|testicular seminoma|testicular seminoma
5294928|NCT00453232|testicular yolk sac tumor|testicular yolk sac tumor
5294929|NCT00453232|testicular yolk sac tumor and teratoma with seminoma|testicular yolk sac tumor and teratoma with seminoma
5294930|NCT00453232|testicular yolk sac tumor and teratoma|testicular yolk sac tumor and teratoma
5294931|NCT00453232|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
5294932|NCT00453232|recurrent extragonadal non-seminomatous germ cell tumor|recurrent extragonadal non-seminomatous germ cell tumor
5294933|NCT00453232|recurrent extragonadal seminoma|recurrent extragonadal seminoma
5294934|NCT00453232|stage IV extragonadal non-seminomatous germ cell tumor|stage iv extragonadal non-seminomatous germ cell tumor
5295442|NCT00451607|newborn|newborn
5294935|NCT00453232|stage IV extragonadal seminoma|stage iv extragonadal seminoma
5294936|NCT00453232|adult teratoma|adult teratoma
5294937|NCT00453232|testicular immature teratoma|testicular immature teratoma
5294938|NCT00453232|testicular mature teratoma|testicular mature teratoma
5294939|NCT00453232|recurrent extragonadal germ cell tumor|recurrent extragonadal germ cell tumor
5294940|NCT00453206|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5294941|NCT00453206|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5294942|NCT00453206|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5294943|NCT00453206|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5294944|NCT00453206|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5294945|NCT00453206|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5294946|NCT00453206|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5294947|NCT00453206|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5294948|NCT00453206|primary myelofibrosis|primary myelofibrosis
5294949|NCT00453206|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5294950|NCT00453206|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5294951|NCT00453206|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5294952|NCT00453206|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5294953|NCT00453206|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
5294954|NCT00453206|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5294955|NCT00453206|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
5294956|NCT00453206|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
5294957|NCT00453206|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
5294958|NCT00453206|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
5294959|NCT00453206|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5294960|NCT00453206|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5294961|NCT00453206|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5294962|NCT00453206|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5294963|NCT00453206|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
5294964|NCT00453206|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
5294965|NCT00453206|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5294966|NCT00453206|prolymphocytic leukemia|prolymphocytic leukemia
5294967|NCT00453206|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5294968|NCT00453206|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5294969|NCT00453206|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5294970|NCT00453206|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5294971|NCT00453206|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5294972|NCT00453206|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5295187|NCT00452699|Salmeterol|salmeterol
5294973|NCT00453206|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5294974|NCT00453206|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5294975|NCT00453206|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5294976|NCT00453206|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5294977|NCT00453206|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5294978|NCT00453206|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5294979|NCT00453206|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5294980|NCT00453206|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5294981|NCT00453206|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5294982|NCT00453206|refractory multiple myeloma|refractory multiple myeloma
5294983|NCT00453206|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5294984|NCT00453206|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5294985|NCT00453206|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5294986|NCT00453206|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5294987|NCT00453206|stage I multiple myeloma|stage i multiple myeloma
5294988|NCT00453206|stage II multiple myeloma|stage ii multiple myeloma
5294989|NCT00453206|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5294990|NCT00453206|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5294991|NCT00453206|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5294992|NCT00453206|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5294993|NCT00453206|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5294994|NCT00453206|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5294995|NCT00453206|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5294996|NCT00453206|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5294997|NCT00453206|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5294998|NCT00453206|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5294999|NCT00453206|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5295000|NCT00453206|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5295001|NCT00453206|stage III multiple myeloma|stage iii multiple myeloma
5295002|NCT00453206|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5295003|NCT00453206|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5295004|NCT00453206|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5295005|NCT00453206|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5295006|NCT00453206|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5295007|NCT00453206|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5295008|NCT00453206|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5295009|NCT00453206|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5295010|NCT00453206|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5295011|NCT00453206|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5295012|NCT00453206|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5295013|NCT00453206|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5295014|NCT00453206|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5295015|NCT00453206|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5295016|NCT00453206|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5295017|NCT00453206|polycythemia vera|polycythemia vera
5295018|NCT00453206|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5295019|NCT00453206|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
5295020|NCT00453206|stage I childhood Hodgkin lymphoma|stage i childhood hodgkin lymphoma
5295021|NCT00453206|stage II childhood Hodgkin lymphoma|stage ii childhood hodgkin lymphoma
5295022|NCT00453206|stage III childhood Hodgkin lymphoma|stage iii childhood hodgkin lymphoma
5295023|NCT00453206|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
5295024|NCT00453206|recurrent childhood anaplastic large cell lymphoma|recurrent childhood anaplastic large cell lymphoma
5295025|NCT00453206|stage I childhood anaplastic large cell lymphoma|stage i childhood anaplastic large cell lymphoma
5295026|NCT00453206|stage II childhood anaplastic large cell lymphoma|stage ii childhood anaplastic large cell lymphoma
5295027|NCT00453206|stage III childhood anaplastic large cell lymphoma|stage iii childhood anaplastic large cell lymphoma
5295028|NCT00453206|stage IV childhood anaplastic large cell lymphoma|stage iv childhood anaplastic large cell lymphoma
5295029|NCT00453206|recurrent childhood grade III lymphomatoid granulomatosis|recurrent childhood grade iii lymphomatoid granulomatosis
5295030|NCT00453206|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
5295031|NCT00453206|stage I childhood large cell lymphoma|stage i childhood large cell lymphoma
5295032|NCT00453206|stage II childhood large cell lymphoma|stage ii childhood large cell lymphoma
5295033|NCT00453206|stage III childhood large cell lymphoma|stage iii childhood large cell lymphoma
5295034|NCT00453206|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
5295035|NCT00453206|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
5295036|NCT00453206|stage I childhood lymphoblastic lymphoma|stage i childhood lymphoblastic lymphoma
5295037|NCT00453206|stage II childhood lymphoblastic lymphoma|stage ii childhood lymphoblastic lymphoma
5295038|NCT00453206|stage III childhood lymphoblastic lymphoma|stage iii childhood lymphoblastic lymphoma
5295039|NCT00453206|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
5295040|NCT00453206|childhood nasal type extranodal NK/T-cell lymphoma|childhood nasal type extranodal nk/t-cell lymphoma
5295041|NCT00453206|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
5295042|NCT00453206|stage I childhood small noncleaved cell lymphoma|stage i childhood small noncleaved cell lymphoma
5295043|NCT00453206|stage II childhood small noncleaved cell lymphoma|stage ii childhood small noncleaved cell lymphoma
5295044|NCT00453206|stage III childhood small noncleaved cell lymphoma|stage iii childhood small noncleaved cell lymphoma
5295045|NCT00453206|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
5295046|NCT00453193|T-Cell Neoplasms|t-cell neoplasms
5295047|NCT00453193|Alemtuzumab|alemtuzumab
5295048|NCT00453193|Pentostatin|pentostatin
5295049|NCT00453193|Campath-1H|campath-1h
5295050|NCT00453193|Deoxycoformycin|deoxycoformycin
5295051|NCT00453193|Lymphoma|lymphoma
5295052|NCT00453193|Leukemia|leukemia
5295053|NCT00453180|Autistic Disorder|autistic disorder
5295054|NCT00453180|Asperger's|asperger's
5295056|NCT00453180|Pervasive Developmental Disorder|pervasive developmental disorder
5295057|NCT00453180|Autism|autism
5295058|NCT00453180|N-acetylcysteine|n-acetylcysteine
5295059|NCT00453180|acetylcysteine|acetylcysteine
5295060|NCT00453180|NAC|nac
5295061|NCT00453180|antioxidant|antioxidant
5295062|NCT00453180|treatment|treatment
5295063|NCT00453180|core symptoms|core symptoms
5295064|NCT00453180|Autism Spectrum Disorders|autism spectrum disorders
5295065|NCT00453180|Asperger's Disorder|asperger's disorder
5295066|NCT00453180|Pervasive Developmental Disorder Not Otherwise Specified|pervasive developmental disorder not otherwise specified
5295067|NCT00453180|Pervasive Developmental Disorders|pervasive developmental disorders
5295068|NCT00453167|Small cell lung cancer|small cell lung cancer
5295069|NCT00453167|second-line therapy|second-line therapy
5295070|NCT00453141|Betamethasone for preterm labor|betamethasone for preterm labor
5295071|NCT00453141|Preterm delivery|preterm delivery
5295072|NCT00453141|Infant Respiratory Distress Syndrome|infant respiratory distress syndrome
5295073|NCT00453128|Calcium Pyrophosphate|calcium pyrophosphate
5295074|NCT00453128|associated conditions|associated conditions
5295075|NCT00453115|Non small cell lung cancer|non small cell lung cancer
5295076|NCT00453115|advanced stage IIIB|advanced stage iiib
5295077|NCT00453115|Stage IV|stage iv
5295078|NCT00453102|Marginal Zone Lymphoma|marginal zone lymphoma
5295079|NCT00453102|Non-gastric extranodal Marginal Zone Lymphoma|non-gastric extranodal marginal zone lymphoma
5295080|NCT00453102|Splenic Marginal Zone Lymphoma|splenic marginal zone lymphoma
5295081|NCT00453102|Nodal Marginal Zone Lymphoma|nodal marginal zone lymphoma
5295082|NCT00453102|Gastric Marginal Zone Lymphoma|gastric marginal zone lymphoma
5295083|NCT00453102|MZL|mzl
5295084|NCT00453102|Non-gastric extranodal MZL|non-gastric extranodal mzl
5295085|NCT00453102|Splenic MZL|splenic mzl
5295086|NCT00453102|Nodal MZL|nodal mzl
5295087|NCT00453102|Gastric MZL|gastric mzl
5295088|NCT00453089|Chinese Herbs|chinese herbs
5295089|NCT00453089|Postmenopausal|postmenopausal
5295090|NCT00453089|Vaginal Atrophy|vaginal atrophy
5295091|NCT00453089|Vulvar Atrophy|vulvar atrophy
5295092|NCT00453089|Symptoms|symptoms
5295093|NCT00453089|Bionovo|bionovo
5295094|NCT00453089|VG101|vg101
5295095|NCT00453076|Biliary Obstruction|biliary obstruction
5295096|NCT00453050|stage III melanoma|stage iii melanoma
5295097|NCT00453050|stage IV melanoma|stage iv melanoma
5295098|NCT00453050|skin metastases|skin metastases
5295099|NCT00453037|hypertension|hypertension
5295100|NCT00453037|self measurement of blood pressure|self measurement of blood pressure
5295101|NCT00453037|education program|education program
5295102|NCT00453037|life style|life style
5295103|NCT00453024|Advanced glaucoma|advanced glaucoma
5295104|NCT00453024|Ahmed glaucoma implant|ahmed glaucoma implant
5295105|NCT00453024|Anterior segment optical coherence tomography|anterior segment optical coherence tomography
5295106|NCT00453024|Pericardial patch graft|pericardial patch graft
5295107|NCT00453024|Tissue glue|tissue glue
5295108|NCT00453024|Scleral flap|scleral flap
5295109|NCT00453024|Sutures|sutures
5295110|NCT00453011|vitreous loss|vitreous loss
5295111|NCT00453011|intraocular lenses|intraocular lenses
5295112|NCT00453011|Patients undergoing extracapsular cataract surgery|patients undergoing extracapsular cataract surgery
5295113|NCT00453011|Vitreous loss with sufficient capsular support for an unsutured posterior chamber lens|vitreous loss with sufficient capsular support for an unsutured posterior chamber lens
5295114|NCT00453011|5% random sample of patients with no vitreous loss|5% random sample of patients with no vitreous loss
5295115|NCT00452998|Sequential Laser Iridotomy|sequential laser iridotomy
5295116|NCT00452998|Q-Switched 532 nm Laser|q-switched 532 nm laser
5295117|NCT00452998|Frequency Doubled Neodymium Yag Laser|frequency doubled neodymium yag laser
5295118|NCT00452972|Cesarean delivery|cesarean delivery
5295119|NCT00452972|Spinal anesthesia|spinal anesthesia
5295120|NCT00452972|Nausea|nausea
5295121|NCT00452972|Vomiting|vomiting
5295122|NCT00452972|Pain|pain
5295123|NCT00452920|cervical squamous cell carcinoma|cervical squamous cell carcinoma
5295124|NCT00452920|stage IIB cervical cancer|stage iib cervical cancer
5295125|NCT00452920|stage III cervical cancer|stage iii cervical cancer
5295126|NCT00452920|stage IVA cervical cancer|stage iva cervical cancer
5295127|NCT00452881|Non-small cell lung cancer|non-small cell lung cancer
5295128|NCT00452881|adjuvant chemotherapy|adjuvant chemotherapy
5295129|NCT00452868|cognitive/functional effects|cognitive/functional effects
5295130|NCT00452868|neurotoxicity|neurotoxicity
5295131|NCT00452868|long-term effects secondary to cancer therapy in children|long-term effects secondary to cancer therapy in children
5295132|NCT00452868|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
5295133|NCT00452868|radiation toxicity|radiation toxicity
5295134|NCT00452868|childhood central nervous system germ cell tumor|childhood central nervous system germ cell tumor
5295135|NCT00452868|childhood choroid plexus tumor|childhood choroid plexus tumor
5295136|NCT00452868|childhood craniopharyngioma|childhood craniopharyngioma
5295137|NCT00452868|childhood grade I meningioma|childhood grade i meningioma
5295138|NCT00452868|childhood grade II meningioma|childhood grade ii meningioma
5295139|NCT00452868|childhood grade III meningioma|childhood grade iii meningioma
5295140|NCT00452868|childhood spinal cord neoplasm|childhood spinal cord neoplasm
5295141|NCT00452868|childhood brain stem glioma|childhood brain stem glioma
5295142|NCT00452868|childhood cerebellar astrocytoma|childhood cerebellar astrocytoma
5295143|NCT00452868|childhood medulloblastoma|childhood medulloblastoma
5295144|NCT00452868|childhood supratentorial primitive neuroectodermal tumor|childhood supratentorial primitive neuroectodermal tumor
5295145|NCT00452868|childhood visual pathway and hypothalamic glioma|childhood visual pathway and hypothalamic glioma
5295146|NCT00452868|childhood subependymal giant cell astrocytoma|childhood subependymal giant cell astrocytoma
5295147|NCT00452868|childhood ependymoma|childhood ependymoma
5295148|NCT00452868|childhood cerebral astrocytoma/malignant glioma|childhood cerebral astrocytoma/malignant glioma
5295149|NCT00452855|Nausea|nausea
5295150|NCT00452855|Vomiting|vomiting
5295151|NCT00452855|Post operative|post operative
5295152|NCT00452855|Propofol remifentanil anaesthesia|propofol remifentanil anaesthesia
5295153|NCT00452855|Sevoflurane remifentanil anaesthesia|sevoflurane remifentanil anaesthesia
5295154|NCT00452816|Chronic Disease|chronic disease
5295155|NCT00452816|Employer Health Costs|employer health costs
5295156|NCT00452816|Health Promotion|health promotion
5295157|NCT00452816|Insurance Benefits|insurance benefits
5295158|NCT00452816|Marketing of Health Services|marketing of health services
5295159|NCT00452816|Mass Screening|mass screening
5295160|NCT00452816|Prevention & Control|prevention & control
5295161|NCT00452816|Tobacco Use Cessation|tobacco use cessation
5295162|NCT00452816|Workplace|workplace
5295163|NCT00452803|Non small cell lung cancer|non small cell lung cancer
5295164|NCT00452790|Vaccines, Pneumococcal|vaccines, pneumococcal
5295165|NCT00452777|Diabetic neuropathy, painful|diabetic neuropathy, painful
5295166|NCT00452777|Adenosine A2A receptor|adenosine a2a receptor
5295167|NCT00452764|COPD|copd
5295168|NCT00452764|Healthy|healthy
5295169|NCT00452764|Regulatory T cell|regulatory t cell
5295170|NCT00452764|Heme oxygenase-1|heme oxygenase-1
5295171|NCT00452764|peripheral blood|peripheral blood
5295172|NCT00452751|gastric cancer|gastric cancer
5295173|NCT00452751|laparoscopic surgery|laparoscopic surgery
5295174|NCT00452751|survival|survival
5295175|NCT00452751|preoperative staging|preoperative staging
5295176|NCT00452751|morbidity|morbidity
5295177|NCT00452751|quality of life|quality of life
5295178|NCT00452751|acute inflammatory reaction|acute inflammatory reaction
5295179|NCT00452751|cost|cost
5295180|NCT00452738|animal-assisted intervention|animal-assisted intervention
5295181|NCT00452738|pre surgery anxiety|pre surgery anxiety
5295182|NCT00452738|post surgery pain medication consumption|post surgery pain medication consumption
5295183|NCT00452712|orthostatism|orthostatism
5295184|NCT00452712|fever|fever
5295185|NCT00452699|fluticasone propionate|fluticasone propionate
5295186|NCT00452699|long-term study|long-term study
5295188|NCT00452699|FLOVENT 250|flovent 250
5295189|NCT00452699|Asthma|asthma
5295190|NCT00452699|ADVAIR 250|advair 250
5295191|NCT00452686|Chinese DT vaccin|chinese dt vaccin
5295192|NCT00452660|IRON|iron
5295193|NCT00452660|oxidative stress|oxidative stress
5295194|NCT00452660|MDS|mds
5295195|NCT00452647|Condition: No specific disease is being studied, few procedures are excluded.|condition: no specific disease is being studied, few procedures are excluded.
5295196|NCT00452647|Focus: To obtain blood pressure data and detect any trends to a statistically significant degree.|focus: to obtain blood pressure data and detect any trends to a statistically significant degree.
5295197|NCT00452634|Irinotecan|irinotecan
5295198|NCT00452634|cisplatin|cisplatin
5295199|NCT00452634|Simvastatin|simvastatin
5295200|NCT00452634|Extensive disease|extensive disease
5295201|NCT00452634|SCLC|sclc
5295202|NCT00452621|blood draw five years after booster-immunization with TBE vaccine to investigate immunogenicity in children|blood draw five years after booster-immunization with tbe vaccine to investigate immunogenicity in children
5295203|NCT00452621|TBE|tbe
5295204|NCT00452582|ischemic stroke|ischemic stroke
5295205|NCT00452582|recovery|recovery
5295206|NCT00452582|sildenafil|sildenafil
5295207|NCT00452569|Relapsed Refractory Multiple Myeloma|relapsed refractory multiple myeloma
5295208|NCT00452556|Prostatic Neoplasms|prostatic neoplasms
5295209|NCT00452556|Radiotherapy|radiotherapy
5295210|NCT00452556|Docetaxel|docetaxel
5295211|NCT00452556|Leuprolide Acetate|leuprolide acetate
5295212|NCT00452543|Major depressive disorder|major depressive disorder
5295213|NCT00452543|Alcoholism|alcoholism
5295214|NCT00452543|Alcohol abuse|alcohol abuse
5295215|NCT00452543|Alcohol dependence|alcohol dependence
5295216|NCT00452530|Prevention of deep vein thrombosis and pulmonary embolism after total knee replacement surgery|prevention of deep vein thrombosis and pulmonary embolism after total knee replacement surgery
5295217|NCT00452517|bare metal stents|bare metal stents
5295218|NCT00452517|sirolimus-eluting stents|sirolimus-eluting stents
5295219|NCT00452517|coronary polytetrafluoroethylene stent graft|coronary polytetrafluoroethylene stent graft
5295220|NCT00452517|acute coronary syndrome|acute coronary syndrome
5295221|NCT00452517|quantitative coronary angiography analysis|quantitative coronary angiography analysis
5295222|NCT00452517|major adverse cardiac events|major adverse cardiac events
5295223|NCT00452517|in-stent restenosis|in-stent restenosis
5295224|NCT00452517|target lesion revascularisation|target lesion revascularisation
5295225|NCT00452478|Hyperphosphataemia|hyperphosphataemia
5295226|NCT00452465|Elderly|elderly
5295227|NCT00452465|Nursing care plan|nursing care plan
5295228|NCT00452465|Quality of Life|quality of life
5295229|NCT00452452|Pneumococcal Vaccines|pneumococcal vaccines
5295230|NCT00452439|Leukemia|leukemia
5295231|NCT00452439|Lymphoma|lymphoma
5295232|NCT00452439|Acute Lymphocytic Leukemia|acute lymphocytic leukemia
5295233|NCT00452439|Lymphoblastic Lymphoma|lymphoblastic lymphoma
5295234|NCT00452439|Actonel|actonel
5295235|NCT00452439|Risedronate|risedronate
5295236|NCT00452439|Bone Loss|bone loss
5295237|NCT00452439|Osteoporosis|osteoporosis
5295238|NCT00452426|Propofol|propofol
5295239|NCT00452426|Diprivan|diprivan
5295240|NCT00452426|Colonoscopy|colonoscopy
5295241|NCT00452426|Endoscopy, Digestive System|endoscopy, digestive system
5295242|NCT00452426|Conscious Sedation|conscious sedation
5295243|NCT00452387|Prostate Cancer|prostate cancer
5295244|NCT00452374|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
5295245|NCT00452374|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
5295246|NCT00452374|CLL|cll
5295247|NCT00452374|Prolymphocytic Leukemia|prolymphocytic leukemia
5295248|NCT00452374|PLL|pll
5295249|NCT00452374|Richter's Transformation|richter's transformation
5295250|NCT00452374|High-grade non-Hodgkin's lymphoma|high-grade non-hodgkin's lymphoma
5295251|NCT00452374|Hodgkin's disease|hodgkin's disease
5295252|NCT00452374|Acute leukemia|acute leukemia
5295253|NCT00452374|Small lymphocytic lymphoma|small lymphocytic lymphoma
5295254|NCT00452374|Oxaliplatin|oxaliplatin
5295255|NCT00452374|Eloxatin|eloxatin
5295256|NCT00452374|Fludarabine|fludarabine
5295257|NCT00452374|Cytarabine|cytarabine
5295258|NCT00452374|Ara-C|ara-c
5295259|NCT00452374|Cytosar|cytosar
5295260|NCT00452374|DepoCyt|depocyt
5295261|NCT00452374|Cytosine arabinosine hydrochloride|cytosine arabinosine hydrochloride
5295262|NCT00452374|Rituximab|rituximab
5295263|NCT00452374|Rituxan|rituxan
5295264|NCT00452348|FLOVENT|flovent
5295265|NCT00452348|fluticasone|fluticasone
5295266|NCT00452348|12 month|12 month
5295267|NCT00452348|salmeterol|salmeterol
5295268|NCT00452348|asthma|asthma
5295269|NCT00452348|ADVAIR|advair
5295270|NCT00452322|Testosterone|testosterone
5295271|NCT00452322|Hypogonadism|hypogonadism
5295272|NCT00452322|Safety|safety
5295273|NCT00452309|peripheral arterial disease|peripheral arterial disease
5295274|NCT00452309|pad|pad
5295275|NCT00452309|ankle brachial index|ankle brachial index
5295276|NCT00452309|abi|abi
5295277|NCT00452296|inpatients with COPD|inpatients with copd
5295278|NCT00452296|glucose control|glucose control
5295279|NCT00452270|Common cold, xylometazoline|common cold, xylometazoline
5295280|NCT00452244|Gefitinib|gefitinib
5295281|NCT00452244|Simvastatin|simvastatin
5295282|NCT00452244|NSCLC|nsclc
5295283|NCT00452244|Advanced NSCLC|advanced nsclc
5295284|NCT00452231|Post-traumatic Stress Disorder|post-traumatic stress disorder
5295285|NCT00452231|Cognitive-Behavioral Therapy|cognitive-behavioral therapy
5295286|NCT00452218|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
5295287|NCT00452218|PAH|pah
5295288|NCT00452205|bone marrow-derived stem cell|bone marrow-derived stem cell
5295289|NCT00452205|bone marrow transplantation|bone marrow transplantation
5295290|NCT00452205|graft versus host disease|graft versus host disease
5295291|NCT00452205|gastrointestinal cancer|gastrointestinal cancer
5295292|NCT00452205|after receiving bone marrow transplantation|after receiving bone marrow transplantation
5295293|NCT00452192|Metabolic syndrome|metabolic syndrome
5295294|NCT00452179|Sleep maintenance|sleep maintenance
5295295|NCT00452179|Insomnia|insomnia
5295296|NCT00452179|Sleep Consolidation|sleep consolidation
5295297|NCT00452179|Sleep|sleep
5295298|NCT00452179|Insomnia, primarily sleep maintenance|insomnia, primarily sleep maintenance
5295299|NCT00452153|legionellosis|legionellosis
5295300|NCT00452153|diagnosis of legionellosis|diagnosis of legionellosis
5295301|NCT00452153|PCR|pcr
5295302|NCT00452140|Breast Cancer|breast cancer
5295303|NCT00452140|investigational drug|investigational drug
5295304|NCT00452140|drug therapy|drug therapy
5295305|NCT00452140|Antineoplastic Protocols|antineoplastic protocols
5295306|NCT00452140|Immunotherapy|immunotherapy
5295307|NCT00452140|Metastatic breast cancer|metastatic breast cancer
5295308|NCT00452140|Advanced breast cancer|advanced breast cancer
5295309|NCT00452140|Stage III to IV breast cancer|stage iii to iv breast cancer
5295310|NCT00452140|Hormonal therapy refractory|hormonal therapy refractory
5295311|NCT00452140|Failure of hormonal therapy|failure of hormonal therapy
5295312|NCT00452140|Her-2/neu expressing breast cancer|her-2/neu expressing breast cancer
5295313|NCT00452140|Her-2/neu|her-2/neu
5295315|NCT00452127|Indolent|indolent
5295316|NCT00452127|Follicular|follicular
5295317|NCT00452114|Bronchiectasis|bronchiectasis
5295318|NCT00452101|Osteoarthritis|osteoarthritis
5295319|NCT00452101|Clinical trial|clinical trial
5295320|NCT00452101|Aquamin F|aquamin f
5295321|NCT00452101|Glucosamine|glucosamine
5295322|NCT00452088|Malaria vaccine|malaria vaccine
5295323|NCT00452088|Safety of MSP 3 LSP|safety of msp 3 lsp
5295324|NCT00452088|Immunogenicity of MSP 3 LSP|immunogenicity of msp 3 lsp
5295325|NCT00452088|Burkina Faso children|burkina faso children
5295326|NCT00452075|EGFR expression|egfr expression
5295327|NCT00452075|erlotinib|erlotinib
5295328|NCT00452062|cuff-leak test|cuff-leak test
5295329|NCT00452062|intubation|intubation
5295330|NCT00452062|corticosteroids|corticosteroids
5295331|NCT00452062|dexamethasone to reduce the occurrence of post-extubation airway obstruction|dexamethasone to reduce the occurrence of post-extubation airway obstruction
5295332|NCT00452049|parathyroidectomy|parathyroidectomy
5295333|NCT00452049|arterial stiffness|arterial stiffness
5295334|NCT00452049|renal function|renal function
5295335|NCT00452036|risk factors|risk factors
5295336|NCT00452036|plain x ray|plain x ray
5295337|NCT00452036|cranial computed tomography|cranial computed tomography
5295338|NCT00452036|minor head injury|minor head injury
5295339|NCT00452023|Myeloproliferative Disorders|myeloproliferative disorders
5295340|NCT00452023|Essential Thrombocythemia|essential thrombocythemia
5295341|NCT00452023|Polycythemia Vera|polycythemia vera
5295342|NCT00452023|Pegasys|pegasys
5295343|NCT00452023|IFN-alpha2a|ifn-alpha2a
5295443|NCT00451607|heart rate variability|heart rate variability
5295344|NCT00452023|Pegylated-Interferon Alpha-2A|pegylated-interferon alpha-2a
5295345|NCT00452023|PEG-IFNa-2a|peg-ifna-2a
5295346|NCT00452010|TENS|tens
5295347|NCT00452010|chronic low back pain|chronic low back pain
5295348|NCT00452010|chronic lumbo-radiculalgia|chronic lumbo-radiculalgia
5295349|NCT00452010|placebo|placebo
5295350|NCT00452010|Roland scale|roland scale
5295351|NCT00451997|AML|aml
5295352|NCT00451997|MDS|mds
5295353|NCT00451997|Gleevec|gleevec
5295354|NCT00451997|Ara-C|ara-c
5295355|NCT00451997|C-Kit Positive Acute Myeloid Leukemia|c-kit positive acute myeloid leukemia
5295356|NCT00451997|High-Risk Myelodysplastic Syndromes|high-risk myelodysplastic syndromes
5295357|NCT00451984|interleukin-2|interleukin-2
5295358|NCT00451984|vaccination|vaccination
5295359|NCT00451984|treatment experienced|treatment experienced
5295360|NCT00451958|Degarelix|degarelix
5295361|NCT00451958|prostate cancer|prostate cancer
5295362|NCT00451932|Malononitrilamide|malononitrilamide
5295363|NCT00451932|Immunosuppression|immunosuppression
5295364|NCT00451932|treatment efficacy|treatment efficacy
5295365|NCT00451932|treatment effectiveness|treatment effectiveness
5295366|NCT00451919|MRI|mri
5295367|NCT00451919|Neuropsychology|neuropsychology
5295368|NCT00451893|Inguinal hernia|inguinal hernia
5295369|NCT00451893|polypropylene mesh|polypropylene mesh
5295370|NCT00451893|heavy-weight mesh|heavy-weight mesh
5295371|NCT00451893|light-weight mesh|light-weight mesh
5295372|NCT00451880|Cancer|cancer
5295373|NCT00451880|Solid Tumors|solid tumors
5295374|NCT00451880|NSCLC|nsclc
5295375|NCT00451867|interstitial cystitis research|interstitial cystitis research
5295376|NCT00451867|painful bladder syndrome research|painful bladder syndrome research
5295377|NCT00451867|pelvic pain research|pelvic pain research
5295378|NCT00451867|interstitial cystitis and autoimmune|interstitial cystitis and autoimmune
5295379|NCT00451867|interstitial cystitis and cellcept|interstitial cystitis and cellcept
5295380|NCT00451867|interstitial cystitis and mycophenolate mofetil|interstitial cystitis and mycophenolate mofetil
5295381|NCT00451867|interstitial cystitis and MMF|interstitial cystitis and mmf
5295382|NCT00451867|interstitial cystitis and inflammation|interstitial cystitis and inflammation
5295383|NCT00451867|inflammatory diseases and immunosupression|inflammatory diseases and immunosupression
5295384|NCT00451854|Drug testing|drug testing
5295385|NCT00451854|Adolescence|adolescence
5295386|NCT00451854|Student athlete|student athlete
5295387|NCT00451854|Substance abuse|substance abuse
5295388|NCT00451854|Alcohol use|alcohol use
5295389|NCT00451854|Drug use|drug use
5295390|NCT00451841|Cough|cough
5295391|NCT00451841|Gastroesophageal reflux|gastroesophageal reflux
5295392|NCT00451841|Exhaled breath condensate|exhaled breath condensate
5295393|NCT00451828|Statins|statins
5295394|NCT00451828|Cholesterol|cholesterol
5295395|NCT00451828|Pharmacogenetics|pharmacogenetics
5295396|NCT00451802|Biotechnology|biotechnology
5295397|NCT00451802|Specimen|specimen
5295398|NCT00451802|Health Management Center|health management center
5295399|NCT00451789|Minor head injury|minor head injury
5295400|NCT00451789|iintracranial bleeding|iintracranial bleeding
5295401|NCT00451789|traumatic brain injury|traumatic brain injury
5295402|NCT00451789|Cranial computed tomography|cranial computed tomography
5295403|NCT00451789|anticoagulatory drugs|anticoagulatory drugs
5295404|NCT00451776|cardiac surgery|cardiac surgery
5295405|NCT00451776|adrenal insufficiency|adrenal insufficiency
5295406|NCT00451776|etomidate|etomidate
5295407|NCT00451776|propofol|propofol
5295408|NCT00451763|Fovea centralis/pathology|fovea centralis/pathology
5295409|NCT00451763|Fundus oculi|fundus oculi
5295410|NCT00451763|Retinal neovascularization|retinal neovascularization
5295411|NCT00451763|Telangiectasis/diagnosis|telangiectasis/diagnosis
5295412|NCT00451763|Tomography, optical coherence|tomography, optical coherence
5295413|NCT00451763|Vitreous Body/drug effects|vitreous body/drug effects
5295414|NCT00451750|phobia|phobia
5295415|NCT00451750|cortisol|cortisol
5295416|NCT00451750|memory|memory
5295417|NCT00451750|treatment|treatment
5295418|NCT00451737|Six-minute walk test|six-minute walk test
5295419|NCT00451737|Neuromuscular system|neuromuscular system
5295420|NCT00451737|Influence factors|influence factors
5295421|NCT00451724|Prospective|prospective
5295422|NCT00451724|Randomized|randomized
5295423|NCT00451724|Double blinded|double blinded
5295424|NCT00451724|Sedation|sedation
5295425|NCT00451724|Ketamine|ketamine
5295426|NCT00451724|Intranasal|intranasal
5295427|NCT00451711|Prophylaxis|prophylaxis
5295428|NCT00451711|Liposomal Amphotericin B|liposomal amphotericin b
5295429|NCT00451711|Acute myeloid leukaemia|acute myeloid leukaemia
5295430|NCT00451711|Invasive Fungal Infections|invasive fungal infections
5295431|NCT00451698|Erythropoietin|erythropoietin
5295432|NCT00451698|Congenital heart surgery|congenital heart surgery
5295433|NCT00451672|aldosteronism, bromocriptin, hypertension|aldosteronism, bromocriptin, hypertension
5295434|NCT00451659|PTSD|ptsd
5295435|NCT00451659|Veterans|veterans
5295436|NCT00451659|Deployed|deployed
5295437|NCT00451620|Type 2 diabetes|type 2 diabetes
5295438|NCT00451620|Hypoglycemia|hypoglycemia
5295439|NCT00451620|Oral hypoglycemic agents|oral hypoglycemic agents
5295440|NCT00451620|Insulin levels|insulin levels
5295441|NCT00451607|premature|premature
5295444|NCT00451607|individualized sensorimotor care|individualized sensorimotor care
5295445|NCT00451607|noise|noise
5295446|NCT00451594|ITP|itp
5295447|NCT00451581|Endoscopic papillary balloon dilatation|endoscopic papillary balloon dilatation
5295448|NCT00451581|Endoscopic sphincterotomy|endoscopic sphincterotomy
5295449|NCT00451581|Choledocholithiasis|choledocholithiasis
5295450|NCT00451581|Efficacy|efficacy
5295451|NCT00451581|Complication|complication
5295452|NCT00451568|Polycystic ovary syndrome|polycystic ovary syndrome
5295453|NCT00451542|Bipolar Disorder|bipolar disorder
5295454|NCT00451542|Relapse|relapse
5295455|NCT00451542|Retrospective|retrospective
5295456|NCT00451516|Plant, medicine|plant, medicine
5295457|NCT00451516|Psychiatry|psychiatry
5295458|NCT00451516|Major depressive disorder|major depressive disorder
5295459|NCT00451516|Anxiety|anxiety
5295460|NCT00451516|Major Depressive Disorder with comorbid anxiety|major depressive disorder with comorbid anxiety
5295461|NCT00451503|Hearing|hearing
5295462|NCT00451503|Auditory rehabilitation|auditory rehabilitation
5295463|NCT00451503|Middle ear implant|middle ear implant
5295464|NCT00451503|Surgery|surgery
5295465|NCT00451490|agomelatin|agomelatin
5295466|NCT00451490|prozac|prozac
5295467|NCT00451490|heart rate variability|heart rate variability
5295468|NCT00451490|major depression|major depression
5295469|NCT00451490|sleep|sleep
5295470|NCT00451490|depressive symptoms|depressive symptoms
5295471|NCT00451464|Apolipoprotein, Gene polymorphism, Hyperlipidemia|apolipoprotein, gene polymorphism, hyperlipidemia
5295472|NCT00451451|relapsing|relapsing
5295473|NCT00451451|multiple sclerosis|multiple sclerosis
5295474|NCT00451451|oral|oral
5295475|NCT00451451|remitting|remitting
5295476|NCT00451438|patellofemoral pain syndrome|patellofemoral pain syndrome
5295477|NCT00451438|electromyography|electromyography
5295478|NCT00451438|gluteus medius|gluteus medius
5295479|NCT00451438|tensor fascia lata|tensor fascia lata
5295480|NCT00451425|pregnancy|pregnancy
5295481|NCT00451425|weight gain|weight gain
5295482|NCT00451425|obesity|obesity
5295483|NCT00451425|macrosomia|macrosomia
5295484|NCT00451412|Venous thromboembolism|venous thromboembolism
5295485|NCT00451412|Medical patients|medical patients
5295486|NCT00451412|Heparin|heparin
5295487|NCT00451412|Low molecular weight heparin|low molecular weight heparin
5295488|NCT00451412|Deep vein thrombosis|deep vein thrombosis
5295489|NCT00451412|Certoparin|certoparin
5295490|NCT00451412|Embolism and Thrombosis|embolism and thrombosis
5295491|NCT00451399|Weight gain|weight gain
5295492|NCT00451399|antipsychotic|antipsychotic
5295493|NCT00451399|lifestyle interventions|lifestyle interventions
5295494|NCT00451399|metformin|metformin
5295495|NCT00451399|antipsychotic-induced weight gain.|antipsychotic-induced weight gain.
5295496|NCT00451373|ARF, dialysis, cytokine, free radical, major operations|arf, dialysis, cytokine, free radical, major operations
5295497|NCT00451360|Diacerein|diacerein
5295498|NCT00451360|Hip osteoarthritis|hip osteoarthritis
5295499|NCT00451360|Structure-modifying effect / Chondromodulating effect|structure-modifying effect / chondromodulating effect
5295500|NCT00451360|Double blind study|double blind study
5295501|NCT00451321|type 1 diabetes mellitus|type 1 diabetes mellitus
5295502|NCT00451321|diabetes mellitus type 1|diabetes mellitus type 1
5295503|NCT00451321|type 1 diabetes|type 1 diabetes
5295504|NCT00451321|diabetes mellitus|diabetes mellitus
5295505|NCT00451321|diabetes|diabetes
5295506|NCT00451308|Induction of labor|induction of labor
5295507|NCT00451308|vaginal delivery|vaginal delivery
5295508|NCT00451308|cesarean section|cesarean section
5295509|NCT00451308|foley balloon cathether|foley balloon cathether
5295510|NCT00451308|method of labor induction|method of labor induction
5295511|NCT00451308|perinatal outcomes|perinatal outcomes
5295512|NCT00451295|Chronic Kidney Disease|chronic kidney disease
5295513|NCT00451295|Dialysis|dialysis
5295514|NCT00451295|Hyperphosphatemia|hyperphosphatemia
5295515|NCT00451269|Malaria|malaria
5295516|NCT00451269|Diagnosis|diagnosis
5295517|NCT00451269|RDT|rdt
5295518|NCT00451269|pLDH|pldh
5295519|NCT00451269|HRP2|hrp2
5295520|NCT00451269|Patients with fever and history of travel in a malaria|patients with fever and history of travel in a malaria
5295521|NCT00451269|country|country
5295522|NCT00451256|coronary artery bypass|coronary artery bypass
5295523|NCT00451256|cardiovascular disease|cardiovascular disease
5295524|NCT00451243|psoriatic arthritis|psoriatic arthritis
5295525|NCT00451230|craving, insulin, leptin|craving, insulin, leptin
5295526|NCT00451204|Multiple sclerosis|multiple sclerosis
5295527|NCT00451204|estrogen|estrogen
5295528|NCT00451204|estriol|estriol
5295529|NCT00451204|progesterone|progesterone
5295530|NCT00451191|benign prostatic hyperplasia|benign prostatic hyperplasia
5295531|NCT00451191|BPH|bph
5295532|NCT00451191|botulinum toxin|botulinum toxin
5295533|NCT00451191|BoNT/A|bont/a
5295534|NCT00451165|Laparoscopic|laparoscopic
5295535|NCT00451165|Colon|colon
5295536|NCT00451165|Rectal|rectal
5295537|NCT00451165|Surgery|surgery
5295538|NCT00451165|Urinary function|urinary function
5295539|NCT00451165|Sexual function|sexual function
5295540|NCT00451165|Bowel function|bowel function
5295541|NCT00451165|Male|male
5295542|NCT00451152|glaucoma|glaucoma
5295543|NCT00451126|emotion|emotion
5295544|NCT00451126|personality|personality
5295545|NCT00451126|social stress|social stress
5295546|NCT00451126|appraisal|appraisal
5295547|NCT00451113|Type 2 diabetes|type 2 diabetes
5295548|NCT00451113|Older adults|older adults
5295549|NCT00451113|Incretins|incretins
5295550|NCT00451113|Hyperglycemia|hyperglycemia
5295551|NCT00451113|Insulin resistance|insulin resistance
5295552|NCT00451087|mechanical properties|mechanical properties
5295553|NCT00451087|electromechanical delay|electromechanical delay
5295554|NCT00451087|viscoelasticity|viscoelasticity
5295555|NCT00451087|VMO|vmo
5295556|NCT00451087|patellofemoral pain syndrome|patellofemoral pain syndrome
5295557|NCT00451074|Stop codon mutations|stop codon mutations
5295558|NCT00451061|distal ureterolithiasis|distal ureterolithiasis
5295559|NCT00451061|α adrenoreceptors antagonist|α adrenoreceptors antagonist
5295560|NCT00451035|Refractory Chronic Myeloid Leukemia in Chronic Phase|refractory chronic myeloid leukemia in chronic phase
5295561|NCT00451035|adults|adults
5295562|NCT00451035|oral LBH589|oral lbh589
5295563|NCT00451022|Fowlpox|fowlpox
5295564|NCT00451022|Vaccinia|vaccinia
5295565|NCT00451022|PSA|psa
5295566|NCT00451022|CEA|cea
5295567|NCT00451022|MUC-1|muc-1
5295568|NCT00451022|Gene Therapy|gene therapy
5295569|NCT00451022|Long Term Survivor|long term survivor
5295570|NCT00451022|Research Specimen|research specimen
5295571|NCT00451009|IVF|ivf
5295572|NCT00451009|Male factor infertility|male factor infertility
5295573|NCT00451009|Cryopreservation|cryopreservation
5295574|NCT00451009|Cryoprotective agents|cryoprotective agents
5295575|NCT00451009|Egg Freezing|egg freezing
5295576|NCT00450983|graft versus host disease|graft versus host disease
5295577|NCT00450983|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5295578|NCT00450983|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5295579|NCT00450983|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
5295580|NCT00450983|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5295581|NCT00450983|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5295582|NCT00450983|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5295583|NCT00450983|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5295584|NCT00450983|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
5295585|NCT00450983|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5295586|NCT00450983|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5295587|NCT00450983|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5295588|NCT00450983|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5295589|NCT00450983|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5295590|NCT00450983|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5295591|NCT00450983|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5295592|NCT00450983|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
5295593|NCT00450983|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5295594|NCT00450983|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5295595|NCT00450983|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5295596|NCT00450983|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5295597|NCT00450983|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5295598|NCT00450983|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
5295599|NCT00450970|Hormone Refractory Prostate Cancer (HRPC)|hormone refractory prostate cancer (hrpc)
5295600|NCT00450970|Hormone Refractory Prostate Cancer|hormone refractory prostate cancer
5295601|NCT00450970|Unlimited Prior Cytotoxic Chemotherapy Regimens|unlimited prior cytotoxic chemotherapy regimens
5295602|NCT00450944|B-cell adult acute lymphoblastic leukemia|b-cell adult acute lymphoblastic leukemia
5295603|NCT00450944|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5295604|NCT00450931|health status unknown|health status unknown
5295605|NCT00450918|Kartagener Syndrome|kartagener syndrome
5295606|NCT00450905|Chronic musculoskeletal pain secondary to Fibromyalgia|chronic musculoskeletal pain secondary to fibromyalgia
5295607|NCT00450892|inflammatory breast cancer|inflammatory breast cancer
5295608|NCT00450892|stage II breast cancer|stage ii breast cancer
5295609|NCT00450892|stage IIIA breast cancer|stage iiia breast cancer
5295610|NCT00450892|stage IIIB breast cancer|stage iiib breast cancer
5295611|NCT00450892|stage IIIC breast cancer|stage iiic breast cancer
5295612|NCT00450866|recurrent breast cancer|recurrent breast cancer
5295613|NCT00450866|stage IV breast cancer|stage iv breast cancer
5295614|NCT00450866|tumors metastatic to brain|tumors metastatic to brain
5295615|NCT00450866|leptomeningeal metastases|leptomeningeal metastases
5295616|NCT00450866|male breast cancer|male breast cancer
5295617|NCT00450853|emesis|emesis
5295618|NCT00450853|granisetron|granisetron
5295619|NCT00450853|pharmacokinetics|pharmacokinetics
5295620|NCT00450853|subcutaneous.|subcutaneous.
5295621|NCT00450840|septic shock|septic shock
5295622|NCT00450840|simvastatin|simvastatin
5295623|NCT00450827|recurrent neuroblastoma|recurrent neuroblastoma
5296234|NCT00448487|Haptoglobin|haptoglobin
5295624|NCT00450801|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
5295625|NCT00450801|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5295626|NCT00450801|stage I mantle cell lymphoma|stage i mantle cell lymphoma
5295627|NCT00450801|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5295628|NCT00450801|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5295629|NCT00450788|Etiology|etiology
5295630|NCT00450788|Carcinogens|carcinogens
5295631|NCT00450788|Esophageal Cancer|esophageal cancer
5295632|NCT00450762|pretreated|pretreated
5295633|NCT00450762|metastatic|metastatic
5295634|NCT00450736|chondrosarcoma|chondrosarcoma
5295635|NCT00450736|adult angiosarcoma|adult angiosarcoma
5295636|NCT00450736|adult fibrosarcoma|adult fibrosarcoma
5295637|NCT00450736|adult leiomyosarcoma|adult leiomyosarcoma
5295638|NCT00450736|adult liposarcoma|adult liposarcoma
5295639|NCT00450736|adult neurofibrosarcoma|adult neurofibrosarcoma
5295640|NCT00450736|adult synovial sarcoma|adult synovial sarcoma
5295641|NCT00450736|childhood angiosarcoma|childhood angiosarcoma
5295642|NCT00450736|childhood fibrosarcoma|childhood fibrosarcoma
5295643|NCT00450736|childhood leiomyosarcoma|childhood leiomyosarcoma
5295644|NCT00450736|childhood liposarcoma|childhood liposarcoma
5295645|NCT00450736|childhood neurofibrosarcoma|childhood neurofibrosarcoma
5295646|NCT00450736|childhood synovial sarcoma|childhood synovial sarcoma
5295647|NCT00450736|nonmetastatic childhood soft tissue sarcoma|nonmetastatic childhood soft tissue sarcoma
5295648|NCT00450736|stage II adult soft tissue sarcoma|stage ii adult soft tissue sarcoma
5295649|NCT00450736|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
5295650|NCT00450736|adult malignant fibrous histiocytoma|adult malignant fibrous histiocytoma
5295651|NCT00450736|adult malignant hemangiopericytoma|adult malignant hemangiopericytoma
5295652|NCT00450736|childhood malignant hemangiopericytoma|childhood malignant hemangiopericytoma
5295653|NCT00450736|localized childhood malignant fibrous histiocytoma of bone|localized childhood malignant fibrous histiocytoma of bone
5295654|NCT00450723|stage I breast cancer|stage i breast cancer
5295655|NCT00450723|stage II breast cancer|stage ii breast cancer
5295656|NCT00450723|male breast cancer|male breast cancer
5295657|NCT00450697|Feeding intolerance in premature infants|feeding intolerance in premature infants
5295658|NCT00450697|Bolus feeding every 4 hours versus every 3 hours|bolus feeding every 4 hours versus every 3 hours
5295659|NCT00450697|Feeding method in premature infants|feeding method in premature infants
5295660|NCT00450671|Fistula-in-ano|fistula-in-ano
5295661|NCT00450671|Anal fistula|anal fistula
5295662|NCT00450671|Perirectal fistula|perirectal fistula
5295663|NCT00450671|Collagen plug|collagen plug
5295664|NCT00450671|Surgisis|surgisis
5295665|NCT00450671|Seton|seton
5295666|NCT00450658|ibuprofen|ibuprofen
5295667|NCT00450658|famotidine|famotidine
5295668|NCT00450658|ulcers|ulcers
5295669|NCT00450658|NSAIDS|nsaids
5295670|NCT00450658|pain|pain
5295671|NCT00450658|arthritis|arthritis
5295672|NCT00450658|chronic regional pain syndrome|chronic regional pain syndrome
5295673|NCT00450658|chronic soft tissue pain|chronic soft tissue pain
5295674|NCT00450658|osteoarthritis|osteoarthritis
5295675|NCT00450658|rheumatoid arthritis|rheumatoid arthritis
5295676|NCT00450658|chronic low back pain|chronic low back pain
5295677|NCT00450645|Cancer|cancer
5295678|NCT00450645|Residual vein thrombosis|residual vein thrombosis
5295679|NCT00450645|Low Molecular Weight Heparin|low molecular weight heparin
5295680|NCT00450645|Optimal duration|optimal duration
5295681|NCT00450632|meningococcal infections|meningococcal infections
5295682|NCT00450632|biotheque|biotheque
5295683|NCT00450632|genetic markers|genetic markers
5295684|NCT00450619|Radionuclide|radionuclide
5295685|NCT00450619|Immunotherapy|immunotherapy
5295686|NCT00450619|Radiation|radiation
5295687|NCT00450619|PSA|psa
5295688|NCT00450619|Hormone Refractory Prostate Cancer|hormone refractory prostate cancer
5295689|NCT00450619|Prostate Cancer|prostate cancer
5295690|NCT00450593|melanoma|melanoma
5295691|NCT00450593|hereditary multiple melanoma|hereditary multiple melanoma
5295692|NCT00450593|recurrent melanoma|recurrent melanoma
5295693|NCT00450593|stage 0 melanoma|stage 0 melanoma
5295694|NCT00450593|stage IV melanoma|stage iv melanoma
5295695|NCT00450593|stage IA melanoma|stage ia melanoma
5295696|NCT00450593|stage IB melanoma|stage ib melanoma
5295697|NCT00450593|stage IIA melanoma|stage iia melanoma
5295698|NCT00450593|stage IIB melanoma|stage iib melanoma
5295699|NCT00450593|stage IIC melanoma|stage iic melanoma
5295700|NCT00450593|stage IIIA melanoma|stage iiia melanoma
5295701|NCT00450593|stage IIIB melanoma|stage iiib melanoma
5295702|NCT00450593|stage IIIC melanoma|stage iiic melanoma
5295703|NCT00450580|protease inhibitor,|protease inhibitor,
5295704|NCT00450580|HIV-1,|hiv-1,
5295705|NCT00450580|Fosamprenavir,|fosamprenavir,
5295706|NCT00450580|non-HDL cholesterol|non-hdl cholesterol
5295707|NCT00450580|ritonavir,|ritonavir,
5295708|NCT00450580|naive,|naive,
5295709|NCT00450567|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5295710|NCT00450567|stage I non-small cell lung cancer|stage i non-small cell lung cancer
5295711|NCT00450567|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
5295712|NCT00450567|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5295713|NCT00450567|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5295714|NCT00450567|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5295715|NCT00450554|Neisseria meningitidis B:14, P1-7, 16|neisseria meningitidis b:14, p1-7, 16
5295716|NCT00450554|Serum bactericidal activity|serum bactericidal activity
5295717|NCT00450554|Menbvac|menbvac
5295718|NCT00450541|Advanced Cancer|advanced cancer
5295719|NCT00450541|Fatigue|fatigue
5295720|NCT00450541|Interview|interview
5295721|NCT00450541|Questionnaire|questionnaire
5295722|NCT00450541|Survey|survey
5295723|NCT00450528|D-dimers|d-dimers
5295724|NCT00450528|surgery|surgery
5295725|NCT00450528|kinetics|kinetics
5295726|NCT00450515|recurrent breast cancer|recurrent breast cancer
5295727|NCT00450515|stage IV breast cancer|stage iv breast cancer
5295728|NCT00450515|male breast cancer|male breast cancer
5295729|NCT00450502|Cytotoxic|cytotoxic
5295730|NCT00450502|Pharmacokinetics|pharmacokinetics
5295731|NCT00450502|Toxicity|toxicity
5295732|NCT00450502|Neoplasms|neoplasms
5295733|NCT00450502|Pharmacogenomics|pharmacogenomics
5295734|NCT00450502|Solid Tumor|solid tumor
5295735|NCT00450502|Lymphoma|lymphoma
5295736|NCT00450489|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
5295737|NCT00450489|Quality of Life|quality of life
5295738|NCT00450489|Satisfaction of medical care delivery|satisfaction of medical care delivery
5295739|NCT00450476|ventilator associated pneumonia|ventilator associated pneumonia
5295740|NCT00450476|prevention|prevention
5295741|NCT00450476|endotracheal intubation|endotracheal intubation
5295742|NCT00450476|mechanical ventilation|mechanical ventilation
5295743|NCT00450463|Immunotherapy|immunotherapy
5295744|NCT00450463|Hormonal Therapy|hormonal therapy
5295745|NCT00450463|Combination Therapy|combination therapy
5295746|NCT00450463|Prostate Specific Antigen|prostate specific antigen
5295747|NCT00450463|Immunoassay|immunoassay
5295748|NCT00450463|Prostate Cancer|prostate cancer
5295749|NCT00450437|Meningococcal|meningococcal
5295750|NCT00450437|meningitis|meningitis
5295751|NCT00450437|vaccine|vaccine
5295752|NCT00450437|adolescents|adolescents
5295753|NCT00450437|adults|adults
5295754|NCT00450424|colon cancer|colon cancer
5295755|NCT00450424|rectal cancer|rectal cancer
5295756|NCT00450424|hereditary non-polyposis colon cancer|hereditary non-polyposis colon cancer
5295757|NCT00450424|recurrent colon cancer|recurrent colon cancer
5295758|NCT00450424|stage I colon cancer|stage i colon cancer
5295759|NCT00450424|stage IIA colon cancer|stage iia colon cancer
5295760|NCT00450424|stage IIB colon cancer|stage iib colon cancer
5295761|NCT00450424|stage IIIA colon cancer|stage iiia colon cancer
5295762|NCT00450424|stage IIIB colon cancer|stage iiib colon cancer
5295763|NCT00450424|stage IIIC colon cancer|stage iiic colon cancer
5295764|NCT00450424|stage IVA colon cancer|stage iva colon cancer
5295765|NCT00450424|stage IVB colon cancer|stage ivb colon cancer
5295766|NCT00450424|recurrent rectal cancer|recurrent rectal cancer
5295767|NCT00450424|stage I rectal cancer|stage i rectal cancer
5295768|NCT00450424|stage IIA rectal cancer|stage iia rectal cancer
5295769|NCT00450424|stage IIB rectal cancer|stage iib rectal cancer
5295770|NCT00450424|stage IIC rectal cancer|stage iic rectal cancer
5295771|NCT00450424|stage IIIA rectal cancer|stage iiia rectal cancer
5295772|NCT00450424|stage IIIB rectal cancer|stage iiib rectal cancer
5295773|NCT00450424|stage IIIC rectal cancer|stage iiic rectal cancer
5295774|NCT00450424|stage IVA rectal cancer|stage iva rectal cancer
5295775|NCT00450424|stage IVB rectal cancer|stage ivb rectal cancer
5295776|NCT00450411|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5295777|NCT00450411|recurrent prostate cancer|recurrent prostate cancer
5295778|NCT00450411|stage I prostate cancer|stage i prostate cancer
5295779|NCT00450411|stage IIB prostate cancer|stage iib prostate cancer
5295780|NCT00450411|stage IIA prostate cancer|stage iia prostate cancer
5295781|NCT00450398|Delayed graft function|delayed graft function
5295782|NCT00450385|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5295783|NCT00450385|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5295784|NCT00450385|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5295785|NCT00450385|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
5295905|NCT00449852|Rehabilitation|rehabilitation
5295786|NCT00450385|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5295787|NCT00450385|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
5295788|NCT00450372|recurrent melanoma|recurrent melanoma
5295789|NCT00450372|stage IV melanoma|stage iv melanoma
5295790|NCT00450359|breast cancer|breast cancer
5295791|NCT00450333|Chronic|chronic
5295792|NCT00450320|AIDS-related Kaposi sarcoma|aids-related kaposi sarcoma
5295793|NCT00450320|recurrent Kaposi sarcoma|recurrent kaposi sarcoma
5295794|NCT00450307|recurrent neuroblastoma|recurrent neuroblastoma
5295795|NCT00450307|stage 4S neuroblastoma|stage 4s neuroblastoma
5295796|NCT00450307|disseminated neuroblastoma|disseminated neuroblastoma
5295797|NCT00450307|localized unresectable neuroblastoma|localized unresectable neuroblastoma
5295798|NCT00450307|regional neuroblastoma|regional neuroblastoma
5295799|NCT00450281|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5295800|NCT00450281|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5295801|NCT00450281|stage IA non-small cell lung cancer|stage ia non-small cell lung cancer
5295802|NCT00450281|stage IB non-small cell lung cancer|stage ib non-small cell lung cancer
5295803|NCT00450281|stage IIA non-small cell lung cancer|stage iia non-small cell lung cancer
5295804|NCT00450281|stage IIB non-small cell lung cancer|stage iib non-small cell lung cancer
5295805|NCT00450268|Graft versus host disease|graft versus host disease
5295806|NCT00450268|Allogeneic hematpoietic stem cell transplantation|allogeneic hematpoietic stem cell transplantation
5295807|NCT00450242|vulvar vestibulitis|vulvar vestibulitis
5295808|NCT00450242|vestibulitis|vestibulitis
5295809|NCT00450216|ibuprofen|ibuprofen
5295810|NCT00450216|famotidine|famotidine
5295811|NCT00450216|ulcers|ulcers
5295812|NCT00450216|NSAIDS|nsaids
5295813|NCT00450216|pain|pain
5295814|NCT00450216|arthritis|arthritis
5295815|NCT00450216|chronic regional pain syndrome|chronic regional pain syndrome
5295816|NCT00450216|chronic soft tissue pain|chronic soft tissue pain
5295817|NCT00450216|osteoarthritis|osteoarthritis
5295818|NCT00450216|rheumatoid arthritis|rheumatoid arthritis
5295819|NCT00450216|chronic low back pain|chronic low back pain
5295820|NCT00450203|adenocarcinoma of the stomach|adenocarcinoma of the stomach
5295821|NCT00450203|adenocarcinoma of the gastro oesophageal junction|adenocarcinoma of the gastro oesophageal junction
5295822|NCT00450203|adenocarcinoma of the lower oesophagus|adenocarcinoma of the lower oesophagus
5295823|NCT00450190|Growth disorders|growth disorders
5295824|NCT00450177|iron|iron
5295825|NCT00450177|critical illness|critical illness
5295826|NCT00450177|anemia|anemia
5295827|NCT00450177|infection|infection
5295828|NCT00450164|Variceal bleeding|variceal bleeding
5295829|NCT00450164|Secondary profilaxis|secondary profilaxis
5295830|NCT00450164|Hemodynamic|hemodynamic
5295831|NCT00450164|Portal hypertension|portal hypertension
5295832|NCT00450151|Pediatric|pediatric
5295833|NCT00450151|Cardiopulmonary bypass Surgery|cardiopulmonary bypass surgery
5295834|NCT00450151|Cardiac Surgery|cardiac surgery
5295835|NCT00450151|Platelet|platelet
5295836|NCT00450151|Platelet Activation Markers|platelet activation markers
5295837|NCT00450151|Platelet Factor4|platelet factor4
5295838|NCT00450151|Transforming Growth Factor Beta|transforming growth factor beta
5295839|NCT00450138|Squamous Cell Carcinoma|squamous cell carcinoma
5295840|NCT00450125|Lung Cancer|lung cancer
5295841|NCT00450125|Lung Resection|lung resection
5295842|NCT00450125|Exercise Stress Test|exercise stress test
5295843|NCT00450125|Six-Minute Walk Test|six-minute walk test
5295844|NCT00450099|Epidural|epidural
5295845|NCT00450099|Labor Analgesia|labor analgesia
5295846|NCT00450099|Bupivacaine|bupivacaine
5295847|NCT00450099|Dose-response|dose-response
5295848|NCT00450099|Minimum effective volume|minimum effective volume
5295849|NCT00450060|postlumbar puncture headache|postlumbar puncture headache
5295850|NCT00450060|atraumatic needle|atraumatic needle
5295851|NCT00450060|Sprotte|sprotte
5295852|NCT00450060|Quincke|quincke
5295853|NCT00450060|lumbar puncture|lumbar puncture
5295854|NCT00450060|headache|headache
5295855|NCT00450060|backache|backache
5295856|NCT00450047|cognitive impairment, ergometer, speed-feedback therapy|cognitive impairment, ergometer, speed-feedback therapy
5295857|NCT00450034|Frail Elderly|frail elderly
5295858|NCT00450034|Patient Education|patient education
5295859|NCT00450034|Drug optimization|drug optimization
5295860|NCT00450034|Underuse|underuse
5295861|NCT00450034|Vulnerable|vulnerable
5295862|NCT00450034|Drug related hospitalization|drug related hospitalization
5295863|NCT00450034|Medical intervention|medical intervention
5295864|NCT00450021|PET|pet
5295865|NCT00450021|CB1 Receptor|cb1 receptor
5295866|NCT00450021|Cannabinoid|cannabinoid
5295867|NCT00450021|[11C] MePPEP|[11c] meppep
5295868|NCT00450021|Brain Imaging|brain imaging
5295869|NCT00450021|Healthy Volunteer|healthy volunteer
5295870|NCT00450021|HV|hv
5295871|NCT00450008|Prostate Cancer|prostate cancer
5295872|NCT00450008|Hormone-Naïve Prostate Cancer|hormone-naïve prostate cancer
5295873|NCT00450008|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5295874|NCT00449982|Genital warts|genital warts
5295875|NCT00449982|Condylomata acuminata|condylomata acuminata
5295876|NCT00449982|Human Papillomavirus|human papillomavirus
5295877|NCT00449982|Polyphenon E|polyphenon e
5295878|NCT00449982|Green tea extract|green tea extract
5295879|NCT00449982|Vulva|vulva
5295880|NCT00449982|Penis|penis
5295881|NCT00449982|Anus|anus
5295882|NCT00449969|AED (automated external defibrillation)|aed (automated external defibrillation)
5295883|NCT00449969|feedback|feedback
5295884|NCT00449969|out of hospital resuscitation|out of hospital resuscitation
5295885|NCT00449943|Cardiac Invasive Catheterization Angiography|cardiac invasive catheterization angiography
5295886|NCT00449943|Single Photon Emission Computed Tomography|single photon emission computed tomography
5295887|NCT00449943|Computed Tomography Angiography|computed tomography angiography
5295888|NCT00449917|visual caracteristics|visual caracteristics
5295889|NCT00449917|macular pigment optical density|macular pigment optical density
5295890|NCT00449917|visual acuity|visual acuity
5295891|NCT00449917|contrast sensibility|contrast sensibility
5295892|NCT00449917|lutein|lutein
5295893|NCT00449917|docosahexaenoic acid (DHA)|docosahexaenoic acid (dha)
5295894|NCT00449904|Cystic fibrosis-related exocrine pancreatic insufficiency|cystic fibrosis-related exocrine pancreatic insufficiency
5295895|NCT00449891|Type 1 diabetes mellitus|type 1 diabetes mellitus
5295896|NCT00449878|cystic fibrosis-related pancreatic insufficiency|cystic fibrosis-related pancreatic insufficiency
5295897|NCT00449865|Parkinson's disease|parkinson's disease
5295898|NCT00449865|creatine|creatine
5295899|NCT00449865|NET-PD|net-pd
5295900|NCT00449865|neuroprotection|neuroprotection
5295901|NCT00449865|PD|pd
5295902|NCT00449852|Randomized Control Trial|randomized control trial
5295903|NCT00449852|Smoking Cessation|smoking cessation
5295904|NCT00449852|Secondary Prevention|secondary prevention
5295906|NCT00449852|Counseling|counseling
5295907|NCT00449839|Insulin pump treatment CSII|insulin pump treatment csii
5295908|NCT00449839|Absorption|absorption
5295909|NCT00449839|Insulin Aspart|insulin aspart
5295910|NCT00449826|ACS|acs
5295911|NCT00449826|Unstable Angina|unstable angina
5295912|NCT00449826|NSTEMI|nstemi
5295913|NCT00449813|Gastroesophageal reflux disease (GERD)|gastroesophageal reflux disease (gerd)
5295914|NCT00449813|Non erosive reflux disease (NERD)|non erosive reflux disease (nerd)
5295915|NCT00449800|Sepsis|sepsis
5295916|NCT00449800|Ceftriaxone|ceftriaxone
5295917|NCT00449800|Pharmacokinetic|pharmacokinetic
5295918|NCT00449800|Intensive care unit|intensive care unit
5295919|NCT00449787|Emergency department|emergency department
5295920|NCT00449787|headache|headache
5295921|NCT00449787|migraine|migraine
5295922|NCT00449774|Food effect|food effect
5295923|NCT00449774|Safety|safety
5295924|NCT00449774|Tolerability|tolerability
5295925|NCT00449774|Water effect|water effect
5295926|NCT00449774|Bioequivalence|bioequivalence
5295927|NCT00449761|Refractory|refractory
5295928|NCT00449761|Chronic Myeloid|chronic myeloid
5295929|NCT00449761|Leukemia|leukemia
5295930|NCT00449761|accelerated phase|accelerated phase
5295931|NCT00449761|blast phase (blast crisis)|blast phase (blast crisis)
5295932|NCT00449761|adults|adults
5295933|NCT00449761|oral LBH589|oral lbh589
5295934|NCT00449748|Systemic Mastocytosis|systemic mastocytosis
5295935|NCT00449748|RAD001|rad001
5295936|NCT00449735|positive isolates|positive isolates
5295937|NCT00449735|ecoli|ecoli
5295938|NCT00449735|blood cultures|blood cultures
5295939|NCT00449735|positive cultures for ecoli|positive cultures for ecoli
5295940|NCT00449735|blood stream infections|blood stream infections
5295941|NCT00449709|Pre-term labor,|pre-term labor,
5295942|NCT00449709|modified release formulation|modified release formulation
5295943|NCT00449709|pharmacokinetics,|pharmacokinetics,
5295944|NCT00449683|Depressive Disorders|depressive disorders
5295945|NCT00449683|Excessive Sweating|excessive sweating
5295946|NCT00449683|Sweating caused by antidepressants for those a depressive disorder|sweating caused by antidepressants for those a depressive disorder
5295947|NCT00449670|Influenza|influenza
5295948|NCT00449670|Influenza Vaccine|influenza vaccine
5295949|NCT00449644|Tuberculosis|tuberculosis
5295950|NCT00449644|MDR TB|mdr tb
5295951|NCT00449631|Glaucoma|glaucoma
5295952|NCT00449631|Drug Resistance, Multiple|drug resistance, multiple
5295953|NCT00449631|Trabeculectomy|trabeculectomy
5295954|NCT00449618|Aspirin|aspirin
5295955|NCT00449618|Ambulatory blood pressure monitoring|ambulatory blood pressure monitoring
5295956|NCT00449618|Chronotherapy|chronotherapy
5295957|NCT00449618|Circadian|circadian
5295958|NCT00449605|Diabetes|diabetes
5295959|NCT00449605|Metformin|metformin
5295960|NCT00449592|Stem cell transplantation|stem cell transplantation
5295961|NCT00449592|Mucositis|mucositis
5295962|NCT00449592|Zinc|zinc
5295963|NCT00449579|Ischemia|ischemia
5295964|NCT00449579|Myocardial|myocardial
5295965|NCT00449579|HF-ECG|hf-ecg
5295966|NCT00449566|Magnetic Resonance Imaging|magnetic resonance imaging
5295967|NCT00449566|Diffusion Tensor Imaging|diffusion tensor imaging
5295968|NCT00449553|Glucose Metabolism Disorder|glucose metabolism disorder
5295969|NCT00449553|Dysmetabolic Syndrome|dysmetabolic syndrome
5295970|NCT00449553|Type II Diabetes|type ii diabetes
5295971|NCT00449553|Diabetes Mellitus, Lipoatrophic|diabetes mellitus, lipoatrophic
5295972|NCT00449553|Dyslipidemia|dyslipidemia
5295973|NCT00449553|Drug Therapy|drug therapy
5295974|NCT00449540|Migraine with aura|migraine with aura
5295975|NCT00449540|aura|aura
5295976|NCT00449540|TMS|tms
5295977|NCT00449527|Mild asthma|mild asthma
5295978|NCT00449527|Moderate asthma|moderate asthma
5295979|NCT00449514|infertility|infertility
5295980|NCT00449514|ovulation dysfunction|ovulation dysfunction
5295981|NCT00449514|endometrium|endometrium
5295982|NCT00449514|tamoxifen|tamoxifen
5295983|NCT00449514|clomiphene citrate|clomiphene citrate
5295984|NCT00449501|Mild Asthma|mild asthma
5295985|NCT00449501|Moderate Asthma|moderate asthma
5295986|NCT00449488|erythropoietin|erythropoietin
5295987|NCT00449488|myocardial infarction|myocardial infarction
5295988|NCT00449488|PCI|pci
5295989|NCT00449488|left ventricular function|left ventricular function
5295990|NCT00449462|CLA|cla
5295991|NCT00449462|liver|liver
5295992|NCT00449462|kidney|kidney
5295993|NCT00449449|Pertubation, tubal flushing, intrauterine insemination.|pertubation, tubal flushing, intrauterine insemination.
5295994|NCT00449436|HIV|hiv
5295995|NCT00449436|treatment experienced|treatment experienced
5295996|NCT00449423|Acute heart failure|acute heart failure
5297668|NCT00445237|TMS|tms
5295997|NCT00449423|Metabolic modulation|metabolic modulation
5295998|NCT00449410|Atrial Fibrillation|atrial fibrillation
5295999|NCT00449410|elderly|elderly
5296000|NCT00449410|cholesterol lowering|cholesterol lowering
5296001|NCT00449410|neurocognitive function|neurocognitive function
5296002|NCT00449410|cerebrovascular lesion|cerebrovascular lesion
5296003|NCT00449397|First Episode Psychosis|first episode psychosis
5296004|NCT00449384|Severe Impairment Battery|severe impairment battery
5296005|NCT00449384|Clinical Dementia Rating|clinical dementia rating
5296006|NCT00449358|bcc|bcc
5296007|NCT00449345|Latent tuberculosis infection|latent tuberculosis infection
5296008|NCT00449345|Health care workers|health care workers
5296009|NCT00449345|Tuberculin skin test|tuberculin skin test
5296010|NCT00449345|Mantoux skin test|mantoux skin test
5296011|NCT00449345|Interferon gamma|interferon gamma
5296012|NCT00449345|Quantiferon|quantiferon
5296013|NCT00449345|Cost effectiveness|cost effectiveness
5296014|NCT00449332|Chronic rejection, lung transplant, cytokines, bos|chronic rejection, lung transplant, cytokines, bos
5296015|NCT00449319|AML|aml
5296016|NCT00449319|adult|adult
5296017|NCT00449319|Hydroxyurea|hydroxyurea
5296018|NCT00449319|Transplant|transplant
5296019|NCT00449319|Toevaluate biological characteristics at diagnosis.|toevaluate biological characteristics at diagnosis.
5296020|NCT00449319|To identify genetic alterations with prognostic relevance.|to identify genetic alterations with prognostic relevance.
5296021|NCT00449319|To follow up cases monitoring minimal disease during remission.|to follow up cases monitoring minimal disease during remission.
5296022|NCT00449319|To evaluate pretreatment therapy in terms of response rate and toxicity.|to evaluate pretreatment therapy in terms of response rate and toxicity.
5296023|NCT00449319|Disease free survival.|disease free survival.
5296024|NCT00449319|Overal survival.|overal survival.
5296025|NCT00449306|Atherosclerosis|atherosclerosis
5296026|NCT00449306|Carotid plaque|carotid plaque
5296027|NCT00449306|Abdominal aortic aneurysm|abdominal aortic aneurysm
5296028|NCT00449306|Vulnerable plaque|vulnerable plaque
5296029|NCT00449306|Angiogenesis|angiogenesis
5296030|NCT00449306|Intraplaque hemorrhage|intraplaque hemorrhage
5296031|NCT00449306|Carotid artery atherosclerosis|carotid artery atherosclerosis
5296032|NCT00449293|Smoking cessation|smoking cessation
5296033|NCT00449293|Tobacco dependence|tobacco dependence
5296034|NCT00449293|Mindfulness|mindfulness
5296035|NCT00449293|fMRI|fmri
5296036|NCT00449293|Craving|craving
5296037|NCT00449280|metastatic|metastatic
5296038|NCT00449280|advanced disease|advanced disease
5296039|NCT00449280|phase I|phase i
5296040|NCT00449267|Lenses, Intraocular|lenses, intraocular
5296041|NCT00449267|Prospective Studies|prospective studies
5296042|NCT00449267|Visual acuity|visual acuity
5296043|NCT00449267|Clinical Trial|clinical trial
5296044|NCT00449241|Acupuncture, Endoscopy|acupuncture, endoscopy
5296045|NCT00449228|Osteoarthritis,|osteoarthritis,
5296046|NCT00449228|hip replacement,|hip replacement,
5296047|NCT00449228|education,|education,
5296048|NCT00449228|randomized controlled trial,|randomized controlled trial,
5296049|NCT00449228|mini-invasive surgery|mini-invasive surgery
5296050|NCT00449215|Peak Bone Mass; Male; Genetic Polymorphisms|peak bone mass; male; genetic polymorphisms
5296051|NCT00449176|Low Back Pain|low back pain
5296052|NCT00449176|Chronic Pain|chronic pain
5296053|NCT00449176|Pain Assessment|pain assessment
5296054|NCT00449176|Tapentadol|tapentadol
5296055|NCT00449163|stage IV colon cancer|stage iv colon cancer
5296056|NCT00449163|stage IV rectal cancer|stage iv rectal cancer
5296057|NCT00449163|adenocarcinoma of the colon|adenocarcinoma of the colon
5296058|NCT00449163|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5296059|NCT00449150|Cetrorelix|cetrorelix
5296060|NCT00449137|recurrent colon cancer|recurrent colon cancer
5296061|NCT00449137|stage IV colon cancer|stage iv colon cancer
5296062|NCT00449137|recurrent rectal cancer|recurrent rectal cancer
5296063|NCT00449137|stage IV rectal cancer|stage iv rectal cancer
5296064|NCT00449124|hepatitis C, vaccine, TG4040|hepatitis c, vaccine, tg4040
5296065|NCT00449098|Glaucoma|glaucoma
5296066|NCT00449098|Collagen matrix|collagen matrix
5296067|NCT00449098|ologen|ologen
5296068|NCT00449098|OculusGen|oculusgen
5296069|NCT00449098|Trabeculectomy|trabeculectomy
5296070|NCT00449098|anti scarring|anti scarring
5296071|NCT00449098|tissue engineering|tissue engineering
5296072|NCT00449098|high risk patient for trabeculectomy|high risk patient for trabeculectomy
5296073|NCT00449098|Aeon Astron|aeon astron
5296074|NCT00449059|heart transplantation|heart transplantation
5296075|NCT00449059|cyclosporine|cyclosporine
5296076|NCT00449059|hypertension|hypertension
5296077|NCT00449059|nitroglycerin|nitroglycerin
5296078|NCT00449046|salmeterol/fluticasone propionate combination|salmeterol/fluticasone propionate combination
5296079|NCT00449046|pediatric bronchial asthma|pediatric bronchial asthma
5296080|NCT00449033|Non-Small Cell Lung Cancer (NSCLC)|non-small cell lung cancer (nsclc)
5296081|NCT00449033|Cancer|cancer
5296082|NCT00449020|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5296083|NCT00449020|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5296084|NCT00449007|Major depressive disorder|major depressive disorder
5296085|NCT00449007|Alcohol abuse|alcohol abuse
5296086|NCT00449007|Alcohol dependence|alcohol dependence
5296087|NCT00449007|Suicide|suicide
5297669|NCT00445224|Knee pain|knee pain
5296088|NCT00448994|adenovirus, fungal, diagnostics, children|adenovirus, fungal, diagnostics, children
5296089|NCT00448981|Preventing upper respiratory tract infections|preventing upper respiratory tract infections
5296090|NCT00448981|Preventing influenza|preventing influenza
5296091|NCT00448981|Preventing the common cold|preventing the common cold
5296092|NCT00448981|Hand hygiene and upper respiratory infections|hand hygiene and upper respiratory infections
5296093|NCT00448981|Mask use in preventing upper respiratory infections|mask use in preventing upper respiratory infections
5296094|NCT00448968|Sepsis|sepsis
5296095|NCT00448968|Ischemia Modified Albumin|ischemia modified albumin
5296096|NCT00448968|Systemic Inflammatory Response Syndrome|systemic inflammatory response syndrome
5296097|NCT00448942|Staphylococcus aureus [B03.510.400.790.750.100]|staphylococcus aureus [b03.510.400.790.750.100]
5296098|NCT00448942|Enterococcus faecalis [B03.510.400.800.280.280]|enterococcus faecalis [b03.510.400.800.280.280]
5296099|NCT00448942|Enterococcus faecium [B03.510.400.800.280.300]|enterococcus faecium [b03.510.400.800.280.300]
5296100|NCT00448942|Bacteremia [C01.252.100]|bacteremia [c01.252.100]
5296101|NCT00448942|Fungemia [C01.703.360]|fungemia [c01.703.360]
5296102|NCT00448942|Infection Control [G03.850.780.200.450]|infection control [g03.850.780.200.450]
5296103|NCT00448942|Antisepsis [G03.850.780.200.450.150]|antisepsis [g03.850.780.200.450.150]
5296104|NCT00448929|Glaucoma|glaucoma
5296105|NCT00448929|Collagen matrix|collagen matrix
5296106|NCT00448929|ologen|ologen
5296107|NCT00448929|OculusGen|oculusgen
5296108|NCT00448929|Trabeculectomy|trabeculectomy
5296109|NCT00448916|Partial-onset seizures; epilepsy; pediatric; pregabalin; 1 year extension study; safety; tolerability|partial-onset seizures; epilepsy; pediatric; pregabalin; 1 year extension study; safety; tolerability
5296110|NCT00448903|diabetic|diabetic
5296111|NCT00448903|foot|foot
5296112|NCT00448903|ulcer|ulcer
5296113|NCT00448903|bemiparin|bemiparin
5296114|NCT00448903|neuropathy|neuropathy
5296115|NCT00448903|neuroishemic|neuroishemic
5296116|NCT00448903|diabetes|diabetes
5296117|NCT00448890|AMPA positive modulator, healthy volunteers|ampa positive modulator, healthy volunteers
5296118|NCT00448877|No specific disease is being studied, few procedures are excluded.|no specific disease is being studied, few procedures are excluded.
5296119|NCT00448877|The focus of the study is to rule out the efficacy of the device, so the aim is to include as wide a variety of procedures as possible.|the focus of the study is to rule out the efficacy of the device, so the aim is to include as wide a variety of procedures as possible.
5296120|NCT00448851|asthma|asthma
5296121|NCT00448851|allergy|allergy
5296122|NCT00448838|recurrent pancreatic cancer|recurrent pancreatic cancer
5296123|NCT00448838|stage III pancreatic cancer|stage iii pancreatic cancer
5296124|NCT00448838|stage IV pancreatic cancer|stage iv pancreatic cancer
5296125|NCT00448838|stage II pancreatic cancer|stage ii pancreatic cancer
5296126|NCT00448825|alcohol dependence|alcohol dependence
5296127|NCT00448825|alcoholism|alcoholism
5296128|NCT00448825|cocaine addiction|cocaine addiction
5296129|NCT00448825|cocaine dependence|cocaine dependence
5296130|NCT00448799|neurological|neurological
5296131|NCT00448799|alzheimers|alzheimers
5296132|NCT00448786|gallbladder|gallbladder
5296133|NCT00448786|AMG 706|amg 706
5296134|NCT00448786|solid tumors|solid tumors
5296135|NCT00448786|Phase 1b|phase 1b
5296136|NCT00448786|Amgen|amgen
5296137|NCT00448760|stage II esophageal cancer|stage ii esophageal cancer
5296138|NCT00448760|stage III esophageal cancer|stage iii esophageal cancer
5296139|NCT00448760|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
5296140|NCT00448747|Ghrelin mimetic, growth hormone secretagogue|ghrelin mimetic, growth hormone secretagogue
5296141|NCT00448734|metastatic|metastatic
5296142|NCT00448734|hormone-refractory|hormone-refractory
5296143|NCT00448734|prostate cancer|prostate cancer
5296144|NCT00448734|picoplatin|picoplatin
5296145|NCT00448734|platinum drug|platinum drug
5296146|NCT00448734|chemotherapy|chemotherapy
5296147|NCT00448734|docetaxel|docetaxel
5296148|NCT00448721|renal cell carcinoma|renal cell carcinoma
5296149|NCT00448721|tyrosine kinase inhibitor failure|tyrosine kinase inhibitor failure
5296150|NCT00448708|Hemodialysis Access|hemodialysis access
5296151|NCT00448695|MRI|mri
5296152|NCT00448695|Laser Thermal Therapy|laser thermal therapy
5296153|NCT00448695|Focal Ablation|focal ablation
5296154|NCT00448695|Prostate Cancer|prostate cancer
5296155|NCT00448682|recurrent gastric cancer|recurrent gastric cancer
5296156|NCT00448682|stage IV gastric cancer|stage iv gastric cancer
5296157|NCT00448682|adenocarcinoma of the stomach|adenocarcinoma of the stomach
5296158|NCT00448669|HIV incidence|hiv incidence
5296159|NCT00448669|HIV prevention|hiv prevention
5296160|NCT00448669|Tenofovir|tenofovir
5296161|NCT00448669|Emtricitabine|emtricitabine
5296162|NCT00448669|Botswana|botswana
5296163|NCT00448669|HIV seronegativity|hiv seronegativity
5296164|NCT00448656|atrial fibrillation|atrial fibrillation
5296165|NCT00448656|epicardial ablation pulmonary veins|epicardial ablation pulmonary veins
5296166|NCT00448656|video assisted thoracic surgery|video assisted thoracic surgery
5296167|NCT00448643|endometrial adenocarcinoma|endometrial adenocarcinoma
5296168|NCT00448643|endometrial clear cell carcinoma|endometrial clear cell carcinoma
5296169|NCT00448643|endometrial papillary carcinoma|endometrial papillary carcinoma
5296170|NCT00448643|stage III endometrial carcinoma|stage iii endometrial carcinoma
5296171|NCT00448643|stage IV endometrial carcinoma|stage iv endometrial carcinoma
5296235|NCT00448474|Disease self-management|disease self-management
5296172|NCT00448630|Atypical antipsychotics, Metabolic syndrome, Safety|atypical antipsychotics, metabolic syndrome, safety
5296173|NCT00448617|live attenuated influenza virus|live attenuated influenza virus
5296174|NCT00448617|inflammation|inflammation
5296175|NCT00448617|flu vaccine|flu vaccine
5296176|NCT00448617|FluMist|flumist
5296177|NCT00448617|smokers|smokers
5296178|NCT00448604|procalcitonin|procalcitonin
5296179|NCT00448604|acute exacerbation|acute exacerbation
5296180|NCT00448604|RT-PCR|rt-pcr
5296181|NCT00448604|Biological Markers|biological markers
5296182|NCT00448578|Acute Mania|acute mania
5296183|NCT00448565|extubation|extubation
5296184|NCT00448565|prediction|prediction
5296185|NCT00448552|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
5296186|NCT00448552|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5296187|NCT00448552|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
5296188|NCT00448552|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
5296189|NCT00448552|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5296190|NCT00448552|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
5296191|NCT00448552|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
5296192|NCT00448552|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5296193|NCT00448552|recurrent basal cell carcinoma of the lip|recurrent basal cell carcinoma of the lip
5296194|NCT00448552|stage IV basal cell carcinoma of the lip|stage iv basal cell carcinoma of the lip
5296195|NCT00448552|recurrent adenoid cystic carcinoma of the oral cavity|recurrent adenoid cystic carcinoma of the oral cavity
5296196|NCT00448552|recurrent mucoepidermoid carcinoma of the oral cavity|recurrent mucoepidermoid carcinoma of the oral cavity
5296197|NCT00448552|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
5296198|NCT00448552|stage IV adenoid cystic carcinoma of the oral cavity|stage iv adenoid cystic carcinoma of the oral cavity
5296199|NCT00448552|stage IV mucoepidermoid carcinoma of the oral cavity|stage iv mucoepidermoid carcinoma of the oral cavity
5296200|NCT00448552|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
5296201|NCT00448552|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
5296202|NCT00448552|recurrent lymphoepithelioma of the nasopharynx|recurrent lymphoepithelioma of the nasopharynx
5296203|NCT00448552|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
5296204|NCT00448552|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
5296205|NCT00448552|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
5296206|NCT00448552|recurrent lymphoepithelioma of the oropharynx|recurrent lymphoepithelioma of the oropharynx
5296207|NCT00448552|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
5296208|NCT00448552|stage IV lymphoepithelioma of the oropharynx|stage iv lymphoepithelioma of the oropharynx
5296209|NCT00448552|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5296210|NCT00448552|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity
5296211|NCT00448552|recurrent inverted papilloma of the paranasal sinus and nasal cavity|recurrent inverted papilloma of the paranasal sinus and nasal cavity
5296212|NCT00448552|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity
5296213|NCT00448552|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
5296214|NCT00448552|stage IV esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iv esthesioneuroblastoma of the paranasal sinus and nasal cavity
5296215|NCT00448552|stage IV inverted papilloma of the paranasal sinus and nasal cavity|stage iv inverted papilloma of the paranasal sinus and nasal cavity
5296216|NCT00448552|stage IV midline lethal granuloma of the paranasal sinus and nasal cavity|stage iv midline lethal granuloma of the paranasal sinus and nasal cavity
5296217|NCT00448552|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
5296218|NCT00448552|recurrent salivary gland cancer|recurrent salivary gland cancer
5296219|NCT00448552|stage IV salivary gland cancer|stage iv salivary gland cancer
5296220|NCT00448552|untreated metastatic squamous neck cancer with occult primary|untreated metastatic squamous neck cancer with occult primary
5296221|NCT00448552|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
5296222|NCT00448539|Refractory Partial Onset Seizures, epilepsy|refractory partial onset seizures, epilepsy
5296223|NCT00448526|Low protein diet, type 2 Diabetic nephropathy|low protein diet, type 2 diabetic nephropathy
5296224|NCT00448526|Comparing the effect of Low protein Diet on diabetic nephropathy to that of normal protein diet|comparing the effect of low protein diet on diabetic nephropathy to that of normal protein diet
5296225|NCT00448513|catechin|catechin
5296226|NCT00448513|oxidative stress|oxidative stress
5296227|NCT00448513|chromosome damage|chromosome damage
5296228|NCT00448513|aged|aged
5296229|NCT00448500|COPD|copd
5296230|NCT00448500|exhaled breath condenate|exhaled breath condenate
5296231|NCT00448500|Exhaled breath condenate, acute exacerbation of COPD|exhaled breath condenate, acute exacerbation of copd
5296232|NCT00448487|Diabetes|diabetes
5296233|NCT00448487|Cardiovascular Disease|cardiovascular disease
5296236|NCT00448474|Community program|community program
5296237|NCT00448461|coronary artery disease|coronary artery disease
5296238|NCT00448461|percutaneous coronary interventions|percutaneous coronary interventions
5296239|NCT00448448|adolescent idiopathic scoliosis|adolescent idiopathic scoliosis
5296240|NCT00448448|orthotics|orthotics
5296241|NCT00448448|bracing|bracing
5296242|NCT00448448|partially randomized preference design|partially randomized preference design
5296243|NCT00448435|Salmeterol|salmeterol
5296244|NCT00448435|Fluticasone propionate|fluticasone propionate
5296245|NCT00448435|Salmeterol/Fluticasone propionate combination|salmeterol/fluticasone propionate combination
5296246|NCT00448435|Pediatric bronchial asthma|pediatric bronchial asthma
5296247|NCT00448422|Traveler's|traveler's
5296248|NCT00448422|Diarrhea|diarrhea
5296249|NCT00448409|Prostate cancer|prostate cancer
5296250|NCT00448409|hormone refractory prostate cancer|hormone refractory prostate cancer
5296251|NCT00448409|androgen resistant prostate cancer|androgen resistant prostate cancer
5296252|NCT00448396|Cancer|cancer
5296253|NCT00448396|EPO|epo
5296254|NCT00448396|Patupilone|patupilone
5296255|NCT00448396|Solid tumors|solid tumors
5296256|NCT00448396|Advanced malignancies|advanced malignancies
5296257|NCT00448370|Anemia, sickle cell|anemia, sickle cell
5296258|NCT00448357|refractory multiple myeloma|refractory multiple myeloma
5296259|NCT00448357|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5296260|NCT00448357|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5296261|NCT00448357|stage II multiple myeloma|stage ii multiple myeloma
5296262|NCT00448357|stage III multiple myeloma|stage iii multiple myeloma
5296263|NCT00448357|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5296264|NCT00448357|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5296265|NCT00448357|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5296266|NCT00448357|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5296267|NCT00448357|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5296268|NCT00448357|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5296269|NCT00448357|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5296270|NCT00448357|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5296271|NCT00448357|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5296272|NCT00448357|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5296273|NCT00448357|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5296274|NCT00448357|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5296275|NCT00448357|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5296276|NCT00448357|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
5296277|NCT00448357|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5296278|NCT00448357|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5296279|NCT00448357|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5296280|NCT00448357|chronic eosinophilic leukemia|chronic eosinophilic leukemia
5296281|NCT00448357|chronic neutrophilic leukemia|chronic neutrophilic leukemia
5296282|NCT00448357|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5296283|NCT00448357|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5296284|NCT00448357|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5296285|NCT00448357|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5296286|NCT00448357|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5296287|NCT00448357|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5296288|NCT00448357|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5296289|NCT00448357|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5296290|NCT00448357|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5296291|NCT00448357|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5296292|NCT00448357|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5296293|NCT00448357|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5296294|NCT00448357|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5296295|NCT00448357|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5296296|NCT00448357|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5296297|NCT00448357|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5296298|NCT00448357|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5296299|NCT00448357|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5296300|NCT00448357|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5296301|NCT00448357|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5296302|NCT00448357|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5296303|NCT00448357|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5296304|NCT00448357|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5296305|NCT00448357|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5296306|NCT00448357|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5296307|NCT00448357|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5296308|NCT00448357|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5296309|NCT00448357|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5296310|NCT00448357|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5296311|NCT00448357|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5296312|NCT00448357|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5296313|NCT00448357|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5296314|NCT00448357|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5296315|NCT00448357|primary myelofibrosis|primary myelofibrosis
5296316|NCT00448357|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5296317|NCT00448357|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5296318|NCT00448357|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5296319|NCT00448357|prolymphocytic leukemia|prolymphocytic leukemia
5296320|NCT00448357|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5296321|NCT00448357|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5296322|NCT00448357|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5296323|NCT00448357|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5296324|NCT00448357|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5296325|NCT00448357|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5296326|NCT00448357|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5296327|NCT00448357|polycythemia vera|polycythemia vera
5296328|NCT00448357|essential thrombocythemia|essential thrombocythemia
5296329|NCT00448357|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5296330|NCT00448357|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5296331|NCT00448357|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5296332|NCT00448357|stage I multiple myeloma|stage i multiple myeloma
5296333|NCT00448357|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
5296334|NCT00448357|adult nasal type extranodal natural killer (NK)/T-cell lymphoma|adult nasal type extranodal natural killer (nk)/t-cell lymphoma
5296335|NCT00448344|veterans|veterans
5296336|NCT00448344|smoking cessation|smoking cessation
5296337|NCT00448331|Mental Disorders|mental disorders
5296338|NCT00448331|Mentally Ill Persons|mentally ill persons
5296339|NCT00448331|Emergency Medicine|emergency medicine
5296340|NCT00448331|Emergency Department|emergency department
5296341|NCT00448331|Screening|screening
5296342|NCT00448318|Controlled clinical trial|controlled clinical trial
5296343|NCT00448305|breast cancer|breast cancer
5296344|NCT00448305|metastatic|metastatic
5296345|NCT00448305|relapsed|relapsed
5296346|NCT00448305|triple-receptor negative|triple-receptor negative
5296347|NCT00448305|EndoTAG-1|endotag-1
5296348|NCT00448305|metastatic or relapsed breast neoplasm|metastatic or relapsed breast neoplasm
5296349|NCT00448292|Depression|depression
5296350|NCT00448292|Major Depressive Disorder|major depressive disorder
5296351|NCT00448292|Major Depression|major depression
5296352|NCT00448292|MDD|mdd
5296353|NCT00448266|Breast cancer|breast cancer
5296354|NCT00448266|high-dose chemotherapy|high-dose chemotherapy
5296355|NCT00448266|Homologous Recombination Deficiency|homologous recombination deficiency
5296356|NCT00448266|Alkylator therapy|alkylator therapy
5296357|NCT00448266|Peripheral Blood Progenitor Cell Support|peripheral blood progenitor cell support
5296358|NCT00448253|Inhalational Anthrax|inhalational anthrax
5296359|NCT00448253|Human Immune globulin|human immune globulin
5296360|NCT00448227|Infants, Herpes simplex infection|infants, herpes simplex infection
5296361|NCT00448214|Factor Xa inhibitor|factor xa inhibitor
5296362|NCT00448214|Atrial fibrillation|atrial fibrillation
5296363|NCT00448214|Stroke|stroke
5296364|NCT00448214|Ischemic attack|ischemic attack
5296365|NCT00448214|thromboembolism|thromboembolism
5296366|NCT00448214|Prevention and control|prevention and control
5296367|NCT00448201|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5296368|NCT00448201|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5296369|NCT00448201|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5296370|NCT00448201|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5296371|NCT00448201|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5296372|NCT00448201|prolymphocytic leukemia|prolymphocytic leukemia
5296373|NCT00448201|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5296374|NCT00448201|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5296375|NCT00448201|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5296376|NCT00448201|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5296377|NCT00448201|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
5296378|NCT00448201|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
5296379|NCT00448201|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
5296380|NCT00448201|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5296381|NCT00448201|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5296382|NCT00448201|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5296383|NCT00448201|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5296384|NCT00448201|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
5296385|NCT00448201|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5296386|NCT00448201|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
5296387|NCT00448201|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
5296388|NCT00448201|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
5296389|NCT00448201|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
5296390|NCT00448201|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5296391|NCT00448201|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5296392|NCT00448201|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5296393|NCT00448201|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5296394|NCT00448201|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
5296395|NCT00448201|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
5296396|NCT00448201|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5296397|NCT00448201|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5296398|NCT00448201|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5296399|NCT00448201|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5296400|NCT00448201|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5296401|NCT00448201|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5296402|NCT00448201|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5296403|NCT00448201|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5296404|NCT00448201|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5296405|NCT00448201|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5296406|NCT00448201|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5296407|NCT00448201|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
5296408|NCT00448201|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5296409|NCT00448201|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
5296410|NCT00448201|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
5296411|NCT00448201|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
5296412|NCT00448201|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5296413|NCT00448201|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5296414|NCT00448201|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5296415|NCT00448201|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5296416|NCT00448201|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5296417|NCT00448201|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5296418|NCT00448201|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5296419|NCT00448201|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5296420|NCT00448201|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5296421|NCT00448201|refractory multiple myeloma|refractory multiple myeloma
5296422|NCT00448201|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5296423|NCT00448201|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5296424|NCT00448201|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5296425|NCT00448201|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5296426|NCT00448201|stage I multiple myeloma|stage i multiple myeloma
5296427|NCT00448201|stage II multiple myeloma|stage ii multiple myeloma
5296428|NCT00448201|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5296429|NCT00448201|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5296430|NCT00448201|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5296431|NCT00448201|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5296432|NCT00448201|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5296433|NCT00448201|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5296434|NCT00448201|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5296435|NCT00448201|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5296436|NCT00448201|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5296437|NCT00448201|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5296438|NCT00448201|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5296439|NCT00448201|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5296440|NCT00448201|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5296441|NCT00448201|stage III multiple myeloma|stage iii multiple myeloma
5296442|NCT00448201|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5296443|NCT00448201|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5296444|NCT00448201|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5296445|NCT00448201|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5296446|NCT00448201|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5296447|NCT00448201|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5296448|NCT00448201|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5296449|NCT00448201|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5296450|NCT00448201|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5296451|NCT00448201|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5296452|NCT00448201|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5296453|NCT00448201|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5296454|NCT00448201|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5296455|NCT00448201|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5296456|NCT00448201|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5296457|NCT00448201|primary myelofibrosis|primary myelofibrosis
5296458|NCT00448201|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
5296459|NCT00448201|adult nasal type extranodal natural killer (NK)/T-cell lymphoma|adult nasal type extranodal natural killer (nk)/t-cell lymphoma
5296460|NCT00448201|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
5296461|NCT00448201|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
5296462|NCT00448188|central venous catheter|central venous catheter
5296463|NCT00448188|international normalized ratio|international normalized ratio
5296464|NCT00448188|thrombocytes|thrombocytes
5296465|NCT00448188|bleeding risk|bleeding risk
5296466|NCT00448188|all patients in need of central venous line|all patients in need of central venous line
5296467|NCT00448188|comparison of patients with normal hemostasis to such with disorders in hemostasis|comparison of patients with normal hemostasis to such with disorders in hemostasis
5296468|NCT00448175|OAB symptoms of urgency, frequency, and urge incontinence|oab symptoms of urgency, frequency, and urge incontinence
5296469|NCT00448162|hypertension, ENaC, Liddle's syndrome, variation|hypertension, enac, liddle's syndrome, variation
5296470|NCT00448149|Kidney cancer|kidney cancer
5296471|NCT00448149|Renal cell carcinoma|renal cell carcinoma
5296472|NCT00448149|Metastatic RCC|metastatic rcc
5296473|NCT00448123|Kidney Stones|kidney stones
5296474|NCT00448123|Ureteral Stones|ureteral stones
5296475|NCT00448123|Flomax|flomax
5296476|NCT00448123|Emergency Medicine|emergency medicine
5296477|NCT00448123|Urology|urology
5296478|NCT00448097|Adenocarcinoma of the Prostate|adenocarcinoma of the prostate
5296479|NCT00448097|Prostate cancer|prostate cancer
5296480|NCT00448097|Pre-Prostatectomy|pre-prostatectomy
5296481|NCT00448097|Neoadjuvant|neoadjuvant
5296482|NCT00448084|Psychogenic Movement Disorders|psychogenic movement disorders
5296483|NCT00448084|Volition|volition
5296484|NCT00448084|fMRI|fmri
5296485|NCT00448084|Functional MRI|functional mri
5296486|NCT00448084|Functional Movement Disorder|functional movement disorder
5296487|NCT00448084|Healthy Volunteer|healthy volunteer
5296489|NCT00448071|Hypotension|hypotension
5296490|NCT00448071|End Stage Renal Disease|end stage renal disease
5296491|NCT00448071|Intra Dialytic Hypotension|intra dialytic hypotension
5296492|NCT00448071|ESRD|esrd
5296493|NCT00448071|Blood Pressure|blood pressure
5296494|NCT00448071|Dialysis|dialysis
5296495|NCT00448058|Flexible-dose|flexible-dose
5296496|NCT00448058|GSK372475|gsk372475
5296497|NCT00448058|MDD|mdd
5296498|NCT00448058|Venlafaxine XR|venlafaxine xr
5296499|NCT00448058|Major Depressive Disorder|major depressive disorder
5296500|NCT00448045|Spinal cord injuries|spinal cord injuries
5296501|NCT00448045|Cough|cough
5296502|NCT00448045|Peak cough flow|peak cough flow
5296503|NCT00448045|Respiratory therapy|respiratory therapy
5296504|NCT00448045|Rehabilitation|rehabilitation
5296505|NCT00448019|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
5296506|NCT00448019|Fludarabine|fludarabine
5296507|NCT00448019|Cyclophosphamide|cyclophosphamide
5296508|NCT00448019|Rituximab|rituximab
5296509|NCT00448019|Bevacizumab|bevacizumab
5296510|NCT00448019|CLL|cll
5296511|NCT00448006|common|common
5296512|NCT00448006|bile|bile
5296513|NCT00448006|duct|duct
5296514|NCT00448006|biliary|biliary
5296515|NCT00448006|malignant|malignant
5296516|NCT00448006|obstruction|obstruction
5296517|NCT00448006|stent|stent
5296518|NCT00447993|Retinitis Pigmentosa|retinitis pigmentosa
5296519|NCT00447993|eye disease|eye disease
5296520|NCT00447993|retinal disorder|retinal disorder
5296521|NCT00447993|CNTF|cntf
5296522|NCT00447980|Retinitis Pigmentosa|retinitis pigmentosa
5296523|NCT00447980|eye disease|eye disease
5296524|NCT00447980|retinal disorder|retinal disorder
5296525|NCT00447980|CNTF|cntf
5296526|NCT00447967|Metastatic Gastric Cancer|metastatic gastric cancer
5296527|NCT00447967|Oxaliplatin|oxaliplatin
5296528|NCT00447967|Irinotecan|irinotecan
5296529|NCT00447954|eye disease|eye disease
5296530|NCT00447954|retinal disorder|retinal disorder
5296531|NCT00447954|CNTF|cntf
5296532|NCT00447928|tendonitis|tendonitis
5296533|NCT00447928|nitroglycerin|nitroglycerin
5296534|NCT00447928|nitric oxide|nitric oxide
5296535|NCT00447928|lateral epicondylitis|lateral epicondylitis
5296536|NCT00447902|treatment experienced|treatment experienced
5296537|NCT00447837|Chronic Sinusitis|chronic sinusitis
5296538|NCT00447824|Pain|pain
5296539|NCT00447824|Neonates|neonates
5296540|NCT00447824|NIDCAP|nidcap
5296541|NCT00447824|Venous|venous
5296542|NCT00447824|Capillary|capillary
5296543|NCT00447811|Methadone|methadone
5296544|NCT00447798|HIV positive|hiv positive
5296545|NCT00447798|crack cocaine user|crack cocaine user
5296546|NCT00447798|inpatient hospital setting|inpatient hospital setting
5296547|NCT00447798|HIV knowledge|hiv knowledge
5296548|NCT00447798|motivation|motivation
5296549|NCT00447798|perceived self-efficacy|perceived self-efficacy
5296550|NCT00447798|risky sexual behavior|risky sexual behavior
5296551|NCT00447798|HIV seronegativity|hiv seronegativity
5296552|NCT00447785|alcoholism|alcoholism
5296553|NCT00447785|nutrition|nutrition
5296554|NCT00447785|craving|craving
5296555|NCT00447785|energy supplies|energy supplies
5296556|NCT00447785|water supplies|water supplies
5296557|NCT00447772|Dysport, Cervical Dystonia|dysport, cervical dystonia
5296558|NCT00447759|Celecoxib|celecoxib
5296559|NCT00447759|Celebrex|celebrex
5296560|NCT00447759|Ibuprofen|ibuprofen
5296561|NCT00447759|Diclofenac|diclofenac
5296562|NCT00447759|NSAID|nsaid
5296563|NCT00447759|Osteoarthritis|osteoarthritis
5296564|NCT00447759|Rheumatoid Arthritis|rheumatoid arthritis
5296565|NCT00447759|Arthritis|arthritis
5296566|NCT00447759|Safety study|safety study
5296567|NCT00447759|Cardiovascular safety|cardiovascular safety
5296568|NCT00447759|Clinical trial|clinical trial
5296569|NCT00447759|PROBE design|probe design
5296570|NCT00447759|University of Dundee|university of dundee
5296571|NCT00447759|Medicines Monitoring Unit|medicines monitoring unit
5296572|NCT00447759|MEMO|memo
5296573|NCT00447759|Professor Tom MacDonald|professor tom macdonald
5296574|NCT00447746|Comparison between D1 and D2 lymphadenectomy for gastric cancer|comparison between d1 and d2 lymphadenectomy for gastric cancer
5296575|NCT00447733|mental health|mental health
5296576|NCT00447733|substance use|substance use
5296577|NCT00447733|treatment|treatment
5296578|NCT00447720|HIV prevention skills|hiv prevention skills
5296579|NCT00447720|Seriously Mentally Ill (SMI)|seriously mentally ill (smi)
5296580|NCT00447720|Substance abuse|substance abuse
5296581|NCT00447720|Philadelphia|philadelphia
5296582|NCT00447720|HIV seronegativity|hiv seronegativity
5296583|NCT00447707|Substance use|substance use
5296584|NCT00447707|Unprotected sex|unprotected sex
5296585|NCT00447707|Behavioral intervention|behavioral intervention
5296586|NCT00447707|HIV care|hiv care
5296587|NCT00447707|Prevention with Positives|prevention with positives
5296588|NCT00447707|HIV seronegativity|hiv seronegativity
5296589|NCT00447694|Iron Chelation|iron chelation
5296590|NCT00447694|Deferasirox|deferasirox
5296591|NCT00447694|Chelator|chelator
5296592|NCT00447694|Desferal|desferal
5296593|NCT00447694|beta-thalassemia|beta-thalassemia
5296594|NCT00447694|Iron overload|iron overload
5296595|NCT00447668|Chronic Low Back Pain|chronic low back pain
5296596|NCT00447668|Yoga|yoga
5296597|NCT00447655|Amputation|amputation
5296598|NCT00447655|Self-management|self-management
5296599|NCT00447655|Rehabilitation|rehabilitation
5296600|NCT00447655|Peer support|peer support
5296601|NCT00447642|immunology|immunology
5296602|NCT00447642|cornea|cornea
5296603|NCT00447642|allograft|allograft
5296604|NCT00447642|corneal allograft rejection|corneal allograft rejection
5296605|NCT00447642|graft failure|graft failure
5296606|NCT00447616|Prostate Cancer|prostate cancer
5296607|NCT00447616|Prostatectomy|prostatectomy
5296608|NCT00447564|opioid dependence|opioid dependence
5296609|NCT00447564|opioid addiction|opioid addiction
5296610|NCT00447564|buprenorphine|buprenorphine
5296611|NCT00447564|methadone|methadone
5296612|NCT00447564|heroin|heroin
5296613|NCT00447564|implant|implant
5296614|NCT00447564|opioid withdrawal|opioid withdrawal
5296615|NCT00447564|opioid pain medication|opioid pain medication
5296616|NCT00447564|suboxone|suboxone
5296617|NCT00447551|Aesthetic facial volume enhancement|aesthetic facial volume enhancement
5296618|NCT00447525|Prevention of : Diphtheria, Tetanus and Poliomyelitis|prevention of : diphtheria, tetanus and poliomyelitis
5296619|NCT00447499|Acromegaly|acromegaly
5296620|NCT00447499|Somatostatin Analogs|somatostatin analogs
5296621|NCT00447499|Somatuline® Autogel®|somatuline® autogel®
5296622|NCT00447499|lanreotide|lanreotide
5296623|NCT00447499|growth hormone|growth hormone
5296624|NCT00447499|IGF-1|igf-1
5296625|NCT00447499|Inappropriate Growth Hormone Secretion Syndrome|inappropriate growth hormone secretion syndrome
5296626|NCT00447499|Somatotropin Hypersecretion Syndrome|somatotropin hypersecretion syndrome
5296627|NCT00447499|Inappropriate GH Secretion Syndrome|inappropriate gh secretion syndrome
5296628|NCT00447486|Osteoarthritis,|osteoarthritis,
5296629|NCT00447486|knee,|knee,
5296630|NCT00447486|GW842166,|gw842166,
5296631|NCT00447486|pain,|pain,
5296632|NCT00447486|efficacy,|efficacy,
5296633|NCT00447486|safety|safety
5296634|NCT00447473|Prostate Cancer|prostate cancer
5296731|NCT00447018|traumatic brain injury|traumatic brain injury
5296635|NCT00447473|progressive hormone refractory prostate cancer|progressive hormone refractory prostate cancer
5296636|NCT00447460|Graft-vs-host disease (GVHD)|graft-vs-host disease (gvhd)
5296637|NCT00447460|Mesenchymal stem cell (MSC)|mesenchymal stem cell (msc)
5296638|NCT00447460|Allogeneic hematopoietic stem cell transplant|allogeneic hematopoietic stem cell transplant
5296639|NCT00447460|Allotransplant|allotransplant
5296640|NCT00447460|Allogenic|allogenic
5296641|NCT00447460|Refractory|refractory
5296642|NCT00447460|CSM/EICH2005|csm/eich2005
5296643|NCT00447434|Nattokinase|nattokinase
5296644|NCT00447434|fibrinolytic factors|fibrinolytic factors
5296645|NCT00447434|blood lipids|blood lipids
5296646|NCT00447434|nutrimental supplement|nutrimental supplement
5296647|NCT00447408|hemodialysis|hemodialysis
5296648|NCT00447408|dietary adherence|dietary adherence
5296649|NCT00447408|sodium|sodium
5296650|NCT00447369|pregabalin|pregabalin
5296651|NCT00447369|Valproic acid|valproic acid
5296652|NCT00447369|migraine|migraine
5296653|NCT00447369|prophylaxis|prophylaxis
5296654|NCT00447369|prevention|prevention
5296655|NCT00447369|treatment|treatment
5296656|NCT00447343|Functional MRI|functional mri
5296657|NCT00447343|Cervical myelopathy|cervical myelopathy
5296658|NCT00447343|Cervical radiculopathy|cervical radiculopathy
5296659|NCT00447343|Brain plasticity and regeneration|brain plasticity and regeneration
5296660|NCT00447330|metastatic esophagogastric adenocarcinomas|metastatic esophagogastric adenocarcinomas
5296661|NCT00447330|ESOPHAGEAL CANCER|esophageal cancer
5296662|NCT00447330|GASTRIC CANCER|gastric cancer
5296663|NCT00447330|ADENOCARCINOMA|adenocarcinoma
5296664|NCT00447330|TARGTED THERAPY|targted therapy
5296665|NCT00447330|BEVACIZUMAB|bevacizumab
5296666|NCT00447330|CAPECITBAINE|capecitbaine
5296667|NCT00447330|OXALIPLATIN|oxaliplatin
5296668|NCT00447330|METASTATIC|metastatic
5296669|NCT00447317|peritoneal dialysis|peritoneal dialysis
5296670|NCT00447317|diet|diet
5296671|NCT00447317|sodium|sodium
5296672|NCT00447304|acute cholecystitis|acute cholecystitis
5296673|NCT00447304|cholecystectomy|cholecystectomy
5296674|NCT00447304|antibiotic treatment|antibiotic treatment
5296675|NCT00447304|moxifloxacin|moxifloxacin
5296676|NCT00447304|intraabdominal infection|intraabdominal infection
5296677|NCT00447304|morbidity and mortality of patients with acute cholecystitis, early surgery versus conservative therapy|morbidity and mortality of patients with acute cholecystitis, early surgery versus conservative therapy
5296678|NCT00447291|Overweight|overweight
5296679|NCT00447291|Obesity|obesity
5296680|NCT00447291|Fish Oil|fish oil
5296681|NCT00447252|bereavement|bereavement
5296682|NCT00447252|grief|grief
5296683|NCT00447239|mechanical ventilated|mechanical ventilated
5296684|NCT00447239|surgical patients|surgical patients
5296685|NCT00447239|pneumonia|pneumonia
5296686|NCT00447239|blood glucose|blood glucose
5296687|NCT00447239|insulin infusion|insulin infusion
5296688|NCT00447239|hospital stay|hospital stay
5296689|NCT00447226|Ovarian Cancer|ovarian cancer
5296690|NCT00447226|Bladder Cancer|bladder cancer
5296691|NCT00447226|ErbB2 positive|erbb2 positive
5296692|NCT00447226|Lapatinib|lapatinib
5296693|NCT00447226|Gastric/Esophageal Cancer|gastric/esophageal cancer
5296694|NCT00447226|Uterine Serous Papillary Cancer|uterine serous papillary cancer
5296695|NCT00447200|Stroke volume|stroke volume
5296696|NCT00447200|SV variation|sv variation
5296697|NCT00447200|Esophagus Doppler|esophagus doppler
5296698|NCT00447200|Goal Directed Therapy|goal directed therapy
5296699|NCT00447187|corneal graft failure|corneal graft failure
5296700|NCT00447187|corneal graft rejection|corneal graft rejection
5296701|NCT00447187|corneal transplant rejection|corneal transplant rejection
5296702|NCT00447174|Grief|grief
5296703|NCT00447174|parental bereavement|parental bereavement
5296704|NCT00447135|Elderly|elderly
5296705|NCT00447135|Trauma|trauma
5296706|NCT00447135|Polymorphonuclear Leukocyte|polymorphonuclear leukocyte
5296707|NCT00447135|Immunity|immunity
5296708|NCT00447122|Pancreatic Cancer|pancreatic cancer
5296709|NCT00447096|Bipolar Type II|bipolar type ii
5296710|NCT00447096|Depression|depression
5296711|NCT00447096|rTMS|rtms
5296712|NCT00447083|Tanning|tanning
5296713|NCT00447083|Musculoskeletal|musculoskeletal
5296714|NCT00447083|Fibromyalgia Syndrome|fibromyalgia syndrome
5296715|NCT00447070|HIV-infection|hiv-infection
5296716|NCT00447070|Dyslipidemia|dyslipidemia
5296717|NCT00447070|Endothelial Dysfunction|endothelial dysfunction
5296718|NCT00447070|Atherosclerosis|atherosclerosis
5296719|NCT00447070|Protease inhibitor|protease inhibitor
5296720|NCT00447070|treatment experienced|treatment experienced
5296721|NCT00447057|nonsquamous|nonsquamous
5296722|NCT00447044|Muscle loss and Maintenance of Muscle function|muscle loss and maintenance of muscle function
5296723|NCT00447031|age related macular degeneration|age related macular degeneration
5296724|NCT00447031|intravitreal bevacizumab|intravitreal bevacizumab
5296725|NCT00447031|intravitreal triamcinolone acetonide|intravitreal triamcinolone acetonide
5296726|NCT00447031|neovascular age related macular degeneration|neovascular age related macular degeneration
5296727|NCT00447018|intracranial pressure|intracranial pressure
5296728|NCT00447018|mannitol|mannitol
5296729|NCT00447018|hypertonic saline solution|hypertonic saline solution
5296730|NCT00447018|brain injury|brain injury
5296732|NCT00447018|Adult patients|adult patients
5296733|NCT00447018|With elevation of intracranial pressure (ICP > 20 mmHg)|with elevation of intracranial pressure (icp > 20 mmhg)
5296734|NCT00447005|Safety|safety
5296736|NCT00447005|Biomarker|biomarker
5296737|NCT00446992|Schizophrenia|schizophrenia
5296738|NCT00446992|Schizoaffective|schizoaffective
5296739|NCT00446992|psychosis|psychosis
5296740|NCT00446992|olanzapine|olanzapine
5296741|NCT00446979|Microbicides|microbicides
5296742|NCT00446979|HIV seronegativity|hiv seronegativity
5296743|NCT00446966|atrial fibrillation|atrial fibrillation
5296744|NCT00446966|coronary artery disease bypass graft surgery|coronary artery disease bypass graft surgery
5296745|NCT00446953|Caesarean section|caesarean section
5296746|NCT00446953|Corticosteroids|corticosteroids
5296747|NCT00446953|Betamethasone|betamethasone
5296748|NCT00446953|Neonatal distress|neonatal distress
5296749|NCT00446927|Pediatrics|pediatrics
5296750|NCT00446927|Cardiology|cardiology
5296751|NCT00446927|Cardiopulmonary Bypass|cardiopulmonary bypass
5296752|NCT00446927|Heart Surgery|heart surgery
5296753|NCT00446927|Cardiac Catheterization|cardiac catheterization
5296754|NCT00446927|Echocardiography|echocardiography
5296755|NCT00446927|Imaging|imaging
5296756|NCT00446927|ICG green dye|icg green dye
5296757|NCT00446914|Hypertension|hypertension
5296758|NCT00446914|Blood Pressure|blood pressure
5296759|NCT00446901|Prostate Cancer|prostate cancer
5296760|NCT00446901|Selenium|selenium
5296761|NCT00446901|Chemoprevention|chemoprevention
5296762|NCT00446901|Gene expression|gene expression
5296763|NCT00446888|cancer|cancer
5296764|NCT00446888|metastasis|metastasis
5296765|NCT00446875|Pain|pain
5296766|NCT00446875|Procedural pain|procedural pain
5296767|NCT00446875|Sucrose|sucrose
5296768|NCT00446875|Infant|infant
5296769|NCT00446862|Definition: Fabry disease|definition: fabry disease
5296770|NCT00446862|Definition: Progression|definition: progression
5296771|NCT00446862|Definition: MDRD GFR|definition: mdrd gfr
5296772|NCT00446862|Definition: Chronic Kidney Disease|definition: chronic kidney disease
5296773|NCT00446862|Definition: Proteinuria|definition: proteinuria
5296774|NCT00446862|Definition: Enzyme Replacement Therapy|definition: enzyme replacement therapy
5296775|NCT00446862|Definition: Anti-proteinuric therapy|definition: anti-proteinuric therapy
5296776|NCT00446849|ulcerative colitis|ulcerative colitis
5296777|NCT00446849|compliance|compliance
5296778|NCT00446849|mesalamine|mesalamine
5296779|NCT00446849|clinical study|clinical study
5296780|NCT00446849|clinical trial|clinical trial
5296781|NCT00446849|clinical research|clinical research
5296782|NCT00446849|maintenance|maintenance
5296783|NCT00446849|long term|long term
5296784|NCT00446849|uc study|uc study
5296785|NCT00446849|uc trial|uc trial
5296786|NCT00446849|uc research|uc research
5296787|NCT00446849|open label|open label
5296788|NCT00446849|once a day|once a day
5296789|NCT00446849|once|once
5296790|NCT00446849|daily|daily
5296791|NCT00446849|daily dosing|daily dosing
5296792|NCT00446849|simple|simple
5296793|NCT00446849|oral|oral
5296794|NCT00446836|Adenocarcinoma of the prostate|adenocarcinoma of the prostate
5296795|NCT00446836|Recurrent prostate cancer|recurrent prostate cancer
5296796|NCT00446836|Hormone refractory prostate cancer|hormone refractory prostate cancer
5296797|NCT00446823|Wound healing|wound healing
5296798|NCT00446823|Venous stasis ulcer|venous stasis ulcer
5296799|NCT00446823|Cellulose dressing|cellulose dressing
5296800|NCT00446823|Gauze dressing|gauze dressing
5296801|NCT00446823|Chronic wound|chronic wound
5296802|NCT00446810|diabetes|diabetes
5296803|NCT00446810|endothelial dysfunction|endothelial dysfunction
5296804|NCT00446810|benfotiamine|benfotiamine
5296805|NCT00446810|postprandial|postprandial
5296806|NCT00446810|autonomic neuropathy|autonomic neuropathy
5296807|NCT00446810|advanced glycation end products|advanced glycation end products
5296808|NCT00446797|Ankle sprain, acute pain, NSAID, celecoxib,|ankle sprain, acute pain, nsaid, celecoxib,
5296809|NCT00446758|Zinc|zinc
5296810|NCT00446758|HIV|hiv
5296811|NCT00446758|Infants|infants
5296812|NCT00446758|Children|children
5296813|NCT00446758|Morbidity|morbidity
5296814|NCT00446758|Child health outcomes|child health outcomes
5296815|NCT00446758|treatment naive|treatment naive
5296816|NCT00446758|treatment experienced|treatment experienced
5296817|NCT00446745|Nutritional and Metabolic Diseases|nutritional and metabolic diseases
5296818|NCT00446745|Insulin resistance|insulin resistance
5296819|NCT00446745|Energy Metabolisms|energy metabolisms
5296820|NCT00446745|Skeletal muscle|skeletal muscle
5296821|NCT00446745|Visceral Adipose Tissue|visceral adipose tissue
5296822|NCT00446719|major depression|major depression
5296823|NCT00446719|antidepressant|antidepressant
5296824|NCT00446719|quality of life|quality of life
5296825|NCT00446719|anxiety|anxiety
5296826|NCT00446706|Intrinsic PEEP|intrinsic peep
5296827|NCT00446680|Mannitol|mannitol
5296828|NCT00446680|Cystic Fibrosis|cystic fibrosis
5296829|NCT00446680|Mucolytic|mucolytic
5296830|NCT00446680|Exacerbation|exacerbation
5296831|NCT00446680|FEV1|fev1
5296832|NCT00446680|Quality of Life|quality of life
5296833|NCT00446641|Infarction, Cerebral|infarction, cerebral
5296834|NCT00446641|Cilostazol|cilostazol
5296835|NCT00446641|Aspirin Resistance|aspirin resistance
5296836|NCT00446628|Non-pharmaceutical|non-pharmaceutical
5296837|NCT00446628|influenza|influenza
5296838|NCT00446628|pandemic|pandemic
5296839|NCT00446615|computer decision support|computer decision support
5296840|NCT00446615|primary care|primary care
5296841|NCT00446615|kidney disease, chronic|kidney disease, chronic
5296842|NCT00446615|prescribing|prescribing
5296843|NCT00446602|PROCRIT|procrit
5296844|NCT00446602|Epoetin alfa|epoetin alfa
5296845|NCT00446602|Myelodysplastic Syndromes|myelodysplastic syndromes
5296847|NCT00446576|Anemia|anemia
5296848|NCT00446576|early renal insufficiency|early renal insufficiency
5296849|NCT00446563|Left ventricular hypertrophy, hypertension, valsartan, amlodipine|left ventricular hypertrophy, hypertension, valsartan, amlodipine
5296850|NCT00446550|Amicus Therapeutics|amicus therapeutics
5296851|NCT00446550|afegostat tartrate|afegostat tartrate
5296852|NCT00446550|isofagomine tartrate|isofagomine tartrate
5296853|NCT00446550|AT2101|at2101
5296854|NCT00446537|Skill Acquisition and the Evolution of Long Term Procedural Memory in participants with ADHD: The Effect of Methylphenidate|skill acquisition and the evolution of long term procedural memory in participants with adhd: the effect of methylphenidate
5296855|NCT00446524|Hypertension, Valsartan, Amlodipine, high blood pressure|hypertension, valsartan, amlodipine, high blood pressure
5296856|NCT00446511|children|children
5296857|NCT00446511|pediatrics|pediatrics
5296858|NCT00446511|high blood pressure|high blood pressure
5296859|NCT00446511|hypertension|hypertension
5296860|NCT00446511|valsartan|valsartan
5296861|NCT00446511|enalapril|enalapril
5296862|NCT00446485|ginkgo biloba|ginkgo biloba
5296863|NCT00446485|cerebrovascular insufficiency|cerebrovascular insufficiency
5296864|NCT00446485|mild cognitive impairment|mild cognitive impairment
5296865|NCT00446485|concentration impairment|concentration impairment
5296866|NCT00446472|diabetes mellitus|diabetes mellitus
5296867|NCT00446472|diabetic neuropathies|diabetic neuropathies
5296868|NCT00446472|peripheral vascular diseases|peripheral vascular diseases
5296869|NCT00446459|CellCept|cellcept
5296870|NCT00446459|Dialysis|dialysis
5296871|NCT00446459|Kidney|kidney
5296872|NCT00446459|Renal|renal
5296873|NCT00446459|Nephropathy|nephropathy
5296874|NCT00446459|Glomerulonephropathy|glomerulonephropathy
5296875|NCT00446459|Immunosuppression|immunosuppression
5296876|NCT00446459|Allograft|allograft
5296877|NCT00446459|Compatibility|compatibility
5296878|NCT00446459|HLA|hla
5296879|NCT00446459|PRA|pra
5296880|NCT00446459|Transplant|transplant
5296881|NCT00446459|Sensitization|sensitization
5296882|NCT00446459|Antibodies|antibodies
5296883|NCT00446459|Diabetes|diabetes
5296884|NCT00446459|Hypertension|hypertension
5296885|NCT00446459|Transplantation, Kidney|transplantation, kidney
5296886|NCT00446407|Depression|depression
5296887|NCT00446407|Primary Care|primary care
5296888|NCT00446407|Developing Countries|developing countries
5296889|NCT00446407|Common mental disorders (depressive and anxiety disorders)|common mental disorders (depressive and anxiety disorders)
5296890|NCT00446394|cognition disorder|cognition disorder
5296891|NCT00446394|functional ability|functional ability
5296892|NCT00446394|psychomotor function|psychomotor function
5296893|NCT00446394|psychopathology|psychopathology
5296894|NCT00446394|quality of life|quality of life
5296895|NCT00446381|Proliferative Diabetic Retinopathy|proliferative diabetic retinopathy
5296896|NCT00446381|Clinically Significant Diabetic Macular Edema|clinically significant diabetic macular edema
5296897|NCT00446381|VEGF|vegf
5296898|NCT00446381|Macugen (pegaptanib)|macugen (pegaptanib)
5296899|NCT00446368|metastatic kidney cancer|metastatic kidney cancer
5296900|NCT00446368|metastatic renal cell cancer|metastatic renal cell cancer
5296901|NCT00446355|C diff|c diff
5296902|NCT00446355|antibiotics|antibiotics
5296903|NCT00446342|leukemia|leukemia
5296904|NCT00446342|lymphoma|lymphoma
5296905|NCT00446342|myeloma|myeloma
5296906|NCT00446342|non-Hodgkin's|non-hodgkin's
5296907|NCT00446342|CLL|cll
5296908|NCT00446342|MCL|mcl
5296909|NCT00446342|MM|mm
5296910|NCT00446342|Phase 1|phase 1
5296911|NCT00446342|hematological malignancy|hematological malignancy
5296912|NCT00446316|Pharmacokinetics|pharmacokinetics
5296913|NCT00446316|Healthy volunteers|healthy volunteers
5296914|NCT00446316|No condition|no condition
5296915|NCT00446316|Pharmacokinetics study|pharmacokinetics study
5296916|NCT00446303|MDS|mds
5296917|NCT00446303|Myelodysplastic Syndromes|myelodysplastic syndromes
5296918|NCT00446303|AML|aml
5296919|NCT00446303|Intensive chemotherapy|intensive chemotherapy
5296920|NCT00446303|azacitidine|azacitidine
5296921|NCT00446290|To determine maximal tolerated dose of DXO regimen|to determine maximal tolerated dose of dxo regimen
5296922|NCT00446277|cataract surgery, endothelial cell, cell loss, diabetes|cataract surgery, endothelial cell, cell loss, diabetes
5296923|NCT00446277|mellitus type II|mellitus type ii
5296924|NCT00446264|diabetes|diabetes
5296925|NCT00446264|hypoglycemia|hypoglycemia
5296926|NCT00446251|Dialysis|dialysis
5296927|NCT00446251|Kidney|kidney
5296928|NCT00446251|Renal|renal
5296929|NCT00446251|Nephropathy|nephropathy
5296930|NCT00446251|Glomerulonephropathy|glomerulonephropathy
5296931|NCT00446251|Immunosuppression|immunosuppression
5296932|NCT00446251|Graft|graft
5296933|NCT00446251|Compatibility|compatibility
5296934|NCT00446251|Transplant|transplant
5296935|NCT00446251|Diabetes|diabetes
5296936|NCT00446251|Hypertension|hypertension
5296937|NCT00446251|Transplantation, Kidney|transplantation, kidney
5296938|NCT00446238|Depression|depression
5296939|NCT00446238|Physical Illness|physical illness
5296940|NCT00446238|Inflammatory Bowel Disease|inflammatory bowel disease
5296941|NCT00446238|Cognitive Behavioral Therapy|cognitive behavioral therapy
5296942|NCT00446225|Lung|lung
5296943|NCT00446225|cancer|cancer
5296944|NCT00446225|EGFR|egfr
5296945|NCT00446225|Epidermal Growth Factor Receptor|epidermal growth factor receptor
5296946|NCT00446225|tyrosine kinase|tyrosine kinase
5296947|NCT00446225|Tarceva®|tarceva®
5296948|NCT00446225|Erlotinib|erlotinib
5296949|NCT00446212|anaesthesia|anaesthesia
5296950|NCT00446212|propofol|propofol
5296951|NCT00446212|desflurane|desflurane
5296952|NCT00446212|dreaming|dreaming
5296953|NCT00446212|electroencephalography|electroencephalography
5296954|NCT00446199|Vasomotor symptom relief|vasomotor symptom relief
5296955|NCT00446199|Postmenopausal women|postmenopausal women
5296956|NCT00446199|Severe to Moderate Vasomotor symptoms|severe to moderate vasomotor symptoms
5296957|NCT00446173|Chronic Myelogenous Leukemia|chronic myelogenous leukemia
5296958|NCT00446173|Leukemia|leukemia
5296959|NCT00446173|Philadelphia (Ph) chromosome positive CML|philadelphia (ph) chromosome positive cml
5296960|NCT00446173|Busulfan|busulfan
5296961|NCT00446173|Busulfex|busulfex
5296962|NCT00446173|Myleran|myleran
5296963|NCT00446173|Cyclophosphamide|cyclophosphamide
5296964|NCT00446173|Cytoxan|cytoxan
5296965|NCT00446173|Neosar|neosar
5296966|NCT00446173|G-CSF|g-csf
5296967|NCT00446173|Filgrastim|filgrastim
5296968|NCT00446173|Neupogen|neupogen
5296969|NCT00446173|GM-CSF|gm-csf
5296970|NCT00446173|Sargramostim|sargramostim
5296971|NCT00446173|Leukine|leukine
5296972|NCT00446160|Congenital Heart Disease|congenital heart disease
5296973|NCT00446160|Surgery|surgery
5296974|NCT00446160|Adult|adult
5296975|NCT00446147|hand-foot syndrome|hand-foot syndrome
5296976|NCT00446147|capecitabine|capecitabine
5296977|NCT00446147|pyridoxine|pyridoxine
5296978|NCT00446147|prevention|prevention
5296979|NCT00446134|Phase 2b Dose-Ranging Study|phase 2b dose-ranging study
5296980|NCT00446121|COPD|copd
5296981|NCT00446108|Pulmonary Stenosis|pulmonary stenosis
5296982|NCT00446108|Right Ventricular Dilation|right ventricular dilation
5296983|NCT00446108|Right Heart Failure|right heart failure
5296984|NCT00446108|Imaging|imaging
5296985|NCT00446108|Tetralogy of Fallot|tetralogy of fallot
5296986|NCT00446095|DLCL|dlcl
5296987|NCT00446095|Nodular lymphoma|nodular lymphoma
5296988|NCT00446095|Mantle cell lymphoma|mantle cell lymphoma
5296989|NCT00446095|Syk kinase|syk kinase
5296990|NCT00446082|Refractory/ resistant carcinoid disease|refractory/ resistant carcinoid disease
5296991|NCT00446082|acromegaly|acromegaly
5296992|NCT00446082|adults|adults
5296993|NCT00446082|pasireotide LAR|pasireotide lar
5296994|NCT00446082|somatostatin analogue|somatostatin analogue
5296995|NCT00446082|SOM230|som230
5296996|NCT00446082|pharmacokinetics|pharmacokinetics
5296997|NCT00446082|Refractory or resistant carcinoid disease and acromegaly|refractory or resistant carcinoid disease and acromegaly
5296998|NCT00446043|Acne Vulgaris|acne vulgaris
5296999|NCT00446043|Adapalene|adapalene
5297000|NCT00446043|Benzoyl Peroxide|benzoyl peroxide
5297001|NCT00446017|coronary artery bypass grafting|coronary artery bypass grafting
5297002|NCT00446017|inotropes|inotropes
5297003|NCT00446017|metabolism|metabolism
5297004|NCT00446017|renal failure|renal failure
5297005|NCT00446004|Pharmacokinetics|pharmacokinetics
5297006|NCT00446004|Healthy volunteers|healthy volunteers
5297007|NCT00446004|No condition|no condition
5297008|NCT00446004|Pharmacokinetics study|pharmacokinetics study
5297009|NCT00445978|Sickle Cell Disease|sickle cell disease
5297011|NCT00445978|6R-BH4|6r-bh4
5297012|NCT00445978|BH4|bh4
5297013|NCT00445978|sapropterin dihydrochloride|sapropterin dihydrochloride
5297014|NCT00445978|endothelial dysfunction|endothelial dysfunction
5297015|NCT00445978|Nitric Oxide|nitric oxide
5297016|NCT00445978|NO|no
5297017|NCT00445965|recurrent childhood medulloblastoma|recurrent childhood medulloblastoma
5297018|NCT00445965|untreated childhood medulloblastoma|untreated childhood medulloblastoma
5297019|NCT00445965|adult supratentorial primitive neuroectodermal tumor (PNET)|adult supratentorial primitive neuroectodermal tumor (pnet)
5297020|NCT00445965|recurrent childhood supratentorial primitive neuroectodermal tumor|recurrent childhood supratentorial primitive neuroectodermal tumor
5297021|NCT00445965|untreated childhood supratentorial primitive neuroectodermal tumor|untreated childhood supratentorial primitive neuroectodermal tumor
5297022|NCT00445965|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5297023|NCT00445965|adult diffuse astrocytoma|adult diffuse astrocytoma
5297024|NCT00445965|adult pilocytic astrocytoma|adult pilocytic astrocytoma
5297025|NCT00445965|adult subependymal giant cell astrocytoma|adult subependymal giant cell astrocytoma
5297026|NCT00445965|recurrent childhood subependymal giant cell astrocytoma|recurrent childhood subependymal giant cell astrocytoma
5297027|NCT00445965|untreated childhood subependymal giant cell astrocytoma|untreated childhood subependymal giant cell astrocytoma
5297298|NCT00445900|essential thrombocythemia|essential thrombocythemia
5297028|NCT00445965|recurrent childhood cerebellar astrocytoma|recurrent childhood cerebellar astrocytoma
5297029|NCT00445965|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
5297030|NCT00445965|untreated childhood cerebellar astrocytoma|untreated childhood cerebellar astrocytoma
5297031|NCT00445965|adult brain stem glioma|adult brain stem glioma
5297032|NCT00445965|adult mixed glioma|adult mixed glioma
5297033|NCT00445965|childhood mixed glioma|childhood mixed glioma
5297034|NCT00445965|recurrent childhood brain stem glioma|recurrent childhood brain stem glioma
5297035|NCT00445965|recurrent childhood visual pathway and hypothalamic glioma|recurrent childhood visual pathway and hypothalamic glioma
5297036|NCT00445965|recurrent childhood visual pathway glioma|recurrent childhood visual pathway glioma
5297037|NCT00445965|untreated childhood brain stem glioma|untreated childhood brain stem glioma
5297038|NCT00445965|untreated childhood visual pathway and hypothalamic glioma|untreated childhood visual pathway and hypothalamic glioma
5297039|NCT00445965|untreated childhood visual pathway glioma|untreated childhood visual pathway glioma
5297040|NCT00445965|regional neuroblastoma|regional neuroblastoma
5297041|NCT00445965|disseminated neuroblastoma|disseminated neuroblastoma
5297042|NCT00445965|recurrent neuroblastoma|recurrent neuroblastoma
5297043|NCT00445965|extraocular retinoblastoma|extraocular retinoblastoma
5297044|NCT00445965|recurrent retinoblastoma|recurrent retinoblastoma
5297045|NCT00445965|adult anaplastic ependymoma|adult anaplastic ependymoma
5297046|NCT00445965|adult ependymoblastoma|adult ependymoblastoma
5297047|NCT00445965|adult ependymoma|adult ependymoma
5297048|NCT00445965|adult myxopapillary ependymoma|adult myxopapillary ependymoma
5297049|NCT00445965|adult subependymoma|adult subependymoma
5297050|NCT00445965|childhood infratentorial ependymoma|childhood infratentorial ependymoma
5297051|NCT00445965|childhood supratentorial ependymoma|childhood supratentorial ependymoma
5297052|NCT00445965|recurrent childhood ependymoma|recurrent childhood ependymoma
5297053|NCT00445965|childhood atypical teratoid/rhabdoid tumor|childhood atypical teratoid/rhabdoid tumor
5297054|NCT00445965|recurrent melanoma|recurrent melanoma
5297055|NCT00445965|stage IV melanoma|stage iv melanoma
5297056|NCT00445965|adult medulloblastoma|adult medulloblastoma
5297057|NCT00445965|chondrosarcoma|chondrosarcoma
5297058|NCT00445965|metastatic osteosarcoma|metastatic osteosarcoma
5297059|NCT00445965|recurrent osteosarcoma|recurrent osteosarcoma
5297060|NCT00445965|metastatic childhood soft tissue sarcoma|metastatic childhood soft tissue sarcoma
5297061|NCT00445965|ovarian sarcoma|ovarian sarcoma
5297062|NCT00445965|recurrent childhood soft tissue sarcoma|recurrent childhood soft tissue sarcoma
5297063|NCT00445965|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
5297064|NCT00445965|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
5297065|NCT00445965|stage III uterine sarcoma|stage iii uterine sarcoma
5297066|NCT00445965|stage IV uterine sarcoma|stage iv uterine sarcoma
5297067|NCT00445965|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
5297068|NCT00445965|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
5297069|NCT00445965|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
5297070|NCT00445965|adult desmoplastic small round cell tumor|adult desmoplastic small round cell tumor
5297071|NCT00445965|adult oligodendroglioma|adult oligodendroglioma
5297072|NCT00445965|adult giant cell glioblastoma|adult giant cell glioblastoma
5297073|NCT00445965|adult gliosarcoma|adult gliosarcoma
5297074|NCT00445965|tumors metastatic to brain|tumors metastatic to brain
5297075|NCT00445965|adult rhabdomyosarcoma|adult rhabdomyosarcoma
5297076|NCT00445965|childhood oligodendroglioma|childhood oligodendroglioma
5297077|NCT00445965|childhood desmoplastic small round cell tumor|childhood desmoplastic small round cell tumor
5297078|NCT00445965|extensive stage small cell lung cancer|extensive stage small cell lung cancer
5297079|NCT00445965|intraocular retinoblastoma|intraocular retinoblastoma
5297080|NCT00445965|recurrent adult brain tumor|recurrent adult brain tumor
5297081|NCT00445965|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
5297082|NCT00445965|recurrent uterine sarcoma|recurrent uterine sarcoma
5297083|NCT00445965|small intestine leiomyosarcoma|small intestine leiomyosarcoma
5297084|NCT00445965|recurrent small intestine cancer|recurrent small intestine cancer
5297085|NCT00445965|recurrent small cell lung cancer|recurrent small cell lung cancer
5297086|NCT00445965|extraocular extension melanoma|extraocular extension melanoma
5297087|NCT00445965|recurrent intraocular melanoma|recurrent intraocular melanoma
5297088|NCT00445965|metastatic intraocular melanoma|metastatic intraocular melanoma
5297089|NCT00445965|iris melanoma|iris melanoma
5297090|NCT00445965|ciliary body and choroid melanoma, medium/large size|ciliary body and choroid melanoma, medium/large size
5297091|NCT00445965|newly diagnosed childhood ependymoma|newly diagnosed childhood ependymoma
5297092|NCT00445965|adult glioblastoma|adult glioblastoma
5297093|NCT00445965|metastatic Ewing sarcoma/peripheral primitive neuroectodermal tumor|metastatic ewing sarcoma/peripheral primitive neuroectodermal tumor
5297094|NCT00445965|recurrent Ewing sarcoma/peripheral primitive neuroectodermal tumor|recurrent ewing sarcoma/peripheral primitive neuroectodermal tumor
5297095|NCT00445965|recurrent childhood pineoblastoma|recurrent childhood pineoblastoma
5297096|NCT00445965|untreated childhood pineoblastoma|untreated childhood pineoblastoma
5297097|NCT00445965|adult pineal gland astrocytoma|adult pineal gland astrocytoma
5297098|NCT00445965|stage IIIA melanoma|stage iiia melanoma
5297099|NCT00445965|stage IIIB melanoma|stage iiib melanoma
5297100|NCT00445965|stage IIIC melanoma|stage iiic melanoma
5297101|NCT00445965|recurrent childhood anaplastic astrocytoma|recurrent childhood anaplastic astrocytoma
5297102|NCT00445965|untreated childhood anaplastic astrocytoma|untreated childhood anaplastic astrocytoma
5297103|NCT00445965|recurrent childhood anaplastic oligoastrocytoma|recurrent childhood anaplastic oligoastrocytoma
5297104|NCT00445965|recurrent childhood anaplastic oligodendroglioma|recurrent childhood anaplastic oligodendroglioma
5297105|NCT00445965|untreated childhood anaplastic oligoastrocytoma|untreated childhood anaplastic oligoastrocytoma
5297106|NCT00445965|untreated childhood anaplastic oligodendroglioma|untreated childhood anaplastic oligodendroglioma
5297107|NCT00445965|recurrent childhood giant cell glioblastoma|recurrent childhood giant cell glioblastoma
5297108|NCT00445965|recurrent childhood glioblastoma|recurrent childhood glioblastoma
5297109|NCT00445965|untreated childhood giant cell glioblastoma|untreated childhood giant cell glioblastoma
5297110|NCT00445965|untreated childhood glioblastoma|untreated childhood glioblastoma
5297111|NCT00445965|recurrent childhood gliosarcoma|recurrent childhood gliosarcoma
5297112|NCT00445965|untreated childhood gliosarcoma|untreated childhood gliosarcoma
5297113|NCT00445965|recurrent childhood gliomatosis cerebri|recurrent childhood gliomatosis cerebri
5297114|NCT00445965|untreated childhood gliomatosis cerebri|untreated childhood gliomatosis cerebri
5297115|NCT00445965|childhood high-grade cerebellar astrocytoma|childhood high-grade cerebellar astrocytoma
5297116|NCT00445965|childhood high-grade cerebral astrocytoma|childhood high-grade cerebral astrocytoma
5297117|NCT00445952|breast cancer in situ|breast cancer in situ
5297118|NCT00445952|stage I breast cancer|stage i breast cancer
5297119|NCT00445952|stage II breast cancer|stage ii breast cancer
5297120|NCT00445952|stage IIIA breast cancer|stage iiia breast cancer
5297121|NCT00445952|stage IIIB breast cancer|stage iiib breast cancer
5297122|NCT00445952|stage IIIC breast cancer|stage iiic breast cancer
5297123|NCT00445952|stage IV breast cancer|stage iv breast cancer
5297124|NCT00445952|recurrent breast cancer|recurrent breast cancer
5297125|NCT00445952|male breast cancer|male breast cancer
5297126|NCT00445952|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5297127|NCT00445952|stage I non-small cell lung cancer|stage i non-small cell lung cancer
5297128|NCT00445952|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
5297129|NCT00445952|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5297130|NCT00445952|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5297131|NCT00445952|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5297132|NCT00445952|extensive stage small cell lung cancer|extensive stage small cell lung cancer
5297133|NCT00445952|recurrent colon cancer|recurrent colon cancer
5297134|NCT00445952|stage I colon cancer|stage i colon cancer
5297135|NCT00445952|stage II colon cancer|stage ii colon cancer
5297136|NCT00445952|stage III colon cancer|stage iii colon cancer
5297137|NCT00445952|stage IV colon cancer|stage iv colon cancer
5297138|NCT00445952|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5297139|NCT00445952|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5297140|NCT00445952|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5297141|NCT00445952|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5297142|NCT00445952|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5297143|NCT00445952|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5297144|NCT00445952|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5297145|NCT00445952|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5297146|NCT00445952|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5297147|NCT00445952|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5297148|NCT00445952|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5297149|NCT00445952|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
5297150|NCT00445952|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5297647|NCT00445341|MCL|mcl
5297151|NCT00445952|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
5297152|NCT00445952|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
5297153|NCT00445952|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
5297154|NCT00445952|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
5297155|NCT00445952|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
5297156|NCT00445952|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
5297157|NCT00445952|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5297158|NCT00445952|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5297159|NCT00445952|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5297160|NCT00445952|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5297161|NCT00445952|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5297162|NCT00445952|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5297163|NCT00445952|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5297164|NCT00445952|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5297229|NCT00445952|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
5297165|NCT00445952|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5297166|NCT00445952|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5297167|NCT00445952|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5297168|NCT00445952|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5297169|NCT00445952|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5297170|NCT00445952|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5297171|NCT00445952|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5297172|NCT00445952|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5297173|NCT00445952|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5297174|NCT00445952|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5297175|NCT00445952|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5297176|NCT00445952|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5297177|NCT00445952|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5297178|NCT00445952|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5297179|NCT00445952|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5297180|NCT00445952|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5297181|NCT00445952|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5297182|NCT00445952|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5297183|NCT00445952|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5297184|NCT00445952|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5297185|NCT00445952|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5297186|NCT00445952|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5297187|NCT00445952|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5297188|NCT00445952|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5297189|NCT00445952|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5297190|NCT00445952|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5297191|NCT00445952|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5297192|NCT00445952|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5297193|NCT00445952|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5297194|NCT00445952|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5297195|NCT00445952|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5297196|NCT00445952|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5297197|NCT00445952|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5297198|NCT00445952|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5297199|NCT00445952|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5297200|NCT00445952|stage I multiple myeloma|stage i multiple myeloma
5297201|NCT00445952|stage II multiple myeloma|stage ii multiple myeloma
5297202|NCT00445952|stage III multiple myeloma|stage iii multiple myeloma
5297203|NCT00445952|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5297204|NCT00445952|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
5297205|NCT00445952|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5297206|NCT00445952|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5297207|NCT00445952|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
5297208|NCT00445952|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
5297209|NCT00445952|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5297210|NCT00445952|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5297211|NCT00445952|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
5297212|NCT00445952|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
5297213|NCT00445952|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
5297214|NCT00445952|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
5297215|NCT00445952|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
5297216|NCT00445952|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
5297217|NCT00445952|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
5297218|NCT00445952|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
5297219|NCT00445952|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
5297220|NCT00445952|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
5297221|NCT00445952|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
5297222|NCT00445952|stage I marginal zone lymphoma|stage i marginal zone lymphoma
5297223|NCT00445952|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
5297224|NCT00445952|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
5297225|NCT00445952|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
5297226|NCT00445952|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
5297227|NCT00445952|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
5297228|NCT00445952|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
5297230|NCT00445952|stage I mantle cell lymphoma|stage i mantle cell lymphoma
5297231|NCT00445952|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
5297232|NCT00445952|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
5297233|NCT00445952|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
5297234|NCT00445952|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
5297235|NCT00445952|refractory multiple myeloma|refractory multiple myeloma
5297236|NCT00445952|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5297237|NCT00445952|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
5297238|NCT00445952|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
5297239|NCT00445952|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
5297240|NCT00445952|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
5297241|NCT00445952|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
5297242|NCT00445952|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
5297243|NCT00445952|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
5297244|NCT00445952|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
5297245|NCT00445952|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
5297246|NCT00445952|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
5297247|NCT00445952|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
5297248|NCT00445952|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
5297249|NCT00445952|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
5297250|NCT00445952|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
5297251|NCT00445952|chronic eosinophilic leukemia|chronic eosinophilic leukemia
5297252|NCT00445952|primary myelofibrosis|primary myelofibrosis
5297253|NCT00445952|chronic neutrophilic leukemia|chronic neutrophilic leukemia
5297254|NCT00445952|essential thrombocythemia|essential thrombocythemia
5297255|NCT00445952|polycythemia vera|polycythemia vera
5297256|NCT00445952|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5297257|NCT00445952|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5297258|NCT00445952|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5297259|NCT00445952|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
5297260|NCT00445952|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
5297261|NCT00445952|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5297262|NCT00445952|acute undifferentiated leukemia|acute undifferentiated leukemia
5297263|NCT00445952|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5297264|NCT00445952|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
5297265|NCT00445952|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
5297266|NCT00445952|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5297267|NCT00445952|refractory hairy cell leukemia|refractory hairy cell leukemia
5297268|NCT00445952|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
5297269|NCT00445952|prolymphocytic leukemia|prolymphocytic leukemia
5297270|NCT00445952|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
5297271|NCT00445952|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
5297272|NCT00445952|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5297273|NCT00445952|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5297274|NCT00445952|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5297275|NCT00445952|post-transplant lymphoproliferative disorder|post-transplant lymphoproliferative disorder
5297276|NCT00445952|extramedullary plasmacytoma|extramedullary plasmacytoma
5297277|NCT00445952|monoclonal gammopathy of undetermined significance|monoclonal gammopathy of undetermined significance
5297278|NCT00445952|primary systemic amyloidosis|primary systemic amyloidosis
5297279|NCT00445952|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5297280|NCT00445952|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5297281|NCT00445952|adult grade III lymphomatoid granulomatosis|adult grade iii lymphomatoid granulomatosis
5297282|NCT00445952|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
5297283|NCT00445952|AIDS-related primary CNS lymphoma|aids-related primary cns lymphoma
5297284|NCT00445952|intraocular lymphoma|intraocular lymphoma
5297285|NCT00445952|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
5297286|NCT00445952|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
5297287|NCT00445952|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
5297288|NCT00445952|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
5297289|NCT00445952|infection|infection
5297290|NCT00445952|limited stage small cell lung cancer|limited stage small cell lung cancer
5297291|NCT00445952|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
5297292|NCT00445913|type 1 diabetes|type 1 diabetes
5297293|NCT00445913|dendritic cells|dendritic cells
5297294|NCT00445913|cell vaccine|cell vaccine
5297295|NCT00445913|safety|safety
5297296|NCT00445913|reversal|reversal
5297297|NCT00445900|primary myelofibrosis|primary myelofibrosis
5297299|NCT00445900|polycythemia vera|polycythemia vera
5297300|NCT00445900|secondary myelofibrosis|secondary myelofibrosis
5297301|NCT00445874|allergic conjunctivitis, ophthalmology, multicenter, controlled|allergic conjunctivitis, ophthalmology, multicenter, controlled
5297302|NCT00445861|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
5297303|NCT00445861|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
5297304|NCT00445861|stage II esophageal cancer|stage ii esophageal cancer
5297305|NCT00445861|stage III esophageal cancer|stage iii esophageal cancer
5297306|NCT00445848|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5297307|NCT00445848|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5297308|NCT00445848|adenocarcinoma of the lung|adenocarcinoma of the lung
5297309|NCT00445835|coronary artery disease|coronary artery disease
5297310|NCT00445835|myocardial infarction|myocardial infarction
5297311|NCT00445835|atherothrombosis|atherothrombosis
5297312|NCT00445835|atherosclerosis|atherosclerosis
5297313|NCT00445822|CML|cml
5297314|NCT00445822|Children|children
5297315|NCT00445822|Imatinib|imatinib
5297316|NCT00445822|bcr-abl|bcr-abl
5297317|NCT00445822|Response|response
5297318|NCT00445822|Imatinib mesylate|imatinib mesylate
5297319|NCT00445809|Kidney|kidney
5297320|NCT00445809|Renal|renal
5297321|NCT00445809|Cardiac Surgery with bypass|cardiac surgery with bypass
5297322|NCT00445809|Cardiovascular surgery with cardiopulmonary bypass|cardiovascular surgery with cardiopulmonary bypass
5297323|NCT00445783|lentigo maligna malignant melanoma|lentigo maligna malignant melanoma
5297324|NCT00445783|stage IV melanoma|stage iv melanoma
5297325|NCT00445783|acral lentiginous malignant melanoma|acral lentiginous malignant melanoma
5297326|NCT00445783|nodular malignant melanoma|nodular malignant melanoma
5297327|NCT00445783|stage IA melanoma|stage ia melanoma
5297328|NCT00445783|stage IB melanoma|stage ib melanoma
5297329|NCT00445783|stage IIA melanoma|stage iia melanoma
5297330|NCT00445783|stage IIB melanoma|stage iib melanoma
5297331|NCT00445783|stage IIC melanoma|stage iic melanoma
5297332|NCT00445783|stage IIIA melanoma|stage iiia melanoma
5297333|NCT00445783|stage IIIB melanoma|stage iiib melanoma
5297334|NCT00445783|stage IIIC melanoma|stage iiic melanoma
5297335|NCT00445770|Rheumatoid Arthritis|rheumatoid arthritis
5297336|NCT00445770|Arthritis|arthritis
5297337|NCT00445757|stage I renal cell cancer|stage i renal cell cancer
5297338|NCT00445757|stage II renal cell cancer|stage ii renal cell cancer
5297339|NCT00445731|poor performance status|poor performance status
5297340|NCT00445731|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5297341|NCT00445731|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5297342|NCT00445731|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5297343|NCT00445731|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5297344|NCT00445731|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5297345|NCT00445731|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5297346|NCT00445731|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5297347|NCT00445731|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5297348|NCT00445731|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5297349|NCT00445731|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
5297350|NCT00445731|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5297351|NCT00445731|chronic eosinophilic leukemia|chronic eosinophilic leukemia
5297352|NCT00445731|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
5297353|NCT00445731|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5297354|NCT00445731|chronic neutrophilic leukemia|chronic neutrophilic leukemia
5297355|NCT00445731|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5297356|NCT00445731|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5297357|NCT00445731|disseminated neuroblastoma|disseminated neuroblastoma
5297358|NCT00445731|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5297359|NCT00445731|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
5297360|NCT00445731|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5297361|NCT00445731|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
5297362|NCT00445731|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5297363|NCT00445731|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
5297364|NCT00445731|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
5297365|NCT00445731|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
5297366|NCT00445731|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
5297367|NCT00445731|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5297368|NCT00445731|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5297369|NCT00445731|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5297370|NCT00445731|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5297371|NCT00445731|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
5297372|NCT00445731|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
5297373|NCT00445731|poor prognosis metastatic gestational trophoblastic tumor|poor prognosis metastatic gestational trophoblastic tumor
5297374|NCT00445731|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5297375|NCT00445731|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5297376|NCT00445731|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5297377|NCT00445731|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5297378|NCT00445731|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5297379|NCT00445731|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5297380|NCT00445731|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5297381|NCT00445731|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5297382|NCT00445731|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5297383|NCT00445731|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5297384|NCT00445731|recurrent breast cancer|recurrent breast cancer
5297385|NCT00445731|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5297386|NCT00445731|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5297387|NCT00445731|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5297388|NCT00445731|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5297389|NCT00445731|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5297390|NCT00445731|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5297391|NCT00445731|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5297392|NCT00445731|recurrent neuroblastoma|recurrent neuroblastoma
5297393|NCT00445731|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5297394|NCT00445731|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
5297395|NCT00445731|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5297396|NCT00445731|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
5297397|NCT00445731|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5297398|NCT00445731|refractory hairy cell leukemia|refractory hairy cell leukemia
5297399|NCT00445731|refractory multiple myeloma|refractory multiple myeloma
5297400|NCT00445731|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5297401|NCT00445731|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5297402|NCT00445731|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5297403|NCT00445731|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5297404|NCT00445731|stage I multiple myeloma|stage i multiple myeloma
5297405|NCT00445731|stage II multiple myeloma|stage ii multiple myeloma
5297406|NCT00445731|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
5297407|NCT00445731|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5297408|NCT00445731|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5297409|NCT00445731|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5297410|NCT00445731|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5297411|NCT00445731|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5297412|NCT00445731|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5297413|NCT00445731|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5297414|NCT00445731|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5297415|NCT00445731|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5297416|NCT00445731|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5297417|NCT00445731|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5297418|NCT00445731|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5297419|NCT00445731|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5297420|NCT00445731|stage III multiple myeloma|stage iii multiple myeloma
5297421|NCT00445731|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5297422|NCT00445731|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5297423|NCT00445731|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
5297424|NCT00445731|stage IIIA breast cancer|stage iiia breast cancer
5297425|NCT00445731|stage IIIB breast cancer|stage iiib breast cancer
5297426|NCT00445731|stage IIIC breast cancer|stage iiic breast cancer
5297427|NCT00445731|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5297428|NCT00445731|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5297429|NCT00445731|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5297430|NCT00445731|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5297431|NCT00445731|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5297432|NCT00445731|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5297433|NCT00445731|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5297434|NCT00445731|stage IV breast cancer|stage iv breast cancer
5297435|NCT00445731|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5297436|NCT00445731|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5297774|NCT00444769|analgesia|analgesia
5297437|NCT00445731|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5297438|NCT00445731|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5297439|NCT00445731|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5297440|NCT00445731|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5297441|NCT00445731|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5297442|NCT00445731|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5297443|NCT00445679|major depressive disorder|major depressive disorder
5297444|NCT00445679|MDD|mdd
5297445|NCT00445679|depression|depression
5297446|NCT00445653|Barrett esophagus|barrett esophagus
5297447|NCT00445627|Type 2 Diabetes|type 2 diabetes
5297448|NCT00445627|Obesity|obesity
5297449|NCT00445627|Overweight|overweight
5297450|NCT00445614|nutrition|nutrition
5297451|NCT00445614|cardiovascular risk|cardiovascular risk
5297452|NCT00445614|inflammation|inflammation
5297453|NCT00445614|vascular function|vascular function
5297454|NCT00445601|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
5297455|NCT00445601|stage 0 bladder cancer|stage 0 bladder cancer
5297456|NCT00445601|stage I bladder cancer|stage i bladder cancer
5297457|NCT00445601|recurrent bladder cancer|recurrent bladder cancer
5297458|NCT00445575|fibrous dysplasia of bone|fibrous dysplasia of bone
5297459|NCT00445575|Mac Cune Albright syndrome|mac cune albright syndrome
5297460|NCT00445575|bisphosphonates|bisphosphonates
5297461|NCT00445575|risedronate|risedronate
5297462|NCT00445562|male breast cancer|male breast cancer
5297463|NCT00445562|recurrent breast cancer|recurrent breast cancer
5297464|NCT00445562|stage IA breast cancer|stage ia breast cancer
5297465|NCT00445562|stage IB breast cancer|stage ib breast cancer
5297466|NCT00445562|stage II breast cancer|stage ii breast cancer
5297467|NCT00445562|stage IIIA breast cancer|stage iiia breast cancer
5297468|NCT00445562|stage IIIB breast cancer|stage iiib breast cancer
5297469|NCT00445562|stage IIIC breast cancer|stage iiic breast cancer
5297470|NCT00445562|stage IV breast cancer|stage iv breast cancer
5297471|NCT00445549|Ovarian|ovarian
5297472|NCT00445549|VEGFR2|vegfr2
5297473|NCT00445549|EGFR|egfr
5297474|NCT00445549|Angiogenesis|angiogenesis
5297475|NCT00445549|Tyrosine Kinase|tyrosine kinase
5297476|NCT00445549|Protein Phosphorylation|protein phosphorylation
5297477|NCT00445549|Vandetanib|vandetanib
5297478|NCT00445549|Ovarian Cancer|ovarian cancer
5297479|NCT00445549|Fallopian Tube Cancer|fallopian tube cancer
5297480|NCT00445549|Peritoneal Cancer|peritoneal cancer
5297481|NCT00445523|Advanced renal cancer|advanced renal cancer
5297482|NCT00445523|metastatic renal cancer|metastatic renal cancer
5297483|NCT00445523|RCC|rcc
5297484|NCT00445523|kidney cancer|kidney cancer
5297485|NCT00445523|M3thodist|m3thodist
5297486|NCT00445510|GSK256066,|gsk256066,
5297487|NCT00445510|allergen,|allergen,
5297488|NCT00445510|challenge,|challenge,
5297489|NCT00445510|repeat dose,|repeat dose,
5297490|NCT00445510|AMP,|amp,
5297491|NCT00445510|mild asthmatics|mild asthmatics
5297492|NCT00445497|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
5297493|NCT00445497|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5297494|NCT00445497|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
5297495|NCT00445497|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5297496|NCT00445497|intraocular lymphoma|intraocular lymphoma
5297497|NCT00445497|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5297498|NCT00445497|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
5297499|NCT00445497|primary central nervous system Hodgkin lymphoma|primary central nervous system hodgkin lymphoma
5297500|NCT00445497|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5297501|NCT00445497|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5297502|NCT00445497|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5297503|NCT00445497|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5297504|NCT00445497|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5297505|NCT00445497|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5297506|NCT00445497|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5297507|NCT00445497|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5297508|NCT00445497|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5297509|NCT00445497|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5297510|NCT00445497|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5297511|NCT00445497|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5297512|NCT00445497|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5297513|NCT00445497|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5297514|NCT00445497|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5297515|NCT00445497|small intestine lymphoma|small intestine lymphoma
5297516|NCT00445497|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5297517|NCT00445497|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5297518|NCT00445497|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5297770|NCT00444795|GIST|gist
5297519|NCT00445497|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5297520|NCT00445497|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5297521|NCT00445497|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5297522|NCT00445497|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5297523|NCT00445497|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5297524|NCT00445497|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
5297525|NCT00445497|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
5297526|NCT00445497|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5297527|NCT00445497|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5297528|NCT00445497|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5297529|NCT00445497|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5297530|NCT00445497|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5297531|NCT00445497|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
5297532|NCT00445497|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5297533|NCT00445497|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5297534|NCT00445497|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5297535|NCT00445497|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5297536|NCT00445497|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5297537|NCT00445497|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5297538|NCT00445497|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5297539|NCT00445497|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5297540|NCT00445497|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
5297541|NCT00445497|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
5297542|NCT00445497|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5297543|NCT00445497|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5297544|NCT00445497|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5297545|NCT00445497|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5297546|NCT00445497|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5297547|NCT00445497|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
5297548|NCT00445497|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5297549|NCT00445497|Waldenström macroglobulinemia|waldenström macroglobulinemia
5297550|NCT00445497|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5297551|NCT00445497|neutropenia|neutropenia
5297552|NCT00445497|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
5297553|NCT00445497|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
5297554|NCT00445497|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
5297555|NCT00445497|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
5297556|NCT00445497|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
5297557|NCT00445497|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
5297558|NCT00445497|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
5297559|NCT00445497|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
5297560|NCT00445497|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
5297561|NCT00445497|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
5297562|NCT00445497|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
5297563|NCT00445497|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
5297564|NCT00445497|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
5297565|NCT00445497|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
5297566|NCT00445497|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
5297567|NCT00445497|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
5297568|NCT00445497|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
5297569|NCT00445497|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
5297570|NCT00445497|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
5297571|NCT00445497|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
5297572|NCT00445497|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
5297573|NCT00445497|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
5297574|NCT00445497|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
5297575|NCT00445497|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
5297576|NCT00445497|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
5297577|NCT00445497|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5297578|NCT00445497|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
5297579|NCT00445497|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
5297667|NCT00445237|major depression|major depression
5297580|NCT00445497|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
5297581|NCT00445497|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
5297582|NCT00445497|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5297583|NCT00445497|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5297584|NCT00445497|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5297585|NCT00445497|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5297586|NCT00445497|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
5297587|NCT00445497|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
5297588|NCT00445497|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
5297589|NCT00445497|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
5297590|NCT00445497|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
5297591|NCT00445497|adult grade III lymphomatoid granulomatosis|adult grade iii lymphomatoid granulomatosis
5297592|NCT00445497|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
5297593|NCT00445497|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
5297594|NCT00445484|stage II multiple myeloma|stage ii multiple myeloma
5297595|NCT00445484|stage III multiple myeloma|stage iii multiple myeloma
5297596|NCT00445484|refractory multiple myeloma|refractory multiple myeloma
5297597|NCT00445471|Autism Spectrum Disorder|autism spectrum disorder
5297598|NCT00445471|Autistic Disorder|autistic disorder
5297599|NCT00445471|Pervasive Developmental Disorder|pervasive developmental disorder
5297600|NCT00445458|cancer|cancer
5297601|NCT00445458|HKI-272|hki-272
5297602|NCT00445458|neratinib|neratinib
5297603|NCT00445458|paclitaxel|paclitaxel
5297604|NCT00445458|Taxol|taxol
5297605|NCT00445458|breast cancer|breast cancer
5297606|NCT00445458|Nerlynx|nerlynx
5297607|NCT00445445|stage I breast cancer|stage i breast cancer
5297608|NCT00445445|stage II breast cancer|stage ii breast cancer
5297609|NCT00445445|stage IIIA breast cancer|stage iiia breast cancer
5297610|NCT00445445|stage IIIB breast cancer|stage iiib breast cancer
5297611|NCT00445445|stage IIIC breast cancer|stage iiic breast cancer
5297612|NCT00445445|stage IV breast cancer|stage iv breast cancer
5297613|NCT00445445|recurrent breast cancer|recurrent breast cancer
5297614|NCT00445445|breast cancer in situ|breast cancer in situ
5297615|NCT00445419|Hepatitis C|hepatitis c
5297616|NCT00445419|Liver disease|liver disease
5297617|NCT00445419|Viral infection|viral infection
5297618|NCT00445419|Virosome|virosome
5297619|NCT00445419|Vaccine|vaccine
5297620|NCT00445419|therapeutic vaccine|therapeutic vaccine
5297621|NCT00445419|Chronic hepatitis C virus infection|chronic hepatitis c virus infection
5297622|NCT00445406|recurrent breast cancer|recurrent breast cancer
5297623|NCT00445406|stage IV breast cancer|stage iv breast cancer
5297624|NCT00445393|Observation|observation
5297625|NCT00445393|Mental health|mental health
5297626|NCT00445393|Scoliosis|scoliosis
5297627|NCT00445393|Screening|screening
5297628|NCT00445393|Adolescent idiopathic scoliosis|adolescent idiopathic scoliosis
5297629|NCT00445367|Multiple Sclerosis|multiple sclerosis
5297630|NCT00445367|Clinically Isolated Syndrome|clinically isolated syndrome
5297631|NCT00445367|Transverse Myelitis|transverse myelitis
5297632|NCT00445367|Neuromyelitis Optica|neuromyelitis optica
5297633|NCT00445367|Acute Disseminated Encephalomyelitis|acute disseminated encephalomyelitis
5297634|NCT00445367|Optic Neuritis|optic neuritis
5297635|NCT00445367|Repository|repository
5297636|NCT00445367|Biobank|biobank
5297637|NCT00445354|cinnamon|cinnamon
5297638|NCT00445354|diabetes|diabetes
5297639|NCT00445354|hemoglobin a1c|hemoglobin a1c
5297640|NCT00445341|Microarray|microarray
5297641|NCT00445341|Proteomics|proteomics
5297642|NCT00445341|Hybrid Schedule|hybrid schedule
5297643|NCT00445341|Tumor Lysis Syndrome|tumor lysis syndrome
5297644|NCT00445341|Cyclin D1|cyclin d1
5297645|NCT00445341|Lymphoma|lymphoma
5297646|NCT00445341|Mantle Cell Lymphoma|mantle cell lymphoma
5297648|NCT00445341|Diffuse Large B-Cell Lymphoma|diffuse large b-cell lymphoma
5297649|NCT00445341|DLBCL|dlbcl
5297650|NCT00445328|hospitalised acutely medically ill patients; Venous Thromboembolism, Infection, Inflammatory Bowel Diseases, Heart Failure, Congestive, Sciatica|hospitalised acutely medically ill patients; venous thromboembolism, infection, inflammatory bowel diseases, heart failure, congestive, sciatica
5297651|NCT00445302|AMD3100|amd3100
5297652|NCT00445289|mechanical ventilation|mechanical ventilation
5297653|NCT00445289|ventilator weaning|ventilator weaning
5297654|NCT00445289|closed-loop|closed-loop
5297655|NCT00445289|ventilation time|ventilation time
5297656|NCT00445276|Osteoarthritis|osteoarthritis
5297657|NCT00445276|Knee|knee
5297658|NCT00445276|Diacerein|diacerein
5297659|NCT00445276|Painful osteoarthritis|painful osteoarthritis
5297660|NCT00445276|Clinical trial|clinical trial
5297661|NCT00445263|CORONARY DISEASE|coronary disease
5297662|NCT00445250|Calcipotriol|calcipotriol
5297663|NCT00445250|Breast|breast
5297664|NCT00445250|Cancer|cancer
5297665|NCT00445250|Radiotherapy|radiotherapy
5297666|NCT00445250|Radiodermatitis in Breast Cancer|radiodermatitis in breast cancer
5297670|NCT00445224|Rehabilitation|rehabilitation
5297671|NCT00445211|Intraaortic balloon pumping|intraaortic balloon pumping
5297672|NCT00445211|Heparin|heparin
5297673|NCT00445211|Limb ischemia|limb ischemia
5297674|NCT00445211|Bleeding|bleeding
5297675|NCT00445198|SCLC|sclc
5297676|NCT00445185|Dialysis|dialysis
5297677|NCT00445185|Pre-dialysis|pre-dialysis
5297678|NCT00445185|Hepatitis B vaccine|hepatitis b vaccine
5297679|NCT00445185|vaccine|vaccine
5297680|NCT00445172|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
5297681|NCT00445172|Motor Neurons|motor neurons
5297682|NCT00445172|Muscular Atrophy|muscular atrophy
5297683|NCT00445159|UT-15C SR, Peripheral Vascular Disease, treprostinil|ut-15c sr, peripheral vascular disease, treprostinil
5297684|NCT00445146|Phase 2|phase 2
5297685|NCT00445146|Open-label|open-label
5297686|NCT00445146|Rollover|rollover
5297687|NCT00445146|Integrase Inhibitor|integrase inhibitor
5297688|NCT00445146|Antiretroviral Agents|antiretroviral agents
5297689|NCT00445146|Highly Active Antiretroviral Activity|highly active antiretroviral activity
5297690|NCT00445146|HAART|haart
5297691|NCT00445146|HIV, HIV-1, AIDS virus, Human Immunodeficiency Virus|hiv, hiv-1, aids virus, human immunodeficiency virus
5297692|NCT00445146|Acquired Immune Deficiency Syndrome Virus|acquired immune deficiency syndrome virus
5297693|NCT00445146|treatment experienced|treatment experienced
5297694|NCT00445133|Neck Pain/Lumbar pain/Magnets/sleep deficiency/ insomnia/|neck pain/lumbar pain/magnets/sleep deficiency/ insomnia/
5297695|NCT00445120|Vernal keratoconjunctivitis|vernal keratoconjunctivitis
5297696|NCT00445120|probiotic|probiotic
5297697|NCT00445120|Lactobacillus Rhamnosus GG|lactobacillus rhamnosus gg
5297698|NCT00445120|Children|children
5297699|NCT00445120|Clinical trial|clinical trial
5297700|NCT00445081|atopic dermatitis|atopic dermatitis
5297701|NCT00445081|prednisolone|prednisolone
5297702|NCT00445081|ciclosporine|ciclosporine
5297703|NCT00445081|SCORAD|scorad
5297704|NCT00445081|DLQI|dlqi
5297705|NCT00445081|QALY|qaly
5297706|NCT00445081|WLQ|wlq
5297707|NCT00445068|Multiple myeloma|multiple myeloma
5297708|NCT00445068|adults|adults
5297709|NCT00445068|LBH589|lbh589
5297710|NCT00445068|refractory|refractory
5297711|NCT00445055|Thyroidectomy|thyroidectomy
5297712|NCT00445055|Nausea|nausea
5297713|NCT00445055|Vomiting|vomiting
5297714|NCT00445055|Droperidol|droperidol
5297715|NCT00445042|Metastatic Renal Cell Carcinoma|metastatic renal cell carcinoma
5297716|NCT00445042|Metastatic RCC|metastatic rcc
5297717|NCT00445042|Kidney Cancer|kidney cancer
5297718|NCT00445042|M3thodist|m3thodist
5297719|NCT00445029|Allergic contact dermatitis|allergic contact dermatitis
5297720|NCT00445029|para-phenylenediamine|para-phenylenediamine
5297721|NCT00445029|effector cells|effector cells
5297722|NCT00445029|regulatory cells|regulatory cells
5297723|NCT00445029|pathophysiology|pathophysiology
5297724|NCT00445016|peripheral regional anesthesia|peripheral regional anesthesia
5297725|NCT00445016|nerve damage|nerve damage
5297726|NCT00445016|adverse effects|adverse effects
5297727|NCT00445016|neurologic complication|neurologic complication
5297728|NCT00445016|neuropathy|neuropathy
5297729|NCT00445003|Diabetic Retinopathy|diabetic retinopathy
5297730|NCT00445003|Diabetic Macular Edema|diabetic macular edema
5297731|NCT00445003|Lucentis|lucentis
5297732|NCT00445003|Ranibizumab|ranibizumab
5297733|NCT00445003|Triamcinolone|triamcinolone
5297734|NCT00445003|Panretinal Photocoagulation|panretinal photocoagulation
5297735|NCT00445003|Combination Therapy|combination therapy
5297736|NCT00445003|pdr|pdr
5297737|NCT00444990|Lumbar pain|lumbar pain
5297738|NCT00444990|magnets|magnets
5297739|NCT00444990|Reduce low back pain|reduce low back pain
5297740|NCT00444977|HIV positive persons|hiv positive persons
5297741|NCT00444977|Not received oral health care in the preceding 12 months.|not received oral health care in the preceding 12 months.
5297742|NCT00444977|treatment naive|treatment naive
5297743|NCT00444977|treatment experienced|treatment experienced
5297744|NCT00444951|N meningitidis|n meningitidis
5297745|NCT00444912|AMD3100|amd3100
5297746|NCT00444912|stem cell mobilization|stem cell mobilization
5297747|NCT00444912|autologous transplant|autologous transplant
5297748|NCT00444912|Non-Hodgkin Lymphoma|non-hodgkin lymphoma
5297749|NCT00444912|Hodgkin Disease|hodgkin disease
5297750|NCT00444899|Intensive treatment|intensive treatment
5297751|NCT00444899|dietician|dietician
5297752|NCT00444886|Thoracic Outlet Syndrome (TOS)|thoracic outlet syndrome (tos)
5297753|NCT00444886|Botulinum Toxin|botulinum toxin
5297754|NCT00444886|Botox|botox
5297755|NCT00444886|Pain|pain
5297756|NCT00444873|Inappropriate Growth Hormone Secretion Syndrome (Acromegaly)|inappropriate growth hormone secretion syndrome (acromegaly)
5297757|NCT00444847|AIDS|aids
5297758|NCT00444847|HIV|hiv
5297759|NCT00444847|Hyperbaric Chamber|hyperbaric chamber
5297760|NCT00444847|treatment experienced|treatment experienced
5297761|NCT00444821|AAA|aaa
5297762|NCT00444821|Aneurysm|aneurysm
5297763|NCT00444821|AneuRx|aneurx
5297764|NCT00444821|Talent|talent
5297765|NCT00444808|Rib fracture|rib fracture
5297766|NCT00444808|Pain|pain
5297767|NCT00444808|intranasal calcitonin|intranasal calcitonin
5297768|NCT00444795|SUTENE|sutene
5297769|NCT00444795|post-marketing surveillance|post-marketing surveillance
5297771|NCT00444795|RCC|rcc
5297772|NCT00444795|Korea|korea
5297773|NCT00444782|Advanced Carcinoma, Hepatocellular|advanced carcinoma, hepatocellular
5297775|NCT00444769|post-operative pain|post-operative pain
5297776|NCT00444769|GW842166|gw842166
5297777|NCT00444769|non-cannabinoid agonist|non-cannabinoid agonist
5297778|NCT00444769|third molar tooth extraction|third molar tooth extraction
5297779|NCT00444756|local anesthesia|local anesthesia
5297780|NCT00444756|analgesia|analgesia
5297781|NCT00444756|peripheral IV|peripheral iv
5297782|NCT00444756|Local anesthesia prior to peripheral IV insertion|local anesthesia prior to peripheral iv insertion
5297783|NCT00444730|Prostate Cancer|prostate cancer
5297784|NCT00444730|Prostatectomy|prostatectomy
5297785|NCT00444730|Pelvic pain|pelvic pain
5297786|NCT00444730|urgency|urgency
5297787|NCT00444730|incontinence|incontinence
5297788|NCT00444730|frequency|frequency
5297789|NCT00444717|statin|statin
5297790|NCT00444717|metabolic syndrome|metabolic syndrome
5297791|NCT00444717|oxidative stress|oxidative stress
5297792|NCT00444717|inflammation|inflammation
5297793|NCT00444691|synovitis score|synovitis score
5297794|NCT00444691|sensitivity to change|sensitivity to change
5297795|NCT00444691|clinical examination|clinical examination
5297796|NCT00444691|ultra-sonography|ultra-sonography
5297797|NCT00444678|Previously untreated metastatic colorectal cancer|previously untreated metastatic colorectal cancer
5297798|NCT00444678|Metastatic Colorectal Cancer|metastatic colorectal cancer
5297799|NCT00444678|combined therapy|combined therapy
5297800|NCT00444678|biologics therapy|biologics therapy
5297801|NCT00444678|antibody|antibody
5297802|NCT00444678|chemotherapy|chemotherapy
5297803|NCT00444678|EGFR|egfr
5297804|NCT00444665|Glaucoma|glaucoma
5297805|NCT00444652|Thromboprophylaxis|thromboprophylaxis
5297806|NCT00444652|Bariatric surgery|bariatric surgery
5297807|NCT00444652|prevention of venous thromboembolism in bariatric surgery|prevention of venous thromboembolism in bariatric surgery
5297808|NCT00444626|nasolabial folds|nasolabial folds
5297809|NCT00444626|facial wrinkles|facial wrinkles
5297810|NCT00444613|Amyotrophic Lateral Sclerosis (ALS)|amyotrophic lateral sclerosis (als)
5297811|NCT00444613|motor neurons|motor neurons
5297812|NCT00444613|muscular atrophy|muscular atrophy
5297813|NCT00444613|Lou Gehrig's Disease|lou gehrig's disease
5297814|NCT00444600|Diabetic Retinopathy|diabetic retinopathy
5297815|NCT00444600|Diabetic Macular Edema|diabetic macular edema
5297816|NCT00444600|Lucentis|lucentis
5297817|NCT00444600|Ranibizumab|ranibizumab
5297818|NCT00444600|Triamcinolone|triamcinolone
5297819|NCT00444600|Laser photocoagulation|laser photocoagulation
5297820|NCT00444600|Combination Therapy|combination therapy
5297821|NCT00444574|Attention Deficit Hyperactivity Disorder (ADHD)|attention deficit hyperactivity disorder (adhd)
5297822|NCT00444561|pramlintide|pramlintide
5297823|NCT00444561|Symlin|symlin
5297824|NCT00444561|Amylin|amylin
5297825|NCT00444548|Equipment|equipment
5297826|NCT00444548|Supplies|supplies
5297827|NCT00444535|VEGF|vegf
5297828|NCT00444535|Tyrosine kinase|tyrosine kinase
5297829|NCT00444535|ErbB2|erbb2
5297830|NCT00444535|Her2-neu|her2-neu
5297831|NCT00444535|metastatic breast cancer|metastatic breast cancer
5297832|NCT00444535|EGFR|egfr
5297833|NCT00444535|ErbB1|erbb1
5297834|NCT00444535|bevacizumab|bevacizumab
5297835|NCT00444535|lapatinib|lapatinib
5297836|NCT00444522|Panic attacks, Staccato® Alprazolam|panic attacks, staccato® alprazolam
5297837|NCT00444509|Asthmatic Patients|asthmatic patients
5297838|NCT00444470|tranexamic acid|tranexamic acid
5297839|NCT00444470|safety|safety
5297840|NCT00444470|efficacy|efficacy
5297841|NCT00444470|spine surgery|spine surgery
5297842|NCT00444470|spinal fusion and decompression|spinal fusion and decompression
5297843|NCT00444470|adult|adult
5297844|NCT00444470|perioperative|perioperative
5297845|NCT00444470|blood loss|blood loss
5297846|NCT00444470|bleeding|bleeding
5297847|NCT00444470|blood transfusion|blood transfusion
5297848|NCT00444457|Vaccine|vaccine
5297849|NCT00444457|Infants|infants
5297850|NCT00444457|Pneumococcal Conjugate Vaccines|pneumococcal conjugate vaccines
5297851|NCT00444457|Vaccines, Pneumococcal|vaccines, pneumococcal
5297852|NCT00444444|Autoimmune pancreatitis, HLA, relapse, Sequence-based typing|autoimmune pancreatitis, hla, relapse, sequence-based typing
5297853|NCT00444418|Drinking|drinking
5297854|NCT00444418|Alcohol problems|alcohol problems
5297855|NCT00444418|Alcoholism|alcoholism
5297856|NCT00444418|Gay men|gay men
5297857|NCT00444418|Bisexual men|bisexual men
5297858|NCT00444418|Moderation-oriented treatment|moderation-oriented treatment
5297859|NCT00444418|Controlled drinking|controlled drinking
5297860|NCT00444418|Non-abstinence based treatment|non-abstinence based treatment
5297861|NCT00444405|lumbar|lumbar
5297862|NCT00444405|disc|disc
5297863|NCT00444405|herniation|herniation
5297864|NCT00444405|discectomy|discectomy
5297865|NCT00444405|fusion|fusion
5297866|NCT00444405|spine|spine
5297867|NCT00444392|Obese|obese
5297868|NCT00444392|type 2 Diabetes Mellitus|type 2 diabetes mellitus
5297869|NCT00444392|Gastric Bypass Surgery|gastric bypass surgery
5297870|NCT00444392|Risk of CVD|risk of cvd
5297871|NCT00444379|Kaposi's sarcoma|kaposi's sarcoma
5297872|NCT00444379|KSHV|kshv
5297873|NCT00444379|AIDS|aids
5297874|NCT00444379|HHV-8|hhv-8
5297875|NCT00444379|treatment naive|treatment naive
5297876|NCT00444327|single nucleotide polymorphism|single nucleotide polymorphism
5297877|NCT00444301|Heart failure|heart failure
5297878|NCT00444301|Pain|pain
5297879|NCT00444301|Symptoms|symptoms
5297880|NCT00444301|Advanced heart failure|advanced heart failure
5297881|NCT00444301|Pain frequency, severity, location, treatments|pain frequency, severity, location, treatments
5297882|NCT00444301|Shortness of breath, anxiety, depression, cognitive function|shortness of breath, anxiety, depression, cognitive function
5297883|NCT00444301|Social support, other conditions and illnesses|social support, other conditions and illnesses
5297884|NCT00444288|Cystic Ovaries|cystic ovaries
5297885|NCT00444288|Hyperandrogenism|hyperandrogenism
5297886|NCT00444288|Anovulation|anovulation
5297887|NCT00444288|Concordance Rates|concordance rates
5297888|NCT00444288|Baseline Heritability|baseline heritability
5297889|NCT00444288|Polycystic Ovary Syndrome|polycystic ovary syndrome
5297890|NCT00444288|POS|pos
5297891|NCT00444275|Gastroesophageal Reflux Disease|gastroesophageal reflux disease
5297892|NCT00444275|Acid Reflux|acid reflux
5297893|NCT00444262|Hemodynamic optimisation|hemodynamic optimisation
5297894|NCT00444262|Esophageal Doppler|esophageal doppler
5297895|NCT00444262|Hydroxy ethyl starch|hydroxy ethyl starch
5297896|NCT00444262|Hip fracture|hip fracture
5297897|NCT00444262|Outcome|outcome
5297898|NCT00444262|Elderly subjects (≥ 70 year old)|elderly subjects (≥ 70 year old)
5297899|NCT00444262|General anesthesia|general anesthesia
5297900|NCT00444249|age-related macular degeneration|age-related macular degeneration
5297901|NCT00444249|melatonin|melatonin
5297902|NCT00444249|blue-light filter|blue-light filter
5297903|NCT00444236|asthma|asthma
5297904|NCT00444236|GERD|gerd
5297905|NCT00444236|reflux|reflux
5297906|NCT00444236|exercise|exercise
5297907|NCT00444223|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5297908|NCT00444223|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5297909|NCT00444223|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5297910|NCT00444184|travoprost/timolol fixed combination|travoprost/timolol fixed combination
5297911|NCT00444171|critically ill|critically ill
5297912|NCT00444171|insulin resistance|insulin resistance
5297913|NCT00444171|intensive insulin therapy|intensive insulin therapy
5297914|NCT00444171|computer algorithm|computer algorithm
5297915|NCT00444158|opioids|opioids
5297916|NCT00444158|chronic pain|chronic pain
5297917|NCT00444132|clopidogrel|clopidogrel
5297918|NCT00444132|platelets|platelets
5297919|NCT00444132|acute coronary syndrome|acute coronary syndrome
5297920|NCT00444132|percutaneous coronary intervention|percutaneous coronary intervention
5297921|NCT00444119|adrenal insufficiency|adrenal insufficiency
5297922|NCT00444119|subjective health status|subjective health status
5297923|NCT00444119|quality of life|quality of life
5297924|NCT00444119|adrenal crisis|adrenal crisis
5297925|NCT00444119|hormone replacement|hormone replacement
5297926|NCT00444119|DHEA|dhea
5297927|NCT00444106|Malaria|malaria
5297928|NCT00444106|hearing|hearing
5297929|NCT00444106|co-artemether|co-artemether
5297930|NCT00444106|auditory|auditory
5297931|NCT00444106|Plasmodium falciparum|plasmodium falciparum
5297932|NCT00444106|marsh fever|marsh fever
5297933|NCT00444106|Plasmodium infections|plasmodium infections
5297934|NCT00444106|remittent fever|remittent fever
5297935|NCT00444106|paludism|paludism
5297936|NCT00444106|artemether|artemether
5297937|NCT00444106|artemisinins|artemisinins
5297938|NCT00444106|benflumetol|benflumetol
5297939|NCT00444106|lumefantrine|lumefantrine
5297940|NCT00444093|radiation therapy|radiation therapy
5297941|NCT00444093|diarrhea|diarrhea
5297942|NCT00444093|enteritis|enteritis
5297943|NCT00444093|supportive therapy|supportive therapy
5297944|NCT00444093|therapy associated diarrhea|therapy associated diarrhea
5297945|NCT00444093|therapy associated enteritis|therapy associated enteritis
5297946|NCT00444093|radiation therapy of the small pelvis|radiation therapy of the small pelvis
5297947|NCT00444080|Ex-PRESS|ex-press
5297948|NCT00444080|TRABECULECTOMY|trabeculectomy
5297949|NCT00444067|Prevention of CSF leak|prevention of csf leak
5297950|NCT00444054|Diet|diet
5297951|NCT00444054|Cancer|cancer
5297952|NCT00444054|Alternative|alternative
5297953|NCT00444054|Breast|breast
5297954|NCT00444054|Colon|colon
5297955|NCT00444054|Cervix|cervix
5297956|NCT00444054|Uterus|uterus
5297957|NCT00444054|Ovary|ovary
5297958|NCT00444054|Metastatic|metastatic
5297959|NCT00444054|Nutrition|nutrition
5297960|NCT00444054|Carbohydrate|carbohydrate
5297961|NCT00444041|metastatic colorectal cancer|metastatic colorectal cancer
5297962|NCT00444041|surgery|surgery
5297963|NCT00444041|chemotherapy|chemotherapy
5297964|NCT00444028|Schizophrenia, Staccato Loxapine|schizophrenia, staccato loxapine
5297965|NCT00444015|Erlotinib|erlotinib
5297966|NCT00444015|Dasatinib|dasatinib
5297967|NCT00444015|Epidermal growth factor receptor (EGFR)|epidermal growth factor receptor (egfr)
5297968|NCT00444015|Tyrosine kinase|tyrosine kinase
5297969|NCT00444015|NSCLC|nsclc
5297970|NCT00444015|Pharmacokinetics (PK)|pharmacokinetics (pk)
5297971|NCT00444015|Lung|lung
5297972|NCT00444002|Hepatitis C|hepatitis c
5297973|NCT00444002|Steatosis|steatosis
5297974|NCT00444002|Oxidative Stress|oxidative stress
5297975|NCT00444002|Antioxidants|antioxidants
5297976|NCT00444002|Inflammation|inflammation
5297977|NCT00444002|Fatty acids|fatty acids
5297978|NCT00443989|Perioperative Myocardial Infarction|perioperative myocardial infarction
5297979|NCT00443989|Stroke|stroke
5297980|NCT00443989|Cardiac Death|cardiac death
5297981|NCT00443989|Cardiac Arrest|cardiac arrest
5297982|NCT00443989|Troponin-T|troponin-t
5297983|NCT00443989|Non-Cardiac surgery|non-cardiac surgery
5297984|NCT00443989|Death|death
5297985|NCT00443976|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5297986|NCT00443976|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5297987|NCT00443976|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5297988|NCT00443976|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5297989|NCT00443976|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5297990|NCT00443976|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5297991|NCT00443976|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5297992|NCT00443976|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5297993|NCT00443976|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5297994|NCT00443976|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5297995|NCT00443976|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5297996|NCT00443976|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5297997|NCT00443976|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5297998|NCT00443976|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5297999|NCT00443976|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5298000|NCT00443976|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5298001|NCT00443976|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5298002|NCT00443976|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5298003|NCT00443976|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5298004|NCT00443976|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5298005|NCT00443976|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5298006|NCT00443976|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5298007|NCT00443976|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5298008|NCT00443976|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5298009|NCT00443976|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5298010|NCT00443976|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5298011|NCT00443976|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5298012|NCT00443976|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5298013|NCT00443976|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5298014|NCT00443976|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5298015|NCT00443976|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5298016|NCT00443976|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5298017|NCT00443976|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5298018|NCT00443976|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5298019|NCT00443976|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5298020|NCT00443976|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5298021|NCT00443976|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5298022|NCT00443976|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5298023|NCT00443976|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5298024|NCT00443976|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5298025|NCT00443976|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
5298026|NCT00443976|adult grade III lymphomatoid granulomatosis|adult grade iii lymphomatoid granulomatosis
5298027|NCT00443976|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
5298028|NCT00443963|Dyspepsia in patients taking NSAIDs|dyspepsia in patients taking nsaids
5298029|NCT00443950|Arthritis|arthritis
5298031|NCT00443937|Kidney Transplantation|kidney transplantation
5298032|NCT00443937|Renal Transplantation|renal transplantation
5298033|NCT00443937|Mycophenolate|mycophenolate
5298034|NCT00443937|Cyclosporine|cyclosporine
5298035|NCT00443937|Everolimus|everolimus
5298036|NCT00443924|Bilateral ocular hypertension or early primary open angle glaucoma|bilateral ocular hypertension or early primary open angle glaucoma
5298037|NCT00443911|age-related macular degeneration, rheopheresis, lutein|age-related macular degeneration, rheopheresis, lutein
5298038|NCT00443898|Toenail fungus|toenail fungus
5298039|NCT00443898|Onychomycosis|onychomycosis
5298040|NCT00443898|Nail fungus|nail fungus
5298041|NCT00443898|Toenail fungal infection|toenail fungal infection
5298042|NCT00443898|Tinea unguium|tinea unguium
5298043|NCT00443898|Dermatophytes|dermatophytes
5298044|NCT00443898|Foot dermatoses|foot dermatoses
5298045|NCT00443885|meropenem|meropenem
5298046|NCT00443885|imipenem|imipenem
5298047|NCT00443885|gram negative organism|gram negative organism
5298048|NCT00443872|Parkinson's disease|parkinson's disease
5298049|NCT00443872|Dopamine agonist adverse effects|dopamine agonist adverse effects
5298050|NCT00443872|MAO-B inhibitor|mao-b inhibitor
5298051|NCT00443872|orally disintegrating selegiline|orally disintegrating selegiline
5298052|NCT00443872|Zelapar|zelapar
5298053|NCT00443859|Persistent Pulmonary Hypertension|persistent pulmonary hypertension
5298054|NCT00443859|N-terminal pro brain natriuretic peptide|n-terminal pro brain natriuretic peptide
5298055|NCT00443846|Prevention of Gastroenteritis due to rotavirus infection. And prevention of Invasive disease caused by Neisseria meningitidis serogroup C.|prevention of gastroenteritis due to rotavirus infection. and prevention of invasive disease caused by neisseria meningitidis serogroup c.
5298056|NCT00443833|Thyrotoxicosis|thyrotoxicosis
5298057|NCT00443833|genetic association study|genetic association study
5298058|NCT00443833|periodic paralysis|periodic paralysis
5298059|NCT00443833|whole genome scan|whole genome scan
5298060|NCT00443820|Toenail fungus|toenail fungus
5298061|NCT00443820|Onychomycosis|onychomycosis
5298062|NCT00443820|Nail fungus|nail fungus
5298063|NCT00443820|Toenail fungal infection|toenail fungal infection
5298064|NCT00443820|Tinea unguium|tinea unguium
5298065|NCT00443820|Dermatophytes|dermatophytes
5298066|NCT00443820|Foot dermatoses|foot dermatoses
5298067|NCT00443794|POLYCAP, Primary Prevention,CVD|polycap, primary prevention,cvd
5298068|NCT00443781|low back pain, degenerative disc disease|low back pain, degenerative disc disease
5298069|NCT00443768|Medication|medication
5298070|NCT00443768|Diagnosis|diagnosis
5298071|NCT00443768|Community|community
5298072|NCT00443755|Inflammatory cytokine|inflammatory cytokine
5298073|NCT00443755|Cardiovascular Disease|cardiovascular disease
5298074|NCT00443755|Thrombotic factors|thrombotic factors
5298075|NCT00443755|Dyslipidemia|dyslipidemia
5298076|NCT00443742|Depression|depression
5298077|NCT00443742|Validation|validation
5298078|NCT00443742|Adolescent|adolescent
5298079|NCT00443742|Validation of three key questions and questionnaire|validation of three key questions and questionnaire
5298080|NCT00443729|treatment experienced|treatment experienced
5298081|NCT00443703|treatment experienced|treatment experienced
5298082|NCT00443690|heart failure|heart failure
5298083|NCT00443690|diuretic|diuretic
5298084|NCT00443690|renal impairment|renal impairment
5298085|NCT00443690|renal function|renal function
5298086|NCT00443664|Primary Open Angle Glaucoma|primary open angle glaucoma
5298087|NCT00443651|Rituxan|rituxan
5298088|NCT00443651|RA|ra
5298089|NCT00443651|DMARD|dmard
5298090|NCT00443651|Active Rheumatoid Arthritis|active rheumatoid arthritis
5298091|NCT00443625|SK3530|sk3530
5298092|NCT00443625|Food effect|food effect
5298093|NCT00443625|Pharmacokinetics|pharmacokinetics
5298094|NCT00443599|Congenital Heart Defects|congenital heart defects
5298095|NCT00443599|Insulin|insulin
5298096|NCT00443599|Euglycemia|euglycemia
5298097|NCT00443599|Normoglycemia|normoglycemia
5298098|NCT00443586|Nurse|nurse
5298099|NCT00443586|Home Visitation|home visitation
5298100|NCT00443586|Welfare|welfare
5298101|NCT00443586|Social Behavior|social behavior
5298102|NCT00443573|metastatic colorectal carcinoma (mCRC)|metastatic colorectal carcinoma (mcrc)
5298103|NCT00443573|colorectal carcinoma (CRC)|colorectal carcinoma (crc)
5298104|NCT00443573|tissue factor|tissue factor
5298105|NCT00443573|factor VIIa|factor viia
5298106|NCT00443573|rNAPc2|rnapc2
5298107|NCT00443573|adenocarcinoma|adenocarcinoma
5298108|NCT00443573|targeted therapy|targeted therapy
5298109|NCT00443573|coagulation-dependent|coagulation-dependent
5298110|NCT00443573|RECIST|recist
5298111|NCT00443573|5-FU-based chemotherapy|5-fu-based chemotherapy
5298112|NCT00443573|FOLFOX|folfox
5298113|NCT00443573|FOLFIRI|folfiri
5298114|NCT00443573|leucovorin|leucovorin
5298115|NCT00443573|XELOX|xelox
5298116|NCT00443560|Labor|labor
5298117|NCT00443560|Epidural Analgesia|epidural analgesia
5298118|NCT00443560|delivery|delivery
5298119|NCT00443560|vacuum extraction|vacuum extraction
5298120|NCT00443560|obstetrical Forceps|obstetrical forceps
5298121|NCT00443547|Prospective|prospective
5298122|NCT00443547|Degenerative Disc Disease|degenerative disc disease
5298123|NCT00443547|Cervical|cervical
5298124|NCT00443547|Translational Plate|translational plate
5298125|NCT00443521|Diabetes Mellitus/ complications|diabetes mellitus/ complications
5298126|NCT00443521|Diabetic Retinopathy|diabetic retinopathy
5298127|NCT00443521|Triamcinolone|triamcinolone
5298128|NCT00443521|Laser coagulation|laser coagulation
5298129|NCT00443521|Tomography, optical coherence|tomography, optical coherence
5298130|NCT00443508|everolimus|everolimus
5298131|NCT00443508|renal transplant|renal transplant
5298132|NCT00443508|tacrolimus|tacrolimus
5298133|NCT00443508|Certican|certican
5298134|NCT00443508|CHRONIC ALLOGRAFT NEPHROPATHY|chronic allograft nephropathy
5298135|NCT00443508|Renal transplant patients|renal transplant patients
5298136|NCT00443482|Asthma|asthma
5298137|NCT00443482|adults|adults
5298138|NCT00443482|B2 agonist|b2 agonist
5298139|NCT00443482|formoterol|formoterol
5298140|NCT00443469|magnetic stimulation|magnetic stimulation
5298141|NCT00443469|neuropathic pain|neuropathic pain
5298142|NCT00443469|spinal|spinal
5298143|NCT00443469|lower limb|lower limb
5298144|NCT00443469|clinical trial|clinical trial
5298145|NCT00443443|Rituximab|rituximab
5298146|NCT00443443|RA|ra
5298147|NCT00443443|Sunstone|sunstone
5298148|NCT00443443|anti-TNF|anti-tnf
5298149|NCT00443443|Rituxan|rituxan
5298150|NCT00443430|Childhood Arthritis|childhood arthritis
5298151|NCT00443430|Juvenile Arthritis|juvenile arthritis
5298152|NCT00443430|Juvenile Arthritis Treatment|juvenile arthritis treatment
5298153|NCT00443430|Childhood Arthritis Drug Treatment|childhood arthritis drug treatment
5298154|NCT00443430|Juvenile Arthritis Remission|juvenile arthritis remission
5298155|NCT00443430|Inactive Disease in Juvenile Arthritis|inactive disease in juvenile arthritis
5298156|NCT00443430|Childhood Polyarthritis|childhood polyarthritis
5298157|NCT00443430|Extended Oligoarthritis|extended oligoarthritis
5298158|NCT00443404|phantom|phantom
5298159|NCT00443404|amputation|amputation
5298160|NCT00443404|analgesia|analgesia
5298161|NCT00443404|pain|pain
5298162|NCT00443404|preemptive|preemptive
5298163|NCT00443404|perioperative|perioperative
5298164|NCT00443404|lower limb amputation|lower limb amputation
5298165|NCT00443404|intensity of phantom limb pain|intensity of phantom limb pain
5298166|NCT00443404|preemptive analgesia reduces phantom pain|preemptive analgesia reduces phantom pain
5298167|NCT00443404|perioperative analgesia reduces phantom pain|perioperative analgesia reduces phantom pain
5298168|NCT00443404|Severe Phantom Limb Pain (VAS>70 mm)|severe phantom limb pain (vas>70 mm)
5298169|NCT00443404|resistant to medical treatment one week before amputation|resistant to medical treatment one week before amputation
5298170|NCT00443391|ADHD|adhd
5298171|NCT00443378|computer counseling|computer counseling
5298172|NCT00443378|HIV|hiv
5298173|NCT00443378|antiretroviral adherence|antiretroviral adherence
5298174|NCT00443378|sexual behavior|sexual behavior
5298175|NCT00443378|prevention with positives|prevention with positives
5298176|NCT00443378|HIV seronegativity|hiv seronegativity
5298177|NCT00443339|Myelodysplastic syndromes with IPSS Low or Int-1|myelodysplastic syndromes with ipss low or int-1
5298178|NCT00443339|Anemia|anemia
5298179|NCT00020475|adult solid tumor|adult solid tumor
5298180|NCT00020475|body system/site cancer|body system/site cancer
5298181|NCT00020475|cancer|cancer
5298182|NCT00020475|extraocular extension melanoma|extraocular extension melanoma
5298183|NCT00020475|eye cancer|eye cancer
5298184|NCT00020475|intraocular melanoma|intraocular melanoma
5298185|NCT00020475|recurrent intraocular melanoma|recurrent intraocular melanoma
5298186|NCT00020475|solid tumor|solid tumor
5298187|NCT00020475|stage, intraocular melanoma|stage, intraocular melanoma
5298188|NCT00020371|adult solid tumor|adult solid tumor
5298189|NCT00020371|bone marrow suppression|bone marrow suppression
5298190|NCT00020371|cancer|cancer
5298191|NCT00020371|cancer-related problem/condition|cancer-related problem/condition
5298192|NCT00020371|neutropenia|neutropenia
5298193|NCT00020371|solid tumor|solid tumor
5298194|NCT00020371|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5298195|NCT00020345|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
5298196|NCT00020345|adult solid tumor|adult solid tumor
5298197|NCT00020345|body system/site cancer|body system/site cancer
5298198|NCT00020345|cancer|cancer
5298199|NCT00020345|cellular diagnosis, pancreatic cancer|cellular diagnosis, pancreatic cancer
5298200|NCT00020345|gastrointestinal cancer|gastrointestinal cancer
5298201|NCT00020345|pancreatic cancer|pancreatic cancer
5298202|NCT00020345|solid tumor|solid tumor
5298203|NCT00020345|stage III pancreatic cancer|stage iii pancreatic cancer
5298204|NCT00020345|stage IV pancreatic cancer|stage iv pancreatic cancer
5298205|NCT00020345|stage IVA pancreatic cancer|stage iva pancreatic cancer
5298206|NCT00020345|stage, pancreatic cancer|stage, pancreatic cancer
5298207|NCT00020267|Ewing's family of tumors|ewing's family of tumors
5298208|NCT00020267|adult soft tissue sarcoma|adult soft tissue sarcoma
5298209|NCT00020267|adult solid tumor|adult solid tumor
5298210|NCT00020267|body system/site cancer|body system/site cancer
5298211|NCT00020267|bone cancer|bone cancer
5298212|NCT00020267|breast cancer|breast cancer
5298213|NCT00020267|cancer|cancer
5298214|NCT00020267|childhood cancer|childhood cancer
5298215|NCT00020267|childhood solid tumor|childhood solid tumor
5298216|NCT00020267|ciliary body and choroid melanoma, medium/large size|ciliary body and choroid melanoma, medium/large size
5298217|NCT00020267|colon cancer|colon cancer
5298218|NCT00020267|colorectal cancer|colorectal cancer
5298219|NCT00020267|extraocular extension melanoma|extraocular extension melanoma
5298220|NCT00020267|eye cancer|eye cancer
5298221|NCT00020267|female reproductive cancer|female reproductive cancer
5298222|NCT00020267|gastrointestinal cancer|gastrointestinal cancer
5298223|NCT00020267|genetic condition|genetic condition
5298224|NCT00020267|intraocular melanoma|intraocular melanoma
5298225|NCT00020267|lung cancer|lung cancer
5298226|NCT00020267|male breast cancer|male breast cancer
5298227|NCT00020267|melanoma|melanoma
5298228|NCT00020267|metastatic osteosarcoma|metastatic osteosarcoma
5298229|NCT00020267|metastatic tumors of the Ewing's family|metastatic tumors of the ewing's family
5298230|NCT00020267|muscle cancer|muscle cancer
5298231|NCT00020267|musculoskeletal cancer|musculoskeletal cancer
5298232|NCT00020267|non-small cell lung cancer|non-small cell lung cancer
5298233|NCT00020267|osteosarcoma|osteosarcoma
5298320|NCT00443170|pharmacokinetic,|pharmacokinetic,
5298234|NCT00020267|osteosarcoma/malignant fibrous histiocytoma of bone|osteosarcoma/malignant fibrous histiocytoma of bone
5298235|NCT00020267|ovarian sarcoma|ovarian sarcoma
5298236|NCT00020267|rectal cancer|rectal cancer
5298237|NCT00020267|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
5298238|NCT00020267|recurrent breast cancer|recurrent breast cancer
5298239|NCT00020267|recurrent colon cancer|recurrent colon cancer
5298240|NCT00020267|recurrent intraocular melanoma|recurrent intraocular melanoma
5298241|NCT00020267|recurrent melanoma|recurrent melanoma
5298242|NCT00020267|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5298243|NCT00020267|recurrent osteosarcoma|recurrent osteosarcoma
5298244|NCT00020267|recurrent rectal cancer|recurrent rectal cancer
5298245|NCT00020267|recurrent tumors of the Ewing's family|recurrent tumors of the ewing's family
5298246|NCT00020267|recurrent uterine sarcoma|recurrent uterine sarcoma
5298247|NCT00020267|skin tumor|skin tumor
5298248|NCT00020267|solid tumor|solid tumor
5298249|NCT00020267|stage IIIB, IV, recurrent, and metastatic breast cancer|stage iiib, iv, recurrent, and metastatic breast cancer
5298250|NCT00020267|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
5298251|NCT00020267|stage IV breast cancer|stage iv breast cancer
5298252|NCT00020267|stage IV colon cancer|stage iv colon cancer
5298253|NCT00020267|stage IV melanoma|stage iv melanoma
5298254|NCT00020267|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5298255|NCT00020267|stage IV rectal cancer|stage iv rectal cancer
5298256|NCT00020267|stage IV uterine sarcoma|stage iv uterine sarcoma
5298257|NCT00020267|stage IVA adult soft tissue sarcoma|stage iva adult soft tissue sarcoma
5298258|NCT00020267|stage IVB adult soft tissue sarcoma|stage ivb adult soft tissue sarcoma
5298259|NCT00020267|stage, Ewing's family of tumors|stage, ewing's family of tumors
5298260|NCT00020267|stage, adult soft tissue sarcoma|stage, adult soft tissue sarcoma
5298261|NCT00020267|stage, breast cancer|stage, breast cancer
5298262|NCT00020267|stage, colon cancer|stage, colon cancer
5298263|NCT00020267|stage, intraocular melanoma|stage, intraocular melanoma
5298264|NCT00020267|stage, melanoma|stage, melanoma
5298265|NCT00020267|stage, non-small cell lung cancer|stage, non-small cell lung cancer
5298266|NCT00020267|stage, osteosarcoma|stage, osteosarcoma
5298267|NCT00020267|stage, rectal cancer|stage, rectal cancer
5298268|NCT00020267|stage, uterine sarcoma|stage, uterine sarcoma
5298269|NCT00020267|thorax/respiratory cancer|thorax/respiratory cancer
5298270|NCT00020267|uterine sarcoma|uterine sarcoma
5298271|NCT00019643|adult solid tumor|adult solid tumor
5298272|NCT00019643|body system/site cancer|body system/site cancer
5298273|NCT00019643|breast cancer|breast cancer
5298274|NCT00019643|cancer|cancer
5298275|NCT00019643|cancer-related problem/condition|cancer-related problem/condition
5298276|NCT00019643|depression|depression
5298277|NCT00019643|depression and suicide|depression and suicide
5298278|NCT00019643|nutrition|nutrition
5298279|NCT00019643|psychosocial effects/treatment|psychosocial effects/treatment
5298280|NCT00019643|quality of life|quality of life
5298281|NCT00019643|solid tumor|solid tumor
5298282|NCT00019643|stage I breast cancer|stage i breast cancer
5298283|NCT00019643|stage I, II, and IIIA breast cancer|stage i, ii, and iiia breast cancer
5298284|NCT00019643|stage II breast cancer|stage ii breast cancer
5298285|NCT00019643|stage III breast cancer|stage iii breast cancer
5298286|NCT00019643|stage IIIA breast cancer|stage iiia breast cancer
5298287|NCT00019643|stage IIIB, IV, recurrent, and metastatic breast cancer|stage iiib, iv, recurrent, and metastatic breast cancer
5298288|NCT00019643|stage, breast cancer|stage, breast cancer
5298289|NCT00443326|Psoriasis|psoriasis
5298290|NCT00443326|PASI|pasi
5298291|NCT00443326|Skin Biopsy|skin biopsy
5298292|NCT00443326|Human Monoclonal Antibody|human monoclonal antibody
5298293|NCT00443313|Cervical neoplasia|cervical neoplasia
5298294|NCT00443313|Screening|screening
5298295|NCT00443313|HPV|hpv
5298296|NCT00443313|Cervical Cancer Screening|cervical cancer screening
5298297|NCT00443300|AML|aml
5298298|NCT00443300|MDS|mds
5298299|NCT00443300|Protected Environment|protected environment
5298300|NCT00443287|Peripheral|peripheral
5298301|NCT00443287|Artery|artery
5298302|NCT00443287|Disease|disease
5298303|NCT00443261|Head and Neck Cancer|head and neck cancer
5298304|NCT00443235|Older patients|older patients
5298305|NCT00443235|untreated patients|untreated patients
5298306|NCT00443222|infliximab|infliximab
5298307|NCT00443222|polymyositis|polymyositis
5298308|NCT00443222|dermatomyositis|dermatomyositis
5298309|NCT00443222|inclusion body myositis|inclusion body myositis
5298310|NCT00443196|Chemosensitivity|chemosensitivity
5298311|NCT00443196|Ovarian Cancer|ovarian cancer
5298312|NCT00443196|Chemotherapy|chemotherapy
5298313|NCT00443196|Fallopian Adenocarcinoma|fallopian adenocarcinoma
5298314|NCT00443196|Peritoneal Adenocarcinoma|peritoneal adenocarcinoma
5298315|NCT00443196|Patients with pathological diagnoses of ovarian, fallopian and primary peritoneal adenocarcinomas.|patients with pathological diagnoses of ovarian, fallopian and primary peritoneal adenocarcinomas.
5298316|NCT00443196|Patients with de novo malignancies and no previous chemotherapy|patients with de novo malignancies and no previous chemotherapy
5298317|NCT00443196|Patients with advanced refractory malignancies who received no more than 2 standard chemotherapy treatment protocols.|patients with advanced refractory malignancies who received no more than 2 standard chemotherapy treatment protocols.
5298318|NCT00443170|repeat dose,|repeat dose,
5298319|NCT00443170|GSK626616AC,|gsk626616ac,
5298321|NCT00443170|single dose,|single dose,
5298322|NCT00443170|cytochrome P450,|cytochrome p450,
5298323|NCT00443170|First time in human,|first time in human,
5298324|NCT00443170|healthy volunteers|healthy volunteers
5298325|NCT00443157|meningococcal B vaccine|meningococcal b vaccine
5298326|NCT00443144|growth hormone receptor polymorphism|growth hormone receptor polymorphism
5298327|NCT00443144|pharmacogenomics|pharmacogenomics
5298328|NCT00443144|growth promoting therapy|growth promoting therapy
5298329|NCT00443131|Adjuvant|adjuvant
5298330|NCT00443131|Malaria|malaria
5298331|NCT00443131|Safety|safety
5298332|NCT00443131|Immunogenicity|immunogenicity
5298333|NCT00443118|Bag and mask|bag and mask
5298334|NCT00443118|Neopuff|neopuff
5298335|NCT00443118|Resuscitation|resuscitation
5298336|NCT00443118|Newborn|newborn
5298337|NCT00443118|Intubation|intubation
5298338|NCT00443118|devices|devices
5298339|NCT00443118|PEEP|peep
5298340|NCT00443092|osteoarthritis|osteoarthritis
5298341|NCT00443092|gout|gout
5298342|NCT00443092|pain|pain
5298343|NCT00443092|uric acid|uric acid
5298344|NCT00443092|tart cherry|tart cherry
5298345|NCT00443092|alternative medicine|alternative medicine
5298346|NCT00443092|knees|knees
5298347|NCT00443079|Clinical Trials|clinical trials
5298348|NCT00443079|Pilot Projects|pilot projects
5298349|NCT00443079|Milk Thistle|milk thistle
5298350|NCT00443079|Liver Function Tests|liver function tests
5298351|NCT00443066|pediatric|pediatric
5298352|NCT00443066|neuromuscular disease|neuromuscular disease
5298353|NCT00443053|superficial vein thrombosis|superficial vein thrombosis
5298354|NCT00443053|superficial thrombophlebitis|superficial thrombophlebitis
5298355|NCT00443053|fondaparinux|fondaparinux
5298356|NCT00443053|deep vein thrombosis|deep vein thrombosis
5298357|NCT00443053|venous thromboembolism treatment|venous thromboembolism treatment
5298358|NCT00443053|thrombosis|thrombosis
5298359|NCT00443014|Stimulation therapy|stimulation therapy
5298360|NCT00443014|Acetylcholinesterase inhibitors|acetylcholinesterase inhibitors
5298361|NCT00443014|Synergetic|synergetic
5298362|NCT00443001|Non-Invasive Blood Pressure|non-invasive blood pressure
5298363|NCT00443001|Sinus Rhythm|sinus rhythm
5298364|NCT00443001|Oscillometric|oscillometric
5298365|NCT00443001|Invasive Blood Pressure|invasive blood pressure
5298366|NCT00443001|AAMI/ANSI SP10 Standard|aami/ansi sp10 standard
5298367|NCT00443001|Compliance with ANSI/AAMI SP10 2002 standard|compliance with ansi/aami sp10 2002 standard
5298368|NCT00442988|NODAT|nodat
5298369|NCT00442988|OGTT|ogtt
5298370|NCT00442988|FPG|fpg
5298371|NCT00442988|Renal Transplanation|renal transplanation
5298372|NCT00442988|Risk Factors|risk factors
5298373|NCT00442988|Predictive value|predictive value
5298374|NCT00442975|Influenza Vaccine|influenza vaccine
5298376|NCT00442949|Acute coronary syndrome|acute coronary syndrome
5298377|NCT00442949|Angioplasty|angioplasty
5298378|NCT00442949|Abciximab|abciximab
5298379|NCT00442949|Troponin release|troponin release
5298380|NCT00442923|Methamphetamine|methamphetamine
5298381|NCT00442923|Coreg|coreg
5298382|NCT00442923|Withdrawal|withdrawal
5298383|NCT00442923|anxiety|anxiety
5298384|NCT00442923|Substance Addiction|substance addiction
5298385|NCT00442910|Safety and Acceptability|safety and acceptability
5298386|NCT00442897|Hypercholesterolaemia|hypercholesterolaemia
5298387|NCT00442884|glucose control in acute stress|glucose control in acute stress
5298388|NCT00442871|Renal Impairment,|renal impairment,
5298389|NCT00442871|chronic immune thrombocytopenia purpura,|chronic immune thrombocytopenia purpura,
5298390|NCT00442871|thrombocytopenia,|thrombocytopenia,
5298391|NCT00442871|chemotherapy induced thrombocytopenia|chemotherapy induced thrombocytopenia
5298392|NCT00442858|cardiac disease|cardiac disease
5298393|NCT00442858|cerebrovascular disease|cerebrovascular disease
5298394|NCT00442858|GH deficiency|gh deficiency
5298395|NCT00442858|diabetes mellitus|diabetes mellitus
5298396|NCT00442858|hypertension|hypertension
5298397|NCT00442858|GH therapy|gh therapy
5298398|NCT00442858|GH deficiency and hypopituitarims|gh deficiency and hypopituitarims
5298399|NCT00020202|adult solid tumor|adult solid tumor
5298400|NCT00020202|body system/site cancer|body system/site cancer
5298401|NCT00020202|cancer|cancer
5298402|NCT00020202|extensive stage small cell lung cancer|extensive stage small cell lung cancer
5298403|NCT00020202|genetic condition|genetic condition
5298404|NCT00020202|lung cancer|lung cancer
5298405|NCT00020202|non-small cell lung cancer|non-small cell lung cancer
5298406|NCT00020202|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5298407|NCT00020202|recurrent small cell lung cancer|recurrent small cell lung cancer
5298408|NCT00020202|small cell lung cancer|small cell lung cancer
5298409|NCT00020202|solid tumor|solid tumor
5298410|NCT00020202|stage III non-small cell lung cancer|stage iii non-small cell lung cancer
5298411|NCT00020202|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5298412|NCT00020202|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5298413|NCT00020202|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5298414|NCT00020202|stage, non-small cell lung cancer|stage, non-small cell lung cancer
5298415|NCT00020202|stage, small cell lung cancer|stage, small cell lung cancer
5298416|NCT00020202|thorax/respiratory cancer|thorax/respiratory cancer
5298417|NCT00020046|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5298418|NCT00020046|adult solid tumor|adult solid tumor
5298419|NCT00020046|body system/site cancer|body system/site cancer
5298420|NCT00020046|cancer|cancer
5298421|NCT00020046|cellular diagnosis, prostate cancer|cellular diagnosis, prostate cancer
5298422|NCT00020046|genetic condition|genetic condition
5298423|NCT00020046|male reproductive cancer|male reproductive cancer
5298424|NCT00020046|prostate cancer|prostate cancer
5298425|NCT00020046|recurrent prostate cancer|recurrent prostate cancer
5298426|NCT00020046|solid tumor|solid tumor
5298427|NCT00020046|stage IV prostate cancer|stage iv prostate cancer
5298428|NCT00020046|stage, prostate cancer|stage, prostate cancer
5298429|NCT00019968|adult soft tissue sarcoma|adult soft tissue sarcoma
5298430|NCT00019968|adult solid tumor|adult solid tumor
5298431|NCT00019968|body system/site cancer|body system/site cancer
5298432|NCT00019968|cancer|cancer
5298433|NCT00019968|muscle cancer|muscle cancer
5298434|NCT00019968|musculoskeletal cancer|musculoskeletal cancer
5298435|NCT00019968|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
5298436|NCT00019968|solid tumor|solid tumor
5298437|NCT00019968|stage IA, IB, and IIA adult soft tissue sarcoma|stage ia, ib, and iia adult soft tissue sarcoma
5298438|NCT00019968|stage II adult soft tissue sarcoma|stage ii adult soft tissue sarcoma
5298439|NCT00019968|stage IIB adult soft tissue sarcoma|stage iib adult soft tissue sarcoma
5298440|NCT00019968|stage IIB, IIC, and III adult soft tissue sarcoma|stage iib, iic, and iii adult soft tissue sarcoma
5298441|NCT00019968|stage IIC adult soft tissue sarcoma|stage iic adult soft tissue sarcoma
5298442|NCT00019968|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
5298443|NCT00019968|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
5298444|NCT00019968|stage IVA adult soft tissue sarcoma|stage iva adult soft tissue sarcoma
5298445|NCT00019968|stage IVB adult soft tissue sarcoma|stage ivb adult soft tissue sarcoma
5298446|NCT00019968|stage, adult soft tissue sarcoma|stage, adult soft tissue sarcoma
5298447|NCT00019890|adult solid tumor|adult solid tumor
5298448|NCT00019890|body system/site cancer|body system/site cancer
5298449|NCT00019890|cancer|cancer
5298450|NCT00019890|melanoma|melanoma
5298451|NCT00019890|recurrent melanoma|recurrent melanoma
5298452|NCT00019890|skin tumor|skin tumor
5298453|NCT00019890|solid tumor|solid tumor
5298454|NCT00019890|stage III melanoma|stage iii melanoma
5298455|NCT00019890|stage IV melanoma|stage iv melanoma
5298456|NCT00019890|stage, melanoma|stage, melanoma
5298457|NCT00019760|adult solid tumor|adult solid tumor
5298458|NCT00019760|body system/site cancer|body system/site cancer
5298459|NCT00019760|cancer|cancer
5298460|NCT00019760|colon cancer|colon cancer
5298461|NCT00019760|colorectal cancer|colorectal cancer
5298462|NCT00019760|gastrointestinal cancer|gastrointestinal cancer
5298463|NCT00019760|genetic condition|genetic condition
5298464|NCT00019760|liver and intrahepatic biliary tract cancer|liver and intrahepatic biliary tract cancer
5298465|NCT00019760|liver metastases|liver metastases
5298466|NCT00019760|metastatic cancer|metastatic cancer
5298467|NCT00019760|rectal cancer|rectal cancer
5298468|NCT00019760|recurrent colon cancer|recurrent colon cancer
5298469|NCT00019760|recurrent rectal cancer|recurrent rectal cancer
5298470|NCT00019760|site, metastatic cancer|site, metastatic cancer
5298471|NCT00019760|solid tumor|solid tumor
5298472|NCT00019760|stage IV colon cancer|stage iv colon cancer
5298473|NCT00019760|stage IV rectal cancer|stage iv rectal cancer
5298474|NCT00019760|stage, colon cancer|stage, colon cancer
5298475|NCT00019760|stage, rectal cancer|stage, rectal cancer
5298476|NCT00019760|unclassified/other cancer|unclassified/other cancer
5298477|NCT00019695|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5298478|NCT00019695|adult solid tumor|adult solid tumor
5298479|NCT00019695|body system/site cancer|body system/site cancer
5298480|NCT00019695|bone metastases|bone metastases
5298481|NCT00019695|cancer|cancer
5298482|NCT00019695|cellular diagnosis, prostate cancer|cellular diagnosis, prostate cancer
5298483|NCT00019695|genetic condition|genetic condition
5298484|NCT00019695|male reproductive cancer|male reproductive cancer
5298485|NCT00019695|metastatic cancer|metastatic cancer
5298486|NCT00019695|prostate cancer|prostate cancer
5298487|NCT00019695|recurrent prostate cancer|recurrent prostate cancer
5298488|NCT00019695|site, metastatic cancer|site, metastatic cancer
5298489|NCT00019695|solid tumor|solid tumor
5298490|NCT00019695|stage IV prostate cancer|stage iv prostate cancer
5298491|NCT00019695|stage, prostate cancer|stage, prostate cancer
5298492|NCT00019695|unclassified/other cancer|unclassified/other cancer
5298493|NCT00019630|Ewing's family of tumors|ewing's family of tumors
5298494|NCT00019630|Wilms' tumor|wilms' tumor
5298495|NCT00019630|adult solid tumor|adult solid tumor
5298496|NCT00019630|body system/site cancer|body system/site cancer
5298497|NCT00019630|bone cancer|bone cancer
5298498|NCT00019630|brain tumor|brain tumor
5298499|NCT00019630|cancer|cancer
5298500|NCT00019630|central nervous system cancer|central nervous system cancer
5298501|NCT00019630|childhood brain stem glioma|childhood brain stem glioma
5298502|NCT00019630|childhood brain tumor|childhood brain tumor
5298503|NCT00019630|childhood cancer|childhood cancer
5298504|NCT00019630|childhood central nervous system germ cell tumor|childhood central nervous system germ cell tumor
5298505|NCT00019630|childhood cerebellar astrocytoma|childhood cerebellar astrocytoma
5298506|NCT00019630|childhood cerebral astrocytoma|childhood cerebral astrocytoma
5298507|NCT00019630|childhood choroid plexus tumor|childhood choroid plexus tumor
5298508|NCT00019630|childhood craniopharyngioma|childhood craniopharyngioma
5298509|NCT00019630|childhood ependymoma|childhood ependymoma
5298510|NCT00019630|childhood extracranial germ cell tumor|childhood extracranial germ cell tumor
5298511|NCT00019630|childhood extragonadal malignant germ cell tumor|childhood extragonadal malignant germ cell tumor
5298512|NCT00019630|childhood liver cancer|childhood liver cancer
5298513|NCT00019630|childhood malignant ovarian germ cell tumor|childhood malignant ovarian germ cell tumor
5298514|NCT00019630|childhood malignant testicular germ cell tumor|childhood malignant testicular germ cell tumor
5298515|NCT00019630|childhood mature and immature teratomas|childhood mature and immature teratomas
5298516|NCT00019630|childhood medulloblastoma|childhood medulloblastoma
5298517|NCT00019630|childhood meningioma|childhood meningioma
5298518|NCT00019630|childhood oligodendroglioma|childhood oligodendroglioma
5298519|NCT00019630|childhood rhabdomyosarcoma|childhood rhabdomyosarcoma
5298520|NCT00019630|childhood soft tissue sarcoma|childhood soft tissue sarcoma
5298521|NCT00019630|childhood solid tumor|childhood solid tumor
5298522|NCT00019630|childhood supratentorial primitive neuroectodermal and pineal tumors|childhood supratentorial primitive neuroectodermal and pineal tumors
5298523|NCT00019630|childhood visual pathway and hypothalamic glioma|childhood visual pathway and hypothalamic glioma
5298524|NCT00019630|endocrine cancer|endocrine cancer
5298525|NCT00019630|gastrointestinal cancer|gastrointestinal cancer
5298526|NCT00019630|genetic condition|genetic condition
5298527|NCT00019630|kidney tumor|kidney tumor
5298528|NCT00019630|kidney/urinary cancer|kidney/urinary cancer
5298529|NCT00019630|liver and intrahepatic biliary tract cancer|liver and intrahepatic biliary tract cancer
5298530|NCT00019630|muscle cancer|muscle cancer
5298531|NCT00019630|musculoskeletal cancer|musculoskeletal cancer
5298532|NCT00019630|neuroblastoma|neuroblastoma
5298533|NCT00019630|osteosarcoma|osteosarcoma
5298534|NCT00019630|osteosarcoma/malignant fibrous histiocytoma of bone|osteosarcoma/malignant fibrous histiocytoma of bone
5298535|NCT00019630|pediatric germ cell tumor|pediatric germ cell tumor
5298536|NCT00019630|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
5298537|NCT00019630|recurrent Wilms' tumor|recurrent wilms' tumor
5298538|NCT00019630|recurrent childhood brain stem glioma|recurrent childhood brain stem glioma
5298539|NCT00019630|recurrent childhood brain tumor|recurrent childhood brain tumor
5298540|NCT00019630|recurrent childhood cerebellar astrocytoma|recurrent childhood cerebellar astrocytoma
5298541|NCT00019630|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
5298542|NCT00019630|recurrent childhood ependymoma|recurrent childhood ependymoma
5298543|NCT00019630|recurrent childhood liver cancer|recurrent childhood liver cancer
5298544|NCT00019630|recurrent childhood malignant germ cell tumor|recurrent childhood malignant germ cell tumor
5298545|NCT00019630|recurrent childhood medulloblastoma|recurrent childhood medulloblastoma
5298546|NCT00019630|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
5298547|NCT00019630|recurrent childhood soft tissue sarcoma|recurrent childhood soft tissue sarcoma
5298548|NCT00019630|recurrent childhood supratentorial primitive neuroectodermal and pineal tumors|recurrent childhood supratentorial primitive neuroectodermal and pineal tumors
5298549|NCT00019630|recurrent childhood visual pathway and hypothalamic glioma|recurrent childhood visual pathway and hypothalamic glioma
5298550|NCT00019630|recurrent neuroblastoma|recurrent neuroblastoma
5298551|NCT00019630|recurrent osteosarcoma|recurrent osteosarcoma
5298552|NCT00019630|recurrent tumors of the Ewing's family|recurrent tumors of the ewing's family
5298553|NCT00019630|solid tumor|solid tumor
5298554|NCT00019630|stage, Ewing's family of tumors|stage, ewing's family of tumors
5298555|NCT00019630|stage, Wilms' tumor|stage, wilms' tumor
5298556|NCT00019630|stage, childhood extracranial germ cell tumor|stage, childhood extracranial germ cell tumor
5298557|NCT00019630|stage, childhood liver cancer|stage, childhood liver cancer
5298558|NCT00019630|stage, childhood medulloblastoma|stage, childhood medulloblastoma
5298559|NCT00019630|stage, childhood rhabdomyosarcoma|stage, childhood rhabdomyosarcoma
5298560|NCT00019630|stage, childhood soft tissue sarcoma|stage, childhood soft tissue sarcoma
5298561|NCT00019630|stage, neuroblastoma|stage, neuroblastoma
5298562|NCT00019630|stage, osteosarcoma|stage, osteosarcoma
5298563|NCT00019630|stage/type, childhood brain tumor|stage/type, childhood brain tumor
5298564|NCT00019630|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
5298565|NCT00019448|adult solid tumor|adult solid tumor
5298566|NCT00019448|body system/site cancer|body system/site cancer
5298567|NCT00019448|cancer|cancer
5298568|NCT00019448|melanoma|melanoma
5298569|NCT00019448|recurrent melanoma|recurrent melanoma
5298570|NCT00019448|skin tumor|skin tumor
5298571|NCT00019448|solid tumor|solid tumor
5298572|NCT00019448|stage IV melanoma|stage iv melanoma
5298573|NCT00019448|stage, melanoma|stage, melanoma
5298574|NCT00019396|adult solid tumor|adult solid tumor
5298575|NCT00019396|body system/site cancer|body system/site cancer
5298576|NCT00019396|cancer|cancer
5298577|NCT00019396|kidney tumor|kidney tumor
5298578|NCT00019396|kidney/urinary cancer|kidney/urinary cancer
5298579|NCT00019396|melanoma|melanoma
5298580|NCT00019396|recurrent melanoma|recurrent melanoma
5298581|NCT00019396|recurrent renal cell cancer|recurrent renal cell cancer
5298582|NCT00019396|renal cell cancer|renal cell cancer
5298583|NCT00019396|skin tumor|skin tumor
5298584|NCT00019396|solid tumor|solid tumor
5298585|NCT00019396|stage IV melanoma|stage iv melanoma
5298586|NCT00019396|stage IV renal cell cancer|stage iv renal cell cancer
5298587|NCT00019396|stage, melanoma|stage, melanoma
5298588|NCT00019396|stage, renal cell cancer|stage, renal cell cancer
5298589|NCT00019188|AIDS-related malignancies|aids-related malignancies
5298590|NCT00019188|Kaposi's sarcoma|kaposi's sarcoma
5298591|NCT00019188|adult solid tumor|adult solid tumor
5298592|NCT00019188|body system/site cancer|body system/site cancer
5298593|NCT00019188|cancer|cancer
5298594|NCT00019188|epidemic Kaposi's sarcoma|epidemic kaposi's sarcoma
5298595|NCT00019188|recurrent Kaposi's sarcoma|recurrent kaposi's sarcoma
5298596|NCT00019188|skin tumor|skin tumor
5298597|NCT00019188|solid tumor|solid tumor
5298598|NCT00019188|stage, Kaposi's sarcoma|stage, kaposi's sarcoma
5298599|NCT00019097|body system/site cancer|body system/site cancer
5298600|NCT00019097|cancer|cancer
5298601|NCT00019097|genetic condition|genetic condition
5298602|NCT00019097|hematopoietic/lymphoid cancer|hematopoietic/lymphoid cancer
5298603|NCT00019097|multiple myeloma|multiple myeloma
5298604|NCT00019097|multiple myeloma and other plasma cell neoplasms|multiple myeloma and other plasma cell neoplasms
5298605|NCT00019097|plasma cell neoplasm|plasma cell neoplasm
5298606|NCT00019097|refractory plasma cell neoplasm|refractory plasma cell neoplasm
5298607|NCT00019097|stage II multiple myeloma|stage ii multiple myeloma
5298608|NCT00019097|stage III multiple myeloma|stage iii multiple myeloma
5298609|NCT00019097|stage, plasma cell neoplasm|stage, plasma cell neoplasm
5298610|NCT00003552|adult solid tumor|adult solid tumor
5298611|NCT00003552|body system/site cancer|body system/site cancer
5298612|NCT00003552|cancer|cancer
5298613|NCT00003552|melanoma|melanoma
5298614|NCT00003552|recurrent melanoma|recurrent melanoma
5298615|NCT00003552|skin tumor|skin tumor
5298616|NCT00003552|solid tumor|solid tumor
5298617|NCT00003552|stage IV melanoma|stage iv melanoma
5298618|NCT00003552|stage, melanoma|stage, melanoma
5298619|NCT00442832|cSSSI|csssi
5298620|NCT00442832|Staph|staph
5298621|NCT00442832|MRSA|mrsa
5298622|NCT00442819|Uremic Pruritus|uremic pruritus
5298623|NCT00442819|Cytokines|cytokines
5298624|NCT00442819|Polymethylmethacrylate Artificial Kidney|polymethylmethacrylate artificial kidney
5298625|NCT00442819|Hemodialysis|hemodialysis
5298626|NCT00442806|ADRC|adrc
5298627|NCT00442806|Stem Cells|stem cells
5298628|NCT00442806|Myocardial Infarction|myocardial infarction
5298629|NCT00442806|STEMI|stemi
5298630|NCT00442806|Heart Disease|heart disease
5298631|NCT00442806|Coronary Artery Disease|coronary artery disease
5298632|NCT00442806|Coronary Disease|coronary disease
5298633|NCT00442806|ST-Elevation|st-elevation
5298635|NCT00442806|Interventional Cardiology|interventional cardiology
5298636|NCT00442806|Heart Attack|heart attack
5298637|NCT00442780|early Parkinson's Disease|early parkinson's disease
5298638|NCT00442780|MOBILE|mobile
5298639|NCT00442780|BIIB014|biib014
5298640|NCT00442767|pediatric|pediatric
5298641|NCT00442767|juvenile|juvenile
5298642|NCT00442767|diabetes mellitus|diabetes mellitus
5298643|NCT00442767|Pediatric type 1 diabetes mellitus|pediatric type 1 diabetes mellitus
5298644|NCT00442754|dendritic cell|dendritic cell
5298645|NCT00442754|tumor vaccine|tumor vaccine
5298646|NCT00442754|NSCLC|nsclc
5298647|NCT00442741|Cancer|cancer
5298648|NCT00442741|EPO906|epo906
5298649|NCT00442741|Patupilone|patupilone
5298650|NCT00442728|Functional electrical stimulation|functional electrical stimulation
5298651|NCT00442728|muscular atrophy|muscular atrophy
5298652|NCT00442728|intensive care|intensive care
5298653|NCT00442715|Exercise-induced asthma,|exercise-induced asthma,
5298654|NCT00442715|early childhood;|early childhood;
5298655|NCT00442715|spirometry,|spirometry,
5298656|NCT00442715|exercise challenge|exercise challenge
5298657|NCT00442715|Data from preschool children who were referred to the Pediatric|data from preschool children who were referred to the pediatric
5298658|NCT00442715|Pulmonary Clinic over a 1-year period were recruited|pulmonary clinic over a 1-year period were recruited
5298659|NCT00442689|Polycystic Ovary Syndrome|polycystic ovary syndrome
5298660|NCT00442689|Metabolic Syndrome|metabolic syndrome
5298661|NCT00442689|PCOS|pcos
5298662|NCT00442689|overweight|overweight
5298663|NCT00442689|infertility|infertility
5298664|NCT00442689|Insulin Resistance|insulin resistance
5298665|NCT00442689|menstrual cycle|menstrual cycle
5298666|NCT00442663|Labor Induction|labor induction
5298667|NCT00442663|Cervical Ripening|cervical ripening
5298668|NCT00442663|Foley Catheter|foley catheter
5298669|NCT00442637|CAIRO3|cairo3
5298670|NCT00442637|DCCG|dccg
5298671|NCT00442637|colorectal cancer|colorectal cancer
5298672|NCT00442637|induction|induction
5298673|NCT00442637|metronomic chemotherapy|metronomic chemotherapy
5298674|NCT00442637|observation|observation
5298675|NCT00442637|capecitabine|capecitabine
5298676|NCT00442637|bevacizumab|bevacizumab
5298677|NCT00442637|oxaliplatin|oxaliplatin
5298678|NCT00442624|insomnia|insomnia
5298679|NCT00442624|glucose metabolism|glucose metabolism
5298680|NCT00442624|insulin resistance|insulin resistance
5298681|NCT00442598|Ovarian|ovarian
5298682|NCT00442598|Cancer|cancer
5298683|NCT00442598|CA-125|ca-125
5298684|NCT00442598|Third-line|third-line
5298685|NCT00442598|Glufosfamide|glufosfamide
5298686|NCT00442546|opioid|opioid
5298687|NCT00442533|Carcinoid|carcinoid
5298688|NCT00442533|Islet Cell Cancer|islet cell cancer
5298689|NCT00442533|Paraganglioma|paraganglioma
5298690|NCT00442533|Pheochromocytoma|pheochromocytoma
5298691|NCT00442507|Esophagus|esophagus
5298692|NCT00442507|Esophagogastric Junction|esophagogastric junction
5298693|NCT00442507|Avastin|avastin
5298694|NCT00442507|Bevacizumab|bevacizumab
5298695|NCT00442507|Erlotinib|erlotinib
5298696|NCT00442494|Atrial fibrillation after cardiac surgery|atrial fibrillation after cardiac surgery
5298697|NCT00442481|MDD|mdd
5298698|NCT00442481|Escitalopram|escitalopram
5298699|NCT00442481|Cipralex|cipralex
5298700|NCT00442481|Sleep|sleep
5298701|NCT00442481|REM|rem
5298702|NCT00442481|SWS|sws
5298703|NCT00442481|Polysomnography|polysomnography
5298704|NCT00442468|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
5298705|NCT00442468|Chronic Bronchitis|chronic bronchitis
5298706|NCT00442468|Spirometry|spirometry
5298707|NCT00442455|Head Neck Carcinoma Erlotinib|head neck carcinoma erlotinib
5298708|NCT00442442|Malaria|malaria
5298709|NCT00442442|mosquito control|mosquito control
5298710|NCT00442442|mosquito coils|mosquito coils
5298711|NCT00442442|LLIN|llin
5298712|NCT00442429|depression; dialysis; kidney failure, chronic|depression; dialysis; kidney failure, chronic
5298713|NCT00019578|adult brain stem glioma|adult brain stem glioma
5298714|NCT00019578|adult brain tumor|adult brain tumor
5298715|NCT00019578|adult central nervous system germ cell tumor|adult central nervous system germ cell tumor
5298716|NCT00019578|adult craniopharyngioma|adult craniopharyngioma
5298717|NCT00019578|adult ependymoma|adult ependymoma
5298718|NCT00019578|adult infiltrating astrocytoma|adult infiltrating astrocytoma
5298719|NCT00019578|adult malignant meningioma|adult malignant meningioma
5298720|NCT00019578|adult medulloblastoma|adult medulloblastoma
5298721|NCT00019578|adult meningioma|adult meningioma
5298722|NCT00019578|adult noninfiltrating astrocytoma|adult noninfiltrating astrocytoma
5298723|NCT00019578|adult oligodendroglioma|adult oligodendroglioma
5298724|NCT00019578|adult pineal parenchymal tumor|adult pineal parenchymal tumor
5298725|NCT00019578|adult solid tumor|adult solid tumor
5298726|NCT00019578|body system/site cancer|body system/site cancer
5298727|NCT00019578|brain metastases|brain metastases
5298728|NCT00019578|brain tumor|brain tumor
5298729|NCT00019578|cancer|cancer
5298730|NCT00019578|central nervous system cancer|central nervous system cancer
5298731|NCT00019578|genetic condition|genetic condition
5298732|NCT00019578|metastatic cancer|metastatic cancer
5298733|NCT00019578|mixed gliomas|mixed gliomas
5298734|NCT00019578|site, metastatic cancer|site, metastatic cancer
5298735|NCT00019578|solid tumor|solid tumor
5298736|NCT00019578|stage IV peripheral primitive neuroectodermal tumor|stage iv peripheral primitive neuroectodermal tumor
5298737|NCT00019578|stage/type, adult brain tumor|stage/type, adult brain tumor
5298738|NCT00019578|unclassified/other cancer|unclassified/other cancer
5298739|NCT00019006|adult solid tumor|adult solid tumor
5298740|NCT00019006|body system/site cancer|body system/site cancer
5298741|NCT00019006|cancer|cancer
5298742|NCT00019006|colon cancer|colon cancer
5298743|NCT00019006|colorectal cancer|colorectal cancer
5298744|NCT00019006|extensive stage small cell lung cancer|extensive stage small cell lung cancer
5298745|NCT00019006|gastrointestinal cancer|gastrointestinal cancer
5298746|NCT00019006|genetic condition|genetic condition
5298747|NCT00019006|limited stage small cell lung cancer|limited stage small cell lung cancer
5298748|NCT00019006|lung cancer|lung cancer
5298749|NCT00019006|non-small cell lung cancer|non-small cell lung cancer
5298750|NCT00019006|pancreatic cancer|pancreatic cancer
5298751|NCT00019006|rectal cancer|rectal cancer
5298752|NCT00019006|recurrent colon cancer|recurrent colon cancer
5298753|NCT00019006|recurrent pancreatic cancer|recurrent pancreatic cancer
5298754|NCT00019006|recurrent rectal cancer|recurrent rectal cancer
5298755|NCT00019006|small cell lung cancer|small cell lung cancer
5298756|NCT00019006|solid tumor|solid tumor
5298757|NCT00019006|stage I pancreatic cancer|stage i pancreatic cancer
5298758|NCT00019006|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
5298759|NCT00019006|stage II pancreatic cancer|stage ii pancreatic cancer
5298760|NCT00019006|stage III colon cancer|stage iii colon cancer
5298761|NCT00019006|stage III non-small cell lung cancer|stage iii non-small cell lung cancer
5298762|NCT00019006|stage III pancreatic cancer|stage iii pancreatic cancer
5298763|NCT00019006|stage III rectal cancer|stage iii rectal cancer
5298764|NCT00019006|stage IV pancreatic cancer|stage iv pancreatic cancer
5298765|NCT00019006|stage IVA pancreatic cancer|stage iva pancreatic cancer
5298766|NCT00019006|stage IVB pancreatic cancer|stage ivb pancreatic cancer
5298767|NCT00019006|stage, colon cancer|stage, colon cancer
5298768|NCT00019006|stage, non-small cell lung cancer|stage, non-small cell lung cancer
5298769|NCT00019006|stage, pancreatic cancer|stage, pancreatic cancer
5298770|NCT00019006|stage, rectal cancer|stage, rectal cancer
5298771|NCT00019006|stage, small cell lung cancer|stage, small cell lung cancer
5298772|NCT00019006|thorax/respiratory cancer|thorax/respiratory cancer
5298773|NCT00442403|Malaria|malaria
5298774|NCT00442403|Plasmodium falciparum|plasmodium falciparum
5298775|NCT00442403|Chemotherapy|chemotherapy
5298776|NCT00442403|Chloroquine|chloroquine
5298777|NCT00442403|Dehydroepiandrosterone sulphate|dehydroepiandrosterone sulphate
5298778|NCT00442390|Cortisol|cortisol
5298779|NCT00442390|adrenal insufficiency|adrenal insufficiency
5298780|NCT00442390|glucose metabolism|glucose metabolism
5298781|NCT00442390|protein metabolism|protein metabolism
5298782|NCT00442390|lipid metabolism|lipid metabolism
5298783|NCT00442390|insulin sensitivity.|insulin sensitivity.
5298784|NCT00442377|Falciparum|falciparum
5298785|NCT00442377|Plasmodium|plasmodium
5298786|NCT00442377|Malaria|malaria
5298787|NCT00442364|PFO|pfo
5298788|NCT00442364|Patent Foramen Ovale|patent foramen ovale
5298789|NCT00442364|Right-to-Left Shunt|right-to-left shunt
5298790|NCT00442364|Sclerotherapy|sclerotherapy
5298791|NCT00442312|Combigan|combigan
5298792|NCT00442299|hemodialysis, urmeic retention solute, biocompatibility|hemodialysis, urmeic retention solute, biocompatibility
5298793|NCT00442286|Hypertension|hypertension
5298794|NCT00442286|High Blood Pressure|high blood pressure
5298795|NCT00442286|Blood Pressure|blood pressure
5298796|NCT00442286|Cardiovascular Disease|cardiovascular disease
5298797|NCT00442286|Resistant Hypertension|resistant hypertension
5298798|NCT00442286|Stage 2 Hypertension|stage 2 hypertension
5298799|NCT00442286|Hypertension that is resistant to treatment|hypertension that is resistant to treatment
5298800|NCT00442260|breast cancer|breast cancer
5298801|NCT00442260|advanced breast cancer|advanced breast cancer
5298802|NCT00442247|anterior vaginal wall prolapse, Pelvicol, biomesh|anterior vaginal wall prolapse, pelvicol, biomesh
5298803|NCT00442247|Anterior vaginal wall prolapse|anterior vaginal wall prolapse
5298804|NCT00442234|Acute|acute
5298805|NCT00442234|pulmonary|pulmonary
5298806|NCT00442234|embolism|embolism
5298807|NCT00442234|accompanying|accompanying
5298808|NCT00442234|hemodynamic|hemodynamic
5298809|NCT00442234|instability|instability
5298810|NCT00442221|Migrane headaches|migrane headaches
5298811|NCT00442208|Healthy adults|healthy adults
5298812|NCT00442208|Phase I|phase i
5298813|NCT00442195|Tissue Procurement|tissue procurement
5298814|NCT00442195|Sample Collection|sample collection
5298815|NCT00442195|Biologic Samples|biologic samples
5298816|NCT00442195|Laboratory Research|laboratory research
5298817|NCT00442195|Healthy Volunteer|healthy volunteer
5298818|NCT00442195|HV|hv
5298819|NCT00442182|autoinflammatory syndromes|autoinflammatory syndromes
5298820|NCT00442169|West Nile Disease|west nile disease
5298821|NCT00442169|Antibody response|antibody response
5298822|NCT00442169|Viremia|viremia
5298823|NCT00442169|Safety|safety
5298824|NCT00442169|Tolerability|tolerability
5298825|NCT00442169|Prevention|prevention
5298826|NCT00442156|Laser photocoagulation|laser photocoagulation
5298827|NCT00442143|CLI|cli
5298828|NCT00442143|PAOD|paod
5298829|NCT00442143|Severe lower limb ischemia|severe lower limb ischemia
5298830|NCT00442130|GM-CSF|gm-csf
5298831|NCT00442130|GM-K562|gm-k562
5298832|NCT00442130|vaccine|vaccine
5298833|NCT00442104|infantile spasms|infantile spasms
5298834|NCT00442104|anticonvulsant|anticonvulsant
5298835|NCT00442104|pediatric epilepsy|pediatric epilepsy
5298836|NCT00442104|West Syndrome|west syndrome
5298837|NCT00442104|epileptic spasms|epileptic spasms
5298838|NCT00442091|Dandelion|dandelion
5298839|NCT00442091|herbal remedy|herbal remedy
5298840|NCT00442091|hand eczema|hand eczema
5298841|NCT00442091|Compositae|compositae
5298842|NCT00442078|Incontinence|incontinence
5298843|NCT00442078|Urinary|urinary
5298844|NCT00442078|Male|male
5298845|NCT00442078|Tape|tape
5298846|NCT00442078|Transobturator|transobturator
5298847|NCT00442065|Abdominal aortic aneurysm study|abdominal aortic aneurysm study
5298848|NCT00442052|Gastroprotective effects|gastroprotective effects
5298849|NCT00442052|Aspirin|aspirin
5298850|NCT00442039|Mania, Lithium, Bipolar, BPCA, pediatrics|mania, lithium, bipolar, bpca, pediatrics
5298851|NCT00442026|Cancer|cancer
5298852|NCT00442026|NSCLC|nsclc
5298853|NCT00442026|Elderly|elderly
5298854|NCT00442026|Chemotherapy|chemotherapy
5298855|NCT00442026|Docetaxel|docetaxel
5298856|NCT00442026|Gemcitabine|gemcitabine
5298857|NCT00442000|Prostate Cancer|prostate cancer
5298858|NCT00442000|Prostatectomy|prostatectomy
5298859|NCT00441987|Japanese|japanese
5298860|NCT00441987|Healthy|healthy
5298861|NCT00441987|Alzheimers Disease|alzheimers disease
5298862|NCT00441974|adefovir dipivoxil|adefovir dipivoxil
5298863|NCT00441974|compensated|compensated
5298864|NCT00441974|chronic hepatitis B|chronic hepatitis b
5298865|NCT00441974|Chinese|chinese
5298866|NCT00441961|Eosinophilic fasciitis, Shulman's syndrome, methotrexate|eosinophilic fasciitis, shulman's syndrome, methotrexate
5298867|NCT00441948|Hirsutism|hirsutism
5298868|NCT00441948|Hypertrichosis|hypertrichosis
5298869|NCT00441935|Urinary Retention|urinary retention
5298870|NCT00441935|Urinary Incontinence|urinary incontinence
5298871|NCT00441935|Pelvic Pain|pelvic pain
5298872|NCT00441922|Cancer|cancer
5298873|NCT00441922|Elderly|elderly
5298874|NCT00441922|Chemotherapy|chemotherapy
5298875|NCT00441922|Docetaxel|docetaxel
5298876|NCT00441922|Vinorelbine|vinorelbine
5298877|NCT00441909|Anti-Infective Agents, Local|anti-infective agents, local
5298878|NCT00441909|Healthy Women|healthy women
5298879|NCT00441909|Microbicides|microbicides
5298880|NCT00441909|UC-781|uc-781
5298881|NCT00441909|Vaginal Gel|vaginal gel
5298882|NCT00441909|HIV Seronegativity|hiv seronegativity
5298883|NCT00441896|infantile spasms|infantile spasms
5298884|NCT00441896|anticonvulsant|anticonvulsant
5298885|NCT00441896|pediatric epilepsy|pediatric epilepsy
5298886|NCT00441896|West Syndrome|west syndrome
5298887|NCT00441896|epileptic spasms|epileptic spasms
5298888|NCT00441870|Cancer|cancer
5298889|NCT00441870|Phase 1|phase 1
5298890|NCT00441870|EC0225|ec0225
5298891|NCT00441870|EC20|ec20
5298892|NCT00441870|Refractory|refractory
5298893|NCT00441870|Metastatic|metastatic
5298894|NCT00441870|Experimental|experimental
5298895|NCT00441857|plant sterols|plant sterols
5298896|NCT00441857|plant stanols|plant stanols
5298897|NCT00441857|cholesterol absorption|cholesterol absorption
5298898|NCT00441844|diabetes, statin, monocyte, crp, inflammation|diabetes, statin, monocyte, crp, inflammation
5298899|NCT00441831|Helicobacter pylori infection|helicobacter pylori infection
5298900|NCT00441831|peptic ulcer disease|peptic ulcer disease
5298901|NCT00441831|distal partial gastrectomy|distal partial gastrectomy
5298902|NCT00441831|bile reflux|bile reflux
5298903|NCT00441831|gastritis|gastritis
5298904|NCT00441831|gastrectomy|gastrectomy
5298905|NCT00441805|Acne|acne
5298906|NCT00441805|RadioFrequency|radiofrequency
5298907|NCT00441792|Sepsis|sepsis
5298908|NCT00441792|Etomidate|etomidate
5298909|NCT00441792|midazolam|midazolam
5298910|NCT00441792|ketamine|ketamine
5298911|NCT00441779|Microchimerism|microchimerism
5298912|NCT00441779|Injuries|injuries
5298913|NCT00441779|Burns|burns
5298914|NCT00441779|Orthopedic Surgery|orthopedic surgery
5298915|NCT00441779|Leukocytes|leukocytes
5298916|NCT00441740|NSCLC|nsclc
5298917|NCT00441740|1st line treatment|1st line treatment
5298918|NCT00441740|Gemcitabine|gemcitabine
5298919|NCT00441740|Vinorelbine|vinorelbine
5298920|NCT00441740|Docetaxel|docetaxel
5298921|NCT00441727|Peptic ulcer|peptic ulcer
5298922|NCT00441727|low-dose ASA|low-dose asa
5298923|NCT00441714|cardiovascular disease|cardiovascular disease
5298924|NCT00441714|ischemia-reperfusion injury|ischemia-reperfusion injury
5298925|NCT00441714|postconditioning|postconditioning
5298926|NCT00441714|annexin targeting|annexin targeting
5298927|NCT00441688|Human Immunodeficiency virus|human immunodeficiency virus
5298928|NCT00441688|HLAgenetics polymorphism|hlagenetics polymorphism
5298929|NCT00441675|Adolescents|adolescents
5298930|NCT00441675|Asthma|asthma
5298931|NCT00441675|long-term follow-up|long-term follow-up
5298932|NCT00441675|symptoms|symptoms
5298933|NCT00441675|bronchial hyperresponsiveness|bronchial hyperresponsiveness
5298934|NCT00441662|Melanoma|melanoma
5298935|NCT00441662|Uvea|uvea
5298936|NCT00441662|Macula|macula
5298937|NCT00441662|Edema|edema
5298938|NCT00441662|Plaque radiotherapy|plaque radiotherapy
5298939|NCT00441662|Brachytherapy|brachytherapy
5298940|NCT00441662|Triamcinolone|triamcinolone
5298941|NCT00441649|ADHD|adhd
5298942|NCT00441636|depression|depression
5298943|NCT00441636|CPAP|cpap
5298944|NCT00441636|obstructive sleep apnea|obstructive sleep apnea
5298945|NCT00441623|chronic kidney disease|chronic kidney disease
5298946|NCT00441623|cardiovascular disease|cardiovascular disease
5298947|NCT00441623|risk stratification|risk stratification
5298948|NCT00441610|Gimatecan|gimatecan
5298949|NCT00441610|topoisomerase I inhibitor|topoisomerase i inhibitor
5298950|NCT00441610|advanced solid tumors|advanced solid tumors
5298951|NCT00441597|ischemia reperfusion injury|ischemia reperfusion injury
5298952|NCT00441597|atorvastatine|atorvastatine
5298953|NCT00441597|preconditioning|preconditioning
5298954|NCT00441597|cardiovascular disease|cardiovascular disease
5298955|NCT00441571|prostate cancer|prostate cancer
5298956|NCT00441571|radiolabeled antibody|radiolabeled antibody
5298957|NCT00441532|prostate|prostate
5298958|NCT00441519|Gastroprotective effects|gastroprotective effects
5298959|NCT00441519|Aspirin|aspirin
5298960|NCT00441506|interruption|interruption
5298961|NCT00441506|critically ill|critically ill
5298962|NCT00441506|sedation|sedation
5298963|NCT00441506|pediatrics|pediatrics
5298964|NCT00441506|critically ill, ventilated children|critically ill, ventilated children
5298965|NCT00441493|Hepatitis C|hepatitis c
5298966|NCT00441493|fluvastatin|fluvastatin
5298967|NCT00441480|Hypercholesterolemia|hypercholesterolemia
5298968|NCT00441480|Hypertriglyceridemia|hypertriglyceridemia
5298969|NCT00441480|Plant sterol|plant sterol
5298970|NCT00441480|Cholesterol|cholesterol
5298971|NCT00441480|Fish oil|fish oil
5298972|NCT00441454|stress urinary incontinence|stress urinary incontinence
5298973|NCT00441454|surgery|surgery
5298974|NCT00441454|tension-free vaginal tape|tension-free vaginal tape
5298975|NCT00441454|retropubic|retropubic
5298976|NCT00441454|transobturator|transobturator
5298977|NCT00441454|quality-of-life|quality-of-life
5298978|NCT00441441|asthma|asthma
5298979|NCT00441441|fluticasone propionate|fluticasone propionate
5298980|NCT00441441|children|children
5298981|NCT00441441|fluticasone propionate/salmeterol|fluticasone propionate/salmeterol
5298982|NCT00441389|Bacteria|bacteria
5298983|NCT00441389|Viruses|viruses
5298984|NCT00441389|COPD|copd
5298985|NCT00441389|infectious etiology for acute exacerbation of COPD|infectious etiology for acute exacerbation of copd
5298986|NCT00441376|Radiofrequency ablation|radiofrequency ablation
5298987|NCT00441376|RFA|rfa
5298988|NCT00441376|Doxorubicin|doxorubicin
5298989|NCT00441376|Liposome|liposome
5298990|NCT00441376|HCC|hcc
5298991|NCT00441376|MLC|mlc
5298992|NCT00441376|hepatocellular carcinoma|hepatocellular carcinoma
5298993|NCT00441376|liver tumor|liver tumor
5298994|NCT00441376|tumor|tumor
5298995|NCT00441376|ablation|ablation
5298996|NCT00441376|heat therapy|heat therapy
5298997|NCT00441376|anti-tumor|anti-tumor
5298998|NCT00441376|liver cancer|liver cancer
5298999|NCT00441376|metastatic liver cancer (MLC)|metastatic liver cancer (mlc)
5299000|NCT00441363|diabetes|diabetes
5299001|NCT00441363|diabetes mellitus|diabetes mellitus
5299002|NCT00441337|malignancies|malignancies
5299003|NCT00441337|cancer|cancer
5299004|NCT00441337|non small cell lung cancer|non small cell lung cancer
5299005|NCT00441337|lung cancer|lung cancer
5299006|NCT00441337|colorectal cancer|colorectal cancer
5299007|NCT00441337|adenocarcinoma|adenocarcinoma
5299008|NCT00441337|melanoma|melanoma
5299009|NCT00441337|malignant melanoma|malignant melanoma
5299010|NCT00441337|renal cancer|renal cancer
5299011|NCT00441337|renal carcinoma|renal carcinoma
5299012|NCT00441337|carcinoma|carcinoma
5299013|NCT00441337|prostate cancer|prostate cancer
5299014|NCT00441337|prostate adenocarcinoma|prostate adenocarcinoma
5299015|NCT00441337|Recurrent or treatment refractory malignancies|recurrent or treatment refractory malignancies
5299016|NCT00441324|Ovarian follicle|ovarian follicle
5299017|NCT00441324|Thecal cells|thecal cells
5299018|NCT00441324|Androgens|androgens
5299019|NCT00441324|FSH sensitivity|fsh sensitivity
5299020|NCT00441311|colorectal cancer screening|colorectal cancer screening
5299021|NCT00441311|primary care physicians|primary care physicians
5299022|NCT00441311|health disparities|health disparities
5299023|NCT00441311|stratified randomized clinical trial|stratified randomized clinical trial
5299024|NCT00441298|microbicides|microbicides
5299025|NCT00441298|safety|safety
5299026|NCT00441298|effectiveness|effectiveness
5299027|NCT00441298|Tenofovir gel|tenofovir gel
5299028|NCT00441298|HIV|hiv
5299029|NCT00441298|young women|young women
5299030|NCT00441298|HIV Seronegativity|hiv seronegativity
5299031|NCT00441285|neurocysticercosis|neurocysticercosis
5299032|NCT00441285|NCC|ncc
5299033|NCT00441285|praziquantel|praziquantel
5299034|NCT00441285|PZQ|pzq
5299035|NCT00441285|albendazole|albendazole
5299036|NCT00441285|ABZ|abz
5299037|NCT00441285|parasite|parasite
5299038|NCT00441285|pig tapeworm|pig tapeworm
5299039|NCT00441285|Taenia solium|taenia solium
5299040|NCT00441285|epilepsy|epilepsy
5299041|NCT00441285|late-onset epilepsy|late-onset epilepsy
5299042|NCT00441285|acquired epilepsy|acquired epilepsy
5299043|NCT00441272|Pioglitazone|pioglitazone
5299044|NCT00441272|Hepatic Steatosis|hepatic steatosis
5299045|NCT00441272|Liver Toxicity|liver toxicity
5299046|NCT00441272|Liver Biopsy|liver biopsy
5299047|NCT00441272|HIV|hiv
5299048|NCT00441272|Treatment Experienced|treatment experienced
5299049|NCT00441272|Treatment Naive|treatment naive
5299050|NCT00441259|Japanese Encephalitis|japanese encephalitis
5299051|NCT00441246|Acute Respiratory Infection|acute respiratory infection
5299052|NCT00441246|Bronchitis|bronchitis
5299053|NCT00441246|Rhinosinusitis|rhinosinusitis
5299054|NCT00441220|Genetic polymorphisms|genetic polymorphisms
5299055|NCT00441220|Cyclophosphamide|cyclophosphamide
5299056|NCT00441220|Cytochrome p450 CYP2C19 (Human)|cytochrome p450 cyp2c19 (human)
5299057|NCT00441220|Systemic Lupus Erythematosus|systemic lupus erythematosus
5299058|NCT00441207|IV Ascorbic Acid|iv ascorbic acid
5299059|NCT00441207|IV Vitamin C|iv vitamin c
5299060|NCT00441207|Cancer|cancer
5299061|NCT00441207|Advanced Solid Tumors|advanced solid tumors
5299062|NCT00441194|Perimetry|perimetry
5299063|NCT00441194|Visual Field|visual field
5299064|NCT00441194|Octopus|octopus
5299065|NCT00441181|Neovascular glaucoma|neovascular glaucoma
5299066|NCT00441181|Travoprost|travoprost
5299067|NCT00441168|Multiple Myeloma|multiple myeloma
5299068|NCT00441168|bortezomib|bortezomib
5299069|NCT00441168|Cancer|cancer
5299070|NCT00441168|Hematology|hematology
5299071|NCT00441168|bone marrow|bone marrow
5299072|NCT00441168|immunoglobulin|immunoglobulin
5299073|NCT00441168|relapse|relapse
5299074|NCT00441168|refractory|refractory
5299075|NCT00441168|plasma cell|plasma cell
5299076|NCT00441168|Velcade|velcade
5299077|NCT00441168|adriamycin|adriamycin
5299078|NCT00441168|dexamethasone|dexamethasone
5299079|NCT00441168|vincristine|vincristine
5299080|NCT00441155|Oncology|oncology
5299081|NCT00441155|Cancer|cancer
5299082|NCT00441155|Imatinib-Resistant Gastrointestinal Stromal Tumors|imatinib-resistant gastrointestinal stromal tumors
5299083|NCT00441155|GIST|gist
5299084|NCT00441155|Nilotinib|nilotinib
5299085|NCT00441155|Imatinib-Resistant Gastrointestinal Stromal Tumors (GIST)|imatinib-resistant gastrointestinal stromal tumors (gist)
5299086|NCT00441142|Newly diagnosed malignant brain tumors.|newly diagnosed malignant brain tumors.
5299087|NCT00441129|Improvement of the blood glucose control|improvement of the blood glucose control
5299088|NCT00441116|dutasteride|dutasteride
5299089|NCT00441116|Androgenic alopecia|androgenic alopecia
5299090|NCT00441116|phase 3|phase 3
5299091|NCT00441103|Subjects with relapsing remitting multiple sclerosis|subjects with relapsing remitting multiple sclerosis
5299092|NCT00441090|Chronic Idiopathic Thrombocytopenic Purpura|chronic idiopathic thrombocytopenic purpura
5299093|NCT00441090|Idiopathic Thrombocytopenic Purpura|idiopathic thrombocytopenic purpura
5299094|NCT00441090|ITP|itp
5299095|NCT00441077|Genetics|genetics
5299096|NCT00441077|Family History|family history
5299097|NCT00441077|Latino|latino
5299098|NCT00441077|Information Seeking|information seeking
5299099|NCT00441077|Lay Health Advisors|lay health advisors
5299100|NCT00441077|Cancer|cancer
5299101|NCT00441077|Heart Disease|heart disease
5299102|NCT00441077|Diabetes|diabetes
5299103|NCT00441077|Information|information
5299104|NCT00441064|High blood pressure, hypertension, aliskiren, low sodium diet|high blood pressure, hypertension, aliskiren, low sodium diet
5299105|NCT00441051|Sunburn, diclofenac, topical NSAID|sunburn, diclofenac, topical nsaid
5299106|NCT00441038|Low back pain|low back pain
5299107|NCT00441038|disability|disability
5299108|NCT00441038|health education|health education
5299109|NCT00441025|MabCampath + CHOP in PTCL|mabcampath + chop in ptcl
5299110|NCT00441012|Haemophilus Influenza, type b and Hepatitis B|haemophilus influenza, type b and hepatitis b
5299111|NCT00440999|P vivax|p vivax
5299112|NCT00440999|malaria|malaria
5299113|NCT00440999|ACT|act
5299114|NCT00440986|Clinical Management|clinical management
5299115|NCT00440986|Phlebotomy|phlebotomy
5299116|NCT00440986|Eritrocytoapheresis|eritrocytoapheresis
5299117|NCT00440973|kidney cancer|kidney cancer
5299118|NCT00440973|M3thodist|m3thodist
5299119|NCT00440960|alfentanil|alfentanil
5299120|NCT00440960|anesthesia|anesthesia
5299121|NCT00440960|bronchoscopy|bronchoscopy
5299122|NCT00440960|lidocaine|lidocaine
5299123|NCT00440960|midazolam|midazolam
5299124|NCT00440960|propofol.|propofol.
5299125|NCT00440947|NORVIR|norvir
5299126|NCT00440947|ARIES|aries
5299127|NCT00440947|EPZICOM|epzicom
5299128|NCT00440947|REYATAZ|reyataz
5299129|NCT00440947|HIV|hiv
5299130|NCT00440947|simplification|simplification
5299131|NCT00440947|Antiretroviral-naive|antiretroviral-naive
5299132|NCT00440934|carcinoma, hepatocellular|carcinoma, hepatocellular
5299133|NCT00440934|electromagnetic fields|electromagnetic fields
5299134|NCT00440921|fibrin sealnat|fibrin sealnat
5299135|NCT00440921|knee replacement|knee replacement
5299136|NCT00440921|hip replacement|hip replacement
5299137|NCT00440921|woud healing|woud healing
5299138|NCT00440921|blood loss|blood loss
5299139|NCT00440921|clinical trial|clinical trial
5299140|NCT00440921|randomized|randomized
5299141|NCT00440908|Dialyzer reuse|dialyzer reuse
5299142|NCT00440908|Inflammatory markers|inflammatory markers
5299143|NCT00440908|Nutritional status|nutritional status
5299144|NCT00440895|Coronary artery stenting|coronary artery stenting
5299145|NCT00440895|Trans-radial|trans-radial
5299146|NCT00440895|Intracoronary|intracoronary
5299147|NCT00440895|Rescue-PCI|rescue-pci
5299148|NCT00440869|N-acetylcysteine|n-acetylcysteine
5299149|NCT00440869|oxidative stress|oxidative stress
5299150|NCT00440869|muscle fatigue|muscle fatigue
5299151|NCT00440869|end-stage renal disease|end-stage renal disease
5299152|NCT00440869|hemodialysis|hemodialysis
5299153|NCT00440856|Intervertebral disc|intervertebral disc
5299154|NCT00440856|Lumbar discectomy|lumbar discectomy
5299155|NCT00440856|Outcome|outcome
5299156|NCT00440856|Radiculopathy due to prolapsed intervertebral disc.|radiculopathy due to prolapsed intervertebral disc.
5299157|NCT00440843|schizophrenia|schizophrenia
5299158|NCT00440843|attention|attention
5299159|NCT00440843|task engagement|task engagement
5299160|NCT00440843|antipsychotics|antipsychotics
5299161|NCT00440843|cognition|cognition
5299162|NCT00440843|cognitive rehabilitation|cognitive rehabilitation
5299163|NCT00440830|acute pain|acute pain
5299164|NCT00440830|nicotine|nicotine
5299165|NCT00440830|nausea|nausea
5299166|NCT00440830|sedation|sedation
5299167|NCT00440817|Lymphoma|lymphoma
5299168|NCT00440817|Rheumatoid arthritis|rheumatoid arthritis
5299169|NCT00440817|Crohn's disease|crohn's disease
5299170|NCT00440817|Remicade|remicade
5299171|NCT00440817|Infliximab|infliximab
5299172|NCT00440804|patent ductus arterious|patent ductus arterious
5299173|NCT00440791|Colon|colon
5299174|NCT00440791|colonic disease|colonic disease
5299175|NCT00440791|capsule endoscopy|capsule endoscopy
5299176|NCT00440791|Suspected or known colonic disease|suspected or known colonic disease
5299177|NCT00440778|Coronary artery stenting|coronary artery stenting
5299178|NCT00440778|Trans-radial|trans-radial
5299179|NCT00440778|Intracoronary|intracoronary
5299180|NCT00440765|Multiple Myeloma|multiple myeloma
5299181|NCT00440765|hematological Neoplasms|hematological neoplasms
5299182|NCT00440765|chemotherapy|chemotherapy
5299183|NCT00440765|efficacy|efficacy
5299184|NCT00440765|safety|safety
5299185|NCT00440765|bortezomib|bortezomib
5299186|NCT00440765|proteasome inhibitor|proteasome inhibitor
5299187|NCT00440752|Artemether-lumefantrine|artemether-lumefantrine
5299188|NCT00440752|Plasmodium falciparum|plasmodium falciparum
5299189|NCT00440752|drug resistance genes|drug resistance genes
5299190|NCT00440739|postoperative pain, etoticoxib, etoricoxib|postoperative pain, etoticoxib, etoricoxib
5299191|NCT00440739|Pain relief after transurethral resection of prostate.|pain relief after transurethral resection of prostate.
5299192|NCT00440726|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
5299193|NCT00440726|Pediatrics|pediatrics
5299194|NCT00440726|Relapsed|relapsed
5299195|NCT00440726|Recurrence|recurrence
5299196|NCT00440726|Bortezomib|bortezomib
5299197|NCT00440726|Velcade|velcade
5299198|NCT00440726|Therapeutic Advances in Childhood Leukemia|therapeutic advances in childhood leukemia
5299199|NCT00440726|Investigational|investigational
5299200|NCT00440726|Childhood|childhood
5299201|NCT00440726|ALL|all
5299202|NCT00440726|Relapsed ALL|relapsed all
5299203|NCT00440726|Refractory ALL|refractory all
5299204|NCT00440726|Relapsed pediatric ALL|relapsed pediatric all
5299205|NCT00440726|Refractory pediatric ALL|refractory pediatric all
5299206|NCT00440726|TACL|tacl
5299207|NCT00440726|Recurrent Pediatric ALL|recurrent pediatric all
5299208|NCT00440713|Posttraumatic Stress Disorder|posttraumatic stress disorder
5299209|NCT00440713|Depression|depression
5299210|NCT00440713|Anxiety|anxiety
5299211|NCT00440713|Efficacy|efficacy
5299212|NCT00440700|Ventilator|ventilator
5299213|NCT00440700|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
5299214|NCT00440700|Anxiety|anxiety
5299215|NCT00440687|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
5299216|NCT00440687|primary care|primary care
5299217|NCT00440687|randomised trials|randomised trials
5299218|NCT00440687|therapeutic interventions|therapeutic interventions
5299219|NCT00440674|Direct Stenting|direct stenting
5299220|NCT00440674|Angioplasty|angioplasty
5299221|NCT00440674|Pre-dilatation|pre-dilatation
5299222|NCT00440674|Drug-eluting stent|drug-eluting stent
5299223|NCT00440661|Osteoarthritis, IL-1|osteoarthritis, il-1
5299224|NCT00440635|Multiple myeloma|multiple myeloma
5299225|NCT00440635|bortezomib, Hematology|bortezomib, hematology
5299226|NCT00440622|Cancer|cancer
5299227|NCT00440622|Metastatic Breast cancer|metastatic breast cancer
5299228|NCT00440622|Her-2 expression|her-2 expression
5299229|NCT00440622|Gemcitabine|gemcitabine
5299230|NCT00440622|Capecitabine|capecitabine
5299231|NCT00440622|Herceptin|herceptin
5299232|NCT00440583|CHOP-Z|chop-z
5299233|NCT00440570|cancer|cancer
5299234|NCT00440570|electromagnetic fields|electromagnetic fields
5299235|NCT00440570|treatment|treatment
5299236|NCT00440557|Anemia|anemia
5299237|NCT00440557|Chronic Kidney disease|chronic kidney disease
5299238|NCT00440557|Kidney disease|kidney disease
5299239|NCT00440557|Epoetin alfa|epoetin alfa
5299240|NCT00440557|Procrit|procrit
5299241|NCT00440544|Tuberculosis|tuberculosis
5299242|NCT00440544|vaccine|vaccine
5299243|NCT00440544|nasal immunization|nasal immunization
5299244|NCT00440518|Lacosamide|lacosamide
5299245|NCT00440518|migraine prophylaxis|migraine prophylaxis
5299246|NCT00440518|Vimpat|vimpat
5299247|NCT00440505|chronic pain|chronic pain
5299248|NCT00440505|pelvic pain|pelvic pain
5299249|NCT00440505|nicotine patch|nicotine patch
5299250|NCT00440479|Multiple Myeloma|multiple myeloma
5299251|NCT00440479|hematological neoplasms|hematological neoplasms
5299252|NCT00440479|chemotherapy|chemotherapy
5299253|NCT00440479|efficacy|efficacy
5299254|NCT00440479|safety|safety
5299255|NCT00440479|bortezomib|bortezomib
5299256|NCT00440479|proteasome inhibitor|proteasome inhibitor
5299257|NCT00440466|Anemia|anemia
5299258|NCT00440466|Reduction in the number of erythrocytes|reduction in the number of erythrocytes
5299259|NCT00440466|Hemoglobin low level|hemoglobin low level
5299260|NCT00440466|Red blood cell deficiency|red blood cell deficiency
5299261|NCT00440466|Procrit|procrit
5299262|NCT00440466|Epoetin alfa|epoetin alfa
5299263|NCT00440466|Chronic kidney disease|chronic kidney disease
5299264|NCT00440453|Internal medicine patients|internal medicine patients
5299265|NCT00440440|hypogonadism|hypogonadism
5299266|NCT00440440|diabetes|diabetes
5299267|NCT00440440|visceral fat|visceral fat
5299268|NCT00440440|hepatic fat|hepatic fat
5299269|NCT00440440|lean mass|lean mass
5299270|NCT00440427|Major Depressive Disorder|major depressive disorder
5299271|NCT00440427|MDD|mdd
5299272|NCT00440414|Cancer|cancer
5299273|NCT00440414|Non-small-cell lung cancer|non-small-cell lung cancer
5299274|NCT00440414|Chemotherapy|chemotherapy
5299275|NCT00440414|Pemetrexed|pemetrexed
5299276|NCT00440414|Erlotinib|erlotinib
5299277|NCT00440401|Surgical treatment of haemorrhage|surgical treatment of haemorrhage
5299278|NCT00440388|cancer|cancer
5299279|NCT00440388|lymphoma|lymphoma
5299280|NCT00440388|Non-Hodgkin's|non-hodgkin's
5299281|NCT00440388|Non-Hodgkins|non-hodgkins
5299282|NCT00440388|AT-101|at-101
5299283|NCT00440388|AT101|at101
5299284|NCT00440388|Rituxan|rituxan
5299285|NCT00440388|Rituximab|rituximab
5299286|NCT00440362|Influenza|influenza
5299287|NCT00440362|Flu|flu
5299288|NCT00440362|A/Wyoming/03/2003|a/wyoming/03/2003
5299289|NCT00440362|Alphavirus|alphavirus
5299290|NCT00440349|Retroperitoneal fibrosis|retroperitoneal fibrosis
5299291|NCT00440349|Tamoxifen|tamoxifen
5299292|NCT00440349|Corticosteroids|corticosteroids
5299293|NCT00440349|Obstructive uropathy|obstructive uropathy
5299294|NCT00440349|Periaortic fibrosis|periaortic fibrosis
5299295|NCT00440349|Chronic periaortitis|chronic periaortitis
5299296|NCT00440336|IOP|iop
5299297|NCT00440336|SLT|slt
5299298|NCT00440336|Laser|laser
5299299|NCT00440336|Cosopt|cosopt
5299300|NCT00440323|Noise induced Situational insomnia,|noise induced situational insomnia,
5299301|NCT00440323|healthy volunteers|healthy volunteers
5299302|NCT00440323|SB-649868,|sb-649868,
5299303|NCT00440323|Zolpidem,|zolpidem,
5299304|NCT00440310|Liver neoplasms|liver neoplasms
5299305|NCT00440310|Liver metastases|liver metastases
5299306|NCT00440310|MCRC|mcrc
5299307|NCT00440310|Litx™|litx™
5299308|NCT00440310|LS11|ls11
5299309|NCT00440310|Colorectal cancer with recurrent liver metastases|colorectal cancer with recurrent liver metastases
5299310|NCT00440297|hepatitis B virus|hepatitis b virus
5299311|NCT00440284|conventional insulin therapy|conventional insulin therapy
5299312|NCT00440284|intensive insulin therapy|intensive insulin therapy
5299313|NCT00440284|self-management|self-management
5299314|NCT00440284|patient education|patient education
5299315|NCT00440284|RCT|rct
5299316|NCT00440284|glycosylated hemoglobin|glycosylated hemoglobin
5299317|NCT00440284|hypoglycemia|hypoglycemia
5299318|NCT00440284|patient preference|patient preference
5299319|NCT00440258|Ovarian hyperstimulation syndrome, dopamine agonists, cabergoline, hemoconcentration, ascites, ovarian perfusion, dopamine receptor 2|ovarian hyperstimulation syndrome, dopamine agonists, cabergoline, hemoconcentration, ascites, ovarian perfusion, dopamine receptor 2
5299320|NCT00440219|Nasal polyps|nasal polyps
5299321|NCT00440219|Steroids|steroids
5299322|NCT00440219|Prednisone|prednisone
5299323|NCT00440219|Nasal polypectomy|nasal polypectomy
5299324|NCT00440219|Blood loss, surgical|blood loss, surgical
5299325|NCT00440206|HIV|hiv
5299326|NCT00440206|Immune Markers|immune markers
5299327|NCT00440180|Obesity|obesity
5299328|NCT00440180|Low sperm count|low sperm count
5299329|NCT00440180|Male infertility|male infertility
5299330|NCT00440167|capecitabine|capecitabine
5299331|NCT00440167|gemcitabine|gemcitabine
5299332|NCT00440167|Erlotinib|erlotinib
5299333|NCT00440167|pancreatic cancer|pancreatic cancer
5299334|NCT00440167|advanced|advanced
5299335|NCT00440128|Casopitant,|casopitant,
5299336|NCT00440128|Neurokinin-1 Receptor Antagonist,|neurokinin-1 receptor antagonist,
5299337|NCT00440128|Drug-Interaction,|drug-interaction,
5299338|NCT00440128|CYP3A|cyp3a
5299339|NCT00440128|NK-1 Receptor Antagonist,|nk-1 receptor antagonist,
5299340|NCT00440128|GW679769,|gw679769,
5299341|NCT00440128|Docetaxel,|docetaxel,
5299342|NCT00440102|ETOMIDATE|etomidate
5299343|NCT00440102|KETAMINE|ketamine
5299344|NCT00440102|RAPID SEQUENCE INTUBATION|rapid sequence intubation
5299345|NCT00440102|PREHOSPITAL|prehospital
5299346|NCT00440102|During rapid sequence intubation|during rapid sequence intubation
5299347|NCT00440089|Cancer|cancer
5299348|NCT00440089|Fatigue|fatigue
5299349|NCT00440089|Breast Cancer|breast cancer
5299350|NCT00440089|Healing|healing
5299351|NCT00440089|Energy Healing|energy healing
5299352|NCT00440089|Complementary|complementary
5299353|NCT00440089|Alternative|alternative
5299354|NCT00440089|Immune|immune
5299355|NCT00440089|Cytokine|cytokine
5299356|NCT00440089|Hormone|hormone
5299357|NCT00440089|Cortisol|cortisol
5299358|NCT00440089|Placebo|placebo
5299359|NCT00440089|Mock Healing|mock healing
5299360|NCT00440076|MDS|mds
5299361|NCT00440076|Velcade|velcade
5299362|NCT00440050|fish oil|fish oil
5299363|NCT00440050|omega-3 fatty acids|omega-3 fatty acids
5299364|NCT00440050|EPA|epa
5299365|NCT00440037|AMG 531|amg 531
5299366|NCT00440037|ITP|itp
5299367|NCT00440037|Long term treatment|long term treatment
5299368|NCT00440037|Japanese|japanese
5299369|NCT00440037|Romiplostim|romiplostim
5299370|NCT00440024|Sun-Damaged Skin|sun-damaged skin
5299371|NCT00440024|Retinoid Intolerance|retinoid intolerance
5299372|NCT00440024|Tazarotene Cream|tazarotene cream
5299373|NCT00440024|Dove facial cleanser|dove facial cleanser
5299374|NCT00440024|Dove moisturizer|dove moisturizer
5299375|NCT00439998|Ultrasound|ultrasound
5299376|NCT00439998|Obesity|obesity
5299377|NCT00439998|Needle Depth|needle depth
5299378|NCT00439985|Type 1 Diabetes Mellitus (T1DM)|type 1 diabetes mellitus (t1dm)
5299379|NCT00439985|Metabolic Control|metabolic control
5299380|NCT00439985|Adherence|adherence
5299381|NCT00439985|Optimism|optimism
5299382|NCT00439985|Parent-Child Collaboration|parent-child collaboration
5299383|NCT00439985|Prevention|prevention
5299384|NCT00439972|Lipoproteins|lipoproteins
5299385|NCT00439972|Apolipoproteins|apolipoproteins
5299386|NCT00439972|Insulin sensitivity|insulin sensitivity
5299387|NCT00439972|Inflammation|inflammation
5299388|NCT00439972|Clotting|clotting
5299389|NCT00439972|Antioxidant status|antioxidant status
5299390|NCT00439972|Vascular reactivity|vascular reactivity
5299391|NCT00439972|Metabolism|metabolism
5299392|NCT00439959|GSK625433,|gsk625433,
5299393|NCT00439959|Hepatitis C,|hepatitis c,
5299394|NCT00439959|metabolic probe,|metabolic probe,
5299395|NCT00439959|food-effect,|food-effect,
5299396|NCT00439959|HCV,|hcv,
5299397|NCT00439959|FTIH|ftih
5299398|NCT00439959|polymerase,|polymerase,
5299399|NCT00439946|pulmonary hypertension|pulmonary hypertension
5299400|NCT00439946|PAH|pah
5299401|NCT00439946|Remodulin|remodulin
5299402|NCT00439946|treprostinil|treprostinil
5299403|NCT00439946|Quality of Life|quality of life
5299404|NCT00439946|rapid switch|rapid switch
5299405|NCT00439933|Obesity|obesity
5299406|NCT00439933|Children|children
5299407|NCT00439933|Weight loss|weight loss
5299408|NCT00439933|Endothelial dysfunction|endothelial dysfunction
5299409|NCT00439933|Intervention|intervention
5299410|NCT00439920|ALL|all
5299411|NCT00439907|Anal sphincter Delivery|anal sphincter delivery
5299412|NCT00439907|Primary repair|primary repair
5299413|NCT00439907|End-to-end repair|end-to-end repair
5299414|NCT00439907|Over-lap repair|over-lap repair
5299415|NCT00439907|Anal manometry|anal manometry
5299416|NCT00439907|Anal sonography|anal sonography
5299417|NCT00439907|Weksner Score|weksner score
5299418|NCT00439907|Rupture of the external anal sphincter during delivery|rupture of the external anal sphincter during delivery
5299419|NCT00439907|Anal sphincter|anal sphincter
5299420|NCT00439907|Anal sphincter rupture|anal sphincter rupture
5299421|NCT00439894|Rheumatoid Arthritis|rheumatoid arthritis
5299422|NCT00439894|etanercept|etanercept
5299423|NCT00439894|Enbrel|enbrel
5299424|NCT00439894|Amgen|amgen
5299425|NCT00439881|inflammation,|inflammation,
5299426|NCT00439881|intravenous,|intravenous,
5299427|NCT00439881|Chronic Obstructive Pulmonary Disease,|chronic obstructive pulmonary disease,
5299428|NCT00439881|P38 inhibitor|p38 inhibitor
5299429|NCT00439881|SB-681323,|sb-681323,
5299430|NCT00439881|rheumatoid arthritis,|rheumatoid arthritis,
5299431|NCT00439868|WELLBUTRIN XL, intraocular pressure, healthy volunteers|wellbutrin xl, intraocular pressure, healthy volunteers
5299432|NCT00439855|Enoxaparin, heparin, hemorrhages|enoxaparin, heparin, hemorrhages
5299433|NCT00439829|follicle|follicle
5299434|NCT00439829|ovary|ovary
5299435|NCT00439829|poor responder|poor responder
5299436|NCT00439829|stimulation|stimulation
5299437|NCT00439829|follicle wave emergence|follicle wave emergence
5299438|NCT00439816|Hypertension Outcomes|hypertension outcomes
5299439|NCT00439816|Health Outcomes|health outcomes
5299440|NCT00439816|Outpatient|outpatient
5299441|NCT00439816|Racial Preference|racial preference
5299442|NCT00439816|Blood Pressure Control|blood pressure control
5299443|NCT00439816|Clinical Trial|clinical trial
5299444|NCT00439816|Intervention|intervention
5299445|NCT00439816|Lifestyle modifications|lifestyle modifications
5299446|NCT00439816|Ethnic Differences|ethnic differences
5299447|NCT00439816|Randomized|randomized
5299448|NCT00439803|CMV|cmv
5299449|NCT00439803|cytomegalovirus|cytomegalovirus
5299450|NCT00439803|Alphavirus|alphavirus
5299451|NCT00439790|implantable cardioverter defibrillator|implantable cardioverter defibrillator
5299452|NCT00439790|Heart failure|heart failure
5299453|NCT00439790|Sudden Cardiac Arrest|sudden cardiac arrest
5299454|NCT00439790|appropriate shock|appropriate shock
5299455|NCT00439790|Defibrillators, Implantable|defibrillators, implantable
5299456|NCT00439764|Low back pain, health education, physical therapy|low back pain, health education, physical therapy
5299457|NCT00439751|Prostate Cancer|prostate cancer
5299458|NCT00439751|Androgen Deprivation Therapy|androgen deprivation therapy
5299459|NCT00439751|Recurrence|recurrence
5299460|NCT00439751|Biochemical Failure|biochemical failure
5299461|NCT00439751|Goserelin|goserelin
5299462|NCT00439738|Obesity, hypertension, valsartan/hydrochlorothiazide|obesity, hypertension, valsartan/hydrochlorothiazide
5299463|NCT00439699|Essential Tremor|essential tremor
5299464|NCT00439699|Memantine|memantine
5299465|NCT00439699|Clinical Trial|clinical trial
5299466|NCT00439673|MDS|mds
5299467|NCT00439673|5-Azacytidine|5-azacytidine
5299468|NCT00439673|valproic acid|valproic acid
5299469|NCT00439673|atra|atra
5299470|NCT00439673|intermediate or high risk|intermediate or high risk
5299471|NCT00439673|Age ≥18 yearsAge|age ≥18 yearsage
5299472|NCT00439660|Rotavirus, diarrhea, vaccine|rotavirus, diarrhea, vaccine
5299473|NCT00439647|Osteoporosis|osteoporosis
5299474|NCT00439647|males|males
5299475|NCT00439647|vertebral fractures|vertebral fractures
5299476|NCT00439647|clinical fractures|clinical fractures
5299477|NCT00439647|bone mineral density|bone mineral density
5299478|NCT00439647|bone biomarkers|bone biomarkers
5299479|NCT00439647|zoledronic acid|zoledronic acid
5299480|NCT00439634|psychometrics|psychometrics
5299481|NCT00439634|schizophrenia|schizophrenia
5299482|NCT00439621|immunotherapy|immunotherapy
5299483|NCT00439621|allergy|allergy
5299484|NCT00439608|esophageal cancer|esophageal cancer
5299485|NCT00439608|gastroesophageal cancer|gastroesophageal cancer
5299486|NCT00439608|gastric cancer|gastric cancer
5299487|NCT00439595|Anaemia|anaemia
5299488|NCT00439595|Diagnosis|diagnosis
5299489|NCT00439595|Primary|primary
5299490|NCT00439595|Care|care
5299491|NCT00439595|Treatment|treatment
5299492|NCT00439582|Lipoproteins|lipoproteins
5299493|NCT00439582|Milk fat|milk fat
5299494|NCT00439582|Public health nutrition|public health nutrition
5299495|NCT00439582|trans fatty acid|trans fatty acid
5299496|NCT00439569|spinal muscular atrophy type II/III|spinal muscular atrophy type ii/iii
5299497|NCT00439569|SMA type II/III|sma type ii/iii
5299498|NCT00439569|spinal muscular atrophy|spinal muscular atrophy
5299499|NCT00439569|SMA|sma
5299500|NCT00439569|sodium phenylbutyrate|sodium phenylbutyrate
5299501|NCT00439569|motor neuron disease|motor neuron disease
5299502|NCT00439569|neuromuscular|neuromuscular
5299503|NCT00439569|survival motor neuron|survival motor neuron
5299504|NCT00439569|SMN|smn
5299505|NCT00439569|dose escalation|dose escalation
5299506|NCT00439556|Lymphoma|lymphoma
5299507|NCT00439556|Bortezomib|bortezomib
5299508|NCT00439556|Velcade|velcade
5299509|NCT00439556|LDP-341|ldp-341
5299510|NCT00439556|MLN341|mln341
5299511|NCT00439556|PS-341|ps-341
5299512|NCT00439556|Carmustine|carmustine
5299513|NCT00439556|Cytarabine|cytarabine
5299514|NCT00439556|Etoposide|etoposide
5299515|NCT00439556|Melphalan|melphalan
5299516|NCT00439556|Rituximab|rituximab
5299517|NCT00439556|BEAM|beam
5299518|NCT00439556|BCNU|bcnu
5299519|NCT00439556|BiCNU®|bicnu®
5299520|NCT00439556|ARA-C|ara-c
5299521|NCT00439556|Cytosar|cytosar
5299522|NCT00439556|DepoCyt®|depocyt®
5299523|NCT00439556|Cytosine arabinosine hydrochloride|cytosine arabinosine hydrochloride
5299524|NCT00439556|VePesid®|vepesid®
5299525|NCT00439556|Rituxan|rituxan
5299526|NCT00439543|Pulmonary fibrosis|pulmonary fibrosis
5299527|NCT00439543|pulmonary hypertension|pulmonary hypertension
5299528|NCT00439543|Iloprost|iloprost
5299529|NCT00439543|Efficacy|efficacy
5299530|NCT00439530|oseltamivir|oseltamivir
5299531|NCT00439530|pharmacokinetics|pharmacokinetics
5299532|NCT00439530|probenecid|probenecid
5299533|NCT00439530|avian influenza|avian influenza
5299534|NCT00439517|Cancer|cancer
5299535|NCT00439517|Colorectal|colorectal
5299536|NCT00439517|Metastatic|metastatic
5299537|NCT00439517|Untreated|untreated
5299538|NCT00439491|Obesity|obesity
5299539|NCT00439491|Insulin resistance|insulin resistance
5299540|NCT00439491|Hypocaloric diet|hypocaloric diet
5299541|NCT00439491|Adipose tissue|adipose tissue
5299542|NCT00439491|adipocytokine|adipocytokine
5299543|NCT00439478|Radioiodine, Thyroid Cancer, Sialadenitis, Xerostomia|radioiodine, thyroid cancer, sialadenitis, xerostomia
5299544|NCT00439387|Serotonin|serotonin
5299545|NCT00439387|Epilepsy|epilepsy
5299546|NCT00439387|Healthy Volunteer|healthy volunteer
5299547|NCT00439387|HV|hv
5299548|NCT00439374|nulliparous|nulliparous
5299549|NCT00439374|pregnancy|pregnancy
5299550|NCT00439374|short cervix|short cervix
5299551|NCT00439374|progesterone|progesterone
5299552|NCT00439361|Hodgkin Lymphoma|hodgkin lymphoma
5299553|NCT00439361|HL|hl
5299554|NCT00439361|Relapsed Classical Hodgkin Lymphoma|relapsed classical hodgkin lymphoma
5299555|NCT00439361|Refractory|refractory
5299556|NCT00439361|Lymphoma|lymphoma
5299557|NCT00439361|Nodular sclerosis|nodular sclerosis
5299558|NCT00439361|Mixed cellularity|mixed cellularity
5299559|NCT00439361|Lymphocyte-rich classical HL|lymphocyte-rich classical hl
5299560|NCT00439361|Bortezomib|bortezomib
5299561|NCT00439361|Velcade|velcade
5299562|NCT00439361|LDP-341|ldp-341
5299563|NCT00439361|MLN341|mln341
5299564|NCT00439361|PS-341|ps-341
5299565|NCT00439361|Carboplatin|carboplatin
5299566|NCT00439361|Paraplatin|paraplatin
5299567|NCT00439361|Etoposide|etoposide
5299568|NCT00439361|VePesid®|vepesid®
5299569|NCT00439361|Ifosfamide|ifosfamide
5299570|NCT00439361|Mesna|mesna
5299571|NCT00439361|Mesnex|mesnex
5299572|NCT00439361|ICE|ice
5299573|NCT00439348|Calcium|calcium
5299574|NCT00439348|Compliance|compliance
5299575|NCT00439348|Medication compliance|medication compliance
5299576|NCT00439348|electronic prescription|electronic prescription
5299577|NCT00439348|over-the-counter medications|over-the-counter medications
5299578|NCT00439348|OTC medications|otc medications
5299579|NCT00439335|Influenza, vaccine, A/H5N1|influenza, vaccine, a/h5n1
5299580|NCT00439322|PTSD|ptsd
5299581|NCT00439296|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
5299582|NCT00439296|Pediatrics|pediatrics
5299583|NCT00439296|Relapsed|relapsed
5299584|NCT00439296|Recurrence|recurrence
5299585|NCT00439296|ABT-751|abt-751
5299586|NCT00439296|Therapeutic Advances in Childhood Leukemia|therapeutic advances in childhood leukemia
5299587|NCT00439296|Investigational|investigational
5299588|NCT00439296|Childhood|childhood
5299589|NCT00439296|ALL|all
5299590|NCT00439296|Relapsed ALL|relapsed all
5299591|NCT00439296|Refractory ALL|refractory all
5299592|NCT00439296|Relapsed pediatric ALL|relapsed pediatric all
5299593|NCT00439296|Refractory pediatric ALL|refractory pediatric all
5299594|NCT00439296|TACL|tacl
5299595|NCT00439283|Ankylosing spondylitis|ankylosing spondylitis
5299596|NCT00439283|infliximab|infliximab
5299597|NCT00439283|Systematic regimen|systematic regimen
5299598|NCT00439283|On-demand regimen|on-demand regimen
5299599|NCT00439270|Metastatic hormone refractory prostate cancer|metastatic hormone refractory prostate cancer
5299600|NCT00439244|Bone Mineral Density (BMD)|bone mineral density (bmd)
5299601|NCT00439244|C-Telopeptides (CTx)|c-telopeptides (ctx)
5299602|NCT00439244|dual x-ray absorptiometry (DXA)|dual x-ray absorptiometry (dxa)
5299603|NCT00439244|pro-collagen type 1 N-propeptide (P1NP)|pro-collagen type 1 n-propeptide (p1np)
5299604|NCT00439244|teriparatide|teriparatide
5299605|NCT00439244|zoledronic acid|zoledronic acid
5299606|NCT00439244|Osteoporosis|osteoporosis
5299607|NCT00439244|postmenopausal women|postmenopausal women
5299608|NCT00439231|Monoclonal Antibody Therapy|monoclonal antibody therapy
5299609|NCT00439231|Biologic Response Modifier Therapy|biologic response modifier therapy
5299610|NCT00439231|CLL|cll
5299611|NCT00439231|SLL|sll
5299612|NCT00439231|chemo-care (CC) 5013- Revlimid|chemo-care (cc) 5013- revlimid
5299613|NCT00439231|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
5299614|NCT00439231|Small Lymphocytic Leukemia|small lymphocytic leukemia
5299615|NCT00439218|spinal muscular atrophy type I|spinal muscular atrophy type i
5299616|NCT00439218|SMA type I|sma type i
5299617|NCT00439218|spinal muscular atrophy|spinal muscular atrophy
5299618|NCT00439218|SMA|sma
5299619|NCT00439218|sodium phenylbutyrate|sodium phenylbutyrate
5299620|NCT00439218|motor neuron disease|motor neuron disease
5299621|NCT00439218|neuromuscular|neuromuscular
5299622|NCT00439218|survival motor neuron|survival motor neuron
5299623|NCT00439218|SMN|smn
5299624|NCT00439218|dose escalation|dose escalation
5299625|NCT00439205|Oral Tumors|oral tumors
5299626|NCT00439205|Oral Margin Spectroscopy|oral margin spectroscopy
5299627|NCT00439205|Oral Spectroscopy|oral spectroscopy
5299628|NCT00439205|Optical Spectroscopy|optical spectroscopy
5299629|NCT00439205|Oral neoplastic lesions|oral neoplastic lesions
5299630|NCT00439205|FastEEM4 System|fasteem4 system
5299631|NCT00439205|Multispectral Digital Microscope|multispectral digital microscope
5299632|NCT00439205|MDM|mdm
5299633|NCT00439205|Nonstandard imaging technology|nonstandard imaging technology
5299634|NCT00439192|OAB, proof of concept|oab, proof of concept
5299635|NCT00439192|Overactive Bladder (OAB)|overactive bladder (oab)
5299636|NCT00439192|with incontinence|with incontinence
5299637|NCT00439179|Pancreatic Cancer|pancreatic cancer
5299638|NCT00439166|doxycycline|doxycycline
5299639|NCT00439166|rifampicin|rifampicin
5299640|NCT00439166|cerebrospinal fluid|cerebrospinal fluid
5299641|NCT00439166|biomarkers|biomarkers
5299642|NCT00439166|beta amyloid|beta amyloid
5299643|NCT00439166|tau|tau
5299644|NCT00439127|thyroglobulin|thyroglobulin
5299645|NCT00439127|thyroid carcinoma|thyroid carcinoma
5299646|NCT00439127|tumour marker|tumour marker
5299647|NCT00439127|radioiodine|radioiodine
5299648|NCT00439127|recombinant human TSH|recombinant human tsh
5299649|NCT00439114|Corneal topography, corneal opacity, keratitis, trachoma|corneal topography, corneal opacity, keratitis, trachoma
5299650|NCT00439101|weight loss|weight loss
5299651|NCT00439101|malignancy|malignancy
5299652|NCT00439101|corticosteroids|corticosteroids
5299653|NCT00439101|supplemental feeding|supplemental feeding
5299654|NCT00439101|adrenal insufficiency|adrenal insufficiency
5299655|NCT00439101|diabetes|diabetes
5299656|NCT00439088|Ambulation|ambulation
5299657|NCT00439088|Ambulatory Monitoring|ambulatory monitoring
5299658|NCT00439088|Activities of Daily Living|activities of daily living
5299659|NCT00439088|Pedometer|pedometer
5299660|NCT00439088|Validation Studies [PT]|validation studies [pt]
5299661|NCT00439075|pulmonary disease|pulmonary disease
5299662|NCT00439075|CPO|cpo
5299663|NCT00439075|CPAP|cpap
5299664|NCT00439075|oxygenation|oxygenation
5299665|NCT00439075|out-of-hospital intervention|out-of-hospital intervention
5299666|NCT00439062|Roxithromycin,Rheumatoid arthritis,Macrolides|roxithromycin,rheumatoid arthritis,macrolides
5299667|NCT00439049|Substance Abuse|substance abuse
5299668|NCT00439049|Treatment|treatment
5299669|NCT00439049|Eligibility|eligibility
5299670|NCT00439036|Opiate|opiate
5299671|NCT00439036|Behavior Therapy|behavior therapy
5299672|NCT00439036|Methadone|methadone
5299673|NCT00439036|Acceptance and Commitment Therapy (ACT)|acceptance and commitment therapy (act)
5299674|NCT00439023|Chronic renal failure, dialysis, hemodialysis,|chronic renal failure, dialysis, hemodialysis,
5299675|NCT00439010|neurological|neurological
5299676|NCT00439010|alzheimer|alzheimer
5299677|NCT00438971|Panic Disorder|panic disorder
5299678|NCT00438971|Anxiety Disorder|anxiety disorder
5299679|NCT00438971|Duloxetine|duloxetine
5299680|NCT00438958|graft versus host disease|graft versus host disease
5299681|NCT00438958|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5299682|NCT00438958|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5299683|NCT00438958|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5299684|NCT00438958|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5299685|NCT00438958|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5299686|NCT00438958|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5299687|NCT00438958|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5299688|NCT00438958|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5299689|NCT00438958|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
5299690|NCT00438958|refractory anemia with excess blasts|refractory anemia with excess blasts
5299691|NCT00438958|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
5299692|NCT00438958|refractory anemia|refractory anemia
5300155|NCT00437242|odiparcil,|odiparcil,
5299693|NCT00438958|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5299694|NCT00438958|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5299695|NCT00438958|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5299696|NCT00438958|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5299697|NCT00438958|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5299698|NCT00438958|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5299699|NCT00438958|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5299700|NCT00438958|primary myelofibrosis|primary myelofibrosis
5299701|NCT00438958|secondary myelofibrosis|secondary myelofibrosis
5299702|NCT00438958|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5299703|NCT00438958|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5299704|NCT00438958|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5299705|NCT00438958|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5299706|NCT00438958|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5299707|NCT00438958|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5299708|NCT00438958|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5299709|NCT00438958|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5299710|NCT00438958|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5299711|NCT00438958|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5299712|NCT00438958|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5299713|NCT00438958|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5299714|NCT00438958|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5299715|NCT00438958|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5299716|NCT00438958|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5299717|NCT00438958|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5299718|NCT00438958|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5299719|NCT00438958|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5299720|NCT00438958|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5299721|NCT00438958|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5299722|NCT00438958|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5299723|NCT00438958|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5299724|NCT00438958|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5299725|NCT00438958|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5299726|NCT00438958|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5299727|NCT00438958|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5299728|NCT00438958|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5299729|NCT00438958|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5299730|NCT00438958|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5299731|NCT00438958|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5299732|NCT00438958|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5299733|NCT00438958|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5299734|NCT00438958|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5299735|NCT00438958|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5299736|NCT00438958|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5299737|NCT00438958|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5299738|NCT00438958|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5299739|NCT00438958|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5299740|NCT00438958|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5299741|NCT00438958|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5299742|NCT00438958|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5299743|NCT00438958|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5299744|NCT00438958|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5299745|NCT00438958|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5299746|NCT00438958|Waldenström macroglobulinemia|waldenström macroglobulinemia
5299747|NCT00438958|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5299748|NCT00438958|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
5299749|NCT00438932|phosphate, phosphorus, FGF-23, PTH, 1,25D|phosphate, phosphorus, fgf-23, pth, 1,25d
5299750|NCT00438906|pancreatic lesions|pancreatic lesions
5299751|NCT00438906|pancreatic cancer|pancreatic cancer
5299752|NCT00438906|peutz-jeghers syndrome|peutz-jeghers syndrome
5299753|NCT00438906|BRCA 2 gene mutation|brca 2 gene mutation
5299754|NCT00438906|FAMMM/p16|fammm/p16
5299755|NCT00438906|Genes, BRCA2|genes, brca2
5299756|NCT00438893|Viscous dietary fiber|viscous dietary fiber
5299757|NCT00438893|Soy protein|soy protein
5299758|NCT00438893|Nuts|nuts
5299759|NCT00438893|Plant sterols|plant sterols
5299760|NCT00438893|Dietary Portfolio|dietary portfolio
5299761|NCT00438893|Compliance|compliance
5299762|NCT00438893|Blood lipids|blood lipids
5299763|NCT00438893|Blood pressure|blood pressure
5299764|NCT00438867|angina|angina
5299765|NCT00438867|FGF-4|fgf-4
5299766|NCT00438867|angiogenesis|angiogenesis
5299767|NCT00438867|growth factor|growth factor
5299768|NCT00438867|myocardia ischemia|myocardia ischemia
5299769|NCT00438867|revascularization|revascularization
5299770|NCT00438854|dasatinib|dasatinib
5299771|NCT00438854|BMS-354825|bms-354825
5299772|NCT00438854|CLL|cll
5299773|NCT00438854|SLL|sll
5299774|NCT00438854|LYN kinase|lyn kinase
5299775|NCT00438841|stage I multiple myeloma|stage i multiple myeloma
5299776|NCT00438841|stage II multiple myeloma|stage ii multiple myeloma
5299777|NCT00438841|stage III multiple myeloma|stage iii multiple myeloma
5299778|NCT00438828|radiation therapy|radiation therapy
5299779|NCT00438828|palliative|palliative
5299780|NCT00438828|pain|pain
5299781|NCT00438815|Hereditary angioedema|hereditary angioedema
5299782|NCT00438815|C1 esterase inhibitor (human)|c1 esterase inhibitor (human)
5299783|NCT00438802|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5299784|NCT00438802|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
5299785|NCT00438802|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5299786|NCT00438802|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
5299787|NCT00438802|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5299788|NCT00438763|CMC arthritis|cmc arthritis
5299789|NCT00438763|splint treatment|splint treatment
5299790|NCT00438763|patient satisfaction|patient satisfaction
5299791|NCT00438763|DASH questionnaire|dash questionnaire
5299792|NCT00438750|distal radius fracture|distal radius fracture
5299793|NCT00438750|rehabilitation|rehabilitation
5299794|NCT00438750|volar plate fixation|volar plate fixation
5299795|NCT00438750|DASH questionnaire|dash questionnaire
5299796|NCT00438737|liver metastases|liver metastases
5299797|NCT00438737|stage IV colon cancer|stage iv colon cancer
5299798|NCT00438737|stage IV rectal cancer|stage iv rectal cancer
5299799|NCT00438737|recurrent colon cancer|recurrent colon cancer
5299800|NCT00438737|recurrent rectal cancer|recurrent rectal cancer
5299801|NCT00438724|Caregivers|caregivers
5299802|NCT00438724|Caregiving|caregiving
5299803|NCT00438724|Spousal relationships|spousal relationships
5299804|NCT00438724|cognition disorders|cognition disorders
5299805|NCT00438724|therapy|therapy
5299806|NCT00438724|mental health|mental health
5299807|NCT00438724|psychosocial|psychosocial
5299808|NCT00438698|Nutrition|nutrition
5299809|NCT00438698|Type 2 Diabetes|type 2 diabetes
5299810|NCT00438685|Substance-Related Disorders|substance-related disorders
5299811|NCT00438685|Depressive Disorder|depressive disorder
5299812|NCT00438685|Anxiety Disorder|anxiety disorder
5299813|NCT00438685|Adolescent|adolescent
5299814|NCT00438685|Behavior Therapy|behavior therapy
5299815|NCT00438685|Cognitive Therapy|cognitive therapy
5299816|NCT00438685|Outpatients|outpatients
5299817|NCT00438685|Family Relations|family relations
5299818|NCT00438685|Systems Theory|systems theory
5299819|NCT00438672|lateral elbow pain|lateral elbow pain
5299820|NCT00438672|tennis elbow|tennis elbow
5299821|NCT00438672|pain|pain
5299822|NCT00438672|psychology|psychology
5299823|NCT00438659|dermatologic complications|dermatologic complications
5299824|NCT00438659|skin reactions secondary to radiation therapy|skin reactions secondary to radiation therapy
5299825|NCT00438659|radiation toxicity|radiation toxicity
5299826|NCT00438659|breast cancer in situ|breast cancer in situ
5299827|NCT00438659|recurrent breast cancer|recurrent breast cancer
5299828|NCT00438659|stage I breast cancer|stage i breast cancer
5299829|NCT00438659|stage II breast cancer|stage ii breast cancer
5299830|NCT00438659|stage IIIA breast cancer|stage iiia breast cancer
5299831|NCT00438659|stage IIIB breast cancer|stage iiib breast cancer
5299832|NCT00438659|stage IIIC breast cancer|stage iiic breast cancer
5299833|NCT00438659|male breast cancer|male breast cancer
5299834|NCT00438659|ductal breast carcinoma in situ|ductal breast carcinoma in situ
5299835|NCT00438659|stage IV breast cancer|stage iv breast cancer
5299836|NCT00438646|Allergy|allergy
5299837|NCT00438646|Asthma|asthma
5299838|NCT00438646|Eczema|eczema
5299839|NCT00438646|Hay Fever|hay fever
5299840|NCT00438646|Epidemiology|epidemiology
5299841|NCT00438633|proximal humerus fracture|proximal humerus fracture
5299842|NCT00438633|rehabilitation|rehabilitation
5299843|NCT00438633|non-operative treatment|non-operative treatment
5299844|NCT00438633|DASH and Constant instruments|dash and constant instruments
5299845|NCT00438607|Moderate to late stage Parkinson's Disease|moderate to late stage parkinson's disease
5299846|NCT00438594|nurse|nurse
5299847|NCT00438594|paraprofessional|paraprofessional
5299848|NCT00438594|home visits|home visits
5299849|NCT00438594|pregnancy|pregnancy
5299850|NCT00438594|welfare|welfare
5299851|NCT00438594|child development|child development
5299852|NCT00438581|Zevalin|zevalin
5299853|NCT00438581|Autologous one Marrow Transplant|autologous one marrow transplant
5299854|NCT00438581|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
5299855|NCT00438568|amyloid protein|amyloid protein
5299856|NCT00438568|brain metabolism|brain metabolism
5299857|NCT00438568|glucose metabolism|glucose metabolism
5299858|NCT00438568|insulin sensitivity /resistance|insulin sensitivity /resistance
5299859|NCT00438568|cognition disorders|cognition disorders
5299860|NCT00438555|obesity,prevention,pediatric|obesity,prevention,pediatric
5299861|NCT00438542|Adiponectin, cord blood, pre-eclampsia|adiponectin, cord blood, pre-eclampsia
5299862|NCT00438516|home visits|home visits
5299863|NCT00438516|pregnancy|pregnancy
5299864|NCT00438516|welfare|welfare
5299865|NCT00438516|child development|child development
5299866|NCT00438516|mortality|mortality
5299867|NCT00438503|Hemodialysis, diabetes mellitus,|hemodialysis, diabetes mellitus,
5299868|NCT00438503|Chronic renal failure, dialysis ,|chronic renal failure, dialysis ,
5299869|NCT00438490|galactorrhea|galactorrhea
5299870|NCT00438490|prolactin|prolactin
5299871|NCT00438490|bone turnover|bone turnover
5299872|NCT00438490|menstrual cycle|menstrual cycle
5299873|NCT00438490|Control Groups|control groups
5299874|NCT00438490|Women|women
5299875|NCT00438477|recurrent breast cancer|recurrent breast cancer
5299876|NCT00438477|stage IIIA breast cancer|stage iiia breast cancer
5299877|NCT00438477|stage IIIB breast cancer|stage iiib breast cancer
5299878|NCT00438477|stage IIIC breast cancer|stage iiic breast cancer
5299879|NCT00438477|stage II breast cancer|stage ii breast cancer
5299880|NCT00438451|elderly|elderly
5299881|NCT00438451|focal epilepsy|focal epilepsy
5299882|NCT00438451|anticonvulsive|anticonvulsive
5299883|NCT00438451|treatment|treatment
5299884|NCT00438451|levetiracetam|levetiracetam
5299885|NCT00438451|lamotrigine|lamotrigine
5299886|NCT00438451|carbamazepine|carbamazepine
5299887|NCT00438438|forced desynchrony|forced desynchrony
5299888|NCT00438438|circadian rhythms|circadian rhythms
5299889|NCT00438438|sleep restriction|sleep restriction
5299890|NCT00438438|sleep homeostasis|sleep homeostasis
5299891|NCT00438438|neurobehavioral performance|neurobehavioral performance
5299892|NCT00438425|Hyperlipidemia|hyperlipidemia
5299893|NCT00438425|Hypercholesterolemia|hypercholesterolemia
5299894|NCT00438425|Dietary modification|dietary modification
5299895|NCT00438425|Portfolio|portfolio
5299896|NCT00438412|Noradrenalin|noradrenalin
5299897|NCT00438412|Endothelin-1|endothelin-1
5299898|NCT00438412|Angiotensin II|angiotensin ii
5299899|NCT00438412|Arginine vasopressin|arginine vasopressin
5299900|NCT00438412|Aldosterone|aldosterone
5299901|NCT00438412|Renin|renin
5299902|NCT00438412|Atrial natriuretic peptide|atrial natriuretic peptide
5299903|NCT00438412|Brain natriuretic peptide|brain natriuretic peptide
5299904|NCT00438412|Blood pressure|blood pressure
5299905|NCT00438412|Apnea|apnea
5299906|NCT00438399|1 Galderma,|1 galderma,
5299907|NCT00438399|2 Scalp Psoriasis|2 scalp psoriasis
5299908|NCT00438399|3 Subject preference|3 subject preference
5299909|NCT00438399|4 Clobetasol propionate|4 clobetasol propionate
5299910|NCT00438399|5 Shampoo|5 shampoo
5299911|NCT00438386|Generalized Anxiety Disorder|generalized anxiety disorder
5299912|NCT00438386|Panic Disorder|panic disorder
5299913|NCT00438386|Anxiety Disorder|anxiety disorder
5299914|NCT00438386|Aripiprazole|aripiprazole
5299915|NCT00438373|Subfertility, Luteinizing hormone, receptor|subfertility, luteinizing hormone, receptor
5299916|NCT00438360|Cyclosporine, chronic plaque psoriasis, intermittent therapy|cyclosporine, chronic plaque psoriasis, intermittent therapy
5299917|NCT00438347|Mild Cognitive Impairment|mild cognitive impairment
5299918|NCT00438347|cognition disorders|cognition disorders
5299919|NCT00438347|brain health|brain health
5299920|NCT00438347|psychological aspect of aging|psychological aspect of aging
5299921|NCT00438347|exercise|exercise
5299922|NCT00438347|physical fitness|physical fitness
5299923|NCT00438334|Benefit|benefit
5299924|NCT00438334|Directional microphones|directional microphones
5299925|NCT00438334|Hearing|hearing
5299926|NCT00438334|Hearing aids|hearing aids
5299927|NCT00438334|Hearing loss|hearing loss
5299928|NCT00438334|Noise|noise
5299929|NCT00438334|Objective benefit|objective benefit
5299930|NCT00438334|Signal-to-noise ratio|signal-to-noise ratio
5299931|NCT00438334|Speech understanding|speech understanding
5299932|NCT00438334|Subjective benefit|subjective benefit
5299933|NCT00438321|Overweight|overweight
5299934|NCT00438321|obesity|obesity
5299935|NCT00438321|testosterone|testosterone
5299936|NCT00438321|diabetes|diabetes
5299937|NCT00438321|metabolic syndrome|metabolic syndrome
5299938|NCT00438321|aging|aging
5299939|NCT00438308|distal radius fracture|distal radius fracture
5299940|NCT00438308|rehabilitation|rehabilitation
5299941|NCT00438308|volar plate fixation|volar plate fixation
5299942|NCT00438308|DASH questionnaire|dash questionnaire
5299943|NCT00438295|glucose in dialysis water, dialysis treatment, temperature|glucose in dialysis water, dialysis treatment, temperature
5299944|NCT00438282|nurse|nurse
5299945|NCT00438282|home visits|home visits
5299946|NCT00438282|pregnancy|pregnancy
5299947|NCT00438282|welfare|welfare
5299948|NCT00438282|child development|child development
5299949|NCT00438269|Infection|infection
5299950|NCT00438269|Empiric|empiric
5299951|NCT00438269|Antibiotics|antibiotics
5299952|NCT00438269|Nosocomial|nosocomial
5299953|NCT00438269|Pyrexia|pyrexia
5299954|NCT00438269|Leukocytosis|leukocytosis
5299955|NCT00438269|Resistance|resistance
5299956|NCT00438256|accelerated short course|accelerated short course
5299957|NCT00438256|proton beam radiation|proton beam radiation
5299958|NCT00438243|Pseudophakic macular edema|pseudophakic macular edema
5299959|NCT00438230|Residual vein thrombosis|residual vein thrombosis
5299960|NCT00438230|Optimal duration|optimal duration
5299961|NCT00438230|Oral anticoagulants|oral anticoagulants
5299962|NCT00438217|precocious puberty, genetics, environmental factors|precocious puberty, genetics, environmental factors
5299963|NCT00438204|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5299964|NCT00438204|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5299965|NCT00438204|adenocarcinoma of the lung|adenocarcinoma of the lung
5299966|NCT00438204|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
5299967|NCT00438204|large cell lung cancer|large cell lung cancer
5299968|NCT00438204|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5299969|NCT00438191|DeQuervain's tenosynovitis|dequervain's tenosynovitis
5299970|NCT00438191|splinting|splinting
5299971|NCT00438191|grip strength|grip strength
5299972|NCT00438191|satisfaction|satisfaction
5299973|NCT00438191|DASH questionnaire|dash questionnaire
5299974|NCT00438165|nurse|nurse
5299975|NCT00438165|home visits|home visits
5299976|NCT00438165|pregnancy|pregnancy
5299977|NCT00438165|welfare|welfare
5299978|NCT00438165|child development|child development
5299979|NCT00438152|Lopinavir|lopinavir
5299980|NCT00438152|Saquinavir|saquinavir
5299981|NCT00438152|Lipids|lipids
5299982|NCT00438152|HIV-1|hiv-1
5299983|NCT00438152|Treatment Experienced|treatment experienced
5299984|NCT00438139|marijuana dependence|marijuana dependence
5299985|NCT00438126|diabetes|diabetes
5299986|NCT00438126|Prevention|prevention
5299987|NCT00438126|American Indian|american indian
5299988|NCT00438113|blood pressure|blood pressure
5299989|NCT00438113|atrial fibrillation|atrial fibrillation
5299990|NCT00438113|catheter ablation|catheter ablation
5299991|NCT00438100|Breast Neoplasms|breast neoplasms
5299992|NCT00438100|Drug Therapy|drug therapy
5299993|NCT00438087|Facial palsy|facial palsy
5299994|NCT00438087|Vestibular schwannoma|vestibular schwannoma
5299995|NCT00438087|Anti-inflammatory drugs|anti-inflammatory drugs
5299996|NCT00438087|Post surgery of vestibular schwannoma|post surgery of vestibular schwannoma
5299997|NCT00438087|or of cranial base tumors|or of cranial base tumors
5299998|NCT00438074|Breast Cancer|breast cancer
5299999|NCT00438074|Diffuse Optical Spectroscopy|diffuse optical spectroscopy
5300000|NCT00438061|Lipoprotein metabolism|lipoprotein metabolism
5300001|NCT00438061|Cardiovascular disease|cardiovascular disease
5300002|NCT00438061|Obesity|obesity
5300003|NCT00438048|Pilocarpine|pilocarpine
5300004|NCT00438048|Artificial saliva|artificial saliva
5300005|NCT00438048|Xerostomia|xerostomia
5300006|NCT00438048|Xerostomy|xerostomy
5300007|NCT00438048|Primary Sjogren|primary sjogren
5300008|NCT00438048|Secondary Sjogren|secondary sjogren
5300009|NCT00438035|Postoperative pain|postoperative pain
5300010|NCT00438035|Heart rate variability, sympathetic, parasympathetic|heart rate variability, sympathetic, parasympathetic
5300011|NCT00438035|Visual analog pain scale|visual analog pain scale
5300012|NCT00438035|Spectral analysis of ECG|spectral analysis of ecg
5300013|NCT00438022|Atopic Dermatitis|atopic dermatitis
5300014|NCT00438022|Eczema Herpeticum|eczema herpeticum
5300015|NCT00438009|coxsackievirus type a21|coxsackievirus type a21
5300016|NCT00438009|oncolytic virus|oncolytic virus
5300017|NCT00438009|melanoma|melanoma
5300018|NCT00437996|Labor analgesia - clonidine - epidural|labor analgesia - clonidine - epidural
5300019|NCT00437957|histone deacetylase|histone deacetylase
5300020|NCT00437957|unresectable brain metastases|unresectable brain metastases
5300021|NCT00437931|hypothyroidism|hypothyroidism
5300022|NCT00437931|hyperthyroidism|hyperthyroidism
5300023|NCT00437931|thyroid dysfunction|thyroid dysfunction
5300024|NCT00437931|ultrasound|ultrasound
5300025|NCT00437931|doppler|doppler
5300026|NCT00437905|peripheral vascular disease|peripheral vascular disease
5300027|NCT00437905|percutaneous transluminal angioplasty|percutaneous transluminal angioplasty
5300028|NCT00437905|cutting balloon|cutting balloon
5300029|NCT00437905|balloon angioplasty|balloon angioplasty
5300030|NCT00437905|randomized controlled trial|randomized controlled trial
5300031|NCT00437905|restenosis|restenosis
5300032|NCT00437905|inflammation|inflammation
5300033|NCT00437892|Statins|statins
5300034|NCT00437892|secondary prevention|secondary prevention
5300035|NCT00437892|venous thromboembolism|venous thromboembolism
5300036|NCT00437892|d-dimer|d-dimer
5300037|NCT00437879|Breast Cancer|breast cancer
5300038|NCT00437879|Ultrasound|ultrasound
5300039|NCT00437840|healthy volunteers,|healthy volunteers,
5300040|NCT00437840|tolerability,|tolerability,
5300041|NCT00437840|pharmacokinetics,|pharmacokinetics,
5300042|NCT00437840|pharmacodynamics|pharmacodynamics
5300043|NCT00437840|safety,|safety,
5300044|NCT00437840|smoking,|smoking,
5300045|NCT00437827|Depression|depression
5300046|NCT00437814|Ketamine|ketamine
5300047|NCT00437814|Traumatic Brain Injury|traumatic brain injury
5300048|NCT00437814|Intracranial Hypertension|intracranial hypertension
5300049|NCT00437788|imaging|imaging
5300050|NCT00437775|Diabetes Mellitus type 2|diabetes mellitus type 2
5300051|NCT00437775|ACE Inhibitors|ace inhibitors
5300052|NCT00437775|ARBs|arbs
5300053|NCT00437775|Adverse drug effect|adverse drug effect
5300054|NCT00437762|Lateral epicondylitis, tennis elbow, treatment|lateral epicondylitis, tennis elbow, treatment
5300055|NCT00437749|Non small cell lung cancer|non small cell lung cancer
5300056|NCT00437749|Advanced|advanced
5300057|NCT00437749|Inoperable|inoperable
5300058|NCT00437749|taxanes|taxanes
5300059|NCT00437749|carboplatin|carboplatin
5300060|NCT00437749|multi-drug resistance|multi-drug resistance
5300061|NCT00437736|solid tumor|solid tumor
5300062|NCT00437736|phase I study|phase i study
5300063|NCT00437736|dose-escalation|dose-escalation
5300064|NCT00437710|bone marrow, cell transplantation, stem cells, PTCA|bone marrow, cell transplantation, stem cells, ptca
5300065|NCT00437697|dalteparin, critically ill, thromboprophylaxis|dalteparin, critically ill, thromboprophylaxis
5300066|NCT00437684|HIV/HCV|hiv/hcv
5300067|NCT00437684|HIV and HCV coinfected patients|hiv and hcv coinfected patients
5300068|NCT00437684|Treatment Experienced|treatment experienced
5300069|NCT00437671|trismus|trismus
5300070|NCT00437671|lockjaw|lockjaw
5300071|NCT00437645|Essential hypertension|essential hypertension
5300072|NCT00437645|blood pressure|blood pressure
5300073|NCT00437645|edema|edema
5300074|NCT00437645|valsartan|valsartan
5300075|NCT00437645|amlodipine|amlodipine
5300076|NCT00437645|combination treatment|combination treatment
5300077|NCT00437632|repeat dose,|repeat dose,
5300078|NCT00437632|placebo,|placebo,
5300079|NCT00437632|Safety,|safety,
5300080|NCT00437632|pharmacodynamics,|pharmacodynamics,
5300081|NCT00437632|tolerability,|tolerability,
5300082|NCT00437632|GSK598809|gsk598809
5300083|NCT00437632|pharmacokinetics,|pharmacokinetics,
5300084|NCT00437593|preretinal membrane|preretinal membrane
5300085|NCT00437593|vitrectomy|vitrectomy
5300086|NCT00437593|uhr-oct|uhr-oct
5300087|NCT00437593|hd-oct|hd-oct
5300088|NCT00437580|Vancomycin Resistant Enterococcus, probiotic|vancomycin resistant enterococcus, probiotic
5300089|NCT00437567|galacto-oligosaccharides|galacto-oligosaccharides
5300090|NCT00437567|prebiotics|prebiotics
5300091|NCT00437567|NEC|nec
5300092|NCT00437541|Insulation|insulation
5300093|NCT00437541|Warmth|warmth
5300094|NCT00437541|Humidity|humidity
5300095|NCT00437541|Damp|damp
5300096|NCT00437541|Cold|cold
5300097|NCT00437541|Respiratory|respiratory
5300098|NCT00437541|Mould|mould
5300099|NCT00437528|Heat flow|heat flow
5300100|NCT00437528|Sensor|sensor
5300101|NCT00437528|Overactive bladder|overactive bladder
5300102|NCT00437528|Urinary incontinence|urinary incontinence
5300103|NCT00437502|Immunotherapeutic vaccine|immunotherapeutic vaccine
5300104|NCT00437502|Ovarian cancer|ovarian cancer
5300105|NCT00437502|epithelial ovarian cancer|epithelial ovarian cancer
5300106|NCT00437502|tubal cancer|tubal cancer
5300107|NCT00437502|peritoneal cancer|peritoneal cancer
5300108|NCT00437502|immunotherapy|immunotherapy
5300109|NCT00437476|HIV/HCV|hiv/hcv
5300110|NCT00437476|HIV and HCV coinfected patients|hiv and hcv coinfected patients
5300111|NCT00437476|Treatment Naive|treatment naive
5300112|NCT00437450|Anemia|anemia
5300113|NCT00437450|myelodysplastic syndromes|myelodysplastic syndromes
5300114|NCT00437450|Low risk|low risk
5300115|NCT00437450|Bone Marrow diseases|bone marrow diseases
5300116|NCT00437437|Advanced or metastatic solid tumors|advanced or metastatic solid tumors
5300117|NCT00437424|Hepatocellular cancer|hepatocellular cancer
5300118|NCT00437424|Other advanced solid malignancies|other advanced solid malignancies
5300119|NCT00437411|Fibromyalgia|fibromyalgia
5300120|NCT00437411|Affect|affect
5300121|NCT00437411|Pain|pain
5300122|NCT00437411|Fatigue|fatigue
5300123|NCT00437411|Sleep|sleep
5300124|NCT00437411|Stress|stress
5300125|NCT00437411|Quality of Life|quality of life
5300126|NCT00437411|Stress, Psychological|stress, psychological
5300127|NCT00437411|Psychophysiology|psychophysiology
5300128|NCT00437411|Randomized Controlled Trials|randomized controlled trials
5300129|NCT00437398|hypoglycemic unawareness|hypoglycemic unawareness
5300130|NCT00437385|therapy resistant depression, severe depression|therapy resistant depression, severe depression
5300131|NCT00437372|solid tumor|solid tumor
5300132|NCT00437372|central nervous system|central nervous system
5300133|NCT00437372|head and neck|head and neck
5300134|NCT00437372|thorax|thorax
5300135|NCT00437372|pelvic area|pelvic area
5300136|NCT00437359|Breast Neoplasms|breast neoplasms
5300137|NCT00437359|Drug Therapy|drug therapy
5300138|NCT00437346|dyspepsia|dyspepsia
5300139|NCT00437346|functional dyspepsia|functional dyspepsia
5300140|NCT00437346|treatment|treatment
5300141|NCT00437346|drug therapy|drug therapy
5300142|NCT00437346|information|information
5300143|NCT00437333|Insulin sensitivity|insulin sensitivity
5300144|NCT00437333|Insulin-sensitizing drug|insulin-sensitizing drug
5300145|NCT00437333|Metformin|metformin
5300146|NCT00437333|PCOS|pcos
5300147|NCT00437333|Treatment|treatment
5300148|NCT00437320|PDT|pdt
5300149|NCT00437320|Photoaging|photoaging
5300150|NCT00437320|Galderma|galderma
5300151|NCT00437281|Partial-onset seizures; epilepsy; pediatric; pregabalin; safety; tolerability; pharmacokinetics|partial-onset seizures; epilepsy; pediatric; pregabalin; safety; tolerability; pharmacokinetics
5300152|NCT00437242|interval,|interval,
5300153|NCT00437242|atrial fibrillation|atrial fibrillation
5300154|NCT00437242|QT,|qt,
5300156|NCT00437229|GW679769,|gw679769,
5300157|NCT00437229|Casopitant,|casopitant,
5300158|NCT00437229|Dexamethasone,|dexamethasone,
5300159|NCT00437229|Healthy Human Volunteer|healthy human volunteer
5300160|NCT00437229|Ondansetron,|ondansetron,
5300161|NCT00437203|Advanced cancer|advanced cancer
5300162|NCT00437190|Cervical Disc Replacement|cervical disc replacement
5300163|NCT00437190|Spondylotic radiculopathy|spondylotic radiculopathy
5300164|NCT00437190|Spondylotic myelopathy|spondylotic myelopathy
5300165|NCT00437190|Myelopathy|myelopathy
5300166|NCT00437190|Radiculopathy|radiculopathy
5300167|NCT00437177|alcoholism|alcoholism
5300168|NCT00437177|apomorphine|apomorphine
5300169|NCT00437177|iodobenzamide|iodobenzamide
5300170|NCT00437177|imaging|imaging
5300171|NCT00437177|spect|spect
5300172|NCT00437177|relapse|relapse
5300173|NCT00437164|NaBr|nabr
5300174|NCT00437164|Sodium Bromide|sodium bromide
5300175|NCT00437164|DEXA Deuterium|dexa deuterium
5300176|NCT00437164|Total Body Water|total body water
5300177|NCT00437164|Insulin|insulin
5300178|NCT00437164|D2O|d2o
5300179|NCT00437164|GW677954|gw677954
5300180|NCT00437164|Randomized Withdrawal|randomized withdrawal
5300181|NCT00437164|T2DM|t2dm
5300182|NCT00437138|Air pollution|air pollution
5300183|NCT00437138|Myocardial ischemia|myocardial ischemia
5300184|NCT00437138|Endothelium|endothelium
5300185|NCT00437138|Fibrinolysis|fibrinolysis
5300186|NCT00437138|Pathophysiology|pathophysiology
5300187|NCT00437138|Diesel exhaust|diesel exhaust
5300188|NCT00437086|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5300189|NCT00437086|primary myelofibrosis|primary myelofibrosis
5300190|NCT00437073|brain metastases|brain metastases
5300191|NCT00437073|ErbB2|erbb2
5300192|NCT00437073|lapatinib|lapatinib
5300193|NCT00437073|Breast Cancer|breast cancer
5300194|NCT00437073|HYCAMTIN|hycamtin
5300195|NCT00437073|topotecan|topotecan
5300196|NCT00437073|capecitabine|capecitabine
5300197|NCT00437073|metastatic breast cancer|metastatic breast cancer
5300198|NCT00437073|TYKERB|tykerb
5300199|NCT00437073|XELODA|xeloda
5300200|NCT00437021|smallpox, vaccine, IMVAMUNE®|smallpox, vaccine, imvamune®
5300201|NCT00437008|endothelial dysfunction|endothelial dysfunction
5300202|NCT00437008|flow-mediated dilatation|flow-mediated dilatation
5300203|NCT00437008|advanced glycation end products|advanced glycation end products
5300204|NCT00437008|postprandial|postprandial
5300205|NCT00436995|Dialysis|dialysis
5300206|NCT00436995|Anaemia|anaemia
5300207|NCT00436969|Orthovisc|orthovisc
5300208|NCT00436969|Osteoarthritis|osteoarthritis
5300209|NCT00436969|Shoulder|shoulder
5300210|NCT00436969|Randomized|randomized
5300211|NCT00436956|VEGF|vegf
5300212|NCT00436956|Angiogenesis|angiogenesis
5300213|NCT00436956|Hormone-Refractory|hormone-refractory
5300214|NCT00436956|Bone Metastases|bone metastases
5300215|NCT00436956|Docetaxel-Resistant|docetaxel-resistant
5300216|NCT00436956|Prostate Cancer|prostate cancer
5300217|NCT00436943|smoking cessation|smoking cessation
5300218|NCT00436943|nicotine replacement therapy|nicotine replacement therapy
5300219|NCT00436943|bupropion|bupropion
5300220|NCT00436943|smoking|smoking
5300221|NCT00436930|recurrent melanoma|recurrent melanoma
5300222|NCT00436930|stage IV melanoma|stage iv melanoma
5300223|NCT00436917|stage I breast cancer|stage i breast cancer
5300224|NCT00436917|stage II breast cancer|stage ii breast cancer
5300225|NCT00436917|stage IIIA breast cancer|stage iiia breast cancer
5300226|NCT00436917|osteoporosis|osteoporosis
5300227|NCT00436904|stage 0 chronic lymphocytic leukemia|stage 0 chronic lymphocytic leukemia
5300228|NCT00436904|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
5300229|NCT00436904|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
5300230|NCT00436904|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
5300231|NCT00436891|Group A Streptococcus, scabies, pyoderma, Fiji|group a streptococcus, scabies, pyoderma, fiji
5300232|NCT00436878|Eating Behavior|eating behavior
5300233|NCT00436878|Children|children
5300234|NCT00436878|Portion size|portion size
5300235|NCT00436878|Experimental|experimental
5300236|NCT00436826|Multiple Sclerosis|multiple sclerosis
5300237|NCT00436826|Relapsing forms|relapsing forms
5300238|NCT00436826|Interferon-beta therapy|interferon-beta therapy
5300239|NCT00436787|Anticoagulation Prophylaxis|anticoagulation prophylaxis
5300240|NCT00436787|Venous Thrombosis|venous thrombosis
5300241|NCT00436787|Deep Vein Thrombosis|deep vein thrombosis
5300242|NCT00436787|Pulmonary Embolism|pulmonary embolism
5300243|NCT00436787|Fondaparinux Sodium|fondaparinux sodium
5300244|NCT00436787|Arixtra|arixtra
5300245|NCT00436787|Pharmakinetics|pharmakinetics
5300246|NCT00436774|long-term effects secondary to cancer therapy in children|long-term effects secondary to cancer therapy in children
5300247|NCT00436774|neurotoxicity|neurotoxicity
5300248|NCT00436774|gastrointestinal complications|gastrointestinal complications
5300249|NCT00436774|pulmonary complications|pulmonary complications
5300250|NCT00436774|sexual dysfunction|sexual dysfunction
5300251|NCT00436774|infertility|infertility
5300252|NCT00436774|urinary complications|urinary complications
5300253|NCT00436774|childhood extragonadal germ cell tumor|childhood extragonadal germ cell tumor
5300431|NCT00436410|stage II renal cell cancer|stage ii renal cell cancer
5300254|NCT00436774|childhood malignant ovarian germ cell tumor|childhood malignant ovarian germ cell tumor
5300255|NCT00436774|childhood malignant testicular germ cell tumor|childhood malignant testicular germ cell tumor
5300256|NCT00436774|childhood teratoma|childhood teratoma
5300257|NCT00436761|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
5300258|NCT00436748|Chronic Kidney Disease|chronic kidney disease
5300259|NCT00436748|Dialysis|dialysis
5300260|NCT00436748|Anemia|anemia
5300261|NCT00436748|Nephrology|nephrology
5300262|NCT00436748|Pediatric|pediatric
5300263|NCT00436748|Hemodialysis|hemodialysis
5300264|NCT00436748|Peritoneal Dialysis|peritoneal dialysis
5300265|NCT00436748|Chronic Renal Insufficiency|chronic renal insufficiency
5300266|NCT00436722|Liver|liver
5300267|NCT00436722|Transplantation|transplantation
5300268|NCT00436722|Tolerance|tolerance
5300269|NCT00436722|Induction|induction
5300270|NCT00436722|Tacrolimus|tacrolimus
5300271|NCT00436722|Liver transplantation|liver transplantation
5300272|NCT00436722|Adult|adult
5300273|NCT00436709|male breast cancer|male breast cancer
5300274|NCT00436709|stage I breast cancer|stage i breast cancer
5300275|NCT00436709|stage II breast cancer|stage ii breast cancer
5300276|NCT00436709|stage IIIA breast cancer|stage iiia breast cancer
5300277|NCT00436683|Hyperphosphataemia|hyperphosphataemia
5300278|NCT00436683|Phosphate binder|phosphate binder
5300279|NCT00436670|Asthma|asthma
5300280|NCT00436670|Allergy|allergy
5300281|NCT00436670|IL-13|il-13
5300282|NCT00436670|IL-4|il-4
5300283|NCT00436670|IL-4R|il-4r
5300284|NCT00436657|Children|children
5300285|NCT00436657|Pediatric|pediatric
5300286|NCT00436657|Peritoneal Tumor|peritoneal tumor
5300287|NCT00436657|Retroperitoneal Tumor|retroperitoneal tumor
5300288|NCT00436657|Gastrointestinal Adenocarcinoma|gastrointestinal adenocarcinoma
5300289|NCT00436657|Desmoplastic Round Cell Tumor|desmoplastic round cell tumor
5300290|NCT00436657|Neuroblastoma|neuroblastoma
5300291|NCT00436657|Ovarian Germ Cell|ovarian germ cell
5300292|NCT00436657|Sarcoma|sarcoma
5300293|NCT00436657|Adrenocorticocarcinoma|adrenocorticocarcinoma
5300294|NCT00436657|Wilms' Tumor|wilms' tumor
5300295|NCT00436657|Rhabdomyosarcoma|rhabdomyosarcoma
5300296|NCT00436657|Desmoplastic Small Round Cell Tumor|desmoplastic small round cell tumor
5300297|NCT00436657|Recurrent Tumors|recurrent tumors
5300298|NCT00436657|Cisplatin|cisplatin
5300299|NCT00436657|Platinol®-AQ|platinol®-aq
5300300|NCT00436657|Platinol®|platinol®
5300301|NCT00436657|CDDP|cddp
5300302|NCT00436657|Abdominal Wash|abdominal wash
5300303|NCT00436657|Hyperthermic Perfusion|hyperthermic perfusion
5300304|NCT00436657|Continuous Hyperthermic Peritoneal Perfusion|continuous hyperthermic peritoneal perfusion
5300305|NCT00436657|CHPP|chpp
5300306|NCT00436644|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5300307|NCT00436644|peritoneal cavity cancer|peritoneal cavity cancer
5300308|NCT00436631|epilepsy|epilepsy
5300309|NCT00436631|seizures|seizures
5300310|NCT00436631|intractable|intractable
5300311|NCT00436631|ketosis|ketosis
5300312|NCT00436631|ketogenic|ketogenic
5300313|NCT00436631|diet|diet
5300314|NCT00436618|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5300315|NCT00436618|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5300316|NCT00436618|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5300317|NCT00436618|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
5300318|NCT00436618|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5300319|NCT00436618|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5300320|NCT00436618|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5300321|NCT00436618|small intestine lymphoma|small intestine lymphoma
5300322|NCT00436618|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5300323|NCT00436618|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
5300324|NCT00436618|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5300325|NCT00436618|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5300326|NCT00436618|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5300327|NCT00436618|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5300328|NCT00436618|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5300329|NCT00436618|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
5300330|NCT00436618|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
5300331|NCT00436618|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5300332|NCT00436618|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5300333|NCT00436618|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5300334|NCT00436618|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5300335|NCT00436618|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5300451|NCT00436384|heart transplant|heart transplant
5300336|NCT00436618|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
5300337|NCT00436618|primary central nervous system Hodgkin lymphoma|primary central nervous system hodgkin lymphoma
5300338|NCT00436618|post-transplant lymphoproliferative disorder|post-transplant lymphoproliferative disorder
5300339|NCT00436618|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5300340|NCT00436592|acute|acute
5300341|NCT00436592|ischemic|ischemic
5300342|NCT00436592|stroke|stroke
5300343|NCT00436592|device|device
5300344|NCT00436592|treatment|treatment
5300345|NCT00436566|cardiac toxicity|cardiac toxicity
5300346|NCT00436566|male breast cancer|male breast cancer
5300347|NCT00436566|stage I breast cancer|stage i breast cancer
5300348|NCT00436566|stage II breast cancer|stage ii breast cancer
5300349|NCT00436566|stage IIIA breast cancer|stage iiia breast cancer
5300350|NCT00436553|Age-related macular degeneration; AMD|age-related macular degeneration; amd
5300351|NCT00436553|choroidal neovascularization|choroidal neovascularization
5300352|NCT00436553|verteporfin|verteporfin
5300353|NCT00436553|ranibizumab|ranibizumab
5300354|NCT00436514|patients|patients
5300355|NCT00436514|medium risk|medium risk
5300356|NCT00436514|asymptomatic|asymptomatic
5300357|NCT00436514|between 50 and 74 years old|between 50 and 74 years old
5300358|NCT00436514|high risk|high risk
5300359|NCT00436514|case|case
5300360|NCT00436514|history of neoplastic colic|history of neoplastic colic
5300361|NCT00436514|cancers|cancers
5300362|NCT00436514|polyps|polyps
5300363|NCT00436501|primary peritoneal cavity cancer|primary peritoneal cavity cancer
5300364|NCT00436501|Ovarian Epithelial Cancer|ovarian epithelial cancer
5300365|NCT00436501|Peritoneal Cancer|peritoneal cancer
5300366|NCT00436501|Fallopian Tube Cancer|fallopian tube cancer
5300367|NCT00436501|VEGF Trap|vegf trap
5300368|NCT00436501|aflibercept|aflibercept
5300369|NCT00436501|vascular endothelial growth factor trap|vascular endothelial growth factor trap
5300370|NCT00436501|Zaltrap|zaltrap
5300371|NCT00436501|docetaxel|docetaxel
5300372|NCT00436501|RP 56976|rp 56976
5300373|NCT00436501|Taxotere|taxotere
5300374|NCT00436501|TXT|txt
5300375|NCT00436488|ICAM-1|icam-1
5300376|NCT00436488|Obesity|obesity
5300377|NCT00436488|Gene variants|gene variants
5300378|NCT00436475|Glucose intolerance|glucose intolerance
5300379|NCT00436475|Type 2 diabetes mellitus|type 2 diabetes mellitus
5300380|NCT00436475|Metabolic syndrome|metabolic syndrome
5300381|NCT00436462|Steroid receptors|steroid receptors
5300382|NCT00436462|Endometrium|endometrium
5300383|NCT00436462|IVF|ivf
5300384|NCT00436462|Follicular phase|follicular phase
5300385|NCT00436436|adult giant cell glioblastoma|adult giant cell glioblastoma
5300386|NCT00436436|adult gliosarcoma|adult gliosarcoma
5300387|NCT00436436|recurrent adult brain tumor|recurrent adult brain tumor
5300388|NCT00436436|adult glioblastoma|adult glioblastoma
5300389|NCT00436423|pancreatic neoplasm|pancreatic neoplasm
5300390|NCT00436423|drug therapy|drug therapy
5300391|NCT00436423|gemcitabine|gemcitabine
5300392|NCT00436423|TS-1|ts-1
5300393|NCT00436410|stage IV colon cancer|stage iv colon cancer
5300394|NCT00436410|stage IV rectal cancer|stage iv rectal cancer
5300395|NCT00436410|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
5300396|NCT00436410|stage IV pancreatic cancer|stage iv pancreatic cancer
5300397|NCT00436410|male breast cancer|male breast cancer
5300398|NCT00436410|stage IV breast cancer|stage iv breast cancer
5300399|NCT00436410|stage IV melanoma|stage iv melanoma
5300400|NCT00436410|stage I breast cancer|stage i breast cancer
5300401|NCT00436410|stage II breast cancer|stage ii breast cancer
5300402|NCT00436410|stage IIIA breast cancer|stage iiia breast cancer
5300403|NCT00436410|stage IIIB breast cancer|stage iiib breast cancer
5300404|NCT00436410|stage IIIC breast cancer|stage iiic breast cancer
5300405|NCT00436410|recurrent breast cancer|recurrent breast cancer
5300406|NCT00436410|recurrent adrenocortical carcinoma|recurrent adrenocortical carcinoma
5300407|NCT00436410|stage I adrenocortical carcinoma|stage i adrenocortical carcinoma
5300408|NCT00436410|stage II adrenocortical carcinoma|stage ii adrenocortical carcinoma
5300409|NCT00436410|stage III adrenocortical carcinoma|stage iii adrenocortical carcinoma
5300410|NCT00436410|stage IV adrenocortical carcinoma|stage iv adrenocortical carcinoma
5300411|NCT00436410|recurrent colon cancer|recurrent colon cancer
5300412|NCT00436410|stage I colon cancer|stage i colon cancer
5300413|NCT00436410|stage II colon cancer|stage ii colon cancer
5300414|NCT00436410|stage III colon cancer|stage iii colon cancer
5300415|NCT00436410|recurrent rectal cancer|recurrent rectal cancer
5300416|NCT00436410|stage I rectal cancer|stage i rectal cancer
5300417|NCT00436410|stage II rectal cancer|stage ii rectal cancer
5300418|NCT00436410|stage III rectal cancer|stage iii rectal cancer
5300419|NCT00436410|advanced adult primary liver cancer|advanced adult primary liver cancer
5300420|NCT00436410|localized resectable adult primary liver cancer|localized resectable adult primary liver cancer
5300421|NCT00436410|recurrent adult primary liver cancer|recurrent adult primary liver cancer
5300422|NCT00436410|recurrent pancreatic cancer|recurrent pancreatic cancer
5300423|NCT00436410|stage I pancreatic cancer|stage i pancreatic cancer
5300424|NCT00436410|stage II pancreatic cancer|stage ii pancreatic cancer
5300425|NCT00436410|stage III pancreatic cancer|stage iii pancreatic cancer
5300426|NCT00436410|recurrent melanoma|recurrent melanoma
5300427|NCT00436410|stage I melanoma|stage i melanoma
5300428|NCT00436410|stage II melanoma|stage ii melanoma
5300429|NCT00436410|stage III melanoma|stage iii melanoma
5300430|NCT00436410|stage I renal cell cancer|stage i renal cell cancer
5300432|NCT00436410|stage III renal cell cancer|stage iii renal cell cancer
5300433|NCT00436410|stage IV renal cell cancer|stage iv renal cell cancer
5300434|NCT00436410|recurrent renal cell cancer|recurrent renal cell cancer
5300435|NCT00436410|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5300436|NCT00436410|stage I ovarian epithelial cancer|stage i ovarian epithelial cancer
5300437|NCT00436410|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
5300438|NCT00436410|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5300439|NCT00436410|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5300440|NCT00436410|gastrointestinal cancer|gastrointestinal cancer
5300441|NCT00436410|adult fibrosarcoma|adult fibrosarcoma
5300442|NCT00436410|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
5300443|NCT00436410|stage I adult soft tissue sarcoma|stage i adult soft tissue sarcoma
5300444|NCT00436410|stage II adult soft tissue sarcoma|stage ii adult soft tissue sarcoma
5300445|NCT00436410|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
5300446|NCT00436410|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
5300447|NCT00436397|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5300448|NCT00436384|liver transplant|liver transplant
5300449|NCT00436384|lung transplant|lung transplant
5300450|NCT00436384|kidney transplant|kidney transplant
5300452|NCT00436384|CMV CMI|cmv cmi
5300453|NCT00436358|Mexico|mexico
5300454|NCT00436358|Intussusception|intussusception
5300455|NCT00436358|Epidemiology|epidemiology
5300456|NCT00436345|analgesia|analgesia
5300457|NCT00436345|Mechanical ventilation|mechanical ventilation
5300458|NCT00436345|pharmaco-economic|pharmaco-economic
5300459|NCT00436345|ICU|icu
5300460|NCT00436332|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5300461|NCT00436332|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5300462|NCT00436332|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5300463|NCT00436332|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
5300464|NCT00436332|adenocarcinoma of the lung|adenocarcinoma of the lung
5300465|NCT00436319|Infertility, downregulation, stimulation, agonists, long|infertility, downregulation, stimulation, agonists, long
5300466|NCT00436306|prevention|prevention
5300467|NCT00436306|behavior|behavior
5300468|NCT00436306|risk reduction behavior|risk reduction behavior
5300469|NCT00436267|recurrent pancreatic cancer|recurrent pancreatic cancer
5300470|NCT00436267|stage IV pancreatic cancer|stage iv pancreatic cancer
5300471|NCT00436267|liver metastases|liver metastases
5300472|NCT00436228|healthy volunteer,|healthy volunteer,
5300473|NCT00436228|Bioavailability,|bioavailability,
5300474|NCT00436228|safety|safety
5300475|NCT00436228|Phase I,|phase i,
5300476|NCT00436215|Sorafenib|sorafenib
5300477|NCT00436215|Ovarian Cancer|ovarian cancer
5300478|NCT00436215|Fallopian Cancer|fallopian cancer
5300479|NCT00436215|Bevacizumab|bevacizumab
5300480|NCT00436215|Peritoneal Cancer|peritoneal cancer
5300481|NCT00436215|Fallopian Tube Cancer|fallopian tube cancer
5300482|NCT00436202|Anemia|anemia
5300483|NCT00436202|Iron|iron
5300484|NCT00436202|Supplement|supplement
5300485|NCT00436189|Ovarian|ovarian
5300486|NCT00436189|Cancer|cancer
5300487|NCT00436189|Pelvic|pelvic
5300488|NCT00436189|Mass|mass
5300489|NCT00436189|Tumor|tumor
5300490|NCT00436189|Adnexal|adnexal
5300491|NCT00436189|Proteomics|proteomics
5300492|NCT00436176|Diabetes mellitus|diabetes mellitus
5300493|NCT00436176|Quality of Health Care|quality of health care
5300494|NCT00436176|Cultural Competency|cultural competency
5300495|NCT00436176|Performance Feedback|performance feedback
5300496|NCT00436176|Health navigator|health navigator
5300497|NCT00436176|Health disparities|health disparities
5300498|NCT00436176|Racial disparities|racial disparities
5300499|NCT00436150|Adolescents|adolescents
5300500|NCT00436150|Depression, postpartum|depression, postpartum
5300501|NCT00436137|Colorectal cancer|colorectal cancer
5300502|NCT00436137|Fecal occult blood test|fecal occult blood test
5300503|NCT00436137|Abnormal test result|abnormal test result
5300504|NCT00436137|Missed diagnosis|missed diagnosis
5300505|NCT00436137|Delayed diagnosis|delayed diagnosis
5300506|NCT00436111|hyperprolactinemia|hyperprolactinemia
5300507|NCT00436111|autoantibody|autoantibody
5300508|NCT00436098|congenital heart disease|congenital heart disease
5300509|NCT00436098|exercise training|exercise training
5300510|NCT00436098|motorpedagogical exercise|motorpedagogical exercise
5300511|NCT00436098|children|children
5300512|NCT00436098|CHD: hemodynamically not significant defects|chd: hemodynamically not significant defects
5300513|NCT00436098|CHD: acyanotic defects after repair|chd: acyanotic defects after repair
5300514|NCT00436098|CHD: cyanotic defects after repair|chd: cyanotic defects after repair
5300515|NCT00436072|ZD6474|zd6474
5300516|NCT00436072|cetuximab|cetuximab
5300517|NCT00436072|irinotecan|irinotecan
5300518|NCT00436046|interferon, vaccine, influenza|interferon, vaccine, influenza
5300519|NCT00436020|clinical trial|clinical trial
5300520|NCT00436020|TMS|tms
5300521|NCT00436020|depression|depression
5300522|NCT00436020|bipolar disorder|bipolar disorder
5300523|NCT00436007|Africa|africa
5300524|NCT00436007|Plasmodium falciparum|plasmodium falciparum
5300525|NCT00436007|Malaria|malaria
5300526|NCT00435994|Infant|infant
5300527|NCT00435994|Respiratory Syncytial Virus|respiratory syncytial virus
5300528|NCT00435994|Bronchiolitis|bronchiolitis
5300529|NCT00435981|Type 1 diabetes|type 1 diabetes
5300530|NCT00435981|GAD65|gad65
5300531|NCT00435981|Autoimmunity|autoimmunity
5300532|NCT00435981|C-peptide|c-peptide
5300533|NCT00435981|Children|children
5300534|NCT00435968|NK Cells|nk cells
5300535|NCT00435968|Cytokines|cytokines
5300536|NCT00435968|Lymphocytes|lymphocytes
5300537|NCT00435968|Immunoglobulins|immunoglobulins
5300538|NCT00435968|Th1 response|th1 response
5300539|NCT00435955|Follicular lymphoma|follicular lymphoma
5300540|NCT00435955|age adjusted IPI >1|age adjusted ipi >1
5300541|NCT00435955|IIL score > 2|iil score > 2
5300542|NCT00435955|Molecular remission|molecular remission
5300543|NCT00435955|High dose chemotherapy and autologous transplantation|high dose chemotherapy and autologous transplantation
5300544|NCT00435955|Rituximab|rituximab
5300545|NCT00435929|Treatment Naive|treatment naive
5300546|NCT00435916|Antigens, CD40|antigens, cd40
5300547|NCT00435916|Antibody, Monoclonal|antibody, monoclonal
5300548|NCT00435916|Lymphoma, Large B-Cell, Diffuse|lymphoma, large b-cell, diffuse
5300549|NCT00435916|Lymphoma, Non-Hodgkin|lymphoma, non-hodgkin
5300550|NCT00435916|Hematologic Diseases|hematologic diseases
5300551|NCT00435916|Immunoproliferative Disorders|immunoproliferative disorders
5300552|NCT00435916|Lymphatic Diseases|lymphatic diseases
5300553|NCT00435916|Lymphoproliferative Disorders|lymphoproliferative disorders
5300554|NCT00435916|Lymphoma|lymphoma
5300555|NCT00435903|smoking|smoking
5300556|NCT00435903|self-monitoring|self-monitoring
5300557|NCT00435903|major mental illness|major mental illness
5300558|NCT00435903|palm pilots|palm pilots
5300559|NCT00435903|subjects with DSM-IV Axis I diagnosis|subjects with dsm-iv axis i diagnosis
5300560|NCT00435890|ED Overcrowding|ed overcrowding
5300561|NCT00435890|Length of stay|length of stay
5300562|NCT00435890|Emergency triage|emergency triage
5300563|NCT00435890|triage|triage
5300564|NCT00435877|Connective Tissue|connective tissue
5300565|NCT00435877|Stromal Cells|stromal cells
5300566|NCT00435877|Surgical Waste|surgical waste
5300567|NCT00435877|In Vivo Studies|in vivo studies
5300568|NCT00435877|Tissue Analysis|tissue analysis
5300569|NCT00435864|recipient of a HSC graft in Acute Myeloblastic Leukemia therapy|recipient of a hsc graft in acute myeloblastic leukemia therapy
5300570|NCT00435864|recipient of a HSC graft in others pathologies treated in hematology of Nantes university hospital or Angers university hospital|recipient of a hsc graft in others pathologies treated in hematology of nantes university hospital or angers university hospital
5300571|NCT00435864|donors are healthy subjects|donors are healthy subjects
5300572|NCT00435838|HLa-B*5701 Abacavir|hla-b*5701 abacavir
5300573|NCT00435812|HBV vaccine|hbv vaccine
5300574|NCT00435812|Hepatitis B vaccine|hepatitis b vaccine
5300575|NCT00435812|Hepatitis B|hepatitis b
5300576|NCT00435812|Hepatitis|hepatitis
5300577|NCT00435812|HBV|hbv
5300578|NCT00435812|Immunostimulatory sequence (ISS)|immunostimulatory sequence (iss)
5300579|NCT00435799|keratoconus|keratoconus
5300580|NCT00435799|corneal cross-linking|corneal cross-linking
5300581|NCT00435799|riboflavine|riboflavine
5300582|NCT00435799|ultraviolet type A rays (UVA)|ultraviolet type a rays (uva)
5300583|NCT00435773|Osteoarthritis|osteoarthritis
5300584|NCT00435773|Leeching|leeching
5300585|NCT00435773|Randomized Controlled Trial|randomized controlled trial
5300586|NCT00435773|Arthralgia|arthralgia
5300587|NCT00435760|COPD|copd
5300588|NCT00435721|schizophrenia|schizophrenia
5300589|NCT00435721|family psychoeducation|family psychoeducation
5300590|NCT00435708|COPD|copd
5300591|NCT00435708|Fruit|fruit
5300592|NCT00435708|Vegetables|vegetables
5300593|NCT00435708|Oxidative stress|oxidative stress
5300594|NCT00435708|Inflammation|inflammation
5300595|NCT00435695|PET scan|pet scan
5300596|NCT00435695|healthy males|healthy males
5300597|NCT00435682|The trial is performed on healthy normal males.|the trial is performed on healthy normal males.
5300598|NCT00435669|Advanced or metastatic solid tumors|advanced or metastatic solid tumors
5300599|NCT00435656|Human immunodeficiency virus|human immunodeficiency virus
5300600|NCT00435643|Sleep apnea,|sleep apnea,
5300601|NCT00435643|adiponectin ,|adiponectin ,
5300602|NCT00435643|HPA axis|hpa axis
5300603|NCT00435630|Education|education
5300604|NCT00435630|Virtual Reality|virtual reality
5300605|NCT00435630|Laparoscopic Surgery|laparoscopic surgery
5300606|NCT00435630|Learning Curve|learning curve
5300607|NCT00435617|stroke rehabilitation|stroke rehabilitation
5300608|NCT00435617|stroke therapy|stroke therapy
5300609|NCT00435617|hand therapy|hand therapy
5300610|NCT00435617|stroke|stroke
5300611|NCT00435617|cerebrovascular stroke|cerebrovascular stroke
5300612|NCT00435617|cerebral stroke|cerebral stroke
5300613|NCT00435604|hyaluronidase|hyaluronidase
5300614|NCT00435604|subcutaneous drug delivery|subcutaneous drug delivery
5300615|NCT00435604|Volunteer Subjects|volunteer subjects
5300616|NCT00435591|Hyponatremia|hyponatremia
5300617|NCT00435591|Euvolemia|euvolemia
5300618|NCT00435591|Hypervolemia|hypervolemia
5300619|NCT00435591|Conivaptan|conivaptan
5300620|NCT00435591|Vaprisol®|vaprisol®
5300621|NCT00435591|YM087|ym087
5300622|NCT00435578|Recurrent Sensitive Small-Cell Lung Cancer|recurrent sensitive small-cell lung cancer
5300623|NCT00435539|Vitreomacular Traction|vitreomacular traction
5300624|NCT00435539|Maculopathy|maculopathy
5300625|NCT00435539|VMT|vmt
5300626|NCT00435539|PVD|pvd
5300627|NCT00435526|traveler's diarrhea|traveler's diarrhea
5300628|NCT00435526|ETEC diarrhea|etec diarrhea
5300629|NCT00435526|passive immunization|passive immunization
5300630|NCT00435526|bovine milk prophylaxis|bovine milk prophylaxis
5300631|NCT00435500|Dental caries, topical fluorides|dental caries, topical fluorides
5300632|NCT00435487|Non-ST Elevation Acute Coronary Syndromes coronary interventions|non-st elevation acute coronary syndromes coronary interventions
5300633|NCT00435474|Cancer|cancer
5300634|NCT00435474|Malignant wounds|malignant wounds
5300635|NCT00435474|Quality of life|quality of life
5300636|NCT00435474|Body-Image|body-image
5300637|NCT00435474|Cancer patients|cancer patients
5300638|NCT00435461|once daily|once daily
5300639|NCT00435461|mountain cedar|mountain cedar
5300640|NCT00435461|fexofenadine|fexofenadine
5300641|NCT00435461|allergic rhinitis|allergic rhinitis
5300642|NCT00435461|fluticasone furoate|fluticasone furoate
5300643|NCT00435448|Benign Prostatic Hyperplasia|benign prostatic hyperplasia
5300644|NCT00435448|BPH|bph
5300645|NCT00435448|Enlarged Prostate|enlarged prostate
5300646|NCT00435435|Alcoholism|alcoholism
5300647|NCT00435435|Dependence|dependence
5300648|NCT00435435|Randomization|randomization
5300649|NCT00435435|Effect|effect
5300650|NCT00435435|Disulfiram|disulfiram
5300651|NCT00435435|Naltrexone|naltrexone
5300652|NCT00435435|Acamprosate|acamprosate
5300653|NCT00435383|Caudal Block|caudal block
5300654|NCT00435383|Oxygen Saturation|oxygen saturation
5300655|NCT00435383|Uni or Bilateral Orchidopexy|uni or bilateral orchidopexy
5300656|NCT00435357|Mobile-bearing|mobile-bearing
5300657|NCT00435357|arthroplasty|arthroplasty
5300658|NCT00435357|fixed-bearing|fixed-bearing
5300659|NCT00435357|knee|knee
5300660|NCT00435357|patella|patella
5300661|NCT00435357|posterior stabilized TKA|posterior stabilized tka
5300662|NCT00435344|Pediatric practice|pediatric practice
5300663|NCT00435344|Smoking cessation|smoking cessation
5300664|NCT00435344|Smoking prevention|smoking prevention
5300665|NCT00435344|Adolescents|adolescents
5300666|NCT00435331|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
5300667|NCT00435331|PPH|pph
5300668|NCT00435305|continuous infusion|continuous infusion
5300669|NCT00435305|epithelial lining fluid|epithelial lining fluid
5300670|NCT00435305|antibiotics|antibiotics
5300671|NCT00435305|pneumonia|pneumonia
5300672|NCT00435305|critical illness|critical illness
5300673|NCT00435279|Insomnia|insomnia
5300674|NCT00435279|Depression|depression
5300675|NCT00435279|Major Depressive Disorder|major depressive disorder
5300676|NCT00435266|myocardial infarction|myocardial infarction
5300677|NCT00435266|remote|remote
5300678|NCT00435266|preconditioning|preconditioning
5300679|NCT00435266|perconditioning|perconditioning
5300680|NCT00435266|cardioprotection|cardioprotection
5300681|NCT00435253|emphysema|emphysema
5300682|NCT00435253|COPD|copd
5300683|NCT00435253|lung volume reduction|lung volume reduction
5300684|NCT00435253|NETT|nett
5300685|NCT00435253|BLVR|blvr
5300686|NCT00435253|biologic lung volume reduction|biologic lung volume reduction
5300687|NCT00435253|bronchoscopic lung volume reduction|bronchoscopic lung volume reduction
5300688|NCT00435227|Respiratory Syncytial Viruses|respiratory syncytial viruses
5300689|NCT00435214|Cytology|cytology
5300690|NCT00435214|papilloma virus|papilloma virus
5300691|NCT00435214|CIN|cin
5300692|NCT00435214|Screening|screening
5300693|NCT00435214|Cervix|cervix
5300694|NCT00435214|Cervical Cancer|cervical cancer
5300695|NCT00435188|Aging|aging
5300696|NCT00435188|Cost analysis|cost analysis
5300697|NCT00435188|Counseling|counseling
5300698|NCT00435188|Disabled Persons|disabled persons
5300699|NCT00435188|Health Promotion|health promotion
5300700|NCT00435188|Mobility Limitation|mobility limitation
5300701|NCT00435188|Physical Activity|physical activity
5300702|NCT00435188|Primary Care|primary care
5300703|NCT00435188|Randomized Clinical Trial|randomized clinical trial
5300704|NCT00435188|Veterans|veterans
5300705|NCT00435175|Estradiol|estradiol
5300706|NCT00435175|Lipolysis|lipolysis
5300707|NCT00435175|Estrogen receptor|estrogen receptor
5300708|NCT00435175|Adrenergic receptors|adrenergic receptors
5300709|NCT00435175|UCP2|ucp2
5300710|NCT00435175|Postmenopausal women|postmenopausal women
5300711|NCT00435162|Children|children
5300712|NCT00435162|pediatrics|pediatrics
5300713|NCT00435162|High Blood Pressure|high blood pressure
5300714|NCT00435162|Hypertension|hypertension
5300715|NCT00435162|Valsartan|valsartan
5300716|NCT00435123|Malnutrition|malnutrition
5300717|NCT00435123|ESRD|esrd
5300718|NCT00435123|Hemodialysis|hemodialysis
5300719|NCT00435110|ARDS|ards
5300720|NCT00435110|ALI|ali
5300721|NCT00435110|Mechanical Ventilation|mechanical ventilation
5300722|NCT00435110|Outcome|outcome
5300723|NCT00435097|colon cancer|colon cancer
5300724|NCT00435097|metastatic colorectal cancer|metastatic colorectal cancer
5300725|NCT00435097|MRI|mri
5300726|NCT00435097|Magnetic resonance imaging|magnetic resonance imaging
5301038|NCT00434070|HIV|hiv
5300727|NCT00435097|Early cancer detection|early cancer detection
5300728|NCT00435097|medical image processing|medical image processing
5300729|NCT00435097|machine learning|machine learning
5300730|NCT00435097|disease modeling|disease modeling
5300731|NCT00435097|Colon Cancer Stage III|colon cancer stage iii
5300732|NCT00435084|Refractory B-CLL|refractory b-cll
5300733|NCT00435084|phase I/II|phase i/ii
5300734|NCT00435084|CD38|cd38
5300735|NCT00435058|intraocular pressure|intraocular pressure
5300736|NCT00435058|contrast sensitivity|contrast sensitivity
5300737|NCT00435058|visual function|visual function
5300738|NCT00435045|Lovaza|lovaza
5300739|NCT00435045|Hyperlipidemias|hyperlipidemias
5300740|NCT00435045|Triglycerides|triglycerides
5300741|NCT00435045|Lipids|lipids
5300742|NCT00435045|omega-3 fatty acids|omega-3 fatty acids
5300743|NCT00435045|Hypercholesterolemia|hypercholesterolemia
5300744|NCT00435045|Hypertriglyceridemia|hypertriglyceridemia
5300745|NCT00435045|omega-3-acid ethyl esters|omega-3-acid ethyl esters
5300746|NCT00435045|Omacor|omacor
5300747|NCT00435045|Dyslipidemias|dyslipidemias
5300748|NCT00435032|ruptured appendicitis|ruptured appendicitis
5300749|NCT00435032|children|children
5300750|NCT00435032|surgery|surgery
5300751|NCT00435032|randomized trial|randomized trial
5300752|NCT00434993|Acute Lung Injury|acute lung injury
5300753|NCT00434993|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
5300754|NCT00434993|Albuterol|albuterol
5300755|NCT00434993|Aerosolized|aerosolized
5300756|NCT00434993|Critical Care|critical care
5300757|NCT00434993|Ventilator|ventilator
5300758|NCT00434980|Cognitive adaption|cognitive adaption
5300759|NCT00434980|Schizophrenia|schizophrenia
5300760|NCT00434980|Cognitive rehabilitation|cognitive rehabilitation
5300761|NCT00434980|Family treatment|family treatment
5300762|NCT00434980|Cognitive deficits|cognitive deficits
5300763|NCT00434980|Serious mental illness|serious mental illness
5300764|NCT00434967|Blood pressure reduction|blood pressure reduction
5300765|NCT00434967|combination therapy|combination therapy
5300766|NCT00434967|candesartan cilexetil|candesartan cilexetil
5300767|NCT00434967|hydrochlorothiazide|hydrochlorothiazide
5300768|NCT00434954|diabetes|diabetes
5300769|NCT00434954|exenatide|exenatide
5300770|NCT00434954|Byetta|byetta
5300771|NCT00434954|Amylin|amylin
5300772|NCT00434954|Lilly|lilly
5300773|NCT00434941|Administration of capecitabine concomitant to radiotherapy|administration of capecitabine concomitant to radiotherapy
5300774|NCT00434941|Her2: negative|her2: negative
5300775|NCT00434928|observational|observational
5300776|NCT00434928|dietary intake|dietary intake
5300777|NCT00434928|nutrient status|nutrient status
5300778|NCT00434928|serum assessors|serum assessors
5300779|NCT00434928|Attention-Deficit/Hyperactivity Disorder (ADHD)|attention-deficit/hyperactivity disorder (adhd)
5300780|NCT00434902|Doppler Echocardiography|doppler echocardiography
5300781|NCT00434902|Pulmonary hypertension|pulmonary hypertension
5300782|NCT00434902|Sickle cell disease|sickle cell disease
5300783|NCT00434889|dementia|dementia
5300784|NCT00434889|falls|falls
5300785|NCT00434889|risk factors|risk factors
5300786|NCT00434876|Alcoholism|alcoholism
5300787|NCT00434876|Insomnia|insomnia
5300788|NCT00434876|Quetiapine|quetiapine
5300789|NCT00434876|Seroquel|seroquel
5300790|NCT00434863|botulinum toxin type A|botulinum toxin type a
5300791|NCT00434863|Dysport®|dysport®
5300792|NCT00434863|Botox®|botox®
5300793|NCT00434863|hyperfunctional forehead lines|hyperfunctional forehead lines
5300794|NCT00434863|randomized controlled trial|randomized controlled trial
5300795|NCT00434863|double-blinded trial|double-blinded trial
5300796|NCT00434863|electromyogram (EMG)|electromyogram (emg)
5300797|NCT00434850|Insulin dependence|insulin dependence
5300798|NCT00434850|Hypoglycemia|hypoglycemia
5300799|NCT00434850|Hyperglycemia unawareness|hyperglycemia unawareness
5300800|NCT00434837|Knee|knee
5300801|NCT00434837|Ligament|ligament
5300802|NCT00434837|ACL|acl
5300803|NCT00434837|Reconstruction|reconstruction
5300804|NCT00434837|Cartilage|cartilage
5300805|NCT00434837|Osteoarthritis|osteoarthritis
5300806|NCT00434811|Insulin dependence|insulin dependence
5300807|NCT00434811|Hypoglycemia|hypoglycemia
5300808|NCT00434811|Hypoglycemia unawareness|hypoglycemia unawareness
5300809|NCT00434798|Campylobacter infections|campylobacter infections
5300810|NCT00434772|hypoglycemia|hypoglycemia
5300811|NCT00434772|glucagon|glucagon
5300812|NCT00434772|neonatal|neonatal
5300813|NCT00434772|gestational diabetes|gestational diabetes
5300814|NCT00434772|insulin|insulin
5300815|NCT00434772|glyburide|glyburide
5300816|NCT00434759|randomized controlled trial|randomized controlled trial
5300817|NCT00434759|stepped-care program|stepped-care program
5300818|NCT00434759|cognitive therapy of social phobia according to D.M. Clark|cognitive therapy of social phobia according to d.m. clark
5300819|NCT00434733|Influenza H5N1, pandemic|influenza h5n1, pandemic
5300820|NCT00434720|GlideScope|glidescope
5300821|NCT00434720|Stylet|stylet
5300822|NCT00434707|glaucoma|glaucoma
5300823|NCT00434707|catarat|catarat
5300824|NCT00434707|small pupils|small pupils
5300825|NCT00434694|Atrial Fibrillation|atrial fibrillation
5300826|NCT00434694|Catheter ablation|catheter ablation
5300827|NCT00434694|Pulmonary Vein|pulmonary vein
5300828|NCT00434668|Non-Small Cell Lung Cancer|non-small cell lung cancer
5300829|NCT00434668|NSCLC|nsclc
5300830|NCT00434668|Adjuvant chemotherapy for completely resected NSCLC|adjuvant chemotherapy for completely resected nsclc
5300831|NCT00434655|Morbid obesity|morbid obesity
5300832|NCT00434655|Bariatric surgery|bariatric surgery
5300833|NCT00434655|Obesity surgery|obesity surgery
5300834|NCT00434655|Gastric banding|gastric banding
5300835|NCT00434655|Sleeve gastrectomy|sleeve gastrectomy
5300836|NCT00434642|Avastin|avastin
5300837|NCT00434642|Ovarian carcinoma|ovarian carcinoma
5300838|NCT00434642|Peritoneal carcinoma|peritoneal carcinoma
5300839|NCT00434642|Peritoneal cancer|peritoneal cancer
5300840|NCT00434642|Fallopian tube cancer|fallopian tube cancer
5300841|NCT00434642|Fallopian tube carcinoma|fallopian tube carcinoma
5300842|NCT00434642|OCEANS|oceans
5300843|NCT00434629|lymphoma|lymphoma
5300844|NCT00434629|Non-Hodgkin's lymphoma|non-hodgkin's lymphoma
5300845|NCT00434629|B-cell lymphoma|b-cell lymphoma
5300846|NCT00434629|Radioimmunotherapy|radioimmunotherapy
5300847|NCT00434629|Bexxar|bexxar
5300848|NCT00434629|tositumomab|tositumomab
5300849|NCT00434629|autologous hematopoietic stem cell transplantation|autologous hematopoietic stem cell transplantation
5300850|NCT00434616|angiogenesis|angiogenesis
5300851|NCT00434616|Arterial Occlusive Diseases|arterial occlusive diseases
5300852|NCT00434616|Leg Ulcer|leg ulcer
5300853|NCT00434616|Gangrene|gangrene
5300854|NCT00434616|Ischemia|ischemia
5300855|NCT00434616|PAOD|paod
5300856|NCT00434616|Amputation|amputation
5300857|NCT00434616|bone marrow|bone marrow
5300858|NCT00434590|Kidney Transplantation|kidney transplantation
5300859|NCT00434590|Mycophenolic Acid|mycophenolic acid
5300860|NCT00434590|Immunosuppression|immunosuppression
5300861|NCT00434590|Cyclosporine|cyclosporine
5300862|NCT00434577|GSK Biologicals|gsk biologicals
5300863|NCT00434577|Herpes Zoster (HZ)|herpes zoster (hz)
5300864|NCT00434577|Vaccine|vaccine
5300865|NCT00434577|Varicella Zoster Virus (VZV)|varicella zoster virus (vzv)
5300866|NCT00434577|Shingles|shingles
5300867|NCT00434564|Stress nuclear scan|stress nuclear scan
5300868|NCT00434564|Acute chest pain|acute chest pain
5300869|NCT00434551|small bowel Crohn's disease|small bowel crohn's disease
5300870|NCT00434551|capsule endoscopy|capsule endoscopy
5300871|NCT00434551|PillCam SB|pillcam sb
5300872|NCT00434551|Patients with suspected small bowel Crohn's disease|patients with suspected small bowel crohn's disease
5300873|NCT00434538|Diabetic|diabetic
5300874|NCT00434538|Foot|foot
5300875|NCT00434538|Ulcer|ulcer
5300876|NCT00434538|Neuropathic|neuropathic
5300877|NCT00434538|Chitosan|chitosan
5300878|NCT00434525|Morbid obesity|morbid obesity
5300879|NCT00434525|Bariatric Surgery|bariatric surgery
5300880|NCT00434525|Obesity Surgery|obesity surgery
5300881|NCT00434525|Omentectomy|omentectomy
5300882|NCT00434525|Sleeve gastrectomy|sleeve gastrectomy
5300883|NCT00434512|Gag|gag
5300884|NCT00434512|vaccine|vaccine
5300885|NCT00434512|adjuvant|adjuvant
5300886|NCT00434512|HIV|hiv
5300887|NCT00434512|Pol|pol
5300888|NCT00434512|Nef|nef
5300889|NCT00434499|Green Tea|green tea
5300890|NCT00434499|Insulin Resistance|insulin resistance
5300891|NCT00434499|Endothelial Dysfunction|endothelial dysfunction
5300892|NCT00434499|Nitric Oxide|nitric oxide
5300893|NCT00434499|Inflammation|inflammation
5300894|NCT00434499|Obesity|obesity
5300895|NCT00434499|Overweight|overweight
5300896|NCT00434499|Diabetes Type 2|diabetes type 2
5300897|NCT00434499|High Blood Pressure|high blood pressure
5300898|NCT00434499|Healthy Volunteer|healthy volunteer
5300899|NCT00434499|HV|hv
5300900|NCT00434460|Ventilator Associated Pneumonia|ventilator associated pneumonia
5300901|NCT00434460|Knowledge Translation|knowledge translation
5300902|NCT00434460|Clinical Practice Guidelines|clinical practice guidelines
5300903|NCT00434460|Education|education
5300904|NCT00434460|Behaviour Change|behaviour change
5300905|NCT00434447|Prostate Cancer|prostate cancer
5300906|NCT00434447|Breast Cancer|breast cancer
5300907|NCT00434447|Multiple Myeloma|multiple myeloma
5300908|NCT00434447|Zoledronic acid|zoledronic acid
5300909|NCT00434447|Bone metastases|bone metastases
5300910|NCT00434447|Skeletal Related Events (SREs)|skeletal related events (sres)
5300911|NCT00434447|Renal Impairment|renal impairment
5300912|NCT00434447|Osteonecrosis of the Jaw (ONJ)|osteonecrosis of the jaw (onj)
5300913|NCT00434447|Bone involvement|bone involvement
5300914|NCT00434447|Multiple Myeloma (MM)|multiple myeloma (mm)
5300915|NCT00434434|AQUA|aqua
5300916|NCT00434434|anti-CD11|anti-cd11
5300917|NCT00434434|CD11a|cd11a
5300918|NCT00434434|Asthma|asthma
5300919|NCT00434434|Allergy|allergy
5300920|NCT00434421|Perennial Allergic Rhinitis|perennial allergic rhinitis
5300921|NCT00434421|Asthma|asthma
5300922|NCT00434421|Sublingual Immunotherapy (SLIT)|sublingual immunotherapy (slit)
5300923|NCT00434408|omphalitis|omphalitis
5300924|NCT00434408|neonates|neonates
5300925|NCT00434408|umbilical cord|umbilical cord
5300926|NCT00434408|infection|infection
5300927|NCT00434408|infant mortality|infant mortality
5300928|NCT00434408|neonate morbidity|neonate morbidity
5300929|NCT00434408|chlorhexidine|chlorhexidine
5300930|NCT00434382|auditory evoked potentials|auditory evoked potentials
5300931|NCT00434382|sensory processing|sensory processing
5300932|NCT00434382|monitoring|monitoring
5300933|NCT00434382|general anesthesia|general anesthesia
5300934|NCT00434356|Avastin|avastin
5300935|NCT00434356|MBC|mbc
5300936|NCT00434356|Breast Cancer|breast cancer
5300937|NCT00434356|Sutent|sutent
5300938|NCT00434343|Interstitial Cystitis|interstitial cystitis
5300939|NCT00434343|Painful Bladder Syndrome|painful bladder syndrome
5300940|NCT00434343|Chronic Prostatitis|chronic prostatitis
5300941|NCT00434343|Chronic Pelvic Pain Syndrome|chronic pelvic pain syndrome
5300942|NCT00434330|anemia|anemia
5300943|NCT00434330|chronic kidney disease|chronic kidney disease
5300944|NCT00434330|CKD|ckd
5300945|NCT00434330|chronic renal failure|chronic renal failure
5300946|NCT00434330|CRF|crf
5300947|NCT00434330|dialysis|dialysis
5300948|NCT00434330|erythropoietin|erythropoietin
5300949|NCT00434330|EPO|epo
5300950|NCT00434330|erythropoiesis stimulating agent|erythropoiesis stimulating agent
5300951|NCT00434330|ESA|esa
5300952|NCT00434330|Hematide™|hematide™
5300953|NCT00434330|hemodialysis|hemodialysis
5300954|NCT00434330|hemoglobin|hemoglobin
5300955|NCT00434330|Hb|hb
5300956|NCT00434330|Hgb|hgb
5300957|NCT00434330|Omontys|omontys
5300958|NCT00434330|peginesatide|peginesatide
5300959|NCT00434330|red blood cell|red blood cell
5300960|NCT00434330|red blood cell production|red blood cell production
5300961|NCT00434317|Metastasis|metastasis
5300962|NCT00434317|Neoplasm|neoplasm
5300963|NCT00434317|pain|pain
5300964|NCT00434317|breast cancer|breast cancer
5300965|NCT00434317|prostate cancer|prostate cancer
5300966|NCT00434317|bone metastasis|bone metastasis
5300967|NCT00434304|Parkinson's Disease|parkinson's disease
5300968|NCT00434304|PD|pd
5300969|NCT00434291|Community-acquired Pneumonia|community-acquired pneumonia
5300970|NCT00434291|fluoroquinolone|fluoroquinolone
5300971|NCT00434291|TG-873870|tg-873870
5300972|NCT00434291|Nemonoxacin|nemonoxacin
5300973|NCT00434278|Lung disease|lung disease
5300974|NCT00434278|CF|cf
5300975|NCT00434278|Pulmozyme|pulmozyme
5300976|NCT00434265|Obesity|obesity
5300977|NCT00434265|Exercise|exercise
5300978|NCT00434265|Fat oxidation|fat oxidation
5300979|NCT00434265|Overweigh (IMC>25 and IMC<30)|overweigh (imc>25 and imc<30)
5300980|NCT00434252|Avastin|avastin
5300981|NCT00434252|BEAM|beam
5300982|NCT00434252|Metastatic melanoma|metastatic melanoma
5300983|NCT00434239|Myelodysplasia|myelodysplasia
5300984|NCT00434239|Lenalidomide|lenalidomide
5300985|NCT00434239|Ancestim|ancestim
5300986|NCT00434239|Pilot trial|pilot trial
5300987|NCT00434239|Biomarkers|biomarkers
5300988|NCT00434226|SABER-L|saber-l
5300989|NCT00434226|NSCLC|nsclc
5300990|NCT00434226|Avastin|avastin
5300991|NCT00434226|Sutent|sutent
5300992|NCT00434200|rheumatoid arthritis|rheumatoid arthritis
5300993|NCT00434200|exercise|exercise
5300994|NCT00434200|damage|damage
5300995|NCT00434187|healthy|healthy
5300996|NCT00434174|Lung cancer|lung cancer
5300997|NCT00434174|Non small cell lung cancer|non small cell lung cancer
5300998|NCT00434174|NSCLC|nsclc
5300999|NCT00434174|RAD001|rad001
5301000|NCT00434174|Everolimus|everolimus
5301001|NCT00434174|Afinitor|afinitor
5301002|NCT00434174|Pemetrexed|pemetrexed
5301003|NCT00434161|Palifermin|palifermin
5301004|NCT00434161|KGF|kgf
5301005|NCT00434161|Clinical Trial|clinical trial
5301006|NCT00434161|Oncology|oncology
5301007|NCT00434161|Oral Mucositis|oral mucositis
5301008|NCT00434161|Multiple Myeloma|multiple myeloma
5301009|NCT00434161|Cataract|cataract
5301010|NCT00434148|Cushing's Disease|cushing's disease
5301011|NCT00434148|pasireotide|pasireotide
5301012|NCT00434148|SOM230|som230
5301013|NCT00434135|gemcitabine|gemcitabine
5301014|NCT00434135|pemetrexed|pemetrexed
5301015|NCT00434135|non-small cell lung cancer|non-small cell lung cancer
5301016|NCT00434122|Assisted Reproductive Technology (ART)|assisted reproductive technology (art)
5301017|NCT00434122|oocyte donors undergoing controlled ovarian hyperstimulation for assisted reproductive technologies|oocyte donors undergoing controlled ovarian hyperstimulation for assisted reproductive technologies
5301018|NCT00434109|Carcinoid|carcinoid
5301019|NCT00434109|Pancreatic|pancreatic
5301020|NCT00434109|Metastatic|metastatic
5301021|NCT00434109|Neuroendocrine|neuroendocrine
5301022|NCT00434109|Tumors|tumors
5301023|NCT00434109|Hepatic|hepatic
5301024|NCT00434109|Artery|artery
5301025|NCT00434109|Embolization|embolization
5301026|NCT00434109|Angiogenesis|angiogenesis
5301027|NCT00434109|Sunitinib|sunitinib
5301028|NCT00434109|Malate|malate
5301029|NCT00434109|Sutent|sutent
5301030|NCT00434109|Tyrosine|tyrosine
5301031|NCT00434109|Kinase|kinase
5301032|NCT00434109|Inhibitor|inhibitor
5301033|NCT00434096|Obesity disease|obesity disease
5301034|NCT00434096|cannabinoid-1 receptor|cannabinoid-1 receptor
5301035|NCT00434083|TREXIMA|trexima
5301036|NCT00434083|MIGRAINE HEADACHES|migraine headaches
5301037|NCT00434083|Subjects may be enrolled if they are 18-65 years of age, have a demonstrated history of migraine headaches|subjects may be enrolled if they are 18-65 years of age, have a demonstrated history of migraine headaches
5301039|NCT00434070|Antiretrovial Therapy|antiretrovial therapy
5301040|NCT00434070|Resistance|resistance
5301041|NCT00434070|Monitoring|monitoring
5301042|NCT00434070|TAMS|tams
5301043|NCT00434070|Treatment Experienced|treatment experienced
5301044|NCT00434057|Pigmented Skin Lesions|pigmented skin lesions
5301045|NCT00434057|Dermatology|dermatology
5301046|NCT00434057|Skin Cancer|skin cancer
5301047|NCT00434057|Melanoma|melanoma
5301048|NCT00434057|MelaFind|melafind
5301049|NCT00434031|locally advanced|locally advanced
5301050|NCT00434031|stage II|stage ii
5301051|NCT00434031|stage IIIa|stage iiia
5301052|NCT00434031|stage IIIb|stage iiib
5301053|NCT00434031|HER-2 positive|her-2 positive
5301054|NCT00434031|primary|primary
5301055|NCT00434018|Wheelchairs|wheelchairs
5301056|NCT00434018|Safety|safety
5301057|NCT00434005|Air pollution|air pollution
5301058|NCT00434005|diesel|diesel
5301059|NCT00434005|antioxidant|antioxidant
5301060|NCT00434005|oxidative stress|oxidative stress
5301061|NCT00434005|endothelial|endothelial
5301062|NCT00434005|HRV|hrv
5301063|NCT00434005|BAR|bar
5301064|NCT00433992|Mitochondria|mitochondria
5301065|NCT00433992|Fat apoptosis|fat apoptosis
5301066|NCT00433992|Lipoatrophy|lipoatrophy
5301067|NCT00433992|Lipodystrophy|lipodystrophy
5301068|NCT00433992|Thymidine|thymidine
5301069|NCT00433992|Treatment experienced|treatment experienced
5301070|NCT00433979|Anti-HIV agents|anti-hiv agents
5301071|NCT00433979|Physiological Effects of Drugs|physiological effects of drugs
5301072|NCT00433979|ARV-associated Adverse Events|arv-associated adverse events
5301073|NCT00433979|HAART|haart
5301074|NCT00433979|Pharmacokinetics|pharmacokinetics
5301075|NCT00433979|Protease Inhibitors|protease inhibitors
5301076|NCT00433979|Non-nucleoside Reverse Transcriptase Inhibitors|non-nucleoside reverse transcriptase inhibitors
5301077|NCT00433979|Women|women
5301078|NCT00433966|Myocardial Infarction|myocardial infarction
5301079|NCT00433966|Angioplasty|angioplasty
5301080|NCT00433966|Myocardial Ischemia|myocardial ischemia
5301081|NCT00433966|Myocardial Reperfusion|myocardial reperfusion
5301082|NCT00433966|Stents|stents
5301083|NCT00433966|Heart Disease|heart disease
5301084|NCT00433953|Pediatric Kidney Transplant|pediatric kidney transplant
5301085|NCT00433953|Kidney Transplant|kidney transplant
5301086|NCT00433953|CellCept|cellcept
5301087|NCT00433953|Mycophenolate Mofetil|mycophenolate mofetil
5301088|NCT00433953|Mycophenolic Acid|mycophenolic acid
5301089|NCT00433940|Hemangioma|hemangioma
5301090|NCT00433940|Corticosteroid|corticosteroid
5301091|NCT00433940|Prednisone|prednisone
5301092|NCT00433927|metastatic|metastatic
5301093|NCT00433914|Meningococcal disease, prevention, vaccination|meningococcal disease, prevention, vaccination
5301094|NCT00433901|obesity in children|obesity in children
5301095|NCT00433901|childhood disorders|childhood disorders
5301096|NCT00433901|overweight children|overweight children
5301097|NCT00433901|physical activity|physical activity
5301098|NCT00433901|home environment|home environment
5301099|NCT00433862|Polycythemia Vera|polycythemia vera
5301100|NCT00433862|Essential Thrombocytosis|essential thrombocytosis
5301101|NCT00433862|Idiopathic Myelofibrosis|idiopathic myelofibrosis
5301102|NCT00433862|Janus Kinase 2|janus kinase 2
5301103|NCT00433862|CD177|cd177
5301104|NCT00433862|Chronic Myeloproliferative Disorders|chronic myeloproliferative disorders
5301105|NCT00433862|PV|pv
5301106|NCT00433862|Essential Thrombocythemia|essential thrombocythemia
5301107|NCT00433862|ET|et
5301108|NCT00433862|IM|im
5301109|NCT00433836|Children|children
5301110|NCT00433836|pediatrics|pediatrics
5301111|NCT00433836|High Blood Pressure|high blood pressure
5301112|NCT00433836|Hypertension|hypertension
5301113|NCT00433836|Valsartan|valsartan
5301114|NCT00433836|enalapril|enalapril
5301115|NCT00433823|Very low level of LDL|very low level of ldl
5301116|NCT00433823|Steroid hormones|steroid hormones
5301117|NCT00433823|Atorvastatin|atorvastatin
5301118|NCT00433823|Ezetimibe|ezetimibe
5301119|NCT00433823|Lipoprotein-a|lipoprotein-a
5301120|NCT00433810|obesity|obesity
5301121|NCT00433810|bariatric surgery|bariatric surgery
5301122|NCT00433810|30-day mortality|30-day mortality
5301123|NCT00433797|Prostate cancer|prostate cancer
5301124|NCT00433797|PSA|psa
5301125|NCT00433797|antioxidant|antioxidant
5301126|NCT00433797|phytochemical|phytochemical
5301127|NCT00433797|tomatoes|tomatoes
5301128|NCT00433797|PUFA|pufa
5301129|NCT00433797|selenium|selenium
5301130|NCT00433797|soy|soy
5301131|NCT00433797|pomegranate|pomegranate
5301132|NCT00433797|grapes|grapes
5301133|NCT00433784|clopidogrel|clopidogrel
5301134|NCT00433784|platelet aggregation|platelet aggregation
5301135|NCT00433784|CYP3A|cyp3a
5301136|NCT00433784|H2 haplotype|h2 haplotype
5301137|NCT00433784|polymorphisms|polymorphisms
5301138|NCT00433771|Malignant|malignant
5301139|NCT00433771|Cholestasis, Extrahepatic|cholestasis, extrahepatic
5301140|NCT00433771|Biliary obstruction|biliary obstruction
5301141|NCT00433758|Diabetes|diabetes
5301142|NCT00433758|Blood glucose monitoring|blood glucose monitoring
5301143|NCT00433758|Non invasive Blood glucose monitoring|non invasive blood glucose monitoring
5301402|NCT00433004|Teen|teen
5301144|NCT00433745|Myelodysplastic Syndrome (MDS)|myelodysplastic syndrome (mds)
5301145|NCT00433745|Acute Myelogenous Leukemia (AML)|acute myelogenous leukemia (aml)
5301146|NCT00433745|Chronic Myelogenous Leukemia (CML)|chronic myelogenous leukemia (cml)
5301147|NCT00433745|Acute Lymphoblastic Leukemia (ALL)|acute lymphoblastic leukemia (all)
5301148|NCT00433745|Wilm's Tumor-1 Peptide|wilm's tumor-1 peptide
5301149|NCT00433745|Leukemia|leukemia
5301150|NCT00433745|Myelodysplastic Syndrome|myelodysplastic syndrome
5301151|NCT00433745|MDS|mds
5301152|NCT00433745|Acute Myelogenous Leukemia|acute myelogenous leukemia
5301153|NCT00433745|AML|aml
5301154|NCT00433745|Chronic Myelogenous Leukemia|chronic myelogenous leukemia
5301155|NCT00433745|CML|cml
5301156|NCT00433745|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
5301157|NCT00433745|ALL|all
5301158|NCT00433732|TREXIMA|trexima
5301159|NCT00433732|MIGRAINE HEADACHES|migraine headaches
5301160|NCT00433732|Subjects may be enrolled if they are 18-65 years of age, have a demonstrated history of migraine headaches|subjects may be enrolled if they are 18-65 years of age, have a demonstrated history of migraine headaches
5301161|NCT00433719|Human immunodeficiency virus|human immunodeficiency virus
5301162|NCT00433719|Tuberculous meningitis|tuberculous meningitis
5301163|NCT00433719|Treatment Naive|treatment naive
5301164|NCT00433706|Prostate adenocarcinoma treated by radiotherapy|prostate adenocarcinoma treated by radiotherapy
5301165|NCT00433680|adolescent|adolescent
5301166|NCT00433680|female|female
5301167|NCT00433680|obesity|obesity
5301168|NCT00433680|body dissatisfaction|body dissatisfaction
5301169|NCT00433667|RWJ-333369|rwj-333369
5301170|NCT00433667|anticonvulsants|anticonvulsants
5301171|NCT00433667|antiepileptic drugs|antiepileptic drugs
5301172|NCT00433654|Bradycardia|bradycardia
5301173|NCT00433654|Slow heart beat|slow heart beat
5301174|NCT00433654|Magnetic resonance imaging (MRI)|magnetic resonance imaging (mri)
5301175|NCT00433641|obesity|obesity
5301176|NCT00433641|pharmacogenetics|pharmacogenetics
5301177|NCT00433641|sibutramine|sibutramine
5301178|NCT00433641|adrenergic|adrenergic
5301179|NCT00433641|serotonergic|serotonergic
5301180|NCT00433641|body composition|body composition
5301181|NCT00433641|gastric emptying|gastric emptying
5301182|NCT00433628|Hemoglobin A1C|hemoglobin a1c
5301183|NCT00433628|HIV|hiv
5301184|NCT00433628|Diabetes|diabetes
5301185|NCT00433628|Diabetes Type 2|diabetes type 2
5301186|NCT00433628|Hyperglycemia|hyperglycemia
5301187|NCT00433602|thromboembolism|thromboembolism
5301188|NCT00433602|recurrent breast cancer|recurrent breast cancer
5301189|NCT00433602|stage IV breast cancer|stage iv breast cancer
5301190|NCT00433602|recurrent colon cancer|recurrent colon cancer
5301191|NCT00433602|stage I colon cancer|stage i colon cancer
5301192|NCT00433602|stage II colon cancer|stage ii colon cancer
5301193|NCT00433602|stage III colon cancer|stage iii colon cancer
5301194|NCT00433602|stage IV colon cancer|stage iv colon cancer
5301195|NCT00433602|recurrent rectal cancer|recurrent rectal cancer
5301196|NCT00433602|stage I rectal cancer|stage i rectal cancer
5301197|NCT00433602|stage II rectal cancer|stage ii rectal cancer
5301198|NCT00433602|stage III rectal cancer|stage iii rectal cancer
5301199|NCT00433602|stage IV rectal cancer|stage iv rectal cancer
5301200|NCT00433602|recurrent gastric cancer|recurrent gastric cancer
5301201|NCT00433602|stage I gastric cancer|stage i gastric cancer
5301202|NCT00433602|stage II gastric cancer|stage ii gastric cancer
5301203|NCT00433602|stage III gastric cancer|stage iii gastric cancer
5301204|NCT00433602|stage IV gastric cancer|stage iv gastric cancer
5301205|NCT00433602|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5301206|NCT00433602|stage I non-small cell lung cancer|stage i non-small cell lung cancer
5301207|NCT00433602|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
5301208|NCT00433602|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5301209|NCT00433602|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5301210|NCT00433602|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5301211|NCT00433602|recurrent small cell lung cancer|recurrent small cell lung cancer
5301212|NCT00433602|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5301213|NCT00433602|stage I ovarian epithelial cancer|stage i ovarian epithelial cancer
5301214|NCT00433602|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
5301215|NCT00433602|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5301216|NCT00433602|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5301217|NCT00433602|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
5301218|NCT00433602|stage I ovarian germ cell tumor|stage i ovarian germ cell tumor
5301219|NCT00433602|stage II ovarian germ cell tumor|stage ii ovarian germ cell tumor
5301220|NCT00433602|stage III ovarian germ cell tumor|stage iii ovarian germ cell tumor
5301221|NCT00433602|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
5301222|NCT00433602|ovarian sarcoma|ovarian sarcoma
5301223|NCT00433602|ovarian stromal cancer|ovarian stromal cancer
5301224|NCT00433602|recurrent pancreatic cancer|recurrent pancreatic cancer
5301225|NCT00433602|stage I pancreatic cancer|stage i pancreatic cancer
5301226|NCT00433602|stage II pancreatic cancer|stage ii pancreatic cancer
5301227|NCT00433602|stage III pancreatic cancer|stage iii pancreatic cancer
5301228|NCT00433602|stage IV pancreatic cancer|stage iv pancreatic cancer
5301229|NCT00433602|recurrent prostate cancer|recurrent prostate cancer
5301230|NCT00433602|stage III prostate cancer|stage iii prostate cancer
5301231|NCT00433602|stage IV prostate cancer|stage iv prostate cancer
5301232|NCT00433602|extensive stage small cell lung cancer|extensive stage small cell lung cancer
5301233|NCT00433602|limited stage small cell lung cancer|limited stage small cell lung cancer
5301234|NCT00433602|stage IIB prostate cancer|stage iib prostate cancer
5301235|NCT00433602|stage IIA prostate cancer|stage iia prostate cancer
5301236|NCT00433602|male breast cancer|male breast cancer
5301237|NCT00433589|invasive ductal breast carcinoma|invasive ductal breast carcinoma
5301238|NCT00433589|invasive lobular breast carcinoma|invasive lobular breast carcinoma
5301239|NCT00433589|stage IA breast cancer|stage ia breast cancer
5301240|NCT00433589|stage IB breast cancer|stage ib breast cancer
5301241|NCT00433589|stage II breast cancer|stage ii breast cancer
5301242|NCT00433589|estrogen receptor-positive breast cancer|estrogen receptor-positive breast cancer
5301243|NCT00433589|progesterone receptor-positive breast cancer|progesterone receptor-positive breast cancer
5301244|NCT00433563|limited stage small cell lung cancer|limited stage small cell lung cancer
5301245|NCT00433524|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5301246|NCT00433498|extensive stage small cell lung cancer|extensive stage small cell lung cancer
5301247|NCT00433498|limited stage small cell lung cancer|limited stage small cell lung cancer
5301248|NCT00433485|basal cell carcinoma of the skin|basal cell carcinoma of the skin
5301249|NCT00433485|nevoid basal cell carcinoma syndrome|nevoid basal cell carcinoma syndrome
5301250|NCT00433472|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
5301251|NCT00433472|adult giant cell glioblastoma|adult giant cell glioblastoma
5301252|NCT00433472|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5301253|NCT00433472|recurrent adult brain tumor|recurrent adult brain tumor
5301254|NCT00433472|adult glioblastoma|adult glioblastoma
5301255|NCT00433472|adult gliosarcoma|adult gliosarcoma
5301256|NCT00433459|childhood lymphocyte depletion Hodgkin lymphoma|childhood lymphocyte depletion hodgkin lymphoma
5301257|NCT00433459|childhood mixed cellularity Hodgkin lymphoma|childhood mixed cellularity hodgkin lymphoma
5301258|NCT00433459|childhood nodular sclerosis Hodgkin lymphoma|childhood nodular sclerosis hodgkin lymphoma
5301259|NCT00433459|stage I childhood Hodgkin lymphoma|stage i childhood hodgkin lymphoma
5301260|NCT00433459|stage II childhood Hodgkin lymphoma|stage ii childhood hodgkin lymphoma
5301261|NCT00433459|stage III childhood Hodgkin lymphoma|stage iii childhood hodgkin lymphoma
5301262|NCT00433459|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
5301263|NCT00433446|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5301264|NCT00433446|stage IV prostate cancer|stage iv prostate cancer
5301265|NCT00433446|recurrent prostate cancer|recurrent prostate cancer
5301266|NCT00433433|adult mixed cellularity Hodgkin lymphoma|adult mixed cellularity hodgkin lymphoma
5301267|NCT00433433|adult nodular sclerosis Hodgkin lymphoma|adult nodular sclerosis hodgkin lymphoma
5301268|NCT00433433|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
5301269|NCT00433433|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
5301270|NCT00433433|adult lymphocyte depletion Hodgkin lymphoma|adult lymphocyte depletion hodgkin lymphoma
5301271|NCT00433420|stage II breast cancer|stage ii breast cancer
5301272|NCT00433420|stage IIIA breast cancer|stage iiia breast cancer
5301273|NCT00433420|stage IIIB breast cancer|stage iiib breast cancer
5301274|NCT00433420|stage IIIC breast cancer|stage iiic breast cancer
5301275|NCT00433407|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5301276|NCT00433407|stage I breast cancer|stage i breast cancer
5301277|NCT00433407|stage II breast cancer|stage ii breast cancer
5301278|NCT00433407|stage IIIA breast cancer|stage iiia breast cancer
5301279|NCT00433407|stage IIIB breast cancer|stage iiib breast cancer
5301280|NCT00433407|stage IIIC breast cancer|stage iiic breast cancer
5301281|NCT00433407|stage IV breast cancer|stage iv breast cancer
5301282|NCT00433407|male breast cancer|male breast cancer
5301283|NCT00433407|recurrent breast cancer|recurrent breast cancer
5301284|NCT00433407|stage I ovarian epithelial cancer|stage i ovarian epithelial cancer
5301285|NCT00433407|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
5301286|NCT00433407|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5301287|NCT00433407|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5301288|NCT00433407|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5301289|NCT00433407|stage I non-small cell lung cancer|stage i non-small cell lung cancer
5301290|NCT00433407|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
5301291|NCT00433407|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5301292|NCT00433407|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5301293|NCT00433407|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5301294|NCT00433407|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5301295|NCT00433407|extensive stage small cell lung cancer|extensive stage small cell lung cancer
5301296|NCT00433407|limited stage small cell lung cancer|limited stage small cell lung cancer
5301297|NCT00433407|recurrent small cell lung cancer|recurrent small cell lung cancer
5301298|NCT00433407|stage I prostate cancer|stage i prostate cancer
5301299|NCT00433407|stage IIB prostate cancer|stage iib prostate cancer
5301300|NCT00433407|stage IIA prostate cancer|stage iia prostate cancer
5301301|NCT00433407|stage III prostate cancer|stage iii prostate cancer
5301302|NCT00433407|stage IV prostate cancer|stage iv prostate cancer
5301303|NCT00433407|recurrent prostate cancer|recurrent prostate cancer
5301304|NCT00433407|stage I uterine sarcoma|stage i uterine sarcoma
5301305|NCT00433407|stage II uterine sarcoma|stage ii uterine sarcoma
5301306|NCT00433407|stage III uterine sarcoma|stage iii uterine sarcoma
5301307|NCT00433407|stage IV uterine sarcoma|stage iv uterine sarcoma
5301308|NCT00433407|recurrent uterine sarcoma|recurrent uterine sarcoma
5301309|NCT00433394|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
5301310|NCT00433368|L-ornithine-L-aspartate,|l-ornithine-l-aspartate,
5301311|NCT00433368|porto-systemic encephalopathy,|porto-systemic encephalopathy,
5301312|NCT00433368|hepatic encephalopathy,|hepatic encephalopathy,
5301313|NCT00433368|liver cirrhosis,|liver cirrhosis,
5301314|NCT00433368|mental state|mental state
5301315|NCT00433355|Chronic Fatigue Syndrome|chronic fatigue syndrome
5301316|NCT00433355|Epstein-Barr Virus|epstein-barr virus
5301317|NCT00433342|Antibiotic|antibiotic
5301318|NCT00433342|p-cresol|p-cresol
5301319|NCT00433342|peritoneal dialysis|peritoneal dialysis
5301320|NCT00433329|pulmonary arterial hypertension|pulmonary arterial hypertension
5301321|NCT00433329|bosentan|bosentan
5301322|NCT00433329|sildenafil|sildenafil
5301323|NCT00433329|combination therapy|combination therapy
5301324|NCT00433329|Compass 3|compass 3
5301325|NCT00433316|ropivacaine|ropivacaine
5301326|NCT00433316|laparoscopy|laparoscopy
5301327|NCT00433316|intraperitoneal|intraperitoneal
5301328|NCT00433316|nebulization|nebulization
5301329|NCT00433316|pain|pain
5301330|NCT00433316|local analgesic|local analgesic
5301331|NCT00433316|gynecology|gynecology
5301332|NCT00433264|peritoneal dialysis|peritoneal dialysis
5301333|NCT00433264|endothelium|endothelium
5301334|NCT00433264|endothelial dysfunction|endothelial dysfunction
5301335|NCT00433238|elderly|elderly
5301336|NCT00433238|Chinese|chinese
5301337|NCT00433238|community living|community living
5301338|NCT00433238|measurement|measurement
5301339|NCT00433238|depression|depression
5301340|NCT00433238|dementia|dementia
5301341|NCT00433238|Geriatric Depression Scale|geriatric depression scale
5301342|NCT00433238|MiniCog|minicog
5301343|NCT00433212|prematurity|prematurity
5301344|NCT00433212|respiratory insufficiency|respiratory insufficiency
5301345|NCT00433212|non-invasive ventilation|non-invasive ventilation
5301346|NCT00433212|bronchopulmonary dysplasia|bronchopulmonary dysplasia
5301347|NCT00433212|hyaline membrane disease|hyaline membrane disease
5301348|NCT00433199|Hypogonadism|hypogonadism
5301349|NCT00433199|Testosterone Deficiency|testosterone deficiency
5301350|NCT00433186|Scleroderma|scleroderma
5301351|NCT00433173|testosterone|testosterone
5301352|NCT00433173|insulin sensitivity|insulin sensitivity
5301353|NCT00433173|insulin resistance|insulin resistance
5301354|NCT00433173|metabolic disorders|metabolic disorders
5301355|NCT00433147|afegostat tartrate|afegostat tartrate
5301356|NCT00433147|isofagomine tartrate|isofagomine tartrate
5301357|NCT00433147|AT2101|at2101
5301358|NCT00433147|Amicus Therapeutics|amicus therapeutics
5301359|NCT00433134|renal transplant recipient|renal transplant recipient
5301360|NCT00433134|adherence|adherence
5301361|NCT00433134|compliance|compliance
5301362|NCT00433134|immunosuppression|immunosuppression
5301363|NCT00433121|Antidepressive Agents|antidepressive agents
5301364|NCT00433121|Neuroleptica|neuroleptica
5301365|NCT00433121|Dementia|dementia
5301366|NCT00433121|Discontinuation study|discontinuation study
5301367|NCT00433121|Behavioural- and Psychological Symptoms in Dementia|behavioural- and psychological symptoms in dementia
5301368|NCT00433108|Hepatitis C|hepatitis c
5301369|NCT00433108|antioxidant|antioxidant
5301370|NCT00433108|liver enzymes|liver enzymes
5301372|NCT00433095|Navelbine|navelbine
5301373|NCT00433095|Herceptin|herceptin
5301374|NCT00433095|oral|oral
5301375|NCT00433095|breast cancer|breast cancer
5301376|NCT00433082|Metabolic syndrome,Ramadan,Fasting,Inflammatory markers,|metabolic syndrome,ramadan,fasting,inflammatory markers,
5301377|NCT00433082|Iran|iran
5301378|NCT00433069|Chronic hepatitis C|chronic hepatitis c
5301379|NCT00433069|Insulin resistance|insulin resistance
5301380|NCT00433069|Pioglitazone|pioglitazone
5301381|NCT00433069|Non-responders|non-responders
5301382|NCT00433056|STI|sti
5301383|NCT00433056|HIV|hiv
5301384|NCT00433056|CD4|cd4
5301385|NCT00433056|HIV-RNA|hiv-rna
5301386|NCT00433056|HAART|haart
5301387|NCT00433043|Heart Failure|heart failure
5301388|NCT00433043|Beta blockers|beta blockers
5301389|NCT00433043|Resynchronization|resynchronization
5301390|NCT00433043|Congestive Heart Failure, NYHA III-IV|congestive heart failure, nyha iii-iv
5301391|NCT00433043|Candidate for BIVPM|candidate for bivpm
5301392|NCT00433043|Not on Target Dose (Coreg 25 Bid or Toprol XL 200 qd)|not on target dose (coreg 25 bid or toprol xl 200 qd)
5301393|NCT00433030|Highly Active Antiretroviral Therapy|highly active antiretroviral therapy
5301394|NCT00433030|HIV Viral load|hiv viral load
5301395|NCT00433030|HIV drug Resistance|hiv drug resistance
5301396|NCT00433030|Thailand|thailand
5301397|NCT00433017|Age-related macular degeneration|age-related macular degeneration
5301398|NCT00433017|AMD|amd
5301399|NCT00433017|Choroidal neovascularization|choroidal neovascularization
5301400|NCT00433017|Verteporfin|verteporfin
5301401|NCT00433017|Ranibizumab|ranibizumab
5301403|NCT00433004|Plan B|plan b
5301404|NCT00433004|Post Partum|post partum
5301405|NCT00433004|Emergency Contraception|emergency contraception
5301406|NCT00432991|Nausea|nausea
5301407|NCT00432991|Vomiting|vomiting
5301408|NCT00432991|Cesarean Section|cesarean section
5301409|NCT00432978|hypoxia|hypoxia
5301410|NCT00432978|endothelin|endothelin
5301411|NCT00432978|exercise|exercise
5301412|NCT00432965|Wound closure|wound closure
5301413|NCT00432965|Accelerated healing|accelerated healing
5301414|NCT00432952|Cardiovascular Heart Disease|cardiovascular heart disease
5301415|NCT00432939|Primary Hyperparathyroidism|primary hyperparathyroidism
5301416|NCT00432926|HIV|hiv
5301417|NCT00432926|STDs|stds
5301418|NCT00432926|Methamphetamine abuse|methamphetamine abuse
5301419|NCT00432926|MSM|msm
5301420|NCT00432926|HIV Seronegativity|hiv seronegativity
5301421|NCT00432913|Eicosapentaenoic acid|eicosapentaenoic acid
5301422|NCT00432913|EPA|epa
5301423|NCT00432913|EPA 99%|epa 99%
5301424|NCT00432913|Fatty acid|fatty acid
5301425|NCT00432913|omega-3|omega-3
5301426|NCT00432913|apoptosis|apoptosis
5301427|NCT00432913|cell proliferation|cell proliferation
5301428|NCT00432913|colonic mucosa|colonic mucosa
5301429|NCT00432913|polyps|polyps
5301430|NCT00432913|adenomatous polyps|adenomatous polyps
5301431|NCT00432913|endoscopy|endoscopy
5301432|NCT00432913|PUFA|pufa
5301433|NCT00432900|Inflammation|inflammation
5301434|NCT00432900|Neuroimmunology|neuroimmunology
5301435|NCT00432900|Multiple Sclerosis|multiple sclerosis
5301436|NCT00432900|MS|ms
5301437|NCT00432900|Healthy Volunteer|healthy volunteer
5301438|NCT00432900|HV|hv
5301439|NCT00432887|caffeine|caffeine
5301440|NCT00432887|coffee|coffee
5301441|NCT00432887|glucose|glucose
5301442|NCT00432887|insulin|insulin
5301443|NCT00432861|cystic fibrosis|cystic fibrosis
5301444|NCT00432861|pancreatic insufficiency|pancreatic insufficiency
5301445|NCT00432861|PANCRECARB® MS-16 (pancrelipase)|pancrecarb® ms-16 (pancrelipase)
5301446|NCT00432861|steatorrhea|steatorrhea
5301447|NCT00432835|Nausea|nausea
5301448|NCT00432835|Vomiting|vomiting
5301449|NCT00432835|Delayed gastric emptying|delayed gastric emptying
5301450|NCT00432835|Diabetes Mellitus|diabetes mellitus
5301451|NCT00432835|Post-Surgical|post-surgical
5301452|NCT00432835|Idiopathic|idiopathic
5301453|NCT00432822|phenylketonuria|phenylketonuria
5301454|NCT00432822|phenylalanine hydroxylase deficiency|phenylalanine hydroxylase deficiency
5301455|NCT00432822|BH4|bh4
5301456|NCT00432822|responsive|responsive
5301457|NCT00432822|tetrahydrobiopterin|tetrahydrobiopterin
5301458|NCT00432822|newborns|newborns
5301459|NCT00432822|infants|infants
5301460|NCT00432822|children|children
5301461|NCT00432822|adolescents|adolescents
5301462|NCT00432809|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
5301463|NCT00432809|Obesity|obesity
5301464|NCT00432796|Anticoagulation|anticoagulation
5301465|NCT00432796|Prosthetic heart valves|prosthetic heart valves
5301466|NCT00432796|Atrial fibrillation|atrial fibrillation
5301467|NCT00432796|Bridging Therapy|bridging therapy
5301468|NCT00432796|Thromboembolism|thromboembolism
5301469|NCT00432796|Warfarin|warfarin
5301470|NCT00432796|Low Molecular Weight Heparin|low molecular weight heparin
5301471|NCT00432783|HIV, antiretroviral therapy, adherence, ritonavir|hiv, antiretroviral therapy, adherence, ritonavir
5301472|NCT00432757|allergic conjunctivitis, ophthalmology, multicenter, controlled|allergic conjunctivitis, ophthalmology, multicenter, controlled
5301473|NCT00432744|mitochondrial diseases|mitochondrial diseases
5301474|NCT00432744|respiratory chain complex I deficiencies|respiratory chain complex i deficiencies
5301475|NCT00432744|respiratory chain complex II deficiencies|respiratory chain complex ii deficiencies
5301476|NCT00432744|respiratory chain complex III deficiencies|respiratory chain complex iii deficiencies
5301477|NCT00432744|respiratory chain complex IV deficiencies|respiratory chain complex iv deficiencies
5301478|NCT00432744|mutations of a gene coding for a respiratory chain component|mutations of a gene coding for a respiratory chain component
5301479|NCT00432731|Prevention of : Varicella|prevention of : varicella
5301480|NCT00432731|Measles|measles
5301481|NCT00432731|Mumps|mumps
5301482|NCT00432731|Rubella|rubella
5301483|NCT00432718|Pneumonia|pneumonia
5301484|NCT00432718|Ventilator Associated Pneumonia|ventilator associated pneumonia
5301485|NCT00432718|Prevention|prevention
5301486|NCT00432705|ankle|ankle
5301487|NCT00432705|sensorimotor|sensorimotor
5301488|NCT00432705|reflex|reflex
5301489|NCT00432705|training|training
5301490|NCT00432692|osteoporosis|osteoporosis
5301491|NCT00432692|falls|falls
5301492|NCT00432692|prevention|prevention
5301493|NCT00432692|elderly|elderly
5301494|NCT00432692|exercise|exercise
5301495|NCT00432692|incidence|incidence
5301496|NCT00432692|obstacle avoidance|obstacle avoidance
5301497|NCT00432679|rosiglitazone|rosiglitazone
5301498|NCT00432679|Avandia|avandia
5301499|NCT00432679|type 2 diabetes mellitus|type 2 diabetes mellitus
5301500|NCT00432679|diabetes|diabetes
5301501|NCT00432653|ankylosing spondylitis|ankylosing spondylitis
5301502|NCT00432653|rituximab|rituximab
5301503|NCT00432653|therapy|therapy
5301504|NCT00432653|magnetic resonance imaging|magnetic resonance imaging
5302255|NCT00429728|smokers,|smokers,
5301505|NCT00432640|(suspected) Non Small Cell Lung Cancer|(suspected) non small cell lung cancer
5301506|NCT00432627|Hepatic impairment|hepatic impairment
5301507|NCT00432627|adults|adults
5301508|NCT00432627|deferasirox|deferasirox
5301509|NCT00432614|Mental Disorder|mental disorder
5301510|NCT00432614|Mood Disorder|mood disorder
5301511|NCT00432614|Depressive Disorder|depressive disorder
5301512|NCT00432601|decision aid|decision aid
5301513|NCT00432601|prostate cancer|prostate cancer
5301514|NCT00432601|patient-physician communication|patient-physician communication
5301515|NCT00432601|decision making|decision making
5301516|NCT00432601|literacy|literacy
5301517|NCT00432588|IUFD|iufd
5301518|NCT00432588|POSTTERM|postterm
5301519|NCT00432588|ROM|rom
5301520|NCT00432575|tobacco use cessation|tobacco use cessation
5301521|NCT00432575|cigarette smokers|cigarette smokers
5301522|NCT00432549|Medication overuse|medication overuse
5301523|NCT00432536|Neuro-monitoring|neuro-monitoring
5301524|NCT00432536|Quality Improvement|quality improvement
5301525|NCT00432536|Cerebral emboli|cerebral emboli
5301526|NCT00432536|Cerebral desaturation|cerebral desaturation
5301527|NCT00432536|Hypotension|hypotension
5301528|NCT00432523|Prevention of : Measles, Mumps, Rubella and Varicella diseases|prevention of : measles, mumps, rubella and varicella diseases
5301529|NCT00432510|Hereditary angioedema|hereditary angioedema
5301530|NCT00432510|C1 esterase inhibitor (human)|c1 esterase inhibitor (human)
5301531|NCT00432484|Lingzhi|lingzhi
5301532|NCT00432484|Sen Miao San|sen miao san
5301533|NCT00432484|Rheumatoid Arthritis|rheumatoid arthritis
5301534|NCT00432471|Skin Cancer|skin cancer
5301535|NCT00432471|Non-Melanoma Skin Cancer|non-melanoma skin cancer
5301536|NCT00432471|Optical Imaging|optical imaging
5301537|NCT00432471|Multispectral Digital Microscope System|multispectral digital microscope system
5301538|NCT00432471|MDM|mdm
5301539|NCT00432458|stage I multiple myeloma|stage i multiple myeloma
5301540|NCT00432445|Children with retinoblastoma|children with retinoblastoma
5301541|NCT00432445|Retinoblastoma|retinoblastoma
5301542|NCT00432445|Pediatrics|pediatrics
5301543|NCT00432445|Proton Beam Radiation Therapy|proton beam radiation therapy
5301544|NCT00432445|Radiation Therapy|radiation therapy
5301545|NCT00432445|Tumor of the Eye|tumor of the eye
5301546|NCT00432445|Ophthalmic EUA|ophthalmic eua
5301547|NCT00432445|Examination under anesthesia|examination under anesthesia
5301548|NCT00432445|Bilateral retinoblastoma|bilateral retinoblastoma
5301549|NCT00432445|Unilateral retinoblastoma|unilateral retinoblastoma
5301550|NCT00432445|Extraocular disease|extraocular disease
5301551|NCT00432445|Intraocular procedure|intraocular procedure
5301552|NCT00432432|Ankylosing Spondylitis|ankylosing spondylitis
5301553|NCT00432432|MTX|mtx
5301554|NCT00432432|Infliximab|infliximab
5301555|NCT00432419|HIV|hiv
5301556|NCT00432419|Non-Hodgkin's lymphoma|non-hodgkin's lymphoma
5301557|NCT00432419|Peripheral blood stem cells transplantation|peripheral blood stem cells transplantation
5301558|NCT00432406|Psoriatic Arthritis|psoriatic arthritis
5301559|NCT00432406|TNF-α|tnf-α
5301560|NCT00432406|Cardiovascular risk|cardiovascular risk
5301561|NCT00432406|Immunomodulatory activities|immunomodulatory activities
5301562|NCT00432380|Placebo|placebo
5301563|NCT00432380|Double blind|double blind
5301564|NCT00432380|Gastroenteritis|gastroenteritis
5301565|NCT00432380|Randomized|randomized
5301680|NCT00432016|DAPD|dapd
5301566|NCT00432380|Oral live attenuated human rotavirus liquid vaccine|oral live attenuated human rotavirus liquid vaccine
5301567|NCT00432367|Malaria in pregnancy|malaria in pregnancy
5301568|NCT00432367|Case management|case management
5301569|NCT00432367|Screening|screening
5301570|NCT00432367|RDT|rdt
5301571|NCT00432367|IPTp|iptp
5301572|NCT00432367|Amodiaquine|amodiaquine
5301573|NCT00432367|Artesunate|artesunate
5301574|NCT00432354|statin|statin
5301575|NCT00432354|systemic lupus erythematosus|systemic lupus erythematosus
5301576|NCT00432354|microcirculation|microcirculation
5301577|NCT00432302|Cancer|cancer
5301578|NCT00432302|Tumor|tumor
5301579|NCT00432302|Malignancy|malignancy
5301580|NCT00432302|Mass Balance|mass balance
5301581|NCT00432302|Chemotherapy|chemotherapy
5301582|NCT00432302|Drug|drug
5301583|NCT00432302|Cancer Treatment|cancer treatment
5301584|NCT00432302|Intravenous Infusion|intravenous infusion
5301585|NCT00432302|Epothilone|epothilone
5301586|NCT00432302|Solid Tumor|solid tumor
5301587|NCT00432289|neurological function|neurological function
5301588|NCT00432276|Glucose Metabolism Disorder|glucose metabolism disorder
5301589|NCT00432276|Dysmetabolic Syndrome|dysmetabolic syndrome
5301590|NCT00432276|Type II Diabetes|type ii diabetes
5301591|NCT00432276|Diabetes Mellitus, Lipoatrophic|diabetes mellitus, lipoatrophic
5301592|NCT00432276|Dyslipidemia|dyslipidemia
5301593|NCT00432276|Hyperglycemia|hyperglycemia
5301594|NCT00432276|Drug Therapy|drug therapy
5301595|NCT00432250|Preterm labor|preterm labor
5301596|NCT00432250|Cervical ultrasonography|cervical ultrasonography
5301597|NCT00432250|Hospital stay|hospital stay
5301598|NCT00432198|Insomnia|insomnia
5301599|NCT00432198|Zolpidem|zolpidem
5301600|NCT00432198|Adolescent|adolescent
5301601|NCT00432185|sBCC|sbcc
5301602|NCT00432185|Topical|topical
5301603|NCT00432185|Dermatology|dermatology
5301604|NCT00432172|Her2neu negative breast cancer.|her2neu negative breast cancer.
5301605|NCT00432172|Neoadjuvant treatment.|neoadjuvant treatment.
5301606|NCT00432159|cervical|cervical
5301607|NCT00432159|spinal|spinal
5301608|NCT00432159|arthroplasty|arthroplasty
5301609|NCT00432159|disc|disc
5301610|NCT00432159|surgical|surgical
5301611|NCT00432159|ACDF|acdf
5301612|NCT00432159|DDD|ddd
5301613|NCT00432146|Graves' disease, Lugol's solution|graves' disease, lugol's solution
5301614|NCT00432133|Physical Activity|physical activity
5301615|NCT00432133|Behavior Change|behavior change
5301616|NCT00432133|Mechanism|mechanism
5301617|NCT00432133|Environmental|environmental
5301618|NCT00432133|Ecological Model of Physical Activity|ecological model of physical activity
5301619|NCT00432107|Advanced cutaneous melanoma|advanced cutaneous melanoma
5301620|NCT00432107|Phase II study|phase ii study
5301621|NCT00432094|childhood extragonadal germ cell tumor|childhood extragonadal germ cell tumor
5301622|NCT00432094|childhood malignant ovarian germ cell tumor|childhood malignant ovarian germ cell tumor
5301623|NCT00432094|childhood malignant testicular germ cell tumor|childhood malignant testicular germ cell tumor
5301624|NCT00432094|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
5301625|NCT00432094|testicular choriocarcinoma and seminoma|testicular choriocarcinoma and seminoma
5301626|NCT00432094|testicular embryonal carcinoma and seminoma|testicular embryonal carcinoma and seminoma
5301627|NCT00432094|testicular embryonal carcinoma and teratoma with seminoma|testicular embryonal carcinoma and teratoma with seminoma
5301628|NCT00432094|testicular embryonal carcinoma and yolk sac tumor with seminoma|testicular embryonal carcinoma and yolk sac tumor with seminoma
5301629|NCT00432094|testicular yolk sac tumor and teratoma with seminoma|testicular yolk sac tumor and teratoma with seminoma
5301630|NCT00432094|testicular choriocarcinoma and embryonal carcinoma|testicular choriocarcinoma and embryonal carcinoma
5301631|NCT00432094|testicular choriocarcinoma and teratoma|testicular choriocarcinoma and teratoma
5301632|NCT00432094|testicular choriocarcinoma and yolk sac tumor|testicular choriocarcinoma and yolk sac tumor
5301633|NCT00432094|testicular choriocarcinoma|testicular choriocarcinoma
5301634|NCT00432094|testicular embryonal carcinoma and teratoma|testicular embryonal carcinoma and teratoma
5301635|NCT00432094|testicular embryonal carcinoma and yolk sac tumor|testicular embryonal carcinoma and yolk sac tumor
5301636|NCT00432094|testicular embryonal carcinoma|testicular embryonal carcinoma
5301637|NCT00432094|testicular yolk sac tumor and teratoma|testicular yolk sac tumor and teratoma
5301638|NCT00432094|testicular yolk sac tumor|testicular yolk sac tumor
5301639|NCT00432094|testicular seminoma|testicular seminoma
5301640|NCT00432094|stage IV extragonadal non-seminomatous germ cell tumor|stage iv extragonadal non-seminomatous germ cell tumor
5301641|NCT00432094|stage IV extragonadal seminoma|stage iv extragonadal seminoma
5301642|NCT00432094|stage I extragonadal non-seminomatous germ cell tumor|stage i extragonadal non-seminomatous germ cell tumor
5301643|NCT00432094|stage I extragonadal seminoma|stage i extragonadal seminoma
5301644|NCT00432094|stage II extragonadal non-seminomatous germ cell tumor|stage ii extragonadal non-seminomatous germ cell tumor
5301645|NCT00432094|stage II extragonadal seminoma|stage ii extragonadal seminoma
5301646|NCT00432094|stage III extragonadal non-seminomatous germ cell tumor|stage iii extragonadal non-seminomatous germ cell tumor
5301647|NCT00432094|stage III extragonadal seminoma|stage iii extragonadal seminoma
5301648|NCT00432094|stage II ovarian germ cell tumor|stage ii ovarian germ cell tumor
5301649|NCT00432094|stage I malignant testicular germ cell tumor|stage i malignant testicular germ cell tumor
5301650|NCT00432094|stage II malignant testicular germ cell tumor|stage ii malignant testicular germ cell tumor
5301651|NCT00432094|adult teratoma|adult teratoma
5301652|NCT00432094|childhood teratoma|childhood teratoma
5301653|NCT00432094|testicular immature teratoma|testicular immature teratoma
5301654|NCT00432094|testicular mature teratoma|testicular mature teratoma
5301655|NCT00432094|adult central nervous system germ cell tumor|adult central nervous system germ cell tumor
5301656|NCT00432094|childhood central nervous system germ cell tumor|childhood central nervous system germ cell tumor
5301657|NCT00432081|Dementia|dementia
5301658|NCT00432081|Inflammation|inflammation
5301659|NCT00432081|Anti-Inflammatory Agents|anti-inflammatory agents
5301660|NCT00432081|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal
5301661|NCT00432081|Drug Therapy|drug therapy
5301662|NCT00432068|Healthy volunteers|healthy volunteers
5301663|NCT00432068|octreotide pamoate|octreotide pamoate
5301664|NCT00432068|pharmacokinetics|pharmacokinetics
5301665|NCT00432055|Adult|adult
5301666|NCT00432055|Cerebral Palsy|cerebral palsy
5301667|NCT00432055|Spastic contractures|spastic contractures
5301668|NCT00432055|Botulinum toxin type A|botulinum toxin type a
5301669|NCT00432042|Mumps and Rubella|mumps and rubella
5301670|NCT00432042|Haemophilus influenzae type b (Infanrix® hexa)|haemophilus influenzae type b (infanrix® hexa)
5301671|NCT00432029|Flicker induced vasodilatation|flicker induced vasodilatation
5301672|NCT00432029|Flow mediated vasodilatation|flow mediated vasodilatation
5301673|NCT00432029|Forearm blood flow|forearm blood flow
5301674|NCT00432029|Retinal vessel diameter|retinal vessel diameter
5301675|NCT00432029|Endothelial dysfunction|endothelial dysfunction
5301676|NCT00432016|HIV|hiv
5301677|NCT00432016|pharmacokinetics|pharmacokinetics
5301678|NCT00432016|zidovudine|zidovudine
5301679|NCT00432016|amdoxovir|amdoxovir
5301681|NCT00432016|AMDX|amdx
5301682|NCT00432016|Treatment Naive|treatment naive
5302256|NCT00429728|non-smokers|non-smokers
5301683|NCT00432003|Treatment Experienced|treatment experienced
5301684|NCT00432003|HIV|hiv
5301685|NCT00432003|Antiretroviral Therapy, Highly Active|antiretroviral therapy, highly active
5301686|NCT00431977|Coronary Atherosclerosis|coronary atherosclerosis
5301687|NCT00431977|Diabetes Mellitus|diabetes mellitus
5301688|NCT00431964|azithromycin, Zithromax|azithromycin, zithromax
5301689|NCT00431951|Healthy Volunteers|healthy volunteers
5301690|NCT00431925|head and neck cancer|head and neck cancer
5301691|NCT00431925|radiation therapy|radiation therapy
5301692|NCT00431925|chemotherapy|chemotherapy
5301693|NCT00431925|mucositis|mucositis
5301694|NCT00431925|cytokines|cytokines
5301695|NCT00431925|gastrostomy|gastrostomy
5301696|NCT00431925|radiotherapy|radiotherapy
5301697|NCT00431912|cutaneous T-cell lymphoma|cutaneous t-cell lymphoma
5301698|NCT00431912|mycosis fungoides|mycosis fungoides
5301699|NCT00431912|Sézary syndrome|sézary syndrome
5301700|NCT00431912|APO866|apo866
5301701|NCT00431912|phase II study|phase ii study
5301702|NCT00431899|nutrition|nutrition
5301703|NCT00431899|omega 3 fatty acids|omega 3 fatty acids
5301704|NCT00431899|insulin resistance|insulin resistance
5301705|NCT00431886|Chest pains|chest pains
5301706|NCT00431886|Computed tomography|computed tomography
5301707|NCT00431886|Emergency|emergency
5301708|NCT00431873|Lymphocytic Leukemia, Chronic (Refractory)|lymphocytic leukemia, chronic (refractory)
5301709|NCT00431873|Phase II|phase ii
5301710|NCT00431860|Coronary atherosclerosis, Spiral Computed Tomography|coronary atherosclerosis, spiral computed tomography
5301711|NCT00431847|Anesthesia, Regional|anesthesia, regional
5301712|NCT00431847|Causalgia|causalgia
5301713|NCT00431847|Trauma|trauma
5301714|NCT00431847|Complex Regional Pain Syndrome Type II|complex regional pain syndrome type ii
5301715|NCT00431847|Neuropathic Pain|neuropathic pain
5301716|NCT00431847|PTSD|ptsd
5301717|NCT00431847|Combat Stress Disorders|combat stress disorders
5301718|NCT00431847|Afghan War, 2001-|afghan war, 2001-
5301719|NCT00431847|Iraq War, 2003-|iraq war, 2003-
5301720|NCT00431834|Permanent Atrial Fibrillation Surgical RF Ablation|permanent atrial fibrillation surgical rf ablation
5301721|NCT00431834|Permanent Atrial Fibrillation|permanent atrial fibrillation
5301722|NCT00431821|Exercise|exercise
5301723|NCT00431821|Rehabilitation|rehabilitation
5301724|NCT00431821|Stroke|stroke
5301725|NCT00431808|Malaria|malaria
5301726|NCT00431808|vaccine|vaccine
5301727|NCT00431808|Apical Membrane Antigene|apical membrane antigene
5301728|NCT00431808|Mali|mali
5301729|NCT00431808|Adults|adults
5301730|NCT00431795|Advanced breast cancer|advanced breast cancer
5301731|NCT00431795|Pegylated liposomal doxorubicin|pegylated liposomal doxorubicin
5301732|NCT00431795|Epirubicin|epirubicin
5301733|NCT00431782|Atrial fibrillation|atrial fibrillation
5301734|NCT00431782|Anticoagulation|anticoagulation
5301735|NCT00431769|Multiple myeloma|multiple myeloma
5301736|NCT00431769|Bortezomib|bortezomib
5301737|NCT00431769|Dexamethasone|dexamethasone
5301738|NCT00431769|VELCADE|velcade
5301739|NCT00431756|Barrett's esophagus|barrett's esophagus
5301740|NCT00431756|gastroesophageal reflux disease (GERD)|gastroesophageal reflux disease (gerd)
5301741|NCT00431756|esophageal cancer|esophageal cancer
5301742|NCT00431756|DNA methylation|dna methylation
5301743|NCT00431743|Fluid Therapy|fluid therapy
5301744|NCT00431743|Crystalloid|crystalloid
5301745|NCT00431743|Colloid|colloid
5301746|NCT00431743|Perioperative|perioperative
5301747|NCT00431743|Optimization|optimization
5301748|NCT00431743|Goal-directed Therapy|goal-directed therapy
5301749|NCT00431717|Coronary Atherosclerosis|coronary atherosclerosis
5301750|NCT00431717|Diabetes Mellitus|diabetes mellitus
5301751|NCT00431704|advanced|advanced
5301752|NCT00431704|her-2 positive|her-2 positive
5301753|NCT00431678|Community-acquired Pneumonia|community-acquired pneumonia
5301754|NCT00431665|Renal Plasma Flow|renal plasma flow
5301755|NCT00431665|Glomerular Filtration Rate|glomerular filtration rate
5301756|NCT00431665|Free fatty acids|free fatty acids
5301757|NCT00431639|Animal-Assisted Therapy|animal-assisted therapy
5301758|NCT00431639|Pain|pain
5301759|NCT00431639|Oncology|oncology
5301760|NCT00431639|Cancer Pain|cancer pain
5301761|NCT00431626|Benign|benign
5301762|NCT00431626|Prostatic|prostatic
5301763|NCT00431626|Hyperplasia|hyperplasia
5301764|NCT00431626|Lower|lower
5301765|NCT00431626|Urinary|urinary
5301766|NCT00431626|Track|track
5301767|NCT00431626|Symptoms|symptoms
5301768|NCT00431626|Laser|laser
5301769|NCT00431626|Transurethral|transurethral
5301770|NCT00431626|Prostate|prostate
5301771|NCT00431613|NSCLC|nsclc
5301772|NCT00431613|Induction chemotherapy|induction chemotherapy
5301773|NCT00431613|Concurrent chemoradiotherapy|concurrent chemoradiotherapy
5301774|NCT00431613|Consolidation therapy|consolidation therapy
5301775|NCT00431613|Docetaxel|docetaxel
5301776|NCT00431613|Gemcitabine|gemcitabine
5301777|NCT00431613|Carboplatin|carboplatin
5301778|NCT00431600|Regional Blood Flow|regional blood flow
5301779|NCT00431600|Color Doppler Optical Coherence Tomography|color doppler optical coherence tomography
5301780|NCT00431600|CDOCT|cdoct
5301781|NCT00431600|Retinal Blood Flow|retinal blood flow
5301782|NCT00431600|Hyperoxia|hyperoxia
5301783|NCT00431600|Vasoconstriction|vasoconstriction
5301784|NCT00431600|Laser Doppler Velocimetry|laser doppler velocimetry
5301785|NCT00431600|Retinal Vessel Analyzer|retinal vessel analyzer
5301786|NCT00431587|morbid obesity|morbid obesity
5301787|NCT00431587|metabolic syndrome|metabolic syndrome
5301788|NCT00431587|visceral fat|visceral fat
5301789|NCT00431587|peripheral fat|peripheral fat
5301790|NCT00431574|schizophrenia|schizophrenia
5301791|NCT00431574|schizoaffective|schizoaffective
5301792|NCT00431574|antipsychotic|antipsychotic
5301793|NCT00431574|randomized control trial|randomized control trial
5301794|NCT00431561|Glioblastoma|glioblastoma
5301795|NCT00431561|Anaplastic astrocytoma|anaplastic astrocytoma
5301796|NCT00431561|Antisense|antisense
5301797|NCT00431561|Cancer|cancer
5301798|NCT00431561|Transforming growth factor beta2 (TGF-beta2)|transforming growth factor beta2 (tgf-beta2)
5301799|NCT00431561|Targeted therapy|targeted therapy
5301800|NCT00431561|Immunotherapy|immunotherapy
5301801|NCT00431561|Brain tumor|brain tumor
5301802|NCT00431561|Central nervous system (CNS)|central nervous system (cns)
5301803|NCT00431561|Convection-enhanced delivery (CED) / microperfusion|convection-enhanced delivery (ced) / microperfusion
5301804|NCT00431561|Locoregional application|locoregional application
5301805|NCT00431535|Fluid|fluid
5301806|NCT00431535|SvO2|svo2
5301807|NCT00431535|Mobilisation|mobilisation
5301808|NCT00431535|Orthostatic function|orthostatic function
5301809|NCT00431509|Osteoarthritis|osteoarthritis
5301810|NCT00431509|Arthroplasty|arthroplasty
5301811|NCT00431509|Replacement|replacement
5301812|NCT00431509|Knee|knee
5301813|NCT00431509|Instrumentation|instrumentation
5301814|NCT00431496|Anemia|anemia
5301815|NCT00431496|Intact Parathyroid Hormone (iPTH)|intact parathyroid hormone (ipth)
5301816|NCT00431496|Secondary Hyperparathyroidism (SHPT)|secondary hyperparathyroidism (shpt)
5301817|NCT00431483|antibacterial agents|antibacterial agents
5301818|NCT00431483|surgery|surgery
5301819|NCT00431483|pharmacist|pharmacist
5301820|NCT00431483|economics, pharmaceutical|economics, pharmaceutical
5301821|NCT00431470|Classroom violence, character, bullying, self esteem|classroom violence, character, bullying, self esteem
5301822|NCT00431444|Osteoporosis|osteoporosis
5301823|NCT00431444|Post-menopausal|post-menopausal
5301824|NCT00431444|Bone mineral density|bone mineral density
5301825|NCT00431405|rheumatoid arthritis|rheumatoid arthritis
5301826|NCT00431405|cardiovascular disease|cardiovascular disease
5301827|NCT00431405|coronary disease|coronary disease
5301828|NCT00431392|Choroidal blood flow|choroidal blood flow
5301829|NCT00431392|NO-synthase|no-synthase
5301830|NCT00431392|light/dark transition|light/dark transition
5301831|NCT00431366|Fatigue|fatigue
5301832|NCT00431366|Repetitive TMS (rTMS)|repetitive tms (rtms)
5301833|NCT00431366|Parkinson's Disease|parkinson's disease
5301834|NCT00431366|Peg Board Test|peg board test
5301835|NCT00431366|Levodopa|levodopa
5301836|NCT00431366|Parkinson Disease|parkinson disease
5301837|NCT00431366|PD|pd
5301838|NCT00431340|Multiple myeloma|multiple myeloma
5301839|NCT00431340|myeloma|myeloma
5301840|NCT00431340|plasma cell myeloma|plasma cell myeloma
5301841|NCT00431340|bone marrow cancer|bone marrow cancer
5301842|NCT00431340|myelomatosis|myelomatosis
5301843|NCT00431340|Kahler's disease|kahler's disease
5301844|NCT00431340|PXD101|pxd101
5301845|NCT00431340|belinostat|belinostat
5301846|NCT00431340|bortezomib|bortezomib
5301847|NCT00431327|patient navigator|patient navigator
5301848|NCT00431327|peer support|peer support
5301849|NCT00431327|colonoscopy|colonoscopy
5301850|NCT00431327|adherence|adherence
5301851|NCT00431327|None: have to be scheduled for screening or diagnostic colonoscopy|none: have to be scheduled for screening or diagnostic colonoscopy
5301852|NCT00431314|End Stage Renal Disease|end stage renal disease
5301853|NCT00431314|Hemodialysis|hemodialysis
5301854|NCT00431314|Critical Limb Ischemia|critical limb ischemia
5301855|NCT00431314|Autofluorescence|autofluorescence
5301856|NCT00431301|Progressive Supranuclear Palsy|progressive supranuclear palsy
5301857|NCT00431301|Epidemiology|epidemiology
5301858|NCT00431301|Case-Control|case-control
5301859|NCT00431301|Genetic|genetic
5301860|NCT00431301|Environmental|environmental
5301861|NCT00431301|Neurodegenerative Disease|neurodegenerative disease
5301862|NCT00431301|Movement Disorders|movement disorders
5301863|NCT00431301|Atypical Parkinsonism|atypical parkinsonism
5301864|NCT00431301|Parkinson Plus|parkinson plus
5301865|NCT00431301|Steele-Richardson-Olszewski|steele-richardson-olszewski
5301866|NCT00431301|PSP|psp
5301867|NCT00431288|nutrition|nutrition
5301868|NCT00431288|adolescent nutrition|adolescent nutrition
5301869|NCT00431288|blood pressure|blood pressure
5301870|NCT00431288|hypertension|hypertension
5301871|NCT00431288|diet therapy|diet therapy
5301872|NCT00431288|patient education|patient education
5301873|NCT00431262|alcoholism|alcoholism
5301874|NCT00431262|antabuse|antabuse
5301875|NCT00431262|disulfiram|disulfiram
5301876|NCT00431262|abstinence|abstinence
5301877|NCT00431262|cognitive behavioural therapy|cognitive behavioural therapy
5301878|NCT00431236|cisplatin|cisplatin
5301879|NCT00431236|CINV|cinv
5301880|NCT00431236|highly emetogenic|highly emetogenic
5301881|NCT00431223|fMRI|fmri
5301882|NCT00431223|working memory|working memory
5301883|NCT00431223|schizophrenia|schizophrenia
5301884|NCT00431223|treatment refractory|treatment refractory
5301885|NCT00431223|cognitive skills training|cognitive skills training
5301886|NCT00431223|dorsolateral prefrontal cortex|dorsolateral prefrontal cortex
5301887|NCT00431223|cognitive remediation|cognitive remediation
5301888|NCT00431223|treatment refractory schizophrenia of > 5 years duration|treatment refractory schizophrenia of > 5 years duration
5301889|NCT00431210|NPC|npc
5301890|NCT00431210|EPV|epv
5301891|NCT00431184|bipolar disorder|bipolar disorder
5301892|NCT00431184|bipolar mania|bipolar mania
5301893|NCT00431184|schizoaffective disorder|schizoaffective disorder
5301894|NCT00431184|schizoaffective mania|schizoaffective mania
5301895|NCT00431184|mania|mania
5301896|NCT00431184|kappa opiates|kappa opiates
5301897|NCT00431184|opiates|opiates
5301898|NCT00431171|spinal cord injuries|spinal cord injuries
5301899|NCT00431171|lithium|lithium
5301900|NCT00431158|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
5301901|NCT00431158|ARDS|ards
5301902|NCT00431158|Respiratory failure|respiratory failure
5301903|NCT00431158|Mechanical Ventilation|mechanical ventilation
5301904|NCT00431158|Positive end expiratory pressure|positive end expiratory pressure
5301905|NCT00431158|Lung recruitment maneuver|lung recruitment maneuver
5301906|NCT00431119|bullous autoimmune disease|bullous autoimmune disease
5301907|NCT00431119|bullous pemphigoid|bullous pemphigoid
5301908|NCT00431119|immunosuppressants|immunosuppressants
5301909|NCT00431119|corticosteroids|corticosteroids
5301910|NCT00431119|mycophenolate mofetil|mycophenolate mofetil
5301911|NCT00431106|Breast cancer|breast cancer
5301912|NCT00431106|Chemotherapy|chemotherapy
5301913|NCT00431106|Vinorelbine|vinorelbine
5301914|NCT00431106|Gemcitabine|gemcitabine
5301915|NCT00431106|Capecitabine|capecitabine
5301916|NCT00431080|Early breast cancer|early breast cancer
5301917|NCT00431080|Axillary node positive|axillary node positive
5301918|NCT00431080|Adjuvant chemotherapy|adjuvant chemotherapy
5301919|NCT00431080|Dose dense|dose dense
5301920|NCT00431080|Docetaxel|docetaxel
5301921|NCT00431080|Paclitaxel|paclitaxel
5301922|NCT00431080|FEC|fec
5301923|NCT00431054|Ovarian Cancer|ovarian cancer
5301924|NCT00431054|Fallopian Tube Cancer|fallopian tube cancer
5301925|NCT00431054|Peritoneal Cancer|peritoneal cancer
5301926|NCT00431054|Perifosine|perifosine
5301927|NCT00431054|Docetaxel|docetaxel
5301928|NCT00431054|Taxotere|taxotere
5301929|NCT00431041|Solifenacin succinate|solifenacin succinate
5301930|NCT00431041|Oxybutynin immediate release|oxybutynin immediate release
5301931|NCT00431041|Xerostomia|xerostomia
5301932|NCT00431041|Overactive bladder|overactive bladder
5301933|NCT00431028|Cataract|cataract
5301934|NCT00431028|Endophthalmitis|endophthalmitis
5301935|NCT00431028|Antibiotics|antibiotics
5301936|NCT00431028|Anti-Inflammatory Agents|anti-inflammatory agents
5301937|NCT00431028|Drug Delivery Systems|drug delivery systems
5301938|NCT00431015|Lung Cancer|lung cancer
5301939|NCT00431015|Cancer of the lung|cancer of the lung
5301940|NCT00431015|Non-small cell lung cancer|non-small cell lung cancer
5301941|NCT00431002|Exercise|exercise
5301942|NCT00431002|Resistance training|resistance training
5301943|NCT00430989|Anaesthesia|anaesthesia
5301944|NCT00430989|Major Surgery|major surgery
5301945|NCT00430989|Coronary artery disease|coronary artery disease
5301946|NCT00430989|Nitrous oxide|nitrous oxide
5301947|NCT00430989|Effects of Nitrous Oxide following Anaesthesia|effects of nitrous oxide following anaesthesia
5301948|NCT00430989|Anaesthesia and coronary artery disease|anaesthesia and coronary artery disease
5301949|NCT00430976|psychomotor function|psychomotor function
5301950|NCT00430976|neuromuscular system|neuromuscular system
5301951|NCT00430976|memory|memory
5301952|NCT00430976|brain electrical activity|brain electrical activity
5301953|NCT00430976|Mental Processes|mental processes
5301954|NCT00430950|Moderate-to-Severe Hypertension|moderate-to-severe hypertension
5301955|NCT00430950|Essential Hypertension|essential hypertension
5301956|NCT00430950|Combination Therapy|combination therapy
5301957|NCT00430950|Fixed-Combination Dose|fixed-combination dose
5301958|NCT00430937|Complicated Skin and Soft Tissue Infections. Daptomycin, Vancomycin, Teicoplanin|complicated skin and soft tissue infections. daptomycin, vancomycin, teicoplanin
5301959|NCT00430937|Complicated skin and soft tissue infections|complicated skin and soft tissue infections
5301960|NCT00430924|Kidney Failure, Chronic|kidney failure, chronic
5301961|NCT00430924|Proteinuria|proteinuria
5301962|NCT00430924|Aldosterone|aldosterone
5301963|NCT00430924|Renin-Angiotensin System|renin-angiotensin system
5301964|NCT00430911|malignant gliomas|malignant gliomas
5301965|NCT00430898|ulcerative colitis basiliximab|ulcerative colitis basiliximab
5301966|NCT00430885|Heart failure|heart failure
5301967|NCT00430885|Myocardial infarction|myocardial infarction
5301968|NCT00430885|Patients with acute myocardial infarction|patients with acute myocardial infarction
5301969|NCT00430872|Spinal Cord Tumor|spinal cord tumor
5301970|NCT00430872|Intramedullary Spinal Cord Tumor|intramedullary spinal cord tumor
5301971|NCT00430872|Extramedullary Spinal Cord Tumor|extramedullary spinal cord tumor
5301972|NCT00430872|Symptoms|symptoms
5301973|NCT00430872|Survey|survey
5301974|NCT00430859|Sepsis|sepsis
5301975|NCT00430859|Alkaline|alkaline
5301976|NCT00430859|Phosphatase|phosphatase
5301977|NCT00430859|Lipopolysaccharide|lipopolysaccharide
5301978|NCT00430846|Antigens,CD30|antigens,cd30
5301979|NCT00430846|Antibody-Drug Conjugate|antibody-drug conjugate
5301980|NCT00430846|Antibodies, Monoclonal|antibodies, monoclonal
5301981|NCT00430846|Lymphoma, Non-Hodgkin|lymphoma, non-hodgkin
5301982|NCT00430846|Disease, Hodgkin|disease, hodgkin
5301983|NCT00430846|Lymphoma, Large-Cell, Anaplastic|lymphoma, large-cell, anaplastic
5301984|NCT00430846|Hematologic Diseases|hematologic diseases
5301985|NCT00430846|Lymphoma|lymphoma
5301986|NCT00430820|Biomarkers|biomarkers
5301987|NCT00430820|Proteomics|proteomics
5301988|NCT00430820|Mass spectrometry|mass spectrometry
5301989|NCT00430820|Atherosclerosis|atherosclerosis
5301990|NCT00430820|Acute coronary syndromes|acute coronary syndromes
5301991|NCT00430820|Myocardial infarction|myocardial infarction
5301992|NCT00430820|Coronary artery disease|coronary artery disease
5301993|NCT00430807|giant cell arteritis,|giant cell arteritis,
5301994|NCT00430807|hydroxychloroquine,|hydroxychloroquine,
5301995|NCT00430807|corticosteroid sparing,|corticosteroid sparing,
5301996|NCT00430807|corticodependence|corticodependence
5301997|NCT00430794|resistant hypertension|resistant hypertension
5301998|NCT00430794|Spironolactone|spironolactone
5301999|NCT00430794|double-blind|double-blind
5302000|NCT00430794|randomised controlled trial|randomised controlled trial
5302001|NCT00430794|ambulatory blood pressure monitoring|ambulatory blood pressure monitoring
5302002|NCT00430781|pazopanib|pazopanib
5302003|NCT00430781|ErB1/ErB2|erb1/erb2
5302004|NCT00430781|lapatinib|lapatinib
5302005|NCT00430781|persistent|persistent
5302006|NCT00430781|VEGF|vegf
5302007|NCT00430781|recurrent|recurrent
5302008|NCT00430781|metastatic cervical cancer|metastatic cervical cancer
5302009|NCT00430781|advanced|advanced
5302010|NCT00430781|FIGO Stage IVB|figo stage ivb
5302011|NCT00430768|Gene Transfer Techniques|gene transfer techniques
5302012|NCT00430768|Gene Therapy|gene therapy
5302013|NCT00430768|AAV|aav
5302014|NCT00430768|AAT|aat
5302015|NCT00430768|Phase I|phase i
5302016|NCT00430768|Intramuscular transfer|intramuscular transfer
5302017|NCT00430729|Roflumilast|roflumilast
5302018|NCT00430703|severe traumatic brain injury|severe traumatic brain injury
5302019|NCT00430703|body weight support treadmill training|body weight support treadmill training
5302020|NCT00430703|Electroencephalogram|electroencephalogram
5302021|NCT00430703|Event Related Potentials|event related potentials
5302022|NCT00430664|pleurodesis|pleurodesis
5302023|NCT00430664|talc|talc
5302024|NCT00430664|iodopovidone|iodopovidone
5302025|NCT00430651|Non Small Cell Lung Cancer|non small cell lung cancer
5302026|NCT00430651|2nd line chemotherapy|2nd line chemotherapy
5302027|NCT00430651|Docetaxel|docetaxel
5302028|NCT00430638|Hypertension|hypertension
5302029|NCT00430638|Angiotensin Receptor Blocker|angiotensin receptor blocker
5302030|NCT00430638|Calcium Channel Blocker|calcium channel blocker
5302031|NCT00430638|Angiotensin Converting Enzyme Inhibitor|angiotensin converting enzyme inhibitor
5302032|NCT00430638|Hydrochlorothiazide|hydrochlorothiazide
5302033|NCT00430638|Stage I and II Hypertension|stage i and ii hypertension
5302034|NCT00430625|VPRIV®|vpriv®
5302035|NCT00430625|Enzyme Replacement Therapy|enzyme replacement therapy
5302036|NCT00430625|Gaucher disease|gaucher disease
5302037|NCT00430625|glucocerebrosidase|glucocerebrosidase
5302038|NCT00430625|beta-glucocerebrosidase|beta-glucocerebrosidase
5302039|NCT00430625|Acid beta-glucocerebrosidase|acid beta-glucocerebrosidase
5302040|NCT00430625|glucosylceramidase|glucosylceramidase
5302041|NCT00430625|D-glucosyl-N-acylsphingosine glucohydrolase|d-glucosyl-n-acylsphingosine glucohydrolase
5302042|NCT00430625|gene activation|gene activation
5302043|NCT00430625|human|human
5302044|NCT00430612|Myocardial Infarction|myocardial infarction
5302045|NCT00430612|Heart Attack|heart attack
5302046|NCT00430612|Beta Blockers|beta blockers
5302047|NCT00430612|Survival|survival
5302048|NCT00430573|cognitive-behavior therapy|cognitive-behavior therapy
5302049|NCT00430573|d-cycloserine|d-cycloserine
5302050|NCT00430573|cognitive enhancer|cognitive enhancer
5302051|NCT00430573|drug dependence|drug dependence
5302052|NCT00430573|opiate dependence|opiate dependence
5302053|NCT00430573|exposure|exposure
5302054|NCT00430573|isolated doses of d-cycloserine|isolated doses of d-cycloserine
5302055|NCT00430573|isolated doses of matching pill placebo|isolated doses of matching pill placebo
5302056|NCT00430573|DCS|dcs
5302057|NCT00430560|work therapy|work therapy
5302058|NCT00430560|cognitive rehabilitation|cognitive rehabilitation
5302059|NCT00430560|schizophrenia|schizophrenia
5302060|NCT00430560|schizoaffective disorder|schizoaffective disorder
5302061|NCT00430560|treatment outcome|treatment outcome
5302062|NCT00430534|Epstein Barr Virus|epstein barr virus
5302063|NCT00430534|Belgium|belgium
5302064|NCT00430534|Infectious mononucleosis|infectious mononucleosis
5302065|NCT00430521|Pandemic Flu|pandemic flu
5302066|NCT00430521|Pandemic influenza vaccine (GSK1119711A)|pandemic influenza vaccine (gsk1119711a)
5302067|NCT00430508|Moderate-to-Severe Hypertension|moderate-to-severe hypertension
5302068|NCT00430508|Essential Hypertension|essential hypertension
5302069|NCT00430508|Combination Therapy|combination therapy
5302070|NCT00430508|Fixed-Combination Dose|fixed-combination dose
5302071|NCT00430495|atacicept|atacicept
5302072|NCT00430495|arthritis|arthritis
5302073|NCT00430482|Substance Dependence|substance dependence
5302074|NCT00430482|Cognitive-Behavior Therapy|cognitive-behavior therapy
5302075|NCT00430482|Opiate Dependence|opiate dependence
5302076|NCT00430482|Treatment Moderators|treatment moderators
5302077|NCT00430469|Lactoferrin|lactoferrin
5302078|NCT00430469|hLF|hlf
5302079|NCT00430469|Neutropenia|neutropenia
5302080|NCT00430469|Myeloablative|myeloablative
5302081|NCT00430469|Treatment|treatment
5302082|NCT00430469|Fungal|fungal
5302083|NCT00430469|Bacterial|bacterial
5302084|NCT00430469|Infections|infections
5302085|NCT00430469|Bone marrow transplant|bone marrow transplant
5302086|NCT00430456|Aerobic exercise|aerobic exercise
5302087|NCT00430456|Balance, postural|balance, postural
5302088|NCT00430456|Cardiovascular deconditioning|cardiovascular deconditioning
5302089|NCT00430456|Gait|gait
5302090|NCT00430456|MRI, functional|mri, functional
5302091|NCT00430456|Physical therapy techniques|physical therapy techniques
5302092|NCT00430456|Self Efficacy|self efficacy
5302093|NCT00430456|Treadmill test|treadmill test
5302094|NCT00430443|Acute Lymphocytic Leukemia|acute lymphocytic leukemia
5302095|NCT00430443|Acute Myelogenous Leukemia|acute myelogenous leukemia
5302096|NCT00430443|Annamycin|annamycin
5302097|NCT00430443|Liposomal Annamycin|liposomal annamycin
5302098|NCT00430417|Pregnancy|pregnancy
5302099|NCT00430417|Lactation|lactation
5302100|NCT00430417|Endocrine System Diseases|endocrine system diseases
5302101|NCT00430417|MusculoSkeletal System Disease|musculoskeletal system disease
5302102|NCT00430417|Hormone|hormone
5302103|NCT00430417|Physiologic Properties|physiologic properties
5302104|NCT00430391|DVD|dvd
5302105|NCT00430391|Multi-media|multi-media
5302106|NCT00430391|Schizophrenia|schizophrenia
5302107|NCT00430391|Normal Comparison|normal comparison
5302108|NCT00430391|Consent procedures|consent procedures
5302109|NCT00430378|Xerostomia|xerostomia
5302110|NCT00430378|Dry Mouth|dry mouth
5302111|NCT00430378|Mouth Dryness|mouth dryness
5302112|NCT00430378|Nasopharyngeal Cancer|nasopharyngeal cancer
5302113|NCT00430378|Acupuncture|acupuncture
5302114|NCT00430365|Myeloma|myeloma
5302115|NCT00430365|Revlimid|revlimid
5302116|NCT00430365|Maintenance therapy|maintenance therapy
5302117|NCT00430365|Autologous Stem Cell Transplantation|autologous stem cell transplantation
5302118|NCT00430313|Nausea|nausea
5302119|NCT00430313|Vomiting|vomiting
5302120|NCT00430313|Electro-Stimulation|electro-stimulation
5302121|NCT00430313|ES|es
5302122|NCT00430313|K1 Acupuncture Point|k1 acupuncture point
5302123|NCT00430313|Yongquan Acupuncture Point|yongquan acupuncture point
5302124|NCT00430313|TAI|tai
5302125|NCT00430313|transarterial infusion|transarterial infusion
5302126|NCT00430313|liver metastasis|liver metastasis
5302127|NCT00430313|chemotherapy induced nausea and vomiting|chemotherapy induced nausea and vomiting
5302128|NCT00430313|CINV|cinv
5302129|NCT00430313|Cisplatin|cisplatin
5302130|NCT00430313|Oxaliplatin|oxaliplatin
5302131|NCT00430300|Dry Powder for Inhalation|dry powder for inhalation
5302132|NCT00430300|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5302133|NCT00430300|Lung Function testing|lung function testing
5302134|NCT00430287|primary open angle glaucoma|primary open angle glaucoma
5302135|NCT00430287|low tension glaucoma|low tension glaucoma
5302136|NCT00430287|pigmentary glaucoma|pigmentary glaucoma
5302137|NCT00430287|exfoliative glaucoma|exfoliative glaucoma
5302138|NCT00430274|glaucoma|glaucoma
5302139|NCT00430274|retinal gliosis-like alterations|retinal gliosis-like alterations
5302140|NCT00430274|optical coherence tomography|optical coherence tomography
5302141|NCT00430274|automated microperimetry|automated microperimetry
5302142|NCT00430261|bronchoalveolar carcinoma|bronchoalveolar carcinoma
5302143|NCT00430261|BAC|bac
5302144|NCT00430261|adenocarcinoma|adenocarcinoma
5302145|NCT00430261|lung cancer|lung cancer
5302146|NCT00430261|oral|oral
5302147|NCT00430261|Stage IIIB and IV lung cancer|stage iiib and iv lung cancer
5302148|NCT00430261|Any bronchoalveolar carcinoma (BAC)|any bronchoalveolar carcinoma (bac)
5302149|NCT00430261|Any adenocarcinoma in a never-smoker|any adenocarcinoma in a never-smoker
5302150|NCT00430248|tophi|tophi
5302151|NCT00430248|hyperuricemia|hyperuricemia
5302152|NCT00430248|uric acid|uric acid
5302153|NCT00430248|Drug Therapy|drug therapy
5302154|NCT00430235|prostate|prostate
5302155|NCT00430235|cancer|cancer
5302156|NCT00430235|BAY 43-9006|bay 43-9006
5302157|NCT00430183|stage I prostate cancer|stage i prostate cancer
5302158|NCT00430183|stage IIB prostate cancer|stage iib prostate cancer
5302159|NCT00430183|stage IIA prostate cancer|stage iia prostate cancer
5302160|NCT00430183|stage III prostate cancer|stage iii prostate cancer
5302161|NCT00430183|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5302162|NCT00430170|ischemia-reperfusion injury|ischemia-reperfusion injury
5302163|NCT00430170|adenosine|adenosine
5302164|NCT00430170|dipyridamole|dipyridamole
5302165|NCT00430170|caffeine|caffeine
5302166|NCT00430157|Vienna Challenge Chamber|vienna challenge chamber
5302167|NCT00430157|Seasonal Allergic Rhinitis|seasonal allergic rhinitis
5302168|NCT00430157|Inflammation|inflammation
5302169|NCT00430118|T-cell childhood acute lymphoblastic leukemia|t-cell childhood acute lymphoblastic leukemia
5302257|NCT00429715|Leishmaniasis vaccine|leishmaniasis vaccine
5302170|NCT00430118|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5302171|NCT00430118|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
5302172|NCT00430118|B-cell childhood acute lymphoblastic leukemia|b-cell childhood acute lymphoblastic leukemia
5302173|NCT00430105|Vasculitis|vasculitis
5302174|NCT00430105|ANCA|anca
5302293|NCT00429611|defibrillation efficacy|defibrillation efficacy
5302175|NCT00430105|Wegener's granulomatosis|wegener's granulomatosis
5302176|NCT00430105|Renal vasculitis|renal vasculitis
5302177|NCT00430105|Cyclophosphamide|cyclophosphamide
5302178|NCT00430053|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
5302179|NCT00430053|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
5302180|NCT00430053|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
5302181|NCT00430053|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
5302182|NCT00430053|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
5302183|NCT00430053|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
5302184|NCT00430053|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
5302185|NCT00430053|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
5302186|NCT00430040|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
5302187|NCT00430040|Hypertension|hypertension
5302188|NCT00430040|Carvedilol CR|carvedilol cr
5302189|NCT00430040|Beta-blocker|beta-blocker
5302190|NCT00430040|Oxidative stress|oxidative stress
5302191|NCT00430040|Inflammation|inflammation
5302192|NCT00430040|Vascular benefits|vascular benefits
5302193|NCT00430027|Esophageal|esophageal
5302194|NCT00430027|Esophagus|esophagus
5302195|NCT00430014|Advanced Cancer|advanced cancer
5302196|NCT00430014|Relapsed|relapsed
5302197|NCT00430014|Atiprimod|atiprimod
5302198|NCT00430014|Guanylyl cyclase receptor antagonist|guanylyl cyclase receptor antagonist
5302199|NCT00430001|Metastatic breast neoplasm|metastatic breast neoplasm
5302200|NCT00429988|breast cancer|breast cancer
5302201|NCT00429975|fluorquinolones,|fluorquinolones,
5302202|NCT00429975|b-lactams,|b-lactams,
5302203|NCT00429975|immunomodulation.|immunomodulation.
5302204|NCT00429962|subfoveal choroidal neovascularization (CNV)|subfoveal choroidal neovascularization (cnv)
5302205|NCT00429962|age-related macular degeneration|age-related macular degeneration
5302206|NCT00429962|ranibizumab monotherapy|ranibizumab monotherapy
5302207|NCT00429962|combined verteporfin-therapy|combined verteporfin-therapy
5302208|NCT00429962|Lucentis® (ranibizumab)|lucentis® (ranibizumab)
5302209|NCT00429962|Visudyne®|visudyne®
5302210|NCT00429962|photodynamic therapy|photodynamic therapy
5302211|NCT00429949|Dasatinib|dasatinib
5302212|NCT00429949|Plateau phase|plateau phase
5302213|NCT00429936|Dry Age Related Macular Degeneration|dry age related macular degeneration
5302214|NCT00429936|Geographic Atrophy|geographic atrophy
5302215|NCT00429910|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5302216|NCT00429910|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5302217|NCT00429910|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5302218|NCT00429910|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
5302219|NCT00429897|Hypertension|hypertension
5302220|NCT00429897|Low Renin|low renin
5302221|NCT00429884|Atrial fibrillation|atrial fibrillation
5302222|NCT00429871|Metastatic breast cancer;|metastatic breast cancer;
5302223|NCT00429871|First line chemotherapy;|first line chemotherapy;
5302224|NCT00429871|Docetaxel;|docetaxel;
5302225|NCT00429871|Epirubicin;|epirubicin;
5302226|NCT00429871|Capecitabine|capecitabine
5302227|NCT00429858|recurrent pancreatic cancer|recurrent pancreatic cancer
5302228|NCT00429858|stage III pancreatic cancer|stage iii pancreatic cancer
5302229|NCT00429858|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
5302230|NCT00429858|stage IV pancreatic cancer|stage iv pancreatic cancer
5302231|NCT00429845|HIV|hiv
5302232|NCT00429845|HAART|haart
5302233|NCT00429845|Nutrition|nutrition
5302234|NCT00429845|Dyslipidemia|dyslipidemia
5302235|NCT00429832|Nausea, vomiting, antiemetic|nausea, vomiting, antiemetic
5302236|NCT00429806|Vaginal atrophy|vaginal atrophy
5302237|NCT00429806|DHEA|dhea
5302238|NCT00429806|Prasterone|prasterone
5302239|NCT00429806|Menopause|menopause
5302240|NCT00429780|Leishmaniasis vaccine|leishmaniasis vaccine
5302241|NCT00429780|Alum-ALM|alum-alm
5302242|NCT00429780|First generation vaccine|first generation vaccine
5302243|NCT00429780|Leishmanin positive|leishmanin positive
5302244|NCT00429780|Healthy Volunteers|healthy volunteers
5302245|NCT00429780|Response to Leishmanin (Leishmanin Skin Test>0)|response to leishmanin (leishmanin skin test>0)
5302246|NCT00429780|No History of Cutaneous Leishmaniasis|no history of cutaneous leishmaniasis
5302247|NCT00429767|Opioid|opioid
5302248|NCT00429767|Cocaine|cocaine
5302249|NCT00429767|Drug Self Administration|drug self administration
5302250|NCT00429754|Nausea and vomiting after using cytostatic drugs|nausea and vomiting after using cytostatic drugs
5302251|NCT00429728|Pharmacokinetics,|pharmacokinetics,
5302252|NCT00429728|tolerability,|tolerability,
5302253|NCT00429728|healthy,|healthy,
5302254|NCT00429728|subjects,|subjects,
5302258|NCT00429715|Alum-ALM|alum-alm
5302259|NCT00429715|First generation vaccine|first generation vaccine
5302260|NCT00429715|Healthy volunteers|healthy volunteers
5302261|NCT00429715|No response to leishmanin|no response to leishmanin
5302262|NCT00429715|No history of cutaneous leishmaniasis|no history of cutaneous leishmaniasis
5302263|NCT00429702|nausea|nausea
5302264|NCT00429702|vomiting|vomiting
5302265|NCT00429702|emetic chemotherapy|emetic chemotherapy
5302266|NCT00429702|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
5302267|NCT00429689|Male, MDD, Testosterone, DHEA-S,Cortisol|male, mdd, testosterone, dhea-s,cortisol
5302268|NCT00429689|Male|male
5302269|NCT00429689|18-65|18-65
5302270|NCT00429689|Major Depression|major depression
5302271|NCT00429676|Randomized|randomized
5302272|NCT00429676|Controlled|controlled
5302273|NCT00429676|Trial|trial
5302274|NCT00429676|Delirium|delirium
5302275|NCT00429676|Haloperidol|haloperidol
5302276|NCT00429663|distal femur|distal femur
5302277|NCT00429663|femur fracture|femur fracture
5302278|NCT00429650|Weight maintenance|weight maintenance
5302279|NCT00429650|Weight loss|weight loss
5302280|NCT00429637|EBC pH|ebc ph
5302281|NCT00429637|Airway acidification|airway acidification
5302282|NCT00429637|Condensimetry|condensimetry
5302283|NCT00429637|ARDS|ards
5302284|NCT00429637|RSV|rsv
5302285|NCT00429637|ALI|ali
5302286|NCT00429637|Airway reconstruction|airway reconstruction
5302287|NCT00429624|Neck Pain|neck pain
5302288|NCT00429624|Chiropractic manipulation|chiropractic manipulation
5302289|NCT00429624|Randomized controlled trial|randomized controlled trial
5302290|NCT00429611|biphasic defibrillation|biphasic defibrillation
5302291|NCT00429611|inhospital|inhospital
5302292|NCT00429611|post-resuscitation myocardial function|post-resuscitation myocardial function
5302294|NCT00429611|high energy versus low energy|high energy versus low energy
5302295|NCT00429611|cardiac arrest patients|cardiac arrest patients
5302296|NCT00429585|tibia fracture|tibia fracture
5302297|NCT00429585|proximal tibia|proximal tibia
5302298|NCT00429572|Breast Cancer|breast cancer
5302299|NCT00429572|PBPC Transplantation|pbpc transplantation
5302300|NCT00429572|Stem Cell Infusion|stem cell infusion
5302301|NCT00429572|Fludarabine|fludarabine
5302302|NCT00429572|Melphalan|melphalan
5302303|NCT00429559|Cancer;|cancer;
5302304|NCT00429559|Ovarian cancer;|ovarian cancer;
5302305|NCT00429559|Recurrent ovarian cancer platinum-resistant|recurrent ovarian cancer platinum-resistant
5302306|NCT00429546|Disclosure|disclosure
5302307|NCT00429546|Serostatus|serostatus
5302308|NCT00429507|Breast Cancer|breast cancer
5302309|NCT00429507|Blood Stem Cell|blood stem cell
5302310|NCT00429507|Bone Metastases|bone metastases
5302311|NCT00429507|Radiation Therapy|radiation therapy
5302312|NCT00429507|Gamma Camera|gamma camera
5302313|NCT00429507|Sm-EDTMP|sm-edtmp
5302314|NCT00429507|Samarium 153-EDTMP|samarium 153-edtmp
5302315|NCT00429507|Stem Cell Transplant|stem cell transplant
5302316|NCT00429507|Autologous Peripheral Blood Stem Cell Transplantation|autologous peripheral blood stem cell transplantation
5302317|NCT00429507|PBSCT|pbsct
5302318|NCT00429507|Questionnaire|questionnaire
5302319|NCT00429494|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
5302320|NCT00429494|GnRH Analogue|gnrh analogue
5302321|NCT00429494|Gonadotropin-releasing hormone analogue|gonadotropin-releasing hormone analogue
5302322|NCT00429494|GnRH-a|gnrh-a
5302323|NCT00429494|Ovarian Function|ovarian function
5302324|NCT00429494|Fertility|fertility
5302325|NCT00429494|Leuprolide Acetate|leuprolide acetate
5302326|NCT00429494|Lupron Depot|lupron depot
5302327|NCT00429494|premature ovarian failure|premature ovarian failure
5302328|NCT00429494|POF|pof
5302329|NCT00429494|Abnormal suppression of menstruation|abnormal suppression of menstruation
5302330|NCT00429494|absence of menstruation|absence of menstruation
5302331|NCT00429481|Oral live attenuated human rotavirus vaccine|oral live attenuated human rotavirus vaccine
5302332|NCT00429481|Gastroenteritis|gastroenteritis
5302333|NCT00429481|Vomiting|vomiting
5302334|NCT00429455|Fertility|fertility
5302335|NCT00429455|Menopause|menopause
5302336|NCT00429455|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
5302337|NCT00429455|Questionnaire|questionnaire
5302338|NCT00429455|Survey|survey
5302339|NCT00429442|Simvastatin|simvastatin
5302340|NCT00429442|CNS Inflammation|cns inflammation
5302341|NCT00429442|Copaxone|copaxone
5302342|NCT00429429|Peanut allergy|peanut allergy
5302343|NCT00429416|Hematologic Malignancies|hematologic malignancies
5302344|NCT00429416|GVHD|gvhd
5302345|NCT00429416|Graft-Versus-Host-Disease|graft-versus-host-disease
5302346|NCT00429416|LLME|llme
5302347|NCT00429416|CD34+ stem cell infusions|cd34+ stem cell infusions
5302348|NCT00429416|CD34- fraction|cd34- fraction
5302349|NCT00429416|Cyclosporine|cyclosporine
5302350|NCT00429416|Mycophenolate Mofetil|mycophenolate mofetil
5302351|NCT00429416|HSCT|hsct
5302352|NCT00429416|Hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
5302353|NCT00429403|Breast Cancer|breast cancer
5302354|NCT00429403|Chemotherapy|chemotherapy
5302355|NCT00429403|Ovarian Function|ovarian function
5302356|NCT00429403|Goserelin|goserelin
5302357|NCT00429403|Zoladex|zoladex
5302358|NCT00429403|Ovary function|ovary function
5302359|NCT00429403|Fertility|fertility
5302360|NCT00429403|Early Menopause|early menopause
5302361|NCT00429390|Metabolic syndrome|metabolic syndrome
5302362|NCT00429390|Ramadan Fasting|ramadan fasting
5302363|NCT00429390|Insulin sensitivity|insulin sensitivity
5302364|NCT00429390|Iran|iran
5302365|NCT00429377|tacrolimus|tacrolimus
5302366|NCT00429377|FK506|fk506
5302367|NCT00429377|lupus nephritis|lupus nephritis
5302368|NCT00429364|Aortic Root Dissection|aortic root dissection
5302369|NCT00429364|Aortic Root Dilation|aortic root dilation
5302370|NCT00429364|Pediatric Heart Network|pediatric heart network
5302371|NCT00429338|Genitourinary|genitourinary
5302372|NCT00429338|Prostate Cancer|prostate cancer
5302373|NCT00429338|Magnetic Resonance Imaging|magnetic resonance imaging
5302374|NCT00429338|MRI|mri
5302375|NCT00429338|Magnetic Resonance Spectroscopic Imaging|magnetic resonance spectroscopic imaging
5302376|NCT00429338|MRSI|mrsi
5302377|NCT00429338|Endorectal MRSI|endorectal mrsi
5302378|NCT00429338|Endorectal magnetic resonance spectroscopy imaging|endorectal magnetic resonance spectroscopy imaging
5302379|NCT00429338|3 Tesla|3 tesla
5302380|NCT00429338|3T Scan|3t scan
5302381|NCT00429338|Endorectal coil|endorectal coil
5302382|NCT00429338|Perfluorocarbon compound|perfluorocarbon compound
5302383|NCT00429338|PFC|pfc
5302384|NCT00429338|PFC-filled endorectal coil|pfc-filled endorectal coil
5302385|NCT00429338|PFC-MRSI|pfc-mrsi
5302386|NCT00429338|AIR-MRSI|air-mrsi
5302387|NCT00429325|acute infectious diarrhea,|acute infectious diarrhea,
5302388|NCT00429325|fecal calprotectin,|fecal calprotectin,
5302389|NCT00429325|stool culture,|stool culture,
5302390|NCT00429325|hemoccult test,|hemoccult test,
5302391|NCT00429325|Guaiac fecal occult blood test (FOBT)|guaiac fecal occult blood test (fobt)
5302392|NCT00429325|fecal lactoferrin|fecal lactoferrin
5302393|NCT00429312|Melanoma|melanoma
5302394|NCT00429312|Oncolytic virus|oncolytic virus
5302395|NCT00429312|Pexa-Vec|pexa-vec
5302396|NCT00429299|neo-adjuvant trastuzumab early breast cancer lapatinib|neo-adjuvant trastuzumab early breast cancer lapatinib
5302397|NCT00429286|Health Services Research|health services research
5302398|NCT00429273|ADHD|adhd
5302399|NCT00429273|Guanfacine|guanfacine
5302400|NCT00429273|Methylphenidate|methylphenidate
5302401|NCT00429273|Focalin XR|focalin xr
5302402|NCT00429273|Pediatric|pediatric
5302403|NCT00429273|Cognitive function|cognitive function
5302404|NCT00429273|Combination therapy|combination therapy
5302405|NCT00429260|depression|depression
5302406|NCT00429260|antidepressive agents|antidepressive agents
5302407|NCT00429247|Occult tumor cells|occult tumor cells
5302408|NCT00429247|Micrometastatic cells|micrometastatic cells
5302409|NCT00429247|Cytokeratin-19|cytokeratin-19
5302410|NCT00429247|Trastuzumab|trastuzumab
5302411|NCT00429247|Completion of Adjuvant Treatment|completion of adjuvant treatment
5302412|NCT00429234|Advanced Cancer|advanced cancer
5302413|NCT00429234|Solid Tumors|solid tumors
5302414|NCT00429234|Dasatinib|dasatinib
5302415|NCT00429234|BMS-354825|bms-354825
5302416|NCT00429234|Sprycel|sprycel
5302417|NCT00429234|Gemcitabine|gemcitabine
5302418|NCT00429234|Gemcitabine Hydrochloride|gemcitabine hydrochloride
5302419|NCT00429234|Gemzar|gemzar
5302420|NCT00429221|ADHD|adhd
5302421|NCT00429208|Nicotine Dependence|nicotine dependence
5302422|NCT00429208|Smoking|smoking
5302423|NCT00429208|Tobacco Use Disorder|tobacco use disorder
5302424|NCT00429208|Nicotine Use Disorder|nicotine use disorder
5302425|NCT00429195|LIPGENE|lipgene
5302426|NCT00429195|Fatty acid|fatty acid
5302427|NCT00429195|Dietary intervention|dietary intervention
5302428|NCT00429195|Metabolic syndrome|metabolic syndrome
5302429|NCT00429195|Insulin resistance|insulin resistance
5302430|NCT00429182|Breast Cancer|breast cancer
5302431|NCT00429182|breast carcinoma|breast carcinoma
5302432|NCT00429182|Carboplatin|carboplatin
5302433|NCT00429182|Paraplatin|paraplatin
5302434|NCT00429182|Cyclophosphamide|cyclophosphamide
5302435|NCT00429182|Neosar|neosar
5302436|NCT00429182|Cytoxan|cytoxan
5302437|NCT00429182|Thiotepa|thiotepa
5302438|NCT00429182|Purged Autologous Stem Cells|purged autologous stem cells
5302439|NCT00429182|Circulating Tumor Cells|circulating tumor cells
5302440|NCT00429182|CTCs|ctcs
5302441|NCT00429169|Major Depressive Disorder|major depressive disorder
5302443|NCT00429156|Non-invasive ventilation|non-invasive ventilation
5302444|NCT00429156|Non-invasive positive pressure ventilation|non-invasive positive pressure ventilation
5302445|NCT00429156|Home ventilation|home ventilation
5302446|NCT00429156|Domiciliary ventilation|domiciliary ventilation
5302447|NCT00429156|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
5302448|NCT00429156|COPD|copd
5302449|NCT00429156|Respiratory failure|respiratory failure
5302450|NCT00429156|Acute hypercapnic respiratory failure|acute hypercapnic respiratory failure
5302451|NCT00429156|NIV|niv
5302452|NCT00429156|NIPPV|nippv
5302453|NCT00429156|Type II respiratory failure|type ii respiratory failure
5302454|NCT00429143|Hematologic Malignancies|hematologic malignancies
5302455|NCT00429143|Two Step Approach|two step approach
5302456|NCT00429143|Haploidentical Transplant|haploidentical transplant
5302457|NCT00429117|Spirituality|spirituality
5302458|NCT00429117|Work Related Stress|work related stress
5302459|NCT00429117|Religious Beliefs|religious beliefs
5302460|NCT00429117|Survey|survey
5302461|NCT00429104|Breast Cancer|breast cancer
5302462|NCT00429104|Carcinoma of the Breast|carcinoma of the breast
5302463|NCT00429104|HER-2/neu Overexpression|her-2/neu overexpression
5302464|NCT00429104|Herceptin|herceptin
5302465|NCT00429104|Trastuzumab|trastuzumab
5302466|NCT00429104|GM-CSF|gm-csf
5302467|NCT00429104|Sargramostim|sargramostim
5302468|NCT00429104|Leukine|leukine
5302469|NCT00429078|Gastric Cancer|gastric cancer
5302470|NCT00429078|T Cells|t cells
5302471|NCT00429078|Gene Transfer|gene transfer
5302472|NCT00429065|Non-Hodgkin lymphoma|non-hodgkin lymphoma
5302473|NCT00429065|rituximab|rituximab
5302474|NCT00429065|immunotherapy|immunotherapy
5302475|NCT00429052|Coronary Disease|coronary disease
5302476|NCT00429052|Coronary Stenosis|coronary stenosis
5302477|NCT00429052|Percutaneous Transluminal Coronary Angioplasty|percutaneous transluminal coronary angioplasty
5302478|NCT00429052|Stents|stents
5302479|NCT00429052|Sirolimus|sirolimus
5302480|NCT00429026|Kidney Cancer|kidney cancer
5302481|NCT00429026|Renal Cell Cancer|renal cell cancer
5302482|NCT00429026|Stem Cell Transplant|stem cell transplant
5302483|NCT00429026|Cyclophosphamide|cyclophosphamide
5302484|NCT00429026|Fludarabine|fludarabine
5302485|NCT00429026|Melphalan|melphalan
5302486|NCT00429026|NST|nst
5302487|NCT00429013|Pressure ulcer|pressure ulcer
5302488|NCT00429013|Lingual electric stimulation|lingual electric stimulation
5302489|NCT00429013|Paraplegic patient|paraplegic patient
5302490|NCT00429013|Pressure Ulcer/Prevention & control|pressure ulcer/prevention & control
5302491|NCT00429000|Hypothermia|hypothermia
5302492|NCT00429000|Infant mortality|infant mortality
5302493|NCT00429000|Infant morbidity|infant morbidity
5302494|NCT00429000|Intervention|intervention
5302495|NCT00429000|Randomisation|randomisation
5302496|NCT00429000|Longitudinal research.|longitudinal research.
5302497|NCT00429000|Low-income country|low-income country
5302498|NCT00428987|Energy Expenditure|energy expenditure
5302499|NCT00428987|Neurocognitive Function|neurocognitive function
5302500|NCT00428987|Obesity|obesity
5302501|NCT00428987|Metabolism|metabolism
5302502|NCT00428987|Phenotype|phenotype
5302503|NCT00428987|Body Composition|body composition
5302504|NCT00428987|Morbid Obesity|morbid obesity
5302505|NCT00428987|Overweight|overweight
5302506|NCT00428987|Healthy Volunteer|healthy volunteer
5302507|NCT00428974|Psoriasis|psoriasis
5302508|NCT00428961|diabetes mellitus|diabetes mellitus
5302509|NCT00428961|insulin resistance|insulin resistance
5302510|NCT00428961|atherosclerosis|atherosclerosis
5302511|NCT00428948|ADPKD|adpkd
5302512|NCT00428948|Polycystic|polycystic
5302513|NCT00428948|kidney|kidney
5302514|NCT00428948|ADPKD (Autosomal Dominant Polycystic Kidney Disease)|adpkd (autosomal dominant polycystic kidney disease)
5302515|NCT00428935|Duchenne|duchenne
5302516|NCT00428935|Muscle|muscle
5302517|NCT00428935|Muscular Dystrophy|muscular dystrophy
5302518|NCT00428935|Gene Therapy|gene therapy
5302519|NCT00428935|Dystrophin|dystrophin
5302520|NCT00428935|Adeno-Associated Virus|adeno-associated virus
5302521|NCT00428935|AAV|aav
5302522|NCT00428922|Metastatic|metastatic
5302523|NCT00428922|Breast Cancer|breast cancer
5302524|NCT00428922|MBC|mbc
5302525|NCT00428909|Pharmacokinetic|pharmacokinetic
5302526|NCT00428909|STI571|sti571
5302527|NCT00428909|imatinib|imatinib
5302528|NCT00428909|CML|cml
5302529|NCT00428909|Chronic Myeloid Leukemia|chronic myeloid leukemia
5302530|NCT00428909|Philadelphia Chromosome|philadelphia chromosome
5302531|NCT00428909|acetaminophen|acetaminophen
5302532|NCT00428896|Breast cancer|breast cancer
5302533|NCT00428896|iressa circulating tumor cells|iressa circulating tumor cells
5302534|NCT00428883|Scleroderma, Systemic|scleroderma, systemic
5302535|NCT00428883|Scleroderma, Diffuse|scleroderma, diffuse
5302536|NCT00428870|Shoulder|shoulder
5302537|NCT00428870|impingement|impingement
5302538|NCT00428870|conservative|conservative
5302539|NCT00428870|acromioplasty|acromioplasty
5302540|NCT00428870|arthroscopy|arthroscopy
5302541|NCT00428844|Osteomyelitis|osteomyelitis
5302542|NCT00428844|Prosthetic Hip|prosthetic hip
5302543|NCT00428844|Prosthetic Knee|prosthetic knee
5302544|NCT00428844|MRSA|mrsa
5302545|NCT00428844|Osteomyelitis Associated with an Infected Prosthetic Hip or Knee Joint|osteomyelitis associated with an infected prosthetic hip or knee joint
5302546|NCT00428844|Staphylococci|staphylococci
5302547|NCT00428831|influenza, genomic data, nasopharyngeal aspirate|influenza, genomic data, nasopharyngeal aspirate
5302548|NCT00428818|MRSA|mrsa
5302549|NCT00428805|body composition|body composition
5302550|NCT00428805|physical activity|physical activity
5302551|NCT00428805|dietary intake|dietary intake
5302552|NCT00428805|children|children
5302553|NCT00428792|ADHD|adhd
5302554|NCT00428792|methylphenidate|methylphenidate
5302555|NCT00428792|children|children
5302556|NCT00428792|food effect|food effect
5302557|NCT00428792|Attention-Deficit Hyperactivity Disorder (ADHD) in children|attention-deficit hyperactivity disorder (adhd) in children
5302558|NCT00428779|Running during 24 hours|running during 24 hours
5302659|NCT00428311|Polycystic ovary syndrome|polycystic ovary syndrome
5302559|NCT00428779|Voluntary evoked force on the muscles|voluntary evoked force on the muscles
5302560|NCT00428779|Electrically evoked force on the muscles|electrically evoked force on the muscles
5302561|NCT00428779|EMG activity|emg activity
5302562|NCT00428779|Muscle biopsy|muscle biopsy
5302563|NCT00428779|subjects will be recruited among experienced ultra-runners|subjects will be recruited among experienced ultra-runners
5302564|NCT00428753|avian influenza, China, H5N1|avian influenza, china, h5n1
5302565|NCT00428727|Diabetic foot|diabetic foot
5302566|NCT00428727|Ulcer|ulcer
5302567|NCT00428727|nitric oxide|nitric oxide
5302568|NCT00428727|treatment|treatment
5302569|NCT00428727|donor|donor
5302570|NCT00428727|controlled trial|controlled trial
5302571|NCT00428701|stress ulcer|stress ulcer
5302572|NCT00428701|critically ill|critically ill
5302573|NCT00428701|gastric acid|gastric acid
5302574|NCT00428701|gastric aspirates|gastric aspirates
5302575|NCT00428701|esomeprazole|esomeprazole
5302576|NCT00428688|Hodgkin's lymphoma|hodgkin's lymphoma
5302577|NCT00428688|cardiovascular disease|cardiovascular disease
5302578|NCT00428688|radiation therapy|radiation therapy
5302579|NCT00428688|Brachial artery flow-mediated dilation (FMD)|brachial artery flow-mediated dilation (fmd)
5302580|NCT00428675|screening|screening
5302581|NCT00428675|fatigue|fatigue
5302582|NCT00428662|coronary stenting|coronary stenting
5302583|NCT00428662|drug eluting stents|drug eluting stents
5302584|NCT00428662|paclitaxel|paclitaxel
5302585|NCT00428662|nanoporous|nanoporous
5302586|NCT00428649|Selenium supplements|selenium supplements
5302587|NCT00428649|Selenoprotein P|selenoprotein p
5302588|NCT00428649|Optimization|optimization
5302589|NCT00428636|ileostomy|ileostomy
5302590|NCT00428636|rectal resection|rectal resection
5302591|NCT00428636|proctectomy|proctectomy
5302592|NCT00428636|stoma closure|stoma closure
5302593|NCT00428623|Patient comfort|patient comfort
5302594|NCT00428623|Wound dressings|wound dressings
5302595|NCT00428623|infection|infection
5302596|NCT00428623|vascular surgery|vascular surgery
5302597|NCT00428571|Type 2 Diabetes|type 2 diabetes
5302598|NCT00428571|Bariatric surgery|bariatric surgery
5302599|NCT00428571|Obesity|obesity
5302600|NCT00428571|Laparoscopic gastric bypass|laparoscopic gastric bypass
5302601|NCT00428571|Laparoscopic adjustable gastric banding|laparoscopic adjustable gastric banding
5302602|NCT00428558|acute myeloid leukemia|acute myeloid leukemia
5302603|NCT00428558|Core Binding Factor|core binding factor
5302604|NCT00428558|t(8;21)|t(8;21)
5302605|NCT00428558|inv(16)|inv(16)
5302606|NCT00428558|timed-sequential induction|timed-sequential induction
5302607|NCT00428545|Advanced Malignancy|advanced malignancy
5302608|NCT00428545|Lymphoma|lymphoma
5302609|NCT00428545|Myeloma|myeloma
5302610|NCT00428545|Solid Tumors|solid tumors
5302611|NCT00428545|Bevacizumab|bevacizumab
5302612|NCT00428545|Avastin|avastin
5302613|NCT00428545|Anti-VEGF monoclonal antibody|anti-vegf monoclonal antibody
5302614|NCT00428545|rhuMAb-VEGF|rhumab-vegf
5302615|NCT00428545|Bortezomib|bortezomib
5302616|NCT00428545|Velcade|velcade
5302617|NCT00428545|PS-341|ps-341
5302618|NCT00428545|LDP-341|ldp-341
5302619|NCT00428545|MLN341|mln341
5302620|NCT00428519|HIV infection|hiv infection
5302621|NCT00428519|Neurokinin-1 receptor antagonist|neurokinin-1 receptor antagonist
5302622|NCT00428519|CCR5 expression|ccr5 expression
5302623|NCT00428519|Treatment Naive|treatment naive
5302624|NCT00428506|ascites|ascites
5302625|NCT00428506|cirrhosis|cirrhosis
5302626|NCT00428506|post-paracentesis circulatory dysfunction|post-paracentesis circulatory dysfunction
5302627|NCT00428506|albumin|albumin
5302628|NCT00428506|portal-hypertension|portal-hypertension
5302629|NCT00428493|human influenza A, H5N1, bird flu, avian influenza, China|human influenza a, h5n1, bird flu, avian influenza, china
5302630|NCT00428467|Heart Failure|heart failure
5302631|NCT00428467|LV Geometry|lv geometry
5302632|NCT00428467|Heart MRT|heart mrt
5302633|NCT00428454|drug-eluting stent|drug-eluting stent
5302634|NCT00428454|chronic total occlusion|chronic total occlusion
5302635|NCT00428454|sirolimus-eluting stent|sirolimus-eluting stent
5302636|NCT00428454|zotarolimus-eluting stent|zotarolimus-eluting stent
5302637|NCT00428454|QCA|qca
5302638|NCT00428441|D-dimer|d-dimer
5302639|NCT00428441|Recurrence|recurrence
5302640|NCT00428441|Venous thromboembolism|venous thromboembolism
5302641|NCT00428428|kidney stone|kidney stone
5302642|NCT00428428|ureteroscopy|ureteroscopy
5302643|NCT00428402|Education|education
5302644|NCT00428402|4th-8th Grade Student|4th-8th grade student
5302645|NCT00428402|MIDAS Project|midas project
5302646|NCT00428402|Focus Group Discussion|focus group discussion
5302647|NCT00428402|Bastrop|bastrop
5302648|NCT00428389|Dementia, Alzheimer's, Rivastigmine, donepezil|dementia, alzheimer's, rivastigmine, donepezil
5302649|NCT00428363|posterior capsule opacification|posterior capsule opacification
5302650|NCT00428363|PCO|pco
5302651|NCT00428363|after cataract|after cataract
5302652|NCT00428363|intraocular lens|intraocular lens
5302653|NCT00428363|optic edge design|optic edge design
5302654|NCT00428363|sharp optic edge|sharp optic edge
5302655|NCT00428337|HIV Seronegativity|hiv seronegativity
5302656|NCT00428337|EP1233|ep1233
5302657|NCT00428337|MVA-mBN32|mva-mbn32
5302658|NCT00428337|HIV Preventive Vaccine|hiv preventive vaccine
5302660|NCT00428311|Hyperandrogenism|hyperandrogenism
5302661|NCT00428311|Hirsutism|hirsutism
5302662|NCT00428311|Cardiovascular risk|cardiovascular risk
5302663|NCT00428311|Chronic inflammation|chronic inflammation
5302664|NCT00428311|Metformin|metformin
5302665|NCT00428311|Cyproterone acetate|cyproterone acetate
5302666|NCT00428311|Oral contraceptives|oral contraceptives
5302667|NCT00428298|Bipolar|bipolar
5302668|NCT00428298|Cognitive|cognitive
5302669|NCT00428298|Attention|attention
5302670|NCT00428298|Memory|memory
5302671|NCT00428298|Manic Depression|manic depression
5302672|NCT00428298|Bi-polar|bi-polar
5302673|NCT00428285|Human Papilloma Virus|human papilloma virus
5302674|NCT00428285|HIV infected MSM|hiv infected msm
5302675|NCT00428285|Treatment Experienced|treatment experienced
5302676|NCT00428285|Treatment Naive|treatment naive
5302677|NCT00428285|Anal Intraepithelial Neoplasia|anal intraepithelial neoplasia
5302678|NCT00428272|Monoclonal Antibody Lexatumumab|monoclonal antibody lexatumumab
5302679|NCT00428272|Interferon Gamma|interferon gamma
5302680|NCT00428272|Solid Tumor|solid tumor
5302681|NCT00428272|Phase I|phase i
5302682|NCT00428272|Malignant Tumor|malignant tumor
5302683|NCT00428272|Metastatic Tumor|metastatic tumor
5302684|NCT00428272|Pediatric Solid Tumor|pediatric solid tumor
5302685|NCT00428272|Ewing Sarcoma|ewing sarcoma
5302686|NCT00428272|Osteosarcoma|osteosarcoma
5302687|NCT00428272|Neuroblastoma|neuroblastoma
5302688|NCT00428272|Rhabdomyosarcoma|rhabdomyosarcoma
5302689|NCT00428246|Chronic Kidney Disease|chronic kidney disease
5302690|NCT00428246|Endothelial dysfunction|endothelial dysfunction
5302691|NCT00428246|Inflammation|inflammation
5302692|NCT00428246|Hypertension|hypertension
5302693|NCT00428246|paricalcitol|paricalcitol
5302694|NCT00428246|Blood pressure|blood pressure
5302695|NCT00428246|Vitamin D|vitamin d
5302696|NCT00428246|Glomerular filtration rate|glomerular filtration rate
5302697|NCT00428233|CLL|cll
5302698|NCT00428233|vaccine|vaccine
5302699|NCT00428220|Potentially other tumor types in the future|potentially other tumor types in the future
5302700|NCT00428207|type 1 diabetes, insulin pump therapy, glycemic stability|type 1 diabetes, insulin pump therapy, glycemic stability
5302701|NCT00428194|stage IIA cervical cancer|stage iia cervical cancer
5302702|NCT00428194|stage IB cervical cancer|stage ib cervical cancer
5302703|NCT00428194|stage IIB cervical cancer|stage iib cervical cancer
5302704|NCT00428194|stage III cervical cancer|stage iii cervical cancer
5302705|NCT00428194|stage IVA cervical cancer|stage iva cervical cancer
5302706|NCT00428194|cervical squamous cell carcinoma|cervical squamous cell carcinoma
5302707|NCT00428181|Brief alcohol intervention|brief alcohol intervention
5302708|NCT00428181|Booster session|booster session
5302709|NCT00428181|Personalized feedback|personalized feedback
5302710|NCT00428181|Motivational interview|motivational interview
5302711|NCT00428181|Injury recidivism|injury recidivism
5302712|NCT00428181|Psychological Interview|psychological interview
5302713|NCT00428181|Risk Reduction Behaviors|risk reduction behaviors
5302714|NCT00428168|Betahistine|betahistine
5302715|NCT00428168|Weight Gain Control|weight gain control
5302716|NCT00428168|Weight Gain due to Olanzapine Treatment|weight gain due to olanzapine treatment
5302717|NCT00428168|Obesity|obesity
5302718|NCT00428168|Schizophrenic disorder|schizophrenic disorder
5302719|NCT00428155|hemostasis|hemostasis
5302720|NCT00428155|angioplasty|angioplasty
5302721|NCT00428155|stenting|stenting
5302722|NCT00428155|closure device|closure device
5302723|NCT00428155|angioseal|angioseal
5302724|NCT00428155|starclose|starclose
5302725|NCT00428142|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5302726|NCT00428142|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5302727|NCT00428142|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5302728|NCT00428142|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5302729|NCT00428142|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5302730|NCT00428142|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5302731|NCT00428129|Acute Iliofemoral Deep Vein Thrombosis|acute iliofemoral deep vein thrombosis
5302732|NCT00428116|HIV-1|hiv-1
5302733|NCT00428116|Pediatric|pediatric
5302734|NCT00428116|HAART|haart
5302735|NCT00428116|Treatment Naive|treatment naive
5302736|NCT00428103|Mitral valve regurgitation|mitral valve regurgitation
5302737|NCT00428090|apolipoprotein E|apolipoprotein e
5302738|NCT00428090|monotherapy|monotherapy
5302739|NCT00428090|cognition|cognition
5302740|NCT00428090|mild|mild
5302741|NCT00428090|rosiglitazone|rosiglitazone
5302742|NCT00428090|Alzheimer's disease|alzheimer's disease
5302743|NCT00428090|moderate|moderate
5302744|NCT00428077|Philadelphia chromosome positive (Ph+) chronic myelogenous leukemia|philadelphia chromosome positive (ph+) chronic myelogenous leukemia
5302745|NCT00428077|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5302746|NCT00428064|Renal allograft|renal allograft
5302747|NCT00428064|Renal|renal
5302748|NCT00428064|Kidney|kidney
5302749|NCT00428064|Transplant|transplant
5302750|NCT00428051|Epidemiology|epidemiology
5302751|NCT00428051|Surveillance|surveillance
5302752|NCT00428051|Streptococcal Pneumonia|streptococcal pneumonia
5302753|NCT00428038|Infant, Premature|infant, premature
5302754|NCT00428038|Bronchopulmonary Dysplasia|bronchopulmonary dysplasia
5302755|NCT00428038|Asthma|asthma
5302756|NCT00428025|pancreatitis|pancreatitis
5302757|NCT00428012|quality of life, kidney transplantation|quality of life, kidney transplantation
5302758|NCT00427999|Hormone-refractory|hormone-refractory
5302759|NCT00427999|prostate cancer|prostate cancer
5302760|NCT00427999|multitargeted|multitargeted
5302761|NCT00427999|tyrosinkinase|tyrosinkinase
5302762|NCT00427986|Diabetes|diabetes
5302763|NCT00427986|Macular oedema|macular oedema
5302764|NCT00427986|Osmosis|osmosis
5302765|NCT00427986|Galactose|galactose
5302766|NCT00427986|Intravenous|intravenous
5302767|NCT00427986|Retinal thickness|retinal thickness
5302768|NCT00427986|Starling|starling
5302769|NCT00427960|cholesterol|cholesterol
5302770|NCT00427960|statin|statin
5302771|NCT00427960|Asian|asian
5302772|NCT00427960|LDL-cholesterol|ldl-cholesterol
5302773|NCT00427947|phantom limb pain|phantom limb pain
5302774|NCT00427947|amputation|amputation
5302775|NCT00427947|anesthetics, local|anesthetics, local
5302776|NCT00427947|postoperative analgesia|postoperative analgesia
5302777|NCT00427947|ropivacaine|ropivacaine
5302778|NCT00427947|analgesia|analgesia
5302779|NCT00427908|Meningococcal serogroups A, C, W-135 and/or Y diseases|meningococcal serogroups a, c, w-135 and/or y diseases
5302780|NCT00427908|Conjugate vaccine|conjugate vaccine
5302781|NCT00427908|Immunogenicity|immunogenicity
5302782|NCT00427908|Meningococcal vaccine|meningococcal vaccine
5302783|NCT00427908|Persistence|persistence
5302784|NCT00427908|Non-inferiority|non-inferiority
5302785|NCT00427895|Vaccine|vaccine
5302786|NCT00427895|Pneumococcal Infections Prevention and Control|pneumococcal infections prevention and control
5302787|NCT00427843|osteoarthritis|osteoarthritis
5302788|NCT00427843|knee|knee
5302789|NCT00427843|gait|gait
5302790|NCT00427843|muscle strength|muscle strength
5302791|NCT00427843|hip|hip
5302792|NCT00427843|exercise|exercise
5302793|NCT00427830|Mycobacterium tuberculosis|mycobacterium tuberculosis
5302794|NCT00427830|85A antigen|85a antigen
5302795|NCT00427830|Recombinant Modified Vaccinia Ankara|recombinant modified vaccinia ankara
5302796|NCT00427830|Phase I study|phase i study
5302797|NCT00427830|Immunogenicity|immunogenicity
5302798|NCT00427830|BCG|bcg
5302799|NCT00427817|Adenoma, Prostatic|adenoma, prostatic
5302800|NCT00427817|Prostate|prostate
5302801|NCT00427817|Proteomics|proteomics
5302802|NCT00427817|Urology|urology
5302803|NCT00427804|Calcium absorption|calcium absorption
5302804|NCT00427804|Vitamin D|vitamin d
5302805|NCT00427791|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
5302806|NCT00427791|Leukemia|leukemia
5302807|NCT00427791|Total Body Irradiation|total body irradiation
5302808|NCT00427791|Etoposide|etoposide
5302809|NCT00427791|Rituximab|rituximab
5302810|NCT00427791|Rituxan|rituxan
5302811|NCT00427791|TBI|tbi
5302812|NCT00427791|ALL|all
5302813|NCT00427778|incontinence ring|incontinence ring
5302814|NCT00427778|pessary|pessary
5302815|NCT00427778|urinary incontinence|urinary incontinence
5302816|NCT00427778|urodynamic study|urodynamic study
5302817|NCT00427778|quality of life|quality of life
5302818|NCT00427778|crossover trial|crossover trial
5302819|NCT00427778|randomised trial|randomised trial
5302820|NCT00427765|Multiple Myeloma|multiple myeloma
5302821|NCT00427765|Hodgkin's Disease|hodgkin's disease
5302822|NCT00427765|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
5302823|NCT00427765|Leukemia|leukemia
5302824|NCT00427765|Lymphoma|lymphoma
5302825|NCT00427765|Busulfan|busulfan
5302826|NCT00427765|Melphalan|melphalan
5302827|NCT00427765|Autologous bone marrow|autologous bone marrow
5302828|NCT00427765|BMT|bmt
5302829|NCT00427765|Peripheral blood stem cell transplant|peripheral blood stem cell transplant
5302830|NCT00427765|PBSCT|pbsct
5302831|NCT00427752|Transgastric|transgastric
5302832|NCT00427752|Endoluminal|endoluminal
5302833|NCT00427752|Peritoneoscopy|peritoneoscopy
5302834|NCT00427752|Diagnostic|diagnostic
5302835|NCT00427752|Feasibility|feasibility
5302836|NCT00427739|Axial Flow Ventricular Assist Device|axial flow ventricular assist device
5302837|NCT00427739|Cardiac CT|cardiac ct
5302838|NCT00427739|Stage IV heart failure|stage iv heart failure
5302839|NCT00427726|Gene Transfer|gene transfer
5302840|NCT00427726|Hematopoietic Stem Cells|hematopoietic stem cells
5302841|NCT00427726|Follow-Up|follow-up
5302842|NCT00427713|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5302843|NCT00427713|stage III rectal cancer|stage iii rectal cancer
5302844|NCT00427713|stage II rectal cancer|stage ii rectal cancer
5302845|NCT00427700|Polycystic Ovary Syndrome|polycystic ovary syndrome
5302846|NCT00427700|clomiphene citrate|clomiphene citrate
5302847|NCT00427700|Raloxifene|raloxifene
5302848|NCT00427674|Parkinson|parkinson
5302849|NCT00427674|Imaging|imaging
5302850|NCT00427661|Sickle Cell Disease|sickle cell disease
5302851|NCT00427661|Thalassemia|thalassemia
5302852|NCT00427661|Hemoglobinopathies|hemoglobinopathies
5302853|NCT00427648|Administration, Intravesical|administration, intravesical
5302854|NCT00427648|Anesthetics, Local|anesthetics, local
5302855|NCT00427635|neonates|neonates
5302856|NCT00427635|infants|infants
5302857|NCT00427635|GERD|gerd
5302858|NCT00427635|reflux|reflux
5302859|NCT00427622|hot flashes|hot flashes
5302860|NCT00427609|Treatment|treatment
5302861|NCT00427609|Psoriasis|psoriasis
5302862|NCT00427609|efficacy|efficacy
5302863|NCT00427609|Bicillin|bicillin
5302864|NCT00427596|GW427353 oral tablets,|gw427353 oral tablets,
5302865|NCT00427596|healthy adult subjects,|healthy adult subjects,
5302866|NCT00427596|food effect|food effect
5302867|NCT00427583|Malignant,|malignant,
5302868|NCT00427583|peripheral,|peripheral,
5302869|NCT00427583|nerve sheath tumors,|nerve sheath tumors,
5302870|NCT00427583|MPNST,|mpnst,
5302871|NCT00427583|neurofibromatosis,|neurofibromatosis,
5302872|NCT00427583|NF1,|nf1,
5302873|NCT00427583|Imatinib mesylate|imatinib mesylate
5302874|NCT00427570|stage II colon cancer|stage ii colon cancer
5302875|NCT00427570|stage III colon cancer|stage iii colon cancer
5302876|NCT00427557|Multiple Myeloma|multiple myeloma
5302877|NCT00427557|Acute Myeloid Leukemia|acute myeloid leukemia
5302878|NCT00427557|Myelodysplastic Syndrome|myelodysplastic syndrome
5302879|NCT00427557|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
5302880|NCT00427557|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
5302881|NCT00427557|Hodgkin's Lymphoma|hodgkin's lymphoma
5302882|NCT00427557|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
5302883|NCT00427557|Cellular Therapy|cellular therapy
5302884|NCT00427557|Umbilical Cord Blood Cells|umbilical cord blood cells
5302885|NCT00427557|Cord Blood Transplantation|cord blood transplantation
5302886|NCT00427557|Stem Cells|stem cells
5302887|NCT00427557|Stem Cell Transplantation|stem cell transplantation
5302888|NCT00427557|Allogeneic|allogeneic
5302889|NCT00427557|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
5302890|NCT00427557|Graft vs. Host Disease|graft vs. host disease
5302891|NCT00427557|GVD|gvd
5302892|NCT00427557|Fludarabine|fludarabine
5302893|NCT00427557|Fludarabine Phosphate|fludarabine phosphate
5302894|NCT00427557|Fludara|fludara
5302895|NCT00427557|Melphalan|melphalan
5302896|NCT00427557|Rituximab|rituximab
5302897|NCT00427557|Rituxan|rituxan
5302898|NCT00427557|Leukemia|leukemia
5302899|NCT00427557|Lymphoma|lymphoma
5302900|NCT00427544|Uterine leiomyomata (Fibroids)|uterine leiomyomata (fibroids)
5302901|NCT00427531|hot flashes|hot flashes
5302902|NCT00427505|Interaction|interaction
5302903|NCT00427505|healthy volunteers|healthy volunteers
5302904|NCT00427505|deferasirox|deferasirox
5302905|NCT00427505|midazolam|midazolam
5302906|NCT00427479|Allergy|allergy
5302907|NCT00427479|Food|food
5302908|NCT00427479|Hay fever|hay fever
5302909|NCT00427479|Screening|screening
5302910|NCT00427453|Mycobacterium tuberculosis|mycobacterium tuberculosis
5302911|NCT00427453|85A antigen|85a antigen
5302912|NCT00427453|Recombinant Modified Vaccinia Virus Ankara|recombinant modified vaccinia virus ankara
5302913|NCT00427453|Phase I study|phase i study
5302914|NCT00427453|Immunogenicity|immunogenicity
5302915|NCT00427453|BCG|bcg
5302916|NCT00427440|Glioma|glioma
5302917|NCT00427440|Brain Tumor|brain tumor
5302918|NCT00427427|non-metastatic breast cancer|non-metastatic breast cancer
5302919|NCT00427427|HER-2 positive breast cancer|her-2 positive breast cancer
5302920|NCT00427427|Herceptin (trastuzumab)|herceptin (trastuzumab)
5302921|NCT00427427|delayed adjuvant therapy|delayed adjuvant therapy
5302922|NCT00427427|acceptability rate|acceptability rate
5303042|NCT00427089|Colon cleansing|colon cleansing
5302923|NCT00427427|non-metastatic, HER-2 positive breast cancer|non-metastatic, her-2 positive breast cancer
5302924|NCT00427414|AIDS-related Kaposi sarcoma|aids-related kaposi sarcoma
5302925|NCT00427414|recurrent Kaposi sarcoma|recurrent kaposi sarcoma
5302926|NCT00427388|Cardiac Surgical Procedures|cardiac surgical procedures
5302927|NCT00427388|Cardiopulmonary Bypass|cardiopulmonary bypass
5302928|NCT00427388|Systemic inflammatory Response Syndrome|systemic inflammatory response syndrome
5302929|NCT00427388|Steroid|steroid
5302930|NCT00427388|Myocardial Infarction|myocardial infarction
5302931|NCT00427388|Randomized Clinical Trial|randomized clinical trial
5302932|NCT00427375|Rectal cancer surgery|rectal cancer surgery
5302933|NCT00427375|Neoadjuvant radiochemotherapy|neoadjuvant radiochemotherapy
5302934|NCT00427375|Randomized clinical trial|randomized clinical trial
5302935|NCT00427375|Multicenter study|multicenter study
5302936|NCT00427349|localized gastrointestinal carcinoid tumor|localized gastrointestinal carcinoid tumor
5302937|NCT00427349|recurrent gastrointestinal carcinoid tumor|recurrent gastrointestinal carcinoid tumor
5302938|NCT00427349|metastatic gastrointestinal carcinoid tumor|metastatic gastrointestinal carcinoid tumor
5302939|NCT00427349|regional gastrointestinal carcinoid tumor|regional gastrointestinal carcinoid tumor
5302940|NCT00427349|gastrinoma|gastrinoma
5302941|NCT00427349|insulinoma|insulinoma
5302942|NCT00427349|WDHA syndrome|wdha syndrome
5302943|NCT00427349|glucagonoma|glucagonoma
5302944|NCT00427349|pancreatic polypeptide tumor|pancreatic polypeptide tumor
5302945|NCT00427349|somatostatinoma|somatostatinoma
5302946|NCT00427349|recurrent islet cell carcinoma|recurrent islet cell carcinoma
5302947|NCT00427349|neuroendocrine tumor|neuroendocrine tumor
5302948|NCT00427336|Severe Aplastic Anemia|severe aplastic anemia
5302949|NCT00427336|Bone Marrow Failure|bone marrow failure
5302950|NCT00427336|Stem Cell Transplantation|stem cell transplantation
5302951|NCT00427336|Fludarabine|fludarabine
5302952|NCT00427336|Cyclophosphamide|cyclophosphamide
5302953|NCT00427336|Antithymocyte Globulin|antithymocyte globulin
5302954|NCT00427336|SAA|saa
5302955|NCT00427336|ATG|atg
5302956|NCT00427336|Cytoxan|cytoxan
5302957|NCT00427336|Neosar|neosar
5302958|NCT00427336|Fludarabine Phosphate|fludarabine phosphate
5302959|NCT00427336|Thymoglobulin|thymoglobulin
5302960|NCT00427323|sleep|sleep
5302961|NCT00427323|aging|aging
5302962|NCT00427323|biological rhythm|biological rhythm
5302963|NCT00427323|melatonin|melatonin
5302964|NCT00427323|alertness|alertness
5302965|NCT00427323|early morning awakening|early morning awakening
5302966|NCT00427323|daytime sleepiness|daytime sleepiness
5302967|NCT00427323|difficulty maintaining sleep|difficulty maintaining sleep
5302968|NCT00427323|sleep maintenance insomnia|sleep maintenance insomnia
5302969|NCT00427310|stage I colon cancer|stage i colon cancer
5302970|NCT00427310|stage II colon cancer|stage ii colon cancer
5302971|NCT00427310|stage III colon cancer|stage iii colon cancer
5302972|NCT00427310|adenocarcinoma of the colon|adenocarcinoma of the colon
5302973|NCT00427297|HIV-1|hiv-1
5302974|NCT00427297|Pediatric|pediatric
5302975|NCT00427297|nevirapine|nevirapine
5302976|NCT00427297|HAART|haart
5302977|NCT00427297|Resistance|resistance
5302978|NCT00427297|Treatment Naive|treatment naive
5302979|NCT00427284|Eplerenone auf die Endothelfunktion bei Patienten mit stabiler koronarer Herzkrankheit|eplerenone auf die endothelfunktion bei patienten mit stabiler koronarer herzkrankheit
5302980|NCT00427271|aspirin|aspirin
5302981|NCT00427271|enalapril|enalapril
5302982|NCT00427271|microalbuminuria|microalbuminuria
5302983|NCT00427271|glomerular filtration rate|glomerular filtration rate
5302984|NCT00427258|healthy subjects|healthy subjects
5302985|NCT00427245|menopausal symptoms|menopausal symptoms
5302986|NCT00427245|infertility|infertility
5302987|NCT00427245|stage IA breast cancer|stage ia breast cancer
5302988|NCT00427245|stage IB breast cancer|stage ib breast cancer
5302989|NCT00427245|stage II breast cancer|stage ii breast cancer
5302990|NCT00427245|stage IIIA breast cancer|stage iiia breast cancer
5302991|NCT00427245|stage IIIB breast cancer|stage iiib breast cancer
5302992|NCT00427245|estrogen receptor-negative breast cancer|estrogen receptor-negative breast cancer
5302993|NCT00427245|estrogen receptor-positive breast cancer|estrogen receptor-positive breast cancer
5302994|NCT00427245|progesterone receptor-negative breast cancer|progesterone receptor-negative breast cancer
5302995|NCT00427232|coronary heart disease|coronary heart disease
5302996|NCT00427232|endothelins|endothelins
5302997|NCT00427232|coronary angiography|coronary angiography
5302998|NCT00427232|blood flow velocity|blood flow velocity
5302999|NCT00427232|fractional flow reserve, myocardial|fractional flow reserve, myocardial
5303000|NCT00427219|Benign Prostatic Hyperplasia|benign prostatic hyperplasia
5303001|NCT00427219|Prostatic Adenoma, Benign|prostatic adenoma, benign
5303002|NCT00427219|Prostatic Hypertrophy, Benign|prostatic hypertrophy, benign
5303003|NCT00427219|Enlarged Prostate|enlarged prostate
5303004|NCT00427219|Prostatism|prostatism
5303005|NCT00427219|Adenoma, Prostatic|adenoma, prostatic
5303006|NCT00427206|acetaminophen|acetaminophen
5303007|NCT00427206|alcohol|alcohol
5303008|NCT00427206|liver injury|liver injury
5303009|NCT00427193|dietary restriction|dietary restriction
5303010|NCT00427193|disease /disorder prevention /control|disease /disorder prevention /control
5303011|NCT00427193|nutrition of aging|nutrition of aging
5303012|NCT00427193|bioenergetics|bioenergetics
5303013|NCT00427193|cardiovascular function|cardiovascular function
5303014|NCT00427193|disease /disorder proneness /risk|disease /disorder proneness /risk
5303015|NCT00427193|insulin sensitivity / resistance|insulin sensitivity / resistance
5303016|NCT00427180|Visual Perception|visual perception
5303017|NCT00427180|Retina|retina
5303018|NCT00427180|Light|light
5303019|NCT00427180|Retinitis Pigmentosa|retinitis pigmentosa
5303020|NCT00427180|Visual acuity|visual acuity
5303021|NCT00427180|Retinal Implant|retinal implant
5303022|NCT00427180|Electrical stimulation|electrical stimulation
5303023|NCT00427167|Blood Stage|blood stage
5303024|NCT00427167|Investigational|investigational
5303025|NCT00427167|Vaccine|vaccine
5303026|NCT00427167|Malaria|malaria
5303027|NCT00427167|Healthy Volunteer|healthy volunteer
5303028|NCT00427167|HV|hv
5303029|NCT00427141|tolerability,|tolerability,
5303030|NCT00427141|pharmacokinetics,|pharmacokinetics,
5303031|NCT00427141|first time in human,|first time in human,
5303032|NCT00427141|food effect|food effect
5303033|NCT00427141|safety,|safety,
5303034|NCT00427128|Major Depression|major depression
5303035|NCT00427128|"true drug response"|"true drug response"
5303036|NCT00427128|"placebo response pattern"|"placebo response pattern"
5303037|NCT00427128|continuation treatment outcomes|continuation treatment outcomes
5303038|NCT00427115|Patients undergoing allogeneic stem cell transplantations|patients undergoing allogeneic stem cell transplantations
5303039|NCT00427102|Oral MRX-1024|oral mrx-1024
5303040|NCT00427102|High-Dose Cisplatin Chemotherapy|high-dose cisplatin chemotherapy
5303041|NCT00427102|Standard Radiation Therapy|standard radiation therapy
5303043|NCT00427089|Polyethylene Glycol|polyethylene glycol
5303044|NCT00427089|Sodium Phosphate|sodium phosphate
5303045|NCT00427076|vancomycin|vancomycin
5303046|NCT00427076|cotrimoxazole|cotrimoxazole
5303234|NCT00426452|Omeprazole|omeprazole
5303047|NCT00427076|trimethoprim/ sulfamethoxazole|trimethoprim/ sulfamethoxazole
5303048|NCT00427076|methicillin-resistant Staphylococcus aureus|methicillin-resistant staphylococcus aureus
5303049|NCT00427076|Health care association infections|health care association infections
5303050|NCT00427076|MRSA bacteremia or other microbiologically documented MRSA infections (defined clinically by CDC criteria)|mrsa bacteremia or other microbiologically documented mrsa infections (defined clinically by cdc criteria)
5303051|NCT00427076|Suspected neurosurgical meningitis|suspected neurosurgical meningitis
5303052|NCT00427076|Sepsis during hemodialysis, catheter-associated and catheter-related infections|sepsis during hemodialysis, catheter-associated and catheter-related infections
5303053|NCT00427076|Ventilator-associated pneumonia|ventilator-associated pneumonia
5303054|NCT00427076|Surgical site infection in the presence of a foreign body|surgical site infection in the presence of a foreign body
5303055|NCT00427063|retinal vessels|retinal vessels
5303056|NCT00427063|tortuosity|tortuosity
5303057|NCT00427050|Actinic Keratoses (AK)|actinic keratoses (ak)
5303058|NCT00427050|PEP005|pep005
5303059|NCT00427050|Topical|topical
5303060|NCT00427050|Dermatology|dermatology
5303061|NCT00427037|Vitamin D deficiency|vitamin d deficiency
5303062|NCT00427037|Chronic Kidney Disease|chronic kidney disease
5303063|NCT00427024|renal transplantation|renal transplantation
5303064|NCT00427024|acute rejection|acute rejection
5303065|NCT00427024|transport|transport
5303066|NCT00427024|transporter|transporter
5303067|NCT00427024|acute rejection after renal transplantation|acute rejection after renal transplantation
5303068|NCT00426998|Choroidal neovascularization due to age-related macular degeneration|choroidal neovascularization due to age-related macular degeneration
5303069|NCT00426985|Tendonitis|tendonitis
5303070|NCT00426985|Bursitis|bursitis
5303071|NCT00426985|Pain|pain
5303072|NCT00426985|Shoulder Pain|shoulder pain
5303073|NCT00426985|Elbow Pain|elbow pain
5303074|NCT00426985|Knee Pain|knee pain
5303075|NCT00426985|Tendon Injury|tendon injury
5303076|NCT00426985|Muscle, Bone and Cartilage Disorders|muscle, bone and cartilage disorders
5303077|NCT00426959|Adenocarcinoma of the prostate|adenocarcinoma of the prostate
5303078|NCT00426959|PSA of less than 10 ng/mL|psa of less than 10 ng/ml
5303079|NCT00426959|Combined Gleason score 6 or less|combined gleason score 6 or less
5303080|NCT00426959|International Prostate Symptom Score (IPSS) must <or= to 18|international prostate symptom score (ipss) must <or= to 18
5303081|NCT00426946|Depression Children Reboxetine|depression children reboxetine
5303082|NCT00426946|A diagnosis of major depressive disorder or a dysthimic disorder according to DSM-IV-TR.|a diagnosis of major depressive disorder or a dysthimic disorder according to dsm-iv-tr.
5303083|NCT00426946|Drug naïve or without chronic medication for at least one month.|drug naïve or without chronic medication for at least one month.
5303084|NCT00426946|Only children who agree to participate and whose parents will sign and informed consent form will be included.|only children who agree to participate and whose parents will sign and informed consent form will be included.
5303085|NCT00426933|cSSSI|csssi
5303086|NCT00426933|MRSA|mrsa
5303087|NCT00426920|pharmacokinetics|pharmacokinetics
5303088|NCT00426920|pharmacodynamics|pharmacodynamics
5303089|NCT00426920|inhaled|inhaled
5303090|NCT00426920|recombinant human insulin|recombinant human insulin
5303091|NCT00426907|Osteoarthritis, Knee|osteoarthritis, knee
5303092|NCT00426907|Osteotomy|osteotomy
5303093|NCT00426907|Healing|healing
5303094|NCT00426907|Rehabilitation|rehabilitation
5303095|NCT00426907|Roentgen Stereometric Analysis|roentgen stereometric analysis
5303096|NCT00426894|surveillance cultures|surveillance cultures
5303097|NCT00426894|children|children
5303098|NCT00426894|cardiac surgery|cardiac surgery
5303099|NCT00426894|perioperative prophylaxis|perioperative prophylaxis
5303100|NCT00426881|Exercise|exercise
5303101|NCT00426881|Resistance training|resistance training
5303102|NCT00426868|ADRC|adrc
5303103|NCT00426868|Stem Cells|stem cells
5303104|NCT00426868|chronic ischemia|chronic ischemia
5303105|NCT00426868|heart disease|heart disease
5303106|NCT00426868|coronary artery disease|coronary artery disease
5303107|NCT00426868|inducible reversible ischemia|inducible reversible ischemia
5303108|NCT00426855|Lymphoma, Non-Hodgkin, Low-Grade|lymphoma, non-hodgkin, low-grade
5303109|NCT00426842|Blood pressure|blood pressure
5303110|NCT00426842|Orthostatic hypotension|orthostatic hypotension
5303111|NCT00426842|Spinal Cord Injury|spinal cord injury
5303112|NCT00426842|Sympathetic vascular control|sympathetic vascular control
5303113|NCT00426842|Midodrine|midodrine
5303114|NCT00426829|Liver Cancer|liver cancer
5303115|NCT00426829|Biliary Tract|biliary tract
5303116|NCT00426829|Hepatocellular Carcinoma|hepatocellular carcinoma
5303117|NCT00426829|Cholangiocarcinoma|cholangiocarcinoma
5303118|NCT00426829|Bevacizumab|bevacizumab
5303119|NCT00426829|Proton Therapy|proton therapy
5303120|NCT00426829|Radiation Therapy|radiation therapy
5303121|NCT00426829|PT|pt
5303122|NCT00426829|RT|rt
5303123|NCT00426829|Proton RT|proton rt
5303124|NCT00426829|Avastin|avastin
5303125|NCT00426829|Anti-VEGF monoclonal antibody|anti-vegf monoclonal antibody
5303126|NCT00426829|rhuMAb-VEGF|rhumab-vegf
5303127|NCT00426816|primary insomnia|primary insomnia
5303128|NCT00426816|PSG sleep recordings|psg sleep recordings
5303129|NCT00426816|daytime cognitive function|daytime cognitive function
5303130|NCT00426816|Insomnia|insomnia
5303131|NCT00426816|SB-649868|sb-649868
5303132|NCT00426777|prostate cancer|prostate cancer
5303133|NCT00426777|prostatic adenoma|prostatic adenoma
5303134|NCT00426777|prostatic neoplasm|prostatic neoplasm
5303135|NCT00426764|peripheral T-cell lymphoma|peripheral t-cell lymphoma
5303136|NCT00426764|T-cell lymphoma|t-cell lymphoma
5303137|NCT00426764|romidepsin|romidepsin
5303138|NCT00426751|Eptifibatide|eptifibatide
5303139|NCT00426751|ST-elevation Myocardial Infarction|st-elevation myocardial infarction
5303140|NCT00426751|STEMI|stemi
5303141|NCT00426751|Abciximab|abciximab
5303142|NCT00426725|labor|labor
5303143|NCT00426725|pain|pain
5303144|NCT00426725|relief|relief
5303145|NCT00426725|labour|labour
5303146|NCT00426725|device|device
5303147|NCT00426712|Chronic kidney failure|chronic kidney failure
5303148|NCT00426712|Chronic kidney disease|chronic kidney disease
5303149|NCT00426712|Hemodialysis|hemodialysis
5303150|NCT00426712|HBV vaccine|hbv vaccine
5303151|NCT00426712|Hepatitis B vaccine|hepatitis b vaccine
5303152|NCT00426712|Hepatitis B|hepatitis b
5303153|NCT00426712|Hepatitis|hepatitis
5303154|NCT00426712|HBV|hbv
5303155|NCT00426712|Prevention & Control|prevention & control
5303156|NCT00426699|enterovirus|enterovirus
5303157|NCT00426699|meningitis|meningitis
5303158|NCT00426699|sepsis|sepsis
5303159|NCT00426699|myocarditis|myocarditis
5303160|NCT00426699|kidney|kidney
5303161|NCT00426699|urine|urine
5303162|NCT00426699|glomerulonephritis|glomerulonephritis
5303163|NCT00426686|thrombotic thrombocytopenic purpura|thrombotic thrombocytopenic purpura
5303164|NCT00426686|prognostic factors|prognostic factors
5303165|NCT00426686|ADAMTS13|adamts13
5303166|NCT00426673|partial onset seizures, phenytoin, dilatin, brivaracetam, interaction|partial onset seizures, phenytoin, dilatin, brivaracetam, interaction
5303167|NCT00426660|HIV Infections|hiv infections
5303168|NCT00426647|Osteoarthritis|osteoarthritis
5303169|NCT00426647|Pain|pain
5303170|NCT00426647|Norspan|norspan
5303171|NCT00426647|Buprenorphine|buprenorphine
5303172|NCT00426647|Tramadol|tramadol
5303173|NCT00426634|Asthma|asthma
5303174|NCT00426634|Allergens|allergens
5303175|NCT00426634|Mold|mold
5303176|NCT00426634|Asthma Counselor|asthma counselor
5303177|NCT00426634|Environmental Remediation|environmental remediation
5303178|NCT00426621|Knee osteoarthritis, degenerative joint disease, knee pain, joint pain, topical NSAID,|knee osteoarthritis, degenerative joint disease, knee pain, joint pain, topical nsaid,
5303179|NCT00426621|diclofenac sodium|diclofenac sodium
5303180|NCT00426608|HPA axis,|hpa axis,
5303181|NCT00426608|Healthy volunteers|healthy volunteers
5303182|NCT00426608|hormones,|hormones,
5303183|NCT00426608|GSK561679,|gsk561679,
5303184|NCT00426608|cortisol,|cortisol,
5303185|NCT00426582|Cancer|cancer
5303186|NCT00426582|maximum tolerated dose|maximum tolerated dose
5303187|NCT00426582|dose-limiting toxicity|dose-limiting toxicity
5303188|NCT00426582|patupilone|patupilone
5303189|NCT00426582|carboplatin|carboplatin
5303190|NCT00426582|pharmacokinetics|pharmacokinetics
5303191|NCT00426556|Breast cancer|breast cancer
5303192|NCT00426556|Cancer of the breast|cancer of the breast
5303193|NCT00426556|Human mammary carcinoma|human mammary carcinoma
5303194|NCT00426556|HER-2|her-2
5303195|NCT00426556|Metastatic|metastatic
5303196|NCT00426556|everolimus|everolimus
5303197|NCT00426556|trastuzumab|trastuzumab
5303198|NCT00426556|paclitaxel|paclitaxel
5303199|NCT00426543|Clinical trial|clinical trial
5303200|NCT00426543|Intervention study|intervention study
5303201|NCT00426543|Double-blind randomised controlled study|double-blind randomised controlled study
5303202|NCT00426530|HER2-overexpressing metastatic breast cancer|her2-overexpressing metastatic breast cancer
5303203|NCT00426530|Breast cancer|breast cancer
5303204|NCT00426530|Cancer of the breast|cancer of the breast
5303205|NCT00426530|Human mammary carcinoma|human mammary carcinoma
5303206|NCT00426530|HER-2|her-2
5303207|NCT00426530|metastatic|metastatic
5303208|NCT00426530|everolimus|everolimus
5303209|NCT00426530|trastuzumab|trastuzumab
5303210|NCT00426530|vinorelbine|vinorelbine
5303211|NCT00426517|MUD Transplant|mud transplant
5303212|NCT00426517|Transplant|transplant
5303213|NCT00426517|AlloPBSC|allopbsc
5303214|NCT00426517|HLA Matched Transplant|hla matched transplant
5303215|NCT00426517|BMT|bmt
5303216|NCT00426517|Congenital Immunodeficiency|congenital immunodeficiency
5303217|NCT00426517|Bone Marrow Transplant|bone marrow transplant
5303218|NCT00426504|Head,|head,
5303219|NCT00426504|Neck,|neck,
5303220|NCT00426504|Cancer,|cancer,
5303221|NCT00426504|Tomotherapy,|tomotherapy,
5303222|NCT00426504|IMRT,|imrt,
5303223|NCT00426478|AMPM, SBP, DBP, Valsartan plus Hydrochlorothiazide, Amlodipine, high blood pressure|ampm, sbp, dbp, valsartan plus hydrochlorothiazide, amlodipine, high blood pressure
5303224|NCT00426465|Motor Practice|motor practice
5303225|NCT00426465|Magnetic Stimulation|magnetic stimulation
5303226|NCT00426465|Stroke|stroke
5303227|NCT00426465|Spacing Effect|spacing effect
5303228|NCT00426465|Massed Practice|massed practice
5303229|NCT00426465|Healthy Volunteer|healthy volunteer
5303230|NCT00426465|HV|hv
5303231|NCT00426452|Vascular endothelial growth factor receptor (VEGF-R) tyrosine kinase inhibitor|vascular endothelial growth factor receptor (vegf-r) tyrosine kinase inhibitor
5303232|NCT00426452|Vatalinib|vatalinib
5303233|NCT00426452|Proton-pump inhibitors|proton-pump inhibitors
5303235|NCT00426452|Healthy Postmenopausal Female Volunteers|healthy postmenopausal female volunteers
5303236|NCT00426439|malaria|malaria
5303237|NCT00426439|Plasmodium falciparum|plasmodium falciparum
5303238|NCT00426439|children|children
5303239|NCT00426439|Guinea-Bissau|guinea-bissau
5303240|NCT00426439|artemether|artemether
5303241|NCT00426439|lumefantrine|lumefantrine
5303242|NCT00426439|chloroquine|chloroquine
5303243|NCT00426439|Coartem|coartem
5303244|NCT00426413|ketosis-prone diabetes|ketosis-prone diabetes
5303245|NCT00426413|diabetic ketoacidosis|diabetic ketoacidosis
5303246|NCT00426413|obesity|obesity
5303247|NCT00426413|insulin dependence|insulin dependence
5303248|NCT00426413|mechanisms|mechanisms
5303249|NCT00426374|HIV|hiv
5303250|NCT00426374|AIDS|aids
5303251|NCT00426374|Troponin|troponin
5303252|NCT00426374|natriuretic peptide|natriuretic peptide
5303253|NCT00426374|heart failure|heart failure
5303254|NCT00426374|heart disease children|heart disease children
5303255|NCT00426374|HIV pediatric|hiv pediatric
5303256|NCT00426374|AIDS pediatric|aids pediatric
5303257|NCT00426361|Human Papillomavirus|human papillomavirus
5303258|NCT00426348|IgA nephropathy|iga nephropathy
5303259|NCT00426348|probucol|probucol
5303260|NCT00426348|valsartan|valsartan
5303261|NCT00426348|treatment|treatment
5303262|NCT00426348|antioxidant|antioxidant
5303263|NCT00426348|IGA nephropathy：a kind of glomerulonephritis,which IgA is the dominant immunodeposit in mesangial areas|iga nephropathy：a kind of glomerulonephritis,which iga is the dominant immunodeposit in mesangial areas
5303264|NCT00426335|breast|breast
5303265|NCT00426335|cancer|cancer
5303266|NCT00426335|cognitive behaviour therapy|cognitive behaviour therapy
5303267|NCT00426335|psychological|psychological
5303268|NCT00426322|maxillary sinus augmentation|maxillary sinus augmentation
5303269|NCT00426322|bone graft|bone graft
5303270|NCT00426322|bovine bone mineral|bovine bone mineral
5303271|NCT00426322|dental implants|dental implants
5303272|NCT00426296|HIV|hiv
5303273|NCT00426296|Reyataz|reyataz
5303274|NCT00426296|atazanavir|atazanavir
5303275|NCT00426296|Norvir|norvir
5303276|NCT00426296|ritonavir|ritonavir
5303277|NCT00426296|Boosted|boosted
5303278|NCT00426296|Lipodystrophy|lipodystrophy
5303279|NCT00426296|Treatment Experienced|treatment experienced
5303280|NCT00426283|Eosinophilic Esophagitis|eosinophilic esophagitis
5303281|NCT00426257|Ovarian Cancer|ovarian cancer
5303282|NCT00426257|stage III|stage iii
5303283|NCT00426257|hyperthermic intraperitoneal chemotherapy|hyperthermic intraperitoneal chemotherapy
5303284|NCT00426257|debulking surgery|debulking surgery
5303285|NCT00426257|HIPEC|hipec
5303286|NCT00426244|Osteopathic Manipulative Medicine|osteopathic manipulative medicine
5303287|NCT00426244|Osteopathic Manipulative Treatment|osteopathic manipulative treatment
5303288|NCT00426244|Pregnancy|pregnancy
5303289|NCT00426244|Physiologic|physiologic
5303290|NCT00426244|Gait|gait
5303291|NCT00426244|Low back pain|low back pain
5303292|NCT00426244|Heart rate variability|heart rate variability
5303293|NCT00426231|Randomized Controlled Trials|randomized controlled trials
5303294|NCT00426231|Health Education|health education
5303295|NCT00426231|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors
5303296|NCT00426231|Patient Nonadherence|patient nonadherence
5303297|NCT00426218|Systemic Juvenile Idiopathic Arthritis|systemic juvenile idiopathic arthritis
5303298|NCT00426218|Immunogenicity|immunogenicity
5303299|NCT00426218|Pharmacokinetics|pharmacokinetics
5303300|NCT00426218|Anti-IL-1ß Monoclonal Antibody|anti-il-1ß monoclonal antibody
5303301|NCT00426218|ACZ885|acz885
5303302|NCT00426218|SJIA|sjia
5303303|NCT00426218|Pediatrics|pediatrics
5303304|NCT00426205|GM-CSF|gm-csf
5303305|NCT00426205|GVAX|gvax
5303306|NCT00426205|Cancer vaccine|cancer vaccine
5303307|NCT00426205|blood stem cell transplantation|blood stem cell transplantation
5303308|NCT00426205|MDS|mds
5303309|NCT00426205|AML|aml
5303310|NCT00426205|CML|cml
5303311|NCT00426192|Immunedefense Suppression|immunedefense suppression
5303312|NCT00426192|Cardiopulmonary Bypass|cardiopulmonary bypass
5303313|NCT00426192|Mannitol|mannitol
5303314|NCT00426192|Hemofiltration|hemofiltration
5303315|NCT00426192|Cytokines|cytokines
5303316|NCT00426192|Receptors, Surface CD14|receptors, surface cd14
5303317|NCT00426179|Imatinib, allergic inflammation, out of allergy season, repeated nasal allergen, seasonal allergic rhinitis, sensitive, Timothy grass pollen, c-kit inhibition|imatinib, allergic inflammation, out of allergy season, repeated nasal allergen, seasonal allergic rhinitis, sensitive, timothy grass pollen, c-kit inhibition
5303318|NCT00426140|EPO|epo
5303319|NCT00426140|Patupilone|patupilone
5303320|NCT00426140|Solid Tumors|solid tumors
5303321|NCT00426127|Pancreatic|pancreatic
5303322|NCT00426127|Docetaxel|docetaxel
5303323|NCT00426127|Doxorubicin|doxorubicin
5303324|NCT00426127|Enoxaparin|enoxaparin
5303325|NCT00426101|Hemophagocytic lymphohistiocytosis|hemophagocytic lymphohistiocytosis
5303326|NCT00426075|Deep vein thrombosis of the lower extremities|deep vein thrombosis of the lower extremities
5303327|NCT00426062|Squamous Cell Carcinoma of Tongue and mouth floor|squamous cell carcinoma of tongue and mouth floor
5303328|NCT00426049|Coronary artery disease|coronary artery disease
5303329|NCT00426049|Stents|stents
5303330|NCT00426049|Immunosuppressive Agents|immunosuppressive agents
5303331|NCT00426049|Coronary restenosis|coronary restenosis
5303332|NCT00426049|Safety|safety
5303333|NCT00426036|Open-label study, healthy subjects, stable impaired renal function, licarbazepine, pharmacokinetics, metabolism, safety.|open-label study, healthy subjects, stable impaired renal function, licarbazepine, pharmacokinetics, metabolism, safety.
5303334|NCT00426023|Vernal keratoconjunctivitis|vernal keratoconjunctivitis
5303335|NCT00426023|Cyclosporine|cyclosporine
5303336|NCT00426023|Children|children
5303337|NCT00426023|Clinical trial|clinical trial
5303338|NCT00426010|Placebo effect|placebo effect
5303339|NCT00426010|Caffeine|caffeine
5303340|NCT00426010|Systolic BP|systolic bp
5303341|NCT00426010|VAS|vas
5303342|NCT00425997|Hypertension, valsartan/HCTZ, amlodipine and HCTZ|hypertension, valsartan/hctz, amlodipine and hctz
5303343|NCT00425984|HIV|hiv
5303344|NCT00425984|Male circumcision|male circumcision
5303345|NCT00425984|Sexually transmitted infections|sexually transmitted infections
5303346|NCT00425984|Sexual risk behaviors|sexual risk behaviors
5303347|NCT00425984|Adult males|adult males
5303348|NCT00425984|Haemophilus ducreyi|haemophilus ducreyi
5303349|NCT00425984|Human papillomavirus|human papillomavirus
5303350|NCT00425984|Rakai|rakai
5303351|NCT00425984|Uganda|uganda
5303352|NCT00425984|HIV seronegativity|hiv seronegativity
5303353|NCT00425984|HPV|hpv
5303354|NCT00425984|STI|sti
5303355|NCT00425958|year and more after TBI|year and more after tbi
5303356|NCT00425958|good vision|good vision
5303357|NCT00425958|at least one functinal hand|at least one functinal hand
5303358|NCT00425958|cap[able od doing shopping during everyday life|cap[able od doing shopping during everyday life
5303359|NCT00425932|Magnetic Resonance Imaging|magnetic resonance imaging
5303360|NCT00425932|Rituximab|rituximab
5303361|NCT00425932|Low Field MRI|low field mri
5303362|NCT00425932|Biomarkers|biomarkers
5303363|NCT00425919|Type 2 Diabetes|type 2 diabetes
5303364|NCT00425919|Diabetes|diabetes
5303365|NCT00425906|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
5303366|NCT00425906|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5303367|NCT00425906|constipation, impaction, and bowel obstruction|constipation, impaction, and bowel obstruction
5303368|NCT00425906|anorexia|anorexia
5303369|NCT00425906|pain|pain
5303370|NCT00425893|influenza|influenza
5303371|NCT00425893|masks|masks
5303372|NCT00425893|transmission|transmission
5303373|NCT00425893|hand hygiene|hand hygiene
5303374|NCT00425893|non-pharmacologic interventions|non-pharmacologic interventions
5303375|NCT00425880|Pregnancy|pregnancy
5303376|NCT00425880|Asthma|asthma
5303377|NCT00425880|Tobacco Abuse|tobacco abuse
5303378|NCT00425880|Exhaled Nitric Oxide|exhaled nitric oxide
5303379|NCT00425867|PAR1 gene|par1 gene
5303380|NCT00425867|polymorphisms|polymorphisms
5303381|NCT00425867|abortions|abortions
5303382|NCT00425867|reccurent abortions|reccurent abortions
5303383|NCT00425867|premature delivery|premature delivery
5303384|NCT00425841|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
5303385|NCT00425841|stage III pancreatic cancer|stage iii pancreatic cancer
5303386|NCT00425841|stage II pancreatic cancer|stage ii pancreatic cancer
5303387|NCT00425815|Cognition|cognition
5303388|NCT00425815|Ampakines|ampakines
5303389|NCT00425815|Schizophrenia|schizophrenia
5303390|NCT00425802|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5303391|NCT00425802|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5303392|NCT00425802|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5303393|NCT00425802|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5303394|NCT00425802|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
5303395|NCT00425802|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5303396|NCT00425802|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5303397|NCT00425802|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5303398|NCT00425802|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5303399|NCT00425802|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5303400|NCT00425802|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5303401|NCT00425802|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5303402|NCT00425802|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5303403|NCT00425802|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5303404|NCT00425802|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5303405|NCT00425802|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5303406|NCT00425802|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5303407|NCT00425802|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5303408|NCT00425802|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5303409|NCT00425802|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5303410|NCT00425802|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
5303411|NCT00425802|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5303412|NCT00425802|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5303413|NCT00425802|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5303414|NCT00425802|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
5303415|NCT00425802|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5303416|NCT00425802|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5303417|NCT00425802|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5303418|NCT00425802|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5303419|NCT00425802|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
5303420|NCT00425802|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5303421|NCT00425802|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5303422|NCT00425802|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5303423|NCT00425802|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5303424|NCT00425802|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5303425|NCT00425789|Deep Chemical Peeling|deep chemical peeling
5303426|NCT00425789|Hyperbaric Therapy|hyperbaric therapy
5303427|NCT00425789|post-deep peel|post-deep peel
5303428|NCT00425776|Breast cancer|breast cancer
5303429|NCT00425776|Acupuncture|acupuncture
5303430|NCT00425776|Post-menopausal hot flushes|post-menopausal hot flushes
5303431|NCT00425776|Se-estradiol|se-estradiol
5303432|NCT00425776|Se-endorphine|se-endorphine
5303433|NCT00425763|malaria|malaria
5303434|NCT00425763|efficacy|efficacy
5303435|NCT00425763|intermittent preventive therapy in infants|intermittent preventive therapy in infants
5303436|NCT00425763|drug resistance|drug resistance
5303437|NCT00425750|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5303438|NCT00425750|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
5303439|NCT00425750|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5303440|NCT00425750|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
5303441|NCT00425750|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5303442|NCT00425750|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
5303443|NCT00425750|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5303444|NCT00425750|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
5303445|NCT00425737|Oral live attenuated human rotavirus vaccine|oral live attenuated human rotavirus vaccine
5303446|NCT00425737|Gastroenteritis|gastroenteritis
5303447|NCT00425724|proteinuria|proteinuria
5303448|NCT00425724|nephritis|nephritis
5303449|NCT00425724|nephrotic syndrome|nephrotic syndrome
5303450|NCT00425724|glomerulonephritis|glomerulonephritis
5303451|NCT00425711|Acamprosate|acamprosate
5303452|NCT00425711|Alcohol Dependence|alcohol dependence
5303453|NCT00425711|Driving Under the Influence|driving under the influence
5303454|NCT00425711|Drug Court|drug court
5303455|NCT00425711|DUI Court|dui court
5303456|NCT00425685|cardiopulmonary resuscitation, ECMO, shock, survival, heart failure, transplantation, heart assist device.|cardiopulmonary resuscitation, ecmo, shock, survival, heart failure, transplantation, heart assist device.
5303457|NCT00425659|Health utility|health utility
5303458|NCT00425659|Home sleep study|home sleep study
5303459|NCT00425646|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5303460|NCT00425646|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5303461|NCT00425646|adenocarcinoma of the lung|adenocarcinoma of the lung
5303462|NCT00425646|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
5303463|NCT00425646|large cell lung cancer|large cell lung cancer
5303464|NCT00425646|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5303465|NCT00425633|Homeopathic|homeopathic
5303466|NCT00425633|Potassium|potassium
5303467|NCT00425633|Dichromate|dichromate
5303468|NCT00425633|Kalium|kalium
5303469|NCT00425633|Bichromicum|bichromicum
5303470|NCT00425633|Mechanical|mechanical
5303471|NCT00425633|Ventilation|ventilation
5303472|NCT00425633|Secretions|secretions
5303473|NCT00425620|Chronic Sinusitis|chronic sinusitis
5303474|NCT00425620|Chronic Rhinosinusitis|chronic rhinosinusitis
5303475|NCT00425607|Hutchinson-Gilford Progeria Syndrome|hutchinson-gilford progeria syndrome
5303476|NCT00425607|HGPS|hgps
5303477|NCT00425607|Progeria|progeria
5303479|NCT00425607|Farnesyltransferase Inhibitor|farnesyltransferase inhibitor
5303480|NCT00425607|Lonafarnib|lonafarnib
5303481|NCT00425594|colonoscopy|colonoscopy
5303482|NCT00425594|bowel preparation|bowel preparation
5303483|NCT00425594|prep|prep
5303484|NCT00425581|N-terminal pro-BNP,|n-terminal pro-bnp,
5303485|NCT00425581|Cardiac Troponin-T,|cardiac troponin-t,
5303486|NCT00425581|Very low birth weight infants|very low birth weight infants
5303487|NCT00425581|hemodynamic instability|hemodynamic instability
5303488|NCT00425581|myocardial dysfunction|myocardial dysfunction
5303489|NCT00425568|hypogonadism|hypogonadism
5303490|NCT00425568|low testosterone level|low testosterone level
5303491|NCT00425568|gonadal deficiency|gonadal deficiency
5303492|NCT00425555|Cutaneous T-Cell Lymphoma, adults|cutaneous t-cell lymphoma, adults
5303493|NCT00425555|Mycosis Fungoides|mycosis fungoides
5303494|NCT00425555|Sézary Syndrome|sézary syndrome
5303495|NCT00425555|CTCL|ctcl
5303496|NCT00425542|Pulmonary embolism|pulmonary embolism
5303497|NCT00425542|Outpatient care|outpatient care
5303498|NCT00425542|Prognosis|prognosis
5303499|NCT00425516|neoadjuvant chemotherapy|neoadjuvant chemotherapy
5303500|NCT00425516|breast cancer|breast cancer
5303501|NCT00425516|sequential treatment|sequential treatment
5303502|NCT00425503|Prostate Cancer|prostate cancer
5303503|NCT00425503|Bortezomib|bortezomib
5303504|NCT00425503|Radical Prostatectomy|radical prostatectomy
5303505|NCT00425503|Phase 2 Clinical Trial|phase 2 clinical trial
5303506|NCT00425477|refractory anemia with excess blasts|refractory anemia with excess blasts
5303507|NCT00425477|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5303508|NCT00425477|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
5303509|NCT00425477|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5303510|NCT00425477|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5303511|NCT00425477|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5303512|NCT00425477|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5303513|NCT00425477|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
5303514|NCT00425477|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
5303515|NCT00425477|refractory cytopenia with multilineage dysplasia|refractory cytopenia with multilineage dysplasia
5303516|NCT00425477|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5303517|NCT00425477|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5303518|NCT00425477|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
5303519|NCT00425477|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
5303520|NCT00425477|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
5303521|NCT00425477|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
5303522|NCT00425477|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
5303523|NCT00425477|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
5303524|NCT00425477|adult pure erythroid leukemia (M6b)|adult pure erythroid leukemia (m6b)
5303525|NCT00425477|adult erythroleukemia (M6a)|adult erythroleukemia (m6a)
5303526|NCT00425477|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
5303527|NCT00425477|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5303528|NCT00425477|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5303529|NCT00425477|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5303530|NCT00425451|Periodontitis|periodontitis
5303531|NCT00425451|Dental Care|dental care
5303532|NCT00425451|Efficacy|efficacy
5303533|NCT00425451|Safety|safety
5303534|NCT00425425|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
5303535|NCT00425425|stage IIA esophageal cancer|stage iia esophageal cancer
5303536|NCT00425425|stage IIB esophageal cancer|stage iib esophageal cancer
5303537|NCT00425425|stage IIIA esophageal cancer|stage iiia esophageal cancer
5303538|NCT00425425|stage IIIB esophageal cancer|stage iiib esophageal cancer
5303539|NCT00425425|stage IIIC esophageal cancer|stage iiic esophageal cancer
5303540|NCT00425399|Schizophrenia|schizophrenia
5303541|NCT00425399|Shiatsu|shiatsu
5303542|NCT00425386|stage III renal cell cancer|stage iii renal cell cancer
5303543|NCT00425386|stage IV renal cell cancer|stage iv renal cell cancer
5303544|NCT00425386|clear cell renal cell carcinoma|clear cell renal cell carcinoma
5303545|NCT00425386|recurrent renal cell cancer|recurrent renal cell cancer
5303546|NCT00425373|Hypertension, Valsartan, Amlodipine, high blood pressure|hypertension, valsartan, amlodipine, high blood pressure
5303547|NCT00425360|stage III pancreatic cancer|stage iii pancreatic cancer
5303548|NCT00425360|stage IV pancreatic cancer|stage iv pancreatic cancer
5303549|NCT00425360|duct cell adenocarcinoma of the pancreas|duct cell adenocarcinoma of the pancreas
5303550|NCT00425360|recurrent pancreatic cancer|recurrent pancreatic cancer
5303551|NCT00425347|Multiple myeloma, MM, plasma cell myeloma, cancer|multiple myeloma, mm, plasma cell myeloma, cancer
5303552|NCT00425334|Blood loss|blood loss
5303553|NCT00425334|Ischemia|ischemia
5303554|NCT00425334|Hemoglobin|hemoglobin
5303555|NCT00425334|Blood Substitutes|blood substitutes
5303556|NCT00425334|Plasma Expanders|plasma expanders
5303557|NCT00425321|Arthritis|arthritis
5303558|NCT00425321|Joints|joints
5303559|NCT00425321|Auto immune|auto immune
5303560|NCT00425308|Everolimus, calcineurine inhibitor, renal transplantation in maintenance, chronic allograft nephropathy|everolimus, calcineurine inhibitor, renal transplantation in maintenance, chronic allograft nephropathy
5303561|NCT00425282|RWJ-333369|rwj-333369
5303562|NCT00425282|anticonvulsants|anticonvulsants
5303563|NCT00425282|antiepileptic drugs|antiepileptic drugs
5303564|NCT00425269|lifestyle intervention|lifestyle intervention
5303565|NCT00425269|Type 2 Diabetes|type 2 diabetes
5303566|NCT00425269|Metabolic syndrome|metabolic syndrome
5303567|NCT00425269|Pakistani women|pakistani women
5303568|NCT00425269|dietary change|dietary change
5303569|NCT00425269|Physical activity|physical activity
5303570|NCT00425269|Norway|norway
5303571|NCT00425243|primary insomnia|primary insomnia
5303572|NCT00425243|chronic insomnia|chronic insomnia
5303573|NCT00425178|Chronic wounds|chronic wounds
5303574|NCT00425178|Diabetes|diabetes
5303575|NCT00425178|Ulcers|ulcers
5303576|NCT00425178|Arterial bypass|arterial bypass
5303577|NCT00425178|Angioplasty|angioplasty
5303578|NCT00425178|Diabetic ulcers|diabetic ulcers
5303579|NCT00425152|stage II colon cancer|stage ii colon cancer
5303580|NCT00425152|stage III colon cancer|stage iii colon cancer
5303581|NCT00425139|Cancer|cancer
5303582|NCT00425139|Video game|video game
5303583|NCT00425139|Adolescent|adolescent
5303584|NCT00425139|Young adult|young adult
5303585|NCT00425126|Delayed Graft Function|delayed graft function
5303586|NCT00425126|Kidney Transplantation|kidney transplantation
5303587|NCT00425113|Mycobacterium Tuberculosis|mycobacterium tuberculosis
5303588|NCT00425113|Anaerobic|anaerobic
5303589|NCT00425113|FDG-PET-HRCT|fdg-pet-hrct
5303590|NCT00425113|HRCT|hrct
5303591|NCT00425113|Lesion Matrix|lesion matrix
5303592|NCT00425113|Tuberculosis|tuberculosis
5303593|NCT00425113|TB|tb
5303594|NCT00425074|slow release ASA|slow release asa
5303595|NCT00425074|platelet functionalism|platelet functionalism
5303596|NCT00425074|secondary cardiovascular prevention|secondary cardiovascular prevention
5303597|NCT00425035|Renal Cancer|renal cancer
5303598|NCT00425022|lung cancer|lung cancer
5303599|NCT00425022|video-assisted thoracic surgery|video-assisted thoracic surgery
5303600|NCT00425009|Berberine|berberine
5303601|NCT00425009|Type 2 diabetes|type 2 diabetes
5303602|NCT00425009|Treatment|treatment
5303603|NCT00424983|Multiple myeloma|multiple myeloma
5303604|NCT00424983|breast cancer|breast cancer
5303605|NCT00424983|zoledronic acid|zoledronic acid
5303606|NCT00424983|pharmacokinetics|pharmacokinetics
5303607|NCT00424970|high altitude|high altitude
5303608|NCT00424970|hypoxia|hypoxia
5303609|NCT00424970|pulmonary hypertension|pulmonary hypertension
5303610|NCT00424970|polycythemia|polycythemia
5303611|NCT00424970|hypoventilation|hypoventilation
5303612|NCT00424957|Ammonia|ammonia
5303613|NCT00424957|Astrocytes|astrocytes
5303614|NCT00424957|Citric acid cycle|citric acid cycle
5303615|NCT00424957|Alpha ketoglutarate dehydrogenase|alpha ketoglutarate dehydrogenase
5303616|NCT00424944|Malaria|malaria
5303617|NCT00424944|Vaccine|vaccine
5303618|NCT00424944|GMZ2|gmz2
5303619|NCT00424944|Safety|safety
5303620|NCT00424944|African|african
5303621|NCT00424944|immunogenicity|immunogenicity
5303622|NCT00424931|narcolepsy|narcolepsy
5303623|NCT00424931|sleepiness|sleepiness
5303624|NCT00424918|Dance|dance
5303625|NCT00424918|Peers|peers
5303626|NCT00424918|middle school-based|middle school-based
5303627|NCT00424918|feasibility|feasibility
5303628|NCT00424866|Peripheral Arterial Disease|peripheral arterial disease
5303629|NCT00424866|Ischemia|ischemia
5303630|NCT00424866|Intermittent Claudication|intermittent claudication
5303631|NCT00424840|lung cancer, Carboplatin, bortezomib, Bevacizumab|lung cancer, carboplatin, bortezomib, bevacizumab
5303632|NCT00424827|pancreatic cancer, gemcitabine, 5-FU, cetuximab, radiation|pancreatic cancer, gemcitabine, 5-fu, cetuximab, radiation
5303633|NCT00424814|HIV mother to child prevention|hiv mother to child prevention
5303634|NCT00424814|HIV Infections|hiv infections
5303635|NCT00424814|Kaletra|kaletra
5303636|NCT00424814|Combivir|combivir
5303637|NCT00424814|HIV Seronegativity|hiv seronegativity
5303638|NCT00424788|multiple sclerosis (MS)|multiple sclerosis (ms)
5303639|NCT00424775|Non-Small Cell Lung Cancer (NSCLC)|non-small cell lung cancer (nsclc)
5303640|NCT00424762|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
5303641|NCT00424762|Congestive Heart Failure|congestive heart failure
5303642|NCT00424762|Cardiopulmonary exercise testing|cardiopulmonary exercise testing
5303643|NCT00424762|intracellular cardiomyocyte triglycerides|intracellular cardiomyocyte triglycerides
5303644|NCT00424762|thiazolidinedione|thiazolidinedione
5303645|NCT00424762|rosiglitazone|rosiglitazone
5303646|NCT00424762|nuclear magnetic resonance|nuclear magnetic resonance
5303647|NCT00424749|Antineutrophil cytoplasmic antibody associated vasculitis|antineutrophil cytoplasmic antibody associated vasculitis
5303648|NCT00424749|Glomerulonephritis|glomerulonephritis
5303649|NCT00424749|Rituximab|rituximab
5303650|NCT00424736|blunt trauma, pediatric patient, imaging, computer tomography|blunt trauma, pediatric patient, imaging, computer tomography
5303651|NCT00424723|pemetrexed|pemetrexed
5303652|NCT00424723|neuroendocrine tumors|neuroendocrine tumors
5303653|NCT00424723|metastatic neuroendocrine tumors|metastatic neuroendocrine tumors
5303654|NCT00424710|choroidal neovascularization|choroidal neovascularization
5303655|NCT00424697|Brain imaging,|brain imaging,
5303656|NCT00424697|fMRI,|fmri,
5303657|NCT00424697|stimulation,|stimulation,
5303658|NCT00424697|pharmacodynamics,|pharmacodynamics,
5303659|NCT00424697|tolerability,|tolerability,
5303660|NCT00424697|healthy subjects|healthy subjects
5303661|NCT00424684|TB|tb
5303662|NCT00424684|Chronic Liver Disease|chronic liver disease
5303663|NCT00424658|breathing disorders|breathing disorders
5303664|NCT00424645|Hematologic Malignancy|hematologic malignancy
5303665|NCT00424645|Solid Tumor|solid tumor
5303666|NCT00424645|Glucarpidase|glucarpidase
5303667|NCT00424645|Voraxaze|voraxaze
5303668|NCT00424645|Delayed Methotrexate Clearance|delayed methotrexate clearance
5303669|NCT00424645|Placebo|placebo
5303670|NCT00424619|Vitamin D|vitamin d
5303671|NCT00424619|Hip fracture|hip fracture
5303672|NCT00424619|Optimal level|optimal level
5303673|NCT00424619|Deficiency|deficiency
5303674|NCT00424619|Functional muscle strength|functional muscle strength
5303675|NCT00424606|High risk node negative|high risk node negative
5303676|NCT00424567|Fracture|fracture
5303677|NCT00424567|non union fracture|non union fracture
5303678|NCT00424567|ununited fracture|ununited fracture
5303679|NCT00424567|pseudarthrosis|pseudarthrosis
5303680|NCT00424541|Pharmacokinetics, pharmacodynamics, safety, RAS profile, SPP100, aliskiren, Japanese, essential hypertension|pharmacokinetics, pharmacodynamics, safety, ras profile, spp100, aliskiren, japanese, essential hypertension
5303681|NCT00424541|Mild to moderate essential hypertension|mild to moderate essential hypertension
5303682|NCT00424528|COPD including chronic bronchitis and emphysema|copd including chronic bronchitis and emphysema
5303683|NCT00424515|Imatinib|imatinib
5303684|NCT00424515|Gleevec|gleevec
5303685|NCT00424489|Refractory Myasthenia Gravis|refractory myasthenia gravis
5303686|NCT00424489|Autologous Stem Cell Transplantation|autologous stem cell transplantation
5303687|NCT00424489|Cyclophosphamide and ATG|cyclophosphamide and atg
5303688|NCT00424476|Autoimmune Diseases|autoimmune diseases
5303689|NCT00424476|Lupus|lupus
5303690|NCT00424476|SLE|sle
5303691|NCT00424476|Systemic Lupus Erythematosus|systemic lupus erythematosus
5303692|NCT00424476|Belimumab|belimumab
5303693|NCT00424476|Antibodies|antibodies
5303694|NCT00424463|Amyotrophic lateral sclerosis (ALS)|amyotrophic lateral sclerosis (als)
5303695|NCT00424450|contrast ultrasound|contrast ultrasound
5303696|NCT00424450|muscle perfusion|muscle perfusion
5303697|NCT00424424|Postoperative Dental Pain|postoperative dental pain
5303698|NCT00424385|AIPC, Prostate cancer|aipc, prostate cancer
5303699|NCT00424385|prostate|prostate
5303700|NCT00424359|Mulitple Sclerosis|mulitple sclerosis
5303701|NCT00424359|Ambulation|ambulation
5303702|NCT00424346|Active Rheumatoid Arthritis|active rheumatoid arthritis
5303703|NCT00424346|anti-interleukin-1beta monoclonal antibody|anti-interleukin-1beta monoclonal antibody
5303704|NCT00424346|methotrexate|methotrexate
5303705|NCT00424320|Acute kidney failure|acute kidney failure
5303706|NCT00424320|Contrast-induced nephropathy|contrast-induced nephropathy
5303707|NCT00424320|Non-ionic contrast media|non-ionic contrast media
5303708|NCT00424320|Ionic contrast media|ionic contrast media
5303709|NCT00424320|Iopamidol|iopamidol
5303710|NCT00424320|Percutaneous coronary intervention|percutaneous coronary intervention
5303711|NCT00424320|Coronariography|coronariography
5303712|NCT00424281|Arixtra, fondaparinux, vasopressor, venous thrombolism|arixtra, fondaparinux, vasopressor, venous thrombolism
5303713|NCT00424268|COPD|copd
5303714|NCT00424268|Roflumilast|roflumilast
5303715|NCT00424255|Cancer of the Head and Neck|cancer of the head and neck
5303716|NCT00424255|Neck cancer|neck cancer
5303717|NCT00424255|Adjuvant|adjuvant
5303718|NCT00424255|Head and neck cancer|head and neck cancer
5303719|NCT00424255|High-risk head and neck cancer|high-risk head and neck cancer
5303720|NCT00424255|Post-surgery|post-surgery
5303721|NCT00424255|Head cancer|head cancer
5303722|NCT00424242|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5303723|NCT00424242|tumors metastatic to brain|tumors metastatic to brain
5303724|NCT00424242|leptomeningeal metastases|leptomeningeal metastases
5303725|NCT00424242|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
5303726|NCT00424242|primary central nervous system Hodgkin lymphoma|primary central nervous system hodgkin lymphoma
5303727|NCT00424242|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
5303728|NCT00424242|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5303729|NCT00424242|chronic eosinophilic leukemia|chronic eosinophilic leukemia
5303730|NCT00424242|primary myelofibrosis|primary myelofibrosis
5303731|NCT00424242|chronic neutrophilic leukemia|chronic neutrophilic leukemia
5303732|NCT00424242|essential thrombocythemia|essential thrombocythemia
5303733|NCT00424242|polycythemia vera|polycythemia vera
5303734|NCT00424242|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5303735|NCT00424242|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5303736|NCT00424242|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5303737|NCT00424242|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5303738|NCT00424242|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5303739|NCT00424242|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5303740|NCT00424242|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5303741|NCT00424242|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5303742|NCT00424242|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5303743|NCT00424242|acute undifferentiated leukemia|acute undifferentiated leukemia
5303744|NCT00424242|mast cell leukemia|mast cell leukemia
5303745|NCT00424242|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
5303746|NCT00424242|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
5303747|NCT00424242|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
5303748|NCT00424242|atypical chronic myeloid leukemia, BCR-ABL negative|atypical chronic myeloid leukemia, bcr-abl negative
5303749|NCT00424242|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5303750|NCT00424242|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5303751|NCT00424242|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5303752|NCT00424242|refractory hairy cell leukemia|refractory hairy cell leukemia
5303753|NCT00424242|prolymphocytic leukemia|prolymphocytic leukemia
5303754|NCT00424242|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
5303755|NCT00424242|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5303756|NCT00424242|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
5303757|NCT00424242|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5303758|NCT00424242|adult grade III lymphomatoid granulomatosis|adult grade iii lymphomatoid granulomatosis
5303759|NCT00424242|intraocular lymphoma|intraocular lymphoma
5303760|NCT00424242|post-transplant lymphoproliferative disorder|post-transplant lymphoproliferative disorder
5303761|NCT00424242|refractory multiple myeloma|refractory multiple myeloma
5303762|NCT00424242|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5303763|NCT00424242|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5303764|NCT00424242|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5303765|NCT00424242|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
5303766|NCT00424242|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
5303767|NCT00424242|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5303768|NCT00424242|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5303769|NCT00424242|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5303770|NCT00424242|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5303771|NCT00424242|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5303772|NCT00424242|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5303773|NCT00424242|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5303774|NCT00424242|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5303775|NCT00424242|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5303776|NCT00424242|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5303777|NCT00424242|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5303778|NCT00424242|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5303779|NCT00424242|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5303780|NCT00424242|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5303781|NCT00424242|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5303782|NCT00424242|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5303783|NCT00424242|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5303784|NCT00424242|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5303785|NCT00424242|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5303786|NCT00424242|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5303787|NCT00424242|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5303788|NCT00424242|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5303789|NCT00424242|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5303790|NCT00424242|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5303791|NCT00424242|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5303792|NCT00424242|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5303793|NCT00424242|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5303794|NCT00424242|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
5303795|NCT00424242|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5303796|NCT00424242|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5303797|NCT00424242|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5303798|NCT00424242|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5303799|NCT00424242|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5303800|NCT00424242|secondary myelofibrosis|secondary myelofibrosis
5303801|NCT00424242|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
5303802|NCT00424242|AIDS-related primary CNS lymphoma|aids-related primary cns lymphoma
5303803|NCT00424242|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
5303804|NCT00424242|stage III multiple myeloma|stage iii multiple myeloma
5303805|NCT00424242|primary systemic amyloidosis|primary systemic amyloidosis
5303806|NCT00424242|extramedullary plasmacytoma|extramedullary plasmacytoma
5303807|NCT00424242|monoclonal gammopathy of undetermined significance|monoclonal gammopathy of undetermined significance
5303808|NCT00424242|isolated plasmacytoma of bone|isolated plasmacytoma of bone
5303809|NCT00424229|MDS INT-2MDS HIGH RISKDELETION 5q[31]Lenalidomide|mds int-2mds high riskdeletion 5q[31]lenalidomide
5303810|NCT00424216|Mood|mood
5303811|NCT00424216|Emotion|emotion
5303812|NCT00424216|Judgment|judgment
5303813|NCT00424216|Cortex|cortex
5303814|NCT00424216|Brain Stimulation|brain stimulation
5303815|NCT00424216|Healthy Volunteer|healthy volunteer
5303817|NCT00424203|cognitive/functional effects|cognitive/functional effects
5303818|NCT00424203|depression|depression
5303819|NCT00424203|malnutrition|malnutrition
5304424|NCT00422448|Genetics|genetics
5303820|NCT00424203|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
5303821|NCT00424203|stage IA breast cancer|stage ia breast cancer
5303822|NCT00424203|stage IB breast cancer|stage ib breast cancer
5303823|NCT00424203|stage II breast cancer|stage ii breast cancer
5303824|NCT00424203|stage IIIA breast cancer|stage iiia breast cancer
5303825|NCT00424203|stage IIIB breast cancer|stage iiib breast cancer
5303826|NCT00424203|stage IIIC breast cancer|stage iiic breast cancer
5303827|NCT00424203|estrogen receptor-negative breast cancer|estrogen receptor-negative breast cancer
5303828|NCT00424203|progesterone receptor-negative breast cancer|progesterone receptor-negative breast cancer
5303829|NCT00424190|Abscess|abscess
5303830|NCT00424190|Antibacterial|antibacterial
5303831|NCT00424190|Antibiotic|antibiotic
5303832|NCT00424190|Antimicrobial|antimicrobial
5303833|NCT00424190|Bacterial infection, skin|bacterial infection, skin
5303834|NCT00424190|Ceftaroline|ceftaroline
5303835|NCT00424190|Ceftaroline acetate|ceftaroline acetate
5303836|NCT00424190|Cellulitis|cellulitis
5303837|NCT00424190|Cephalosporin|cephalosporin
5303838|NCT00424190|Complicated skin and skin structure infection|complicated skin and skin structure infection
5303839|NCT00424190|cSSSI|csssi
5303840|NCT00424190|Intravenous|intravenous
5303841|NCT00424190|Methicillin-resistant Staphylococcus Aureus (MRSA)|methicillin-resistant staphylococcus aureus (mrsa)
5303842|NCT00424190|PPI-0903|ppi-0903
5303843|NCT00424190|Prodrug|prodrug
5303844|NCT00424190|Skin disease, bacterial|skin disease, bacterial
5303845|NCT00424190|Skin infection|skin infection
5303846|NCT00424190|Staphylococcal skin infection|staphylococcal skin infection
5303847|NCT00424190|Staphylococcus aureus|staphylococcus aureus
5303848|NCT00424190|Streptococcal skin infection|streptococcal skin infection
5303849|NCT00424190|Surgical site infection|surgical site infection
5303850|NCT00424190|TAK-599|tak-599
5303851|NCT00424177|idiopathic thrombocytopenic purpura|idiopathic thrombocytopenic purpura
5303852|NCT00424177|ITP|itp
5303853|NCT00424177|thrombocytopenia|thrombocytopenia
5303854|NCT00424177|platelets|platelets
5303855|NCT00424164|male breast cancer|male breast cancer
5303856|NCT00424164|stage IIIB breast cancer|stage iiib breast cancer
5303857|NCT00424164|stage IIIC breast cancer|stage iiic breast cancer
5303858|NCT00424164|stage IV breast cancer|stage iv breast cancer
5303859|NCT00424164|recurrent breast cancer|recurrent breast cancer
5303860|NCT00424151|Graves' Disease|graves' disease
5303861|NCT00424151|Dysthyroid Ophthalmopathy|dysthyroid ophthalmopathy
5303862|NCT00424151|Thyroid related orbitopathy|thyroid related orbitopathy
5303863|NCT00424138|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5303864|NCT00424138|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5303865|NCT00424138|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5303866|NCT00424138|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5303867|NCT00424125|Asthma|asthma
5303868|NCT00424125|Compliance|compliance
5303869|NCT00424125|Randomized clinical trial|randomized clinical trial
5303870|NCT00424112|motivation to change|motivation to change
5303871|NCT00424112|treatment motivation|treatment motivation
5303872|NCT00424112|alcohol use disorders|alcohol use disorders
5303873|NCT00424099|Advanced Cancer|advanced cancer
5303874|NCT00424099|Fatigue|fatigue
5303875|NCT00424099|Nursing Telephone Intervention|nursing telephone intervention
5303876|NCT00424099|NTI|nti
5303877|NCT00424099|Methylphenidate|methylphenidate
5303878|NCT00424099|Placebo|placebo
5303879|NCT00424099|Ritalin|ritalin
5303880|NCT00424060|adult glioblastoma|adult glioblastoma
5303881|NCT00424060|recurrent adult brain tumor|recurrent adult brain tumor
5303882|NCT00424060|adult giant cell glioblastoma|adult giant cell glioblastoma
5303883|NCT00424060|adult gliosarcoma|adult gliosarcoma
5303884|NCT00424047|Multiple Myeloma|multiple myeloma
5303885|NCT00424047|Celgene|celgene
5303886|NCT00424047|Revlimid|revlimid
5303887|NCT00424047|CC-5013|cc-5013
5303888|NCT00424034|safety|safety
5303889|NCT00424034|Pharmacokinetics|pharmacokinetics
5303890|NCT00424034|effect of food on pharmacokinetics|effect of food on pharmacokinetics
5303891|NCT00424008|Glucocorticosteroids|glucocorticosteroids
5303892|NCT00424008|Dry Powder Inhaler|dry powder inhaler
5303893|NCT00424008|Bronchodilator|bronchodilator
5303894|NCT00424008|Metered-Dose Inhaler|metered-dose inhaler
5303895|NCT00423969|Depression|depression
5303896|NCT00423969|Cognitive Impairment|cognitive impairment
5303897|NCT00423956|Teeth root resorption, ultrasound, therapy|teeth root resorption, ultrasound, therapy
5303898|NCT00423943|cognition|cognition
5303899|NCT00423943|memory|memory
5303900|NCT00423930|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
5303901|NCT00423930|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
5303902|NCT00423930|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5303903|NCT00423930|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
5303904|NCT00423930|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5303905|NCT00423930|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
5303906|NCT00423930|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5303907|NCT00423930|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
5303908|NCT00423930|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5303909|NCT00423930|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
5303910|NCT00423930|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
5303911|NCT00423930|tongue cancer|tongue cancer
5303912|NCT00423917|stage IV breast cancer|stage iv breast cancer
5303913|NCT00423917|male breast cancer|male breast cancer
5303914|NCT00423917|recurrent breast cancer|recurrent breast cancer
5303915|NCT00423904|Early intervention|early intervention
5303916|NCT00423904|Brief intervention|brief intervention
5303917|NCT00423904|alcohol|alcohol
5303918|NCT00423904|general hospital|general hospital
5303919|NCT00423865|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5303920|NCT00423865|CISPLATIN|cisplatin
5303921|NCT00423865|RAD001 (EVEROLIMUS)|rad001 (everolimus)
5303922|NCT00423865|06-129|06-129
5303923|NCT00423852|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
5303924|NCT00423852|stage III ovarian germ cell tumor|stage iii ovarian germ cell tumor
5303925|NCT00423852|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
5303926|NCT00423852|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
5303927|NCT00423852|adult central nervous system germ cell tumor|adult central nervous system germ cell tumor
5303928|NCT00423852|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
5303929|NCT00423852|stage II malignant testicular germ cell tumor|stage ii malignant testicular germ cell tumor
5303930|NCT00423852|recurrent extragonadal non-seminomatous germ cell tumor|recurrent extragonadal non-seminomatous germ cell tumor
5303931|NCT00423852|recurrent extragonadal seminoma|recurrent extragonadal seminoma
5303932|NCT00423852|stage III extragonadal non-seminomatous germ cell tumor|stage iii extragonadal non-seminomatous germ cell tumor
5303933|NCT00423852|stage III extragonadal seminoma|stage iii extragonadal seminoma
5303934|NCT00423852|stage IV extragonadal non-seminomatous germ cell tumor|stage iv extragonadal non-seminomatous germ cell tumor
5303935|NCT00423852|stage IV extragonadal seminoma|stage iv extragonadal seminoma
5303936|NCT00423852|recurrent extragonadal germ cell tumor|recurrent extragonadal germ cell tumor
5303937|NCT00423852|adult teratoma|adult teratoma
5303938|NCT00423852|testicular immature teratoma|testicular immature teratoma
5303939|NCT00423852|testicular mature teratoma|testicular mature teratoma
5303940|NCT00423839|Mycobacterium tuberculosis|mycobacterium tuberculosis
5303941|NCT00423839|Antigen 85A|antigen 85a
5303942|NCT00423839|Modified Vaccinia Virus Ankara (MVA).|modified vaccinia virus ankara (mva).
5303943|NCT00423826|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5303944|NCT00423826|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5303945|NCT00423826|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
5303946|NCT00423826|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5303947|NCT00423826|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5304045|NCT00423722|Hospice Care|hospice care
5303948|NCT00423826|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5303949|NCT00423826|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
5303950|NCT00423826|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5303951|NCT00423826|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5303952|NCT00423826|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5303953|NCT00423826|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5303954|NCT00423826|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5303955|NCT00423826|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5303956|NCT00423826|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5303957|NCT00423826|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5303958|NCT00423826|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
5303959|NCT00423826|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
5303960|NCT00423826|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
5303961|NCT00423826|adult acute promyelocytic leukemia (M3)|adult acute promyelocytic leukemia (m3)
5303962|NCT00423826|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
5303963|NCT00423826|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
5303964|NCT00423826|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
5303965|NCT00423826|adult erythroleukemia (M6a)|adult erythroleukemia (m6a)
5303966|NCT00423826|adult pure erythroid leukemia (M6b)|adult pure erythroid leukemia (m6b)
5303967|NCT00423826|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
5303968|NCT00423826|childhood acute myeloblastic leukemia without maturation (M1)|childhood acute myeloblastic leukemia without maturation (m1)
5303969|NCT00423826|childhood acute myeloblastic leukemia with maturation (M2)|childhood acute myeloblastic leukemia with maturation (m2)
5303970|NCT00423826|childhood acute promyelocytic leukemia (M3)|childhood acute promyelocytic leukemia (m3)
5304425|NCT00422448|Nevi|nevi
5303971|NCT00423826|childhood acute myelomonocytic leukemia (M4)|childhood acute myelomonocytic leukemia (m4)
5303972|NCT00423826|childhood acute monoblastic leukemia (M5a)|childhood acute monoblastic leukemia (m5a)
5303973|NCT00423826|childhood acute monocytic leukemia (M5b)|childhood acute monocytic leukemia (m5b)
5303974|NCT00423826|childhood acute erythroleukemia (M6)|childhood acute erythroleukemia (m6)
5303975|NCT00423826|childhood acute megakaryocytic leukemia (M7)|childhood acute megakaryocytic leukemia (m7)
5303976|NCT00423826|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
5303977|NCT00423826|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5303978|NCT00423826|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5303979|NCT00423826|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5303980|NCT00423826|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5303981|NCT00423826|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
5303982|NCT00423826|adult grade III lymphomatoid granulomatosis|adult grade iii lymphomatoid granulomatosis
5303983|NCT00423826|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
5303984|NCT00423826|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
5303985|NCT00423826|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5303986|NCT00423826|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5303987|NCT00423826|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5303988|NCT00423826|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5303989|NCT00423826|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5303990|NCT00423826|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5303991|NCT00423826|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5303992|NCT00423826|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5303993|NCT00423826|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5303994|NCT00423826|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5303995|NCT00423826|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5303996|NCT00423826|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5303997|NCT00423826|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5303998|NCT00423826|stage I multiple myeloma|stage i multiple myeloma
5303999|NCT00423826|stage II multiple myeloma|stage ii multiple myeloma
5304000|NCT00423826|stage III multiple myeloma|stage iii multiple myeloma
5304001|NCT00423826|extramedullary plasmacytoma|extramedullary plasmacytoma
5304002|NCT00423826|isolated plasmacytoma of bone|isolated plasmacytoma of bone
5304003|NCT00423826|monoclonal gammopathy of undetermined significance|monoclonal gammopathy of undetermined significance
5304004|NCT00423826|primary systemic amyloidosis|primary systemic amyloidosis
5304005|NCT00423826|refractory multiple myeloma|refractory multiple myeloma
5304006|NCT00423826|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5304007|NCT00423826|childhood acute minimally differentiated myeloid leukemia (M0)|childhood acute minimally differentiated myeloid leukemia (m0)
5304008|NCT00423826|childhood grade III lymphomatoid granulomatosis|childhood grade iii lymphomatoid granulomatosis
5304009|NCT00423826|childhood nasal type extranodal NK/T-cell lymphoma|childhood nasal type extranodal nk/t-cell lymphoma
5304010|NCT00423826|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
5304011|NCT00423826|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
5304012|NCT00423826|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
5304013|NCT00423826|childhood diffuse large cell lymphoma|childhood diffuse large cell lymphoma
5304014|NCT00423826|childhood immunoblastic large cell lymphoma|childhood immunoblastic large cell lymphoma
5304015|NCT00423826|Burkitt lymphoma|burkitt lymphoma
5304016|NCT00423826|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
5304017|NCT00423826|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5304018|NCT00423826|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5304019|NCT00423826|recurrent childhood grade III lymphomatoid granulomatosis|recurrent childhood grade iii lymphomatoid granulomatosis
5304020|NCT00423826|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5304021|NCT00423826|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5304022|NCT00423826|secondary myelofibrosis|secondary myelofibrosis
5304024|NCT00423813|Fibro|fibro
5304025|NCT00423813|pain|pain
5304026|NCT00423813|Body pain|body pain
5304027|NCT00423813|tenderness|tenderness
5304028|NCT00423813|stiffness|stiffness
5304029|NCT00423813|muscular pain|muscular pain
5304030|NCT00423813|joint pain|joint pain
5304031|NCT00423787|Allergy|allergy
5304032|NCT00423787|Allergoid|allergoid
5304033|NCT00423787|Specific Immunotherapy|specific immunotherapy
5304034|NCT00423774|Allogeneic Hematopoietic Stem Cell Transplant|allogeneic hematopoietic stem cell transplant
5304035|NCT00423774|Psychological Distress|psychological distress
5304036|NCT00423774|Coping|coping
5304037|NCT00423774|Cognitive Behavior Therapy|cognitive behavior therapy
5304038|NCT00423774|Bone Marrow Transplant|bone marrow transplant
5304039|NCT00423774|Coping Skills|coping skills
5304040|NCT00423761|Pharmacokinetics,|pharmacokinetics,
5304041|NCT00423761|tolerability,|tolerability,
5304042|NCT00423761|healthy,|healthy,
5304043|NCT00423761|subjects|subjects
5304044|NCT00423722|Advanced Cancer|advanced cancer
5304046|NCT00423722|Caregiver|caregiver
5304047|NCT00423722|Saline|saline
5304048|NCT00423722|Hydration|hydration
5304049|NCT00423722|Dehydration|dehydration
5304050|NCT00423709|Hodgkin's Disease|hodgkin's disease
5304051|NCT00423709|Allogeneic Blood Stem Cell Transplantation|allogeneic blood stem cell transplantation
5304052|NCT00423709|Bone Marrow Transplantation|bone marrow transplantation
5304053|NCT00423709|Fludarabine|fludarabine
5304054|NCT00423709|Melphalan|melphalan
5304055|NCT00423696|stage IV colon cancer|stage iv colon cancer
5304056|NCT00423696|stage IV rectal cancer|stage iv rectal cancer
5304057|NCT00423696|recurrent colon cancer|recurrent colon cancer
5304058|NCT00423696|recurrent rectal cancer|recurrent rectal cancer
5304059|NCT00423683|Cancer|cancer
5304060|NCT00423683|thromboembolism|thromboembolism
5304061|NCT00423657|Abscess|abscess
5304062|NCT00423657|Antibacterial|antibacterial
5304063|NCT00423657|Antibiotic|antibiotic
5304064|NCT00423657|Antimicrobial|antimicrobial
5304065|NCT00423657|Bacterial infection, skin|bacterial infection, skin
5304066|NCT00423657|Ceftaroline|ceftaroline
5304067|NCT00423657|Ceftaroline acetate|ceftaroline acetate
5304068|NCT00423657|Cellulitis|cellulitis
5304069|NCT00423657|Cephalosporin|cephalosporin
5304070|NCT00423657|Complicated skin and skin structure infection (cSSSI)|complicated skin and skin structure infection (csssi)
5304071|NCT00423657|cSSSI|csssi
5304072|NCT00423657|Intravenous|intravenous
5304073|NCT00423657|Methicillin-resistant Staphylococcus Aureus (MRSA)|methicillin-resistant staphylococcus aureus (mrsa)
5304074|NCT00423657|PPI-0903|ppi-0903
5304075|NCT00423657|Prodrug|prodrug
5304076|NCT00423657|Skin disease, bacterial|skin disease, bacterial
5304077|NCT00423657|Skin infection|skin infection
5304078|NCT00423657|Staphylococcal skin infection|staphylococcal skin infection
5304079|NCT00423657|Staphylococcus aureus|staphylococcus aureus
5304080|NCT00423657|Streptococcal skin infection|streptococcal skin infection
5304081|NCT00423657|Surgical site infection|surgical site infection
5304082|NCT00423657|TAK-599|tak-599
5304083|NCT00423644|Multiple Myeloma|multiple myeloma
5304084|NCT00423644|arsenic|arsenic
5304085|NCT00423644|cancer study|cancer study
5304086|NCT00423644|failed treatment|failed treatment
5304087|NCT00423631|Pain|pain
5304088|NCT00423631|Fibromyalgia|fibromyalgia
5304089|NCT00423631|Internet|internet
5304090|NCT00423618|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
5304091|NCT00423618|stage I adult soft tissue sarcoma|stage i adult soft tissue sarcoma
5304092|NCT00423618|stage II adult soft tissue sarcoma|stage ii adult soft tissue sarcoma
5304093|NCT00423618|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
5304094|NCT00423618|adult synovial sarcoma|adult synovial sarcoma
5304095|NCT00423618|adult angiosarcoma|adult angiosarcoma
5304096|NCT00423618|adult epithelioid sarcoma|adult epithelioid sarcoma
5304097|NCT00423618|adult extraskeletal chondrosarcoma|adult extraskeletal chondrosarcoma
5304098|NCT00423618|adult leiomyosarcoma|adult leiomyosarcoma
5304099|NCT00423618|adult liposarcoma|adult liposarcoma
5304100|NCT00423618|adult malignant fibrous histiocytoma|adult malignant fibrous histiocytoma
5304101|NCT00423618|adult malignant hemangiopericytoma|adult malignant hemangiopericytoma
5304102|NCT00423618|adult malignant mesenchymoma|adult malignant mesenchymoma
5304103|NCT00423618|adult fibrosarcoma|adult fibrosarcoma
5304104|NCT00423618|adult neurofibrosarcoma|adult neurofibrosarcoma
5304105|NCT00423618|adult alveolar soft-part sarcoma|adult alveolar soft-part sarcoma
5304107|NCT00423605|Fibro|fibro
5304108|NCT00423605|Pain|pain
5304109|NCT00423605|Body Pain|body pain
5304110|NCT00423605|Tenderness|tenderness
5304111|NCT00423605|Joint pain|joint pain
5304112|NCT00423605|Stiffness|stiffness
5304113|NCT00423605|Muscular Pain|muscular pain
5304114|NCT00423566|Mycobacterium tuberculosis|mycobacterium tuberculosis
5304115|NCT00423566|85A antigen|85a antigen
5304116|NCT00423566|Recombinant Modified Vaccinia virus Ankara|recombinant modified vaccinia virus ankara
5304117|NCT00423566|Phase I study|phase i study
5304118|NCT00423566|Immunogenicity|immunogenicity
5304119|NCT00423553|Nitrite and Cytoprotection|nitrite and cytoprotection
5304120|NCT00423553|Ischemic Preconditioning|ischemic preconditioning
5304121|NCT00423553|Atrial Trabeculae Contractile Function|atrial trabeculae contractile function
5304122|NCT00423553|Ischemia|ischemia
5304123|NCT00423540|magnesium infusion|magnesium infusion
5304124|NCT00423540|magnesium sulfate|magnesium sulfate
5304125|NCT00423540|rest cramps|rest cramps
5304126|NCT00423540|nocturnal leg cramps|nocturnal leg cramps
5304127|NCT00423540|muscle cramps|muscle cramps
5304128|NCT00423540|fractional urinary excretion|fractional urinary excretion
5304129|NCT00423540|urinary excretion|urinary excretion
5304130|NCT00423540|24 hour urine|24 hour urine
5304131|NCT00423540|serum magnesium|serum magnesium
5304132|NCT00423540|magnesium deficiency|magnesium deficiency
5304133|NCT00423540|family practice|family practice
5304134|NCT00423540|general practice|general practice
5304135|NCT00423540|richmond|richmond
5304136|NCT00423540|cramp frequency|cramp frequency
5304137|NCT00423540|magnesium status|magnesium status
5304138|NCT00423540|urinary magnesium|urinary magnesium
5304139|NCT00423540|cramp diary|cramp diary
5304140|NCT00423540|sf 36|sf 36
5304426|NCT00422448|Nevogenesis|nevogenesis
5304141|NCT00423527|multiple sclerosis|multiple sclerosis
5304142|NCT00423527|central pain|central pain
5304143|NCT00423527|levetiracetam|levetiracetam
5304144|NCT00423514|graft versus host disease|graft versus host disease
5304145|NCT00423514|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5304146|NCT00423514|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5304147|NCT00423514|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
5304148|NCT00423514|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
5304149|NCT00423514|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5304150|NCT00423514|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5304151|NCT00423514|acute undifferentiated leukemia|acute undifferentiated leukemia
5304152|NCT00423514|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5304153|NCT00423514|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5304154|NCT00423514|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
5304155|NCT00423514|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5304156|NCT00423514|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5304157|NCT00423514|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5304158|NCT00423514|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5304159|NCT00423514|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5304160|NCT00423514|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5304161|NCT00423514|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
5304162|NCT00423514|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5304163|NCT00423514|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5304164|NCT00423514|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5304165|NCT00423514|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5304166|NCT00423514|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5304167|NCT00423514|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5304168|NCT00423514|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5304169|NCT00423514|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
5304170|NCT00423475|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5304171|NCT00423475|stage IIB prostate cancer|stage iib prostate cancer
5304172|NCT00423475|stage IIA prostate cancer|stage iia prostate cancer
5304173|NCT00423475|stage III prostate cancer|stage iii prostate cancer
5304174|NCT00423475|recurrent prostate cancer|recurrent prostate cancer
5304175|NCT00423475|stage IV prostate cancer|stage iv prostate cancer
5304176|NCT00423462|Psychotherapy|psychotherapy
5304177|NCT00423462|Long-term effects|long-term effects
5304178|NCT00423449|Advanced Stage IIIB/IV Non-Small Cell Lung Cancer|advanced stage iiib/iv non-small cell lung cancer
5304179|NCT00423436|Non-Small Cell Lung Cancer|non-small cell lung cancer
5304180|NCT00423436|Small Cell Lung Cancer|small cell lung cancer
5304181|NCT00423436|Voice Response System|voice response system
5304182|NCT00423436|Questionnaire|questionnaire
5304183|NCT00423436|Survey|survey
5304184|NCT00423436|NSCLC|nsclc
5304185|NCT00423410|Cancer|cancer
5304186|NCT00423410|Tumor|tumor
5304187|NCT00423410|Lymphoma|lymphoma
5304188|NCT00423397|squamous cell carcinoma of the skin|squamous cell carcinoma of the skin
5304189|NCT00423397|recurrent skin cancer|recurrent skin cancer
5304190|NCT00423384|Ibandronate|ibandronate
5304191|NCT00423384|Placebo|placebo
5304192|NCT00423384|Doubleblind|doubleblind
5304193|NCT00423384|Bone|bone
5304194|NCT00423384|loss|loss
5304195|NCT00423384|Kidney|kidney
5304196|NCT00423384|transplant|transplant
5304197|NCT00423371|first Carpometacarpal (CMC) Joint|first carpometacarpal (cmc) joint
5304198|NCT00423358|rheumatoid arthritis|rheumatoid arthritis
5304199|NCT00423358|hypovitaminosis D|hypovitaminosis d
5304200|NCT00423358|bone turnover|bone turnover
5304201|NCT00423358|ergocalciferol|ergocalciferol
5304202|NCT00423332|cancer|cancer
5304203|NCT00423332|tumour|tumour
5304204|NCT00423332|advanced cancer|advanced cancer
5304205|NCT00423332|Metastatic renal cell carcinoma|metastatic renal cell carcinoma
5304206|NCT00423332|kidney cancer|kidney cancer
5304207|NCT00423332|RECENTIN|recentin
5304208|NCT00423319|Prevention of deep vein thrombosis and|prevention of deep vein thrombosis and
5304209|NCT00423319|pulmonary embolism after total hip replacement surgery|pulmonary embolism after total hip replacement surgery
5304210|NCT00423293|stage II anal cancer|stage ii anal cancer
5304211|NCT00423293|stage IIIA anal cancer|stage iiia anal cancer
5304212|NCT00423293|stage IIIB anal cancer|stage iiib anal cancer
5304213|NCT00423293|basaloid carcinoma of the anus|basaloid carcinoma of the anus
5304214|NCT00423293|cloacogenic carcinoma of the anus|cloacogenic carcinoma of the anus
5304215|NCT00423293|squamous cell carcinoma of the anus|squamous cell carcinoma of the anus
5304216|NCT00423280|Endothelium|endothelium
5304217|NCT00423280|Nitric Oxide|nitric oxide
5304218|NCT00423280|Magnetic Resonance Imaging|magnetic resonance imaging
5304219|NCT00423280|Tetrahydrobiopterin|tetrahydrobiopterin
5304220|NCT00423254|Cancer Vaccine|cancer vaccine
5304221|NCT00423228|Alzheimer's disease|alzheimer's disease
5304222|NCT00423228|cognitive impairment|cognitive impairment
5304223|NCT00423228|cholinesterase inhibitors|cholinesterase inhibitors
5304224|NCT00423228|sustained-release implants|sustained-release implants
5304225|NCT00423228|long acting treatment|long acting treatment
5304227|NCT00423189|Lucentis|lucentis
5304228|NCT00423189|Visudyne|visudyne
5304229|NCT00423189|PDT|pdt
5304230|NCT00423189|AMD|amd
5304231|NCT00423189|ARMD|armd
5304232|NCT00423189|Age|age
5304233|NCT00423189|Related|related
5304234|NCT00423189|Macular|macular
5304235|NCT00423189|Degeneration|degeneration
5304236|NCT00423163|Aspergillosis/blood|aspergillosis/blood
5304237|NCT00423163|micafungin|micafungin
5304238|NCT00423163|voriconazole|voriconazole
5304239|NCT00423163|Aspergillus|aspergillus
5304240|NCT00423124|Hematological malignancies|hematological malignancies
5304241|NCT00423124|HSV-TK|hsv-tk
5304242|NCT00423124|Haploidentical HCT|haploidentical hct
5304243|NCT00423124|GvHD|gvhd
5304244|NCT00423124|GvL|gvl
5304245|NCT00423111|Multiple sclerosis|multiple sclerosis
5304246|NCT00423111|Memory|memory
5304247|NCT00423111|Cognitive deficits|cognitive deficits
5304248|NCT00423111|MRI|mri
5304249|NCT00423111|Hippocampus|hippocampus
5304250|NCT00423111|Prefrontal cortex|prefrontal cortex
5304251|NCT00423098|Lupus Nephritis|lupus nephritis
5304252|NCT00423098|enteric-coated mycophenolate sodium|enteric-coated mycophenolate sodium
5304253|NCT00423098|EC-MPS|ec-mps
5304254|NCT00423098|Myfortic|myfortic
5304255|NCT00423085|rivastigmine，Alzheimer's Disease, transdermal patch|rivastigmine，alzheimer's disease, transdermal patch
5304256|NCT00423072|cleft palate|cleft palate
5304257|NCT00423072|palatoplasty|palatoplasty
5304258|NCT00423072|otitis|otitis
5304259|NCT00423072|middle ear|middle ear
5304260|NCT00423072|Eustachian tube|eustachian tube
5304261|NCT00423059|intravitreal bevacizumab|intravitreal bevacizumab
5304262|NCT00423059|proliferative diabetic retinopathy|proliferative diabetic retinopathy
5304263|NCT00423059|VEGF|vegf
5304264|NCT00423059|PEDF|pedf
5304265|NCT00423046|Vaccines|vaccines
5304266|NCT00423046|Cervical cancer|cervical cancer
5304267|NCT00423046|Immunogenicity|immunogenicity
5304268|NCT00423046|Humans|humans
5304269|NCT00423046|Safety|safety
5304270|NCT00423046|Viral infections|viral infections
5304271|NCT00423046|Human papillomavirus (HPV)|human papillomavirus (hpv)
5304272|NCT00423046|Comparative study|comparative study
5304273|NCT00423046|Human papillomavirus vaccine|human papillomavirus vaccine
5304274|NCT00423046|Adults|adults
5304275|NCT00423020|Acute myocardial infarction|acute myocardial infarction
5304276|NCT00423020|Restenosis|restenosis
5304277|NCT00423020|erythropoietin|erythropoietin
5304278|NCT00423020|EPOC-AMI|epoc-ami
5304279|NCT00422994|end stage renal impairment|end stage renal impairment
5304280|NCT00422994|tolerability|tolerability
5304281|NCT00422994|ropinirole|ropinirole
5304282|NCT00422994|pharmacokinetics|pharmacokinetics
5304283|NCT00422994|hemodialysis|hemodialysis
5304284|NCT00422981|Dementia|dementia
5304285|NCT00422981|Memory|memory
5304286|NCT00422981|Alzheimers|alzheimers
5304287|NCT00422981|Cognition|cognition
5304288|NCT00422981|Mind|mind
5304289|NCT00422981|Aging|aging
5304290|NCT00422968|Coronary artery disease|coronary artery disease
5304291|NCT00422968|Stent|stent
5304292|NCT00422968|Bypass surgery, coronary artery|bypass surgery, coronary artery
5304293|NCT00422955|fluid retention|fluid retention
5304294|NCT00422955|Autonomic Neuropathy|autonomic neuropathy
5304295|NCT00422929|otitis media|otitis media
5304296|NCT00422929|ear|ear
5304297|NCT00422929|acute otitis|acute otitis
5304298|NCT00422929|middle ear|middle ear
5304299|NCT00422929|Eustachian tube|eustachian tube
5304300|NCT00422929|recurrent acute otitis media|recurrent acute otitis media
5304301|NCT00422929|chronic otitis media with effusion|chronic otitis media with effusion
5304302|NCT00422929|no significant history of otitis media|no significant history of otitis media
5304303|NCT00422903|neo-adjuvant|neo-adjuvant
5304304|NCT00422903|letrozole|letrozole
5304305|NCT00422903|lapatinib|lapatinib
5304306|NCT00422903|primary breast cancer|primary breast cancer
5304307|NCT00422890|Acute myeloid leukaemia or Myelodysplastic syndrome|acute myeloid leukaemia or myelodysplastic syndrome
5304308|NCT00422877|Liver Cancer|liver cancer
5304309|NCT00422851|otitis|otitis
5304310|NCT00422851|gas diffusion|gas diffusion
5304311|NCT00422851|Eustachian tube|eustachian tube
5304312|NCT00422851|tympanic membrane|tympanic membrane
5304313|NCT00422838|Hepatitis C|hepatitis c
5304314|NCT00422838|Liver|liver
5304315|NCT00422838|immunology|immunology
5304316|NCT00422838|regulation|regulation
5304317|NCT00422838|Genotype 1,2,3|genotype 1,2,3
5304318|NCT00422838|Treatment|treatment
5304319|NCT00422838|Chronic|chronic
5304320|NCT00422838|Pegylated interferon|pegylated interferon
5304321|NCT00422838|Ribavirin|ribavirin
5304322|NCT00422825|Food effect|food effect
5304323|NCT00422825|bioavailability|bioavailability
5304324|NCT00422825|pharmacokinetic|pharmacokinetic
5304325|NCT00422825|imatinib|imatinib
5304326|NCT00422825|STI571|sti571
5304423|NCT00422448|Histopathology|histopathology
5304327|NCT00422825|modified release formulation of STI571|modified release formulation of sti571
5304328|NCT00422825|CML|cml
5304329|NCT00422825|Chronic Myeloid Leukemia|chronic myeloid leukemia
5304330|NCT00422825|Philadelphia Chromosome|philadelphia chromosome
5304331|NCT00422812|Migraine, Staccato Prochlorperazine|migraine, staccato prochlorperazine
5304332|NCT00422812|Migraine headache with or without aura.|migraine headache with or without aura.
5304333|NCT00422799|relapsed Waldenstrom's macroglobulinemia|relapsed waldenstrom's macroglobulinemia
5304334|NCT00422799|refractory Waldenstrom's macroglobulinemia|refractory waldenstrom's macroglobulinemia
5304335|NCT00422799|Velcade|velcade
5304336|NCT00422799|WM|wm
5304337|NCT00422786|Refractory Clear Cell Renal Cell Carcinoma|refractory clear cell renal cell carcinoma
5304338|NCT00422786|Phase II|phase ii
5304339|NCT00422786|Thallion|thallion
5304340|NCT00422786|TLN-232|tln-232
5304341|NCT00422786|CAP-232|cap-232
5304342|NCT00422786|M2PK|m2pk
5304343|NCT00422773|phase I/II|phase i/ii
5304344|NCT00422773|cetuximab|cetuximab
5304345|NCT00422773|oxaliplatin|oxaliplatin
5304346|NCT00422773|irinotecan|irinotecan
5304347|NCT00422773|5-FU|5-fu
5304348|NCT00422773|chemotherapy|chemotherapy
5304349|NCT00422773|dose escalation|dose escalation
5304350|NCT00422773|safety|safety
5304351|NCT00422760|esophageal perforation|esophageal perforation
5304352|NCT00422760|COPD|copd
5304353|NCT00422747|asthma|asthma
5304354|NCT00422747|transient wheezing|transient wheezing
5304355|NCT00422747|early diagnosis|early diagnosis
5304356|NCT00422747|exhaled air|exhaled air
5304357|NCT00422747|nitrogen monoxide|nitrogen monoxide
5304358|NCT00422747|airway resistance|airway resistance
5304359|NCT00422721|early severe retinal dystrophy|early severe retinal dystrophy
5304360|NCT00422721|amaurosis of leber|amaurosis of leber
5304361|NCT00422695|HIV|hiv
5304362|NCT00422695|Quantitative Sensory Testing|quantitative sensory testing
5304363|NCT00422695|Neuropathy|neuropathy
5304364|NCT00422695|Treatment Experienced|treatment experienced
5304365|NCT00422695|Treatment Naive|treatment naive
5304366|NCT00422682|Solid tumors|solid tumors
5304367|NCT00422669|Pacemaker|pacemaker
5304368|NCT00422669|Implantable Pulse Generator (IPG)|implantable pulse generator (ipg)
5304369|NCT00422669|AV Conduction Disturbance|av conduction disturbance
5304370|NCT00422669|Select Site Pacing|select site pacing
5304371|NCT00422656|relapsed Waldenstrom's Macroglobulinemia|relapsed waldenstrom's macroglobulinemia
5304372|NCT00422656|refractory Waldenstrom's Macroglobulinemia|refractory waldenstrom's macroglobulinemia
5304373|NCT00422656|WM|wm
5304374|NCT00422656|perifosine|perifosine
5304375|NCT00422643|OA,HA,Intra-articular|oa,ha,intra-articular
5304376|NCT00422630|Weight loss|weight loss
5304377|NCT00422630|Obesity|obesity
5304378|NCT00422630|Metabolic Syndrome|metabolic syndrome
5304379|NCT00422630|Diet|diet
5304380|NCT00422630|Hypertension|hypertension
5304381|NCT00422630|Diabetes|diabetes
5304382|NCT00422630|Cholesterol|cholesterol
5304383|NCT00422617|psoriasis|psoriasis
5304384|NCT00422617|alefacept|alefacept
5304385|NCT00422604|COPD|copd
5304386|NCT00422604|plethysmography.|plethysmography.
5304387|NCT00422604|muscarinic receptor antagonist|muscarinic receptor antagonist
5304388|NCT00422604|anticholinergic|anticholinergic
5304389|NCT00422591|Cytarabine, Idarubicin|cytarabine, idarubicin
5304390|NCT00422591|Leukemia|leukemia
5304391|NCT00422591|Acute Myeloid Leukemia|acute myeloid leukemia
5304392|NCT00422591|AML|aml
5304393|NCT00422591|Cytarabine|cytarabine
5304394|NCT00422591|Idarubicin|idarubicin
5304395|NCT00422578|erectile dysfunction|erectile dysfunction
5304396|NCT00422578|tadalafil|tadalafil
5304397|NCT00422565|Coronary Artery Disease|coronary artery disease
5304398|NCT00422565|Stent|stent
5304399|NCT00422565|Myocardial Infarction|myocardial infarction
5304400|NCT00422552|inspiratory capacity, FEV1, COPD|inspiratory capacity, fev1, copd
5304401|NCT00422539|trichloroacetic acid|trichloroacetic acid
5304402|NCT00422539|varicella scar|varicella scar
5304403|NCT00422526|Preterm delivery, short cervix, progesterone|preterm delivery, short cervix, progesterone
5304404|NCT00422500|Lung Cancer|lung cancer
5304405|NCT00422500|Advanced Lung Cancer|advanced lung cancer
5304406|NCT00422500|Chemotherapy Symptoms|chemotherapy symptoms
5304407|NCT00422500|Disease-Related Symptoms|disease-related symptoms
5304408|NCT00422500|Treatment-Related Symptoms|treatment-related symptoms
5304409|NCT00422500|Symptom Management|symptom management
5304410|NCT00422500|Questionnaire|questionnaire
5304411|NCT00422500|Telephone Interactive System|telephone interactive system
5304412|NCT00422500|IVR Telephone System|ivr telephone system
5304413|NCT00422500|DNA Repair Capacity|dna repair capacity
5304414|NCT00422500|DRC|drc
5304415|NCT00422500|Cognitive Symptoms|cognitive symptoms
5304416|NCT00422487|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
5304417|NCT00422474|Ischemic stroke|ischemic stroke
5304418|NCT00422474|Baroreflex sensitivity|baroreflex sensitivity
5304419|NCT00422474|Prognosis|prognosis
5304420|NCT00422474|Cardiovascular autonomic regulation|cardiovascular autonomic regulation
5304421|NCT00422461|Clinical Trial, Randomized Controlled Trial, Humans, Cyclic Nucleotide Phosphodiesterases Type 5|clinical trial, randomized controlled trial, humans, cyclic nucleotide phosphodiesterases type 5
5304422|NCT00422448|Dermoscopy|dermoscopy
5304427|NCT00422435|Percutaneous coronary intervention (PCI)|percutaneous coronary intervention (pci)
5304428|NCT00422435|Drug eluting stent (DES)|drug eluting stent (des)
5304429|NCT00422422|Brivaracetam|brivaracetam
5304430|NCT00422422|Epilepsy|epilepsy
5304431|NCT00422422|Child|child
5304432|NCT00422422|Pharmacokinetics|pharmacokinetics
5304433|NCT00422422|Adolescents|adolescents
5304434|NCT00422409|SEMS|sems
5304435|NCT00422396|Hypertrigliceridemia|hypertrigliceridemia
5304436|NCT00422396|Metabolic syndrome|metabolic syndrome
5304437|NCT00422396|Obesity|obesity
5304438|NCT00422396|Fenofibrate|fenofibrate
5304439|NCT00422396|Lipoproteins|lipoproteins
5304440|NCT00422396|Cytokines|cytokines
5304441|NCT00422357|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
5304442|NCT00422357|Urtica Dioica (or stinging nettle)|urtica dioica (or stinging nettle)
5304443|NCT00422357|Hypoglycemic agents|hypoglycemic agents
5304444|NCT00422344|RAD001|rad001
5304445|NCT00422344|Sunitinib|sunitinib
5304446|NCT00422344|renal|renal
5304447|NCT00422344|kidney|kidney
5304448|NCT00422331|Bipolar I Disorder|bipolar i disorder
5304449|NCT00422331|Bipolar Disorder|bipolar disorder
5304450|NCT00422331|Lithium|lithium
5304451|NCT00422318|Heart Failure|heart failure
5304452|NCT00422318|Insulin|insulin
5304453|NCT00422318|Metabolism|metabolism
5304454|NCT00422318|Pharmacology|pharmacology
5304455|NCT00422318|Uric Acid|uric acid
5304456|NCT00422305|Infant, Premature|infant, premature
5304457|NCT00422305|Bronchopulmonary dysplasia|bronchopulmonary dysplasia
5304458|NCT00422305|asthma|asthma
5304459|NCT00422292|Menactra vaccine|menactra vaccine
5304460|NCT00422292|Meningococcal meningitis|meningococcal meningitis
5304461|NCT00422292|Measles|measles
5304462|NCT00422292|Mumps|mumps
5304463|NCT00422292|Rubella|rubella
5304464|NCT00422292|Varicella vaccines|varicella vaccines
5304465|NCT00422292|Haemophilus influenzae type b|haemophilus influenzae type b
5304466|NCT00422292|Pneumococcal conjugate vaccine|pneumococcal conjugate vaccine
5304467|NCT00422279|Bone Inductive Implant|bone inductive implant
5304468|NCT00422266|Dyslipidemia|dyslipidemia
5304469|NCT00422253|insulin resistance|insulin resistance
5304470|NCT00422253|insulin secretion|insulin secretion
5304471|NCT00422253|advanced glycation end-products|advanced glycation end-products
5304472|NCT00422240|Acne vulgaris|acne vulgaris
5304473|NCT00422240|Adapalene|adapalene
5304474|NCT00422240|Benzoyl Peroxide|benzoyl peroxide
5304475|NCT00422214|Bipolar Disorder|bipolar disorder
5304476|NCT00422214|Bipolar Depression,|bipolar depression,
5304477|NCT00422214|Manic Depression|manic depression
5304478|NCT00422214|Seroquel|seroquel
5304479|NCT00422214|Seroquel SR|seroquel sr
5304480|NCT00422214|quetiapine fumarate|quetiapine fumarate
5304481|NCT00422201|Cortisol|cortisol
5304482|NCT00422201|Cushing's Syndrome|cushing's syndrome
5304483|NCT00422201|Ectopic ACTH Secretion|ectopic acth secretion
5304484|NCT00422201|Cushing Syndrome|cushing syndrome
5304485|NCT00422175|Safety, tolerability, pharmacokinetics, pharmacodynamics, oral, BAF312, healthy volunteers|safety, tolerability, pharmacokinetics, pharmacodynamics, oral, baf312, healthy volunteers
5304486|NCT00422149|Sublingual immunotherapy|sublingual immunotherapy
5304487|NCT00422149|Rhinoconjunctivitis|rhinoconjunctivitis
5304488|NCT00422136|middle ear|middle ear
5304489|NCT00422136|otitis|otitis
5304490|NCT00422136|genetics|genetics
5304491|NCT00422123|Bipolar Disorder|bipolar disorder
5304492|NCT00422123|Bipolar Mania|bipolar mania
5304493|NCT00422123|Manic Depression|manic depression
5304494|NCT00422123|Seroquel|seroquel
5304495|NCT00422123|Seroquel SR|seroquel sr
5304496|NCT00422123|quetiapine fumarate|quetiapine fumarate
5304497|NCT00422110|Seletracetam|seletracetam
5304498|NCT00422110|Epilepsies|epilepsies
5304499|NCT00422110|Partial|partial
5304500|NCT00422110|Epilepsy|epilepsy
5304501|NCT00422110|Focal|focal
5304502|NCT00422084|Malaria|malaria
5304503|NCT00422084|ACT|act
5304504|NCT00422084|P falciparum|p falciparum
5304505|NCT00422071|Transcranial Magnetic Stimulation (TMS)|transcranial magnetic stimulation (tms)
5304506|NCT00422071|Dopamine|dopamine
5304507|NCT00422071|Gambling|gambling
5304508|NCT00422071|Healthy Volunteer|healthy volunteer
5304509|NCT00422071|HV|hv
5304510|NCT00422032|Myelodysplastic Syndrome|myelodysplastic syndrome
5304511|NCT00422032|Leukemia|leukemia
5304512|NCT00422032|Clofarabine|clofarabine
5304513|NCT00422032|MDS|mds
5304514|NCT00422019|Renal Cancer|renal cancer
5304515|NCT00422019|Kidney Cancer|kidney cancer
5304516|NCT00422006|bariatric surgery planned|bariatric surgery planned
5304517|NCT00421993|Acne vulgaris|acne vulgaris
5304518|NCT00421993|Adapalene|adapalene
5304519|NCT00421993|Benzoyl Peroxide|benzoyl peroxide
5304520|NCT00421967|Postoperative pain|postoperative pain
5304521|NCT00421954|psychosis NOS|psychosis nos
5304522|NCT00421954|MDD w/ psychotic features|mdd w/ psychotic features
5304523|NCT00421954|bipolar disorder w. psychotic features|bipolar disorder w. psychotic features
5304524|NCT00421941|enteral feeding|enteral feeding
5304525|NCT00421941|critical care|critical care
5304526|NCT00421941|fish oil|fish oil
5304527|NCT00421941|surgical|surgical
5304528|NCT00421928|Chronic Pain|chronic pain
5304529|NCT00421928|Osteoarthritis, Knee|osteoarthritis, knee
5304530|NCT00421928|tapentadol|tapentadol
5304531|NCT00421928|Pain Assessment|pain assessment
5304532|NCT00421902|Hot flashes, prostate cancer, acupuncture|hot flashes, prostate cancer, acupuncture
5304533|NCT00421889|Ovarian cancer|ovarian cancer
5304534|NCT00421889|Ovarian Neoplasms|ovarian neoplasms
5304535|NCT00421889|Primary peritoneal|primary peritoneal
5304536|NCT00421889|Epithelial ovarian|epithelial ovarian
5304537|NCT00421889|Fallopian tube|fallopian tube
5304538|NCT00421889|Bladder cancer|bladder cancer
5304539|NCT00421889|belinostat|belinostat
5304540|NCT00421889|PXD101|pxd101
5304541|NCT00421889|mixed mullerian cancer of ovarian origin|mixed mullerian cancer of ovarian origin
5304542|NCT00421876|cardiac rehabilitation|cardiac rehabilitation
5304543|NCT00421876|lifestyle management|lifestyle management
5304544|NCT00421876|risk factor management|risk factor management
5304545|NCT00421876|myocardial infarction|myocardial infarction
5304546|NCT00421876|randomized trials|randomized trials
5304547|NCT00421863|hypertension|hypertension
5304548|NCT00421863|systolic blood pressure|systolic blood pressure
5304549|NCT00421837|influenza, flu, genotypic analysis, sub-study|influenza, flu, genotypic analysis, sub-study
5304550|NCT00421811|cancer|cancer
5304551|NCT00421811|tumors|tumors
5304552|NCT00421811|melanoma|melanoma
5304553|NCT00421811|anticarcinogenic agents|anticarcinogenic agents
5304554|NCT00421811|antineoplastic agents|antineoplastic agents
5304555|NCT00421811|cadherins|cadherins
5304556|NCT00421811|solid tumors|solid tumors
5304557|NCT00421798|tuberculosis, paucibacillary, mycobacteria, Mexico, Colombia|tuberculosis, paucibacillary, mycobacteria, mexico, colombia
5304558|NCT00421785|N-acetylcysteine|n-acetylcysteine
5304559|NCT00421785|Peritoneal Dialysis|peritoneal dialysis
5304560|NCT00421785|ADMA|adma
5304561|NCT00421772|cerebral ventriculomegaly|cerebral ventriculomegaly
5304562|NCT00421772|prenatal diagnostic|prenatal diagnostic
5304563|NCT00421772|neuropsychological outcome|neuropsychological outcome
5304564|NCT00421759|Sensory loss|sensory loss
5304565|NCT00421759|psychomotor function|psychomotor function
5304566|NCT00421759|balance|balance
5304567|NCT00421759|gait|gait
5304568|NCT00421733|Type 2 Diabetic Nephropathy|type 2 diabetic nephropathy
5304569|NCT00421720|remifentanil|remifentanil
5304570|NCT00421720|sufentanil|sufentanil
5304571|NCT00421720|propofol|propofol
5304572|NCT00421720|analgesia|analgesia
5304573|NCT00421720|sedation|sedation
5304574|NCT00421720|mechanically ventilated|mechanically ventilated
5304575|NCT00421720|intensive care|intensive care
5304576|NCT00421720|pharmacoeconomic|pharmacoeconomic
5304577|NCT00421720|weaning|weaning
5304578|NCT00421720|delirium|delirium
5304579|NCT00421720|randomized|randomized
5304580|NCT00421720|Germany|germany
5304581|NCT00421707|Irritable Bowel Syndrome safety|irritable bowel syndrome safety
5304582|NCT00421681|Aging|aging
5304583|NCT00421681|exercise|exercise
5304584|NCT00421681|health behavior|health behavior
5304586|NCT00421668|Tanzania|tanzania
5304587|NCT00421668|Micronutrients|micronutrients
5304588|NCT00421668|Infants/children|infants/children
5304589|NCT00421668|Infectious Disease|infectious disease
5304590|NCT00421668|Growth faltering|growth faltering
5304591|NCT00421629|health insurance|health insurance
5304592|NCT00421629|hospitalization insurance|hospitalization insurance
5304593|NCT00421629|community based health insurance|community based health insurance
5304594|NCT00421629|health care access|health care access
5304595|NCT00421629|developing countries|developing countries
5304596|NCT00421629|randomized controlled trials|randomized controlled trials
5304597|NCT00421616|Calorimetry|calorimetry
5304598|NCT00421616|Overweight|overweight
5304599|NCT00421616|Weight loss|weight loss
5304600|NCT00421616|Appetite|appetite
5304601|NCT00421603|Cocaine|cocaine
5304602|NCT00421603|Adderall|adderall
5304603|NCT00421603|Topiramate|topiramate
5304604|NCT00421603|ADHD|adhd
5304605|NCT00421590|Randomized, partially blind, placebo controlled, crossover, drug interaction with concomitant antacid, pharmacokinetics, pharmacodynamics, SMC021|randomized, partially blind, placebo controlled, crossover, drug interaction with concomitant antacid, pharmacokinetics, pharmacodynamics, smc021
5304606|NCT00421577|Caries Diagnosis|caries diagnosis
5304607|NCT00421577|Replica technique|replica technique
5304608|NCT00421564|Menopausal|menopausal
5304609|NCT00421564|Traditional Chinese Medicine|traditional chinese medicine
5304610|NCT00421551|HIV Infections|hiv infections
5304611|NCT00421551|darunavir|darunavir
5304612|NCT00421551|Ritonavir|ritonavir
5304613|NCT00421551|HIV Protease Inhibitors|hiv protease inhibitors
5304614|NCT00421551|treatment experienced|treatment experienced
5304615|NCT00421538|Deep vein Thrombosis|deep vein thrombosis
5304616|NCT00421538|Calf vein thrombosis|calf vein thrombosis
5304617|NCT00421538|Low-molecular weight heparin|low-molecular weight heparin
5304618|NCT00421538|Placebo|placebo
5304619|NCT00421538|Elastic contention|elastic contention
5304620|NCT00421538|Compression Ultrasonography|compression ultrasonography
5304621|NCT00421525|multiple myeloma|multiple myeloma
5304622|NCT00421525|Myeloma, Plasma-Cell|myeloma, plasma-cell
5304623|NCT00421525|PLASMACYTOMA|plasmacytoma
5304624|NCT00421512|Renal cell carcinoma|renal cell carcinoma
5304625|NCT00421512|Metastatic|metastatic
5304626|NCT00421512|Kidney Cancer|kidney cancer
5304627|NCT00421512|Bevacizumab|bevacizumab
5304628|NCT00421512|Sunitinib|sunitinib
5304629|NCT00421486|Oral human papillomavirus infection|oral human papillomavirus infection
5304630|NCT00421486|HIV-infection|hiv-infection
5304631|NCT00421486|High-risk HPV viral load|high-risk hpv viral load
5304632|NCT00421486|Oral human papillomavirus infection in HIV-positive men|oral human papillomavirus infection in hiv-positive men
5304633|NCT00421486|Treatment Experienced|treatment experienced
5304634|NCT00421486|Treatment Naive|treatment naive
5304635|NCT00421473|HIV|hiv
5304636|NCT00421473|Malaria prophylaxis|malaria prophylaxis
5304637|NCT00421473|Treatment Experienced|treatment experienced
5304638|NCT00421460|Nebido in hypogonadism with erectile dysfunction|nebido in hypogonadism with erectile dysfunction
5304639|NCT00421447|Breast Cancer|breast cancer
5304640|NCT00421447|pQCT|pqct
5304641|NCT00421447|Anastrozole|anastrozole
5304642|NCT00421447|bone geometry|bone geometry
5304643|NCT00421434|Hepatitis C|hepatitis c
5304644|NCT00421421|Acute Urinary Retention|acute urinary retention
5304645|NCT00421421|Benign Prostatic Hyperplasia|benign prostatic hyperplasia
5304646|NCT00421421|Trial Without Catheter|trial without catheter
5304647|NCT00421408|Dietary protein|dietary protein
5304648|NCT00421408|Calcium|calcium
5304649|NCT00421408|Parathyroid hormone|parathyroid hormone
5304650|NCT00421408|Bone markers|bone markers
5304651|NCT00421408|Bone mineral density|bone mineral density
5304652|NCT00421408|IGF-1|igf-1
5304653|NCT00421408|Urine Calcium|urine calcium
5304654|NCT00421395|NHL|nhl
5304655|NCT00421395|B-cell NHL|b-cell nhl
5304656|NCT00421395|Non-Hodgkins lymphoma|non-hodgkins lymphoma
5304657|NCT00421369|Major depressive disorder|major depressive disorder
5304658|NCT00421369|Antidepressants|antidepressants
5304659|NCT00421369|Triiodothyronine (T3)|triiodothyronine (t3)
5304660|NCT00421369|Thyroid Function|thyroid function
5304661|NCT00421369|Augmentation|augmentation
5304662|NCT00421369|Thyroid pathway genes|thyroid pathway genes
5304663|NCT00421356|amputation, transfemoral, lower extremity, prosthetic knee|amputation, transfemoral, lower extremity, prosthetic knee
5304664|NCT00421343|disease/disorder proneness/risk|disease/disorder proneness/risk
5304665|NCT00421343|osteoporotic fractures|osteoporotic fractures
5304666|NCT00421343|accidental falls|accidental falls
5304667|NCT00421343|aging|aging
5304668|NCT00421330|Abdominal aortic aneurysm|abdominal aortic aneurysm
5304669|NCT00421330|AAA|aaa
5304670|NCT00421330|randomised controlled trial|randomised controlled trial
5304671|NCT00421330|Endovascular repair|endovascular repair
5304672|NCT00421330|conventional open repair|conventional open repair
5304673|NCT00421317|Ocular, Metastatic melanoma|ocular, metastatic melanoma
5304674|NCT00421265|prostate cancer|prostate cancer
5304675|NCT00421265|active surveillance|active surveillance
5304676|NCT00421265|indolent features|indolent features
5304677|NCT00421252|clopidogrel|clopidogrel
5304678|NCT00421252|hemorrhagic complication|hemorrhagic complication
5304679|NCT00421252|vascular complication|vascular complication
5304680|NCT00421252|antiplatelet agent|antiplatelet agent
5304681|NCT00421252|stenting|stenting
5304682|NCT00421252|percutaneous coronary intervention|percutaneous coronary intervention
5304683|NCT00421252|risk|risk
5304684|NCT00421252|ischemia|ischemia
5304685|NCT00421252|troponin|troponin
5304686|NCT00421252|sheath size|sheath size
5304687|NCT00421239|hypertensive urgency|hypertensive urgency
5304688|NCT00421239|arterial hypertension|arterial hypertension
5304689|NCT00421226|Safety, tolerability, pharmacokinetics, pharmacodynamics, ACZ885, Japanese,|safety, tolerability, pharmacokinetics, pharmacodynamics, acz885, japanese,
5304690|NCT00421213|APL|apl
5304691|NCT00421213|Lymphoma|lymphoma
5304692|NCT00421213|T-cell Lymphoma|t-cell lymphoma
5304693|NCT00421213|Peripheral T-cell Lymphoma|peripheral t-cell lymphoma
5304694|NCT00421200|Hip arthroplasty|hip arthroplasty
5304695|NCT00421200|Anesthesia, spinal|anesthesia, spinal
5304696|NCT00421200|Hypotension|hypotension
5304697|NCT00421200|Ischemia|ischemia
5304698|NCT00421200|Blood substitutes|blood substitutes
5304699|NCT00421200|Plasma expanders|plasma expanders
5304700|NCT00421187|Antibiotic resistant neutropenic fever|antibiotic resistant neutropenic fever
5304701|NCT00421187|ARNF|arnf
5304702|NCT00421187|Ambisome|ambisome
5304703|NCT00421187|Liposomal amphotericin B|liposomal amphotericin b
5304704|NCT00421174|Etanercept|etanercept
5304705|NCT00421174|IPS|ips
5304706|NCT00421161|olive oil|olive oil
5304707|NCT00421161|stasis dermatitis|stasis dermatitis
5304708|NCT00421161|Patients with stasis dermatitis for at least six months.|patients with stasis dermatitis for at least six months.
5304709|NCT00421122|Chinese patients|chinese patients
5304710|NCT00421122|COPD|copd
5304711|NCT00421109|Urticaria|urticaria
5304712|NCT00421109|Hives|hives
5304713|NCT00421109|Wheals|wheals
5304714|NCT00421109|Flare|flare
5304715|NCT00421109|Chronic|chronic
5304716|NCT00421109|Idiopathic|idiopathic
5304717|NCT00421109|Erythema|erythema
5304718|NCT00421109|Skin diseases, vascular|skin diseases, vascular
5304719|NCT00421109|Hypersensitivity, Immediate|hypersensitivity, immediate
5304720|NCT00421109|Allergic|allergic
5304721|NCT00421109|Cutaneous|cutaneous
5304722|NCT00421096|uterine cervical cancer|uterine cervical cancer
5304723|NCT00421083|Erectile dysfunction as a result of traumatic spinal cord injury|erectile dysfunction as a result of traumatic spinal cord injury
5304724|NCT00421070|Aggression|aggression
5304725|NCT00421070|Massage|massage
5304726|NCT00421070|Stress|stress
5304727|NCT00421070|Psychiatric inpatient|psychiatric inpatient
5304728|NCT00421057|Breast Cancer|breast cancer
5304729|NCT00421057|Cancer-Related Fatigue|cancer-related fatigue
5304730|NCT00421057|Fatigue|fatigue
5304731|NCT00421057|Exercise|exercise
5304732|NCT00421057|Strength Training|strength training
5304733|NCT00421057|Endurance Exercise|endurance exercise
5304734|NCT00421057|Questionnaire|questionnaire
5304735|NCT00421057|Survey|survey
5304736|NCT00421044|EPO|epo
5304737|NCT00421044|Patupilone|patupilone
5304738|NCT00421044|Solid Tumors|solid tumors
5304739|NCT00421018|Asthma|asthma
5304740|NCT00421018|Allergy|allergy
5304741|NCT00421018|Cytokines|cytokines
5304742|NCT00421018|Glucocorticoids|glucocorticoids
5304743|NCT00421018|Inflammation|inflammation
5304744|NCT00421018|Nitric Oxide (NO)|nitric oxide (no)
5304745|NCT00421018|Quality of Life|quality of life
5304746|NCT00421018|Self-Rated Health|self-rated health
5304747|NCT00421018|Stress|stress
5304748|NCT00420992|hip|hip
5304749|NCT00420992|knee|knee
5304750|NCT00420992|pain|pain
5304751|NCT00420992|osteoarthritis|osteoarthritis
5304752|NCT00420992|OA|oa
5304753|NCT00420992|Kadian|kadian
5304754|NCT00420992|Alpharma|alpharma
5304755|NCT00420992|naltrexone|naltrexone
5304756|NCT00420992|Opioid|opioid
5304757|NCT00420992|morphine|morphine
5304758|NCT00420992|Embeda|embeda
5304759|NCT00420992|ALO-01|alo-01
5304760|NCT00420966|lower respiratory tract infection|lower respiratory tract infection
5304761|NCT00420966|respiratory syncytial virus infections|respiratory syncytial virus infections
5304762|NCT00420966|palivizumab|palivizumab
5304763|NCT00420966|outcomes|outcomes
5304764|NCT00420966|utilization|utilization
5304765|NCT00420966|compliance|compliance
5304766|NCT00420940|vibration|vibration
5304767|NCT00420940|mechanical loading|mechanical loading
5304768|NCT00420940|bone mineral density|bone mineral density
5304769|NCT00420940|women's health|women's health
5304770|NCT00420940|osteoporosis|osteoporosis
5304771|NCT00420927|Early Rheumatoid Arthritis|early rheumatoid arthritis
5304772|NCT00420927|Tumor Necrosis Factor Optimization|tumor necrosis factor optimization
5304773|NCT00420914|Thrombocytopenia|thrombocytopenia
5304774|NCT00420914|Platelets|platelets
5304775|NCT00420914|Dose|dose
5304776|NCT00420914|Bleeding|bleeding
5304777|NCT00420901|function|function
5304778|NCT00420901|inhibition|inhibition
5304779|NCT00420875|plantar fasciitis|plantar fasciitis
5304780|NCT00420875|plantar fasciosis|plantar fasciosis
5304781|NCT00420875|Achilles tendinosis|achilles tendinosis
5304782|NCT00420875|Achilles tendinitis|achilles tendinitis
5304783|NCT00420875|heel pain|heel pain
5304784|NCT00420875|fasciosis|fasciosis
5304785|NCT00420875|fasciitis|fasciitis
5304786|NCT00420875|tendinosis|tendinosis
5304787|NCT00420875|tendinitis|tendinitis
5304788|NCT00420875|conservative treatment|conservative treatment
5304789|NCT00420862|Lung neoplasms|lung neoplasms
5304790|NCT00420862|Early diagnosis|early diagnosis
5304791|NCT00420862|Screening|screening
5304792|NCT00420862|Spiral Computed Tomography|spiral computed tomography
5304793|NCT00420862|Randomized Controlled Trial|randomized controlled trial
5304794|NCT00420836|Cystic fibrosis, tobramycin, PARI eFlow, PARI LC Plus, nebulizer, pharmacokinetic|cystic fibrosis, tobramycin, pari eflow, pari lc plus, nebulizer, pharmacokinetic
5304795|NCT00420823|First Episode Psychosis|first episode psychosis
5304796|NCT00420797|Faecal seepage|faecal seepage
5304797|NCT00420797|ileal pouch anal anastomosis (IPAA)|ileal pouch anal anastomosis (ipaa)
5304798|NCT00420797|quality of life|quality of life
5304799|NCT00420797|faecal incontinence|faecal incontinence
5304800|NCT00420797|ileo-anal pouch construction|ileo-anal pouch construction
5304801|NCT00420797|phenylephrine hydrochloride gel|phenylephrine hydrochloride gel
5304802|NCT00420797|IPAA-related faecal incontinence|ipaa-related faecal incontinence
5304803|NCT00420797|placebo|placebo
5304804|NCT00420784|Genotype 1|genotype 1
5304805|NCT00420771|Benzodiazepine|benzodiazepine
5304806|NCT00420771|Gabapentin|gabapentin
5304807|NCT00420771|Methadone|methadone
5304808|NCT00420758|Infant|infant
5304809|NCT00420758|Malnutrition|malnutrition
5304810|NCT00420758|Sub-Saharan Africa|sub-saharan africa
5304811|NCT00420758|Treatment|treatment
5304812|NCT00420758|Growth|growth
5304813|NCT00420758|Haemoglobin|haemoglobin
5304814|NCT00420758|Fortified spread|fortified spread
5304815|NCT00420758|Food supplement|food supplement
5304816|NCT00420719|ALS|als
5304817|NCT00420719|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
5304818|NCT00420719|Lou Gehrig's disease|lou gehrig's disease
5304819|NCT00420719|Diaphragm for Ventilatory Assist|diaphragm for ventilatory assist
5304820|NCT00420719|Diaphragm Pacing|diaphragm pacing
5304821|NCT00420667|unfractionated heparin|unfractionated heparin
5304822|NCT00420667|enoxaparin|enoxaparin
5304823|NCT00420667|low molecular weight heparin|low molecular weight heparin
5304824|NCT00420667|bypass surgery|bypass surgery
5304825|NCT00420667|bleeding|bleeding
5304826|NCT00420654|Turner syndrome|turner syndrome
5304827|NCT00420654|growth hormone treatment|growth hormone treatment
5304828|NCT00420654|positron emission tomography|positron emission tomography
5304829|NCT00420654|heart|heart
5304830|NCT00420641|MDD|mdd
5304831|NCT00420641|flexible-dose|flexible-dose
5304832|NCT00420641|Major Depressive Disorder|major depressive disorder
5304833|NCT00420641|paroxetine|paroxetine
5304834|NCT00420641|GSK372475|gsk372475
5304835|NCT00420615|Cancer|cancer
5304836|NCT00420615|EPO906|epo906
5304837|NCT00420615|Patupilone|patupilone
5304838|NCT00420589|Weight loss|weight loss
5304839|NCT00420589|Weight regain|weight regain
5304840|NCT00420589|Weight maintenance|weight maintenance
5304841|NCT00420576|Post-menopausal|post-menopausal
5304842|NCT00420576|Traditional Chinese Medicine|traditional chinese medicine
5304843|NCT00420576|Randomized|randomized
5304844|NCT00420563|Cancer, palliative treatment|cancer, palliative treatment
5304845|NCT00420550|Interstitial Cystitis|interstitial cystitis
5304846|NCT00420550|Pelvic pain|pelvic pain
5304847|NCT00420550|Guided Imagery|guided imagery
5304848|NCT00420537|Kidney|kidney
5304849|NCT00420537|Heart Transplantation|heart transplantation
5304850|NCT00420537|Creatinine|creatinine
5304851|NCT00420537|Glomerular Filtration Rate|glomerular filtration rate
5304852|NCT00420524|EPO|epo
5304853|NCT00420524|Patupilone|patupilone
5304854|NCT00420524|Solid Tumors|solid tumors
5304855|NCT00420511|Type 2 diabetes|type 2 diabetes
5304856|NCT00420511|beta-cell function|beta-cell function
5304857|NCT00420511|sitagliptin|sitagliptin
5304858|NCT00420511|intensive insulin therapy|intensive insulin therapy
5304859|NCT00420498|Schizophrenia|schizophrenia
5304860|NCT00420498|Prefrontal Cortical Function|prefrontal cortical function
5304861|NCT00420498|Smoking|smoking
5304862|NCT00420498|Cognition|cognition
5304863|NCT00420498|Positive and Negative Symptoms|positive and negative symptoms
5304864|NCT00420498|Tobacco|tobacco
5304865|NCT00420498|Cigarette Smoking|cigarette smoking
5304866|NCT00420498|Dopamine|dopamine
5304867|NCT00420485|Maximum Tolerated Dose|maximum tolerated dose
5304868|NCT00420485|Solid Tumors|solid tumors
5304869|NCT00420485|Dose Limiting Toxicity|dose limiting toxicity
5304870|NCT00420485|Topoisomerase-1 Inhibitor|topoisomerase-1 inhibitor
5304871|NCT00420433|Breast Cancer|breast cancer
5304872|NCT00420433|Bone Metastases|bone metastases
5304873|NCT00420433|Radiography|radiography
5304874|NCT00420433|X-Ray|x-ray
5304875|NCT00420433|Computed Tomography|computed tomography
5304876|NCT00420433|CT Scan|ct scan
5304877|NCT00420433|Skeletal Scintigraphy|skeletal scintigraphy
5304878|NCT00420394|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
5304879|NCT00420394|Adjuvant chemoradiotherapy|adjuvant chemoradiotherapy
5304880|NCT00420394|Adenocarcinoma of stomach and gastroesophageal junction|adenocarcinoma of stomach and gastroesophageal junction
5304881|NCT00420381|Recurrent Cancer|recurrent cancer
5304882|NCT00420368|Infant|infant
5304883|NCT00420368|Malnutrition|malnutrition
5304884|NCT00420368|Sub-Saharan Africa|sub-saharan africa
5304885|NCT00420368|Treatment|treatment
5304886|NCT00420368|Growth|growth
5304887|NCT00420368|Haemoglobin|haemoglobin
5304888|NCT00420368|Fortified spread|fortified spread
5304889|NCT00420368|Food supplement|food supplement
5304890|NCT00420355|antiretroviral therapy|antiretroviral therapy
5304891|NCT00420355|protease inhibitors|protease inhibitors
5304892|NCT00420355|drug interactions|drug interactions
5304893|NCT00420355|HIV infection|hiv infection
5304894|NCT00420355|acquired immunodeficiency syndrome|acquired immunodeficiency syndrome
5304895|NCT00420355|Treatment Experienced|treatment experienced
5304896|NCT00420342|Pre-Hypertension in Postmenopausal Women|pre-hypertension in postmenopausal women
5304897|NCT00420316|Intussusception|intussusception
5304898|NCT00420316|Gastroenteritis|gastroenteritis
5304899|NCT00420316|Finland|finland
5304900|NCT00420303|Refractory Heel Enthesitis in Spondylarthropathy|refractory heel enthesitis in spondylarthropathy
5304901|NCT00420303|Spondylarthropathy|spondylarthropathy
5304902|NCT00420303|Refractory Heel Enthesitis|refractory heel enthesitis
5304903|NCT00420290|inflammation|inflammation
5304904|NCT00420290|end stage renal disease|end stage renal disease
5304905|NCT00420277|Hip arthroplasty|hip arthroplasty
5304906|NCT00420277|Anesthesia, spinal|anesthesia, spinal
5304907|NCT00420277|Hypotension|hypotension
5304908|NCT00420277|Ischemia|ischemia
5304909|NCT00420277|Blood substitutes|blood substitutes
5304910|NCT00420277|Plasma expanders|plasma expanders
5304911|NCT00420238|Axial Ankylosing Spondylitis|axial ankylosing spondylitis
5304912|NCT00420238|Adult|adult
5304913|NCT00420225|Cystocele|cystocele
5304914|NCT00420225|surgery|surgery
5304915|NCT00420225|mesh|mesh
5304916|NCT00420225|genital prolapse|genital prolapse
5304917|NCT00420212|relapsing|relapsing
5304918|NCT00420212|oral|oral
5304919|NCT00420212|remitting|remitting
5304920|NCT00420212|multiple sclerosis|multiple sclerosis
5304921|NCT00420173|cutaneous lupus erythematosus|cutaneous lupus erythematosus
5304922|NCT00420173|standardized evaluation|standardized evaluation
5304923|NCT00420173|core set questionnaire|core set questionnaire
5304924|NCT00420173|epidemiological data|epidemiological data
5304925|NCT00420173|laboratory features|laboratory features
5304926|NCT00420160|Smoking cessation|smoking cessation
5304927|NCT00420160|Exercise|exercise
5304928|NCT00420160|Nicotine Patch|nicotine patch
5304929|NCT00420160|Disease Prevention|disease prevention
5304930|NCT00420147|knee osteoarthritis|knee osteoarthritis
5304931|NCT00420147|orthosis|orthosis
5304932|NCT00420147|wedge|wedge
5304933|NCT00420147|gait|gait
5304934|NCT00420134|mesenchymal stem cell|mesenchymal stem cell
5304935|NCT00420134|end stage liver disease|end stage liver disease
5304936|NCT00420134|Cirrhosis|cirrhosis
5304937|NCT00420134|stem cell therapy|stem cell therapy
5304938|NCT00420121|standardized evaluation|standardized evaluation
5304939|NCT00420121|core set questionnaire|core set questionnaire
5304940|NCT00420121|epidemiological data|epidemiological data
5304941|NCT00420121|laboratory analysis|laboratory analysis
5304942|NCT00420108|Heart Failure, Congestive|heart failure, congestive
5304943|NCT00420108|Cardiac Pacemaker, Artificial|cardiac pacemaker, artificial
5304944|NCT00420108|Ventricular Pressure|ventricular pressure
5304945|NCT00420095|diabetes|diabetes
5304946|NCT00420095|type 1|type 1
5304947|NCT00420095|type 2|type 2
5304948|NCT00420082|Rhinitis|rhinitis
5304949|NCT00420082|Seasonal|seasonal
5304950|NCT00420082|Allergic|allergic
5304951|NCT00420082|Pollen allergy|pollen allergy
5304952|NCT00420082|Environmental Exposure Chamber|environmental exposure chamber
5304953|NCT00420082|Challenge Chamber|challenge chamber
5304954|NCT00420043|Food effect|food effect
5304955|NCT00420043|bioavailability|bioavailability
5304956|NCT00420043|pharmacokinetic|pharmacokinetic
5304957|NCT00420043|STI571|sti571
5304958|NCT00420043|modified release formulation of STI571|modified release formulation of sti571
5304959|NCT00420043|CML|cml
5304960|NCT00420043|Chronic Myeloid Leukemia|chronic myeloid leukemia
5304961|NCT00420043|Philadelphia Chromosome|philadelphia chromosome
5304962|NCT00420043|imatinib|imatinib
5304963|NCT00420030|upfront abciximab|upfront abciximab
5304964|NCT00420030|PCI|pci
5304965|NCT00420030|cardiogenic shock|cardiogenic shock
5304966|NCT00420017|Amiodarone|amiodarone
5304967|NCT00420017|Atrial fibrillation|atrial fibrillation
5304968|NCT00420017|Surgical procedures, thoracic|surgical procedures, thoracic
5304969|NCT00419991|Tigecycline|tigecycline
5304970|NCT00419991|Staphylococcal Infections|staphylococcal infections
5304971|NCT00419991|Catheter|catheter
5304972|NCT00419952|Moderate Asthma|moderate asthma
5304973|NCT00419952|Severe Asthma|severe asthma
5304974|NCT00419939|Severe traumatic brain injury|severe traumatic brain injury
5304975|NCT00419939|Intensive neurorehabilitation|intensive neurorehabilitation
5304976|NCT00419939|"Patient Participation[Professional-Patient Relations"|"patient participation[professional-patient relations"
5304977|NCT00419939|Re-learning|re-learning
5304978|NCT00419939|Daily life activities|daily life activities
5304979|NCT00419939|Rehabilitation|rehabilitation
5304980|NCT00419926|Renal, Kidney, Intensified, Enteric-coated mycophenolate sodium, Transplant|renal, kidney, intensified, enteric-coated mycophenolate sodium, transplant
5304981|NCT00419913|Ovulation Induction|ovulation induction
5304982|NCT00419913|In vitro Fertilization|in vitro fertilization
5304983|NCT00419913|Pregnancy|pregnancy
5304984|NCT00419900|breast cancer|breast cancer
5304985|NCT00419900|diagnosis|diagnosis
5304986|NCT00419900|x-ray diffraction|x-ray diffraction
5304987|NCT00419900|synchrotron|synchrotron
5304988|NCT00419900|hair|hair
5304989|NCT00419887|Safety, tolerability, pharmacokinetics, pharmacodynamics, LAF237, vildagliptin, Chinese, healthy volunteers|safety, tolerability, pharmacokinetics, pharmacodynamics, laf237, vildagliptin, chinese, healthy volunteers
5304990|NCT00419874|Blood-brain barrier|blood-brain barrier
5304991|NCT00419874|Post traumatic epilepsy|post traumatic epilepsy
5304992|NCT00419874|Seizures|seizures
5304993|NCT00419861|Influenza, surveillance, flu, parent protocol|influenza, surveillance, flu, parent protocol
5304994|NCT00419848|Acne|acne
5304995|NCT00419848|Azithromycin|azithromycin
5304996|NCT00419848|Doxycycline|doxycycline
5304997|NCT00419835|diabetic nephropathy|diabetic nephropathy
5304998|NCT00419835|proteinuria|proteinuria
5304999|NCT00419835|CKD progression|ckd progression
5305000|NCT00419835|dialysis|dialysis
5305001|NCT00419822|Acupuncture|acupuncture
5305002|NCT00419822|Range of Motion|range of motion
5305003|NCT00419822|Quality of Life|quality of life
5305004|NCT00419809|methotrexate,|methotrexate,
5305005|NCT00419809|SB-681323,|sb-681323,
5305006|NCT00419809|p38 MAP Kinase Inhibitor,|p38 map kinase inhibitor,
5305007|NCT00419809|liver function|liver function
5305008|NCT00419809|Rheumatoid Arthritis,|rheumatoid arthritis,
5305009|NCT00419796|Osteoarthritis, controlled hypertension, lumiracoxib, ibuprofen, high blood pressure|osteoarthritis, controlled hypertension, lumiracoxib, ibuprofen, high blood pressure
5305010|NCT00419783|Allergic rhinitis|allergic rhinitis
5305011|NCT00419783|Urticaria|urticaria
5305012|NCT00419770|zygomycosis|zygomycosis
5305013|NCT00419770|Rhizopus|rhizopus
5305014|NCT00419770|iron|iron
5305015|NCT00419770|iron-chelation|iron-chelation
5305016|NCT00419770|adjunctive therapy|adjunctive therapy
5305017|NCT00419757|Moderate asthma|moderate asthma
5305018|NCT00419757|Severe asthma|severe asthma
5305019|NCT00419744|COPD|copd
5305020|NCT00419731|nicotine|nicotine
5305021|NCT00419731|smoking|smoking
5305022|NCT00419731|addiction|addiction
5305023|NCT00419705|acute stroke|acute stroke
5305024|NCT00419705|infrared laser therapy|infrared laser therapy
5305025|NCT00419705|clinical trial|clinical trial
5305026|NCT00419705|safety|safety
5305027|NCT00419705|effectiveness|effectiveness
5305028|NCT00419692|pharmacokinetic,|pharmacokinetic,
5305029|NCT00419692|RLS|rls
5305030|NCT00419692|formulation,|formulation,
5305031|NCT00419692|food effect,|food effect,
5305032|NCT00419692|controlled release for RLS,|controlled release for rls,
5305033|NCT00419692|SK&F101468,|sk&f101468,
5305034|NCT00419679|breast cancer|breast cancer
5305035|NCT00419679|hair|hair
5305036|NCT00419679|fibre|fibre
5305037|NCT00419679|synchrotron|synchrotron
5305038|NCT00419679|x-ray diffraction|x-ray diffraction
5305039|NCT00419666|Calcitriol|calcitriol
5305040|NCT00419666|Psoriasis|psoriasis
5305041|NCT00419666|PK|pk
5305042|NCT00419666|Adolescents|adolescents
5305043|NCT00419653|schizophrenia fMRI drug therapy amisulpride|schizophrenia fmri drug therapy amisulpride
5305044|NCT00419640|Sinus node disease|sinus node disease
5305045|NCT00419640|AV node disease|av node disease
5305046|NCT00419627|proteomics of solid tumors|proteomics of solid tumors
5305047|NCT00419601|ventilated newborns (≥ 36 SSW)and infants (≤60 days)|ventilated newborns (≥ 36 ssw)and infants (≤60 days)
5305048|NCT00419601|of any medical condition|of any medical condition
5305049|NCT00419588|infant, premature|infant, premature
5305050|NCT00419588|Bronchopulmonary dysplasia|bronchopulmonary dysplasia
5305051|NCT00419588|asthma|asthma
5305052|NCT00419575|renal|renal
5305053|NCT00419575|transplantation|transplantation
5305054|NCT00419575|immunosuppression|immunosuppression
5305055|NCT00419575|monitoring|monitoring
5305056|NCT00419562|oral insulin|oral insulin
5305057|NCT00419562|autoantigen|autoantigen
5305058|NCT00419562|self tolerance|self tolerance
5305059|NCT00419562|oral tolerance|oral tolerance
5305060|NCT00419562|DPT-1|dpt-1
5305061|NCT00419562|prevention|prevention
5305062|NCT00419562|"at risk for developing type 1 diabetes"|"at risk for developing type 1 diabetes"
5305063|NCT00419562|juvenile diabetes|juvenile diabetes
5305064|NCT00419562|T1D|t1d
5305065|NCT00419562|diabetes mellitus|diabetes mellitus
5305066|NCT00419562|Type 1 diabetes TrialNet|type 1 diabetes trialnet
5305067|NCT00419562|TrialNet|trialnet
5305068|NCT00419549|ERCP|ercp
5305069|NCT00419549|Pancreatitis|pancreatitis
5305070|NCT00419549|Nitroglycerine|nitroglycerine
5305071|NCT00419549|Valdecoxib|valdecoxib
5305072|NCT00419536|LBH|lbh
5305073|NCT00419536|LBH589|lbh589
5305074|NCT00419536|Prostate Cancer|prostate cancer
5305075|NCT00419536|HRPC|hrpc
5305076|NCT00419510|Genetic counseling|genetic counseling
5305077|NCT00419510|BRCA1 and BRCA2|brca1 and brca2
5305078|NCT00419510|African American|african american
5305079|NCT00419497|Paleolithic diet|paleolithic diet
5305080|NCT00419497|Mediterranean-style diet|mediterranean-style diet
5305081|NCT00419497|Glucose tolerance|glucose tolerance
5305082|NCT00419497|Diabetes type 2|diabetes type 2
5305083|NCT00419497|Weight loss|weight loss
5305084|NCT00419497|Waist|waist
5305085|NCT00419471|Depression|depression
5305086|NCT00419471|Myocardial infarction|myocardial infarction
5305087|NCT00419471|Angina, unstable|angina, unstable
5305088|NCT00419458|ventilator weaning|ventilator weaning
5305089|NCT00419458|weaning|weaning
5305090|NCT00419458|respiratory failure|respiratory failure
5305091|NCT00419458|inspiratory muscle strength training|inspiratory muscle strength training
5305092|NCT00419445|Attention Deficit Hyperactivity Disorder in adults|attention deficit hyperactivity disorder in adults
5305093|NCT00419432|Pediatrics|pediatrics
5305094|NCT00419432|Cerebral Palsy|cerebral palsy
5305095|NCT00419432|Gait Analysis|gait analysis
5305096|NCT00419432|Orthopedic Surgery|orthopedic surgery
5305097|NCT00419419|Raynaud's|raynaud's
5305098|NCT00419406|UVA1|uva1
5305099|NCT00419406|N-B UVB|n-b uvb
5305100|NCT00419406|phototherapy|phototherapy
5305101|NCT00419406|atopic dermatitis|atopic dermatitis
5305102|NCT00419406|SCORAD index|scorad index
5305103|NCT00419393|Keppra XR|keppra xr
5305104|NCT00419393|Levetiracetam XR|levetiracetam xr
5305105|NCT00419393|long term|long term
5305106|NCT00419393|partial seizures|partial seizures
5305107|NCT00419380|clogged ear tubes|clogged ear tubes
5305108|NCT00419354|Pacemaker|pacemaker
5305109|NCT00419354|Tricuspid regurgitation|tricuspid regurgitation
5305110|NCT00419341|Immune globulin subcutaneous|immune globulin subcutaneous
5305111|NCT00419341|SCIG|scig
5305112|NCT00419341|Primary immunodeficiency|primary immunodeficiency
5305113|NCT00419341|PID|pid
5305114|NCT00419328|solid tumors NGR-hTNF|solid tumors ngr-htnf
5305115|NCT00419315|alcoholism|alcoholism
5305116|NCT00419315|primary care|primary care
5305117|NCT00419315|treatment|treatment
5305118|NCT00419289|COPD, rehabilitation, quality of life|copd, rehabilitation, quality of life
5305119|NCT00419276|Total knee arthroplasty, postoperative analgesia|total knee arthroplasty, postoperative analgesia
5305120|NCT00419276|Primary, unilateral, total knee arthroplasty|primary, unilateral, total knee arthroplasty
5305121|NCT00419263|influenza|influenza
5305122|NCT00419263|flu|flu
5305123|NCT00419250|relapsed|relapsed
5305124|NCT00419250|refractory|refractory
5305125|NCT00419250|fludarabine|fludarabine
5305126|NCT00419250|Revlimid|revlimid
5305127|NCT00419250|lenalidomide|lenalidomide
5305128|NCT00419250|CLL|cll
5305129|NCT00419250|B-cell CLL|b-cell cll
5305130|NCT00419250|CC-5013|cc-5013
5305131|NCT00419250|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
5305132|NCT00419237|hepatic impairment pharmacokinetics|hepatic impairment pharmacokinetics
5305133|NCT00419224|Peripheral blood stem cell transplantation|peripheral blood stem cell transplantation
5305134|NCT00419224|Non-myeloabalative|non-myeloabalative
5305135|NCT00419224|Influenza vaccination|influenza vaccination
5305136|NCT00419224|Humoral immune response|humoral immune response
5305137|NCT00419224|Immunogenicity|immunogenicity
5305138|NCT00419211|Pregnancy, Exercise, Depression|pregnancy, exercise, depression
5305139|NCT00419198|Ischemia|ischemia
5305140|NCT00419198|Reperfusion|reperfusion
5305141|NCT00419198|Myocardial infarction|myocardial infarction
5305142|NCT00419198|Postconditioning|postconditioning
5305143|NCT00419185|macular hole surgery|macular hole surgery
5305144|NCT00419185|indocyanine green|indocyanine green
5305145|NCT00419185|trypan blue|trypan blue
5305146|NCT00419185|internal limiting membrane|internal limiting membrane
5305147|NCT00419172|Pharmacokinetics|pharmacokinetics
5305148|NCT00419172|Deferasirox|deferasirox
5305149|NCT00419172|Exjade|exjade
5305150|NCT00419172|ICL670|icl670
5305151|NCT00419172|Rifampicin|rifampicin
5305152|NCT00419172|Healthy, Volunteers|healthy, volunteers
5305153|NCT00419159|Colorectal cancer|colorectal cancer
5305154|NCT00419159|metastatic colorectal adenocarcinoma|metastatic colorectal adenocarcinoma
5305155|NCT00419159|anti-EGFR antibody|anti-egfr antibody
5305156|NCT00419146|Schizophrenia|schizophrenia
5305157|NCT00419146|Schizophreniform disorders|schizophreniform disorders
5305158|NCT00419146|Schizoaffective disorder|schizoaffective disorder
5305159|NCT00419146|Psychotic disorders|psychotic disorders
5305160|NCT00419146|Randomized Controlled Trials|randomized controlled trials
5305161|NCT00419146|Longitudinal Studies|longitudinal studies
5305162|NCT00419146|Fatty Acids, Omega-3|fatty acids, omega-3
5305163|NCT00419146|Eicosapentaenoic Acid|eicosapentaenoic acid
5305164|NCT00419146|Vitamins|vitamins
5305165|NCT00419146|Antioxidants|antioxidants
5305166|NCT00419146|Ascorbic Acid|ascorbic acid
5305167|NCT00419146|Alpha-Tocopherol|alpha-tocopherol
5305168|NCT00419146|Placebos|placebos
5305169|NCT00419146|Antipsychotic Agents|antipsychotic agents
5305170|NCT00419146|Oxidative Stress|oxidative stress
5305171|NCT00419146|Fatty Acids, Unsaturated|fatty acids, unsaturated
5305172|NCT00419146|Phospholipases|phospholipases
5305173|NCT00419146|Niacin|niacin
5305174|NCT00419146|Adverse effects|adverse effects
5305175|NCT00419146|Delusions|delusions
5305176|NCT00419146|Hallucinations|hallucinations
5305177|NCT00419146|Neuropsychological Tests|neuropsychological tests
5305178|NCT00419146|Attention|attention
5305179|NCT00419146|Memory|memory
5305180|NCT00419146|Hypertriglyceridemia|hypertriglyceridemia
5305181|NCT00419146|Models, Statistical|models, statistical
5305182|NCT00419133|Cholera|cholera
5305183|NCT00419133|Vaccine|vaccine
5305184|NCT00419133|Kolkata|kolkata
5305185|NCT00419133|West Bengal|west bengal
5305186|NCT00419133|India|india
5305187|NCT00419133|Immunogenicity|immunogenicity
5305188|NCT00419133|Safety|safety
5305189|NCT00419094|Keppra XR|keppra xr
5305190|NCT00419094|conversion to monotherapy|conversion to monotherapy
5305191|NCT00419094|partial seizures|partial seizures
5305192|NCT00419081|leukemia|leukemia
5305193|NCT00419081|lymphoma|lymphoma
5305194|NCT00419055|percutaneous coronary intervention|percutaneous coronary intervention
5305195|NCT00419042|cancer|cancer
5305196|NCT00419042|Lung cancer|lung cancer
5305197|NCT00419042|None small-cell lung cancer|none small-cell lung cancer
5305198|NCT00419029|combat|combat
5305199|NCT00419029|depression|depression
5305200|NCT00419029|PTSD|ptsd
5305201|NCT00419029|substance abuse|substance abuse
5305202|NCT00418990|Multivitamin|multivitamin
5305203|NCT00418990|Academic performance|academic performance
5305204|NCT00418977|Anorexia Nervosa|anorexia nervosa
5305205|NCT00418964|Anterior cruciate ligament rupture|anterior cruciate ligament rupture
5305206|NCT00418964|Anterior cruciate ligament(A02.513.514.100)|anterior cruciate ligament(a02.513.514.100)
5305207|NCT00418951|Voriconazole|voriconazole
5305208|NCT00418951|Vfend|vfend
5305209|NCT00418951|Liposomal amphotericin B|liposomal amphotericin b
5305210|NCT00418951|Ambisome|ambisome
5305211|NCT00418951|Acute Myelogenous Leukemia|acute myelogenous leukemia
5305212|NCT00418951|Myelodysplastic Syndrome|myelodysplastic syndrome
5305213|NCT00418951|AML|aml
5305214|NCT00418951|MDS|mds
5305215|NCT00418938|EGFR|egfr
5305216|NCT00418938|FOLFIRI|folfiri
5305217|NCT00418938|2nd Line Therapy|2nd line therapy
5305218|NCT00418938|2nd Line mCRC Therapy|2nd line mcrc therapy
5305219|NCT00418938|mCRC|mcrc
5305220|NCT00418938|Irinotecan|irinotecan
5305221|NCT00418938|panitumumab|panitumumab
5305222|NCT00418938|bevacizumab|bevacizumab
5305223|NCT00418899|Brain Tumor|brain tumor
5305224|NCT00418899|Glioma|glioma
5305225|NCT00418899|Linkage Study|linkage study
5305226|NCT00418899|Survey|survey
5305227|NCT00418899|Gliogene|gliogene
5305228|NCT00418899|High-risk familial brain tumor pedigrees|high-risk familial brain tumor pedigrees
5305229|NCT00418886|NSCLC|nsclc
5305230|NCT00418886|Non Small Cell Lung Cancer|non small cell lung cancer
5305231|NCT00418873|schizophrenia|schizophrenia
5305232|NCT00418873|zotepine|zotepine
5305233|NCT00418873|risperidone|risperidone
5305234|NCT00418873|second generation antipsychotic|second generation antipsychotic
5305235|NCT00418860|Angioplasty, Transluminal, Percutaneous Coronary|angioplasty, transluminal, percutaneous coronary
5305236|NCT00418860|Stent thrombosis|stent thrombosis
5305237|NCT00418860|Zotarolimus-eluting stent|zotarolimus-eluting stent
5305238|NCT00418847|pediatrics|pediatrics
5305239|NCT00418847|lysosomal storage diseases|lysosomal storage diseases
5305240|NCT00418847|Gangliosidoses GM2|gangliosidoses gm2
5305241|NCT00418847|Tay-Sachs disease|tay-sachs disease
5305242|NCT00418847|Sandhoff disease|sandhoff disease
5305243|NCT00418847|Infantile GM2-activator deficiency|infantile gm2-activator deficiency
5305244|NCT00418847|Miglustat|miglustat
5305245|NCT00418808|motor|motor
5305246|NCT00418808|development|development
5305247|NCT00418808|multiple pregnancies|multiple pregnancies
5305248|NCT00418808|general movement|general movement
5305249|NCT00418808|video recording|video recording
5305250|NCT00418795|Acute Intermittent Porphyria|acute intermittent porphyria
5305251|NCT00418795|treatment|treatment
5305252|NCT00418795|Acute attack|acute attack
5305253|NCT00418769|nilotinib|nilotinib
5305254|NCT00418769|bioavailability|bioavailability
5305255|NCT00418769|tablet|tablet
5305256|NCT00418769|capsule|capsule
5305257|NCT00418769|PK|pk
5305258|NCT00418769|healthy, subject(s),|healthy, subject(s),
5305259|NCT00418756|nilotinib|nilotinib
5305260|NCT00418756|Rifampin|rifampin
5305261|NCT00418756|PK|pk
5305262|NCT00418756|healthy subjects|healthy subjects
5305263|NCT00418743|cancer|cancer
5305264|NCT00418743|Lung cancer|lung cancer
5305265|NCT00418743|small-cell lung cancer|small-cell lung cancer
5305266|NCT00418730|androgenetic alopecia|androgenetic alopecia
5305267|NCT00418730|male pattern hair loss|male pattern hair loss
5305268|NCT00418730|male pattern baldness|male pattern baldness
5305269|NCT00418730|androgenetic alopecia or male pattern hair loss|androgenetic alopecia or male pattern hair loss
5305270|NCT00418704|cancer|cancer
5305271|NCT00418704|Lung cancer|lung cancer
5305272|NCT00418704|None small-cell lung cancer|none small-cell lung cancer
5305273|NCT00418691|Brain Tumor|brain tumor
5305274|NCT00418691|Methylphenidate|methylphenidate
5305275|NCT00418691|Ritalin|ritalin
5305276|NCT00418691|Modafinil|modafinil
5305277|NCT00418691|Provigil|provigil
5305278|NCT00418691|Fatigue|fatigue
5305279|NCT00418691|Concentration|concentration
5305280|NCT00418665|Revlimid|revlimid
5305281|NCT00418665|Lenalidomide|lenalidomide
5305282|NCT00418665|Low Platelet Count|low platelet count
5305283|NCT00418665|Low Risk Myelodysplastic Syndrome|low risk myelodysplastic syndrome
5305284|NCT00418665|Intermediate 1 Myelodysplastic Syndrome|intermediate 1 myelodysplastic syndrome
5305285|NCT00418665|MDS|mds
5305286|NCT00418665|Myelodysplastic Syndrome|myelodysplastic syndrome
5305287|NCT00418652|Normal Controls|normal controls
5305288|NCT00418639|Chronic Hepatitis C|chronic hepatitis c
5305289|NCT00418626|nilotinib|nilotinib
5305290|NCT00418626|hepatic impairment|hepatic impairment
5305291|NCT00418626|Child-Pugh scale|child-pugh scale
5305292|NCT00418626|PK|pk
5305293|NCT00418626|healthy, subject(s)|healthy, subject(s)
5305294|NCT00418626|Subjects with impaired hepatic function and healthy subjects|subjects with impaired hepatic function and healthy subjects
5305295|NCT00418600|Secondary Hyperparathyroidism|secondary hyperparathyroidism
5305296|NCT00418600|Hectorol® (doxercalciferol capsules)|hectorol® (doxercalciferol capsules)
5305297|NCT00418600|Hectorol® (doxercalciferol injection)|hectorol® (doxercalciferol injection)
5305298|NCT00418587|Vitamin D|vitamin d
5305299|NCT00418587|Lupus|lupus
5305300|NCT00418574|Ovarian cancer|ovarian cancer
5305301|NCT00418574|Abagovomab|abagovomab
5305302|NCT00418561|rhASA|rhasa
5305303|NCT00418561|MLD|mld
5305304|NCT00418561|Metazym|metazym
5305305|NCT00418535|Lymphoma, NK/T-Cell|lymphoma, nk/t-cell
5305306|NCT00418522|Insulin Glargine Diabetes HbA1c|insulin glargine diabetes hba1c
5305307|NCT00418509|Dose proportionality|dose proportionality
5305308|NCT00418509|pharmacokinetics|pharmacokinetics
5305309|NCT00418509|mometasone|mometasone
5305310|NCT00418509|formoterol|formoterol
5305311|NCT00418509|Healthy volunteers study|healthy volunteers study
5305312|NCT00418496|Unresectable|unresectable
5305313|NCT00418496|Metastatic|metastatic
5305314|NCT00418483|thrombolytic|thrombolytic
5305315|NCT00418483|thrombolysis|thrombolysis
5305316|NCT00418483|acute peripheral arterial occlusion|acute peripheral arterial occlusion
5305317|NCT00418483|peripheral vascular disease|peripheral vascular disease
5305318|NCT00418483|thrombosis|thrombosis
5305319|NCT00418483|endovascular|endovascular
5305320|NCT00418470|Cystic fibrosis|cystic fibrosis
5305321|NCT00418470|Catheterization, peripheral|catheterization, peripheral
5305322|NCT00418470|Phlebitis|phlebitis
5305323|NCT00418470|Anti-Bacterial Agents|anti-bacterial agents
5305324|NCT00418470|Osmolar Concentration|osmolar concentration
5305325|NCT00418457|Breast Cancer|breast cancer
5305420|NCT00417950|acarbose|acarbose
5305326|NCT00418457|Anesthesia; regional|anesthesia; regional
5305327|NCT00418457|cancer recurrence|cancer recurrence
5305328|NCT00418457|Anesthesia; inhalational|anesthesia; inhalational
5305329|NCT00418457|Analgesia; opioid|analgesia; opioid
5305330|NCT00418444|Breast cancer,group psychotherapy,RCT,women's mental health|breast cancer,group psychotherapy,rct,women's mental health
5305331|NCT00418418|Cell transplantation|cell transplantation
5305332|NCT00418418|Heart failure|heart failure
5305333|NCT00418418|Clinical trials|clinical trials
5305334|NCT00418405|Arthritis, Rheumatoid|arthritis, rheumatoid
5305335|NCT00418405|Cohort Studies|cohort studies
5305336|NCT00418392|pneumothorax, aspiration, minocycline, pleurodesis|pneumothorax, aspiration, minocycline, pleurodesis
5305337|NCT00418379|Sublingual immunotherapy|sublingual immunotherapy
5305338|NCT00418379|Grass pollen tablet|grass pollen tablet
5305339|NCT00418379|Allergic rhinoconjunctivitis|allergic rhinoconjunctivitis
5305340|NCT00418366|Mild, moderate, severe renal insufficiency|mild, moderate, severe renal insufficiency
5305341|NCT00418366|End stage renal disease|end stage renal disease
5305342|NCT00418353|Antenatal corticosteroids|antenatal corticosteroids
5305343|NCT00418353|Betamethasone|betamethasone
5305344|NCT00418353|Dexamethasone|dexamethasone
5305345|NCT00418353|Premature|premature
5305346|NCT00418340|Irritable Bowel Syndrome,|irritable bowel syndrome,
5305347|NCT00418340|Visceral hypersensitivity,|visceral hypersensitivity,
5305348|NCT00418340|probiotic therapy,|probiotic therapy,
5305349|NCT00418340|immune response|immune response
5305350|NCT00418327|Tarceva|tarceva
5305351|NCT00418327|refractory and relapsed malignant brain tumors|refractory and relapsed malignant brain tumors
5305352|NCT00418327|newly diagnosed brain stem glioma|newly diagnosed brain stem glioma
5305353|NCT00418301|Pain|pain
5305354|NCT00418301|Neurostimulation|neurostimulation
5305355|NCT00418288|GLP-1|glp-1
5305356|NCT00418288|glucose metabolism|glucose metabolism
5305357|NCT00418288|Type 2 diabetes|type 2 diabetes
5305358|NCT00418288|brain|brain
5305359|NCT00418288|PET|pet
5305360|NCT00418275|Cerebrovascular Stroke|cerebrovascular stroke
5305361|NCT00418262|fetal alcohol syndrome|fetal alcohol syndrome
5305362|NCT00418262|attention deficit disorder|attention deficit disorder
5305363|NCT00418262|attention deficit disorder with hyperactivity|attention deficit disorder with hyperactivity
5305364|NCT00418262|ADD|add
5305365|NCT00418262|FAS|fas
5305366|NCT00418262|FASD|fasd
5305367|NCT00418262|ADHD|adhd
5305368|NCT00418249|Androgenetic Alopecia|androgenetic alopecia
5305369|NCT00418249|Telogen effluvium|telogen effluvium
5305370|NCT00418249|Chronic telogen effluvium|chronic telogen effluvium
5305371|NCT00418249|Menopause|menopause
5305372|NCT00418249|Female Androgenetic Alopecia (FAGA)|female androgenetic alopecia (faga)
5305373|NCT00418223|Urinary retention|urinary retention
5305374|NCT00418223|Child birth|child birth
5305375|NCT00418223|Catheterization|catheterization
5305376|NCT00418223|Ultrasound|ultrasound
5305377|NCT00418210|Accelerated Partial Breast Irradiation|accelerated partial breast irradiation
5305378|NCT00418210|Conformal Radiation Therapy|conformal radiation therapy
5305379|NCT00418210|Feasibility|feasibility
5305380|NCT00418210|Early breast cancer|early breast cancer
5305381|NCT00418197|spinal stenosis|spinal stenosis
5305382|NCT00418197|low back pain|low back pain
5305383|NCT00418197|spondylolisthesis|spondylolisthesis
5305384|NCT00418197|lumbar spinal stenosis|lumbar spinal stenosis
5305385|NCT00418197|leg pain|leg pain
5305386|NCT00418197|spinal diseases|spinal diseases
5305387|NCT00418184|ADHD|adhd
5305388|NCT00418184|inattentive|inattentive
5305389|NCT00418184|impulsive|impulsive
5305390|NCT00418184|hyperactive|hyperactive
5305391|NCT00418184|poor academic performance|poor academic performance
5305392|NCT00418184|poor self-discipline|poor self-discipline
5305393|NCT00418184|low self-esteem|low self-esteem
5305394|NCT00418158|Pulmonary complications|pulmonary complications
5305395|NCT00418145|Relapsing Forms of Multiple Sclerosis|relapsing forms of multiple sclerosis
5305396|NCT00418132|SSc|ssc
5305397|NCT00418132|Systemic Sclerosis|systemic sclerosis
5305398|NCT00418132|Progressive Systemic Sclerosis|progressive systemic sclerosis
5305399|NCT00418106|Premature birth|premature birth
5305400|NCT00418106|Pumping breast milk|pumping breast milk
5305401|NCT00418106|Kangaroo holding|kangaroo holding
5305402|NCT00418093|mullerian carcinoma|mullerian carcinoma
5305403|NCT00418067|Coronary Artery Disease|coronary artery disease
5305404|NCT00418067|Stent|stent
5305405|NCT00418028|capecitabine|capecitabine
5305406|NCT00418028|schedule|schedule
5305407|NCT00418028|breast cancer|breast cancer
5305408|NCT00418015|µ-opioid receptor|µ-opioid receptor
5305409|NCT00418015|neuraxial labor analgesia|neuraxial labor analgesia
5305410|NCT00418015|pharmacogenetics|pharmacogenetics
5305411|NCT00418002|Single-rising dose , multiple rising dose, elderly, cognitive, , pharmacokinetic, impairment.|single-rising dose , multiple rising dose, elderly, cognitive, , pharmacokinetic, impairment.
5305412|NCT00418002|Healthy elderly male and female subjects|healthy elderly male and female subjects
5305413|NCT00417989|Glycemic control|glycemic control
5305414|NCT00417989|Sensor|sensor
5305415|NCT00417976|Advanced Pancreatic Cancer|advanced pancreatic cancer
5305416|NCT00417963|Carotid|carotid
5305417|NCT00417963|Artery|artery
5305418|NCT00417963|Stenosis|stenosis
5305419|NCT00417950|diabetes|diabetes
5305421|NCT00417950|alcohol|alcohol
5305422|NCT00417950|inflammation|inflammation
5305423|NCT00417950|oxidative stress|oxidative stress
5305424|NCT00417950|Mild diabetes mellitus|mild diabetes mellitus
5305425|NCT00417924|Patient education|patient education
5305426|NCT00417924|Patient satisfaction|patient satisfaction
5305427|NCT00417924|Eye health|eye health
5305428|NCT00417911|multiple myeloma|multiple myeloma
5305429|NCT00417911|autologous stem cell transplantation|autologous stem cell transplantation
5305430|NCT00417911|high-dose melphalan|high-dose melphalan
5305431|NCT00417911|bortezomib|bortezomib
5305432|NCT00417911|consolidation|consolidation
5305433|NCT00417911|event free survival|event free survival
5305434|NCT00417911|phase III|phase iii
5305435|NCT00417898|Stroke|stroke
5305436|NCT00417898|Cerebral Ischemia|cerebral ischemia
5305437|NCT00417898|Tissue Plasminogen Activator|tissue plasminogen activator
5305438|NCT00417898|Aspirin|aspirin
5305439|NCT00417898|Human|human
5305440|NCT00417898|Cerebral Reperfusion|cerebral reperfusion
5305441|NCT00417872|Clostridium difficile|clostridium difficile
5305442|NCT00417846|Age-Related Macular Degeneration|age-related macular degeneration
5305443|NCT00417846|Optical Coherence Tomography, OCT|optical coherence tomography, oct
5305444|NCT00417846|Preferential Hyperacuity Perimeter, PHP|preferential hyperacuity perimeter, php
5305445|NCT00417846|Amsler Grid|amsler grid
5305446|NCT00417820|Safety, tolerability, pharmacodynamics, single administration, BCT194, healthy volunteers, psoriasis|safety, tolerability, pharmacodynamics, single administration, bct194, healthy volunteers, psoriasis
5305447|NCT00417807|refractory desmoplastic small round cell tumors|refractory desmoplastic small round cell tumors
5305448|NCT00417807|PDGF-R|pdgf-r
5305449|NCT00417794|attention deficit hyperactivity disorder|attention deficit hyperactivity disorder
5305450|NCT00417794|ADHD|adhd
5305451|NCT00417794|fetal alcohol syndrome|fetal alcohol syndrome
5305452|NCT00417794|FAS|fas
5305453|NCT00417794|FASD|fasd
5305454|NCT00417794|atomoxetine hcl|atomoxetine hcl
5305455|NCT00417781|ADHD, adolescence, family study, endophenotype, outcome|adhd, adolescence, family study, endophenotype, outcome
5305456|NCT00417768|tissue plasminogen activator|tissue plasminogen activator
5305457|NCT00417768|intraabdominal|intraabdominal
5305458|NCT00417768|abscess|abscess
5305459|NCT00417768|percutaneous drainage|percutaneous drainage
5305460|NCT00417755|Nutritional intake|nutritional intake
5305461|NCT00417755|Mechanical ventilation|mechanical ventilation
5305462|NCT00417755|Enteral feeding|enteral feeding
5305463|NCT00417742|headache|headache
5305464|NCT00417742|migraine headache|migraine headache
5305465|NCT00417742|tension headache|tension headache
5305466|NCT00417729|Diabetes|diabetes
5305467|NCT00417729|Acarobse|acarobse
5305468|NCT00417729|Metformin|metformin
5305469|NCT00417729|oxidative stress|oxidative stress
5305470|NCT00417729|Mean amplitude Glycemic Excursion|mean amplitude glycemic excursion
5305471|NCT00417729|Meal test|meal test
5305472|NCT00417716|Diffuse Diabetic Macular Edema|diffuse diabetic macular edema
5305473|NCT00417716|Intravitreal Bevacizumab|intravitreal bevacizumab
5305474|NCT00417716|Anti-VEGF drugs|anti-vegf drugs
5305475|NCT00417703|Intraocular Pressure|intraocular pressure
5305476|NCT00417703|Intravitreous Injection|intravitreous injection
5305477|NCT00417703|Ranibizumab|ranibizumab
5305478|NCT00417690|Crohn's Disease|crohn's disease
5305479|NCT00417690|Acute Flare|acute flare
5305480|NCT00417690|Mild to moderate Crohn's Disease|mild to moderate crohn's disease
5305481|NCT00417690|Ileocecal distribution|ileocecal distribution
5305482|NCT00417677|Advanced Renal Carcinoma|advanced renal carcinoma
5305483|NCT00417664|cardiac surgery|cardiac surgery
5305484|NCT00417664|valvular surgery|valvular surgery
5305485|NCT00417664|delirium|delirium
5305486|NCT00417664|postoperative delirium|postoperative delirium
5305487|NCT00417664|cognitive dysfunction|cognitive dysfunction
5305488|NCT00417664|altered mental status|altered mental status
5305489|NCT00417651|Bacterial|bacterial
5305490|NCT00417651|contamination|contamination
5305491|NCT00417651|gastrotomy|gastrotomy
5305492|NCT00417651|Complications|complications
5305493|NCT00417638|myocardial infarction|myocardial infarction
5305494|NCT00417638|acute intervention|acute intervention
5305495|NCT00417638|percutaneous intervention|percutaneous intervention
5305496|NCT00417638|endovascular cooling|endovascular cooling
5305497|NCT00417638|endovascular rewarming|endovascular rewarming
5305498|NCT00417625|Coronary Artery Perfusion|coronary artery perfusion
5305499|NCT00417625|MRI|mri
5305500|NCT00417625|Fractional Flow Reserve|fractional flow reserve
5305501|NCT00417625|Coronary Flow Reserve|coronary flow reserve
5305502|NCT00417625|Collateral Artery Perfusion|collateral artery perfusion
5305503|NCT00417625|Cardiovascular Disease|cardiovascular disease
5305504|NCT00417625|Coronary Artery Disease|coronary artery disease
5305505|NCT00417625|CAD|cad
5305506|NCT00417612|Rickets, Hypophosphatemia|rickets, hypophosphatemia
5305507|NCT00417612|Rickets, Vitamin D-Resistant|rickets, vitamin d-resistant
5305508|NCT00417612|Rickets, X-linked hypophosphatemic|rickets, x-linked hypophosphatemic
5305509|NCT00417599|Prevention of overweight|prevention of overweight
5305510|NCT00417599|Prevention of obesity|prevention of obesity
5305511|NCT00417599|Treatment of overweight|treatment of overweight
5305512|NCT00417599|Treatment of obesity|treatment of obesity
5305513|NCT00417586|Stroke|stroke
5305514|NCT00417573|Immunodeficiency|immunodeficiency
5305515|NCT00417573|Gammaglobulin|gammaglobulin
5305516|NCT00417573|IgG subclass deficiency with recurrent infections|igg subclass deficiency with recurrent infections
5305517|NCT00417560|Influenza A/H5N1|influenza a/h5n1
5305518|NCT00417560|vaccine|vaccine
5305519|NCT00417560|avian influenza H5N1|avian influenza h5n1
5305520|NCT00417560|H5N1|h5n1
5305521|NCT00417547|Self Concept|self concept
5305522|NCT00417547|Eating Disorder|eating disorder
5305523|NCT00417547|Body Mass Index|body mass index
5305524|NCT00417547|Dressing|dressing
5305525|NCT00417547|Islamic Veil|islamic veil
5305526|NCT00417534|Coronary Disease|coronary disease
5305527|NCT00417534|Inflammation|inflammation
5305528|NCT00417534|Genetics|genetics
5305529|NCT00417534|HLA Antigens|hla antigens
5305530|NCT00417534|Aortic Valve|aortic valve
5305531|NCT00417521|Adolescents|adolescents
5305532|NCT00417521|Anorexia|anorexia
5305533|NCT00417521|Eating disorder|eating disorder
5305534|NCT00417521|Family therapy|family therapy
5305535|NCT00417508|function|function
5305536|NCT00417508|elderly|elderly
5305537|NCT00417508|ADL|adl
5305538|NCT00417508|nutritional supplementation|nutritional supplementation
5305539|NCT00417508|Quality of life|quality of life
5305540|NCT00417508|handgrip strength|handgrip strength
5305541|NCT00417508|Body Composition|body composition
5305542|NCT00417495|adenocarcinoma, breast, multifocal lesions, surgery|adenocarcinoma, breast, multifocal lesions, surgery
5305543|NCT00417482|Risperidone treatment, psychosis, agitation, aggression,|risperidone treatment, psychosis, agitation, aggression,
5305544|NCT00417482|discontinuation, placebo|discontinuation, placebo
5305545|NCT00417456|Acne|acne
5305546|NCT00417456|Telemedicine|telemedicine
5305547|NCT00417456|Dermatology|dermatology
5305548|NCT00417443|epidural|epidural
5305549|NCT00417443|clonidine|clonidine
5305550|NCT00417443|hyperalgesia|hyperalgesia
5305551|NCT00417443|laparotomy|laparotomy
5305552|NCT00417417|Endothelium|endothelium
5305553|NCT00417417|Inflammation|inflammation
5305554|NCT00417417|Nitric Oxide|nitric oxide
5305555|NCT00417417|Rilonacept|rilonacept
5305556|NCT00417417|Cytokines|cytokines
5305557|NCT00417417|Coronary Artery Disease|coronary artery disease
5305558|NCT00417417|CAD|cad
5305559|NCT00417417|Atherosclerosis|atherosclerosis
5305560|NCT00417404|preterm|preterm
5305561|NCT00417404|nutrition|nutrition
5305562|NCT00417404|vitamin A|vitamin a
5305563|NCT00417404|electroretinogram|electroretinogram
5305564|NCT00417404|conjunctiva|conjunctiva
5305565|NCT00417404|vitamin A status|vitamin a status
5305566|NCT00417404|conjunctival health|conjunctival health
5305567|NCT00417378|ACS|acs
5305568|NCT00417365|odor|odor
5305569|NCT00417365|douching|douching
5305570|NCT00417365|BV|bv
5305571|NCT00417365|vaginitis|vaginitis
5305572|NCT00417365|vaginal|vaginal
5305573|NCT00417365|yeast|yeast
5305574|NCT00417365|ecosystem|ecosystem
5305575|NCT00417365|Lactobacilli|lactobacilli
5305576|NCT00417365|Nugent|nugent
5305577|NCT00417365|Amsel|amsel
5305578|NCT00417352|no intervention|no intervention
5305579|NCT00417352|bracing restricted forearm and wrist movement|bracing restricted forearm and wrist movement
5305580|NCT00417352|bracing with added mass near elbow|bracing with added mass near elbow
5305581|NCT00417352|bracing with added mass near wrist|bracing with added mass near wrist
5305582|NCT00417339|hemodialysis|hemodialysis
5305583|NCT00417339|dialysis adequacy|dialysis adequacy
5305584|NCT00417339|uremic retention solute|uremic retention solute
5305585|NCT00417326|ONO-5046Na|ono-5046na
5305586|NCT00417326|acute respiratory failure|acute respiratory failure
5305587|NCT00417326|community-acquired pneumonia|community-acquired pneumonia
5305588|NCT00417313|knee pain|knee pain
5305589|NCT00417313|acupuncture /acupressure|acupuncture /acupressure
5305590|NCT00417313|alternative medicine|alternative medicine
5305591|NCT00417313|analgesia|analgesia
5305592|NCT00417313|arthritis therapy|arthritis therapy
5305593|NCT00417313|chronic pain|chronic pain
5305594|NCT00417313|functional ability|functional ability
5305595|NCT00417300|PTSD|ptsd
5305596|NCT00417300|Cognitive Behavioral Treatment|cognitive behavioral treatment
5305597|NCT00417300|Child Sexual Abuse|child sexual abuse
5305598|NCT00417287|Pancreas|pancreas
5305599|NCT00417287|Cancer|cancer
5305600|NCT00417287|Carcinoma|carcinoma
5305601|NCT00417274|Cancer of Prostate|cancer of prostate
5305602|NCT00417274|Prostate Cancer|prostate cancer
5305603|NCT00417274|Cancer of the Prostate|cancer of the prostate
5305604|NCT00417274|Neoplasms, Prostate|neoplasms, prostate
5305605|NCT00417274|Neoplasms, Prostatic|neoplasms, prostatic
5305606|NCT00417274|Prostate Neoplasms|prostate neoplasms
5305607|NCT00417274|Prostatic Cancer|prostatic cancer
5305608|NCT00417274|Androgen-Independent Prostate Cancer|androgen-independent prostate cancer
5305609|NCT00417261|ATF936, AXT914, healthy subjects, pharmacokinetics, parathyroid hormone, osteoporosis|atf936, axt914, healthy subjects, pharmacokinetics, parathyroid hormone, osteoporosis
5305610|NCT00417261|Healthy male and female subjects|healthy male and female subjects
5305611|NCT00417235|catheter related infection|catheter related infection
5305612|NCT00417235|catheter dressing|catheter dressing
5305613|NCT00417235|prevention|prevention
5305614|NCT00417235|Chlorhexidine impregnated dressings|chlorhexidine impregnated dressings
5305615|NCT00417235|Infection|infection
5305616|NCT00417235|catheterization|catheterization
5305617|NCT00417209|advanced pancreatic cancer|advanced pancreatic cancer
5305618|NCT00417196|pharmacodynamic effects, safety, healthy subjects,|pharmacodynamic effects, safety, healthy subjects,
5305619|NCT00417196|Healthy male and female subjects|healthy male and female subjects
5305620|NCT00417183|GnRH antagonist|gnrh antagonist
5305621|NCT00417183|GnRH agonist|gnrh agonist
5305622|NCT00417183|Long protocol|long protocol
5305623|NCT00417183|Flexible|flexible
5305624|NCT00417170|High Blood pressure|high blood pressure
5305625|NCT00417170|Hypertension|hypertension
5305626|NCT00417170|metabolic syndrome|metabolic syndrome
5305627|NCT00417170|insulin resistance|insulin resistance
5305628|NCT00417170|endothelial dysfunction|endothelial dysfunction
5305629|NCT00417170|pre-diabetic|pre-diabetic
5305630|NCT00417170|amlodipine,|amlodipine,
5305631|NCT00417170|aliskiren,|aliskiren,
5305632|NCT00417170|IGT,|igt,
5305633|NCT00417170|IFG,|ifg,
5305634|NCT00417170|MBF|mbf
5305635|NCT00417157|GnRH antagonist|gnrh antagonist
5305636|NCT00417157|Poor responders|poor responders
5305637|NCT00417157|Oocyte donation|oocyte donation
5305638|NCT00417157|Modified natural cycle|modified natural cycle
5305639|NCT00417144|OHSS|ohss
5305640|NCT00417144|PCOS|pcos
5305641|NCT00417144|GnRH antagonist|gnrh antagonist
5305642|NCT00417144|GnRH agonist|gnrh agonist
5305643|NCT00417131|Islet transplantation,|islet transplantation,
5305644|NCT00417131|coagulation,|coagulation,
5305645|NCT00417131|graft destruction,|graft destruction,
5305646|NCT00417131|islet imaging|islet imaging
5305647|NCT00417118|Anxiety|anxiety
5305648|NCT00417118|clinical trials|clinical trials
5305649|NCT00417105|hemodialysis|hemodialysis
5305650|NCT00417105|dialysis adequacy|dialysis adequacy
5305651|NCT00417105|chronic kidney disease|chronic kidney disease
5305652|NCT00417092|coronary artery bypass grafting|coronary artery bypass grafting
5305653|NCT00417092|reduced left ventricular function|reduced left ventricular function
5305654|NCT00417092|postoperative pacing|postoperative pacing
5305655|NCT00417092|cardiac resynchronization|cardiac resynchronization
5305656|NCT00417079|Cancer|cancer
5305657|NCT00417079|Prostate|prostate
5305658|NCT00417066|poor responders|poor responders
5305659|NCT00417066|GnRH antagonist|gnrh antagonist
5305660|NCT00417066|GnRH agonist|gnrh agonist
5305661|NCT00417066|flare up|flare up
5305662|NCT00417066|short protocol|short protocol
5305663|NCT00417053|disseminated neuroblastoma|disseminated neuroblastoma
5305664|NCT00417053|localized resectable neuroblastoma|localized resectable neuroblastoma
5305665|NCT00417053|localized unresectable neuroblastoma|localized unresectable neuroblastoma
5305666|NCT00417053|regional neuroblastoma|regional neuroblastoma
5305667|NCT00417053|stage 4S neuroblastoma|stage 4s neuroblastoma
5305668|NCT00417040|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5305669|NCT00417040|recurrent prostate cancer|recurrent prostate cancer
5305670|NCT00417040|stage IV prostate cancer|stage iv prostate cancer
5305671|NCT00417027|Patient controlled epidural analgesia|patient controlled epidural analgesia
5305672|NCT00417027|Labor analgesia|labor analgesia
5305673|NCT00417027|Epidural analgesia|epidural analgesia
5305674|NCT00417014|stage I childhood Hodgkin lymphoma|stage i childhood hodgkin lymphoma
5305675|NCT00417014|stage II childhood Hodgkin lymphoma|stage ii childhood hodgkin lymphoma
5305676|NCT00417014|stage III childhood Hodgkin lymphoma|stage iii childhood hodgkin lymphoma
5305677|NCT00417014|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
5305678|NCT00417014|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
5305679|NCT00417001|sedation|sedation
5305680|NCT00417001|colonoscopy|colonoscopy
5305681|NCT00417001|Aroma therapy|aroma therapy
5305682|NCT00416988|melanoma|melanoma
5305683|NCT00416988|weight changes|weight changes
5305684|NCT00416975|breast cancer|breast cancer
5305685|NCT00416962|Oseltamivir, amantidine, Symmetrel, Tamiflu|oseltamivir, amantidine, symmetrel, tamiflu
5305686|NCT00416949|anaplastic thyroid cancer|anaplastic thyroid cancer
5305687|NCT00416949|insular thyroid cancer|insular thyroid cancer
5305688|NCT00416949|thyroid gland medullary carcinoma|thyroid gland medullary carcinoma
5305689|NCT00416949|recurrent thyroid cancer|recurrent thyroid cancer
5305690|NCT00416949|stage I follicular thyroid cancer|stage i follicular thyroid cancer
5305691|NCT00416949|stage I papillary thyroid cancer|stage i papillary thyroid cancer
5305692|NCT00416949|stage II follicular thyroid cancer|stage ii follicular thyroid cancer
5305693|NCT00416949|stage II papillary thyroid cancer|stage ii papillary thyroid cancer
5305694|NCT00416949|stage III follicular thyroid cancer|stage iii follicular thyroid cancer
5305695|NCT00416949|stage III papillary thyroid cancer|stage iii papillary thyroid cancer
5305696|NCT00416949|stage IVA follicular thyroid cancer|stage iva follicular thyroid cancer
5305697|NCT00416949|stage IVB follicular thyroid cancer|stage ivb follicular thyroid cancer
5305698|NCT00416949|stage IVC follicular thyroid cancer|stage ivc follicular thyroid cancer
5305699|NCT00416949|stage IVA papillary thyroid cancer|stage iva papillary thyroid cancer
5305700|NCT00416949|stage IVB papillary thyroid cancer|stage ivb papillary thyroid cancer
5305701|NCT00416949|stage IVC papillary thyroid cancer|stage ivc papillary thyroid cancer
5305702|NCT00416923|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5305703|NCT00416923|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5305704|NCT00416923|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5305705|NCT00416923|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5305706|NCT00416923|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5305707|NCT00416923|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5305708|NCT00416923|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5305709|NCT00416923|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5305710|NCT00416923|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5305711|NCT00416923|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5305712|NCT00416923|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5305713|NCT00416923|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5305714|NCT00416923|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5305715|NCT00416923|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5305716|NCT00416923|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5305717|NCT00416923|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5305718|NCT00416923|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5305719|NCT00416923|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5305720|NCT00416923|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5305721|NCT00416923|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5305722|NCT00416923|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5305723|NCT00416923|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5305724|NCT00416923|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5305725|NCT00416923|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5305726|NCT00416923|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
5305727|NCT00416923|leptomeningeal metastases|leptomeningeal metastases
5305728|NCT00416923|intraocular lymphoma|intraocular lymphoma
5305729|NCT00416923|AIDS-related primary CNS lymphoma|aids-related primary cns lymphoma
5305730|NCT00416923|Waldenström macroglobulinemia|waldenström macroglobulinemia
5305731|NCT00416923|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5305732|NCT00416923|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5305733|NCT00416923|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5305734|NCT00416910|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5305735|NCT00416910|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5305736|NCT00416910|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5305737|NCT00416910|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
5305738|NCT00416910|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
5305739|NCT00416897|stage I multiple myeloma|stage i multiple myeloma
5305740|NCT00416897|stage II multiple myeloma|stage ii multiple myeloma
5305741|NCT00416897|stage III multiple myeloma|stage iii multiple myeloma
5305742|NCT00416897|renal failure|renal failure
5305743|NCT00416884|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5305744|NCT00416884|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
5305745|NCT00416884|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5305746|NCT00416871|stage IV renal cell cancer|stage iv renal cell cancer
5305747|NCT00416871|recurrent renal cell cancer|recurrent renal cell cancer
5305748|NCT00416858|stage III esophageal cancer|stage iii esophageal cancer
5305749|NCT00416845|pharmacodynamic effects, cardiac effects, healthy subjects, synthetic sphingosine 1 phosphate (S1P) receptor modulator|pharmacodynamic effects, cardiac effects, healthy subjects, synthetic sphingosine 1 phosphate (s1p) receptor modulator
5305750|NCT00416845|Healthy male and female subjects|healthy male and female subjects
5305751|NCT00416832|stage II childhood Hodgkin lymphoma|stage ii childhood hodgkin lymphoma
5305752|NCT00416832|stage III childhood Hodgkin lymphoma|stage iii childhood hodgkin lymphoma
5305753|NCT00416832|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
5305754|NCT00416832|stage I childhood Hodgkin lymphoma|stage i childhood hodgkin lymphoma
5305755|NCT00416819|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
5305756|NCT00416819|primary central nervous system Hodgkin lymphoma|primary central nervous system hodgkin lymphoma
5305757|NCT00416780|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
5305758|NCT00416780|recurrent breast cancer|recurrent breast cancer
5305759|NCT00416780|stage I breast cancer|stage i breast cancer
5305760|NCT00416780|stage II breast cancer|stage ii breast cancer
5305761|NCT00416780|stage IV breast cancer|stage iv breast cancer
5305762|NCT00416767|metastatic gastrointestinal carcinoid tumor|metastatic gastrointestinal carcinoid tumor
5305763|NCT00416767|recurrent gastrointestinal carcinoid tumor|recurrent gastrointestinal carcinoid tumor
5305764|NCT00416767|regional gastrointestinal carcinoid tumor|regional gastrointestinal carcinoid tumor
5305765|NCT00416767|gastrinoma|gastrinoma
5305766|NCT00416767|insulinoma|insulinoma
5305767|NCT00416767|WDHA syndrome|wdha syndrome
5305768|NCT00416767|glucagonoma|glucagonoma
5305769|NCT00416767|pancreatic polypeptide tumor|pancreatic polypeptide tumor
5305770|NCT00416767|somatostatinoma|somatostatinoma
5305771|NCT00416767|recurrent islet cell carcinoma|recurrent islet cell carcinoma
5305772|NCT00416754|breast cancer|breast cancer
5305773|NCT00416754|stage I breast cancer|stage i breast cancer
5305774|NCT00416754|stage II breast cancer|stage ii breast cancer
5305775|NCT00416754|stage IIIA breast cancer|stage iiia breast cancer
5305776|NCT00416754|stage IIIB breast cancer|stage iiib breast cancer
5305777|NCT00416754|stage IIIC breast cancer|stage iiic breast cancer
5305778|NCT00416754|stage IV breast cancer|stage iv breast cancer
5305779|NCT00416741|Metabolic Syndrome|metabolic syndrome
5305780|NCT00416741|Obesity|obesity
5305781|NCT00416741|Hyperlipidemia|hyperlipidemia
5305782|NCT00416741|High blood pressure|high blood pressure
5305783|NCT00416741|Diabetes|diabetes
5305784|NCT00416728|Aliskiren , Valsartan , bioavailability, hypertension|aliskiren , valsartan , bioavailability, hypertension
5305785|NCT00416728|Healthy male and female subjects|healthy male and female subjects
5305786|NCT00416702|safety study, pharmacokinetic effects, healthy subjects, hepatic impairment, liver|safety study, pharmacokinetic effects, healthy subjects, hepatic impairment, liver
5305787|NCT00416702|Subjects with mild and moderate hepatic impairment and healthy subjects|subjects with mild and moderate hepatic impairment and healthy subjects
5305788|NCT00416689|nausea and vomiting|nausea and vomiting
5305789|NCT00416689|pulmonary carcinoid tumor|pulmonary carcinoid tumor
5305790|NCT00416689|recurrent breast cancer|recurrent breast cancer
5305791|NCT00416689|stage I breast cancer|stage i breast cancer
5305792|NCT00416689|stage II breast cancer|stage ii breast cancer
5305793|NCT00416689|stage IIIA breast cancer|stage iiia breast cancer
5305794|NCT00416689|stage IIIB breast cancer|stage iiib breast cancer
5305795|NCT00416689|stage IIIC breast cancer|stage iiic breast cancer
5305796|NCT00416689|stage IV breast cancer|stage iv breast cancer
5305797|NCT00416689|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5305798|NCT00416689|stage I non-small cell lung cancer|stage i non-small cell lung cancer
5305799|NCT00416689|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
5305800|NCT00416689|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5305801|NCT00416689|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5305802|NCT00416689|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5305803|NCT00416689|extensive stage small cell lung cancer|extensive stage small cell lung cancer
5305804|NCT00416689|limited stage small cell lung cancer|limited stage small cell lung cancer
5305805|NCT00416689|recurrent small cell lung cancer|recurrent small cell lung cancer
5305806|NCT00416676|localized resectable neuroblastoma|localized resectable neuroblastoma
5305807|NCT00416676|localized unresectable neuroblastoma|localized unresectable neuroblastoma
5305808|NCT00416676|regional neuroblastoma|regional neuroblastoma
5305809|NCT00416663|Stem cells|stem cells
5305810|NCT00416663|Progenitor cells|progenitor cells
5305811|NCT00416663|Angina Pectoris|angina pectoris
5305812|NCT00416663|Heart Failure|heart failure
5305813|NCT00416663|Angiogenesis|angiogenesis
5305814|NCT00416650|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5305815|NCT00416650|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5305816|NCT00416650|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
5305817|NCT00416650|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5305818|NCT00416637|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5305819|NCT00416624|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5305820|NCT00416624|extramedullary plasmacytoma|extramedullary plasmacytoma
5305821|NCT00416624|isolated plasmacytoma of bone|isolated plasmacytoma of bone
5305822|NCT00416624|refractory multiple myeloma|refractory multiple myeloma
5305823|NCT00416624|stage I multiple myeloma|stage i multiple myeloma
5305824|NCT00416624|stage II multiple myeloma|stage ii multiple myeloma
5305825|NCT00416624|stage III multiple myeloma|stage iii multiple myeloma
5305826|NCT00416624|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
5305827|NCT00416624|post-transplant lymphoproliferative disorder|post-transplant lymphoproliferative disorder
5305828|NCT00416624|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
5305829|NCT00416624|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
5305830|NCT00416624|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
5305831|NCT00416624|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
5305832|NCT00416624|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
5305833|NCT00416624|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
5305834|NCT00416624|AIDS-related primary CNS lymphoma|aids-related primary cns lymphoma
5305835|NCT00416624|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
5305836|NCT00416624|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5305837|NCT00416624|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
5305838|NCT00416624|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
5305839|NCT00416624|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
5305840|NCT00416624|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
5305841|NCT00416624|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5305842|NCT00416624|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
5306305|NCT00415597|ALO-01|alo-01
5305843|NCT00416624|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
5305844|NCT00416624|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
5305845|NCT00416624|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
5305846|NCT00416624|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5305847|NCT00416624|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
5305848|NCT00416624|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
5305849|NCT00416624|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5305850|NCT00416624|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5305851|NCT00416624|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5305852|NCT00416624|adult grade III lymphomatoid granulomatosis|adult grade iii lymphomatoid granulomatosis
5305853|NCT00416624|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
5305854|NCT00416624|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5305855|NCT00416624|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5305856|NCT00416624|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
5305857|NCT00416624|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5305858|NCT00416624|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
5305859|NCT00416624|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
5305860|NCT00416624|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
5305861|NCT00416624|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
5305862|NCT00416624|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5305863|NCT00416624|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5305864|NCT00416624|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5305865|NCT00416624|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5305866|NCT00416624|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
5305867|NCT00416624|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
5305868|NCT00416624|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
5305869|NCT00416624|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
5305870|NCT00416624|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
5305871|NCT00416624|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
5305872|NCT00416624|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
5305873|NCT00416624|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
5305874|NCT00416624|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
5305875|NCT00416624|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
5305876|NCT00416624|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
5305877|NCT00416624|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
5305878|NCT00416624|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
5305879|NCT00416624|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
5305880|NCT00416624|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
5305881|NCT00416624|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
5305882|NCT00416624|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
5305883|NCT00416624|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5305884|NCT00416624|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5305885|NCT00416624|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5305886|NCT00416624|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5305887|NCT00416624|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5305888|NCT00416624|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5305889|NCT00416624|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
5305890|NCT00416624|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5305891|NCT00416624|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5305892|NCT00416624|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
5305893|NCT00416624|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5305894|NCT00416624|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5305895|NCT00416624|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
5305896|NCT00416624|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
5305897|NCT00416624|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
5305898|NCT00416624|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5305899|NCT00416624|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5305900|NCT00416624|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5305901|NCT00416624|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5305902|NCT00416624|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5305903|NCT00416624|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5305904|NCT00416624|stage I mantle cell lymphoma|stage i mantle cell lymphoma
5305905|NCT00416624|stage I marginal zone lymphoma|stage i marginal zone lymphoma
5305906|NCT00416624|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5305907|NCT00416624|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5305908|NCT00416624|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5305909|NCT00416624|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5305910|NCT00416624|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
5305911|NCT00416624|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5305912|NCT00416624|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5305913|NCT00416624|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5305914|NCT00416624|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5305915|NCT00416624|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5305916|NCT00416624|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5305917|NCT00416624|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5305918|NCT00416624|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5305919|NCT00416624|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5305920|NCT00416624|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
5305921|NCT00416624|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5305922|NCT00416624|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5305923|NCT00416624|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5305924|NCT00416624|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5305925|NCT00416624|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5305926|NCT00416624|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5305927|NCT00416624|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5305928|NCT00416624|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5305929|NCT00416624|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5305930|NCT00416624|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5305931|NCT00416624|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
5305932|NCT00416624|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
5305933|NCT00416624|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
5305934|NCT00416624|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5305935|NCT00416624|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5305936|NCT00416624|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5305937|NCT00416624|refractory hairy cell leukemia|refractory hairy cell leukemia
5305938|NCT00416624|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
5305939|NCT00416624|prolymphocytic leukemia|prolymphocytic leukemia
5305940|NCT00416624|anemia|anemia
5305941|NCT00416624|monoclonal gammopathy of undetermined significance|monoclonal gammopathy of undetermined significance
5305942|NCT00416624|primary systemic amyloidosis|primary systemic amyloidosis
5305943|NCT00416624|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
5305944|NCT00416624|acute undifferentiated leukemia|acute undifferentiated leukemia
5305945|NCT00416624|mast cell leukemia|mast cell leukemia
5305946|NCT00416624|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
5305947|NCT00416624|untreated hairy cell leukemia|untreated hairy cell leukemia
5305948|NCT00416611|High blood pressure|high blood pressure
5305949|NCT00416611|Awareness|awareness
5305950|NCT00416611|Treatment|treatment
5305951|NCT00416611|Effective Control|effective control
5305952|NCT00416611|Coronary heart disease risk reduction|coronary heart disease risk reduction
5305953|NCT00416611|Hypertension|hypertension
5305954|NCT00416585|acne|acne
5305955|NCT00416585|isotretinoin|isotretinoin
5305956|NCT00416585|calcium. vitamin D|calcium. vitamin d
5305957|NCT00416572|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
5305958|NCT00416572|stage I breast cancer|stage i breast cancer
5305959|NCT00416572|stage II breast cancer|stage ii breast cancer
5305960|NCT00416559|long-term effects secondary to cancer therapy in children|long-term effects secondary to cancer therapy in children
5305961|NCT00416559|localized resectable neuroblastoma|localized resectable neuroblastoma
5305962|NCT00416559|localized unresectable neuroblastoma|localized unresectable neuroblastoma
5305963|NCT00416559|regional neuroblastoma|regional neuroblastoma
5305964|NCT00416546|Healthy Caucasians|healthy caucasians
5305965|NCT00416546|Healthy Japanese subjects|healthy japanese subjects
5305966|NCT00416546|Immunosuppressant|immunosuppressant
5305967|NCT00416546|early T-cell activation blockers|early t-cell activation blockers
5305968|NCT00416546|inhibition of protein kinase C|inhibition of protein kinase c
5305969|NCT00416533|recurrent prostate cancer|recurrent prostate cancer
5305970|NCT00416533|stage III prostate cancer|stage iii prostate cancer
5305971|NCT00416533|stage IV prostate cancer|stage iv prostate cancer
5305972|NCT00416533|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5305973|NCT00416520|Chronic Kidney Disease|chronic kidney disease
5305974|NCT00416520|Dialysis|dialysis
5305975|NCT00416520|Hyperphosphatemia|hyperphosphatemia
5305976|NCT00416520|Phosphate binder|phosphate binder
5305977|NCT00416507|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
5305978|NCT00416507|stage III pancreatic cancer|stage iii pancreatic cancer
5305979|NCT00416507|stage II pancreatic cancer|stage ii pancreatic cancer
5305980|NCT00416494|adenocarcinoma of the colon|adenocarcinoma of the colon
5305981|NCT00416494|recurrent colon cancer|recurrent colon cancer
5305982|NCT00416494|stage IV colon cancer|stage iv colon cancer
5305983|NCT00416494|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5305984|NCT00416494|recurrent rectal cancer|recurrent rectal cancer
5305985|NCT00416494|stage IV rectal cancer|stage iv rectal cancer
5305986|NCT00416481|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5305987|NCT00416468|Aliskiren , Valsartan, bioavailability, hypertension|aliskiren , valsartan, bioavailability, hypertension
5305988|NCT00416468|Healthy male and female subjects|healthy male and female subjects
5305989|NCT00416442|healthy subjects, safety, tolerability, dose escalation, pharmacokinetics, benzodiazepine|healthy subjects, safety, tolerability, dose escalation, pharmacokinetics, benzodiazepine
5305990|NCT00416442|Healthy male and female subjects|healthy male and female subjects
5305991|NCT00416429|recurrent renal cell cancer|recurrent renal cell cancer
5305992|NCT00416429|stage IV renal cell cancer|stage iv renal cell cancer
5305993|NCT00416403|breast cancer in situ|breast cancer in situ
5305994|NCT00416403|ductal breast carcinoma in situ|ductal breast carcinoma in situ
5305995|NCT00416403|stage IA breast cancer|stage ia breast cancer
5305996|NCT00416403|stage IB breast cancer|stage ib breast cancer
5305997|NCT00416390|benign prostatic hyperplasia|benign prostatic hyperplasia
5305998|NCT00416390|stage I prostate cancer|stage i prostate cancer
5305999|NCT00416390|stage IIB prostate cancer|stage iib prostate cancer
5306000|NCT00416390|stage IIA prostate cancer|stage iia prostate cancer
5306001|NCT00416390|stage III prostate cancer|stage iii prostate cancer
5306002|NCT00416390|stage IV prostate cancer|stage iv prostate cancer
5306003|NCT00416377|stage I childhood Hodgkin lymphoma|stage i childhood hodgkin lymphoma
5306004|NCT00416377|stage II childhood Hodgkin lymphoma|stage ii childhood hodgkin lymphoma
5306005|NCT00416377|stage III childhood Hodgkin lymphoma|stage iii childhood hodgkin lymphoma
5306006|NCT00416377|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
5306007|NCT00416377|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
5306008|NCT00416364|hernia|hernia
5306009|NCT00416364|inguinal|inguinal
5306010|NCT00416364|quality of life|quality of life
5306011|NCT00416351|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5306012|NCT00416351|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
5306013|NCT00416351|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5306014|NCT00416351|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
5306015|NCT00416351|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5306016|NCT00416351|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
5306017|NCT00416351|prolymphocytic leukemia|prolymphocytic leukemia
5306018|NCT00416351|childhood nasal type extranodal NK/T-cell lymphoma|childhood nasal type extranodal nk/t-cell lymphoma
5306019|NCT00416351|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
5306020|NCT00416351|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5306021|NCT00416351|small intestine lymphoma|small intestine lymphoma
5306022|NCT00416338|renal failure|renal failure
5306023|NCT00416338|infection|infection
5306024|NCT00416338|peritonitis|peritonitis
5306025|NCT00416325|prostate cancer|prostate cancer
5306026|NCT00416312|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5306027|NCT00416312|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5306028|NCT00416312|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5306029|NCT00416312|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5306030|NCT00416312|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5306031|NCT00416312|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5306032|NCT00416312|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5306033|NCT00416312|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5306034|NCT00416312|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5306035|NCT00416312|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5306036|NCT00416312|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5306037|NCT00416312|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5306038|NCT00416312|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5306039|NCT00416312|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5306040|NCT00416312|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5306041|NCT00416312|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5306042|NCT00416312|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5306043|NCT00416312|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5306044|NCT00416312|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5306045|NCT00416312|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5306306|NCT00415597|Embeda|embeda
5306046|NCT00416312|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5306047|NCT00416312|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5306048|NCT00416312|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5306049|NCT00416312|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5306050|NCT00416312|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5306051|NCT00416312|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5306052|NCT00416312|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5306053|NCT00416312|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5306054|NCT00416312|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5306055|NCT00416312|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5306056|NCT00416312|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5306057|NCT00416312|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5306058|NCT00416312|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5306059|NCT00416312|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5306060|NCT00416312|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5306061|NCT00416312|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5306062|NCT00416312|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5306063|NCT00416312|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5306064|NCT00416312|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5306065|NCT00416312|Waldenström macroglobulinemia|waldenström macroglobulinemia
5306066|NCT00416312|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
5306067|NCT00416312|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
5306068|NCT00416312|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
5306069|NCT00416312|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
5306070|NCT00416312|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
5306071|NCT00416312|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
5306072|NCT00416312|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
5306073|NCT00416312|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
5306074|NCT00416312|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
5306075|NCT00416312|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
5306076|NCT00416312|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
5306077|NCT00416312|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
5306078|NCT00416312|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
5306079|NCT00416312|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5306080|NCT00416312|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
5306081|NCT00416312|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
5306082|NCT00416312|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
5306083|NCT00416312|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
5306084|NCT00416312|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5306085|NCT00416312|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5306086|NCT00416312|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5306087|NCT00416312|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5306088|NCT00416312|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
5306089|NCT00416312|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
5306090|NCT00416312|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
5306091|NCT00416312|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
5306092|NCT00416312|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
5306093|NCT00416312|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
5306094|NCT00416312|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
5306095|NCT00416312|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
5306096|NCT00416312|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
5306097|NCT00416312|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
5306098|NCT00416312|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
5306099|NCT00416312|stage I mantle cell lymphoma|stage i mantle cell lymphoma
5306100|NCT00416312|stage I marginal zone lymphoma|stage i marginal zone lymphoma
5306101|NCT00416312|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
5306102|NCT00416312|adult grade III lymphomatoid granulomatosis|adult grade iii lymphomatoid granulomatosis
5306103|NCT00416312|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
5306104|NCT00416312|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
5306105|NCT00416312|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
5306106|NCT00416299|Cardiac biomarker|cardiac biomarker
5306107|NCT00416299|cardiac surgery|cardiac surgery
5306108|NCT00416299|elderly|elderly
5306109|NCT00416299|postoperative complications|postoperative complications
5306110|NCT00416299|Patients aged 75 years or older undergoing cardiac surgery|patients aged 75 years or older undergoing cardiac surgery
5306111|NCT00416286|Cetylpyridinium chlorid|cetylpyridinium chlorid
5306112|NCT00416286|Sustained release|sustained release
5306113|NCT00416286|orthodontic patients|orthodontic patients
5306114|NCT00416286|streptococcus mutans|streptococcus mutans
5306115|NCT00416286|Lactobacillus|lactobacillus
5306116|NCT00416286|Rate of bacterial load in saliva of orthodontic patients|rate of bacterial load in saliva of orthodontic patients
5306117|NCT00416273|Multiple Myeloma|multiple myeloma
5306118|NCT00416273|Bortezomib|bortezomib
5306119|NCT00416273|PS341|ps341
5306120|NCT00416273|Proteasome inhibitor|proteasome inhibitor
5306121|NCT00416273|Consolidation therapy|consolidation therapy
5306122|NCT00416260|Respiratory Distress Syndrome, Adult|respiratory distress syndrome, adult
5306123|NCT00416260|High-Frequency Ventilation|high-frequency ventilation
5306124|NCT00416260|Respiration, Artificial|respiration, artificial
5306125|NCT00416247|Hypnosis|hypnosis
5306126|NCT00416247|TMS|tms
5306127|NCT00416247|Cortical excitability|cortical excitability
5306128|NCT00416221|Depression|depression
5306129|NCT00416221|Lexapro|lexapro
5306130|NCT00416208|Multiple Myeloma|multiple myeloma
5306131|NCT00416208|Clinical trial|clinical trial
5306132|NCT00416208|Bortezomib|bortezomib
5306133|NCT00416208|PS341|ps341
5306134|NCT00416208|Proteasome inhibitor|proteasome inhibitor
5306135|NCT00416208|Consolidation therapy|consolidation therapy
5306136|NCT00416182|Cystic fibrosis|cystic fibrosis
5306137|NCT00416182|chronic sinusitis|chronic sinusitis
5306138|NCT00416182|mucolytic|mucolytic
5306139|NCT00416169|Frontotemporal Dementia|frontotemporal dementia
5306140|NCT00416169|Pick Complex|pick complex
5306141|NCT00416169|galantamine hydrobromide|galantamine hydrobromide
5306142|NCT00416156|Obesity|obesity
5306143|NCT00416156|Inflammation|inflammation
5306144|NCT00416143|Bed rest for idiopathic sudden sensorineural hearing loss|bed rest for idiopathic sudden sensorineural hearing loss
5306145|NCT00416130|Phase I/II Clinical Trial|phase i/ii clinical trial
5306146|NCT00416130|Vorinostat|vorinostat
5306147|NCT00416130|SAHA|saha
5306148|NCT00416130|Recurrent Breast Cancer|recurrent breast cancer
5306149|NCT00416130|Metastatic Breast Cancer|metastatic breast cancer
5306150|NCT00416117|Neck pain|neck pain
5306151|NCT00416117|Cervical pain|cervical pain
5306152|NCT00416117|Radicular pain|radicular pain
5306153|NCT00416117|Manual therapy|manual therapy
5306154|NCT00416117|Mobilization|mobilization
5306155|NCT00416117|Manipulation|manipulation
5306156|NCT00416104|analgesia|analgesia
5306157|NCT00416091|Tourette disorder, ADHD, comorbidity, neuropsychological|tourette disorder, adhd, comorbidity, neuropsychological
5306158|NCT00416078|technology development and assessment|technology development and assessment
5306159|NCT00416078|internet|internet
5306160|NCT00416078|randomized control trial|randomized control trial
5306161|NCT00416052|calcium|calcium
5306162|NCT00416052|calciuria|calciuria
5306163|NCT00416052|PTH|pth
5306164|NCT00416052|1,25-vitamin D|1,25-vitamin d
5306165|NCT00416052|Calcitriol|calcitriol
5306166|NCT00416052|bone mineral density|bone mineral density
5306167|NCT00416052|osteodensitometry|osteodensitometry
5306168|NCT00416039|midazolam|midazolam
5306169|NCT00416039|sublingual|sublingual
5306170|NCT00416039|oral morphine|oral morphine
5306171|NCT00416039|children|children
5306172|NCT00416039|bone fracture|bone fracture
5306173|NCT00416039|bone fracture with a deformed member|bone fracture with a deformed member
5306174|NCT00416026|Quality improvement|quality improvement
5306175|NCT00416026|Patient-centered care|patient-centered care
5306176|NCT00416026|Acute coronary syndrome|acute coronary syndrome
5306177|NCT00416026|Telephone counseling|telephone counseling
5306178|NCT00416013|Beta Natriuretic Peptide|beta natriuretic peptide
5306179|NCT00416013|Troponin|troponin
5306180|NCT00416013|Hemodialysis|hemodialysis
5306181|NCT00416000|Open/Elective EVAR patients|open/elective evar patients
5306182|NCT00415987|Multiple Myeloma|multiple myeloma
5306183|NCT00415974|Weight Loss|weight loss
5306184|NCT00415974|Obesity|obesity
5306185|NCT00415974|Overweight|overweight
5306186|NCT00415974|Physical Activity|physical activity
5306187|NCT00415974|Nutrition|nutrition
5306188|NCT00415974|Primary Care Physicians|primary care physicians
5306189|NCT00415974|Primary Care|primary care
5306190|NCT00415974|Counseling|counseling
5306191|NCT00415974|Adolescent|adolescent
5306192|NCT00415961|Percutaneous Coronary Intervention (PCI)|percutaneous coronary intervention (pci)
5306193|NCT00415961|Drug-eluting stent (DES)|drug-eluting stent (des)
5306194|NCT00415948|Heart|heart
5306195|NCT00415948|Cardiac|cardiac
5306196|NCT00415948|Acute Coronary Syndrome|acute coronary syndrome
5306197|NCT00415948|Sample Procurement|sample procurement
5306198|NCT00415922|Bioequivalence|bioequivalence
5306199|NCT00415922|bioavailability|bioavailability
5306200|NCT00415922|carbidopa|carbidopa
5306201|NCT00415922|levodopa|levodopa
5306202|NCT00415922|entacapone|entacapone
5306203|NCT00415922|fasting condition|fasting condition
5306637|NCT00414414|Prednisone|prednisone
5306204|NCT00415922|Healthy volunteers study|healthy volunteers study
5306205|NCT00415909|Leukemia|leukemia
5306206|NCT00415909|Chronic Myelogenous Leukemia|chronic myelogenous leukemia
5306207|NCT00415909|CML|cml
5306208|NCT00415909|Imatinib|imatinib
5306209|NCT00415909|Gleevec|gleevec
5306210|NCT00415909|TALL-104|tall-104
5306211|NCT00415896|weaning|weaning
5306212|NCT00415896|work of breathing|work of breathing
5306213|NCT00415896|spontaneous breathing trial|spontaneous breathing trial
5306214|NCT00415896|rapid shallow breathing|rapid shallow breathing
5306215|NCT00415883|Relative bioavailability, formulation, Japanese, valsartan, healthy subjects|relative bioavailability, formulation, japanese, valsartan, healthy subjects
5306216|NCT00415870|Overweight|overweight
5306217|NCT00415870|Cell Phone|cell phone
5306218|NCT00415870|Technology|technology
5306219|NCT00415857|Chronic Myelogenous Leukemia|chronic myelogenous leukemia
5306220|NCT00415857|Leukemia|leukemia
5306221|NCT00415857|Peptide Vaccine|peptide vaccine
5306222|NCT00415857|PR1 Peptide|pr1 peptide
5306223|NCT00415857|Imatinib|imatinib
5306224|NCT00415857|Gleevec|gleevec
5306225|NCT00415857|GM-CSF|gm-csf
5306226|NCT00415857|Sargramostim|sargramostim
5306227|NCT00415857|Leukine|leukine
5306228|NCT00415857|Peginterferon alfa-2b|peginterferon alfa-2b
5306229|NCT00415857|Peg-Intron|peg-intron
5306230|NCT00415844|Bioequivalence|bioequivalence
5306231|NCT00415844|bioavailability|bioavailability
5306232|NCT00415844|carbidopa|carbidopa
5306233|NCT00415844|levodopa|levodopa
5306234|NCT00415844|entacapone|entacapone
5306235|NCT00415844|fasting condition|fasting condition
5306236|NCT00415844|Healthy volunteers study|healthy volunteers study
5306237|NCT00415831|Bioequivalence|bioequivalence
5306238|NCT00415831|bioavailability|bioavailability
5306239|NCT00415831|carbidopa|carbidopa
5306240|NCT00415831|levodopa|levodopa
5306241|NCT00415831|entacapone|entacapone
5306242|NCT00415831|fed condition|fed condition
5306243|NCT00415831|Healthy volunteers study|healthy volunteers study
5306244|NCT00415818|Lung Cancer|lung cancer
5306245|NCT00415818|NSCLC|nsclc
5306246|NCT00415818|Cancer Vaccine|cancer vaccine
5306247|NCT00415818|Stage IV Non-Small Cell Lung Cancer|stage iv non-small cell lung cancer
5306248|NCT00415818|Stage IIIb Non-Small Cell Lung Cancer with effusion|stage iiib non-small cell lung cancer with effusion
5306249|NCT00415792|Ovulation induction|ovulation induction
5306250|NCT00415792|hCG|hcg
5306251|NCT00415792|GnRH agonist|gnrh agonist
5306252|NCT00415792|hyper-responders|hyper-responders
5306253|NCT00415779|hormone refractory|hormone refractory
5306254|NCT00415779|bone metastasis|bone metastasis
5306255|NCT00415779|chemotherapy|chemotherapy
5306256|NCT00415779|biphosphonates|biphosphonates
5306257|NCT00415766|recombinant hCG|recombinant hcg
5306258|NCT00415766|urinary hCG|urinary hcg
5306259|NCT00415740|Bioequivalence|bioequivalence
5306260|NCT00415740|bioavailability|bioavailability
5306261|NCT00415740|carbidopa|carbidopa
5306262|NCT00415740|levodopa|levodopa
5306263|NCT00415740|entacapone|entacapone
5306264|NCT00415740|fasting|fasting
5306265|NCT00415740|Healthy volunteers study|healthy volunteers study
5306266|NCT00415714|Primary Insomnia|primary insomnia
5306267|NCT00415714|Chronic Insomnia|chronic insomnia
5306268|NCT00415714|Biofeedback|biofeedback
5306269|NCT00415714|Sleeplessness|sleeplessness
5306270|NCT00415701|Etomidate|etomidate
5306271|NCT00415701|Propofol|propofol
5306272|NCT00415701|Adrenocortical Insufficiency|adrenocortical insufficiency
5306273|NCT00415701|Hemodynamic Process|hemodynamic process
5306274|NCT00415701|Vasoactive Agonists|vasoactive agonists
5306275|NCT00415701|Coronary Artery Bypass|coronary artery bypass
5306276|NCT00415701|Ischemic Coronary Heart Disease|ischemic coronary heart disease
5306277|NCT00415701|Mitral valve reconstruction/replacement|mitral valve reconstruction/replacement
5306278|NCT00415701|Mitral valve regurgitation|mitral valve regurgitation
5306279|NCT00415701|Heart Valve Prosthesis|heart valve prosthesis
5306280|NCT00415701|Cardiopulmonary Bypass|cardiopulmonary bypass
5306281|NCT00415688|lifestyle modification|lifestyle modification
5306282|NCT00415688|weight loss|weight loss
5306283|NCT00415688|hyperglycemia|hyperglycemia
5306284|NCT00415688|hypoglycemic agents|hypoglycemic agents
5306285|NCT00415675|Lung Cancer|lung cancer
5306286|NCT00415675|Abdominal Cancer|abdominal cancer
5306287|NCT00415675|Tissue Motion|tissue motion
5306288|NCT00415675|Breathing|breathing
5306289|NCT00415675|Motion CT Scans|motion ct scans
5306290|NCT00415649|HIV Preventive Vaccine|hiv preventive vaccine
5306291|NCT00415649|HIV Seronegativity|hiv seronegativity
5306292|NCT00415610|cerebral hemorrhage|cerebral hemorrhage
5306293|NCT00415610|intracerebral hemorrhage|intracerebral hemorrhage
5306294|NCT00415610|stroke|stroke
5306295|NCT00415610|hypertension|hypertension
5306296|NCT00415610|blood pressure|blood pressure
5306297|NCT00415610|nicardipine|nicardipine
5306298|NCT00415610|antihypertensive agent|antihypertensive agent
5306299|NCT00415610|hematoma expansion|hematoma expansion
5306300|NCT00415597|chronic pain|chronic pain
5306301|NCT00415597|joint pain|joint pain
5306302|NCT00415597|back pain|back pain
5306303|NCT00415597|diabetic peripheral neuropathy|diabetic peripheral neuropathy
5306304|NCT00415597|post herpetic neuralgia|post herpetic neuralgia
5306307|NCT00415597|Chronic Non-Malignant Pain|chronic non-malignant pain
5306308|NCT00415584|hypercalcemia|hypercalcemia
5306309|NCT00415584|transplant|transplant
5306310|NCT00415571|Hypogonadism|hypogonadism
5306311|NCT00415571|Erectile Dysfunction|erectile dysfunction
5306312|NCT00415558|Atrial Fibrillation|atrial fibrillation
5306313|NCT00415545|Heart Failure|heart failure
5306314|NCT00415545|Patient Education|patient education
5306315|NCT00415532|splenectomy|splenectomy
5306316|NCT00415532|platelet|platelet
5306317|NCT00415532|AMG 531|amg 531
5306318|NCT00415532|thrombopoietin|thrombopoietin
5306319|NCT00415532|blood disorder|blood disorder
5306320|NCT00415532|bleeding disorder|bleeding disorder
5306321|NCT00415532|immune thrombocytopenic purpura|immune thrombocytopenic purpura
5306322|NCT00415532|idiopathic thrombocytopenic purpura|idiopathic thrombocytopenic purpura
5306323|NCT00415532|immune (idiopathic) thrombocytopenic purpura|immune (idiopathic) thrombocytopenic purpura
5306324|NCT00415532|TPO|tpo
5306325|NCT00415532|thrombopoietic protein|thrombopoietic protein
5306326|NCT00415519|Amyotrophic lateral sclerosis|amyotrophic lateral sclerosis
5306327|NCT00415519|free radical scavenger|free radical scavenger
5306328|NCT00415493|rhinitis|rhinitis
5306329|NCT00415493|non-allergic rhinitis|non-allergic rhinitis
5306330|NCT00415493|rhinomanometry|rhinomanometry
5306331|NCT00415493|cold air|cold air
5306332|NCT00415493|triggers: cold, dry air inhalation|triggers: cold, dry air inhalation
5306333|NCT00415493|warm, most air inhalation|warm, most air inhalation
5306334|NCT00415493|Nonallergic rhinitis; normal controls|nonallergic rhinitis; normal controls
5306335|NCT00415467|Brain Tumor|brain tumor
5306336|NCT00415467|Radiation Therapy System|radiation therapy system
5306337|NCT00415467|GliaSite RTS|gliasite rts
5306338|NCT00415454|Pancreatic Cancer|pancreatic cancer
5306339|NCT00415441|physiotherapy|physiotherapy
5306340|NCT00415441|exercise|exercise
5306341|NCT00415441|manual therapy|manual therapy
5306342|NCT00415441|shoulder pain|shoulder pain
5306343|NCT00415441|rotator cuff|rotator cuff
5306344|NCT00415415|Racial Disparities|racial disparities
5306345|NCT00415415|Psychosocial Risk Factors|psychosocial risk factors
5306346|NCT00415415|Neighborhood Socioeconomic Status|neighborhood socioeconomic status
5306347|NCT00415415|CVD|cvd
5306348|NCT00415415|CHD|chd
5306349|NCT00415402|Vitamin D3|vitamin d3
5306350|NCT00415402|morbidity|morbidity
5306351|NCT00415402|mortality|mortality
5306352|NCT00415402|low birth weight|low birth weight
5306353|NCT00415402|supplementation|supplementation
5306354|NCT00415402|TH1|th1
5306355|NCT00415402|TH2|th2
5306356|NCT00415402|CRP|crp
5306357|NCT00415402|Neopterin|neopterin
5306358|NCT00415402|immune response|immune response
5306359|NCT00415389|Stroke|stroke
5306360|NCT00415389|interactive educational program|interactive educational program
5306361|NCT00415389|acute ischemic stroke|acute ischemic stroke
5306362|NCT00415376|seizure|seizure
5306363|NCT00415376|adult tumors metastatic to brain|adult tumors metastatic to brain
5306364|NCT00415376|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5306365|NCT00415350|Bronchiectasis|bronchiectasis
5306366|NCT00415350|Macrolide|macrolide
5306367|NCT00415350|Azithromycin|azithromycin
5306368|NCT00415350|Antibiotic prophylaxis|antibiotic prophylaxis
5306369|NCT00415350|Immunomodulation|immunomodulation
5306370|NCT00415350|Inflammation|inflammation
5306371|NCT00415350|Lung function|lung function
5306372|NCT00415350|Sputum|sputum
5306373|NCT00415350|Bacterial colonization|bacterial colonization
5306374|NCT00415337|lung|lung
5306375|NCT00415337|neoplasm|neoplasm
5306376|NCT00415337|bronchoscopy|bronchoscopy
5306377|NCT00415337|ultrasonography|ultrasonography
5306378|NCT00415337|histology|histology
5306379|NCT00415311|Liver Transplantation|liver transplantation
5306380|NCT00415311|rhMBL|rhmbl
5306381|NCT00415298|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
5306382|NCT00415298|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
5306383|NCT00415298|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
5306384|NCT00415298|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
5306385|NCT00415298|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
5306386|NCT00415298|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
5306387|NCT00415298|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
5306388|NCT00415298|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
5306389|NCT00415298|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
5306390|NCT00415298|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
5306391|NCT00415298|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5306392|NCT00415298|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5306393|NCT00415298|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5306394|NCT00415298|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
5306395|NCT00415298|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5306396|NCT00415285|Breast|breast
5306397|NCT00415285|Cancer|cancer
5306398|NCT00415285|Early-Stage|early-stage
5306399|NCT00415285|Chemotherapy|chemotherapy
5306400|NCT00415233|stage I follicular thyroid cancer|stage i follicular thyroid cancer
5306401|NCT00415233|stage I papillary thyroid cancer|stage i papillary thyroid cancer
5306402|NCT00415233|stage II follicular thyroid cancer|stage ii follicular thyroid cancer
5306403|NCT00415233|stage II papillary thyroid cancer|stage ii papillary thyroid cancer
5306404|NCT00415233|stage III follicular thyroid cancer|stage iii follicular thyroid cancer
5306405|NCT00415233|stage III papillary thyroid cancer|stage iii papillary thyroid cancer
5306406|NCT00415233|stage IV follicular thyroid cancer|stage iv follicular thyroid cancer
5306407|NCT00415233|stage IV papillary thyroid cancer|stage iv papillary thyroid cancer
5306408|NCT00415220|Chiropractic|chiropractic
5306409|NCT00415220|Manipulation|manipulation
5306410|NCT00415220|Back surgery|back surgery
5306411|NCT00415220|Herniated lumbar disc|herniated lumbar disc
5306412|NCT00415220|Sciatica|sciatica
5306413|NCT00415220|Lumbar microdiscectomy|lumbar microdiscectomy
5306414|NCT00415220|Cost-effectiveness|cost-effectiveness
5306415|NCT00415207|CYP2C8|cyp2c8
5306416|NCT00415207|MDR1|mdr1
5306417|NCT00415207|Pharmacogenetics|pharmacogenetics
5306418|NCT00415207|Paclitaxel|paclitaxel
5306419|NCT00415181|CYP2C8|cyp2c8
5306420|NCT00415181|MDR1|mdr1
5306421|NCT00415181|Pharmacogenetics|pharmacogenetics
5306422|NCT00415181|Paclitaxel|paclitaxel
5306423|NCT00415142|Depression|depression
5306424|NCT00415142|Major depressive disorders|major depressive disorders
5306425|NCT00415142|Controlled clinical trial|controlled clinical trial
5306426|NCT00415129|Influenza|influenza
5306427|NCT00415129|Orthomyxoviridae Infections|orthomyxoviridae infections
5306428|NCT00415129|Influenza Pandemics|influenza pandemics
5306429|NCT00415129|A/H5N1 strain|a/h5n1 strain
5306430|NCT00415116|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5306431|NCT00415103|Emesis|emesis
5306432|NCT00415103|Nausea|nausea
5306433|NCT00415103|leukemia|leukemia
5306434|NCT00415103|lymphoma|lymphoma
5306435|NCT00415090|Nevirapine|nevirapine
5306436|NCT00415090|Antiretroviral treatment|antiretroviral treatment
5306437|NCT00415090|Triple nucleoside therapy|triple nucleoside therapy
5306438|NCT00415090|HIV|hiv
5306439|NCT00415090|Treatment Experienced|treatment experienced
5306440|NCT00415064|Multiple Myeloma|multiple myeloma
5306441|NCT00415064|Perifosine|perifosine
5306442|NCT00415064|Lenalidomide|lenalidomide
5306443|NCT00415064|Dexamethasone|dexamethasone
5306444|NCT00415051|Rift Valley Fever, vaccine|rift valley fever, vaccine
5306445|NCT00415038|hypertension|hypertension
5306446|NCT00415038|pharmacogenomic|pharmacogenomic
5306447|NCT00415038|adducin|adducin
5306448|NCT00415038|ouabain|ouabain
5306449|NCT00415038|rostafuroxin|rostafuroxin
5306450|NCT00415025|long-term effects secondary to cancer therapy in adults|long-term effects secondary to cancer therapy in adults
5306451|NCT00415025|oral complications of radiation therapy|oral complications of radiation therapy
5306452|NCT00415025|radiation toxicity|radiation toxicity
5306453|NCT00415025|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
5306454|NCT00415025|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5306455|NCT00415025|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
5306456|NCT00415025|stage III verrucous carcinoma of the larynx|stage iii verrucous carcinoma of the larynx
5306457|NCT00415025|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5306458|NCT00415025|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
5306459|NCT00415025|stage III lymphoepithelioma of the oropharynx|stage iii lymphoepithelioma of the oropharynx
5306460|NCT00415025|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
5306461|NCT00415025|stage IV lymphoepithelioma of the oropharynx|stage iv lymphoepithelioma of the oropharynx
5306462|NCT00415025|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5306463|NCT00415025|stage III basal cell carcinoma of the lip|stage iii basal cell carcinoma of the lip
5306464|NCT00415025|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
5306465|NCT00415025|stage IV basal cell carcinoma of the lip|stage iv basal cell carcinoma of the lip
5306466|NCT00415025|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5306467|NCT00415025|stage III adenoid cystic carcinoma of the oral cavity|stage iii adenoid cystic carcinoma of the oral cavity
5306468|NCT00415025|stage III mucoepidermoid carcinoma of the oral cavity|stage iii mucoepidermoid carcinoma of the oral cavity
5306469|NCT00415025|stage III verrucous carcinoma of the oral cavity|stage iii verrucous carcinoma of the oral cavity
5306470|NCT00415025|stage IV adenoid cystic carcinoma of the oral cavity|stage iv adenoid cystic carcinoma of the oral cavity
5306471|NCT00415025|stage IV mucoepidermoid carcinoma of the oral cavity|stage iv mucoepidermoid carcinoma of the oral cavity
5306472|NCT00415025|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
5306473|NCT00415025|metastatic squamous neck cancer with occult primary|metastatic squamous neck cancer with occult primary
5306635|NCT00414414|Co-infection|co-infection
5306474|NCT00415025|stage III lymphoepithelioma of the nasopharynx|stage iii lymphoepithelioma of the nasopharynx
5306475|NCT00415025|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
5306476|NCT00415025|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
5306477|NCT00415025|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
5306478|NCT00415025|stage III esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iii esthesioneuroblastoma of the paranasal sinus and nasal cavity
5306479|NCT00415025|stage III inverted papilloma of the paranasal sinus and nasal cavity|stage iii inverted papilloma of the paranasal sinus and nasal cavity
5306480|NCT00415025|stage III midline lethal granuloma of the paranasal sinus and nasal cavity|stage iii midline lethal granuloma of the paranasal sinus and nasal cavity
5306481|NCT00415025|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
5306482|NCT00415025|stage IV esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iv esthesioneuroblastoma of the paranasal sinus and nasal cavity
5306483|NCT00415025|stage IV inverted papilloma of the paranasal sinus and nasal cavity|stage iv inverted papilloma of the paranasal sinus and nasal cavity
5306484|NCT00415025|stage IV midline lethal granuloma of the paranasal sinus and nasal cavity|stage iv midline lethal granuloma of the paranasal sinus and nasal cavity
5306485|NCT00415025|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
5306486|NCT00415025|stage III salivary gland cancer|stage iii salivary gland cancer
5306487|NCT00415025|stage IV salivary gland cancer|stage iv salivary gland cancer
5306488|NCT00415025|recurrent salivary gland cancer|recurrent salivary gland cancer
5306489|NCT00415025|recurrent lymphoepithelioma of the nasopharynx|recurrent lymphoepithelioma of the nasopharynx
5306490|NCT00415025|recurrent lymphoepithelioma of the oropharynx|recurrent lymphoepithelioma of the oropharynx
5306491|NCT00415025|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
5306492|NCT00415025|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
5306493|NCT00415025|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
5306494|NCT00415025|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
5306495|NCT00415025|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
5306496|NCT00415025|recurrent adenoid cystic carcinoma of the oral cavity|recurrent adenoid cystic carcinoma of the oral cavity
5306497|NCT00415025|recurrent mucoepidermoid carcinoma of the oral cavity|recurrent mucoepidermoid carcinoma of the oral cavity
5306498|NCT00415025|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
5306499|NCT00415025|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity
5306500|NCT00415025|recurrent inverted papilloma of the paranasal sinus and nasal cavity|recurrent inverted papilloma of the paranasal sinus and nasal cavity
5306501|NCT00415025|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity
5306502|NCT00415025|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
5306503|NCT00415025|recurrent basal cell carcinoma of the lip|recurrent basal cell carcinoma of the lip
5306504|NCT00415025|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
5306505|NCT00415025|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
5306506|NCT00415025|untreated metastatic squamous neck cancer with occult primary|untreated metastatic squamous neck cancer with occult primary
5306507|NCT00414999|Macular degeneration|macular degeneration
5306508|NCT00414999|Vascular diseases|vascular diseases
5306509|NCT00414999|Retinal disorders|retinal disorders
5306510|NCT00414999|Macular edema|macular edema
5306511|NCT00414960|Healthy|healthy
5306512|NCT00414960|Prevention|prevention
5306513|NCT00414947|Bioequivalence|bioequivalence
5306514|NCT00414947|safety|safety
5306515|NCT00414947|LAF237|laf237
5306516|NCT00414947|vildagliptin|vildagliptin
5306517|NCT00414947|Chinese|chinese
5306518|NCT00414947|healthy subjects|healthy subjects
5306519|NCT00414934|cancer|cancer
5306520|NCT00414934|bone scan|bone scan
5306521|NCT00414934|NaF bone PET|naf bone pet
5306522|NCT00414921|Attention deficit hyperactivity disorder|attention deficit hyperactivity disorder
5306523|NCT00414921|ADHD|adhd
5306524|NCT00414921|clonidine|clonidine
5306525|NCT00414921|methylphenidate|methylphenidate
5306526|NCT00414921|MPH|mph
5306527|NCT00414908|Chronic Pancreatitis|chronic pancreatitis
5306528|NCT00414908|Pancreatectomy|pancreatectomy
5306529|NCT00414908|Pancreatic Exocrine Insufficiency|pancreatic exocrine insufficiency
5306530|NCT00414882|TB, tuberculosis, Mycobacterium tuberculosis, Brazil|tb, tuberculosis, mycobacterium tuberculosis, brazil
5306531|NCT00414869|Liver|liver
5306532|NCT00414869|Portal pressure|portal pressure
5306533|NCT00414869|Fibrosis|fibrosis
5306534|NCT00414869|Nitric oxide|nitric oxide
5306535|NCT00414856|GERD|gerd
5306536|NCT00414856|gastroesophageal reflux disease|gastroesophageal reflux disease
5306537|NCT00414856|meal-induced gastroesophageal reflux events|meal-induced gastroesophageal reflux events
5306538|NCT00414843|Storage|storage
5306539|NCT00414843|Bile|bile
5306540|NCT00414843|Biomarkers|biomarkers
5306541|NCT00414843|biliary malignancies|biliary malignancies
5306542|NCT00414830|prevention|prevention
5306543|NCT00414830|health technology assessment|health technology assessment
5306544|NCT00414830|population based|population based
5306545|NCT00414830|fracture|fracture
5306546|NCT00414817|Inhaled Corticosteroids|inhaled corticosteroids
5306547|NCT00414817|ICS|ics
5306548|NCT00414817|Adherence|adherence
5306549|NCT00414804|Pain|pain
5306550|NCT00414804|Neurostimulation|neurostimulation
5306551|NCT00414778|Safety, pharmacokinetics, oral, single dose, multiple dose, LHT344, Chinese, healthy subjects|safety, pharmacokinetics, oral, single dose, multiple dose, lht344, chinese, healthy subjects
5306552|NCT00414765|Metastatic Renal Cell Carcinoma|metastatic renal cell carcinoma
5306553|NCT00414765|Metastatic Melanoma|metastatic melanoma
5306554|NCT00414765|Aldesleukin|aldesleukin
5306555|NCT00414765|IL-2|il-2
5306556|NCT00414752|Smoking, abstinence, craving, smoker, AFQ056, nicotine, placebo|smoking, abstinence, craving, smoker, afq056, nicotine, placebo
5306557|NCT00414739|growth of dendritic cells|growth of dendritic cells
5306558|NCT00414739|prevention|prevention
5306559|NCT00414726|ischemic stroke|ischemic stroke
5306560|NCT00414726|normobaric oxygen therapy|normobaric oxygen therapy
5306561|NCT00414713|Upper GI bleeding|upper gi bleeding
5306562|NCT00414713|Cirrhosis|cirrhosis
5306563|NCT00414713|Portal hypertension|portal hypertension
5306564|NCT00414713|Non-variceal bleeding|non-variceal bleeding
5306565|NCT00414713|Transfusion|transfusion
5306566|NCT00414700|Cartilage|cartilage
5306567|NCT00414700|Articular|articular
5306568|NCT00414700|Femoral|femoral
5306569|NCT00414700|Knee|knee
5306570|NCT00414687|Primary or secondary Pulmonary hypertension|primary or secondary pulmonary hypertension
5306571|NCT00414687|Iloprost|iloprost
5306572|NCT00414687|Inhaled|inhaled
5306573|NCT00414687|Long-term treatment|long-term treatment
5306574|NCT00414661|Observational non-interventional long-term safety|observational non-interventional long-term safety
5306575|NCT00414648|Lymphangiomyomatosis|lymphangiomyomatosis
5306576|NCT00414648|Lung Disease|lung disease
5306577|NCT00414635|HIV/AIDS|hiv/aids
5306578|NCT00414635|efavirenz|efavirenz
5306579|NCT00414635|tenofovir|tenofovir
5306580|NCT00414635|emtricitabine|emtricitabine
5306581|NCT00414635|FOTO|foto
5306582|NCT00414635|treatment interruption|treatment interruption
5306583|NCT00414635|Atripla|atripla
5306584|NCT00414635|Truvada|truvada
5306585|NCT00414635|Treatment Experienced|treatment experienced
5306586|NCT00414622|Alzheimer|alzheimer
5306587|NCT00414622|Probable Alzheimer disease|probable alzheimer disease
5306588|NCT00414609|myocardial infarction, aliskiren, heart failure|myocardial infarction, aliskiren, heart failure
5306589|NCT00414609|Post acute myocardial infarction with systolic dysfunction|post acute myocardial infarction with systolic dysfunction
5306590|NCT00414583|Cerebrovascular Accident|cerebrovascular accident
5306591|NCT00414583|Cerebrovascular Accident, Acute|cerebrovascular accident, acute
5306592|NCT00414583|CVA (Cerebrovascular Accident)|cva (cerebrovascular accident)
5306593|NCT00414583|Cerebral Stroke|cerebral stroke
5306594|NCT00414583|Stroke, Acute|stroke, acute
5306595|NCT00414583|Cerebrovascular Stroke|cerebrovascular stroke
5306596|NCT00414583|Fabry Disease|fabry disease
5306597|NCT00414583|Anderson-Fabry Disease|anderson-fabry disease
5306598|NCT00414583|Fabry's Disease|fabry's disease
5306599|NCT00414570|Positron Emission Tomography (PET)|positron emission tomography (pet)
5306600|NCT00414570|3'-deoxy-3'(18F)fluorothymidine ([18F]FLT)|3'-deoxy-3'(18f)fluorothymidine ([18f]flt)
5306601|NCT00414557|Musculoskeletal diseases|musculoskeletal diseases
5306602|NCT00414557|Joint diseases|joint diseases
5306603|NCT00414544|Nasolabial folds|nasolabial folds
5306604|NCT00414544|Dermal filler|dermal filler
5306605|NCT00414544|Injectable dermal filler|injectable dermal filler
5306606|NCT00414544|Soft tissue augmentation|soft tissue augmentation
5306607|NCT00414518|Acute Infection|acute infection
5306608|NCT00414518|Early HIV Infection|early hiv infection
5306609|NCT00414518|Short-Term Antiretroviral Therapy|short-term antiretroviral therapy
5306610|NCT00414518|Treatment Interruption|treatment interruption
5306611|NCT00414518|Antiretroviral Drug (ARV)|antiretroviral drug (arv)
5306612|NCT00414518|ART|art
5306613|NCT00414492|metastatic colorectal cancer|metastatic colorectal cancer
5306614|NCT00414492|liver metastasis|liver metastasis
5306615|NCT00414492|tumor margins|tumor margins
5306616|NCT00414492|neoadjuvant therapy|neoadjuvant therapy
5306617|NCT00414479|schistosomiasis|schistosomiasis
5306618|NCT00414479|anaemia|anaemia
5306619|NCT00414479|malaria|malaria
5306620|NCT00414479|iron deficiency|iron deficiency
5306621|NCT00414453|Neuropathic pain|neuropathic pain
5306622|NCT00414453|Chronic pain|chronic pain
5306623|NCT00414453|Multiple sclerosis|multiple sclerosis
5306624|NCT00414453|Central neuropathic pain|central neuropathic pain
5306625|NCT00414453|Peripheral neuropathic pain|peripheral neuropathic pain
5306626|NCT00414453|Opioid analgesic|opioid analgesic
5306627|NCT00414453|Lidocaine|lidocaine
5306628|NCT00414440|end-stage renal disease, ESRD, autosomal dominant polycystic kidney disease, ADPKD, everolimus|end-stage renal disease, esrd, autosomal dominant polycystic kidney disease, adpkd, everolimus
5306629|NCT00414427|Knee Osteoarthritis|knee osteoarthritis
5306630|NCT00414427|Ultrasonography|ultrasonography
5306631|NCT00414427|Corticosteroids|corticosteroids
5306632|NCT00414414|TB|tb
5306633|NCT00414414|Tuberculosis|tuberculosis
5306634|NCT00414414|HIV|hiv
5306636|NCT00414414|Steroid|steroid
5306638|NCT00414414|oral corticosteroids|oral corticosteroids
5306639|NCT00414414|TB Treatment|tb treatment
5306640|NCT00414414|South Africa|south africa
5306641|NCT00414388|AIPC|aipc
5306642|NCT00414375|Perforated Appendicitis|perforated appendicitis
5306643|NCT00414375|Abscess|abscess
5306644|NCT00414375|Appendectomy|appendectomy
5306645|NCT00414362|Bacteremia|bacteremia
5306646|NCT00414362|Urinary Tract Infections|urinary tract infections
5306647|NCT00414362|Fluoroquinolone|fluoroquinolone
5306648|NCT00414349|Topical analgesic|topical analgesic
5306649|NCT00414349|Multiple dose|multiple dose
5306650|NCT00414336|Blood Stage|blood stage
5306651|NCT00414336|Investigational|investigational
5306652|NCT00414336|Endemic|endemic
5306653|NCT00414336|Malaria|malaria
5306654|NCT00414310|Decitabine|decitabine
5306655|NCT00414310|Dacogen|dacogen
5306656|NCT00414310|5-AZA|5-aza
5306657|NCT00414310|Valproic Acid|valproic acid
5306658|NCT00414310|Myelodysplastic Syndrome|myelodysplastic syndrome
5306659|NCT00414310|Acute Myelogenous Leukemia|acute myelogenous leukemia
5306660|NCT00414310|MDS|mds
5306661|NCT00414310|AML|aml
5306662|NCT00414297|CAD|cad
5306663|NCT00414297|ECP|ecp
5306664|NCT00414297|CFI|cfi
5306665|NCT00414297|CPI|cpi
5306666|NCT00414297|MPR|mpr
5306667|NCT00414284|HIV/AIDS|hiv/aids
5306668|NCT00414284|viremia|viremia
5306669|NCT00414284|Kaletra|kaletra
5306670|NCT00414284|pharmacokinetics|pharmacokinetics
5306671|NCT00414284|viral load|viral load
5306672|NCT00414284|LPV/r|lpv/r
5306673|NCT00414284|Treatment Experienced|treatment experienced
5306674|NCT00414271|gastric cancer, neo-adjuvant chemotherapy|gastric cancer, neo-adjuvant chemotherapy
5306675|NCT00414258|Pain Response|pain response
5306676|NCT00414232|Rectal Cancer|rectal cancer
5306677|NCT00414232|Chemoradiation|chemoradiation
5306678|NCT00414232|Rectal Cancer receiving chemoradiation.|rectal cancer receiving chemoradiation.
5306679|NCT00414206|AMD|amd
5306680|NCT00414206|Wet AMD|wet amd
5306681|NCT00414193|AmpC beta-lactamase|ampc beta-lactamase
5306682|NCT00414193|Bacteremia|bacteremia
5306683|NCT00414193|Piperacillin|piperacillin
5306684|NCT00414193|Tazobactam|tazobactam
5306685|NCT00414167|Binge eating|binge eating
5306686|NCT00414167|Obesity|obesity
5306687|NCT00414167|Medication|medication
5306688|NCT00414167|Craving|craving
5306689|NCT00414167|Emotional eating|emotional eating
5306690|NCT00414154|Group based patient education,|group based patient education,
5306691|NCT00414154|multidisciplinary,|multidisciplinary,
5306692|NCT00414154|physical activity,|physical activity,
5306693|NCT00414154|adherence to treatment,|adherence to treatment,
5306694|NCT00414154|quality of life|quality of life
5306695|NCT00414141|Allergy|allergy
5306696|NCT00414141|Allergoid|allergoid
5306697|NCT00414141|Specific Immunotherapy|specific immunotherapy
5306698|NCT00414128|vasculitis|vasculitis
5306699|NCT00414128|ANCA|anca
5306700|NCT00414128|mycophenolate mofetil|mycophenolate mofetil
5306701|NCT00414128|cyclophosphamide|cyclophosphamide
5306702|NCT00414128|Anti neutrophil cytoplasm antibody associated vasculitis|anti neutrophil cytoplasm antibody associated vasculitis
5306703|NCT00414115|Observational controlled study|observational controlled study
5306704|NCT00414115|Genomic biomarkers|genomic biomarkers
5306705|NCT00414115|Adverse drug reaction|adverse drug reaction
5306706|NCT00414115|In children OR adults|in children or adults
5306707|NCT00414102|Chronic Insomnia|chronic insomnia
5306708|NCT00414102|Sleep Initiation and Maintenance Disorder|sleep initiation and maintenance disorder
5306709|NCT00414102|Drug Therapy|drug therapy
5306710|NCT00414076|Uterine Leiomyosarcoma|uterine leiomyosarcoma
5306711|NCT00414076|Uterine Neoplasm|uterine neoplasm
5306712|NCT00414076|Uterine Sarcomas|uterine sarcomas
5306713|NCT00414076|Uterine Cancer|uterine cancer
5306714|NCT00414076|Uterus|uterus
5306715|NCT00414076|LMS|lms
5306716|NCT00414076|ER Positivity|er positivity
5306717|NCT00414076|Femara|femara
5306718|NCT00414076|Letrozole|letrozole
5306719|NCT00414063|Fecal Energy|fecal energy
5306720|NCT00414063|Urine Energy|urine energy
5306721|NCT00414063|Bomb Calorimetry|bomb calorimetry
5306722|NCT00414063|Gut Maintenance Flora|gut maintenance flora
5306723|NCT00414063|Obesity|obesity
5306724|NCT00414063|Energy Metabolism|energy metabolism
5306725|NCT00414037|insomnia|insomnia
5306726|NCT00414037|lunesta|lunesta
5306727|NCT00414037|eszopiclone|eszopiclone
5306728|NCT00414037|pain|pain
5306729|NCT00414037|fMRI|fmri
5306730|NCT00414024|Opioid, constipation, tegaserod|opioid, constipation, tegaserod
5306731|NCT00414011|Removal of corneal epithelium followed by excimer laser treatment during prk|removal of corneal epithelium followed by excimer laser treatment during prk
5306732|NCT00413998|Functional ischaemic mitral regurgitation|functional ischaemic mitral regurgitation
5306733|NCT00413985|Low Birth Weight|low birth weight
5306734|NCT00413985|Fortified Human Milk|fortified human milk
5306735|NCT00413985|breastfeeding|breastfeeding
5306736|NCT00413985|infants|infants
5306737|NCT00413985|growth|growth
5306738|NCT00413959|NHL|nhl
5306739|NCT00413946|Premature infant|premature infant
5306740|NCT00413946|developmental outcome|developmental outcome
5306741|NCT00413933|falls|falls
5306742|NCT00413933|prevention|prevention
5306743|NCT00413933|elderly|elderly
5306744|NCT00413933|multidisciplinary intervention|multidisciplinary intervention
5306745|NCT00413933|health care utilization|health care utilization
5306746|NCT00413920|Steroids avoidance,|steroids avoidance,
5306747|NCT00413920|enteric-coated mycophenolate sodium (EC-MPS),|enteric-coated mycophenolate sodium (ec-mps),
5306748|NCT00413920|de novo renal transplantation|de novo renal transplantation
5306749|NCT00413881|Residual refractive error left over from initial LASIK correction.|residual refractive error left over from initial lasik correction.
5306750|NCT00413881|Higher Order aberrations measured using a wavefront analyzer.|higher order aberrations measured using a wavefront analyzer.
5306751|NCT00413868|Myopia with our without astigmatism|myopia with our without astigmatism
5306752|NCT00413855|Abdominal pain|abdominal pain
5306753|NCT00413855|Appendectomy|appendectomy
5306754|NCT00413855|Laparoscopy|laparoscopy
5306755|NCT00413855|Chronic appendicitis|chronic appendicitis
5306756|NCT00413855|Appendicopathy|appendicopathy
5306757|NCT00413842|Transcranial Direct Current Stimulation (tDCS)|transcranial direct current stimulation (tdcs)
5306758|NCT00413842|Plasticity|plasticity
5306759|NCT00413842|Primary Motor Cortex|primary motor cortex
5306760|NCT00413842|Cerebellum|cerebellum
5306761|NCT00413842|Transcranial Magnetic Stimulation (TMS)|transcranial magnetic stimulation (tms)
5306762|NCT00413842|Healthy Volunteer|healthy volunteer
5306763|NCT00413842|HV|hv
5306764|NCT00413829|age related macular degeneration|age related macular degeneration
5306765|NCT00413829|anti-VEGF therapy|anti-vegf therapy
5306766|NCT00413816|Anemia|anemia
5306767|NCT00413816|Critically ill|critically ill
5306768|NCT00413803|Hemodialysis|hemodialysis
5306769|NCT00413803|Nocturnal dialysis|nocturnal dialysis
5306770|NCT00413803|Cardiovascular disease|cardiovascular disease
5306771|NCT00413803|Quality of Life|quality of life
5306772|NCT00413803|left ventricular hypertrophy|left ventricular hypertrophy
5306773|NCT00413790|Heart rate, overactive bladder|heart rate, overactive bladder
5306774|NCT00413751|Large pupils rendering night vision difficulties such as haloes, glare, and monocular diplopia|large pupils rendering night vision difficulties such as haloes, glare, and monocular diplopia
5306775|NCT00413738|Central venous catheter|central venous catheter
5306776|NCT00413738|Catheter related bloodstream infection|catheter related bloodstream infection
5306777|NCT00413738|Heparin|heparin
5306778|NCT00413738|Chlorhexidine|chlorhexidine
5306779|NCT00413738|Sulfadiazine|sulfadiazine
5306780|NCT00413725|HIV Seronegativity|hiv seronegativity
5306781|NCT00413725|HIV Preventive Vaccine|hiv preventive vaccine
5306782|NCT00413725|Adenovirus|adenovirus
5306783|NCT00413712|Supraventricular Tachycardia|supraventricular tachycardia
5306784|NCT00413712|Calcium Channel Blockers|calcium channel blockers
5306785|NCT00413712|Verapamil|verapamil
5306786|NCT00413712|Diltiazem|diltiazem
5306787|NCT00413712|Adenosine|adenosine
5306788|NCT00413699|long-term|long-term
5306789|NCT00413699|open-label|open-label
5306790|NCT00413699|safety|safety
5306791|NCT00413686|Mixed solid tumors|mixed solid tumors
5306792|NCT00413673|Naturally occurring low to moderate myopia, with or without low levels of astigmatism in U.S. Army personnel|naturally occurring low to moderate myopia, with or without low levels of astigmatism in u.s. army personnel
5306793|NCT00413660|DMARD therapy|dmard therapy
5306794|NCT00413647|CardioPET|cardiopet
5306795|NCT00413647|Coronary Artery Disease|coronary artery disease
5306796|NCT00413647|Electrocardiogram|electrocardiogram
5306797|NCT00413647|Radiation Dosimetry|radiation dosimetry
5306798|NCT00413621|MRI|mri
5306799|NCT00413621|Alzheimer Disease|alzheimer disease
5306800|NCT00413621|Amyloid|amyloid
5306801|NCT00413621|AD|ad
5306802|NCT00413621|Healthy Volunteer|healthy volunteer
5306803|NCT00413621|HV|hv
5306804|NCT00413608|Human|human
5306805|NCT00413608|Adults|adults
5306806|NCT00413608|Male|male
5306807|NCT00413608|Alleles|alleles
5306808|NCT00413608|Genotype|genotype
5306809|NCT00413608|Platelet Aggregation/drug effects|platelet aggregation/drug effects
5306810|NCT00413608|Platelet Aggregation Inhibitors/*pharmacology|platelet aggregation inhibitors/*pharmacology
5306811|NCT00413608|Platelet Function Tests|platelet function tests
5306812|NCT00413608|Pharmacogenetics|pharmacogenetics
5306813|NCT00413608|*Polymorphism, Genetic|*polymorphism, genetic
5306814|NCT00413608|Ticlopidine/*analogs & derivatives/pharmacology|ticlopidine/*analogs & derivatives/pharmacology
5306815|NCT00413608|Healthy subjects|healthy subjects
5306816|NCT00413595|Cerebrovascular Accident|cerebrovascular accident
5306817|NCT00413595|Cerebrovascular Accident, Acute|cerebrovascular accident, acute
5306818|NCT00413595|Fabry Disease|fabry disease
5306819|NCT00413595|Fabry's Disease|fabry's disease
5306820|NCT00413595|Anderson-Fabry Disease|anderson-fabry disease
5306821|NCT00413595|CVA (Cerebrovascular Accident)|cva (cerebrovascular accident)
5306822|NCT00413595|Stroke, acute|stroke, acute
5306823|NCT00413595|Cerebral Stroke|cerebral stroke
5306824|NCT00413582|Pectus Excavatum|pectus excavatum
5306825|NCT00413582|Bar Repair|bar repair
5306826|NCT00413582|Pain Control|pain control
5306827|NCT00413582|Pectus Excavatum Repair|pectus excavatum repair
5306828|NCT00413556|Rhinitis|rhinitis
5306829|NCT00413556|Oral tablets|oral tablets
5306830|NCT00413556|Ig G4|ig g4
5306831|NCT00413556|grass pollen|grass pollen
5306832|NCT00413556|inmunotherapy|inmunotherapy
5306833|NCT00413543|COPD|copd
5306834|NCT00413543|exacerbation|exacerbation
5306835|NCT00413543|pulmonary rehabilitation|pulmonary rehabilitation
5306836|NCT00413543|exercise tolerance|exercise tolerance
5306837|NCT00413543|exacerbations|exacerbations
5306838|NCT00413543|quality of life|quality of life
5306839|NCT00413543|readmissions|readmissions
5306840|NCT00413517|Naturally occurring myopia with or without astigmatism|naturally occurring myopia with or without astigmatism
5306841|NCT00413504|Fondaparinux|fondaparinux
5306842|NCT00413504|Monotherapy|monotherapy
5306843|NCT00413504|Deep Vein thrombosis|deep vein thrombosis
5306844|NCT00413504|Pulmonary Embolism|pulmonary embolism
5306845|NCT00413504|Anticoagulation|anticoagulation
5306846|NCT00413491|Breast Cancer|breast cancer
5306847|NCT00413491|BRCA1 gene|brca1 gene
5306848|NCT00413491|BRCA2 gene|brca2 gene
5306849|NCT00413491|Magnetic Resonance Imaging|magnetic resonance imaging
5306850|NCT00413491|Mammography|mammography
5306851|NCT00413491|Ultrasonography|ultrasonography
5306852|NCT00413478|5-Aza|5-aza
5306853|NCT00413478|Azacytidine|azacytidine
5306854|NCT00413478|Vidaza|vidaza
5306855|NCT00413478|CLL|cll
5306856|NCT00413478|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
5306857|NCT00413478|Richter's transformation|richter's transformation
5306858|NCT00413478|Leukemia|leukemia
5306859|NCT00413465|Renal Plasma Flow|renal plasma flow
5306860|NCT00413465|Endotoxemia|endotoxemia
5306861|NCT00413465|Type 2 diabetes|type 2 diabetes
5306862|NCT00413452|Rheumatoid Arthritis|rheumatoid arthritis
5306863|NCT00413452|Etanercept|etanercept
5306864|NCT00413452|Enbrel|enbrel
5306865|NCT00413452|Amgen|amgen
5306866|NCT00413439|Isavuconazole|isavuconazole
5306867|NCT00413439|BAL8557|bal8557
5306868|NCT00413439|ASP9766|asp9766
5306869|NCT00413439|chemotherapy|chemotherapy
5306870|NCT00413439|prophylaxis|prophylaxis
5306871|NCT00413439|systemic fungal infection|systemic fungal infection
5306872|NCT00413426|Pharmacokinetics|pharmacokinetics
5306873|NCT00413426|oral|oral
5306874|NCT00413426|single dose|single dose
5306875|NCT00413426|table|table
5306876|NCT00413426|suspension|suspension
5306877|NCT00413426|release|release
5306878|NCT00413426|darifenacin|darifenacin
5306879|NCT00413426|healthy subjects|healthy subjects
5306880|NCT00413426|Healthy volunteers study|healthy volunteers study
5306881|NCT00413413|Hypertension, valsartan, amlodipine, high blood pressure|hypertension, valsartan, amlodipine, high blood pressure
5306882|NCT00413400|Inflammation|inflammation
5306883|NCT00413400|Visceral adiposity|visceral adiposity
5306884|NCT00413400|TNF|tnf
5306885|NCT00413400|Adiponectin|adiponectin
5306886|NCT00413400|glucose tolerance|glucose tolerance
5306887|NCT00413400|endothelial function|endothelial function
5306888|NCT00413400|metabolic syndrome|metabolic syndrome
5306889|NCT00413387|Asthma|asthma
5306890|NCT00413387|Combinations|combinations
5306891|NCT00413387|Inhaled therapy|inhaled therapy
5306892|NCT00413387|Corticosteroids|corticosteroids
5306893|NCT00413387|Long acting bronchodilators|long acting bronchodilators
5306894|NCT00413387|Beclomethasone|beclomethasone
5306895|NCT00413387|Formoterol|formoterol
5306896|NCT00413387|Budesonide|budesonide
5306897|NCT00413374|Lovenox|lovenox
5306898|NCT00413374|Enoxaparin|enoxaparin
5306899|NCT00413374|Prophylaxis|prophylaxis
5306900|NCT00413374|Pulmonary Embolism|pulmonary embolism
5306901|NCT00413374|Acute Deep Vein Thrombosis|acute deep vein thrombosis
5306902|NCT00413374|Venous Thrombosis|venous thrombosis
5306903|NCT00413374|Thrombosis|thrombosis
5306904|NCT00413374|Anticoagulation|anticoagulation
5306905|NCT00413361|Systemic Lupus Erythematosus|systemic lupus erythematosus
5306906|NCT00413361|Hydroxychloroquine|hydroxychloroquine
5306907|NCT00413348|Type 2 diabetes|type 2 diabetes
5306908|NCT00413348|Probiotics|probiotics
5306909|NCT00413348|Insulin-resistance|insulin-resistance
5306910|NCT00413348|Inflammation|inflammation
5306911|NCT00413348|Hyperinsulinemic euglycemic clamp|hyperinsulinemic euglycemic clamp
5306912|NCT00413348|Endotoxin|endotoxin
5306913|NCT00413335|Childhood and Adolescent Obesity|childhood and adolescent obesity
5306914|NCT00413335|Metabolic phenotype|metabolic phenotype
5306915|NCT00413335|Impaired Glucose Tolerance|impaired glucose tolerance
5306916|NCT00413335|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
5306917|NCT00413335|Insulin Sensitivity|insulin sensitivity
5306918|NCT00413335|Insulin Resistance|insulin resistance
5306919|NCT00413335|Abdominal fat partitioning|abdominal fat partitioning
5306920|NCT00413335|Impaired Glucose Tolerance (IGT)|impaired glucose tolerance (igt)
5306921|NCT00413335|Type 2 Diabetes Mellitus (T2DM)|type 2 diabetes mellitus (t2dm)
5306922|NCT00413322|Advanced Solid tumor|advanced solid tumor
5306923|NCT00413322|Adenosarcoma|adenosarcoma
5306924|NCT00413322|Androgen-independent prostate cancer|androgen-independent prostate cancer
5306925|NCT00413322|belinostat|belinostat
5306926|NCT00413322|bladder cancer|bladder cancer
5306927|NCT00413322|bladder neoplasms|bladder neoplasms
5306928|NCT00413322|Breast cancer|breast cancer
5306929|NCT00413322|Carcinoma, Bronchogenic|carcinoma, bronchogenic
5306930|NCT00413322|Carcinoma, Non-Small-Cell Lung|carcinoma, non-small-cell lung
5306931|NCT00413322|Carcinoma, Small Cell|carcinoma, small cell
5306932|NCT00413322|Carcinosarcoma|carcinosarcoma
5306933|NCT00413322|Chondrosarcoma|chondrosarcoma
5306934|NCT00413322|Coin Lesion, Pulmonary|coin lesion, pulmonary
5306935|NCT00413322|colorectal cancer|colorectal cancer
5306936|NCT00413322|Esophageal Neoplasms|esophageal neoplasms
5306937|NCT00413322|Facial Neoplasms|facial neoplasms
5306938|NCT00413322|Fibrosarcoma|fibrosarcoma
5306939|NCT00413322|head and neck cancer|head and neck cancer
5306940|NCT00413322|Hemangiosarcoma|hemangiosarcoma
5306941|NCT00413322|Histiocytoma, Malignant Fibrous|histiocytoma, malignant fibrous
5306942|NCT00413322|kidney cancer|kidney cancer
5306943|NCT00413322|Leiomyosarcoma|leiomyosarcoma
5306944|NCT00413322|Liposarcoma|liposarcoma
5306945|NCT00413322|lung cancer|lung cancer
5306946|NCT00413322|lung neoplasms|lung neoplasms
5306947|NCT00413322|Lymphangiosarcoma|lymphangiosarcoma
5306948|NCT00413322|mesothelioma|mesothelioma
5306949|NCT00413322|mesothelioma, cystic|mesothelioma, cystic
5306950|NCT00413322|Mixed Tumor, Mesodermal|mixed tumor, mesodermal
5306951|NCT00413322|Mouth Neoplasms|mouth neoplasms
5306952|NCT00413322|Myosarcoma|myosarcoma
5306953|NCT00413322|Myxosarcoma|myxosarcoma
5306954|NCT00413322|Osteosarcoma|osteosarcoma
5306955|NCT00413322|Otorhinolaryngologic Neoplasms|otorhinolaryngologic neoplasms
5306956|NCT00413322|Ovarian cancer|ovarian cancer
5306957|NCT00413322|Pancoast's Syndrome|pancoast's syndrome
5306958|NCT00413322|Parathyroid Neoplasms|parathyroid neoplasms
5306959|NCT00413322|Phyllodes Tumor|phyllodes tumor
5306960|NCT00413322|Pulmonary Sclerosing Hemangioma|pulmonary sclerosing hemangioma
5306961|NCT00413322|sarcoma|sarcoma
5306962|NCT00413322|thyroid cancer|thyroid cancer
5306963|NCT00413322|Thyroid Neoplasms|thyroid neoplasms
5306964|NCT00413322|Tracheal Neoplasms|tracheal neoplasms
5306965|NCT00413322|PXD101|pxd101
5306966|NCT00413309|Acute Coronary Syndrome|acute coronary syndrome
5306967|NCT00413309|Percutaneous Coronary Intervention|percutaneous coronary intervention
5306968|NCT00413309|Antiplatelet Therapy|antiplatelet therapy
5306969|NCT00413309|PillCam|pillcam
5306970|NCT00413309|Endoscopy|endoscopy
5306971|NCT00413296|PTSD|ptsd
5306972|NCT00413296|Anxiety|anxiety
5306973|NCT00413296|Pharmacotherapy|pharmacotherapy
5306974|NCT00413296|Levetiracetam|levetiracetam
5306975|NCT00413296|Relapse prevention|relapse prevention
5306976|NCT00413283|Advanced Non-Small Cell Lung Cancer|advanced non-small cell lung cancer
5306977|NCT00413283|Chemotherapy Induced Thrombocytopenia|chemotherapy induced thrombocytopenia
5306978|NCT00413283|CIT|cit
5306979|NCT00413283|NSCLC|nsclc
5306980|NCT00413283|Stage IIIB NSCLC|stage iiib nsclc
5306981|NCT00413283|Stage IV NSCLC|stage iv nsclc
5306982|NCT00413283|Gemcitabine|gemcitabine
5306983|NCT00413283|Carboplatin|carboplatin
5306984|NCT00413283|Cisplatin|cisplatin
5306985|NCT00413270|Imatinib resistant,|imatinib resistant,
5306986|NCT00413270|Imatinib intolerant,|imatinib intolerant,
5306987|NCT00413270|CML- blast crisis,|cml- blast crisis,
5306988|NCT00413270|CML- Accelerated phase,|cml- accelerated phase,
5306989|NCT00413270|CML- chronic phase,|cml- chronic phase,
5306990|NCT00413270|nilotinib,|nilotinib,
5306991|NCT00413270|Chronic myelogenous leukemia,|chronic myelogenous leukemia,
5306992|NCT00413270|blast crisis,|blast crisis,
5306993|NCT00413270|accelerated phase,|accelerated phase,
5306994|NCT00413270|chronic phase|chronic phase
5306995|NCT00413257|Postoperative Hyperalgesia|postoperative hyperalgesia
5306996|NCT00413257|cardiac Surgical Procedures|cardiac surgical procedures
5306997|NCT00413257|Nefopam|nefopam
5306998|NCT00413257|Randomized Controlled Trials|randomized controlled trials
5306999|NCT00413257|Pain and chronic disease|pain and chronic disease
5307000|NCT00413244|Hypogonadal|hypogonadal
5307001|NCT00413244|coronary artery disease|coronary artery disease
5307002|NCT00413244|percutaneous coronary intervention (PCI)|percutaneous coronary intervention (pci)
5307003|NCT00413231|Thoracic Aneurysm|thoracic aneurysm
5307004|NCT00413231|Endovascular Aortic Repair (EVAR)|endovascular aortic repair (evar)
5307005|NCT00413231|Endovascular Stent Graft|endovascular stent graft
5307006|NCT00413231|Endograft|endograft
5307007|NCT00413231|Thoracic Aortic Aneurysm|thoracic aortic aneurysm
5307008|NCT00413231|Endovascular procedure|endovascular procedure
5307009|NCT00413231|Descending Thoracic Aneurysm|descending thoracic aneurysm
5307010|NCT00413231|Valiant Stent Graft System|valiant stent graft system
5307011|NCT00413218|Invasive Candida infections|invasive candida infections
5307012|NCT00413218|BAL8557|bal8557
5307013|NCT00413218|ASP9766|asp9766
5307014|NCT00413218|Isavuconazole|isavuconazole
5307015|NCT00413218|Candidemia|candidemia
5307016|NCT00413218|Candidemia and other invasive candida infections|candidemia and other invasive candida infections
5307017|NCT00413218|Phase III study|phase iii study
5307018|NCT00413179|Polycystic Ovarian Syndrome|polycystic ovarian syndrome
5307019|NCT00413179|Chronic Anovulation|chronic anovulation
5307020|NCT00413179|Chronic Oligoovulation|chronic oligoovulation
5307021|NCT00413179|Infertility|infertility
5307022|NCT00413179|Hyperandrogenism|hyperandrogenism
5307023|NCT00413179|Metformin|metformin
5307024|NCT00413179|Ovulation induction|ovulation induction
5307025|NCT00413166|Acute Promyelocytic Leukemia|acute promyelocytic leukemia
5307026|NCT00413166|APL|apl
5307027|NCT00413166|ATRA|atra
5307028|NCT00413166|All-Trans Retinoic Acid|all-trans retinoic acid
5307029|NCT00413166|Arsenic Trioxide|arsenic trioxide
5307030|NCT00413166|Theophylline|theophylline
5307031|NCT00413166|Gemtuzumab|gemtuzumab
5307032|NCT00413153|HIV|hiv
5307033|NCT00413153|Kaletra|kaletra
5307034|NCT00413153|Reyataz|reyataz
5307035|NCT00413153|Insulin sensitivity|insulin sensitivity
5307036|NCT00413153|Lipids|lipids
5307037|NCT00413153|Body Composition|body composition
5307038|NCT00413153|Receiving Kaletra|receiving kaletra
5307039|NCT00413153|Treatment Experienced|treatment experienced
5307040|NCT00413140|childhood disease|childhood disease
5307041|NCT00413140|cystic fibrosis|cystic fibrosis
5307042|NCT00413140|exhaled breath condensate|exhaled breath condensate
5307043|NCT00413140|exhaled nitric oxide|exhaled nitric oxide
5307044|NCT00413140|airway inflammation|airway inflammation
5307045|NCT00413140|non-invasive inflammatory markers|non-invasive inflammatory markers
5307046|NCT00413140|controls|controls
5307047|NCT00413140|children|children
5307048|NCT00413127|Systemic lidocaine|systemic lidocaine
5307049|NCT00413127|peridural lidocaine|peridural lidocaine
5307050|NCT00413127|perioperative analgesia|perioperative analgesia
5307051|NCT00413127|inflammation|inflammation
5307052|NCT00413127|Anesthesia|anesthesia
5307053|NCT00413088|renal insufficency|renal insufficency
5307054|NCT00413088|low molecular weight heparin|low molecular weight heparin
5307055|NCT00413088|pharmacokinetics|pharmacokinetics
5307056|NCT00413088|elderly|elderly
5307057|NCT00413075|Solid tumors|solid tumors
5307058|NCT00413075|Adenosarcoma|adenosarcoma
5307059|NCT00413075|B-cell lymphoma|b-cell lymphoma
5307060|NCT00413075|belinostat|belinostat
5307061|NCT00413075|bladder cancer|bladder cancer
5307062|NCT00413075|Breast cancer|breast cancer
5307063|NCT00413075|Carcinoma, Non-Small-Cell Lung|carcinoma, non-small-cell lung
5307064|NCT00413075|Carcinoma, Small Cell|carcinoma, small cell
5307065|NCT00413075|Chondrosarcoma|chondrosarcoma
5307066|NCT00413075|colorectal cancer|colorectal cancer
5307067|NCT00413075|Esophageal Neoplasms|esophageal neoplasms
5307068|NCT00413075|Fibrosarcoma|fibrosarcoma
5307069|NCT00413075|head and neck cancer|head and neck cancer
5307070|NCT00413075|Hemangiosarcoma|hemangiosarcoma
5307071|NCT00413075|Hodgkins Disease|hodgkins disease
5307072|NCT00413075|kidney cancer|kidney cancer
5307073|NCT00413075|Leiomyosarcoma|leiomyosarcoma
5307074|NCT00413075|Liposarcoma|liposarcoma
5307075|NCT00413075|lung cancer|lung cancer
5307076|NCT00413075|lymphoma|lymphoma
5307077|NCT00413075|mesothelioma|mesothelioma
5307078|NCT00413075|mesothelioma, cystic|mesothelioma, cystic
5307079|NCT00413075|Mixed Tumor, Mesodermal|mixed tumor, mesodermal
5307080|NCT00413075|Osteosarcoma|osteosarcoma
5307081|NCT00413075|Otorhinolaryngologic Neoplasms|otorhinolaryngologic neoplasms
5307082|NCT00413075|Ovarian cancer|ovarian cancer
5307083|NCT00413075|Parathyroid Neoplasms|parathyroid neoplasms
5307084|NCT00413075|Prostate cancer|prostate cancer
5307085|NCT00413075|sarcoma|sarcoma
5307086|NCT00413075|T-cell lymphoma|t-cell lymphoma
5307087|NCT00413075|thyroid cancer|thyroid cancer
5307088|NCT00413075|PXD101|pxd101
5307089|NCT00413049|Hypertension, valsartan, amlodipine, high blood pressure|hypertension, valsartan, amlodipine, high blood pressure
5307090|NCT00413036|Celgene|celgene
5307091|NCT00413036|Revlimid|revlimid
5307092|NCT00413036|CC-5013|cc-5013
5307093|NCT00413036|Non-hodgkin's lymphoma|non-hodgkin's lymphoma
5307094|NCT00413036|Lenalidomide|lenalidomide
5307095|NCT00413036|CC5013|cc5013
5307096|NCT00413036|NHL|nhl
5307097|NCT00413023|depression|depression
5307098|NCT00413023|major depressive disorder|major depressive disorder
5307099|NCT00413023|MDD|mdd
5307100|NCT00412997|advanced solid tumor|advanced solid tumor
5307101|NCT00412997|Cutaneous T-cell lymphoma|cutaneous t-cell lymphoma
5307102|NCT00412997|Phase I|phase i
5307103|NCT00412997|HDAC inhibitor|hdac inhibitor
5307104|NCT00412997|Adult patients|adult patients
5307105|NCT00412971|Recurrence of bladder cancer|recurrence of bladder cancer
5307106|NCT00412971|Fluorescence cystoscopy|fluorescence cystoscopy
5307107|NCT00412932|Hypertension|hypertension
5307108|NCT00412932|Angiotensin Receptor Blocker|angiotensin receptor blocker
5307109|NCT00412932|Calcium Channel Blocker|calcium channel blocker
5307110|NCT00412932|Angiotensin Converting Enzyme Inhibitor|angiotensin converting enzyme inhibitor
5307111|NCT00412932|Hydrochlorothiazide|hydrochlorothiazide
5307112|NCT00412932|Stage I and II Hypertension|stage i and ii hypertension
5307113|NCT00412919|Myeloma|myeloma
5307114|NCT00412919|Relapsed|relapsed
5307115|NCT00412919|Refractory|refractory
5307116|NCT00412906|Low-grade inflammation|low-grade inflammation
5307117|NCT00412906|insulin resistance|insulin resistance
5307118|NCT00412906|Metabolism|metabolism
5307119|NCT00412906|Type 2 diabetes|type 2 diabetes
5307120|NCT00412906|Endotoxemia|endotoxemia
5307121|NCT00412906|Fat tissue|fat tissue
5307122|NCT00412906|Muscle tissue|muscle tissue
5307123|NCT00412906|RT-PCR|rt-pcr
5307124|NCT00412893|Invasive fungal disease|invasive fungal disease
5307125|NCT00412893|BAL8557|bal8557
5307126|NCT00412893|Isavuconazole|isavuconazole
5307127|NCT00412893|ASP9766|asp9766
5307128|NCT00412893|Filamentous fungi|filamentous fungi
5307129|NCT00412893|Phase III|phase iii
5307130|NCT00412893|Aspergillus species|aspergillus species
5307131|NCT00412867|Cerebral Infarction|cerebral infarction
5307132|NCT00412867|acute ischemic stroke|acute ischemic stroke
5307133|NCT00412867|Brain ischemia|brain ischemia
5307134|NCT00412841|Avascular Necrosis|avascular necrosis
5307135|NCT00412841|Lipitor|lipitor
5307136|NCT00412841|SLE|sle
5307137|NCT00412828|Melanoma|melanoma
5307138|NCT00412828|CR011-vcMMAE|cr011-vcmmae
5307139|NCT00412815|insulin sensitivity|insulin sensitivity
5307140|NCT00412815|coronary artery disease|coronary artery disease
5307141|NCT00412815|exercise training|exercise training
5307142|NCT00412802|enoxaparine|enoxaparine
5307143|NCT00412802|acute coronary syndrome|acute coronary syndrome
5307144|NCT00412802|renal failure|renal failure
5307145|NCT00412802|dose adaptation|dose adaptation
5307146|NCT00412789|Advanced solid tumor|advanced solid tumor
5307147|NCT00412789|Patupilone|patupilone
5307148|NCT00412763|Acute hepatitis|acute hepatitis
5307149|NCT00412763|Acute viral hepatitis|acute viral hepatitis
5307150|NCT00412763|Acute nonviral hepatitis|acute nonviral hepatitis
5307151|NCT00412763|Silymarin|silymarin
5307152|NCT00412763|Milk Thistle|milk thistle
5307153|NCT00412750|hepatitis B|hepatitis b
5307154|NCT00412750|hepatitis B Virus (HBV)|hepatitis b virus (hbv)
5307155|NCT00412750|chronic hepatitis B|chronic hepatitis b
5307156|NCT00412750|telbivudine|telbivudine
5307157|NCT00412750|peginterferon|peginterferon
5307158|NCT00412724|diet|diet
5307159|NCT00412724|acceptability|acceptability
5307160|NCT00412724|palatability|palatability
5307161|NCT00412724|food|food
5307162|NCT00412724|questionnaire|questionnaire
5307163|NCT00412724|Food habits|food habits
5307164|NCT00412672|Myocardial infarction|myocardial infarction
5307165|NCT00412672|contrast echocardiography|contrast echocardiography
5307166|NCT00412672|collateral circulation|collateral circulation
5307167|NCT00412659|Sinus, Pilonidal|sinus, pilonidal
5307168|NCT00412659|Pilonidal sinus|pilonidal sinus
5307169|NCT00412659|Pilonidal cysts|pilonidal cysts
5307170|NCT00412659|Pilonidal disease|pilonidal disease
5307171|NCT00412659|midline excision|midline excision
5307172|NCT00412659|Karydakis operation|karydakis operation
5307173|NCT00412659|expertise based study|expertise based study
5307174|NCT00412659|surgery|surgery
5307175|NCT00412659|therapy|therapy
5307176|NCT00412646|HIV|hiv
5307177|NCT00412646|AIDS|aids
5307178|NCT00412646|Dose finding study|dose finding study
5307179|NCT00412646|TMC125-C203|tmc125-c203
5307180|NCT00412646|Treatment Experienced|treatment experienced
5307181|NCT00412633|Obesity|obesity
5307182|NCT00412633|Men|men
5307183|NCT00412633|Overweight|overweight
5307184|NCT00412607|Ventricular Tachycardia|ventricular tachycardia
5307185|NCT00412607|Heart Diseases|heart diseases
5307186|NCT00412607|Arrhythmia|arrhythmia
5307187|NCT00412594|Hairy Cell Leukemia|hairy cell leukemia
5307188|NCT00412594|Leukemia|leukemia
5307189|NCT00412594|2CDA|2cda
5307190|NCT00412594|2-chlorodeoxyadenosine|2-chlorodeoxyadenosine
5307191|NCT00412594|Rituximab|rituximab
5307192|NCT00412594|Rituxan|rituxan
5307193|NCT00412594|HCL|hcl
5307194|NCT00412581|Melanoma|melanoma
5307195|NCT00412581|Lenalidomide|lenalidomide
5307196|NCT00412581|Dacarbazine|dacarbazine
5307197|NCT00412581|CC-5013|cc-5013
5307198|NCT00412581|Revlimid|revlimid
5307199|NCT00412581|DTIC|dtic
5307200|NCT00412568|Naturally occuring myopia with or without astigmatism.|naturally occuring myopia with or without astigmatism.
5307201|NCT00412542|Glioblastoma Multiforme|glioblastoma multiforme
5307202|NCT00412542|Glioma|glioma
5307203|NCT00412542|Thalidomide|thalidomide
5307204|NCT00412542|Thalomid|thalomid
5307205|NCT00412542|CPT-11|cpt-11
5307206|NCT00412542|Irinotecan|irinotecan
5307207|NCT00412542|malignant glioma|malignant glioma
5307208|NCT00412529|HBeAg-positive, chronic hepatitis B|hbeag-positive, chronic hepatitis b
5307209|NCT00412529|telbivudine|telbivudine
5307210|NCT00412529|entecavir|entecavir
5307211|NCT00412529|viral kinetics|viral kinetics
5307212|NCT00412516|Japanese Encephalitis|japanese encephalitis
5307213|NCT00412516|Japanese B Encephalitis|japanese b encephalitis
5307214|NCT00412516|Japanese B Viral Encephalitis|japanese b viral encephalitis
5307215|NCT00412516|Viral Encephalitis, Japanese B|viral encephalitis, japanese b
5307216|NCT00412490|Oral Cavity Cancer|oral cavity cancer
5307217|NCT00412490|Body Image|body image
5307218|NCT00412490|Smoking|smoking
5307219|NCT00412490|Appearance|appearance
5307220|NCT00412490|Questionnaire|questionnaire
5307221|NCT00412490|Interview|interview
5307222|NCT00412477|HIV|hiv
5307223|NCT00412477|Lfn-p24|lfn-p24
5307224|NCT00412477|Anthrax|anthrax
5307225|NCT00412477|IM|im
5307226|NCT00412477|HIV-1|hiv-1
5307227|NCT00412477|HIV Preventive Vaccine|hiv preventive vaccine
5307228|NCT00412464|fondaparinux|fondaparinux
5307229|NCT00412464|thrombosis|thrombosis
5307230|NCT00412464|heparin-induced thrombocytopenia|heparin-induced thrombocytopenia
5307231|NCT00412464|pediatrics|pediatrics
5307232|NCT00412451|Diabetic Macular Edema|diabetic macular edema
5307233|NCT00412451|PVD|pvd
5307234|NCT00412451|DME|dme
5307235|NCT00412451|Diabetic Retinopathy|diabetic retinopathy
5307236|NCT00412438|Atrial Fibrillation|atrial fibrillation
5307237|NCT00412425|Melanoma|melanoma
5307238|NCT00412425|Nausea|nausea
5307239|NCT00412425|Vomiting|vomiting
5307240|NCT00412425|Palonosetron|palonosetron
5307241|NCT00412425|Cisplatin|cisplatin
5307242|NCT00412425|Vinblastine|vinblastine
5307243|NCT00412425|Loss of Appetite|loss of appetite
5307244|NCT00412425|Weight loss|weight loss
5307245|NCT00412412|Cancer of Breast|cancer of breast
5307246|NCT00412412|Cancer of the Breast|cancer of the breast
5307247|NCT00412399|Employment|employment
5307248|NCT00412399|Negative workplace events|negative workplace events
5307249|NCT00412399|Healthy controls|healthy controls
5307250|NCT00412399|Fatigue|fatigue
5307251|NCT00412399|Physical activity|physical activity
5307252|NCT00412386|Pediatric|pediatric
5307253|NCT00412386|Congenital Heart Disease|congenital heart disease
5307254|NCT00412386|Imaging|imaging
5307255|NCT00412373|Schizoaffective Disorder|schizoaffective disorder
5307256|NCT00412373|antipsychotic|antipsychotic
5307257|NCT00412373|paliperidone|paliperidone
5307258|NCT00412373|placebo|placebo
5307259|NCT00412360|Double cord blood|double cord blood
5307260|NCT00412347|hyperglycemia|hyperglycemia
5307261|NCT00412347|diabetes|diabetes
5307262|NCT00412347|insulin drip|insulin drip
5307263|NCT00412347|hypoglycemia|hypoglycemia
5307264|NCT00412347|general wards|general wards
5307265|NCT00412321|Lymphoma, Non-Hodgkin|lymphoma, non-hodgkin
5307266|NCT00412321|Multiple Myeloma|multiple myeloma
5307267|NCT00412321|Castleman's disease|castleman's disease
5307268|NCT00412321|intravenous|intravenous
5307269|NCT00412321|IL-6|il-6
5307270|NCT00412308|spinal cord injury|spinal cord injury
5307271|NCT00412308|ventilator dependency|ventilator dependency
5307272|NCT00412308|ventilator weaning|ventilator weaning
5307273|NCT00412308|tidal volume|tidal volume
5307274|NCT00412295|Naturally occuring myopia with or without astigmatism.|naturally occuring myopia with or without astigmatism.
5307275|NCT00412295|Wavefront errors|wavefront errors
5307276|NCT00412269|Insulin Sensitivity|insulin sensitivity
5307277|NCT00412269|Total abdominal fat|total abdominal fat
5307278|NCT00412269|Visceral abdominal fat|visceral abdominal fat
5307279|NCT00412269|Reproductive Hormones|reproductive hormones
5307280|NCT00412269|Menopause|menopause
5307281|NCT00412269|Diabetes|diabetes
5307282|NCT00412269|Fat Distribution|fat distribution
5307283|NCT00412269|Sex Hormones|sex hormones
5307284|NCT00412256|Treatment|treatment
5307285|NCT00412256|Disease activity|disease activity
5307286|NCT00412256|Clinical trial|clinical trial
5307287|NCT00412243|Burkitt's Lymphoma|burkitt's lymphoma
5307288|NCT00412243|Lymphoblastic Lymphoma|lymphoblastic lymphoma
5307289|NCT00412243|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
5307290|NCT00412243|Clofarabine|clofarabine
5307291|NCT00412243|Clofarex|clofarex
5307292|NCT00412243|Clolar|clolar
5307293|NCT00412243|Cyclophosphamide|cyclophosphamide
5307294|NCT00412243|Neosar|neosar
5307295|NCT00412243|Cytoxan|cytoxan
5307296|NCT00412230|Pre-eclampsia|pre-eclampsia
5307297|NCT00412230|Gestational diabetes|gestational diabetes
5307298|NCT00412230|Insulin resistance|insulin resistance
5307299|NCT00412230|hypertension in pregnancy|hypertension in pregnancy
5307300|NCT00412204|double-blind|double-blind
5307301|NCT00412204|placebo-controlled|placebo-controlled
5307302|NCT00412204|crossover|crossover
5307303|NCT00412204|effects of tiotropium bromide|effects of tiotropium bromide
5307304|NCT00412204|gas exchange|gas exchange
5307305|NCT00412204|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5307306|NCT00412204|exercise.|exercise.
5307307|NCT00412191|healthy volunteers|healthy volunteers
5307308|NCT00412191|bioequivalence|bioequivalence
5307309|NCT00412191|food effects|food effects
5307310|NCT00412178|Internet|internet
5307311|NCT00412178|mobile communication|mobile communication
5307312|NCT00412178|glucose monitoring|glucose monitoring
5307313|NCT00412165|Prevention of Type 2 Diabetes|prevention of type 2 diabetes
5307314|NCT00412165|Adolescents|adolescents
5307315|NCT00412165|Obesity|obesity
5307316|NCT00412165|Overweight|overweight
5307317|NCT00412165|Internet Technology|internet technology
5307318|NCT00412165|Cell Phone|cell phone
5307319|NCT00412152|A randomised|a randomised
5307320|NCT00412152|double blind|double blind
5307321|NCT00412152|parallel group|parallel group
5307322|NCT00412152|multicentre study to demonstrate improvement in symptoms of constipation in subjects with non malignant pain|multicentre study to demonstrate improvement in symptoms of constipation in subjects with non malignant pain
5307323|NCT00412152|Moderate to severe chronic non-malignant pain|moderate to severe chronic non-malignant pain
5307324|NCT00412139|vascular calcifications|vascular calcifications
5307325|NCT00412139|uremic toxins|uremic toxins
5307326|NCT00412139|renal osteodystrophy|renal osteodystrophy
5307327|NCT00412139|Dialysis|dialysis
5307328|NCT00412126|Diabetes Mellitus|diabetes mellitus
5307329|NCT00412126|Coronary Restenosis|coronary restenosis
5307330|NCT00412126|Insulin|insulin
5307331|NCT00412126|Angioplasty|angioplasty
5307332|NCT00412100|A randomised|a randomised
5307333|NCT00412100|double-blind|double-blind
5307334|NCT00412100|double-dummy|double-dummy
5307335|NCT00412100|parallel-group multicentre study to demonstrate improvement in symptoms of constipation|parallel-group multicentre study to demonstrate improvement in symptoms of constipation
5307336|NCT00412100|Moderate to severe, chronic non-malignant pain|moderate to severe, chronic non-malignant pain
5307337|NCT00412087|vitamin D|vitamin d
5307338|NCT00412087|cholecalciferol|cholecalciferol
5307339|NCT00412087|pregnant women|pregnant women
5307340|NCT00412074|Breastfeeding|breastfeeding
5307341|NCT00412074|Vitamin D|vitamin d
5307342|NCT00412074|Vitamin D deficiency|vitamin d deficiency
5307343|NCT00412061|Cancer|cancer
5307344|NCT00412061|Carcinoid|carcinoid
5307345|NCT00412061|Tumor|tumor
5307346|NCT00412061|Neuroendocrine|neuroendocrine
5307347|NCT00412061|Carcinoma|carcinoma
5307348|NCT00412061|Everolimus|everolimus
5307349|NCT00412061|Octreotide|octreotide
5307350|NCT00412022|early breast cancer|early breast cancer
5307351|NCT00412022|adjuvant therapy|adjuvant therapy
5307352|NCT00412022|premenopause|premenopause
5307353|NCT00412022|premenopausal|premenopausal
5307354|NCT00412022|menopausal status|menopausal status
5307355|NCT00412022|postmenopause|postmenopause
5307356|NCT00412022|bone mineral density|bone mineral density
5307357|NCT00412022|hormone sensitive|hormone sensitive
5307358|NCT00412022|aromatase inhibitors|aromatase inhibitors
5307359|NCT00412022|letrozole|letrozole
5307360|NCT00412022|disease-free survival|disease-free survival
5307361|NCT00412009|tuberculosis|tuberculosis
5307362|NCT00412009|control|control
5307363|NCT00412009|treatment|treatment
5307364|NCT00412009|adherence|adherence
5307365|NCT00411996|indinavir/ritonavir|indinavir/ritonavir
5307366|NCT00411996|HIV/TB|hiv/tb
5307367|NCT00411996|rifampicin|rifampicin
5307368|NCT00411996|PK and efficacy of IDV/RTV 600/100 mg BID with rifampicin|pk and efficacy of idv/rtv 600/100 mg bid with rifampicin
5307369|NCT00411996|Treatment Naive|treatment naive
5307370|NCT00411983|chronic HIV infection|chronic hiv infection
5307371|NCT00411983|long term cohort of HIV infection|long term cohort of hiv infection
5307372|NCT00411970|23 gauge pars plana vitrectomy|23 gauge pars plana vitrectomy
5307373|NCT00411970|conjunctival erythema and injection|conjunctival erythema and injection
5307374|NCT00411970|20 gauge pars plana vitrectomy|20 gauge pars plana vitrectomy
5307375|NCT00411970|vitreous and retinal surgery|vitreous and retinal surgery
5307376|NCT00411957|atazanavir/ritonavir|atazanavir/ritonavir
5307377|NCT00411957|pharmacokinetic of ATV/r200/100 OD+2NRTIs|pharmacokinetic of atv/r200/100 od+2nrtis
5307378|NCT00411944|tacrolimus pharmacokinetics|tacrolimus pharmacokinetics
5307379|NCT00411944|CYP3A4 - CYP3A5|cyp3a4 - cyp3a5
5307380|NCT00411944|P-glycoprotein|p-glycoprotein
5307381|NCT00411944|single nucleotide polymorphisms|single nucleotide polymorphisms
5307382|NCT00411944|renal transplantation|renal transplantation
5307383|NCT00411944|calcineurin-inhibitor-associated nephrotoxicity|calcineurin-inhibitor-associated nephrotoxicity
5307384|NCT00411905|Myelodysplastic syndromes|myelodysplastic syndromes
5307385|NCT00411905|IPSS Int-2 and High risk|ipss int-2 and high risk
5307386|NCT00411905|Bortezomib|bortezomib
5307387|NCT00411905|Low dose Cytarabine|low dose cytarabine
5307388|NCT00411905|Bone Marrow diseases|bone marrow diseases
5307389|NCT00411879|Heart Arrest|heart arrest
5307390|NCT00411879|Cardiopulmonary Resuscitation|cardiopulmonary resuscitation
5307391|NCT00411879|Epinephrine|epinephrine
5307392|NCT00411879|Vasopressin|vasopressin
5307393|NCT00411879|Adrenal Cortex Hormones|adrenal cortex hormones
5307394|NCT00411866|safety|safety
5307395|NCT00411866|pharmacokinetics,|pharmacokinetics,
5307396|NCT00411853|Prostate, Hormone Refractory, Cancer|prostate, hormone refractory, cancer
5307397|NCT00411840|stem cell therapy|stem cell therapy
5307398|NCT00411840|peripheral arterial disease|peripheral arterial disease
5307399|NCT00411840|limb ischemia|limb ischemia
5307400|NCT00411827|Cytology|cytology
5307401|NCT00411827|Keratomileusis, Laser In Situ|keratomileusis, laser in situ
5307402|NCT00411827|Keratectomy, Photorefractive, Excimer Laser|keratectomy, photorefractive, excimer laser
5307403|NCT00411814|melbourne,|melbourne,
5307404|NCT00411814|healthy|healthy
5307405|NCT00411814|antibody,|antibody,
5307406|NCT00411814|male,|male,
5307407|NCT00411814|Safety and pharmacokinetic study,|safety and pharmacokinetic study,
5307408|NCT00411814|mild asthmatic patients,|mild asthmatic patients,
5307409|NCT00411814|australia|australia
5307410|NCT00411814|monoclonal|monoclonal
5307411|NCT00411814|female,|female,
5307412|NCT00411814|volunteers,|volunteers,
5307413|NCT00411801|bleeding disorder|bleeding disorder
5307414|NCT00411801|universal plasma|universal plasma
5307415|NCT00411801|plasma|plasma
5307416|NCT00411801|plasma exchange|plasma exchange
5307417|NCT00411788|HER-2 positive|her-2 positive
5307418|NCT00411788|breast cancer|breast cancer
5307419|NCT00411788|HER-2 positive breast cancer|her-2 positive breast cancer
5307420|NCT00411762|Pancreatic|pancreatic
5307421|NCT00411736|Cystic Fibrosis|cystic fibrosis
5307422|NCT00411736|Pseudomonas aeruginosa|pseudomonas aeruginosa
5307423|NCT00411736|Azithromycin|azithromycin
5307424|NCT00411736|Intermittent pulmonary infection|intermittent pulmonary infection
5307425|NCT00411723|multiple sclerosis, chronic-progressive, relapsing-remitting|multiple sclerosis, chronic-progressive, relapsing-remitting
5307426|NCT00411671|Lung Cancer|lung cancer
5307427|NCT00411671|Non-Small Cell Lung Cancer|non-small cell lung cancer
5307428|NCT00411671|NSCLC|nsclc
5307429|NCT00411671|Sorafenib|sorafenib
5307430|NCT00411671|BAY 43-9006|bay 43-9006
5307431|NCT00411671|Battle Program|battle program
5307432|NCT00411645|prevention|prevention
5307433|NCT00411645|prophylaxis|prophylaxis
5307434|NCT00411645|Cytomegalovirus|cytomegalovirus
5307435|NCT00411645|CMV|cmv
5307436|NCT00411645|allogeneic stem cell transplant|allogeneic stem cell transplant
5307437|NCT00411645|SCT|sct
5307438|NCT00411632|Lung Cancer|lung cancer
5307439|NCT00411632|Non-Small Cell Lung Cancer|non-small cell lung cancer
5307440|NCT00411632|NSCLC|nsclc
5307441|NCT00411632|Erlotinib|erlotinib
5307442|NCT00411632|Tarceva|tarceva
5307443|NCT00411632|Bexarotene|bexarotene
5307444|NCT00411632|Targretin|targretin
5307445|NCT00411632|OSI-774|osi-774
5307446|NCT00411632|Battle Program|battle program
5307447|NCT00411619|Tuberous Sclerosis Complex (TSC)|tuberous sclerosis complex (tsc)
5307448|NCT00411619|Subendymal Giant Cell Astrocytomas (SEGA'S)|subendymal giant cell astrocytomas (sega's)
5307449|NCT00411619|Mammalian Target of Rapamycin (mTOR)|mammalian target of rapamycin (mtor)
5307450|NCT00411619|Everolimus (RAD001)|everolimus (rad001)
5307451|NCT00411619|Tuberous Sclerosis with Subependymal Giant Cell Astrocytomas|tuberous sclerosis with subependymal giant cell astrocytomas
5307452|NCT00411606|Healthy|healthy
5307453|NCT00411606|Allergy|allergy
5307454|NCT00411606|Allergic Rhinoconjunctivitis|allergic rhinoconjunctivitis
5307455|NCT00411593|Non-Small Cell Lung Cancer|non-small cell lung cancer
5307456|NCT00411593|Lung Cancer|lung cancer
5307457|NCT00411593|NSCLC|nsclc
5307458|NCT00411593|Bortezomib|bortezomib
5307459|NCT00411593|Bevacizumab|bevacizumab
5307460|NCT00411580|Mild, moderate Alzheimer's Disease (AD), Aß-specific antibody, CAD106|mild, moderate alzheimer's disease (ad), aß-specific antibody, cad106
5307461|NCT00411567|markers, inflammation, optimal, sub-optimal, corticosteroid, bronchial asthma|markers, inflammation, optimal, sub-optimal, corticosteroid, bronchial asthma
5307462|NCT00411541|acute lymphoblastic leukemia, maintenance, BFM protocol|acute lymphoblastic leukemia, maintenance, bfm protocol
5307463|NCT00411541|intermediate risk childhood acute lymphoblastic leukemia|intermediate risk childhood acute lymphoblastic leukemia
5307464|NCT00411528|Prostate Cancer|prostate cancer
5307465|NCT00411528|Hormone Refractory|hormone refractory
5307466|NCT00411528|patupilone|patupilone
5307467|NCT00411528|docetaxel|docetaxel
5307468|NCT00411463|Interpersonal Therapy|interpersonal therapy
5307469|NCT00411463|Social Rhythm Therapy|social rhythm therapy
5307470|NCT00411463|Bipolar Disorder|bipolar disorder
5307471|NCT00411463|Depression|depression
5307472|NCT00411463|Seroquel|seroquel
5307473|NCT00411450|k-ras|k-ras
5307474|NCT00411450|biomarker|biomarker
5307475|NCT00411450|colorectal|colorectal
5307476|NCT00411450|colon|colon
5307477|NCT00411450|rectal|rectal
5307478|NCT00411450|FOLFOX|folfox
5307479|NCT00411450|FOLFIRI|folfiri
5307480|NCT00411424|Rheumatoid Arthritis|rheumatoid arthritis
5307481|NCT00411424|Randomized Control Trial|randomized control trial
5307482|NCT00411424|Treatment outcomes|treatment outcomes
5307483|NCT00411424|Monoclonal antibody|monoclonal antibody
5307484|NCT00411411|GLP-1|glp-1
5307485|NCT00411411|GIP|gip
5307486|NCT00411411|Incretin hormones|incretin hormones
5307487|NCT00411411|DPP-IV inhibitor|dpp-iv inhibitor
5307488|NCT00411411|Hyperglycaemic clamp|hyperglycaemic clamp
5307489|NCT00411411|Meal test|meal test
5307490|NCT00411398|Anxiety, SNRI, SSRI,GAD,SAD|anxiety, snri, ssri,gad,sad
5307491|NCT00411385|Chronic Hepatitis C|chronic hepatitis c
5307492|NCT00411385|Hepatitis C|hepatitis c
5307493|NCT00411385|CHC|chc
5307494|NCT00411385|HepC|hepc
5307495|NCT00411385|Genotype 1|genotype 1
5307496|NCT00411385|Hepatitis|hepatitis
5307497|NCT00411385|HCV|hcv
5307498|NCT00411372|Questionnaire|questionnaire
5307499|NCT00411372|COPD|copd
5307500|NCT00411372|Shortness of Breath|shortness of breath
5307501|NCT00411359|Refractory angina|refractory angina
5307502|NCT00411359|Cardiac rehabilitation|cardiac rehabilitation
5307503|NCT00411359|Symptomology|symptomology
5307504|NCT00411359|Physical ability|physical ability
5307505|NCT00411359|Exercise|exercise
5307506|NCT00411359|Psychology|psychology
5307507|NCT00411359|Quality of life|quality of life
5307508|NCT00411359|Risk factors|risk factors
5307509|NCT00411346|Asthma|asthma
5307510|NCT00411346|Self-Monitoring|self-monitoring
5307511|NCT00411346|Cost-effectiveness|cost-effectiveness
5307512|NCT00411333|diabetic retinopathy|diabetic retinopathy
5307513|NCT00411333|fluorescein angiography|fluorescein angiography
5307514|NCT00411333|steroid|steroid
5307515|NCT00411333|anti-angiogenesis|anti-angiogenesis
5307516|NCT00411320|Asthma|asthma
5307517|NCT00411320|Smoking|smoking
5307518|NCT00411320|Steroid Resistance|steroid resistance
5307519|NCT00411320|Corticosteroid insensitivity|corticosteroid insensitivity
5307520|NCT00411307|Analgesia|analgesia
5307521|NCT00411307|Postoperative pain|postoperative pain
5307522|NCT00411294|ergocalciferol|ergocalciferol
5307523|NCT00411294|chronic kidney disease|chronic kidney disease
5307524|NCT00411294|secondary hyperparathyroidism|secondary hyperparathyroidism
5307525|NCT00411294|vitamin D deficiency|vitamin d deficiency
5307526|NCT00411281|acute myeloid leukemia/transient myeloproliferative disorder|acute myeloid leukemia/transient myeloproliferative disorder
5307527|NCT00411268|Chronic low back pain|chronic low back pain
5307528|NCT00411268|OROS hydromorphone slow release tablet|oros hydromorphone slow release tablet
5307529|NCT00411268|Quality of Life|quality of life
5307530|NCT00411255|Blink Reflex|blink reflex
5307531|NCT00411255|Transcranial Magnetic Stimulation (TMS)|transcranial magnetic stimulation (tms)
5307532|NCT00411255|Dystonia|dystonia
5307533|NCT00411255|Blepharospasm|blepharospasm
5307534|NCT00411255|BSP|bsp
5307535|NCT00411255|Focal Dystonia|focal dystonia
5307536|NCT00411242|agomelatine, major depressive disorder, MDD, depression|agomelatine, major depressive disorder, mdd, depression
5307537|NCT00411216|vestibular rehabilitation|vestibular rehabilitation
5307538|NCT00411216|vestibular hypofunction|vestibular hypofunction
5307539|NCT00411203|Protein kinase C, tamoxifen, acute mania, clinical trial|protein kinase c, tamoxifen, acute mania, clinical trial
5307540|NCT00411190|Osteoarthritis|osteoarthritis
5307541|NCT00411190|Postmenopausal|postmenopausal
5307542|NCT00411190|Osteoporosis|osteoporosis
5307543|NCT00411177|end-stage renal disease|end-stage renal disease
5307544|NCT00411177|hemodialysis|hemodialysis
5307545|NCT00411177|cardiovascular morbidity and mortality|cardiovascular morbidity and mortality
5307546|NCT00411177|high flux dialyser|high flux dialyser
5307547|NCT00411177|on-line hemodiafiltration|on-line hemodiafiltration
5307548|NCT00411177|arterial stiffness|arterial stiffness
5307549|NCT00411177|inflammation|inflammation
5307550|NCT00411177|life quality|life quality
5307551|NCT00411177|left ventricular hypertrophy|left ventricular hypertrophy
5307552|NCT00411164|knee pain|knee pain
5307553|NCT00411164|hip pain|hip pain
5307554|NCT00411164|opioid|opioid
5307555|NCT00411151|Adenocarcinoma of esophagogastric junction|adenocarcinoma of esophagogastric junction
5307556|NCT00411151|Adenocarcinoma of lower esophagus (Barrett carcinoma)|adenocarcinoma of lower esophagus (barrett carcinoma)
5307557|NCT00411138|endometrial clear cell carcinoma|endometrial clear cell carcinoma
5307558|NCT00411138|stage II endometrial carcinoma|stage ii endometrial carcinoma
5307559|NCT00411138|stage IA grade 3 endometrial carcinoma|stage ia grade 3 endometrial carcinoma
5307560|NCT00411138|stage IB endometrial carcinoma|stage ib endometrial carcinoma
5307561|NCT00411138|stage IIIA endometrial carcinoma|stage iiia endometrial carcinoma
5307562|NCT00411138|stage IIIB endometrial carcinoma|stage iiib endometrial carcinoma
5307563|NCT00411138|stage IIIC endometrial carcinoma|stage iiic endometrial carcinoma
5307564|NCT00411125|Postmenopausal|postmenopausal
5307565|NCT00411125|osteoporosis|osteoporosis
5307566|NCT00411125|Pharmacokinetics/dynamics|pharmacokinetics/dynamics
5307567|NCT00411125|Calcitonin|calcitonin
5307568|NCT00411112|Sentinel node|sentinel node
5307569|NCT00411112|Isosulphan blue|isosulphan blue
5307570|NCT00411112|Isotopic detection|isotopic detection
5307571|NCT00411112|Survival|survival
5307572|NCT00411099|agomelatine, major depressive disorder, MDD, depression|agomelatine, major depressive disorder, mdd, depression
5307573|NCT00411086|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
5307574|NCT00411086|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
5307575|NCT00411086|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
5307576|NCT00411086|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5307577|NCT00411086|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5307578|NCT00411086|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5307579|NCT00411086|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
5307580|NCT00411086|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
5307581|NCT00411086|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
5307582|NCT00411086|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5307583|NCT00411086|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5307584|NCT00411086|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5307585|NCT00411086|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5307586|NCT00411086|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5307587|NCT00411086|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5307588|NCT00411086|Granulocyte-Macrophage Colony Stimulating Factor|granulocyte-macrophage colony stimulating factor
5307589|NCT00411086|GM-CSF|gm-csf
5307590|NCT00411086|Rituximab|rituximab
5307591|NCT00411086|Rituxan|rituxan
5307592|NCT00411073|darapladib|darapladib
5307593|NCT00411073|moxifloxacin|moxifloxacin
5307594|NCT00411073|QT study|qt study
5307595|NCT00411060|Rotator Cuff Tear|rotator cuff tear
5307596|NCT00411047|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5307597|NCT00411047|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5307598|NCT00411047|adenocarcinoma of the lung|adenocarcinoma of the lung
5307599|NCT00411047|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
5307600|NCT00411047|large cell lung cancer|large cell lung cancer
5307601|NCT00411034|Opioids|opioids
5307602|NCT00411034|Chronic Cancer Pain|chronic cancer pain
5307603|NCT00411034|analgesic|analgesic
5307604|NCT00410995|Physically fit volunteers|physically fit volunteers
5307605|NCT00410982|Lymphoid Malignancies|lymphoid malignancies
5307606|NCT00410982|Hodgkin's Disease|hodgkin's disease
5307607|NCT00410982|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
5307608|NCT00410982|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
5307609|NCT00410982|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
5307610|NCT00410982|Hematopoietic Cell Transplantation|hematopoietic cell transplantation
5307611|NCT00410982|Myeloma|myeloma
5307612|NCT00410982|Leukemia|leukemia
5307613|NCT00410982|Lymphoma|lymphoma
5307614|NCT00410982|Busulfan|busulfan
5307615|NCT00410982|Busulfex|busulfex
5307616|NCT00410982|Myleran|myleran
5307617|NCT00410982|Gemcitabine|gemcitabine
5307618|NCT00410982|Gemcitabine Hydrochloride|gemcitabine hydrochloride
5307619|NCT00410982|Gemzar|gemzar
5307620|NCT00410982|Melphalan|melphalan
5307621|NCT00410982|Alkeran|alkeran
5307622|NCT00410969|resuscitation|resuscitation
5307623|NCT00410969|hypothermia|hypothermia
5307624|NCT00410956|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
5307625|NCT00410956|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
5307626|NCT00410956|advanced adult primary liver cancer|advanced adult primary liver cancer
5307627|NCT00410956|recurrent adult primary liver cancer|recurrent adult primary liver cancer
5307628|NCT00410956|adult primary cholangiocellular carcinoma|adult primary cholangiocellular carcinoma
5307629|NCT00410943|Cancer pain|cancer pain
5307630|NCT00410943|Oral analgesic|oral analgesic
5307631|NCT00410943|OROS hydromorphone HCI|oros hydromorphone hci
5307632|NCT00410930|Immunotherapy, major allergen, birch|immunotherapy, major allergen, birch
5307633|NCT00410878|Opioids|opioids
5307634|NCT00410878|Chronic cancer pain|chronic cancer pain
5307635|NCT00410878|Analgesic|analgesic
5307636|NCT00410865|Oral Premalignancies|oral premalignancies
5307637|NCT00410865|Mouth Cancer|mouth cancer
5307638|NCT00410865|Dysplasia/Carcinoma in Situ (CIS) of the Oral Cavity|dysplasia/carcinoma in situ (cis) of the oral cavity
5307639|NCT00410865|Dysplasia/Carcinoma in situ (CIS) of the Oral Pharynx|dysplasia/carcinoma in situ (cis) of the oral pharynx
5307640|NCT00410865|Advexin|advexin
5307641|NCT00410865|Gene Therapy|gene therapy
5307642|NCT00410865|INGN 201|ingn 201
5307643|NCT00410865|Wild Type p53 Gene Induction|wild type p53 gene induction
5307644|NCT00410852|Insulin|insulin
5307645|NCT00410852|Hyperglycemia|hyperglycemia
5307646|NCT00410852|Hypoglycemia|hypoglycemia
5307647|NCT00410852|Intensive care|intensive care
5307648|NCT00410852|Critical care|critical care
5307649|NCT00410813|stage IV breast cancer|stage iv breast cancer
5307650|NCT00410813|male breast cancer|male breast cancer
5307651|NCT00410813|recurrent breast cancer|recurrent breast cancer
5307652|NCT00410813|bone metastases|bone metastases
5307653|NCT00410800|Insulin Resistance|insulin resistance
5307654|NCT00410800|Body Composition|body composition
5307655|NCT00410800|Kinetic Modeling|kinetic modeling
5307656|NCT00410787|Chronic cancer pain|chronic cancer pain
5307657|NCT00410787|OROS hydromorphone HCI (slow release)|oros hydromorphone hci (slow release)
5307658|NCT00410787|long-term repeated dosing|long-term repeated dosing
5307659|NCT00410774|stage III pancreatic cancer|stage iii pancreatic cancer
5307660|NCT00410774|stage I pancreatic cancer|stage i pancreatic cancer
5307661|NCT00410774|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
5307662|NCT00410774|stage II pancreatic cancer|stage ii pancreatic cancer
5307663|NCT00410761|ZD6474|zd6474
5307664|NCT00410761|MTC|mtc
5307665|NCT00410761|Hereditary Medullary Thyroid Cancer|hereditary medullary thyroid cancer
5307666|NCT00410761|Sporadic Medullary Thyroid Cancer|sporadic medullary thyroid cancer
5307667|NCT00410761|Medullary Thyroid Cancer|medullary thyroid cancer
5307668|NCT00410748|Chronic cancer pain|chronic cancer pain
5307669|NCT00410748|chronic pain|chronic pain
5307670|NCT00410735|ONO-1078|ono-1078
5307671|NCT00410735|chronic sinusitis|chronic sinusitis
5307672|NCT00410722|Nutrition|nutrition
5307673|NCT00410722|Type 2 Diabetes|type 2 diabetes
5307674|NCT00410709|Pediculosis Capitis|pediculosis capitis
5307675|NCT00410709|Head Lice|head lice
5307676|NCT00410709|Crawlers|crawlers
5307677|NCT00410709|Ova|ova
5307678|NCT00410709|Nits|nits
5307679|NCT00410696|High-dose chemotherapy|high-dose chemotherapy
5307680|NCT00410696|Growth factor|growth factor
5307681|NCT00410696|Pegfilgrastim|pegfilgrastim
5307682|NCT00410683|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5307683|NCT00410683|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5307684|NCT00410670|Gene|gene
5307685|NCT00410670|Genetics|genetics
5307686|NCT00410670|Family History|family history
5307687|NCT00410670|Radiation Therapy|radiation therapy
5307688|NCT00410670|Children|children
5307689|NCT00410657|graft versus host disease|graft versus host disease
5307690|NCT00410657|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5307691|NCT00410657|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5307692|NCT00410657|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5307693|NCT00410657|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5307694|NCT00410657|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5307695|NCT00410657|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5307696|NCT00410657|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5307697|NCT00410657|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5307698|NCT00410657|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
5307699|NCT00410657|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5307700|NCT00410657|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
5307701|NCT00410657|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5307702|NCT00410657|chronic eosinophilic leukemia|chronic eosinophilic leukemia
5307703|NCT00410657|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
5307704|NCT00410657|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5307705|NCT00410657|chronic neutrophilic leukemia|chronic neutrophilic leukemia
5307706|NCT00410657|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5307707|NCT00410657|disseminated neuroblastoma|disseminated neuroblastoma
5307708|NCT00410657|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5307709|NCT00410657|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
5307710|NCT00410657|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
5307711|NCT00410657|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5307712|NCT00410657|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
5307713|NCT00410657|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5307714|NCT00410657|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5307715|NCT00410657|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5307716|NCT00410657|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5307717|NCT00410657|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5307718|NCT00410657|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
5307824|NCT00410488|Vomiting|vomiting
5307719|NCT00410657|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5307720|NCT00410657|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5307721|NCT00410657|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
5307722|NCT00410657|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5307723|NCT00410657|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5307724|NCT00410657|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
5307725|NCT00410657|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5307726|NCT00410657|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5307727|NCT00410657|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
5307728|NCT00410657|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5307729|NCT00410657|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5307730|NCT00410657|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5307731|NCT00410657|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5307732|NCT00410657|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5307733|NCT00410657|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5307734|NCT00410657|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5307735|NCT00410657|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5307736|NCT00410657|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5307737|NCT00410657|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5307738|NCT00410657|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5307739|NCT00410657|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5307740|NCT00410657|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5307741|NCT00410657|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5307742|NCT00410657|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
5307743|NCT00410657|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5307744|NCT00410657|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5307745|NCT00410657|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5307746|NCT00410657|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
5307747|NCT00410657|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5307748|NCT00410657|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5307749|NCT00410657|poor prognosis metastatic gestational trophoblastic tumor|poor prognosis metastatic gestational trophoblastic tumor
5307750|NCT00410657|stage I multiple myeloma|stage i multiple myeloma
5307751|NCT00410657|stage II multiple myeloma|stage ii multiple myeloma
5307752|NCT00410657|stage III multiple myeloma|stage iii multiple myeloma
5307753|NCT00410657|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
5307754|NCT00410657|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5307755|NCT00410657|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5307756|NCT00410657|aggressive, noncontiguous stage II adult non-Hodgkin lymphoma|aggressive, noncontiguous stage ii adult non-hodgkin lymphoma
5307757|NCT00410657|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5307758|NCT00410657|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5307759|NCT00410657|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5307760|NCT00410657|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5307761|NCT00410657|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
5307762|NCT00410657|stage IIIA breast cancer|stage iiia breast cancer
5307763|NCT00410657|stage IIIB breast cancer|stage iiib breast cancer
5307764|NCT00410657|stage IIIC breast cancer|stage iiic breast cancer
5307765|NCT00410657|stage IV breast cancer|stage iv breast cancer
5307766|NCT00410657|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
5307767|NCT00410657|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
5307768|NCT00410657|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
5307769|NCT00410644|Non-malignant chronic pain|non-malignant chronic pain
5307770|NCT00410644|pain|pain
5307771|NCT00410644|analgesics|analgesics
5307772|NCT00410644|opioid|opioid
5307773|NCT00410631|localized resectable neuroblastoma|localized resectable neuroblastoma
5307774|NCT00410631|localized unresectable neuroblastoma|localized unresectable neuroblastoma
5307775|NCT00410631|regional neuroblastoma|regional neuroblastoma
5307776|NCT00410631|stage 4S neuroblastoma|stage 4s neuroblastoma
5307777|NCT00410631|disseminated neuroblastoma|disseminated neuroblastoma
5307778|NCT00410631|recurrent neuroblastoma|recurrent neuroblastoma
5307779|NCT00410618|cognitive/functional effects|cognitive/functional effects
5307780|NCT00410618|long-term effects secondary to cancer therapy in adults|long-term effects secondary to cancer therapy in adults
5307781|NCT00410618|recurrent colon cancer|recurrent colon cancer
5307782|NCT00410618|stage I colon cancer|stage i colon cancer
5307783|NCT00410618|stage II colon cancer|stage ii colon cancer
5307784|NCT00410618|stage III colon cancer|stage iii colon cancer
5307785|NCT00410618|stage IV colon cancer|stage iv colon cancer
5307786|NCT00410592|GERD|gerd
5307787|NCT00410592|acid reflux|acid reflux
5307788|NCT00410592|heartburn|heartburn
5307789|NCT00410592|PPI|ppi
5307790|NCT00410592|Hispanic|hispanic
5307791|NCT00410579|pain|pain
5307792|NCT00410579|fatigue|fatigue
5307793|NCT00410579|long-term effects secondary to cancer therapy in adults|long-term effects secondary to cancer therapy in adults
5307794|NCT00410579|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
5307795|NCT00410579|stage II rectal cancer|stage ii rectal cancer
5307796|NCT00410579|stage III rectal cancer|stage iii rectal cancer
5307797|NCT00410579|stage II colon cancer|stage ii colon cancer
5307798|NCT00410579|stage III colon cancer|stage iii colon cancer
5307799|NCT00410579|adenocarcinoma of the colon|adenocarcinoma of the colon
5307800|NCT00410566|Acid sphingomyelinase deficiency|acid sphingomyelinase deficiency
5307801|NCT00410566|Niemann-Pick disease|niemann-pick disease
5307802|NCT00410566|Lysosomal storage disorder|lysosomal storage disorder
5307803|NCT00410566|Enzyme replacement therapy|enzyme replacement therapy
5307804|NCT00410566|Treatment|treatment
5307805|NCT00410540|Cancer pain|cancer pain
5307806|NCT00410540|Oral analgesic|oral analgesic
5307807|NCT00410540|OROS hydromorphone HCL|oros hydromorphone hcl
5307808|NCT00410540|Morphine sulfate|morphine sulfate
5307809|NCT00410527|Antibacterials|antibacterials
5307810|NCT00410527|Colonization|colonization
5307811|NCT00410527|Infection|infection
5307812|NCT00410527|Pneumonia|pneumonia
5307813|NCT00410527|Resistance|resistance
5307814|NCT00410514|Beta-3 Receptor Agonist|beta-3 receptor agonist
5307815|NCT00410514|YM178|ym178
5307816|NCT00410514|Men|men
5307817|NCT00410514|Lower Urinary Tract Symptoms|lower urinary tract symptoms
5307818|NCT00410514|Bladder Outlet Obstruction|bladder outlet obstruction
5307819|NCT00410501|Pharmacokinetics, interaction, QAB149, indacaterol, ketoconazole, healthy subjects|pharmacokinetics, interaction, qab149, indacaterol, ketoconazole, healthy subjects
5307820|NCT00410488|Sarcoma|sarcoma
5307821|NCT00410488|Palonosetron|palonosetron
5307822|NCT00410488|Aloxi|aloxi
5307823|NCT00410488|Nausea|nausea
5307825|NCT00410475|Ionizing Radiation|ionizing radiation
5307826|NCT00410475|Cohort Study|cohort study
5307827|NCT00410475|Radiation-Induced Neoplasms|radiation-induced neoplasms
5307828|NCT00410475|Radiologic Technologists|radiologic technologists
5307829|NCT00410475|Ultraviolet Radiation|ultraviolet radiation
5307830|NCT00410462|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
5307831|NCT00410462|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
5307832|NCT00410462|adult liposarcoma|adult liposarcoma
5307833|NCT00410462|adult fibrosarcoma|adult fibrosarcoma
5307834|NCT00410462|adult malignant fibrous histiocytoma|adult malignant fibrous histiocytoma
5307835|NCT00410462|adult leiomyosarcoma|adult leiomyosarcoma
5307836|NCT00410462|adult rhabdomyosarcoma|adult rhabdomyosarcoma
5307837|NCT00410462|adult alveolar soft-part sarcoma|adult alveolar soft-part sarcoma
5307838|NCT00410462|adult malignant mesenchymoma|adult malignant mesenchymoma
5307839|NCT00410462|adult angiosarcoma|adult angiosarcoma
5307840|NCT00410462|adult epithelioid sarcoma|adult epithelioid sarcoma
5307841|NCT00410462|adult neurofibrosarcoma|adult neurofibrosarcoma
5307842|NCT00410462|adult synovial sarcoma|adult synovial sarcoma
5307843|NCT00410462|recurrent uterine sarcoma|recurrent uterine sarcoma
5307844|NCT00410462|stage IV uterine sarcoma|stage iv uterine sarcoma
5307845|NCT00410462|ovarian sarcoma|ovarian sarcoma
5307846|NCT00410462|small intestine leiomyosarcoma|small intestine leiomyosarcoma
5307847|NCT00410462|recurrent small intestine cancer|recurrent small intestine cancer
5307951|NCT00409981|paccocath|paccocath
5307848|NCT00410449|End stage renal disease treated by hemodialysis|end stage renal disease treated by hemodialysis
5307849|NCT00410449|Hemodialysis vascular access patency|hemodialysis vascular access patency
5307850|NCT00410449|Vitamin E|vitamin e
5307851|NCT00410449|oxidative markers|oxidative markers
5307852|NCT00410449|pentosidine|pentosidine
5307853|NCT00410449|hydroxynonenal|hydroxynonenal
5307854|NCT00410449|levuglandin|levuglandin
5307855|NCT00410436|Type 1 Diabetes|type 1 diabetes
5307856|NCT00410436|Resistance Exercise|resistance exercise
5307857|NCT00410436|Aerobic Exercise|aerobic exercise
5307858|NCT00410423|Leukemia|leukemia
5307859|NCT00410423|Acute Myeloid Leukemia|acute myeloid leukemia
5307860|NCT00410423|Acute Lymphoid / Lymphoblastic Leukemia|acute lymphoid / lymphoblastic leukemia
5307861|NCT00410397|Low back pain|low back pain
5307862|NCT00410397|Hip pain|hip pain
5307863|NCT00410384|Antibodies|antibodies
5307864|NCT00410384|Autoimmune Diseases|autoimmune diseases
5307865|NCT00410384|Systemic Lupus Erythematosus|systemic lupus erythematosus
5307866|NCT00410384|SLE|sle
5307867|NCT00410384|Belimumab|belimumab
5307868|NCT00410384|Lupus|lupus
5307869|NCT00410371|tolerability|tolerability
5307870|NCT00410371|safety|safety
5307871|NCT00410371|Pharmacokinetic characteristics|pharmacokinetic characteristics
5307872|NCT00410358|Gimatecan|gimatecan
5307873|NCT00410358|topoisomerase I inhibitor|topoisomerase i inhibitor
5307874|NCT00410358|advanced solid tumors|advanced solid tumors
5307875|NCT00410332|tonsillectomy|tonsillectomy
5307876|NCT00410332|pain|pain
5307877|NCT00410332|homeopathy|homeopathy
5307878|NCT00410332|Traumeel|traumeel
5307879|NCT00410306|Hypogonadism|hypogonadism
5307880|NCT00410306|Nebido|nebido
5307881|NCT00410306|Testosterone|testosterone
5307882|NCT00410306|Observational Study|observational study
5307883|NCT00410293|Heart failure|heart failure
5307884|NCT00410293|Diagnostic|diagnostic
5307885|NCT00410293|Natriuretic peptide|natriuretic peptide
5307886|NCT00410293|NT-pro B-type natriuretic peptide|nt-pro b-type natriuretic peptide
5307887|NCT00410293|Length of stay|length of stay
5307888|NCT00410293|Costs|costs
5307889|NCT00410267|glaucoma|glaucoma
5307890|NCT00410267|Post operative from selective laser trabeculoplasty|post operative from selective laser trabeculoplasty
5307891|NCT00410241|Genome|genome
5307892|NCT00410241|Cardiovascular|cardiovascular
5307893|NCT00410241|Volunteers|volunteers
5307894|NCT00410241|Genes|genes
5307895|NCT00410241|Atherosclerosis|atherosclerosis
5307896|NCT00410241|Coronary Artery Calcification|coronary artery calcification
5307897|NCT00410228|safety, tolerability, pharmacokinetics, pharmacodynamics, AHT956|safety, tolerability, pharmacokinetics, pharmacodynamics, aht956
5307898|NCT00410189|Non-Small Cell Lung Cancer|non-small cell lung cancer
5307899|NCT00410189|NSCLC|nsclc
5307900|NCT00410189|Lung Cancer|lung cancer
5307901|NCT00410189|ZD6474|zd6474
5307902|NCT00410189|Zactima|zactima
5307903|NCT00410189|Vandetanib|vandetanib
5307904|NCT00410189|BATTLE Program|battle program
5307905|NCT00410163|B-cell|b-cell
5307906|NCT00410163|cyclophosphamide|cyclophosphamide
5307907|NCT00410163|fludarabine|fludarabine
5307908|NCT00410163|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
5307909|NCT00410163|Ofatumumab|ofatumumab
5307910|NCT00410150|Status asthmaticus|status asthmaticus
5307911|NCT00410150|Asthma|asthma
5307912|NCT00410150|Helium|helium
5307913|NCT00410150|Children|children
5307914|NCT00410124|advanced kidney cancer|advanced kidney cancer
5307915|NCT00410124|everolimus|everolimus
5307916|NCT00410124|kidney cancer|kidney cancer
5307917|NCT00410124|oral therapy|oral therapy
5307918|NCT00410111|sepsis|sepsis
5307919|NCT00410111|encephalopathy|encephalopathy
5307920|NCT00410111|cerebral perfusion|cerebral perfusion
5307921|NCT00410111|electroencephalogram|electroencephalogram
5307922|NCT00410098|asthma|asthma
5307923|NCT00410098|yoga|yoga
5307924|NCT00410098|heat|heat
5307925|NCT00410098|humidity|humidity
5307926|NCT00410098|bikram|bikram
5307927|NCT00410059|Non-Small Cell Lung Cancer|non-small cell lung cancer
5307928|NCT00410059|Lung Cancer|lung cancer
5307929|NCT00410059|NSCLC|nsclc
5307930|NCT00410059|Erlotinib|erlotinib
5307931|NCT00410059|Tarceva|tarceva
5307932|NCT00410059|OSI-774|osi-774
5307933|NCT00410059|Battle Program|battle program
5307934|NCT00410020|alpha linolenic acid|alpha linolenic acid
5307935|NCT00410020|atrial fibrillation|atrial fibrillation
5307936|NCT00410020|omega 3 fatty acids|omega 3 fatty acids
5307937|NCT00410020|diet|diet
5307938|NCT00410020|rapeseed oil|rapeseed oil
5307939|NCT00410020|canola oil|canola oil
5307940|NCT00410020|cardiovascular diseases|cardiovascular diseases
5307941|NCT00410007|ADPKD|adpkd
5307942|NCT00410007|Urinary Aquaporin-2|urinary aquaporin-2
5307943|NCT00410007|ENaC|enac
5307944|NCT00410007|Fractional sodium excretion|fractional sodium excretion
5307945|NCT00410007|High/low sodium diet|high/low sodium diet
5307946|NCT00409994|Colorectal cancer|colorectal cancer
5307947|NCT00409994|M-tor inhibitor|m-tor inhibitor
5307948|NCT00409994|Rapamycin|rapamycin
5307949|NCT00409981|in stent restenosis|in stent restenosis
5308070|NCT00409422|overweight|overweight
5307950|NCT00409981|paclitaxel coated balloon catheter|paclitaxel coated balloon catheter
5307952|NCT00409981|drug eluting balloon|drug eluting balloon
5307953|NCT00409968|Lung Cancer|lung cancer
5307954|NCT00409968|Non Small Cell Lung Cancer|non small cell lung cancer
5307955|NCT00409968|BATTLE Program|battle program
5307956|NCT00409968|Umbrella Trial|umbrella trial
5307957|NCT00409968|Tumor Biopsy|tumor biopsy
5307958|NCT00409968|NSCLC|nsclc
5307959|NCT00409955|Lamellar transplant|lamellar transplant
5307960|NCT00409955|Lyophilization|lyophilization
5307961|NCT00409955|Corneas storage|corneas storage
5307962|NCT00409955|Keratoconus patients|keratoconus patients
5307963|NCT00409955|Best corrected visual acuity < 20/60|best corrected visual acuity < 20/60
5307964|NCT00409955|Signed the consent inform|signed the consent inform
5307965|NCT00409942|Chronic heart failure|chronic heart failure
5307966|NCT00409942|Torasemide prolonged release|torasemide prolonged release
5307967|NCT00409942|Myocardial fibrosis|myocardial fibrosis
5307968|NCT00409942|Loop diuretics|loop diuretics
5307969|NCT00409942|Peptide of procollagen type 1|peptide of procollagen type 1
5307970|NCT00409929|Safety, tolerability, pharmacokinetics, pharmacodynamics, AEB071, healthy subjects, transplantation|safety, tolerability, pharmacokinetics, pharmacodynamics, aeb071, healthy subjects, transplantation
5307971|NCT00409916|chronic heart failure|chronic heart failure
5307972|NCT00409916|heart failure|heart failure
5307973|NCT00409916|congestive heart failure|congestive heart failure
5307974|NCT00409916|impedance cardiography|impedance cardiography
5307975|NCT00409916|ICG|icg
5307976|NCT00409916|transthoracic electrical bioimpedance|transthoracic electrical bioimpedance
5307977|NCT00409916|non-invasive|non-invasive
5307978|NCT00409916|TEB|teb
5307979|NCT00409890|Buscopan|buscopan
5307980|NCT00409890|Hyoscine|hyoscine
5307981|NCT00409890|Shortens|shortens
5307982|NCT00409890|Labor|labor
5307983|NCT00409890|Stage|stage
5307984|NCT00409864|Gallbaldder Cancer|gallbaldder cancer
5307985|NCT00409864|Endoscopic stenting|endoscopic stenting
5307986|NCT00409864|Percutaneous biliary drainage|percutaneous biliary drainage
5307987|NCT00409851|HYPERTENSION, VALSARTAN, AMLODIPINE,SAFETY|hypertension, valsartan, amlodipine,safety
5307988|NCT00409838|Rheumatoid Arthritis, with inadequate response to methotrexate|rheumatoid arthritis, with inadequate response to methotrexate
5307989|NCT00409799|Bone graft substitute|bone graft substitute
5307990|NCT00409799|Promotion of bone healing|promotion of bone healing
5307991|NCT00409786|Obesity|obesity
5307992|NCT00409786|Diabetes|diabetes
5307993|NCT00409786|Internet|internet
5307994|NCT00409786|Obesity with high cardiovascular risk|obesity with high cardiovascular risk
5307995|NCT00409760|HYEPRTENSION, VALSARTAN, AMLODIPINE, high blood pressure|hyeprtension, valsartan, amlodipine, high blood pressure
5307996|NCT00409747|Immunology|immunology
5307997|NCT00409747|Microglia|microglia
5307998|NCT00409747|NF-Kappa-B|nf-kappa-b
5307999|NCT00409747|Antibiotic|antibiotic
5308000|NCT00409747|Autism|autism
5308001|NCT00409747|Minocycline|minocycline
5308002|NCT00409747|Regressive Autism|regressive autism
5308003|NCT00409734|pyloric|pyloric
5308004|NCT00409734|stenosis|stenosis
5308005|NCT00409721|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
5308006|NCT00409721|ALS|als
5308007|NCT00409721|Motor Neuron Disease|motor neuron disease
5308008|NCT00409721|MND|mnd
5308009|NCT00409721|Memantine|memantine
5308010|NCT00409708|Attention Deficit Hyperactivity Disorder,|attention deficit hyperactivity disorder,
5308011|NCT00409708|ADHD|adhd
5308012|NCT00409708|Cytogenetic abnormalities,|cytogenetic abnormalities,
5308013|NCT00409708|extended-release methylphenidate,|extended-release methylphenidate,
5308014|NCT00409695|Acute Graft versus Host Disease|acute graft versus host disease
5308015|NCT00409695|aGVHD|agvhd
5308016|NCT00409695|Blood And Marrow Transplantation|blood and marrow transplantation
5308017|NCT00409695|Thymoglobulin|thymoglobulin
5308018|NCT00409695|ATG|atg
5308019|NCT00409682|Crohn's Disease|crohn's disease
5308020|NCT00409669|Barraquer tonometer|barraquer tonometer
5308021|NCT00409669|Intraocular pressure|intraocular pressure
5308022|NCT00409669|Tonometry|tonometry
5308023|NCT00409643|HYPERTENSION, VALSARTAN, AMLODIPINE, high blood pressure|hypertension, valsartan, amlodipine, high blood pressure
5308024|NCT00409630|Asthma|asthma
5308025|NCT00409591|Thailand|thailand
5308026|NCT00409591|Developing Countries|developing countries
5308027|NCT00409591|Prophylaxis|prophylaxis
5308028|NCT00409591|Mother-to-child transmission|mother-to-child transmission
5308029|NCT00409591|HIV-1|hiv-1
5308030|NCT00409591|HIV-1 infection|hiv-1 infection
5308031|NCT00409591|HIV Seronegativity|hiv seronegativity
5308032|NCT00409578|Post acute coronary syndrome|post acute coronary syndrome
5308033|NCT00409578|Acute|acute
5308034|NCT00409578|coronary syndrome|coronary syndrome
5308035|NCT00409578|B-type natriuretic peptide|b-type natriuretic peptide
5308036|NCT00409578|N-terminal|n-terminal
5308037|NCT00409578|pro-B-type natriuretic peptide|pro-b-type natriuretic peptide
5308038|NCT00409578|myocardial infarctions|myocardial infarctions
5308039|NCT00409565|head and neck cancer|head and neck cancer
5308040|NCT00409565|cetuximab|cetuximab
5308041|NCT00409565|bevacizumab|bevacizumab
5308042|NCT00409565|squamous cell carcinoma|squamous cell carcinoma
5308043|NCT00409565|SCCHN|scchn
5308044|NCT00409565|Squamous Cell Carcinoma of the Head and Neck|squamous cell carcinoma of the head and neck
5308045|NCT00409526|Iloprost|iloprost
5308046|NCT00409526|PPHN|pphn
5308047|NCT00409526|Newborn|newborn
5308048|NCT00409526|Pulmonary Hypertension|pulmonary hypertension
5308049|NCT00409526|Term|term
5308050|NCT00409526|Persistent Pulmonary Hypertension of the Newborn|persistent pulmonary hypertension of the newborn
5308051|NCT00409500|Safety, tolerability, pharmacokinetics, AQW051, food, Japanese, healthy male subjects|safety, tolerability, pharmacokinetics, aqw051, food, japanese, healthy male subjects
5308052|NCT00409500|Healthy volunteers study|healthy volunteers study
5308053|NCT00409487|obstructive sleep apnea|obstructive sleep apnea
5308054|NCT00409487|hypertension|hypertension
5308055|NCT00409487|ambulatory bloop pressure monitoring|ambulatory bloop pressure monitoring
5308056|NCT00409448|TBI|tbi
5308057|NCT00409448|intracranial edema|intracranial edema
5308058|NCT00409448|brain edema|brain edema
5308059|NCT00409448|craniocerebral trauma|craniocerebral trauma
5308060|NCT00409448|head injury|head injury
5308061|NCT00409448|brain hemorrhage, traumatic|brain hemorrhage, traumatic
5308062|NCT00409448|subdural hematoma|subdural hematoma
5308063|NCT00409448|brain concussion|brain concussion
5308064|NCT00409448|head injuries, closed|head injuries, closed
5308065|NCT00409448|epidural hematoma|epidural hematoma
5308066|NCT00409448|extra-axial hemorrhage|extra-axial hemorrhage
5308067|NCT00409448|cortical contusion|cortical contusion
5308068|NCT00409435|Postural tachycardia syndrome (POTS)|postural tachycardia syndrome (pots)
5308069|NCT00409422|pediatric obesity|pediatric obesity
5308071|NCT00409422|insulin resistance|insulin resistance
5308072|NCT00409422|hyperinsulinemia|hyperinsulinemia
5308073|NCT00409422|weight management program|weight management program
5308074|NCT00409422|family-based|family-based
5308075|NCT00409409|Sublingual immunotherapy|sublingual immunotherapy
5308076|NCT00409409|Grass pollen tablet|grass pollen tablet
5308077|NCT00409409|Allergic rhinoconjunctivitis|allergic rhinoconjunctivitis
5308078|NCT00409396|Ulcerative|ulcerative
5308079|NCT00409396|Colitis|colitis
5308080|NCT00409396|PGE-M|pge-m
5308081|NCT00409396|fecal calprotectin|fecal calprotectin
5308082|NCT00409396|disease biomarkers|disease biomarkers
5308083|NCT00409383|Advanced Melanoma|advanced melanoma
5308084|NCT00409383|Normal baseline LDH|normal baseline ldh
5308085|NCT00409383|Chemotherapy naive|chemotherapy naive
5308086|NCT00409357|urinary tract|urinary tract
5308087|NCT00409344|Thoracoabdominal Aortic Aneurysm|thoracoabdominal aortic aneurysm
5308088|NCT00409344|Dexmedetomidine|dexmedetomidine
5308089|NCT00409344|Mechanical ventilation|mechanical ventilation
5308090|NCT00409331|Head and Neck Cancer|head and neck cancer
5308091|NCT00409331|HNSCC|hnscc
5308092|NCT00409331|Submandibular and Sublingual Salivary Sparing|submandibular and sublingual salivary sparing
5308093|NCT00409331|Amifostine|amifostine
5308094|NCT00409331|Ethyol|ethyol
5308095|NCT00409331|Radiation Therapy|radiation therapy
5308096|NCT00409318|Inflammation|inflammation
5308097|NCT00409318|Visceral adiposity|visceral adiposity
5308098|NCT00409318|TNF|tnf
5308099|NCT00409318|CRP|crp
5308100|NCT00409318|Adiponectin|adiponectin
5308101|NCT00409318|Insulin resistance|insulin resistance
5308102|NCT00409318|metabolic syndrome|metabolic syndrome
5308103|NCT00409292|RAD001|rad001
5308104|NCT00409292|metastatic pancreatic cancer|metastatic pancreatic cancer
5308105|NCT00409279|Aging|aging
5308106|NCT00409279|Parent / Adult-child interaction|parent / adult-child interaction
5308107|NCT00409279|Family caregivers|family caregivers
5308108|NCT00409279|Alzheimer's|alzheimer's
5308109|NCT00409279|Caregiving|caregiving
5308110|NCT00409253|PRE-ECLAMPSIA-URAPIDIL-NICARDIPINE|pre-eclampsia-urapidil-nicardipine
5308111|NCT00409240|Group Intervention|group intervention
5308112|NCT00409240|Pharmacotherapy|pharmacotherapy
5308113|NCT00409240|Behavioral Modification|behavioral modification
5308114|NCT00409240|Diabetes|diabetes
5308115|NCT00409227|swl|swl
5308116|NCT00409227|lithotripsy|lithotripsy
5308117|NCT00409227|stone disease|stone disease
5308118|NCT00409227|urolithiasis|urolithiasis
5308119|NCT00409227|nephrolithiasis|nephrolithiasis
5308120|NCT00409214|Glioma|glioma
5308121|NCT00409214|Litx™|litx™
5308122|NCT00409214|LS11|ls11
5308123|NCT00409214|Glioblastoma multiforme|glioblastoma multiforme
5308124|NCT00409214|Anaplastic Astrocytoma|anaplastic astrocytoma
5308125|NCT00409214|GBM|gbm
5308126|NCT00409214|AA|aa
5308127|NCT00409201|schizophrenia|schizophrenia
5308128|NCT00409201|reboxetine|reboxetine
5308129|NCT00409201|cognitive|cognitive
5308130|NCT00409201|behavior|behavior
5308131|NCT00409188|Non-Small Cell Lung Carcinoma;|non-small cell lung carcinoma;
5308132|NCT00409188|stage III;|stage iii;
5308133|NCT00409188|unresectable;|unresectable;
5308134|NCT00409188|vaccine; Tecemotide; L-BLP25;|vaccine; tecemotide; l-blp25;
5308135|NCT00409188|Cyclophosphamide;|cyclophosphamide;
5308136|NCT00409188|placebo controlled;|placebo controlled;
5308137|NCT00409188|randomized;|randomized;
5308138|NCT00409188|double blind;|double blind;
5308139|NCT00409188|immunotherapy;|immunotherapy;
5308140|NCT00409175|FAP|fap
5308141|NCT00409175|Fx-1006A|fx-1006a
5308142|NCT00409175|transthyretin|transthyretin
5308143|NCT00409175|TTR|ttr
5308144|NCT00409175|amyloid|amyloid
5308145|NCT00409175|polyneuropathy|polyneuropathy
5308146|NCT00409175|V30M|v30m
5308147|NCT00409175|familial|familial
5308148|NCT00409175|hereditary|hereditary
5308149|NCT00409175|amyloidosis|amyloidosis
5308150|NCT00409175|FoldRx|foldrx
5308151|NCT00409162|Tattoo removal|tattoo removal
5308152|NCT00409149|Hypertension|hypertension
5308153|NCT00409149|Diet|diet
5308154|NCT00409149|physical exercise|physical exercise
5308155|NCT00409149|naturopathic|naturopathic
5308156|NCT00409149|group therapy|group therapy
5308157|NCT00409149|Qi Gong|qi gong
5308158|NCT00409136|Alert|alert
5308159|NCT00409136|Deep Vein Thrombosis|deep vein thrombosis
5308160|NCT00409136|Pulmonary Embolism|pulmonary embolism
5308161|NCT00409136|Venous Thromboembolism|venous thromboembolism
5308162|NCT00409136|Prophylaxis|prophylaxis
5308163|NCT00409136|Anticoagulation|anticoagulation
5308164|NCT00409123|vasospastic women|vasospastic women
5308165|NCT00409123|controls|controls
5308166|NCT00409123|core cooling|core cooling
5308167|NCT00409123|core warming|core warming
5308168|NCT00409123|external cooling|external cooling
5308169|NCT00409123|external warming|external warming
5308170|NCT00409123|LDF|ldf
5308171|NCT00409123|choroidal blood flow|choroidal blood flow
5308172|NCT00409123|temperature|temperature
5308173|NCT00409123|vasospastic subjects|vasospastic subjects
5308174|NCT00409123|normal subjects|normal subjects
5308175|NCT00409110|Ocular Pulse Amplitude|ocular pulse amplitude
5308176|NCT00409110|Dynamic Contour Tonometry|dynamic contour tonometry
5308177|NCT00409110|Pulsatility Index|pulsatility index
5308178|NCT00409110|Choroidal Laser Doppler Flowmetry|choroidal laser doppler flowmetry
5308179|NCT00409110|Finometer|finometer
5308180|NCT00409097|ADMA|adma
5308181|NCT00409097|MOF|mof
5308182|NCT00409097|Critical illness|critical illness
5308183|NCT00409084|varices|varices
5308184|NCT00409084|band ligation|band ligation
5308185|NCT00409084|portal hypertension|portal hypertension
5308186|NCT00409084|primary prophylaxis|primary prophylaxis
5308187|NCT00409084|cirrhosis|cirrhosis
5308188|NCT00409084|beta blockers|beta blockers
5308189|NCT00409071|Non metastatic breast cancer|non metastatic breast cancer
5308190|NCT00409071|Adjuvant chemotherapy|adjuvant chemotherapy
5308191|NCT00409071|Nausea|nausea
5308192|NCT00409071|Vomiting|vomiting
5308193|NCT00409071|Quality of life|quality of life
5308194|NCT00409071|Homeopathy|homeopathy
5308195|NCT00409058|TBI (Traumatic Brain Injury)|tbi (traumatic brain injury)
5308196|NCT00409058|Intracranial Edema|intracranial edema
5308197|NCT00409058|Brain Edema|brain edema
5308198|NCT00409058|Craniocerebral Trauma|craniocerebral trauma
5308199|NCT00409058|Head Injury|head injury
5308323|NCT00408525|memory problems|memory problems
5308200|NCT00409058|Brain Hemorrhage, Traumatic|brain hemorrhage, traumatic
5308201|NCT00409058|Subdural Hematoma|subdural hematoma
5308202|NCT00409058|Brain Concussion|brain concussion
5308203|NCT00409058|Head Injuries, Closed|head injuries, closed
5308204|NCT00409045|Obstructive Sleep Apnea|obstructive sleep apnea
5308205|NCT00409045|Pulmonary Embolism|pulmonary embolism
5308206|NCT00409045|male and female patients suspected of having a pulmonary embolism.|male and female patients suspected of having a pulmonary embolism.
5308207|NCT00409032|osteoporosis|osteoporosis
5308208|NCT00409032|BMD|bmd
5308209|NCT00409032|CTX|ctx
5308210|NCT00409032|Post menopausal|post menopausal
5308211|NCT00409032|strontium|strontium
5308212|NCT00409032|bone turnover|bone turnover
5308213|NCT00409032|clinical development|clinical development
5308214|NCT00408980|diet|diet
5308215|NCT00408980|breast milk fat|breast milk fat
5308216|NCT00408967|Ovarian|ovarian
5308217|NCT00408967|Cancer|cancer
5308218|NCT00408967|Epithelial|epithelial
5308219|NCT00408967|Recurrent|recurrent
5308220|NCT00408967|Platinum|platinum
5308221|NCT00408967|Second-line therapy|second-line therapy
5308222|NCT00408967|Maintenance Therapy|maintenance therapy
5308223|NCT00408967|Biologic|biologic
5308224|NCT00408967|Targeted Therapy|targeted therapy
5308225|NCT00408967|Antibody|antibody
5308226|NCT00408941|EEG|eeg
5308227|NCT00408941|AEP|aep
5308228|NCT00408941|Artefacts|artefacts
5308229|NCT00408941|Propofol|propofol
5308230|NCT00408941|Local Anaesthesia|local anaesthesia
5308231|NCT00408928|Graft-versus-Host Disease|graft-versus-host disease
5308232|NCT00408928|bortezomib|bortezomib
5308233|NCT00408915|Lisuride|lisuride
5308234|NCT00408915|Continuous Dopaminergic Stimulation|continuous dopaminergic stimulation
5308235|NCT00408915|Motor Fluctuations|motor fluctuations
5308236|NCT00408915|Off-Times|off-times
5308237|NCT00408915|Troublesome Dyskinesia|troublesome dyskinesia
5308238|NCT00408915|Parkinson's Disease with motor fluctuations with OFF periods and/or troublesome dyskinesias of more than four hours per day|parkinson's disease with motor fluctuations with off periods and/or troublesome dyskinesias of more than four hours per day
5308239|NCT00408889|liver transplantation|liver transplantation
5308240|NCT00408889|organ failure|organ failure
5308241|NCT00408889|outcome|outcome
5308242|NCT00408863|Breast cancer|breast cancer
5308243|NCT00408863|Tibolone|tibolone
5308244|NCT00408863|Climacteric symptoms|climacteric symptoms
5308245|NCT00408850|sympathetic nervous system, pioglitazone, metabolic syndrome|sympathetic nervous system, pioglitazone, metabolic syndrome
5308246|NCT00408824|insulin resistance|insulin resistance
5308247|NCT00408824|adipocytokine|adipocytokine
5308248|NCT00408824|Metabolic syndrome|metabolic syndrome
5308249|NCT00408824|Diabetes|diabetes
5308250|NCT00408798|Treatment of Alopecia areata with intracutaneous injections of Botulinum Toxin A|treatment of alopecia areata with intracutaneous injections of botulinum toxin a
5308251|NCT00408785|Botulinum Toxin Type A|botulinum toxin type a
5308252|NCT00408785|safety|safety
5308253|NCT00408785|efficacy|efficacy
5308254|NCT00408785|glabellar lines|glabellar lines
5308255|NCT00408772|liver metastases|liver metastases
5308256|NCT00408772|stage IV colon cancer|stage iv colon cancer
5308257|NCT00408772|stage IV rectal cancer|stage iv rectal cancer
5308258|NCT00408772|adenocarcinoma of the colon|adenocarcinoma of the colon
5308259|NCT00408772|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5308260|NCT00408772|recurrent colon cancer|recurrent colon cancer
5308261|NCT00408772|recurrent rectal cancer|recurrent rectal cancer
5308262|NCT00408759|xerostomia|xerostomia
5308263|NCT00408759|hypnosis|hypnosis
5308264|NCT00408759|dry mouth|dry mouth
5308265|NCT00408759|radiotherapy|radiotherapy
5308266|NCT00408759|head and neck cancer|head and neck cancer
5308267|NCT00408746|stomatognathic system|stomatognathic system
5308268|NCT00408746|maxilla|maxilla
5308269|NCT00408746|palate|palate
5308270|NCT00408746|development|development
5308271|NCT00408720|Spectral OCT|spectral oct
5308272|NCT00408720|SLO|slo
5308273|NCT00408720|Retinal Imagining|retinal imagining
5308274|NCT00408707|local infiltration analgesia|local infiltration analgesia
5308275|NCT00408707|postoperative pain|postoperative pain
5308276|NCT00408707|ropivacaine|ropivacaine
5308277|NCT00408668|Malaria Vaccine|malaria vaccine
5308278|NCT00408642|adherence|adherence
5308279|NCT00408642|treatment|treatment
5308280|NCT00408642|antiretroviral|antiretroviral
5308281|NCT00408642|HAART|haart
5308282|NCT00408642|HIV|hiv
5308283|NCT00408642|Treatment Naive|treatment naive
5308284|NCT00408629|Ulcerative Colitis|ulcerative colitis
5308285|NCT00408629|Adalimumab|adalimumab
5308286|NCT00408629|TNF Antagonist|tnf antagonist
5308287|NCT00408629|Mayo Score|mayo score
5308288|NCT00408603|second line treatment|second line treatment
5308289|NCT00408603|platinum resistant|platinum resistant
5308290|NCT00408603|ovary|ovary
5308291|NCT00408603|ovaries|ovaries
5308292|NCT00408603|cancer|cancer
5308293|NCT00408603|epithelial|epithelial
5308294|NCT00408603|carcinomas|carcinomas
5308295|NCT00408603|tumor|tumor
5308296|NCT00408590|ovarian clear cell cystadenocarcinoma|ovarian clear cell cystadenocarcinoma
5308297|NCT00408590|ovarian endometrioid adenocarcinoma|ovarian endometrioid adenocarcinoma
5308298|NCT00408590|primary peritoneal cavity cancer|primary peritoneal cavity cancer
5308299|NCT00408590|ovarian mixed epithelial carcinoma|ovarian mixed epithelial carcinoma
5308300|NCT00408590|ovarian mucinous cystadenocarcinoma|ovarian mucinous cystadenocarcinoma
5308301|NCT00408590|ovarian serous cystadenocarcinoma|ovarian serous cystadenocarcinoma
5308302|NCT00408590|ovarian undifferentiated adenocarcinoma|ovarian undifferentiated adenocarcinoma
5308303|NCT00408590|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5308304|NCT00408590|Brenner tumor|brenner tumor
5308305|NCT00408577|glucose intolerance|glucose intolerance
5308306|NCT00408577|cardiovascular disease|cardiovascular disease
5308307|NCT00408577|insulin resistance|insulin resistance
5308308|NCT00408577|endothelial dysfunction|endothelial dysfunction
5308309|NCT00408564|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
5308310|NCT00408564|stage II pancreatic cancer|stage ii pancreatic cancer
5308311|NCT00408564|stage III pancreatic cancer|stage iii pancreatic cancer
5308312|NCT00408551|stage IV colon cancer|stage iv colon cancer
5308313|NCT00408551|stage IV rectal cancer|stage iv rectal cancer
5308314|NCT00408551|liver metastases|liver metastases
5308315|NCT00408551|recurrent colon cancer|recurrent colon cancer
5308316|NCT00408551|recurrent rectal cancer|recurrent rectal cancer
5308317|NCT00408538|Microbicide|microbicide
5308318|NCT00408538|HIV|hiv
5308319|NCT00408538|Prevention|prevention
5308320|NCT00408538|Rectal|rectal
5308321|NCT00408538|HIV Prevention|hiv prevention
5308322|NCT00408525|memory loss|memory loss
5308324|NCT00408525|alzheimer's|alzheimer's
5308325|NCT00408525|forgetfulness|forgetfulness
5308326|NCT00408525|forgetting|forgetting
5308327|NCT00408512|treatment|treatment
5308328|NCT00408512|adverse events|adverse events
5308329|NCT00408512|adherence|adherence
5308331|NCT00408512|polymorphism|polymorphism
5308332|NCT00408499|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5308333|NCT00408499|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5308334|NCT00408499|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5308335|NCT00408499|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5308336|NCT00408499|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5308337|NCT00408447|stem cell transplant|stem cell transplant
5308338|NCT00408447|sickle cell disease|sickle cell disease
5308339|NCT00408447|thalassemia|thalassemia
5308340|NCT00408447|moderately ablative|moderately ablative
5308341|NCT00408447|cord blood transplant|cord blood transplant
5308342|NCT00408447|matched family donor|matched family donor
5308343|NCT00408434|PPARgamma agonist|ppargamma agonist
5308643|NCT00406822|OculusGen|oculusgen
5308344|NCT00408434|advanced or metastatic malignancies|advanced or metastatic malignancies
5308345|NCT00408434|Tumor|tumor
5308346|NCT00408434|Cancer|cancer
5308347|NCT00408408|stage I breast cancer|stage i breast cancer
5308348|NCT00408408|stage II breast cancer|stage ii breast cancer
5308349|NCT00408408|stage IIIA breast cancer|stage iiia breast cancer
5308350|NCT00408395|influenza|influenza
5308351|NCT00408395|children|children
5308352|NCT00408395|vaccine|vaccine
5308353|NCT00408395|influenza disease|influenza disease
5308354|NCT00408382|Lipitor|lipitor
5308355|NCT00408382|atorvastatin|atorvastatin
5308356|NCT00408382|Hypercholesteremia|hypercholesteremia
5308357|NCT00408382|yellow coronary plaque|yellow coronary plaque
5308358|NCT00408369|prophylactic|prophylactic
5308359|NCT00408369|malaria|malaria
5308360|NCT00408369|challenge|challenge
5308361|NCT00408356|Zinc treatment|zinc treatment
5308362|NCT00408356|supplementation|supplementation
5308363|NCT00408356|Enterotoxigenic E. coli|enterotoxigenic e. coli
5308364|NCT00408356|diarrhoea|diarrhoea
5308365|NCT00408317|Cystic Fibrosis|cystic fibrosis
5308366|NCT00408317|Exocrine Pancreatic Insufficiency|exocrine pancreatic insufficiency
5308367|NCT00408317|Ultrase® MT20|ultrase® mt20
5308368|NCT00408304|interferon alpha|interferon alpha
5308369|NCT00408304|depression|depression
5308370|NCT00408304|omega 3|omega 3
5308371|NCT00408291|fracture|fracture
5308372|NCT00408291|shoulder|shoulder
5308373|NCT00408291|bone density|bone density
5308374|NCT00408291|healing|healing
5308375|NCT00408278|Acute Promyelocytic Leukemia|acute promyelocytic leukemia
5308376|NCT00408265|Nicotine Dependence|nicotine dependence
5308377|NCT00408265|Contingency Management|contingency management
5308378|NCT00408252|recurrent or locally advanced|recurrent or locally advanced
5308379|NCT00408252|cytokine failure|cytokine failure
5308380|NCT00408239|Factor Xa inhibitor|factor xa inhibitor
5308381|NCT00408239|Thromboembolism|thromboembolism
5308382|NCT00408239|Arthroplasty|arthroplasty
5308383|NCT00408239|Knee Replacement|knee replacement
5308384|NCT00408239|Prevention and Control|prevention and control
5308385|NCT00408200|Atrial fibrillation|atrial fibrillation
5308386|NCT00408200|Atrial arrhythmia|atrial arrhythmia
5308387|NCT00408187|Randomized Controlled Trials|randomized controlled trials
5308388|NCT00408187|Immunosuppression|immunosuppression
5308389|NCT00408187|Adult|adult
5308390|NCT00408187|Chronic Disease|chronic disease
5308391|NCT00408187|Dermatologic Agents|dermatologic agents
5308392|NCT00408187|Female|female
5308393|NCT00408187|Humans|humans
5308394|NCT00408187|Male|male
5308395|NCT00408187|Middle Aged|middle aged
5308396|NCT00408187|Severity of Illness Index|severity of illness index
5308397|NCT00408187|Treatment Outcome|treatment outcome
5308398|NCT00408187|Quality of Life|quality of life
5308399|NCT00408187|Double-Blind Method|double-blind method
5308400|NCT00408174|IBD|ibd
5308401|NCT00408174|UC|uc
5308402|NCT00408174|Ulcerative Colitis|ulcerative colitis
5308403|NCT00408174|Inflammatory Bowel Disease|inflammatory bowel disease
5308404|NCT00408161|Contingency Management|contingency management
5308405|NCT00408161|Alcohol Dependence|alcohol dependence
5308406|NCT00408135|Respiratory Tract Infections|respiratory tract infections
5308407|NCT00408135|Skin Diseases|skin diseases
5308408|NCT00408135|Sinusitis|sinusitis
5308409|NCT00408109|Avian Influenza|avian influenza
5308410|NCT00408109|Healthy|healthy
5308411|NCT00408109|Immunity|immunity
5308412|NCT00408109|Preventive|preventive
5308413|NCT00408109|Bird Flu|bird flu
5308414|NCT00408109|Healthy Volunteer|healthy volunteer
5308415|NCT00408109|HV|hv
5308416|NCT00408096|osteoarthritis|osteoarthritis
5308417|NCT00408096|shoulder|shoulder
5308418|NCT00408096|resurfacing|resurfacing
5308419|NCT00408096|prosthesis|prosthesis
5308420|NCT00408070|ovarian cancer|ovarian cancer
5308421|NCT00408070|fallopian tube cancer|fallopian tube cancer
5308422|NCT00408070|peritoneal cancer|peritoneal cancer
5308423|NCT00408057|lipid lowering|lipid lowering
5308424|NCT00408057|target achievement|target achievement
5308425|NCT00408057|Patients with established cardiovascular disease|patients with established cardiovascular disease
5308426|NCT00408031|Major depressive disorder|major depressive disorder
5308427|NCT00408031|NMDA receptor|nmda receptor
5308428|NCT00408031|Treatment-Resistant|treatment-resistant
5308429|NCT00408031|D-cycloserine|d-cycloserine
5308430|NCT00407992|Headache|headache
5308431|NCT00407992|Migraine|migraine
5308432|NCT00407940|Thrombosis|thrombosis
5308433|NCT00407940|Claudication|claudication
5308434|NCT00407914|wrinkles|wrinkles
5308435|NCT00407914|soft tissue filler|soft tissue filler
5308436|NCT00407914|Aquamid|aquamid
5308437|NCT00407901|Visually Challenged|visually challenged
5308438|NCT00407901|Legally Blind|legally blind
5308439|NCT00407901|Functional Assessment Questionnaire|functional assessment questionnaire
5308440|NCT00407901|Low Functioning|low functioning
5308441|NCT00407901|High Functioning|high functioning
5308442|NCT00407875|Prostate|prostate
5308443|NCT00407875|Cancer|cancer
5308444|NCT00407875|Radiation|radiation
5308445|NCT00407862|insulin resistance|insulin resistance
5308446|NCT00407862|beta cell function|beta cell function
5309790|NCT00402428|Hepatitis|hepatitis
5308447|NCT00407862|endothelial dysfunction|endothelial dysfunction
5308448|NCT00407836|HIV|hiv
5308449|NCT00407836|CD4 T cell level|cd4 t cell level
5308450|NCT00407836|CD4 autoimmunity|cd4 autoimmunity
5308451|NCT00407836|Viral load|viral load
5308452|NCT00407836|T cell vaccination|t cell vaccination
5308453|NCT00407836|HIV Therapeutic Vaccine|hiv therapeutic vaccine
5308454|NCT00407823|Child|child
5308455|NCT00407823|Septic shock|septic shock
5308456|NCT00407823|Resuscitation|resuscitation
5308457|NCT00407823|Central venous oxygen saturation|central venous oxygen saturation
5308458|NCT00407823|Cardiac output|cardiac output
5308459|NCT00407823|Goal-directed therapy|goal-directed therapy
5308460|NCT00407797|Lyrica|lyrica
5308461|NCT00407797|Epilepsies - Partial|epilepsies - partial
5308462|NCT00407784|primary aldosteronism|primary aldosteronism
5308463|NCT00407784|hypertension|hypertension
5308464|NCT00407784|aldosteron-renin ratio|aldosteron-renin ratio
5308465|NCT00407784|eplerenone|eplerenone
5308466|NCT00407784|aldosteron-receptor antagonist|aldosteron-receptor antagonist
5308467|NCT00407784|screening|screening
5308468|NCT00407771|platelet function assay|platelet function assay
5308469|NCT00407771|Glycoprotein inhibitors|glycoprotein inhibitors
5308470|NCT00407771|percutaneous coronary intervention|percutaneous coronary intervention
5308471|NCT00407771|Diabetes Mellitus|diabetes mellitus
5308472|NCT00407758|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5308473|NCT00407758|primary peritoneal cavity cancer|primary peritoneal cavity cancer
5308474|NCT00407745|Pain|pain
5308475|NCT00407745|central neuropathic pain|central neuropathic pain
5308476|NCT00407732|hepatitis C|hepatitis c
5308477|NCT00407732|mental disorder|mental disorder
5308478|NCT00407732|substance use|substance use
5308479|NCT00407732|psychosocial intervention|psychosocial intervention
5308480|NCT00407719|Choroidal Neovascularization|choroidal neovascularization
5308481|NCT00407706|Breast Cancer, FACS, SCM, Malignant, Benign, Lymphocytes|breast cancer, facs, scm, malignant, benign, lymphocytes
5308482|NCT00407693|Dosimetry|dosimetry
5308483|NCT00407693|Effective Dose|effective dose
5308484|NCT00407693|Radiation-Absorbed Dose|radiation-absorbed dose
5308485|NCT00407680|Type 2 diabetes mellitus|type 2 diabetes mellitus
5308486|NCT00407680|Hypertension|hypertension
5308487|NCT00407680|Angiotensin II Receptor Blocker|angiotensin ii receptor blocker
5308488|NCT00407680|Diabetic nephropathy|diabetic nephropathy
5308489|NCT00407667|hemiparesis|hemiparesis
5308490|NCT00407667|rehabilitation|rehabilitation
5308491|NCT00407667|upper limb rehabilitation|upper limb rehabilitation
5308492|NCT00407667|arm therapy|arm therapy
5308493|NCT00407641|diabetes mellitus|diabetes mellitus
5308494|NCT00407641|chronic hemodialysis|chronic hemodialysis
5308495|NCT00407641|anticoagulation|anticoagulation
5308496|NCT00407641|outcome|outcome
5308497|NCT00407628|Stroke|stroke
5308498|NCT00407628|Diffusion spectrum tractography|diffusion spectrum tractography
5308499|NCT00407628|Functional MRI (fMRI)|functional mri (fmri)
5308500|NCT00407628|Lower extremity|lower extremity
5308501|NCT00407602|retinitis pigmentosa|retinitis pigmentosa
5308502|NCT00407602|device|device
5308503|NCT00407602|retinal implant|retinal implant
5308504|NCT00407602|retinal prosthesis|retinal prosthesis
5308505|NCT00407602|RP|rp
5308506|NCT00407602|outer retinal degeneration|outer retinal degeneration
5308507|NCT00407576|Alzheimer's Disease|alzheimer's disease
5308508|NCT00407576|Positron Emission Tomography|positron emission tomography
5308509|NCT00407576|Brain|brain
5308510|NCT00407576|Neurochemistry|neurochemistry
5308511|NCT00407576|Beta-Amyloid Plaques|beta-amyloid plaques
5308512|NCT00407576|PET|pet
5308513|NCT00407576|MeS-IMPY|mes-impy
5308514|NCT00407576|Alzheimer Disease|alzheimer disease
5308515|NCT00407576|AD|ad
5308516|NCT00407576|Dementia|dementia
5308517|NCT00407576|Healthy Volunteer|healthy volunteer
5308518|NCT00407576|HV|hv
5308519|NCT00407550|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5308520|NCT00407550|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5308521|NCT00407550|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5308522|NCT00407498|P 276-00|p 276-00
5308523|NCT00407498|Advanced Refractory Neoplasm|advanced refractory neoplasm
5308524|NCT00407498|Maximum Tolerated Dose|maximum tolerated dose
5308525|NCT00407498|Dose Limiting Toxicity|dose limiting toxicity
5308526|NCT00407498|Pharmacokinetics|pharmacokinetics
5308527|NCT00407472|Bio-equivalence study in healthy volunteers, indication|bio-equivalence study in healthy volunteers, indication
5308528|NCT00407472|of product is growth hormone deficiency|of product is growth hormone deficiency
5308529|NCT00407446|PDE5 inhibition|pde5 inhibition
5308530|NCT00407446|chronic heart failure|chronic heart failure
5308531|NCT00407446|endothelial function|endothelial function
5308532|NCT00407446|exercise ventilation|exercise ventilation
5308533|NCT00407433|Gemcitabine|gemcitabine
5308534|NCT00407433|Oxaliplatine|oxaliplatine
5308535|NCT00407433|Paediatric solid tumors|paediatric solid tumors
5308536|NCT00407433|Other CNS tumors|other cns tumors
5308537|NCT00407433|Other miscellaneous solid non-CNS tumours|other miscellaneous solid non-cns tumours
5308538|NCT00407420|Childhood|childhood
5308539|NCT00407420|Obesity|obesity
5308540|NCT00407420|Behavior modification|behavior modification
5308541|NCT00407420|Insulin resistance|insulin resistance
5308542|NCT00407407|Epithelial ovarian|epithelial ovarian
5308543|NCT00407407|Primary peritoneal or fallopian tube carcinoma|primary peritoneal or fallopian tube carcinoma
5308544|NCT00407407|Abraxane|abraxane
5308545|NCT00407407|Carboplatin|carboplatin
5308546|NCT00407394|Pneumonia|pneumonia
5308547|NCT00407394|Wheezing|wheezing
5308548|NCT00407394|Treatment|treatment
5308549|NCT00407394|Children|children
5308550|NCT00407394|India|india
5308551|NCT00407381|DME|dme
5308552|NCT00407355|vein occlusion|vein occlusion
5308553|NCT00407355|macular edema|macular edema
5308554|NCT00407342|Psoriasis|psoriasis
5308555|NCT00407342|biologics|biologics
5308556|NCT00407342|alefacept|alefacept
5308557|NCT00407342|Narrowband UVB|narrowband uvb
5308558|NCT00407342|Phototherapy|phototherapy
5308559|NCT00407342|Half-side comparison|half-side comparison
5308560|NCT00407329|BPH|bph
5308561|NCT00407316|Uveitis|uveitis
5308562|NCT00407316|Quality of life|quality of life
5308563|NCT00407316|Visual function|visual function
5308564|NCT00407290|pregnancy|pregnancy
5308565|NCT00407290|vaginal delivery|vaginal delivery
5308566|NCT00407277|nicotine dependence|nicotine dependence
5308567|NCT00407277|smoking|smoking
5308568|NCT00407277|nicotine patch|nicotine patch
5308569|NCT00407277|double-blind|double-blind
5308570|NCT00407277|randomized|randomized
5308571|NCT00407277|placebo|placebo
5308572|NCT00407277|psychosis|psychosis
5308573|NCT00407277|schizophrenia|schizophrenia
5308574|NCT00407277|schizophreniform|schizophreniform
5308575|NCT00407277|schizoaffective disorder|schizoaffective disorder
5308576|NCT00407264|bronchial squamous metaplasia|bronchial squamous metaplasia
5308577|NCT00407264|bronchial squamous dysplasia|bronchial squamous dysplasia
5308578|NCT00407251|refractory|refractory
5308579|NCT00407251|prostate|prostate
5308580|NCT00407251|hormone|hormone
5308581|NCT00407238|barrier function, multi-purpose solutions, silicone hydrogel contact lenses|barrier function, multi-purpose solutions, silicone hydrogel contact lenses
5308582|NCT00407212|early stage idiopathic Parkinson's disease|early stage idiopathic parkinson's disease
5308583|NCT00407199|social phobia, anxiety, quetiapine|social phobia, anxiety, quetiapine
5308584|NCT00407186|CRITICS|critics
5308585|NCT00407186|gastric cancer|gastric cancer
5308586|NCT00407186|surgery|surgery
5308587|NCT00407186|adjuvant|adjuvant
5308588|NCT00407186|chemotherapy|chemotherapy
5308589|NCT00407186|chemoradiotherapy|chemoradiotherapy
5308590|NCT00407186|capecitabine|capecitabine
5308591|NCT00407186|cisplatin|cisplatin
5308592|NCT00407186|epirubicin|epirubicin
5308593|NCT00407160|Kidney transplant|kidney transplant
5308594|NCT00407160|Tolerance induction|tolerance induction
5308595|NCT00407160|High PRA kidney recipients|high pra kidney recipients
5308596|NCT00407147|bacterial infection|bacterial infection
5308597|NCT00407147|empiric antibiotic treatment|empiric antibiotic treatment
5308598|NCT00407147|duration antibiotic treatment|duration antibiotic treatment
5308599|NCT00407147|reduce antibiotic treatment|reduce antibiotic treatment
5308600|NCT00407147|procalcitonin|procalcitonin
5308601|NCT00407147|PCT Kryptor|pct kryptor
5308602|NCT00407147|sepsis|sepsis
5308603|NCT00407147|Intensive Care Unit|intensive care unit
5308604|NCT00407147|antibiotic treatment|antibiotic treatment
5308605|NCT00407121|Neovascular Membrane|neovascular membrane
5308606|NCT00407121|Uveitis|uveitis
5308607|NCT00407121|Bevacizumab|bevacizumab
5308608|NCT00407108|vitreoretinal surgery|vitreoretinal surgery
5308609|NCT00407095|Parkinson Disease|parkinson disease
5308610|NCT00407043|Dry Eye Disease|dry eye disease
5308611|NCT00407043|Lotemax|lotemax
5308612|NCT00407043|Restasis|restasis
5308613|NCT00407043|Loteprednol|loteprednol
5308614|NCT00407043|Cyclosporine|cyclosporine
5308615|NCT00407004|acute-on-chronic liver failure, MARS, Prometheus, bilirubin, bile acids, cytokines|acute-on-chronic liver failure, mars, prometheus, bilirubin, bile acids, cytokines
5308616|NCT00406991|retinal blood flow|retinal blood flow
5308617|NCT00406991|diabetic retinopathy|diabetic retinopathy
5308618|NCT00406991|microthrombosis|microthrombosis
5308619|NCT00406991|aspirin|aspirin
5308620|NCT00406991|clopidogrel|clopidogrel
5308621|NCT00406978|MYELOMA|myeloma
5308622|NCT00406978|THALIDOMIDE|thalidomide
5308623|NCT00406978|DEFIBRODITE|defibrodite
5308624|NCT00406939|Gene Therapy|gene therapy
5308625|NCT00406939|Immunology|immunology
5308626|NCT00406939|Phase I Clinical Trial|phase i clinical trial
5308627|NCT00406900|uveal melanoma|uveal melanoma
5308628|NCT00406900|metastatic disease|metastatic disease
5308629|NCT00406874|infertility|infertility
5308630|NCT00406874|semen quality|semen quality
5308631|NCT00406874|sexual function|sexual function
5308632|NCT00406874|blood pressure|blood pressure
5308633|NCT00406874|omega 3 fats|omega 3 fats
5308634|NCT00406874|folic acid|folic acid
5308635|NCT00406861|reaction|reaction
5308636|NCT00406861|ENL|enl
5308637|NCT00406861|leprosy|leprosy
5308638|NCT00406835|Whole Brain Radiation Therapy|whole brain radiation therapy
5308639|NCT00406835|Stereotactic Radiosurgery|stereotactic radiosurgery
5308640|NCT00406835|Brain metastases|brain metastases
5308641|NCT00406822|Glaucoma|glaucoma
5308642|NCT00406822|collagen matrix|collagen matrix
5308644|NCT00406822|trabeculectomy|trabeculectomy
5308645|NCT00406822|tissue engineering|tissue engineering
5308646|NCT00406809|Sezary syndrome|sezary syndrome
5308647|NCT00406809|cutaneous T-cell lymphoma|cutaneous t-cell lymphoma
5308648|NCT00406809|follicular lymphoma|follicular lymphoma
5308649|NCT00406809|marginal zone lymphoma|marginal zone lymphoma
5308650|NCT00406809|indolent T-cell lymphoma|indolent t-cell lymphoma
5308651|NCT00406809|Navitoclax|navitoclax
5308652|NCT00406809|Non-Hodgkin's lymphoma|non-hodgkin's lymphoma
5308653|NCT00406809|peripheral T-cell lymphoma|peripheral t-cell lymphoma
5308654|NCT00406809|ABT-263|abt-263
5308655|NCT00406809|lymphoid malignancies|lymphoid malignancies
5308656|NCT00406809|chronic lymphoid leukemia|chronic lymphoid leukemia
5308657|NCT00406809|mycosis fungoides|mycosis fungoides
5308658|NCT00406809|mantle cell lymphoma|mantle cell lymphoma
5308659|NCT00406783|Allergic Rhinitis|allergic rhinitis
5308660|NCT00406783|Intermittent Allergic Rhinitis|intermittent allergic rhinitis
5308661|NCT00406770|Obesity|obesity
5308662|NCT00406770|Light therapy|light therapy
5308663|NCT00406770|Hypocaloric diet|hypocaloric diet
5308664|NCT00406757|T-cell|t-cell
5308665|NCT00406757|T-ALL|t-all
5308666|NCT00406757|T-LBL|t-lbl
5308667|NCT00406757|506U78|506u78
5308668|NCT00406757|ara-G|ara-g
5308669|NCT00406757|ara-GTP|ara-gtp
5308670|NCT00406757|Lymphoma|lymphoma
5308671|NCT00406757|Leukemia|leukemia
5308672|NCT00406744|neovascularization|neovascularization
5308673|NCT00406731|Endothelin-1|endothelin-1
5308674|NCT00406731|L-NG-Monomethyl Arginine|l-ng-monomethyl arginine
5308675|NCT00406731|Optic Nerve Head blood flow|optic nerve head blood flow
5308676|NCT00406718|Medication Adherence|medication adherence
5308677|NCT00406718|Psychosocial Treatment|psychosocial treatment
5308678|NCT00406718|Cognitive Adaptation Training|cognitive adaptation training
5308679|NCT00406718|Med-e Monitor|med-e monitor
5308680|NCT00406718|Adaptive Function|adaptive function
5308681|NCT00406705|Exercise Tolerance|exercise tolerance
5308682|NCT00406705|Dyspnea|dyspnea
5308683|NCT00406705|Rehabilitation|rehabilitation
5308684|NCT00406705|Helium|helium
5308685|NCT00406692|Zonisamide|zonisamide
5308686|NCT00406692|Alcoholism|alcoholism
5308687|NCT00406692|Alcohol|alcohol
5308688|NCT00406679|pain, postoperative|pain, postoperative
5308689|NCT00406679|surgery, oral|surgery, oral
5308690|NCT00406679|surgery, dental|surgery, dental
5308691|NCT00406640|MDD|mdd
5308692|NCT00406640|Major Depressive Disorder|major depressive disorder
5308693|NCT00406640|Depression|depression
5308694|NCT00406627|filariasis, lymphatic filariasis, Egypt|filariasis, lymphatic filariasis, egypt
5308695|NCT00406614|High Blood Pressure|high blood pressure
5308696|NCT00406588|Parkinson Disease|parkinson disease
5308697|NCT00406575|Congestive heart failure|congestive heart failure
5308698|NCT00406575|Relaxin|relaxin
5308699|NCT00406575|Hemodynamics|hemodynamics
5308700|NCT00406575|Renal function|renal function
5308701|NCT00406562|uncontrolled|uncontrolled
5308702|NCT00406549|Staphylococcus aureus|staphylococcus aureus
5308703|NCT00406549|Nasal colonization|nasal colonization
5308704|NCT00406549|pre-surgical patients|pre-surgical patients
5308705|NCT00406549|Sensitivity|sensitivity
5308706|NCT00406549|Specificity|specificity
5308707|NCT00406549|Nasal Staphylococcus aureus in pre-surgical patients|nasal staphylococcus aureus in pre-surgical patients
5308708|NCT00406536|Cystic Fibrosis|cystic fibrosis
5308709|NCT00406536|Pancreatic Insufficiency|pancreatic insufficiency
5308710|NCT00406536|LYM-X-SORB™|lym-x-sorb™
5308711|NCT00406536|LXS|lxs
5308712|NCT00406484|Methadone|methadone
5308713|NCT00406484|Counseling|counseling
5308714|NCT00406484|HIV risk reduction|hiv risk reduction
5308715|NCT00406484|HIV Seronegativity|hiv seronegativity
5308716|NCT00406471|Ischemic|ischemic
5308717|NCT00406471|Central|central
5308718|NCT00406471|Retinal|retinal
5308719|NCT00406471|Vein|vein
5308720|NCT00406471|Occlusion|occlusion
5308721|NCT00406471|Ranibizumab|ranibizumab
5308722|NCT00406471|Lucentis|lucentis
5308723|NCT00406471|CRVO|crvo
5308724|NCT00406471|ISCRVO|iscrvo
5308725|NCT00406458|Diabetic neuropathy|diabetic neuropathy
5308726|NCT00406458|Diabetes Type I or II|diabetes type i or ii
5308727|NCT00406458|Mild to moderate sensorimotor diabetic polyneuropathy|mild to moderate sensorimotor diabetic polyneuropathy
5308728|NCT00406445|Metabolism|metabolism
5308729|NCT00406445|Li-Fraumeni Syndrome|li-fraumeni syndrome
5308730|NCT00406432|BRL029060/Paroxetine CR|brl029060/paroxetine cr
5308731|NCT00406432|pharmacokinetics|pharmacokinetics
5308732|NCT00406432|repeat dose|repeat dose
5308733|NCT00406419|anti-CD20|anti-cd20
5308734|NCT00406419|stage|stage
5308735|NCT00406419|CD20|cd20
5308736|NCT00406419|RA|ra
5308737|NCT00406393|Acute Myelogenous Leukemia|acute myelogenous leukemia
5308738|NCT00406393|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
5308739|NCT00406393|Chronic Myelogenous Leukemia|chronic myelogenous leukemia
5308740|NCT00406380|Telangiectasias|telangiectasias
5308741|NCT00406380|Leakage|leakage
5308742|NCT00406380|Bevacizumab|bevacizumab
5308743|NCT00406380|Telangiectasias secondary to Branch Retinal Vein Occlusion (BRVO)|telangiectasias secondary to branch retinal vein occlusion (brvo)
5308844|NCT00405769|statin intolerance|statin intolerance
5308744|NCT00406380|Idiopathic juxtafoveal retinal telangiectasias|idiopathic juxtafoveal retinal telangiectasias
5308745|NCT00406315|ziprasidone, quetiapine (Seroquel) switch, open label, flexible dose, schizophrenia, schizoaffective disorder|ziprasidone, quetiapine (seroquel) switch, open label, flexible dose, schizophrenia, schizoaffective disorder
5308746|NCT00406302|NSCLC|nsclc
5308747|NCT00406302|non-small-cell lung cancer|non-small-cell lung cancer
5308748|NCT00406276|Lung Cancer|lung cancer
5308749|NCT00406263|nuclear sclerotic cataract|nuclear sclerotic cataract
5308750|NCT00406263|cataract|cataract
5308751|NCT00406211|Rubella|rubella
5308752|NCT00406211|Varicella|varicella
5308753|NCT00406211|Measles|measles
5308754|NCT00406211|Mumps|mumps
5308755|NCT00406211|Germany|germany
5308756|NCT00406211|Austria|austria
5308757|NCT00406198|Sepsis syndrom|sepsis syndrom
5308758|NCT00406198|severe sepsis|severe sepsis
5308759|NCT00406198|septic shock|septic shock
5308760|NCT00406198|hemofiltration|hemofiltration
5308761|NCT00406198|multiple organ failure|multiple organ failure
5308762|NCT00406185|Registry|registry
5308763|NCT00406185|cardiac catheterization laboratory|cardiac catheterization laboratory
5308764|NCT00406185|coronary heart disease|coronary heart disease
5308765|NCT00406185|cardiovascular disease|cardiovascular disease
5308766|NCT00406159|Autism|autism
5308767|NCT00406159|Hyperbaric Oxygen Therapy|hyperbaric oxygen therapy
5308768|NCT00406159|Behavioral assessments|behavioral assessments
5308769|NCT00406120|eye|eye
5308770|NCT00406120|uvea|uvea
5308771|NCT00406120|iris|iris
5308772|NCT00406120|choroid|choroid
5308773|NCT00406120|ciliary body|ciliary body
5308774|NCT00406120|melanoma|melanoma
5308775|NCT00406120|iris melanoma|iris melanoma
5308776|NCT00406120|choroidal melanoma|choroidal melanoma
5308777|NCT00406120|ciliary body melanoma|ciliary body melanoma
5308778|NCT00406120|uveal melanoma|uveal melanoma
5308779|NCT00406120|posterior uveal melanoma|posterior uveal melanoma
5308780|NCT00406120|prognosis|prognosis
5308781|NCT00406120|metastasis|metastasis
5308782|NCT00406120|genetic testing|genetic testing
5308783|NCT00406120|molecular testing|molecular testing
5308784|NCT00406120|gene expression profiling|gene expression profiling
5308785|NCT00406107|branch retinal vein occlusion|branch retinal vein occlusion
5308786|NCT00406107|macular edema|macular edema
5308787|NCT00406107|pegaptanib sodium|pegaptanib sodium
5308788|NCT00406107|vascular endothelial growth factor|vascular endothelial growth factor
5308789|NCT00406094|NARES|nares
5308790|NCT00406094|eosinophils|eosinophils
5308791|NCT00406094|nasal symptoms|nasal symptoms
5308792|NCT00406068|Bladder neoplasm|bladder neoplasm
5308793|NCT00406068|Intravesical drug administration|intravesical drug administration
5308794|NCT00406068|Neoplasm recurrence, local|neoplasm recurrence, local
5308795|NCT00406068|Transitional cell, carcinoma|transitional cell, carcinoma
5308796|NCT00406068|Carcinoma in situ|carcinoma in situ
5308797|NCT00406068|Mycobacterium|mycobacterium
5308798|NCT00406042|glaucoma|glaucoma
5308799|NCT00406042|trabeculoplasty|trabeculoplasty
5308800|NCT00406042|steroids|steroids
5308801|NCT00406016|Acute spinal cord injury;|acute spinal cord injury;
5308802|NCT00406003|BRL029060/Paroxetine CR|brl029060/paroxetine cr
5308803|NCT00406003|pharmacokinetics|pharmacokinetics
5308804|NCT00406003|safety|safety
5308805|NCT00405990|HIV|hiv
5308806|NCT00405990|MTCT|mtct
5308807|NCT00405990|heterosexual behaviour|heterosexual behaviour
5308808|NCT00405990|sexual risk behaviour|sexual risk behaviour
5308809|NCT00405990|couple counselling|couple counselling
5308810|NCT00405990|Voluntary counselling and testing|voluntary counselling and testing
5308811|NCT00405990|HIV Seronegativity|hiv seronegativity
5308812|NCT00405977|Neuromuscular block|neuromuscular block
5308813|NCT00405977|Magnesium|magnesium
5308814|NCT00405977|Rocuronium|rocuronium
5308815|NCT00405977|Time course of action|time course of action
5308816|NCT00405938|Breast cancer|breast cancer
5308817|NCT00405938|Metastatic breast cancer|metastatic breast cancer
5308818|NCT00405938|Bevacizumab|bevacizumab
5308819|NCT00405938|Anastrozole|anastrozole
5308820|NCT00405938|Fulvestrant|fulvestrant
5308821|NCT00405925|AIDS|aids
5308822|NCT00405925|Treatment Naive|treatment naive
5308823|NCT00405899|Allergy|allergy
5308824|NCT00405899|Seasonal Allergic Rhinitis|seasonal allergic rhinitis
5308825|NCT00405899|Perennial Allergic Rhinitis|perennial allergic rhinitis
5308826|NCT00405873|Primary hepatocellular carcinoma|primary hepatocellular carcinoma
5308827|NCT00405873|Liver cancer|liver cancer
5308828|NCT00405873|Tumour response|tumour response
5308829|NCT00405873|Quality of life|quality of life
5308830|NCT00405847|Sleep|sleep
5308831|NCT00405847|Critical illness|critical illness
5308832|NCT00405847|Cytokine|cytokine
5308833|NCT00405834|Pressure Ulcers|pressure ulcers
5308834|NCT00405821|AIDS|aids
5308835|NCT00405821|HIV Disease Progression|hiv disease progression
5308836|NCT00405821|Quality of Life|quality of life
5308837|NCT00405821|HIV Viral Load|hiv viral load
5308838|NCT00405821|Genital Ulcers|genital ulcers
5308839|NCT00405821|HIV|hiv
5308840|NCT00405821|Treatment Naive|treatment naive
5308841|NCT00405795|Pressure Ulcer|pressure ulcer
5308842|NCT00405782|metastatic breast cancer|metastatic breast cancer
5308843|NCT00405782|exercise intervention|exercise intervention
5308845|NCT00405769|hyperlipidemia|hyperlipidemia
5308846|NCT00405769|lifestyle changes|lifestyle changes
5308847|NCT00405769|red yeast rice|red yeast rice
5308848|NCT00405756|Newly Diagnosed Multiple Myeloma|newly diagnosed multiple myeloma
5308849|NCT00405756|Celgene|celgene
5308850|NCT00405756|CC-5013|cc-5013
5308851|NCT00405756|Revlimid|revlimid
5308852|NCT00405756|Lenalidomide|lenalidomide
5308853|NCT00405756|Melphalan|melphalan
5308854|NCT00405756|Prednisone|prednisone
5308855|NCT00405756|Elderly|elderly
5308856|NCT00405743|CP-4055|cp-4055
5308857|NCT00405743|ELACYT™|elacyt™
5308858|NCT00405743|Cancer|cancer
5308859|NCT00405743|Refractory|refractory
5308860|NCT00405743|Relapsed|relapsed
5308861|NCT00405743|Hematologic Malignancies|hematologic malignancies
5308862|NCT00405743|Leukemia|leukemia
5308863|NCT00405743|ALL|all
5308864|NCT00405743|AML|aml
5308865|NCT00405743|AMM|amm
5308866|NCT00405743|CLL|cll
5308867|NCT00405743|CML|cml
5308868|NCT00405743|CMML|cmml
5308869|NCT00405743|MDS|mds
5308870|NCT00405730|Cataracts|cataracts
5308871|NCT00405717|ischemic heart disease|ischemic heart disease
5308872|NCT00405717|acute coronary syndromes|acute coronary syndromes
5308873|NCT00405717|percutaneous transluminal coronary angioplasty|percutaneous transluminal coronary angioplasty
5308874|NCT00405717|statin|statin
5308875|NCT00405717|clopidogrel|clopidogrel
5308876|NCT00405704|Vesicoureteral Reflux|vesicoureteral reflux
5308877|NCT00405704|Urinary Tract Infections|urinary tract infections
5308878|NCT00405704|Renal Scarring|renal scarring
5308879|NCT00405704|Antibiotic Resistance|antibiotic resistance
5308880|NCT00405704|Controlled Clinical Trial|controlled clinical trial
5308881|NCT00405704|Trimethoprim-Sulfamethoxazole|trimethoprim-sulfamethoxazole
5308882|NCT00405704|Children|children
5308883|NCT00405691|Medical Device|medical device
5308884|NCT00405691|Spine|spine
5308885|NCT00405691|Lumbar Spinal Stenosis|lumbar spinal stenosis
5308886|NCT00405691|Degenerative Spondylolisthesis|degenerative spondylolisthesis
5308887|NCT00405691|Facet Arthrosis|facet arthrosis
5308888|NCT00405691|Back and Leg Pain|back and leg pain
5308889|NCT00405691|Spine Research|spine research
5308890|NCT00405691|Medical Device Research|medical device research
5308891|NCT00405691|Impliant|impliant
5308892|NCT00405691|Lumbar Treatment|lumbar treatment
5308893|NCT00405691|Spinal Treatment|spinal treatment
5308894|NCT00405691|Spinal Device|spinal device
5308895|NCT00405678|Exercise Intervention|exercise intervention
5308896|NCT00405678|Breast Cancer|breast cancer
5308897|NCT00405678|Neo-Adjuvant Therapy|neo-adjuvant therapy
5308898|NCT00405678|Operable Breast Cancer Stage I-II receiving neo-adjuvant chemotherapy|operable breast cancer stage i-ii receiving neo-adjuvant chemotherapy
5308899|NCT00405665|Cystic Fibrosis|cystic fibrosis
5308900|NCT00405665|L-Arginine|l-arginine
5308901|NCT00405665|Pediatrics|pediatrics
5308902|NCT00405665|pulmonary function|pulmonary function
5308903|NCT00405652|Liver transplantation, mycophenolate, GI problems, Quality of Life|liver transplantation, mycophenolate, gi problems, quality of life
5308904|NCT00405626|post partum hemmorhage,Arnica montana,Bellis Perenis|post partum hemmorhage,arnica montana,bellis perenis
5308905|NCT00405613|Aspirin|aspirin
5308906|NCT00405613|Bleeding|bleeding
5308907|NCT00405613|Clinical Trial|clinical trial
5308908|NCT00405613|Dental Extraction|dental extraction
5308909|NCT00405600|Lumbar degenerative disease|lumbar degenerative disease
5308910|NCT00405600|spinal stenosis|spinal stenosis
5308911|NCT00405600|spondylolisthesis|spondylolisthesis
5308912|NCT00405600|non instrumented surgery|non instrumented surgery
5308913|NCT00405600|instrumented surgery|instrumented surgery
5308914|NCT00405600|BMP-2|bmp-2
5308915|NCT00405574|prostate|prostate
5308916|NCT00405574|PSA|psa
5308917|NCT00405574|antiangiogenic|antiangiogenic
5308918|NCT00405574|copper|copper
5308919|NCT00405574|ATN-224|atn-224
5308920|NCT00405561|Advanced Colorectal Carcinoma|advanced colorectal carcinoma
5308921|NCT00405535|OCD|ocd
5308922|NCT00405535|Obsessive Compulsive Disorder|obsessive compulsive disorder
5308923|NCT00405535|Glycine|glycine
5308924|NCT00405522|Lumbar Puncture|lumbar puncture
5308925|NCT00405522|Pediatrics|pediatrics
5308926|NCT00405522|Propofol|propofol
5308927|NCT00405522|Remifentanil|remifentanil
5308928|NCT00405522|sedation|sedation
5308929|NCT00405522|Oncology|oncology
5308930|NCT00405509|Upper Respiratory Infection|upper respiratory infection
5308931|NCT00405509|Common Cold|common cold
5308932|NCT00405483|arthroplasty|arthroplasty
5308933|NCT00405483|RSA|rsa
5308934|NCT00405483|micromotion|micromotion
5308935|NCT00405483|osteoarthritis|osteoarthritis
5308936|NCT00405483|minimally invasive|minimally invasive
5308937|NCT00405483|ProfemurZ|profemurz
5308938|NCT00405470|arthroplasty|arthroplasty
5308939|NCT00405470|RSA|rsa
5308940|NCT00405470|micromotion|micromotion
5308941|NCT00405470|osteoarthritis|osteoarthritis
5308942|NCT00405444|Pediatrics|pediatrics
5308943|NCT00405444|Pain|pain
5308944|NCT00405444|Voiding Cystourethrogram|voiding cystourethrogram
5308945|NCT00405444|Catheterization|catheterization
5308946|NCT00405444|Fentanyl|fentanyl
5308947|NCT00405431|glaucoma filtering surgery|glaucoma filtering surgery
5308948|NCT00405431|restasis|restasis
5308949|NCT00405431|conjunctival inflammation|conjunctival inflammation
5308950|NCT00405405|Head and neck cancer|head and neck cancer
5308951|NCT00405405|Parotid gland cancer|parotid gland cancer
5308952|NCT00405405|thyroid gland cancer|thyroid gland cancer
5308953|NCT00405405|melanoma|melanoma
5308954|NCT00405405|Chemoradiotherapy|chemoradiotherapy
5308955|NCT00405405|bevacizumab|bevacizumab
5308956|NCT00405405|erlotinib|erlotinib
5308957|NCT00405392|risedronate|risedronate
5308958|NCT00405392|Ibandronate|ibandronate
5308959|NCT00405392|preference|preference
5308960|NCT00405392|Osteoporosis|osteoporosis
5308961|NCT00405379|arthroplasty|arthroplasty
5308963|NCT00405379|Osteoarthritis|osteoarthritis
5308964|NCT00405379|trabecular metal mesh|trabecular metal mesh
5308965|NCT00405366|stage II renal cell cancer|stage ii renal cell cancer
5308966|NCT00405366|stage III renal cell cancer|stage iii renal cell cancer
5308967|NCT00405366|stage IV renal cell cancer|stage iv renal cell cancer
5308968|NCT00405353|multiple sclerosis|multiple sclerosis
5308969|NCT00405353|testosterone|testosterone
5308970|NCT00405327|tumor vaccine|tumor vaccine
5308971|NCT00405327|metastatic solid tumors|metastatic solid tumors
5308972|NCT00405327|recurrent tumors|recurrent tumors
5308973|NCT00405314|respiratory failure|respiratory failure
5308974|NCT00405314|non invasive ventilation|non invasive ventilation
5308975|NCT00405314|prehospital|prehospital
5308976|NCT00405314|endotracheal intubation|endotracheal intubation
5308977|NCT00405314|continuous positive airway pressure|continuous positive airway pressure
5308978|NCT00405301|Tuberculosis|tuberculosis
5308979|NCT00405301|Drug Induced Hepatotoxicity|drug induced hepatotoxicity
5308980|NCT00405301|Anti-tuberculosis drugs|anti-tuberculosis drugs
5308981|NCT00405301|India|india
5308982|NCT00405288|Hemorrhoids|hemorrhoids
5308983|NCT00405288|Pregnancy|pregnancy
5308984|NCT00405288|antihemorrhoidal|antihemorrhoidal
5308985|NCT00405288|Proctofoam|proctofoam
5308986|NCT00405288|infants|infants
5308987|NCT00405275|antineoplastic|antineoplastic
5308988|NCT00405275|antiparasitics|antiparasitics
5308989|NCT00405275|antirheumatics|antirheumatics
5308990|NCT00405275|chronic diseases|chronic diseases
5308991|NCT00405275|clinical trial|clinical trial
5308992|NCT00405275|connective tissue|connective tissue
5308993|NCT00405275|double-blind|double-blind
5308994|NCT00405275|drug treatment|drug treatment
5308995|NCT00405275|gastric medications|gastric medications
5308996|NCT00405275|joint|joint
5308997|NCT00405275|multi-site trial|multi-site trial
5308998|NCT00405275|musculoskeletal|musculoskeletal
5308999|NCT00405275|randomized|randomized
5309000|NCT00405275|rheumatoid arthritis|rheumatoid arthritis
5309001|NCT00405262|Pediatrics|pediatrics
5309002|NCT00405262|Postoperative Analgesia|postoperative analgesia
5309003|NCT00405262|orthopedic surgery|orthopedic surgery
5309004|NCT00405262|Iliac Crest Bone Graft|iliac crest bone graft
5309005|NCT00405262|Osteotomy|osteotomy
5309006|NCT00405262|cleft palate|cleft palate
5309007|NCT00405249|HIV-1|hiv-1
5309008|NCT00405249|Treatment Experienced|treatment experienced
5309009|NCT00405236|inflammation|inflammation
5309010|NCT00405236|exacerbations|exacerbations
5309011|NCT00405210|hormone-resistant|hormone-resistant
5309012|NCT00405210|metastatic prostatic cancer|metastatic prostatic cancer
5309013|NCT00405210|pharmacokinetics|pharmacokinetics
5309014|NCT00405210|naïve patient|naïve patient
5309015|NCT00405197|MUFA|mufa
5309016|NCT00405197|Mediterranean diet|mediterranean diet
5309017|NCT00405197|Insulin resistance|insulin resistance
5309018|NCT00405197|metabolic syndrome X|metabolic syndrome x
5309019|NCT00405184|PID|pid
5309020|NCT00405184|IVIg|ivig
5309021|NCT00405184|IntragamP|intragamp
5309022|NCT00405171|Efavirenz|efavirenz
5309023|NCT00405171|Nevirapine|nevirapine
5309024|NCT00405171|Dyslipidemia|dyslipidemia
5309025|NCT00405171|HIV|hiv
5309026|NCT00405158|Lactation mastitis|lactation mastitis
5309027|NCT00405158|Breast inflammation|breast inflammation
5309028|NCT00405158|Breastfeeding|breastfeeding
5309029|NCT00405158|Care interventions|care interventions
5309030|NCT00405158|Acupuncture treatment|acupuncture treatment
5309031|NCT00405158|Antibiotic therapy|antibiotic therapy
5309032|NCT00405145|Epilepsy|epilepsy
5309033|NCT00405145|MRI|mri
5309034|NCT00405145|EEG|eeg
5309035|NCT00405145|Neuroimaging|neuroimaging
5309036|NCT00405119|tolerance|tolerance
5309037|NCT00405119|pharmacodynamics|pharmacodynamics
5309038|NCT00405119|ranitidine|ranitidine
5309039|NCT00405119|esomeprazole|esomeprazole
5309040|NCT00405119|pharmacokinetics|pharmacokinetics
5309041|NCT00405119|gastroesophageal reflux disease (GERD)|gastroesophageal reflux disease (gerd)
5309042|NCT00405119|AH23844|ah23844
5309043|NCT00405106|stress|stress
5309044|NCT00405106|anxiety|anxiety
5309045|NCT00405106|myopia progression|myopia progression
5309046|NCT00405106|accommodation|accommodation
5309047|NCT00405106|vergence|vergence
5309048|NCT00405093|cardiopulmonary bypass|cardiopulmonary bypass
5309049|NCT00405093|circulatory arrest|circulatory arrest
5309050|NCT00405093|aprotinin|aprotinin
5309051|NCT00405093|thoracic aorta surgery|thoracic aorta surgery
5309052|NCT00405080|Rifampin GW679769|rifampin gw679769
5309053|NCT00405067|Cholesterol|cholesterol
5309054|NCT00405015|rosiglitazone|rosiglitazone
5309055|NCT00405015|ischemia-reperfusion injury|ischemia-reperfusion injury
5309056|NCT00405015|human|human
5309057|NCT00405015|Annexin A5 scintigraphy|annexin a5 scintigraphy
5309058|NCT00405015|metabolic syndrome|metabolic syndrome
5309059|NCT00405002|Acute respiratory failure|acute respiratory failure
5309060|NCT00404989|HIV|hiv
5309061|NCT00404989|HBV|hbv
5309062|NCT00404989|Hepatitis|hepatitis
5309063|NCT00404989|Pregnancy|pregnancy
5309064|NCT00404989|Registry|registry
5309065|NCT00404976|inflammometry|inflammometry
5309066|NCT00404976|exhaled breath condensate|exhaled breath condensate
5309067|NCT00404976|fractional exhaled nitric oxide|fractional exhaled nitric oxide
5309068|NCT00404976|asthma|asthma
5309069|NCT00404976|children|children
5309070|NCT00404963|GSK376501,|gsk376501,
5309071|NCT00404963|First Time in Human,|first time in human,
5309072|NCT00404963|Single Dose,|single dose,
5309073|NCT00404963|Dose Escalation,|dose escalation,
5309074|NCT00404963|Healthy Overweight/Obese Volunteer|healthy overweight/obese volunteer
5309075|NCT00404950|hyperglycemia|hyperglycemia
5309076|NCT00404950|cardiopulmonary bypass|cardiopulmonary bypass
5309077|NCT00404950|renal injury|renal injury
5309078|NCT00404950|diabetes|diabetes
5309079|NCT00404924|Non-Small-Cell Lung Carcinoma|non-small-cell lung carcinoma
5309080|NCT00404924|Adenocarcinoma|adenocarcinoma
5309081|NCT00404924|Squamous Cell Carcinoma|squamous cell carcinoma
5309082|NCT00404924|Large Cell Carcinoma|large cell carcinoma
5309083|NCT00404911|Oppositional Defiant Disorder|oppositional defiant disorder
5309084|NCT00404898|World Trade Center dust|world trade center dust
5309085|NCT00404885|uveitis|uveitis
5309086|NCT00404885|calcineurin|calcineurin
5309087|NCT00404885|inflammation|inflammation
5309088|NCT00404872|Stroke|stroke
5309089|NCT00404859|inflammometry|inflammometry
5309090|NCT00404859|exhaled breath condensate|exhaled breath condensate
5309091|NCT00404859|fractional exhaled nitric oxide|fractional exhaled nitric oxide
5309092|NCT00404859|asthma|asthma
5309093|NCT00404859|cystic fibrosis|cystic fibrosis
5309094|NCT00404859|monitoring|monitoring
5309095|NCT00404859|exacerbations|exacerbations
5309096|NCT00404859|paediatric|paediatric
5309097|NCT00404846|Hyperbaric oxygenation therapy|hyperbaric oxygenation therapy
5309098|NCT00404846|HBOT|hbot
5309099|NCT00404846|Autism|autism
5309100|NCT00404833|idiopathic membranous nephropathy or focal segmental glomerulosclerosis|idiopathic membranous nephropathy or focal segmental glomerulosclerosis
5309101|NCT00404820|osteoporosis|osteoporosis
5309102|NCT00404820|bisphosphonate|bisphosphonate
5309103|NCT00404820|biomarker|biomarker
5309104|NCT00404820|zoledronic acid|zoledronic acid
5309105|NCT00404820|alendronate|alendronate
5309106|NCT00404820|postmenopausal|postmenopausal
5309107|NCT00404807|Continuous positive airway pressure|continuous positive airway pressure
5309108|NCT00404807|cardiovascular diseases|cardiovascular diseases
5309109|NCT00404807|sleep apnea syndromes|sleep apnea syndromes
5309110|NCT00404807|sleep breathing disorders|sleep breathing disorders
5309111|NCT00404807|sham CPAP|sham cpap
5309112|NCT00404794|membranous lupus nephritis|membranous lupus nephritis
5309113|NCT00404781|ischemic heart disease|ischemic heart disease
5309114|NCT00404781|acute coronary syndromes|acute coronary syndromes
5309115|NCT00404781|percutaneous transluminal coronary angioplasty|percutaneous transluminal coronary angioplasty
5309116|NCT00404781|platelet function|platelet function
5309117|NCT00404781|aspirin|aspirin
5309118|NCT00404781|clopidogrel|clopidogrel
5309119|NCT00404781|cilostazol|cilostazol
5309120|NCT00404768|Premature Labor|premature labor
5309121|NCT00404768|Pre Term Labor|pre term labor
5309122|NCT00404768|intravenous|intravenous
5309123|NCT00404768|fetal fibronectin|fetal fibronectin
5309124|NCT00404755|Depression|depression
5309125|NCT00404742|uveitis|uveitis
5309126|NCT00404742|calcineurin|calcineurin
5309127|NCT00404729|Glaucoma|glaucoma
5309128|NCT00404729|Optic Neuropathy, Ischemic|optic neuropathy, ischemic
5309129|NCT00404729|Visual Pathways,|visual pathways,
5309130|NCT00404729|Optic nerve|optic nerve
5309131|NCT00404729|Neural conduction|neural conduction
5309132|NCT00404690|Gastroschisis|gastroschisis
5309133|NCT00404690|Silo|silo
5309134|NCT00404690|Operative closure|operative closure
5309135|NCT00404664|influenza vaccine|influenza vaccine
5309136|NCT00404664|influenza immunization|influenza immunization
5309137|NCT00404664|reminder letters|reminder letters
5309138|NCT00404664|raffle prize|raffle prize
5309139|NCT00404651|Diphtheria|diphtheria
5309140|NCT00404651|Tetanus|tetanus
5309141|NCT00404651|Pertussis|pertussis
5309142|NCT00404651|Hepatitis B|hepatitis b
5309143|NCT00404651|Poliomyelitis|poliomyelitis
5309144|NCT00404651|Invasive Haemophilus influenzae type b.|invasive haemophilus influenzae type b.
5309145|NCT00404638|Enuresis Nocturna|enuresis nocturna
5309146|NCT00404638|Paula Method|paula method
5309147|NCT00404638|Circular muscle exercise|circular muscle exercise
5309148|NCT00404638|Sphincter|sphincter
5309149|NCT00404625|Bacteremia caused by ESBL-producing Enterobacteriaceae|bacteremia caused by esbl-producing enterobacteriaceae
5309150|NCT00404625|Pneumonia caused by ESBL-producing Enterobacteriaceae|pneumonia caused by esbl-producing enterobacteriaceae
5309309|NCT00404001|Hypercholesterolemia|hypercholesterolemia
5309151|NCT00404625|Abdomen infections due to ESBL-producing Enterobacteriaceae|abdomen infections due to esbl-producing enterobacteriaceae
5309152|NCT00404625|Skin infections caused by ESBL-producing Enterobacteriaceae|skin infections caused by esbl-producing enterobacteriaceae
5309153|NCT00404625|Urinary infections due to ESBL-producing Enterobacteriaceae|urinary infections due to esbl-producing enterobacteriaceae
5309154|NCT00404612|uveitis|uveitis
5309155|NCT00404612|calcineurin|calcineurin
5309156|NCT00404599|simvastatin, atorvastatin, oxidative stress|simvastatin, atorvastatin, oxidative stress
5309157|NCT00404586|Environmental Challenge Chamber|environmental challenge chamber
5309158|NCT00404586|GW784568X|gw784568x
5309159|NCT00404586|Intranasal|intranasal
5309160|NCT00404573|Schizophrenia|schizophrenia
5309161|NCT00404560|CTLA4 Mutation|ctla4 mutation
5309162|NCT00404560|Recurrent Infections|recurrent infections
5309163|NCT00404560|Immunodeficiency|immunodeficiency
5309164|NCT00404560|Phagocytes|phagocytes
5309165|NCT00404560|PI3K|pi3k
5309166|NCT00404560|DOCK8|dock8
5309167|NCT00404560|STAT 1|stat 1
5309168|NCT00404560|Genetic Mutation|genetic mutation
5309169|NCT00404560|Cytokines|cytokines
5309170|NCT00404560|Auto-antibodies|auto-antibodies
5309171|NCT00404560|Infection Susceptibility|infection susceptibility
5309172|NCT00404560|Immune Disorders|immune disorders
5309173|NCT00404560|Immune Defects of Phagocytes|immune defects of phagocytes
5309174|NCT00404560|Unusual, Chronic Bacterial, Mycobacterial, and Fungal Infections|unusual, chronic bacterial, mycobacterial, and fungal infections
5309175|NCT00404547|Asthma|asthma
5309176|NCT00404547|Alvesco®|alvesco®
5309177|NCT00404547|Ciclesonide|ciclesonide
5309178|NCT00404534|functional dyspepsia|functional dyspepsia
5309179|NCT00404534|Helicobacter pylori|helicobacter pylori
5309180|NCT00404534|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal
5309181|NCT00404534|Gastritis|gastritis
5309182|NCT00404521|Tumor|tumor
5309183|NCT00404521|PM02734|pm02734
5309184|NCT00404521|PharmaMar|pharmamar
5309185|NCT00404508|Hydralazine|hydralazine
5309186|NCT00404508|Magnesium Valproate|magnesium valproate
5309187|NCT00404508|Chemotherapy resistance|chemotherapy resistance
5309188|NCT00404508|Epigenetic therapy|epigenetic therapy
5309189|NCT00404482|uveitis|uveitis
5309190|NCT00404482|jia|jia
5309191|NCT00404482|Cyclosporine A|cyclosporine a
5309192|NCT00404482|MTX|mtx
5309193|NCT00404443|Acupuncture|acupuncture
5309194|NCT00404443|Electroacupuncture|electroacupuncture
5309195|NCT00404443|Rheumatoid arthritis|rheumatoid arthritis
5309196|NCT00404430|Endothelial function|endothelial function
5309197|NCT00404430|Peripheral Arterial Tone|peripheral arterial tone
5309198|NCT00404430|Systemic Inflammation|systemic inflammation
5309199|NCT00404430|Oxidative Stress|oxidative stress
5309200|NCT00404430|Respiratory and peripheral muscular function|respiratory and peripheral muscular function
5309201|NCT00404430|Cardiovascular risk|cardiovascular risk
5309202|NCT00404430|COPD severity|copd severity
5309203|NCT00404417|pain|pain
5309204|NCT00404417|lumbar|lumbar
5309205|NCT00404404|recurrent breast cancer|recurrent breast cancer
5309206|NCT00404404|stage IV breast cancer|stage iv breast cancer
5309207|NCT00404391|Moderate to severe pain following bunionectomy surgery|moderate to severe pain following bunionectomy surgery
5309208|NCT00404378|Healthy subjects|healthy subjects
5309209|NCT00404378|Pharmacokinetics|pharmacokinetics
5309210|NCT00404378|Drug interaction|drug interaction
5309211|NCT00404378|Ketoconazole|ketoconazole
5309212|NCT00404378|Casopitant|casopitant
5309213|NCT00404365|depression|depression
5309214|NCT00404365|extensive stage small cell lung cancer|extensive stage small cell lung cancer
5309215|NCT00404365|limited stage small cell lung cancer|limited stage small cell lung cancer
5309216|NCT00404365|recurrent small cell lung cancer|recurrent small cell lung cancer
5309217|NCT00404365|stage I non-small cell lung cancer|stage i non-small cell lung cancer
5309218|NCT00404365|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
5309219|NCT00404365|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5309220|NCT00404365|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5309221|NCT00404365|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5309222|NCT00404365|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5309223|NCT00404352|Rebif New Formulation|rebif new formulation
5309224|NCT00404352|Clinical Isolated Syndrome|clinical isolated syndrome
5309225|NCT00404352|Multiple Sclerosis|multiple sclerosis
5309226|NCT00404339|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
5309227|NCT00404339|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
5309228|NCT00404339|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
5309229|NCT00404339|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
5309230|NCT00404339|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
5309231|NCT00404339|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
5309232|NCT00404339|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
5309308|NCT00404001|Primary Hypercholesterolemia|primary hypercholesterolemia
5309233|NCT00404339|stage I squamous cell carcinoma of the paranasal sinus and nasal cavity|stage i squamous cell carcinoma of the paranasal sinus and nasal cavity
5309234|NCT00404339|stage II squamous cell carcinoma of the paranasal sinus and nasal cavity|stage ii squamous cell carcinoma of the paranasal sinus and nasal cavity
5309235|NCT00404339|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
5309236|NCT00404339|stage I squamous cell carcinoma of the hypopharynx|stage i squamous cell carcinoma of the hypopharynx
5309237|NCT00404339|stage I squamous cell carcinoma of the larynx|stage i squamous cell carcinoma of the larynx
5309238|NCT00404339|stage I squamous cell carcinoma of the nasopharynx|stage i squamous cell carcinoma of the nasopharynx
5309239|NCT00404339|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
5309240|NCT00404339|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
5309241|NCT00404339|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
5309242|NCT00404339|stage II squamous cell carcinoma of the nasopharynx|stage ii squamous cell carcinoma of the nasopharynx
5309243|NCT00404339|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
5309244|NCT00404339|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
5309245|NCT00404339|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
5309246|NCT00404339|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
5309247|NCT00404339|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
5309248|NCT00404339|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
5309249|NCT00404339|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
5309250|NCT00404339|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
5309251|NCT00404339|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
5309252|NCT00404339|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5309253|NCT00404339|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5309254|NCT00404339|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5309255|NCT00404339|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
5309256|NCT00404339|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5309257|NCT00404339|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
5309258|NCT00404339|tongue cancer|tongue cancer
5309259|NCT00404326|Cervical carcinoma|cervical carcinoma
5309260|NCT00404326|Epigenetic therapy|epigenetic therapy
5309261|NCT00404326|Hydralazine|hydralazine
5309262|NCT00404326|Valproate|valproate
5309263|NCT00404326|Microarray analysis|microarray analysis
5309264|NCT00404287|C reactive protein|c reactive protein
5309265|NCT00404287|Inflammation|inflammation
5309266|NCT00404287|Aortic valve stenosis|aortic valve stenosis
5309267|NCT00404287|progression|progression
5309268|NCT00404274|healthy human volunteer|healthy human volunteer
5309269|NCT00404274|GW679769|gw679769
5309270|NCT00404274|warfarin|warfarin
5309271|NCT00404274|casopitant|casopitant
5309272|NCT00404261|Fluticasone Propionate|fluticasone propionate
5309273|NCT00404261|healthcare professional satisfaction|healthcare professional satisfaction
5309274|NCT00404261|patient satisfaction|patient satisfaction
5309275|NCT00404261|metered dose inhaler with counter|metered dose inhaler with counter
5309276|NCT00404261|Salmeterol|salmeterol
5309277|NCT00404261|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
5309278|NCT00404248|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5309279|NCT00404248|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
5309280|NCT00404248|adult giant cell glioblastoma|adult giant cell glioblastoma
5309281|NCT00404248|recurrent adult brain tumor|recurrent adult brain tumor
5309282|NCT00404248|adult glioblastoma|adult glioblastoma
5309283|NCT00404248|adult gliosarcoma|adult gliosarcoma
5309284|NCT00404235|stage IV melanoma|stage iv melanoma
5309285|NCT00404235|recurrent melanoma|recurrent melanoma
5309286|NCT00404222|Acute Pain following Bunionectomy|acute pain following bunionectomy
5309287|NCT00404183|Pain associated with osteoarthritis|pain associated with osteoarthritis
5309288|NCT00404170|imaging|imaging
5309289|NCT00404170|Parkinson|parkinson
5309290|NCT00404170|progression|progression
5309291|NCT00404157|Lupus|lupus
5309292|NCT00404157|U2970g|u2970g
5309293|NCT00404144|small vessel|small vessel
5309294|NCT00404144|paclitaxel coated balloon catheter|paclitaxel coated balloon catheter
5309295|NCT00404144|pepcad|pepcad
5309296|NCT00404144|drug eluting balloon|drug eluting balloon
5309297|NCT00404118|long-term care|long-term care
5309298|NCT00404118|satisfaction|satisfaction
5309299|NCT00404118|cost|cost
5309300|NCT00404105|Excimer laser|excimer laser
5309301|NCT00404092|aspergillosis|aspergillosis
5309302|NCT00404092|caspofungin|caspofungin
5309303|NCT00404092|maximum tolerated dose|maximum tolerated dose
5309304|NCT00404079|Chronic low back pain|chronic low back pain
5309305|NCT00404014|MCI following CABG surgery|mci following cabg surgery
5309306|NCT00404001|Microbia|microbia
5309307|NCT00404001|MD-0727|md-0727
5309310|NCT00404001|Hyperlipidemia|hyperlipidemia
5309311|NCT00404001|Dyslipidemia|dyslipidemia
5309312|NCT00404001|Cholesterol|cholesterol
5309313|NCT00404001|LDL|ldl
5309314|NCT00403962|anxiety|anxiety
5309315|NCT00403962|Social Anxiety Disorder|social anxiety disorder
5309316|NCT00403962|SAD|sad
5309317|NCT00403936|osteopathic manipulation|osteopathic manipulation
5309318|NCT00403936|autonomic nervous system|autonomic nervous system
5309319|NCT00403923|Lactose intolerance|lactose intolerance
5309320|NCT00403923|Ulcerative colitis|ulcerative colitis
5309321|NCT00403923|Lactose|lactose
5309322|NCT00403923|Threshold|threshold
5309323|NCT00403897|Constipation|constipation
5309324|NCT00403884|Drusen|drusen
5309325|NCT00403884|Geographic atrophy|geographic atrophy
5309326|NCT00403884|diabetes|diabetes
5309327|NCT00403884|macular edema|macular edema
5309328|NCT00403884|laser|laser
5309329|NCT00403884|retinal pigment epithelium|retinal pigment epithelium
5309330|NCT00403871|Anaesthesia|anaesthesia
5309331|NCT00403871|Pregnency|pregnency
5309332|NCT00403871|Heart disease|heart disease
5309333|NCT00403845|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
5309334|NCT00403845|COPD|copd
5309335|NCT00403845|QAB149|qab149
5309336|NCT00403845|indacaterol|indacaterol
5309337|NCT00403845|long acting β2-agonist|long acting β2-agonist
5309338|NCT00403806|Adenotonsillectomy|adenotonsillectomy
5309339|NCT00403806|Pediatrics|pediatrics
5309340|NCT00403806|Postoperative Nausea and Vomiting|postoperative nausea and vomiting
5309341|NCT00403806|Pain|pain
5309342|NCT00403806|Oral intake|oral intake
5309343|NCT00403806|Dexamethasone|dexamethasone
5309344|NCT00403806|Dose finding|dose finding
5309345|NCT00403780|Critical limb ischemia|critical limb ischemia
5309346|NCT00403780|Pain control|pain control
5309347|NCT00403780|Rest pain in lower limb ischemia|rest pain in lower limb ischemia
5309348|NCT00403780|pregabalin|pregabalin
5309349|NCT00403780|randomized controlled study|randomized controlled study
5309350|NCT00403780|Ischemia, therapy|ischemia, therapy
5309351|NCT00403780|Lower extremity, blood supply|lower extremity, blood supply
5309352|NCT00403780|Pain, prevention & control|pain, prevention & control
5309353|NCT00403780|Pain, therapy|pain, therapy
5309354|NCT00403767|Atrial Fibrillation|atrial fibrillation
5309355|NCT00403767|Stroke|stroke
5309356|NCT00403767|Embolism|embolism
5309357|NCT00403767|Non-central nervous system systemic embolism|non-central nervous system systemic embolism
5309358|NCT00403767|Non-valvular atrial fibrillation|non-valvular atrial fibrillation
5309359|NCT00403767|Blood Clot|blood clot
5309360|NCT00403767|Rivaroxaban|rivaroxaban
5309361|NCT00403767|Warfarin|warfarin
5309362|NCT00403767|Anticoagulants|anticoagulants
5309363|NCT00403767|Arrhythmias, Cardiac|arrhythmias, cardiac
5309364|NCT00403754|asthma|asthma
5309365|NCT00403754|QAB149|qab149
5309366|NCT00403754|indacaterol|indacaterol
5309367|NCT00403754|long acting β2-agonist|long acting β2-agonist
5309368|NCT00403754|bronchodilator|bronchodilator
5309369|NCT00403741|behavior|behavior
5309370|NCT00403741|physical activity|physical activity
5309371|NCT00403741|motivation|motivation
5309372|NCT00403728|Ischemia|ischemia
5309373|NCT00403728|Reperfusion|reperfusion
5309374|NCT00403728|Myocardial infarction|myocardial infarction
5309375|NCT00403728|ciclosporin A|ciclosporin a
5309376|NCT00403728|acute myocardial infarction|acute myocardial infarction
5309377|NCT00403702|Retinal detachment|retinal detachment
5309378|NCT00403702|proliferative vitreoretinopathy|proliferative vitreoretinopathy
5309379|NCT00403702|heavier-than-water internal tamponades|heavier-than-water internal tamponades
5309380|NCT00403689|Increased non-specific inflammatory markers|increased non-specific inflammatory markers
5309381|NCT00403676|nurse practitioner|nurse practitioner
5309382|NCT00403676|rheumatology care|rheumatology care
5309383|NCT00403676|outpatient clinic|outpatient clinic
5309384|NCT00403676|patient satisfaction|patient satisfaction
5309385|NCT00403663|Body mass index|body mass index
5309386|NCT00403663|Combined Spinal-Epidural Anesthesia|combined spinal-epidural anesthesia
5309387|NCT00403663|Cesarean section|cesarean section
5309388|NCT00403663|Obesity|obesity
5309389|NCT00403650|Sarcoidosis|sarcoidosis
5309390|NCT00403650|Dyspnea|dyspnea
5309391|NCT00403650|Interstitial lung disease|interstitial lung disease
5309392|NCT00403637|Asthma, indacaterol, long acting β2-agonist|asthma, indacaterol, long acting β2-agonist
5309393|NCT00403585|Adefovir Dipivoxil(Hepsera)|adefovir dipivoxil(hepsera)
5309394|NCT00403585|Chronic Hepatitis B (CHB)|chronic hepatitis b (chb)
5309395|NCT00403572|Preeclampsia|preeclampsia
5309396|NCT00403572|Trans cranial Doppler|trans cranial doppler
5309397|NCT00403572|Cardiac output|cardiac output
5309398|NCT00403572|systemic vascular resistance|systemic vascular resistance
5309399|NCT00403572|blood pressure|blood pressure
5309400|NCT00403559|seborrheic dermatitis|seborrheic dermatitis
5309401|NCT00403546|Schizophrenia|schizophrenia
5309402|NCT00403533|Hepatitis C|hepatitis c
5309403|NCT00403533|viral load|viral load
5309404|NCT00403533|antiviral therapy|antiviral therapy
5309405|NCT00403533|cholesterol|cholesterol
5309406|NCT00403533|atorvastatin|atorvastatin
5309407|NCT00403520|Alzheimer's disease|alzheimer's disease
5309408|NCT00403520|Mild cognitive impairment|mild cognitive impairment
5309409|NCT00403507|Mild Dementia|mild dementia
5309410|NCT00403507|Mild Alzheimer|mild alzheimer
5309411|NCT00403507|Cognitive Impairment|cognitive impairment
5309412|NCT00403507|Cholinesterase Inhibitor|cholinesterase inhibitor
5309413|NCT00403507|Exercise|exercise
5309414|NCT00403507|Physical activity|physical activity
5309415|NCT00403507|Behavior|behavior
5309416|NCT00403507|Memory loss|memory loss
5309417|NCT00403494|Intermittent Claudication|intermittent claudication
5309418|NCT00403494|IC|ic
5309419|NCT00403494|Symptomatic Peripheral Arterial Disease|symptomatic peripheral arterial disease
5309420|NCT00403494|Peripheral Arterial Disease|peripheral arterial disease
5309421|NCT00403494|PAD|pad
5309422|NCT00403494|6R-BH4|6r-bh4
5309423|NCT00403494|BH4|bh4
5309424|NCT00403494|sapropterin dihydrochloride|sapropterin dihydrochloride
5309425|NCT00403494|endothelial dysfunction|endothelial dysfunction
5309426|NCT00403494|Nitric Oxide|nitric oxide
5309427|NCT00403494|NO|no
5309428|NCT00403481|Hypertension|hypertension
5309429|NCT00403481|Angiotensin Receptor Blocker|angiotensin receptor blocker
5309430|NCT00403481|Calcium Channel Blocker|calcium channel blocker
5309431|NCT00403481|Angiotensin Converting Enzyme Inhibitor|angiotensin converting enzyme inhibitor
5309432|NCT00403481|Hydrochlorothiazide|hydrochlorothiazide
5309433|NCT00403481|Stage I and II Hypertension|stage i and ii hypertension
5309434|NCT00403481|Type II Diabetes|type ii diabetes
5309435|NCT00403455|Clinical|clinical
5309436|NCT00403455|Genetics|genetics
5309437|NCT00403455|Monoamine transporter|monoamine transporter
5309438|NCT00403455|Pharmacogenetics|pharmacogenetics
5309439|NCT00403455|Post Traumatic Stress Disorder|post traumatic stress disorder
5309440|NCT00403442|Macular Degeneration|macular degeneration
5309441|NCT00403429|oral chemotherapy|oral chemotherapy
5309442|NCT00403429|platinum resistant|platinum resistant
5309443|NCT00403429|platinum refractory|platinum refractory
5309444|NCT00403429|second line|second line
5309445|NCT00403416|AEB071|aeb071
5309446|NCT00403416|Tacrolimus|tacrolimus
5309447|NCT00403416|Mycophenolic acid|mycophenolic acid
5309448|NCT00403416|Basiliximab|basiliximab
5309449|NCT00403416|Rejection|rejection
5309450|NCT00403416|Kidney function|kidney function
5309451|NCT00403416|Immunosuppression|immunosuppression
5309452|NCT00403403|SCLC|sclc
5309453|NCT00403403|SALUTE|salute
5309454|NCT00403403|Lung Cancer|lung cancer
5309455|NCT00403403|Avastin|avastin
5309456|NCT00403377|melanoma|melanoma
5309457|NCT00403377|basal cell carcinoma of the skin|basal cell carcinoma of the skin
5309458|NCT00403377|squamous cell carcinoma of the skin|squamous cell carcinoma of the skin
5309459|NCT00403364|Helicobacter pylori infection|helicobacter pylori infection
5309460|NCT00403364|Treatment|treatment
5309461|NCT00403364|Double blind placebo controlled trial|double blind placebo controlled trial
5309462|NCT00403351|Risk|risk
5309463|NCT00403351|Coronary artery disease|coronary artery disease
5309464|NCT00403351|Heart Rate variability|heart rate variability
5309465|NCT00403351|Pulse wave analysis|pulse wave analysis
5309466|NCT00403351|BNP|bnp
5309467|NCT00403351|CRP|crp
5309468|NCT00403338|myocardial ischemia|myocardial ischemia
5309469|NCT00403338|coronary disease|coronary disease
5309470|NCT00403338|heart disease|heart disease
5309471|NCT00403338|Coronary Stenosis [MeSH heading: C14.280.647.250.285]|coronary stenosis [mesh heading: c14.280.647.250.285]
5309472|NCT00403325|Central Serous Chorioretinopathy|central serous chorioretinopathy
5309473|NCT00403312|Physical Activity|physical activity
5309474|NCT00403312|Wellness Programs|wellness programs
5309475|NCT00403312|Pharmacological Smoking Cessation|pharmacological smoking cessation
5309476|NCT00403299|Coronary artery disease|coronary artery disease
5309477|NCT00403299|Cardiac transplantation|cardiac transplantation
5309478|NCT00403299|Coronary artery disease in heart transplanted patients|coronary artery disease in heart transplanted patients
5309479|NCT00403286|Chronic|chronic
5309480|NCT00403286|Obstructive|obstructive
5309481|NCT00403286|Pulmonary|pulmonary
5309482|NCT00403286|Disease|disease
5309483|NCT00403286|COPD|copd
5309484|NCT00403286|Safety|safety
5309485|NCT00403286|Efficacy|efficacy
5309486|NCT00403286|Pharmacokinetic|pharmacokinetic
5309487|NCT00403286|Dose-finding|dose-finding
5309488|NCT00403273|Painful Knee Arthroplasty|painful knee arthroplasty
5309489|NCT00403273|Botulinum Toxin A|botulinum toxin a
5309490|NCT00403273|Randomized Controlled Trial|randomized controlled trial
5309491|NCT00403273|Pain and Function|pain and function
5309492|NCT00403260|malaria|malaria
5309493|NCT00403260|ACT|act
5309494|NCT00403260|P falciparum|p falciparum
5309495|NCT00403260|pyronaridine|pyronaridine
5309496|NCT00403260|artesunate|artesunate
5309497|NCT00403247|Schizophrenia|schizophrenia
5309498|NCT00403247|Schizoaffective Disorder|schizoaffective disorder
5309499|NCT00403247|Homocysteine|homocysteine
5309500|NCT00403247|Vitamins|vitamins
5309501|NCT00403234|Postoperative pain|postoperative pain
5309502|NCT00403234|opioid|opioid
5309503|NCT00403234|transdermal|transdermal
5309504|NCT00403234|TKA (total knee arthroplasty)|tka (total knee arthroplasty)
5309505|NCT00403221|Gene therapy|gene therapy
5309506|NCT00403221|Prostate cancer|prostate cancer
5309507|NCT00403221|Immunology, Angiogenesis inhibition|immunology, angiogenesis inhibition
5309508|NCT00403221|Phase I clinical trial|phase i clinical trial
5309509|NCT00403208|Ventilation, Mechanical|ventilation, mechanical
5309510|NCT00403208|Sedation|sedation
5309511|NCT00403195|Ocular Ischemic Syndrome|ocular ischemic syndrome
5309512|NCT00403182|recurrent breast cancer|recurrent breast cancer
5309513|NCT00403182|stage IIIA breast cancer|stage iiia breast cancer
5309514|NCT00403182|stage IIIB breast cancer|stage iiib breast cancer
5309515|NCT00403182|stage IIIC breast cancer|stage iiic breast cancer
5309516|NCT00403182|stage IV breast cancer|stage iv breast cancer
5309517|NCT00403169|stage III renal cell cancer|stage iii renal cell cancer
5309518|NCT00403169|stage IV renal cell cancer|stage iv renal cell cancer
5309519|NCT00403169|recurrent renal cell cancer|recurrent renal cell cancer
5309520|NCT00403156|Macular Degeneration|macular degeneration
5309521|NCT00403143|intraocular lens, colour vision, blue-light filtering|intraocular lens, colour vision, blue-light filtering
5309522|NCT00403117|Naltrexone|naltrexone
5309523|NCT00403117|Smoked Marijuana|smoked marijuana
5309524|NCT00403104|ONO-2506PO|ono-2506po
5309525|NCT00403104|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
5309526|NCT00403104|ALS|als
5309527|NCT00403091|Diabetes mellitus|diabetes mellitus
5309528|NCT00403091|Internet|internet
5309529|NCT00403091|Education, Professional|education, professional
5309530|NCT00403091|Quality Indicators, Health Care|quality indicators, health care
5309531|NCT00403091|Quality of Health Care|quality of health care
5309532|NCT00403091|Hypertension|hypertension
5309533|NCT00403091|Hyperlipidemia|hyperlipidemia
5309534|NCT00403078|Carotid Artery Stenting (Endovascular)|carotid artery stenting (endovascular)
5309535|NCT00403065|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5309536|NCT00403065|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5309537|NCT00403065|tumors metastatic to brain|tumors metastatic to brain
5309538|NCT00403052|colorectal|colorectal
5309539|NCT00403052|cancer|cancer
5309540|NCT00403052|carcinoma|carcinoma
5309541|NCT00403052|metastatic|metastatic
5309542|NCT00403052|colon|colon
5309543|NCT00403052|rectal|rectal
5309544|NCT00403052|neoplasm|neoplasm
5309545|NCT00403052|cetuximab|cetuximab
5309546|NCT00403052|irinotecan|irinotecan
5309547|NCT00403052|1018 ISS|1018 iss
5309548|NCT00403052|combination therapy|combination therapy
5309549|NCT00403039|Central Retinal Vein Occlusion|central retinal vein occlusion
5309550|NCT00403026|Bevacizumab (Avastin)|bevacizumab (avastin)
5309551|NCT00403026|Intravitreal injection|intravitreal injection
5309552|NCT00403026|VEGF|vegf
5309553|NCT00403026|CRVO|crvo
5309554|NCT00403026|BRVO|brvo
5309555|NCT00403026|PDR|pdr
5309556|NCT00403026|CNVM|cnvm
5309557|NCT00403013|nerve block/*methods|nerve block/*methods
5309558|NCT00403013|Anesthetics, Local/pharmacokinetics|anesthetics, local/pharmacokinetics
5309559|NCT00403013|*Brachial Plexus|*brachial plexus
5309560|NCT00403000|recurrent prostate cancer|recurrent prostate cancer
5309561|NCT00402987|sore throat|sore throat
5309562|NCT00402987|acute pain|acute pain
5309563|NCT00402974|osteocalcin|osteocalcin
5309564|NCT00402974|vitamin K|vitamin k
5309565|NCT00402974|carboxylation|carboxylation
5309566|NCT00402974|healthy children|healthy children
5309567|NCT00402961|Acupuncture|acupuncture
5309568|NCT00402961|Post-Colectomy Ileus|post-colectomy ileus
5309569|NCT00402961|Abdominal Surgery|abdominal surgery
5309570|NCT00402961|Colon Surgery|colon surgery
5309571|NCT00402948|High eosinophils level in sputum|high eosinophils level in sputum
5309572|NCT00402935|long-term effects secondary to cancer therapy in adults|long-term effects secondary to cancer therapy in adults
5309573|NCT00402935|long-term effects secondary to cancer therapy in children|long-term effects secondary to cancer therapy in children
5309574|NCT00402935|sexual dysfunction and infertility|sexual dysfunction and infertility
5309575|NCT00402935|sexuality and reproductive issues|sexuality and reproductive issues
5309576|NCT00402935|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5309577|NCT00402935|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
5309578|NCT00402935|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5309579|NCT00402935|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5309580|NCT00402935|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
5309581|NCT00402935|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
5309582|NCT00402935|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5309583|NCT00402935|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5309584|NCT00402935|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5309585|NCT00402935|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
5309586|NCT00402935|untreated childhood acute myeloid leukemia and other myeloid malignancies|untreated childhood acute myeloid leukemia and other myeloid malignancies
5309587|NCT00402935|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5309588|NCT00402935|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
5309589|NCT00402935|stage I childhood Hodgkin lymphoma|stage i childhood hodgkin lymphoma
5309590|NCT00402935|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
5309591|NCT00402935|stage II childhood Hodgkin lymphoma|stage ii childhood hodgkin lymphoma
5309684|NCT00402688|Prostatitis|prostatitis
5309592|NCT00402935|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5309593|NCT00402935|stage III childhood Hodgkin lymphoma|stage iii childhood hodgkin lymphoma
5309594|NCT00402935|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5309595|NCT00402935|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
5309596|NCT00402935|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5309597|NCT00402935|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
5309598|NCT00402935|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5309599|NCT00402935|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
5309600|NCT00402935|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
5309601|NCT00402935|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5309602|NCT00402935|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5309603|NCT00402935|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5309604|NCT00402935|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5309605|NCT00402935|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5309606|NCT00402922|Coronary Heart Disease|coronary heart disease
5309607|NCT00402909|Type 2 diabetes,|type 2 diabetes,
5309608|NCT00402909|fasting glucose,|fasting glucose,
5309609|NCT00402909|postprandial glucose,|postprandial glucose,
5309610|NCT00402909|blood sugar,|blood sugar,
5309611|NCT00402909|HbA1c,|hba1c,
5309612|NCT00402909|insulin,|insulin,
5309613|NCT00402909|glargine,|glargine,
5309614|NCT00402909|metformin,|metformin,
5309615|NCT00402909|thiazolidinedione|thiazolidinedione
5309616|NCT00402896|Lung Cancer|lung cancer
5309617|NCT00402896|Non-Small Cell Lung Cancer|non-small cell lung cancer
5309618|NCT00402896|Pleural Effusion|pleural effusion
5309619|NCT00402896|Indwelling Intrapleural Denver Catheter|indwelling intrapleural denver catheter
5309620|NCT00402896|ZD6474|zd6474
5309621|NCT00402896|Vascular Endothelial Growth Factor Receptor|vascular endothelial growth factor receptor
5309622|NCT00402896|VEGFR|vegfr
5309623|NCT00402896|Epidermal Growth factor Receptor|epidermal growth factor receptor
5309624|NCT00402896|EGFR|egfr
5309625|NCT00402896|Tyrosine Kinase Inhibitor|tyrosine kinase inhibitor
5309626|NCT00402857|Parenting Education|parenting education
5309627|NCT00402857|Child, Preschool|child, preschool
5309628|NCT00402857|Preventive Intervention|preventive intervention
5309629|NCT00402857|Primary Health Care|primary health care
5309630|NCT00402857|Pediatrics|pediatrics
5309631|NCT00402857|Attention Deficit Disorders|attention deficit disorders
5309632|NCT00402857|Oppositional Defiant Disorder|oppositional defiant disorder
5309633|NCT00402857|Disruptive Behavior Disorder|disruptive behavior disorder
5309634|NCT00402844|Multicenter|multicenter
5309635|NCT00402844|Pelvic organ prolapse|pelvic organ prolapse
5309636|NCT00402844|Prospective|prospective
5309637|NCT00402844|Transvaginal mesh|transvaginal mesh
5309638|NCT00402818|Moderate to severe plaque psoriasis|moderate to severe plaque psoriasis
5309639|NCT00402805|Influenza vaccine|influenza vaccine
5309640|NCT00402805|Intradermal|intradermal
5309641|NCT00402805|Lung transplantation|lung transplantation
5309642|NCT00402792|Acute pain following bunionectomy surgery|acute pain following bunionectomy surgery
5309643|NCT00402779|Oral Cancer|oral cancer
5309644|NCT00402779|Oral IEN Lesion with LOH|oral ien lesion with loh
5309645|NCT00402779|Loss of Heterozygosity|loss of heterozygosity
5309646|NCT00402779|Intraepithelial Neoplasia|intraepithelial neoplasia
5309647|NCT00402779|Placebo|placebo
5309648|NCT00402779|Erlotinib|erlotinib
5309649|NCT00402779|Tarceva|tarceva
5309650|NCT00402779|OSI-774|osi-774
5309651|NCT00402766|Mesothelioma|mesothelioma
5309652|NCT00402766|Pleural Mesothelioma|pleural mesothelioma
5309653|NCT00402766|Peritoneal Mesothelioma|peritoneal mesothelioma
5309654|NCT00402766|PDGF-R|pdgf-r
5309655|NCT00402766|Pemetrexed|pemetrexed
5309656|NCT00402766|Alimta|alimta
5309657|NCT00402766|Cisplatin|cisplatin
5309658|NCT00402766|Imatinib Mesylate|imatinib mesylate
5309659|NCT00402766|Gleevec|gleevec
5309660|NCT00402766|Platinol|platinol
5309661|NCT00402766|Platinol-AQ|platinol-aq
5309662|NCT00402766|CDDP|cddp
5309663|NCT00402766|Ly231514|ly231514
5309664|NCT00402766|Multitargeted Antifolate|multitargeted antifolate
5309665|NCT00402766|NSC-698037|nsc-698037
5309666|NCT00402766|STI571|sti571
5309667|NCT00402766|NSSC-716051|nssc-716051
5309668|NCT00402753|Cancer, Exercise, Health Related Quality of Life, PBSCT|cancer, exercise, health related quality of life, pbsct
5309669|NCT00402740|Carotid|carotid
5309670|NCT00402740|Artery|artery
5309671|NCT00402740|Disease|disease
5309672|NCT00402740|Stent|stent
5309673|NCT00402740|PROTECT|protect
5309674|NCT00402740|XACT|xact
5309675|NCT00402740|EMBOSHIELD|emboshield
5309676|NCT00402714|Allogeneic Stem Cell Transplant|allogeneic stem cell transplant
5309677|NCT00402701|walking|walking
5309678|NCT00402701|motor activity|motor activity
5309679|NCT00402701|students|students
5309680|NCT00402701|schools|schools
5309681|NCT00402701|transportation|transportation
5309682|NCT00402701|motor vehicles|motor vehicles
5309683|NCT00402688|Chronic Prostatitis|chronic prostatitis
5309685|NCT00402688|levofloxacin|levofloxacin
5309686|NCT00402688|Levaquin|levaquin
5309687|NCT00402675|NSTEMI|nstemi
5309688|NCT00402675|infarction|infarction
5309689|NCT00402675|treatment|treatment
5309690|NCT00402675|percutaneous coronary intervention|percutaneous coronary intervention
5309691|NCT00402675|non-ST-elevation myocardial infarction|non-st-elevation myocardial infarction
5309692|NCT00402662|everolimus|everolimus
5309693|NCT00402662|imatinib|imatinib
5309694|NCT00402649|influenza, A/H5N1, avian influenza, vaccine|influenza, a/h5n1, avian influenza, vaccine
5309695|NCT00402623|sarcoidosis|sarcoidosis
5309696|NCT00402623|quercetin|quercetin
5309697|NCT00402623|supplementation|supplementation
5309698|NCT00402623|oxidative stress|oxidative stress
5309699|NCT00402623|inflammation|inflammation
5309700|NCT00402610|HIV|hiv
5309701|NCT00402610|Tuberculosis|tuberculosis
5309702|NCT00402610|Chemoprophylaxis|chemoprophylaxis
5309703|NCT00402610|Anergy|anergy
5309704|NCT00402610|AIDS|aids
5309705|NCT00402597|Acute Coronary Syndrome (ACS)|acute coronary syndrome (acs)
5309706|NCT00402597|Myocardial Ischemia|myocardial ischemia
5309707|NCT00402597|Rivaroxaban (BAY59-7939)|rivaroxaban (bay59-7939)
5309708|NCT00402597|Anti-platelet agents|anti-platelet agents
5309709|NCT00402597|Aspirin|aspirin
5309710|NCT00402597|Thienopyridine|thienopyridine
5309711|NCT00402597|Clopidogrel|clopidogrel
5309712|NCT00402571|acetaminophen|acetaminophen
5309713|NCT00402571|alcohol|alcohol
5309714|NCT00402571|liver injury|liver injury
5309715|NCT00402558|Acute Myeloid Leukemia|acute myeloid leukemia
5309716|NCT00402558|Chronic Myelogenous Leukemia|chronic myelogenous leukemia
5309717|NCT00402558|Myelodysplastic Syndrome|myelodysplastic syndrome
5309718|NCT00402558|Leukemia|leukemia
5309719|NCT00402558|NK Cells|nk cells
5309720|NCT00402558|Natural Killer Cells|natural killer cells
5309721|NCT00402558|Fludarabine|fludarabine
5309722|NCT00402558|Busulfan|busulfan
5309723|NCT00402558|Thymoglobulin|thymoglobulin
5309724|NCT00402558|AML|aml
5309725|NCT00402558|CML|cml
5309726|NCT00402558|MDS|mds
5309727|NCT00402558|ATG|atg
5309728|NCT00402558|Antithymocyte globulin|antithymocyte globulin
5309729|NCT00402558|Busulfex|busulfex
5309730|NCT00402558|Myleran®|myleran®
5309731|NCT00402558|Fludarabine Phosphate|fludarabine phosphate
5309732|NCT00402558|G-CSF|g-csf
5309733|NCT00402558|Filgrastim|filgrastim
5309734|NCT00402558|Neupogen|neupogen
5309735|NCT00402558|Interleukin-2|interleukin-2
5309736|NCT00402558|IL-2|il-2
5309737|NCT00402558|Aldesleukin|aldesleukin
5309738|NCT00402558|Proleukin|proleukin
5309739|NCT00402558|Tacrolimus|tacrolimus
5309740|NCT00402558|Prograf|prograf
5309741|NCT00402558|Methotrexate|methotrexate
5309742|NCT00402545|SCCHN|scchn
5309743|NCT00402545|C-TPF|c-tpf
5309744|NCT00402545|5-FU|5-fu
5309745|NCT00402545|squamous cell carcinoma of the head and neck|squamous cell carcinoma of the head and neck
5309746|NCT00402532|Lung Transplantation|lung transplantation
5309747|NCT00402532|Immunosuppression|immunosuppression
5309748|NCT00402532|Mortality|mortality
5309749|NCT00402532|Graft rejection|graft rejection
5309750|NCT00402532|Bronchiolitis obliterans|bronchiolitis obliterans
5309751|NCT00402532|Opportunistic infections|opportunistic infections
5309752|NCT00402532|Nephrotoxicity|nephrotoxicity
5309753|NCT00402519|accelerated partial breast irradiation|accelerated partial breast irradiation
5309754|NCT00402519|multicatheter brachytherapy|multicatheter brachytherapy
5309755|NCT00402519|high dose rate brachytherapy|high dose rate brachytherapy
5309756|NCT00402519|pulsed dose rate brachytherapy|pulsed dose rate brachytherapy
5309757|NCT00402506|coronary|coronary
5309758|NCT00402506|surgery|surgery
5309759|NCT00402506|ischemia|ischemia
5309760|NCT00402506|reperfusion injury|reperfusion injury
5309761|NCT00402506|cardiac|cardiac
5309762|NCT00402506|heart|heart
5309763|NCT00402506|neurological|neurological
5309764|NCT00402506|cardiopulmonary bypass|cardiopulmonary bypass
5309765|NCT00402506|cardioprotection|cardioprotection
5309766|NCT00402506|myocardium|myocardium
5309767|NCT00402506|myocardial|myocardial
5309768|NCT00402506|myocardial revascularization|myocardial revascularization
5309769|NCT00402493|Glaucoma|glaucoma
5309770|NCT00402493|Ocular Hypertension|ocular hypertension
5309771|NCT00402493|Xalatan|xalatan
5309772|NCT00402493|Alpahgan|alpahgan
5309773|NCT00402493|Ibuprofen|ibuprofen
5309774|NCT00402493|Non-Steroidal Anti-Inflammatory|non-steroidal anti-inflammatory
5309775|NCT00402493|Brimonidine|brimonidine
5309776|NCT00402493|Latanoprost|latanoprost
5309777|NCT00402493|Eye Pressure|eye pressure
5309778|NCT00402493|Intra-Ocular Pressure|intra-ocular pressure
5309779|NCT00402480|Sickle Cell Anemia with Elevated TCD flow velocity|sickle cell anemia with elevated tcd flow velocity
5309780|NCT00402467|Prevention of venous thromboembolism|prevention of venous thromboembolism
5309781|NCT00402454|HIV|hiv
5309782|NCT00402454|Tuberculosis|tuberculosis
5309783|NCT00402454|Prophylaxis|prophylaxis
5309784|NCT00402454|AIDS|aids
5309785|NCT00402428|Chronic Hepatitis C|chronic hepatitis c
5309786|NCT00402428|Hepatitis C|hepatitis c
5309787|NCT00402428|CHC|chc
5309788|NCT00402428|HepC|hepc
5309789|NCT00402428|Genotype 1|genotype 1
5309791|NCT00402428|HCV|hcv
5309792|NCT00402415|metastatic|metastatic
5309793|NCT00402415|malignancy|malignancy
5309794|NCT00402415|advanced solid tumors|advanced solid tumors
5309795|NCT00402415|unresectable|unresectable
5309796|NCT00402415|Solid Tumors|solid tumors
5309797|NCT00402402|Tuberculin skin test|tuberculin skin test
5309798|NCT00402402|Quantiferon-TB Gold assay|quantiferon-tb gold assay
5309799|NCT00402402|Chronic liver disease|chronic liver disease
5309800|NCT00402402|Liver transplantation|liver transplantation
5309801|NCT00402402|Latent tuberculosis infection|latent tuberculosis infection
5309802|NCT00402389|Perinatal Depression|perinatal depression
5309803|NCT00402389|Postpartum Depression|postpartum depression
5309804|NCT00402389|Omega-3 Fatty Acids|omega-3 fatty acids
5309805|NCT00402389|Eicosapentaenoic Acid (EPA)|eicosapentaenoic acid (epa)
5309806|NCT00402389|Docosahexaenoic Acid (DHA)|docosahexaenoic acid (dha)
5309807|NCT00402389|Pregnancy|pregnancy
5309808|NCT00402389|Psychotherapy|psychotherapy
5309809|NCT00402376|End-stage heart failure|end-stage heart failure
5309810|NCT00402376|heart failure;|heart failure;
5309811|NCT00402376|ventricular assist device;|ventricular assist device;
5309812|NCT00402376|statin;|statin;
5309813|NCT00402376|heart transplantation;|heart transplantation;
5309814|NCT00402376|myocardial function;|myocardial function;
5309815|NCT00402376|mitochondrial respiratory function;|mitochondrial respiratory function;
5309816|NCT00402363|Lovaza|lovaza
5309817|NCT00402363|Omega-3 fatty acids|omega-3 fatty acids
5309818|NCT00402363|Omacor|omacor
5309819|NCT00402363|Paroxysmal atrial fibrillation|paroxysmal atrial fibrillation
5309820|NCT00402350|Staccato Fentanyl, Pharmacokinetics, Pharmacodynamics, inhaled fentanyl|staccato fentanyl, pharmacokinetics, pharmacodynamics, inhaled fentanyl
5309821|NCT00402337|Constipation|constipation
5309822|NCT00402337|Chronic Constipation|chronic constipation
5309823|NCT00402337|Microbia|microbia
5309824|NCT00402337|linaclotide|linaclotide
5309825|NCT00402337|linaclotide acetate|linaclotide acetate
5309826|NCT00402337|MD-1100|md-1100
5309827|NCT00402324|Mixed episode associated with Bipolar I|mixed episode associated with bipolar i
5309828|NCT00402311|Health Services for the Aged|health services for the aged
5309829|NCT00402311|Geriatric Psychiatry|geriatric psychiatry
5309830|NCT00402298|PTSD|ptsd
5309831|NCT00402298|MDMA|mdma
5309832|NCT00402298|psychotherapy|psychotherapy
5309833|NCT00402298|Posttraumatic stress disorder|posttraumatic stress disorder
5309834|NCT00402298|Israel|israel
5309835|NCT00402285|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5309836|NCT00402285|stage I prostate cancer|stage i prostate cancer
5309837|NCT00402285|stage IIB prostate cancer|stage iib prostate cancer
5309838|NCT00402285|stage IIA prostate cancer|stage iia prostate cancer
5309839|NCT00402272|drug eluting stents|drug eluting stents
5309840|NCT00402272|stents|stents
5309841|NCT00402272|Angioplasty|angioplasty
5309842|NCT00402272|coronary artery disease|coronary artery disease
5309843|NCT00402272|total coronary occlusion|total coronary occlusion
5309844|NCT00402272|coronary artery restenosis|coronary artery restenosis
5309845|NCT00402272|stent thrombosis|stent thrombosis
5309846|NCT00402272|vascular disease|vascular disease
5309847|NCT00402272|myocardial ischemia|myocardial ischemia
5309848|NCT00402272|coronary artery stenosis|coronary artery stenosis
5309849|NCT00402259|acute non-variceal upper gastrointestinal bleeding|acute non-variceal upper gastrointestinal bleeding
5309850|NCT00402246|Randomized Controlled Trials|randomized controlled trials
5309851|NCT00402246|Defibrillators|defibrillators
5309852|NCT00402246|Remote Consultation|remote consultation
5309853|NCT00402207|asthma|asthma
5309854|NCT00402207|non-invasive inflammometry|non-invasive inflammometry
5309855|NCT00402207|exhaled nitric oxide|exhaled nitric oxide
5309856|NCT00402207|exhaled breath condensate|exhaled breath condensate
5309857|NCT00402207|paediatric|paediatric
5309858|NCT00402207|extrafine HFA-beclomethasone|extrafine hfa-beclomethasone
5309859|NCT00402207|HFA-fluticasone|hfa-fluticasone
5309860|NCT00402194|Obesity|obesity
5309861|NCT00402194|Insulin resistance|insulin resistance
5309862|NCT00402194|Impaired glucose tolerance|impaired glucose tolerance
5309863|NCT00402194|pre-diabetes|pre-diabetes
5309864|NCT00402181|Myeloma|myeloma
5309865|NCT00402181|Intravenous|intravenous
5309866|NCT00402181|Monoclonal antibody|monoclonal antibody
5309867|NCT00402181|Siltuximab|siltuximab
5309868|NCT00402181|Dexamethasone|dexamethasone
5309869|NCT00402181|CNTO 328|cnto 328
5309870|NCT00402155|electroretinogram|electroretinogram
5309871|NCT00402155|visual evoked potential|visual evoked potential
5309872|NCT00402155|contrast sensitivity|contrast sensitivity
5309873|NCT00402142|HIV Infection|hiv infection
5309874|NCT00402142|Dendritic cell vaccine|dendritic cell vaccine
5309875|NCT00402142|Autologous virus|autologous virus
5309876|NCT00402142|Heat inactivated|heat inactivated
5309877|NCT00402142|HIV Therapeutic Vaccine|hiv therapeutic vaccine
5309878|NCT00402129|Ethnic Skin|ethnic skin
5309879|NCT00402129|Laser|laser
5309880|NCT00402129|Photobiology|photobiology
5309881|NCT00402129|Quality of life|quality of life
5309882|NCT00402103|Hypertension, aliskiren, amlodipine, HCTZ, blood pressure|hypertension, aliskiren, amlodipine, hctz, blood pressure
5309883|NCT00402090|thiopurines|thiopurines
5309884|NCT00402090|thiopurine methyl transferase|thiopurine methyl transferase
5309885|NCT00402090|toxicity|toxicity
5309886|NCT00402090|pharmacogenomics|pharmacogenomics
5309887|NCT00402077|overweight|overweight
5309888|NCT00402077|obesity|obesity
5309889|NCT00402077|pramlintide|pramlintide
5309890|NCT00402077|Symlin|symlin
5309891|NCT00402077|sibutramine|sibutramine
5309892|NCT00402077|Meridia|meridia
5309893|NCT00402077|phentermine|phentermine
5309894|NCT00402077|Amylin|amylin
5309895|NCT00402064|bisphosphonates|bisphosphonates
5309896|NCT00402064|children|children
5309897|NCT00402064|dental|dental
5309898|NCT00402064|Osteomyelitis|osteomyelitis
5309899|NCT00402064|medication|medication
5309900|NCT00402025|Metastatic|metastatic
5309901|NCT00402025|Pancreas|pancreas
5309902|NCT00402025|Adenocarcinoma|adenocarcinoma
5309903|NCT00402012|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
5309904|NCT00401999|PET|pet
5309905|NCT00401999|C-11 Raclopride|c-11 raclopride
5309906|NCT00401999|Dopamine|dopamine
5309907|NCT00401999|OPRM1|oprm1
5309908|NCT00401999|Alcohol|alcohol
5309909|NCT00401999|Healthy Volunteer|healthy volunteer
5309910|NCT00401999|HV|hv
5309911|NCT00401986|Refractory Asthma|refractory asthma
5309912|NCT00401986|Bronchial Thermoplasty|bronchial thermoplasty
5309913|NCT00401986|Alair System|alair system
5309914|NCT00401986|RISA (Research in Severe Asthma)|risa (research in severe asthma)
5309915|NCT00401960|Enterococcus|enterococcus
5309916|NCT00401960|Daptomycin|daptomycin
5309917|NCT00401960|Endocarditis|endocarditis
5309918|NCT00401947|HCV|hcv
5309919|NCT00401947|Chronic|chronic
5309920|NCT00401947|Hepatitis|hepatitis
5309921|NCT00401934|cholera, Vibrio cholerae, diarrhea, Bangladesh, children|cholera, vibrio cholerae, diarrhea, bangladesh, children
5309922|NCT00401908|Acute gastrointestinal bleeding|acute gastrointestinal bleeding
5309923|NCT00401908|Acute coronary syndrome|acute coronary syndrome
5309924|NCT00401895|TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT|transjugular intrahepatic portosystemic shunt
5309925|NCT00401895|Covered stents|covered stents
5309926|NCT00401895|portal hypertension|portal hypertension
5309927|NCT00401895|hepatic encephalopathy|hepatic encephalopathy
5309928|NCT00401882|Cardiac arrest|cardiac arrest
5309929|NCT00401882|Sudden Cardiac Death|sudden cardiac death
5309930|NCT00401882|Ventricular Fibrillation|ventricular fibrillation
5309931|NCT00401882|Pulseless Ventricular Tachycardia|pulseless ventricular tachycardia
5309932|NCT00401882|Cardiopulmonary resuscitation|cardiopulmonary resuscitation
5309933|NCT00401869|vigor|vigor
5309934|NCT00401869|function|function
5309935|NCT00401869|well-being|well-being
5309936|NCT00401869|hand-strength|hand-strength
5309937|NCT00401869|surgery|surgery
5309938|NCT00401869|anemia|anemia
5309939|NCT00401869|transfusion|transfusion
5309940|NCT00401869|strength|strength
5309941|NCT00401869|quality-of-life|quality-of-life
5309942|NCT00401856|Cardiomyopathy|cardiomyopathy
5309943|NCT00401856|Fibrosis|fibrosis
5309944|NCT00401856|Magnetic-Resonance|magnetic-resonance
5309945|NCT00401856|Eplerenone|eplerenone
5309946|NCT00401843|multiple myeloma|multiple myeloma
5309947|NCT00401843|Monoclonal Antibody|monoclonal antibody
5309948|NCT00401843|Intravenous|intravenous
5309949|NCT00401843|refractory or relapsed multiple myeloma|refractory or relapsed multiple myeloma
5309950|NCT00401843|velcade|velcade
5309951|NCT00401843|bortezomib|bortezomib
5309952|NCT00401830|Fibromyalgia Syndrome|fibromyalgia syndrome
5309953|NCT00401830|Lacosamide|lacosamide
5309954|NCT00401830|Vimpat|vimpat
5309955|NCT00401830|Harkoseride|harkoseride
5309956|NCT00401804|Multiple Myeloma|multiple myeloma
5309957|NCT00401804|renal impairment|renal impairment
5309958|NCT00401804|Velcade|velcade
5309959|NCT00401778|Lung Cancer|lung cancer
5309960|NCT00401765|Prostatic neoplasm|prostatic neoplasm
5309961|NCT00401765|intravenous|intravenous
5309962|NCT00401765|docetaxel|docetaxel
5309963|NCT00401765|monoclonal antibody|monoclonal antibody
5309964|NCT00401752|NSAID-associated gastric ulcer|nsaid-associated gastric ulcer
5309965|NCT00401726|Major Depressive Disorder|major depressive disorder
5309966|NCT00401726|Depression|depression
5309967|NCT00401726|Anxiety|anxiety
5309968|NCT00401713|submacular membrane|submacular membrane
5309969|NCT00401713|transplantation of RPE|transplantation of rpe
5309970|NCT00401713|translocation of RPE and Choroid|translocation of rpe and choroid
5309971|NCT00401700|influenza|influenza
5309972|NCT00401700|influenza vaccine|influenza vaccine
5309973|NCT00401700|pregnancy|pregnancy
5309974|NCT00401687|Reduced Heart Function|reduced heart function
5309975|NCT00401674|ovarian cancer|ovarian cancer
5309976|NCT00401674|elderly|elderly
5309977|NCT00401674|weekly chemotherapy|weekly chemotherapy
5309978|NCT00401674|first-line|first-line
5309980|NCT00401648|photosensitive|photosensitive
5309981|NCT00401648|epileptic|epileptic
5309982|NCT00401648|brivaracetam|brivaracetam
5309983|NCT00401648|PPR|ppr
5309984|NCT00401648|AED|aed
5309985|NCT00401635|advanced|advanced
5309986|NCT00401635|recurrent|recurrent
5309987|NCT00401635|chemotherapy|chemotherapy
5309988|NCT00401635|first-line|first-line
5309989|NCT00401609|elderly|elderly
5309990|NCT00401596|ALTO|alto
5309991|NCT00401583|GW786034 (pazopanib) cytochrome P450 interaction|gw786034 (pazopanib) cytochrome p450 interaction
5309992|NCT00401570|Antibody|antibody
5309993|NCT00401570|Pancreas|pancreas
5309994|NCT00401570|Carcinoma|carcinoma
5309995|NCT00401570|Cancer|cancer
5309996|NCT00401570|Pancreatic|pancreatic
5309997|NCT00401557|Leishmaniasis, Leishmania (Viannia), Colombia|leishmaniasis, leishmania (viannia), colombia
5309998|NCT00401544|anemia|anemia
5309999|NCT00401544|chemotherapy induced anemia|chemotherapy induced anemia
5310000|NCT00401544|darbepoetin alfa|darbepoetin alfa
5310001|NCT00401544|cancer|cancer
5310002|NCT00401531|Hepatitis B|hepatitis b
5310003|NCT00401531|Polio|polio
5310004|NCT00401531|Diphtheria|diphtheria
5310005|NCT00401531|Pertussis|pertussis
5310006|NCT00401531|H. influenzae type b|h. influenzae type b
5310007|NCT00401518|Spinal Stenosis|spinal stenosis
5310008|NCT00401518|Lumbar Spinal Stenosis|lumbar spinal stenosis
5310009|NCT00401518|Facet Arthroplasty|facet arthroplasty
5310010|NCT00401518|Posterior Fusion|posterior fusion
5310011|NCT00401518|Facet Arthritis|facet arthritis
5310012|NCT00401505|rubella|rubella
5310013|NCT00401505|rubella vaccine|rubella vaccine
5310014|NCT00401505|postpartum|postpartum
5310015|NCT00401505|immunity|immunity
5310016|NCT00401492|elderly|elderly
5310017|NCT00401492|chemotherapy|chemotherapy
5310018|NCT00401492|quality of life|quality of life
5310019|NCT00401492|ADL|adl
5310020|NCT00401492|toxicity|toxicity
5310021|NCT00401479|GW427353|gw427353
5310022|NCT00401479|b3-Adrenergic Receptor Agonist|b3-adrenergic receptor agonist
5310023|NCT00401479|Irritable Bowel Syndrome (IBS)|irritable bowel syndrome (ibs)
5310024|NCT00401479|pharmacokinetics|pharmacokinetics
5310025|NCT00401479|tolerability|tolerability
5310026|NCT00401479|gastrointestinal transit|gastrointestinal transit
5310027|NCT00401466|prophylactic ICD therapy|prophylactic icd therapy
5310028|NCT00401466|home monitoring|home monitoring
5310029|NCT00401466|follow-up interval|follow-up interval
5310030|NCT00401466|remote follow-up|remote follow-up
5310031|NCT00401440|Medical termination of pregnancy|medical termination of pregnancy
5310032|NCT00401440|Induction of abortion|induction of abortion
5310033|NCT00401440|Misoprostol|misoprostol
5310034|NCT00401440|MTP in second trimester|mtp in second trimester
5310035|NCT00401440|400 microgram vaginal misoprostol|400 microgram vaginal misoprostol
5310036|NCT00401427|HER2 overexpression|her2 overexpression
5310037|NCT00401427|combination therapy|combination therapy
5310038|NCT00401414|Warfarin|warfarin
5310039|NCT00401414|Thrombosis|thrombosis
5310040|NCT00401414|Genetics|genetics
5310041|NCT00401414|Nomogram|nomogram
5310042|NCT00401414|Pulmonary Embolism|pulmonary embolism
5310043|NCT00401414|Deep Vein Thrombosis|deep vein thrombosis
5310044|NCT00401414|Dosing|dosing
5310045|NCT00401414|INR|inr
5310046|NCT00401414|Anticoagulation|anticoagulation
5310047|NCT00401414|Therapy|therapy
5310048|NCT00401414|Orthopedic Surgery|orthopedic surgery
5310049|NCT00401388|Chemo Insensitive Sarcomas|chemo insensitive sarcomas
5310050|NCT00401388|Chondrosarcomas|chondrosarcomas
5310051|NCT00401388|Alveolar soft part sarcomas|alveolar soft part sarcomas
5310052|NCT00401388|Extra skeletal myxoid chondrosarcomas|extra skeletal myxoid chondrosarcomas
5310053|NCT00401388|Perifosine|perifosine
5310054|NCT00401349|Leishmania|leishmania
5310055|NCT00401349|Mif Alleles|mif alleles
5310056|NCT00401349|Colombia|colombia
5310057|NCT00401349|children|children
5310058|NCT00401336|Magnetic resonance imaging|magnetic resonance imaging
5310059|NCT00401336|Hepatic iron|hepatic iron
5310060|NCT00401336|Steatosis|steatosis
5310061|NCT00401297|Leishmaniasis|leishmaniasis
5310062|NCT00401297|L. Viannia|l. viannia
5310063|NCT00401297|Leishmania|leishmania
5310064|NCT00401297|Colombia|colombia
5310066|NCT00401258|irritable bowel syndrome|irritable bowel syndrome
5310067|NCT00401258|irritable bowel|irritable bowel
5310068|NCT00401206|dexmedetomidine|dexmedetomidine
5310069|NCT00401206|sedation|sedation
5310070|NCT00401206|bronchoscopy|bronchoscopy
5310071|NCT00401206|COPD|copd
5310072|NCT00401193|Menorrhagia|menorrhagia
5310073|NCT00401193|Heavy Menstrual Bleeding|heavy menstrual bleeding
5310074|NCT00401180|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5310075|NCT00401167|Alzheimer's disease|alzheimer's disease
5310076|NCT00401167|behavioral and psychological symptoms of dementia|behavioral and psychological symptoms of dementia
5310077|NCT00401167|severe Alzheimer's disease|severe alzheimer's disease
5310078|NCT00401167|memantine|memantine
5310079|NCT00401167|agitation|agitation
5310080|NCT00401167|aggression|aggression
5310081|NCT00401154|Spastic Diplegia|spastic diplegia
5310082|NCT00401154|Cerebral Palsy|cerebral palsy
5310083|NCT00401154|Children|children
5310084|NCT00401154|Adolescents|adolescents
5310085|NCT00401154|Strengthening|strengthening
5310086|NCT00401154|Endurance|endurance
5310087|NCT00401141|Systemic lupus|systemic lupus
5310088|NCT00401141|B lymphocytes|b lymphocytes
5310089|NCT00401141|transcriptomas|transcriptomas
5310090|NCT00401128|clear cell renal cell carcinoma|clear cell renal cell carcinoma
5310091|NCT00401128|recurrent renal cell cancer|recurrent renal cell cancer
5310092|NCT00401128|papillary renal cell carcinoma|papillary renal cell carcinoma
5310093|NCT00401128|stage IV renal cell cancer|stage iv renal cell cancer
5310094|NCT00401102|self-injurious behavior|self-injurious behavior
5310095|NCT00401102|depression|depression
5310096|NCT00401102|adolescents|adolescents
5310097|NCT00401102|psychotherapy|psychotherapy
5310098|NCT00401089|negative symptoms schizophrenia|negative symptoms schizophrenia
5310099|NCT00401089|Atypical antipsychotics|atypical antipsychotics
5310100|NCT00401089|Neurocognition impairment|neurocognition impairment
5310101|NCT00401089|obesity risk factor|obesity risk factor
5310102|NCT00401089|Diabetes insulin resistance schizophrenia|diabetes insulin resistance schizophrenia
5310103|NCT00401076|SA-001|sa-001
5310104|NCT00401076|Pancreatic Exocrine Insufficiency|pancreatic exocrine insufficiency
5310105|NCT00401076|Chronic Pancreatitis|chronic pancreatitis
5310106|NCT00401076|Pancreatectomy|pancreatectomy
5310107|NCT00401063|Cancer|cancer
5310108|NCT00401063|Acupuncture|acupuncture
5310109|NCT00401063|Cancer Pain|cancer pain
5310110|NCT00401063|Quality of life|quality of life
5310111|NCT00401050|patellofemoral pain syndrome|patellofemoral pain syndrome
5310112|NCT00401050|chiropractic|chiropractic
5310113|NCT00401050|knee pain|knee pain
5310114|NCT00401050|chiropractic manipulation|chiropractic manipulation
5310115|NCT00401050|Graston Instrument Soft Tissue Mobilization(GISTM)|graston instrument soft tissue mobilization(gistm)
5310116|NCT00401024|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
5310117|NCT00401024|adult oligodendroglioma|adult oligodendroglioma
5310118|NCT00401024|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5310119|NCT00401024|adult giant cell glioblastoma|adult giant cell glioblastoma
5310120|NCT00401024|adult gliosarcoma|adult gliosarcoma
5310121|NCT00401024|recurrent adult brain tumor|recurrent adult brain tumor
5310122|NCT00401024|adult brain stem glioma|adult brain stem glioma
5310123|NCT00401024|adult mixed glioma|adult mixed glioma
5310124|NCT00401024|adult glioblastoma|adult glioblastoma
5310125|NCT00401024|adult pilocytic astrocytoma|adult pilocytic astrocytoma
5310126|NCT00401024|adult diffuse astrocytoma|adult diffuse astrocytoma
5310127|NCT00401024|adult anaplastic ependymoma|adult anaplastic ependymoma
5310128|NCT00401024|adult ependymoma|adult ependymoma
5310129|NCT00401024|adult myxopapillary ependymoma|adult myxopapillary ependymoma
5310130|NCT00401024|adult subependymoma|adult subependymoma
5310131|NCT00401024|adult pineal gland astrocytoma|adult pineal gland astrocytoma
5310132|NCT00401024|adult subependymal giant cell astrocytoma|adult subependymal giant cell astrocytoma
5310133|NCT00401011|Perifosine|perifosine
5310134|NCT00401011|Bortezomib|bortezomib
5310135|NCT00401011|Dexamethasone|dexamethasone
5310136|NCT00401011|Relapsed or Refractory Multiple Myeloma|relapsed or refractory multiple myeloma
5310137|NCT00400998|Seasonal Allergic Rhinitis|seasonal allergic rhinitis
5310138|NCT00400998|Quality of Life|quality of life
5310139|NCT00400998|Efficacy|efficacy
5310140|NCT00400998|Validation|validation
5310141|NCT00400998|Fluticasone Propionate|fluticasone propionate
5310142|NCT00400985|Heart Failure, Congestive|heart failure, congestive
5310143|NCT00400985|Diagnostic|diagnostic
5310144|NCT00400985|Ambulatory Monitoring|ambulatory monitoring
5310145|NCT00400985|Intrathoracic Impedance|intrathoracic impedance
5310146|NCT00400972|GlideScope|glidescope
5310147|NCT00400972|videolaryngoscopy|videolaryngoscopy
5310148|NCT00400972|intubation|intubation
5310149|NCT00400972|nasal|nasal
5310150|NCT00400972|nasotracheal|nasotracheal
5310151|NCT00400972|laryngoscopy|laryngoscopy
5310152|NCT00400972|anesthesia|anesthesia
5310153|NCT00400959|cell therapy|cell therapy
5310154|NCT00400959|acute myocardial infarction|acute myocardial infarction
5310155|NCT00400946|drug/agent toxicity by tissue/organ|drug/agent toxicity by tissue/organ
5310156|NCT00400946|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
5310157|NCT00400946|L1 childhood acute lymphoblastic leukemia|l1 childhood acute lymphoblastic leukemia
5310158|NCT00400946|L2 childhood acute lymphoblastic leukemia|l2 childhood acute lymphoblastic leukemia
5310159|NCT00400946|T-cell childhood acute lymphoblastic leukemia|t-cell childhood acute lymphoblastic leukemia
5310160|NCT00400933|Psycho-education|psycho-education
5310161|NCT00400933|Eating disorders|eating disorders
5310162|NCT00400933|Personality disorders|personality disorders
5310163|NCT00400933|Relatives and close friends|relatives and close friends
5310164|NCT00400933|Caregiver burden|caregiver burden
5310165|NCT00400907|long-term effects secondary to cancer therapy in adults|long-term effects secondary to cancer therapy in adults
5310166|NCT00400907|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
5310167|NCT00400907|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
5310168|NCT00400907|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5310169|NCT00400907|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5310170|NCT00400907|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5310171|NCT00400894|prostate cancer|prostate cancer
5310172|NCT00400894|annexin A3|annexin a3
5310173|NCT00400894|early detection|early detection
5310174|NCT00400894|exprimate urine|exprimate urine
5310175|NCT00400881|mechanical ventilation|mechanical ventilation
5310176|NCT00400881|weaning|weaning
5310177|NCT00400881|respiratory failure|respiratory failure
5310178|NCT00400881|spontaneous breathing trial|spontaneous breathing trial
5310277|NCT00400543|heart disease|heart disease
5311239|NCT00396513|PCOS|pcos
5310179|NCT00400868|rheumatoid arthritis, occupational therapy, joint protection|rheumatoid arthritis, occupational therapy, joint protection
5310180|NCT00400855|Asthma|asthma
5310181|NCT00400855|AMP challenge|amp challenge
5310182|NCT00400842|SA-001|sa-001
5310183|NCT00400842|Pancreatic Exocrine Insufficiency|pancreatic exocrine insufficiency
5310184|NCT00400842|Pancreatectomy|pancreatectomy
5310185|NCT00400816|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
5310186|NCT00400816|adult mixed glioma|adult mixed glioma
5310187|NCT00400803|Carcinoma, Non-Small-Cell Lung|carcinoma, non-small-cell lung
5310188|NCT00400803|Gemcitabine|gemcitabine
5310189|NCT00400803|Carboplatin|carboplatin
5310190|NCT00400803|Bevacizumab|bevacizumab
5310191|NCT00400803|Biological therapy|biological therapy
5310192|NCT00400803|Drug therapy|drug therapy
5310193|NCT00400790|neurocognitive decline|neurocognitive decline
5310194|NCT00400790|coronary artery bypass surgery|coronary artery bypass surgery
5310195|NCT00400790|composite morbidity|composite morbidity
5310196|NCT00400790|postoperative care cost|postoperative care cost
5310197|NCT00400777|Valsartan|valsartan
5310198|NCT00400777|hydrochlorothiazide|hydrochlorothiazide
5310199|NCT00400777|amlodipine|amlodipine
5310200|NCT00400777|hypertension|hypertension
5310201|NCT00400777|high blood pressure|high blood pressure
5310202|NCT00400764|NHL|nhl
5310203|NCT00400764|Follicular NHL|follicular nhl
5310204|NCT00400764|Rituxan|rituxan
5310205|NCT00400764|Apo2L/TRAIL|apo2l/trail
5310206|NCT00400751|Health-compromised smokers, family cessation intervention|health-compromised smokers, family cessation intervention
5310207|NCT00400738|HIV-1 infection|hiv-1 infection
5310208|NCT00400738|pharmacokinetics|pharmacokinetics
5310209|NCT00400738|protease inhibitor|protease inhibitor
5310210|NCT00400738|double boosted protease inhibitors|double boosted protease inhibitors
5310211|NCT00400738|PIs|pis
5310212|NCT00400738|Treatment Naive|treatment naive
5310213|NCT00400725|maintenance|maintenance
5310214|NCT00400725|scalp psoriasis|scalp psoriasis
5310215|NCT00400725|Galderma|galderma
5310216|NCT00400712|mobility|mobility
5310217|NCT00400712|strength|strength
5310218|NCT00400712|balance|balance
5310219|NCT00400712|function|function
5310220|NCT00400712|reintegration|reintegration
5310221|NCT00400712|community|community
5310222|NCT00400699|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
5310223|NCT00400699|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5310224|NCT00400686|anemia|anemia
5310225|NCT00400686|stage I multiple myeloma|stage i multiple myeloma
5310226|NCT00400686|stage II multiple myeloma|stage ii multiple myeloma
5310227|NCT00400686|stage III multiple myeloma|stage iii multiple myeloma
5310228|NCT00400686|refractory multiple myeloma|refractory multiple myeloma
5310229|NCT00400673|Acute myelogenous leukemia|acute myelogenous leukemia
5310230|NCT00400673|Adult patients|adult patients
5310231|NCT00400673|Cytogenetic risk class|cytogenetic risk class
5310232|NCT00400673|Clinico-cytogenetic risk model|clinico-cytogenetic risk model
5310233|NCT00400673|Risk-oriented therapy|risk-oriented therapy
5310234|NCT00400660|GSK615915 asthma surfactant MDI|gsk615915 asthma surfactant mdi
5310235|NCT00400647|kidney transplant|kidney transplant
5310236|NCT00400647|enteric-coated mycophenolate sodium|enteric-coated mycophenolate sodium
5310237|NCT00400647|quality of life|quality of life
5310238|NCT00400647|gastrointestinal symptoms|gastrointestinal symptoms
5310239|NCT00400621|acetaminophen|acetaminophen
5310240|NCT00400621|alcohol|alcohol
5310241|NCT00400621|liver injury|liver injury
5310242|NCT00400608|pediatrics|pediatrics
5310243|NCT00400608|ADVAIR Inhaler|advair inhaler
5310244|NCT00400608|Asthma|asthma
5310245|NCT00400608|ADVAIR DISKUS|advair diskus
5310246|NCT00400595|peritonitis|peritonitis
5310247|NCT00400595|catheter related infection|catheter related infection
5310248|NCT00400595|exit site ointments|exit site ointments
5310249|NCT00400595|mupirocin|mupirocin
5310250|NCT00400595|Polysporin Triple|polysporin triple
5310251|NCT00400582|Heart failure|heart failure
5310252|NCT00400582|Gene polymorphism|gene polymorphism
5310253|NCT00400582|Candesartan|candesartan
5310254|NCT00400582|ACE inhibitors|ace inhibitors
5310255|NCT00400582|BNP|bnp
5310256|NCT00400582|Pharmacogenomics|pharmacogenomics
5310257|NCT00400569|Sunitinib malate|sunitinib malate
5310258|NCT00400569|SUTENT|sutent
5310259|NCT00400569|SU011248|su011248
5310260|NCT00400569|Soft tissue sarcoma|soft tissue sarcoma
5310261|NCT00400569|Gastrointestinal stromal tumors (GIST)|gastrointestinal stromal tumors (gist)
5310262|NCT00400569|MFH|mfh
5310263|NCT00400569|Tyrosine kinase inhibitor|tyrosine kinase inhibitor
5310264|NCT00400569|Imatinib mesylate|imatinib mesylate
5310265|NCT00400569|Phase II|phase ii
5310266|NCT00400556|mobilization|mobilization
5310267|NCT00400556|ATRA|atra
5310268|NCT00400556|G-CSF|g-csf
5310269|NCT00400556|filgrastim|filgrastim
5310270|NCT00400556|retinoids|retinoids
5310271|NCT00400556|stem cell mobilization|stem cell mobilization
5310272|NCT00400556|hematopoietic stem and progenitor cells|hematopoietic stem and progenitor cells
5310273|NCT00400543|obstructive sleep apnea|obstructive sleep apnea
5310274|NCT00400543|arterial stiffness|arterial stiffness
5310275|NCT00400543|atherosclerosis|atherosclerosis
5310276|NCT00400543|CPAP|cpap
5310278|NCT00400517|stage III prostate cancer|stage iii prostate cancer
5310279|NCT00400517|stage II prostate cancer|stage ii prostate cancer
5310280|NCT00400517|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5310281|NCT00400517|stage I prostate cancer|stage i prostate cancer
5310282|NCT00400517|stage IV prostate cancer|stage iv prostate cancer
5310283|NCT00400504|Thrombelastograph|thrombelastograph
5310284|NCT00400504|Cancer|cancer
5310285|NCT00400504|Thromboembolism|thromboembolism
5310286|NCT00400504|Hypercoagulable|hypercoagulable
5310287|NCT00400491|diabetes|diabetes
5310288|NCT00400491|insulin|insulin
5310289|NCT00400491|glycated hemoglobin|glycated hemoglobin
5310290|NCT00400491|cholecalciferol|cholecalciferol
5310291|NCT00400491|vitamin D|vitamin d
5310292|NCT00400478|DLBCL|dlbcl
5310293|NCT00400478|NHL 13|nhl 13
5310294|NCT00400478|Rituximab|rituximab
5310295|NCT00400478|maintenance|maintenance
5310296|NCT00400465|thyroid|thyroid
5310297|NCT00400465|thyroidectomy|thyroidectomy
5310298|NCT00400465|dressing|dressing
5310299|NCT00400452|wheelchair|wheelchair
5310300|NCT00400452|skills|skills
5310301|NCT00400452|long-term-care|long-term-care
5310302|NCT00400452|caregivers|caregivers
5310303|NCT00400426|Palliative radiotherapy|palliative radiotherapy
5310304|NCT00400426|Recurrent|recurrent
5310305|NCT00400426|Head and neck Neoplasm|head and neck neoplasm
5310306|NCT00400426|Quality of life|quality of life
5310307|NCT00400413|Neuropsychology|neuropsychology
5310308|NCT00400413|fMRI|fmri
5310309|NCT00400413|Reading|reading
5310310|NCT00400413|Phonology|phonology
5310311|NCT00400413|Deafness|deafness
5310312|NCT00400400|RenalTransplantation|renaltransplantation
5310313|NCT00400400|KidneyTransplantation|kidneytransplantation
5310314|NCT00400400|MPA|mpa
5310315|NCT00400400|EC-MPS|ec-mps
5310316|NCT00400387|recurrent pregnancy loss|recurrent pregnancy loss
5310317|NCT00400374|Head and Neck Cancer|head and neck cancer
5310318|NCT00400335|Testosterone|testosterone
5310319|NCT00400335|Men|men
5310320|NCT00400335|Hypogonadism|hypogonadism
5310321|NCT00400335|Dutasteride|dutasteride
5310322|NCT00400335|DHT|dht
5310323|NCT00400335|Androgen deficiency|androgen deficiency
5310324|NCT00400322|glioblastoma multiforme|glioblastoma multiforme
5310325|NCT00400322|cytomegalovirus infection|cytomegalovirus infection
5310326|NCT00400322|antiviral treatment|antiviral treatment
5310327|NCT00400322|valganciclovir|valganciclovir
5310328|NCT00400270|Asthma|asthma
5310329|NCT00400270|Randomised controlled trial|randomised controlled trial
5310330|NCT00400270|Breathing exercises|breathing exercises
5310331|NCT00400270|Relaxation exercises|relaxation exercises
5310332|NCT00400270|Primary care|primary care
5310333|NCT00400257|Heart Failure|heart failure
5310334|NCT00400257|BNP|bnp
5310335|NCT00400244|wheelchairs|wheelchairs
5310336|NCT00400244|skills|skills
5310337|NCT00400244|french|french
5310338|NCT00400231|metabolic syndrome|metabolic syndrome
5310339|NCT00400231|Triglycerides|triglycerides
5310340|NCT00400231|Insulin Resistance|insulin resistance
5310341|NCT00400231|inflammation|inflammation
5310342|NCT00400231|Cardiovascular Disease|cardiovascular disease
5310343|NCT00400231|Elevated triglycerides|elevated triglycerides
5310344|NCT00400231|without diabetes|without diabetes
5310345|NCT00400205|Squamous Cell Carcinoma of the Oral Cavity|squamous cell carcinoma of the oral cavity
5310346|NCT00400192|Microchimerism|microchimerism
5310347|NCT00400192|Injuries|injuries
5310348|NCT00400192|Leukocytes|leukocytes
5310349|NCT00400192|Immunologic Techniques|immunologic techniques
5310350|NCT00400179|Gastric Cancer|gastric cancer
5310351|NCT00400166|Peer support|peer support
5310352|NCT00400166|Psychiatric disability|psychiatric disability
5310353|NCT00400166|Mutual support|mutual support
5310354|NCT00400166|Psychiatric Rehabilitation|psychiatric rehabilitation
5310355|NCT00400140|Myopia, defocus|myopia, defocus
5310356|NCT00400127|transfemoral amputee|transfemoral amputee
5310357|NCT00400127|silicon suspension|silicon suspension
5310358|NCT00400127|balance|balance
5310359|NCT00400127|gait|gait
5310360|NCT00400114|esophageal|esophageal
5310361|NCT00400114|esophagus|esophagus
5310362|NCT00400114|cancer|cancer
5310363|NCT00400114|sutent|sutent
5310364|NCT00400114|sunitinib|sunitinib
5310365|NCT00400101|Malaria|malaria
5310366|NCT00400101|Vaccine|vaccine
5310367|NCT00400101|Plasmodium|plasmodium
5310368|NCT00400101|falciparum|falciparum
5310369|NCT00400101|Phase I|phase i
5310370|NCT00400101|Peptide|peptide
5310371|NCT00400101|Virosome|virosome
5310372|NCT00400101|safety|safety
5310373|NCT00400101|immunogenicity|immunogenicity
5310374|NCT00400088|Major Depressive Disorder|major depressive disorder
5310375|NCT00400088|Depression|depression
5310376|NCT00400088|Bipolar Disorder|bipolar disorder
5310377|NCT00400088|Manic Depressive Illness|manic depressive illness
5310378|NCT00400088|Randomized Trial|randomized trial
5310379|NCT00400088|Antidepressant Treatment|antidepressant treatment
5310380|NCT00400088|Lithium Treatment|lithium treatment
5310381|NCT00400075|Polyarteritis|polyarteritis
5310382|NCT00400075|Vasculitis|vasculitis
5310383|NCT00400075|Therapy|therapy
5310384|NCT00400075|Cyclophosphamide|cyclophosphamide
5310385|NCT00400075|Azathioprine|azathioprine
5310386|NCT00400062|Critical care|critical care
5310387|NCT00400062|delirium|delirium
5310388|NCT00400062|long-term cognitive impairment|long-term cognitive impairment
5310389|NCT00400062|mechanical ventilation|mechanical ventilation
5310390|NCT00400062|critical illness|critical illness
5310391|NCT00400062|dementia|dementia
5310392|NCT00400062|aging|aging
5310393|NCT00400062|sedatives and analgesics|sedatives and analgesics
5310394|NCT00400036|cod protein|cod protein
5310395|NCT00400036|insulin sensitivity|insulin sensitivity
5310396|NCT00400036|plasma lipids|plasma lipids
5310397|NCT00400036|glucose tolerance|glucose tolerance
5310398|NCT00400036|plasma inflammatory markers|plasma inflammatory markers
5310399|NCT00400036|skeletal muscle insulin signaling|skeletal muscle insulin signaling
5310400|NCT00400036|type 2 diabetes|type 2 diabetes
5310401|NCT00400036|humans|humans
5310402|NCT00400023|Advanced Solid Tumors|advanced solid tumors
5310403|NCT00400010|Expert system|expert system
5310404|NCT00400010|Transtheoretical Model of Behavior Change|transtheoretical model of behavior change
5310405|NCT00400010|Brief intervention|brief intervention
5310406|NCT00400010|General hospital|general hospital
5310407|NCT00399997|Exercise|exercise
5310408|NCT00399997|Exercise referral|exercise referral
5310409|NCT00399997|Lifestyle diseases|lifestyle diseases
5310410|NCT00399997|Sedentary behavior|sedentary behavior
5310411|NCT00399984|Continuing Medical Education|continuing medical education
5310412|NCT00399971|Idiopathic Aplastic Anemia|idiopathic aplastic anemia
5310413|NCT00399971|Has Failed Conventional Immunosuppressive Therapy|has failed conventional immunosuppressive therapy
5310414|NCT00399971|Not Eligible For Bone Marrow Transplantation|not eligible for bone marrow transplantation
5310415|NCT00399971|C15.378.071.085|c15.378.071.085
5310542|NCT00399373|disease management|disease management
5310416|NCT00399945|Cystic fibrosis, tobramycin, PARI eFlow, PARI LC Plus, nebulizer, pharmacoscintigraphy|cystic fibrosis, tobramycin, pari eflow, pari lc plus, nebulizer, pharmacoscintigraphy
5310417|NCT00399932|metabolic syndrome|metabolic syndrome
5310418|NCT00399932|insulin resistance|insulin resistance
5310419|NCT00399932|NASH|nash
5310420|NCT00399932|hepatic fibrosis|hepatic fibrosis
5310421|NCT00399932|Fibroscan|fibroscan
5310422|NCT00399932|elastography by MRI|elastography by mri
5310423|NCT00399919|Perhipheral Artery Disease|perhipheral artery disease
5310424|NCT00399919|Claudication|claudication
5310425|NCT00399919|Exercise|exercise
5310426|NCT00399919|Intermittent Claudication due to Peripheral Artery Disease|intermittent claudication due to peripheral artery disease
5310427|NCT00399893|Childhood obesity|childhood obesity
5310428|NCT00399893|Prader-Willi Syndrome|prader-willi syndrome
5310429|NCT00399893|Octreotide|octreotide
5310430|NCT00399893|Ghrelin|ghrelin
5310431|NCT00399893|Weight loss|weight loss
5310432|NCT00399893|Body composition|body composition
5310433|NCT00399893|Energy expenditure|energy expenditure
5310434|NCT00399880|Clinical Trial|clinical trial
5310435|NCT00399880|Behavioral/Social|behavioral/social
5310436|NCT00399880|Cardiovascular Disease|cardiovascular disease
5310437|NCT00399880|Risk Factors/Analysis|risk factors/analysis
5310438|NCT00399867|multiple myeloma|multiple myeloma
5310439|NCT00399867|refractory|refractory
5310440|NCT00399867|cell adhesion mediated drug resistance|cell adhesion mediated drug resistance
5310441|NCT00399841|Pain|pain
5310442|NCT00399841|Chronic Pain|chronic pain
5310443|NCT00399841|Neurostimulation|neurostimulation
5310444|NCT00399815|Chronic viral hepatitis C|chronic viral hepatitis c
5310445|NCT00399815|HCV RNA|hcv rna
5310446|NCT00399815|Fibroscan|fibroscan
5310447|NCT00399815|Fibrotest|fibrotest
5310448|NCT00399815|hepatic elastography by MRI|hepatic elastography by mri
5310449|NCT00399789|Non-Small-Cell Lung|non-small-cell lung
5310450|NCT00399789|Perifosine|perifosine
5310451|NCT00399776|bone mineral|bone mineral
5310452|NCT00399776|antipsychotic therapy|antipsychotic therapy
5310453|NCT00399776|bone mineral accrual|bone mineral accrual
5310454|NCT00399776|bone mineral content|bone mineral content
5310455|NCT00399763|Adolescent|adolescent
5310456|NCT00399763|ADHD|adhd
5310458|NCT00399737|ACE activity|ace activity
5310459|NCT00399737|Fermented milk peptides|fermented milk peptides
5310460|NCT00399737|Healthy male volunteers|healthy male volunteers
5310461|NCT00399698|Severe conduct problems|severe conduct problems
5310462|NCT00399698|Risperidone|risperidone
5310463|NCT00399698|Risperdal|risperdal
5310464|NCT00399685|HIV|hiv
5310465|NCT00399672|HCV|hcv
5310466|NCT00399672|injection drug users|injection drug users
5310467|NCT00399672|ribavirin|ribavirin
5310468|NCT00399672|pegylated interferon|pegylated interferon
5310469|NCT00399672|illicit drug users|illicit drug users
5310470|NCT00399659|Opioid, constipation, tegaserod|opioid, constipation, tegaserod
5310471|NCT00399633|VIP|vip
5310472|NCT00399633|PACAP|pacap
5310473|NCT00399633|CGRP|cgrp
5310474|NCT00399633|Prostanoids|prostanoids
5310475|NCT00399620|Periodontitis|periodontitis
5310476|NCT00399620|Diabetes|diabetes
5310477|NCT00399620|Gingival crevicular fluid|gingival crevicular fluid
5310478|NCT00399620|GCF|gcf
5310479|NCT00399620|Saliva|saliva
5310480|NCT00399620|Chromogranin|chromogranin
5310481|NCT00399620|Electrophorèse|electrophorèse
5310482|NCT00399620|Western Blot|western blot
5310483|NCT00399620|RT-HPLC|rt-hplc
5310484|NCT00399607|colonic neoplasms|colonic neoplasms
5310485|NCT00399607|colorectal adenoma|colorectal adenoma
5310486|NCT00399607|calcium|calcium
5310487|NCT00399607|vitamin D|vitamin d
5310488|NCT00399594|Mechanical dyssynchrony|mechanical dyssynchrony
5310489|NCT00399594|Biventricular pacing|biventricular pacing
5310490|NCT00399594|Cardiac resynchronization therapy|cardiac resynchronization therapy
5310491|NCT00399581|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
5310492|NCT00399581|Acute Lung Injury|acute lung injury
5310493|NCT00399581|Mechanical Ventilation|mechanical ventilation
5310494|NCT00399581|Lung|lung
5310495|NCT00399568|Pain|pain
5310496|NCT00399568|Gynecologic|gynecologic
5310497|NCT00399568|IV Acetaminophen|iv acetaminophen
5310498|NCT00399568|Postoperative|postoperative
5310499|NCT00399568|Analgesic|analgesic
5310500|NCT00399555|Single Ventricle|single ventricle
5310501|NCT00399555|Hypoplastic Left Heart|hypoplastic left heart
5310502|NCT00399555|Developmental|developmental
5310503|NCT00399542|Irritable Bowel Syndrome With Constipation|irritable bowel syndrome with constipation
5310504|NCT00399529|Stage IV HER-2/neu overexpressing breast cancer|stage iv her-2/neu overexpressing breast cancer
5310505|NCT00399516|Pain|pain
5310506|NCT00399516|Neurostimulation|neurostimulation
5310507|NCT00399516|Back pain|back pain
5310508|NCT00399516|Chronic Pain|chronic pain
5310509|NCT00399503|Noninvasive assessment|noninvasive assessment
5310510|NCT00399503|Combined parameter|combined parameter
5310511|NCT00399503|Holter|holter
5310512|NCT00399490|Monoclonal antibody|monoclonal antibody
5310513|NCT00399464|Benign Prostatic Hyperplasia|benign prostatic hyperplasia
5310514|NCT00399464|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists
5310515|NCT00399464|alfuzosin|alfuzosin
5310516|NCT00399451|Sleep Apnea,Obstructive|sleep apnea,obstructive
5310517|NCT00399451|apnea-hypopnea index (AHI)|apnea-hypopnea index (ahi)
5310518|NCT00399451|polidocanol|polidocanol
5310519|NCT00399451|sclerotherapy|sclerotherapy
5310520|NCT00399451|pharynges|pharynges
5310521|NCT00399438|Diarrhea-predominant irritable bowel syndrome|diarrhea-predominant irritable bowel syndrome
5310522|NCT00399425|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight
5310523|NCT00399425|Bemiparin|bemiparin
5310524|NCT00399425|Foot Ulcer, Diabetic|foot ulcer, diabetic
5310525|NCT00399425|Diabetic Angiopathies|diabetic angiopathies
5310526|NCT00399425|Primary Health Care|primary health care
5310527|NCT00399412|S-ICD|s-icd
5310528|NCT00399412|ICD|icd
5310529|NCT00399412|ECG signals|ecg signals
5310530|NCT00399412|Resting|resting
5310531|NCT00399399|Churg-Strauss|churg-strauss
5310532|NCT00399399|Vasculitis|vasculitis
5310533|NCT00399399|Therapy|therapy
5310534|NCT00399399|Cyclophosphamide|cyclophosphamide
5310535|NCT00399399|Azathioprine|azathioprine
5310536|NCT00399386|S ICD|s icd
5310537|NCT00399386|ICD|icd
5310538|NCT00399386|Ablation|ablation
5310539|NCT00399386|EP study|ep study
5310540|NCT00399386|Paediatric|paediatric
5310541|NCT00399386|ECG|ecg
5310543|NCT00399373|substance abuse|substance abuse
5310544|NCT00399360|HIV|hiv
5310545|NCT00399360|Metabolic Syndrome|metabolic syndrome
5310546|NCT00399360|Lifestyle Modification|lifestyle modification
5310547|NCT00399360|Metformin|metformin
5310548|NCT00399360|Treatment Experienced|treatment experienced
5310549|NCT00399347|Diabetes Mellitus, prevalence , Ethiopians Jews, Israel|diabetes mellitus, prevalence , ethiopians jews, israel
5310550|NCT00399334|Schizophrenia|schizophrenia
5310551|NCT00399334|Schizoaffective|schizoaffective
5310552|NCT00399334|relapse|relapse
5310553|NCT00399334|risk factors|risk factors
5310554|NCT00399334|Observational study|observational study
5310555|NCT00399334|Antipsychotic medication|antipsychotic medication
5310556|NCT00399321|Post menopause women receiving adjuvant care|post menopause women receiving adjuvant care
5310557|NCT00399308|wound|wound
5310558|NCT00399308|leg|leg
5310559|NCT00399308|venous|venous
5310560|NCT00399308|chronic|chronic
5310561|NCT00399308|wound healing|wound healing
5310562|NCT00399295|Analgesia|analgesia
5310563|NCT00399282|Rheumatoid arthritis|rheumatoid arthritis
5310564|NCT00399282|Health related quality of life|health related quality of life
5310565|NCT00399282|Omega 3 fatty acids|omega 3 fatty acids
5310566|NCT00399282|Vitamin E|vitamin e
5310567|NCT00399269|Anemia|anemia
5310568|NCT00399256|contrast-induced nephropathy|contrast-induced nephropathy
5310569|NCT00399256|Acetylcysteine|acetylcysteine
5310570|NCT00399256|Zinc|zinc
5310571|NCT00399256|Cystatin C|cystatin c
5310572|NCT00399256|Creatinine|creatinine
5310573|NCT00399243|cluster headache|cluster headache
5310574|NCT00399243|sumatriptan|sumatriptan
5310575|NCT00399217|subcutaneous ICD|subcutaneous icd
5310576|NCT00399217|ICD|icd
5310577|NCT00399217|DFT|dft
5310578|NCT00399217|Pacing threshold|pacing threshold
5310579|NCT00399217|Polarity|polarity
5310580|NCT00399191|anemia|anemia
5310581|NCT00399191|iron deficiency anemia|iron deficiency anemia
5310582|NCT00399191|iron deficiency|iron deficiency
5310583|NCT00399191|absorption|absorption
5310584|NCT00399191|iron absorption|iron absorption
5310585|NCT00399191|iron uptake|iron uptake
5310586|NCT00399178|Osteoarthritis|osteoarthritis
5310587|NCT00399178|Norspan versus Tramadol|norspan versus tramadol
5310588|NCT00399178|Randomised|randomised
5310589|NCT00399178|Efficacy and safety|efficacy and safety
5310590|NCT00399178|OA pain of the hip and/or knee|oa pain of the hip and/or knee
5310591|NCT00399165|Oral Contraception for Men|oral contraception for men
5310592|NCT00399165|Contraceptive agent|contraceptive agent
5310593|NCT00399152|Perifosine|perifosine
5310594|NCT00399152|Sunitinib Malate|sunitinib malate
5310595|NCT00399152|Renal cancer|renal cancer
5310596|NCT00399152|GIST|gist
5310597|NCT00399152|advanced cancers|advanced cancers
5310598|NCT00399074|Sickle Cell anemia|sickle cell anemia
5310599|NCT00399074|Malaria|malaria
5310600|NCT00399074|Presumptive treatment|presumptive treatment
5310601|NCT00399074|Sulfadoxine- pyrimethamine|sulfadoxine- pyrimethamine
5310602|NCT00399074|Children|children
5310603|NCT00399074|Uganda|uganda
5310604|NCT00399048|Pain|pain
5310605|NCT00399048|Osteoarthritis|osteoarthritis
5310606|NCT00399048|knee Osteoarthritis|knee osteoarthritis
5310607|NCT00399048|hip Osteoarthritis .|hip osteoarthritis .
5310608|NCT00399035|Colorectal Cancer|colorectal cancer
5310609|NCT00399035|Cediranib|cediranib
5310610|NCT00399035|RECENTIN|recentin
5310611|NCT00399009|Circular stapling devices|circular stapling devices
5310612|NCT00399009|anastomotic leak|anastomotic leak
5310613|NCT00399009|anastomotic dehiscence|anastomotic dehiscence
5310614|NCT00399009|rectal cancer|rectal cancer
5310615|NCT00398996|antiretroviral therapy|antiretroviral therapy
5310616|NCT00398996|HIV|hiv
5310617|NCT00398996|Opportunistic infections|opportunistic infections
5310618|NCT00398996|CD4|cd4
5310619|NCT00398996|Viral load|viral load
5310620|NCT00398996|TB/HIV co infection|tb/hiv co infection
5310621|NCT00398996|Treatment Naive|treatment naive
5310622|NCT00398983|Acute Myelogenous Leukemia|acute myelogenous leukemia
5310623|NCT00398983|AML|aml
5310624|NCT00398983|Remission|remission
5310625|NCT00398983|Decitabine|decitabine
5310626|NCT00398983|Maintenance Therapy|maintenance therapy
5310627|NCT00398970|Endobronchial ultrasonography|endobronchial ultrasonography
5310628|NCT00398970|Fluoroscopy|fluoroscopy
5310629|NCT00398970|Guide sheath|guide sheath
5310630|NCT00398970|Peripheral pulmonary lesion|peripheral pulmonary lesion
5310631|NCT00398970|Transbronchial biopsy|transbronchial biopsy
5310632|NCT00398957|Analgesia|analgesia
5310633|NCT00398944|Guideline based decision support system, Hypertension, Diabetes|guideline based decision support system, hypertension, diabetes
5310634|NCT00398905|Prevention of venous thromboembolism|prevention of venous thromboembolism
5310635|NCT00398892|Type 2 diabetes mellitus|type 2 diabetes mellitus
5310636|NCT00398892|Glycaemic control|glycaemic control
5310637|NCT00398892|Lipoic acid|lipoic acid
5310638|NCT00398892|Diabetic nephropathy|diabetic nephropathy
5310639|NCT00398879|Capecitabine|capecitabine
5310640|NCT00398866|Hyaluronan|hyaluronan
5310641|NCT00398866|Carpometacarpal|carpometacarpal
5310642|NCT00398866|Outcomes|outcomes
5310643|NCT00398866|Carpometacarpal Joints|carpometacarpal joints
5310644|NCT00398853|insulin|insulin
5310645|NCT00398853|glucose|glucose
5310646|NCT00398853|chromium|chromium
5310647|NCT00398840|Cancer|cancer
5310648|NCT00398840|Solid Tumors|solid tumors
5310649|NCT00398840|advanced solid tumors|advanced solid tumors
5310650|NCT00398827|American Society of Anesthesiologists (ASA)|american society of anesthesiologists (asa)
5310651|NCT00398827|Observer's Assessment of Alertness Scale (OAA/S)|observer's assessment of alertness scale (oaa/s)
5310652|NCT00398827|Aldrete Scoring System|aldrete scoring system
5310653|NCT00398827|Surgery or procedure using monitored care anesthesia|surgery or procedure using monitored care anesthesia
5310654|NCT00398827|Surgery or procedure at least 30 minutes in duration|surgery or procedure at least 30 minutes in duration
5310655|NCT00398814|Perifosine|perifosine
5310656|NCT00398814|Sorafenib|sorafenib
5310657|NCT00398814|Renal cancer|renal cancer
5310658|NCT00398814|Hepatocellular cancer|hepatocellular cancer
5310659|NCT00398814|other advanced solid tumors|other advanced solid tumors
5310660|NCT00398801|gastroparesis|gastroparesis
5310661|NCT00398788|Pain|pain
5310662|NCT00398775|procalcitonin guided antibiotic discontinuation|procalcitonin guided antibiotic discontinuation
5310663|NCT00398775|fever of unknown origin|fever of unknown origin
5310664|NCT00398749|Anemia|anemia
5310665|NCT00398749|Neoplasms|neoplasms
5310666|NCT00398749|Antineoplastic agents|antineoplastic agents
5310667|NCT00398749|Chemotherapy|chemotherapy
5310668|NCT00398749|Efficacy|efficacy
5310669|NCT00398749|Epoetin alfa|epoetin alfa
5310670|NCT00398736|Presence of severe sepsis and septic shock, mechanical ventilation|presence of severe sepsis and septic shock, mechanical ventilation
5310671|NCT00398723|Narrowband UBV Phototherapy|narrowband ubv phototherapy
5310672|NCT00398723|Skin biopsies|skin biopsies
5310673|NCT00398710|Waldenström's Macroglobulinemia|waldenström's macroglobulinemia
5310674|NCT00398710|Perifosine|perifosine
5310675|NCT00398697|perifosine|perifosine
5310676|NCT00398697|gemcitabine|gemcitabine
5310677|NCT00398684|Thailand|thailand
5310678|NCT00398684|Developing countries|developing countries
5310679|NCT00398684|prophylaxis|prophylaxis
5310680|NCT00398684|mother to child transmission|mother to child transmission
5310681|NCT00398684|HIV-1|hiv-1
5310682|NCT00398684|HIV-1 infection|hiv-1 infection
5310683|NCT00398684|HIV Seronegativity|hiv seronegativity
5310684|NCT00398671|primary successful cardio-pulmonary resuscitation|primary successful cardio-pulmonary resuscitation
5310685|NCT00398671|pre-hospital setting|pre-hospital setting
5310686|NCT00398658|Endophthalmitis|endophthalmitis
5310687|NCT00398658|Post-traumatic Endophthalmitis|post-traumatic endophthalmitis
5310688|NCT00398658|Bacterial Endophthalmitis|bacterial endophthalmitis
5310689|NCT00398658|Prophylaxis of Endophthalmitis|prophylaxis of endophthalmitis
5310690|NCT00398658|Intra Ocular Injection of antibiotics|intra ocular injection of antibiotics
5310691|NCT00398645|GW685698X|gw685698x
5310692|NCT00398645|Adults|adults
5310693|NCT00398645|Pharmacokinetics|pharmacokinetics
5310694|NCT00398645|Pharmacogenetics|pharmacogenetics
5310695|NCT00398645|Asthma|asthma
5310696|NCT00398645|Adolescents|adolescents
5310697|NCT00398593|Adherence with therapy|adherence with therapy
5310698|NCT00398593|Adherence enhancing intervention|adherence enhancing intervention
5310699|NCT00398593|Nonadherence|nonadherence
5310700|NCT00398593|Ulcerative colitis|ulcerative colitis
5310701|NCT00398580|DHT|dht
5310702|NCT00398580|Testosterone|testosterone
5310703|NCT00398580|Hypogonadism|hypogonadism
5310704|NCT00398580|Dutasteride|dutasteride
5310705|NCT00398580|Androgen deficiency|androgen deficiency
5310706|NCT00398567|HKI-272|hki-272
5310707|NCT00398567|neratinib|neratinib
5310708|NCT00398567|trastuzumab|trastuzumab
5310709|NCT00398567|breast cancer|breast cancer
5310710|NCT00398567|Nerlynx|nerlynx
5310711|NCT00398567|PB-272|pb-272
5310712|NCT00398567|HER2|her2
5310713|NCT00398554|stage II childhood Hodgkin lymphoma|stage ii childhood hodgkin lymphoma
5310714|NCT00398554|stage III childhood Hodgkin lymphoma|stage iii childhood hodgkin lymphoma
5310715|NCT00398554|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
5310716|NCT00398554|stage I childhood Hodgkin lymphoma|stage i childhood hodgkin lymphoma
5310717|NCT00398554|childhood lymphocyte depletion Hodgkin lymphoma|childhood lymphocyte depletion hodgkin lymphoma
5310718|NCT00398554|childhood mixed cellularity Hodgkin lymphoma|childhood mixed cellularity hodgkin lymphoma
5310719|NCT00398554|childhood nodular sclerosis Hodgkin lymphoma|childhood nodular sclerosis hodgkin lymphoma
5310720|NCT00398528|Multiple Sclerosis|multiple sclerosis
5310721|NCT00398528|Disease Modifying Therapy|disease modifying therapy
5310722|NCT00398489|stage IIIA breast cancer|stage iiia breast cancer
5310723|NCT00398489|stage IIIB breast cancer|stage iiib breast cancer
5310724|NCT00398489|stage IIIC breast cancer|stage iiic breast cancer
5310725|NCT00398489|stage II breast cancer|stage ii breast cancer
5310726|NCT00398489|inflammatory breast cancer|inflammatory breast cancer
5310727|NCT00398476|taste|taste
5310728|NCT00398476|questionnaire|questionnaire
5310729|NCT00398476|preference|preference
5310730|NCT00398476|attributes|attributes
5310731|NCT00398476|odor|odor
5310732|NCT00398476|after taste|after taste
5310733|NCT00398476|scent|scent
5310734|NCT00398463|tirofiban|tirofiban
5310735|NCT00398463|aspirin resistance|aspirin resistance
5310736|NCT00398463|clopidogrel resistance|clopidogrel resistance
5310737|NCT00398450|recurrent melanoma|recurrent melanoma
5310738|NCT00398450|stage IV melanoma|stage iv melanoma
5310739|NCT00398437|tumors metastatic to brain|tumors metastatic to brain
5310740|NCT00398437|stage IV breast cancer|stage iv breast cancer
5310741|NCT00398424|Impaired Hepatic Function|impaired hepatic function
5310742|NCT00398411|prophylaxis|prophylaxis
5310743|NCT00398411|bacteremia|bacteremia
5310744|NCT00398411|moxifloxacin|moxifloxacin
5310745|NCT00398411|stem cell transplantation|stem cell transplantation
5310746|NCT00398411|Hodgkin disease|hodgkin disease
5310747|NCT00398411|non-Hodgkin lymphoma|non-hodgkin lymphoma
5310748|NCT00398411|multiple myeloma|multiple myeloma
5310749|NCT00398411|solid tumor|solid tumor
5310750|NCT00398411|autologous stem cell transplantation|autologous stem cell transplantation
5310751|NCT00398398|gastric cancer|gastric cancer
5310752|NCT00398398|chemotherapy|chemotherapy
5310753|NCT00398398|cetuximab|cetuximab
5310754|NCT00398398|capecitabine|capecitabine
5310755|NCT00398398|oxaliplatin|oxaliplatin
5310756|NCT00398385|squamous cell lung cancer|squamous cell lung cancer
5310757|NCT00398385|adenocarcinoma of the lung|adenocarcinoma of the lung
5310758|NCT00398385|adenosquamous cell lung cancer|adenosquamous cell lung cancer
5310759|NCT00398385|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
5310760|NCT00398385|large cell lung cancer|large cell lung cancer
5310761|NCT00398385|stage IB non-small cell lung cancer|stage ib non-small cell lung cancer
5310762|NCT00398385|stage IIA non-small cell lung cancer|stage iia non-small cell lung cancer
5310763|NCT00398385|stage IIB non-small cell lung cancer|stage iib non-small cell lung cancer
5310764|NCT00398359|Obesity|obesity
5310765|NCT00398359|Overweight|overweight
5310766|NCT00398359|Children|children
5310767|NCT00398359|Behavioral|behavioral
5310768|NCT00398359|Motivational|motivational
5310769|NCT00398359|Family|family
5310770|NCT00398359|Primary care|primary care
5310771|NCT00398333|Colorectal Neoplasms|colorectal neoplasms
5310772|NCT00398333|Eicosapentaenoic Acid|eicosapentaenoic acid
5310773|NCT00398333|Quality of Life|quality of life
5310774|NCT00398333|Nutritional Status|nutritional status
5310775|NCT00398307|Renal Impairment|renal impairment
5310776|NCT00398281|prostate cancer|prostate cancer
5310777|NCT00398268|Fracture|fracture
5310778|NCT00398268|Forearm|forearm
5310779|NCT00398268|Distal|distal
5310780|NCT00398268|Child|child
5310781|NCT00398268|Treatment|treatment
5310782|NCT00398255|arthritis|arthritis
5310783|NCT00398255|self management|self management
5310784|NCT00398255|patient education|patient education
5310785|NCT00398242|fracture|fracture
5310786|NCT00398242|forearm|forearm
5310787|NCT00398242|midshaft|midshaft
5310788|NCT00398242|child|child
5310789|NCT00398242|treatment|treatment
5310790|NCT00398229|In-Vitro Fertilization|in-vitro fertilization
5310791|NCT00398229|human chorionic gonadotropin|human chorionic gonadotropin
5310792|NCT00398229|frozen-thawed embryo transfer|frozen-thawed embryo transfer
5310793|NCT00398229|implantation rate|implantation rate
5310794|NCT00398216|Anti-coagulant|anti-coagulant
5310795|NCT00398216|hip replacement|hip replacement
5310796|NCT00398216|hip replacement surgery|hip replacement surgery
5310797|NCT00398216|unilateral hip replacement surgery|unilateral hip replacement surgery
5310798|NCT00398216|DeepVein Thrombosis|deepvein thrombosis
5310799|NCT00398216|Venous Thromboembolism|venous thromboembolism
5310800|NCT00398216|pulmonary embolism|pulmonary embolism
5310801|NCT00398216|Prevention of Blood Clots|prevention of blood clots
5310802|NCT00398203|NaviAid™ BGE Device|naviaid™ bge device
5310803|NCT00398203|Small Intestine|small intestine
5310804|NCT00398203|Intestinal Diseases|intestinal diseases
5310805|NCT00398190|Smoking|smoking
5310806|NCT00398190|Tobacco use disorder|tobacco use disorder
5310807|NCT00398138|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5310808|NCT00398138|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5310809|NCT00398138|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5310810|NCT00398138|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5310811|NCT00398138|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5310812|NCT00398138|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5310813|NCT00398138|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5310814|NCT00398138|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5310815|NCT00398138|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5310816|NCT00398138|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5310817|NCT00398138|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5310818|NCT00398138|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5310819|NCT00398138|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5310820|NCT00398138|advanced malignant mesothelioma|advanced malignant mesothelioma
5310821|NCT00398138|recurrent malignant mesothelioma|recurrent malignant mesothelioma
5310822|NCT00398138|primary peritoneal cavity cancer|primary peritoneal cavity cancer
5310823|NCT00398125|GSK364735|gsk364735
5310824|NCT00398125|HIV-1|hiv-1
5310825|NCT00398125|integrase inhibitor|integrase inhibitor
5310826|NCT00398086|Metastatic Pancreatic Cancer, Abraxane, Gemcitabine|metastatic pancreatic cancer, abraxane, gemcitabine
5310827|NCT00398073|stage II melanoma|stage ii melanoma
5310828|NCT00398073|stage III melanoma|stage iii melanoma
5310829|NCT00398073|stage IV melanoma|stage iv melanoma
5310830|NCT00398073|recurrent melanoma|recurrent melanoma
5310831|NCT00398073|ciliary body and choroid melanoma, medium/large size|ciliary body and choroid melanoma, medium/large size
5310832|NCT00398073|ciliary body and choroid melanoma, small size|ciliary body and choroid melanoma, small size
5310833|NCT00398073|recurrent intraocular melanoma|recurrent intraocular melanoma
5310834|NCT00398073|metastatic intraocular melanoma|metastatic intraocular melanoma
5310835|NCT00398060|life-style counseling|life-style counseling
5310836|NCT00398060|type 2 diabetes|type 2 diabetes
5310837|NCT00398060|prediabetes|prediabetes
5310838|NCT00398060|physical activity|physical activity
5310839|NCT00398060|diet|diet
5310840|NCT00398060|cognitive-behavioral|cognitive-behavioral
5310841|NCT00398047|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5310842|NCT00398047|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
5310843|NCT00398047|refractory anemia with excess blasts|refractory anemia with excess blasts
5310844|NCT00398047|refractory anemia|refractory anemia
5310845|NCT00398047|refractory cytopenia with multilineage dysplasia|refractory cytopenia with multilineage dysplasia
5310846|NCT00398047|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5310847|NCT00398047|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5310848|NCT00398047|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
5310849|NCT00398034|opioids|opioids
5310850|NCT00398034|pain|pain
5310851|NCT00398034|hypogonadism|hypogonadism
5310852|NCT00398034|depression|depression
5310853|NCT00398034|fatigue|fatigue
5310854|NCT00398034|cognition|cognition
5310855|NCT00398034|libido|libido
5310856|NCT00398021|constipation|constipation
5310857|NCT00398021|bowel habits|bowel habits
5310858|NCT00398008|Buprenorphine|buprenorphine
5310859|NCT00398008|Naltrexone|naltrexone
5310860|NCT00398008|HIV risk reduction behavior|hiv risk reduction behavior
5310861|NCT00398008|Counseling|counseling
5311238|NCT00396526|India|india
5310862|NCT00398008|HIV Seronegativity|hiv seronegativity
5310863|NCT00397995|Fracture|fracture
5310864|NCT00397995|Forearm|forearm
5310865|NCT00397995|Distal|distal
5310866|NCT00397995|Child|child
5310867|NCT00397995|Treatment|treatment
5310868|NCT00397969|colon cancer|colon cancer
5310869|NCT00397969|rectal cancer|rectal cancer
5310870|NCT00397969|precancerous condition|precancerous condition
5310871|NCT00397943|Tuberculosis|tuberculosis
5310872|NCT00397930|cancer-related sleep disturbance|cancer-related sleep disturbance
5310873|NCT00397930|fatigue|fatigue
5310874|NCT00397930|sleep disorders|sleep disorders
5310875|NCT00397904|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
5310876|NCT00397904|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
5310877|NCT00397904|recurrent esophageal cancer|recurrent esophageal cancer
5310878|NCT00397904|recurrent gastric cancer|recurrent gastric cancer
5310879|NCT00397904|adenocarcinoma of the stomach|adenocarcinoma of the stomach
5310880|NCT00397904|stage IV esophageal cancer|stage iv esophageal cancer
5310881|NCT00397904|stage IV gastric cancer|stage iv gastric cancer
5310882|NCT00397865|Obesity|obesity
5310883|NCT00397865|Overweight|overweight
5310884|NCT00397852|Fracture|fracture
5310885|NCT00397852|Forearm|forearm
5310886|NCT00397852|Distal|distal
5310887|NCT00397852|Child|child
5310888|NCT00397852|Treatment|treatment
5310889|NCT00397839|male osteoporosis|male osteoporosis
5310890|NCT00397839|osteoporosis|osteoporosis
5310891|NCT00397839|bisphonates|bisphonates
5310892|NCT00397839|bone|bone
5310893|NCT00397800|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5310894|NCT00397800|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5310895|NCT00397800|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
5310896|NCT00397800|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5310897|NCT00397800|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5310898|NCT00397800|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5310899|NCT00397800|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5310900|NCT00397800|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5310901|NCT00397774|Palliative care|palliative care
5310902|NCT00397774|Physical exercise|physical exercise
5310903|NCT00397774|Physical function|physical function
5310904|NCT00397761|inflammatory breast cancer|inflammatory breast cancer
5310905|NCT00397761|stage II breast cancer|stage ii breast cancer
5310906|NCT00397761|stage IIIA breast cancer|stage iiia breast cancer
5310907|NCT00397761|stage IIIB breast cancer|stage iiib breast cancer
5310908|NCT00397748|Phospholipase A2|phospholipase a2
5310909|NCT00397748|D2 Receptors|d2 receptors
5310910|NCT00397748|Apomorphine|apomorphine
5310911|NCT00397748|Trimethobenzamide|trimethobenzamide
5310912|NCT00397748|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
5310913|NCT00397748|ADHD|adhd
5310914|NCT00397748|Healthy Volunteer|healthy volunteer
5310915|NCT00397748|HV|hv
5310916|NCT00397735|pregnancy|pregnancy
5310917|NCT00397735|chorioamnionitis|chorioamnionitis
5310918|NCT00397735|preterm labor|preterm labor
5310919|NCT00397735|preterm premature rupture of the membranes|preterm premature rupture of the membranes
5310920|NCT00397735|Intra-amniotic infection|intra-amniotic infection
5310921|NCT00397735|Intra-amniotic inflammation|intra-amniotic inflammation
5310922|NCT00397722|safety|safety
5310923|NCT00397722|outpatients with a diagnosis of Social Anxiety disorder (SocAD).|outpatients with a diagnosis of social anxiety disorder (socad).
5310924|NCT00397722|effectiveness|effectiveness
5310925|NCT00397709|Latent tuberculosis infection.|latent tuberculosis infection.
5310926|NCT00397709|Isoniazid.|isoniazid.
5310927|NCT00397709|Rifampin.|rifampin.
5310928|NCT00397709|Clinical trial.|clinical trial.
5310929|NCT00397709|treatment of latent tuberculosis infection|treatment of latent tuberculosis infection
5310930|NCT00397696|Parkinson|parkinson
5310931|NCT00397696|imaging|imaging
5310932|NCT00397696|nicotinic receptors|nicotinic receptors
5310933|NCT00397657|carotid intima media thickness|carotid intima media thickness
5310934|NCT00397657|atherosclerosis|atherosclerosis
5310935|NCT00397657|niacin|niacin
5310936|NCT00397657|coronary heart disease|coronary heart disease
5310937|NCT00397657|HDL-C|hdl-c
5310938|NCT00397657|LDL-C|ldl-c
5310939|NCT00397644|pediatrician|pediatrician
5310940|NCT00397644|well-child care visit|well-child care visit
5310941|NCT00397644|low-income children|low-income children
5310942|NCT00397644|family psychosocial problem|family psychosocial problem
5310943|NCT00397605|bipolar|bipolar
5310944|NCT00397605|therapeutic potential|therapeutic potential
5310945|NCT00397605|neurocognitive performance|neurocognitive performance
5310946|NCT00397605|cannabinoids|cannabinoids
5310947|NCT00397592|Growth Hormone|growth hormone
5310948|NCT00397592|Cardiovascular System|cardiovascular system
5310949|NCT00397592|Endothelial Progenitor Cells|endothelial progenitor cells
5310950|NCT00397579|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5310951|NCT00397579|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5310952|NCT00397579|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5310953|NCT00397579|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5310954|NCT00397579|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5310955|NCT00397579|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5310956|NCT00397579|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5310957|NCT00397579|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
5310958|NCT00397579|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5310959|NCT00397579|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5310960|NCT00397579|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5310961|NCT00397579|blastic plasmacytoid dendritic cell neoplasm|blastic plasmacytoid dendritic cell neoplasm
5310962|NCT00397579|plasmacytoid dendritic cell leukemia|plasmacytoid dendritic cell leukemia
5310963|NCT00397579|CD123+|cd123+
5310964|NCT00397566|HIV|hiv
5310965|NCT00397566|Treatment Experienced|treatment experienced
5310966|NCT00397540|HBV DNA|hbv dna
5310967|NCT00397540|HCC|hcc
5310968|NCT00397540|recurrence|recurrence
5310969|NCT00397540|PEIT|peit
5310970|NCT00397540|RFTA|rfta
5310971|NCT00397514|Biventricular pacing|biventricular pacing
5310972|NCT00397514|Congenital heart disease|congenital heart disease
5310973|NCT00397514|Tissue Doppler echocardiography|tissue doppler echocardiography
5310974|NCT00397501|cognitive/functional effects|cognitive/functional effects
5310975|NCT00397501|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
5310976|NCT00397501|drug/agent toxicity by tissue/organ|drug/agent toxicity by tissue/organ
5310977|NCT00397501|recurrent breast cancer|recurrent breast cancer
5310978|NCT00397501|stage IV breast cancer|stage iv breast cancer
5310979|NCT00397501|adult tumors metastatic to brain|adult tumors metastatic to brain
5310980|NCT00397488|recurrent bladder cancer|recurrent bladder cancer
5310981|NCT00397488|stage IV bladder cancer|stage iv bladder cancer
5310982|NCT00397488|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
5310983|NCT00397488|anterior urethral cancer|anterior urethral cancer
5310984|NCT00397488|posterior urethral cancer|posterior urethral cancer
5310985|NCT00397488|recurrent urethral cancer|recurrent urethral cancer
5310986|NCT00397488|metastatic transitional cell cancer of the renal pelvis and ureter|metastatic transitional cell cancer of the renal pelvis and ureter
5310987|NCT00397488|recurrent transitional cell cancer of the renal pelvis and ureter|recurrent transitional cell cancer of the renal pelvis and ureter
5310988|NCT00397488|urethral cancer associated with invasive bladder cancer|urethral cancer associated with invasive bladder cancer
5310989|NCT00397462|Osteoporosis|osteoporosis
5310990|NCT00397462|Sarcopenia|sarcopenia
5310991|NCT00397462|Calf muscle pump|calf muscle pump
5310992|NCT00397462|Venous insufficiency|venous insufficiency
5310993|NCT00397462|DEXA|dexa
5310994|NCT00397462|Soleus muscle|soleus muscle
5310995|NCT00397462|APG|apg
5310996|NCT00397449|Malaria, malaria vaccine, randomised, safety, immunogenicity|malaria, malaria vaccine, randomised, safety, immunogenicity
5310997|NCT00397423|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
5310998|NCT00397423|Granulocyte Colony Stimulating Factor|granulocyte colony stimulating factor
5310999|NCT00397423|Randomized Control Trial Study|randomized control trial study
5311000|NCT00397410|hip protectors|hip protectors
5311001|NCT00397410|uptake and adherence|uptake and adherence
5311002|NCT00397410|Nursing home residents|nursing home residents
5311003|NCT00397410|efficacy|efficacy
5311004|NCT00397410|prevention|prevention
5311005|NCT00397397|Urinary Calculi|urinary calculi
5311006|NCT00397397|Rowatinex|rowatinex
5311007|NCT00397397|Alfuzosin|alfuzosin
5311008|NCT00397397|Drug Therapy|drug therapy
5311009|NCT00397358|Peritoneal Dialysis|peritoneal dialysis
5311010|NCT00397358|Hypertriglyceridemia|hypertriglyceridemia
5311011|NCT00397358|Extraneal(7.5% icodextrin)Peritoneal Dialysis Solution|extraneal(7.5% icodextrin)peritoneal dialysis solution
5311012|NCT00397345|Renal|renal
5311013|NCT00397345|TroVax|trovax
5311014|NCT00397345|survival|survival
5311015|NCT00397345|metastatic|metastatic
5311016|NCT00397345|Kidney|kidney
5311017|NCT00397345|cancer|cancer
5311018|NCT00397345|immunotherapy|immunotherapy
5311143|NCT00396812|Autoimmune disease|autoimmune disease
5311019|NCT00397345|Locally advanced or metastatic, measurable, histologically proven clear cell renal carcinoma.|locally advanced or metastatic, measurable, histologically proven clear cell renal carcinoma.
5311020|NCT00397332|GVHD|gvhd
5311021|NCT00397319|Growth Hormone|growth hormone
5311022|NCT00397319|Cardiovascular System|cardiovascular system
5311023|NCT00397293|AT101|at101
5311024|NCT00397293|AT-101|at-101
5311025|NCT00397293|cancer|cancer
5311026|NCT00397293|lung|lung
5311027|NCT00397293|small-cell|small-cell
5311028|NCT00397293|topotecan|topotecan
5311029|NCT00397280|Neutrophil|neutrophil
5311030|NCT00397280|Immunity|immunity
5311031|NCT00397280|Signal Transduction|signal transduction
5311032|NCT00397280|Lipopolysaccharide|lipopolysaccharide
5311033|NCT00397280|Cholesterol|cholesterol
5311034|NCT00397280|Healthy Volunteer|healthy volunteer
5311036|NCT00397267|Dyspnea|dyspnea
5311037|NCT00397267|Cough|cough
5311038|NCT00397254|Migraine|migraine
5311039|NCT00397254|rizatriptan|rizatriptan
5311040|NCT00397228|Parkinson|parkinson
5311041|NCT00397228|imaging|imaging
5311042|NCT00397228|dopamine transporter|dopamine transporter
5311043|NCT00397215|H5N1|h5n1
5311044|NCT00397215|influenza|influenza
5311045|NCT00397215|vaccine|vaccine
5311046|NCT00397202|Menstruation|menstruation
5311047|NCT00397189|Primary insomnia as defined by DSM IV criteria|primary insomnia as defined by dsm iv criteria
5311048|NCT00397163|Coronary artery bypass graft surgery|coronary artery bypass graft surgery
5311049|NCT00397163|Remote ischemic preconditioning|remote ischemic preconditioning
5311050|NCT00397163|Troponin-T|troponin-t
5311051|NCT00397150|Infant Nutrition [G06.696.259.750]|infant nutrition [g06.696.259.750]
5311052|NCT00397150|Infant Care [N02.421.088.120] +|infant care [n02.421.088.120] +
5311053|NCT00397150|Diarrhea, Infantile [C23.888.821.214.500]|diarrhea, infantile [c23.888.821.214.500]
5311054|NCT00397150|Child Health Services [N02.421.143.130] +|child health services [n02.421.143.130] +
5311055|NCT00397150|Counseling [N02.421.143.303]|counseling [n02.421.143.303]
5311056|NCT00397150|Growth [G07.574.249] +|growth [g07.574.249] +
5311057|NCT00397150|Micronutrients [D11.430]|micronutrients [d11.430]
5311058|NCT00397150|Breast Feeding [G06.696.259.750.500]|breast feeding [g06.696.259.750.500]
5311059|NCT00397137|Symptomatic haemorrhoids|symptomatic haemorrhoids
5311060|NCT00397137|haemorrhoidectomy|haemorrhoidectomy
5311061|NCT00397137|stapled anopexy|stapled anopexy
5311062|NCT00397111|Morphometry|morphometry
5311063|NCT00397111|BOLD|bold
5311064|NCT00397111|fMRI|fmri
5311065|NCT00397111|Spectrometry|spectrometry
5311066|NCT00397111|Relaxometry|relaxometry
5311067|NCT00397111|Healthy Volunteer|healthy volunteer
5311068|NCT00397111|HV|hv
5311069|NCT00397098|Anxiety disorders, Relapse prevention|anxiety disorders, relapse prevention
5311070|NCT00397072|Glioblastoma recurrent,temozolomide, epothilone|glioblastoma recurrent,temozolomide, epothilone
5311071|NCT00397059|Escitalopram|escitalopram
5311072|NCT00397059|Pharmacokinetics|pharmacokinetics
5311073|NCT00397059|Pharmacodynamics|pharmacodynamics
5311074|NCT00397059|CYP2C19|cyp2c19
5311075|NCT00397059|Pupillometry|pupillometry
5311076|NCT00397059|healthy volunteers|healthy volunteers
5311077|NCT00397046|Advanced Malignant Solid Tumors|advanced malignant solid tumors
5311078|NCT00397046|HKI-272|hki-272
5311079|NCT00397046|Neratinib|neratinib
5311080|NCT00397046|Nerlynx|nerlynx
5311081|NCT00397033|Schizoaffective Disorder|schizoaffective disorder
5311082|NCT00397033|antipsychotic|antipsychotic
5311083|NCT00397033|paliperidone|paliperidone
5311084|NCT00397033|placebo|placebo
5311085|NCT00397020|quetiapine|quetiapine
5311086|NCT00397020|divalproex|divalproex
5311087|NCT00397007|tinnitus|tinnitus
5311088|NCT00397007|biofeedback|biofeedback
5311089|NCT00397007|psychophysiological reactivity|psychophysiological reactivity
5311090|NCT00397007|intervention|intervention
5311091|NCT00396994|biomechanics|biomechanics
5311092|NCT00396994|osteogenesis|osteogenesis
5311093|NCT00396994|osteoporosis|osteoporosis
5311094|NCT00396994|bone regeneration|bone regeneration
5311095|NCT00396981|Intracranial saccular aneurysms|intracranial saccular aneurysms
5311096|NCT00396981|Endovascular coiling therapy|endovascular coiling therapy
5311097|NCT00396981|Retreatment|retreatment
5311098|NCT00396981|Raymond scale|raymond scale
5311099|NCT00396981|Matrix|matrix
5311100|NCT00396981|GDC|gdc
5311101|NCT00396981|Guglielmi Detachable Coil|guglielmi detachable coil
5311102|NCT00396968|AMD3100|amd3100
5311103|NCT00396968|Acute Myelogenous Leukemai|acute myelogenous leukemai
5311104|NCT00396968|Myelodysplastic Syndromes|myelodysplastic syndromes
5311105|NCT00396968|Allogeneic stem cell transplantation|allogeneic stem cell transplantation
5311106|NCT00396955|osteoarthritis|osteoarthritis
5311107|NCT00396955|arthritis|arthritis
5311108|NCT00396955|pain|pain
5311109|NCT00396942|Electroencephalogram (EEG)|electroencephalogram (eeg)
5311110|NCT00396942|Nerve Conduction Study|nerve conduction study
5311111|NCT00396942|Transcranial Magnetic Stimulation (TMS)|transcranial magnetic stimulation (tms)
5311112|NCT00396942|Motor Evoked Potential|motor evoked potential
5311113|NCT00396942|Parkinson Disease|parkinson disease
5311114|NCT00396942|PD|pd
5311115|NCT00396942|Healthy Volunteer|healthy volunteer
5311116|NCT00396942|HV|hv
5311117|NCT00396929|Paclitaxel|paclitaxel
5311118|NCT00396929|Restenosis|restenosis
5311119|NCT00396929|Stent|stent
5311120|NCT00396929|Intracoronary Dosis|intracoronary dosis
5311121|NCT00396929|Paclitaxel-eluting Stent|paclitaxel-eluting stent
5311122|NCT00396916|cancer patients|cancer patients
5311123|NCT00396903|Anaesthetic techniques|anaesthetic techniques
5311124|NCT00396903|epidural catheters|epidural catheters
5311125|NCT00396903|paraesthesia|paraesthesia
5311126|NCT00396903|side effects.|side effects.
5311127|NCT00396890|Theta Burst Stimulation|theta burst stimulation
5311128|NCT00396890|Repetitive TMS (rTMS)|repetitive tms (rtms)
5311129|NCT00396890|Transcranial Magnetic Stimulation (TMS)|transcranial magnetic stimulation (tms)
5311130|NCT00396890|Primary Motor Cortex|primary motor cortex
5311131|NCT00396890|Interhemispheric Disinhibition|interhemispheric disinhibition
5311132|NCT00396890|Healthy Volunteer|healthy volunteer
5311133|NCT00396890|HV|hv
5311134|NCT00396877|cyanotic congenital heart disease|cyanotic congenital heart disease
5311135|NCT00396877|shunt palliation|shunt palliation
5311136|NCT00396877|thrombosis|thrombosis
5311137|NCT00396877|clopidogrel|clopidogrel
5311138|NCT00396864|cutaneous lymphoma|cutaneous lymphoma
5311139|NCT00396864|marginal zone lymphoma|marginal zone lymphoma
5311140|NCT00396825|Care giving|care giving
5311141|NCT00396825|Alzheimer's Disease|alzheimer's disease
5311142|NCT00396825|Stress management|stress management
5311144|NCT00396812|Biologic response modifiers|biologic response modifiers
5311145|NCT00396812|Disease-modifying antirheumatic drugs (DMARDS)|disease-modifying antirheumatic drugs (dmards)
5311146|NCT00396812|Immune system|immune system
5311147|NCT00396812|Rheumatoid arthritis (RA)|rheumatoid arthritis (ra)
5311148|NCT00396812|Rituximab (anti-CD20 monoclonal antibodies)|rituximab (anti-cd20 monoclonal antibodies)
5311149|NCT00396786|Prevention of venous thromboembolism|prevention of venous thromboembolism
5311150|NCT00396773|electrocoagulation,pregnancy,brian waves|electrocoagulation,pregnancy,brian waves
5311151|NCT00396760|cardiac surgery|cardiac surgery
5311152|NCT00396760|blood transfusion|blood transfusion
5311153|NCT00396760|antifibrinolytics|antifibrinolytics
5311154|NCT00396760|aprotinin|aprotinin
5311155|NCT00396760|tranexamic acid|tranexamic acid
5311156|NCT00396747|Early rheumatoid arthritis,|early rheumatoid arthritis,
5311157|NCT00396747|glucocorticoids,|glucocorticoids,
5311158|NCT00396747|pulse therapy,|pulse therapy,
5311159|NCT00396747|infliximab,|infliximab,
5311160|NCT00396747|TNF blockade|tnf blockade
5311161|NCT00396734|Imaging|imaging
5311162|NCT00396734|cocaine|cocaine
5311163|NCT00396734|methadone|methadone
5311164|NCT00396734|craving|craving
5311165|NCT00396734|PET|pet
5311166|NCT00396734|FDG|fdg
5311167|NCT00396734|D2|d2
5311168|NCT00396734|Modafinil|modafinil
5311169|NCT00396734|Topiramate|topiramate
5311170|NCT00396721|Nephropathy, IGA|nephropathy, iga
5311171|NCT00396721|Pilot trial|pilot trial
5311172|NCT00396721|Sirolimus|sirolimus
5311173|NCT00396721|Rapamune|rapamune
5311174|NCT00396708|Robotics|robotics
5311175|NCT00396708|Rehabilitation|rehabilitation
5311176|NCT00396708|Arm|arm
5311177|NCT00396708|Stroke|stroke
5311178|NCT00396708|Weakness|weakness
5311179|NCT00396708|Outpatient|outpatient
5311180|NCT00396708|Chronic|chronic
5311181|NCT00396695|PTSD, traumatic memory|ptsd, traumatic memory
5311182|NCT00396682|HCC|hcc
5311183|NCT00396682|T cell|t cell
5311184|NCT00396669|Nicotine|nicotine
5311185|NCT00396669|Dopamine|dopamine
5311186|NCT00396669|Imaging|imaging
5311187|NCT00396669|Raclopride|raclopride
5311188|NCT00396669|Addiction|addiction
5311189|NCT00396669|Genetics|genetics
5311190|NCT00396656|hypertension|hypertension
5311191|NCT00396656|valsartan|valsartan
5311192|NCT00396656|atenolol|atenolol
5311193|NCT00396656|hydrochlorothiazide|hydrochlorothiazide
5311194|NCT00396656|microcirculation|microcirculation
5311195|NCT00396656|arterial compliance|arterial compliance
5311196|NCT00396656|pulse wave analysis|pulse wave analysis
5311197|NCT00396643|Ultra-High Risk|ultra-high risk
5311198|NCT00396643|Psychosis|psychosis
5311199|NCT00396643|Schizophrenia|schizophrenia
5311200|NCT00396643|Omega-3 fatty acids|omega-3 fatty acids
5311201|NCT00396643|RCT|rct
5311202|NCT00396630|Transmission|transmission
5311203|NCT00396630|Gastroenteritis|gastroenteritis
5311204|NCT00396630|Shedding|shedding
5311205|NCT00396630|rotavirus|rotavirus
5311206|NCT00396630|HRV vaccine|hrv vaccine
5311207|NCT00396617|Laryngeal or pharyngo-laryngeal's carcinoma,|laryngeal or pharyngo-laryngeal's carcinoma,
5311208|NCT00396617|voice prosthesis tracheooesophageal shunt,|voice prosthesis tracheooesophageal shunt,
5311209|NCT00396617|titanium beads,|titanium beads,
5311210|NCT00396617|cellular colonization|cellular colonization
5311211|NCT00396617|Laryngeal or pharyngo-laryngeal's carcinoma|laryngeal or pharyngo-laryngeal's carcinoma
5311212|NCT00396604|indacaterol|indacaterol
5311213|NCT00396604|long acting beta agonist|long acting beta agonist
5311214|NCT00396591|Ovarian cancer|ovarian cancer
5311215|NCT00396591|malignant ascites|malignant ascites
5311216|NCT00396591|angiogenesis|angiogenesis
5311217|NCT00396591|angiogenesis inhibition|angiogenesis inhibition
5311218|NCT00396591|VEGF-Trap fusion recombinant protein|vegf-trap fusion recombinant protein
5311219|NCT00396578|aerosolized antibiotics|aerosolized antibiotics
5311220|NCT00396578|ventilator associated pneumonia|ventilator associated pneumonia
5311221|NCT00396578|clinical pulmonary infection score|clinical pulmonary infection score
5311222|NCT00396578|bacterial resistance|bacterial resistance
5311223|NCT00396565|Schizophrenia|schizophrenia
5311224|NCT00396565|JNS007ER|jns007er
5311225|NCT00396565|Positive and Negative Syndrome Scale (PANSS)|positive and negative syndrome scale (panss)
5311226|NCT00396565|Paliperidone|paliperidone
5311227|NCT00396565|Extended Release Osmotic Controlled-Release Oral Delivery System (OROS) paliperidone|extended release osmotic controlled-release oral delivery system (oros) paliperidone
5311228|NCT00396552|refractory transcranial magnetic stimulation|refractory transcranial magnetic stimulation
5311229|NCT00396552|obsessive compulsive disorder|obsessive compulsive disorder
5311230|NCT00396552|randomized|randomized
5311231|NCT00396552|placebo-controlled|placebo-controlled
5311232|NCT00396552|double-blind|double-blind
5311233|NCT00396526|Nonsevere pneumonia|nonsevere pneumonia
5311234|NCT00396526|treatment|treatment
5311235|NCT00396526|underfives|underfives
5311236|NCT00396526|children|children
5311237|NCT00396526|Community|community
5311240|NCT00396513|Statin|statin
5311241|NCT00396513|Metformin|metformin
5311242|NCT00396513|Testosterone|testosterone
5311243|NCT00396513|Menstrual cycle|menstrual cycle
5311244|NCT00396513|Lipids|lipids
5311245|NCT00396500|Deworming|deworming
5311246|NCT00396500|Malnutrition|malnutrition
5311247|NCT00396500|children|children
5311248|NCT00396500|Community|community
5311249|NCT00396500|India|india
5311250|NCT00396487|Metastatic colorectal cancer|metastatic colorectal cancer
5311251|NCT00396487|tailored treatment|tailored treatment
5311252|NCT00396487|genetic markers|genetic markers
5311253|NCT00396487|gene polymorphism|gene polymorphism
5311254|NCT00396487|chemotherapy|chemotherapy
5311255|NCT00396474|Small for gestational age, Insulin Sensitivity Index, growth hormone treatment|small for gestational age, insulin sensitivity index, growth hormone treatment
5311256|NCT00396461|Critical Illness|critical illness
5311257|NCT00396461|Fat Emulsions, Intravenous|fat emulsions, intravenous
5311258|NCT00396461|Superinfection|superinfection
5311259|NCT00396461|Parenteral Nutrition|parenteral nutrition
5311260|NCT00396435|anaemia|anaemia
5311261|NCT00396435|renal transplantation|renal transplantation
5311262|NCT00396435|kidney failure|kidney failure
5311263|NCT00396422|psoriasis|psoriasis
5311264|NCT00396422|skin|skin
5311265|NCT00396422|auto immune|auto immune
5311266|NCT00396396|Creatinine clearance|creatinine clearance
5311267|NCT00396396|Acetylcysteine|acetylcysteine
5311268|NCT00396383|Multiple Myeloma|multiple myeloma
5311269|NCT00396383|Stem cell mobilization|stem cell mobilization
5311270|NCT00396383|apheresis|apheresis
5311271|NCT00396370|tuberculosis, Bacillus Calmette-Guérin, parent protocol|tuberculosis, bacillus calmette-guérin, parent protocol
5311272|NCT00396357|Type 2 diabetes|type 2 diabetes
5311273|NCT00396357|vildagliptin|vildagliptin
5311274|NCT00396357|hemoglobin A1c|hemoglobin a1c
5311275|NCT00396357|metformin|metformin
5311276|NCT00396344|Systemic sepsis|systemic sepsis
5311277|NCT00396331|Multiple Myeloma|multiple myeloma
5311278|NCT00396331|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
5311279|NCT00396331|autologous transplantation|autologous transplantation
5311280|NCT00396331|AMD3100|amd3100
5311281|NCT00396331|stem cell mobilization|stem cell mobilization
5311282|NCT00396331|plerixafor|plerixafor
5311283|NCT00396318|TNKase|tnkase
5311284|NCT00396318|CVA|cva
5311285|NCT00396318|CVAD|cvad
5311286|NCT00396318|Central venous access catheter|central venous access catheter
5311287|NCT00396305|Influenza, vaccine, efficacy, elderly|influenza, vaccine, efficacy, elderly
5311288|NCT00396292|Anemia|anemia
5311289|NCT00396292|postpartum|postpartum
5311290|NCT00396292|Postpartum anemia|postpartum anemia
5311291|NCT00396279|Giant Cell Tumor of Bone|giant cell tumor of bone
5311292|NCT00396266|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
5311293|NCT00396266|Multiple Myeloma|multiple myeloma
5311294|NCT00396266|stem cell mobilization|stem cell mobilization
5311295|NCT00396266|AMD3100|amd3100
5311296|NCT00396266|autologous transplantation|autologous transplantation
5311297|NCT00396253|HD|hd
5311298|NCT00396253|TNKase|tnkase
5311299|NCT00396253|Hemodialysis|hemodialysis
5311300|NCT00396253|Catheter clearance|catheter clearance
5311301|NCT00396240|rosuvastatin|rosuvastatin
5311302|NCT00396240|hypercholesterolaemia|hypercholesterolaemia
5311303|NCT00396240|cholesterol|cholesterol
5311304|NCT00396240|LDL-C|ldl-c
5311305|NCT00396240|triglyceride|triglyceride
5311306|NCT00396240|plasma lipids|plasma lipids
5311307|NCT00396240|compliance|compliance
5311308|NCT00396227|Type 2 diabetes|type 2 diabetes
5311309|NCT00396227|vildagliptin|vildagliptin
5311310|NCT00396227|hemoglobin A1c|hemoglobin a1c
5311311|NCT00396227|metformin|metformin
5311312|NCT00396214|Schizophrenia|schizophrenia
5311313|NCT00396214|weight changes|weight changes
5311314|NCT00396201|Hodgkin's Disease|hodgkin's disease
5311315|NCT00396201|Stem cell mobilization|stem cell mobilization
5311316|NCT00396201|apheresis|apheresis
5311317|NCT00396188|Keratoconus|keratoconus
5311318|NCT00396188|LASIK|lasik
5311319|NCT00396188|Orthokeratology|orthokeratology
5311320|NCT00396188|Pellucid Marginal Degeneration|pellucid marginal degeneration
5311321|NCT00396188|Refractive Surgery|refractive surgery
5311322|NCT00396188|normal cornea|normal cornea
5311323|NCT00396188|post myopic LASIK|post myopic lasik
5311324|NCT00396188|post hyperopic LASIK|post hyperopic lasik
5311325|NCT00396188|corneal pathologies (e.g. pellucid marginal degeneration)|corneal pathologies (e.g. pellucid marginal degeneration)
5311326|NCT00396149|rBet v 1|rbet v 1
5311327|NCT00396149|Birch pollen allergy|birch pollen allergy
5311328|NCT00396149|Sublingual Immunotherapy|sublingual immunotherapy
5311329|NCT00396136|Congestive Heart Failure|congestive heart failure
5311330|NCT00396136|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
5311331|NCT00396136|Left Ventricular Lead|left ventricular lead
5311332|NCT00396123|Chronic Kidney Disease|chronic kidney disease
5311333|NCT00396123|Anemia|anemia
5311334|NCT00396110|cholesterol|cholesterol
5311335|NCT00396110|coronary heart disease|coronary heart disease
5311336|NCT00396110|rosuvastatin|rosuvastatin
5311337|NCT00396110|LDL-C goal|ldl-c goal
5311338|NCT00396110|hypercholesterolemia|hypercholesterolemia
5311339|NCT00396097|ISS|iss
5311340|NCT00396097|human growth hormone|human growth hormone
5311341|NCT00396084|tuberculosis, linezolid, gatifloxacin, levofloxacin, isoniazid, moxifloxacin, Brazil|tuberculosis, linezolid, gatifloxacin, levofloxacin, isoniazid, moxifloxacin, brazil
5311342|NCT00396071|Type 2 diabetes|type 2 diabetes
5311343|NCT00396071|vildagliptin|vildagliptin
5311344|NCT00396071|incretin effect|incretin effect
5311345|NCT00396071|metformin|metformin
5311346|NCT00396045|Multiple Myeloma, Lenalidomide, elderly patients|multiple myeloma, lenalidomide, elderly patients
5311347|NCT00396032|HD|hd
5311348|NCT00396032|Hemodialysis|hemodialysis
5311349|NCT00396032|Catheter clearance|catheter clearance
5311350|NCT00396032|TNKase|tnkase
5311351|NCT00396032|Renal Insufficiency|renal insufficiency
5311352|NCT00395993|anemia|anemia
5311353|NCT00395993|heavy uterine bleeding|heavy uterine bleeding
5311354|NCT00395993|menorrhagia|menorrhagia
5311355|NCT00395993|Anemia secondary to heavy uterine bleeding|anemia secondary to heavy uterine bleeding
5311356|NCT00395967|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
5311357|NCT00395967|Multiple Myeloma|multiple myeloma
5311358|NCT00395967|stem cell mobilization|stem cell mobilization
5311359|NCT00395967|autologous transplantation|autologous transplantation
5311360|NCT00395967|AMD3100|amd3100
5311361|NCT00395954|Lactose Intolerance|lactose intolerance
5311362|NCT00395954|Lactose|lactose
5311363|NCT00395954|Threshold|threshold
5311364|NCT00395928|heart|heart
5311365|NCT00395928|echocardiography|echocardiography
5311366|NCT00395928|diastolic function|diastolic function
5311367|NCT00395928|left ventricle|left ventricle
5311368|NCT00395928|right ventricle|right ventricle
5311369|NCT00395928|cigarette smoking|cigarette smoking
5311370|NCT00395928|Smoking|smoking
5311371|NCT00395928|Heart Ventricles|heart ventricles
5311372|NCT00395928|Diastole|diastole
5311373|NCT00395928|Doppler Echocardiography|doppler echocardiography
5311374|NCT00395915|schizophrenia|schizophrenia
5311375|NCT00395915|antipsychotics|antipsychotics
5311376|NCT00395915|treatment non response|treatment non response
5311377|NCT00395915|pragmatic trial|pragmatic trial
5311378|NCT00395902|Sensipar|sensipar
5311379|NCT00395902|cinacalcet|cinacalcet
5311380|NCT00395902|Mimpara|mimpara
5311381|NCT00395889|Lung Transplantation|lung transplantation
5311382|NCT00395889|Physical Activities in Daily Life|physical activities in daily life
5311383|NCT00395889|Pulmonary Rehabilitation|pulmonary rehabilitation
5311384|NCT00395889|Functional Status|functional status
5311385|NCT00395876|TNKase|tnkase
5311386|NCT00395876|CVA|cva
5311387|NCT00395876|CVAD|cvad
5311388|NCT00395876|Central venous access catheter|central venous access catheter
5311389|NCT00395876|CVA catheter|cva catheter
5311390|NCT00395850|cocaine dependence|cocaine dependence
5311391|NCT00395850|disulfiram|disulfiram
5311392|NCT00395850|clinical trial|clinical trial
5311393|NCT00395850|methadone maintenance|methadone maintenance
5311394|NCT00395850|pharmacogenetics|pharmacogenetics
5311395|NCT00395850|dopamine beta-hydroxylase|dopamine beta-hydroxylase
5311396|NCT00395837|Aging|aging
5311397|NCT00395837|Wellness|wellness
5311398|NCT00395837|Aerobic exercise|aerobic exercise
5311399|NCT00395837|Prevention|prevention
5311400|NCT00395824|citrate|citrate
5311401|NCT00395824|anticoagulation|anticoagulation
5311402|NCT00395824|heparin-coated membrane|heparin-coated membrane
5311403|NCT00395811|Myocardial Infarction|myocardial infarction
5311404|NCT00395811|stem cell therapy|stem cell therapy
5311405|NCT00395811|Coronary Artery Bypass Grafting|coronary artery bypass grafting
5311406|NCT00395798|cervical intervertebral disc displacement|cervical intervertebral disc displacement
5311407|NCT00395798|cervical spondylosis|cervical spondylosis
5311408|NCT00395798|radiculopathy|radiculopathy
5311409|NCT00395798|neck collar|neck collar
5311410|NCT00395798|brace|brace
5311411|NCT00395798|physiotherapy|physiotherapy
5311412|NCT00395798|treatment|treatment
5311413|NCT00395798|rehabilitation|rehabilitation
5311414|NCT00395785|Carotid stenosis|carotid stenosis
5311415|NCT00395785|Intracranial Embolism|intracranial embolism
5311416|NCT00395785|Carotid artery|carotid artery
5311417|NCT00395785|Carotid stent|carotid stent
5311418|NCT00395785|Embolic protection|embolic protection
5311419|NCT00395785|TriActiv ProGuard System|triactiv proguard system
5311420|NCT00395785|Carotid angioplasty|carotid angioplasty
5311421|NCT00395772|Treatment of venous thromboembolism|treatment of venous thromboembolism
5311422|NCT00395759|contrast sensitivity|contrast sensitivity
5311423|NCT00395733|Gadovist|gadovist
5311424|NCT00395733|Gadavist|gadavist
5311425|NCT00395733|MRI Imaging|mri imaging
5311426|NCT00395733|vascular diseases|vascular diseases
5311427|NCT00395733|Chinese|chinese
5311428|NCT00395720|TB|tb
5311429|NCT00395720|Tuberculosis|tuberculosis
5311430|NCT00395720|HIV|hiv
5311431|NCT00395720|Vaccine|vaccine
5311432|NCT00395720|MVA85A|mva85a
5311433|NCT00395720|HIV Therapeutic Vaccine|hiv therapeutic vaccine
5311434|NCT00395707|Macular Degeneration|macular degeneration
5311435|NCT00395707|Age Related Macular Degeneration|age related macular degeneration
5311436|NCT00395707|Retinal Angiomatous Proliferations|retinal angiomatous proliferations
5311437|NCT00395694|epilepsy|epilepsy
5311438|NCT00395694|Incidence of rash|incidence of rash
5311439|NCT00395694|safety evaluation for initial dose|safety evaluation for initial dose
5311440|NCT00395694|patients with Valproic acid|patients with valproic acid
5311441|NCT00395681|Obesity|obesity
5311442|NCT00395681|Propofol|propofol
5311443|NCT00395681|Morbidly obese|morbidly obese
5311444|NCT00395681|BMI|bmi
5311445|NCT00395668|TETRA|tetra
5311446|NCT00395668|EMF|emf
5311447|NCT00395668|Human exposure study|human exposure study
5311448|NCT00395668|Symptoms|symptoms
5311449|NCT00395668|Well-being|well-being
5311450|NCT00395668|Cognitive function|cognitive function
5311451|NCT00395655|locally advanced breast cancer|locally advanced breast cancer
5311452|NCT00395655|hydralazine|hydralazine
5311453|NCT00395655|magnesium valproate|magnesium valproate
5311454|NCT00395655|epigenetic therapy|epigenetic therapy
5311455|NCT00395655|gene expression|gene expression
5311456|NCT00395642|Congestive Heart Failure|congestive heart failure
5311457|NCT00395642|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
5311458|NCT00395642|Home Monitoring|home monitoring
5311459|NCT00395642|Telemonitoring|telemonitoring
5311460|NCT00395642|Remote Monitoring|remote monitoring
5311461|NCT00395629|Deferasirox|deferasirox
5311462|NCT00395629|ICL670A|icl670a
5311463|NCT00395629|Iron chelators|iron chelators
5311464|NCT00395629|Deferiprone|deferiprone
5311465|NCT00395629|Transfusional Hemochromatosis|transfusional hemochromatosis
5311466|NCT00395590|OSA inflammatory cytokines, metabolic syndrome|osa inflammatory cytokines, metabolic syndrome
5311467|NCT00395564|Urologic Surgery|urologic surgery
5311468|NCT00395551|choroidal neovascularization|choroidal neovascularization
5311469|NCT00395551|Choroidal Neovascularization Not related to Age-Related Macular Degeneration|choroidal neovascularization not related to age-related macular degeneration
5311470|NCT00395538|Parathyroid|parathyroid
5311471|NCT00395538|Bone Biopsy|bone biopsy
5311472|NCT00395538|Calcium-Sensing Receptor|calcium-sensing receptor
5311473|NCT00395538|Bone Density|bone density
5311474|NCT00395538|Bone Turnover|bone turnover
5311475|NCT00395538|Hypoparathyroidism|hypoparathyroidism
5311476|NCT00395512|Glucose Metabolism Disorder|glucose metabolism disorder
5311477|NCT00395512|Dysmetabolic Syndrome|dysmetabolic syndrome
5311478|NCT00395512|Type II Diabetes|type ii diabetes
5311479|NCT00395512|Diabetes Mellitus, Lipoatrophic|diabetes mellitus, lipoatrophic
5311480|NCT00395512|Dyslipidemia|dyslipidemia
5311481|NCT00395512|Drug Therapy|drug therapy
5311482|NCT00395499|Risperidone|risperidone
5311483|NCT00395499|9-Hydroxyrisperidone|9-hydroxyrisperidone
5311484|NCT00395499|Plasma|plasma
5311485|NCT00395499|Saliva|saliva
5311486|NCT00395499|children|children
5311487|NCT00395486|rosuvastatin|rosuvastatin
5311488|NCT00395486|lipoprotein|lipoprotein
5311489|NCT00395486|metabolic syndrome|metabolic syndrome
5311490|NCT00395460|Gadovist|gadovist
5311491|NCT00395460|Gadavist|gadavist
5311492|NCT00395460|Contrast agent|contrast agent
5311493|NCT00395460|Brain|brain
5311494|NCT00395460|Spine disease|spine disease
5311495|NCT00395460|Magnetic Resonance Imaging|magnetic resonance imaging
5311496|NCT00395447|Cardiac Pacemaker|cardiac pacemaker
5311497|NCT00395447|Defibrillator|defibrillator
5311498|NCT00395447|Replacement|replacement
5311499|NCT00395447|Upgrade|upgrade
5311500|NCT00395434|Advanced Solid Tumors|advanced solid tumors
5311501|NCT00395434|Advanced Solid Tumours|advanced solid tumours
5311502|NCT00395434|Advanced Solid Tumor|advanced solid tumor
5311503|NCT00395434|Advanced Solid Tumour|advanced solid tumour
5311504|NCT00395434|Advanced|advanced
5311505|NCT00395434|Malignant|malignant
5311506|NCT00395434|Solid|solid
5311507|NCT00395434|Tumors|tumors
5311508|NCT00395434|Tumours|tumours
5311509|NCT00395434|Tumor|tumor
5311510|NCT00395434|Tumour|tumour
5311511|NCT00395434|Cancer|cancer
5311512|NCT00395434|Malignant Solid Tumors|malignant solid tumors
5311513|NCT00395434|Malignant Solid Tumours|malignant solid tumours
5311514|NCT00395434|Malignant Solid Tumor|malignant solid tumor
5311515|NCT00395434|Malignant Solid Tumour|malignant solid tumour
5311516|NCT00395434|Metastatic Cancer|metastatic cancer
5311517|NCT00395434|Metastatic Disease|metastatic disease
5311518|NCT00395434|Advanced Cancer|advanced cancer
5311519|NCT00395434|Vascular Disrupting Agent|vascular disrupting agent
5311520|NCT00395434|Anti-angiogenesis agent|anti-angiogenesis agent
5311521|NCT00395434|Phase 1|phase 1
5311522|NCT00395421|treatment-naive|treatment-naive
5311523|NCT00395395|Postmenopausal|postmenopausal
5311524|NCT00395395|osteoporosis|osteoporosis
5311525|NCT00395395|Pharmacokinetics/dynamics|pharmacokinetics/dynamics
5311526|NCT00395395|Calcitonin|calcitonin
5311527|NCT00395382|Vascular calcification|vascular calcification
5311528|NCT00395382|Arterial stiffness|arterial stiffness
5311529|NCT00395382|Cardiovascular risk|cardiovascular risk
5311530|NCT00395382|Bone mineral metabolism|bone mineral metabolism
5311531|NCT00395382|Calcium|calcium
5311532|NCT00395369|aprotinin|aprotinin
5311533|NCT00395369|cardiac surgery|cardiac surgery
5311534|NCT00395369|neurological dysfunction|neurological dysfunction
5311535|NCT00395369|optical coherance tomography|optical coherance tomography
5311536|NCT00395356|Diet|diet
5311537|NCT00395356|Caloric restriction|caloric restriction
5311538|NCT00395356|Intermittent diet|intermittent diet
5311539|NCT00395356|Obesity|obesity
5311540|NCT00395356|Postmenopausal women|postmenopausal women
5311541|NCT00395330|Respiratory Function Tests|respiratory function tests
5311542|NCT00395330|Oscillometry|oscillometry
5311543|NCT00395330|World Trade Center Disaster|world trade center disaster
5311544|NCT00395330|Environmental Exposure|environmental exposure
5311545|NCT00395330|Distal Airways|distal airways
5311546|NCT00395317|magnetic resonance imaging|magnetic resonance imaging
5311547|NCT00395317|multiple sclerosis|multiple sclerosis
5311548|NCT00395317|SB-683699|sb-683699
5311549|NCT00395291|Chronic kidney disease|chronic kidney disease
5311550|NCT00395291|End stage renal disease|end stage renal disease
5311551|NCT00395278|KSHV|kshv
5311552|NCT00395278|Kaposi's Sarcoma|kaposi's sarcoma
5311553|NCT00395278|HIV|hiv
5311554|NCT00395278|Kaposi Sarcoma|kaposi sarcoma
5311555|NCT00395265|Deep Vein Thrombosis|deep vein thrombosis
5311556|NCT00395265|Chronic Venous Insufficiency|chronic venous insufficiency
5311557|NCT00395265|Post Thrombotic Syndrome|post thrombotic syndrome
5311558|NCT00395265|Blood Coagulation|blood coagulation
5311559|NCT00395265|Inflammation|inflammation
5311560|NCT00395252|pancreatic cancer|pancreatic cancer
5311561|NCT00395252|adjuvant chemotherapy|adjuvant chemotherapy
5311562|NCT00395252|phase 2|phase 2
5311563|NCT00395252|R0 or R1 resected Adenocarcinoma of the Pancreas|r0 or r1 resected adenocarcinoma of the pancreas
5311564|NCT00395239|Asthma|asthma
5311565|NCT00395239|Inhaled corticosteroid|inhaled corticosteroid
5311566|NCT00395239|ICS|ics
5311567|NCT00395239|Metabolites|metabolites
5311568|NCT00395239|Induced sputum|induced sputum
5311569|NCT00395239|Virtual Asthma Clinic|virtual asthma clinic
5311570|NCT00395226|Rosacea|rosacea
5311571|NCT00395213|Anxiety|anxiety
5311572|NCT00395213|Major Depression|major depression
5311573|NCT00395213|Anorexia|anorexia
5311574|NCT00395213|Bulimia|bulimia
5311575|NCT00395213|OCD|ocd
5311576|NCT00395213|Antidepressant|antidepressant
5311577|NCT00395213|SSRI|ssri
5311578|NCT00395213|SNRI|snri
5311579|NCT00395200|Multiple Sclerosis|multiple sclerosis
5311580|NCT00395200|Safety|safety
5311581|NCT00395200|Therapeutics|therapeutics
5311582|NCT00395200|Mesenchymal Stem Cells|mesenchymal stem cells
5311583|NCT00395200|Multipotent Mesenchymal Stromal Cells|multipotent mesenchymal stromal cells
5311584|NCT00395200|Optic Neuritis|optic neuritis
5311585|NCT00395174|Influenza|influenza
5311586|NCT00395161|sepsis|sepsis
5311587|NCT00395161|prevention|prevention
5311588|NCT00395161|mineral supplementation|mineral supplementation
5311589|NCT00395135|Obesity|obesity
5311590|NCT00395135|Weight loss|weight loss
5311591|NCT00395135|lorcaserin|lorcaserin
5311592|NCT00395135|APD356|apd356
5311593|NCT00395135|BLOOM|bloom
5311594|NCT00395135|Hypertension|hypertension
5311595|NCT00395135|Dyslipidemia|dyslipidemia
5311596|NCT00395135|Sleep apnea|sleep apnea
5311597|NCT00395135|glucose tolerance|glucose tolerance
5311598|NCT00395135|cardiovascular disease|cardiovascular disease
5311599|NCT00395135|Arena|arena
5311600|NCT00395122|Band Atrophy|band atrophy
5311601|NCT00395122|Optical Coherence Tomography|optical coherence tomography
5311602|NCT00395122|Scanning Laser Polarimetry|scanning laser polarimetry
5311603|NCT00395122|Chiasmal Lesions|chiasmal lesions
5311604|NCT00395109|cancer|cancer
5311605|NCT00395109|hypoxia|hypoxia
5311606|NCT00395109|PET scan|pet scan
5311607|NCT00395109|CT scan|ct scan
5311608|NCT00395096|Exhaled Nitric Oxide|exhaled nitric oxide
5311609|NCT00395096|Asthma|asthma
5311610|NCT00395096|Tobacco Smoke|tobacco smoke
5311611|NCT00395096|Allergen|allergen
5311612|NCT00395070|Melanoma|melanoma
5311613|NCT00395070|DTIC|dtic
5311614|NCT00395070|TMZ|tmz
5311615|NCT00395070|Stage 3|stage 3
5311616|NCT00395070|Stage 4|stage 4
5311617|NCT00395070|Metastatic|metastatic
5311618|NCT00395070|Metastatic Melanoma (Stage 3, Stage 4 Melanoma)|metastatic melanoma (stage 3, stage 4 melanoma)
5311619|NCT00395044|Cannabis treatment|cannabis treatment
5311620|NCT00395044|marijuana treatment|marijuana treatment
5311621|NCT00395031|schizophrenia|schizophrenia
5311622|NCT00395031|Schizoaffective Disorder|schizoaffective disorder
5311623|NCT00395031|metabolic markers|metabolic markers
5311624|NCT00395031|ziprasidone|ziprasidone
5311625|NCT00395031|diabetes|diabetes
5311626|NCT00395018|Chronic Hepatitis B Virus, Liver Transplant|chronic hepatitis b virus, liver transplant
5311627|NCT00395005|Kallikrein|kallikrein
5311628|NCT00395005|Cytokines|cytokines
5311629|NCT00395005|Proteinuria|proteinuria
5311630|NCT00395005|Renal function|renal function
5311631|NCT00395005|Chronic kidney disease|chronic kidney disease
5311632|NCT00394992|Colorectal cancer|colorectal cancer
5311633|NCT00394992|Liver metastasis|liver metastasis
5311634|NCT00394992|Radical resection|radical resection
5311635|NCT00394992|Adjuvant therapy|adjuvant therapy
5311636|NCT00394992|Bevacizumab|bevacizumab
5311637|NCT00394992|Capecitabine|capecitabine
5311638|NCT00394992|Oxaliplatin|oxaliplatin
5311639|NCT00394992|Hepatica|hepatica
5311640|NCT00394940|COPD|copd
5311641|NCT00394940|Emphysema|emphysema
5311642|NCT00394940|Chronic Bronchitis|chronic bronchitis
5311643|NCT00394940|Inflammation|inflammation
5311644|NCT00394940|CD14|cd14
5311645|NCT00394940|TLR4|tlr4
5311646|NCT00394940|Proteomics|proteomics
5311647|NCT00394927|Non-Interventional|non-interventional
5311648|NCT00394927|Surveillance|surveillance
5311649|NCT00394927|Adverse Effects|adverse effects
5311650|NCT00394927|AntiEpileptic Drug treatment|antiepileptic drug treatment
5311651|NCT00394888|Hemangioma|hemangioma
5311652|NCT00394888|PHACE|phace
5311653|NCT00394888|Lumbosacral hemangioma|lumbosacral hemangioma
5311654|NCT00394888|Occult Spinal Dysraphism|occult spinal dysraphism
5311655|NCT00394875|Randomized controlled trial|randomized controlled trial
5311656|NCT00394875|Delegation, Professional|delegation, professional
5311657|NCT00394875|Nurses|nurses
5311658|NCT00394849|Tonsillectomy|tonsillectomy
5311659|NCT00394849|Suturing of tonsillar pillars|suturing of tonsillar pillars
5311660|NCT00394849|pain|pain
5311661|NCT00394849|postoperative hemorrhage, bleeding|postoperative hemorrhage, bleeding
5311662|NCT00394836|ofatumumab|ofatumumab
5311663|NCT00394836|rituximab|rituximab
5311664|NCT00394836|NHL|nhl
5311665|NCT00394836|CD20|cd20
5311666|NCT00394836|refractory|refractory
5311667|NCT00394823|Hypertension, valsartan, compliance|hypertension, valsartan, compliance
5311668|NCT00394784|gram negative bacteria|gram negative bacteria
5311669|NCT00394784|culture|culture
5311670|NCT00394784|infection|infection
5311671|NCT00394771|oral contraceptives|oral contraceptives
5311672|NCT00394771|breakthrough bleeding|breakthrough bleeding
5311673|NCT00394771|spotting|spotting
5311674|NCT00394758|ultrasonic surgical aspiration|ultrasonic surgical aspiration
5311675|NCT00394758|CO2 laser surgery|co2 laser surgery
5311676|NCT00394758|vulvar dysplasia|vulvar dysplasia
5311677|NCT00394758|vaginal dysplasia|vaginal dysplasia
5311678|NCT00394758|recurrence|recurrence
5311679|NCT00394745|Hypertension, Metabolic Syndrome, lipid subfractions|hypertension, metabolic syndrome, lipid subfractions
5311680|NCT00394732|chronic low back pain|chronic low back pain
5311681|NCT00394732|total disc replacement|total disc replacement
5311682|NCT00394732|multidisciplinary rehabilitation|multidisciplinary rehabilitation
5311683|NCT00394732|clinical effects|clinical effects
5311684|NCT00394732|cost effectiveness|cost effectiveness
5311685|NCT00394732|randomized controlled trial|randomized controlled trial
5311686|NCT00394732|multicenter study|multicenter study
5311687|NCT00394706|cardiac arrest|cardiac arrest
5311688|NCT00394706|cardiopulmonary resuscitation|cardiopulmonary resuscitation
5311689|NCT00394693|Primary CBCL including (WHO/EORTC classification 2005)|primary cbcl including (who/eortc classification 2005)
5311690|NCT00394693|Primary cutaneous marginal zone B-cell lymphoma|primary cutaneous marginal zone b-cell lymphoma
5311691|NCT00394693|Primary cutaneous follicle center B-cell lymphoma|primary cutaneous follicle center b-cell lymphoma
5311692|NCT00394693|Primary cutaneous diffuse large B-cell other than leg type|primary cutaneous diffuse large b-cell other than leg type
5311693|NCT00394693|Histologically consistent with primary CBCL|histologically consistent with primary cbcl
5311694|NCT00394693|Relapse or active disease|relapse or active disease
5311695|NCT00394680|coronary revascularization|coronary revascularization
5311696|NCT00394680|stent inmplantation|stent inmplantation
5311697|NCT00394680|coronary bypass|coronary bypass
5311698|NCT00394628|Glioblastoma Multiforme|glioblastoma multiforme
5311699|NCT00394628|Radiotherapy|radiotherapy
5311700|NCT00394628|temozolomide|temozolomide
5311701|NCT00394628|adjuvant temozolomide|adjuvant temozolomide
5311702|NCT00394602|Gastric Cancer|gastric cancer
5311703|NCT00394602|Pancreatic Cancer|pancreatic cancer
5311704|NCT00394602|Cervical Cancer|cervical cancer
5311705|NCT00394602|Vulvar Cancer|vulvar cancer
5311706|NCT00394602|Endometrial Cancer|endometrial cancer
5311707|NCT00394602|Anal Cancer|anal cancer
5311708|NCT00394602|Quality of Life|quality of life
5311709|NCT00394602|Questionnaire|questionnaire
5311710|NCT00394602|Interview|interview
5311711|NCT00394602|Emesis|emesis
5311712|NCT00394602|Nausea|nausea
5311713|NCT00394602|Survey|survey
5311714|NCT00394576|Kidney School|kidney school
5311715|NCT00394576|Short Test of Functional Health Literacy|short test of functional health literacy
5311716|NCT00394576|Chronic Kidney Disease Knowledge Assessment Tool of Nutrition|chronic kidney disease knowledge assessment tool of nutrition
5311717|NCT00394576|Short Form 12 version 2|short form 12 version 2
5311718|NCT00394576|Kidney Disease Self-Management Survey|kidney disease self-management survey
5311719|NCT00394576|Three Day Dietary Diary|three day dietary diary
5311720|NCT00394563|osteoarthritis monoclonal antibody|osteoarthritis monoclonal antibody
5311721|NCT00394550|laryngomalacia|laryngomalacia
5311722|NCT00394550|supraglottoplasty|supraglottoplasty
5311723|NCT00394550|Tonsillectomy|tonsillectomy
5311724|NCT00394550|Adenoidectomy|adenoidectomy
5311725|NCT00394550|obstructive sleep apnea|obstructive sleep apnea
5311726|NCT00394550|Laser|laser
5311727|NCT00394550|Polysomnogram|polysomnogram
5311728|NCT00394550|airway obstruction|airway obstruction
5311729|NCT00394524|ICU|icu
5311730|NCT00394524|hyperglycemia|hyperglycemia
5311731|NCT00394524|glucommander|glucommander
5311732|NCT00394498|Myocardial Infarction|myocardial infarction
5311733|NCT00394498|Stem Cells|stem cells
5311734|NCT00394485|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5311735|NCT00394485|Procaterol|procaterol
5311736|NCT00394485|Tiotropium|tiotropium
5311737|NCT00394472|Heartburn|heartburn
5311738|NCT00394472|Patient reported symptoms|patient reported symptoms
5311739|NCT00394472|Proton pump inhibitor|proton pump inhibitor
5311740|NCT00394459|Anaesthetic techniques|anaesthetic techniques
5311741|NCT00394459|epidural|epidural
5311742|NCT00394459|catheters|catheters
5311743|NCT00394459|paraesthesia|paraesthesia
5311744|NCT00394459|side effects|side effects
5311745|NCT00394459|Anesthesia, Epidural [E03.155.086.131]|anesthesia, epidural [e03.155.086.131]
5311746|NCT00394446|Solid Tumors|solid tumors
5311747|NCT00394446|Refractory|refractory
5311748|NCT00394446|Brain|brain
5311749|NCT00394433|TPCA|tpca
5311750|NCT00394433|Taxotere|taxotere
5311751|NCT00394433|Platinum|platinum
5311752|NCT00394433|Avastin|avastin
5311753|NCT00394433|Camptosar|camptosar
5311754|NCT00394433|gastric cancer|gastric cancer
5311755|NCT00394407|inpatient|inpatient
5311756|NCT00394407|diabetes management|diabetes management
5311757|NCT00394407|insulin therapy|insulin therapy
5311758|NCT00394381|acute myeloid leukemia|acute myeloid leukemia
5311759|NCT00394381|myelodysplastic syndrome|myelodysplastic syndrome
5311760|NCT00394381|autologous CIK cells|autologous cik cells
5311761|NCT00394381|autologous peripheral blood stem cell transplant|autologous peripheral blood stem cell transplant
5311762|NCT00394368|asthma|asthma
5311763|NCT00394368|combinations|combinations
5311764|NCT00394368|inhaled therapy|inhaled therapy
5311765|NCT00394368|corticosteroids|corticosteroids
5311766|NCT00394368|long acting bronchodilators|long acting bronchodilators
5311767|NCT00394368|salmeterol|salmeterol
5311768|NCT00394368|beclomethasone|beclomethasone
5311769|NCT00394368|formoterol|formoterol
5311770|NCT00394368|fluticasone|fluticasone
5311771|NCT00394316|CD34 Stem Cells|cd34 stem cells
5311772|NCT00394316|Busulfan|busulfan
5311773|NCT00394316|Gene Therapy|gene therapy
5311774|NCT00394316|Immune Reconstitution|immune reconstitution
5311775|NCT00394316|Engraftment|engraftment
5311776|NCT00394316|Chronic Granulomatous Disease (CGD)|chronic granulomatous disease (cgd)
5311777|NCT00394316|Gp91 Phox Deficiency|gp91 phox deficiency
5311778|NCT00394316|Peripheral Blood Stem Cells|peripheral blood stem cells
5311779|NCT00394316|Bone Marrow Transplantation|bone marrow transplantation
5311780|NCT00394316|Chronic Granulomatous Disease|chronic granulomatous disease
5311781|NCT00394316|CGD|cgd
5311782|NCT00394303|Open heart surgery|open heart surgery
5311783|NCT00394303|Diabetes mellitus|diabetes mellitus
5311784|NCT00394303|Hyperglycemia|hyperglycemia
5311785|NCT00394303|Surgical site infection|surgical site infection
5311786|NCT00394303|Normoglycemia|normoglycemia
5311787|NCT00394290|Down Syndrome|down syndrome
5311788|NCT00394290|Obstructive Sleep Apnea Syndrome|obstructive sleep apnea syndrome
5311789|NCT00394290|Continuous Positive Pressure|continuous positive pressure
5311790|NCT00394290|Hypersomnia|hypersomnia
5311791|NCT00394264|low back pain|low back pain
5311792|NCT00394264|active duty military personnel|active duty military personnel
5311793|NCT00394264|manual/manipulative therapy|manual/manipulative therapy
5311794|NCT00394264|osteopathic manipulative treatment|osteopathic manipulative treatment
5311795|NCT00394264|physical medicine|physical medicine
5311796|NCT00394251|Adjuvant therapy|adjuvant therapy
5311797|NCT00394251|Bevacizumab|bevacizumab
5311798|NCT00394251|Abraxane|abraxane
5311799|NCT00394251|Early stage breast cancer|early stage breast cancer
5311800|NCT00394225|6-Minute Walk Test|6-minute walk test
5311801|NCT00394225|COPD|copd
5311802|NCT00394225|Helium-Hyperoxia|helium-hyperoxia
5311803|NCT00394225|Exercise|exercise
5311804|NCT00394225|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
5311805|NCT00394212|Weight Loss|weight loss
5311806|NCT00394212|Transoral Suturing|transoral suturing
5311807|NCT00394212|Dilated gastrojejunostomy|dilated gastrojejunostomy
5311808|NCT00394212|Inadequate weight loss following primary RYGB|inadequate weight loss following primary rygb
5311809|NCT00394199|Asthma|asthma
5311810|NCT00394199|Fluticasone Propionate|fluticasone propionate
5311811|NCT00394199|formoterol fumarate|formoterol fumarate
5311812|NCT00394199|Pressurized metered dose inhaler|pressurized metered dose inhaler
5311813|NCT00394199|Hydrofluoroalkane|hydrofluoroalkane
5311814|NCT00394199|Mild to Moderate Asthma|mild to moderate asthma
5311815|NCT00394186|GW427353|gw427353
5311816|NCT00394186|b3-Adrenergic Receptor Agonist|b3-adrenergic receptor agonist
5311817|NCT00394186|Irritable Bowel Syndrome (IBS)|irritable bowel syndrome (ibs)
5311818|NCT00394186|efficacy|efficacy
5311819|NCT00394186|tolerability|tolerability
5311820|NCT00394186|pharmacokinetics|pharmacokinetics
5311821|NCT00394173|IBS|ibs
5311822|NCT00394173|diarrhea|diarrhea
5311823|NCT00394173|gastrointestinal functional disorder|gastrointestinal functional disorder
5311824|NCT00394173|IBS-D|ibs-d
5311825|NCT00394147|advanced|advanced
5311826|NCT00394147|head|head
5311827|NCT00394147|neck|neck
5311828|NCT00394147|cancer|cancer
5311829|NCT00394134|Melanoma|melanoma
5311830|NCT00394134|Sun Exposure|sun exposure
5311831|NCT00394134|Sun Protection|sun protection
5311832|NCT00394134|Interview|interview
5311833|NCT00394121|Asthma|asthma
5311834|NCT00394121|Fluticasone Propionate|fluticasone propionate
5311936|NCT00393731|induction|induction
5311835|NCT00394121|Formoterol Fumarate|formoterol fumarate
5311836|NCT00394121|Pressurized metered does inhaler|pressurized metered does inhaler
5311837|NCT00394121|Hydrofluoroalkane|hydrofluoroalkane
5311838|NCT00394121|Mild to moderate-severe asthma|mild to moderate-severe asthma
5311839|NCT00394095|Bipolar Disorder|bipolar disorder
5311840|NCT00394095|Weight Gain|weight gain
5311841|NCT00394082|Metastatic breast cancer, Abraxane, Bevacizumab|metastatic breast cancer, abraxane, bevacizumab
5311842|NCT00394056|placebo|placebo
5311843|NCT00394056|balanced|balanced
5311844|NCT00394056|paroxetine|paroxetine
5311845|NCT00394056|repeated dose|repeated dose
5311846|NCT00394056|Hearing Loss|hearing loss
5311847|NCT00394056|loudness|loudness
5311848|NCT00394056|combination|combination
5311849|NCT00394056|Tinnitus|tinnitus
5311850|NCT00394056|vestipitant (GW597599)|vestipitant (gw597599)
5311851|NCT00394056|randomised|randomised
5311852|NCT00394056|annoyance|annoyance
5311853|NCT00394056|crossover|crossover
5311854|NCT00394043|Carpal Tunnel Sydrome|carpal tunnel sydrome
5311855|NCT00394043|Osteopathic Manipulative Treatment|osteopathic manipulative treatment
5311856|NCT00394043|Osteopathic Manipulative Medicine|osteopathic manipulative medicine
5311857|NCT00394043|Physical Medicine|physical medicine
5311858|NCT00394030|GSK716155 pharmacodynamics pharmacokinetics injection site|gsk716155 pharmacodynamics pharmacokinetics injection site
5311859|NCT00394017|Heading Health Plan Implementation|heading health plan implementation
5311860|NCT00394017|Computer-Assisted Instruction|computer-assisted instruction
5311861|NCT00394017|General Practice|general practice
5311862|NCT00394017|Dementia|dementia
5311863|NCT00394017|education|education
5311864|NCT00394004|Decision Making|decision making
5311865|NCT00394004|Health Disparities|health disparities
5311866|NCT00394004|Hispanic|hispanic
5311867|NCT00394004|African-American|african-american
5311868|NCT00394004|Clinical Trials|clinical trials
5311869|NCT00394004|HIV Positive|hiv positive
5311870|NCT00393991|Asthma|asthma
5311871|NCT00393991|Fluticasone Propionate|fluticasone propionate
5311872|NCT00393991|Formoterol Fumarate|formoterol fumarate
5311873|NCT00393991|Pressurized metered dose inhaler|pressurized metered dose inhaler
5311874|NCT00393991|Hydrofluoroalkane|hydrofluoroalkane
5311875|NCT00393991|Mild to Moderate Asthma|mild to moderate asthma
5311876|NCT00393978|Bipolar mania|bipolar mania
5311877|NCT00393978|Cannabis consumption|cannabis consumption
5311878|NCT00393965|Metastases|metastases
5311879|NCT00393965|Refractory|refractory
5311880|NCT00393965|Brain|brain
5311881|NCT00393952|Asthma|asthma
5311882|NCT00393952|Fluticasone Propionate|fluticasone propionate
5311883|NCT00393952|Formoterol Fumarate|formoterol fumarate
5311884|NCT00393952|Pressurized metered dose inhaler|pressurized metered dose inhaler
5311885|NCT00393952|Hydrofluoroalkane|hydrofluoroalkane
5311886|NCT00393952|Moderate-Severe Asthma|moderate-severe asthma
5311887|NCT00393939|advanced breast cancer|advanced breast cancer
5311888|NCT00393939|sunitinib|sunitinib
5311889|NCT00393939|docetaxel|docetaxel
5311890|NCT00393939|Phase 3|phase 3
5311891|NCT00393926|Robotics|robotics
5311892|NCT00393926|Rehabilitation|rehabilitation
5311893|NCT00393926|Upper Extremity|upper extremity
5311894|NCT00393926|CVA|cva
5311895|NCT00393913|Sleep Apnea|sleep apnea
5311896|NCT00393913|Sleep-Disordered Breathing|sleep-disordered breathing
5311897|NCT00393913|Snoring|snoring
5311898|NCT00393900|otitis media|otitis media
5311899|NCT00393900|tympanostomy tube|tympanostomy tube
5311900|NCT00393900|eustachian tube function|eustachian tube function
5311901|NCT00393900|gas exchange|gas exchange
5311902|NCT00393900|tympanostomy tubes|tympanostomy tubes
5311903|NCT00393887|Inguinal hernia|inguinal hernia
5311904|NCT00393887|polypropylene|polypropylene
5311905|NCT00393887|Biodesign IHM|biodesign ihm
5311906|NCT00393887|lichtenstein|lichtenstein
5311907|NCT00393874|Anxiety D/O|anxiety d/o
5311908|NCT00393874|Mood D/O|mood d/o
5311909|NCT00393861|Germ Cell Tumor|germ cell tumor
5311910|NCT00393861|Germ Cell Cancer|germ cell cancer
5311911|NCT00393848|Hip Replacement Arthroplasty|hip replacement arthroplasty
5311912|NCT00393848|Hip Replacement Surgery|hip replacement surgery
5311913|NCT00393848|Hip Surgery|hip surgery
5311914|NCT00393848|Hip Rehabilitation|hip rehabilitation
5311915|NCT00393848|Avascular Necrosis|avascular necrosis
5311916|NCT00393848|Knee replacement surgery|knee replacement surgery
5311917|NCT00393848|Total knee arthroplasty|total knee arthroplasty
5311919|NCT00393822|Palifermin|palifermin
5311920|NCT00393822|Oral Mucositis|oral mucositis
5311921|NCT00393822|Clinical Trial|clinical trial
5311922|NCT00393822|Amgen|amgen
5311923|NCT00393822|Oncology|oncology
5311924|NCT00393822|Colon Cancer|colon cancer
5311925|NCT00393809|transitional cell carcinoma|transitional cell carcinoma
5311926|NCT00393809|H19 gene|h19 gene
5311927|NCT00393809|plasmid|plasmid
5311928|NCT00393809|diphtheria toxin|diphtheria toxin
5311929|NCT00393783|Breast Cancer|breast cancer
5311930|NCT00393783|Metastatic|metastatic
5311931|NCT00393783|HER2|her2
5311932|NCT00393783|04-101|04-101
5311933|NCT00393770|Risk of type 2 diabetes|risk of type 2 diabetes
5311934|NCT00393757|Malaria, Plasmodium falciparum, Kenya|malaria, plasmodium falciparum, kenya
5311935|NCT00393731|labor|labor
5311937|NCT00393731|misoprostol|misoprostol
5311938|NCT00393731|oxytocin|oxytocin
5311939|NCT00393705|diabetes|diabetes
5311940|NCT00393705|type 2|type 2
5311941|NCT00393692|Age-related macular degeneration|age-related macular degeneration
5311942|NCT00393692|Geographic atrophy|geographic atrophy
5311943|NCT00393692|drusen|drusen
5311944|NCT00393679|Children 6-59 months|children 6-59 months
5311945|NCT00393679|P.falciparum|p.falciparum
5311946|NCT00393679|Haemoglobin|haemoglobin
5311947|NCT00393679|Informed consent|informed consent
5311948|NCT00393679|ACT|act
5311949|NCT00393666|Absence|absence
5311950|NCT00393666|Epilepsy|epilepsy
5311951|NCT00393666|Seizure|seizure
5311952|NCT00393666|Brain|brain
5311953|NCT00393653|osteoarthritis|osteoarthritis
5311954|NCT00393653|gastroesophageal reflux disease|gastroesophageal reflux disease
5311955|NCT00393653|practice-based research|practice-based research
5311956|NCT00393653|N-of-1 trial|n-of-1 trial
5311957|NCT00393653|prescription|prescription
5311958|NCT00393653|single-patient trial|single-patient trial
5311959|NCT00393640|Early Initiation of lactogenesis II|early initiation of lactogenesis ii
5311960|NCT00393627|Dementia|dementia
5311961|NCT00393627|Sleep disturbance|sleep disturbance
5311962|NCT00393627|Behavioral strategies|behavioral strategies
5311963|NCT00393627|Alzheimer's Disease|alzheimer's disease
5311964|NCT00393627|Adult Family Homes|adult family homes
5311965|NCT00393614|CSWS, interiktal epileptiform activity|csws, interiktal epileptiform activity
5311966|NCT00393601|Cystectomy|cystectomy
5311967|NCT00393588|Brain|brain
5311968|NCT00393588|Cognitive Deficits|cognitive deficits
5311969|NCT00393588|Cognitive Testing|cognitive testing
5311970|NCT00393588|MRI|mri
5311971|NCT00393588|Multiple Sclerosis|multiple sclerosis
5311972|NCT00393588|MS|ms
5311973|NCT00393588|Healthy Volunteer|healthy volunteer
5311974|NCT00393588|HV|hv
5311975|NCT00393575|HIV Prevention|hiv prevention
5311976|NCT00393575|HIV positive communities|hiv positive communities
5311977|NCT00393562|excessive sleepiness|excessive sleepiness
5311978|NCT00393562|hypersomnolence|hypersomnolence
5311979|NCT00393562|Parkinson's disease|parkinson's disease
5311980|NCT00393549|Median Neuropathy at the wrist (MNW)|median neuropathy at the wrist (mnw)
5311981|NCT00393536|Depression|depression
5311982|NCT00393536|Guidelines|guidelines
5311983|NCT00393536|Educational outreach visiting|educational outreach visiting
5311984|NCT00393536|Prescribing|prescribing
5311985|NCT00393510|Diabetic Foot Ulcer|diabetic foot ulcer
5311986|NCT00393510|Traditional Chinese Medicine|traditional chinese medicine
5311987|NCT00393497|Breast Cancer|breast cancer
5311988|NCT00393497|lymphedema|lymphedema
5311989|NCT00393471|Arthritis|arthritis
5311990|NCT00393471|Rheumatoid|rheumatoid
5311991|NCT00393471|Safety|safety
5311992|NCT00393458|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
5311993|NCT00393458|COPD|copd
5311994|NCT00393458|indacaterol|indacaterol
5311995|NCT00393458|long-acting β2 agonist|long-acting β2 agonist
5311996|NCT00393445|GLP-1|glp-1
5311997|NCT00393445|Exendin(9-39)|exendin(9-39)
5311998|NCT00393445|Insulin|insulin
5311999|NCT00393445|Glucagon|glucagon
5312000|NCT00393445|Human physiology|human physiology
5312001|NCT00393432|Action Observation|action observation
5312002|NCT00393432|Motor Memory|motor memory
5312003|NCT00393432|Transcranial Magnetic Stimulation (TMS)|transcranial magnetic stimulation (tms)
5312004|NCT00393432|Use-Dependent Plasticity|use-dependent plasticity
5312005|NCT00393432|Healthy Volunteer|healthy volunteer
5312006|NCT00393432|HV|hv
5312007|NCT00393419|hypertension|hypertension
5312008|NCT00393419|hyperlipidemia|hyperlipidemia
5312009|NCT00393419|adherence|adherence
5312010|NCT00393419|pharmacist|pharmacist
5312011|NCT00393419|elderly|elderly
5312012|NCT00393419|medication|medication
5312013|NCT00393406|Objective Risk|objective risk
5312014|NCT00393406|Gail Model|gail model
5312015|NCT00393406|Subjective Risk|subjective risk
5312016|NCT00393406|Medical Risk-Reducing Strategies|medical risk-reducing strategies
5312017|NCT00393406|Physical Activity, Diet, Alcohol Use|physical activity, diet, alcohol use
5312018|NCT00393406|Breast Cancer Risk|breast cancer risk
5312019|NCT00393393|osteoarthritis|osteoarthritis
5312020|NCT00393393|knee|knee
5312021|NCT00393393|hylan|hylan
5312022|NCT00393380|Myelogenous Leukemia, Chronic|myelogenous leukemia, chronic
5312023|NCT00393380|Myelodysplasia|myelodysplasia
5312024|NCT00393380|Parathyroid Hormone|parathyroid hormone
5312025|NCT00393380|Umbilical Cord Blood Stem Cell Transplantation|umbilical cord blood stem cell transplantation
5312026|NCT00393367|Asthma|asthma
5312027|NCT00393367|Acute|acute
5312028|NCT00393367|Treatment|treatment
5312029|NCT00393367|Children|children
5312030|NCT00393367|Pediatric|pediatric
5312031|NCT00393367|Inhaled corticosteroid|inhaled corticosteroid
5312032|NCT00393367|Budesonide|budesonide
5312033|NCT00393367|Budesonide inhalation suspension|budesonide inhalation suspension
5312034|NCT00393367|Asthma score|asthma score
5312035|NCT00393367|Emergency|emergency
5312036|NCT00393367|Emergency Department|emergency department
5312037|NCT00393367|Asthma flare|asthma flare
5312038|NCT00393367|Clinical trial|clinical trial
5312313|NCT00392548|GBM|gbm
5312039|NCT00393367|Randomized clinical trial|randomized clinical trial
5312040|NCT00393367|Randomized trial|randomized trial
5312041|NCT00393367|Pulmonary index score|pulmonary index score
5312042|NCT00393367|Hospitalization|hospitalization
5312043|NCT00393367|Moderate asthma|moderate asthma
5312044|NCT00393367|Severe asthma|severe asthma
5312045|NCT00393367|Mixing budesonide|mixing budesonide
5312046|NCT00393367|Budesonide admixture|budesonide admixture
5312047|NCT00393367|Albuterol|albuterol
5312048|NCT00393367|Continuous albuterol|continuous albuterol
5312049|NCT00393367|Ipratropium bromide|ipratropium bromide
5312050|NCT00393341|Breast Cancer|breast cancer
5312051|NCT00393315|in stent restenosis|in stent restenosis
5312052|NCT00393315|paclitaxel coated balloon catheter|paclitaxel coated balloon catheter
5312053|NCT00393315|pepcad|pepcad
5312054|NCT00393315|drug eluting balloon|drug eluting balloon
5312055|NCT00393302|HIV testing in pregnant women|hiv testing in pregnant women
5312056|NCT00393289|Calcium absorption|calcium absorption
5312057|NCT00393289|D-vitamin status|d-vitamin status
5312058|NCT00393289|Whole body calcium retention|whole body calcium retention
5312059|NCT00393289|Calcium intake|calcium intake
5312060|NCT00393289|PTH status|pth status
5312061|NCT00393276|Treatment Experienced|treatment experienced
5312062|NCT00393276|Treatment Naive|treatment naive
5312063|NCT00393276|Immunizations|immunizations
5312064|NCT00393250|Hypnosis|hypnosis
5312065|NCT00393250|Symptom Management|symptom management
5312066|NCT00393250|Pain Management|pain management
5312067|NCT00393250|Sickle Cell Disease|sickle cell disease
5312068|NCT00393250|Pain|pain
5312069|NCT00393224|Epidemiology|epidemiology
5312070|NCT00393224|Nasopharyngeal Carcinoma|nasopharyngeal carcinoma
5312071|NCT00393224|Genetic|genetic
5312072|NCT00393224|Viruses|viruses
5312073|NCT00393224|Cancer|cancer
5312074|NCT00393224|NPC|npc
5312075|NCT00393198|Intrauterine System|intrauterine system
5312076|NCT00393198|Contraception|contraception
5312077|NCT00393198|Menorrhagia|menorrhagia
5312078|NCT00393185|Immunosuppression|immunosuppression
5312079|NCT00393185|Primary Biliary Cirrhosis|primary biliary cirrhosis
5312080|NCT00393185|Allogeneic Hematopoietic Stem Cell|allogeneic hematopoietic stem cell
5312081|NCT00393172|exercise|exercise
5312082|NCT00393172|breast cancer|breast cancer
5312083|NCT00393172|prevention|prevention
5312084|NCT00393172|obesity|obesity
5312085|NCT00393172|estrogen metabolism|estrogen metabolism
5312086|NCT00393172|oxidative stress|oxidative stress
5312087|NCT00393172|IGF-1|igf-1
5312088|NCT00393159|Effusion|effusion
5312089|NCT00393159|Otitis|otitis
5312090|NCT00393159|Media|media
5312091|NCT00393159|Ear|ear
5312092|NCT00393159|Popper|popper
5312093|NCT00393159|Children|children
5312094|NCT00393146|Rheumatoid arthritis|rheumatoid arthritis
5312095|NCT00393146|MRI|mri
5312096|NCT00393120|HIV-infection|hiv-infection
5312097|NCT00393120|viral load|viral load
5312098|NCT00393120|CCR5|ccr5
5312099|NCT00393120|viral tropism|viral tropism
5312100|NCT00393120|HIV-1 infection|hiv-1 infection
5312101|NCT00393120|Treatment Naive|treatment naive
5312102|NCT00393107|follicular lymphoma|follicular lymphoma
5312103|NCT00393107|non-Hodgkin lymphoma|non-hodgkin lymphoma
5312104|NCT00393107|Fludarabine|fludarabine
5312105|NCT00393107|Cyclophosphamide|cyclophosphamide
5312106|NCT00393107|Rituximab|rituximab
5312107|NCT00393107|combination|combination
5312108|NCT00393107|immuno-chemotherapy|immuno-chemotherapy
5312109|NCT00393107|relapsed|relapsed
5312110|NCT00393094|Brain Tumor|brain tumor
5312111|NCT00393094|Chemotherapy|chemotherapy
5312112|NCT00393094|Progression|progression
5312113|NCT00393094|Radiotherapy|radiotherapy
5312114|NCT00393094|Antiangiogenesis|antiangiogenesis
5312115|NCT00393094|Glioma|glioma
5312116|NCT00393042|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
5312117|NCT00393042|sleep|sleep
5312118|NCT00393042|side effects|side effects
5312119|NCT00393042|stimulants|stimulants
5312120|NCT00393029|Tumor Regression|tumor regression
5312121|NCT00393029|In Vivo Cell Survival|in vivo cell survival
5312122|NCT00393029|Toxicity Profile|toxicity profile
5312123|NCT00393029|Metastatic Renal Cell Cancer|metastatic renal cell cancer
5312124|NCT00393029|Cancer|cancer
5312125|NCT00393029|Metastatic Cancer|metastatic cancer
5312126|NCT00393003|Anesthesia|anesthesia
5312127|NCT00393003|Sedation|sedation
5312128|NCT00392990|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
5312129|NCT00392990|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5312130|NCT00392990|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5312131|NCT00392990|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
5312132|NCT00392990|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
5312133|NCT00392990|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
5312134|NCT00392977|Manganese|manganese
5312135|NCT00392977|Neonatal Intensive Care|neonatal intensive care
5312136|NCT00392977|MRI|mri
5312137|NCT00392977|Parenteral Nutrition|parenteral nutrition
5312138|NCT00392977|Prematurity|prematurity
5312139|NCT00392964|Antacids|antacids
5312315|NCT00392548|urine|urine
5312140|NCT00392964|Proton pump inhibitors|proton pump inhibitors
5312141|NCT00392964|aspirin|aspirin
5312142|NCT00392964|ischemic heart disease|ischemic heart disease
5312143|NCT00392964|Dyspepsia|dyspepsia
5312144|NCT00392951|ALPS|alps
5312145|NCT00392951|Autoimmune|autoimmune
5312146|NCT00392951|Cytopenias|cytopenias
5312147|NCT00392951|Treatment|treatment
5312148|NCT00392951|Sirolimus|sirolimus
5312149|NCT00392951|Rapamycin|rapamycin
5312150|NCT00392951|Lymph Nodes|lymph nodes
5312151|NCT00392951|Spleen|spleen
5312152|NCT00392951|Hemolytic Anemia|hemolytic anemia
5312153|NCT00392951|Immune Thrombocytopenia|immune thrombocytopenia
5312154|NCT00392951|Neutropenia|neutropenia
5312155|NCT00392951|ITP|itp
5312156|NCT00392951|Lupus|lupus
5312157|NCT00392938|recurrent prostate cancer|recurrent prostate cancer
5312158|NCT00392938|stage IV prostate cancer|stage iv prostate cancer
5312159|NCT00392938|bone metastases|bone metastases
5312160|NCT00392925|overweight|overweight
5312161|NCT00392925|obesity|obesity
5312162|NCT00392925|pramlintide|pramlintide
5312163|NCT00392925|leptin|leptin
5312164|NCT00392925|Amylin|amylin
5312165|NCT00392912|testosterone|testosterone
5312166|NCT00392912|hypogonadal|hypogonadal
5312167|NCT00392912|cerebral glucose metabolism|cerebral glucose metabolism
5312168|NCT00392912|PET scan|pet scan
5312169|NCT00392912|Alzheimer's disease|alzheimer's disease
5312170|NCT00392899|stage II colon cancer|stage ii colon cancer
5312171|NCT00392899|stage II rectal cancer|stage ii rectal cancer
5312172|NCT00392899|adenocarcinoma of the colon|adenocarcinoma of the colon
5312173|NCT00392899|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5312174|NCT00392886|untreated childhood medulloblastoma|untreated childhood medulloblastoma
5312175|NCT00392886|untreated childhood supratentorial primitive neuroectodermal tumor|untreated childhood supratentorial primitive neuroectodermal tumor
5312176|NCT00392886|childhood infratentorial ependymoma|childhood infratentorial ependymoma
5312177|NCT00392886|childhood supratentorial ependymoma|childhood supratentorial ependymoma
5312178|NCT00392886|newly diagnosed childhood ependymoma|newly diagnosed childhood ependymoma
5312179|NCT00392886|childhood high-grade cerebral astrocytoma|childhood high-grade cerebral astrocytoma
5312180|NCT00392886|childhood oligodendroglioma|childhood oligodendroglioma
5312181|NCT00392886|childhood atypical teratoid/rhabdoid tumor|childhood atypical teratoid/rhabdoid tumor
5312182|NCT00392886|childhood choroid plexus tumor|childhood choroid plexus tumor
5312183|NCT00392886|untreated childhood cerebellar astrocytoma|untreated childhood cerebellar astrocytoma
5312184|NCT00392886|untreated childhood visual pathway and hypothalamic glioma|untreated childhood visual pathway and hypothalamic glioma
5312185|NCT00392886|untreated childhood pineoblastoma|untreated childhood pineoblastoma
5312186|NCT00392873|Amenorrhea|amenorrhea
5312187|NCT00392873|Energy deficiency|energy deficiency
5312188|NCT00392873|Resting energy expenditure|resting energy expenditure
5312189|NCT00392873|Bone metabolism|bone metabolism
5312190|NCT00392873|Bone mineral density|bone mineral density
5312191|NCT00392873|Exercise|exercise
5312192|NCT00392860|Wheelchair|wheelchair
5312193|NCT00392860|Handrims|handrims
5312194|NCT00392860|Rehabilitation|rehabilitation
5312195|NCT00392860|Upper extremity|upper extremity
5312196|NCT00392847|Child mental disorder|child mental disorder
5312197|NCT00392847|Home visit|home visit
5312198|NCT00392847|Postnatal depression|postnatal depression
5312199|NCT00392847|Social Support|social support
5312200|NCT00392847|Random selection|random selection
5312201|NCT00392834|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
5312202|NCT00392834|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5312203|NCT00392834|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5312204|NCT00392834|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
5312205|NCT00392834|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
5312206|NCT00392834|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
5312207|NCT00392808|Meningococcal vaccine|meningococcal vaccine
5312208|NCT00392808|Immunization, secondary|immunization, secondary
5312209|NCT00392808|vaccines conjugated|vaccines conjugated
5312210|NCT00392808|Meningococcal disease|meningococcal disease
5312211|NCT00392795|Critical Care|critical care
5312212|NCT00392795|Delirium|delirium
5312213|NCT00392795|Long-term cognitive impairment|long-term cognitive impairment
5312214|NCT00392795|mechanical ventilation|mechanical ventilation
5312215|NCT00392795|Critical illness|critical illness
5312216|NCT00392795|dementia|dementia
5312217|NCT00392795|sedatives and analgesics|sedatives and analgesics
5312218|NCT00392795|aging|aging
5312219|NCT00392782|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5312220|NCT00392782|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5312221|NCT00392782|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
5312222|NCT00392782|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5312223|NCT00392782|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5312224|NCT00392782|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5312225|NCT00392782|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5312314|NCT00392548|glioblastoma|glioblastoma
5312226|NCT00392782|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5312227|NCT00392782|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5312228|NCT00392782|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5312229|NCT00392782|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5312230|NCT00392782|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5312231|NCT00392782|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5312232|NCT00392782|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5312233|NCT00392782|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
5312234|NCT00392782|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5312235|NCT00392782|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5312236|NCT00392769|Endometrial Cancer|endometrial cancer
5312237|NCT00392769|Progressive or Recurrent Endometrial Cancer|progressive or recurrent endometrial cancer
5312238|NCT00392769|Cetuximab|cetuximab
5312239|NCT00392769|C225|c225
5312240|NCT00392769|Erbitux™|erbitux™
5312241|NCT00392769|IMC-C225|imc-c225
5312242|NCT00392769|Epidermal growth factor receptor|epidermal growth factor receptor
5312243|NCT00392769|EGFR|egfr
5312244|NCT00392769|Endometrioid Tumor|endometrioid tumor
5312245|NCT00392769|Serous Tumor|serous tumor
5312246|NCT00392769|Clear cell Tumor|clear cell tumor
5312247|NCT00392769|Mixed malignant Mullerian Tumors|mixed malignant mullerian tumors
5312248|NCT00392756|Kallmann Syndrome|kallmann syndrome
5312249|NCT00392756|Hypogonadotropic Hypogonadism|hypogonadotropic hypogonadism
5312250|NCT00392756|GnRH deficiency|gnrh deficiency
5312251|NCT00392756|Pulsatile GnRH|pulsatile gnrh
5312252|NCT00392743|Bolus|bolus
5312253|NCT00392743|11C-Raclopride|11c-raclopride
5312254|NCT00392743|Schizophrenia|schizophrenia
5312255|NCT00392743|123I-IBZM|123i-ibzm
5312256|NCT00392743|SPECT|spect
5312257|NCT00392743|Receptor Occupancy|receptor occupancy
5312258|NCT00392743|PET|pet
5312259|NCT00392743|MRI|mri
5312260|NCT00392743|Antipsychotics|antipsychotics
5312261|NCT00392743|Bolus/Infusion|bolus/infusion
5312262|NCT00392730|Manganese|manganese
5312263|NCT00392730|Neonatal Intensive Care|neonatal intensive care
5312264|NCT00392730|MRI|mri
5312265|NCT00392730|Parenteral Nutrition|parenteral nutrition
5312266|NCT00392730|Prematurity|prematurity
5312267|NCT00392717|lipoprotein metabolism|lipoprotein metabolism
5312268|NCT00392717|cardiovascular disease|cardiovascular disease
5312269|NCT00392717|obesity|obesity
5312270|NCT00392691|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5312271|NCT00392691|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5312272|NCT00392691|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5312273|NCT00392691|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5312274|NCT00392691|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5312275|NCT00392691|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5312276|NCT00392691|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5312277|NCT00392691|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5312278|NCT00392691|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5312279|NCT00392691|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5312280|NCT00392691|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5312281|NCT00392691|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5312282|NCT00392691|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5312283|NCT00392691|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5312284|NCT00392691|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5312285|NCT00392691|Waldenström macroglobulinemia|waldenström macroglobulinemia
5312286|NCT00392678|Type 2 Diabetes|type 2 diabetes
5312287|NCT00392678|Inflammation|inflammation
5312288|NCT00392678|Obesity|obesity
5312289|NCT00392678|Metabolic Syndrome|metabolic syndrome
5312290|NCT00392665|SCCHN|scchn
5312291|NCT00392665|erlotinib|erlotinib
5312292|NCT00392665|tarceva|tarceva
5312293|NCT00392639|Heart arrest|heart arrest
5312294|NCT00392639|Cardiopulmonary resuscitation|cardiopulmonary resuscitation
5312295|NCT00392639|Humans|humans
5312296|NCT00392639|Hypothermia|hypothermia
5312297|NCT00392639|Brain diseases|brain diseases
5312298|NCT00392639|Hypoxia-ischemia|hypoxia-ischemia
5312299|NCT00392639|Cost Benefit Analysis|cost benefit analysis
5312300|NCT00392639|Prospective study|prospective study
5312301|NCT00392639|Comparative study|comparative study
5312302|NCT00392639|Treatment outcome|treatment outcome
5312303|NCT00392639|Hypothermia for|hypothermia for
5312304|NCT00392639|out-of-hospital cardiac arrest|out-of-hospital cardiac arrest
5312305|NCT00392639|from cardiac origin|from cardiac origin
5312306|NCT00392639|successfully resuscitated|successfully resuscitated
5312307|NCT00392587|Pharmacodynamics|pharmacodynamics
5312308|NCT00392587|Pharmacokinetics|pharmacokinetics
5312309|NCT00392587|Tolerability|tolerability
5312310|NCT00392587|COPD|copd
5312311|NCT00392587|Safety|safety
5312312|NCT00392574|Gastroenteritis|gastroenteritis
5312316|NCT00392548|VEGF|vegf
5312317|NCT00392548|radiation|radiation
5312318|NCT00392548|Patients must be enrolled to an RTOG GBM study that prescribes 6000 cGy of radiation therapy.|patients must be enrolled to an rtog gbm study that prescribes 6000 cgy of radiation therapy.
5312319|NCT00392535|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5312320|NCT00392535|stage IIB prostate cancer|stage iib prostate cancer
5312321|NCT00392535|stage IIA prostate cancer|stage iia prostate cancer
5312322|NCT00392535|stage III prostate cancer|stage iii prostate cancer
5312323|NCT00392522|Anxiety|anxiety
5312324|NCT00392522|Cough|cough
5312325|NCT00392522|Number of general anaesthesias (due to procedure failure)|number of general anaesthesias (due to procedure failure)
5312326|NCT00392522|Patients satisfaction|patients satisfaction
5312327|NCT00392522|Chest physician satisfaction|chest physician satisfaction
5312328|NCT00392509|critical limb ischemia|critical limb ischemia
5312329|NCT00392509|cell therapy for angiogenesis|cell therapy for angiogenesis
5312330|NCT00392509|aldehyde dehydrogenase-bright cells|aldehyde dehydrogenase-bright cells
5312331|NCT00392509|peripheral artery disease|peripheral artery disease
5312332|NCT00392509|peripheral vascular disease|peripheral vascular disease
5312333|NCT00392509|leg pain|leg pain
5312334|NCT00392509|PVD|pvd
5312335|NCT00392509|PAD|pad
5312336|NCT00392509|CLI|cli
5312337|NCT00392509|amputation|amputation
5312338|NCT00392509|limb salvage|limb salvage
5312339|NCT00392483|Heading Health Plan Implementation|heading health plan implementation
5312340|NCT00392483|Computer-Assisted Instruction|computer-assisted instruction
5312341|NCT00392483|General Practice|general practice
5312342|NCT00392483|Dementia|dementia
5312343|NCT00392470|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5312344|NCT00392470|stage III rectal cancer|stage iii rectal cancer
5312345|NCT00392470|stage IV rectal cancer|stage iv rectal cancer
5312346|NCT00392457|Idiopathic Hypogonadotropic Hypogonadism|idiopathic hypogonadotropic hypogonadism
5312347|NCT00392457|Kallmann Syndrome|kallmann syndrome
5312348|NCT00392457|Agonadal|agonadal
5312349|NCT00392418|iron deficiency anemia|iron deficiency anemia
5312350|NCT00392418|hematologic disease|hematologic disease
5312351|NCT00392418|infancy|infancy
5312352|NCT00392418|pediatrics|pediatrics
5312353|NCT00392418|Sprinkles®|sprinkles®
5312354|NCT00392418|iron|iron
5312355|NCT00392418|micronutrient|micronutrient
5312356|NCT00392405|Contrast Induced Nephropathy|contrast induced nephropathy
5312357|NCT00392392|Breast Cancer|breast cancer
5312358|NCT00392379|Tobacco use disorder|tobacco use disorder
5312359|NCT00392379|Tobacco cessation|tobacco cessation
5312360|NCT00392366|MRI guided Laser Therapy|mri guided laser therapy
5312361|NCT00392366|Laser Interstitial Thermal Therapy|laser interstitial thermal therapy
5312362|NCT00392366|Magnetic Resonance Thermal Imaging|magnetic resonance thermal imaging
5312363|NCT00392366|Liver Metastasis|liver metastasis
5312364|NCT00392340|recurrent neuroblastoma|recurrent neuroblastoma
5312365|NCT00392340|disseminated neuroblastoma|disseminated neuroblastoma
5312366|NCT00392314|hodgkin lymphoma|hodgkin lymphoma
5312367|NCT00392314|PET/CT|pet/ct
5312368|NCT00392314|Therapy|therapy
5312369|NCT00392301|wound healing|wound healing
5312370|NCT00392301|skin|skin
5312371|NCT00392301|graft donor site|graft donor site
5312372|NCT00392301|donor site|donor site
5312373|NCT00392301|transepidermal water loss|transepidermal water loss
5312374|NCT00392288|Bronchial Asthma|bronchial asthma
5312375|NCT00392275|Cataract|cataract
5312376|NCT00392275|Aqueous absorption|aqueous absorption
5312377|NCT00392275|Funtioning Filtering Blebs|funtioning filtering blebs
5312378|NCT00392262|Moderate essential hypertension (WHO grade II)|moderate essential hypertension (who grade ii)
5312379|NCT00392249|Schizophrenia|schizophrenia
5312380|NCT00392249|Drug adherence|drug adherence
5312381|NCT00392236|Schizoaffective Disorder|schizoaffective disorder
5312382|NCT00392197|OPC-14597|opc-14597
5312383|NCT00392197|Schizophrenia|schizophrenia
5312384|NCT00392184|accelerated partial breast irradiation|accelerated partial breast irradiation
5312385|NCT00392184|multicatheter brachytherapy|multicatheter brachytherapy
5312386|NCT00392184|high dose rate brachytherapy|high dose rate brachytherapy
5312387|NCT00392184|pulsed dose rate brachytherapy|pulsed dose rate brachytherapy
5312388|NCT00392145|Pediatrics|pediatrics
5312389|NCT00392145|Gastroenteritis|gastroenteritis
5312390|NCT00392145|Dehydration|dehydration
5312391|NCT00392145|IV Rehydration|iv rehydration
5312393|NCT00392119|MR-guided therapy|mr-guided therapy
5312394|NCT00392119|Laser interstitial thermal therapy|laser interstitial thermal therapy
5312395|NCT00392119|brain metastasis|brain metastasis
5312396|NCT00392119|Magnetic Resonance Thermal imaging (MRTI)|magnetic resonance thermal imaging (mrti)
5312397|NCT00392106|atrial fibrillation|atrial fibrillation
5312398|NCT00392106|arrhythmia|arrhythmia
5312399|NCT00392106|AF ablation|af ablation
5312400|NCT00392106|antiarrhythmic agent|antiarrhythmic agent
5312401|NCT00392106|catheter ablation|catheter ablation
5312402|NCT00392106|pulmonary veins|pulmonary veins
5312403|NCT00392093|Systemic lupus erythematosus|systemic lupus erythematosus
5312404|NCT00392093|Menopause hormonal therapy|menopause hormonal therapy
5312405|NCT00392093|Menopausal symptoms|menopausal symptoms
5312406|NCT00392093|Bone mineral density|bone mineral density
5312407|NCT00392054|Atrial Fibrillation|atrial fibrillation
5312408|NCT00392054|Paroxysmal|paroxysmal
5312409|NCT00392054|Pulmonary Vein Isolation|pulmonary vein isolation
5312410|NCT00392054|Ablation Catheter|ablation catheter
5312411|NCT00392054|Anti-arrhythmic Drug Therapy|anti-arrhythmic drug therapy
5312412|NCT00392054|First Line Therapy|first line therapy
5312413|NCT00392041|Fibromyalgia|fibromyalgia
5312414|NCT00392041|Insomnia|insomnia
5312415|NCT00392041|Sleep|sleep
5312416|NCT00392041|Eszopiclone|eszopiclone
5312417|NCT00392041|Lunesta|lunesta
5312418|NCT00392028|Ertapenem|ertapenem
5312419|NCT00392028|Bone drug level|bone drug level
5312420|NCT00392028|Blood drug level|blood drug level
5312421|NCT00392028|Tissue drug level|tissue drug level
5312422|NCT00392015|Malaria Vaccine|malaria vaccine
5312423|NCT00392015|Adenovirus|adenovirus
5312424|NCT00392015|Plasmodium falciparum|plasmodium falciparum
5312425|NCT00392002|GERD|gerd
5312426|NCT00391989|Ph+ Acute Lymphoblastic Leukaemia|ph+ acute lymphoblastic leukaemia
5312427|NCT00391989|Dasatinib|dasatinib
5312428|NCT00391989|targeted therapy|targeted therapy
5312429|NCT00391989|Patients with Ph positive and or BCR ABL positive ALL|patients with ph positive and or bcr abl positive all
5312430|NCT00391976|Cystic fibrosis|cystic fibrosis
5312431|NCT00391950|Prostate cancer|prostate cancer
5312432|NCT00391950|Cancer treatment induced bone loss (CTIBL)|cancer treatment induced bone loss (ctibl)
5312433|NCT00391950|Androgen deprivation therapy (ADT)|androgen deprivation therapy (adt)
5312434|NCT00391937|"resurfacing hip [MESH]"|"resurfacing hip [mesh]"
5312435|NCT00391937|"conventional position method"|"conventional position method"
5312436|NCT00391937|"surgery, computer-assisted [MESH]"|"surgery, computer-assisted [mesh]"
5312437|NCT00391924|Dehydroepiandrosterone|dehydroepiandrosterone
5312438|NCT00391924|Fatigue|fatigue
5312439|NCT00391924|Quality of life|quality of life
5312440|NCT00391924|Lupus Erythematosus, Systemic|lupus erythematosus, systemic
5312441|NCT00391924|Sjogren's Syndrome|sjogren's syndrome
5312442|NCT00391924|Bone mineral density|bone mineral density
5312443|NCT00391911|Rhabdomyolysis|rhabdomyolysis
5312444|NCT00391911|CRRT|crrt
5312445|NCT00391911|N-Acetylcysteine|n-acetylcysteine
5312446|NCT00391898|Parkinson's disease, adults, levodopa/carbidopa/entacapone, wearing-off, activities of daily living|parkinson's disease, adults, levodopa/carbidopa/entacapone, wearing-off, activities of daily living
5312447|NCT00391872|ACS|acs
5312448|NCT00391872|Acute coronary syndrome|acute coronary syndrome
5312449|NCT00391872|Heart attack|heart attack
5312450|NCT00391872|Unstable angina|unstable angina
5312451|NCT00391872|Coronary artery disease|coronary artery disease
5312452|NCT00391859|Pharmacist-initiated Intervention Trial in OsteoArthritis|pharmacist-initiated intervention trial in osteoarthritis
5312453|NCT00391846|Heart Failure|heart failure
5312454|NCT00391846|Ventricular Dysfunction|ventricular dysfunction
5312455|NCT00391846|NTproBNP|ntprobnp
5312456|NCT00391833|Alzheimer's disease, Ginseng, CD34|alzheimer's disease, ginseng, cd34
5312457|NCT00391820|constipation|constipation
5312458|NCT00391820|chronic|chronic
5312459|NCT00391820|bowel function|bowel function
5312460|NCT00391807|Contraception|contraception
5312461|NCT00391794|Memory|memory
5312462|NCT00391794|Alzheimer's disease|alzheimer's disease
5312463|NCT00391794|Dementia|dementia
5312464|NCT00391794|Support Group|support group
5312465|NCT00391794|Psychosocial|psychosocial
5312466|NCT00391781|mechanical infertility|mechanical infertility
5312467|NCT00391781|hysterosalpingogram|hysterosalpingogram
5312468|NCT00391781|hysterosalpingography|hysterosalpingography
5312469|NCT00391768|influenza, oseltamivir, Tamiflu®, antiviral, children, infants|influenza, oseltamivir, tamiflu®, antiviral, children, infants
5312470|NCT00391755|Migraine Headache|migraine headache
5312471|NCT00391742|Brief intervention|brief intervention
5312472|NCT00391742|Motivational Interviewing|motivational interviewing
5312473|NCT00391742|Primary care|primary care
5312474|NCT00391742|Stepped-care|stepped-care
5312475|NCT00391729|ADHD|adhd
5312476|NCT00391716|Alcohol|alcohol
5312477|NCT00391716|Alcohol treatment|alcohol treatment
5312478|NCT00391716|Alcoholism|alcoholism
5312479|NCT00391716|Alcohol Dependence|alcohol dependence
5312480|NCT00391703|Cystic fibrosis|cystic fibrosis
5312481|NCT00391703|mucoviscidosis|mucoviscidosis
5312482|NCT00391703|electrostimulation|electrostimulation
5312483|NCT00391703|retraining|retraining
5312484|NCT00391690|Serum bone marker|serum bone marker
5312485|NCT00391690|Prostate cancer|prostate cancer
5312486|NCT00391690|Bisphosphonates|bisphosphonates
5312487|NCT00391690|Early detection of metastasis|early detection of metastasis
5312488|NCT00391677|Cognitive Rehabilitation|cognitive rehabilitation
5312489|NCT00391677|Behavior Therapy|behavior therapy
5312490|NCT00391664|Endometrial cancer|endometrial cancer
5312491|NCT00391664|Ovarian Cancer|ovarian cancer
5312492|NCT00391664|Cervical Cancer|cervical cancer
5312493|NCT00391664|Genital Cancer|genital cancer
5312494|NCT00391664|Vulvar Cancer|vulvar cancer
5312495|NCT00391664|Vaginal Cancer|vaginal cancer
5312496|NCT00391664|Other Gynecological Cancers|other gynecological cancers
5312497|NCT00391651|UTI|uti
5312498|NCT00391638|HIV and Hepatitis B coinfection|hiv and hepatitis b coinfection
5312499|NCT00391638|Peg interferon|peg interferon
5312500|NCT00391638|tenofovir|tenofovir
5312501|NCT00391638|emtricitabine|emtricitabine
5312502|NCT00391638|Hepatitis B e Antigens|hepatitis b e antigens
5312503|NCT00391638|Treatment Experienced|treatment experienced
5312504|NCT00391625|Gaucher disease, Enzyme Replacement Therapy|gaucher disease, enzyme replacement therapy
5312505|NCT00391612|COPD (Chronic Obstructive Pulmonary Disease)|copd (chronic obstructive pulmonary disease)
5312506|NCT00391612|Emphysema|emphysema
5312507|NCT00391612|Hyperinflation|hyperinflation
5312508|NCT00391612|Minimally Invasive|minimally invasive
5312509|NCT00391599|Cesarean Section,|cesarean section,
5312510|NCT00391599|Enema|enema
5312511|NCT00391586|erlotinib|erlotinib
5312512|NCT00391586|NSCLC|nsclc
5312513|NCT00391586|chemotherapy|chemotherapy
5312514|NCT00391586|platinum|platinum
5312515|NCT00391586|lung|lung
5312516|NCT00391586|lung cancer|lung cancer
5312517|NCT00391560|refractory leukemia|refractory leukemia
5312518|NCT00391547|Gingivitis Disease|gingivitis disease
5312519|NCT00391534|Epilepsy|epilepsy
5312520|NCT00391534|oxcarbazepine|oxcarbazepine
5312521|NCT00391521|Oncology. All solid Tumour disease.|oncology. all solid tumour disease.
5312522|NCT00391508|Ostomy|ostomy
5312523|NCT00391508|Peristomal skin|peristomal skin
5312524|NCT00391508|Skin complication|skin complication
5312525|NCT00391495|ADHD|adhd
5312526|NCT00391495|Cytokines|cytokines
5312527|NCT00391495|CR-P|cr-p
5312528|NCT00391482|IV Drug Users|iv drug users
5312529|NCT00391482|Hepatitis C Virus|hepatitis c virus
5312530|NCT00391482|Human Immunodeficiency Virus|human immunodeficiency virus
5312531|NCT00391482|Intervention|intervention
5312532|NCT00391482|HIV Seronegativity|hiv seronegativity
5312533|NCT00391469|cardiac arrest|cardiac arrest
5312534|NCT00391469|mild hypothermia|mild hypothermia
5312535|NCT00391456|animal-assisted therapy|animal-assisted therapy
5312536|NCT00391456|dog hospital visit|dog hospital visit
5312537|NCT00391456|heart failure|heart failure
5312538|NCT00391443|BUILD 3|build 3
5312539|NCT00391443|Idiopathic Pulmonary Fibrosis|idiopathic pulmonary fibrosis
5312540|NCT00391443|Tracleer|tracleer
5312541|NCT00391443|Interstitial Lung Disease|interstitial lung disease
5312542|NCT00391443|bosentan|bosentan
5312543|NCT00391443|Actelion|actelion
5312544|NCT00391430|PTSD|ptsd
5312545|NCT00391430|Trauma|trauma
5312546|NCT00391430|Sexual Abuse|sexual abuse
5312547|NCT00391430|Sexual Assault|sexual assault
5312548|NCT00391417|hot flush|hot flush
5312549|NCT00391417|hot flash|hot flash
5312550|NCT00391417|estrogen|estrogen
5312551|NCT00391417|vaginal atrophy|vaginal atrophy
5312552|NCT00391404|Childhood cancer survivors|childhood cancer survivors
5312553|NCT00391404|Osteoporosis|osteoporosis
5312554|NCT00391404|Bone mineral density|bone mineral density
5312555|NCT00391404|Therapy|therapy
5312556|NCT00391404|Bisphosphonate|bisphosphonate
5312557|NCT00391404|Randomized controlled trial|randomized controlled trial
5312558|NCT00391391|Influenza|influenza
5312559|NCT00391391|Orthomyxoviruses|orthomyxoviruses
5312560|NCT00391391|Inactivated Split-virion influenza vaccine|inactivated split-virion influenza vaccine
5312561|NCT00391391|Infants|infants
5312562|NCT00391391|children.|children.
5312563|NCT00391378|Diffusion-Weighted Magnetic Resonance Imaging|diffusion-weighted magnetic resonance imaging
5312564|NCT00391378|MRI (Magnetic Resonance Imaging)|mri (magnetic resonance imaging)
5312565|NCT00391378|Stroke|stroke
5312566|NCT00391378|Cognition|cognition
5312567|NCT00391378|Heart|heart
5312568|NCT00391365|ankle osteoarthritis|ankle osteoarthritis
5312569|NCT00391365|arthritis|arthritis
5312570|NCT00391365|arthrodesis|arthrodesis
5312571|NCT00391365|arthroplasty|arthroplasty
5312572|NCT00391365|Gait|gait
5312573|NCT00391365|step count|step count
5312574|NCT00391365|walking|walking
5312575|NCT00391352|Multiple Sclerosis|multiple sclerosis
5312576|NCT00391352|Disease Modifying Therapy|disease modifying therapy
5312577|NCT00391339|Bryophyllum p.|bryophyllum p.
5312578|NCT00391339|Nifedipine|nifedipine
5312579|NCT00391339|Tocolysis|tocolysis
5312580|NCT00391326|Bivalirudin|bivalirudin
5312581|NCT00391326|Heparin|heparin
5312582|NCT00391326|Bleeding|bleeding
5312583|NCT00391326|TIMI flow|timi flow
5312584|NCT00391326|STEMI|stemi
5312585|NCT00391313|Chikungunya|chikungunya
5312586|NCT00391313|Chikungunya disease|chikungunya disease
5312587|NCT00391300|melanoma|melanoma
5312588|NCT00391300|basal cell carcinoma of the skin|basal cell carcinoma of the skin
5312589|NCT00391300|squamous cell carcinoma of the skin|squamous cell carcinoma of the skin
5312590|NCT00391287|Red-Cell Aplasia due to Chronic Kidney Failure|red-cell aplasia due to chronic kidney failure
5312591|NCT00391287|Aplastic Anemia|aplastic anemia
5312592|NCT00391287|Recombinant Erythropoietin|recombinant erythropoietin
5312593|NCT00391287|Surveillance Registry|surveillance registry
5312594|NCT00391287|Registries|registries
5312595|NCT00391261|weight gain|weight gain
5312596|NCT00391261|obesity|obesity
5312597|NCT00391261|metabolism|metabolism
5312598|NCT00391248|non-small cell lung cancer|non-small cell lung cancer
5312599|NCT00391248|palliative radiation|palliative radiation
5312600|NCT00391248|tarceva|tarceva
5312601|NCT00391248|palliative thoracic radiation therapy|palliative thoracic radiation therapy
5312602|NCT00391235|bipolar disorder|bipolar disorder
5312603|NCT00391235|magnetic resonance imaging|magnetic resonance imaging
5312604|NCT00391235|white matter|white matter
5312605|NCT00391235|diffusion tensor imaging|diffusion tensor imaging
5312606|NCT00391235|children|children
5312607|NCT00391235|adolescents|adolescents
5312608|NCT00391222|Bipolar I Disorder|bipolar i disorder
5312609|NCT00391222|Intramuscular injection|intramuscular injection
5312610|NCT00391222|prevention of mood episodes|prevention of mood episodes
5312611|NCT00391222|long acting injectable|long acting injectable
5312612|NCT00391222|risperidone|risperidone
5312613|NCT00391183|Gallbladder cancer|gallbladder cancer
5312614|NCT00391183|Quality of life|quality of life
5312615|NCT00391183|Stenting|stenting
5312616|NCT00391183|Survival|survival
5312617|NCT00391183|Performance status|performance status
5312618|NCT00391170|Oral Chronic GVHD|oral chronic gvhd
5312619|NCT00391170|Topical Dexamethasone|topical dexamethasone
5312620|NCT00391170|Tissue Markers|tissue markers
5312621|NCT00391170|Salivary Proteomics|salivary proteomics
5312622|NCT00391170|Quality of Life|quality of life
5312623|NCT00391170|Oral Chronic Graft Versus Host Disease|oral chronic graft versus host disease
5312624|NCT00391170|Oral Pain|oral pain
5312625|NCT00391170|Mouth Pain|mouth pain
5312626|NCT00391157|Múltiple Myeloma|múltiple myeloma
5312627|NCT00391157|Transplant|transplant
5312628|NCT00391157|Patients <65 years.|patients <65 years.
5312629|NCT00391144|Pattern Dystrophy|pattern dystrophy
5312630|NCT00391144|Choroidal Neovascularization|choroidal neovascularization
5312631|NCT00391144|Intravitreal Avastin Injection|intravitreal avastin injection
5312632|NCT00391131|PID|pid
5312633|NCT00391131|SCIG|scig
5312634|NCT00391131|Ig|ig
5312635|NCT00391131|Quality of Life|quality of life
5312636|NCT00391131|Serious Bacterial Infections|serious bacterial infections
5312637|NCT00391105|intubation|intubation
5312638|NCT00391105|Sedation|sedation
5312639|NCT00391105|Analgesia|analgesia
5312640|NCT00391105|preterm neonate|preterm neonate
5312641|NCT00391105|remifentanil|remifentanil
5312642|NCT00391105|morphine|morphine
5312643|NCT00391105|respiratory distress syndrome|respiratory distress syndrome
5312644|NCT00391079|Central Neuropathic Pain|central neuropathic pain
5312645|NCT00391066|CD23+/CD20+ B-cell CLL|cd23+/cd20+ b-cell cll
5312646|NCT00391066|CLL|cll
5312647|NCT00391053|Influenza|influenza
5312648|NCT00391053|Orthomyxoviruses|orthomyxoviruses
5312649|NCT00391053|Inactivated Split-virion influenza vaccine|inactivated split-virion influenza vaccine
5312650|NCT00391053|Adults|adults
5312651|NCT00391040|diabetes mellitus, structured treatment and teaching, education,|diabetes mellitus, structured treatment and teaching, education,
5312652|NCT00391040|elderly patients, geriatrics|elderly patients, geriatrics
5312653|NCT00391027|type 2 diabetes, insulin, glycemic control|type 2 diabetes, insulin, glycemic control
5312654|NCT00391014|Acute myeloid Leukemia|acute myeloid leukemia
5312655|NCT00391014|Allogeneic haematopoietic progenitor cell transplant|allogeneic haematopoietic progenitor cell transplant
5312656|NCT00391014|Acute Invasive Aspergillosis|acute invasive aspergillosis
5312657|NCT00391001|mania|mania
5312658|NCT00391001|bipolar disorder|bipolar disorder
5312659|NCT00391001|taurine|taurine
5312660|NCT00391001|adolescents|adolescents
5312661|NCT00390988|blood count|blood count
5312662|NCT00390988|capillary|capillary
5312663|NCT00390988|venous|venous
5312664|NCT00390988|Adult|adult
5312665|NCT00390988|reference values|reference values
5312666|NCT00390975|Tegaserod|tegaserod
5312667|NCT00390975|diabetes|diabetes
5312668|NCT00390975|diabetic gastroparesis|diabetic gastroparesis
5312669|NCT00390975|gastric emptying|gastric emptying
5312670|NCT00390975|gastric retention|gastric retention
5312671|NCT00390975|electrogastrography|electrogastrography
5312672|NCT00390962|copeptin|copeptin
5312673|NCT00390962|vasopressin|vasopressin
5312674|NCT00390962|Adh|adh
5312675|NCT00390962|SIADH|siadh
5312676|NCT00390962|diabetes insipidus|diabetes insipidus
5312677|NCT00390962|stroke|stroke
5312678|NCT00390962|risk factors|risk factors
5312679|NCT00390962|Neurological patients with ischemic and hemorrhagic stroke and patients undergoing intracranial surgery.|neurological patients with ischemic and hemorrhagic stroke and patients undergoing intracranial surgery.
5312680|NCT00390949|HIV prevention|hiv prevention
5312681|NCT00390949|Zimbabwe|zimbabwe
5312682|NCT00390949|Core groups|core groups
5312683|NCT00390949|Peer education|peer education
5312684|NCT00390949|Syndromic management|syndromic management
5312685|NCT00390949|Commercial sex workers|commercial sex workers
5312686|NCT00390949|Condom distribution|condom distribution
5312687|NCT00390949|HIV Seronegativity|hiv seronegativity
5312688|NCT00390923|smoking|smoking
5312689|NCT00390923|nicotine dependence|nicotine dependence
5312690|NCT00390923|double-blind|double-blind
5312691|NCT00390923|placebo-controlled|placebo-controlled
5312692|NCT00390923|randomized|randomized
5312693|NCT00390923|full substitution therapy|full substitution therapy
5312694|NCT00390923|selegiline|selegiline
5312695|NCT00390910|Pneumococcal vaccine|pneumococcal vaccine
5312696|NCT00390910|Preterm|preterm
5312697|NCT00390910|Safety|safety
5312698|NCT00390910|Pneumococcal disease|pneumococcal disease
5312699|NCT00390910|Immunogenicity|immunogenicity
5312700|NCT00390897|chronic myeloid leukaemia|chronic myeloid leukaemia
5312701|NCT00390897|Glivec|glivec
5312702|NCT00390897|Interferon|interferon
5312703|NCT00390884|Fluzone®|fluzone®
5312704|NCT00390884|Influenza|influenza
5312705|NCT00390884|Influenza virus infection|influenza virus infection
5312706|NCT00390884|Influenza vaccine|influenza vaccine
5312707|NCT00390871|Patient|patient
5312708|NCT00390871|Must be|must be
5312709|NCT00390871|Under|under
5312710|NCT00390858|β-thalassemia major|β-thalassemia major
5312711|NCT00390858|iron overload|iron overload
5312712|NCT00390858|deferasirox|deferasirox
5312713|NCT00390858|pediatric rare anemia|pediatric rare anemia
5312714|NCT00390845|MAP kinase|map kinase
5312715|NCT00390845|SB681323|sb681323
5312716|NCT00390845|neuropathic pain|neuropathic pain
5312717|NCT00390845|patients|patients
5312718|NCT00390845|P38|p38
5312719|NCT00390845|nerve trauma|nerve trauma
5312720|NCT00390832|STEMI|stemi
5312721|NCT00390819|Community acquired pneumonia|community acquired pneumonia
5312722|NCT00390806|Brain metastases from Non-Small Cell Lung Cancer|brain metastases from non-small cell lung cancer
5312723|NCT00390806|Brain metastases brain tumor lung cancer oral chemotherapy HYCAMTIN topotecan NSCLC WBRT whole brain radiation|brain metastases brain tumor lung cancer oral chemotherapy hycamtin topotecan nsclc wbrt whole brain radiation
5312724|NCT00390793|Acute Lymphocytic Leukemia|acute lymphocytic leukemia
5312725|NCT00390793|Leukemia|leukemia
5312726|NCT00390793|ALL|all
5312727|NCT00390793|Philadelphia-Positive ALL|philadelphia-positive all
5312728|NCT00390793|BCR-ABL Positive ALL|bcr-abl positive all
5312729|NCT00390793|Dasatinib|dasatinib
5312730|NCT00390793|Hyper-CVAD|hyper-cvad
5312731|NCT00390793|Cyclophosphamide|cyclophosphamide
5312732|NCT00390793|Cytoxan|cytoxan
5312733|NCT00390793|Vincristine|vincristine
5312734|NCT00390793|Vincasar|vincasar
5312735|NCT00390793|Doxorubicin|doxorubicin
5312736|NCT00390793|Adriamycin|adriamycin
5312737|NCT00390793|Dexamethasone|dexamethasone
5312738|NCT00390793|Decadron|decadron
5312739|NCT00390793|Sprycel|sprycel
5312740|NCT00390780|Miconazole Lauriad|miconazole lauriad
5312741|NCT00390780|Oropharyngeal candidiasis|oropharyngeal candidiasis
5312742|NCT00390780|HIV patients|hiv patients
5312743|NCT00390780|Mycology|mycology
5312744|NCT00390780|Clinical picture of Oropharyngeal candidiasis|clinical picture of oropharyngeal candidiasis
5312745|NCT00390780|Candida culture positive|candida culture positive
5312746|NCT00390780|Treatment Experienced|treatment experienced
5312747|NCT00390767|Peripheral arterial disease|peripheral arterial disease
5312748|NCT00390767|Peripheral vascular disease|peripheral vascular disease
5312749|NCT00390767|Claudication|claudication
5312750|NCT00390767|Cell therapy|cell therapy
5312751|NCT00390767|Gene therapy|gene therapy
5312752|NCT00390767|Endothelial cells|endothelial cells
5312753|NCT00390767|Smooth muscle cells|smooth muscle cells
5312754|NCT00390767|Angiogenesis|angiogenesis
5312755|NCT00390754|pregnancy|pregnancy
5312756|NCT00390754|unintended|unintended
5312757|NCT00390754|menses|menses
5312758|NCT00390741|hip fracture|hip fracture
5312759|NCT00390741|bone mineral density|bone mineral density
5312760|NCT00390741|exercise|exercise
5312761|NCT00390715|Acute Myeloblastic Leukemia|acute myeloblastic leukemia
5312762|NCT00390702|Ventricular septal defect|ventricular septal defect
5312763|NCT00390702|VSD|vsd
5312764|NCT00390676|cancer|cancer
5312765|NCT00390676|tumors|tumors
5312766|NCT00390676|anticarcinogenic agents|anticarcinogenic agents
5312767|NCT00390676|antineoplastic agents|antineoplastic agents
5312768|NCT00390676|cadherins|cadherins
5312769|NCT00390676|solid tumors|solid tumors
5312770|NCT00390663|Paediatric|paediatric
5312771|NCT00390663|Epistaxis|epistaxis
5312772|NCT00390663|Nose bleed|nose bleed
5312773|NCT00390663|Naseptin|naseptin
5312774|NCT00390650|Anxiety|anxiety
5312775|NCT00390650|clinical trials|clinical trials
5312776|NCT00390637|Diogenes|diogenes
5312777|NCT00390637|Diet Intervention|diet intervention
5312778|NCT00390637|Family|family
5312779|NCT00390637|Glycemic Index|glycemic index
5312780|NCT00390637|Protein|protein
5312781|NCT00390624|Urodilatin|urodilatin
5312782|NCT00390624|Mannitol|mannitol
5312783|NCT00390624|Acute Kidney Failure|acute kidney failure
5312784|NCT00390611|Ovarian Cancer|ovarian cancer
5312785|NCT00390598|colonoscopy|colonoscopy
5312786|NCT00390598|large bowel preparation|large bowel preparation
5312787|NCT00390598|bowel cleansing|bowel cleansing
5312788|NCT00390598|randomized controlled trial|randomized controlled trial
5312789|NCT00390585|Renal Insufficiency|renal insufficiency
5312790|NCT00390585|Angioplasty, Transluminal, Percutaneous Coronary|angioplasty, transluminal, percutaneous coronary
5312791|NCT00390585|Contrast media|contrast media
5312792|NCT00390572|sleep|sleep
5312793|NCT00390572|consultation and referral|consultation and referral
5312794|NCT00390572|outcome assessment|outcome assessment
5312795|NCT00390572|primary care|primary care
5312796|NCT00390559|Nicotine Replacement Therapy|nicotine replacement therapy
5312797|NCT00390559|Tobacco Smoking|tobacco smoking
5312798|NCT00390559|Smoking stimuli|smoking stimuli
5312799|NCT00390559|Gender|gender
5312800|NCT00390533|Anxiety|anxiety
5312801|NCT00390533|clinical trials|clinical trials
5312802|NCT00390520|Type 2 diabetes|type 2 diabetes
5312803|NCT00390520|vildagliptin|vildagliptin
5312804|NCT00390520|glucagon|glucagon
5312805|NCT00390520|hypoglycemia|hypoglycemia
5312806|NCT00390507|Acceleromyography|acceleromyography
5312807|NCT00390507|TOF-Watch|tof-watch
5312808|NCT00390507|Posttetanic count|posttetanic count
5312809|NCT00390507|Train of four|train of four
5312810|NCT00390507|Neuromuscular blockade|neuromuscular blockade
5312811|NCT00390494|Fibroids|fibroids
5312812|NCT00390494|Leiomyoma|leiomyoma
5312813|NCT00390494|Hysterectomy|hysterectomy
5312814|NCT00390494|Myomectomy|myomectomy
5312815|NCT00390494|Uterine Fibroid Embolization|uterine fibroid embolization
5312816|NCT00390494|Questionnaire|questionnaire
5312817|NCT00390481|Carotid Occlusion|carotid occlusion
5312818|NCT00390481|Cognition|cognition
5312819|NCT00390468|Tandutinib|tandutinib
5312820|NCT00390468|MLN518|mln518
5312821|NCT00390468|CT53518|ct53518
5312822|NCT00390468|pain|pain
5312823|NCT00390468|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5312824|NCT00390468|recurrent prostate cancer|recurrent prostate cancer
5312825|NCT00390468|stage IV prostate cancer|stage iv prostate cancer
5312826|NCT00390468|bone metastases|bone metastases
5312827|NCT00390468|hormone-based castration|hormone-based castration
5312828|NCT00390442|cardiogenic pulmonary edema|cardiogenic pulmonary edema
5312829|NCT00390442|non invasive ventilation|non invasive ventilation
5312830|NCT00390442|CPAP|cpap
5312831|NCT00390429|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5312832|NCT00390429|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5312833|NCT00390429|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5312834|NCT00390429|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5312835|NCT00390416|Metastatic|metastatic
5312836|NCT00390416|Gastroesophageal|gastroesophageal
5312837|NCT00390416|Docetaxel|docetaxel
5312838|NCT00390416|Cisplatin|cisplatin
5312839|NCT00390416|Fluorouracil|fluorouracil
5312840|NCT00390416|Bevacizumab|bevacizumab
5312841|NCT00390416|Metastatic Gastroesophageal Adenocarcinoma|metastatic gastroesophageal adenocarcinoma
5312842|NCT00390416|06-096|06-096
5312843|NCT00390403|adult glioblastoma|adult glioblastoma
5312844|NCT00390403|adult gliosarcoma|adult gliosarcoma
5312845|NCT00390403|adult giant cell glioblastoma|adult giant cell glioblastoma
5312846|NCT00390390|Heartburn, frequent heartburn, proton pump inhibitor, lansoprazole|heartburn, frequent heartburn, proton pump inhibitor, lansoprazole
5312847|NCT00390377|x-ray diffraction|x-ray diffraction
5312848|NCT00390377|hair|hair
5312849|NCT00390377|breast cancer|breast cancer
5312850|NCT00390377|synchrotron|synchrotron
5312851|NCT00390364|adenocarcinoma of the colon|adenocarcinoma of the colon
5312852|NCT00390364|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5312853|NCT00390364|recurrent colon cancer|recurrent colon cancer
5312854|NCT00390364|stage III colon cancer|stage iii colon cancer
5312855|NCT00390364|stage IV colon cancer|stage iv colon cancer
5312856|NCT00390364|recurrent rectal cancer|recurrent rectal cancer
5312857|NCT00390364|stage III rectal cancer|stage iii rectal cancer
5312858|NCT00390364|stage IV rectal cancer|stage iv rectal cancer
5312859|NCT00390351|Optical coherence tomography|optical coherence tomography
5312860|NCT00390338|recurrent melanoma|recurrent melanoma
5312861|NCT00390338|stage IV melanoma|stage iv melanoma
5312862|NCT00390338|stage IIIA melanoma|stage iiia melanoma
5312863|NCT00390338|stage IIIB melanoma|stage iiib melanoma
5312864|NCT00390338|stage IIIC melanoma|stage iiic melanoma
5312865|NCT00390312|Post operative pain|post operative pain
5312866|NCT00390312|Third molar extraction|third molar extraction
5312867|NCT00390312|Dental surgery|dental surgery
5312868|NCT00390312|Morphine|morphine
5312869|NCT00390286|Telemedicine|telemedicine
5312870|NCT00390273|diabetes|diabetes
5312871|NCT00390273|metformin|metformin
5312872|NCT00390273|hyperlactatemia|hyperlactatemia
5312873|NCT00390221|MS|ms
5312874|NCT00390221|multiple sclerosis|multiple sclerosis
5312875|NCT00390208|Macular Degeneration|macular degeneration
5312876|NCT00390208|Degenerative changes in the macula lutea of the retina.|degenerative changes in the macula lutea of the retina.
5313229|NCT00388908|vertebral fractures|vertebral fractures
5312877|NCT00390208|Maculopathy, Age-Related|maculopathy, age-related
5312878|NCT00390208|Age-Related Maculopathies|age-related maculopathies
5312879|NCT00390208|Age-Related Maculopathy|age-related maculopathy
5312880|NCT00390208|Maculopathies, Age-Related|maculopathies, age-related
5312881|NCT00390208|RETINAL DEGENERATION|retinal degeneration
5312882|NCT00390208|ARMD|armd
5312883|NCT00390208|AMD|amd
5312884|NCT00390208|Lucentis|lucentis
5312885|NCT00390208|Visudyne|visudyne
5312886|NCT00390208|Photodynamic Therapy|photodynamic therapy
5312887|NCT00390208|Verteporfin|verteporfin
5312888|NCT00390208|Ranibizumab|ranibizumab
5312889|NCT00390208|Intravitreal Dexamethasone|intravitreal dexamethasone
5312890|NCT00390195|Hepatocellular carcinoma|hepatocellular carcinoma
5312891|NCT00390195|RAD001|rad001
5312892|NCT00390195|Rapamycin|rapamycin
5312893|NCT00390195|Randomize|randomize
5312894|NCT00390195|Phase I|phase i
5312895|NCT00390195|Phase II|phase ii
5312896|NCT00390195|Pharmacokinetics|pharmacokinetics
5312897|NCT00390182|GI tumors|gi tumors
5312898|NCT00390182|Locally Advanced|locally advanced
5312899|NCT00390182|Metastatic|metastatic
5312900|NCT00390182|Hepatobiliary|hepatobiliary
5312901|NCT00390182|Ovary|ovary
5312902|NCT00390169|breast neoplasms|breast neoplasms
5312903|NCT00390169|stress|stress
5312904|NCT00390169|personality|personality
5312905|NCT00390169|psychology|psychology
5312906|NCT00390156|refractory|refractory
5312907|NCT00390156|prior treatment|prior treatment
5312908|NCT00390156|solid tumors|solid tumors
5312909|NCT00390156|phase I|phase i
5312910|NCT00390156|phase 1|phase 1
5312911|NCT00390143|Immunogenicity|immunogenicity
5312912|NCT00390143|Meningococcal vaccine|meningococcal vaccine
5312913|NCT00390143|Conjugate vaccine|conjugate vaccine
5312914|NCT00390143|Persistence|persistence
5312915|NCT00390130|Vaccination|vaccination
5312916|NCT00390130|Pediatrics|pediatrics
5312917|NCT00390130|Pain|pain
5312918|NCT00390117|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5312919|NCT00390117|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5312920|NCT00390117|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5312921|NCT00390117|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5312922|NCT00390117|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5312923|NCT00390117|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5312924|NCT00390117|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5312925|NCT00390117|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5312926|NCT00390117|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5312927|NCT00390117|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5312928|NCT00390117|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5312929|NCT00390117|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5312930|NCT00390117|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5312931|NCT00390117|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
5312932|NCT00390117|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
5312933|NCT00390117|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
5312934|NCT00390117|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5312935|NCT00390117|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5312936|NCT00390117|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5312937|NCT00390104|Neuromuscular Disease|neuromuscular disease
5312938|NCT00390104|Muscle weakness|muscle weakness
5312939|NCT00390104|Muscle atrophy|muscle atrophy
5312940|NCT00390091|Lupus|lupus
5312941|NCT00390091|Nephritis|nephritis
5312942|NCT00390091|Kidney|kidney
5312943|NCT00390091|SLE|sle
5312944|NCT00390091|Systemic Lupus Erythematosus|systemic lupus erythematosus
5312945|NCT00390091|Nephritis, Lupus|nephritis, lupus
5312946|NCT00390078|Vaccine|vaccine
5312947|NCT00390078|Safety|safety
5312948|NCT00390078|T-cell epitope|t-cell epitope
5312949|NCT00390078|Acquired Immune Deficiency Syndrome Virus|acquired immune deficiency syndrome virus
5312950|NCT00390078|HIV Therapeutic Vaccine|hiv therapeutic vaccine
5312951|NCT00390065|Follow-up|follow-up
5312952|NCT00390065|Premature infants|premature infants
5312953|NCT00390065|Nitric Oxide|nitric oxide
5312954|NCT00390065|Respiratory function testing|respiratory function testing
5312955|NCT00390065|Neurodevelopmental outcomes|neurodevelopmental outcomes
5312956|NCT00390039|Pain, postoperative|pain, postoperative
5312957|NCT00390039|Surgery, orthopedic|surgery, orthopedic
5312958|NCT00390039|Morphine|morphine
5312959|NCT00390026|Neovascular age-related macular degeneration|neovascular age-related macular degeneration
5312960|NCT00390026|Bevacizumab|bevacizumab
5312961|NCT00390026|Photodynamic therapy|photodynamic therapy
5312962|NCT00390013|Vulvar Pain|vulvar pain
5312963|NCT00389948|Heartburn, frequent heartburn, proton pump inhibitor, lansoprazole|heartburn, frequent heartburn, proton pump inhibitor, lansoprazole
5312964|NCT00389935|Gastrointestinal Bleeding|gastrointestinal bleeding
5312965|NCT00389935|Arteriovenous Malformation|arteriovenous malformation
5312966|NCT00389935|Angiodysplasia|angiodysplasia
5312967|NCT00389935|Hereditary Hemorrhagic Telangiectasia|hereditary hemorrhagic telangiectasia
5312968|NCT00389935|Obscure Bleeding|obscure bleeding
5312969|NCT00389922|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5312970|NCT00389909|Premature infants|premature infants
5312971|NCT00389909|Apnea|apnea
5312972|NCT00389909|Doxapram|doxapram
5312973|NCT00389909|pharmacokinetics|pharmacokinetics
5312974|NCT00389883|supratentorial brain tumors|supratentorial brain tumors
5312975|NCT00389883|propofol|propofol
5312976|NCT00389883|sevoflurane|sevoflurane
5312977|NCT00389883|remifentanil|remifentanil
5312978|NCT00389883|sufentanil.|sufentanil.
5312979|NCT00389870|recurrent colon cancer|recurrent colon cancer
5312980|NCT00389870|stage IV colon cancer|stage iv colon cancer
5312981|NCT00389870|recurrent rectal cancer|recurrent rectal cancer
5312982|NCT00389870|stage IV rectal cancer|stage iv rectal cancer
5312983|NCT00389870|adenocarcinoma of the colon|adenocarcinoma of the colon
5312984|NCT00389870|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5312985|NCT00389857|Influenza|influenza
5312986|NCT00389857|Influenza Virus Vaccine|influenza virus vaccine
5312987|NCT00389857|Fluzone®|fluzone®
5312988|NCT00389844|hip fracture|hip fracture
5312989|NCT00389844|exercise|exercise
5312990|NCT00389844|motivation|motivation
5312991|NCT00389831|Rotigotine|rotigotine
5312992|NCT00389831|Rotigotine nasal spray|rotigotine nasal spray
5312993|NCT00389831|Efficacy, safety and tolerability|efficacy, safety and tolerability
5312994|NCT00389831|Restless Legs Syndrome|restless legs syndrome
5312995|NCT00389818|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
5312996|NCT00389818|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5312997|NCT00389818|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
5312998|NCT00389818|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5312999|NCT00389818|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5313000|NCT00389818|AIDS-related diffuse large cell lymphoma|aids-related diffuse large cell lymphoma
5313001|NCT00389818|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
5313002|NCT00389818|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5313003|NCT00389818|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
5313004|NCT00389818|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5313005|NCT00389818|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5313006|NCT00389818|AIDS-related immunoblastic large cell lymphoma|aids-related immunoblastic large cell lymphoma
5313007|NCT00389818|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
5313008|NCT00389818|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
5313009|NCT00389818|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
5313010|NCT00389818|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5313011|NCT00389818|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5313012|NCT00389818|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
5313013|NCT00389805|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5313014|NCT00389805|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5313015|NCT00389805|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5313016|NCT00389805|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5313017|NCT00389766|localized unresectable neuroblastoma|localized unresectable neuroblastoma
5313018|NCT00389766|recurrent neuroblastoma|recurrent neuroblastoma
5313019|NCT00389766|regional neuroblastoma|regional neuroblastoma
5313020|NCT00389766|localized resectable neuroblastoma|localized resectable neuroblastoma
5313021|NCT00389766|disseminated neuroblastoma|disseminated neuroblastoma
5313023|NCT00389753|Hydratation|hydratation
5313024|NCT00389753|After Treatment|after treatment
5313025|NCT00389714|pedodontics|pedodontics
5313026|NCT00389714|carious|carious
5313027|NCT00389714|dental restoration|dental restoration
5313028|NCT00389714|antibacterial|antibacterial
5313029|NCT00389714|nanoparticles|nanoparticles
5313030|NCT00389701|stage I multiple myeloma|stage i multiple myeloma
5313031|NCT00389701|stage II multiple myeloma|stage ii multiple myeloma
5313032|NCT00389701|stage III multiple myeloma|stage iii multiple myeloma
5313033|NCT00389701|refractory multiple myeloma|refractory multiple myeloma
5313034|NCT00389688|stage I non-small cell lung cancer|stage i non-small cell lung cancer
5313035|NCT00389688|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
5313036|NCT00389649|congestive heart failure|congestive heart failure
5313037|NCT00389649|pacemaker|pacemaker
5313038|NCT00389649|heart rate|heart rate
5313039|NCT00389636|Diabetes|diabetes
5313040|NCT00389636|Foot|foot
5313041|NCT00389636|Extremity|extremity
5313042|NCT00389636|Ulcer|ulcer
5313043|NCT00389636|Wound|wound
5313044|NCT00389636|Gauze|gauze
5313045|NCT00389610|stage I pancreatic cancer|stage i pancreatic cancer
5313046|NCT00389610|stage II pancreatic cancer|stage ii pancreatic cancer
5313047|NCT00389610|stage III pancreatic cancer|stage iii pancreatic cancer
5313048|NCT00389610|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
5313049|NCT00389597|degenerative disc disease|degenerative disc disease
5313050|NCT00389597|cervical arthroplasty|cervical arthroplasty
5313051|NCT00389597|Mobi C|mobi c
5313052|NCT00389597|multilevel|multilevel
5313053|NCT00389597|anterior cervical discectomy and fusion|anterior cervical discectomy and fusion
5313054|NCT00389584|cognitive/functional effects|cognitive/functional effects
5313055|NCT00389584|poor performance status|poor performance status
5313056|NCT00389584|long-term effects secondary to cancer therapy in adults|long-term effects secondary to cancer therapy in adults
5313057|NCT00389584|long-term effects secondary to cancer therapy in children|long-term effects secondary to cancer therapy in children
5313058|NCT00389584|adult tumors metastatic to brain|adult tumors metastatic to brain
5313059|NCT00389584|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5313060|NCT00389584|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
5313061|NCT00389558|Skin colonization|skin colonization
5313062|NCT00389558|Antiseptic|antiseptic
5313063|NCT00389558|Epicutaneocavous catheter dressing|epicutaneocavous catheter dressing
5313064|NCT00389558|Infant|infant
5313065|NCT00389532|Influenza|influenza
5313066|NCT00389532|Influenza Vaccine|influenza vaccine
5313067|NCT00389519|Hypertension/*etiology|hypertension/*etiology
5313068|NCT00389519|Blood Pressure|blood pressure
5313069|NCT00389519|Pediatric|pediatric
5313070|NCT00389519|Adolescent|adolescent
5313071|NCT00389519|Child|child
5313072|NCT00389506|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
5313073|NCT00389506|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5313074|NCT00389506|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5313075|NCT00389506|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5313076|NCT00389493|OCD|ocd
5313077|NCT00389493|Augmentation|augmentation
5313078|NCT00389493|Antipsychotics|antipsychotics
5313079|NCT00389493|Cognitive-Behavioral Therapy|cognitive-behavioral therapy
5313080|NCT00389480|Solid Tumors|solid tumors
5313081|NCT00389480|Solid Malignancies|solid malignancies
5313082|NCT00389480|Phase I|phase i
5313083|NCT00389467|stroke|stroke
5313084|NCT00389467|ischemic stroke|ischemic stroke
5313085|NCT00389467|blood clot|blood clot
5313086|NCT00389467|Merci Retriever|merci retriever
5313087|NCT00389467|Penumbra System|penumbra system
5313088|NCT00389467|embolectomy|embolectomy
5313089|NCT00389467|magnetic resonance imaging|magnetic resonance imaging
5313090|NCT00389467|MRI|mri
5313091|NCT00389467|CT|ct
5313092|NCT00389467|SPOTRIAS|spotrias
5313093|NCT00389454|Acetaminophen|acetaminophen
5313094|NCT00389454|Fever|fever
5313095|NCT00389454|cerebro spinal fluid|cerebro spinal fluid
5313096|NCT00389454|Infants|infants
5313097|NCT00389441|VEGFR inhibitor|vegfr inhibitor
5313098|NCT00389441|tyrosine kinase inhibitor|tyrosine kinase inhibitor
5313099|NCT00389441|anti-angiogenic|anti-angiogenic
5313100|NCT00389441|carcinoma|carcinoma
5313101|NCT00389441|papillary|papillary
5313102|NCT00389441|follicular|follicular
5313103|NCT00389441|medullary|medullary
5313104|NCT00389441|anaplastic|anaplastic
5313105|NCT00389428|Hematologic malignancies|hematologic malignancies
5313106|NCT00389428|Malignancies, hematologic|malignancies, hematologic
5313107|NCT00389428|Hematopoietic malignancies|hematopoietic malignancies
5313108|NCT00389415|Type 2 Diabetes|type 2 diabetes
5313109|NCT00389415|Vildagliptin|vildagliptin
5313110|NCT00389415|HbA1c|hba1c
5313111|NCT00389402|lipids|lipids
5313112|NCT00389402|lipodystrophy|lipodystrophy
5313113|NCT00389402|fat distribution|fat distribution
5313114|NCT00389402|hiv-1|hiv-1
5313115|NCT00389402|antiretroviral therapy|antiretroviral therapy
5313116|NCT00389402|Treatment Naive|treatment naive
5313117|NCT00389389|Advanced Solid Malignancies|advanced solid malignancies
5313118|NCT00389389|Advanced solid tumors|advanced solid tumors
5313119|NCT00389389|Cancer|cancer
5313120|NCT00389389|Phase I|phase i
5313121|NCT00389389|Solid tumors|solid tumors
5313122|NCT00389389|Solid malignancies|solid malignancies
5313123|NCT00389337|Sepsis|sepsis
5313124|NCT00389337|SIRS|sirs
5313125|NCT00389337|Biomarkers|biomarkers
5313126|NCT00389337|xMAP|xmap
5313127|NCT00389324|Primary immune deficiency|primary immune deficiency
5313128|NCT00389311|Microbicide|microbicide
5313129|NCT00389311|Safety|safety
5313130|NCT00389311|HIV prevention|hiv prevention
5313131|NCT00389311|HIV Seronegativity|hiv seronegativity
5313132|NCT00389298|Chronic hepatitis C|chronic hepatitis c
5313133|NCT00389298|Viral kinetics|viral kinetics
5313134|NCT00389298|Phase II|phase ii
5313135|NCT00389298|Pharmacokinetics (PK)|pharmacokinetics (pk)
5313136|NCT00389298|Safety and tolerability|safety and tolerability
5313137|NCT00389285|Carcinoma, renal cell|carcinoma, renal cell
5313138|NCT00389285|interleukin-21|interleukin-21
5313139|NCT00389285|sorafenib|sorafenib
5313140|NCT00389285|Immunotherapy|immunotherapy
5313141|NCT00389259|Insecticides|insecticides
5313142|NCT00389259|Organophosphate|organophosphate
5313143|NCT00389259|Scopolamine|scopolamine
5313144|NCT00389259|randomized control study|randomized control study
5313145|NCT00389259|Organophosphate or carbamate intoxication|organophosphate or carbamate intoxication
5313146|NCT00389246|obesity|obesity
5313147|NCT00389246|genetic consultation|genetic consultation
5313148|NCT00389246|randomized controlled trial|randomized controlled trial
5313149|NCT00389220|Coronary Disease|coronary disease
5313150|NCT00389220|Coronary Stenosis|coronary stenosis
5313151|NCT00389220|Angioplasty|angioplasty
5313152|NCT00389220|Coronary Restenosis|coronary restenosis
5313153|NCT00389220|Drug Eluting Stent|drug eluting stent
5313154|NCT00389194|HIV-1 infection|hiv-1 infection
5313155|NCT00389194|fat distribution|fat distribution
5313156|NCT00389194|lipodystrophy|lipodystrophy
5313157|NCT00389194|lipids|lipids
5313158|NCT00389194|kidney function|kidney function
5313159|NCT00389194|Treatment Experienced|treatment experienced
5313160|NCT00389181|Unruptured brain arteriovenous malformation|unruptured brain arteriovenous malformation
5313161|NCT00389181|AVM|avm
5313162|NCT00389181|BAVM|bavm
5313163|NCT00389181|Stroke|stroke
5313164|NCT00389181|Intracranial Hemorrhage|intracranial hemorrhage
5313165|NCT00389168|Hypertension|hypertension
5313166|NCT00389168|Cardiac hypertrophy|cardiac hypertrophy
5313167|NCT00389168|Angiotensin|angiotensin
5313168|NCT00389168|Human|human
5313263|NCT00388804|Hormone Therapy|hormone therapy
5313169|NCT00389155|Advanced or metastatic transitional cell carcinoma of the urothelium|advanced or metastatic transitional cell carcinoma of the urothelium
5313170|NCT00389142|pelvic pain|pelvic pain
5313171|NCT00389142|urinary frequency|urinary frequency
5313172|NCT00389142|painful bladder|painful bladder
5313173|NCT00389142|urinary urgency|urinary urgency
5313174|NCT00389129|Platelets|platelets
5313175|NCT00389129|Aspirin Resistance|aspirin resistance
5313176|NCT00389129|Platelet aggregation|platelet aggregation
5313177|NCT00389090|temozolomide resistant|temozolomide resistant
5313178|NCT00389090|anaplastic glioma|anaplastic glioma
5313179|NCT00389090|anaplastic astrocytoma|anaplastic astrocytoma
5313180|NCT00389090|anaplastic oligodendroglioma|anaplastic oligodendroglioma
5313181|NCT00389090|anaplastic oligoastrocytoma|anaplastic oligoastrocytoma
5313182|NCT00389077|perifosine|perifosine
5313183|NCT00389077|solid tumors|solid tumors
5313184|NCT00389077|lymphomas|lymphomas
5313185|NCT00389077|anticancer agent|anticancer agent
5313186|NCT00389064|Generalised Anxiety Disorder|generalised anxiety disorder
5313187|NCT00389064|GAD|gad
5313188|NCT00389051|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
5313189|NCT00389051|Malignant lymphoma|malignant lymphoma
5313190|NCT00389038|headache|headache
5313191|NCT00389038|coping skills training|coping skills training
5313192|NCT00389038|amitriptyline|amitriptyline
5313193|NCT00389038|attention control|attention control
5313194|NCT00389025|Subject with clinical history of seasonal allergic conjunctivitis|subject with clinical history of seasonal allergic conjunctivitis
5313195|NCT00389012|rehabilitation|rehabilitation
5313196|NCT00389012|hemiplegic gait|hemiplegic gait
5313197|NCT00389012|exercise therapy|exercise therapy
5313198|NCT00389012|physical therapy|physical therapy
5313199|NCT00388999|Multiple Myeloma|multiple myeloma
5313200|NCT00388999|Stem Cell Transplant|stem cell transplant
5313201|NCT00388999|rhMBL|rhmbl
5313202|NCT00388973|Major Depressive Disorder|major depressive disorder
5313203|NCT00388973|MDD|mdd
5313204|NCT00388960|small cell lung cancer|small cell lung cancer
5313205|NCT00388960|amrubicin|amrubicin
5313206|NCT00388947|vaginal prolapse|vaginal prolapse
5313207|NCT00388947|cystocele|cystocele
5313208|NCT00388947|rectocele|rectocele
5313209|NCT00388947|enterocele|enterocele
5313210|NCT00388947|apical prolapse|apical prolapse
5313211|NCT00388947|vaginal vault prolapse|vaginal vault prolapse
5313212|NCT00388934|Percutaneous coronary intervention|percutaneous coronary intervention
5313213|NCT00388934|Angina pectoris|angina pectoris
5313214|NCT00388934|Stent|stent
5313215|NCT00388921|Vitamin A|vitamin a
5313216|NCT00388921|Children|children
5313217|NCT00388921|Severe malnutrition|severe malnutrition
5313218|NCT00388921|Retinol|retinol
5313219|NCT00388921|Retinol binding protein|retinol binding protein
5313220|NCT00388921|Diarrhoea|diarrhoea
5313221|NCT00388921|ALRI|alri
5313222|NCT00388921|Age 6-59 months|age 6-59 months
5313223|NCT00388921|Either sex|either sex
5313224|NCT00388921|Severe malnutrition as defined by the presence of any of the followings:|severe malnutrition as defined by the presence of any of the followings:
5313225|NCT00388921|Bipedal oedema|bipedal oedema
5313226|NCT00388921|Weight (measured after correction of dehydration) for height Z score <-3 of the National Center for Health Statistics (NCHS) reference|weight (measured after correction of dehydration) for height z score <-3 of the national center for health statistics (nchs) reference
5313227|NCT00388921|Written informed consent of respective parents/ guardians for participation of the children in the study.|written informed consent of respective parents/ guardians for participation of the children in the study.
5313228|NCT00388921|Children having diarrhoea (watery or invasive) or cough and cold or both for the last 48 hours.|children having diarrhoea (watery or invasive) or cough and cold or both for the last 48 hours.
5313230|NCT00388908|osteoporosis|osteoporosis
5313231|NCT00388908|prevention|prevention
5313232|NCT00388908|case-finding|case-finding
5313233|NCT00388908|quality improvement|quality improvement
5313234|NCT00388895|Acute lymphoblastic Leukemia|acute lymphoblastic leukemia
5313235|NCT00388869|renal artery|renal artery
5313236|NCT00388869|calcium|calcium
5313237|NCT00388869|CT|ct
5313238|NCT00388869|hypertension|hypertension
5313239|NCT00388856|antioxidant supplementation|antioxidant supplementation
5313240|NCT00388856|preeclampsia|preeclampsia
5313241|NCT00388856|prevention|prevention
5313242|NCT00388843|carotid atherosclerosis|carotid atherosclerosis
5313243|NCT00388843|magnetic resonance imaging|magnetic resonance imaging
5313244|NCT00388843|atherosclerosis|atherosclerosis
5313245|NCT00388843|ultrasound|ultrasound
5313246|NCT00388843|inflammation|inflammation
5313247|NCT00388843|statins|statins
5313248|NCT00388843|vulnerable plaque|vulnerable plaque
5313249|NCT00388843|stroke|stroke
5313250|NCT00388830|Gallbladder|gallbladder
5313251|NCT00388830|Ultrasound|ultrasound
5313252|NCT00388830|Emergency Medicine|emergency medicine
5313253|NCT00388817|Hypertension|hypertension
5313254|NCT00388817|Blood pressure|blood pressure
5313255|NCT00388817|Adherence|adherence
5313256|NCT00388817|Compliance|compliance
5313257|NCT00388817|Pharmacist|pharmacist
5313258|NCT00388817|Pharmacy|pharmacy
5313259|NCT00388817|Costs|costs
5313260|NCT00388804|Prostate Cancer|prostate cancer
5313261|NCT00388804|External Beam Radiotherapy|external beam radiotherapy
5313262|NCT00388804|Radiation Therapy|radiation therapy
5313264|NCT00388804|Bicalutamide|bicalutamide
5313265|NCT00388804|Casodex|casodex
5313266|NCT00388804|Leuprolide|leuprolide
5313267|NCT00388804|Lupron|lupron
5313268|NCT00388804|Goserelin|goserelin
5313269|NCT00388804|Zoladex|zoladex
5313270|NCT00388804|Flutamide|flutamide
5313271|NCT00388804|EBRT|ebrt
5313272|NCT00388791|symptomatology|symptomatology
5313273|NCT00388791|Schein questionnaire|schein questionnaire
5313274|NCT00388791|fluoresceien staining|fluoresceien staining
5313275|NCT00388765|bronchoscopy|bronchoscopy
5313276|NCT00388765|sample bank|sample bank
5313277|NCT00388765|research study volunteer|research study volunteer
5313278|NCT00388752|Acupuncture|acupuncture
5313279|NCT00388752|Phantom limb pain|phantom limb pain
5313280|NCT00388752|Residual limb pain|residual limb pain
5313281|NCT00388752|amputation|amputation
5313282|NCT00388752|amputee|amputee
5313283|NCT00388752|traumatic|traumatic
5313284|NCT00388752|surgical|surgical
5313285|NCT00388752|Traumatic amputation upper extremity|traumatic amputation upper extremity
5313286|NCT00388752|Traumatic amputation lower extremity|traumatic amputation lower extremity
5313287|NCT00388752|Surgical amputation upper extremity|surgical amputation upper extremity
5313288|NCT00388752|Surgical amputation lower extremity|surgical amputation lower extremity
5313289|NCT00388739|Pediatric Asthma|pediatric asthma
5313290|NCT00388739|Pulmicort|pulmicort
5313291|NCT00388739|TEDAS ED|tedas ed
5313292|NCT00388739|Acute exacerbation of asthma|acute exacerbation of asthma
5313293|NCT00388739|Chronic asthma|chronic asthma
5313294|NCT00388726|Locally recurrent breast cancer|locally recurrent breast cancer
5313295|NCT00388726|metastatic breast cancer|metastatic breast cancer
5313296|NCT00388713|Radiation therapy|radiation therapy
5313297|NCT00388713|Radiation-Induced Atherosclerosis|radiation-induced atherosclerosis
5313298|NCT00388713|Carotid Artery Diseases|carotid artery diseases
5313299|NCT00388713|Breast Cancer|breast cancer
5313300|NCT00388713|Intima Media thickening Ultrasound|intima media thickening ultrasound
5313301|NCT00388700|Colorectal cancer, DAVANAT, colon cancer, 5-FU|colorectal cancer, davanat, colon cancer, 5-fu
5313302|NCT00388687|Hypoxia|hypoxia
5313303|NCT00388687|FAZA|faza
5313304|NCT00388687|PET|pet
5313305|NCT00388687|Radiochemotherapy|radiochemotherapy
5313306|NCT00388674|Chronic Hepatitis B Virus|chronic hepatitis b virus
5313307|NCT00388661|sleep problems|sleep problems
5313308|NCT00388661|quality of life|quality of life
5313309|NCT00388661|melatonin|melatonin
5313310|NCT00388661|sleep apnea|sleep apnea
5313311|NCT00388661|medication|medication
5313312|NCT00388661|preload|preload
5313313|NCT00388661|nutritional status|nutritional status
5313314|NCT00388661|ProBNP|probnp
5313315|NCT00388648|Dialysis|dialysis
5313316|NCT00388648|Vegan Diet|vegan diet
5313317|NCT00388648|Mortality|mortality
5313318|NCT00388648|Morbidity|morbidity
5313319|NCT00388648|Treatment outcome|treatment outcome
5313320|NCT00388635|Multiple Myeloma|multiple myeloma
5313321|NCT00388635|Patients over 65 years old|patients over 65 years old
5313322|NCT00388622|Heart failure|heart failure
5313323|NCT00388622|Adherence|adherence
5313324|NCT00388622|Compliance|compliance
5313325|NCT00388622|Pharmacy|pharmacy
5313326|NCT00388622|Pharmacist|pharmacist
5313327|NCT00388622|Health-related quality of life|health-related quality of life
5313328|NCT00388622|Clinical exacerbation|clinical exacerbation
5313329|NCT00388622|Costs|costs
5313330|NCT00388596|SB-751689|sb-751689
5313331|NCT00388596|osteoporosis|osteoporosis
5313332|NCT00388596|drug interaction|drug interaction
5313333|NCT00388596|ketoconazole|ketoconazole
5313334|NCT00388596|atorvastatin|atorvastatin
5313335|NCT00388596|rosuvastatin|rosuvastatin
5313336|NCT00388583|Influenza|influenza
5313337|NCT00388583|Orthomyxoviruses|orthomyxoviruses
5313338|NCT00388583|Inactivated Split-virion influenza vaccine|inactivated split-virion influenza vaccine
5313339|NCT00388583|Elderly.|elderly.
5313340|NCT00388570|Asthma|asthma
5313341|NCT00388570|adult|adult
5313342|NCT00388570|paediatric|paediatric
5313343|NCT00388570|NIOX MINO®|niox mino®
5313344|NCT00388570|NIOX®|niox®
5313345|NCT00388570|nitric oxide|nitric oxide
5313346|NCT00388570|airway inflammation|airway inflammation
5313347|NCT00388570|open−label|open−label
5313348|NCT00388570|single−cohort|single−cohort
5313349|NCT00388531|Acute Lymphoblastic Leucemia|acute lymphoblastic leucemia
5313350|NCT00388531|Aggressive Non-Hodgkin-Lymphoma|aggressive non-hodgkin-lymphoma
5313351|NCT00388531|CNS relapse|cns relapse
5313352|NCT00388531|Cytarabine liposome|cytarabine liposome
5313353|NCT00388505|tobramycin|tobramycin
5313354|NCT00388492|HIV Infected|hiv infected
5313355|NCT00388466|whole body vibration|whole body vibration
5313356|NCT00388466|muscle function|muscle function
5313357|NCT00388466|cystic fibrosis|cystic fibrosis
5313358|NCT00388466|mechanography|mechanography
5313359|NCT00388466|chair-rising-test|chair-rising-test
5313360|NCT00388453|Healthy volunteers|healthy volunteers
5313361|NCT00388440|Mumps|mumps
5313362|NCT00388440|Singapore|singapore
5313363|NCT00388440|Rubella|rubella
5313364|NCT00388440|Measles|measles
5313365|NCT00388427|advanced cancer|advanced cancer
5313366|NCT00388427|solid tumor|solid tumor
5313367|NCT00388427|solid malignancies|solid malignancies
5313368|NCT00388427|phase I|phase i
5313369|NCT00388401|Postoperative Ileus|postoperative ileus
5313370|NCT00388388|Remodeling|remodeling
5313371|NCT00388388|Resistance arteries|resistance arteries
5313372|NCT00388388|angiotensin receptor blocker|angiotensin receptor blocker
5313373|NCT00388388|thiazide diuretic|thiazide diuretic
5313374|NCT00388362|GVHD|gvhd
5313375|NCT00388336|Anemia|anemia
5313376|NCT00388336|Neoplasms, Hemoglobin values|neoplasms, hemoglobin values
5313377|NCT00388336|PROCRIT|procrit
5313378|NCT00388336|Epoetin alfa|epoetin alfa
5313379|NCT00388323|Alcohol|alcohol
5313380|NCT00388323|Hepatitis|hepatitis
5313381|NCT00388323|Cirrhosis|cirrhosis
5313382|NCT00388323|Inflammation|inflammation
5313383|NCT00388323|Cytokines|cytokines
5313384|NCT00388323|ADIPOKINES|adipokines
5313385|NCT00388323|Adipose tissue|adipose tissue
5313386|NCT00388310|cellulitis|cellulitis
5313387|NCT00388310|furuncles|furuncles
5313388|NCT00388310|carbuncles|carbuncles
5313389|NCT00388310|abscess|abscess
5313390|NCT00388297|Subclinical Hypothyroidism|subclinical hypothyroidism
5313391|NCT00388297|Hypothyroxinemia|hypothyroxinemia
5313392|NCT00388297|Thyroid|thyroid
5313393|NCT00388297|Pregnancy|pregnancy
5313394|NCT00388297|Intellectual Development|intellectual development
5313395|NCT00388284|hemostasis|hemostasis
5313396|NCT00388284|arterial sealing|arterial sealing
5313397|NCT00388271|Alpha-blocker|alpha-blocker
5313398|NCT00388271|Alfuzosin|alfuzosin
5313399|NCT00388271|Xatral|xatral
5313400|NCT00388271|ESWL|eswl
5313401|NCT00388258|Postoperative ileus|postoperative ileus
5313402|NCT00388245|PCI|pci
5313403|NCT00388245|CABG|cabg
5313404|NCT00388245|Ejection Fraction|ejection fraction
5313405|NCT00388245|Myocardial Revascularization|myocardial revascularization
5313406|NCT00388232|COPD|copd
5313407|NCT00388232|prevalence|prevalence
5313408|NCT00388232|smoke|smoke
5313409|NCT00388232|biomass|biomass
5313410|NCT00388232|occupational|occupational
5313411|NCT00388232|Malatya|malatya
5313412|NCT00388232|Turkey|turkey
5313413|NCT00388219|Buprenorphine|buprenorphine
5313414|NCT00388219|Transdermal patch|transdermal patch
5313415|NCT00388219|Centrally acting analgesic|centrally acting analgesic
5313416|NCT00388219|Plasma level|plasma level
5313417|NCT00388219|Healthy volunteers|healthy volunteers
5313418|NCT00388206|NSCLC|nsclc
5313419|NCT00388206|Avastin|avastin
5313420|NCT00388206|anti-VEGF|anti-vegf
5313421|NCT00388206|lung cancer|lung cancer
5313422|NCT00388206|colorectal cancer|colorectal cancer
5313423|NCT00388206|ARIES|aries
5313424|NCT00388206|Colon Cancer|colon cancer
5313425|NCT00388193|ALL (L3)|all (l3)
5313426|NCT00388193|BURKITT's LYMPHOMA|burkitt's lymphoma
5313427|NCT00388193|RITUXIMAB|rituximab
5313428|NCT00388180|cholesterol|cholesterol
5313429|NCT00388180|inflammation|inflammation
5313430|NCT00388180|fat|fat
5313431|NCT00388167|Invader fungal infection (IFI)|invader fungal infection (ifi)
5313432|NCT00388167|Invasive Aspergillosis (AI)|invasive aspergillosis (ai)
5313433|NCT00388167|Invasive Candidiasis (CI)|invasive candidiasis (ci)
5313434|NCT00388167|Caspofungin acetate|caspofungin acetate
5313435|NCT00388154|Endometrial Cancer|endometrial cancer
5313436|NCT00388154|Gemcitabine|gemcitabine
5313437|NCT00388154|Gemzar|gemzar
5313438|NCT00388154|Gemcitabine Hydrochloride|gemcitabine hydrochloride
5313439|NCT00388154|Cisplatin|cisplatin
5313440|NCT00388154|Platinol-AQ|platinol-aq
5313441|NCT00388154|Platinol|platinol
5313442|NCT00388154|CDDP|cddp
5313443|NCT00388141|Preterm Infant;|preterm infant;
5313444|NCT00388141|NIDCAP;|nidcap;
5313445|NCT00388141|Neonatal Care,|neonatal care,
5313446|NCT00388141|Intervention Study;|intervention study;
5313447|NCT00388141|Growth and Development;|growth and development;
5313448|NCT00388141|Maternal Self-esteem.|maternal self-esteem.
5313449|NCT00388141|Maternal Social support|maternal social support
5313450|NCT00388141|NICU|nicu
5313451|NCT00388128|Intermittent Claudication|intermittent claudication
5313452|NCT00388128|PAD|pad
5313453|NCT00388128|Caffeine|caffeine
5313454|NCT00388128|Walking capacity|walking capacity
5313455|NCT00388128|ABI|abi
5313456|NCT00388128|QoL|qol
5313457|NCT00388128|Growth factor|growth factor
5313458|NCT00388115|ductal breast carcinoma in situ|ductal breast carcinoma in situ
5313459|NCT00388115|stage I breast cancer|stage i breast cancer
5313460|NCT00388115|stage II breast cancer|stage ii breast cancer
5313461|NCT00388115|breast cancer in situ|breast cancer in situ
5313462|NCT00388089|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5313463|NCT00388089|extensive stage small cell lung cancer|extensive stage small cell lung cancer
5313464|NCT00388089|recurrent small cell lung cancer|recurrent small cell lung cancer
5313465|NCT00388076|carboplatin|carboplatin
5313466|NCT00388076|lapatinib|lapatinib
5313467|NCT00388076|TAXOL|taxol
5313468|NCT00388076|PARAPLATIN|paraplatin
5313469|NCT00388076|paclitaxel|paclitaxel
5313470|NCT00388076|TYKERB|tykerb
5313471|NCT00388076|Pazopanib|pazopanib
5313472|NCT00388063|Neuroendocrine|neuroendocrine
5313473|NCT00388063|Carcinoma|carcinoma
5313474|NCT00388063|Atiprimod|atiprimod
5313475|NCT00388063|Carcinoid|carcinoid
5313476|NCT00388050|Decision aid, diabetes, primary care|decision aid, diabetes, primary care
5313477|NCT00388024|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
5313478|NCT00388024|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
5313479|NCT00388024|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
5313480|NCT00388024|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
5313481|NCT00388024|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
5313482|NCT00388024|stage III lymphoepithelioma of the nasopharynx|stage iii lymphoepithelioma of the nasopharynx
5313483|NCT00388024|stage III lymphoepithelioma of the oropharynx|stage iii lymphoepithelioma of the oropharynx
5313484|NCT00388024|squamous cell carcinoma of unknown primary|squamous cell carcinoma of unknown primary
5313485|NCT00388024|newly diagnosed carcinoma of unknown primary|newly diagnosed carcinoma of unknown primary
5313486|NCT00388024|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
5313487|NCT00388024|untreated metastatic squamous neck cancer with occult primary|untreated metastatic squamous neck cancer with occult primary
5313488|NCT00388024|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5313489|NCT00388024|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5313490|NCT00388024|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5313491|NCT00388024|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
5313492|NCT00388024|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5313493|NCT00388024|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
5313494|NCT00388024|stage IV lymphoepithelioma of the oropharynx|stage iv lymphoepithelioma of the oropharynx
5313495|NCT00388011|Post surgical pain|post surgical pain
5313496|NCT00388011|Bunionectomy|bunionectomy
5313497|NCT00388011|Hammer Toe Syndrome|hammer toe syndrome
5313498|NCT00388011|Morphine|morphine
5313499|NCT00387998|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5313500|NCT00387972|Type 2 diabetes mellitus (T2DM)|type 2 diabetes mellitus (t2dm)
5313501|NCT00387972|glycosylated hemoglobin (HbA1c)|glycosylated hemoglobin (hba1c)
5313502|NCT00387972|denagliptin|denagliptin
5313503|NCT00387972|diabetes treatment|diabetes treatment
5313504|NCT00387972|glycemic control|glycemic control
5313505|NCT00387959|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5313506|NCT00387959|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5313507|NCT00387959|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5313508|NCT00387959|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5313509|NCT00387959|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5313510|NCT00387959|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5313511|NCT00387959|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
5313512|NCT00387959|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5313513|NCT00387959|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5313514|NCT00387959|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5313515|NCT00387959|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5313516|NCT00387959|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5313517|NCT00387959|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5313518|NCT00387959|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5313519|NCT00387959|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5313520|NCT00387959|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5313521|NCT00387959|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5313522|NCT00387959|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5313523|NCT00387959|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5313524|NCT00387959|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5313525|NCT00387959|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5313526|NCT00387959|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5313527|NCT00387959|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5313528|NCT00387959|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5313529|NCT00387959|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5313530|NCT00387959|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5313531|NCT00387959|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5313532|NCT00387959|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
5313533|NCT00387959|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5313534|NCT00387959|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5313535|NCT00387959|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
5313536|NCT00387959|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5313719|NCT00387348|stage IV esophageal cancer|stage iv esophageal cancer
5313537|NCT00387959|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5313538|NCT00387959|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5313539|NCT00387959|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5313540|NCT00387946|smoking|smoking
5313541|NCT00387946|cessation|cessation
5313542|NCT00387946|tobacco|tobacco
5313543|NCT00387933|recurrent adult brain tumor|recurrent adult brain tumor
5313544|NCT00387933|adult glioblastoma|adult glioblastoma
5313545|NCT00387933|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5313546|NCT00387933|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
5313547|NCT00387933|adult gliosarcoma|adult gliosarcoma
5313548|NCT00387933|adult giant cell glioblastoma|adult giant cell glioblastoma
5313549|NCT00387933|adult anaplastic ependymoma|adult anaplastic ependymoma
5313550|NCT00387933|adult brain stem glioma|adult brain stem glioma
5313551|NCT00387933|adult mixed glioma|adult mixed glioma
5313552|NCT00387933|adult pineal gland astrocytoma|adult pineal gland astrocytoma
5313553|NCT00387907|Herceptin|herceptin
5313554|NCT00387907|Taxane|taxane
5313555|NCT00387907|Breast Cancer|breast cancer
5313556|NCT00387894|adult glioblastoma|adult glioblastoma
5313557|NCT00387894|adult gliosarcoma|adult gliosarcoma
5313558|NCT00387894|recurrent adult brain tumor|recurrent adult brain tumor
5313559|NCT00387881|sumatriptan succinate,|sumatriptan succinate,
5313560|NCT00387881|naproxen sodium,|naproxen sodium,
5313561|NCT00387881|parallel group,|parallel group,
5313562|NCT00387881|double-blind,|double-blind,
5313563|NCT00387881|placebo-controlled,|placebo-controlled,
5313564|NCT00387881|Combination product,|combination product,
5313565|NCT00387881|migrainous headache|migrainous headache
5313566|NCT00387881|Probable migraine, a sub-type of Migraine|probable migraine, a sub-type of migraine
5313567|NCT00387881|probable migraine,|probable migraine,
5313568|NCT00387868|Thymoma|thymoma
5313569|NCT00387868|Thymic carcinoma|thymic carcinoma
5313570|NCT00387868|Preoperative chemotherapy and radiation|preoperative chemotherapy and radiation
5313571|NCT00387868|Response rate|response rate
5313572|NCT00387855|suicide|suicide
5313573|NCT00387855|depression|depression
5313574|NCT00387777|Buprenorphine|buprenorphine
5313575|NCT00387777|Transdermal patch|transdermal patch
5313576|NCT00387777|multidose|multidose
5313577|NCT00387777|Centrally acting analgesic|centrally acting analgesic
5313578|NCT00387777|Plasma level|plasma level
5313579|NCT00387777|Healthy volunteers|healthy volunteers
5313580|NCT00387764|renal cell carcinoma|renal cell carcinoma
5313581|NCT00387764|pazopanib|pazopanib
5313582|NCT00387764|anti-angiogenic therapy|anti-angiogenic therapy
5313583|NCT00387764|open label|open label
5313584|NCT00387738|Ragweed|ragweed
5313585|NCT00387738|Allergy|allergy
5313586|NCT00387738|Allergic|allergic
5313587|NCT00387738|Rhinitis|rhinitis
5313588|NCT00387738|Hay Fever|hay fever
5313589|NCT00387738|Seasonal|seasonal
5313590|NCT00387738|Treatment|treatment
5313591|NCT00387738|Immunotherapy|immunotherapy
5313592|NCT00387738|Vaccine|vaccine
5313593|NCT00387725|Adolescent|adolescent
5313594|NCT00387725|Meningococcal|meningococcal
5313595|NCT00387725|Safety|safety
5313596|NCT00387712|exercise|exercise
5313597|NCT00387712|inflammation|inflammation
5313598|NCT00387712|motor performance|motor performance
5313599|NCT00387712|skeletal muscle|skeletal muscle
5313600|NCT00387712|chronic stroke survivors|chronic stroke survivors
5313601|NCT00387712|treadmill exercise|treadmill exercise
5313602|NCT00387699|limited stage small cell lung cancer|limited stage small cell lung cancer
5313603|NCT00387673|electrical stimulation|electrical stimulation
5313604|NCT00387673|hand|hand
5313605|NCT00387673|Rehabilitation|rehabilitation
5313606|NCT00387673|spinal cord injury|spinal cord injury
5313607|NCT00387660|extensive stage small cell lung cancer|extensive stage small cell lung cancer
5313608|NCT00387660|limited stage small cell lung cancer|limited stage small cell lung cancer
5313609|NCT00387660|recurrent small cell lung cancer|recurrent small cell lung cancer
5313610|NCT00387647|myeloid|myeloid
5313611|NCT00387647|acute|acute
5313612|NCT00387647|monocytic|monocytic
5313613|NCT00387634|tick born encephalitis, TBE, adults|tick born encephalitis, tbe, adults
5313614|NCT00387621|heart failure|heart failure
5313615|NCT00387621|diastolic dysfunction|diastolic dysfunction
5313616|NCT00387621|systolic dysfunction|systolic dysfunction
5313617|NCT00387621|preclinical|preclinical
5313618|NCT00387621|natriuretic peptide|natriuretic peptide
5313619|NCT00387621|B-type natriuretic peptide|b-type natriuretic peptide
5313620|NCT00387621|cyclic guanosine monophosphate|cyclic guanosine monophosphate
5313621|NCT00387608|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5313622|NCT00387608|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5313623|NCT00387608|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5313624|NCT00387608|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5313625|NCT00387608|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5313626|NCT00387608|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5313627|NCT00387608|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5313818|NCT00387023|Eye|eye
5313628|NCT00387608|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5313629|NCT00387608|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5313630|NCT00387608|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5313631|NCT00387608|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5313632|NCT00387608|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5313633|NCT00387608|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5313634|NCT00387595|Family History|family history
5313635|NCT00387595|CAD|cad
5313636|NCT00387595|CAC|cac
5313637|NCT00387595|cIMT|cimt
5313638|NCT00387595|CV Risk Factors|cv risk factors
5313639|NCT00387582|Diabetes|diabetes
5313640|NCT00387582|Macular Edema|macular edema
5313641|NCT00387582|Diabetic Retinopathy|diabetic retinopathy
5313642|NCT00387582|Lucentis|lucentis
5313643|NCT00387582|Ranibizumab|ranibizumab
5313644|NCT00387569|Toddlers|toddlers
5313645|NCT00387569|Vaccine|vaccine
5313646|NCT00387569|Safety|safety
5313647|NCT00387556|ketamine|ketamine
5313648|NCT00387556|children|children
5313649|NCT00387556|emesis|emesis
5313650|NCT00387530|recurrent lymphoepithelioma of the nasopharynx|recurrent lymphoepithelioma of the nasopharynx
5313651|NCT00387530|post-transplant lymphoproliferative disorder|post-transplant lymphoproliferative disorder
5313652|NCT00387530|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
5313653|NCT00387530|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5313654|NCT00387530|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
5313655|NCT00387530|AIDS-related primary CNS lymphoma|aids-related primary cns lymphoma
5313656|NCT00387530|recurrent gastric cancer|recurrent gastric cancer
5313657|NCT00387517|Diastolic|diastolic
5313658|NCT00387517|systolic|systolic
5313659|NCT00387517|hypertension|hypertension
5313660|NCT00387517|aliskiren|aliskiren
5313661|NCT00387517|blood pressure|blood pressure
5313662|NCT00387517|hydrochlorothiazide|hydrochlorothiazide
5313663|NCT00387517|HCTZ|hctz
5313664|NCT00387504|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5313665|NCT00387478|Allergy|allergy
5313666|NCT00387478|Specific Immunotherapy|specific immunotherapy
5313667|NCT00387478|Tree|tree
5313668|NCT00387478|Environmental Exposure Chamber|environmental exposure chamber
5313669|NCT00387452|Aging|aging
5313670|NCT00387452|Type 2 diabetes|type 2 diabetes
5313671|NCT00387452|exercise|exercise
5313672|NCT00387452|aerobic training|aerobic training
5313673|NCT00387452|strength training|strength training
5313674|NCT00387452|glucose metabolism arterial baroreceptors|glucose metabolism arterial baroreceptors
5313675|NCT00387452|heart rate variability|heart rate variability
5313676|NCT00387452|cerebral autoregulation|cerebral autoregulation
5313677|NCT00387452|tilt table study|tilt table study
5313678|NCT00387452|transcranial Doppler|transcranial doppler
5313679|NCT00387452|autonomic nervous system|autonomic nervous system
5313680|NCT00387439|Anal incontinence|anal incontinence
5313681|NCT00387439|Gastroenterology|gastroenterology
5313682|NCT00387439|Anoperineal physiotherapy|anoperineal physiotherapy
5313683|NCT00387439|Randomized clinical trial|randomized clinical trial
5313684|NCT00387413|Duloxetine|duloxetine
5313685|NCT00387413|GSK189254|gsk189254
5313686|NCT00387413|Healthy volunteers|healthy volunteers
5313687|NCT00387413|Phase I.|phase i.
5313688|NCT00387413|Electrical hyperalgesia model|electrical hyperalgesia model
5313689|NCT00387400|adult giant cell glioblastoma|adult giant cell glioblastoma
5313690|NCT00387400|adult gliosarcoma|adult gliosarcoma
5313691|NCT00387400|recurrent adult brain tumor|recurrent adult brain tumor
5313692|NCT00387400|adult glioblastoma|adult glioblastoma
5313693|NCT00387387|pharmacokinetics|pharmacokinetics
5313694|NCT00387387|colorectal cancer|colorectal cancer
5313695|NCT00387387|pazopanib|pazopanib
5313696|NCT00387387|capecitabine|capecitabine
5313697|NCT00387387|CapeOx|capeox
5313698|NCT00387387|5-fluorouracil|5-fluorouracil
5313699|NCT00387387|oxaliplatin|oxaliplatin
5313700|NCT00387387|combination therapy|combination therapy
5313701|NCT00387387|FOLFOX 6|folfox 6
5313702|NCT00387361|Post-Operative Nausea|post-operative nausea
5313703|NCT00387361|Nausea|nausea
5313704|NCT00387361|Anesthesia|anesthesia
5313705|NCT00387361|Osteopathic Manipulative Treatment|osteopathic manipulative treatment
5313706|NCT00387361|Osteopathic Manipulative Medicine|osteopathic manipulative medicine
5313707|NCT00387361|Manipulation, Osteopathic|manipulation, osteopathic
5313708|NCT00387361|Osteopathy|osteopathy
5313709|NCT00387361|Texas College of Osteopathic Medicine|texas college of osteopathic medicine
5313711|NCT00387348|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
5313712|NCT00387348|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5313713|NCT00387348|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5313714|NCT00387348|extensive stage small cell lung cancer|extensive stage small cell lung cancer
5313715|NCT00387348|advanced adult primary liver cancer|advanced adult primary liver cancer
5313716|NCT00387348|depression|depression
5313717|NCT00387348|stage III pancreatic cancer|stage iii pancreatic cancer
5313718|NCT00387348|stage IV pancreatic cancer|stage iv pancreatic cancer
5313922|NCT00386685|Breast|breast
5313720|NCT00387348|stage IV gastric cancer|stage iv gastric cancer
5313721|NCT00387348|stage IVA colon cancer|stage iva colon cancer
5313722|NCT00387348|stage IVB colon cancer|stage ivb colon cancer
5313723|NCT00387348|stage IVA rectal cancer|stage iva rectal cancer
5313724|NCT00387348|stage IVB rectal cancer|stage ivb rectal cancer
5313725|NCT00387348|unresectable gallbladder cancer|unresectable gallbladder cancer
5313726|NCT00387348|unresectable extrahepatic bile duct cancer|unresectable extrahepatic bile duct cancer
5313727|NCT00387322|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5313728|NCT00387322|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5313729|NCT00387322|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5313730|NCT00387322|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5313731|NCT00387309|Bowel|bowel
5313732|NCT00387283|WNV|wnv
5313733|NCT00387283|West Nile virus|west nile virus
5313734|NCT00387283|WNV meningoencephalitis|wnv meningoencephalitis
5313735|NCT00387270|Huntington's disease|huntington's disease
5313736|NCT00387270|Dimebon|dimebon
5313737|NCT00387270|dose-escalation|dose-escalation
5313738|NCT00387270|Phase 1-2a|phase 1-2a
5313739|NCT00387270|randomized|randomized
5313740|NCT00387270|controlled|controlled
5313741|NCT00387270|double-blind|double-blind
5313742|NCT00387270|Unified Huntington's Disease Rating Scale|unified huntington's disease rating scale
5313743|NCT00387257|platelet aggregation|platelet aggregation
5313744|NCT00387257|SB-659032|sb-659032
5313745|NCT00387257|rilapladib|rilapladib
5313746|NCT00387244|Pain;|pain;
5313747|NCT00387244|Back Pain;|back pain;
5313748|NCT00387244|Neurostimulation|neurostimulation
5313749|NCT00387231|Myocardial Ischemia|myocardial ischemia
5313750|NCT00387231|Randomized Controlled Trials|randomized controlled trials
5313751|NCT00387231|Angioplasty, Transluminal, Percutaneous Coronary|angioplasty, transluminal, percutaneous coronary
5313752|NCT00387231|Drug Therapy|drug therapy
5313753|NCT00387218|Exercise|exercise
5313754|NCT00387218|Physical Functional Ability|physical functional ability
5313755|NCT00387218|Spinal Range of Motion|spinal range of motion
5313756|NCT00387218|Balance|balance
5313757|NCT00387218|Economy of Movement|economy of movement
5313758|NCT00387218|Aerobic Conditioning|aerobic conditioning
5313759|NCT00387218|Quality of Life|quality of life
5313760|NCT00387218|Adherence|adherence
5313761|NCT00387205|chronic administration|chronic administration
5313762|NCT00387205|monotherapy and combination therapies|monotherapy and combination therapies
5313763|NCT00387205|solid|solid
5313764|NCT00387205|lapatinib (TYKERB, TYVERB)|lapatinib (tykerb, tyverb)
5313765|NCT00387205|malignant tumor|malignant tumor
5313766|NCT00387205|Pazopanib|pazopanib
5313767|NCT00387205|GW786034|gw786034
5313768|NCT00387205|cancer|cancer
5313769|NCT00387205|safety|safety
5313770|NCT00387192|Von Willebrand Disease|von willebrand disease
5313771|NCT00387192|Factor VIII|factor viii
5313772|NCT00387192|Von Willebrand Factor|von willebrand factor
5313773|NCT00387192|Pharmacokinetics|pharmacokinetics
5313774|NCT00387179|Circadian Rhythm Sleep Disorders|circadian rhythm sleep disorders
5313775|NCT00387166|Type 2 Diabetes|type 2 diabetes
5313776|NCT00387166|Cardiovascular|cardiovascular
5313777|NCT00387166|Blood Pressure|blood pressure
5313778|NCT00387166|Hispanic|hispanic
5313779|NCT00387166|Women|women
5313780|NCT00387166|Social Context|social context
5313781|NCT00387166|Psychosocial|psychosocial
5313782|NCT00387153|Oncology|oncology
5313783|NCT00387153|Cancer|cancer
5313784|NCT00387153|Blood Cancers|blood cancers
5313785|NCT00387140|Dental Pain, Postoperative|dental pain, postoperative
5313786|NCT00387127|Neck Cancer|neck cancer
5313787|NCT00387127|Locally advanced head and neck cancer|locally advanced head and neck cancer
5313788|NCT00387127|locally advanced|locally advanced
5313789|NCT00387127|Head and Neck cancer|head and neck cancer
5313790|NCT00387127|lapatinib|lapatinib
5313791|NCT00387127|EGFR/ErbB2 inhibitor|egfr/erbb2 inhibitor
5313792|NCT00387127|Head Cancer|head cancer
5313793|NCT00387114|C-reactive protein|c-reactive protein
5313794|NCT00387114|nitrotyrosine|nitrotyrosine
5313795|NCT00387114|oxidative stress|oxidative stress
5313796|NCT00387114|resistin|resistin
5313797|NCT00387114|vitamin C|vitamin c
5313798|NCT00387101|Diabetic Foot Ulcer|diabetic foot ulcer
5313799|NCT00387101|Diabetes Mellitus|diabetes mellitus
5313800|NCT00387101|Debridement|debridement
5313801|NCT00387101|Dermal-LSR|dermal-lsr
5313802|NCT00387101|Standard of Care|standard of care
5313803|NCT00387075|Parkinson Disease|parkinson disease
5313804|NCT00387075|SPECT imaging|spect imaging
5313805|NCT00387062|Breast Cancer|breast cancer
5313806|NCT00387062|Cognitive Impairment|cognitive impairment
5313807|NCT00387062|Chemofog|chemofog
5313808|NCT00387062|Chemobrain|chemobrain
5313809|NCT00387062|Post-chemotherapy cognitive impairment|post-chemotherapy cognitive impairment
5313810|NCT00387049|Anxiety Sensitivity|anxiety sensitivity
5313811|NCT00387023|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
5313812|NCT00387023|Orbital Lymphoma|orbital lymphoma
5313813|NCT00387023|Rituximab|rituximab
5313814|NCT00387023|Rituxan|rituxan
5313815|NCT00387023|Zevalin|zevalin
5313816|NCT00387023|Ibritumomab tiuxetan|ibritumomab tiuxetan
5313817|NCT00387023|IDEC-Y2B8|idec-y2b8
5313819|NCT00386984|hepatocellular carcinoma; Sandostatin-LAR; RCT|hepatocellular carcinoma; sandostatin-lar; rct
5313820|NCT00386971|L-carnitine|l-carnitine
5313821|NCT00386971|HIV|hiv
5313822|NCT00386971|TGRL metabolism|tgrl metabolism
5313823|NCT00386971|postprandial|postprandial
5313824|NCT00386971|HIV Treatment Experienced|hiv treatment experienced
5313825|NCT00386958|corneal ulcers|corneal ulcers
5313826|NCT00386958|bacterial keratitis|bacterial keratitis
5313827|NCT00386958|childhood blindness|childhood blindness
5313828|NCT00386958|povidone-iodine|povidone-iodine
5313829|NCT00386945|Tobacco|tobacco
5313830|NCT00386945|Cessation.|cessation.
5313831|NCT00386945|Chiropractic patients.|chiropractic patients.
5313832|NCT00386945|Doctors of Chiropractic.|doctors of chiropractic.
5313833|NCT00386945|Health care providers.|health care providers.
5313834|NCT00386945|Behavioral intervention.|behavioral intervention.
5313835|NCT00386945|Tobacco intervention.|tobacco intervention.
5313836|NCT00386945|Cigarettes.|cigarettes.
5313837|NCT00386945|Smokeless tobacco.|smokeless tobacco.
5313838|NCT00386945|Smoking intervention.|smoking intervention.
5313839|NCT00386906|Melanoma|melanoma
5313840|NCT00386906|Conjunctival Melanoma|conjunctival melanoma
5313841|NCT00386906|Malignant Melanoma of the Conjunctiva|malignant melanoma of the conjunctiva
5313842|NCT00386906|Malignant Melanoma of the Eyelid|malignant melanoma of the eyelid
5313843|NCT00386906|Sebaceous Cell Carcinoma|sebaceous cell carcinoma
5313844|NCT00386906|Sebaceous Cell Carcinoma of the Conjunctiva|sebaceous cell carcinoma of the conjunctiva
5313845|NCT00386906|Sebaceous Cell Carcinoma of the Eyelid|sebaceous cell carcinoma of the eyelid
5313846|NCT00386906|Sentinel Lymph Node|sentinel lymph node
5313847|NCT00386906|Lymphatic Mapping|lymphatic mapping
5313848|NCT00386906|Eyelid|eyelid
5313849|NCT00386906|Eyelid Lesion|eyelid lesion
5313850|NCT00386867|medical abortion|medical abortion
5313851|NCT00386867|mifepristone|mifepristone
5313852|NCT00386867|misoprostol|misoprostol
5313853|NCT00386867|buccal administration|buccal administration
5313854|NCT00386854|exercise|exercise
5313855|NCT00386854|lipid metabolism|lipid metabolism
5313856|NCT00386854|lipoproteins|lipoproteins
5313857|NCT00386854|insulin resistance|insulin resistance
5313858|NCT00386854|inflammation|inflammation
5313859|NCT00386841|Major depression|major depression
5313860|NCT00386841|First degree relatives|first degree relatives
5313861|NCT00386841|Escitalopram|escitalopram
5313862|NCT00386841|Cortisol|cortisol
5313863|NCT00386841|Cognition|cognition
5313864|NCT00386841|Personality|personality
5313865|NCT00386841|Endo-phenotype|endo-phenotype
5313866|NCT00386828|colorectal cancer|colorectal cancer
5313867|NCT00386828|advanced colorectal cancer|advanced colorectal cancer
5313868|NCT00386802|Neutropenia|neutropenia
5313869|NCT00386802|Antifungals|antifungals
5313870|NCT00386789|Typhoid Fever|typhoid fever
5313871|NCT00386789|Serological Survey|serological survey
5313872|NCT00386789|Follow-Up|follow-up
5313873|NCT00386789|Protection|protection
5313874|NCT00386776|computers|computers
5313875|NCT00386776|diagnosis|diagnosis
5313876|NCT00386776|medical records|medical records
5313877|NCT00386776|physician patient relations|physician patient relations
5313878|NCT00386776|medical history taking|medical history taking
5313879|NCT00386776|medical informatics applications|medical informatics applications
5313880|NCT00386763|Marsh fever|marsh fever
5313881|NCT00386763|Plasmodium infections|plasmodium infections
5313882|NCT00386763|Remittent fever|remittent fever
5313883|NCT00386763|Paludism|paludism
5313884|NCT00386763|Artemether|artemether
5313885|NCT00386763|Artemisinins|artemisinins
5313886|NCT00386763|Malaria|malaria
5313887|NCT00386763|Benflumetol|benflumetol
5313888|NCT00386763|Lumefantrine|lumefantrine
5313889|NCT00386750|Malaria|malaria
5313890|NCT00386750|hearing|hearing
5313891|NCT00386750|co-artemether|co-artemether
5313892|NCT00386750|auditory|auditory
5313893|NCT00386750|Plasmodium falciparum|plasmodium falciparum
5313894|NCT00386750|marsh fever|marsh fever
5313895|NCT00386750|Plasmodium infections|plasmodium infections
5313896|NCT00386750|remittent fever|remittent fever
5313897|NCT00386750|paludism|paludism
5313898|NCT00386750|artemether|artemether
5313899|NCT00386750|artemisinins|artemisinins
5313900|NCT00386750|benflumetol|benflumetol
5313901|NCT00386750|lumefantrine|lumefantrine
5313902|NCT00386737|Asthma|asthma
5313903|NCT00386737|Breath Testing|breath testing
5313904|NCT00386737|Laser Spectroscopy|laser spectroscopy
5313905|NCT00386737|eNO|eno
5313906|NCT00386737|Nitric Oxide|nitric oxide
5313907|NCT00386737|Lower Airway Inflammation|lower airway inflammation
5313908|NCT00386737|Carbon Dioxide|carbon dioxide
5313909|NCT00386737|CO2|co2
5313910|NCT00386724|Pain|pain
5313911|NCT00386724|Neurostimulation|neurostimulation
5313912|NCT00386724|Leg Pain|leg pain
5313913|NCT00386724|Back Pain|back pain
5313914|NCT00386711|suicide|suicide
5313915|NCT00386711|depressed patients|depressed patients
5313916|NCT00386711|primary care|primary care
5313917|NCT00386698|Influenza,|influenza,
5313918|NCT00386698|improved vaccine,|improved vaccine,
5313919|NCT00386698|influenza disease|influenza disease
5313920|NCT00386698|elderly|elderly
5313921|NCT00386685|Cancer|cancer
5313923|NCT00386685|metastatic breast cancer|metastatic breast cancer
5313924|NCT00386672|Calcium|calcium
5313925|NCT00386672|Vitamin D|vitamin d
5313926|NCT00386672|Weight Loss|weight loss
5313927|NCT00386672|Overweight|overweight
5313928|NCT00386672|Obesity|obesity
5313929|NCT00386672|Lite Orange Juice|lite orange juice
5313930|NCT00386646|Dry eye syndromes therapy|dry eye syndromes therapy
5313931|NCT00386633|Vaccine|vaccine
5313932|NCT00386633|Safety|safety
5313933|NCT00386633|T-cell epitope|t-cell epitope
5313934|NCT00386633|Acquired Immune Deficiency Syndrome Virus|acquired immune deficiency syndrome virus
5313935|NCT00386633|HIV Preventive Vaccine|hiv preventive vaccine
5313936|NCT00386620|Breast Cancer|breast cancer
5313937|NCT00386620|Cancer Control|cancer control
5313938|NCT00386620|Spousal Relationships|spousal relationships
5313939|NCT00386620|Questionnaire|questionnaire
5313940|NCT00386620|Interview|interview
5313941|NCT00386620|Pain|pain
5313942|NCT00386607|Hypertension, aliskiren, valsartan, HCTZ, blood pressure|hypertension, aliskiren, valsartan, hctz, blood pressure
5313943|NCT00386594|Barrett Esophagus|barrett esophagus
5313944|NCT00386594|High grade dysplasia|high grade dysplasia
5313945|NCT00386594|Carcinoma in situ|carcinoma in situ
5313946|NCT00386594|825A|825a
5313947|NCT00386542|vaccination|vaccination
5313948|NCT00386542|influenza vaccine|influenza vaccine
5313949|NCT00386542|jet injection|jet injection
5313950|NCT00386542|intradermal injection|intradermal injection
5313951|NCT00386542|infancy|infancy
5313952|NCT00386542|children|children
5313953|NCT00386542|dose-sparing|dose-sparing
5313954|NCT00386542|cutaneous vaccination|cutaneous vaccination
5313955|NCT00386542|Dominican Republic|dominican republic
5313956|NCT00386542|pandemic preparedness|pandemic preparedness
5313957|NCT00386542|jet injector|jet injector
5313958|NCT00386542|reduced dosage|reduced dosage
5313959|NCT00386542|immunogenicity|immunogenicity
5313960|NCT00386542|reactogenicity|reactogenicity
5313962|NCT00386542|needle-free|needle-free
5313963|NCT00386542|immune response|immune response
5313964|NCT00386542|hemagglutination inhibition|hemagglutination inhibition
5313965|NCT00386542|Infant|infant
5313966|NCT00386529|low dose aspirin|low dose aspirin
5313967|NCT00386529|Hypertension|hypertension
5313968|NCT00386529|administration time dependent effect|administration time dependent effect
5313969|NCT00386516|cholangiocarcinoma|cholangiocarcinoma
5313970|NCT00386516|bile duct|bile duct
5313971|NCT00386516|biliary|biliary
5313972|NCT00386516|intra-hepatic|intra-hepatic
5313973|NCT00386516|extra-hepatic|extra-hepatic
5313974|NCT00386516|gall bladder|gall bladder
5313975|NCT00386516|cancer|cancer
5313976|NCT00386516|carcinoma|carcinoma
5313977|NCT00386516|metastatic|metastatic
5313978|NCT00386516|metastasis|metastasis
5313979|NCT00386516|advanced|advanced
5313980|NCT00386516|recurrent|recurrent
5313981|NCT00386490|celiac disease|celiac disease
5313982|NCT00386490|larazotide acetate|larazotide acetate
5313983|NCT00386477|Povidone iodine|povidone iodine
5313984|NCT00386477|postoperative infection|postoperative infection
5313985|NCT00386477|presurgical cleansing|presurgical cleansing
5313986|NCT00386464|bipap|bipap
5313987|NCT00386464|lou gehrigs disease|lou gehrigs disease
5313988|NCT00386464|motor neuron disease|motor neuron disease
5313989|NCT00386464|respiratory muscles|respiratory muscles
5313990|NCT00386451|Intravenous chemotherapy|intravenous chemotherapy
5313991|NCT00386412|Cytomegalovirus infection|cytomegalovirus infection
5313992|NCT00386399|Advanced Pancreatic Cancer|advanced pancreatic cancer
5313993|NCT00386399|Mutated BRCA2 Gene|mutated brca2 gene
5313994|NCT00386399|Recurrent Pancreatic Cancer|recurrent pancreatic cancer
5313995|NCT00386386|hydration|hydration
5313996|NCT00386386|prehospital|prehospital
5313997|NCT00386386|mass casualty incident|mass casualty incident
5313998|NCT00386373|Chronic Myeloid Leukemia|chronic myeloid leukemia
5313999|NCT00386373|CML|cml
5314000|NCT00386373|ALL|all
5314001|NCT00386373|AML|aml
5314002|NCT00386373|Leukemia|leukemia
5314003|NCT00386373|Imatinib Mesylate|imatinib mesylate
5314004|NCT00386373|Gleevec|gleevec
5314005|NCT00386373|Philadelphia-Positive|philadelphia-positive
5314006|NCT00386373|Bone marrow transplant|bone marrow transplant
5314007|NCT00386373|BMT|bmt
5314008|NCT00386373|Stem cell transplant|stem cell transplant
5314009|NCT00386373|SCT|sct
5314010|NCT00386347|HIV|hiv
5314011|NCT00386347|repeat dose|repeat dose
5314012|NCT00386347|pharmacokinetics|pharmacokinetics
5314013|NCT00386347|bioavailability|bioavailability
5314014|NCT00386347|single-dose|single-dose
5314015|NCT00386347|food effect|food effect
5314016|NCT00386334|insomnia|insomnia
5314017|NCT00386334|chronic|chronic
5314018|NCT00386334|primary|primary
5314019|NCT00386321|Zevalin|zevalin
5314020|NCT00386321|Zevalin plus CHOP|zevalin plus chop
5314021|NCT00386321|Diffuse large B-cell lymphoma|diffuse large b-cell lymphoma
5314022|NCT00386321|First line Diffuse large B-cell lymphoma|first line diffuse large b-cell lymphoma
5314023|NCT00386308|Heavy Menstrual Bleeding|heavy menstrual bleeding
5314024|NCT00386308|Menorrhagia|menorrhagia
5314025|NCT00386282|Mifepristone|mifepristone
5314026|NCT00386282|Misoprostol|misoprostol
5314335|NCT00384995|Bicarbonate|bicarbonate
5314027|NCT00386282|Buccal administration|buccal administration
5314028|NCT00386269|codeine phosphate analgesia|codeine phosphate analgesia
5314029|NCT00386256|telehealth|telehealth
5314030|NCT00386256|telerehabilitation|telerehabilitation
5314031|NCT00386256|deconditioning|deconditioning
5314032|NCT00386256|exercise|exercise
5314033|NCT00386243|analgesia|analgesia
5314034|NCT00386243|analgesics|analgesics
5314035|NCT00386243|cognitive behavioral therapy|cognitive behavioral therapy
5314036|NCT00386243|Pain|pain
5314037|NCT00386243|self-management|self-management
5314038|NCT00386243|stepped care|stepped care
5314039|NCT00386243|musculoskeletal pain|musculoskeletal pain
5314040|NCT00386230|transmission|transmission
5314041|NCT00386230|infant|infant
5314042|NCT00386230|HIV|hiv
5314043|NCT00386230|pregnancy|pregnancy
5314044|NCT00386230|HIV-1 infection|hiv-1 infection
5314045|NCT00386230|HIV Seronegativity|hiv seronegativity
5314046|NCT00386217|Cervical Cancer|cervical cancer
5314047|NCT00386217|Breast Cancer|breast cancer
5314048|NCT00386217|Hodgkin's Disease|hodgkin's disease
5314049|NCT00386217|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
5314050|NCT00386217|Female Infertility|female infertility
5314051|NCT00386217|Telephone Survey|telephone survey
5314052|NCT00386204|Q-switched Ruby laser|q-switched ruby laser
5314053|NCT00386191|Platelet Aggregation Inhibitors|platelet aggregation inhibitors
5314054|NCT00386191|Ischemic cerebrovascular disease|ischemic cerebrovascular disease
5314055|NCT00386178|vitamin E|vitamin e
5314056|NCT00386178|gamma tocopherol|gamma tocopherol
5314057|NCT00386178|moderate to severe asthma|moderate to severe asthma
5314058|NCT00386178|healthy subjects|healthy subjects
5314059|NCT00386165|larazotide acetate|larazotide acetate
5314060|NCT00386152|Anemia|anemia
5314061|NCT00386152|Cancer|cancer
5314062|NCT00386152|Chemotherapy-Induced Anemia|chemotherapy-induced anemia
5314063|NCT00386152|Epoetin alfa|epoetin alfa
5314064|NCT00386152|Darbepoetin alfa|darbepoetin alfa
5314065|NCT00386139|Diastolic|diastolic
5314066|NCT00386139|systolic|systolic
5314067|NCT00386139|hypertension|hypertension
5314068|NCT00386139|aliskiren|aliskiren
5314069|NCT00386139|blood pressure|blood pressure
5314070|NCT00386139|hydrochlorothiazide, HCTZ|hydrochlorothiazide, hctz
5314071|NCT00386126|Heart Failure|heart failure
5314072|NCT00386126|Anemia|anemia
5314073|NCT00386126|Treatment|treatment
5314074|NCT00386113|Influenza|influenza
5314075|NCT00386113|improved vaccine|improved vaccine
5314076|NCT00386113|elderly|elderly
5314077|NCT00386100|Fasting Plasma Glucose|fasting plasma glucose
5314078|NCT00386100|Dual energy X ray absorptiometry (DXA)|dual energy x ray absorptiometry (dxa)
5314079|NCT00386100|Drug-naive|drug-naive
5314080|NCT00386100|Type 2 diabetes mellitus|type 2 diabetes mellitus
5314081|NCT00386100|Bone Mineral Density|bone mineral density
5314082|NCT00386100|Hyperglycemia|hyperglycemia
5314083|NCT00386100|HbA1c|hba1c
5314084|NCT00386087|Breast Cancer|breast cancer
5314085|NCT00386087|Cancer of the Breast|cancer of the breast
5314086|NCT00386074|NaFeEDTA|nafeedta
5314087|NCT00386074|electrolytic iron|electrolytic iron
5314088|NCT00386074|efficacy|efficacy
5314089|NCT00386074|whole maize flour|whole maize flour
5314090|NCT00386074|phytate|phytate
5314091|NCT00386074|school-age children|school-age children
5314092|NCT00386074|controlled trial|controlled trial
5314093|NCT00386074|Africa|africa
5314094|NCT00386061|Obesity|obesity
5314095|NCT00386061|risk factors|risk factors
5314096|NCT00386048|Cognitive Behavioral Therapy|cognitive behavioral therapy
5314097|NCT00386048|Pediatric Sickle Cell Disease|pediatric sickle cell disease
5314098|NCT00386048|Pain Management|pain management
5314099|NCT00386035|Treatment Experienced|treatment experienced
5314100|NCT00386022|Gonadotropin-releasing hormone|gonadotropin-releasing hormone
5314101|NCT00386022|Estrogens|estrogens
5314102|NCT00386022|postmenopausal women|postmenopausal women
5314103|NCT00386022|Pituitary hormones|pituitary hormones
5314104|NCT00386009|Benign Prostatic Hyperplasia|benign prostatic hyperplasia
5314105|NCT00386009|Benign Prostatic Hypertrophy|benign prostatic hypertrophy
5314106|NCT00385996|Carcinoma,non-small cell lung|carcinoma,non-small cell lung
5314107|NCT00385996|preoperative|preoperative
5314108|NCT00385996|Tarceva|tarceva
5314109|NCT00385996|Response rate|response rate
5314110|NCT00385983|thyroidectomy|thyroidectomy
5314111|NCT00385983|thyroid neoplasm|thyroid neoplasm
5314112|NCT00385983|postoperative complications|postoperative complications
5314113|NCT00385983|cost effectiveness|cost effectiveness
5314114|NCT00385957|Treatment Naive|treatment naive
5314115|NCT00385931|Hypertension|hypertension
5314116|NCT00385931|high cholesterol|high cholesterol
5314117|NCT00385931|valsartan|valsartan
5314118|NCT00385931|simvastatin|simvastatin
5314119|NCT00385918|Cardiovascular Fitness|cardiovascular fitness
5314120|NCT00385918|Exercise|exercise
5314121|NCT00385918|Gait|gait
5314122|NCT00385918|Spinal Cord Injury|spinal cord injury
5314123|NCT00385918|Treadmill Training|treadmill training
5314124|NCT00385892|Healthy volonteers|healthy volonteers
5314125|NCT00385892|Abdominal binder|abdominal binder
5314126|NCT00385892|IAP|iap
5314127|NCT00385892|MAP|map
5314128|NCT00385892|APP|app
5314129|NCT00385866|Patient Navigator|patient navigator
5314130|NCT00385866|Community health|community health
5314131|NCT00385866|Communication|communication
5314132|NCT00385853|PTK|ptk
5314133|NCT00385853|temozolomide|temozolomide
5314134|NCT00385853|glioblastoma|glioblastoma
5314135|NCT00385840|Influenza vaccine|influenza vaccine
5314136|NCT00385840|Influenza|influenza
5314137|NCT00385827|Cancer|cancer
5314138|NCT00385827|Prostate|prostate
5314139|NCT00385827|IL-6|il-6
5314140|NCT00385827|Mitoxantrone|mitoxantrone
5314141|NCT00385827|Metastatic prostate cancer|metastatic prostate cancer
5314142|NCT00385801|cocaine|cocaine
5314143|NCT00385801|dependence|dependence
5314144|NCT00385801|risperidal|risperidal
5314145|NCT00385801|MRI|mri
5314146|NCT00385788|Hodgkin's Disease|hodgkin's disease
5314147|NCT00385788|Stem Cell Transplantation|stem cell transplantation
5314148|NCT00385788|Antithymocyte Globulin|antithymocyte globulin
5314149|NCT00385788|Gemcitabine|gemcitabine
5314150|NCT00385788|Gemzar|gemzar
5314151|NCT00385788|Fludarabine|fludarabine
5314152|NCT00385788|Fludarabine Phosphate|fludarabine phosphate
5314153|NCT00385788|Melphalan|melphalan
5314154|NCT00385788|Allogeneic stem cell transplantation|allogeneic stem cell transplantation
5314155|NCT00385788|AST|ast
5314156|NCT00385788|SCT|sct
5314157|NCT00385788|ATG|atg
5314158|NCT00385788|Thymoglobulin|thymoglobulin
5314159|NCT00385775|Cancer|cancer
5314160|NCT00385775|solid tumours|solid tumours
5314161|NCT00385775|refractory|refractory
5314162|NCT00385775|antisense|antisense
5314163|NCT00385775|oligonucleotide|oligonucleotide
5314164|NCT00385762|Human volunteers|human volunteers
5314165|NCT00385749|Implanted cardioverter defibrillator|implanted cardioverter defibrillator
5314166|NCT00385749|congestive heart failure|congestive heart failure
5314167|NCT00385749|right ventricular lead placement|right ventricular lead placement
5314168|NCT00385749|select site pacing|select site pacing
5314169|NCT00385736|Moderate to Severe Ulcerative Colitis|moderate to severe ulcerative colitis
5314170|NCT00385736|Double-blind|double-blind
5314171|NCT00385736|Adalimumab|adalimumab
5314172|NCT00385736|Induction of Clinical Remission|induction of clinical remission
5314173|NCT00385723|affect|affect
5314174|NCT00385723|inflammation|inflammation
5314175|NCT00385710|Progressive supranuclear palsy (PSP)|progressive supranuclear palsy (psp)
5314176|NCT00385697|Randomized|randomized
5314177|NCT00385697|Double Blind|double blind
5314178|NCT00385697|Parallel Group|parallel group
5314179|NCT00385697|Controlled Clinical Trial|controlled clinical trial
5314180|NCT00385684|Agitation|agitation
5314181|NCT00385684|Alzheimer Disease|alzheimer disease
5314182|NCT00385684|Analgesics|analgesics
5314183|NCT00385684|Dementia|dementia
5314184|NCT00385684|Narcotics|narcotics
5314185|NCT00385684|Opioid|opioid
5314186|NCT00385684|Pain|pain
5314187|NCT00385684|Palliative Care|palliative care
5314188|NCT00385684|Psychomotor|psychomotor
5314189|NCT00385684|Suffering, Physical|suffering, physical
5314190|NCT00385658|Dyslipidemia|dyslipidemia
5314191|NCT00385658|metabolic syndrome|metabolic syndrome
5314192|NCT00385658|fluvastatin|fluvastatin
5314193|NCT00385658|fenofibrate|fenofibrate
5314194|NCT00385658|simvastatin|simvastatin
5314195|NCT00385658|ezetimibe|ezetimibe
5314196|NCT00385645|HIV seronegativity|hiv seronegativity
5314197|NCT00385632|Treatment Experienced|treatment experienced
5314198|NCT00385606|prolonged continuous infusion|prolonged continuous infusion
5314199|NCT00385606|Cox-2 inhibitors|cox-2 inhibitors
5314200|NCT00385567|AIDS|aids
5314201|NCT00385567|Treatment Experienced|treatment experienced
5314202|NCT00385554|Microbicide|microbicide
5314203|NCT00385554|HIV prevention|hiv prevention
5314204|NCT00385554|Botswana|botswana
5314205|NCT00385554|Preventing acquisition of HIV infection|preventing acquisition of hiv infection
5314206|NCT00385554|HIV Seronegativity|hiv seronegativity
5314207|NCT00385541|pain|pain
5314208|NCT00385541|morphine|morphine
5314209|NCT00385541|hydromorphone|hydromorphone
5314210|NCT00385541|nausea|nausea
5314211|NCT00385541|vomiting|vomiting
5314212|NCT00385541|pruritis|pruritis
5314213|NCT00385528|Case complexity|case complexity
5314214|NCT00385528|INTERMED|intermed
5314215|NCT00385528|Consultation liaison psychiatry|consultation liaison psychiatry
5314216|NCT00385528|depression|depression
5314217|NCT00385502|toenail|toenail
5314218|NCT00385502|fungus|fungus
5314219|NCT00385502|onychomycosis|onychomycosis
5314220|NCT00385502|antifungal|antifungal
5314221|NCT00385502|anti-fungal|anti-fungal
5314222|NCT00385502|nail|nail
5314223|NCT00385476|Advanced Cancer|advanced cancer
5314224|NCT00385476|Medication Knowledge|medication knowledge
5314225|NCT00385476|Emergency Center|emergency center
5314226|NCT00385476|Questionnaire|questionnaire
5314227|NCT00385476|Survey|survey
5314228|NCT00385463|Asthma|asthma
5314229|NCT00385463|Rhinitis|rhinitis
5314230|NCT00385463|Allergic Asthma|allergic asthma
5314231|NCT00385437|Driving safety|driving safety
5314232|NCT00385437|maintenance of wakefulness test|maintenance of wakefulness test
5314233|NCT00385437|major depressive disorder|major depressive disorder
5314234|NCT00385437|mirtazapine|mirtazapine
5314235|NCT00385398|tumors metastatic to brain|tumors metastatic to brain
5314236|NCT00385398|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5314237|NCT00385372|low pseudoallergen diet|low pseudoallergen diet
5314238|NCT00385372|elimination diet|elimination diet
5314239|NCT00385372|provocation diet|provocation diet
5314240|NCT00385372|oral provocation|oral provocation
5314241|NCT00385372|natural food ingredients|natural food ingredients
5314242|NCT00385372|food additives|food additives
5314243|NCT00385372|flavours|flavours
5314244|NCT00385346|Expressive writing|expressive writing
5314245|NCT00385346|Male infertility|male infertility
5314246|NCT00385333|Mitochondrion|mitochondrion
5314247|NCT00385333|Retina|retina
5314248|NCT00385333|Mitochondria|mitochondria
5314249|NCT00385333|Metabolism|metabolism
5314250|NCT00385333|In Vivo Imaging|in vivo imaging
5314251|NCT00385333|Age-Related Macular Degeneration|age-related macular degeneration
5314252|NCT00385333|AMD|amd
5314253|NCT00385333|Diabetic Retinopathy|diabetic retinopathy
5314254|NCT00385333|DR|dr
5314255|NCT00385333|Hippel-Lindau Disease|hippel-lindau disease
5314256|NCT00385333|VHL|vhl
5314257|NCT00385307|Depression|depression
5314258|NCT00385307|Clinical Trials|clinical trials
5314259|NCT00385307|Major Depressive Disorder|major depressive disorder
5314260|NCT00385294|Genetic|genetic
5314261|NCT00385294|pain|pain
5314262|NCT00385294|obstetrical|obstetrical
5314263|NCT00385281|proteomic profiling, influenza, vaccine, FluMist|proteomic profiling, influenza, vaccine, flumist
5314264|NCT00385268|cocaine|cocaine
5314265|NCT00385255|Immunogenicity,|immunogenicity,
5314266|NCT00385255|Influenza|influenza
5314267|NCT00385255|Co-administration,|co-administration,
5314268|NCT00385255|Tdap,|tdap,
5314269|NCT00385242|coronary artery disease|coronary artery disease
5314270|NCT00385242|left ventricular dysfunction|left ventricular dysfunction
5314271|NCT00385242|positron emission tomography|positron emission tomography
5314272|NCT00385242|viable myocardium|viable myocardium
5314273|NCT00385242|revascularization|revascularization
5314274|NCT00385242|cost effectiveness|cost effectiveness
5314275|NCT00385229|Asphyxia neonatorum|asphyxia neonatorum
5314276|NCT00385229|Birth Injury|birth injury
5314277|NCT00385229|Meconium Aspiration Syndrome|meconium aspiration syndrome
5314278|NCT00385216|Third Molar|third molar
5314279|NCT00385216|Pain|pain
5314280|NCT00385203|cancer|cancer
5314281|NCT00385203|tumour|tumour
5314282|NCT00385203|advanced cancer|advanced cancer
5314283|NCT00385203|Metastatic Gastro-Intestinal Stromal Tumours|metastatic gastro-intestinal stromal tumours
5314284|NCT00385203|gastro-intestinal cancer|gastro-intestinal cancer
5314285|NCT00385203|RECENTIN|recentin
5314286|NCT00385190|SAD|sad
5314287|NCT00385164|lung neoplasms|lung neoplasms
5314288|NCT00385164|positron emissions tomography|positron emissions tomography
5314289|NCT00385164|radiotherapy planning|radiotherapy planning
5314290|NCT00385151|Post conditioning|post conditioning
5314291|NCT00385138|Percutaneous Coronary Intervention (PCI)|percutaneous coronary intervention (pci)
5314292|NCT00385138|ACS|acs
5314293|NCT00385125|relapsed|relapsed
5314294|NCT00385125|refractory|refractory
5314295|NCT00385125|CD 20 positive|cd 20 positive
5314296|NCT00385112|Cardiology|cardiology
5314297|NCT00385112|Echocardiograms|echocardiograms
5314298|NCT00385112|Surgery|surgery
5314299|NCT00385112|Valve Disease|valve disease
5314300|NCT00385112|Heart Valve Disease|heart valve disease
5314301|NCT00385099|IBS|ibs
5314302|NCT00385099|stress|stress
5314303|NCT00385099|CRF1|crf1
5314304|NCT00385086|Sciatica|sciatica
5314305|NCT00385086|Pain|pain
5314306|NCT00385086|TNF-alpha|tnf-alpha
5314307|NCT00385086|Discectomy|discectomy
5314308|NCT00385086|Fibrosis|fibrosis
5314309|NCT00385086|Spine|spine
5314310|NCT00385047|malaria|malaria
5314311|NCT00385047|vaccine|vaccine
5314312|NCT00385047|AMA-1 (apical membrane antigen-1)|ama-1 (apical membrane antigen-1)
5314313|NCT00385047|efficacy|efficacy
5314314|NCT00385034|randomized controlled trial|randomized controlled trial
5314315|NCT00385034|RCT|rct
5314316|NCT00385034|partner violence|partner violence
5314317|NCT00385034|IPV|ipv
5314318|NCT00385034|screening|screening
5314319|NCT00385034|family practice|family practice
5314320|NCT00385034|computer|computer
5314321|NCT00385021|Advanced|advanced
5314322|NCT00385021|metastatic|metastatic
5314323|NCT00385021|colorectal|colorectal
5314324|NCT00385021|cancer|cancer
5314325|NCT00385021|Avastin|avastin
5314326|NCT00385008|Combination product, sumatriptan succinate, naproxen sodium, absorption, pharmacokinetics, disintegration, gastric transit, gastric scintigraphy|combination product, sumatriptan succinate, naproxen sodium, absorption, pharmacokinetics, disintegration, gastric transit, gastric scintigraphy
5314327|NCT00384995|Contrast Induced Nephropathy|contrast induced nephropathy
5314328|NCT00384995|Chronic Kidney Disease|chronic kidney disease
5314329|NCT00384995|Acute Renal Failure|acute renal failure
5314330|NCT00384995|End-stage Renal Disease|end-stage renal disease
5314331|NCT00384995|Cardiovascular diseases|cardiovascular diseases
5314332|NCT00384995|Coronary catheterization|coronary catheterization
5314333|NCT00384995|Percutaneous coronary intervention|percutaneous coronary intervention
5314334|NCT00384995|Intra-arterial angiography|intra-arterial angiography
5314336|NCT00384995|Saline|saline
5314337|NCT00384982|Bone marrow-derived stem cells|bone marrow-derived stem cells
5314338|NCT00384982|Acute myocardial infarction|acute myocardial infarction
5314339|NCT00384969|RAD001|rad001
5314340|NCT00384969|Sorafenib|sorafenib
5314341|NCT00384969|Renal Cell Carcinoma|renal cell carcinoma
5314342|NCT00384969|Metastatic|metastatic
5314343|NCT00384956|MDS either de novo or secondary, fitting any of the WHO classifications.|mds either de novo or secondary, fitting any of the who classifications.
5314344|NCT00384943|postpartum depression|postpartum depression
5314345|NCT00384943|exercise|exercise
5314346|NCT00384891|Superficial urothelial cell carcinoma of bladder|superficial urothelial cell carcinoma of bladder
5314347|NCT00384891|NMIBC|nmibc
5314348|NCT00384891|Non Muscle Invasive Bladder Cancer|non muscle invasive bladder cancer
5314349|NCT00384891|Hyperthermia|hyperthermia
5314350|NCT00384891|Bladder instillation|bladder instillation
5314351|NCT00384891|Mitomycin C|mitomycin c
5314352|NCT00384891|RITE|rite
5314353|NCT00384891|SHTC|shtc
5314354|NCT00384891|Intravesical|intravesical
5314355|NCT00384865|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
5314356|NCT00384852|Fracture|fracture
5314357|NCT00384852|Humerus|humerus
5314358|NCT00384826|Adenocarcinoma, Bronchiolo-Alveolar|adenocarcinoma, bronchiolo-alveolar
5314359|NCT00384787|HIV Seronegativity|hiv seronegativity
5314360|NCT00384787|Adenoviral Vector Vaccine|adenoviral vector vaccine
5314361|NCT00384787|DNA Plasmid Vaccine|dna plasmid vaccine
5314362|NCT00384787|HIV Preventive Vaccine|hiv preventive vaccine
5314363|NCT00384774|Migraine|migraine
5314364|NCT00384748|Cerebrovascular Accident|cerebrovascular accident
5314365|NCT00384748|Rehabilitation|rehabilitation
5314366|NCT00384748|Telemedicine|telemedicine
5314367|NCT00384735|bone tumor|bone tumor
5314368|NCT00384735|soft tissue tumor|soft tissue tumor
5314369|NCT00384722|Left ventricular lead|left ventricular lead
5314370|NCT00384722|Pacing|pacing
5314371|NCT00384722|Heart Failure|heart failure
5314372|NCT00384709|Elderly|elderly
5314373|NCT00384709|Hospitalization|hospitalization
5314374|NCT00384709|Geriatrics|geriatrics
5314375|NCT00384709|Mortality|mortality
5314376|NCT00384709|Readmission|readmission
5314377|NCT00384709|Length of Stay|length of stay
5314378|NCT00384696|Risk Perception|risk perception
5314379|NCT00384696|Smoking Cessation|smoking cessation
5314380|NCT00384696|Nicotine Replacement Therapy|nicotine replacement therapy
5314381|NCT00384696|Questionnaire|questionnaire
5314382|NCT00384696|Nicotine|nicotine
5314383|NCT00384683|Endothelial Dysfunction|endothelial dysfunction
5314384|NCT00384683|Endothelial Cells|endothelial cells
5314385|NCT00384683|Perioperative Outcome|perioperative outcome
5314386|NCT00384683|Blood Sample|blood sample
5314387|NCT00384670|dengue|dengue
5314388|NCT00384670|vaccine|vaccine
5314389|NCT00384657|chronic heart failure|chronic heart failure
5314390|NCT00384657|chronic kidney disease|chronic kidney disease
5314391|NCT00384657|anemia|anemia
5314392|NCT00384657|intravenous iron|intravenous iron
5314393|NCT00384644|heart failure|heart failure
5314394|NCT00384644|sepsis|sepsis
5314395|NCT00384644|septic shock|septic shock
5314396|NCT00384644|cardiogenic shock|cardiogenic shock
5314397|NCT00384631|Neovascular|neovascular
5314398|NCT00384631|Glaucoma|glaucoma
5314399|NCT00384631|Bevacizumab|bevacizumab
5314400|NCT00384631|Avastin|avastin
5314401|NCT00384631|Intravitreal|intravitreal
5314402|NCT00384631|IOP|iop
5314403|NCT00384618|Kidney, Antioxidants, Statin, Carotid IMT|kidney, antioxidants, statin, carotid imt
5314404|NCT00384592|heartburn|heartburn
5314405|NCT00384592|reflux|reflux
5314406|NCT00384592|proton pump inhibitor|proton pump inhibitor
5314407|NCT00384592|GERD|gerd
5314408|NCT00384592|GORD|gord
5314409|NCT00384579|back|back
5314410|NCT00384579|pain|pain
5314411|NCT00384540|-Heart Transplant, Allograft Vasculopathy, Dobutamine Stress Echocardiography, Brain Natriuretic Peptide|-heart transplant, allograft vasculopathy, dobutamine stress echocardiography, brain natriuretic peptide
5314412|NCT00384540|Vasculopathy|vasculopathy
5314413|NCT00384527|Clostridium difficile|clostridium difficile
5314414|NCT00384514|Coronary Artery disease with chronic stable angina|coronary artery disease with chronic stable angina
5314415|NCT00384501|keratoconus|keratoconus
5314416|NCT00384501|Intacs|intacs
5314417|NCT00384488|Diabetes mellitus|diabetes mellitus
5314418|NCT00384488|Weight control|weight control
5314419|NCT00384488|Healthy eating|healthy eating
5314420|NCT00384488|Physical Activity|physical activity
5314421|NCT00384475|Seasonal Allergic Rhinitis|seasonal allergic rhinitis
5314422|NCT00384475|Ciclesonide|ciclesonide
5314423|NCT00384475|Hay Fever|hay fever
5314424|NCT00384475|SAR|sar
5314425|NCT00384462|Premature infants (32-35 weeks GA) <6 months of age at the start of the RSV season who are not receiving palivizumab and do not have CLD of prematurity|premature infants (32-35 weeks ga) <6 months of age at the start of the rsv season who are not receiving palivizumab and do not have cld of prematurity
5314426|NCT00384462|Respiratory Syncytial Viruses|respiratory syncytial viruses
5314427|NCT00384449|Eales|eales
5314428|NCT00384436|Major Depressive Disorder|major depressive disorder
5314429|NCT00384423|Alzheimer's Disease|alzheimer's disease
5314430|NCT00384423|AD|ad
5314431|NCT00384423|PRX-03140|prx-03140
5314432|NCT00384423|Dementia|dementia
5314433|NCT00384423|Epix|epix
5314434|NCT00384423|Predix|predix
5314435|NCT00384423|Cognition enhancing|cognition enhancing
5314436|NCT00384410|Pain|pain
5314437|NCT00384410|Insomnia|insomnia
5314438|NCT00384410|Nabilone|nabilone
5314439|NCT00384397|Menactra vaccine|menactra vaccine
5314440|NCT00384397|Meningococcal meningitis|meningococcal meningitis
5314441|NCT00384397|Measles|measles
5314442|NCT00384397|Mumps|mumps
5314443|NCT00384397|Rubella|rubella
5314444|NCT00384397|Varicella virus|varicella virus
5314445|NCT00384397|Haemophilus influenzae type b|haemophilus influenzae type b
5314446|NCT00384397|Pneumococcal conjugate vaccine|pneumococcal conjugate vaccine
5314447|NCT00384384|Dialysis|dialysis
5314448|NCT00384384|Serum potassium|serum potassium
5314449|NCT00384384|18b glycyrrhetinic acid|18b glycyrrhetinic acid
5314450|NCT00384384|insulin sensitivity|insulin sensitivity
5314451|NCT00384371|back|back
5314452|NCT00384371|pain|pain
5314453|NCT00384358|Fractures|fractures
5314454|NCT00384345|bright light treatment|bright light treatment
5314455|NCT00384345|exercise|exercise
5314456|NCT00384345|body fat index|body fat index
5314457|NCT00384345|mood|mood
5314458|NCT00384345|sleep|sleep
5314459|NCT00384345|fatigue|fatigue
5314460|NCT00384332|Bipolar Depression|bipolar depression
5314461|NCT00384332|Weight gain bipolar medicine|weight gain bipolar medicine
5314462|NCT00384332|side effects olanzapine|side effects olanzapine
5314463|NCT00384332|gastrointestinal hormones bipolar medicine|gastrointestinal hormones bipolar medicine
5314464|NCT00384319|resuscitation|resuscitation
5314465|NCT00384319|hypothermia|hypothermia
5314466|NCT00384306|COPD|copd
5314467|NCT00384306|prednisolone|prednisolone
5314468|NCT00384306|bone biopsy|bone biopsy
5314469|NCT00384306|tetracycline labelling|tetracycline labelling
5314470|NCT00384267|malaria, infants, preterm babies, neonates, Mali|malaria, infants, preterm babies, neonates, mali
5314471|NCT00384254|Tobacco.|tobacco.
5314472|NCT00384254|Cessation.|cessation.
5314473|NCT00384254|Dental patients.|dental patients.
5314474|NCT00384254|Dentists.|dentists.
5314475|NCT00384254|Hygienists.|hygienists.
5314476|NCT00384254|Dental assistants.|dental assistants.
5314477|NCT00384254|Health care providers.|health care providers.
5314478|NCT00384254|Behavioral intervention.|behavioral intervention.
5314479|NCT00384254|Tobacco intervention.|tobacco intervention.
5314480|NCT00384254|Cigarettes.|cigarettes.
5314481|NCT00384254|Smokeless tobacco.|smokeless tobacco.
5314482|NCT00384254|Smoking intervention.|smoking intervention.
5314483|NCT00384241|Blood Pressure, High|blood pressure, high
5314484|NCT00384241|Stress|stress
5314485|NCT00384241|Inflammation|inflammation
5314486|NCT00384228|Chronic Myelogenous Leukemia|chronic myelogenous leukemia
5314487|NCT00384228|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
5314488|NCT00384202|Tacrolimus|tacrolimus
5314489|NCT00384202|Liver Transplantation|liver transplantation
5314490|NCT00384189|Asthma|asthma
5314491|NCT00384189|Ciclesonide|ciclesonide
5314492|NCT00384189|children|children
5314493|NCT00384176|Metastatic Colorectal Cancer|metastatic colorectal cancer
5314494|NCT00384176|RECENTIN|recentin
5314495|NCT00384163|cardiac|cardiac
5314496|NCT00384163|adult|adult
5314497|NCT00384163|PVR|pvr
5314498|NCT00384150|galiximab|galiximab
5314499|NCT00384150|antibody|antibody
5314500|NCT00384150|refractory|refractory
5314501|NCT00384150|follicular|follicular
5314502|NCT00384150|relapsed|relapsed
5314503|NCT00384150|NHL|nhl
5314504|NCT00384150|rituximab|rituximab
5314505|NCT00384150|retreatment|retreatment
5314506|NCT00384137|Tacrolimus|tacrolimus
5314507|NCT00384137|Kidney Transplantation|kidney transplantation
5314508|NCT00384124|Bowens disease|bowens disease
5314509|NCT00384124|Squamous cell carcinoma in situ of the skin|squamous cell carcinoma in situ of the skin
5314510|NCT00384124|imiquimod|imiquimod
5314511|NCT00384098|Psoriasis|psoriasis
5314512|NCT00384072|postmenopausal|postmenopausal
5314513|NCT00384072|women|women
5314514|NCT00384072|SERM|serm
5314515|NCT00384072|osteoporosis|osteoporosis
5314516|NCT00384033|MDD|mdd
5314517|NCT00384033|Major Depressive Disorder|major depressive disorder
5314518|NCT00384033|Depression|depression
5314519|NCT00384020|Major Depression Disorder|major depression disorder
5314520|NCT00384020|Antidepressant|antidepressant
5314521|NCT00384020|Pharmacogenomics|pharmacogenomics
5314522|NCT00384020|Cytochrome P450|cytochrome p450
5314523|NCT00384020|Serotonin Transporter|serotonin transporter
5314524|NCT00384007|back pain|back pain
5314525|NCT00384007|herniated disc|herniated disc
5314526|NCT00384007|leg pain|leg pain
5314527|NCT00384007|pinched nerves|pinched nerves
5314528|NCT00384007|sciatica|sciatica
5314529|NCT00384007|radiculopathy|radiculopathy
5314530|NCT00383994|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
5314531|NCT00383994|CLL|cll
5314532|NCT00383994|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
5314533|NCT00383994|B-Cell Lymphoma|b-cell lymphoma
5314534|NCT00383994|Lymphoma|lymphoma
5314535|NCT00383994|granulocyte-macrophage colony-stimulating factor|granulocyte-macrophage colony-stimulating factor
5314536|NCT00383994|Leukemia|leukemia
5314537|NCT00383994|NK Cells|nk cells
5314538|NCT00383994|Rituximab|rituximab
5314539|NCT00383994|GM-CSF|gm-csf
5314540|NCT00383994|Non-myeloablative Allogeneic Stem Cell Transplantation|non-myeloablative allogeneic stem cell transplantation
5314541|NCT00383994|Stem Cell Transplant|stem cell transplant
5314542|NCT00383981|malondialdehyde optoelectronic vitamin complex|malondialdehyde optoelectronic vitamin complex
5314543|NCT00383942|Pregnancy|pregnancy
5314544|NCT00383942|Extra amniotic saline infusion|extra amniotic saline infusion
5314545|NCT00383942|Misoprostol|misoprostol
5314546|NCT00383942|Labor induction|labor induction
5314547|NCT00383929|Blood pressure reduction|blood pressure reduction
5314548|NCT00383929|combination therapy|combination therapy
5314549|NCT00383929|candesartan cilexetil|candesartan cilexetil
5314550|NCT00383929|hydrochlorothiazide|hydrochlorothiazide
5314551|NCT00383916|healthy|healthy
5314552|NCT00383890|American Society of Anesthesiologists (ASA)|american society of anesthesiologists (asa)
5314553|NCT00383890|Mallampati Score|mallampati score
5314554|NCT00383890|Ramsay Sedation Scale (RSS)|ramsay sedation scale (rss)
5314555|NCT00383864|liver fibrosis|liver fibrosis
5314556|NCT00383864|portal pressure|portal pressure
5314557|NCT00383864|antiviral therapy|antiviral therapy
5314558|NCT00383851|ATN-224|atn-224
5314559|NCT00383851|Temozolomide|temozolomide
5314560|NCT00383851|Combination|combination
5314561|NCT00383851|Sequential|sequential
5314562|NCT00383851|Anti-angiogenic|anti-angiogenic
5314563|NCT00383851|Copper|copper
5314564|NCT00383838|brief motivational intervention; teens; substance use|brief motivational intervention; teens; substance use
5314565|NCT00383825|conjunctival autografts|conjunctival autografts
5314566|NCT00383825|amniotic membrane|amniotic membrane
5314567|NCT00383825|indocyanine green angiography|indocyanine green angiography
5314568|NCT00383825|pterygium surgery|pterygium surgery
5314569|NCT00383812|Polypoidal choroidal vasculopathy|polypoidal choroidal vasculopathy
5314570|NCT00383812|Intravitreal Bevacizumab|intravitreal bevacizumab
5314571|NCT00383799|Ventricular tachycardia|ventricular tachycardia
5314572|NCT00383786|PTSD|ptsd
5314573|NCT00383786|Substance P|substance p
5314574|NCT00383786|Treatment Study|treatment study
5314575|NCT00383786|Placebo|placebo
5314576|NCT00383786|Controlled|controlled
5314577|NCT00383786|Post Traumatic Stress Disorder|post traumatic stress disorder
5314578|NCT00383773|retinal vein occlusion|retinal vein occlusion
5314579|NCT00383773|rTPA|rtpa
5314580|NCT00383747|cognition|cognition
5314581|NCT00383747|nicotine|nicotine
5314582|NCT00383747|schizophrenia|schizophrenia
5314583|NCT00383734|HIV-Associated Lipodystrophy Syndrome|hiv-associated lipodystrophy syndrome
5314584|NCT00383734|polylactic acid|polylactic acid
5314585|NCT00383734|polyacrylamide gels|polyacrylamide gels
5314586|NCT00383695|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5314587|NCT00383695|stage I rectal cancer|stage i rectal cancer
5314588|NCT00383695|stage II rectal cancer|stage ii rectal cancer
5314589|NCT00383695|stage III rectal cancer|stage iii rectal cancer
5314590|NCT00383682|postamputation pain|postamputation pain
5314591|NCT00383682|phantom pain|phantom pain
5314592|NCT00383682|stump pain|stump pain
5314593|NCT00383682|neuroma pain|neuroma pain
5314594|NCT00383682|opioid|opioid
5314595|NCT00383682|mexiletine|mexiletine
5314596|NCT00383669|HIV|hiv
5314597|NCT00383669|AIDS|aids
5314598|NCT00383669|Disease Progression|disease progression
5314599|NCT00383669|Multivitamins|multivitamins
5314600|NCT00383669|Anti-Retroviral Therapy|anti-retroviral therapy
5314601|NCT00383669|HAART|haart
5314602|NCT00383669|Tanzania|tanzania
5314603|NCT00383669|Africa|africa
5314604|NCT00383656|gonadotropin releasing hormone|gonadotropin releasing hormone
5314605|NCT00383656|GnRH deficiency|gnrh deficiency
5314606|NCT00383656|hypothalamic amenorrhea|hypothalamic amenorrhea
5314607|NCT00383656|hypogonadotropic hypogonadism|hypogonadotropic hypogonadism
5314608|NCT00383656|Kallman's syndrome|kallman's syndrome
5314609|NCT00383656|infertility|infertility
5314610|NCT00383630|End Stage Heart Failure|end stage heart failure
5314611|NCT00383630|LVAD|lvad
5314612|NCT00383630|Bone Marrow Transplantation|bone marrow transplantation
5314613|NCT00383630|Stem Cell Transplantation|stem cell transplantation
5314614|NCT00383617|pre-radiographic|pre-radiographic
5314615|NCT00383617|screening|screening
5314616|NCT00383617|early diagnosis|early diagnosis
5314617|NCT00383578|Type 2 diabetes|type 2 diabetes
5314618|NCT00383578|vildagliptin|vildagliptin
5314619|NCT00383578|hemoglobin A1c|hemoglobin a1c
5314620|NCT00383578|metformin|metformin
5314621|NCT00383539|Influenza|influenza
5314622|NCT00383539|Orthomyxoviruses|orthomyxoviruses
5314623|NCT00383539|Inactivated Split-virion influenza vaccine|inactivated split-virion influenza vaccine
5314624|NCT00383539|Adults|adults
5314625|NCT00383526|Influenza|influenza
5314626|NCT00383526|Orthomyxoviruses|orthomyxoviruses
5314627|NCT00383526|Inactivated Split-virion influenza vaccine|inactivated split-virion influenza vaccine
5314628|NCT00383526|elderly|elderly
5314629|NCT00383513|Lupus|lupus
5314630|NCT00383513|Antibody|antibody
5314631|NCT00383513|B-Cell Immunotherapy|b-cell immunotherapy
5314632|NCT00383461|tobacco use disorder|tobacco use disorder
5314633|NCT00383448|Stem cell transplantation|stem cell transplantation
5314729|NCT00383097|LMP1|lmp1
5314634|NCT00383448|Inborn errors of metabolism|inborn errors of metabolism
5314635|NCT00383448|Adrenoleukodystrophy (ALD)|adrenoleukodystrophy (ald)
5314636|NCT00383448|Metachromatic leukodystrophy (MLD)|metachromatic leukodystrophy (mld)
5314637|NCT00383448|Globoid cell leukodystrophy (GLD or Krabbe)|globoid cell leukodystrophy (gld or krabbe)
5314638|NCT00383448|Tay Sachs|tay sachs
5314639|NCT00383448|Sandhoff|sandhoff
5314640|NCT00383448|Sanfilippo syndrome|sanfilippo syndrome
5314641|NCT00383448|Mucopolysaccharidosis III (MPS-III)|mucopolysaccharidosis iii (mps-iii)
5314642|NCT00383448|GM1 gangliosidosis|gm1 gangliosidosis
5314643|NCT00383448|I-cell|i-cell
5314644|NCT00383448|mucolipidosis|mucolipidosis
5314645|NCT00383409|breast|breast
5314646|NCT00383409|cancer|cancer
5314647|NCT00383409|fatigue|fatigue
5314648|NCT00383409|multivitamins|multivitamins
5314649|NCT00383357|Performance|performance
5314650|NCT00383357|Gait stability|gait stability
5314651|NCT00383357|sedative|sedative
5314652|NCT00383357|hypnotic|hypnotic
5314653|NCT00383357|quality of life|quality of life
5314654|NCT00383357|sleep disorder|sleep disorder
5314655|NCT00383357|wakefulness|wakefulness
5314656|NCT00383357|sleeping pills|sleeping pills
5314657|NCT00383357|Cognitive function|cognitive function
5314658|NCT00383344|Crohn Disease|crohn disease
5314659|NCT00383344|Positron Emission Tomography|positron emission tomography
5314660|NCT00383344|Colonoscopy|colonoscopy
5314661|NCT00383318|Neonate|neonate
5314662|NCT00383318|Hyperbilirubinemia|hyperbilirubinemia
5314663|NCT00383318|Jaundice|jaundice
5314664|NCT00383318|G6PD Deficiency|g6pd deficiency
5314665|NCT00383318|Gilbert's Syndrome|gilbert's syndrome
5314666|NCT00383305|neonatal|neonatal
5314667|NCT00383305|hypoxic|hypoxic
5314668|NCT00383305|ischemic|ischemic
5314669|NCT00383305|encephalopathy|encephalopathy
5314670|NCT00383305|HIE|hie
5314671|NCT00383305|birth asphyxia|birth asphyxia
5314672|NCT00383305|neonatal encephalopathy|neonatal encephalopathy
5314673|NCT00383305|Asphyxia Neonatorum|asphyxia neonatorum
5314674|NCT00383305|hypothermia, therapeutic|hypothermia, therapeutic
5314675|NCT00383305|brain cooling|brain cooling
5314676|NCT00383305|selective head cooling|selective head cooling
5314677|NCT00383279|recurrent cervical cancer|recurrent cervical cancer
5314678|NCT00383279|stage 0 cervical cancer|stage 0 cervical cancer
5314679|NCT00383279|stage IA cervical cancer|stage ia cervical cancer
5314680|NCT00383279|stage IB cervical cancer|stage ib cervical cancer
5314681|NCT00383279|stage IIA cervical cancer|stage iia cervical cancer
5314682|NCT00383279|stage IIB cervical cancer|stage iib cervical cancer
5314683|NCT00383279|stage III cervical cancer|stage iii cervical cancer
5314684|NCT00383279|stage IVA cervical cancer|stage iva cervical cancer
5314685|NCT00383279|stage IVB cervical cancer|stage ivb cervical cancer
5314686|NCT00383279|recurrent uterine sarcoma|recurrent uterine sarcoma
5314687|NCT00383279|stage I uterine sarcoma|stage i uterine sarcoma
5314688|NCT00383279|stage II uterine sarcoma|stage ii uterine sarcoma
5314689|NCT00383279|stage III uterine sarcoma|stage iii uterine sarcoma
5314690|NCT00383279|stage IV uterine sarcoma|stage iv uterine sarcoma
5314691|NCT00383279|borderline ovarian surface epithelial-stromal tumor|borderline ovarian surface epithelial-stromal tumor
5314692|NCT00383279|ovarian sarcoma|ovarian sarcoma
5314693|NCT00383279|ovarian stromal cancer|ovarian stromal cancer
5314694|NCT00383279|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5314695|NCT00383279|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
5314696|NCT00383279|stage I ovarian epithelial cancer|stage i ovarian epithelial cancer
5314697|NCT00383279|stage I ovarian germ cell tumor|stage i ovarian germ cell tumor
5314698|NCT00383279|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
5314699|NCT00383279|stage II ovarian germ cell tumor|stage ii ovarian germ cell tumor
5314700|NCT00383279|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5314701|NCT00383279|stage III ovarian germ cell tumor|stage iii ovarian germ cell tumor
5314702|NCT00383279|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5314703|NCT00383279|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
5314704|NCT00383214|Lupus,|lupus,
5314705|NCT00383214|antibody,|antibody,
5314706|NCT00383214|B-cell immunotherapy|b-cell immunotherapy
5314707|NCT00383201|Contact Lens Care|contact lens care
5314708|NCT00383188|Arthritis, Rheumatoid|arthritis, rheumatoid
5314709|NCT00383175|Ocular Accommodation|ocular accommodation
5314710|NCT00383175|Reading|reading
5314711|NCT00383162|Combination Product|combination product
5314712|NCT00383162|naproxen sodium|naproxen sodium
5314713|NCT00383162|sumatriptan succinate|sumatriptan succinate
5314714|NCT00383162|short acting triptan|short acting triptan
5314715|NCT00383162|migraine, acute|migraine, acute
5314716|NCT00383162|Poor response|poor response
5314717|NCT00383136|STEMI|stemi
5314718|NCT00383136|Primary Angioplasty|primary angioplasty
5314719|NCT00383136|Abciximab|abciximab
5314720|NCT00383136|Tirofiban|tirofiban
5314721|NCT00383123|Fluarix|fluarix
5314722|NCT00383123|Influenza|influenza
5314723|NCT00383110|Diabetes|diabetes
5314724|NCT00383110|Health Outcomes|health outcomes
5314725|NCT00383110|Racial Preference|racial preference
5314726|NCT00383110|Clinical Trial|clinical trial
5314727|NCT00383110|Ethnic Differences|ethnic differences
5314728|NCT00383097|CTLs|ctls
5314730|NCT00383097|LMP2|lmp2
5314731|NCT00383097|CYTOTOXIC T-LYMPHOCYTES|cytotoxic t-lymphocytes
5314732|NCT00383097|CD45|cd45
5314733|NCT00383097|ANTIBODY|antibody
5314734|NCT00383097|EBV-POSITIVE HODGKIN'S|ebv-positive hodgkin's
5314735|NCT00383097|NON-HODGKIN'S LYMPHOMA|non-hodgkin's lymphoma
5314736|NCT00383084|Pain|pain
5314737|NCT00383084|Physical Activity|physical activity
5314738|NCT00383084|Fatigue|fatigue
5314739|NCT00383084|Lifestyle Activity|lifestyle activity
5314740|NCT00383071|Apheresis|apheresis
5314741|NCT00383071|Avian Flu|avian flu
5314742|NCT00383071|Healthy Volunteers|healthy volunteers
5314743|NCT00383071|Infectious Diseases|infectious diseases
5314744|NCT00383071|IVIG|ivig
5314745|NCT00383071|Healthy Volunteer|healthy volunteer
5314746|NCT00383071|HV|hv
5314747|NCT00383058|obesity|obesity
5314748|NCT00383058|green tea|green tea
5314749|NCT00383045|Buprenorphine|buprenorphine
5314750|NCT00383045|Naltrexone|naltrexone
5314751|NCT00383045|HIV risk reduction behavior|hiv risk reduction behavior
5314752|NCT00383045|Counseling|counseling
5314753|NCT00383006|Psychotherapy, Group|psychotherapy, group
5314754|NCT00383006|Stress Disorders, Post-Traumatic|stress disorders, post-traumatic
5314755|NCT00383006|Ambulatory Care|ambulatory care
5314756|NCT00382993|migraine with or without aura|migraine with or without aura
5314757|NCT00382993|naproxen sodium|naproxen sodium
5314758|NCT00382993|combination product|combination product
5314759|NCT00382993|sumatriptan succinate|sumatriptan succinate
5314760|NCT00382993|poor response|poor response
5314761|NCT00382993|short acting triptan|short acting triptan
5314762|NCT00382993|migraine, acute|migraine, acute
5314763|NCT00382980|influenza, vaccine, A/H5N1, aluminum hydroxide, Vero cell|influenza, vaccine, a/h5n1, aluminum hydroxide, vero cell
5314764|NCT00382967|Parkinsonian Syndromes, Parkinsonism, DaTSCAN, SPECT, clinical management, quality of life, movement disorder|parkinsonian syndromes, parkinsonism, datscan, spect, clinical management, quality of life, movement disorder
5314765|NCT00382967|Clinically uncertain Parkinsonian Syndromes|clinically uncertain parkinsonian syndromes
5314766|NCT00382954|Acute Myelogenous Leukemia|acute myelogenous leukemia
5314767|NCT00382954|AML|aml
5314768|NCT00382954|Relapse|relapse
5314769|NCT00382954|Elderly|elderly
5314770|NCT00382954|Velcade|velcade
5314771|NCT00382954|Idarubicin|idarubicin
5314772|NCT00382954|Bortezomib|bortezomib
5314773|NCT00382928|Randomized Controlled Trials|randomized controlled trials
5314774|NCT00382928|Defibrillators|defibrillators
5314775|NCT00382928|Medical Devices|medical devices
5314776|NCT00382915|Smoking|smoking
5314777|NCT00382915|Topography|topography
5314778|NCT00382915|Nicotine|nicotine
5314779|NCT00382902|Contact Lens Care|contact lens care
5314780|NCT00382889|Anti-Asthmatic Agents|anti-asthmatic agents
5314781|NCT00382889|corticosteroids|corticosteroids
5314782|NCT00382889|symptom-driven|symptom-driven
5314783|NCT00382889|beclomethasone|beclomethasone
5314784|NCT00382889|salbutamol|salbutamol
5314785|NCT00382876|apnea, hypoxia, car seat, car bed|apnea, hypoxia, car seat, car bed
5314786|NCT00382863|heart failure|heart failure
5314787|NCT00382863|cardiac support|cardiac support
5314788|NCT00382863|Paracor|paracor
5314789|NCT00382863|HeartNet|heartnet
5314790|NCT00382863|PEERLESS-HF|peerless-hf
5314791|NCT00382850|Nissen fundoplication|nissen fundoplication
5314792|NCT00382850|gastroesophageal reflux|gastroesophageal reflux
5314793|NCT00382837|Lupus,|lupus,
5314794|NCT00382837|Antibody,|antibody,
5314795|NCT00382837|B-Cell immunotherapy|b-cell immunotherapy
5314796|NCT00382824|Progressive Supranuclear Palsy|progressive supranuclear palsy
5314797|NCT00382824|Atypical Parkinsonism|atypical parkinsonism
5314798|NCT00382824|CoQ10|coq10
5314799|NCT00382811|Recurrent Ovarian Epithelial Cancer|recurrent ovarian epithelial cancer
5314800|NCT00382811|Stage IV Ovarian Epithelial Cancer|stage iv ovarian epithelial cancer
5314801|NCT00382811|Peritoneal Cavity Cancer|peritoneal cavity cancer
5314802|NCT00382811|Stage III Ovarian Epithelial Cancer|stage iii ovarian epithelial cancer
5314803|NCT00382785|online|online
5314804|NCT00382785|support|support
5314805|NCT00382785|breast cancer|breast cancer
5314806|NCT00382772|HRV vaccine|hrv vaccine
5314807|NCT00382772|Diarrhoea|diarrhoea
5314808|NCT00382772|Rotavirus|rotavirus
5314809|NCT00382746|Congestive|congestive
5314810|NCT00382746|Heart|heart
5314811|NCT00382746|Failure|failure
5314812|NCT00382746|CHF|chf
5314813|NCT00382733|Solid Tumors|solid tumors
5314814|NCT00382707|repetitive transcranial magnetic stimulation|repetitive transcranial magnetic stimulation
5314815|NCT00382707|low frequency|low frequency
5314816|NCT00382707|frontal lobe epilepsy|frontal lobe epilepsy
5314817|NCT00382707|brain excitability|brain excitability
5314818|NCT00382707|electromyography|electromyography
5314819|NCT00382694|Myeloma|myeloma
5314820|NCT00382694|Induction therapy|induction therapy
5314821|NCT00382694|High-dose melphalan|high-dose melphalan
5314822|NCT00382694|Autologous stem cell support|autologous stem cell support
5314823|NCT00382694|Fludarabine|fludarabine
5314824|NCT00382694|Cyclophosphamide|cyclophosphamide
5314825|NCT00382694|Dexamethasone|dexamethasone
5314826|NCT00382694|Safety|safety
5314827|NCT00382694|Toxicity|toxicity
5314828|NCT00382681|Contact Lens Care|contact lens care
5315026|NCT00382083|Mammogram|mammogram
5314829|NCT00382668|hepatically impaired|hepatically impaired
5314830|NCT00382655|Prevention|prevention
5314831|NCT00382655|Emergency Medical Services|emergency medical services
5314832|NCT00382655|Emergency Medical Technicians|emergency medical technicians
5314833|NCT00382642|alcoholism, alcohol disorder, drinking,alcohol|alcoholism, alcohol disorder, drinking,alcohol
5314834|NCT00382629|Multiple sclerosis|multiple sclerosis
5314835|NCT00382629|MS|ms
5314836|NCT00382629|Bayhill|bayhill
5314837|NCT00382629|BHT-3009|bht-3009
5314838|NCT00382629|immunotherapy|immunotherapy
5314839|NCT00382616|behavioral problems|behavioral problems
5314840|NCT00382616|learning problems|learning problems
5314841|NCT00382616|inattentive|inattentive
5314842|NCT00382616|impulsive|impulsive
5314843|NCT00382616|hyperactive|hyperactive
5314844|NCT00382616|children|children
5314845|NCT00382616|phosphatidylserine|phosphatidylserine
5314846|NCT00382616|long-chain polyunsaturated fatty acid|long-chain polyunsaturated fatty acid
5314847|NCT00382616|eicosapentaenoic acid|eicosapentaenoic acid
5314848|NCT00382616|docosahexaenoic acid|docosahexaenoic acid
5314849|NCT00382616|omega3:omega6 ratio|omega3:omega6 ratio
5314850|NCT00382616|eicosapentaenoic acid:arachidonic acid ratio|eicosapentaenoic acid:arachidonic acid ratio
5314851|NCT00382616|Test of Variables of Attention|test of variables of attention
5314852|NCT00382616|ADHD index scores|adhd index scores
5314853|NCT00382603|Contact Lens Care|contact lens care
5314854|NCT00382590|Acute Myelogenous Leukemia|acute myelogenous leukemia
5314855|NCT00382590|AML|aml
5314856|NCT00382590|Myelodysplastic Syndrome|myelodysplastic syndrome
5314857|NCT00382590|Leukemia|leukemia
5314858|NCT00382590|MDS|mds
5314859|NCT00382590|Azacytidine|azacytidine
5314860|NCT00382590|5-Azacytidine|5-azacytidine
5314861|NCT00382590|5-aza|5-aza
5314862|NCT00382590|Vidaza|vidaza
5314863|NCT00382590|5-AZC|5-azc
5314864|NCT00382590|AZA-CR|aza-cr
5314865|NCT00382590|Ladakamycin|ladakamycin
5314866|NCT00382590|Ara-C|ara-c
5314867|NCT00382590|Cytarabine|cytarabine
5314868|NCT00382590|Cytosar|cytosar
5314869|NCT00382590|DepoCyt|depocyt
5314870|NCT00382590|Cytosine arabinosine hydrochloride|cytosine arabinosine hydrochloride
5314871|NCT00382590|Valproic Acid|valproic acid
5314872|NCT00382590|VPA|vpa
5314873|NCT00382590|Depakene|depakene
5314874|NCT00382564|Imaging|imaging
5314875|NCT00382564|Arteriosclerosis|arteriosclerosis
5314876|NCT00382564|Hardening of the arteries|hardening of the arteries
5314877|NCT00382564|MRA|mra
5314878|NCT00382564|Narrowing of Vessels|narrowing of vessels
5314879|NCT00382564|Noninvasive Plaque Imaging|noninvasive plaque imaging
5314880|NCT00382564|Atherosclerotic Disease|atherosclerotic disease
5314881|NCT00382564|Plaque|plaque
5314882|NCT00382564|Arteries|arteries
5314883|NCT00382564|Diabetes|diabetes
5314884|NCT00382564|Hypertension|hypertension
5314885|NCT00382551|Alcohol|alcohol
5314886|NCT00382551|Red wine|red wine
5314887|NCT00382551|Endothelial function|endothelial function
5314888|NCT00382551|Flow-mediated vasodilation|flow-mediated vasodilation
5314889|NCT00382551|Cardiovascular disease|cardiovascular disease
5314890|NCT00382538|mifepristone|mifepristone
5314891|NCT00382538|induction|induction
5314892|NCT00382538|abortion|abortion
5314893|NCT00382538|injection, intra-amniotic|injection, intra-amniotic
5314894|NCT00382525|Bradyarrhythmia|bradyarrhythmia
5314895|NCT00382525|Atrial Fibrillation|atrial fibrillation
5314896|NCT00382525|Ventricular Tachycardia|ventricular tachycardia
5314897|NCT00382525|Ventricular Fibrillation|ventricular fibrillation
5314898|NCT00382525|Heart Failure|heart failure
5314899|NCT00382525|Pacemaker|pacemaker
5314900|NCT00382525|Implantable Cardioverter Defibrillator|implantable cardioverter defibrillator
5314901|NCT00382525|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
5314902|NCT00382525|Loop recorder|loop recorder
5314903|NCT00382525|Registry|registry
5314904|NCT00382512|Moderate Plaque Psoriasis|moderate plaque psoriasis
5314905|NCT00382499|Intravenous Lidocaine|intravenous lidocaine
5314906|NCT00382499|Lidocaine Infusion|lidocaine infusion
5314907|NCT00382499|Total Abdominal Hysterectomy|total abdominal hysterectomy
5314908|NCT00382499|Analgesia|analgesia
5314909|NCT00382499|Anesthesia|anesthesia
5314910|NCT00382499|Adjunct|adjunct
5314911|NCT00382486|Intestinal transplant|intestinal transplant
5314912|NCT00382486|Bone marrow|bone marrow
5314913|NCT00382486|Irradiation of allograft|irradiation of allograft
5314914|NCT00382473|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
5314915|NCT00382473|Overweight|overweight
5314916|NCT00382473|Fatty acid oxidation|fatty acid oxidation
5314917|NCT00382473|Mitochondria|mitochondria
5314918|NCT00382473|Exercise|exercise
5314919|NCT00382447|breath actuated nebulizer|breath actuated nebulizer
5314920|NCT00382447|nebulizer|nebulizer
5314921|NCT00382434|emergency pharmacist|emergency pharmacist
5314922|NCT00382434|emergency medicine|emergency medicine
5314923|NCT00382434|emergency department|emergency department
5314924|NCT00382434|medical error|medical error
5314925|NCT00382434|adverse event|adverse event
5314926|NCT00382434|pharmacist|pharmacist
5314927|NCT00382434|patient safety|patient safety
5314928|NCT00382421|Myocardial Ischemia|myocardial ischemia
5315027|NCT00382083|Pain|pain
5314929|NCT00382421|Randomized Controlled Trials|randomized controlled trials
5314930|NCT00382421|Drug Therapy|drug therapy
5314931|NCT00382408|Acute respiratory disease prevention|acute respiratory disease prevention
5314932|NCT00382408|Adenovirus|adenovirus
5314933|NCT00382395|Glaucoma shunt|glaucoma shunt
5314934|NCT00382395|Ocular implant|ocular implant
5314935|NCT00382395|Gold|gold
5314936|NCT00382395|trabeculectomy|trabeculectomy
5314937|NCT00382382|Autism|autism
5314938|NCT00382382|Asperger Syndrome|asperger syndrome
5314939|NCT00382382|Restricted repetitive behavior|restricted repetitive behavior
5314940|NCT00382382|Stereotyped patterns of behavior|stereotyped patterns of behavior
5314941|NCT00382382|Typically Developing children|typically developing children
5314942|NCT00382382|Human Volunteers|human volunteers
5314943|NCT00382369|familial vocal cord paralysis|familial vocal cord paralysis
5314944|NCT00382369|genetic screening|genetic screening
5314945|NCT00382356|Benign Prostatic Enlargement|benign prostatic enlargement
5314946|NCT00382356|Benign Prostatic Hypertrophy|benign prostatic hypertrophy
5314947|NCT00382356|Dutasteride|dutasteride
5314948|NCT00382356|5-alpha reductase inhibitors|5-alpha reductase inhibitors
5314949|NCT00382356|Hormonal therapy|hormonal therapy
5314950|NCT00382343|Prevention|prevention
5314951|NCT00382343|Pyelonephritis|pyelonephritis
5314952|NCT00382343|Renal scars|renal scars
5314953|NCT00382343|Vesico-ureteral reflux|vesico-ureteral reflux
5314954|NCT00382343|Dimercaptosuccinic acid renal scan (DMSA)|dimercaptosuccinic acid renal scan (dmsa)
5314955|NCT00382330|Vulva|vulva
5314956|NCT00382317|MSCT indications|msct indications
5314957|NCT00382304|Clostridium difficile-associated diarrhea|clostridium difficile-associated diarrhea
5314958|NCT00382304|C. difficile|c. difficile
5314959|NCT00382304|CDAD|cdad
5314960|NCT00382304|Clostridium difficile|clostridium difficile
5314961|NCT00382304|Clostridium difficile Disease|clostridium difficile disease
5314962|NCT00382304|Clostridium Enterocolitis|clostridium enterocolitis
5314963|NCT00382304|Antibiotic-Associated Colitis|antibiotic-associated colitis
5314964|NCT00382304|Infectious diarrhea|infectious diarrhea
5314965|NCT00382291|OCD|ocd
5314966|NCT00382291|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation
5314967|NCT00382291|Placebos|placebos
5314968|NCT00382291|Cognitive Behavior Therapy|cognitive behavior therapy
5314969|NCT00382291|Child Psychiatry|child psychiatry
5314970|NCT00382291|Activation Syndrome|activation syndrome
5314971|NCT00382291|Psychometrics|psychometrics
5314972|NCT00382278|Stem cell|stem cell
5314973|NCT00382278|Liver cirrhosis|liver cirrhosis
5314974|NCT00382278|Cellular therapy|cellular therapy
5314975|NCT00382278|Autologous|autologous
5314976|NCT00382278|Bone marrow|bone marrow
5314977|NCT00382265|urolithiasis|urolithiasis
5314978|NCT00382265|renal colic|renal colic
5314979|NCT00382265|kidney stones|kidney stones
5314980|NCT00382265|urinary stone disease|urinary stone disease
5314981|NCT00382252|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5314982|NCT00382252|lung metastases|lung metastases
5314983|NCT00382239|diabetes|diabetes
5314984|NCT00382239|exenatide|exenatide
5314985|NCT00382239|LY2148568|ly2148568
5314986|NCT00382239|Lilly|lilly
5314987|NCT00382239|Amylin|amylin
5314988|NCT00382239|Japan|japan
5314989|NCT00382226|Glaucoma|glaucoma
5314990|NCT00382200|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5314991|NCT00382200|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5314992|NCT00382187|influenza|influenza
5314993|NCT00382187|pandemic influenza|pandemic influenza
5314994|NCT00382187|influenza vaccine|influenza vaccine
5314995|NCT00382187|adjuvanted influenza vaccine|adjuvanted influenza vaccine
5314996|NCT00382187|H5N1 influenza antigen|h5n1 influenza antigen
5314997|NCT00382187|MF59|mf59
5314998|NCT00382187|Pandemic influenza disease|pandemic influenza disease
5314999|NCT00382174|pressure ulcers|pressure ulcers
5315000|NCT00382174|cutaneous wound- healing|cutaneous wound- healing
5315001|NCT00382174|chronic wound-healing|chronic wound-healing
5315002|NCT00382174|Thymosin Beta 4|thymosin beta 4
5315003|NCT00382174|laminin-5|laminin-5
5315004|NCT00382161|impotence|impotence
5315005|NCT00382161|erectile dysfunction|erectile dysfunction
5315006|NCT00382161|cardiovascular risk factor|cardiovascular risk factor
5315007|NCT00382161|statin|statin
5315008|NCT00382148|TOPS|tops
5315009|NCT00382148|Peanut allergy|peanut allergy
5315010|NCT00382148|Peanut-induced allergy|peanut-induced allergy
5315011|NCT00382148|Allergy|allergy
5315012|NCT00382135|Impotence|impotence
5315013|NCT00382135|erectile dysfunction|erectile dysfunction
5315014|NCT00382135|semen|semen
5315015|NCT00382135|sperm|sperm
5315016|NCT00382135|Healthy male volunteers|healthy male volunteers
5315017|NCT00382135|men with mild erectile dysfunction|men with mild erectile dysfunction
5315018|NCT00382122|Glaucoma|glaucoma
5315019|NCT00382122|Ocular hypertension|ocular hypertension
5315020|NCT00382122|Dry eye|dry eye
5315021|NCT00382122|Ocular surface disease|ocular surface disease
5315022|NCT00382096|Type 2 diabetes|type 2 diabetes
5315023|NCT00382096|vildagliptin|vildagliptin
5315024|NCT00382096|metformin|metformin
5315025|NCT00382096|hemoglobin A1c|hemoglobin a1c
5315028|NCT00382083|Discomfort|discomfort
5315029|NCT00382083|Breast|breast
5315030|NCT00382083|Pre-medication|pre-medication
5315031|NCT00382070|stage I breast cancer|stage i breast cancer
5315032|NCT00382070|stage II breast cancer|stage ii breast cancer
5315033|NCT00382070|stage IIIA breast cancer|stage iiia breast cancer
5315034|NCT00382057|Testosterone|testosterone
5315035|NCT00382057|Insulin resistance|insulin resistance
5315036|NCT00382057|Insulin sensitivity|insulin sensitivity
5315037|NCT00382057|Metabolic disorders|metabolic disorders
5315038|NCT00382044|Kidney Failure, Chronic|kidney failure, chronic
5315039|NCT00382044|Dialysis|dialysis
5315040|NCT00382044|Anemia|anemia
5315041|NCT00382044|epoetin|epoetin
5315042|NCT00382018|recurrent breast cancer|recurrent breast cancer
5315043|NCT00382018|stage IV breast cancer|stage iv breast cancer
5315044|NCT00381992|sexual risk behavior|sexual risk behavior
5315045|NCT00381992|diabetes mellitus|diabetes mellitus
5315046|NCT00381992|hypertension|hypertension
5315047|NCT00381992|obesity|obesity
5315048|NCT00381992|human immunodeficiency virus|human immunodeficiency virus
5315049|NCT00381992|hyperlipidemia|hyperlipidemia
5315050|NCT00381992|chlamydia|chlamydia
5315051|NCT00381979|Depression|depression
5315052|NCT00381979|Anxiety|anxiety
5315053|NCT00381979|Adolescents|adolescents
5315054|NCT00381979|Treatment|treatment
5315055|NCT00381979|Supportive Expressive Therapy|supportive expressive therapy
5315056|NCT00381966|Prostate Cancer|prostate cancer
5315057|NCT00381966|Brachytherapy|brachytherapy
5315058|NCT00381927|Breast Cancer Risk|breast cancer risk
5315059|NCT00381927|Counseling|counseling
5315060|NCT00381927|Prevention|prevention
5315061|NCT00381927|Anxiety|anxiety
5315062|NCT00381927|BRCA1 mutation|brca1 mutation
5315063|NCT00381927|BRCA2 mutation|brca2 mutation
5315064|NCT00381927|Tamoxifen|tamoxifen
5315065|NCT00381914|Infants|infants
5315066|NCT00381914|Vitamin D|vitamin d
5315067|NCT00381914|Dose-response|dose-response
5315068|NCT00381901|stage II breast cancer|stage ii breast cancer
5315069|NCT00381901|stage IIIA breast cancer|stage iiia breast cancer
5315070|NCT00381901|stage IIIB breast cancer|stage iiib breast cancer
5315071|NCT00381901|stage IA breast cancer|stage ia breast cancer
5315072|NCT00381901|stage IB breast cancer|stage ib breast cancer
5315073|NCT00381901|recurrent breast cancer|recurrent breast cancer
5315074|NCT00381901|stage IIIC breast cancer|stage iiic breast cancer
5315075|NCT00381888|thromboembolism|thromboembolism
5315076|NCT00381888|cervical cancer|cervical cancer
5315077|NCT00381888|endometrial cancer|endometrial cancer
5315078|NCT00381888|ovarian epithelial cancer|ovarian epithelial cancer
5315079|NCT00381888|ovarian germ cell tumor|ovarian germ cell tumor
5315080|NCT00381888|borderline ovarian surface epithelial-stromal tumor|borderline ovarian surface epithelial-stromal tumor
5315081|NCT00381888|ovarian sarcoma|ovarian sarcoma
5315082|NCT00381888|ovarian stromal cancer|ovarian stromal cancer
5315083|NCT00381888|uterine sarcoma|uterine sarcoma
5315084|NCT00381888|vaginal cancer|vaginal cancer
5315085|NCT00381888|vulvar cancer|vulvar cancer
5315086|NCT00381888|fallopian tube cancer|fallopian tube cancer
5315087|NCT00381875|HIV infection|hiv infection
5315088|NCT00381862|nausea and vomiting|nausea and vomiting
5315089|NCT00381862|recurrent colon cancer|recurrent colon cancer
5315090|NCT00381862|stage IV colon cancer|stage iv colon cancer
5315091|NCT00381862|recurrent rectal cancer|recurrent rectal cancer
5315092|NCT00381862|stage IV rectal cancer|stage iv rectal cancer
5315093|NCT00381849|Cystone|cystone
5315094|NCT00381849|Uricare|uricare
5315095|NCT00381849|Computerized tomography|computerized tomography
5315096|NCT00381849|Kidney calculi|kidney calculi
5315097|NCT00381849|Supersaturation|supersaturation
5315098|NCT00381849|Nephrolithiasis|nephrolithiasis
5315099|NCT00381849|Quantitative CT|quantitative ct
5315100|NCT00381836|Prostate Cancer|prostate cancer
5315101|NCT00381836|Anemia|anemia
5315102|NCT00381836|Blood transfusion|blood transfusion
5315103|NCT00381836|Cancer|cancer
5315104|NCT00381836|Critical illness|critical illness
5315105|NCT00381836|Drug efficacy|drug efficacy
5315106|NCT00381836|Drug safety|drug safety
5315107|NCT00381836|Drug tolerability|drug tolerability
5315108|NCT00381836|Erythropoietin|erythropoietin
5315109|NCT00381836|Fatigue|fatigue
5315110|NCT00381836|Hemoglobin|hemoglobin
5315111|NCT00381836|Human|human
5315112|NCT00381836|Male|male
5315113|NCT00381836|Multicenter study|multicenter study
5315114|NCT00381836|Quality of life|quality of life
5315115|NCT00381836|Questionnaire|questionnaire
5315116|NCT00381836|Randomized controlled trial|randomized controlled trial
5315117|NCT00381836|Recombinant erythropoietin|recombinant erythropoietin
5315118|NCT00381823|Pregnant women|pregnant women
5315119|NCT00381823|Intervention Studies|intervention studies
5315120|NCT00381823|African Americans|african americans
5315121|NCT00381823|Infant Mortality|infant mortality
5315122|NCT00381823|Environmental Tobacco Smoke Pollution|environmental tobacco smoke pollution
5315123|NCT00381823|Depression|depression
5315124|NCT00381823|Partner Abuse|partner abuse
5315125|NCT00381823|Tobacco Smoke|tobacco smoke
5315126|NCT00381810|Rituxan|rituxan
5315127|NCT00381810|SLE|sle
5315128|NCT00381810|Lupus|lupus
5315129|NCT00381784|YMSM|ymsm
5315130|NCT00381784|HIV/AIDS|hiv/aids
5315131|NCT00381784|Condom use|condom use
5315132|NCT00381784|Drug users|drug users
5315133|NCT00381784|Minority women|minority women
5315134|NCT00381771|Globus Pharyngeus|globus pharyngeus
5315135|NCT00381771|Xerostomia|xerostomia
5315136|NCT00381771|Salivary Hypofunction|salivary hypofunction
5315137|NCT00381771|Pharyngoxerosis|pharyngoxerosis
5315138|NCT00381758|ADHD|adhd
5315139|NCT00381758|Methylphenidate|methylphenidate
5315140|NCT00381758|Metadate CD|metadate cd
5315141|NCT00381758|Concerta|concerta
5315142|NCT00381758|COMACS|comacs
5315143|NCT00381758|Attention Deficit Hyperactivity Disorder (ADHD)|attention deficit hyperactivity disorder (adhd)
5315144|NCT00381732|Impotence|impotence
5315145|NCT00381732|erectile dysfunction|erectile dysfunction
5315146|NCT00381706|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
5315147|NCT00381706|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
5315148|NCT00381706|stage IV esophageal cancer|stage iv esophageal cancer
5315149|NCT00381706|recurrent esophageal cancer|recurrent esophageal cancer
5315150|NCT00381693|primary myelofibrosis|primary myelofibrosis
5315151|NCT00381693|polycythemia vera|polycythemia vera
5315152|NCT00381693|essential thrombocythemia|essential thrombocythemia
5315153|NCT00381693|secondary myelofibrosis|secondary myelofibrosis
5315154|NCT00381667|safety|safety
5315155|NCT00381667|GW642444M|gw642444m
5315156|NCT00381667|Single Dose|single dose
5315157|NCT00381667|pharmacodynamics|pharmacodynamics
5315158|NCT00381667|pharmacokinetics|pharmacokinetics
5315159|NCT00381667|GW642444H|gw642444h
5315160|NCT00381667|tolerability|tolerability
5315161|NCT00381654|Solid Tumors|solid tumors
5315162|NCT00381654|Tyrosine Kinases|tyrosine kinases
5315163|NCT00381628|Anatomy|anatomy
5315164|NCT00381628|cells|cells
5315165|NCT00381628|epithelial cells|epithelial cells
5315166|NCT00381628|blood cells|blood cells
5315167|NCT00381628|cystic fibrosis|cystic fibrosis
5315168|NCT00381628|equipment and supplies|equipment and supplies
5315169|NCT00381628|disposable equipment|disposable equipment
5315170|NCT00381628|reagent kits|reagent kits
5315171|NCT00381615|Meningococcal disease|meningococcal disease
5315172|NCT00381615|prevention|prevention
5315173|NCT00381615|vaccination|vaccination
5315174|NCT00381602|End stage renal disease|end stage renal disease
5315175|NCT00381602|Hemodialysis|hemodialysis
5315176|NCT00381602|Malnutrition|malnutrition
5315177|NCT00381602|End stage renal disease (ESRD)|end stage renal disease (esrd)
5315178|NCT00381589|clozapine-induced hypersalivation|clozapine-induced hypersalivation
5315179|NCT00381576|Resistance training|resistance training
5315180|NCT00381576|Strength training|strength training
5315181|NCT00381576|Training adaptations|training adaptations
5315182|NCT00381576|CNS|cns
5315183|NCT00381563|Bracing|bracing
5315184|NCT00381563|Patellofemoral|patellofemoral
5315185|NCT00381563|Osteoarthritis|osteoarthritis
5315186|NCT00381537|childhood epilepsy|childhood epilepsy
5315187|NCT00381537|Active childhood epilepsy|active childhood epilepsy
5315188|NCT00381524|human immunodeficiency virus|human immunodeficiency virus
5315189|NCT00381524|behavior change|behavior change
5315190|NCT00381511|pulmonary embolism,|pulmonary embolism,
5315191|NCT00381511|deferred diagnosis,|deferred diagnosis,
5315192|NCT00381511|protective anticoagulation|protective anticoagulation
5315193|NCT00381511|anticoagulants|anticoagulants
5315194|NCT00381472|Parkinson's Disease|parkinson's disease
5315195|NCT00381472|Dyskinesia|dyskinesia
5315196|NCT00381472|Adjunctive Therapy with L-dopa|adjunctive therapy with l-dopa
5315197|NCT00381446|corneal staining|corneal staining
5315198|NCT00381446|contact lens care|contact lens care
5315199|NCT00381446|multipurpose solution|multipurpose solution
5315200|NCT00381433|HCV|hcv
5315201|NCT00381433|Hepatitis C virus|hepatitis c virus
5315202|NCT00381407|ADHD|adhd
5315203|NCT00381407|Organizational Skills|organizational skills
5315204|NCT00381407|Contingency Management|contingency management
5315205|NCT00381394|amphotericin B|amphotericin b
5315206|NCT00381394|safety|safety
5315207|NCT00381394|tolerability and pharmacokinetics of oral sitamaquine|tolerability and pharmacokinetics of oral sitamaquine
5315208|NCT00381394|Visceral leishmaniasis|visceral leishmaniasis
5315209|NCT00381381|Alzheimer's disease|alzheimer's disease
5315210|NCT00381368|breast cancer|breast cancer
5315211|NCT00381368|skeletal metastases|skeletal metastases
5315212|NCT00381368|bisphosphonate therapy|bisphosphonate therapy
5315213|NCT00381368|Breast cancer with painful skeletal metastases|breast cancer with painful skeletal metastases
5315214|NCT00381355|asthma|asthma
5315215|NCT00381355|children|children
5315216|NCT00381355|written action plan|written action plan
5315217|NCT00381355|education|education
5315218|NCT00381355|guided self-management|guided self-management
5315219|NCT00381355|efficacy|efficacy
5315220|NCT00381355|compliance|compliance
5315221|NCT00381355|b2-agonists|b2-agonists
5315222|NCT00381355|inhaled corticosteroids|inhaled corticosteroids
5315223|NCT00381355|oral steroids|oral steroids
5315224|NCT00381355|relapse|relapse
5315225|NCT00381355|randomised controlled trial|randomised controlled trial
5315226|NCT00381355|emergency department|emergency department
5315227|NCT00381342|diabetes|diabetes
5315228|NCT00381342|exenatide|exenatide
5315229|NCT00381342|Amylin|amylin
5315230|NCT00381342|Lilly|lilly
5315231|NCT00381342|monotherapy|monotherapy
5315232|NCT00381329|Motivational Interviewing|motivational interviewing
5315233|NCT00381329|Structured Brief Advice|structured brief advice
5315234|NCT00381329|Adolescent Smoking|adolescent smoking
5315235|NCT00381329|Behavioral Intervention|behavioral intervention
5315236|NCT00381329|Smoking|smoking
5315237|NCT00381329|Primary Care|primary care
5315238|NCT00381329|Tobacco|tobacco
5315239|NCT00381303|HIV|hiv
5315240|NCT00381303|AIDS|aids
5315241|NCT00381303|Immunodeficiency Virus, Human|immunodeficiency virus, human
5315242|NCT00381303|Females|females
5315243|NCT00381303|Women|women
5315244|NCT00381303|PREZISTA|prezista
5315245|NCT00381303|darunavir|darunavir
5315246|NCT00381303|TMC114|tmc114
5315247|NCT00381303|Protease Inhibitor|protease inhibitor
5315248|NCT00381290|Arthritis|arthritis
5315249|NCT00381290|Arthritis, Degenerative|arthritis, degenerative
5315250|NCT00381290|Knee Health|knee health
5315251|NCT00381290|Obesity|obesity
5315252|NCT00381290|Overweight|overweight
5315253|NCT00381290|Osteoarthritis|osteoarthritis
5315254|NCT00381290|Weight Loss|weight loss
5315255|NCT00381290|Diet|diet
5315256|NCT00381290|Exercise|exercise
5315257|NCT00381290|Knee Pain|knee pain
5315258|NCT00381277|nephrolithiasis|nephrolithiasis
5315259|NCT00381277|citrate|citrate
5315260|NCT00381277|oxalate|oxalate
5315261|NCT00381251|vaginal atrophy|vaginal atrophy
5315262|NCT00381251|postmenopausal osteoporosis|postmenopausal osteoporosis
5315263|NCT00381251|menopause|menopause
5315264|NCT00381251|hot flashes|hot flashes
5315265|NCT00381238|Alzheimer's Disease|alzheimer's disease
5315266|NCT00381238|Rosiglitazone|rosiglitazone
5315267|NCT00381225|Radio-frequency ablation; Head and Neck neoplasia.|radio-frequency ablation; head and neck neoplasia.
5315268|NCT00381212|Immunotherapeutic injection|immunotherapeutic injection
5315269|NCT00381199|fibromyalgia|fibromyalgia
5315270|NCT00381199|cannabinoid|cannabinoid
5315271|NCT00381199|chronic pain|chronic pain
5315272|NCT00381199|sleep|sleep
5315273|NCT00381199|insomnia|insomnia
5315274|NCT00381199|diffuse widespread pain|diffuse widespread pain
5315275|NCT00381199|antidepressant|antidepressant
5315276|NCT00381186|impaired glucose tolerance|impaired glucose tolerance
5315277|NCT00381186|type 2 diabetes|type 2 diabetes
5315278|NCT00381173|MGI PHARMA|mgi pharma
5315279|NCT00381173|ZYC3-002|zyc3-002
5315280|NCT00381173|ZYC300|zyc300
5315281|NCT00381173|plasmid DNA|plasmid dna
5315282|NCT00381173|cyclophosphamide|cyclophosphamide
5315283|NCT00381173|Cytoxan|cytoxan
5315284|NCT00381173|advanced breast cancer|advanced breast cancer
5315285|NCT00381173|advanced ovarian cancer|advanced ovarian cancer
5315286|NCT00381173|hormone refractory prostate cancer|hormone refractory prostate cancer
5315287|NCT00381173|advanced colon cancer|advanced colon cancer
5315288|NCT00381173|advanced renal cancer|advanced renal cancer
5315289|NCT00381173|advanced stage malignancies|advanced stage malignancies
5315290|NCT00381173|immune therapy|immune therapy
5315291|NCT00381173|gene therapy|gene therapy
5315292|NCT00381173|biologic therapy|biologic therapy
5315293|NCT00381173|T-regulatory cells|t-regulatory cells
5315294|NCT00381173|cancer vaccine|cancer vaccine
5315295|NCT00381173|vaccine|vaccine
5315296|NCT00381173|Advanced stage malignancies-ovary, breast, colon, prostate|advanced stage malignancies-ovary, breast, colon, prostate
5315297|NCT00381160|weight loss|weight loss
5315298|NCT00381160|obesity|obesity
5315299|NCT00381160|sugar-sweetened beverages|sugar-sweetened beverages
5315300|NCT00381160|diet|diet
5315301|NCT00381160|adolescence|adolescence
5315302|NCT00381134|double-blind|double-blind
5315303|NCT00381134|placebo-controlled|placebo-controlled
5315304|NCT00381134|nephropathy|nephropathy
5315305|NCT00381134|blood pressure|blood pressure
5315306|NCT00381134|urine albumin to creatinine ratio|urine albumin to creatinine ratio
5315307|NCT00381134|placebo|placebo
5315308|NCT00381121|Tissue Biobank|tissue biobank
5315309|NCT00381121|molecular markers|molecular markers
5315310|NCT00381121|molecular pathways|molecular pathways
5315311|NCT00381108|BPH|bph
5315312|NCT00381082|Pediculus|pediculus
5315313|NCT00381082|capitis|capitis
5315314|NCT00381082|lice|lice
5315315|NCT00381069|Recreation Centers|recreation centers
5315316|NCT00381069|Families|families
5315317|NCT00381069|Obesity Prevention|obesity prevention
5315318|NCT00381056|labor and delivery care|labor and delivery care
5315319|NCT00381056|teamwork training|teamwork training
5315320|NCT00381056|crew resource management|crew resource management
5315321|NCT00381056|cluster-randomized trial|cluster-randomized trial
5315322|NCT00381043|Alcohol Dependence|alcohol dependence
5315323|NCT00381043|Family Medicine Setting|family medicine setting
5315324|NCT00381043|University of North Carolina at Chapel Hill|university of north carolina at chapel hill
5315325|NCT00381030|beta-Adrenergic Blockers|beta-adrenergic blockers
5315326|NCT00381030|Disease Management|disease management
5315327|NCT00381004|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
5315328|NCT00381004|Leukemia|leukemia
5315329|NCT00381004|Cyclophosphamide|cyclophosphamide
5315330|NCT00381004|Fludarabine|fludarabine
5315331|NCT00381004|Sargramostim|sargramostim
5315332|NCT00381004|Rituximab|rituximab
5315333|NCT00381004|GM-CSF|gm-csf
5315334|NCT00381004|FCR|fcr
5315335|NCT00380978|labor pain|labor pain
5315336|NCT00380978|cesarean section|cesarean section
5315337|NCT00380978|epidural analgesia|epidural analgesia
5315338|NCT00380978|opioid analgesics|opioid analgesics
5315339|NCT00380978|local anesthetics|local anesthetics
5315340|NCT00380978|labor induced|labor induced
5315341|NCT00380965|Chemotherapy-induced|chemotherapy-induced
5315342|NCT00380965|neuropathy|neuropathy
5315343|NCT00380965|cancer|cancer
5315344|NCT00380952|IDC|idc
5315345|NCT00380952|DCIS|dcis
5315346|NCT00380952|ILC|ilc
5315347|NCT00380926|polyunsatturated fatty acids|polyunsatturated fatty acids
5315348|NCT00380926|nutrition|nutrition
5315349|NCT00380926|low-dose allergen challenge|low-dose allergen challenge
5315350|NCT00380926|exhaled nitric oxide|exhaled nitric oxide
5315351|NCT00380887|bioavailability|bioavailability
5315352|NCT00380887|bioequivalence|bioequivalence
5315353|NCT00380887|marketed product|marketed product
5315354|NCT00380887|Premarin|premarin
5315355|NCT00380887|Medroxyprogesterone acetate|medroxyprogesterone acetate
5315357|NCT00380887|Postmenopausal|postmenopausal
5315358|NCT00380887|vasomotor symptoms|vasomotor symptoms
5315359|NCT00380874|Pain|pain
5315360|NCT00380874|chemotherapy|chemotherapy
5315361|NCT00380861|Total Knee Replacement|total knee replacement
5315362|NCT00380861|Flexion|flexion
5315363|NCT00380861|Range of Motion|range of motion
5315364|NCT00380861|Activities of Daily Living|activities of daily living
5315365|NCT00380861|Implant design|implant design
5315366|NCT00380861|Subject Satisfaction|subject satisfaction
5315367|NCT00380861|Non-inflammatory arthritis|non-inflammatory arthritis
5315368|NCT00380848|sleep apnea|sleep apnea
5315369|NCT00380848|end stage renal disease|end stage renal disease
5315370|NCT00380848|hemodiafiltration|hemodiafiltration
5315371|NCT00380835|metastatic breast cancer|metastatic breast cancer
5315372|NCT00380835|amrubicin|amrubicin
5315373|NCT00380822|alpa-glucosidase inhibitor|alpa-glucosidase inhibitor
5315374|NCT00380796|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5315375|NCT00380796|COPD|copd
5315376|NCT00380770|HIV|hiv
5315377|NCT00380770|AIDS|aids
5315378|NCT00380770|Kaposi's sarcoma|kaposi's sarcoma
5315379|NCT00380770|Human herpesvirus 8|human herpesvirus 8
5315380|NCT00380757|cardiac arrest|cardiac arrest
5315381|NCT00380757|CPR|cpr
5315382|NCT00380757|resuscitation|resuscitation
5315383|NCT00380757|fatigue|fatigue
5315384|NCT00380757|quality|quality
5315385|NCT00380731|Social Anxiety Disorder|social anxiety disorder
5315386|NCT00380731|Magnetic Resonance Imaging|magnetic resonance imaging
5315387|NCT00380731|Cognitive Behavior Therapy|cognitive behavior therapy
5315388|NCT00380640|Pediatrics|pediatrics
5315389|NCT00380640|Epidermolysis Bullosa|epidermolysis bullosa
5315390|NCT00380640|Trimethoprim|trimethoprim
5315391|NCT00380640|Wound Healing|wound healing
5315392|NCT00380614|Acute Hepatitis B, Lamivudine|acute hepatitis b, lamivudine
5315393|NCT00380575|hyponatremia|hyponatremia
5315394|NCT00380575|hypervolemic|hypervolemic
5315395|NCT00380575|euvolemic|euvolemic
5315396|NCT00380575|vasopressins|vasopressins
5315397|NCT00380575|YM087|ym087
5315398|NCT00380562|Quality of life|quality of life
5315399|NCT00380562|Cognitive Functioning|cognitive functioning
5315400|NCT00380562|Activities of Daily Living|activities of daily living
5315401|NCT00380562|Disability prevention|disability prevention
5315402|NCT00380549|osteoarthritis, hip replacement|osteoarthritis, hip replacement
5315403|NCT00380536|Peer-led Education|peer-led education
5315404|NCT00380510|Family Physicians|family physicians
5315405|NCT00380510|Adolescents|adolescents
5315406|NCT00380510|Preventive Care|preventive care
5315407|NCT00380510|Health Behavior|health behavior
5315408|NCT00380497|Pediatrics|pediatrics
5315409|NCT00380497|Colonoscopy|colonoscopy
5315410|NCT00380497|Bowel cleanout|bowel cleanout
5315411|NCT00380497|Poly-Ethylene Glycol|poly-ethylene glycol
5315412|NCT00380497|Pico-Salax|pico-salax
5315413|NCT00380471|bath PUVA|bath puva
5315414|NCT00380458|Obstructive|obstructive
5315415|NCT00380458|Sleep|sleep
5315416|NCT00380458|Apnea|apnea
5315417|NCT00380458|Pain|pain
5315418|NCT00380458|UPPP|uppp
5315419|NCT00380458|Tonsillectomy|tonsillectomy
5315420|NCT00380458|Narcotics|narcotics
5315421|NCT00380445|Vildagliptin, Type 2 diabetes|vildagliptin, type 2 diabetes
5315422|NCT00380419|Pregnancy|pregnancy
5315423|NCT00380419|Postpartum Depression|postpartum depression
5315424|NCT00380406|Gonadotropin releasing hormone agonist|gonadotropin releasing hormone agonist
5315425|NCT00380406|GnRH|gnrh
5315426|NCT00380406|Fertility|fertility
5315427|NCT00380406|Fertility preservation|fertility preservation
5315428|NCT00380406|Oncology|oncology
5315429|NCT00380406|Cancer|cancer
5315430|NCT00380406|Chemotherapy|chemotherapy
5315431|NCT00380393|Malaria|malaria
5315432|NCT00380393|Plasmodium|plasmodium
5315433|NCT00380393|RTS|rts
5315434|NCT00380393|S/AS01|s/as01
5315435|NCT00380393|Falciparum|falciparum
5315436|NCT00380380|Vildagliptin, type 2 diabetes, gastric emptying|vildagliptin, type 2 diabetes, gastric emptying
5315437|NCT00380354|allergen|allergen
5315438|NCT00380354|methacholine|methacholine
5315439|NCT00380354|GSK256066|gsk256066
5315440|NCT00380354|mild asthmatics|mild asthmatics
5315441|NCT00380354|repeat dose|repeat dose
5315442|NCT00380354|challenge|challenge
5315443|NCT00380354|late asthmatic response|late asthmatic response
5315444|NCT00380328|Pharmacokinetic|pharmacokinetic
5315445|NCT00380328|healthy subjects|healthy subjects
5315446|NCT00380315|Cough|cough
5315447|NCT00380315|Chronic bronchitis|chronic bronchitis
5315448|NCT00380315|PNDs|pnds
5315449|NCT00380315|Post Nasal Drip syndrome|post nasal drip syndrome
5315450|NCT00380315|GERD|gerd
5315451|NCT00380315|gastroesophageal reflux disease|gastroesophageal reflux disease
5315452|NCT00380315|bronchiectasis|bronchiectasis
5315453|NCT00380302|Alzheimer's disease|alzheimer's disease
5315454|NCT00380302|symptomatic|symptomatic
5315455|NCT00380302|cognition|cognition
5315456|NCT00380289|Essential hypertension|essential hypertension
5315457|NCT00380289|Glucose metabolism|glucose metabolism
5315458|NCT00380289|Thiazides|thiazides
5315459|NCT00380289|Beta blockers|beta blockers
5315460|NCT00380276|Alzheimer's|alzheimer's
5315461|NCT00380276|Dementia|dementia
5315462|NCT00380276|Dementia of Alzheimer Type|dementia of alzheimer type
5315463|NCT00380237|Bird Flu|bird flu
5315464|NCT00380237|Avian Flu|avian flu
5315465|NCT00380224|schizophrenia|schizophrenia
5315466|NCT00380211|Thimerosal reduced content|thimerosal reduced content
5315467|NCT00380211|Immunogenicity, safety, reactogenicity|immunogenicity, safety, reactogenicity
5315468|NCT00380211|Young and elderly adults|young and elderly adults
5315469|NCT00380211|Influenza vaccine|influenza vaccine
5315470|NCT00380185|Peripheral Arterial Disease|peripheral arterial disease
5315471|NCT00380185|Atherosclerosis|atherosclerosis
5315472|NCT00380172|AMD|amd
5315473|NCT00380172|Macular Degeneration|macular degeneration
5315474|NCT00380172|Retinal Degeneration|retinal degeneration
5315475|NCT00380159|Extension study to ACH443-014A|extension study to ach443-014a
5315476|NCT00380146|Malaria|malaria
5315477|NCT00380146|Intermittent presumptive treatment|intermittent presumptive treatment
5315478|NCT00380146|IPT|ipt
5315479|NCT00380146|Pharmacokinetic|pharmacokinetic
5315480|NCT00380146|Efficacy|efficacy
5315481|NCT00380146|Gametocyte|gametocyte
5315482|NCT00380146|Molecular markers|molecular markers
5315483|NCT00380133|COPD SB-681323 prednisolone biomarkers|copd sb-681323 prednisolone biomarkers
5315484|NCT00380107|Minor surgery|minor surgery
5315485|NCT00380107|Volume optimization|volume optimization
5315486|NCT00380107|Volume deficit|volume deficit
5315487|NCT00380107|Epidural anesthesia|epidural anesthesia
5315488|NCT00380094|ACS|acs
5315489|NCT00380094|NSTEMI|nstemi
5315490|NCT00380094|Myeloperoxidase|myeloperoxidase
5315491|NCT00380094|nonST segment elevation myocardial infarction|nonst segment elevation myocardial infarction
5315492|NCT00380081|Insomnia|insomnia
5315493|NCT00380055|Cancer Screening|cancer screening
5315494|NCT00380055|Navigators|navigators
5315495|NCT00380055|Community Outreach|community outreach
5315496|NCT00380055|Behavioral Change|behavioral change
5315497|NCT00380055|Access|access
5315498|NCT00380042|Cortical Electrical Stimulation|cortical electrical stimulation
5315499|NCT00380042|Treatment Resistant Depression|treatment resistant depression
5315500|NCT00380042|Major Depressive Disorder|major depressive disorder
5315501|NCT00380029|stage II bladder cancer|stage ii bladder cancer
5315502|NCT00380029|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
5315503|NCT00380016|Angioplasty|angioplasty
5315504|NCT00380016|Stent|stent
5315505|NCT00380016|Coronary Artery Disease|coronary artery disease
5315506|NCT00380016|Peripheral Artery Disease|peripheral artery disease
5315507|NCT00380016|Percutaneous Coronary Intervention|percutaneous coronary intervention
5315508|NCT00380016|CAD|cad
5315509|NCT00380016|PAD|pad
5315510|NCT00380016|Cardiovascular Disease|cardiovascular disease
5315511|NCT00379990|iNOS|inos
5315512|NCT00379990|Exhaled NO|exhaled no
5315513|NCT00379990|Rheumatoid arthritis|rheumatoid arthritis
5315514|NCT00379938|Parvovirus B-19, Parvoviridae, vaccine|parvovirus b-19, parvoviridae, vaccine
5315515|NCT00379925|Physical Activity|physical activity
5315516|NCT00379925|Exercise|exercise
5315517|NCT00379925|Dietary Habits|dietary habits
5315518|NCT00379899|calcification|calcification
5315519|NCT00379899|vascular calcification|vascular calcification
5315520|NCT00379899|coronary vascular calcification|coronary vascular calcification
5315521|NCT00379899|chronic kidney disease|chronic kidney disease
5315522|NCT00379899|end stage renal disease|end stage renal disease
5315523|NCT00379899|dialysis|dialysis
5315524|NCT00379886|ECT|ect
5315525|NCT00379886|Depression|depression
5315526|NCT00379886|Anesthiticum|anesthiticum
5315527|NCT00379886|Propofol|propofol
5315528|NCT00379886|Thiopental|thiopental
5315529|NCT00379847|hyponatremia|hyponatremia
5315530|NCT00379847|hypervolemic|hypervolemic
5315531|NCT00379847|euvolemic|euvolemic
5315532|NCT00379847|treatment outcomes|treatment outcomes
5315533|NCT00379847|YM087|ym087
5315534|NCT00379834|glaucoma|glaucoma
5315535|NCT00379834|diurnal|diurnal
5315536|NCT00379834|intraocular pressure|intraocular pressure
5315635|NCT00379444|tobacco, intervention, tobacco cessation, ALaska Natives,|tobacco, intervention, tobacco cessation, alaska natives,
5315537|NCT00379821|chloroquine, malaria, Plasmodium falciparum, Malawi, children|chloroquine, malaria, plasmodium falciparum, malawi, children
5315538|NCT00379808|coronary heart disease|coronary heart disease
5315539|NCT00379808|montelukast|montelukast
5315540|NCT00379808|inflammation|inflammation
5315541|NCT00379795|CNV|cnv
5315542|NCT00379795|Lucentis|lucentis
5315543|NCT00379795|AMD|amd
5315544|NCT00379795|Age-related macular degeneration|age-related macular degeneration
5315545|NCT00379795|RVO|rvo
5315546|NCT00379769|diabetes|diabetes
5315547|NCT00379769|CV outcomes|cv outcomes
5315548|NCT00379769|rosiglitazone|rosiglitazone
5315549|NCT00379769|Type II diabetes|type ii diabetes
5315550|NCT00379769|sulfonylurea|sulfonylurea
5315551|NCT00379769|RECORD|record
5315552|NCT00379769|metformin|metformin
5315553|NCT00379756|Erectile dysfunction, impotence|erectile dysfunction, impotence
5315554|NCT00379730|CT scan|ct scan
5315555|NCT00379730|breathing tests|breathing tests
5315556|NCT00379730|lung function tests|lung function tests
5315557|NCT00379730|biomarkers|biomarkers
5315558|NCT00379730|prednisolone|prednisolone
5315559|NCT00379730|IOS|ios
5315560|NCT00379730|COPD|copd
5315561|NCT00379730|clinical outcomes|clinical outcomes
5315562|NCT00379717|helical tomotherapy|helical tomotherapy
5315563|NCT00379717|dose escalation|dose escalation
5315564|NCT00379717|chemotherapy|chemotherapy
5315565|NCT00379704|Tissue factor|tissue factor
5315566|NCT00379704|Obesity|obesity
5315567|NCT00379704|Adipose tissue|adipose tissue
5315568|NCT00379704|Microparticles|microparticles
5315569|NCT00379691|spinal|spinal
5315570|NCT00379691|Cesarean section|cesarean section
5315571|NCT00379691|hypotension|hypotension
5315572|NCT00379691|nausea|nausea
5315573|NCT00379691|vomiting|vomiting
5315574|NCT00379691|phenylephrine|phenylephrine
5315575|NCT00379678|atopic dermatitis|atopic dermatitis
5315576|NCT00379665|Lung|lung
5315577|NCT00379665|Chemotherapy|chemotherapy
5315578|NCT00379665|Cisplatin|cisplatin
5315579|NCT00379665|Intratumoral|intratumoral
5315580|NCT00379665|Bronchoscope|bronchoscope
5315581|NCT00379665|Brachytherapy|brachytherapy
5315582|NCT00379652|Community Health Centers|community health centers
5315583|NCT00379652|Diabetes|diabetes
5315584|NCT00379652|Blood Pressure, High|blood pressure, high
5315585|NCT00379639|Pancreatic cancer|pancreatic cancer
5315586|NCT00379639|advanced solid tumors|advanced solid tumors
5315587|NCT00379626|Paraphilia|paraphilia
5315588|NCT00379626|Hormonal treatment|hormonal treatment
5315589|NCT00379626|Cognitive treatment|cognitive treatment
5315590|NCT00379600|Anti-inflammatory treatment|anti-inflammatory treatment
5315591|NCT00379600|Rheumatoid Arthritis|rheumatoid arthritis
5315592|NCT00379587|Rituximab|rituximab
5315593|NCT00379587|Chronic GVHD|chronic gvhd
5315594|NCT00379574|diffuse large B-cell lymphoma|diffuse large b-cell lymphoma
5315595|NCT00379574|Bortezomib|bortezomib
5315596|NCT00379574|CHOP|chop
5315597|NCT00379574|Lenograstim|lenograstim
5315598|NCT00379561|Prostate Cancer|prostate cancer
5315599|NCT00379561|Recurrent Prostate Cancer|recurrent prostate cancer
5315600|NCT00379561|Non-Metastatic prostate cancer|non-metastatic prostate cancer
5315601|NCT00379561|Recurrent Localized Prostate Cancer with Biochemical Failure|recurrent localized prostate cancer with biochemical failure
5315602|NCT00379535|pregnancy , lack of iodine|pregnancy , lack of iodine
5315603|NCT00379535|lack of iodine during pregnancy|lack of iodine during pregnancy
5315604|NCT00379522|hemorrhagic|hemorrhagic
5315605|NCT00379522|shock|shock
5315606|NCT00379522|traumatic|traumatic
5315607|NCT00379522|shock treatment|shock treatment
5315608|NCT00379522|vasopressin|vasopressin
5315609|NCT00379522|Circulatory Collapse|circulatory collapse
5315610|NCT00379522|Hypovolemic Shock|hypovolemic shock
5315611|NCT00379509|recurrent breast cancer|recurrent breast cancer
5315612|NCT00379509|stage IIIA breast cancer|stage iiia breast cancer
5315613|NCT00379509|stage IIIB breast cancer|stage iiib breast cancer
5315614|NCT00379509|stage IIIC breast cancer|stage iiic breast cancer
5315615|NCT00379509|stage IV breast cancer|stage iv breast cancer
5315616|NCT00379509|male breast cancer|male breast cancer
5315617|NCT00379496|Fibromyalgia|fibromyalgia
5315618|NCT00379496|Acupuncture|acupuncture
5315619|NCT00379496|Randomized study|randomized study
5315620|NCT00379483|Transfusional iron overload|transfusional iron overload
5315621|NCT00379483|Deferasirox|deferasirox
5315622|NCT00379470|Brain tumor|brain tumor
5315623|NCT00379470|Treatment|treatment
5315624|NCT00379470|Minimal toxicity|minimal toxicity
5315625|NCT00379470|GBM|gbm
5315626|NCT00379470|Glioblastoma|glioblastoma
5315627|NCT00379470|Recurrent|recurrent
5315628|NCT00379470|TTFields|ttfields
5315629|NCT00379457|alveolar childhood rhabdomyosarcoma|alveolar childhood rhabdomyosarcoma
5315630|NCT00379457|previously untreated childhood rhabdomyosarcoma|previously untreated childhood rhabdomyosarcoma
5315631|NCT00379457|childhood malignant mesenchymoma|childhood malignant mesenchymoma
5315632|NCT00379457|nonmetastatic childhood soft tissue sarcoma|nonmetastatic childhood soft tissue sarcoma
5315633|NCT00379457|embryonal childhood rhabdomyosarcoma|embryonal childhood rhabdomyosarcoma
5315634|NCT00379457|embryonal-botryoid childhood rhabdomyosarcoma|embryonal-botryoid childhood rhabdomyosarcoma
5316207|NCT00378092|Risperidone|risperidone
5315636|NCT00379444|Native Americans, pregnancy, women|native americans, pregnancy, women
5315637|NCT00379405|Saquinavir/ritonavir|saquinavir/ritonavir
5315638|NCT00379405|Single therapy|single therapy
5315639|NCT00379405|Virological efficacy|virological efficacy
5315640|NCT00379405|Safety|safety
5315641|NCT00379405|HIV-1|hiv-1
5315642|NCT00379392|Stroke|stroke
5315643|NCT00379392|Mental Imagery|mental imagery
5315644|NCT00379392|Constraint Induced Therapy|constraint induced therapy
5315645|NCT00379379|electroacupuncture, plasma glucose, plasma insulin|electroacupuncture, plasma glucose, plasma insulin
5315646|NCT00379366|Randomized Controlled Trials|randomized controlled trials
5315647|NCT00379366|Renal Dialysis|renal dialysis
5315648|NCT00379366|Graft Occlusion, Vascular|graft occlusion, vascular
5315649|NCT00379366|Angioplasty|angioplasty
5315650|NCT00379366|Vascular Patency|vascular patency
5315651|NCT00379366|Radiation, Ionizing|radiation, ionizing
5315652|NCT00379353|Advanced Cancers|advanced cancers
5315653|NCT00379353|Anorexia|anorexia
5315654|NCT00379353|Fatigue|fatigue
5315655|NCT00379353|Thalidomide|thalidomide
5315656|NCT00379353|Placebo|placebo
5315657|NCT00379327|Pregnancy|pregnancy
5315658|NCT00379327|Acupuncture|acupuncture
5315659|NCT00379327|Pregnancy Outcome|pregnancy outcome
5315660|NCT00379327|Randomized Controlled Trial|randomized controlled trial
5315661|NCT00379327|Double-Blind Method|double-blind method
5315662|NCT00379314|Incontinence|incontinence
5315663|NCT00379314|Urinary|urinary
5315664|NCT00379314|Female|female
5315665|NCT00379314|Surgery|surgery
5315666|NCT00379314|Complications|complications
5315667|NCT00379301|Atrial Fibrillation|atrial fibrillation
5315668|NCT00379301|A-Fib|a-fib
5315669|NCT00379301|AF|af
5315670|NCT00379301|Persistent|persistent
5315671|NCT00379301|Permanent|permanent
5315672|NCT00379301|Pulmonary Vein Isolation|pulmonary vein isolation
5315673|NCT00379301|Ablation|ablation
5315674|NCT00379275|Sarcoidosis|sarcoidosis
5315675|NCT00379275|Uveitis|uveitis
5315676|NCT00379275|Pulmonary Sarcoidosis|pulmonary sarcoidosis
5315677|NCT00379275|HLA-Typing|hla-typing
5315678|NCT00379275|Cytokines|cytokines
5315679|NCT00379275|Serum Markers|serum markers
5315680|NCT00379262|Nasopharyngeal Carcinoma|nasopharyngeal carcinoma
5315681|NCT00379262|Chemoradiotherapy|chemoradiotherapy
5315682|NCT00379262|Accelerated Fractionation|accelerated fractionation
5315683|NCT00379249|hypercholesterolemia|hypercholesterolemia
5315684|NCT00379249|statin|statin
5315685|NCT00379249|compliance|compliance
5315686|NCT00379236|osteoarthritis|osteoarthritis
5315687|NCT00379236|knee|knee
5315688|NCT00379223|retinal vein occlusion|retinal vein occlusion
5315689|NCT00379223|vitrectomy|vitrectomy
5315690|NCT00379223|surgery|surgery
5315691|NCT00379223|retinal disorders|retinal disorders
5315692|NCT00379223|vascular diseases|vascular diseases
5315693|NCT00379210|Attention|attention
5315694|NCT00379210|ERP|erp
5315695|NCT00379210|event-related potentials|event-related potentials
5315696|NCT00379210|fMRI|fmri
5315697|NCT00379210|functional magnetic resonance imaging|functional magnetic resonance imaging
5315698|NCT00379210|MBSR|mbsr
5315699|NCT00379210|Mindfulness Based Stress Reduction|mindfulness based stress reduction
5315700|NCT00379210|Mindfulness Meditation Training|mindfulness meditation training
5315701|NCT00379210|MMT|mmt
5315702|NCT00379197|stage IV breast cancer, estrogen receptor positive|stage iv breast cancer, estrogen receptor positive
5315703|NCT00379197|recurrent breast cancer|recurrent breast cancer
5315704|NCT00379197|hormone-refractory, metastatic breast cancer|hormone-refractory, metastatic breast cancer
5315705|NCT00379184|arthritis|arthritis
5315706|NCT00379171|Children|children
5315707|NCT00379171|Complementary feeding|complementary feeding
5315708|NCT00379171|Breast feeding|breast feeding
5315709|NCT00379171|Cow's milk|cow's milk
5315710|NCT00379171|Formula|formula
5315711|NCT00379171|Protein|protein
5315712|NCT00379171|LCPUFA|lcpufa
5315713|NCT00379171|Fish oil|fish oil
5315714|NCT00379171|Lipid profile|lipid profile
5315715|NCT00379171|Intestinal inflammation|intestinal inflammation
5315716|NCT00379171|Intestinal microbiota|intestinal microbiota
5315717|NCT00379158|multiple micronutrient supplements|multiple micronutrient supplements
5315718|NCT00379158|home-fortification|home-fortification
5315719|NCT00379158|complementary foods|complementary foods
5315720|NCT00379158|infants|infants
5315721|NCT00379158|Ghana|ghana
5315722|NCT00379145|uterine leiomyosarcoma|uterine leiomyosarcoma
5315723|NCT00379145|recurrent uterine sarcoma|recurrent uterine sarcoma
5315724|NCT00379145|stage III uterine sarcoma|stage iii uterine sarcoma
5315725|NCT00379145|stage IV uterine sarcoma|stage iv uterine sarcoma
5315726|NCT00379132|Glioma|glioma
5315727|NCT00379132|prostatic|prostatic
5315728|NCT00379132|breast|breast
5315729|NCT00379132|non-small cell lung|non-small cell lung
5315730|NCT00379132|melanoma|melanoma
5315731|NCT00379132|colorectal|colorectal
5315732|NCT00379132|pancreatic|pancreatic
5315733|NCT00379119|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5315734|NCT00379119|recurrent prostate cancer|recurrent prostate cancer
5315735|NCT00379119|stage I prostate cancer|stage i prostate cancer
5315736|NCT00379119|stage IIB prostate cancer|stage iib prostate cancer
5315737|NCT00379119|stage IIA prostate cancer|stage iia prostate cancer
5315738|NCT00379119|stage III prostate cancer|stage iii prostate cancer
5315739|NCT00379106|Supportive|supportive
5315740|NCT00379106|Mastectomy|mastectomy
5315741|NCT00379106|Quality of Life|quality of life
5315742|NCT00379106|Arm Function|arm function
5315743|NCT00379093|Alcohol|alcohol
5315744|NCT00379093|Comorbidity|comorbidity
5315745|NCT00379093|Aging|aging
5315746|NCT00379093|Brief Advice|brief advice
5315747|NCT00379093|Randomized Trial|randomized trial
5315748|NCT00379067|Benign Prostatic Hyperplasia|benign prostatic hyperplasia
5315749|NCT00379067|Nocturia|nocturia
5315750|NCT00379067|Actigraphy|actigraphy
5315751|NCT00379067|Tamsulosin|tamsulosin
5315752|NCT00379054|social support, smoking, smoking cessation, intervention,|social support, smoking, smoking cessation, intervention,
5315753|NCT00379054|telephone counseling|telephone counseling
5315754|NCT00379041|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
5315755|NCT00379041|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
5315756|NCT00379028|COPD|copd
5315757|NCT00379015|stage IIIB breast cancer|stage iiib breast cancer
5315758|NCT00379015|stage IIIC breast cancer|stage iiic breast cancer
5315759|NCT00379015|stage IV breast cancer|stage iv breast cancer
5315760|NCT00379002|Interstitial Cystitis|interstitial cystitis
5315761|NCT00379002|Sexual Dysfunction|sexual dysfunction
5315762|NCT00379002|Vulvodynia|vulvodynia
5315763|NCT00379002|Pelvic Pain|pelvic pain
5315764|NCT00379002|incontinence|incontinence
5315765|NCT00378976|HIV infection|hiv infection
5315766|NCT00378976|HIV shedding|hiv shedding
5315767|NCT00378976|HSV suppression|hsv suppression
5315768|NCT00378976|Co-infected|co-infected
5315770|NCT00378976|Reactivation|reactivation
5315771|NCT00378976|Valacyclovir|valacyclovir
5315772|NCT00378950|Congestive Heart Failure|congestive heart failure
5315773|NCT00378937|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5315774|NCT00378937|pain|pain
5315775|NCT00378885|HIV-prevention|hiv-prevention
5315776|NCT00378885|Internet Prevention intervention|internet prevention intervention
5315777|NCT00378885|Online randomized controlled trial|online randomized controlled trial
5315778|NCT00378885|Effect evaluation|effect evaluation
5315779|NCT00378885|MSM|msm
5315780|NCT00378885|Steady relationships|steady relationships
5315781|NCT00378859|Children|children
5315782|NCT00378859|Milk|milk
5315783|NCT00378859|Meat|meat
5315784|NCT00378859|Animal Protein|animal protein
5315785|NCT00378859|Growth Factors|growth factors
5315786|NCT00378859|IGF-I|igf-i
5315787|NCT00378859|IGFBP-3|igfbp-3
5315788|NCT00378859|Insulin|insulin
5315789|NCT00378846|fever, sweats, and hot flashes|fever, sweats, and hot flashes
5315790|NCT00378833|Primary Hypercholesterolemia or Mixed Hyperlipidemia|primary hypercholesterolemia or mixed hyperlipidemia
5315791|NCT00378820|Children|children
5315792|NCT00378820|Whey|whey
5315793|NCT00378820|Casein|casein
5315794|NCT00378820|Milk minerals|milk minerals
5315795|NCT00378820|Growth factors|growth factors
5315796|NCT00378820|IGF-I|igf-i
5315797|NCT00378820|Insulin|insulin
5315798|NCT00378781|infection|infection
5315799|NCT00378781|poor vascular access|poor vascular access
5315800|NCT00378781|thromboembolism|thromboembolism
5315801|NCT00378781|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5315802|NCT00378781|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5315803|NCT00378781|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5315804|NCT00378781|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5315805|NCT00378781|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5315806|NCT00378781|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5315807|NCT00378781|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5315808|NCT00378781|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5315809|NCT00378781|atypical chronic myeloid leukemia, BCR-ABL negative|atypical chronic myeloid leukemia, bcr-abl negative
5315810|NCT00378781|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5315811|NCT00378781|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
5315812|NCT00378781|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
5315813|NCT00378781|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
5315814|NCT00378781|chronic eosinophilic leukemia|chronic eosinophilic leukemia
5315815|NCT00378781|primary myelofibrosis|primary myelofibrosis
5315816|NCT00378781|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5315817|NCT00378781|chronic neutrophilic leukemia|chronic neutrophilic leukemia
5315818|NCT00378781|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5315819|NCT00378781|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5315820|NCT00378781|disseminated neuroblastoma|disseminated neuroblastoma
5315821|NCT00378781|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5315822|NCT00378781|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
5316884|NCT00376155|drugs|drugs
5315823|NCT00378781|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
5315824|NCT00378781|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5315825|NCT00378781|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
5315826|NCT00378781|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5315827|NCT00378781|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
5315828|NCT00378781|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
5315829|NCT00378781|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
5315830|NCT00378781|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
5315831|NCT00378781|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5315832|NCT00378781|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5315833|NCT00378781|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5315834|NCT00378781|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5315835|NCT00378781|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
5315836|NCT00378781|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
5315837|NCT00378781|poor prognosis metastatic gestational trophoblastic tumor|poor prognosis metastatic gestational trophoblastic tumor
5315838|NCT00378781|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5315839|NCT00378781|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5315840|NCT00378781|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5315841|NCT00378781|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5315842|NCT00378781|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5315843|NCT00378781|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5315844|NCT00378781|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5315845|NCT00378781|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5315846|NCT00378781|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5315847|NCT00378781|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5315848|NCT00378781|recurrent breast cancer|recurrent breast cancer
5315849|NCT00378781|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
5315850|NCT00378781|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5315851|NCT00378781|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5315852|NCT00378781|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
5315853|NCT00378781|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
5315854|NCT00378781|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
5315855|NCT00378781|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5315856|NCT00378781|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5315857|NCT00378781|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5315858|NCT00378781|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5315859|NCT00378781|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5315860|NCT00378781|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5315861|NCT00378781|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5315862|NCT00378781|recurrent neuroblastoma|recurrent neuroblastoma
5315863|NCT00378781|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5315864|NCT00378781|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
5315865|NCT00378781|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5315866|NCT00378781|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
5315867|NCT00378781|recurrent Wilms tumor and other childhood kidney tumors|recurrent wilms tumor and other childhood kidney tumors
5315868|NCT00378781|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5315869|NCT00378781|refractory hairy cell leukemia|refractory hairy cell leukemia
5315870|NCT00378781|refractory multiple myeloma|refractory multiple myeloma
5315871|NCT00378781|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5315872|NCT00378781|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5315873|NCT00378781|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5315874|NCT00378781|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5315875|NCT00378781|stage I multiple myeloma|stage i multiple myeloma
5315876|NCT00378781|stage II multiple myeloma|stage ii multiple myeloma
5315877|NCT00378781|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
5315878|NCT00378781|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5315879|NCT00378781|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5315880|NCT00378781|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5315881|NCT00378781|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5315882|NCT00378781|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5315883|NCT00378781|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5315884|NCT00378781|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5315885|NCT00378781|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5315886|NCT00378781|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5315887|NCT00378781|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5315888|NCT00378781|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5315889|NCT00378781|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5315890|NCT00378781|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5315891|NCT00378781|stage III multiple myeloma|stage iii multiple myeloma
5315892|NCT00378781|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5315893|NCT00378781|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5315894|NCT00378781|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
5315895|NCT00378781|stage IIIA breast cancer|stage iiia breast cancer
5315896|NCT00378781|stage IIIB breast cancer|stage iiib breast cancer
5315897|NCT00378781|stage IIIC breast cancer|stage iiic breast cancer
5315898|NCT00378781|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5315899|NCT00378781|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5315900|NCT00378781|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5315901|NCT00378781|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5315902|NCT00378781|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5315903|NCT00378781|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5315904|NCT00378781|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5315905|NCT00378781|stage IV breast cancer|stage iv breast cancer
5315906|NCT00378781|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5315907|NCT00378781|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5315908|NCT00378781|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5315909|NCT00378781|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5315910|NCT00378781|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5315911|NCT00378781|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5315912|NCT00378781|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5315913|NCT00378781|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5315914|NCT00378781|acute undifferentiated leukemia|acute undifferentiated leukemia
5315915|NCT00378781|mast cell leukemia|mast cell leukemia
5315916|NCT00378781|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
5315917|NCT00378781|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
5315918|NCT00378781|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
5315919|NCT00378781|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
5315920|NCT00378781|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
5315921|NCT00378781|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
5315922|NCT00378781|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
5315923|NCT00378781|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
5315924|NCT00378781|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
5315925|NCT00378781|prolymphocytic leukemia|prolymphocytic leukemia
5315926|NCT00378781|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
5315927|NCT00378781|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
5315928|NCT00378781|stage I childhood Hodgkin lymphoma|stage i childhood hodgkin lymphoma
5315929|NCT00378781|stage II childhood Hodgkin lymphoma|stage ii childhood hodgkin lymphoma
5315930|NCT00378781|stage III childhood Hodgkin lymphoma|stage iii childhood hodgkin lymphoma
5315931|NCT00378781|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
5315932|NCT00378781|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5315933|NCT00378781|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
5315934|NCT00378781|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
5315935|NCT00378781|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
5315936|NCT00378781|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
5315937|NCT00378781|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
5315938|NCT00378781|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
5315939|NCT00378781|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
5315940|NCT00378781|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
5315941|NCT00378781|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
5315942|NCT00378781|adult grade III lymphomatoid granulomatosis|adult grade iii lymphomatoid granulomatosis
5315943|NCT00378781|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
5315944|NCT00378781|childhood grade III lymphomatoid granulomatosis|childhood grade iii lymphomatoid granulomatosis
5315945|NCT00378781|recurrent childhood grade III lymphomatoid granulomatosis|recurrent childhood grade iii lymphomatoid granulomatosis
5315946|NCT00378781|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
5315947|NCT00378781|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
5315948|NCT00378781|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
5315949|NCT00378781|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
5315950|NCT00378781|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
5316885|NCT00376142|Intention|intention
5315951|NCT00378781|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
5315952|NCT00378781|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
5315953|NCT00378781|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
5315954|NCT00378781|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
5315955|NCT00378781|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
5315956|NCT00378781|stage I mantle cell lymphoma|stage i mantle cell lymphoma
5315957|NCT00378781|stage I marginal zone lymphoma|stage i marginal zone lymphoma
5315958|NCT00378781|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
5315959|NCT00378781|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
5315960|NCT00378781|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
5315961|NCT00378781|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
5315962|NCT00378781|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
5315963|NCT00378781|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
5315964|NCT00378781|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
5315965|NCT00378781|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
5315966|NCT00378781|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
5315967|NCT00378781|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
5315968|NCT00378781|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
5315969|NCT00378781|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
5315970|NCT00378781|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
5315971|NCT00378781|stage I childhood large cell lymphoma|stage i childhood large cell lymphoma
5315972|NCT00378781|stage II childhood large cell lymphoma|stage ii childhood large cell lymphoma
5315973|NCT00378781|stage III childhood large cell lymphoma|stage iii childhood large cell lymphoma
5315974|NCT00378781|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
5315975|NCT00378781|stage I childhood lymphoblastic lymphoma|stage i childhood lymphoblastic lymphoma
5315976|NCT00378781|stage II childhood lymphoblastic lymphoma|stage ii childhood lymphoblastic lymphoma
5315977|NCT00378781|stage III childhood lymphoblastic lymphoma|stage iii childhood lymphoblastic lymphoma
5315978|NCT00378781|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
5315979|NCT00378781|stage I childhood small noncleaved cell lymphoma|stage i childhood small noncleaved cell lymphoma
5315980|NCT00378781|stage II childhood small noncleaved cell lymphoma|stage ii childhood small noncleaved cell lymphoma
5315981|NCT00378781|stage III childhood small noncleaved cell lymphoma|stage iii childhood small noncleaved cell lymphoma
5315982|NCT00378781|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
5315983|NCT00378781|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
5315984|NCT00378781|post-transplant lymphoproliferative disorder|post-transplant lymphoproliferative disorder
5315985|NCT00378781|intraocular lymphoma|intraocular lymphoma
5315986|NCT00378781|stage I melanoma|stage i melanoma
5315987|NCT00378781|stage II melanoma|stage ii melanoma
5315988|NCT00378781|stage III melanoma|stage iii melanoma
5315989|NCT00378781|stage IV melanoma|stage iv melanoma
5315990|NCT00378781|recurrent melanoma|recurrent melanoma
5315991|NCT00378781|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5315992|NCT00378781|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
5315993|NCT00378781|stage I adult soft tissue sarcoma|stage i adult soft tissue sarcoma
5315994|NCT00378781|stage II adult soft tissue sarcoma|stage ii adult soft tissue sarcoma
5315995|NCT00378781|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
5315996|NCT00378781|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
5315997|NCT00378781|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
5315998|NCT00378781|metastatic childhood soft tissue sarcoma|metastatic childhood soft tissue sarcoma
5315999|NCT00378781|nonmetastatic childhood soft tissue sarcoma|nonmetastatic childhood soft tissue sarcoma
5316000|NCT00378781|recurrent childhood soft tissue sarcoma|recurrent childhood soft tissue sarcoma
5316001|NCT00378781|localized Ewing sarcoma/peripheral primitive neuroectodermal tumor|localized ewing sarcoma/peripheral primitive neuroectodermal tumor
5316002|NCT00378781|metastatic Ewing sarcoma/peripheral primitive neuroectodermal tumor|metastatic ewing sarcoma/peripheral primitive neuroectodermal tumor
5316003|NCT00378781|recurrent Ewing sarcoma/peripheral primitive neuroectodermal tumor|recurrent ewing sarcoma/peripheral primitive neuroectodermal tumor
5316004|NCT00378781|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
5316005|NCT00378781|previously untreated childhood rhabdomyosarcoma|previously untreated childhood rhabdomyosarcoma
5316006|NCT00378781|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
5316007|NCT00378781|recurrent uterine sarcoma|recurrent uterine sarcoma
5316008|NCT00378781|stage I uterine sarcoma|stage i uterine sarcoma
5316009|NCT00378781|stage II uterine sarcoma|stage ii uterine sarcoma
5316010|NCT00378781|stage III uterine sarcoma|stage iii uterine sarcoma
5316011|NCT00378781|stage IV uterine sarcoma|stage iv uterine sarcoma
5316012|NCT00378781|localized osteosarcoma|localized osteosarcoma
5316013|NCT00378781|metastatic osteosarcoma|metastatic osteosarcoma
5316014|NCT00378781|recurrent osteosarcoma|recurrent osteosarcoma
5316886|NCT00376142|Behaviour|behaviour
5316015|NCT00378781|chondrosarcoma|chondrosarcoma
5316016|NCT00378781|small intestine leiomyosarcoma|small intestine leiomyosarcoma
5316017|NCT00378781|recurrent small intestine cancer|recurrent small intestine cancer
5316018|NCT00378781|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
5316019|NCT00378768|stage I multiple myeloma|stage i multiple myeloma
5316020|NCT00378768|stage II multiple myeloma|stage ii multiple myeloma
5316021|NCT00378768|stage III multiple myeloma|stage iii multiple myeloma
5316022|NCT00378768|refractory multiple myeloma|refractory multiple myeloma
5316023|NCT00378755|velcade|velcade
5316024|NCT00378755|myeloma|myeloma
5316025|NCT00378755|VAD regimen|vad regimen
5316026|NCT00378755|Transplantation, Autologous|transplantation, autologous
5316027|NCT00378742|Glaucoma|glaucoma
5316028|NCT00378742|Gene|gene
5316029|NCT00378742|Phenotype-Genotype correlation|phenotype-genotype correlation
5316030|NCT00378742|Molecular Diagnosis|molecular diagnosis
5316031|NCT00378742|Retinal Degeneration|retinal degeneration
5316032|NCT00378742|Inherited Eye Disease|inherited eye disease
5316033|NCT00378742|Retinitis Pigmentosa|retinitis pigmentosa
5316034|NCT00378742|Macular Dystrophy|macular dystrophy
5316035|NCT00378742|Congenital Glaucoma|congenital glaucoma
5316036|NCT00378729|PCOS|pcos
5316037|NCT00378729|FERTILOSCOPY|fertiloscopy
5316038|NCT00378729|Ovarian hyperstimulation|ovarian hyperstimulation
5316039|NCT00378729|Multiple pregnancies|multiple pregnancies
5316040|NCT00378729|Patient with PCOS (Rotterdam criteria)|patient with pcos (rotterdam criteria)
5316041|NCT00378729|Failure of treatment with Clomiphene Citrate|failure of treatment with clomiphene citrate
5316042|NCT00378729|Age between 18 and 36 years old|age between 18 and 36 years old
5316043|NCT00378729|Spermogram must be normal|spermogram must be normal
5316044|NCT00378729|Permeability of Fallopian tubes|permeability of fallopian tubes
5316045|NCT00378716|stage II colon cancer|stage ii colon cancer
5316046|NCT00378716|stage III colon cancer|stage iii colon cancer
5316047|NCT00378716|adenocarcinoma of the colon|adenocarcinoma of the colon
5316048|NCT00378690|Prostate Cancer|prostate cancer
5316049|NCT00378690|Prostate Specific Antigen|prostate specific antigen
5316050|NCT00378677|Powder inhalation|powder inhalation
5316051|NCT00378677|Side effects|side effects
5316052|NCT00378677|Nephrotoxicity|nephrotoxicity
5316053|NCT00378677|Calcineurin inhibitor|calcineurin inhibitor
5316054|NCT00378677|Bronchiolitis obliterans syndrome|bronchiolitis obliterans syndrome
5316055|NCT00378677|Forced Expiratory Volume|forced expiratory volume
5316056|NCT00378664|urinary incontinence|urinary incontinence
5316057|NCT00378664|spinal cord injury|spinal cord injury
5316058|NCT00378664|spina bifida|spina bifida
5316059|NCT00378651|Intubation, Endotracheal|intubation, endotracheal
5316060|NCT00378651|Anesthesia, General|anesthesia, general
5316061|NCT00378638|lymph|lymph
5316062|NCT00378638|node|node
5316063|NCT00378638|positive|positive
5316064|NCT00378638|breast|breast
5316065|NCT00378638|cancer|cancer
5316066|NCT00378638|metastases|metastases
5316067|NCT00378638|angiogenesis|angiogenesis
5316068|NCT00378638|bevacizumab|bevacizumab
5316069|NCT00378638|chemotherapy|chemotherapy
5316070|NCT00378612|trials|trials
5316071|NCT00378612|stents|stents
5316072|NCT00378612|coronary occlusions|coronary occlusions
5316073|NCT00378547|Tonsillectomy|tonsillectomy
5316074|NCT00378547|pregabalin|pregabalin
5316075|NCT00378547|dexamethasone|dexamethasone
5316076|NCT00378547|multimodal postoperative analgesia|multimodal postoperative analgesia
5316077|NCT00378534|Chronic Myelogenous Leukemia (CML)|chronic myelogenous leukemia (cml)
5316078|NCT00378534|Acute Myelogenous Leukemia (AML)|acute myelogenous leukemia (aml)
5316079|NCT00378534|Chronic Lymphocytic Leukemia (CLL)|chronic lymphocytic leukemia (cll)
5316080|NCT00378534|Acute Lymphoblastic Leukemia (ALL)|acute lymphoblastic leukemia (all)
5316081|NCT00378534|Myelodysplastic Syndrome (MDS)|myelodysplastic syndrome (mds)
5316082|NCT00378534|Leukemia|leukemia
5316083|NCT00378534|Chronic Myelogenous Leukemia|chronic myelogenous leukemia
5316084|NCT00378534|CML|cml
5316085|NCT00378534|Acute Myeloid Leukemia|acute myeloid leukemia
5316086|NCT00378534|AML|aml
5316087|NCT00378534|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
5316088|NCT00378534|CLL|cll
5316089|NCT00378534|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
5316090|NCT00378534|ALL|all
5316091|NCT00378534|Myelodysplasia Syndrome|myelodysplasia syndrome
5316092|NCT00378521|Raynaud's|raynaud's
5316093|NCT00378521|Nitroglycerin|nitroglycerin
5316094|NCT00378521|topical gel|topical gel
5316095|NCT00378521|cold hands|cold hands
5316096|NCT00378521|painful hands|painful hands
5316097|NCT00378521|scleroderma|scleroderma
5316098|NCT00378508|immune therapy|immune therapy
5316099|NCT00378508|autoimmunity|autoimmunity
5316100|NCT00378508|insulin secretion|insulin secretion
5316101|NCT00378508|diabetes mellitus|diabetes mellitus
5316102|NCT00378495|miltefosine|miltefosine
5316103|NCT00378495|kala azar|kala azar
5316104|NCT00378495|Brazil|brazil
5316105|NCT00378482|Melanoma and other tumors|melanoma and other tumors
5316106|NCT00378469|Hepcidin|hepcidin
5316107|NCT00378469|Hemojuvelin|hemojuvelin
5316108|NCT00378469|Iron|iron
5316109|NCT00378469|Healthy volunteers|healthy volunteers
5316110|NCT00378417|Otitis Media|otitis media
5316111|NCT00378417|Pneumococcal Infections|pneumococcal infections
5316112|NCT00378417|Pneumococcal Vaccines|pneumococcal vaccines
5316113|NCT00378417|Proportional Hazards Models|proportional hazards models
5316114|NCT00378417|Prospective Studies|prospective studies
5316115|NCT00378417|Streptococcus pneumoniae|streptococcus pneumoniae
5316116|NCT00378417|Vaccines, Conjugate|vaccines, conjugate
5316117|NCT00378404|NSCLC|nsclc
5316118|NCT00378404|Non-Small Cell Lung Cancer|non-small cell lung cancer
5316119|NCT00378404|Non-Small Cell|non-small cell
5316120|NCT00378404|Lung Cancer|lung cancer
5316121|NCT00378404|Docetaxel|docetaxel
5316122|NCT00378404|Radiation|radiation
5316123|NCT00378404|Metastatic|metastatic
5316124|NCT00378404|Recurrent|recurrent
5316125|NCT00378391|ST-Elevation Myocardial Infarction|st-elevation myocardial infarction
5316126|NCT00378391|upstream abciximab|upstream abciximab
5316127|NCT00378391|guideline adherence|guideline adherence
5316128|NCT00378391|hospital networking|hospital networking
5316129|NCT00378365|Acute promyelocytic leukaemia|acute promyelocytic leukaemia
5316130|NCT00378365|ATRA|atra
5316131|NCT00378365|Idarubicin|idarubicin
5316132|NCT00378365|Arsenic trioxide|arsenic trioxide
5316133|NCT00378365|Patient with a newly acute promyelocytic leukaemia (APL)|patient with a newly acute promyelocytic leukaemia (apl)
5316134|NCT00378365|Unmapped MeSH term|unmapped mesh term
5316135|NCT00378352|Acute Myocardial Infarction|acute myocardial infarction
5316136|NCT00378352|Left Ventricular Remodeling|left ventricular remodeling
5316137|NCT00378352|Cardiac Magnetic Resonance Imaging|cardiac magnetic resonance imaging
5316138|NCT00378352|Endothelial Progenitor Cells|endothelial progenitor cells
5316139|NCT00378352|Infarct Size|infarct size
5316140|NCT00378339|arthrosis|arthrosis
5316141|NCT00378339|gold|gold
5316142|NCT00378326|paraneoplastic syndrome|paraneoplastic syndrome
5316143|NCT00378313|NSABP|nsabp
5316144|NCT00378313|gemcitabine|gemcitabine
5316145|NCT00378313|epirubicin|epirubicin
5316146|NCT00378313|paclitaxel|paclitaxel
5316147|NCT00378313|Taxol|taxol
5316148|NCT00378313|breast cancer|breast cancer
5316149|NCT00378313|neoadjuvant chemotherapy|neoadjuvant chemotherapy
5316150|NCT00378313|primary chemotherapy|primary chemotherapy
5316151|NCT00378300|Atopic Dermatitis|atopic dermatitis
5316152|NCT00378300|Probiotics|probiotics
5316153|NCT00378300|T Regulatory Cells|t regulatory cells
5316154|NCT00378287|Acid Reflux|acid reflux
5316155|NCT00378287|Proton Pump Inhibitor|proton pump inhibitor
5316156|NCT00378287|GERD|gerd
5316157|NCT00378274|Neuropathic pain|neuropathic pain
5316158|NCT00378274|Chronic pain|chronic pain
5316159|NCT00378274|Depression|depression
5316160|NCT00378274|Anxiety|anxiety
5316161|NCT00378261|Rheumatoid Arthritis|rheumatoid arthritis
5316162|NCT00378248|Personality disorders,|personality disorders,
5316163|NCT00378248|Day treatment,|day treatment,
5316164|NCT00378248|Group psychotherapy,|group psychotherapy,
5316165|NCT00378248|Combined psychotherapy,|combined psychotherapy,
5316166|NCT00378248|Outcome,|outcome,
5316167|NCT00378248|Attachment pattern|attachment pattern
5316168|NCT00378235|neurosurgery, craniotomy|neurosurgery, craniotomy
5316169|NCT00378235|convection-enhanced delivery|convection-enhanced delivery
5316170|NCT00378235|CNS interstitial infusion|cns interstitial infusion
5316171|NCT00378235|recombinant toxins|recombinant toxins
5316172|NCT00378235|malignant glioma, recurrent|malignant glioma, recurrent
5316173|NCT00378235|catheter,|catheter,
5316174|NCT00378235|intratumoral therapy|intratumoral therapy
5316175|NCT00378235|positive pressure microinfusion|positive pressure microinfusion
5316176|NCT00378222|Myeloma previously untreated|myeloma previously untreated
5316177|NCT00378222|Single autologous transplantation|single autologous transplantation
5316178|NCT00378222|Double autologous transplantation|double autologous transplantation
5316179|NCT00378222|Complete response|complete response
5316180|NCT00378209|relapsed multiple myeloma|relapsed multiple myeloma
5316181|NCT00378209|refractory multiple myeloma|refractory multiple myeloma
5316182|NCT00378196|Idiopathic Parafoveal Telangiectasia (IPT)|idiopathic parafoveal telangiectasia (ipt)
5316183|NCT00378196|Also Known As Idiopathic Juxtafoveal Telangiectasia (IJFT)|also known as idiopathic juxtafoveal telangiectasia (ijft)
5316184|NCT00378183|weight loss|weight loss
5316185|NCT00378183|behavioral therapy|behavioral therapy
5316186|NCT00378183|risperidone|risperidone
5316187|NCT00378183|switching antipsychotics|switching antipsychotics
5316188|NCT00378183|schizoaffective disorder|schizoaffective disorder
5316189|NCT00378183|Risperdal|risperdal
5316190|NCT00378183|schizophrenia|schizophrenia
5316191|NCT00378183|olanzapine|olanzapine
5316192|NCT00378183|Zyprexa|zyprexa
5316193|NCT00378170|intubation|intubation
5316194|NCT00378170|difficulty|difficulty
5316195|NCT00378170|Macintosh|macintosh
5316196|NCT00378170|dental damage|dental damage
5316197|NCT00378170|complications|complications
5316198|NCT00378157|autism|autism
5316199|NCT00378157|joint attention|joint attention
5316200|NCT00378157|intervention|intervention
5316201|NCT00378157|joint engagement|joint engagement
5316202|NCT00378157|language|language
5316203|NCT00378118|HIV-1|hiv-1
5316204|NCT00378118|HIV-2|hiv-2
5316205|NCT00378105|newly diagnosed multiple myeloma|newly diagnosed multiple myeloma
5316206|NCT00378092|Schizophrenia|schizophrenia
5316208|NCT00378092|Risperdal consta|risperdal consta
5316209|NCT00378053|Radiation|radiation
5316210|NCT00378053|Exposure|exposure
5316211|NCT00378053|Hand|hand
5316212|NCT00378053|Orthopaedic|orthopaedic
5316213|NCT00378053|Surgeons|surgeons
5316214|NCT00378027|Pulmonary Embolism|pulmonary embolism
5316215|NCT00378027|PE|pe
5316216|NCT00378027|Outpatient|outpatient
5316217|NCT00378027|Anticoagulation|anticoagulation
5316218|NCT00378014|Liver transplantation, everolimus, CNI|liver transplantation, everolimus, cni
5316219|NCT00378001|Infertility, FSH, IVF, Ovarian stimulation|infertility, fsh, ivf, ovarian stimulation
5316220|NCT00377988|Contraception|contraception
5316221|NCT00377988|Hormonal contraception|hormonal contraception
5316222|NCT00377988|Oral contraception|oral contraception
5316223|NCT00377988|Ethinyl estradiol|ethinyl estradiol
5316224|NCT00377988|Progestin|progestin
5316225|NCT00377988|Transdermal|transdermal
5316226|NCT00377988|Thrombosis|thrombosis
5316227|NCT00377988|Venous thromboembolism|venous thromboembolism
5316228|NCT00377975|UCP-1|ucp-1
5316229|NCT00377975|ephedrine|ephedrine
5316230|NCT00377975|caffeine|caffeine
5316231|NCT00377975|pioglitazone|pioglitazone
5316232|NCT00377962|thoracic transplant recipients|thoracic transplant recipients
5316233|NCT00377962|everolimus|everolimus
5316234|NCT00377962|immunosuppressants|immunosuppressants
5316235|NCT00377949|Systemic Sclerosis|systemic sclerosis
5316236|NCT00377949|Scleroderma|scleroderma
5316237|NCT00377949|Pulmonary Hypertension|pulmonary hypertension
5316238|NCT00377949|PHAROS|pharos
5316239|NCT00377949|PHROS|phros
5316240|NCT00377949|Exercise Echocardiogram|exercise echocardiogram
5316241|NCT00377949|Pulmonary Functional Tests|pulmonary functional tests
5316242|NCT00377949|Six minute walk tests|six minute walk tests
5316243|NCT00377949|6 minute walk tests|6 minute walk tests
5316244|NCT00377949|Right heart catheterization|right heart catheterization
5316245|NCT00377936|Adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
5316246|NCT00377936|Locally advanced|locally advanced
5316247|NCT00377936|Metastatic|metastatic
5316248|NCT00377923|pharmacodynamic and pharmacokinetic study|pharmacodynamic and pharmacokinetic study
5316249|NCT00377923|Progesterone|progesterone
5316250|NCT00377923|healthy volunteers|healthy volunteers
5316251|NCT00377923|Endometrial decidualisation|endometrial decidualisation
5316252|NCT00377910|Chronic Achilles tendinopathy|chronic achilles tendinopathy
5316253|NCT00377910|Polidocanol|polidocanol
5316254|NCT00377910|Ultrasound|ultrasound
5316255|NCT00377910|Efficacy|efficacy
5316256|NCT00377910|RCT|rct
5316257|NCT00377897|critical leg ischemia|critical leg ischemia
5316258|NCT00377897|PAD|pad
5316259|NCT00377897|cell therapy|cell therapy
5316260|NCT00377884|THA|tha
5316261|NCT00377871|Stentless|stentless
5316262|NCT00377871|Biological|biological
5316263|NCT00377871|aortic|aortic
5316264|NCT00377871|heart|heart
5316265|NCT00377871|valve|valve
5316266|NCT00377871|prosthesis|prosthesis
5316267|NCT00377871|artificial|artificial
5316268|NCT00377858|diabetes|diabetes
5316269|NCT00377858|type 2|type 2
5316270|NCT00377845|self test|self test
5316271|NCT00377845|PAP smear|pap smear
5316272|NCT00377845|tampon test|tampon test
5316273|NCT00377845|cervical dysplasia|cervical dysplasia
5316274|NCT00377832|Fetal tachycardia|fetal tachycardia
5316275|NCT00377832|Fever in labor|fever in labor
5316276|NCT00377832|Acetaminophen|acetaminophen
5316277|NCT00377832|Non reassuring fetal status|non reassuring fetal status
5316278|NCT00377819|RANKL|rankl
5316279|NCT00377819|RANK|rank
5316280|NCT00377819|denosumab|denosumab
5316281|NCT00377819|AMG 162|amg 162
5316282|NCT00377819|osteoporosis|osteoporosis
5316283|NCT00377819|bone turnover|bone turnover
5316284|NCT00377819|bone mineral density|bone mineral density
5316285|NCT00377819|clinical trial|clinical trial
5316286|NCT00377819|postmenopausal osteoporosis|postmenopausal osteoporosis
5316287|NCT00377819|alendronate|alendronate
5316288|NCT00377819|total hip bone mineral density|total hip bone mineral density
5316289|NCT00377806|Superficial thrombophlebitis, diclofenac gel, non steroidal antiinflammatory drugs|superficial thrombophlebitis, diclofenac gel, non steroidal antiinflammatory drugs
5316290|NCT00377780|Breast cancer|breast cancer
5316291|NCT00377780|metastatic|metastatic
5316292|NCT00377780|cardiotoxicity|cardiotoxicity
5316293|NCT00377780|liposomal|liposomal
5316294|NCT00377780|doxorubicin|doxorubicin
5316295|NCT00377780|trastuzumab|trastuzumab
5316296|NCT00377780|docetaxel|docetaxel
5316297|NCT00377780|HER2/neu positive metastatic breast cancer|her2/neu positive metastatic breast cancer
5316298|NCT00377767|Chronic Care Model|chronic care model
5316299|NCT00377767|Obesity|obesity
5316300|NCT00377767|Overweight|overweight
5316301|NCT00377767|Children|children
5316302|NCT00377767|Body Mass Index|body mass index
5316303|NCT00377767|Primary Care|primary care
5316304|NCT00377754|dengue virus, immunity, hemorrhagic fever, Philippines|dengue virus, immunity, hemorrhagic fever, philippines
5316305|NCT00377728|Seasonal Allergic Rhinitis Inflammation Vienna CHallenge Chamber|seasonal allergic rhinitis inflammation vienna challenge chamber
5316306|NCT00377715|Dimebon, Alzheimer's Disease, Alzheimer's Disease Assessment Scale-cognitive subscale (ADAS-cog)|dimebon, alzheimer's disease, alzheimer's disease assessment scale-cognitive subscale (adas-cog)
5316307|NCT00377702|Coronary Heart Disease|coronary heart disease
5316308|NCT00377702|Risk Factors|risk factors
5316309|NCT00377702|Heart Failure|heart failure
5316310|NCT00377689|Accidental falls|accidental falls
5316311|NCT00377689|Cerebrovascular accident|cerebrovascular accident
5316312|NCT00377689|Balance|balance
5316313|NCT00377689|ADL|adl
5316314|NCT00377689|Self efficacy|self efficacy
5316315|NCT00377689|Quality of Life|quality of life
5316316|NCT00377689|Gait parameters|gait parameters
5316317|NCT00377676|diabetes|diabetes
5316318|NCT00377676|diabetes mellitus|diabetes mellitus
5316319|NCT00377611|Influenza vaccine|influenza vaccine
5316320|NCT00377598|Herpes Zoster|herpes zoster
5316321|NCT00377598|Neuralgia|neuralgia
5316322|NCT00377598|Drug Therapy|drug therapy
5316323|NCT00377585|Elderly|elderly
5316324|NCT00377585|Improved vaccine|improved vaccine
5316325|NCT00377585|Influenza|influenza
5316326|NCT00377585|Influenza disease|influenza disease
5316327|NCT00377572|Immunoglobulins|immunoglobulins
5316328|NCT00377572|Immunoglobulin E|immunoglobulin e
5316329|NCT00377572|omalizumab|omalizumab
5316330|NCT00377572|anti-IgE|anti-ige
5316331|NCT00377559|Breast cancer|breast cancer
5316332|NCT00377559|metastatic|metastatic
5316333|NCT00377559|cardiotoxicity|cardiotoxicity
5316334|NCT00377559|liposomal|liposomal
5316335|NCT00377559|doxorubicin|doxorubicin
5316336|NCT00377559|docetaxel|docetaxel
5316337|NCT00377559|HER2/neu negative metastatic breast cancer|her2/neu negative metastatic breast cancer
5316338|NCT00377546|Retinal Surgery|retinal surgery
5316339|NCT00377533|wheelchairs|wheelchairs
5316340|NCT00377533|caregivers|caregivers
5316341|NCT00377533|skills|skills
5316342|NCT00377507|catechin|catechin
5316343|NCT00377507|elderly|elderly
5316344|NCT00377507|mouth washing|mouth washing
5316345|NCT00377507|disabled|disabled
5316346|NCT00377507|colonized|colonized
5316347|NCT00377494|malaria, Plasmodium falciparum, vaccine, Ghana|malaria, plasmodium falciparum, vaccine, ghana
5316348|NCT00377468|THC|thc
5316349|NCT00377468|CRPS|crps
5316350|NCT00377468|Pain|pain
5316351|NCT00377468|Complex Regional Pain Syndrome|complex regional pain syndrome
5316352|NCT00377468|Neuropathic Pain|neuropathic pain
5316353|NCT00377468|Chronic|chronic
5316354|NCT00377468|Prevention|prevention
5316355|NCT00377455|scleroderma|scleroderma
5316356|NCT00377455|systemic sclerosis|systemic sclerosis
5316357|NCT00377455|bosentan|bosentan
5316358|NCT00377455|pulmonary hypertension|pulmonary hypertension
5316359|NCT00377455|PHAROS|pharos
5316360|NCT00377455|PHROS|phros
5316361|NCT00377455|exercise echocardiogram|exercise echocardiogram
5316362|NCT00377429|Epithelial Cancer|epithelial cancer
5316363|NCT00377429|Epithelial Carcinoma|epithelial carcinoma
5316364|NCT00377429|Epithelial Ovarian Cancer|epithelial ovarian cancer
5316365|NCT00377429|Epithelial Ovarian Carcinoma|epithelial ovarian carcinoma
5316366|NCT00377429|Fallopian Tube Cancer|fallopian tube cancer
5316367|NCT00377429|Fallopian Tube Carcinoma|fallopian tube carcinoma
5316368|NCT00377429|Ovarian Cancer|ovarian cancer
5316369|NCT00377429|Ovarian Carcinoma|ovarian carcinoma
5316370|NCT00377429|Ovarian Epithelial Cancer|ovarian epithelial cancer
5316371|NCT00377429|Ovarian Epithelial Carcinoma|ovarian epithelial carcinoma
5316372|NCT00377429|Peritoneal Cancer|peritoneal cancer
5316373|NCT00377429|Peritoneal Carcinoma|peritoneal carcinoma
5316374|NCT00377429|Advanced Epithelial Ovarian Cancer|advanced epithelial ovarian cancer
5316375|NCT00377416|Gene Transfer Techniques|gene transfer techniques
5316376|NCT00377416|Gene Therapy|gene therapy
5316377|NCT00377403|rhinosinusitis, sinusitis, amoxicillin|rhinosinusitis, sinusitis, amoxicillin
5316378|NCT00377390|Immunoglobulin|immunoglobulin
5316379|NCT00377390|IgE|ige
5316380|NCT00377390|Omalizumab|omalizumab
5316381|NCT00377377|GH release|gh release
5316382|NCT00377377|Pharmacokinetics|pharmacokinetics
5316383|NCT00377377|Safety|safety
5316384|NCT00377364|Acetaminophen|acetaminophen
5316385|NCT00377364|corticosteroids|corticosteroids
5316386|NCT00377364|prednisone|prednisone
5316387|NCT00377351|Public Health|public health
5316388|NCT00377351|Elderly Population|elderly population
5316389|NCT00377351|Neurodegenerative Diseases|neurodegenerative diseases
5316390|NCT00377351|Exposure|exposure
5316391|NCT00377351|Lifestyle|lifestyle
5316392|NCT00377338|Bronchoscopy|bronchoscopy
5316393|NCT00377338|Diagnostic imaging|diagnostic imaging
5316394|NCT00377338|Laser scanning confocal microscopy|laser scanning confocal microscopy
5316395|NCT00377338|Pulmonary Alveoli|pulmonary alveoli
5316396|NCT00377338|Healthy volunteers|healthy volunteers
5316397|NCT00377338|Diffuse peripheral lung disease|diffuse peripheral lung disease
5316398|NCT00377338|Focal peripheral lung disease|focal peripheral lung disease
5316399|NCT00377312|Endocrine System Diseases|endocrine system diseases
5316713|NCT00376701|Photodynamic Therapy|photodynamic therapy
5316400|NCT00377312|MusculoSkeletal System Disease|musculoskeletal system disease
5316401|NCT00377312|Hormone|hormone
5316402|NCT00377312|Physiologic Properties|physiologic properties
5316403|NCT00377299|Amphetamine Abuse|amphetamine abuse
5316404|NCT00377299|Amphetamine Dependence|amphetamine dependence
5316405|NCT00377299|Bipolar Disorder|bipolar disorder
5318040|NCT00372164|Guidelines|guidelines
5316406|NCT00377299|Major Depressive Disorder|major depressive disorder
5316407|NCT00377299|Citicoline|citicoline
5316408|NCT00377286|Osteoarthritis|osteoarthritis
5316409|NCT00377286|Knee Pain|knee pain
5316410|NCT00377286|Glucosamine|glucosamine
5316411|NCT00377286|MRI|mri
5316412|NCT00377286|CTX-II|ctx-ii
5316413|NCT00377286|Biomarkers|biomarkers
5316414|NCT00377286|Skin quality|skin quality
5316415|NCT00377260|acute otitis media, infants, children|acute otitis media, infants, children
5316416|NCT00377247|Carcinoma|carcinoma
5316417|NCT00377247|Head|head
5316418|NCT00377247|Neck|neck
5316419|NCT00377247|Oral Cavity|oral cavity
5316420|NCT00377247|Oropharynx|oropharynx
5316421|NCT00377247|Mouth|mouth
5316422|NCT00377208|Blood Pressure, High|blood pressure, high
5316423|NCT00377195|Marginal Zone Lymphoma|marginal zone lymphoma
5316424|NCT00377195|Involved field radiotherapy|involved field radiotherapy
5316425|NCT00377195|H. pylori|h. pylori
5316426|NCT00377169|Treatment Experienced|treatment experienced
5316427|NCT00377156|cognitive/functional effects|cognitive/functional effects
5316428|NCT00377156|tumors metastatic to brain|tumors metastatic to brain
5316429|NCT00377156|stage IV breast cancer|stage iv breast cancer
5316430|NCT00377156|stage IV prostate cancer|stage iv prostate cancer
5316431|NCT00377156|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5316432|NCT00377156|male breast cancer|male breast cancer
5316433|NCT00377156|recurrent breast cancer|recurrent breast cancer
5316434|NCT00377156|recurrent prostate cancer|recurrent prostate cancer
5316435|NCT00377156|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5316436|NCT00377143|warfarin|warfarin
5316437|NCT00377143|pharmacogenomic|pharmacogenomic
5316438|NCT00377143|CYP2C9|cyp2c9
5316439|NCT00377143|VKORC1|vkorc1
5316440|NCT00377143|polymorphism, single nucleotide|polymorphism, single nucleotide
5316441|NCT00377130|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
5316442|NCT00377130|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5316443|NCT00377091|pulmonary embolism|pulmonary embolism
5316444|NCT00377091|venous thromboembolism|venous thromboembolism
5316445|NCT00377091|pharmacoeconomic|pharmacoeconomic
5316446|NCT00377091|heparin|heparin
5316447|NCT00377091|unfractionated heparin|unfractionated heparin
5316448|NCT00377091|fondaparinux|fondaparinux
5316449|NCT00377091|length of stay|length of stay
5316450|NCT00377091|costs|costs
5316451|NCT00377091|bleeding|bleeding
5316452|NCT00377091|thrombosis|thrombosis
5316453|NCT00377078|recombinant human lactoferrin|recombinant human lactoferrin
5316454|NCT00377052|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5316455|NCT00377039|ACR 1990 Fibromyalgia|acr 1990 fibromyalgia
5316456|NCT00377039|Fibromyalgia Impact Questionnaire|fibromyalgia impact questionnaire
5316457|NCT00377026|weight loss|weight loss
5316458|NCT00377026|postpartum|postpartum
5316459|NCT00377026|weight retention|weight retention
5316460|NCT00376987|renal cell carcinoma|renal cell carcinoma
5316461|NCT00376987|bladder cancer|bladder cancer
5316462|NCT00376987|cervical cancer|cervical cancer
5316463|NCT00376987|esophageal cancer|esophageal cancer
5316464|NCT00376987|gastric cancer|gastric cancer
5316465|NCT00376987|adult acute myeloid leukemia|adult acute myeloid leukemia
5316466|NCT00376987|pancreatic cancer|pancreatic cancer
5316467|NCT00376987|hypopharyngeal cancer|hypopharyngeal cancer
5316468|NCT00376987|lip and oral cavity cancer|lip and oral cavity cancer
5316469|NCT00376987|laryngeal cancer|laryngeal cancer
5316470|NCT00376987|nasopharyngeal cancer|nasopharyngeal cancer
5316471|NCT00376987|oropharyngeal cancer|oropharyngeal cancer
5316472|NCT00376987|paranasal sinus and nasal cavity cancer|paranasal sinus and nasal cavity cancer
5316473|NCT00376987|non-small cell lung cancer|non-small cell lung cancer
5316474|NCT00376987|small cell lung cancer|small cell lung cancer
5316475|NCT00376987|adult primary liver cancer|adult primary liver cancer
5316476|NCT00376987|tongue cancer|tongue cancer
5316477|NCT00376987|tobacco use disorder|tobacco use disorder
5316478|NCT00376974|glaucoma|glaucoma
5316479|NCT00376974|compliance|compliance
5316480|NCT00376974|intraocular pressure|intraocular pressure
5316481|NCT00376974|video|video
5316482|NCT00376961|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
5316483|NCT00376961|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5316484|NCT00376961|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5316485|NCT00376961|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5316486|NCT00376948|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
5316487|NCT00376948|stage III pancreatic cancer|stage iii pancreatic cancer
5316488|NCT00376948|stage IV pancreatic cancer|stage iv pancreatic cancer
5316489|NCT00376948|recurrent pancreatic cancer|recurrent pancreatic cancer
5316490|NCT00376935|Treatment Experienced|treatment experienced
5316491|NCT00376922|pain|pain
5316492|NCT00376922|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
5316493|NCT00376922|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5316494|NCT00376922|acute undifferentiated leukemia|acute undifferentiated leukemia
5316495|NCT00376922|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5316496|NCT00376922|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5316497|NCT00376922|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5316498|NCT00376922|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5316499|NCT00376922|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5316500|NCT00376922|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
5316501|NCT00376922|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5316502|NCT00376922|chronic eosinophilic leukemia|chronic eosinophilic leukemia
5316503|NCT00376922|primary myelofibrosis|primary myelofibrosis
5316504|NCT00376922|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5316505|NCT00376922|chronic neutrophilic leukemia|chronic neutrophilic leukemia
5316506|NCT00376922|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5316507|NCT00376922|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5316508|NCT00376922|essential thrombocythemia|essential thrombocythemia
5316509|NCT00376922|extramedullary plasmacytoma|extramedullary plasmacytoma
5316510|NCT00376922|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
5316511|NCT00376922|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
5316512|NCT00376922|polycythemia vera|polycythemia vera
5316513|NCT00376922|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5316514|NCT00376922|primary systemic amyloidosis|primary systemic amyloidosis
5316515|NCT00376922|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
5316516|NCT00376922|prolymphocytic leukemia|prolymphocytic leukemia
5316517|NCT00376922|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5316518|NCT00376922|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5316519|NCT00376922|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
5316520|NCT00376922|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5316521|NCT00376922|stage III multiple myeloma|stage iii multiple myeloma
5316522|NCT00376922|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
5316523|NCT00376922|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5316524|NCT00376922|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5316525|NCT00376922|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5316526|NCT00376922|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5316527|NCT00376922|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
5316528|NCT00376922|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5316529|NCT00376922|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5316530|NCT00376922|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
5316531|NCT00376922|mast cell leukemia|mast cell leukemia
5316532|NCT00376922|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
5316533|NCT00376922|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
5316534|NCT00376922|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
5316535|NCT00376922|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
5316536|NCT00376922|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
5316537|NCT00376922|refractory hairy cell leukemia|refractory hairy cell leukemia
5316538|NCT00376922|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
5316539|NCT00376922|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5316540|NCT00376922|untreated hairy cell leukemia|untreated hairy cell leukemia
5316541|NCT00376922|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5316542|NCT00376922|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
5316543|NCT00376922|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
5316544|NCT00376922|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5316545|NCT00376922|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5316546|NCT00376922|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5316547|NCT00376922|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
5316548|NCT00376922|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5316549|NCT00376922|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
5316550|NCT00376922|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
5316551|NCT00376922|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
5316552|NCT00376922|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
5316553|NCT00376922|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5316554|NCT00376922|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
5316555|NCT00376922|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
5316556|NCT00376922|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
5316557|NCT00376922|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
5316558|NCT00376922|adult grade III lymphomatoid granulomatosis|adult grade iii lymphomatoid granulomatosis
5316559|NCT00376922|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
5316560|NCT00376922|Waldenström macroglobulinemia|waldenström macroglobulinemia
5318433|NCT00370500|Epigenetics|epigenetics
5316561|NCT00376922|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
5316562|NCT00376922|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
5316563|NCT00376922|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5316564|NCT00376922|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
5316565|NCT00376922|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5316566|NCT00376922|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5316567|NCT00376922|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
5316568|NCT00376922|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
5316569|NCT00376922|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
5316570|NCT00376922|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5316571|NCT00376922|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
5316572|NCT00376922|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
5316573|NCT00376922|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5316574|NCT00376922|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5316575|NCT00376922|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5316576|NCT00376922|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
5316577|NCT00376922|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
5316578|NCT00376922|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
5316579|NCT00376922|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5316580|NCT00376922|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5316581|NCT00376922|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5316582|NCT00376922|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5316583|NCT00376922|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5316584|NCT00376922|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5316585|NCT00376922|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
5316586|NCT00376922|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
5316587|NCT00376922|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5316588|NCT00376922|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
5316589|NCT00376922|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5316590|NCT00376922|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5316591|NCT00376922|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
5316592|NCT00376922|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
5316593|NCT00376922|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5316594|NCT00376922|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
5316595|NCT00376922|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5316596|NCT00376922|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5316597|NCT00376922|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
5316598|NCT00376922|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
5316599|NCT00376922|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
5316600|NCT00376922|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5316601|NCT00376922|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5316602|NCT00376922|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5316603|NCT00376922|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5316604|NCT00376922|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5316605|NCT00376922|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5316606|NCT00376922|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
5316607|NCT00376922|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
5316608|NCT00376922|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
5316609|NCT00376922|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5316610|NCT00376922|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5316611|NCT00376922|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5316612|NCT00376922|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5316613|NCT00376922|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5316614|NCT00376922|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5316615|NCT00376922|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
5316616|NCT00376922|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5316617|NCT00376922|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5316618|NCT00376922|stage I mantle cell lymphoma|stage i mantle cell lymphoma
5316619|NCT00376922|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5316620|NCT00376922|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5318434|NCT00370487|Abortion|abortion
5316621|NCT00376922|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
5316622|NCT00376922|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5316623|NCT00376922|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5316624|NCT00376922|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
5316625|NCT00376922|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5316626|NCT00376922|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5316627|NCT00376922|stage I marginal zone lymphoma|stage i marginal zone lymphoma
5316628|NCT00376922|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5316629|NCT00376922|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5316630|NCT00376922|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
5316631|NCT00376922|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
5316632|NCT00376922|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5316633|NCT00376922|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
5316634|NCT00376922|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5316635|NCT00376922|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5316636|NCT00376922|isolated plasmacytoma of bone|isolated plasmacytoma of bone
5316637|NCT00376922|monoclonal gammopathy of undetermined significance|monoclonal gammopathy of undetermined significance
5316638|NCT00376922|refractory multiple myeloma|refractory multiple myeloma
5316639|NCT00376922|stage I multiple myeloma|stage i multiple myeloma
5316640|NCT00376922|stage II multiple myeloma|stage ii multiple myeloma
5316641|NCT00376922|post-transplant lymphoproliferative disorder|post-transplant lymphoproliferative disorder
5316642|NCT00376922|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
5316643|NCT00376909|breast cancer|breast cancer
5316644|NCT00376909|cervical cancer|cervical cancer
5316645|NCT00376909|colon cancer|colon cancer
5316646|NCT00376909|rectal cancer|rectal cancer
5316647|NCT00376896|IBS fMRI|ibs fmri
5316648|NCT00376883|multiple myeloma|multiple myeloma
5316649|NCT00376883|pamidronate prophylaxis|pamidronate prophylaxis
5316650|NCT00376883|dose comparison|dose comparison
5316651|NCT00376883|quality of life|quality of life
5316652|NCT00376883|skeletal event|skeletal event
5316653|NCT00376883|response|response
5316654|NCT00376883|survival|survival
5316656|NCT00376870|STENT|stent
5316657|NCT00376870|Coronary|coronary
5316658|NCT00376870|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
5316659|NCT00376857|Indocyanine green, toxicity, epiretinal membrane, visual field defect|indocyanine green, toxicity, epiretinal membrane, visual field defect
5316660|NCT00376844|stage I endometrial carcinoma|stage i endometrial carcinoma
5316661|NCT00376831|colonoscopy|colonoscopy
5316662|NCT00376831|conscious sedation|conscious sedation
5316663|NCT00376831|midazolam|midazolam
5316664|NCT00376831|ketamine|ketamine
5316665|NCT00376831|fentanyl|fentanyl
5316666|NCT00376818|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
5316667|NCT00376818|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5316668|NCT00376818|adult anaplastic ependymoma|adult anaplastic ependymoma
5316669|NCT00376818|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
5316670|NCT00376818|adult giant cell glioblastoma|adult giant cell glioblastoma
5316671|NCT00376818|adult gliosarcoma|adult gliosarcoma
5316672|NCT00376818|adult medulloblastoma|adult medulloblastoma
5316673|NCT00376818|adult anaplastic meningioma|adult anaplastic meningioma
5316674|NCT00376818|adult papillary meningioma|adult papillary meningioma
5316675|NCT00376818|adult mixed glioma|adult mixed glioma
5316676|NCT00376818|recurrent adult brain tumor|recurrent adult brain tumor
5316677|NCT00376818|adult glioblastoma|adult glioblastoma
5316678|NCT00376818|adult grade III meningioma|adult grade iii meningioma
5316679|NCT00376805|stage IV breast cancer|stage iv breast cancer
5316680|NCT00376805|male breast cancer|male breast cancer
5316681|NCT00376805|recurrent breast cancer|recurrent breast cancer
5316682|NCT00376792|stage IIB prostate cancer|stage iib prostate cancer
5316683|NCT00376792|stage IIA prostate cancer|stage iia prostate cancer
5316684|NCT00376792|stage III prostate cancer|stage iii prostate cancer
5316685|NCT00376792|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5316686|NCT00376779|Haemophilus influenzae type b|haemophilus influenzae type b
5316687|NCT00376779|Double-blind|double-blind
5316688|NCT00376779|Finland|finland
5316689|NCT00376779|randomized|randomized
5316690|NCT00376779|phase 2|phase 2
5316691|NCT00376779|GSK Biologicals|gsk biologicals
5316692|NCT00376779|DTPa-HBV-IPV/Hib|dtpa-hbv-ipv/hib
5316693|NCT00376766|Cluster seizure|cluster seizure
5316694|NCT00376766|seizure clustering|seizure clustering
5316695|NCT00376766|repetitive seizure|repetitive seizure
5316696|NCT00376766|Drug resistant epilepsy|drug resistant epilepsy
5316697|NCT00376766|Levetiracetam|levetiracetam
5316698|NCT00376766|keppra|keppra
5316699|NCT00376753|Transcranial Magnetic Stimulation (TMS)|transcranial magnetic stimulation (tms)
5316700|NCT00376753|Writer's Cramp|writer's cramp
5316701|NCT00376753|Electromyogram|electromyogram
5316702|NCT00376753|Focal Hand Dystonia|focal hand dystonia
5316703|NCT00376753|FHD|fhd
5316704|NCT00376753|Healthy Volunteer|healthy volunteer
5316705|NCT00376753|HV|hv
5316706|NCT00376740|breast cancer, postmenopausal, letrozole, zoledronic acid, adjuvant,bone mineral density|breast cancer, postmenopausal, letrozole, zoledronic acid, adjuvant,bone mineral density
5316707|NCT00376727|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5316708|NCT00376714|plethysmography|plethysmography
5316709|NCT00376714|muscarinic receptor antagonist|muscarinic receptor antagonist
5316710|NCT00376714|COPD|copd
5316711|NCT00376714|repeat dosing|repeat dosing
5316712|NCT00376701|Choroidal Neovascularization|choroidal neovascularization
5316714|NCT00376701|Age Related Macular Degeneration|age related macular degeneration
5316715|NCT00376701|Triamcinolone Acetonide|triamcinolone acetonide
5316716|NCT00376701|Avastin|avastin
5316717|NCT00376701|Visudyne|visudyne
5316718|NCT00376675|fatigue|fatigue
5316719|NCT00376675|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5316720|NCT00376662|HRT|hrt
5316721|NCT00376662|Etidronate|etidronate
5316722|NCT00376662|Fractures|fractures
5316723|NCT00376662|Osteoporosis|osteoporosis
5316724|NCT00376662|Asthma|asthma
5316725|NCT00376662|Glucocorticoids|glucocorticoids
5316726|NCT00376649|crohns|crohns
5316727|NCT00376649|quality of life|quality of life
5316728|NCT00376649|lifestyle changing|lifestyle changing
5316729|NCT00376649|remmision|remmision
5316730|NCT00376597|lymphedema|lymphedema
5316731|NCT00376597|stage IA breast cancer|stage ia breast cancer
5316732|NCT00376597|stage IB breast cancer|stage ib breast cancer
5316733|NCT00376597|stage II breast cancer|stage ii breast cancer
5316734|NCT00376597|stage IIIA breast cancer|stage iiia breast cancer
5316735|NCT00376597|stage IIIB breast cancer|stage iiib breast cancer
5316736|NCT00376597|stage IIIC breast cancer|stage iiic breast cancer
5316737|NCT00376584|Primary Hypercholesteremia|primary hypercholesteremia
5316738|NCT00376584|Mixed Hyperlipidemia|mixed hyperlipidemia
5316739|NCT00376571|PCI|pci
5316740|NCT00376571|Bifurcation lesion|bifurcation lesion
5316741|NCT00376558|cocaine dependence|cocaine dependence
5316742|NCT00376545|Functional Magnetic Resonance Imaging (fMRI)|functional magnetic resonance imaging (fmri)
5316743|NCT00376545|Visuomotor|visuomotor
5316744|NCT00376545|Occipital Cortex|occipital cortex
5316745|NCT00376545|Prefrontal Cortex|prefrontal cortex
5316746|NCT00376545|Healthy Volunteer|healthy volunteer
5316747|NCT00376545|HV|hv
5316748|NCT00376532|Cardiac Ischemia|cardiac ischemia
5316749|NCT00376532|Cardiac Arrhythmia|cardiac arrhythmia
5316750|NCT00376532|Defibrillator|defibrillator
5316751|NCT00376532|Matrix Metalloproteinase|matrix metalloproteinase
5316752|NCT00376532|Genetic Polymorphism|genetic polymorphism
5316753|NCT00376519|graft versus host disease|graft versus host disease
5316754|NCT00376519|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5316755|NCT00376519|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5316756|NCT00376519|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5316757|NCT00376519|refractory anemia with excess blasts|refractory anemia with excess blasts
5316758|NCT00376519|myelodysplastic syndromes|myelodysplastic syndromes
5316759|NCT00376519|chronic myelogenous leukemia|chronic myelogenous leukemia
5316760|NCT00376519|refractory anemia|refractory anemia
5316761|NCT00376519|prolymphocytic leukemia|prolymphocytic leukemia
5316762|NCT00376519|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5316763|NCT00376519|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5316764|NCT00376519|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
5316765|NCT00376519|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5316766|NCT00376519|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5316767|NCT00376519|follicular lymphoma|follicular lymphoma
5316768|NCT00376519|mantle cell lymphoma|mantle cell lymphoma
5316769|NCT00376519|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
5316770|NCT00376519|secondary myelofibrosis|secondary myelofibrosis
5316771|NCT00376519|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5316772|NCT00376519|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5316773|NCT00376519|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5316774|NCT00376519|marginal zone lymphoma|marginal zone lymphoma
5316775|NCT00376519|diffuse large cell lymphoma|diffuse large cell lymphoma
5316776|NCT00376519|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5316777|NCT00376519|lymphoblastic lymphoma|lymphoblastic lymphoma
5316778|NCT00376519|immunoblastic large cell lymphoma|immunoblastic large cell lymphoma
5316779|NCT00376519|multiple myeloma|multiple myeloma
5316780|NCT00376506|Aspiration|aspiration
5316781|NCT00376506|Rehabilitation|rehabilitation
5316782|NCT00376506|Swallowing Disorders|swallowing disorders
5316783|NCT00376506|Stroke|stroke
5316784|NCT00376506|Parkinson's Disease|parkinson's disease
5316785|NCT00376506|Dysphagia|dysphagia
5316786|NCT00376506|Parkinson Disease|parkinson disease
5316787|NCT00376506|PD|pd
5316788|NCT00376493|Abortion|abortion
5316789|NCT00376493|Infection|infection
5316790|NCT00376493|Antibiotics|antibiotics
5316791|NCT00376493|Treatment|treatment
5316792|NCT00376493|Pregnancy complications|pregnancy complications
5316793|NCT00376480|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
5316887|NCT00376142|Evidence-based practice|evidence-based practice
5316794|NCT00376480|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5316795|NCT00376480|refractory anemia with excess blasts|refractory anemia with excess blasts
5316796|NCT00376480|refractory anemia|refractory anemia
5316797|NCT00376480|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5316798|NCT00376480|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
5316799|NCT00376480|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
5316800|NCT00376480|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5316801|NCT00376480|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5316802|NCT00376480|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5316803|NCT00376480|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5316804|NCT00376480|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5316805|NCT00376480|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5316806|NCT00376480|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5316807|NCT00376480|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5316808|NCT00376480|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5316809|NCT00376480|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
5316810|NCT00376467|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
5316811|NCT00376467|Philadelphia positive|philadelphia positive
5316812|NCT00376467|Adult|adult
5316813|NCT00376467|Elderly|elderly
5316814|NCT00376467|Imatinib|imatinib
5316815|NCT00376454|neuropathic pain|neuropathic pain
5316816|NCT00376441|vaginal|vaginal
5316817|NCT00376441|incontinence|incontinence
5316818|NCT00376441|sexual function|sexual function
5316819|NCT00376428|Cystic Fibrosis Transmembrane Conductance Regulator|cystic fibrosis transmembrane conductance regulator
5316820|NCT00376428|Premature termination codon|premature termination codon
5316821|NCT00376428|Gentamicin-induced readthrough|gentamicin-induced readthrough
5316822|NCT00376415|Lessertia frutescens|lessertia frutescens
5316823|NCT00376415|Sutherlandia frutescens|sutherlandia frutescens
5316824|NCT00376415|Phase 1 clinical trial|phase 1 clinical trial
5316825|NCT00376415|Human safety study|human safety study
5316826|NCT00376402|Pandemic|pandemic
5316827|NCT00376402|Influenza|influenza
5316828|NCT00376402|Prevention|prevention
5316829|NCT00376402|Vaccine|vaccine
5316830|NCT00376402|Prevention of Pandemic Influenza|prevention of pandemic influenza
5316831|NCT00376376|levofloxacin|levofloxacin
5316832|NCT00376376|pharmacodynamic|pharmacodynamic
5316833|NCT00376376|bactericidal|bactericidal
5316834|NCT00376363|glaucoma|glaucoma
5316835|NCT00376363|Ahmed implant|ahmed implant
5316836|NCT00376363|Baerveldt implant|baerveldt implant
5316837|NCT00376350|Low Back Pain|low back pain
5316838|NCT00376350|Chronic|chronic
5316839|NCT00376350|Manipulation|manipulation
5316840|NCT00376350|Chiropractic|chiropractic
5316841|NCT00376350|Massage|massage
5316842|NCT00376337|Invasive Aspergillosis|invasive aspergillosis
5316843|NCT00376337|Salvage Therapy|salvage therapy
5316844|NCT00376337|Micafungin|micafungin
5316845|NCT00376324|pharmacokinetics|pharmacokinetics
5316846|NCT00376324|human bone|human bone
5316847|NCT00376311|Lequesne's algo-functional score|lequesne's algo-functional score
5316848|NCT00376311|Biomarkers of joint metabolism|biomarkers of joint metabolism
5316849|NCT00376298|incontinence|incontinence
5316850|NCT00376298|prostate cancer|prostate cancer
5316851|NCT00376298|interstitial cystitis|interstitial cystitis
5316852|NCT00376272|atrial fibrillation,atrial remodeling,dysrhythmias,valsartan|atrial fibrillation,atrial remodeling,dysrhythmias,valsartan
5316853|NCT00376259|lamivudine resistance|lamivudine resistance
5316854|NCT00376259|Hepatitis B virus|hepatitis b virus
5316855|NCT00376233|Schizophrenia,|schizophrenia,
5316856|NCT00376233|Cannabinoids,|cannabinoids,
5316857|NCT00376233|Arachidonic Acid,|arachidonic acid,
5316858|NCT00376233|Niacin,|niacin,
5316859|NCT00376233|Prostaglandins|prostaglandins
5316860|NCT00376220|Bipolar|bipolar
5316861|NCT00376220|Depression|depression
5316862|NCT00376207|Cerebral infarct|cerebral infarct
5316863|NCT00376207|physical exercise|physical exercise
5316864|NCT00376207|insulin sensitivity|insulin sensitivity
5316865|NCT00376207|low grade chronic inflammation|low grade chronic inflammation
5316866|NCT00376207|intervention|intervention
5316867|NCT00376207|HOMA|homa
5316868|NCT00376207|PASE|pase
5316869|NCT00376194|Pervasive Developmental Disorder|pervasive developmental disorder
5316870|NCT00376194|Alternative Therapy|alternative therapy
5316871|NCT00376194|Autism|autism
5316872|NCT00376194|Asperger's Disorder|asperger's disorder
5316873|NCT00376194|Clinical Trial|clinical trial
5316874|NCT00376194|Autism Spectrum Disorder|autism spectrum disorder
5316875|NCT00376194|ASD|asd
5316876|NCT00376194|Asperger Disorder|asperger disorder
5316877|NCT00376181|type 2 diabetes|type 2 diabetes
5316878|NCT00376181|hypertension|hypertension
5316879|NCT00376181|blood pressure|blood pressure
5316880|NCT00376181|diastolic blood pressure|diastolic blood pressure
5316881|NCT00376155|malaria|malaria
5316882|NCT00376155|prevention|prevention
5316883|NCT00376155|intermittent|intermittent
5316888|NCT00376142|Intervention|intervention
5316889|NCT00376116|Implantable cardioverter-defibrillator|implantable cardioverter-defibrillator
5316890|NCT00376116|Pacemaker|pacemaker
5316891|NCT00376116|Cardiac resynchronisation therapy|cardiac resynchronisation therapy
5316892|NCT00376116|Heart failure|heart failure
5316893|NCT00376116|Predictor|predictor
5316894|NCT00376116|Mortality|mortality
5316895|NCT00376116|Rehospitalization|rehospitalization
5316896|NCT00376116|Telemedicine|telemedicine
5316897|NCT00376116|Home Monitoring|home monitoring
5316898|NCT00376103|Brain Tumor|brain tumor
5316899|NCT00376103|GBM|gbm
5316900|NCT00376103|Glioblastoma Multiforme|glioblastoma multiforme
5316901|NCT00376103|Glioblastoma|glioblastoma
5316902|NCT00376103|Brachytherapy|brachytherapy
5316903|NCT00376103|Temozolomide|temozolomide
5316904|NCT00376103|Temodar|temodar
5316905|NCT00376090|MVA vector|mva vector
5316906|NCT00376090|Immunogenicity|immunogenicity
5316907|NCT00376090|HIV vaccine|hiv vaccine
5316908|NCT00376090|HIV preventative vaccine|hiv preventative vaccine
5316909|NCT00376077|Thrombocytopenia|thrombocytopenia
5316910|NCT00376077|pediatric|pediatric
5316911|NCT00376077|methylprednisolone|methylprednisolone
5316912|NCT00376077|intracranial hemorrhage|intracranial hemorrhage
5316913|NCT00376077|intravenous immune globulin|intravenous immune globulin
5316914|NCT00376064|Growth hormone (GH)|growth hormone (gh)
5316915|NCT00376064|IGF-1|igf-1
5316916|NCT00376064|Acromegaly|acromegaly
5316917|NCT00376064|Pituitary adenoma|pituitary adenoma
5316918|NCT00376064|Brain tumor|brain tumor
5316919|NCT00376064|Brain cancer|brain cancer
5316920|NCT00376064|Octreotide acetate|octreotide acetate
5316921|NCT00376051|frontotemporal lobar degeneration|frontotemporal lobar degeneration
5316922|NCT00376051|frontotemporal dementia|frontotemporal dementia
5316923|NCT00376051|serotonin|serotonin
5316924|NCT00376051|dementia|dementia
5316925|NCT00376051|behavioural disturbances|behavioural disturbances
5316926|NCT00376038|GSK189074|gsk189074
5316927|NCT00376038|T2DM|t2dm
5316928|NCT00376038|GSK189075|gsk189075
5316929|NCT00376038|Glucophage|glucophage
5316930|NCT00376038|Obesity|obesity
5316931|NCT00376038|Diabetes|diabetes
5316932|NCT00376038|Metformin|metformin
5316933|NCT00376038|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
5316934|NCT00376038|Drug Interaction|drug interaction
5316935|NCT00376025|Kashin-Beck Disease|kashin-beck disease
5316936|NCT00376025|Kashin-Beck Osteoarthropathy|kashin-beck osteoarthropathy
5316937|NCT00376012|Chemotherapy for TB in HIV infection|chemotherapy for tb in hiv infection
5316938|NCT00375986|Cesarean delivery|cesarean delivery
5316939|NCT00375986|Placental removal|placental removal
5316940|NCT00375986|Blood loss|blood loss
5316941|NCT00375973|Fatigue|fatigue
5316942|NCT00375973|Fatigue syndrome, chronic|fatigue syndrome, chronic
5316943|NCT00375973|Chronic fatigue syndrome|chronic fatigue syndrome
5316944|NCT00375973|CFS|cfs
5316945|NCT00375973|Fibromyalgia|fibromyalgia
5316946|NCT00375960|Pain associated with diabetes Type I or Type II|pain associated with diabetes type i or type ii
5316947|NCT00375960|Neuropathic Pain due to diabetes|neuropathic pain due to diabetes
5316948|NCT00375960|Diabetic peripheral neuropathic pain|diabetic peripheral neuropathic pain
5316949|NCT00375960|Pain|pain
5316950|NCT00375960|Diabetes with burning sensation in the arms and/or legs|diabetes with burning sensation in the arms and/or legs
5316951|NCT00375960|Diabetes with tingling sensation in the arms and/or legs|diabetes with tingling sensation in the arms and/or legs
5316952|NCT00375960|Neuropathic Pain Due to Diabetes Type I or Type II|neuropathic pain due to diabetes type i or type ii
5316953|NCT00375947|exercise|exercise
5316954|NCT00375947|hand disability|hand disability
5316955|NCT00375947|arthritis|arthritis
5316956|NCT00375947|AUSCAN|auscan
5316957|NCT00375934|Bunionectomy|bunionectomy
5316958|NCT00375934|Bunion surgery|bunion surgery
5316959|NCT00375934|Post-operative pain|post-operative pain
5316960|NCT00375921|diet|diet
5316961|NCT00375921|food|food
5316962|NCT00375921|taste|taste
5316963|NCT00375921|smell|smell
5316964|NCT00375921|head and neck|head and neck
5316965|NCT00375921|radiation|radiation
5316966|NCT00375921|chemotherapy|chemotherapy
5316967|NCT00375908|Neonatal Encephalopathy|neonatal encephalopathy
5316968|NCT00375908|Hypoxic-Ischemic Brain Injury|hypoxic-ischemic brain injury
5316969|NCT00375908|Umbilical Cord Blood|umbilical cord blood
5316970|NCT00375908|Proteomics|proteomics
5316971|NCT00375895|Cyclosporin|cyclosporin
5316972|NCT00375895|Peginterferon|peginterferon
5316973|NCT00375895|Ribavirin|ribavirin
5316974|NCT00375895|Chronic hepatitis C|chronic hepatitis c
5316975|NCT00375895|Liver transplantation|liver transplantation
5316976|NCT00375869|Neuroprotection|neuroprotection
5316977|NCT00375869|neuron specific enolase|neuron specific enolase
5316978|NCT00375869|CSF glutamate levels|csf glutamate levels
5316979|NCT00375869|Darbepoetin Alfa|darbepoetin alfa
5316980|NCT00375856|arthroplasty|arthroplasty
5316981|NCT00375856|knee|knee
5316982|NCT00375856|computer-assist|computer-assist
5316983|NCT00375856|gait|gait
5316984|NCT00375856|Total knee arthroplasty|total knee arthroplasty
5316985|NCT00375856|knee prostheses|knee prostheses
5316986|NCT00375804|Endometrial Cancer|endometrial cancer
5316987|NCT00375791|Relapsed Multiple Myeloma|relapsed multiple myeloma
5316988|NCT00375791|Refractory Multiple Myeloma|refractory multiple myeloma
5316989|NCT00375778|Parkinson's Disease|parkinson's disease
5316990|NCT00375778|Positron Emission Tomography|positron emission tomography
5316991|NCT00375778|Memantine|memantine
5316992|NCT00375778|NMDA antagonists|nmda antagonists
5316993|NCT00375778|Cerebral Blood Flow|cerebral blood flow
5316994|NCT00375778|Cerebral Metabolic Rate of Oxygen|cerebral metabolic rate of oxygen
5316995|NCT00375765|Dutasteride|dutasteride
5316996|NCT00375765|BPH|bph
5316997|NCT00375765|Prostate cancer|prostate cancer
5316998|NCT00375765|Gene expression|gene expression
5316999|NCT00375765|PSA|psa
5317000|NCT00375752|Breast cancer|breast cancer
5317001|NCT00375752|Anti tumor potential|anti tumor potential
5317002|NCT00375752|Letrozole|letrozole
5317003|NCT00375752|Zoledronic acid|zoledronic acid
5317004|NCT00375752|Neoadjuvant treatment|neoadjuvant treatment
5317005|NCT00375752|Hormone responsive breast cancer|hormone responsive breast cancer
5317006|NCT00375739|Actinic Keratosis|actinic keratosis
5317007|NCT00375739|Topical|topical
5317008|NCT00375739|Solar Keratosis|solar keratosis
5317009|NCT00375739|Sun Spots|sun spots
5317010|NCT00375739|Dermatology|dermatology
5317011|NCT00375726|Dengue Fever|dengue fever
5317012|NCT00375726|Dengue Vaccine|dengue vaccine
5317013|NCT00375726|Dengue Virus|dengue virus
5317014|NCT00375726|Dengue Hemorrhagic Fever|dengue hemorrhagic fever
5317015|NCT00375726|Dengue Shock Syndrome|dengue shock syndrome
5317016|NCT00375713|Dermatitis|dermatitis
5317017|NCT00375713|Eczema|eczema
5317018|NCT00375713|Pruritus|pruritus
5317019|NCT00375713|Xyzal|xyzal
5317020|NCT00375713|Zyrtec|zyrtec
5317021|NCT00375713|Levocetirizine|levocetirizine
5317022|NCT00375713|Cetirizine|cetirizine
5317023|NCT00375700|food|food
5317024|NCT00375700|diet|diet
5317025|NCT00375700|oral supplement|oral supplement
5317026|NCT00375700|head and neck cancer|head and neck cancer
5317027|NCT00375700|radiation|radiation
5317028|NCT00375687|Prostate cancer|prostate cancer
5317029|NCT00375661|hepatocellular carcinoma|hepatocellular carcinoma
5317030|NCT00375648|Prostate|prostate
5317031|NCT00375648|Cancer|cancer
5317032|NCT00375648|Bone metastases|bone metastases
5317033|NCT00375648|Zoledronic acid|zoledronic acid
5317034|NCT00375648|Bone metastases-related pain|bone metastases-related pain
5317035|NCT00375648|Prostate cancer|prostate cancer
5317036|NCT00375635|mFPSA|mfpsa
5317037|NCT00375635|Uremic toxins|uremic toxins
5317038|NCT00375635|Protein bound toxins|protein bound toxins
5317039|NCT00375635|Uremia|uremia
5317040|NCT00375635|Chronic hemodialysis|chronic hemodialysis
5317041|NCT00375622|HHT|hht
5317042|NCT00375622|Epistaxis|epistaxis
5317043|NCT00375622|Tamoxifen|tamoxifen
5317044|NCT00375622|Hemoglobin|hemoglobin
5317045|NCT00375609|Prevention of Venous Thromboembolism|prevention of venous thromboembolism
5317046|NCT00375583|Lymphatic Filariasis|lymphatic filariasis
5317047|NCT00375583|Diethylcarbamazine|diethylcarbamazine
5317048|NCT00375583|Microfilariae|microfilariae
5317049|NCT00375583|Helminths|helminths
5317050|NCT00375583|Nematode|nematode
5317051|NCT00375544|Laser Therapy, Low-Level|laser therapy, low-level
5317052|NCT00375544|Osteoarthritis|osteoarthritis
5317053|NCT00375544|Phototherapy|phototherapy
5317054|NCT00375544|Osteoarthritis, knee|osteoarthritis, knee
5317055|NCT00375544|Light-emitting diode|light-emitting diode
5317056|NCT00375531|Post Traumatic Stress Disorder|post traumatic stress disorder
5317057|NCT00375531|Mindfulness Meditation|mindfulness meditation
5317058|NCT00375518|Thoracic Surgery|thoracic surgery
5317059|NCT00375518|Cardiopulmonary complications|cardiopulmonary complications
5317060|NCT00375518|Atorvastatin|atorvastatin
5317061|NCT00375505|Breast Cancer|breast cancer
5317062|NCT00375505|Premenopausal|premenopausal
5317063|NCT00375505|Bone mineral density|bone mineral density
5317064|NCT00375505|Cancer therapy induced bone loss|cancer therapy induced bone loss
5317065|NCT00375505|zoledronic acid|zoledronic acid
5317066|NCT00375492|diabetes|diabetes
5317067|NCT00375492|overweight|overweight
5317068|NCT00375492|obesity|obesity
5317069|NCT00375492|weight loss|weight loss
5317070|NCT00375492|exenatide|exenatide
5317071|NCT00375492|Amylin|amylin
5317072|NCT00375492|Lilly|lilly
5317073|NCT00375466|Hemorrhage|hemorrhage
5317074|NCT00375466|Transfusion|transfusion
5317075|NCT00375466|Blood components|blood components
5317076|NCT00375466|Fibrinolysis|fibrinolysis
5317077|NCT00375466|Platelet activation|platelet activation
5317078|NCT00375453|Paclitaxel|paclitaxel
5317079|NCT00375453|Advanced Solid Tumors|advanced solid tumors
5317080|NCT00375440|Tranexamic Acid|tranexamic acid
5317205|NCT00375037|hand washing|hand washing
5317081|NCT00375440|Revision Total Hip Replacement|revision total hip replacement
5317082|NCT00375440|Reduction in Blood Loss|reduction in blood loss
5317083|NCT00375427|Breast cancer|breast cancer
5317084|NCT00375427|Zoledronic acid|zoledronic acid
5317085|NCT00375427|Skeletal related events (SRE)|skeletal related events (sre)
5317086|NCT00375414|Enteral tube feeding,|enteral tube feeding,
5317087|NCT00375414|endoscopic gastropexy,|endoscopic gastropexy,
5317580|NCT00373607|Adult|adult
5317088|NCT00375414|percutaneous endoscopic gastrostomy,|percutaneous endoscopic gastrostomy,
5317089|NCT00375414|PEG|peg
5317090|NCT00375388|Type 2 diabetes mellitus|type 2 diabetes mellitus
5317091|NCT00375388|Metformin on top of insulin therapy|metformin on top of insulin therapy
5317092|NCT00375388|Randomized placebo-controlled trial|randomized placebo-controlled trial
5317093|NCT00375388|Diabetes regulation|diabetes regulation
5317094|NCT00375388|Daily dose of insulin|daily dose of insulin
5317095|NCT00375388|Body Weight|body weight
5317096|NCT00375388|Patients with type 2 diabetes|patients with type 2 diabetes
5317097|NCT00375388|Intensive insulin therapy|intensive insulin therapy
5317098|NCT00375388|Age: 30-80 years|age: 30-80 years
5317099|NCT00375388|Body mass index|body mass index
5317100|NCT00375388|Lipids|lipids
5317101|NCT00375388|Blood Pressure|blood pressure
5317102|NCT00375388|Endothelial function|endothelial function
5317103|NCT00375388|Low grade inflammation|low grade inflammation
5317104|NCT00375388|Fibrinolysis|fibrinolysis
5317105|NCT00375388|Microvascular complications|microvascular complications
5317106|NCT00375388|Macrovascular complications|macrovascular complications
5317107|NCT00375375|Minimal hepatic encephalopathy|minimal hepatic encephalopathy
5317108|NCT00375375|Hepatic encephalopathy|hepatic encephalopathy
5317109|NCT00375375|Subclinical hepatic encephalopathy|subclinical hepatic encephalopathy
5317110|NCT00375375|Health related quality of life|health related quality of life
5317111|NCT00375362|nitroglycerin|nitroglycerin
5317112|NCT00375362|morphine|morphine
5317113|NCT00375362|patient controlled analgesia|patient controlled analgesia
5317114|NCT00375362|total knee arthroplasty|total knee arthroplasty
5317115|NCT00375349|fatty liver|fatty liver
5317116|NCT00375349|statin|statin
5317117|NCT00375349|non-alcoholic|non-alcoholic
5317118|NCT00375336|Aortic valve|aortic valve
5317119|NCT00375336|Calcification|calcification
5317120|NCT00375336|Endothelial dysfunction|endothelial dysfunction
5317121|NCT00375336|Calcium metabolism|calcium metabolism
5317122|NCT00375336|Coronary artery disease|coronary artery disease
5317123|NCT00375323|factor VIII inhibitor|factor viii inhibitor
5317124|NCT00375310|Phase I|phase i
5317125|NCT00375310|Pancreas Cancer|pancreas cancer
5317126|NCT00375310|Chemo-radiotherapy|chemo-radiotherapy
5317127|NCT00375297|antidepressants|antidepressants
5317128|NCT00375297|sexual dysfunction|sexual dysfunction
5317129|NCT00375297|women|women
5317130|NCT00375297|sildenafil|sildenafil
5317131|NCT00375297|PDE5 inhibitors|pde5 inhibitors
5317132|NCT00375297|serotonin reuptake inhibitor antidepressants|serotonin reuptake inhibitor antidepressants
5317133|NCT00375271|Monitoring, Intraoperative|monitoring, intraoperative
5317134|NCT00375271|Hemodynamic Processes|hemodynamic processes
5317135|NCT00375271|Treatment Protocols|treatment protocols
5317136|NCT00375258|Adult trauma patients with ongoing significant haemorrhage or at risk of significant haemorrhage|adult trauma patients with ongoing significant haemorrhage or at risk of significant haemorrhage
5317137|NCT00375245|phase I|phase i
5317138|NCT00375245|metastatic|metastatic
5317139|NCT00375245|advanced cancer|advanced cancer
5317140|NCT00375245|lung cancer|lung cancer
5317141|NCT00375245|renal cancer|renal cancer
5317142|NCT00375245|kidney cancer|kidney cancer
5317143|NCT00375245|head and neck cancer|head and neck cancer
5317144|NCT00375245|bladder cancer|bladder cancer
5317145|NCT00375245|breast cancer|breast cancer
5317146|NCT00375245|colorectal cancer|colorectal cancer
5317147|NCT00375245|esophagus|esophagus
5317148|NCT00375245|GIST|gist
5317149|NCT00375245|liver cancer|liver cancer
5317150|NCT00375245|melanoma|melanoma
5317151|NCT00375245|mesothelioma|mesothelioma
5317152|NCT00375245|lymphoma|lymphoma
5317153|NCT00375245|ovary cancer|ovary cancer
5317154|NCT00375245|ovarian cancer|ovarian cancer
5317155|NCT00375245|pancreas cancer|pancreas cancer
5317156|NCT00375245|pancreatic cancer|pancreatic cancer
5317157|NCT00375245|prostate cancer|prostate cancer
5317158|NCT00375245|stomach cancer|stomach cancer
5317159|NCT00375245|thyroid cancer|thyroid cancer
5317160|NCT00375245|Metastatic solid tumor|metastatic solid tumor
5317161|NCT00375232|Exercise-Induced Bronchospasm|exercise-induced bronchospasm
5317162|NCT00375232|Asthma|asthma
5317163|NCT00375232|Cardiopulmonary Stress Test|cardiopulmonary stress test
5317164|NCT00375232|Eucapnic Voluntary Hyperventilation|eucapnic voluntary hyperventilation
5317165|NCT00375232|Induced sputum|induced sputum
5317166|NCT00375219|Chronic Myeloid Leukemia|chronic myeloid leukemia
5317167|NCT00375219|CML|cml
5317168|NCT00375219|HHT|hht
5317169|NCT00375219|Homoharringtonine|homoharringtonine
5317170|NCT00375219|Omacetaxine|omacetaxine
5317171|NCT00375219|T315i|t315i
5317172|NCT00375219|ChemGenex|chemgenex
5317173|NCT00375219|ChemGenex Pharmaceuticals|chemgenex pharmaceuticals
5317174|NCT00375206|PowderMed, DNA vaccine, influenza|powdermed, dna vaccine, influenza
5317175|NCT00375193|small cell lung cancer|small cell lung cancer
5317176|NCT00375193|amrubicin|amrubicin
5317177|NCT00375180|food|food
5317178|NCT00375180|diet|diet
5317179|NCT00375180|mucositis|mucositis
5317180|NCT00375180|xerostomia|xerostomia
5317181|NCT00375180|dysphagia|dysphagia
5317182|NCT00375180|taste|taste
5317183|NCT00375180|smell|smell
5317184|NCT00375180|head and neck|head and neck
5317185|NCT00375180|radiation|radiation
5317186|NCT00375180|chemotherapy|chemotherapy
5317187|NCT00375167|Recovery, Hope, Empowerment, Randomized Control Trial|recovery, hope, empowerment, randomized control trial
5317188|NCT00375154|Acute respiratory failure|acute respiratory failure
5317189|NCT00375154|Prehospital care|prehospital care
5317190|NCT00375154|Noninvasive ventilation|noninvasive ventilation
5317191|NCT00375154|Emergency|emergency
5317192|NCT00375128|Malaria|malaria
5317193|NCT00375128|Vaccine|vaccine
5317194|NCT00375128|Prime-boost|prime-boost
5317195|NCT00375128|Challenge|challenge
5317196|NCT00375102|acupuncture|acupuncture
5317197|NCT00375102|relaxation response|relaxation response
5317198|NCT00375102|homeless|homeless
5317199|NCT00375102|veterans|veterans
5317200|NCT00375102|randomized trials|randomized trials
5317201|NCT00375089|Early-onset Morbid Obesity|early-onset morbid obesity
5317202|NCT00375063|left main stenosis|left main stenosis
5317203|NCT00375063|Percutaneous Coronary Intervention|percutaneous coronary intervention
5317204|NCT00375063|Coronary Artery Bypass Grafting|coronary artery bypass grafting
5317206|NCT00375037|cluster randomized trial|cluster randomized trial
5317207|NCT00375037|performance feedback|performance feedback
5317208|NCT00375037|healthcare workers|healthcare workers
5317209|NCT00375037|Hand hygiene|hand hygiene
5317210|NCT00375037|hand washing adherence|hand washing adherence
5317211|NCT00375024|Patient navigation|patient navigation
5317212|NCT00375024|Breast cancer|breast cancer
5317213|NCT00375024|Colon cancer|colon cancer
5317214|NCT00375024|Questionnaire|questionnaire
5317215|NCT00375011|MELD-Model of End Stage Liver Disease score|meld-model of end stage liver disease score
5317216|NCT00375011|CTP-Child-Turcotte-Pugh score|ctp-child-turcotte-pugh score
5317217|NCT00375011|MEGX-monoethylglycinexylidide-resultant of metabolism of lidocaine|megx-monoethylglycinexylidide-resultant of metabolism of lidocaine
5317218|NCT00375011|HCC-Hepatocellular carcinoma|hcc-hepatocellular carcinoma
5317219|NCT00375011|HCV-Hepatitis C virus|hcv-hepatitis c virus
5317220|NCT00375011|NASH-Non-alcoholic Steatohepatitis|nash-non-alcoholic steatohepatitis
5317221|NCT00374998|Malaria|malaria
5317222|NCT00374998|Vaccine|vaccine
5317223|NCT00374998|Prime-boost|prime-boost
5317224|NCT00374985|chemoradiation|chemoradiation
5317225|NCT00374985|docetaxel|docetaxel
5317226|NCT00374985|oxaliplatin|oxaliplatin
5317227|NCT00374985|gastric|gastric
5317228|NCT00374985|neoadjuvant|neoadjuvant
5317229|NCT00374985|radiochemotherapy|radiochemotherapy
5317230|NCT00374959|Prevention of pneumonia|prevention of pneumonia
5317231|NCT00374959|ceftriaxone|ceftriaxone
5317232|NCT00374959|continuous aspiration|continuous aspiration
5317233|NCT00374959|subglottic secretions|subglottic secretions
5317234|NCT00374959|Mechanical ventilation with Endotracheal intubation.|mechanical ventilation with endotracheal intubation.
5317235|NCT00374959|Absence of infection|absence of infection
5317236|NCT00374933|AML|aml
5317237|NCT00374933|ALL|all
5317238|NCT00374933|MDS|mds
5317239|NCT00374933|Allogeneic transplant|allogeneic transplant
5317240|NCT00374933|Acute Myelogenous Leukemia|acute myelogenous leukemia
5317241|NCT00374933|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
5317242|NCT00374933|Myelodysplastic Syndrome|myelodysplastic syndrome
5317243|NCT00374933|Adoptive cell therapy|adoptive cell therapy
5317244|NCT00374933|Non-myeloablative|non-myeloablative
5317245|NCT00374920|bipolar|bipolar
5317246|NCT00374920|mania|mania
5317247|NCT00374920|mixed|mixed
5317248|NCT00374894|2,3-dimercaptosuccinic acid|2,3-dimercaptosuccinic acid
5317249|NCT00374894|Blood Lead Levels|blood lead levels
5317250|NCT00374894|children|children
5317251|NCT00374894|multi-nutrients|multi-nutrients
5317252|NCT00374842|Influenza vaccine|influenza vaccine
5317253|NCT00374842|Prophylaxis Influenza vaccine|prophylaxis influenza vaccine
5317254|NCT00374829|randomised prospective trial|randomised prospective trial
5317255|NCT00374829|medication refill compliance|medication refill compliance
5317256|NCT00374829|hypertension|hypertension
5317257|NCT00374829|ambulatory blood pressure monitoring|ambulatory blood pressure monitoring
5317258|NCT00374829|information technology based patient support system|information technology based patient support system
5317259|NCT00374829|process of care, quality of life, pharmacoeconomics|process of care, quality of life, pharmacoeconomics
5317260|NCT00374829|multidisciplinary patient management|multidisciplinary patient management
5317261|NCT00374803|Kidney|kidney
5317262|NCT00374803|Transplant|transplant
5317263|NCT00374803|Corticosteroid|corticosteroid
5317264|NCT00374803|Myfortic|myfortic
5317265|NCT00374790|Lead toxicity|lead toxicity
5317266|NCT00374777|Insomnia|insomnia
5317267|NCT00374777|schizophrenia|schizophrenia
5317268|NCT00374777|manic-depressive psychosis|manic-depressive psychosis
5317269|NCT00374777|zolpidem|zolpidem
5317270|NCT00374764|Autism, Applied Behavioral Analysis, Risperidone|autism, applied behavioral analysis, risperidone
5317271|NCT00374751|Samarium|samarium
5317272|NCT00374751|Kyphoplasty|kyphoplasty
5317273|NCT00374751|Pain management|pain management
5317274|NCT00374751|Bone metastases|bone metastases
5317275|NCT00374751|Histologically proven malignancy in the primary site|histologically proven malignancy in the primary site
5317276|NCT00374751|Radiographic evidence of bone metastasis|radiographic evidence of bone metastasis
5317277|NCT00374751|Significant pain equal or more than score 5|significant pain equal or more than score 5
5317581|NCT00373607|Children|children
5317278|NCT00374751|Karnofsky Performance status >40|karnofsky performance status >40
5317279|NCT00374751|The patient must sign a study specific informed consent|the patient must sign a study specific informed consent
5317280|NCT00374738|Guided Imagery for Trauma (GIFT)|guided imagery for trauma (gift)
5317281|NCT00374738|Posttraumatic Stress Disorder (PTSD)|posttraumatic stress disorder (ptsd)
5317282|NCT00374738|Military Sexual Trauma (MST)|military sexual trauma (mst)
5317283|NCT00374738|Military Sexual Trauma - related PTSD|military sexual trauma - related ptsd
5317284|NCT00374725|Ulcerative Colitis|ulcerative colitis
5317285|NCT00374725|Probiotic|probiotic
5317286|NCT00374725|Placebo controlled trial|placebo controlled trial
5317287|NCT00374725|Lactobacillus rhamnosus|lactobacillus rhamnosus
5317288|NCT00374725|Lactobacillus acidophilus|lactobacillus acidophilus
5317289|NCT00374712|Phosphate|phosphate
5317290|NCT00374712|Dialysis|dialysis
5317291|NCT00374712|Klotho|klotho
5317292|NCT00374712|Hemodialysis|hemodialysis
5317293|NCT00374699|Velcade|velcade
5317294|NCT00374699|Bortezomib|bortezomib
5317295|NCT00374699|CHOP|chop
5317296|NCT00374699|Peripheral T-cell lymphomas(PTCLs)|peripheral t-cell lymphomas(ptcls)
5317297|NCT00374699|natural killer (NK)-cell lymphomas|natural killer (nk)-cell lymphomas
5317298|NCT00374686|cytomegalovirus|cytomegalovirus
5317299|NCT00374686|kidney|kidney
5317300|NCT00374686|transplantation|transplantation
5317301|NCT00374686|valganciclovir|valganciclovir
5317302|NCT00374686|preemptive|preemptive
5317303|NCT00374673|TMS|tms
5317304|NCT00374673|chronic pain|chronic pain
5317305|NCT00374673|fibromyalgia|fibromyalgia
5317306|NCT00374673|IBS|ibs
5317307|NCT00374673|burning mouth syndrome|burning mouth syndrome
5317308|NCT00374673|predictive factors|predictive factors
5317309|NCT00374660|Irofulven|irofulven
5317310|NCT00374660|Oxaliplatin|oxaliplatin
5317311|NCT00374647|Renal|renal
5317312|NCT00374647|Kidney|kidney
5317313|NCT00374647|Transplant|transplant
5317314|NCT00374608|pediatric|pediatric
5317315|NCT00374608|congenital complete heart block|congenital complete heart block
5317316|NCT00374608|dual chamber pacemaker|dual chamber pacemaker
5317317|NCT00374595|Kidney Transplant|kidney transplant
5317318|NCT00374595|Vascular Risk|vascular risk
5317319|NCT00374595|inflammation|inflammation
5317320|NCT00374595|Diabetes|diabetes
5317321|NCT00374595|Insulin resistance|insulin resistance
5317322|NCT00374595|Chronic kidney disease|chronic kidney disease
5317323|NCT00374582|Bioelectric impedance analysis|bioelectric impedance analysis
5317324|NCT00374582|BIA|bia
5317325|NCT00374582|ESLD|esld
5317326|NCT00374582|LVP|lvp
5317327|NCT00374582|Large volume paracentesis|large volume paracentesis
5317329|NCT00374582|Liver|liver
5317330|NCT00374582|Hepatic|hepatic
5317331|NCT00374569|Gymnastics, Computerized Dynamic Posturography, Balance|gymnastics, computerized dynamic posturography, balance
5317332|NCT00374556|eszopiclone|eszopiclone
5317333|NCT00374556|insomnia|insomnia
5317334|NCT00374543|Bipolar Disorder|bipolar disorder
5317335|NCT00374543|Generalized Anxiety Disorder|generalized anxiety disorder
5317336|NCT00374543|Double-blind|double-blind
5317337|NCT00374543|Placebo-controlled|placebo-controlled
5317338|NCT00374543|Ziprasidone|ziprasidone
5317339|NCT00374517|Mycobacterium Tuberculosis|mycobacterium tuberculosis
5317340|NCT00374517|Pimonidazole Hydrochloride|pimonidazole hydrochloride
5317341|NCT00374517|Recurrent Tuberculosis|recurrent tuberculosis
5317342|NCT00374517|Hypoxyprobe|hypoxyprobe
5317343|NCT00374517|mRNA Expression|mrna expression
5317344|NCT00374517|Pulmonary Tuberculosis|pulmonary tuberculosis
5317345|NCT00374491|ACL|acl
5317346|NCT00374491|Bone Screw|bone screw
5317347|NCT00374491|Knee|knee
5317348|NCT00374478|Scopolamine|scopolamine
5317349|NCT00374478|Antiemetic|antiemetic
5317350|NCT00374478|Task performance and analysis|task performance and analysis
5317351|NCT00374478|Psychomotor vigilance test|psychomotor vigilance test
5317352|NCT00374465|Dilated Cardiomyopathy|dilated cardiomyopathy
5317353|NCT00374465|Heart Failure|heart failure
5317354|NCT00374452|hypertension|hypertension
5317355|NCT00374452|practice guidelines|practice guidelines
5317356|NCT00374452|quality of health care|quality of health care
5317357|NCT00374452|decision support systems|decision support systems
5317358|NCT00374452|evidence-based medicine|evidence-based medicine
5317359|NCT00374452|medical informatics|medical informatics
5317360|NCT00374439|depression|depression
5317361|NCT00374439|adolescents|adolescents
5317362|NCT00374439|prevention|prevention
5317363|NCT00374439|schools|schools
5317364|NCT00374426|depression|depression
5317365|NCT00374426|diabetes mellitus|diabetes mellitus
5317366|NCT00374426|depression recurrence|depression recurrence
5317367|NCT00374413|DDD|ddd
5317368|NCT00374413|artificial disc|artificial disc
5317369|NCT00374400|Kidney|kidney
5317370|NCT00374400|Transplant|transplant
5317371|NCT00374400|Paired donation|paired donation
5317372|NCT00374400|Living donor|living donor
5317373|NCT00374387|Healthy women|healthy women
5317374|NCT00374374|probiotic|probiotic
5317375|NCT00374361|insulin sensitivity|insulin sensitivity
5317376|NCT00374361|endothelial function|endothelial function
5317377|NCT00374361|adolescence|adolescence
5317378|NCT00374361|lipids|lipids
5317379|NCT00374361|puberty|puberty
5317380|NCT00374348|Schizophrenia with OCD|schizophrenia with ocd
5317381|NCT00374348|Schizophrenia with-comorbid symptoms of Obsessive Compulsive Disorder(OCD)|schizophrenia with-comorbid symptoms of obsessive compulsive disorder(ocd)
5317382|NCT00374335|prospective cohort study|prospective cohort study
5317383|NCT00374322|Breast Cancer|breast cancer
5317384|NCT00374322|ErbB2-overexpressing|erbb2-overexpressing
5317385|NCT00374322|early-stage breast cancer|early-stage breast cancer
5317386|NCT00374322|adjuvant|adjuvant
5317387|NCT00374309|Hemorrhagic Fever|hemorrhagic fever
5317388|NCT00374309|Healthy|healthy
5317389|NCT00374309|Immunity|immunity
5317390|NCT00374309|T -Cells|t -cells
5317391|NCT00374309|Filovirus|filovirus
5317392|NCT00374309|Healthy Volunteer|healthy volunteer
5317393|NCT00374309|HV|hv
5317394|NCT00374296|Leukemia|leukemia
5317395|NCT00374296|MDS|mds
5317396|NCT00374296|Phase II|phase ii
5317397|NCT00374296|Acute Myelogenous Leukemia (AML)|acute myelogenous leukemia (aml)
5317398|NCT00374296|High Risk Myelodysplastic Syndromes (MDS)|high risk myelodysplastic syndromes (mds)
5317399|NCT00374283|Monitoring|monitoring
5317400|NCT00374283|Polyomavirus|polyomavirus
5317401|NCT00374283|Kidney|kidney
5317402|NCT00374283|Pancreas|pancreas
5317403|NCT00374283|Transplant|transplant
5317404|NCT00374270|Diabetes (type I and type II)|diabetes (type i and type ii)
5317405|NCT00374257|NB-UVB|nb-uvb
5317406|NCT00374257|cGVHD|cgvhd
5317407|NCT00374244|schizophrenia|schizophrenia
5317408|NCT00374244|pimozide|pimozide
5317409|NCT00374244|clozapine|clozapine
5317410|NCT00374231|Liver|liver
5317411|NCT00374231|Transplant|transplant
5317412|NCT00374231|Corticosteroid withdrawal|corticosteroid withdrawal
5317413|NCT00374231|Tacrolimus|tacrolimus
5317414|NCT00374231|CellCept|cellcept
5317415|NCT00374231|MMF|mmf
5317416|NCT00374231|Mycophenolate mofetil|mycophenolate mofetil
5317417|NCT00374218|Carbohydrate|carbohydrate
5317418|NCT00374218|Glycemic index|glycemic index
5317419|NCT00374218|Randomized|randomized
5317420|NCT00374218|Double-blind|double-blind
5317421|NCT00374218|Glucose|glucose
5317422|NCT00374218|Insulin|insulin
5317423|NCT00374218|C-reactive protein|c-reactive protein
5317424|NCT00374205|Ghana|ghana
5317425|NCT00374205|Effectiveness|effectiveness
5317426|NCT00374205|Safety|safety
5317427|NCT00374205|Drug-Resistance|drug-resistance
5317428|NCT00374205|ACT|act
5317429|NCT00374205|Coartem|coartem
5317430|NCT00374205|Arsucam|arsucam
5317431|NCT00374192|Menopause|menopause
5317432|NCT00374192|Insomnia|insomnia
5317433|NCT00374192|Depression|depression
5317434|NCT00374192|Anxiety|anxiety
5317435|NCT00374192|Sleep|sleep
5317436|NCT00374192|Lunesta|lunesta
5317437|NCT00374192|Quality of Life|quality of life
5317438|NCT00374166|Anti-anxiety agents|anti-anxiety agents
5317439|NCT00374166|antidepressive agents|antidepressive agents
5317440|NCT00374166|controlled clinical trial|controlled clinical trial
5317441|NCT00374153|Alcohol|alcohol
5317442|NCT00374153|Drinking|drinking
5317443|NCT00374153|College|college
5317444|NCT00374153|Motivational|motivational
5317445|NCT00374153|Feedback|feedback
5317446|NCT00374153|Assessment|assessment
5317447|NCT00374140|small cell|small cell
5317448|NCT00374140|lung|lung
5317449|NCT00374127|Marijuana|marijuana
5317450|NCT00374127|Comparison between joints and blunts|comparison between joints and blunts
5317451|NCT00374127|Pharmacokinetic effects|pharmacokinetic effects
5317452|NCT00374114|cervical|cervical
5317453|NCT00374114|dysplasia|dysplasia
5317454|NCT00374101|PPIs,|ppis,
5317455|NCT00374101|endoscopic therapy,|endoscopic therapy,
5317456|NCT00374101|peptic ulcers,|peptic ulcers,
5317457|NCT00374101|upper gastrointestinal bleeding,|upper gastrointestinal bleeding,
5317458|NCT00374101|non-variceal upper gastrointestinal bleeding|non-variceal upper gastrointestinal bleeding
5317459|NCT00374088|N-acetylcysteine|n-acetylcysteine
5317460|NCT00374088|Myocardial dysfunction|myocardial dysfunction
5317461|NCT00374088|Transposition of the Great Arteries|transposition of the great arteries
5317462|NCT00374075|Spinal Muscular Atrophy (SMA)|spinal muscular atrophy (sma)
5317463|NCT00374075|Valproic Acid|valproic acid
5317464|NCT00374062|Mohs Surgery|mohs surgery
5317465|NCT00374049|Prostate|prostate
5317466|NCT00374049|vaccine|vaccine
5317467|NCT00374049|immunosuppression|immunosuppression
5317468|NCT00374049|dendritic cells|dendritic cells
5317469|NCT00374036|chemotherapy|chemotherapy
5317470|NCT00374036|stomach cancer metastatic|stomach cancer metastatic
5317471|NCT00374036|Capecitabine|capecitabine
5317472|NCT00374036|Irinotecan|irinotecan
5317473|NCT00374023|Zinc|zinc
5317474|NCT00374023|vitamin A|vitamin a
5317475|NCT00374023|immunity|immunity
5317476|NCT00374023|morbidity|morbidity
5317477|NCT00374023|height gain|height gain
5317478|NCT00374023|weight gain|weight gain
5317479|NCT00374023|Children aged between 1 and 3 years|children aged between 1 and 3 years
5317480|NCT00374023|Weight for age between 70% and 61% of NCHS standard|weight for age between 70% and 61% of nchs standard
5317481|NCT00374023|Acute diarrhoeal Patients|acute diarrhoeal patients
5317482|NCT00374023|No signs of vitamin A deficiency|no signs of vitamin a deficiency
5317688|NCT00373230|rural|rural
5317483|NCT00374023|Who has not received measles vaccine|who has not received measles vaccine
5317484|NCT00374010|end-of-life decision making|end-of-life decision making
5317485|NCT00374010|advance care planning|advance care planning
5317486|NCT00373984|shoulder|shoulder
5317487|NCT00373984|thoracotomy|thoracotomy
5317488|NCT00373971|Activities of daily living|activities of daily living
5317489|NCT00373971|Elderly|elderly
5317490|NCT00373971|Nutrition|nutrition
5317491|NCT00373971|Postoperative|postoperative
5317492|NCT00373971|Hip fractures|hip fractures
5317493|NCT00373971|Hip replacement|hip replacement
5317494|NCT00373971|Knee replacement|knee replacement
5317495|NCT00373945|HLA-B*5701|hla-b*5701
5317496|NCT00373945|pharmacogenetic marker|pharmacogenetic marker
5317497|NCT00373945|hypersensitivity to abacavir,|hypersensitivity to abacavir,
5317498|NCT00373945|retrospective analysis|retrospective analysis
5317499|NCT00373932|Exercise|exercise
5317500|NCT00373932|Physical Activity|physical activity
5317501|NCT00373932|Adherence|adherence
5317502|NCT00373906|MALT Lymphoma, Bortezomib|malt lymphoma, bortezomib
5317503|NCT00373893|Pain|pain
5317504|NCT00373893|Hyperalgesia|hyperalgesia
5317505|NCT00373893|capsaicin|capsaicin
5317506|NCT00373880|Aripiprazole|aripiprazole
5317507|NCT00373880|Cocaine abuse|cocaine abuse
5317508|NCT00373867|Secondary prevention|secondary prevention
5317509|NCT00373867|Physical therapy|physical therapy
5317510|NCT00373867|Fear-avoidance beliefs|fear-avoidance beliefs
5317511|NCT00373867|Disability|disability
5317512|NCT00373854|Hypoglycemia|hypoglycemia
5317513|NCT00373854|Endothelial function|endothelial function
5317514|NCT00373841|Lung|lung
5317515|NCT00373841|Fibrosis|fibrosis
5317516|NCT00373841|Idiopathic|idiopathic
5317517|NCT00373841|Biomarkers|biomarkers
5317518|NCT00373841|Genomics|genomics
5317519|NCT00373841|Longitudinal|longitudinal
5317520|NCT00373828|Chest Pain|chest pain
5317521|NCT00373828|Chest Wall|chest wall
5317522|NCT00373828|Angina Pectoris|angina pectoris
5317523|NCT00373828|Atypical Chest Pain|atypical chest pain
5317524|NCT00373828|Physical Examination|physical examination
5317525|NCT00373828|Myocardial Perfusion Imaging|myocardial perfusion imaging
5317526|NCT00373828|Observational Study|observational study
5317527|NCT00373828|Non-Cardiac Chest Pain|non-cardiac chest pain
5317528|NCT00373828|Ischemic Heart Disease|ischemic heart disease
5317529|NCT00373815|acute GVHD|acute gvhd
5317530|NCT00373815|Immunosuppression|immunosuppression
5317531|NCT00373789|Botulinum Toxin A|botulinum toxin a
5317532|NCT00373789|Urinary Incontinence|urinary incontinence
5317533|NCT00373789|Detrusor Overactivity|detrusor overactivity
5317534|NCT00373776|mucosal|mucosal
5317535|NCT00373776|leishmaniasis|leishmaniasis
5317536|NCT00373776|miltefosine|miltefosine
5317537|NCT00373763|Congenital diaphragmatic hernia|congenital diaphragmatic hernia
5317538|NCT00373763|tracheal occlusion|tracheal occlusion
5317539|NCT00373763|fetus|fetus
5317540|NCT00373763|fetal surgery|fetal surgery
5317541|NCT00373763|fetoscopy|fetoscopy
5317542|NCT00373750|Native American health|native american health
5317543|NCT00373750|Teen pregnancy|teen pregnancy
5317544|NCT00373750|Family strengthening|family strengthening
5317545|NCT00373750|Substance abuse prevention|substance abuse prevention
5317546|NCT00373750|Injury prevention|injury prevention
5317547|NCT00373724|sacroiliac joint|sacroiliac joint
5317548|NCT00373724|low back pain|low back pain
5317549|NCT00373724|radiofrequency|radiofrequency
5317550|NCT00373698|Stress Disorders, Posttraumatic|stress disorders, posttraumatic
5317551|NCT00373698|Delivery of Health Care, Integrated|delivery of health care, integrated
5317552|NCT00373698|Primary Health Care|primary health care
5317553|NCT00373698|Veterans|veterans
5317554|NCT00373698|Depression|depression
5317555|NCT00373685|GI events in patients with moderate GI risk treated with NSAIDS|gi events in patients with moderate gi risk treated with nsaids
5317556|NCT00373672|schizophrenia|schizophrenia
5317557|NCT00373672|cognition|cognition
5317558|NCT00373659|Neovascularization|neovascularization
5317559|NCT00373659|Age-related macular degeneration|age-related macular degeneration
5317560|NCT00373659|Ranibizumab (Lucentis)|ranibizumab (lucentis)
5317561|NCT00373659|Optical coherence tomography|optical coherence tomography
5317562|NCT00373659|Intravitreal injection|intravitreal injection
5317563|NCT00373646|MALT Lymphoma|malt lymphoma
5317564|NCT00373646|thalidomide|thalidomide
5317565|NCT00373646|disseminated MALT Lymphoma or at relapse following HP-eradication|disseminated malt lymphoma or at relapse following hp-eradication
5317566|NCT00373646|or chemotherapy or radiation|or chemotherapy or radiation
5317567|NCT00373633|THoracic Surgery|thoracic surgery
5317568|NCT00373633|thoracic epidural|thoracic epidural
5317569|NCT00373633|epidural|epidural
5317570|NCT00373633|thoracotomy|thoracotomy
5317571|NCT00373633|intercostal nerve block|intercostal nerve block
5317572|NCT00373633|intercostal|intercostal
5317573|NCT00373633|nerve block|nerve block
5317574|NCT00373620|endometrial cancer|endometrial cancer
5317575|NCT00373620|high risk|high risk
5317576|NCT00373620|weekly paclitaxel|weekly paclitaxel
5317577|NCT00373620|Cuncurrent chemoradiation|cuncurrent chemoradiation
5317578|NCT00373607|Non complicated malaria|non complicated malaria
5317579|NCT00373607|Microscopy|microscopy
5317582|NCT00373594|Cold agglutinin disease|cold agglutinin disease
5317583|NCT00373594|Hemolytic|hemolytic
5317584|NCT00373594|Anemia|anemia
5317585|NCT00373594|Lymphoproliferative disease|lymphoproliferative disease
5317586|NCT00373594|Monoclonal antibodies|monoclonal antibodies
5317587|NCT00373594|Rituximab|rituximab
5317588|NCT00373594|Fludarabine|fludarabine
5317589|NCT00373581|Vigabatrin|vigabatrin
5317590|NCT00373581|GABA levels|gaba levels
5317591|NCT00373581|Smoked cocaine|smoked cocaine
5317592|NCT00373568|mucosal|mucosal
5317593|NCT00373568|miltefosine|miltefosine
5317594|NCT00373555|Sarcoidosis|sarcoidosis
5317595|NCT00373555|mediastinal adenopathy|mediastinal adenopathy
5317596|NCT00373555|bronchoscopy|bronchoscopy
5317597|NCT00373555|Transbronchial needle aspiration|transbronchial needle aspiration
5317598|NCT00373555|endobronchial ultrasonography|endobronchial ultrasonography
5317599|NCT00373542|Restless Legs Syndrome|restless legs syndrome
5317600|NCT00373542|ropinirole|ropinirole
5317601|NCT00373542|polysomnography|polysomnography
5317602|NCT00373542|RLS|rls
5317603|NCT00373542|PSG|psg
5317604|NCT00373529|Acute myelogenous leukemia|acute myelogenous leukemia
5317605|NCT00373529|Acute myeloid leukemia|acute myeloid leukemia
5317606|NCT00373529|newly Diagnosed AML|newly diagnosed aml
5317607|NCT00373529|Clofarabine|clofarabine
5317608|NCT00373529|CLASSIC II|classic ii
5317609|NCT00373529|CLO243|clo243
5317610|NCT00373516|psoriasis|psoriasis
5317611|NCT00373516|topical therapy|topical therapy
5317612|NCT00373503|Lofexidine|lofexidine
5317613|NCT00373503|Oral THC|oral thc
5317614|NCT00373503|Cannabinoids|cannabinoids
5317615|NCT00373477|Depression|depression
5317616|NCT00373477|Primary Care|primary care
5317617|NCT00373477|Care Manager|care manager
5317618|NCT00373464|Postoperative pain|postoperative pain
5317619|NCT00373464|Opioid|opioid
5317620|NCT00373464|Etoricoxib|etoricoxib
5317621|NCT00373464|Ketorolac|ketorolac
5317622|NCT00373464|Laparoscopic Surgery|laparoscopic surgery
5317623|NCT00373464|Surgical Procedures, Gynecologic|surgical procedures, gynecologic
5317624|NCT00373451|NSTEMI|nstemi
5317625|NCT00373438|Congenital diaphragmatic hernia|congenital diaphragmatic hernia
5317626|NCT00373438|tracheal occlusion|tracheal occlusion
5317627|NCT00373438|fetus|fetus
5317628|NCT00373438|fetal surgery|fetal surgery
5317629|NCT00373438|fetoscopy|fetoscopy
5317630|NCT00373438|ECMO|ecmo
5317631|NCT00373425|Adjuvant Non-small Cell Lung Cancer|adjuvant non-small cell lung cancer
5317632|NCT00373425|Tarceva|tarceva
5317633|NCT00373425|Early-stage Lung Cancer|early-stage lung cancer
5317634|NCT00373425|Adjuvant|adjuvant
5317635|NCT00373425|RADIANT|radiant
5317636|NCT00373425|NSCLC|nsclc
5317637|NCT00373425|EGFR-positive tumor|egfr-positive tumor
5317638|NCT00373425|Stage IB Non-small Cell Lung Cancer|stage ib non-small cell lung cancer
5317639|NCT00373425|Stage II Non-small Cell Lung Cancer|stage ii non-small cell lung cancer
5317640|NCT00373425|Stage IIIA Non-small Cell Lung Cancer|stage iiia non-small cell lung cancer
5317641|NCT00373412|cytomegalovirus|cytomegalovirus
5317642|NCT00373412|vaccine|vaccine
5317643|NCT00373412|T cell|t cell
5317644|NCT00373412|antibodies|antibodies
5317645|NCT00373399|Cannabinoids|cannabinoids
5317646|NCT00373399|Risk taking|risk taking
5317647|NCT00373399|Decision making|decision making
5317648|NCT00373386|growth hormone|growth hormone
5317649|NCT00373386|endothelial function|endothelial function
5317650|NCT00373373|Sorafenib|sorafenib
5317651|NCT00373373|Acute Myeloid Leukemia|acute myeloid leukemia
5317652|NCT00373373|Flt3|flt3
5317653|NCT00373373|AML|aml
5317654|NCT00373373|Kinase Inhibitor|kinase inhibitor
5317655|NCT00373360|pulmonary hypertension|pulmonary hypertension
5317656|NCT00373360|PAH|pah
5317657|NCT00373360|Remodulin|remodulin
5317658|NCT00373360|treprostinil|treprostinil
5317659|NCT00373360|Quality of Life|quality of life
5317660|NCT00373360|Rapid Switch|rapid switch
5317661|NCT00373334|gastroesophageal reflux disease|gastroesophageal reflux disease
5317662|NCT00373334|GERD|gerd
5317663|NCT00373334|heartburn|heartburn
5317664|NCT00373308|Quality of Life|quality of life
5317665|NCT00373295|Baclofen|baclofen
5317666|NCT00373295|Marijuana Dependence|marijuana dependence
5317667|NCT00373295|Marijuana Withdrawal|marijuana withdrawal
5317668|NCT00373282|PVR|pvr
5317669|NCT00373282|Retinal detachment|retinal detachment
5317670|NCT00373282|Silicone oil|silicone oil
5317671|NCT00373282|Triamcinolone|triamcinolone
5317672|NCT00373269|Acute ischemic stroke|acute ischemic stroke
5317673|NCT00373269|Stroke|stroke
5317674|NCT00373269|Hyperglycemia|hyperglycemia
5317675|NCT00373269|Procoagulation|procoagulation
5317676|NCT00373269|Diabetes|diabetes
5317677|NCT00373269|Blood coagulation|blood coagulation
5317678|NCT00373256|Breast cancer|breast cancer
5317679|NCT00373256|advanced|advanced
5317680|NCT00373256|sunitinib|sunitinib
5317681|NCT00373256|bevacizumab|bevacizumab
5317682|NCT00373256|paclitaxel|paclitaxel
5317683|NCT00373256|Phase 3|phase 3
5317684|NCT00373243|hepatic impairment pharmacokinetics|hepatic impairment pharmacokinetics
5317685|NCT00373230|weight loss|weight loss
5317686|NCT00373230|telemedicine|telemedicine
5317687|NCT00373230|african-american|african-american
5317689|NCT00373217|fallopian tube cancer|fallopian tube cancer
5317690|NCT00373217|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5317691|NCT00373217|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5317692|NCT00373217|primary peritoneal cavity cancer|primary peritoneal cavity cancer
5317693|NCT00373204|Advanced non-small cell lung cancer|advanced non-small cell lung cancer
5317694|NCT00373204|Non-small cell lung cancer|non-small cell lung cancer
5317695|NCT00373204|Lung cancer|lung cancer
5317696|NCT00373204|Metastatic lung cancer|metastatic lung cancer
5317697|NCT00373204|Second line treatment for advanced lung cancer|second line treatment for advanced lung cancer
5317698|NCT00373204|Cancer|cancer
5317699|NCT00373204|Advanced lung cancer|advanced lung cancer
5317700|NCT00373191|stage I breast cancer|stage i breast cancer
5317701|NCT00373191|stage II breast cancer|stage ii breast cancer
5317702|NCT00373191|stage IIIA breast cancer|stage iiia breast cancer
5317703|NCT00373191|stage IIIB breast cancer|stage iiib breast cancer
5317704|NCT00373191|stage IIIC breast cancer|stage iiic breast cancer
5317705|NCT00373191|ductal breast carcinoma in situ|ductal breast carcinoma in situ
5317706|NCT00373178|rosiglitazone|rosiglitazone
5317707|NCT00373178|metformin|metformin
5317708|NCT00373165|Renal Transplantation|renal transplantation
5317709|NCT00373165|CMV|cmv
5317710|NCT00373165|Ganciclovir|ganciclovir
5317711|NCT00373165|Prophylaxis|prophylaxis
5317712|NCT00373165|Preemptive Therapy|preemptive therapy
5317713|NCT00373165|Graft Survival|graft survival
5317714|NCT00373165|Proteomics|proteomics
5317715|NCT00373152|stage I breast cancer|stage i breast cancer
5317716|NCT00373152|stage II breast cancer|stage ii breast cancer
5317717|NCT00373152|stage IIIA breast cancer|stage iiia breast cancer
5317718|NCT00373152|stage IIIC breast cancer|stage iiic breast cancer
5317719|NCT00373152|stage IV breast cancer|stage iv breast cancer
5317720|NCT00373139|Pregnancy,|pregnancy,
5317721|NCT00373139|Screening,|screening,
5317722|NCT00373139|Whole Blood|whole blood
5317723|NCT00373126|nicotine|nicotine
5317724|NCT00373126|schizophrenia|schizophrenia
5317725|NCT00373126|reward|reward
5317726|NCT00373126|withdrawal|withdrawal
5317727|NCT00373113|advanced breast cancer|advanced breast cancer
5317728|NCT00373113|metastatic breast cancer|metastatic breast cancer
5317729|NCT00373113|treatment resistant|treatment resistant
5317730|NCT00373113|treatment failure|treatment failure
5317731|NCT00373100|Zinc|zinc
5317732|NCT00373100|placebo|placebo
5317733|NCT00373100|severe pneumonia|severe pneumonia
5317734|NCT00373100|children|children
5317735|NCT00373087|Parkinson's disease|parkinson's disease
5317736|NCT00373087|Catechol O-methyltransferase|catechol o-methyltransferase
5317737|NCT00373087|Entacapone|entacapone
5317738|NCT00373087|pharmacogenetic|pharmacogenetic
5317739|NCT00373074|Spinal Puncture Headache|spinal puncture headache
5317740|NCT00373048|HIV-1 malaria Clinical Trial|hiv-1 malaria clinical trial
5317741|NCT00373035|prostate cancer|prostate cancer
5317742|NCT00373022|depression|depression
5317743|NCT00373022|anxiety disorder|anxiety disorder
5317744|NCT00373022|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
5317745|NCT00373022|stage II colon cancer|stage ii colon cancer
5317746|NCT00373022|stage III colon cancer|stage iii colon cancer
5317747|NCT00373022|stage II rectal cancer|stage ii rectal cancer
5317748|NCT00373022|stage III rectal cancer|stage iii rectal cancer
5317749|NCT00373009|Low back pain|low back pain
5317750|NCT00373009|Primary prevention|primary prevention
5317751|NCT00373009|Secondary prevention|secondary prevention
5317752|NCT00373009|Lumbar stabilization|lumbar stabilization
5317753|NCT00373009|Psychosocial education|psychosocial education
5317754|NCT00372983|chronic HCV|chronic hcv
5317755|NCT00372983|Failed treatment|failed treatment
5317756|NCT00372983|genotype 1|genotype 1
5317757|NCT00372983|failed treatment with pegylated interferon plus ribavirin|failed treatment with pegylated interferon plus ribavirin
5317758|NCT00372970|gastroparesis|gastroparesis
5317759|NCT00372970|vomiting|vomiting
5317760|NCT00372970|nausea|nausea
5317761|NCT00372970|bloating|bloating
5317762|NCT00372970|dyspepsia|dyspepsia
5317763|NCT00372957|pharmacodynamics|pharmacodynamics
5317764|NCT00372957|Diabetes|diabetes
5317765|NCT00372957|pharmacokinetics|pharmacokinetics
5317766|NCT00372944|advanced pancreatic cancer|advanced pancreatic cancer
5317767|NCT00372944|metastatic pancreatic cancer|metastatic pancreatic cancer
5317768|NCT00372944|AZD6244|azd6244
5317769|NCT00372905|follicular lymphoma|follicular lymphoma
5317770|NCT00372892|Idiopathic Thrombocytopenic Purpura|idiopathic thrombocytopenic purpura
5317771|NCT00372892|Rituximab|rituximab
5317772|NCT00372892|Feasibility study|feasibility study
5317773|NCT00372879|amyotrophic lateral sclerosis|amyotrophic lateral sclerosis
5317774|NCT00372879|vitamin E|vitamin e
5317775|NCT00372879|muscle cramp|muscle cramp
5317776|NCT00372840|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
5317777|NCT00372840|stage I breast cancer|stage i breast cancer
5317778|NCT00372840|stage II breast cancer|stage ii breast cancer
5317779|NCT00372840|stage IIIA breast cancer|stage iiia breast cancer
5317780|NCT00372840|stage IIIA colon cancer|stage iiia colon cancer
5317781|NCT00372840|stage I prostate cancer|stage i prostate cancer
5317782|NCT00372840|stage IIB prostate cancer|stage iib prostate cancer
5317783|NCT00372840|stage IIA prostate cancer|stage iia prostate cancer
5317784|NCT00372840|stage III prostate cancer|stage iii prostate cancer
5317785|NCT00372840|stage I non-small cell lung cancer|stage i non-small cell lung cancer
5317786|NCT00372840|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
5317787|NCT00372840|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5317788|NCT00372840|limited stage small cell lung cancer|limited stage small cell lung cancer
5317789|NCT00372840|stage I rectal cancer|stage i rectal cancer
5317790|NCT00372840|stage IIA rectal cancer|stage iia rectal cancer
5317791|NCT00372840|stage IIB rectal cancer|stage iib rectal cancer
5317792|NCT00372840|stage IIC rectal cancer|stage iic rectal cancer
5317793|NCT00372840|stage IIIA rectal cancer|stage iiia rectal cancer
5317794|NCT00372840|pulmonary carcinoid tumor|pulmonary carcinoid tumor
5317795|NCT00372840|stage I thymoma|stage i thymoma
5317796|NCT00372840|stage II thymoma|stage ii thymoma
5317797|NCT00372840|stage III thymoma|stage iii thymoma
5317798|NCT00372840|stage I colon cancer|stage i colon cancer
5317799|NCT00372840|stage IIA colon cancer|stage iia colon cancer
5317800|NCT00372840|stage IIB colon cancer|stage iib colon cancer
5317801|NCT00372840|stage IIC colon cancer|stage iic colon cancer
5317802|NCT00372840|stage IA malignant mesothelioma|stage ia malignant mesothelioma
5317803|NCT00372840|stage IB malignant mesothelioma|stage ib malignant mesothelioma
5317804|NCT00372840|stage II malignant mesothelioma|stage ii malignant mesothelioma
5317805|NCT00372840|stage III malignant mesothelioma|stage iii malignant mesothelioma
5317806|NCT00372814|diabetes|diabetes
5317807|NCT00372814|regimen adherence|regimen adherence
5317808|NCT00372814|metabolic control|metabolic control
5317809|NCT00372814|adolescents|adolescents
5317810|NCT00372814|family therapy|family therapy
5317811|NCT00372801|Osteoarthritis|osteoarthritis
5317812|NCT00372801|Ibuprofen|ibuprofen
5317813|NCT00372801|COX2|cox2
5317814|NCT00372801|VAS|vas
5317815|NCT00372801|knee|knee
5317816|NCT00372801|single dose|single dose
5317817|NCT00372788|NSCLC|nsclc
5317818|NCT00372788|Advanced Non-Small Cell Lung Cancer|advanced non-small cell lung cancer
5317819|NCT00372788|AZD6244|azd6244
5317820|NCT00372775|brain metastases|brain metastases
5317821|NCT00372775|Sunitinib|sunitinib
5317822|NCT00372775|Phase 2|phase 2
5317823|NCT00372762|Insulin resistance|insulin resistance
5317824|NCT00372762|heart failure|heart failure
5317825|NCT00372762|diuretic therapy|diuretic therapy
5317826|NCT00372749|Alcohol dependence|alcohol dependence
5317827|NCT00372749|Craving|craving
5317828|NCT00372749|Disulfiram|disulfiram
5317829|NCT00372749|Cue exposure|cue exposure
5317830|NCT00372736|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5317831|NCT00372723|toxic epidermal necrlysis|toxic epidermal necrlysis
5317832|NCT00372723|ten|ten
5317833|NCT00372710|Breast cancer|breast cancer
5317834|NCT00372710|Palliation|palliation
5317835|NCT00372710|Bone metastasis|bone metastasis
5317836|NCT00372710|Zoledronic acid|zoledronic acid
5317837|NCT00372697|acromegaly|acromegaly
5317838|NCT00372697|octreotide acetate|octreotide acetate
5317839|NCT00372697|partial responder patients|partial responder patients
5317840|NCT00372684|Plasmodium falciparum|plasmodium falciparum
5317841|NCT00372684|Malaria|malaria
5317842|NCT00372684|Imported malaria|imported malaria
5317843|NCT00372684|Severe malaria|severe malaria
5317844|NCT00372684|Uncomplicated malaria|uncomplicated malaria
5317845|NCT00372684|Intensive Care Units|intensive care units
5317846|NCT00372684|Polymorphism, Genetic|polymorphism, genetic
5317847|NCT00372684|Parasitic Sensitivity Tests|parasitic sensitivity tests
5317848|NCT00372684|Inflammation Mediators|inflammation mediators
5317849|NCT00372671|Cardiac Rehabilitation|cardiac rehabilitation
5317850|NCT00372671|Improving Cardiac Rehabilitation Participation|improving cardiac rehabilitation participation
5317851|NCT00372658|hysterosalpingogram|hysterosalpingogram
5317852|NCT00372658|intracervical local anesthesia|intracervical local anesthesia
5317853|NCT00372658|pain perception|pain perception
5317854|NCT00372658|visual analogue scale|visual analogue scale
5317855|NCT00372645|Healthy|healthy
5317856|NCT00372632|Pregnancy malaria prevention|pregnancy malaria prevention
5317857|NCT00372619|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5317858|NCT00372619|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5317859|NCT00372619|acute undifferentiated leukemia|acute undifferentiated leukemia
5317860|NCT00372619|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
5317861|NCT00372619|childhood acute minimally differentiated myeloid leukemia (M0)|childhood acute minimally differentiated myeloid leukemia (m0)
5317862|NCT00372619|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
5317863|NCT00372619|childhood acute myeloblastic leukemia without maturation (M1)|childhood acute myeloblastic leukemia without maturation (m1)
5317864|NCT00372619|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
5317865|NCT00372619|childhood acute myeloblastic leukemia with maturation (M2)|childhood acute myeloblastic leukemia with maturation (m2)
5317866|NCT00372619|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
5317947|NCT00372463|diabetes|diabetes
5317867|NCT00372619|childhood acute myelomonocytic leukemia (M4)|childhood acute myelomonocytic leukemia (m4)
5317868|NCT00372619|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
5317869|NCT00372619|childhood acute monoblastic leukemia (M5a)|childhood acute monoblastic leukemia (m5a)
5317870|NCT00372619|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
5317871|NCT00372619|childhood acute monocytic leukemia (M5b)|childhood acute monocytic leukemia (m5b)
5317872|NCT00372619|adult erythroleukemia (M6a)|adult erythroleukemia (m6a)
5317873|NCT00372619|adult pure erythroid leukemia (M6b)|adult pure erythroid leukemia (m6b)
5317874|NCT00372619|childhood acute erythroleukemia (M6)|childhood acute erythroleukemia (m6)
5317875|NCT00372619|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
5317876|NCT00372619|childhood acute megakaryocytic leukemia (M7)|childhood acute megakaryocytic leukemia (m7)
5317877|NCT00372619|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5317878|NCT00372619|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5317879|NCT00372606|Obesity|obesity
5317880|NCT00372606|Overweight|overweight
5317881|NCT00372606|Hispanics|hispanics
5317882|NCT00372606|Online|online
5317883|NCT00372606|Weight Loss|weight loss
5317884|NCT00372593|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5317885|NCT00372593|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5317886|NCT00372593|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5317887|NCT00372593|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5317888|NCT00372593|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
5317889|NCT00372593|untreated childhood acute myeloid leukemia and other myeloid malignancies|untreated childhood acute myeloid leukemia and other myeloid malignancies
5317890|NCT00372593|adult acute basophilic leukemia|adult acute basophilic leukemia
5317891|NCT00372593|adult acute eosinophilic leukemia|adult acute eosinophilic leukemia
5317892|NCT00372593|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
5317893|NCT00372593|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
5317894|NCT00372593|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
5317895|NCT00372593|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
5317896|NCT00372593|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
5317897|NCT00372593|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
5317898|NCT00372593|adult erythroleukemia (M6a)|adult erythroleukemia (m6a)
5317899|NCT00372593|adult pure erythroid leukemia (M6b)|adult pure erythroid leukemia (m6b)
5317900|NCT00372593|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
5317901|NCT00372593|childhood acute basophilic leukemia|childhood acute basophilic leukemia
5317902|NCT00372593|childhood acute eosinophilic leukemia|childhood acute eosinophilic leukemia
5317903|NCT00372593|childhood acute minimally differentiated myeloid leukemia (M0)|childhood acute minimally differentiated myeloid leukemia (m0)
5317904|NCT00372593|childhood acute myeloblastic leukemia without maturation (M1)|childhood acute myeloblastic leukemia without maturation (m1)
5317905|NCT00372593|childhood acute myeloblastic leukemia with maturation (M2)|childhood acute myeloblastic leukemia with maturation (m2)
5317906|NCT00372593|childhood acute myelomonocytic leukemia (M4)|childhood acute myelomonocytic leukemia (m4)
5317907|NCT00372593|childhood acute monocytic leukemia (M5b)|childhood acute monocytic leukemia (m5b)
5317908|NCT00372593|childhood acute monoblastic leukemia (M5a)|childhood acute monoblastic leukemia (m5a)
5317909|NCT00372593|childhood acute erythroleukemia (M6)|childhood acute erythroleukemia (m6)
5317910|NCT00372593|childhood acute megakaryocytic leukemia (M7)|childhood acute megakaryocytic leukemia (m7)
5317911|NCT00372541|ceftriaxone|ceftriaxone
5317912|NCT00372541|chloramphenicol|chloramphenicol
5317913|NCT00372541|severe pneumonia|severe pneumonia
5317914|NCT00372541|children|children
5317915|NCT00372515|epidermal growth factor|epidermal growth factor
5317916|NCT00372515|EGFR|egfr
5317917|NCT00372515|lung cancer|lung cancer
5317918|NCT00372515|Iressa|iressa
5317919|NCT00372515|Gefitinib|gefitinib
5317920|NCT00372502|sepsis|sepsis
5317921|NCT00372502|shock|shock
5317922|NCT00372502|emergency department|emergency department
5317923|NCT00372502|resuscitation|resuscitation
5317924|NCT00372489|anemia|anemia
5317925|NCT00372489|chronic kidney disease|chronic kidney disease
5317926|NCT00372489|CKD|ckd
5317927|NCT00372489|chronic renal failure|chronic renal failure
5317928|NCT00372489|CRF|crf
5317929|NCT00372489|dialysis|dialysis
5317930|NCT00372489|erythropoietin|erythropoietin
5317931|NCT00372489|EPO|epo
5317932|NCT00372489|erythropoiesis stimulating agent|erythropoiesis stimulating agent
5317933|NCT00372489|ESA|esa
5317934|NCT00372489|Hematide™|hematide™
5317935|NCT00372489|hemodialysis|hemodialysis
5317936|NCT00372489|hemoglobin|hemoglobin
5317938|NCT00372489|Hgb|hgb
5317939|NCT00372489|Omontys|omontys
5317940|NCT00372489|peginesatide|peginesatide
5317941|NCT00372489|red blood cell|red blood cell
5317942|NCT00372489|red blood cell production|red blood cell production
5317943|NCT00372476|Breast cancer|breast cancer
5317944|NCT00372476|Tyrosine inhibitor|tyrosine inhibitor
5317945|NCT00372476|Chemotherapy|chemotherapy
5317946|NCT00372476|Imatinib|imatinib
5317948|NCT00372463|type 2 diabetes|type 2 diabetes
5317949|NCT00372463|type II diabetes|type ii diabetes
5317950|NCT00372463|diabetes mellitus|diabetes mellitus
5317951|NCT00372463|diabetes type 2|diabetes type 2
5317952|NCT00372463|diabetes type II|diabetes type ii
5317953|NCT00372463|diabetes education|diabetes education
5317954|NCT00372463|patient education|patient education
5317955|NCT00372463|workshop|workshop
5317956|NCT00372463|class|class
5317957|NCT00372463|education|education
5317958|NCT00372463|online|online
5317959|NCT00372463|on-line|on-line
5317960|NCT00372463|internet|internet
5317961|NCT00372463|web|web
5317962|NCT00372450|recurrent esophageal cancer|recurrent esophageal cancer
5317963|NCT00372450|stage III esophageal cancer|stage iii esophageal cancer
5317964|NCT00372450|stage IV esophageal cancer|stage iv esophageal cancer
5317965|NCT00372450|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
5317966|NCT00372450|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
5317967|NCT00372450|gastrointestinal complications|gastrointestinal complications
5317968|NCT00372437|Refractory solid tumors|refractory solid tumors
5317969|NCT00372437|Phase I/II|phase i/ii
5317970|NCT00372437|Refractory and solid tumors|refractory and solid tumors
5317971|NCT00372424|Breast cancer over-expressing HER2. First-line treatment with sunitinib/docetaxel/trastuzumab.|breast cancer over-expressing her2. first-line treatment with sunitinib/docetaxel/trastuzumab.
5317972|NCT00372411|Stroke|stroke
5317973|NCT00372411|Rehabilitation|rehabilitation
5317974|NCT00372411|Single-blind|single-blind
5317975|NCT00372411|Clinical Trial|clinical trial
5317976|NCT00372411|Randomized controlled trial|randomized controlled trial
5317977|NCT00372411|Upper extremity|upper extremity
5317978|NCT00372411|Robotics|robotics
5317979|NCT00372398|scleroderma|scleroderma
5317980|NCT00372398|sclerosis|sclerosis
5317981|NCT00372398|atherosclerosis|atherosclerosis
5317982|NCT00372372|corticosteroids, bone mineral, risedronate, bisphosphonate|corticosteroids, bone mineral, risedronate, bisphosphonate
5317983|NCT00372359|Attention Deficit Disorder|attention deficit disorder
5317984|NCT00372359|Hyperactivity|hyperactivity
5317985|NCT00372359|Methylphenidate|methylphenidate
5317986|NCT00372333|musculoskeletal pain; soft tissue inflammation; IDEA-033|musculoskeletal pain; soft tissue inflammation; idea-033
5317987|NCT00372320|Adenovirus|adenovirus
5317988|NCT00372320|Aquaporin-1|aquaporin-1
5317989|NCT00372320|Gene Transfer|gene transfer
5317990|NCT00372320|Radiation-Induced Salivary Hypofunction|radiation-induced salivary hypofunction
5317991|NCT00372320|Salivary Gland|salivary gland
5317992|NCT00372320|Xerostomia|xerostomia
5317993|NCT00372320|Salivary Dysfunction|salivary dysfunction
5317994|NCT00372320|Hyposalivation|hyposalivation
5317995|NCT00372320|Dry mouth|dry mouth
5317996|NCT00372320|head and neck cancer|head and neck cancer
5317997|NCT00372320|side effects radiation damage|side effects radiation damage
5317998|NCT00372294|Toxoplasmosis|toxoplasmosis
5317999|NCT00372294|Chorioretinitis|chorioretinitis
5318000|NCT00372294|Intravitreal Clindamycin|intravitreal clindamycin
5318001|NCT00372294|Dexamethasone in chorioretinitis|dexamethasone in chorioretinitis
5318002|NCT00372294|Toxoplasmic|toxoplasmic
5318003|NCT00372281|MRI, CLIAVIST, MACROPHAGE, INFECTION, SPINE|mri, cliavist, macrophage, infection, spine
5318004|NCT00372268|Comparison of four conditionings of the insufflated gas during laparoscopy and their consequences on the core temperature and the post-operative pain.|comparison of four conditionings of the insufflated gas during laparoscopy and their consequences on the core temperature and the post-operative pain.
5318005|NCT00372268|Women with womb pathology needing laparoscopic surgery|women with womb pathology needing laparoscopic surgery
5318006|NCT00372268|No emergency|no emergency
5318007|NCT00372268|Aged over 18 years|aged over 18 years
5318008|NCT00372242|Mal-nutrition|mal-nutrition
5318009|NCT00372242|Morbidity|morbidity
5318010|NCT00372242|Nutrition Education|nutrition education
5318011|NCT00372242|Complementary Feeding|complementary feeding
5318012|NCT00372242|Weight gain|weight gain
5318013|NCT00372242|Height|height
5318014|NCT00372216|myocardial infarction|myocardial infarction
5318015|NCT00372216|Clopidogrel|clopidogrel
5318016|NCT00372216|primary PCI|primary pci
5318017|NCT00372216|TIMI-flow|timi-flow
5318018|NCT00372216|STEMI within 6 hrs.|stemi within 6 hrs.
5318019|NCT00372203|Non-small cell lung cancer|non-small cell lung cancer
5318020|NCT00372203|NSCLC|nsclc
5318021|NCT00372203|EBUS|ebus
5318022|NCT00372203|Endobronchial ultrasound|endobronchial ultrasound
5318023|NCT00372203|mediastinoscopy|mediastinoscopy
5318024|NCT00372190|Pelvic organ prolapse|pelvic organ prolapse
5318025|NCT00372190|recurrence|recurrence
5318026|NCT00372190|mesh|mesh
5318027|NCT00372190|complications|complications
5318028|NCT00372190|treatment|treatment
5318029|NCT00372177|monoclonal antibody|monoclonal antibody
5318030|NCT00372177|diagnostics|diagnostics
5318031|NCT00372177|RA|ra
5318032|NCT00372177|Immunoglobulins|immunoglobulins
5318033|NCT00372177|molecular target|molecular target
5318034|NCT00372177|Tc99m-pertechnetate|tc99m-pertechnetate
5318035|NCT00372177|Fab-fragment of Anti-human CD4|fab-fragment of anti-human cd4
5318036|NCT00372177|Radiopharmaceutical|radiopharmaceutical
5318037|NCT00372177|chronic inflammatory diseases|chronic inflammatory diseases
5318038|NCT00372177|active Rheumatoid Arthritis|active rheumatoid arthritis
5318039|NCT00372164|ASIPP|asipp
5318041|NCT00372151|Schizophrenia|schizophrenia
5318042|NCT00372151|Schizoaffective disorders|schizoaffective disorders
5318043|NCT00372151|Theonine|theonine
5318044|NCT00372151|Augmentation|augmentation
5318045|NCT00372138|Abdominal aortic aneurysms|abdominal aortic aneurysms
5318046|NCT00372138|Endoleaks|endoleaks
5318047|NCT00372138|Prevention|prevention
5318048|NCT00372125|Prader-Willi syndrome|prader-willi syndrome
5318049|NCT00372125|Growth hormone|growth hormone
5318050|NCT00372125|Body composition|body composition
5318051|NCT00372112|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
5318052|NCT00372112|COPD|copd
5318053|NCT00372099|Postmenopausal women|postmenopausal women
5318054|NCT00372099|bone microarchitecture|bone microarchitecture
5318055|NCT00372099|peripheral quantitative micro-CT|peripheral quantitative micro-ct
5318056|NCT00372099|salmon calcitonin|salmon calcitonin
5318057|NCT00372034|contact lenses|contact lenses
5318058|NCT00372034|intolerance|intolerance
5318059|NCT00372034|punctal plugs|punctal plugs
5318060|NCT00372034|tear volume|tear volume
5318061|NCT00372034|Intolerance to contact lens wear due to dryness symptoms|intolerance to contact lens wear due to dryness symptoms
5318062|NCT00372021|non arthritic ischemic optic neuropathy|non arthritic ischemic optic neuropathy
5318063|NCT00372021|anterior ischemic optic neuropathy|anterior ischemic optic neuropathy
5318064|NCT00372021|Optic nerve Neurotomy|optic nerve neurotomy
5318065|NCT00371995|Visceral leishmaniasis|visceral leishmaniasis
5318066|NCT00371995|kala-azar|kala-azar
5318067|NCT00371995|miltefosine|miltefosine
5318068|NCT00371995|AmBisome|ambisome
5318069|NCT00371982|Fish oil|fish oil
5318070|NCT00371982|Type 2 diabetic women|type 2 diabetic women
5318071|NCT00371982|adiposity|adiposity
5318072|NCT00371982|adipose tissue inflammation|adipose tissue inflammation
5318073|NCT00371982|PAI-1|pai-1
5318074|NCT00371982|Insulin sensitivity|insulin sensitivity
5318075|NCT00371969|Unsafe drinking|unsafe drinking
5318076|NCT00371969|Human Immunodeficiency Virus|human immunodeficiency virus
5318077|NCT00371969|Motivational Interviewing|motivational interviewing
5318078|NCT00371956|raloxifene|raloxifene
5318079|NCT00371956|estrogen|estrogen
5318080|NCT00371956|receptor|receptor
5318081|NCT00371956|modulation|modulation
5318082|NCT00371956|osteoporosis|osteoporosis
5318083|NCT00371956|steroid|steroid
5318084|NCT00371956|Steroids|steroids
5318085|NCT00371943|variceal bleeding,band ligation, beta-blocker|variceal bleeding,band ligation, beta-blocker
5318086|NCT00371943|had history of esophageal variceal bleeding|had history of esophageal variceal bleeding
5318087|NCT00371904|Rituximab|rituximab
5318088|NCT00371904|donor|donor
5318089|NCT00371904|sensitised|sensitised
5318090|NCT00371904|antibody|antibody
5318091|NCT00371904|rejection|rejection
5318092|NCT00371878|Vaccine|vaccine
5318093|NCT00371878|Lung|lung
5318094|NCT00371878|Bronchoalveolar lavage|bronchoalveolar lavage
5318095|NCT00371878|Lymphocyte|lymphocyte
5318096|NCT00371878|Immunoglobulin|immunoglobulin
5318097|NCT00371878|HIV|hiv
5318098|NCT00371878|Streptococcus pneumoniae|streptococcus pneumoniae
5318099|NCT00371878|Conjugate vaccine|conjugate vaccine
5318100|NCT00371865|Behavior therapy|behavior therapy
5318101|NCT00371865|Chronic pain|chronic pain
5318102|NCT00371865|Cognitive therapy|cognitive therapy
5318103|NCT00371865|Meditation|meditation
5318104|NCT00371865|Mindfulness|mindfulness
5318105|NCT00371865|Psychotherapy|psychotherapy
5318106|NCT00371839|Hearing Loss|hearing loss
5318107|NCT00371839|Hearing Aids|hearing aids
5318108|NCT00371839|Rehabilitation of hearing impaired|rehabilitation of hearing impaired
5318109|NCT00371826|Renal transplantation|renal transplantation
5318110|NCT00371826|everolimus|everolimus
5318111|NCT00371826|Immunosuppressants|immunosuppressants
5318112|NCT00371800|Cinnamon|cinnamon
5318113|NCT00371800|Type 1 Diabetes|type 1 diabetes
5318114|NCT00371800|Adolescent|adolescent
5318115|NCT00371800|HbA1c|hba1c
5318116|NCT00371774|Psoriasis|psoriasis
5318117|NCT00371774|Plaque Psoriasis|plaque psoriasis
5318118|NCT00371774|Amevive®|amevive®
5318119|NCT00371774|alefacept|alefacept
5318120|NCT00371761|Hepatitis B virus|hepatitis b virus
5318121|NCT00371761|Pegylated interferon alfa-2b (PegIntron)|pegylated interferon alfa-2b (pegintron)
5318122|NCT00371735|Malaria CDA LAPDAP Africa|malaria cda lapdap africa
5318123|NCT00371722|Cesarean section|cesarean section
5318124|NCT00371722|Appendectomy|appendectomy
5318125|NCT00371683|Prevention of deep vein thrombosis and pulmonary embolism after total knee replacement surgery|prevention of deep vein thrombosis and pulmonary embolism after total knee replacement surgery
5318126|NCT00371670|Knee, osteoarthritis, pain, disease modifying|knee, osteoarthritis, pain, disease modifying
5318127|NCT00371657|obesity|obesity
5318128|NCT00371657|small for gestation age|small for gestation age
5318129|NCT00371657|intrauterine growth restriction|intrauterine growth restriction
5318130|NCT00371644|Stress Disorders, Post-Traumatic|stress disorders, post-traumatic
5318131|NCT00371644|Cognitive Processing Therapy|cognitive processing therapy
5318132|NCT00371644|Military sexual trauma|military sexual trauma
5318133|NCT00371644|Psychology, Military|psychology, military
5318134|NCT00371644|Veterans|veterans
5318135|NCT00371644|Rape|rape
5318136|NCT00371644|Veterans, psychology|veterans, psychology
5318137|NCT00371644|Healthcare utilization|healthcare utilization
5318138|NCT00371631|biofilm|biofilm
5318139|NCT00371631|clinical trial|clinical trial
5318140|NCT00371631|Escherichia coli|escherichia coli
5318141|NCT00371631|urinary catheter|urinary catheter
5318142|NCT00371618|Fluoroscopy|fluoroscopy
5318143|NCT00371618|Interventional Pain Management Procedures|interventional pain management procedures
5318144|NCT00371605|Voriconazole|voriconazole
5318145|NCT00371605|Liver Transplant|liver transplant
5318146|NCT00371605|Fungal Infection|fungal infection
5318147|NCT00371592|Treatment Naive|treatment naive
5318148|NCT00371579|rosuvastatin|rosuvastatin
5318149|NCT00371579|hepatitis C|hepatitis c
5318150|NCT00371579|geranylgeranylation|geranylgeranylation
5318151|NCT00371579|HCV-RNA load|hcv-rna load
5318152|NCT00371566|squamous cell carcinoma of head and neck|squamous cell carcinoma of head and neck
5318153|NCT00371566|lapatinib|lapatinib
5318154|NCT00371566|ErbB1/ErbB2 inhibitor|erbb1/erbb2 inhibitor
5318155|NCT00371566|apoptosis|apoptosis
5318156|NCT00371553|relapsed or cisplatin-refractory germ cell cancer|relapsed or cisplatin-refractory germ cell cancer
5318157|NCT00371553|germ cell cancer|germ cell cancer
5318158|NCT00371553|SU011248 (Sunitinib)|su011248 (sunitinib)
5318159|NCT00371540|Africa|africa
5318160|NCT00371540|Antiretrovirals|antiretrovirals
5318161|NCT00371527|Bronchitis|bronchitis
5318162|NCT00371527|Acute bronchitis|acute bronchitis
5318163|NCT00371527|Ipratropium|ipratropium
5318164|NCT00371527|Cough|cough
5318165|NCT00371527|Metered dose inhaler|metered dose inhaler
5318166|NCT00371527|Antibiotic prescriptions|antibiotic prescriptions
5318167|NCT00371527|Sputum production|sputum production
5318168|NCT00371501|lupus|lupus
5318169|NCT00371501|atherosclerosis|atherosclerosis
5318170|NCT00371501|thrombosis|thrombosis
5318171|NCT00371501|statin|statin
5318172|NCT00371501|lipid|lipid
5318173|NCT00371488|ErbB2|erbb2
5318174|NCT00371488|Stage IV breast cancer|stage iv breast cancer
5318175|NCT00371488|ErbB1|erbb1
5318176|NCT00371488|breast cancer|breast cancer
5318177|NCT00371488|lapatinib|lapatinib
5318178|NCT00371488|Herceptin|herceptin
5318179|NCT00371488|trastuzumab|trastuzumab
5318180|NCT00371462|intervention study|intervention study
5318181|NCT00371462|technology|technology
5318182|NCT00371462|weight loss|weight loss
5318183|NCT00371449|hearing loss|hearing loss
5318184|NCT00371449|hearing aids|hearing aids
5318185|NCT00371436|Counseling|counseling
5318186|NCT00371436|Education|education
5318187|NCT00371436|Evaluation studies|evaluation studies
5318188|NCT00371436|Quality of health care|quality of health care
5318189|NCT00371436|Rehabilitation of hearing impaired|rehabilitation of hearing impaired
5318190|NCT00371436|Triage|triage
5318191|NCT00371410|Vitrectomy|vitrectomy
5318192|NCT00371410|Intravitreal triamcinolone acetonide|intravitreal triamcinolone acetonide
5318193|NCT00371410|Macular focal laser photocoagulation|macular focal laser photocoagulation
5318194|NCT00371410|Best-corrected visual acuity|best-corrected visual acuity
5318195|NCT00371410|Central macular thickness|central macular thickness
5318196|NCT00371397|yoga|yoga
5318197|NCT00371397|immune function|immune function
5318198|NCT00371397|stress|stress
5318199|NCT00371397|health|health
5318200|NCT00371397|mood|mood
5318201|NCT00371397|skin barrier repair|skin barrier repair
5318202|NCT00371384|massage|massage
5318203|NCT00371384|back pain|back pain
5318204|NCT00371384|effectiveness|effectiveness
5318205|NCT00371371|clinical trial|clinical trial
5318206|NCT00371371|chronic critical limb ischemia|chronic critical limb ischemia
5318207|NCT00371371|leg pain|leg pain
5318208|NCT00371371|cell therapy|cell therapy
5318209|NCT00371371|bone marrow|bone marrow
5318210|NCT00371371|mononuclear|mononuclear
5318211|NCT00371371|progenitor cell|progenitor cell
5318212|NCT00371371|stem cell|stem cell
5318213|NCT00371371|critical limb ischemia|critical limb ischemia
5318214|NCT00371371|nonhealing leg ulcer|nonhealing leg ulcer
5318215|NCT00371345|Recurrent, locally-advanced, or metastatic breast cancer|recurrent, locally-advanced, or metastatic breast cancer
5318216|NCT00371332|chronic periodontitis, mouth|chronic periodontitis, mouth
5318217|NCT00371332|Moderate to advanced chronic periodontitis|moderate to advanced chronic periodontitis
5318218|NCT00371319|lupus|lupus
5318219|NCT00371319|nephritis|nephritis
5318220|NCT00371319|tacrolimus|tacrolimus
5318221|NCT00371319|mycophenolate mofetil|mycophenolate mofetil
5318222|NCT00371306|Diabetes|diabetes
5318223|NCT00371306|Pregnancy|pregnancy
5318224|NCT00371293|Sleep Apnea|sleep apnea
5318225|NCT00371293|C-Reactive Protein|c-reactive protein
5318226|NCT00371293|Obesity|obesity
5318227|NCT00371293|Insulin Resistance|insulin resistance
5318228|NCT00371293|Arterial stiffness|arterial stiffness
5318229|NCT00371280|hydroxyapatite|hydroxyapatite
5318230|NCT00371280|peg|peg
5318231|NCT00371280|prosthetic motility|prosthetic motility
5318232|NCT00371280|orbital implant|orbital implant
5318233|NCT00371267|cognitive behavioral therapy|cognitive behavioral therapy
5318234|NCT00371267|pain|pain
5318235|NCT00371254|Recurrent, locally-advanced, or 'triple negative' metastatic breast cancer|recurrent, locally-advanced, or 'triple negative' metastatic breast cancer
5318236|NCT00371241|ECMO|ecmo
5318237|NCT00371241|extracorporeal membrane oxygenation|extracorporeal membrane oxygenation
5318238|NCT00371241|cytokines|cytokines
5318239|NCT00371241|chemokines|chemokines
5318240|NCT00371228|cord clamping|cord clamping
5318241|NCT00371228|hematocrit|hematocrit
5318242|NCT00371228|hemoglobin|hemoglobin
5318243|NCT00371228|timing|timing
5318244|NCT00371215|hemostasis|hemostasis
5318245|NCT00371215|grafting, skin|grafting, skin
5318246|NCT00371215|hemostatics|hemostatics
5318247|NCT00371215|phase 2|phase 2
5318248|NCT00371202|keratoconus, penetrating keratoplasty,|keratoconus, penetrating keratoplasty,
5318249|NCT00371202|deep lamellar keratoplasty|deep lamellar keratoplasty
5318250|NCT00371202|big bubble technique|big bubble technique
5318251|NCT00371189|circumsporozoite, malaria, vaccine|circumsporozoite, malaria, vaccine
5318252|NCT00371176|Cognitive Behavior Therapy|cognitive behavior therapy
5318253|NCT00371176|Cognitive enhancers|cognitive enhancers
5318254|NCT00371176|Combat Disorders|combat disorders
5318255|NCT00371176|D-Cycloserine|d-cycloserine
5318256|NCT00371176|Stress Disorders, Post-Traumatic|stress disorders, post-traumatic
5318257|NCT00371163|Identification of genes by microarray analyses.|identification of genes by microarray analyses.
5318258|NCT00371137|FMS|fms
5318259|NCT00371137|Fibro|fibro
5318260|NCT00371137|pain|pain
5318261|NCT00371137|Body pain|body pain
5318262|NCT00371137|tenderness|tenderness
5318263|NCT00371137|joint pain|joint pain
5318264|NCT00371137|stiffness|stiffness
5318265|NCT00371137|muscular pain|muscular pain
5318266|NCT00371124|Myopia treatment|myopia treatment
5318267|NCT00371124|Atropine|atropine
5318268|NCT00371111|Resistant uveitic cystoid macular edema|resistant uveitic cystoid macular edema
5318269|NCT00371111|intravitreal triamcinolone|intravitreal triamcinolone
5318270|NCT00371111|intravitreal bevacizumab|intravitreal bevacizumab
5318271|NCT00371098|influenza vaccination|influenza vaccination
5318272|NCT00371098|coronary artery disease|coronary artery disease
5318273|NCT00371098|prevention|prevention
5318274|NCT00371098|acute coronary syndromes|acute coronary syndromes
5318275|NCT00371085|heart failure|heart failure
5318276|NCT00371085|quality improvement|quality improvement
5318277|NCT00371085|patient education|patient education
5318278|NCT00371085|health care economics|health care economics
5318279|NCT00371072|Aphakic Glaucoma|aphakic glaucoma
5318280|NCT00371072|trabeculectomy with mitomycin- C|trabeculectomy with mitomycin- c
5318281|NCT00371072|Ahmed glaucoma implant|ahmed glaucoma implant
5318282|NCT00371059|Agitation|agitation
5318283|NCT00371059|Dementia|dementia
5318284|NCT00371059|Alzheimer's|alzheimer's
5318285|NCT00371046|preterm labor|preterm labor
5318286|NCT00371046|transvaginal ultrasound cervical length|transvaginal ultrasound cervical length
5318287|NCT00371046|fetal fibronectin|fetal fibronectin
5318288|NCT00371046|preterm birth|preterm birth
5318289|NCT00371020|silicone oil|silicone oil
5318290|NCT00371020|PVR|pvr
5318291|NCT00371020|retinal redetachment|retinal redetachment
5318292|NCT00371020|low molecular weight heparin|low molecular weight heparin
5318293|NCT00371020|5-FU|5-fu
5318294|NCT00370994|post-lumbar surgery syndrome|post-lumbar surgery syndrome
5318295|NCT00370994|percutaneous lumbar epidural adhesiolysis|percutaneous lumbar epidural adhesiolysis
5318296|NCT00370994|hypertonic saline neurolysis|hypertonic saline neurolysis
5318297|NCT00370981|investigational drug|investigational drug
5318298|NCT00370981|ejaculation|ejaculation
5318299|NCT00370968|Children|children
5318300|NCT00370968|India|india
5318301|NCT00370968|Hospital|hospital
5318302|NCT00370968|Zinc|zinc
5318303|NCT00370968|Malnutrition|malnutrition
5318304|NCT00370968|Treatment|treatment
5318305|NCT00370955|Phacoemulsification|phacoemulsification
5318306|NCT00370955|Corneal endothelial cell loss|corneal endothelial cell loss
5318307|NCT00370955|Hydrodynamic parameters|hydrodynamic parameters
5318308|NCT00370955|Total ultrasound energy|total ultrasound energy
5318309|NCT00370955|Total infused fluids|total infused fluids
5318310|NCT00370942|GW823093C|gw823093c
5318311|NCT00370942|diabetes|diabetes
5318312|NCT00370942|type 2 diabetes mellitus|type 2 diabetes mellitus
5318313|NCT00370942|DPP-IV inhibitor|dpp-iv inhibitor
5318314|NCT00370916|Clinical Decision Support Systems|clinical decision support systems
5318315|NCT00370916|Continuity of Patient Care|continuity of patient care
5318316|NCT00370916|Medication Errors|medication errors
5318317|NCT00370916|Drug Adverse Effects|drug adverse effects
5318318|NCT00370903|cesarean|cesarean
5318319|NCT00370903|planned|planned
5318320|NCT00370903|emergent|emergent
5318321|NCT00370903|postpartum depression|postpartum depression
5318322|NCT00370890|nasopharyngeal cancer|nasopharyngeal cancer
5318323|NCT00370890|adjuvant chemotherapy|adjuvant chemotherapy
5318324|NCT00370890|EBV DNA|ebv dna
5318325|NCT00370890|PET CT scan|pet ct scan
5318326|NCT00370877|Post-partum hemorrhage|post-partum hemorrhage
5318327|NCT00370877|Arterial embolization|arterial embolization
5318328|NCT00370877|Surgery|surgery
5318329|NCT00370877|Hysterectomy|hysterectomy
5318330|NCT00370877|Activated recombinant human factor VII|activated recombinant human factor vii
5318331|NCT00370864|Pandemic|pandemic
5318332|NCT00370864|Influenza|influenza
5318333|NCT00370864|Prevention|prevention
5318334|NCT00370864|Vaccine|vaccine
5318335|NCT00370864|Prevention of Pandemic Influenza|prevention of pandemic influenza
5318336|NCT00370851|intravitreal Avastin|intravitreal avastin
5318337|NCT00370851|BRVO|brvo
5318338|NCT00370851|Macular edema|macular edema
5318339|NCT00370838|Tics|tics
5318340|NCT00370838|Tourette syndrome|tourette syndrome
5318341|NCT00370838|levetiracetam|levetiracetam
5318342|NCT00370838|clonidine|clonidine
5318343|NCT00370825|Visceral leishmaniasis|visceral leishmaniasis
5318344|NCT00370825|miltefosine|miltefosine
5318345|NCT00370825|AmBisome|ambisome
5318346|NCT00370825|Combination|combination
5318347|NCT00370812|amniotic membrane transplantation|amniotic membrane transplantation
5318348|NCT00370812|ocular chemical burns|ocular chemical burns
5318349|NCT00370799|Caudal Epidural injections|caudal epidural injections
5318350|NCT00370799|lumbar disc herniation|lumbar disc herniation
5318351|NCT00370799|spinal stenosis|spinal stenosis
5318352|NCT00370799|discogenic pain|discogenic pain
5318353|NCT00370799|post-lumbar laminectomy syndrome|post-lumbar laminectomy syndrome
5318354|NCT00370786|Choroidal neovascularization (CNV)|choroidal neovascularization (cnv)
5318355|NCT00370786|Bevacizumab|bevacizumab
5318356|NCT00370786|Non AMD|non amd
5318357|NCT00370786|High myopia|high myopia
5318358|NCT00370786|angioid streaks|angioid streaks
5318359|NCT00370786|Ocular histoplasmosis|ocular histoplasmosis
5318360|NCT00370786|Idiopathic|idiopathic
5318361|NCT00370773|Failed Back Surgery Syndrome|failed back surgery syndrome
5318362|NCT00370773|Back Pain|back pain
5318363|NCT00370773|Chronic Pain|chronic pain
5318364|NCT00370773|Spinal Cord Stimulation|spinal cord stimulation
5318365|NCT00370760|PVR|pvr
5318366|NCT00370760|Oral colchicine|oral colchicine
5318367|NCT00370760|Dexamethasone|dexamethasone
5318368|NCT00370760|low molecular weight heparin|low molecular weight heparin
5318369|NCT00370760|5-FU|5-fu
5318370|NCT00370734|botulinum toxin|botulinum toxin
5318371|NCT00370734|thyroid eye disease|thyroid eye disease
5318372|NCT00370734|lid retraction|lid retraction
5318373|NCT00370721|Proliferative diabetic retinopathy(PDR)|proliferative diabetic retinopathy(pdr)
5318374|NCT00370721|Pan retinal photocoagulation (PRP)|pan retinal photocoagulation (prp)
5318375|NCT00370721|Vitreous hemorrhage|vitreous hemorrhage
5318376|NCT00370721|Traction retinal detachment|traction retinal detachment
5318377|NCT00370721|Neovascularization on disc (NVD)|neovascularization on disc (nvd)
5318378|NCT00370721|Neovascularization elsewhere (NVE)|neovascularization elsewhere (nve)
5318379|NCT00370721|Fibrous proliferation on disc (FPD)|fibrous proliferation on disc (fpd)
5318380|NCT00370721|Fibrous proliferaiton elsewhere (FPE)|fibrous proliferaiton elsewhere (fpe)
5318381|NCT00370708|Cesarean|cesarean
5318382|NCT00370708|Oral|oral
5318383|NCT00370708|Intake|intake
5318384|NCT00370695|Chronic back pain|chronic back pain
5318385|NCT00370695|Intractable neuropathic back pain|intractable neuropathic back pain
5318386|NCT00370695|Lumbar radiculopathy|lumbar radiculopathy
5318387|NCT00370695|Spinal cord stimulation|spinal cord stimulation
5318388|NCT00370669|Bevacizumab|bevacizumab
5318389|NCT00370669|CSME|csme
5318390|NCT00370669|MPC|mpc
5318391|NCT00370669|Triamcinolone acetonide|triamcinolone acetonide
5318392|NCT00370656|Diabetic Peripheral Neuropathy|diabetic peripheral neuropathy
5318393|NCT00370643|hyperglycaemia|hyperglycaemia
5318394|NCT00370643|open heart surgery|open heart surgery
5318395|NCT00370643|intensive care unit|intensive care unit
5318396|NCT00370630|CRVO|crvo
5318397|NCT00370630|Intravitreal Avastin|intravitreal avastin
5318398|NCT00370630|Intravitreal triamcinolone|intravitreal triamcinolone
5318399|NCT00370617|chronic hepatitis C|chronic hepatitis c
5318400|NCT00370617|insulin resistance|insulin resistance
5318401|NCT00370617|therapy|therapy
5318402|NCT00370604|Parturient|parturient
5318403|NCT00370604|Obstetrics|obstetrics
5318404|NCT00370604|Pregnancy|pregnancy
5318405|NCT00370604|Labour|labour
5318406|NCT00370604|Labor|labor
5318407|NCT00370604|Headache|headache
5318408|NCT00370604|Epidural|epidural
5318409|NCT00370604|Analgesia|analgesia
5318410|NCT00370604|Anesthesia|anesthesia
5318411|NCT00370604|Anaesthesia|anaesthesia
5318412|NCT00370591|Inhaled corticosteroids|inhaled corticosteroids
5318413|NCT00370591|Asthma|asthma
5318414|NCT00370578|STEMI, THROMBUS, ASPIRATION DEVICE, NO REFLOW|stemi, thrombus, aspiration device, no reflow
5318415|NCT00370539|Photodynamic therapy,|photodynamic therapy,
5318416|NCT00370539|Bevacizumab,|bevacizumab,
5318417|NCT00370539|Triamcinolone,|triamcinolone,
5318418|NCT00370539|Age-related macular degeneration,|age-related macular degeneration,
5318419|NCT00370539|Choroidal neovascular membrane|choroidal neovascular membrane
5318420|NCT00370526|heart failure|heart failure
5318421|NCT00370526|resynchronization|resynchronization
5318422|NCT00370526|CRT|crt
5318423|NCT00370526|Bi-V pacemaker|bi-v pacemaker
5318424|NCT00370526|LV lead placement|lv lead placement
5318425|NCT00370526|hemodynamic assessment|hemodynamic assessment
5318426|NCT00370526|CRT Outcomes|crt outcomes
5318427|NCT00370513|pazopanib|pazopanib
5318428|NCT00370513|liver cancer|liver cancer
5318429|NCT00370513|hepatocellular cancer|hepatocellular cancer
5318430|NCT00370500|Schizophrenia|schizophrenia
5318431|NCT00370500|Dopamine transporter gene|dopamine transporter gene
5318432|NCT00370500|DNA methylation|dna methylation
5318435|NCT00370487|Midlevel providers|midlevel providers
5318436|NCT00370487|South Africa|south africa
5318437|NCT00370487|Viet Nam|viet nam
5318438|NCT00370474|Bi-V lead|bi-v lead
5318439|NCT00370474|Magnetic Navigation|magnetic navigation
5318440|NCT00370474|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
5318441|NCT00370461|Basic Cardiac Life Support|basic cardiac life support
5318442|NCT00370461|Termination of Resuscitation|termination of resuscitation
5318443|NCT00370461|Emergency Medical Services|emergency medical services
5318444|NCT00370461|Primary Care Paramedics|primary care paramedics
5318445|NCT00370461|Out of Hospital Cardiac Arrest|out of hospital cardiac arrest
5318446|NCT00370435|rheumatoid arthritis|rheumatoid arthritis
5318447|NCT00370435|safety|safety
5318448|NCT00370435|GW274150|gw274150
5318449|NCT00370435|pharmacokinetics|pharmacokinetics
5318450|NCT00370435|tolerability|tolerability
5318451|NCT00370422|Cystoid macular edema|cystoid macular edema
5318452|NCT00370422|Diabetic macular edema|diabetic macular edema
5318453|NCT00370422|Hard exudates|hard exudates
5318454|NCT00370422|Intravitreal bevacizumab|intravitreal bevacizumab
5318455|NCT00370422|Intravitreal triamcinolone|intravitreal triamcinolone
5318456|NCT00370422|Macular thickness|macular thickness
5318457|NCT00370409|Rebleeding|rebleeding
5318458|NCT00370409|Diabetic vitreous hemorrhage|diabetic vitreous hemorrhage
5318459|NCT00370409|Cryotherapy|cryotherapy
5318460|NCT00370396|Streptococcus pneumonia, pneumococcal conjugate vaccine|streptococcus pneumonia, pneumococcal conjugate vaccine
5318461|NCT00370383|Non Small Cell Lung Cancer|non small cell lung cancer
5318462|NCT00370383|PATIENTS ≥ 70 YEARS WITH UNRESECTABLE STAGE 3 OR 4 NSCLC|patients ≥ 70 years with unresectable stage 3 or 4 nsclc
5318463|NCT00370370|Bevacizumab,|bevacizumab,
5318464|NCT00370370|Triamcinolone|triamcinolone
5318465|NCT00370370|Age-related macular degeneration|age-related macular degeneration
5318466|NCT00370370|Choroidal neovascular membrane|choroidal neovascular membrane
5318467|NCT00370357|Microbicide|microbicide
5318468|NCT00370357|SPL7013|spl7013
5318469|NCT00370357|VivaGel|vivagel
5318470|NCT00370344|Gallbladder diseases|gallbladder diseases
5318471|NCT00370344|gallstones|gallstones
5318472|NCT00370344|cholecystectomy|cholecystectomy
5318473|NCT00370344|minilaparotomy|minilaparotomy
5318474|NCT00370344|laparoscopy|laparoscopy
5318475|NCT00370331|ITP|itp
5318476|NCT00370331|idiopathic|idiopathic
5318477|NCT00370331|platelets|platelets
5318478|NCT00370331|purpura|purpura
5318479|NCT00370331|thrombocytopenia|thrombocytopenia
5318480|NCT00370331|Idiopathic Thrombocytopenic Purpura|idiopathic thrombocytopenic purpura
5318481|NCT00370331|thrombocytopenic|thrombocytopenic
5318482|NCT00370318|Pneumococcal Disease|pneumococcal disease
5318483|NCT00370305|11ß-hydroxysteroid dehydrogenase|11ß-hydroxysteroid dehydrogenase
5318484|NCT00370305|rosiglitazone|rosiglitazone
5318485|NCT00370305|insulin sensitivity|insulin sensitivity
5318486|NCT00370305|Impaired glucose tolerance|impaired glucose tolerance
5318487|NCT00370279|Pseudophakic retinal detachment,|pseudophakic retinal detachment,
5318488|NCT00370279|Aphakic retinal detachment,|aphakic retinal detachment,
5318489|NCT00370279|Scleral buckling,|scleral buckling,
5318490|NCT00370279|Primary vitrectomy,|primary vitrectomy,
5318491|NCT00370279|Proliferative vitreoretinopathy|proliferative vitreoretinopathy
5318492|NCT00370266|Macular edema|macular edema
5318493|NCT00370266|Branch retinal vein occlusion|branch retinal vein occlusion
5318494|NCT00370266|Intravitreal triamcinolone|intravitreal triamcinolone
5318495|NCT00370266|Macular thickness|macular thickness
5318496|NCT00370266|Retinal neovascularization|retinal neovascularization
5318497|NCT00370253|hepatorenal syndrome|hepatorenal syndrome
5318498|NCT00370253|ascites|ascites
5318499|NCT00370253|portal hypertension|portal hypertension
5318500|NCT00370253|cirrhosis|cirrhosis
5318501|NCT00370240|Female|female
5318502|NCT00370240|Anesthetics,local|anesthetics,local
5318503|NCT00370227|Streptococcus pneumonia, pneumococcal conjugate vaccine|streptococcus pneumonia, pneumococcal conjugate vaccine
5318504|NCT00370214|Pulmonary arterial hypertension|pulmonary arterial hypertension
5318505|NCT00370214|Lung diseases|lung diseases
5318506|NCT00370214|Heart diseases|heart diseases
5318507|NCT00370214|Pulmonary circulation|pulmonary circulation
5318508|NCT00370214|Vascular resistance|vascular resistance
5318509|NCT00370214|PAH|pah
5318510|NCT00370214|Hypertension|hypertension
5318511|NCT00370201|retinal detachment|retinal detachment
5318512|NCT00370201|proliferative vitreoretinopathy|proliferative vitreoretinopathy
5318513|NCT00370188|problem gambling|problem gambling
5318514|NCT00370188|topiramate|topiramate
5318515|NCT00370123|endometriosis|endometriosis
5318516|NCT00370123|apoptosis|apoptosis
5318517|NCT00370123|regulatory T cells|regulatory t cells
5318518|NCT00370097|Asthma infants FLOVENT spacer|asthma infants flovent spacer
5318519|NCT00370071|MS|ms
5318520|NCT00370058|ect|ect
5318521|NCT00370058|depression|depression
5318522|NCT00370058|homocysteine|homocysteine
5318523|NCT00370058|mthfr genotype|mthfr genotype
5318524|NCT00370032|mucosal blood flow d-IBS|mucosal blood flow d-ibs
5318525|NCT00370019|Premature Ovarian Failure|premature ovarian failure
5318526|NCT00370019|Ovulation|ovulation
5318527|NCT00370019|Fertility|fertility
5318528|NCT00370019|Estrogen Replacement|estrogen replacement
5319398|NCT00366509|Lung|lung
5318529|NCT00370019|Follicle Function|follicle function
5318530|NCT00370019|Premature Menopause|premature menopause
5318531|NCT00370019|POF|pof
5318532|NCT00370006|cytomegalovirus|cytomegalovirus
5318533|NCT00370006|vaccine|vaccine
5318534|NCT00370006|T cell|t cell
5318535|NCT00370006|antibodies|antibodies
5318536|NCT00369993|asthma|asthma
5318537|NCT00369993|spacer|spacer
5318538|NCT00369967|Contraception|contraception
5318539|NCT00369967|Adolescents|adolescents
5318540|NCT00369967|Contraceptive vaginal ring|contraceptive vaginal ring
5318541|NCT00369967|Quick start|quick start
5318542|NCT00369954|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5318543|NCT00369954|fallopian tube cancer|fallopian tube cancer
5318544|NCT00369954|peritoneal cavity cancer|peritoneal cavity cancer
5318545|NCT00369915|Cholinergic|cholinergic
5318546|NCT00369915|Unipolar|unipolar
5318547|NCT00369915|Bipolar|bipolar
5318548|NCT00369915|Depression|depression
5318549|NCT00369915|Muscarinic|muscarinic
5318550|NCT00369915|Scopolamine|scopolamine
5318551|NCT00369915|Major Depressive Disorder|major depressive disorder
5318552|NCT00369915|MDD|mdd
5318553|NCT00369915|Bipolar Disorder|bipolar disorder
5318554|NCT00369915|BP|bp
5318555|NCT00369902|pain|pain
5318556|NCT00369902|acupuncture|acupuncture
5318557|NCT00369889|Thymoma|thymoma
5318558|NCT00369889|Thymic Cancer|thymic cancer
5318559|NCT00369876|Burns|burns
5318560|NCT00369876|Anorexia|anorexia
5318561|NCT00369876|Neuropeptide|neuropeptide
5318562|NCT00369876|Leptin|leptin
5318563|NCT00369876|Adiponectin|adiponectin
5318564|NCT00369876|Gherlin|gherlin
5318565|NCT00369863|Cystoid macular edema|cystoid macular edema
5318566|NCT00369863|Diabetic macular edema|diabetic macular edema
5318567|NCT00369863|Hard exudates|hard exudates
5318568|NCT00369863|Intravitreal triamcinolone|intravitreal triamcinolone
5318569|NCT00369863|Macular thickness|macular thickness
5318570|NCT00369850|osteoporosis|osteoporosis
5318571|NCT00369850|stage I breast cancer|stage i breast cancer
5318572|NCT00369850|stage II breast cancer|stage ii breast cancer
5318573|NCT00369850|stage IIIA breast cancer|stage iiia breast cancer
5318574|NCT00369824|HPV|hpv
5318575|NCT00369824|HPV, diptheria, pertussis, tetanus, meningitis|hpv, diptheria, pertussis, tetanus, meningitis
5318576|NCT00369811|Cholecystectomy, postoperative|cholecystectomy, postoperative
5318577|NCT00369798|Unipolar Depression|unipolar depression
5318578|NCT00369798|Phosphorylation|phosphorylation
5318579|NCT00369798|Affinity States|affinity states
5318580|NCT00369798|Compartment Analysis|compartment analysis
5318581|NCT00369798|(R)-(11)C Rolipram|(r)-(11)c rolipram
5318582|NCT00369798|Depression|depression
5318583|NCT00369798|Major Depressive Disorder|major depressive disorder
5318584|NCT00369798|MDD|mdd
5318585|NCT00369798|Healthy Volunteer|healthy volunteer
5318586|NCT00369798|HV|hv
5318587|NCT00369785|cognitive/functional effects|cognitive/functional effects
5318588|NCT00369785|fatigue|fatigue
5318589|NCT00369785|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
5318590|NCT00369785|radiation toxicity|radiation toxicity
5318591|NCT00369785|tumors metastatic to brain|tumors metastatic to brain
5318592|NCT00369785|adult brain stem glioma|adult brain stem glioma
5318593|NCT00369785|adult central nervous system germ cell tumor|adult central nervous system germ cell tumor
5318594|NCT00369785|adult choroid plexus tumor|adult choroid plexus tumor
5318595|NCT00369785|adult craniopharyngioma|adult craniopharyngioma
5318596|NCT00369785|adult mixed glioma|adult mixed glioma
5318597|NCT00369785|adult anaplastic meningioma|adult anaplastic meningioma
5318598|NCT00369785|meningeal melanocytoma|meningeal melanocytoma
5318599|NCT00369785|adult meningeal hemangiopericytoma|adult meningeal hemangiopericytoma
5318600|NCT00369785|adult grade I meningioma|adult grade i meningioma
5318601|NCT00369785|adult grade II meningioma|adult grade ii meningioma
5318602|NCT00369785|adult grade III meningioma|adult grade iii meningioma
5318603|NCT00369785|adult papillary meningioma|adult papillary meningioma
5318604|NCT00369785|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
5318605|NCT00369785|adult oligodendroglioma|adult oligodendroglioma
5318606|NCT00369785|adult pineoblastoma|adult pineoblastoma
5318607|NCT00369785|adult pineocytoma|adult pineocytoma
5318608|NCT00369785|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5318609|NCT00369785|adult diffuse astrocytoma|adult diffuse astrocytoma
5318610|NCT00369785|adult glioblastoma|adult glioblastoma
5318611|NCT00369785|adult giant cell glioblastoma|adult giant cell glioblastoma
5318612|NCT00369785|adult gliosarcoma|adult gliosarcoma
5318613|NCT00369785|adult pilocytic astrocytoma|adult pilocytic astrocytoma
5318614|NCT00369785|adult ependymoblastoma|adult ependymoblastoma
5318615|NCT00369785|adult medulloblastoma|adult medulloblastoma
5318616|NCT00369785|adult supratentorial primitive neuroectodermal tumor (PNET)|adult supratentorial primitive neuroectodermal tumor (pnet)
5318617|NCT00369785|adult anaplastic ependymoma|adult anaplastic ependymoma
5318618|NCT00369785|adult ependymoma|adult ependymoma
5318619|NCT00369785|adult myxopapillary ependymoma|adult myxopapillary ependymoma
5318620|NCT00369785|adult subependymoma|adult subependymoma
5318621|NCT00369772|Aranesp|aranesp
5318622|NCT00369772|Anemia|anemia
5318623|NCT00369772|Kidney Disease|kidney disease
5318624|NCT00369772|Hemoglobin|hemoglobin
5318625|NCT00369772|darbepoetin alfa|darbepoetin alfa
5318626|NCT00369772|QoL|qol
5318627|NCT00369759|Acute Lower Respiratory Infection|acute lower respiratory infection
5318628|NCT00369759|Retractions|retractions
5318629|NCT00369759|Bronchiolitis or pneumonia|bronchiolitis or pneumonia
5318630|NCT00369759|Wheezing|wheezing
5318631|NCT00369759|Rales|rales
5318632|NCT00369759|Crackles|crackles
5318633|NCT00369746|Depression|depression
5318634|NCT00369746|Alcohol Abuse|alcohol abuse
5318635|NCT00369746|Alcohol Dependence|alcohol dependence
5318636|NCT00369733|Aranesp|aranesp
5318637|NCT00369733|Anemia|anemia
5318638|NCT00369733|Kidney Disease|kidney disease
5318639|NCT00369733|Hemoglobin|hemoglobin
5318640|NCT00369733|darbepoetin alfa|darbepoetin alfa
5318641|NCT00369733|QoL|qol
5318642|NCT00369720|Prematurity|prematurity
5318643|NCT00369720|Resuscitation|resuscitation
5318644|NCT00369720|Room Air|room air
5318645|NCT00369707|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
5318646|NCT00369694|Esophageal varices|esophageal varices
5318647|NCT00369694|Portal Hypertension|portal hypertension
5318648|NCT00369694|Melena|melena
5318649|NCT00369694|Hematemesis|hematemesis
5318650|NCT00369694|Gastrointestinal Hemorrhage|gastrointestinal hemorrhage
5318651|NCT00369694|Terlipressin|terlipressin
5318652|NCT00369694|Efficacy|efficacy
5318653|NCT00369694|Safety|safety
5318654|NCT00369681|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
5318655|NCT00369681|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5318656|NCT00369681|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5318657|NCT00369681|adult lymphocyte depletion Hodgkin lymphoma|adult lymphocyte depletion hodgkin lymphoma
5318658|NCT00369681|adult mixed cellularity Hodgkin lymphoma|adult mixed cellularity hodgkin lymphoma
5318659|NCT00369681|adult nodular sclerosis Hodgkin lymphoma|adult nodular sclerosis hodgkin lymphoma
5318660|NCT00369668|Rehabilitation|rehabilitation
5318661|NCT00369668|Physical Therapy Techniques|physical therapy techniques
5318662|NCT00369668|Occupational Therapy|occupational therapy
5318663|NCT00369668|Upper Extremity; Motor skills|upper extremity; motor skills
5318664|NCT00369642|Cognitive-behavioral therapy|cognitive-behavioral therapy
5318665|NCT00369642|Children|children
5318666|NCT00369642|Obsessive-compulsive disorder|obsessive-compulsive disorder
5318667|NCT00369642|Intensive Cognitive-behavioral therapy|intensive cognitive-behavioral therapy
5318668|NCT00369642|Weekly Cognitive-behavioral therapy|weekly cognitive-behavioral therapy
5318669|NCT00369629|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5318782|NCT00369252|EGFR|egfr
5318670|NCT00369629|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
5318671|NCT00369629|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
5318672|NCT00369629|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
5318673|NCT00369629|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
5318674|NCT00369629|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
5318675|NCT00369629|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
5318676|NCT00369629|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
5318677|NCT00369629|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
5318678|NCT00369629|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5318679|NCT00369603|Alzheimer's Disease|alzheimer's disease
5318680|NCT00369603|fMRI|fmri
5318681|NCT00369603|Functional Neuroimaging|functional neuroimaging
5318682|NCT00369603|Allosteric Nicotinic Receptor Modulation|allosteric nicotinic receptor modulation
5318683|NCT00369603|Acetylcholinesterase Inhibition|acetylcholinesterase inhibition
5318684|NCT00369603|Head to head|head to head
5318685|NCT00369603|Dose escalation|dose escalation
5318686|NCT00369603|Biomarker|biomarker
5318687|NCT00369577|Agitation|agitation
5318688|NCT00369577|Schizophrenia|schizophrenia
5318689|NCT00369564|neurotoxicity|neurotoxicity
5318690|NCT00369564|peripheral neuropathy|peripheral neuropathy
5318691|NCT00369564|stage I Wilms tumor|stage i wilms tumor
5318692|NCT00369564|stage II Wilms tumor|stage ii wilms tumor
5318693|NCT00369564|stage III Wilms tumor|stage iii wilms tumor
5318694|NCT00369564|stage IV Wilms tumor|stage iv wilms tumor
5318695|NCT00369564|stage V Wilms tumor|stage v wilms tumor
5318696|NCT00369564|previously untreated childhood rhabdomyosarcoma|previously untreated childhood rhabdomyosarcoma
5318697|NCT00369564|childhood grade III lymphomatoid granulomatosis|childhood grade iii lymphomatoid granulomatosis
5318698|NCT00369564|childhood diffuse large cell lymphoma|childhood diffuse large cell lymphoma
5318699|NCT00369564|childhood immunoblastic large cell lymphoma|childhood immunoblastic large cell lymphoma
5318700|NCT00369564|stage I childhood large cell lymphoma|stage i childhood large cell lymphoma
5318701|NCT00369564|stage II childhood large cell lymphoma|stage ii childhood large cell lymphoma
5318702|NCT00369564|stage III childhood large cell lymphoma|stage iii childhood large cell lymphoma
5318703|NCT00369564|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
5318704|NCT00369564|stage I childhood lymphoblastic lymphoma|stage i childhood lymphoblastic lymphoma
5318705|NCT00369564|stage II childhood lymphoblastic lymphoma|stage ii childhood lymphoblastic lymphoma
5318706|NCT00369564|stage III childhood lymphoblastic lymphoma|stage iii childhood lymphoblastic lymphoma
5319913|NCT00365092|Literacy|literacy
5318707|NCT00369564|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
5318708|NCT00369564|childhood Burkitt lymphoma|childhood burkitt lymphoma
5318709|NCT00369564|stage I childhood small noncleaved cell lymphoma|stage i childhood small noncleaved cell lymphoma
5318710|NCT00369564|stage II childhood small noncleaved cell lymphoma|stage ii childhood small noncleaved cell lymphoma
5318711|NCT00369564|stage III childhood small noncleaved cell lymphoma|stage iii childhood small noncleaved cell lymphoma
5318712|NCT00369564|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
5318713|NCT00369564|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
5318714|NCT00369538|Podocyte - podocyturia - microparticles - angiotensin receptor antagonist - glomerulosclerosis|podocyte - podocyturia - microparticles - angiotensin receptor antagonist - glomerulosclerosis
5318715|NCT00369538|Patients presenting with stable glomerular nephropathy with proteinuria, normal or slightly altered renal function, with hypertension|patients presenting with stable glomerular nephropathy with proteinuria, normal or slightly altered renal function, with hypertension
5318716|NCT00369512|Phase II|phase ii
5318717|NCT00369512|Erlotinib|erlotinib
5318718|NCT00369512|Radiotherapy|radiotherapy
5318719|NCT00369512|Squamous Cell Carcinomas|squamous cell carcinomas
5318720|NCT00369512|Cutaneous|cutaneous
5318721|NCT00369512|Stage III|stage iii
5318722|NCT00369486|diabetic|diabetic
5318723|NCT00369486|macular|macular
5318724|NCT00369486|edema|edema
5318725|NCT00369486|peribulbar|peribulbar
5318726|NCT00369486|triamcinolone|triamcinolone
5318727|NCT00369486|acetonide|acetonide
5318728|NCT00369486|laser|laser
5318729|NCT00369486|photocoagulation|photocoagulation
5318730|NCT00369486|intraocular|intraocular
5318731|NCT00369486|DME|dme
5318732|NCT00369473|rheumatoid arthritis|rheumatoid arthritis
5318733|NCT00369460|recurrent pancreatic cancer|recurrent pancreatic cancer
5318734|NCT00369460|stage III pancreatic cancer|stage iii pancreatic cancer
5318735|NCT00369460|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
5318736|NCT00369460|stage IV pancreatic cancer|stage iv pancreatic cancer
5318737|NCT00369447|Non small cell lung cancer|non small cell lung cancer
5318738|NCT00369447|NSCLC|nsclc
5318739|NCT00369447|Nimotuzumab|nimotuzumab
5318740|NCT00369447|TheraCIM|theracim
5318741|NCT00369447|h-R3|h-r3
5318742|NCT00369447|YM BioSciences|ym biosciences
5318743|NCT00369447|Radiation|radiation
5318744|NCT00369447|Non small cell lung cancer, Stage IIb, III and IV|non small cell lung cancer, stage iib, iii and iv
5318745|NCT00369421|Dietary Therapy|dietary therapy
5318746|NCT00369421|Biochemical Defects|biochemical defects
5318747|NCT00369421|Enzyme Defects|enzyme defects
5318748|NCT00369421|Transport|transport
5318749|NCT00369421|Rare Diseases|rare diseases
5318750|NCT00369421|Varied Disorders|varied disorders
5318751|NCT00369421|Screening|screening
5318752|NCT00369421|Relatives|relatives
5318753|NCT00369408|Randomized Trial|randomized trial
5318754|NCT00369408|Medication for Heavy Drinking|medication for heavy drinking
5318755|NCT00369408|Naltrexone Treatment|naltrexone treatment
5318756|NCT00369408|Daily vs. Targeted Administration|daily vs. targeted administration
5318757|NCT00369395|melanoma|melanoma
5318758|NCT00369395|antibody|antibody
5318759|NCT00369395|angiogenesis|angiogenesis
5318760|NCT00369395|volociximab|volociximab
5318761|NCT00369382|Heart Transplant|heart transplant
5318762|NCT00369382|Kidney Failure|kidney failure
5318763|NCT00369343|Major Depressive Disorder|major depressive disorder
5318764|NCT00369343|vasomotor symptoms|vasomotor symptoms
5318765|NCT00369343|menopause|menopause
5318766|NCT00369343|diabetic neuropathy|diabetic neuropathy
5318767|NCT00369343|fibromyalgia|fibromyalgia
5318768|NCT00369330|atrial fibrillation|atrial fibrillation
5318769|NCT00369330|early cardioversion|early cardioversion
5318770|NCT00369330|electrical cardioversion|electrical cardioversion
5318771|NCT00369304|Health|health
5318772|NCT00369278|Renal transplantation, mycophenolate|renal transplantation, mycophenolate
5318773|NCT00369265|Gastroesophageal reflux|gastroesophageal reflux
5318774|NCT00369265|Laryngitis|laryngitis
5318775|NCT00369265|Hoarseness|hoarseness
5318776|NCT00369265|Dysphonia|dysphonia
5318777|NCT00369265|Proton pump inhibitor|proton pump inhibitor
5318778|NCT00369252|Nimotuzumab|nimotuzumab
5318779|NCT00369252|TheraCIM|theracim
5318780|NCT00369252|H-R3|h-r3
5318781|NCT00369252|Solid tumours|solid tumours
5318783|NCT00369252|Monoclonal antibody|monoclonal antibody
5318784|NCT00369239|Early psychosis|early psychosis
5318785|NCT00369239|premorbid functioning|premorbid functioning
5318786|NCT00369239|Scale for Assessment of Insight|scale for assessment of insight
5318787|NCT00369239|Risperdal Consta|risperdal consta
5318788|NCT00369239|risperidone long acting injectable|risperidone long acting injectable
5318789|NCT00369226|Velcade|velcade
5318790|NCT00369226|Bortezomib|bortezomib
5318791|NCT00369226|Allogeneic Stem Cell Transplant|allogeneic stem cell transplant
5318792|NCT00369226|GVHD|gvhd
5318793|NCT00369213|Crossover trial|crossover trial
5318794|NCT00369213|condom failure|condom failure
5318795|NCT00369213|additional spermicidal lubricant|additional spermicidal lubricant
5318796|NCT00369148|glinides|glinides
5318797|NCT00369148|premixed insulin|premixed insulin
5318798|NCT00369148|combination therapy|combination therapy
5318799|NCT00369148|glycemic control|glycemic control
5318800|NCT00369135|work|work
5318801|NCT00369135|Musculoskeletal Disorders|musculoskeletal disorders
5318802|NCT00369109|recurrent colon cancer|recurrent colon cancer
5318803|NCT00369109|stage III colon cancer|stage iii colon cancer
5318804|NCT00369109|stage IV colon cancer|stage iv colon cancer
5318805|NCT00369109|recurrent rectal cancer|recurrent rectal cancer
5318806|NCT00369109|stage III rectal cancer|stage iii rectal cancer
5318807|NCT00369109|stage IV rectal cancer|stage iv rectal cancer
5318808|NCT00369109|recurrent pancreatic cancer|recurrent pancreatic cancer
5318809|NCT00369109|stage II pancreatic cancer|stage ii pancreatic cancer
5318810|NCT00369109|stage III pancreatic cancer|stage iii pancreatic cancer
5318811|NCT00369109|stage IV pancreatic cancer|stage iv pancreatic cancer
5318812|NCT00369109|recurrent breast cancer|recurrent breast cancer
5318813|NCT00369109|stage IIIA breast cancer|stage iiia breast cancer
5318814|NCT00369109|stage IIIB breast cancer|stage iiib breast cancer
5318815|NCT00369109|stage IIIC breast cancer|stage iiic breast cancer
5318816|NCT00369109|stage IV breast cancer|stage iv breast cancer
5318817|NCT00369096|Peritoneal Dialysis|peritoneal dialysis
5318818|NCT00369096|Bemiparin|bemiparin
5318819|NCT00369096|Icodextrin|icodextrin
5318820|NCT00369096|Peritoneal Transport Disorders|peritoneal transport disorders
5318821|NCT00369083|Frail elderly|frail elderly
5318822|NCT00369083|Hospital at home|hospital at home
5318823|NCT00369070|AMG 706|amg 706
5318824|NCT00369070|Bevacizumab|bevacizumab
5318825|NCT00369070|Paclitaxel and Carboplatin|paclitaxel and carboplatin
5318826|NCT00369070|Randomized|randomized
5318827|NCT00369070|Non-Small Cell Lung Cancer|non-small cell lung cancer
5318828|NCT00369057|Intraocular pressure|intraocular pressure
5318829|NCT00369057|Prostatectomy|prostatectomy
5318830|NCT00369057|Robotic|robotic
5318831|NCT00369057|Glaucoma|glaucoma
5318832|NCT00369057|Carbon dioxide|carbon dioxide
5318833|NCT00369044|decompensated heart failure|decompensated heart failure
5318834|NCT00369044|prednisone|prednisone
5318835|NCT00369044|diuretics|diuretics
5318836|NCT00369044|diuresis|diuresis
5318837|NCT00369031|HIV|hiv
5318838|NCT00369031|vaccine|vaccine
5318839|NCT00369031|nasal immunization|nasal immunization
5318840|NCT00369018|photodynamic therapy|photodynamic therapy
5318841|NCT00369018|methyl aminolevulinate|methyl aminolevulinate
5318842|NCT00369018|hexaminolevulinate|hexaminolevulinate
5318843|NCT00369018|dose-finding|dose-finding
5318844|NCT00369018|cervical dysplasia|cervical dysplasia
5318845|NCT00369005|Transfusions|transfusions
5318846|NCT00369005|Erythrocyte|erythrocyte
5318847|NCT00369005|Anemia|anemia
5318848|NCT00369005|Brain|brain
5318849|NCT00369005|Infant, Premature|infant, premature
5318850|NCT00368979|Benign Prostatic Hyperplasia BPH dutasteride|benign prostatic hyperplasia bph dutasteride
5318851|NCT00368966|Pneumococcal|pneumococcal
5318852|NCT00368966|Pediatric|pediatric
5318853|NCT00368966|Vaccine|vaccine
5318854|NCT00368940|Memory Deficits|memory deficits
5318855|NCT00368940|Geriatric Depression|geriatric depression
5318856|NCT00368940|Cognitive Impairment|cognitive impairment
5318857|NCT00368940|Executive Dysfunction|executive dysfunction
5318858|NCT00368940|Disability|disability
5318859|NCT00368940|Problem Solving Therapy|problem solving therapy
5318860|NCT00368914|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5318861|NCT00368901|Aranesp|aranesp
5318862|NCT00368901|Anemia|anemia
5318863|NCT00368901|Kidney Disease|kidney disease
5318864|NCT00368901|Hemoglobin|hemoglobin
5318865|NCT00368901|darbepoetin alfa|darbepoetin alfa
5318866|NCT00368901|QoL|qol
5318867|NCT00368862|Alcoholism|alcoholism
5318868|NCT00368862|Depression|depression
5318869|NCT00368862|Efficacy study|efficacy study
5318870|NCT00368862|Memantine|memantine
5318871|NCT00368862|Escitalopram|escitalopram
5318872|NCT00368849|Huntington Disease|huntington disease
5318873|NCT00368849|Chorea|chorea
5318874|NCT00368849|Attention|attention
5318875|NCT00368849|ADHD|adhd
5318876|NCT00368849|ADD|add
5318877|NCT00368849|Strattera|strattera
5318878|NCT00368849|Atomoxetine|atomoxetine
5318879|NCT00368836|Capnography|capnography
5318880|NCT00368836|Thromboembolism|thromboembolism
5318881|NCT00368836|Arthroplasty|arthroplasty
5318882|NCT00368836|D-dimer|d-dimer
5318883|NCT00368823|point of care|point of care
5318884|NCT00368823|evidence based medicine|evidence based medicine
5318885|NCT00368810|Children|children
5318886|NCT00368810|Cross-Sectional|cross-sectional
5318887|NCT00368810|Glycosylphosphatidylinositol|glycosylphosphatidylinositol
5318888|NCT00368810|Cytokines|cytokines
5318889|NCT00368810|Peripheral Blood Mononuclear Cells|peripheral blood mononuclear cells
5318890|NCT00368810|Malaria|malaria
5318891|NCT00368797|Gene Therapy|gene therapy
5318892|NCT00368797|PAOD|paod
5318893|NCT00368797|CLI|cli
5318894|NCT00368771|Irritable Bowel Syndrome|irritable bowel syndrome
5318895|NCT00368771|Abdominal Pain|abdominal pain
5318896|NCT00368771|Abdominal Discomfort|abdominal discomfort
5318897|NCT00368771|Diarrhea|diarrhea
5318898|NCT00368771|Constipation|constipation
5318899|NCT00368771|IBS|ibs
5318900|NCT00368758|Meteorism|meteorism
5318901|NCT00368758|Bloating|bloating
5318902|NCT00368758|Irritable bowel syndrome (IBS)|irritable bowel syndrome (ibs)
5318903|NCT00368758|Probiotics|probiotics
5318904|NCT00368758|Bowel gas|bowel gas
5318905|NCT00368732|Congenital Heart Defects|congenital heart defects
5318906|NCT00368706|solifenacin|solifenacin
5318907|NCT00368706|Overactive bladder|overactive bladder
5318908|NCT00368706|Urinary incontinence|urinary incontinence
5318909|NCT00368706|Treatment outcomes|treatment outcomes
5318910|NCT00368706|VESIcare|vesicare
5318911|NCT00368680|Respiratory Distress Syndrome|respiratory distress syndrome
5318912|NCT00368680|Early Bubble CPAP|early bubble cpap
5318913|NCT00368680|Mechanical Ventilation|mechanical ventilation
5318914|NCT00368680|Surfactant|surfactant
5318915|NCT00368667|Anorexia Nervosa|anorexia nervosa
5318916|NCT00368667|Body Composition|body composition
5318917|NCT00368667|Metabolic Rate|metabolic rate
5318918|NCT00368628|acute ischemic stroke|acute ischemic stroke
5318919|NCT00368628|sleep apnea|sleep apnea
5318920|NCT00368628|continuous positive airway pressure|continuous positive airway pressure
5318921|NCT00368615|melanoma|melanoma
5318922|NCT00368615|malignant melanoma|malignant melanoma
5318923|NCT00368589|atherosclerotic plaque|atherosclerotic plaque
5318924|NCT00368589|USPIO|uspio
5318925|NCT00368589|Atheroma|atheroma
5318926|NCT00368589|thrombo-embolic stroke|thrombo-embolic stroke
5318927|NCT00368589|magnetic resonance imaging|magnetic resonance imaging
5318928|NCT00368589|Ultra small Super-Paramagnetic Iron Oxide|ultra small super-paramagnetic iron oxide
5318929|NCT00368576|SB-480848|sb-480848
5318930|NCT00368576|methacholine challenge|methacholine challenge
5318931|NCT00368576|asthma|asthma
5318932|NCT00368576|inhaled steroid|inhaled steroid
5318933|NCT00368550|Alcohol Drinking|alcohol drinking
5318934|NCT00368550|Alcohol Dependence|alcohol dependence
5318935|NCT00368550|Sertraline Pharmacotherapy|sertraline pharmacotherapy
5318936|NCT00368550|Alcoholism Subtypes|alcoholism subtypes
5318937|NCT00368550|Early- versus Late-Onset Alcoholism|early- versus late-onset alcoholism
5318938|NCT00368537|skin infection|skin infection
5318939|NCT00368537|antibiotics|antibiotics
5318940|NCT00368524|cocaine dependence|cocaine dependence
5318941|NCT00368524|mental disorder|mental disorder
5318942|NCT00368524|dual diagnoses|dual diagnoses
5318943|NCT00368524|homelessness|homelessness
5318944|NCT00368511|Fall Prevention|fall prevention
5318945|NCT00368511|Dynamic Posturography|dynamic posturography
5318946|NCT00368511|Nolwenn Effect|nolwenn effect
5318947|NCT00368511|Music Listening|music listening
5318948|NCT00368498|teicoplanin|teicoplanin
5318949|NCT00368485|diaphragm electrical activity|diaphragm electrical activity
5318950|NCT00368485|non invasive ventilation|non invasive ventilation
5318951|NCT00368485|patient ventilator interaction|patient ventilator interaction
5318952|NCT00368472|Refractory|refractory
5318953|NCT00368472|Partial|partial
5318954|NCT00368472|Seizures|seizures
5318955|NCT00368459|raloxifene, women|raloxifene, women
5318956|NCT00368446|Nontuberculous Mycobacterial Infection|nontuberculous mycobacterial infection
5318957|NCT00368446|Primary Ciliary Dyskinesia|primary ciliary dyskinesia
5318958|NCT00368446|Cystic Fibrosis|cystic fibrosis
5318959|NCT00368446|Pseudohypoaldosteronism|pseudohypoaldosteronism
5318960|NCT00368446|Chronic Granulomatous Disease|chronic granulomatous disease
5318961|NCT00368446|Mycobacterial Infection|mycobacterial infection
5318962|NCT00368446|PCD|pcd
5318963|NCT00368446|CF|cf
5318964|NCT00368446|PHA|pha
5318965|NCT00368446|Healthy Volunteer|healthy volunteer
5318966|NCT00368446|HV|hv
5318967|NCT00368433|Sensory Processing|sensory processing
5318968|NCT00368433|Electromyogram|electromyogram
5318969|NCT00368433|Tic Disorder|tic disorder
5318970|NCT00368433|Tourette Syndrome|tourette syndrome
5318971|NCT00368433|Tourette's Syndrome|tourette's syndrome
5318972|NCT00368433|Healthy Volunteer|healthy volunteer
5318973|NCT00368433|HV|hv
5318974|NCT00368420|ovarian cancer|ovarian cancer
5318975|NCT00368420|recurrence|recurrence
5318976|NCT00368420|surgery|surgery
5318977|NCT00368407|308-nm excimer laser|308-nm excimer laser
5318978|NCT00368407|vitiligo|vitiligo
5318979|NCT00368394|Insulin glulisine|insulin glulisine
5318980|NCT00368394|Euglycaemic clamp|euglycaemic clamp
5318981|NCT00368394|Diabetes mellitus Type 1|diabetes mellitus type 1
5318982|NCT00368381|sepsis|sepsis
5318983|NCT00368381|septicemia|septicemia
5318984|NCT00368381|sepsis syndrome|sepsis syndrome
5318985|NCT00368381|adrenal insufficiency|adrenal insufficiency
5318986|NCT00368381|adrenal cortex hormones|adrenal cortex hormones
5318987|NCT00368381|hydrocortisone|hydrocortisone
5318988|NCT00368381|fludrocortisone|fludrocortisone
5318989|NCT00368355|haploidenticalstem cell transplant|haploidenticalstem cell transplant
5318990|NCT00368355|acute lymphoblastic leukemia|acute lymphoblastic leukemia
5318991|NCT00368355|Non Hodgkins Lymphoma|non hodgkins lymphoma
5318992|NCT00368355|Myelodysplastic Syndrome|myelodysplastic syndrome
5318993|NCT00368355|Acute myeloid leukemia|acute myeloid leukemia
5318994|NCT00368355|Chronic myelogenous leukemia|chronic myelogenous leukemia
5318995|NCT00368355|Hemophagocytic lymphohistiocytosis (HLH)|hemophagocytic lymphohistiocytosis (hlh)
5318996|NCT00368355|Familial hemophagocytic lymphohistiocytosis (FLH)|familial hemophagocytic lymphohistiocytosis (flh)
5318997|NCT00368355|Viral-associated hemophagocytic syndrome (VAHS)|viral-associated hemophagocytic syndrome (vahs)
5318998|NCT00368355|X-linked lymphoproliferative disease (XLP)|x-linked lymphoproliferative disease (xlp)
5318999|NCT00368316|Dysentery|dysentery
5319000|NCT00368316|S. sonnei|s. sonnei
5319001|NCT00368316|Antibody Response|antibody response
5319002|NCT00368316|Protection|protection
5319003|NCT00368303|Major Depression|major depression
5319004|NCT00368303|paroxetine controlled release (CR)|paroxetine controlled release (cr)
5319005|NCT00368303|paroxetine immediate release (IR)|paroxetine immediate release (ir)
5319006|NCT00368290|cocaine dependence|cocaine dependence
5319007|NCT00368290|hiv prevention|hiv prevention
5319008|NCT00368277|Systolic hypertension|systolic hypertension
5319009|NCT00368277|hypertension|hypertension
5319010|NCT00368277|aliskiren|aliskiren
5319011|NCT00368277|blood pressure|blood pressure
5319012|NCT00368277|ramipril|ramipril
5319013|NCT00368277|HTN|htn
5319014|NCT00368264|lupus|lupus
5319015|NCT00368264|nephritis|nephritis
5319016|NCT00368264|membraneous|membraneous
5319017|NCT00368264|proteinuria|proteinuria
5319018|NCT00368264|TNF|tnf
5319019|NCT00368264|infliximab|infliximab
5319020|NCT00368264|azathioprine|azathioprine
5319021|NCT00368264|autoantibodies|autoantibodies
5319022|NCT00368251|Unverricht-Lundborg Disease|unverricht-lundborg disease
5319023|NCT00368251|Baltic Myoclonus|baltic myoclonus
5319024|NCT00368251|Progressive Myoclonic Epilepsies|progressive myoclonic epilepsies
5319025|NCT00368251|Myoclonus|myoclonus
5319026|NCT00368251|Brivaracetam|brivaracetam
5319027|NCT00368238|Platelet function tests|platelet function tests
5319028|NCT00368238|Erythropoietin|erythropoietin
5319029|NCT00368238|Aspirin|aspirin
5319030|NCT00368238|Clopidogrel|clopidogrel
5319031|NCT00368225|Viral Hepatitis|viral hepatitis
5319032|NCT00368225|Hepatitis C|hepatitis c
5319033|NCT00368225|HCV|hcv
5319034|NCT00368225|Liver Transplant|liver transplant
5319035|NCT00368225|Renal Transplant|renal transplant
5319036|NCT00368225|Kidney Transplant|kidney transplant
5319037|NCT00368212|Somatization|somatization
5319038|NCT00368212|Refractory Symptoms|refractory symptoms
5319039|NCT00368199|single photon emission computer tomography (SPECT)|single photon emission computer tomography (spect)
5319040|NCT00368199|transcranial sonography|transcranial sonography
5319041|NCT00368199|transcranial duplex scanning|transcranial duplex scanning
5319042|NCT00368199|parkinson's disease|parkinson's disease
5319043|NCT00368199|atypical parkinson syndromes|atypical parkinson syndromes
5319044|NCT00368199|parkinsonism|parkinsonism
5319045|NCT00368199|parkinsonian|parkinsonian
5319046|NCT00368199|diagnostic|diagnostic
5319047|NCT00368199|progressive supranuclear paralysis|progressive supranuclear paralysis
5319048|NCT00368160|Next day driving|next day driving
5319049|NCT00368147|Hemodialysis|hemodialysis
5319050|NCT00368147|Arteriovenous Fistula|arteriovenous fistula
5319051|NCT00368147|Arteriovenous Graft|arteriovenous graft
5319052|NCT00368147|Left Ventricular Hypertrophy|left ventricular hypertrophy
5319053|NCT00368147|Brain Natriuretic Peptide|brain natriuretic peptide
5319054|NCT00368134|Type 2 Diabetes|type 2 diabetes
5319055|NCT00368134|Vildagliptin|vildagliptin
5319056|NCT00368134|HbA1c|hba1c
5319057|NCT00368121|Multiple Myeloma|multiple myeloma
5319058|NCT00368121|Cetuximab|cetuximab
5319059|NCT00368095|DM|dm
5319060|NCT00368095|HT|ht
5319061|NCT00368095|Dyslipidemia|dyslipidemia
5319062|NCT00368095|Obesity|obesity
5319063|NCT00368095|Cardiovascular disease|cardiovascular disease
5319064|NCT00368095|Cerebrovascular disease|cerebrovascular disease
5319065|NCT00368095|Myocardial infarction|myocardial infarction
5319066|NCT00368095|stroke|stroke
5319067|NCT00368095|Metabolic syndrome|metabolic syndrome
5319068|NCT00368095|CVD-CAD|cvd-cad
5319069|NCT00368082|EBV-Positive Lymphoma|ebv-positive lymphoma
5319070|NCT00368082|Hodgkin´s Disease (HD)|hodgkin´s disease (hd)
5319071|NCT00368082|Non-Hodgkin's lymphoma (NHL)|non-hodgkin's lymphoma (nhl)
5319072|NCT00368082|relapsed Hodgkin's disease|relapsed hodgkin's disease
5319073|NCT00368082|relapsed non-Hodgkin's disease|relapsed non-hodgkin's disease
5319074|NCT00368082|lymphoma|lymphoma
5319075|NCT00368082|TGFbeta resistant LMP-specific CTLs|tgfbeta resistant lmp-specific ctls
5319076|NCT00368082|cytotoxic T cells|cytotoxic t cells
5319077|NCT00368069|Epilepsy|epilepsy
5319078|NCT00368069|Keppra® XR|keppra® xr
5319079|NCT00368069|Levetiracetam XR|levetiracetam xr
5319080|NCT00368069|Extended release|extended release
5319081|NCT00368043|Pituitary|pituitary
5319082|NCT00368043|Adrenal|adrenal
5319083|NCT00368043|Growth|growth
5319084|NCT00368043|Cortisol|cortisol
5319085|NCT00368043|Stress Response|stress response
5319086|NCT00368043|Adoption|adoption
5319087|NCT00368043|Thyroid Hormone|thyroid hormone
5319088|NCT00368043|Psychosocial Adjustment|psychosocial adjustment
5319089|NCT00368043|Healthy Volunteer|healthy volunteer
5319090|NCT00368043|HV|hv
5319091|NCT00368030|Insomnia related to major depressive disorder.|insomnia related to major depressive disorder.
5319092|NCT00368004|Coloboma|coloboma
5319093|NCT00368004|Genetics|genetics
5319094|NCT00368004|Optic Nerve Coloboma|optic nerve coloboma
5319095|NCT00368004|Chorioretinal Coloboma|chorioretinal coloboma
5319096|NCT00368004|Iris Coloboma|iris coloboma
5319097|NCT00368004|Uveal Coloboma|uveal coloboma
5319098|NCT00367991|Platelet function tests|platelet function tests
5319099|NCT00367991|Erythropoietin|erythropoietin
5319100|NCT00367991|Myocardial infarction|myocardial infarction
5319101|NCT00367978|Hypertension, diabetes, African-American, amlodipine/benazepril|hypertension, diabetes, african-american, amlodipine/benazepril
5319102|NCT00367965|Insomnia related to rheumatoid arthritis (RA)|insomnia related to rheumatoid arthritis (ra)
5319103|NCT00367952|HIV|hiv
5319104|NCT00367952|apricitabine|apricitabine
5319105|NCT00367952|drug resistance|drug resistance
5319106|NCT00367952|reverse transcriptase|reverse transcriptase
5319107|NCT00367952|lamivudine|lamivudine
5319108|NCT00367939|Hypertension|hypertension
5319109|NCT00367926|ginseng|ginseng
5319110|NCT00367926|polysaccharides|polysaccharides
5319111|NCT00367926|postprandial glycemia|postprandial glycemia
5319112|NCT00367926|area under the glucose curve|area under the glucose curve
5319113|NCT00367926|peak incremental glucose|peak incremental glucose
5319114|NCT00367913|pulmonary disease|pulmonary disease
5319115|NCT00367913|Treatment of Opportunist Mycobacteria|treatment of opportunist mycobacteria
5319116|NCT00367913|Clarithromycin|clarithromycin
5319117|NCT00367913|Ciprofloxacin|ciprofloxacin
5319118|NCT00367913|M.vaccae|m.vaccae
5319119|NCT00367913|Pulmonary diseases caused by Opportunist Mycobacteria|pulmonary diseases caused by opportunist mycobacteria
5319120|NCT00367900|Diet|diet
5319121|NCT00367900|Lifestyle|lifestyle
5319122|NCT00367900|Neurodegenerative Diseases|neurodegenerative diseases
5319123|NCT00367900|Elderly Population|elderly population
5319124|NCT00367900|Public Health|public health
5319125|NCT00367900|Parkinson Disease|parkinson disease
5319126|NCT00367900|Environment|environment
5319127|NCT00367887|Hepatitis C|hepatitis c
5319128|NCT00367874|Opiate dependence|opiate dependence
5319129|NCT00367874|Benzodiazepine dependence|benzodiazepine dependence
5319130|NCT00367874|Polydrug Abuse|polydrug abuse
5319131|NCT00367874|Detoxification|detoxification
5319132|NCT00367874|Withdrawal Treatment|withdrawal treatment
5319133|NCT00367861|GIST|gist
5319134|NCT00367861|Glivec®|glivec®
5319135|NCT00367861|randomized|randomized
5319136|NCT00367861|phase III|phase iii
5319137|NCT00367848|suspected fractures in the ankle and wrist|suspected fractures in the ankle and wrist
5319138|NCT00367822|Restless Legs Syndrome|restless legs syndrome
5319139|NCT00367822|dopamine agonist|dopamine agonist
5319140|NCT00367822|lisuride|lisuride
5319141|NCT00367822|ropinirole|ropinirole
5319142|NCT00367809|Meditation|meditation
5319143|NCT00367809|Mindfulness|mindfulness
5319144|NCT00367809|Organ Transplant|organ transplant
5319145|NCT00367809|Transplantation|transplantation
5319146|NCT00367809|Minnesota|minnesota
5319147|NCT00367809|Immune suppressive therapy|immune suppressive therapy
5319148|NCT00367796|Craniosynostosis|craniosynostosis
5319149|NCT00367796|Philadelphia Type|philadelphia type
5319150|NCT00367770|bosentan|bosentan
5319151|NCT00367770|PAH related to Eisenmenger physiology|pah related to eisenmenger physiology
5319152|NCT00367770|Tracleer|tracleer
5319153|NCT00367757|paroxysmal atrial fibrillation|paroxysmal atrial fibrillation
5319154|NCT00367757|persistent atrial fibrillation|persistent atrial fibrillation
5319155|NCT00367757|high burden of atrial fibrillation|high burden of atrial fibrillation
5319156|NCT00367757|atrial fibrillation ablation|atrial fibrillation ablation
5319157|NCT00367757|Pulmonary vein isolation|pulmonary vein isolation
5319158|NCT00367757|AF trigger|af trigger
5319159|NCT00367757|complex fractionated electrograms|complex fractionated electrograms
5319160|NCT00367757|CFE|cfe
5319161|NCT00367757|CFAE|cfae
5319162|NCT00367757|complex fractionated atrial electrograms|complex fractionated atrial electrograms
5319163|NCT00367757|refractory antiarrhythmic medication|refractory antiarrhythmic medication
5319164|NCT00367757|PVAI|pvai
5319165|NCT00367757|Ensite NavX|ensite navx
5319166|NCT00367757|NavX|navx
5319167|NCT00367757|CoolPath catheter|coolpath catheter
5319168|NCT00367757|irrigated ablation catheter|irrigated ablation catheter
5319169|NCT00367757|high burden of paroxysmal or persistent atrial fibrillation|high burden of paroxysmal or persistent atrial fibrillation
5319170|NCT00367757|candidates for AF ablation|candidates for af ablation
5319171|NCT00367757|symptomatic AF|symptomatic af
5319172|NCT00367757|AF is refractory to at least one antiarrhythmic medication|af is refractory to at least one antiarrhythmic medication
5319173|NCT00367744|mitochondria|mitochondria
5319174|NCT00367744|HIV|hiv
5319175|NCT00367744|lipoatrophy|lipoatrophy
5319176|NCT00367731|HIV|hiv
5319177|NCT00367731|AIDS|aids
5319178|NCT00367731|Neurological complications|neurological complications
5319179|NCT00367731|HAART|haart
5319180|NCT00367692|Scleritis|scleritis
5319181|NCT00367679|pazopanib|pazopanib
5319182|NCT00367679|I-ELCAP|i-elcap
5319183|NCT00367679|non-small cell lung cancer|non-small cell lung cancer
5319184|NCT00367679|antiangiogenesis|antiangiogenesis
5319185|NCT00367679|NSCLC|nsclc
5319186|NCT00367679|GW786034|gw786034
5319187|NCT00367640|Sublingual immunotherapy|sublingual immunotherapy
5319188|NCT00367640|Grass pollen tablet|grass pollen tablet
5319189|NCT00367640|Allergic rhinoconjunctivitis|allergic rhinoconjunctivitis
5319190|NCT00367627|Children|children
5319191|NCT00367627|Malnutrition|malnutrition
5319192|NCT00367627|Ascaris Lumbricoides|ascaris lumbricoides
5319193|NCT00367627|Trichuris trichiura Morbidity|trichuris trichiura morbidity
5319194|NCT00367627|Helminthiasis|helminthiasis
5319195|NCT00367627|Children 2-5 years|children 2-5 years
5319196|NCT00367627|Stool RME +ve for helminthiasis|stool rme +ve for helminthiasis
5319197|NCT00367614|Adolescents|adolescents
5319198|NCT00367614|GERD|gerd
5319199|NCT00367588|chemotherapy|chemotherapy
5319200|NCT00367588|diet|diet
5319201|NCT00367588|hematological malignancy|hematological malignancy
5319202|NCT00367588|infection prevention|infection prevention
5319203|NCT00367588|protective isolation|protective isolation
5319204|NCT00367588|Patients with cytopenia due to intensive chemotherapy for hematological malignancy|patients with cytopenia due to intensive chemotherapy for hematological malignancy
5319205|NCT00367575|alcoholism|alcoholism
5319206|NCT00367575|drinking|drinking
5319207|NCT00367575|randomized|randomized
5319208|NCT00367575|internet personalized alcohol feedback|internet personalized alcohol feedback
5319209|NCT00367562|IGA NEPHROPATHY|iga nephropathy
5319210|NCT00367562|STEROIDS|steroids
5319211|NCT00367562|ENALAPRIL|enalapril
5319212|NCT00367562|VALSARTAN|valsartan
5319213|NCT00367562|PROTEINURIA|proteinuria
5319214|NCT00367562|IMMUNOGLOBULIN A NEPHROPATHY (IGA NEPHROPATHY)|immunoglobulin a nephropathy (iga nephropathy)
5319215|NCT00367549|Labor|labor
5319216|NCT00367549|instrumental delivery|instrumental delivery
5319217|NCT00367549|nutrition|nutrition
5319218|NCT00367549|epidural anesthesia|epidural anesthesia
5319219|NCT00367549|oxytocin|oxytocin
5319220|NCT00367536|Health|health
5319221|NCT00367523|Echocardiogram|echocardiogram
5319222|NCT00367523|Nigeria|nigeria
5319223|NCT00367523|Screening|screening
5319224|NCT00367523|Sickle Cell Disease|sickle cell disease
5319225|NCT00367523|Genetics|genetics
5319226|NCT00367497|aggressive non-Hodgkin's lymphoma|aggressive non-hodgkin's lymphoma
5319227|NCT00367497|salvage chemotherapy|salvage chemotherapy
5319228|NCT00367497|rituximab|rituximab
5319229|NCT00367471|metastatic|metastatic
5319230|NCT00367471|paclitaxel|paclitaxel
5319231|NCT00367471|lapatinib|lapatinib
5319232|NCT00367471|trastuzumab|trastuzumab
5319233|NCT00367471|carboplatin|carboplatin
5319234|NCT00367471|breast cancer|breast cancer
5319235|NCT00367458|Viremia|viremia
5319236|NCT00367458|Statin|statin
5319237|NCT00367458|HIV Replication|hiv replication
5319238|NCT00367458|Cholesterol|cholesterol
5319239|NCT00367458|Lipid Raft|lipid raft
5319240|NCT00367458|HIV Infection|hiv infection
5319241|NCT00367458|HIV Positive|hiv positive
5319242|NCT00367432|Epilepsies|epilepsies
5319243|NCT00367432|Partial|partial
5319244|NCT00367432|Keppra|keppra
5319245|NCT00367432|levetiracetam|levetiracetam
5319246|NCT00367393|Pimecrolimus, skin atrophy, dermoscopy, atopic dermatitis, eczema|pimecrolimus, skin atrophy, dermoscopy, atopic dermatitis, eczema
5319247|NCT00367380|Malaria|malaria
5319248|NCT00367380|Sporozoite|sporozoite
5319249|NCT00367380|Challenge Model|challenge model
5319250|NCT00367380|Plasmodium vivax|plasmodium vivax
5319251|NCT00367380|Human Volunteers|human volunteers
5319252|NCT00367367|embryo transfer|embryo transfer
5319253|NCT00367367|hysteroscopy|hysteroscopy
5319254|NCT00367367|curettage|curettage
5319255|NCT00367367|iv-vitro fertilization|iv-vitro fertilization
5319256|NCT00367367|molecular markers|molecular markers
5319257|NCT00367367|endometrial receptivity|endometrial receptivity
5319258|NCT00367367|endometrial dating|endometrial dating
5319259|NCT00367354|Imaging Technology|imaging technology
5319260|NCT00367354|Cardiology|cardiology
5319261|NCT00367341|Depression, Treatment, Imaging|depression, treatment, imaging
5319262|NCT00367328|Hidradenitis Supperativa|hidradenitis supperativa
5319263|NCT00367315|Osteoarthritis, lumiracoxib, celecoxib, cyclooxygenase-2 inhibitors|osteoarthritis, lumiracoxib, celecoxib, cyclooxygenase-2 inhibitors
5319264|NCT00367302|addiction|addiction
5319265|NCT00367302|jail|jail
5319266|NCT00367302|opiates|opiates
5319267|NCT00367302|buprenorphine|buprenorphine
5319268|NCT00367302|clinical trial|clinical trial
5319269|NCT00367276|Females requiring contraceptives|females requiring contraceptives
5319270|NCT00367263|Asthma|asthma
5319271|NCT00367224|vitiligo|vitiligo
5319272|NCT00367224|tolerance|tolerance
5319273|NCT00367224|ultraviolet B.|ultraviolet b.
5319274|NCT00367211|Gastric Ulcers|gastric ulcers
5319275|NCT00367211|NSAID|nsaid
5319276|NCT00367211|Arthritis|arthritis
5319277|NCT00367185|Multiple myeloma|multiple myeloma
5319278|NCT00367185|Elderly patients|elderly patients
5319279|NCT00367185|Thalidomide|thalidomide
5319280|NCT00367185|Autologous transplantation|autologous transplantation
5319281|NCT00367172|human immunodeficiency virus|human immunodeficiency virus
5319282|NCT00367172|acquired immunodeficiency syndrome|acquired immunodeficiency syndrome
5319283|NCT00367172|substance abuse|substance abuse
5319284|NCT00367172|directly administered antiretroviral therapy|directly administered antiretroviral therapy
5319285|NCT00367172|adherence, directly observed therapy|adherence, directly observed therapy
5319286|NCT00367159|Vesico-ureteral reflux, autologous adipocytes, adipocytes graft|vesico-ureteral reflux, autologous adipocytes, adipocytes graft
5319287|NCT00367146|liver transplantation|liver transplantation
5319288|NCT00367146|children|children
5319289|NCT00367146|immunosuppression|immunosuppression
5319914|NCT00365092|Attention|attention
5319290|NCT00367146|mycophenolatmofetil|mycophenolatmofetil
5319291|NCT00367146|calcineurin inhibitor|calcineurin inhibitor
5319292|NCT00367146|kidney disease|kidney disease
5319293|NCT00367133|diabetic|diabetic
5319294|NCT00367133|macular|macular
5319295|NCT00367133|edema|edema
5319296|NCT00367133|intravitreal|intravitreal
5319297|NCT00367133|triamcinolone|triamcinolone
5319298|NCT00367133|laser|laser
5319299|NCT00367133|photocoagulation|photocoagulation
5319300|NCT00367133|DME|dme
5319301|NCT00367107|Autism spectrum disorders|autism spectrum disorders
5319302|NCT00367107|long-term outcomes|long-term outcomes
5319303|NCT00367107|caregiver burden|caregiver burden
5319304|NCT00367107|birth cohort|birth cohort
5319305|NCT00367107|nested case-control study|nested case-control study
5319306|NCT00367094|Hypertension, benazepril, hydrochlorothiazide, fixed combination|hypertension, benazepril, hydrochlorothiazide, fixed combination
5319307|NCT00367081|Toxoplasmic Encephalitis|toxoplasmic encephalitis
5319308|NCT00367081|AIDS|aids
5319309|NCT00367068|Cerebral palsy|cerebral palsy
5319310|NCT00367068|Spasticity|spasticity
5319311|NCT00367068|Child|child
5319312|NCT00367068|Baclofen|baclofen
5319313|NCT00367068|Intrathecal injection|intrathecal injection
5319314|NCT00367055|Beta cell function|beta cell function
5319315|NCT00367055|Type 2 diabetes|type 2 diabetes
5319316|NCT00367055|Combination treatment|combination treatment
5319317|NCT00367029|Physical Activity|physical activity
5319318|NCT00367003|Depression, Unipolar, Bipolar-II, DBS, Imaging|depression, unipolar, bipolar-ii, dbs, imaging
5319319|NCT00366990|Arterial Stiffening|arterial stiffening
5319320|NCT00366977|Cessation|cessation
5319321|NCT00366977|Smoking|smoking
5319322|NCT00366977|Quitline|quitline
5319323|NCT00366977|Policies|policies
5319324|NCT00366977|Counseling|counseling
5319325|NCT00366951|Cervical Ripening|cervical ripening
5319326|NCT00366951|Labor, Induced|labor, induced
5319327|NCT00366951|Balloon Dilation|balloon dilation
5319328|NCT00366951|Oxytocin|oxytocin
5319329|NCT00366938|Osteoarthritis, lumiracoxib, celecoxib, Cox-2|osteoarthritis, lumiracoxib, celecoxib, cox-2
5319330|NCT00366912|work of breathing|work of breathing
5319331|NCT00366912|pressure time product|pressure time product
5319332|NCT00366912|muscle pressures|muscle pressures
5319333|NCT00366899|Vaccine|vaccine
5319334|NCT00366899|Infants|infants
5319335|NCT00366886|cardiac|cardiac
5319336|NCT00366886|pediatric|pediatric
5319337|NCT00366886|surgery|surgery
5319338|NCT00366886|blood markers|blood markers
5319339|NCT00366873|Infant|infant
5319340|NCT00366873|Term|term
5319341|NCT00366860|soy|soy
5319342|NCT00366860|isoflavones|isoflavones
5319343|NCT00366860|bone resorption|bone resorption
5319344|NCT00366860|osteogenesis|osteogenesis
5319345|NCT00366860|diet|diet
5319346|NCT00366860|hyperlipidemia|hyperlipidemia
5319347|NCT00366847|cardiac|cardiac
5319348|NCT00366847|MRI|mri
5319349|NCT00366847|pediatrics|pediatrics
5319350|NCT00366834|Anthracycline|anthracycline
5319351|NCT00366834|Cyclophosphamide|cyclophosphamide
5319352|NCT00366834|Moderately|moderately
5319353|NCT00366834|Nausea|nausea
5319354|NCT00366834|Emetogenic|emetogenic
5319355|NCT00366834|Vomiting|vomiting
5319356|NCT00366821|cardiac|cardiac
5319357|NCT00366821|pediatric|pediatric
5319358|NCT00366821|genetic|genetic
5319359|NCT00366782|Respiratory Tract Disease|respiratory tract disease
5319360|NCT00366782|Bovine|bovine
5319361|NCT00366782|Chimeric Vaccine|chimeric vaccine
5319362|NCT00366756|Vision|vision
5319363|NCT00366756|Visual Acuity|visual acuity
5319364|NCT00366730|Amebiasis|amebiasis
5319365|NCT00366730|Entamoeba histolytica|entamoeba histolytica
5319366|NCT00366717|Cancer under chemotherapy|cancer under chemotherapy
5319367|NCT00366704|Schizophrenia|schizophrenia
5319368|NCT00366691|cataract|cataract
5319369|NCT00366678|Safety|safety
5319370|NCT00366678|Vaccine|vaccine
5319371|NCT00366652|Healthy|healthy
5319372|NCT00366639|Heart failure, congestive|heart failure, congestive
5319373|NCT00366639|Heart decompensation|heart decompensation
5319374|NCT00366626|Alcohol dependence|alcohol dependence
5319375|NCT00366626|Alcoholism|alcoholism
5319376|NCT00366626|Craving|craving
5319377|NCT00366626|Genetic|genetic
5319378|NCT00366613|Cataract|cataract
5319379|NCT00366613|Cataract Extraction|cataract extraction
5319380|NCT00366600|Breast Cancer|breast cancer
5319381|NCT00366600|Health|health
5319382|NCT00366600|Pharmacokinetics|pharmacokinetics
5319383|NCT00366600|healthy subjects|healthy subjects
5319384|NCT00366561|neonates|neonates
5319385|NCT00366561|neurological complications|neurological complications
5319386|NCT00366561|surgery|surgery
5319387|NCT00366548|Vaccine|vaccine
5319388|NCT00366548|Infant|infant
5319389|NCT00366535|Muscle Pain|muscle pain
5319390|NCT00366535|Fibrositis Allodynia|fibrositis allodynia
5319391|NCT00366535|Stiffness|stiffness
5319392|NCT00366535|Tender Points|tender points
5319393|NCT00366535|Fibromyalgia|fibromyalgia
5319394|NCT00366522|Safety|safety
5319395|NCT00366522|Healthy|healthy
5319396|NCT00366522|healthy subjects|healthy subjects
5319397|NCT00366509|Vac A Toxin|vac a toxin
5319399|NCT00366509|Bronchoscopy|bronchoscopy
5319400|NCT00366509|Endoscopy|endoscopy
5319401|NCT00366509|Cytotoxin|cytotoxin
5319402|NCT00366509|Pulmonary Disease|pulmonary disease
5319403|NCT00366509|Lung Disease|lung disease
5319404|NCT00366509|Genetic Disease|genetic disease
5319405|NCT00366509|Oropharyngeal Disease|oropharyngeal disease
5319406|NCT00366509|Pulmonary Fibrosis|pulmonary fibrosis
5319407|NCT00366509|Asthma|asthma
5319408|NCT00366483|healthy young volunteers|healthy young volunteers
5319409|NCT00366483|healthy elderly volunteers|healthy elderly volunteers
5319410|NCT00366483|Alzheimer's disease|alzheimer's disease
5319411|NCT00366483|5HT1A antagonist|5ht1a antagonist
5319412|NCT00366483|Health|health
5319413|NCT00366483|Pharmacokinetics|pharmacokinetics
5319414|NCT00366444|Bunionectomy|bunionectomy
5319415|NCT00366444|Bunion surgery|bunion surgery
5319416|NCT00366444|Post-operative pain|post-operative pain
5319417|NCT00366431|OIBD|oibd
5319418|NCT00366431|OIC|oic
5319419|NCT00366431|Opioid|opioid
5319420|NCT00366431|Constipation|constipation
5319421|NCT00366431|Laxative|laxative
5319422|NCT00366418|CLL|cll
5319423|NCT00366418|Monoclonal Antibody Therapy|monoclonal antibody therapy
5319424|NCT00366418|Anti CD20|anti cd20
5319425|NCT00366418|Biologic Response Modifier Therapy|biologic response modifier therapy
5319426|NCT00366418|Fractionated-Dose|fractionated-dose
5319427|NCT00366418|Low-Dose|low-dose
5319428|NCT00366418|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
5319429|NCT00366405|cataract|cataract
5319430|NCT00366392|Low Vision|low vision
5319431|NCT00366392|Optical Aids|optical aids
5319432|NCT00366353|Mechanical Ventilation|mechanical ventilation
5319433|NCT00366353|Spontaneous Breathing Trial|spontaneous breathing trial
5319434|NCT00366353|Sedation|sedation
5319435|NCT00366340|safety|safety
5319436|NCT00366340|Vaccine|vaccine
5319437|NCT00366327|Schizophrenia|schizophrenia
5319438|NCT00366314|Blood samples|blood samples
5319439|NCT00366314|Medication administration|medication administration
5319440|NCT00366314|CICU|cicu
5319441|NCT00366314|PICU|picu
5319442|NCT00366314|NICU|nicu
5319443|NCT00366301|type 2 diabetes|type 2 diabetes
5319444|NCT00366301|insulin|insulin
5319445|NCT00366301|insulin injection|insulin injection
5319446|NCT00366301|metformin|metformin
5319447|NCT00366301|C-reactive protein|c-reactive protein
5319448|NCT00366301|insulin sensitivity|insulin sensitivity
5319449|NCT00366301|glycemic control|glycemic control
5319450|NCT00366301|inflammation|inflammation
5319451|NCT00366288|Healthy|healthy
5319452|NCT00366288|Safety|safety
5319453|NCT00366275|follicular lymphoma|follicular lymphoma
5319454|NCT00366275|rituximab|rituximab
5319455|NCT00366275|immunochemotherapy|immunochemotherapy
5319456|NCT00366275|peripheral blood stem cells (PBSC) mobilization|peripheral blood stem cells (pbsc) mobilization
5319457|NCT00366275|in vivo purging|in vivo purging
5319458|NCT00366275|autotransplant|autotransplant
5319459|NCT00366275|bcl-2 rearrangement|bcl-2 rearrangement
5319460|NCT00366275|molecular response|molecular response
5319461|NCT00366262|Health|health
5319462|NCT00366249|Diabetic foot infection|diabetic foot infection
5319463|NCT00366249|Osteomyelitis|osteomyelitis
5319464|NCT00366249|Diabetes Complications|diabetes complications
5319465|NCT00366249|Foot ulcer|foot ulcer
5319466|NCT00366249|Skin infection|skin infection
5319467|NCT00366236|Amebiasis|amebiasis
5319468|NCT00366236|Entamoeba histolytica|entamoeba histolytica
5319469|NCT00366223|infection|infection
5319470|NCT00366223|candida|candida
5319471|NCT00366210|stroke|stroke
5319472|NCT00366210|rehabilitation|rehabilitation
5319473|NCT00366210|physical therapy|physical therapy
5319474|NCT00366210|occupational therapy|occupational therapy
5319475|NCT00366210|arm|arm
5319476|NCT00366197|Rapid Shallow Breathing Index|rapid shallow breathing index
5319477|NCT00366197|Mechanical Ventilation|mechanical ventilation
5319478|NCT00366184|Neuromodulation|neuromodulation
5319479|NCT00366184|Stroke|stroke
5319480|NCT00366184|Motor Cortex|motor cortex
5319481|NCT00366184|Motor Learning|motor learning
5319482|NCT00366184|L-Dopa|l-dopa
5319483|NCT00366184|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
5319484|NCT00366184|Levodopa|levodopa
5319485|NCT00366184|Healthy Volunteer|healthy volunteer
5319486|NCT00366184|HV|hv
5319487|NCT00366171|Schizophrenia|schizophrenia
5319488|NCT00366158|Patients with intact AV conduction|patients with intact av conduction
5319489|NCT00366145|acute GVHD|acute gvhd
5319490|NCT00366145|steroid refractory GVHD|steroid refractory gvhd
5319491|NCT00366145|severe steroid refractory acute GVHD|severe steroid refractory acute gvhd
5319492|NCT00366145|steroid refractory|steroid refractory
5319493|NCT00366145|Steroid Refractory Acute Graft Versus Host Disease|steroid refractory acute graft versus host disease
5319494|NCT00366132|Diabetic|diabetic
5319495|NCT00366132|Foot Ulcers|foot ulcers
5319496|NCT00366132|TRT|trt
5319497|NCT00366132|DermaGold|dermagold
5319498|NCT00366132|Shockwave|shockwave
5319499|NCT00366132|ESWT|eswt
5319500|NCT00366132|Diabetes Mellitus|diabetes mellitus
5319501|NCT00366119|hypertension|hypertension
5319502|NCT00366119|ramipril|ramipril
5319503|NCT00366119|blood pressure|blood pressure
5319504|NCT00366119|artery stiffness|artery stiffness
5319505|NCT00366119|BNP|bnp
5319506|NCT00366119|CRP|crp
5319507|NCT00366106|Relapsed Multiple Myeloma|relapsed multiple myeloma
5319508|NCT00366106|Refractory Multiple Myeloma|refractory multiple myeloma
5319509|NCT00366093|Menopause|menopause
5319510|NCT00366093|Perimenopause|perimenopause
5319511|NCT00366080|GSK189254 H3 Histamine Narcolepsy|gsk189254 h3 histamine narcolepsy
5319512|NCT00366067|Bronchial asthma|bronchial asthma
5319513|NCT00366067|Phenytoin|phenytoin
5319514|NCT00366067|Antiepileptic drugs|antiepileptic drugs
5319515|NCT00366067|Efficacy|efficacy
5319516|NCT00366028|Organization Innovation|organization innovation
5319517|NCT00366028|Diffusion of Innovation|diffusion of innovation
5319518|NCT00366028|Evidence-based Medicine|evidence-based medicine
5319519|NCT00366028|Infection Control|infection control
5319520|NCT00366015|Coronary Artery Disease|coronary artery disease
5319521|NCT00366015|PCI|pci
5319522|NCT00366015|Drug eluting stents|drug eluting stents
5319523|NCT00366015|Coronary Hybrid Revascularization|coronary hybrid revascularization
5319524|NCT00366015|Robotic CABG|robotic cabg
5319525|NCT00366002|Darifenacin,Overactive Bladder,antimuscarinic,M3 muscarinic receptor antagonist|darifenacin,overactive bladder,antimuscarinic,m3 muscarinic receptor antagonist
5319526|NCT00365989|Fibroids|fibroids
5319527|NCT00365989|leiomyoma|leiomyoma
5319528|NCT00365989|neoplasm|neoplasm
5319529|NCT00365989|benign tumors|benign tumors
5319530|NCT00365976|Insomnia|insomnia
5319531|NCT00365976|Low Back Pain|low back pain
5319532|NCT00365976|Hypnotics|hypnotics
5319533|NCT00365976|Eszopiclone|eszopiclone
5319534|NCT00365976|Pain|pain
5319535|NCT00365976|Disability|disability
5319536|NCT00365963|lung cancer, caregivers, support, resources, education|lung cancer, caregivers, support, resources, education
5319537|NCT00365950|Duration of anticoagulation|duration of anticoagulation
5319538|NCT00365950|Deep vein thrombosis and/or pulmonary embolism|deep vein thrombosis and/or pulmonary embolism
5319539|NCT00365937|immunotherapy|immunotherapy
5319540|NCT00365937|adjuvants|adjuvants
5319541|NCT00365937|IMP321|imp321
5319542|NCT00365937|Montanide ISA51 VG|montanide isa51 vg
5319543|NCT00365937|tumor-specific peptides|tumor-specific peptides
5319544|NCT00365924|12 month therapy with postmenopausal women with osteoporosis to examine changes in bone quality parameters|12 month therapy with postmenopausal women with osteoporosis to examine changes in bone quality parameters
5319545|NCT00365911|No specific condition|no specific condition
5319546|NCT00365898|Chronic non-malignant pain, opioid|chronic non-malignant pain, opioid
5319547|NCT00365885|Medical Informatics|medical informatics
5319548|NCT00365885|Decision Support Systems, Clinical|decision support systems, clinical
5319549|NCT00365885|Community Health Services|community health services
5319550|NCT00365885|Costs and Cost analysis|costs and cost analysis
5319551|NCT00365872|Sarcoma|sarcoma
5319552|NCT00365872|Intratumoral injection|intratumoral injection
5319553|NCT00365872|Dendritic cells|dendritic cells
5319554|NCT00365872|Neo-adjuvant treatment|neo-adjuvant treatment
5319555|NCT00365872|Immunotherapy|immunotherapy
5319556|NCT00365872|Pheresis|pheresis
5319557|NCT00365872|Radiation|radiation
5319558|NCT00365859|Serious behavioral problems in children and adolescents with AD|serious behavioral problems in children and adolescents with ad
5319559|NCT00365859|behavioral problems|behavioral problems
5319560|NCT00365846|prevent kidney rejection|prevent kidney rejection
5319561|NCT00365833|Transplantation|transplantation
5319562|NCT00365833|Cardiovascular|cardiovascular
5319563|NCT00365833|Renal|renal
5319564|NCT00365820|Opioid, constipation, tegaserod|opioid, constipation, tegaserod
5319565|NCT00365820|Opioid-induced constipation|opioid-induced constipation
5319566|NCT00365807|Obesity|obesity
5319567|NCT00365807|Overweight|overweight
5319568|NCT00365807|Behavioral treatment|behavioral treatment
5319569|NCT00365807|Family involvement|family involvement
5319570|NCT00365794|Aging|aging
5319571|NCT00365794|Older men|older men
5319572|NCT00365794|Abdominal obesity|abdominal obesity
5319573|NCT00365794|Central obesity|central obesity
5319574|NCT00365794|Insulin resistance|insulin resistance
5319575|NCT00365794|Low testosterone|low testosterone
5319576|NCT00365781|Injection Site Reaction|injection site reaction
5319577|NCT00365781|Subcutaneous administration|subcutaneous administration
5319578|NCT00365781|Dermatological effects|dermatological effects
5319579|NCT00365781|Antisense|antisense
5319580|NCT00365768|stage II childhood lymphoblastic lymphoma|stage ii childhood lymphoblastic lymphoma
5319581|NCT00365768|stage III childhood lymphoblastic lymphoma|stage iii childhood lymphoblastic lymphoma
5319582|NCT00365768|stage II childhood small noncleaved cell lymphoma|stage ii childhood small noncleaved cell lymphoma
5319583|NCT00365768|stage I Wilms tumor|stage i wilms tumor
5319584|NCT00365768|stage II Wilms tumor|stage ii wilms tumor
5319585|NCT00365768|stage III Wilms tumor|stage iii wilms tumor
5319586|NCT00365768|stage IV Wilms tumor|stage iv wilms tumor
5319587|NCT00365768|stage V Wilms tumor|stage v wilms tumor
5319588|NCT00365768|childhood grade III lymphomatoid granulomatosis|childhood grade iii lymphomatoid granulomatosis
5319589|NCT00365768|childhood diffuse large cell lymphoma|childhood diffuse large cell lymphoma
5319590|NCT00365768|childhood immunoblastic large cell lymphoma|childhood immunoblastic large cell lymphoma
5319591|NCT00365768|stage I childhood large cell lymphoma|stage i childhood large cell lymphoma
5319592|NCT00365768|stage I childhood lymphoblastic lymphoma|stage i childhood lymphoblastic lymphoma
5319593|NCT00365768|stage I childhood small noncleaved cell lymphoma|stage i childhood small noncleaved cell lymphoma
5319594|NCT00365768|stage II childhood large cell lymphoma|stage ii childhood large cell lymphoma
5319595|NCT00365768|stage III childhood large cell lymphoma|stage iii childhood large cell lymphoma
5319596|NCT00365768|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
5319597|NCT00365768|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
5319598|NCT00365768|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
5319599|NCT00365768|childhood Burkitt lymphoma|childhood burkitt lymphoma
5319600|NCT00365768|stage III childhood small noncleaved cell lymphoma|stage iii childhood small noncleaved cell lymphoma
5319601|NCT00365768|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
5319602|NCT00365768|childhood nasal type extranodal NK/T-cell lymphoma|childhood nasal type extranodal nk/t-cell lymphoma
5319603|NCT00365768|previously untreated childhood rhabdomyosarcoma|previously untreated childhood rhabdomyosarcoma
5319604|NCT00365768|localized Ewing sarcoma/PNET|localized ewing sarcoma/pnet
5319605|NCT00365768|metastatic Ewing sarcoma/PNET|metastatic ewing sarcoma/pnet
5319606|NCT00365768|neurotoxicity|neurotoxicity
5319607|NCT00365768|peripheral neuropathy|peripheral neuropathy
5319608|NCT00365755|disseminated neuroblastoma|disseminated neuroblastoma
5319609|NCT00365742|red yeast rice|red yeast rice
5319610|NCT00365742|pharmaceutical grade fish oil|pharmaceutical grade fish oil
5319611|NCT00365742|simvastatin|simvastatin
5319612|NCT00365742|primary prevention|primary prevention
5319613|NCT00365729|genitoanal HPV infection|genitoanal hpv infection
5319614|NCT00365729|HIV infection|hiv infection
5319615|NCT00365716|HPV 6/11/16/18 infection and related genital disease|hpv 6/11/16/18 infection and related genital disease
5319616|NCT00365703|Infant, Premature|infant, premature
5319617|NCT00365703|Tube feeding|tube feeding
5319618|NCT00365690|AIDS|aids
5319619|NCT00365690|Older Adults|older adults
5319620|NCT00365690|Telephone|telephone
5319621|NCT00365690|Telemedicine|telemedicine
5319622|NCT00365651|obesity|obesity
5319623|NCT00365651|overweight|overweight
5319624|NCT00365638|PCOS|pcos
5319625|NCT00365638|statin|statin
5319626|NCT00365638|testosterone|testosterone
5319627|NCT00365638|lipids|lipids
5319628|NCT00365625|Psoriasis|psoriasis
5319629|NCT00365625|JAM3 protein, human|jam3 protein, human
5319630|NCT00365625|Cell Adhesion Molecules|cell adhesion molecules
5319631|NCT00365625|Skin|skin
5319632|NCT00365625|Inflammation|inflammation
5319633|NCT00365625|Lymphocytes|lymphocytes
5319635|NCT00365612|HIV-1|hiv-1
5319636|NCT00365612|AIDS|aids
5319637|NCT00365612|Human Immunodeficiency Virus|human immunodeficiency virus
5319638|NCT00365612|HIV-1 Infection|hiv-1 infection
5319639|NCT00365599|Breast cancer|breast cancer
5319640|NCT00365599|Suberoylanilide hydroxamic acid (SAHA)|suberoylanilide hydroxamic acid (saha)
5319641|NCT00365599|Vorinostat|vorinostat
5319642|NCT00365599|Tamoxifen|tamoxifen
5319643|NCT00365599|Anti-hormonal therapy|anti-hormonal therapy
5319644|NCT00365599|Estrogen receptor positive|estrogen receptor positive
5319645|NCT00365599|Progesterone receptor positive|progesterone receptor positive
5319646|NCT00365599|Metastatic disease|metastatic disease
5319647|NCT00365599|Aromatase inhibitors (Ais)|aromatase inhibitors (ais)
5319648|NCT00365599|Histone deacetylase (HDAC) inhibitors|histone deacetylase (hdac) inhibitors
5319649|NCT00365599|Selective estrogen receptor modulators(SERMS)|selective estrogen receptor modulators(serms)
5319650|NCT00365586|Pain|pain
5319651|NCT00365586|Osteoarthritis|osteoarthritis
5319652|NCT00365586|Knee|knee
5319653|NCT00365586|NSAID|nsaid
5319654|NCT00365547|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5319655|NCT00365547|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5319656|NCT00365547|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5319657|NCT00365547|adenocarcinoma of the lung|adenocarcinoma of the lung
5319658|NCT00365547|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
5319659|NCT00365547|large cell lung cancer|large cell lung cancer
5319660|NCT00365534|First colonoscopy examination|first colonoscopy examination
5319661|NCT00365521|Organ transplant patients receiving immunosuppressive therapy|organ transplant patients receiving immunosuppressive therapy
5319662|NCT00365508|bladder cancer|bladder cancer
5319663|NCT00365508|cervical cancer|cervical cancer
5319664|NCT00365508|esophageal cancer|esophageal cancer
5319665|NCT00365508|gastric cancer|gastric cancer
5319666|NCT00365508|renal cell carcinoma|renal cell carcinoma
5319667|NCT00365508|adult primary liver cancer|adult primary liver cancer
5319668|NCT00365508|non-small cell lung cancer|non-small cell lung cancer
5319669|NCT00365508|small cell lung cancer|small cell lung cancer
5319670|NCT00365508|pancreatic cancer|pancreatic cancer
5319671|NCT00365508|hypopharyngeal cancer|hypopharyngeal cancer
5319672|NCT00365508|laryngeal cancer|laryngeal cancer
5319673|NCT00365508|lip and oral cavity cancer|lip and oral cavity cancer
5319674|NCT00365508|nasopharyngeal cancer|nasopharyngeal cancer
5319675|NCT00365508|oropharyngeal cancer|oropharyngeal cancer
5319676|NCT00365508|paranasal sinus and nasal cavity cancer|paranasal sinus and nasal cavity cancer
5319677|NCT00365508|adult acute myeloid leukemia|adult acute myeloid leukemia
5319678|NCT00365508|tongue cancer|tongue cancer
5319679|NCT00365508|tobacco use disorder|tobacco use disorder
5319680|NCT00365495|Type 2 diabetes|type 2 diabetes
5319681|NCT00365495|physical training|physical training
5319682|NCT00365495|mitochondrial function|mitochondrial function
5319683|NCT00365482|Epilepsy|epilepsy
5319684|NCT00365482|Bipolar Disorder|bipolar disorder
5319685|NCT00365469|Probiotics|probiotics
5319686|NCT00365469|Eczema|eczema
5319687|NCT00365469|Asthma|asthma
5319688|NCT00365469|Allergic Rhinitis|allergic rhinitis
5319689|NCT00365469|Prevention|prevention
5319690|NCT00365469|Immunological responses|immunological responses
5319691|NCT00365456|Lumbar Spine Bone Mineral Density (BMD)|lumbar spine bone mineral density (bmd)
5319692|NCT00365443|anogenital warts|anogenital warts
5319693|NCT00365443|premalignancy|premalignancy
5319694|NCT00365443|HPV|hpv
5319695|NCT00365443|Human papillomavirus|human papillomavirus
5319696|NCT00365430|Patient safety|patient safety
5319697|NCT00365430|Adverse event|adverse event
5319698|NCT00365430|Prevention|prevention
5319699|NCT00365430|Knowledge|knowledge
5319700|NCT00365430|Inpatient|inpatient
5319701|NCT00365430|Hospital|hospital
5319702|NCT00365430|Nursing home|nursing home
5319703|NCT00365430|Long term care|long term care
5319704|NCT00365430|Nurse|nurse
5319705|NCT00365417|NSABP|nsabp
5319706|NCT00365417|Doxorubicin|doxorubicin
5319707|NCT00365417|Cyclophosphamide|cyclophosphamide
5319708|NCT00365417|Bevacizumab|bevacizumab
5319709|NCT00365417|Capecitabine|capecitabine
5319710|NCT00365417|Docetaxel|docetaxel
5319711|NCT00365417|Breast cancer|breast cancer
5319712|NCT00365417|Locally advanced|locally advanced
5319713|NCT00365417|Neoadjuvant|neoadjuvant
5319714|NCT00365417|Locally advanced breast cancer|locally advanced breast cancer
5319715|NCT00365404|Behavioral change|behavioral change
5319716|NCT00365404|Weight management|weight management
5319717|NCT00365404|Physical activity|physical activity
5319718|NCT00365339|HIV|hiv
5319719|NCT00365339|Protease Inhibitor|protease inhibitor
5319720|NCT00365326|AC133|ac133
5319721|NCT00365326|coronary|coronary
5319722|NCT00365326|bone marrow|bone marrow
5319723|NCT00365326|autologous|autologous
5319724|NCT00365326|coronary artery disease|coronary artery disease
5319725|NCT00365313|celecoxib|celecoxib
5319726|NCT00365313|oesomeprazole|oesomeprazole
5319727|NCT00365313|arthritis|arthritis
5319728|NCT00365313|ulcer bleeding|ulcer bleeding
5319729|NCT00365300|GERD|gerd
5319730|NCT00365300|Infants|infants
5319731|NCT00365300|Gastroesophageal Reflux|gastroesophageal reflux
5319732|NCT00365287|stage IV breast cancer|stage iv breast cancer
5319733|NCT00365287|recurrent renal cell cancer|recurrent renal cell cancer
5319734|NCT00365287|stage III renal cell cancer|stage iii renal cell cancer
5319735|NCT00365287|stage IV renal cell cancer|stage iv renal cell cancer
5319736|NCT00365287|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5319737|NCT00365287|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5319738|NCT00365287|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5319739|NCT00365287|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5319740|NCT00365287|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5319741|NCT00365287|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5319742|NCT00365287|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5319743|NCT00365287|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5319744|NCT00365287|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5319745|NCT00365287|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5319746|NCT00365287|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5319747|NCT00365287|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5319748|NCT00365287|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
5319749|NCT00365287|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5319750|NCT00365287|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5319751|NCT00365287|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5319752|NCT00365287|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5319753|NCT00365287|stage I multiple myeloma|stage i multiple myeloma
5319754|NCT00365287|stage II multiple myeloma|stage ii multiple myeloma
5319755|NCT00365287|stage III multiple myeloma|stage iii multiple myeloma
5319756|NCT00365287|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5319757|NCT00365287|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5319758|NCT00365287|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5319759|NCT00365287|refractory anemia|refractory anemia
5319760|NCT00365287|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5319761|NCT00365287|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5319762|NCT00365287|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
5319763|NCT00365287|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
5319915|NCT00365092|Middle-ear effusion|middle-ear effusion
5319764|NCT00365287|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
5319765|NCT00365287|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5319865|NCT00365274|Antibiotics|antibiotics
5319766|NCT00365287|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5319767|NCT00365287|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
5319768|NCT00365287|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5319769|NCT00365287|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
5319770|NCT00365287|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
5319771|NCT00365287|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
5319772|NCT00365287|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
5319773|NCT00365287|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5319774|NCT00365287|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5319775|NCT00365287|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5319776|NCT00365287|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5319777|NCT00365287|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
5319778|NCT00365287|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
5319779|NCT00365287|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5319780|NCT00365287|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5319781|NCT00365287|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5319782|NCT00365287|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5319783|NCT00365287|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5319784|NCT00365287|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5319785|NCT00365287|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5319786|NCT00365287|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5319787|NCT00365287|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
5319788|NCT00365287|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
5319789|NCT00365287|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
5319790|NCT00365287|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5319791|NCT00365287|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5319792|NCT00365287|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5319793|NCT00365287|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5319794|NCT00365287|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5319795|NCT00365287|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5319796|NCT00365287|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5319797|NCT00365287|refractory multiple myeloma|refractory multiple myeloma
5319798|NCT00365287|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5319799|NCT00365287|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5319800|NCT00365287|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5319801|NCT00365287|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5319802|NCT00365287|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5319803|NCT00365287|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5319804|NCT00365287|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5319805|NCT00365287|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5319806|NCT00365287|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5319807|NCT00365287|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5319808|NCT00365287|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5319809|NCT00365287|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5319810|NCT00365287|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5319811|NCT00365287|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5319812|NCT00365287|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5319813|NCT00365287|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5319814|NCT00365287|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5319815|NCT00365287|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5319816|NCT00365287|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5319817|NCT00365287|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5319818|NCT00365287|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5319819|NCT00365287|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5319820|NCT00365287|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5319821|NCT00365287|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5319822|NCT00365287|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5319823|NCT00365287|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5319916|NCT00365092|Educational status|educational status
5319824|NCT00365287|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
5319825|NCT00365287|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
5319826|NCT00365287|refractory cytopenia with multilineage dysplasia|refractory cytopenia with multilineage dysplasia
5319827|NCT00365287|refractory anemia with excess blasts|refractory anemia with excess blasts
5319828|NCT00365287|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
5319829|NCT00365274|non-Hodgkin's lymphoma|non-hodgkin's lymphoma
5319830|NCT00365274|NHL|nhl
5319831|NCT00365274|murine monoclonal antibody|murine monoclonal antibody
5319832|NCT00365274|mAb|mab
5319833|NCT00365274|SGN-30|sgn-30
5319834|NCT00365274|CHOP|chop
5319835|NCT00365274|Cyclophosphamide|cyclophosphamide
5319836|NCT00365274|Doxorubicin Hydrochloride|doxorubicin hydrochloride
5319837|NCT00365274|Vincristine|vincristine
5319838|NCT00365274|Prednisone|prednisone
5319839|NCT00365274|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5319840|NCT00365274|Lymphoma|lymphoma
5319841|NCT00365274|Lymphoma, Large B-Cell, Diffuse|lymphoma, large b-cell, diffuse
5319842|NCT00365274|Lymphoma, Non-Hodgkin|lymphoma, non-hodgkin
5319843|NCT00365274|Lymphoma, Large-Cell, Anaplastic|lymphoma, large-cell, anaplastic
5319844|NCT00365274|Neoplasms by Histologic Type|neoplasms by histologic type
5319845|NCT00365274|Neoplasms|neoplasms
5319846|NCT00365274|Lymphoproliferative Disorders|lymphoproliferative disorders
5319847|NCT00365274|Lymphatic Diseases|lymphatic diseases
5319848|NCT00365274|Immunoproliferative Disorders|immunoproliferative disorders
5319849|NCT00365274|Immune System Diseases|immune system diseases
5319850|NCT00365274|Lymphoma, B-Cell|lymphoma, b-cell
5319851|NCT00365274|Lymphoma, T-Cell|lymphoma, t-cell
5319852|NCT00365274|Antibodies|antibodies
5319853|NCT00365274|Antibodies, Monoclonal|antibodies, monoclonal
5319854|NCT00365274|Immunologic Factors|immunologic factors
5319855|NCT00365274|Physiological Effects of Drugs|physiological effects of drugs
5319856|NCT00365274|Pharmacologic Actions|pharmacologic actions
5319857|NCT00365274|Immunosuppressive Agents|immunosuppressive agents
5319858|NCT00365274|Antirheumatic Agents|antirheumatic agents
5319859|NCT00365274|Therapeutic Uses|therapeutic uses
5319860|NCT00365274|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating
5319861|NCT00365274|Alkylating Agents|alkylating agents
5319862|NCT00365274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
5319863|NCT00365274|Antineoplastic Agents|antineoplastic agents
5319864|NCT00365274|Myeloablative Agonists|myeloablative agonists
5319866|NCT00365274|Antineoplastic|antineoplastic
5319867|NCT00365261|pain|pain
5319868|NCT00365261|fatigue|fatigue
5319869|NCT00365261|sleep|sleep
5319870|NCT00365261|bone marrow transplant|bone marrow transplant
5319871|NCT00365261|cancer|cancer
5319872|NCT00365248|Surgical resection of the liver with or without segmental transplantation|surgical resection of the liver with or without segmental transplantation
5319873|NCT00365222|Temozolomide|temozolomide
5319874|NCT00365222|Temodar|temodar
5319875|NCT00365222|Glioblastoma|glioblastoma
5319876|NCT00365222|Gliosarcoma|gliosarcoma
5319877|NCT00365222|Brain Tumor|brain tumor
5319878|NCT00365222|Quality of Life|quality of life
5319879|NCT00365222|Neurological|neurological
5319880|NCT00365196|Autonomic Nervous System|autonomic nervous system
5319881|NCT00365183|Non Small Cell Lung Cancer|non small cell lung cancer
5319882|NCT00365183|Lung Cancer|lung cancer
5319883|NCT00365183|Metastatic Lung Cancer|metastatic lung cancer
5319884|NCT00365183|Inoperable Lung Cancer|inoperable lung cancer
5319885|NCT00365183|Advanced Lung Cancer|advanced lung cancer
5319886|NCT00365183|Large Cell Lung Cancer|large cell lung cancer
5319887|NCT00365183|Adenocarcinoma, lung|adenocarcinoma, lung
5319888|NCT00365183|Squamous Cell Carcinoma, lung|squamous cell carcinoma, lung
5319889|NCT00365183|Squamous Cell Lung Cancer|squamous cell lung cancer
5319890|NCT00365183|Large Cell Carcinoma, lung|large cell carcinoma, lung
5319891|NCT00365183|Cancer of the Lung|cancer of the lung
5319892|NCT00365183|Carcinoma|carcinoma
5319893|NCT00365183|Bronchogenic|bronchogenic
5319894|NCT00365144|stage IV pancreatic cancer|stage iv pancreatic cancer
5319895|NCT00365144|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
5319896|NCT00365144|recurrent pancreatic cancer|recurrent pancreatic cancer
5319897|NCT00365131|Type I Gaucher disease|type i gaucher disease
5319898|NCT00365131|Glucocerebrosidase Deficiency Disease|glucocerebrosidase deficiency disease
5319899|NCT00365118|Port wine stains|port wine stains
5319900|NCT00365118|naevus flammeus|naevus flammeus
5319901|NCT00365105|pain|pain
5319902|NCT00365105|bone metastases|bone metastases
5319903|NCT00365105|extensive stage small cell lung cancer|extensive stage small cell lung cancer
5319904|NCT00365105|recurrent breast cancer|recurrent breast cancer
5319905|NCT00365105|stage IV breast cancer|stage iv breast cancer
5319906|NCT00365105|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5319907|NCT00365105|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5319908|NCT00365105|recurrent prostate cancer|recurrent prostate cancer
5319909|NCT00365105|stage IV prostate cancer|stage iv prostate cancer
5319910|NCT00365092|Insertion of tympanostomy tubes|insertion of tympanostomy tubes
5319911|NCT00365092|Otitis media with effusion|otitis media with effusion
5319912|NCT00365092|Child development|child development
5319917|NCT00365092|Behavior|behavior
5319918|NCT00365092|Social behavior|social behavior
5319919|NCT00365092|Achievement|achievement
5319920|NCT00365040|myopia|myopia
5319921|NCT00365040|excimer laser|excimer laser
5319922|NCT00365027|GNRH agonist|gnrh agonist
5319923|NCT00365027|ovarian hyperstimulation syndrome|ovarian hyperstimulation syndrome
5319924|NCT00365027|Embryo cryopreservation|embryo cryopreservation
5319925|NCT00365014|aplastic anemia|aplastic anemia
5319926|NCT00365014|myelodysplastic syndromes|myelodysplastic syndromes
5319927|NCT00365014|cytopenias|cytopenias
5319928|NCT00365014|acute myeloid leukemia|acute myeloid leukemia
5319929|NCT00365014|myelodysplastic/myeloproliferative diseases|myelodysplastic/myeloproliferative diseases
5319930|NCT00365014|benzene poisoning|benzene poisoning
5319931|NCT00364988|pioglitazone|pioglitazone
5319932|NCT00364988|losartan|losartan
5319933|NCT00364988|proteinuria|proteinuria
5319934|NCT00364988|end stage renal disease (ESRD)|end stage renal disease (esrd)
5319935|NCT00364975|gourmet healthy cooking|gourmet healthy cooking
5319936|NCT00364975|quality of life|quality of life
5319937|NCT00364975|adjuvant chemotherapy|adjuvant chemotherapy
5319938|NCT00364975|weight|weight
5319939|NCT00364975|breast cancer|breast cancer
5319940|NCT00364962|NPC|npc
5319941|NCT00364962|Nasopharyngectomy|nasopharyngectomy
5319942|NCT00364962|KTP laser|ktp laser
5319943|NCT00364962|recurrence|recurrence
5319944|NCT00364949|Polycystic Ovary Syndrome|polycystic ovary syndrome
5319945|NCT00364949|PCOS|pcos
5319946|NCT00364949|Pregnant|pregnant
5319947|NCT00364949|Cord Blood|cord blood
5319948|NCT00364936|palliative care|palliative care
5319949|NCT00364936|hospice|hospice
5319950|NCT00364936|end-of-life|end-of-life
5319951|NCT00364936|symptom control|symptom control
5319952|NCT00364936|evaluation|evaluation
5319953|NCT00364936|effectiveness|effectiveness
5319954|NCT00364923|Peripheral T-cell Lymphoma|peripheral t-cell lymphoma
5319955|NCT00364923|T-cell Lymphoma|t-cell lymphoma
5319956|NCT00364923|Lymphoma|lymphoma
5319957|NCT00364923|PDX|pdx
5319958|NCT00364923|Pralatrexate|pralatrexate
5319959|NCT00364923|Vitamin B12|vitamin b12
5319960|NCT00364923|Folic acid|folic acid
5319961|NCT00364910|Myocardial Infarction (MI)|myocardial infarction (mi)
5319962|NCT00364910|Cognitive Behavioral Therapy (CBT)|cognitive behavioral therapy (cbt)
5319963|NCT00364910|Adherence|adherence
5319964|NCT00364910|Depression|depression
5319965|NCT00364884|chronic kidney disease|chronic kidney disease
5319966|NCT00364871|Obesity|obesity
5319967|NCT00364858|Type 1 Gaucher Disease|type 1 gaucher disease
5319968|NCT00364858|Glucocerebrosidase Deficiency Disease|glucocerebrosidase deficiency disease
5319969|NCT00364845|Quality of Life|quality of life
5319970|NCT00364845|Chronic Kidney Disease|chronic kidney disease
5319971|NCT00364845|Anemia|anemia
5319972|NCT00364819|Primary Biliary Cirrhosis|primary biliary cirrhosis
5319973|NCT00364806|Migraine|migraine
5319974|NCT00364806|Headache|headache
5319975|NCT00364793|HIV, Pediatric|hiv, pediatric
5319976|NCT00364767|Moderate alcohol consumption|moderate alcohol consumption
5319977|NCT00364767|Fat and carbohydrate oxidative capacity|fat and carbohydrate oxidative capacity
5319978|NCT00364767|Postprandial glycemic response|postprandial glycemic response
5319979|NCT00364754|Tesmilifene|tesmilifene
5319980|NCT00364754|DPPE|dppe
5319981|NCT00364754|Breast cancer|breast cancer
5319982|NCT00364754|Cyclophosphamide|cyclophosphamide
5319983|NCT00364754|Epirubicin|epirubicin
5319984|NCT00364754|Pharmacokinetic|pharmacokinetic
5319985|NCT00364715|Nuclear localization, annexin A1, oral SCC|nuclear localization, annexin a1, oral scc
5319986|NCT00364702|Virtual Reality|virtual reality
5319987|NCT00364702|ADHD|adhd
5319988|NCT00364702|Methylphenidate|methylphenidate
5319989|NCT00364689|Encephalopathy, Hepatic|encephalopathy, hepatic
5319990|NCT00364689|Portosystemic Encephalopathy|portosystemic encephalopathy
5319991|NCT00364689|Encephalopathy, Hepatocerebral|encephalopathy, hepatocerebral
5319992|NCT00364689|Encephalopathy, Portal-Systemic|encephalopathy, portal-systemic
5319993|NCT00364689|Encephalopathy, Portosystemic|encephalopathy, portosystemic
5319994|NCT00364689|Hepatic Coma|hepatic coma
5319995|NCT00364689|Hepatic Stupor|hepatic stupor
5319996|NCT00364689|Hepatocerebral Encephalopathy|hepatocerebral encephalopathy
5319997|NCT00364689|Portal-Systemic Encephalopathy|portal-systemic encephalopathy
5319998|NCT00364676|Vinorelbine|vinorelbine
5319999|NCT00364676|solid tumors|solid tumors
5320000|NCT00364676|Hodgkins|hodgkins
5320001|NCT00364676|Non hodgkins|non hodgkins
5320002|NCT00364676|Lymphoma|lymphoma
5320003|NCT00364676|Advanced solid tumors|advanced solid tumors
5320004|NCT00364663|NSCLC|nsclc
5320005|NCT00364663|staging|staging
5320006|NCT00364663|18F-FDG PET|18f-fdg pet
5320007|NCT00364663|decision tree model|decision tree model
5320008|NCT00364663|cost-effectiveness|cost-effectiveness
5320009|NCT00364650|Renal transplantation|renal transplantation
5320010|NCT00364650|Diarrhea|diarrhea
5320011|NCT00364650|Immunosuppression|immunosuppression
5320012|NCT00364650|Probiotics|probiotics
5320013|NCT00364637|Sevoflurane|sevoflurane
5320014|NCT00364637|Anesthesia|anesthesia
5320015|NCT00364637|Troponin|troponin
5320016|NCT00364637|Myocardial Preconditioning|myocardial preconditioning
5320123|NCT00364247|Acute pain|acute pain
5320017|NCT00364637|Surgery, Cardiac|surgery, cardiac
5320018|NCT00364637|Stents|stents
5320019|NCT00364637|Non-cardiac Surgery|non-cardiac surgery
5320020|NCT00364637|Surgery|surgery
5320021|NCT00364624|lung cancer|lung cancer
5320022|NCT00364624|adrenal insufficiency|adrenal insufficiency
5320023|NCT00364598|Anginera|anginera
5320024|NCT00364598|LVAD|lvad
5320025|NCT00364598|Transplant|transplant
5320026|NCT00364598|Histology|histology
5320027|NCT00364598|LVAD implantation as a bridge to transplant|lvad implantation as a bridge to transplant
5320028|NCT00364572|sciatica|sciatica
5320029|NCT00364572|low back pain|low back pain
5320030|NCT00364572|epidural|epidural
5320031|NCT00364572|tumor necrosis factor|tumor necrosis factor
5320032|NCT00364559|intracerebral hemorrhage|intracerebral hemorrhage
5320033|NCT00364559|statins|statins
5320034|NCT00364559|rosuvastatin|rosuvastatin
5320035|NCT00364559|stroke|stroke
5320036|NCT00364546|Osteoarthritis|osteoarthritis
5320037|NCT00364546|Pain|pain
5320038|NCT00364546|Low Back Pain|low back pain
5320039|NCT00364546|Hip Pain|hip pain
5320040|NCT00364546|Knee Pain|knee pain
5320041|NCT00364546|Backache|backache
5320042|NCT00364546|tapentadol|tapentadol
5320043|NCT00364533|Arthralgia|arthralgia
5320044|NCT00364533|Pain|pain
5320045|NCT00364533|Pain Assessment|pain assessment
5320046|NCT00364533|Hip Replacement|hip replacement
5320047|NCT00364533|Tapentadol|tapentadol
5320048|NCT00364520|Hematologic Diseases|hematologic diseases
5320049|NCT00364520|Benzene|benzene
5320050|NCT00364520|Genetic Polymorphisms|genetic polymorphisms
5320051|NCT00364494|Hematocrit|hematocrit
5320052|NCT00364494|Hemodilution|hemodilution
5320053|NCT00364494|Blood Transfusion|blood transfusion
5320054|NCT00364494|Cardiopulmonary Bypass|cardiopulmonary bypass
5320055|NCT00364494|Multiple Organ Failure|multiple organ failure
5320056|NCT00364494|Surgery, Cardiac|surgery, cardiac
5320057|NCT00364494|Kidney Failure|kidney failure
5320058|NCT00364494|Cardiac Surgical Procedures|cardiac surgical procedures
5320059|NCT00364481|apnea|apnea
5320060|NCT00364481|tongue|tongue
5320061|NCT00364481|exercises|exercises
5320062|NCT00364481|reflux|reflux
5320063|NCT00364481|airway|airway
5320064|NCT00364481|upper|upper
5320065|NCT00364481|fatigue|fatigue
5320066|NCT00364468|pegfilgrastim|pegfilgrastim
5320067|NCT00364468|neutropenia|neutropenia
5320068|NCT00364468|cancer patients|cancer patients
5320069|NCT00364468|lymphoma|lymphoma
5320070|NCT00364455|Hormone refractory prostate cancer|hormone refractory prostate cancer
5320071|NCT00364455|Anemia|anemia
5320072|NCT00364455|Quality-of-life|quality-of-life
5320073|NCT00364442|asthma|asthma
5320074|NCT00364429|schizophrenic patients|schizophrenic patients
5320075|NCT00364429|SPET|spet
5320076|NCT00364429|NMDA receptor|nmda receptor
5320077|NCT00364429|ligand [123]I-CNS 1261|ligand [123]i-cns 1261
5320078|NCT00364416|Heart Failure, congestive|heart failure, congestive
5320079|NCT00364416|Heart decompensation|heart decompensation
5320080|NCT00364403|Glycemic index|glycemic index
5320081|NCT00364403|Glycemic load|glycemic load
5320082|NCT00364403|Low fat|low fat
5320083|NCT00364403|Impaired glucose tolerance|impaired glucose tolerance
5320084|NCT00364403|Large for gestational age infant|large for gestational age infant
5320085|NCT00364403|Excessive body weight|excessive body weight
5320086|NCT00364390|CABG|cabg
5320087|NCT00364390|Anginera|anginera
5320089|NCT00364351|Non Small Cell Lung Cancer|non small cell lung cancer
5320090|NCT00364351|NSCLC|nsclc
5320091|NCT00364338|gourmet healthy cooking|gourmet healthy cooking
5320092|NCT00364338|quality of life|quality of life
5320093|NCT00364338|preimenopause|preimenopause
5320094|NCT00364338|weight|weight
5320095|NCT00364338|lipids|lipids
5320096|NCT00364325|Heart failure, congestive|heart failure, congestive
5320097|NCT00364325|Heart decompensation|heart decompensation
5320098|NCT00364312|behavior therapy|behavior therapy
5320099|NCT00364312|dietary control|dietary control
5320100|NCT00364312|exercise|exercise
5320101|NCT00364312|diabetes mellitus|diabetes mellitus
5320102|NCT00364312|behavior modification|behavior modification
5320103|NCT00364312|blood glucose|blood glucose
5320104|NCT00364312|clinical trial|clinical trial
5320105|NCT00364312|diabetes education|diabetes education
5320106|NCT00364312|health behavior|health behavior
5320107|NCT00364312|health care service utilization|health care service utilization
5320108|NCT00364312|obesity|obesity
5320109|NCT00364312|quality of life|quality of life
5320110|NCT00364299|Ventilator-associated pneumonia|ventilator-associated pneumonia
5320111|NCT00364299|Mechanical ventilation|mechanical ventilation
5320112|NCT00364299|Tracheal tube cuff pressure|tracheal tube cuff pressure
5320113|NCT00364286|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
5320114|NCT00364286|Small Lymphocytic Lymphoma|small lymphocytic lymphoma
5320115|NCT00364286|Prolymphocytic Leukemia|prolymphocytic leukemia
5320116|NCT00364286|Leukemia|leukemia
5320117|NCT00364286|Lymphoma|lymphoma
5320118|NCT00364286|Dasatinib|dasatinib
5320119|NCT00364286|BMS-354825|bms-354825
5320120|NCT00364273|Asthma|asthma
5320121|NCT00364260|Anemia|anemia
5320122|NCT00364260|epoetin alfa|epoetin alfa
5320124|NCT00364247|bunionectomy|bunionectomy
5320125|NCT00364234|Renal Osteodystrophy|renal osteodystrophy
5320126|NCT00364195|Metastatic breast cancer|metastatic breast cancer
5320127|NCT00364195|Tesmilifene|tesmilifene
5320128|NCT00364195|DPPE|dppe
5320129|NCT00364182|Hemophilia B|hemophilia b
5320130|NCT00364182|BeneFIX|benefix
5320131|NCT00364169|constipation|constipation
5320132|NCT00364169|cancer|cancer
5320133|NCT00364169|surgery|surgery
5320134|NCT00364169|intervention|intervention
5320135|NCT00364169|nursing|nursing
5320136|NCT00364169|postoperative|postoperative
5320137|NCT00364143|Cancer|cancer
5320138|NCT00364143|Advanced Solid Tumor|advanced solid tumor
5320139|NCT00364143|Oncology|oncology
5320140|NCT00364117|150 discharges|150 discharges
5320141|NCT00364117|adults|adults
5320142|NCT00364117|Internal Medicine|internal medicine
5320143|NCT00364104|Iron deficiency|iron deficiency
5320144|NCT00364104|Helicobacter infection|helicobacter infection
5320145|NCT00364104|Epidemiology|epidemiology
5320146|NCT00364091|allergic conjunctivitis, ophthalmology, multicenter, controlled|allergic conjunctivitis, ophthalmology, multicenter, controlled
5320147|NCT00364078|Cross-sectional correlational study|cross-sectional correlational study
5320148|NCT00364078|Uncertainty|uncertainty
5320149|NCT00364078|Locus of Control|locus of control
5320150|NCT00364078|Quality of life|quality of life
5320151|NCT00364078|Transitoriness|transitoriness
5320152|NCT00364078|Cancer care|cancer care
5320153|NCT00364052|Valganciclovir, Oral Ganciclovir, Liver transplant|valganciclovir, oral ganciclovir, liver transplant
5320154|NCT00364013|Oncology|oncology
5320155|NCT00364013|Cancer|cancer
5320156|NCT00364013|metastatic colorectal cancer|metastatic colorectal cancer
5320157|NCT00364013|EGFr|egfr
5320158|NCT00364013|Panitumumab|panitumumab
5320159|NCT00364013|Clinical Trail|clinical trail
5320160|NCT00364013|Amgen|amgen
5320161|NCT00364000|haemodialysis|haemodialysis
5320162|NCT00364000|hyperphosphatemia|hyperphosphatemia
5320163|NCT00364000|sevelamer|sevelamer
5320164|NCT00364000|calcium acetate|calcium acetate
5320165|NCT00363987|nephropathy with type 2 diabetes|nephropathy with type 2 diabetes
5320166|NCT00363974|AML|aml
5320167|NCT00363974|leukemia|leukemia
5320168|NCT00363974|relapse|relapse
5320169|NCT00363974|refractory|refractory
5320170|NCT00363974|antisense|antisense
5320171|NCT00363974|oligonucleotide|oligonucleotide
5320172|NCT00363961|End stage renal disease|end stage renal disease
5320173|NCT00363961|Maintenance dialysis|maintenance dialysis
5320174|NCT00363961|Resistance exercise|resistance exercise
5320175|NCT00363961|Muscle wasting|muscle wasting
5320176|NCT00363961|Disability|disability
5320177|NCT00363948|MK-0431|mk-0431
5320178|NCT00363948|ONO-5435|ono-5435
5320179|NCT00363948|Type 2 diabetes mellitus|type 2 diabetes mellitus
5320180|NCT00363922|Coronary Artery Bypass [E04.100.376.719.332]|coronary artery bypass [e04.100.376.719.332]
5320181|NCT00363909|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
5320182|NCT00363909|hot flashes|hot flashes
5320183|NCT00363909|breast cancer|breast cancer
5320184|NCT00363896|COPD|copd
5320185|NCT00363896|Lung function|lung function
5320186|NCT00363896|Exacerbations|exacerbations
5320187|NCT00363896|Quality of Life|quality of life
5320188|NCT00363870|Influenza vaccine|influenza vaccine
5320189|NCT00363870|Prophylaxis Influenza vaccine|prophylaxis influenza vaccine
5320190|NCT00363857|fatigue|fatigue
5320191|NCT00363857|sleep|sleep
5320192|NCT00363857|sleep disorder|sleep disorder
5320193|NCT00363857|Legs|legs
5320194|NCT00363857|RLS|rls
5320195|NCT00363857|Restless Legs Syndrome|restless legs syndrome
5320196|NCT00363857|Ropinirole|ropinirole
5320197|NCT00363844|MK-0431|mk-0431
5320198|NCT00363844|ONO-5435|ono-5435
5320199|NCT00363844|Type 2 diabetes mellitus|type 2 diabetes mellitus
5320200|NCT00363818|Endothelial function|endothelial function
5320201|NCT00363818|Platelet function|platelet function
5320202|NCT00363818|Coronary artery disease|coronary artery disease
5320203|NCT00363818|Thrombosis|thrombosis
5320204|NCT00363818|Aggregation|aggregation
5320205|NCT00363805|lung cancer|lung cancer
5320206|NCT00363805|prevention|prevention
5320207|NCT00363805|green tea|green tea
5320208|NCT00363805|former smokers|former smokers
5320209|NCT00363792|Healthy subjects|healthy subjects
5320210|NCT00363779|Large Granular Lymphocyte (LGL)|large granular lymphocyte (lgl)
5320211|NCT00363779|LGL|lgl
5320212|NCT00363779|Leukemia|leukemia
5320213|NCT00363779|Cyclosporine|cyclosporine
5320214|NCT00363779|Microarray|microarray
5320215|NCT00363779|Gene Expression|gene expression
5320216|NCT00363779|Cyclosporin|cyclosporin
5320217|NCT00363779|Large Granular Lymphocyte Leukemia|large granular lymphocyte leukemia
5320218|NCT00363779|LGL Leukemia|lgl leukemia
5320219|NCT00363753|Transient ischemic attack|transient ischemic attack
5320220|NCT00363753|Stroke|stroke
5320221|NCT00363753|Aspirin|aspirin
5320222|NCT00363753|Clopidogrel|clopidogrel
5320223|NCT00363740|GW685698X|gw685698x
5320224|NCT00363740|allergic rhinitis|allergic rhinitis
5320225|NCT00363740|Seasonal Allergic Rhinitis|seasonal allergic rhinitis
5320226|NCT00363727|dyskinesia|dyskinesia
5320227|NCT00363727|SINEMET|sinemet
5320228|NCT00363727|Parkinson's disease|parkinson's disease
5320229|NCT00363727|controlled release ropinirole|controlled release ropinirole
5320230|NCT00363701|Protonpumpinhibitors|protonpumpinhibitors
5320231|NCT00363701|withdrawal|withdrawal
5320232|NCT00363701|longterm treatment|longterm treatment
5320233|NCT00363701|dyspepsia|dyspepsia
5320234|NCT00363701|functional dyspepsia|functional dyspepsia
5320235|NCT00363701|gastrooesophageal reflux|gastrooesophageal reflux
5320236|NCT00363701|upper endoscopy|upper endoscopy
5320237|NCT00363688|Non life threatening allergic reaction|non life threatening allergic reaction
5320238|NCT00363688|oral challenge|oral challenge
5320239|NCT00363688|penicillin|penicillin
5320240|NCT00363688|skin testing|skin testing
5320241|NCT00363675|Hand Burns|hand burns
5320242|NCT00363675|Pediatrics|pediatrics
5320243|NCT00363649|Philadelphia chromosome positive chronic myelogenous leukemia|philadelphia chromosome positive chronic myelogenous leukemia
5320244|NCT00363649|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5320245|NCT00363636|relapsed|relapsed
5320246|NCT00363636|NHL|nhl
5320247|NCT00363636|pharmacokinetics|pharmacokinetics
5320248|NCT00363636|antibody|antibody
5320249|NCT00363636|safety|safety
5320250|NCT00363636|galiximab|galiximab
5320251|NCT00363636|efficacy|efficacy
5320252|NCT00363636|rituximab|rituximab
5320253|NCT00363636|refractory|refractory
5320254|NCT00363610|Advanced and/or Metastatic Solid Tumors and Lymphoma|advanced and/or metastatic solid tumors and lymphoma
5320255|NCT00363597|dyspepsia|dyspepsia
5320256|NCT00363597|gastrointestinal disease|gastrointestinal disease
5320257|NCT00363597|indigestion|indigestion
5320258|NCT00363584|localized resectable adult primary liver cancer|localized resectable adult primary liver cancer
5320259|NCT00363584|cholangiocarcinoma of the extrahepatic bile duct|cholangiocarcinoma of the extrahepatic bile duct
5320260|NCT00363584|cholangiocarcinoma of the gallbladder|cholangiocarcinoma of the gallbladder
5320261|NCT00363584|adenocarcinoma of the gallbladder|adenocarcinoma of the gallbladder
5320262|NCT00363584|adenocarcinoma with squamous metaplasia of the gallbladder|adenocarcinoma with squamous metaplasia of the gallbladder
5320263|NCT00363584|anaplastic carcinoma of the gallbladder|anaplastic carcinoma of the gallbladder
5320264|NCT00363584|localized gallbladder cancer|localized gallbladder cancer
5320265|NCT00363584|localized extrahepatic bile duct cancer|localized extrahepatic bile duct cancer
5320266|NCT00363584|squamous cell carcinoma of the gallbladder|squamous cell carcinoma of the gallbladder
5320267|NCT00363584|adult primary cholangiocellular carcinoma|adult primary cholangiocellular carcinoma
5320268|NCT00363558|skin graft|skin graft
5320269|NCT00363558|fixation|fixation
5320270|NCT00363558|cyanoacrylate glue|cyanoacrylate glue
5320271|NCT00363558|skin staples|skin staples
5320272|NCT00363545|Prophylaxis against gastroenteritis caused by Rotavirus|prophylaxis against gastroenteritis caused by rotavirus
5320273|NCT00363532|migraine with out aura|migraine with out aura
5320274|NCT00363519|MK-0431|mk-0431
5320275|NCT00363519|ONO-5435|ono-5435
5320276|NCT00363519|Type 2 diabetes mellitus|type 2 diabetes mellitus
5320277|NCT00363506|nutritional|nutritional
5320278|NCT00363506|C10.228.140.546.399.750|c10.228.140.546.399.750
5320279|NCT00363480|Asthma|asthma
5320280|NCT00363480|Asthma Control Test|asthma control test
5320281|NCT00363480|SERETIDE|seretide
5320282|NCT00363467|Busulfan|busulfan
5320283|NCT00363467|Acute myeloid leukemia (AML)|acute myeloid leukemia (aml)
5320284|NCT00363467|Hematopoietic Stem Cell Transplantation (HSCT)|hematopoietic stem cell transplantation (hsct)
5320285|NCT00363467|Dendritic cells|dendritic cells
5320286|NCT00363467|Bone marrow transplantation|bone marrow transplantation
5320287|NCT00363467|PBSC mobilization|pbsc mobilization
5320288|NCT00363467|Autologous stem cells|autologous stem cells
5320289|NCT00363454|Phase I|phase i
5320290|NCT00363454|Pharmacokinetics|pharmacokinetics
5320291|NCT00363454|TCN-PM|tcn-pm
5320292|NCT00363454|VD-0002|vd-0002
5320293|NCT00363454|Immunohistochemistry|immunohistochemistry
5320294|NCT00363454|Serum tumor marker|serum tumor marker
5320295|NCT00363454|Akt phosphorylation|akt phosphorylation
5320296|NCT00363454|Ex vivo testing|ex vivo testing
5320297|NCT00363454|metastatic|metastatic
5320298|NCT00363441|head and neck neoplasms|head and neck neoplasms
5320299|NCT00363441|squamous cell cancer|squamous cell cancer
5320300|NCT00363441|intensity modulated radiotherapy|intensity modulated radiotherapy
5320301|NCT00363428|pulmonary complications|pulmonary complications
5320302|NCT00363428|perioperative/postoperative complications|perioperative/postoperative complications
5320303|NCT00363428|tobacco use disorder|tobacco use disorder
5320304|NCT00363428|non-small cell lung cancer|non-small cell lung cancer
5320305|NCT00363428|small cell lung cancer|small cell lung cancer
5320306|NCT00363402|Cystic Fibrosis|cystic fibrosis
5320307|NCT00363389|Hysteroscopy|hysteroscopy
5320308|NCT00363389|Misoprostol|misoprostol
5320309|NCT00363389|Uterine hemorrhage|uterine hemorrhage
5320310|NCT00363389|Uterine cervix|uterine cervix
5320311|NCT00363389|Dilatation|dilatation
5320312|NCT00363376|olanzapine|olanzapine
5320313|NCT00363376|zonisamide|zonisamide
5320314|NCT00363376|weight gain|weight gain
5320315|NCT00363376|bipolar disorder|bipolar disorder
5320316|NCT00363376|psychotic disorders|psychotic disorders
5320317|NCT00363363|Pediatrics|pediatrics
5320318|NCT00363363|Fontan Procedure|fontan procedure
5320319|NCT00363363|Physical Activity|physical activity
5320320|NCT00363363|Physical Fitness|physical fitness
5320321|NCT00363363|Congenital Heart Defects|congenital heart defects
5320322|NCT00363363|exercise rehabilitation|exercise rehabilitation
5320323|NCT00363337|Adults|adults
5320324|NCT00363337|Bipolar Depression|bipolar depression
5320325|NCT00363337|Bipolar Disorder|bipolar disorder
5320326|NCT00363337|Bipolar I|bipolar i
5320327|NCT00363337|Bipolar II|bipolar ii
5320328|NCT00363337|Depression|depression
5320329|NCT00363324|stem cell|stem cell
5320330|NCT00363324|acute myocardial infarction|acute myocardial infarction
5320331|NCT00363311|Dutasteride Prostate Cancer Expectant management REDEEM|dutasteride prostate cancer expectant management redeem
5320332|NCT00363298|D-amphetamine, dextro-amphetamine, stimulant drug|d-amphetamine, dextro-amphetamine, stimulant drug
5320333|NCT00363285|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5320334|NCT00363285|stage III prostate cancer|stage iii prostate cancer
5320335|NCT00363285|stage IV prostate cancer|stage iv prostate cancer
5320336|NCT00363246|Elderly|elderly
5320337|NCT00363246|Fall risk|fall risk
5320338|NCT00363246|Veterans|veterans
5320339|NCT00363246|WheelChairs|wheelchairs
5320340|NCT00363246|Injury|injury
5320341|NCT00363233|type 2 diabetes|type 2 diabetes
5320342|NCT00363233|lignans|lignans
5320343|NCT00363233|flaxseed|flaxseed
5320344|NCT00363233|cholesterol|cholesterol
5320345|NCT00363220|Infection|infection
5320346|NCT00363220|E coli|e coli
5320347|NCT00363220|Klebsiella|klebsiella
5320348|NCT00363220|ESBL|esbl
5320349|NCT00363207|behavior|behavior
5320350|NCT00363207|local anesthesia|local anesthesia
5320351|NCT00363207|behavior after dental local anesthesia|behavior after dental local anesthesia
5320352|NCT00363194|Pazopanib GW786034 Advanced cancer Metastatic cancer|pazopanib gw786034 advanced cancer metastatic cancer
5320353|NCT00363181|Insulin resistance|insulin resistance
5320354|NCT00363181|Metabolic problems|metabolic problems
5320355|NCT00363181|Weight gain|weight gain
5320356|NCT00363181|Mental health problems|mental health problems
5320357|NCT00363181|Mental disorders|mental disorders
5320358|NCT00363181|Antipsychotic medication|antipsychotic medication
5320359|NCT00363181|Olanzapine|olanzapine
5320360|NCT00363168|Hemorrhagic Choroidal Neovascularization|hemorrhagic choroidal neovascularization
5320361|NCT00363155|chronic|chronic
5320362|NCT00363155|hepatitis b|hepatitis b
5320363|NCT00363142|HIV-1 LEXIVA Ritonavir Once-daily|hiv-1 lexiva ritonavir once-daily
5320364|NCT00363129|neurotoxicity|neurotoxicity
5320365|NCT00363129|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5320366|NCT00363116|Kidney transplant|kidney transplant
5320367|NCT00363116|Pancreas transplant|pancreas transplant
5320368|NCT00363116|Daclizumab|daclizumab
5320369|NCT00363116|Tacrolimus|tacrolimus
5320370|NCT00363116|Mycophenolate mofetil|mycophenolate mofetil
5320371|NCT00363116|Steroids|steroids
5320372|NCT00363116|Immunosuppression|immunosuppression
5320373|NCT00363116|Acute allograft rejection|acute allograft rejection
5320374|NCT00363090|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
5320375|NCT00363090|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
5320376|NCT00363090|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5320377|NCT00363090|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
5320378|NCT00363090|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5320379|NCT00363090|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5320380|NCT00363090|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5320381|NCT00363090|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5320382|NCT00363090|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
5320383|NCT00363090|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5320384|NCT00363090|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
5320385|NCT00363090|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
5320386|NCT00363090|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
5320387|NCT00363077|Influenza vaccine|influenza vaccine
5320388|NCT00363077|Prophylaxis Influenza vaccine|prophylaxis influenza vaccine
5320389|NCT00363051|Pancreatic|pancreatic
5320390|NCT00363051|Tumor|tumor
5320391|NCT00363051|Islet Cell|islet cell
5320392|NCT00363051|Carcinoma|carcinoma
5320393|NCT00363051|Neuroendocrine|neuroendocrine
5320394|NCT00363051|Endocrine|endocrine
5320395|NCT00363051|Atypical Carcinoid|atypical carcinoid
5320396|NCT00363051|RADIANT1|radiant1
5320397|NCT00363051|RADIANT-1|radiant-1
5320398|NCT00363038|Bruising|bruising
5320399|NCT00363038|Topical 20% arnica|topical 20% arnica
5320400|NCT00363025|Acute myeloid leukemia|acute myeloid leukemia
5320401|NCT00363025|Older patients|older patients
5320402|NCT00363025|Patient aged 65 years or more|patient aged 65 years or more
5320403|NCT00363012|stage IIIA breast cancer|stage iiia breast cancer
5320404|NCT00363012|stage IIIB breast cancer|stage iiib breast cancer
5320405|NCT00363012|stage IIIC breast cancer|stage iiic breast cancer
5320406|NCT00363012|stage IV breast cancer|stage iv breast cancer
5320501|NCT00362427|Hepatitis B|hepatitis b
5320407|NCT00363012|male breast cancer|male breast cancer
5320408|NCT00362999|Allergic|allergic
5320409|NCT00362999|Rhinitis|rhinitis
5320410|NCT00362999|Pharmacogenetics|pharmacogenetics
5320411|NCT00362999|Histamine|histamine
5320412|NCT00362986|dermatologic complications|dermatologic complications
5320413|NCT00362986|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5320414|NCT00362973|male breast cancer|male breast cancer
5320415|NCT00362973|recurrent breast cancer|recurrent breast cancer
5320416|NCT00362973|stage I breast cancer|stage i breast cancer
5320417|NCT00362973|stage II breast cancer|stage ii breast cancer
5320418|NCT00362973|stage IIIA breast cancer|stage iiia breast cancer
5320419|NCT00362973|stage IIIB breast cancer|stage iiib breast cancer
5320420|NCT00362973|stage IIIC breast cancer|stage iiic breast cancer
5320421|NCT00362973|stage IV breast cancer|stage iv breast cancer
5320422|NCT00362960|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
5320423|NCT00362960|Diabetic Nephropathy|diabetic nephropathy
5320424|NCT00362960|Inflammatory Markers|inflammatory markers
5320425|NCT00362960|Proteinuria|proteinuria
5320426|NCT00362960|Renal Disease|renal disease
5320427|NCT00362947|Superficial vein thrombosis|superficial vein thrombosis
5320428|NCT00362947|thrombophlebitis|thrombophlebitis
5320429|NCT00362947|LMWH|lmwh
5320430|NCT00362947|parnaparin|parnaparin
5320431|NCT00362934|Hyperlipidemia Combined|hyperlipidemia combined
5320432|NCT00362934|efficacy combination fenofibrate simvastatin versus atorvastatin|efficacy combination fenofibrate simvastatin versus atorvastatin
5320433|NCT00362921|adult glioblastoma multiforme|adult glioblastoma multiforme
5320434|NCT00362921|adult gliosarcoma|adult gliosarcoma
5320435|NCT00362921|recurrent adult brain tumor|recurrent adult brain tumor
5320436|NCT00362908|Obesity|obesity
5320437|NCT00362908|Hypertension|hypertension
5320438|NCT00362908|Insulin Resistance|insulin resistance
5320439|NCT00362869|Enteroaggregative Escherichia coli, diarrhea, challenge|enteroaggregative escherichia coli, diarrhea, challenge
5320440|NCT00362856|larazotide acetate|larazotide acetate
5320441|NCT00362843|11C-Leucine|11c-leucine
5320442|NCT00362843|Positron Emission Tomography (PET)|positron emission tomography (pet)
5320443|NCT00362843|Cerebral Protein Synthesis|cerebral protein synthesis
5320444|NCT00362843|Propofol|propofol
5320445|NCT00362843|Fragile X|fragile x
5320446|NCT00362843|Fragile X Syndrome|fragile x syndrome
5320447|NCT00362817|Recurrent|recurrent
5320448|NCT00362817|Symptomatic|symptomatic
5320449|NCT00362804|tetrabenazine|tetrabenazine
5320450|NCT00362804|partial response|partial response
5320451|NCT00362804|psychosis|psychosis
5320452|NCT00362804|schizophrenia|schizophrenia
5320453|NCT00362804|schizoaffective disorder|schizoaffective disorder
5320454|NCT00362804|partial response to antipsychotics|partial response to antipsychotics
5320455|NCT00362791|voluntary counseling and testing|voluntary counseling and testing
5320456|NCT00362791|HIV/STD prevention counseling|hiv/std prevention counseling
5320457|NCT00362791|HIV/STD prevention intervention|hiv/std prevention intervention
5320458|NCT00362791|counseling efficacy|counseling efficacy
5320459|NCT00362765|Type 2 Diabetes|type 2 diabetes
5320460|NCT00362765|Dyslipidemia|dyslipidemia
5320461|NCT00362765|Hyperinsulinemic|hyperinsulinemic
5320462|NCT00362765|Clamp|clamp
5320463|NCT00362765|Metformin|metformin
5320464|NCT00362765|Fenofibrate|fenofibrate
5320465|NCT00362752|norfloxacin|norfloxacin
5320466|NCT00362752|hepatopulmonary syndrome|hepatopulmonary syndrome
5320467|NCT00362726|HIV|hiv
5320468|NCT00362687|HIV, HAART|hiv, haart
5320469|NCT00362661|PTSD|ptsd
5320470|NCT00362661|cortisol|cortisol
5320471|NCT00362661|memory|memory
5320472|NCT00362661|treatment|treatment
5320473|NCT00362622|Travalert|travalert
5320474|NCT00362622|open angle glaucoma|open angle glaucoma
5320475|NCT00362609|Safety|safety
5320476|NCT00362596|Acyclovir|acyclovir
5320477|NCT00362596|HIV|hiv
5320478|NCT00362596|HSV|hsv
5320479|NCT00362583|Cancer pain with breakthrough pain episodes|cancer pain with breakthrough pain episodes
5320480|NCT00362570|Newly diagnosed|newly diagnosed
5320481|NCT00362544|antifungal prophylaxis|antifungal prophylaxis
5320482|NCT00362544|allogeneic stem-cell transplantation|allogeneic stem-cell transplantation
5320483|NCT00362544|acute leukaemia|acute leukaemia
5320484|NCT00362544|antifungal prophylaxis treatment of allogeneic stem-cell transplantation and acute leukaemia|antifungal prophylaxis treatment of allogeneic stem-cell transplantation and acute leukaemia
5320485|NCT00362518|atherosclerosis|atherosclerosis
5320486|NCT00362518|vitamin C|vitamin c
5320487|NCT00362518|vitamin E|vitamin e
5320489|NCT00362492|Ultrasonography|ultrasonography
5320490|NCT00362492|asymptomatic deep venous thrombosis|asymptomatic deep venous thrombosis
5320491|NCT00362492|extended duration prophylaxis|extended duration prophylaxis
5320492|NCT00362492|short duration prophylaxis|short duration prophylaxis
5320493|NCT00362479|pregnancy prevention|pregnancy prevention
5320494|NCT00362479|oral contraceptives|oral contraceptives
5320495|NCT00362466|Leukemia (chronic myeloid leukemia - chronic phase)|leukemia (chronic myeloid leukemia - chronic phase)
5320496|NCT00362440|HIV lipodystrophy|hiv lipodystrophy
5320497|NCT00362440|Leptin|leptin
5320498|NCT00362440|Fat wasting|fat wasting
5320499|NCT00362440|Pioglitazone|pioglitazone
5320500|NCT00362440|Insulin resistance|insulin resistance
5320502|NCT00362427|Pertussis|pertussis
5320503|NCT00362427|Diphtheria|diphtheria
5320504|NCT00362427|Tetanus|tetanus
5320505|NCT00362427|H. influenzae type b|h. influenzae type b
5320506|NCT00362427|Polio|polio
5320507|NCT00362414|Stroke|stroke
5320508|NCT00362401|Psychoacoustics|psychoacoustics
5320509|NCT00362401|Quality of Life|quality of life
5320510|NCT00362401|Heart Valve Prosthesis|heart valve prosthesis
5320511|NCT00362388|Coronary artery disease|coronary artery disease
5320512|NCT00362388|Ischemic heart disease|ischemic heart disease
5320513|NCT00362388|Angiogenesis|angiogenesis
5320514|NCT00362388|Cells|cells
5320515|NCT00362388|Cardiac surgery|cardiac surgery
5320516|NCT00362375|Adult|adult
5320517|NCT00362375|*HIV Infections/pc [Prevention & Control]|*hiv infections/pc [prevention & control]
5320518|NCT00362375|Female|female
5320519|NCT00362375|Humans|humans
5320520|NCT00362375|Risk-Taking|risk-taking
5320521|NCT00362375|Safe Sex|safe sex
5320522|NCT00362375|Sexual Behavior|sexual behavior
5320523|NCT00362375|HIV Testing|hiv testing
5320524|NCT00362362|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
5320525|NCT00362362|Primary Lateral Sclerosis|primary lateral sclerosis
5320526|NCT00362362|Genetics|genetics
5320527|NCT00362362|Blood Sample|blood sample
5320528|NCT00362362|PLS|pls
5320529|NCT00362362|ALS|als
5320530|NCT00362349|ITP|itp
5320531|NCT00362349|IVIg|ivig
5320532|NCT00362349|Platelet count|platelet count
5320533|NCT00362349|Bleeding|bleeding
5320534|NCT00362336|Hepatitis B|hepatitis b
5320535|NCT00362336|Polio|polio
5320536|NCT00362336|Diphtheria|diphtheria
5320537|NCT00362336|Pertussis|pertussis
5320538|NCT00362336|H. influenzae type b|h. influenzae type b
5320539|NCT00362323|Treatment of Dyslipidemia and of Type 2 Diabetes Mellitus|treatment of dyslipidemia and of type 2 diabetes mellitus
5320540|NCT00362310|classical kaposi's sarcoma|classical kaposi's sarcoma
5320541|NCT00362310|treatment|treatment
5320542|NCT00362310|HIV protease inhibitor indinavir|hiv protease inhibitor indinavir
5320543|NCT00362284|Alzheimer's disease|alzheimer's disease
5320544|NCT00362284|coping|coping
5320545|NCT00362284|quality of life|quality of life
5320546|NCT00362284|caregiving|caregiving
5320547|NCT00362271|Healthy Subjects|healthy subjects
5320548|NCT00362245|Amikacin|amikacin
5320549|NCT00362245|Pharmacokinetics|pharmacokinetics
5320550|NCT00362245|Pharmacodynamics|pharmacodynamics
5320551|NCT00362245|Intra-Thecal injection|intra-thecal injection
5320552|NCT00362232|Prevention of venous thromboembolism|prevention of venous thromboembolism
5320553|NCT00362219|topical|topical
5320554|NCT00362219|morphine|morphine
5320555|NCT00362219|pain|pain
5320556|NCT00362219|skin-wound|skin-wound
5320557|NCT00362219|skin-graft|skin-graft
5320558|NCT00362219|peripheral analgesia|peripheral analgesia
5320559|NCT00362219|burn|burn
5320560|NCT00362206|Hyperlipidemia Combined, efficacy combination fenofibrate simvastatin versus pravastatin|hyperlipidemia combined, efficacy combination fenofibrate simvastatin versus pravastatin
5320561|NCT00362206|Hyperlipidemia Combined|hyperlipidemia combined
5320562|NCT00362193|Diabetes|diabetes
5320563|NCT00362193|Chronic disease management|chronic disease management
5320564|NCT00362193|Relapse|relapse
5320565|NCT00362180|LDL-cholesterol|ldl-cholesterol
5320566|NCT00362180|apoB-100|apob-100
5320567|NCT00362180|apoB-48|apob-48
5320568|NCT00362180|triglyceride|triglyceride
5320569|NCT00362180|HeFH|hefh
5320570|NCT00362180|FHBL|fhbl
5320571|NCT00362167|Clinical Experience|clinical experience
5320572|NCT00362167|Educational Training|educational training
5320573|NCT00362167|Pain Syndromes|pain syndromes
5320574|NCT00362167|Analgesia|analgesia
5320575|NCT00362167|Pain Medicine|pain medicine
5320576|NCT00362167|Therapy|therapy
5320577|NCT00362167|Neuropathic|neuropathic
5320578|NCT00362167|Chronic Pain|chronic pain
5320579|NCT00362167|Acute Pain|acute pain
5320580|NCT00362167|Analgesics|analgesics
5320581|NCT00362167|Medication|medication
5320582|NCT00362167|Evaluation|evaluation
5320583|NCT00362141|levetiracetam|levetiracetam
5320584|NCT00362141|status|status
5320585|NCT00362141|epilepticus|epilepticus
5320586|NCT00362128|Blood Pressure, High|blood pressure, high
5320587|NCT00362128|Obesity|obesity
5320588|NCT00362128|Tobacco Use Disorder|tobacco use disorder
5320589|NCT00362115|hypertension|hypertension
5320590|NCT00362115|blood pressure|blood pressure
5320591|NCT00362115|diastolic blood pressure|diastolic blood pressure
5320592|NCT00362115|drug therapy|drug therapy
5320593|NCT00362102|EGFR-detectable metastatic colorectal carcinoma with documented progressive disease to irinotecan-based chemotherapy and failure|egfr-detectable metastatic colorectal carcinoma with documented progressive disease to irinotecan-based chemotherapy and failure
5320594|NCT00362089|n-3 fatty acids|n-3 fatty acids
5320595|NCT00362089|n-6 fatty acids|n-6 fatty acids
5320596|NCT00362089|long chain polyunsaturated fatty acids|long chain polyunsaturated fatty acids
5320597|NCT00362089|pregnancy|pregnancy
5320598|NCT00362089|lactation|lactation
5320599|NCT00362089|breast feeding|breast feeding
5320600|NCT00362089|breast milk|breast milk
5320601|NCT00362089|adipose tissue|adipose tissue
5320602|NCT00362089|newborn|newborn
5320603|NCT00362089|fetal development|fetal development
5320604|NCT00362076|Perception|perception
5320605|NCT00362076|Development|development
5320606|NCT00362076|Cognition|cognition
5320607|NCT00362076|Vision|vision
5320608|NCT00362076|Infants|infants
5320609|NCT00362076|Autonomic Function|autonomic function
5320610|NCT00362076|Cardiac Vagal Tone|cardiac vagal tone
5320611|NCT00362076|Categorization|categorization
5320612|NCT00362076|Habituation|habituation
5320613|NCT00362076|Motion-Carried Information|motion-carried information
5320614|NCT00362063|growth hormone|growth hormone
5320615|NCT00362050|malaria, falciparum|malaria, falciparum
5320616|NCT00362050|uncomplicated Plasmodium falciparum malaria|uncomplicated plasmodium falciparum malaria
5320617|NCT00361998|Uncomplicated Cystitis|uncomplicated cystitis
5320618|NCT00361998|Nitrofurantoin Macrocrystals|nitrofurantoin macrocrystals
5320619|NCT00361985|Gastric bypass|gastric bypass
5320620|NCT00361985|Anastomotic stricture|anastomotic stricture
5320621|NCT00361985|Morbid obesity|morbid obesity
5320622|NCT00361985|Bariatric surgery|bariatric surgery
5320623|NCT00361985|Omeprazole|omeprazole
5320624|NCT00361959|fluticasone propionate/salmeterol combination|fluticasone propionate/salmeterol combination
5320625|NCT00361959|tiotropium|tiotropium
5320626|NCT00361959|SERETIDE|seretide
5320627|NCT00361959|COPD exacerbation|copd exacerbation
5320628|NCT00361946|Type 2 diabetes|type 2 diabetes
5320629|NCT00361946|Lean|lean
5320630|NCT00361946|Obese|obese
5320631|NCT00361920|steroid resistant asthma|steroid resistant asthma
5320632|NCT00361907|Pulsatile intravenous insulin|pulsatile intravenous insulin
5320633|NCT00361907|Oral carbohydrate loading|oral carbohydrate loading
5320634|NCT00361907|Respiratory Quotients|respiratory quotients
5320635|NCT00361907|Hypoglycemia|hypoglycemia
5320636|NCT00361907|Diabetic Complications|diabetic complications
5320637|NCT00361907|Circulating vascular and inflammatory markers|circulating vascular and inflammatory markers
5320638|NCT00361868|Treatment of Dyslipidemia and of Type 2 Diabetes Mellitus|treatment of dyslipidemia and of type 2 diabetes mellitus
5320639|NCT00361855|MI|mi
5320640|NCT00361842|Colorectal cancer|colorectal cancer
5320641|NCT00361842|Colorectal carcinoma|colorectal carcinoma
5320642|NCT00361842|Colonic cancer|colonic cancer
5320643|NCT00361842|Rectal cancer|rectal cancer
5320644|NCT00361829|Development|development
5320645|NCT00361829|Childhood Growth|childhood growth
5320646|NCT00361816|Maternal Effect Gene|maternal effect gene
5320647|NCT00361816|Embryonic Development|embryonic development
5320648|NCT00361816|Infertility|infertility
5320649|NCT00361803|chemotherapy|chemotherapy
5320650|NCT00361803|recurrent|recurrent
5320651|NCT00361803|refractory|refractory
5320652|NCT00361803|research|research
5320653|NCT00361803|cancer|cancer
5320654|NCT00361803|pharmacokinetics|pharmacokinetics
5320655|NCT00361790|Healthy Subjects|healthy subjects
5320656|NCT00361777|Obesity|obesity
5320657|NCT00361777|Pseudo-Cushing State|pseudo-cushing state
5320658|NCT00361777|Hypercortisolism|hypercortisolism
5320659|NCT00361777|Cushing's Syndrome|cushing's syndrome
5320660|NCT00361777|Cushing Syndrome|cushing syndrome
5320661|NCT00361751|Glucose metabolism|glucose metabolism
5320662|NCT00361751|Fat Metabolism|fat metabolism
5320663|NCT00361751|Insulin Resistance|insulin resistance
5320664|NCT00361751|Protein Metabolism|protein metabolism
5320665|NCT00361751|Tracer Methodology|tracer methodology
5320666|NCT00361738|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
5320667|NCT00361725|severe sepsis|severe sepsis
5320668|NCT00361725|organ failure|organ failure
5320669|NCT00361725|activated protein C|activated protein c
5320670|NCT00361725|thrombomodulin|thrombomodulin
5320671|NCT00361725|EPCR|epcr
5320672|NCT00361712|Epidural|epidural
5320673|NCT00361712|analgesia|analgesia
5320674|NCT00361712|labor|labor
5320675|NCT00361712|cytokines|cytokines
5320676|NCT00361699|stroke|stroke
5320677|NCT00361699|brain ischemia|brain ischemia
5320678|NCT00361699|cerebrovascular accident|cerebrovascular accident
5320679|NCT00361699|statin|statin
5320680|NCT00361699|hydroxymethylglutaryl-CoA reductase inhibitors|hydroxymethylglutaryl-coa reductase inhibitors
5320681|NCT00361699|cholesterol|cholesterol
5320682|NCT00361699|hypercholesterolemia|hypercholesterolemia
5320683|NCT00361699|hyperlipidemia|hyperlipidemia
5320684|NCT00361699|multicenter studies|multicenter studies
5320685|NCT00361699|prospective studies|prospective studies
5320686|NCT00361699|endpoint determination|endpoint determination
5320687|NCT00361699|randomized controlled trials|randomized controlled trials
5320688|NCT00361699|recurrence|recurrence
5320689|NCT00361699|pravastatin|pravastatin
5320690|NCT00361699|c-reactive Protein|c-reactive protein
5320691|NCT00361686|tramadol|tramadol
5320692|NCT00361686|remifentanyl|remifentanyl
5320693|NCT00361686|patient controlled analgesia|patient controlled analgesia
5320694|NCT00361686|abortion|abortion
5320695|NCT00361673|Health Disparities|health disparities
5320696|NCT00361673|Built Environments|built environments
5320697|NCT00361660|Motor skills|motor skills
5320698|NCT00361660|Occupational Therapy|occupational therapy
5320699|NCT00361660|Physical Therapy Techniques|physical therapy techniques
5320700|NCT00361660|Rehabilitation|rehabilitation
5320701|NCT00361660|Upper Extremity|upper extremity
5320702|NCT00361660|Stroke|stroke
5320703|NCT00361634|Etanercept|etanercept
5320704|NCT00361634|Enbrel|enbrel
5320705|NCT00361634|DCE-MRI|dce-mri
5320706|NCT00361634|RA|ra
5320707|NCT00361621|VELCADE|velcade
5320708|NCT00361608|diabetes|diabetes
5320709|NCT00361608|hypoglycemia|hypoglycemia
5320710|NCT00361608|monitor|monitor
5320711|NCT00361608|children with Type I Diabetes|children with type i diabetes
5320712|NCT00361595|osteoporosis|osteoporosis
5320713|NCT00361595|zoledronic acid|zoledronic acid
5320714|NCT00361595|forteo|forteo
5320715|NCT00361582|Osteoarthritis|osteoarthritis
5320716|NCT00361582|tapentadol|tapentadol
5320717|NCT00361582|knee-replacement|knee-replacement
5320718|NCT00361582|hip replacement|hip replacement
5320719|NCT00361582|pain|pain
5320720|NCT00361569|vaginal atrophy|vaginal atrophy
5320721|NCT00361569|vaginal dryness|vaginal dryness
5320722|NCT00361569|vaginal itching|vaginal itching
5320723|NCT00361569|vaginal pain|vaginal pain
5320724|NCT00361556|low back pain|low back pain
5320725|NCT00361556|disability|disability
5320726|NCT00361556|health education|health education
5320727|NCT00361556|primary care|primary care
5320728|NCT00361543|Schizophrenia|schizophrenia
5320729|NCT00361543|Mental Illness|mental illness
5320730|NCT00361543|SERM|serm
5320731|NCT00361543|Raloxifene|raloxifene
5320732|NCT00361543|Cognition|cognition
5320733|NCT00361530|stroke|stroke
5320734|NCT00361530|brain ischemia|brain ischemia
5320735|NCT00361530|cerebrovascular accident|cerebrovascular accident
5320736|NCT00361530|statin|statin
5320737|NCT00361530|hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors
5320738|NCT00361530|cholesterol|cholesterol
5320739|NCT00361530|hypercholesterolemia|hypercholesterolemia
5320740|NCT00361530|hyperlipidemia|hyperlipidemia
5320741|NCT00361530|multicenter studies|multicenter studies
5320742|NCT00361530|prospective studies|prospective studies
5320743|NCT00361530|endpoint determination|endpoint determination
5320744|NCT00361530|randomized controlled trials|randomized controlled trials
5320745|NCT00361530|recurrence|recurrence
5320746|NCT00361530|pravastatin|pravastatin
5320747|NCT00361530|plaque|plaque
5320748|NCT00361530|tunica intima|tunica intima
5320749|NCT00361530|tunica media|tunica media
5320750|NCT00361530|ultrasonography|ultrasonography
5320751|NCT00361530|carotid arteries|carotid arteries
5320752|NCT00361517|GM monitoring|gm monitoring
5320753|NCT00361517|Immunocompromised|immunocompromised
5320754|NCT00361517|hematological disorder|hematological disorder
5320755|NCT00361517|Allogenic HSCT recipients|allogenic hsct recipients
5320756|NCT00361517|Aspergillus PCR assay|aspergillus pcr assay
5320757|NCT00361504|Osteoarthritis|osteoarthritis
5320758|NCT00361504|Pain|pain
5320759|NCT00361504|Low Back Pain|low back pain
5320760|NCT00361504|Hip Pain|hip pain
5320761|NCT00361504|Knee Pain|knee pain
5320762|NCT00361504|Backache|backache
5320763|NCT00361504|Tapentadol|tapentadol
5320764|NCT00361491|Depression|depression
5320765|NCT00361491|antidepressive disorders|antidepressive disorders
5320766|NCT00361491|controlled clinical trial|controlled clinical trial
5320767|NCT00361478|exercise|exercise
5320768|NCT00361478|postnatal depression|postnatal depression
5320769|NCT00361478|psychological health|psychological health
5320770|NCT00361478|well-being|well-being
5320771|NCT00361426|COPD|copd
5320772|NCT00361426|Respiration Rate|respiration rate
5320773|NCT00361426|Monitoring|monitoring
5320774|NCT00361413|Stem cell transplantation|stem cell transplantation
5320775|NCT00361413|GVHD|gvhd
5320776|NCT00361413|Graft Versus Host Disease|graft versus host disease
5320777|NCT00361400|pregnancy|pregnancy
5320778|NCT00361400|hormonal contraception|hormonal contraception
5320779|NCT00361387|Sarcoidosis|sarcoidosis
5320780|NCT00361387|Sarcoid|sarcoid
5320781|NCT00361374|Depression|depression
5320782|NCT00361374|Omega-3|omega-3
5320783|NCT00361374|Boston|boston
5320784|NCT00361348|Palifermin|palifermin
5320785|NCT00361348|drug interaction|drug interaction
5320786|NCT00361335|Rheumatoid arthritis|rheumatoid arthritis
5320787|NCT00361335|Golimumab|golimumab
5320788|NCT00361335|Methotrexate|methotrexate
5320789|NCT00361335|Tumor Necrosis Factor-alpha|tumor necrosis factor-alpha
5320790|NCT00361335|Immunology|immunology
5320791|NCT00361309|liver cancer|liver cancer
5320792|NCT00361309|HCC|hcc
5320793|NCT00361296|refractory anemia with excess blasts|refractory anemia with excess blasts
5320794|NCT00361296|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
5320795|NCT00361296|refractory anemia|refractory anemia
5320796|NCT00361296|refractory cytopenia with multilineage dysplasia|refractory cytopenia with multilineage dysplasia
5320797|NCT00361296|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5320798|NCT00361296|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5320799|NCT00361296|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5320800|NCT00361270|Biofeedback|biofeedback
5320801|NCT00361270|Hypnosis|hypnosis
5320802|NCT00361270|Low Back Pain, Recurrent|low back pain, recurrent
5320803|NCT00361270|Pain beliefs|pain beliefs
5320804|NCT00361270|Pain coping strategies|pain coping strategies
5320805|NCT00361270|Pain intensity|pain intensity
5320806|NCT00361270|Pain interference|pain interference
5320807|NCT00361270|Pain quality|pain quality
5320808|NCT00361270|Self-help treatment|self-help treatment
5320809|NCT00361270|Sleep dysfunction|sleep dysfunction
5320810|NCT00361257|Treatment Experienced|treatment experienced
5320811|NCT00361244|Sutent|sutent
5320812|NCT00361231|Avastin|avastin
5320813|NCT00361231|GEMOX|gemox
5320814|NCT00361218|depression|depression
5320815|NCT00361218|biology|biology
5320816|NCT00361205|Parkinson's Disease, pharmacology, compliance, dopaminergic|parkinson's disease, pharmacology, compliance, dopaminergic
5320817|NCT00361192|temporal arteritis|temporal arteritis
5320818|NCT00361192|duplex of temporal artery|duplex of temporal artery
5320819|NCT00361192|biopsy of temporal artery|biopsy of temporal artery
5320820|NCT00361179|Observation|observation
5320821|NCT00361179|Post-treatment|post-treatment
5320822|NCT00361166|Schizophrenia|schizophrenia
5320823|NCT00361166|psychosis|psychosis
5320824|NCT00361166|delusions|delusions
5320825|NCT00361166|hallucination|hallucination
5320826|NCT00361140|Busulfan|busulfan
5320827|NCT00361140|Fludarabine|fludarabine
5320828|NCT00361140|Chimerism|chimerism
5320829|NCT00361140|Allogeneic stem cell transplantation (HCT)|allogeneic stem cell transplantation (hct)
5320830|NCT00361140|Myelodysplastic Syndromes|myelodysplastic syndromes
5320831|NCT00361140|Leukemia Myeloproliferative disorders (MPD)|leukemia myeloproliferative disorders (mpd)
5320832|NCT00361140|Leukemia, Lymphocytic|leukemia, lymphocytic
5320833|NCT00361140|Myeloma|myeloma
5320834|NCT00361140|Lymphoma|lymphoma
5320835|NCT00361140|AUC|auc
5320836|NCT00361140|Hematologic malignancies|hematologic malignancies
5320837|NCT00361127|Heart failure|heart failure
5320838|NCT00361127|pulmonary edema|pulmonary edema
5320839|NCT00361127|ACE-inhibitors|ace-inhibitors
5320840|NCT00361127|lung diffusion|lung diffusion
5320841|NCT00361127|exercise capacity|exercise capacity
5320842|NCT00361127|Chronic heart failure|chronic heart failure
5320843|NCT00361101|HIV|hiv
5320844|NCT00361101|X4 tropic virus|x4 tropic virus
5320845|NCT00361088|Velcade (PS-341)|velcade (ps-341)
5320846|NCT00361088|Bortezomib|bortezomib
5320847|NCT00361088|Zarnestra (R115777)|zarnestra (r115777)
5320848|NCT00361088|Tipifarnib|tipifarnib
5320849|NCT00361075|Perimenopause|perimenopause
5320850|NCT00361075|Abdominal adipose tissue|abdominal adipose tissue
5320851|NCT00361075|Women's health|women's health
5320852|NCT00361075|Cholesterol|cholesterol
5320853|NCT00361075|Lipid Metabolism|lipid metabolism
5320854|NCT00361062|aggressive|aggressive
5320855|NCT00361062|SSRI's|ssri's
5320856|NCT00361062|simulation|simulation
5320857|NCT00361062|behavioral|behavioral
5320858|NCT00361062|Side Effects, Psychological|side effects, psychological
5320859|NCT00361062|adverse effects|adverse effects
5320860|NCT00361062|Serotonin Reuptake Inhibitors|serotonin reuptake inhibitors
5320861|NCT00361062|aggressive behavior|aggressive behavior
5320862|NCT00361062|computer simulation|computer simulation
5320863|NCT00361049|graft versus host disease|graft versus host disease
5320864|NCT00361049|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5320865|NCT00361049|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5320866|NCT00361049|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5320867|NCT00361049|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5320868|NCT00361049|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5320869|NCT00361049|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5320870|NCT00361049|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5320871|NCT00361049|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5320872|NCT00361049|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5320873|NCT00361049|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
5320874|NCT00361049|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5320875|NCT00361049|chronic eosinophilic leukemia|chronic eosinophilic leukemia
5320876|NCT00361049|primary myelofibrosis|primary myelofibrosis
5320877|NCT00361049|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5320878|NCT00361049|chronic neutrophilic leukemia|chronic neutrophilic leukemia
5320879|NCT00361049|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5320880|NCT00361049|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5320881|NCT00361049|disseminated neuroblastoma|disseminated neuroblastoma
5320882|NCT00361049|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5320883|NCT00361049|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
5320884|NCT00361049|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5320885|NCT00361049|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
5320886|NCT00361049|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5320887|NCT00361049|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
5320958|NCT00360997|Physical therapy|physical therapy
5320888|NCT00361049|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
5320889|NCT00361049|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
5320890|NCT00361049|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
5320891|NCT00361049|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5320892|NCT00361049|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5320893|NCT00361049|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5320894|NCT00361049|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5320895|NCT00361049|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
5320896|NCT00361049|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
5320897|NCT00361049|poor prognosis metastatic gestational trophoblastic tumor|poor prognosis metastatic gestational trophoblastic tumor
5320898|NCT00361049|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5320899|NCT00361049|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5320900|NCT00361049|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5320901|NCT00361049|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5320902|NCT00361049|stage I multiple myeloma|stage i multiple myeloma
5320903|NCT00361049|stage II multiple myeloma|stage ii multiple myeloma
5320904|NCT00361049|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
5320905|NCT00361049|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5320906|NCT00361049|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5320907|NCT00361049|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5320908|NCT00361049|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5320909|NCT00361049|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5320910|NCT00361049|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5320911|NCT00361049|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5320912|NCT00361049|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5320913|NCT00361049|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5320914|NCT00361049|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5320915|NCT00361049|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5320916|NCT00361049|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5320917|NCT00361049|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5320918|NCT00361049|stage III multiple myeloma|stage iii multiple myeloma
5320919|NCT00361049|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5320920|NCT00361049|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5320921|NCT00361049|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
5320922|NCT00361049|stage IIIA breast cancer|stage iiia breast cancer
5320923|NCT00361049|stage IIIB breast cancer|stage iiib breast cancer
5320924|NCT00361049|stage IIIC breast cancer|stage iiic breast cancer
5320925|NCT00361049|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5320926|NCT00361049|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5320927|NCT00361049|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5320928|NCT00361049|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5320929|NCT00361049|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5320930|NCT00361049|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5320931|NCT00361049|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5320932|NCT00361049|stage IV breast cancer|stage iv breast cancer
5320933|NCT00361049|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5320934|NCT00361049|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5320935|NCT00361049|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5320936|NCT00361049|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5320937|NCT00361049|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5320938|NCT00361049|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5320939|NCT00361049|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5320940|NCT00361049|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5320941|NCT00361036|Leiomyoma|leiomyoma
5320942|NCT00361036|Leiomyomatosis|leiomyomatosis
5320943|NCT00361036|Uterine Neoplasms|uterine neoplasms
5320944|NCT00361036|BeadBlock|beadblock
5320945|NCT00361036|Embsophere|embsophere
5320946|NCT00361036|Embolization|embolization
5320947|NCT00361036|Uterine fibroid embolization|uterine fibroid embolization
5320948|NCT00361023|Angiotensin type 1 receptor blocker (ARB)|angiotensin type 1 receptor blocker (arb)
5320949|NCT00361023|losartan|losartan
5320950|NCT00361023|type 2 diabetes|type 2 diabetes
5320951|NCT00361023|insulin sensitivity and secretion|insulin sensitivity and secretion
5320952|NCT00361023|glucose metabolism|glucose metabolism
5320953|NCT00361010|Keppra|keppra
5320954|NCT00361010|Epilepsy|epilepsy
5320955|NCT00361010|Childhood Absence Epilepsy|childhood absence epilepsy
5320956|NCT00361010|Seizures|seizures
5320957|NCT00360997|Stroke rehabilitation|stroke rehabilitation
5320959|NCT00360984|CSII|csii
5320960|NCT00360984|insulin analog|insulin analog
5320961|NCT00360984|severe hypoglycaemia|severe hypoglycaemia
5320962|NCT00360984|altered hypoglycaemia awareness|altered hypoglycaemia awareness
5320963|NCT00360984|diabetes quality of life|diabetes quality of life
5320964|NCT00360984|CGMS|cgms
5320965|NCT00360971|mucositis|mucositis
5320966|NCT00360971|pain|pain
5320967|NCT00360971|radiation toxicity|radiation toxicity
5320968|NCT00360971|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
5320969|NCT00360971|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5320970|NCT00360971|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
5320971|NCT00360971|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5320972|NCT00360971|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
5320973|NCT00360971|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5320974|NCT00360971|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
5320975|NCT00360971|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5320976|NCT00360958|ultrafiltration|ultrafiltration
5320977|NCT00360958|heart failure|heart failure
5320978|NCT00360958|fluid overload|fluid overload
5320979|NCT00360945|childhood oligodendroglioma|childhood oligodendroglioma
5320980|NCT00360945|untreated childhood cerebellar astrocytoma|untreated childhood cerebellar astrocytoma
5320981|NCT00360945|childhood high-grade cerebral astrocytoma|childhood high-grade cerebral astrocytoma
5320982|NCT00360945|childhood low-grade cerebral astrocytoma|childhood low-grade cerebral astrocytoma
5320983|NCT00360945|recurrent childhood cerebellar astrocytoma|recurrent childhood cerebellar astrocytoma
5320984|NCT00360945|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
5320985|NCT00360945|recurrent childhood brain tumor|recurrent childhood brain tumor
5320986|NCT00360932|facial lipoatrophy|facial lipoatrophy
5320987|NCT00360932|HIV/AIDs|hiv/aids
5320988|NCT00360919|casomorphin|casomorphin
5320989|NCT00360919|cheese|cheese
5320990|NCT00360919|craving|craving
5320991|NCT00360919|casein|casein
5320992|NCT00360919|milk|milk
5320993|NCT00360906|RRMS|rrms
5320994|NCT00360906|Omega-3|omega-3
5320995|NCT00360906|Treatment|treatment
5320996|NCT00360867|Extension study|extension study
5320997|NCT00360867|solid tumors|solid tumors
5320998|NCT00360854|untreated childhood brain stem glioma|untreated childhood brain stem glioma
5320999|NCT00360854|recurrent childhood cerebellar astrocytoma|recurrent childhood cerebellar astrocytoma
5321000|NCT00360854|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
5321001|NCT00360854|recurrent childhood ependymoma|recurrent childhood ependymoma
5321002|NCT00360854|recurrent childhood medulloblastoma|recurrent childhood medulloblastoma
5321003|NCT00360854|recurrent childhood supratentorial primitive neuroectodermal tumor|recurrent childhood supratentorial primitive neuroectodermal tumor
5321004|NCT00360854|recurrent childhood visual pathway and hypothalamic glioma|recurrent childhood visual pathway and hypothalamic glioma
5321005|NCT00360854|childhood central nervous system germ cell tumor|childhood central nervous system germ cell tumor
5321006|NCT00360854|childhood choroid plexus tumor|childhood choroid plexus tumor
5321007|NCT00360854|childhood craniopharyngioma|childhood craniopharyngioma
5321008|NCT00360854|childhood grade I meningioma|childhood grade i meningioma
5321009|NCT00360854|childhood grade II meningioma|childhood grade ii meningioma
5321010|NCT00360854|childhood grade III meningioma|childhood grade iii meningioma
5321011|NCT00360854|childhood low-grade cerebral astrocytoma|childhood low-grade cerebral astrocytoma
5321012|NCT00360854|childhood infratentorial ependymoma|childhood infratentorial ependymoma
5321013|NCT00360854|childhood supratentorial ependymoma|childhood supratentorial ependymoma
5321014|NCT00360854|recurrent childhood brain tumor|recurrent childhood brain tumor
5321015|NCT00360854|recurrent childhood subependymal giant cell astrocytoma|recurrent childhood subependymal giant cell astrocytoma
5321016|NCT00360854|recurrent childhood pineoblastoma|recurrent childhood pineoblastoma
5321017|NCT00360841|auricular|auricular
5321018|NCT00360841|acupuncture|acupuncture
5321019|NCT00360828|Recurrent Anaplastic Astrocytoma|recurrent anaplastic astrocytoma
5321020|NCT00360828|Mixed Malignant Glioma|mixed malignant glioma
5321021|NCT00360828|Oligodendroglioma|oligodendroglioma
5321022|NCT00360828|Irinotecan|irinotecan
5321023|NCT00360828|Brain tumor|brain tumor
5321024|NCT00360828|Nitrosoureas|nitrosoureas
5321025|NCT00360828|Brain and nervous system|brain and nervous system
5321026|NCT00360802|chronic low back pain|chronic low back pain
5321027|NCT00360802|cognitive-behavioral therapy|cognitive-behavioral therapy
5321028|NCT00360802|Mindful Based Stress Reduction|mindful based stress reduction
5321029|NCT00360802|pain clinics|pain clinics
5321030|NCT00360802|anxiety|anxiety
5321031|NCT00360802|quality of life|quality of life
5321032|NCT00360802|chronic pain|chronic pain
5321033|NCT00360789|STROKE REHABILITATION|stroke rehabilitation
5321034|NCT00360789|pHYSICAL THERAPY|physical therapy
5321035|NCT00360750|intraocular retinoblastoma|intraocular retinoblastoma
5321036|NCT00360750|extraocular retinoblastoma|extraocular retinoblastoma
5321037|NCT00360737|Clinical Trials|clinical trials
5321038|NCT00360737|Investigational Drug|investigational drug
5321039|NCT00360737|Healthy Volunteers|healthy volunteers
5321040|NCT00360737|Botulinum Antitoxin|botulinum antitoxin
5321041|NCT00360737|Phoenix, Arizona|phoenix, arizona
5321042|NCT00360724|dysthymia|dysthymia
5321043|NCT00360724|dysthymic disorder|dysthymic disorder
5321044|NCT00360724|chronic depression|chronic depression
5321045|NCT00360724|chronic low-grade depression|chronic low-grade depression
5321046|NCT00360724|atypical depression|atypical depression
5321047|NCT00360724|minor depression|minor depression
5321048|NCT00360724|depression NOS|depression nos
5321049|NCT00360724|depression|depression
5321050|NCT00360724|depressive disorder|depressive disorder
5321051|NCT00360724|mood disorder|mood disorder
5321052|NCT00360724|unipolar depression|unipolar depression
5321053|NCT00360724|low-grade depression|low-grade depression
5321054|NCT00360711|Moral Distress|moral distress
5321055|NCT00360711|Nondirectiveness|nondirectiveness
5321056|NCT00360711|Ethical Dilemma|ethical dilemma
5321057|NCT00360685|Tacrolimus|tacrolimus
5321058|NCT00360685|Methotrexate|methotrexate
5321059|NCT00360685|Mycophenolate mofetil|mycophenolate mofetil
5321060|NCT00360685|Mucositis|mucositis
5321061|NCT00360685|Acute graft-versus-host disease (aGVHD)|acute graft-versus-host disease (agvhd)
5321062|NCT00360685|Engraftment|engraftment
5321063|NCT00360685|hemolytic/uremic syndrome (HUS)|hemolytic/uremic syndrome (hus)
5321064|NCT00360685|Thrombotic thrombocytopenic purpura (TTP)|thrombotic thrombocytopenic purpura (ttp)
5321065|NCT00360672|Acute Myelogenous Leukemia|acute myelogenous leukemia
5321066|NCT00360672|Myelodysplastic Syndrome|myelodysplastic syndrome
5321067|NCT00360659|Obstructive sleep Apnea|obstructive sleep apnea
5321068|NCT00360659|Hypertension|hypertension
5321069|NCT00360659|Vasoactive hormones|vasoactive hormones
5321070|NCT00360646|LIVER DIS|liver dis
5321071|NCT00360646|CHEM IND|chem ind
5321072|NCT00360646|Drugs|drugs
5321073|NCT00360646|Drug induced liver injury|drug induced liver injury
5321074|NCT00360646|phenotype|phenotype
5321075|NCT00360646|cholestatic liver injury|cholestatic liver injury
5321076|NCT00360646|hepatocellular liver injury|hepatocellular liver injury
5321077|NCT00360646|mixed liver injury|mixed liver injury
5321078|NCT00360646|genotype|genotype
5321079|NCT00360633|Parkinson's Disease|parkinson's disease
5321080|NCT00360633|Impulse control disorder|impulse control disorder
5321081|NCT00360633|Dopamine agonist withdrawal syndrome|dopamine agonist withdrawal syndrome
5321082|NCT00360633|Anxiety|anxiety
5321083|NCT00360633|Depression|depression
5321084|NCT00360633|Healthcare Utilization|healthcare utilization
5321085|NCT00360633|Disability|disability
5321086|NCT00360633|Quality of life|quality of life
5321087|NCT00360633|Cognitive function|cognitive function
5321088|NCT00360633|Psychosis|psychosis
5321089|NCT00360633|Apathy|apathy
5321090|NCT00360633|Dyskinesias|dyskinesias
5321091|NCT00360633|Wearing off|wearing off
5321092|NCT00360594|alcoholism|alcoholism
5321093|NCT00360581|Smoking abstinence|smoking abstinence
5321094|NCT00360568|carbidopa|carbidopa
5321095|NCT00360568|severe motor fluctuations|severe motor fluctuations
5321096|NCT00360568|intestinal gel|intestinal gel
5321097|NCT00360568|levodopa|levodopa
5321098|NCT00360568|efficacy|efficacy
5321099|NCT00360568|levodopa carbidopa intestinal gel|levodopa carbidopa intestinal gel
5321100|NCT00360568|dyskinesia|dyskinesia
5321101|NCT00360568|Parkinson's Disease|parkinson's disease
5321102|NCT00360568|Duodopa|duodopa
5321103|NCT00360568|levodopa-carbidopa|levodopa-carbidopa
5321104|NCT00360568|DUOPA|duopa
5321105|NCT00360516|healthy volunteers|healthy volunteers
5321106|NCT00360503|Cystic fibrosis|cystic fibrosis
5321107|NCT00360503|Antibiotic resistance|antibiotic resistance
5321108|NCT00360503|Microbiology|microbiology
5321109|NCT00360490|Idiopathic Menorrhagia|idiopathic menorrhagia
5321110|NCT00360477|Kidney stone removal surgery|kidney stone removal surgery
5321111|NCT00360451|Prevention|prevention
5321112|NCT00360451|Child|child
5321113|NCT00360451|Adolescent|adolescent
5321114|NCT00360451|Parent|parent
5321115|NCT00360438|Leukemia|leukemia
5321116|NCT00360438|Lymphoma|lymphoma
5321117|NCT00360438|Tumor Lysis Syndrome|tumor lysis syndrome
5321118|NCT00360438|TLS|tls
5321119|NCT00360438|Rasburicase|rasburicase
5321120|NCT00360438|Elitek|elitek
5321121|NCT00360425|anemia|anemia
5321122|NCT00360425|intravenous iron|intravenous iron
5321123|NCT00360425|pharmacokinetics|pharmacokinetics
5321124|NCT00360425|QTc|qtc
5321125|NCT00360399|Escitalopram|escitalopram
5321126|NCT00360399|Duloxetine|duloxetine
5321127|NCT00360399|Cognitive Behavioral Therapy|cognitive behavioral therapy
5321128|NCT00360399|PET|pet
5321129|NCT00360399|fMRI|fmri
5321130|NCT00360373|bariatric|bariatric
5321131|NCT00360373|obesity|obesity
5321132|NCT00360373|insulin resistance|insulin resistance
5321133|NCT00360373|gastric bypass|gastric bypass
5321134|NCT00360373|adolescent|adolescent
5321135|NCT00360360|Neoplasm, Unknown Primary|neoplasm, unknown primary
5321136|NCT00360334|diabetes|diabetes
5321137|NCT00360334|exenatide|exenatide
5321138|NCT00360334|insulin glargine|insulin glargine
5321139|NCT00360334|Lilly|lilly
5321140|NCT00360334|Amylin|amylin
5321141|NCT00360282|Migraine|migraine
5321142|NCT00360282|Triptans|triptans
5321143|NCT00360282|Motion Sickness|motion sickness
5321144|NCT00360256|Depression|depression
5321145|NCT00360256|Amplichip P450 tests|amplichip p450 tests
5321146|NCT00360256|Antidepressants|antidepressants
5321147|NCT00360230|Vaccine|vaccine
5321148|NCT00360230|Prophylaxis Plasmodium falciparum malaria|prophylaxis plasmodium falciparum malaria
5321149|NCT00360230|Plasmodium falciparum|plasmodium falciparum
5321150|NCT00360230|Malaria|malaria
5321151|NCT00360217|Omega-3|omega-3
5321152|NCT00360217|Triglyceride|triglyceride
5321153|NCT00360217|Hyperlipidemia|hyperlipidemia
5321154|NCT00360217|Coronary Artery Disease|coronary artery disease
5321155|NCT00360217|Fatty Acids|fatty acids
5321156|NCT00360217|Safety|safety
5321157|NCT00360217|Fish Oil|fish oil
5321158|NCT00360217|Docosohexanoic Acid|docosohexanoic acid
5321159|NCT00360204|Infant health|infant health
5321160|NCT00360204|parenting competence|parenting competence
5321161|NCT00360204|Home nurse visit|home nurse visit
5321162|NCT00360204|maternal post-partum care|maternal post-partum care
5321163|NCT00360204|postpartum health utilization|postpartum health utilization
5321164|NCT00360204|Breastfeeding|breastfeeding
5321165|NCT00360178|hypertension|hypertension
5321166|NCT00360178|valsartan|valsartan
5321167|NCT00360178|amlodipine|amlodipine
5321168|NCT00360178|hydrochlorothiazide|hydrochlorothiazide
5321169|NCT00360152|Breast Cancer|breast cancer
5321170|NCT00360152|Axilla|axilla
5321171|NCT00360152|Ultrasound|ultrasound
5321172|NCT00360152|FNA|fna
5321173|NCT00360152|Molecular Analysis|molecular analysis
5321174|NCT00360139|Sculptra|sculptra
5321175|NCT00360139|lipoatrophy|lipoatrophy
5321176|NCT00360139|emaciation|emaciation
5321177|NCT00360139|facial|facial
5321178|NCT00360139|dermal filler|dermal filler
5321179|NCT00360139|poly-L-lactic acid|poly-l-lactic acid
5321180|NCT00360139|Dermik|dermik
5321181|NCT00360139|SpaMD|spamd
5321182|NCT00360139|Sanofi|sanofi
5321183|NCT00360139|Facial lipoatrophy|facial lipoatrophy
5321184|NCT00360139|Facial emaciation|facial emaciation
5321185|NCT00360126|Lamictal|lamictal
5321186|NCT00360126|lamotrigine|lamotrigine
5321187|NCT00360126|Open-Label Extension Study|open-label extension study
5321188|NCT00360126|Bipolar Disorder|bipolar disorder
5321189|NCT00360087|Treatment Study|treatment study
5321190|NCT00360087|Sickle Cell Anemia|sickle cell anemia
5321191|NCT00360087|6-Minute Walk|6-minute walk
5321192|NCT00360087|Right Heart Catheterization|right heart catheterization
5321193|NCT00360087|Tracleer|tracleer
5321194|NCT00360087|Sickle Cell|sickle cell
5321195|NCT00360087|SCD|scd
5321196|NCT00360074|secondary hypothyroidism|secondary hypothyroidism
5321197|NCT00360074|body weight adjusted thyroxin dose|body weight adjusted thyroxin dose
5321198|NCT00360074|triiodothyronine supplementation|triiodothyronine supplementation
5321199|NCT00360061|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
5321200|NCT00360061|Adolescents|adolescents
5321201|NCT00360061|Cognitive Behaviour Therapy|cognitive behaviour therapy
5321202|NCT00360048|oxytocin|oxytocin
5321203|NCT00360048|tnf|tnf
5321204|NCT00360048|sepsis|sepsis
5321205|NCT00360048|lps|lps
5321206|NCT00360009|Parkinson's disease|parkinson's disease
5321207|NCT00360009|Parkinson disease|parkinson disease
5321208|NCT00360009|PD|pd
5321209|NCT00360009|deep brain stimulation|deep brain stimulation
5321210|NCT00360009|DBS|dbs
5321211|NCT00360009|subthalamic nucleus|subthalamic nucleus
5321212|NCT00360009|STN|stn
5321213|NCT00360009|globus pallidus interna|globus pallidus interna
5321214|NCT00360009|GPi|gpi
5321215|NCT00360009|mood|mood
5321216|NCT00360009|motor symptoms|motor symptoms
5321217|NCT00360009|cognition|cognition
5321218|NCT00360009|emotion|emotion
5321219|NCT00360009|memory|memory
5321220|NCT00360009|attention|attention
5321221|NCT00360009|tremor|tremor
5321222|NCT00360009|rigidity|rigidity
5321223|NCT00360009|bradykinesia|bradykinesia
5321224|NCT00359996|diabetes|diabetes
5321225|NCT00359996|quality improvement|quality improvement
5321226|NCT00359996|community health center|community health center
5321227|NCT00359996|health disparities|health disparities
5321228|NCT00359983|Humans|humans
5321229|NCT00359983|Meningococcal vaccines|meningococcal vaccines
5321230|NCT00359983|Immunogenicity|immunogenicity
5321231|NCT00359983|Vaccines|vaccines
5321232|NCT00359983|H. influenzae type b vaccine|h. influenzae type b vaccine
5321233|NCT00359983|Conjugate|conjugate
5321234|NCT00359983|Toddlers|toddlers
5321235|NCT00359983|Comparative study|comparative study
5321236|NCT00359983|Neisseria meningitidis|neisseria meningitidis
5321237|NCT00359970|Diarrhea|diarrhea
5321238|NCT00359970|Travel|travel
5321239|NCT00359970|Travelers' diarrhea|travelers' diarrhea
5321240|NCT00359970|Azithromycin|azithromycin
5321241|NCT00359970|Loperamide|loperamide
5321242|NCT00359970|Treatment|treatment
5321243|NCT00359970|Antibiotic|antibiotic
5321244|NCT00359957|Pediatric obesity|pediatric obesity
5321245|NCT00359957|Physical activity|physical activity
5321246|NCT00359957|Visceral fat|visceral fat
5321247|NCT00359957|Weight|weight
5321248|NCT00359944|Alzheimer|alzheimer
5321249|NCT00359944|Dementia|dementia
5321250|NCT00359931|Neural Networks|neural networks
5321251|NCT00359931|Mathematical Modeling|mathematical modeling
5321252|NCT00359931|Auditory Processing|auditory processing
5321253|NCT00359931|Tinnitis|tinnitis
5321254|NCT00359931|Hearing Loss|hearing loss
5321255|NCT00359918|infarction|infarction
5321256|NCT00359918|facilitated PCI|facilitated pci
5321257|NCT00359918|primary PCI|primary pci
5321258|NCT00359918|infarct size|infarct size
5321259|NCT00359918|fibrinolysis|fibrinolysis
5321260|NCT00359918|ST-elevation myocardial infarction (STEMI)|st-elevation myocardial infarction (stemi)
5321261|NCT00359905|Benign prostatic hyperplasia|benign prostatic hyperplasia
5321262|NCT00359905|alpha-blockers|alpha-blockers
5321263|NCT00359879|diabetes|diabetes
5321264|NCT00359879|exenatide|exenatide
5321265|NCT00359879|Lilly|lilly
5321266|NCT00359879|Amylin|amylin
5321267|NCT00359853|Norfloxacin, primary prophylaxis, SBP|norfloxacin, primary prophylaxis, sbp
5321268|NCT00359840|darbepoetin alfa|darbepoetin alfa
5321269|NCT00359840|anemia|anemia
5321270|NCT00359840|cancer patients|cancer patients
5321271|NCT00359840|chemotherapy|chemotherapy
5321272|NCT00359814|Cyclosporine|cyclosporine
5321273|NCT00359814|renal insufficiency, chronic|renal insufficiency, chronic
5321274|NCT00359814|long-term care|long-term care
5321275|NCT00359801|Large Simple Trial|large simple trial
5321276|NCT00359775|Coping|coping
5321277|NCT00359775|psychosocial|psychosocial
5321278|NCT00359775|Quality of Life|quality of life
5321279|NCT00359775|problem solving|problem solving
5321280|NCT00359762|exenatide|exenatide
5321281|NCT00359762|diabetes|diabetes
5321282|NCT00359762|Amylin|amylin
5321283|NCT00359762|Lilly|lilly
5321284|NCT00359762|glimepiride|glimepiride
5321285|NCT00359736|alveolitis, fibrosing|alveolitis, fibrosing
5321286|NCT00359736|exercise, aerobic|exercise, aerobic
5321287|NCT00359736|fibrosis, pulmonary|fibrosis, pulmonary
5321288|NCT00359736|hypertension, pulmonary|hypertension, pulmonary
5321289|NCT00359723|Parkinson's disease|parkinson's disease
5321290|NCT00359723|PD|pd
5321291|NCT00359723|methylphenidate|methylphenidate
5321292|NCT00359723|Ritalin|ritalin
5321293|NCT00359723|MPD|mpd
5321294|NCT00359710|Multiracial Populations|multiracial populations
5321295|NCT00359710|Human Genetic Variation|human genetic variation
5321296|NCT00359710|Family History|family history
5321297|NCT00359710|Admixture|admixture
5321298|NCT00359710|Physician-Patient Communication|physician-patient communication
5321299|NCT00359710|Ancestry|ancestry
5321300|NCT00359710|Self-Identified Multiracial Adults|self-identified multiracial adults
5321301|NCT00359710|Interview|interview
5321302|NCT00359684|Cystinosis|cystinosis
5321303|NCT00359684|Cystine|cystine
5321304|NCT00359684|Lysomal Storage Disease|lysomal storage disease
5321305|NCT00359684|Mutation Analysis|mutation analysis
5321306|NCT00359684|Metabolic Disease|metabolic disease
5321307|NCT00359658|Cyclosporine|cyclosporine
5321308|NCT00359658|Glucocorticoids|glucocorticoids
5321309|NCT00359658|renal insufficiency, chronic|renal insufficiency, chronic
5321310|NCT00359658|long-term care|long-term care
5321311|NCT00359645|Screening|screening
5321312|NCT00359645|Upper aerodigestive tract cancer|upper aerodigestive tract cancer
5321313|NCT00359645|Alcohol|alcohol
5321314|NCT00359645|Tobacco|tobacco
5321315|NCT00359645|Randomized trial|randomized trial
5321316|NCT00359632|Optic neuropathy following long-term linezolid use|optic neuropathy following long-term linezolid use
5321317|NCT00359619|HPV vaccine|hpv vaccine
5321318|NCT00359606|DNA Methylation|dna methylation
5321319|NCT00359606|Advanced Cancer|advanced cancer
5321320|NCT00359606|Methyltransferase Inhibitor|methyltransferase inhibitor
5321321|NCT00359606|Epigenetics|epigenetics
5321322|NCT00359606|Gene Re-Expression|gene re-expression
5321323|NCT00359593|Stroke|stroke
5321324|NCT00359593|Rehabilitation|rehabilitation
5321325|NCT00359593|Knowledge translation|knowledge translation
5321326|NCT00359593|Evidence based practice|evidence based practice
5321327|NCT00359593|Outcomes|outcomes
5321328|NCT00359580|Ancestry|ancestry
5321329|NCT00359567|nausea and vomiting|nausea and vomiting
5321330|NCT00359554|Influenza|influenza
5321331|NCT00359541|CYP2C9|cyp2c9
5321332|NCT00359541|CYP2C19|cyp2c19
5321333|NCT00359541|Pharmacology|pharmacology
5321334|NCT00359541|Genotype|genotype
5321335|NCT00359541|Metabolism|metabolism
5321336|NCT00359515|Archived Samples|archived samples
5321337|NCT00359515|Mutation Screening|mutation screening
5321338|NCT00359515|Genotype-Phenotype Correlation|genotype-phenotype correlation
5321339|NCT00359515|Pediatric Developmental Disorder|pediatric developmental disorder
5321340|NCT00359515|Cataracts|cataracts
5321341|NCT00359515|Mutation Detection|mutation detection
5321342|NCT00359515|Lowe Syndrome|lowe syndrome
5321343|NCT00359515|Genotype|genotype
5321344|NCT00359476|Locally advanced/metastatic gastric adenocarcinoma|locally advanced/metastatic gastric adenocarcinoma
5321345|NCT00359476|adenocarcinoma-gastroesophageal junction|adenocarcinoma-gastroesophageal junction
5321346|NCT00359476|Gastric Adenocarcinoma|gastric adenocarcinoma
5321347|NCT00359463|hepatitis C-associated thrombocytopenia|hepatitis c-associated thrombocytopenia
5321348|NCT00359463|chemotherapy induced thrombocytopenia|chemotherapy induced thrombocytopenia
5321349|NCT00359463|thrombocytopenia|thrombocytopenia
5321350|NCT00359463|hepatic impairment|hepatic impairment
5321451|NCT00359138|Histamine H1 Antagonists|histamine h1 antagonists
5321351|NCT00359463|chronic immune thrombocytopenia purpura|chronic immune thrombocytopenia purpura
5321352|NCT00359450|Locally advanced or metastatic non-small cell lung cancer|locally advanced or metastatic non-small cell lung cancer
5321353|NCT00359424|acute ischemic stroke|acute ischemic stroke
5321354|NCT00359424|rt-PA|rt-pa
5321355|NCT00359424|thrombolytic|thrombolytic
5321356|NCT00359424|recombinant tissue plasminogen activator|recombinant tissue plasminogen activator
5321357|NCT00359424|recanalization|recanalization
5321358|NCT00359424|blood clot|blood clot
5321359|NCT00359424|stroke|stroke
5321360|NCT00359424|clot-dissolving|clot-dissolving
5321361|NCT00359424|Activase®|activase®
5321362|NCT00359424|Actilyse®|actilyse®
5321363|NCT00359424|Concentric Merci® Retriever|concentric merci® retriever
5321364|NCT00359424|EKOS® Micro-Infusion catheter (MicroLysus)|ekos® micro-infusion catheter (microlysus)
5321365|NCT00359424|The Penumbra System™|the penumbra system™
5321366|NCT00359424|Standard microcatheter|standard microcatheter
5321367|NCT00359411|Epstein-Barr Virus|epstein-barr virus
5321368|NCT00359411|B-Cell Lymphoma|b-cell lymphoma
5321369|NCT00359411|Herpes Virus|herpes virus
5321370|NCT00359411|Infectious Mononucleosis|infectious mononucleosis
5321371|NCT00359398|Cardiopulmonary bypass|cardiopulmonary bypass
5321372|NCT00359398|Blood component removal|blood component removal
5321373|NCT00359385|primary hyperparathyroidism|primary hyperparathyroidism
5321374|NCT00359385|hyperparathyroidism|hyperparathyroidism
5321375|NCT00359385|PHPT|phpt
5321377|NCT00359385|hypercalcemia|hypercalcemia
5321378|NCT00359385|bone density|bone density
5321379|NCT00359385|osteoporosis|osteoporosis
5321380|NCT00359385|bone turnover|bone turnover
5321381|NCT00359385|DXA|dxa
5321382|NCT00359385|pQCT|pqct
5321383|NCT00359385|cQCT|cqct
5321384|NCT00359385|alendronate|alendronate
5321385|NCT00359385|Fosamax|fosamax
5321386|NCT00359385|parathyroid hormone|parathyroid hormone
5321387|NCT00359385|parathyroid surgery|parathyroid surgery
5321388|NCT00359385|parathyroidectomy|parathyroidectomy
5321389|NCT00359385|Silverberg|silverberg
5321390|NCT00359385|Rubin|rubin
5321391|NCT00359385|Bilezikian|bilezikian
5321392|NCT00359385|treatment|treatment
5321393|NCT00359372|Chronic Heart Failure|chronic heart failure
5321394|NCT00359372|Cardiac Resynchronization|cardiac resynchronization
5321395|NCT00359372|Magnetic Resonance Imaging|magnetic resonance imaging
5321396|NCT00359372|Biventricular Pacing|biventricular pacing
5321397|NCT00359372|Heart Function|heart function
5321398|NCT00359372|CRT|crt
5321399|NCT00359359|Small Cell Lung Cancer|small cell lung cancer
5321400|NCT00359346|Plasmapheresis|plasmapheresis
5321401|NCT00359346|Auto-antibodies|auto-antibodies
5321402|NCT00359346|Autonomic Nervous System|autonomic nervous system
5321403|NCT00359346|Dysautonomia|dysautonomia
5321404|NCT00359346|Sympathetic Nervous System|sympathetic nervous system
5321405|NCT00359346|Autonomic Failure|autonomic failure
5321406|NCT00359320|Pancreaticoduodenectomy|pancreaticoduodenectomy
5321407|NCT00359320|Pancreaticojejunostomy|pancreaticojejunostomy
5321408|NCT00359320|Pancreatic Cancer|pancreatic cancer
5321409|NCT00359307|Genetic|genetic
5321410|NCT00359307|Longitudinal|longitudinal
5321411|NCT00359307|Prospective|prospective
5321412|NCT00359307|Epidemiology|epidemiology
5321413|NCT00359307|Heart Attack|heart attack
5321414|NCT00359294|Tumor|tumor
5321415|NCT00359294|Lymphoma|lymphoma
5321416|NCT00359294|Zalypsis|zalypsis
5321417|NCT00359294|PharmaMar|pharmamar
5321418|NCT00359294|PM00104|pm00104
5321419|NCT00359281|healthy volunteers|healthy volunteers
5321420|NCT00359268|Polymerase Chain Reaction|polymerase chain reaction
5321421|NCT00359268|Random Priming|random priming
5321422|NCT00359268|Nucleic Acid|nucleic acid
5321423|NCT00359268|Viral Genome|viral genome
5321424|NCT00359268|Virus|virus
5321425|NCT00359268|Identification|identification
5321426|NCT00359255|Exercise|exercise
5321427|NCT00359255|rehabilitation|rehabilitation
5321428|NCT00359255|upper limb|upper limb
5321429|NCT00359255|inpatient|inpatient
5321430|NCT00359255|RCT|rct
5321431|NCT00359255|activities of daily living|activities of daily living
5321432|NCT00359242|Infant Sleep|infant sleep
5321433|NCT00359242|Infant Diet|infant diet
5321434|NCT00359242|Infant Temperament|infant temperament
5321435|NCT00359242|Rapid Infant weight gain|rapid infant weight gain
5321436|NCT00359242|Infant Development|infant development
5321437|NCT00359242|Parenting Competence|parenting competence
5321438|NCT00359242|infant weight gain|infant weight gain
5321439|NCT00359216|Hypopnea Syndrome|hypopnea syndrome
5321440|NCT00359203|syncope|syncope
5321441|NCT00359203|implantable loop recorder|implantable loop recorder
5321442|NCT00359190|lapatinib|lapatinib
5321443|NCT00359190|breast cancer|breast cancer
5321444|NCT00359190|treatment-naive|treatment-naive
5321445|NCT00359177|emesis liver problems hepatic impairment GW679769|emesis liver problems hepatic impairment gw679769
5321446|NCT00359164|AMD|amd
5321447|NCT00359164|Avastin|avastin
5321448|NCT00359164|Visudyne|visudyne
5321449|NCT00359164|Medical condition being studied AMD|medical condition being studied amd
5321450|NCT00359151|Perioperative care of total arthroplasty assessing opioid consumption|perioperative care of total arthroplasty assessing opioid consumption
5321656|NCT00358397|Bacteria|bacteria
5321452|NCT00359138|Anti-Allergic Agents|anti-allergic agents
5321453|NCT00359125|bipolar|bipolar
5321454|NCT00359125|RU-486|ru-486
5321455|NCT00359125|mifepristone|mifepristone
5321456|NCT00359125|neurocognition|neurocognition
5321457|NCT00359125|mood|mood
5321458|NCT00359125|cortisol|cortisol
5321459|NCT00359125|HPA axis|hpa axis
5321460|NCT00359112|Type 2 diabetes|type 2 diabetes
5321461|NCT00359112|overweight|overweight
5321462|NCT00359112|AVANDAMET|avandamet
5321463|NCT00359112|metformin|metformin
5321464|NCT00359112|sulphonylurea|sulphonylurea
5321465|NCT00359099|Hepatic Medicine|hepatic medicine
5321466|NCT00359099|Surgery|surgery
5321467|NCT00359086|Relapsed and Refractory Lymphoma|relapsed and refractory lymphoma
5321468|NCT00359086|Phase II|phase ii
5321469|NCT00359073|asthma|asthma
5321470|NCT00359073|leukotrienes|leukotrienes
5321471|NCT00359073|rhinovirus|rhinovirus
5321472|NCT00359060|Physical activity|physical activity
5321473|NCT00359060|Sex steroid hormones|sex steroid hormones
5321474|NCT00359060|Breast cancer risk|breast cancer risk
5321475|NCT00359060|Intervention study|intervention study
5321476|NCT00359060|Postmenopausal women|postmenopausal women
5321477|NCT00359047|Osteoporosis|osteoporosis
5321478|NCT00359047|Fragility fracture|fragility fracture
5321479|NCT00359047|Women|women
5321480|NCT00359047|Randomised control trial|randomised control trial
5321481|NCT00359047|Patient education|patient education
5321482|NCT00359047|Diagnosis|diagnosis
5321483|NCT00359047|Treatment|treatment
5321484|NCT00359034|Doppler ultrasound|doppler ultrasound
5321485|NCT00359034|pulsewave velocity|pulsewave velocity
5321486|NCT00359034|intrauterine growth restriction|intrauterine growth restriction
5321487|NCT00359034|Fetal Pulsewave Velocity|fetal pulsewave velocity
5321488|NCT00359021|HIV-1|hiv-1
5321489|NCT00359021|treatment experienced|treatment experienced
5321490|NCT00359021|virologic failure|virologic failure
5321491|NCT00359008|AMD|amd
5321492|NCT00359008|CNV|cnv
5321493|NCT00359008|PHP|php
5321494|NCT00358995|Cognitive Behavioral Therapy|cognitive behavioral therapy
5321495|NCT00358995|Primary Obsessions|primary obsessions
5321496|NCT00358995|Obsessive Compulsive Disorder|obsessive compulsive disorder
5321497|NCT00358995|Compulsive Disorder|compulsive disorder
5321498|NCT00358982|Relapsed or Refractory Hodgkin's Lymphoma|relapsed or refractory hodgkin's lymphoma
5321499|NCT00358982|Phase II|phase ii
5321500|NCT00358969|borderline personality disorder|borderline personality disorder
5321501|NCT00358969|guanfacine|guanfacine
5321502|NCT00358969|impulsivity|impulsivity
5321503|NCT00358969|aggression|aggression
5321504|NCT00358969|affective instability|affective instability
5321505|NCT00358956|medullary thyroid cancer|medullary thyroid cancer
5321506|NCT00358956|MTC|mtc
5321507|NCT00358956|hereditary medullary thyroid cancer|hereditary medullary thyroid cancer
5321508|NCT00358956|thyroid cancer|thyroid cancer
5321509|NCT00358943|Gaucher Disease|gaucher disease
5321510|NCT00358943|Glucocerebrosidase Deficiency Disease|glucocerebrosidase deficiency disease
5321511|NCT00358930|squamous cell carcinoma of the head and neck|squamous cell carcinoma of the head and neck
5321512|NCT00358904|Hill Sachs|hill sachs
5321513|NCT00358904|Weber osteotomy|weber osteotomy
5321514|NCT00358904|shoulder dislocation|shoulder dislocation
5321515|NCT00358891|Prematurity|prematurity
5321516|NCT00358891|Chronic Lung Disease|chronic lung disease
5321517|NCT00358891|Respiratory Health|respiratory health
5321518|NCT00358891|Neurodevelopment|neurodevelopment
5321519|NCT00358891|Preschool|preschool
5321520|NCT00358891|Influencing Factors|influencing factors
5321521|NCT00358878|Ascites|ascites
5321522|NCT00358878|Liver Cirrhosis|liver cirrhosis
5321523|NCT00358865|Virtual Reality|virtual reality
5321524|NCT00358865|ABI|abi
5321525|NCT00358865|Projected system|projected system
5321526|NCT00358852|Schizophrenia|schizophrenia
5321527|NCT00358852|Mental disorder|mental disorder
5321528|NCT00358852|Schizoaffective disorder|schizoaffective disorder
5321529|NCT00358852|Schizophreniform disorder|schizophreniform disorder
5321530|NCT00358852|Epidemiological study|epidemiological study
5321531|NCT00358852|Scale validation|scale validation
5321532|NCT00358852|Relapse|relapse
5321533|NCT00358852|Short Term Hospitalization|short term hospitalization
5321534|NCT00358852|PRE-COG|pre-cog
5321535|NCT00358852|RISSCH4075|rissch4075
5321536|NCT00358839|Familial hemiplegic migraine type 1 and 2|familial hemiplegic migraine type 1 and 2
5321537|NCT00358839|CGRP|cgrp
5321538|NCT00358839|middle cerebral artery|middle cerebral artery
5321539|NCT00358839|superficial temporal artery|superficial temporal artery
5321540|NCT00358839|headache|headache
5321541|NCT00358839|genotype|genotype
5321542|NCT00358839|Healthy Volunteers|healthy volunteers
5321543|NCT00358813|emesis|emesis
5321544|NCT00358813|renal impairment|renal impairment
5321545|NCT00358813|GW679769|gw679769
5321546|NCT00358813|kidney problems|kidney problems
5321547|NCT00358800|OSAHS and REMStar Auto with C-Flex|osahs and remstar auto with c-flex
5321548|NCT00358787|Supracondylar fracture|supracondylar fracture
5321549|NCT00358787|humerus|humerus
5321550|NCT00358787|ulnar nerve injury|ulnar nerve injury
5321551|NCT00358787|Baumann's angle|baumann's angle
5321657|NCT00358397|Bacteriolytic|bacteriolytic
5321552|NCT00358787|Supracondylar fracture of the humerus|supracondylar fracture of the humerus
5321553|NCT00358774|homeopathic|homeopathic
5321554|NCT00358774|common cold|common cold
5321555|NCT00358774|Research Subjects|research subjects
5321556|NCT00358761|Lone Star Tick|lone star tick
5321557|NCT00358761|Borrelia|borrelia
5321558|NCT00358761|Skin Biopsy|skin biopsy
5321559|NCT00358761|Spirochete|spirochete
5321560|NCT00358761|Erythema Migrans|erythema migrans
5321561|NCT00358761|Southern Tick-Assoicated Rash Illness|southern tick-assoicated rash illness
5321562|NCT00358761|STARI|stari
5321563|NCT00358748|Preterm|preterm
5321564|NCT00358748|hypotension|hypotension
5321565|NCT00358748|steroids|steroids
5321566|NCT00358748|hydrocortisone|hydrocortisone
5321567|NCT00358735|SAFE|safe
5321568|NCT00358735|CECT|cect
5321569|NCT00358735|SFT|sft
5321570|NCT00358735|ActiveCare|activecare
5321571|NCT00358735|ActiveCare+SFT|activecare+sft
5321572|NCT00358735|Deep Vein Thrombosis prevention|deep vein thrombosis prevention
5321573|NCT00358735|Total Hip Replacement|total hip replacement
5321574|NCT00358735|Total Hip Arthroplasty|total hip arthroplasty
5321575|NCT00358735|Low Molecular Weight Heparin|low molecular weight heparin
5321576|NCT00358735|MCS|mcs
5321577|NCT00358709|Cognitive-behavioral therapy|cognitive-behavioral therapy
5321578|NCT00358709|symptom management|symptom management
5321579|NCT00358709|first psychotic episode|first psychotic episode
5321580|NCT00358696|tenofovir|tenofovir
5321581|NCT00358696|didanosine|didanosine
5321583|NCT00358696|hepatitis c virus infection|hepatitis c virus infection
5321584|NCT00358696|treatment|treatment
5321585|NCT00358683|certolizunab pegol|certolizunab pegol
5321586|NCT00358683|long term safety follow-up|long term safety follow-up
5321587|NCT00358683|Chrohn's disease|chrohn's disease
5321588|NCT00358683|infliximab failures patients|infliximab failures patients
5321589|NCT00358683|Greek population|greek population
5321590|NCT00358644|Acute Myeloid Leukemia|acute myeloid leukemia
5321591|NCT00358644|AML|aml
5321592|NCT00358644|Decitabine|decitabine
5321593|NCT00358644|Dacogen|dacogen
5321594|NCT00358644|MGI PHARMA, INC.|mgi pharma, inc.
5321595|NCT00358631|depression|depression
5321596|NCT00358631|antidepressive agents|antidepressive agents
5321597|NCT00358631|controlled clinical trial|controlled clinical trial
5321598|NCT00358618|Randomized|randomized
5321599|NCT00358618|double-blind|double-blind
5321600|NCT00358618|3-group clinical interventional study|3-group clinical interventional study
5321601|NCT00358605|OSAHS|osahs
5321602|NCT00358605|Oral Appliance|oral appliance
5321603|NCT00358605|Hypopnoea Syndrome|hypopnoea syndrome
5321604|NCT00358592|surgical instruments|surgical instruments
5321605|NCT00358592|cesarean section|cesarean section
5321606|NCT00358592|obesity|obesity
5321607|NCT00358579|Vasopressin|vasopressin
5321608|NCT00358579|Adrenaline|adrenaline
5321609|NCT00358579|Survival|survival
5321610|NCT00358579|Return of spontaneous of circulation|return of spontaneous of circulation
5321611|NCT00358566|Advanced|advanced
5321612|NCT00358566|Unresesctable|unresesctable
5321613|NCT00358566|Adenocarcinoma|adenocarcinoma
5321614|NCT00358566|Pancreatic cancer|pancreatic cancer
5321615|NCT00358553|Human Volunteers|human volunteers
5321616|NCT00358540|sarcoma|sarcoma
5321617|NCT00358540|eltrombopag|eltrombopag
5321618|NCT00358540|thrombopoiesis|thrombopoiesis
5321619|NCT00358540|thrombocytopenia|thrombocytopenia
5321620|NCT00358514|Tibia|tibia
5321621|NCT00358514|fracture|fracture
5321622|NCT00358514|compartment syndrome|compartment syndrome
5321623|NCT00358514|fasciotomy|fasciotomy
5321624|NCT00358501|Defibrotide|defibrotide
5321625|NCT00358501|Severe veno occlusive disease|severe veno occlusive disease
5321626|NCT00358501|Multi organ failure|multi organ failure
5321627|NCT00358501|Stem cell transplant|stem cell transplant
5321628|NCT00358501|Liver|liver
5321629|NCT00358501|Regimen related toxicity|regimen related toxicity
5321630|NCT00358501|Day 100 survival|day 100 survival
5321631|NCT00358488|Safety|safety
5321632|NCT00358488|Asthmatic patients|asthmatic patients
5321633|NCT00358488|GSK159797|gsk159797
5321634|NCT00358488|Efficacy|efficacy
5321635|NCT00358475|perennial allergic rhinitis|perennial allergic rhinitis
5321636|NCT00358462|NGU, M genitalium, Ureaplasma, azithromycin, doxycycline|ngu, m genitalium, ureaplasma, azithromycin, doxycycline
5321637|NCT00358449|eosinophilic|eosinophilic
5321638|NCT00358449|mepolizumab|mepolizumab
5321639|NCT00358449|esophagitis|esophagitis
5321640|NCT00358436|COPD|copd
5321641|NCT00358436|Lung function|lung function
5321642|NCT00358436|Exacerbations|exacerbations
5321643|NCT00358436|Quality of Life|quality of life
5321644|NCT00358423|CME|cme
5321645|NCT00358423|Pegaptanib|pegaptanib
5321646|NCT00358423|Post-Surgical Ocular Inflammation|post-surgical ocular inflammation
5321647|NCT00358410|Functional Dyspepsia|functional dyspepsia
5321648|NCT00358410|Barostat|barostat
5321649|NCT00358410|Stomach|stomach
5321650|NCT00358397|Solid Tumor|solid tumor
5321651|NCT00358397|Clostridial|clostridial
5321652|NCT00358397|Spore-forming bacteria|spore-forming bacteria
5321653|NCT00358397|hypoxia|hypoxia
5321654|NCT00358397|anaerobes|anaerobes
5321655|NCT00358397|Clostridium novyi|clostridium novyi
5321658|NCT00358397|Tumor lysis|tumor lysis
5321659|NCT00358397|Necrosis|necrosis
5321660|NCT00358397|Colon Cancer|colon cancer
5321661|NCT00358397|Lung Cancer|lung cancer
5321662|NCT00358397|Sarcoma|sarcoma
5321663|NCT00358397|Bladder Cancer|bladder cancer
5321664|NCT00358397|Rectal Cancer|rectal cancer
5321665|NCT00358397|Gastric Cancer|gastric cancer
5321666|NCT00358397|Pancreatic Cancer|pancreatic cancer
5321667|NCT00358397|Experimental Therapy|experimental therapy
5321668|NCT00358397|Solid Tumors|solid tumors
5321669|NCT00358384|tolerability|tolerability
5321670|NCT00358384|safety|safety
5321671|NCT00358384|angiogenesis|angiogenesis
5321672|NCT00358384|vascular endothelial growth factor|vascular endothelial growth factor
5321673|NCT00358384|pharmacodynamics|pharmacodynamics
5321674|NCT00358384|pharmacokinetics|pharmacokinetics
5321675|NCT00358384|microplaque|microplaque
5321676|NCT00358384|VEGF|vegf
5321677|NCT00358384|GW786034|gw786034
5321678|NCT00358371|bioavailability flucloxacillin|bioavailability flucloxacillin
5321679|NCT00358358|COPD|copd
5321680|NCT00358358|Impulse Oscillometry System|impulse oscillometry system
5321681|NCT00358358|Computerized Tomography|computerized tomography
5321682|NCT00358345|AMD|amd
5321683|NCT00358332|malaria, vaccine, Mali, children|malaria, vaccine, mali, children
5321684|NCT00358319|Valproic Acid (VPA)|valproic acid (vpa)
5321685|NCT00358319|Karenitecin|karenitecin
5321686|NCT00358319|Malignant Melanoma|malignant melanoma
5321687|NCT00358319|Histone deacetylases (HDAC)inhibitors|histone deacetylases (hdac)inhibitors
5321688|NCT00358319|Topoisomerase I inhibitor|topoisomerase i inhibitor
5321689|NCT00358319|metastatic|metastatic
5321690|NCT00358306|Endothelium|endothelium
5321691|NCT00358306|Chronic Kidney Disease|chronic kidney disease
5321692|NCT00358306|Acute Kidney Injury|acute kidney injury
5321693|NCT00358306|Hemolytic-uremic syndrome (HUS)|hemolytic-uremic syndrome (hus)
5321694|NCT00358293|Multiple Sclerosis|multiple sclerosis
5321695|NCT00358293|Spasticity|spasticity
5321696|NCT00358293|Sublingual Tizanidine|sublingual tizanidine
5321697|NCT00358293|Ashworth Scores|ashworth scores
5321698|NCT00358293|Spasticity in Multiple Sclerosis Patients|spasticity in multiple sclerosis patients
5321699|NCT00358280|Patients ASA category I ～ II|patients asa category i ～ ii
5321700|NCT00358280|Unilateral Lower limb surgery|unilateral lower limb surgery
5321701|NCT00358280|Spinal Anesthesia|spinal anesthesia
5321702|NCT00358267|Inferior Turbinate Reduction|inferior turbinate reduction
5321703|NCT00358267|Partial Resection of Inferior Turbinates (PRIT)|partial resection of inferior turbinates (prit)
5321704|NCT00358267|Radiofrequency Ablation (RFA)|radiofrequency ablation (rfa)
5321705|NCT00358267|NOSE scale|nose scale
5321706|NCT00358267|Nasal Obstruction|nasal obstruction
5321707|NCT00358241|Nerve block, postoperative pain, analgesia|nerve block, postoperative pain, analgesia
5321708|NCT00358228|Smoking cessation|smoking cessation
5321709|NCT00358228|Abstinence|abstinence
5321710|NCT00358215|Survival study|survival study
5321711|NCT00358215|morbidity and mortality|morbidity and mortality
5321712|NCT00358215|heart failure hospitalization|heart failure hospitalization
5321713|NCT00358215|all-cause death|all-cause death
5321714|NCT00358215|patient-reported outcomes|patient-reported outcomes
5321715|NCT00358215|Kansas City Cardiomyopathy questionnaire|kansas city cardiomyopathy questionnaire
5321716|NCT00358215|anemia treatment|anemia treatment
5321717|NCT00358202|intramuscular antibiotics|intramuscular antibiotics
5321718|NCT00358202|nursing home acquired pneumonia|nursing home acquired pneumonia
5321719|NCT00358202|nhap|nhap
5321720|NCT00358202|pharmacoeconomics|pharmacoeconomics
5321721|NCT00358202|cefepime|cefepime
5321722|NCT00358202|ceftriaxone|ceftriaxone
5321723|NCT00358189|deep brain stimulation|deep brain stimulation
5321724|NCT00358189|gait|gait
5321725|NCT00358189|manual dexterity|manual dexterity
5321726|NCT00358189|parkinson's disease|parkinson's disease
5321727|NCT00358176|Treatment osteoporosis postmenopausal|treatment osteoporosis postmenopausal
5321728|NCT00358163|angiogenesis|angiogenesis
5321729|NCT00358163|taxane|taxane
5321730|NCT00358163|tyrosine kinase|tyrosine kinase
5321731|NCT00358163|pharmacokinetics|pharmacokinetics
5321732|NCT00358163|Vatalanib|vatalanib
5321733|NCT00358163|Taxol|taxol
5321734|NCT00358150|Type 1 Gaucher Disease|type 1 gaucher disease
5321735|NCT00358150|Glucocerebrosidase Deficiency Disease|glucocerebrosidase deficiency disease
5321736|NCT00358137|Blood Pressure, High|blood pressure, high
5321737|NCT00358111|high-grade disease|high-grade disease
5321738|NCT00358111|Cervical examination|cervical examination
5321739|NCT00358111|targeting biopsies|targeting biopsies
5321740|NCT00358111|dysplasia|dysplasia
5321741|NCT00358111|cancer|cancer
5321742|NCT00358098|PET|pet
5321743|NCT00358098|hormone positive breast cancer|hormone positive breast cancer
5321744|NCT00358085|Endovascular|endovascular
5321745|NCT00358085|Vascular Surgical Procedures|vascular surgical procedures
5321746|NCT00358085|Aneurysm|aneurysm
5321747|NCT00358085|Expertise Based Methodology|expertise based methodology
5321748|NCT00358072|Acute lymphoblastic leukemia|acute lymphoblastic leukemia
5321749|NCT00358072|Adult patients|adult patients
5321750|NCT00358072|Minimal residual disease|minimal residual disease
5321751|NCT00358072|Risk-oriented therapy|risk-oriented therapy
5321752|NCT00358059|diabetes mellitus|diabetes mellitus
5321753|NCT00358059|adolescence|adolescence
5321754|NCT00358059|adherence|adherence
5321755|NCT00358059|glycemic control|glycemic control
5321756|NCT00358059|adaptation|adaptation
5321757|NCT00358059|communication|communication
5321758|NCT00358046|Hyperphosphatemia|hyperphosphatemia
5321759|NCT00358046|Chronic kidney disease|chronic kidney disease
5321760|NCT00358046|Dialysis|dialysis
5321761|NCT00358046|Hyperphosphatemia in CKD patients on dialysis|hyperphosphatemia in ckd patients on dialysis
5321762|NCT00358020|MYELOMA, THALIDOMIDE, BORTEZOMIB|myeloma, thalidomide, bortezomib
5321763|NCT00358007|Kilovoltage Imaging|kilovoltage imaging
5321764|NCT00358007|Cone-beam CT|cone-beam ct
5321765|NCT00358007|CBCT|cbct
5321766|NCT00358007|radiation therapy|radiation therapy
5321767|NCT00358007|head and neck neoplasms|head and neck neoplasms
5321768|NCT00357994|carbidopa|carbidopa
5321769|NCT00357994|levodopa-carbidopa|levodopa-carbidopa
5321770|NCT00357994|levodopa|levodopa
5321771|NCT00357994|levodopa/carbidopa suspension|levodopa/carbidopa suspension
5321772|NCT00357994|dyskinesia|dyskinesia
5321773|NCT00357994|Duodopa|duodopa
5321774|NCT00357994|levodopa-carbidopa intestinal gel|levodopa-carbidopa intestinal gel
5321775|NCT00357994|Severe Motor Fluctuations|severe motor fluctuations
5321776|NCT00357994|DUOPA|duopa
5321777|NCT00357981|Contraceptive patch|contraceptive patch
5321778|NCT00357981|menstruation|menstruation
5321779|NCT00357981|economics|economics
5321780|NCT00357942|Morphine|morphine
5321781|NCT00357942|Mouthwash|mouthwash
5321782|NCT00357942|Mucositis|mucositis
5321783|NCT00357942|Pain|pain
5321784|NCT00357942|Cancer|cancer
5321785|NCT00357942|Child|child
5321786|NCT00357942|Adolescent|adolescent
5321787|NCT00357929|permissive hypercarbia|permissive hypercarbia
5321788|NCT00357929|weaning from mechanical ventilation|weaning from mechanical ventilation
5321789|NCT00357916|PEP005|pep005
5321790|NCT00357916|Safety|safety
5321791|NCT00357903|Rheumatoid Arthritis, Etanercept, Long-term Safety, Enbrel|rheumatoid arthritis, etanercept, long-term safety, enbrel
5321792|NCT00357890|type 1 diabetes|type 1 diabetes
5321793|NCT00357890|diabetes|diabetes
5321794|NCT00357890|new onset|new onset
5321795|NCT00357890|CSII|csii
5321796|NCT00357890|insulin glargine|insulin glargine
5321797|NCT00357890|insulin sensitivity|insulin sensitivity
5321798|NCT00357890|beta cell function|beta cell function
5321799|NCT00357890|beta cell preservation|beta cell preservation
5321800|NCT00357851|pancreatitis, blood loss|pancreatitis, blood loss
5321801|NCT00357838|normal healthy women|normal healthy women
5321802|NCT00357812|Herpes Simplex Virus Type 1|herpes simplex virus type 1
5321803|NCT00357812|Herpes Simplex Keratitis|herpes simplex keratitis
5321804|NCT00357812|Cornea|cornea
5321805|NCT00357812|Dendretic Ulcer|dendretic ulcer
5321806|NCT00357812|In vivo Confocal Microscopy|in vivo confocal microscopy
5321807|NCT00357812|Nested Multi-plex PCR|nested multi-plex pcr
5321808|NCT00357812|Monoclonal Antibody|monoclonal antibody
5321809|NCT00357812|Glycoprotein D|glycoprotein d
5321810|NCT00357812|Glycoprotein C|glycoprotein c
5321811|NCT00357799|Venipuncture|venipuncture
5321812|NCT00357799|Randomized Controlled Trial|randomized controlled trial
5321813|NCT00357799|Intravenous Access|intravenous access
5321814|NCT00357799|Children|children
5321815|NCT00357799|Emergency Department Nursing|emergency department nursing
5321816|NCT00357799|VeinViewer|veinviewer
5321817|NCT00357799|Pediatrics|pediatrics
5321818|NCT00357799|Emergency Nursing|emergency nursing
5321819|NCT00357786|Lysosomal Disease|lysosomal disease
5321820|NCT00357786|Glycolipid|glycolipid
5321821|NCT00357786|Stroke|stroke
5321822|NCT00357786|Peripheral Neuropathy|peripheral neuropathy
5321823|NCT00357786|Storage Disorder|storage disorder
5321824|NCT00357760|Metastatic Renal Cell Carcinoma|metastatic renal cell carcinoma
5321825|NCT00357760|VEGF Trap|vegf trap
5321826|NCT00357747|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5321827|NCT00357734|lung cancer|lung cancer
5321828|NCT00357734|breast cancer|breast cancer
5321829|NCT00357695|Praxis|praxis
5321830|NCT00357695|Grasping|grasping
5321831|NCT00357695|Premotor Cortex|premotor cortex
5321832|NCT00357695|Visuo-Motor Integration|visuo-motor integration
5321833|NCT00357695|Motor Imagination|motor imagination
5321834|NCT00357682|esophageal cancer|esophageal cancer
5321835|NCT00357682|Barrett's esophagus|barrett's esophagus
5321836|NCT00357669|Unverricht-Lundborg disease|unverricht-lundborg disease
5321837|NCT00357669|Baltic myoclonus|baltic myoclonus
5321838|NCT00357669|progressive myoclonic epilepsies|progressive myoclonic epilepsies
5321839|NCT00357669|myoclonus|myoclonus
5321840|NCT00357669|brivaracetam|brivaracetam
5321841|NCT00357656|Hemophilia A (severe or moderately severe)|hemophilia a (severe or moderately severe)
5321842|NCT00357643|calcium|calcium
5321843|NCT00357643|vitamin D|vitamin d
5321844|NCT00357643|bone loss|bone loss
5321845|NCT00357630|adenocarcinoma of unknown primary|adenocarcinoma of unknown primary
5321846|NCT00357630|newly diagnosed carcinoma of unknown primary|newly diagnosed carcinoma of unknown primary
5321847|NCT00357630|undifferentiated carcinoma of unknown primary|undifferentiated carcinoma of unknown primary
5321848|NCT00357630|pain|pain
5322079|NCT00357084|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5321849|NCT00357617|stage I squamous cell carcinoma of the hypopharynx|stage i squamous cell carcinoma of the hypopharynx
5321850|NCT00357617|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
5321851|NCT00357617|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
5321852|NCT00357617|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5321853|NCT00357617|stage I squamous cell carcinoma of the larynx|stage i squamous cell carcinoma of the larynx
5321854|NCT00357617|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
5321855|NCT00357617|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
5321856|NCT00357617|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5321857|NCT00357617|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
5321858|NCT00357617|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
5321859|NCT00357617|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
5321860|NCT00357617|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5321861|NCT00357617|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
5321862|NCT00357617|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
5321863|NCT00357617|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
5321864|NCT00357617|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5321865|NCT00357617|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
5321866|NCT00357617|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
5321867|NCT00357617|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
5321868|NCT00357617|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
5321869|NCT00357604|HIV|hiv
5321870|NCT00357604|Protease Inhibitor|protease inhibitor
5321871|NCT00357591|Heart Failure|heart failure
5321872|NCT00357591|Acute Decompensation|acute decompensation
5321873|NCT00357591|Chronic Heart Failure|chronic heart failure
5321874|NCT00357578|Macrophages|macrophages
5321875|NCT00357578|Biopsy|biopsy
5321876|NCT00357578|Genetic Analysis|genetic analysis
5321877|NCT00357578|Geographic Atrophy|geographic atrophy
5321878|NCT00357578|Choroidal Neovascularization|choroidal neovascularization
5321879|NCT00357578|Fibroblast|fibroblast
5321880|NCT00357578|Disciform|disciform
5321881|NCT00357578|Age-Related Macular Degeneration|age-related macular degeneration
5321882|NCT00357565|MDS|mds
5321883|NCT00357565|AML|aml
5321884|NCT00357552|Treatment Experienced|treatment experienced
5321885|NCT00357526|vaginal ring|vaginal ring
5321886|NCT00357526|Oral contraceptive pills|oral contraceptive pills
5321887|NCT00357526|Teenagers|teenagers
5321888|NCT00357526|Young women|young women
5321889|NCT00357526|Patient satisfaction|patient satisfaction
5321890|NCT00357513|Cerebrovascular Disease|cerebrovascular disease
5321891|NCT00357513|Gene Chip|gene chip
5321892|NCT00357513|Inflammation|inflammation
5321893|NCT00357513|Pathophysiology Stroke|pathophysiology stroke
5321894|NCT00357513|Stroke Genomics|stroke genomics
5321895|NCT00357513|Stroke Subtypes|stroke subtypes
5321896|NCT00357513|Neuroimaging|neuroimaging
5321897|NCT00357513|Clinical Outcome Measures|clinical outcome measures
5321898|NCT00357513|Stroke|stroke
5321899|NCT00357513|CVA|cva
5321900|NCT00357513|Healthy Volunteer|healthy volunteer
5321901|NCT00357513|HV|hv
5321902|NCT00357513|Normal Control|normal control
5321903|NCT00357500|Metronomic|metronomic
5321904|NCT00357500|antiangiogenic|antiangiogenic
5321905|NCT00357487|Sentinel lymph node|sentinel lymph node
5321906|NCT00357487|Breast cancer|breast cancer
5321907|NCT00357487|Lymphoscintigraphy|lymphoscintigraphy
5321908|NCT00357487|Probe|probe
5321909|NCT00357487|Operative gamma camera|operative gamma camera
5321910|NCT00357487|Breast cancer and sentinel lymph node biopsy|breast cancer and sentinel lymph node biopsy
5321911|NCT00357487|Use of lymphoscintigraphy|use of lymphoscintigraphy
5321912|NCT00357487|Use of intraoperative gamma camera|use of intraoperative gamma camera
5321913|NCT00357487|Use of intraoperative probe|use of intraoperative probe
5321914|NCT00357474|HCC, TACE, PEIT|hcc, tace, peit
5321915|NCT00357461|stage IV melanoma|stage iv melanoma
5321916|NCT00357461|recurrent melanoma|recurrent melanoma
5321917|NCT00357435|Cornea|cornea
5321918|NCT00357435|Genetics|genetics
5321919|NCT00357435|Dystrophy|dystrophy
5321920|NCT00357435|Gene|gene
5321921|NCT00357435|Mapping|mapping
5321922|NCT00357435|Molecular|molecular
5321923|NCT00357435|Bietti|bietti
5321924|NCT00357435|Fleck|fleck
5321925|NCT00357435|Positional Cloning|positional cloning
5321926|NCT00357435|Linkage|linkage
5321927|NCT00357422|HCC, operation, percutaneous ethanol injection|hcc, operation, percutaneous ethanol injection
5321928|NCT00357409|GABA|gaba
5321929|NCT00357409|Occipital|occipital
5321930|NCT00357409|Vision|vision
5321931|NCT00357409|Plasticity|plasticity
5321932|NCT00357409|MRS|mrs
5321933|NCT00357409|Blind|blind
5322169|NCT00356733|cardiorenal syndrome|cardiorenal syndrome
5321934|NCT00357396|metastatic Ewing sarcoma/peripheral primitive neuroectodermal tumor|metastatic ewing sarcoma/peripheral primitive neuroectodermal tumor
5321935|NCT00357396|recurrent Ewing sarcoma/peripheral primitive neuroectodermal tumor|recurrent ewing sarcoma/peripheral primitive neuroectodermal tumor
5321936|NCT00357357|Alzheimer's disease|alzheimer's disease
5321937|NCT00357344|Obesity|obesity
5321938|NCT00357344|Gray Matter|gray matter
5321939|NCT00357344|Eating Behavior|eating behavior
5321940|NCT00357344|Brain MRI|brain mri
5321941|NCT00357344|Body Weight Regulation|body weight regulation
5321942|NCT00357331|postmenopausal osteopenia|postmenopausal osteopenia
5321943|NCT00357331|treatment|treatment
5321944|NCT00357331|bone loss|bone loss
5321946|NCT00357266|Interleukin 2|interleukin 2
5321947|NCT00357266|Interleukin 2 Receptor|interleukin 2 receptor
5321948|NCT00357266|Microarrays|microarrays
5321949|NCT00357266|Genetic Expression|genetic expression
5321950|NCT00357266|Daclizumab|daclizumab
5321951|NCT00357266|HAT|hat
5321952|NCT00357266|Zenapax|zenapax
5321953|NCT00357266|Proteins|proteins
5321954|NCT00357266|RNA|rna
5321955|NCT00357266|Ocular Inflammatory Disease|ocular inflammatory disease
5321956|NCT00357253|untreated childhood brain stem glioma|untreated childhood brain stem glioma
5321957|NCT00357253|childhood high-grade cerebral astrocytoma|childhood high-grade cerebral astrocytoma
5321958|NCT00357253|untreated childhood cerebellar astrocytoma|untreated childhood cerebellar astrocytoma
5321959|NCT00357240|Protease inhibitor|protease inhibitor
5321960|NCT00357227|Atrial fibrillation|atrial fibrillation
5321961|NCT00357227|Stroke|stroke
5321962|NCT00357227|Vascular Dementia|vascular dementia
5321963|NCT00357227|Mild Cognitive Impairment|mild cognitive impairment
5321964|NCT00357214|bone turnover|bone turnover
5321965|NCT00357214|calcium excretion|calcium excretion
5321966|NCT00357214|nitrogen excretion|nitrogen excretion
5321967|NCT00357214|potassium bicarbonate|potassium bicarbonate
5321968|NCT00357214|muscle loss|muscle loss
5321969|NCT00357214|muscle atrophy|muscle atrophy
5321970|NCT00357214|bone loss|bone loss
5321971|NCT00357123|abdominal sepsis|abdominal sepsis
5321972|NCT00357123|sepsis|sepsis
5321973|NCT00357123|rosuvastatin|rosuvastatin
5321974|NCT00357110|Breast neoplasms|breast neoplasms
5321975|NCT00357110|breast cancer|breast cancer
5321976|NCT00357110|early breast cancer|early breast cancer
5321977|NCT00357110|oncology|oncology
5321978|NCT00357110|cancer|cancer
5321979|NCT00357110|breast cancer micrometastasis|breast cancer micrometastasis
5321980|NCT00357110|fulvestrant|fulvestrant
5321981|NCT00357097|randomised|randomised
5321982|NCT00357097|ropinirole|ropinirole
5321983|NCT00357097|depression|depression
5321984|NCT00357097|RLS|rls
5321985|NCT00357097|placebo|placebo
5321986|NCT00357097|mood|mood
5321987|NCT00357097|double-blind|double-blind
5321988|NCT00357097|restless legs syndrome|restless legs syndrome
5321989|NCT00357097|germany|germany
5321990|NCT00357084|graft versus host disease|graft versus host disease
5321991|NCT00357084|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5321992|NCT00357084|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5321993|NCT00357084|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5321994|NCT00357084|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5321995|NCT00357084|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5321996|NCT00357084|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5321997|NCT00357084|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5321998|NCT00357084|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5321999|NCT00357084|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
5322000|NCT00357084|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5322001|NCT00357084|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
5322002|NCT00357084|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
5322003|NCT00357084|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
5322004|NCT00357084|chronic eosinophilic leukemia|chronic eosinophilic leukemia
5322005|NCT00357084|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
5322006|NCT00357084|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5322007|NCT00357084|chronic neutrophilic leukemia|chronic neutrophilic leukemia
5322008|NCT00357084|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5322009|NCT00357084|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5322010|NCT00357084|disseminated neuroblastoma|disseminated neuroblastoma
5322011|NCT00357084|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5322012|NCT00357084|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
5322013|NCT00357084|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
5322014|NCT00357084|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5322015|NCT00357084|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
5322016|NCT00357084|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5322017|NCT00357084|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
5322018|NCT00357084|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
5322019|NCT00357084|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
5322020|NCT00357084|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
5322021|NCT00357084|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5322022|NCT00357084|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5322023|NCT00357084|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5322024|NCT00357084|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5322025|NCT00357084|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
5322026|NCT00357084|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
5322027|NCT00357084|poor prognosis metastatic gestational trophoblastic tumor|poor prognosis metastatic gestational trophoblastic tumor
5322028|NCT00357084|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
5322029|NCT00357084|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5322030|NCT00357084|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5322031|NCT00357084|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5322032|NCT00357084|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5322033|NCT00357084|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5322034|NCT00357084|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5322035|NCT00357084|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5322036|NCT00357084|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5322037|NCT00357084|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5322038|NCT00357084|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5322039|NCT00357084|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
5322040|NCT00357084|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5322041|NCT00357084|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5322042|NCT00357084|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
5322043|NCT00357084|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
5322044|NCT00357084|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
5322045|NCT00357084|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
5322046|NCT00357084|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5322047|NCT00357084|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5322048|NCT00357084|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5322049|NCT00357084|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5322050|NCT00357084|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5322051|NCT00357084|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5322052|NCT00357084|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5322053|NCT00357084|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5322054|NCT00357084|recurrent Wilms tumor and other childhood kidney tumors|recurrent wilms tumor and other childhood kidney tumors
5322055|NCT00357084|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5322056|NCT00357084|refractory hairy cell leukemia|refractory hairy cell leukemia
5322057|NCT00357084|refractory multiple myeloma|refractory multiple myeloma
5322058|NCT00357084|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5322059|NCT00357084|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5322060|NCT00357084|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5322061|NCT00357084|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5322062|NCT00357084|stage I multiple myeloma|stage i multiple myeloma
5322063|NCT00357084|stage II multiple myeloma|stage ii multiple myeloma
5322064|NCT00357084|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
5322065|NCT00357084|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5322066|NCT00357084|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5322067|NCT00357084|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5322068|NCT00357084|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5322069|NCT00357084|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5322070|NCT00357084|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5322071|NCT00357084|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5322072|NCT00357084|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5322073|NCT00357084|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5322074|NCT00357084|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5322075|NCT00357084|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5322076|NCT00357084|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5322077|NCT00357084|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5322078|NCT00357084|stage III multiple myeloma|stage iii multiple myeloma
5322474|NCT00355576|Selection|selection
5322080|NCT00357084|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
5322081|NCT00357084|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5322082|NCT00357084|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5322083|NCT00357084|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5322084|NCT00357084|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5322085|NCT00357084|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5322086|NCT00357084|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5322087|NCT00357084|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5322088|NCT00357084|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5322089|NCT00357084|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5322090|NCT00357084|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5322091|NCT00357084|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5322092|NCT00357084|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5322093|NCT00357084|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5322094|NCT00357084|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5322095|NCT00357084|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
5322096|NCT00357084|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
5322097|NCT00357071|Autoimmunity|autoimmunity
5322098|NCT00357071|Cell Mediated Immunity|cell mediated immunity
5322099|NCT00357071|S Antigen|s antigen
5322100|NCT00357071|Cell Proliferation|cell proliferation
5322101|NCT00357071|Uveitis|uveitis
5322102|NCT00357071|Cell Proliferation Assays|cell proliferation assays
5322103|NCT00357071|Auto-Antibody|auto-antibody
5322104|NCT00357071|Auto-Antigens|auto-antigens
5322105|NCT00357058|Deafferentiation-Induced Plasticity|deafferentiation-induced plasticity
5322106|NCT00357058|fMRI|fmri
5322107|NCT00357058|Cortical Reorganization|cortical reorganization
5322108|NCT00357058|Tactile Performance|tactile performance
5322109|NCT00357058|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
5322110|NCT00357058|Tactile Discrimination|tactile discrimination
5322111|NCT00357058|Plasticity|plasticity
5322112|NCT00357058|Healthy Volunteer|healthy volunteer
5322113|NCT00357058|HV|hv
5322114|NCT00357058|Normal Control|normal control
5322115|NCT00357006|Schizophrenia|schizophrenia
5322116|NCT00357006|Estrogen|estrogen
5322117|NCT00357006|Psychosis|psychosis
5322118|NCT00356993|nicotine replacement therapy|nicotine replacement therapy
5322119|NCT00356993|smoking cessation|smoking cessation
5322120|NCT00356980|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5322121|NCT00356967|smoking|smoking
5322122|NCT00356967|cessation|cessation
5322123|NCT00356967|tobacco|tobacco
5322124|NCT00356967|smoking cessation|smoking cessation
5322125|NCT00356967|tobacco use cessation|tobacco use cessation
5322126|NCT00356954|Kidney failure|kidney failure
5322127|NCT00356954|Contrast media|contrast media
5322128|NCT00356954|Antioxidant|antioxidant
5322129|NCT00356954|Prevention|prevention
5322130|NCT00356941|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5322131|NCT00356941|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
5322132|NCT00356941|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5322133|NCT00356941|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5322134|NCT00356928|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5322135|NCT00356928|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5322136|NCT00356928|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5322137|NCT00356928|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5322138|NCT00356928|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5322139|NCT00356915|Nail fungus|nail fungus
5322140|NCT00356915|Onychomycosis|onychomycosis
5322141|NCT00356915|Itraconazole|itraconazole
5322142|NCT00356915|Toenail|toenail
5322143|NCT00356863|Intervention|intervention
5322144|NCT00356863|Awareness|awareness
5322145|NCT00356863|Cardiac Rehabilitation (CR)|cardiac rehabilitation (cr)
5322146|NCT00356863|Coronary Artery Patients|coronary artery patients
5322147|NCT00356863|Coronary Artery Bypass Grafting Surgery (CABG)|coronary artery bypass grafting surgery (cabg)
5322148|NCT00356824|Child|child
5322149|NCT00356811|Lapatinib|lapatinib
5322150|NCT00356811|Metastatic breast cancer|metastatic breast cancer
5322151|NCT00356811|Paclitaxel|paclitaxel
5322152|NCT00356811|ErbB2-amplification|erbb2-amplification
5322153|NCT00356811|GW572016|gw572016
5322154|NCT00356798|pandemic|pandemic
5322155|NCT00356798|influenza|influenza
5322156|NCT00356798|H5N1|h5n1
5322157|NCT00356798|vaccine|vaccine
5322158|NCT00356785|lifestyle|lifestyle
5322159|NCT00356785|diet|diet
5322160|NCT00356785|exercise|exercise
5322161|NCT00356785|physical activity|physical activity
5322162|NCT00356785|obesity|obesity
5322163|NCT00356759|warfarin|warfarin
5322164|NCT00356759|prothrombin time|prothrombin time
5322165|NCT00356759|monitoring|monitoring
5322166|NCT00356746|Perioperative inflammatory response|perioperative inflammatory response
5322167|NCT00356746|General anesthesia|general anesthesia
5322168|NCT00356746|Toll-Like Receptors|toll-like receptors
5322170|NCT00356733|erythropoietin|erythropoietin
5322171|NCT00356733|Heart Failure, Congestive|heart failure, congestive
5322172|NCT00356733|Renal Insufficiency, Chronic|renal insufficiency, chronic
5322173|NCT00356707|Body Mass Index|body mass index
5322174|NCT00356681|AMG 706|amg 706
5322175|NCT00356681|Paclitaxel|paclitaxel
5322176|NCT00356681|Metastatic Breast Cancer|metastatic breast cancer
5322177|NCT00356681|Antiangiogenic|antiangiogenic
5322178|NCT00356681|Bevacizumab|bevacizumab
5322179|NCT00356668|HFNC|hfnc
5322180|NCT00356668|NCPAP|ncpap
5322181|NCT00356668|nasal continuous positive airway pressure|nasal continuous positive airway pressure
5322182|NCT00356668|humidified high flow nasal cannula|humidified high flow nasal cannula
5322183|NCT00356668|esophageal pressure|esophageal pressure
5322184|NCT00356668|gas flow|gas flow
5322185|NCT00356655|Depressive disorder|depressive disorder
5322186|NCT00356655|Patient compliance|patient compliance
5322187|NCT00356655|Antidepressive Agents|antidepressive agents
5322188|NCT00356655|Patient education|patient education
5322189|NCT00356655|Community pharmacy services|community pharmacy services
5322190|NCT00356655|Counseling|counseling
5322191|NCT00356642|PK|pk
5322192|NCT00356642|GW842470X|gw842470x
5322193|NCT00356642|safety|safety
5322194|NCT00356642|tolerability|tolerability
5322195|NCT00356642|PD|pd
5322196|NCT00356642|Atopic Dermatitis|atopic dermatitis
5322197|NCT00356629|bronchopulmonary ignition|bronchopulmonary ignition
5322198|NCT00356629|condensate of exhaled air|condensate of exhaled air
5322199|NCT00356629|Mucoviscidosis|mucoviscidosis
5322200|NCT00356629|Asthma|asthma
5322201|NCT00356616|Antiretroviral treatment|antiretroviral treatment
5322202|NCT00356616|virological failure|virological failure
5322203|NCT00356616|HIV|hiv
5322204|NCT00356603|Migraine|migraine
5322205|NCT00356603|Sumatriptan Succinate Injection Kit|sumatriptan succinate injection kit
5322206|NCT00356603|Cluster Headache|cluster headache
5322207|NCT00356603|self-injection|self-injection
5322208|NCT00356590|Rheumatoid Arthritis|rheumatoid arthritis
5322209|NCT00356590|Etanercept|etanercept
5322210|NCT00356590|Long-term Safety|long-term safety
5322211|NCT00356590|Enbrel|enbrel
5322212|NCT00356564|Prophylaxis for hepatitis B disease|prophylaxis for hepatitis b disease
5322213|NCT00356551|Teen pregnancy|teen pregnancy
5322214|NCT00356551|Family strengthening|family strengthening
5322215|NCT00356551|Substance abuse prevention|substance abuse prevention
5322216|NCT00356551|Depression prevention|depression prevention
5322217|NCT00356551|Parent involvement|parent involvement
5322218|NCT00356512|Phosphate|phosphate
5322219|NCT00356512|Vitamin D|vitamin d
5322220|NCT00356512|Hypoparathyroidism|hypoparathyroidism
5322221|NCT00356512|Phosphatonin|phosphatonin
5322222|NCT00356512|Clamp|clamp
5322223|NCT00356486|Chronic Hepatitis C|chronic hepatitis c
5322224|NCT00356486|Co-infection|co-infection
5322225|NCT00356486|Induction dose|induction dose
5322226|NCT00356486|HIV|hiv
5322227|NCT00356486|HIV Infections|hiv infections
5322228|NCT00356473|Rheumatoid arthritis|rheumatoid arthritis
5322229|NCT00356473|Atherosclerosis|atherosclerosis
5322230|NCT00356473|High density lipoprotein (HDL) cholesterol|high density lipoprotein (hdl) cholesterol
5322231|NCT00356473|Statins|statins
5322232|NCT00356473|HDL anti-inflammatory properties|hdl anti-inflammatory properties
5322233|NCT00356473|Atorvastatin|atorvastatin
5322234|NCT00356434|deep vein thrombosis|deep vein thrombosis
5322235|NCT00356434|thrombophilia|thrombophilia
5322236|NCT00356434|pregnancy|pregnancy
5322237|NCT00356434|thromboprophylaxis|thromboprophylaxis
5322238|NCT00356434|decreased mobility|decreased mobility
5322239|NCT00356434|hospitalization|hospitalization
5322240|NCT00356408|CDP870|cdp870
5322241|NCT00356408|certolizumab pegol|certolizumab pegol
5322242|NCT00356408|Crohn's Disease|crohn's disease
5322243|NCT00356395|endothelial function, insulin resistance, adipocytokines|endothelial function, insulin resistance, adipocytokines
5322244|NCT00356382|probiotic|probiotic
5322245|NCT00356382|Lactobacillus (L.) casei|lactobacillus (l.) casei
5322246|NCT00356382|cultured dairy drink|cultured dairy drink
5322247|NCT00356382|Health|health
5322248|NCT00356369|Immunogenicity|immunogenicity
5322249|NCT00356369|Healthy|healthy
5322250|NCT00356369|Persistence|persistence
5322251|NCT00356369|Meningococcal vaccine|meningococcal vaccine
5322252|NCT00356369|Non-inferiority|non-inferiority
5322253|NCT00356369|Meningococcal A C W Y Diseases|meningococcal a c w y diseases
5322254|NCT00356369|meningococcal serogroups A, C, W & Y diseases|meningococcal serogroups a, c, w & y diseases
5322255|NCT00356343|NMES|nmes
5322256|NCT00356343|Cerebral Palsy|cerebral palsy
5322257|NCT00356343|Spastic Diplegia|spastic diplegia
5322258|NCT00356343|Electrical Stimulation|electrical stimulation
5322259|NCT00356343|Children|children
5322260|NCT00356330|pacemaker|pacemaker
5322261|NCT00356330|magnetic resonance imaging|magnetic resonance imaging
5322262|NCT00356330|safety|safety
5322263|NCT00356317|Culture|culture
5322264|NCT00356317|Family|family
5322265|NCT00356317|Therapy|therapy
5322266|NCT00356304|Dysthymia|dysthymia
5322267|NCT00356304|Major Depression|major depression
5322268|NCT00356304|Hispanics|hispanics
5322269|NCT00356304|Latinos|latinos
5322475|NCT00355576|ALS|als
5322270|NCT00356304|Motivational Interviewing|motivational interviewing
5322271|NCT00356304|Adherence|adherence
5322272|NCT00356291|HIV|hiv
5322273|NCT00356291|AIDS|aids
5322274|NCT00356291|Prevention|prevention
5322275|NCT00356291|Serious Mental Illness|serious mental illness
5322276|NCT00356278|D-Cycloserine|d-cycloserine
5322277|NCT00356278|Virtual Reality|virtual reality
5322278|NCT00356278|Exposure Therapy|exposure therapy
5322279|NCT00356278|Veterans|veterans
5322280|NCT00356278|Cognitive Behavior Therapy|cognitive behavior therapy
5322281|NCT00356278|Translational Research|translational research
5322282|NCT00356265|Blood Pressure Nitric Oxide|blood pressure nitric oxide
5322284|NCT00356265|Phenylephrine|phenylephrine
5322285|NCT00356265|Vasoreactivity|vasoreactivity
5322286|NCT00356265|Blood Pressure|blood pressure
5322287|NCT00356239|Defibrillators, Implantable|defibrillators, implantable
5322288|NCT00356239|Heart Failure, Congestive|heart failure, congestive
5322289|NCT00356239|Magnetic Resonance Imaging|magnetic resonance imaging
5322290|NCT00356226|norepinephrine|norepinephrine
5322291|NCT00356226|renin|renin
5322292|NCT00356226|aldosterone|aldosterone
5322293|NCT00356226|hemodynamics|hemodynamics
5322294|NCT00356226|spironolactone|spironolactone
5322295|NCT00356213|morbid obesity|morbid obesity
5322296|NCT00356213|bariatric surgery|bariatric surgery
5322297|NCT00356213|sleeve-gastrectomy|sleeve-gastrectomy
5322298|NCT00356213|Roux-Y-gastric bypass|roux-y-gastric bypass
5322299|NCT00356213|outcome|outcome
5322300|NCT00356213|weight loss|weight loss
5322301|NCT00356174|Food Allergy|food allergy
5322302|NCT00356161|colorectal neoplasms|colorectal neoplasms
5322303|NCT00356161|hepatocellular carcinoma|hepatocellular carcinoma
5322304|NCT00356161|gallbladder cancer|gallbladder cancer
5322305|NCT00356161|bile duct cancer|bile duct cancer
5322306|NCT00356161|hepatic arterial infusion|hepatic arterial infusion
5322307|NCT00356148|breast cancer|breast cancer
5322308|NCT00356148|breast surgery|breast surgery
5322309|NCT00356148|clean wound|clean wound
5322310|NCT00356148|overweight|overweight
5322311|NCT00356148|prophylaxis|prophylaxis
5322312|NCT00356148|antibiotics|antibiotics
5322313|NCT00356122|Lung|lung
5322314|NCT00356122|non-small cell|non-small cell
5322315|NCT00356122|chemotherapy|chemotherapy
5322316|NCT00356122|tumor|tumor
5322317|NCT00356122|advanced|advanced
5322318|NCT00356122|recurrent|recurrent
5322319|NCT00356122|metastatic|metastatic
5322320|NCT00356122|Non-Small Cell Lung Cancer (NSCLC)|non-small cell lung cancer (nsclc)
5322321|NCT00356070|Attention Deficit Hyperactivity Disorder, treatment,|attention deficit hyperactivity disorder, treatment,
5322322|NCT00356070|Strattera,|strattera,
5322323|NCT00356070|rehabilitation|rehabilitation
5322324|NCT00356057|atrial fibrillation|atrial fibrillation
5322325|NCT00356057|AV node ablation|av node ablation
5322326|NCT00356057|pacemaker|pacemaker
5322327|NCT00356057|congestive heart failure|congestive heart failure
5322328|NCT00356044|Transradial access|transradial access
5322329|NCT00356044|Femoral access|femoral access
5322330|NCT00356044|Femoral vs radial access|femoral vs radial access
5322331|NCT00356031|Avastin|avastin
5322332|NCT00356018|Epilepsy|epilepsy
5322333|NCT00356018|Compliance|compliance
5322334|NCT00356005|falciparum malaria|falciparum malaria
5322335|NCT00356005|therapy|therapy
5322336|NCT00356005|azithromycin|azithromycin
5322337|NCT00356005|artesunate|artesunate
5322338|NCT00356005|Coartem|coartem
5322339|NCT00356005|Bangladesh|bangladesh
5322340|NCT00355992|Myocardial Ischemia|myocardial ischemia
5322341|NCT00355992|Chest pain|chest pain
5322342|NCT00355992|Ischemia Modified Albumin|ischemia modified albumin
5322343|NCT00355992|Acute Coronary Syndrome|acute coronary syndrome
5322344|NCT00355979|Obesity, intragastric balloon, Pharmacotherapy|obesity, intragastric balloon, pharmacotherapy
5322345|NCT00355966|Premature rupture of membranes|premature rupture of membranes
5322346|NCT00355966|Induction of labour with Misoprostol|induction of labour with misoprostol
5322347|NCT00355966|Induction of labour with PGE2 gel|induction of labour with pge2 gel
5322348|NCT00355953|Post-Menopausal Women|post-menopausal women
5322349|NCT00355953|Osteoporosis|osteoporosis
5322350|NCT00355953|Phytoestrogen|phytoestrogen
5322351|NCT00355953|Genistein|genistein
5322352|NCT00355940|endovascular|endovascular
5322353|NCT00355940|aortic|aortic
5322354|NCT00355940|repair|repair
5322355|NCT00355940|navigation|navigation
5322356|NCT00355940|DynaCT|dynact
5322357|NCT00355940|position|position
5322358|NCT00355940|sensor|sensor
5322359|NCT00355927|Deep brain stimulation|deep brain stimulation
5322360|NCT00355927|Microelectrode recordings|microelectrode recordings
5322361|NCT00355927|Basal Ganglia|basal ganglia
5322362|NCT00355927|Sedation|sedation
5322363|NCT00355927|Propofol|propofol
5322364|NCT00355914|Lumbar Facet Joint Nerve Block|lumbar facet joint nerve block
5322365|NCT00355901|Ulcerative Colitis|ulcerative colitis
5322366|NCT00355901|Colitis|colitis
5322367|NCT00355901|Steroid-Refractory|steroid-refractory
5322368|NCT00355901|Visilizumab|visilizumab
5322369|NCT00355901|Intravenous Steroid-Refractory Ulcerative Colitis (IVSR-UC)|intravenous steroid-refractory ulcerative colitis (ivsr-uc)
5322370|NCT00355888|Cancer|cancer
5322766|NCT00354562|ABT-751|abt-751
5322371|NCT00355888|Advanced or Metastatic Solid Tumor|advanced or metastatic solid tumor
5322372|NCT00355875|newborn|newborn
5322373|NCT00355875|preterm|preterm
5322374|NCT00355875|resuscitation|resuscitation
5322375|NCT00355875|oxidative injury|oxidative injury
5322376|NCT00355875|protein carbonyl|protein carbonyl
5322377|NCT00355862|Sirolimus|sirolimus
5322378|NCT00355862|mTOR|mtor
5322379|NCT00355862|HCC-recurrence free survival|hcc-recurrence free survival
5322380|NCT00355862|Liver transplant recipients|liver transplant recipients
5322381|NCT00355862|HCC recurrence free survival|hcc recurrence free survival
5322382|NCT00355836|Motor Imagery|motor imagery
5322383|NCT00355836|Stroke|stroke
5322384|NCT00355836|Neuro-rehabilitation|neuro-rehabilitation
5322385|NCT00355836|health psychology|health psychology
5322386|NCT00355836|neuroscience|neuroscience
5322387|NCT00355836|randomised controlled trial|randomised controlled trial
5322388|NCT00355823|electric field|electric field
5322389|NCT00355823|wound current|wound current
5322390|NCT00355823|wound healing|wound healing
5322391|NCT00355823|bioelectric field|bioelectric field
5322392|NCT00355823|chronic ulcer|chronic ulcer
5322393|NCT00355823|diabetic|diabetic
5322394|NCT00355823|Diabetes|diabetes
5322395|NCT00355823|aging|aging
5322396|NCT00355810|Probiotics|probiotics
5322397|NCT00355797|Bradycardia|bradycardia
5322398|NCT00355797|Sinus Node Dysfunction|sinus node dysfunction
5322399|NCT00355797|Chronotropic incompetence|chronotropic incompetence
5322400|NCT00355797|Pacemaker|pacemaker
5322401|NCT00355797|Rate adaptive|rate adaptive
5322402|NCT00355784|growth hormone|growth hormone
5322403|NCT00355784|overfeeding|overfeeding
5322404|NCT00355784|energy expenditure|energy expenditure
5322405|NCT00355784|protein metabolism|protein metabolism
5322406|NCT00355784|lipid metabolism|lipid metabolism
5322407|NCT00355771|allergic rhinitis|allergic rhinitis
5322408|NCT00355771|histamine antagonist|histamine antagonist
5322409|NCT00355771|sleep disorder|sleep disorder
5322410|NCT00355758|Prostate Cancer Detection by Serum Proteomic Profiling|prostate cancer detection by serum proteomic profiling
5322411|NCT00355745|Breast|breast
5322412|NCT00355745|tumor|tumor
5322413|NCT00355745|ultrasound|ultrasound
5322414|NCT00355745|biopsy|biopsy
5322415|NCT00355745|Breast mammographic or ultrasound findings|breast mammographic or ultrasound findings
5322416|NCT00355732|Respiration|respiration
5322417|NCT00355732|COPD|copd
5322418|NCT00355732|Mechanical Ventilation|mechanical ventilation
5322419|NCT00355732|Ventilator Weaning|ventilator weaning
5322420|NCT00355732|Respiratory Failure|respiratory failure
5322421|NCT00355732|ICU|icu
5322422|NCT00355732|Pressure Support Ventilation|pressure support ventilation
5322423|NCT00355719|Nevirapine|nevirapine
5322424|NCT00355719|Atazanavir|atazanavir
5322425|NCT00355719|Pharmacokinetics|pharmacokinetics
5322426|NCT00355719|Interactions|interactions
5322427|NCT00355706|chronic low back pain|chronic low back pain
5322428|NCT00355706|thoracic facet joint|thoracic facet joint
5322429|NCT00355706|nerve block|nerve block
5322430|NCT00355693|Anxiety|anxiety
5322431|NCT00355693|Dental|dental
5322432|NCT00355693|Oral|oral
5322433|NCT00355693|Surgery|surgery
5322434|NCT00355693|Colonoscopy|colonoscopy
5322435|NCT00355693|Propofol|propofol
5322436|NCT00355693|Sedation|sedation
5322437|NCT00355693|Effect|effect
5322438|NCT00355693|Reaction|reaction
5322439|NCT00355680|Retina|retina
5322440|NCT00355680|Retinal Diseases|retinal diseases
5322441|NCT00355680|Retinal Vessels|retinal vessels
5322442|NCT00355680|Laser Coagulation|laser coagulation
5322443|NCT00355667|diuretics|diuretics
5322444|NCT00355667|furosemide|furosemide
5322445|NCT00355667|azosemide|azosemide
5322446|NCT00355667|congestive heart failure|congestive heart failure
5322447|NCT00355654|Diphtheria|diphtheria
5322448|NCT00355654|Tetanus|tetanus
5322449|NCT00355654|Pertussis|pertussis
5322450|NCT00355654|Poliomyelitis|poliomyelitis
5322451|NCT00355654|Haemophilus influenzae type b|haemophilus influenzae type b
5322452|NCT00355654|Hepatitis B|hepatitis b
5322453|NCT00355641|Ropinirole|ropinirole
5322454|NCT00355641|Restless Legs Syndrome|restless legs syndrome
5322455|NCT00355641|RLS|rls
5322456|NCT00355628|Pain|pain
5322457|NCT00355628|Cancer|cancer
5322458|NCT00355628|Neoplasm|neoplasm
5322459|NCT00355628|Continual Reassessment Method|continual reassessment method
5322460|NCT00355628|Pain Associated with Cancer/Neoplasms|pain associated with cancer/neoplasms
5322461|NCT00355615|Heterozygous Familial Hypercholesterolemia|heterozygous familial hypercholesterolemia
5322462|NCT00355602|Antibiotics|antibiotics
5322463|NCT00355602|Controlled Clinical Trial|controlled clinical trial
5322464|NCT00355589|Hypertension|hypertension
5322465|NCT00355589|High Blood Pressure|high blood pressure
5322466|NCT00355589|Diuretic|diuretic
5322467|NCT00355589|Angiotensin converting enzyme inhibitor|angiotensin converting enzyme inhibitor
5322468|NCT00355589|Ambulatory blood pressure monitoring|ambulatory blood pressure monitoring
5322469|NCT00355576|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
5322470|NCT00355576|Celecoxib|celecoxib
5322471|NCT00355576|Creatine|creatine
5322472|NCT00355576|Minocycline|minocycline
5322473|NCT00355576|Combination|combination
5322476|NCT00355576|Motor Neuron Disease|motor neuron disease
5322477|NCT00355550|Mild Cognitive Impairment|mild cognitive impairment
5322478|NCT00355550|Cognition disorders|cognition disorders
5322479|NCT00355550|nutritional supplement|nutritional supplement
5322480|NCT00355550|dietary supplement|dietary supplement
5322481|NCT00355524|HIV-1|hiv-1
5322482|NCT00355524|Darunavir|darunavir
5322483|NCT00355524|Ritonavir|ritonavir
5322484|NCT00355524|TMC114|tmc114
5322485|NCT00355511|heart failure, congestive|heart failure, congestive
5322486|NCT00355511|patient care team|patient care team
5322487|NCT00355511|randomized controlled trial|randomized controlled trial
5322488|NCT00355511|disease management|disease management
5322489|NCT00355511|drug therapy|drug therapy
5322490|NCT00355511|diet therapy|diet therapy
5322491|NCT00355511|hospitalization|hospitalization
5322492|NCT00355511|mortality|mortality
5322493|NCT00355498|functional magnetic resonance imaging|functional magnetic resonance imaging
5322494|NCT00355498|positron emission tomography|positron emission tomography
5322495|NCT00355498|beta-amyloid|beta-amyloid
5322496|NCT00355498|tau|tau
5322497|NCT00355485|Acne|acne
5322498|NCT00355485|Microdermabrasion|microdermabrasion
5322499|NCT00355472|Adult T-Cell Leukemia|adult t-cell leukemia
5322500|NCT00355472|ATL|atl
5322501|NCT00355472|Adult Peripheral T-Cell Lymphoma|adult peripheral t-cell lymphoma
5322502|NCT00355472|PTCL|ptcl
5322503|NCT00355459|Meibomian Gland Dystrophy|meibomian gland dystrophy
5322504|NCT00355446|Cataract|cataract
5322505|NCT00355446|Human Aqueous|human aqueous
5322506|NCT00355433|urinary incontinence|urinary incontinence
5322507|NCT00355433|urodynamics|urodynamics
5322508|NCT00355433|temperature|temperature
5322509|NCT00355407|Aranesp|aranesp
5322510|NCT00355407|allogeneic stem cell transplant|allogeneic stem cell transplant
5322511|NCT00355381|Information Services|information services
5322512|NCT00355381|Randomized Controlled Trials|randomized controlled trials
5322513|NCT00355381|Medical Records Systems, Computerized|medical records systems, computerized
5322514|NCT00355381|Internet|internet
5322515|NCT00355381|Librarians|librarians
5322516|NCT00355381|Breast Neoplasms|breast neoplasms
5322517|NCT00355381|Patient Satisfaction|patient satisfaction
5322518|NCT00355381|Health Personnel|health personnel
5322519|NCT00355381|Costs and Cost Analysis|costs and cost analysis
5322520|NCT00355381|Premature Birth|premature birth
5322521|NCT00355368|intubation|intubation
5322522|NCT00355368|intensive care|intensive care
5322523|NCT00355368|neuromuscular depolarizing agents|neuromuscular depolarizing agents
5322524|NCT00355368|neuromuscular nondepolarizing agents|neuromuscular nondepolarizing agents
5322525|NCT00355368|neuromuscular blocking agents|neuromuscular blocking agents
5322526|NCT00355355|Hepatocellular carcinoma|hepatocellular carcinoma
5322527|NCT00355355|HCC|hcc
5322528|NCT00355355|Liver Neoplasms|liver neoplasms
5322529|NCT00355355|Talaporfin Sodium (LS11)|talaporfin sodium (ls11)
5322530|NCT00355355|Light emitting diodes (LEDs)|light emitting diodes (leds)
5322531|NCT00355355|Light activation|light activation
5322532|NCT00355342|Osteoporosis|osteoporosis
5322533|NCT00355342|Bone Mineral Density|bone mineral density
5322534|NCT00355342|Osteopenia|osteopenia
5322535|NCT00355342|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5322536|NCT00355342|COPD|copd
5322537|NCT00355329|Traditional Chinese Medicine (TCM)|traditional chinese medicine (tcm)
5322538|NCT00355329|Autism|autism
5322539|NCT00355329|Autistic Spectrum Disorder|autistic spectrum disorder
5322540|NCT00355329|Tongue Acupuncture (TAC)|tongue acupuncture (tac)
5322541|NCT00355329|18F-fluorodeoxyglucose Positron Emission Tomography (PET)|18f-fluorodeoxyglucose positron emission tomography (pet)
5322542|NCT00355329|children|children
5322543|NCT00355316|Breast Cancer|breast cancer
5322544|NCT00355316|Peripheral|peripheral
5322545|NCT00355316|Blood|blood
5322546|NCT00355303|Premature rupture of membranes at term|premature rupture of membranes at term
5322547|NCT00355303|Induction of labour|induction of labour
5322548|NCT00355303|Misoprostol|misoprostol
5322549|NCT00355303|PGE2 gel|pge2 gel
5322550|NCT00355303|Immediate induction with PGE2 gel|immediate induction with pge2 gel
5322551|NCT00355303|Immediate induction with Misoprostol|immediate induction with misoprostol
5322552|NCT00355290|Chronic Oral Anticoagulation|chronic oral anticoagulation
5322553|NCT00355277|Tricyclic antidepressants|tricyclic antidepressants
5322554|NCT00355277|Neuropathic pain|neuropathic pain
5322555|NCT00355277|Local anaesthesia|local anaesthesia
5322556|NCT00355277|Transcutaneous|transcutaneous
5322557|NCT00355251|Atorvastatin|atorvastatin
5322558|NCT00355251|Viral replication|viral replication
5322559|NCT00355251|HIV-1|hiv-1
5322560|NCT00355251|plasma cholesterol|plasma cholesterol
5322561|NCT00355251|Cell membrane cholesterol|cell membrane cholesterol
5322562|NCT00355225|insecticide-treated bednets|insecticide-treated bednets
5322563|NCT00355225|malaria|malaria
5322564|NCT00355225|africa|africa
5322565|NCT00355225|social marketing|social marketing
5322566|NCT00355225|ante-natal care|ante-natal care
5322567|NCT00355225|ITN coverage|itn coverage
5322568|NCT00355225|ITn use|itn use
5322569|NCT00355212|percutaneous ethanol injection|percutaneous ethanol injection
5322570|NCT00355212|radiofrequency|radiofrequency
5322571|NCT00355212|liver cirrhosis|liver cirrhosis
5322572|NCT00355212|carcinoma, hepatocellular|carcinoma, hepatocellular
5322573|NCT00355199|DLBCL|dlbcl
5322574|NCT00355199|R-HDS|r-hds
5322575|NCT00355199|R-CHOP14|r-chop14
5322576|NCT00355186|acute myocardial infarction|acute myocardial infarction
5322577|NCT00355186|MRI|mri
5322578|NCT00355186|bone marrow cells|bone marrow cells
5322579|NCT00355186|stem cells|stem cells
5322580|NCT00355186|remodeling|remodeling
5322581|NCT00355160|Headache|headache
5322582|NCT00355160|Sinusitis|sinusitis
5322583|NCT00355160|Rhinitis|rhinitis
5322584|NCT00355160|Facial Pain|facial pain
5322585|NCT00355147|Ischemic stroke|ischemic stroke
5322586|NCT00355147|Preventive medicine|preventive medicine
5322587|NCT00355147|Transient Ischemic Attack|transient ischemic attack
5322588|NCT00355147|Neurology|neurology
5322589|NCT00355147|Risk management|risk management
5322590|NCT00355134|fingolimod|fingolimod
5322591|NCT00355134|FTY720|fty720
5322592|NCT00355134|relapsing-remitting multiple sclerosis|relapsing-remitting multiple sclerosis
5322593|NCT00355134|MS|ms
5322594|NCT00355134|RRMS|rrms
5322595|NCT00355121|Meningococcal meningitis|meningococcal meningitis
5322596|NCT00355121|Tetanus|tetanus
5322597|NCT00355121|Diphtheria|diphtheria
5322598|NCT00355121|Pertussis|pertussis
5322599|NCT00355121|Poliomyelitis|poliomyelitis
5322600|NCT00355121|Neisseria meningitidis|neisseria meningitidis
5322601|NCT00355108|Rendu Osler syndrome|rendu osler syndrome
5322602|NCT00355108|Epistaxis|epistaxis
5322603|NCT00355108|Tranexamic acid|tranexamic acid
5322604|NCT00355108|clinical trial|clinical trial
5322605|NCT00355095|multiple sclerosis|multiple sclerosis
5322606|NCT00355095|add-on Therapy|add-on therapy
5322607|NCT00355095|erythropoietin|erythropoietin
5322608|NCT00355095|methylprednisolone|methylprednisolone
5322609|NCT00355095|autoimmune optic neuritis|autoimmune optic neuritis
5322610|NCT00355082|epilepsy|epilepsy
5322611|NCT00355082|lamotrigine|lamotrigine
5322612|NCT00355082|Lamictal|lamictal
5322613|NCT00355082|monotherapy|monotherapy
5322614|NCT00355069|pediatric|pediatric
5322615|NCT00355069|asthma|asthma
5322616|NCT00355069|translational research|translational research
5322617|NCT00355069|health information technology|health information technology
5322618|NCT00355056|Migraine|migraine
5322619|NCT00355056|PFO|pfo
5322620|NCT00355056|Migraine Headache|migraine headache
5322621|NCT00355056|patent foramen ovale|patent foramen ovale
5322622|NCT00355043|Zinc treatment|zinc treatment
5322623|NCT00355043|Bronchiolitis|bronchiolitis
5322624|NCT00355043|Wheezing|wheezing
5322625|NCT00355043|Children aged 2 months to 23 months|children aged 2 months to 23 months
5322626|NCT00355043|Diagnosed case of acute bronchiolitis|diagnosed case of acute bronchiolitis
5322627|NCT00355004|colon cancer|colon cancer
5322628|NCT00355004|rectal cancer|rectal cancer
5322629|NCT00354978|Colorectal Cancer|colorectal cancer
5322630|NCT00354978|FOLFIRI|folfiri
5322631|NCT00354978|Irinotecan|irinotecan
5322632|NCT00354978|CPT-11|cpt-11
5322633|NCT00354978|Leucovorin|leucovorin
5322634|NCT00354978|LV|lv
5322635|NCT00354978|Folinic Acid|folinic acid
5322636|NCT00354978|Fluorouracil|fluorouracil
5322637|NCT00354978|5-FU|5-fu
5322638|NCT00354978|Adrucil|adrucil
5322639|NCT00354978|Efudex|efudex
5322640|NCT00354978|Bevacizumab|bevacizumab
5322641|NCT00354978|Avastin|avastin
5322642|NCT00354978|Anti-VEGF monoclonal antibody|anti-vegf monoclonal antibody
5322643|NCT00354978|rhuMAb-VEGF|rhumab-vegf
5322644|NCT00354965|ABS|abs
5322645|NCT00354965|Acute Bacterial|acute bacterial
5322646|NCT00354965|Sinusitis|sinusitis
5322647|NCT00354965|Bacterial Sinusitis|bacterial sinusitis
5322648|NCT00354952|Healthy volunteers|healthy volunteers
5322649|NCT00354952|Antibiotic exposure|antibiotic exposure
5322650|NCT00354952|Resistance selection|resistance selection
5322651|NCT00354926|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
5322652|NCT00354926|rituximab|rituximab
5322653|NCT00354926|humanized monoclonal antibody|humanized monoclonal antibody
5322654|NCT00354926|anti-CD20 monoclonal antibody|anti-cd20 monoclonal antibody
5322655|NCT00354913|adult grade I meningioma|adult grade i meningioma
5322656|NCT00354913|adult grade II meningioma|adult grade ii meningioma
5322657|NCT00354913|adult grade III meningioma|adult grade iii meningioma
5322658|NCT00354913|adult papillary meningioma|adult papillary meningioma
5322659|NCT00354913|adult anaplastic meningioma|adult anaplastic meningioma
5322660|NCT00354913|recurrent adult brain tumor|recurrent adult brain tumor
5322661|NCT00354913|glioblastoma multiforme (GBM)|glioblastoma multiforme (gbm)
5322662|NCT00354913|Imatinib|imatinib
5322663|NCT00354913|Imatinib mesylate|imatinib mesylate
5322664|NCT00354913|Hydroxyurea|hydroxyurea
5322665|NCT00354913|Droxia|droxia
5322666|NCT00354913|Hydrea|hydrea
5322667|NCT00354913|Hydroxycarbamide|hydroxycarbamide
5322668|NCT00354913|Gleevec|gleevec
5322669|NCT00354913|Meningioma|meningioma
5322670|NCT00354900|breast cancer|breast cancer
5322671|NCT00354900|fibrinolysis|fibrinolysis
5322672|NCT00354900|urokinase-type plasminogen activator|urokinase-type plasminogen activator
5322673|NCT00354900|plasminogen activator inhibitor|plasminogen activator inhibitor
5322674|NCT00354900|aprotinin|aprotinin
5322675|NCT00354900|plasmin/alpha-2-antiplasmin complex|plasmin/alpha-2-antiplasmin complex
5322676|NCT00354887|Gastrointestinal Cancer|gastrointestinal cancer
5322677|NCT00354887|Small Bowel Cancer|small bowel cancer
5322678|NCT00354887|Ampulla of Vater|ampulla of vater
5322679|NCT00354887|Capecitabine|capecitabine
5322680|NCT00354887|Xeloda|xeloda
5322681|NCT00354887|Oxaliplatin|oxaliplatin
5322682|NCT00354887|Eloxatin|eloxatin
5322683|NCT00354874|GW642444 asthmatic subjects safety tolerability PD and PK|gw642444 asthmatic subjects safety tolerability pd and pk
5322684|NCT00354861|Healthy volunteers|healthy volunteers
5322685|NCT00354861|IMP321|imp321
5322686|NCT00354861|Adjuvant|adjuvant
5322687|NCT00354861|Pharmacodynamics|pharmacodynamics
5322688|NCT00354822|Zevalin|zevalin
5322689|NCT00354822|Lymphoma, Non-Hodgkin|lymphoma, non-hodgkin
5322690|NCT00354809|cognition|cognition
5322691|NCT00354809|Primary Insomnia|primary insomnia
5322692|NCT00354809|sleep|sleep
5322693|NCT00354809|polysomnography|polysomnography
5322694|NCT00354796|bleeding|bleeding
5322695|NCT00354796|anticoagulation|anticoagulation
5322696|NCT00354796|LMWH|lmwh
5322697|NCT00354796|Enoxaparin|enoxaparin
5322698|NCT00354783|Very low birth weight premature infants|very low birth weight premature infants
5322699|NCT00354783|Kicking|kicking
5322700|NCT00354783|Stepping|stepping
5322701|NCT00354783|Walking|walking
5322702|NCT00354783|Motor development|motor development
5322703|NCT00354783|Kinematics|kinematics
5322704|NCT00354770|Trichotillomania|trichotillomania
5322705|NCT00354770|Hair-pulling|hair-pulling
5322706|NCT00354757|gastroesophageal reflux disease, proton-pump inhibitor test|gastroesophageal reflux disease, proton-pump inhibitor test
5322707|NCT00354744|adult rhabdomyosarcoma|adult rhabdomyosarcoma
5322708|NCT00354744|previously untreated childhood rhabdomyosarcoma|previously untreated childhood rhabdomyosarcoma
5322709|NCT00354744|adult malignant mesenchymoma|adult malignant mesenchymoma
5322710|NCT00354744|childhood malignant mesenchymoma|childhood malignant mesenchymoma
5322711|NCT00354744|metastatic childhood soft tissue sarcoma|metastatic childhood soft tissue sarcoma
5322712|NCT00354744|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
5322713|NCT00354731|nephrotic syndrome, pentoxifylline, corticosteroid|nephrotic syndrome, pentoxifylline, corticosteroid
5322714|NCT00354705|Colon Cancer|colon cancer
5322715|NCT00354705|Adenocarcinoma of the Colon|adenocarcinoma of the colon
5322716|NCT00354705|Cancer Recurrence|cancer recurrence
5322717|NCT00354705|Survey|survey
5322718|NCT00354705|Chemotherapy|chemotherapy
5322719|NCT00354705|Surgery|surgery
5322720|NCT00354679|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
5322721|NCT00354679|recurrent esophageal cancer|recurrent esophageal cancer
5322722|NCT00354679|stage III esophageal cancer|stage iii esophageal cancer
5322723|NCT00354679|stage II esophageal cancer|stage ii esophageal cancer
5322724|NCT00354666|inhaled|inhaled
5322725|NCT00354666|asthmatic subjects|asthmatic subjects
5322726|NCT00354666|GSK159797|gsk159797
5322727|NCT00354666|safety and tolerability|safety and tolerability
5322728|NCT00354666|efficacy|efficacy
5322729|NCT00354666|dry powder|dry powder
5322730|NCT00354653|HBeAg|hbeag
5322731|NCT00354653|HBV|hbv
5322732|NCT00354653|CHRONIC HEPATITIS|chronic hepatitis
5322733|NCT00354653|lamivudine|lamivudine
5322734|NCT00354640|breast cancer|breast cancer
5322735|NCT00354640|breast cancer in situ|breast cancer in situ
5322736|NCT00354640|ductal breast carcinoma in situ|ductal breast carcinoma in situ
5322737|NCT00354640|stage I breast cancer|stage i breast cancer
5322738|NCT00354640|stage II breast cancer|stage ii breast cancer
5322739|NCT00354640|stage IIIA breast cancer|stage iiia breast cancer
5322740|NCT00354640|stage IIIB breast cancer|stage iiib breast cancer
5322741|NCT00354640|stage IIIC breast cancer|stage iiic breast cancer
5322742|NCT00354627|HIV-1|hiv-1
5322743|NCT00354627|Early Access Program (EAP)|early access program (eap)
5322744|NCT00354627|TMC125|tmc125
5322745|NCT00354627|treatment-experienced|treatment-experienced
5322746|NCT00354627|failing multiple antiretroviral (ARV) regimens|failing multiple antiretroviral (arv) regimens
5322747|NCT00354627|limited to no treatment options|limited to no treatment options
5322748|NCT00354601|fallopian tube cancer|fallopian tube cancer
5322749|NCT00354601|peritoneal cavity cancer|peritoneal cavity cancer
5322750|NCT00354601|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5322751|NCT00354601|ovarian clear cell cystadenocarcinoma|ovarian clear cell cystadenocarcinoma
5322752|NCT00354601|ovarian endometrioid adenocarcinoma|ovarian endometrioid adenocarcinoma
5322753|NCT00354601|ovarian mucinous cystadenocarcinoma|ovarian mucinous cystadenocarcinoma
5322754|NCT00354601|ovarian serous cystadenocarcinoma|ovarian serous cystadenocarcinoma
5322755|NCT00354601|ovarian undifferentiated adenocarcinoma|ovarian undifferentiated adenocarcinoma
5322756|NCT00354588|chronic renal failure|chronic renal failure
5322757|NCT00354588|arterial stiffness|arterial stiffness
5322758|NCT00354588|arterial wave reflections|arterial wave reflections
5322759|NCT00354575|Constipation;|constipation;
5322760|NCT00354575|Chinese herb;|chinese herb;
5322761|NCT00354575|Long-term care;|long-term care;
5322762|NCT00354575|Integrative Chinese Medicine and Western Medicine;|integrative chinese medicine and western medicine;
5322763|NCT00354562|Lung Cancer|lung cancer
5322764|NCT00354562|Non-Small Cell Lung Cancer|non-small cell lung cancer
5322765|NCT00354562|NSCLC|nsclc
5322767|NCT00354562|docetaxel|docetaxel
5322768|NCT00354562|Taxotere|taxotere
5322769|NCT00354549|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5322770|NCT00354549|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5322771|NCT00354549|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5322772|NCT00354549|adenocarcinoma of the lung|adenocarcinoma of the lung
5322773|NCT00354549|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
5322774|NCT00354549|large cell lung cancer|large cell lung cancer
5322775|NCT00354536|GSK716155|gsk716155
5322776|NCT00354536|albiglutide|albiglutide
5322777|NCT00354536|pharmacodynamics|pharmacodynamics
5322778|NCT00354536|pharmacokinetics|pharmacokinetics
5322779|NCT00354523|Solid Tumor|solid tumor
5322780|NCT00354523|Thyroid Cancer|thyroid cancer
5322781|NCT00354523|Medullary Thyroid Cancer|medullary thyroid cancer
5322783|NCT00354523|Advanced Metastatic Medullary Thyroid Carcinoma|advanced metastatic medullary thyroid carcinoma
5322784|NCT00354523|Capecitabine|capecitabine
5322785|NCT00354523|Dacarbazine|dacarbazine
5322786|NCT00354523|Imatinib|imatinib
5322787|NCT00354523|Gleevec|gleevec
5322788|NCT00354523|Imatinib Mesylate|imatinib mesylate
5322789|NCT00354523|DTIC-Dome|dtic-dome
5322790|NCT00354523|Xeloda|xeloda
5322791|NCT00354510|atopic dermatitis|atopic dermatitis
5322792|NCT00354510|GW842470X|gw842470x
5322793|NCT00354510|PDE4 inhibitor|pde4 inhibitor
5322794|NCT00354497|prostate cancer|prostate cancer
5322795|NCT00354484|anemia|anemia
5322796|NCT00354484|postpartum|postpartum
5322797|NCT00354458|heart failure|heart failure
5322798|NCT00354458|diuretic|diuretic
5322799|NCT00354458|renal impairment|renal impairment
5322800|NCT00354458|renal function|renal function
5322801|NCT00354445|Age-Related Macular Degeneration (AMD)|age-related macular degeneration (amd)
5322802|NCT00354445|pegaptanib sodium|pegaptanib sodium
5322803|NCT00354445|subfoveal CNV|subfoveal cnv
5322804|NCT00354445|macugen|macugen
5322805|NCT00354432|recurrent prostate cancer|recurrent prostate cancer
5322806|NCT00354432|stage I prostate cancer|stage i prostate cancer
5322807|NCT00354432|stage IIB prostate cancer|stage iib prostate cancer
5322808|NCT00354432|stage IIA prostate cancer|stage iia prostate cancer
5322809|NCT00354432|stage III prostate cancer|stage iii prostate cancer
5322810|NCT00354432|stage IV prostate cancer|stage iv prostate cancer
5322811|NCT00354432|hot flashes|hot flashes
5322812|NCT00354406|Abciximab|abciximab
5322813|NCT00354406|Magnetic Resonance Imaging|magnetic resonance imaging
5322814|NCT00354406|Percutaneous Transluminal Coronary Angioplasty|percutaneous transluminal coronary angioplasty
5322815|NCT00354393|localized malignant mesothelioma|localized malignant mesothelioma
5322816|NCT00354393|sarcomatous mesothelioma|sarcomatous mesothelioma
5322817|NCT00354393|advanced malignant mesothelioma|advanced malignant mesothelioma
5322818|NCT00354393|epithelial mesothelioma|epithelial mesothelioma
5322819|NCT00354380|Malaria|malaria
5322820|NCT00354380|Africa|africa
5322821|NCT00354380|Methalyne-blue|methalyne-blue
5322822|NCT00354380|Artesunate|artesunate
5322823|NCT00354380|Amodiaquine|amodiaquine
5322824|NCT00354367|Crohn Disease|crohn disease
5322825|NCT00354367|Certolizumab pegol|certolizumab pegol
5322826|NCT00354367|Fistula|fistula
5322827|NCT00354354|COPD|copd
5322828|NCT00354354|Combivent|combivent
5322829|NCT00354354|Exercise|exercise
5322830|NCT00354354|Bronchodilator|bronchodilator
5322831|NCT00354354|Kinetics|kinetics
5322832|NCT00354328|HCM|hcm
5322833|NCT00354328|Echocardiography|echocardiography
5322834|NCT00354328|Diastolic Dysfunction|diastolic dysfunction
5322835|NCT00354328|Enalapril|enalapril
5322836|NCT00354315|Shared decision making|shared decision making
5322837|NCT00354315|Optimal drug prescription|optimal drug prescription
5322838|NCT00354302|osteoporosis|osteoporosis
5322839|NCT00354302|stage I breast cancer|stage i breast cancer
5322840|NCT00354302|stage II breast cancer|stage ii breast cancer
5322841|NCT00354302|stage IIIA breast cancer|stage iiia breast cancer
5322842|NCT00354276|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5322843|NCT00354276|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5322844|NCT00354276|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
5322845|NCT00354276|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
5322846|NCT00354276|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
5322847|NCT00354276|adult erythroleukemia (M6a)|adult erythroleukemia (m6a)
5322848|NCT00354276|adult pure erythroid leukemia (M6b)|adult pure erythroid leukemia (m6b)
5322849|NCT00354276|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
5322850|NCT00354276|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
5322851|NCT00354276|adult acute basophilic leukemia|adult acute basophilic leukemia
5322852|NCT00354276|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
5322853|NCT00354276|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
5322854|NCT00354276|adult acute eosinophilic leukemia|adult acute eosinophilic leukemia
5322855|NCT00354276|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
5322856|NCT00354263|Healthy male volunteers|healthy male volunteers
5322857|NCT00354263|IMP321|imp321
5322858|NCT00354263|Adjuvant|adjuvant
5322859|NCT00354263|Monotherapy|monotherapy
5322860|NCT00354263|Pharmacokinetics/Pharmacodynamics|pharmacokinetics/pharmacodynamics
5322861|NCT00354237|diabetes mellitus|diabetes mellitus
5322862|NCT00354237|cardiac rehabilitation|cardiac rehabilitation
5322863|NCT00354237|insulin|insulin
5322864|NCT00354224|recurrent gastric cancer|recurrent gastric cancer
5322865|NCT00354224|stage III gastric cancer|stage iii gastric cancer
5322866|NCT00354224|stage IV gastric cancer|stage iv gastric cancer
5322867|NCT00354211|Cardiac Output|cardiac output
5322868|NCT00354211|Hemodynamic Phenomena|hemodynamic phenomena
5322869|NCT00354198|rapidly progressive glomerulonephritis|rapidly progressive glomerulonephritis
5322870|NCT00354198|pentoxifylline|pentoxifylline
5322871|NCT00354172|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5322872|NCT00354172|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5322873|NCT00354172|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5322874|NCT00354172|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5322875|NCT00354172|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5322876|NCT00354172|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
5322877|NCT00354172|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5322878|NCT00354172|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
5322879|NCT00354172|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5322880|NCT00354172|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5322881|NCT00354172|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5322882|NCT00354172|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5322883|NCT00354172|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5322884|NCT00354172|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5322885|NCT00354172|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
5322886|NCT00354159|Implantable cardioverter defibrillator|implantable cardioverter defibrillator
5322887|NCT00354159|Intracardiac pressures|intracardiac pressures
5322888|NCT00354146|Farnesyl transferase inhibitor|farnesyl transferase inhibitor
5322889|NCT00354146|relapsed or refractory acute myeloid leukemia|relapsed or refractory acute myeloid leukemia
5322890|NCT00354133|Parkinson Disease|parkinson disease
5322891|NCT00354133|Deep Brain Stimulation|deep brain stimulation
5322892|NCT00354133|PDQ-39|pdq-39
5322893|NCT00354081|Coronary Artery Disease|coronary artery disease
5322894|NCT00354081|Myocardial Infarction|myocardial infarction
5322895|NCT00354081|Cerebrovascular Stroke|cerebrovascular stroke
5322896|NCT00354081|Homocysteine|homocysteine
5322897|NCT00354081|Folic Acid|folic acid
5322898|NCT00354081|Vitamin B 12|vitamin b 12
5322899|NCT00354081|Vitamin B 6|vitamin b 6
5322900|NCT00354068|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
5322901|NCT00354068|adult giant cell glioblastoma|adult giant cell glioblastoma
5322902|NCT00354068|adult gliosarcoma|adult gliosarcoma
5322903|NCT00354068|adult mixed glioma|adult mixed glioma
5322904|NCT00354068|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5322905|NCT00354068|recurrent adult brain tumor|recurrent adult brain tumor
5322906|NCT00354068|adult glioblastoma|adult glioblastoma
5322907|NCT00354042|GW597901X|gw597901x
5322908|NCT00354042|Asthma|asthma
5322909|NCT00354042|Crossover|crossover
5322910|NCT00354042|dose ascending|dose ascending
5322911|NCT00354042|repeat dose|repeat dose
5322912|NCT00354042|inhaled|inhaled
5322913|NCT00354029|hemorrhoids|hemorrhoids
5322914|NCT00354029|hemorrhoidectomy|hemorrhoidectomy
5322915|NCT00354029|S (+) ketamine|s (+) ketamine
5322916|NCT00354029|pain|pain
5322917|NCT00354016|influenza|influenza
5322918|NCT00354016|vaccine|vaccine
5322919|NCT00354003|Parkinson|parkinson
5322920|NCT00354003|Imaging|imaging
5322921|NCT00353990|insulin|insulin
5322922|NCT00353990|bioavailability|bioavailability
5322923|NCT00353990|duodenum|duodenum
5322924|NCT00353990|infusion|infusion
5322925|NCT00353990|healthy|healthy
5322926|NCT00353990|diabetes|diabetes
5322927|NCT00353990|absorption|absorption
5322928|NCT00353977|Cytomegalovirus|cytomegalovirus
5322929|NCT00353977|Vaccine|vaccine
5322930|NCT00353977|CMV|cmv
5322931|NCT00353977|Immunization|immunization
5322932|NCT00353977|Peripheral Blood Stem Cell Transplantation|peripheral blood stem cell transplantation
5322933|NCT00353977|Stem Cell Allotransplant|stem cell allotransplant
5322934|NCT00353951|primary care|primary care
5322935|NCT00353951|lower respiratory tract infection|lower respiratory tract infection
5322936|NCT00353951|antibiotics|antibiotics
5322937|NCT00353951|cough|cough
5322938|NCT00353938|PTSD, MDMA, psychotherapy, Switzerland|ptsd, mdma, psychotherapy, switzerland
5322939|NCT00353925|Hypertrophy|hypertrophy
5322940|NCT00353925|LVH|lvh
5322941|NCT00353925|Cardiac|cardiac
5322942|NCT00353925|Blood Pressure|blood pressure
5322943|NCT00353925|Papillary Muscle|papillary muscle
5322944|NCT00353912|Blood|blood
5322945|NCT00353912|Venous|venous
5322946|NCT00353912|Systolic|systolic
5322947|NCT00353912|Diastolic|diastolic
5322948|NCT00353912|Pulse|pulse
5322949|NCT00353912|Pressure|pressure
5322950|NCT00353899|Magnetic Resonance Imaging|magnetic resonance imaging
5322951|NCT00353899|Pediatric|pediatric
5322952|NCT00353899|Normal Volunteer|normal volunteer
5322953|NCT00353899|Electrocardiogram|electrocardiogram
5322954|NCT00353899|Cardiac|cardiac
5322955|NCT00353899|Healthy Volunteer|healthy volunteer
5322956|NCT00353899|HV|hv
5322957|NCT00353886|Retrospective|retrospective
5322958|NCT00353886|Epilepsy|epilepsy
5322959|NCT00353886|Antiepileptic Drugs|antiepileptic drugs
5322960|NCT00353886|Behavioral Development|behavioral development
5322961|NCT00353886|Intellectual Development|intellectual development
5322962|NCT00353873|FLIXOTIDE|flixotide
5322963|NCT00353873|asthmatics children 4-11 years|asthmatics children 4-11 years
5322964|NCT00353873|SERETIDE|seretide
5322965|NCT00353873|asthma-control|asthma-control
5322966|NCT00353860|Leukemia|leukemia
5322967|NCT00353860|Transplant - Mortality|transplant - mortality
5322968|NCT00353860|Immunosuppression|immunosuppression
5322969|NCT00353860|Radiation|radiation
5322970|NCT00353860|Cure|cure
5322971|NCT00353860|Peripheral Blood Stem Cells|peripheral blood stem cells
5322972|NCT00353860|Graft-Versus Leukemia/Myeloma|graft-versus leukemia/myeloma
5322973|NCT00353860|Graft-Versus-Host Disease|graft-versus-host disease
5322974|NCT00353860|Cyclosporine|cyclosporine
5322975|NCT00353860|Fludarabine|fludarabine
5322976|NCT00353847|acupuncture, RCTs, chronic LBP|acupuncture, rcts, chronic lbp
5322977|NCT00353834|endothelial dysfunction|endothelial dysfunction
5322978|NCT00353834|subclinical inflammation|subclinical inflammation
5322979|NCT00353834|flow mediated brachial artery dilation|flow mediated brachial artery dilation
5322980|NCT00353834|pulse wave analysis|pulse wave analysis
5322981|NCT00353834|glucagon like polypeptide mimetics|glucagon like polypeptide mimetics
5322982|NCT00353834|type 2 diabetes mellitus|type 2 diabetes mellitus
5322983|NCT00353821|Tumor Necrosis Factor Alpha (TNF-Alpha)|tumor necrosis factor alpha (tnf-alpha)
5322984|NCT00353821|Interferon-Gamma (IFN-Gamma)|interferon-gamma (ifn-gamma)
5322985|NCT00353821|Interleukin-10 (IL-10)|interleukin-10 (il-10)
5322986|NCT00353821|Interleukin-6 (IL-6)|interleukin-6 (il-6)
5322987|NCT00353821|Interleukin-1 (IL-1 Ra)|interleukin-1 (il-1 ra)
5322988|NCT00353821|Interleukin-1 Receptor Antagonist (IL-1 Ra)|interleukin-1 receptor antagonist (il-1 ra)
5322989|NCT00353821|Vitamin D Receptor (VitD R)|vitamin d receptor (vitd r)
5322990|NCT00353795|MESA|mesa
5322991|NCT00353795|MRI|mri
5322992|NCT00353795|Cardiovascular|cardiovascular
5322993|NCT00353795|Cardiac|cardiac
5322994|NCT00353795|Coronary|coronary
5322995|NCT00353795|Atherosclerosis|atherosclerosis
5322996|NCT00353782|Dyslipidemia|dyslipidemia
5322997|NCT00353782|Hypertriglyceridemia|hypertriglyceridemia
5322998|NCT00353782|Hyperalphalipoproteinemia|hyperalphalipoproteinemia
5322999|NCT00353782|Atheroembolism|atheroembolism
5323000|NCT00353782|Atherosclerosis|atherosclerosis
5323001|NCT00353782|Dyslipoproteinemia|dyslipoproteinemia
5323002|NCT00353782|Hypercholesterolemia|hypercholesterolemia
5323003|NCT00353782|hypoalphalipoproteinemia|hypoalphalipoproteinemia
5323004|NCT00353769|scalp laceration|scalp laceration
5323005|NCT00353769|tissue adhesive|tissue adhesive
5323006|NCT00353769|wound care|wound care
5323007|NCT00353769|cost effectiveness|cost effectiveness
5323008|NCT00353743|infected abortion|infected abortion
5323009|NCT00353743|treatment period|treatment period
5323010|NCT00353743|doxycycline|doxycycline
5323011|NCT00353743|metronidazole|metronidazole
5323012|NCT00353743|placebo|placebo
5323013|NCT00353730|Serial Analysis of Gene Expression|serial analysis of gene expression
5323014|NCT00353730|Carotid Artery Plaque|carotid artery plaque
5323015|NCT00353730|Atherosclerosis|atherosclerosis
5323016|NCT00353717|breast|breast
5323017|NCT00353717|basal like|basal like
5323018|NCT00353717|carcinoma|carcinoma
5323019|NCT00353717|metastatic|metastatic
5323020|NCT00353717|EGFR|egfr
5323021|NCT00353704|Intervertebral disk displacement|intervertebral disk displacement
5323022|NCT00353704|disk prolapse|disk prolapse
5323023|NCT00353704|pregabalin|pregabalin
5323024|NCT00353678|Hip replacement|hip replacement
5323025|NCT00353678|Arthroplasty|arthroplasty
5323026|NCT00353678|Prevention|prevention
5323027|NCT00353678|Thromboembolism|thromboembolism
5323028|NCT00353678|Treatment outcomes|treatment outcomes
5323029|NCT00353678|Arthroplasty, replacement, hip|arthroplasty, replacement, hip
5323030|NCT00353665|amyotrophic lateral sclerosis|amyotrophic lateral sclerosis
5323031|NCT00353665|motor neuron disease|motor neuron disease
5323032|NCT00353665|memantine|memantine
5323033|NCT00353665|clinical trial|clinical trial
5323034|NCT00353652|Blood Pressure, High|blood pressure, high
5323035|NCT00353639|Ulcera|ulcera
5323036|NCT00353639|Telomerase|telomerase
5323037|NCT00353639|TERT|tert
5323038|NCT00353639|TERC|terc
5323039|NCT00353639|SBDS|sbds
5323040|NCT00353639|DNA Helicase|dna helicase
5323041|NCT00353639|Inflammatory Bowel Disease|inflammatory bowel disease
5323042|NCT00353639|IBD|ibd
5323043|NCT00353626|Amputation|amputation
5323044|NCT00353626|trans tibial|trans tibial
5323045|NCT00353626|prosthesis|prosthesis
5323046|NCT00353626|motion analysis|motion analysis
5323047|NCT00353613|Antibiotic prophylaxis|antibiotic prophylaxis
5323048|NCT00353600|Proteinuria|proteinuria
5323049|NCT00353600|Renal Failure|renal failure
5323050|NCT00353600|Angiotension Converting Enzyme Inhibitor|angiotension converting enzyme inhibitor
5323051|NCT00353600|Glomerular Filtration Rate|glomerular filtration rate
5323052|NCT00353587|insulin sensitizer|insulin sensitizer
5323053|NCT00353587|type 2 diabetes|type 2 diabetes
5323054|NCT00353587|diabetes|diabetes
5323055|NCT00353587|glucose control|glucose control
5323056|NCT00353574|Resistant Hypertension|resistant hypertension
5323057|NCT00353548|Bulimia Nervosa|bulimia nervosa
5323058|NCT00353548|Binge Eating Disorder|binge eating disorder
5323059|NCT00353548|Obesity|obesity
5323060|NCT00353548|Anorexia Nervosa|anorexia nervosa
5323061|NCT00353535|glomerulosclerosis, focal|glomerulosclerosis, focal
5323062|NCT00353535|pretransplant immunosuppression|pretransplant immunosuppression
5323063|NCT00353535|total lymphoid irradiation|total lymphoid irradiation
5323064|NCT00353535|renal transplant|renal transplant
5323065|NCT00353535|recurrence|recurrence
5323066|NCT00353496|Non functioning entero-pancreatic tumours|non functioning entero-pancreatic tumours
5323067|NCT00353483|Breast Cancer|breast cancer
5323068|NCT00353483|Neoadjuvant|neoadjuvant
5323069|NCT00353470|PD|pd
5323070|NCT00353470|CBT|cbt
5323071|NCT00353470|PFPP|pfpp
5323072|NCT00353457|Adjuvant therapy|adjuvant therapy
5323073|NCT00353457|Rectal cancer|rectal cancer
5323074|NCT00353457|Capecitabine|capecitabine
5323075|NCT00353457|Oxaliplatin|oxaliplatin
5323076|NCT00353457|Cetuximab|cetuximab
5323077|NCT00353457|Erbitux|erbitux
5323078|NCT00353444|head injury|head injury
5323079|NCT00353444|transcranial Doppler|transcranial doppler
5323080|NCT00353444|pulsatility index|pulsatility index
5323081|NCT00353444|vasospasm in head injury|vasospasm in head injury
5323082|NCT00353431|Hyperglycaemia|hyperglycaemia
5323083|NCT00353431|algorithm|algorithm
5323084|NCT00353431|emergency|emergency
5323085|NCT00353431|s.c. insulin therapy|s.c. insulin therapy
5323086|NCT00353431|Emergency patient|emergency patient
5323087|NCT00353405|Adolescents|adolescents
5323088|NCT00353405|Sexually Transmitted Infections|sexually transmitted infections
5323089|NCT00353405|Gonorrhea|gonorrhea
5323090|NCT00353405|Chlamydia Infections|chlamydia infections
5323091|NCT00353366|safety|safety
5323092|NCT00353366|Post-marketing surveillance (PMS)|post-marketing surveillance (pms)
5323093|NCT00353366|Rotarix|rotarix
5323094|NCT00353366|oral|oral
5323095|NCT00353366|Filipino|filipino
5323096|NCT00353366|Rotavirus|rotavirus
5323097|NCT00353366|Gastroenteritis|gastroenteritis
5323098|NCT00353366|Human Rotavirus (HRV) vaccine|human rotavirus (hrv) vaccine
5323099|NCT00353353|no specific conditions|no specific conditions
5323100|NCT00353340|sodium bicarbonate,|sodium bicarbonate,
5323101|NCT00353340|n-acetylcisteine,|n-acetylcisteine,
5323102|NCT00353340|contrast nephropathy,|contrast nephropathy,
5323103|NCT00353340|cardiac catheterisation|cardiac catheterisation
5323104|NCT00353327|HIV|hiv
5323105|NCT00353327|Passive immunotherapy|passive immunotherapy
5323106|NCT00353301|Carcinoma, Renal Cell|carcinoma, renal cell
5323107|NCT00353301|Receptor, Epidermal Growth Factor|receptor, epidermal growth factor
5323108|NCT00353301|mTOR protein|mtor protein
5323109|NCT00353301|Sirolimus|sirolimus
5323110|NCT00353301|Erlotinib|erlotinib
5323111|NCT00353275|Strict glycemic control|strict glycemic control
5323112|NCT00353249|Cognitive Behavioral Therapy|cognitive behavioral therapy
5323113|NCT00353249|CBT|cbt
5323114|NCT00353249|Homeless Women|homeless women
5323115|NCT00353236|delivery of preterm infant and/or twins|delivery of preterm infant and/or twins
5323116|NCT00353223|Heart Failure|heart failure
5323117|NCT00353223|Functional Impairment|functional impairment
5323118|NCT00353223|Health-Related Quality of Life|health-related quality of life
5323119|NCT00353223|Telemedicine|telemedicine
5323120|NCT00353210|IVF|ivf
5323121|NCT00353210|embryos|embryos
5323122|NCT00353210|research|research
5323123|NCT00353210|donation|donation
5323124|NCT00353210|surplus|surplus
5323125|NCT00353210|stem cells|stem cells
5323126|NCT00353210|abnormal embryo|abnormal embryo
5323127|NCT00353210|screening|screening
5323128|NCT00353197|IVF|ivf
5323129|NCT00353197|embryos|embryos
5323130|NCT00353197|research|research
5323131|NCT00353197|donation|donation
5323132|NCT00353197|surplus|surplus
5323133|NCT00353197|stem cells|stem cells
5323134|NCT00353184|Acute|acute
5323135|NCT00353184|Asthma|asthma
5323136|NCT00353184|Child|child
5323137|NCT00353184|Pediatric|pediatric
5323138|NCT00353184|Emergency|emergency
5323139|NCT00353184|Oral|oral
5323140|NCT00353184|Montelukast|montelukast
5323141|NCT00353184|Forced Expiratory Volume in One Second|forced expiratory volume in one second
5323142|NCT00353184|FEV1|fev1
5323143|NCT00353171|Smoking|smoking
5323144|NCT00353171|PCB|pcb
5323145|NCT00353171|DDE|dde
5323146|NCT00353171|Menstrual Cycle|menstrual cycle
5323147|NCT00353171|NC Infant Feeding Study|nc infant feeding study
5323148|NCT00353158|Phototesting|phototesting
5323149|NCT00353158|UVR/UVA|uvr/uva
5323150|NCT00353158|Sunburn|sunburn
5323151|NCT00353158|Doxycycline|doxycycline
5323152|NCT00353158|Voriconazole|voriconazole
5323153|NCT00353158|Phototoxicity|phototoxicity
5323154|NCT00353158|Healthy Volunteer|healthy volunteer
5323155|NCT00353158|HV|hv
5323156|NCT00353145|Unknown Primary Neoplasms|unknown primary neoplasms
5323157|NCT00353145|UPC|upc
5323158|NCT00353145|Unknown Primary Cancer|unknown primary cancer
5323159|NCT00353145|Questionnaire|questionnaire
5323160|NCT00353145|Gemcitabine|gemcitabine
5323161|NCT00353145|Gemcitabine Hydrochloride|gemcitabine hydrochloride
5323162|NCT00353145|Gemzar|gemzar
5323163|NCT00353145|Oxaliplatin|oxaliplatin
5323164|NCT00353145|Eloxatin|eloxatin
5323165|NCT00353145|Gemox|gemox
5323166|NCT00353119|Palmoplantar pustulosis|palmoplantar pustulosis
5323167|NCT00353119|Psoriasis|psoriasis
5323168|NCT00353119|Etanercept|etanercept
5323169|NCT00353106|Graft-Versus-Host Disease|graft-versus-host disease
5323170|NCT00353106|GVHD|gvhd
5323171|NCT00353106|Chronic Graft-Versus-Host Disease|chronic graft-versus-host disease
5323172|NCT00353106|cGVHD|cgvhd
5323173|NCT00353106|Interview|interview
5323174|NCT00353106|Questionnaire|questionnaire
5323175|NCT00353106|Survey|survey
5323176|NCT00353106|Caregiver|caregiver
5323177|NCT00353093|deep vein thrombosis,D-dimer,ultrasonography|deep vein thrombosis,d-dimer,ultrasonography
5323178|NCT00353080|Prevention of postmenopausal osteoporosis|prevention of postmenopausal osteoporosis
5323179|NCT00353067|unstable angina|unstable angina
5323180|NCT00353067|myocardial infarction|myocardial infarction
5323181|NCT00353067|coronary thrombosis|coronary thrombosis
5323182|NCT00353067|coronary atherosclerosis|coronary atherosclerosis
5323183|NCT00353054|Caltrate|caltrate
5323184|NCT00353054|Lipoproteins|lipoproteins
5323185|NCT00353054|Glucose|glucose
5323186|NCT00353054|Insulin|insulin
5323187|NCT00353054|Blood pressure|blood pressure
5323188|NCT00353054|Body fat|body fat
5323189|NCT00353054|Body weight|body weight
5323190|NCT00353054|Women|women
5323191|NCT00353054|Diet|diet
5323192|NCT00353054|Macronutrients|macronutrients
5323193|NCT00353041|topical|topical
5323194|NCT00353041|anesthetic|anesthetic
5323195|NCT00353041|pain|pain
5323196|NCT00353028|Fluvoxamine Maleate|fluvoxamine maleate
5323197|NCT00353028|Depression|depression
5323198|NCT00353028|Children and Adolescents|children and adolescents
5323199|NCT00353015|Gastrointestinal cancer|gastrointestinal cancer
5323200|NCT00353015|high grade gastrointestinal neuroendocrine carcinoma|high grade gastrointestinal neuroendocrine carcinoma
5323201|NCT00353015|High grade neuroendocrine carcinoma of unknown primary site|high grade neuroendocrine carcinoma of unknown primary site
5323202|NCT00353015|Cisplatin|cisplatin
5323203|NCT00353015|Platinol-AQ|platinol-aq
5323204|NCT00353015|Platinol|platinol
5323205|NCT00353015|CDDP|cddp
5323206|NCT00353015|CPT-11|cpt-11
5323207|NCT00353015|Irinotecan|irinotecan
5323208|NCT00353002|Pain|pain
5323209|NCT00353002|Ametop|ametop
5323210|NCT00353002|Liposomal Lidocaine|liposomal lidocaine
5323211|NCT00353002|Venous cannulation|venous cannulation
5323212|NCT00352976|Bone Marrow transplant|bone marrow transplant
5323213|NCT00352976|stem cell transplant|stem cell transplant
5323214|NCT00352976|cord blood transplant|cord blood transplant
5323215|NCT00352976|total body irradiation|total body irradiation
5323216|NCT00352976|thymic shielding|thymic shielding
5323217|NCT00352963|Open, phase 3, Infanrix hexa™, Hib-MenC, co-administered|open, phase 3, infanrix hexa™, hib-menc, co-administered
5323218|NCT00352950|NSCLC, Lung cancer|nsclc, lung cancer
5323219|NCT00352950|Panitumumab|panitumumab
5323220|NCT00352950|Sirolimus|sirolimus
5323221|NCT00352950|mTOR|mtor
5323222|NCT00352950|Monoclonal antibody|monoclonal antibody
5323223|NCT00352937|Coronary Arteriosclerosis|coronary arteriosclerosis
5323224|NCT00352937|Tomography, X-Ray Computed|tomography, x-ray computed
5323225|NCT00352937|Tomography, Emission-Computed, Single-Photon|tomography, emission-computed, single-photon
5323226|NCT00352924|Cancer|cancer
5323227|NCT00352924|Pesticides|pesticides
5323228|NCT00352924|Agriculture|agriculture
5323229|NCT00352911|HIV-1|hiv-1
5323230|NCT00352885|Cancer|cancer
5323231|NCT00352885|IL-2 therapy|il-2 therapy
5323232|NCT00352885|Antidepressant|antidepressant
5323233|NCT00352885|Immune system|immune system
5323234|NCT00352885|Neuroendocrine response|neuroendocrine response
5323235|NCT00352872|Pharmacogenetics|pharmacogenetics
5323236|NCT00352872|Toxicity|toxicity
5323237|NCT00352872|Pre-Menopausal|pre-menopausal
5323238|NCT00352872|Women|women
5323239|NCT00352872|Doxorubicin|doxorubicin
5323240|NCT00352872|Cyclophosphamide|cyclophosphamide
5323241|NCT00352872|Breast Cancer|breast cancer
5323242|NCT00352872|Chemotherapy|chemotherapy
5323243|NCT00352859|Cancer|cancer
5323244|NCT00352859|Renal Cell Cancer|renal cell cancer
5323245|NCT00352859|RCC|rcc
5323246|NCT00352846|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
5323247|NCT00352846|Lymphoma|lymphoma
5323248|NCT00352846|Zoledronic Acid|zoledronic acid
5323249|NCT00352846|Zoledronate|zoledronate
5323250|NCT00352846|Zometa|zometa
5323251|NCT00352846|Vitamin D|vitamin d
5323252|NCT00352846|Calcium Carbonate|calcium carbonate
5323253|NCT00352846|Bone Loss|bone loss
5323254|NCT00352833|gastric cancer|gastric cancer
5323255|NCT00352833|investigational drug|investigational drug
5323256|NCT00352833|adjuvant therapy|adjuvant therapy
5323257|NCT00352833|intraoperative|intraoperative
5323258|NCT00352833|intraperitoneal|intraperitoneal
5323259|NCT00352833|EpCAM-positive tumor|epcam-positive tumor
5323260|NCT00352820|Caregiver|caregiver
5323261|NCT00352820|Brain cancer|brain cancer
5323262|NCT00352820|Glioma|glioma
5323263|NCT00352820|Questionnaire|questionnaire
5323264|NCT00352820|Survey|survey
5323265|NCT00352820|Interview|interview
5323266|NCT00352807|Cataract|cataract
5323267|NCT00352794|Combination chemotherapy|combination chemotherapy
5323268|NCT00352794|Myelofibrosis (MF)|myelofibrosis (mf)
5323269|NCT00352781|nicotine replacement therapy|nicotine replacement therapy
5323270|NCT00352781|smoking cessation|smoking cessation
5323271|NCT00352768|Fluvoxamine Maleate|fluvoxamine maleate
5323272|NCT00352768|OCD|ocd
5323273|NCT00352768|Children and Adolescents|children and adolescents
5323274|NCT00352742|Multiple myeloma|multiple myeloma
5323275|NCT00352742|bortezomib|bortezomib
5323276|NCT00352742|ATN-224|atn-224
5323277|NCT00352742|refractory|refractory
5323278|NCT00352742|relapsed|relapsed
5323279|NCT00352742|antiangiogenic|antiangiogenic
5323280|NCT00352729|Burns|burns
5323281|NCT00352729|ACell|acell
5323282|NCT00352729|Donor Site|donor site
5323283|NCT00352703|Oral mucositis|oral mucositis
5323284|NCT00352703|Non-Hodgkin's lymphoma (NHL)|non-hodgkin's lymphoma (nhl)
5323285|NCT00352703|conditioning chemotherapy|conditioning chemotherapy
5323286|NCT00352703|autologous PBSCT|autologous pbsct
5323287|NCT00352703|multiple myeloma (MM)|multiple myeloma (mm)
5323288|NCT00352703|Melphalan|melphalan
5323289|NCT00352664|Advanced Cancer|advanced cancer
5323290|NCT00352664|Cancer Pain|cancer pain
5323291|NCT00352664|Donepezil|donepezil
5323292|NCT00352664|Sedation|sedation
5323293|NCT00352664|Placebo|placebo
5323294|NCT00352651|Acute Herpes Zoster (AHZ)|acute herpes zoster (ahz)
5323295|NCT00352651|Postherpetic Neuralgia (PHN)|postherpetic neuralgia (phn)
5323296|NCT00352651|Pregabalin|pregabalin
5323297|NCT00352651|Lyrica|lyrica
5323298|NCT00352651|Pain|pain
5323299|NCT00352638|colon cancer|colon cancer
5323300|NCT00352638|rectal cancer|rectal cancer
5323301|NCT00352625|Tendonitis|tendonitis
5323302|NCT00352625|Bursitis|bursitis
5323303|NCT00352625|Pain|pain
5323304|NCT00352625|Shoulder Pain|shoulder pain
5323305|NCT00352625|Elbow Pain|elbow pain
5323306|NCT00352625|Knee Pain|knee pain
5323307|NCT00352625|Tendon Injury|tendon injury
5323308|NCT00352625|Muscle, Bone and Cartilage Disorders|muscle, bone and cartilage disorders
5323309|NCT00352612|clinical trial|clinical trial
5323310|NCT00352612|randomized|randomized
5323311|NCT00352612|blinded|blinded
5323312|NCT00352612|controlled|controlled
5323313|NCT00352599|Neurofibromatosis Type 1|neurofibromatosis type 1
5323314|NCT00352599|NF1|nf1
5323315|NCT00352599|Lovastatin|lovastatin
5323316|NCT00352599|statin|statin
5323317|NCT00352586|Classical Conditioning|classical conditioning
5323318|NCT00352586|Learning|learning
5323319|NCT00352586|NMDA|nmda
5323320|NCT00352586|Startle|startle
5323321|NCT00352586|Eyeblink|eyeblink
5323322|NCT00352586|Anxiety|anxiety
5323323|NCT00352586|Fear Conditioning|fear conditioning
5323324|NCT00352586|Fear Potentiated Startle|fear potentiated startle
5323325|NCT00352586|Extinction|extinction
5323326|NCT00352586|D-cycloserine|d-cycloserine
5323327|NCT00352586|Healthy Volunteer|healthy volunteer
5323328|NCT00352586|HV|hv
5323329|NCT00352586|Normal Control|normal control
5323330|NCT00352573|Ethics, Clinical|ethics, clinical
5323331|NCT00352573|Physician's Role|physician's role
5323332|NCT00352573|Health Care Rationing|health care rationing
5323333|NCT00352573|Knowledge, Attitudes, Practices|knowledge, attitudes, practices
5323334|NCT00352573|Questionnaires|questionnaires
5323335|NCT00352573|Survey|survey
5323336|NCT00352573|Ethics|ethics
5323337|NCT00352560|Patients with Paroxysmal Atrial Fibrillation (PAF)|patients with paroxysmal atrial fibrillation (paf)
5323338|NCT00352547|Immunosuppresant|immunosuppresant
5323339|NCT00352547|Genetic Polymorphism|genetic polymorphism
5323340|NCT00352547|Drug Metabolism|drug metabolism
5323341|NCT00352547|Pharmacogenetics|pharmacogenetics
5323342|NCT00352547|Rapamycin|rapamycin
5323343|NCT00352521|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5323344|NCT00352521|adult mixed glioma|adult mixed glioma
5323345|NCT00352521|adult giant cell glioblastoma|adult giant cell glioblastoma
5323346|NCT00352521|adult gliosarcoma|adult gliosarcoma
5323347|NCT00352521|recurrent adult brain tumor|recurrent adult brain tumor
5323348|NCT00352521|adult glioblastoma|adult glioblastoma
5323349|NCT00352521|adult anaplastic ependymoma|adult anaplastic ependymoma
5323350|NCT00352521|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
5323351|NCT00352521|adult pineal gland astrocytoma|adult pineal gland astrocytoma
5323352|NCT00352508|Internet, dietary advice, saturated fat|internet, dietary advice, saturated fat
5323353|NCT00352495|childhood low-grade cerebral astrocytoma|childhood low-grade cerebral astrocytoma
5323354|NCT00352495|recurrent childhood cerebellar astrocytoma|recurrent childhood cerebellar astrocytoma
5323355|NCT00352495|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
5323436|NCT00352352|Children|children
5323356|NCT00352495|childhood oligodendroglioma|childhood oligodendroglioma
5323357|NCT00352495|neurofibromatosis type 1|neurofibromatosis type 1
5323358|NCT00352495|recurrent childhood visual pathway and hypothalamic glioma|recurrent childhood visual pathway and hypothalamic glioma
5323359|NCT00352495|untreated childhood visual pathway and hypothalamic glioma|untreated childhood visual pathway and hypothalamic glioma
5323360|NCT00352482|Pulmonary Hypertension|pulmonary hypertension
5323361|NCT00352482|Idiopathic Pulmonary Fibrosis|idiopathic pulmonary fibrosis
5323362|NCT00352469|Alcoholism|alcoholism
5323363|NCT00352469|Anxiety|anxiety
5323364|NCT00352469|GAD|gad
5323365|NCT00352469|PTSD|ptsd
5323366|NCT00352469|Panic Disorder|panic disorder
5323367|NCT00352469|OCD|ocd
5323368|NCT00352456|Amygdala|amygdala
5323369|NCT00352456|Facial Affect|facial affect
5323370|NCT00352456|Instrumental Learning|instrumental learning
5323371|NCT00352456|Psychopathy|psychopathy
5323372|NCT00352456|Emotion|emotion
5323373|NCT00352456|Orbitofrontal Cortex|orbitofrontal cortex
5323374|NCT00352456|Healthy Volunteer|healthy volunteer
5323375|NCT00352456|HV|hv
5323376|NCT00352443|adult grade III lymphomatoid granulomatosis|adult grade iii lymphomatoid granulomatosis
5323377|NCT00352443|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
5323378|NCT00352443|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
5323379|NCT00352443|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5323380|NCT00352443|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5323381|NCT00352443|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5323382|NCT00352443|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5323383|NCT00352443|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5323384|NCT00352443|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5323385|NCT00352443|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5323386|NCT00352443|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5323387|NCT00352443|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5323388|NCT00352443|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5323389|NCT00352443|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5323390|NCT00352443|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5323391|NCT00352443|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5323392|NCT00352443|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5323393|NCT00352443|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5323394|NCT00352443|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5323395|NCT00352443|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5323396|NCT00352443|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5323397|NCT00352443|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5323398|NCT00352443|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5323399|NCT00352443|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5323400|NCT00352443|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5323401|NCT00352443|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5323402|NCT00352443|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5323403|NCT00352443|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5323404|NCT00352443|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5323405|NCT00352443|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5323406|NCT00352443|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5323407|NCT00352443|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5323408|NCT00352443|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
5323409|NCT00352443|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
5323410|NCT00352430|Nitric Oxide|nitric oxide
5323411|NCT00352430|PDE Inhibitors|pde inhibitors
5323412|NCT00352430|Pulmonary Hypertension|pulmonary hypertension
5323413|NCT00352430|Sickle Cell|sickle cell
5323414|NCT00352430|Thalassemia|thalassemia
5323415|NCT00352430|Sickle Cell Anemia|sickle cell anemia
5323416|NCT00352404|Endomicroscopy|endomicroscopy
5323417|NCT00352404|Chromoendoscopy|chromoendoscopy
5323418|NCT00352404|Chromoscopy|chromoscopy
5323419|NCT00352404|Ulcerative Colitis|ulcerative colitis
5323420|NCT00352404|Intraepithelial Neoplasia|intraepithelial neoplasia
5323421|NCT00352391|Non-Small Cell Lung Cancer|non-small cell lung cancer
5323422|NCT00352391|Head And Neck Cancer|head and neck cancer
5323423|NCT00352391|Lung Cancer|lung cancer
5323424|NCT00352391|Bronchoscopy|bronchoscopy
5323425|NCT00352391|Laryngoscopy|laryngoscopy
5323426|NCT00352391|NSCLC|nsclc
5323427|NCT00352391|Disease Free Survival|disease free survival
5323428|NCT00352391|Current Smoker|current smoker
5323429|NCT00352391|Former Smoker|former smoker
5323430|NCT00352378|Primary|primary
5323431|NCT00352352|Traditional Chinese Medicine (TCM)|traditional chinese medicine (tcm)
5323432|NCT00352352|Alternative Medicine (AM)|alternative medicine (am)
5323433|NCT00352352|Tongue Acupuncture (TAC)|tongue acupuncture (tac)
5323434|NCT00352352|Autism Spectrum Disorder (ASD)|autism spectrum disorder (asd)
5323435|NCT00352352|Autism|autism
5323437|NCT00352339|Schizophrenia|schizophrenia
5323438|NCT00352339|Switching|switching
5323439|NCT00352339|Early stage|early stage
5323440|NCT00352339|Risperidone|risperidone
5323441|NCT00352339|Aripirazole|aripirazole
5323442|NCT00352313|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
5323443|NCT00352313|adult gliosarcoma|adult gliosarcoma
5323444|NCT00352313|adult mixed glioma|adult mixed glioma
5323445|NCT00352313|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5323446|NCT00352313|recurrent adult brain tumor|recurrent adult brain tumor
5323447|NCT00352313|adult glioblastoma|adult glioblastoma
5323448|NCT00352313|adult giant cell glioblastoma|adult giant cell glioblastoma
5323449|NCT00352287|Visceral fat|visceral fat
5323450|NCT00352287|Impaired glucose tolerance|impaired glucose tolerance
5323451|NCT00352287|Insulin resistance|insulin resistance
5323452|NCT00352287|Growth hormone|growth hormone
5323453|NCT00352287|Thiazolidinedione|thiazolidinedione
5323454|NCT00352261|Barrett's Esophagus|barrett's esophagus
5323455|NCT00352248|Alternative Medicine (AM)|alternative medicine (am)
5323456|NCT00352248|Traditional Chinese Medicine|traditional chinese medicine
5323457|NCT00352248|Tongue Acupuncture|tongue acupuncture
5323458|NCT00352248|Autistic Spectrum Disorder|autistic spectrum disorder
5323459|NCT00352248|Autism|autism
5323460|NCT00352248|Children|children
5323461|NCT00352235|Chronic hepatitis C|chronic hepatitis c
5323462|NCT00352235|KRN7000|krn7000
5323463|NCT00352235|a-GalCer|a-galcer
5323464|NCT00352235|immunotherapy|immunotherapy
5323465|NCT00352235|Natural Killer T cells|natural killer t cells
5323466|NCT00352235|interferon|interferon
5323467|NCT00352222|iliac arteries|iliac arteries
5323468|NCT00352222|implantation|implantation
5323469|NCT00352222|treatment of atherosclerotic disease|treatment of atherosclerotic disease
5323470|NCT00352222|stenosed|stenosed
5323471|NCT00352222|occlusive|occlusive
5323472|NCT00352209|Cyclophosphamide|cyclophosphamide
5323473|NCT00352209|Preparative Regimens|preparative regimens
5323474|NCT00352209|Risk Factors|risk factors
5323475|NCT00352209|Chart Review|chart review
5323476|NCT00352209|Incidence|incidence
5323477|NCT00352196|Asperger's Disorder|asperger's disorder
5323478|NCT00352196|Risperidone|risperidone
5323479|NCT00352196|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
5323480|NCT00352196|Social Skills|social skills
5323481|NCT00352183|Hyperlipidemia Combined|hyperlipidemia combined
5323482|NCT00352183|Combination of fenofibrate and simvastatin|combination of fenofibrate and simvastatin
5323483|NCT00352170|calcium|calcium
5323484|NCT00352170|vitamin D|vitamin d
5323485|NCT00352170|secondary hyperparathyroidism|secondary hyperparathyroidism
5323486|NCT00352170|osteoporotic fractures|osteoporotic fractures
5323487|NCT00352157|Soy|soy
5323488|NCT00352157|Dermatology|dermatology
5323489|NCT00352157|Skin|skin
5323490|NCT00352157|Hair|hair
5323491|NCT00352157|Finger Nails|finger nails
5323492|NCT00352157|Weight Loss|weight loss
5323493|NCT00352157|Body Mass Index|body mass index
5323494|NCT00352157|Photoaging of Skin|photoaging of skin
5323495|NCT00352157|Skin Wrinkling|skin wrinkling
5323496|NCT00352131|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5323497|NCT00352131|stage II pancreatic cancer|stage ii pancreatic cancer
5323498|NCT00352131|stage III pancreatic cancer|stage iii pancreatic cancer
5323499|NCT00352131|stage IV pancreatic cancer|stage iv pancreatic cancer
5323500|NCT00352131|recurrent pancreatic cancer|recurrent pancreatic cancer
5323501|NCT00352118|oral complications of radiation therapy|oral complications of radiation therapy
5323502|NCT00352118|oral complications of chemotherapy|oral complications of chemotherapy
5323503|NCT00352118|mucositis|mucositis
5323504|NCT00352118|xerostomia|xerostomia
5323505|NCT00352118|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
5323506|NCT00352118|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5323507|NCT00352118|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
5323508|NCT00352118|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5323509|NCT00352118|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
5323510|NCT00352118|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5323511|NCT00352118|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
5323512|NCT00352118|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5323513|NCT00352105|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
5323514|NCT00352105|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5323515|NCT00352105|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
5323516|NCT00352105|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5323517|NCT00352105|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
5323518|NCT00352105|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5323519|NCT00352105|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
5323616|NCT00351819|Opioid|opioid
5323617|NCT00351819|Hypogonadism|hypogonadism
5323520|NCT00352105|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5323521|NCT00352092|Kidney disease|kidney disease
5323522|NCT00352092|Renal transplant|renal transplant
5323523|NCT00352092|HLA Identical|hla identical
5323524|NCT00352092|Living Donor|living donor
5323525|NCT00352092|Corticosteroid free|corticosteroid free
5323526|NCT00352092|Calcineurin sparing|calcineurin sparing
5323527|NCT00352092|Adults|adults
5323528|NCT00352079|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
5323529|NCT00352079|stage 0 bladder cancer|stage 0 bladder cancer
5323530|NCT00352079|stage I bladder cancer|stage i bladder cancer
5323531|NCT00352079|recurrent bladder cancer|recurrent bladder cancer
5323532|NCT00352066|Human Immunodeficiency Virus|human immunodeficiency virus
5323533|NCT00352066|anti-retroviral therapy|anti-retroviral therapy
5323534|NCT00352066|nucleoside analogue|nucleoside analogue
5323535|NCT00352066|reverse transcriptase|reverse transcriptase
5323536|NCT00352066|apricitabine|apricitabine
5323537|NCT00352066|tipranavir|tipranavir
5323538|NCT00352066|bioequivalence|bioequivalence
5323539|NCT00352066|drug-drug interaction|drug-drug interaction
5323540|NCT00352066|pharmacokinetics|pharmacokinetics
5323541|NCT00352053|Phase 3|phase 3
5323542|NCT00352053|Randomized, Double-Blind|randomized, double-blind
5323543|NCT00352053|Control|control
5323544|NCT00352053|Treatment-Experienced|treatment-experienced
5323545|NCT00352053|OBR|obr
5323546|NCT00352053|Optimized background regimen|optimized background regimen
5323547|NCT00352053|Highly Active Antiretroviral Therapy|highly active antiretroviral therapy
5323548|NCT00352053|HAART|haart
5323549|NCT00352053|HIV|hiv
5323550|NCT00352053|HIV-1|hiv-1
5323551|NCT00352053|AIDS Virus|aids virus
5323552|NCT00352053|Human Immunodeficiency Virus|human immunodeficiency virus
5323553|NCT00352053|Acquired Immune Deficiency Syndrome Virus|acquired immune deficiency syndrome virus
5323554|NCT00352053|Virus|virus
5323555|NCT00352053|Human Immunodeficiency|human immunodeficiency
5323556|NCT00352053|Pediatrics|pediatrics
5323557|NCT00352027|Hodgkin's Disease|hodgkin's disease
5323558|NCT00352014|Monitoring of antiplatelet therapy|monitoring of antiplatelet therapy
5323559|NCT00352014|antiplatelet therapy|antiplatelet therapy
5323560|NCT00352014|platelet function assays|platelet function assays
5323561|NCT00352014|Aspirin|aspirin
5323562|NCT00352014|Clopidogrel|clopidogrel
5323563|NCT00352014|elective PCI|elective pci
5323564|NCT00352001|refractory anemia with excess blasts|refractory anemia with excess blasts
5323565|NCT00352001|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5323566|NCT00352001|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5323567|NCT00352001|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5323568|NCT00352001|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5323569|NCT00351988|Lung Cancer|lung cancer
5323570|NCT00351988|Non-Small Cell Lung Cancer|non-small cell lung cancer
5323571|NCT00351988|Breast Cancer|breast cancer
5323572|NCT00351988|Psychosocial|psychosocial
5323573|NCT00351988|Behavioral|behavioral
5323574|NCT00351988|Caregiver|caregiver
5323575|NCT00351988|Interview|interview
5323576|NCT00351988|Questionnaire|questionnaire
5323577|NCT00351988|Minority Caregiver|minority caregiver
5323578|NCT00351988|Non-Minority Caregiver|non-minority caregiver
5323579|NCT00351988|Survey|survey
5323580|NCT00351962|lung neoplasms|lung neoplasms
5323581|NCT00351962|metastatic lung cancer|metastatic lung cancer
5323582|NCT00351962|stereotactic radiation|stereotactic radiation
5323583|NCT00351949|Advanced or metastatic renal cell carcinoma|advanced or metastatic renal cell carcinoma
5323584|NCT00351949|IMP321|imp321
5323585|NCT00351949|Monotherapy|monotherapy
5323586|NCT00351949|LAG-3|lag-3
5323587|NCT00351949|CD223|cd223
5323588|NCT00351936|Schizophrenia|schizophrenia
5323589|NCT00351936|Diabetes|diabetes
5323590|NCT00351936|Obesity|obesity
5323591|NCT00351936|Olanzapine|olanzapine
5323592|NCT00351936|Insulin Resistance|insulin resistance
5323593|NCT00351910|Major Depressive Disorder|major depressive disorder
5323594|NCT00351910|MDD|mdd
5323595|NCT00351884|Type 2 diabetes|type 2 diabetes
5323596|NCT00351884|vildagliptin|vildagliptin
5323597|NCT00351884|Hemoglobin A1c|hemoglobin a1c
5323598|NCT00351871|HCV|hcv
5323599|NCT00351858|Breast Cancer|breast cancer
5323600|NCT00351858|investigational drug|investigational drug
5323601|NCT00351858|drug therapy|drug therapy
5323602|NCT00351858|Antineoplastic Protocols|antineoplastic protocols
5323603|NCT00351858|Immunotherapy|immunotherapy
5323604|NCT00351858|Metastatic breast cancer|metastatic breast cancer
5323605|NCT00351858|Advanced breast cancer|advanced breast cancer
5323606|NCT00351858|Stage III to IV breast cancer|stage iii to iv breast cancer
5323607|NCT00351858|Hormonal therapy refractory|hormonal therapy refractory
5323608|NCT00351858|Failure of hormonal therapy|failure of hormonal therapy
5323609|NCT00351858|Her-2/neu expressing breast cancer|her-2/neu expressing breast cancer
5323610|NCT00351858|low to moderate Her-2/neu expression|low to moderate her-2/neu expression
5323611|NCT00351832|Type 2 diabetes|type 2 diabetes
5323612|NCT00351832|Vildagliptin|vildagliptin
5323613|NCT00351832|Hemoglobin A1c|hemoglobin a1c
5323614|NCT00351819|Testosterone|testosterone
5323615|NCT00351819|Pain|pain
5323618|NCT00351806|acute intracerebral infarction|acute intracerebral infarction
5323619|NCT00351780|fractional flow reserve|fractional flow reserve
5323620|NCT00351780|bifurcation|bifurcation
5323621|NCT00351780|stent|stent
5323622|NCT00351767|Diabetes|diabetes
5323623|NCT00351767|Dabetic Feet|dabetic feet
5323624|NCT00351741|Burns|burns
5323625|NCT00351715|Sublingual Methadone|sublingual methadone
5323626|NCT00351715|Cancer related breakthrough pain|cancer related breakthrough pain
5323627|NCT00351715|feasibility study|feasibility study
5323628|NCT00351715|Phase II/open label|phase ii/open label
5323629|NCT00351715|Outpatients|outpatients
5323630|NCT00351715|Safety/ efficacy|safety/ efficacy
5323631|NCT00351715|previously receiving opioids|previously receiving opioids
5323632|NCT00351715|speak English|speak english
5323633|NCT00351702|Preventive therapy|preventive therapy
5323634|NCT00351689|Probiotic bacteria|probiotic bacteria
5323635|NCT00351689|cutaneous immune homeostasis|cutaneous immune homeostasis
5323636|NCT00351689|UV radiation|uv radiation
5323637|NCT00351689|dietary supplement|dietary supplement
5323638|NCT00351676|Drug Therapy|drug therapy
5323639|NCT00351676|Hospitals, Teaching|hospitals, teaching
5323640|NCT00351676|Hospitals, Community|hospitals, community
5323641|NCT00351676|Interprofessional relations|interprofessional relations
5323642|NCT00351676|Patient Care Team|patient care team
5323643|NCT00351676|Pharmacists|pharmacists
5323644|NCT00351676|Pharmacy Service, Hospital|pharmacy service, hospital
5323645|NCT00351676|Comparative Study|comparative study
5323646|NCT00351676|Hospitalization|hospitalization
5323647|NCT00351663|Venous Thrombosis|venous thrombosis
5323648|NCT00351663|Critical Illness|critical illness
5323649|NCT00351663|Blood Coagulation|blood coagulation
5323650|NCT00351663|Factor Xa|factor xa
5323651|NCT00351650|Imaging|imaging
5323652|NCT00351650|Type 1 Diabetes Mellitus (T1DM)|type 1 diabetes mellitus (t1dm)
5323653|NCT00351650|Islet|islet
5323654|NCT00351650|B Cell Mass|b cell mass
5323655|NCT00351650|Pet Scan|pet scan
5323656|NCT00351650|Type 1 Diabetes|type 1 diabetes
5323657|NCT00351650|T1DM|t1dm
5323658|NCT00351650|Pancreas|pancreas
5323659|NCT00351650|Healthy Volunteer|healthy volunteer
5323660|NCT00351650|HV|hv
5323661|NCT00351637|Sublingual methadone|sublingual methadone
5323662|NCT00351637|iatrogenic|iatrogenic
5323663|NCT00351637|treatment related incident breakthrough pain|treatment related incident breakthrough pain
5323664|NCT00351637|feasibility study|feasibility study
5323665|NCT00351637|Phase II/open-label|phase ii/open-label
5323666|NCT00351637|inpatients|inpatients
5323667|NCT00351637|Safety/efficacy|safety/efficacy
5323668|NCT00351637|Cancer related breakthrough pain|cancer related breakthrough pain
5323669|NCT00351637|previously receiving opioids|previously receiving opioids
5323670|NCT00351637|speak English|speak english
5323671|NCT00351624|DHA supplementation|dha supplementation
5323672|NCT00351624|Cognitive function|cognitive function
5323673|NCT00351624|Preschool children|preschool children
5323674|NCT00351624|Attention and behavior|attention and behavior
5323675|NCT00351624|Healthy Children|healthy children
5323676|NCT00351611|epilepsy partial seizure treatment with pregabalin or placebo|epilepsy partial seizure treatment with pregabalin or placebo
5323677|NCT00351611|vision testing|vision testing
5323678|NCT00351598|Tumour Volume|tumour volume
5323679|NCT00351598|Prognostic value|prognostic value
5323680|NCT00351585|Vildagliptin|vildagliptin
5323681|NCT00351585|Type 2 diabetes|type 2 diabetes
5323682|NCT00351585|Insulin secretion|insulin secretion
5323683|NCT00351585|Beta cell|beta cell
5323684|NCT00351572|colon cancer|colon cancer
5323685|NCT00351559|allograft|allograft
5323686|NCT00351559|rejection|rejection
5323687|NCT00351559|biopsy|biopsy
5323688|NCT00351559|gene|gene
5323689|NCT00351559|expression|expression
5323690|NCT00351559|cardiac|cardiac
5323691|NCT00351559|heart|heart
5323692|NCT00351559|transplant|transplant
5323693|NCT00351546|Vildagliptin|vildagliptin
5323694|NCT00351546|Type 2 diabetes|type 2 diabetes
5323695|NCT00351546|Insulin sensitivity|insulin sensitivity
5323696|NCT00351546|Insulin action|insulin action
5323697|NCT00351533|Respiratory distress syndrome, adult|respiratory distress syndrome, adult
5323698|NCT00351533|Acute lung injury|acute lung injury
5323699|NCT00351533|Acute respiratory distress syndrome|acute respiratory distress syndrome
5323700|NCT00351533|ARDS, human|ards, human
5323701|NCT00351533|Fish oils|fish oils
5323702|NCT00351533|Fatty Acids, Omega-3|fatty acids, omega-3
5323703|NCT00351533|Docosahexaenoic Acids|docosahexaenoic acids
5323704|NCT00351533|Eicosapentaenoic Acid|eicosapentaenoic acid
5323705|NCT00351520|Anthoponotic Cutaneous leishmaniasis|anthoponotic cutaneous leishmaniasis
5323706|NCT00351520|Glucantime|glucantime
5323707|NCT00351520|Miltefosine|miltefosine
5323708|NCT00351507|Vildagliptin|vildagliptin
5323709|NCT00351507|Type 2 diabetes|type 2 diabetes
5323710|NCT00351494|embolization|embolization
5323711|NCT00351494|contrast enhanced ultrasound|contrast enhanced ultrasound
5323712|NCT00351494|myoma|myoma
5323713|NCT00351494|uterine artery|uterine artery
5323714|NCT00351494|microvascularisation|microvascularisation
5323715|NCT00351481|IVF|ivf
5323716|NCT00351481|endometrial receptivity|endometrial receptivity
5323717|NCT00351481|embryo implantation|embryo implantation
5323718|NCT00351481|recurrent implantation failure|recurrent implantation failure
5323719|NCT00351468|eltrombopag olamine|eltrombopag olamine
5323720|NCT00351468|SB-497115-GR|sb-497115-gr
5323721|NCT00351468|idiopathic thrombocytopenic purpura|idiopathic thrombocytopenic purpura
5323722|NCT00351468|thrombocytopenia|thrombocytopenia
5323723|NCT00351468|ITP|itp
5323724|NCT00351468|platelets|platelets
5323725|NCT00351455|hernia|hernia
5323726|NCT00351455|incisional hernia|incisional hernia
5323727|NCT00351455|ventral hernia|ventral hernia
5323728|NCT00351455|umbilical hernia|umbilical hernia
5323729|NCT00351442|Host Resistance|host resistance
5323730|NCT00351429|Glaucoma|glaucoma
5323731|NCT00351429|Trabeculectomy|trabeculectomy
5323732|NCT00351429|Sutures|sutures
5323733|NCT00351416|GnRH deficiency|gnrh deficiency
5323734|NCT00351416|GnRH antagonist|gnrh antagonist
5323735|NCT00351416|Letrozole|letrozole
5323736|NCT00351416|GnRH|gnrh
5323737|NCT00351416|FSH|fsh
5323738|NCT00351416|LH|lh
5323739|NCT00351416|Inhibins|inhibins
5323740|NCT00351403|Chronic HCV infection|chronic hcv infection
5323741|NCT00351403|Genotype 1|genotype 1
5323742|NCT00351403|Individually adapted therapy|individually adapted therapy
5323743|NCT00351403|Peginterferon alfa-2b|peginterferon alfa-2b
5323744|NCT00351403|Ribavirin|ribavirin
5323745|NCT00351403|Sustained viral response (SVR)|sustained viral response (svr)
5323746|NCT00351390|congestive heart failure treatment|congestive heart failure treatment
5323747|NCT00351390|congestive heart failure, prognosis|congestive heart failure, prognosis
5323748|NCT00351390|NT-proBNP testing|nt-probnp testing
5323749|NCT00351377|Autoimmune disease, mycophenolate, GI problems|autoimmune disease, mycophenolate, gi problems
5323750|NCT00351364|atherosclerosis|atherosclerosis
5323751|NCT00351364|inflammation|inflammation
5323752|NCT00351364|leukotriene blockade|leukotriene blockade
5323753|NCT00351364|endothelial function|endothelial function
5323754|NCT00351351|Kidney Stones|kidney stones
5323755|NCT00351351|Renal Calculi|renal calculi
5323756|NCT00351312|Pressure ulcers|pressure ulcers
5323757|NCT00351312|socks|socks
5323758|NCT00351312|foot pressure|foot pressure
5323759|NCT00351299|Delirium|delirium
5323760|NCT00351299|Agitation|agitation
5323761|NCT00351299|Sedation|sedation
5323762|NCT00351299|Dexmedetomidine|dexmedetomidine
5323763|NCT00351299|Surgical|surgical
5323764|NCT00351286|peripheral arterial disease|peripheral arterial disease
5323765|NCT00351286|peripheral vascular disease|peripheral vascular disease
5323766|NCT00351286|claudication|claudication
5323767|NCT00351273|Chlamydia|chlamydia
5323768|NCT00351260|Bifurcation|bifurcation
5323769|NCT00351260|Coronary|coronary
5323770|NCT00351260|Stenosis|stenosis
5323771|NCT00351260|Stent|stent
5323772|NCT00351260|drug elution|drug elution
5323773|NCT00351247|Myocardial Infarction|myocardial infarction
5323774|NCT00351247|Primary PCI|primary pci
5323775|NCT00351247|Postconditioning|postconditioning
5323776|NCT00351247|MRI|mri
5323777|NCT00351234|Diabetes Mellitus Type I,|diabetes mellitus type i,
5323778|NCT00351234|Hypoglycemia,|hypoglycemia,
5323779|NCT00351234|Carnitine|carnitine
5323780|NCT00351208|Spinal cord stimulation|spinal cord stimulation
5323781|NCT00351208|Spinal cord stimulation efficacy|spinal cord stimulation efficacy
5323782|NCT00351208|Spinal cord stimulators|spinal cord stimulators
5323783|NCT00351208|Stimulation frequencies|stimulation frequencies
5323784|NCT00351208|Stimulation pulse-widths|stimulation pulse-widths
5323785|NCT00351208|Varying settings|varying settings
5323786|NCT00351195|Hepatocellular carcinoma|hepatocellular carcinoma
5323787|NCT00351195|Etoposide|etoposide
5323788|NCT00351195|Oxaliplatin|oxaliplatin
5323789|NCT00351195|Capecitabine|capecitabine
5323790|NCT00351182|Scrub typhus|scrub typhus
5323791|NCT00351182|Telithromycin|telithromycin
5323792|NCT00351182|Doxycycline|doxycycline
5323793|NCT00351182|5 day Course of Telithromycin versus Doxycycline for the Treatment of Mild to Moderate Scrub Typhus|5 day course of telithromycin versus doxycycline for the treatment of mild to moderate scrub typhus
5323794|NCT00351169|Major Depressive Disorder|major depressive disorder
5323795|NCT00351169|MDD|mdd
5323796|NCT00351156|Gaucher Disease|gaucher disease
5323797|NCT00351156|Gaucher Disease, Type 1|gaucher disease, type 1
5323798|NCT00351156|Gaucher Disease, Type 2|gaucher disease, type 2
5323799|NCT00351156|Gaucher Disease, Type 3|gaucher disease, type 3
5323800|NCT00351156|Neuronopathic Gaucher Disease|neuronopathic gaucher disease
5323801|NCT00351156|Non-Neuronopathic Gaucher Disease|non-neuronopathic gaucher disease
5323802|NCT00351156|Lysosomal Storage Disease|lysosomal storage disease
5323803|NCT00351156|Metabolism, Inborn Errors|metabolism, inborn errors
5323804|NCT00351156|Metabolic Diseases|metabolic diseases
5323805|NCT00351156|Sphingolipidoses|sphingolipidoses
5323806|NCT00351156|Genetic Diseases, Inborn|genetic diseases, inborn
5323807|NCT00351143|QoL|qol
5323808|NCT00351143|Asthma|asthma
5323809|NCT00351143|asthma compliance enhancement|asthma compliance enhancement
5323810|NCT00351143|Salmeterol/fluticasone|salmeterol/fluticasone
5323811|NCT00351143|Total control|total control
5323812|NCT00351143|SERETIDE|seretide
5323813|NCT00351143|FEV1|fev1
5323814|NCT00351130|Hypertension,|hypertension,
5323815|NCT00351130|stage 1 hypertension,|stage 1 hypertension,
5323816|NCT00351130|stage 2 hypertension,|stage 2 hypertension,
5323817|NCT00351130|valsartan,|valsartan,
5323818|NCT00351130|amlodipine,|amlodipine,
5323819|NCT00351117|St. John's Wort|st. john's wort
5323820|NCT00351117|Selective Serotonin Receptor Inhibitor|selective serotonin receptor inhibitor
5323821|NCT00351117|Microvasculature|microvasculature
5323822|NCT00351117|Natural Health Products|natural health products
5323823|NCT00351104|Sprain|sprain
5323824|NCT00351104|Strain|strain
5323825|NCT00351104|Pain|pain
5323826|NCT00351104|Ankle Pain|ankle pain
5323827|NCT00351104|Muscle, Bone and Cartilage Disorders|muscle, bone and cartilage disorders
5323828|NCT00351078|Cystic fibrosis|cystic fibrosis
5323829|NCT00351078|Nonsense mutation|nonsense mutation
5323830|NCT00351078|Premature stop codon|premature stop codon
5323831|NCT00351078|CF|cf
5323832|NCT00351078|PTC124|ptc124
5323833|NCT00351065|erectile dysfunction, PDE-5 inhibitor|erectile dysfunction, pde-5 inhibitor
5323834|NCT00351052|Pimecrolimus, Atopic Dermatitis, Eczema, Pediatric|pimecrolimus, atopic dermatitis, eczema, pediatric
5323835|NCT00351026|opioid dependence|opioid dependence
5323836|NCT00351026|methadone|methadone
5323837|NCT00351026|HIV|hiv
5323838|NCT00351013|malaria|malaria
5323839|NCT00351013|Plasmodium falciparum|plasmodium falciparum
5323840|NCT00351013|Tropica Nosode|tropica nosode
5323841|NCT00351013|Homeopathy|homeopathy
5323842|NCT00351000|Schizophrenia|schizophrenia
5323843|NCT00351000|Ziprasidone|ziprasidone
5323844|NCT00351000|Diabetes|diabetes
5323845|NCT00351000|Insulin Resistance|insulin resistance
5323846|NCT00350987|Procalcitonin, guidelines, LRTI, non-inferiority|procalcitonin, guidelines, lrti, non-inferiority
5323847|NCT00350987|COLD|cold
5323848|NCT00350961|Cholangiocarcinoma|cholangiocarcinoma
5323849|NCT00350961|Fixed dose rate|fixed dose rate
5323850|NCT00350961|Gemcitabine|gemcitabine
5323851|NCT00350961|Oxaliplatin|oxaliplatin
5323852|NCT00350961|Capecitabine|capecitabine
5323853|NCT00350948|Ovary|ovary
5323854|NCT00350935|fMRI|fmri
5323855|NCT00350935|Visual perception|visual perception
5323856|NCT00350935|Attention|attention
5323857|NCT00350909|drug abuse|drug abuse
5323858|NCT00350896|trapezotrapezoidial|trapezotrapezoidial
5323859|NCT00350896|scaphotrapezial|scaphotrapezial
5323860|NCT00350896|thumb|thumb
5323861|NCT00350896|pain|pain
5323862|NCT00350896|orthoses|orthoses
5323863|NCT00350896|Osteoarthritis in the BTOA concerns the trapezometacarpal joint|osteoarthritis in the btoa concerns the trapezometacarpal joint
5323864|NCT00350883|Cognitive Therapy|cognitive therapy
5323865|NCT00350883|Negative Symptoms|negative symptoms
5323866|NCT00350883|Functional Outcomes|functional outcomes
5323867|NCT00350883|Schizophrenia|schizophrenia
5323868|NCT00350883|Schizoaffective Disorder|schizoaffective disorder
5323869|NCT00350870|disulfiram|disulfiram
5323870|NCT00350870|cognitive behavioral therapy|cognitive behavioral therapy
5323871|NCT00350870|contingency management|contingency management
5323872|NCT00350870|drug abuse therapy|drug abuse therapy
5323873|NCT00350870|educational/resource design/development|educational/resource design/development
5323874|NCT00350844|Sickle Cell Disease|sickle cell disease
5323875|NCT00350844|Pulmonary Hypertension|pulmonary hypertension
5323876|NCT00350831|Solid tumor|solid tumor
5323877|NCT00350818|Acute Myelogenous Leukemia|acute myelogenous leukemia
5323878|NCT00350818|Myelodysplastic Syndrome|myelodysplastic syndrome
5323879|NCT00350818|Allogeneic Transplantation|allogeneic transplantation
5323880|NCT00350818|Leukemia|leukemia
5323881|NCT00350818|Azacitidine|azacitidine
5323882|NCT00350818|Vidaza|vidaza
5323883|NCT00350805|Schizophrenia|schizophrenia
5323884|NCT00350805|Time perception|time perception
5323885|NCT00350805|Cortical synchronization|cortical synchronization
5323886|NCT00350805|Electroencephalography|electroencephalography
5323887|NCT00350779|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
5323888|NCT00350766|Myocardial Infarction|myocardial infarction
5323889|NCT00350766|Myocardial Ischemia|myocardial ischemia
5323890|NCT00350766|Ventricular Remodeling|ventricular remodeling
5323891|NCT00350766|Bone Marrow Cell Transplantation|bone marrow cell transplantation
5323892|NCT00350766|Stem cells|stem cells
5323893|NCT00350753|Cholangiocarcinoma|cholangiocarcinoma
5323894|NCT00350727|relapsed|relapsed
5323895|NCT00350727|lapatinib|lapatinib
5323896|NCT00350727|Pazopanib|pazopanib
5323897|NCT00350727|glioblastoma|glioblastoma
5323898|NCT00350714|HCV (Hepatitis C Virus)|hcv (hepatitis c virus)
5323899|NCT00350714|MBT (Methacetin Breath Test)|mbt (methacetin breath test)
5323900|NCT00350714|Hepatitis C Virus Patients|hepatitis c virus patients
5323901|NCT00350701|DM type 2|dm type 2
5323902|NCT00350701|Hypogonadism|hypogonadism
5323903|NCT00350701|Testosterone|testosterone
5323904|NCT00350701|AndroGel|androgel
5323905|NCT00350688|Bladder,|bladder,
5323906|NCT00350688|Cancer,|cancer,
5323907|NCT00350688|Chemoradiation,|chemoradiation,
5323908|NCT00350688|IMRT,|imrt,
5323909|NCT00350688|tomotherapy|tomotherapy
5323910|NCT00350662|Deferiprone|deferiprone
5323911|NCT00350662|L1|l1
5323912|NCT00350662|Desferrioxamine|desferrioxamine
5323913|NCT00350662|Hemochromatosis|hemochromatosis
5323914|NCT00350662|Iron overload|iron overload
5323915|NCT00350662|Thalassemia|thalassemia
5323916|NCT00350649|behavior modification|behavior modification
5323917|NCT00350649|cognitive behavioral therapy|cognitive behavioral therapy
5323918|NCT00350649|combination therapy|combination therapy
5323919|NCT00350649|drug abuse therapy|drug abuse therapy
5323920|NCT00350649|drug addition|drug addition
5323921|NCT00350649|human therapy evaluation|human therapy evaluation
5323922|NCT00350649|psychotherapy|psychotherapy
5323923|NCT00350649|clinical trial phase II|clinical trial phase ii
5323924|NCT00350649|coping|coping
5323925|NCT00350649|drug and alcohol abstinence|drug and alcohol abstinence
5323926|NCT00350649|longitudinal human study|longitudinal human study
5323927|NCT00350649|outcomes research|outcomes research
5323928|NCT00350649|outpatient care|outpatient care
5323929|NCT00350649|psychological reinforcement|psychological reinforcement
5323930|NCT00350649|therapy compliance|therapy compliance
5323931|NCT00350649|behavior and social research tag|behavior and social research tag
5323932|NCT00350649|human subjects|human subjects
5323933|NCT00350649|neuropsychological test|neuropsychological test
5323934|NCT00350649|patient oriented research|patient oriented research
5323935|NCT00350636|OAB, anticholineric, oxybutynin, urge urinary incontinence|oab, anticholineric, oxybutynin, urge urinary incontinence
5323936|NCT00350623|AIDS|aids
5323937|NCT00350610|cognitive behavior therapy|cognitive behavior therapy
5323938|NCT00350610|computer assisted instruction|computer assisted instruction
5323939|NCT00350610|drug abuse therapy|drug abuse therapy
5323940|NCT00350610|educational resource design and development|educational resource design and development
5323941|NCT00350597|Malignant Melanoma|malignant melanoma
5323942|NCT00350597|Adjuvant Therapy|adjuvant therapy
5323943|NCT00350597|Cytokine Therapy|cytokine therapy
5323944|NCT00350597|Immunologic Testing|immunologic testing
5323945|NCT00350584|Mindfulness|mindfulness
5323946|NCT00350584|Psychoeducation|psychoeducation
5323947|NCT00350584|Telehealth Intervention|telehealth intervention
5323948|NCT00350571|behavior therapy|behavior therapy
5323949|NCT00350571|counseling|counseling
5323950|NCT00350571|drug abuse therapy|drug abuse therapy
5323951|NCT00350571|outpatient care|outpatient care
5323952|NCT00350571|therapy compliance|therapy compliance
5323953|NCT00350571|clinical trial phase I|clinical trial phase i
5323954|NCT00350571|coping|coping
5323955|NCT00350571|outcomes research|outcomes research
5323956|NCT00350571|satisfaction|satisfaction
5323957|NCT00350571|social psychology|social psychology
5323958|NCT00350571|patient oriented research|patient oriented research
5323959|NCT00350532|pain, chronic pain|pain, chronic pain
5323960|NCT00350532|acetylcholine|acetylcholine
5323961|NCT00350532|clonidine|clonidine
5323962|NCT00350532|a2-adrenergic agonists|a2-adrenergic agonists
5323963|NCT00350532|alpha2-adrenergic agonists|alpha2-adrenergic agonists
5323964|NCT00350519|Hemostasis, Surgical|hemostasis, surgical
5323965|NCT00350519|Epoetin alfa|epoetin alfa
5323966|NCT00350519|Surgery|surgery
5323967|NCT00350519|Abdomen|abdomen
5323968|NCT00350519|Pelvis|pelvis
5323969|NCT00350519|PROCRIT|procrit
5323970|NCT00350519|pRBC|prbc
5323971|NCT00350519|Blood transfusion|blood transfusion
5323972|NCT00350519|Packed red blood cell transfusion|packed red blood cell transfusion
5323973|NCT00350480|acute uterine bleeding|acute uterine bleeding
5323974|NCT00350467|Schizophrenia|schizophrenia
5323975|NCT00350467|DSM-IV|dsm-iv
5323976|NCT00350467|PANSS|panss
5323977|NCT00350467|informed consent|informed consent
5323978|NCT00350441|Sildenafil Citrate|sildenafil citrate
5323979|NCT00350441|Cardiopulmonary bypass|cardiopulmonary bypass
5323980|NCT00350441|Open heart surgery|open heart surgery
5323981|NCT00350428|Acute primary angle closure|acute primary angle closure
5323982|NCT00350428|Laser preipheral iridotomy|laser preipheral iridotomy
5323983|NCT00350428|Phacoemulsification|phacoemulsification
5323984|NCT00350415|ulcerative colitis, inflammatory bowel disease|ulcerative colitis, inflammatory bowel disease
5323985|NCT00350402|Parkinson's disease|parkinson's disease
5323986|NCT00350402|PD|pd
5323987|NCT00350402|masked faces|masked faces
5323988|NCT00350402|diminished facial expressivity|diminished facial expressivity
5323989|NCT00350402|diminished facial expression|diminished facial expression
5323990|NCT00350402|high intensity respiratory muscle strength training|high intensity respiratory muscle strength training
5323991|NCT00350402|MST|mst
5323992|NCT00350389|Falls, Older persons|falls, older persons
5323993|NCT00350376|asthma|asthma
5323994|NCT00350376|allergies|allergies
5323995|NCT00350376|Xolair|xolair
5323996|NCT00350376|Advair|advair
5323997|NCT00350350|XEROSTOMIA|xerostomia
5323998|NCT00350350|MOUTH DRYNESS|mouth dryness
5323999|NCT00350350|ELDERLY|elderly
5324000|NCT00350350|ORAL LUBRICANT|oral lubricant
5324001|NCT00350298|Monoclonal antibody,|monoclonal antibody,
5324002|NCT00350298|Clostridium difficile Associated Diarrhea|clostridium difficile associated diarrhea
5324003|NCT00350285|cannabis|cannabis
5324004|NCT00350285|marijuana|marijuana
5324005|NCT00350272|HIV-1 treatment naive|hiv-1 treatment naive
5324006|NCT00350233|Bone Tumors|bone tumors
5324007|NCT00350233|Bone Cancer|bone cancer
5324008|NCT00350233|Prostate Cancer|prostate cancer
5324009|NCT00350233|lung cancer|lung cancer
5324010|NCT00350220|Single ventricle|single ventricle
5324109|NCT00349726|Prematurity|prematurity
5324011|NCT00350220|Bidirectional Glenn|bidirectional glenn
5324012|NCT00350220|Fontan|fontan
5324013|NCT00350220|Congenital cardiac disease|congenital cardiac disease
5324014|NCT00350220|Red blood cell transfusion|red blood cell transfusion
5324015|NCT00350220|oxygen utilization|oxygen utilization
5324016|NCT00350220|lactate level|lactate level
5324017|NCT00350220|hemoglobin level|hemoglobin level
5324018|NCT00350194|Fatty Acids, Omega-3|fatty acids, omega-3
5324019|NCT00350168|Blood pressure|blood pressure
5324020|NCT00350168|Venous pressure|venous pressure
5324021|NCT00350168|Systolic pressure|systolic pressure
5324022|NCT00350168|Diastolic pressure|diastolic pressure
5324023|NCT00350168|Pulse pressure|pulse pressure
5324024|NCT00350155|Video capsule endoscopy, healthy volunteers, naproxen, omeprazole, lumiracoxib, small bowel|video capsule endoscopy, healthy volunteers, naproxen, omeprazole, lumiracoxib, small bowel
5324025|NCT00350142|Stereotactic Body Radiotherapy (SBRT)|stereotactic body radiotherapy (sbrt)
5324026|NCT00350142|pancreas cancer|pancreas cancer
5324027|NCT00350142|locally advanced|locally advanced
5324028|NCT00350142|local control|local control
5324029|NCT00350142|Gemcitabine|gemcitabine
5324030|NCT00350129|glucose|glucose
5324031|NCT00350129|vasospasm|vasospasm
5324032|NCT00350129|RVA|rva
5324033|NCT00350129|LDF|ldf
5324034|NCT00350129|vasospastic subjects|vasospastic subjects
5324035|NCT00350129|non-vasospastic subjects|non-vasospastic subjects
5324036|NCT00350116|plaque psoriasis|plaque psoriasis
5324037|NCT00350116|Vitamin B12|vitamin b12
5324038|NCT00350090|Anemia|anemia
5324039|NCT00350090|Neoplasms|neoplasms
5324040|NCT00350090|Hemoglobin values|hemoglobin values
5324041|NCT00350077|Burns|burns
5324042|NCT00350064|Metabolic Syndrome|metabolic syndrome
5324043|NCT00350064|Obesity|obesity
5324044|NCT00350064|Exercise|exercise
5324045|NCT00350064|Diabetes|diabetes
5324046|NCT00350064|Physical Activity|physical activity
5324047|NCT00350051|Prostate cancer|prostate cancer
5324048|NCT00350051|Metastatic androgen-independent prostate cancer|metastatic androgen-independent prostate cancer
5324049|NCT00350025|urothelial|urothelial
5324050|NCT00350025|urologic|urologic
5324051|NCT00350025|neoplasm|neoplasm
5324052|NCT00350025|advanced|advanced
5324053|NCT00350025|metastatic|metastatic
5324054|NCT00350012|stroke|stroke
5324055|NCT00350012|visual|visual
5324056|NCT00350012|spatial neglect|spatial neglect
5324057|NCT00349999|Vibrio cholerae, Cholera, Bangladesh, esophagogastroduodenoscopy, sub-study|vibrio cholerae, cholera, bangladesh, esophagogastroduodenoscopy, sub-study
5324058|NCT00349973|Schizophrenia|schizophrenia
5324059|NCT00349973|Positive symptoms|positive symptoms
5324060|NCT00349973|Negative symptoms|negative symptoms
5324061|NCT00349973|Cognitive deficits|cognitive deficits
5324062|NCT00349960|Erythropoiesis stimulating agent|erythropoiesis stimulating agent
5324063|NCT00349960|Dosing frequency|dosing frequency
5324064|NCT00349960|Hemodialysis|hemodialysis
5324065|NCT00349960|Therapeutic equivalence|therapeutic equivalence
5324066|NCT00349934|Metastatic breast cancer|metastatic breast cancer
5324067|NCT00349934|IMP321|imp321
5324068|NCT00349934|hLAG-3Ig|hlag-3ig
5324069|NCT00349934|LAG-3|lag-3
5324070|NCT00349934|CD223|cd223
5324071|NCT00349934|Chemotherapy|chemotherapy
5324072|NCT00349934|Paclitaxel|paclitaxel
5324073|NCT00349934|Combination therapy|combination therapy
5324074|NCT00349921|pain|pain
5324075|NCT00349921|chronic pain|chronic pain
5324076|NCT00349921|clonidine|clonidine
5324077|NCT00349921|adenosine|adenosine
5324078|NCT00349921|complex regional pain syndrome|complex regional pain syndrome
5324079|NCT00349921|CRPS|crps
5324080|NCT00349921|a2-adrenergic agonists|a2-adrenergic agonists
5324081|NCT00349921|alpha2-adrenergic agonists|alpha2-adrenergic agonists
5324082|NCT00349908|Atherosclerosis,Wide Neck Aneurysm|atherosclerosis,wide neck aneurysm
5324083|NCT00349895|Percutaneous Transluminal Coronary Angioplasty|percutaneous transluminal coronary angioplasty
5324084|NCT00349895|Stent implantation|stent implantation
5324085|NCT00349869|inflammatory arthritis|inflammatory arthritis
5324086|NCT00349869|rheumatoid arthritis|rheumatoid arthritis
5324087|NCT00349869|knee osteoarthritis|knee osteoarthritis
5324088|NCT00349869|arthritis|arthritis
5324089|NCT00349869|yoga|yoga
5324090|NCT00349804|temperature|temperature
5324091|NCT00349804|Temperature Homeostasis|temperature homeostasis
5324092|NCT00349791|Natural Menopause|natural menopause
5324093|NCT00349765|cardiovascular disease|cardiovascular disease
5324094|NCT00349765|saturated fat|saturated fat
5324095|NCT00349765|trans fat|trans fat
5324096|NCT00349765|polyunsaturated fat|polyunsaturated fat
5324097|NCT00349765|diet|diet
5324098|NCT00349765|intramyocellular lipid|intramyocellular lipid
5324099|NCT00349752|certolizumab pegol|certolizumab pegol
5324100|NCT00349752|Cimzia|cimzia
5324101|NCT00349752|Crohn's Disease|crohn's disease
5324102|NCT00349752|Inflammatory Bowel Disease|inflammatory bowel disease
5324103|NCT00349739|age related macular degeneration|age related macular degeneration
5324104|NCT00349726|NICHD Neonatal Research Network|nichd neonatal research network
5324105|NCT00349726|Pharmacokinetics|pharmacokinetics
5324106|NCT00349726|Inositol|inositol
5324107|NCT00349726|Very Low Birth Weight (VLBW)|very low birth weight (vlbw)
5324108|NCT00349726|Extremely Low Birth Weight (ELBW)|extremely low birth weight (elbw)
5324110|NCT00349713|Plasmodium falciparum Malaria, Mali, adjuvant|plasmodium falciparum malaria, mali, adjuvant
5324111|NCT00349700|healing|healing
5324112|NCT00349700|skin|skin
5324113|NCT00349700|infection|infection
5324114|NCT00349700|wound therapy|wound therapy
5324115|NCT00349674|Wegener's granulomatosis,|wegener's granulomatosis,
5324116|NCT00349674|microscopic polyangiitis,|microscopic polyangiitis,
5324117|NCT00349674|ANCA-associated vasculitis,|anca-associated vasculitis,
5324118|NCT00349674|methotrexate,|methotrexate,
5324119|NCT00349674|azathioprine|azathioprine
5324120|NCT00349661|clopidogrel|clopidogrel
5324121|NCT00349661|omeprazole|omeprazole
5324122|NCT00349648|subacromial|subacromial
5324123|NCT00349648|impingement|impingement
5324124|NCT00349648|acromioplasty|acromioplasty
5324125|NCT00349648|physiotherapy|physiotherapy
5324126|NCT00349635|Weight loss and diet.|weight loss and diet.
5324127|NCT00349622|amyotrophic lateral sclerosis|amyotrophic lateral sclerosis
5324128|NCT00349622|ALS|als
5324129|NCT00349622|ceftriaxone|ceftriaxone
5324130|NCT00349622|cephalosporin antibiotic|cephalosporin antibiotic
5324131|NCT00349622|motor neurons|motor neurons
5324132|NCT00349596|Hypomethylating agent|hypomethylating agent
5324133|NCT00349596|Chemotherapy|chemotherapy
5324134|NCT00349596|Relapsed or refractory ALL|relapsed or refractory all
5324135|NCT00349596|Acute Lymphocytic Leukemia (ALL)|acute lymphocytic leukemia (all)
5324136|NCT00349570|thrombus|thrombus
5324137|NCT00349570|aspiration catheter|aspiration catheter
5324138|NCT00349557|Prostate Cancer|prostate cancer
5324139|NCT00349557|High-Risk Prostate Cancer|high-risk prostate cancer
5324140|NCT00349557|1st line therapy|1st line therapy
5324141|NCT00349544|Neck pain|neck pain
5324142|NCT00349544|Cervicalgia|cervicalgia
5324143|NCT00349544|Quality of life|quality of life
5324144|NCT00349544|Disability|disability
5324145|NCT00349518|Chronic and Advanced Phase CML and|chronic and advanced phase cml and
5324146|NCT00349518|Philadelphia Chromosome Positive ALL with imatinib intolerance or resistance|philadelphia chromosome positive all with imatinib intolerance or resistance
5324147|NCT00349505|previous treatment surgery + 6 cycles of platinum based chemotherapy|previous treatment surgery + 6 cycles of platinum based chemotherapy
5324148|NCT00349492|Small Cell Lung Cancer|small cell lung cancer
5324149|NCT00349492|Extensive Disease|extensive disease
5324150|NCT00349492|Chemotherapy|chemotherapy
5324151|NCT00349492|Randomisation|randomisation
5324152|NCT00349479|stroke|stroke
5324153|NCT00349479|tissue plasminogen activator|tissue plasminogen activator
5324154|NCT00349479|t-PA|t-pa
5324155|NCT00349479|barrier assessment and interactive educational intervention|barrier assessment and interactive educational intervention
5324156|NCT00349479|BA-IEI|ba-iei
5324157|NCT00349466|Keratoconjunctivitis Sicca|keratoconjunctivitis sicca
5324158|NCT00349466|KCS|kcs
5324159|NCT00349466|Dry Eye|dry eye
5324160|NCT00349453|Deferiprone|deferiprone
5324161|NCT00349453|L1|l1
5324162|NCT00349453|Desferrioxamine|desferrioxamine
5324163|NCT00349453|Hemochromatosis|hemochromatosis
5324164|NCT00349453|Iron overload|iron overload
5324165|NCT00349453|Thalassemia|thalassemia
5324166|NCT00349440|Dry eye|dry eye
5324167|NCT00349427|Insulin|insulin
5324168|NCT00349427|BRL49653 /rosiglitazone|brl49653 /rosiglitazone
5324169|NCT00349427|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
5324170|NCT00349414|Advanced glaucoma|advanced glaucoma
5324171|NCT00349414|Refractory glaucoma|refractory glaucoma
5324172|NCT00349414|Cyclophotocoagulation|cyclophotocoagulation
5324173|NCT00349414|Transscleral cyclophotocoagulation|transscleral cyclophotocoagulation
5324174|NCT00349414|Micropulse transscleral cyclophotocoagulation|micropulse transscleral cyclophotocoagulation
5324175|NCT00349401|pain|pain
5324176|NCT00349401|chronic pain|chronic pain
5324177|NCT00349401|morphine|morphine
5324178|NCT00349401|ketorolac|ketorolac
5324179|NCT00349388|Mesalamine|mesalamine
5324180|NCT00349388|Ulcerative Colitis|ulcerative colitis
5324181|NCT00349375|Hyperlipidemia Combined, efficacy combination fenofibrate simvastatin|hyperlipidemia combined, efficacy combination fenofibrate simvastatin
5324182|NCT00349323|Community directed treatment,|community directed treatment,
5324183|NCT00349323|soil-transmitted helminth infections,|soil-transmitted helminth infections,
5324184|NCT00349323|treatment coverage,|treatment coverage,
5324185|NCT00349323|Zambia|zambia
5324186|NCT00349284|Hyperlipidemia Combined and features of the metabolic syndrome, efficacy combination fenofibrate ezetimibe|hyperlipidemia combined and features of the metabolic syndrome, efficacy combination fenofibrate ezetimibe
5324187|NCT00349271|Chagas Cardiomyopathy|chagas cardiomyopathy
5324188|NCT00349271|Dilated Cardiomyopathy|dilated cardiomyopathy
5324189|NCT00349271|stem cells|stem cells
5324190|NCT00349271|Therapeutics|therapeutics
5324191|NCT00349271|Randomized Controlled Trials|randomized controlled trials
5324192|NCT00349258|OHSS|ohss
5324193|NCT00349258|PCOS|pcos
5324194|NCT00349258|Previous high response|previous high response
5324195|NCT00349258|GnRH antagonist|gnrh antagonist
5324196|NCT00349258|GnRH agonist|gnrh agonist
5324197|NCT00349258|IVF|ivf
5324198|NCT00349245|Endotracheal|endotracheal
5324199|NCT00349245|Awake fiberoptic intubation|awake fiberoptic intubation
5324200|NCT00349245|Dexmedetomidine|dexmedetomidine
5324201|NCT00349245|Remifentanil|remifentanil
5324202|NCT00349232|childhood obesity|childhood obesity
5324203|NCT00349232|lifestyle intervention|lifestyle intervention
5324204|NCT00349232|school health program|school health program
5324205|NCT00349232|special primary education|special primary education
5324206|NCT00349219|first-line|first-line
5324207|NCT00349219|second-line|second-line
5324208|NCT00349219|targeted therapy|targeted therapy
5324209|NCT00349193|Relapsing Remitting Multiple Sclerosis|relapsing remitting multiple sclerosis
5324210|NCT00349180|Total Hip Replacement|total hip replacement
5324211|NCT00349180|Enoxaparin|enoxaparin
5324212|NCT00349167|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5324213|NCT00349141|Pandemic influenza|pandemic influenza
5324214|NCT00349128|Treatment of Dyslipidemia and of Type 2 Diabetes Mellitus|treatment of dyslipidemia and of type 2 diabetes mellitus
5324215|NCT00349102|Non-small-cell lung cancer|non-small-cell lung cancer
5324216|NCT00349102|Breath-hold|breath-hold
5324217|NCT00349102|Radiation pneumonitis|radiation pneumonitis
5324218|NCT00349102|Serum cytokines|serum cytokines
5324219|NCT00349102|LENT-SOMA scale|lent-soma scale
5324220|NCT00349102|Non-metastatic non-small-cell lung cancer|non-metastatic non-small-cell lung cancer
5324221|NCT00349089|Non-small cell lung cancer|non-small cell lung cancer
5324222|NCT00349089|adjuvant therapy|adjuvant therapy
5324223|NCT00349089|clinical feasibility rate|clinical feasibility rate
5324224|NCT00349050|trigeminal neuralgia|trigeminal neuralgia
5324225|NCT00349050|neuropathic pain|neuropathic pain
5324226|NCT00349050|complex regional pain syndrome|complex regional pain syndrome
5324227|NCT00349050|reflex sympathetic dystrophy|reflex sympathetic dystrophy
5324228|NCT00349050|pain|pain
5324229|NCT00349050|chronic pain|chronic pain
5324230|NCT00349050|transcranial magnetic stimulation|transcranial magnetic stimulation
5324231|NCT00349050|TMS|tms
5324232|NCT00349050|laboratory pain assessment|laboratory pain assessment
5324233|NCT00349037|DNA vaccine|dna vaccine
5324234|NCT00349037|influenza|influenza
5324235|NCT00349037|immunogenicity|immunogenicity
5324236|NCT00349037|tolerability|tolerability
5324237|NCT00349037|PMED|pmed
5324238|NCT00349037|efficacy|efficacy
5324239|NCT00349037|challenge virus|challenge virus
5324240|NCT00349024|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
5324241|NCT00349024|pain|pain
5324242|NCT00349024|childhood acute lymphoblastic leukemia|childhood acute lymphoblastic leukemia
5324243|NCT00349024|childhood Hodgkin lymphoma|childhood hodgkin lymphoma
5324244|NCT00349024|chondrosarcoma|chondrosarcoma
5324245|NCT00349024|osteosarcoma|osteosarcoma
5324246|NCT00349024|childhood soft tissue sarcoma|childhood soft tissue sarcoma
5324247|NCT00349024|Wilms tumor and other childhood kidney tumors|wilms tumor and other childhood kidney tumors
5324248|NCT00349024|neuroblastoma|neuroblastoma
5324249|NCT00349024|childhood acute myeloid leukemia/other myeloid malignancies|childhood acute myeloid leukemia/other myeloid malignancies
5324250|NCT00349024|childhood large cell lymphoma|childhood large cell lymphoma
5324251|NCT00349024|childhood lymphoblastic lymphoma|childhood lymphoblastic lymphoma
5324252|NCT00349024|childhood small noncleaved cell lymphoma|childhood small noncleaved cell lymphoma
5324253|NCT00349024|childhood rhabdomyosarcoma|childhood rhabdomyosarcoma
5324254|NCT00349024|childhood brain stem glioma|childhood brain stem glioma
5324255|NCT00349024|childhood central nervous system germ cell tumor|childhood central nervous system germ cell tumor
5324256|NCT00349024|childhood cerebellar astrocytoma|childhood cerebellar astrocytoma
5324257|NCT00349024|childhood cerebral astrocytoma/malignant glioma|childhood cerebral astrocytoma/malignant glioma
5324258|NCT00349024|childhood choroid plexus tumor|childhood choroid plexus tumor
5324259|NCT00349024|childhood craniopharyngioma|childhood craniopharyngioma
5324260|NCT00349024|childhood ependymoma|childhood ependymoma
5324261|NCT00349024|childhood medulloblastoma|childhood medulloblastoma
5324262|NCT00349024|childhood meningioma|childhood meningioma
5324263|NCT00349024|childhood oligodendroglioma|childhood oligodendroglioma
5324264|NCT00349024|childhood atypical teratoid/rhabdoid tumor|childhood atypical teratoid/rhabdoid tumor
5324265|NCT00349024|childhood spinal cord neoplasm|childhood spinal cord neoplasm
5324266|NCT00349024|childhood supratentorial primitive neuroectodermal tumor|childhood supratentorial primitive neuroectodermal tumor
5324267|NCT00349024|childhood visual pathway and hypothalamic glioma|childhood visual pathway and hypothalamic glioma
5324268|NCT00349024|chordoma|chordoma
5324269|NCT00349024|mucositis|mucositis
5324270|NCT00349024|Ewing sarcoma/peripheral primitive neuroectodermal tumor (PNET)|ewing sarcoma/peripheral primitive neuroectodermal tumor (pnet)
5324271|NCT00349011|menopause|menopause
5324272|NCT00349011|genetic counseling|genetic counseling
5324273|NCT00349011|breast cancer|breast cancer
5324274|NCT00349011|tamoxifen|tamoxifen
5324275|NCT00349011|chemoprevention|chemoprevention
5324276|NCT00348998|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5324277|NCT00348998|stage IIB prostate cancer|stage iib prostate cancer
5324278|NCT00348998|stage IIA prostate cancer|stage iia prostate cancer
5324279|NCT00348998|stage III prostate cancer|stage iii prostate cancer
5324280|NCT00348998|stage IV prostate cancer|stage iv prostate cancer
5324281|NCT00348972|Glargine|glargine
5324282|NCT00348972|prediabetes|prediabetes
5324283|NCT00348972|impaired glucose tolerance|impaired glucose tolerance
5324284|NCT00348972|impaired fasting glucose|impaired fasting glucose
5324285|NCT00348959|Haematological Malignancies|haematological malignancies
5324286|NCT00348959|Autologous Stem Cell Transplantation|autologous stem cell transplantation
5324287|NCT00348959|Allogeneic Stem Cell Transplantation|allogeneic stem cell transplantation
5324288|NCT00348959|Quality of Life|quality of life
5324289|NCT00348959|Life Threatening Illness|life threatening illness
5324290|NCT00348959|Art in Health Care|art in health care
5324291|NCT00348959|Randomised Controlled Trial|randomised controlled trial
5324292|NCT00348959|Mixed Methods Research|mixed methods research
5324293|NCT00348946|Klinefelter syndrome|klinefelter syndrome
5324294|NCT00348946|androgen|androgen
5324295|NCT00348946|androgen oxandrolone|androgen oxandrolone
5324296|NCT00348933|Developmental Delay|developmental delay
5324297|NCT00348933|Mental Retardation|mental retardation
5324298|NCT00348933|Ataxia|ataxia
5324299|NCT00348933|Microcephaly|microcephaly
5324300|NCT00348933|Seizures|seizures
5324301|NCT00348920|Aortic Valve|aortic valve
5324302|NCT00348920|Aortic Stenosis|aortic stenosis
5324303|NCT00348920|High Spinal Anesthesia|high spinal anesthesia
5324304|NCT00348920|Total Spinal Anesthesia|total spinal anesthesia
5324305|NCT00348920|Stress Response|stress response
5324306|NCT00348920|Inflammatory Mediators|inflammatory mediators
5324307|NCT00348920|Renal Function|renal function
5324308|NCT00348920|Hemodynamic Stability|hemodynamic stability
5324309|NCT00348907|doppler|doppler
5324310|NCT00348907|CIVIQ quality of life|civiq quality of life
5324311|NCT00348907|Hydrotherapy|hydrotherapy
5324312|NCT00348907|anticoagulants|anticoagulants
5324313|NCT00348881|Diphtheria|diphtheria
5324314|NCT00348881|Tetanus|tetanus
5324315|NCT00348881|Pertussis|pertussis
5324316|NCT00348881|Hepatitis B Hansenula (HB)|hepatitis b hansenula (hb)
5324317|NCT00348881|Haemophilus influenzae type b|haemophilus influenzae type b
5324318|NCT00348868|HIV Infection|hiv infection
5324319|NCT00348868|Opioid dependence|opioid dependence
5324320|NCT00348868|DSM-IV criteria for opioid dependence|dsm-iv criteria for opioid dependence
5324321|NCT00348855|High Blood Pressure|high blood pressure
5324322|NCT00348855|High cardiovascular risk|high cardiovascular risk
5324323|NCT00348855|Type 2 diabetes|type 2 diabetes
5324324|NCT00348855|Reaching goals|reaching goals
5324325|NCT00348842|Immunotherapy|immunotherapy
5324326|NCT00348829|CHF|chf
5324327|NCT00348829|mitral insufficiency|mitral insufficiency
5324328|NCT00348829|conductance catheter|conductance catheter
5324329|NCT00348829|mitral valve repair|mitral valve repair
5324330|NCT00348816|stage I prostate cancer|stage i prostate cancer
5324331|NCT00348816|stage IIB prostate cancer|stage iib prostate cancer
5324332|NCT00348816|stage IIA prostate cancer|stage iia prostate cancer
5324333|NCT00348816|stage III prostate cancer|stage iii prostate cancer
5324334|NCT00348816|stage IV prostate cancer|stage iv prostate cancer
5324335|NCT00348790|adult grade I meningioma|adult grade i meningioma
5324336|NCT00348790|adult grade II meningioma|adult grade ii meningioma
5324337|NCT00348790|adult grade III meningioma|adult grade iii meningioma
5324338|NCT00348790|adult malignant hemangiopericytoma|adult malignant hemangiopericytoma
5324339|NCT00348790|adult anaplastic meningioma|adult anaplastic meningioma
5324340|NCT00348790|adult papillary meningioma|adult papillary meningioma
5324341|NCT00348790|adult melanocytic lesion|adult melanocytic lesion
5324342|NCT00348790|recurrent adult brain tumor|recurrent adult brain tumor
5324343|NCT00348777|Visual analogic Scale of pain|visual analogic scale of pain
5324344|NCT00348777|Womac indice|womac indice
5324345|NCT00348777|SF-36 quality of life|sf-36 quality of life
5324346|NCT00348777|Hydrotherapy|hydrotherapy
5324347|NCT00348764|lauromacrogol|lauromacrogol
5324348|NCT00348764|Sclerotherapy|sclerotherapy
5324349|NCT00348738|radiotherapy|radiotherapy
5324350|NCT00348738|clinical trial|clinical trial
5324351|NCT00348738|erythropoietin|erythropoietin
5324352|NCT00348738|cervix cancer|cervix cancer
5324353|NCT00348738|Phase III|phase iii
5324354|NCT00348738|2 Arms|2 arms
5324355|NCT00348725|Treatment of Dyslipidemia and of Type 2 Diabetes Mellitus|treatment of dyslipidemia and of type 2 diabetes mellitus
5324356|NCT00348686|LVH|lvh
5324357|NCT00348660|Screening for Hepatitis C in Pregnancy|screening for hepatitis c in pregnancy
5324358|NCT00348647|Prevention|prevention
5324359|NCT00348647|Exercise|exercise
5324360|NCT00348647|Overuse|overuse
5324361|NCT00348647|Anterior knee pain syndrome|anterior knee pain syndrome
5324362|NCT00348647|Exertional lower leg pain|exertional lower leg pain
5324363|NCT00348647|Prospective|prospective
5324364|NCT00348647|Risk factors|risk factors
5324365|NCT00348647|Hip|hip
5324366|NCT00348634|Constipation, Tegaserod, orocecal transit, colonic transit, gastric emptying|constipation, tegaserod, orocecal transit, colonic transit, gastric emptying
5324367|NCT00348621|cataract surgery|cataract surgery
5324368|NCT00348621|refractive correction|refractive correction
5324369|NCT00348621|low vision services|low vision services
5324370|NCT00348621|nursing home|nursing home
5324371|NCT00348621|visual impairment|visual impairment
5324372|NCT00348608|Coronary|coronary
5324373|NCT00348608|Angiography|angiography
5324374|NCT00348608|X-ray|x-ray
5324375|NCT00348608|CAD|cad
5324376|NCT00348595|Prostate Cancer|prostate cancer
5324377|NCT00348569|CT|ct
5324378|NCT00348569|Coronary|coronary
5324379|NCT00348569|Cardiac|cardiac
5324380|NCT00348569|Angiography|angiography
5324381|NCT00348569|X-ray|x-ray
5324382|NCT00348569|CAD|cad
5324383|NCT00348569|Chest pain|chest pain
5324384|NCT00348543|age-related macula degeneration|age-related macula degeneration
5324385|NCT00348543|prophylactic laser treatment|prophylactic laser treatment
5324386|NCT00348543|exudative complication|exudative complication
5324387|NCT00348530|Systolic heart failure; Therapy; Cardiomyopathy|systolic heart failure; therapy; cardiomyopathy
5324388|NCT00348491|Dental surgery|dental surgery
5324389|NCT00348491|acute pain|acute pain
5324390|NCT00348491|lumiracoxib|lumiracoxib
5324391|NCT00348491|celecoxib|celecoxib
5324392|NCT00348491|Moderate to severe pain following dental surgery|moderate to severe pain following dental surgery
5324393|NCT00348478|trachoma|trachoma
5324394|NCT00348478|chlamydia trachomatis|chlamydia trachomatis
5324395|NCT00348478|water|water
5324396|NCT00348478|health education|health education
5324397|NCT00348478|face washing|face washing
5324398|NCT00348465|Brachytherapy|brachytherapy
5324399|NCT00348465|Prostate volume|prostate volume
5324400|NCT00348452|osteoarthritis pain; knee; hip; extended release analgesia; opioid|osteoarthritis pain; knee; hip; extended release analgesia; opioid
5324401|NCT00348426|Food Borne Botulism|food borne botulism
5324402|NCT00348413|Graves ophthalmopathy/therapy|graves ophthalmopathy/therapy
5324403|NCT00348413|Randomized controlled trial|randomized controlled trial
5324404|NCT00348413|Methylprednisolone|methylprednisolone
5324405|NCT00348413|Methotrexate|methotrexate
5324406|NCT00348387|Imovax polio|imovax polio
5324407|NCT00348387|poliomyelitis|poliomyelitis
5324408|NCT00348374|type two diabetes, insulin, HbA1c|type two diabetes, insulin, hba1c
5324409|NCT00348361|Hay fever|hay fever
5324410|NCT00348361|biomarkers|biomarkers
5324411|NCT00348309|apolipoprotein E|apolipoprotein e
5324412|NCT00348309|Alzheimer's disease|alzheimer's disease
5324413|NCT00348309|cognition|cognition
5324414|NCT00348309|rosiglitazone|rosiglitazone
5324415|NCT00348309|adjunctive therapy|adjunctive therapy
5324416|NCT00348296|Scleroderma, Systemic|scleroderma, systemic
5324417|NCT00348270|Cataract|cataract
5324418|NCT00348270|Intraocular lens|intraocular lens
5324419|NCT00348270|Aberration|aberration
5324420|NCT00348270|Wavefront|wavefront
5324421|NCT00348231|diabetes mellitus, biphasic insulin analogue|diabetes mellitus, biphasic insulin analogue
5324422|NCT00348218|Neurovision|neurovision
5324423|NCT00348218|Myopia Therapy|myopia therapy
5324424|NCT00348192|Alzheimer's Disease|alzheimer's disease
5324425|NCT00348192|cognition global functioning|cognition global functioning
5324426|NCT00348192|symptomatic|symptomatic
5324427|NCT00348192|SB-742457|sb-742457
5324428|NCT00348179|Vascular abnormalities|vascular abnormalities
5324429|NCT00348179|Type 1 diabetes|type 1 diabetes
5324430|NCT00348179|Healthy control subjects|healthy control subjects
5324431|NCT00348153|Uveitis|uveitis
5324432|NCT00348153|Adalimumab|adalimumab
5324433|NCT00348153|TNF alpha|tnf alpha
5324434|NCT00348140|adjunctive therapy|adjunctive therapy
5324435|NCT00348140|moderate|moderate
5324436|NCT00348140|Alzheimer's disease|alzheimer's disease
5324437|NCT00348140|apolipoprotein E|apolipoprotein e
5324438|NCT00348140|mild|mild
5324439|NCT00348140|rosiglitazone|rosiglitazone
5324440|NCT00348140|cognition|cognition
5324441|NCT00348127|Neurovision|neurovision
5324442|NCT00348127|Myopia Therapy|myopia therapy
5324443|NCT00348114|autologous|autologous
5324444|NCT00348114|transplantation ex-vivo expanded limbal epithelium|transplantation ex-vivo expanded limbal epithelium
5324445|NCT00348114|limbal deficiency|limbal deficiency
5324446|NCT00348101|Patients undergoing major vascular surgery having documented CAD or risk factors for CAD|patients undergoing major vascular surgery having documented cad or risk factors for cad
5324447|NCT00348088|Metastatic|metastatic
5324448|NCT00348088|Melanoma|melanoma
5324449|NCT00348088|Untreated|untreated
5324450|NCT00348088|Biomarker|biomarker
5324451|NCT00348075|Neurovision|neurovision
5324452|NCT00348075|Adult myopia|adult myopia
5324453|NCT00348075|Therapy|therapy
5324454|NCT00348049|LASIK|lasik
5324455|NCT00348049|PRK|prk
5324456|NCT00348049|Myopia|myopia
5324457|NCT00348036|Major Depression|major depression
5324458|NCT00348036|Trauma|trauma
5324459|NCT00348036|Primary Care|primary care
5324460|NCT00348036|Low-Income Patients|low-income patients
5324461|NCT00348010|osteoarthritis|osteoarthritis
5324462|NCT00348010|knee pain|knee pain
5324463|NCT00348010|extended release analgesia|extended release analgesia
5324464|NCT00348010|opioid|opioid
5324465|NCT00347971|Lymphoma, Non-Hodgkin|lymphoma, non-hodgkin
5324466|NCT00347971|interleukin-21|interleukin-21
5324467|NCT00347971|rituximab|rituximab
5324468|NCT00347971|Immunotherapy|immunotherapy
5324469|NCT00347958|Tetanus,|tetanus,
5324470|NCT00347958|Diphtheria,|diphtheria,
5324471|NCT00347958|Pertussis|pertussis
5324472|NCT00347945|convergence insufficiency, vision therapy, orthoptics|convergence insufficiency, vision therapy, orthoptics
5324473|NCT00347919|GW786034|gw786034
5324474|NCT00347919|Quality of Life|quality of life
5324475|NCT00347919|GW572016|gw572016
5324476|NCT00347919|Lapatinib|lapatinib
5324477|NCT00347919|Pazopanib|pazopanib
5324478|NCT00347919|Metastatic|metastatic
5324479|NCT00347919|Breast cancer|breast cancer
5324480|NCT00347919|Genetics|genetics
5324481|NCT00347919|FISH|fish
5324482|NCT00347919|Advanced|advanced
5324483|NCT00347893|Primary open angle glaucoma|primary open angle glaucoma
5324484|NCT00347893|Ocular hypertension|ocular hypertension
5324485|NCT00347893|Pseudo-exfoliative glaucoma|pseudo-exfoliative glaucoma
5324486|NCT00347893|Pigment Dispersion glaucoma|pigment dispersion glaucoma
5324487|NCT00347893|selective laser trabeculoplasty|selective laser trabeculoplasty
5324488|NCT00347893|intraocular pressure|intraocular pressure
5324489|NCT00347880|Bronchiolitis|bronchiolitis
5324490|NCT00347880|ANP|anp
5324491|NCT00347880|BNP|bnp
5324492|NCT00347880|Atrial Natriuretic Peptide|atrial natriuretic peptide
5324493|NCT00347880|Brain Natriuretic Peptide|brain natriuretic peptide
5324494|NCT00347880|Vasopressin|vasopressin
5324495|NCT00347880|ADH|adh
5324496|NCT00347880|Pediatric|pediatric
5324497|NCT00347880|Respiratory Distress|respiratory distress
5324498|NCT00347880|Fluid Balance|fluid balance
5324499|NCT00347867|IUGR|iugr
5324500|NCT00347867|PET|pet
5324501|NCT00347867|Pregnancy|pregnancy
5324502|NCT00347867|Viagra|viagra
5324503|NCT00347867|Sildenafil citrate|sildenafil citrate
5324504|NCT00347854|Normal, healthy eyes (other than correction for visual acuity)|normal, healthy eyes (other than correction for visual acuity)
5324505|NCT00347828|Antibiotic prophylaxis|antibiotic prophylaxis
5324506|NCT00347828|Vigamox|vigamox
5324507|NCT00347828|Moxifloxacin|moxifloxacin
5324508|NCT00347828|Zymar|zymar
5324509|NCT00347828|Gatifloxacin|gatifloxacin
5324510|NCT00347828|Preoperative antibiotic|preoperative antibiotic
5324511|NCT00347828|Eye infection|eye infection
5324512|NCT00347789|glaucoma|glaucoma
5324513|NCT00347789|trabeculectomy|trabeculectomy
5324514|NCT00347789|filtering bleb revision|filtering bleb revision
5324515|NCT00347789|intraocular pressure|intraocular pressure
5324516|NCT00347789|needling procedure|needling procedure
5324517|NCT00347789|mitomycin C|mitomycin c
5324518|NCT00347776|trichiasis|trichiasis
5324519|NCT00347776|azithromycin|azithromycin
5324520|NCT00347776|trichiasis surgery|trichiasis surgery
5324521|NCT00347776|topical tetracycline|topical tetracycline
5324522|NCT00347763|trachoma|trachoma
5324523|NCT00347763|chlamydia|chlamydia
5324524|NCT00347763|flies|flies
5324525|NCT00347763|permethrin|permethrin
5324526|NCT00347750|Lopinavir|lopinavir
5324527|NCT00347750|Pharmacokinetic|pharmacokinetic
5324528|NCT00347750|Pharmacodynamic|pharmacodynamic
5324529|NCT00347750|Ethiopian population|ethiopian population
5324530|NCT00347750|Caucasian population|caucasian population
5324531|NCT00347724|chronic low back pain; chronic pain; low back pain; extended-release analgesia; opioid|chronic low back pain; chronic pain; low back pain; extended-release analgesia; opioid
5324532|NCT00347698|diabetic retinopathy|diabetic retinopathy
5324533|NCT00347698|bevacizumab|bevacizumab
5324534|NCT00347698|photocoagulation|photocoagulation
5324535|NCT00347685|chronic non-malignant pain; chronic pain; non-malignant|chronic non-malignant pain; chronic pain; non-malignant
5324536|NCT00347685|pain; moderate pain; severe pain|pain; moderate pain; severe pain
5324537|NCT00347672|Bird Flu|bird flu
5324538|NCT00347659|Lung volume reduction|lung volume reduction
5324539|NCT00347659|Bronchoscopy|bronchoscopy
5324540|NCT00347659|Emphysema|emphysema
5324541|NCT00347659|COPD|copd
5324542|NCT00347659|NETT|nett
5324543|NCT00347659|Lung disease|lung disease
5324544|NCT00347659|COLD|cold
5324545|NCT00347659|BLVR|blvr
5324546|NCT00347607|trachoma|trachoma
5324547|NCT00347607|chlamydia trachomatis|chlamydia trachomatis
5324548|NCT00347607|surveillance|surveillance
5324549|NCT00347607|azithromycin|azithromycin
5324550|NCT00347594|Corneal surface topography|corneal surface topography
5324551|NCT00347594|Ocular aberrations|ocular aberrations
5324552|NCT00347581|convergence insufficiency|convergence insufficiency
5324553|NCT00347581|base-in prism|base-in prism
5324554|NCT00347581|orthoptics|orthoptics
5324555|NCT00347581|vision therapy|vision therapy
5324556|NCT00347568|decision aids|decision aids
5324557|NCT00347568|high risk|high risk
5324558|NCT00347568|breast cancer|breast cancer
5324559|NCT00347568|breast cancer prevention|breast cancer prevention
5324560|NCT00347555|malaria, falciparum, Plasmodium falciparum malaria, vaccine|malaria, falciparum, plasmodium falciparum malaria, vaccine
5324561|NCT00347542|Vitamin D|vitamin d
5324562|NCT00347542|Diabetes|diabetes
5324563|NCT00347542|Insulin sensitivity|insulin sensitivity
5324564|NCT00347542|Obesity|obesity
5324565|NCT00347529|DNA vaccine, influenza, immunogenicity, tolerability, PMED, pandemic|dna vaccine, influenza, immunogenicity, tolerability, pmed, pandemic
5324566|NCT00347516|IOL formula|iol formula
5324567|NCT00347516|High myopia|high myopia
5324568|NCT00347516|axial length|axial length
5324569|NCT00347477|cardiac arrest|cardiac arrest
5324570|NCT00347477|hypothermia|hypothermia
5324571|NCT00347477|neurologic outcome|neurologic outcome
5324572|NCT00347477|edema|edema
5324573|NCT00347464|Kleinfelter|kleinfelter
5324574|NCT00347451|myopia|myopia
5324575|NCT00347451|optical coherence tomography|optical coherence tomography
5324576|NCT00347438|breast cancer|breast cancer
5324577|NCT00347438|neoadjuvant|neoadjuvant
5324578|NCT00347438|locally advanced|locally advanced
5324579|NCT00347425|Switch Study|switch study
5324580|NCT00347425|Schizophrenia|schizophrenia
5324581|NCT00347425|Atypical Antipsychotics|atypical antipsychotics
5324582|NCT00347412|NSCLC|nsclc
5324583|NCT00347412|Stage IIIb|stage iiib
5324584|NCT00347412|Stage IV|stage iv
5324585|NCT00347412|Non Small Cell Lung Cancer (NSCLC)|non small cell lung cancer (nsclc)
5324586|NCT00347412|NSCLC Stage IIIb with malignant pleural/pericardial effusion|nsclc stage iiib with malignant pleural/pericardial effusion
5324587|NCT00347412|NSCLC Stage IV|nsclc stage iv
5324588|NCT00347399|macular degeneration|macular degeneration
5324589|NCT00347399|antibodies|antibodies
5324590|NCT00347399|angiogenesis inhibitor|angiogenesis inhibitor
5324591|NCT00347386|Infants|infants
5324592|NCT00347386|India|india
5324593|NCT00347386|Zinc|zinc
5324594|NCT00347386|Bacterial illness|bacterial illness
5324595|NCT00347386|Treatment|treatment
5324596|NCT00347373|conjugated linoleic acid|conjugated linoleic acid
5324597|NCT00347373|obesity|obesity
5324598|NCT00347373|body composition|body composition
5324599|NCT00347373|body fat mass|body fat mass
5324600|NCT00347373|lean body mass|lean body mass
5324601|NCT00347360|carvedilol|carvedilol
5324602|NCT00347360|hypertension|hypertension
5324603|NCT00347360|lisinopril|lisinopril
5324604|NCT00347360|factorial|factorial
5324605|NCT00347334|Torticollis|torticollis
5324606|NCT00347334|infant home positioning|infant home positioning
5324607|NCT00347334|head control|head control
5324608|NCT00347321|Percutaneous tracheostomy|percutaneous tracheostomy
5324609|NCT00347321|Endotracheal intubation|endotracheal intubation
5324610|NCT00347321|Mechanical ventilation|mechanical ventilation
5324611|NCT00347321|Cardiac surgery|cardiac surgery
5324612|NCT00347321|Ventilator-free days|ventilator-free days
5324613|NCT00347308|brow ptosis, facial aesthetics, browlift, facelift|brow ptosis, facial aesthetics, browlift, facelift
5324614|NCT00347282|Post enucleation socket syndrome|post enucleation socket syndrome
5324615|NCT00347282|Multi-slice computed tomography scan|multi-slice computed tomography scan
5324616|NCT00347282|Prospective studies|prospective studies
5324617|NCT00347282|Tomography, X Ray Computed|tomography, x ray computed
5324618|NCT00347269|Anxiety Disorders|anxiety disorders
5324619|NCT00347269|Post-traumatic Stress Disorder|post-traumatic stress disorder
5324620|NCT00347269|Generalized Anxiety Disorder|generalized anxiety disorder
5324621|NCT00347269|Panic Disorder|panic disorder
5324622|NCT00347269|Social Anxiety Disorder|social anxiety disorder
5324623|NCT00347269|Stress|stress
5324624|NCT00347269|Stress Disorders, Traumatic|stress disorders, traumatic
5324625|NCT00347269|Stress Disorders, Post-Traumatic|stress disorders, post-traumatic
5324626|NCT00347269|Mental Health Disorders|mental health disorders
5324627|NCT00347230|Intacs ring segments|intacs ring segments
5324628|NCT00347230|Keratoconus|keratoconus
5324629|NCT00347217|Cholesterol|cholesterol
5324630|NCT00347217|rosuvastatin|rosuvastatin
5324631|NCT00347217|LDL-C goal|ldl-c goal
5324632|NCT00347217|observational study|observational study
5324633|NCT00347217|primary prevention|primary prevention
5324634|NCT00347217|secondary prevention|secondary prevention
5324635|NCT00347204|PRK|prk
5324636|NCT00347204|laser vision correction|laser vision correction
5324637|NCT00347204|surface ablation|surface ablation
5324638|NCT00347204|pain|pain
5324639|NCT00347204|wound healing|wound healing
5324640|NCT00347204|corneal haze|corneal haze
5324641|NCT00347191|Corneal thickness|corneal thickness
5324642|NCT00347191|Intraocular pressure|intraocular pressure
5324643|NCT00347191|Instrumentation|instrumentation
5324644|NCT00347191|Glaucoma|glaucoma
5324645|NCT00347191|Keratoconus|keratoconus
5324646|NCT00347178|Asymptomatic Narrow Angles|asymptomatic narrow angles
5324647|NCT00347178|Primary Angle Closure Suspects|primary angle closure suspects
5324648|NCT00347178|Laser Peripheral Iridotomy|laser peripheral iridotomy
5324649|NCT00347178|Randomised Controlled Trial|randomised controlled trial
5324650|NCT00347165|macular degeneration|macular degeneration
5324651|NCT00347165|angiogenesis|angiogenesis
5324652|NCT00347165|antibodies|antibodies
5324653|NCT00347152|Intellectual disabilities|intellectual disabilities
5324654|NCT00347152|development disabilities|development disabilities
5324655|NCT00347152|behavior disorders|behavior disorders
5324656|NCT00347152|stable epilepsy|stable epilepsy
5324657|NCT00347139|Tolerability|tolerability
5324658|NCT00347139|Pharmacodynamics|pharmacodynamics
5324659|NCT00347139|Safety|safety
5324660|NCT00347139|Pharmacokinetics|pharmacokinetics
5324661|NCT00347139|GW642444|gw642444
5324662|NCT00347139|Asthmatic patients|asthmatic patients
5324663|NCT00347139|Efficacy|efficacy
5324664|NCT00347126|Glaucoma|glaucoma
5324665|NCT00347126|Latanoprost|latanoprost
5324666|NCT00347126|Travoprost|travoprost
5324667|NCT00347126|Intraocular pressure|intraocular pressure
5324668|NCT00347126|Hyperemia|hyperemia
5324669|NCT00347113|P. falciparum|p. falciparum
5324670|NCT00347113|malaria|malaria
5324671|NCT00347113|schistosome infections|schistosome infections
5324672|NCT00347113|soil-transmitted helminths infection|soil-transmitted helminths infection
5324673|NCT00347113|anaemia|anaemia
5324674|NCT00347113|immune response|immune response
5324675|NCT00347113|Tanzania|tanzania
5324676|NCT00347087|Insulin sensitivity|insulin sensitivity
5324677|NCT00347087|chronic heart failure|chronic heart failure
5324678|NCT00347087|metabolism|metabolism
5324679|NCT00347074|Keratoconus, corneal topography, ocular aberrometry, visual outcome, contact lens wear, quality of life|keratoconus, corneal topography, ocular aberrometry, visual outcome, contact lens wear, quality of life
5324680|NCT00347061|Benign Prostatic Hyperplasiam|benign prostatic hyperplasiam
5324681|NCT00347061|Adrenergic alpha-antagonist|adrenergic alpha-antagonist
5324682|NCT00347048|Ulcerative colitis|ulcerative colitis
5324683|NCT00347048|tacrolimus|tacrolimus
5324684|NCT00347048|FK506|fk506
5324685|NCT00347048|treatment outcome|treatment outcome
5324686|NCT00347022|Multislice computed tomography (MSCT)indications|multislice computed tomography (msct)indications
5324687|NCT00347009|Cirrhosis|cirrhosis
5324688|NCT00347009|Advanced Fibrosis|advanced fibrosis
5324689|NCT00347009|Chronic Hepatitis B|chronic hepatitis b
5324690|NCT00347009|Adefovir Dipivoxil|adefovir dipivoxil
5324691|NCT00346996|diabetes|diabetes
5324692|NCT00346996|insulin|insulin
5324693|NCT00346996|insulin analogues|insulin analogues
5324694|NCT00346996|hypoglycaemia|hypoglycaemia
5324695|NCT00346996|severe hypoglycaemia|severe hypoglycaemia
5324696|NCT00346970|Metabolic Syndrome|metabolic syndrome
5324697|NCT00346970|High Density Lipoprotein|high density lipoprotein
5324698|NCT00346970|Extended-Release Niacin|extended-release niacin
5324699|NCT00346970|Endothelial Function|endothelial function
5324700|NCT00346970|Endothelial Progenitor Cells|endothelial progenitor cells
5324701|NCT00346931|glaucoma|glaucoma
5324702|NCT00346931|cataract|cataract
5324703|NCT00346931|surgery|surgery
5324704|NCT00346931|intraocular pressure|intraocular pressure
5324705|NCT00346931|phacoemulsification|phacoemulsification
5324706|NCT00346931|trabeculotomy|trabeculotomy
5324707|NCT00346918|ADPKD|adpkd
5324708|NCT00346918|autosomal dominant polycystic kidney disease|autosomal dominant polycystic kidney disease
5324709|NCT00346918|Sirolimus|sirolimus
5324710|NCT00346918|volumetry|volumetry
5324711|NCT00346905|GERD|gerd
5324712|NCT00346905|Gastroesophageal Reflux Disease|gastroesophageal reflux disease
5324713|NCT00346905|Reflux|reflux
5324714|NCT00346905|Enteryx|enteryx
5324715|NCT00346892|Prophylaxis rotavirus|prophylaxis rotavirus
5324716|NCT00346879|fondaparinux for prevention of blood clots|fondaparinux for prevention of blood clots
5324717|NCT00346853|Dark adaptation inhibition|dark adaptation inhibition
5324718|NCT00346853|Stargardt macular dystrophy|stargardt macular dystrophy
5324719|NCT00346853|4-Methylpyrazole (4-MP)|4-methylpyrazole (4-mp)
5324720|NCT00346853|Antizol|antizol
5324721|NCT00346853|Fomepizole|fomepizole
5324722|NCT00346840|Labor induction|labor induction
5324723|NCT00346840|cervical ripening|cervical ripening
5324724|NCT00346840|misoprostol|misoprostol
5324725|NCT00346840|vaginal insert|vaginal insert
5324726|NCT00346814|Retinopathy of prematurity|retinopathy of prematurity
5324727|NCT00346814|antiangiogenic therapy|antiangiogenic therapy
5324728|NCT00346801|Non-Small Cell Lung Cancer|non-small cell lung cancer
5324729|NCT00346801|Lung Cancer|lung cancer
5324730|NCT00346801|Celecoxib|celecoxib
5324731|NCT00346801|Cisplatin|cisplatin
5324732|NCT00346801|Platinol|platinol
5324733|NCT00346801|CPT-11|cpt-11
5324734|NCT00346801|Irinotecan|irinotecan
5324735|NCT00346801|SC-58635|sc-58635
5324736|NCT00346801|Celebrex|celebrex
5324737|NCT00346801|Radiation Therapy|radiation therapy
5324738|NCT00346775|questionnaire|questionnaire
5324739|NCT00346775|nasal spray|nasal spray
5324740|NCT00346775|Seasonal allergic rhinitis|seasonal allergic rhinitis
5324741|NCT00346775|nasal spray questionnaire|nasal spray questionnaire
5324742|NCT00346775|allergic rhinitis|allergic rhinitis
5324743|NCT00346762|Former Plasma Donors|former plasma donors
5324744|NCT00346762|Commercial Plasma Donors|commercial plasma donors
5324745|NCT00346762|Long-Term Nonprogressors|long-term nonprogressors
5324746|NCT00346762|Host Factors|host factors
5324747|NCT00346762|Viral Factors|viral factors
5324748|NCT00346762|HIV|hiv
5324749|NCT00346749|Inflammation|inflammation
5324750|NCT00346749|FEV1|fev1
5324751|NCT00346749|Sputum|sputum
5324752|NCT00346736|Alternative medicine|alternative medicine
5324753|NCT00346736|Traditional Chinese medicine|traditional chinese medicine
5324754|NCT00346736|Acupuncture|acupuncture
5324755|NCT00346736|Autistic Spectrum Disorder|autistic spectrum disorder
5324756|NCT00346736|Autism|autism
5324757|NCT00346736|Children|children
5324758|NCT00346723|Influenza, Vaccine, CHMP criteria|influenza, vaccine, chmp criteria
5324759|NCT00346710|communication|communication
5324760|NCT00346710|patient experience|patient experience
5324761|NCT00346710|fellowship training|fellowship training
5324762|NCT00346697|AIDS|aids
5324763|NCT00346697|HIV|hiv
5324764|NCT00346697|HAART|haart
5324765|NCT00346697|Lipids|lipids
5324766|NCT00346697|Triglycerides|triglycerides
5324767|NCT00346697|Cholesterol|cholesterol
5324768|NCT00346697|omega-3 fatty acids|omega-3 fatty acids
5324769|NCT00346697|bone turnover|bone turnover
5324770|NCT00346697|inflammation|inflammation
5324771|NCT00346697|insulin resistance|insulin resistance
5324772|NCT00346684|Lymphoma|lymphoma
5324773|NCT00346684|LPHD|lphd
5324774|NCT00346684|Rituximab|rituximab
5324775|NCT00346671|Reiki|reiki
5324776|NCT00346671|Stress|stress
5324777|NCT00346671|CAM|cam
5324778|NCT00346658|Osteoporosis|osteoporosis
5324779|NCT00346658|bone density|bone density
5324780|NCT00346658|magnesium|magnesium
5324781|NCT00346658|vitamin D|vitamin d
5324782|NCT00346645|NON-SMALL CELL LUNG CANCER METASTATIC|non-small cell lung cancer metastatic
5324783|NCT00346632|AML|aml
5324784|NCT00346632|ALL|all
5324785|NCT00346632|MDS|mds
5324786|NCT00346632|CML|cml
5324787|NCT00346632|Kinase Inhibitor|kinase inhibitor
5324788|NCT00346606|Chronic Idiopathic Urticaria|chronic idiopathic urticaria
5324789|NCT00346606|Desloratadine|desloratadine
5324790|NCT00346606|Denosin|denosin
5324791|NCT00346606|Levocetirizine|levocetirizine
5324792|NCT00346567|mother-to-child-transmission|mother-to-child-transmission
5324793|NCT00346567|PMTCT|pmtct
5324794|NCT00346567|HIV|hiv
5324795|NCT00346567|resistance|resistance
5324796|NCT00346567|NNRTI|nnrti
5324797|NCT00346554|COPD|copd
5324798|NCT00346554|Sleep disorders|sleep disorders
5324799|NCT00346554|pulmonary rehabilitation|pulmonary rehabilitation
5324800|NCT00346541|glaucoma|glaucoma
5324801|NCT00346541|polymorphism, genetic|polymorphism, genetic
5324802|NCT00346515|carotid artery|carotid artery
5324803|NCT00346515|carotid stenosis|carotid stenosis
5324804|NCT00346515|carotid stenting|carotid stenting
5324805|NCT00346515|embolic protection|embolic protection
5324806|NCT00346489|Trabeculectomy|trabeculectomy
5324807|NCT00346489|5-fluorouracil|5-fluorouracil
5324808|NCT00346489|Mitomycin C|mitomycin c
5324809|NCT00346476|TB|tb
5324810|NCT00346476|Transmission|transmission
5324811|NCT00346476|Genetic Diversity|genetic diversity
5324812|NCT00346476|Genetic Testing|genetic testing
5324813|NCT00346476|RFLP|rflp
5324814|NCT00346463|Allopurinol|allopurinol
5324815|NCT00346463|Fetal Growth Retardation|fetal growth retardation
5324816|NCT00346463|Oxidative Stress|oxidative stress
5324817|NCT00346463|Placental Insufficiency|placental insufficiency
5324818|NCT00346450|Culture|culture
5324819|NCT00346450|Conjunctiva|conjunctiva
5324820|NCT00346450|transplantation|transplantation
5324821|NCT00346450|pterygium|pterygium
5324822|NCT00346450|ocular surface|ocular surface
5324823|NCT00346437|angina|angina
5324824|NCT00346437|FGF-4|fgf-4
5324825|NCT00346437|angiogenesis|angiogenesis
5324826|NCT00346437|adenovector|adenovector
5324827|NCT00346437|growth factor|growth factor
5324828|NCT00346437|myocardial ischemia|myocardial ischemia
5324829|NCT00346437|revascularization|revascularization
5324830|NCT00346424|occluded central catheter|occluded central catheter
5324831|NCT00346424|central venous access devices dysfunction|central venous access devices dysfunction
5324832|NCT00346424|withdrawal occlusion|withdrawal occlusion
5324833|NCT00346424|Thrombosis|thrombosis
5324834|NCT00346424|Venous thrombosis|venous thrombosis
5324835|NCT00346411|rheumatoid arthritis|rheumatoid arthritis
5324836|NCT00346411|mood|mood
5324837|NCT00346411|adherence|adherence
5324838|NCT00346411|medication|medication
5324839|NCT00346398|asthma|asthma
5324840|NCT00346398|allergen|allergen
5324841|NCT00346398|allergic disease|allergic disease
5324842|NCT00346398|allergen immunotherapy|allergen immunotherapy
5324843|NCT00346398|allergic sensitization|allergic sensitization
5324844|NCT00346398|atopic dermatitis|atopic dermatitis
5324845|NCT00346398|eczema|eczema
5324846|NCT00346398|food allergy|food allergy
5324847|NCT00346398|oral mucosal immunoprophylaxis (OMIP)|oral mucosal immunoprophylaxis (omip)
5324848|NCT00346385|recurrent small cell lung cancer|recurrent small cell lung cancer
5324849|NCT00346385|merkel cell carcinoma|merkel cell carcinoma
5324850|NCT00346385|ovarian cancer|ovarian cancer
5324851|NCT00346372|Ocular Melanoma|ocular melanoma
5324852|NCT00346372|Optical Coherence Tomography|optical coherence tomography
5324853|NCT00346372|Eye Tumor|eye tumor
5324854|NCT00346372|Choroidal Melanoma|choroidal melanoma
5324855|NCT00346372|Uveal Melanoma|uveal melanoma
5324856|NCT00346359|graft versus host disease|graft versus host disease
5324857|NCT00346359|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5324858|NCT00346359|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
5324859|NCT00346359|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5324973|NCT00345982|Schizophrenia|schizophrenia
5324860|NCT00346359|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5324861|NCT00346359|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5324862|NCT00346359|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5324863|NCT00346359|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5324864|NCT00346359|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
5324865|NCT00346359|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5324866|NCT00346359|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5324867|NCT00346359|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5324868|NCT00346359|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5324869|NCT00346359|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
5324870|NCT00346359|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5324871|NCT00346359|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
5325052|NCT00345774|PAH|pah
5324872|NCT00346359|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
5324873|NCT00346359|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5324874|NCT00346359|chronic eosinophilic leukemia|chronic eosinophilic leukemia
5324875|NCT00346359|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
5324876|NCT00346359|chronic neutrophilic leukemia|chronic neutrophilic leukemia
5324877|NCT00346359|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5324878|NCT00346359|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5324879|NCT00346359|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5324880|NCT00346359|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5324881|NCT00346359|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5324882|NCT00346359|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
5324883|NCT00346346|Immunity|immunity
5324884|NCT00346346|Memory|memory
5324885|NCT00346346|ELISPOT|elispot
5324886|NCT00346346|Malaria|malaria
5324887|NCT00346346|Prospective|prospective
5324888|NCT00346333|Retinitis Pigmentosa, Inherited Retinal Degeneration|retinitis pigmentosa, inherited retinal degeneration
5324889|NCT00346320|stage I non-small cell lung cancer|stage i non-small cell lung cancer
5324890|NCT00346320|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
5324891|NCT00346320|adenocarcinoma of the lung|adenocarcinoma of the lung
5324892|NCT00346320|adenosquamous cell lung cancer|adenosquamous cell lung cancer
5324893|NCT00346320|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
5324894|NCT00346320|large cell lung cancer|large cell lung cancer
5324895|NCT00346320|squamous cell lung cancer|squamous cell lung cancer
5324896|NCT00346294|Rheumatoid Arthritis|rheumatoid arthritis
5324897|NCT00346294|Device|device
5324898|NCT00346294|Auto-injector|auto-injector
5324899|NCT00346294|SureClick|sureclick
5324900|NCT00346294|Enbrel|enbrel
5324901|NCT00346294|Etanercept|etanercept
5324902|NCT00346281|unresectable pancreatic cancer|unresectable pancreatic cancer
5324903|NCT00346281|brachytherapy|brachytherapy
5324904|NCT00346281|32P|32p
5324905|NCT00346281|BioSilicon|biosilicon
5324906|NCT00346281|locally advanced|locally advanced
5324907|NCT00346281|gemcitabine|gemcitabine
5324908|NCT00346281|intratumourally|intratumourally
5324909|NCT00346281|unresectable|unresectable
5324910|NCT00346255|stage I multiple myeloma|stage i multiple myeloma
5324911|NCT00346255|stage II multiple myeloma|stage ii multiple myeloma
5324912|NCT00346255|stage III multiple myeloma|stage iii multiple myeloma
5324913|NCT00346242|thalassemia|thalassemia
5324914|NCT00346242|zoledronic acid|zoledronic acid
5324915|NCT00346242|skeletal events|skeletal events
5324916|NCT00346229|stage III B breast cancer|stage iii b breast cancer
5324917|NCT00346229|stage III C breast cancer|stage iii c breast cancer
5324918|NCT00346229|stage IV breast cancer|stage iv breast cancer
5324919|NCT00346229|inflammatory breast cancer|inflammatory breast cancer
5324920|NCT00346229|recurrent breast cancer|recurrent breast cancer
5324921|NCT00346177|heart|heart
5324922|NCT00346177|stem Cells|stem cells
5324923|NCT00346177|low EF|low ef
5324924|NCT00346177|heart attack|heart attack
5324925|NCT00346177|cardiomyopathy|cardiomyopathy
5324926|NCT00346177|congestive heart failure|congestive heart failure
5324927|NCT00346177|cardiovascular disease|cardiovascular disease
5324928|NCT00346177|Heart Failure|heart failure
5324929|NCT00346177|Low Ejection Fraction|low ejection fraction
5324930|NCT00346151|renal transplantation|renal transplantation
5324931|NCT00346151|kidney transplantation|kidney transplantation
5324932|NCT00346151|renal allograft recipient|renal allograft recipient
5324933|NCT00346151|anti-rejection drugs|anti-rejection drugs
5324934|NCT00346151|immunosuppression protocol|immunosuppression protocol
5324935|NCT00346151|immunosuppression withdrawal|immunosuppression withdrawal
5324936|NCT00346125|soft tissue sarcoma|soft tissue sarcoma
5324937|NCT00346125|Malignant fibrous histiocytoma|malignant fibrous histiocytoma
5324938|NCT00346125|Liposarcoma|liposarcoma
5324939|NCT00346125|Fibrosarcoma|fibrosarcoma
5324940|NCT00346125|Leiomyosarcoma|leiomyosarcoma
5324941|NCT00346125|Synovial sarcoma|synovial sarcoma
5324942|NCT00346125|Malignant peripheral nerve sheath tumor (MPNST)|malignant peripheral nerve sheath tumor (mpnst)
5324943|NCT00346125|Epithelioid sarcoma|epithelioid sarcoma
5324944|NCT00346112|ICD|icd
5324945|NCT00346112|distress|distress
5324946|NCT00346112|anxiety|anxiety
5324947|NCT00346112|quality-of-life|quality-of-life
5324948|NCT00346099|NSABP|nsabp
5324949|NCT00346099|panitumumab|panitumumab
5324950|NCT00346099|rectal cancer|rectal cancer
5324951|NCT00346099|colorectal cancer|colorectal cancer
5324952|NCT00346099|oxaliplatin|oxaliplatin
5324953|NCT00346099|capecitabine|capecitabine
5324954|NCT00346099|combined modality therapy|combined modality therapy
5324955|NCT00346099|combined pelvic radiation therapy|combined pelvic radiation therapy
5324956|NCT00346099|Rectal cancer with or without metastasis|rectal cancer with or without metastasis
5324957|NCT00346086|CpG oligonucleotide vaccine|cpg oligonucleotide vaccine
5324958|NCT00346086|ragweed immunotherapy|ragweed immunotherapy
5324959|NCT00346073|Prophylaxis for diphtheria, tetanus, pertussis|prophylaxis for diphtheria, tetanus, pertussis
5324960|NCT00346073|Immunogenicity, booster, dTpa|immunogenicity, booster, dtpa
5324961|NCT00346060|Dry age related macular degeneration.|dry age related macular degeneration.
5324962|NCT00346060|Retinal Transplant|retinal transplant
5324963|NCT00346060|Fetal Tissue|fetal tissue
5324964|NCT00346060|Early treatment diabetic retinopathy study|early treatment diabetic retinopathy study
5324965|NCT00346060|20/200 or worse.|20/200 or worse.
5324966|NCT00346021|Children's behavior towards hat use|children's behavior towards hat use
5324967|NCT00346008|melanoma|melanoma
5324968|NCT00346008|recurrent melanoma|recurrent melanoma
5324969|NCT00346008|stage I melanoma|stage i melanoma
5324970|NCT00346008|stage II melanoma|stage ii melanoma
5324971|NCT00346008|stage III melanoma|stage iii melanoma
5324972|NCT00346008|stage IV melanoma|stage iv melanoma
5324974|NCT00345982|Treatment-resistant|treatment-resistant
5324975|NCT00345982|sertindole|sertindole
5324976|NCT00345982|clozapine|clozapine
5324977|NCT00345969|Testosterone Replacement Therapy|testosterone replacement therapy
5324978|NCT00345969|Physical Frailty|physical frailty
5324979|NCT00345969|Hip Fracture|hip fracture
5324980|NCT00345956|Prophylaxis against gastroenteritis caused by Rotavirus|prophylaxis against gastroenteritis caused by rotavirus
5324981|NCT00345943|Eating Disorders|eating disorders
5324982|NCT00345943|Bulimia Nervosa|bulimia nervosa
5324983|NCT00345943|Bulimia|bulimia
5324984|NCT00345943|fMRI|fmri
5324985|NCT00345943|Magnetic Resonance Imaging|magnetic resonance imaging
5324986|NCT00345930|Complementary and alternative medicine|complementary and alternative medicine
5324987|NCT00345930|Complementary therapies|complementary therapies
5324988|NCT00345930|Alternative therapies|alternative therapies
5324989|NCT00345930|Prescription Drugs|prescription drugs
5324990|NCT00345930|Non prescription Drugs|non prescription drugs
5324991|NCT00345930|Liver Disease|liver disease
5324992|NCT00345930|Chemical Ind|chemical ind
5324993|NCT00345930|Phenotype|phenotype
5324994|NCT00345930|Proteomics|proteomics
5324995|NCT00345930|Metabolomics|metabolomics
5324996|NCT00345930|Cholestatic Liver Injury|cholestatic liver injury
5324997|NCT00345930|Hepatocellular Liver Injury|hepatocellular liver injury
5324998|NCT00345930|Mixed Liver Injury|mixed liver injury
5324999|NCT00345930|Matched Case Control Studies|matched case control studies
5325000|NCT00345930|Genotype|genotype
5325001|NCT00345930|Liver Dis|liver dis
5325002|NCT00345930|Chem Ind|chem ind
5325003|NCT00345917|Retinitis Pigmentosa|retinitis pigmentosa
5325004|NCT00345917|Retinal Transplant|retinal transplant
5325005|NCT00345917|Fetal Tissue|fetal tissue
5325006|NCT00345917|Early treatment diabetic retinopathy study|early treatment diabetic retinopathy study
5325007|NCT00345917|20/200 or worse.|20/200 or worse.
5325008|NCT00345904|influenza, vaccine|influenza, vaccine
5325009|NCT00345904|prophylaxis of influenza|prophylaxis of influenza
5325010|NCT00345891|Lung neoplasms|lung neoplasms
5325011|NCT00345891|Family|family
5325012|NCT00345891|Stress|stress
5325013|NCT00345878|HPV-16/18 L1 VLP AS04|hpv-16/18 l1 vlp as04
5325014|NCT00345878|Cervical neoplasia|cervical neoplasia
5325015|NCT00345878|Cervical cancer|cervical cancer
5325016|NCT00345878|Human Papillomavirus (HPV)|human papillomavirus (hpv)
5325017|NCT00345878|Double-blind|double-blind
5325018|NCT00345878|AS04|as04
5325019|NCT00345865|Hodgkin lymphoma|hodgkin lymphoma
5325020|NCT00345865|non-Hodgkin lymphoma|non-hodgkin lymphoma
5325021|NCT00345865|HIV-associated lymphoma|hiv-associated lymphoma
5325022|NCT00345852|twin to twin transfusion syndrome|twin to twin transfusion syndrome
5325023|NCT00345852|fetoscopic selective laser photocoagulation|fetoscopic selective laser photocoagulation
5325024|NCT00345852|amnioreduction|amnioreduction
5325025|NCT00345839|Cinacalcet HCl|cinacalcet hcl
5325026|NCT00345839|Cinacalcet|cinacalcet
5325027|NCT00345839|AMG 073|amg 073
5325028|NCT00345839|Sensipar|sensipar
5325029|NCT00345839|Mimpara|mimpara
5325030|NCT00345839|Calcimimetic|calcimimetic
5325031|NCT00345839|Hemodialysis|hemodialysis
5325033|NCT00345839|Secondary hyperparathyroidism (HPT)|secondary hyperparathyroidism (hpt)
5325034|NCT00345826|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5325035|NCT00345826|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5325036|NCT00345826|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5325037|NCT00345826|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5325038|NCT00345826|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5325039|NCT00345826|chronic myelogenous leukemia, BCR-ABL1 positive|chronic myelogenous leukemia, bcr-abl1 positive
5325040|NCT00345813|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5325041|NCT00345813|stage I prostate cancer|stage i prostate cancer
5325042|NCT00345813|stage IIB prostate cancer|stage iib prostate cancer
5325043|NCT00345813|stage IIA prostate cancer|stage iia prostate cancer
5325044|NCT00345813|stage III prostate cancer|stage iii prostate cancer
5325045|NCT00345813|stage IV prostate cancer|stage iv prostate cancer
5325046|NCT00345800|Endocrine Evaluation cataplexy|endocrine evaluation cataplexy
5325047|NCT00345800|sodium oxybate (xyrem)|sodium oxybate (xyrem)
5325048|NCT00345787|Osteoarthritic Pain|osteoarthritic pain
5325049|NCT00345774|Pulmonary Hypertension|pulmonary hypertension
5325050|NCT00345774|PH|ph
5325051|NCT00345774|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
5325053|NCT00345774|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5325054|NCT00345774|COPD|copd
5325055|NCT00345774|PRX-08066|prx-08066
5325056|NCT00345774|Predix|predix
5325057|NCT00345761|Advanced and/or metastatic colorectal cancer|advanced and/or metastatic colorectal cancer
5325058|NCT00345735|Cancer pain with breakthrough pain episodes|cancer pain with breakthrough pain episodes
5325059|NCT00345722|Strawberry|strawberry
5325060|NCT00345722|Almond|almond
5325061|NCT00345722|Soy protein|soy protein
5325062|NCT00345722|viscous dietary fibre|viscous dietary fibre
5325063|NCT00345722|plant sterols|plant sterols
5325064|NCT00345722|portfolio diet|portfolio diet
5325065|NCT00345722|blood lipids|blood lipids
5325066|NCT00345722|compliance|compliance
5325067|NCT00345722|blood pressure|blood pressure
5325068|NCT00345709|Ovarian Cancer|ovarian cancer
5325069|NCT00345709|Peritoneal Cancer|peritoneal cancer
5325070|NCT00345709|Fallopian Tube Cancer|fallopian tube cancer
5325071|NCT00345709|Elizabeth Registry|elizabeth registry
5325072|NCT00345709|Questionnaire|questionnaire
5325073|NCT00345709|Registry|registry
5325074|NCT00345709|Survey|survey
5325075|NCT00345696|Capecitabine|capecitabine
5325076|NCT00345696|Oxaliplatin|oxaliplatin
5325077|NCT00345696|Bevacizumab|bevacizumab
5325078|NCT00345696|First line|first line
5325079|NCT00345683|H. influenzae type B vaccine|h. influenzae type b vaccine
5325080|NCT00345683|Infants|infants
5325081|NCT00345683|Neisseria meningitidis|neisseria meningitidis
5325082|NCT00345683|Vaccines, conjugate|vaccines, conjugate
5325083|NCT00345683|Meningococcal vaccines|meningococcal vaccines
5325084|NCT00345683|Prophylaxis|prophylaxis
5325085|NCT00345683|Comparative study|comparative study
5325086|NCT00345683|Safety|safety
5325087|NCT00345683|Humans|humans
5325088|NCT00345670|Lower respiratory tract illness|lower respiratory tract illness
5325089|NCT00345670|RSV and PIV3 infection|rsv and piv3 infection
5325090|NCT00345657|Hyperlipidemia|hyperlipidemia
5325091|NCT00345657|Dyslipidemia|dyslipidemia
5325092|NCT00345657|Niacin|niacin
5325093|NCT00345657|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors
5325094|NCT00345657|Combination lipid therapy|combination lipid therapy
5325095|NCT00345657|Lovastatin|lovastatin
5325096|NCT00345644|Postmenopausal|postmenopausal
5325097|NCT00345631|Closure Device|closure device
5325098|NCT00345631|Angiography|angiography
5325099|NCT00345631|Angioplasty|angioplasty
5325100|NCT00345631|Hemostasis|hemostasis
5325101|NCT00345631|Heart Catheterization|heart catheterization
5325102|NCT00345631|Peripheral Angiography|peripheral angiography
5325103|NCT00345631|Femoral Closure|femoral closure
5325104|NCT00345631|Vascular Closure|vascular closure
5325105|NCT00345631|Coronary Angiography|coronary angiography
5325106|NCT00345618|Deep venous thrombosis|deep venous thrombosis
5325107|NCT00345618|pulmonary embolism|pulmonary embolism
5325108|NCT00345618|anticoagulant drugs|anticoagulant drugs
5325109|NCT00345605|Argininosuccinic Acid Lyase Deficiency|argininosuccinic acid lyase deficiency
5325111|NCT00345579|Prophylaxis|prophylaxis
5325112|NCT00345579|Neisseria meningitidis Vaccines, conjugate|neisseria meningitidis vaccines, conjugate
5325113|NCT00345579|Infants|infants
5325114|NCT00345579|Meningococcal vaccines|meningococcal vaccines
5325115|NCT00345579|H. influenzae type B vaccine|h. influenzae type b vaccine
5325116|NCT00345579|Humans|humans
5325117|NCT00345579|Safety|safety
5325118|NCT00345566|cerebral palsy|cerebral palsy
5325119|NCT00345566|protein composition|protein composition
5325120|NCT00345566|gastric emptying rate|gastric emptying rate
5325121|NCT00345566|tube feeding|tube feeding
5325122|NCT00345553|Biliary Atresia|biliary atresia
5325123|NCT00345553|Cholestasis|cholestasis
5325124|NCT00345540|Platinum Resistant Tumors of Ovarian Origin|platinum resistant tumors of ovarian origin
5325125|NCT00345527|Problem gambling|problem gambling
5325126|NCT00345527|Clinically significant anger|clinically significant anger
5325127|NCT00345514|Children|children
5325128|NCT00345514|Self-efficacy|self-efficacy
5325129|NCT00345514|Organization|organization
5325130|NCT00345514|Process of care|process of care
5325131|NCT00345501|contrast media|contrast media
5325132|NCT00345501|contrast nephropathy|contrast nephropathy
5325133|NCT00345475|Birth Defects|birth defects
5325134|NCT00345475|Epilepsy|epilepsy
5325135|NCT00345475|High Risk Pregnancy|high risk pregnancy
5325136|NCT00345462|Influenza, Vaccine, CHMP criteria|influenza, vaccine, chmp criteria
5325137|NCT00345449|cystic fibrosis,|cystic fibrosis,
5325138|NCT00345449|lung disease,|lung disease,
5325139|NCT00345449|lung transplantation,|lung transplantation,
5325140|NCT00345449|decision aid|decision aid
5325141|NCT00345436|Insulin Sensitivity|insulin sensitivity
5325142|NCT00345436|Moderate intensity|moderate intensity
5325143|NCT00345436|Insulin Resistance|insulin resistance
5325144|NCT00345436|Exercise Intervention|exercise intervention
5325145|NCT00345410|obesity and dyslipidemia|obesity and dyslipidemia
5325146|NCT00345397|cecostomy|cecostomy
5325147|NCT00345397|colonoscopy|colonoscopy
5325148|NCT00345397|colostomy|colostomy
5325149|NCT00345397|constipation|constipation
5325150|NCT00345397|endoscopy, gastrointestinal|endoscopy, gastrointestinal
5325151|NCT00345397|fecal incontinence|fecal incontinence
5325152|NCT00345397|percutaneous|percutaneous
5325153|NCT00345397|quality of life|quality of life
5325154|NCT00345397|spinal cord injury|spinal cord injury
5325155|NCT00345384|Dexmedetomidine|dexmedetomidine
5325156|NCT00345384|Sedation|sedation
5325157|NCT00345384|Opioid|opioid
5325158|NCT00345384|Respiratory depression|respiratory depression
5325159|NCT00345371|methamphetamine addiction|methamphetamine addiction
5325160|NCT00345358|Booster vaccination|booster vaccination
5325161|NCT00345358|Catch-up vaccination|catch-up vaccination
5325162|NCT00345358|Pneumococcal vaccine|pneumococcal vaccine
5325163|NCT00345358|Immunogenicity|immunogenicity
5325164|NCT00345358|Safety|safety
5325165|NCT00345358|Pneumococcal disease|pneumococcal disease
5325166|NCT00345345|Neutropenia|neutropenia
5325167|NCT00345345|Monoclonal Antibody Therapy|monoclonal antibody therapy
5325168|NCT00345345|Anti-CD52|anti-cd52
5325169|NCT00345345|T-LGL Leukemia|t-lgl leukemia
5325170|NCT00345345|LGL Leukemia|lgl leukemia
5325171|NCT00345345|Anemia|anemia
5325172|NCT00345345|Immunosuppression|immunosuppression
5325173|NCT00345345|Chronic T Cell Lymphocytosis with Neutropenia|chronic t cell lymphocytosis with neutropenia
5325174|NCT00345345|Leukemia|leukemia
5325175|NCT00345319|rabies|rabies
5325176|NCT00345319|vaccine|vaccine
5325177|NCT00345319|post-exposure prophylaxis|post-exposure prophylaxis
5325178|NCT00345306|endometrial preparation|endometrial preparation
5325179|NCT00345306|Utrogestan|utrogestan
5325180|NCT00345306|Endometrin|endometrin
5325181|NCT00345293|Prostate Cancer|prostate cancer
5325182|NCT00345280|Cystic fibrosis|cystic fibrosis
5325183|NCT00345280|eye|eye
5325184|NCT00345280|inflammation|inflammation
5325185|NCT00345280|apoptosis|apoptosis
5325186|NCT00345280|C11+|c11+
5325187|NCT00345267|Asthma|asthma
5325188|NCT00345267|Children|children
5325189|NCT00345267|Integrated Care Pathway|integrated care pathway
5325190|NCT00345267|Evidence based medicine|evidence based medicine
5325191|NCT00345267|Prescribing errors|prescribing errors
5325192|NCT00345241|Blepharitis|blepharitis
5325193|NCT00345228|High myopia|high myopia
5325194|NCT00345228|Choroidal neovascularisation|choroidal neovascularisation
5325195|NCT00345228|Lacquer crack|lacquer crack
5325196|NCT00345228|Fundus fluorescein angiography|fundus fluorescein angiography
5325197|NCT00345228|Indocyanine green angiography|indocyanine green angiography
5325198|NCT00345228|Axial length|axial length
5325199|NCT00345215|Urinary Aquaporin 2|urinary aquaporin 2
5325200|NCT00345215|High/low Sodium Diet|high/low sodium diet
5325201|NCT00345215|Fractional Sodium Excretion|fractional sodium excretion
5325202|NCT00345202|HMG-COA reductase inhibition|hmg-coa reductase inhibition
5325203|NCT00345202|GFR|gfr
5325204|NCT00345202|RPF|rpf
5325205|NCT00345202|FE|fe
5325206|NCT00345202|CL|cl
5325207|NCT00345189|Hsp90 inhibitor|hsp90 inhibitor
5325208|NCT00345189|CNF2024|cnf2024
5325209|NCT00345189|Advanced Solid Tumors|advanced solid tumors
5325210|NCT00345176|age-related macular degeneration|age-related macular degeneration
5325211|NCT00345176|AMD|amd
5325212|NCT00345176|lutein|lutein
5325213|NCT00345176|zeaxanthin|zeaxanthin
5325214|NCT00345176|docosahexaenoic acid|docosahexaenoic acid
5325215|NCT00345176|eicosapentaenoic acid|eicosapentaenoic acid
5325216|NCT00345163|Glioblastoma Multiforme|glioblastoma multiforme
5325217|NCT00345163|Avastin|avastin
5325218|NCT00345163|Brain Cancer|brain cancer
5325219|NCT00345163|GBM|gbm
5325220|NCT00345150|hypertension|hypertension
5325221|NCT00345150|nitric oxide|nitric oxide
5325222|NCT00345150|renal hemodynamics|renal hemodynamics
5325223|NCT00345137|Renal hemodynamics|renal hemodynamics
5325224|NCT00345137|Nitric oxide|nitric oxide
5325225|NCT00345124|urinary aquaporin-2|urinary aquaporin-2
5325226|NCT00345124|ENaC|enac
5325227|NCT00345124|fractional sodium excretion|fractional sodium excretion
5325228|NCT00345124|High/low sodium diet|high/low sodium diet
5325229|NCT00345111|Restor IOL versus Conventional IOL|restor iol versus conventional iol
5325230|NCT00345098|Depression, Antidepressive agents|depression, antidepressive agents
5325231|NCT00345098|Clinical Trial|clinical trial
5325232|NCT00345098|Phase III|phase iii
5325233|NCT00345098|Multicenter study|multicenter study
5325234|NCT00345072|Menopause|menopause
5325235|NCT00345072|Decision aids|decision aids
5325236|NCT00345072|Internet|internet
5325237|NCT00345072|Hormone Replacement Therapy|hormone replacement therapy
5325238|NCT00345072|Breast Cancer|breast cancer
5325239|NCT00345072|Cardiovascular Disease|cardiovascular disease
5325240|NCT00345072|Osteoporosis|osteoporosis
5325241|NCT00345059|second line|second line
5325242|NCT00345059|monochemotherapy|monochemotherapy
5325243|NCT00345059|combination chemotherapy|combination chemotherapy
5325244|NCT00345059|platinum refractory|platinum refractory
5325245|NCT00345059|previously treated|previously treated
5325246|NCT00345046|Glaucoma|glaucoma
5325247|NCT00345046|Cataract|cataract
5325248|NCT00345033|Glucose Metabolism|glucose metabolism
5325249|NCT00345020|Deep Lamellar Endotheliam Keratoplasty|deep lamellar endotheliam keratoplasty
5325250|NCT00345007|Retinal detachment|retinal detachment
5325251|NCT00345007|Macular function|macular function
5325252|NCT00345007|Multifocal electrophysiology|multifocal electrophysiology
5325253|NCT00344994|Restless Legs Syndrome|restless legs syndrome
5325254|NCT00344994|Mirapex (pramipexole)|mirapex (pramipexole)
5325255|NCT00344994|Requip(Ropinirole)|requip(ropinirole)
5325256|NCT00344994|Dopamine Agonist|dopamine agonist
5325257|NCT00344981|Cell Cycle Agents|cell cycle agents
5325258|NCT00344955|HMG-COA reductase inhibition|hmg-coa reductase inhibition
5325259|NCT00344955|GFR|gfr
5325260|NCT00344955|RPF|rpf
5325261|NCT00344955|FE|fe
5325262|NCT00344955|CL|cl
5325263|NCT00344916|Renal hemodynamics|renal hemodynamics
5325264|NCT00344916|Nitric oxide|nitric oxide
5325265|NCT00344903|Atherosclerosis|atherosclerosis
5325266|NCT00344903|Heart Failure|heart failure
5325267|NCT00344903|Ventricular Hypertrophy|ventricular hypertrophy
5325268|NCT00344903|Myocardial Infarction|myocardial infarction
5325269|NCT00344903|Screening|screening
5325270|NCT00344903|Hypertension|hypertension
5325271|NCT00344903|Diabetes|diabetes
5325272|NCT00344903|Obesity|obesity
5325273|NCT00344903|Metabolic Syndrome|metabolic syndrome
5325274|NCT00344890|Cervical fusion|cervical fusion
5325275|NCT00344890|Anterior Cervical Discectomy and Fusion|anterior cervical discectomy and fusion
5325276|NCT00344890|ACDF|acdf
5325277|NCT00344877|Epilepsy|epilepsy
5325278|NCT00344877|Temporal Lobe Epilepsy|temporal lobe epilepsy
5325279|NCT00344877|Cortical Excitability|cortical excitability
5325280|NCT00344877|Transcranial Direct Current Stimulation (tDCS)|transcranial direct current stimulation (tdcs)
5325281|NCT00344877|Memory Testing|memory testing
5325282|NCT00344877|Seizures|seizures
5325283|NCT00344877|Transcranial Magnetic Stimulation (TMS)|transcranial magnetic stimulation (tms)
5325284|NCT00344877|Memory|memory
5325285|NCT00344877|Plasticity|plasticity
5325286|NCT00344864|Contact Lenses Higher Order Aberrations|contact lenses higher order aberrations
5325287|NCT00344851|menstrual cyclicity|menstrual cyclicity
5325288|NCT00344851|insulin resistance|insulin resistance
5325289|NCT00344851|body fat distribution|body fat distribution
5325290|NCT00344851|pancreatic ß-cell function|pancreatic ß-cell function
5325291|NCT00344851|inflammatory markers|inflammatory markers
5325292|NCT00344851|liver function tests|liver function tests
5325293|NCT00344838|LADARWave™|ladarwave™
5325294|NCT00344838|WaveScan Wavefront™ Systems|wavescan wavefront™ systems
5325295|NCT00344825|B- Chronic Lymphocytic Leukemia|b- chronic lymphocytic leukemia
5325296|NCT00344799|Choroidal Melanoma|choroidal melanoma
5325297|NCT00344799|Choroidal Malignant Melanoma|choroidal malignant melanoma
5325298|NCT00344799|Ocular Melanoma|ocular melanoma
5325299|NCT00344799|Uveal Melanoma|uveal melanoma
5325300|NCT00344786|CLL|cll
5325301|NCT00344786|CNF2024|cnf2024
5325302|NCT00344786|Hsp90 inhibitor|hsp90 inhibitor
5325303|NCT00344773|Locally advanced (IIIB) pulmonary adenocarcinoma with EGFR mutation|locally advanced (iiib) pulmonary adenocarcinoma with egfr mutation
5325304|NCT00344773|Metastatic (IV) pulmonary adenocarcinoma with EGFR mutation|metastatic (iv) pulmonary adenocarcinoma with egfr mutation
5325305|NCT00344773|Recurrent pulmonary adenocarcinoma with EGFR mutation|recurrent pulmonary adenocarcinoma with egfr mutation
5325306|NCT00344747|intervention program|intervention program
5325307|NCT00344747|diet|diet
5325308|NCT00344747|physical activity|physical activity
5325309|NCT00344747|adolescents|adolescents
5325310|NCT00344747|obesity|obesity
5325311|NCT00344734|Nitric oxide|nitric oxide
5325312|NCT00344734|Renal hemodynamics|renal hemodynamics
5325313|NCT00344721|Meibomian Gland Syndrome|meibomian gland syndrome
5325314|NCT00344721|Blepharitis|blepharitis
5325315|NCT00344708|Tissue-Cultured Human Amniotic Epithelial Cells onto damaged corneal surface|tissue-cultured human amniotic epithelial cells onto damaged corneal surface
5325316|NCT00344682|memantine|memantine
5325317|NCT00344682|Namenda|namenda
5325318|NCT00344682|augmentation|augmentation
5325319|NCT00344682|add-on|add-on
5325320|NCT00344682|depression|depression
5325321|NCT00344682|MDD (major depressive disorder)|mdd (major depressive disorder)
5325322|NCT00344682|unipolar depression|unipolar depression
5325323|NCT00344682|NMDA|nmda
5325324|NCT00344682|ketamine|ketamine
5325325|NCT00344682|uncompetitive NMDA receptor antagonist|uncompetitive nmda receptor antagonist
5325326|NCT00344669|underweight|underweight
5325327|NCT00344669|preschool|preschool
5325328|NCT00344669|mass deworming|mass deworming
5325329|NCT00344656|Eating Disorders|eating disorders
5325330|NCT00344656|Anorexia Nervosa|anorexia nervosa
5325331|NCT00344643|Comparison of Daily wear versus Extended wear in bacterial binding and corneal epithelial thickness|comparison of daily wear versus extended wear in bacterial binding and corneal epithelial thickness
5325332|NCT00344617|Choroidal neovascularisation|choroidal neovascularisation
5325333|NCT00344617|Polypoidal choroidal vasculopathy|polypoidal choroidal vasculopathy
5325334|NCT00344617|Intravitreal injection|intravitreal injection
5325335|NCT00344617|Avastin|avastin
5325336|NCT00344604|Patients who have undergone routine LASIK as a primary refractive procedure for myopia, hyperopia, or astigmatism.|patients who have undergone routine lasik as a primary refractive procedure for myopia, hyperopia, or astigmatism.
5325337|NCT00344591|HIV|hiv
5325338|NCT00344591|AIDS|aids
5325339|NCT00344578|Higher Order Abberations|higher order abberations
5325340|NCT00344539|asexual blood stage vaccine, Plasmodium falciparum malaria|asexual blood stage vaccine, plasmodium falciparum malaria
5325341|NCT00344526|AL amyloidosis|al amyloidosis
5325342|NCT00344526|Autologous stem cell transplantation|autologous stem cell transplantation
5325343|NCT00344526|Melphalan|melphalan
5325344|NCT00344526|Dexamethasone|dexamethasone
5325345|NCT00344513|registry|registry
5325346|NCT00344513|OPTIMIZE|optimize
5325347|NCT00344513|Heart failure|heart failure
5325348|NCT00344513|OPTIMIZE-HF|optimize-hf
5325349|NCT00344500|Antipsychotic|antipsychotic
5325350|NCT00344500|Bipolar|bipolar
5325351|NCT00344500|Diabetes|diabetes
5325352|NCT00344500|Mental Illness|mental illness
5325353|NCT00344500|Nutrition|nutrition
5325354|NCT00344500|Obesity|obesity
5325355|NCT00344500|Schizoaffective|schizoaffective
5325356|NCT00344500|Schizophrenia|schizophrenia
5325357|NCT00344500|Weight Gain|weight gain
5325358|NCT00344500|Weight Loss|weight loss
5325359|NCT00344474|Prevention|prevention
5325360|NCT00344474|Addiction|addiction
5325361|NCT00344474|Personality|personality
5325362|NCT00344474|Adolescents|adolescents
5325363|NCT00344474|Binge Drinking|binge drinking
5325364|NCT00344474|Alcohol Abuse|alcohol abuse
5325365|NCT00344474|Comorbidity|comorbidity
5325366|NCT00344474|Depression|depression
5325367|NCT00344474|Anxiety|anxiety
5325368|NCT00344474|Antisocial Behaviour|antisocial behaviour
5325369|NCT00344448|Adhesion Molecule|adhesion molecule
5325370|NCT00344448|Interventional Study|interventional study
5325371|NCT00344448|Immunomodulation|immunomodulation
5325372|NCT00344448|Autoimmunity|autoimmunity
5325373|NCT00344448|Sjogren Syndrome|sjogren syndrome
5325374|NCT00344448|SS|ss
5325375|NCT00344435|Hemophilia|hemophilia
5325376|NCT00344435|Antibody|antibody
5325377|NCT00344435|Mutations|mutations
5325378|NCT00344435|SNP|snp
5325379|NCT00344435|clotting|clotting
5325380|NCT00344422|Anthracyclines|anthracyclines
5325381|NCT00344422|Liposomes|liposomes
5325382|NCT00344422|Liposomal|liposomal
5325383|NCT00344422|Vincristine|vincristine
5325384|NCT00344422|Doxorubicin|doxorubicin
5325385|NCT00344422|Dexamethasone|dexamethasone
5325386|NCT00344422|Pegylated Liposomal Doxorubicin|pegylated liposomal doxorubicin
5325387|NCT00344422|DOXIL|doxil
5325388|NCT00344422|drug resistant myeloma|drug resistant myeloma
5325389|NCT00344409|darbepoetin alfa|darbepoetin alfa
5325390|NCT00344409|anemia|anemia
5325391|NCT00344409|cancer patients|cancer patients
5325392|NCT00344409|platinum containing chemotherapy|platinum containing chemotherapy
5325393|NCT00344383|oral contraceptive|oral contraceptive
5325394|NCT00344383|breakthrough bleeding|breakthrough bleeding
5325395|NCT00344383|spotting|spotting
5325396|NCT00344370|Pitavastatin|pitavastatin
5325397|NCT00344370|Type II Diabetes Mellitus|type ii diabetes mellitus
5325398|NCT00344370|Combined Dyslipidemia|combined dyslipidemia
5325399|NCT00344344|Asthma|asthma
5325400|NCT00344344|Cockroach|cockroach
5325401|NCT00344344|Dust Mite|dust mite
5325402|NCT00344344|Extermination|extermination
5325403|NCT00344344|Targeted Cleaning|targeted cleaning
5325404|NCT00344344|Allergy|allergy
5325405|NCT00344344|Prevention|prevention
5325406|NCT00344331|Lysosomal Storage|lysosomal storage
5325407|NCT00344331|Biomarkers|biomarkers
5325408|NCT00344331|Longitudinal|longitudinal
5325409|NCT00344331|Niemann Pick Type C|niemann pick type c
5325410|NCT00344331|NPC|npc
5325411|NCT00344331|Lysosomal Storage Disorder|lysosomal storage disorder
5325412|NCT00344318|Immunogenicity|immunogenicity
5325413|NCT00344318|Safety|safety
5325414|NCT00344318|Pneumococcal vaccine|pneumococcal vaccine
5325415|NCT00344318|Pneumococcal disease|pneumococcal disease
5325416|NCT00344305|children, FluMist, shedding,|children, flumist, shedding,
5325417|NCT00344292|Polymorphism, Genetic|polymorphism, genetic
5325418|NCT00344292|Coronary Artery Disease|coronary artery disease
5325419|NCT00344292|Coronary Arteriosclerosis|coronary arteriosclerosis
5325420|NCT00344292|Polymorphism, Single Nucleotide|polymorphism, single nucleotide
5325421|NCT00344292|SNPs|snps
5325422|NCT00344279|Coinfection|coinfection
5325423|NCT00344279|AIDS|aids
5325424|NCT00344279|Lymphatic Filariasis|lymphatic filariasis
5325425|NCT00344279|Diethylcarbamazine (DEC)|diethylcarbamazine (dec)
5325426|NCT00344279|Albendazole|albendazole
5325427|NCT00344266|Obesity|obesity
5325428|NCT00344266|Adipose Tissue|adipose tissue
5325429|NCT00344266|Microarrays|microarrays
5325430|NCT00344266|Cytokines|cytokines
5325431|NCT00344266|Eicosanoids|eicosanoids
5325432|NCT00344266|Gene Expression|gene expression
5325433|NCT00344266|Adipokines|adipokines
5325434|NCT00344266|Inflammation|inflammation
5325435|NCT00344266|Weight Loss|weight loss
5325436|NCT00344266|Lipid Products|lipid products
5325437|NCT00344253|Uveitis|uveitis
5325438|NCT00344253|Macular Edema|macular edema
5325439|NCT00344253|Interferon|interferon
5325440|NCT00344253|Multiple Sclerosis|multiple sclerosis
5325441|NCT00344253|Encephalomyelitis disseminata (ED)|encephalomyelitis disseminata (ed)
5325442|NCT00344240|type 2 diabetes|type 2 diabetes
5325443|NCT00344240|exercise|exercise
5325444|NCT00344240|activity guidance|activity guidance
5325445|NCT00344240|health education|health education
5325446|NCT00344227|neovascularization|neovascularization
5325447|NCT00344227|age-related macular degeneration|age-related macular degeneration
5325448|NCT00344227|vascular endothelial growth factor (VEGF)|vascular endothelial growth factor (vegf)
5325449|NCT00344227|antigen-binding fragment (Fab)|antigen-binding fragment (fab)
5325450|NCT00344227|antiangiogenesis|antiangiogenesis
5325451|NCT00344227|optical coherence tomography (OCT)|optical coherence tomography (oct)
5325452|NCT00344214|HIV|hiv
5325453|NCT00344214|STDs|stds
5325454|NCT00344214|Methamphetamine|methamphetamine
5325455|NCT00344201|Pterygium|pterygium
5325456|NCT00344201|Fibrin adhesive|fibrin adhesive
5325457|NCT00344201|Conjunctival graft|conjunctival graft
5325458|NCT00344201|Ocular surface reconstruction|ocular surface reconstruction
5325459|NCT00344188|Cutaneous|cutaneous
5325460|NCT00344188|Visceral|visceral
5325461|NCT00344188|PCR|pcr
5325462|NCT00344188|Mucocutaneous|mucocutaneous
5325463|NCT00344188|Biopsy|biopsy
5325464|NCT00344188|Leishmanial Infection|leishmanial infection
5325465|NCT00344188|Leishmaniasis|leishmaniasis
5325466|NCT00344175|hypercholesterolemia|hypercholesterolemia
5325467|NCT00344175|dyslipidemia|dyslipidemia
5325468|NCT00344175|CHD|chd
5325469|NCT00344175|pitavastatin|pitavastatin
5325470|NCT00344175|simvastatin|simvastatin
5325471|NCT00344175|2 or more risk factors for coronary heart disease|2 or more risk factors for coronary heart disease
5325472|NCT00344175|combined dyslipidemia|combined dyslipidemia
5325473|NCT00344162|Epidemiology|epidemiology
5325474|NCT00344162|Population|population
5325475|NCT00344162|Pregnancy|pregnancy
5325476|NCT00344162|Preeclampsia|preeclampsia
5325477|NCT00344149|Idiopathic Thrombocytopenic Purpura|idiopathic thrombocytopenic purpura
5325478|NCT00344149|Rituximab|rituximab
5325479|NCT00344149|Splenectomy|splenectomy
5325480|NCT00344149|Response|response
5325481|NCT00344149|Treatment|treatment
5325482|NCT00344149|treatment of Idiopathic Thrombocytopenic Purpura|treatment of idiopathic thrombocytopenic purpura
5325483|NCT00344136|Blood Pressure, High|blood pressure, high
5325484|NCT00344136|Stroke|stroke
5325485|NCT00344136|Hypertension|hypertension
5325486|NCT00344136|Diabetes Mellitus|diabetes mellitus
5325487|NCT00344136|Obesity|obesity
5325488|NCT00344136|Cerebrovascular Accident|cerebrovascular accident
5325489|NCT00344136|Atherosclerosis|atherosclerosis
5325490|NCT00344123|HIV|hiv
5325491|NCT00344110|Hypertension, aliskiren, blood pressure, renin|hypertension, aliskiren, blood pressure, renin
5325492|NCT00344097|soy protein|soy protein
5325493|NCT00344097|pain|pain
5325494|NCT00344097|thoracotomy|thoracotomy
5325495|NCT00344084|Leishmania Major|leishmania major
5325496|NCT00344084|Phlebotomus Duboscqi|phlebotomus duboscqi
5325497|NCT00344084|Dermatology|dermatology
5325498|NCT00344084|Vector-Transmitted Disease|vector-transmitted disease
5325499|NCT00344084|Africa|africa
5325500|NCT00344084|Cutaneous Leishmaniasis|cutaneous leishmaniasis
5325501|NCT00344084|CL|cl
5325502|NCT00344071|Clinical|clinical
5325503|NCT00344071|Tissue|tissue
5325504|NCT00344071|Photographs|photographs
5325505|NCT00344071|Women|women
5325506|NCT00344071|Case-Control|case-control
5325507|NCT00344058|pregnancy|pregnancy
5325508|NCT00344058|preeclampsia|preeclampsia
5325509|NCT00344058|treatment|treatment
5325510|NCT00344045|Subjects with postoperative pain after Total Hip Arthroplasty|subjects with postoperative pain after total hip arthroplasty
5325511|NCT00344032|Double-blind|double-blind
5325512|NCT00344032|Human Papillomavirus|human papillomavirus
5325513|NCT00344032|Phase IIIb|phase iiib
5325514|NCT00344032|Controlled|controlled
5325515|NCT00344032|Randomized|randomized
5325516|NCT00344032|India|india
5325517|NCT00344019|Acute coronary syndrome|acute coronary syndrome
5325518|NCT00344019|Percutaneous coronary intervention|percutaneous coronary intervention
5325519|NCT00344019|Peri-procedure myocardial infarction|peri-procedure myocardial infarction
5325520|NCT00344006|Malaria CDA COARTEM Africa pediatrics children|malaria cda coartem africa pediatrics children
5325521|NCT00343993|noninvasive positive pressure ventilation|noninvasive positive pressure ventilation
5325522|NCT00343993|acute lung injury|acute lung injury
5325523|NCT00343993|acute respiratory distress syndrome|acute respiratory distress syndrome
5325524|NCT00343954|sickle cell disease|sickle cell disease
5325525|NCT00343941|HIV-1 infection|hiv-1 infection
5325526|NCT00343941|Tucaresol|tucaresol
5325527|NCT00343941|Viral suppression|viral suppression
5325528|NCT00343915|Persistence|persistence
5325529|NCT00343915|Hepatitis B vaccine|hepatitis b vaccine
5325530|NCT00343902|Hawthorn|hawthorn
5325531|NCT00343902|Crataegus|crataegus
5325532|NCT00343902|Herbs|herbs
5325533|NCT00343889|Diphtheria|diphtheria
5325534|NCT00343889|Tetanus|tetanus
5325535|NCT00343889|Pertussis|pertussis
5325536|NCT00343889|Hepatitis B Hansenula (HB)|hepatitis b hansenula (hb)
5325537|NCT00343889|Haemophilus influenzae type b|haemophilus influenzae type b
5325538|NCT00343889|Haemophilus Influenzae|haemophilus influenzae
5325539|NCT00343876|hs-CRP|hs-crp
5325540|NCT00343876|aspirin|aspirin
5325541|NCT00343876|clopidogrel|clopidogrel
5325542|NCT00343850|idiopathic chronic inflammatory disease of large intestine|idiopathic chronic inflammatory disease of large intestine
5325543|NCT00343850|ulcerative colitis|ulcerative colitis
5325544|NCT00343850|inactive ulcerative colitis|inactive ulcerative colitis
5325545|NCT00343850|chronic disease of large intestine|chronic disease of large intestine
5325546|NCT00343850|medication adherence|medication adherence
5325547|NCT00343850|Asacol|asacol
5325548|NCT00343850|mesalamine|mesalamine
5325549|NCT00343824|Burn wounds - Silver Dressings - Bacterial Control|burn wounds - silver dressings - bacterial control
5325550|NCT00343811|Attention-Deficit/Hyper Activity Disorder|attention-deficit/hyper activity disorder
5325551|NCT00343811|ADHD|adhd
5325552|NCT00343759|Breast cancer|breast cancer
5325553|NCT00343759|Tyrosine kinase inhibitors|tyrosine kinase inhibitors
5325554|NCT00343759|Lapatinib|lapatinib
5325555|NCT00343759|Biologic response modifiers|biologic response modifiers
5325556|NCT00343759|Magnetic resonance imaging|magnetic resonance imaging
5325557|NCT00343759|Treatment-naive, operable|treatment-naive, operable
5325558|NCT00343733|diabetic peripheral neuropathy|diabetic peripheral neuropathy
5325559|NCT00343733|postherpetic neuralgia|postherpetic neuralgia
5325560|NCT00343733|traumatic injury|traumatic injury
5325561|NCT00343733|complex regional pain syndrome|complex regional pain syndrome
5325562|NCT00343733|back pain|back pain
5325563|NCT00343733|neck pain|neck pain
5325564|NCT00343733|fibromyalgia|fibromyalgia
5325565|NCT00343733|chronic pancreatitis|chronic pancreatitis
5325566|NCT00343733|osteoarthritis|osteoarthritis
5325567|NCT00343720|VELCADE|velcade
5325568|NCT00343720|Alimta|alimta
5325569|NCT00343720|locally advanced|locally advanced
5325570|NCT00343720|metastatic|metastatic
5325571|NCT00343720|non-small cell lung cancer|non-small cell lung cancer
5325572|NCT00343720|complete response|complete response
5325573|NCT00343720|partial response|partial response
5325574|NCT00343720|Locally Advanced or Metastatic Non-Small Cell Lung Cancer|locally advanced or metastatic non-small cell lung cancer
5325575|NCT00343707|Social Anxiety Disorder|social anxiety disorder
5325576|NCT00343707|brain imaging|brain imaging
5325577|NCT00343707|Positron Emission Tomography|positron emission tomography
5325578|NCT00343707|antidepressant|antidepressant
5325579|NCT00343681|Influenza|influenza
5325580|NCT00343681|Orthomyxoviridae Infections|orthomyxoviridae infections
5325581|NCT00343681|Orthomyxoviruses|orthomyxoviruses
5325582|NCT00343681|Split-virion influenza vaccine|split-virion influenza vaccine
5325583|NCT00343668|advanced gastric cancer|advanced gastric cancer
5325584|NCT00343668|First-line therapy|first-line therapy
5325585|NCT00343668|S-1|s-1
5325586|NCT00343668|irinotecan|irinotecan
5325587|NCT00343655|Hypercholesterolemia|hypercholesterolemia
5325588|NCT00343642|Crohn's disease|crohn's disease
5325589|NCT00343642|Fructooligosaccharide|fructooligosaccharide
5325590|NCT00343642|Inulin|inulin
5325591|NCT00343642|Diet|diet
5325592|NCT00343642|Treatment|treatment
5325593|NCT00343642|Bacterial flora|bacterial flora
5325594|NCT00343642|Oxidative stress|oxidative stress
5325595|NCT00343629|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5325596|NCT00343616|cognitive/functional effects|cognitive/functional effects
5325597|NCT00343616|fatigue|fatigue
5325598|NCT00343616|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
5325599|NCT00343616|stage I breast cancer|stage i breast cancer
5325600|NCT00343616|stage II breast cancer|stage ii breast cancer
5325601|NCT00343616|stage IIIA breast cancer|stage iiia breast cancer
5325602|NCT00343603|maculopathy|maculopathy
5325603|NCT00343577|proteinuria|proteinuria
5325604|NCT00343577|ARBs|arbs
5325605|NCT00343577|agalsidase-beta|agalsidase-beta
5325606|NCT00343577|MDRD estimated GFR|mdrd estimated gfr
5325607|NCT00343577|Chronic kidney disease|chronic kidney disease
5325608|NCT00343551|Hypertension, ambulatory blood pressure, missed dose, aliskiren|hypertension, ambulatory blood pressure, missed dose, aliskiren
5325609|NCT00343525|HCV|hcv
5325610|NCT00343525|monoclonal antibody|monoclonal antibody
5325611|NCT00343525|phase 1|phase 1
5325612|NCT00343512|inflammatory breast cancer|inflammatory breast cancer
5325613|NCT00343512|stage II breast cancer|stage ii breast cancer
5325614|NCT00343512|stage IIIA breast cancer|stage iiia breast cancer
5325615|NCT00343512|stage IIIB breast cancer|stage iiib breast cancer
5325616|NCT00343512|stage IIIC breast cancer|stage iiic breast cancer
5325617|NCT00343499|atrial fibrillation|atrial fibrillation
5325618|NCT00343499|valsartan|valsartan
5325619|NCT00343499|sinus rhythm|sinus rhythm
5325620|NCT00343499|persistent atrial fibrillation undergoing electrical cardioversion to restore normal sinus rhythm|persistent atrial fibrillation undergoing electrical cardioversion to restore normal sinus rhythm
5325621|NCT00343486|Overactive Bladder|overactive bladder
5325622|NCT00343473|Fuch's dystrophy|fuch's dystrophy
5325623|NCT00343473|corneal disorders|corneal disorders
5325624|NCT00343473|cornea|cornea
5325625|NCT00343473|lasik|lasik
5325626|NCT00343473|refractive surgery|refractive surgery
5325627|NCT00343460|nausea and vomiting|nausea and vomiting
5325628|NCT00343460|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5325629|NCT00343447|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
5325630|NCT00343447|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
5325631|NCT00343447|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5325632|NCT00343447|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5325633|NCT00343434|stage I breast cancer|stage i breast cancer
5325634|NCT00343434|stage II breast cancer|stage ii breast cancer
5325635|NCT00343434|stage IIIA breast cancer|stage iiia breast cancer
5325636|NCT00343434|stage IIIB breast cancer|stage iiib breast cancer
5326595|NCT00340548|HIV|hiv
5325637|NCT00343434|stage IIIC breast cancer|stage iiic breast cancer
5325638|NCT00343434|obesity|obesity
5325639|NCT00343421|Diphtheria|diphtheria
5325640|NCT00343421|Tetanus|tetanus
5325641|NCT00343421|Pertussis|pertussis
5325642|NCT00343421|Poliomyelitis|poliomyelitis
5325643|NCT00343421|Haemophilus influenzae type b|haemophilus influenzae type b
5325644|NCT00343421|Pneumococcal infections|pneumococcal infections
5325645|NCT00343408|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5325646|NCT00343408|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5325647|NCT00343408|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5325648|NCT00343408|recurrent colon cancer|recurrent colon cancer
5325649|NCT00343408|stage III colon cancer|stage iii colon cancer
5325650|NCT00343408|stage IV colon cancer|stage iv colon cancer
5325651|NCT00343408|recurrent rectal cancer|recurrent rectal cancer
5325652|NCT00343408|stage III rectal cancer|stage iii rectal cancer
5325653|NCT00343408|stage IV rectal cancer|stage iv rectal cancer
5325654|NCT00343395|rosiglitazone|rosiglitazone
5325655|NCT00343395|metformin|metformin
5325656|NCT00343395|hs-CRP|hs-crp
5325657|NCT00343395|inflammation|inflammation
5325658|NCT00343382|sexuality and reproductive issues|sexuality and reproductive issues
5325659|NCT00343382|sexual dysfunction|sexual dysfunction
5325660|NCT00343382|recurrent breast cancer|recurrent breast cancer
5325661|NCT00343382|stage I breast cancer|stage i breast cancer
5325662|NCT00343382|stage II breast cancer|stage ii breast cancer
5325663|NCT00343382|stage IIIA breast cancer|stage iiia breast cancer
5325664|NCT00343382|stage IIIB breast cancer|stage iiib breast cancer
5325665|NCT00343382|stage IIIC breast cancer|stage iiic breast cancer
5325666|NCT00343382|stage IV breast cancer|stage iv breast cancer
5325667|NCT00343369|B-cell childhood acute lymphoblastic leukemia|b-cell childhood acute lymphoblastic leukemia
5325668|NCT00343369|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5325669|NCT00343369|T-cell childhood acute lymphoblastic leukemia|t-cell childhood acute lymphoblastic leukemia
5325670|NCT00343369|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
5325671|NCT00343356|Bladder neoplasm;|bladder neoplasm;
5325672|NCT00343356|Carcinoma;|carcinoma;
5325673|NCT00343356|Epirubicin;|epirubicin;
5325674|NCT00343356|BCG;|bcg;
5325675|NCT00343356|Perfusion|perfusion
5325676|NCT00343317|puerperal sepsis|puerperal sepsis
5325677|NCT00343317|HIV infection|hiv infection
5325678|NCT00343317|prophylactic antibiotics|prophylactic antibiotics
5325679|NCT00343304|Stroke.Robot.Ergometer.Group OT|stroke.robot.ergometer.group ot
5325680|NCT00343291|Non-Small Cell Lung Cancer|non-small cell lung cancer
5325681|NCT00343291|Malignant pleural effusions|malignant pleural effusions
5325682|NCT00343278|Valaciclovir Hydrochloride|valaciclovir hydrochloride
5325683|NCT00343278|hemodialysis patient|hemodialysis patient
5325684|NCT00343278|ALDH|aldh
5325685|NCT00343278|pharmacokinetics|pharmacokinetics
5325686|NCT00343278|Japanese|japanese
5325687|NCT00343265|Preterm birth|preterm birth
5325688|NCT00343265|Multiple pregnancy|multiple pregnancy
5325689|NCT00343265|Vaginal progesterone|vaginal progesterone
5325690|NCT00343265|Preterm birth in multiple pregnancy|preterm birth in multiple pregnancy
5325691|NCT00343226|Basiliximab, transplantation, liver, renal function|basiliximab, transplantation, liver, renal function
5325692|NCT00343213|Prognostic value of p16INK4a|prognostic value of p16ink4a
5325693|NCT00343213|CIN 1|cin 1
5325694|NCT00343213|LSIL|lsil
5325695|NCT00343213|HPV|hpv
5325696|NCT00343187|Tarceva|tarceva
5325697|NCT00343187|Rash|rash
5325698|NCT00343187|EGFR-1 Rash|egfr-1 rash
5325699|NCT00343187|erlotinib|erlotinib
5325700|NCT00343187|Aczone|aczone
5325701|NCT00343187|Dapsone|dapsone
5325702|NCT00343187|Non-small Cell Lung Cancer|non-small cell lung cancer
5325703|NCT00343187|subjects treated with Tarceva for non-small cell lung cancer (NSCLC) who subsequently develop a rash suspected to be related to Tarceva|subjects treated with tarceva for non-small cell lung cancer (nsclc) who subsequently develop a rash suspected to be related to tarceva
5325704|NCT00343174|stroke|stroke
5325705|NCT00343174|vascular diseases|vascular diseases
5325706|NCT00343161|Nexium|nexium
5325707|NCT00343135|Skin|skin
5325708|NCT00343135|AUGMENTIN|augmentin
5325709|NCT00343135|1gm|1gm
5325710|NCT00343135|Soft|soft
5325711|NCT00343135|tissue|tissue
5325712|NCT00343135|Infections|infections
5325713|NCT00343122|liver|liver
5325714|NCT00343122|cirrhosis|cirrhosis
5325715|NCT00343122|hepatopulmonary syndrome|hepatopulmonary syndrome
5325716|NCT00343096|intranasal|intranasal
5325717|NCT00343096|buccal|buccal
5325718|NCT00343096|lorazepam|lorazepam
5325719|NCT00343096|paediatric|paediatric
5325720|NCT00343096|convulsions|convulsions
5325721|NCT00343083|Head and Neck Neoplasms|head and neck neoplasms
5325722|NCT00343044|platinum resistant ovarian cancer|platinum resistant ovarian cancer
5325723|NCT00343044|recurrent ovarian cancer|recurrent ovarian cancer
5325724|NCT00343044|platinum resistant cancer|platinum resistant cancer
5325725|NCT00343031|Insecticides|insecticides
5325726|NCT00343031|Children|children
5325727|NCT00343031|Women|women
5325728|NCT00343031|Infection|infection
5325729|NCT00343031|DDT|ddt
5325730|NCT00343031|Contaminant|contaminant
5325731|NCT00343018|Preschoolers|preschoolers
5325732|NCT00343018|Young Children|young children
5325733|NCT00343018|Eyewitness|eyewitness
5325734|NCT00343018|Memory|memory
5325735|NCT00343005|Blood-Stage|blood-stage
5325736|NCT00343005|Investigational|investigational
5325737|NCT00343005|Endemic|endemic
5325738|NCT00343005|Malaria|malaria
5325739|NCT00343005|Vaccine|vaccine
5325740|NCT00342992|Vitamin E|vitamin e
5325741|NCT00342992|Micronutrients|micronutrients
5325742|NCT00342992|Genetics|genetics
5325743|NCT00342992|Smoking|smoking
5325744|NCT00342992|Biomarkers|biomarkers
5325745|NCT00342966|Metabolism|metabolism
5325746|NCT00342966|Tracer Studies|tracer studies
5325747|NCT00342966|Chemoprevention|chemoprevention
5325748|NCT00342966|Selenomethionine|selenomethionine
5325749|NCT00342966|Plasma Selenoproteins|plasma selenoproteins
5325750|NCT00342953|saline|saline
5325751|NCT00342953|silicone|silicone
5325752|NCT00342953|Breast Implants|breast implants
5325753|NCT00342953|augmentation mammoplasty|augmentation mammoplasty
5325754|NCT00342953|visk|visk
5325755|NCT00342940|influenza|influenza
5325756|NCT00342940|influenza vaccine|influenza vaccine
5325757|NCT00342940|flu|flu
5325758|NCT00342940|vaccination|vaccination
5325759|NCT00342940|immunogenicity|immunogenicity
5325760|NCT00342927|American Indians|american indians
5325761|NCT00342927|Complications|complications
5325762|NCT00342927|Genetics|genetics
5325763|NCT00342927|Linkage|linkage
5325764|NCT00342927|Type 2 Diabetes|type 2 diabetes
5325765|NCT00342927|Diabetic Kidney Disease|diabetic kidney disease
5325766|NCT00342888|Childhood Cancer|childhood cancer
5325767|NCT00342888|Pesticides|pesticides
5325768|NCT00342888|Polychlorinated Biphenyls|polychlorinated biphenyls
5325769|NCT00342888|Organochlorines|organochlorines
5325770|NCT00342888|Polybrominated Diphenyl Ethers|polybrominated diphenyl ethers
5325771|NCT00342875|Bladder Cancer|bladder cancer
5325772|NCT00342875|Exposure|exposure
5325773|NCT00342875|Drinking Water|drinking water
5325774|NCT00342862|Pregnancy|pregnancy
5325775|NCT00342862|Amevive|amevive
5325776|NCT00342862|alefacept|alefacept
5325777|NCT00342862|Registry|registry
5325778|NCT00342862|Psoriasis|psoriasis
5325779|NCT00342849|Clinical Trial|clinical trial
5325780|NCT00342849|Low-level Lead Poisoning|low-level lead poisoning
5325781|NCT00342849|Chelation|chelation
5325782|NCT00342849|Developmental Assessment|developmental assessment
5325783|NCT00342849|Succimer|succimer
5325784|NCT00342836|Akt|akt
5325785|NCT00342836|Immunohistochemistry|immunohistochemistry
5325786|NCT00342836|Myoinositol|myoinositol
5325787|NCT00342836|Bronchial Specimens|bronchial specimens
5325788|NCT00342836|Phosphorylation|phosphorylation
5325789|NCT00342823|Linkage Analysis|linkage analysis
5325790|NCT00342823|Canidate Gene Analysis|canidate gene analysis
5325791|NCT00342823|Genome Scan|genome scan
5325792|NCT00342823|L. Chagasi|l. chagasi
5325793|NCT00342823|Visceral Leishmania|visceral leishmania
5325794|NCT00342810|Eye Diseases|eye diseases
5325795|NCT00342797|second primary cancer|second primary cancer
5325796|NCT00342797|retinoblastoma|retinoblastoma
5325797|NCT00342797|RB1 germline mutation|rb1 germline mutation
5325798|NCT00342784|Mutation|mutation
5325799|NCT00342784|Cancer Genetics|cancer genetics
5325800|NCT00342771|Tobacco Use|tobacco use
5325801|NCT00342771|Tumor Biology|tumor biology
5325802|NCT00342771|Biomarker|biomarker
5325803|NCT00342771|Risk Factor|risk factor
5325804|NCT00342771|Health Disparity|health disparity
5325805|NCT00342758|Asthma|asthma
5325806|NCT00342758|Wheeze|wheeze
5325807|NCT00342758|Environment|environment
5325808|NCT00342758|Diet|diet
5325809|NCT00342758|Infection|infection
5325810|NCT00342732|Genetics|genetics
5325811|NCT00342732|Fat Intake|fat intake
5325812|NCT00342732|Pima Indians|pima indians
5325813|NCT00342732|Weight Control|weight control
5325814|NCT00342732|Appetite Control|appetite control
5325815|NCT00342706|Teen Pregnancy|teen pregnancy
5325816|NCT00342706|Short Inter-Pregnancy Intervals|short inter-pregnancy intervals
5325817|NCT00342693|Radiation|radiation
5325818|NCT00342693|Screening|screening
5325819|NCT00342693|Cancer|cancer
5325820|NCT00342693|Nodules|nodules
5325821|NCT00342693|Nuclear|nuclear
5325822|NCT00342693|Thyroid Screening|thyroid screening
5325823|NCT00342693|Thyroid Gland|thyroid gland
5325824|NCT00342667|Preterm Birth|preterm birth
5325825|NCT00342667|Predictors of Outcome|predictors of outcome
5325826|NCT00342667|Neonatal/Infant Complications|neonatal/infant complications
5325827|NCT00342667|Neurologic Development|neurologic development
5325828|NCT00342667|(SqrRoot) mniotic Fluid|(sqrroot) mniotic fluid
5325829|NCT00342667|Cerebral Palsy|cerebral palsy
5325830|NCT00342667|Risk Factors|risk factors
5325831|NCT00342654|Epidemiology|epidemiology
5325832|NCT00342654|Cancer|cancer
5325833|NCT00342654|Environment|environment
5325834|NCT00342654|Genetics|genetics
5325835|NCT00342654|Nutrition|nutrition
5325836|NCT00342641|Lymphoma|lymphoma
5325837|NCT00342641|Multiple Myeloma|multiple myeloma
5325838|NCT00342641|Thyroiditis|thyroiditis
5325839|NCT00342641|Cohort Study|cohort study
5325840|NCT00342641|Record linkage study|record linkage study
5325841|NCT00342641|Hepatitis C|hepatitis c
5325842|NCT00342628|Antibody|antibody
5325843|NCT00342628|Reactions|reactions
5325844|NCT00342628|Vaccine|vaccine
5325845|NCT00342628|Conjugate Vaccine|conjugate vaccine
5325846|NCT00342628|Typhoid Fever|typhoid fever
5325847|NCT00342628|Trial|trial
5325848|NCT00342628|Safety|safety
5325849|NCT00342628|Immunogenicity|immunogenicity
5325850|NCT00342628|Comparability|comparability
5325851|NCT00342628|DTP|dtp
5325852|NCT00342602|JC Virus|jc virus
5325853|NCT00342602|Opportunistic Infection|opportunistic infection
5325854|NCT00342602|Single Nucleotide Polymorphism|single nucleotide polymorphism
5325855|NCT00342602|Genotype|genotype
5325856|NCT00342602|Sequencing|sequencing
5325857|NCT00342589|Pneumocystis|pneumocystis
5325858|NCT00342589|HIV|hiv
5325859|NCT00342589|Oral Wash|oral wash
5325860|NCT00342589|PCR|pcr
5325861|NCT00342589|Drug Resistance|drug resistance
5325862|NCT00342576|Filarial Parasites|filarial parasites
5325863|NCT00342576|Wuchereria Bancrofti|wuchereria bancrofti
5325864|NCT00342576|Brugia Malayi|brugia malayi
5325865|NCT00342576|Diethylcarbamazine (DEC)|diethylcarbamazine (dec)
5325866|NCT00342576|Ivermectin|ivermectin
5325867|NCT00342563|mecamylamine|mecamylamine
5325868|NCT00342563|treatment|treatment
5325869|NCT00342563|alcohol dependence|alcohol dependence
5325870|NCT00342563|smoking|smoking
5325871|NCT00342550|Pregnancy|pregnancy
5325872|NCT00342550|Preterm Birth|preterm birth
5325873|NCT00342550|Pregnancy Complications|pregnancy complications
5325874|NCT00342537|Pathology|pathology
5325875|NCT00342537|Genetics|genetics
5325876|NCT00342537|Testicular Cancer|testicular cancer
5325877|NCT00342537|Familial|familial
5325878|NCT00342537|Cancer Epidemiology|cancer epidemiology
5325879|NCT00342524|IVIG|ivig
5325880|NCT00342524|Plasmapheresis|plasmapheresis
5325881|NCT00342524|Blood Collection|blood collection
5325882|NCT00342524|Immune Globulin|immune globulin
5325883|NCT00342524|Severe Acute Respiratory Syndrome|severe acute respiratory syndrome
5325884|NCT00342524|SARS|sars
5325885|NCT00342511|Pap|pap
5325886|NCT00342511|Hybrid Capture 2|hybrid capture 2
5325887|NCT00342511|HSIL|hsil
5325888|NCT00342511|Colposcopy|colposcopy
5325889|NCT00342511|CIN|cin
5325890|NCT00342511|Specimen Collection|specimen collection
5325891|NCT00342498|DNA|dna
5325892|NCT00342498|Hormone|hormone
5325893|NCT00342498|Resistance|resistance
5325894|NCT00342498|Skeleton|skeleton
5325895|NCT00342485|Cellular Immunity|cellular immunity
5325896|NCT00342485|HIV-infected|hiv-infected
5325897|NCT00342485|Immune Deficiency|immune deficiency
5325898|NCT00342485|Cancer|cancer
5325899|NCT00342485|Transplantation|transplantation
5325900|NCT00342472|Esophageal Cancer|esophageal cancer
5325901|NCT00342472|Polycyclic Aromatic Hydrocarbons|polycyclic aromatic hydrocarbons
5325902|NCT00342446|GONADOTROPIN|gonadotropin
5325903|NCT00342446|CLOMIPHENE|clomiphene
5325904|NCT00342446|Ovulation-Stimulating Drugs|ovulation-stimulating drugs
5325905|NCT00342433|Androgens|androgens
5325906|NCT00342433|Serum|serum
5325907|NCT00342433|Tissue|tissue
5325908|NCT00342407|Cancer Risk|cancer risk
5325909|NCT00342407|Cosmic Radiation|cosmic radiation
5325910|NCT00342407|Airlines|airlines
5325911|NCT00342407|Flight Attendants|flight attendants
5325912|NCT00342407|Circadian Rhythm|circadian rhythm
5325913|NCT00342394|Biological Monitoring|biological monitoring
5325914|NCT00342394|Exposure Determinants|exposure determinants
5325915|NCT00342394|Exposure Validation|exposure validation
5325916|NCT00342394|Occupational Exposure|occupational exposure
5325917|NCT00342394|Pesticides|pesticides
5325918|NCT00342394|Agriculture|agriculture
5325919|NCT00342381|Motor fatigue|motor fatigue
5325920|NCT00342381|Cognitive fatigue|cognitive fatigue
5325921|NCT00342368|CPAP|cpap
5325922|NCT00342368|ARDS|ards
5325923|NCT00342368|ALI|ali
5325924|NCT00342368|Hypoxemia|hypoxemia
5325925|NCT00342368|Intubation|intubation
5325926|NCT00342355|Protease Inhibitors|protease inhibitors
5325927|NCT00342355|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5325928|NCT00342355|AIDS|aids
5325929|NCT00342355|Opportunistic Infections|opportunistic infections
5325930|NCT00342355|Resource-Poor|resource-poor
5325931|NCT00342342|Genetics|genetics
5325932|NCT00342329|Case-Control|case-control
5325933|NCT00342329|Hydrocarbons|hydrocarbons
5325934|NCT00342329|Metals|metals
5325935|NCT00342329|Silica|silica
5325936|NCT00342329|Tobacco Smoke|tobacco smoke
5325937|NCT00342329|Lupus Nephritis|lupus nephritis
5325938|NCT00342329|Environmental Exposures|environmental exposures
5325939|NCT00342329|Occupational Exposures|occupational exposures
5325940|NCT00342316|Acute Myeloid Leukemia|acute myeloid leukemia
5325941|NCT00342316|Stem Cell Transplantation|stem cell transplantation
5325942|NCT00342316|Reduced Intensity Conditioning|reduced intensity conditioning
5325943|NCT00342316|Survival|survival
5325944|NCT00342316|Relapse|relapse
5325945|NCT00342303|Premature Infants|premature infants
5325946|NCT00342303|Fatty Acid Metabolism|fatty acid metabolism
5326596|NCT00340548|HCV|hcv
5325947|NCT00342303|Polyunsaturated Fatty Acids|polyunsaturated fatty acids
5325948|NCT00342303|Infant Formula|infant formula
5325949|NCT00342303|Gas-chromatography|gas-chromatography
5325950|NCT00342303|Mass Spectrometry|mass spectrometry
5325951|NCT00342290|Pathophysiological Volume Measurement|pathophysiological volume measurement
5325952|NCT00342290|Power Doppler Ultrasound|power doppler ultrasound
5325953|NCT00342290|Prediction of Adverse Pregnancy Outcome|prediction of adverse pregnancy outcome
5325954|NCT00342290|Subchorionic Hemorrhage|subchorionic hemorrhage
5325955|NCT00342277|Premature Rupture of Membranes|premature rupture of membranes
5325956|NCT00342277|Genetic Risk Factors|genetic risk factors
5325957|NCT00342277|Tissue Specific Expression|tissue specific expression
5325958|NCT00342277|Quantitative Real Time PCR|quantitative real time pcr
5325959|NCT00342277|Preterm Birth|preterm birth
5325960|NCT00342277|Expression Profiling|expression profiling
5325961|NCT00342277|Microarrays|microarrays
5325962|NCT00342264|Lung Cancer|lung cancer
5325963|NCT00342264|Smoking|smoking
5325964|NCT00342264|Diesel Exhaust|diesel exhaust
5325965|NCT00342251|Macular Degeneration|macular degeneration
5325966|NCT00342251|Retinal Images|retinal images
5325967|NCT00342251|Risk Factors|risk factors
5325968|NCT00342251|Linkage Analysis|linkage analysis
5325969|NCT00342251|Gene|gene
5325970|NCT00342251|Mutation|mutation
5325971|NCT00342225|Observation|observation
5325972|NCT00342225|Mothers|mothers
5325973|NCT00342225|Description|description
5325974|NCT00342212|Walking|walking
5325975|NCT00342212|Jogging|jogging
5325976|NCT00342212|Bridging Study|bridging study
5325977|NCT00342212|Data Comparability|data comparability
5325978|NCT00342212|Healthy Adults|healthy adults
5325979|NCT00342212|Healthy Volunteer|healthy volunteer
5325980|NCT00342212|HV|hv
5325981|NCT00342199|Incidence|incidence
5325982|NCT00342199|Prevalence|prevalence
5325983|NCT00342199|Immunity|immunity
5325984|NCT00342199|Bacteriology|bacteriology
5325985|NCT00342199|Pathogenesis|pathogenesis
5325986|NCT00342186|China|china
5325987|NCT00342186|Cancer|cancer
5325988|NCT00342186|Hepatitis B|hepatitis b
5325989|NCT00342186|Genetics|genetics
5325990|NCT00342186|Liver Disease|liver disease
5325991|NCT00342186|HBV|hbv
5325992|NCT00342173|Cervix|cervix
5325993|NCT00342173|Natural History|natural history
5325994|NCT00342173|Neoplasia|neoplasia
5325995|NCT00342173|HPV|hpv
5325996|NCT00342173|Costa Rica|costa rica
5325997|NCT00342160|AIDS|aids
5325998|NCT00342160|HIV Infectiousness|hiv infectiousness
5325999|NCT00342160|Immunity|immunity
5326000|NCT00342160|CTL|ctl
5326001|NCT00342160|Epidemiology|epidemiology
5326002|NCT00342147|EBV|ebv
5326003|NCT00342147|NPC|npc
5326004|NCT00342134|Demyelination|demyelination
5326005|NCT00342134|Inflammation|inflammation
5326006|NCT00342134|Immunosuppression|immunosuppression
5326007|NCT00342134|Autoimmunity|autoimmunity
5326008|NCT00342134|Bone Marrow|bone marrow
5326009|NCT00342134|Multiple Sclerosis|multiple sclerosis
5326010|NCT00342121|Cancer|cancer
5326011|NCT00342121|NHL|nhl
5326012|NCT00342121|Pesticides|pesticides
5326013|NCT00342121|Atrazine|atrazine
5326014|NCT00342121|Organophosphates|organophosphates
5326015|NCT00342121|Cancer Risk|cancer risk
5326016|NCT00342121|Normal Control|normal control
5326017|NCT00342095|Autoimmune Diseases|autoimmune diseases
5326018|NCT00342095|Estrogen|estrogen
5326019|NCT00342095|Silica|silica
5326020|NCT00342095|Pesticides|pesticides
5326021|NCT00342095|Major Histocompatibility Complex|major histocompatibility complex
5326022|NCT00342095|Genetic Susceptibility|genetic susceptibility
5326023|NCT00342082|Zidovudine|zidovudine
5326024|NCT00342082|HIV|hiv
5326025|NCT00342082|Cord Blood|cord blood
5326026|NCT00342069|Decision Making|decision making
5326027|NCT00342069|Genetic Counseling|genetic counseling
5326028|NCT00342069|Pregnancy Options|pregnancy options
5326029|NCT00342069|Attitudes Toward Reproductive Options|attitudes toward reproductive options
5326030|NCT00342069|Beliefs About Down Syndrome Risk|beliefs about down syndrome risk
5326031|NCT00342069|Down Syndrome Risk|down syndrome risk
5326032|NCT00342069|Pregnancy|pregnancy
5326033|NCT00342056|Pharmacogenetics|pharmacogenetics
5326034|NCT00342056|Transporter Proteins|transporter proteins
5326035|NCT00342056|Drug Exposure|drug exposure
5326036|NCT00342056|Imatinib|imatinib
5326037|NCT00342056|Retrospective|retrospective
5326038|NCT00342056|Cancer|cancer
5326039|NCT00342043|Sickle Trait|sickle trait
5326040|NCT00342043|Fetal Hemoglobin|fetal hemoglobin
5326041|NCT00342043|Hemoglobin C|hemoglobin c
5326042|NCT00342043|Beta-Thalassemia|beta-thalassemia
5326043|NCT00342043|Artesunate-Amodiaquine|artesunate-amodiaquine
5326044|NCT00342030|Respiratory|respiratory
5326045|NCT00342030|Polymorphism|polymorphism
5326046|NCT00342030|Fruit|fruit
5326047|NCT00342030|COPD|copd
5326048|NCT00342030|Prospective|prospective
5326049|NCT00342030|Diet|diet
5326050|NCT00342017|Filarial Infections|filarial infections
5326051|NCT00342017|Helminths|helminths
5326052|NCT00342017|Tuberculosis|tuberculosis
5326053|NCT00342017|Filarial Infection|filarial infection
5326054|NCT00342004|Shanghai|shanghai
5326055|NCT00342004|Residential History|residential history
5326056|NCT00342004|Exposure Assessment|exposure assessment
5326057|NCT00342004|Cohort Study|cohort study
5326058|NCT00342004|Molecular Epidemiology|molecular epidemiology
5326059|NCT00341991|DNA Repair|dna repair
5326060|NCT00341991|Genes|genes
5326061|NCT00341991|Pigmentation|pigmentation
5326062|NCT00341991|Skin Cancer|skin cancer
5326063|NCT00341991|Sun Exposure|sun exposure
5326064|NCT00341965|DDT|ddt
5326065|NCT00341965|DDE|dde
5326066|NCT00341965|Androgen Levels|androgen levels
5326067|NCT00341965|Farming|farming
5326068|NCT00341965|Antiandrogen|antiandrogen
5326069|NCT00341952|Case-Control Study|case-control study
5326070|NCT00341952|Non-Hodgkin Lymphoma|non-hodgkin lymphoma
5326071|NCT00341939|Drug Therapy|drug therapy
5326072|NCT00341939|Pharmacogenetics|pharmacogenetics
5326073|NCT00341939|Cancer|cancer
5326074|NCT00341939|Pharmacodynamics|pharmacodynamics
5326075|NCT00341939|Parmacokinetics|parmacokinetics
5326076|NCT00341913|Research|research
5326077|NCT00341913|Repository|repository
5326078|NCT00341913|Registry|registry
5326079|NCT00341913|Surveillance|surveillance
5326080|NCT00341913|Databases|databases
5326081|NCT00341900|Chromosome Translocations|chromosome translocations
5326082|NCT00341900|Cosmic Radiation|cosmic radiation
5326083|NCT00341900|Airline Flight Crew|airline flight crew
5326084|NCT00341900|Airlines|airlines
5326085|NCT00341900|Flight Crew|flight crew
5326086|NCT00341900|Occupational Exposure|occupational exposure
5326087|NCT00341887|Screening|screening
5326088|NCT00341887|AIDS|aids
5326089|NCT00341887|Antiretrovirals|antiretrovirals
5326090|NCT00341887|Military|military
5326091|NCT00341887|Force readiness|force readiness
5326092|NCT00341874|DNA Mutations|dna mutations
5326093|NCT00341874|Genetic Variation|genetic variation
5326094|NCT00341874|GENETIC LINKAGE|genetic linkage
5326095|NCT00341874|Gene Expression Patterns|gene expression patterns
5326096|NCT00341874|Hereditary Hearing Disorder|hereditary hearing disorder
5326097|NCT00341861|Bladder Cancer|bladder cancer
5326098|NCT00341861|Occupational and Environmental Risks|occupational and environmental risks
5326099|NCT00341861|Lifestyle Factors|lifestyle factors
5326100|NCT00341861|Epidemiology|epidemiology
5326101|NCT00341861|Genetic Susceptibility|genetic susceptibility
5326102|NCT00341848|Apoptosis|apoptosis
5326103|NCT00341848|Environment|environment
5326104|NCT00341848|Infection|infection
5326105|NCT00341848|Inflammation|inflammation
5326106|NCT00341848|Leiomyoma|leiomyoma
5326107|NCT00341848|Uterine Leiomyoma|uterine leiomyoma
5326108|NCT00341848|Uterus|uterus
5326109|NCT00341835|Association|association
5326110|NCT00341835|Cancer|cancer
5326111|NCT00341835|Linkage|linkage
5326112|NCT00341822|Amniocentesis|amniocentesis
5326113|NCT00341822|Chorionic Villus Sampling|chorionic villus sampling
5326114|NCT00341822|Fertility|fertility
5326115|NCT00341822|Genetic Counseling|genetic counseling
5326116|NCT00341822|Decisional Conflict|decisional conflict
5326117|NCT00341822|Prenatal Testing|prenatal testing
5326118|NCT00341822|Questionnaire|questionnaire
5326119|NCT00341809|Natural Killer Cells|natural killer cells
5326120|NCT00341809|Autoimmune Disease|autoimmune disease
5326121|NCT00341809|Chronic Inflammation|chronic inflammation
5326122|NCT00341809|Two-Locus Interaction|two-locus interaction
5326123|NCT00341809|Allele/Haplotype Analysis|allele/haplotype analysis
5326124|NCT00341796|AIDS|aids
5326125|NCT00341796|HIV|hiv
5326126|NCT00341796|Perinatal|perinatal
5326127|NCT00341796|Transmission|transmission
5326128|NCT00341796|Antiretroviral|antiretroviral
5326129|NCT00341796|Outcomes|outcomes
5326130|NCT00341783|Plasmodium|plasmodium
5326131|NCT00341783|Falciparum|falciparum
5326132|NCT00341783|Screening|screening
5326133|NCT00341783|Malaria|malaria
5326134|NCT00341757|Family Reports|family reports
5326135|NCT00341757|Cancer|cancer
5326136|NCT00341757|Questionnaire|questionnaire
5326137|NCT00341757|Validity|validity
5326138|NCT00341757|Surveillance|surveillance
5326139|NCT00341744|Vision|vision
5326140|NCT00341744|Aids|aids
5326141|NCT00341731|Cystic Ovaries|cystic ovaries
5326142|NCT00341731|Environmental Factors|environmental factors
5326143|NCT00341731|Heritability|heritability
5326144|NCT00341731|Hyperandrogenism|hyperandrogenism
5326145|NCT00341731|Twin Study|twin study
5326146|NCT00341718|Interview|interview
5326147|NCT00341718|Genetics|genetics
5326148|NCT00341705|AIDS|aids
5326149|NCT00341705|Cancer|cancer
5326150|NCT00341705|Hepatitis C Virus|hepatitis c virus
5326151|NCT00341705|HIV|hiv
5326152|NCT00341705|Natural History|natural history
5326153|NCT00341705|Hemophilia|hemophilia
5326154|NCT00341705|Hepatitis C|hepatitis c
5326155|NCT00341692|Mammary|mammary
5326156|NCT00341692|Development|development
5326157|NCT00341692|Cancer|cancer
5326158|NCT00341692|Risk|risk
5326159|NCT00341692|Genes|genes
5326160|NCT00341679|Autoimmune Diseases|autoimmune diseases
5326161|NCT00341679|Genetic Risk Factors|genetic risk factors
5326162|NCT00341679|Polymyositis|polymyositis
5326163|NCT00341679|Dermatomyositis|dermatomyositis
5326164|NCT00341679|Connective Tissue Disorders|connective tissue disorders
5326165|NCT00341679|Idiopathic Inflammatory Myopathies|idiopathic inflammatory myopathies
5326166|NCT00341679|Inclusion Body Myositis|inclusion body myositis
5326167|NCT00341679|Pathogenesis|pathogenesis
5326168|NCT00341679|Environmental Risk Factor|environmental risk factor
5326169|NCT00341679|IIM|iim
5326170|NCT00341666|Immune Regulation|immune regulation
5326171|NCT00341666|Co-Infection|co-infection
5326172|NCT00341666|Filariasis|filariasis
5326173|NCT00341666|Immunology|immunology
5326174|NCT00341666|Filarial Infection|filarial infection
5326175|NCT00341653|Asthma|asthma
5326176|NCT00341653|Pulmonary Function|pulmonary function
5326177|NCT00341653|Air Pollution|air pollution
5326178|NCT00341653|Genetic Polymorphism|genetic polymorphism
5326179|NCT00341653|Environmental Tobacco Agents|environmental tobacco agents
5326180|NCT00341640|Teen Pregnancy|teen pregnancy
5326181|NCT00341627|Bone Tumor|bone tumor
5326182|NCT00341627|Familial Chordoma|familial chordoma
5326183|NCT00341627|Gene Mapping|gene mapping
5326184|NCT00341627|Genetics|genetics
5326185|NCT00341627|Sporadic Chordoma|sporadic chordoma
5326186|NCT00341614|Exercise|exercise
5326187|NCT00341614|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
5326188|NCT00341614|Postmenopause|postmenopause
5326189|NCT00341614|Diet|diet
5326190|NCT00341601|Mycobacterium Tuberculosis|mycobacterium tuberculosis
5326191|NCT00341601|TLR-2|tlr-2
5326192|NCT00341601|Recurrent Tuberculosis|recurrent tuberculosis
5326193|NCT00341601|Phenolic Glycolipid|phenolic glycolipid
5326194|NCT00341601|mRNA Expression Profiles|mrna expression profiles
5326195|NCT00341588|Testicular Cancer|testicular cancer
5326196|NCT00341588|Epidemiology|epidemiology
5326197|NCT00341588|Testicular Germ Cell Cancer|testicular germ cell cancer
5326198|NCT00341588|TGCT|tgct
5326199|NCT00341588|Healthy Volunteer|healthy volunteer
5326200|NCT00341575|Family Systems|family systems
5326201|NCT00341575|Communication|communication
5326202|NCT00341575|Information Diffusion|information diffusion
5326203|NCT00341575|Social Networks|social networks
5326204|NCT00341575|Family Dynamics|family dynamics
5326205|NCT00341562|Gene Expression Profiling|gene expression profiling
5326206|NCT00341562|Vascular Disease|vascular disease
5326207|NCT00341549|Linkage|linkage
5326208|NCT00341549|Genetics|genetics
5326209|NCT00341549|Mapping|mapping
5326210|NCT00341549|Gene|gene
5326211|NCT00341549|Susceptibility|susceptibility
5326212|NCT00341549|Myopia|myopia
5326213|NCT00341549|Nearsightedness|nearsightedness
5326214|NCT00341549|Refraction|refraction
5326215|NCT00341549|Eye|eye
5326216|NCT00341536|Diet|diet
5326217|NCT00341536|Pilot|pilot
5326218|NCT00341536|Cohort|cohort
5326219|NCT00341536|Environmental|environmental
5326220|NCT00341536|Chronic Disease|chronic disease
5326221|NCT00341523|Cytology|cytology
5326222|NCT00341523|Endoscopy|endoscopy
5326223|NCT00341523|Esophageal Cancer|esophageal cancer
5326224|NCT00341523|Early Detection|early detection
5326225|NCT00341523|Treatment|treatment
5326226|NCT00341510|Risk Behavior|risk behavior
5326227|NCT00341510|Health Status|health status
5326228|NCT00341510|Adolescence|adolescence
5326229|NCT00341510|Positive Health Behaviors|positive health behaviors
5326230|NCT00341510|Social Support|social support
5326231|NCT00341510|Health Behavior|health behavior
5326232|NCT00341510|Survey|survey
5326233|NCT00341497|Leukoplakia|leukoplakia
5326234|NCT00341497|Oral Mucosa|oral mucosa
5326235|NCT00341497|Biomarkers|biomarkers
5326236|NCT00341484|Genetics|genetics
5326237|NCT00341484|Liver Cancer|liver cancer
5326239|NCT00341471|School|school
5326240|NCT00341471|Sixth Grade|sixth grade
5326241|NCT00341471|Curricular|curricular
5326242|NCT00341471|Howard University|howard university
5326243|NCT00341471|D.C.|d.c.
5326244|NCT00341471|Adolescent Pregnancy|adolescent pregnancy
5326245|NCT00341471|Intervention|intervention
5326246|NCT00341458|Breast Cancer|breast cancer
5326247|NCT00341458|Environment|environment
5326248|NCT00341458|Genetics|genetics
5326249|NCT00341458|Epidemiology|epidemiology
5326250|NCT00341445|Environmental Intervention|environmental intervention
5326251|NCT00341445|Indoor Allergens|indoor allergens
5326252|NCT00341445|Environment|environment
5326253|NCT00341432|NRT Study|nrt study
5326254|NCT00341432|Smoking Cessation|smoking cessation
5326255|NCT00341419|ABC Transporter|abc transporter
5326256|NCT00341419|ABCC6|abcc6
5326257|NCT00341419|Slkin Laxity|slkin laxity
5326258|NCT00341419|Genetic Association|genetic association
5326259|NCT00341419|Angiod Streaks|angiod streaks
5326260|NCT00341419|Pseudoxanthoma Elasticum|pseudoxanthoma elasticum
5326261|NCT00341419|PXE|pxe
5326262|NCT00341406|Obesity|obesity
5326263|NCT00341406|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
5326264|NCT00341406|Adipose Cell Turn Over|adipose cell turn over
5326265|NCT00341393|HIV Infection|hiv infection
5326266|NCT00341393|AIDS|aids
5326267|NCT00341393|Viral Load|viral load
5326268|NCT00341393|Retroviral Treatment|retroviral treatment
5326269|NCT00341393|Uganda|uganda
5326270|NCT00341380|Cancer|cancer
5326271|NCT00341380|Lung Cancer|lung cancer
5326272|NCT00341380|Surgical Resection|surgical resection
5326273|NCT00341380|Non-Small Cell Lung Cancer|non-small cell lung cancer
5326274|NCT00341380|NSCLC|nsclc
5326275|NCT00341367|Analgesic|analgesic
5326276|NCT00341367|Back Pain|back pain
5326277|NCT00341367|Lumbar Disc|lumbar disc
5326278|NCT00341367|Nerve|nerve
5326279|NCT00341367|Radiculopathy|radiculopathy
5326280|NCT00341354|Pneumonia|pneumonia
5326281|NCT00341354|Bacterial Infection|bacterial infection
5326282|NCT00341354|Nosocomial Infection|nosocomial infection
5326283|NCT00341354|Trachea|trachea
5326284|NCT00341354|Biofilm|biofilm
5326285|NCT00341354|Mucus Shaver|mucus shaver
5326286|NCT00341341|Smoking|smoking
5326287|NCT00341341|Smoking Cessation|smoking cessation
5326288|NCT00341341|GSTM1|gstm1
5326289|NCT00341341|Glutathione S. Transferase|glutathione s. transferase
5326290|NCT00341341|Lung Cancer|lung cancer
5326291|NCT00341341|Smokers|smokers
5326292|NCT00341341|Genetic Risk Communication|genetic risk communication
5326293|NCT00341328|India|india
5326294|NCT00341328|Pulmonary Tuberculosis|pulmonary tuberculosis
5326295|NCT00341328|Category-I Pulmonary Tuberculosis|category-i pulmonary tuberculosis
5326296|NCT00341328|Immunomodulator|immunomodulator
5326297|NCT00341328|Mycobacterium w|mycobacterium w
5326298|NCT00341315|Epidemiology|epidemiology
5326299|NCT00341315|DDT|ddt
5326300|NCT00341315|BMI|bmi
5326301|NCT00341315|Serum|serum
5326302|NCT00341315|Case-Control Study|case-control study
5326303|NCT00341302|HIV|hiv
5326304|NCT00341302|AIDS|aids
5326305|NCT00341302|Perinatal|perinatal
5326306|NCT00341302|Transmission|transmission
5326307|NCT00341302|Antiretroviral|antiretroviral
5326308|NCT00341302|Outcomes|outcomes
5326309|NCT00341289|Submersion|submersion
5326310|NCT00341289|Epidemiology|epidemiology
5326311|NCT00341289|Fatal|fatal
5326312|NCT00341289|Child|child
5326313|NCT00341289|Swim|swim
5326314|NCT00341289|Drowning|drowning
5326315|NCT00341289|Survey|survey
5326316|NCT00341276|Esophageal Cancer|esophageal cancer
5326317|NCT00341276|Genetics|genetics
5326318|NCT00341276|Polymorphism|polymorphism
5326319|NCT00341276|Susceptibility Genes|susceptibility genes
5326320|NCT00341276|Tumor|tumor
5326321|NCT00341263|Twins|twins
5326322|NCT00341263|Clinical Research|clinical research
5326323|NCT00341263|Endocrinology|endocrinology
5326324|NCT00341263|Breast Cancer|breast cancer
5326325|NCT00341263|Biochemical Epidemiology|biochemical epidemiology
5326326|NCT00341250|Blood Stage|blood stage
5326327|NCT00341250|Investigational|investigational
5326328|NCT00341250|Endemic|endemic
5326329|NCT00341250|Malaria|malaria
5326330|NCT00341237|Polymorphism|polymorphism
5326331|NCT00341237|Genotype|genotype
5326332|NCT00341237|Phenotype|phenotype
5326333|NCT00341237|Environmental Factor|environmental factor
5326334|NCT00341237|Single Nucleotide Polymorphism|single nucleotide polymorphism
5326335|NCT00341224|Aggression|aggression
5326336|NCT00341224|Violence|violence
5326337|NCT00341224|Adolescents|adolescents
5326338|NCT00341224|Randomized Trial|randomized trial
5326339|NCT00341224|Behavioral Intervention|behavioral intervention
5326340|NCT00341211|AIDS|aids
5326341|NCT00341211|Cancer|cancer
5326342|NCT00341211|Epidemiology|epidemiology
5326343|NCT00341211|Immunology|immunology
5326344|NCT00341211|Virology|virology
5326345|NCT00341198|Rheumatoid Arthritis|rheumatoid arthritis
5326346|NCT00341198|Lupus|lupus
5326347|NCT00341198|Scleroderma|scleroderma
5326348|NCT00341198|Sjogren's Syndrome|sjogren's syndrome
5326349|NCT00341198|Farming|farming
5326350|NCT00341198|Autoimmune Disease|autoimmune disease
5326351|NCT00341198|Exposure|exposure
5326352|NCT00341185|Biodosimetry|biodosimetry
5326353|NCT00341185|Dose Reconstruction|dose reconstruction
5326354|NCT00341185|Radioactive Fallout|radioactive fallout
5326355|NCT00341185|Thyroid Screening|thyroid screening
5326356|NCT00341185|Ultrasound|ultrasound
5326357|NCT00341172|Retinitis|retinitis
5326358|NCT00341172|Cytomegalovirus|cytomegalovirus
5326359|NCT00341172|HIV-1|hiv-1
5326360|NCT00341172|Polymorphisms|polymorphisms
5326361|NCT00341172|HAART|haart
5326362|NCT00341159|Breast|breast
5326363|NCT00341159|BRCA1|brca1
5326364|NCT00341159|BRCA2|brca2
5326365|NCT00341159|Inherited|inherited
5326366|NCT00341159|Association|association
5326367|NCT00341159|Breast Cancer|breast cancer
5326368|NCT00341159|Population-Based|population-based
5326369|NCT00341159|Cancer Susceptibility Alleles|cancer susceptibility alleles
5326370|NCT00341146|Cancer|cancer
5326371|NCT00341146|Catonese Chinese|catonese chinese
5326372|NCT00341146|Genetic Predisposition|genetic predisposition
5326373|NCT00341146|Genotyping|genotyping
5326374|NCT00341146|Triad analysis|triad analysis
5326375|NCT00341146|Nasopharyngeal Cancer|nasopharyngeal cancer
5326376|NCT00341146|NPC|npc
5326377|NCT00341133|Laterality|laterality
5326378|NCT00341133|Heterotaxy|heterotaxy
5326379|NCT00341133|Holoprosencephaly|holoprosencephaly
5326380|NCT00341133|Genetic Testing|genetic testing
5326381|NCT00341133|Congential Cardiac Malformations|congential cardiac malformations
5326597|NCT00340548|Hepatitis C|hepatitis c
5326382|NCT00341133|Disturbed Internal Organ Positioning|disturbed internal organ positioning
5326383|NCT00341120|Genotypes|genotypes
5326384|NCT00341120|Mutation|mutation
5326385|NCT00341120|Folate|folate
5326386|NCT00341120|Male Infertility|male infertility
5326387|NCT00341120|Nutrition|nutrition
5326388|NCT00341107|Cancer|cancer
5326389|NCT00341107|Genes|genes
5326390|NCT00341107|Screening|screening
5326391|NCT00341107|Primary Care|primary care
5326392|NCT00341107|Inherited Susceptibility|inherited susceptibility
5326393|NCT00341094|Cohort|cohort
5326394|NCT00341094|Radiation|radiation
5326395|NCT00341094|In Utero|in utero
5326396|NCT00341094|Genomic|genomic
5326397|NCT00341081|Short Tandem Repeat|short tandem repeat
5326398|NCT00341081|Molecular Epidemiology|molecular epidemiology
5326399|NCT00341081|Viral Infection|viral infection
5326400|NCT00341081|Mixture Detection|mixture detection
5326401|NCT00341081|Intervention & Education|intervention & education
5326402|NCT00341081|Intervention|intervention
5326403|NCT00341081|Education|education
5326404|NCT00341068|Birth Defects|birth defects
5326405|NCT00341068|Genetics|genetics
5326406|NCT00341068|Folic Acid|folic acid
5326407|NCT00341068|Gene-Environment Interactions|gene-environment interactions
5326408|NCT00341068|Neural Tube Defects|neural tube defects
5326409|NCT00341068|Cleft Lip|cleft lip
5326410|NCT00341068|Cleft Palate|cleft palate
5326411|NCT00341068|Mutations|mutations
5326412|NCT00341055|Anemia|anemia
5326413|NCT00341055|Hemoglobin|hemoglobin
5326414|NCT00341055|Chemotherapy|chemotherapy
5326415|NCT00341055|Epoetin alfa|epoetin alfa
5326416|NCT00341042|Normal Values|normal values
5326417|NCT00341042|Complete Blood Count|complete blood count
5326418|NCT00341042|HIV|hiv
5326419|NCT00341042|Tuberculosis|tuberculosis
5326420|NCT00341042|Flow Cytometry|flow cytometry
5326421|NCT00341029|Longitudinal Study|longitudinal study
5326422|NCT00341029|Chromosomal Effects|chromosomal effects
5326423|NCT00341029|Sister Chromatid Exchanges|sister chromatid exchanges
5326424|NCT00341029|Micronuclei|micronuclei
5326425|NCT00341029|Stimulants|stimulants
5326426|NCT00341029|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
5326427|NCT00341029|ADHD|adhd
5326428|NCT00341016|Radiation|radiation
5326429|NCT00341003|Plasmodium Falciparum|plasmodium falciparum
5326430|NCT00341003|Hemoglobin E|hemoglobin e
5326431|NCT00341003|Mefloquine|mefloquine
5326432|NCT00341003|Artemisinin|artemisinin
5326433|NCT00341003|Piperaquine|piperaquine
5326434|NCT00341003|Malaria|malaria
5326435|NCT00340990|Tuberculosis|tuberculosis
5326436|NCT00340990|HIV|hiv
5326437|NCT00340990|CD4+ T Cell|cd4+ t cell
5326438|NCT00340990|Interferon-Gamma|interferon-gamma
5326439|NCT00340990|Lymphocyte Proliferation|lymphocyte proliferation
5326440|NCT00340977|Birth Defects|birth defects
5326441|NCT00340977|Case-Control Studies|case-control studies
5326442|NCT00340977|Genetic Susceptibility|genetic susceptibility
5326443|NCT00340964|Photography|photography
5326444|NCT00340964|Self-Esteem|self-esteem
5326445|NCT00340964|Perceived Social Stigma|perceived social stigma
5326446|NCT00340964|Hopefulness|hopefulness
5326447|NCT00340964|Cleft Lip and Palate|cleft lip and palate
5326448|NCT00340964|Hemifacial Microsomia|hemifacial microsomia
5326449|NCT00340964|Treacher Collins Syndrome|treacher collins syndrome
5326450|NCT00340964|Mobius Syndrome|mobius syndrome
5326451|NCT00340964|Apert Syndrome|apert syndrome
5326452|NCT00340964|Videography|videography
5326453|NCT00340964|Craniofacial Differences|craniofacial differences
5326454|NCT00340964|Self -Esteem|self -esteem
5326455|NCT00340951|Regulatory T Cells|regulatory t cells
5326456|NCT00340951|Bronchiolitis Obliterans Syndrome|bronchiolitis obliterans syndrome
5326457|NCT00340951|Genetic Polymorphism|genetic polymorphism
5326458|NCT00340951|Innate Immunity|innate immunity
5326459|NCT00340951|Transplantation|transplantation
5326460|NCT00340951|Lung Transplantation|lung transplantation
5326461|NCT00340938|Adherence|adherence
5326462|NCT00340938|Education|education
5326463|NCT00340938|Problem Solving|problem solving
5326464|NCT00340938|Motivation|motivation
5326465|NCT00340938|Locus of Responsibility|locus of responsibility
5326466|NCT00340912|Skin Biopsy|skin biopsy
5326467|NCT00340899|Perinatal Mortality|perinatal mortality
5326468|NCT00340899|Perinatal Morbidity|perinatal morbidity
5326469|NCT00340899|Preterm Birth|preterm birth
5326470|NCT00340899|Pregnancy Complications|pregnancy complications
5326471|NCT00340899|Pregnancy|pregnancy
5326472|NCT00340886|Genetic Susceptibility|genetic susceptibility
5326473|NCT00340886|Single Nucleotide Polymorphism|single nucleotide polymorphism
5326474|NCT00340886|Environmental Risk Factor|environmental risk factor
5326475|NCT00340886|Allelic Variants|allelic variants
5326476|NCT00340886|Ascertainment by Genotype|ascertainment by genotype
5326477|NCT00340873|Molecular Epidemiology|molecular epidemiology
5326478|NCT00340873|Cross-Sectional|cross-sectional
5326479|NCT00340873|Gene-Enviroment Interaction|gene-enviroment interaction
5326480|NCT00340860|Ultrasound|ultrasound
5326481|NCT00340860|Biobank|biobank
5326482|NCT00340860|Urine|urine
5326483|NCT00340860|Blood|blood
5326484|NCT00340860|Exposure|exposure
5326598|NCT00340548|Hemophilia|hemophilia
5326485|NCT00340860|Norway Mother and Child Study|norway mother and child study
5326486|NCT00340847|Molecular Profiling|molecular profiling
5326487|NCT00340847|In Situ Hybridization|in situ hybridization
5326488|NCT00340847|SAGE|sage
5326489|NCT00340847|Tumor Markers|tumor markers
5326490|NCT00340847|IHC|ihc
5326491|NCT00340847|Lung Cancer|lung cancer
5326492|NCT00340847|Genetics|genetics
5326493|NCT00340834|FTY720|fty720
5326494|NCT00340834|Interferon|interferon
5326495|NCT00340834|RRMS|rrms
5326496|NCT00340834|Multiple Sclerosis|multiple sclerosis
5326497|NCT00340834|Efficacy|efficacy
5326498|NCT00340821|HTLV-I|htlv-i
5326499|NCT00340808|Endometrial Cancer|endometrial cancer
5326500|NCT00340808|Epidemiology|epidemiology
5326501|NCT00340808|Questionnaire|questionnaire
5326502|NCT00340808|Etiology|etiology
5326503|NCT00340808|Biomarkers|biomarkers
5326504|NCT00340795|Media Analysis|media analysis
5326505|NCT00340795|Nutrition|nutrition
5326506|NCT00340795|Physical Activity|physical activity
5326507|NCT00340795|After-School|after-school
5326508|NCT00340795|Exercise|exercise
5326509|NCT00340782|Menstrual Cycles|menstrual cycles
5326510|NCT00340782|Early Pregnancy|early pregnancy
5326511|NCT00340782|Reproductive Hormones|reproductive hormones
5326512|NCT00340782|Stress|stress
5326513|NCT00340782|Adrenal Function|adrenal function
5326514|NCT00340769|Cytokines|cytokines
5326515|NCT00340769|Inflammation|inflammation
5326516|NCT00340769|mRNA Stability|mrna stability
5326517|NCT00340769|Pygmy|pygmy
5326518|NCT00340769|Zinc Finger Proteins|zinc finger proteins
5326519|NCT00340769|Ethnic Group|ethnic group
5326520|NCT00340756|GCMS|gcms
5326521|NCT00340756|LCMS-MS|lcms-ms
5326522|NCT00340743|Heterocyclic Aminos|heterocyclic aminos
5326523|NCT00340743|Cruciferous Vegetables|cruciferous vegetables
5326524|NCT00340743|Yogurt|yogurt
5326525|NCT00340743|Chlorophyllin|chlorophyllin
5326526|NCT00340743|Comet Assay|comet assay
5326527|NCT00340743|Diet|diet
5326528|NCT00340743|Healthy Volunteer|healthy volunteer
5326529|NCT00340730|Health Education|health education
5326530|NCT00340730|Mentoring|mentoring
5326531|NCT00340730|Parenting|parenting
5326532|NCT00340730|Social Skills Training|social skills training
5326533|NCT00340730|Violence|violence
5326534|NCT00340730|Intervention|intervention
5326535|NCT00340730|Youth Injury|youth injury
5326536|NCT00340717|Methylation|methylation
5326537|NCT00340717|Genes|genes
5326538|NCT00340717|Screening|screening
5326539|NCT00340717|Prospective|prospective
5326540|NCT00340717|Diagnosis|diagnosis
5326541|NCT00340704|tamsulosin|tamsulosin
5326542|NCT00340704|pediatric|pediatric
5326543|NCT00340704|neurogenic bladder|neurogenic bladder
5326544|NCT00340691|Parasite|parasite
5326545|NCT00340691|Chemotherapy|chemotherapy
5326546|NCT00340691|Wuchereria Bancrofti|wuchereria bancrofti
5326547|NCT00340678|Angiotensin II Receptor Antagonist|angiotensin ii receptor antagonist
5326548|NCT00340678|Therapeutic Trial|therapeutic trial
5326549|NCT00340678|Glomerular Filtration Rate|glomerular filtration rate
5326550|NCT00340678|Kidney Biopsy|kidney biopsy
5326551|NCT00340678|Non-Insulin Dependent Diabetes Mellitus|non-insulin dependent diabetes mellitus
5326552|NCT00340665|Soy|soy
5326553|NCT00340665|Infant Formula|infant formula
5326554|NCT00340665|Sexual Development|sexual development
5326555|NCT00340665|Hormone|hormone
5326556|NCT00340665|Isoflavones|isoflavones
5326557|NCT00340652|Soy|soy
5326558|NCT00340652|Isoflavones|isoflavones
5326559|NCT00340652|Infant Formula|infant formula
5326560|NCT00340652|Sexual Development|sexual development
5326561|NCT00340652|Hormone|hormone
5326562|NCT00340639|Adherence|adherence
5326563|NCT00340639|Chronic Illness|chronic illness
5326564|NCT00340639|Adolescent|adolescent
5326565|NCT00340639|Family|family
5326566|NCT00340639|Self-Regulation|self-regulation
5326567|NCT00340626|Whole Genome Sequencing|whole genome sequencing
5326568|NCT00340626|Cleft Palate|cleft palate
5326569|NCT00340613|Type 1 Diabetes|type 1 diabetes
5326570|NCT00340613|Poorly controlled glucose|poorly controlled glucose
5326571|NCT00340613|adolescents|adolescents
5326572|NCT00340600|Cancer|cancer
5326573|NCT00340600|DES|des
5326574|NCT00340600|Endocrine Disrupting Chemicals|endocrine disrupting chemicals
5326575|NCT00340600|In Utero|in utero
5326576|NCT00340587|Zona Pellucida|zona pellucida
5326577|NCT00340587|Human Eggs|human eggs
5326578|NCT00340587|ZP1, ZP2, ZP3|zp1, zp2, zp3
5326579|NCT00340587|Fertilization|fertilization
5326580|NCT00340574|Human|human
5326581|NCT00340574|Clinical Trial|clinical trial
5326582|NCT00340574|Mosquito|mosquito
5326583|NCT00340574|Healthy Volunteer|healthy volunteer
5326584|NCT00340574|HV|hv
5326585|NCT00340561|Test Track|test track
5326586|NCT00340561|Distraction|distraction
5326587|NCT00340561|Motor Vehicle|motor vehicle
5326588|NCT00340561|Learning|learning
5326589|NCT00340561|Inexperience|inexperience
5326590|NCT00340548|Genotyping|genotyping
5326591|NCT00340548|Polymorphisms|polymorphisms
5326592|NCT00340548|Co-Infection|co-infection
5326593|NCT00340548|Chemokines|chemokines
5326594|NCT00340548|Associations|associations
5326599|NCT00340535|Disinfection byproducts|disinfection byproducts
5326600|NCT00340535|Genetic Variation|genetic variation
5326601|NCT00340535|Trihalomethanes|trihalomethanes
5326602|NCT00340522|Sarcoma|sarcoma
5326603|NCT00340522|Brain Tumor|brain tumor
5326604|NCT00340522|Embryonal Tumor|embryonal tumor
5326605|NCT00340522|Tumor Array|tumor array
5326606|NCT00340522|Childhood Cancer|childhood cancer
5326607|NCT00340522|Plexiform Neurofibromas|plexiform neurofibromas
5326608|NCT00340522|Drug Screening|drug screening
5326609|NCT00340522|Immunohistochemistry|immunohistochemistry
5326610|NCT00340509|Genetics|genetics
5326611|NCT00340509|Population|population
5326612|NCT00340509|CHD Risk|chd risk
5326613|NCT00340509|Epidemiology|epidemiology
5326614|NCT00340509|Gene Mapping|gene mapping
5326615|NCT00340496|Schwannoma|schwannoma
5326616|NCT00340496|Meningioma|meningioma
5326617|NCT00340496|Follow-Up|follow-up
5326618|NCT00340496|Radiation Therapy|radiation therapy
5326619|NCT00340496|Cohort|cohort
5326620|NCT00340483|Smoking Cessation|smoking cessation
5326621|NCT00340483|Young Adults|young adults
5326622|NCT00340483|Quit Smoking|quit smoking
5326623|NCT00340483|Email|email
5326624|NCT00340483|Social Marketing|social marketing
5326625|NCT00340470|Injury|injury
5326626|NCT00340470|Motor Vehicle|motor vehicle
5326627|NCT00340470|Parenting|parenting
5326628|NCT00340470|Randomized Trial|randomized trial
5326629|NCT00340470|Behavioral Intervention|behavioral intervention
5326630|NCT00340457|Case-Control Study|case-control study
5326631|NCT00340457|Renal Cell Carcinoma|renal cell carcinoma
5326632|NCT00340457|Kidney Cancer|kidney cancer
5326633|NCT00340457|Diet|diet
5326634|NCT00340457|Occupation|occupation
5326635|NCT00340444|Linkage|linkage
5326636|NCT00340444|Covariates|covariates
5326637|NCT00340444|Association|association
5326638|NCT00340444|Fine Mapping|fine mapping
5326639|NCT00340444|Inflammatory Bowel Disease|inflammatory bowel disease
5326640|NCT00340444|Ulcerative Colitis|ulcerative colitis
5326641|NCT00340444|Crohn's Disease|crohn's disease
5326642|NCT00340431|Human|human
5326643|NCT00340431|Clinical Trial|clinical trial
5326644|NCT00340431|Mosquito|mosquito
5326645|NCT00340418|Bronchoalveolar Lavage|bronchoalveolar lavage
5326646|NCT00340418|Acute Rejection|acute rejection
5326647|NCT00340418|Chronic Rejection|chronic rejection
5326648|NCT00340418|Genetic Polymorphisms|genetic polymorphisms
5326649|NCT00340418|Innate Immunity|innate immunity
5326650|NCT00340418|Lung Transplantation|lung transplantation
5326651|NCT00340418|Lung Allograft Rejection|lung allograft rejection
5326652|NCT00340405|Blood|blood
5326653|NCT00340405|Lung Cancer|lung cancer
5326654|NCT00340405|Occupational Exposure|occupational exposure
5326655|NCT00340405|Radon|radon
5326656|NCT00340405|Arsenic|arsenic
5326657|NCT00340392|Mammary Stem Cells|mammary stem cells
5326658|NCT00340392|Breast Cancer|breast cancer
5326659|NCT00340392|Cancer Stem Cells|cancer stem cells
5326660|NCT00340392|Gene Expression Profiling|gene expression profiling
5326661|NCT00340379|Psychotic|psychotic
5326662|NCT00340366|Homocysteine|homocysteine
5326663|NCT00340366|Vitamin B12|vitamin b12
5326664|NCT00340366|Birth Defects|birth defects
5326665|NCT00340366|Pregnancy|pregnancy
5326666|NCT00340366|Folate|folate
5326667|NCT00340366|Irish Individuals|irish individuals
5326668|NCT00340353|Gene Expression|gene expression
5326669|NCT00340353|Drug Sensitivity|drug sensitivity
5326670|NCT00340353|TFE3|tfe3
5326671|NCT00340353|ASPL-TFE3|aspl-tfe3
5326672|NCT00340353|NOD-SCID Mice|nod-scid mice
5326673|NCT00340353|Sarcoma|sarcoma
5326674|NCT00340353|Alveolar Soft Part Sarcoma|alveolar soft part sarcoma
5326675|NCT00340353|ASPS|asps
5326676|NCT00340340|Population-Based Case Control Study|population-based case control study
5326677|NCT00340340|Lung Cancer|lung cancer
5326678|NCT00340340|Epidemiology|epidemiology
5326679|NCT00340340|Smoking|smoking
5326680|NCT00340340|Smokers|smokers
5326681|NCT00340340|Genetics|genetics
5326682|NCT00340327|healthy subjects|healthy subjects
5326683|NCT00340314|symptomatic|symptomatic
5326684|NCT00340314|paroxysmal|paroxysmal
5326685|NCT00340314|atrial fibrillation|atrial fibrillation
5326686|NCT00340301|Polymorphism|polymorphism
5326687|NCT00340301|Neurodegenerative Diseases|neurodegenerative diseases
5326688|NCT00340301|ALS|als
5326689|NCT00340288|Fibroids|fibroids
5326690|NCT00340288|Life Style/Endrocrinology|life style/endrocrinology
5326691|NCT00340288|Magnetic Resonance Imaging|magnetic resonance imaging
5326692|NCT00340288|Molecular Characterization|molecular characterization
5326693|NCT00340288|Symptoms/Clinical Outcome|symptoms/clinical outcome
5326694|NCT00340288|Uterine Fibroids|uterine fibroids
5326695|NCT00340275|Bacterial Vaginosis|bacterial vaginosis
5326696|NCT00340275|Vaginal Infection|vaginal infection
5326697|NCT00340275|Vaginitis|vaginitis
5326698|NCT00340275|Cohort Study|cohort study
5326699|NCT00340275|Sexually Transmitted Disease|sexually transmitted disease
5326700|NCT00340262|Supplemental Hormone Use|supplemental hormone use
5326701|NCT00340262|Osteoporosis|osteoporosis
5326702|NCT00340262|Endogenous Sex Hormones|endogenous sex hormones
5326808|NCT00339911|Venipuncture|venipuncture
5326703|NCT00340249|Premature Rupture of the Membranes (PROM)|premature rupture of the membranes (prom)
5326704|NCT00340249|Preterm Delivery|preterm delivery
5326705|NCT00340249|In-Utero Fetal Demise|in-utero fetal demise
5326706|NCT00340249|Chorioamnionitis|chorioamnionitis
5326707|NCT00340249|Spontaneous Abortion|spontaneous abortion
5326708|NCT00340223|Immunity|immunity
5326709|NCT00340223|Mutations|mutations
5326710|NCT00340223|Viral Selection|viral selection
5326711|NCT00340223|Disease Progression|disease progression
5326712|NCT00340223|RNA|rna
5326713|NCT00340210|Biomarkers|biomarkers
5326714|NCT00340210|Breast Cancer|breast cancer
5326715|NCT00340210|Etiology|etiology
5326716|NCT00340210|Hormones|hormones
5326717|NCT00340210|Prospective Study|prospective study
5326718|NCT00340184|concurrent|concurrent
5326719|NCT00340184|chemoradiation|chemoradiation
5326720|NCT00340184|paclitaxel|paclitaxel
5326721|NCT00340184|carboplatin|carboplatin
5326722|NCT00340171|Intrauterine Growth Retardation|intrauterine growth retardation
5326723|NCT00340171|Macrosomia|macrosomia
5326724|NCT00340171|Fetal Volume|fetal volume
5326725|NCT00340171|Fetal Anatomy|fetal anatomy
5326726|NCT00340171|Prediction of Birthweight|prediction of birthweight
5326727|NCT00340171|3D Ultrasonography|3d ultrasonography
5326728|NCT00340171|Fetus|fetus
5326729|NCT00340171|Prenatal Diagnosis|prenatal diagnosis
5326730|NCT00340158|Mammary|mammary
5326731|NCT00340158|Diagnosis|diagnosis
5326732|NCT00340158|Aggressive|aggressive
5326733|NCT00340158|Pathology|pathology
5326734|NCT00340158|Epidemiology|epidemiology
5326735|NCT00340132|Non-Insulin Dependent Diabetes|non-insulin dependent diabetes
5326736|NCT00340132|Insulin Resistance|insulin resistance
5326737|NCT00340132|Insulin Secretion|insulin secretion
5326738|NCT00340132|Glucose Tolerance|glucose tolerance
5326739|NCT00340132|Adipose Tissue|adipose tissue
5326740|NCT00340132|Preadipocytes|preadipocytes
5326741|NCT00340119|CHOICE Cohort|choice cohort
5326742|NCT00340119|End Stage Renal Disease|end stage renal disease
5326743|NCT00340119|Epidemiology|epidemiology
5326744|NCT00340119|Prevention|prevention
5326745|NCT00340119|Single Nucleotide Polymorphisms|single nucleotide polymorphisms
5326746|NCT00340119|ESRD|esrd
5326747|NCT00340106|Infant Health Study|infant health study
5326748|NCT00340106|Environmental Tobacco Smoke|environmental tobacco smoke
5326749|NCT00340106|Infant Health|infant health
5326750|NCT00340093|Adherence|adherence
5326751|NCT00340093|Behavioral Intervention|behavioral intervention
5326752|NCT00340093|Adolescence|adolescence
5326753|NCT00340093|Self-Regulation|self-regulation
5326754|NCT00340093|Behavioral Medicine|behavioral medicine
5326755|NCT00340093|Diabetes|diabetes
5326756|NCT00340080|Abacavir|abacavir
5326757|NCT00340080|Pharmacogenetics|pharmacogenetics
5326758|NCT00340080|hypersensitivity|hypersensitivity
5326759|NCT00340080|HLA-B*5701|hla-b*5701
5326760|NCT00340054|brain tumor|brain tumor
5326761|NCT00340028|Ovulation|ovulation
5326762|NCT00340028|Diary Record|diary record
5326763|NCT00340028|Urine Collection|urine collection
5326764|NCT00340028|Leutinizing Hormone|leutinizing hormone
5326765|NCT00340028|Blood Collection|blood collection
5326766|NCT00340028|Pregnancy|pregnancy
5326767|NCT00340015|Cancer|cancer
5326768|NCT00340015|Mortality|mortality
5326769|NCT00340015|Lifestyle Factors|lifestyle factors
5326770|NCT00340015|Cohort|cohort
5326771|NCT00340002|Fetal Anatomy|fetal anatomy
5326772|NCT00340002|Pregnancy|pregnancy
5326773|NCT00340002|Prenatal Diagnosis|prenatal diagnosis
5326774|NCT00339989|Molecular Markers|molecular markers
5326775|NCT00339989|Human Papillomavirus|human papillomavirus
5326776|NCT00339989|Cervix|cervix
5326777|NCT00339989|Cancer|cancer
5326778|NCT00339989|Microarray|microarray
5326779|NCT00339976|Case-Control Study|case-control study
5326780|NCT00339976|Death Certificates|death certificates
5326781|NCT00339976|National Death Index|national death index
5326782|NCT00339976|Cause of Death Information|cause of death information
5326783|NCT00339976|Lead Exposure|lead exposure
5326784|NCT00339976|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
5326785|NCT00339976|ALS|als
5326786|NCT00339963|Microarray|microarray
5326787|NCT00339963|Lymphoma|lymphoma
5326788|NCT00339963|Gene Expression|gene expression
5326789|NCT00339963|Molecular Diagnosis|molecular diagnosis
5326790|NCT00339963|Prognosis|prognosis
5326791|NCT00339963|Leukemia|leukemia
5326792|NCT00339963|Myeloma|myeloma
5326793|NCT00339963|Lymphoid Malignancy|lymphoid malignancy
5326794|NCT00339950|Colorectal adenoma|colorectal adenoma
5326795|NCT00339950|Screening|screening
5326796|NCT00339950|Diet|diet
5326797|NCT00339950|Risk Factors|risk factors
5326798|NCT00339937|Human Herpes virus 8 (HHV8)|human herpes virus 8 (hhv8)
5326799|NCT00339937|Kaposi sarcoma (KS)|kaposi sarcoma (ks)
5326800|NCT00339924|Clinical Decision-Making|clinical decision-making
5326801|NCT00339924|Physician Bias|physician bias
5326802|NCT00339924|Genetics|genetics
5326803|NCT00339924|Race|race
5326804|NCT00339924|Ethnicity|ethnicity
5326805|NCT00339924|Human Genetic Variation|human genetic variation
5326806|NCT00339911|Repository|repository
5326807|NCT00339911|Phlebotomy|phlebotomy
5326809|NCT00339911|Anemia|anemia
5326810|NCT00339911|Occupational Health Services|occupational health services
5326811|NCT00339898|Minimal Residual Disease|minimal residual disease
5326812|NCT00339898|Ewings Sarcoma|ewings sarcoma
5326813|NCT00339885|Monogenic Diabetes|monogenic diabetes
5326814|NCT00339885|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
5326815|NCT00339885|QTL|qtl
5326816|NCT00339872|healthy subjects|healthy subjects
5326817|NCT00339859|Molecular Epidemiology of Lung Cancer|molecular epidemiology of lung cancer
5326818|NCT00339859|Health Disparities|health disparities
5326819|NCT00339846|Craniosynostosis|craniosynostosis
5326820|NCT00339846|Craniofrontonasal Syndrome|craniofrontonasal syndrome
5326821|NCT00339846|CFNS|cfns
5326822|NCT00339833|Salsalate|salsalate
5326823|NCT00339833|Insulin Resistance|insulin resistance
5326824|NCT00339833|Diabetes Mellitus|diabetes mellitus
5326825|NCT00339833|Inflammation|inflammation
5326826|NCT00339833|Diabetes|diabetes
5326827|NCT00339833|HCV|hcv
5326828|NCT00339807|Retrovirus|retrovirus
5326829|NCT00339807|Caribbean|caribbean
5326830|NCT00339807|Transmission|transmission
5326831|NCT00339807|Genetic|genetic
5326832|NCT00339807|Viral Markers|viral markers
5326833|NCT00339807|HTLV-1|htlv-1
5326834|NCT00339794|Racial Profiling|racial profiling
5326835|NCT00339794|Genomics|genomics
5326836|NCT00339794|Genetic Testing|genetic testing
5326837|NCT00339794|Family History|family history
5326838|NCT00339794|Family Physician|family physician
5326839|NCT00339781|Fetomaternal Microchimerism|fetomaternal microchimerism
5326840|NCT00339781|Cell Trafficking|cell trafficking
5326841|NCT00339781|Discordant Twins|discordant twins
5326842|NCT00339781|Maternofetal Microchimerism|maternofetal microchimerism
5326843|NCT00339781|Diabetes Type I|diabetes type i
5326844|NCT00339781|Twins|twins
5326845|NCT00339768|Helicobacter Pylori|helicobacter pylori
5326846|NCT00339768|Gastric Cancer Prevention|gastric cancer prevention
5326847|NCT00339768|Precancerous Gastric Lesions|precancerous gastric lesions
5326848|NCT00339742|Esophageal Cancer|esophageal cancer
5326849|NCT00339742|Case-Control Study|case-control study
5326850|NCT00339742|Environmental Risk Factors|environmental risk factors
5326851|NCT00339742|Genetic Risk Factors|genetic risk factors
5326852|NCT00339729|Children|children
5326853|NCT00339729|Behavior|behavior
5326854|NCT00339729|Epidemiology|epidemiology
5326855|NCT00339729|Lead|lead
5326856|NCT00339729|Learning Disorder|learning disorder
5326857|NCT00339716|Cohort|cohort
5326858|NCT00339716|Radiation|radiation
5326859|NCT00339716|In Utero|in utero
5326860|NCT00339703|Resistin|resistin
5326861|NCT00339703|Asthma|asthma
5326862|NCT00339703|CRP|crp
5326863|NCT00339703|Diabetes|diabetes
5326864|NCT00339703|FIZZ|fizz
5326865|NCT00339690|Asthma|asthma
5326866|NCT00339690|Allergy|allergy
5326867|NCT00339690|Intervention|intervention
5326868|NCT00339690|Behaviors|behaviors
5326869|NCT00339690|Test-Kit|test-kit
5326870|NCT00339690|Dust Mites Allergen|dust mites allergen
5326871|NCT00339677|Measurement Error|measurement error
5326872|NCT00339677|Dietary Assessment|dietary assessment
5326873|NCT00339677|Dietary Intake|dietary intake
5326874|NCT00339677|Energy|energy
5326875|NCT00339677|Protein|protein
5326876|NCT00339664|Pharmacokinetics|pharmacokinetics
5326877|NCT00339664|Quantify|quantify
5326878|NCT00339664|HPLC|hplc
5326879|NCT00339664|LC/MS|lc/ms
5326880|NCT00339664|Pharmacodynamics|pharmacodynamics
5326881|NCT00339651|Precursors|precursors
5326882|NCT00339651|Endometrial Cancer|endometrial cancer
5326883|NCT00339651|Hyperplasia|hyperplasia
5326884|NCT00339651|Progression|progression
5326885|NCT00339638|Epidemiology|epidemiology
5326886|NCT00339638|Risk Prediction|risk prediction
5326887|NCT00339638|Biomarkers|biomarkers
5326888|NCT00339638|Nested Case Control|nested case control
5326889|NCT00339625|Intervention|intervention
5326890|NCT00339625|Diet|diet
5326891|NCT00339625|Colon|colon
5326892|NCT00339612|Perinatal|perinatal
5326893|NCT00339612|HIV|hiv
5326894|NCT00339612|AIDS|aids
5326895|NCT00339599|Atherosclerosis|atherosclerosis
5326896|NCT00339599|Single Nucleotide Polymorphisms|single nucleotide polymorphisms
5326897|NCT00339599|Monocyte Chemotactic Protein-1|monocyte chemotactic protein-1
5326898|NCT00339599|Inflammation|inflammation
5326899|NCT00339599|Eotaxin|eotaxin
5326900|NCT00339586|Non-small cell lung cancer|non-small cell lung cancer
5326901|NCT00339586|tyrosine kinase inhibition|tyrosine kinase inhibition
5326902|NCT00339586|first-line treatment|first-line treatment
5326903|NCT00339586|mutant EGFR-gene|mutant egfr-gene
5326904|NCT00339573|Asthma|asthma
5326905|NCT00339573|Dust Mite|dust mite
5326906|NCT00339573|Cockroach|cockroach
5326907|NCT00339573|Lead Toxicity|lead toxicity
5326908|NCT00339573|Allergy|allergy
5326909|NCT00339560|Ampulla of Vater|ampulla of vater
5326910|NCT00339560|Gallbaldder|gallbaldder
5326911|NCT00339560|Cancer|cancer
5326912|NCT00339560|Extrahepatic Bile Duct|extrahepatic bile duct
5326913|NCT00339547|Leiomyomas|leiomyomas
5326914|NCT00339547|Ultrasound|ultrasound
5326915|NCT00339547|Hysterectomy|hysterectomy
5326916|NCT00339547|Epidemiology|epidemiology
5326917|NCT00339547|Hyperinsulinemia|hyperinsulinemia
5326918|NCT00339534|African Men|african men
5326919|NCT00339534|Case-Control Study|case-control study
5326920|NCT00339534|Prostate Cancer|prostate cancer
5326921|NCT00339534|Cancer|cancer
5326922|NCT00339521|Asthma|asthma
5326923|NCT00339521|Mexico|mexico
5326924|NCT00339521|Candidate Genes|candidate genes
5326925|NCT00339521|Triads|triads
5326926|NCT00339521|Polymorphism|polymorphism
5326927|NCT00339508|Linkage Analysis|linkage analysis
5326928|NCT00339508|Cancer Genetics|cancer genetics
5326929|NCT00339508|Software|software
5326930|NCT00339508|Bug Reports|bug reports
5326931|NCT00339508|Computer Programs|computer programs
5326932|NCT00339508|Data Analysis|data analysis
5326933|NCT00339495|Prostate|prostate
5326934|NCT00339495|Screening Trail|screening trail
5326935|NCT00339495|Ovarian|ovarian
5326936|NCT00339495|Lung|lung
5326937|NCT00339495|Colorectal|colorectal
5326938|NCT00339482|Epidemiology|epidemiology
5326939|NCT00339482|Type 2 Diabetes|type 2 diabetes
5326940|NCT00339482|Vascular Complications|vascular complications
5326941|NCT00339482|Retinopathy|retinopathy
5326942|NCT00339482|Nephropathy|nephropathy
5326943|NCT00339482|Genetics|genetics
5326944|NCT00339469|Prevention|prevention
5326945|NCT00339469|Colorectal Neoplasms|colorectal neoplasms
5326946|NCT00339469|Insulin Resistance|insulin resistance
5326947|NCT00339469|Inflammation Obesity|inflammation obesity
5326948|NCT00339469|Adenoma|adenoma
5326949|NCT00339456|Therapy|therapy
5326950|NCT00339456|Africa|africa
5326951|NCT00339456|Structured|structured
5326952|NCT00339456|Interruption|interruption
5326953|NCT00339456|Antiretroviral|antiretroviral
5326954|NCT00339456|HIV|hiv
5326955|NCT00339443|Buccal Cells|buccal cells
5326956|NCT00339443|Concordance|concordance
5326957|NCT00339443|DNA Yields|dna yields
5326958|NCT00339443|pH Meter|ph meter
5326959|NCT00339443|Urine pH|urine ph
5326960|NCT00339443|Calibration|calibration
5326961|NCT00339430|Genotyping|genotyping
5326962|NCT00339430|HIV|hiv
5326963|NCT00339430|HPV|hpv
5326964|NCT00339430|HCV|hcv
5326965|NCT00339430|HBV|hbv
5326966|NCT00339417|Lymphatic Filariasis|lymphatic filariasis
5326967|NCT00339417|Chemotherapy|chemotherapy
5326968|NCT00339404|Genotyping|genotyping
5326969|NCT00339404|Linkage Analysis|linkage analysis
5326970|NCT00339404|Cancer|cancer
5326971|NCT00339404|Hereditary Melanoma|hereditary melanoma
5326972|NCT00339391|Adjustment|adjustment
5326973|NCT00339391|Environmental Complexity|environmental complexity
5326974|NCT00339391|Mental Illness|mental illness
5326975|NCT00339391|Non-literate|non-literate
5326976|NCT00339391|West Africa|west africa
5326977|NCT00339391|Stress|stress
5326978|NCT00339391|Knowledge|knowledge
5326979|NCT00339391|Mental Health|mental health
5326980|NCT00339391|AIDS|aids
5326981|NCT00339378|Record Linkage|record linkage
5326982|NCT00339378|Retrospective|retrospective
5326983|NCT00339378|Cohort|cohort
5326984|NCT00339378|Registries|registries
5326985|NCT00339378|Agricultural|agricultural
5326986|NCT00339365|Infants|infants
5326987|NCT00339365|Toddlers|toddlers
5326988|NCT00339365|Attachment|attachment
5326989|NCT00339365|Maltreatment|maltreatment
5326990|NCT00339365|Foster Care|foster care
5326991|NCT00339352|Brain|brain
5326992|NCT00339352|Exposures|exposures
5326993|NCT00339352|Genetics|genetics
5326994|NCT00339352|Glioma|glioma
5326995|NCT00339352|Occupations|occupations
5326996|NCT00339339|Dental Materials|dental materials
5326997|NCT00339339|Resins|resins
5326998|NCT00339339|BisDMA|bisdma
5326999|NCT00339339|Absorption|absorption
5327000|NCT00339339|Systemic|systemic
5327001|NCT00339326|Human Herpes virus 8 (HHV8)|human herpes virus 8 (hhv8)
5327002|NCT00339326|Kaposis sarcoma (KS)|kaposis sarcoma (ks)
5327003|NCT00339326|Kaposi Sarcoma|kaposi sarcoma
5327004|NCT00339326|Karposi Sarcoma-Associated Herpesvirus|karposi sarcoma-associated herpesvirus
5327005|NCT00339326|KSHV|kshv
5327006|NCT00339326|KS|ks
5327007|NCT00339313|Obesity|obesity
5327008|NCT00339313|Etiology|etiology
5327009|NCT00339313|Macronutrient Selection|macronutrient selection
5327010|NCT00339313|Taste Preference|taste preference
5327011|NCT00339313|Mixed Meal Test|mixed meal test
5327012|NCT00339300|Etiology|etiology
5327013|NCT00339300|Brain Cancer|brain cancer
5327014|NCT00339300|Epidemiology|epidemiology
5327015|NCT00339300|Brain Tumors|brain tumors
5327016|NCT00339300|Glioma|glioma
5327017|NCT00339287|Inflammation|inflammation
5327018|NCT00339287|Innate Immunity|innate immunity
5327019|NCT00339287|Macrophages|macrophages
5327020|NCT00339287|Neutrophils|neutrophils
5327021|NCT00339287|Pathogenesis|pathogenesis
5327022|NCT00339274|Repositories|repositories
5327023|NCT00339274|Pathology|pathology
5327024|NCT00339274|Belarus|belarus
5327025|NCT00339274|Russia|russia
5327026|NCT00339274|Ukraine|ukraine
5327027|NCT00339261|Cardiovascular|cardiovascular
5327028|NCT00339261|Renal|renal
5327029|NCT00339261|Autoimmune Disease|autoimmune disease
5327030|NCT00339261|Genetics|genetics
5327031|NCT00339261|Mortality|mortality
5327032|NCT00339248|Hyperplasia|hyperplasia
5327033|NCT00339248|Atypia|atypia
5327034|NCT00339248|Polymorphism|polymorphism
5327035|NCT00339248|Progression|progression
5327036|NCT00339248|Epidemiology|epidemiology
5327037|NCT00339235|Preterm Birth Prevention|preterm birth prevention
5327038|NCT00339235|Preterm Birth|preterm birth
5327039|NCT00339235|Pregnancy|pregnancy
5327040|NCT00339235|Pregnancy Complications|pregnancy complications
5327041|NCT00339222|Genetics|genetics
5327042|NCT00339222|Kindreds|kindreds
5327043|NCT00339222|Mediterranean Population|mediterranean population
5327044|NCT00339222|Nevi|nevi
5327045|NCT00339222|Pigmentation|pigmentation
5327046|NCT00339222|Melanoma-Prone Families|melanoma-prone families
5327047|NCT00339222|Sun Exposure|sun exposure
5327048|NCT00339222|Melanoma|melanoma
5327049|NCT00339209|Genetic Polymorphisms|genetic polymorphisms
5327050|NCT00339209|Acute Rejection|acute rejection
5327051|NCT00339209|Bronchiolitis Obliterans Syndrome|bronchiolitis obliterans syndrome
5327052|NCT00339209|Transplant Rejection|transplant rejection
5327053|NCT00339209|Innate Immunity|innate immunity
5327054|NCT00339209|Lung Transplantation Rejection|lung transplantation rejection
5327056|NCT00339196|MDS High risk|mds high risk
5327057|NCT00339196|Demethylating agents|demethylating agents
5327058|NCT00339196|HDAC Inhibitors|hdac inhibitors
5327059|NCT00339183|Oncology|oncology
5327060|NCT00339183|Cancer|cancer
5327061|NCT00339183|Metastatic Colorectal Cancer|metastatic colorectal cancer
5327062|NCT00339183|EGFr|egfr
5327063|NCT00339183|Panitumumab|panitumumab
5327064|NCT00339183|Clinical Trial|clinical trial
5327065|NCT00339183|Amgen|amgen
5327066|NCT00339170|Schizoaffective Disorder|schizoaffective disorder
5327067|NCT00339170|Schizophrenic Disorders|schizophrenic disorders
5327068|NCT00339170|Psychotic Disorders|psychotic disorders
5327069|NCT00339170|Cognition|cognition
5327070|NCT00339157|IDIOPATHIC JUVENILE ARTHRITIS|idiopathic juvenile arthritis
5327071|NCT00339157|PEDIATRICS|pediatrics
5327072|NCT00339157|ORPHAN DISEASE|orphan disease
5327073|NCT00339157|INTERLEUKIN - 1|interleukin - 1
5327074|NCT00339157|RECEPTORS , INTERLEUKINS|receptors , interleukins
5327075|NCT00339157|ANTAGONISTS|antagonists
5327076|NCT00339144|Solid tumors (including relapsed disease) that are refractory to standard therapies or for which no effective standard therapy exists|solid tumors (including relapsed disease) that are refractory to standard therapies or for which no effective standard therapy exists
5327077|NCT00339131|radiopharmaceutical|radiopharmaceutical
5327078|NCT00339131|radiation dosimetry|radiation dosimetry
5327079|NCT00339131|iodine|iodine
5327080|NCT00339131|MIBG|mibg
5327081|NCT00339131|iobenguane|iobenguane
5327082|NCT00339131|Ultratrace|ultratrace
5327083|NCT00339131|neuroendocrine tumors|neuroendocrine tumors
5327084|NCT00339105|Acute|acute
5327085|NCT00339105|Coronary|coronary
5327086|NCT00339105|Syndrome|syndrome
5327087|NCT00339105|HyperQ|hyperq
5327088|NCT00339105|High|high
5327089|NCT00339105|Frequency|frequency
5327090|NCT00339105|ECG|ecg
5327091|NCT00339105|chest|chest
5327092|NCT00339105|pain|pain
5327093|NCT00339092|HIV|hiv
5327094|NCT00339092|ART|art
5327095|NCT00339066|Late-Life Depression|late-life depression
5327096|NCT00339053|thoracic aortic aneurysm|thoracic aortic aneurysm
5327097|NCT00339053|immunonutrition|immunonutrition
5327098|NCT00339053|respiratory failure|respiratory failure
5327099|NCT00339053|lenght of stay ICU|lenght of stay icu
5327100|NCT00339040|HPV|hpv
5327101|NCT00339027|child care centers|child care centers
5327102|NCT00339027|community based research|community based research
5327103|NCT00339027|behavioral health|behavioral health
5327104|NCT00339027|health literacy|health literacy
5327105|NCT00339027|unmet healthcare needs|unmet healthcare needs
5327106|NCT00339001|Erythropoietin|erythropoietin
5327107|NCT00339001|Iron|iron
5327108|NCT00339001|Retinopathy of prematurity|retinopathy of prematurity
5327109|NCT00338988|Gastrointestinal|gastrointestinal
5327110|NCT00338988|Capecitabine|capecitabine
5327111|NCT00338988|Oxaliplatin|oxaliplatin
5327112|NCT00338988|Carcinoma of the Gallbladder|carcinoma of the gallbladder
5327113|NCT00338988|Carcinoma of the Intrahepatic or Extrahepatic Biliary Tract|carcinoma of the intrahepatic or extrahepatic biliary tract
5327114|NCT00338988|Xeloda|xeloda
5327115|NCT00338988|Eloxatin|eloxatin
5327116|NCT00338975|Psychotic Disorders|psychotic disorders
5327117|NCT00338975|Schizoaffective Disorder|schizoaffective disorder
5327118|NCT00338975|Cognitive Behavioral Therapy|cognitive behavioral therapy
5327119|NCT00338975|Social Skills Training|social skills training
5327120|NCT00338962|SSRI|ssri
5327121|NCT00338962|treatment|treatment
5327122|NCT00338962|naltrexone|naltrexone
5327123|NCT00338962|alcohol dependence|alcohol dependence
5327124|NCT00338962|Desipramine|desipramine
5327125|NCT00338962|depression|depression
5327126|NCT00338962|PTSD|ptsd
5327127|NCT00338949|Ziprasidone|ziprasidone
5327128|NCT00338949|Olanzapine|olanzapine
5327129|NCT00338949|Risperidone|risperidone
5327130|NCT00338949|Schizoaffective Disorder|schizoaffective disorder
5327131|NCT00338949|Insulin Sensitivity|insulin sensitivity
5327132|NCT00338949|Visceral Adiposity|visceral adiposity
5327133|NCT00338949|Metabolic Syndrome|metabolic syndrome
5327134|NCT00338936|Hypertension|hypertension
5327135|NCT00338936|Valsartan|valsartan
5327136|NCT00338936|Hydrochlorothiazide|hydrochlorothiazide
5327137|NCT00338910|healthy volunteers|healthy volunteers
5327138|NCT00338897|Venous Thromboembolism|venous thromboembolism
5327139|NCT00338897|Prevention|prevention
5327140|NCT00338897|Arthroplasty|arthroplasty
5327141|NCT00338897|Replacement|replacement
5327142|NCT00338897|Hip|hip
5327143|NCT00338897|orthopedic surgery|orthopedic surgery
5327144|NCT00338845|STDs|stds
5327145|NCT00338832|Lifestyle Intervention|lifestyle intervention
5327146|NCT00338832|Schizoaffective Disorder|schizoaffective disorder
5327147|NCT00338819|DVT prevention|dvt prevention
5327148|NCT00338819|Hemodynamic study|hemodynamic study
5327149|NCT00338819|IPC|ipc
5327150|NCT00338819|CECT|cect
5327151|NCT00338806|Prevention|prevention
5327152|NCT00338806|Mood Disorders|mood disorders
5327153|NCT00338806|Unipolar Depression|unipolar depression
5327154|NCT00338793|Tuberculosis;|tuberculosis;
5327155|NCT00338793|Pleural effusion;|pleural effusion;
5327156|NCT00338793|Corticosteroids.|corticosteroids.
5327157|NCT00338780|Chronic Hepatitis B|chronic hepatitis b
5327158|NCT00338780|Lamivudine|lamivudine
5327159|NCT00338780|HBeAg negative|hbeag negative
5327160|NCT00338767|AIDS|aids
5327161|NCT00338767|DOT|dot
5327162|NCT00338767|Directly Observed Therapy|directly observed therapy
5327163|NCT00338728|Breast Cancer|breast cancer
5327164|NCT00338728|Letrozole|letrozole
5327165|NCT00338728|Imatinib Mesylate|imatinib mesylate
5327166|NCT00338728|Gleevec|gleevec
5327167|NCT00338728|Femara|femara
5327168|NCT00338715|Effectiveness|effectiveness
5327169|NCT00338715|Pulmonary Vein Isolation Procedure|pulmonary vein isolation procedure
5327170|NCT00338715|Coronary Artery Bypass Surgery|coronary artery bypass surgery
5327171|NCT00338715|Atrial Fibrillation|atrial fibrillation
5327172|NCT00338702|Diabetic|diabetic
5327173|NCT00338702|Foot|foot
5327174|NCT00338702|Ulcer|ulcer
5327175|NCT00338702|Autologous|autologous
5327176|NCT00338702|Platelet|platelet
5327177|NCT00338702|Gel|gel
5327178|NCT00338689|infant formula|infant formula
5327179|NCT00338689|protein content|protein content
5327180|NCT00338689|growth|growth
5327181|NCT00338689|obesity|obesity
5327182|NCT00338689|breast feeding|breast feeding
5327183|NCT00338676|Aortic stenosis|aortic stenosis
5327184|NCT00338676|Elderly|elderly
5327185|NCT00338663|anterior cruciate ligament reconstruction|anterior cruciate ligament reconstruction
5327186|NCT00338663|knee immobilization|knee immobilization
5327187|NCT00338663|postoperative pain|postoperative pain
5327188|NCT00338624|lower urinary tract symptoms|lower urinary tract symptoms
5327189|NCT00338624|DITROPAN XL|ditropan xl
5327190|NCT00338624|oxybutynin extended release tablets|oxybutynin extended release tablets
5327191|NCT00338611|vision therapy|vision therapy
5327192|NCT00338611|orthoptics|orthoptics
5327193|NCT00338611|pencil push-up therapy|pencil push-up therapy
5327194|NCT00338598|glycine|glycine
5327195|NCT00338598|treatment|treatment
5327196|NCT00338598|alcohol dependence|alcohol dependence
5327197|NCT00338598|schizophrenia|schizophrenia
5327198|NCT00338585|PAO|pao
5327199|NCT00338585|acute peripheral arterial occlusion|acute peripheral arterial occlusion
5327200|NCT00338585|thrombolysis|thrombolysis
5327201|NCT00338585|blood clot|blood clot
5327202|NCT00338585|leg attack|leg attack
5327203|NCT00338585|alfimeprase|alfimeprase
5327204|NCT00338585|thrombus|thrombus
5327205|NCT00338585|embolism|embolism
5327206|NCT00338585|thromboembolism|thromboembolism
5327207|NCT00338585|claudication|claudication
5327208|NCT00338585|thrombolytic|thrombolytic
5327209|NCT00338585|thrombosis|thrombosis
5327210|NCT00338585|plasminogen activator|plasminogen activator
5327211|NCT00338585|arterial flow|arterial flow
5327212|NCT00338572|Inflammation|inflammation
5327213|NCT00338572|Blood Pressure, High|blood pressure, high
5327214|NCT00338559|Strabismus|strabismus
5327215|NCT00338559|LMA|lma
5327216|NCT00338559|ET Tube|et tube
5327217|NCT00338559|POV|pov
5327218|NCT00338546|Cocaine|cocaine
5327219|NCT00338546|Sympathetic nerve activity|sympathetic nerve activity
5327220|NCT00338546|Blood pressure|blood pressure
5327221|NCT00338546|Cutaneous vasoconstriction|cutaneous vasoconstriction
5327222|NCT00338546|Coronary vasoconstriction|coronary vasoconstriction
5327223|NCT00338533|childhood glaucoma|childhood glaucoma
5327224|NCT00338520|Cerebral malaria, phenylalanine, Tanzania|cerebral malaria, phenylalanine, tanzania
5327225|NCT00338507|Chronic Bronchitis|chronic bronchitis
5327226|NCT00338507|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5327227|NCT00338468|Anemia|anemia
5327228|NCT00338468|Elderly|elderly
5327229|NCT00338468|Hemoglobin level|hemoglobin level
5327230|NCT00338468|Chronic Kidney Disease|chronic kidney disease
5327231|NCT00338455|Congestive heart failure|congestive heart failure
5327232|NCT00338455|cardiac transplantation|cardiac transplantation
5327233|NCT00338455|renal insufficiency|renal insufficiency
5327234|NCT00338455|renal failure|renal failure
5327235|NCT00338455|dialysis|dialysis
5327236|NCT00338455|ultrafiltration|ultrafiltration
5327237|NCT00338455|vasodilator|vasodilator
5327238|NCT00338455|Natrecor (nesiritide)|natrecor (nesiritide)
5327239|NCT00338442|Immune compromised|immune compromised
5327240|NCT00338442|Varicella Zoster Virus ( VZV) Infection|varicella zoster virus ( vzv) infection
5327241|NCT00338442|Pediatric|pediatric
5327242|NCT00338429|sleep onset latency|sleep onset latency
5327243|NCT00338429|bedtime resistance|bedtime resistance
5327244|NCT00338416|Chemotherapy Induced Anemia|chemotherapy induced anemia
5327245|NCT00338416|PROCRIT (Epoetin alfa)|procrit (epoetin alfa)
5327246|NCT00338416|Chemotherapy|chemotherapy
5327247|NCT00338416|Epoetin alfa|epoetin alfa
5327248|NCT00338403|CPAP pressure of -5cm/water during cold, dry air exposure|cpap pressure of -5cm/water during cold, dry air exposure
5327249|NCT00338403|CPAP pressure of 0cm/water during cold, dry air exposure|cpap pressure of 0cm/water during cold, dry air exposure
5327250|NCT00338403|CPAP pressure of 5cm/water during cold, dry air exposure|cpap pressure of 5cm/water during cold, dry air exposure
5327251|NCT00338403|CPAP pressure of 10cm/water during cold, dry air exposure|cpap pressure of 10cm/water during cold, dry air exposure
5327252|NCT00338390|Antiretrovirals|antiretrovirals
5327253|NCT00338390|CD4 cell count|cd4 cell count
5327254|NCT00338390|toxicity|toxicity
5327255|NCT00338377|Melanoma|melanoma
5327256|NCT00338377|Regional nodal disease|regional nodal disease
5327257|NCT00338377|Dendritic Cell Immunization|dendritic cell immunization
5327258|NCT00338377|Lymphodepletion|lymphodepletion
5327259|NCT00338377|Adoptive Cell Transfer|adoptive cell transfer
5327260|NCT00338377|T Cells|t cells
5327261|NCT00338377|Vaccine|vaccine
5327262|NCT00338377|Cyclosphosphamide|cyclosphosphamide
5327263|NCT00338377|Cytoxan|cytoxan
5327264|NCT00338377|Neosar|neosar
5327265|NCT00338377|Dendritic Cells|dendritic cells
5327266|NCT00338377|Tumor Infiltrating Lymphocytes|tumor infiltrating lymphocytes
5327267|NCT00338377|TIL Cells|til cells
5327268|NCT00338377|MART Peptide|mart peptide
5327269|NCT00338377|Fludarabine|fludarabine
5327270|NCT00338377|Fludarabine Phosphate|fludarabine phosphate
5327271|NCT00338377|Fludara|fludara
5327272|NCT00338377|Proleukin|proleukin
5327273|NCT00338377|IL-2|il-2
5327274|NCT00338377|Interleukin-2|interleukin-2
5327275|NCT00338377|Leptomeningeal disease|leptomeningeal disease
5327276|NCT00338364|Pediatric pain|pediatric pain
5327277|NCT00338364|Pediatric anxiety|pediatric anxiety
5327278|NCT00338364|Painful procedures|painful procedures
5327279|NCT00338338|essential hypertension|essential hypertension
5327280|NCT00338338|Amlodipine|amlodipine
5327281|NCT00338338|blood pressure|blood pressure
5327282|NCT00338338|lacidipine|lacidipine
5327283|NCT00338325|Pediatric Anxiety|pediatric anxiety
5327284|NCT00338325|Pediatric Pain|pediatric pain
5327285|NCT00338312|Natural Menopause|natural menopause
5327286|NCT00338312|HSDD|hsdd
5327287|NCT00338299|Anemia|anemia
5327288|NCT00338299|hemoglobin|hemoglobin
5327289|NCT00338299|chemotherapy|chemotherapy
5327290|NCT00338299|subcutaneous injection|subcutaneous injection
5327291|NCT00338299|Epoetin alfa|epoetin alfa
5327292|NCT00338286|anemia|anemia
5327293|NCT00338286|metastatic breast cancer|metastatic breast cancer
5327294|NCT00338286|Hemoglobin|hemoglobin
5327295|NCT00338286|progression-free survival (PFS)|progression-free survival (pfs)
5327296|NCT00338286|erythropoiesis-stimulating agents (ESA)|erythropoiesis-stimulating agents (esa)
5327297|NCT00338273|Bipolar I disorder with major depressive episode|bipolar i disorder with major depressive episode
5327298|NCT00338247|advanced|advanced
5327299|NCT00338247|TYKERB|tykerb
5327300|NCT00338247|HER2 positive|her2 positive
5327301|NCT00338247|Stage IIIc|stage iiic
5327302|NCT00338247|ErbB2 positive|erbb2 positive
5327303|NCT00338247|GW572016|gw572016
5327304|NCT00338247|metastatic|metastatic
5327305|NCT00338247|Stage IIIb|stage iiib
5327306|NCT00338247|breast cancer|breast cancer
5327307|NCT00338234|anemia|anemia
5327308|NCT00338234|intensive care|intensive care
5327309|NCT00338234|cardiac surgery|cardiac surgery
5327310|NCT00338234|iron metabolism|iron metabolism
5327311|NCT00338234|hepcidin|hepcidin
5327312|NCT00338221|Diarrhea, Malnutrition, Brazil|diarrhea, malnutrition, brazil
5327313|NCT00338208|low vision|low vision
5327314|NCT00338208|glaucoma|glaucoma
5327315|NCT00338195|Caffeine dependence|caffeine dependence
5327316|NCT00338195|Caffeine withdrawal|caffeine withdrawal
5327317|NCT00338182|Solid tumor|solid tumor
5327318|NCT00338156|Left Ventricle Remodelling|left ventricle remodelling
5327319|NCT00338156|Collagen markers|collagen markers
5327320|NCT00338156|Neurohormones|neurohormones
5327321|NCT00338156|Cardiac MRI|cardiac mri
5327322|NCT00338143|Plaque psoriasis|plaque psoriasis
5327323|NCT00338143|Antipsoriatic|antipsoriatic
5327324|NCT00338130|Melanoma|melanoma
5327325|NCT00338130|Phase II|phase ii
5327326|NCT00338130|AZD6244|azd6244
5327327|NCT00338130|temozolomide|temozolomide
5327328|NCT00338117|Dementia|dementia
5327329|NCT00338117|neurodegenerative disorder|neurodegenerative disorder
5327330|NCT00338117|impairment of memory|impairment of memory
5327331|NCT00338117|galantamine|galantamine
5327332|NCT00338117|galanthamine|galanthamine
5327333|NCT00338117|acetylcholinesterase inhibitor|acetylcholinesterase inhibitor
5327334|NCT00338117|Mini Mental State Examination score|mini mental state examination score
5327335|NCT00338104|insulin|insulin
5327336|NCT00338104|glargine|glargine
5327337|NCT00338104|intravenous|intravenous
5327338|NCT00338104|subcutaneous|subcutaneous
5327339|NCT00338104|hospital|hospital
5327340|NCT00338104|diabetes|diabetes
5327341|NCT00338104|glucose|glucose
5327342|NCT00338104|inpatient|inpatient
5327343|NCT00338091|Renal Insufficiency,Chronic|renal insufficiency,chronic
5327344|NCT00338091|Disease Progression|disease progression
5327345|NCT00338091|Proteinuria|proteinuria
5327346|NCT00338091|Dose-Response Relationship,Drug|dose-response relationship,drug
5327347|NCT00338091|Benazepril|benazepril
5327348|NCT00338091|Losartan|losartan
5327349|NCT00338065|Intraocular Pressure|intraocular pressure
5327350|NCT00338052|Contraception|contraception
5327351|NCT00338039|Pancreatic Cancer|pancreatic cancer
5327352|NCT00338039|Cetuximab|cetuximab
5327353|NCT00338039|C225|c225
5327354|NCT00338039|Erbitux|erbitux
5327355|NCT00338039|Gemcitabine|gemcitabine
5327356|NCT00338039|Oxaliplatin|oxaliplatin
5327357|NCT00338039|Eloxatin|eloxatin
5327358|NCT00338039|Capecitabine|capecitabine
5327359|NCT00338039|Xeloda|xeloda
5327360|NCT00338026|Solid Tumors|solid tumors
5327361|NCT00338026|Thallion|thallion
5327362|NCT00338026|TLN-4601|tln-4601
5327363|NCT00338026|Ecopia|ecopia
5327364|NCT00338026|ECO-4601|eco-4601
5327365|NCT00338026|Patients with histologically confirmed solid tumors:|patients with histologically confirmed solid tumors:
5327366|NCT00338026|High Grade Glioma|high grade glioma
5327367|NCT00338026|Colorectal|colorectal
5327368|NCT00338026|Lung|lung
5327369|NCT00338026|Breast|breast
5327370|NCT00338026|Ovarian|ovarian
5327371|NCT00338026|Pancreatic|pancreatic
5327372|NCT00338026|Prostate|prostate
5327373|NCT00338013|sleep|sleep
5327374|NCT00338000|Chronic renal failure|chronic renal failure
5327375|NCT00338000|left ventricular hypertrophy|left ventricular hypertrophy
5327376|NCT00338000|epoetin alfa|epoetin alfa
5327377|NCT00337974|cognitive enhancement|cognitive enhancement
5327378|NCT00337974|memory|memory
5327379|NCT00337974|auditory memory|auditory memory
5327380|NCT00337974|speech|speech
5327381|NCT00337974|computerized|computerized
5327382|NCT00337961|Optic Nerve Sheath Fenestration|optic nerve sheath fenestration
5327383|NCT00337948|Anemia|anemia
5327384|NCT00337948|Epoetin Alfa|epoetin alfa
5327385|NCT00337948|Chemotherapy|chemotherapy
5327386|NCT00337948|Anemia due to Cancer|anemia due to cancer
5327387|NCT00337935|Long Term Care Facilities|long term care facilities
5327388|NCT00337935|subcutaneous injections|subcutaneous injections
5327389|NCT00337935|PROCRIT|procrit
5327390|NCT00337935|Epoetin alfa|epoetin alfa
5327391|NCT00337935|Anemia|anemia
5327392|NCT00337922|EPZICOM|epzicom
5327393|NCT00337922|Lamivudine|lamivudine
5327394|NCT00337922|Abacavir|abacavir
5327395|NCT00337922|pharmacokinetics|pharmacokinetics
5327396|NCT00337922|Japanese|japanese
5327397|NCT00337909|cognitive enhancement|cognitive enhancement
5327398|NCT00337909|memory|memory
5327399|NCT00337909|auditory memory|auditory memory
5327400|NCT00337909|speech|speech
5327401|NCT00337909|computerized|computerized
5327402|NCT00337896|vaccine, influenza, A/H5N1, CMI, sub-study|vaccine, influenza, a/h5n1, cmi, sub-study
5327403|NCT00337883|Glioblastoma Multiforme|glioblastoma multiforme
5327404|NCT00337883|glioma|glioma
5327405|NCT00337883|Grade IV glioma|grade iv glioma
5327406|NCT00337870|Pediatric Anxiety|pediatric anxiety
5327407|NCT00337870|Pediatric Pain|pediatric pain
5327408|NCT00337870|Emergency room procedures|emergency room procedures
5327409|NCT00337818|Non-inferiority|non-inferiority
5327410|NCT00337818|Immunogenicity|immunogenicity
5327411|NCT00337818|HPV Vaccine Consistency|hpv vaccine consistency
5327412|NCT00337805|colloid|colloid
5327413|NCT00337805|crystalloid|crystalloid
5327414|NCT00337805|hemodynamics|hemodynamics
5327415|NCT00337805|flow-directed|flow-directed
5327416|NCT00337805|resuscitation|resuscitation
5327417|NCT00337766|Blood Loss|blood loss
5327418|NCT00337766|Postoperative Blood loss|postoperative blood loss
5327419|NCT00337753|Gambling|gambling
5327420|NCT00337714|Central venous catheter,|central venous catheter,
5327421|NCT00337714|bloodstream infections,|bloodstream infections,
5327422|NCT00337714|intensive care unit|intensive care unit
5327423|NCT00337688|Cerebral Palsy|cerebral palsy
5327424|NCT00337688|Spasticity|spasticity
5327425|NCT00337688|Joystick|joystick
5327426|NCT00337688|Wheelchair|wheelchair
5327427|NCT00337688|rehabilitation|rehabilitation
5327428|NCT00337636|NCL|ncl
5327429|NCT00337636|INCL|incl
5327430|NCT00337636|LINCL|lincl
5327431|NCT00337636|Batten disease|batten disease
5327432|NCT00337636|Infantile Neuronal Ceroid Lipofuscinosis (INCL)|infantile neuronal ceroid lipofuscinosis (incl)
5327433|NCT00337636|Late Infantile Neuronal Ceroid Lipofuscinosis (LINCL)|late infantile neuronal ceroid lipofuscinosis (lincl)
5327434|NCT00337623|Cataracts|cataracts
5327435|NCT00337623|Corticosteroids|corticosteroids
5327436|NCT00337623|Scheimpflug|scheimpflug
5327437|NCT00337623|Lens autofluorescence|lens autofluorescence
5327438|NCT00337597|Normal saline|normal saline
5327439|NCT00337597|Dextrose 5% in water|dextrose 5% in water
5327440|NCT00337597|neurostimulation|neurostimulation
5327441|NCT00337597|Continuous regional analgesia after total knee arthroplasty|continuous regional analgesia after total knee arthroplasty
5327442|NCT00337584|out patient surgery|out patient surgery
5327443|NCT00337584|quality improvement|quality improvement
5327444|NCT00337571|Serious behavioral problems in children and adolescents with AD|serious behavioral problems in children and adolescents with ad
5327445|NCT00337558|treatment outcomes|treatment outcomes
5327446|NCT00337558|Overactive bladder|overactive bladder
5327447|NCT00337558|Solifenacin succinate|solifenacin succinate
5327448|NCT00337558|urinary incontinence|urinary incontinence
5327449|NCT00337558|urge incontinence|urge incontinence
5327450|NCT00337558|frequency|frequency
5327451|NCT00337545|Metastatic|metastatic
5327452|NCT00337545|Refractory|refractory
5327453|NCT00337519|chronic lymphocytic leukemia|chronic lymphocytic leukemia
5327454|NCT00337519|reduced intensity conditioning|reduced intensity conditioning
5327455|NCT00337519|alemtuzumab|alemtuzumab
5327456|NCT00337519|allogeneic stem cell transplantation|allogeneic stem cell transplantation
5327457|NCT00337506|the efficacy and safety of Velcade plus dexamethasone|the efficacy and safety of velcade plus dexamethasone
5327458|NCT00337506|Multiple Myeloma|multiple myeloma
5327459|NCT00337480|acute coronary syndrome|acute coronary syndrome
5327460|NCT00337480|cardiovascular risk factors|cardiovascular risk factors
5327461|NCT00337480|smoking habits|smoking habits
5327462|NCT00337480|obesity|obesity
5327463|NCT00337480|sedentary lifestyle|sedentary lifestyle
5327464|NCT00337480|overweight|overweight
5327465|NCT00337480|education|education
5327466|NCT00337480|follow up after hospitalization|follow up after hospitalization
5327467|NCT00337467|HIV-Infected Patients Evidencing Virologic Suppression|hiv-infected patients evidencing virologic suppression
5327468|NCT00337454|Imatinib resistant or intolerant CML|imatinib resistant or intolerant cml
5327469|NCT00337454|Treatment resistant or intolerant Ph+ALL|treatment resistant or intolerant ph+all
5327470|NCT00337441|Chronic Anemia|chronic anemia
5327471|NCT00337441|Anemia|anemia
5327472|NCT00337441|Chronic Diseases|chronic diseases
5327473|NCT00337441|Elderly|elderly
5327474|NCT00337441|Epoetin alfa|epoetin alfa
5327475|NCT00337441|Fatigue|fatigue
5327476|NCT00337441|Quality of life|quality of life
5327477|NCT00337441|Mobility|mobility
5327478|NCT00337402|Gastrostomy|gastrostomy
5327479|NCT00337402|Quality of life|quality of life
5327480|NCT00337389|Metastatic|metastatic
5327481|NCT00337389|Colorectal|colorectal
5327482|NCT00337389|Cancer|cancer
5327483|NCT00337389|CoFactor|cofactor
5327484|NCT00337389|Stage IV|stage iv
5327485|NCT00337350|Schizophrenia|schizophrenia
5327486|NCT00337350|Glucose Metabolism|glucose metabolism
5327487|NCT00337350|Insulin Resistance|insulin resistance
5327488|NCT00337337|Diabetes|diabetes
5327489|NCT00337337|rice|rice
5327490|NCT00337337|fiber|fiber
5327491|NCT00337324|Diabetic neuropathy|diabetic neuropathy
5327492|NCT00337324|Complications of diabetes|complications of diabetes
5327493|NCT00337324|Neuropathies|neuropathies
5327494|NCT00337324|Electromagnetic stimulation|electromagnetic stimulation
5327495|NCT00337324|Neuropathic pain|neuropathic pain
5327496|NCT00337298|Diabetes|diabetes
5327497|NCT00337298|Retinopathy|retinopathy
5327498|NCT00337298|Blood Pressure|blood pressure
5327499|NCT00337298|Amlodipine|amlodipine
5327500|NCT00337298|Lisinopril|lisinopril
5327501|NCT00337285|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
5327502|NCT00337285|Attention Deficit Disorders with Hyperactivity|attention deficit disorders with hyperactivity
5327503|NCT00337285|Attention Deficit Hyperactivity Disorders|attention deficit hyperactivity disorders
5327504|NCT00337272|chronic insomnia|chronic insomnia
5327505|NCT00337259|marginal zone lymphoma|marginal zone lymphoma
5327506|NCT00337259|gemcitabine|gemcitabine
5327507|NCT00337246|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5327508|NCT00337246|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
5327509|NCT00337246|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
5327510|NCT00337246|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5327511|NCT00337246|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5327512|NCT00337233|fatigue|fatigue
5327513|NCT00337233|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
5327514|NCT00337233|recurrent breast cancer|recurrent breast cancer
5327515|NCT00337233|stage I breast cancer|stage i breast cancer
5327516|NCT00337233|stage II breast cancer|stage ii breast cancer
5327517|NCT00337233|stage IIIA breast cancer|stage iiia breast cancer
5327518|NCT00337233|stage IIIB breast cancer|stage iiib breast cancer
5327519|NCT00337233|stage IIIC breast cancer|stage iiic breast cancer
5327520|NCT00337233|stage IV breast cancer|stage iv breast cancer
5327521|NCT00337233|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5327522|NCT00337233|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
5327523|NCT00337233|stage I ovarian epithelial cancer|stage i ovarian epithelial cancer
5327524|NCT00337233|stage I ovarian germ cell tumor|stage i ovarian germ cell tumor
5327525|NCT00337233|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
5327526|NCT00337233|stage II ovarian germ cell tumor|stage ii ovarian germ cell tumor
5327527|NCT00337233|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5327692|NCT00336544|Cethromycin|cethromycin
5327528|NCT00337233|stage III ovarian germ cell tumor|stage iii ovarian germ cell tumor
5327529|NCT00337233|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5327530|NCT00337233|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
5327531|NCT00337220|allograft|allograft
5327532|NCT00337220|graft|graft
5327533|NCT00337207|adult glioblastoma|adult glioblastoma
5327534|NCT00337207|adult gliosarcoma|adult gliosarcoma
5327535|NCT00337207|recurrent adult brain tumor|recurrent adult brain tumor
5327536|NCT00337207|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5327537|NCT00337207|adult giant cell glioblastoma|adult giant cell glioblastoma
5327538|NCT00337181|HIV-1|hiv-1
5327539|NCT00337181|Natural History|natural history
5327540|NCT00337181|HIV vaccine|hiv vaccine
5327541|NCT00337181|Thailand|thailand
5327542|NCT00337168|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5327543|NCT00337168|L1 adult acute lymphoblastic leukemia|l1 adult acute lymphoblastic leukemia
5327544|NCT00337168|L2 adult acute lymphoblastic leukemia|l2 adult acute lymphoblastic leukemia
5327545|NCT00337168|B-cell adult acute lymphoblastic leukemia|b-cell adult acute lymphoblastic leukemia
5327546|NCT00337168|T-cell adult acute lymphoblastic leukemia|t-cell adult acute lymphoblastic leukemia
5327547|NCT00337155|Recurrent Prostate Cancer|recurrent prostate cancer
5327548|NCT00337155|metastatic Cancer|metastatic cancer
5327549|NCT00337142|gestational diabetes|gestational diabetes
5327550|NCT00337142|newborn|newborn
5327551|NCT00337142|hypoglycemia|hypoglycemia
5327552|NCT00337129|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
5327553|NCT00337129|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
5327554|NCT00337129|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
5327555|NCT00337129|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
5327556|NCT00337129|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
5327557|NCT00337129|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
5327558|NCT00337129|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
5327559|NCT00337129|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5327560|NCT00337129|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5327561|NCT00337129|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5327562|NCT00337129|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5327563|NCT00337129|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
5327564|NCT00337129|untreated metastatic squamous neck cancer with occult primary|untreated metastatic squamous neck cancer with occult primary
5327565|NCT00337129|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
5327566|NCT00337090|Over Active Bladder|over active bladder
5327567|NCT00337090|Urinary incontinence|urinary incontinence
5327568|NCT00337090|YM178|ym178
5327569|NCT00337090|Symptomatic Over Active Bladder|symptomatic over active bladder
5327570|NCT00337077|Eribulin Mesylate|eribulin mesylate
5327571|NCT00337077|metastatic hormone refractory prostate cancer|metastatic hormone refractory prostate cancer
5327572|NCT00337077|Halichondrin B Analog|halichondrin b analog
5327573|NCT00337064|Breast cancer treatment|breast cancer treatment
5327574|NCT00337064|Partial breast radiation|partial breast radiation
5327575|NCT00337064|Radiation Therapy|radiation therapy
5327576|NCT00337064|Adjuvant Treatment|adjuvant treatment
5327577|NCT00337051|Renal transplantation|renal transplantation
5327578|NCT00337051|renal allograft|renal allograft
5327579|NCT00337051|end-stage renal disease|end-stage renal disease
5327580|NCT00337051|renal failure|renal failure
5327581|NCT00337051|general anaesthesia|general anaesthesia
5327582|NCT00337051|inhaled anaesthetic|inhaled anaesthetic
5327583|NCT00337051|Sevoflurane|sevoflurane
5327584|NCT00337051|ischemia|ischemia
5327585|NCT00337051|reperfusion|reperfusion
5327586|NCT00337051|ischemic lesions|ischemic lesions
5327587|NCT00336973|Plaque Psoriasis|plaque psoriasis
5327588|NCT00336973|Raptiva|raptiva
5327589|NCT00336973|Anti-TNF|anti-tnf
5327590|NCT00336960|stage II rectal cancer|stage ii rectal cancer
5327591|NCT00336960|stage III rectal cancer|stage iii rectal cancer
5327592|NCT00336960|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5327593|NCT00336947|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
5327594|NCT00336947|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5327595|NCT00336947|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
5327596|NCT00336947|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5327597|NCT00336947|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
5327598|NCT00336947|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5327599|NCT00336947|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
5327600|NCT00336947|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5327885|NCT00335634|Intimacy|intimacy
5327601|NCT00336947|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
5327602|NCT00336947|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
5327603|NCT00336934|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5327604|NCT00336934|recurrent prostate cancer|recurrent prostate cancer
5327605|NCT00336934|stage I prostate cancer|stage i prostate cancer
5327606|NCT00336934|stage II prostate cancer|stage ii prostate cancer
5327607|NCT00336934|stage III prostate cancer|stage iii prostate cancer
5327608|NCT00336934|stage IV prostate cancer|stage iv prostate cancer
5327609|NCT00336908|Intensive Care,Neonatal|intensive care,neonatal
5327610|NCT00336908|Parenteral nutrition|parenteral nutrition
5327611|NCT00336908|Fat emulsions,Intravenous|fat emulsions,intravenous
5327612|NCT00336895|Liver transplantation|liver transplantation
5327613|NCT00336895|mycophenolate mofetil|mycophenolate mofetil
5327614|NCT00336895|gastrointestinal|gastrointestinal
5327615|NCT00336895|adverse effects|adverse effects
5327616|NCT00336882|traumatic brain injury|traumatic brain injury
5327617|NCT00336882|propofol|propofol
5327618|NCT00336882|oxidative stress|oxidative stress
5327619|NCT00336882|microdialysis|microdialysis
5327620|NCT00336856|Colon Cancer|colon cancer
5327621|NCT00336843|Zevalin|zevalin
5327622|NCT00336843|B-cell non-Hodgkin's lymphoma|b-cell non-hodgkin's lymphoma
5327623|NCT00336843|autologous stem cell transplantation|autologous stem cell transplantation
5327624|NCT00336843|BuCyE regimen|bucye regimen
5327625|NCT00336830|Cardiac Rehabilitation|cardiac rehabilitation
5327626|NCT00336830|Improving Cardiac Rehabilitation Participation|improving cardiac rehabilitation participation
5327627|NCT00336830|coronary angioplasty|coronary angioplasty
5327628|NCT00336830|coronary artery bypass surgery|coronary artery bypass surgery
5327629|NCT00336817|Liver transplantation|liver transplantation
5327630|NCT00336817|mycophenolate mofetil|mycophenolate mofetil
5327631|NCT00336817|gastrointestinal|gastrointestinal
5327632|NCT00336817|adverse effects|adverse effects
5327633|NCT00336791|Breast Cancer|breast cancer
5327634|NCT00336791|Gene Expression|gene expression
5327635|NCT00336791|Fluorouracil|fluorouracil
5327636|NCT00336791|Cyclophosphamide|cyclophosphamide
5327637|NCT00336791|Doxorubicin|doxorubicin
5327638|NCT00336791|Paclitaxel|paclitaxel
5327639|NCT00336765|solid tumors|solid tumors
5327640|NCT00336752|undisplaced ,unstable wEBER B ankle fractures|undisplaced ,unstable weber b ankle fractures
5327641|NCT00336752|operative intervention|operative intervention
5327642|NCT00336752|non operative intervention|non operative intervention
5327643|NCT00336739|Gastric acidity determination|gastric acidity determination
5327644|NCT00336739|Calcium sensing receptor|calcium sensing receptor
5327645|NCT00336713|depression|depression
5327646|NCT00336713|antidepressive agents|antidepressive agents
5327647|NCT00336713|controlled clinical trial|controlled clinical trial
5327648|NCT00336700|Pancreas|pancreas
5327649|NCT00336700|Cancer|cancer
5327650|NCT00336700|Pancreatic|pancreatic
5327651|NCT00336687|Thrombopenia|thrombopenia
5327652|NCT00336687|Reanimation|reanimation
5327653|NCT00336687|Thrombopenia in reanimation|thrombopenia in reanimation
5327654|NCT00336674|Type 1 diabetes|type 1 diabetes
5327655|NCT00336661|Periodontitis|periodontitis
5327656|NCT00336661|Chronic Periodontitis|chronic periodontitis
5327657|NCT00336661|Gingivitis|gingivitis
5327658|NCT00336661|PERIOWAVE|periowave
5327659|NCT00336661|Photodynamic Disinfection|photodynamic disinfection
5327660|NCT00336648|Pancreatic Neoplasms|pancreatic neoplasms
5327661|NCT00336648|Bevacizumab|bevacizumab
5327662|NCT00336648|Gemcitabine|gemcitabine
5327663|NCT00336648|Radiation Therapy|radiation therapy
5327664|NCT00336648|adenocarcinoma of the pancreatic head|adenocarcinoma of the pancreatic head
5327665|NCT00336648|adenocarcinoma of the uncinate process|adenocarcinoma of the uncinate process
5327666|NCT00336635|smallpox, vaccine, immunity|smallpox, vaccine, immunity
5327667|NCT00336622|Carpal Tunnel Syndrome|carpal tunnel syndrome
5327668|NCT00336622|Splints|splints
5327669|NCT00336596|middle cerebral artery occlusion|middle cerebral artery occlusion
5327670|NCT00336596|intracranial embolism and thrombosis|intracranial embolism and thrombosis
5327671|NCT00336596|ultrasound enhanced thrombolysis|ultrasound enhanced thrombolysis
5327672|NCT00336596|Patients receiving iv thrombolytic therapy (t-PA)|patients receiving iv thrombolytic therapy (t-pa)
5327673|NCT00336583|oxaliplatin|oxaliplatin
5327674|NCT00336583|ESHAOX|eshaox
5327675|NCT00336583|refractory|refractory
5327676|NCT00336583|relapsed|relapsed
5327677|NCT00336583|non-hodgkin's lymphoma|non-hodgkin's lymphoma
5327678|NCT00336570|Oxidative Stress|oxidative stress
5327679|NCT00336570|Endothelial Function|endothelial function
5327680|NCT00336570|Flow Mediated Dilation|flow mediated dilation
5327681|NCT00336557|High-Dose Interferon|high-dose interferon
5327682|NCT00336557|Neutralizing Antibodies|neutralizing antibodies
5327683|NCT00336544|Pneumonia|pneumonia
5327684|NCT00336544|Respiratory|respiratory
5327685|NCT00336544|Infection|infection
5327686|NCT00336544|Infectious|infectious
5327687|NCT00336544|Advanced|advanced
5327688|NCT00336544|Life|life
5327689|NCT00336544|Sciences|sciences
5327690|NCT00336544|Lung|lung
5327691|NCT00336544|Pulmonary|pulmonary
5327693|NCT00336544|Clarithromycin|clarithromycin
5327694|NCT00336544|Biaxin|biaxin
5327695|NCT00336531|prophylactic itraconazole|prophylactic itraconazole
5327696|NCT00336531|Relapsed pediatric solid tumors|relapsed pediatric solid tumors
5327697|NCT00336531|Embryonal brain tumor|embryonal brain tumor
5327698|NCT00336505|Pneumonia|pneumonia
5327699|NCT00336505|Respiratory|respiratory
5327700|NCT00336505|Infection|infection
5327701|NCT00336505|Infectious|infectious
5327702|NCT00336505|Advanced|advanced
5327703|NCT00336505|Life|life
5327704|NCT00336505|Sciences|sciences
5327705|NCT00336505|Lung|lung
5327706|NCT00336505|Pulmonary|pulmonary
5327707|NCT00336505|Cethromycin|cethromycin
5327708|NCT00336505|Restanza|restanza
5327709|NCT00336505|Clarithromycin|clarithromycin
5327710|NCT00336505|Biaxin|biaxin
5327711|NCT00336492|Ulcerative colitis|ulcerative colitis
5327712|NCT00336492|inflammatory bowel disease|inflammatory bowel disease
5327713|NCT00336492|children|children
5327714|NCT00336466|Cardiac bypass surgery|cardiac bypass surgery
5327715|NCT00336453|Influenza|influenza
5327716|NCT00336427|MRSA|mrsa
5327717|NCT00336427|Colonization|colonization
5327718|NCT00336427|Pregnancy|pregnancy
5327719|NCT00336427|Neonates|neonates
5327720|NCT00336414|Juvenile Systemic Lupus Erythematosus nephritis|juvenile systemic lupus erythematosus nephritis
5327721|NCT00336414|randomised actively controlled clinical trial|randomised actively controlled clinical trial
5327722|NCT00336414|cyclophosphamide|cyclophosphamide
5327723|NCT00336414|prednisone|prednisone
5327724|NCT00336414|azathioprine|azathioprine
5327725|NCT00336414|methylprednisolone|methylprednisolone
5327726|NCT00336401|anesthesia|anesthesia
5327727|NCT00336401|non cardiac surgery|non cardiac surgery
5327728|NCT00336401|cardiac outcomes|cardiac outcomes
5327729|NCT00336388|Malaria|malaria
5327730|NCT00336362|Beta Thalassemia Major|beta thalassemia major
5327731|NCT00336362|Hematopoietic Stem Cell Mobilization|hematopoietic stem cell mobilization
5327732|NCT00336362|Gene Transfer Techniques|gene transfer techniques
5327733|NCT00336349|diabetes mellitus|diabetes mellitus
5327734|NCT00336349|neuropathic pain|neuropathic pain
5327735|NCT00336323|diabetic|diabetic
5327736|NCT00336323|macular|macular
5327737|NCT00336323|edema|edema
5327738|NCT00336323|avastin|avastin
5327739|NCT00336323|bevacizumab|bevacizumab
5327740|NCT00336323|anti-VEGF|anti-vegf
5327741|NCT00336323|retinal thickness|retinal thickness
5327742|NCT00336323|visual acuity|visual acuity
5327743|NCT00336323|DME|dme
5327744|NCT00336310|Diabetes Mellitus|diabetes mellitus
5327745|NCT00336310|Treatment|treatment
5327746|NCT00336310|Repaglinide|repaglinide
5327747|NCT00336297|screening|screening
5327748|NCT00336297|screening methods|screening methods
5327749|NCT00336297|intimate partner violence|intimate partner violence
5327750|NCT00336284|Telemonitoring|telemonitoring
5327751|NCT00336284|ICD|icd
5327752|NCT00336284|Reduction of office follow-ups|reduction of office follow-ups
5327753|NCT00336271|coffee|coffee
5327754|NCT00336271|caffeine|caffeine
5327755|NCT00336271|healthy subjects|healthy subjects
5327756|NCT00336258|Deep Vein Thrombosis|deep vein thrombosis
5327757|NCT00336258|Cancer|cancer
5327758|NCT00336258|US- Doppler|us- doppler
5327759|NCT00336258|Procoagulant Microparticles|procoagulant microparticles
5327760|NCT00336258|Asymptomatic|asymptomatic
5327761|NCT00336245|Contraception|contraception
5327762|NCT00336245|Women|women
5327763|NCT00336245|HIV/AIDS|hiv/aids
5327764|NCT00336245|IUD|iud
5327765|NCT00336245|IUCD|iucd
5327766|NCT00336232|Vitamin K metabolism|vitamin k metabolism
5327767|NCT00336232|Bone health|bone health
5327768|NCT00336232|Metabolism|metabolism
5327769|NCT00336219|GERD|gerd
5327770|NCT00336219|Pantoprazole|pantoprazole
5327771|NCT00336206|Low dose Alemtuzumab|low dose alemtuzumab
5327772|NCT00336206|Chronic lymphocytic leukemia|chronic lymphocytic leukemia
5327773|NCT00336206|B-Cell|b-cell
5327774|NCT00336193|home visitation|home visitation
5327775|NCT00336193|family outcomes|family outcomes
5327776|NCT00336193|competency training|competency training
5327777|NCT00336180|Adolescent|adolescent
5327778|NCT00336180|Adolescent behavior|adolescent behavior
5327779|NCT00336180|Adolescent development|adolescent development
5327780|NCT00336180|Drinking behavior|drinking behavior
5327781|NCT00336180|Health behavior|health behavior
5327782|NCT00336180|Reproductive Behavior|reproductive behavior
5327783|NCT00336180|Sexual Behavior|sexual behavior
5327784|NCT00336180|South Africa|south africa
5327785|NCT00336167|carnitine palmitoyl transferase 2 deficiency|carnitine palmitoyl transferase 2 deficiency
5327786|NCT00336167|Fatty acid oxidation|fatty acid oxidation
5327787|NCT00336167|Mitochondria|mitochondria
5327788|NCT00336128|infant|infant
5327789|NCT00336128|kindergarten|kindergarten
5327790|NCT00336128|obesity|obesity
5327791|NCT00336128|adiposity|adiposity
5327792|NCT00336115|pertussis|pertussis
5327793|NCT00336115|bone marrow transplant|bone marrow transplant
5327794|NCT00336102|fatigue|fatigue
5327795|NCT00336102|hypothyroidism|hypothyroidism
5327796|NCT00336102|stage I breast cancer|stage i breast cancer
5327797|NCT00336102|stage II breast cancer|stage ii breast cancer
5327798|NCT00336102|stage IIIA breast cancer|stage iiia breast cancer
5327799|NCT00336102|stage IIIB breast cancer|stage iiib breast cancer
5327800|NCT00336089|fatigue|fatigue
5327801|NCT00336089|pain|pain
5327802|NCT00336089|cancer survivor|cancer survivor
5327803|NCT00336089|breast cancer in situ|breast cancer in situ
5327804|NCT00336089|inflammatory breast cancer|inflammatory breast cancer
5327805|NCT00336089|stage IA breast cancer|stage ia breast cancer
5327806|NCT00336089|stage IB breast cancer|stage ib breast cancer
5327807|NCT00336089|stage II breast cancer|stage ii breast cancer
5327808|NCT00336089|stage IIIA breast cancer|stage iiia breast cancer
5327809|NCT00336089|stage IIIB breast cancer|stage iiib breast cancer
5327810|NCT00336089|stage IIIC breast cancer|stage iiic breast cancer
5327811|NCT00336089|stage IV breast cancer|stage iv breast cancer
5327812|NCT00336089|recurrent breast cancer|recurrent breast cancer
5327813|NCT00336076|Mast cell disease|mast cell disease
5327814|NCT00336076|Anaphylaxis|anaphylaxis
5327815|NCT00336076|c-kit|c-kit
5327816|NCT00336076|Mutation|mutation
5327817|NCT00336076|Mastocytosis (suspected or proven)|mastocytosis (suspected or proven)
5327818|NCT00336050|Air Pollution|air pollution
5327819|NCT00336050|Pulmonary Function|pulmonary function
5327820|NCT00336011|pacemaker|pacemaker
5327821|NCT00336011|magnetic resonance imaging|magnetic resonance imaging
5327822|NCT00336011|safety|safety
5327823|NCT00335985|polymyositis, dermatomyositis|polymyositis, dermatomyositis
5327824|NCT00335985|High-dose intravenous immunoglobulin|high-dose intravenous immunoglobulin
5327825|NCT00335985|Venoglobulin-IH|venoglobulin-ih
5327826|NCT00335985|Steroid-resistant polymyositis(PM) and dermatomyositis(DM)|steroid-resistant polymyositis(pm) and dermatomyositis(dm)
5327827|NCT00335972|Carotid Endarterectomy patients|carotid endarterectomy patients
5327828|NCT00335959|adenocarcinoma of the stomach|adenocarcinoma of the stomach
5327829|NCT00335959|stage I gastric cancer|stage i gastric cancer
5327830|NCT00335959|stage II gastric cancer|stage ii gastric cancer
5327831|NCT00335959|stage III gastric cancer|stage iii gastric cancer
5327832|NCT00335933|Postherpetic Neuralgia (PHN)|postherpetic neuralgia (phn)
5327833|NCT00335920|Sudden Hearing Loss|sudden hearing loss
5327834|NCT00335920|intratympanic|intratympanic
5327835|NCT00335920|steroids|steroids
5327836|NCT00335907|Clinical trial|clinical trial
5327837|NCT00335907|Controlled clinical trial|controlled clinical trial
5327838|NCT00335907|Shock, Septic|shock, septic
5327839|NCT00335894|Infertility|infertility
5327840|NCT00335894|IVF|ivf
5327841|NCT00335894|ART|art
5327842|NCT00335894|hMG|hmg
5327843|NCT00335881|Prophylaxis for hepatitis B disease|prophylaxis for hepatitis b disease
5327844|NCT00335868|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5327845|NCT00335868|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5327846|NCT00335868|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5327847|NCT00335868|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5327848|NCT00335855|Device, influenza|device, influenza
5327849|NCT00335829|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
5327850|NCT00335829|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
5327851|NCT00335829|advanced adult primary liver cancer|advanced adult primary liver cancer
5327852|NCT00335829|recurrent adult primary liver cancer|recurrent adult primary liver cancer
5327853|NCT00335816|stage II rectal cancer|stage ii rectal cancer
5327854|NCT00335816|stage III rectal cancer|stage iii rectal cancer
5327855|NCT00335816|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5327856|NCT00335751|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
5327857|NCT00335751|stage I adult soft tissue sarcoma|stage i adult soft tissue sarcoma
5327858|NCT00335751|localized osteosarcoma|localized osteosarcoma
5327859|NCT00335751|metastatic osteosarcoma|metastatic osteosarcoma
5327860|NCT00335751|recurrent osteosarcoma|recurrent osteosarcoma
5327861|NCT00335751|stage II adult soft tissue sarcoma|stage ii adult soft tissue sarcoma
5327862|NCT00335751|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
5327863|NCT00335751|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
5327864|NCT00335725|Ovarian stimulation|ovarian stimulation
5327865|NCT00335725|Infertility|infertility
5327866|NCT00335725|ICSI|icsi
5327867|NCT00335725|FSH|fsh
5327868|NCT00335712|ONO-5129|ono-5129
5327869|NCT00335712|type 2 diabetes mellitus|type 2 diabetes mellitus
5327870|NCT00335699|Hypercholesterolemia with nondiabetic metabolic syndrome|hypercholesterolemia with nondiabetic metabolic syndrome
5327871|NCT00335686|Mitochondrial toxicity|mitochondrial toxicity
5327872|NCT00335686|Lopinavir-rtv|lopinavir-rtv
5327873|NCT00335686|Nevirapine|nevirapine
5327874|NCT00335686|DNA mitochondrial/DNA nuclear|dna mitochondrial/dna nuclear
5327875|NCT00335660|Idiopathic Detrusor Overactivity|idiopathic detrusor overactivity
5327876|NCT00335660|NK-1 Receptor Antagonist|nk-1 receptor antagonist
5327877|NCT00335660|Neurokinin|neurokinin
5327878|NCT00335660|Urge Incontinence|urge incontinence
5327879|NCT00335647|stage III multiple myeloma|stage iii multiple myeloma
5327880|NCT00335647|refractory multiple myeloma|refractory multiple myeloma
5327881|NCT00335647|stage II multiple myeloma|stage ii multiple myeloma
5327882|NCT00335634|Prostate Cancer|prostate cancer
5327883|NCT00335634|Radical Prostatectomy|radical prostatectomy
5327884|NCT00335634|Sexual Dysfunction|sexual dysfunction
5327886|NCT00335634|Adaptation|adaptation
5327887|NCT00335634|Psychosocial Oncology|psychosocial oncology
5327888|NCT00335621|COPD|copd
5327889|NCT00335621|ipratropium|ipratropium
5327890|NCT00335621|tiotropium|tiotropium
5327891|NCT00335595|colorectal cancer|colorectal cancer
5327892|NCT00335595|Bevacizumab|bevacizumab
5327893|NCT00335595|capecitabine|capecitabine
5327894|NCT00335595|oxaliplatin|oxaliplatin
5327895|NCT00335582|alpha 2 agonists|alpha 2 agonists
5327896|NCT00335582|cardiac events|cardiac events
5327897|NCT00335582|non cardiac surgery|non cardiac surgery
5327898|NCT00335569|Infertility, sterility, hCG, IVF|infertility, sterility, hcg, ivf
5327899|NCT00335543|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
5327900|NCT00335543|stage I pancreatic cancer|stage i pancreatic cancer
5327901|NCT00335543|stage II pancreatic cancer|stage ii pancreatic cancer
5327902|NCT00335543|stage III pancreatic cancer|stage iii pancreatic cancer
5327903|NCT00335517|Lumbar surgery|lumbar surgery
5327904|NCT00335517|Surgery L3-S1|surgery l3-s1
5327905|NCT00335517|DepoDur|depodur
5327906|NCT00335517|Post-operative pain|post-operative pain
5327907|NCT00335517|Pain control|pain control
5327908|NCT00335517|Pain relief|pain relief
5327909|NCT00335491|small cell lung cancer|small cell lung cancer
5327910|NCT00335491|non-small cell lung cancer|non-small cell lung cancer
5327911|NCT00335491|colon cancer|colon cancer
5327912|NCT00335491|prostate cancer|prostate cancer
5327913|NCT00335491|breast cancer|breast cancer
5327914|NCT00335491|male breast cancer|male breast cancer
5327915|NCT00335491|fatigue|fatigue
5327916|NCT00335491|lymphoma|lymphoma
5327917|NCT00335491|ovarian epithelial cancer|ovarian epithelial cancer
5327918|NCT00335491|bladder cancer|bladder cancer
5327919|NCT00335491|esophageal cancer|esophageal cancer
5327920|NCT00335478|neutropenia|neutropenia
5327921|NCT00335478|infection|infection
5327922|NCT00335478|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5327923|NCT00335478|fever, sweats, and hot flashes|fever, sweats, and hot flashes
5327924|NCT00335452|platelet aggregation inhibitors|platelet aggregation inhibitors
5327925|NCT00335452|acute coronary disease|acute coronary disease
5327926|NCT00335452|percutaneous coronary|percutaneous coronary
5327927|NCT00335413|Renal autoregulation|renal autoregulation
5327928|NCT00335413|Glomerular filtration rate|glomerular filtration rate
5327929|NCT00335413|Type 1 diabetes|type 1 diabetes
5327930|NCT00335374|Parkinson's disease|parkinson's disease
5327931|NCT00335361|Male Contraceptive Devices|male contraceptive devices
5327932|NCT00335361|Intra Vas Device (IVD)|intra vas device (ivd)
5327933|NCT00335361|Male Sterilization|male sterilization
5327934|NCT00335361|Vasectomy|vasectomy
5327935|NCT00335361|Intra Vas Deferens Occlusion|intra vas deferens occlusion
5327936|NCT00335361|Vas Occlusion|vas occlusion
5327937|NCT00335348|Multiple Myeloma|multiple myeloma
5327938|NCT00335348|Relapse|relapse
5327939|NCT00335348|Bortezomib|bortezomib
5327940|NCT00335348|Dexamethasone|dexamethasone
5327941|NCT00335348|Maintenance|maintenance
5327942|NCT00335335|Coronary|coronary
5327943|NCT00335335|Angiography|angiography
5327944|NCT00335335|X-ray|x-ray
5327945|NCT00335335|CAD|cad
5327946|NCT00335322|Human Immunodeficiency Virus (HIV)|human immunodeficiency virus (hiv)
5327947|NCT00335309|chronic rhinosinusitis|chronic rhinosinusitis
5327948|NCT00335309|sinus irrigation|sinus irrigation
5327949|NCT00335296|PFO|pfo
5327950|NCT00335296|Migraine|migraine
5327951|NCT00335296|Stroke|stroke
5327952|NCT00335296|TIA (transient ischemic attack)|tia (transient ischemic attack)
5327953|NCT00335296|Decompression Illness|decompression illness
5327954|NCT00335270|HIV Type 1|hiv type 1
5327955|NCT00335257|Drospirenone|drospirenone
5327956|NCT00335257|Safety|safety
5327957|NCT00335257|INAS|inas
5327958|NCT00335231|Post-cataract surgery endophthalmitis|post-cataract surgery endophthalmitis
5327959|NCT00335218|Early postmenopausal state|early postmenopausal state
5327960|NCT00335218|Climacteric symptoms|climacteric symptoms
5327961|NCT00335218|Hormone replacement therapy|hormone replacement therapy
5327962|NCT00335205|ropinirole|ropinirole
5327963|NCT00335205|dopamine|dopamine
5327964|NCT00335205|D2|d2
5327965|NCT00335205|depression|depression
5327966|NCT00335205|bipolar|bipolar
5327967|NCT00335192|Intracellular concentrations|intracellular concentrations
5327968|NCT00335192|Plasma concentration|plasma concentration
5327969|NCT00335192|Abacavir|abacavir
5327970|NCT00335192|Tenofovir|tenofovir
5327971|NCT00335192|Lamivudine (3TC)|lamivudine (3tc)
5327972|NCT00335192|Pharmacokinetic interactions|pharmacokinetic interactions
5327973|NCT00335179|Actinic keratosis|actinic keratosis
5327974|NCT00335179|AK|ak
5327975|NCT00335179|imiquimod|imiquimod
5327976|NCT00335179|confocal microscopy|confocal microscopy
5327977|NCT00335179|gene microarray|gene microarray
5327978|NCT00335166|Parkinson Disease|parkinson disease
5327979|NCT00335153|severe motor fluctuations|severe motor fluctuations
5327980|NCT00335153|levodopa|levodopa
5327981|NCT00335153|levodopa/carbidopa intestinal gel|levodopa/carbidopa intestinal gel
5327982|NCT00335153|efficacy|efficacy
5327983|NCT00335153|dyskinesia|dyskinesia
5327984|NCT00335153|Parkinson's Disease|parkinson's disease
5327985|NCT00335153|carbidopa|carbidopa
5327986|NCT00335153|DUOPA|duopa
5327987|NCT00335140|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
5327988|NCT00335114|cyclosporine, dry eye syndrome, contact lens|cyclosporine, dry eye syndrome, contact lens
5327989|NCT00335101|Coronary Artery Disease (CAD), Renal Impairment, Serum creatinine (SCr), Iodixanol, Ioversol, Iopromide, Contrast Induced Nephropathy (CIN)|coronary artery disease (cad), renal impairment, serum creatinine (scr), iodixanol, ioversol, iopromide, contrast induced nephropathy (cin)
5327990|NCT00335088|Prophylaxis,|prophylaxis,
5327991|NCT00335088|Intraocular surgery|intraocular surgery
5327992|NCT00335088|Lacrimal sac|lacrimal sac
5327993|NCT00335088|Eye lid|eye lid
5327994|NCT00335088|No conditions|no conditions
5327995|NCT00335062|Autoimmune thyroid disease|autoimmune thyroid disease
5327996|NCT00335062|Children and Adolescents|children and adolescents
5327997|NCT00335062|TSH Receptor Antibodies|tsh receptor antibodies
5327998|NCT00335049|myopia progression|myopia progression
5327999|NCT00335049|bifocal|bifocal
5328000|NCT00335036|Implantable Cardioverter Defibrillator|implantable cardioverter defibrillator
5328001|NCT00335036|Ventricular Arrhythmia|ventricular arrhythmia
5328002|NCT00335036|Sudden Cardiac Death|sudden cardiac death
5328003|NCT00335036|Congenital Heart Disease|congenital heart disease
5328004|NCT00335036|Pediatric Electrophysiology|pediatric electrophysiology
5328005|NCT00335023|postpartum hemorrhage|postpartum hemorrhage
5328006|NCT00335023|red blood cell transfusion|red blood cell transfusion
5328007|NCT00335023|health related quality of life|health related quality of life
5328008|NCT00335010|Nitroglycerine|nitroglycerine
5328009|NCT00335010|gastroesophageal anastomosis|gastroesophageal anastomosis
5328010|NCT00335010|microvascular bloodflow|microvascular bloodflow
5328011|NCT00335010|microvascular hemoglobinsaturation|microvascular hemoglobinsaturation
5328012|NCT00334997|stage I squamous cell carcinoma of the larynx|stage i squamous cell carcinoma of the larynx
5328013|NCT00334997|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
5328014|NCT00334997|stage 0 laryngeal cancer|stage 0 laryngeal cancer
5328015|NCT00334984|childhood fibrosarcoma|childhood fibrosarcoma
5328016|NCT00334984|childhood neurofibrosarcoma|childhood neurofibrosarcoma
5328017|NCT00334984|childhood synovial sarcoma|childhood synovial sarcoma
5328018|NCT00334984|chondrosarcoma|chondrosarcoma
5328019|NCT00334984|localized osteosarcoma|localized osteosarcoma
5328020|NCT00334984|metastatic osteosarcoma|metastatic osteosarcoma
5328021|NCT00334984|metastatic childhood soft tissue sarcoma|metastatic childhood soft tissue sarcoma
5328022|NCT00334984|nonmetastatic childhood soft tissue sarcoma|nonmetastatic childhood soft tissue sarcoma
5328023|NCT00334984|metastatic Ewing sarcoma/peripheral primitive neuroectodermal tumor|metastatic ewing sarcoma/peripheral primitive neuroectodermal tumor
5328024|NCT00334984|localized Ewing sarcoma/peripheral primitive neuroectodermal tumor|localized ewing sarcoma/peripheral primitive neuroectodermal tumor
5328025|NCT00334984|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
5328026|NCT00334984|previously untreated childhood rhabdomyosarcoma|previously untreated childhood rhabdomyosarcoma
5328027|NCT00334984|childhood alveolar soft-part sarcoma|childhood alveolar soft-part sarcoma
5328028|NCT00334984|childhood angiosarcoma|childhood angiosarcoma
5328029|NCT00334984|childhood epithelioid sarcoma|childhood epithelioid sarcoma
5328030|NCT00334984|childhood leiomyosarcoma|childhood leiomyosarcoma
5328031|NCT00334984|childhood liposarcoma|childhood liposarcoma
5328032|NCT00334984|localized childhood malignant fibrous histiocytoma of bone|localized childhood malignant fibrous histiocytoma of bone
5328033|NCT00334984|metastatic childhood malignant fibrous histiocytoma of bone|metastatic childhood malignant fibrous histiocytoma of bone
5328034|NCT00334984|childhood malignant mesenchymoma|childhood malignant mesenchymoma
5328035|NCT00334984|dermatofibrosarcoma protuberans|dermatofibrosarcoma protuberans
5328036|NCT00334984|childhood desmoplastic small round cell tumor|childhood desmoplastic small round cell tumor
5328037|NCT00334971|African-American|african-american
5328038|NCT00334971|estradiol|estradiol
5328039|NCT00334971|luteinizing hormone|luteinizing hormone
5328040|NCT00334971|follicle stimulating hormone|follicle stimulating hormone
5328041|NCT00334971|androstenedione|androstenedione
5328042|NCT00334971|aromatase|aromatase
5328043|NCT00334971|inhibins|inhibins
5328044|NCT00334971|ovarian|ovarian
5328045|NCT00334971|Healthy volunteers|healthy volunteers
5328046|NCT00334971|Fragile X|fragile x
5328047|NCT00334945|Fibroblast Growth Factors|fibroblast growth factors
5328048|NCT00334945|Bone development|bone development
5328049|NCT00334932|refractory multiple myeloma|refractory multiple myeloma
5328050|NCT00334932|stage I multiple myeloma|stage i multiple myeloma
5328051|NCT00334932|stage II multiple myeloma|stage ii multiple myeloma
5328052|NCT00334932|stage III multiple myeloma|stage iii multiple myeloma
5328053|NCT00334919|Diabetes|diabetes
5328054|NCT00334919|Pre-Diabetes|pre-diabetes
5328055|NCT00334919|Anti-Inflammatory Diet|anti-inflammatory diet
5328056|NCT00334919|Diet Study|diet study
5328057|NCT00334919|Inflammation|inflammation
5328058|NCT00334919|Diabetic Diet|diabetic diet
5328059|NCT00334906|memantine|memantine
5328060|NCT00334906|Alzheimer's disease|alzheimer's disease
5328061|NCT00334906|MRI|mri
5328062|NCT00334906|moderate Alzheimer's disease|moderate alzheimer's disease
5328063|NCT00334880|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
5328064|NCT00334880|Attention Deficit Disorders with Hyperactivity|attention deficit disorders with hyperactivity
5328065|NCT00334880|Attention Deficit Hyperactivity Disorders|attention deficit hyperactivity disorders
5328066|NCT00334867|localized Ewing sarcoma/peripheral primitive neuroectodermal tumor|localized ewing sarcoma/peripheral primitive neuroectodermal tumor
5328067|NCT00334854|childhood synovial sarcoma|childhood synovial sarcoma
5328068|NCT00334854|nonmetastatic childhood soft tissue sarcoma|nonmetastatic childhood soft tissue sarcoma
5328069|NCT00334854|childhood alveolar soft-part sarcoma|childhood alveolar soft-part sarcoma
5328070|NCT00334854|childhood angiosarcoma|childhood angiosarcoma
5328071|NCT00334854|childhood epithelioid sarcoma|childhood epithelioid sarcoma
5328072|NCT00334854|childhood fibrosarcoma|childhood fibrosarcoma
5328073|NCT00334854|childhood leiomyosarcoma|childhood leiomyosarcoma
5328074|NCT00334854|childhood liposarcoma|childhood liposarcoma
5328075|NCT00334854|childhood neurofibrosarcoma|childhood neurofibrosarcoma
5328076|NCT00334854|localized childhood malignant fibrous histiocytoma of bone|localized childhood malignant fibrous histiocytoma of bone
5328077|NCT00334854|childhood malignant hemangiopericytoma|childhood malignant hemangiopericytoma
5328078|NCT00334854|dermatofibrosarcoma protuberans|dermatofibrosarcoma protuberans
5328079|NCT00334854|chondrosarcoma|chondrosarcoma
5328080|NCT00334828|Severe sepsis|severe sepsis
5328081|NCT00334828|septic shock|septic shock
5328082|NCT00334828|sepsis|sepsis
5328083|NCT00334776|recurrent melanoma|recurrent melanoma
5328084|NCT00334776|stage IV melanoma|stage iv melanoma
5328085|NCT00334776|ciliary body and choroid melanoma, medium/large size|ciliary body and choroid melanoma, medium/large size
5328086|NCT00334776|iris melanoma|iris melanoma
5328087|NCT00334776|recurrent intraocular melanoma|recurrent intraocular melanoma
5328088|NCT00334776|extraocular extension melanoma|extraocular extension melanoma
5328089|NCT00334763|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5328090|NCT00334763|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5328091|NCT00334763|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5328092|NCT00334763|squamous cell lung cancer|squamous cell lung cancer
5328093|NCT00334750|Glaucoma, Open-Angle Ocular Hypertension Risk factors Canadian|glaucoma, open-angle ocular hypertension risk factors canadian
5328094|NCT00334737|erythropoietin|erythropoietin
5328095|NCT00334737|darbepoetin|darbepoetin
5328096|NCT00334737|transfusions|transfusions
5328097|NCT00334737|neonates|neonates
5328098|NCT00334737|outcomes|outcomes
5328099|NCT00334737|neurodevelopment|neurodevelopment
5328100|NCT00334724|Cardiovascular disease|cardiovascular disease
5328101|NCT00334724|Vascular disease|vascular disease
5328102|NCT00334724|Hypertension|hypertension
5328103|NCT00334724|Home blood pressure measurement|home blood pressure measurement
5328104|NCT00334711|Permanent Neonatal Diabetes|permanent neonatal diabetes
5328105|NCT00334711|Kir6.2|kir6.2
5328106|NCT00334711|KCNJ11|kcnj11
5328107|NCT00334711|Infancy onset diabetes|infancy onset diabetes
5328108|NCT00334711|Sulfonylurea|sulfonylurea
5328109|NCT00334672|hemophagocytic lymphohistiocytosis|hemophagocytic lymphohistiocytosis
5328110|NCT00334659|HIV-1 Infection|hiv-1 infection
5328111|NCT00334646|cyclophosphamide|cyclophosphamide
5328112|NCT00334646|CINV|cinv
5328113|NCT00334646|Chemotherapy induced nausea and vomiting|chemotherapy induced nausea and vomiting
5328114|NCT00334633|bacterial vaginosis|bacterial vaginosis
5328115|NCT00334633|tinidazole|tinidazole
5328116|NCT00334620|randomised double-blinded trial|randomised double-blinded trial
5328117|NCT00334620|rehabilitation|rehabilitation
5328118|NCT00334620|radon spa therapy|radon spa therapy
5328119|NCT00334620|long-term effectiveness|long-term effectiveness
5328120|NCT00334607|HRV vaccine|hrv vaccine
5328121|NCT00334607|diarrhoea|diarrhoea
5328122|NCT00334607|rotavirus|rotavirus
5328123|NCT00334594|epithelial mesothelioma|epithelial mesothelioma
5328124|NCT00334594|sarcomatous mesothelioma|sarcomatous mesothelioma
5328125|NCT00334594|stage IA malignant mesothelioma|stage ia malignant mesothelioma
5328126|NCT00334594|stage IB malignant mesothelioma|stage ib malignant mesothelioma
5328127|NCT00334594|stage II malignant mesothelioma|stage ii malignant mesothelioma
5328128|NCT00334594|stage III malignant mesothelioma|stage iii malignant mesothelioma
5328129|NCT00334568|AVANDIA|avandia
5328130|NCT00334568|Alzheimers Disease|alzheimers disease
5328131|NCT00334555|trichomoniasis|trichomoniasis
5328132|NCT00334555|partner notification|partner notification
5328133|NCT00334542|breast cancer|breast cancer
5328134|NCT00334542|ductal breast carcinoma in situ|ductal breast carcinoma in situ
5328135|NCT00334542|breast cancer in situ|breast cancer in situ
5328136|NCT00334542|stage I breast cancer|stage i breast cancer
5328137|NCT00334542|stage II breast cancer|stage ii breast cancer
5328138|NCT00334542|stage IIIA breast cancer|stage iiia breast cancer
5328139|NCT00334542|stage IIIB breast cancer|stage iiib breast cancer
5328140|NCT00334542|stage IIIC breast cancer|stage iiic breast cancer
5328141|NCT00334529|Tamiflu|tamiflu
5328143|NCT00334529|Antiviral|antiviral
5328144|NCT00334529|Neuraminidase Inhibitor|neuraminidase inhibitor
5328145|NCT00334529|Pharmacokinetic Trial|pharmacokinetic trial
5328146|NCT00334529|Healthy Volunteer|healthy volunteer
5328147|NCT00334529|HV|hv
5328148|NCT00334516|Motor Neuron Disease|motor neuron disease
5328149|NCT00334516|Cognitive Testing|cognitive testing
5328150|NCT00334516|Movement-Related Potential|movement-related potential
5328151|NCT00334516|MRI|mri
5328152|NCT00334516|Neuropsychologic Testing|neuropsychologic testing
5328153|NCT00334516|Primary Lateral Sclerosis|primary lateral sclerosis
5328154|NCT00334516|PLS|pls
5328155|NCT00334516|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
5328156|NCT00334516|ALS|als
5328157|NCT00334516|Healthy Volunteer|healthy volunteer
5328158|NCT00334516|HV|hv
5328159|NCT00334503|alpa-glucosidase inhibitor,Biguanide|alpa-glucosidase inhibitor,biguanide
5328160|NCT00334490|Pulmonary Hypertension|pulmonary hypertension
5328161|NCT00334490|Sildenafil|sildenafil
5328162|NCT00334490|Viagra|viagra
5328163|NCT00334490|Cardiac Surgery|cardiac surgery
5328164|NCT00334490|Cardiopulmonary Bypass|cardiopulmonary bypass
5328165|NCT00334477|erectile dysfunction|erectile dysfunction
5328166|NCT00334477|chronic renal dysfunction|chronic renal dysfunction
5328167|NCT00334477|tadalafil|tadalafil
5328168|NCT00334464|warfarin metabolism|warfarin metabolism
5328169|NCT00334464|CYP2C0|cyp2c0
5328170|NCT00334464|anticoagulation|anticoagulation
5328171|NCT00334464|genotyping|genotyping
5328172|NCT00334464|DVT|dvt
5328173|NCT00334464|PE|pe
5328174|NCT00334451|Heart Failure|heart failure
5328175|NCT00334451|Remote Monitoring|remote monitoring
5328176|NCT00334451|Implantable Device|implantable device
5328177|NCT00334438|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5328178|NCT00334438|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5328179|NCT00334438|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5328180|NCT00334438|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5328181|NCT00334438|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5328182|NCT00334399|alpa-glucosidase inhibitor,Biguanide|alpa-glucosidase inhibitor,biguanide
5328183|NCT00334386|Hypertension|hypertension
5328184|NCT00334386|Anti-hypertensive effect|anti-hypertensive effect
5328185|NCT00334386|Diuretic|diuretic
5328186|NCT00334373|Myocardial infarction|myocardial infarction
5328187|NCT00334373|Magnetic Resonance Imaging|magnetic resonance imaging
5328188|NCT00334373|Coronary Angioplasty|coronary angioplasty
5328189|NCT00334334|Streptococcus pneumonia, vaccine|streptococcus pneumonia, vaccine
5328190|NCT00334321|IMRT|imrt
5328191|NCT00334321|Tomotherapy|tomotherapy
5328192|NCT00334321|Post-Hysterectomy|post-hysterectomy
5328193|NCT00334321|Endometrial Cancer|endometrial cancer
5328194|NCT00334295|Recurrent or metastatic endometrial carcinoma|recurrent or metastatic endometrial carcinoma
5328195|NCT00334282|Metastatic|metastatic
5328196|NCT00334282|Anti-angiogenesis|anti-angiogenesis
5328197|NCT00334282|GW786034|gw786034
5328198|NCT00334282|Pazopanib|pazopanib
5328199|NCT00334269|obesity|obesity
5328200|NCT00334269|physical activity|physical activity
5328201|NCT00334269|daily energy intake|daily energy intake
5328202|NCT00334269|nutrition|nutrition
5328203|NCT00334269|healthy lifestyle|healthy lifestyle
5328204|NCT00334269|Aboriginal|aboriginal
5328205|NCT00334269|body fat|body fat
5328206|NCT00334269|exercise|exercise
5328207|NCT00334269|education|education
5328208|NCT00334269|family|family
5328209|NCT00334269|body mass index|body mass index
5328210|NCT00334269|knowledge|knowledge
5328211|NCT00334269|randomized controlled trial|randomized controlled trial
5328212|NCT00334269|community|community
5328213|NCT00334269|intervention|intervention
5328214|NCT00334269|Six Nations Indian Reserve|six nations indian reserve
5328215|NCT00334269|household|household
5328216|NCT00334269|health counselling|health counselling
5328217|NCT00334256|PMTCT|pmtct
5328218|NCT00334256|Resistance|resistance
5328219|NCT00334256|HIV infection|hiv infection
5328220|NCT00334256|Pregnancy|pregnancy
5328221|NCT00334243|in vitro fertilization|in vitro fertilization
5328222|NCT00334243|infertile|infertile
5328223|NCT00334243|infertility|infertility
5328224|NCT00334243|pregnancy|pregnancy
5328225|NCT00334243|pregnancy rates|pregnancy rates
5328226|NCT00334243|microflare protocol|microflare protocol
5328227|NCT00334243|antagonist protocol|antagonist protocol
5328228|NCT00334243|demi-halt protocol|demi-halt protocol
5328229|NCT00334243|poor responders|poor responders
5328230|NCT00334243|low antral follicle count|low antral follicle count
5328231|NCT00334243|Infertile Patients undergoing in vitro fertilization (IVF)|infertile patients undergoing in vitro fertilization (ivf)
5328232|NCT00334243|Patients with a previous poor response to ovarian stimulation|patients with a previous poor response to ovarian stimulation
5328233|NCT00334243|Patients with an antral follicle count of less than 10|patients with an antral follicle count of less than 10
5328234|NCT00334230|Functional Magnetic Resonance Imaging (fMRI)|functional magnetic resonance imaging (fmri)
5328235|NCT00334230|Transcranial Magnetic Stimulation (TMS)|transcranial magnetic stimulation (tms)
5328236|NCT00334230|Locomotion|locomotion
5328237|NCT00334230|Cortical Reorganization|cortical reorganization
5328238|NCT00334230|Rehabilitation|rehabilitation
5328240|NCT00334230|Stroke|stroke
5328241|NCT00334230|Healthy Volunteer|healthy volunteer
5328242|NCT00334230|HV|hv
5328243|NCT00334217|Psychology: cognitive aspects|psychology: cognitive aspects
5328244|NCT00334217|Substance-Related Disorders|substance-related disorders
5328245|NCT00334217|treatment efficacy|treatment efficacy
5328246|NCT00334204|Platelet Function Analyser-100 (PFA-100)|platelet function analyser-100 (pfa-100)
5328247|NCT00334204|renal failure|renal failure
5328248|NCT00334204|kidney biopsy|kidney biopsy
5328249|NCT00334204|bleeding|bleeding
5328250|NCT00334204|hematoma|hematoma
5328251|NCT00334191|Cardiac surgery,|cardiac surgery,
5328252|NCT00334191|Cardiopulmonary bypass,|cardiopulmonary bypass,
5328253|NCT00334191|Oxidative stress,|oxidative stress,
5328254|NCT00334191|Acute renal dysfunction,|acute renal dysfunction,
5328255|NCT00334191|Sodium Bicarbonate|sodium bicarbonate
5328256|NCT00334178|Migraine|migraine
5328257|NCT00334178|Migraine prophylaxis|migraine prophylaxis
5328258|NCT00334152|NK-1|nk-1
5328259|NCT00334152|antiemetics|antiemetics
5328260|NCT00334152|casopitant mesylate|casopitant mesylate
5328261|NCT00334152|postoperative nausea and vomiting|postoperative nausea and vomiting
5328262|NCT00334152|ondansetron hydrochloride|ondansetron hydrochloride
5328263|NCT00334152|5HT3|5ht3
5328264|NCT00334152|ZOFRAN|zofran
5328265|NCT00334152|PONV|ponv
5328266|NCT00334139|serum bone markers|serum bone markers
5328267|NCT00334139|bone metastasis|bone metastasis
5328268|NCT00334139|prostate cancer|prostate cancer
5328269|NCT00334139|breast cancer|breast cancer
5328270|NCT00334139|quality of life|quality of life
5328271|NCT00334139|bisphosphonates|bisphosphonates
5328272|NCT00334126|Schizophrenia|schizophrenia
5328273|NCT00334126|Antipsychotic|antipsychotic
5328274|NCT00334126|paliperidone|paliperidone
5328275|NCT00334126|quetiapine|quetiapine
5328276|NCT00334126|Seroquel|seroquel
5328277|NCT00334126|placebo|placebo
5328278|NCT00334113|Diabetes Mellitus|diabetes mellitus
5328279|NCT00334113|Exercise|exercise
5328280|NCT00334113|Obesity|obesity
5328281|NCT00334113|Telemedicine|telemedicine
5328282|NCT00334100|Exercise|exercise
5328283|NCT00334100|multiple sclerosis|multiple sclerosis
5328284|NCT00334100|treadmill|treadmill
5328285|NCT00334087|primary dental prevention|primary dental prevention
5328286|NCT00334087|early childhood caries|early childhood caries
5328287|NCT00334087|prenatal oral care|prenatal oral care
5328288|NCT00334074|AML|aml
5328289|NCT00334074|MDS|mds
5328290|NCT00334074|CML|cml
5328291|NCT00334074|Relapsed|relapsed
5328292|NCT00334074|Refractory|refractory
5328293|NCT00334074|Chemo treatment|chemo treatment
5328294|NCT00334074|Clofarabine|clofarabine
5328295|NCT00334074|Cytarabine|cytarabine
5328296|NCT00334074|standard or poor cytogenetic risk AML|standard or poor cytogenetic risk aml
5328297|NCT00334074|untreated high-risk (>10% blasts) MDS|untreated high-risk (>10% blasts) mds
5328298|NCT00334074|CML in accelerated phase or blast crisis|cml in accelerated phase or blast crisis
5328299|NCT00334074|Elderly AML patients with risk of anthracycline toxicity|elderly aml patients with risk of anthracycline toxicity
5328300|NCT00334061|Penumbra|penumbra
5328301|NCT00334061|Ischemic|ischemic
5328302|NCT00334061|Stroke|stroke
5328303|NCT00334061|Intervention|intervention
5328304|NCT00334061|Neurovascular|neurovascular
5328305|NCT00334061|Thrombus|thrombus
5328306|NCT00334061|Embolectomy|embolectomy
5328307|NCT00334061|Ischemic stroke|ischemic stroke
5328308|NCT00334048|Medication-induced sexual dysfunction|medication-induced sexual dysfunction
5328309|NCT00334048|SSRI-induced sexual dysfunction|ssri-induced sexual dysfunction
5328310|NCT00334048|Anorgasmia|anorgasmia
5328311|NCT00334048|Delayed ejaculation|delayed ejaculation
5328312|NCT00334048|Sexual dysfunction|sexual dysfunction
5328313|NCT00334048|Antidepressant-induced sexual dysfunction|antidepressant-induced sexual dysfunction
5328314|NCT00334048|Requip|requip
5328315|NCT00334048|Ropinirole|ropinirole
5328316|NCT00334048|Dopamine agonist|dopamine agonist
5328317|NCT00334048|Serotonin reuptake inhibitor|serotonin reuptake inhibitor
5328318|NCT00334048|Sexual dysfunction, physiological, medication-induced|sexual dysfunction, physiological, medication-induced
5328319|NCT00334022|Fuzeon|fuzeon
5328320|NCT00334022|Viral Decay|viral decay
5328321|NCT00334009|Cardiac Surgery|cardiac surgery
5328322|NCT00334009|Cardiopulmonary Bypass|cardiopulmonary bypass
5328323|NCT00334009|COMT-Polymorphism|comt-polymorphism
5328324|NCT00334009|Vasoplegia|vasoplegia
5328325|NCT00334009|Catecholamines|catecholamines
5328326|NCT00334009|Acute Renal Failure|acute renal failure
5328327|NCT00333970|cognition|cognition
5328328|NCT00333970|neuropsychology|neuropsychology
5328329|NCT00333970|Rehabilitation|rehabilitation
5328330|NCT00333970|treatment efficacy|treatment efficacy
5328331|NCT00333970|cognitive remediation|cognitive remediation
5328332|NCT00333957|capsule endoscopy|capsule endoscopy
5328333|NCT00333944|Organophosphorus poisoning|organophosphorus poisoning
5328334|NCT00333944|Atropine|atropine
5328335|NCT00333944|Pralidoxime|pralidoxime
5328336|NCT00333944|Intermediate syndrome.|intermediate syndrome.
5328337|NCT00333931|Impulsive Aggression|impulsive aggression
5328338|NCT00333931|Posttraumatic Stress Disorder|posttraumatic stress disorder
5328339|NCT00333918|Cataract Extraction|cataract extraction
5328340|NCT00333918|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal
5328341|NCT00333905|Exercise|exercise
5328342|NCT00333905|Exercise Therapy|exercise therapy
5328343|NCT00333892|primary HIV infection|primary hiv infection
5328344|NCT00333892|chronic HIV infection|chronic hiv infection
5328345|NCT00333879|Rehabilitation|rehabilitation
5328346|NCT00333879|Sensory Aid|sensory aid
5328347|NCT00333840|CML|cml
5328348|NCT00333840|STI571|sti571
5328349|NCT00333840|imatinib|imatinib
5328350|NCT00333840|interferon|interferon
5328351|NCT00333840|interferon alpha|interferon alpha
5328352|NCT00333840|cytosine arabinoside|cytosine arabinoside
5328353|NCT00333840|chronic myeloid leukemia|chronic myeloid leukemia
5328354|NCT00333840|Philadelphia chromosome positive|philadelphia chromosome positive
5328355|NCT00333827|Dilated Cardiomyopathy|dilated cardiomyopathy
5328356|NCT00333827|stem cells|stem cells
5328357|NCT00333827|Therapeutics|therapeutics
5328358|NCT00333827|Randomized Controlled Trials|randomized controlled trials
5328359|NCT00333801|Posttraumatic Stress Disorder|posttraumatic stress disorder
5328360|NCT00333801|Veterans|veterans
5328361|NCT00333801|Vocational Rehabilitation|vocational rehabilitation
5328362|NCT00333801|Supported Employment|supported employment
5328363|NCT00333801|Individual Placement and Support|individual placement and support
5328364|NCT00333788|Crohn's Disease|crohn's disease
5328365|NCT00333788|Certolizumab pegol|certolizumab pegol
5328366|NCT00333788|CDP870|cdp870
5328367|NCT00333788|Cimzia|cimzia
5328368|NCT00333762|aging|aging
5328369|NCT00333762|blindness|blindness
5328370|NCT00333762|wheelchairs|wheelchairs
5328371|NCT00333762|spinal cord injury|spinal cord injury
5328372|NCT00333749|children|children
5328373|NCT00333736|Injection site reactions|injection site reactions
5328374|NCT00333736|enfuvirtide administration|enfuvirtide administration
5328375|NCT00333723|Rosiglitazone|rosiglitazone
5328376|NCT00333723|Glyburide|glyburide
5328377|NCT00333723|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
5328378|NCT00333723|African American|african american
5328379|NCT00333723|Hispanic|hispanic
5328380|NCT00333710|Rehabilitation|rehabilitation
5328381|NCT00333710|Telecommunication|telecommunication
5328382|NCT00333697|Deep vein thrombosis|deep vein thrombosis
5328383|NCT00333697|Duplex ultrasound|duplex ultrasound
5328384|NCT00333697|Pulmonary embolism|pulmonary embolism
5328385|NCT00333671|Macular oedema|macular oedema
5328386|NCT00333671|Diabetes|diabetes
5328387|NCT00333671|Pathogenesis|pathogenesis
5328388|NCT00333671|Osmolality|osmolality
5328389|NCT00333671|Retinal thickness|retinal thickness
5328390|NCT00333658|psychotherapy, group|psychotherapy, group
5328391|NCT00333658|rehabilitation, vocational|rehabilitation, vocational
5328392|NCT00333658|treatment outcome|treatment outcome
5328393|NCT00333645|Liver transplantation|liver transplantation
5328394|NCT00333645|Invasive fungal infection|invasive fungal infection
5328395|NCT00333645|Invasive aspergillosis|invasive aspergillosis
5328396|NCT00333645|Prophylaxis|prophylaxis
5328397|NCT00333645|Caspofungin|caspofungin
5328398|NCT00333632|Sleep|sleep
5328399|NCT00333632|Dexmedetomidine|dexmedetomidine
5328400|NCT00333632|Postoperative care|postoperative care
5328401|NCT00333632|Sedation|sedation
5328402|NCT00333619|sleep disorders|sleep disorders
5328403|NCT00333619|rehabilitation|rehabilitation
5328404|NCT00333619|rehabilitation outcomes|rehabilitation outcomes
5328405|NCT00333593|Dialysis|dialysis
5328406|NCT00333593|Large pore dialyser|large pore dialyser
5328407|NCT00333593|Cytokines|cytokines
5328408|NCT00333593|Noradrenaline|noradrenaline
5328409|NCT00333580|Ethnography|ethnography
5328410|NCT00333580|Psychometrics|psychometrics
5328411|NCT00333580|Qualitative Research|qualitative research
5328412|NCT00333567|arthroscopic knee surgery|arthroscopic knee surgery
5328413|NCT00333567|cyclooxygenase-2 inhibitors|cyclooxygenase-2 inhibitors
5328414|NCT00333567|lumiracoxib|lumiracoxib
5328415|NCT00333567|COX189|cox189
5328416|NCT00333567|Ambulatory arthroscopic knee surgery|ambulatory arthroscopic knee surgery
5328417|NCT00333554|DHA|dha
5328418|NCT00333554|docosahexaenoic acid|docosahexaenoic acid
5328419|NCT00333554|omega-3 fatty acid|omega-3 fatty acid
5328420|NCT00333554|fish oil|fish oil
5328421|NCT00333554|pregnancy|pregnancy
5328422|NCT00333554|infancy|infancy
5328423|NCT00333554|prevention|prevention
5328424|NCT00333554|"at risk for developing type 1 diabetes"|"at risk for developing type 1 diabetes"
5328425|NCT00333554|juvenile diabetes|juvenile diabetes
5328426|NCT00333554|T1D|t1d
5328427|NCT00333554|diabetes mellitus|diabetes mellitus
5328428|NCT00333554|Type 1 diabetes TrialNet|type 1 diabetes trialnet
5328429|NCT00333554|TrialNet|trialnet
5328430|NCT00333554|dietary supplementation|dietary supplementation
5328431|NCT00333554|nutrition|nutrition
5328432|NCT00333541|Contraceptive behavior|contraceptive behavior
5328433|NCT00333541|Internet Use|internet use
5328434|NCT00333541|Adolescent pregnancy|adolescent pregnancy
5328435|NCT00333541|Unintended pregnancy|unintended pregnancy
5328436|NCT00333528|Chemical Warfare Agents|chemical warfare agents
5328437|NCT00333528|Chemical Nerve Agent Intoxication|chemical nerve agent intoxication
5328438|NCT00333528|Chemical Terrorism|chemical terrorism
5328439|NCT00333515|Chemical nerve agent intoxication|chemical nerve agent intoxication
5328440|NCT00333502|Cancer, Neoplasms, Solid Tumor, Ovarian Cancer, Lung Cancer,|cancer, neoplasms, solid tumor, ovarian cancer, lung cancer,
5328441|NCT00333502|Non Small Cell Lung Cancer, Pancreatic Cancer,|non small cell lung cancer, pancreatic cancer,
5328442|NCT00333502|Breast Cancer, Colon Cancer, Endometrial Cancer,|breast cancer, colon cancer, endometrial cancer,
5328443|NCT00333502|Kidney (Renal Cell) Cancer, Melanoma, Prostate Cancer,|kidney (renal cell) cancer, melanoma, prostate cancer,
5328444|NCT00333502|Skin Cancer, Thyroid Cancer,|skin cancer, thyroid cancer,
5328445|NCT00333502|Solid Malignancies|solid malignancies
5328446|NCT00333489|valsartan|valsartan
5328447|NCT00333489|amlodipine|amlodipine
5328448|NCT00333489|hypertension|hypertension
5328449|NCT00333437|Scleroderma, Systemic|scleroderma, systemic
5328450|NCT00333424|HIV|hiv
5328451|NCT00333424|Human Immunodeficiency Virus|human immunodeficiency virus
5328452|NCT00333424|Prophylactic vaccine|prophylactic vaccine
5328453|NCT00333398|CSL Influenza Vaccine, influenza, vaccine, immunogenicity|csl influenza vaccine, influenza, vaccine, immunogenicity
5328454|NCT00333385|Ceftazidime|ceftazidime
5328455|NCT00333385|Continuous infusion|continuous infusion
5328456|NCT00333385|Antibiotic course|antibiotic course
5328457|NCT00333333|Thrombocytopenia|thrombocytopenia
5328458|NCT00333333|Small for Gestational Age (SGA)|small for gestational age (sga)
5328459|NCT00333333|Preeclampsia|preeclampsia
5328460|NCT00333320|acute myocardial infarction|acute myocardial infarction
5328461|NCT00333320|postconditioning|postconditioning
5328462|NCT00333320|coronary reserve|coronary reserve
5328463|NCT00333320|ejection fraction|ejection fraction
5328464|NCT00333307|relaxin|relaxin
5328465|NCT00333307|preeclampsia|preeclampsia
5328466|NCT00333281|Healthy Volunteers|healthy volunteers
5328467|NCT00333242|Pain|pain
5328468|NCT00333242|opioid|opioid
5328469|NCT00333242|hyperalgesia|hyperalgesia
5328470|NCT00333242|methadone|methadone
5328471|NCT00333229|Breast Cancer|breast cancer
5328472|NCT00333229|premenopausal|premenopausal
5328473|NCT00333229|Bone Mineral density|bone mineral density
5328474|NCT00333229|Cancer therapy induced bone loss|cancer therapy induced bone loss
5328475|NCT00333229|zoledronic acid|zoledronic acid
5328476|NCT00333203|epimacular membrane|epimacular membrane
5328477|NCT00333190|stem cell transplant|stem cell transplant
5328478|NCT00333190|graft versus host disease|graft versus host disease
5328479|NCT00333190|GVHD|gvhd
5328480|NCT00333190|CD+8 T cell depletion|cd+8 t cell depletion
5328481|NCT00333177|Schizoaffective Disorder, Depressed Type|schizoaffective disorder, depressed type
5328482|NCT00333177|Schizophreniform Disorder|schizophreniform disorder
5328483|NCT00333177|First-Episode Schizophrenia|first-episode schizophrenia
5328484|NCT00333177|Supported Employment|supported employment
5328485|NCT00333177|Cognitive Remediation|cognitive remediation
5328486|NCT00333177|Health Behavior Training|health behavior training
5328487|NCT00333177|Antipsychotic Medication|antipsychotic medication
5328488|NCT00333164|intracranial arteriosclerosis|intracranial arteriosclerosis
5328489|NCT00333164|cilostazol|cilostazol
5328490|NCT00333164|Platelete aggrigation inhibitors dual antiplatelet therapy|platelete aggrigation inhibitors dual antiplatelet therapy
5328491|NCT00333164|Drug therapy, combination|drug therapy, combination
5328492|NCT00333164|Clinical trials|clinical trials
5328493|NCT00333138|FTY720|fty720
5328494|NCT00333138|MS|ms
5328495|NCT00333138|Multiple Sclerosis|multiple sclerosis
5328496|NCT00333138|RRMS|rrms
5328497|NCT00333112|Treatment Outcome|treatment outcome
5328498|NCT00333112|Urology|urology
5328499|NCT00333112|Solifenacin succinate|solifenacin succinate
5328500|NCT00333112|Urinary Incontinence|urinary incontinence
5328501|NCT00333099|Enteral nutrition|enteral nutrition
5328502|NCT00333099|immunonutrients|immunonutrients
5328503|NCT00333099|head and neck cancer|head and neck cancer
5328504|NCT00333099|esophageal cancer|esophageal cancer
5328505|NCT00333099|chemoradiotherapy|chemoradiotherapy
5328506|NCT00333099|H&N or esophageal cancer patients with a chemoradiotherapy treatment.|h&n or esophageal cancer patients with a chemoradiotherapy treatment.
5328507|NCT00333086|Endometrial Cancer|endometrial cancer
5328508|NCT00333086|Aromatase inhibitor|aromatase inhibitor
5328509|NCT00333086|Letrozole|letrozole
5328510|NCT00333073|urinary incontinence|urinary incontinence
5328511|NCT00333073|Bulkamid|bulkamid
5328512|NCT00333047|Metastatic breast cancer|metastatic breast cancer
5328513|NCT00333047|Aromatase inhibitor|aromatase inhibitor
5328514|NCT00333047|Letrozole|letrozole
5328515|NCT00333034|Psoriasis|psoriasis
5328516|NCT00333021|Fondaparinux Abdominal surgery Japanese VTE|fondaparinux abdominal surgery japanese vte
5328517|NCT00333008|Diffuse Large B Cell Lymphoma|diffuse large b cell lymphoma
5328518|NCT00333008|CDOP|cdop
5328519|NCT00333008|Dose Dense|dose dense
5328520|NCT00333008|Anne Arbor Stage I-IV|anne arbor stage i-iv
5328521|NCT00333008|Any IPI score|any ipi score
5328522|NCT00332995|HIV Seronegativity|hiv seronegativity
5328523|NCT00332982|best practices, performance improvement, intensive care, measurement|best practices, performance improvement, intensive care, measurement
5328524|NCT00332969|Open label|open label
5328525|NCT00332969|phase II|phase ii
5328526|NCT00332969|disease|disease
5328527|NCT00332969|clinical trial|clinical trial
5328528|NCT00332969|Octreotide|octreotide
5328529|NCT00332969|thymoma|thymoma
5328530|NCT00332969|cancer|cancer
5328531|NCT00332969|tumor|tumor
5328532|NCT00332943|colorectal polyps|colorectal polyps
5328533|NCT00332943|colorectal cancer|colorectal cancer
5328534|NCT00332943|Virtual colonoscopy|virtual colonoscopy
5328535|NCT00332943|Fecal tagging|fecal tagging
5328536|NCT00332943|MR colonography|mr colonography
5328537|NCT00332930|HIV|hiv
5328538|NCT00332930|Therapeutic vaccine|therapeutic vaccine
5328539|NCT00332917|Parkinson's disease|parkinson's disease
5328540|NCT00332904|betablocker|betablocker
5328541|NCT00332904|aldosterone antagonist|aldosterone antagonist
5328542|NCT00332904|peripheral haemodynamics|peripheral haemodynamics
5328543|NCT00332904|cardiac haemodynamics|cardiac haemodynamics
5328544|NCT00332904|oxygenation|oxygenation
5328545|NCT00332891|Anxiety|anxiety
5328546|NCT00332891|Anti-Anxiety Agents|anti-anxiety agents
5328547|NCT00332891|controlled Clinical Trials|controlled clinical trials
5328548|NCT00332878|Behavioral Intervention|behavioral intervention
5328549|NCT00332878|HIV|hiv
5328550|NCT00332878|HSV2|hsv2
5328551|NCT00332865|Head and neck cancer|head and neck cancer
5328552|NCT00332865|Radiotherapy|radiotherapy
5328553|NCT00332865|Dysphagia|dysphagia
5328554|NCT00332865|Exercise|exercise
5328555|NCT00332865|Deglutition|deglutition
5328556|NCT00332865|Randomized controlled trial|randomized controlled trial
5328557|NCT00332865|Quality of life|quality of life
5328558|NCT00332865|Tube feeding|tube feeding
5328559|NCT00332852|Postive breast cancer|postive breast cancer
5328560|NCT00332852|postmenopausal|postmenopausal
5328561|NCT00332852|disease free survival|disease free survival
5328562|NCT00332852|letrozole|letrozole
5328563|NCT00332852|early adjuvant treatment|early adjuvant treatment
5328564|NCT00332852|primary hormone receptor|primary hormone receptor
5328565|NCT00332839|enteric-coated mycophenolate sodium, everolimus, CNI-free regimen|enteric-coated mycophenolate sodium, everolimus, cni-free regimen
5328566|NCT00332826|Inhaled insulin|inhaled insulin
5328567|NCT00332826|Diabetes Type I and II with Asthma|diabetes type i and ii with asthma
5328568|NCT00332813|HIV Risk Behavior|hiv risk behavior
5328569|NCT00332813|Pregnancy|pregnancy
5328570|NCT00332813|Drug Abuse|drug abuse
5328571|NCT00332800|Stroke-Nutritional Supplementation-Functional Recovery|stroke-nutritional supplementation-functional recovery
5328572|NCT00332787|Major Depressive Disorder|major depressive disorder
5328573|NCT00332735|spinal|spinal
5328574|NCT00332735|anesthesia|anesthesia
5328575|NCT00332735|articaine|articaine
5328576|NCT00332735|bupivacaine|bupivacaine
5328577|NCT00332735|outpatient|outpatient
5328578|NCT00332735|surgery|surgery
5328579|NCT00332735|limbs|limbs
5328580|NCT00332709|Breast cancer|breast cancer
5328581|NCT00332709|postmenopausal|postmenopausal
5328582|NCT00332709|bone mineral density|bone mineral density
5328583|NCT00332709|Zoledronic acid|zoledronic acid
5328584|NCT00332709|Letrozole|letrozole
5328585|NCT00332709|extended adjuvant treatment.|extended adjuvant treatment.
5328586|NCT00332709|Postmenopausal women with primary hormone receptor positive breast cancer|postmenopausal women with primary hormone receptor positive breast cancer
5328587|NCT00332696|bowel obstruction,|bowel obstruction,
5328588|NCT00332696|peritoneal carcinomatosis|peritoneal carcinomatosis
5328589|NCT00332696|Octreotide|octreotide
5328590|NCT00332696|inoperable|inoperable
5328591|NCT00332683|Dysphagia|dysphagia
5328592|NCT00332683|spine surgery|spine surgery
5328593|NCT00332683|cuff pressure|cuff pressure
5328594|NCT00332670|(Non-seasonal) Depression|(non-seasonal) depression
5328595|NCT00332670|bright light therapy|bright light therapy
5328596|NCT00332670|randomized controlled trial|randomized controlled trial
5328597|NCT00332670|suprachiasmatic nucleus|suprachiasmatic nucleus
5328598|NCT00332670|HPA-axis|hpa-axis
5328599|NCT00332670|DHEA|dhea
5328600|NCT00332670|melatonin|melatonin
5328601|NCT00332670|actigraphy|actigraphy
5328602|NCT00332670|elderly|elderly
5328603|NCT00332670|self-efficacy|self-efficacy
5328604|NCT00332670|social support|social support
5328605|NCT00332631|Cardiac surgery,|cardiac surgery,
5328606|NCT00332631|Cardiopulmonary bypass,|cardiopulmonary bypass,
5328607|NCT00332631|Oxidative stress,|oxidative stress,
5328608|NCT00332631|Acute renal dysfunction,|acute renal dysfunction,
5328609|NCT00332631|N-acetylcysteine|n-acetylcysteine
5328610|NCT00332618|MULTICENTER|multicenter
5328611|NCT00332618|CONTROLLED|controlled
5328612|NCT00332618|PARALLEL GROUPS|parallel groups
5328613|NCT00332605|Methamphetamine Dependence|methamphetamine dependence
5328614|NCT00332592|Necrotizing Enterocolitis|necrotizing enterocolitis
5328615|NCT00332592|Intragastric microdialysis|intragastric microdialysis
5328616|NCT00332592|Peritoneal microdialysis|peritoneal microdialysis
5328617|NCT00332592|Infants|infants
5328618|NCT00332579|Compulsive Shoplifting|compulsive shoplifting
5328619|NCT00332579|Kleptomania|kleptomania
5328620|NCT00332579|Compulsive Stealing|compulsive stealing
5328621|NCT00332514|pharmacist intervention|pharmacist intervention
5328622|NCT00332514|post-discharge telephone call|post-discharge telephone call
5328623|NCT00332514|black hole|black hole
5328624|NCT00332462|Liver transplantation, Cyclosporine|liver transplantation, cyclosporine
5328625|NCT00332449|early breast feeding|early breast feeding
5328626|NCT00332449|hypoglycemia|hypoglycemia
5328627|NCT00332449|newborn|newborn
5328628|NCT00332410|Voriconazole|voriconazole
5328629|NCT00332410|renal transplant|renal transplant
5328630|NCT00332410|kidney function|kidney function
5328631|NCT00332410|kidneys|kidneys
5328632|NCT00332371|Intensive Care|intensive care
5328633|NCT00332371|Shock, Septic|shock, septic
5328634|NCT00332371|Adsorption|adsorption
5328635|NCT00332371|Sorption Detoxification|sorption detoxification
5328636|NCT00332332|Phase IV|phase iv
5328637|NCT00332332|Psoriasis|psoriasis
5328638|NCT00332332|Inflammation|inflammation
5328639|NCT00332319|spinal cord injury|spinal cord injury
5328640|NCT00332319|urgency|urgency
5328641|NCT00332319|Overactive bladder|overactive bladder
5328642|NCT00332319|neurogenic|neurogenic
5328643|NCT00332319|neurometry|neurometry
5328644|NCT00332319|frequency|frequency
5328645|NCT00332319|urge incontinence|urge incontinence
5328646|NCT00332306|Once daily antiretroviral treatment|once daily antiretroviral treatment
5328647|NCT00332306|Concomitant antituberculosis treatment|concomitant antituberculosis treatment
5328648|NCT00332306|HIV Infections|hiv infections
5328649|NCT00332280|solid tumors|solid tumors
5328650|NCT00332280|clinical benefit|clinical benefit
5328651|NCT00332280|quality of life|quality of life
5328652|NCT00332280|esophageal cancer|esophageal cancer
5328653|NCT00332280|colon cancer|colon cancer
5328654|NCT00332280|pancreatic cancer|pancreatic cancer
5328655|NCT00332280|gastric cancer|gastric cancer
5328656|NCT00332280|liver cancer|liver cancer
5328657|NCT00332280|gall bladder cancer|gall bladder cancer
5328658|NCT00332280|prostate cancer|prostate cancer
5328659|NCT00332280|gynecological cancer|gynecological cancer
5328660|NCT00332280|lung cancer|lung cancer
5328661|NCT00332280|Tumors of GI tract, prostate and gynaecological|tumors of gi tract, prostate and gynaecological
5328662|NCT00332267|Sepsis|sepsis
5328663|NCT00332267|Hypoxia|hypoxia
5328664|NCT00332267|Altitude Sickness|altitude sickness
5328665|NCT00332267|Endotoxin|endotoxin
5328666|NCT00332267|Cytokines|cytokines
5328667|NCT00332267|Cerebral blood flow|cerebral blood flow
5328668|NCT00332267|Cerebral metabolism|cerebral metabolism
5328669|NCT00332267|Reactive oxygen species|reactive oxygen species
5328670|NCT00332254|Anterior cruciate ligament tear|anterior cruciate ligament tear
5328671|NCT00332254|Meniscus tear|meniscus tear
5328672|NCT00332254|Chondral injury|chondral injury
5328673|NCT00332241|Serious behavioral problems in children and adolescents with AD|serious behavioral problems in children and adolescents with ad
5328674|NCT00332241|Behavioral Problems|behavioral problems
5328675|NCT00332228|opiate dependence|opiate dependence
5328676|NCT00332228|heroin dependence|heroin dependence
5328677|NCT00332228|naltrexone|naltrexone
5328678|NCT00332228|cognitive behavioral therapy|cognitive behavioral therapy
5328679|NCT00332215|Cystic Fibrosis|cystic fibrosis
5328680|NCT00332215|Antioxidants|antioxidants
5328681|NCT00332215|Inhalational therapy|inhalational therapy
5328682|NCT00332215|Induced sputum|induced sputum
5328683|NCT00332215|Airway inflammation|airway inflammation
5328684|NCT00332189|PKU|pku
5328685|NCT00332176|Hepatitis C|hepatitis c
5328686|NCT00332176|Celgosivir|celgosivir
5328687|NCT00332176|HCV|hcv
5328688|NCT00332176|Genotype 1|genotype 1
5328689|NCT00332176|Treatment-naive|treatment-naive
5328690|NCT00332176|Early viral kinetics|early viral kinetics
5328691|NCT00332163|STEPP|stepp
5328692|NCT00332163|STEP|step
5328693|NCT00332163|STEEP|steep
5328694|NCT00332163|mCRC|mcrc
5328695|NCT00332163|Skin Toxicities|skin toxicities
5328696|NCT00332163|Skin Rash|skin rash
5328697|NCT00332163|Metastatic Colorectal Cancer|metastatic colorectal cancer
5328698|NCT00332163|Anti-EGFr Skin Rash|anti-egfr skin rash
5328699|NCT00332163|colon cancer|colon cancer
5328700|NCT00332163|colorectal cancer|colorectal cancer
5328701|NCT00332163|rectal cancer|rectal cancer
5328702|NCT00332150|parents|parents
5328703|NCT00332150|newborn|newborn
5328704|NCT00332150|clinical trials|clinical trials
5328705|NCT00332111|transplant|transplant
5328706|NCT00332111|pancreas|pancreas
5328707|NCT00332098|Childhood Mood Disorders|childhood mood disorders
5328708|NCT00332098|Family Treatment|family treatment
5328709|NCT00332098|Psychoeducation|psychoeducation
5328710|NCT00332098|Pharmacotherapy|pharmacotherapy
5328711|NCT00332098|Family Functioning|family functioning
5328712|NCT00332098|Psychosocial Intervention|psychosocial intervention
5328713|NCT00332046|fMRI placebo GW679769 Social Anxiety Disorder SAD|fmri placebo gw679769 social anxiety disorder sad
5328714|NCT00332033|Fibroids|fibroids
5328715|NCT00332033|Leiomyoma|leiomyoma
5328716|NCT00332033|Pirfenidone|pirfenidone
5328717|NCT00332033|Misoprostol|misoprostol
5328718|NCT00332033|Non-Surgical|non-surgical
5328719|NCT00332033|Collagen|collagen
5328720|NCT00332033|Uterus|uterus
5328721|NCT00332033|Uterine Fibroids|uterine fibroids
5328722|NCT00332033|Uterine Leiomyoma|uterine leiomyoma
5328723|NCT00331942|Breast|breast
5328724|NCT00331942|Cancer|cancer
5328725|NCT00331942|Associated|associated
5328726|NCT00331942|Antibodies|antibodies
5328727|NCT00331929|Asthma|asthma
5328728|NCT00331929|Allergy|allergy
5328729|NCT00331929|Respiratory|respiratory
5328730|NCT00331929|Pollution|pollution
5328731|NCT00331929|Children|children
5328732|NCT00331929|Air pollution|air pollution
5328733|NCT00331890|Neuroprotection|neuroprotection
5328734|NCT00331890|Acute ischemic stroke|acute ischemic stroke
5328735|NCT00331890|Cerebral infarction|cerebral infarction
5328736|NCT00331877|family|family
5328737|NCT00331877|end-of-life|end-of-life
5328738|NCT00331877|intensive care unit|intensive care unit
5328739|NCT00331864|AMD, ranibizumab|amd, ranibizumab
5328740|NCT00331838|Prevention|prevention
5328741|NCT00331838|Venous Thrombosis|venous thrombosis
5328742|NCT00331838|Orthopedic Surgery|orthopedic surgery
5328743|NCT00331825|Schizophrenia, EPS, risperidone, olanzapine|schizophrenia, eps, risperidone, olanzapine
5328744|NCT00331812|Hypermetabolism|hypermetabolism
5328745|NCT00331812|Mitochondrial abnormalities|mitochondrial abnormalities
5328746|NCT00331812|Oxidant/antioxidant status|oxidant/antioxidant status
5328747|NCT00331799|Depression|depression
5328748|NCT00331799|Pharmacotherapy|pharmacotherapy
5328749|NCT00331799|Duloxetine|duloxetine
5328750|NCT00331786|colon cancer|colon cancer
5328751|NCT00331786|rectal cancer|rectal cancer
5328752|NCT00331773|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5328753|NCT00331773|stage IIB prostate cancer|stage iib prostate cancer
5328754|NCT00331773|stage IIA prostate cancer|stage iia prostate cancer
5328755|NCT00331760|stage I endometrial carcinoma|stage i endometrial carcinoma
5328756|NCT00331760|stage II endometrial carcinoma|stage ii endometrial carcinoma
5328757|NCT00331760|stage III endometrial carcinoma|stage iii endometrial carcinoma
5328758|NCT00331760|endometrial adenoacanthoma|endometrial adenoacanthoma
5328759|NCT00331760|endometrial adenocarcinoma|endometrial adenocarcinoma
5328760|NCT00331760|endometrial adenosquamous cell carcinoma|endometrial adenosquamous cell carcinoma
5328761|NCT00331760|stage IB cervical cancer|stage ib cervical cancer
5328762|NCT00331760|stage IIA cervical cancer|stage iia cervical cancer
5328763|NCT00331760|stage IIB cervical cancer|stage iib cervical cancer
5328764|NCT00331760|cervical adenocarcinoma|cervical adenocarcinoma
5328765|NCT00331760|cervical adenosquamous cell carcinoma|cervical adenosquamous cell carcinoma
5328766|NCT00331760|cervical squamous cell carcinoma|cervical squamous cell carcinoma
5328767|NCT00331721|Acute Ischemic Stroke|acute ischemic stroke
5328768|NCT00331708|Malaria|malaria
5328769|NCT00331708|Efficacy|efficacy
5328770|NCT00331708|Pharmacokinetic|pharmacokinetic
5328771|NCT00331708|Gametocyte|gametocyte
5328772|NCT00331708|Molecular markers|molecular markers
5328773|NCT00331708|Sulfadoxine-pyrimethamine|sulfadoxine-pyrimethamine
5328774|NCT00331708|Artesunate|artesunate
5328775|NCT00331708|Artemisinin|artemisinin
5328776|NCT00331695|Progesterone|progesterone
5328777|NCT00331695|Preterm delivery|preterm delivery
5328778|NCT00331695|Preterm labor|preterm labor
5328779|NCT00331695|Cervical length|cervical length
5328780|NCT00331695|ultrasonography|ultrasonography
5328781|NCT00331669|deep brain stimulation|deep brain stimulation
5328782|NCT00331669|pallidum|pallidum
5328783|NCT00331669|tardive dystonia|tardive dystonia
5328784|NCT00331669|randomized|randomized
5328785|NCT00331669|double blind|double blind
5328786|NCT00331669|multicenter|multicenter
5328787|NCT00331656|noninvasive|noninvasive
5328788|NCT00331656|positive|positive
5328789|NCT00331656|cuirass|cuirass
5328790|NCT00331656|ventilation|ventilation
5328791|NCT00331656|respiratory|respiratory
5328792|NCT00331656|failure|failure
5328793|NCT00331630|stage I breast cancer|stage i breast cancer
5328794|NCT00331630|stage II breast cancer|stage ii breast cancer
5328795|NCT00331630|stage IIIA breast cancer|stage iiia breast cancer
5328796|NCT00331630|stage IIIB breast cancer|stage iiib breast cancer
5328797|NCT00331630|stage IIIC breast cancer|stage iiic breast cancer
5328798|NCT00331565|Bariatric surgery|bariatric surgery
5328799|NCT00331565|Bioavailability|bioavailability
5328800|NCT00331565|Bioequivalence|bioequivalence
5328801|NCT00331565|Atorvastatin|atorvastatin
5328802|NCT00331565|CYP's|cyp's
5328803|NCT00331565|P-gp|p-gp
5328804|NCT00331565|OATP|oatp
5328805|NCT00331539|Cochlear implant|cochlear implant
5328806|NCT00331539|threshold (T) measurement|threshold (t) measurement
5328807|NCT00331539|comfort (C) level|comfort (c) level
5328808|NCT00331539|profound hearing loss|profound hearing loss
5328809|NCT00331539|auditory stimuli|auditory stimuli
5328810|NCT00331539|profound hearing loss patients eligible for the study should be capable of providing reliable|profound hearing loss patients eligible for the study should be capable of providing reliable
5328811|NCT00331539|subjective counted thresholds and has good NRT recordings, implanted with|subjective counted thresholds and has good nrt recordings, implanted with
5328812|NCT00331539|the Nucleus Freedom system|the nucleus freedom system
5328813|NCT00331526|adult glioblastoma|adult glioblastoma
5328814|NCT00331526|adult gliosarcoma|adult gliosarcoma
5328815|NCT00331526|adult giant cell glioblastoma|adult giant cell glioblastoma
5328816|NCT00331487|Glucose Metabolism Disorder|glucose metabolism disorder
5328817|NCT00331487|Dysmetabolic Syndrome|dysmetabolic syndrome
5328818|NCT00331487|Type II Diabetes|type ii diabetes
5328819|NCT00331487|Diabetes Mellitus|diabetes mellitus
5328820|NCT00331487|Lipoatrophic|lipoatrophic
5328821|NCT00331487|Dyslipidemia|dyslipidemia
5328822|NCT00331487|Drug Therapy|drug therapy
5328823|NCT00331474|BCG|bcg
5328824|NCT00331474|HIV|hiv
5328825|NCT00331474|Immune responses|immune responses
5328826|NCT00331474|Delayed vaccination|delayed vaccination
5328827|NCT00331474|Infant morbidity|infant morbidity
5328828|NCT00331474|Nutritional status|nutritional status
5328829|NCT00331474|Morbidity|morbidity
5328830|NCT00331474|Mortality|mortality
5328831|NCT00331448|Treatment Experienced|treatment experienced
5328832|NCT00331448|Lipoatrophy|lipoatrophy
5328833|NCT00331448|Lipohypertrophy|lipohypertrophy
5328834|NCT00331448|Glucose|glucose
5328835|NCT00331448|Cholesterol|cholesterol
5328836|NCT00331448|Triglycerides|triglycerides
5328837|NCT00331448|MRI|mri
5328838|NCT00331448|DXA|dxa
5328839|NCT00331448|Carotid IMT|carotid imt
5328840|NCT00331448|LDL|ldl
5328841|NCT00331448|HDL|hdl
5328842|NCT00331435|AMD|amd
5328843|NCT00331435|PCV|pcv
5328844|NCT00331435|PDT|pdt
5328845|NCT00331422|ovarian clear cell cystadenocarcinoma|ovarian clear cell cystadenocarcinoma
5328846|NCT00331422|ovarian endometrioid adenocarcinoma|ovarian endometrioid adenocarcinoma
5328847|NCT00331422|ovarian mixed epithelial carcinoma|ovarian mixed epithelial carcinoma
5328848|NCT00331422|ovarian mucinous cystadenocarcinoma|ovarian mucinous cystadenocarcinoma
5328849|NCT00331422|ovarian serous cystadenocarcinoma|ovarian serous cystadenocarcinoma
5328850|NCT00331422|ovarian undifferentiated adenocarcinoma|ovarian undifferentiated adenocarcinoma
5329101|NCT00330434|Smoking|smoking
5328851|NCT00331422|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5328852|NCT00331422|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5328853|NCT00331422|peritoneal cavity cancer|peritoneal cavity cancer
5328854|NCT00331422|fallopian tube cancer|fallopian tube cancer
5328855|NCT00331422|Brenner tumor|brenner tumor
5328856|NCT00331409|stage III renal cell cancer|stage iii renal cell cancer
5328857|NCT00331409|stage IV renal cell cancer|stage iv renal cell cancer
5328858|NCT00331409|clear cell renal cell carcinoma|clear cell renal cell carcinoma
5328859|NCT00331409|recurrent renal cell cancer|recurrent renal cell cancer
5328860|NCT00331357|acute idiopathic thrombocytopenic purpura|acute idiopathic thrombocytopenic purpura
5328861|NCT00331357|paediatric|paediatric
5328862|NCT00331357|quality of life|quality of life
5328863|NCT00331331|Uveitis|uveitis
5328864|NCT00331331|Intermediate Uveitis|intermediate uveitis
5328865|NCT00331331|Pars Planitis|pars planitis
5328866|NCT00331331|Macular Edema|macular edema
5328867|NCT00331331|Vasculitis|vasculitis
5328868|NCT00331331|Ocular Inflammatory Disease|ocular inflammatory disease
5328869|NCT00331318|Transcranial Direct Current Stimulation (tDCS)|transcranial direct current stimulation (tdcs)
5328870|NCT00331318|Transcranial Magnetic Stimulation (TMS)|transcranial magnetic stimulation (tms)
5328871|NCT00331318|Motor Learning|motor learning
5328872|NCT00331318|Brain Plasticity|brain plasticity
5328873|NCT00331318|Healthy Volunteer|healthy volunteer
5328874|NCT00331318|HV|hv
5328875|NCT00331305|Exercise|exercise
5328876|NCT00331292|Asthma bronchoscopy|asthma bronchoscopy
5328877|NCT00331279|polycystic ovary syndrome|polycystic ovary syndrome
5328878|NCT00331279|insulin resistance|insulin resistance
5328879|NCT00331279|cinnamon|cinnamon
5328880|NCT00331253|Indocyanine Green-Mediated Photothrombosis|indocyanine green-mediated photothrombosis
5328881|NCT00331253|Neovascular|neovascular
5328882|NCT00331253|Age-Related Macular Degeneration|age-related macular degeneration
5328883|NCT00331227|flavonoids|flavonoids
5328884|NCT00331227|food supplements|food supplements
5328885|NCT00331227|endothelial function|endothelial function
5328886|NCT00331227|no conditions allowed, healthy volunteers only|no conditions allowed, healthy volunteers only
5328887|NCT00331214|Surgical menopause|surgical menopause
5328888|NCT00331214|HSDD|hsdd
5328889|NCT00331201|NEC|nec
5328890|NCT00331188|Esophageal Variceal Bleeding|esophageal variceal bleeding
5328891|NCT00331188|Portal Hypertension|portal hypertension
5328892|NCT00331188|Hepatic Cirrhosis|hepatic cirrhosis
5328893|NCT00331188|Cirrhosis|cirrhosis
5328894|NCT00331188|Liver Cirrhosis|liver cirrhosis
5328895|NCT00331188|Somatostatin Analog|somatostatin analog
5328896|NCT00331188|Vapreotide|vapreotide
5328897|NCT00331188|Acute Esophageal Variceal Bleeding|acute esophageal variceal bleeding
5328898|NCT00331162|Renal Transplantation|renal transplantation
5328899|NCT00331162|Pancreas Transplantation|pancreas transplantation
5328900|NCT00331162|Graft Rejection|graft rejection
5328901|NCT00331162|Immunosuppression|immunosuppression
5328902|NCT00331162|Kidney failure, chronic|kidney failure, chronic
5328903|NCT00331162|Diabetes Mellitus, Type 1|diabetes mellitus, type 1
5328904|NCT00331162|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
5328905|NCT00331149|safety|safety
5328906|NCT00331149|efficacy|efficacy
5328907|NCT00331149|L-dopa|l-dopa
5328908|NCT00331149|ropinirole PR|ropinirole pr
5328909|NCT00331149|Parkinson's disease|parkinson's disease
5328910|NCT00331149|ropinirole IR|ropinirole ir
5328911|NCT00331149|adjunctive therapy|adjunctive therapy
5328912|NCT00331149|superiority|superiority
5328913|NCT00331149|REQUIP|requip
5328914|NCT00331149|health outcomes|health outcomes
5328915|NCT00331136|malaria|malaria
5328916|NCT00331136|pyronaridine|pyronaridine
5328917|NCT00331136|artesunate|artesunate
5328918|NCT00331136|falciparum|falciparum
5328919|NCT00331136|ACT|act
5328920|NCT00331123|Surgical menopause|surgical menopause
5328921|NCT00331123|HSDD|hsdd
5328922|NCT00331097|elderly|elderly
5328923|NCT00331097|adjuvant therapy|adjuvant therapy
5328924|NCT00331097|intermediate risk|intermediate risk
5328925|NCT00331097|high risk|high risk
5328926|NCT00331084|prevention of post inflammation in cataract surgery|prevention of post inflammation in cataract surgery
5328927|NCT00331071|Contraception|contraception
5328928|NCT00331071|Hormonal contraception|hormonal contraception
5328929|NCT00331071|Oral contraception|oral contraception
5329028|NCT00330616|depression|depression
5328930|NCT00331071|Ethinyl estradiol, Progestin, Contraception|ethinyl estradiol, progestin, contraception
5328931|NCT00331071|Transdermal|transdermal
5328932|NCT00331058|Severe Asthma bronchoscopy|severe asthma bronchoscopy
5328933|NCT00331045|Opioids|opioids
5328934|NCT00331045|cancer|cancer
5328935|NCT00331045|constipation|constipation
5328936|NCT00331032|VivaGel™, sexually transmitted, microbicide, herpes simplex|vivagel™, sexually transmitted, microbicide, herpes simplex
5328937|NCT00331019|Streptococcus Group B|streptococcus group b
5328938|NCT00331019|Pregnancy|pregnancy
5328939|NCT00331006|Blood Coagulation Factor Inhibitors|blood coagulation factor inhibitors
5328940|NCT00330993|mifepristone|mifepristone
5328941|NCT00330993|misoprostol|misoprostol
5328942|NCT00330993|medical abortion|medical abortion
5328943|NCT00330993|buccal administration|buccal administration
5328944|NCT00330980|Cognition|cognition
5328945|NCT00330980|Statins|statins
5328946|NCT00330980|Serotonin|serotonin
5328947|NCT00330980|Cholesterol|cholesterol
5328948|NCT00330967|Fat Emulsions, Intravenous|fat emulsions, intravenous
5328949|NCT00330967|Free Fatty Acids|free fatty acids
5328950|NCT00330967|Glucose Clamp Technique|glucose clamp technique
5328951|NCT00330967|Inflammation|inflammation
5328952|NCT00330967|Insulin Resistance|insulin resistance
5328953|NCT00330967|Muscle, Skeletal|muscle, skeletal
5328954|NCT00330967|NF-Kappa B|nf-kappa b
5328955|NCT00330954|viral response genes|viral response genes
5328956|NCT00330902|malaria|malaria
5328957|NCT00330902|subpatent parasitaemia|subpatent parasitaemia
5328958|NCT00330902|dry season|dry season
5328959|NCT00330902|primaquine|primaquine
5328960|NCT00330902|Plasmodium falciparum infection detected by PCR|plasmodium falciparum infection detected by pcr
5328961|NCT00330889|Rheumatoid Arthritis|rheumatoid arthritis
5328962|NCT00330876|pitavastatin|pitavastatin
5328963|NCT00330876|hypercholesterolemia|hypercholesterolemia
5328964|NCT00330876|combined dyslipidemia|combined dyslipidemia
5328965|NCT00330863|Relapse|relapse
5328966|NCT00330863|Prevention|prevention
5328967|NCT00330863|Schizophrenia|schizophrenia
5328968|NCT00330863|Injectable Medication|injectable medication
5328969|NCT00330850|Migraine|migraine
5328970|NCT00330850|Photophobia|photophobia
5328971|NCT00330850|Phonophobia|phonophobia
5328972|NCT00330850|Aura|aura
5329102|NCT00330434|Drinking|drinking
5328973|NCT00330824|prevention of post inflammation in LASIK surgery|prevention of post inflammation in lasik surgery
5328974|NCT00330811|Pediatrics|pediatrics
5328975|NCT00330811|Non-cardiac Illness|non-cardiac illness
5328976|NCT00330811|B-type Natriuretic Peptide (BNP)|b-type natriuretic peptide (bnp)
5328977|NCT00330798|Photorefractive Keratectomy|photorefractive keratectomy
5328978|NCT00330772|Cardiac Surger|cardiac surger
5328979|NCT00330772|Coronary Artery Bypass Grafting|coronary artery bypass grafting
5328980|NCT00330772|Graft patency|graft patency
5328981|NCT00330772|Aspirin|aspirin
5328982|NCT00330772|Clopidogrel|clopidogrel
5328983|NCT00330772|Hemorrhage|hemorrhage
5328984|NCT00330772|Transfusion|transfusion
5328985|NCT00330759|Bone metastases|bone metastases
5328986|NCT00330759|lytic bone lesions|lytic bone lesions
5328987|NCT00330759|advanced cancer|advanced cancer
5328988|NCT00330759|multiple myeloma|multiple myeloma
5328989|NCT00330759|lymphoma|lymphoma
5328990|NCT00330759|solid tumors|solid tumors
5328991|NCT00330759|skeletal related events|skeletal related events
5328992|NCT00330759|skeletal fractures|skeletal fractures
5328993|NCT00330759|spinal cord compressions, radiation to bone|spinal cord compressions, radiation to bone
5328994|NCT00330759|surgery to bone, bisphosphonates|surgery to bone, bisphosphonates
5328995|NCT00330759|denosumab|denosumab
5328996|NCT00330746|elderly|elderly
5328997|NCT00330746|chemotherapy|chemotherapy
5328998|NCT00330746|targeted therapy|targeted therapy
5328999|NCT00330746|combination therapy|combination therapy
5329000|NCT00330746|sequential therapy|sequential therapy
5329001|NCT00330746|randomized phase II|randomized phase ii
5329002|NCT00330746|one year survival|one year survival
5329003|NCT00330733|Cardiovascular Disease|cardiovascular disease
5329004|NCT00330733|Inflammation|inflammation
5329005|NCT00330733|Insulin Resistance|insulin resistance
5329006|NCT00330733|Type 2 DM|type 2 dm
5329007|NCT00330720|Personal Emergency Response System|personal emergency response system
5329008|NCT00330720|Anxiety|anxiety
5329009|NCT00330720|Fear of Falling|fear of falling
5329010|NCT00330720|RCT|rct
5329011|NCT00330707|bladder cancer|bladder cancer
5329012|NCT00330707|BCG|bcg
5329013|NCT00330707|interferon alpha|interferon alpha
5329014|NCT00330694|Physical Therapy|physical therapy
5329015|NCT00330694|Organisation of care|organisation of care
5329016|NCT00330681|Amyotrophic lateral sclerosis|amyotrophic lateral sclerosis
5329017|NCT00330681|free radical scavenger|free radical scavenger
5329018|NCT00330668|Insulin-like Growth Factor Deficiency|insulin-like growth factor deficiency
5329019|NCT00330668|IGF-1|igf-1
5329020|NCT00330668|Short Stature|short stature
5329021|NCT00330655|Binge eating|binge eating
5329022|NCT00330655|Obesity|obesity
5329023|NCT00330655|Eating disorder|eating disorder
5329024|NCT00330642|Streptococcus Group B|streptococcus group b
5329025|NCT00330642|Pregnancy|pregnancy
5329026|NCT00330616|WELLBUTRIN|wellbutrin
5329027|NCT00330616|elderly|elderly
5329029|NCT00330616|Pharmacokinetics|pharmacokinetics
5329030|NCT00330603|Cough|cough
5329031|NCT00330603|Gastroesophageal Reflux|gastroesophageal reflux
5329032|NCT00330590|Central Venous|central venous
5329033|NCT00330590|Ultrasonography|ultrasonography
5329034|NCT00330590|Catheterization|catheterization
5329035|NCT00330564|VHL Syndrome|vhl syndrome
5329036|NCT00330564|Von Hippel-Lindau Syndrome|von hippel-lindau syndrome
5329037|NCT00330564|VHL Disease|vhl disease
5329038|NCT00330564|Kidney|kidney
5329039|NCT00330564|Retina|retina
5329040|NCT00330564|Brain|brain
5329041|NCT00330564|Spinal cord|spinal cord
5329042|NCT00330564|Pancreas|pancreas
5329043|NCT00330564|Inner ear|inner ear
5329044|NCT00330564|Cysts|cysts
5329045|NCT00330564|Tumors|tumors
5329046|NCT00330564|Sunitinib Malate|sunitinib malate
5329047|NCT00330564|SU011248|su011248
5329048|NCT00330564|Sutent|sutent
5329049|NCT00330564|VHL|vhl
5329050|NCT00330564|Sunitinib|sunitinib
5329051|NCT00330564|Renal cell carcinoma|renal cell carcinoma
5329052|NCT00330564|Hemangioblastoma|hemangioblastoma
5329053|NCT00330564|Endothelium|endothelium
5329054|NCT00330551|Schizoaffective Disorder, Depressed Type|schizoaffective disorder, depressed type
5329055|NCT00330551|Schizophreniform Disorder|schizophreniform disorder
5329056|NCT00330551|First-episode Schizophrenia|first-episode schizophrenia
5329057|NCT00330551|Injectable Risperidone|injectable risperidone
5329058|NCT00330538|Osteoporosis|osteoporosis
5329059|NCT00330538|Childhood acute lymphoblastic leukemia|childhood acute lymphoblastic leukemia
5329060|NCT00330512|regional anestesia|regional anestesia
5329061|NCT00330512|cesarean section|cesarean section
5329062|NCT00330512|hypotention|hypotention
5329063|NCT00330512|newborn|newborn
5329064|NCT00330499|Locally invasive|locally invasive
5329065|NCT00330499|Bladder cancer|bladder cancer
5329066|NCT00330499|Chemoradiotherapy|chemoradiotherapy
5329067|NCT00330499|Efficacy|efficacy
5329068|NCT00330499|Organ conservation|organ conservation
5329069|NCT00330486|Acamprosate|acamprosate
5329070|NCT00330486|Addiction|addiction
5329071|NCT00330486|Alcoholism|alcoholism
5329072|NCT00330486|Alcohol dependence|alcohol dependence
5329073|NCT00330486|Bipolar disorder|bipolar disorder
5329074|NCT00330486|Depression|depression
5329075|NCT00330486|Impulsivity|impulsivity
5329076|NCT00330486|Mania|mania
5329077|NCT00330486|Substance abuse|substance abuse
5329078|NCT00330460|Osteoporosis|osteoporosis
5329079|NCT00330460|Osteopenia|osteopenia
5329080|NCT00330460|AMG 162|amg 162
5329081|NCT00330460|Fracture - hip|fracture - hip
5329082|NCT00330460|Postmenopausal|postmenopausal
5329083|NCT00330447|pregnancy|pregnancy
5329084|NCT00330447|in utero|in utero
5329085|NCT00330447|chemotherapy|chemotherapy
5329086|NCT00330447|radiotherapy|radiotherapy
5329087|NCT00330447|cancer|cancer
5329088|NCT00330447|offspring|offspring
5329089|NCT00330447|neonatal|neonatal
5329090|NCT00330447|long term|long term
5329091|NCT00330447|follow up|follow up
5329092|NCT00330447|cancer during pregnancy|cancer during pregnancy
5329093|NCT00330447|chemotherapy and radiotherapy during pregnancy|chemotherapy and radiotherapy during pregnancy
5329094|NCT00330447|long term follow up of children|long term follow up of children
5329095|NCT00330434|Alcohol|alcohol
5329096|NCT00330434|Bupropion|bupropion
5329097|NCT00330434|Chlorzoxazone|chlorzoxazone
5329098|NCT00330434|Interaction|interaction
5329099|NCT00330434|Induction|induction
5329100|NCT00330434|Depression|depression
5329103|NCT00330434|Cytochrome P450 Enzyme|cytochrome p450 enzyme
5329104|NCT00330434|CYP2B6|cyp2b6
5329105|NCT00330434|CYP2E1|cyp2e1
5329106|NCT00330434|Pharmacogenetics|pharmacogenetics
5329107|NCT00330434|Pharmacokinetics|pharmacokinetics
5329108|NCT00330434|Pharmacodynamics|pharmacodynamics
5329109|NCT00330434|Boston|boston
5329110|NCT00330434|Tufts University|tufts university
5329111|NCT00330408|Adherence|adherence
5329112|NCT00330408|GP training|gp training
5329113|NCT00330408|Medication Event Monitoring System(MEMS)|medication event monitoring system(mems)
5329114|NCT00330408|Antihypertensive Medication|antihypertensive medication
5329115|NCT00330408|Hypertension|hypertension
5329116|NCT00330356|Dietary Salt|dietary salt
5329117|NCT00330356|Blood Pressure|blood pressure
5329118|NCT00330356|Normotensives|normotensives
5329119|NCT00330343|morphine|morphine
5329120|NCT00330343|naloxone|naloxone
5329121|NCT00330343|pediatrics|pediatrics
5329122|NCT00330343|adverse effects|adverse effects
5329123|NCT00330343|pain|pain
5329124|NCT00330330|Fasting plasma glucose|fasting plasma glucose
5329125|NCT00330330|HbA1c|hba1c
5329126|NCT00330317|Letrozole|letrozole
5329127|NCT00330317|Breast Conserving Surgery|breast conserving surgery
5329128|NCT00330317|NeoAdjuvant|neoadjuvant
5329129|NCT00330317|Early Breast Cancer|early breast cancer
5329130|NCT00330304|Tuberculosis|tuberculosis
5329131|NCT00330304|Child|child
5329132|NCT00330304|HIV|hiv
5329133|NCT00330304|prophylaxis|prophylaxis
5329134|NCT00330304|mortality|mortality
5329135|NCT00330291|PTSD|ptsd
5329136|NCT00330291|Xyrem|xyrem
5329137|NCT00330291|Sleep problems|sleep problems
5329138|NCT00330278|Cesarean section|cesarean section
5329139|NCT00330278|Antibiotic prophylaxis|antibiotic prophylaxis
5329140|NCT00330278|Cefazolin|cefazolin
5329141|NCT00330252|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
5329142|NCT00330252|Relapsed Chronic Lymphocytic Leukemia|relapsed chronic lymphocytic leukemia
5329143|NCT00330252|Alemtuzumab|alemtuzumab
5329144|NCT00330252|Campath|campath
5329145|NCT00330252|Rituximab|rituximab
5329146|NCT00330252|Rituxan|rituxan
5329147|NCT00330239|Substance Abuse|substance abuse
5329148|NCT00330239|Trauma|trauma
5329149|NCT00330239|Dependence|dependence
5329150|NCT00330226|schizophrenia|schizophrenia
5329151|NCT00330226|bipolar disorder|bipolar disorder
5329152|NCT00330226|atypical antipsychotics|atypical antipsychotics
5329153|NCT00330226|mood stabilizers|mood stabilizers
5329154|NCT00330226|biological markers|biological markers
5329155|NCT00330213|transthoracic|transthoracic
5329156|NCT00330213|echocardiography|echocardiography
5329157|NCT00330213|red wine|red wine
5329158|NCT00330213|cognac|cognac
5329159|NCT00330213|coronary reactivity|coronary reactivity
5329160|NCT00330200|Fasting plasma glucose|fasting plasma glucose
5329161|NCT00330200|HbA1c|hba1c
5329162|NCT00330200|Metabolism|metabolism
5329163|NCT00330187|nicotine dependence|nicotine dependence
5329164|NCT00330187|bupropion SR|bupropion sr
5329165|NCT00330187|smoking cessation|smoking cessation
5329166|NCT00330187|adolescents|adolescents
5329167|NCT00330187|contingency management|contingency management
5329168|NCT00330174|Alcoholism|alcoholism
5329169|NCT00330174|Mood|mood
5329170|NCT00330174|Anxiety|anxiety
5329171|NCT00330174|Acamprosate|acamprosate
5329172|NCT00330148|trypanosomiasis|trypanosomiasis
5329173|NCT00330148|gambiense|gambiense
5329174|NCT00330148|combination drug therapy|combination drug therapy
5329175|NCT00330148|sleeping sickness|sleeping sickness
5329176|NCT00330148|Uganda|uganda
5329177|NCT00330135|hip osteoarthritis|hip osteoarthritis
5329178|NCT00330135|Hyaluronic acid|hyaluronic acid
5329179|NCT00330135|Viscosupplementation|viscosupplementation
5329180|NCT00330135|intra-articular injections|intra-articular injections
5329181|NCT00330122|radius articular displaced fractures|radius articular displaced fractures
5329182|NCT00330122|fore locked plate|fore locked plate
5329183|NCT00330122|external radiocarpal fixer|external radiocarpal fixer
5329184|NCT00330109|glioma|glioma
5329185|NCT00330109|machine learning|machine learning
5329186|NCT00330109|advanced diagnostic imaging|advanced diagnostic imaging
5329187|NCT00330096|bone loss, osteoporosis, prevention, hesperidin|bone loss, osteoporosis, prevention, hesperidin
5329188|NCT00330070|8-week treatment|8-week treatment
5329189|NCT00330070|oral tablets|oral tablets
5329190|NCT00330070|persistent moderate to severe asthma|persistent moderate to severe asthma
5329191|NCT00330070|AQLQ|aqlq
5329192|NCT00330070|asthma control|asthma control
5329193|NCT00330070|quality of life|quality of life
5329194|NCT00330018|BMT|bmt
5329195|NCT00330018|CMV|cmv
5329196|NCT00330018|GVHD|gvhd
5329197|NCT00330005|psychotherapy|psychotherapy
5329198|NCT00330005|bipolar disorder|bipolar disorder
5329199|NCT00330005|psychodynamic|psychodynamic
5329200|NCT00330005|psychoeducation|psychoeducation
5329201|NCT00330005|illness management|illness management
5329202|NCT00330005|controlled trial|controlled trial
5329203|NCT00330005|pilot study|pilot study
5329204|NCT00329979|aortic stenosis|aortic stenosis
5329205|NCT00329979|radial|radial
5329206|NCT00329979|femoral|femoral
5329207|NCT00329979|vascular access site|vascular access site
5329208|NCT00329979|embolism|embolism
5329209|NCT00329979|cerebral|cerebral
5329210|NCT00329979|MRI|mri
5329211|NCT00329979|stroke|stroke
5329212|NCT00329966|Influenza|influenza
5329213|NCT00329966|adult|adult
5329214|NCT00329966|elderly|elderly
5329215|NCT00329966|vaccine|vaccine
5329216|NCT00329940|Letrozole|letrozole
5329217|NCT00329940|breast cancer|breast cancer
5329218|NCT00329940|critical musculoskeletal|critical musculoskeletal
5329219|NCT00329940|postmenopausal|postmenopausal
5329220|NCT00329940|rheumatologic tolerance|rheumatologic tolerance
5329221|NCT00329927|Adjuvanted Influenza Vaccine|adjuvanted influenza vaccine
5329222|NCT00329914|Preterm delivery|preterm delivery
5329223|NCT00329914|Prevention|prevention
5329224|NCT00329914|Twins|twins
5329225|NCT00329914|Progesterone|progesterone
5329226|NCT00329901|Meningitis|meningitis
5329227|NCT00329901|healthy subject|healthy subject
5329228|NCT00329901|vaccine|vaccine
5329229|NCT00329888|Endoscopic papillary balloon dilatation|endoscopic papillary balloon dilatation
5329230|NCT00329888|Endoscopic sphincterotomy|endoscopic sphincterotomy
5329231|NCT00329862|Laparoscopic Adjustable Gastric Banding|laparoscopic adjustable gastric banding
5329232|NCT00329862|Truncal Vagotomy|truncal vagotomy
5329233|NCT00329862|Lap Band|lap band
5329234|NCT00329862|Lap Banding|lap banding
5329235|NCT00329862|Obesity Surgery|obesity surgery
5329236|NCT00329862|Bariatric surgery|bariatric surgery
5329237|NCT00329862|Weight Loss Surgery|weight loss surgery
5329238|NCT00329849|Meningitis|meningitis
5329239|NCT00329849|children|children
5329240|NCT00329849|vaccine|vaccine
5329241|NCT00329849|safety|safety
5329242|NCT00329849|efficacy|efficacy
5329550|NCT00328575|Parenchymal|parenchymal
5329243|NCT00329823|Hidradenitis suppurativa, etanercept|hidradenitis suppurativa, etanercept
5329244|NCT00329797|osteoporosis|osteoporosis
5329245|NCT00329797|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5329246|NCT00329797|stage IIB prostate cancer|stage iib prostate cancer
5329247|NCT00329797|stage IIA prostate cancer|stage iia prostate cancer
5329248|NCT00329797|stage III prostate cancer|stage iii prostate cancer
5329249|NCT00329797|stage IV prostate cancer|stage iv prostate cancer
5329250|NCT00329784|peanut allergy|peanut allergy
5329251|NCT00329784|egg allergy|egg allergy
5329252|NCT00329784|eczema|eczema
5329253|NCT00329784|peanut|peanut
5329254|NCT00329784|allergy|allergy
5329255|NCT00329784|allergies|allergies
5329256|NCT00329784|allergic reaction|allergic reaction
5329257|NCT00329784|anaphylaxis|anaphylaxis
5329258|NCT00329784|infants|infants
5329259|NCT00329784|children|children
5329260|NCT00329758|moderate head injury|moderate head injury
5329261|NCT00329758|rosuvastatin|rosuvastatin
5329262|NCT00329758|statin|statin
5329263|NCT00329758|amnesia|amnesia
5329264|NCT00329758|orientation|orientation
5329265|NCT00329745|Rotavirus Gastroenteritis|rotavirus gastroenteritis
5329266|NCT00329745|Human rotavirus vaccine, efficacy, infants|human rotavirus vaccine, efficacy, infants
5329267|NCT00329706|mild cognitive impairment|mild cognitive impairment
5329268|NCT00329706|Alzheimer's disease|alzheimer's disease
5329269|NCT00329706|dementia|dementia
5329270|NCT00329706|FDG|fdg
5329271|NCT00329706|PET|pet
5329272|NCT00329680|Sepsis|sepsis
5329273|NCT00329680|Severe Sepsis|severe sepsis
5329274|NCT00329680|Septic Shock|septic shock
5329275|NCT00329680|Enteral Nutrition|enteral nutrition
5329276|NCT00329680|Antioxidants|antioxidants
5329277|NCT00329680|EPA|epa
5329278|NCT00329680|GLA|gla
5329279|NCT00329680|Nutrition|nutrition
5329280|NCT00329680|Intensive Care|intensive care
5329281|NCT00329680|ICU|icu
5329282|NCT00329667|heart valve|heart valve
5329283|NCT00329667|mitral|mitral
5329284|NCT00329667|aortic|aortic
5329285|NCT00329667|valvular disease|valvular disease
5329286|NCT00329654|Burn wounds, light therapy|burn wounds, light therapy
5329287|NCT00329628|Prevention|prevention
5329288|NCT00329628|Thromboembolism|thromboembolism
5329289|NCT00329615|Cancer cachexia|cancer cachexia
5329290|NCT00329615|Tumor host metabolism|tumor host metabolism
5329291|NCT00329602|Moderate|moderate
5329292|NCT00329602|Restless Legs Syndrome|restless legs syndrome
5329293|NCT00329602|Severe|severe
5329294|NCT00329602|ropinirole|ropinirole
5329295|NCT00329589|Malignancies of the central nervous system, head and neck area|malignancies of the central nervous system, head and neck area
5329296|NCT00329589|and cervix|and cervix
5329297|NCT00329563|Cardiac Arrest|cardiac arrest
5329298|NCT00329563|Hypothermia|hypothermia
5329299|NCT00329550|Certolizumab pegol|certolizumab pegol
5329300|NCT00329550|Cimzia|cimzia
5329301|NCT00329550|CZP|czp
5329302|NCT00329537|Crohn's Disease|crohn's disease
5329303|NCT00329537|Sargramostim|sargramostim
5329304|NCT00329537|CDAI|cdai
5329305|NCT00329537|Moderately to severely active Crohn's Disease|moderately to severely active crohn's disease
5329306|NCT00329524|Tinnitus|tinnitus
5329307|NCT00329524|TMS|tms
5329308|NCT00329524|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
5329309|NCT00329511|pregnancy|pregnancy
5329310|NCT00329511|hypertension|hypertension
5329311|NCT00329511|compliance|compliance
5329312|NCT00329511|clonidine patch|clonidine patch
5329313|NCT00329511|methyldopa|methyldopa
5329314|NCT00329498|ascorbic acid|ascorbic acid
5329315|NCT00329485|Elevated BNP Levels in CHF patients|elevated bnp levels in chf patients
5329316|NCT00329459|menstrual migraine|menstrual migraine
5329317|NCT00329459|headache|headache
5329318|NCT00329459|early intervention|early intervention
5329319|NCT00329459|dysmenorrhea|dysmenorrhea
5329320|NCT00329446|GAD|gad
5329321|NCT00329446|anxiety|anxiety
5329322|NCT00329433|Deep venous thrombosis|deep venous thrombosis
5329323|NCT00329433|DVT|dvt
5329324|NCT00329433|Heparin induced thrombocytopenia|heparin induced thrombocytopenia
5329325|NCT00329433|HIT|hit
5329326|NCT00329433|Direct thrombin inhibitor|direct thrombin inhibitor
5329327|NCT00329420|Crohn's Disease|crohn's disease
5329328|NCT00329420|CDP870|cdp870
5329329|NCT00329420|Certolizumab pegol|certolizumab pegol
5329330|NCT00329420|CZP|czp
5329331|NCT00329407|Alcoholism|alcoholism
5329332|NCT00329407|Heavy Drinking|heavy drinking
5329333|NCT00329407|Alcohol Dependence|alcohol dependence
5329334|NCT00329394|Ketamine|ketamine
5329335|NCT00329394|Analgesia|analgesia
5329336|NCT00329394|Alcool-dependent|alcool-dependent
5329337|NCT00329394|carcinological surgery|carcinological surgery
5329338|NCT00329381|Allergic|allergic
5329339|NCT00329381|Asthma|asthma
5329340|NCT00329381|Immunotherapy|immunotherapy
5329341|NCT00329368|Cancer|cancer
5329342|NCT00329368|Vaccine|vaccine
5329343|NCT00329368|Phase I|phase i
5329344|NCT00329368|FolateImmune|folateimmune
5329345|NCT00329368|Recurrent|recurrent
5329346|NCT00329368|Refractory|refractory
5329347|NCT00329368|Experimental|experimental
5329348|NCT00329355|menstrual migraine|menstrual migraine
5329349|NCT00329355|headache|headache
5329350|NCT00329355|early intervention|early intervention
5329351|NCT00329355|dysmenorrhea|dysmenorrhea
5329352|NCT00329342|Low back pain;|low back pain;
5329353|NCT00329342|Return to work;|return to work;
5329354|NCT00329342|Posture|posture
5329355|NCT00329329|Advanced solid malignancies|advanced solid malignancies
5329356|NCT00329316|Pre-term labor|pre-term labor
5329357|NCT00329316|progesterone|progesterone
5329358|NCT00329303|Moderate to severe chronic plaque psoriasis|moderate to severe chronic plaque psoriasis
5329359|NCT00329303|anti TNF α|anti tnf α
5329360|NCT00329303|CDP 870|cdp 870
5329361|NCT00329303|Cimzia®|cimzia®
5329362|NCT00329303|certolizumab pegol|certolizumab pegol
5329363|NCT00329303|retreatment|retreatment
5329364|NCT00329290|pregnancy|pregnancy
5329365|NCT00329290|anticoagulation|anticoagulation
5329366|NCT00329290|enoxaparin|enoxaparin
5329367|NCT00329290|prosthetic heart valves|prosthetic heart valves
5329368|NCT00329277|age-related macular degeneration|age-related macular degeneration
5329369|NCT00329277|preferred retinal locus|preferred retinal locus
5329370|NCT00329277|macular perimetry|macular perimetry
5329371|NCT00329264|GAD|gad
5329372|NCT00329264|anxiety|anxiety
5329373|NCT00329251|HIV|hiv
5329374|NCT00329251|Viral load|viral load
5329375|NCT00329251|Vaccines|vaccines
5329376|NCT00329251|Immunotherapy|immunotherapy
5329377|NCT00329225|Type 2 Diabetes Mellitus Thiazolidinediones Insulin|type 2 diabetes mellitus thiazolidinediones insulin
5329378|NCT00329212|Pharmacokinetics|pharmacokinetics
5329379|NCT00329212|Bioavailability|bioavailability
5329380|NCT00329212|Therapeutic Equivalency|therapeutic equivalency
5329381|NCT00329199|Depression|depression
5329382|NCT00329199|Adolescents|adolescents
5329383|NCT00329199|Family Therapy|family therapy
5329384|NCT00329199|Primary Care|primary care
5329385|NCT00329199|Family Conflict|family conflict
5329386|NCT00329186|Healthy Subjects|healthy subjects
5329387|NCT00329186|Major Depressive Disorder|major depressive disorder
5329388|NCT00329186|Depression|depression
5329389|NCT00329186|Cytochrome P-450 CYP2D6|cytochrome p-450 cyp2d6
5329390|NCT00329186|Pharmacokinetics|pharmacokinetics
5329391|NCT00329186|Health|health
5329392|NCT00329147|Healthy Subjects|healthy subjects
5329393|NCT00329147|Major Depressive Disorder|major depressive disorder
5329394|NCT00329147|Depression|depression
5329395|NCT00329121|SCCIS|sccis
5329396|NCT00329121|Bowens disease|bowens disease
5329397|NCT00329121|PEP005|pep005
5329398|NCT00329121|Topical|topical
5329399|NCT00329121|Dermatology|dermatology
5329400|NCT00329121|Cutaneous Squamous Cell Carcinoma in situ|cutaneous squamous cell carcinoma in situ
5329401|NCT00329095|Glaucoma|glaucoma
5329402|NCT00329095|Compliance|compliance
5329403|NCT00329069|statin|statin
5329404|NCT00329069|atorvastatin|atorvastatin
5329405|NCT00329069|hypercholesterolemia|hypercholesterolemia
5329406|NCT00329069|coronary artery disease|coronary artery disease
5329407|NCT00329069|monocyte|monocyte
5329408|NCT00329069|collateral formation|collateral formation
5329409|NCT00329069|arteriogenesis|arteriogenesis
5329410|NCT00329069|chemotaxis|chemotaxis
5329411|NCT00329069|migration|migration
5329412|NCT00329069|growth factors|growth factors
5329413|NCT00329069|vascular endothelial growth factor A|vascular endothelial growth factor a
5329414|NCT00329069|placenta growth factor 1|placenta growth factor 1
5329415|NCT00329069|hepatocyte growth factor|hepatocyte growth factor
5329416|NCT00329069|monocyte chemotactic protein 1|monocyte chemotactic protein 1
5329417|NCT00329056|Parkinson's disease|parkinson's disease
5329418|NCT00329056|MitoQ|mitoq
5329419|NCT00329056|UPDRS|updrs
5329420|NCT00329043|Prostate Cancer|prostate cancer
5329421|NCT00329043|Adenocarcinoma of the Prostate|adenocarcinoma of the prostate
5329422|NCT00329043|Ductal Adenocarcinoma of the Prostate|ductal adenocarcinoma of the prostate
5329423|NCT00329043|Hormonal Ablation|hormonal ablation
5329424|NCT00329043|Radical Prostatectomy|radical prostatectomy
5329425|NCT00329043|LHRH Agonist|lhrh agonist
5329426|NCT00329043|Lupron|lupron
5329427|NCT00329043|Leuprolide|leuprolide
5329428|NCT00329043|Sunitinib Malate|sunitinib malate
5329429|NCT00329043|SU011248|su011248
5329430|NCT00329030|Large B-Cell Lymphoma|large b-cell lymphoma
5329431|NCT00329030|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
5329432|NCT00329017|SNPs|snps
5329433|NCT00329017|single nucleotide polymorphism|single nucleotide polymorphism
5329434|NCT00329017|breast atypia|breast atypia
5329435|NCT00329017|breast epithelial hyperplasia|breast epithelial hyperplasia
5329436|NCT00329017|high risk for breast cancer|high risk for breast cancer
5329437|NCT00329004|Solid Tumors|solid tumors
5329438|NCT00328991|wart|wart
5329439|NCT00328991|common wart|common wart
5329440|NCT00328991|verruca vulgaris|verruca vulgaris
5329441|NCT00328991|verruca plantaris|verruca plantaris
5329442|NCT00328991|plantar wart|plantar wart
5329443|NCT00328991|duct tape|duct tape
5329444|NCT00328991|occlusion therapy|occlusion therapy
5329445|NCT00328978|schizophrenia|schizophrenia
5329446|NCT00328978|schizoaffective disorders|schizoaffective disorders
5329447|NCT00328965|Korean patients|korean patients
5329448|NCT00328965|Type 2 diabetes|type 2 diabetes
5329449|NCT00328965|Endothelial function|endothelial function
5329450|NCT00328965|lacidipine|lacidipine
5329451|NCT00328965|Essential hypertension|essential hypertension
5329452|NCT00328952|schizophrenia|schizophrenia
5329453|NCT00328952|auditory verbal hallucination|auditory verbal hallucination
5329454|NCT00328952|antipsychotic treatment|antipsychotic treatment
5329455|NCT00328939|ARIXTRA|arixtra
5329456|NCT00328939|prevention of DVT|prevention of dvt
5329457|NCT00328926|Hypogonadotropic Hypogonadism (LH <1.2 IU/L)|hypogonadotropic hypogonadism (lh <1.2 iu/l)
5329458|NCT00328926|Placebo|placebo
5329459|NCT00328926|Luveris® 75 IU|luveris® 75 iu
5329460|NCT00328926|Luveris® 25 IU|luveris® 25 iu
5329461|NCT00328926|Recombinant human chorionic gonadotropin (r-hCG)|recombinant human chorionic gonadotropin (r-hcg)
5329462|NCT00328913|satiety|satiety
5329463|NCT00328913|food intake|food intake
5329464|NCT00328913|mood|mood
5329465|NCT00328913|wellness|wellness
5329466|NCT00328913|weight management|weight management
5329467|NCT00328900|Galvanic skin response|galvanic skin response
5329468|NCT00328900|Anesthesia|anesthesia
5329469|NCT00328900|Atropine|atropine
5329470|NCT00328887|Esophageal Neoplasms|esophageal neoplasms
5329471|NCT00328874|Progressive Supranuclear Palsy|progressive supranuclear palsy
5329472|NCT00328874|Coenzyme Q10|coenzyme q10
5329473|NCT00328861|Adoptive Cell Therapy|adoptive cell therapy
5329474|NCT00328861|Cutaneous Melanoma|cutaneous melanoma
5329475|NCT00328861|Clinical Response|clinical response
5329476|NCT00328861|Rate of Repopulation|rate of repopulation
5329477|NCT00328861|Toxicity Profile|toxicity profile
5329478|NCT00328861|Metastatic Melanoma|metastatic melanoma
5329479|NCT00328861|Metastatic Kidney Cancer|metastatic kidney cancer
5329480|NCT00328848|patient care management|patient care management
5329481|NCT00328848|chronic disease|chronic disease
5329482|NCT00328835|Optic Nerve|optic nerve
5329483|NCT00328835|Glaucoma|glaucoma
5329484|NCT00328822|Primary insomnia|primary insomnia
5329485|NCT00328822|Quetiapine|quetiapine
5329486|NCT00328822|Randomized controlled trial|randomized controlled trial
5329487|NCT00328822|Double blind|double blind
5329488|NCT00328796|Perineal|perineal
5329489|NCT00328796|repair|repair
5329490|NCT00328796|episiotomies|episiotomies
5329491|NCT00328796|midwives|midwives
5329492|NCT00328796|pain relief|pain relief
5329493|NCT00328796|Episiotomy|episiotomy
5329494|NCT00328783|Breast cancer|breast cancer
5329495|NCT00328783|Active Breathing Control|active breathing control
5329496|NCT00328783|Active Breathing Coordinator|active breathing coordinator
5329497|NCT00328783|ABC|abc
5329498|NCT00328770|liver transplant|liver transplant
5329499|NCT00328770|hepatocellular carcinoma|hepatocellular carcinoma
5329500|NCT00328770|sirolimus|sirolimus
5329501|NCT00328757|gynecologic cancer|gynecologic cancer
5329502|NCT00328757|cervical cancer|cervical cancer
5329503|NCT00328757|ovarian cancer|ovarian cancer
5329504|NCT00328757|endometrial cancer|endometrial cancer
5329505|NCT00328757|radical abdominal hysterectomy|radical abdominal hysterectomy
5329506|NCT00328757|pelvic lymphadenectomy|pelvic lymphadenectomy
5329507|NCT00328757|surgical staging|surgical staging
5329508|NCT00328757|postoperative feeding|postoperative feeding
5329509|NCT00328757|Early-stage gynecologic cancer patients|early-stage gynecologic cancer patients
5329510|NCT00328744|Weight|weight
5329511|NCT00328744|Dietary intake|dietary intake
5329512|NCT00328744|Energy|energy
5329513|NCT00328744|Hedonics|hedonics
5329514|NCT00328744|Behavioral|behavioral
5329515|NCT00328744|Sensory-specific satiety|sensory-specific satiety
5329516|NCT00328744|Monotony|monotony
5329517|NCT00328731|Allergy|allergy
5329518|NCT00328731|NAET|naet
5329519|NCT00328718|Persistent Asthma|persistent asthma
5329520|NCT00328718|pediatric asthmatic|pediatric asthmatic
5329521|NCT00328718|asthma control|asthma control
5329522|NCT00328705|Sensing|sensing
5329523|NCT00328705|Capture Management|capture management
5329524|NCT00328705|Heart Failure|heart failure
5329525|NCT00328705|ICD Indication|icd indication
5329526|NCT00328692|heart failure|heart failure
5329527|NCT00328692|diuretic|diuretic
5329528|NCT00328692|renal impairment|renal impairment
5329529|NCT00328692|renal function|renal function
5329530|NCT00328679|abdominal|abdominal
5329531|NCT00328679|stomach|stomach
5329532|NCT00328679|dyspepsia|dyspepsia
5329533|NCT00328679|food allergy|food allergy
5329534|NCT00328653|vernal keratoconjunctivitis (VKC), eye, allergy, cyclosporin|vernal keratoconjunctivitis (vkc), eye, allergy, cyclosporin
5329535|NCT00328640|CVA|cva
5329536|NCT00328640|Ischemic stroke|ischemic stroke
5329537|NCT00328627|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
5329538|NCT00328627|Drug Therapy|drug therapy
5329539|NCT00328627|Diabetes Mellitus, Non Insulin Dependent|diabetes mellitus, non insulin dependent
5329540|NCT00328627|Glucose Intolerance|glucose intolerance
5329541|NCT00328627|Hyperglycemia|hyperglycemia
5329542|NCT00328614|Locally advanced prostate cancer|locally advanced prostate cancer
5329543|NCT00328614|positive lymph nodes|positive lymph nodes
5329544|NCT00328588|Treatment Efficacy|treatment efficacy
5329545|NCT00328588|Treatment Effectiveness|treatment effectiveness
5329546|NCT00328588|Disease Management|disease management
5329547|NCT00328588|Treatment|treatment
5329548|NCT00328588|Safety|safety
5329549|NCT00328575|Brain metastases|brain metastases
5329551|NCT00328575|Neoplasm|neoplasm
5329552|NCT00328575|IMRT|imrt
5329553|NCT00328575|Intensity Modulated Radiation Therapy|intensity modulated radiation therapy
5329554|NCT00328562|Advanced NSCLC|advanced nsclc
5329555|NCT00328562|Non-Small Cell Lung Carcinoma|non-small cell lung carcinoma
5329556|NCT00328562|Stage IV NSCLC|stage iv nsclc
5329557|NCT00328549|Natural History,|natural history,
5329558|NCT00328549|Hepatitis C Infection|hepatitis c infection
5329559|NCT00328549|Ribavirin|ribavirin
5329560|NCT00328549|Pegylated Interferon|pegylated interferon
5329561|NCT00328549|Interferon|interferon
5329562|NCT00328536|flow-mediated vasodilatation|flow-mediated vasodilatation
5329563|NCT00328536|endothelial dysfunction|endothelial dysfunction
5329564|NCT00328536|omega-3 fatty acids|omega-3 fatty acids
5329565|NCT00328536|type 2 diabetes mellitus|type 2 diabetes mellitus
5329566|NCT00328536|postprandial state|postprandial state
5329567|NCT00328510|Stereotactic radiotherapy|stereotactic radiotherapy
5329568|NCT00328484|COPD|copd
5329569|NCT00328484|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5329570|NCT00328484|Exercise|exercise
5329571|NCT00328484|Emphysema|emphysema
5329572|NCT00328484|Chronic Bronchitis|chronic bronchitis
5329573|NCT00328471|patient care management|patient care management
5329574|NCT00328471|cerebrovascular accident|cerebrovascular accident
5329575|NCT00328458|CNS and head and neck cancers|cns and head and neck cancers
5329576|NCT00328458|Histologically confirmed CNS malignancy head and neck|histologically confirmed cns malignancy head and neck
5329577|NCT00328458|there is on standard therapy or|there is on standard therapy or
5329578|NCT00328458|have failed standard therapy|have failed standard therapy
5329579|NCT00328445|Curriculum|curriculum
5329580|NCT00328445|Classroom management|classroom management
5329581|NCT00328445|School-wide climate|school-wide climate
5329582|NCT00328445|Parent involvement|parent involvement
5329583|NCT00328432|early breast cancer|early breast cancer
5329584|NCT00328432|double-blind randomized placebo-controlled|double-blind randomized placebo-controlled
5329585|NCT00328432|RCT|rct
5329586|NCT00328432|pre-surgical model|pre-surgical model
5329587|NCT00328432|DCIS model|dcis model
5329588|NCT00328432|COX-2 inhibitor|cox-2 inhibitor
5329589|NCT00328432|celecoxib|celecoxib
5329590|NCT00328432|Ki-67 placebo|ki-67 placebo
5329591|NCT00328419|Photoprotection,|photoprotection,
5329592|NCT00328419|Parenteral nutrition|parenteral nutrition
5329593|NCT00328419|Oxidant stress|oxidant stress
5329594|NCT00328419|Infant, Premature|infant, premature
5329595|NCT00328393|Hypertension|hypertension
5329596|NCT00328380|Travelers' Diarrhea|travelers' diarrhea
5329597|NCT00328380|Xifaxan|xifaxan
5329598|NCT00328380|Rifaximin|rifaximin
5329599|NCT00328380|Escherichia coli|escherichia coli
5329600|NCT00328380|E coli|e coli
5329601|NCT00328380|EAEC|eaec
5329602|NCT00328380|Enteroaggregative E coli|enteroaggregative e coli
5329603|NCT00328380|ETEC|etec
5329604|NCT00328380|Enterotoxigenic E coli|enterotoxigenic e coli
5329605|NCT00328367|schizophrenia|schizophrenia
5329606|NCT00328367|aripiprazole|aripiprazole
5329607|NCT00328367|clozapine|clozapine
5329608|NCT00328341|traumatic brain injury|traumatic brain injury
5329609|NCT00328341|hemorrhagic shock|hemorrhagic shock
5329610|NCT00328341|multisystem trauma|multisystem trauma
5329611|NCT00328341|under resuscitation|under resuscitation
5329612|NCT00328341|tissue oxygen monitoring|tissue oxygen monitoring
5329613|NCT00328315|Myocardial Perfusion SPECT|myocardial perfusion spect
5329614|NCT00328302|Diabetes|diabetes
5329615|NCT00328302|Kidney function|kidney function
5329616|NCT00328302|24 ambulatory blood pressure|24 ambulatory blood pressure
5329617|NCT00328302|Kidney biopsy|kidney biopsy
5329618|NCT00328289|Dialysis associated hypotension|dialysis associated hypotension
5329619|NCT00328289|Urea removal|urea removal
5329620|NCT00328263|Bio-K+CL1285|bio-k+cl1285
5329621|NCT00328263|Probiotics|probiotics
5329622|NCT00328263|Antibiotics-associated diarrhea|antibiotics-associated diarrhea
5329623|NCT00328263|Clostridium difficile-associated diarrhea|clostridium difficile-associated diarrhea
5329624|NCT00328263|Lactobacillus acidophilus|lactobacillus acidophilus
5329625|NCT00328263|Clostridium Difficile|clostridium difficile
5329626|NCT00328250|Internet|internet
5329627|NCT00328250|CBT|cbt
5329628|NCT00328250|Insomnia|insomnia
5329629|NCT00328250|Sleep|sleep
5329630|NCT00328237|Cord Blood Transplant|cord blood transplant
5329631|NCT00328237|Umbilical cord blood transplant|umbilical cord blood transplant
5329632|NCT00328237|Transplant|transplant
5329633|NCT00328237|Fludarabine|fludarabine
5329634|NCT00328237|Total Body Irradiation|total body irradiation
5329635|NCT00328237|Cyclophosphamide|cyclophosphamide
5329636|NCT00328224|ritalin|ritalin
5329637|NCT00328224|ADHA|adha
5329638|NCT00328224|dental status|dental status
5329639|NCT00328224|periodontal status|periodontal status
5329640|NCT00328224|Attention-Deficit Hyperactivity Disorder|attention-deficit hyperactivity disorder
5329641|NCT00328224|Dental trauma|dental trauma
5329642|NCT00328198|CAMPATH|campath
5329643|NCT00328198|Alemtuzumab|alemtuzumab
5329644|NCT00328198|Leukemia|leukemia
5329645|NCT00328198|MabCampath|mabcampath
5329646|NCT00328198|Chronic|chronic
5329647|NCT00328198|Subcutaneous|subcutaneous
5329648|NCT00328198|CLL|cll
5329649|NCT00328198|C-CLL|c-cll
5329650|NCT00328198|Relapsed|relapsed
5329651|NCT00328198|Refractory|refractory
5329652|NCT00328198|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
5329653|NCT00328185|pediatric|pediatric
5329654|NCT00328185|heart disease|heart disease
5329655|NCT00328185|orthotopic heart transplantation|orthotopic heart transplantation
5329656|NCT00328185|allograft fibrosis|allograft fibrosis
5329657|NCT00328159|FAO disorders|fao disorders
5329658|NCT00328159|long-chain FAO enzyme defects|long-chain fao enzyme defects
5329659|NCT00328159|inborn errors of metabolism|inborn errors of metabolism
5329660|NCT00328159|carnitine palmitoyltransferase 1 (CPT1),|carnitine palmitoyltransferase 1 (cpt1),
5329661|NCT00328159|carnitine-acylcarnitine translocase (CAT),|carnitine-acylcarnitine translocase (cat),
5329662|NCT00328159|carnitine palmitoyltransferase 2 (CPT2),|carnitine palmitoyltransferase 2 (cpt2),
5329663|NCT00328159|very-long chain acyl-CoA dehydrogenase (VLCAD),|very-long chain acyl-coa dehydrogenase (vlcad),
5329664|NCT00328159|L-3-hydroxy-acyl-CoA dehydrogenase (LCHAD)|l-3-hydroxy-acyl-coa dehydrogenase (lchad)
5329665|NCT00328159|or trifunctional protein (MTP).|or trifunctional protein (mtp).
5329666|NCT00328146|pediatric|pediatric
5329667|NCT00328146|cardiac|cardiac
5329668|NCT00328146|re-operative surgery|re-operative surgery
5329669|NCT00328133|recombinant Factor VIIa|recombinant factor viia
5329670|NCT00328133|traumatic hemorrhage|traumatic hemorrhage
5329671|NCT00328133|hemorrhagic shock|hemorrhagic shock
5329672|NCT00328133|coagulopathy|coagulopathy
5329673|NCT00328120|Advanced breast cancer|advanced breast cancer
5329674|NCT00328120|Faslodex|faslodex
5329675|NCT00328107|Influenza|influenza
5329676|NCT00328094|Tight|tight
5329677|NCT00328094|Glycemic|glycemic
5329678|NCT00328094|control|control
5329679|NCT00328094|outcomes|outcomes
5329680|NCT00328094|peripheral vascular disease|peripheral vascular disease
5329681|NCT00328094|infection|infection
5329682|NCT00328094|cardiovascular|cardiovascular
5329683|NCT00328094|morbidity|morbidity
5329684|NCT00328094|mortality|mortality
5329685|NCT00328081|Obesity|obesity
5329686|NCT00328081|Weight gain|weight gain
5329687|NCT00328081|Anti-obesity medication|anti-obesity medication
5329688|NCT00328081|Anti-obesity management strategies|anti-obesity management strategies
5329689|NCT00328081|Body Weight|body weight
5329690|NCT00328068|ASAS classification|asas classification
5329691|NCT00328068|ASAS diagnostic criteria|asas diagnostic criteria
5329692|NCT00328068|spondyloarthritis|spondyloarthritis
5329693|NCT00328068|spondyloarthropathy|spondyloarthropathy
5329694|NCT00328068|spondylitis, ankylosing|spondylitis, ankylosing
5329695|NCT00328068|modified New York criteria for AS|modified new york criteria for as
5329696|NCT00328068|ESSG criteria for SpA|essg criteria for spa
5329697|NCT00328068|Amor criteria for SpA|amor criteria for spa
5329698|NCT00328068|arthritis|arthritis
5329699|NCT00328068|enthesitis|enthesitis
5329700|NCT00328068|magnetic resonance imaging|magnetic resonance imaging
5329701|NCT00328055|functional ability|functional ability
5329702|NCT00328055|patient care management|patient care management
5329703|NCT00328055|communication|communication
5329704|NCT00328055|literacy|literacy
5329705|NCT00328042|Self-care|self-care
5329706|NCT00328042|Quality of Life|quality of life
5329707|NCT00328042|Chronic disease|chronic disease
5329708|NCT00328029|Busulfan|busulfan
5329709|NCT00328029|pharmacokinetic|pharmacokinetic
5329710|NCT00328029|respiratory function assessment|respiratory function assessment
5329711|NCT00328029|Busulfan pharmacokinetic and respiratory function tests|busulfan pharmacokinetic and respiratory function tests
5329712|NCT00328016|hypertension|hypertension
5329713|NCT00328016|high blood pressure|high blood pressure
5329714|NCT00328016|meditation|meditation
5329715|NCT00327990|ibandronate|ibandronate
5329716|NCT00327990|osteoporosis|osteoporosis
5329717|NCT00327990|preference|preference
5329718|NCT00327990|case-finding|case-finding
5329719|NCT00327990|post-menopausal|post-menopausal
5329720|NCT00327990|alendronate|alendronate
5329721|NCT00327977|hypoxemia|hypoxemia
5329722|NCT00327977|palliative neonatal surgery|palliative neonatal surgery
5329723|NCT00327964|malaria|malaria
5329724|NCT00327964|fever|fever
5329725|NCT00327964|Uganda|uganda
5329726|NCT00327964|children|children
5329727|NCT00327964|rapid diagnostic tests|rapid diagnostic tests
5329728|NCT00327964|RDTs|rdts
5329729|NCT00327964|Africa|africa
5329730|NCT00327951|pediatric|pediatric
5329731|NCT00327951|cardiac|cardiac
5329732|NCT00327951|weight gain pre-operative|weight gain pre-operative
5329733|NCT00327951|trisomy 21|trisomy 21
5329734|NCT00327951|complete atrioventricular canal|complete atrioventricular canal
5329735|NCT00327938|Remifentanil|remifentanil
5329736|NCT00327938|Skin Conductance|skin conductance
5329737|NCT00327938|Anesthesia|anesthesia
5329738|NCT00327938|Analgesics, Opioid|analgesics, opioid
5329739|NCT00327925|Ovarian|ovarian
5329740|NCT00327925|Cancer|cancer
5329741|NCT00327925|Antibodies|antibodies
5329742|NCT00327925|Ovarian Cancer Associated Antibodies|ovarian cancer associated antibodies
5329743|NCT00327912|Obesity|obesity
5329744|NCT00327912|Surgery|surgery
5329745|NCT00327912|Gastric bypass|gastric bypass
5329746|NCT00327912|Biliopancreatic diversion with Duodenal switch|biliopancreatic diversion with duodenal switch
5329747|NCT00327912|Laparoscopy|laparoscopy
5329748|NCT00327899|pediatric|pediatric
5329749|NCT00327899|congestive heart failure|congestive heart failure
5329750|NCT00327899|inotropes|inotropes
5329751|NCT00327886|pediatric|pediatric
5329752|NCT00327886|Glenn operation|glenn operation
5329753|NCT00327886|Cyanosis|cyanosis
5329754|NCT00327873|breathlessness|breathlessness
5329755|NCT00327873|shortness of breath|shortness of breath
5329756|NCT00327873|end-of-life care|end-of-life care
5329757|NCT00327873|hospice|hospice
5329758|NCT00327808|Smokers|smokers
5329759|NCT00327808|Adults|adults
5329760|NCT00327808|Inflammatory markers|inflammatory markers
5329761|NCT00327795|congenital heart disease|congenital heart disease
5329762|NCT00327795|pediatric|pediatric
5329763|NCT00327795|surgical outcomes|surgical outcomes
5329764|NCT00327782|pediatric|pediatric
5329765|NCT00327782|palliative care|palliative care
5329766|NCT00327782|end stage heart failure|end stage heart failure
5329767|NCT00327769|Advanced breast cancer|advanced breast cancer
5329768|NCT00327769|fulvestrant|fulvestrant
5329769|NCT00327769|anastrozole|anastrozole
5329770|NCT00327756|Depression|depression
5329771|NCT00327756|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
5329772|NCT00327756|Mitochondrial Enhancer|mitochondrial enhancer
5329773|NCT00327756|Manic Depressive|manic depressive
5329774|NCT00327756|Bioenergetics|bioenergetics
5329775|NCT00327756|Bipolar Disorder|bipolar disorder
5329776|NCT00327756|Manic Depression|manic depression
5329777|NCT00327743|Cancer Alternative Therapies|cancer alternative therapies
5329778|NCT00327743|Metastatic Breast Cancer|metastatic breast cancer
5329779|NCT00327730|Muscle|muscle
5329780|NCT00327730|Spasm|spasm
5329781|NCT00327730|Back|back
5329782|NCT00327730|Pain|pain
5329783|NCT00327717|Epilepsy|epilepsy
5329784|NCT00327717|Partial seizures|partial seizures
5329785|NCT00327704|Septic Shock|septic shock
5329786|NCT00327691|Major cardiovascular event|major cardiovascular event
5329787|NCT00327691|Major Coronary event|major coronary event
5329788|NCT00327691|Revascularization|revascularization
5329789|NCT00327678|ALL,|all,
5329790|NCT00327678|young patients,|young patients,
5329791|NCT00327678|chemotherapy,|chemotherapy,
5329792|NCT00327678|Mabtera,|mabtera,
5329793|NCT00327678|Imatinib,|imatinib,
5329794|NCT00327678|allogeneic transplant|allogeneic transplant
5329795|NCT00327665|pneumonia|pneumonia
5329796|NCT00327665|pneumococcal vaccine|pneumococcal vaccine
5329797|NCT00327665|elderly subjects|elderly subjects
5329798|NCT00327665|invasive pneumococcal diseases|invasive pneumococcal diseases
5329799|NCT00327665|Prophylaxis|prophylaxis
5329800|NCT00327652|carcinoma|carcinoma
5329801|NCT00327652|liver|liver
5329802|NCT00327652|hepatic|hepatic
5329803|NCT00327652|metastasis|metastasis
5329804|NCT00327652|Listeria|listeria
5329805|NCT00327626|Fasting plasma glucose|fasting plasma glucose
5329806|NCT00327626|HbA1c|hba1c
5329807|NCT00327626|Oral antidiabetic agent(s)|oral antidiabetic agent(s)
5329809|NCT00327613|glaucoma|glaucoma
5329810|NCT00327613|MMP|mmp
5329811|NCT00327613|DNA degradation|dna degradation
5329812|NCT00327613|POAG|poag
5329813|NCT00327613|Healthy subjects|healthy subjects
5329814|NCT00327587|hypertension|hypertension
5329815|NCT00327587|valsartan|valsartan
5329816|NCT00327587|amlodipine|amlodipine
5329817|NCT00327587|HCTZ|hctz
5329818|NCT00327561|Inflammation|inflammation
5329819|NCT00327561|Periodontitis|periodontitis
5329820|NCT00327561|Endothelial function|endothelial function
5329821|NCT00327561|Atherosclerosis|atherosclerosis
5329822|NCT00327561|Controlled trial|controlled trial
5329823|NCT00327509|mRNA|mrna
5329824|NCT00327509|glaucoma|glaucoma
5329825|NCT00327483|Transplant|transplant
5329826|NCT00327483|Medication error|medication error
5329827|NCT00327483|Patient Safety|patient safety
5329828|NCT00327483|Information technology|information technology
5329829|NCT00327470|neovascular age related macular degeneration|neovascular age related macular degeneration
5329830|NCT00327470|choroidal neovascularization|choroidal neovascularization
5329831|NCT00327457|colorectal cancer screening|colorectal cancer screening
5329832|NCT00327457|sigmoidoscopy|sigmoidoscopy
5329833|NCT00327457|colonoscopy|colonoscopy
5329834|NCT00327444|Ovarian neoplasm|ovarian neoplasm
5329835|NCT00327444|Ascites|ascites
5329836|NCT00327444|Angiogenesis inhibitor|angiogenesis inhibitor
5329837|NCT00327444|Vascular Endothelial Growth Factor A|vascular endothelial growth factor a
5329838|NCT00327444|Recombinant fusion protein|recombinant fusion protein
5329839|NCT00327431|Hypertension|hypertension
5329840|NCT00327431|Blood Pressure|blood pressure
5329841|NCT00327431|Psychosocial Factors|psychosocial factors
5329842|NCT00327405|POAG|poag
5329843|NCT00327405|Primary Open Angle Glaucoma|primary open angle glaucoma
5329844|NCT00327405|Trabeculectomy|trabeculectomy
5329845|NCT00327405|Combined Phacotrabeculectomy|combined phacotrabeculectomy
5329846|NCT00327405|Combined Glaucoma Cataract Surgery|combined glaucoma cataract surgery
5329847|NCT00327405|Releasable Suture|releasable suture
5329848|NCT00327405|Ocular Compresssion|ocular compresssion
5329849|NCT00327392|Arthroscopy|arthroscopy
5329850|NCT00327392|AV Shunt|av shunt
5329851|NCT00327392|Bunion|bunion
5329852|NCT00327392|Dilatation and Curettage|dilatation and curettage
5329853|NCT00327392|Esophagogastroduodenoscopy|esophagogastroduodenoscopy
5329854|NCT00327392|Hysteroscopy|hysteroscopy
5329855|NCT00327392|Lithotripsy|lithotripsy
5329856|NCT00327392|Rotator Cuff/ Shoulder|rotator cuff/ shoulder
5329857|NCT00327392|Transesophageal Echocardiography|transesophageal echocardiography
5329858|NCT00327392|Ureteroscopy|ureteroscopy
5329859|NCT00327392|AQUAVAN|aquavan
5329860|NCT00327392|Sedation|sedation
5329861|NCT00327379|Bloodloss|bloodloss
5329862|NCT00327379|Transfusion Requirements in Patients Undergoing Elective Spinal Fusion Surgery|transfusion requirements in patients undergoing elective spinal fusion surgery
5329863|NCT00327366|Menstrual Cycle|menstrual cycle
5329864|NCT00327366|Light Therapy|light therapy
5329865|NCT00327366|Sex Hormones|sex hormones
5329866|NCT00327366|Ovulation|ovulation
5329867|NCT00327353|Asthma|asthma
5329868|NCT00327353|Salmeterol|salmeterol
5329869|NCT00327353|Formoterol|formoterol
5329870|NCT00327353|Airway resistance|airway resistance
5329871|NCT00327340|Metastatic hormone refractory prostate cancer (HRPC)|metastatic hormone refractory prostate cancer (hrpc)
5329872|NCT00327301|POAG|poag
5329873|NCT00327301|Parkinson's disease|parkinson's disease
5329874|NCT00327301|cellular proteome|cellular proteome
5329875|NCT00327301|human leucocytes|human leucocytes
5329876|NCT00327301|vasospasm|vasospasm
5329877|NCT00327301|POAG patients|poag patients
5329878|NCT00327301|Patients with Parkinson's disease|patients with parkinson's disease
5329879|NCT00327301|Healthy subjects|healthy subjects
5329880|NCT00327288|Hormone refractory prostate cancer|hormone refractory prostate cancer
5329881|NCT00327262|chronic myeloid leukemia|chronic myeloid leukemia
5329883|NCT00327262|bcr/abl+|bcr/abl+
5329884|NCT00327262|imatinib|imatinib
5329885|NCT00327236|Paraneoplastic Neurologic Syndromes|paraneoplastic neurologic syndromes
5329886|NCT00327223|Metastatic cancer|metastatic cancer
5329887|NCT00327223|Disseminated malignant disease|disseminated malignant disease
5329888|NCT00327210|BGAT|bgat
5329889|NCT00327210|Blood Glucose Awareness Training|blood glucose awareness training
5329890|NCT00327210|Diabetes|diabetes
5329891|NCT00327210|T1DM|t1dm
5329892|NCT00327210|Internet|internet
5329893|NCT00327210|Web|web
5329894|NCT00327210|Intervention|intervention
5329895|NCT00327210|Treatment|treatment
5329896|NCT00327210|Behavior|behavior
5329897|NCT00327210|Education|education
5329898|NCT00327210|Awareness|awareness
5329899|NCT00327197|bronchoscopy|bronchoscopy
5329900|NCT00327197|Sputum induction|sputum induction
5329901|NCT00327197|Prednisolone|prednisolone
5329902|NCT00327197|Asthma|asthma
5329903|NCT00327197|biomarkers|biomarkers
5329904|NCT00327171|ovarian cancer|ovarian cancer
5329905|NCT00327171|angiogenesis|angiogenesis
5329906|NCT00327171|angiogenesis inhibition|angiogenesis inhibition
5329907|NCT00327171|VEGF-Trap fusion recombinant protein|vegf-trap fusion recombinant protein
5329908|NCT00327171|Cancer and other neoplasms|cancer and other neoplasms
5329909|NCT00327158|Reaming|reaming
5329910|NCT00327158|fracture|fracture
5329911|NCT00327158|emboli|emboli
5329912|NCT00327145|HCTZ|hctz
5329913|NCT00327145|hypertension|hypertension
5329914|NCT00327145|valsartan|valsartan
5329915|NCT00327145|amlodipine|amlodipine
5329916|NCT00327132|Early-stage Lg/Hg Gastric MALT Lymphoma|early-stage lg/hg gastric malt lymphoma
5329917|NCT00327132|Eradication of Helicobacter pylori (Hp)|eradication of helicobacter pylori (hp)
5329918|NCT00327119|EGFR|egfr
5329919|NCT00327119|Fully human|fully human
5329920|NCT00327119|Monoclonal antibody|monoclonal antibody
5329921|NCT00327119|Panitumumab|panitumumab
5329922|NCT00327119|ABX-EGF|abx-egf
5329923|NCT00327119|AMG954|amg954
5329924|NCT00327119|Colorectal Cancer|colorectal cancer
5329925|NCT00327119|Japan|japan
5329926|NCT00327106|hip fracture|hip fracture
5329927|NCT00327106|transfusion|transfusion
5329928|NCT00327106|tranexamic acid|tranexamic acid
5329929|NCT00327106|fondaparinux|fondaparinux
5329930|NCT00327093|Colorectal cancer,|colorectal cancer,
5329931|NCT00327093|immunohistochemistry,|immunohistochemistry,
5329932|NCT00327093|monoclonal antibodies,|monoclonal antibodies,
5329933|NCT00327093|predictive model,|predictive model,
5329934|NCT00327093|antiangiogenic agents,|antiangiogenic agents,
5329935|NCT00327093|medical imaging|medical imaging
5329936|NCT00327093|Colorectal cancer with liver metastases|colorectal cancer with liver metastases
5329937|NCT00327080|HIV|hiv
5329938|NCT00327080|AIDS|aids
5329939|NCT00327080|Pulmonary Hypertension|pulmonary hypertension
5329940|NCT00327080|Blood Flow Studies|blood flow studies
5329941|NCT00327080|Right Heart Catheterization|right heart catheterization
5329942|NCT00327080|HIV Infection|hiv infection
5329943|NCT00327080|HIV Associated Pulmonary Hypertension|hiv associated pulmonary hypertension
5329944|NCT00327080|Healthy Volunteer|healthy volunteer
5329945|NCT00327080|HV|hv
5329946|NCT00327067|Hemoglobin|hemoglobin
5329947|NCT00327067|Iron Supplementation|iron supplementation
5329948|NCT00327067|Donor Retention|donor retention
5329949|NCT00327067|Iron Stores|iron stores
5329950|NCT00327067|Ferritin|ferritin
5329951|NCT00327067|Transferrin Saturation|transferrin saturation
5329952|NCT00327067|Healthy Volunteer|healthy volunteer
5329953|NCT00327067|HV|hv
5329954|NCT00327067|Blood Donors|blood donors
5329955|NCT00327054|Dyslipidaemia|dyslipidaemia
5329956|NCT00327054|Herbal medicine|herbal medicine
5329957|NCT00327054|Home remedy|home remedy
5329958|NCT00327054|Alternative medicine|alternative medicine
5329959|NCT00327054|Metabolic syndrome|metabolic syndrome
5329960|NCT00327041|Aspirin|aspirin
5329961|NCT00327041|Clopidogrel|clopidogrel
5329962|NCT00327041|Balloon Angioplasty|balloon angioplasty
5329963|NCT00327041|Coronary Thrombosis|coronary thrombosis
5329964|NCT00327028|Bronchial asthma|bronchial asthma
5329965|NCT00327028|Phenytoin, Diphenine|phenytoin, diphenine
5329966|NCT00327028|Antiepileptic drugs|antiepileptic drugs
5329967|NCT00327028|Efficacy|efficacy
5329968|NCT00327002|Low HDL|low hdl
5329969|NCT00327002|Metabolic syndrome|metabolic syndrome
5329970|NCT00327002|low HDL Cholesterol in setting of metabolic syndrome|low hdl cholesterol in setting of metabolic syndrome
5329971|NCT00326989|Extracorporal shock wave therapy|extracorporal shock wave therapy
5329972|NCT00326989|Cell therapy|cell therapy
5329973|NCT00326976|Angioplasty, Transluminal, Percutaneous Coronary|angioplasty, transluminal, percutaneous coronary
5329974|NCT00326976|Myocardial Revascularization|myocardial revascularization
5329975|NCT00326950|Cancer|cancer
5329976|NCT00326950|Tumors|tumors
5329977|NCT00326950|Phase I|phase i
5329978|NCT00326950|E7389|e7389
5329979|NCT00326924|Transfusion|transfusion
5329980|NCT00326898|Sorafenib|sorafenib
5329981|NCT00326898|Sunitinib|sunitinib
5329982|NCT00326898|Renal Carcinoma|renal carcinoma
5329983|NCT00326885|Ascites|ascites
5329984|NCT00326885|Epithelial Cancer|epithelial cancer
5329985|NCT00326885|Epithelial Carcinoma|epithelial carcinoma
5329986|NCT00326885|Epithelial Ovarian Cancer|epithelial ovarian cancer
5329987|NCT00326885|Epithelial Ovarian Carcinoma|epithelial ovarian carcinoma
5329988|NCT00326885|Fallopian Tube Cancer|fallopian tube cancer
5329989|NCT00326885|Fallopian Tube Carcinoma|fallopian tube carcinoma
5329990|NCT00326885|Malignant Ascites|malignant ascites
5329991|NCT00326885|Ovarian Cancer|ovarian cancer
5329992|NCT00326885|Ovarian Carcinoma|ovarian carcinoma
5329993|NCT00326885|Ovarian Epithelial Cancer|ovarian epithelial cancer
5329994|NCT00326885|Ovarian Epithelial Carcinoma|ovarian epithelial carcinoma
5329995|NCT00326885|Peritoneal Cancer|peritoneal cancer
5329996|NCT00326885|Peritoneal Carcinoma|peritoneal carcinoma
5329997|NCT00326885|Recurrent Ascites|recurrent ascites
5329998|NCT00326885|Recurrent Malignant Ascites|recurrent malignant ascites
5329999|NCT00326885|Recurrent Symptomatic Malignant Ascites|recurrent symptomatic malignant ascites
5330000|NCT00326885|Symptomatic Malignant Ascites|symptomatic malignant ascites
5330001|NCT00326885|Symptomatic Ascites|symptomatic ascites
5330002|NCT00326885|Neoplasms, Glandular and Epithelial|neoplasms, glandular and epithelial
5330003|NCT00326885|Ovarian Neoplasms|ovarian neoplasms
5330004|NCT00326885|Fallopian Tube Neoplasms|fallopian tube neoplasms
5330005|NCT00326885|Peritoneal Neoplasms|peritoneal neoplasms
5330006|NCT00326859|analgesia strategies|analgesia strategies
5330007|NCT00326859|pain|pain
5330008|NCT00326859|extensive dressing change|extensive dressing change
5330009|NCT00326833|Vitamin B12 deficiency|vitamin b12 deficiency
5330010|NCT00326833|Vitamin B12 absorption|vitamin b12 absorption
5330011|NCT00326833|Holotranscobalamin|holotranscobalamin
5330012|NCT00326820|hypercalcemia of malignancy|hypercalcemia of malignancy
5330013|NCT00326820|stage IV breast cancer|stage iv breast cancer
5330014|NCT00326820|bone metastases|bone metastases
5330015|NCT00326820|recurrent breast cancer|recurrent breast cancer
5330016|NCT00326820|male breast cancer|male breast cancer
5330017|NCT00326807|naltrexone|naltrexone
5330018|NCT00326807|alcohol|alcohol
5330019|NCT00326807|gambling|gambling
5330020|NCT00326807|concurrent|concurrent
5330021|NCT00326794|Nonsurgical proximal humerus fracture|nonsurgical proximal humerus fracture
5330022|NCT00326794|Rehabilitation|rehabilitation
5330023|NCT00326794|Physiotherapy|physiotherapy
5330024|NCT00326794|randomised controlled trial|randomised controlled trial
5330025|NCT00326781|Nicotine nasal spray + counseling|nicotine nasal spray + counseling
5330026|NCT00326781|Transdermal nicotine + counseling|transdermal nicotine + counseling
5330027|NCT00326742|Alcoholism|alcoholism
5330028|NCT00326742|Risk factors|risk factors
5330029|NCT00326742|Adolescence|adolescence
5330030|NCT00326742|Stress test|stress test
5330031|NCT00326742|HPA system|hpa system
5330032|NCT00326742|Family adversity|family adversity
5330033|NCT00326742|Candidate genes|candidate genes
5330034|NCT00326742|Cortisol|cortisol
5330035|NCT00326742|Adrenocorticotrophin|adrenocorticotrophin
5330036|NCT00326729|burns|burns
5330037|NCT00326729|thermal injury|thermal injury
5330038|NCT00326729|hemodynamics|hemodynamics
5330039|NCT00326729|microcirculation|microcirculation
5330040|NCT00326716|HIV-1 infected pregnant women, either treatment naive or on ATV/RTV combined with ZDV/3TC|hiv-1 infected pregnant women, either treatment naive or on atv/rtv combined with zdv/3tc
5330041|NCT00326703|hypoxia|hypoxia
5330042|NCT00326703|hypobaric|hypobaric
5330043|NCT00326703|altitude|altitude
5330044|NCT00326690|Congestive Heart Failure|congestive heart failure
5330045|NCT00326690|Coronary Artery Disease|coronary artery disease
5330046|NCT00326690|Ischemic Cardiomyopathy|ischemic cardiomyopathy
5330047|NCT00326690|Idiopathic Cardiomyopathy|idiopathic cardiomyopathy
5330048|NCT00326677|Depression Prevention|depression prevention
5330049|NCT00326677|Prevention of Depression|prevention of depression
5330050|NCT00326677|Depression in the Elderly|depression in the elderly
5330051|NCT00326677|Late Life Depression|late life depression
5330052|NCT00326677|Depression in Old Age|depression in old age
5330053|NCT00326677|Treatment of Depression in Primary Care Patients|treatment of depression in primary care patients
5330054|NCT00326677|Sub syndromal depression|sub syndromal depression
5330055|NCT00326677|Minor Depression|minor depression
5330056|NCT00326651|infertility|infertility
5330057|NCT00326651|pregnancy|pregnancy
5330058|NCT00326651|conception|conception
5330059|NCT00326651|conceive|conceive
5330060|NCT00326651|conceiving|conceiving
5330061|NCT00326651|trying to conceive|trying to conceive
5330062|NCT00326651|get pregnant|get pregnant
5330063|NCT00326651|conception kit|conception kit
5330064|NCT00326651|conception cap|conception cap
5330065|NCT00326651|fertility|fertility
5330066|NCT00326651|Women who are actively trying to become pregnant|women who are actively trying to become pregnant
5330067|NCT00326638|prostate, IMRT, tomotherapy, radiation, cancer|prostate, imrt, tomotherapy, radiation, cancer
5330068|NCT00326612|Seizures|seizures
5330069|NCT00326599|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5330070|NCT00326599|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5330071|NCT00326599|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5330072|NCT00326599|squamous cell lung cancer|squamous cell lung cancer
5330073|NCT00326573|Diabetes|diabetes
5330074|NCT00326573|Teenagers|teenagers
5330075|NCT00326573|Motivational Interviewing|motivational interviewing
5330076|NCT00326560|Pterygium excision|pterygium excision
5330077|NCT00326560|Cut and paste|cut and paste
5330078|NCT00326560|Tisseel fibrin glue|tisseel fibrin glue
5330079|NCT00326560|Conjunctival autograft|conjunctival autograft
5330080|NCT00326534|Sarcoidosis|sarcoidosis
5330081|NCT00326534|Rickettsia|rickettsia
5330082|NCT00326534|Serological reactions|serological reactions
5330083|NCT00326534|Polymerase chain reaction|polymerase chain reaction
5330084|NCT00326521|Pregnant Women|pregnant women
5330085|NCT00326521|Epidural Anesthesia|epidural anesthesia
5330086|NCT00326521|Fever|fever
5330087|NCT00326521|Chorioamnionitis|chorioamnionitis
5330088|NCT00326521|Intrauterine pressure catheter|intrauterine pressure catheter
5330089|NCT00326521|Pregnancy|pregnancy
5330090|NCT00326508|T Lymphocytes|t lymphocytes
5330091|NCT00326508|IL-2 Conjugate|il-2 conjugate
5330092|NCT00326508|CD25|cd25
5330093|NCT00326508|T Regulatory Cells|t regulatory cells
5330094|NCT00326508|Autoimmunity|autoimmunity
5330095|NCT00326508|Uveitis|uveitis
5330096|NCT00326508|Daclizumab|daclizumab
5330097|NCT00326508|Denileukin Diftitox|denileukin diftitox
5330098|NCT00326508|Immune Tolerance|immune tolerance
5330099|NCT00326508|T Cell|t cell
5330100|NCT00326495|Sorafenib|sorafenib
5330101|NCT00326495|Cetuximab|cetuximab
5330102|NCT00326495|Advanced Cancer|advanced cancer
5330103|NCT00326495|Phase II|phase ii
5330104|NCT00326495|Colorectal Cancer|colorectal cancer
5330105|NCT00326495|Colon Cancer|colon cancer
5330106|NCT00326495|Rectal Cancer|rectal cancer
5330107|NCT00326495|CRC|crc
5330108|NCT00326495|Metastatic Colorectal Cancer|metastatic colorectal cancer
5330109|NCT00326482|Drug Toxicity|drug toxicity
5330110|NCT00326482|Steatohepatitis|steatohepatitis
5330111|NCT00326482|Hepatotoxicity|hepatotoxicity
5330112|NCT00326482|Liver Biopsy|liver biopsy
5330113|NCT00326482|Elevated transaminases|elevated transaminases
5330114|NCT00326482|HIV|hiv
5330115|NCT00326482|Liver Fibrosis|liver fibrosis
5330116|NCT00326456|ovarian cancer|ovarian cancer
5330117|NCT00326456|chemotherapy|chemotherapy
5330118|NCT00326456|first-line|first-line
5330119|NCT00326443|Salmonella, vaccine, typhoid fever, S. Typhi|salmonella, vaccine, typhoid fever, s. typhi
5330120|NCT00326430|Social Phobia|social phobia
5330121|NCT00326430|Cognitive Therapy|cognitive therapy
5330122|NCT00326430|Interpersonal Therapy|interpersonal therapy
5330123|NCT00326430|Efficacy|efficacy
5330124|NCT00326430|Process-Outcome|process-outcome
5330125|NCT00326417|Severe Aplastic Anemia|severe aplastic anemia
5330126|NCT00326404|Oral Contraceptives|oral contraceptives
5330127|NCT00326404|Adolescents|adolescents
5330128|NCT00326404|Compliance|compliance
5330129|NCT00326391|Attention Deficit Disorder with Hyperactivity, ADHD, Attention Deficit Disorder Adult|attention deficit disorder with hyperactivity, adhd, attention deficit disorder adult
5330130|NCT00326365|mechanical ventilation|mechanical ventilation
5330131|NCT00326365|secretions|secretions
5330132|NCT00326365|viscosity|viscosity
5330133|NCT00326365|homeopathy|homeopathy
5330134|NCT00326365|kalium bichromate|kalium bichromate
5330135|NCT00326365|extubation|extubation
5330136|NCT00326352|Sedation|sedation
5330137|NCT00326352|Propofol|propofol
5330138|NCT00326352|Remifentanil|remifentanil
5330139|NCT00326352|recovery|recovery
5330140|NCT00326339|R935788|r935788
5330141|NCT00326339|Rheumatoid Arthritis|rheumatoid arthritis
5330142|NCT00326339|Syk Kinase|syk kinase
5330143|NCT00326313|Group B streptococci|group b streptococci
5330144|NCT00326313|virulent|virulent
5330145|NCT00326313|morbidity|morbidity
5330146|NCT00326313|mortality|mortality
5330147|NCT00326300|Attention Deficit Hyperactivity Disorder, ADHD, Attention Deficit Disorder Adult|attention deficit hyperactivity disorder, adhd, attention deficit disorder adult
5330148|NCT00326287|Community-Acquired Pneumonia|community-acquired pneumonia
5330149|NCT00326287|Cephalosporins|cephalosporins
5330150|NCT00326287|Methicillin-Resistant Staphylococcus Aureus|methicillin-resistant staphylococcus aureus
5330151|NCT00326248|postoperative nausea and vomiting PONV antiemetics NK-1 5HT3 casopitant mesylate ZOFRAN ondansetron hydrochloride|postoperative nausea and vomiting ponv antiemetics nk-1 5ht3 casopitant mesylate zofran ondansetron hydrochloride
5330152|NCT00326235|Opioid withdrawal|opioid withdrawal
5330153|NCT00326235|Buspirone|buspirone
5330154|NCT00326235|Methadone taper|methadone taper
5330155|NCT00326222|Patient Education as a Topic|patient education as a topic
5330156|NCT00326222|Self-Management Program|self-management program
5330157|NCT00326222|Health promotion|health promotion
5330158|NCT00326222|Self Efficacy|self efficacy
5330159|NCT00326222|Quality of life|quality of life
5330160|NCT00326209|UC|uc
5330161|NCT00326209|Ulcerative colitis|ulcerative colitis
5330162|NCT00326209|Inflammatory bowel disease|inflammatory bowel disease
5330163|NCT00326209|IBD|ibd
5330164|NCT00326196|CABG|cabg
5330165|NCT00326196|Coronary Disease|coronary disease
5330166|NCT00326196|Diabetes|diabetes
5330167|NCT00326196|PCI|pci
5330168|NCT00326170|Combination Chemotherapy|combination chemotherapy
5330169|NCT00326170|MDS|mds
5330170|NCT00326170|High-Risk Myelodysplastic Syndrome|high-risk myelodysplastic syndrome
5330171|NCT00326170|AML|aml
5330172|NCT00326170|Acute myelogenous leukemia|acute myelogenous leukemia
5330173|NCT00326170|valproic acid|valproic acid
5330174|NCT00326170|VPA|vpa
5330175|NCT00326170|Depakene|depakene
5330176|NCT00326170|5-azacytidine|5-azacytidine
5330177|NCT00326170|5-aza|5-aza
5330178|NCT00326170|Azacitidine|azacitidine
5330179|NCT00326170|5-AZC|5-azc
5330180|NCT00326170|Vidaza|vidaza
5330181|NCT00326170|AZA-CR|aza-cr
5330182|NCT00326170|Ladakamycin|ladakamycin
5330183|NCT00326170|NSC-102816|nsc-102816
5330184|NCT00326170|All-trans retinoic acid|all-trans retinoic acid
5330185|NCT00326170|ATRA|atra
5330186|NCT00326170|Tretinoin|tretinoin
5330187|NCT00326170|Vesanoid|vesanoid
5330188|NCT00326157|antifungal primary prophylaxis treatment|antifungal primary prophylaxis treatment
5330189|NCT00326157|allogeneic stem-cell transplantation|allogeneic stem-cell transplantation
5330190|NCT00326157|antifungal primary prophylaxis treatment of high risk patients undergoing allogeneic stem-cell transplantation|antifungal primary prophylaxis treatment of high risk patients undergoing allogeneic stem-cell transplantation
5330191|NCT00326144|MDD|mdd
5330192|NCT00326144|Depression|depression
5330193|NCT00326118|Meningococcal serogroup C diseases|meningococcal serogroup c diseases
5330194|NCT00326118|H.influenzae type b diseases|h.influenzae type b diseases
5330195|NCT00326105|MDD|mdd
5330196|NCT00326105|Depression|depression
5330197|NCT00326079|Open angle|open angle
5330198|NCT00326079|Glaucoma|glaucoma
5330199|NCT00326079|Surgery|surgery
5330200|NCT00326066|Open angle|open angle
5330201|NCT00326066|Glaucoma|glaucoma
5330202|NCT00326066|Surgery|surgery
5330203|NCT00326066|Cataract|cataract
5330204|NCT00326053|Asthma Reoccurrence|asthma reoccurrence
5330205|NCT00326053|Acute Asthma|acute asthma
5330206|NCT00326053|Patient Discharge|patient discharge
5330207|NCT00326053|Emergency Service, Hospital|emergency service, hospital
5330208|NCT00326053|Asthma Exacerbation|asthma exacerbation
5330209|NCT00326053|Asthma Relapse|asthma relapse
5330210|NCT00326040|Open angle|open angle
5330211|NCT00326040|Glaucoma|glaucoma
5330212|NCT00326040|Refractory|refractory
5330213|NCT00326040|Surgery|surgery
5330214|NCT00326027|GERD|gerd
5330215|NCT00326027|Pantoprazole|pantoprazole
5330216|NCT00326027|NERD|nerd
5330217|NCT00326014|Open angle|open angle
5330218|NCT00326014|Glaucoma|glaucoma
5330219|NCT00326014|Cataract|cataract
5330220|NCT00326014|Surgery|surgery
5330221|NCT00326001|Transvenous Catheter Ablation|transvenous catheter ablation
5330222|NCT00326001|Radiofrequency Catheter Ablation|radiofrequency catheter ablation
5330223|NCT00326001|Atrial flutter|atrial flutter
5330224|NCT00326001|Catheter Ablation|catheter ablation
5330225|NCT00325988|Neuroimmunology|neuroimmunology
5330226|NCT00325988|Demyelinating Disease|demyelinating disease
5330227|NCT00325988|Genetics|genetics
5330228|NCT00325988|Proteins|proteins
5330229|NCT00325975|Smallpox|smallpox
5330230|NCT00325975|Variola|variola
5330231|NCT00325975|Orthopoxvirus|orthopoxvirus
5330232|NCT00325975|Virus|virus
5330233|NCT00325975|Immunogenicity|immunogenicity
5330234|NCT00325975|Smallpox Vaccine|smallpox vaccine
5330235|NCT00325962|Hypertension|hypertension
5330236|NCT00325962|Type 2 Diabetes|type 2 diabetes
5330237|NCT00325962|6R-BH4|6r-bh4
5330238|NCT00325962|BH4|bh4
5330239|NCT00325962|BH4 deficiency|bh4 deficiency
5330240|NCT00325962|sapropterin dihydrochloride|sapropterin dihydrochloride
5330241|NCT00325962|endothelial dysfunction|endothelial dysfunction
5330242|NCT00325962|NO|no
5330243|NCT00325962|Nitric Oxide|nitric oxide
5330244|NCT00325936|metabolic syndrome|metabolic syndrome
5330245|NCT00325936|Hypertension|hypertension
5330246|NCT00325936|CCB|ccb
5330247|NCT00325936|cilnidipine|cilnidipine
5330248|NCT00325923|Decision making|decision making
5330249|NCT00325923|Decision support|decision support
5330250|NCT00325923|Decisional conflict|decisional conflict
5330251|NCT00325923|Menopause|menopause
5330252|NCT00325923|Natural health products|natural health products
5330253|NCT00325923|Herbs|herbs
5330254|NCT00325923|Complementary medicine|complementary medicine
5330255|NCT00325923|Complementary therapies|complementary therapies
5330256|NCT00325910|Diabetes|diabetes
5330257|NCT00325910|Heart Failure|heart failure
5330258|NCT00325910|Mortality|mortality
5330259|NCT00325910|Hospitalization|hospitalization
5330260|NCT00325910|Feasability|feasability
5330261|NCT00325884|coronary artery disease|coronary artery disease
5330262|NCT00325884|bifurcation lesions|bifurcation lesions
5330263|NCT00325884|percutaneous interventions|percutaneous interventions
5330264|NCT00325884|stenting|stenting
5330265|NCT00325884|outcomes|outcomes
5330266|NCT00325884|death|death
5330267|NCT00325884|myocardial infarction|myocardial infarction
5330268|NCT00325858|osteoarthritis pain|osteoarthritis pain
5330269|NCT00325858|knee|knee
5330270|NCT00325858|hip|hip
5330271|NCT00325858|extended-release analgesia|extended-release analgesia
5330272|NCT00325858|opioid|opioid
5330273|NCT00325845|Investigational|investigational
5330274|NCT00325845|Therapeutic|therapeutic
5330275|NCT00325845|Efficacy|efficacy
5330276|NCT00325845|Safety|safety
5330277|NCT00325845|Outcomes|outcomes
5330278|NCT00325845|Lumbar facet joint arthrosis|lumbar facet joint arthrosis
5330279|NCT00325845|Lumbar facet joint arthropathy|lumbar facet joint arthropathy
5330280|NCT00325832|Hypertension|hypertension
5330281|NCT00325832|Blood Pressure|blood pressure
5330282|NCT00325832|Systolic Pressure|systolic pressure
5330283|NCT00325832|Diastolic Pressure|diastolic pressure
5330284|NCT00325832|Blood Pressure Monitoring, Ambulatory|blood pressure monitoring, ambulatory
5330285|NCT00325819|Acetaminophen|acetaminophen
5330286|NCT00325819|Vaccination|vaccination
5330287|NCT00325819|Immunization|immunization
5330288|NCT00325793|nicardipine|nicardipine
5330289|NCT00325793|hypertension|hypertension
5330290|NCT00325793|intracerebral hemorrhage|intracerebral hemorrhage
5330291|NCT00325793|ischemic stroke|ischemic stroke
5330292|NCT00325780|Kowa|kowa
5330293|NCT00325780|Hypercholesterolemia|hypercholesterolemia
5330294|NCT00325780|dyslipidemia|dyslipidemia
5330295|NCT00325780|pitavastatin|pitavastatin
5330296|NCT00325780|NK-104|nk-104
5330297|NCT00325780|Hypercholesterolemia or combined dyslipidemia|hypercholesterolemia or combined dyslipidemia
5330298|NCT00325767|mucociliary clearance|mucociliary clearance
5330299|NCT00325767|beta-adrenergic drugs|beta-adrenergic drugs
5330300|NCT00325767|inhalation|inhalation
5330301|NCT00325767|aerosol|aerosol
5330302|NCT00325754|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5330303|NCT00325754|COPD|copd
5330304|NCT00325741|Lupus|lupus
5330305|NCT00325741|Systemic Lupus Erythematosus|systemic lupus erythematosus
5330306|NCT00325741|Blood Stem Cell Transplantation|blood stem cell transplantation
5330307|NCT00325728|Chronic Insomnia|chronic insomnia
5330308|NCT00325728|Sleep Initiation and Maintenance Disorder|sleep initiation and maintenance disorder
5330309|NCT00325728|Drug Therapy|drug therapy
5330310|NCT00325728|Alzheimer disease|alzheimer disease
5330311|NCT00325702|HIV|hiv
5330312|NCT00325702|prevention|prevention
5330313|NCT00325676|GERD|gerd
5330314|NCT00325676|Pantoprazole|pantoprazole
5330315|NCT00325676|Complete Remission|complete remission
5330316|NCT00325663|acupuncture|acupuncture
5330317|NCT00325663|double-blind|double-blind
5330318|NCT00325663|sham control|sham control
5330319|NCT00325663|osteoarthritis|osteoarthritis
5330320|NCT00325663|pain|pain
5330321|NCT00325650|Prediabetic state|prediabetic state
5330322|NCT00325650|Impaired fasting glucose|impaired fasting glucose
5330323|NCT00325650|Impaired glucose Tolerance|impaired glucose tolerance
5330324|NCT00325637|CHERISH|cherish
5330325|NCT00325637|Ischemic Stroke|ischemic stroke
5330326|NCT00325624|Blood Pressure|blood pressure
5330327|NCT00325624|Diabetes mellitus|diabetes mellitus
5330328|NCT00325624|Hypertension|hypertension
5330329|NCT00325624|Home Care|home care
5330330|NCT00325624|Glucometer|glucometer
5330331|NCT00325611|Palliative care|palliative care
5330332|NCT00325611|End of life care|end of life care
5330333|NCT00325585|Human Immunodeficiency Viruses|human immunodeficiency viruses
5330334|NCT00325585|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5330335|NCT00325585|Substance Abuse|substance abuse
5330336|NCT00325585|Sexually Transmitted Disease, Viral|sexually transmitted disease, viral
5330337|NCT00325585|Intervention Studies|intervention studies
5330338|NCT00325585|Women's Health|women's health
5330339|NCT00325546|Obesity|obesity
5330340|NCT00325533|Blood Pressure, High|blood pressure, high
5330341|NCT00325533|Blacks|blacks
5330342|NCT00325533|African Americans|african americans
5330343|NCT00325507|Renal cell cancer|renal cell cancer
5330344|NCT00325507|requiring IL-2 treatment|requiring il-2 treatment
5330447|NCT00325065|Vasopressin|vasopressin
5330448|NCT00325065|Mood Disorder|mood disorder
5330345|NCT00325507|Locally advanced or metastatic renal cell carcinoma|locally advanced or metastatic renal cell carcinoma
5330346|NCT00325494|Pancreatic Cancer|pancreatic cancer
5330347|NCT00325494|Mesothelioma|mesothelioma
5330348|NCT00325494|Ovarian Cancer|ovarian cancer
5330349|NCT00325494|Non-Small Cell Lung Cancer|non-small cell lung cancer
5330350|NCT00325494|Mesothelin|mesothelin
5330351|NCT00325468|bone loss|bone loss
5330352|NCT00325468|osteoporosis|osteoporosis
5330353|NCT00325442|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
5330354|NCT00325429|Type 2 diabetes|type 2 diabetes
5330355|NCT00325429|Vildagliptin|vildagliptin
5330356|NCT00325429|HbA1c|hba1c
5330357|NCT00325416|melphalan|melphalan
5330358|NCT00325416|topotecan|topotecan
5330359|NCT00325416|topoisomerase|topoisomerase
5330360|NCT00325416|bone marrow transplant|bone marrow transplant
5330361|NCT00325416|drug sequence|drug sequence
5330362|NCT00325403|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
5330363|NCT00325390|SR25990C|sr25990c
5330364|NCT00325390|Platelet Aggregation Inhibitors|platelet aggregation inhibitors
5330365|NCT00325390|NSTEACS|nsteacs
5330366|NCT00325377|low back pain|low back pain
5330367|NCT00325377|pain|pain
5330368|NCT00325377|magnetism|magnetism
5330369|NCT00325377|electromagnetic fields|electromagnetic fields
5330370|NCT00325377|visual analogue pain scale|visual analogue pain scale
5330371|NCT00325351|Ovarian cancer|ovarian cancer
5330372|NCT00325351|Ovarian neoplasms, epithelium|ovarian neoplasms, epithelium
5330373|NCT00325338|Allergy|allergy
5330374|NCT00325338|Specific Immunotherapy|specific immunotherapy
5330375|NCT00325338|Ragweed|ragweed
5330376|NCT00325338|Environmental Exposure Chamber|environmental exposure chamber
5330377|NCT00325325|Kidney Transplantation|kidney transplantation
5330378|NCT00325312|Neck Pain|neck pain
5330379|NCT00325312|Complementary Therapies|complementary therapies
5330380|NCT00325312|Subcutaneous Carbon Dioxide Insufflations|subcutaneous carbon dioxide insufflations
5330381|NCT00325312|Acute Treatment|acute treatment
5330382|NCT00325273|Lactobacillus rhamnosus|lactobacillus rhamnosus
5330383|NCT00325273|Atopic dermatitis|atopic dermatitis
5330384|NCT00325273|Allergic rhinitis|allergic rhinitis
5330385|NCT00325273|Asthma|asthma
5330386|NCT00325273|Infant|infant
5330387|NCT00325273|Pregnancy|pregnancy
5330388|NCT00325260|influenza|influenza
5330389|NCT00325260|non-inferiority|non-inferiority
5330390|NCT00325260|Influvac|influvac
5330391|NCT00325260|Agrippal|agrippal
5330392|NCT00325260|healthy subjects|healthy subjects
5330393|NCT00325247|ZINC SUPPLEMENTATION|zinc supplementation
5330394|NCT00325247|ACUTE DIARRHOEA|acute diarrhoea
5330395|NCT00325247|UNDER FIVE CHILDREN|under five children
5330396|NCT00325247|RURAL BANGLADESH|rural bangladesh
5330397|NCT00325221|implantable cardioverter-defibrillator|implantable cardioverter-defibrillator
5330398|NCT00325221|telemedicine|telemedicine
5330399|NCT00325221|Home Monitoring|home monitoring
5330400|NCT00325221|psychosomatic|psychosomatic
5330401|NCT00325221|ventricular tachyarrhythmia|ventricular tachyarrhythmia
5330402|NCT00325221|quality of life|quality of life
5330403|NCT00325221|Electric Countershock|electric countershock
5330404|NCT00325182|Alcoholism|alcoholism
5330405|NCT00325169|Cross-over|cross-over
5330406|NCT00325169|Tiotropium|tiotropium
5330407|NCT00325169|Triple|triple
5330408|NCT00325169|COPD|copd
5330409|NCT00325169|SERETIDE 50/500|seretide 50/500
5330410|NCT00325169|Dyspnoea|dyspnoea
5330411|NCT00325169|Impulse oscillometry|impulse oscillometry
5330412|NCT00325169|Plethysmography|plethysmography
5330413|NCT00325117|Type 2 diabetes|type 2 diabetes
5330414|NCT00325117|Vildagliptin|vildagliptin
5330415|NCT00325117|HbA1c|hba1c
5330416|NCT00325104|Multiple Endocrine Neoplasia|multiple endocrine neoplasia
5330417|NCT00325104|Gastrinoma|gastrinoma
5330418|NCT00325104|Prolacinoma|prolacinoma
5330419|NCT00325104|Medullary Thyroid Cancer|medullary thyroid cancer
5330420|NCT00325104|Insulinoma|insulinoma
5330421|NCT00325104|MEN1|men1
5330422|NCT00325104|MEN2A|men2a
5330423|NCT00325104|Familial Primary Hyperparathytoidism|familial primary hyperparathytoidism
5330424|NCT00325091|Writer's Cramp|writer's cramp
5330425|NCT00325091|Electroencephalogram (EEG)|electroencephalogram (eeg)
5330426|NCT00325091|Transcranial Magnetic Stimulation (TMS)|transcranial magnetic stimulation (tms)
5330427|NCT00325091|Fine Motor Skills|fine motor skills
5330428|NCT00325091|Focal Hand Dystonia|focal hand dystonia
5330429|NCT00325091|Writer Cramp|writer cramp
5330430|NCT00325091|Healthy Volunteer|healthy volunteer
5330431|NCT00325091|HV|hv
5330432|NCT00325078|Remicade|remicade
5330433|NCT00325078|Crohn's Disease|crohn's disease
5330434|NCT00325078|IBD|ibd
5330435|NCT00325078|CGD Infection|cgd infection
5330436|NCT00325078|Infliximab|infliximab
5330437|NCT00325078|Chorionic Granulomatous Disease|chorionic granulomatous disease
5330438|NCT00325078|CGD|cgd
5330439|NCT00325078|Inflammatory Bowel Disease|inflammatory bowel disease
5330440|NCT00325065|Amygdala|amygdala
5330441|NCT00325065|Emotion|emotion
5330442|NCT00325065|Memory|memory
5330443|NCT00325065|Threat|threat
5330444|NCT00325065|Peptides|peptides
5330445|NCT00325065|Neuropeptides|neuropeptides
5330446|NCT00325065|Oxytocin|oxytocin
5330449|NCT00325039|Urinary Incontinence, Stress|urinary incontinence, stress
5330450|NCT00325039|Surgery|surgery
5330451|NCT00325026|Preterm gestation|preterm gestation
5330452|NCT00325026|Cervical ripening|cervical ripening
5330453|NCT00325026|Labor induction|labor induction
5330454|NCT00325026|Misoprostol|misoprostol
5330455|NCT00325026|Foley bulb|foley bulb
5330456|NCT00325013|Primary Sclerosing Cholangitis|primary sclerosing cholangitis
5330457|NCT00325013|PSC|psc
5330458|NCT00325013|DHA|dha
5330459|NCT00325013|Docosahexaenoic Acid|docosahexaenoic acid
5330460|NCT00324974|Gastroesophageal Reflux Disease|gastroesophageal reflux disease
5330461|NCT00324974|infant|infant
5330462|NCT00324974|lansoprazole oral suspension|lansoprazole oral suspension
5330463|NCT00324974|PPI|ppi
5330464|NCT00324961|adefovir dipivoxil|adefovir dipivoxil
5330465|NCT00324961|e Antigen negative|e antigen negative
5330466|NCT00324961|chronic hepatitis B|chronic hepatitis b
5330467|NCT00324961|Chinese|chinese
5330468|NCT00324948|Female sexual arousal disorder|female sexual arousal disorder
5330469|NCT00324948|Female sexual dysfunction|female sexual dysfunction
5330470|NCT00324922|Vancomycin|vancomycin
5330471|NCT00324922|Trimethoprim-Sulfamethoxazole Combination|trimethoprim-sulfamethoxazole combination
5330472|NCT00324896|Parkinson's|parkinson's
5330473|NCT00324896|insomnia|insomnia
5330474|NCT00324896|drug|drug
5330475|NCT00324896|eszopiclone|eszopiclone
5330476|NCT00324896|placebo|placebo
5330477|NCT00324883|sodium intake|sodium intake
5330478|NCT00324883|sodium excretion|sodium excretion
5330479|NCT00324883|chloride excretion|chloride excretion
5330480|NCT00324883|creatinine|creatinine
5330481|NCT00324883|hypertension|hypertension
5330482|NCT00324857|Osteoarthritis, Knee|osteoarthritis, knee
5330483|NCT00324857|race|race
5330484|NCT00324857|ethnicity|ethnicity
5330485|NCT00324857|knee replacement|knee replacement
5330486|NCT00324831|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
5330487|NCT00324831|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5330488|NCT00324831|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5330489|NCT00324831|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5330490|NCT00324818|bacterial vaginosis|bacterial vaginosis
5330491|NCT00324818|treatment|treatment
5330492|NCT00324805|AJCC v6|ajcc v6
5330493|NCT00324779|B-cell childhood acute lymphoblastic leukemia|b-cell childhood acute lymphoblastic leukemia
5330494|NCT00324779|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
5330495|NCT00324779|stage I childhood large cell lymphoma|stage i childhood large cell lymphoma
5330496|NCT00324779|stage II childhood large cell lymphoma|stage ii childhood large cell lymphoma
5330497|NCT00324779|stage III childhood large cell lymphoma|stage iii childhood large cell lymphoma
5330498|NCT00324779|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
5330499|NCT00324779|stage I childhood lymphoblastic lymphoma|stage i childhood lymphoblastic lymphoma
5330500|NCT00324779|stage II childhood lymphoblastic lymphoma|stage ii childhood lymphoblastic lymphoma
5330501|NCT00324779|stage III childhood lymphoblastic lymphoma|stage iii childhood lymphoblastic lymphoma
5330502|NCT00324779|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
5330503|NCT00324779|stage I childhood small noncleaved cell lymphoma|stage i childhood small noncleaved cell lymphoma
5330504|NCT00324779|stage II childhood small noncleaved cell lymphoma|stage ii childhood small noncleaved cell lymphoma
5330505|NCT00324779|stage III childhood small noncleaved cell lymphoma|stage iii childhood small noncleaved cell lymphoma
5330506|NCT00324779|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
5330507|NCT00324753|cancer|cancer
5330508|NCT00324753|screening|screening
5330509|NCT00324753|communication|communication
5330510|NCT00324753|prevention|prevention
5330511|NCT00324727|liver metastases|liver metastases
5330512|NCT00324727|extraocular extension melanoma|extraocular extension melanoma
5330513|NCT00324727|stage IV melanoma|stage iv melanoma
5330514|NCT00324727|recurrent melanoma|recurrent melanoma
5330515|NCT00324727|recurrent intraocular melanoma|recurrent intraocular melanoma
5330516|NCT00324727|metastatic intraocular melanoma|metastatic intraocular melanoma
5330517|NCT00324727|iris melanoma|iris melanoma
5330518|NCT00324727|ciliary body and choroid melanoma, medium/large size|ciliary body and choroid melanoma, medium/large size
5330519|NCT00324714|osteoporosis|osteoporosis
5330520|NCT00324714|ductal breast carcinoma in situ|ductal breast carcinoma in situ
5330521|NCT00324714|breast cancer in situ|breast cancer in situ
5330522|NCT00324701|Mental Health|mental health
5330523|NCT00324701|Geriatric Medicine|geriatric medicine
5330524|NCT00324701|Depression|depression
5330525|NCT00324701|Health Service Delivery|health service delivery
5330526|NCT00324701|Aged|aged
5330527|NCT00324688|HIV-1|hiv-1
5330528|NCT00324688|Methadone|methadone
5330529|NCT00324688|HIV-1 infection|hiv-1 infection
5330530|NCT00324675|type 2 diabetes,|type 2 diabetes,
5330531|NCT00324675|glomerular filtration rate,|glomerular filtration rate,
5330532|NCT00324675|renal plasma flow,|renal plasma flow,
5330533|NCT00324675|endothelial dysfunction,|endothelial dysfunction,
5330534|NCT00324675|proteinuria,|proteinuria,
5330535|NCT00324675|diabetic nephropathy|diabetic nephropathy
5330836|NCT00323999|Menorrhagia|menorrhagia
5330536|NCT00324662|Implantable cardioverter-defibrillator|implantable cardioverter-defibrillator
5330537|NCT00324662|Ventricular tachyarrhythmia|ventricular tachyarrhythmia
5330538|NCT00324662|Supraventricular tachyarrhythmia|supraventricular tachyarrhythmia
5330539|NCT00324662|Electric Countershock|electric countershock
5330540|NCT00324649|HIV-1|hiv-1
5330541|NCT00324623|stage IV melanoma|stage iv melanoma
5330542|NCT00324623|recurrent melanoma|recurrent melanoma
5330543|NCT00324610|fluoropyrimidines|fluoropyrimidines
5330544|NCT00324610|metastases|metastases
5330545|NCT00324610|pharmacokinetics|pharmacokinetics
5330546|NCT00324610|phase 1-2 study|phase 1-2 study
5330547|NCT00324597|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5330548|NCT00324597|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
5330549|NCT00324597|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5330550|NCT00324597|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5330551|NCT00324597|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5330552|NCT00324597|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5330553|NCT00324597|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5330554|NCT00324597|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5330555|NCT00324597|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5330556|NCT00324597|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5330557|NCT00324597|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5330558|NCT00324597|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5330559|NCT00324597|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5330560|NCT00324597|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
5330561|NCT00324597|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
5330562|NCT00324597|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
5330563|NCT00324597|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5330564|NCT00324597|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5330565|NCT00324597|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5330566|NCT00324597|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
5330567|NCT00324597|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5330568|NCT00324597|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5330569|NCT00324597|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5330570|NCT00324597|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5330571|NCT00324597|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5330572|NCT00324597|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5330573|NCT00324597|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5330574|NCT00324597|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5330575|NCT00324597|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5330576|NCT00324597|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5330577|NCT00324597|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5330578|NCT00324597|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5330579|NCT00324597|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5330580|NCT00324597|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5330581|NCT00324597|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5330582|NCT00324597|Waldenström macroglobulinemia|waldenström macroglobulinemia
5330583|NCT00324597|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5330584|NCT00324597|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
5330585|NCT00324597|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
5330586|NCT00324597|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5330587|NCT00324597|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5330588|NCT00324597|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5330589|NCT00324597|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5330590|NCT00324597|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5330591|NCT00324597|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5330592|NCT00324597|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5330593|NCT00324597|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
5330594|NCT00324597|adenocarcinoma of the lung|adenocarcinoma of the lung
5330595|NCT00324597|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
5330596|NCT00324597|large cell lung cancer|large cell lung cancer
5330597|NCT00324597|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5330598|NCT00324597|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5330599|NCT00324597|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5330600|NCT00324597|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5330601|NCT00324597|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5330602|NCT00324597|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5330603|NCT00324597|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5330604|NCT00324597|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5330605|NCT00324597|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5330606|NCT00324597|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5330607|NCT00324597|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5330608|NCT00324597|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
5330609|NCT00324597|post-transplant lymphoproliferative disorder|post-transplant lymphoproliferative disorder
5330610|NCT00324597|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5330611|NCT00324584|type 1 diabetes mellitus|type 1 diabetes mellitus
5330612|NCT00324584|telecare|telecare
5330613|NCT00324584|telemedicine|telemedicine
5330614|NCT00324584|insulin pump therapy|insulin pump therapy
5330615|NCT00324558|Bemiparin|bemiparin
5330616|NCT00324558|small cell lung carcinoma|small cell lung carcinoma
5330617|NCT00324545|Obesity|obesity
5330618|NCT00324545|Diets|diets
5330619|NCT00324545|Heart Disease|heart disease
5330620|NCT00324545|Randomized controlled trial|randomized controlled trial
5330621|NCT00324545|Ischemia.|ischemia.
5330622|NCT00324519|second trimester|second trimester
5330623|NCT00324519|pregnancy termination|pregnancy termination
5330624|NCT00324519|misoprostol|misoprostol
5330625|NCT00324519|foley bulb|foley bulb
5330626|NCT00324493|Severe Hemophilia|severe hemophilia
5330627|NCT00324493|Musculoskeletal Function|musculoskeletal function
5330628|NCT00324493|Factor Replacement|factor replacement
5330629|NCT00324467|NON-HODGKIN'S LYMPHOMA|non-hodgkin's lymphoma
5330630|NCT00324467|POSITRON EMISSION TOMOGRAPHY|positron emission tomography
5330631|NCT00324467|PET|pet
5330632|NCT00324467|DLBCL|dlbcl
5330633|NCT00324467|R-CHOP|r-chop
5330634|NCT00324467|R-ICE|r-ice
5330635|NCT00324454|motor neuron disease|motor neuron disease
5330636|NCT00324454|amyotrophic lateral sclerosis primary lateral|amyotrophic lateral sclerosis primary lateral
5330637|NCT00324454|sclerosis; progressive muscular atrophy|sclerosis; progressive muscular atrophy
5330638|NCT00324454|cramps|cramps
5330639|NCT00324454|spasticity|spasticity
5330640|NCT00324441|Fibromyalgia|fibromyalgia
5330641|NCT00324441|Rehabilitation|rehabilitation
5330642|NCT00324441|Physical Medicine|physical medicine
5330643|NCT00324441|Whole-Body Hyperthermia|whole-body hyperthermia
5330644|NCT00324441|Water-Filtered Near Infrared|water-filtered near infrared
5330645|NCT00324428|TMS|tms
5330646|NCT00324428|Visceral Pain|visceral pain
5330647|NCT00324428|Analgesia|analgesia
5330648|NCT00324428|Pancreatic Cancer|pancreatic cancer
5330649|NCT00324428|Cancer|cancer
5330650|NCT00324428|Electric stimulation therapy|electric stimulation therapy
5330651|NCT00324428|Electric stimulation|electric stimulation
5330652|NCT00324428|Pain|pain
5330653|NCT00324428|Safety|safety
5330654|NCT00324415|stage I anal cancer|stage i anal cancer
5330655|NCT00324415|stage II anal cancer|stage ii anal cancer
5330656|NCT00324415|stage IIIA anal cancer|stage iiia anal cancer
5330657|NCT00324415|stage IIIB anal cancer|stage iiib anal cancer
5330658|NCT00324415|squamous cell carcinoma of the anus|squamous cell carcinoma of the anus
5330659|NCT00324415|basaloid carcinoma of the anus|basaloid carcinoma of the anus
5330660|NCT00324415|cloacogenic carcinoma of the anus|cloacogenic carcinoma of the anus
5330661|NCT00324402|brain natriuretic peptide|brain natriuretic peptide
5330662|NCT00324402|pregnancy|pregnancy
5330663|NCT00324402|biomarker|biomarker
5330664|NCT00324389|Interferon, Gene Expression in Liver, Lymphocytes, High Density Oligonucleotide Microarray Expression Analysis, African American, Hepatitis C|interferon, gene expression in liver, lymphocytes, high density oligonucleotide microarray expression analysis, african american, hepatitis c
5330665|NCT00324363|exenatide|exenatide
5330666|NCT00324363|diabetes|diabetes
5330667|NCT00324363|Amylin|amylin
5330668|NCT00324363|Lilly|lilly
5330669|NCT00324363|China|china
5330670|NCT00324350|Diabetes Mellitus|diabetes mellitus
5330671|NCT00324350|Fracture|fracture
5330672|NCT00324350|Falls|falls
5330673|NCT00324350|Height Loss|height loss
5330674|NCT00324324|infection|infection
5330675|NCT00324324|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5330676|NCT00324324|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5330677|NCT00324324|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5330678|NCT00324324|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5330679|NCT00324324|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5330680|NCT00324324|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5330681|NCT00324324|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5330682|NCT00324324|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5330683|NCT00324324|atypical chronic myeloid leukemia, BCR-ABL negative|atypical chronic myeloid leukemia, bcr-abl negative
5330684|NCT00324324|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5330685|NCT00324324|chronic eosinophilic leukemia|chronic eosinophilic leukemia
5330686|NCT00324324|primary myelofibrosis|primary myelofibrosis
5330687|NCT00324324|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5330837|NCT00323999|fibroids|fibroids
5330688|NCT00324324|chronic neutrophilic leukemia|chronic neutrophilic leukemia
5330689|NCT00324324|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5330690|NCT00324324|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5330691|NCT00324324|disseminated neuroblastoma|disseminated neuroblastoma
5330692|NCT00324324|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5330693|NCT00324324|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
5330694|NCT00324324|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5330695|NCT00324324|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
5330696|NCT00324324|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5330697|NCT00324324|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
5330698|NCT00324324|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
5330699|NCT00324324|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
5330800|NCT00324220|Phase I/II|phase i/ii
5330700|NCT00324324|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
5330701|NCT00324324|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5330702|NCT00324324|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5330703|NCT00324324|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5330704|NCT00324324|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5330705|NCT00324324|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
5330706|NCT00324324|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
5330707|NCT00324324|poor prognosis metastatic gestational trophoblastic tumor|poor prognosis metastatic gestational trophoblastic tumor
5330708|NCT00324324|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5330709|NCT00324324|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5330710|NCT00324324|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5330711|NCT00324324|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5330712|NCT00324324|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5330713|NCT00324324|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5330714|NCT00324324|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5330715|NCT00324324|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5330716|NCT00324324|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5330717|NCT00324324|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5330718|NCT00324324|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5330719|NCT00324324|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5330720|NCT00324324|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5330721|NCT00324324|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5330722|NCT00324324|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5330723|NCT00324324|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5330724|NCT00324324|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5330725|NCT00324324|recurrent neuroblastoma|recurrent neuroblastoma
5330726|NCT00324324|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5330727|NCT00324324|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
5330728|NCT00324324|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5330729|NCT00324324|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
5330730|NCT00324324|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5330731|NCT00324324|refractory hairy cell leukemia|refractory hairy cell leukemia
5330732|NCT00324324|refractory multiple myeloma|refractory multiple myeloma
5330733|NCT00324324|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5330734|NCT00324324|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5330735|NCT00324324|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5330736|NCT00324324|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5330737|NCT00324324|stage I multiple myeloma|stage i multiple myeloma
5330738|NCT00324324|stage II multiple myeloma|stage ii multiple myeloma
5330739|NCT00324324|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
5330740|NCT00324324|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5330741|NCT00324324|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5330742|NCT00324324|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5330743|NCT00324324|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5330744|NCT00324324|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5330745|NCT00324324|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5330746|NCT00324324|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5330747|NCT00324324|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5330748|NCT00324324|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5330838|NCT00323999|polyps|polyps
5330749|NCT00324324|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5330750|NCT00324324|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5330751|NCT00324324|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5330752|NCT00324324|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5330753|NCT00324324|stage III multiple myeloma|stage iii multiple myeloma
5330754|NCT00324324|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5330755|NCT00324324|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5330756|NCT00324324|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
5330757|NCT00324324|stage IIIA breast cancer|stage iiia breast cancer
5330758|NCT00324324|stage IIIB breast cancer|stage iiib breast cancer
5330759|NCT00324324|stage IIIC breast cancer|stage iiic breast cancer
5330760|NCT00324324|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5330761|NCT00324324|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5330762|NCT00324324|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5330763|NCT00324324|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5330764|NCT00324324|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5330765|NCT00324324|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5330766|NCT00324324|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5330767|NCT00324324|stage IV breast cancer|stage iv breast cancer
5330768|NCT00324324|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5330769|NCT00324324|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5330770|NCT00324324|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5330771|NCT00324324|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5330772|NCT00324324|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5330773|NCT00324324|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5330774|NCT00324324|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5330775|NCT00324324|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5330776|NCT00324298|drug/agent toxicity by tissue/organ|drug/agent toxicity by tissue/organ
5330777|NCT00324298|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
5330778|NCT00324285|Diarrhoea|diarrhoea
5330779|NCT00324285|severe malnutrition|severe malnutrition
5330780|NCT00324285|amylase resistant starch|amylase resistant starch
5330781|NCT00324285|ORS|ors
5330782|NCT00324272|Groin dissection|groin dissection
5330783|NCT00324272|Axilla (or axillary) dissection|axilla (or axillary) dissection
5330784|NCT00324272|Lymph node dissection|lymph node dissection
5330785|NCT00324272|Lymphadenectomy|lymphadenectomy
5330786|NCT00324272|Seroma|seroma
5330787|NCT00324272|Wound drainage|wound drainage
5330788|NCT00324272|Fibrin sealant|fibrin sealant
5330789|NCT00324272|Malignant melanoma|malignant melanoma
5330790|NCT00324272|Squamous cell carcinoma|squamous cell carcinoma
5330791|NCT00324246|vaginal infection|vaginal infection
5330792|NCT00324246|color appearance|color appearance
5330793|NCT00324246|new developed indicator strips (NEW NORMA-SENSE)|new developed indicator strips (new norma-sense)
5330794|NCT00324246|in-vitro|in-vitro
5330795|NCT00324246|vaginal secretion|vaginal secretion
5330796|NCT00324246|elevated pH|elevated ph
5330797|NCT00324233|Residual urine|residual urine
5330798|NCT00324233|Hematuria|hematuria
5330799|NCT00324233|Ultra sound|ultra sound
5330801|NCT00324207|Type 1 diabetes mellitus|type 1 diabetes mellitus
5330802|NCT00324207|Insulin mRNA|insulin mrna
5330803|NCT00324194|Leukemia|leukemia
5330804|NCT00324194|Myelodysplastic Syndromes|myelodysplastic syndromes
5330805|NCT00324194|Phase I|phase i
5330806|NCT00324181|normal-tension glaucoma|normal-tension glaucoma
5330807|NCT00324181|psychopathology|psychopathology
5330808|NCT00324181|Hong Kong|hong kong
5330809|NCT00324168|Bacterial Infections|bacterial infections
5330810|NCT00324168|Eye Diseases|eye diseases
5330811|NCT00324168|Bacterial Keratitis|bacterial keratitis
5330812|NCT00324168|Visual Acuity|visual acuity
5330813|NCT00324155|Stage IIIc N3 (unresectable)|stage iiic n3 (unresectable)
5330814|NCT00324155|Stage IV melanoma|stage iv melanoma
5330815|NCT00324142|Bacterial vaginosis|bacterial vaginosis
5330816|NCT00324142|Tinidazole|tinidazole
5330817|NCT00324142|Vaginitis|vaginitis
5330818|NCT00324129|Leukemia|leukemia
5330819|NCT00324129|Myelodysplastic Syndromes|myelodysplastic syndromes
5330820|NCT00324129|Phase I|phase i
5330821|NCT00324103|HIV|hiv
5330822|NCT00324103|Chronic Infection|chronic infection
5330823|NCT00324103|Clinical Trial|clinical trial
5330824|NCT00324103|Structured Treatment Interruption|structured treatment interruption
5330825|NCT00324077|Chronic phase chronic myelogenous leukemia (CML)|chronic phase chronic myelogenous leukemia (cml)
5330826|NCT00324064|Growth hormone deficiency|growth hormone deficiency
5330827|NCT00324038|OA|oa
5330828|NCT00324038|Elderly|elderly
5330829|NCT00324038|Pain|pain
5330830|NCT00324038|OA of the hips and/or knees|oa of the hips and/or knees
5330831|NCT00324025|Cryptococcal meningitis|cryptococcal meningitis
5330832|NCT00324012|Adrenocortical Carcinoma|adrenocortical carcinoma
5330833|NCT00324012|cisplatin|cisplatin
5330834|NCT00324012|taxotere|taxotere
5330835|NCT00323999|Hysteroscopic resection|hysteroscopic resection
5330839|NCT00323986|COPD|copd
5330840|NCT00323986|tracheotomy|tracheotomy
5330841|NCT00323986|azithromycin|azithromycin
5330842|NCT00323986|exacerbation|exacerbation
5330843|NCT00323986|hospitalisation|hospitalisation
5330844|NCT00323986|exhaled breath condensate|exhaled breath condensate
5330845|NCT00323973|Chagas, Heart failure, Cardiomiopathy|chagas, heart failure, cardiomiopathy
5330846|NCT00323960|Juvenile dermatomyositis|juvenile dermatomyositis
5330847|NCT00323960|randomised actively controlled clinical trial|randomised actively controlled clinical trial
5330848|NCT00323960|prednisone|prednisone
5330849|NCT00323960|cyclosporine|cyclosporine
5330850|NCT00323960|methotrexate|methotrexate
5330851|NCT00323960|effectiveness|effectiveness
5330852|NCT00323947|ADHD|adhd
5330853|NCT00323947|Seizures|seizures
5330854|NCT00323947|Methylphenidate|methylphenidate
5330855|NCT00323947|Stimulant|stimulant
5330856|NCT00323934|metastatic solid tumor|metastatic solid tumor
5330857|NCT00323934|aggressive non Hodgkin's Lymphoma|aggressive non hodgkin's lymphoma
5330858|NCT00323934|Phase I|phase i
5330859|NCT00323934|Advanced Solid Tumors|advanced solid tumors
5330860|NCT00323908|Breast Cancer|breast cancer
5330861|NCT00323908|prevention|prevention
5330862|NCT00323908|tissue sampling|tissue sampling
5330863|NCT00323908|polymorphisms|polymorphisms
5330864|NCT00323908|steroid and carcinogen metabolism|steroid and carcinogen metabolism
5330865|NCT00323882|Prostate Cancer|prostate cancer
5330866|NCT00323882|Oncology|oncology
5330867|NCT00323882|Prostate|prostate
5330868|NCT00323882|Cancer|cancer
5330869|NCT00323882|Metastatic|metastatic
5330870|NCT00323882|Hormone|hormone
5330871|NCT00323882|PSA|psa
5330872|NCT00323882|Metastatic Hormone-Refractory Prostate Cancer (HRPC)|metastatic hormone-refractory prostate cancer (hrpc)
5330873|NCT00323856|Hemophilia A|hemophilia a
5330874|NCT00323856|Plasma-derived treatment|plasma-derived treatment
5330875|NCT00323856|Factor VIII|factor viii
5330876|NCT00323856|Inhibitor|inhibitor
5330877|NCT00323843|Kidney stone|kidney stone
5330878|NCT00323843|ureteropyeloscopy|ureteropyeloscopy
5330879|NCT00323843|renal pelvic pressure|renal pelvic pressure
5330880|NCT00323830|gastric cancer|gastric cancer
5330881|NCT00323830|radiotherapy|radiotherapy
5330882|NCT00323830|postoperative therapy|postoperative therapy
5330883|NCT00323830|chemotherapy|chemotherapy
5330884|NCT00323804|Maintenance therapy|maintenance therapy
5330885|NCT00323804|Non-responder patients|non-responder patients
5330886|NCT00323804|Ribavirin/peginterferon combination therapy|ribavirin/peginterferon combination therapy
5330887|NCT00323804|Hepatitis C, Chronic|hepatitis c, chronic
5330888|NCT00323791|recurrent renal cell cancer|recurrent renal cell cancer
5330889|NCT00323791|clear cell renal cell carcinoma|clear cell renal cell carcinoma
5330890|NCT00323791|papillary renal cell carcinoma|papillary renal cell carcinoma
5330891|NCT00323791|stage IV renal cell cancer|stage iv renal cell cancer
5330892|NCT00323778|hyalgan|hyalgan
5330893|NCT00323778|knee|knee
5330894|NCT00323778|osteoarthritis|osteoarthritis
5330895|NCT00323778|MRI|mri
5330896|NCT00323765|Transcranial Magnetic Stimulation (TMS)|transcranial magnetic stimulation (tms)
5330897|NCT00323765|Cervical Dystonia|cervical dystonia
5330898|NCT00323765|Plasticity|plasticity
5330899|NCT00323765|Healthy Volunteer|healthy volunteer
5330900|NCT00323765|HV|hv
5330901|NCT00323752|Blood loss, Erythropoetin|blood loss, erythropoetin
5330902|NCT00323739|kidney cancer|kidney cancer
5330903|NCT00323739|bevacizumab|bevacizumab
5330904|NCT00323713|Chronic renal insufficiency|chronic renal insufficiency
5330905|NCT00323713|CKD stage 4|ckd stage 4
5330906|NCT00323713|CKD stage 5|ckd stage 5
5330907|NCT00323713|Protein intake|protein intake
5330908|NCT00323713|Low protein diet|low protein diet
5330909|NCT00323713|Very low protein diet|very low protein diet
5330910|NCT00323713|Ketoanalogs|ketoanalogs
5330911|NCT00323713|Renal death|renal death
5330912|NCT00323700|ADHD|adhd
5330913|NCT00323700|Effectiveness|effectiveness
5330914|NCT00323700|ODD|odd
5330915|NCT00323687|HIV-1 Infection|hiv-1 infection
5330916|NCT00323674|Hernia Inguinalis|hernia inguinalis
5330917|NCT00323661|Pacing|pacing
5330918|NCT00323661|Rate-adaptive|rate-adaptive
5330919|NCT00323661|Quality of life|quality of life
5330920|NCT00323661|Cognitive performance|cognitive performance
5330921|NCT00323661|Atrial fibrillation|atrial fibrillation
5330922|NCT00323661|Pacemaker sensor|pacemaker sensor
5330923|NCT00323635|nocturia|nocturia
5330924|NCT00323635|urinary incontinence|urinary incontinence
5330925|NCT00323635|overactive bladder|overactive bladder
5330926|NCT00323635|tolterodine|tolterodine
5330927|NCT00323635|sleep|sleep
5330928|NCT00323635|sleep disorder|sleep disorder
5330929|NCT00323635|menopause|menopause
5330930|NCT00323635|midlife women|midlife women
5330931|NCT00323635|psychological tests|psychological tests
5330932|NCT00323609|Kyphoplasty|kyphoplasty
5330933|NCT00323609|Vertebroplasty|vertebroplasty
5330934|NCT00323609|Balloon Kyphoplasty|balloon kyphoplasty
5330935|NCT00323609|Inflatable Bone Tamp|inflatable bone tamp
5330936|NCT00323609|Spine|spine
5330937|NCT00323609|Back Pain|back pain
5330938|NCT00323609|Vertebral Compression Fracture|vertebral compression fracture
5330939|NCT00323609|Vertebral Body Compression Fracture|vertebral body compression fracture
5330940|NCT00323583|Cancer|cancer
5330941|NCT00323583|Pancreatic Cancer|pancreatic cancer
5330942|NCT00323583|Cancer Alternative Therapies|cancer alternative therapies
5330943|NCT00323583|Living with Cancer|living with cancer
5330944|NCT00323557|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
5330945|NCT00323557|Leukemia|leukemia
5330946|NCT00323557|Sargramostim|sargramostim
5330947|NCT00323557|Pneumococcal Pneumonia|pneumococcal pneumonia
5330948|NCT00323557|Pneumococcal Vaccine|pneumococcal vaccine
5330949|NCT00323557|Prevnar|prevnar
5330950|NCT00323557|GM-CSF|gm-csf
5330951|NCT00323557|CLL|cll
5330952|NCT00323544|HIV 1|hiv 1
5330953|NCT00323544|HIV 1 infection|hiv 1 infection
5330954|NCT00323531|thoracoscopy|thoracoscopy
5330955|NCT00323531|fibrinolysis|fibrinolysis
5330956|NCT00323531|empyema|empyema
5330957|NCT00323531|children|children
5330958|NCT00323518|oral mucositis|oral mucositis
5330959|NCT00323518|hematologic|hematologic
5330960|NCT00323518|autologous stem cell transplant|autologous stem cell transplant
5330961|NCT00323518|velafermin|velafermin
5330962|NCT00323518|stomatitis|stomatitis
5330963|NCT00323518|oncology - supportive care|oncology - supportive care
5330964|NCT00323518|mouth diseases|mouth diseases
5330965|NCT00323492|HIV 1 Infection|hiv 1 infection
5330966|NCT00323479|breast cancer treatment|breast cancer treatment
5330967|NCT00323479|joint disorders|joint disorders
5330968|NCT00323453|Appendectomy|appendectomy
5330969|NCT00323453|Surgery|surgery
5330970|NCT00323453|Infection|infection
5330971|NCT00323440|Familial Mediterranean fever|familial mediterranean fever
5330972|NCT00323440|Inflammation|inflammation
5330973|NCT00323440|Attacks|attacks
5330974|NCT00323440|Remission|remission
5330975|NCT00323440|RNA|rna
5330976|NCT00323440|Cytokines|cytokines
5330977|NCT00323440|Inflammatory proteins|inflammatory proteins
5330978|NCT00323440|MEFV|mefv
5330979|NCT00323440|mutations|mutations
5330980|NCT00323440|Colchicine|colchicine
5330981|NCT00323440|Treatment|treatment
5330982|NCT00323440|microarray RNA analysis|microarray rna analysis
5330983|NCT00323427|Audiology|audiology
5330984|NCT00323427|Coping behaviors|coping behaviors
5330985|NCT00323427|Counseling|counseling
5330986|NCT00323427|Hearing aids|hearing aids
5330987|NCT00323427|Hearing impairment|hearing impairment
5330988|NCT00323427|Patient-centered care|patient-centered care
5330989|NCT00323427|Psychological adaptation|psychological adaptation
5330990|NCT00323427|Psychological adjustment|psychological adjustment
5330991|NCT00323427|Rehabilitation|rehabilitation
5330992|NCT00323427|Social adjustment|social adjustment
5330993|NCT00323427|Aural Rehabilitation|aural rehabilitation
5330994|NCT00323414|PUFA|pufa
5330995|NCT00323414|NASH|nash
5330996|NCT00323414|Fatty Liver|fatty liver
5330997|NCT00323414|Insulin resistance|insulin resistance
5330998|NCT00323414|Metabolic syndrome|metabolic syndrome
5330999|NCT00323414|Nonalcoholic fatty liver disease|nonalcoholic fatty liver disease
5331000|NCT00323414|Nonalcoholic steatohepatitis|nonalcoholic steatohepatitis
5331001|NCT00323414|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
5331002|NCT00323401|Pregnancy|pregnancy
5331003|NCT00323401|Parturition|parturition
5331004|NCT00323401|Depression|depression
5331005|NCT00323401|Randomized|randomized
5331006|NCT00323401|Antenatal classes|antenatal classes
5331007|NCT00323375|Malaria|malaria
5331008|NCT00323375|Aminoquinolines|aminoquinolines
5331009|NCT00323375|Drug Resistance|drug resistance
5331010|NCT00323375|Chloroquine Resistance|chloroquine resistance
5331011|NCT00323362|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5331012|NCT00323362|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5331013|NCT00323349|Glucose Tolerance Test|glucose tolerance test
5331014|NCT00323349|Health Knowledge, Attitudes, Practice|health knowledge, attitudes, practice
5331015|NCT00323349|Motivation|motivation
5331016|NCT00323349|Communication|communication
5331017|NCT00323349|Health Behavior|health behavior
5331018|NCT00323323|Untreated|untreated
5331019|NCT00323323|CD-20 Negative|cd-20 negative
5331020|NCT00323323|Large B-Cell Lymphomas|large b-cell lymphomas
5331021|NCT00323310|disease of the central nervous system (brain or spine)|disease of the central nervous system (brain or spine)
5331022|NCT00323284|Open angle|open angle
5331023|NCT00323284|Glaucoma|glaucoma
5331024|NCT00323284|Cataract|cataract
5331025|NCT00323284|Surgery|surgery
5331026|NCT00323271|Chronic pain|chronic pain
5331027|NCT00323271|Cognitive behavioral therapy|cognitive behavioral therapy
5331028|NCT00323271|Multiple sclerosis|multiple sclerosis
5331029|NCT00323271|Randomized controlled trial|randomized controlled trial
5331030|NCT00323258|Heart disease|heart disease
5331031|NCT00323258|Coronary disease|coronary disease
5331032|NCT00323258|Patient compliance|patient compliance
5331033|NCT00323258|Treatment refusal|treatment refusal
5331034|NCT00323258|Pharmacists|pharmacists
5331035|NCT00323258|Continuity of patient care|continuity of patient care
5331036|NCT00323258|Evidence-based medicine|evidence-based medicine
5331037|NCT00323258|Patient education|patient education
5331038|NCT00323258|Adherence|adherence
5331039|NCT00323245|Randomized clinical trial|randomized clinical trial
5331040|NCT00323245|osteoporosis|osteoporosis
5331041|NCT00323245|urinary incontinence|urinary incontinence
5331042|NCT00323245|physiotherapy|physiotherapy
5331043|NCT00323245|education|education
5331044|NCT00323232|DHS, Intertrochanteric|dhs, intertrochanteric
5331045|NCT00323219|Cellulitis, RCT, emergency Department, Double-blind, Equivalence trial, Moxifloxacin, Cefazolin, Probenecid.|cellulitis, rct, emergency department, double-blind, equivalence trial, moxifloxacin, cefazolin, probenecid.
5331046|NCT00323206|melanoma|melanoma
5331047|NCT00323206|electroporation|electroporation
5331048|NCT00323206|IL-12|il-12
5331049|NCT00323206|gene therapy|gene therapy
5331050|NCT00323206|gene transfer|gene transfer
5331051|NCT00323193|Behavioral interventions|behavioral interventions
5331052|NCT00323193|Mental Illness|mental illness
5331053|NCT00323193|Obesity|obesity
5331054|NCT00323193|Psycho-educational interventions|psycho-educational interventions
5331055|NCT00323193|Weight management|weight management
5331056|NCT00323167|Variant Cystic Fibrosis|variant cystic fibrosis
5331057|NCT00323167|Primary Ciliary Dyskinesia|primary ciliary dyskinesia
5331058|NCT00323154|Morphine, analgesia|morphine, analgesia
5331059|NCT00323141|Hernia umbilicalis|hernia umbilicalis
5331060|NCT00323115|immunotherapy|immunotherapy
5331061|NCT00323115|cancer vaccine|cancer vaccine
5331062|NCT00323115|glioblastoma multiforme|glioblastoma multiforme
5331063|NCT00323089|microcoil|microcoil
5331064|NCT00323089|subcentimetre nodules|subcentimetre nodules
5331065|NCT00323063|recurrent breast cancer|recurrent breast cancer
5331066|NCT00323063|stage IV breast cancer|stage iv breast cancer
5331067|NCT00323063|male breast cancer|male breast cancer
5331068|NCT00323063|stage IIIA breast cancer|stage iiia breast cancer
5331069|NCT00323063|stage IIIB breast cancer|stage iiib breast cancer
5331070|NCT00323063|stage IIIC breast cancer|stage iiic breast cancer
5331071|NCT00323037|heart failure|heart failure
5331072|NCT00323024|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
5331073|NCT00323024|Pulmonary Hypertension|pulmonary hypertension
5331074|NCT00323024|Idiopathic PAH|idiopathic pah
5331075|NCT00323024|PH associated with connective tissue disease (CTD)|ph associated with connective tissue disease (ctd)
5331076|NCT00323024|PH associated with interstitial lung disease (ILD)|ph associated with interstitial lung disease (ild)
5331077|NCT00323024|PH associated with congestive heart failure (CHF)|ph associated with congestive heart failure (chf)
5331078|NCT00323024|PH associated with chronic obstructive pulmonary disease (COPD)|ph associated with chronic obstructive pulmonary disease (copd)
5331079|NCT00322985|T-cell lymphoma|t-cell lymphoma
5331080|NCT00322985|lenalidomide|lenalidomide
5331081|NCT00322972|Bacterial Infections|bacterial infections
5331082|NCT00322972|Chlamydia Infections|chlamydia infections
5331083|NCT00322972|Eye Diseases|eye diseases
5331084|NCT00322959|dendritic cells|dendritic cells
5331085|NCT00322959|Tai-Chi-Chuan|tai-chi-chuan
5331086|NCT00322946|Dengue Fever|dengue fever
5331087|NCT00322946|Dengue Vaccine|dengue vaccine
5331088|NCT00322946|Dengue Virus|dengue virus
5331089|NCT00322946|Dengue Hemorrhagic Fever|dengue hemorrhagic fever
5331090|NCT00322946|Dengue Shock Syndrome|dengue shock syndrome
5331091|NCT00322933|intermittent renal replacement therapy|intermittent renal replacement therapy
5331092|NCT00322933|continuous renal replacement therapy|continuous renal replacement therapy
5331093|NCT00322933|acute renal failure|acute renal failure
5331094|NCT00322933|renal recovery|renal recovery
5331095|NCT00322933|mortality|mortality
5331096|NCT00322920|cervical cancer|cervical cancer
5331097|NCT00322920|topotecan|topotecan
5331098|NCT00322920|Stage IVB cervical cancer|stage ivb cervical cancer
5331099|NCT00322920|Persistent or recurrent cervical cancer|persistent or recurrent cervical cancer
5331100|NCT00322907|malaria|malaria
5331101|NCT00322907|treatment|treatment
5331102|NCT00322907|cotrifazid|cotrifazid
5331103|NCT00322907|clinical trial|clinical trial
5331104|NCT00322907|efficacy|efficacy
5331105|NCT00322894|Breast cancer|breast cancer
5331106|NCT00322894|Risk factors|risk factors
5331107|NCT00322894|Treatment|treatment
5331108|NCT00322894|Clinico-pathologic|clinico-pathologic
5331109|NCT00322894|Outcomes|outcomes
5331110|NCT00322894|Tissue repository|tissue repository
5331111|NCT00322894|Registry|registry
5331112|NCT00322881|carboplatin|carboplatin
5331113|NCT00322881|paclitaxel|paclitaxel
5331114|NCT00322881|elderly women|elderly women
5331115|NCT00322868|Prescription drugs|prescription drugs
5331116|NCT00322868|Administration, oral|administration, oral
5331117|NCT00322868|Durable medical equipment|durable medical equipment
5331118|NCT00322868|Kinetics|kinetics
5331119|NCT00322842|Non-Hodgkin's lymphoma|non-hodgkin's lymphoma
5331120|NCT00322842|Multiple Myeloma|multiple myeloma
5331121|NCT00322842|Stem cell mobilization|stem cell mobilization
5331122|NCT00322829|Group B Streptococcus, Strepotococcus agalactiae, detection|group b streptococcus, strepotococcus agalactiae, detection
5331123|NCT00322816|Malaria, Plasmodium falciparum, Gambia, larvicides|malaria, plasmodium falciparum, gambia, larvicides
5331124|NCT00322803|panic disorder|panic disorder
5331125|NCT00322803|proof of concept|proof of concept
5331126|NCT00322777|Major depression|major depression
5331127|NCT00322777|Spirituality|spirituality
5331128|NCT00322777|Randomized clinical trial|randomized clinical trial
5331129|NCT00322764|manic depression|manic depression
5331130|NCT00322764|bipolar disorder|bipolar disorder
5331131|NCT00322764|depression|depression
5331132|NCT00322764|uridine|uridine
5331133|NCT00322764|RG2417|rg2417
5331134|NCT00322738|malaria, Plasmodium falciparum, Gambia, larvicides, vector|malaria, plasmodium falciparum, gambia, larvicides, vector
5331135|NCT00322699|Bladder Cancer|bladder cancer
5331136|NCT00322699|Photodynamic Therapy|photodynamic therapy
5331137|NCT00322699|Photofrin|photofrin
5331138|NCT00322699|Photosensitization|photosensitization
5331139|NCT00322699|Photoradiation|photoradiation
5331140|NCT00322686|oglemilast|oglemilast
5331141|NCT00322686|asthma|asthma
5331142|NCT00322686|allergen|allergen
5331143|NCT00322686|prevention|prevention
5331144|NCT00322686|prophylaxis|prophylaxis
5331145|NCT00322686|Allergen-Induced Asthma|allergen-induced asthma
5331146|NCT00322673|acute myeloid leukemia|acute myeloid leukemia
5331147|NCT00322673|AML|aml
5331148|NCT00322608|Solid Tumors|solid tumors
5331149|NCT00322608|Lymphomas|lymphomas
5331150|NCT00322595|Anxiety|anxiety
5331151|NCT00322595|GAD|gad
5331152|NCT00322582|familial cardiomyopathy|familial cardiomyopathy
5331153|NCT00322582|genetics analysis|genetics analysis
5331154|NCT00322569|Percutaneous coronary intervention (PCI)|percutaneous coronary intervention (pci)
5331155|NCT00322569|Drug eluting stent (DES)|drug eluting stent (des)
5331156|NCT00322556|Immunoglobulin Intravenous|immunoglobulin intravenous
5331157|NCT00322556|Agammaglobulinemia|agammaglobulinemia
5331158|NCT00322556|Hypogammaglobulinemia|hypogammaglobulinemia
5331159|NCT00322556|Common variable immunodeficiency|common variable immunodeficiency
5331160|NCT00322556|Immunoglobulin G|immunoglobulin g
5331161|NCT00322556|Children|children
5331162|NCT00322543|Percutaneous coronary intervention (PCI)|percutaneous coronary intervention (pci)
5331163|NCT00322543|Drug eluting stent (DES)|drug eluting stent (des)
5331164|NCT00322491|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
5331165|NCT00322491|Multiple Myeloma|multiple myeloma
5331166|NCT00322491|Stem cell mobilization|stem cell mobilization
5331167|NCT00322465|non-gonococcal urethritis, doxycycline, azithromycin, sexually transmitted, tinidazole|non-gonococcal urethritis, doxycycline, azithromycin, sexually transmitted, tinidazole
5331168|NCT00322452|NSCLC|nsclc
5331169|NCT00322452|Gefitinib|gefitinib
5331170|NCT00322439|plaque Psoriasis patients|plaque psoriasis patients
5331171|NCT00322439|TNF-inhibitor naïve|tnf-inhibitor naïve
5331172|NCT00322426|Freezing of Gait|freezing of gait
5331173|NCT00322426|Parkinson's Disease|parkinson's disease
5331174|NCT00322426|Sensory Cues|sensory cues
5331175|NCT00322413|Epoetin alfa|epoetin alfa
5331176|NCT00322413|Epoetin omega|epoetin omega
5331177|NCT00322413|Comparative efficacy trial|comparative efficacy trial
5331178|NCT00322413|Renal anemia|renal anemia
5331179|NCT00322400|Clinical trial|clinical trial
5331180|NCT00322400|AMG 706|amg 706
5331181|NCT00322400|Anti-angiogenesis|anti-angiogenesis
5331182|NCT00322400|Locally Recurrent|locally recurrent
5331183|NCT00322400|Metastatic|metastatic
5331184|NCT00322400|Breast Cancer|breast cancer
5331185|NCT00322400|VEGF|vegf
5331186|NCT00322400|Angiogenesis Inhibitor|angiogenesis inhibitor
5331187|NCT00322400|Oral|oral
5331188|NCT00322400|Multi-kinase Inhibitor|multi-kinase inhibitor
5331189|NCT00322400|Anti-tumor|anti-tumor
5331190|NCT00322400|PDGF receptor|pdgf receptor
5331191|NCT00322400|Paclitaxel|paclitaxel
5331192|NCT00322400|Docetaxel|docetaxel
5331193|NCT00322400|Targeted Therapy|targeted therapy
5331194|NCT00322400|Oncology|oncology
5331195|NCT00322400|Amgen|amgen
5331196|NCT00322400|c-Kit|c-kit
5331197|NCT00322387|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
5331198|NCT00322387|Multiple Myeloma|multiple myeloma
5331199|NCT00322387|Stem cell mobilization|stem cell mobilization
5331200|NCT00322348|oncology|oncology
5331201|NCT00322348|cancer|cancer
5331202|NCT00322348|breast cancer|breast cancer
5331203|NCT00322335|H.influenzae type b Disease|h.influenzae type b disease
5331204|NCT00322322|L-carnitine supplementation|l-carnitine supplementation
5331205|NCT00322322|Hemodialysis|hemodialysis
5331206|NCT00322322|Anaemia|anaemia
5331207|NCT00322322|Erythropoietin responsiveness|erythropoietin responsiveness
5331208|NCT00322309|Cocaine|cocaine
5331209|NCT00322309|Substance Abuse|substance abuse
5331210|NCT00322296|Parapsoriasis|parapsoriasis
5331211|NCT00322296|Cutaneous T-cell lymphoma|cutaneous t-cell lymphoma
5331212|NCT00322296|Mycosis fungoides|mycosis fungoides
5331213|NCT00322296|Bexarotene|bexarotene
5331214|NCT00322296|Retinoids|retinoids
5331215|NCT00322283|oglemilast|oglemilast
5331216|NCT00322283|asthma|asthma
5331217|NCT00322283|exercise|exercise
5331218|NCT00322283|prevention|prevention
5331219|NCT00322283|prophylaxis|prophylaxis
5331220|NCT00322270|Occluded Central Venous Access Devices|occluded central venous access devices
5331221|NCT00322270|Occluded Catheters|occluded catheters
5331222|NCT00322270|Thrombosis|thrombosis
5331223|NCT00322270|thrombosis, catheter|thrombosis, catheter
5331224|NCT00322270|alfimeprase|alfimeprase
5331225|NCT00322270|thrombotic occlusion|thrombotic occlusion
5331226|NCT00322270|thrombosis, CVAD|thrombosis, cvad
5331227|NCT00322270|thrombosis, catheters|thrombosis, catheters
5331228|NCT00322244|Osteoarthritis|osteoarthritis
5331229|NCT00322244|Massage therapy|massage therapy
5331230|NCT00322192|Stroke rehabilitation|stroke rehabilitation
5331231|NCT00322192|Physical Therapy|physical therapy
5331232|NCT00322179|Microarray Analysis|microarray analysis
5331233|NCT00322179|Obesity|obesity
5331234|NCT00322179|Chronic Hepatitis C|chronic hepatitis c
5331235|NCT00322166|accidental falls|accidental falls
5331236|NCT00322166|vitamin D|vitamin d
5331237|NCT00322166|parathyroid hormone|parathyroid hormone
5331238|NCT00322166|osteoporosis|osteoporosis
5331239|NCT00322153|memantine|memantine
5331240|NCT00322153|Alzheimer's disease|alzheimer's disease
5331241|NCT00322153|moderate to severe Alzheimer's disease|moderate to severe alzheimer's disease
5331242|NCT00322140|Metastatic|metastatic
5331243|NCT00322140|Triterpenoids|triterpenoids
5331244|NCT00322140|2-Cyano-3,12-Dioxooleana-1,9(11)Dien-28oic Acid|2-cyano-3,12-dioxooleana-1,9(11)dien-28oic acid
5331245|NCT00322140|Dose-Limiting|dose-limiting
5331246|NCT00322140|Pharmacokinetic|pharmacokinetic
5331247|NCT00322140|Solid Tumor|solid tumor
5331248|NCT00322140|Lymphoma|lymphoma
5331249|NCT00322127|Hematopoietic Stem Cells|hematopoietic stem cells
5331250|NCT00322127|Stem Cell Mobilization|stem cell mobilization
5331251|NCT00322127|CXCR4|cxcr4
5331252|NCT00322127|SDF-1|sdf-1
5331253|NCT00322127|Healthy Volunteer|healthy volunteer
5331254|NCT00322127|HV|hv
5331255|NCT00322114|prostate cancer|prostate cancer
5331256|NCT00322062|Colon cleansing|colon cleansing
5331257|NCT00322049|Dengue, Vaccine, Thailand|dengue, vaccine, thailand
5331258|NCT00322036|Alzheimer Disease|alzheimer disease
5331259|NCT00322036|Dementia|dementia
5331260|NCT00322023|Negative symptoms|negative symptoms
5331261|NCT00322023|NMDA|nmda
5331262|NCT00322023|Glutamate|glutamate
5331263|NCT00322023|Glycine|glycine
5331264|NCT00322010|mechanical ventilation|mechanical ventilation
5331265|NCT00322010|physical therapy|physical therapy
5331266|NCT00322010|occupational therapy|occupational therapy
5331267|NCT00322010|mobilization|mobilization
5331268|NCT00322010|clinical protocols|clinical protocols
5331269|NCT00322010|ICU acquired weakness|icu acquired weakness
5331270|NCT00322010|critical illness myopathy|critical illness myopathy
5331271|NCT00322010|muscle atrophy|muscle atrophy
5331272|NCT00322010|intensive care unit|intensive care unit
5331273|NCT00322010|randomized controlled trial|randomized controlled trial
5331274|NCT00321997|AMD|amd
5331275|NCT00321997|Age-Related Macular Degeneration|age-related macular degeneration
5331276|NCT00321997|Macular Degeneration|macular degeneration
5331277|NCT00321997|Macugen|macugen
5331278|NCT00321997|pegaptanib sodium|pegaptanib sodium
5331279|NCT00321984|Gastroesophageal Reflux Disease(GERD)|gastroesophageal reflux disease(gerd)
5331280|NCT00321984|Heartburn|heartburn
5331281|NCT00321971|Anxiety|anxiety
5331282|NCT00321971|Mild Cognitive Impairment|mild cognitive impairment
5331283|NCT00321971|MCI|mci
5331284|NCT00321971|Cognitive Impairment|cognitive impairment
5331285|NCT00321971|Alzheimer's Disease|alzheimer's disease
5331286|NCT00321971|Caregiver Burden|caregiver burden
5331287|NCT00321971|Caregiver Stress|caregiver stress
5331288|NCT00321971|Family Dementia Caregiving|family dementia caregiving
5331289|NCT00321971|Spousal Dementia Caregiving|spousal dementia caregiving
5331290|NCT00321958|Barrett Esophagus|barrett esophagus
5331291|NCT00321958|Esophageal Neoplasm|esophageal neoplasm
5331292|NCT00321958|Deglutition disorders|deglutition disorders
5331293|NCT00321958|Cryotherapy|cryotherapy
5331294|NCT00321958|Cryosurgery|cryosurgery
5331295|NCT00321958|GERD|gerd
5331296|NCT00321958|Neoplasm|neoplasm
5331297|NCT00321958|Esophagus|esophagus
5331298|NCT00321958|Endoscopy, Digestive System|endoscopy, digestive system
5331299|NCT00321945|Atrial Fibrillation|atrial fibrillation
5331300|NCT00321945|Atrial Flutter|atrial flutter
5331301|NCT00321945|Angiotensin Converting Enzyme Inhibitor|angiotensin converting enzyme inhibitor
5331302|NCT00321945|Angiotensin Receptor Blocker|angiotensin receptor blocker
5331303|NCT00321906|Rejection in lung transplant|rejection in lung transplant
5331304|NCT00321893|Small cell lung cancer|small cell lung cancer
5331305|NCT00321893|Non-small cell lung cancer|non-small cell lung cancer
5331306|NCT00321893|Budesonide|budesonide
5331307|NCT00321893|Entocort EC|entocort ec
5331308|NCT00321893|Pulmicort Respules|pulmicort respules
5331309|NCT00321893|Rhinocort aqua|rhinocort aqua
5331310|NCT00321893|Aerosol budesonide treatment|aerosol budesonide treatment
5331311|NCT00321893|Smoking|smoking
5331312|NCT00321880|fatigue|fatigue
5331313|NCT00321880|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
5331314|NCT00321880|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5331315|NCT00321880|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5331316|NCT00321880|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5331317|NCT00321880|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5331318|NCT00321880|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5331319|NCT00321880|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5331320|NCT00321880|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5331321|NCT00321880|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
5331322|NCT00321880|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
5331323|NCT00321867|rectocele|rectocele
5331324|NCT00321867|pelvic prolapse|pelvic prolapse
5331325|NCT00321867|graft|graft
5331326|NCT00321867|surgical repair|surgical repair
5331327|NCT00321828|adenocarcinoma of the colon|adenocarcinoma of the colon
5331328|NCT00321828|stage IV colon cancer|stage iv colon cancer
5331329|NCT00321815|advanced carcinoma non-small cell lung EGFR positive Erlotinib Tarceva PF-3512676 Phase II immunotherapy immune modulator|advanced carcinoma non-small cell lung egfr positive erlotinib tarceva pf-3512676 phase ii immunotherapy immune modulator
5331330|NCT00321802|atrial fibrillation|atrial fibrillation
5331331|NCT00321802|statin therapy|statin therapy
5331332|NCT00321802|CRP levels|crp levels
5331333|NCT00321802|Paroxysmal Atrial Fibrillation|paroxysmal atrial fibrillation
5331334|NCT00321789|self care|self care
5331335|NCT00321789|social support|social support
5331336|NCT00321763|Influenza|influenza
5331337|NCT00321763|Influenza vaccine|influenza vaccine
5331338|NCT00321750|Oral erosive lichen planus|oral erosive lichen planus
5331339|NCT00321750|pimecrolimus cream|pimecrolimus cream
5331340|NCT00321737|Erosive Esophagitis|erosive esophagitis
5331341|NCT00321711|MDS|mds
5331342|NCT00321711|Myelodysplastic Syndromes|myelodysplastic syndromes
5331343|NCT00321711|Refractory Cytopenias|refractory cytopenias
5331344|NCT00321711|Thrombocytopenia|thrombocytopenia
5331345|NCT00321698|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5331346|NCT00321698|stage II prostate cancer|stage ii prostate cancer
5331347|NCT00321698|stage III prostate cancer|stage iii prostate cancer
5331348|NCT00321672|Analgesics|analgesics
5331349|NCT00321672|Capsaicin|capsaicin
5331350|NCT00321672|Neuropathic pain|neuropathic pain
5331351|NCT00321672|Neuropathy|neuropathy
5331352|NCT00321672|Distal sensory polyneuropathy|distal sensory polyneuropathy
5331353|NCT00321672|Peripheral neuropathy|peripheral neuropathy
5331354|NCT00321672|Dermal assessment|dermal assessment
5331355|NCT00321672|Pain measurement|pain measurement
5331356|NCT00321659|fibromyalgia|fibromyalgia
5331357|NCT00321659|self-management|self-management
5331358|NCT00321659|exercise|exercise
5331359|NCT00321659|patient education|patient education
5331360|NCT00321646|prostate cancer|prostate cancer
5331361|NCT00321646|bevacizumab|bevacizumab
5331362|NCT00321646|docetaxel|docetaxel
5331363|NCT00321646|radical prostatectomy|radical prostatectomy
5331364|NCT00321633|stage IV breast cancer|stage iv breast cancer
5331365|NCT00321633|recurrent breast cancer|recurrent breast cancer
5331366|NCT00321633|hereditary breast/ovarian cancer (BRCA1, BRCA2)|hereditary breast/ovarian cancer (brca1, brca2)
5331367|NCT00321633|BRCA1 mutation carrier|brca1 mutation carrier
5331368|NCT00321633|BRCA2 mutation carrier|brca2 mutation carrier
5331369|NCT00321620|Bone metastases|bone metastases
5331370|NCT00321620|Hormone-refractory prostate cancer|hormone-refractory prostate cancer
5331371|NCT00321620|Skeletal|skeletal
5331372|NCT00321620|Fractures|fractures
5331373|NCT00321620|Compressions|compressions
5331374|NCT00321620|Bisphosphonates|bisphosphonates
5331375|NCT00321581|VEGFR2|vegfr2
5331376|NCT00321581|Tyrosine Kinase Inhibitor|tyrosine kinase inhibitor
5331377|NCT00321581|Antiangiogenesis|antiangiogenesis
5331378|NCT00321581|Solid Tumors|solid tumors
5331379|NCT00321581|Childhood Cancer|childhood cancer
5331380|NCT00321581|Solid Tumor|solid tumor
5331381|NCT00321581|Recurrent Solid Tumor|recurrent solid tumor
5331382|NCT00321581|Treatment Resistant Solid Tumor|treatment resistant solid tumor
5331383|NCT00321581|Acute Myelogenous Leukemia|acute myelogenous leukemia
5331384|NCT00321581|AML|aml
5331385|NCT00321568|Multiple Sclerosis|multiple sclerosis
5331386|NCT00321568|Magnetic Resonance|magnetic resonance
5331387|NCT00321568|MRI|mri
5331388|NCT00321568|Magnetic Field|magnetic field
5331389|NCT00321568|MS|ms
5331390|NCT00321555|Biologic Therapy|biologic therapy
5331391|NCT00321555|Monoclonal Antibody|monoclonal antibody
5331392|NCT00321555|Immunotherapy|immunotherapy
5331393|NCT00321555|Pseudomonas Exotoxin|pseudomonas exotoxin
5331394|NCT00321555|Targeted Therapy|targeted therapy
5331395|NCT00321555|Hairy Cell Leukemia|hairy cell leukemia
5331396|NCT00321555|HCL|hcl
5331397|NCT00321542|Computed tomography|computed tomography
5331398|NCT00321542|Diabetes mellitus|diabetes mellitus
5331399|NCT00321542|Coronary atherosclerosis|coronary atherosclerosis
5331400|NCT00321542|Non-invasive imaging|non-invasive imaging
5331401|NCT00321529|Cervical spine instability|cervical spine instability
5331402|NCT00321529|Penning Study|penning study
5331403|NCT00321516|Bipolar type I Disorder|bipolar type i disorder
5331404|NCT00321503|acid reflux|acid reflux
5331405|NCT00321503|LPR|lpr
5331406|NCT00321503|gastroesophageal reflux|gastroesophageal reflux
5331407|NCT00321503|GERD|gerd
5331408|NCT00321503|pH probe|ph probe
5331409|NCT00321503|proton pump inhibitor|proton pump inhibitor
5331410|NCT00321503|PPI|ppi
5331411|NCT00321490|MDD|mdd
5331412|NCT00321490|Quetiapine fumarate, sustained release|quetiapine fumarate, sustained release
5331413|NCT00321490|Depression|depression
5331414|NCT00321477|Overactive Bladder|overactive bladder
5331415|NCT00321464|Fractures|fractures
5331416|NCT00321464|Compressions|compressions
5331417|NCT00321464|Bisphosphonates|bisphosphonates
5331418|NCT00321464|Bone metastases|bone metastases
5331419|NCT00321464|Breast cancer|breast cancer
5331420|NCT00321464|Skeletal|skeletal
5331421|NCT00321464|Radiation|radiation
5331422|NCT00321464|Surgery to Bone|surgery to bone
5331423|NCT00321451|insomnia|insomnia
5331424|NCT00321451|cognitive behavior therapy|cognitive behavior therapy
5331425|NCT00321438|HIV-1|hiv-1
5331426|NCT00321438|GW873140|gw873140
5331427|NCT00321438|CCR5 antagonist|ccr5 antagonist
5331428|NCT00321438|experienced|experienced
5331429|NCT00321438|treatment experienced|treatment experienced
5331430|NCT00321412|Crohn's disease|crohn's disease
5331431|NCT00321412|IBD|ibd
5331432|NCT00321412|Inflammatory Bowel Disease|inflammatory bowel disease
5331433|NCT00321412|Fistula|fistula
5331434|NCT00321399|CORONARY ANATOMY|coronary anatomy
5331435|NCT00321399|Coronary Artery Disease|coronary artery disease
5331436|NCT00321399|SPECT|spect
5331437|NCT00321399|PET|pet
5331438|NCT00321399|PET/CT|pet/ct
5331439|NCT00321399|CTA|cta
5331440|NCT00321386|Glaucoma|glaucoma
5331441|NCT00321386|Open Angle|open angle
5331442|NCT00321386|Normal Tension|normal tension
5331443|NCT00321373|Influenza|influenza
5331444|NCT00321373|Influenza vaccine|influenza vaccine
5331445|NCT00321360|propofol|propofol
5331446|NCT00321360|sedation|sedation
5331447|NCT00321347|Cancer|cancer
5331448|NCT00321347|Pain|pain
5331449|NCT00321347|Lidocaine|lidocaine
5331450|NCT00321334|non-small cell lung cancer|non-small cell lung cancer
5331451|NCT00321334|Chemotherapy|chemotherapy
5331452|NCT00321334|surgery|surgery
5331453|NCT00321334|neo-adjuvant|neo-adjuvant
5331454|NCT00321334|adjuvant|adjuvant
5331455|NCT00321334|RCT|rct
5331456|NCT00321321|Type 2 diabetes mellitus|type 2 diabetes mellitus
5331457|NCT00321321|Glucose dependent insulinotropic polypeptide|glucose dependent insulinotropic polypeptide
5331458|NCT00321321|Sulfonylurea compounds|sulfonylurea compounds
5331459|NCT00321321|insulin secretion|insulin secretion
5331460|NCT00321321|Sulfonylurea receptor subunit-SUR1|sulfonylurea receptor subunit-sur1
5331461|NCT00321321|Impaired incretin effect|impaired incretin effect
5331462|NCT00321308|advanced carcinoma, non-small cell lung cancer, phase II, pemetrexed, Alimta, PF-3512676, immunotherapy, immunomodulator|advanced carcinoma, non-small cell lung cancer, phase ii, pemetrexed, alimta, pf-3512676, immunotherapy, immunomodulator
5331463|NCT00321295|Bi-ventricular pacing|bi-ventricular pacing
5331464|NCT00321295|Cardiac Surgery|cardiac surgery
5331465|NCT00321295|Cardiomyopahty|cardiomyopahty
5331466|NCT00321295|Heart Failure|heart failure
5331467|NCT00321282|Atrial Fibrillation|atrial fibrillation
5331468|NCT00321282|Coronary Artery Bypass Graft|coronary artery bypass graft
5331469|NCT00321282|Risk Stratification|risk stratification
5331470|NCT00321269|Home Monitoring|home monitoring
5331471|NCT00321269|Heart Failure|heart failure
5331472|NCT00321269|Depression|depression
5331473|NCT00321256|islet transplantation|islet transplantation
5331474|NCT00321256|brittle diabetes|brittle diabetes
5331475|NCT00321256|severe hypoglycemia|severe hypoglycemia
5331476|NCT00321256|type 1 diabetes mellitus|type 1 diabetes mellitus
5331477|NCT00321243|triage|triage
5331478|NCT00321230|Colon cleansing|colon cleansing
5331479|NCT00321217|rheumatoid arthritis|rheumatoid arthritis
5331480|NCT00321217|pharmacogenetics|pharmacogenetics
5331481|NCT00321217|anti-TNF|anti-tnf
5331482|NCT00321217|high throughput genotyping|high throughput genotyping
5331483|NCT00321204|Atrial Fibrillation|atrial fibrillation
5331484|NCT00321204|Atrial Flutter|atrial flutter
5331485|NCT00321204|Cardiac Surgery|cardiac surgery
5331486|NCT00321204|Thiazolidinediones|thiazolidinediones
5331487|NCT00321178|Mycobacterium ulcerans|mycobacterium ulcerans
5331488|NCT00321178|Buruli ulcer|buruli ulcer
5331489|NCT00321178|Ghana|ghana
5331490|NCT00321178|randomized comparison|randomized comparison
5331491|NCT00321178|streptomycin|streptomycin
5331492|NCT00321178|rifampicin|rifampicin
5331493|NCT00321178|clarithromycin|clarithromycin
5331494|NCT00321165|nutrition|nutrition
5331495|NCT00321165|parenteral|parenteral
5331496|NCT00321165|infection|infection
5331497|NCT00321165|katheter|katheter
5331498|NCT00321165|taurolidine|taurolidine
5331499|NCT00321165|acridine orange|acridine orange
5331500|NCT00321165|prevention|prevention
5331501|NCT00321139|biomarkers|biomarkers
5331502|NCT00321139|oxidative stress|oxidative stress
5331503|NCT00321139|intravascular ultrasound|intravascular ultrasound
5331504|NCT00321126|Zinc|zinc
5331505|NCT00321126|Shigella|shigella
5331506|NCT00321126|Children|children
5331507|NCT00321126|Bangladesh|bangladesh
5331508|NCT00321113|MARGINAL KIDNEY|marginal kidney
5331509|NCT00321113|TACROLIMUS|tacrolimus
5331510|NCT00321113|IMMUNOSUPPRESSION|immunosuppression
5331511|NCT00321113|ELDERLY RECEPIENTS|elderly recepients
5331512|NCT00321100|metastatic|metastatic
5331513|NCT00321100|colorectal|colorectal
5331514|NCT00321100|cancer|cancer
5331515|NCT00321100|initial therapy|initial therapy
5331516|NCT00321087|Movement Disorder|movement disorder
5331517|NCT00321074|IMMUNOSUPPRESSION|immunosuppression
5331518|NCT00321074|TACROLIMUS|tacrolimus
5331519|NCT00321074|MARGINAL LIVERS|marginal livers
5331520|NCT00321074|PHARMACOKINETICS|pharmacokinetics
5331521|NCT00321061|HIV Negative|hiv negative
5331522|NCT00321061|Healthy|healthy
5331523|NCT00321061|Immunity|immunity
5331524|NCT00321061|Preventive|preventive
5331525|NCT00321061|Virus|virus
5331526|NCT00321061|Healthy Volunteer|healthy volunteer
5331527|NCT00321061|HV|hv
5331528|NCT00321048|breast cancer|breast cancer
5331529|NCT00321048|SPECT|spect
5331530|NCT00321048|ABC device|abc device
5331531|NCT00321048|Invasive adenocarcinoma of the left breast|invasive adenocarcinoma of the left breast
5331532|NCT00321048|Ductal Carcinoma In Situ of the left breast|ductal carcinoma in situ of the left breast
5331533|NCT00321035|Glaucoma|glaucoma
5331534|NCT00321035|Pterygium|pterygium
5331535|NCT00321035|collagen matrix|collagen matrix
5331536|NCT00321035|oculusgen|oculusgen
5331537|NCT00321035|ologen|ologen
5331538|NCT00321035|trabeculectomy|trabeculectomy
5331539|NCT00321035|anti scarring|anti scarring
5331540|NCT00321035|prevent recurrence|prevent recurrence
5331541|NCT00321035|tissue engineering|tissue engineering
5331542|NCT00321035|Aeon Astron|aeon astron
5331543|NCT00321022|Transient Ischemic Attack (TIA)|transient ischemic attack (tia)
5331544|NCT00321022|Diagnostic Protocol|diagnostic protocol
5331545|NCT00321022|Observational Medicine|observational medicine
5331546|NCT00321022|Emergency Department Observational Unit|emergency department observational unit
5331547|NCT00321009|Myocardial Infarction|myocardial infarction
5331548|NCT00321009|Left Ventricular Mural Thrombus|left ventricular mural thrombus
5331549|NCT00321009|Low Molecular Weight Heparin|low molecular weight heparin
5331550|NCT00321009|Enoxaparin|enoxaparin
5331551|NCT00321009|Warfarin|warfarin
5331552|NCT00321009|Echocardiograms|echocardiograms
5331553|NCT00320996|Pelvic mass|pelvic mass
5331554|NCT00320983|Cancer|cancer
5331555|NCT00320983|Cervix|cervix
5331556|NCT00320970|TGF-Beta 1|tgf-beta 1
5331557|NCT00320970|Angiotensin II|angiotensin ii
5331558|NCT00320970|Advanced glycation end products|advanced glycation end products
5331559|NCT00320957|Glaucoma|glaucoma
5331560|NCT00320957|Pterygium|pterygium
5331561|NCT00320957|collagen matrix|collagen matrix
5331562|NCT00320957|OculusGen|oculusgen
5331563|NCT00320957|trabeculectomy|trabeculectomy
5331564|NCT00320957|Anti scarring|anti scarring
5331565|NCT00320957|pterygium recurrence|pterygium recurrence
5331566|NCT00320957|tissue engineering|tissue engineering
5331567|NCT00320957|Aeon Astron|aeon astron
5331568|NCT00320957|ologen|ologen
5331569|NCT00320931|Coronary artery disease|coronary artery disease
5331570|NCT00320931|PET CT scan|pet ct scan
5331571|NCT00320931|Stress test|stress test
5331572|NCT00320931|Rubudium|rubudium
5331573|NCT00320918|Unresectable/metastatic cholangiocarcinoma|unresectable/metastatic cholangiocarcinoma
5331574|NCT00320918|Cancer|cancer
5331575|NCT00320918|Chart Review|chart review
5331576|NCT00320905|Cardiac Rehabilitation|cardiac rehabilitation
5331577|NCT00320905|Cognitive functioning|cognitive functioning
5331578|NCT00320905|Cardiovascular disease|cardiovascular disease
5331579|NCT00320892|Death Rattle|death rattle
5331580|NCT00320892|Noise level|noise level
5331581|NCT00320892|Primary Care|primary care
5331582|NCT00320879|diabetes|diabetes
5331583|NCT00320879|microalbuminuria|microalbuminuria
5331584|NCT00320879|angiotensin II receptor blockade|angiotensin ii receptor blockade
5331585|NCT00320879|irbesartan|irbesartan
5331586|NCT00320879|dose-response|dose-response
5331587|NCT00320879|randomized|randomized
5331588|NCT00320879|double-blind|double-blind
5331589|NCT00320879|renin-angiotensin-aldosterone system|renin-angiotensin-aldosterone system
5331590|NCT00320879|clinical|clinical
5331591|NCT00320879|hypertension|hypertension
5331592|NCT00320866|Hypodermoclysis|hypodermoclysis
5331593|NCT00320866|Evaluation of Symptoms|evaluation of symptoms
5331594|NCT00320853|Diabetes|diabetes
5331595|NCT00320853|Vitamin D|vitamin d
5331596|NCT00320853|Insulin sensitivity|insulin sensitivity
5331597|NCT00320853|Insulin secretion|insulin secretion
5331598|NCT00320840|preterm infants|preterm infants
5331599|NCT00320840|twins|twins
5331600|NCT00320840|motherhood|motherhood
5331601|NCT00320840|internal resources|internal resources
5331602|NCT00320840|familial resources|familial resources
5331603|NCT00320827|Apoptosis|apoptosis
5331604|NCT00320827|Death receptor 5|death receptor 5
5331605|NCT00320827|Cancer|cancer
5331606|NCT00320827|Advanced solid malignancies and lymphomas (without leukemic component)|advanced solid malignancies and lymphomas (without leukemic component)
5331607|NCT00320801|Chronic pain|chronic pain
5331608|NCT00320801|osteoarthritis|osteoarthritis
5331609|NCT00320801|transdermal|transdermal
5331610|NCT00320788|Neovascular Age-Related Macular Degeneration|neovascular age-related macular degeneration
5331611|NCT00320775|Neovascular Age-Related Macular Degeneration|neovascular age-related macular degeneration
5331612|NCT00320762|Glaucoma|glaucoma
5331613|NCT00320762|Pterygium|pterygium
5331614|NCT00320762|collagen matrix|collagen matrix
5331615|NCT00320762|OculusGen|oculusgen
5331616|NCT00320762|trabeculectomy|trabeculectomy
5331617|NCT00320762|Anti scarring|anti scarring
5331618|NCT00320762|pterygium recurrence|pterygium recurrence
5331619|NCT00320762|tissue engineering|tissue engineering
5331620|NCT00320762|Aeon Astron|aeon astron
5331621|NCT00320749|Advanced Pancreatic Cancer|advanced pancreatic cancer
5331622|NCT00320736|schizophrenia|schizophrenia
5331623|NCT00320736|cognitive function|cognitive function
5331624|NCT00320736|cholinergic medication|cholinergic medication
5331625|NCT00320736|nicotinic receptor agonist|nicotinic receptor agonist
5331626|NCT00320723|schizophrenia|schizophrenia
5331627|NCT00320723|smoking cessation|smoking cessation
5331628|NCT00320723|nicotine|nicotine
5331629|NCT00320723|patch|patch
5331630|NCT00320723|bupropion|bupropion
5331631|NCT00320723|nicotine replacement therapy|nicotine replacement therapy
5331632|NCT00320723|cognitive behavioral therapy|cognitive behavioral therapy
5331633|NCT00320710|Breast cancer|breast cancer
5331634|NCT00320710|zoledronic acid|zoledronic acid
5331635|NCT00320710|bone metastases|bone metastases
5331636|NCT00320697|schizophrenia|schizophrenia
5331637|NCT00320697|smoking cessation|smoking cessation
5331638|NCT00320697|relapse prevention|relapse prevention
5331639|NCT00320697|nicotine|nicotine
5331640|NCT00320697|bupropion|bupropion
5331641|NCT00320697|cognitive behavioral therapy|cognitive behavioral therapy
5331642|NCT00320697|nicotine replacement therapy|nicotine replacement therapy
5331643|NCT00320684|Serotonin Transporter|serotonin transporter
5331644|NCT00320684|Positron-Emission Tomography|positron-emission tomography
5331645|NCT00320671|First-episode|first-episode
5331646|NCT00320671|Schizoaffective Disorder|schizoaffective disorder
5331647|NCT00320671|Schizophreniform Disorder|schizophreniform disorder
5331648|NCT00320671|Psychotic Disorder Not Otherwise Specified NOS|psychotic disorder not otherwise specified nos
5331649|NCT00320671|Aripiprazole|aripiprazole
5331650|NCT00320671|Clozapine|clozapine
5331651|NCT00320671|Risperidone|risperidone
5331652|NCT00320658|Plasmodium falciparum|plasmodium falciparum
5331653|NCT00320632|Major Depressive Disorder|major depressive disorder
5331654|NCT00320632|MDD|mdd
5331655|NCT00320619|Aminocaproic Acids|aminocaproic acids
5331656|NCT00320619|Blood Transfusion|blood transfusion
5331657|NCT00320606|allograft function|allograft function
5331658|NCT00320606|anti-rejection|anti-rejection
5331659|NCT00320606|immunosuppression withdrawal|immunosuppression withdrawal
5331660|NCT00320606|liver transplant|liver transplant
5331661|NCT00320606|liver transplantation|liver transplantation
5331662|NCT00320606|living donor transplant|living donor transplant
5331663|NCT00320593|Myopia|myopia
5331664|NCT00320593|Progressive Addition Lenses (PALs)|progressive addition lenses (pals)
5331665|NCT00320593|Single Vision Lenses (SVLs)|single vision lenses (svls)
5331666|NCT00320593|Accommodative lags|accommodative lags
5331667|NCT00320593|Near esophoria|near esophoria
5331668|NCT00320593|Refractive error|refractive error
5331669|NCT00320580|Metrorrhagia|metrorrhagia
5331670|NCT00320580|oral contraception|oral contraception
5331671|NCT00320580|breakthrough bleeding|breakthrough bleeding
5331672|NCT00320580|spotting|spotting
5331673|NCT00320567|osteoporosis|osteoporosis
5331674|NCT00320567|anorexia nervosa|anorexia nervosa
5331675|NCT00320567|pediatric|pediatric
5331676|NCT00320541|Breast Cancer|breast cancer
5331677|NCT00320541|Cancer of Breast|cancer of breast
5331678|NCT00320541|Cancer of the breast|cancer of the breast
5331679|NCT00320541|Breast Neoplasms|breast neoplasms
5331680|NCT00320476|Multiple myeloma|multiple myeloma
5331681|NCT00320450|SB-681323|sb-681323
5331682|NCT00320450|CRP|crp
5331683|NCT00320450|Rheumatoid Arthritis SB-681323 CRP RA|rheumatoid arthritis sb-681323 crp ra
5331684|NCT00320450|Rheumatoid Arthritis|rheumatoid arthritis
5331685|NCT00320450|RA|ra
5331686|NCT00320437|trauma|trauma
5331687|NCT00320437|anxiety|anxiety
5331688|NCT00320437|antenatal|antenatal
5331689|NCT00320437|mothers|mothers
5331690|NCT00320437|children|children
5331691|NCT00320437|Gene x Environment Interaction|gene x environment interaction
5331692|NCT00320424|Xa factor|xa factor
5331693|NCT00320424|VTE|vte
5331694|NCT00320424|MOSLL|mosll
5331695|NCT00320424|pentasaccharide|pentasaccharide
5331696|NCT00320411|Stage IV breast cancer|stage iv breast cancer
5331697|NCT00320411|Herceptin|herceptin
5331698|NCT00320411|metastatic breast cancer|metastatic breast cancer
5331699|NCT00320411|ErbB1|erbb1
5331700|NCT00320411|ErbB2|erbb2
5331701|NCT00320411|trastuzumab|trastuzumab
5331702|NCT00320411|lapatinib|lapatinib
5331703|NCT00320398|Fondaparinux|fondaparinux
5331704|NCT00320398|Hip Replacement Arthroplasty|hip replacement arthroplasty
5331705|NCT00320398|VTE|vte
5331706|NCT00320398|THR|thr
5331707|NCT00320398|MOSLL|mosll
5331708|NCT00320398|pentasaccharide|pentasaccharide
5331709|NCT00320398|Xa factor|xa factor
5331710|NCT00320385|lapatinib|lapatinib
5331711|NCT00320385|GW572016|gw572016
5331712|NCT00320385|ErbB2|erbb2
5331713|NCT00320385|EGFR|egfr
5331714|NCT00320385|ErbB1|erbb1
5331715|NCT00320385|MBC|mbc
5331716|NCT00320385|FISH amplification|fish amplification
5331717|NCT00320385|Metastatic Breast Cancer|metastatic breast cancer
5331718|NCT00320385|dual tyrosine kinase inhibitor|dual tyrosine kinase inhibitor
5331719|NCT00320385|Her-2/neu|her-2/neu
5331720|NCT00320372|Major Depressive Disorder|major depressive disorder
5331721|NCT00320372|Treatment-resistant Depression|treatment-resistant depression
5331722|NCT00320359|First-line Cisplatin|first-line cisplatin
5331723|NCT00320359|Small Cell Lung Cancer|small cell lung cancer
5331724|NCT00320359|topotecan|topotecan
5331725|NCT00320359|etoposide|etoposide
5331726|NCT00320359|Extensive Disease|extensive disease
5331727|NCT00320346|Pandemic|pandemic
5331728|NCT00320346|Influenza|influenza
5331729|NCT00320346|Prevention|prevention
5331730|NCT00320346|Vaccine|vaccine
5331731|NCT00320346|Prevention of Pandemic Influenza|prevention of pandemic influenza
5331732|NCT00320333|COPD|copd
5331733|NCT00320333|rehabilitation|rehabilitation
5331734|NCT00320333|health services research|health services research
5331735|NCT00320320|No prior chemotherapy|no prior chemotherapy
5331736|NCT00320307|Human Immunodeficiency Virus|human immunodeficiency virus
5331737|NCT00320307|HIV|hiv
5331738|NCT00320307|Abacavir regime|abacavir regime
5331739|NCT00320307|ABC|abc
5331740|NCT00320281|Botox|botox
5331741|NCT00320268|MDD|mdd
5331742|NCT00320268|Quetiapine fumarate, sustained release|quetiapine fumarate, sustained release
5331743|NCT00320268|Depression|depression
5331744|NCT00320255|anticoagulant|anticoagulant
5331745|NCT00320242|Parkinson's disease|parkinson's disease
5331746|NCT00320242|laser cane|laser cane
5331747|NCT00320242|freezing of gait|freezing of gait
5331748|NCT00320242|visual cues|visual cues
5331749|NCT00320229|angioplasty|angioplasty
5331750|NCT00320229|stent|stent
5331751|NCT00320229|abciximab|abciximab
5331752|NCT00320229|Platelet Glycoprotein GPIIb-IIIa Complex|platelet glycoprotein gpiib-iiia complex
5331753|NCT00320229|myocardial infarction|myocardial infarction
5331754|NCT00320216|Psoriasis|psoriasis
5331755|NCT00320216|CNTO 1275|cnto 1275
5331756|NCT00320216|Ustekinumab|ustekinumab
5331757|NCT00320216|Stelara|stelara
5331758|NCT00320216|Interleukin-12|interleukin-12
5331759|NCT00320216|IL-12|il-12
5331760|NCT00320216|Interleukin-23|interleukin-23
5331761|NCT00320216|IL-23|il-23
5331762|NCT00320203|open-angle|open-angle
5331763|NCT00320203|glaucoma|glaucoma
5331764|NCT00320190|Chronic phase CML, with a suboptimal response after treatment with imatinib|chronic phase cml, with a suboptimal response after treatment with imatinib
5331765|NCT00320177|Binge Eating|binge eating
5331766|NCT00320177|Food Intake|food intake
5331767|NCT00320177|Obesity|obesity
5331768|NCT00320177|Melanocortin-4 Receptor Gene|melanocortin-4 receptor gene
5331769|NCT00320177|Child|child
5331770|NCT00320177|Macronutrient Composition|macronutrient composition
5331771|NCT00320164|Healthy Volunteers|healthy volunteers
5331772|NCT00320151|chronic lung disease|chronic lung disease
5331773|NCT00320138|PTSD|ptsd
5331774|NCT00320138|Posttraumatic Stress|posttraumatic stress
5331775|NCT00320138|Acupuncture|acupuncture
5331776|NCT00320138|Randomized Controlled Trial|randomized controlled trial
5331777|NCT00320138|Complementary medicine|complementary medicine
5331778|NCT00320138|Alternative medicine|alternative medicine
5331779|NCT00320138|Chinese medicine|chinese medicine
5331780|NCT00320138|military healthcare|military healthcare
5331781|NCT00320125|Dairy|dairy
5331782|NCT00320125|Calcium|calcium
5331783|NCT00320125|Pregnancy|pregnancy
5331784|NCT00320125|Fetus|fetus
5331785|NCT00320125|Bone mineralization|bone mineralization
5331786|NCT00320112|telemedicine|telemedicine
5331787|NCT00320112|case management|case management
5331788|NCT00320112|insulin|insulin
5331789|NCT00320112|self-care|self-care
5331790|NCT00320099|septic shock|septic shock
5331791|NCT00320099|adrenal insufficiency|adrenal insufficiency
5331792|NCT00320099|glucose control|glucose control
5331793|NCT00320099|mineralocorticoids|mineralocorticoids
5331794|NCT00320073|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5331795|NCT00320060|Diabetic nephropathy|diabetic nephropathy
5331796|NCT00320060|Advanced Glycation Endproduct Inhibitor|advanced glycation endproduct inhibitor
5331797|NCT00320060|Pyridorin|pyridorin
5331798|NCT00320060|Pyridoxamine|pyridoxamine
5331799|NCT00320047|Binge Eating Disorder|binge eating disorder
5331800|NCT00320034|levalbuterol|levalbuterol
5331801|NCT00320034|asthma|asthma
5331802|NCT00320034|allergen provocation|allergen provocation
5331803|NCT00320034|airway inflammation|airway inflammation
5331804|NCT00320034|clinical trial|clinical trial
5331805|NCT00320021|Diabetic nephropathy|diabetic nephropathy
5331806|NCT00320021|Advanced Glycation Endproduct Inhibitor|advanced glycation endproduct inhibitor
5331807|NCT00320021|Pyridorin|pyridorin
5331808|NCT00320021|Pyridoxamine|pyridoxamine
5331809|NCT00319982|Hypertrophic Cardiomyopathy|hypertrophic cardiomyopathy
5331810|NCT00319982|Left ventricular hypertrophy|left ventricular hypertrophy
5331811|NCT00319982|Diltiazem|diltiazem
5331812|NCT00319969|small cell lung cancer|small cell lung cancer
5331813|NCT00319969|amrubicin|amrubicin
5331814|NCT00319956|premature infant|premature infant
5331815|NCT00319956|respiratory distress syndrome|respiratory distress syndrome
5331816|NCT00319956|mechanical ventilation|mechanical ventilation
5331817|NCT00319943|Cognitive remediation|cognitive remediation
5331818|NCT00319943|Cognitive impairment|cognitive impairment
5331819|NCT00319943|computer|computer
5331820|NCT00319943|training|training
5331821|NCT00319930|Chronic lymphocytic leukemia|chronic lymphocytic leukemia
5331822|NCT00319930|CLL|cll
5331823|NCT00319930|ZAP-70|zap-70
5331824|NCT00319930|Hsp90 inhibitor|hsp90 inhibitor
5331825|NCT00319917|Tacrolimus|tacrolimus
5331826|NCT00319917|Rheumatoid Arthritis|rheumatoid arthritis
5331827|NCT00319917|Tacrolimus anhydrous|tacrolimus anhydrous
5331828|NCT00319904|Schizophrenia|schizophrenia
5331829|NCT00319904|DNA|dna
5331830|NCT00319891|Alzheimer's|alzheimer's
5331831|NCT00319891|AD|ad
5331832|NCT00319891|Mild Cognitive Impairment|mild cognitive impairment
5331833|NCT00319891|Dementia|dementia
5331834|NCT00319891|Cognitive remediation|cognitive remediation
5331835|NCT00319891|computer-based training|computer-based training
5331836|NCT00319865|Multiple Myeloma Relapsed|multiple myeloma relapsed
5331837|NCT00319852|Diphteria;|diphteria;
5331838|NCT00319852|Tetanus;|tetanus;
5331839|NCT00319852|Pertussis;|pertussis;
5331840|NCT00319852|Poliomyelitis;|poliomyelitis;
5331841|NCT00319852|acellular|acellular
5331842|NCT00319839|Head cancer|head cancer
5331843|NCT00319839|Neck cancer|neck cancer
5331844|NCT00319839|cetuximab|cetuximab
5331845|NCT00319839|abraxane|abraxane
5331846|NCT00319839|erbitux|erbitux
5331847|NCT00319839|IMC-225|imc-225
5331848|NCT00319839|NSC-714692|nsc-714692
5331849|NCT00319826|Staphylococcus aureus, S. aureus, bacteremia, sepsis|staphylococcus aureus, s. aureus, bacteremia, sepsis
5331850|NCT00319774|End-stage renal disease|end-stage renal disease
5331851|NCT00319774|Hemodialysis|hemodialysis
5331852|NCT00319774|Hypertension|hypertension
5331853|NCT00319774|Hypotension|hypotension
5331854|NCT00319774|Blood volume|blood volume
5331855|NCT00319774|Hypervolemia|hypervolemia
5331856|NCT00319774|Quality of life|quality of life
5331857|NCT00319774|Biofeedback system|biofeedback system
5331858|NCT00319761|glomerulonephritis|glomerulonephritis
5331859|NCT00319761|proteinuria|proteinuria
5331860|NCT00319761|chronic kidney diseases|chronic kidney diseases
5331861|NCT00319748|Breast|breast
5331862|NCT00319748|Ovarian|ovarian
5331863|NCT00319748|Endometrial|endometrial
5331864|NCT00319748|Cervical|cervical
5331865|NCT00319748|Metastatic|metastatic
5331866|NCT00319748|852A|852a
5331867|NCT00319748|IRM|irm
5331868|NCT00319748|Oncology|oncology
5331869|NCT00319748|Metastatic Cervical Cancer|metastatic cervical cancer
5331870|NCT00319748|Metastatic Ovarian Cancer|metastatic ovarian cancer
5331871|NCT00319748|Metastatic Breast Cancer|metastatic breast cancer
5331872|NCT00319748|Metastatic Endometrial Cancer|metastatic endometrial cancer
5331873|NCT00319722|autism|autism
5331874|NCT00319722|pervasive developmental disorder|pervasive developmental disorder
5331875|NCT00319722|evoked potentials|evoked potentials
5331876|NCT00319722|EEG|eeg
5331877|NCT00319722|Coherence|coherence
5331878|NCT00319709|depression|depression
5331879|NCT00319709|antidepressive agents|antidepressive agents
5331880|NCT00319709|controlled clinical trial|controlled clinical trial
5331881|NCT00319696|systemic sclerosis|systemic sclerosis
5331882|NCT00319696|digital ulcers|digital ulcers
5331883|NCT00319696|bosentan|bosentan
5331884|NCT00319696|open label|open label
5331885|NCT00319696|finger ulcers|finger ulcers
5331886|NCT00319683|Cancer|cancer
5331887|NCT00319683|Tumors|tumors
5331888|NCT00319683|Neoplasms|neoplasms
5331889|NCT00319683|Anticarcinogenic Agents|anticarcinogenic agents
5331890|NCT00319683|Antineoplastic Agents|antineoplastic agents
5331891|NCT00319683|Dihydrouracil Dehydrogenase (NADP)|dihydrouracil dehydrogenase (nadp)
5331892|NCT00319670|constipation|constipation
5331893|NCT00319670|pediatric|pediatric
5331894|NCT00319657|Kidney Transplantation|kidney transplantation
5331895|NCT00319657|Blood Stem Cell Transplantation|blood stem cell transplantation
5331896|NCT00319631|Respiratory Distress Syndrome, Adult|respiratory distress syndrome, adult
5331897|NCT00319605|Cross sectional study|cross sectional study
5331898|NCT00319605|acceptability|acceptability
5331899|NCT00319605|levetiracetam|levetiracetam
5331900|NCT00319605|oral solution|oral solution
5331901|NCT00319605|Keppra|keppra
5331902|NCT00319592|Japanese encephalitis|japanese encephalitis
5331903|NCT00319592|ChimeriVax™-JE|chimerivax™-je
5331904|NCT00319592|JE-VAX®|je-vax®
5331905|NCT00319579|living kidney donors|living kidney donors
5331906|NCT00319579|prospective|prospective
5331907|NCT00319579|medical|medical
5331908|NCT00319579|psychosocial|psychosocial
5331909|NCT00319566|Coronary Heart Disease|coronary heart disease
5331910|NCT00319566|Hormone replacement therapy|hormone replacement therapy
5331911|NCT00319566|Estrogen|estrogen
5331912|NCT00319566|Postmenopausal women|postmenopausal women
5331913|NCT00319553|Tetanus|tetanus
5331914|NCT00319553|diphtheria|diphtheria
5331915|NCT00319553|acellular pertussis|acellular pertussis
5331916|NCT00319540|Depression|depression
5331917|NCT00319540|psychoeducation|psychoeducation
5331918|NCT00319540|RCT|rct
5331919|NCT00319540|primary health services|primary health services
5331920|NCT00319527|long term outcome|long term outcome
5331921|NCT00319527|living kidney donor|living kidney donor
5331922|NCT00319501|Acute Repetitive Seizures|acute repetitive seizures
5331923|NCT00319501|ARS|ars
5331924|NCT00319501|Diazepam|diazepam
5331925|NCT00319501|Cluster Seizures|cluster seizures
5331926|NCT00319488|Wheezing|wheezing
5331927|NCT00319488|Respiratory Tract Illness|respiratory tract illness
5331928|NCT00319462|point A, cervical cancer, radiotherapy|point a, cervical cancer, radiotherapy
5331929|NCT00319436|parenting intervention|parenting intervention
5331930|NCT00319436|family intervention|family intervention
5331931|NCT00319436|maternal substance abuse|maternal substance abuse
5331932|NCT00319436|mother-child relations|mother-child relations
5331933|NCT00319436|parent-child relations|parent-child relations
5331934|NCT00319423|Hip Osteoarthritis, Exercise therapy, Patient Education|hip osteoarthritis, exercise therapy, patient education
5331935|NCT00319410|Menorrhagia|menorrhagia
5331936|NCT00319410|intrauterine diagnosis|intrauterine diagnosis
5331937|NCT00319410|visual analogue scale|visual analogue scale
5331938|NCT00319397|vascular resistance|vascular resistance
5331939|NCT00319397|vasomotion|vasomotion
5331940|NCT00319397|coronary disorder|coronary disorder
5331941|NCT00319397|hemodynamics|hemodynamics
5331942|NCT00319397|physical fitness|physical fitness
5331943|NCT00319384|congestive heart failure|congestive heart failure
5331944|NCT00319384|heart failure|heart failure
5331945|NCT00319384|ultrafiltration therapy|ultrafiltration therapy
5331946|NCT00319384|fluid overload|fluid overload
5331947|NCT00319371|vasospasm|vasospasm
5331948|NCT00319371|circadian|circadian
5331949|NCT00319371|sleep-disorders|sleep-disorders
5331950|NCT00319358|chronic pancreatitis|chronic pancreatitis
5331951|NCT00319358|antioxidant supplementation|antioxidant supplementation
5331952|NCT00319358|oxidative stress|oxidative stress
5331953|NCT00319345|Traumatic brain injury|traumatic brain injury
5331954|NCT00319345|Intracranial pressure|intracranial pressure
5331955|NCT00319345|Osmotherapy|osmotherapy
5331956|NCT00319345|Glasgow outcome score|glasgow outcome score
5331957|NCT00319345|Mannitol|mannitol
5331958|NCT00319345|Sodium-Lactate|sodium-lactate
5331959|NCT00319332|non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
5331960|NCT00319332|follicular lymphoma|follicular lymphoma
5331961|NCT00319332|BEXXAR|bexxar
5331962|NCT00319332|ZEVALIN|zevalin
5331963|NCT00319332|Iodine I 131 Tositumomab|iodine i 131 tositumomab
5331964|NCT00319332|Ibritumomab Tiuxetan|ibritumomab tiuxetan
5331965|NCT00319332|Follicular, mixed small-cleaved and large-cell|follicular, mixed small-cleaved and large-cell
5331966|NCT00319332|Diffuse large cell non-Hodgkin's lymphoma following or concurrent with a diagnosis of follicular lymphoma|diffuse large cell non-hodgkin's lymphoma following or concurrent with a diagnosis of follicular lymphoma
5331967|NCT00319319|major depressive disorder,|major depressive disorder,
5331968|NCT00319319|serotonin selective reuptake inhibitor,|serotonin selective reuptake inhibitor,
5331969|NCT00319319|mecamylamine,|mecamylamine,
5331970|NCT00319319|controlled trial,|controlled trial,
5331971|NCT00319319|cigarette smoking|cigarette smoking
5331972|NCT00319306|Respiratory Tract Diseases|respiratory tract diseases
5331973|NCT00319306|Bronchial Diseases|bronchial diseases
5331974|NCT00319306|Anti-asthmatic agents|anti-asthmatic agents
5331975|NCT00319306|Anti-asthmatic drugs|anti-asthmatic drugs
5331976|NCT00319306|Bronchodilators|bronchodilators
5331977|NCT00319280|Osteoarthritis, Knee|osteoarthritis, knee
5331978|NCT00319280|Osteotomy|osteotomy
5331979|NCT00319280|Healing|healing
5331980|NCT00319280|Roentgen Stereometric Analysis|roentgen stereometric analysis
5331981|NCT00319267|bosentan|bosentan
5331982|NCT00319267|children|children
5331983|NCT00319267|pharmacokinetics|pharmacokinetics
5331984|NCT00319267|pulmonary arterial hypertension|pulmonary arterial hypertension
5331985|NCT00319254|Advanced Breast Cancer|advanced breast cancer
5331986|NCT00319241|parenting intervention|parenting intervention
5331987|NCT00319241|substance abuse treatment|substance abuse treatment
5331988|NCT00319241|mother-child relations|mother-child relations
5331989|NCT00319241|parent-child relations|parent-child relations
5331990|NCT00319241|child abuse and neglect|child abuse and neglect
5331991|NCT00319228|AT-III deficiency|at-iii deficiency
5331992|NCT00319228|AT-III concentrate|at-iii concentrate
5331993|NCT00319228|Bleeding disorders|bleeding disorders
5331994|NCT00319228|Blood disorders|blood disorders
5331995|NCT00319215|ramelteon|ramelteon
5331996|NCT00319215|zopiclone|zopiclone
5331997|NCT00319215|driving|driving
5331998|NCT00319215|memory|memory
5331999|NCT00319215|balance|balance
5332000|NCT00319215|psychomotor|psychomotor
5332001|NCT00319202|Impaired fasting glucose|impaired fasting glucose
5332002|NCT00319202|Abdominal obesity|abdominal obesity
5332003|NCT00319202|HOMA|homa
5332004|NCT00319202|Angiotensin-receptor blocker|angiotensin-receptor blocker
5332005|NCT00319189|Nateglinide|nateglinide
5332006|NCT00319189|Renal|renal
5332007|NCT00319189|Kidney|kidney
5332008|NCT00319189|Transplantation|transplantation
5332009|NCT00319189|Diabets|diabets
5332010|NCT00319189|Glucose|glucose
5332011|NCT00319176|Pregnancy|pregnancy
5332012|NCT00319176|Enoxaparin|enoxaparin
5332013|NCT00319176|Anticoagulation|anticoagulation
5332014|NCT00319163|oral contraceptive|oral contraceptive
5332015|NCT00319163|therapeutic equivalency|therapeutic equivalency
5332016|NCT00319163|contraceptives, oral, combined|contraceptives, oral, combined
5332017|NCT00319150|Erythropoetin resistance|erythropoetin resistance
5332018|NCT00319150|End Stage Renal Disease on hemodialysis|end stage renal disease on hemodialysis
5332019|NCT00319137|GW274150|gw274150
5332020|NCT00319137|Nitric Oxide|nitric oxide
5332021|NCT00319137|acute migraine|acute migraine
5332118|NCT00318695|Prevention|prevention
5332119|NCT00318695|Immunological responses|immunological responses
5332022|NCT00319124|Hip Osteoarthritis, muscle strength, range of motion, aerobic capacity, functional capacity, health-related quality of life|hip osteoarthritis, muscle strength, range of motion, aerobic capacity, functional capacity, health-related quality of life
5332023|NCT00319111|pulmonary hypertension|pulmonary hypertension
5332024|NCT00319111|bosentan|bosentan
5332025|NCT00319111|BENEFIT|benefit
5332026|NCT00319111|CTEPH|cteph
5332027|NCT00319111|inoperable chronic thromboembolic pulmonary hypertension (CTEPH)|inoperable chronic thromboembolic pulmonary hypertension (cteph)
5332028|NCT00319098|Adjuvanted pandemic influenza candidate vaccine|adjuvanted pandemic influenza candidate vaccine
5332029|NCT00319098|Influenza|influenza
5332030|NCT00319085|Arthroplasty,|arthroplasty,
5332031|NCT00319085|Hip,|hip,
5332032|NCT00319085|Pre-heating,|pre-heating,
5332033|NCT00319085|Radiostereometric analysis,|radiostereometric analysis,
5332034|NCT00319085|Dual-Energy Radiographic Absorptiometry,|dual-energy radiographic absorptiometry,
5332035|NCT00319046|Type 1 Gaucher Disease|type 1 gaucher disease
5332036|NCT00319046|miglustat|miglustat
5332037|NCT00319046|enzyme replacement therapy|enzyme replacement therapy
5332038|NCT00319033|interstitial lung disease|interstitial lung disease
5332039|NCT00319033|scleroderma|scleroderma
5332040|NCT00319033|bosentan|bosentan
5332041|NCT00319020|bosentan|bosentan
5332042|NCT00319020|pulmonary arterial hypertension|pulmonary arterial hypertension
5332043|NCT00319020|children|children
5332044|NCT00319020|FUTURE 1|future 1
5332045|NCT00318981|Medication trial|medication trial
5332046|NCT00318981|ADHD|adhd
5332047|NCT00318981|Concerta|concerta
5332048|NCT00318981|Efficacy trial|efficacy trial
5332049|NCT00318968|Acid Reflux|acid reflux
5332050|NCT00318968|Nexium|nexium
5332051|NCT00318968|Esomeprazole|esomeprazole
5332052|NCT00318955|Dexmedetomidine, Sedation, Extubation, Phase 4|dexmedetomidine, sedation, extubation, phase 4
5332053|NCT00318942|Sepsis|sepsis
5332054|NCT00318942|Multiple Trauma|multiple trauma
5332055|NCT00318942|Hypovolemic Shock|hypovolemic shock
5332056|NCT00318929|Treatment Efficacy|treatment efficacy
5332057|NCT00318929|pharmacokinetics|pharmacokinetics
5332058|NCT00318903|Chemotherapy for cancer of the esophagus|chemotherapy for cancer of the esophagus
5332059|NCT00318903|Radiotherapy for cancer of the esophagus|radiotherapy for cancer of the esophagus
5332060|NCT00318903|Surgery for cancer of the esophagus|surgery for cancer of the esophagus
5332061|NCT00318903|Chemotherapy, radiotherapy, surgery for esophageal cancer|chemotherapy, radiotherapy, surgery for esophageal cancer
5332062|NCT00318890|Chemotherapy and Radiotherapy for Head and Neck Cancer|chemotherapy and radiotherapy for head and neck cancer
5332063|NCT00318890|Chemotherapy, Radiotherapy Squamous Cell Carcinoma Head Neck|chemotherapy, radiotherapy squamous cell carcinoma head neck
5332064|NCT00318877|Obesity|obesity
5332065|NCT00318877|Physical activity|physical activity
5332066|NCT00318864|depression|depression
5332067|NCT00318864|cardiovascular risk|cardiovascular risk
5332068|NCT00318864|mechanisms|mechanisms
5332069|NCT00318851|Carotid Artery stenting|carotid artery stenting
5332070|NCT00318851|Stroke|stroke
5332071|NCT00318825|Pain|pain
5332072|NCT00318825|Colonoscopy|colonoscopy
5332073|NCT00318825|Sedation|sedation
5332074|NCT00318812|Randomized controlled trial (RCT)|randomized controlled trial (rct)
5332075|NCT00318812|Prospective Studies|prospective studies
5332076|NCT00318812|ferric oxide, saccharated|ferric oxide, saccharated
5332077|NCT00318812|Peptides|peptides
5332078|NCT00318812|Heme|heme
5332079|NCT00318812|Iron|iron
5332080|NCT00318812|Erythropoietin,|erythropoietin,
5332081|NCT00318812|Recombinant|recombinant
5332082|NCT00318812|Ferritin|ferritin
5332083|NCT00318812|Transferrin|transferrin
5332084|NCT00318812|Treatment Outcome|treatment outcome
5332085|NCT00318799|prevention of unintended pregnancies|prevention of unintended pregnancies
5332086|NCT00318773|PMS|pms
5332087|NCT00318773|PMDD|pmdd
5332088|NCT00318773|sertraline|sertraline
5332089|NCT00318773|antidepressant|antidepressant
5332090|NCT00318773|extended treatment|extended treatment
5332091|NCT00318773|relapse|relapse
5332092|NCT00318760|Drug Cue|drug cue
5332093|NCT00318760|Relapse|relapse
5332094|NCT00318760|Stress|stress
5332095|NCT00318760|Craving|craving
5332096|NCT00318747|Amb a 1-Immunostimulatory Oligodeoxyribonucleotide Conjugate|amb a 1-immunostimulatory oligodeoxyribonucleotide conjugate
5332097|NCT00318747|AIC|aic
5332098|NCT00318747|Amb a I Protein|amb a i protein
5332099|NCT00318747|Ragweed Allergy|ragweed allergy
5332100|NCT00318747|Hay Fever|hay fever
5332101|NCT00318747|Wheeze|wheeze
5332102|NCT00318747|Immunotherapy|immunotherapy
5332103|NCT00318747|Tolerance|tolerance
5332104|NCT00318747|Immunostimulatory|immunostimulatory
5332105|NCT00318747|Ragweed Season|ragweed season
5332106|NCT00318747|Asthma|asthma
5332107|NCT00318747|Asthmatics|asthmatics
5332108|NCT00318747|Asthmatic|asthmatic
5332109|NCT00318721|Leishmania donovani|leishmania donovani
5332110|NCT00318721|cluster-randomised control trial|cluster-randomised control trial
5332111|NCT00318721|Long Lasting Impregnated Nets|long lasting impregnated nets
5332112|NCT00318721|Bednets|bednets
5332113|NCT00318721|Sandflies|sandflies
5332114|NCT00318695|Probiotics|probiotics
5332115|NCT00318695|Eczema|eczema
5332116|NCT00318695|Asthma|asthma
5332117|NCT00318695|Allergic Rhinitis|allergic rhinitis
5332120|NCT00318682|biopsy|biopsy
5332121|NCT00318682|FIBROSCAN|fibroscan
5332122|NCT00318669|Anxiety|anxiety
5332123|NCT00318669|SAD|sad
5332124|NCT00318669|Social|social
5332125|NCT00318669|Disorder|disorder
5332126|NCT00318656|type 2 diabetes|type 2 diabetes
5332127|NCT00318656|rosiglitazone|rosiglitazone
5332128|NCT00318656|metformin|metformin
5332129|NCT00318656|glimepiride|glimepiride
5332130|NCT00318656|glycemia|glycemia
5332131|NCT00318643|Non-invasive bladder cancer|non-invasive bladder cancer
5332132|NCT00318643|Chemophase|chemophase
5332133|NCT00318643|Intravesical administration|intravesical administration
5332134|NCT00318643|Superficial Bladder Cancer|superficial bladder cancer
5332135|NCT00318630|Asthma AVANDIA Inflammation|asthma avandia inflammation
5332136|NCT00318617|peroxisome proliferator activated receptors,|peroxisome proliferator activated receptors,
5332137|NCT00318617|PPARs,|ppars,
5332138|NCT00318617|Heart Failure,|heart failure,
5332139|NCT00318617|cardiac energetics,|cardiac energetics,
5332140|NCT00318617|MRI,|mri,
5332141|NCT00318617|GW501516X|gw501516x
5332142|NCT00318617|fatty acid metabolism,|fatty acid metabolism,
5332143|NCT00318604|plasma circulating DNA|plasma circulating dna
5332144|NCT00318604|hean and neck cancers|hean and neck cancers
5332145|NCT00318604|esophageal cancer|esophageal cancer
5332146|NCT00318604|localized head and neck cancers|localized head and neck cancers
5332147|NCT00318604|localized esophageal cancer|localized esophageal cancer
5332148|NCT00318578|convulsive status epilepticus|convulsive status epilepticus
5332149|NCT00318578|outcome|outcome
5332150|NCT00318578|prognosis factors|prognosis factors
5332151|NCT00318578|seizure duration|seizure duration
5332152|NCT00318578|adult|adult
5332153|NCT00318578|electroencephalogram|electroencephalogram
5332154|NCT00318578|intensive care unit|intensive care unit
5332155|NCT00318565|Heart Disease|heart disease
5332156|NCT00318565|Atrial Flutter|atrial flutter
5332157|NCT00318565|Typical Atrial Flutter|typical atrial flutter
5332158|NCT00318552|Antibiotic Therapy|antibiotic therapy
5332159|NCT00318552|sepsis treatment|sepsis treatment
5332160|NCT00318552|Meropenem|meropenem
5332161|NCT00318539|Obsessive Compulsive Disorder|obsessive compulsive disorder
5332162|NCT00318513|breast cancer|breast cancer
5332163|NCT00318513|lymphedema|lymphedema
5332164|NCT00318513|extremity|extremity
5332165|NCT00318513|women|women
5332166|NCT00318500|Endometriosis|endometriosis
5332167|NCT00318500|Dysmenorrhea|dysmenorrhea
5332168|NCT00318500|Pelvic pain|pelvic pain
5332169|NCT00318500|Dyspareunia|dyspareunia
5332170|NCT00318487|Dental implants|dental implants
5332171|NCT00318474|Proteinuria|proteinuria
5332172|NCT00318474|Immunoglobulin A|immunoglobulin a
5332173|NCT00318448|Child Psychology|child psychology
5332174|NCT00318448|Pediatric Psychology|pediatric psychology
5332175|NCT00318448|Insomnia|insomnia
5332176|NCT00318448|Sleeplessness|sleeplessness
5332177|NCT00318409|Methamphetamine|methamphetamine
5332178|NCT00318409|HIV|hiv
5332179|NCT00318396|THA|tha
5332180|NCT00318383|Vaccine|vaccine
5332181|NCT00318383|Immunogenicity|immunogenicity
5332182|NCT00318383|Randomized Controlled Trial|randomized controlled trial
5332183|NCT00318370|Ovarian Cancer|ovarian cancer
5332184|NCT00318370|Primary Fallopian Tube Cancer|primary fallopian tube cancer
5332185|NCT00318370|Peritoneal Cancer|peritoneal cancer
5332186|NCT00318357|Cardiac Resynchronization therapy (CRT)|cardiac resynchronization therapy (crt)
5332187|NCT00318357|All-cause mortality|all-cause mortality
5332188|NCT00318357|Long-term follow-up|long-term follow-up
5332189|NCT00318331|Glutamine|glutamine
5332190|NCT00318331|Critical Illness|critical illness
5332191|NCT00318331|Enteral Feeding|enteral feeding
5332192|NCT00318331|Blood Volume Analysis|blood volume analysis
5332193|NCT00318318|Premarin,|premarin,
5332194|NCT00318318|HRT,|hrt,
5332195|NCT00318318|RNA,|rna,
5332196|NCT00318318|Gene Expression.|gene expression.
5332197|NCT00318318|Postmenopausal Women|postmenopausal women
5332198|NCT00318292|preemptive analgesia|preemptive analgesia
5332199|NCT00318292|paracervical block|paracervical block
5332200|NCT00318292|vaginal hysterectomy|vaginal hysterectomy
5332201|NCT00318279|Surgical education|surgical education
5332202|NCT00318279|Vascular anastomosis|vascular anastomosis
5332203|NCT00318279|Simulator|simulator
5332204|NCT00318279|Randomized controlled trial|randomized controlled trial
5332205|NCT00318266|Detection of Bladder Cancer using NMP22 Urine Test Kit|detection of bladder cancer using nmp22 urine test kit
5332206|NCT00318253|Cranberry juice|cranberry juice
5332207|NCT00318253|Antiadhesion|antiadhesion
5332208|NCT00318253|Urinary tract infection|urinary tract infection
5332209|NCT00318253|vaginosis|vaginosis
5332210|NCT00318240|High Intensity Focused Ultrasound|high intensity focused ultrasound
5332211|NCT00318240|Men|men
5332212|NCT00318240|Locally recurrent prostate cancer.|locally recurrent prostate cancer.
5332213|NCT00318227|Postoperative care|postoperative care
5332214|NCT00318227|Cardiac Surgery|cardiac surgery
5332215|NCT00318227|Blood Transfusion|blood transfusion
5332216|NCT00318214|toe ulcer|toe ulcer
5332217|NCT00318214|heel ulcer|heel ulcer
5332218|NCT00318214|foot ulcer|foot ulcer
5332219|NCT00318214|diabetic feet|diabetic feet
5332220|NCT00318214|diabetic foot|diabetic foot
5332221|NCT00318214|complications of diabetes|complications of diabetes
5332222|NCT00318201|Healthy Subjects|healthy subjects
5332223|NCT00318188|scleroderma|scleroderma
5332224|NCT00318188|HAQ|haq
5332225|NCT00318188|Intensive care reeducation, readaptation|intensive care reeducation, readaptation
5332226|NCT00318175|Systemic Scleroderma|systemic scleroderma
5332227|NCT00318175|Dermal Sclerosis|dermal sclerosis
5332228|NCT00318175|Bosentan|bosentan
5332229|NCT00318175|Endothelin Receptor Antagonist|endothelin receptor antagonist
5332230|NCT00318175|Rodnan Skin Score|rodnan skin score
5332231|NCT00318162|autism|autism
5332232|NCT00318162|PDD|pdd
5332233|NCT00318162|LDN|ldn
5332234|NCT00318162|naltrexone|naltrexone
5332235|NCT00318136|BRIDGE|bridge
5332236|NCT00318136|NSCLC|nsclc
5332237|NCT00318136|Lung Cancer|lung cancer
5332238|NCT00318136|Avastin|avastin
5332239|NCT00318123|Simplification therapy|simplification therapy
5332240|NCT00318123|Efficacy|efficacy
5332241|NCT00318123|Safety|safety
5332242|NCT00318123|Virological effectiveness|virological effectiveness
5332243|NCT00318123|Immunological effectiveness|immunological effectiveness
5332244|NCT00318123|HIV|hiv
5332245|NCT00318110|Metastatic|metastatic
5332246|NCT00318110|Renal|renal
5332247|NCT00318110|Cell|cell
5332248|NCT00318110|Carcinoma|carcinoma
5332249|NCT00318110|Unrelated|unrelated
5332250|NCT00318110|Donor|donor
5332251|NCT00318110|Transplant|transplant
5332252|NCT00318110|stage IV|stage iv
5332253|NCT00318110|clear cell|clear cell
5332254|NCT00318097|McCune Albright Syndrome|mccune albright syndrome
5332255|NCT00318097|Histamine regulation|histamine regulation
5332256|NCT00318084|Gastroesophageal reflux disease|gastroesophageal reflux disease
5332257|NCT00318084|Heartburn|heartburn
5332258|NCT00318084|Acid-related diseases|acid-related diseases
5332259|NCT00318084|Acid reflux disease|acid reflux disease
5332260|NCT00318084|Nexium|nexium
5332261|NCT00318071|Stroke|stroke
5332262|NCT00318071|Ischemic|ischemic
5332263|NCT00318071|Thrombus|thrombus
5332264|NCT00318071|Embolectomy|embolectomy
5332265|NCT00318071|Thrombectomy|thrombectomy
5332266|NCT00318071|Merci|merci
5332267|NCT00318071|Concentric|concentric
5332268|NCT00318071|Embolus|embolus
5332269|NCT00318071|Embolism|embolism
5332270|NCT00318071|Mechanical|mechanical
5332271|NCT00318045|Refractive error|refractive error
5332272|NCT00318045|Asthenopia|asthenopia
5332273|NCT00318032|Randomised control trial|randomised control trial
5332274|NCT00318032|Screening|screening
5332275|NCT00318032|Intensive management|intensive management
5332276|NCT00318032|Diabetes mellitus|diabetes mellitus
5332277|NCT00318032|Type 2 diabetes|type 2 diabetes
5332278|NCT00318019|Energy|energy
5332279|NCT00318019|Energy Level|energy level
5332280|NCT00318006|chronic|chronic
5332281|NCT00318006|nasal|nasal
5332282|NCT00318006|sinus|sinus
5332283|NCT00318006|symptoms|symptoms
5332284|NCT00317980|Cutaneous leishmaniasis|cutaneous leishmaniasis
5332285|NCT00317980|Leishmania braziliensis|leishmania braziliensis
5332286|NCT00317980|Pentavalent antimony|pentavalent antimony
5332287|NCT00317980|Meglumine antimoniate|meglumine antimoniate
5332288|NCT00317967|Hypertrophic cardiomyopathy|hypertrophic cardiomyopathy
5332289|NCT00317967|Statin therapy|statin therapy
5332290|NCT00317967|Regression|regression
5332291|NCT00317967|Heart failure|heart failure
5332292|NCT00317967|Arrhythmias|arrhythmias
5332293|NCT00317967|Sudden cardiac death|sudden cardiac death
5332294|NCT00317954|Diabetic nephropathy|diabetic nephropathy
5332295|NCT00317954|Spironolactone|spironolactone
5332296|NCT00317954|Aldosterone antagonism|aldosterone antagonism
5332297|NCT00317954|Renoprotection|renoprotection
5332298|NCT00317941|Multiple Sclerosis|multiple sclerosis
5332299|NCT00317941|RRMS|rrms
5332300|NCT00317928|Polycystic Ovary Syndrome|polycystic ovary syndrome
5332301|NCT00317928|Metformin|metformin
5332302|NCT00317928|Metabolic Syndrome|metabolic syndrome
5332303|NCT00317928|Hyperandrogenism|hyperandrogenism
5332304|NCT00317928|Ovulation|ovulation
5332305|NCT00317902|Anemia|anemia
5332306|NCT00317902|erythropoetin|erythropoetin
5332307|NCT00317902|Epoetin alfa|epoetin alfa
5332308|NCT00317902|erythropoetin recombinant|erythropoetin recombinant
5332309|NCT00317902|HIV, AIDS|hiv, aids
5332310|NCT00317889|THA|tha
5332311|NCT00317876|Fanconi anemia|fanconi anemia
5332312|NCT00317837|Fracture of Femoral Neck|fracture of femoral neck
5332313|NCT00317811|stage I multiple myeloma|stage i multiple myeloma
5332314|NCT00317811|stage II multiple myeloma|stage ii multiple myeloma
5332315|NCT00317811|stage III multiple myeloma|stage iii multiple myeloma
5332316|NCT00317798|drug/agent toxicity by tissue/organ|drug/agent toxicity by tissue/organ
5332317|NCT00317798|stage I multiple myeloma|stage i multiple myeloma
5332318|NCT00317798|stage II multiple myeloma|stage ii multiple myeloma
5332319|NCT00317798|stage III multiple myeloma|stage iii multiple myeloma
5332320|NCT00317798|refractory multiple myeloma|refractory multiple myeloma
5332321|NCT00317785|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5332322|NCT00317785|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5332323|NCT00317785|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5332324|NCT00317785|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5332325|NCT00317785|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5332326|NCT00317785|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5332327|NCT00317785|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5332328|NCT00317785|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5332329|NCT00317785|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5332330|NCT00317785|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5332331|NCT00317785|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5332332|NCT00317785|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5332333|NCT00317785|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5332334|NCT00317785|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
5332335|NCT00317785|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5332336|NCT00317785|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
5332337|NCT00317785|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
5332338|NCT00317785|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
5332339|NCT00317785|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
5332340|NCT00317785|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5332341|NCT00317785|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5332342|NCT00317785|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5332343|NCT00317785|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5332344|NCT00317785|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
5332345|NCT00317785|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
5332346|NCT00317785|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5332347|NCT00317785|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5332348|NCT00317785|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5332349|NCT00317785|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5332350|NCT00317785|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5332351|NCT00317785|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5332352|NCT00317785|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5332353|NCT00317785|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5332354|NCT00317785|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5332355|NCT00317785|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5332356|NCT00317785|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5332357|NCT00317785|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5332358|NCT00317785|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5332359|NCT00317785|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5332360|NCT00317785|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5332361|NCT00317785|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5332362|NCT00317785|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5332363|NCT00317785|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5332364|NCT00317785|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5332365|NCT00317785|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5332366|NCT00317785|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5332367|NCT00317785|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5332368|NCT00317785|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5332369|NCT00317785|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5332370|NCT00317785|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5332371|NCT00317785|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5332372|NCT00317785|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5332373|NCT00317785|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5332374|NCT00317785|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5332375|NCT00317785|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5332376|NCT00317785|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5332377|NCT00317785|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5332378|NCT00317785|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5332379|NCT00317785|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5332380|NCT00317785|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5332381|NCT00317785|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5332382|NCT00317785|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5332383|NCT00317785|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5332384|NCT00317785|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5332385|NCT00317785|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5332386|NCT00317785|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5332387|NCT00317785|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5332388|NCT00317785|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5332389|NCT00317785|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5332390|NCT00317785|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5332391|NCT00317785|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5332392|NCT00317785|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5332393|NCT00317785|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5332394|NCT00317772|Epithelial Ovarian Cancer|epithelial ovarian cancer
5332395|NCT00317772|Peritoneal Cancer|peritoneal cancer
5332396|NCT00317772|Fallopian Tube Cancer|fallopian tube cancer
5332397|NCT00317772|Epidermal Growth Factor|epidermal growth factor
5332398|NCT00317772|Platinum Hypersensitivity|platinum hypersensitivity
5332399|NCT00317772|Hycamtin|hycamtin
5332400|NCT00317772|Gefitinib|gefitinib
5332401|NCT00317772|Iressa|iressa
5332402|NCT00317772|Topotecan|topotecan
5332403|NCT00317772|EGFR|egfr
5332404|NCT00317759|stage IV melanoma|stage iv melanoma
5332405|NCT00317759|recurrent melanoma|recurrent melanoma
5332406|NCT00317746|HIV/HCV Co-infection|hiv/hcv co-infection
5332407|NCT00317746|Depression|depression
5332408|NCT00317746|Citalopram|citalopram
5332409|NCT00317733|Ketoprofen|ketoprofen
5332410|NCT00317733|Transfersome|transfersome
5332411|NCT00317733|Osteoarthritis, Knee|osteoarthritis, knee
5332412|NCT00317720|Breast Cancer|breast cancer
5332413|NCT00317720|Metastatic Breast Cancer|metastatic breast cancer
5332414|NCT00317720|Trastuzumab|trastuzumab
5332415|NCT00317720|RAD001|rad001
5332416|NCT00317720|Herceptin|herceptin
5332417|NCT00317707|cardiovascular risk|cardiovascular risk
5332418|NCT00317707|cardiovascular diseases|cardiovascular diseases
5332419|NCT00317707|cardiovascular prevention|cardiovascular prevention
5332420|NCT00317707|polyunsaturated fatty acids|polyunsaturated fatty acids
5332421|NCT00317707|diabetes|diabetes
5332422|NCT00317707|hypertension|hypertension
5332423|NCT00317707|hypercholesterolemia|hypercholesterolemia
5332424|NCT00317707|obesity|obesity
5332425|NCT00317694|Hyperphosphatemia|hyperphosphatemia
5332426|NCT00317694|Phosphate binder|phosphate binder
5332427|NCT00317681|Cutaneous lupus erythematosus|cutaneous lupus erythematosus
5332428|NCT00317681|Tacrolimus ointment|tacrolimus ointment
5332429|NCT00317681|Topical treatment|topical treatment
5332430|NCT00317681|Skin lesions|skin lesions
5332431|NCT00317655|back pain|back pain
5332432|NCT00317642|acute myelogenous leukemia|acute myelogenous leukemia
5332433|NCT00317642|acute myeloid leukemia|acute myeloid leukemia
5332434|NCT00317642|relapsed AML|relapsed aml
5332435|NCT00317642|refractory AML|refractory aml
5332436|NCT00317642|clofarabine|clofarabine
5332437|NCT00317642|cytarabine|cytarabine
5332438|NCT00317642|CLO341|clo341
5332439|NCT00317642|clolar|clolar
5332440|NCT00317629|leishmaniasis|leishmaniasis
5332441|NCT00317629|nitric oxide|nitric oxide
5332442|NCT00317629|treatment|treatment
5332443|NCT00317629|donor|donor
5332444|NCT00317629|controlled trial|controlled trial
5332445|NCT00317616|FALS|fals
5332446|NCT00317616|SOD1|sod1
5332447|NCT00317616|familial|familial
5332448|NCT00317616|genetic testing|genetic testing
5332449|NCT00317616|genetic counseling|genetic counseling
5332450|NCT00317616|ALS|als
5332451|NCT00317616|C9ORF72|c9orf72
5332452|NCT00317616|TARDBP|tardbp
5332453|NCT00317616|VCP|vcp
5332454|NCT00317616|FUS|fus
5332455|NCT00317616|PFN1|pfn1
5332456|NCT00317603|autologous vaccination|autologous vaccination
5332457|NCT00317603|GM-CSF|gm-csf
5332458|NCT00317603|adenoviral mediated gene transfer|adenoviral mediated gene transfer
5332459|NCT00317603|Stage IV breast cancer|stage iv breast cancer
5332460|NCT00317590|Diagnosis|diagnosis
5332461|NCT00317590|Rapid Diagnostic Test|rapid diagnostic test
5332462|NCT00317590|Management|management
5332463|NCT00317590|Attributable Fraction|attributable fraction
5332464|NCT00317590|Threshold|threshold
5332465|NCT00317577|Low-pressure glaucoma|low-pressure glaucoma
5332466|NCT00317577|Normal tension glaucoma|normal tension glaucoma
5332467|NCT00317577|Neuroprotection|neuroprotection
5332468|NCT00317577|Brimonidine|brimonidine
5332469|NCT00317577|Visual field progression|visual field progression
5332470|NCT00317564|Birth Defects|birth defects
5332471|NCT00317564|High Risk Pregnancy|high risk pregnancy
5332472|NCT00317564|Multiple Sclerosis|multiple sclerosis
5332473|NCT00317551|Aberration control|aberration control
5332474|NCT00317551|Accommodative facility|accommodative facility
5332475|NCT00317551|Accommodative response|accommodative response
5332476|NCT00317551|Peripheral refraction|peripheral refraction
5332477|NCT00317551|Accommodative convergence to accommodation ratio|accommodative convergence to accommodation ratio
5332478|NCT00317538|Rheumatoid Arthritis|rheumatoid arthritis
5332479|NCT00317538|Switching|switching
5332480|NCT00317538|Structural Damage|structural damage
5332481|NCT00317538|MRI|mri
5332482|NCT00317525|Refractive error|refractive error
5332483|NCT00317525|Asthenopia|asthenopia
5332484|NCT00317512|Hemoglobin Based Oxygen carrier|hemoglobin based oxygen carrier
5332485|NCT00317512|HBOC 201|hboc 201
5332486|NCT00317512|Percutaneous Revascularization|percutaneous revascularization
5332487|NCT00317512|Percutaneous Coronary Intervention|percutaneous coronary intervention
5332488|NCT00317512|Non ST-segment Elevation Myocardial Infarction|non st-segment elevation myocardial infarction
5332489|NCT00317512|Tissue Oxygenation|tissue oxygenation
5332490|NCT00317512|Transluminal Percutaneous Coronary Angioplasty|transluminal percutaneous coronary angioplasty
5332491|NCT00317486|pulmonary arterial hypertension|pulmonary arterial hypertension
5332492|NCT00317486|Eisenmenger physiology|eisenmenger physiology
5332493|NCT00317486|bosentan|bosentan
5332494|NCT00317473|Vaccine|vaccine
5332495|NCT00317473|Phase 1|phase 1
5332496|NCT00317473|Plasmodium falciparum|plasmodium falciparum
5332497|NCT00317473|Malaria|malaria
5332498|NCT00317473|Merozoite surface protein-1|merozoite surface protein-1
5332499|NCT00317473|MSP-1|msp-1
5332500|NCT00317473|Falciparum malaria protein 1|falciparum malaria protein 1
5332501|NCT00317473|FMP-1|fmp-1
5332502|NCT00317473|AS02A|as02a
5332503|NCT00317460|Drug Abuse|drug abuse
5332504|NCT00317460|Drug Addiction|drug addiction
5332505|NCT00317460|Drug Dependence|drug dependence
5332506|NCT00317460|Drug Use Disorders|drug use disorders
5332507|NCT00317460|Drug Use Disorder|drug use disorder
5332508|NCT00317460|Substance Abuse|substance abuse
5332509|NCT00317460|Substance Use Disorder|substance use disorder
5332510|NCT00317460|Buprenorphine|buprenorphine
5332511|NCT00317460|Opiate Addiction|opiate addiction
5332512|NCT00317447|Sciatica|sciatica
5332513|NCT00317447|Lower back pain|lower back pain
5332514|NCT00317447|Prednisone|prednisone
5332515|NCT00317447|Randomized, controlled clinical trial|randomized, controlled clinical trial
5332516|NCT00317434|ovarian cancer|ovarian cancer
5332517|NCT00317421|Phosphodiesterase 5|phosphodiesterase 5
5332518|NCT00317421|Sildenafil|sildenafil
5332519|NCT00317421|Hypertension|hypertension
5332520|NCT00317421|Blood pressure|blood pressure
5332521|NCT00317421|Arterial stiffness|arterial stiffness
5332522|NCT00317421|Endothelial function|endothelial function
5332523|NCT00317408|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5332524|NCT00317408|recurrent childhood anaplastic large cell lymphoma|recurrent childhood anaplastic large cell lymphoma
5332525|NCT00317408|stage III childhood anaplastic large cell lymphoma|stage iii childhood anaplastic large cell lymphoma
5332526|NCT00317408|stage IV childhood anaplastic large cell lymphoma|stage iv childhood anaplastic large cell lymphoma
5332527|NCT00317395|Non ST elevation Acute Coronary Syndrome|non st elevation acute coronary syndrome
5332528|NCT00317395|Early invasive strategy|early invasive strategy
5332529|NCT00317395|Percutaneous Coronary Intervention|percutaneous coronary intervention
5332530|NCT00317382|lumbar puncture|lumbar puncture
5332531|NCT00317382|headache|headache
5332532|NCT00317382|traumatic tap|traumatic tap
5332533|NCT00317369|OPC-6535|opc-6535
5332534|NCT00317369|Crohn's disease|crohn's disease
5332535|NCT00317356|OPC-6535|opc-6535
5332536|NCT00317356|ulcerative colitis|ulcerative colitis
5332537|NCT00317343|Patients candidate to a PCI with a planned anticoagulation regime other than unfractionated heparin in monotherapy|patients candidate to a pci with a planned anticoagulation regime other than unfractionated heparin in monotherapy
5332539|NCT00317317|Acupuncture|acupuncture
5332540|NCT00317317|Pregnant|pregnant
5332541|NCT00317304|Hot flashes|hot flashes
5332542|NCT00317304|vasomotor symptoms|vasomotor symptoms
5332543|NCT00317304|menopause|menopause
5332544|NCT00317304|mindfulness based stress reduction|mindfulness based stress reduction
5332545|NCT00317304|meditation|meditation
5332546|NCT00317291|Acupuncture|acupuncture
5332547|NCT00317291|HIV|hiv
5332548|NCT00317291|AIDS|aids
5332549|NCT00317291|Symptom management|symptom management
5332550|NCT00317291|Non-invasive|non-invasive
5332551|NCT00317291|Complementary Therapies|complementary therapies
5332552|NCT00317291|Treatment Experienced|treatment experienced
5332553|NCT00317278|Massage|massage
5332554|NCT00317278|immune system|immune system
5332555|NCT00317278|preterm infants|preterm infants
5332556|NCT00317265|coronary artery disease|coronary artery disease
5332557|NCT00317265|coronary bypass surgery|coronary bypass surgery
5332558|NCT00317265|complete arterial coronary surgery|complete arterial coronary surgery
5332559|NCT00317265|internal mammary artery|internal mammary artery
5332560|NCT00317252|contrast induced nephropathy|contrast induced nephropathy
5332561|NCT00317252|contrast nephropathy|contrast nephropathy
5332562|NCT00317252|contrast media|contrast media
5332563|NCT00317252|kidney diseases|kidney diseases
5332564|NCT00317252|angiotensin converting enzyme inhibitors|angiotensin converting enzyme inhibitors
5332565|NCT00317239|Anemia|anemia
5332566|NCT00317239|Chronic Kidney Disease|chronic kidney disease
5332567|NCT00317239|Iron|iron
5332568|NCT00317226|Anemia|anemia
5332569|NCT00317226|CKD|ckd
5332570|NCT00317226|Chronic Kidney Disease|chronic kidney disease
5332571|NCT00317226|Iron|iron
5332572|NCT00317226|Maintenance Dose|maintenance dose
5332573|NCT00317213|Smoking|smoking
5332574|NCT00317213|Nicotine|nicotine
5332575|NCT00317213|Withdrawal|withdrawal
5332667|NCT00316810|Campath 1H|campath 1h
5332576|NCT00317213|Phospholipids|phospholipids
5332577|NCT00317213|Cell membrane fluidity|cell membrane fluidity
5332578|NCT00317213|Smoking cessation|smoking cessation
5332579|NCT00317148|Hot Flashes|hot flashes
5332580|NCT00317148|Menopause|menopause
5332581|NCT00317148|Quality of Life|quality of life
5332582|NCT00317148|Hot flushes|hot flushes
5332583|NCT00317109|meningococcal serogroups A and C diseases|meningococcal serogroups a and c diseases
5332584|NCT00317109|tetanus|tetanus
5332585|NCT00317109|hepatitis B|hepatitis b
5332586|NCT00317109|pertussis|pertussis
5332587|NCT00317109|Haemophilus influenzae type b|haemophilus influenzae type b
5332588|NCT00317109|meningococcal vaccine|meningococcal vaccine
5332589|NCT00317109|Prophylaxis diphtheria|prophylaxis diphtheria
5332590|NCT00317096|Drug Therapy|drug therapy
5332591|NCT00317096|Maintenance|maintenance
5332592|NCT00317096|rituximab|rituximab
5332593|NCT00317083|Cough Reflex|cough reflex
5332594|NCT00317083|Citric acid|citric acid
5332595|NCT00317083|Obesity|obesity
5332596|NCT00317083|Sleep apnea syndrome|sleep apnea syndrome
5332597|NCT00317070|PBS/IC|pbs/ic
5332598|NCT00317070|Painful bladder syndrome including Interstitial cystitis|painful bladder syndrome including interstitial cystitis
5332599|NCT00317057|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
5332600|NCT00317057|Outpatient management|outpatient management
5332601|NCT00317057|nurse-lead patient education|nurse-lead patient education
5332602|NCT00317044|Moderate to severe Asthma|moderate to severe asthma
5332603|NCT00317044|Gastroesophageal Reflux Disease|gastroesophageal reflux disease
5332604|NCT00317044|esomeprazole|esomeprazole
5332605|NCT00317044|GERD|gerd
5332606|NCT00317031|Alcoholism|alcoholism
5332607|NCT00317031|Drug Therapy|drug therapy
5332608|NCT00317018|depression|depression
5332609|NCT00317018|quality improvement|quality improvement
5332610|NCT00317018|implementation|implementation
5332611|NCT00317018|translation|translation
5332612|NCT00317018|evidence-based practice|evidence-based practice
5332613|NCT00317018|collaborative care|collaborative care
5332614|NCT00317018|adoption|adoption
5332615|NCT00317018|sustainability|sustainability
5332616|NCT00317018|cost-effectiveness|cost-effectiveness
5332617|NCT00317018|rural|rural
5332618|NCT00317005|hemodialysis|hemodialysis
5332619|NCT00317005|chronic uremia|chronic uremia
5332620|NCT00317005|hyperhomocysteinemia|hyperhomocysteinemia
5332621|NCT00317005|folate|folate
5332622|NCT00316992|Insomnia|insomnia
5332623|NCT00316992|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5332624|NCT00316992|Drug Therapy|drug therapy
5332625|NCT00316979|migraine|migraine
5332626|NCT00316979|transcranial magnetic stimulation|transcranial magnetic stimulation
5332627|NCT00316979|repetitive transcranial magnetic stimulation|repetitive transcranial magnetic stimulation
5332628|NCT00316979|rTMS|rtms
5332629|NCT00316966|Nutritional status, dietary intervention, health care use, costs|nutritional status, dietary intervention, health care use, costs
5332630|NCT00316940|stage I multiple myeloma|stage i multiple myeloma
5332631|NCT00316940|stage II multiple myeloma|stage ii multiple myeloma
5332632|NCT00316940|stage III multiple myeloma|stage iii multiple myeloma
5332633|NCT00316940|refractory multiple myeloma|refractory multiple myeloma
5332634|NCT00316927|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5332635|NCT00316927|stage III prostate cancer|stage iii prostate cancer
5332636|NCT00316927|stage IV prostate cancer|stage iv prostate cancer
5332637|NCT00316914|neurotoxicity|neurotoxicity
5332638|NCT00316914|stage II colon cancer|stage ii colon cancer
5332639|NCT00316914|stage III colon cancer|stage iii colon cancer
5332640|NCT00316914|adenocarcinoma of the colon|adenocarcinoma of the colon
5332641|NCT00316914|stage II rectal cancer|stage ii rectal cancer
5332642|NCT00316914|stage III rectal cancer|stage iii rectal cancer
5332643|NCT00316914|stage IV rectal cancer|stage iv rectal cancer
5332644|NCT00316914|stage IV colon cancer|stage iv colon cancer
5332645|NCT00316914|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5332646|NCT00316901|stage IV renal cell cancer|stage iv renal cell cancer
5332647|NCT00316901|stage IV melanoma|stage iv melanoma
5332648|NCT00316901|recurrent melanoma|recurrent melanoma
5332649|NCT00316901|recurrent renal cell cancer|recurrent renal cell cancer
5332650|NCT00316888|squamous cell carcinoma of the anus|squamous cell carcinoma of the anus
5332651|NCT00316888|stage I anal cancer|stage i anal cancer
5332652|NCT00316888|stage II anal cancer|stage ii anal cancer
5332653|NCT00316888|stage IIIA anal cancer|stage iiia anal cancer
5332654|NCT00316888|stage IIIB anal cancer|stage iiib anal cancer
5332655|NCT00316888|basaloid carcinoma of the anus|basaloid carcinoma of the anus
5332656|NCT00316888|cloacogenic carcinoma of the anus|cloacogenic carcinoma of the anus
5332657|NCT00316875|stage IV breast cancer|stage iv breast cancer
5332658|NCT00316875|recurrent breast cancer|recurrent breast cancer
5332659|NCT00316875|male breast cancer|male breast cancer
5332660|NCT00316862|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
5332661|NCT00316862|stage II esophageal cancer|stage ii esophageal cancer
5332662|NCT00316862|stage III esophageal cancer|stage iii esophageal cancer
5332663|NCT00316836|stage I breast cancer|stage i breast cancer
5332664|NCT00316836|stage II breast cancer|stage ii breast cancer
5332665|NCT00316836|stage IIIA breast cancer|stage iiia breast cancer
5332666|NCT00316823|thyroid cancer|thyroid cancer
5332668|NCT00316810|Alemtuzumab|alemtuzumab
5332669|NCT00316810|Tacrolimus|tacrolimus
5332670|NCT00316810|Pancreas-kidney transplantation|pancreas-kidney transplantation
5332671|NCT00316810|immunosuppression|immunosuppression
5332672|NCT00316810|prevention of acute rejection|prevention of acute rejection
5332673|NCT00316797|SPECT|spect
5332674|NCT00316797|Nuclear Medicine|nuclear medicine
5332675|NCT00316784|osteoarthritis; knee; IDEA-033|osteoarthritis; knee; idea-033
5332676|NCT00316745|irinotecan|irinotecan
5332677|NCT00316745|S-1|s-1
5332678|NCT00316745|Oxaliplatin|oxaliplatin
5332679|NCT00316745|l-leucovorin|l-leucovorin
5332680|NCT00316745|Fluorouracil|fluorouracil
5332681|NCT00316745|Metastatic colorectal cancer|metastatic colorectal cancer
5332682|NCT00316745|phase III|phase iii
5332683|NCT00316732|Avodart|avodart
5332684|NCT00316732|IPSS|ipss
5332685|NCT00316732|BPH|bph
5332686|NCT00316732|dutasteride|dutasteride
5332687|NCT00316732|EQ-5D|eq-5d
5332688|NCT00316732|Observational|observational
5332689|NCT00316719|treatment naive|treatment naive
5332690|NCT00316719|CHB|chb
5332691|NCT00316719|adefovir|adefovir
5332692|NCT00316719|monotherapy|monotherapy
5332693|NCT00316706|Prophylaxis HPV-16/18 infections and cervical neoplasia|prophylaxis hpv-16/18 infections and cervical neoplasia
5332694|NCT00316693|HPV Vaccine Efficacy|hpv vaccine efficacy
5332695|NCT00316667|epidemiology|epidemiology
5332696|NCT00316667|risk factors|risk factors
5332697|NCT00316654|Prevention of Meningococcal Meningitis|prevention of meningococcal meningitis
5332698|NCT00316654|vaccines, conjugate|vaccines, conjugate
5332699|NCT00316654|immunology|immunology
5332700|NCT00316654|child|child
5332701|NCT00316654|antibody persistence|antibody persistence
5332702|NCT00316628|influenza|influenza
5332703|NCT00316628|elderly|elderly
5332704|NCT00316628|vaccine|vaccine
5332705|NCT00316615|influenza|influenza
5332706|NCT00316615|non elderly adult and elderly|non elderly adult and elderly
5332707|NCT00316615|vaccine|vaccine
5332708|NCT00316602|Atopic dermatitis|atopic dermatitis
5332709|NCT00316602|Smallpox|smallpox
5332710|NCT00316602|Vaccination|vaccination
5332711|NCT00316589|HIV|hiv
5332712|NCT00316589|treatment experienced|treatment experienced
5332713|NCT00316589|treatment vaccinia naive|treatment vaccinia naive
5332714|NCT00316576|Kidney failure, Acute|kidney failure, acute
5332715|NCT00316576|Genetic Polymorphism|genetic polymorphism
5332716|NCT00316576|Angiotensin-converting enzyme|angiotensin-converting enzyme
5332717|NCT00316563|cannabinoids|cannabinoids
5332718|NCT00316563|taste disorders|taste disorders
5332719|NCT00316563|olfaction disorders|olfaction disorders
5332720|NCT00316563|cancer|cancer
5332721|NCT00316563|palliative medicine|palliative medicine
5332722|NCT00316563|caloric intake|caloric intake
5332723|NCT00316563|appetite|appetite
5332724|NCT00316563|reward|reward
5332725|NCT00316563|tetrahydrocannabinol/therapeutic use|tetrahydrocannabinol/therapeutic use
5332726|NCT00316563|anorexia/drug therapy|anorexia/drug therapy
5332727|NCT00316563|quality of life|quality of life
5332728|NCT00316563|chemosensory changes/drug therapy|chemosensory changes/drug therapy
5332729|NCT00316550|Irritable Bowel Syndrome (IBS)|irritable bowel syndrome (ibs)
5332730|NCT00316537|diabetes|diabetes
5332731|NCT00316537|foot ulcers|foot ulcers
5332732|NCT00316537|nicotine gel|nicotine gel
5332733|NCT00316537|wound healing|wound healing
5332734|NCT00316524|Smallpox|smallpox
5332735|NCT00316524|Vaccination|vaccination
5332736|NCT00316524|Prevention|prevention
5332737|NCT00316511|advanced solid malignancies|advanced solid malignancies
5332738|NCT00316511|B-cell lymphoma|b-cell lymphoma
5332739|NCT00316511|Aroplatin|aroplatin
5332740|NCT00316511|L-NDDP|l-nddp
5332741|NCT00316511|MTD|mtd
5332742|NCT00316511|advanced solid malignancies or B-cell lymphoma|advanced solid malignancies or b-cell lymphoma
5332743|NCT00316498|Eye Movement|eye movement
5332744|NCT00316498|Niemann Pick C|niemann pick c
5332745|NCT00316485|Bone|bone
5332746|NCT00316485|Microbiology|microbiology
5332747|NCT00316485|Dental Pulp Stem Cell|dental pulp stem cell
5332748|NCT00316485|Wisdom Teeth|wisdom teeth
5332749|NCT00316485|Biopsy|biopsy
5332750|NCT00316485|Third Molar Extraction|third molar extraction
5332751|NCT00316472|Hyperphosphatemia|hyperphosphatemia
5332752|NCT00316472|End Stage Renal Disease|end stage renal disease
5332753|NCT00316472|Renal Osteodystrophy|renal osteodystrophy
5332754|NCT00316459|Healthy|healthy
5332755|NCT00316459|Cardiac|cardiac
5332756|NCT00316459|Pharmacokinetics|pharmacokinetics
5332757|NCT00316394|Preventive Health Care|preventive health care
5332758|NCT00316394|Annual Health Check-up|annual health check-up
5332759|NCT00316394|Primary Care|primary care
5332760|NCT00316394|Reminders|reminders
5332761|NCT00316381|stem cells|stem cells
5332762|NCT00316381|acute myocardial infarction|acute myocardial infarction
5332763|NCT00316381|regeneration|regeneration
5332764|NCT00316381|left ventricular ejection fraction|left ventricular ejection fraction
5332765|NCT00316368|Bi-Ventricular pacing post coronary artery bypass graft|bi-ventricular pacing post coronary artery bypass graft
5332766|NCT00316368|coronary artery bypass graft|coronary artery bypass graft
5332767|NCT00316355|Anxiety|anxiety
5332768|NCT00316355|Behavior therapy|behavior therapy
5332769|NCT00316355|Cognitive-behavioral therapy|cognitive-behavioral therapy
5332770|NCT00316355|Stepped care|stepped care
5332771|NCT00316355|Cost-effectiveness|cost-effectiveness
5332772|NCT00316342|Low back pain|low back pain
5332773|NCT00316342|Industrial workers|industrial workers
5332774|NCT00316342|Recurrent back pain|recurrent back pain
5332775|NCT00316342|Back supports|back supports
5332776|NCT00316342|Back health education|back health education
5332777|NCT00316342|Rehabilitation|rehabilitation
5332778|NCT00316316|OCD|ocd
5332779|NCT00316303|Serious Mental Illness|serious mental illness
5332780|NCT00316303|Dual Diagnosis|dual diagnosis
5332781|NCT00316303|Mental Disorders|mental disorders
5332782|NCT00316303|Substance-Related Disorders|substance-related disorders
5332783|NCT00316290|ADHD|adhd
5332784|NCT00316290|Cognitive Behavioral Therapy|cognitive behavioral therapy
5332785|NCT00316290|Parent Training|parent training
5332786|NCT00316277|Opiate Analgesic Dependence|opiate analgesic dependence
5332787|NCT00316264|Respiratory Syncytial Virus|respiratory syncytial virus
5332788|NCT00316264|Premature and under 6 mos. of age|premature and under 6 mos. of age
5332789|NCT00316264|Chronic Lung Disease over 6 mos. of age|chronic lung disease over 6 mos. of age
5332790|NCT00316264|palivizumab|palivizumab
5332791|NCT00316264|motavizumab|motavizumab
5332792|NCT00316264|RSV|rsv
5332793|NCT00316251|Somatosensory dysfunction|somatosensory dysfunction
5332794|NCT00316212|Coronary Artery Bypass Graft Surgery involving Cardiopulmonary Bypass|coronary artery bypass graft surgery involving cardiopulmonary bypass
5332795|NCT00316186|chemonaive|chemonaive
5332796|NCT00316186|small cell lung cancer|small cell lung cancer
5332797|NCT00316186|untreated|untreated
5332798|NCT00316186|Lung cancer|lung cancer
5332799|NCT00316186|HYCAMTIN|hycamtin
5332800|NCT00316186|first-line|first-line
5332801|NCT00316186|extensive disease|extensive disease
5332802|NCT00316173|HYCAMTIN|hycamtin
5332803|NCT00316173|ovarian cancer|ovarian cancer
5332804|NCT00316173|recurrent|recurrent
5332805|NCT00316173|relapsed|relapsed
5332806|NCT00316173|carboplatin|carboplatin
5332807|NCT00316173|topotecan|topotecan
5332808|NCT00316173|potentially platinum-sensitive|potentially platinum-sensitive
5332809|NCT00316160|sexual dysfunction|sexual dysfunction
5332810|NCT00316160|Depression|depression
5332811|NCT00316160|MDD|mdd
5332812|NCT00316147|diphtheria|diphtheria
5332813|NCT00316147|tetanus|tetanus
5332814|NCT00316147|poliomyelitis|poliomyelitis
5332815|NCT00316147|pertussis|pertussis
5332816|NCT00316147|hepatitis B|hepatitis b
5332817|NCT00316147|Prophylaxis|prophylaxis
5332818|NCT00316147|Haemophilus influenza type b diseases|haemophilus influenza type b diseases
5332819|NCT00316134|Pleural Diseases|pleural diseases
5332820|NCT00316134|Pleural Effusion|pleural effusion
5332821|NCT00316134|Pleural Effusion, Malignant|pleural effusion, malignant
5332822|NCT00316134|Pleural Neoplasms|pleural neoplasms
5332823|NCT00316134|Neoplasms, Pleural|neoplasms, pleural
5332824|NCT00316121|One or Two Level Degenerative Disc Disease|one or two level degenerative disc disease
5332825|NCT00316108|Carotid|carotid
5332826|NCT00316108|Carotid Artery Stenting|carotid artery stenting
5332827|NCT00316108|Stent|stent
5332828|NCT00316108|Carotid Endarterectomy|carotid endarterectomy
5332829|NCT00316108|Stroke|stroke
5332830|NCT00316108|Transient Ischemic Attack|transient ischemic attack
5332831|NCT00316108|Stenosis|stenosis
5332832|NCT00316108|Atherosclerotic Disease|atherosclerotic disease
5332833|NCT00001675|Brain Imaging|brain imaging
5332834|NCT00001675|Affect|affect
5332835|NCT00001675|Limbic System|limbic system
5332836|NCT00001675|Cerebral Blood Volume|cerebral blood volume
5332837|NCT00001675|Alcoholism|alcoholism
5332838|NCT00001675|Emotion|emotion
5332839|NCT00001675|Brain|brain
5332840|NCT00001675|Operant|operant
5332841|NCT00001675|Autonomic|autonomic
5332842|NCT00001675|Relapse|relapse
5332843|NCT00001675|Normal Volunteer|normal volunteer
5332844|NCT00001673|Alcoholics|alcoholics
5332845|NCT00001673|Screening|screening
5332846|NCT00001673|Healthy Volunteers|healthy volunteers
5332847|NCT00001673|Violent Abusers|violent abusers
5332848|NCT00001673|Illicit Drug Testing|illicit drug testing
5332849|NCT00001673|Blood Tests|blood tests
5332850|NCT00001673|Normal Volunteer|normal volunteer
5332851|NCT00316069|Erythropoiesis|erythropoiesis
5332852|NCT00316069|Leukapheresis|leukapheresis
5332853|NCT00316069|G-CSF|g-csf
5332854|NCT00316069|Mobilization|mobilization
5332855|NCT00316069|Stem Cells|stem cells
5332856|NCT00316069|Apheresis|apheresis
5332857|NCT00316069|Blood Donation|blood donation
5332858|NCT00316069|Healthy Volunteer|healthy volunteer
5332859|NCT00316069|HV|hv
5332860|NCT00316056|Genetic Literacy|genetic literacy
5332861|NCT00316056|Learning|learning
5332862|NCT00316056|Genetic Knowledge|genetic knowledge
5332863|NCT00316056|Public Understanding of Science|public understanding of science
5332864|NCT00316056|Science Education|science education
5332865|NCT00316056|Healthy Volunteer|healthy volunteer
5332866|NCT00316056|HV|hv
5332867|NCT00316043|Urinary tract infections|urinary tract infections
5332868|NCT00316043|Renal failure|renal failure
5332869|NCT00316043|Renal scarring|renal scarring
5332870|NCT00316043|Prevention|prevention
5332871|NCT00316043|Primary Care|primary care
5332872|NCT00316043|General Practice|general practice
5332873|NCT00316043|Intervention Studies|intervention studies
5332874|NCT00316043|Children|children
5332875|NCT00316030|AML|aml
5332876|NCT00316030|Acute Myeloid Leukemia|acute myeloid leukemia
5332877|NCT00316030|Bexarotene|bexarotene
5332878|NCT00316030|Leukemia|leukemia
5332879|NCT00316017|Trauma|trauma
5332880|NCT00316017|Shock|shock
5332881|NCT00316004|Traumatic|traumatic
5332882|NCT00316004|Brain injury|brain injury
5332883|NCT00315991|BG perception|bg perception
5332884|NCT00315991|hypoglycemic awareness|hypoglycemic awareness
5332885|NCT00315991|pediatric T1DM|pediatric t1dm
5332886|NCT00315978|Risk Assessment|risk assessment
5332887|NCT00315978|Decision Support Technique|decision support technique
5332888|NCT00315978|Physician-Patient Relations|physician-patient relations
5332889|NCT00315978|Prevention and Control|prevention and control
5332890|NCT00315965|Diffusion|diffusion
5332891|NCT00315965|Membrane diffusing capacity|membrane diffusing capacity
5332892|NCT00315965|Alveolar capillary gas diffusion|alveolar capillary gas diffusion
5332893|NCT00315965|Transfer factor|transfer factor
5332894|NCT00315965|Nitric oxide diffusion|nitric oxide diffusion
5332895|NCT00315952|type 1 diabetes mellitus|type 1 diabetes mellitus
5332896|NCT00315952|inhaled insulin|inhaled insulin
5332897|NCT00315952|Positron Emission Tomography|positron emission tomography
5332898|NCT00315939|Diabetes|diabetes
5332899|NCT00315939|hypoglycemic episodes|hypoglycemic episodes
5332900|NCT00315926|Cardiac morbidity|cardiac morbidity
5332901|NCT00315926|Melatonin|melatonin
5332902|NCT00315926|Surgery|surgery
5332903|NCT00315926|Postoperative|postoperative
5332904|NCT00315913|Labor|labor
5332905|NCT00315913|Dysfunctional Labor|dysfunctional labor
5332906|NCT00315913|Labor Arrest|labor arrest
5332907|NCT00315913|Primary Cesarean Section Prevention|primary cesarean section prevention
5332908|NCT00315900|Seroquel|seroquel
5332909|NCT00315900|Depakote ER|depakote er
5332910|NCT00315900|Nursing Home|nursing home
5332911|NCT00315900|Quetiapine|quetiapine
5332912|NCT00315900|Divalproex ER|divalproex er
5332913|NCT00315900|Agitation|agitation
5332914|NCT00315887|low back pain|low back pain
5332915|NCT00315887|opioid|opioid
5332916|NCT00315887|transdermal|transdermal
5332917|NCT00315874|chronic back pain|chronic back pain
5332918|NCT00315874|opioid|opioid
5332919|NCT00315874|transdermal|transdermal
5332920|NCT00315861|ovarian carcinoma|ovarian carcinoma
5332921|NCT00315861|endometrial carcinoma|endometrial carcinoma
5332922|NCT00315861|cervical carcinoma|cervical carcinoma
5332923|NCT00315861|lung carcinoma|lung carcinoma
5332924|NCT00315848|chronic pain|chronic pain
5332925|NCT00315848|osteoarthritis|osteoarthritis
5332926|NCT00315848|opioid|opioid
5332927|NCT00315848|transdermal|transdermal
5332928|NCT00315835|postoperative pain|postoperative pain
5332929|NCT00315835|opioid|opioid
5332930|NCT00315835|transdermal|transdermal
5332931|NCT00315822|Surgery|surgery
5332932|NCT00315822|colon|colon
5332933|NCT00315809|leprosy, Philippines|leprosy, philippines
5332934|NCT00315796|Mind-Body Intervention|mind-body intervention
5332935|NCT00315796|Distraction|distraction
5332936|NCT00315796|Biophilic|biophilic
5332937|NCT00315796|Cancer|cancer
5332938|NCT00315796|pain|pain
5332939|NCT00315796|Bedscapes|bedscapes
5332940|NCT00315796|procedures|procedures
5332941|NCT00315796|bone marrow aspirate|bone marrow aspirate
5332942|NCT00315796|bone marrow biopsy|bone marrow biopsy
5332943|NCT00315783|hypertrophic cardiomyopathy|hypertrophic cardiomyopathy
5332944|NCT00315783|echocardiography|echocardiography
5332945|NCT00315783|magnetic resonance imaging|magnetic resonance imaging
5332946|NCT00315770|overweight|overweight
5332947|NCT00315770|Metabolic syndrome|metabolic syndrome
5332948|NCT00315744|moderate asthma|moderate asthma
5332949|NCT00315744|fluticasone|fluticasone
5332950|NCT00315744|children|children
5332951|NCT00315744|salmeterol|salmeterol
5332952|NCT00315744|steroid-sparing|steroid-sparing
5332953|NCT00315744|Asthma|asthma
5332954|NCT00315731|Bexxar|bexxar
5332955|NCT00315731|tositumomab and iodine I 131 tositumomab therapeutic regiment|tositumomab and iodine i 131 tositumomab therapeutic regiment
5332956|NCT00315731|fission|fission
5332957|NCT00315731|Non-Hodgkin's lymphoma|non-hodgkin's lymphoma
5332958|NCT00315731|Iodine I 131 Tositumomab|iodine i 131 tositumomab
5332959|NCT00315731|pharmacokinetics|pharmacokinetics
5332960|NCT00315731|tellurium|tellurium
5332961|NCT00315718|Hintonia latiflora extract|hintonia latiflora extract
5332962|NCT00315718|Diabetes mellitus type 2|diabetes mellitus type 2
5332963|NCT00315718|HbA1c|hba1c
5332964|NCT00315718|Safety|safety
5332965|NCT00315718|Liver function tests|liver function tests
5332966|NCT00315705|clofarabine|clofarabine
5332967|NCT00315705|acute leukemia|acute leukemia
5332968|NCT00315705|ALL|all
5332969|NCT00315705|AML|aml
5332970|NCT00315705|clolar|clolar
5332971|NCT00315705|CLO218|clo218
5332972|NCT00315692|Ovarian Neoplasms|ovarian neoplasms
5332973|NCT00315679|recurrent aphthous stomatitis|recurrent aphthous stomatitis
5332974|NCT00315679|recurrent mouth ulcers|recurrent mouth ulcers
5332975|NCT00315679|pentoxifylline|pentoxifylline
5332976|NCT00315679|clinical trial|clinical trial
5332977|NCT00315679|double blind|double blind
5332978|NCT00315679|placebo controlled|placebo controlled
5332979|NCT00315679|randomized|randomized
5332980|NCT00315666|Chronic tension-type headache|chronic tension-type headache
5332981|NCT00315653|Bladder Cancer|bladder cancer
5332982|NCT00315653|Cancer of Bladder|cancer of bladder
5332983|NCT00315653|Bladder Tumors|bladder tumors
5332984|NCT00315653|Cancer of the Bladder|cancer of the bladder
5332985|NCT00315653|Neoplasms, Bladder|neoplasms, bladder
5332986|NCT00315640|Elevated IOP due to intravitreal triamcinolone therapy|elevated iop due to intravitreal triamcinolone therapy
5332987|NCT00315627|Islet Transplantation|islet transplantation
5332988|NCT00315614|Islet Transplantation|islet transplantation
5332989|NCT00315601|Telithromycin (drug)|telithromycin (drug)
5332990|NCT00315601|Azithromycin (drug)|azithromycin (drug)
5332991|NCT00315601|Bronchoalveolar lavage (procedure)|bronchoalveolar lavage (procedure)
5332992|NCT00315601|Pharmacokinetics|pharmacokinetics
5332993|NCT00315588|Islet Transplantation|islet transplantation
5332994|NCT00315575|Dementia|dementia
5332995|NCT00315575|brain circulation|brain circulation
5332996|NCT00315575|disease /disorder proneness /risk|disease /disorder proneness /risk
5332997|NCT00315575|neuropathology|neuropathology
5332998|NCT00315575|neurophysiology|neurophysiology
5332999|NCT00315575|aging|aging
5333000|NCT00315575|apolipoprotein E|apolipoprotein e
5333001|NCT00315575|genotype|genotype
5333002|NCT00315575|hemodynamics|hemodynamics
5333003|NCT00315575|memory|memory
5333004|NCT00315575|temporal lobe /cortex|temporal lobe /cortex
5333005|NCT00315562|stroke|stroke
5333006|NCT00315562|carotid stenosis|carotid stenosis
5333007|NCT00315562|carotid endarterectomy|carotid endarterectomy
5333008|NCT00315562|timing|timing
5333009|NCT00315549|Tonsillitis|tonsillitis
5333010|NCT00315549|pharyngitis|pharyngitis
5333011|NCT00315549|penicillin|penicillin
5333012|NCT00315549|telithromycin|telithromycin
5333013|NCT00315549|ketolides|ketolides
5333014|NCT00315549|clinical trials|clinical trials
5333015|NCT00315523|Levocetirizine|levocetirizine
5333016|NCT00315523|Xyzal|xyzal
5333017|NCT00315523|Rhinitis|rhinitis
5333018|NCT00315523|Allergic|allergic
5333019|NCT00315523|Seasonal|seasonal
5333020|NCT00315523|Ragweed|ragweed
5333021|NCT00315510|Ischemia-reperfusion|ischemia-reperfusion
5333022|NCT00315510|Annexin A5|annexin a5
5333023|NCT00315497|Giant Cell Arteritis|giant cell arteritis
5333024|NCT00315484|Anemia|anemia
5333025|NCT00315484|chemotherapy|chemotherapy
5333026|NCT00315484|hemoglobin level|hemoglobin level
5333027|NCT00315484|recombinant human erythropoietin|recombinant human erythropoietin
5333028|NCT00315484|epoetin alfa|epoetin alfa
5333029|NCT00315484|darbepoetin alfa|darbepoetin alfa
5333030|NCT00315471|Vasculitis|vasculitis
5333031|NCT00315458|osteoarthritis|osteoarthritis
5333032|NCT00315458|opioid|opioid
5333033|NCT00315458|transdermal|transdermal
5333034|NCT00315445|chronic back pain|chronic back pain
5333035|NCT00315445|opioid|opioid
5333036|NCT00315445|transdermal|transdermal
5333037|NCT00315432|Natural History, Hepatitis C Infection, HIV Infection, HCV/HIV co-infection Ribavirin, Pegylated Interferon, Interferon|natural history, hepatitis c infection, hiv infection, hcv/hiv co-infection ribavirin, pegylated interferon, interferon
5333038|NCT00315419|Large Granular Lymphocyte Leukemia|large granular lymphocyte leukemia
5333039|NCT00315419|Amegakaryocytic Thrombocytopenic Purpura|amegakaryocytic thrombocytopenic purpura
5333040|NCT00315419|Idiopathic Pure Red Cell Aplasia|idiopathic pure red cell aplasia
5333041|NCT00315419|Paroxysmal Nocturnal Hemoglobinuria|paroxysmal nocturnal hemoglobinuria
5333042|NCT00315406|PAN|pan
5333043|NCT00315406|Periarteritis Nodosa|periarteritis nodosa
5333044|NCT00315393|GPA|gpa
5333045|NCT00315393|MPA|mpa
5333046|NCT00315393|WG|wg
5333047|NCT00315380|EGPA|egpa
5333048|NCT00315380|CSS|css
5333049|NCT00315367|Multiple Sclerosis|multiple sclerosis
5333050|NCT00315367|Memory impairment|memory impairment
5333051|NCT00315354|obesity|obesity
5333052|NCT00315354|nutrition|nutrition
5333053|NCT00315328|Amblyopia|amblyopia
5333054|NCT00315328|Atropine|atropine
5333055|NCT00315328|Patching|patching
5333056|NCT00315315|Nasolacrimal duct obstruction|nasolacrimal duct obstruction
5333057|NCT00315315|Balloon catheter nasolacrimal duct dilation|balloon catheter nasolacrimal duct dilation
5333058|NCT00315315|Nasolacrimal intubation|nasolacrimal intubation
5333059|NCT00315315|Simple Nasolacrimal duct probing|simple nasolacrimal duct probing
5333060|NCT00315302|Amblyopia|amblyopia
5333061|NCT00315302|Atropine|atropine
5333062|NCT00315302|Plano lens|plano lens
5333063|NCT00315289|Nasolacrimal duct obstruction|nasolacrimal duct obstruction
5333064|NCT00315289|Simple probing|simple probing
5333065|NCT00315289|Balloon catheter dilation|balloon catheter dilation
5333066|NCT00315289|Nasolacrimal intubation|nasolacrimal intubation
5333067|NCT00315276|ADHD|adhd
5333068|NCT00315263|DNA|dna
5333069|NCT00315263|Genomics|genomics
5333070|NCT00315263|SNPs|snps
5333071|NCT00315263|Neonatology|neonatology
5333072|NCT00315263|Chronic Lung Disease|chronic lung disease
5333073|NCT00315263|Periventricular Brain Injury|periventricular brain injury
5333074|NCT00315263|Hypoxic Respiratory Failure|hypoxic respiratory failure
5333075|NCT00315250|Parkinson|parkinson
5333076|NCT00315224|Isolated systolic Hypertension|isolated systolic hypertension
5333077|NCT00315224|exercise|exercise
5333078|NCT00315224|pulse pressure|pulse pressure
5333079|NCT00315224|endothelium|endothelium
5333080|NCT00315211|Small Cell Lung Cancer Recurrent|small cell lung cancer recurrent
5333081|NCT00315198|amblyopia|amblyopia
5333082|NCT00315198|patching|patching
5333083|NCT00315198|visual activities|visual activities
5333084|NCT00315185|Advanced Non-small Cell Lung Cancer|advanced non-small cell lung cancer
5333085|NCT00315185|First Line Treatment|first line treatment
5333086|NCT00315172|Adipose Tissue|adipose tissue
5333087|NCT00315172|Weight Gain|weight gain
5333088|NCT00315172|Pediatric|pediatric
5333089|NCT00315172|Body Composition|body composition
5333090|NCT00315172|Thermogenesis|thermogenesis
5333091|NCT00315172|Exercise|exercise
5333092|NCT00315172|Healthy Volunteer|healthy volunteer
5333093|NCT00315172|HV|hv
5333094|NCT00315159|Squamous|squamous
5333095|NCT00315159|Cell|cell
5333096|NCT00315159|Carcinoma|carcinoma
5333097|NCT00315159|Vulva|vulva
5333098|NCT00315159|Sentinel Node|sentinel node
5333099|NCT00315146|Body Composition|body composition
5333100|NCT00315146|Sarcopenia|sarcopenia
5333101|NCT00315146|Weight loss trials|weight loss trials
5333102|NCT00315146|Intervention studies|intervention studies
5333103|NCT00315146|Elderly|elderly
5333104|NCT00315133|Diabetes mellitus|diabetes mellitus
5333105|NCT00315133|Stem cells|stem cells
5333106|NCT00315133|Autologous stem cell transplantation|autologous stem cell transplantation
5333107|NCT00315133|Autoimmune diseases|autoimmune diseases
5333108|NCT00315120|Randomized controlled trial|randomized controlled trial
5333109|NCT00315120|Low back pain|low back pain
5333110|NCT00315120|Spinal manipulative therapy|spinal manipulative therapy
5333111|NCT00315120|Spinal manipulation|spinal manipulation
5333112|NCT00315120|Osteopathic manipulation|osteopathic manipulation
5333113|NCT00315120|Osteopathic medicine|osteopathic medicine
5333114|NCT00315120|Physical therapy modalities|physical therapy modalities
5333115|NCT00315094|home parenteral nutrition|home parenteral nutrition
5333116|NCT00315081|Schizophrenia|schizophrenia
5333117|NCT00315081|Hyperprolactinemia|hyperprolactinemia
5333118|NCT00315081|Risperidone|risperidone
5333119|NCT00315081|Bromocriptin|bromocriptin
5333120|NCT00315068|arrythmia|arrythmia
5333121|NCT00315068|atrial fibrillation|atrial fibrillation
5333122|NCT00315068|proteins|proteins
5333123|NCT00315055|Hepatitis B|hepatitis b
5333124|NCT00315055|Polio|polio
5333125|NCT00315055|Diphtheria|diphtheria
5333126|NCT00315055|Pertussis|pertussis
5333127|NCT00315055|H influenzae type b|h influenzae type b
5333128|NCT00315042|Tonsillitis|tonsillitis
5333129|NCT00315042|pharyngitis|pharyngitis
5333130|NCT00315042|penicillin|penicillin
5333131|NCT00315042|telithromycin|telithromycin
5333132|NCT00315042|ketolides|ketolides
5333133|NCT00315042|clinical trials|clinical trials
5333134|NCT00315029|Implementation|implementation
5333135|NCT00315029|Single embryo transfer|single embryo transfer
5333136|NCT00315029|ICSI|icsi
5333137|NCT00315029|IVF|ivf
5333138|NCT00315029|prevention|prevention
5333139|NCT00315016|albuminuria|albuminuria
5333140|NCT00315016|eplerenone|eplerenone
5333141|NCT00315016|ACE inhibition|ace inhibition
5333142|NCT00315016|renal function|renal function
5333143|NCT00315016|endothelial function|endothelial function
5333144|NCT00315003|Otitis Media|otitis media
5333145|NCT00315003|Suppurative|suppurative
5333146|NCT00315003|Purulent|purulent
5333147|NCT00315003|Ketolide|ketolide
5333148|NCT00315003|Azithromycin|azithromycin
5333149|NCT00315003|Telithromycin|telithromycin
5333150|NCT00315003|Controlled Clinical Trials|controlled clinical trials
5333151|NCT00314990|Venous thrombosis|venous thrombosis
5333152|NCT00314990|Deep-vein thrombosis|deep-vein thrombosis
5333153|NCT00314990|Pulmonary embolism|pulmonary embolism
5333154|NCT00314990|Homocysteine|homocysteine
5333155|NCT00314990|B-vitamins|b-vitamins
5333156|NCT00314990|Folate|folate
5333157|NCT00314990|Vitamin B12|vitamin b12
5333158|NCT00314990|Vitamin B6|vitamin b6
5333159|NCT00314977|Large resectable breast cancer|large resectable breast cancer
5333160|NCT00314977|Locally advanced breast cancer|locally advanced breast cancer
5333161|NCT00314977|Neoadjuvant therapy|neoadjuvant therapy
5333162|NCT00314951|CDAD, Clostridium difficile, diarrhea|cdad, clostridium difficile, diarrhea
5333163|NCT00314951|Clostridium difficile-Associated Diarrhea|clostridium difficile-associated diarrhea
5333164|NCT00314925|advanced carcinoma|advanced carcinoma
5333165|NCT00314925|carcinoid|carcinoid
5333166|NCT00314925|neuroendocrine features|neuroendocrine features
5333167|NCT00314925|oncolytic virus|oncolytic virus
5333168|NCT00314925|phase I study|phase i study
5333169|NCT00314925|dose escalation study|dose escalation study
5333170|NCT00314925|rhabdomyosarcoma|rhabdomyosarcoma
5333171|NCT00314925|alveolar rhabdomyosarcoma|alveolar rhabdomyosarcoma
5333172|NCT00314925|medulloblastoma|medulloblastoma
5333173|NCT00314925|rhabdoid|rhabdoid
5333174|NCT00314925|glioblastoma|glioblastoma
5333175|NCT00314925|ewing's sarcoma|ewing's sarcoma
5333176|NCT00314925|pediatric oncologies|pediatric oncologies
5333177|NCT00314925|neuroblastoma|neuroblastoma
5333178|NCT00314925|wilms' tumor|wilms' tumor
5333179|NCT00314925|retinoblastoma|retinoblastoma
5333180|NCT00314925|Large cell lung cancer|large cell lung cancer
5333181|NCT00314899|Malaria, Plasmodium falciparum, Kenya, immunity|malaria, plasmodium falciparum, kenya, immunity
5333182|NCT00314886|Diet|diet
5333183|NCT00314886|Fiber|fiber
5333184|NCT00314886|Irritable Bowel Syndrome|irritable bowel syndrome
5333185|NCT00314886|Colonic Flora|colonic flora
5333186|NCT00314873|Thymic malignancy|thymic malignancy
5333187|NCT00314873|Thymic Carcinoma|thymic carcinoma
5333188|NCT00314860|Restless Legs Syndrome|restless legs syndrome
5333189|NCT00314847|Myocardial infarction|myocardial infarction
5333190|NCT00314847|Cardiogenic shock|cardiogenic shock
5333191|NCT00314847|Extracorporeal Life Support-Impella|extracorporeal life support-impella
5333192|NCT00314834|hemodialysis|hemodialysis
5333193|NCT00314834|intradialytic parenteral nutrition|intradialytic parenteral nutrition
5333194|NCT00314834|oral supplementation|oral supplementation
5333195|NCT00314834|survival|survival
5333196|NCT00314834|hospitalization|hospitalization
5333197|NCT00314834|serum albumin|serum albumin
5333198|NCT00314834|prealbumin|prealbumin
5333199|NCT00314834|transthyretin|transthyretin
5333200|NCT00314821|bipolar disorder, ropinirole, depression|bipolar disorder, ropinirole, depression
5333201|NCT00314808|primary gliomas|primary gliomas
5333202|NCT00314808|brain tumors|brain tumors
5333203|NCT00314808|vomiting|vomiting
5333204|NCT00314808|appetite suppression|appetite suppression
5333205|NCT00314808|appetite|appetite
5333206|NCT00314795|pure red cell aplasia|pure red cell aplasia
5333207|NCT00314795|PRCA|prca
5333208|NCT00314795|chronic kidney disease|chronic kidney disease
5333209|NCT00314795|CKD|ckd
5333210|NCT00314795|chronic renal failure|chronic renal failure
5333211|NCT00314795|CRF|crf
5333212|NCT00314795|anemia|anemia
5333213|NCT00314795|erythropoietin|erythropoietin
5333214|NCT00314795|EPO|epo
5333215|NCT00314795|erythropoiesis stimulating agent|erythropoiesis stimulating agent
5333216|NCT00314795|ESA|esa
5333217|NCT00314795|hemoglobin|hemoglobin
5333218|NCT00314795|Hb|hb
5333219|NCT00314795|Hgb|hgb
5333220|NCT00314795|red blood cell|red blood cell
5333221|NCT00314795|red blood cell production|red blood cell production
5333222|NCT00314782|metastatic hormone-refractory prostate cancer (HRPC)|metastatic hormone-refractory prostate cancer (hrpc)
5333223|NCT00314769|Transcranial Direct Current Stimulation (TDCS)|transcranial direct current stimulation (tdcs)
5333224|NCT00314769|Motor Learning|motor learning
5333225|NCT00314769|Transcranial Magnetic Stimulation (TMS)|transcranial magnetic stimulation (tms)
5333226|NCT00314769|Cortical Re-Organization|cortical re-organization
5333227|NCT00314769|Neuroplasticity|neuroplasticity
5333228|NCT00314769|Neurorehabilitation|neurorehabilitation
5333229|NCT00314769|TBI|tbi
5333230|NCT00314769|Stroke|stroke
5333231|NCT00314769|Healthy Volunteer|healthy volunteer
5333232|NCT00314769|HV|hv
5333233|NCT00314756|imiquimod cream|imiquimod cream
5333234|NCT00314756|nodular basal cell carcinoma|nodular basal cell carcinoma
5333235|NCT00314756|curettage|curettage
5333236|NCT00314743|Patients with Non-Hodgkins Lymphoma or Multiple Myeloma|patients with non-hodgkins lymphoma or multiple myeloma
5333237|NCT00314704|shock|shock
5333238|NCT00314704|hypotension|hypotension
5333239|NCT00314704|circulatory failure|circulatory failure
5333240|NCT00314704|septic shock|septic shock
5333241|NCT00314704|cardiogenic shock|cardiogenic shock
5333242|NCT00314691|fetal DNA|fetal dna
5333243|NCT00314691|prenatal diagnosis|prenatal diagnosis
5333244|NCT00314691|maternal plasma|maternal plasma
5333245|NCT00314691|Diagnostic potential of cell-free fetal DNA circulating in maternal blood|diagnostic potential of cell-free fetal dna circulating in maternal blood
5333246|NCT00314678|Ovarian|ovarian
5333247|NCT00314678|Peritoneal|peritoneal
5333248|NCT00314665|Sarcoidosis|sarcoidosis
5333249|NCT00314665|Chronic Uveitis|chronic uveitis
5333250|NCT00314665|Uveitis|uveitis
5333251|NCT00314665|Thalidomide|thalidomide
5333252|NCT00314652|Osteoarthritis|osteoarthritis
5333253|NCT00314652|chronic pain|chronic pain
5333254|NCT00314652|opioid|opioid
5333255|NCT00314652|transdermal|transdermal
5333256|NCT00314626|Antiviral efficacy|antiviral efficacy
5333257|NCT00314626|Tolerability|tolerability
5333258|NCT00314626|Immunologic response|immunologic response
5333259|NCT00314626|Virologic response|virologic response
5333260|NCT00314626|HIV|hiv
5333261|NCT00314613|Schizophreniform; Schizophrenia; Schizoaffective Disorders|schizophreniform; schizophrenia; schizoaffective disorders
5333262|NCT00314600|Fracture|fracture
5333263|NCT00314600|Forearm|forearm
5333264|NCT00314600|Midshaft|midshaft
5333265|NCT00314600|Child|child
5333266|NCT00314600|Cast|cast
5333267|NCT00314587|fracture|fracture
5333268|NCT00314587|forearm|forearm
5333269|NCT00314587|midshaft|midshaft
5333270|NCT00314587|child|child
5333271|NCT00314587|treatment|treatment
5333272|NCT00314574|Persistent Asthma|persistent asthma
5333273|NCT00314574|EXTRA|extra
5333274|NCT00314574|Xolair|xolair
5333275|NCT00314574|Difficult Breathing|difficult breathing
5333276|NCT00314561|Rosiglitazone|rosiglitazone
5333277|NCT00314561|Pioglitazone|pioglitazone
5333278|NCT00314561|FMD|fmd
5333279|NCT00314561|PWV|pwv
5333280|NCT00314561|atherosclerosis|atherosclerosis
5333281|NCT00314548|ARDS|ards
5333282|NCT00314548|pulmonary hypertension|pulmonary hypertension
5333283|NCT00314548|prostacyclins|prostacyclins
5333284|NCT00314509|Asthma|asthma
5333285|NCT00314509|Ciclesonide|ciclesonide
5333286|NCT00314509|Formoterol Fumarate|formoterol fumarate
5333287|NCT00314509|Long-acting beta2-agonists|long-acting beta2-agonists
5333288|NCT00314509|LABA|laba
5333289|NCT00314509|Steroids|steroids
5333290|NCT00314483|Mesenchymal stem cells|mesenchymal stem cells
5333291|NCT00314483|GVHD|gvhd
5333292|NCT00314483|Treatment|treatment
5333293|NCT00314483|Steroid refractory GVHD|steroid refractory gvhd
5333294|NCT00314457|pain control|pain control
5333295|NCT00314457|intra-articular pain control device|intra-articular pain control device
5333296|NCT00314457|ACL repair|acl repair
5333297|NCT00314457|Bankart Repair|bankart repair
5333298|NCT00314444|Psychogenic|psychogenic
5333299|NCT00314444|Psychogenic Movement Disorders|psychogenic movement disorders
5333300|NCT00314431|neonatal chronic lung disease|neonatal chronic lung disease
5333301|NCT00314431|bronchopulmonary dysplasia|bronchopulmonary dysplasia
5333302|NCT00314431|prematurity|prematurity
5333303|NCT00314431|telephone follow up|telephone follow up
5333304|NCT00314431|care coordination|care coordination
5333305|NCT00314431|children with special health care needs|children with special health care needs
5333306|NCT00314418|Colonoscopy|colonoscopy
5333307|NCT00314418|technique|technique
5333308|NCT00314418|time|time
5333309|NCT00314418|duration|duration
5333310|NCT00314418|position|position
5333311|NCT00314418|abdominal pressure|abdominal pressure
5333312|NCT00314405|sentinel lymph node|sentinel lymph node
5333313|NCT00314405|SLN|sln
5333314|NCT00314405|probe|probe
5333315|NCT00314405|breast cancer|breast cancer
5333316|NCT00314405|lymphoscintigraphy|lymphoscintigraphy
5333317|NCT00314405|methylene blue dye|methylene blue dye
5333318|NCT00314392|Experimental pain|experimental pain
5333319|NCT00314392|Placebo analgesia|placebo analgesia
5333320|NCT00314392|Heart rate variability|heart rate variability
5333321|NCT00314392|Skin conductance|skin conductance
5333322|NCT00314379|Diabetes|diabetes
5333323|NCT00314379|Endothelial Function|endothelial function
5333324|NCT00314379|Haptoglobin|haptoglobin
5333325|NCT00314366|stem cell|stem cell
5333326|NCT00314366|autologous|autologous
5333327|NCT00314366|ischemia|ischemia
5333328|NCT00314353|NSABP|nsabp
5333329|NCT00314353|bevacizumab|bevacizumab
5333330|NCT00314353|capecitabine|capecitabine
5333331|NCT00314353|oxaliplatin|oxaliplatin
5333332|NCT00314353|irinotecan|irinotecan
5333333|NCT00314353|rectal cancer|rectal cancer
5333334|NCT00314353|colon cancer|colon cancer
5333335|NCT00314353|colorectal cancer|colorectal cancer
5333336|NCT00314340|Chronic Pain|chronic pain
5333337|NCT00314340|Opioids|opioids
5333338|NCT00314327|first episode|first episode
5333339|NCT00314327|schizophrenia|schizophrenia
5333340|NCT00314327|risperidone|risperidone
5333341|NCT00314314|Bipolar Disorder, memory, executive functioning|bipolar disorder, memory, executive functioning
5333342|NCT00314301|cerebral palsy|cerebral palsy
5333343|NCT00314301|resistance|resistance
5333344|NCT00314301|movement|movement
5333345|NCT00314301|biomechanics|biomechanics
5333346|NCT00314288|Parkinson's Disease|parkinson's disease
5333347|NCT00314288|Dyskinesia|dyskinesia
5333348|NCT00314288|L-dopa-induced dyskinesia|l-dopa-induced dyskinesia
5333349|NCT00314275|Pharmacokinetics|pharmacokinetics
5333350|NCT00314275|Coronary Artery Disease|coronary artery disease
5333351|NCT00314275|PCI|pci
5333352|NCT00314275|Drug Eluting Stent|drug eluting stent
5333353|NCT00314262|Skin Lesions|skin lesions
5333354|NCT00314262|Premalignant Lesion|premalignant lesion
5333355|NCT00314249|Fibromyalgia|fibromyalgia
5333356|NCT00314236|Cartilage repair|cartilage repair
5333357|NCT00314236|Cartilage|cartilage
5333358|NCT00314236|Knee|knee
5333359|NCT00314236|Knee Pain|knee pain
5333360|NCT00314236|Microfracture|microfracture
5333361|NCT00314236|arthroscopy|arthroscopy
5333362|NCT00314236|bone marrow stimulation|bone marrow stimulation
5333363|NCT00314236|Chondrogenesis|chondrogenesis
5333364|NCT00314236|Scaffold|scaffold
5333365|NCT00314236|Chitosan|chitosan
5333366|NCT00314236|A02.165.165|a02.165.165
5333367|NCT00314236|A10.165.382.332|a10.165.382.332
5333368|NCT00314236|G07.574.500.325.377.625.180|g07.574.500.325.377.625.180
5333369|NCT00314236|A10.165.382.400|a10.165.382.400
5333370|NCT00314236|Articular Cartilage Repair|articular cartilage repair
5333371|NCT00314210|Generalised Anxiety Disorder|generalised anxiety disorder
5333372|NCT00314197|automated counseling system|automated counseling system
5333373|NCT00314197|telephone-based intervention|telephone-based intervention
5333374|NCT00314197|behavior change|behavior change
5333375|NCT00314184|Bipolar I disorder.|bipolar i disorder.
5333376|NCT00314171|open-angle glaucoma|open-angle glaucoma
5333377|NCT00314171|ocular hypertension|ocular hypertension
5333378|NCT00314132|Japanese Encephalitis|japanese encephalitis
5333379|NCT00314132|Encephalitis virus|encephalitis virus
5333380|NCT00314132|ChimeriVax™-JE Vaccine|chimerivax™-je vaccine
5333776|NCT00312650|progressive|progressive
5333381|NCT00314119|Tumor Imaging|tumor imaging
5333382|NCT00314119|NF1|nf1
5333383|NCT00314119|Neurofibromatosis|neurofibromatosis
5333384|NCT00314106|Clinical Response|clinical response
5333385|NCT00314106|Stage IV Melanoma|stage iv melanoma
5333386|NCT00314106|Adoptive Cell Therapy|adoptive cell therapy
5333387|NCT00314106|Tumor Infiltrating Lymphocytes|tumor infiltrating lymphocytes
5333388|NCT00314106|Immunologic Response|immunologic response
5333389|NCT00314106|Metastatic Melanoma|metastatic melanoma
5333390|NCT00314093|Clinical Response|clinical response
5333391|NCT00314093|Stage IV Melanoma|stage iv melanoma
5333392|NCT00314093|Immunotoxin|immunotoxin
5333393|NCT00314093|T Regulatory Cells|t regulatory cells
5333394|NCT00314093|CD25+ Cells|cd25+ cells
5333395|NCT00314093|Metastatic Melanoma|metastatic melanoma
5333396|NCT00314080|Botulism|botulism
5333397|NCT00314080|Botulinum anti-toxin|botulinum anti-toxin
5333398|NCT00314080|Repetitive nerve stimulation|repetitive nerve stimulation
5333399|NCT00314080|Respiratory failure|respiratory failure
5333400|NCT00314067|Quality of Health Care|quality of health care
5333401|NCT00314067|Primary Health Care|primary health care
5333402|NCT00314067|Education|education
5333403|NCT00314067|E-Learning|e-learning
5333404|NCT00314067|Alcohol-related Disorders|alcohol-related disorders
5333405|NCT00314054|Hepatitis C|hepatitis c
5333406|NCT00314054|Hepatic Impairment|hepatic impairment
5333407|NCT00314054|Healthy Volunteer|healthy volunteer
5333408|NCT00314054|Phase 1|phase 1
5333409|NCT00314054|Hepacivirus|hepacivirus
5333410|NCT00314041|Infant|infant
5333411|NCT00314041|Conjugate vaccine|conjugate vaccine
5333412|NCT00314041|Meningococcal|meningococcal
5333413|NCT00314041|Antibody|antibody
5333414|NCT00314041|Immune memory|immune memory
5333415|NCT00314041|Health|health
5333416|NCT00314041|Meningococcal Vaccines|meningococcal vaccines
5333417|NCT00314028|African American|african american
5333419|NCT00314028|Sexually Transmitted Diseases|sexually transmitted diseases
5333420|NCT00314028|Condoms|condoms
5333421|NCT00314002|Massive pulmonary embolism|massive pulmonary embolism
5333422|NCT00314002|Catheter thrombectomy|catheter thrombectomy
5333423|NCT00313976|Multiple Sclerosis|multiple sclerosis
5333424|NCT00313976|Early secondary progressive Multiple Sclerosis|early secondary progressive multiple sclerosis
5333425|NCT00313963|Anemia, Sickle Cell|anemia, sickle cell
5333426|NCT00313963|Magnesium Sulfate|magnesium sulfate
5333427|NCT00313963|pediatric|pediatric
5333428|NCT00313950|measles|measles
5333429|NCT00313950|rubella|rubella
5333430|NCT00313950|mumps|mumps
5333431|NCT00313950|hepatitis A|hepatitis a
5333432|NCT00313924|URGENCY FREQUENCY SYNDROME|urgency frequency syndrome
5333433|NCT00313924|URGE INCONTINENCE|urge incontinence
5333434|NCT00313911|Diphtheria|diphtheria
5333435|NCT00313911|Tetanus|tetanus
5333436|NCT00313911|Pertussis|pertussis
5333437|NCT00313911|Recombinant Hepatitis B|recombinant hepatitis b
5333438|NCT00313911|Poliomyelitis|poliomyelitis
5333439|NCT00313911|Haemophilus influenzae type b|haemophilus influenzae type b
5333440|NCT00313911|Tetanus protein|tetanus protein
5333441|NCT00313898|quality of sexual life, Mild erectile dysfunction|quality of sexual life, mild erectile dysfunction
5333442|NCT00313872|gastric cancer|gastric cancer
5333443|NCT00313872|chemotherapy|chemotherapy
5333444|NCT00313872|irinotecan|irinotecan
5333445|NCT00313872|docetaxel|docetaxel
5333446|NCT00313859|colorectal cancer|colorectal cancer
5333447|NCT00313859|metastatic|metastatic
5333448|NCT00313846|Chronic pain|chronic pain
5333449|NCT00313846|opioid|opioid
5333450|NCT00313846|transdermal|transdermal
5333451|NCT00313846|osteoarthritis|osteoarthritis
5333452|NCT00313833|Chronic pain|chronic pain
5333453|NCT00313833|elderly|elderly
5333454|NCT00313833|supervised living|supervised living
5333455|NCT00313833|opioid|opioid
5333456|NCT00313833|transdermal|transdermal
5333457|NCT00313820|Post-stroke pain, pregabalin|post-stroke pain, pregabalin
5333458|NCT00313807|contrast nephropathy|contrast nephropathy
5333459|NCT00313807|renal failure|renal failure
5333460|NCT00313807|Travasol|travasol
5333461|NCT00313781|randomized|randomized
5333462|NCT00313781|non-comparative|non-comparative
5333463|NCT00313781|efficacy|efficacy
5333464|NCT00313768|advanced carcinoma, non-small cell lung, Phase II, paclitaxel, Taxol, carboplatin, Paraplatin, bevacizumab, Avastin, PF-3512676, immunotherapy, immunomodulator|advanced carcinoma, non-small cell lung, phase ii, paclitaxel, taxol, carboplatin, paraplatin, bevacizumab, avastin, pf-3512676, immunotherapy, immunomodulator
5333465|NCT00313755|colonoscopy, narrow band imaging,|colonoscopy, narrow band imaging,
5333466|NCT00313755|high definition endoscopy|high definition endoscopy
5333467|NCT00313755|colorectal cancer|colorectal cancer
5333468|NCT00313755|dysplasia|dysplasia
5333469|NCT00313755|hereditary non-polyposis colorectal cancer|hereditary non-polyposis colorectal cancer
5333470|NCT00313755|Lynch Syndrome|lynch syndrome
5333471|NCT00313755|HNPCC|hnpcc
5333472|NCT00313729|adult oligodendroglioma|adult oligodendroglioma
5333473|NCT00313729|adult mixed glioma|adult mixed glioma
5333474|NCT00313729|adult diffuse astrocytoma|adult diffuse astrocytoma
5333475|NCT00313729|adult pilocytic astrocytoma|adult pilocytic astrocytoma
5333476|NCT00313729|adult pineal gland astrocytoma|adult pineal gland astrocytoma
5333477|NCT00313716|anemia|anemia
5333876|NCT00312260|Analgesia|analgesia
5333478|NCT00313716|traumatic brain injury|traumatic brain injury
5333479|NCT00313716|recombinant human erythropoietin|recombinant human erythropoietin
5333480|NCT00313716|rhEpo|rhepo
5333481|NCT00313716|erythropoietin|erythropoietin
5333482|NCT00313716|TBI|tbi
5333483|NCT00313716|Epo|epo
5333484|NCT00313703|headache|headache
5333485|NCT00313703|emergency department|emergency department
5333486|NCT00313703|migraine|migraine
5333487|NCT00313703|recurrent headache|recurrent headache
5333488|NCT00313690|Lung Cancer|lung cancer
5333489|NCT00313677|muscular dystrophy|muscular dystrophy
5333490|NCT00313677|MD|md
5333491|NCT00313677|fukutin-related protein gene|fukutin-related protein gene
5333492|NCT00313677|limb girdle|limb girdle
5333493|NCT00313677|FKRP gene|fkrp gene
5333494|NCT00313677|congenital muscular dystrophy|congenital muscular dystrophy
5333495|NCT00313677|childhood onset LGMD|childhood onset lgmd
5333496|NCT00313677|adult onset LGMD|adult onset lgmd
5333497|NCT00313677|POMT1|pomt1
5333498|NCT00313677|POMT2|pomt2
5333499|NCT00313677|POMGnT|pomgnt
5333500|NCT00313677|LARGE|large
5333501|NCT00313677|alpha dystroglycan|alpha dystroglycan
5333502|NCT00313677|dystroglycanopathy|dystroglycanopathy
5333503|NCT00313677|ISPD|ispd
5333504|NCT00313677|DPM|dpm
5333505|NCT00313677|GMPPB|gmppb
5333506|NCT00313677|B3GNT1|b3gnt1
5333507|NCT00313677|B3GALNT2|b3galnt2
5333508|NCT00313677|GTDC2|gtdc2
5333509|NCT00313677|TMEM5|tmem5
5333510|NCT00313677|Fukutin|fukutin
5333511|NCT00313677|DAG1|dag1
5333512|NCT00313677|POMK|pomk
5333513|NCT00313625|stage I multiple myeloma|stage i multiple myeloma
5333514|NCT00313625|stage II multiple myeloma|stage ii multiple myeloma
5333515|NCT00313625|stage III multiple myeloma|stage iii multiple myeloma
5333516|NCT00313625|refractory multiple myeloma|refractory multiple myeloma
5333517|NCT00313599|recurrent breast cancer|recurrent breast cancer
5333518|NCT00313599|stage IV breast cancer|stage iv breast cancer
5333519|NCT00313599|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5333520|NCT00313599|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5333521|NCT00313599|recurrent prostate cancer|recurrent prostate cancer
5333522|NCT00313599|stage IV prostate cancer|stage iv prostate cancer
5333523|NCT00313599|recurrent bladder cancer|recurrent bladder cancer
5333524|NCT00313599|stage IV bladder cancer|stage iv bladder cancer
5333525|NCT00313599|recurrent gastric cancer|recurrent gastric cancer
5333526|NCT00313599|stage IV gastric cancer|stage iv gastric cancer
5333527|NCT00313599|recurrent esophageal cancer|recurrent esophageal cancer
5333528|NCT00313599|stage IV esophageal cancer|stage iv esophageal cancer
5333529|NCT00313599|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
5333530|NCT00313599|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
5333531|NCT00313599|adult central nervous system germ cell tumor|adult central nervous system germ cell tumor
5333532|NCT00313599|ovarian choriocarcinoma|ovarian choriocarcinoma
5333533|NCT00313599|ovarian dysgerminoma|ovarian dysgerminoma
5333534|NCT00313599|ovarian embryonal carcinoma|ovarian embryonal carcinoma
5333535|NCT00313599|ovarian yolk sac tumor|ovarian yolk sac tumor
5333536|NCT00313599|ovarian mixed germ cell tumor|ovarian mixed germ cell tumor
5333537|NCT00313599|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5333538|NCT00313599|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5333539|NCT00313599|recurrent extragonadal non-seminomatous germ cell tumor|recurrent extragonadal non-seminomatous germ cell tumor
5333540|NCT00313599|recurrent extragonadal seminoma|recurrent extragonadal seminoma
5333541|NCT00313599|stage IV extragonadal non-seminomatous germ cell tumor|stage iv extragonadal non-seminomatous germ cell tumor
5333542|NCT00313599|stage IV extragonadal seminoma|stage iv extragonadal seminoma
5333543|NCT00313599|recurrent extragonadal germ cell tumor|recurrent extragonadal germ cell tumor
5333544|NCT00313573|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5333545|NCT00313573|pain|pain
5333546|NCT00313573|depression|depression
5333547|NCT00313560|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
5333548|NCT00313560|stage I pancreatic cancer|stage i pancreatic cancer
5333549|NCT00313560|stage II pancreatic cancer|stage ii pancreatic cancer
5333550|NCT00313547|Blood pressure|blood pressure
5333551|NCT00313547|Hypertension|hypertension
5333552|NCT00313547|Renin|renin
5333553|NCT00313547|Aldosterone|aldosterone
5333554|NCT00313547|Heart rate variability|heart rate variability
5333555|NCT00313534|recurrent prostate cancer|recurrent prostate cancer
5333556|NCT00313534|stage IIB prostate cancer|stage iib prostate cancer
5333557|NCT00313534|stage IIA prostate cancer|stage iia prostate cancer
5333558|NCT00313534|stage III prostate cancer|stage iii prostate cancer
5333559|NCT00313534|stage I prostate cancer|stage i prostate cancer
5333560|NCT00313521|untreated childhood cerebellar astrocytoma|untreated childhood cerebellar astrocytoma
5333561|NCT00313521|childhood high-grade cerebral astrocytoma|childhood high-grade cerebral astrocytoma
5333562|NCT00313508|stage IV melanoma|stage iv melanoma
5333563|NCT00313508|recurrent melanoma|recurrent melanoma
5333564|NCT00313508|ciliary body and choroid melanoma, medium/large size|ciliary body and choroid melanoma, medium/large size
5333565|NCT00313508|recurrent intraocular melanoma|recurrent intraocular melanoma
5333566|NCT00313508|metastatic intraocular melanoma|metastatic intraocular melanoma
5333877|NCT00312260|Gabapentin|gabapentin
5333567|NCT00313508|extraocular extension melanoma|extraocular extension melanoma
5333568|NCT00313508|iris melanoma|iris melanoma
5333569|NCT00313495|Huntington disease, observational, family members, biomarker|huntington disease, observational, family members, biomarker
5333570|NCT00313469|Pharmacokinetics/Pharmacodynamics|pharmacokinetics/pharmacodynamics
5333571|NCT00313469|Elderly|elderly
5333572|NCT00313469|Anticoagulants|anticoagulants
5333573|NCT00313443|Anti-Arrhythmia Agents|anti-arrhythmia agents
5333574|NCT00313443|Amiodarone, chronic treatment|amiodarone, chronic treatment
5333575|NCT00313443|Amiodarone, adverse effects|amiodarone, adverse effects
5333576|NCT00313443|Biopsy, Fine-Needle, Adipose tissue|biopsy, fine-needle, adipose tissue
5333577|NCT00313443|Drug concentrations in tissues|drug concentrations in tissues
5333578|NCT00313443|Drug accumulation in tissues|drug accumulation in tissues
5333579|NCT00313430|Urine concentration ability|urine concentration ability
5333580|NCT00313430|chronic renal insufficiency|chronic renal insufficiency
5333581|NCT00313430|hypertension|hypertension
5333582|NCT00313430|aquaporin2|aquaporin2
5333583|NCT00313430|Patients with chronic renal insufficiency|patients with chronic renal insufficiency
5333584|NCT00313430|Patients with hypertension|patients with hypertension
5333585|NCT00313430|Healthy volunteers|healthy volunteers
5333586|NCT00313417|Creatine|creatine
5333587|NCT00313417|major depressive disorders|major depressive disorders
5333588|NCT00313404|Norovirus|norovirus
5333589|NCT00313404|Gastroenteritis|gastroenteritis
5333590|NCT00313404|Clinical Trial|clinical trial
5333591|NCT00313404|Stomach flu|stomach flu
5333592|NCT00313378|Thoracotomy|thoracotomy
5333593|NCT00313378|Neuropathic pain|neuropathic pain
5333594|NCT00313378|Nerve trauma|nerve trauma
5333595|NCT00313378|Ketamine|ketamine
5333596|NCT00313378|NMDA receptors|nmda receptors
5333597|NCT00313352|adult|adult
5333598|NCT00313352|cardiac|cardiac
5333599|NCT00313352|transposition of great arteries|transposition of great arteries
5333600|NCT00313352|beta-adrenergic blockers|beta-adrenergic blockers
5333601|NCT00313339|myocardial infarction|myocardial infarction
5333602|NCT00313339|bone marrow|bone marrow
5333603|NCT00313339|cd34+|cd34+
5333604|NCT00313339|stem cells|stem cells
5333605|NCT00313326|Adaptive Support ventilation|adaptive support ventilation
5333606|NCT00313326|Weaning|weaning
5333607|NCT00313248|Breast Cancer|breast cancer
5333608|NCT00313248|Metastatic Breast Cancer|metastatic breast cancer
5333609|NCT00313235|Dendritic Vaccine|dendritic vaccine
5333610|NCT00313235|Melanoma|melanoma
5333611|NCT00313235|Cyclophosphamide (CPA)|cyclophosphamide (cpa)
5333612|NCT00313222|CTEPH|cteph
5333613|NCT00313222|bosentan|bosentan
5333614|NCT00313209|Roflumilast|roflumilast
5333615|NCT00313209|Salmeterol|salmeterol
5333616|NCT00313209|COPD|copd
5333617|NCT00313209|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
5333618|NCT00313196|Pulmonary Hypertension|pulmonary hypertension
5333619|NCT00313196|Sickle Cell Disease|sickle cell disease
5333620|NCT00313196|Sickle cell anemia|sickle cell anemia
5333621|NCT00313196|bosentan|bosentan
5333622|NCT00313196|ASSET|asset
5333623|NCT00313196|ASSET-2|asset-2
5333624|NCT00313183|Type 1 Diabetes|type 1 diabetes
5333625|NCT00313183|pediatric|pediatric
5333626|NCT00313183|pramlintide|pramlintide
5333627|NCT00313183|Symlin|symlin
5333628|NCT00313183|Amylin|amylin
5333629|NCT00313170|oncology|oncology
5333630|NCT00313170|cancer|cancer
5333631|NCT00313170|breast cancer|breast cancer
5333632|NCT00313157|Atrial fibrillation|atrial fibrillation
5333633|NCT00313131|bacterial vaginosis|bacterial vaginosis
5333634|NCT00313131|vaginal candidiasis|vaginal candidiasis
5333635|NCT00313131|trichomoniasis|trichomoniasis
5333636|NCT00313131|vaginitis|vaginitis
5333637|NCT00313131|Ghana|ghana
5333638|NCT00313131|Togo|togo
5333639|NCT00313131|Mali|mali
5333640|NCT00313131|Guinea|guinea
5333641|NCT00313118|oxidative stress parameters|oxidative stress parameters
5333642|NCT00313105|smoking cessation|smoking cessation
5333643|NCT00313105|smokeless tobacco|smokeless tobacco
5333644|NCT00313105|nicotine patch|nicotine patch
5333645|NCT00313105|nicotine buccal tablets|nicotine buccal tablets
5333646|NCT00313105|retreatment|retreatment
5333647|NCT00313105|adherence|adherence
5333648|NCT00313092|OSAS|osas
5333649|NCT00313092|glaucoma|glaucoma
5333650|NCT00313092|MMP|mmp
5333651|NCT00313066|CTGF|ctgf
5333652|NCT00313066|fibrogenic cytokine|fibrogenic cytokine
5333653|NCT00313066|FGF|fgf
5333654|NCT00313066|pleural fibrosis|pleural fibrosis
5333655|NCT00313040|physical activity|physical activity
5333656|NCT00313040|sedentary|sedentary
5333657|NCT00313040|behavioral medicine|behavioral medicine
5333658|NCT00313040|motivational interviewing|motivational interviewing
5333659|NCT00313014|Low back pain|low back pain
5333660|NCT00313014|opioid|opioid
5333661|NCT00313014|transdermal|transdermal
5333662|NCT00313014|Butrans|butrans
5333663|NCT00312988|Ovarian cancer|ovarian cancer
5333664|NCT00312962|Schizoaffective Disorder|schizoaffective disorder
5333665|NCT00312962|Cognitive Remediation|cognitive remediation
5333666|NCT00312962|fMRI|fmri
5333667|NCT00312949|Patient participation|patient participation
5333668|NCT00312949|Patient education|patient education
5333669|NCT00312949|Consumer involvement|consumer involvement
5333670|NCT00312936|Medication adherence|medication adherence
5333671|NCT00312936|Medication compliance|medication compliance
5333672|NCT00312936|Quality of Life|quality of life
5333673|NCT00312936|Stress reduction|stress reduction
5333674|NCT00312936|mindfulness based stress reduction|mindfulness based stress reduction
5333675|NCT00312936|HIV/AIDS|hiv/aids
5333676|NCT00312936|treatment experienced|treatment experienced
5333677|NCT00312923|HIV|hiv
5333678|NCT00312923|lipids|lipids
5333679|NCT00312923|dyslipidemia|dyslipidemia
5333680|NCT00312923|policosanol|policosanol
5333681|NCT00312923|treatment experienced|treatment experienced
5333682|NCT00312910|Cirrhosis|cirrhosis
5333683|NCT00312910|Probiotics|probiotics
5333684|NCT00312910|Hepatic encephalopathy|hepatic encephalopathy
5333685|NCT00312910|Ammonia|ammonia
5333686|NCT00312897|Adolescents|adolescents
5333687|NCT00312897|Depression|depression
5333688|NCT00312897|Fish Oil|fish oil
5333689|NCT00312897|Omega-3 Fatty Acids|omega-3 fatty acids
5333690|NCT00312897|Psychiatry|psychiatry
5333691|NCT00312884|telemonitoring|telemonitoring
5333692|NCT00312884|heart failure|heart failure
5333693|NCT00312884|randomised|randomised
5333694|NCT00312884|hospitalisation|hospitalisation
5333695|NCT00312884|HomMed|hommed
5333696|NCT00312871|Chronic renal failure|chronic renal failure
5333697|NCT00312871|Anemia|anemia
5333698|NCT00312871|Renal replacement therapy|renal replacement therapy
5333699|NCT00312871|Epoetin|epoetin
5333700|NCT00312871|Epoetin alfa|epoetin alfa
5333701|NCT00312871|erythropoietin|erythropoietin
5333702|NCT00312871|Chronic kidney failure|chronic kidney failure
5333703|NCT00312871|end-stage renal disease|end-stage renal disease
5333704|NCT00312858|Hepatitis A Virus|hepatitis a virus
5333705|NCT00312845|B-cell Non-Hodgkin's Lymphoma|b-cell non-hodgkin's lymphoma
5333706|NCT00312832|HIV|hiv
5333707|NCT00312832|d4T|d4t
5333708|NCT00312832|TDF|tdf
5333709|NCT00312832|lipoatrophy|lipoatrophy
5333710|NCT00312832|treatment experienced|treatment experienced
5333711|NCT00312832|HIV-infection|hiv-infection
5333712|NCT00312819|Non-small cel lung cancer|non-small cel lung cancer
5333713|NCT00312819|chemotherapy|chemotherapy
5333714|NCT00312819|randomized phaseII|randomized phaseii
5333715|NCT00312819|disulfiram|disulfiram
5333716|NCT00312819|antiangiogenesis|antiangiogenesis
5333717|NCT00312819|placebo|placebo
5333718|NCT00312806|Gastroesophageal Reflux Disease|gastroesophageal reflux disease
5333719|NCT00312806|GERD|gerd
5333720|NCT00312806|Pantoprazole|pantoprazole
5333721|NCT00312806|ReQuestTM|requesttm
5333722|NCT00312793|Anterior Cruciate Ligament reconstruction surgery|anterior cruciate ligament reconstruction surgery
5333723|NCT00312780|albuminuria|albuminuria
5333724|NCT00312780|diabetic nephropathy|diabetic nephropathy
5333725|NCT00312780|diabetes|diabetes
5333726|NCT00312767|Agalsidase beta|agalsidase beta
5333727|NCT00312767|alpha Galactosidase A|alpha galactosidase a
5333728|NCT00312767|aGAL|agal
5333729|NCT00312767|rh aGAL|rh agal
5333730|NCT00312767|Fabry|fabry
5333731|NCT00312767|GL3|gl3
5333732|NCT00312767|Fabrazyme|fabrazyme
5333733|NCT00312767|dialysis|dialysis
5333734|NCT00312767|hemodialysis|hemodialysis
5333735|NCT00312741|community-acquired pneumonia|community-acquired pneumonia
5333736|NCT00312741|microbiological tests|microbiological tests
5333737|NCT00312741|urinary antigen|urinary antigen
5333738|NCT00312741|selection of antibiotic treatment|selection of antibiotic treatment
5333739|NCT00312728|Brain Cancer|brain cancer
5333740|NCT00312728|Brain Metastases|brain metastases
5333741|NCT00312728|Avastin|avastin
5333742|NCT00312728|NSCLC|nsclc
5333743|NCT00312728|Lung Cancer|lung cancer
5333744|NCT00312728|PASSPORT|passport
5333745|NCT00312715|Deiodinase|deiodinase
5333746|NCT00312715|Levothyroxine|levothyroxine
5333747|NCT00312715|Liothyronine|liothyronine
5333748|NCT00312715|Lipid Metabolism|lipid metabolism
5333749|NCT00312715|Healthy Volunteer|healthy volunteer
5333750|NCT00312715|HV|hv
5333751|NCT00312702|Vaccine|vaccine
5333752|NCT00312702|Malaria|malaria
5333753|NCT00312702|Liver Stage Antigen-1|liver stage antigen-1
5333754|NCT00312702|Falciparum Malaria Protein-11|falciparum malaria protein-11
5333755|NCT00312702|AS02A|as02a
5333756|NCT00312702|adjuvant|adjuvant
5333757|NCT00312689|congenital|congenital
5333758|NCT00312689|lacrimal|lacrimal
5333759|NCT00312689|stenosis|stenosis
5333760|NCT00312689|bacteria|bacteria
5333761|NCT00312689|microbiological|microbiological
5333762|NCT00312676|Tolerability|tolerability
5333763|NCT00312676|Depakote DR|depakote dr
5333764|NCT00312676|Depakote ER|depakote er
5333765|NCT00312676|Elderly|elderly
5333766|NCT00312676|Conversion|conversion
5333767|NCT00312663|Vaccine|vaccine
5333768|NCT00312663|Phase I/II|phase i/ii
5333769|NCT00312663|Malaria|malaria
5333770|NCT00312663|Liver Stage Antigen -1|liver stage antigen -1
5333771|NCT00312663|Falciparum Malaria Protein -11|falciparum malaria protein -11
5333772|NCT00312663|AS01B|as01b
5333773|NCT00312663|adjuvant|adjuvant
5333774|NCT00312650|ovarian cancer|ovarian cancer
5333775|NCT00312650|recurrent|recurrent
5333777|NCT00312637|Breast Cancer Staging|breast cancer staging
5333778|NCT00312624|ICD implantation|icd implantation
5333779|NCT00312624|cardiac MRI|cardiac mri
5333780|NCT00312624|cardiomyopathy|cardiomyopathy
5333781|NCT00312624|ventricular arrhythmias|ventricular arrhythmias
5333782|NCT00312624|LVEF 35% or less|lvef 35% or less
5333783|NCT00312624|indication for ICD implantation as part of standard of care|indication for icd implantation as part of standard of care
5333784|NCT00312611|Gastric pacing device|gastric pacing device
5333785|NCT00312611|Obesity|obesity
5333786|NCT00312598|schizophrenia|schizophrenia
5333787|NCT00312598|BMI|bmi
5333788|NCT00312598|weight|weight
5333789|NCT00312598|aripiprazole|aripiprazole
5333790|NCT00312598|antipsychotic|antipsychotic
5333791|NCT00312598|Mood Disorders with psychotic features|mood disorders with psychotic features
5333792|NCT00312585|pregnancy|pregnancy
5333793|NCT00312585|acupuncture|acupuncture
5333794|NCT00312572|Osteoarthritis, opioid, transdermal|osteoarthritis, opioid, transdermal
5333795|NCT00312559|Parkinson's Disease|parkinson's disease
5333796|NCT00312546|Virus Latency|virus latency
5333797|NCT00312546|Valproic Acid|valproic acid
5333798|NCT00312546|Histone Deacetylase|histone deacetylase
5333799|NCT00312533|knee|knee
5333800|NCT00312533|injection|injection
5333801|NCT00312533|function|function
5333802|NCT00312533|osteoarthritis|osteoarthritis
5333803|NCT00312507|Meconium Aspiration Syndrome|meconium aspiration syndrome
5333804|NCT00312507|Surfactant|surfactant
5333805|NCT00312507|Bronchoalveolar Lavage|bronchoalveolar lavage
5333806|NCT00312507|newborns|newborns
5333807|NCT00312468|AIDS|aids
5333808|NCT00312455|Substance abuse|substance abuse
5333809|NCT00312455|Depression|depression
5333810|NCT00312455|Aggression|aggression
5333811|NCT00312442|Prostate cancer after radiation therapy|prostate cancer after radiation therapy
5333812|NCT00312429|Hematological Malignancies|hematological malignancies
5333813|NCT00312429|Leukemia|leukemia
5333814|NCT00312429|Lymphoma|lymphoma
5333815|NCT00312429|Myelodysplasia|myelodysplasia
5333816|NCT00312429|Multiple Myeloma|multiple myeloma
5333817|NCT00312416|Choroidal blood flow|choroidal blood flow
5333818|NCT00312416|Clonidin|clonidin
5333819|NCT00312416|Brimonidin|brimonidin
5333820|NCT00312403|Glaucoma|glaucoma
5333821|NCT00312403|Gene Polymorphism|gene polymorphism
5333822|NCT00312403|Metalloproteinase|metalloproteinase
5333823|NCT00312390|Amblyopia|amblyopia
5333824|NCT00312390|Retinal vessel diameters|retinal vessel diameters
5333825|NCT00312390|Retinal blood flow|retinal blood flow
5333826|NCT00312390|Flicker|flicker
5333827|NCT00312377|Non-small cell lung cancer|non-small cell lung cancer
5333828|NCT00312377|NSCLC|nsclc
5333829|NCT00312364|toe ulcer|toe ulcer
5333830|NCT00312364|heel ulcer|heel ulcer
5333831|NCT00312364|foot ulcer|foot ulcer
5333832|NCT00312364|diabetic feet|diabetic feet
5333833|NCT00312364|diabetic foot|diabetic foot
5333834|NCT00312364|complications of diabetes|complications of diabetes
5333835|NCT00312351|AMD|amd
5333836|NCT00312351|Age-Related Macular Degeneration|age-related macular degeneration
5333837|NCT00312351|Macular Degeneration|macular degeneration
5333838|NCT00312351|Macugen|macugen
5333839|NCT00312351|pegaptanib sodium|pegaptanib sodium
5333840|NCT00312351|ERG|erg
5333841|NCT00312351|specular microscopy|specular microscopy
5333842|NCT00312351|Age-Related Mcular Degeneration (AMD)|age-related mcular degeneration (amd)
5333843|NCT00312325|Optic nerve head blood flow|optic nerve head blood flow
5333844|NCT00312325|Choroidal blood flow|choroidal blood flow
5333845|NCT00312325|Prednisolone|prednisolone
5333846|NCT00312325|Graves´ Ophthalmopathy|graves´ ophthalmopathy
5333847|NCT00312325|optic neuritis|optic neuritis
5333848|NCT00312312|Asthma|asthma
5333849|NCT00312312|Allergic rhinitis|allergic rhinitis
5333850|NCT00312312|Atopy|atopy
5333851|NCT00312312|Exhaled nitric oxide|exhaled nitric oxide
5333852|NCT00312312|Specific immunotherapy|specific immunotherapy
5333853|NCT00312312|Atopic diseases|atopic diseases
5333854|NCT00312299|Double-Blind Method|double-blind method
5333855|NCT00312299|Clinical Trials, Randomized|clinical trials, randomized
5333856|NCT00312299|Lenses, Intraocular|lenses, intraocular
5333857|NCT00312299|Prospective Studies|prospective studies
5333858|NCT00312299|PMMA|pmma
5333859|NCT00312299|Visual acuity|visual acuity
5333860|NCT00312286|Cervical Neoplasms|cervical neoplasms
5333861|NCT00312286|Drug Therapy|drug therapy
5333862|NCT00312286|Human Papillomavirus|human papillomavirus
5333863|NCT00312286|Cervical Human Papillomavirus|cervical human papillomavirus
5333864|NCT00312286|Cervical Dysplasia|cervical dysplasia
5333865|NCT00312286|Chemoprevention|chemoprevention
5333866|NCT00312286|High Risk Cervical Human Papillomavirus|high risk cervical human papillomavirus
5333867|NCT00312286|Atypical Squamous Cells of Undetermined Significance|atypical squamous cells of undetermined significance
5333868|NCT00312286|Low Grade Intraepithelial Lesions|low grade intraepithelial lesions
5333869|NCT00312273|Heart Arrest|heart arrest
5333870|NCT00312273|Cardiopulmonary Resuscitation|cardiopulmonary resuscitation
5333871|NCT00312273|Aminophylline|aminophylline
5333872|NCT00312273|Bradycardia|bradycardia
5333873|NCT00312273|Humans|humans
5333874|NCT00312273|Emergency Medical Services|emergency medical services
5333875|NCT00312260|Pain|pain
5333878|NCT00312260|Amitriptyline|amitriptyline
5333879|NCT00312260|Pediatrics|pediatrics
5333880|NCT00312247|Walking|walking
5333881|NCT00312247|Muscle Strength|muscle strength
5333882|NCT00312247|Energy Cost|energy cost
5333883|NCT00312247|Quality of Life|quality of life
5333884|NCT00312234|Muscular Disease|muscular disease
5333885|NCT00312234|Fibromyalgia|fibromyalgia
5333886|NCT00312234|Exercise Therapy|exercise therapy
5333887|NCT00312234|Qigong|qigong
5333888|NCT00312234|Aerobic Exercise|aerobic exercise
5333889|NCT00312234|pediatrics|pediatrics
5333890|NCT00312221|Osteoarthritis, opioid, transdermal|osteoarthritis, opioid, transdermal
5333891|NCT00312195|Chronic pain|chronic pain
5333892|NCT00312195|opioid|opioid
5333893|NCT00312195|transdermal|transdermal
5333894|NCT00312195|Butrans™ [BTDS]|butrans™ [btds]
5333895|NCT00312169|HIV|hiv
5333896|NCT00312169|NNRTI|nnrti
5333897|NCT00312169|Incomplete virologic suppression|incomplete virologic suppression
5333898|NCT00312169|treatment experienced|treatment experienced
5333899|NCT00312143|De novo Kidney Transplant recipients, enteric-coated mycophenolate sodium|de novo kidney transplant recipients, enteric-coated mycophenolate sodium
5333900|NCT00312130|Vildaglptin|vildaglptin
5333901|NCT00312130|Pre-diabetes|pre-diabetes
5333902|NCT00312117|contrast induced nephropathy|contrast induced nephropathy
5333903|NCT00312117|sodium bicarbonate|sodium bicarbonate
5333904|NCT00312117|cardiac catheterization|cardiac catheterization
5333905|NCT00312091|Pharmacokinetics|pharmacokinetics
5333906|NCT00312091|Treatment Experienced|treatment experienced
5333907|NCT00312078|Minimal Hepatic Encephalopathy|minimal hepatic encephalopathy
5333908|NCT00312078|Cirrhosis|cirrhosis
5333909|NCT00312065|servocontrolled|servocontrolled
5333910|NCT00312065|radiant warmer|radiant warmer
5333911|NCT00312065|thermistor|thermistor
5333912|NCT00312065|heat shield|heat shield
5333913|NCT00312052|Coronary Artery Disease|coronary artery disease
5333914|NCT00312039|HIV-1|hiv-1
5333915|NCT00312039|treatment experienced|treatment experienced
5333916|NCT00312026|Plaque Psoriasis|plaque psoriasis
5333917|NCT00312026|Hands|hands
5333918|NCT00312026|Feet|feet
5333919|NCT00312026|Hand|hand
5333920|NCT00312013|low molecular weight heparin|low molecular weight heparin
5333921|NCT00312013|nadroparin|nadroparin
5333922|NCT00312013|non-small cell lung cancer|non-small cell lung cancer
5333923|NCT00312013|cancer survival|cancer survival
5333924|NCT00312013|prostate cancer|prostate cancer
5333925|NCT00312013|pancreatic cancer|pancreatic cancer
5333926|NCT00312000|colorectal|colorectal
5333927|NCT00312000|cancer|cancer
5333928|NCT00312000|capecitabine|capecitabine
5333929|NCT00312000|irinotecan|irinotecan
5333930|NCT00312000|oxaliplatin|oxaliplatin
5333931|NCT00311987|Hypercholesterolemia|hypercholesterolemia
5333932|NCT00311987|Thyroid hormone|thyroid hormone
5333933|NCT00311987|Diiodothyropropionic acid|diiodothyropropionic acid
5333934|NCT00311987|Therapy|therapy
5333935|NCT00311974|Dihydralazine|dihydralazine
5333936|NCT00311974|Sympathetic activation|sympathetic activation
5333937|NCT00311974|Fractional sodium excretion|fractional sodium excretion
5333938|NCT00311961|COPD|copd
5333939|NCT00311961|Exacerbations|exacerbations
5333940|NCT00311961|Corticosteroids|corticosteroids
5333941|NCT00311961|Oral|oral
5333942|NCT00311961|Intravenous|intravenous
5333943|NCT00311961|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
5333944|NCT00311948|Teen smokers|teen smokers
5333945|NCT00311948|Quithelper|quithelper
5333946|NCT00311948|Tobacco|tobacco
5333947|NCT00311948|Tobacco Website|tobacco website
5333948|NCT00311948|Website Intervention|website intervention
5333949|NCT00311948|Tobacco counseling|tobacco counseling
5333950|NCT00311948|Tobacco abstinence|tobacco abstinence
5333951|NCT00311935|Hernia|hernia
5333952|NCT00311935|Inguinal|inguinal
5333953|NCT00311935|Groin|groin
5333954|NCT00311935|Laparoscopic|laparoscopic
5333955|NCT00311935|Open|open
5333956|NCT00311935|Abdominal wall|abdominal wall
5333957|NCT00311922|Diabetes|diabetes
5333958|NCT00311922|Education|education
5333959|NCT00311922|Health Literacy|health literacy
5333960|NCT00311909|Tourette Syndrome|tourette syndrome
5333961|NCT00311909|Deep Brain Stimulation|deep brain stimulation
5333962|NCT00311909|Video assessment|video assessment
5333963|NCT00311909|YGTSS|ygtss
5333964|NCT00311909|TSSL|tssl
5333965|NCT00311896|Cancer|cancer
5333966|NCT00311896|Thrombosis|thrombosis
5333967|NCT00311896|Catheter|catheter
5333968|NCT00311896|Bemiparin|bemiparin
5333969|NCT00311896|Prophylaxis|prophylaxis
5333970|NCT00311883|Cystic Fibrosis|cystic fibrosis
5333971|NCT00311883|Induced sputum|induced sputum
5333972|NCT00311883|Lung inflammation|lung inflammation
5333973|NCT00311857|Cetuximab|cetuximab
5333974|NCT00311831|Pediatrics|pediatrics
5333975|NCT00311831|Gastroenteritis|gastroenteritis
5333976|NCT00311831|Education|education
5333977|NCT00311792|training|training
5333978|NCT00311792|teaching|teaching
5333979|NCT00311792|curriculum|curriculum
5333980|NCT00311779|Pediculosis capitis|pediculosis capitis
5333981|NCT00311779|Head Lice|head lice
5333982|NCT00311779|Crawlers|crawlers
5333984|NCT00311766|Epidermolysis Bullosa|epidermolysis bullosa
5333985|NCT00311766|cutaneous wound-healing|cutaneous wound-healing
5333986|NCT00311766|chronic wound-healing|chronic wound-healing
5333987|NCT00311766|Thymosin Beta 4|thymosin beta 4
5333988|NCT00311766|laminin-5|laminin-5
5333989|NCT00311753|heparin, thromboprophylaxis, medical patients, acutely ill|heparin, thromboprophylaxis, medical patients, acutely ill
5333990|NCT00311753|Acutely ill non surgical patients|acutely ill non surgical patients
5333991|NCT00311753|Immobilization|immobilization
5333992|NCT00311740|Hypertension,|hypertension,
5333993|NCT00311740|Valsartan,|valsartan,
5333994|NCT00311740|Hydrochlorothiazide|hydrochlorothiazide
5333995|NCT00311727|Cell-Mediated Immune Responses, Influenza, A/H5N1, Vaccine, sub-study|cell-mediated immune responses, influenza, a/h5n1, vaccine, sub-study
5333996|NCT00311714|Influenza, United Kingdom|influenza, united kingdom
5333997|NCT00311701|Influenza, pediatric|influenza, pediatric
5333998|NCT00311688|IL-2|il-2
5333999|NCT00311688|Immunomodulatory Therapies|immunomodulatory therapies
5334000|NCT00311675|influenza, A/H5N1, vaccine|influenza, a/h5n1, vaccine
5334001|NCT00311649|H5N1, Influenza|h5n1, influenza
5334002|NCT00311636|stage I breast cancer|stage i breast cancer
5334003|NCT00311636|stage II breast cancer|stage ii breast cancer
5334004|NCT00311636|stage IIIA breast cancer|stage iiia breast cancer
5334005|NCT00311636|stage IIIB breast cancer|stage iiib breast cancer
5334006|NCT00311636|stage IIIC breast cancer|stage iiic breast cancer
5334007|NCT00311623|stage III prostate cancer|stage iii prostate cancer
5334008|NCT00311623|stage I prostate cancer|stage i prostate cancer
5334009|NCT00311623|stage IIB prostate cancer|stage iib prostate cancer
5334010|NCT00311623|stage IIA prostate cancer|stage iia prostate cancer
5334011|NCT00311623|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5334012|NCT00311610|recurrent colon cancer|recurrent colon cancer
5334013|NCT00311610|stage IV colon cancer|stage iv colon cancer
5334014|NCT00311610|recurrent rectal cancer|recurrent rectal cancer
5334015|NCT00311610|stage IV rectal cancer|stage iv rectal cancer
5334016|NCT00311597|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5334017|NCT00311584|recurrent neuroblastoma|recurrent neuroblastoma
5334018|NCT00311571|bedrest|bedrest
5334019|NCT00311571|spaceflight|spaceflight
5334020|NCT00311571|Weightlessness|weightlessness
5334021|NCT00311571|Countermeasure|countermeasure
5334022|NCT00311558|stage IV melanoma|stage iv melanoma
5334023|NCT00311558|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
5334024|NCT00311558|recurrent melanoma|recurrent melanoma
5334025|NCT00311545|recurrent renal cell cancer|recurrent renal cell cancer
5334026|NCT00311545|stage IV renal cell cancer|stage iv renal cell cancer
5334027|NCT00311545|stage III renal cell cancer|stage iii renal cell cancer
5334028|NCT00311519|Subcutaneous hydration|subcutaneous hydration
5334029|NCT00311519|Hylenex|hylenex
5334030|NCT00311519|Hyaluronidase|hyaluronidase
5334031|NCT00311506|Pulmozyme|pulmozyme
5334032|NCT00311493|TBE|tbe
5334033|NCT00311493|vaccine|vaccine
5334034|NCT00311493|adults|adults
5334035|NCT00311480|influenza|influenza
5334036|NCT00311480|pandemic influenza|pandemic influenza
5334037|NCT00311480|influenza vaccine|influenza vaccine
5334038|NCT00311480|adjuvanted influenza vaccine|adjuvanted influenza vaccine
5334039|NCT00311467|renal cell cancer|renal cell cancer
5334040|NCT00311441|TBE, children, vaccine|tbe, children, vaccine
5334041|NCT00311428|Influenza|influenza
5334042|NCT00311428|Children|children
5334043|NCT00311428|Vaccine|vaccine
5334044|NCT00311415|Prevention of Meningococcal Meningitis|prevention of meningococcal meningitis
5334045|NCT00311415|meningococcal vaccines|meningococcal vaccines
5334046|NCT00311415|conjugate|conjugate
5334047|NCT00311415|immunology|immunology
5334048|NCT00311415|infant|infant
5334049|NCT00311415|antibody persistence|antibody persistence
5334050|NCT00311389|Glaucoma|glaucoma
5334051|NCT00311389|POAG|poag
5334052|NCT00311389|OAG|oag
5334053|NCT00311389|OHT|oht
5334054|NCT00311350|Safety|safety
5334055|NCT00311350|Health|health
5334056|NCT00311350|Pharmacokinetics|pharmacokinetics
5334057|NCT00311350|ileus|ileus
5334058|NCT00311337|VELCADE|velcade
5334059|NCT00311337|bortezomib|bortezomib
5334060|NCT00311337|maintenance treatment|maintenance treatment
5334061|NCT00311337|multiple myeloma|multiple myeloma
5334062|NCT00311337|primary disease|primary disease
5334063|NCT00311324|behavioral intervention|behavioral intervention
5334064|NCT00311311|Kidney transplant|kidney transplant
5334065|NCT00311311|Renal transplant|renal transplant
5334066|NCT00311311|Immunosuppression|immunosuppression
5334067|NCT00311311|Atherosclerosis|atherosclerosis
5334068|NCT00311311|Graft Rejection|graft rejection
5334069|NCT00311298|tuberculosis|tuberculosis
5334070|NCT00311298|hiv|hiv
5334071|NCT00311298|diabetes|diabetes
5334072|NCT00311298|protein-energy|protein-energy
5334073|NCT00311298|micronutrients|micronutrients
5334074|NCT00311285|Electromyography|electromyography
5334075|NCT00311285|Glucocorticoids|glucocorticoids
5334076|NCT00311285|Heart Rate|heart rate
5334077|NCT00311285|Physical workload|physical workload
5334078|NCT00311285|Mental workload|mental workload
5334079|NCT00311285|Ergonomics|ergonomics
5334080|NCT00311285|Laparoscopy|laparoscopy
5334081|NCT00311285|Workload|workload
5334082|NCT00311285|Biomechanics|biomechanics
5334083|NCT00311272|dendritic cells|dendritic cells
5334084|NCT00311272|antigens, neoplasm|antigens, neoplasm
5334085|NCT00311246|Sarcoidosis|sarcoidosis
5334086|NCT00311246|Humira|humira
5334087|NCT00311246|Adalimumab|adalimumab
5334088|NCT00311246|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors
5334089|NCT00311233|child|child
5334090|NCT00311233|psychosocial|psychosocial
5334091|NCT00311233|predictors|predictors
5334092|NCT00311233|cohort|cohort
5334093|NCT00311233|recurrent|recurrent
5334094|NCT00311220|tuberculosis|tuberculosis
5334095|NCT00311220|latent tuberculosis|latent tuberculosis
5334096|NCT00311220|tuberculin skin test|tuberculin skin test
5334097|NCT00311220|quantiferon TB-RD1|quantiferon tb-rd1
5334098|NCT00311220|contact screening|contact screening
5334099|NCT00311220|elderly|elderly
5334100|NCT00311207|diagnostic kit|diagnostic kit
5334101|NCT00311207|immunochromatography test|immunochromatography test
5334102|NCT00311207|PCR detection kit|pcr detection kit
5334103|NCT00311207|luminex|luminex
5334104|NCT00311194|Heart failure|heart failure
5334105|NCT00311194|Education|education
5334106|NCT00311194|CD-ROM|cd-rom
5334107|NCT00311194|Randomization|randomization
5334108|NCT00311194|Hospitalization|hospitalization
5334109|NCT00311194|Readmission|readmission
5334110|NCT00311194|Death|death
5334111|NCT00311194|Knowledge|knowledge
5334112|NCT00311181|ICD|icd
5334113|NCT00311181|Defibrillation|defibrillation
5334114|NCT00311181|ULV|ulv
5334115|NCT00311181|Tuned|tuned
5334116|NCT00311155|Olmesartan medoxomil|olmesartan medoxomil
5334117|NCT00311155|Hypertension|hypertension
5334118|NCT00311142|Sleep pattern|sleep pattern
5334119|NCT00311142|newborn|newborn
5334120|NCT00311142|actigraphy|actigraphy
5334121|NCT00311142|delivery mode|delivery mode
5334122|NCT00311142|Parents' approval|parents' approval
5334123|NCT00311116|Vitamin E|vitamin e
5334124|NCT00311116|Cancer|cancer
5334125|NCT00311116|pediatrics|pediatrics
5334126|NCT00311116|supportive care|supportive care
5334127|NCT00311116|oral mucositis|oral mucositis
5334128|NCT00311116|Bayesian analysis|bayesian analysis
5334129|NCT00311116|N-of-1 trial|n-of-1 trial
5334130|NCT00311116|prophylaxis|prophylaxis
5334131|NCT00311103|Elderly|elderly
5334132|NCT00311103|Disability|disability
5334133|NCT00311103|Musculoskeletal diseases|musculoskeletal diseases
5334134|NCT00311090|Deep Venous Thrombosis|deep venous thrombosis
5334135|NCT00311051|Asthma|asthma
5334136|NCT00311051|Allergens|allergens
5334137|NCT00311051|house dust mites|house dust mites
5334138|NCT00311051|Ramatroban|ramatroban
5334139|NCT00311051|Montelukast|montelukast
5334140|NCT00311051|Bronchial Provocation Tests|bronchial provocation tests
5334141|NCT00311038|ONO-1101|ono-1101
5334142|NCT00311038|Landiolol Hydrochloride|landiolol hydrochloride
5334143|NCT00311038|Multi-slice CT|multi-slice ct
5334144|NCT00311038|Coronary Artery Disease|coronary artery disease
5334145|NCT00311025|stroke|stroke
5334146|NCT00311025|physical therapy|physical therapy
5334147|NCT00311025|rehabilitation|rehabilitation
5334148|NCT00311025|exercise|exercise
5334149|NCT00311025|longterm follow-up|longterm follow-up
5334150|NCT00311012|Hypertension, Aliskiren|hypertension, aliskiren
5334151|NCT00310999|Cervical Vertebrae|cervical vertebrae
5334152|NCT00310999|Intubation, Intratracheal|intubation, intratracheal
5334153|NCT00310999|Laryngoscopes|laryngoscopes
5334154|NCT00310999|Fluoroscopy|fluoroscopy
5334155|NCT00310986|Attention Deficit Disorder with Hyperactivity|attention deficit disorder with hyperactivity
5334156|NCT00310986|meditation|meditation
5334157|NCT00310986|breathing meditation|breathing meditation
5334158|NCT00310986|Anapanasathi|anapanasathi
5334159|NCT00310986|randomized controlled trial|randomized controlled trial
5334160|NCT00310986|nonpharmacologic treatment|nonpharmacologic treatment
5334287|NCT00310440|Cervical discectomy|cervical discectomy
5334161|NCT00310986|complementary and alternative medicine|complementary and alternative medicine
5334162|NCT00310973|HIV|hiv
5334163|NCT00310973|Prevention|prevention
5334164|NCT00310973|Risk Behavior Reduction|risk behavior reduction
5334165|NCT00310973|Roma|roma
5334166|NCT00310973|Bulgaria|bulgaria
5334167|NCT00310973|HIV seronegativity|hiv seronegativity
5334168|NCT00310960|infantile esotropia|infantile esotropia
5334169|NCT00310960|acquired non-accommodative esotropia|acquired non-accommodative esotropia
5334170|NCT00310960|acquired partially accommodative esotropia|acquired partially accommodative esotropia
5334171|NCT00310947|Coronary artery disease|coronary artery disease
5334172|NCT00310947|Coronary flow reserve|coronary flow reserve
5334173|NCT00310947|Heart failure|heart failure
5334174|NCT00310947|prospective randomised|prospective randomised
5334175|NCT00310934|heroin dependence|heroin dependence
5334176|NCT00310934|methadone|methadone
5334177|NCT00310934|buprenorphine|buprenorphine
5334178|NCT00310934|contingency management|contingency management
5334179|NCT00310934|relapse prevention|relapse prevention
5334180|NCT00310908|Renal|renal
5334181|NCT00310908|Colic|colic
5334182|NCT00310908|Calculi|calculi
5334183|NCT00310908|Treatment|treatment
5334184|NCT00310895|Refractory|refractory
5334185|NCT00310895|Relapsed|relapsed
5334186|NCT00310882|breast cancer|breast cancer
5334187|NCT00310882|digitalis like compounds|digitalis like compounds
5334188|NCT00310882|prognostic factor|prognostic factor
5334189|NCT00310869|Preterm Birth|preterm birth
5334190|NCT00310869|Prematurity|prematurity
5334191|NCT00310869|NIDCAP|nidcap
5334192|NCT00310869|Adolescence|adolescence
5334193|NCT00310869|Developmental Care|developmental care
5334194|NCT00310869|Follow-up|follow-up
5334195|NCT00310869|Neurobehavior|neurobehavior
5334196|NCT00310856|meningitis|meningitis
5334197|NCT00310856|children|children
5334198|NCT00310856|vaccine|vaccine
5334199|NCT00310830|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
5334200|NCT00310830|Pulmonary hypertension|pulmonary hypertension
5334201|NCT00310830|Sickle Cell Disease|sickle cell disease
5334202|NCT00310830|Sickle cell anemia|sickle cell anemia
5334203|NCT00310830|ASSET|asset
5334204|NCT00310830|ASSET-1|asset-1
5334205|NCT00310817|meningitis|meningitis
5334206|NCT00310817|children|children
5334207|NCT00310817|vaccine|vaccine
5334208|NCT00310804|Influenza|influenza
5334209|NCT00310804|Flu|flu
5334210|NCT00310804|Cell-Derived|cell-derived
5334211|NCT00310804|Egg-Derived|egg-derived
5334212|NCT00310804|Healthy Adults|healthy adults
5334213|NCT00310804|Safety|safety
5334214|NCT00310804|Immunogenicity|immunogenicity
5334215|NCT00310804|Vaccination|vaccination
5334216|NCT00310791|anorexia nervosa|anorexia nervosa
5334217|NCT00310791|adolescents|adolescents
5334218|NCT00310791|dual-energy x-ray absorptiometry|dual-energy x-ray absorptiometry
5334219|NCT00310791|dehydroepiandrosterone (DHEA)|dehydroepiandrosterone (dhea)
5334220|NCT00310791|osteoporosis|osteoporosis
5334221|NCT00310778|High sodium diet|high sodium diet
5334222|NCT00310778|Low sodium diet|low sodium diet
5334223|NCT00310778|Renin-angiotensin system blockers|renin-angiotensin system blockers
5334224|NCT00310778|AT1 receptor (AT1R) antagonist|at1 receptor (at1r) antagonist
5334225|NCT00310778|ACE inhibition|ace inhibition
5334226|NCT00310765|abdominal pain|abdominal pain
5334227|NCT00310765|surgical adhesions|surgical adhesions
5334228|NCT00310726|Mother to Child Transmission of HIV|mother to child transmission of hiv
5334229|NCT00310726|Postnatal HIV transmission|postnatal hiv transmission
5334230|NCT00310726|HIV|hiv
5334231|NCT00310726|Breastfeeding|breastfeeding
5334232|NCT00310726|Perinatal HIV Transmission|perinatal hiv transmission
5334233|NCT00310726|HIV Seronegativity|hiv seronegativity
5334234|NCT00310713|Prevention of Meningococcal Meningitis|prevention of meningococcal meningitis
5334235|NCT00310713|vaccines|vaccines
5334236|NCT00310713|conjugate|conjugate
5334237|NCT00310713|immunology|immunology
5334238|NCT00310713|children|children
5334239|NCT00310713|antibody persistence|antibody persistence
5334240|NCT00310700|Prevention of Meningococcal Meningitis|prevention of meningococcal meningitis
5334241|NCT00310700|vaccines, conjugate|vaccines, conjugate
5334242|NCT00310700|immunology|immunology
5334243|NCT00310700|infant|infant
5334244|NCT00310700|antibody persistence|antibody persistence
5334245|NCT00310687|Prevention of Meningococcal Meningitis|prevention of meningococcal meningitis
5334246|NCT00310687|vaccines|vaccines
5334247|NCT00310687|conjugate|conjugate
5334248|NCT00310687|immunology|immunology
5334249|NCT00310687|antibody persistence|antibody persistence
5334250|NCT00310674|Prevention of Meningococcal Meningitis|prevention of meningococcal meningitis
5334251|NCT00310674|meningococcal vaccines|meningococcal vaccines
5334252|NCT00310674|conjugate|conjugate
5334253|NCT00310674|Immunology|immunology
5334254|NCT00310674|infant|infant
5334255|NCT00310661|sarizotan|sarizotan
5334256|NCT00310661|neuroleptic-induced tardive dyskinesia|neuroleptic-induced tardive dyskinesia
5334257|NCT00310648|Influenza, elderly, vaccine|influenza, elderly, vaccine
5334258|NCT00310635|Prevention of meningococcal infection|prevention of meningococcal infection
5334259|NCT00310622|HyperQ|hyperq
5334260|NCT00310622|Ischemia|ischemia
5334261|NCT00310622|dobutamine|dobutamine
5334262|NCT00310609|Structural abnormalities of the aortic arch and cerebral branches|structural abnormalities of the aortic arch and cerebral branches
5334263|NCT00310596|ECG safety|ecg safety
5334264|NCT00310583|tactile hyperalgesia|tactile hyperalgesia
5334265|NCT00310583|neuropathic pain|neuropathic pain
5334266|NCT00310583|enriched design|enriched design
5334267|NCT00310583|peripheral nerve lesion|peripheral nerve lesion
5334268|NCT00310583|plexus lesion|plexus lesion
5334269|NCT00310583|radicular lesion|radicular lesion
5334270|NCT00310583|spinal lesion|spinal lesion
5334271|NCT00310583|polyneuropathy|polyneuropathy
5334272|NCT00310583|postzosteric neuralgia|postzosteric neuralgia
5334273|NCT00310570|distal|distal
5334274|NCT00310570|interphalangeal|interphalangeal
5334275|NCT00310570|extensor tendon|extensor tendon
5334276|NCT00310570|avulsion|avulsion
5334277|NCT00310505|visceral leishmaniasis|visceral leishmaniasis
5334278|NCT00310505|amphotericin B|amphotericin b
5334279|NCT00310505|Kala-azar|kala-azar
5334280|NCT00310479|Magnetic Resonance Imaging|magnetic resonance imaging
5334281|NCT00310479|prostate cancer imaging|prostate cancer imaging
5334282|NCT00310479|3T MRS|3t mrs
5334283|NCT00310479|functional imaging|functional imaging
5334284|NCT00310440|Degenerative disc disease|degenerative disc disease
5334285|NCT00310440|P-15 Bone Putty|p-15 bone putty
5334286|NCT00310440|Bone graft|bone graft
5334288|NCT00310440|Cervical spine|cervical spine
5334289|NCT00310427|Anxiety|anxiety
5334290|NCT00310427|Alcohol Dependence|alcohol dependence
5334291|NCT00310427|Alcoholism|alcoholism
5334292|NCT00310414|Imaging Studies|imaging studies
5334293|NCT00310414|Botulinum Toxin|botulinum toxin
5334294|NCT00310414|Writer's Cramp|writer's cramp
5334295|NCT00310414|Focal Hand Dystonia|focal hand dystonia
5334296|NCT00310414|FHD|fhd
5334297|NCT00310414|Writer Cramp|writer cramp
5334298|NCT00310414|Healthy Volunteer|healthy volunteer
5334299|NCT00310414|HV|hv
5334300|NCT00310401|brain death|brain death
5334301|NCT00310401|organ donor|organ donor
5334302|NCT00310401|pulmonary edema|pulmonary edema
5334303|NCT00310401|albuterol|albuterol
5334304|NCT00310401|hypoxia|hypoxia
5334305|NCT00310401|lung transplantation|lung transplantation
5334306|NCT00310401|infiltrates|infiltrates
5334307|NCT00310388|Partial Seizures|partial seizures
5334308|NCT00310388|Epilepsy|epilepsy
5334309|NCT00310388|RTG115097|rtg115097
5334310|NCT00310388|Complex Partial Seizures|complex partial seizures
5334311|NCT00310388|Anticonvulsant|anticonvulsant
5334312|NCT00310388|Potassium Channels|potassium channels
5334313|NCT00310388|Epilepsies, Partial|epilepsies, partial
5334314|NCT00310375|Epilepsy|epilepsy
5334315|NCT00310375|Partial Seizures|partial seizures
5334316|NCT00310375|Potassium Channels|potassium channels
5334317|NCT00310375|Anticonvulsant|anticonvulsant
5334318|NCT00310375|Complex Partial Seizures|complex partial seizures
5334319|NCT00310375|Epilepsies, Partial|epilepsies, partial
5334320|NCT00310375|RTG115098|rtg115098
5334321|NCT00310362|telephone|telephone
5334322|NCT00310362|telemedicine|telemedicine
5334323|NCT00310362|mass screening|mass screening
5334324|NCT00310362|patient education|patient education
5334325|NCT00310362|Patient compliance|patient compliance
5334326|NCT00310349|pneumococcal vaccine|pneumococcal vaccine
5334327|NCT00310349|clinical trial|clinical trial
5334328|NCT00310349|Indigenous|indigenous
5334329|NCT00310349|Maternal|maternal
5334330|NCT00310349|Streptococcus pneumoniae|streptococcus pneumoniae
5334331|NCT00310323|sleep apnea|sleep apnea
5334332|NCT00310323|phenotyping|phenotyping
5334333|NCT00310323|cytochrome P450|cytochrome p450
5334334|NCT00310323|drug metabolism|drug metabolism
5334335|NCT00310323|child|child
5334336|NCT00310310|Continuous positive airway pressure|continuous positive airway pressure
5334337|NCT00310310|Patient compliance|patient compliance
5334338|NCT00310310|Self-care|self-care
5334339|NCT00310284|Insomnia|insomnia
5334340|NCT00310284|Sleep|sleep
5334341|NCT00310271|DNA vaccine, immunotherapy, HSV-2, PMED|dna vaccine, immunotherapy, hsv-2, pmed
5334342|NCT00310245|CD4-guided STI|cd4-guided sti
5334343|NCT00310245|Keywords:|keywords:
5334344|NCT00310245|HAART|haart
5334345|NCT00310245|Clinical outcome|clinical outcome
5334346|NCT00310245|Resistance|resistance
5334347|NCT00310245|Costs|costs
5334348|NCT00310245|Prognostic factors|prognostic factors
5334349|NCT00310245|pulse therapy|pulse therapy
5334350|NCT00310245|treatment experienced|treatment experienced
5334351|NCT00310245|treatment interruption|treatment interruption
5334352|NCT00310232|Quality of Life|quality of life
5334353|NCT00310232|Blood transfusion|blood transfusion
5334354|NCT00310219|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
5334355|NCT00310219|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5334356|NCT00310219|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5334357|NCT00310219|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5334358|NCT00310206|Influenza, pandemic, H5N1, vaccine|influenza, pandemic, h5n1, vaccine
5334359|NCT00310167|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
5334360|NCT00310167|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
5334361|NCT00310167|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
5334362|NCT00310167|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
5334363|NCT00310167|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5334364|NCT00310167|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
5334365|NCT00310167|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5334366|NCT00310167|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
5334367|NCT00310167|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5334368|NCT00310167|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5334369|NCT00310167|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5334370|NCT00310167|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5334371|NCT00310167|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5334372|NCT00310167|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5334373|NCT00310167|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5334374|NCT00310167|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5334375|NCT00310167|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5334376|NCT00310167|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5334377|NCT00310167|Marginal zone lymphoma|marginal zone lymphoma
5334378|NCT00310154|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5334379|NCT00310154|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5334380|NCT00310154|adenosquamous cell lung cancer|adenosquamous cell lung cancer
5334381|NCT00310154|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
5334382|NCT00310154|large cell lung cancer|large cell lung cancer
5334383|NCT00310154|squamous cell lung cancer|squamous cell lung cancer
5334384|NCT00310154|adenocarcinoma of the lung|adenocarcinoma of the lung
5334385|NCT00310141|non-small cell lung cancer|non-small cell lung cancer
5334386|NCT00310141|small cell lung cancer|small cell lung cancer
5334387|NCT00310128|AIDS-related diffuse large cell lymphoma|aids-related diffuse large cell lymphoma
5334388|NCT00310128|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
5334389|NCT00310128|AIDS-related small noncleaved cell lymphoma|aids-related small noncleaved cell lymphoma
5334390|NCT00310128|AIDS-related diffuse mixed cell lymphoma|aids-related diffuse mixed cell lymphoma
5334391|NCT00310128|AIDS-related immunoblastic large cell lymphoma|aids-related immunoblastic large cell lymphoma
5334392|NCT00310128|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
5334393|NCT00310128|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
5334394|NCT00310128|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5334395|NCT00310128|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5334396|NCT00310128|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5334397|NCT00310128|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5334398|NCT00310128|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
5334399|NCT00310128|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
5334500|NCT00309868|echocardiogram|echocardiogram
5334400|NCT00310128|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5334401|NCT00310128|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5334402|NCT00310128|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5334403|NCT00310128|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5334404|NCT00310128|contiguous stage II adult Burkitt's lymphoma|contiguous stage ii adult burkitt's lymphoma
5334405|NCT00310128|noncontiguous stage II adult Burkitt's lymphoma|noncontiguous stage ii adult burkitt's lymphoma
5334406|NCT00310128|recurrent adult Burkitt's lymphoma|recurrent adult burkitt's lymphoma
5334407|NCT00310128|stage I adult Burkitt's lymphoma|stage i adult burkitt's lymphoma
5334408|NCT00310128|stage III adult Burkitt's lymphoma|stage iii adult burkitt's lymphoma
5334409|NCT00310128|stage IV adult Burkitt's lymphoma|stage iv adult burkitt's lymphoma
5334410|NCT00310128|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5334411|NCT00310128|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
5334412|NCT00310128|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5334413|NCT00310128|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5334414|NCT00310128|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
5334415|NCT00310128|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5334416|NCT00310128|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5334417|NCT00310128|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
5334418|NCT00310128|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
5334419|NCT00310128|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5334420|NCT00310128|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
5334421|NCT00310128|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5334422|NCT00310128|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5334423|NCT00310128|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
5334424|NCT00310128|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
5334425|NCT00310128|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5334426|NCT00310128|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
5334427|NCT00310128|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5334428|NCT00310128|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5334429|NCT00310115|non-small cell lung cancer|non-small cell lung cancer
5334430|NCT00310115|small cell lung cancer|small cell lung cancer
5334431|NCT00310115|bladder cancer|bladder cancer
5334432|NCT00310115|cervical cancer|cervical cancer
5334433|NCT00310115|esophageal cancer|esophageal cancer
5334434|NCT00310115|gastric cancer|gastric cancer
5334435|NCT00310115|renal cell carcinoma|renal cell carcinoma
5334436|NCT00310115|adult primary liver cancer|adult primary liver cancer
5334437|NCT00310115|pancreatic cancer|pancreatic cancer
5334438|NCT00310115|hypopharyngeal cancer|hypopharyngeal cancer
5334439|NCT00310115|lip and oral cavity cancer|lip and oral cavity cancer
5334440|NCT00310115|laryngeal cancer|laryngeal cancer
5334441|NCT00310115|nasopharyngeal cancer|nasopharyngeal cancer
5334442|NCT00310115|oropharyngeal cancer|oropharyngeal cancer
5334617|NCT00309478|Cyclophosphamide|cyclophosphamide
5334443|NCT00310115|paranasal sinus and nasal cavity cancer|paranasal sinus and nasal cavity cancer
5334444|NCT00310115|adult acute myeloid leukemia|adult acute myeloid leukemia
5334445|NCT00310115|tobacco use disorder|tobacco use disorder
5334446|NCT00310089|stage IIIA breast cancer|stage iiia breast cancer
5334447|NCT00310089|stage IIIB breast cancer|stage iiib breast cancer
5334448|NCT00310089|stage IIIC breast cancer|stage iiic breast cancer
5334449|NCT00310089|inflammatory breast cancer|inflammatory breast cancer
5334450|NCT00310076|carcinoma of the appendix|carcinoma of the appendix
5334451|NCT00310076|stage II colon cancer|stage ii colon cancer
5334452|NCT00310076|stage III colon cancer|stage iii colon cancer
5334453|NCT00310076|stage IV colon cancer|stage iv colon cancer
5334454|NCT00310076|recurrent colon cancer|recurrent colon cancer
5334455|NCT00310076|stage II rectal cancer|stage ii rectal cancer
5334456|NCT00310076|stage III rectal cancer|stage iii rectal cancer
5334457|NCT00310076|stage IV rectal cancer|stage iv rectal cancer
5334458|NCT00310076|recurrent rectal cancer|recurrent rectal cancer
5334459|NCT00310063|nausea and vomiting|nausea and vomiting
5334460|NCT00310063|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
5334461|NCT00310050|stage II pancreatic cancer|stage ii pancreatic cancer
5334462|NCT00310050|stage III pancreatic cancer|stage iii pancreatic cancer
5334463|NCT00310050|stage IV pancreatic cancer|stage iv pancreatic cancer
5334464|NCT00310011|metastatic transitional cell cancer of the renal pelvis and ureter|metastatic transitional cell cancer of the renal pelvis and ureter
5334465|NCT00310011|recurrent transitional cell cancer of the renal pelvis and ureter|recurrent transitional cell cancer of the renal pelvis and ureter
5334466|NCT00310011|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
5334467|NCT00310011|regional transitional cell cancer of the renal pelvis and ureter|regional transitional cell cancer of the renal pelvis and ureter
5334468|NCT00310011|stage IV bladder cancer|stage iv bladder cancer
5334469|NCT00310011|recurrent bladder cancer|recurrent bladder cancer
5334470|NCT00309998|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5334471|NCT00309998|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5334472|NCT00309998|adenocarcinoma of the lung|adenocarcinoma of the lung
5334473|NCT00309998|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
5334474|NCT00309998|large cell lung cancer|large cell lung cancer
5334475|NCT00309998|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5334476|NCT00309985|metastatic hormone-sensitive prostate cancer|metastatic hormone-sensitive prostate cancer
5334477|NCT00309985|docetaxel|docetaxel
5334478|NCT00309972|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5334479|NCT00309972|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5334480|NCT00309933|cognitive/functional effects|cognitive/functional effects
5334481|NCT00309933|spiritual concerns|spiritual concerns
5334482|NCT00309933|sexuality and reproductive issues|sexuality and reproductive issues
5334483|NCT00309933|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
5334484|NCT00309933|cancer survivor|cancer survivor
5334485|NCT00309933|stage I breast cancer|stage i breast cancer
5334486|NCT00309933|stage II breast cancer|stage ii breast cancer
5334487|NCT00309933|stage IIIA breast cancer|stage iiia breast cancer
5334488|NCT00309933|stage IIIB breast cancer|stage iiib breast cancer
5334489|NCT00309933|stage IIIC breast cancer|stage iiic breast cancer
5334490|NCT00309920|stage IIIA breast cancer|stage iiia breast cancer
5334491|NCT00309920|stage IIIC breast cancer|stage iiic breast cancer
5334492|NCT00309894|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5334493|NCT00309894|recurrent prostate cancer|recurrent prostate cancer
5334494|NCT00309881|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5334495|NCT00309881|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
5334496|NCT00309881|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
5334497|NCT00309881|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5334498|NCT00309881|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5334499|NCT00309868|heart catheterization|heart catheterization
5334501|NCT00309868|nesiritide|nesiritide
5334502|NCT00309842|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5334503|NCT00309842|primary myelofibrosis|primary myelofibrosis
5334504|NCT00309842|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5334505|NCT00309842|myelodysplastic syndromes|myelodysplastic syndromes
5334506|NCT00309842|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
5334507|NCT00309842|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5334508|NCT00309842|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5334509|NCT00309842|recurrent lymphoblastic lymphoma|recurrent lymphoblastic lymphoma
5334510|NCT00309842|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5334511|NCT00309842|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
5334512|NCT00309842|recurrent follicular lymphoma|recurrent follicular lymphoma
5334513|NCT00309842|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5334514|NCT00309842|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5334515|NCT00309842|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5334516|NCT00309842|refractory multiple myeloma|refractory multiple myeloma
5334517|NCT00309842|chronic myelogenous leukemia|chronic myelogenous leukemia
5334518|NCT00309842|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5334519|NCT00309842|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5334520|NCT00309842|multiple myeloma|multiple myeloma
5334521|NCT00309842|adult lymphoblastic lymphoma|adult lymphoblastic lymphoma
5334522|NCT00309842|refractory anemia with excess blasts|refractory anemia with excess blasts
5334523|NCT00309842|refractory anemia|refractory anemia
5334524|NCT00309842|Burkitt lymphoma|burkitt lymphoma
5334525|NCT00309842|childhood large cell lymphoma|childhood large cell lymphoma
5334526|NCT00309842|adult Burkitt lymphoma|adult burkitt lymphoma
5334527|NCT00309842|mantle cell lymphoma|mantle cell lymphoma
5334528|NCT00309842|childhood lymphoblastic lymphoma|childhood lymphoblastic lymphoma
5334529|NCT00309842|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
5334530|NCT00309816|Exercise stress test|exercise stress test
5334531|NCT00309803|Carotid artery|carotid artery
5334532|NCT00309803|distal protection device|distal protection device
5334533|NCT00309790|exercise stress test|exercise stress test
5334534|NCT00309777|hypercholesterolemia|hypercholesterolemia
5334535|NCT00309777|kowa|kowa
5334536|NCT00309777|dyslipidemia|dyslipidemia
5334537|NCT00309777|pitavastatin|pitavastatin
5334538|NCT00309777|NK-104|nk-104
5334539|NCT00309777|Primary Hypercholesterolemia or Combined Dyslipidemia|primary hypercholesterolemia or combined dyslipidemia
5334540|NCT00309751|Kowa|kowa
5334541|NCT00309751|Type II Diabetes Mellitus|type ii diabetes mellitus
5334542|NCT00309751|Combined Dyslipidemia|combined dyslipidemia
5334543|NCT00309751|pitavastatin|pitavastatin
5334544|NCT00309751|NK-104|nk-104
5334545|NCT00309751|Atorvastatin|atorvastatin
5334546|NCT00309738|Kowa|kowa
5334547|NCT00309738|KRE|kre
5334548|NCT00309738|Hypercholesterolemia|hypercholesterolemia
5334549|NCT00309738|combined dyslipidemia|combined dyslipidemia
5334550|NCT00309738|dyslipidemia|dyslipidemia
5334551|NCT00309738|pitavastatin|pitavastatin
5334552|NCT00309738|NK-104|nk-104
5334553|NCT00309738|simvastatin|simvastatin
5334554|NCT00309725|Alzheimer's Disease|alzheimer's disease
5334555|NCT00309725|cardiac arrhythmias|cardiac arrhythmias
5334556|NCT00309712|diabetes|diabetes
5334557|NCT00309712|combination lipid treatment|combination lipid treatment
5334558|NCT00309712|statin|statin
5334559|NCT00309712|fibrate|fibrate
5334560|NCT00309712|hypercholesteremia|hypercholesteremia
5334561|NCT00309712|mixed dyslipidemia|mixed dyslipidemia
5334562|NCT00309699|Affective psychosis|affective psychosis
5334563|NCT00309699|mixed-state|mixed-state
5334564|NCT00309699|bipolar disorder|bipolar disorder
5334565|NCT00309699|manic disorder|manic disorder
5334566|NCT00309699|manic-depressive psychosis|manic-depressive psychosis
5334567|NCT00309699|mania|mania
5334568|NCT00309699|manic state|manic state
5334569|NCT00309699|paliperidone|paliperidone
5334570|NCT00309699|paliperidone ER.|paliperidone er.
5334571|NCT00309686|Affective psychosis|affective psychosis
5334572|NCT00309686|bipolar disorder|bipolar disorder
5334573|NCT00309686|manic disorder|manic disorder
5334574|NCT00309686|manic-depressive psychosis|manic-depressive psychosis
5334575|NCT00309686|mania|mania
5334576|NCT00309686|manic state|manic state
5334577|NCT00309686|paliperidone|paliperidone
5334578|NCT00309686|paliperidone ER|paliperidone er
5334579|NCT00309686|adjunctive therapy|adjunctive therapy
5334580|NCT00309673|tuberculosis, tuberculin, childhood, pain|tuberculosis, tuberculin, childhood, pain
5334581|NCT00309660|PPARgamma ligand|ppargamma ligand
5334582|NCT00309660|Rosiglitazone|rosiglitazone
5334583|NCT00309660|Enema|enema
5334584|NCT00309647|prophylaxis of pandemic influenza|prophylaxis of pandemic influenza
5334585|NCT00309634|prophylaxis of pandemic influenza|prophylaxis of pandemic influenza
5334586|NCT00309621|Hand Dermatoses,|hand dermatoses,
5334587|NCT00309621|hand dermatitis|hand dermatitis
5334588|NCT00309621|hand eczema|hand eczema
5334589|NCT00309621|chronic hand dermatitis|chronic hand dermatitis
5334590|NCT00309621|retinoid|retinoid
5334591|NCT00309569|Cyclophosphamide|cyclophosphamide
5334592|NCT00309569|Methotrexate|methotrexate
5334593|NCT00309569|Fluorouracil|fluorouracil
5334594|NCT00309569|Epirubicine|epirubicine
5334595|NCT00309569|Breast Cancer|breast cancer
5334596|NCT00309556|Epirubicin|epirubicin
5334597|NCT00309556|Docetaxel|docetaxel
5334598|NCT00309556|Capecitabine|capecitabine
5334599|NCT00309556|Herceptin|herceptin
5334600|NCT00309556|Breast cancer|breast cancer
5334601|NCT00309543|Fluorouracil|fluorouracil
5334602|NCT00309543|Leucovorin|leucovorin
5334603|NCT00309543|Colon cancer|colon cancer
5334604|NCT00309530|Fluorouracil|fluorouracil
5334605|NCT00309530|Levamisol|levamisol
5334606|NCT00309530|Interferon|interferon
5334607|NCT00309530|Colon cancer|colon cancer
5334608|NCT00309517|Fluorouracil|fluorouracil
5334609|NCT00309517|Leucovorin|leucovorin
5334610|NCT00309517|MAb 17-1A|mab 17-1a
5334611|NCT00309517|Rectal cancer|rectal cancer
5334612|NCT00309504|magnetic resonance imaging|magnetic resonance imaging
5334613|NCT00309504|magnetic resonance spectroscopy|magnetic resonance spectroscopy
5334614|NCT00309491|Tamoxifen|tamoxifen
5334615|NCT00309491|Aminoglutethimide|aminoglutethimide
5334616|NCT00309491|Breast cancer|breast cancer
5334618|NCT00309478|Methotrexate|methotrexate
5334619|NCT00309478|Fluorouracil|fluorouracil
5334620|NCT00309478|Goserelin|goserelin
5334621|NCT00309478|Tamoxifen|tamoxifen
5334622|NCT00309478|Breast cancer|breast cancer
5334623|NCT00309465|Diabetes|diabetes
5334624|NCT00309465|Insulin Glargine|insulin glargine
5334626|NCT00309452|First episode psychosis|first episode psychosis
5334627|NCT00309452|Specialized care|specialized care
5334628|NCT00309452|Phase-specific treatment|phase-specific treatment
5334629|NCT00309452|Schizophrenia|schizophrenia
5334630|NCT00309452|Disorders with psychotic features|disorders with psychotic features
5334631|NCT00309426|atherosclerosis|atherosclerosis
5334632|NCT00309413|Schizophrenia and Disorders with Psychotic Features|schizophrenia and disorders with psychotic features
5334633|NCT00309400|History|history
5334634|NCT00309400|Phenylketonuria|phenylketonuria
5334635|NCT00309400|Galactosemia|galactosemia
5334636|NCT00309400|Screening|screening
5334637|NCT00309400|Treatment|treatment
5334638|NCT00309387|Cataract|cataract
5334639|NCT00309387|Nutritional supplements|nutritional supplements
5334640|NCT00309374|LPS|lps
5334641|NCT00309374|Statins|statins
5334642|NCT00309374|leukocyte mRNA expression profiles|leukocyte mrna expression profiles
5334643|NCT00309361|Soft Tissue Anesthesia (Numbness)|soft tissue anesthesia (numbness)
5334644|NCT00309335|Soft Tissue Anesthesia (Numbness)|soft tissue anesthesia (numbness)
5334645|NCT00309322|Soft Tissue Anesthesia (Numbness)|soft tissue anesthesia (numbness)
5334646|NCT00309296|smoking cessation|smoking cessation
5334647|NCT00309296|smoking reduction|smoking reduction
5334648|NCT00309296|nicotine replacement therapy|nicotine replacement therapy
5334649|NCT00309270|Campath-1H, low-dose immunosuppression, T regulatives cells|campath-1h, low-dose immunosuppression, t regulatives cells
5334650|NCT00309231|diabetes mellitus|diabetes mellitus
5334651|NCT00309231|islet transplantation|islet transplantation
5334652|NCT00309218|Pediatric renal transplantation|pediatric renal transplantation
5334653|NCT00309218|Steroid withdrawal|steroid withdrawal
5334654|NCT00309218|Mycophenolate Mofetil|mycophenolate mofetil
5334655|NCT00309218|Cyclosporine A|cyclosporine a
5334656|NCT00309218|Stable graft function|stable graft function
5334657|NCT00309218|children|children
5334658|NCT00309218|renal transplantation|renal transplantation
5334659|NCT00309205|HIV seronegativity|hiv seronegativity
5334660|NCT00309192|Diabetes, Macular Edema, Triamcinolone|diabetes, macular edema, triamcinolone
5334661|NCT00309179|Advanced colorectal cancer|advanced colorectal cancer
5334662|NCT00309127|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
5334663|NCT00309127|DM Nephropathy|dm nephropathy
5334664|NCT00309127|Structured care|structured care
5334665|NCT00309114|UTI|uti
5334666|NCT00309114|SCI|sci
5334667|NCT00309114|E coli|e coli
5334668|NCT00309114|Prevention|prevention
5334669|NCT00309101|Tacrolimus|tacrolimus
5334670|NCT00309101|Myasthenia Gravis|myasthenia gravis
5334671|NCT00309088|Tacrolimus|tacrolimus
5334672|NCT00309088|Myasthenia Gravis|myasthenia gravis
5334673|NCT00309075|Stenosis of the calf and/or pedal arteries|stenosis of the calf and/or pedal arteries
5334674|NCT00309062|Allergy|allergy
5334675|NCT00309062|Birch pollen|birch pollen
5334676|NCT00309062|Recombinant|recombinant
5334677|NCT00309036|Allergy|allergy
5334678|NCT00309036|Grass pollen|grass pollen
5334679|NCT00309036|Recombinant|recombinant
5334680|NCT00309023|Advanced Solid Tumors|advanced solid tumors
5334681|NCT00309010|Focal Hand Dystonia|focal hand dystonia
5334682|NCT00309010|Motor Planning|motor planning
5334683|NCT00309010|Transcranial Magnetic Stimulation (TMS)|transcranial magnetic stimulation (tms)
5334684|NCT00309010|MRI (Magnetic Resonance Imaging)|mri (magnetic resonance imaging)
5334685|NCT00309010|FHD|fhd
5334686|NCT00309010|Writer's Cramp|writer's cramp
5334687|NCT00309010|Healthy Volunteer|healthy volunteer
5334688|NCT00309010|HV|hv
5334689|NCT00308997|Auditory Hallucinations|auditory hallucinations
5334690|NCT00308997|Schizophrenia|schizophrenia
5334691|NCT00308997|Schizoaffective Disorder|schizoaffective disorder
5334692|NCT00308997|Repetitive Transcranial Magnetic Stimulation|repetitive transcranial magnetic stimulation
5334693|NCT00308997|Wernicke's Area|wernicke's area
5334694|NCT00308997|Superior Temporal Gyrus|superior temporal gyrus
5334695|NCT00308984|Pediatrics|pediatrics
5334696|NCT00308984|Intraoperative Awareness|intraoperative awareness
5334697|NCT00308984|Pediatric Anesthesia|pediatric anesthesia
5334698|NCT00308958|cystic fibrosis|cystic fibrosis
5334699|NCT00308958|chest physiotherapy|chest physiotherapy
5334700|NCT00308958|airway clearance|airway clearance
5334701|NCT00308958|bronchiectasis|bronchiectasis
5334702|NCT00308945|Glaucoma|glaucoma
5334703|NCT00308945|Blood flow|blood flow
5334704|NCT00308945|Choroid|choroid
5334705|NCT00308945|Retina|retina
5334706|NCT00308945|Prostaglandin analogues|prostaglandin analogues
5334707|NCT00308932|fluticasone|fluticasone
5334708|NCT00308932|asthma therapy|asthma therapy
5334709|NCT00308932|spacer inhaler|spacer inhaler
5334710|NCT00308932|HFA-134a|hfa-134a
5334711|NCT00308906|infection|infection
5334712|NCT00308906|renal dysfunction|renal dysfunction
5334713|NCT00308906|aminoglycoside|aminoglycoside
5334714|NCT00308906|protein|protein
5334715|NCT00308906|child|child
5334716|NCT00308893|Antidepressants|antidepressants
5334717|NCT00308893|escitalopram|escitalopram
5334718|NCT00308893|Genetic polymorphism|genetic polymorphism
5334719|NCT00308880|Tranexamic acid|tranexamic acid
5334720|NCT00308880|head neck surgery|head neck surgery
5334721|NCT00308867|PDT|pdt
5334722|NCT00308867|AK|ak
5334723|NCT00308867|Cryosurgery|cryosurgery
5334724|NCT00308854|AK|ak
5334725|NCT00308854|PDT|pdt
5334726|NCT00308841|"Objective: To evaluate the efficacy of intrauterine lidocaine instillation in reducing patient discomfort during the removal of a lost IUD"|"objective: to evaluate the efficacy of intrauterine lidocaine instillation in reducing patient discomfort during the removal of a lost iud"
5334727|NCT00308815|Resuscitation|resuscitation
5334728|NCT00308815|Out-of-hospital cardiac arrest|out-of-hospital cardiac arrest
5334729|NCT00308815|cardiac arrest|cardiac arrest
5334730|NCT00308815|CPR|cpr
5334731|NCT00308802|Kidney|kidney
5334732|NCT00308802|Transplant|transplant
5334733|NCT00308802|Rejection|rejection
5334734|NCT00308802|Kidney Disease|kidney disease
5334735|NCT00308802|Kidney Failure|kidney failure
5334736|NCT00308802|End Stage Renal Disease|end stage renal disease
5334737|NCT00308789|Continuous Positive Airway Pressure|continuous positive airway pressure
5334738|NCT00308789|Infant,newborn|infant,newborn
5334739|NCT00308789|Artificial respiration|artificial respiration
5334740|NCT00308763|Smoking Cessation|smoking cessation
5334741|NCT00308763|Nicotine Dependence|nicotine dependence
5334742|NCT00308724|Generalized Anxiety Disorder|generalized anxiety disorder
5334743|NCT00308724|Geriatric|geriatric
5334744|NCT00308711|Cervical ripening|cervical ripening
5334745|NCT00308711|Induction of labor|induction of labor
5334746|NCT00308711|Dinoprostone vaginal insert|dinoprostone vaginal insert
5334747|NCT00308711|Cervidil|cervidil
5334748|NCT00308711|Misoprostol vaginal insert|misoprostol vaginal insert
5334749|NCT00308711|Modified Bishop's Score|modified bishop's score
5334750|NCT00308711|PGE2|pge2
5334751|NCT00308711|PGE1|pge1
5334752|NCT00308711|Uterine Hyperstimulation|uterine hyperstimulation
5334753|NCT00308711|Cesarean section|cesarean section
5334754|NCT00308698|recombinant human erythropoietin|recombinant human erythropoietin
5334755|NCT00308698|adiponectin|adiponectin
5334756|NCT00308698|mortality|mortality
5334757|NCT00308685|Asthma|asthma
5334758|NCT00308685|Pediatric asthma|pediatric asthma
5334759|NCT00308633|Cardiac Rehabilitation|cardiac rehabilitation
5334760|NCT00308633|Apoptosis|apoptosis
5334761|NCT00308633|Gene Expression|gene expression
5334762|NCT00308633|Nitric Oxide|nitric oxide
5334763|NCT00308633|Reactive Oxygen Species|reactive oxygen species
5334764|NCT00308633|Coronary Artery Disease|coronary artery disease
5334765|NCT00308633|CAD|cad
5334766|NCT00308620|HIV|hiv
5334767|NCT00308620|chloroquine|chloroquine
5334768|NCT00308620|disease progression|disease progression
5334769|NCT00308620|inflammation|inflammation
5334770|NCT00308620|treatment naive|treatment naive
5334771|NCT00308607|melanoma|melanoma
5334772|NCT00308607|metastatic|metastatic
5334773|NCT00308607|bevacizumab|bevacizumab
5334774|NCT00308594|cervical radiculopathy|cervical radiculopathy
5334775|NCT00308594|dexamethasone|dexamethasone
5334776|NCT00308594|corticosteroid|corticosteroid
5334777|NCT00308594|oral|oral
5334778|NCT00308581|Crohn's Disease|crohn's disease
5334779|NCT00308581|Certolizumab pegol|certolizumab pegol
5334780|NCT00308568|screening colonoscopy|screening colonoscopy
5334781|NCT00308568|adherence|adherence
5334782|NCT00308555|Cannabis|cannabis
5334783|NCT00308555|Morphine|morphine
5334784|NCT00308555|Oxycodone|oxycodone
5334785|NCT00308555|Marijuana|marijuana
5334786|NCT00308555|chronic pain|chronic pain
5334787|NCT00308542|eye diseases|eye diseases
5334788|NCT00308542|diabetic eye problems|diabetic eye problems
5334789|NCT00308529|Carcinoma Small Cell Lung|carcinoma small cell lung
5334790|NCT00308529|Lung Cancer|lung cancer
5334791|NCT00308516|Rectal Cancer|rectal cancer
5334792|NCT00308516|Cancer of the Rectum|cancer of the rectum
5334793|NCT00308516|Colorectal Cancer|colorectal cancer
5334794|NCT00308516|Bevacizumab|bevacizumab
5334795|NCT00308503|Primary Insomnia|primary insomnia
5334796|NCT00308503|Sleep Maintenance Insomnia|sleep maintenance insomnia
5334797|NCT00308503|Awakening|awakening
5334798|NCT00308477|eye diseases|eye diseases
5334799|NCT00308451|chromium|chromium
5334800|NCT00308451|chromium picolinate|chromium picolinate
5334801|NCT00308451|type 2 diabetes mellitus|type 2 diabetes mellitus
5334802|NCT00308451|fructosamine|fructosamine
5334803|NCT00308451|glycemic control|glycemic control
5334804|NCT00308451|OGTT|ogtt
5334805|NCT00308438|Crohn Disease|crohn disease
5334806|NCT00308438|Crohn's Disease|crohn's disease
5334807|NCT00308425|Renal transplantation, EC-MPS|renal transplantation, ec-mps
5334808|NCT00308412|Respiratory Tract Infection|respiratory tract infection
5334809|NCT00308386|Nurse Case Management|nurse case management
5334810|NCT00308386|Diabetes|diabetes
5334811|NCT00308386|Hypertension|hypertension
5334812|NCT00308386|Hyperlipidemia|hyperlipidemia
5334813|NCT00308386|Behavior therapy|behavior therapy
5334814|NCT00308386|Motivational interviewing|motivational interviewing
5334815|NCT00308360|Hostility|hostility
5334816|NCT00308360|Impulsivity|impulsivity
5334817|NCT00308360|Aggression|aggression
5334818|NCT00308334|Domperidone|domperidone
5334819|NCT00308334|breast milk|breast milk
5334820|NCT00308334|breast milk composition|breast milk composition
5334821|NCT00308334|preterm infant|preterm infant
5334822|NCT00308334|neonate|neonate
5334823|NCT00308334|nutrition|nutrition
5334824|NCT00308269|Cancer|cancer
5334825|NCT00308269|Phase I|phase i
5334826|NCT00308269|EC145|ec145
5334827|NCT00308269|Recurrent|recurrent
5334828|NCT00308269|Refractory|refractory
5334829|NCT00308269|Solid Tumors|solid tumors
5334830|NCT00308269|Experimental|experimental
5334831|NCT00308256|Type1 diabetes;|type1 diabetes;
5334832|NCT00308256|nurse-counselling;|nurse-counselling;
5334833|NCT00308256|adolescent|adolescent
5334834|NCT00308243|Cystic Fibrosis|cystic fibrosis
5334835|NCT00308243|Sodium Pyruvate|sodium pyruvate
5334836|NCT00308243|Reactive Oxygen Species|reactive oxygen species
5334837|NCT00308243|Inflammation of Lung|inflammation of lung
5334838|NCT00308230|Congenital, BNP|congenital, bnp
5334839|NCT00308217|Heart Disease, Congenital|heart disease, congenital
5334840|NCT00308217|Single Ventricle|single ventricle
5334841|NCT00308217|Hypoplastic Left Heart Syndrome|hypoplastic left heart syndrome
5334842|NCT00308204|discoid lupus|discoid lupus
5334843|NCT00308204|lupus|lupus
5334844|NCT00308204|discoid lupus erythematosus|discoid lupus erythematosus
5334845|NCT00308204|lupus of the scalp|lupus of the scalp
5334846|NCT00308191|COPD|copd
5334847|NCT00308191|Formoterol|formoterol
5334848|NCT00308191|Tiotropium|tiotropium
5334849|NCT00308178|Abraxane|abraxane
5334850|NCT00308178|dose-dense chemotherapy|dose-dense chemotherapy
5334851|NCT00308178|taxol|taxol
5334852|NCT00308165|Recurrent Primary Malignant Brain Tumors|recurrent primary malignant brain tumors
5334853|NCT00308165|Brain Tumors|brain tumors
5334854|NCT00308165|Neoplasms, Brain|neoplasms, brain
5334855|NCT00308165|Brain Cancer|brain cancer
5334856|NCT00308165|Brain cancer treatment|brain cancer treatment
5334857|NCT00308165|Topotecan|topotecan
5334858|NCT00308152|Colonoscopy|colonoscopy
5334859|NCT00308152|Rehydration|rehydration
5334860|NCT00308152|Sedation|sedation
5334861|NCT00308139|diabetes|diabetes
5334862|NCT00308139|exenatide|exenatide
5334863|NCT00308139|long acting release|long acting release
5334864|NCT00308139|LAR|lar
5334865|NCT00308139|Amylin|amylin
5334866|NCT00308139|Lilly|lilly
5334867|NCT00308126|Abdominal operation|abdominal operation
5334868|NCT00308113|Muscular dystrophy|muscular dystrophy
5334869|NCT00308113|Duchenne|duchenne
5334870|NCT00308113|CoQ10|coq10
5334871|NCT00308113|prednisone|prednisone
5334872|NCT00308100|Liver Transplantation|liver transplantation
5334873|NCT00308087|Sargramostim|sargramostim
5334874|NCT00308087|Leukine|leukine
5334876|NCT00308074|behavioral problems|behavioral problems
5334877|NCT00308074|aggression|aggression
5334878|NCT00308074|autism|autism
5334879|NCT00308074|aripiprazole|aripiprazole
5334880|NCT00308061|Plasmodium falciparum|plasmodium falciparum
5334881|NCT00308061|malaria|malaria
5334882|NCT00308061|merozoite surface protein-1|merozoite surface protein-1
5334883|NCT00308048|Interferon|interferon
5334884|NCT00308048|Pegylated interferon|pegylated interferon
5334885|NCT00308048|Pegylated interferon alfa 2b|pegylated interferon alfa 2b
5334886|NCT00308048|Hepatitis C|hepatitis c
5334887|NCT00308048|Genotype 2|genotype 2
5334888|NCT00308048|Genotype 3|genotype 3
5334889|NCT00308048|Rapid virological response|rapid virological response
5334890|NCT00308048|Short treatment|short treatment
5334891|NCT00308048|14 weeks treatment|14 weeks treatment
5334892|NCT00308048|health related quality of life|health related quality of life
5334893|NCT00308048|sick leave|sick leave
5334894|NCT00308048|Injecting drug use|injecting drug use
5334895|NCT00308022|Acute Lung Injury|acute lung injury
5334896|NCT00308022|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
5334897|NCT00308022|High Frequency Percussive Ventilation|high frequency percussive ventilation
5334898|NCT00308022|Ventilator Associated Pneumonia|ventilator associated pneumonia
5334899|NCT00308009|Pelvic Organ Prolapse|pelvic organ prolapse
5334900|NCT00308009|Urinary stress incontinence|urinary stress incontinence
5334901|NCT00308009|Surgery|surgery
5334902|NCT00307996|CoQ10|coq10
5334903|NCT00307996|hemodialysis|hemodialysis
5334904|NCT00307996|oxidative marker|oxidative marker
5334905|NCT00307996|antioxidant|antioxidant
5334906|NCT00307970|fluticasone|fluticasone
5334907|NCT00307970|asthma therapy|asthma therapy
5334908|NCT00307970|spacer inhaler|spacer inhaler
5334909|NCT00307970|HFA-134a|hfa-134a
5334910|NCT00307957|Obstructive Sleep Apnea|obstructive sleep apnea
5334911|NCT00307957|Daytime Sleepiness|daytime sleepiness
5334912|NCT00307957|Pillar Palatal Implants|pillar palatal implants
5334913|NCT00307944|Acid Reflux|acid reflux
5334914|NCT00307944|Obstructive Sleep Apnea|obstructive sleep apnea
5334915|NCT00307944|Daytime Sleepiness|daytime sleepiness
5334916|NCT00307931|Certolizumab pegol|certolizumab pegol
5334917|NCT00307931|Cimzia|cimzia
5334918|NCT00307931|Crohn's disease|crohn's disease
5334919|NCT00307931|Greek patients|greek patients
5334920|NCT00307918|acupuncture, intraocular pressure, glaucoma|acupuncture, intraocular pressure, glaucoma
5334921|NCT00307905|homeopathy|homeopathy
5334922|NCT00307905|pain|pain
5334923|NCT00307905|traumeel s|traumeel s
5334924|NCT00307905|Fracture of neck of femur|fracture of neck of femur
5334925|NCT00307905|Surgical correction of fracture of neck of hip|surgical correction of fracture of neck of hip
5334926|NCT00307892|Homeopathy|homeopathy
5334927|NCT00307892|Traumeel S|traumeel s
5334928|NCT00307892|Arthroscopy|arthroscopy
5334929|NCT00307892|Pain management|pain management
5334930|NCT00307892|Post-operative pain following arthroscopy|post-operative pain following arthroscopy
5334931|NCT00307879|Myocardial infarction|myocardial infarction
5334932|NCT00307879|revascularization|revascularization
5334933|NCT00307879|granulocyte colony stimulating factor (G-CSF)|granulocyte colony stimulating factor (g-csf)
5334934|NCT00307866|Known or suspected focal liver lesions detected by spiral CT|known or suspected focal liver lesions detected by spiral ct
5334935|NCT00307853|homeopathy|homeopathy
5334936|NCT00307853|pain|pain
5334937|NCT00307853|traumeel s|traumeel s
5334938|NCT00307853|total knee arthroplasty|total knee arthroplasty
5334939|NCT00307853|total hip arthroplasty|total hip arthroplasty
5334940|NCT00307840|hemodialysis; secondary hyperparathyroidism; hypercalcemia; hyperphosphatemia; vitamin D|hemodialysis; secondary hyperparathyroidism; hypercalcemia; hyperphosphatemia; vitamin d
5334941|NCT00307827|Steroid-Refractory|steroid-refractory
5334942|NCT00307827|IVSR-UC|ivsr-uc
5334943|NCT00307827|Ulcerative Colitis|ulcerative colitis
5334944|NCT00307814|Anemia|anemia
5334945|NCT00307814|Low Blood Count|low blood count
5334946|NCT00307814|Chronic Kidney Failure|chronic kidney failure
5334947|NCT00307814|Chronic Kidney Disease|chronic kidney disease
5334948|NCT00307814|epoetin alfa|epoetin alfa
5334949|NCT00307814|recombinant human erythropoietin|recombinant human erythropoietin
5334950|NCT00307801|Dysfunctional uterine bleeding|dysfunctional uterine bleeding
5334951|NCT00307788|Psychiatric Comorbidity|psychiatric comorbidity
5334952|NCT00307788|Acupuncture|acupuncture
5334953|NCT00307788|expectancy|expectancy
5334954|NCT00307775|oestradiol, faecal incontinence, post menopausal|oestradiol, faecal incontinence, post menopausal
5334955|NCT00307775|post menopausal women with faecal incontinence|post menopausal women with faecal incontinence
5334956|NCT00307762|Stroke|stroke
5334957|NCT00307762|Physiotherapy|physiotherapy
5334958|NCT00307762|Effectiveness|effectiveness
5334959|NCT00307762|Gait trainer|gait trainer
5334960|NCT00307749|Neuropathy|neuropathy
5334961|NCT00307749|Nerve Conduction|nerve conduction
5334962|NCT00307736|Fluorouracil|fluorouracil
5334963|NCT00307736|bevacizumab|bevacizumab
5334964|NCT00307736|erlotinib|erlotinib
5334965|NCT00307736|external beam radiation therapy|external beam radiation therapy
5334966|NCT00307736|EBRT|ebrt
5334967|NCT00307723|EBRT|ebrt
5334968|NCT00307723|advanced pancreatic cancer|advanced pancreatic cancer
5334969|NCT00307710|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
5334970|NCT00307710|Influenza Vaccination|influenza vaccination
5334971|NCT00307710|Trivalent Baculovirus-Expressed Influenza HA vaccine|trivalent baculovirus-expressed influenza ha vaccine
5334972|NCT00307710|Antineoplastic Therapy|antineoplastic therapy
5334973|NCT00307697|Letter intervention|letter intervention
5334974|NCT00307697|Depression|depression
5334975|NCT00307697|Anxiety|anxiety
5334976|NCT00307697|Primary health care|primary health care
5334977|NCT00307684|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
5334978|NCT00307684|Adult|adult
5334979|NCT00307684|Long term safety|long term safety
5334980|NCT00307684|Efficacy|efficacy
5334981|NCT00307684|Quality of life|quality of life
5334982|NCT00307671|Systemic necrotizing vasculitides|systemic necrotizing vasculitides
5334983|NCT00307671|corticosteroids; azathioprine; mycophenolate mofetil;|corticosteroids; azathioprine; mycophenolate mofetil;
5334984|NCT00307671|cyclophosphamide|cyclophosphamide
5334985|NCT00307671|Elderly patients|elderly patients
5334986|NCT00307671|Randomized controlled trial|randomized controlled trial
5334987|NCT00307658|ANCA associated Vasculitides|anca associated vasculitides
5334988|NCT00307658|Relapse|relapse
5334989|NCT00307658|intravenous Immunoglobulins|intravenous immunoglobulins
5334990|NCT00307658|Corticosteroid|corticosteroid
5334991|NCT00307658|Immunosuppressant|immunosuppressant
5334992|NCT00307645|ANCA associated systemic vasculitis|anca associated systemic vasculitis
5334993|NCT00307645|Maintenance therapy|maintenance therapy
5334994|NCT00307645|Azathioprine|azathioprine
5334995|NCT00307645|Mycophenolate mofetil|mycophenolate mofetil
5334996|NCT00307632|Contraception|contraception
5334997|NCT00307632|Hormonal patch|hormonal patch
5334998|NCT00307632|Norelgestromine|norelgestromine
5334999|NCT00307632|Ethinyl estradiol|ethinyl estradiol
5335000|NCT00307619|Binge-Eating Disorder|binge-eating disorder
5335001|NCT00307606|Mastectomy|mastectomy
5335003|NCT00307606|Breast cancer|breast cancer
5335004|NCT00307606|Glucocorticoid|glucocorticoid
5335005|NCT00307593|Systemic ANCA+ vascularizes|systemic anca+ vascularizes
5335006|NCT00307593|Relapse|relapse
5335007|NCT00307593|Corticosteroids|corticosteroids
5335008|NCT00307593|Immunosuppressant|immunosuppressant
5335009|NCT00307593|Infliximab/rituximab|infliximab/rituximab
5335010|NCT00307593|Patients with relapsing or refractory forms of ANCA|patients with relapsing or refractory forms of anca
5335011|NCT00307593|associated vasculitides Microscopic polyangiitis|associated vasculitides microscopic polyangiitis
5335012|NCT00307580|CVADS|cvads
5335013|NCT00307502|protease inhibitors|protease inhibitors
5335014|NCT00307502|non-nucleoside analog reverse transcriptase inhibitors|non-nucleoside analog reverse transcriptase inhibitors
5335015|NCT00307502|pharmacokinetic models|pharmacokinetic models
5335016|NCT00307502|treatment experienced|treatment experienced
5335017|NCT00307502|HIV|hiv
5335018|NCT00307476|Fecal Incontinence|fecal incontinence
5335019|NCT00307476|Fecal Containment Devices|fecal containment devices
5335020|NCT00307476|Skin Integrity|skin integrity
5335021|NCT00307463|end-stage renal disease|end-stage renal disease
5335022|NCT00307463|hemodialysis|hemodialysis
5335023|NCT00307463|volume control|volume control
5335024|NCT00307463|ultrafiltration|ultrafiltration
5335025|NCT00307463|inflammation|inflammation
5335026|NCT00307463|cardiovascular disease|cardiovascular disease
5335027|NCT00307463|left ventricular hypertrophy|left ventricular hypertrophy
5335028|NCT00307463|dietary salt restriction|dietary salt restriction
5335029|NCT00307450|Dyskinesias|dyskinesias
5335030|NCT00307450|Parkinson's disease|parkinson's disease
5335031|NCT00307450|Levetiracetam|levetiracetam
5335032|NCT00307450|Treatment|treatment
5335033|NCT00307437|Moderate to Severe Plaque-Type Psoriasis|moderate to severe plaque-type psoriasis
5335034|NCT00307437|interleukin 23|interleukin 23
5335035|NCT00307437|IL-12|il-12
5335036|NCT00307437|interleukin-12|interleukin-12
5335037|NCT00307437|interleukin-23|interleukin-23
5335038|NCT00307437|CNTO1275|cnto1275
5335039|NCT00307437|biologic|biologic
5335040|NCT00307437|Psoriasis|psoriasis
5335041|NCT00307437|CNTO 1275|cnto 1275
5335042|NCT00307437|IL23|il23
5335043|NCT00307437|interleukin 12|interleukin 12
5335044|NCT00307437|IL-23|il-23
5335045|NCT00307437|IL12|il12
5335046|NCT00307437|ustekinumab|ustekinumab
5335047|NCT00307411|Metabolic syndrome|metabolic syndrome
5335048|NCT00307398|AMD|amd
5335049|NCT00307398|Dry AMD|dry amd
5335050|NCT00307398|Drusen|drusen
5335051|NCT00307398|CNV|cnv
5335052|NCT00307385|Motor Recovery|motor recovery
5335053|NCT00307385|Transcranial Direct Current Stimulation (tDCS)|transcranial direct current stimulation (tdcs)
5335054|NCT00307385|Homeostatic Plasticity|homeostatic plasticity
5335055|NCT00307385|Ipsilesional Primary Motor Cortex|ipsilesional primary motor cortex
5335056|NCT00307385|Paretic Fingers Motor Sequence|paretic fingers motor sequence
5335057|NCT00307385|Motor Cortex|motor cortex
5335058|NCT00307385|Motor Function|motor function
5335059|NCT00307385|Motor Learning|motor learning
5335060|NCT00307385|Premotor Cortex|premotor cortex
5335061|NCT00307385|Primary Motor Cortex|primary motor cortex
5335062|NCT00307385|Stroke|stroke
5335063|NCT00307385|Healthy Volunteer|healthy volunteer
5335064|NCT00307385|HV|hv
5335065|NCT00307346|Movement-Related Potential|movement-related potential
5335066|NCT00307346|Electroencephalogram|electroencephalogram
5335067|NCT00307346|Psychogenic Movement Disorders|psychogenic movement disorders
5335068|NCT00307346|Psychogenic Movement Disorder|psychogenic movement disorder
5335069|NCT00307346|Healthy Volunteer|healthy volunteer
5335070|NCT00307346|HV|hv
5335071|NCT00307333|very low birth weight infants|very low birth weight infants
5335072|NCT00307333|heart rate characteristics|heart rate characteristics
5335073|NCT00307320|pregnancy|pregnancy
5335074|NCT00307320|stress|stress
5335075|NCT00307320|anxiety|anxiety
5335076|NCT00307307|atherosclerosis|atherosclerosis
5335077|NCT00307307|HDL cholesterol|hdl cholesterol
5335078|NCT00307307|niacin|niacin
5335079|NCT00307307|MR imaging|mr imaging
5335080|NCT00307294|Prostate|prostate
5335081|NCT00307294|Androgen|androgen
5335082|NCT00307294|AIPC|aipc
5335083|NCT00307294|Doxil|doxil
5335084|NCT00307268|ADHD Effectiveness|adhd effectiveness
5335085|NCT00307255|unspecified adult solid tumor|unspecified adult solid tumor
5335086|NCT00307255|protocol specific|protocol specific
5335087|NCT00307255|Paclitaxel|paclitaxel
5335088|NCT00307255|Abraxane|abraxane
5335089|NCT00307255|Gemcitabine|gemcitabine
5335090|NCT00307255|Gemzar|gemzar
5335091|NCT00307255|Phase I|phase i
5335092|NCT00307255|Lineberger|lineberger
5335093|NCT00307242|Adefovir Dipivoxil|adefovir dipivoxil
5335094|NCT00307242|Lamivudine|lamivudine
5335095|NCT00307242|Hepatitis B|hepatitis b
5335096|NCT00307229|metastatic breast cancer|metastatic breast cancer
5335097|NCT00307229|recurrent breast cancer|recurrent breast cancer
5335098|NCT00307216|First Episode Psychosis|first episode psychosis
5335099|NCT00307216|Early Psychosis|early psychosis
5335100|NCT00307216|Psychosocial Intervention|psychosocial intervention
5335101|NCT00307203|Bupropion|bupropion
5335102|NCT00307203|Zyban|zyban
5335103|NCT00307203|Wellbutrin|wellbutrin
5335104|NCT00307203|Smoking cessation|smoking cessation
5335105|NCT00307203|Schizophrenia|schizophrenia
5335106|NCT00307203|Schizoaffective disorder|schizoaffective disorder
5335107|NCT00307203|Cognitive Behavioral Therapy|cognitive behavioral therapy
5335108|NCT00307190|BED|bed
5335109|NCT00307177|influenza vaccine, baculovirus, immunogenicity, lymphoma|influenza vaccine, baculovirus, immunogenicity, lymphoma
5335110|NCT00307164|Treatment Experienced|treatment experienced
5335111|NCT00307164|Uridine|uridine
5335112|NCT00307151|Treatment Naive|treatment naive
5335113|NCT00307151|Mother-To-Child Transmission|mother-to-child transmission
5335114|NCT00307151|MTCT|mtct
5335115|NCT00307151|Pediatrics|pediatrics
5335116|NCT00307151|Viral resistance|viral resistance
5335117|NCT00307138|Coronary artery bypass, Off-pump|coronary artery bypass, off-pump
5335118|NCT00307138|Hetastarch|hetastarch
5335119|NCT00307138|Plasma substitutes|plasma substitutes
5335120|NCT00307138|Equivalence|equivalence
5335121|NCT00307125|Organ Transplantation|organ transplantation
5335122|NCT00307125|Graft function/survival|graft function/survival
5335123|NCT00307125|Immunosuppression|immunosuppression
5335124|NCT00307125|anti-CD20 (rituximab)|anti-cd20 (rituximab)
5335125|NCT00307112|Group A streptococcus, Nicaragua, Rheumatic Heart Disease|group a streptococcus, nicaragua, rheumatic heart disease
5335126|NCT00307099|bacterial diseases|bacterial diseases
5335127|NCT00307073|Pacemaker|pacemaker
5335128|NCT00307073|Managed Ventricular Pacing|managed ventricular pacing
5335129|NCT00307073|Ventricular Pacing|ventricular pacing
5335130|NCT00307047|Stents|stents
5335131|NCT00307047|Angioplasty|angioplasty
5335132|NCT00307047|Total coronary occlusion|total coronary occlusion
5335133|NCT00307047|coronary restenosis|coronary restenosis
5335134|NCT00307047|stent thrombosis|stent thrombosis
5335135|NCT00307034|Primary vaccination|primary vaccination
5335136|NCT00307034|Pneumococcal disease|pneumococcal disease
5335137|NCT00307034|Safety|safety
5335138|NCT00307034|Booster vaccination|booster vaccination
5335139|NCT00307034|Immunogenicity|immunogenicity
5335140|NCT00307034|Pneumococcal vaccine|pneumococcal vaccine
5335141|NCT00307034|Dose comparison|dose comparison
5335142|NCT00307021|Parasitic Diseases|parasitic diseases
5335143|NCT00307021|Malaria, Falciparum|malaria, falciparum
5335144|NCT00307021|Malaria|malaria
5335145|NCT00307021|Coccidiosis|coccidiosis
5335146|NCT00307008|Prophylaxis Invasive pneumococcal diseases and pneumonia|prophylaxis invasive pneumococcal diseases and pneumonia
5335147|NCT00306995|prophylaxis of pandemic influenza|prophylaxis of pandemic influenza
5335148|NCT00306982|Prophylaxis Influenza vaccine|prophylaxis influenza vaccine
5335149|NCT00306969|mycosis fungoides, Sézary Syndrome|mycosis fungoides, sézary syndrome
5335150|NCT00306956|Infant|infant
5335151|NCT00306956|Newborn|newborn
5335152|NCT00306956|pacifier|pacifier
5335153|NCT00306956|dummies|dummies
5335154|NCT00306956|breastfeeding|breastfeeding
5335155|NCT00306956|Sudden Infant Death|sudden infant death
5335156|NCT00306956|SIDS|sids
5335157|NCT00306956|Pacifiers|pacifiers
5335158|NCT00306930|Total Hip Replacement|total hip replacement
5335159|NCT00306930|post-traumatic arthritis|post-traumatic arthritis
5335160|NCT00306917|Total Hip Replacement|total hip replacement
5335161|NCT00306904|Macular|macular
5335162|NCT00306904|Edema|edema
5335163|NCT00306904|Diabetic|diabetic
5335164|NCT00306904|Retinopathy|retinopathy
5335165|NCT00306891|Advanced solid tumours|advanced solid tumours
5335166|NCT00306891|Advanced cancer|advanced cancer
5335167|NCT00306891|tumor|tumor
5335168|NCT00306891|tumour|tumour
5335169|NCT00306891|RECENTIN|recentin
5335170|NCT00306865|Neurotransmitter|neurotransmitter
5335171|NCT00306865|Neuroimaging|neuroimaging
5335172|NCT00306865|Movement Disorder|movement disorder
5335173|NCT00306865|Focal Hand Dystonia|focal hand dystonia
5335174|NCT00306865|FHD|fhd
5335175|NCT00306865|HV|hv
5335176|NCT00306852|Glaucoma|glaucoma
5335177|NCT00306852|Trabeculectomy|trabeculectomy
5335178|NCT00306852|Tube shunt surgery|tube shunt surgery
5335179|NCT00306839|Tissucol|tissucol
5335180|NCT00306839|Tisseel|tisseel
5335181|NCT00306839|Lichtenstein|lichtenstein
5335182|NCT00306839|hernia|hernia
5335183|NCT00306839|inguinal|inguinal
5335184|NCT00306826|Impaired glucose tolerance|impaired glucose tolerance
5335185|NCT00306813|refractory or relapsed multiple myeloma|refractory or relapsed multiple myeloma
5335186|NCT00306813|CC-5013|cc-5013
5335187|NCT00306813|Revlimid|revlimid
5335188|NCT00306813|lenalidomide|lenalidomide
5335189|NCT00306813|RAD|rad
5335190|NCT00306800|Methyl aminolevulinate|methyl aminolevulinate
5335191|NCT00306800|Photodynamic therapy|photodynamic therapy
5335192|NCT00306800|Aktilite CL128 LED light source|aktilite cl128 led light source
5335193|NCT00306800|Multiple Actinic Keratosis|multiple actinic keratosis
5335194|NCT00306787|Herpes simplex|herpes simplex
5335195|NCT00306787|genital herpes|genital herpes
5335196|NCT00306787|famciclovir|famciclovir
5335197|NCT00306787|valacyclovir|valacyclovir
5335198|NCT00306787|Recurrent genital herpes|recurrent genital herpes
5335199|NCT00306774|osteoarthritis|osteoarthritis
5335200|NCT00306774|vitamin D|vitamin d
5335201|NCT00306774|knee pain|knee pain
5335202|NCT00306774|cartilage loss|cartilage loss
5335203|NCT00306774|WOMAC|womac
5335204|NCT00306774|MRI|mri
5335205|NCT00306774|cartilage volume|cartilage volume
5335206|NCT00306774|OA|oa
5335207|NCT00306774|physical function|physical function
5335208|NCT00306774|web-based|web-based
5335209|NCT00306774|internet-based|internet-based
5335210|NCT00306748|Chronic Constipation|chronic constipation
5335211|NCT00306748|Chronic Idiopathic Constipation|chronic idiopathic constipation
5335212|NCT00306748|Constipation|constipation
5335213|NCT00306748|CIC|cic
5335214|NCT00306748|CC|cc
5335215|NCT00306748|MD-1100|md-1100
5335216|NCT00306748|MD-1100 Acetate|md-1100 acetate
5335217|NCT00306748|Microbia|microbia
5335218|NCT00306748|Microbia, Inc.|microbia, inc.
5335219|NCT00306748|linaclotide|linaclotide
5335220|NCT00306748|linaclotide acetate|linaclotide acetate
5335221|NCT00306735|Multiple Myeloma|multiple myeloma
5335222|NCT00306735|Stem Cell Transplantation|stem cell transplantation
5335223|NCT00306735|CINV|cinv
5335224|NCT00306722|Bronchoscopy|bronchoscopy
5335225|NCT00306722|Sedation|sedation
5335226|NCT00306722|AQUAVAN|aquavan
5335227|NCT00306722|fospropofol disodium|fospropofol disodium
5335228|NCT00306722|Flexible bronchoscopy|flexible bronchoscopy
5335229|NCT00306709|obesity|obesity
5335230|NCT00306709|behavior change|behavior change
5335231|NCT00306709|cultural adaptations|cultural adaptations
5335232|NCT00306709|weight loss|weight loss
5335233|NCT00306696|rosiglitazone|rosiglitazone
5335234|NCT00306696|fluid retention|fluid retention
5335235|NCT00306696|Type 2 diabetes|type 2 diabetes
5335236|NCT00306696|diuretics|diuretics
5335237|NCT00306683|Hypothalamic-pituitary lesions|hypothalamic-pituitary lesions
5335238|NCT00306683|Craniopharyngioma|craniopharyngioma
5335239|NCT00306683|Obesity|obesity
5335240|NCT00306683|Diazoxide|diazoxide
5335241|NCT00306683|Hyperinsulinemia|hyperinsulinemia
5335242|NCT00306683|Pediatric neurosurgery|pediatric neurosurgery
5335243|NCT00306683|Oncology|oncology
5335244|NCT00306683|Pituitary|pituitary
5335245|NCT00306683|Hypothalamus|hypothalamus
5335246|NCT00306670|Acquired Hemophilia A|acquired hemophilia a
5335247|NCT00306670|Anti-Factor VIII antibodies|anti-factor viii antibodies
5335248|NCT00306670|Anti-Factor VIII inhibitors|anti-factor viii inhibitors
5335249|NCT00306670|Hemophilia A|hemophilia a
5335250|NCT00306670|Factor VIII inhibitors|factor viii inhibitors
5335251|NCT00306657|Glaucoma Open-Angle|glaucoma open-angle
5335252|NCT00306657|Normal tension glaucoma progressive|normal tension glaucoma progressive
5335253|NCT00306657|chronic open angle glaucoma progressive|chronic open angle glaucoma progressive
5335254|NCT00306657|optic nerve sheath fenestration|optic nerve sheath fenestration
5335255|NCT00306657|cerebrospinal fluid|cerebrospinal fluid
5335256|NCT00306657|Beta-Trace Protein|beta-trace protein
5335257|NCT00306644|rosiglitazone|rosiglitazone
5335258|NCT00306644|Type 2 diabetes|type 2 diabetes
5335259|NCT00306644|intima media thickness|intima media thickness
5335260|NCT00306644|Insulin resistance|insulin resistance
5335261|NCT00306631|Advanced and Metastatic Breast Cancer|advanced and metastatic breast cancer
5335262|NCT00306605|Emotional experiences|emotional experiences
5335263|NCT00306605|fathers|fathers
5335264|NCT00306605|stress|stress
5335265|NCT00306605|depressive symptomatology|depressive symptomatology
5335266|NCT00306605|NICU|nicu
5335267|NCT00306605|preterm birth|preterm birth
5335268|NCT00306592|Multiple Sclerosis|multiple sclerosis
5335269|NCT00306592|MS|ms
5335270|NCT00306579|Ischemic Stroke|ischemic stroke
5335271|NCT00306579|Myocardial ischemia|myocardial ischemia
5335272|NCT00306579|Myocardial necrosis|myocardial necrosis
5335273|NCT00306527|Influenza|influenza
5335274|NCT00306527|adult/elderly|adult/elderly
5335275|NCT00306527|flu cell culture|flu cell culture
5335276|NCT00306527|vaccine|vaccine
5335277|NCT00306514|metastatic malignant melanoma of the skin|metastatic malignant melanoma of the skin
5335278|NCT00306501|Training|training
5335279|NCT00306501|Cortical Stimulation|cortical stimulation
5335280|NCT00306501|Sensory Stimulation|sensory stimulation
5335281|NCT00306501|Brain Imaging|brain imaging
5335282|NCT00306501|Transcranial Magnetic Stimulation (TMS)|transcranial magnetic stimulation (tms)
5335283|NCT00306501|Swallowing|swallowing
5335284|NCT00306501|Dysphagia|dysphagia
5335285|NCT00306501|Stroke|stroke
5335286|NCT00306501|CVA|cva
5335287|NCT00306501|Cerebral Vascular Accident|cerebral vascular accident
5335288|NCT00306501|Healthy Volunteer|healthy volunteer
5335289|NCT00306501|HV|hv
5335290|NCT00306488|Retinal Pigment Epithelium|retinal pigment epithelium
5335291|NCT00306488|Dynamic Light Scattering (DLS)|dynamic light scattering (dls)
5335292|NCT00306488|Visual Acuity Decrease|visual acuity decrease
5335293|NCT00306488|Intra-ocular Pressure|intra-ocular pressure
5335294|NCT00306488|Autofluorescence of Retina|autofluorescence of retina
5335295|NCT00306488|Age-Related Macular Degeneration|age-related macular degeneration
5335296|NCT00306488|AMD|amd
5335297|NCT00306475|schizophrenia, cognition, mood stabilizer|schizophrenia, cognition, mood stabilizer
5335298|NCT00306462|Premature Labor|premature labor
5335299|NCT00306462|Premature Birth|premature birth
5335300|NCT00306462|Magnesium sulfate|magnesium sulfate
5335301|NCT00306462|Nifedipine|nifedipine
5335302|NCT00306449|Weight gain|weight gain
5335303|NCT00306449|obesity|obesity
5335304|NCT00306449|overweight|overweight
5335305|NCT00306449|young adults|young adults
5335306|NCT00306449|lipid disorders|lipid disorders
5335307|NCT00306449|insulin resistance|insulin resistance
5335308|NCT00306449|randomized controled study|randomized controled study
5335309|NCT00306436|Diabetes|diabetes
5335310|NCT00306436|renal deficiency|renal deficiency
5335311|NCT00306436|hypertension|hypertension
5335312|NCT00306423|exercise|exercise
5335313|NCT00306410|Vitamin D deficiency|vitamin d deficiency
5335314|NCT00306410|HIV/AIDS|hiv/aids
5335315|NCT00306410|HAART|haart
5335316|NCT00306410|T-Lymphocytes, Regulatory|t-lymphocytes, regulatory
5335317|NCT00306410|insulin resistance|insulin resistance
5336244|NCT00303537|metformin|metformin
5335318|NCT00306410|bone density|bone density
5335319|NCT00306397|Kidney transplantation|kidney transplantation
5335320|NCT00306397|Steroid free|steroid free
5335321|NCT00306397|Calcineurin inhibitor free|calcineurin inhibitor free
5335322|NCT00306397|Tacrolimus|tacrolimus
5335323|NCT00306397|Sirolimus|sirolimus
5335324|NCT00306384|Glucose Metabolism Disorder|glucose metabolism disorder
5335325|NCT00306384|Dysmetabolic Syndrome|dysmetabolic syndrome
5335326|NCT00306384|Type II Diabetes|type ii diabetes
5335327|NCT00306384|Diabetes Mellitus,|diabetes mellitus,
5335328|NCT00306384|Lipoatrophic|lipoatrophic
5335329|NCT00306384|Dyslipidemia|dyslipidemia
5335330|NCT00306384|Drug Therapy|drug therapy
5335331|NCT00306371|diode|diode
5335332|NCT00306371|laser|laser
5335333|NCT00306371|acne|acne
5335334|NCT00306371|acne scar|acne scar
5335335|NCT00306358|absorption test|absorption test
5335336|NCT00306358|cobalamin|cobalamin
5335337|NCT00306358|holotranscobalamin|holotranscobalamin
5335338|NCT00306358|vitamin B12|vitamin b12
5335339|NCT00306345|Outreach|outreach
5335340|NCT00306345|Major general surgery|major general surgery
5335341|NCT00306345|Intensive care|intensive care
5335342|NCT00306345|Serious adverse events|serious adverse events
5335343|NCT00306332|Allogeneic Stem cell transplantation|allogeneic stem cell transplantation
5335344|NCT00306332|T-cell depletion|t-cell depletion
5335345|NCT00306332|B-cell depletion|b-cell depletion
5335346|NCT00306332|Immunomagnetic selection|immunomagnetic selection
5335347|NCT00306319|Tuberculosis|tuberculosis
5335348|NCT00306293|Recurrent Genital Herpes|recurrent genital herpes
5335349|NCT00306280|Helicobacter pylori|helicobacter pylori
5335350|NCT00306280|phototherapy|phototherapy
5335351|NCT00306280|peptic ulcer|peptic ulcer
5335352|NCT00306280|gastric cancer|gastric cancer
5335353|NCT00306267|Anemia|anemia
5335354|NCT00306267|non-chemotherapy-induced|non-chemotherapy-induced
5335355|NCT00306267|non-radiation therapy-induced|non-radiation therapy-induced
5335356|NCT00306267|cancer|cancer
5335357|NCT00306267|non-myeloid|non-myeloid
5335358|NCT00306241|Cervical neoplasia|cervical neoplasia
5335359|NCT00306241|Cervical cancer|cervical cancer
5335360|NCT00306241|Double-blind|double-blind
5335361|NCT00306241|HPV-16/18 L1 VLP AS04|hpv-16/18 l1 vlp as04
5335362|NCT00306241|HPV|hpv
5335363|NCT00306241|AS04|as04
5335364|NCT00306228|ST elevation acute myocardial infarction|st elevation acute myocardial infarction
5335365|NCT00306228|Thrombolysis|thrombolysis
5335366|NCT00306228|Early routine percutaneous coronary intervention|early routine percutaneous coronary intervention
5335367|NCT00306228|tirofiban|tirofiban
5335368|NCT00306228|paclitaxel|paclitaxel
5335369|NCT00306215|double-blind|double-blind
5335370|NCT00306215|placebo-controlled|placebo-controlled
5335371|NCT00306215|multicenter|multicenter
5335372|NCT00306215|efficacy|efficacy
5335373|NCT00306215|safety|safety
5335374|NCT00306202|Relapsed and Refractory Leukemia|relapsed and refractory leukemia
5335376|NCT00306189|RANK|rank
5335377|NCT00306189|denosumab|denosumab
5335378|NCT00306189|AMG 162|amg 162
5335379|NCT00306189|osteoporosis|osteoporosis
5335380|NCT00306189|bone turnover|bone turnover
5335381|NCT00306189|bone mineral density|bone mineral density
5335382|NCT00306189|Japanese|japanese
5335383|NCT00306176|rosiglitazone,exercise,cardiovascular risk factors|rosiglitazone,exercise,cardiovascular risk factors
5335384|NCT00306163|Asthma|asthma
5335385|NCT00306163|AMP|amp
5335386|NCT00306163|Ciclesonide|ciclesonide
5335387|NCT00306163|Fluticasone propionate|fluticasone propionate
5335388|NCT00306150|Prevention of blood loss|prevention of blood loss
5335389|NCT00306150|Blood Loss, Surgical|blood loss, surgical
5335390|NCT00306150|Blood Loss, Postoperative|blood loss, postoperative
5335391|NCT00306124|Dementia|dementia
5335392|NCT00306124|Mild Cognitive Impairment|mild cognitive impairment
5335393|NCT00306124|MCI|mci
5335394|NCT00306124|levodopa|levodopa
5335395|NCT00306124|learning|learning
5335396|NCT00306124|enhancement|enhancement
5335397|NCT00306111|stem cell transplantation|stem cell transplantation
5335398|NCT00306111|stem cell mobilization|stem cell mobilization
5335399|NCT00306111|high-dose therapy|high-dose therapy
5335400|NCT00306098|Transplantation, Islets of Langerhans|transplantation, islets of langerhans
5335401|NCT00306085|Peripheral arterial disease,|peripheral arterial disease,
5335402|NCT00306085|blood marrow cells,|blood marrow cells,
5335403|NCT00306085|therapeutic angiogenesis.|therapeutic angiogenesis.
5335404|NCT00306046|PETScan|petscan
5335405|NCT00306046|Positron-Emission Tomography|positron-emission tomography
5335406|NCT00306046|Bisphosphonate|bisphosphonate
5335407|NCT00306046|Biochemical Markers|biochemical markers
5335408|NCT00306046|Paget's Disease of Bone (monostotic and polyostotic)|paget's disease of bone (monostotic and polyostotic)
5335409|NCT00306033|myasthenia gravis|myasthenia gravis
5335410|NCT00306033|immunoglobulin|immunoglobulin
5335411|NCT00306033|intravenous immunoglobulin|intravenous immunoglobulin
5335412|NCT00306033|treatment|treatment
5335413|NCT00306020|Skin ulcers|skin ulcers
5335414|NCT00306020|Topical morphine|topical morphine
5335415|NCT00306020|Chronic pain|chronic pain
5335416|NCT00306020|Cancer|cancer
5335417|NCT00306007|Pregnancy|pregnancy
5335418|NCT00306007|Unplanned pregnancy|unplanned pregnancy
5335419|NCT00306007|Psychosocial|psychosocial
5335420|NCT00306007|Measure|measure
5335421|NCT00305968|Quality of life|quality of life
5335422|NCT00305968|Gastrointestinal symptoms|gastrointestinal symptoms
5335423|NCT00305968|Health related costs|health related costs
5335424|NCT00305955|amblyopia|amblyopia
5335425|NCT00305955|bilateral amblyopia|bilateral amblyopia
5335426|NCT00305955|refractive error|refractive error
5335427|NCT00305942|Lung Cancer|lung cancer
5335428|NCT00305942|Carcinoma, Small Cell|carcinoma, small cell
5335429|NCT00305929|Treatment of localized prostate cancer|treatment of localized prostate cancer
5335430|NCT00305929|Localized prostate cancer|localized prostate cancer
5335431|NCT00305916|MSCT|msct
5335432|NCT00305916|Idiopathic Cardiomyopathy|idiopathic cardiomyopathy
5335433|NCT00305916|Sinus rhythm|sinus rhythm
5335434|NCT00305903|Dementia,|dementia,
5335435|NCT00305903|Alzheimer's,|alzheimer's,
5335436|NCT00305903|Rivastigmine,|rivastigmine,
5335437|NCT00305903|Memantine|memantine
5335438|NCT00305851|fatigue|fatigue
5335439|NCT00305851|pain|pain
5335440|NCT00305851|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
5335441|NCT00305851|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5335442|NCT00305851|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5335443|NCT00305851|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5335444|NCT00305851|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5335445|NCT00305851|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5335446|NCT00305851|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5335447|NCT00305851|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5335448|NCT00305851|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5335449|NCT00305851|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
5335450|NCT00305851|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5335451|NCT00305851|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
5335452|NCT00305851|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
5335453|NCT00305851|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
5335454|NCT00305851|chronic eosinophilic leukemia|chronic eosinophilic leukemia
5335455|NCT00305851|primary myelofibrosis|primary myelofibrosis
5335456|NCT00305851|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5335457|NCT00305851|chronic neutrophilic leukemia|chronic neutrophilic leukemia
5335458|NCT00305851|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5335459|NCT00305851|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5335460|NCT00305851|disseminated neuroblastoma|disseminated neuroblastoma
5335461|NCT00305851|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5335462|NCT00305851|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
5335463|NCT00305851|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
5335464|NCT00305851|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5335465|NCT00305851|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
5335466|NCT00305851|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5335467|NCT00305851|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
5335468|NCT00305851|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
5335469|NCT00305851|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
5335470|NCT00305851|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
5335471|NCT00305851|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5335472|NCT00305851|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5335473|NCT00305851|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5335474|NCT00305851|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5335475|NCT00305851|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
5335476|NCT00305851|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
5335477|NCT00305851|high risk metastatic gestational trophoblastic tumor|high risk metastatic gestational trophoblastic tumor
5335478|NCT00305851|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
5335479|NCT00305851|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5335480|NCT00305851|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5335481|NCT00305851|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5335482|NCT00305851|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5335483|NCT00305851|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5335484|NCT00305851|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5335485|NCT00305851|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5335486|NCT00305851|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5335487|NCT00305851|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5335488|NCT00305851|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5335489|NCT00305851|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
5335490|NCT00305851|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5335491|NCT00305851|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5335492|NCT00305851|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
5335493|NCT00305851|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
5335494|NCT00305851|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
5335495|NCT00305851|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
5335496|NCT00305851|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5335497|NCT00305851|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5335498|NCT00305851|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5335499|NCT00305851|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5335500|NCT00305851|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5335501|NCT00305851|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5335502|NCT00305851|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5335503|NCT00305851|recurrent neuroblastoma|recurrent neuroblastoma
5335504|NCT00305851|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5335505|NCT00305851|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
5335506|NCT00305851|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5335507|NCT00305851|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
5335508|NCT00305851|recurrent Wilms tumor and other childhood kidney tumors|recurrent wilms tumor and other childhood kidney tumors
5335509|NCT00305851|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5335510|NCT00305851|refractory hairy cell leukemia|refractory hairy cell leukemia
5335511|NCT00305851|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5335512|NCT00305851|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5335513|NCT00305851|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5335514|NCT00305851|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5335515|NCT00305851|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5335516|NCT00305851|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5335517|NCT00305851|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5335518|NCT00305851|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5335519|NCT00305851|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5335520|NCT00305851|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5335521|NCT00305851|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5335522|NCT00305851|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5335523|NCT00305851|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5335524|NCT00305851|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5335525|NCT00305851|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5335526|NCT00305851|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5335527|NCT00305851|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5335528|NCT00305851|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5335529|NCT00305851|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
5335530|NCT00305851|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5335531|NCT00305851|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5335532|NCT00305851|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5335533|NCT00305851|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5335534|NCT00305851|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5335535|NCT00305851|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5335536|NCT00305851|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5335537|NCT00305851|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5335538|NCT00305851|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5335539|NCT00305851|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5335540|NCT00305851|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5335541|NCT00305851|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5335542|NCT00305851|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5335543|NCT00305851|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5335544|NCT00305851|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5335545|NCT00305851|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
5335546|NCT00305851|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5335547|NCT00305851|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
5335548|NCT00305851|Ewing sarcoma|ewing sarcoma
5335549|NCT00305851|childhood brain tumor|childhood brain tumor
5335550|NCT00305851|adult brain tumor|adult brain tumor
5335551|NCT00305851|osteosarcoma|osteosarcoma
5336347|NCT00303225|Monkeypox|monkeypox
5335552|NCT00305838|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5335553|NCT00305838|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5335554|NCT00305838|stage IIIA ovarian epithelial cancer|stage iiia ovarian epithelial cancer
5335555|NCT00305838|stage IIIB ovarian epithelial cancer|stage iiib ovarian epithelial cancer
5335556|NCT00305838|stage IIIC ovarian epithelial cancer|stage iiic ovarian epithelial cancer
5335557|NCT00305838|recurrent fallopian tube cancer|recurrent fallopian tube cancer
5335558|NCT00305838|stage IIIA fallopian tube cancer|stage iiia fallopian tube cancer
5335559|NCT00305838|stage IIIB fallopian tube cancer|stage iiib fallopian tube cancer
5335560|NCT00305838|stage IIIC fallopian tube cancer|stage iiic fallopian tube cancer
5335561|NCT00305838|stage IV fallopian tube cancer|stage iv fallopian tube cancer
5335562|NCT00305838|recurrent primary peritoneal cavity cancer|recurrent primary peritoneal cavity cancer
5335563|NCT00305838|stage IIIA primary peritoneal cavity cancer|stage iiia primary peritoneal cavity cancer
5335564|NCT00305838|stage IIIB primary peritoneal cavity cancer|stage iiib primary peritoneal cavity cancer
5335565|NCT00305838|stage IIIC primary peritoneal cavity cancer|stage iiic primary peritoneal cavity cancer
5335566|NCT00305838|stage IV primary peritoneal cavity cancer|stage iv primary peritoneal cavity cancer
5335567|NCT00305825|recurrent breast cancer|recurrent breast cancer
5335568|NCT00305825|stage IIIA breast cancer|stage iiia breast cancer
5335569|NCT00305825|stage IIIB breast cancer|stage iiib breast cancer
5335570|NCT00305825|stage IIIC breast cancer|stage iiic breast cancer
5335571|NCT00305825|stage IV breast cancer|stage iv breast cancer
5335572|NCT00305812|stage I multiple myeloma|stage i multiple myeloma
5335573|NCT00305812|stage II multiple myeloma|stage ii multiple myeloma
5335574|NCT00305812|stage III multiple myeloma|stage iii multiple myeloma
5335575|NCT00305799|neurotoxicity|neurotoxicity
5335818|NCT00304993|Metabolic Syndrome|metabolic syndrome
5335576|NCT00305799|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5335577|NCT00305786|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5335578|NCT00305786|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5335579|NCT00305786|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5335580|NCT00305760|stage III pancreatic cancer|stage iii pancreatic cancer
5335581|NCT00305760|recurrent pancreatic cancer|recurrent pancreatic cancer
5335582|NCT00305760|duct cell adenocarcinoma of the pancreas|duct cell adenocarcinoma of the pancreas
5335583|NCT00305760|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
5335584|NCT00305760|stage IV pancreatic cancer|stage iv pancreatic cancer
5335585|NCT00305747|recurrent prostate cancer|recurrent prostate cancer
5335586|NCT00305747|stage I prostate cancer|stage i prostate cancer
5335587|NCT00305747|stage II prostate cancer|stage ii prostate cancer
5335588|NCT00305747|stage III prostate cancer|stage iii prostate cancer
5335589|NCT00305747|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5335590|NCT00305747|stage IV prostate cancer|stage iv prostate cancer
5335591|NCT00305708|thrombocytopenia|thrombocytopenia
5335592|NCT00305708|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
5335593|NCT00305708|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
5335594|NCT00305708|Diamond-Blackfan anemia|diamond-blackfan anemia
5335595|NCT00305708|congenital amegakaryocytic thrombocytopenia|congenital amegakaryocytic thrombocytopenia
5335596|NCT00305708|Fanconi anemia|fanconi anemia
5335597|NCT00305708|severe congenital neutropenia|severe congenital neutropenia
5335598|NCT00305708|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5335599|NCT00305669|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5335600|NCT00305669|stage I prostate cancer|stage i prostate cancer
5335601|NCT00305669|stage IIB prostate cancer|stage iib prostate cancer
5335602|NCT00305669|stage IIA prostate cancer|stage iia prostate cancer
5335603|NCT00305669|stage III prostate cancer|stage iii prostate cancer
5335604|NCT00305643|Hand-Foot Syndrome|hand-foot syndrome
5335605|NCT00305643|cancer-related problem/condition|cancer-related problem/condition
5335606|NCT00305643|drug/agent toxicity by tissue/organ|drug/agent toxicity by tissue/organ
5335607|NCT00305643|pain|pain
5335608|NCT00305643|palmar-plantar erythrodysesthesia|palmar-plantar erythrodysesthesia
5335609|NCT00305643|stage IV breast cancer|stage iv breast cancer
5335610|NCT00305643|male breast cancer|male breast cancer
5335611|NCT00305643|recurrent breast cancer|recurrent breast cancer
5335612|NCT00305643|stage IV colon cancer|stage iv colon cancer
5335613|NCT00305643|stage IV rectal cancer|stage iv rectal cancer
5335614|NCT00305643|recurrent colon cancer|recurrent colon cancer
5335615|NCT00305643|recurrent rectal cancer|recurrent rectal cancer
5335616|NCT00305643|Celecoxib|celecoxib
5335617|NCT00305643|Celebrex|celebrex
5335618|NCT00305643|Capecitabine|capecitabine
5335619|NCT00305643|Xeloda|xeloda
5335620|NCT00305630|Corticosteroids|corticosteroids
5335621|NCT00305630|Triamcinolone|triamcinolone
5335622|NCT00305630|Photodynamic therapy|photodynamic therapy
5335623|NCT00305630|Choroidal neovascularization|choroidal neovascularization
5335624|NCT00305630|Age-related macular degeneration|age-related macular degeneration
5335625|NCT00305617|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5335626|NCT00305617|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5335627|NCT00305591|magnetic resonance imaging|magnetic resonance imaging
5335628|NCT00305591|magnetic resonance spectroscopy|magnetic resonance spectroscopy
5335629|NCT00305591|functional magnetic resonance imaging|functional magnetic resonance imaging
5335630|NCT00305591|cirrhosis|cirrhosis
5335631|NCT00305591|hepatic encephalopathy|hepatic encephalopathy
5335632|NCT00305591|l-ornithine l-aspartate|l-ornithine l-aspartate
5335633|NCT00305578|Bipolar|bipolar
5335634|NCT00305578|Depression|depression
5335635|NCT00305578|Incomplete Response|incomplete response
5335636|NCT00305565|Depression|depression
5335637|NCT00305565|Chronic Depression|chronic depression
5335638|NCT00305565|Bipolar Disorder|bipolar disorder
5335639|NCT00305552|Randomized controlled trial|randomized controlled trial
5335640|NCT00305552|Thalidomide vs placebo|thalidomide vs placebo
5335641|NCT00305552|skin sarcoidosis|skin sarcoidosis
5335642|NCT00305552|Thalidomide|thalidomide
5335643|NCT00305539|Giant Cell Arteritis|giant cell arteritis
5335644|NCT00305539|Placebo|placebo
5335645|NCT00305539|Anti-TNF|anti-tnf
5335646|NCT00305539|Multicenter-randomized-trial|multicenter-randomized-trial
5335647|NCT00305539|Proved GCA according to ACR criteria (HUNDER et al 1990)|proved gca according to acr criteria (hunder et al 1990)
5335648|NCT00305513|right hemispheric CVA|right hemispheric cva
5335649|NCT00305513|neglect|neglect
5335650|NCT00305513|phasic alert treatment|phasic alert treatment
5335651|NCT00305513|PET scan|pet scan
5335652|NCT00305513|patients post right hemispheric CVA (stroke)|patients post right hemispheric cva (stroke)
5335653|NCT00305500|OCD|ocd
5335654|NCT00305500|Escitalopram|escitalopram
5335655|NCT00305487|Hay Fever|hay fever
5335656|NCT00305487|Seasonal Allergic Rhinitis|seasonal allergic rhinitis
5335657|NCT00305487|Nasal spray|nasal spray
5335658|NCT00305487|Ciclesonide|ciclesonide
5335659|NCT00305487|Allergic Rhinitis|allergic rhinitis
5335660|NCT00305474|Negative symptoms|negative symptoms
5335661|NCT00305474|neuropsychological deficits|neuropsychological deficits
5335662|NCT00305474|Cognitive function|cognitive function
5335663|NCT00305474|diagnostic|diagnostic
5335664|NCT00305474|prevention|prevention
5335665|NCT00305461|Asthma|asthma
5335666|NCT00305461|Quality of Life|quality of life
5335667|NCT00305461|Ciclesonide|ciclesonide
5335668|NCT00305448|oncology|oncology
5335669|NCT00305448|cancer|cancer
5335670|NCT00305448|breast cancer|breast cancer
5335671|NCT00305435|AMG 531, ITP, Phase 2, Japanese|amg 531, itp, phase 2, japanese
5335672|NCT00305409|Crohn's|crohn's
5335673|NCT00305409|TNF-alpha|tnf-alpha
5335674|NCT00305409|Synbiotic|synbiotic
5335675|NCT00305409|Probiotic|probiotic
5335676|NCT00305396|Kidney transplantation|kidney transplantation
5335677|NCT00305396|immunosuppression|immunosuppression
5335678|NCT00305396|sirolimus|sirolimus
5335679|NCT00305396|Thymoglobulin|thymoglobulin
5335680|NCT00305383|Viramidine|viramidine
5335681|NCT00305383|Peginterferon alfa-2b|peginterferon alfa-2b
5335682|NCT00305383|Valeant|valeant
5335683|NCT00305383|Hepatitis C|hepatitis c
5335684|NCT00305383|Rapid virologic response|rapid virologic response
5335685|NCT00305383|HCV RNA|hcv rna
5335686|NCT00305370|clinical trial|clinical trial
5335687|NCT00305370|aripiprazole|aripiprazole
5335688|NCT00305370|methylphenidate|methylphenidate
5335689|NCT00305370|Bipolar Disorder|bipolar disorder
5335690|NCT00305370|Attention-Deficit Hyperactivity Disorder|attention-deficit hyperactivity disorder
5335691|NCT00305370|ADHD|adhd
5335692|NCT00305357|Post-Herpetic Neuralgia|post-herpetic neuralgia
5335693|NCT00305357|Acute Herpes Zoster|acute herpes zoster
5335694|NCT00305344|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
5335695|NCT00305344|Umbilical Cord|umbilical cord
5335696|NCT00305344|Regeneration|regeneration
5335697|NCT00305344|Insulin|insulin
5335698|NCT00305344|Islets of Langerhans|islets of langerhans
5335699|NCT00305331|Parkinson's disease|parkinson's disease
5335700|NCT00305331|Domperidone|domperidone
5335701|NCT00305331|Peripheral edema|peripheral edema
5335702|NCT00305331|Pramipexole|pramipexole
5335703|NCT00305331|Ropinirole|ropinirole
5335704|NCT00305305|Agenesis Corpus Callosum|agenesis corpus callosum
5335705|NCT00305305|Polymicrogyria|polymicrogyria
5335706|NCT00305305|Dandy-Walker|dandy-walker
5335707|NCT00305305|Brain Malformation|brain malformation
5335708|NCT00305305|Autism|autism
5335709|NCT00305305|Epilepsy|epilepsy
5335710|NCT00305305|Mental Retardation|mental retardation
5335711|NCT00305305|MRI|mri
5335712|NCT00305305|Agenesis of the Corpus Callosum (complete or partial)|agenesis of the corpus callosum (complete or partial)
5335713|NCT00305305|Confirmed by a brain MRI.|confirmed by a brain mri.
5335714|NCT00305305|Aicardi Syndrome.|aicardi syndrome.
5335715|NCT00305266|CIDP|cidp
5335716|NCT00305266|IVIG|ivig
5335717|NCT00305266|gammaglobulin|gammaglobulin
5335718|NCT00305266|Chronic Inflammatory Demyelinating Polyradiculoneuropathy|chronic inflammatory demyelinating polyradiculoneuropathy
5335719|NCT00305253|maternal mortality|maternal mortality
5335720|NCT00305253|obstetric hemorrhage|obstetric hemorrhage
5335721|NCT00305240|Myocardial Infarction|myocardial infarction
5335722|NCT00305240|Microvolt T Wave Alternans Test|microvolt t wave alternans test
5335723|NCT00305240|Implantable Cardioverter Defibrillator (ICD)|implantable cardioverter defibrillator (icd)
5335724|NCT00305240|Ventricular Arrythmias|ventricular arrythmias
5335725|NCT00305227|urinary tract infection|urinary tract infection
5335726|NCT00305227|cystitis|cystitis
5335727|NCT00305227|Lactobacillus|lactobacillus
5335728|NCT00305227|probiotic|probiotic
5335729|NCT00305227|prevention|prevention
5335730|NCT00305214|Myocardial Infarction|myocardial infarction
5335731|NCT00305214|Microvolt T Wave Alternans Test|microvolt t wave alternans test
5335732|NCT00305214|Implantable Cardioverter Defibrillator (ICD)|implantable cardioverter defibrillator (icd)
5335733|NCT00305214|Ventricular Arrhythmia|ventricular arrhythmia
5335734|NCT00305201|Mucocutaneous Lymph Node Syndrome|mucocutaneous lymph node syndrome
5335735|NCT00305201|Kawasaki disease|kawasaki disease
5335736|NCT00305201|Endothelial dysfunction|endothelial dysfunction
5335737|NCT00305201|Pravastatin|pravastatin
5335738|NCT00305201|Statin therapy|statin therapy
5335739|NCT00305188|Neurotoxicity syndromes|neurotoxicity syndromes
5335740|NCT00305188|Paresthesia|paresthesia
5335741|NCT00305188|Oxaliplatin|oxaliplatin
5335742|NCT00305188|Xaliproden|xaliproden
5335743|NCT00305175|Hydroxyurea|hydroxyurea
5335744|NCT00305175|Sickle Cell Anemia|sickle cell anemia
5335745|NCT00305162|Acute Coronary Syndrome (ACS)|acute coronary syndrome (acs)
5335746|NCT00305162|Percutaneous Coronary Intervention (PCI)|percutaneous coronary intervention (pci)
5335747|NCT00305162|non-ST-segment elevation myocardial infarction (NSTEMI)|non-st-segment elevation myocardial infarction (nstemi)
5335748|NCT00305162|ST-segment elevation myocardial infarction (STEMI)|st-segment elevation myocardial infarction (stemi)
5335749|NCT00305149|Hodgkin Lymphoma|hodgkin lymphoma
5335750|NCT00305149|BEACOPP|beacopp
5335751|NCT00305149|PET|pet
5335752|NCT00305149|Gallium|gallium
5335753|NCT00305149|Tailored therapy|tailored therapy
5335754|NCT00305136|thoracotomy|thoracotomy
5335755|NCT00305136|post-operative pain|post-operative pain
5335756|NCT00305136|chronic pain|chronic pain
5335757|NCT00305136|endogenous analgesia|endogenous analgesia
5335758|NCT00305136|temporal summation|temporal summation
5335759|NCT00305136|central sensitization|central sensitization
5335760|NCT00305136|prediction|prediction
5335761|NCT00305136|Patients Who Should Undergo Thoracotomy|patients who should undergo thoracotomy
5335762|NCT00305123|Pharyngitis, Mali, Group A Streptococcus, Children|pharyngitis, mali, group a streptococcus, children
5335763|NCT00305110|Pain|pain
5335764|NCT00305110|Acute|acute
5335765|NCT00305110|Emergency Department|emergency department
5335766|NCT00305110|Severe|severe
5335767|NCT00305110|Hydromorphone|hydromorphone
5335768|NCT00305110|Dilaudid|dilaudid
5335769|NCT00305110|Adult|adult
5335770|NCT00305097|coffee|coffee
5335771|NCT00305097|caffeine|caffeine
5335772|NCT00305097|glucose tolerance|glucose tolerance
5335773|NCT00305097|body weight|body weight
5335774|NCT00305097|insulin sensitivity|insulin sensitivity
5335775|NCT00305097|randomized controlled trial|randomized controlled trial
5335776|NCT00305084|NGR-hTNF|ngr-htnf
5335777|NCT00305084|doxorubicin|doxorubicin
5335778|NCT00305084|solid tumors|solid tumors
5335779|NCT00305071|pyuria|pyuria
5335780|NCT00305071|urinary tract infections|urinary tract infections
5335781|NCT00305071|Vaccinium macrocarpon|vaccinium macrocarpon
5335782|NCT00305058|Elderly|elderly
5335783|NCT00305058|Hydromorphone|hydromorphone
5335784|NCT00305058|Morphine|morphine
5335785|NCT00305058|Pain|pain
5335786|NCT00305058|Acute|acute
5335787|NCT00305058|Emergency Department|emergency department
5335788|NCT00305045|Major Depressive Disorder|major depressive disorder
5335789|NCT00305045|Repetitive Transcranial Magnetic Stimulation|repetitive transcranial magnetic stimulation
5335790|NCT00305045|Treatment resistance|treatment resistance
5335791|NCT00305006|cerebral palsy|cerebral palsy
5335792|NCT00305006|constraint-induced therapy|constraint-induced therapy
5335793|NCT00305006|constraint-induced movement therapy|constraint-induced movement therapy
5335794|NCT00305006|CP|cp
5335795|NCT00305006|hemiplegia|hemiplegia
5335796|NCT00305006|hand|hand
5335797|NCT00305006|forced use|forced use
5335798|NCT00305006|motor control|motor control
5335799|NCT00305006|children|children
5335800|NCT00305006|HABIT|habit
5335801|NCT00305006|Hand-arm bimanual intensive therapy|hand-arm bimanual intensive therapy
5335802|NCT00305006|Bilateral training|bilateral training
5335803|NCT00305006|Bimanual training|bimanual training
5335804|NCT00305006|functional therapy|functional therapy
5335805|NCT00305006|physical therapy|physical therapy
5335806|NCT00305006|occupational therapy|occupational therapy
5335807|NCT00305006|intensive|intensive
5335808|NCT00305006|pediatric|pediatric
5335809|NCT00305006|development|development
5335810|NCT00305006|upper extremity|upper extremity
5335811|NCT00305006|hemiplegic|hemiplegic
5335812|NCT00304993|fenofibrate|fenofibrate
5335813|NCT00304993|niacin|niacin
5335814|NCT00304993|rosiglitazone|rosiglitazone
5335815|NCT00304993|LDL phenotype pattern B|ldl phenotype pattern b
5335816|NCT00304993|small, dense LDL|small, dense ldl
5335817|NCT00304993|insulin resistance|insulin resistance
5335819|NCT00304967|Cataract|cataract
5335820|NCT00304967|Normal Lenses|normal lenses
5335821|NCT00304967|Lens Crystallines|lens crystallines
5335822|NCT00304967|Dynamic or Quasielastic Light Scattering (DLS)|dynamic or quasielastic light scattering (dls)
5335823|NCT00304967|Eye Examinations|eye examinations
5335824|NCT00304967|Healthy Volunteer|healthy volunteer
5335825|NCT00304967|HV|hv
5335826|NCT00304967|Eye Examination|eye examination
5335827|NCT00304954|Age-Related Macular Degeneration|age-related macular degeneration
5335828|NCT00304954|Rapamycin|rapamycin
5335829|NCT00304954|Remicade|remicade
5335830|NCT00304954|Daclizumab|daclizumab
5335831|NCT00304954|Immunosuppression|immunosuppression
5335832|NCT00304954|Infliximab|infliximab
5335833|NCT00304954|Choroidal Neovascularization|choroidal neovascularization
5335834|NCT00304954|Sirolimus|sirolimus
5335835|NCT00304954|AMD|amd
5335836|NCT00304954|Ocular Inflammation|ocular inflammation
5335837|NCT00304941|Breast Cancer|breast cancer
5335838|NCT00304941|Family History|family history
5335839|NCT00304941|Pre/Post Menopausal|pre/post menopausal
5335840|NCT00304941|Prevention|prevention
5335841|NCT00304941|Risk-Factor|risk-factor
5335842|NCT00304941|Body-Mass-Index|body-mass-index
5335843|NCT00304941|BRCA1|brca1
5335844|NCT00304941|Insulin|insulin
5335845|NCT00304941|Genetic Counseling|genetic counseling
5335846|NCT00304941|Penetrance|penetrance
5335847|NCT00304941|Risk Assessment|risk assessment
5335848|NCT00304941|Healthy Volunteer|healthy volunteer
5335849|NCT00304941|HV|hv
5335850|NCT00304915|HIV, depression|hiv, depression
5335851|NCT00304915|patient care management|patient care management
5335852|NCT00304915|patient care team|patient care team
5335853|NCT00304902|MRSA|mrsa
5335854|NCT00304902|Methicillin Resistant Staphylococcus aureus|methicillin resistant staphylococcus aureus
5335855|NCT00304902|Staphylococcus aureus Bacteremia|staphylococcus aureus bacteremia
5335856|NCT00304889|Clostridium difficile|clostridium difficile
5335857|NCT00304876|Clostridium difficile associated diarrhea|clostridium difficile associated diarrhea
5335858|NCT00304863|CDAD|cdad
5335859|NCT00304863|Clostridium difficile Associated Diarrhea|clostridium difficile associated diarrhea
5335860|NCT00304850|polyamines|polyamines
5335861|NCT00304850|pain|pain
5335862|NCT00304850|breast cancer|breast cancer
5335863|NCT00304850|mastectomy|mastectomy
5335864|NCT00304850|post operative pain|post operative pain
5335865|NCT00304837|Nonhealing leg ulcers|nonhealing leg ulcers
5335866|NCT00304837|Ischemic rest pain|ischemic rest pain
5335867|NCT00304824|Glaucoma|glaucoma
5335868|NCT00304824|Olfactory functions|olfactory functions
5335869|NCT00304824|Sniffing Sticks Test|sniffing sticks test
5335870|NCT00304811|MRSA|mrsa
5335871|NCT00304811|Methicillin Resistant Staphylococcus aureus|methicillin resistant staphylococcus aureus
5335872|NCT00304798|Transient Ischemic Attack (TIA).|transient ischemic attack (tia).
5335873|NCT00304798|Stroke.|stroke.
5335874|NCT00304798|Hospital admission.|hospital admission.
5335875|NCT00304772|Candida|candida
5335876|NCT00304772|bloodstream infection|bloodstream infection
5335877|NCT00304772|fluconazole|fluconazole
5335878|NCT00304772|micafungin|micafungin
5335879|NCT00304772|randomized controlled trial|randomized controlled trial
5335880|NCT00304759|prostate cancer|prostate cancer
5335881|NCT00304759|localized prostate cancer|localized prostate cancer
5335882|NCT00304759|intermediate risk|intermediate risk
5335883|NCT00304759|prostate specific antigen|prostate specific antigen
5335884|NCT00304759|PSA|psa
5335885|NCT00304759|radiation fractionation|radiation fractionation
5335886|NCT00304759|shorter schedule|shorter schedule
5335887|NCT00304759|quality of life|quality of life
5335888|NCT00304733|neuropathic foot ulcerations - total contact cast - custom -made footwear - off-loading|neuropathic foot ulcerations - total contact cast - custom -made footwear - off-loading
5335889|NCT00304720|Lymphoma|lymphoma
5335890|NCT00304720|Leukemia|leukemia
5335891|NCT00304694|NPC|npc
5335892|NCT00304694|Induction chemotherapy|induction chemotherapy
5335893|NCT00304694|Therapeutic response|therapeutic response
5335894|NCT00304694|18F-FDG PET|18f-fdg pet
5335895|NCT00304681|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
5335896|NCT00304681|OROS* Methylphenidate|oros* methylphenidate
5335897|NCT00304668|HIV-1|hiv-1
5335898|NCT00304668|HIV Seronegativity|hiv seronegativity
5335899|NCT00304655|Schizophrenia|schizophrenia
5335900|NCT00304655|Schizoaffective disorder|schizoaffective disorder
5335901|NCT00304655|Aripiprazole|aripiprazole
5335902|NCT00304642|HIV-1|hiv-1
5335903|NCT00304642|HIV Seronegativity|hiv seronegativity
5335904|NCT00304629|Alzheimer's disease|alzheimer's disease
5335905|NCT00304629|cholinesterase inhibitors|cholinesterase inhibitors
5335906|NCT00304629|galantamine|galantamine
5335907|NCT00304616|Schizophrenia|schizophrenia
5335908|NCT00304616|Aripiprazole|aripiprazole
5335909|NCT00304603|Obesity|obesity
5335910|NCT00304603|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
5335911|NCT00304603|Topiramate|topiramate
5335912|NCT00304603|Pharmacogenomics|pharmacogenomics
5335913|NCT00304603|DNA Polymorphism|dna polymorphism
5335914|NCT00304577|Strabismus|strabismus
5335915|NCT00304577|Esotropia|esotropia
5335916|NCT00304577|Surgical techniques|surgical techniques
5335917|NCT00304564|Posturography, Fall Prevention, Geriatrics, Nolwenn Effect|posturography, fall prevention, geriatrics, nolwenn effect
5335918|NCT00304551|CHC with compensated LC|chc with compensated lc
5335919|NCT00304538|diabetes|diabetes
5335920|NCT00304525|Anti-angiogenesis therapy|anti-angiogenesis therapy
5335921|NCT00304525|Kinase inhibitor therapy|kinase inhibitor therapy
5335922|NCT00304525|Raf inhibitor|raf inhibitor
5335923|NCT00304525|Locally Advanced Melanoma|locally advanced melanoma
5335924|NCT00304512|Amicus Therapeutics|amicus therapeutics
5335925|NCT00304512|AT1001|at1001
5335926|NCT00304512|Migalastat|migalastat
5335927|NCT00304512|Pharmacokinetics|pharmacokinetics
5335928|NCT00304512|Substrate|substrate
5335929|NCT00304499|OROS®|oros®
5335930|NCT00304499|middle age|middle age
5335931|NCT00304499|elderly|elderly
5335932|NCT00304499|oxybutynin|oxybutynin
5335933|NCT00304499|urinary incontinenence|urinary incontinenence
5335934|NCT00304499|women|women
5335935|NCT00304473|Schizophrenia|schizophrenia
5335936|NCT00304460|Serum Protein Levels|serum protein levels
5335937|NCT00304460|Lymphocyte Phenotypes|lymphocyte phenotypes
5335938|NCT00304460|Predictive Analysis|predictive analysis
5335939|NCT00304460|Serum Cytokines|serum cytokines
5335940|NCT00304460|Kidney Cancer|kidney cancer
5335941|NCT00304460|Renal Cell Cancer|renal cell cancer
5335942|NCT00304460|Melanoma|melanoma
5335943|NCT00304460|Metastatic Melanoma|metastatic melanoma
5335944|NCT00304447|Leukemia|leukemia
5335945|NCT00304447|Mylotarg|mylotarg
5335946|NCT00304447|Safety|safety
5335947|NCT00304447|Adverse Events|adverse events
5335948|NCT00304434|Adverse effects|adverse effects
5335949|NCT00304434|Antiviral|antiviral
5335950|NCT00304434|Clinical trial|clinical trial
5335951|NCT00304434|Oseltamivir|oseltamivir
5335952|NCT00304434|Pharmacokinetics|pharmacokinetics
5335953|NCT00304434|Probenecid|probenecid
5335954|NCT00304421|Gastroesophageal Reflux Disease|gastroesophageal reflux disease
5335955|NCT00304421|Proton Pump Inhibitors|proton pump inhibitors
5335956|NCT00304421|Gastric pH|gastric ph
5335957|NCT00304421|Gastric Acid Secretion|gastric acid secretion
5335958|NCT00304408|Clostridium difficile|clostridium difficile
5335959|NCT00304395|Community Acquired Pneumonia|community acquired pneumonia
5335961|NCT00304382|Pneumococcus|pneumococcus
5335962|NCT00304382|Pneumococcal pneumonia|pneumococcal pneumonia
5335963|NCT00304369|Clostridium difficile|clostridium difficile
5335964|NCT00304356|Clostridium difficile Associated Diarrhea|clostridium difficile associated diarrhea
5335965|NCT00304330|gram negative infection|gram negative infection
5335966|NCT00304317|calculi|calculi
5335967|NCT00304317|ureteral calculi|ureteral calculi
5335968|NCT00304317|ureter|ureter
5335969|NCT00304304|child care centers|child care centers
5335970|NCT00304304|asthma triggers|asthma triggers
5335971|NCT00304304|community-based research|community-based research
5335972|NCT00304291|Novantrone|novantrone
5335973|NCT00304278|Head and Neck Cancer|head and neck cancer
5335974|NCT00304278|Erlotinib|erlotinib
5335975|NCT00304278|RADPLAT|radplat
5335976|NCT00304265|Pertussis,|pertussis,
5335977|NCT00304265|Diphtheria,|diphtheria,
5335978|NCT00304265|Tetanus,|tetanus,
5335979|NCT00304265|Poliomyelitis|poliomyelitis
5335980|NCT00304239|Methyl aminolevulinate|methyl aminolevulinate
5335981|NCT00304239|Photodynamic therapy|photodynamic therapy
5335982|NCT00304239|Aktilite CL128 LED light source|aktilite cl128 led light source
5335983|NCT00304239|Multiple Actinic Keratosis|multiple actinic keratosis
5335984|NCT00304226|Valsartan,|valsartan,
5335985|NCT00304226|amlodipine,|amlodipine,
5335986|NCT00304226|hydrochlorothiazide|hydrochlorothiazide
5335987|NCT00304213|hypogonadism|hypogonadism
5335988|NCT00304213|testosterone|testosterone
5335989|NCT00304213|aging|aging
5335990|NCT00304213|Total testosterone < 300 ng/dL|total testosterone < 300 ng/dl
5335991|NCT00304213|Bioavailable testosterone < 70 ng/dL|bioavailable testosterone < 70 ng/dl
5335992|NCT00304200|Metastatic Malignant Melanoma|metastatic malignant melanoma
5335993|NCT00304187|Binge-Eating Disorder|binge-eating disorder
5335994|NCT00304161|Depression|depression
5335995|NCT00304161|Parkinson's Disease|parkinson's disease
5335996|NCT00304161|Atomoxetine|atomoxetine
5335997|NCT00304148|Renal Insufficiency Chronic|renal insufficiency chronic
5335998|NCT00304135|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
5335999|NCT00304135|unresectable extrahepatic bile duct cancer|unresectable extrahepatic bile duct cancer
5336000|NCT00304135|unresectable gallbladder cancer|unresectable gallbladder cancer
5336001|NCT00304096|recurrent breast cancer|recurrent breast cancer
5336002|NCT00304096|stage IIIA breast cancer|stage iiia breast cancer
5336003|NCT00304096|stage IIIB breast cancer|stage iiib breast cancer
5336004|NCT00304096|stage IIIC breast cancer|stage iiic breast cancer
5336005|NCT00304096|stage IV breast cancer|stage iv breast cancer
5336006|NCT00304096|male breast cancer|male breast cancer
5336007|NCT00304096|invasive lobular breast carcinoma|invasive lobular breast carcinoma
5336008|NCT00304083|adult neurofibrosarcoma|adult neurofibrosarcoma
5336009|NCT00304083|childhood neurofibrosarcoma|childhood neurofibrosarcoma
5336010|NCT00304083|metastatic childhood soft tissue sarcoma|metastatic childhood soft tissue sarcoma
5336011|NCT00304083|nonmetastatic childhood soft tissue sarcoma|nonmetastatic childhood soft tissue sarcoma
5336012|NCT00304083|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
5336013|NCT00304083|neurofibromatosis type 1|neurofibromatosis type 1
5336014|NCT00304031|adult glioblastoma|adult glioblastoma
5336015|NCT00304031|adult giant cell glioblastoma|adult giant cell glioblastoma
5336016|NCT00304031|adult gliosarcoma|adult gliosarcoma
5336017|NCT00304018|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5336348|NCT00303225|Vaccinia|vaccinia
5336018|NCT00304018|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5336019|NCT00304018|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5336020|NCT00304018|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5336021|NCT00304018|adult acute erythroid leukemia (M6)|adult acute erythroid leukemia (m6)
5336022|NCT00304018|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
5336023|NCT00304018|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
5336024|NCT00304018|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
5336025|NCT00304018|refractory multiple myeloma|refractory multiple myeloma
5336026|NCT00304018|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5336027|NCT00304018|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5336028|NCT00304018|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5336029|NCT00304018|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5336030|NCT00304018|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5336031|NCT00304018|stage II multiple myeloma|stage ii multiple myeloma
5336032|NCT00304018|stage III multiple myeloma|stage iii multiple myeloma
5336033|NCT00304018|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5336034|NCT00304018|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5336035|NCT00304018|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5336036|NCT00304018|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5336037|NCT00304018|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5336038|NCT00304018|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5336039|NCT00304018|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5336040|NCT00304018|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5336041|NCT00304018|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5336042|NCT00304018|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5336043|NCT00304018|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5336044|NCT00304018|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5336045|NCT00304018|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5336046|NCT00304018|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5336047|NCT00304018|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
5336048|NCT00304018|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5336049|NCT00304018|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5336050|NCT00304018|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
5336051|NCT00304018|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5336052|NCT00304018|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
5336053|NCT00304018|stage I multiple myeloma|stage i multiple myeloma
5336054|NCT00304005|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5336055|NCT00304005|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5336056|NCT00304005|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5336057|NCT00303992|stage IV breast cancer|stage iv breast cancer
5336058|NCT00303992|recurrent breast cancer|recurrent breast cancer
5336059|NCT00303979|Systolic Heart Failure|systolic heart failure
5336060|NCT00303979|Quality of Care|quality of care
5336061|NCT00303979|Outcomes|outcomes
5336062|NCT00303979|Evidence-based Guidelines|evidence-based guidelines
5336063|NCT00303979|Recommended Therapies|recommended therapies
5336064|NCT00303940|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
5336065|NCT00303940|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
5336066|NCT00303940|recurrent childhood soft tissue sarcoma|recurrent childhood soft tissue sarcoma
5336067|NCT00303940|recurrent Ewing sarcoma/peripheral primitive neuroectodermal tumor|recurrent ewing sarcoma/peripheral primitive neuroectodermal tumor
5336068|NCT00303940|recurrent osteosarcoma|recurrent osteosarcoma
5336069|NCT00303940|recurrent neuroblastoma|recurrent neuroblastoma
5336070|NCT00303940|recurrent Wilms tumor and other childhood kidney tumors|recurrent wilms tumor and other childhood kidney tumors
5336071|NCT00303940|recurrent childhood malignant germ cell tumor|recurrent childhood malignant germ cell tumor
5336072|NCT00303940|recurrent childhood liver cancer|recurrent childhood liver cancer
5336073|NCT00303940|recurrent childhood brain stem glioma|recurrent childhood brain stem glioma
5336074|NCT00303940|recurrent childhood cerebellar astrocytoma|recurrent childhood cerebellar astrocytoma
5336075|NCT00303940|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
5336076|NCT00303940|recurrent childhood ependymoma|recurrent childhood ependymoma
5336077|NCT00303940|recurrent childhood medulloblastoma|recurrent childhood medulloblastoma
5336078|NCT00303940|recurrent childhood supratentorial primitive neuroectodermal tumor|recurrent childhood supratentorial primitive neuroectodermal tumor
5336079|NCT00303940|childhood atypical teratoid/rhabdoid tumor|childhood atypical teratoid/rhabdoid tumor
5336080|NCT00303940|childhood low-grade cerebral astrocytoma|childhood low-grade cerebral astrocytoma
5336081|NCT00303940|childhood high-grade cerebral astrocytoma|childhood high-grade cerebral astrocytoma
5336082|NCT00303940|childhood choroid plexus tumor|childhood choroid plexus tumor
5336083|NCT00303940|childhood craniopharyngioma|childhood craniopharyngioma
5336084|NCT00303940|childhood infratentorial ependymoma|childhood infratentorial ependymoma
5336085|NCT00303940|childhood supratentorial ependymoma|childhood supratentorial ependymoma
5336086|NCT00303940|childhood oligodendroglioma|childhood oligodendroglioma
5336087|NCT00303940|recurrent childhood visual pathway and hypothalamic glioma|recurrent childhood visual pathway and hypothalamic glioma
5336088|NCT00303940|recurrent childhood brain tumor|recurrent childhood brain tumor
5336089|NCT00303940|childhood central nervous system germ cell tumor|childhood central nervous system germ cell tumor
5336090|NCT00303940|childhood grade I meningioma|childhood grade i meningioma
5336091|NCT00303940|childhood grade II meningioma|childhood grade ii meningioma
5336092|NCT00303940|childhood grade III meningioma|childhood grade iii meningioma
5336093|NCT00303940|childhood malignant ovarian germ cell tumor|childhood malignant ovarian germ cell tumor
5336094|NCT00303940|childhood malignant testicular germ cell tumor|childhood malignant testicular germ cell tumor
5336095|NCT00303940|childhood teratoma|childhood teratoma
5336096|NCT00303927|recurrent pancreatic cancer|recurrent pancreatic cancer
5336097|NCT00303927|stage IV pancreatic cancer|stage iv pancreatic cancer
5336098|NCT00303914|pain|pain
5336099|NCT00303914|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
5336100|NCT00303914|cognitive/functional effects|cognitive/functional effects
5336101|NCT00303914|recurrent breast cancer|recurrent breast cancer
5336102|NCT00303914|stage I breast cancer|stage i breast cancer
5336103|NCT00303914|stage II breast cancer|stage ii breast cancer
5336104|NCT00303914|stage IIIA breast cancer|stage iiia breast cancer
5336105|NCT00303914|stage IIIB breast cancer|stage iiib breast cancer
5336106|NCT00303914|stage IIIC breast cancer|stage iiic breast cancer
5336107|NCT00303914|stage IV breast cancer|stage iv breast cancer
5336108|NCT00303914|recurrent colon cancer|recurrent colon cancer
5336109|NCT00303914|stage I colon cancer|stage i colon cancer
5336110|NCT00303914|stage II colon cancer|stage ii colon cancer
5336111|NCT00303914|stage III colon cancer|stage iii colon cancer
5336112|NCT00303914|stage IV colon cancer|stage iv colon cancer
5336113|NCT00303914|recurrent rectal cancer|recurrent rectal cancer
5336114|NCT00303914|stage I rectal cancer|stage i rectal cancer
5336115|NCT00303914|stage II rectal cancer|stage ii rectal cancer
5336116|NCT00303914|stage III rectal cancer|stage iii rectal cancer
5336117|NCT00303914|stage IV rectal cancer|stage iv rectal cancer
5336118|NCT00303914|extensive stage small cell lung cancer|extensive stage small cell lung cancer
5336119|NCT00303914|limited stage small cell lung cancer|limited stage small cell lung cancer
5336120|NCT00303914|recurrent small cell lung cancer|recurrent small cell lung cancer
5336121|NCT00303914|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5336122|NCT00303914|stage I non-small cell lung cancer|stage i non-small cell lung cancer
5336123|NCT00303914|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
5336124|NCT00303914|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5336125|NCT00303914|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5336126|NCT00303914|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5336127|NCT00303914|recurrent prostate cancer|recurrent prostate cancer
5336128|NCT00303914|stage I prostate cancer|stage i prostate cancer
5336129|NCT00303914|stage IIB prostate cancer|stage iib prostate cancer
5336130|NCT00303914|stage IIA prostate cancer|stage iia prostate cancer
5336131|NCT00303914|stage III prostate cancer|stage iii prostate cancer
5336132|NCT00303914|stage IV prostate cancer|stage iv prostate cancer
5336133|NCT00303914|male breast cancer|male breast cancer
5336134|NCT00303914|pulmonary carcinoid tumor|pulmonary carcinoid tumor
5336135|NCT00303901|lung metastases|lung metastases
5336136|NCT00303901|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5336137|NCT00303901|recurrent small cell lung cancer|recurrent small cell lung cancer
5336138|NCT00303901|stage I non-small cell lung cancer|stage i non-small cell lung cancer
5336139|NCT00303901|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
5336140|NCT00303901|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5336141|NCT00303901|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5336142|NCT00303901|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5336143|NCT00303901|extensive stage small cell lung cancer|extensive stage small cell lung cancer
5336144|NCT00303901|limited stage small cell lung cancer|limited stage small cell lung cancer
5336145|NCT00303901|pulmonary carcinoid tumor|pulmonary carcinoid tumor
5336146|NCT00303888|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5336147|NCT00303888|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5336148|NCT00303888|stage IIIA ovarian epithelial cancer|stage iiia ovarian epithelial cancer
5336149|NCT00303888|stage IIIB ovarian epithelial cancer|stage iiib ovarian epithelial cancer
5336150|NCT00303888|stage IIIC ovarian epithelial cancer|stage iiic ovarian epithelial cancer
5336151|NCT00303888|recurrent primary peritoneal cavity cancer|recurrent primary peritoneal cavity cancer
5336152|NCT00303888|stage IIIA primary peritoneal cavity cancer|stage iiia primary peritoneal cavity cancer
5336153|NCT00303888|stage IIIB primary peritoneal cavity cancer|stage iiib primary peritoneal cavity cancer
5336154|NCT00303888|stage IIIC primary peritoneal cavity cancer|stage iiic primary peritoneal cavity cancer
5336155|NCT00303888|stage IV primary peritoneal cavity cancer|stage iv primary peritoneal cavity cancer
5336156|NCT00303888|recurrent fallopian tube cancer|recurrent fallopian tube cancer
5336157|NCT00303888|stage IIIA fallopian tube cancer|stage iiia fallopian tube cancer
5336158|NCT00303888|stage IIIB fallopian tube cancer|stage iiib fallopian tube cancer
5336159|NCT00303888|stage IIIC fallopian tube cancer|stage iiic fallopian tube cancer
5336160|NCT00303888|stage IV fallopian tube cancer|stage iv fallopian tube cancer
5336161|NCT00303875|recurrent prostate cancer|recurrent prostate cancer
5336162|NCT00303875|stage I prostate cancer|stage i prostate cancer
5336163|NCT00303875|stage IIB prostate cancer|stage iib prostate cancer
5336164|NCT00303875|stage IIA prostate cancer|stage iia prostate cancer
5336165|NCT00303875|stage III prostate cancer|stage iii prostate cancer
5336166|NCT00303875|stage IV prostate cancer|stage iv prostate cancer
5336167|NCT00303875|recurrent breast cancer|recurrent breast cancer
5336168|NCT00303875|stage I breast cancer|stage i breast cancer
5336169|NCT00303875|stage II breast cancer|stage ii breast cancer
5336170|NCT00303875|stage IIIA breast cancer|stage iiia breast cancer
5336171|NCT00303875|stage IIIB breast cancer|stage iiib breast cancer
5336172|NCT00303875|stage IIIC breast cancer|stage iiic breast cancer
5336173|NCT00303875|stage IV breast cancer|stage iv breast cancer
5336174|NCT00303875|recurrent colon cancer|recurrent colon cancer
5336175|NCT00303875|stage I colon cancer|stage i colon cancer
5336176|NCT00303875|stage II colon cancer|stage ii colon cancer
5336177|NCT00303875|stage III colon cancer|stage iii colon cancer
5336178|NCT00303875|stage IV colon cancer|stage iv colon cancer
5336179|NCT00303875|recurrent rectal cancer|recurrent rectal cancer
5336180|NCT00303875|stage I rectal cancer|stage i rectal cancer
5336181|NCT00303875|stage II rectal cancer|stage ii rectal cancer
5336182|NCT00303875|stage III rectal cancer|stage iii rectal cancer
5336183|NCT00303875|stage IV rectal cancer|stage iv rectal cancer
5336184|NCT00303810|childhood infratentorial ependymoma|childhood infratentorial ependymoma
5336185|NCT00303810|childhood supratentorial ependymoma|childhood supratentorial ependymoma
5336186|NCT00303810|untreated childhood medulloblastoma|untreated childhood medulloblastoma
5336187|NCT00303810|newly diagnosed childhood ependymoma|newly diagnosed childhood ependymoma
5336188|NCT00303810|untreated childhood supratentorial primitive neuroectodermal tumor|untreated childhood supratentorial primitive neuroectodermal tumor
5336189|NCT00303784|hot flashes|hot flashes
5336190|NCT00303784|anemia|anemia
5336191|NCT00303784|osteoporosis|osteoporosis
5336192|NCT00303784|cardiovascular complications|cardiovascular complications
5336193|NCT00303784|recurrent prostate cancer|recurrent prostate cancer
5336194|NCT00303784|stage III prostate cancer|stage iii prostate cancer
5336195|NCT00303784|stage IV prostate cancer|stage iv prostate cancer
5336196|NCT00303784|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5336197|NCT00303771|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5336198|NCT00303771|stage IV rectal cancer|stage iv rectal cancer
5336199|NCT00303771|stage IV colon cancer|stage iv colon cancer
5336200|NCT00303771|adenocarcinoma of the colon|adenocarcinoma of the colon
5336201|NCT00303771|recurrent colon cancer|recurrent colon cancer
5336202|NCT00303771|recurrent rectal cancer|recurrent rectal cancer
5336203|NCT00303758|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
5336204|NCT00303758|recurrent pancreatic cancer|recurrent pancreatic cancer
5336205|NCT00303758|stage IV pancreatic cancer|stage iv pancreatic cancer
5336206|NCT00303745|adenocarcinoma of the colon|adenocarcinoma of the colon
5336207|NCT00303745|recurrent colon cancer|recurrent colon cancer
5336208|NCT00303745|stage IV colon cancer|stage iv colon cancer
5336209|NCT00303745|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5336210|NCT00303745|recurrent rectal cancer|recurrent rectal cancer
5336211|NCT00303745|stage IV rectal cancer|stage iv rectal cancer
5336212|NCT00303732|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5336213|NCT00303732|recurrent renal cell cancer|recurrent renal cell cancer
5336214|NCT00303732|stage IV renal cell cancer|stage iv renal cell cancer
5336215|NCT00303719|leukemia|leukemia
5336216|NCT00303719|lymphoma|lymphoma
5336217|NCT00303719|myeloma|myeloma
5336218|NCT00303706|CABG, Endoscopic, Radial Artery|cabg, endoscopic, radial artery
5336219|NCT00303706|Radial Artery Conduit|radial artery conduit
5336220|NCT00303706|Coronary Artery Bypass Surgery|coronary artery bypass surgery
5336221|NCT00303706|Endoscopic technique|endoscopic technique
5336222|NCT00303667|NK cells|nk cells
5336223|NCT00303667|natural killer cells|natural killer cells
5336224|NCT00303667|immunotherapy|immunotherapy
5336225|NCT00303667|hematopoietic cell transplant|hematopoietic cell transplant
5336226|NCT00303667|acute myelogenous leukemia|acute myelogenous leukemia
5336227|NCT00303654|recurrent bladder cancer|recurrent bladder cancer
5336228|NCT00303654|stage I bladder cancer|stage i bladder cancer
5336229|NCT00303654|stage II bladder cancer|stage ii bladder cancer
5336230|NCT00303654|stage III bladder cancer|stage iii bladder cancer
5336231|NCT00303654|stage IV bladder cancer|stage iv bladder cancer
5336232|NCT00303641|Cardiopulmonary bypass|cardiopulmonary bypass
5336233|NCT00303641|Inflammatory reaction|inflammatory reaction
5336234|NCT00303628|Rectal cancer|rectal cancer
5336235|NCT00303628|Bevacizumab|bevacizumab
5336236|NCT00303615|ER (-) and PR (-)|er (-) and pr (-)
5336237|NCT00303576|HIV-1|hiv-1
5336238|NCT00303576|HIV Seronegativity|hiv seronegativity
5336239|NCT00303550|skin infection|skin infection
5336240|NCT00303550|complicated skin infection|complicated skin infection
5336241|NCT00303550|skin structure infection|skin structure infection
5336242|NCT00303550|Complicated Skin and Skin Structure Infection|complicated skin and skin structure infection
5336243|NCT00303537|hepatitis|hepatitis
5336245|NCT00303537|non-alcoholic fatty liver (NAFLD)|non-alcoholic fatty liver (nafld)
5336246|NCT00303537|non-alcoholic steatohepatitis (NASH)|non-alcoholic steatohepatitis (nash)
5336247|NCT00303537|Nonalcoholic fatty liver disease|nonalcoholic fatty liver disease
5336248|NCT00303511|adult|adult
5336249|NCT00303511|pacemaker|pacemaker
5336250|NCT00303511|bradycardia|bradycardia
5336251|NCT00303511|tachycardia|tachycardia
5336252|NCT00303511|heart failure|heart failure
5336253|NCT00303472|MDS|mds
5336254|NCT00303472|Myelodysplastic Syndromes|myelodysplastic syndromes
5336255|NCT00303472|Refractory Cytopenias|refractory cytopenias
5336256|NCT00303472|Thrombocytopenia|thrombocytopenia
5336257|NCT00303459|sildenafil|sildenafil
5336258|NCT00303459|Combination Drug Therapy|combination drug therapy
5336259|NCT00303459|bosentan|bosentan
5336260|NCT00303459|Pulmonary Hypertension|pulmonary hypertension
5336261|NCT00303459|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
5336262|NCT00303459|Multicenter Study|multicenter study
5336263|NCT00303459|Antihypertensive Agents|antihypertensive agents
5336264|NCT00303459|Tracleer|tracleer
5336265|NCT00303459|endothelin receptor antagonist|endothelin receptor antagonist
5336266|NCT00303459|Randomized Controlled Trial|randomized controlled trial
5336267|NCT00303459|Phosphodiesterase type 5 inhibitor (PDE5i)|phosphodiesterase type 5 inhibitor (pde5i)
5336268|NCT00303459|Outcome Assessment|outcome assessment
5336269|NCT00303446|Motor Neuron|motor neuron
5336270|NCT00303446|Androgen Receptor|androgen receptor
5336271|NCT00303446|Polyglutamine|polyglutamine
5336272|NCT00303446|X-Linked|x-linked
5336273|NCT00303446|Ligand Dependency|ligand dependency
5336274|NCT00303446|Spinal and Bulbar Muscular Atrophy|spinal and bulbar muscular atrophy
5336275|NCT00303446|SBMA|sbma
5336276|NCT00303446|Kennedy Disease|kennedy disease
5336277|NCT00303433|Prevention|prevention
5336278|NCT00303433|Post-Operative tates|post-operative tates
5336279|NCT00303433|Delirium|delirium
5336280|NCT00303433|Namenda|namenda
5336281|NCT00303420|catheter|catheter
5336282|NCT00303420|hemodialysis|hemodialysis
5336283|NCT00303420|dysfunction|dysfunction
5336284|NCT00303420|thrombolytic|thrombolytic
5336285|NCT00303420|alteplase|alteplase
5336286|NCT00303394|Type 2 Diabetes, IL-1, inflammation, glucotoxicity, insulin|type 2 diabetes, il-1, inflammation, glucotoxicity, insulin
5336287|NCT00303368|Neurofibromatosis (NF1)|neurofibromatosis (nf1)
5336288|NCT00303368|Tibial Dysplasia (TD)|tibial dysplasia (td)
5336289|NCT00303355|jugular venous pulse|jugular venous pulse
5336290|NCT00303342|sleep|sleep
5336291|NCT00303342|arousal|arousal
5336292|NCT00303342|stress|stress
5336293|NCT00303342|cortisol|cortisol
5336294|NCT00303342|catecholamines|catecholamines
5336295|NCT00303329|β-thalassemia|β-thalassemia
5336296|NCT00303329|rare chronic anemia|rare chronic anemia
5336297|NCT00303329|iron overload|iron overload
5336298|NCT00303329|deferasirox|deferasirox
5336299|NCT00303329|chronic anemias|chronic anemias
5336300|NCT00303329|transfusional hemosiderosis|transfusional hemosiderosis
5336301|NCT00303316|Diphtheria|diphtheria
5336302|NCT00303316|Tetanus|tetanus
5336303|NCT00303316|Pertussis|pertussis
5336304|NCT00303316|whooping cough|whooping cough
5336305|NCT00303316|Haemophilus influenzae type b|haemophilus influenzae type b
5336306|NCT00303316|Hepatitis B|hepatitis b
5336307|NCT00303316|Poliomyelitis|poliomyelitis
5336308|NCT00303303|Snake envenomation|snake envenomation
5336309|NCT00303303|Antivenins|antivenins
5336310|NCT00303303|Disability evaluation|disability evaluation
5336311|NCT00303303|Activities of daily living|activities of daily living
5336312|NCT00303290|Early Chronic Phase CML|early chronic phase cml
5336313|NCT00303290|Peg Interferon Alpha 2b|peg interferon alpha 2b
5336314|NCT00303290|Peg Intron|peg intron
5336315|NCT00303290|Ara-C|ara-c
5336316|NCT00303290|Cytosine Arabinoside|cytosine arabinoside
5336317|NCT00303277|Alzheimer's disease|alzheimer's disease
5336318|NCT00303277|beta-amyloid|beta-amyloid
5336319|NCT00303277|statins|statins
5336320|NCT00303264|functional dyspepsia|functional dyspepsia
5336321|NCT00303264|cholecystokinin|cholecystokinin
5336322|NCT00303264|CCK|cck
5336323|NCT00303264|gastrointestinal|gastrointestinal
5336324|NCT00303264|intestinal transit|intestinal transit
5336325|NCT00303264|GI motility|gi motility
5336326|NCT00303264|bloating|bloating
5336327|NCT00303264|upper GI discomfort|upper gi discomfort
5336328|NCT00303264|upper GI|upper gi
5336329|NCT00303264|early satiety|early satiety
5336330|NCT00303264|nausea|nausea
5336331|NCT00303264|belching|belching
5336332|NCT00303264|retching|retching
5336333|NCT00303264|vomiting|vomiting
5336334|NCT00303264|GERD|gerd
5336335|NCT00303251|Locally Advanced or Metastatic Melanoma|locally advanced or metastatic melanoma
5336336|NCT00303238|Inflammation|inflammation
5336337|NCT00303238|Interleukin-1|interleukin-1
5336338|NCT00303238|C-reactive protein|c-reactive protein
5336339|NCT00303238|Genotype|genotype
5336340|NCT00303238|Rose Hips|rose hips
5336341|NCT00303238|Blueberry|blueberry
5336342|NCT00303238|Blackberry|blackberry
5336343|NCT00303238|Aframomum melegueta|aframomum melegueta
5336344|NCT00303238|Resveravine|resveravine
5336345|NCT00303225|Biodefense|biodefense
5336346|NCT00303225|Smallpox|smallpox
5336349|NCT00303225|Prophylaxis|prophylaxis
5336350|NCT00303225|Healthy Volunteer|healthy volunteer
5336351|NCT00303225|HV|hv
5336352|NCT00303212|heart failure|heart failure
5336353|NCT00303212|CHF|chf
5336354|NCT00303212|telemedicine|telemedicine
5336355|NCT00303212|disease management|disease management
5336356|NCT00303199|Multiple Myeloma|multiple myeloma
5336357|NCT00303199|Arsenic|arsenic
5336358|NCT00303199|Cancer study|cancer study
5336359|NCT00303199|Failed treatment|failed treatment
5336360|NCT00303186|Rheumatoid Arthritis|rheumatoid arthritis
5336361|NCT00303173|Pre-eclampsia|pre-eclampsia
5336362|NCT00303173|hypertension|hypertension
5336363|NCT00303173|blood pressure|blood pressure
5336364|NCT00303173|pregnancy|pregnancy
5336365|NCT00303173|randomized clinical trial|randomized clinical trial
5336366|NCT00303173|guided imagery|guided imagery
5336367|NCT00303173|relaxation|relaxation
5336368|NCT00303173|psychophysiology|psychophysiology
5336369|NCT00303173|mind-body|mind-body
5336370|NCT00303160|heliobacter pylori infection|heliobacter pylori infection
5336371|NCT00303160|reactive oxygen species|reactive oxygen species
5336372|NCT00303160|antioxidants|antioxidants
5336373|NCT00303147|Expressive Writing|expressive writing
5336374|NCT00303147|Written Emotional Expression|written emotional expression
5336375|NCT00303147|Caregiver Stress|caregiver stress
5336376|NCT00303147|Cognition|cognition
5336377|NCT00303134|islet cell|islet cell
5336378|NCT00303134|diabetes|diabetes
5336379|NCT00303134|transplant|transplant
5336380|NCT00303134|immunosuppression|immunosuppression
5336381|NCT00303134|autoimmunity|autoimmunity
5336382|NCT00303134|alloimmunity|alloimmunity
5336383|NCT00303121|Glaucoma|glaucoma
5336384|NCT00303121|Compliance|compliance
5336385|NCT00303121|Therapy|therapy
5336386|NCT00303121|Administration technique|administration technique
5336387|NCT00303082|Probiotics|probiotics
5336388|NCT00303082|Bacterial Vaginosis|bacterial vaginosis
5336389|NCT00303082|Premature birth|premature birth
5336390|NCT00303082|Intra-uterine Infection|intra-uterine infection
5336391|NCT00303082|Periventricular leukomalacia|periventricular leukomalacia
5336392|NCT00303069|S. aureus;|s. aureus;
5336393|NCT00303069|Vaccine|vaccine
5336394|NCT00303069|FIM|fim
5336395|NCT00303056|Osteoarthritis|osteoarthritis
5336396|NCT00303056|knee|knee
5336397|NCT00303043|Hemodynamic monitoring|hemodynamic monitoring
5336398|NCT00303043|Mixed venous saturation|mixed venous saturation
5336399|NCT00303043|Critically ill patients|critically ill patients
5336400|NCT00303030|Fecal incontinence|fecal incontinence
5336401|NCT00303030|Biofeedback|biofeedback
5336402|NCT00303030|Patient Satisfaction|patient satisfaction
5336403|NCT00303030|Quality of LifeTreatment Outcome|quality of lifetreatment outcome
5336404|NCT00303030|Injections|injections
5336405|NCT00302991|Observational|observational
5336406|NCT00302991|cross-sectional|cross-sectional
5336407|NCT00302991|health-related quality of life|health-related quality of life
5336408|NCT00302991|adverse effects|adverse effects
5336409|NCT00302991|Baker´s AEP scale validation|baker´s aep scale validation
5336410|NCT00302991|epilepsy|epilepsy
5336411|NCT00302978|Height phobia|height phobia
5336412|NCT00302978|fear of heights|fear of heights
5336413|NCT00302978|specific phobia|specific phobia
5336414|NCT00302965|Plasma|plasma
5336415|NCT00302965|Trauma|trauma
5336416|NCT00302965|Critical Care|critical care
5336417|NCT00302952|Arthritis, Rheumatoid|arthritis, rheumatoid
5336418|NCT00302939|Aging|aging
5336419|NCT00302926|Weight loss|weight loss
5336420|NCT00302926|obesity|obesity
5336421|NCT00302926|energy restriction|energy restriction
5336422|NCT00302913|Clopidogrel|clopidogrel
5336423|NCT00302913|Coronary Artery Disease|coronary artery disease
5336424|NCT00302913|Dose-Response Relationship, Drug|dose-response relationship, drug
5336425|NCT00302913|Drug Resistance|drug resistance
5336426|NCT00302913|PCI|pci
5336427|NCT00302900|Blood Donation|blood donation
5336428|NCT00302900|Syncope|syncope
5336429|NCT00302900|Vasovagal Reactions|vasovagal reactions
5336430|NCT00302887|fibromyalgia|fibromyalgia
5336431|NCT00302887|connective tissue manipulation|connective tissue manipulation
5336432|NCT00302887|ultrasound therapy|ultrasound therapy
5336433|NCT00302887|high voltage pulsed galvanic stimulation|high voltage pulsed galvanic stimulation
5336434|NCT00302874|diabetes|diabetes
5336435|NCT00302874|hyperglycemia|hyperglycemia
5336436|NCT00302874|hospital|hospital
5336437|NCT00302874|medicine ward|medicine ward
5336438|NCT00302861|B-Cll|b-cll
5336439|NCT00302848|Venous thromboembolism|venous thromboembolism
5336440|NCT00302848|Drospirenone|drospirenone
5336441|NCT00302835|Analgesics|analgesics
5336442|NCT00302835|Chronic Kidney Failure|chronic kidney failure
5336443|NCT00302822|HIV infections|hiv infections
5336444|NCT00302822|Fuzeon|fuzeon
5336445|NCT00302822|Truvada|truvada
5336446|NCT00302822|AIDS|aids
5336447|NCT00302822|Treatment Naive|treatment naive
5336448|NCT00302809|Flavonoids|flavonoids
5336449|NCT00302809|Arterial stiffness|arterial stiffness
5336450|NCT00302809|Blood pressure|blood pressure
5336451|NCT00302809|Endothelium|endothelium
5336452|NCT00302809|Inflammation|inflammation
5336453|NCT00302796|Low Back Pain,|low back pain,
5336454|NCT00302783|Education, Medical|education, medical
5336455|NCT00302783|Education, Competency-Based|education, competency-based
5336456|NCT00302783|Multi-Source Feedback|multi-source feedback
5336457|NCT00302783|Communication|communication
5336458|NCT00302783|Professionalism|professionalism
5336459|NCT00302770|Patients with SAD|patients with sad
5336460|NCT00302757|NHL|nhl
5336461|NCT00302757|low and high grade non-Hodgkin lymphoma|low and high grade non-hodgkin lymphoma
5336462|NCT00302744|Anxiety|anxiety
5336463|NCT00302744|Depression|depression
5336464|NCT00302744|Mood|mood
5336465|NCT00302744|Cancer|cancer
5336466|NCT00302744|Quality of Life|quality of life
5336467|NCT00302744|Psychiatric|psychiatric
5336468|NCT00302744|Psilocybin|psilocybin
5336469|NCT00302744|Alternative|alternative
5336470|NCT00302744|Los Angeles|los angeles
5336471|NCT00302718|Physician Incentive Plan|physician incentive plan
5336472|NCT00302718|Quality of Health Care|quality of health care
5336473|NCT00302718|Reimbursement, Incentive|reimbursement, incentive
5336474|NCT00302718|Randomized Controlled Trial|randomized controlled trial
5336475|NCT00302718|Physicians|physicians
5336476|NCT00302718|Reward|reward
5336477|NCT00302705|Ambulatory blood pressure monitoring|ambulatory blood pressure monitoring
5336478|NCT00302705|Valsartan|valsartan
5336479|NCT00302705|Enalapril|enalapril
5336480|NCT00302705|Missing dose|missing dose
5336481|NCT00302679|Colonoscopy|colonoscopy
5336482|NCT00302679|Sigmoidoscopy|sigmoidoscopy
5336483|NCT00302679|Colon cancer screening|colon cancer screening
5336484|NCT00302679|Pain|pain
5336485|NCT00302679|Screening|screening
5336486|NCT00302666|Contraception, Bleeding pattern|contraception, bleeding pattern
5336487|NCT00302627|bisphosphonates|bisphosphonates
5336488|NCT00302627|vitamin D|vitamin d
5336489|NCT00302627|calcium supplement|calcium supplement
5336490|NCT00302627|corticosteroid therapy|corticosteroid therapy
5336491|NCT00302627|fractures|fractures
5336492|NCT00302614|obstructive sleep apnea|obstructive sleep apnea
5336493|NCT00302614|snoring|snoring
5336494|NCT00302614|collapsibility|collapsibility
5336495|NCT00302614|upper airway|upper airway
5336496|NCT00302601|Pulmonary embolism|pulmonary embolism
5336497|NCT00302601|Right heart strain|right heart strain
5336498|NCT00302601|Lung scintigraphy|lung scintigraphy
5336499|NCT00302601|Pulmonary angiography|pulmonary angiography
5336500|NCT00302588|metastatic carcinoma|metastatic carcinoma
5336501|NCT00302588|cervical lymph nodes|cervical lymph nodes
5336502|NCT00302588|unknown primary|unknown primary
5336503|NCT00302588|diagnosis|diagnosis
5336504|NCT00302588|result|result
5336505|NCT00302575|Substance-Related Disorders|substance-related disorders
5336506|NCT00302575|Prisoners|prisoners
5336507|NCT00302562|laryngeal cancer|laryngeal cancer
5336508|NCT00302562|hypopharyngeal cancer|hypopharyngeal cancer
5336509|NCT00302562|CXCR4|cxcr4
5336510|NCT00302562|CXCL12|cxcl12
5336511|NCT00302562|matrix metalloproteinases(MMPs)|matrix metalloproteinases(mmps)
5336512|NCT00302562|metastasis|metastasis
5336513|NCT00302549|Tacrolimus|tacrolimus
5336514|NCT00302549|Cyclophosphamide|cyclophosphamide
5336515|NCT00302549|Treatment|treatment
5336516|NCT00302549|Lupus Nephritis|lupus nephritis
5336517|NCT00302536|Idiopathic Focal Segmental Glomerulosclerosis|idiopathic focal segmental glomerulosclerosis
5336518|NCT00302536|Treatment|treatment
5336519|NCT00302536|Steroids|steroids
5336520|NCT00302523|Idiopathic Membranous Nephropathy|idiopathic membranous nephropathy
5336521|NCT00302523|Treatment|treatment
5336522|NCT00302523|Tacrolimus|tacrolimus
5336523|NCT00302523|Cyclophosphamide|cyclophosphamide
5336524|NCT00302510|lipoprotein glomerulopathy|lipoprotein glomerulopathy
5336525|NCT00302510|treatment|treatment
5336526|NCT00302510|immunoadsorption|immunoadsorption
5336527|NCT00302510|apolipoprotein E|apolipoprotein e
5336528|NCT00302458|healthy volunteers|healthy volunteers
5336529|NCT00302432|smoking reduction|smoking reduction
5336530|NCT00302432|group therapy|group therapy
5336531|NCT00302432|cigarette holders|cigarette holders
5336532|NCT00302432|"Flowers Menthol"|"flowers menthol"
5336533|NCT00302419|Acute myocardial infarction|acute myocardial infarction
5336534|NCT00302419|primary angioplasty|primary angioplasty
5336535|NCT00302419|streptokinase|streptokinase
5336536|NCT00302419|microvasculature|microvasculature
5336537|NCT00302393|healthy volunteers|healthy volunteers
5336538|NCT00302341|Pulmonary disease|pulmonary disease
5336540|NCT00302341|Hypoxemia|hypoxemia
5336541|NCT00302341|AIDS|aids
5336542|NCT00302341|Pneumocystis jiroveci|pneumocystis jiroveci
5336543|NCT00302315|postcesarean physiotherapy|postcesarean physiotherapy
5336544|NCT00302315|incisional pain|incisional pain
5336545|NCT00302315|functional activity|functional activity
5336546|NCT00302315|connective tissue manipulation|connective tissue manipulation
5336547|NCT00302315|transcutaneous electrical nerve stimulation|transcutaneous electrical nerve stimulation
5336548|NCT00302302|Blood glucose|blood glucose
5336549|NCT00302302|Insulin|insulin
5336550|NCT00302302|Triglyceride|triglyceride
5336551|NCT00302302|GIP|gip
5336552|NCT00302302|GLP-1|glp-1
5336553|NCT00302302|L-arabinose|l-arabinose
5336554|NCT00302302|Appetite|appetite
5336555|NCT00302302|Energy intake|energy intake
5336556|NCT00302289|green tea|green tea
5336557|NCT00302289|caffeine|caffeine
5336558|NCT00302289|tyrosine|tyrosine
5336559|NCT00302289|energy expenditure|energy expenditure
5336560|NCT00302289|energy intake|energy intake
5336561|NCT00302276|Body fat loss|body fat loss
5336562|NCT00302276|energy expenditure|energy expenditure
5336563|NCT00302276|capsaicin|capsaicin
5336564|NCT00302276|caffeine|caffeine
5336565|NCT00302276|green tea|green tea
5336566|NCT00302276|calcium|calcium
5336567|NCT00302276|fecal fat|fecal fat
5336568|NCT00302276|fecal energy|fecal energy
5336569|NCT00302263|Green tea|green tea
5336570|NCT00302263|capsaicin|capsaicin
5336571|NCT00302263|tyrosine|tyrosine
5336572|NCT00302263|caffeine|caffeine
5336573|NCT00302263|energy expenditure|energy expenditure
5336574|NCT00302263|catecholamines|catecholamines
5336575|NCT00302250|Cardiovascular|cardiovascular
5336576|NCT00302250|Flow-mediated vasodilation (FMD)|flow-mediated vasodilation (fmd)
5336577|NCT00302250|Pulse perfusion-mediated vasodilation (PPMV)|pulse perfusion-mediated vasodilation (ppmv)
5336578|NCT00302250|Endothelial function|endothelial function
5336579|NCT00302250|Heart failure|heart failure
5336580|NCT00302237|carotid, stenting, angioplasty|carotid, stenting, angioplasty
5336581|NCT00302224|safety|safety
5336582|NCT00302224|type 2 diabetes|type 2 diabetes
5336583|NCT00302211|PAH|pah
5336584|NCT00302211|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
5336585|NCT00302198|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
5336586|NCT00302185|Palliative Care|palliative care
5336587|NCT00302185|Acupuncture|acupuncture
5336588|NCT00302185|Symptom Management|symptom management
5336589|NCT00302185|Quality of Life|quality of life
5336590|NCT00302172|Cancer|cancer
5336591|NCT00302172|solid tumor|solid tumor
5336592|NCT00302172|metastatic|metastatic
5336593|NCT00302172|primary tumor|primary tumor
5336594|NCT00302159|Chemotherapy|chemotherapy
5336595|NCT00302159|Radiation|radiation
5336596|NCT00302159|Brain Tumor|brain tumor
5336597|NCT00302159|GBM|gbm
5336598|NCT00302159|Radiosensitizer|radiosensitizer
5336599|NCT00302159|Glioblastoma|glioblastoma
5336600|NCT00302159|Glioblastoma Multiforme|glioblastoma multiforme
5336601|NCT00302146|Lysosomal Storage Disorder|lysosomal storage disorder
5336602|NCT00302146|Carrier|carrier
5336603|NCT00302146|L-Dopa Uptake|l-dopa uptake
5336604|NCT00302146|Glucocerebrosidase|glucocerebrosidase
5336605|NCT00302146|Pathogenesis|pathogenesis
5336606|NCT00302146|Carbidopa|carbidopa
5336607|NCT00302146|Gaucher Disease|gaucher disease
5336608|NCT00302146|Parkinson Disease|parkinson disease
5336609|NCT00302146|[O-15]-Water|[o-15]-water
5336610|NCT00302146|6-[F-18]Fluoro-L-dopa|6-[f-18]fluoro-l-dopa
5336611|NCT00302146|Healthy Volunteer|healthy volunteer
5336612|NCT00302146|HV|hv
5336613|NCT00302133|Alcoholism Bipolar Disorder Pharmacotherapy Naltrexone|alcoholism bipolar disorder pharmacotherapy naltrexone
5336614|NCT00302120|Magnetic Resonance Imaging|magnetic resonance imaging
5336615|NCT00302120|Breast Neoplasms|breast neoplasms
5336616|NCT00302120|Diagnostic Trial|diagnostic trial
5336617|NCT00302107|Mirtazapine|mirtazapine
5336618|NCT00302107|PTSD|ptsd
5336619|NCT00302107|Veterans|veterans
5336620|NCT00302107|antidepressant|antidepressant
5336621|NCT00302081|Hepatitis C, Chronic|hepatitis c, chronic
5336622|NCT00302081|Genotype 2 and Genotype 3|genotype 2 and genotype 3
5336623|NCT00302068|Exercise|exercise
5336624|NCT00302029|Cytomegalovirus, risk factors, seroprevalence|cytomegalovirus, risk factors, seroprevalence
5336625|NCT00302016|Chronic myeloid leukemia|chronic myeloid leukemia
5336626|NCT00302016|AMN 107|amn 107
5336627|NCT00302016|Imatinib resistant or intolerant|imatinib resistant or intolerant
5336628|NCT00302016|nilotinib|nilotinib
5336629|NCT00302016|enact|enact
5336630|NCT00301990|stage IV renal cell cancer|stage iv renal cell cancer
5336631|NCT00301990|recurrent renal cell cancer|recurrent renal cell cancer
5336632|NCT00301990|clear cell renal cell carcinoma|clear cell renal cell carcinoma
5336633|NCT00301951|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5336634|NCT00301951|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5336635|NCT00301951|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5336636|NCT00301951|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5336637|NCT00301951|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5336638|NCT00301951|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5336639|NCT00301951|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5336640|NCT00301951|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5336641|NCT00301951|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
5336642|NCT00301951|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5336643|NCT00301951|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5336644|NCT00301951|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5336645|NCT00301951|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5336646|NCT00301951|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5336647|NCT00301951|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5336648|NCT00301951|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5336649|NCT00301951|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5336650|NCT00301951|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5336651|NCT00301951|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5336652|NCT00301951|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
5336653|NCT00301951|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5336654|NCT00301951|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5336655|NCT00301951|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5336656|NCT00301951|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5336657|NCT00301951|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5336658|NCT00301951|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5336659|NCT00301951|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5336660|NCT00301951|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5336661|NCT00301951|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5336662|NCT00301951|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5336663|NCT00301951|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5336664|NCT00301951|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
5336665|NCT00301951|refractory multiple myeloma|refractory multiple myeloma
5336666|NCT00301951|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5336667|NCT00301951|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5336668|NCT00301951|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5336669|NCT00301951|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5336670|NCT00301951|stage I multiple myeloma|stage i multiple myeloma
5336671|NCT00301951|stage II multiple myeloma|stage ii multiple myeloma
5336672|NCT00301951|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
5336673|NCT00301951|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5336674|NCT00301951|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5336675|NCT00301951|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5336676|NCT00301951|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5336677|NCT00301951|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5336678|NCT00301951|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5336679|NCT00301951|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5336680|NCT00301951|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5336681|NCT00301951|stage III multiple myeloma|stage iii multiple myeloma
5336682|NCT00301951|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5336683|NCT00301951|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5336684|NCT00301951|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5336685|NCT00301951|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5336686|NCT00301951|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5336687|NCT00301951|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5336688|NCT00301951|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5336689|NCT00301951|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5336690|NCT00301951|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5336691|NCT00301951|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5336692|NCT00301925|stage I breast cancer|stage i breast cancer
5336693|NCT00301925|stage II breast cancer|stage ii breast cancer
5336694|NCT00301925|stage IIIA breast cancer|stage iiia breast cancer
5336695|NCT00301925|male breast cancer|male breast cancer
5336696|NCT00301912|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5336697|NCT00301912|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5336698|NCT00301912|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5336699|NCT00301912|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5336700|NCT00301912|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5336701|NCT00301912|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5336702|NCT00301912|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5336703|NCT00301912|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5336704|NCT00301912|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5336705|NCT00301912|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5336706|NCT00301912|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5336707|NCT00301912|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5336708|NCT00301912|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5336709|NCT00301912|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5336710|NCT00301912|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
5336711|NCT00301912|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
5336712|NCT00301912|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5337632|NCT00298584|Neonates|neonates
5336713|NCT00301912|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5336714|NCT00301912|anemia|anemia
5336715|NCT00301912|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5336716|NCT00301912|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5336717|NCT00301912|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5336718|NCT00301912|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
5336719|NCT00301912|stage II multiple myeloma|stage ii multiple myeloma
5336720|NCT00301912|stage III multiple myeloma|stage iii multiple myeloma
5336721|NCT00301912|refractory multiple myeloma|refractory multiple myeloma
5336722|NCT00301912|polycythemia vera|polycythemia vera
5336723|NCT00301912|essential thrombocythemia|essential thrombocythemia
5336724|NCT00301912|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5336725|NCT00301912|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5336726|NCT00301912|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5336727|NCT00301912|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5336728|NCT00301912|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5336729|NCT00301912|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5336730|NCT00301912|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5336731|NCT00301912|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5336732|NCT00301912|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5336733|NCT00301912|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5336734|NCT00301912|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5336735|NCT00301912|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5336736|NCT00301912|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5336737|NCT00301912|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5336738|NCT00301912|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5336739|NCT00301912|chronic eosinophilic leukemia|chronic eosinophilic leukemia
5336740|NCT00301912|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
5336741|NCT00301912|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5336742|NCT00301912|chronic neutrophilic leukemia|chronic neutrophilic leukemia
5336743|NCT00301912|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
5336744|NCT00301912|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5336745|NCT00301912|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
5336746|NCT00301912|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
5336747|NCT00301912|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
5336748|NCT00301912|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
5336749|NCT00301912|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5336750|NCT00301912|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5336751|NCT00301912|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5336752|NCT00301912|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5336753|NCT00301912|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
5336754|NCT00301912|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
5336755|NCT00301912|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5336756|NCT00301912|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5336757|NCT00301912|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5336758|NCT00301912|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5336759|NCT00301912|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5336760|NCT00301912|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5336761|NCT00301912|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5336762|NCT00301912|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5336763|NCT00301912|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5336764|NCT00301912|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5336765|NCT00301912|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5336766|NCT00301912|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5336767|NCT00301912|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5336768|NCT00301912|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5336769|NCT00301912|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5336770|NCT00301912|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5336771|NCT00301912|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5336772|NCT00301912|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5336773|NCT00301912|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5336774|NCT00301912|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5336775|NCT00301912|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5336776|NCT00301912|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5336777|NCT00301912|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5336778|NCT00301912|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5336779|NCT00301912|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5336780|NCT00301912|stage I multiple myeloma|stage i multiple myeloma
5336781|NCT00301912|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
5336782|NCT00301899|recurrent breast cancer|recurrent breast cancer
5336783|NCT00301899|male breast cancer|male breast cancer
5336784|NCT00301899|stage IIIA breast cancer|stage iiia breast cancer
5336785|NCT00301899|stage IIIB breast cancer|stage iiib breast cancer
5336786|NCT00301899|stage IIIC breast cancer|stage iiic breast cancer
5336787|NCT00301899|stage IV breast cancer|stage iv breast cancer
5336788|NCT00301886|pain|pain
5336789|NCT00301886|hypercalcemia of malignancy|hypercalcemia of malignancy
5336790|NCT00301886|stage IV breast cancer|stage iv breast cancer
5336791|NCT00301886|bone metastases|bone metastases
5336792|NCT00301886|recurrent breast cancer|recurrent breast cancer
5336793|NCT00301873|osteoporosis|osteoporosis
5336794|NCT00301873|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5336795|NCT00301873|adult giant cell glioblastoma|adult giant cell glioblastoma
5336796|NCT00301873|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
5336797|NCT00301873|adult gliosarcoma|adult gliosarcoma
5336798|NCT00301873|adult mixed glioma|adult mixed glioma
5336799|NCT00301873|recurrent adult brain tumor|recurrent adult brain tumor
5336800|NCT00301873|adult glioblastoma|adult glioblastoma
5336801|NCT00301860|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
5336802|NCT00301860|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
5336803|NCT00301860|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5336804|NCT00301860|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5336805|NCT00301860|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
5336806|NCT00301860|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
5336807|NCT00301860|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5336808|NCT00301860|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5336809|NCT00301860|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5336810|NCT00301860|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
5336811|NCT00301860|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
5336812|NCT00301860|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
5336813|NCT00301860|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
5336814|NCT00301847|tumors metastatic to brain|tumors metastatic to brain
5336815|NCT00301847|recurrent renal cell cancer|recurrent renal cell cancer
5336816|NCT00301847|stage IV renal cell cancer|stage iv renal cell cancer
5336817|NCT00301834|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5336818|NCT00301834|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5336819|NCT00301834|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5336820|NCT00301834|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
5336821|NCT00301834|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
5336822|NCT00301834|congenital amegakaryocytic thrombocytopenia|congenital amegakaryocytic thrombocytopenia
5336823|NCT00301834|Diamond-Blackfan anemia|diamond-blackfan anemia
5336824|NCT00301834|severe congenital neutropenia|severe congenital neutropenia
5336825|NCT00301834|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5336826|NCT00301834|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5336827|NCT00301834|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
5336828|NCT00301821|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
5336829|NCT00301821|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5336830|NCT00301821|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5336831|NCT00301821|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5336832|NCT00301808|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5336833|NCT00301808|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5336834|NCT00301782|testicular choriocarcinoma and embryonal carcinoma|testicular choriocarcinoma and embryonal carcinoma
5336835|NCT00301782|testicular choriocarcinoma and teratoma|testicular choriocarcinoma and teratoma
5336836|NCT00301782|testicular choriocarcinoma and yolk sac tumor|testicular choriocarcinoma and yolk sac tumor
5336837|NCT00301782|testicular choriocarcinoma|testicular choriocarcinoma
5336838|NCT00301782|testicular embryonal carcinoma and teratoma|testicular embryonal carcinoma and teratoma
5336839|NCT00301782|testicular embryonal carcinoma and yolk sac tumor|testicular embryonal carcinoma and yolk sac tumor
5336840|NCT00301782|testicular embryonal carcinoma|testicular embryonal carcinoma
5336841|NCT00301782|testicular yolk sac tumor|testicular yolk sac tumor
5336842|NCT00301782|testicular yolk sac tumor and teratoma|testicular yolk sac tumor and teratoma
5336843|NCT00301782|stage I malignant testicular germ cell tumor|stage i malignant testicular germ cell tumor
5336844|NCT00301782|stage II malignant testicular germ cell tumor|stage ii malignant testicular germ cell tumor
5336845|NCT00301782|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
5337836|NCT00297687|Health|health
5336846|NCT00301782|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
5336847|NCT00301782|recurrent extragonadal non-seminomatous germ cell tumor|recurrent extragonadal non-seminomatous germ cell tumor
5336848|NCT00301782|stage I extragonadal non-seminomatous germ cell tumor|stage i extragonadal non-seminomatous germ cell tumor
5336849|NCT00301782|stage II extragonadal non-seminomatous germ cell tumor|stage ii extragonadal non-seminomatous germ cell tumor
5336850|NCT00301782|stage III extragonadal non-seminomatous germ cell tumor|stage iii extragonadal non-seminomatous germ cell tumor
5336851|NCT00301782|stage IV extragonadal non-seminomatous germ cell tumor|stage iv extragonadal non-seminomatous germ cell tumor
5336852|NCT00301782|recurrent extragonadal germ cell tumor|recurrent extragonadal germ cell tumor
5336853|NCT00301782|testicular immature teratoma|testicular immature teratoma
5336854|NCT00301782|testicular mature teratoma|testicular mature teratoma
5336855|NCT00301782|adult teratoma|adult teratoma
5336856|NCT00301730|lung metastases|lung metastases
5336857|NCT00301730|stage IV breast cancer|stage iv breast cancer
5336858|NCT00301730|recurrent breast cancer|recurrent breast cancer
5336859|NCT00301691|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5336860|NCT00301678|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5336861|NCT00301652|ANCA|anca
5336862|NCT00301652|vasculitis|vasculitis
5336863|NCT00301652|mycophenolate mofetil|mycophenolate mofetil
5336864|NCT00301652|cyclophosphamide|cyclophosphamide
5336865|NCT00301652|treatment|treatment
5336866|NCT00301626|tobacco|tobacco
5336867|NCT00301626|nicotine|nicotine
5336868|NCT00301626|smoking reduction|smoking reduction
5336869|NCT00301613|Henoch-Schonlein purpura nephritis Mycophenolate mofetil|henoch-schonlein purpura nephritis mycophenolate mofetil
5336870|NCT00301613|Cyclophosphamide|cyclophosphamide
5336871|NCT00301613|treatment|treatment
5336872|NCT00301600|Crescentic IgA nephropathy|crescentic iga nephropathy
5336873|NCT00301600|Mycophenolate mofetil|mycophenolate mofetil
5336874|NCT00301600|Cyclophosphamide|cyclophosphamide
5336875|NCT00301600|treatment|treatment
5336876|NCT00301587|spina bifida|spina bifida
5336877|NCT00301587|birth defects|birth defects
5336878|NCT00301587|folic acid|folic acid
5336879|NCT00301587|nervous system diseases|nervous system diseases
5336880|NCT00301587|folate|folate
5336881|NCT00301587|Vitamin B|vitamin b
5336882|NCT00301574|Alzheimer's disease|alzheimer's disease
5336883|NCT00301574|Cognitive dysfunction|cognitive dysfunction
5336884|NCT00301561|Antiretroviral treatment|antiretroviral treatment
5336885|NCT00301561|Expanded access|expanded access
5336886|NCT00301561|Africa|africa
5336887|NCT00301561|Treatment Naive|treatment naive
5336888|NCT00301548|antineoplastic protocols|antineoplastic protocols
5336889|NCT00301548|neoadjuvant therapy|neoadjuvant therapy
5336890|NCT00301548|perioperative chemotherapy|perioperative chemotherapy
5336891|NCT00301548|fluorouracil|fluorouracil
5336892|NCT00301535|Coronary Artery Bypass Graft|coronary artery bypass graft
5336893|NCT00301535|memory loss after cardiac surgery|memory loss after cardiac surgery
5336894|NCT00301535|side effects of bypass|side effects of bypass
5336895|NCT00301522|Coronary|coronary
5336896|NCT00301522|Artery|artery
5336897|NCT00301522|Stenosis|stenosis
5336898|NCT00301522|Drug-eluting|drug-eluting
5336899|NCT00301522|stent|stent
5336900|NCT00301522|restenosis|restenosis
5336901|NCT00301522|revascularization|revascularization
5336902|NCT00301483|multiple trauma|multiple trauma
5336903|NCT00301483|bleeding injuries|bleeding injuries
5336904|NCT00301483|gunshot wounds|gunshot wounds
5336905|NCT00301483|stab wounds|stab wounds
5336906|NCT00301483|penetrating injuries|penetrating injuries
5336907|NCT00301483|blunt trauma|blunt trauma
5336908|NCT00301483|multiple wounds|multiple wounds
5336909|NCT00301470|Ureter, obstruction|ureter, obstruction
5336910|NCT00301470|Diagnostic techniques, urological|diagnostic techniques, urological
5336911|NCT00301470|MRI, functional|mri, functional
5336912|NCT00301457|Hormone Sensitive Primary Breast Cancer|hormone sensitive primary breast cancer
5336913|NCT00301457|Adjuvant Treatment|adjuvant treatment
5336914|NCT00301457|Aromatase Inhibitor|aromatase inhibitor
5336915|NCT00301444|phantom limb pain|phantom limb pain
5336916|NCT00301444|limb amputation|limb amputation
5336917|NCT00301431|Fibromyalgia|fibromyalgia
5336918|NCT00301431|Adults|adults
5336919|NCT00301431|Outpatients|outpatients
5336920|NCT00301431|Adult|adult
5336921|NCT00301431|Double-Blind Method|double-blind method
5336922|NCT00301418|Glioblastoma Multiforme|glioblastoma multiforme
5336923|NCT00301418|Anaplastic Astrocytoma|anaplastic astrocytoma
5336924|NCT00301418|High Grade Glial Neoplasms|high grade glial neoplasms
5336925|NCT00301418|Brain Tumor|brain tumor
5336926|NCT00301405|prostatitis|prostatitis
5336927|NCT00301405|pelvic pain|pelvic pain
5336928|NCT00301392|Glucose intolerance|glucose intolerance
5336929|NCT00301392|Diabetes mellitus|diabetes mellitus
5336930|NCT00301392|Statins,HMG-CoA|statins,hmg-coa
5336931|NCT00301379|Cholangiocarcinoma|cholangiocarcinoma
5336932|NCT00301379|Observational|observational
5336933|NCT00301366|alpha 1-Antitrypsin Deficiency|alpha 1-antitrypsin deficiency
5336934|NCT00301366|alpha 1-Antitrypsin|alpha 1-antitrypsin
5336935|NCT00301366|pulmonary emphysema|pulmonary emphysema
5336936|NCT00301353|early menopause|early menopause
5337837|NCT00297687|Adult|adult
5336937|NCT00301353|isoflavones/phyto-estrogens|isoflavones/phyto-estrogens
5336938|NCT00301353|bone metabolism|bone metabolism
5336939|NCT00301353|bone mineral density|bone mineral density
5336940|NCT00301353|hormones|hormones
5336941|NCT00301249|Diabetes|diabetes
5336942|NCT00301249|Nephropathy|nephropathy
5336943|NCT00301249|Diabetic Nephropathy|diabetic nephropathy
5336944|NCT00301249|Genome Scan|genome scan
5336945|NCT00301249|Genetic Research|genetic research
5336946|NCT00301236|ADHD, children, CADS-T, Dexmethylphenidate-HCl, extended release|adhd, children, cads-t, dexmethylphenidate-hcl, extended release
5336947|NCT00301197|Childhood obesity|childhood obesity
5336948|NCT00301197|intervention|intervention
5336949|NCT00301197|obesity|obesity
5336950|NCT00301197|weight loss|weight loss
5336951|NCT00301197|behavior therapy|behavior therapy
5336952|NCT00301197|peer group|peer group
5336953|NCT00301197|social support network|social support network
5336954|NCT00301197|child|child
5336955|NCT00301197|clinical research|clinical research
5336956|NCT00301197|human subject|human subject
5336957|NCT00301184|HIV Seronegativity|hiv seronegativity
5336958|NCT00301184|HIV Preventive Vaccine|hiv preventive vaccine
5336959|NCT00301184|HIV DNA Vaccine|hiv dna vaccine
5336960|NCT00301184|Modified Vaccinia Ankara Vaccine|modified vaccinia ankara vaccine
5336961|NCT00301171|Wheezing|wheezing
5336962|NCT00301158|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5336963|NCT00301145|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5336964|NCT00301119|small cell lung cancer|small cell lung cancer
5336965|NCT00301119|non-small cell lung cancer|non-small cell lung cancer
5336966|NCT00301119|smoker lung cancer screening|smoker lung cancer screening
5336967|NCT00301119|low dose spiral CT screening|low dose spiral ct screening
5336968|NCT00301106|stage IV breast cancer|stage iv breast cancer
5336969|NCT00301106|liver metastases|liver metastases
5336970|NCT00301093|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5336971|NCT00301093|Philadelphia chromosome positive chronic myelogenous leukemia|philadelphia chromosome positive chronic myelogenous leukemia
5336972|NCT00301080|pain|pain
5336973|NCT00301080|neurotoxicity|neurotoxicity
5336974|NCT00301080|breast cancer|breast cancer
5336975|NCT00301067|stage IV melanoma|stage iv melanoma
5336976|NCT00301067|recurrent melanoma|recurrent melanoma
5336977|NCT00301054|Anaemia|anaemia
5336978|NCT00301054|Malaria|malaria
5336979|NCT00301054|Rural Area in Ghana|rural area in ghana
5336980|NCT00301041|invasive ductal breast carcinoma|invasive ductal breast carcinoma
5336981|NCT00301041|invasive lobular breast carcinoma|invasive lobular breast carcinoma
5336982|NCT00301041|stage I breast cancer|stage i breast cancer
5336983|NCT00301041|stage II breast cancer|stage ii breast cancer
5336984|NCT00301041|stage IIIA breast cancer|stage iiia breast cancer
5336985|NCT00301028|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5336986|NCT00301028|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5336987|NCT00301028|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5336988|NCT00301028|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
5336989|NCT00301028|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5336990|NCT00301002|safety|safety
5336991|NCT00301002|effectiveness|effectiveness
5336992|NCT00301002|Alefacept|alefacept
5336993|NCT00301002|Palmar|palmar
5336994|NCT00301002|Plantar|plantar
5336995|NCT00301002|Pustulosis|pustulosis
5336996|NCT00300976|Blood glucose|blood glucose
5336997|NCT00300976|Blood pressure|blood pressure
5336998|NCT00300976|Lipids|lipids
5336999|NCT00300963|psychosis|psychosis
5337000|NCT00300963|cognition|cognition
5337001|NCT00300950|Pancreas Cancer|pancreas cancer
5337002|NCT00300950|resected pancreas cancer|resected pancreas cancer
5337003|NCT00300950|non-metastatic pancreas cancer|non-metastatic pancreas cancer
5337004|NCT00300911|Natriuretic Peptide, Brain|natriuretic peptide, brain
5337005|NCT00300911|Heart Failure, Congestive|heart failure, congestive
5337006|NCT00300898|contained lumbar herniated disc|contained lumbar herniated disc
5337007|NCT00300898|nucleoplasty|nucleoplasty
5337008|NCT00300898|percutaneous decompression|percutaneous decompression
5337009|NCT00300898|Dekompressor|dekompressor
5337010|NCT00300898|intervertebral electrothermal disc decompression|intervertebral electrothermal disc decompression
5337011|NCT00300898|IDET|idet
5337012|NCT00300885|Non-Small Cell Lung Cancer|non-small cell lung cancer
5337013|NCT00300885|NSCLC|nsclc
5337014|NCT00300820|Bipolar Disorder|bipolar disorder
5337015|NCT00300820|Affected Adults and Adult Siblings|affected adults and adult siblings
5337016|NCT00300820|Interest in Genetic Counseling|interest in genetic counseling
5337017|NCT00300820|Bipolar|bipolar
5337018|NCT00300820|Genes|genes
5337019|NCT00300820|Familial|familial
5337020|NCT00300820|Education|education
5337021|NCT00300820|Testing|testing
5337022|NCT00300820|BP|bp
5337023|NCT00300820|Adult Siblings|adult siblings
5337024|NCT00300807|Hepatitis C|hepatitis c
5337025|NCT00300807|Monoclonal Antibody|monoclonal antibody
5337026|NCT00300807|failed IFN/RBV treatment|failed ifn/rbv treatment
5337027|NCT00300781|phase 2|phase 2
5337028|NCT00300781|HER2+ breast cancer|her2+ breast cancer
5337029|NCT00300781|monotherapy neratinib|monotherapy neratinib
5337030|NCT00300781|HKI-272|hki-272
5337031|NCT00300781|Neratinib|neratinib
5337032|NCT00300781|Nerlynx|nerlynx
5337033|NCT00300781|PB-272|pb-272
5337034|NCT00300768|onchocerciasis|onchocerciasis
5337035|NCT00300768|onchocerca volvulus|onchocerca volvulus
5337036|NCT00300768|river blindness|river blindness
5337037|NCT00300768|ivermectin|ivermectin
5337038|NCT00300768|moxidectin|moxidectin
5337039|NCT00300755|GERD|gerd
5337040|NCT00300755|Children|children
5337041|NCT00300755|Child|child
5337042|NCT00300755|Child, Preschool|child, preschool
5337043|NCT00300742|drinking|drinking
5337044|NCT00300742|eating|eating
5337045|NCT00300742|obesity|obesity
5337046|NCT00300742|alcohol|alcohol
5337047|NCT00300742|binge eating|binge eating
5337048|NCT00300729|Cyclooxygenase-2 inhibitors|cyclooxygenase-2 inhibitors
5337049|NCT00300729|Celecoxib|celecoxib
5337050|NCT00300729|Carcinoma, non-small-cell lung|carcinoma, non-small-cell lung
5337051|NCT00300729|Antineoplastic agents|antineoplastic agents
5337052|NCT00300729|Therapy, palliative|therapy, palliative
5337053|NCT00300729|Survival|survival
5337054|NCT00300716|Multiple Sclerosis|multiple sclerosis
5337055|NCT00300716|Cognitive impairment|cognitive impairment
5337056|NCT00300716|Memantine|memantine
5337057|NCT00300716|Placebo|placebo
5337058|NCT00300716|Neuropsychological tests|neuropsychological tests
5337059|NCT00300716|Quality of life|quality of life
5337060|NCT00300716|Fatigue|fatigue
5337061|NCT00300703|Cardiac Arrest|cardiac arrest
5337062|NCT00300690|Lower extremity bypass surgery|lower extremity bypass surgery
5337063|NCT00300690|femoro-popliteal bypass|femoro-popliteal bypass
5337064|NCT00300690|Dacron material|dacron material
5337065|NCT00300690|PTFE material|ptfe material
5337066|NCT00300677|Pharmacokinetics|pharmacokinetics
5337067|NCT00300677|Voriconazole|voriconazole
5337068|NCT00300677|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
5337069|NCT00300651|Cognitive Behavioral Therapy|cognitive behavioral therapy
5337070|NCT00300651|Schizophrenia|schizophrenia
5337071|NCT00300651|Cognitive Biases|cognitive biases
5337072|NCT00300651|Efficacy|efficacy
5337073|NCT00300638|Alcoholism|alcoholism
5337074|NCT00300638|Emotion|emotion
5337075|NCT00300638|Cognition|cognition
5337076|NCT00300638|Brain scans|brain scans
5337077|NCT00300625|Syncope|syncope
5337078|NCT00300625|Near syncope|near syncope
5337079|NCT00300625|San Francisco Syncope rule|san francisco syncope rule
5337080|NCT00300586|Non-small cell lung cancer ;|non-small cell lung cancer ;
5337081|NCT00300586|metastatic ;|metastatic ;
5337082|NCT00300586|chemotherapy ;|chemotherapy ;
5337083|NCT00300586|erlotinib|erlotinib
5337084|NCT00300573|dexelvucitabine|dexelvucitabine
5337086|NCT00300573|Treatment Experienced|treatment experienced
5337087|NCT00300573|HIV-1|hiv-1
5337088|NCT00300560|ESBL-producing E.coli Infections|esbl-producing e.coli infections
5337089|NCT00300560|ESBL-producing Klebsiella pneumoniae Infections|esbl-producing klebsiella pneumoniae infections
5337090|NCT00300560|Colistin|colistin
5337091|NCT00300547|colorectal cancer|colorectal cancer
5337092|NCT00300547|polyps|polyps
5337093|NCT00300547|Virtual colonoscopy|virtual colonoscopy
5337094|NCT00300547|synchronous carcinoma|synchronous carcinoma
5337095|NCT00300547|MR colonography|mr colonography
5337096|NCT00300534|Diagnosis|diagnosis
5337097|NCT00300521|hepatocellular carcinoma|hepatocellular carcinoma
5337098|NCT00300521|liver transplantation|liver transplantation
5337099|NCT00300521|adenovirus-thymidine kinase enzyme|adenovirus-thymidine kinase enzyme
5337100|NCT00300521|gene therapy|gene therapy
5337101|NCT00300521|immunosuppression|immunosuppression
5337102|NCT00300508|Hormone receptor positive breast cancer|hormone receptor positive breast cancer
5337103|NCT00300495|Atrial fibrillation|atrial fibrillation
5337104|NCT00300495|Lung cancer|lung cancer
5337105|NCT00300495|Pulmonary resection|pulmonary resection
5337106|NCT00300495|Post-operative complications|post-operative complications
5337107|NCT00300482|Dyslipidemia|dyslipidemia
5337108|NCT00300482|Coronary Heart Disease|coronary heart disease
5337109|NCT00300482|Mixed Dyslipidemia|mixed dyslipidemia
5337110|NCT00300469|Mixed Dyslipidemia|mixed dyslipidemia
5337111|NCT00300469|Coronary Heart Disease|coronary heart disease
5337112|NCT00300469|Dyslipidemia|dyslipidemia
5337113|NCT00300456|Dyslipidemia|dyslipidemia
5337114|NCT00300456|Coronary Heart Disease|coronary heart disease
5337115|NCT00300456|Mixed Dyslipidemia|mixed dyslipidemia
5337116|NCT00300417|Flavivirus|flavivirus
5337117|NCT00300417|Mosquito|mosquito
5337118|NCT00300417|Immunity|immunity
5337119|NCT00300417|Preventive|preventive
5337120|NCT00300417|West Nile Fever|west nile fever
5337121|NCT00300417|West Nile Virus|west nile virus
5337122|NCT00300417|Vaccine|vaccine
5337123|NCT00300417|Healthy Volunteer|healthy volunteer
5337124|NCT00300417|HV|hv
5337125|NCT00300404|Schizophrenia|schizophrenia
5337126|NCT00300404|Psychosis|psychosis
5337127|NCT00300404|Depression|depression
5337128|NCT00300404|Affective Disorder|affective disorder
5337129|NCT00300391|Delirium|delirium
5337130|NCT00300391|Mechanical ventilation|mechanical ventilation
5338699|NCT00295373|Exercise|exercise
5337131|NCT00300391|Intensive care|intensive care
5337132|NCT00300391|Haloperidol|haloperidol
5337133|NCT00300378|Depression|depression
5337134|NCT00300378|Adult|adult
5337135|NCT00300378|Outpatients|outpatients
5337136|NCT00300365|HDL cholesterol|hdl cholesterol
5337137|NCT00300365|Metabolic syndrome|metabolic syndrome
5337138|NCT00300352|Coronary artery disease|coronary artery disease
5337139|NCT00300352|Folic acid|folic acid
5337140|NCT00300352|Endothelial function|endothelial function
5337141|NCT00300300|ACL computer-assisted surgery graft|acl computer-assisted surgery graft
5337142|NCT00300287|Type 2 diabetes|type 2 diabetes
5337143|NCT00300287|Vildagliptin|vildagliptin
5337144|NCT00300274|Everolimus|everolimus
5337145|NCT00300274|heart transplant|heart transplant
5337146|NCT00300274|heart disease|heart disease
5337147|NCT00300274|transplantation|transplantation
5337148|NCT00300274|heart IVUS assessment at 12 months|heart ivus assessment at 12 months
5337149|NCT00300274|rate of graft loss|rate of graft loss
5337150|NCT00300274|acute rejection episodes|acute rejection episodes
5337151|NCT00300274|survival|survival
5337152|NCT00300261|Heart Failure|heart failure
5337153|NCT00300248|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
5337154|NCT00300248|Acute Lung Injury|acute lung injury
5337155|NCT00300248|Respiratory Failure|respiratory failure
5337156|NCT00300248|ARDS, Human|ards, human
5337157|NCT00300235|Sickle Cell Anemia|sickle cell anemia
5337158|NCT00300222|dermal assessment|dermal assessment
5337159|NCT00300222|pain measurement|pain measurement
5337160|NCT00300222|diary|diary
5337161|NCT00300222|PHN|phn
5337162|NCT00300222|shingles|shingles
5337163|NCT00300222|neuropathy|neuropathy
5337164|NCT00300222|analgesics|analgesics
5337165|NCT00300222|capsaicin|capsaicin
5337166|NCT00300222|postherpetic neuralgia|postherpetic neuralgia
5337167|NCT00300196|Stroke|stroke
5337168|NCT00300196|Fibrinogen|fibrinogen
5337169|NCT00300196|Reperfusion|reperfusion
5337170|NCT00300196|Thrombolysis|thrombolysis
5337171|NCT00300183|HIV|hiv
5337172|NCT00300183|health services accessibility|health services accessibility
5337173|NCT00300183|health services research|health services research
5337174|NCT00300183|homeless|homeless
5337175|NCT00300183|social support|social support
5337176|NCT00300183|AIDS|aids
5337177|NCT00300183|substance abuse|substance abuse
5337178|NCT00300183|mental health|mental health
5337179|NCT00300183|quality of life|quality of life
5337180|NCT00300183|outreach|outreach
5337181|NCT00300183|harm reduction|harm reduction
5337182|NCT00300170|HIV|hiv
5337183|NCT00300170|race|race
5337184|NCT00300170|unstable housing|unstable housing
5337185|NCT00300170|health services accessibility|health services accessibility
5337186|NCT00300170|health services utilization|health services utilization
5337187|NCT00300170|substance abuse|substance abuse
5337188|NCT00300170|AIDS|aids
5337189|NCT00300170|health services research|health services research
5337190|NCT00300170|social support|social support
5337191|NCT00300170|depression|depression
5337192|NCT00300170|trust|trust
5337193|NCT00300170|discrimination|discrimination
5337194|NCT00300157|Left main coronary artery stenosis, stent, Taxus|left main coronary artery stenosis, stent, taxus
5337195|NCT00300157|Unprotected left main coronary artery disease|unprotected left main coronary artery disease
5337196|NCT00300157|Percutaneous coronary intervention with Taxus stent|percutaneous coronary intervention with taxus stent
5337197|NCT00300131|Bioabsorbable|bioabsorbable
5337198|NCT00300131|Coronary Stent|coronary stent
5337199|NCT00300131|Everolimus|everolimus
5337200|NCT00300131|drug eluting stents|drug eluting stents
5337201|NCT00300131|stents|stents
5337202|NCT00300131|angioplasty|angioplasty
5337203|NCT00300131|coronary artery disease|coronary artery disease
5337204|NCT00300131|total coronary occlusion|total coronary occlusion
5337205|NCT00300131|coronary artery restenosis|coronary artery restenosis
5337206|NCT00300131|stent thrombosis|stent thrombosis
5337207|NCT00300131|vascular disease|vascular disease
5337208|NCT00300131|myocardial ischemia|myocardial ischemia
5337209|NCT00300131|coronary artery stenosis|coronary artery stenosis
5337210|NCT00300105|Patients diagnosed with type 2 diabetes who have participated in and completed the randomized, double-blind, parallel-group, multi-center study GALLANT 4|patients diagnosed with type 2 diabetes who have participated in and completed the randomized, double-blind, parallel-group, multi-center study gallant 4
5337211|NCT00300079|Ocular Hypertension Patients|ocular hypertension patients
5337212|NCT00300066|Glomerular Filtration Rate|glomerular filtration rate
5337213|NCT00300066|Serum Cystatin C|serum cystatin c
5337214|NCT00300066|Body Composition|body composition
5337215|NCT00300066|bioelectrical impedance spectroscopy|bioelectrical impedance spectroscopy
5337216|NCT00300053|angina|angina
5337217|NCT00300040|Amputation|amputation
5337218|NCT00300040|Lower limb|lower limb
5337219|NCT00300040|Critical Limb Ischemia|critical limb ischemia
5337220|NCT00300040|residual limb|residual limb
5337221|NCT00300040|Peripheral Vascular Disease|peripheral vascular disease
5337222|NCT00300040|re-amputation|re-amputation
5337223|NCT00300040|Lower Limb Ischemia|lower limb ischemia
5337225|NCT00300027|Advanced Gastrointestinal Malignancies|advanced gastrointestinal malignancies
5337226|NCT00300014|Post vitrectomy|post vitrectomy
5338700|NCT00295373|Statin|statin
5337227|NCT00300014|Recurrent diabetic vitreous hemorrhage|recurrent diabetic vitreous hemorrhage
5337228|NCT00300014|Intravitreal triamcinolone injection|intravitreal triamcinolone injection
5337229|NCT00300001|Cancer|cancer
5337230|NCT00300001|Symptom Management|symptom management
5337231|NCT00300001|Supportive Symptom Interventions|supportive symptom interventions
5337232|NCT00300001|Symptom Severity|symptom severity
5337233|NCT00300001|quality of life|quality of life
5337234|NCT00300001|Home-based symptom monitoring|home-based symptom monitoring
5337235|NCT00299988|Immunotherapy|immunotherapy
5337236|NCT00299988|Amyloid beta protein|amyloid beta protein
5337237|NCT00299988|Antibodies|antibodies
5337238|NCT00299988|Alzheimer's|alzheimer's
5337239|NCT00299988|Dementia|dementia
5337240|NCT00299975|Randomized Controlled Trials|randomized controlled trials
5337241|NCT00299975|Medicine, Chinese Traditional|medicine, chinese traditional
5337242|NCT00299975|Medicine, Herbal|medicine, herbal
5337243|NCT00299975|Constipation|constipation
5337244|NCT00299962|gene therapy|gene therapy
5337245|NCT00299962|immunotherapy|immunotherapy
5337246|NCT00299936|hepatitis C|hepatitis c
5337247|NCT00299936|chronic hepatitis C|chronic hepatitis c
5337248|NCT00299936|ribavirin|ribavirin
5337249|NCT00299936|WIN-R|win-r
5337250|NCT00299923|drug therapy|drug therapy
5337251|NCT00299923|Interferon|interferon
5337252|NCT00299897|HIV|hiv
5337253|NCT00299897|AIDS|aids
5337254|NCT00299897|Treatment Resistance|treatment resistance
5337255|NCT00299897|Treatment Failure|treatment failure
5337256|NCT00299897|Mutations|mutations
5337257|NCT00299897|GP120|gp120
5337258|NCT00299897|Entry Inhibitors|entry inhibitors
5337259|NCT00299897|HAART|haart
5337260|NCT00299897|antiretroviral|antiretroviral
5337261|NCT00299897|antiviral|antiviral
5337262|NCT00299897|ARV|arv
5337263|NCT00299897|CCR5|ccr5
5337264|NCT00299897|CXCR4|cxcr4
5337265|NCT00299897|receptors|receptors
5337266|NCT00299897|intracellular fluid|intracellular fluid
5337267|NCT00299897|lipid rafts|lipid rafts
5337268|NCT00299897|cholesterol|cholesterol
5337269|NCT00299897|chemokine|chemokine
5337270|NCT00299897|Treatment Experienced|treatment experienced
5337271|NCT00299884|Randomized|randomized
5337272|NCT00299884|non-blinded|non-blinded
5337273|NCT00299884|prospective|prospective
5337274|NCT00299884|open-label|open-label
5337275|NCT00299884|LDL-C|ldl-c
5337276|NCT00299884|HDL-C|hdl-c
5337277|NCT00299871|Type 2 diabetes|type 2 diabetes
5337278|NCT00299858|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5337279|NCT00299858|Theophylline|theophylline
5337280|NCT00299858|Exercise testing|exercise testing
5337281|NCT00299845|gastroesophageal reflux|gastroesophageal reflux
5337282|NCT00299845|children|children
5337283|NCT00299845|lansoprazole|lansoprazole
5337284|NCT00299845|cytochrome P450 2C19 (CYP2C19)|cytochrome p450 2c19 (cyp2c19)
5337285|NCT00299845|pharmacogenomics|pharmacogenomics
5337286|NCT00299845|genetic polymorphisms|genetic polymorphisms
5337287|NCT00299845|individualized medicine|individualized medicine
5337288|NCT00299845|pharmacokinetics/dynamics|pharmacokinetics/dynamics
5337289|NCT00299832|Hypertension, aliskiren, blood pressure, rennin|hypertension, aliskiren, blood pressure, rennin
5337290|NCT00299819|Lupus|lupus
5337291|NCT00299806|Hypertension, aliskiren, blood pressure, rennin|hypertension, aliskiren, blood pressure, rennin
5337292|NCT00299793|Epilepsy|epilepsy
5337293|NCT00299793|Quality of life|quality of life
5337294|NCT00299780|Mobilization|mobilization
5337295|NCT00299780|Stem Cell|stem cell
5337296|NCT00299780|Parathyroid Hormone|parathyroid hormone
5337297|NCT00299754|Low dose misoprostol|low dose misoprostol
5337298|NCT00299754|dinoprostone|dinoprostone
5337299|NCT00299754|cervical priming|cervical priming
5337300|NCT00299741|Sutent|sutent
5337301|NCT00299741|Sunitinib|sunitinib
5337302|NCT00299741|Bone|bone
5337303|NCT00299741|Metastatic|metastatic
5337304|NCT00299741|Hormone-refractory|hormone-refractory
5337305|NCT00299741|Biomarkers|biomarkers
5337306|NCT00299728|NY-ESO-1|ny-eso-1
5337307|NCT00299728|Vaccine|vaccine
5337308|NCT00299728|Adjuvant or metastatic setting|adjuvant or metastatic setting
5337309|NCT00299728|Several tumor types eligible|several tumor types eligible
5337310|NCT00299715|Affective psychosis|affective psychosis
5337311|NCT00299715|mixed-state|mixed-state
5337312|NCT00299715|bipolar disorder|bipolar disorder
5337313|NCT00299715|manic disorder|manic disorder
5337314|NCT00299715|manic-depressive|manic-depressive
5337315|NCT00299715|psychosis|psychosis
5337316|NCT00299715|mania|mania
5337317|NCT00299715|manic state|manic state
5337318|NCT00299715|paliperidone|paliperidone
5337319|NCT00299715|paliperidone ER.|paliperidone er.
5337320|NCT00299702|Schizophrenia|schizophrenia
5337321|NCT00299702|Relapse|relapse
5337322|NCT00299702|Remission|remission
5337323|NCT00299702|Treatment Outcome|treatment outcome
5337324|NCT00299702|long-acting injectable|long-acting injectable
5337325|NCT00299689|Melanoma|melanoma
5337326|NCT00299689|Metastatic|metastatic
5337327|NCT00299689|Stage IV|stage iv
5337329|NCT00299676|Alzheimer's Disease|alzheimer's disease
5337330|NCT00299676|Dementia|dementia
5337331|NCT00299676|Post Marketing|post marketing
5337332|NCT00299676|Prospective Studies|prospective studies
5337333|NCT00299676|Longitudinal Studies|longitudinal studies
5337334|NCT00299676|New Zealand|new zealand
5337335|NCT00299676|Cholinesterase Inhibitors|cholinesterase inhibitors
5337336|NCT00299676|Observational|observational
5337337|NCT00299676|Outcomes|outcomes
5337338|NCT00299663|group A streptococcal infection|group a streptococcal infection
5337339|NCT00299663|genital tract|genital tract
5337340|NCT00299663|CARRIER|carrier
5337341|NCT00299663|patients with GAS isolation|patients with gas isolation
5337342|NCT00299663|Streptococcus Group A|streptococcus group a
5337343|NCT00299650|ARDS|ards
5337344|NCT00299650|mortality|mortality
5337345|NCT00299650|mechanical ventilation|mechanical ventilation
5337346|NCT00299650|pneumonia|pneumonia
5337347|NCT00299650|muscle relaxants|muscle relaxants
5337348|NCT00299624|venous thromboembolism risk,|venous thromboembolism risk,
5337349|NCT00299624|elderly,|elderly,
5337350|NCT00299624|hypercoagulability|hypercoagulability
5337351|NCT00299624|fibrinolysis|fibrinolysis
5337352|NCT00299624|microparticles|microparticles
5337353|NCT00299611|OCD|ocd
5337354|NCT00299611|Anxiety|anxiety
5337355|NCT00299611|Pharmacotherapy|pharmacotherapy
5337356|NCT00299611|Sertraline|sertraline
5337357|NCT00299611|Levetiracetam|levetiracetam
5337358|NCT00299598|antibacterial|antibacterial
5337359|NCT00299598|composite|composite
5337360|NCT00299598|polyethylenimine|polyethylenimine
5337361|NCT00299598|nanoparticle|nanoparticle
5337362|NCT00299585|dental implant|dental implant
5337363|NCT00299585|dental implantation|dental implantation
5337364|NCT00299585|osseointegration|osseointegration
5337365|NCT00299585|bone cement|bone cement
5337366|NCT00299585|osteoconductivity|osteoconductivity
5337367|NCT00299585|brushite|brushite
5337368|NCT00299585|calcium phosphate|calcium phosphate
5337369|NCT00299585|bone augmentation|bone augmentation
5337370|NCT00299585|primary stability|primary stability
5337371|NCT00299585|immediate implantation|immediate implantation
5337372|NCT00299585|Mandibular Ridge Augmentation|mandibular ridge augmentation
5337373|NCT00299585|Maxillary Ridge Augmentation|maxillary ridge augmentation
5337374|NCT00299585|synthetic implants for rebuilding the alveolar ridge|synthetic implants for rebuilding the alveolar ridge
5337375|NCT00299572|alendronate|alendronate
5337376|NCT00299572|peritoneal dialysis|peritoneal dialysis
5337377|NCT00299572|vascular calcification|vascular calcification
5337378|NCT00299572|bone mineral density|bone mineral density
5337379|NCT00299559|common cold|common cold
5337380|NCT00299559|organic chemicals|organic chemicals
5337381|NCT00299559|menthol|menthol
5337382|NCT00299559|cineole|cineole
5337383|NCT00299559|camphor|camphor
5337384|NCT00299559|etheric oils|etheric oils
5337385|NCT00299559|alternative medicine|alternative medicine
5337386|NCT00299559|smart textiles|smart textiles
5337387|NCT00299546|Rheumatoid Arthritis|rheumatoid arthritis
5337388|NCT00299546|Anti-TNFa agents|anti-tnfa agents
5337389|NCT00299546|subcutaneous injection|subcutaneous injection
5337390|NCT00299520|skin infection|skin infection
5337391|NCT00299520|complicated skin infection|complicated skin infection
5337392|NCT00299520|skin structure infection|skin structure infection
5337393|NCT00299507|exudative AMD|exudative amd
5337394|NCT00299507|age-related macular degeneration (AMD)|age-related macular degeneration (amd)
5337395|NCT00299494|Lymphoma|lymphoma
5337396|NCT00299494|NHL|nhl
5337397|NCT00299481|Tissue Bank|tissue bank
5337398|NCT00299481|Endometrial neoplasm|endometrial neoplasm
5337399|NCT00299481|uterine cervical neoplasm|uterine cervical neoplasm
5337400|NCT00299481|ovarian neoplasm|ovarian neoplasm
5337401|NCT00299481|leiomyoma|leiomyoma
5337402|NCT00299481|DNA|dna
5337403|NCT00299481|RNA|rna
5337404|NCT00299481|Protein|protein
5337405|NCT00299481|Serum|serum
5337406|NCT00299468|hypertension|hypertension
5337407|NCT00299468|home care|home care
5337408|NCT00299468|patient activation|patient activation
5337409|NCT00299468|stages-of-change|stages-of-change
5337410|NCT00299442|behavior|behavior
5337411|NCT00299442|conduct|conduct
5337412|NCT00299442|child|child
5337413|NCT00299442|parenting|parenting
5337414|NCT00299442|self-help|self-help
5337415|NCT00299442|media-based|media-based
5337416|NCT00299429|Stent|stent
5337417|NCT00299429|drug-eluting stent|drug-eluting stent
5337418|NCT00299429|Minimally invasive bypass surgery|minimally invasive bypass surgery
5337419|NCT00299429|left anterior descending|left anterior descending
5337420|NCT00299416|Stroke|stroke
5337421|NCT00299416|Nonhemorrhagic|nonhemorrhagic
5337422|NCT00299416|hypothermia|hypothermia
5337423|NCT00299403|Depressive disorder,|depressive disorder,
5337424|NCT00299403|Antidepressant effect,|antidepressant effect,
5337425|NCT00299403|rTMS,|rtms,
5337426|NCT00299403|ECT,|ect,
5337427|NCT00299403|cognition,|cognition,
5337428|NCT00299403|Saliva cortisol|saliva cortisol
5337429|NCT00299403|noninferiority trial|noninferiority trial
5337430|NCT00299390|Sagopilone|sagopilone
5337431|NCT00299390|Epothilone|epothilone
5337432|NCT00299390|SCLC|sclc
5337433|NCT00299390|Small Cell Lung Cancer|small cell lung cancer
5337434|NCT00299390|Lung Cancer|lung cancer
5337435|NCT00299377|STEMI|stemi
5337436|NCT00299377|infarct size|infarct size
5337437|NCT00299377|primary PCI|primary pci
5337438|NCT00299377|no-reflow|no-reflow
5337439|NCT00299377|ST-elevation myocardial infarction|st-elevation myocardial infarction
5337440|NCT00299364|Climacteric symptoms|climacteric symptoms
5337441|NCT00299364|Black Cohosh|black cohosh
5337442|NCT00299364|Efficacy|efficacy
5337443|NCT00299364|Safety|safety
5337444|NCT00299338|HIV|hiv
5337445|NCT00299338|AIDS|aids
5337446|NCT00299338|CD4|cd4
5337447|NCT00299338|HAART|haart
5337448|NCT00299338|antiretroviral|antiretroviral
5337449|NCT00299338|treatment failure|treatment failure
5337450|NCT00299338|resistance|resistance
5337451|NCT00299338|CCR4|ccr4
5337452|NCT00299338|CXCR5|cxcr5
5337453|NCT00299338|gp120|gp120
5337454|NCT00299338|gp41|gp41
5337455|NCT00299338|cholesterol|cholesterol
5337456|NCT00299338|lipid rafts|lipid rafts
5337457|NCT00299338|intracellular fluid|intracellular fluid
5337458|NCT00299338|receptors|receptors
5337459|NCT00299338|chemokine|chemokine
5337460|NCT00299338|antigens|antigens
5337461|NCT00299338|Treatment Experienced|treatment experienced
5337462|NCT00299312|Loss of Purposeful Hand Use Syndrome|loss of purposeful hand use syndrome
5337463|NCT00299312|Loss of Communication|loss of communication
5337464|NCT00299312|Stereotypic Hand Movements|stereotypic hand movements
5337465|NCT00299312|MECP2 mutation|mecp2 mutation
5337466|NCT00299312|MECP2 duplication|mecp2 duplication
5337467|NCT00299312|CDKL5 mutation|cdkl5 mutation
5337468|NCT00299312|FOXG1 mutation|foxg1 mutation
5337469|NCT00299286|Ki67|ki67
5337470|NCT00299286|Molecular|molecular
5337471|NCT00299286|antiproliferative|antiproliferative
5337472|NCT00299273|Obesity;|obesity;
5337473|NCT00299273|Low calorie high fat/protein diet;|low calorie high fat/protein diet;
5337474|NCT00299273|Low-carbohydrate diet|low-carbohydrate diet
5337475|NCT00299273|Weight Loss|weight loss
5337476|NCT00299260|cytomegalovirus, glycoprotein B vaccine, allograft|cytomegalovirus, glycoprotein b vaccine, allograft
5337477|NCT00299247|Malaria, Plasmodium falciparum, drug resistance, Colombia|malaria, plasmodium falciparum, drug resistance, colombia
5337478|NCT00299234|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
5337479|NCT00299221|immunosuppression|immunosuppression
5337480|NCT00299221|steroid withdrawal|steroid withdrawal
5337481|NCT00299221|rejection|rejection
5337482|NCT00299221|coronary disease|coronary disease
5337483|NCT00299221|cytomegalovirus infection|cytomegalovirus infection
5337484|NCT00299208|Malaria|malaria
5337485|NCT00299195|Oral Leukoplakia|oral leukoplakia
5337486|NCT00299195|Benign Neoplasms|benign neoplasms
5337487|NCT00299195|Chemoprevention|chemoprevention
5337488|NCT00299195|Pan-cyclooxygenase (COX) inhibitor|pan-cyclooxygenase (cox) inhibitor
5337489|NCT00299195|sulindac|sulindac
5337490|NCT00299195|04-099|04-099
5337491|NCT00299182|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
5337492|NCT00299182|Lymphoma|lymphoma
5337493|NCT00299182|Mantle Cell Lymphoma|mantle cell lymphoma
5337494|NCT00299182|AMG 531|amg 531
5337495|NCT00299182|Romiplostim|romiplostim
5337496|NCT00299182|Placebo|placebo
5337497|NCT00299182|R-HyperCVAD|r-hypercvad
5337498|NCT00299182|R-Ara-C/MTX|r-ara-c/mtx
5337499|NCT00299182|Cyclophosphamide|cyclophosphamide
5337500|NCT00299182|Cytarabine|cytarabine
5337501|NCT00299182|Dexamethasone|dexamethasone
5337502|NCT00299182|Doxorubicin|doxorubicin
5337503|NCT00299182|Methotrexate|methotrexate
5337504|NCT00299182|Rituximab|rituximab
5337505|NCT00299182|Vincristine|vincristine
5337506|NCT00299182|Decadron|decadron
5337507|NCT00299182|Neosar|neosar
5337508|NCT00299182|AD|ad
5337509|NCT00299182|Hydroxydaunomycin hydrocholoride|hydroxydaunomycin hydrocholoride
5337510|NCT00299182|Ara-C|ara-c
5337511|NCT00299182|Cytosar|cytosar
5337512|NCT00299182|DepoCyt|depocyt
5337513|NCT00299182|Cytosine arabinosine hydrochloride|cytosine arabinosine hydrochloride
5337514|NCT00299169|N of 1 trial|n of 1 trial
5337515|NCT00299169|diabetes mellitus|diabetes mellitus
5337516|NCT00299169|HMG CoA Reductase Inhibitors|hmg coa reductase inhibitors
5337517|NCT00299169|cardiovascular disease|cardiovascular disease
5337518|NCT00299156|Myelodysplastic Syndrome|myelodysplastic syndrome
5337519|NCT00299156|MDS|mds
5337520|NCT00299156|Chronic Myelomonocytic Leukemia|chronic myelomonocytic leukemia
5337521|NCT00299156|CMML|cmml
5337522|NCT00299156|Clofarabine|clofarabine
5337523|NCT00299156|Clofarex|clofarex
5337524|NCT00299156|Clolar|clolar
5337525|NCT00299156|Chemotherapy|chemotherapy
5337526|NCT00299143|SIPA|sipa
5337527|NCT00299143|acute coronary syndrome|acute coronary syndrome
5337528|NCT00299130|RA|ra
5337529|NCT00299130|Rituxan|rituxan
5337530|NCT00299130|SERENE|serene
5337531|NCT00299117|Smoking cessation|smoking cessation
5337532|NCT00299117|Stress|stress
5337533|NCT00299117|Nicotine dependence|nicotine dependence
5337534|NCT00299117|Complication, postoperative|complication, postoperative
5337535|NCT00299104|Rituxan|rituxan
5337536|NCT00299104|MTX|mtx
5337537|NCT00299104|RA|ra
5337538|NCT00299104|IMAGE|image
5337539|NCT00299104|WA17047|wa17047
5337540|NCT00299091|Therapeutic drug monitoring|therapeutic drug monitoring
5337541|NCT00299091|Treatment Naive|treatment naive
5337542|NCT00299091|Treatment Experienced|treatment experienced
5337543|NCT00299091|HIV|hiv
5337544|NCT00299065|Asthma, bronchial|asthma, bronchial
5337545|NCT00299065|Asthma, exercise-induced|asthma, exercise-induced
5337546|NCT00299065|Anti-asthmatic agents|anti-asthmatic agents
5337547|NCT00299052|Tibia|tibia
5337548|NCT00299052|Fracture|fracture
5337549|NCT00299052|DBM|dbm
5337550|NCT00299039|Randomized controlled trial|randomized controlled trial
5337551|NCT00299039|Clinical trial|clinical trial
5337552|NCT00299039|Breast tumor surgery|breast tumor surgery
5337553|NCT00299039|Outpatient surgery|outpatient surgery
5337554|NCT00299039|Analgesia|analgesia
5337555|NCT00299039|Outpatient analgesia|outpatient analgesia
5337556|NCT00299039|Post surgical analgesia|post surgical analgesia
5337557|NCT00299039|≥ 18 and ≤ 70 years of age|≥ 18 and ≤ 70 years of age
5337558|NCT00299039|Elective outpatient breast surgery for:|elective outpatient breast surgery for:
5337559|NCT00299039|lumpectomy/quadrantectomy +/- Sentinel Lymph Node Biopsy|lumpectomy/quadrantectomy +/- sentinel lymph node biopsy
5337560|NCT00299039|lumpectomy/quadrantectomy with Axillary Node Dissection|lumpectomy/quadrantectomy with axillary node dissection
5337561|NCT00299039|simple mastectomy +/- Sentinel Lymph Node Biopsy|simple mastectomy +/- sentinel lymph node biopsy
5337562|NCT00299039|Modified Radical mastectomy|modified radical mastectomy
5337563|NCT00299026|Coronary Artery Disease|coronary artery disease
5337564|NCT00299026|Percutaneous Coronary Intervention|percutaneous coronary intervention
5337565|NCT00299026|Stent Implant|stent implant
5337566|NCT00299026|Drug-coated Stent|drug-coated stent
5337567|NCT00299013|Ulcerative colitis|ulcerative colitis
5337568|NCT00298987|Chronic Myeloid Leukemia Accelerated and Blast Phase|chronic myeloid leukemia accelerated and blast phase
5337569|NCT00298987|Leukemia, Acute, Philadelphia-Positive|leukemia, acute, philadelphia-positive
5337570|NCT00298974|Osteoarthritis of the hip or knee|osteoarthritis of the hip or knee
5337571|NCT00298935|Randomized Controlled Trial|randomized controlled trial
5337572|NCT00298935|Pregnant Women|pregnant women
5337573|NCT00298922|Cystic Fibrosis|cystic fibrosis
5337574|NCT00298922|Burkholderia cepacia complex|burkholderia cepacia complex
5337575|NCT00298896|Lung|lung
5337576|NCT00298896|Squamous Cell|squamous cell
5337577|NCT00298896|Small Cell|small cell
5337578|NCT00298896|Carcinoma|carcinoma
5337579|NCT00298896|Cancer|cancer
5337580|NCT00298896|Small Cell Lung Cancer|small cell lung cancer
5337581|NCT00298883|Renal|renal
5337582|NCT00298883|Transplant|transplant
5337583|NCT00298883|PRA|pra
5337584|NCT00298870|pulmonary tuberculosis|pulmonary tuberculosis
5337585|NCT00298870|isoniazid|isoniazid
5337586|NCT00298870|arylamine N-acetyltransferase 2|arylamine n-acetyltransferase 2
5337587|NCT00298870|pharmacogenomics|pharmacogenomics
5337588|NCT00298870|genetic polymorphisms|genetic polymorphisms
5337589|NCT00298870|individualized medicine|individualized medicine
5337590|NCT00298870|drug-induced hepatotoxity|drug-induced hepatotoxity
5337591|NCT00298857|Healthy|healthy
5337592|NCT00298857|Obesity|obesity
5337593|NCT00298857|Pharmacokinetics|pharmacokinetics
5337594|NCT00298844|Type 2 diabetes mellitus|type 2 diabetes mellitus
5337595|NCT00298844|Macrovascular disease|macrovascular disease
5337596|NCT00298844|Diastolic dysfunction|diastolic dysfunction
5337597|NCT00298844|Intima media thickness|intima media thickness
5337598|NCT00298844|Single- photon emission computed tomography (SPECT)|single- photon emission computed tomography (spect)
5337599|NCT00298818|Epilepsy|epilepsy
5337600|NCT00298818|Mental Retardation|mental retardation
5337601|NCT00298818|Developmental Disabilities|developmental disabilities
5337602|NCT00298805|Migraine|migraine
5337603|NCT00298805|Headache|headache
5337604|NCT00298805|Depression|depression
5337605|NCT00298805|Quality of Life|quality of life
5337606|NCT00298792|Cognitive Behavioral Treatment|cognitive behavioral treatment
5337607|NCT00298792|Alcohol Dependence|alcohol dependence
5337608|NCT00298792|Functional Analysis|functional analysis
5337609|NCT00298792|Experience Sampling|experience sampling
5337610|NCT00298792|Interactive Voice Response|interactive voice response
5337611|NCT00298779|patients with advanced solid tumors or Non-Hodgkins's Lymphoma|patients with advanced solid tumors or non-hodgkins's lymphoma
5337612|NCT00298727|Knowledge transfer|knowledge transfer
5337613|NCT00298727|Clinical decision-making|clinical decision-making
5337614|NCT00298727|Outcome measures|outcome measures
5337615|NCT00298714|Hepatitis C, Chronic|hepatitis c, chronic
5337616|NCT00298701|Allergy|allergy
5337617|NCT00298662|Multiple Sclerosis|multiple sclerosis
5337618|NCT00298662|Betaseron-Prograf|betaseron-prograf
5337619|NCT00298662|patients of Multiple Sclerosis|patients of multiple sclerosis
5337620|NCT00298662|Secondary Progressive type|secondary progressive type
5337621|NCT00298662|Relapsing-Remitting type|relapsing-remitting type
5337622|NCT00298649|pesticide safety|pesticide safety
5337623|NCT00298649|migrant and seasonal farmworkers|migrant and seasonal farmworkers
5337624|NCT00298649|Latino/Hispanic|latino/hispanic
5337625|NCT00298649|agricultural health|agricultural health
5337626|NCT00298649|occupational health|occupational health
5337627|NCT00298610|Uncomplicated Malaria|uncomplicated malaria
5337628|NCT00298610|GMP artesunate|gmp artesunate
5337629|NCT00298584|Diagnostic techniques, urological|diagnostic techniques, urological
5337630|NCT00298584|urinary catheterization|urinary catheterization
5337631|NCT00298584|Aspiration|aspiration
5337633|NCT00298584|Neonatal Intensive Care Unit|neonatal intensive care unit
5337634|NCT00298584|Infant, Newborn|infant, newborn
5337635|NCT00298584|Infant, Premature|infant, premature
5337636|NCT00298584|Infant, Low-birth weight|infant, low-birth weight
5337637|NCT00298571|Cesarean Delivery|cesarean delivery
5337638|NCT00298571|Post-operative|post-operative
5337639|NCT00298571|Pain|pain
5337640|NCT00298571|Local Anesthetic|local anesthetic
5337641|NCT00298558|cognition disorder|cognition disorder
5337642|NCT00298558|cognitive behavior therapy|cognitive behavior therapy
5337643|NCT00298558|functional ability|functional ability
5337644|NCT00298532|Pediatrics|pediatrics
5337645|NCT00298532|Seizure|seizure
5337646|NCT00298532|Trauma|trauma
5337647|NCT00298532|Respiratory|respiratory
5337648|NCT00298532|Cardiac|cardiac
5337649|NCT00298532|Arrest|arrest
5337650|NCT00298506|Tacrolimus|tacrolimus
5337651|NCT00298506|Mycophenolate mofetil|mycophenolate mofetil
5337652|NCT00298506|Cyclophosphamide|cyclophosphamide
5337653|NCT00298506|Lupus nephritis|lupus nephritis
5337654|NCT00298506|Treatment|treatment
5337655|NCT00298493|ICU|icu
5337656|NCT00298493|Sedation strategies|sedation strategies
5337657|NCT00298493|Daily sedative interruption|daily sedative interruption
5337658|NCT00298493|Sedation protocols|sedation protocols
5337659|NCT00298480|preterm labor|preterm labor
5337660|NCT00298480|transvaginal ultrasound|transvaginal ultrasound
5337661|NCT00298480|dynamic cervical change|dynamic cervical change
5337662|NCT00298467|ALCL|alcl
5337663|NCT00298467|csALCL|csalcl
5337664|NCT00298467|pcALCL|pcalcl
5337665|NCT00298467|Lymphoma|lymphoma
5337666|NCT00298467|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
5337667|NCT00298467|Anaplastic Large Cell Lymphoma|anaplastic large cell lymphoma
5337668|NCT00298467|classic systemci Anaplastic Large Cell Lymphoma (csALCL)|classic systemci anaplastic large cell lymphoma (csalcl)
5337669|NCT00298467|primary cutaneous Anaplastic Large Cell Lymphoma (pcALCL)|primary cutaneous anaplastic large cell lymphoma (pcalcl)
5337670|NCT00298454|renal failure|renal failure
5337671|NCT00298454|oliguric|oliguric
5337672|NCT00298454|critically ill|critically ill
5337673|NCT00298454|furosemide|furosemide
5337674|NCT00298441|intravenous iron administration|intravenous iron administration
5337675|NCT00298428|stent|stent
5337676|NCT00298428|percutaneous coronary intervention|percutaneous coronary intervention
5337677|NCT00298428|platelet aggregation|platelet aggregation
5337678|NCT00298428|clopidogrel|clopidogrel
5337679|NCT00298428|shear|shear
5337680|NCT00298428|metabolic syndrome|metabolic syndrome
5337681|NCT00298415|2-years survival|2-years survival
5337682|NCT00298402|macrophage|macrophage
5337683|NCT00298402|MMP|mmp
5337684|NCT00298402|CT scan|ct scan
5337685|NCT00298389|macrophage|macrophage
5337686|NCT00298389|phagocytosis|phagocytosis
5337687|NCT00298389|exacerbation|exacerbation
5337688|NCT00298376|Cow’s milk allergy,|cow’s milk allergy,
5337689|NCT00298376|food allergy|food allergy
5337690|NCT00298376|oral tolerance,|oral tolerance,
5337691|NCT00298376|infant,|infant,
5337692|NCT00298376|regulatory T cells,|regulatory t cells,
5337693|NCT00298376|intestinal microflora|intestinal microflora
5337694|NCT00298363|Hepatitis; Hepatitis B virus; Tenofovir|hepatitis; hepatitis b virus; tenofovir
5337695|NCT00298350|Phase 2|phase 2
5337696|NCT00298350|Phase II|phase ii
5337697|NCT00298350|Randomized|randomized
5337698|NCT00298350|Controlled|controlled
5337699|NCT00298350|Comparator|comparator
5337700|NCT00298350|Partially Blind|partially blind
5337701|NCT00298350|Protease Inhibitors|protease inhibitors
5337702|NCT00298350|Integrase Inhibitors|integrase inhibitors
5337703|NCT00298350|Antiviral Agents|antiviral agents
5337704|NCT00298350|Antiretroviral Agents|antiretroviral agents
5337706|NCT00298350|ARV|arv
5337707|NCT00298350|Highly Activity Antiretroviral Therapy|highly activity antiretroviral therapy
5337708|NCT00298350|HAART|haart
5337709|NCT00298350|Treatment Experienced|treatment experienced
5337710|NCT00298324|GvHD|gvhd
5337711|NCT00298324|graft versus host disease|graft versus host disease
5337712|NCT00298324|extensive|extensive
5337713|NCT00298324|myfortic|myfortic
5337714|NCT00298298|lung cancer|lung cancer
5337715|NCT00298298|non-small cell lung cancere|non-small cell lung cancere
5337716|NCT00298298|vaccine|vaccine
5337717|NCT00298298|immunotherapy|immunotherapy
5337718|NCT00298285|mechanical valve replacement|mechanical valve replacement
5337719|NCT00298285|warfarin|warfarin
5337720|NCT00298246|Neurodevelopmental Disorders|neurodevelopmental disorders
5337721|NCT00298246|Neurological Disorder|neurological disorder
5337722|NCT00298246|Children- Onset|children- onset
5337723|NCT00298246|Children|children
5337724|NCT00298246|Pervasive Developmental Disorder|pervasive developmental disorder
5337725|NCT00298246|PDD|pdd
5337726|NCT00298246|Autism|autism
5337727|NCT00298246|Healthy Volunteer|healthy volunteer
5337728|NCT00298246|HV|hv
5337729|NCT00298233|Antibody Response|antibody response
5337730|NCT00298233|Antiviral Efficacy|antiviral efficacy
5337731|NCT00298233|Bird Flu|bird flu
5337732|NCT00298233|Severe Respiratory Distress|severe respiratory distress
5337733|NCT00298233|Viral Replication and Shedding|viral replication and shedding
5337734|NCT00298220|Family Practice|family practice
5337735|NCT00298220|Intervention Studies|intervention studies
5337736|NCT00298220|Prevention and Control|prevention and control
5337737|NCT00298207|high blood pressure|high blood pressure
5337738|NCT00298207|hypertension|hypertension
5337739|NCT00298207|adult|adult
5337740|NCT00298207|African Americans|african americans
5337741|NCT00298207|Walking|walking
5337742|NCT00298168|Delayed Graft Function|delayed graft function
5337743|NCT00298142|Cervicogenic Headache|cervicogenic headache
5337744|NCT00298142|Migraine|migraine
5337745|NCT00298142|Tension Type Headache|tension type headache
5337746|NCT00298103|Antibiotic resistant|antibiotic resistant
5337747|NCT00298103|Infection|infection
5337748|NCT00298090|Oxygenation|oxygenation
5337749|NCT00298077|Infection|infection
5337750|NCT00298077|transplant recipients|transplant recipients
5337751|NCT00298064|Cervical cancer|cervical cancer
5337752|NCT00298064|EGFR|egfr
5337753|NCT00298064|cervical|cervical
5337754|NCT00298064|genomic|genomic
5337755|NCT00298064|DNA|dna
5337756|NCT00298064|markers|markers
5337757|NCT00298064|prognostic|prognostic
5337758|NCT00298064|gene|gene
5337759|NCT00298064|epidermal growth factor|epidermal growth factor
5337760|NCT00298051|Iron-deficiency anemia|iron-deficiency anemia
5337761|NCT00298051|Umbilical cord clamping|umbilical cord clamping
5337762|NCT00298051|Infant|infant
5337763|NCT00298025|Infertility|infertility
5337764|NCT00298025|Cetrotide|cetrotide
5337765|NCT00298025|Antagon|antagon
5337766|NCT00298025|Recombinant human follicle stimulating hormone (r-hFSH)|recombinant human follicle stimulating hormone (r-hfsh)
5337767|NCT00298025|Human Menopausal Gonadotropin (hMG)|human menopausal gonadotropin (hmg)
5337768|NCT00298025|Recombinant Human Choriogonadotropin (r-hCG)|recombinant human choriogonadotropin (r-hcg)
5337769|NCT00298012|Methotrexate|methotrexate
5337770|NCT00298012|Magnetic Resonance Imaging|magnetic resonance imaging
5337771|NCT00298012|Anterior uveitis|anterior uveitis
5337772|NCT00297947|schizophrenia|schizophrenia
5337773|NCT00297947|quetiapine|quetiapine
5337774|NCT00297947|schizoaffective disorder|schizoaffective disorder
5337775|NCT00297934|dual-task|dual-task
5337776|NCT00297934|postural control|postural control
5337777|NCT00297934|cognitive|cognitive
5337778|NCT00297908|Ethanol levels|ethanol levels
5337779|NCT00297908|Dermal absorbtion|dermal absorbtion
5337780|NCT00297895|sentinel lymph node dissection|sentinel lymph node dissection
5337781|NCT00297895|complete lymph node dissection|complete lymph node dissection
5337782|NCT00297895|surgical|surgical
5337783|NCT00297882|Efficacy|efficacy
5337784|NCT00297882|Safety|safety
5337785|NCT00297882|Children|children
5337786|NCT00297882|Cameroon|cameroon
5337787|NCT00297856|Boostrix|boostrix
5337788|NCT00297830|Heart Transplantation|heart transplantation
5337789|NCT00297830|Liver Transplantation|liver transplantation
5337790|NCT00297830|Immunosuppression|immunosuppression
5337791|NCT00297830|Bone Density/drug effects|bone density/drug effects
5337792|NCT00297830|Alendronate|alendronate
5337793|NCT00297830|Zoledronic acid|zoledronic acid
5337794|NCT00297830|Comparative study|comparative study
5337795|NCT00297830|Humans|humans
5337796|NCT00297817|Meningococcal Disease; Meningococcal Meningitis; Vaccine|meningococcal disease; meningococcal meningitis; vaccine
5337797|NCT00297804|Coronary Artery Disease|coronary artery disease
5337798|NCT00297804|Percutaneous Coronary Intervention|percutaneous coronary intervention
5337799|NCT00297804|Stent Implant|stent implant
5337800|NCT00297804|Drug-coated Stent|drug-coated stent
5337801|NCT00297791|rectal cancer|rectal cancer
5337802|NCT00297791|laparoscopic technique|laparoscopic technique
5337803|NCT00297791|open technique|open technique
5337804|NCT00297791|clinical trial|clinical trial
5337805|NCT00297791|multicenter study|multicenter study
5337806|NCT00297791|randomized controlled trial|randomized controlled trial
5337807|NCT00297791|Tumor Below 15cm|tumor below 15cm
5337808|NCT00297791|curative surgical resection|curative surgical resection
5337809|NCT00297791|no evidence for distant metastases|no evidence for distant metastases
5337810|NCT00297765|Renal Transplantation|renal transplantation
5337811|NCT00297765|Therapeutics|therapeutics
5337812|NCT00297765|Treatment Outcome|treatment outcome
5337813|NCT00297765|Safety|safety
5337814|NCT00297752|facial burns|facial burns
5337815|NCT00297752|cerium flammazine|cerium flammazine
5337816|NCT00297752|quality of life|quality of life
5337817|NCT00297752|randomised clinical trial|randomised clinical trial
5337818|NCT00297739|Aggression|aggression
5337819|NCT00297739|ADHD|adhd
5337820|NCT00297739|Antipsychotic|antipsychotic
5337821|NCT00297726|Osteoarthritis, Knee|osteoarthritis, knee
5337822|NCT00297726|Osteoarthritis, Hip|osteoarthritis, hip
5337823|NCT00297726|Osteoarthritis, Ankle|osteoarthritis, ankle
5337824|NCT00297726|Arthritis|arthritis
5337825|NCT00297726|Self-Management|self-management
5337826|NCT00297700|Smoking|smoking
5337827|NCT00297700|Dental|dental
5337828|NCT00297700|Cessation|cessation
5337829|NCT00297700|Prevention|prevention
5337830|NCT00297700|Control|control
5337831|NCT00297700|Quitline|quitline
5337832|NCT00297700|5A-Model|5a-model
5337833|NCT00297700|Cost-effective|cost-effective
5337834|NCT00297687|Vaccines|vaccines
5337835|NCT00297687|Healthy Adults|healthy adults
5337838|NCT00297687|Meningococcal Vaccines|meningococcal vaccines
5337839|NCT00297674|clarithromycin|clarithromycin
5337840|NCT00297674|sepsis|sepsis
5337841|NCT00297674|immunomodulation|immunomodulation
5337842|NCT00297661|Coronary Revascularization|coronary revascularization
5337843|NCT00297661|Sirolimus-eluting stents|sirolimus-eluting stents
5337844|NCT00297661|Paclitaxel-eluting stents|paclitaxel-eluting stents
5337845|NCT00297648|Certolizumab pegol|certolizumab pegol
5337846|NCT00297648|Crohn's disease|crohn's disease
5337847|NCT00297648|Mucosal healing|mucosal healing
5337848|NCT00297635|Hyperglycemia|hyperglycemia
5337849|NCT00297635|Insulin Infusion Systems|insulin infusion systems
5337850|NCT00297635|Blood Glucose Self-Monitoring|blood glucose self-monitoring
5337851|NCT00297609|Resuscitation medication errors|resuscitation medication errors
5337852|NCT00297609|critical care|critical care
5337853|NCT00297609|pediatrics|pediatrics
5337854|NCT00297609|clinical decision support systems|clinical decision support systems
5337855|NCT00297609|computerized physician order entry|computerized physician order entry
5337856|NCT00297596|Metastatic|metastatic
5337857|NCT00297596|HER2/neu+|her2/neu+
5337858|NCT00297570|CML|cml
5337859|NCT00297570|Imatinib|imatinib
5337860|NCT00297570|Pegylated Interferon|pegylated interferon
5337861|NCT00297570|Philadelphia Positive CML|philadelphia positive cml
5337862|NCT00297544|impotence|impotence
5337863|NCT00297544|endothelial function|endothelial function
5337864|NCT00297544|autonomic nervous system|autonomic nervous system
5337865|NCT00297531|Chronic Periodontitis|chronic periodontitis
5337866|NCT00297531|Periodontitis|periodontitis
5337867|NCT00297531|Photodynamic disinfection|photodynamic disinfection
5337868|NCT00297531|PDD|pdd
5337869|NCT00297531|PDT|pdt
5337870|NCT00297531|Periowave|periowave
5337871|NCT00297531|Scaling and Root Planing|scaling and root planing
5337872|NCT00297531|SRP|srp
5337873|NCT00297518|Adult Periodontitis|adult periodontitis
5337874|NCT00297518|Chronic Periodontitis|chronic periodontitis
5337875|NCT00297518|PDD|pdd
5337876|NCT00297518|PDT|pdt
5337877|NCT00297518|Photodynamic Disinfection|photodynamic disinfection
5337878|NCT00297518|SRP|srp
5337879|NCT00297518|Scaling and Root Planing|scaling and root planing
5337880|NCT00297505|Cocaine; citalopram; impulsivity; serotonin|cocaine; citalopram; impulsivity; serotonin
5337881|NCT00297492|Smoking Cessation|smoking cessation
5337882|NCT00297492|Tobacco|tobacco
5337883|NCT00297479|Tobacco Cessation|tobacco cessation
5337884|NCT00297479|Smoking Cessation|smoking cessation
5337885|NCT00297466|tobacco use|tobacco use
5337886|NCT00297466|smoking cessation|smoking cessation
5337887|NCT00297466|emergency department|emergency department
5337888|NCT00297440|Smoking|smoking
5337889|NCT00297440|Exercise|exercise
5337890|NCT00297440|Adolescent|adolescent
5337891|NCT00297440|Girls|girls
5337892|NCT00297427|urinary incontinence|urinary incontinence
5337893|NCT00297414|Mild Cognitive Impairment|mild cognitive impairment
5337894|NCT00297414|Dementia|dementia
5337895|NCT00297414|Galantamine|galantamine
5337896|NCT00297414|Memory disorders|memory disorders
5337897|NCT00297414|Isolated memory impairment|isolated memory impairment
5337898|NCT00297414|Alzheimer's disease|alzheimer's disease
5337899|NCT00297388|schizophrenia|schizophrenia
5337900|NCT00297388|schizoaffective disorder|schizoaffective disorder
5337901|NCT00297388|long-acting risperidone|long-acting risperidone
5337902|NCT00297388|intramuscular injection risperidone|intramuscular injection risperidone
5337903|NCT00297388|risperidone|risperidone
5337904|NCT00297375|treatment|treatment
5337905|NCT00297375|Pain|pain
5337906|NCT00297375|acute|acute
5337907|NCT00297375|migraine|migraine
5337908|NCT00297375|headache|headache
5337909|NCT00297362|Alzheimer Disease|alzheimer disease
5337910|NCT00297362|Dementia|dementia
5337911|NCT00297362|Brain Disease|brain disease
5337912|NCT00297362|Memory Loss|memory loss
5337913|NCT00297362|Caregiver|caregiver
5337914|NCT00297362|Galantamine hydrobromide|galantamine hydrobromide
5337915|NCT00297362|Nervous System Diseases|nervous system diseases
5337916|NCT00297362|Mental Disorders|mental disorders
5337917|NCT00297349|Seizures|seizures
5337918|NCT00297349|Epilepsy|epilepsy
5337919|NCT00297349|Tonic-clonic|tonic-clonic
5337920|NCT00297349|Lennox-Gastaut Syndrome|lennox-gastaut syndrome
5337921|NCT00297349|Focal Epilepsy|focal epilepsy
5337922|NCT00297349|Topiramate|topiramate
5337923|NCT00297349|Epilepsy in Children|epilepsy in children
5337924|NCT00297336|Topiramate|topiramate
5337925|NCT00297336|Migraine|migraine
5337926|NCT00297336|Headache|headache
5337927|NCT00297336|Chronic headache|chronic headache
5337928|NCT00297336|Chronic migraine|chronic migraine
5337929|NCT00297323|Seizures|seizures
5337930|NCT00297323|Epilepsy|epilepsy
5337931|NCT00297323|Topiramate|topiramate
5337932|NCT00297323|Epilepsy in Children|epilepsy in children
5337933|NCT00297310|Tacrolimus|tacrolimus
5337934|NCT00297310|Kidney transplantation|kidney transplantation
5337935|NCT00297310|Transplantation|transplantation
5337936|NCT00297310|Kidney failure|kidney failure
5337937|NCT00297310|chronic|chronic
5337938|NCT00297310|P-Glycoprotein|p-glycoprotein
5338046|NCT00297050|Normal Volunteers|normal volunteers
5337939|NCT00297297|Solitary solid and scintigraphically cold thyroid nodules|solitary solid and scintigraphically cold thyroid nodules
5337940|NCT00297284|systemic lupus erythematosus|systemic lupus erythematosus
5337941|NCT00297284|cognitive efficiency|cognitive efficiency
5337942|NCT00297284|cognitive dysfunction|cognitive dysfunction
5337943|NCT00297284|cognition|cognition
5337944|NCT00297284|memory|memory
5337945|NCT00297284|attention|attention
5337946|NCT00297284|modafinil|modafinil
5337947|NCT00297284|provigil|provigil
5337948|NCT00297271|Dementia|dementia
5337949|NCT00297271|Mild Cognitive Impairment|mild cognitive impairment
5337950|NCT00297271|Patient Registries|patient registries
5337951|NCT00297271|Prospective Studies|prospective studies
5337952|NCT00297271|Longitudinal Studies|longitudinal studies
5337953|NCT00297271|Australia|australia
5337954|NCT00297271|Cholinesterase Inhibitors|cholinesterase inhibitors
5337955|NCT00297271|Observational|observational
5337956|NCT00297271|Non-randomized|non-randomized
5337957|NCT00297258|Sarcoma|sarcoma
5337958|NCT00297258|Synovial sarcoma|synovial sarcoma
5337959|NCT00297258|Pazopanib(GW786034)|pazopanib(gw786034)
5337960|NCT00297258|Adipocytic tumors|adipocytic tumors
5337961|NCT00297258|Leiomyosarcoma|leiomyosarcoma
5337962|NCT00297258|Phase II|phase ii
5337963|NCT00297245|gastrodin|gastrodin
5337964|NCT00297232|Multiple Sclerosis|multiple sclerosis
5337965|NCT00297232|MS|ms
5337966|NCT00297219|Hemodialysis|hemodialysis
5337967|NCT00297219|Coronary artery calcification|coronary artery calcification
5337968|NCT00297219|Adynamic bone disease|adynamic bone disease
5337969|NCT00297219|Dialysate calcium|dialysate calcium
5337970|NCT00297219|Bone mineral density|bone mineral density
5337971|NCT00297219|Bone histomorphometry|bone histomorphometry
5337972|NCT00297206|pharmacokinetics herpes varicella herpes labialis Epstein-Barr virus|pharmacokinetics herpes varicella herpes labialis epstein-barr virus
5337973|NCT00297193|Crohn's Disease|crohn's disease
5337974|NCT00297193|HSCT|hsct
5337975|NCT00297193|Autologous|autologous
5337976|NCT00297193|EBMT|ebmt
5337977|NCT00297193|ECCO|ecco
5337978|NCT00297180|hunger|hunger
5337979|NCT00297180|obesity|obesity
5337980|NCT00297180|sodium-dependent glucose transporter|sodium-dependent glucose transporter
5337981|NCT00297180|GW869682|gw869682
5337982|NCT00297180|body composition|body composition
5337983|NCT00297180|SGLT2 inhibitor|sglt2 inhibitor
5337984|NCT00297180|weight loss|weight loss
5337985|NCT00297167|CF|cf
5337986|NCT00297167|Cystic Fibrosis|cystic fibrosis
5337987|NCT00297167|EPI|epi
5337988|NCT00297167|Exocrine Pancreatic Insufficiency|exocrine pancreatic insufficiency
5337989|NCT00297167|Pancreatic|pancreatic
5337990|NCT00297167|Enzyme|enzyme
5337991|NCT00297167|PEP|pep
5337992|NCT00297154|Heart failure, congestive|heart failure, congestive
5337993|NCT00297154|Metabolic Syndrome X|metabolic syndrome x
5337994|NCT00297154|Obesity|obesity
5337995|NCT00297141|Preoperative|preoperative
5337996|NCT00297141|Radiochemotherapy|radiochemotherapy
5337997|NCT00297141|Newly Diagnosed|newly diagnosed
5337998|NCT00297141|Primary Operable|primary operable
5337999|NCT00297141|Locally Advanced|locally advanced
5338000|NCT00297141|Rectal Carcinoma|rectal carcinoma
5338001|NCT00297141|T3|t3
5338002|NCT00297141|Lower Rectum|lower rectum
5338003|NCT00297141|Middle Rectum|middle rectum
5338004|NCT00297141|ABCSG|abcsg
5338005|NCT00297141|TAKO|tako
5338006|NCT00297141|95|95
5338007|NCT00297141|05|05
5338008|NCT00297128|pilot study|pilot study
5338009|NCT00297128|rectal|rectal
5338010|NCT00297128|cancer|cancer
5338011|NCT00297128|phase II|phase ii
5338012|NCT00297128|preoperative|preoperative
5338013|NCT00297128|chemoradiation|chemoradiation
5338014|NCT00297128|capecitabine|capecitabine
5338015|NCT00297128|cetuximab|cetuximab
5338016|NCT00297128|operable|operable
5338017|NCT00297128|T4|t4
5338018|NCT00297128|ABCSG|abcsg
5338019|NCT00297128|TAKO|tako
5338020|NCT00297128|R03|r03
5338021|NCT00297128|96|96
5338022|NCT00297128|06|06
5338023|NCT00297115|Roflumilast|roflumilast
5338024|NCT00297115|COPD|copd
5338025|NCT00297115|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
5338026|NCT00297102|Roflumilast|roflumilast
5338027|NCT00297102|COPD|copd
5338028|NCT00297102|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
5338029|NCT00297089|Lung Cancer|lung cancer
5338030|NCT00297089|ABT-751|abt-751
5338031|NCT00297089|NSCLC|nsclc
5338032|NCT00297089|Alimta|alimta
5338033|NCT00297089|Non-Small-Cell Lung Cancer|non-small-cell lung cancer
5338034|NCT00297089|pemetrexed|pemetrexed
5338035|NCT00297076|HIV-1|hiv-1
5338036|NCT00297076|GW873140|gw873140
5338037|NCT00297076|CCR5 antagonist|ccr5 antagonist
5338038|NCT00297076|experienced|experienced
5338039|NCT00297076|Treatment Experienced|treatment experienced
5338040|NCT00297063|rosiglitazone|rosiglitazone
5338041|NCT00297063|vandia|vandia
5338042|NCT00297063|Type 2 diabetes mellitus|type 2 diabetes mellitus
5338043|NCT00297063|diabetes;|diabetes;
5338044|NCT00297050|Influenza Virus|influenza virus
5338045|NCT00297050|Avian Influenza|avian influenza
5338047|NCT00297050|Neuraminidase Inhibitor|neuraminidase inhibitor
5338048|NCT00297050|Viral Disease|viral disease
5338049|NCT00297050|Healthy Volunteer|healthy volunteer
5338050|NCT00297050|HV|hv
5338051|NCT00297037|oral lichen planus, pimecrolimus 1% cream|oral lichen planus, pimecrolimus 1% cream
5338052|NCT00296985|Cardiac surgery|cardiac surgery
5338053|NCT00296985|Cellsaver|cellsaver
5338054|NCT00296985|Neurocognitive Function|neurocognitive function
5338055|NCT00296985|Neuronal Protection|neuronal protection
5338056|NCT00296985|Quality of Life|quality of life
5338057|NCT00296972|peg interferon|peg interferon
5338058|NCT00296972|ribavirin|ribavirin
5338059|NCT00296972|HAART|haart
5338060|NCT00296972|HIV|hiv
5338061|NCT00296972|Chronic Hepatitis C|chronic hepatitis c
5338062|NCT00296972|Treatment Experienced|treatment experienced
5338063|NCT00296959|Dyskinesia|dyskinesia
5338064|NCT00296959|AMPA receptor antagonists|ampa receptor antagonists
5338065|NCT00296946|Sialorrhoea|sialorrhoea
5338066|NCT00296933|Major Depression|major depression
5338067|NCT00296933|Antidepressant|antidepressant
5338068|NCT00296933|Pharmacotherapy|pharmacotherapy
5338069|NCT00296933|Memory functioning|memory functioning
5338070|NCT00296933|Memory Impairment|memory impairment
5338071|NCT00296920|Deep Brain Stimulation|deep brain stimulation
5338072|NCT00296920|Treatment failure|treatment failure
5338073|NCT00296907|cancer|cancer
5338074|NCT00296907|siblings|siblings
5338075|NCT00296907|behavior|behavior
5338076|NCT00296907|psychological adaptation|psychological adaptation
5338077|NCT00296907|intervention|intervention
5338078|NCT00296881|Periodontitis|periodontitis
5338079|NCT00296881|Photodynamic Disinfection|photodynamic disinfection
5338080|NCT00296881|PERIOWAVE|periowave
5338081|NCT00296881|Scaling and Root Planing|scaling and root planing
5338082|NCT00296881|SRP|srp
5338083|NCT00296868|reflex sympathetic dystrophy|reflex sympathetic dystrophy
5338084|NCT00296868|ascorbic acid|ascorbic acid
5338085|NCT00296868|primary prevention|primary prevention
5338086|NCT00296868|radius fractures|radius fractures
5338087|NCT00296855|Peripheral artery disease|peripheral artery disease
5338088|NCT00296842|posttraumatic stress disorder|posttraumatic stress disorder
5338089|NCT00296842|children|children
5338090|NCT00296842|injury|injury
5338091|NCT00296842|road traffic accident|road traffic accident
5338092|NCT00296829|Influenza;|influenza;
5338093|NCT00296829|Orthomyxoviruses;|orthomyxoviruses;
5338094|NCT00296829|Inactivated Split-virion influenza vaccine;|inactivated split-virion influenza vaccine;
5338095|NCT00296829|Elderly.|elderly.
5338096|NCT00296803|metabolic syndrome|metabolic syndrome
5338097|NCT00296777|Major Depression|major depression
5338098|NCT00296777|Dysthymia|dysthymia
5338099|NCT00296777|f-MRI|f-mri
5338100|NCT00296777|Escitalopram|escitalopram
5338101|NCT00296777|Bupropion|bupropion
5338102|NCT00296777|Imipramine|imipramine
5338103|NCT00296777|Neuropsychologic test|neuropsychologic test
5338104|NCT00296777|Dichotic listening|dichotic listening
5338106|NCT00296777|ERP|erp
5338107|NCT00296764|Happy Puppet Syndrome|happy puppet syndrome
5338108|NCT00296764|Developmental Disorders|developmental disorders
5338109|NCT00296725|Major Depression|major depression
5338110|NCT00296725|Dysthymia|dysthymia
5338111|NCT00296725|Depression NOS|depression nos
5338112|NCT00296725|Dichotic Listening|dichotic listening
5338113|NCT00296725|Fluoxetine|fluoxetine
5338114|NCT00296725|Imipramine|imipramine
5338115|NCT00296725|Placebo|placebo
5338116|NCT00296725|Predictors|predictors
5338117|NCT00296712|Major Depression|major depression
5338118|NCT00296712|Dysthymia|dysthymia
5338119|NCT00296712|Depression NOS|depression nos
5338120|NCT00296712|Escitalopram|escitalopram
5338121|NCT00296712|Bupropion|bupropion
5338122|NCT00296712|Dual Therapy|dual therapy
5338123|NCT00296712|Combination Therapy|combination therapy
5338124|NCT00296699|Atypical Depression|atypical depression
5338125|NCT00296699|Major Depressive Disorder|major depressive disorder
5338126|NCT00296699|Dysthymic Disorder|dysthymic disorder
5338127|NCT00296699|Atypical Features|atypical features
5338128|NCT00296699|Duloxetine|duloxetine
5338129|NCT00296686|Major Depression|major depression
5338130|NCT00296686|Refractory Depression|refractory depression
5338131|NCT00296686|Tranylcypromine|tranylcypromine
5338132|NCT00296686|Dextroamphetamine|dextroamphetamine
5338133|NCT00296686|Triiodothyronine|triiodothyronine
5338134|NCT00296673|Rehabilitation, Side Bridge test, Muscular endurance|rehabilitation, side bridge test, muscular endurance
5338135|NCT00296660|Acute Infection|acute infection
5338136|NCT00296634|H5N1, Influenza, vaccine|h5n1, influenza, vaccine
5338137|NCT00296621|glutamine|glutamine
5338138|NCT00296621|nutrition|nutrition
5338139|NCT00296621|children|children
5338140|NCT00296621|pediatrics|pediatrics
5338141|NCT00296621|randomized controlled clinical trial|randomized controlled clinical trial
5338142|NCT00296621|therapy|therapy
5338143|NCT00296621|supplement|supplement
5338144|NCT00296621|oral administration|oral administration
5338145|NCT00296621|handicap|handicap
5338146|NCT00296608|stage II rectal cancer|stage ii rectal cancer
5338147|NCT00296608|stage III rectal cancer|stage iii rectal cancer
5338148|NCT00296608|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5338149|NCT00296556|Ulcerative colitis|ulcerative colitis
5338150|NCT00296556|EP4 agonist|ep4 agonist
5338151|NCT00296556|PGE2|pge2
5338152|NCT00296543|hemodialysis|hemodialysis
5338153|NCT00296543|sudden cardiac death|sudden cardiac death
5338154|NCT00296530|Asthma|asthma
5338155|NCT00296530|Allergic Rhinitis|allergic rhinitis
5338156|NCT00296517|depression|depression
5338157|NCT00296517|double-blind|double-blind
5338158|NCT00296517|placebo-controlled|placebo-controlled
5338159|NCT00296517|bupropion hydrochloride|bupropion hydrochloride
5338160|NCT00296517|SSRI|ssri
5338161|NCT00296517|comparative study|comparative study
5338162|NCT00296517|non-responder|non-responder
5338163|NCT00296504|antiretroviral therapy naive subjects|antiretroviral therapy naive subjects
5338164|NCT00296504|fosamprenavir|fosamprenavir
5338165|NCT00296504|HIV-1|hiv-1
5338166|NCT00296504|protease inhibitor|protease inhibitor
5338167|NCT00296504|pro-drug|pro-drug
5338168|NCT00296504|antiretroviral therapy|antiretroviral therapy
5338169|NCT00296504|LEXIVA|lexiva
5338170|NCT00296504|AGENERASE|agenerase
5338171|NCT00296504|GW433908|gw433908
5338172|NCT00296504|amprenavir|amprenavir
5338173|NCT00296491|Allergic Rhinitis|allergic rhinitis
5338174|NCT00296491|Asthma|asthma
5338175|NCT00296452|cancer|cancer
5338176|NCT00296452|nutrition|nutrition
5338177|NCT00296426|Adverse Drug Event|adverse drug event
5338178|NCT00296426|Inpatients|inpatients
5338179|NCT00296426|Outcome assessment|outcome assessment
5338180|NCT00296413|epilepsy|epilepsy
5338181|NCT00296413|menstrual cycle|menstrual cycle
5338182|NCT00296413|valproate|valproate
5338183|NCT00296413|lamotrigine|lamotrigine
5338184|NCT00296413|oral contraceptive|oral contraceptive
5338185|NCT00296400|Hyperlipidemia|hyperlipidemia
5338186|NCT00296400|Proteinuria|proteinuria
5338187|NCT00296400|Diabetes Mellitus|diabetes mellitus
5338188|NCT00296374|Hyperlipidemia|hyperlipidemia
5338189|NCT00296374|Proteinuria|proteinuria
5338190|NCT00296374|Diabetes Mellitus|diabetes mellitus
5338191|NCT00296361|Tacrolimus|tacrolimus
5338192|NCT00296361|Kidney Transplantation|kidney transplantation
5338193|NCT00296361|Immunosuppression|immunosuppression
5338194|NCT00296361|Adult|adult
5338195|NCT00296361|Treatment Outcomes|treatment outcomes
5338196|NCT00296348|Tacrolimus|tacrolimus
5338197|NCT00296348|Kidney Transplantation|kidney transplantation
5338198|NCT00296348|Child|child
5338199|NCT00296348|Treatment Outcome|treatment outcome
5338200|NCT00296348|Immunosuppression|immunosuppression
5338201|NCT00296335|Stomach cancer|stomach cancer
5338202|NCT00296335|Adjuvant chemotherapy|adjuvant chemotherapy
5338203|NCT00296335|Mitomycin|mitomycin
5338204|NCT00296335|Cisplatin|cisplatin
5338205|NCT00296335|Doxifluridine|doxifluridine
5338206|NCT00296322|stomach cancer|stomach cancer
5338207|NCT00296322|adjuvant chemotherapy|adjuvant chemotherapy
5338208|NCT00296322|mitomycin|mitomycin
5338209|NCT00296322|cisplatin|cisplatin
5338210|NCT00296322|doxifluridine|doxifluridine
5338211|NCT00296309|Tacrolimus|tacrolimus
5338212|NCT00296309|Kidney Transplantation|kidney transplantation
5338213|NCT00296309|Immunosuppression|immunosuppression
5338214|NCT00296309|Adult|adult
5338215|NCT00296309|Treatment Outcomes|treatment outcomes
5338216|NCT00296296|kidney Transplant|kidney transplant
5338217|NCT00296296|Type II Diabetes|type ii diabetes
5338218|NCT00296296|Diabetic Nephropathy|diabetic nephropathy
5338219|NCT00296296|Immunosuppression|immunosuppression
5338220|NCT00296296|Cyclosporin|cyclosporin
5338221|NCT00296296|Tacrolimus|tacrolimus
5338222|NCT00296283|Relatives|relatives
5338223|NCT00296283|Bipolar Disorder|bipolar disorder
5338224|NCT00296283|Psychoeducation|psychoeducation
5338225|NCT00296244|steroid-free immunosuppression|steroid-free immunosuppression
5338226|NCT00296244|liver transplantation|liver transplantation
5338227|NCT00296231|premature infants|premature infants
5338228|NCT00296231|very low birthweight infants|very low birthweight infants
5338229|NCT00296231|high frequency ventilation|high frequency ventilation
5338230|NCT00296231|nasal ventilation|nasal ventilation
5338231|NCT00296205|Multiple Sclerosis|multiple sclerosis
5338232|NCT00296205|Cyclophosphamide|cyclophosphamide
5338233|NCT00296205|autoimmune|autoimmune
5338234|NCT00296192|Rotigotine|rotigotine
5338235|NCT00296192|Rotigotine nasal spray|rotigotine nasal spray
5338236|NCT00296192|Efficacy, safety and tolerability|efficacy, safety and tolerability
5338237|NCT00296192|Parkinson's disease|parkinson's disease
5338238|NCT00296166|Atrial fibrillation|atrial fibrillation
5338239|NCT00296166|Permanent Atrial fibrillation|permanent atrial fibrillation
5338240|NCT00296166|catheter ablation|catheter ablation
5338241|NCT00296166|thoracoscopy|thoracoscopy
5338242|NCT00296166|Arrhythmia|arrhythmia
5338243|NCT00296166|Heart|heart
5338244|NCT00296153|Human immunodeficiency Virus (HIV)|human immunodeficiency virus (hiv)
5338245|NCT00296153|Highly Active Antiviral Therapy (HAART)|highly active antiviral therapy (haart)
5338246|NCT00296153|Ischemic Heart Disease|ischemic heart disease
5338247|NCT00296153|OMACOR|omacor
5338248|NCT00296153|Triglycerides|triglycerides
5338249|NCT00296153|Endothelial function|endothelial function
5338250|NCT00296153|Treatment Experienced|treatment experienced
5338903|NCT00294567|IVUS|ivus
5338251|NCT00296140|post-stroke depression|post-stroke depression
5338252|NCT00296140|clinical reminder|clinical reminder
5338253|NCT00296140|self-management|self-management
5338254|NCT00296114|Cancer|cancer
5338255|NCT00296114|Pancreas|pancreas
5338256|NCT00296101|Physical Inactivity|physical inactivity
5338257|NCT00296088|Mechanical Ventilation|mechanical ventilation
5338258|NCT00296088|Critical Care|critical care
5338259|NCT00296088|Respiratory Failure|respiratory failure
5338260|NCT00296062|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5338261|NCT00296062|stage III colon cancer|stage iii colon cancer
5338262|NCT00296062|stage IV colon cancer|stage iv colon cancer
5338263|NCT00296062|stage III rectal cancer|stage iii rectal cancer
5338264|NCT00296062|stage IV rectal cancer|stage iv rectal cancer
5338265|NCT00296062|recurrent colon cancer|recurrent colon cancer
5338266|NCT00296062|recurrent rectal cancer|recurrent rectal cancer
5338267|NCT00296049|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5338268|NCT00296049|infection|infection
5338269|NCT00296049|neutropenia|neutropenia
5338270|NCT00296049|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
5338271|NCT00296036|drug/agent toxicity by tissue/organ|drug/agent toxicity by tissue/organ
5338272|NCT00296036|stage I breast cancer|stage i breast cancer
5338273|NCT00296036|stage II breast cancer|stage ii breast cancer
5338274|NCT00296036|stage IIIA breast cancer|stage iiia breast cancer
5338275|NCT00296036|stage IIIB breast cancer|stage iiib breast cancer
5338276|NCT00296036|stage IIIC breast cancer|stage iiic breast cancer
5338277|NCT00296036|stage IV breast cancer|stage iv breast cancer
5338278|NCT00296036|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5338279|NCT00296023|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5338280|NCT00296023|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5338281|NCT00296023|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5338282|NCT00296023|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5338283|NCT00296023|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5338284|NCT00296023|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5338285|NCT00296023|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5338286|NCT00296023|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5338287|NCT00296023|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5338288|NCT00296023|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5338289|NCT00296023|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5338290|NCT00296023|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5338291|NCT00296023|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5338292|NCT00296023|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
5338293|NCT00296023|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5338294|NCT00296023|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5338295|NCT00296023|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
5338296|NCT00296023|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5338297|NCT00296023|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5338298|NCT00296023|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
5338299|NCT00296023|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5338300|NCT00296023|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5338301|NCT00296023|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5338302|NCT00296023|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5338303|NCT00296023|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
5338304|NCT00296023|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5338305|NCT00296023|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5338306|NCT00296023|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
5338307|NCT00296023|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5338308|NCT00296023|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5338309|NCT00296023|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
5338310|NCT00296023|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5338311|NCT00296023|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5338312|NCT00296023|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5338313|NCT00296023|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5338314|NCT00296023|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5338315|NCT00296023|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5338316|NCT00296023|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5338317|NCT00296023|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5338318|NCT00296023|stage II multiple myeloma|stage ii multiple myeloma
5338319|NCT00296023|stage III multiple myeloma|stage iii multiple myeloma
5338904|NCT00294567|Plaque|plaque
5338320|NCT00296023|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5338321|NCT00296023|primary myelofibrosis|primary myelofibrosis
5338322|NCT00296023|polycythemia vera|polycythemia vera
5338323|NCT00296023|prolymphocytic leukemia|prolymphocytic leukemia
5338324|NCT00296023|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
5338325|NCT00296023|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5338326|NCT00296023|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5338327|NCT00296023|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5338328|NCT00296023|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5338329|NCT00296023|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5338330|NCT00296023|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
5338331|NCT00296023|refractory anemia with excess blasts|refractory anemia with excess blasts
5338332|NCT00296023|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5338333|NCT00296023|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5338334|NCT00296023|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5338335|NCT00296023|Waldenström macroglobulinemia|waldenström macroglobulinemia
5338336|NCT00296023|essential thrombocythemia|essential thrombocythemia
5338337|NCT00296023|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5338338|NCT00296023|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5338339|NCT00296023|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5338340|NCT00296023|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5338341|NCT00296023|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5338342|NCT00296023|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5338343|NCT00296023|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
5338344|NCT00296023|stage I multiple myeloma|stage i multiple myeloma
5338345|NCT00296010|stage I breast cancer|stage i breast cancer
5338346|NCT00296010|stage II breast cancer|stage ii breast cancer
5338347|NCT00296010|stage IIIA breast cancer|stage iiia breast cancer
5338348|NCT00295997|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5338349|NCT00295997|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5338350|NCT00295997|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5338351|NCT00295997|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5338352|NCT00295997|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5338353|NCT00295997|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5338354|NCT00295997|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5338355|NCT00295997|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
5338356|NCT00295997|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5338357|NCT00295997|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
5338358|NCT00295997|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
5338359|NCT00295997|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
5338360|NCT00295997|chronic eosinophilic leukemia|chronic eosinophilic leukemia
5338361|NCT00295997|primary myelofibrosis|primary myelofibrosis
5338362|NCT00295997|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5338363|NCT00295997|chronic neutrophilic leukemia|chronic neutrophilic leukemia
5338364|NCT00295997|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5338365|NCT00295997|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5338366|NCT00295997|essential thrombocythemia|essential thrombocythemia
5338367|NCT00295997|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
5338368|NCT00295997|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
5338369|NCT00295997|polycythemia vera|polycythemia vera
5338370|NCT00295997|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5338371|NCT00295997|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5338372|NCT00295997|prolymphocytic leukemia|prolymphocytic leukemia
5338373|NCT00295997|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5338374|NCT00295997|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5338375|NCT00295997|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5338376|NCT00295997|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5338377|NCT00295997|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
5338378|NCT00295997|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5338379|NCT00295997|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5338380|NCT00295997|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
5338381|NCT00295997|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5338382|NCT00295997|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5338383|NCT00295997|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5339005|NCT00294164|Serostim®|serostim®
5338384|NCT00295997|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5338385|NCT00295997|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5338386|NCT00295997|refractory multiple myeloma|refractory multiple myeloma
5338387|NCT00295997|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5338388|NCT00295997|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5338389|NCT00295997|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5338390|NCT00295997|stage II multiple myeloma|stage ii multiple myeloma
5338391|NCT00295997|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5338392|NCT00295997|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5338393|NCT00295997|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5338394|NCT00295997|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5338395|NCT00295997|stage III multiple myeloma|stage iii multiple myeloma
5338396|NCT00295997|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5338397|NCT00295997|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5338398|NCT00295997|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5338399|NCT00295997|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5338400|NCT00295997|recurrent renal cell cancer|recurrent renal cell cancer
5338401|NCT00295997|stage IV renal cell cancer|stage iv renal cell cancer
5338402|NCT00295997|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5338403|NCT00295997|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5338404|NCT00295997|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5338405|NCT00295997|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5338406|NCT00295997|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
5338407|NCT00295984|classic Kaposi sarcoma|classic kaposi sarcoma
5338408|NCT00295984|recurrent Kaposi sarcoma|recurrent kaposi sarcoma
5338409|NCT00295971|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
5338410|NCT00295971|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
5338411|NCT00295971|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5338412|NCT00295971|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5338413|NCT00295971|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5338414|NCT00295971|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5338415|NCT00295971|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
5338416|NCT00295971|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5338417|NCT00295971|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
5338418|NCT00295971|refractory anemia with excess blasts|refractory anemia with excess blasts
5338419|NCT00295971|severe congenital neutropenia|severe congenital neutropenia
5338420|NCT00295971|congenital amegakaryocytic thrombocytopenia|congenital amegakaryocytic thrombocytopenia
5338421|NCT00295971|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
5338422|NCT00295971|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
5338423|NCT00295958|recurrent melanoma|recurrent melanoma
5338424|NCT00295958|stage IV melanoma|stage iv melanoma
5338425|NCT00295958|skin cancer|skin cancer
5338426|NCT00295945|pain|pain
5338427|NCT00295945|perioperative/postoperative complications|perioperative/postoperative complications
5338428|NCT00295945|stage III cervical cancer|stage iii cervical cancer
5338429|NCT00295945|recurrent cervical cancer|recurrent cervical cancer
5338430|NCT00295945|stage IB cervical cancer|stage ib cervical cancer
5338431|NCT00295945|stage IIB cervical cancer|stage iib cervical cancer
5338432|NCT00295945|stage IVB cervical cancer|stage ivb cervical cancer
5338433|NCT00295945|stage IA cervical cancer|stage ia cervical cancer
5338434|NCT00295945|stage IIA cervical cancer|stage iia cervical cancer
5338435|NCT00295945|stage IVA cervical cancer|stage iva cervical cancer
5338436|NCT00295945|stage I endometrial carcinoma|stage i endometrial carcinoma
5338437|NCT00295945|stage II endometrial carcinoma|stage ii endometrial carcinoma
5338438|NCT00295945|stage III endometrial carcinoma|stage iii endometrial carcinoma
5338439|NCT00295945|stage IV endometrial carcinoma|stage iv endometrial carcinoma
5338440|NCT00295945|recurrent endometrial carcinoma|recurrent endometrial carcinoma
5338441|NCT00295945|stage I uterine sarcoma|stage i uterine sarcoma
5338442|NCT00295945|stage II uterine sarcoma|stage ii uterine sarcoma
5338443|NCT00295945|stage III uterine sarcoma|stage iii uterine sarcoma
5338444|NCT00295945|stage IV uterine sarcoma|stage iv uterine sarcoma
5338445|NCT00295945|recurrent uterine sarcoma|recurrent uterine sarcoma
5338446|NCT00295945|ovarian sarcoma|ovarian sarcoma
5338447|NCT00295945|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5338448|NCT00295945|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
5338449|NCT00295945|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5338450|NCT00295945|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
5338451|NCT00295945|ovarian stromal cancer|ovarian stromal cancer
5338452|NCT00295945|recurrent fallopian tube cancer|recurrent fallopian tube cancer
5338453|NCT00295945|stage IA fallopian tube cancer|stage ia fallopian tube cancer
5338454|NCT00295945|stage IB fallopian tube cancer|stage ib fallopian tube cancer
5338455|NCT00295945|stage IC fallopian tube cancer|stage ic fallopian tube cancer
5339006|NCT00294164|Placebo|placebo
5338456|NCT00295945|stage IIA fallopian tube cancer|stage iia fallopian tube cancer
5338457|NCT00295945|stage IIB fallopian tube cancer|stage iib fallopian tube cancer
5338458|NCT00295945|stage IIC fallopian tube cancer|stage iic fallopian tube cancer
5338459|NCT00295945|stage IIIA fallopian tube cancer|stage iiia fallopian tube cancer
5338460|NCT00295945|stage IIIB fallopian tube cancer|stage iiib fallopian tube cancer
5338461|NCT00295945|stage IIIC fallopian tube cancer|stage iiic fallopian tube cancer
5338462|NCT00295945|stage IV fallopian tube cancer|stage iv fallopian tube cancer
5338463|NCT00295945|stage IA ovarian epithelial cancer|stage ia ovarian epithelial cancer
5338464|NCT00295945|stage IB ovarian epithelial cancer|stage ib ovarian epithelial cancer
5338465|NCT00295945|stage IC ovarian epithelial cancer|stage ic ovarian epithelial cancer
5338466|NCT00295945|stage IIA ovarian epithelial cancer|stage iia ovarian epithelial cancer
5338467|NCT00295945|stage IIB ovarian epithelial cancer|stage iib ovarian epithelial cancer
5338468|NCT00295945|stage IIC ovarian epithelial cancer|stage iic ovarian epithelial cancer
5338469|NCT00295945|stage IIIA ovarian epithelial cancer|stage iiia ovarian epithelial cancer
5338470|NCT00295945|stage IIIB ovarian epithelial cancer|stage iiib ovarian epithelial cancer
5338471|NCT00295945|stage IIIC ovarian epithelial cancer|stage iiic ovarian epithelial cancer
5338472|NCT00295945|stage IA ovarian germ cell tumor|stage ia ovarian germ cell tumor
5338473|NCT00295945|stage IB ovarian germ cell tumor|stage ib ovarian germ cell tumor
5338474|NCT00295945|stage IC ovarian germ cell tumor|stage ic ovarian germ cell tumor
5338475|NCT00295945|stage IIA ovarian germ cell tumor|stage iia ovarian germ cell tumor
5338476|NCT00295945|stage IIB ovarian germ cell tumor|stage iib ovarian germ cell tumor
5338477|NCT00295945|stage IIC ovarian germ cell tumor|stage iic ovarian germ cell tumor
5338478|NCT00295945|stage IIIA ovarian germ cell tumor|stage iiia ovarian germ cell tumor
5338479|NCT00295945|stage IIIB ovarian germ cell tumor|stage iiib ovarian germ cell tumor
5338480|NCT00295945|stage IIIC ovarian germ cell tumor|stage iiic ovarian germ cell tumor
5338481|NCT00295932|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5338482|NCT00295932|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5338483|NCT00295932|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5338484|NCT00295932|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5338485|NCT00295932|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5338486|NCT00295932|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
5338487|NCT00295932|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5338488|NCT00295932|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5338489|NCT00295932|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
5338490|NCT00295932|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5338491|NCT00295932|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5338492|NCT00295932|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5338493|NCT00295919|recurrent neuroblastoma|recurrent neuroblastoma
5338494|NCT00295906|melanoma|melanoma
5338495|NCT00295906|skin cancer|skin cancer
5338496|NCT00295893|inflammatory breast cancer|inflammatory breast cancer
5338497|NCT00295893|stage II breast cancer|stage ii breast cancer
5338498|NCT00295893|stage IIIA breast cancer|stage iiia breast cancer
5338499|NCT00295893|stage IIIB breast cancer|stage iiib breast cancer
5338500|NCT00295893|stage IIIC breast cancer|stage iiic breast cancer
5338501|NCT00295893|male breast cancer|male breast cancer
5338502|NCT00295893|Paget disease of the breast with invasive ductal carcinoma|paget disease of the breast with invasive ductal carcinoma
5338503|NCT00295893|invasive ductal breast carcinoma with predominant intraductal component|invasive ductal breast carcinoma with predominant intraductal component
5338504|NCT00295893|invasive ductal breast carcinoma|invasive ductal breast carcinoma
5338505|NCT00295893|medullary ductal breast carcinoma with lymphocytic infiltrate|medullary ductal breast carcinoma with lymphocytic infiltrate
5338506|NCT00295893|comedo ductal breast carcinoma|comedo ductal breast carcinoma
5338507|NCT00295893|invasive lobular breast carcinoma with predominant in situ component|invasive lobular breast carcinoma with predominant in situ component
5338508|NCT00295893|invasive lobular breast carcinoma|invasive lobular breast carcinoma
5338509|NCT00295893|mucinous ductal breast carcinoma|mucinous ductal breast carcinoma
5338510|NCT00295893|papillary ductal breast carcinoma|papillary ductal breast carcinoma
5338511|NCT00295893|tubular ductal breast carcinoma|tubular ductal breast carcinoma
5338512|NCT00295880|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5338513|NCT00295880|adult acute myeloid leukemia|adult acute myeloid leukemia
5338514|NCT00295880|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
5338515|NCT00295880|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5338516|NCT00295880|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5338517|NCT00295880|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
5338518|NCT00295880|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5338519|NCT00295880|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5338520|NCT00295880|refractory anemia with excess blasts|refractory anemia with excess blasts
5338521|NCT00295880|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5338522|NCT00295880|myelodysplastic syndromes|myelodysplastic syndromes
5338523|NCT00295880|adult diffuse large cell lymphoma|adult diffuse large cell lymphoma
5338598|NCT00295763|thyroid stimulating hormone|thyroid stimulating hormone
5338524|NCT00295880|adult diffuse mixed cell lymphoma|adult diffuse mixed cell lymphoma
5338525|NCT00295880|adult diffuse small cleaved cell lymphoma|adult diffuse small cleaved cell lymphoma
5338526|NCT00295880|adult lymphoblastic lymphoma|adult lymphoblastic lymphoma
5338527|NCT00295880|grade 3 follicular lymphoma|grade 3 follicular lymphoma
5338528|NCT00295880|mantle cell lymphoma|mantle cell lymphoma
5338529|NCT00295880|childhood large cell lymphoma|childhood large cell lymphoma
5338530|NCT00295880|childhood lymphoblastic lymphoma|childhood lymphoblastic lymphoma
5338531|NCT00295880|adult acute lymphoblastic leukemia|adult acute lymphoblastic leukemia
5338532|NCT00295880|acute lymphoblastic leukemia|acute lymphoblastic leukemia
5338533|NCT00295880|refractory anemia|refractory anemia
5338534|NCT00295880|refractory cytopenia|refractory cytopenia
5338535|NCT00295880|childhood acute myeloid leukemia|childhood acute myeloid leukemia
5338536|NCT00295880|adult immunoblastic large cell lymphoma|adult immunoblastic large cell lymphoma
5338537|NCT00295880|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5338538|NCT00295880|chronic eosinophilic leukemia|chronic eosinophilic leukemia
5338539|NCT00295880|chronic neutrophilic leukemia|chronic neutrophilic leukemia
5338540|NCT00295880|childhood small noncleaved cell lymphoma|childhood small noncleaved cell lymphoma
5338541|NCT00295880|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
5338542|NCT00295867|stage I breast cancer|stage i breast cancer
5338543|NCT00295867|stage II breast cancer|stage ii breast cancer
5338544|NCT00295867|stage IIIA breast cancer|stage iiia breast cancer
5338545|NCT00295867|stage IIIB breast cancer|stage iiib breast cancer
5338546|NCT00295867|stage IIIC breast cancer|stage iiic breast cancer
5338547|NCT00295854|Interstitial Cystitis|interstitial cystitis
5338548|NCT00295854|urgency|urgency
5338549|NCT00295854|frequency|frequency
5338550|NCT00295854|MN-001|mn-001
5338551|NCT00295854|Global Response Assessment|global response assessment
5338552|NCT00295854|bladder pain/urgency|bladder pain/urgency
5338553|NCT00295854|O'Leary Sant IC Symptom and Problem Index|o'leary sant ic symptom and problem index
5338554|NCT00295841|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5338555|NCT00295841|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5338556|NCT00295841|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5338557|NCT00295841|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5338558|NCT00295841|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5338559|NCT00295841|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5338560|NCT00295841|adult acute basophilic leukemia|adult acute basophilic leukemia
5338561|NCT00295841|adult acute eosinophilic leukemia|adult acute eosinophilic leukemia
5338562|NCT00295841|adult erythroleukemia (M6a)|adult erythroleukemia (m6a)
5338563|NCT00295841|adult pure erythroid leukemia (M6b)|adult pure erythroid leukemia (m6b)
5338564|NCT00295841|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
5338565|NCT00295841|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
5338566|NCT00295841|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
5338567|NCT00295841|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
5338568|NCT00295841|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
5338569|NCT00295841|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
5338570|NCT00295841|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
5338571|NCT00295828|VEGF|vegf
5338572|NCT00295828|iris neovascularization|iris neovascularization
5338573|NCT00295828|diabetic retinopathy|diabetic retinopathy
5338574|NCT00295828|Macugen|macugen
5338575|NCT00295802|Prostate Cancer|prostate cancer
5338576|NCT00295802|HIFU|hifu
5338577|NCT00295802|EDAP|edap
5338578|NCT00295802|Low Risk, Localized Prostate Cancer|low risk, localized prostate cancer
5338579|NCT00295789|cervical cancer|cervical cancer
5338580|NCT00295789|palliative chemotherapy|palliative chemotherapy
5338581|NCT00295789|recurrent|recurrent
5338582|NCT00295789|persistent|persistent
5338583|NCT00295789|stageⅣb|stageⅳb
5338584|NCT00295789|cisplatin|cisplatin
5338585|NCT00295789|carboplatin|carboplatin
5338586|NCT00295789|paclitaxel|paclitaxel
5338587|NCT00295776|Inclusion Criteria:Minimum of 4 on the Likert Pain Scale.If currently taking TCA and/or Gabapentin, need to have been on stable dose for minimum of 4 weeks.|inclusion criteria:minimum of 4 on the likert pain scale.if currently taking tca and/or gabapentin, need to have been on stable dose for minimum of 4 weeks.
5338588|NCT00295776|Exclusion Criteria:|exclusion criteria:
5338589|NCT00295776|Currently on any antiepilepic drugs (AED), except for Gabapentin.|currently on any antiepilepic drugs (aed), except for gabapentin.
5338590|NCT00295776|Currently taking opioid or unwilling to washout prior to the study,|currently taking opioid or unwilling to washout prior to the study,
5338591|NCT00295776|Pregnant and lactating,|pregnant and lactating,
5338592|NCT00295776|Have active severe systemic disease,|have active severe systemic disease,
5338593|NCT00295776|History of Stevens-Johnson syndrome or TEN,|history of stevens-johnson syndrome or ten,
5338594|NCT00295763|papillary thyroid cancer|papillary thyroid cancer
5338595|NCT00295763|follicular thyroid cancer|follicular thyroid cancer
5338596|NCT00295763|recombinant human TSH|recombinant human tsh
5338597|NCT00295763|Thyrogen|thyrogen
5338599|NCT00295763|thyroid remnant ablation|thyroid remnant ablation
5338600|NCT00295763|radioiodine|radioiodine
5338601|NCT00295750|Prostate Cancer|prostate cancer
5338602|NCT00295737|allergic rhinitis|allergic rhinitis
5338603|NCT00295724|bicifadine|bicifadine
5338604|NCT00295724|chronic low back pain|chronic low back pain
5338605|NCT00295711|bicifadine|bicifadine
5338606|NCT00295711|chronic low back pain|chronic low back pain
5338607|NCT00295698|HIV|hiv
5338608|NCT00295698|Lymphatic filariasis|lymphatic filariasis
5338609|NCT00295698|Diethylcarbamazine|diethylcarbamazine
5338610|NCT00295698|Interaction|interaction
5338611|NCT00295698|Tanzania|tanzania
5338612|NCT00295685|Reflux|reflux
5338613|NCT00295685|GERD|gerd
5338614|NCT00295672|Non-Small-Cell Lung,radiotherapy, Chemotherapy, vinorelbine|non-small-cell lung,radiotherapy, chemotherapy, vinorelbine
5338615|NCT00295659|Gestational Diabetes|gestational diabetes
5338616|NCT00295659|Screening|screening
5338617|NCT00295659|Cost-effectiveness|cost-effectiveness
5338618|NCT00295659|obstetrical outcomes|obstetrical outcomes
5338619|NCT00295646|ABCSG|abcsg
5338620|NCT00295646|12|12
5338621|NCT00295646|Phase 3|phase 3
5338622|NCT00295646|breast cancer|breast cancer
5338623|NCT00295646|anastrozole|anastrozole
5338624|NCT00295646|tamoxifen|tamoxifen
5338625|NCT00295646|zoledronic acid|zoledronic acid
5338626|NCT00295646|premenopausal|premenopausal
5338627|NCT00295646|hormone receptor-positive|hormone receptor-positive
5338628|NCT00295646|Stage I|stage i
5338629|NCT00295646|Stage II|stage ii
5338630|NCT00295646|bone mineral density|bone mineral density
5338632|NCT00295646|bisphosphonate|bisphosphonate
5338633|NCT00295646|zoledronate|zoledronate
5338634|NCT00295620|Hormone receptor positive breast cancer|hormone receptor positive breast cancer
5338635|NCT00295607|Tacrolimus|tacrolimus
5338636|NCT00295607|Liver Transplantation|liver transplantation
5338637|NCT00295607|Immunosuppression|immunosuppression
5338638|NCT00295607|Adult|adult
5338639|NCT00295607|Treatment Outcome|treatment outcome
5338640|NCT00295594|Tacrolimus|tacrolimus
5338641|NCT00295594|Liver Transplantation|liver transplantation
5338642|NCT00295594|Treatment Outcome|treatment outcome
5338643|NCT00295594|Immunosuppression|immunosuppression
5338644|NCT00295581|Human|human
5338645|NCT00295581|Clinical Trial|clinical trial
5338646|NCT00295581|Mosquito|mosquito
5338647|NCT00295581|Healthy Volunteer|healthy volunteer
5338648|NCT00295581|HV|hv
5338649|NCT00295568|Transcranial Magnetic Stimulation (TMS)|transcranial magnetic stimulation (tms)
5338650|NCT00295568|Motor Learning|motor learning
5338651|NCT00295568|Accuracy|accuracy
5338652|NCT00295568|Tracking Motor Task|tracking motor task
5338653|NCT00295568|Healthy Volunteer|healthy volunteer
5338654|NCT00295568|HV|hv
5338655|NCT00295555|ambulatory blood pressure monitoring|ambulatory blood pressure monitoring
5338656|NCT00295555|doxazosin|doxazosin
5338657|NCT00295555|alpha1-adrenergic antagonists|alpha1-adrenergic antagonists
5338658|NCT00295555|sympathetic nervous activity|sympathetic nervous activity
5338659|NCT00295555|diabetic nephropathy|diabetic nephropathy
5338660|NCT00295555|essential hypertension|essential hypertension
5338661|NCT00295555|power spectral analysis|power spectral analysis
5338662|NCT00295555|morning surge|morning surge
5338663|NCT00295542|ambulatory blood pressure monitoring|ambulatory blood pressure monitoring
5338664|NCT00295542|cardiovascular risk|cardiovascular risk
5338665|NCT00295542|chronotherapy|chronotherapy
5338666|NCT00295542|circadian pattern|circadian pattern
5338667|NCT00295529|Primary health care|primary health care
5338668|NCT00295529|Breast neoplasm|breast neoplasm
5338669|NCT00295529|Education|education
5338670|NCT00295516|Rhesus|rhesus
5338671|NCT00295516|Isoimmunization|isoimmunization
5338672|NCT00295516|Red Cell Alloimmunization|red cell alloimmunization
5338673|NCT00295516|Fetal Hemolytic Anemia|fetal hemolytic anemia
5338674|NCT00295516|Erythroblastosis fetalis|erythroblastosis fetalis
5338675|NCT00295503|mesothelioma|mesothelioma
5338676|NCT00295503|bevacizumab|bevacizumab
5338677|NCT00295503|chemotherapy|chemotherapy
5338678|NCT00295490|double blind randomised controlled trial|double blind randomised controlled trial
5338679|NCT00295490|phase II|phase ii
5338680|NCT00295490|Devil's Claw|devil's claw
5338681|NCT00295490|osteoarthritis of the knee|osteoarthritis of the knee
5338682|NCT00295490|osteoarthritis of the hip|osteoarthritis of the hip
5338683|NCT00295477|HIV|hiv
5338684|NCT00295477|Treatment Experienced|treatment experienced
5338685|NCT00295464|Antenatal glucocorticoid|antenatal glucocorticoid
5338686|NCT00295464|Premature birth|premature birth
5338687|NCT00295438|robot-based tele-echography|robot-based tele-echography
5338688|NCT00295438|tele-medicine|tele-medicine
5338689|NCT00295425|psoriasis|psoriasis
5338690|NCT00295425|randomized clinical trial|randomized clinical trial
5338691|NCT00295425|cyclosporine A|cyclosporine a
5338692|NCT00295425|mycophenolate mofetil|mycophenolate mofetil
5338693|NCT00295425|immunosuppression|immunosuppression
5338694|NCT00295399|cerebrovascular accident|cerebrovascular accident
5338695|NCT00295399|traumatic brain injury|traumatic brain injury
5338696|NCT00295399|stroke|stroke
5338697|NCT00295399|telerehabilitation|telerehabilitation
5338698|NCT00295373|Hypercholesterolemia|hypercholesterolemia
5338701|NCT00295373|Rosuvastatin|rosuvastatin
5338702|NCT00295373|TLR4|tlr4
5338703|NCT00295373|Inflammation|inflammation
5338704|NCT00295360|cholestasis|cholestasis
5338705|NCT00295360|BCRP|bcrp
5338706|NCT00295360|multidrug resistance|multidrug resistance
5338707|NCT00295360|duodenum|duodenum
5338708|NCT00295360|bile acids|bile acids
5338709|NCT00295360|ABCG2|abcg2
5338710|NCT00295334|adherence|adherence
5338711|NCT00295334|glycemic control|glycemic control
5338712|NCT00295308|Opioid Dependence|opioid dependence
5338713|NCT00295308|Clonidine|clonidine
5338714|NCT00295308|Buprenorphine|buprenorphine
5338715|NCT00295308|Opioid Abstinence|opioid abstinence
5338716|NCT00295308|Relapse|relapse
5338717|NCT00295295|vibration|vibration
5338718|NCT00295295|bone density|bone density
5338719|NCT00295282|Ulcerative Colitis|ulcerative colitis
5338720|NCT00295282|UC|uc
5338721|NCT00295282|Colitis|colitis
5338722|NCT00295256|randomized trial|randomized trial
5338723|NCT00295256|diabetes|diabetes
5338724|NCT00295256|pregnancy|pregnancy
5338725|NCT00295230|respiratory distress syndrome|respiratory distress syndrome
5338726|NCT00295230|very low birth weight infant|very low birth weight infant
5338727|NCT00295230|mechanical ventilation|mechanical ventilation
5338728|NCT00295217|Fibroids|fibroids
5338729|NCT00295217|Uterine Leiomyomas|uterine leiomyomas
5338730|NCT00295217|ExAblate|exablate
5338731|NCT00295217|MrgFUS|mrgfus
5338732|NCT00295204|Syncope|syncope
5338733|NCT00295204|pre-syncope|pre-syncope
5338734|NCT00295204|palpitations|palpitations
5338735|NCT00295191|end-stage renal disease|end-stage renal disease
5338736|NCT00295191|hemodialysis|hemodialysis
5338737|NCT00295191|cardiovascular morbidity and mortality|cardiovascular morbidity and mortality
5338738|NCT00295191|high flux dialyser|high flux dialyser
5338739|NCT00295191|ultrapure dialysate|ultrapure dialysate
5338740|NCT00295191|coronary vascular calcifications|coronary vascular calcifications
5338741|NCT00295191|carotid intima-media thickness|carotid intima-media thickness
5338742|NCT00295191|atherosclerosis|atherosclerosis
5338743|NCT00295152|elderly/aged|elderly/aged
5338744|NCT00295152|occupational therapy|occupational therapy
5338745|NCT00295152|daily activities|daily activities
5338746|NCT00295152|caregivers|caregivers
5338747|NCT00295152|sense of competence|sense of competence
5338748|NCT00295139|treatment|treatment
5338749|NCT00295139|dual diagnosis|dual diagnosis
5338750|NCT00295126|Edentulous|edentulous
5338751|NCT00295126|Tooth Loss|tooth loss
5338752|NCT00295126|APC|apc
5338753|NCT00295126|Autologous platelet concentrate|autologous platelet concentrate
5338754|NCT00295113|Pulmonary arterial pressure|pulmonary arterial pressure
5338755|NCT00295113|COPD|copd
5338756|NCT00295113|Cardiac output|cardiac output
5338757|NCT00295113|pulmonary and cardiac functions|pulmonary and cardiac functions
5338758|NCT00295113|pulmonary arterial pressure measurements|pulmonary arterial pressure measurements
5338759|NCT00295100|Tamoxifen|tamoxifen
5338760|NCT00295100|Prevention|prevention
5338761|NCT00295100|Breast Cancer|breast cancer
5338762|NCT00295100|MRI|mri
5338763|NCT00295087|Premature Ovarian Failure|premature ovarian failure
5338764|NCT00295087|X-Chromosome Inactivation|x-chromosome inactivation
5338765|NCT00295074|traumatic brain injury|traumatic brain injury
5338766|NCT00295074|head injury|head injury
5338767|NCT00295074|concussion|concussion
5338768|NCT00295074|neuropsychologic test|neuropsychologic test
5338769|NCT00295061|alpha 1-Antitrypsin Deficiency|alpha 1-antitrypsin deficiency
5338770|NCT00295061|alpha 1-Antitrypsin|alpha 1-antitrypsin
5338771|NCT00295061|pulmonary emphysema|pulmonary emphysema
5338772|NCT00295048|treatment|treatment
5338773|NCT00295048|cognition|cognition
5338774|NCT00295048|schizophrenia|schizophrenia
5338775|NCT00295022|Levocetirizine|levocetirizine
5338776|NCT00295022|Xyzal|xyzal
5338777|NCT00295022|Rhinitis|rhinitis
5338778|NCT00295022|Allergic|allergic
5338779|NCT00295022|Seasonal|seasonal
5338780|NCT00295022|Ragweed|ragweed
5338781|NCT00294996|Metastatic Her2+ Breast cancer|metastatic her2+ breast cancer
5338782|NCT00294996|Myocet|myocet
5338783|NCT00294996|liposomal doxorubicin|liposomal doxorubicin
5338784|NCT00294996|trastuzumab|trastuzumab
5338785|NCT00294931|Lung Cancer, Small Cell|lung cancer, small cell
5338786|NCT00294931|Extensive|extensive
5338787|NCT00294918|Human Immunodeficiency Virus-associated Adipose Redistribution Syndrome (HARS)|human immunodeficiency virus-associated adipose redistribution syndrome (hars)
5338788|NCT00294918|Human Immunodeficiency Virus Infections|human immunodeficiency virus infections
5338789|NCT00294918|Serostim®|serostim®
5338790|NCT00294918|recombinant human growth hormone (r-hGH)|recombinant human growth hormone (r-hgh)
5338791|NCT00294905|COPD|copd
5338792|NCT00294905|smoking cessation|smoking cessation
5338793|NCT00294905|implementation|implementation
5338794|NCT00294905|patient counseling|patient counseling
5338795|NCT00294905|general practice|general practice
5338796|NCT00294892|HIV|hiv
5338797|NCT00294892|mother to child transmission; MTCT|mother to child transmission; mtct
5338798|NCT00294892|nevirapine resistance|nevirapine resistance
5338799|NCT00294892|pharmacokinetics|pharmacokinetics
5338800|NCT00294892|Treatment Naive|treatment naive
5339113|NCT00293748|Stroke|stroke
5338801|NCT00294866|End Stage Renal Disease|end stage renal disease
5338802|NCT00294866|Inflammation|inflammation
5338803|NCT00294853|Coronary calcium score|coronary calcium score
5338804|NCT00294853|Coronary artery disease|coronary artery disease
5338805|NCT00294853|Cardiac transplantation|cardiac transplantation
5338806|NCT00294853|Coronary calcium score in heart transplanted patients|coronary calcium score in heart transplanted patients
5338807|NCT00294853|Coronary artery disease in heart transplanted patients|coronary artery disease in heart transplanted patients
5338808|NCT00294827|Liver transplantation|liver transplantation
5338809|NCT00294814|Cardiac Surgery|cardiac surgery
5338810|NCT00294814|CABG|cabg
5338811|NCT00294814|Microemboli|microemboli
5338812|NCT00294814|Transcranial Doppler|transcranial doppler
5338813|NCT00294814|Cognitive Decline|cognitive decline
5338814|NCT00294814|Anastomotic Device|anastomotic device
5338815|NCT00294814|Proximal Anastomosis|proximal anastomosis
5338816|NCT00294814|Coronary Artery Bypass Graft (CABG)|coronary artery bypass graft (cabg)
5338817|NCT00294801|knee osteoarthritis|knee osteoarthritis
5338818|NCT00294788|Influenza|influenza
5338819|NCT00294788|bioadjuvant|bioadjuvant
5338820|NCT00294788|probiotic|probiotic
5338821|NCT00294788|HAI|hai
5338822|NCT00294788|immunity|immunity
5338823|NCT00294788|vaccine|vaccine
5338824|NCT00294788|Immune response to influenza vaccine|immune response to influenza vaccine
5338825|NCT00294775|diastolic dysfunction|diastolic dysfunction
5338826|NCT00294775|Reverse Remodelling|reverse remodelling
5338827|NCT00294762|NSCLC|nsclc
5338828|NCT00294762|Erlotinib|erlotinib
5338829|NCT00294762|Tarceva|tarceva
5338830|NCT00294762|Lung Cancer|lung cancer
5338831|NCT00294749|Prostate,|prostate,
5338832|NCT00294749|Infection,|infection,
5338833|NCT00294749|Biopsy,|biopsy,
5338834|NCT00294749|Antibiotic,|antibiotic,
5338835|NCT00294749|Prophylaxis|prophylaxis
5338836|NCT00294736|lung cancer|lung cancer
5338837|NCT00294736|erlotinib|erlotinib
5338838|NCT00294736|NSCLC|nsclc
5338839|NCT00294736|smokers|smokers
5338840|NCT00294710|Hypertension, aliskiren, hydrochlorothiazide, amlodipine|hypertension, aliskiren, hydrochlorothiazide, amlodipine
5338841|NCT00294697|polymorphisms|polymorphisms
5338842|NCT00294697|innate immune response|innate immune response
5338843|NCT00294697|immunomonitoring|immunomonitoring
5338844|NCT00294697|immuno paralysis|immuno paralysis
5338845|NCT00294684|biliary atresia|biliary atresia
5338846|NCT00294684|hepatoportoenterostomy|hepatoportoenterostomy
5338847|NCT00294684|corticosteroids|corticosteroids
5338848|NCT00294671|familial amyloid polyneuropathy|familial amyloid polyneuropathy
5338849|NCT00294671|familial amyloidosis|familial amyloidosis
5338850|NCT00294671|diflunisal|diflunisal
5338851|NCT00294671|amyloidosis|amyloidosis
5338852|NCT00294671|transthyretin|transthyretin
5338853|NCT00294671|peripheral neuropathy|peripheral neuropathy
5338854|NCT00294671|autonomic neuropathy|autonomic neuropathy
5338855|NCT00294671|amyloid cardiomyopathy|amyloid cardiomyopathy
5338856|NCT00294658|myasthenia gravis|myasthenia gravis
5338857|NCT00294658|thymectomy|thymectomy
5338858|NCT00294658|prednisone|prednisone
5338859|NCT00294658|corticosteroid|corticosteroid
5338860|NCT00294658|extended transsternal thymectomy|extended transsternal thymectomy
5338861|NCT00294658|ETTX|ettx
5338862|NCT00294658|MG|mg
5338863|NCT00294658|thymus|thymus
5338864|NCT00294658|thymoma|thymoma
5338865|NCT00294645|Remote Follow Up|remote follow up
5338866|NCT00294645|Diagnostic|diagnostic
5338867|NCT00294645|Bradycardia|bradycardia
5338868|NCT00294632|Mantle Cell Lymphoma|mantle cell lymphoma
5338869|NCT00294632|B-Cell Non-Hodgkin's Lymphoma|b-cell non-hodgkin's lymphoma
5338870|NCT00294632|Transformed Large Cell Lymphoma|transformed large cell lymphoma
5338871|NCT00294632|Follicular Lymphoma|follicular lymphoma
5338872|NCT00294632|Lymphoma|lymphoma
5338873|NCT00294632|MCL|mcl
5338874|NCT00294632|Lenalidomide|lenalidomide
5338876|NCT00294632|Revlimid™|revlimid™
5338877|NCT00294632|Rituximab|rituximab
5338878|NCT00294632|Rituxan|rituxan
5338879|NCT00294619|Growth hormone deficiency|growth hormone deficiency
5338880|NCT00294606|vasopressor agents|vasopressor agents
5338881|NCT00294606|carotid endarterectomy|carotid endarterectomy
5338882|NCT00294606|cardiac function|cardiac function
5338883|NCT00294606|transesophageal echocardiography|transesophageal echocardiography
5338884|NCT00294606|wall motion abnormalities|wall motion abnormalities
5338885|NCT00294593|Down syndrome|down syndrome
5338886|NCT00294593|folinic acid therapy|folinic acid therapy
5338887|NCT00294593|cognitive functions|cognitive functions
5338888|NCT00294580|Malaria|malaria
5338889|NCT00294580|Cognition|cognition
5338890|NCT00294580|Prevention & control|prevention & control
5338891|NCT00294580|Anemia|anemia
5338892|NCT00294580|Chemoprophylaxis|chemoprophylaxis
5338893|NCT00294580|Mortality|mortality
5338894|NCT00294580|Children|children
5338895|NCT00294580|Randomized controlled trial|randomized controlled trial
5338896|NCT00294580|Education|education
5338897|NCT00294580|Long-term effects|long-term effects
5338898|NCT00294580|The Gambia|the gambia
5338899|NCT00294580|Africa, West|africa, west
5338900|NCT00294567|Hypertension|hypertension
5338901|NCT00294567|PCI|pci
5338902|NCT00294567|Calcium Channel Blockers|calcium channel blockers
5338905|NCT00294554|Parkinson's Disease|parkinson's disease
5338906|NCT00294554|Cognitive Impairment|cognitive impairment
5338907|NCT00294554|Dementia|dementia
5338908|NCT00294554|Memory|memory
5338909|NCT00294541|sickle cell disease|sickle cell disease
5338910|NCT00294541|sickle cell anemia|sickle cell anemia
5338911|NCT00294528|osteoarthritis, knee|osteoarthritis, knee
5338912|NCT00294528|total knee arthroplasty|total knee arthroplasty
5338913|NCT00294528|range of motion|range of motion
5338914|NCT00294528|satisfaction|satisfaction
5338915|NCT00294489|HCV|hcv
5338916|NCT00294489|Fibrosis|fibrosis
5338917|NCT00294489|Breath test|breath test
5338918|NCT00294476|IVIg|ivig
5338919|NCT00294476|Cancer|cancer
5338920|NCT00294476|Melanoma|melanoma
5338921|NCT00294463|postmenopause|postmenopause
5338922|NCT00294463|endometrium|endometrium
5338923|NCT00294463|Gene Expression Profiling|gene expression profiling
5338924|NCT00294463|Histology, Comparative|histology, comparative
5338925|NCT00294463|Hormone Replacement Therapy|hormone replacement therapy
5338926|NCT00294463|Hormones|hormones
5338927|NCT00294437|Prostate Cancer|prostate cancer
5338928|NCT00294437|Zometa|zometa
5338929|NCT00294424|Waiting time|waiting time
5338930|NCT00294424|Total hip replacement|total hip replacement
5338931|NCT00294424|Total knee replacement|total knee replacement
5338932|NCT00294424|Quality of life|quality of life
5338933|NCT00294424|The15D|the15d
5338934|NCT00294424|Harris Hip Score|harris hip score
5338935|NCT00294424|Knee Score|knee score
5338936|NCT00294424|Pain measurement|pain measurement
5338937|NCT00294424|Cost-effectiveness|cost-effectiveness
5338938|NCT00294424|Medication|medication
5338939|NCT00294424|Health services|health services
5338940|NCT00294424|Social services|social services
5338941|NCT00294424|Randomized Controlled Trial|randomized controlled trial
5338942|NCT00294398|Asthma, Controller Medications|asthma, controller medications
5338943|NCT00294385|Breast Cancer|breast cancer
5338944|NCT00294385|Docetaxel|docetaxel
5338945|NCT00294359|colorectal neoplasm|colorectal neoplasm
5338946|NCT00294346|Social Anxiety Disorder|social anxiety disorder
5338947|NCT00294346|Social Phobia|social phobia
5338948|NCT00294320|Aldara|aldara
5338949|NCT00294320|Actinic Keratosis|actinic keratosis
5338950|NCT00294307|Nursing Models of Care|nursing models of care
5338951|NCT00294307|Collaborative Care|collaborative care
5338952|NCT00294307|Care Management|care management
5338953|NCT00294307|Transitional Care|transitional care
5338954|NCT00294307|Advanced Practice Nurse Care Interventions|advanced practice nurse care interventions
5338955|NCT00294307|Cognitive Impairment|cognitive impairment
5338956|NCT00294307|Dementia|dementia
5338957|NCT00294307|Delirium|delirium
5338958|NCT00294294|vaccine|vaccine
5338959|NCT00294294|infant|infant
5338960|NCT00294281|Pain|pain
5338961|NCT00294281|Tenderness|tenderness
5338962|NCT00294281|Depression|depression
5338963|NCT00294281|Work Disability|work disability
5338964|NCT00294281|Physical Function|physical function
5338965|NCT00294281|Quality of Life|quality of life
5338966|NCT00294281|Chronic Pain|chronic pain
5338967|NCT00294268|obesity|obesity
5338968|NCT00294268|CBT|cbt
5338969|NCT00294268|motivational enhancement therapy|motivational enhancement therapy
5338970|NCT00294268|weight loss maintenance|weight loss maintenance
5338971|NCT00294255|mixed mania|mixed mania
5338972|NCT00294255|depression|depression
5338973|NCT00294255|irritability|irritability
5338974|NCT00294242|pregnancy|pregnancy
5338975|NCT00294242|membranes sweeping|membranes sweeping
5338976|NCT00294242|prelabor rupture of membranes|prelabor rupture of membranes
5338977|NCT00294229|Low back pain|low back pain
5338978|NCT00294229|Spinal manipulative therapy|spinal manipulative therapy
5338979|NCT00294229|Randomised controlled trial|randomised controlled trial
5338980|NCT00294216|Omacor|omacor
5338981|NCT00294216|Omega-3 PUFA|omega-3 pufa
5338982|NCT00294216|Endarterectomy|endarterectomy
5338983|NCT00294216|Carotid Plaque stability|carotid plaque stability
5338984|NCT00294216|Structural changes|structural changes
5338985|NCT00294216|inflammation|inflammation
5338986|NCT00294203|Digestive System Surgical Procedures|digestive system surgical procedures
5338987|NCT00294203|Post-Operative Care|post-operative care
5338988|NCT00294203|Fatigue|fatigue
5338989|NCT00294203|Quality of Life|quality of life
5338990|NCT00294203|Erythrocyte Transfusion|erythrocyte transfusion
5338991|NCT00294203|Esophagectomy|esophagectomy
5338992|NCT00294203|Gastric Cancer|gastric cancer
5338993|NCT00294203|Hepatectomy|hepatectomy
5338994|NCT00294203|Pancreatic Cancer|pancreatic cancer
5338995|NCT00294203|Rectum|rectum
5338996|NCT00294190|Lung Cancer|lung cancer
5338997|NCT00294190|Extensive stage|extensive stage
5338998|NCT00294190|Small Cell Lung Cancer|small cell lung cancer
5338999|NCT00294177|Trophoblastic Neoplasms|trophoblastic neoplasms
5339000|NCT00294177|Chorionic Gonadotropin|chorionic gonadotropin
5339001|NCT00294177|Molecular Conformation|molecular conformation
5339002|NCT00294164|Human Immunodeficiency Virus-associated Adipose Redistribution Syndrome (HARS)|human immunodeficiency virus-associated adipose redistribution syndrome (hars)
5339003|NCT00294164|Human Immunodeficiency Virus Infections|human immunodeficiency virus infections
5339004|NCT00294164|recombinant human growth hormone (r-hGH)|recombinant human growth hormone (r-hgh)
5339007|NCT00294151|breast cancer|breast cancer
5339008|NCT00294151|prostate cancer|prostate cancer
5339009|NCT00294151|vertebral metastasis|vertebral metastasis
5339010|NCT00294151|vertebroplasty|vertebroplasty
5339011|NCT00294151|vertebral metastasis from breast cancer|vertebral metastasis from breast cancer
5339012|NCT00294151|vertebral metastasis from prostate cancer|vertebral metastasis from prostate cancer
5339013|NCT00294125|Medical Food|medical food
5339014|NCT00294125|Botanicals|botanicals
5339015|NCT00294125|Phytochemicals|phytochemicals
5339016|NCT00294112|mesenchymal stem cells|mesenchymal stem cells
5339017|NCT00294099|A/H5N1, Influenza, Vaccine|a/h5n1, influenza, vaccine
5339018|NCT00294086|valsartan,|valsartan,
5339019|NCT00294086|chronic heart failure,|chronic heart failure,
5339020|NCT00294073|femoral block|femoral block
5339021|NCT00294073|fascia iliaca block|fascia iliaca block
5339022|NCT00294073|ACL repair|acl repair
5339023|NCT00294073|post-operative analgesia|post-operative analgesia
5339024|NCT00294073|knee surgery|knee surgery
5339025|NCT00294073|ACL damage|acl damage
5339026|NCT00294073|knee damage|knee damage
5339027|NCT00294060|Pacemaker|pacemaker
5339028|NCT00294060|Bradycardia|bradycardia
5339029|NCT00294047|Vaccine|vaccine
5339030|NCT00294047|Human papillomavirus|human papillomavirus
5339031|NCT00294047|Cervical Cancer|cervical cancer
5339032|NCT00294047|Cervical Infection|cervical infection
5339033|NCT00294034|Registry|registry
5339034|NCT00294034|Pacemaker|pacemaker
5339035|NCT00294034|Diagnostics|diagnostics
5339036|NCT00294008|Schizophrenia|schizophrenia
5339037|NCT00294008|Treatment adherence|treatment adherence
5339038|NCT00294008|Antipsychotic agents|antipsychotic agents
5339039|NCT00294008|Risperidone|risperidone
5339040|NCT00294008|Long-acting injectable|long-acting injectable
5339041|NCT00294008|Risperdal tablet|risperdal tablet
5339042|NCT00294008|Risperidal Consta|risperidal consta
5339043|NCT00293982|Patient satisfaction|patient satisfaction
5339044|NCT00293982|Patient expectations|patient expectations
5339045|NCT00293982|Pediatric emergency department|pediatric emergency department
5339046|NCT00293969|Pain|pain
5339047|NCT00293969|Morphine|morphine
5339048|NCT00293956|hypothyroxinemia|hypothyroxinemia
5339049|NCT00293956|full term infants|full term infants
5339050|NCT00293956|near term infants|near term infants
5339051|NCT00293956|respiratory distress|respiratory distress
5339052|NCT00293956|thyroid disease|thyroid disease
5339053|NCT00293943|Atrial fibrillation|atrial fibrillation
5339054|NCT00293943|Pulmonary vein ablation|pulmonary vein ablation
5339055|NCT00293943|Linear lesions|linear lesions
5339056|NCT00293930|Treatment Outcome|treatment outcome
5339057|NCT00293930|Tacrolimus|tacrolimus
5339058|NCT00293930|Safety|safety
5339059|NCT00293930|Psoriasis|psoriasis
5339060|NCT00293917|Treatment Outcome|treatment outcome
5339061|NCT00293917|Tacrolimus|tacrolimus
5339062|NCT00293917|Safety|safety
5339063|NCT00293917|Psoriasis|psoriasis
5339064|NCT00293904|Allergy|allergy
5339065|NCT00293904|Grass Pollen|grass pollen
5339066|NCT00293904|Systemic Immunotherapy|systemic immunotherapy
5339067|NCT00293891|Treatment Outcome|treatment outcome
5339068|NCT00293891|Tacrolimus|tacrolimus
5339069|NCT00293891|Safety|safety
5339070|NCT00293891|Psoriasis|psoriasis
5339071|NCT00293865|Breast infiltrative cancer|breast infiltrative cancer
5339072|NCT00293852|Heart failure, Congestive|heart failure, congestive
5339073|NCT00293852|Metabolic Syndrome X|metabolic syndrome x
5339074|NCT00293852|Ambulatory Care|ambulatory care
5339075|NCT00293852|Health behavior|health behavior
5339076|NCT00293839|bladder|bladder
5339077|NCT00293839|overactive|overactive
5339078|NCT00293826|ACR criteria|acr criteria
5339079|NCT00293826|methotrexate|methotrexate
5339080|NCT00293826|DMARDs|dmards
5339081|NCT00293826|patient reported outcomes|patient reported outcomes
5339082|NCT00293826|joint assessment|joint assessment
5339083|NCT00293813|Post Menopausal|post menopausal
5339084|NCT00293813|Osteoporosis|osteoporosis
5339085|NCT00293813|MicroCT|microct
5339086|NCT00293813|Amgen|amgen
5339087|NCT00293813|denosumab|denosumab
5339088|NCT00293813|Extreme CT|extreme ct
5339089|NCT00293813|XCT|xct
5339090|NCT00293813|Fosamax|fosamax
5339091|NCT00293813|Alendronate|alendronate
5339092|NCT00293800|Open-angle|open-angle
5339093|NCT00293800|glaucoma|glaucoma
5339094|NCT00293800|ocular|ocular
5339095|NCT00293800|hypertension|hypertension
5339096|NCT00293787|Open-angle|open-angle
5339097|NCT00293787|glaucoma|glaucoma
5339098|NCT00293787|ocular|ocular
5339099|NCT00293787|hypertension|hypertension
5339100|NCT00293774|Prospective|prospective
5339101|NCT00293774|Conventional therapy|conventional therapy
5339102|NCT00293774|Registry|registry
5339103|NCT00293774|Metal-on-metal|metal-on-metal
5339104|NCT00293774|Ceramic-on-ceramic|ceramic-on-ceramic
5339105|NCT00293774|Hip Arthroplasty|hip arthroplasty
5339106|NCT00293761|open-angle|open-angle
5339107|NCT00293761|glaucoma|glaucoma
5339108|NCT00293761|ocular|ocular
5339109|NCT00293761|hypertension|hypertension
5339110|NCT00293748|Genomics|genomics
5339111|NCT00293748|Statins|statins
5339112|NCT00293748|Coronary Heart Disease|coronary heart disease
5339114|NCT00293748|Inflammation|inflammation
5339115|NCT00293748|Gene Expression|gene expression
5339116|NCT00293748|Vascular Risk|vascular risk
5339117|NCT00293748|Peripheral Blood Mononuclear Cells|peripheral blood mononuclear cells
5339118|NCT00293748|Atorvastatin|atorvastatin
5339119|NCT00293748|Vascular Disease|vascular disease
5339120|NCT00293748|Vascular Disease Risk|vascular disease risk
5339121|NCT00293735|Preeclampsia|preeclampsia
5339122|NCT00293735|Pregnancy|pregnancy
5339123|NCT00293735|Hypertension|hypertension
5339124|NCT00293735|Eclampsia|eclampsia
5339125|NCT00293735|HELLP Syndrome|hellp syndrome
5339126|NCT00293735|Seizures|seizures
5339127|NCT00293735|Prevention|prevention
5339128|NCT00293722|Arthritis|arthritis
5339129|NCT00293709|Arthritis|arthritis
5339130|NCT00293696|biomarker study|biomarker study
5339131|NCT00293696|Patients with clinically localised prostate cancer|patients with clinically localised prostate cancer
5339132|NCT00293683|cesarean|cesarean
5339133|NCT00293683|closure|closure
5339134|NCT00293683|skin|skin
5339135|NCT00293683|staple|staple
5339136|NCT00293683|absorbable|absorbable
5339137|NCT00293683|metal|metal
5339138|NCT00293644|Pregnancy Complications|pregnancy complications
5339139|NCT00293644|Hyperemesis Gravidarum|hyperemesis gravidarum
5339140|NCT00293644|Diclectin|diclectin
5339141|NCT00293644|doxylamine succinate|doxylamine succinate
5339142|NCT00293644|pyridoxine hydrochloride|pyridoxine hydrochloride
5339143|NCT00293618|Implementation of prediction rules|implementation of prediction rules
5339144|NCT00293618|Decision Support Systems, Clinical|decision support systems, clinical
5339145|NCT00293618|PONV|ponv
5339146|NCT00293618|Emesis|emesis
5339147|NCT00293618|Nausea|nausea
5339148|NCT00293618|Vomiting|vomiting
5339149|NCT00293618|Postoperative|postoperative
5339150|NCT00293618|Implementation|implementation
5339151|NCT00293618|prediction rule|prediction rule
5339152|NCT00293618|impact study|impact study
5339153|NCT00293618|decision support|decision support
5339154|NCT00293618|clinical decision support|clinical decision support
5339155|NCT00293605|aseptic loosening|aseptic loosening
5339156|NCT00293605|femoral stem design|femoral stem design
5339157|NCT00293592|Heart surgery|heart surgery
5339158|NCT00293592|Cardiopulmonary bypass|cardiopulmonary bypass
5339159|NCT00293592|Systemic Inflammatory Response Syndrome (SIRS)|systemic inflammatory response syndrome (sirs)
5339160|NCT00293579|head and neck cancer|head and neck cancer
5339161|NCT00293540|metastatic|metastatic
5339162|NCT00293540|secondary|secondary
5339163|NCT00293540|Hormone Receptor-Positive Breast Cancer|hormone receptor-positive breast cancer
5339164|NCT00293527|Metastatic|metastatic
5339165|NCT00293514|standard surgical treatment for air leakage in pulmonary lobectomy|standard surgical treatment for air leakage in pulmonary lobectomy
5339166|NCT00293501|clear cell renal cell carcinoma|clear cell renal cell carcinoma
5339167|NCT00293501|stage IV renal cell cancer|stage iv renal cell cancer
5339168|NCT00293501|recurrent renal cell cancer|recurrent renal cell cancer
5339169|NCT00293488|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5339170|NCT00293488|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
5339171|NCT00293488|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5339172|NCT00293488|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5339173|NCT00293488|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5339174|NCT00293488|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5339175|NCT00293488|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5339176|NCT00293488|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
5339177|NCT00293488|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5339178|NCT00293488|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5339179|NCT00293488|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5339180|NCT00293488|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5339181|NCT00293488|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5339182|NCT00293488|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5339183|NCT00293488|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5339184|NCT00293488|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5339185|NCT00293462|mucositis|mucositis
5339186|NCT00293462|radiation toxicity|radiation toxicity
5339187|NCT00293462|recurrent squamous and basal cell carcinoma of the hypopharynx,larynx,lip,nasopharynx|recurrent squamous and basal cell carcinoma of the hypopharynx,larynx,lip,nasopharynx
5339188|NCT00293462|oropharynx, paranasal sinus and nasal cavity|oropharynx, paranasal sinus and nasal cavity
5339189|NCT00293462|stage I-IV lymphoepithelioma of the nasopharynx|stage i-iv lymphoepithelioma of the nasopharynx
5339190|NCT00293462|stage I-IV lymphoepithelioma of the oropharynx|stage i-iv lymphoepithelioma of the oropharynx
5339191|NCT00293462|Recurrent and stage I-IV esthesioneuroblastoma of the paranasal sinus and nasal cavity|recurrent and stage i-iv esthesioneuroblastoma of the paranasal sinus and nasal cavity
5339192|NCT00293462|Recurrent and stage I-IV inverted papilloma of the paranasal sinus and nasal cavity|recurrent and stage i-iv inverted papilloma of the paranasal sinus and nasal cavity
5339193|NCT00293462|Recurrent and stage I-IV midline lethal granuloma of the paranasal sinus and nasal cavity|recurrent and stage i-iv midline lethal granuloma of the paranasal sinus and nasal cavity
5339663|NCT00291811|G-CSF|g-csf
5339194|NCT00293462|untreated, current,metastatic squamous neck cancer with occult primary|untreated, current,metastatic squamous neck cancer with occult primary
5339195|NCT00293462|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
5339196|NCT00293462|recurrent lymphoepithelioma of the oropharynx|recurrent lymphoepithelioma of the oropharynx
5339197|NCT00293462|stage I verrucous carcinoma of the larynx|stage i verrucous carcinoma of the larynx
5339198|NCT00293462|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
5339199|NCT00293462|stage I verrucous carcinoma of the oral cavity|stage i verrucous carcinoma of the oral cavity
5339200|NCT00293462|stage II verrucous carcinoma of the larynx|stage ii verrucous carcinoma of the larynx
5339201|NCT00293462|stage II verrucous carcinoma of the oral cavity|stage ii verrucous carcinoma of the oral cavity
5339202|NCT00293462|stage III verrucous carcinoma of the larynx|stage iii verrucous carcinoma of the larynx
5339203|NCT00293462|stage III verrucous carcinoma of the oral cavity|stage iii verrucous carcinoma of the oral cavity
5339204|NCT00293462|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
5339205|NCT00293462|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
5339206|NCT00293462|recurrent adenoid cystic carcinoma of the oral cavity|recurrent adenoid cystic carcinoma of the oral cavity
5339207|NCT00293462|stage I adenoid cystic carcinoma of the oral cavity|stage i adenoid cystic carcinoma of the oral cavity
5339208|NCT00293462|stage II adenoid cystic carcinoma of the oral cavity|stage ii adenoid cystic carcinoma of the oral cavity
5339209|NCT00293462|stage III adenoid cystic carcinoma of the oral cavity|stage iii adenoid cystic carcinoma of the oral cavity
5339210|NCT00293462|stage IV adenoid cystic carcinoma of the oral cavity|stage iv adenoid cystic carcinoma of the oral cavity
5339211|NCT00293462|recurrent mucoepidermoid carcinoma of the oral cavity|recurrent mucoepidermoid carcinoma of the oral cavity
5339212|NCT00293462|stage I mucoepidermoid carcinoma of the oral cavity|stage i mucoepidermoid carcinoma of the oral cavity
5339213|NCT00293462|stage II mucoepidermoid carcinoma of the oral cavity|stage ii mucoepidermoid carcinoma of the oral cavity
5339214|NCT00293462|stage III mucoepidermoid carcinoma of the oral cavity|stage iii mucoepidermoid carcinoma of the oral cavity
5339215|NCT00293462|stage IV mucoepidermoid carcinoma of the oral cavity|stage iv mucoepidermoid carcinoma of the oral cavity
5339216|NCT00293462|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
5339217|NCT00293462|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
5339218|NCT00293462|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
5339219|NCT00293462|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
5339220|NCT00293462|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5339221|NCT00293462|tongue cancer|tongue cancer
5339222|NCT00293436|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
5339223|NCT00293436|advanced adult primary liver cancer|advanced adult primary liver cancer
5339224|NCT00293436|localized resectable adult primary liver cancer|localized resectable adult primary liver cancer
5339225|NCT00293423|adult glioblastoma|adult glioblastoma
5339226|NCT00293423|recurrent adult brain tumor|recurrent adult brain tumor
5339227|NCT00293410|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5339228|NCT00293410|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5339229|NCT00293410|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5339230|NCT00293410|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5339231|NCT00293410|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5339232|NCT00293410|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5339233|NCT00293410|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5339234|NCT00293410|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5339235|NCT00293410|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
5339236|NCT00293410|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5339237|NCT00293410|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
5339238|NCT00293410|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5339239|NCT00293410|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
5339240|NCT00293410|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5339241|NCT00293410|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5339242|NCT00293410|acute undifferentiated leukemia|acute undifferentiated leukemia
5339243|NCT00293410|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5339244|NCT00293410|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
5339245|NCT00293410|adult acute basophilic leukemia|adult acute basophilic leukemia
5339246|NCT00293410|adult acute eosinophilic leukemia|adult acute eosinophilic leukemia
5339247|NCT00293410|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
5339248|NCT00293410|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
5339249|NCT00293410|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
5339250|NCT00293410|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
5339251|NCT00293410|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
5339664|NCT00291798|pilot study|pilot study
5339252|NCT00293410|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
5339253|NCT00293410|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
5339254|NCT00293410|adult acute promyelocytic leukemia (M3)|adult acute promyelocytic leukemia (m3)
5339255|NCT00293410|adult erythroleukemia (M6a)|adult erythroleukemia (m6a)
5339256|NCT00293410|adult pure erythroid leukemia (M6b)|adult pure erythroid leukemia (m6b)
5339257|NCT00293410|childhood acute basophilic leukemia|childhood acute basophilic leukemia
5339258|NCT00293410|childhood acute monocytic leukemia (M5b)|childhood acute monocytic leukemia (m5b)
5339259|NCT00293410|childhood acute eosinophilic leukemia|childhood acute eosinophilic leukemia
5339260|NCT00293410|childhood acute erythroleukemia (M6)|childhood acute erythroleukemia (m6)
5339261|NCT00293410|childhood acute megakaryocytic leukemia (M7)|childhood acute megakaryocytic leukemia (m7)
5339262|NCT00293410|childhood acute minimally differentiated myeloid leukemia (M0)|childhood acute minimally differentiated myeloid leukemia (m0)
5339263|NCT00293410|childhood acute myeloblastic leukemia with maturation (M2)|childhood acute myeloblastic leukemia with maturation (m2)
5339264|NCT00293410|childhood acute myeloblastic leukemia without maturation (M1)|childhood acute myeloblastic leukemia without maturation (m1)
5339265|NCT00293410|childhood acute myelomonocytic leukemia (M4)|childhood acute myelomonocytic leukemia (m4)
5339266|NCT00293410|childhood acute monoblastic leukemia (M5a)|childhood acute monoblastic leukemia (m5a)
5339267|NCT00293410|childhood acute promyelocytic leukemia (M3)|childhood acute promyelocytic leukemia (m3)
5339268|NCT00293397|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
5339269|NCT00293397|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
5339270|NCT00293384|nausea and vomiting|nausea and vomiting
5339271|NCT00293384|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5339272|NCT00293384|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5339273|NCT00293384|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5339274|NCT00293384|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5339275|NCT00293384|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5339276|NCT00293384|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5339277|NCT00293384|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5339278|NCT00293384|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5339279|NCT00293384|atypical chronic myeloid leukemia, BCR-ABL negative|atypical chronic myeloid leukemia, bcr-abl negative
5339280|NCT00293384|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5339281|NCT00293384|chronic eosinophilic leukemia|chronic eosinophilic leukemia
5339282|NCT00293384|primary myelofibrosis|primary myelofibrosis
5339283|NCT00293384|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5339284|NCT00293384|chronic neutrophilic leukemia|chronic neutrophilic leukemia
5339285|NCT00293384|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5339286|NCT00293384|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5339287|NCT00293384|disseminated neuroblastoma|disseminated neuroblastoma
5339288|NCT00293384|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5339289|NCT00293384|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
5339290|NCT00293384|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5339291|NCT00293384|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
5339292|NCT00293384|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5339293|NCT00293384|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
5339294|NCT00293384|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
5339295|NCT00293384|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
5339296|NCT00293384|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
5339297|NCT00293384|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5339298|NCT00293384|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5339299|NCT00293384|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5339300|NCT00293384|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5339301|NCT00293384|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
5339302|NCT00293384|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
5339303|NCT00293384|poor prognosis metastatic gestational trophoblastic tumor|poor prognosis metastatic gestational trophoblastic tumor
5339304|NCT00293384|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5339305|NCT00293384|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5339306|NCT00293384|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5339307|NCT00293384|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5339308|NCT00293384|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5339309|NCT00293384|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5339310|NCT00293384|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5339311|NCT00293384|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5339312|NCT00293384|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5339313|NCT00293384|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5339314|NCT00293384|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5339315|NCT00293384|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5339316|NCT00293384|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5339317|NCT00293384|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5339318|NCT00293384|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5339319|NCT00293384|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5339320|NCT00293384|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5339321|NCT00293384|recurrent neuroblastoma|recurrent neuroblastoma
5339322|NCT00293384|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5339323|NCT00293384|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
5339324|NCT00293384|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5339325|NCT00293384|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
5339326|NCT00293384|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5339327|NCT00293384|refractory hairy cell leukemia|refractory hairy cell leukemia
5339328|NCT00293384|refractory multiple myeloma|refractory multiple myeloma
5339329|NCT00293384|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5339330|NCT00293384|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5339331|NCT00293384|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5339332|NCT00293384|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5339333|NCT00293384|stage I multiple myeloma|stage i multiple myeloma
5339334|NCT00293384|stage II multiple myeloma|stage ii multiple myeloma
5339335|NCT00293384|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
5339336|NCT00293384|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5339337|NCT00293384|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5339338|NCT00293384|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5339339|NCT00293384|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5339340|NCT00293384|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5339341|NCT00293384|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5339342|NCT00293384|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5339343|NCT00293384|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5339344|NCT00293384|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5339345|NCT00293384|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5339346|NCT00293384|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5339347|NCT00293384|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5339348|NCT00293384|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5339349|NCT00293384|stage III multiple myeloma|stage iii multiple myeloma
5339350|NCT00293384|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5339351|NCT00293384|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5339352|NCT00293384|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
5339353|NCT00293384|stage IIIA breast cancer|stage iiia breast cancer
5339354|NCT00293384|stage IIIB breast cancer|stage iiib breast cancer
5339355|NCT00293384|stage IIIC breast cancer|stage iiic breast cancer
5339356|NCT00293384|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5339357|NCT00293384|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5339358|NCT00293384|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5339359|NCT00293384|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5339360|NCT00293384|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5339361|NCT00293384|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5339362|NCT00293384|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5339363|NCT00293384|stage IV breast cancer|stage iv breast cancer
5339364|NCT00293384|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5339365|NCT00293384|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5339366|NCT00293384|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5339367|NCT00293384|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5339368|NCT00293384|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5339369|NCT00293384|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5339370|NCT00293384|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5339371|NCT00293384|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5339372|NCT00293371|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5339373|NCT00293371|recurrent prostate cancer|recurrent prostate cancer
5339374|NCT00293371|stage IV prostate cancer|stage iv prostate cancer
5339375|NCT00293358|childhood central nervous system germ cell tumor|childhood central nervous system germ cell tumor
5339376|NCT00293358|adult central nervous system germ cell tumor|adult central nervous system germ cell tumor
5339377|NCT00293358|childhood central nervous system choriocarcinoma|childhood central nervous system choriocarcinoma
5339665|NCT00291798|exemestane|exemestane
5339378|NCT00293358|childhood central nervous system embryonal tumor|childhood central nervous system embryonal tumor
5339379|NCT00293358|childhood central nervous system yolk sac tumor|childhood central nervous system yolk sac tumor
5339380|NCT00293332|stage I non-small cell lung cancer|stage i non-small cell lung cancer
5339381|NCT00293332|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
5339382|NCT00293332|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5339383|NCT00293319|recurrent neuroblastoma|recurrent neuroblastoma
5339384|NCT00293293|stage I ovarian epithelial cancer|stage i ovarian epithelial cancer
5339385|NCT00293293|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
5339386|NCT00293293|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5339387|NCT00293293|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5339388|NCT00293293|peritoneal cavity cancer|peritoneal cavity cancer
5339389|NCT00293280|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5339390|NCT00293280|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5339391|NCT00293280|adenocarcinoma of the lung|adenocarcinoma of the lung
5339392|NCT00293280|adenosquamous cell lung cancer|adenosquamous cell lung cancer
5339393|NCT00293280|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
5339394|NCT00293280|large cell lung cancer|large cell lung cancer
5339395|NCT00293280|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5339396|NCT00293280|squamous cell lung cancer|squamous cell lung cancer
5339397|NCT00293267|Treatment Experienced|treatment experienced
5339398|NCT00293254|Treatment Experienced|treatment experienced
5339399|NCT00293241|Pacemaker or ICD replacement|pacemaker or icd replacement
5339400|NCT00293228|Latent tuberculosis|latent tuberculosis
5339401|NCT00293228|biomarkers|biomarkers
5339402|NCT00293228|isoniazid|isoniazid
5339403|NCT00293228|ELISPOT|elispot
5339404|NCT00293228|PPD positive individuals|ppd positive individuals
5339405|NCT00293202|etanercept|etanercept
5339406|NCT00293202|malnutrition|malnutrition
5339407|NCT00293202|inflammation|inflammation
5339408|NCT00293202|hemodialysis|hemodialysis
5339409|NCT00293189|hip fracture|hip fracture
5339410|NCT00293189|epidemiology|epidemiology
5339411|NCT00293189|genetics|genetics
5339412|NCT00293189|p2x7|p2x7
5339413|NCT00293176|Cognitive impairment|cognitive impairment
5339414|NCT00293176|Memory Loss|memory loss
5339415|NCT00293150|diastolic heart failure|diastolic heart failure
5339416|NCT00293150|heart failure|heart failure
5339417|NCT00293137|Chronic systolic heart failure|chronic systolic heart failure
5339418|NCT00293137|Heart Failure|heart failure
5339419|NCT00293124|Gastrointestinal Stromal Tumors|gastrointestinal stromal tumors
5339420|NCT00293124|Glivec|glivec
5339421|NCT00293111|Multiple Myeloma|multiple myeloma
5339422|NCT00293111|Relapsed Multiple Myeloma|relapsed multiple myeloma
5339423|NCT00293111|Refractory Multiple Myeloma|refractory multiple myeloma
5339424|NCT00293098|Iron overload|iron overload
5339425|NCT00293098|Thalassemia|thalassemia
5339426|NCT00293098|Iron induced heart disease|iron induced heart disease
5339427|NCT00293098|deferoxamine (Desferal)|deferoxamine (desferal)
5339428|NCT00293098|Deferiprone|deferiprone
5339429|NCT00293085|NSCLC|nsclc
5339430|NCT00293085|Docetaxel|docetaxel
5339431|NCT00293072|Rituximab, ANCA, vasculitis, lupus,|rituximab, anca, vasculitis, lupus,
5339432|NCT00293059|Dysfunctional Uterine Bleeding|dysfunctional uterine bleeding
5339433|NCT00293046|Allergy|allergy
5339434|NCT00293033|Breakthrough Pain in Cancer Patients|breakthrough pain in cancer patients
5339435|NCT00293020|Breakthrough Pain in Cancer Patients|breakthrough pain in cancer patients
5339436|NCT00292994|Metabolic Syndrome|metabolic syndrome
5339437|NCT00292994|Hyperlipidemia|hyperlipidemia
5339438|NCT00292994|Type 2 diabetes mellitus|type 2 diabetes mellitus
5339439|NCT00292994|Insulin resistance|insulin resistance
5339440|NCT00292994|Weight loss|weight loss
5339441|NCT00292994|Obesity|obesity
5339442|NCT00292994|Exercise|exercise
5339443|NCT00292994|Hypertension|hypertension
5339444|NCT00292981|C1 Inhibitor|c1 inhibitor
5339445|NCT00292981|Hereditary angioedema|hereditary angioedema
5339446|NCT00292981|Acute HAE attack|acute hae attack
5339447|NCT00292968|Health Behavior|health behavior
5339448|NCT00292968|Prevention|prevention
5339449|NCT00292968|Informatics|informatics
5339450|NCT00292968|Electronic Health Record|electronic health record
5339451|NCT00292955|Cervical Cancer, Cetuximab, Phase II Clinical Trials|cervical cancer, cetuximab, phase ii clinical trials
5339452|NCT00292955|Stage IB2-IVB Carcinoma of the Cervix|stage ib2-ivb carcinoma of the cervix
5339453|NCT00292942|artesunate|artesunate
5339454|NCT00292942|artemisinin|artemisinin
5339455|NCT00292942|falciparum|falciparum
5339456|NCT00292929|artesunate|artesunate
5339457|NCT00292929|artemisinin|artemisinin
5339458|NCT00292929|falciparum|falciparum
5339459|NCT00292916|whole body vibration|whole body vibration
5339460|NCT00292916|exercise|exercise
5339461|NCT00292916|elderly woman|elderly woman
5339462|NCT00292916|Bone Mineral Density|bone mineral density
5339463|NCT00292916|falls|falls
5339464|NCT00292916|higher age|higher age
5339465|NCT00292903|Perinatal Depression|perinatal depression
5339466|NCT00292903|Interpersonal Psychotherapy|interpersonal psychotherapy
5339467|NCT00292890|injection devices|injection devices
5339468|NCT00292890|injection technique|injection technique
5339469|NCT00292890|insulin needles|insulin needles
5339470|NCT00292890|insulin administration|insulin administration
5339471|NCT00292877|1. Eosinophilic bronchitis, 2. Asthma, 3. Steroid dependent asthma, 4. Sputum eosinophils, 5. SB-240563 (Mepolizumab)|1. eosinophilic bronchitis, 2. asthma, 3. steroid dependent asthma, 4. sputum eosinophils, 5. sb-240563 (mepolizumab)
5339472|NCT00292864|Cancer|cancer
5339473|NCT00292864|Carcinoma|carcinoma
5339474|NCT00292864|Adenocarcinoma|adenocarcinoma
5339475|NCT00292864|Tumor|tumor
5339476|NCT00292864|Advanced solid tumors|advanced solid tumors
5339477|NCT00292838|Eosinophilic bronchitis with asthma|eosinophilic bronchitis with asthma
5339478|NCT00292838|Eosinophilic bronchitis without asthma|eosinophilic bronchitis without asthma
5339479|NCT00292825|vasovagal syncope|vasovagal syncope
5339480|NCT00292825|syncope|syncope
5339481|NCT00292825|cardioinhibitory syncope|cardioinhibitory syncope
5339482|NCT00292825|neurocardiogenic syncope|neurocardiogenic syncope
5339483|NCT00292825|pacing|pacing
5339484|NCT00292825|closed loop pacing|closed loop pacing
5339485|NCT00292825|tilt table|tilt table
5339486|NCT00292812|Infant nutrition|infant nutrition
5339487|NCT00292812|Nucleotides|nucleotides
5339488|NCT00292812|Infant formula|infant formula
5339489|NCT00292799|Polycystic ovary syndrome|polycystic ovary syndrome
5339490|NCT00292799|Obesity|obesity
5339491|NCT00292799|metformin|metformin
5339492|NCT00292799|orlistat|orlistat
5339493|NCT00292786|Functional Electrical Stimulation|functional electrical stimulation
5339494|NCT00292786|FES|fes
5339495|NCT00292786|Walking|walking
5339496|NCT00292786|Practice|practice
5339497|NCT00292786|Coordination|coordination
5339498|NCT00292786|Posture|posture
5339499|NCT00292773|Anovulation|anovulation
5339500|NCT00292773|Obesity|obesity
5339501|NCT00292773|bariatric surgery|bariatric surgery
5339502|NCT00292708|Antibiotics|antibiotics
5339503|NCT00292708|Prophylaxis|prophylaxis
5339504|NCT00292708|Surgical wound infection|surgical wound infection
5339505|NCT00292656|Allergy|allergy
5339506|NCT00292591|vitamin D|vitamin d
5339507|NCT00292591|cholecalciferol|cholecalciferol
5339508|NCT00292591|pregnancy|pregnancy
5339509|NCT00292591|bone mineral density|bone mineral density
5339510|NCT00292578|Allergy|allergy
5339511|NCT00292578|Sugar Intolerance|sugar intolerance
5339512|NCT00292578|Fatigue|fatigue
5339513|NCT00292552|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
5339514|NCT00292552|longitudinal|longitudinal
5339515|NCT00292552|eclipse|eclipse
5339516|NCT00292539|Pacemaker|pacemaker
5339517|NCT00292539|NYHA class|nyha class
5339518|NCT00292539|Ejection fraction|ejection fraction
5339519|NCT00292539|Heart Failure|heart failure
5339520|NCT00292526|Chemotherapy induced cardiotoxicity|chemotherapy induced cardiotoxicity
5339521|NCT00292526|Troponin|troponin
5339522|NCT00292526|Heart failure|heart failure
5339523|NCT00292500|CABG, anastomotic device; myocardial revascularization|cabg, anastomotic device; myocardial revascularization
5339524|NCT00292474|coronary artery disease|coronary artery disease
5339525|NCT00292474|percutaneous coronary interventions|percutaneous coronary interventions
5339526|NCT00292474|stent implant|stent implant
5339527|NCT00292474|drug-coated stent|drug-coated stent
5339528|NCT00292461|Epilepsy|epilepsy
5339529|NCT00292461|seizures|seizures
5339530|NCT00292422|Arthritis, Rheumatoid|arthritis, rheumatoid
5339531|NCT00292422|Methotrexate|methotrexate
5339532|NCT00292422|Antirheumatic Agents|antirheumatic agents
5339533|NCT00292383|Cardiac Pacing, artificial|cardiac pacing, artificial
5339534|NCT00292383|Atrial Fibrillation|atrial fibrillation
5339535|NCT00292383|Heart failure|heart failure
5339536|NCT00292383|Pacemaker leads|pacemaker leads
5339537|NCT00292383|Lead position|lead position
5339538|NCT00292383|Higher degree AV-Block|higher degree av-block
5339539|NCT00292370|Atypical Antipsychotics|atypical antipsychotics
5339540|NCT00292370|Controlled Trial|controlled trial
5339541|NCT00292370|Paroxetine|paroxetine
5339542|NCT00292370|Quetiapine|quetiapine
5339543|NCT00292370|Stress Disorders, Post-Traumatic|stress disorders, post-traumatic
5339544|NCT00292370|Treatment refractory|treatment refractory
5339545|NCT00292370|Treatment resistant|treatment resistant
5339546|NCT00292344|Travelers' diarrhea|travelers' diarrhea
5339547|NCT00292344|rifaximin|rifaximin
5339548|NCT00292344|loperamide|loperamide
5339549|NCT00292344|enterotoxigenic E. coli|enterotoxigenic e. coli
5339550|NCT00292331|gastric varices|gastric varices
5339551|NCT00292331|liver cirrhosis|liver cirrhosis
5339552|NCT00292331|hepatocelluar carcinoma|hepatocelluar carcinoma
5339553|NCT00292331|rebleeding|rebleeding
5339554|NCT00292331|long-term|long-term
5339555|NCT00292318|adequate relief|adequate relief
5339556|NCT00292318|anorectal manometry|anorectal manometry
5339557|NCT00292318|biofeedback therapy|biofeedback therapy
5339558|NCT00292318|fecal incontinence|fecal incontinence
5339559|NCT00292305|PCI|pci
5339560|NCT00292305|Bifurcation lesion|bifurcation lesion
5339561|NCT00292279|Impact of Omega 3 fatty acid on outcome|impact of omega 3 fatty acid on outcome
5339562|NCT00292279|Omega-3 fatty acid|omega-3 fatty acid
5339563|NCT00292279|Carcinoma surgery|carcinoma surgery
5339564|NCT00292279|Digestive System|digestive system
5339565|NCT00292279|Parenteral Nutrition|parenteral nutrition
5339566|NCT00292279|Fat Emulsions, Intravenous|fat emulsions, intravenous
5339567|NCT00292279|Clinical outcome|clinical outcome
5339568|NCT00292279|SIRS|sirs
5339569|NCT00292279|Infectious complication|infectious complication
5339570|NCT00292279|Postoperative hospital stay|postoperative hospital stay
5339571|NCT00292279|Cost of postoperative period|cost of postoperative period
5339572|NCT00292279|Post-operative nutritional cost & total treatment cost|post-operative nutritional cost & total treatment cost
5339573|NCT00292266|Relapsing-remitting Multiple Sclerosis|relapsing-remitting multiple sclerosis
5339574|NCT00292266|Rebif®|rebif®
5339575|NCT00292266|Avonex®|avonex®
5339576|NCT00292266|interferon-beta-1a|interferon-beta-1a
5339577|NCT00292253|MS|ms
5339578|NCT00292240|brief motivational intervention; teens; substance use|brief motivational intervention; teens; substance use
5339579|NCT00292227|advanced-stage idiopathic Parkinson's disease|advanced-stage idiopathic parkinson's disease
5339580|NCT00292214|paracetamol|paracetamol
5339581|NCT00292214|acetaminophen|acetaminophen
5339582|NCT00292214|pharmacokinetic|pharmacokinetic
5339583|NCT00292214|intravenous|intravenous
5339584|NCT00292214|oral|oral
5339585|NCT00292214|analgesia|analgesia
5339586|NCT00292214|pain|pain
5339587|NCT00292214|opioid|opioid
5339588|NCT00292201|Asthma|asthma
5339589|NCT00292201|Statin|statin
5339590|NCT00292188|Phase 4, post-traumatic neuropathic pain, neuropathic pain, Nep, post surgical pain, nerve injury, phantom limb pain, international|phase 4, post-traumatic neuropathic pain, neuropathic pain, nep, post surgical pain, nerve injury, phantom limb pain, international
5339591|NCT00292175|colonoscopy, narrow band imaging (NBI), ulcerative colitis|colonoscopy, narrow band imaging (nbi), ulcerative colitis
5339592|NCT00292162|Chronic Heart Failure|chronic heart failure
5339593|NCT00292162|Atrial Fibrillation|atrial fibrillation
5339594|NCT00292162|Radiofrequency Ablation|radiofrequency ablation
5339595|NCT00292136|Cocaine Dependence|cocaine dependence
5339596|NCT00292136|Drug Relapse|drug relapse
5339597|NCT00292136|Pharmacokinetics|pharmacokinetics
5339598|NCT00292136|EMA|ema
5339599|NCT00292136|Polydrug Abuse|polydrug abuse
5339600|NCT00292110|HIV|hiv
5339601|NCT00292110|Opiate Substitution|opiate substitution
5339602|NCT00292110|Pharmacokinetics|pharmacokinetics
5339603|NCT00292110|ECG|ecg
5339604|NCT00292110|Polydrug Abuse|polydrug abuse
5339605|NCT00292097|Respiratory failure|respiratory failure
5339606|NCT00292097|Tracheostomy|tracheostomy
5339607|NCT00292097|Percutaneous dilatation tracheostomy|percutaneous dilatation tracheostomy
5339608|NCT00292097|Endotracheal Conversion|endotracheal conversion
5339609|NCT00292097|Traumatic brain injury|traumatic brain injury
5339610|NCT00292084|Hepatitis C|hepatitis c
5339611|NCT00292084|Celgosivir|celgosivir
5339612|NCT00292084|HCV|hcv
5339613|NCT00292084|Genotype 1|genotype 1
5339614|NCT00292084|Non-responders|non-responders
5339615|NCT00292084|End of Treatment Response|end of treatment response
5339616|NCT00292084|Sustained Viral Response|sustained viral response
5339617|NCT00292058|Telepsychiatry|telepsychiatry
5339618|NCT00292058|Videoconference|videoconference
5339619|NCT00292058|Psychiatric consultation|psychiatric consultation
5339620|NCT00292058|Equivalence trial|equivalence trial
5339621|NCT00292045|NY-ESO-1 protein, immunization, advanced prostate cancer|ny-eso-1 protein, immunization, advanced prostate cancer
5339622|NCT00292032|cardiac arrest|cardiac arrest
5339623|NCT00292032|diagnosis|diagnosis
5339624|NCT00292032|genetics|genetics
5339625|NCT00292032|testing|testing
5339626|NCT00292006|clinical scaphoid fracture|clinical scaphoid fracture
5339627|NCT00292006|pediatric|pediatric
5339628|NCT00291993|Obstructive sleep apnea|obstructive sleep apnea
5339629|NCT00291993|Vasoactive hormones|vasoactive hormones
5339630|NCT00291993|Blood pressure|blood pressure
5339631|NCT00291980|Dialysis|dialysis
5339632|NCT00291980|Pre-dialysis|pre-dialysis
5339633|NCT00291980|Hepatitis B vaccine|hepatitis b vaccine
5339634|NCT00291980|Prophylaxis hepatitis B infection|prophylaxis hepatitis b infection
5339635|NCT00291954|Dialysis|dialysis
5339636|NCT00291954|Pre-dialysis|pre-dialysis
5339637|NCT00291954|Hepatitis B vaccine|hepatitis b vaccine
5339638|NCT00291954|Prophylaxis hepatitis B infection|prophylaxis hepatitis b infection
5339639|NCT00291941|Dialysis|dialysis
5339640|NCT00291941|Pre-dialysis|pre-dialysis
5339641|NCT00291941|Hepatitis B vaccine|hepatitis b vaccine
5339642|NCT00291941|Prophylaxis|prophylaxis
5339643|NCT00291915|early arthritis, methotrexate, adalimumab|early arthritis, methotrexate, adalimumab
5339644|NCT00291902|CHD|chd
5339645|NCT00291902|coronary heart disease|coronary heart disease
5339646|NCT00291902|atherosclerosis|atherosclerosis
5339647|NCT00291902|inflammation|inflammation
5339648|NCT00291876|HAVRIX™|havrix™
5339649|NCT00291876|Hepatitis A|hepatitis a
5339650|NCT00291863|end stage renal failure|end stage renal failure
5339651|NCT00291863|peritoneal dialysis|peritoneal dialysis
5339652|NCT00291863|simvastatin|simvastatin
5339653|NCT00291863|endothelium|endothelium
5339654|NCT00291863|vasodilation|vasodilation
5339655|NCT00291850|NSCLC|nsclc
5339656|NCT00291837|ovarian|ovarian
5339657|NCT00291837|CT-2106|ct-2106
5339658|NCT00291824|Cardiovascular risks|cardiovascular risks
5339659|NCT00291824|Motivational interviewing|motivational interviewing
5339660|NCT00291824|Behavior change|behavior change
5339661|NCT00291824|Primary care setting|primary care setting
5339662|NCT00291811|AMD3100|amd3100
5339666|NCT00291798|endocrinotherapy|endocrinotherapy
5339667|NCT00291798|mamma carcinoma|mamma carcinoma
5339668|NCT00291798|neoadjuvant|neoadjuvant
5339669|NCT00291798|ABCSG|abcsg
5339670|NCT00291798|17|17
5339671|NCT00291785|colorectal cancer|colorectal cancer
5339672|NCT00291785|camptothecin|camptothecin
5339673|NCT00291772|Type 1 Diabetes|type 1 diabetes
5339674|NCT00291772|hypoglycemia|hypoglycemia
5339675|NCT00291772|hyperglycemia|hyperglycemia
5339676|NCT00291746|GERD|gerd
5339677|NCT00291733|Levetiracetam|levetiracetam
5339678|NCT00291733|Levodopa-induced dyskinesias|levodopa-induced dyskinesias
5339679|NCT00291733|Parkinson's|parkinson's
5339680|NCT00291720|Aldosterone|aldosterone
5339681|NCT00291720|Spironolactone|spironolactone
5339682|NCT00291720|Chronic Kidney Disease|chronic kidney disease
5339683|NCT00291720|Arterial Stiffness|arterial stiffness
5339684|NCT00291707|head|head
5339685|NCT00291707|neck|neck
5339686|NCT00291707|Cetuximab|cetuximab
5339687|NCT00291707|Pemetrexed|pemetrexed
5339688|NCT00291694|breast atypia|breast atypia
5339689|NCT00291694|double-blind randomized clinical trial|double-blind randomized clinical trial
5339690|NCT00291694|RCT|rct
5339691|NCT00291694|celecoxib|celecoxib
5339692|NCT00291694|COX-2 inhibitor|cox-2 inhibitor
5339693|NCT00291694|placebo|placebo
5339694|NCT00291694|high risk for breast cancer|high risk for breast cancer
5339695|NCT00291694|breast epithelial hyperplasia|breast epithelial hyperplasia
5339696|NCT00291694|ki-67|ki-67
5339697|NCT00291694|chemoprevention|chemoprevention
5339698|NCT00291681|Inflammatory Bowel Disease|inflammatory bowel disease
5339699|NCT00291681|B cell selection|b cell selection
5339700|NCT00291668|Crohn's Disease|crohn's disease
5339701|NCT00291668|CDP870, Certolizumab pegol|cdp870, certolizumab pegol
5339702|NCT00291655|NEWLY DIAGNOSED EPILEPSY|newly diagnosed epilepsy
5339703|NCT00291655|LEVETIRACETAM|levetiracetam
5339704|NCT00291655|KEPPRA|keppra
5339705|NCT00291655|N01175 (NCT00175903)|n01175 (nct00175903)
5339706|NCT00291642|Levocetirizine|levocetirizine
5339707|NCT00291642|Xyzal|xyzal
5339708|NCT00291642|Rhinitis|rhinitis
5339709|NCT00291642|Allergic|allergic
5339710|NCT00291642|Seasonal|seasonal
5339711|NCT00291642|Ragweed|ragweed
5339712|NCT00291629|Myocardial infarction|myocardial infarction
5339713|NCT00291629|revascularization|revascularization
5339714|NCT00291629|drug eluting stents|drug eluting stents
5339715|NCT00291616|chronic hepatitis B, pegylated interferon, thymosin alpha|chronic hepatitis b, pegylated interferon, thymosin alpha
5339716|NCT00291603|dialysis|dialysis
5339717|NCT00291603|Renal Dialysis|renal dialysis
5339718|NCT00291603|inflammation|inflammation
5339719|NCT00291603|quality of life|quality of life
5339720|NCT00291603|End Stage Kidney Failure|end stage kidney failure
5339721|NCT00291590|diabetes|diabetes
5339722|NCT00291590|behavioral change|behavioral change
5339723|NCT00291590|chronic care model|chronic care model
5339724|NCT00291590|stage of change|stage of change
5339725|NCT00291590|Medicaid|medicaid
5339726|NCT00291590|Dual eligible|dual eligible
5339727|NCT00291590|ethnic|ethnic
5339728|NCT00291590|self-care|self-care
5339729|NCT00291577|advanced|advanced
5339730|NCT00291577|sunitinib (Sutent)|sunitinib (sutent)
5339731|NCT00291577|docetaxel|docetaxel
5339732|NCT00291577|Phase 1B|phase 1b
5339733|NCT00291564|Observational|observational
5339734|NCT00291564|Heart Failure|heart failure
5339735|NCT00291564|Continuous Cardiac Resynchronization Therapy|continuous cardiac resynchronization therapy
5339736|NCT00291525|valve|valve
5339737|NCT00291525|prosthesis|prosthesis
5339738|NCT00291525|antithrombotics|antithrombotics
5339739|NCT00291525|randomized|randomized
5339740|NCT00291512|HIV|hiv
5339741|NCT00291512|STDs|stds
5339742|NCT00291512|Methamphetamine abuse|methamphetamine abuse
5339743|NCT00291512|MSM|msm
5339744|NCT00291499|symptomatic OA of the hand|symptomatic oa of the hand
5339745|NCT00291460|COPD|copd
5339746|NCT00291460|respiratory failure|respiratory failure
5339747|NCT00291460|inspiratory muscle training|inspiratory muscle training
5339748|NCT00291434|Head and neck cancer|head and neck cancer
5339749|NCT00291434|Fractionation|fractionation
5339750|NCT00291434|Radiotherapy|radiotherapy
5339751|NCT00291434|Conventional fractionation|conventional fractionation
5339752|NCT00291434|Hyperfractionation|hyperfractionation
5339753|NCT00291434|Accelerated fractionation|accelerated fractionation
5339754|NCT00291421|Alzheimer's Disease|alzheimer's disease
5339755|NCT00291421|Dementia|dementia
5339756|NCT00291421|Brain Disease|brain disease
5339757|NCT00291421|Memory Loss|memory loss
5339758|NCT00291421|Caregiver|caregiver
5339759|NCT00291421|Primary Caregiver|primary caregiver
5339760|NCT00291421|Observation|observation
5339761|NCT00291421|galantamine|galantamine
5339762|NCT00291421|donepezil|donepezil
5339763|NCT00291421|rivastigmine|rivastigmine
5339764|NCT00291421|Quality of life|quality of life
5339765|NCT00291382|Total asthma control|total asthma control
5339766|NCT00291382|airway hyper-responsiveness|airway hyper-responsiveness
5339767|NCT00291382|adult|adult
5339768|NCT00291382|Asthma|asthma
5339769|NCT00291369|Metastatic renal cell carcinoma|metastatic renal cell carcinoma
5339770|NCT00291369|Interleukin-2|interleukin-2
5339771|NCT00291369|Interferon alfa|interferon alfa
5339772|NCT00291369|Cytokines|cytokines
5339773|NCT00291369|Survival|survival
5339774|NCT00291356|Diabetes|diabetes
5339775|NCT00291356|sodium dependent glucose transporter|sodium dependent glucose transporter
5339776|NCT00291356|SGLT2|sglt2
5339777|NCT00291356|GSK189075|gsk189075
5339778|NCT00291356|GSK189074|gsk189074
5339779|NCT00291356|SGLT1|sglt1
5339780|NCT00291356|GW869683|gw869683
5339781|NCT00291343|hepatitis B|hepatitis b
5339782|NCT00291343|meningococcal vaccine|meningococcal vaccine
5339783|NCT00291343|pertussis|pertussis
5339784|NCT00291343|Prophylaxis diphtheria|prophylaxis diphtheria
5339785|NCT00291343|meningococcal serogroups A and C diseases|meningococcal serogroups a and c diseases
5339786|NCT00291343|tetanus|tetanus
5339787|NCT00291343|Haemophilus influenzae type b|haemophilus influenzae type b
5339788|NCT00291317|pediatric spinal cord injury|pediatric spinal cord injury
5339789|NCT00291317|FES cycling|fes cycling
5339790|NCT00291317|bone mineral density|bone mineral density
5339791|NCT00291317|quality of life|quality of life
5339792|NCT00291304|Magnetic Resonance Imaging|magnetic resonance imaging
5339793|NCT00291304|Pathology|pathology
5339794|NCT00291278|Endometriosis|endometriosis
5339795|NCT00291278|Bone Mineral Density|bone mineral density
5339796|NCT00291278|Osteopenia|osteopenia
5339797|NCT00291278|Osteoporosis|osteoporosis
5339798|NCT00291278|DEXA Scan|dexa scan
5339799|NCT00291278|Menopause|menopause
5339800|NCT00291278|Screening|screening
5339801|NCT00291278|Healthy Volunteer|healthy volunteer
5339802|NCT00291278|HV|hv
5339803|NCT00291265|Bradykinesia|bradykinesia
5339804|NCT00291265|Tremor|tremor
5339805|NCT00291265|Speech|speech
5339806|NCT00291265|Rigidity|rigidity
5339807|NCT00291265|Neurodegeneration|neurodegeneration
5339808|NCT00291265|Parkinson Disease|parkinson disease
5339809|NCT00291265|PD|pd
5339810|NCT00291226|schizophrenia prodrome|schizophrenia prodrome
5339811|NCT00291200|Psychosis|psychosis
5339812|NCT00291200|Basic Symptoms|basic symptoms
5339813|NCT00291174|Ventricular Arrhythmia|ventricular arrhythmia
5339814|NCT00291174|Myocardial Infarction|myocardial infarction
5339815|NCT00291174|Ventricular Dysfunction|ventricular dysfunction
5339816|NCT00291174|Coronary Artery Disease|coronary artery disease
5339817|NCT00291174|Structural Heart Disease|structural heart disease
5339818|NCT00291174|Arrhythmia|arrhythmia
5339819|NCT00291174|Cardiomyopathies|cardiomyopathies
5339820|NCT00291161|Delivery of Health Care, Integrated|delivery of health care, integrated
5339821|NCT00291161|United States Department of Veterans Affairs|united states department of veterans affairs
5339822|NCT00291161|Dementia|dementia
5339823|NCT00291161|Patient Care Management|patient care management
5339824|NCT00291148|Neuropathic pain|neuropathic pain
5339825|NCT00291148|Multiple Sclerosis|multiple sclerosis
5339826|NCT00291148|pregabalin|pregabalin
5339827|NCT00291148|paroxetine|paroxetine
5339828|NCT00291135|breast atypia|breast atypia
5339829|NCT00291135|open label pilot study|open label pilot study
5339830|NCT00291135|letrozole|letrozole
5339831|NCT00291135|fine needle aspiration|fine needle aspiration
5339832|NCT00291135|high risk for breast cancer|high risk for breast cancer
5339833|NCT00291135|breast epithelial hyperplasia|breast epithelial hyperplasia
5339834|NCT00291135|Ki-67|ki-67
5339835|NCT00291135|hormones plus chemoprevention|hormones plus chemoprevention
5339836|NCT00291135|chemoprevention|chemoprevention
5339837|NCT00291122|breast atypia|breast atypia
5339838|NCT00291122|breast epithelial hyperplasia|breast epithelial hyperplasia
5339839|NCT00291122|ki-67|ki-67
5339840|NCT00291122|RTPCR|rtpcr
5339841|NCT00291122|microdissection|microdissection
5339842|NCT00291109|breast atypia|breast atypia
5339843|NCT00291109|breast epithelial hyperplasia|breast epithelial hyperplasia
5339844|NCT00291109|Ki-67|ki-67
5339845|NCT00291109|RTPCR|rtpcr
5339846|NCT00291109|microdissection|microdissection
5339847|NCT00291096|breast atypia|breast atypia
5339848|NCT00291096|fine needle aspiration|fine needle aspiration
5339849|NCT00291096|high risk for breast cancer|high risk for breast cancer
5339850|NCT00291096|breast epithelial hyperplasia|breast epithelial hyperplasia
5339851|NCT00291083|NAF|naf
5339852|NCT00291083|nipple aspirate fluid|nipple aspirate fluid
5339853|NCT00291083|breast atypia|breast atypia
5339854|NCT00291083|high risk for breast cancer|high risk for breast cancer
5339855|NCT00291083|breast epithelial hyperplasia|breast epithelial hyperplasia
5339856|NCT00291083|Ki-67|ki-67
5339857|NCT00291083|hormones plus chemoprevention|hormones plus chemoprevention
5339858|NCT00291083|chemoprevention|chemoprevention
5339859|NCT00291070|ADHD|adhd
5339860|NCT00291070|attention|attention
5339861|NCT00291070|insomnia|insomnia
5339862|NCT00291070|hyperactivity|hyperactivity
5339863|NCT00291070|anxiety|anxiety
5339864|NCT00291057|Pediculosis|pediculosis
5339865|NCT00291057|Head Lice|head lice
5339866|NCT00291044|pregnancy, genital herpes|pregnancy, genital herpes
5339867|NCT00291031|nightmare|nightmare
5339868|NCT00291031|sleep disorder|sleep disorder
5339869|NCT00291031|sleep|sleep
5339870|NCT00291031|imagery rehearsal|imagery rehearsal
5340211|NCT00290511|Zevalin|zevalin
5339871|NCT00291031|anxiety disorders|anxiety disorders
5339872|NCT00291031|mood disorders|mood disorders
5339873|NCT00291031|personality disorders|personality disorders
5339874|NCT00291018|ProDisc|prodisc
5339875|NCT00291018|ProDisc-C|prodisc-c
5339876|NCT00291018|Spinal Fusion|spinal fusion
5339877|NCT00291018|Anterior cervical diskectomy|anterior cervical diskectomy
5339878|NCT00291018|Cervical spine|cervical spine
5339879|NCT00291018|Disc disease|disc disease
5339880|NCT00291018|Implant|implant
5339881|NCT00291018|Degenerative disc disease|degenerative disc disease
5339882|NCT00291018|Intervertebral disc|intervertebral disc
5339883|NCT00291005|Prostate cancer|prostate cancer
5339884|NCT00291005|HRPC|hrpc
5339885|NCT00291005|AIPC|aipc
5339886|NCT00291005|Hormone refractory|hormone refractory
5339887|NCT00291005|Androgen independent|androgen independent
5339888|NCT00291005|Docetaxel|docetaxel
5339889|NCT00291005|Taxotere|taxotere
5339890|NCT00291005|prednisolone|prednisolone
5339891|NCT00290992|urate oxidase, hyperuricemia, lymphoma, leukemia|urate oxidase, hyperuricemia, lymphoma, leukemia
5339892|NCT00290979|HMR1964, insulin glulisine, Diabetes Mellitus, Type 1|hmr1964, insulin glulisine, diabetes mellitus, type 1
5339893|NCT00290966|docetaxel|docetaxel
5339894|NCT00290966|stomach neoplasm|stomach neoplasm
5339895|NCT00290953|Metastases|metastases
5339896|NCT00290940|Diabetes mellitus, Type 2|diabetes mellitus, type 2
5339897|NCT00290940|High blood sugar|high blood sugar
5339898|NCT00290940|Hyperglycemia|hyperglycemia
5339899|NCT00290940|Antihyperglycemic agents|antihyperglycemic agents
5339900|NCT00290940|CS-917|cs-917
5339901|NCT00290927|HMR1964, insulin glulisine, Diabetes Mellitus, Type 2|hmr1964, insulin glulisine, diabetes mellitus, type 2
5339902|NCT00290888|Rotator Cuff Tear|rotator cuff tear
5339903|NCT00290888|Tendon Repair|tendon repair
5339904|NCT00290888|Acromioplasty|acromioplasty
5339905|NCT00290888|Arthroscopy|arthroscopy
5339906|NCT00290888|Orthopedic Surgery|orthopedic surgery
5339907|NCT00290875|cspine injury|cspine injury
5339908|NCT00290875|radiography|radiography
5339909|NCT00290875|clinical impact|clinical impact
5339910|NCT00290875|dissemination|dissemination
5339911|NCT00290862|Osteoporosis|osteoporosis
5339912|NCT00290862|Spine fracture|spine fracture
5339913|NCT00290862|Back Pain|back pain
5339914|NCT00290862|Vertebroplasty|vertebroplasty
5339915|NCT00290862|Vertebral compression fractures related to osteoporosis|vertebral compression fractures related to osteoporosis
5339916|NCT00290823|Taenia|taenia
5339917|NCT00290823|Seizures|seizures
5339918|NCT00290823|Tapeworm|tapeworm
5339919|NCT00290823|Parasite|parasite
5339920|NCT00290771|imatinib mesylate|imatinib mesylate
5339921|NCT00290771|hydroxyurea|hydroxyurea
5339922|NCT00290771|protein tyrosine kinases|protein tyrosine kinases
5339923|NCT00290771|glioma|glioma
5339924|NCT00290771|glioblastoma multiforme|glioblastoma multiforme
5339925|NCT00290771|recurrent glioblastoma multiforme|recurrent glioblastoma multiforme
5339926|NCT00290771|GBM|gbm
5339927|NCT00290771|MacDonald criteria|macdonald criteria
5339928|NCT00290745|breast cancer in situ|breast cancer in situ
5339929|NCT00290745|ductal breast carcinoma in situ|ductal breast carcinoma in situ
5339930|NCT00290732|stage I breast cancer|stage i breast cancer
5339931|NCT00290732|stage II breast cancer|stage ii breast cancer
5339932|NCT00290732|stage IIIA breast cancer|stage iiia breast cancer
5339933|NCT00290732|stage IIIC breast cancer|stage iiic breast cancer
5339934|NCT00290732|stage IV breast cancer|stage iv breast cancer
5339935|NCT00290732|breast cancer in situ|breast cancer in situ
5339936|NCT00290732|ductal breast carcinoma in situ|ductal breast carcinoma in situ
5339937|NCT00290719|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
5339938|NCT00290719|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
5339939|NCT00290719|stage II esophageal cancer|stage ii esophageal cancer
5339940|NCT00290719|stage III esophageal cancer|stage iii esophageal cancer
5339941|NCT00290706|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5339942|NCT00290706|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5339943|NCT00290706|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5339944|NCT00290706|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5339945|NCT00290706|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5339946|NCT00290706|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5339947|NCT00290706|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5339948|NCT00290693|recurrent pancreatic cancer|recurrent pancreatic cancer
5339949|NCT00290693|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
5339950|NCT00290693|stage IV pancreatic cancer|stage iv pancreatic cancer
5339951|NCT00290680|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5339952|NCT00290667|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
5339953|NCT00290667|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5339954|NCT00290667|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
5339955|NCT00290667|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5339956|NCT00290667|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5339957|NCT00290667|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
5339958|NCT00290667|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
5339959|NCT00290667|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
5339960|NCT00290667|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5339961|NCT00290667|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5339962|NCT00290667|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
5339963|NCT00290667|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
5339964|NCT00290667|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
5339965|NCT00290667|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5339966|NCT00290667|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5339967|NCT00290667|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
5339968|NCT00290667|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
5339969|NCT00290667|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
5339970|NCT00290667|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5339971|NCT00290667|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5339972|NCT00290667|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
5339973|NCT00290667|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
5339974|NCT00290667|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
5339975|NCT00290667|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5339976|NCT00290667|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5339977|NCT00290667|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
5339978|NCT00290667|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
5339979|NCT00290667|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
5339980|NCT00290667|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5339981|NCT00290667|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5339982|NCT00290667|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5339983|NCT00290667|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
5339984|NCT00290667|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
5339985|NCT00290667|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
5339986|NCT00290667|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5339987|NCT00290667|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5339988|NCT00290667|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5339989|NCT00290667|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5339990|NCT00290667|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5339991|NCT00290667|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5339992|NCT00290654|ductal breast carcinoma in situ|ductal breast carcinoma in situ
5339993|NCT00290654|breast cancer in situ|breast cancer in situ
5339994|NCT00290641|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5339995|NCT00290641|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5339996|NCT00290641|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5339997|NCT00290641|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5339998|NCT00290641|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5339999|NCT00290641|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5340000|NCT00290641|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
5340001|NCT00290641|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5340002|NCT00290641|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5340003|NCT00290641|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
5340004|NCT00290641|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5340005|NCT00290641|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5340006|NCT00290641|refractory anemia with excess blasts|refractory anemia with excess blasts
5340007|NCT00290641|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5340008|NCT00290641|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5340009|NCT00290641|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5340010|NCT00290641|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
5340011|NCT00290641|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5340012|NCT00290641|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5340013|NCT00290641|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5340014|NCT00290641|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5340015|NCT00290641|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5340016|NCT00290641|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5340017|NCT00290641|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5340018|NCT00290641|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
5340019|NCT00290641|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5340020|NCT00290641|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5340021|NCT00290641|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5340022|NCT00290641|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
5340023|NCT00290641|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5340024|NCT00290641|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5340025|NCT00290641|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5340026|NCT00290641|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
5340027|NCT00290641|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
5340028|NCT00290641|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5340029|NCT00290641|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5340030|NCT00290641|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5340031|NCT00290641|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5340032|NCT00290641|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5340033|NCT00290641|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5340034|NCT00290641|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5340035|NCT00290641|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5340036|NCT00290641|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5340037|NCT00290641|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5340038|NCT00290641|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
5340039|NCT00290641|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
5340040|NCT00290641|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
5340041|NCT00290641|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5340042|NCT00290641|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
5340043|NCT00290641|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
5340044|NCT00290641|refractory cytopenia with multilineage dysplasia|refractory cytopenia with multilineage dysplasia
5340045|NCT00290641|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5340046|NCT00290641|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5340047|NCT00290641|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
5340048|NCT00290641|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5340049|NCT00290641|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5340050|NCT00290641|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5340051|NCT00290641|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5340052|NCT00290641|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
5340053|NCT00290641|chronic eosinophilic leukemia|chronic eosinophilic leukemia
5340054|NCT00290641|chronic neutrophilic leukemia|chronic neutrophilic leukemia
5340055|NCT00290641|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
5340056|NCT00290641|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
5340057|NCT00290641|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
5340058|NCT00290641|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
5340059|NCT00290641|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
5340060|NCT00290641|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
5340061|NCT00290641|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
5340062|NCT00290641|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
5340063|NCT00290641|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
5340064|NCT00290641|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
5340065|NCT00290641|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
5340066|NCT00290641|stage I childhood lymphoblastic lymphoma|stage i childhood lymphoblastic lymphoma
5340067|NCT00290641|stage II childhood lymphoblastic lymphoma|stage ii childhood lymphoblastic lymphoma
5340068|NCT00290641|stage I childhood small noncleaved cell lymphoma|stage i childhood small noncleaved cell lymphoma
5340069|NCT00290641|stage II childhood small noncleaved cell lymphoma|stage ii childhood small noncleaved cell lymphoma
5340070|NCT00290641|stage III childhood small noncleaved cell lymphoma|stage iii childhood small noncleaved cell lymphoma
5340071|NCT00290641|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
5340072|NCT00290641|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
5340073|NCT00290641|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
5340074|NCT00290641|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
5340075|NCT00290641|stage I mantle cell lymphoma|stage i mantle cell lymphoma
5340880|NCT00287768|docetaxel|docetaxel
5340076|NCT00290641|stage I childhood large cell lymphoma|stage i childhood large cell lymphoma
5340077|NCT00290641|stage II childhood large cell lymphoma|stage ii childhood large cell lymphoma
5340078|NCT00290641|stage III childhood large cell lymphoma|stage iii childhood large cell lymphoma
5340079|NCT00290641|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
5340080|NCT00290641|stage III childhood lymphoblastic lymphoma|stage iii childhood lymphoblastic lymphoma
5340081|NCT00290641|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
5340082|NCT00290641|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5340083|NCT00290641|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
5340084|NCT00290628|graft versus host disease|graft versus host disease
5340085|NCT00290628|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5340086|NCT00290628|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5340087|NCT00290628|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5340088|NCT00290628|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5340089|NCT00290628|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5340090|NCT00290628|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5340091|NCT00290628|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5340092|NCT00290628|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5340093|NCT00290628|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
5340094|NCT00290628|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5340095|NCT00290628|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
5340096|NCT00290628|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
5340097|NCT00290628|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
5340098|NCT00290628|chronic eosinophilic leukemia|chronic eosinophilic leukemia
5340099|NCT00290628|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
5340100|NCT00290628|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5340101|NCT00290628|chronic neutrophilic leukemia|chronic neutrophilic leukemia
5340102|NCT00290628|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5340103|NCT00290628|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5340104|NCT00290628|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5340105|NCT00290628|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
5340106|NCT00290628|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
5340107|NCT00290628|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5340108|NCT00290628|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
5340109|NCT00290628|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5340110|NCT00290628|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
5340111|NCT00290628|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
5340112|NCT00290628|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
5340113|NCT00290628|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
5340114|NCT00290628|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5340115|NCT00290628|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5340116|NCT00290628|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5340117|NCT00290628|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5340118|NCT00290628|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
5340119|NCT00290628|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
5340120|NCT00290628|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5340121|NCT00290628|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5340122|NCT00290628|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5340123|NCT00290628|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5340124|NCT00290628|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5340125|NCT00290628|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5340126|NCT00290628|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5340127|NCT00290628|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5340128|NCT00290628|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5340129|NCT00290628|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5340130|NCT00290628|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
5340131|NCT00290628|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5340132|NCT00290628|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5340133|NCT00290628|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
5340134|NCT00290628|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
5340210|NCT00290511|Follicular Lymphoma|follicular lymphoma
5340135|NCT00290628|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
5340136|NCT00290628|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5340137|NCT00290628|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5340138|NCT00290628|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5340139|NCT00290628|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5340140|NCT00290628|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5340141|NCT00290628|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5340142|NCT00290628|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5340143|NCT00290628|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5340144|NCT00290628|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5340145|NCT00290628|refractory hairy cell leukemia|refractory hairy cell leukemia
5340146|NCT00290628|refractory multiple myeloma|refractory multiple myeloma
5340147|NCT00290628|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5340148|NCT00290628|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5340149|NCT00290628|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5340150|NCT00290628|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5340151|NCT00290628|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5340152|NCT00290628|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5340153|NCT00290628|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5340154|NCT00290628|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5340155|NCT00290628|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5340156|NCT00290628|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5340157|NCT00290628|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5340158|NCT00290628|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5340159|NCT00290628|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5340160|NCT00290628|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5340161|NCT00290628|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5340162|NCT00290628|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5340163|NCT00290628|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5340164|NCT00290628|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5340165|NCT00290628|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5340166|NCT00290628|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5340167|NCT00290628|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5340168|NCT00290628|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5340169|NCT00290628|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5340170|NCT00290628|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5340171|NCT00290628|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5340172|NCT00290628|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5340173|NCT00290628|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5340174|NCT00290628|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5340175|NCT00290628|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5340176|NCT00290628|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5340177|NCT00290628|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5340178|NCT00290628|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5340179|NCT00290628|Diamond-Blackfan anemia|diamond-blackfan anemia
5340180|NCT00290628|Fanconi anemia|fanconi anemia
5340181|NCT00290628|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
5340182|NCT00290615|adenocarcinoma of the colon|adenocarcinoma of the colon
5340183|NCT00290615|recurrent colon cancer|recurrent colon cancer
5340184|NCT00290615|stage IV colon cancer|stage iv colon cancer
5340185|NCT00290615|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5340186|NCT00290615|recurrent rectal cancer|recurrent rectal cancer
5340187|NCT00290615|stage IV rectal cancer|stage iv rectal cancer
5340188|NCT00290602|Acute respiratory distress syndrome|acute respiratory distress syndrome
5340189|NCT00290602|corticosteroids|corticosteroids
5340190|NCT00290602|postoperative complications|postoperative complications
5340191|NCT00290602|cytokines|cytokines
5340192|NCT00290589|low back pain|low back pain
5340193|NCT00290589|emergency department|emergency department
5340194|NCT00290589|corticosteroids|corticosteroids
5340195|NCT00290576|Digestive and Nutritional Effects|digestive and nutritional effects
5340196|NCT00290576|Safety and Growth|safety and growth
5340197|NCT00290576|Feeding Tolerance|feeding tolerance
5340198|NCT00290550|Advanced Non-Small Cell Lung Cancer|advanced non-small cell lung cancer
5340199|NCT00290550|NSCLC|nsclc
5340200|NCT00290537|Non-Small Cell Lung Cancer|non-small cell lung cancer
5340201|NCT00290537|Lung Cancer|lung cancer
5340202|NCT00290537|Carboplatin|carboplatin
5340203|NCT00290537|Paclitaxel|paclitaxel
5340204|NCT00290537|ZD6474|zd6474
5340205|NCT00290537|NSCLC|nsclc
5340206|NCT00290524|Oral alimentation following colorectal surgery|oral alimentation following colorectal surgery
5340207|NCT00290524|anastomosis|anastomosis
5340208|NCT00290524|laparoscopy|laparoscopy
5340209|NCT00290524|hospitalization stay|hospitalization stay
5340212|NCT00290511|Ibritumomab Tiuxetan|ibritumomab tiuxetan
5340213|NCT00290511|IDEC-Y2B8|idec-y2b8
5340214|NCT00290511|Fludarabine|fludarabine
5340215|NCT00290511|Fludara|fludara
5340216|NCT00290511|Dexamethasone|dexamethasone
5340217|NCT00290511|Mitoxantrone|mitoxantrone
5340218|NCT00290511|Rituximab|rituximab
5340219|NCT00290511|Rituxan|rituxan
5340220|NCT00290511|R-FND|r-fnd
5340221|NCT00290511|Fludarabine Phosphate|fludarabine phosphate
5340222|NCT00290511|Decadron|decadron
5340223|NCT00290498|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
5340224|NCT00290498|B-Cell Non-Hodgkin's Lymphoma|b-cell non-hodgkin's lymphoma
5340225|NCT00290498|Lymphoma|lymphoma
5340226|NCT00290498|Cyclophosphamide|cyclophosphamide
5340227|NCT00290498|Cytarabine|cytarabine
5340228|NCT00290498|Doxorubicin|doxorubicin
5340229|NCT00290498|Hyper-CVAD|hyper-cvad
5340230|NCT00290498|Methotrexate|methotrexate
5340231|NCT00290498|Prednisone|prednisone
5340232|NCT00290498|Rituximab|rituximab
5340233|NCT00290498|Vincristine|vincristine
5340234|NCT00290498|R-CHOP|r-chop
5340235|NCT00290498|R-HCVAD|r-hcvad
5340236|NCT00290498|Dexamethasone|dexamethasone
5340237|NCT00290498|Decadron|decadron
5340238|NCT00290498|Leucovorin|leucovorin
5340239|NCT00290498|Ara-C|ara-c
5340240|NCT00290498|Cytosar|cytosar
5340241|NCT00290498|Cytoxan|cytoxan
5340242|NCT00290498|DepoCyt|depocyt
5340243|NCT00290498|Cytosine arabinosine hydrochloride|cytosine arabinosine hydrochloride
5340245|NCT00290498|Hydroxydaunomycin hydrochloride|hydroxydaunomycin hydrochloride
5340246|NCT00290498|Neosar|neosar
5340247|NCT00290485|non-resectable tumor|non-resectable tumor
5340248|NCT00290485|high-risk tumor|high-risk tumor
5340249|NCT00290485|metastasis|metastasis
5340250|NCT00290485|Response Evaluation Criteria in Solid Tumors (RECIST)|response evaluation criteria in solid tumors (recist)
5340251|NCT00290485|Gleevec|gleevec
5340252|NCT00290485|Imatinib mesylate|imatinib mesylate
5340253|NCT00290459|Gynecologic Disease|gynecologic disease
5340254|NCT00290459|Gynecologic Cancer|gynecologic cancer
5340255|NCT00290459|Prognostic Markers|prognostic markers
5340256|NCT00290433|Lymphoma|lymphoma
5340257|NCT00290433|Peripheral T Cell|peripheral t cell
5340258|NCT00290433|HCVIDDOXIL Regimen|hcviddoxil regimen
5340259|NCT00290433|ARA-C|ara-c
5340260|NCT00290433|Cytosar|cytosar
5340261|NCT00290433|DepoCyt|depocyt
5340262|NCT00290433|Cytosine arabinosine hydrochloride|cytosine arabinosine hydrochloride
5340263|NCT00290433|Pegylated Liposomal Doxorubicin|pegylated liposomal doxorubicin
5340264|NCT00290433|Doxorubicin hydrochloride|doxorubicin hydrochloride
5340265|NCT00290433|Doxil|doxil
5340266|NCT00290433|Cyclophosphamide|cyclophosphamide
5340267|NCT00290433|Cytoxan|cytoxan
5340268|NCT00290433|Neosar|neosar
5340269|NCT00290433|Dexamethasone|dexamethasone
5340270|NCT00290433|Decadron|decadron
5340271|NCT00290433|Mesna|mesna
5340272|NCT00290433|Methotrexate|methotrexate
5340273|NCT00290433|Vincristine|vincristine
5340274|NCT00290433|G-CSF|g-csf
5340275|NCT00290433|Filgrastim|filgrastim
5340276|NCT00290433|Neupogen|neupogen
5340277|NCT00290420|malaria|malaria
5340278|NCT00290420|Plasmodium vivax|plasmodium vivax
5340279|NCT00290420|pregnancy|pregnancy
5340280|NCT00290420|chemoprophylaxis|chemoprophylaxis
5340281|NCT00290407|chronic lymphocytic leukemia|chronic lymphocytic leukemia
5340282|NCT00290407|small lymphocytic lymphoma|small lymphocytic lymphoma
5340283|NCT00290407|rituximab|rituximab
5340284|NCT00290407|beta-glucan|beta-glucan
5340285|NCT00290394|Blood Pressure,|blood pressure,
5340286|NCT00290394|rosiglitazone,Diabetes Mellitus, Type 2,|rosiglitazone,diabetes mellitus, type 2,
5340287|NCT00290381|Allergic rhinitis|allergic rhinitis
5340288|NCT00290368|Nasal allergen challenge|nasal allergen challenge
5340289|NCT00290368|Allergic rhinitis|allergic rhinitis
5340290|NCT00290368|Timothy grass pollen|timothy grass pollen
5340291|NCT00290368|inflammatory mediators|inflammatory mediators
5340292|NCT00290329|Safety|safety
5340293|NCT00290329|Meningococcal disease|meningococcal disease
5340294|NCT00290329|Meningitidis serogroups A, C,W & Y diseases|meningitidis serogroups a, c,w & y diseases
5340295|NCT00290329|Meningococcal vaccine|meningococcal vaccine
5340296|NCT00290316|Hepatocellular carcinoma|hepatocellular carcinoma
5340297|NCT00290316|Cholangiocarcinoma|cholangiocarcinoma
5340298|NCT00290316|Metastasis|metastasis
5340299|NCT00290316|Liver neoplasm|liver neoplasm
5340300|NCT00290290|Prevention|prevention
5340301|NCT00290290|Antiseptic Preoperative Scrub|antiseptic preoperative scrub
5340302|NCT00290290|Postoperative Wound Infection|postoperative wound infection
5340303|NCT00290251|Endometrium|endometrium
5340304|NCT00290251|Progesterone|progesterone
5340305|NCT00290251|Estrogen|estrogen
5340306|NCT00290251|Fibroid|fibroid
5340307|NCT00290251|Hysterectomy|hysterectomy
5340308|NCT00290251|Leiomyoma|leiomyoma
5340309|NCT00290251|Uterine Fibroids|uterine fibroids
5340310|NCT00290251|Fibroids|fibroids
5340311|NCT00290238|Chronic Low Back Pain|chronic low back pain
5340312|NCT00290238|Lower Extremity Pain|lower extremity pain
5340313|NCT00290238|Central Sensitization|central sensitization
5340314|NCT00290238|Percutaneous Neuromodulation Therapy|percutaneous neuromodulation therapy
5341283|NCT00286078|Headache|headache
5340315|NCT00290225|Posttraumatic stress disorder|posttraumatic stress disorder
5340316|NCT00290225|depression|depression
5340317|NCT00290225|disaster mental health|disaster mental health
5340318|NCT00290225|yoga|yoga
5340319|NCT00290225|Breathwork|breathwork
5340320|NCT00290225|exposure treatments|exposure treatments
5340321|NCT00290212|Women|women
5340322|NCT00290212|Bone density|bone density
5340323|NCT00290212|Menopause|menopause
5340324|NCT00290212|Dietary Supplements|dietary supplements
5340325|NCT00290212|Vitamin K2|vitamin k2
5340326|NCT00290199|Fetal Membranes, Premature Rupture|fetal membranes, premature rupture
5340327|NCT00290199|Labor, Induced|labor, induced
5340328|NCT00290199|Foley Catheter|foley catheter
5340329|NCT00290186|Cerebral Palsy|cerebral palsy
5340330|NCT00290186|Spastic Cerebral Palsy|spastic cerebral palsy
5340331|NCT00290186|CP|cp
5340332|NCT00290186|Hyperbaric|hyperbaric
5340333|NCT00290186|HBOT|hbot
5340334|NCT00290173|pre term labor|pre term labor
5340335|NCT00290173|therapy|therapy
5340336|NCT00290173|maintenance|maintenance
5340337|NCT00290160|Hyperkalemia|hyperkalemia
5340338|NCT00290160|Protein|protein
5340339|NCT00290160|Hyperglycemia|hyperglycemia
5340340|NCT00290160|ELBW|elbw
5340341|NCT00290147|Dengue|dengue
5340342|NCT00290147|DNA vaccine|dna vaccine
5340343|NCT00290134|Hypogonadism|hypogonadism
5340344|NCT00290134|Testosterone|testosterone
5340345|NCT00290121|Schizophrenia|schizophrenia
5340346|NCT00290121|Atypical antipsychotics|atypical antipsychotics
5340347|NCT00290121|Weight gain|weight gain
5340348|NCT00290121|Appetite|appetite
5340349|NCT00290121|fMRI|fmri
5340350|NCT00290108|BIS|bis
5340351|NCT00290108|Propofol|propofol
5340352|NCT00290108|hemodynamic|hemodynamic
5340353|NCT00290108|pharmacokinetic|pharmacokinetic
5340354|NCT00290095|Multiple Myeloma|multiple myeloma
5340355|NCT00290095|Quality of Life|quality of life
5340356|NCT00290095|Response Shift|response shift
5340357|NCT00290095|Clinically Important Difference|clinically important difference
5340358|NCT00290082|sedation|sedation
5340359|NCT00290082|midazolam|midazolam
5340360|NCT00290082|loxapine|loxapine
5340361|NCT00290082|agitation|agitation
5340362|NCT00290082|emergency department|emergency department
5340363|NCT00290082|toxicological analysis|toxicological analysis
5340364|NCT00290069|Renal function|renal function
5340365|NCT00290069|Serum creatinine|serum creatinine
5340366|NCT00290069|Immunosuppression|immunosuppression
5340367|NCT00290069|Rejection|rejection
5340368|NCT00290056|CHD|chd
5340369|NCT00290056|Arrhythmia|arrhythmia
5340370|NCT00290056|ICD|icd
5340371|NCT00290056|Omega-3 PUFA|omega-3 pufa
5340372|NCT00290056|Nutrition|nutrition
5340373|NCT00290043|Insulin glulisine|insulin glulisine
5340374|NCT00290043|Diabetes mellitus Type 1|diabetes mellitus type 1
5340375|NCT00290043|Postprandial Period|postprandial period
5340376|NCT00290043|Pharmacokinetics|pharmacokinetics
5340377|NCT00290043|Glucodynamics|glucodynamics
5340378|NCT00290030|acute urinary retention|acute urinary retention
5340379|NCT00290030|International Prostate Symptom Score (IPSS)|international prostate symptom score (ipss)
5340380|NCT00290004|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
5340381|NCT00290004|Small Lymphocytic Lymphoma|small lymphocytic lymphoma
5340382|NCT00290004|Leukemia|leukemia
5340383|NCT00290004|Lymphoma|lymphoma
5340384|NCT00290004|Motexafin Gadolinium|motexafin gadolinium
5340385|NCT00290004|Relapsed Chronic Lymphocytic Leukemia|relapsed chronic lymphocytic leukemia
5340386|NCT00290004|Relapsed Small Lymphocytic Lymphoma|relapsed small lymphocytic lymphoma
5340387|NCT00290004|Refractory Chronic Lymphocytic Leukemia|refractory chronic lymphocytic leukemia
5340388|NCT00290004|Refractory Small Lymphocytic Lymphoma|refractory small lymphocytic lymphoma
5340389|NCT00289978|Multiple Sclerosis|multiple sclerosis
5340390|NCT00289978|FTY720|fty720
5340391|NCT00289978|Fingolimod|fingolimod
5340392|NCT00289965|Alcohol Abuse|alcohol abuse
5340393|NCT00289965|Alcohol Drinking|alcohol drinking
5340394|NCT00289965|Intervention Studies|intervention studies
5340395|NCT00289965|Computer-Assisted Instruction|computer-assisted instruction
5340396|NCT00289965|College Students|college students
5340397|NCT00289952|HIV infections|hiv infections
5340398|NCT00289952|Histone deacetylase Inhibitor|histone deacetylase inhibitor
5340399|NCT00289952|HIV Reservoirs|hiv reservoirs
5340400|NCT00289952|Peripheral Blood Mononuclear Cells|peripheral blood mononuclear cells
5340401|NCT00289952|Valproic Acid|valproic acid
5340402|NCT00289952|Treatment Experienced|treatment experienced
5340403|NCT00289939|women|women
5340404|NCT00289939|women's health|women's health
5340405|NCT00289939|HIV|hiv
5340406|NCT00289939|risk factors|risk factors
5340407|NCT00289939|risk behaviors|risk behaviors
5340408|NCT00289939|prevention|prevention
5340409|NCT00289939|motivational interviewing|motivational interviewing
5340410|NCT00289939|domestic violence|domestic violence
5340411|NCT00289939|partner violence|partner violence
5340412|NCT00289939|behavioral trial|behavioral trial
5340413|NCT00289939|community justice|community justice
5340414|NCT00289939|criminal justice|criminal justice
5340415|NCT00289926|low libido|low libido
5340416|NCT00289926|lack of wellbeing|lack of wellbeing
5340417|NCT00289913|Hepatitis A virus|hepatitis a virus
5340418|NCT00289861|Schizophrenia|schizophrenia
5340419|NCT00289861|risperidone|risperidone
5340420|NCT00289861|prolactin|prolactin
5340421|NCT00289861|clozapine|clozapine
5340422|NCT00289835|Coronary Artery Bypass Grafting|coronary artery bypass grafting
5340423|NCT00289835|Drug Eluting Stent|drug eluting stent
5340424|NCT00289835|Saphenous Vein Graft|saphenous vein graft
5340425|NCT00289822|chronic heart failure|chronic heart failure
5340426|NCT00289822|myocardial infarction|myocardial infarction
5340427|NCT00289783|Primary and booster vaccination|primary and booster vaccination
5340428|NCT00289783|Neisseria meningitidis|neisseria meningitidis
5340429|NCT00289783|Hib disease|hib disease
5340430|NCT00289783|Meningococcal vaccine|meningococcal vaccine
5340431|NCT00289783|Meningococcal disease|meningococcal disease
5340432|NCT00289783|Children|children
5340433|NCT00289783|Immunogenicity|immunogenicity
5340434|NCT00289783|Safety|safety
5340435|NCT00289783|Infants|infants
5340436|NCT00289770|TWINRIX™ ADULT|twinrix™ adult
5340437|NCT00289770|Hepatitis A|hepatitis a
5340438|NCT00289770|Hepatitis B|hepatitis b
5340439|NCT00289757|Havrix™|havrix™
5340440|NCT00289757|Hepatitis A|hepatitis a
5340441|NCT00289744|Hepatitis A|hepatitis a
5340442|NCT00289744|Hepatitis B|hepatitis b
5340443|NCT00289744|TWINRIX™ ADULT|twinrix™ adult
5340444|NCT00289731|Combined hepatitis A and hepatitis B vaccine|combined hepatitis a and hepatitis b vaccine
5340445|NCT00289731|Hepatitis B|hepatitis b
5340446|NCT00289731|Hepatitis A|hepatitis a
5340447|NCT00289731|Monovalent hepatitis A and hepatitis B vaccines|monovalent hepatitis a and hepatitis b vaccines
5340448|NCT00289718|Combined Hepatitis A and B vaccine|combined hepatitis a and b vaccine
5340449|NCT00289718|Hepatitis A|hepatitis a
5340450|NCT00289718|Hepatitis B|hepatitis b
5340451|NCT00289705|Obesity|obesity
5340452|NCT00289705|Surgery|surgery
5340453|NCT00289705|Adolescent|adolescent
5340454|NCT00289705|Roux-en-Y gastric bypass|roux-en-y gastric bypass
5340455|NCT00289705|Laparoscopic|laparoscopic
5340456|NCT00289666|Sleep Disorder|sleep disorder
5340457|NCT00289666|CPAP|cpap
5340458|NCT00289653|nicotine dependence,|nicotine dependence,
5340459|NCT00289653|transdermal nicotine patch,|transdermal nicotine patch,
5340460|NCT00289653|smoking while receiving nicotine replacement,|smoking while receiving nicotine replacement,
5340461|NCT00289653|comorbidities|comorbidities
5340462|NCT00289640|Stage III (unresectable)|stage iii (unresectable)
5340463|NCT00289640|Stage IV melanoma|stage iv melanoma
5340464|NCT00289627|Previously treated melanoma|previously treated melanoma
5340465|NCT00289627|Unresectable Stage III|unresectable stage iii
5340466|NCT00289627|Stage IV|stage iv
5340467|NCT00289614|contrast induced nephropathy|contrast induced nephropathy
5340468|NCT00289601|aspirin|aspirin
5340469|NCT00289601|clopidogrel|clopidogrel
5340470|NCT00289601|resistance|resistance
5340471|NCT00289601|angioplasty|angioplasty
5340472|NCT00289601|percutaneous coronary intervention|percutaneous coronary intervention
5340473|NCT00289601|myocardial infarction|myocardial infarction
5340474|NCT00289588|Methicillin-resistant Staphylococcus aureus|methicillin-resistant staphylococcus aureus
5340475|NCT00289588|Staphylococcus aureus|staphylococcus aureus
5340476|NCT00289588|MRSA|mrsa
5340477|NCT00289588|CA-MRSA|ca-mrsa
5340478|NCT00289575|Femur head aseptic osteonecrosis|femur head aseptic osteonecrosis
5340479|NCT00289575|Bone reconstruction|bone reconstruction
5340480|NCT00289575|Macroporous biphasic calcium phosphate granules|macroporous biphasic calcium phosphate granules
5340481|NCT00289562|B-cell|b-cell
5340482|NCT00289562|leukemia|leukemia
5340483|NCT00289562|B-lymphoblastic leukemia|b-lymphoblastic leukemia
5340484|NCT00289562|lymphoma|lymphoma
5340485|NCT00289562|B-All|b-all
5340486|NCT00289549|CLL|cll
5340487|NCT00289549|Chronic lymphocytic leukemia|chronic lymphocytic leukemia
5340488|NCT00289549|leukemia|leukemia
5340489|NCT00289549|Advanced, fludarabine-refractory CLL|advanced, fludarabine-refractory cll
5340490|NCT00289523|Major Depressive Disorder, Depressive Disorder, Unipolar Depression, Antidepressants, Electroencephalography|major depressive disorder, depressive disorder, unipolar depression, antidepressants, electroencephalography
5340491|NCT00289497|Charcot|charcot
5340492|NCT00289497|foot|foot
5340493|NCT00289497|ulceration|ulceration
5340494|NCT00289497|neuropathy|neuropathy
5340495|NCT00289484|Mood disorder|mood disorder
5340496|NCT00289471|Sensitivity and specificity|sensitivity and specificity
5340497|NCT00289471|Physician's practice patterns|physician's practice patterns
5340498|NCT00289471|Health Care costs|health care costs
5340499|NCT00289471|Quality of Health Care|quality of health care
5340500|NCT00289458|older adults, falls, arthritis, aquatic, exercise|older adults, falls, arthritis, aquatic, exercise
5340501|NCT00289419|Arthroplasty, Replacement, Hip|arthroplasty, replacement, hip
5340502|NCT00289419|Anesthetics, Local|anesthetics, local
5340503|NCT00289419|Pain, Postoperative|pain, postoperative
5340504|NCT00289406|hypertension|hypertension
5340505|NCT00289380|Nutritional Risk Screening(NRS)|nutritional risk screening(nrs)
5340506|NCT00289380|Malnutrition|malnutrition
5340507|NCT00289380|Overweight|overweight
5340508|NCT00289380|Obesity|obesity
5340509|NCT00289380|Clinical nutritional support|clinical nutritional support
5340510|NCT00289380|Clinical outcome|clinical outcome
5340511|NCT00289380|Cost effectiveness|cost effectiveness
5340512|NCT00289380|Complication|complication
5340513|NCT00289380|Infective complications|infective complications
5340514|NCT00289354|chromium|chromium
5340515|NCT00289354|chromium picolinate|chromium picolinate
5340516|NCT00289354|type 2 diabetes mellitus|type 2 diabetes mellitus
5340517|NCT00289354|HbA1c|hba1c
5340518|NCT00289354|hyperglycemia|hyperglycemia
5340519|NCT00289354|cholesterol|cholesterol
5340520|NCT00289302|Heart Failure|heart failure
5340521|NCT00289302|Cardiac pacing|cardiac pacing
5340522|NCT00289302|Cardiac resynchronization therapy|cardiac resynchronization therapy
5340523|NCT00289302|Implantable Cardioverter Defibrillator|implantable cardioverter defibrillator
5340524|NCT00289289|Atrial Fibrillation|atrial fibrillation
5340525|NCT00289289|Atrial Tachyarrhythmia|atrial tachyarrhythmia
5340526|NCT00289289|Arrhythmia|arrhythmia
5340527|NCT00289289|Bradycardia|bradycardia
5340528|NCT00289289|Cardiac Pacemaker|cardiac pacemaker
5340529|NCT00289289|IPG Indication|ipg indication
5340530|NCT00289289|Pacing|pacing
5340531|NCT00289276|Cardiomyopathy|cardiomyopathy
5340532|NCT00289276|Ventricular Ejection Fraction|ventricular ejection fraction
5340533|NCT00289276|Congestive Heart Failure|congestive heart failure
5340534|NCT00289276|Impedance|impedance
5340535|NCT00289263|metastatic breast cancer|metastatic breast cancer
5340536|NCT00289263|maintenance chemotherapy|maintenance chemotherapy
5340537|NCT00289250|Malaria|malaria
5340538|NCT00289250|Gametocytes|gametocytes
5340539|NCT00289250|Asymptomatic carriers|asymptomatic carriers
5340540|NCT00289237|Lifestyle intervention|lifestyle intervention
5340541|NCT00289237|Behavioural changes|behavioural changes
5340542|NCT00289237|CHD|chd
5340543|NCT00289237|Type 2 diabetes|type 2 diabetes
5340544|NCT00289224|bivalent killed whole cell oral cholera vaccine|bivalent killed whole cell oral cholera vaccine
5340545|NCT00289224|double blind randomized clinical trial|double blind randomized clinical trial
5340546|NCT00289211|Hereditary angioedema|hereditary angioedema
5340547|NCT00289211|HAE|hae
5340548|NCT00289211|C1 esterase inhibitor (human)|c1 esterase inhibitor (human)
5340549|NCT00289211|C1INH-nf|c1inh-nf
5340550|NCT00289198|GW685698X|gw685698x
5340551|NCT00289198|perennial allergic rhinitis|perennial allergic rhinitis
5340552|NCT00289198|allergic rhinitis|allergic rhinitis
5340553|NCT00289185|Coccidiosis|coccidiosis
5340554|NCT00289185|Parasitic Diseases|parasitic diseases
5340555|NCT00289185|Malaria, Falciparum|malaria, falciparum
5340556|NCT00289185|Malaria|malaria
5340557|NCT00289159|aged 18-50|aged 18-50
5340558|NCT00289159|remitting evolution|remitting evolution
5340559|NCT00289159|less than two years of evolution|less than two years of evolution
5340560|NCT00289159|MS patients|ms patients
5340561|NCT00289146|kidney cancer, immunology|kidney cancer, immunology
5340562|NCT00289133|Arthroplasty, Replacement, Knee|arthroplasty, replacement, knee
5340563|NCT00289120|urolithiasis, cola|urolithiasis, cola
5340564|NCT00289107|Total Knee Replacement|total knee replacement
5340565|NCT00289107|Knee Prosthesis|knee prosthesis
5340566|NCT00289081|Total Knee Replacement|total knee replacement
5340567|NCT00289068|cataract surgery|cataract surgery
5340568|NCT00289068|phacoemulsification sleeve|phacoemulsification sleeve
5340569|NCT00289055|Peripheral Artery Occlusive Disease|peripheral artery occlusive disease
5340570|NCT00289042|atrial fibrillation|atrial fibrillation
5340571|NCT00289042|atrial thrombus|atrial thrombus
5340572|NCT00289042|cardioversion|cardioversion
5340573|NCT00289042|enoxaparin|enoxaparin
5340574|NCT00289042|low molecular weight heparin|low molecular weight heparin
5340575|NCT00289042|transesophageal echocardiography|transesophageal echocardiography
5340576|NCT00289016|gene transfer|gene transfer
5340577|NCT00289016|gene therapy|gene therapy
5340578|NCT00289016|oncolytic virus|oncolytic virus
5340579|NCT00289016|GM-CSF|gm-csf
5340580|NCT00289016|melanoma|melanoma
5340581|NCT00288990|MS|ms
5340582|NCT00288977|Diabetes|diabetes
5340583|NCT00288977|Islet Transplantation|islet transplantation
5340584|NCT00288964|balloon|balloon
5340585|NCT00288964|fiber|fiber
5340586|NCT00288964|respiratory|respiratory
5340587|NCT00288964|oxygenator|oxygenator
5340588|NCT00288964|Heart Failure|heart failure
5340589|NCT00288964|ARDS|ards
5340590|NCT00288964|COPD|copd
5340591|NCT00288938|Suspicious mole|suspicious mole
5340592|NCT00288938|Congenital Nevus|congenital nevus
5340593|NCT00288938|Skin Cancer|skin cancer
5340594|NCT00288938|Moles|moles
5340595|NCT00288938|Pigmented lesion|pigmented lesion
5340596|NCT00288938|LCMN|lcmn
5340597|NCT00288912|Self-Care|self-care
5340598|NCT00288912|Telemedicine|telemedicine
5340599|NCT00288912|Pain|pain
5340600|NCT00288912|Veterans|veterans
5340601|NCT00288899|Informed Consent|informed consent
5340602|NCT00288899|Medical Record Systems, computerized|medical record systems, computerized
5340603|NCT00288899|Comprehension|comprehension
5340604|NCT00288899|Anxiety|anxiety
5340605|NCT00288899|Personal Satisfactin|personal satisfactin
5340606|NCT00288886|Compliance|compliance
5340607|NCT00288886|Aftercare|aftercare
5340608|NCT00288886|Reinforcement, social|reinforcement, social
5340609|NCT00288886|Alcoholics Anonymous|alcoholics anonymous
5340610|NCT00288886|Support Groups|support groups
5340611|NCT00288886|Treatment Outcome|treatment outcome
5340612|NCT00288873|Vitamin D deficiency|vitamin d deficiency
5340613|NCT00288873|Secondary hyperparathyroidism|secondary hyperparathyroidism
5340614|NCT00288873|Obesity|obesity
5340615|NCT00288860|telemedicine|telemedicine
5340616|NCT00288860|treatment compliance|treatment compliance
5340617|NCT00288860|mental health|mental health
5340618|NCT00288847|Patella Dislocation|patella dislocation
5340619|NCT00288847|Surface EMG|surface emg
5340620|NCT00288847|Gender difference|gender difference
5340621|NCT00288834|stroke|stroke
5340622|NCT00288834|dysphagia|dysphagia
5340623|NCT00288834|rehabilitation|rehabilitation
5340624|NCT00288834|biofeedback|biofeedback
5340625|NCT00288821|Gynaecological malignancy|gynaecological malignancy
5340626|NCT00288821|Diagnostic Accuracy|diagnostic accuracy
5340627|NCT00288821|DWIBS|dwibs
5340628|NCT00288821|Lymph Nodes|lymph nodes
5340629|NCT00288821|Metastasis|metastasis
5340630|NCT00288808|Blood|blood
5340631|NCT00288808|Coagulation|coagulation
5340632|NCT00288808|PT/InR|pt/inr
5340633|NCT00288808|Warfarin|warfarin
5340634|NCT00288808|Mechanical Valve|mechanical valve
5340635|NCT00288795|Fatigue|fatigue
5340636|NCT00288795|Polarity|polarity
5340637|NCT00288795|Massage|massage
5340638|NCT00288782|Mirtazapine|mirtazapine
5340639|NCT00288782|Antidepressant|antidepressant
5340640|NCT00288782|Positron Emission Tomography|positron emission tomography
5340641|NCT00288769|Recurrent aphthous stomatitis|recurrent aphthous stomatitis
5340642|NCT00288769|vitamin B12|vitamin b12
5340643|NCT00288756|arrythmias|arrythmias
5340644|NCT00288730|Heart Failure|heart failure
5340645|NCT00288730|Renal Dysfunction|renal dysfunction
5340646|NCT00288730|Cardiomyopathy|cardiomyopathy
5340647|NCT00288730|Heart Decompensation|heart decompensation
5340648|NCT00288730|Dyspnea Paroxysmal|dyspnea paroxysmal
5340649|NCT00288704|Familial Cold Autoinflammatory Syndrome (FCAS)|familial cold autoinflammatory syndrome (fcas)
5340650|NCT00288704|Muckle-Wells Syndrome (MWS)|muckle-wells syndrome (mws)
5340651|NCT00288704|CIAS1|cias1
5340652|NCT00288704|NLRP-3|nlrp-3
5340653|NCT00288704|PYPAF1|pypaf1
5340654|NCT00288704|Cryopyrin|cryopyrin
5340655|NCT00288704|CAPS|caps
5340656|NCT00288704|Interleukin-1|interleukin-1
5340657|NCT00288691|Treatment-resistant menorrhagia|treatment-resistant menorrhagia
5340658|NCT00288678|Diabetic shared care|diabetic shared care
5340659|NCT00288678|Health manager|health manager
5340660|NCT00288678|Prospective Study|prospective study
5340661|NCT00288678|Health Care Quality, Access, and Evaluation|health care quality, access, and evaluation
5340662|NCT00288665|Myocardial infarction|myocardial infarction
5340663|NCT00288665|aspiration|aspiration
5340664|NCT00288665|thrombectomy|thrombectomy
5340665|NCT00288665|ventricular remodeling|ventricular remodeling
5340666|NCT00288639|Pregabalin for partial seizures|pregabalin for partial seizures
5340667|NCT00288626|hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
5340668|NCT00288626|HCT- autologous hematopoietic cell transplant|hct- autologous hematopoietic cell transplant
5340669|NCT00288626|HDIT-high-dose immunosuppressive therapy|hdit-high-dose immunosuppressive therapy
5340670|NCT00288626|BEAM -Carmustine (BCNU), Etoposide (VP-16), Cytarabine (ara-C), and Melphalan|beam -carmustine (bcnu), etoposide (vp-16), cytarabine (ara-c), and melphalan
5340671|NCT00288613|ESRD|esrd
5340672|NCT00288613|Daily Hemodialysis|daily hemodialysis
5340673|NCT00288613|Hemodialysis|hemodialysis
5340674|NCT00288613|Kidney Failure|kidney failure
5340675|NCT00288613|Kidney Disease|kidney disease
5340676|NCT00288600|Immunoglobulins, Intravenous|immunoglobulins, intravenous
5340677|NCT00288600|Hyperbilirubinemia|hyperbilirubinemia
5340678|NCT00288600|Erythroblastosis, Fetal|erythroblastosis, fetal
5340679|NCT00288600|Exchange Transfusion, Whole Blood|exchange transfusion, whole blood
5340680|NCT00288587|Heart Failure|heart failure
5340681|NCT00288587|Congestive Heart Failure|congestive heart failure
5340682|NCT00288587|CHF|chf
5340683|NCT00288574|Depression|depression
5340684|NCT00288561|ARMD, ranibizumab, verteporfin|armd, ranibizumab, verteporfin
5340685|NCT00288535|coronary bifurcation ; PCI; modified T-Stenting; sirolimus stent|coronary bifurcation ; pci; modified t-stenting; sirolimus stent
5340686|NCT00288496|mechanical bowel preparation, colorectal surgery, anastomotic dehiscence|mechanical bowel preparation, colorectal surgery, anastomotic dehiscence
5340687|NCT00288444|Advanced malignancies.|advanced malignancies.
5340688|NCT00288431|cancer|cancer
5340689|NCT00288431|sarcoma|sarcoma
5340690|NCT00288418|Colonization of the catheter|colonization of the catheter
5340691|NCT00288418|Catheter related bloodstream infection|catheter related bloodstream infection
5340692|NCT00288405|Intracranial|intracranial
5340693|NCT00288405|Wide-neck|wide-neck
5340694|NCT00288405|Saccular|saccular
5340695|NCT00288405|Aneurysms|aneurysms
5340696|NCT00288379|Asthma|asthma
5340697|NCT00288379|allergen challenge|allergen challenge
5340698|NCT00288379|airway responsiveness|airway responsiveness
5340699|NCT00288379|airway inflammation|airway inflammation
5340700|NCT00288379|Symbicort®|symbicort®
5340701|NCT00288366|schizophrenia|schizophrenia
5340702|NCT00288366|schizoaffective disorder|schizoaffective disorder
5340703|NCT00288366|bipolar disorder|bipolar disorder
5340704|NCT00288366|metabolic syndrome|metabolic syndrome
5340705|NCT00288353|schizophrenia|schizophrenia
5340706|NCT00288353|schizoaffective disorder|schizoaffective disorder
5340707|NCT00288353|bipolar disorder|bipolar disorder
5340708|NCT00288353|metabolic syndrome|metabolic syndrome
5340709|NCT00288340|psychotic disorders|psychotic disorders
5340710|NCT00288340|auditory hallucinations|auditory hallucinations
5340711|NCT00288340|brain structure|brain structure
5340712|NCT00288340|psychiatric disorder with auditory hallucinations (at least one every 20 minutes)|psychiatric disorder with auditory hallucinations (at least one every 20 minutes)
5340713|NCT00288340|schizophrenia/schizoaffective disorder without auditory hallucinations|schizophrenia/schizoaffective disorder without auditory hallucinations
5340714|NCT00288327|diet|diet
5340715|NCT00288327|physical activity|physical activity
5340716|NCT00288327|smoking cessation|smoking cessation
5340717|NCT00288314|PTSD|ptsd
5340718|NCT00288314|MRI, Functional|mri, functional
5340719|NCT00288314|Anxiety|anxiety
5340720|NCT00288314|Working Memory|working memory
5340721|NCT00288314|Processing speed|processing speed
5340722|NCT00288301|diet|diet
5340723|NCT00288301|physical activity|physical activity
5340724|NCT00288301|weight management|weight management
5340725|NCT00288275|Ovarian Cancer|ovarian cancer
5340726|NCT00288275|Fallopian Tube Cancer|fallopian tube cancer
5340727|NCT00288275|Peritoneal Cancer|peritoneal cancer
5340728|NCT00288275|Assay|assay
5340729|NCT00288275|Chemotherapy|chemotherapy
5340730|NCT00288275|Recurrent|recurrent
5340731|NCT00288275|Refractory|refractory
5340732|NCT00288275|Persistent|persistent
5340733|NCT00288275|Chemoresponse|chemoresponse
5340734|NCT00288275|Sensitivity|sensitivity
5340735|NCT00288275|Precision Therapeutics|precision therapeutics
5340736|NCT00288262|hot flashes|hot flashes
5340737|NCT00288262|melatonin|melatonin
5340738|NCT00288262|depression|depression
5340739|NCT00288262|sleep|sleep
5340740|NCT00288262|luteinizing hormone|luteinizing hormone
5340741|NCT00288262|postmenopause|postmenopause
5340742|NCT00288249|Breast Cancer|breast cancer
5340743|NCT00288249|Breast Neoplasms|breast neoplasms
5340744|NCT00288236|Type 2 diabetes mellitus|type 2 diabetes mellitus
5340745|NCT00288210|Myocardial Infarction|myocardial infarction
5340746|NCT00288210|Stents|stents
5340747|NCT00288210|Sirolimus|sirolimus
5340748|NCT00288210|abciximab|abciximab
5340749|NCT00288145|worksite|worksite
5340750|NCT00288145|weight gain prevention (among adults)|weight gain prevention (among adults)
5340751|NCT00288145|obesity (among adults)|obesity (among adults)
5340752|NCT00288145|physical activity|physical activity
5340753|NCT00288145|nutrition|nutrition
5340754|NCT00288132|Diabetes|diabetes
5340755|NCT00288132|self-management|self-management
5340756|NCT00288132|telemedicine|telemedicine
5340757|NCT00288132|retinal|retinal
5340758|NCT00288132|screening|screening
5340759|NCT00288119|Barrett's Esophagus|barrett's esophagus
5340760|NCT00288106|recurrent prostate cancer|recurrent prostate cancer
5340761|NCT00288106|stage I prostate cancer|stage i prostate cancer
5340762|NCT00288106|stage II prostate cancer|stage ii prostate cancer
5340763|NCT00288106|stage III prostate cancer|stage iii prostate cancer
5340764|NCT00288106|stage IV prostate cancer|stage iv prostate cancer
5340765|NCT00288080|stage III prostate cancer|stage iii prostate cancer
5340766|NCT00288080|stage IIB prostate cancer|stage iib prostate cancer
5340767|NCT00288080|stage IIA prostate cancer|stage iia prostate cancer
5340768|NCT00288080|stage IV prostate cancer|stage iv prostate cancer
5340769|NCT00288054|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5340770|NCT00288054|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5340771|NCT00288054|adenocarcinoma of the lung|adenocarcinoma of the lung
5340772|NCT00288054|large cell lung cancer|large cell lung cancer
5340773|NCT00288054|squamous cell lung cancer|squamous cell lung cancer
5340774|NCT00288028|stage I multiple myeloma|stage i multiple myeloma
5340775|NCT00288028|stage II multiple myeloma|stage ii multiple myeloma
5340776|NCT00288028|stage III multiple myeloma|stage iii multiple myeloma
5340777|NCT00288028|refractory multiple myeloma|refractory multiple myeloma
5340778|NCT00288015|adult angiosarcoma|adult angiosarcoma
5340779|NCT00288015|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
5340780|NCT00288015|stage I adult soft tissue sarcoma|stage i adult soft tissue sarcoma
5340781|NCT00288015|stage II adult soft tissue sarcoma|stage ii adult soft tissue sarcoma
5340782|NCT00288015|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
5340783|NCT00288015|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
5340784|NCT00288002|inflammatory breast cancer|inflammatory breast cancer
5340785|NCT00288002|stage II breast cancer|stage ii breast cancer
5340786|NCT00288002|stage IIIA breast cancer|stage iiia breast cancer
5340787|NCT00288002|stage IIIB breast cancer|stage iiib breast cancer
5340788|NCT00288002|stage IIIC breast cancer|stage iiic breast cancer
5340789|NCT00288002|stage IA breast cancer|stage ia breast cancer
5340790|NCT00288002|stage IB breast cancer|stage ib breast cancer
5340791|NCT00288002|estrogen receptor-negative breast cancer|estrogen receptor-negative breast cancer
5340792|NCT00288002|estrogen receptor-positive breast cancer|estrogen receptor-positive breast cancer
5340793|NCT00288002|HER2-negative breast cancer|her2-negative breast cancer
5340794|NCT00288002|HER2-positive breast cancer|her2-positive breast cancer
5340795|NCT00287989|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5340796|NCT00287989|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5340797|NCT00287989|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5340798|NCT00287976|childhood hepatoblastoma|childhood hepatoblastoma
5340799|NCT00287976|recurrent childhood liver cancer|recurrent childhood liver cancer
5340800|NCT00287963|adenocarcinoma of the lung|adenocarcinoma of the lung
5340801|NCT00287963|adenosquamous cell lung cancer|adenosquamous cell lung cancer
5340802|NCT00287963|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
5340803|NCT00287963|combined type small cell lung cancer|combined type small cell lung cancer
5340804|NCT00287963|intermediate type small cell lung cancer|intermediate type small cell lung cancer
5340805|NCT00287963|large cell lung cancer|large cell lung cancer
5340806|NCT00287963|lymphocyte-like type small cell lung cancer|lymphocyte-like type small cell lung cancer
5340807|NCT00287963|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5340808|NCT00287963|recurrent small cell lung cancer|recurrent small cell lung cancer
5340809|NCT00287963|squamous cell lung cancer|squamous cell lung cancer
5340810|NCT00287950|disseminated neuroblastoma|disseminated neuroblastoma
5340811|NCT00287950|localized resectable neuroblastoma|localized resectable neuroblastoma
5340812|NCT00287950|localized unresectable neuroblastoma|localized unresectable neuroblastoma
5340813|NCT00287950|regional neuroblastoma|regional neuroblastoma
5340814|NCT00287950|stage 4S neuroblastoma|stage 4s neuroblastoma
5340815|NCT00287924|childhood infratentorial ependymoma|childhood infratentorial ependymoma
5340816|NCT00287924|childhood supratentorial ependymoma|childhood supratentorial ependymoma
5340817|NCT00287924|newly diagnosed childhood ependymoma|newly diagnosed childhood ependymoma
5340818|NCT00287911|cervical adenocarcinoma|cervical adenocarcinoma
5340819|NCT00287911|cervical adenosquamous cell carcinoma|cervical adenosquamous cell carcinoma
5340820|NCT00287911|cervical squamous cell carcinoma|cervical squamous cell carcinoma
5340821|NCT00287911|stage IB cervical cancer|stage ib cervical cancer
5340822|NCT00287911|stage IIA cervical cancer|stage iia cervical cancer
5340823|NCT00287911|stage IIB cervical cancer|stage iib cervical cancer
5340824|NCT00287911|stage III cervical cancer|stage iii cervical cancer
5340825|NCT00287911|stage IVA cervical cancer|stage iva cervical cancer
5340826|NCT00287898|breast cancer|breast cancer
5340827|NCT00287885|recurrent cervical cancer|recurrent cervical cancer
5340828|NCT00287885|stage III cervical cancer|stage iii cervical cancer
5340829|NCT00287885|stage IVA cervical cancer|stage iva cervical cancer
5340830|NCT00287885|stage IVB cervical cancer|stage ivb cervical cancer
5340831|NCT00287885|stage III endometrial carcinoma|stage iii endometrial carcinoma
5340832|NCT00287885|recurrent endometrial carcinoma|recurrent endometrial carcinoma
5340833|NCT00287885|stage IV endometrial carcinoma|stage iv endometrial carcinoma
5340834|NCT00287885|fallopian tube cancer|fallopian tube cancer
5340835|NCT00287885|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5340836|NCT00287885|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5340837|NCT00287885|stage III ovarian germ cell tumor|stage iii ovarian germ cell tumor
5340838|NCT00287885|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
5340839|NCT00287885|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
5340840|NCT00287885|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5340841|NCT00287885|recurrent uterine sarcoma|recurrent uterine sarcoma
5340842|NCT00287885|stage III uterine sarcoma|stage iii uterine sarcoma
5340843|NCT00287885|stage IV uterine sarcoma|stage iv uterine sarcoma
5340844|NCT00287885|stage III vaginal cancer|stage iii vaginal cancer
5340845|NCT00287885|recurrent vaginal cancer|recurrent vaginal cancer
5340846|NCT00287885|stage IVA vaginal cancer|stage iva vaginal cancer
5340847|NCT00287885|stage IVB vaginal cancer|stage ivb vaginal cancer
5340848|NCT00287885|stage III vulvar cancer|stage iii vulvar cancer
5340849|NCT00287885|recurrent vulvar cancer|recurrent vulvar cancer
5340850|NCT00287885|stage IV vulvar cancer|stage iv vulvar cancer
5340851|NCT00287885|ovarian sarcoma|ovarian sarcoma
5340852|NCT00287885|ovarian stromal cancer|ovarian stromal cancer
5340853|NCT00287885|peritoneal cavity cancer|peritoneal cavity cancer
5340854|NCT00287872|stage II multiple myeloma|stage ii multiple myeloma
5340855|NCT00287872|stage III multiple myeloma|stage iii multiple myeloma
5340856|NCT00287859|fallopian tube cancer|fallopian tube cancer
5340857|NCT00287859|peritoneal cavity cancer|peritoneal cavity cancer
5340858|NCT00287859|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5340859|NCT00287846|desmoid tumor|desmoid tumor
5340860|NCT00287820|schizophrenia|schizophrenia
5340861|NCT00287820|diabetes|diabetes
5340862|NCT00287820|metabolic syndrome|metabolic syndrome
5340863|NCT00287820|hyperglycemia|hyperglycemia
5340864|NCT00287820|glucose|glucose
5340865|NCT00287820|insulin|insulin
5340866|NCT00287820|lipids|lipids
5340867|NCT00287820|IL-6|il-6
5340868|NCT00287820|prolactin|prolactin
5340869|NCT00287807|Diabetes mellitus, type 2|diabetes mellitus, type 2
5340870|NCT00287807|Blood Glucose Self-Monitoring|blood glucose self-monitoring
5340871|NCT00287807|life style|life style
5340872|NCT00287794|rheumatoid arthritis|rheumatoid arthritis
5340873|NCT00287794|sleep disturbance|sleep disturbance
5340874|NCT00287781|Migraine|migraine
5340875|NCT00287781|Lidocaine|lidocaine
5340876|NCT00287781|Headache|headache
5340877|NCT00287768|gastric cancer|gastric cancer
5340878|NCT00287768|advanced gastric cancer|advanced gastric cancer
5340881|NCT00287768|phase III study|phase iii study
5340882|NCT00287755|gastric cancer|gastric cancer
5340883|NCT00287755|S-1|s-1
5340884|NCT00287755|chemosensitivity|chemosensitivity
5340885|NCT00287755|adjuvant|adjuvant
5340886|NCT00287742|risperidone|risperidone
5340887|NCT00287742|antipsychotic agents|antipsychotic agents
5340888|NCT00287742|Alzheimer's disease|alzheimer's disease
5340889|NCT00287742|dementia|dementia
5340890|NCT00287742|psychosis|psychosis
5340891|NCT00287729|Idiopathic|idiopathic
5340892|NCT00287729|Pulmonary|pulmonary
5340893|NCT00287729|Fibrosis|fibrosis
5340894|NCT00287729|Lung|lung
5340895|NCT00287729|Pirfenidone|pirfenidone
5340896|NCT00287729|InterMune|intermune
5340897|NCT00287716|Idiopathic|idiopathic
5340898|NCT00287716|Pulmonary|pulmonary
5340899|NCT00287716|Fibrosis|fibrosis
5340900|NCT00287716|Lung|lung
5340901|NCT00287716|Pirfenidone|pirfenidone
5340902|NCT00287716|InterMune|intermune
5340903|NCT00287703|Major depression|major depression
5340904|NCT00287703|Treatment resistant|treatment resistant
5340905|NCT00287703|PEMF|pemf
5340906|NCT00287703|AQT|aqt
5340907|NCT00287703|Hamilton|hamilton
5340908|NCT00287690|arteries|arteries
5340909|NCT00287690|blood flow|blood flow
5340910|NCT00287690|coronary artery disease|coronary artery disease
5340911|NCT00287690|diet|diet
5340912|NCT00287677|Growth Hormone|growth hormone
5340913|NCT00287677|HIV-1|hiv-1
5340914|NCT00287677|Vaccination|vaccination
5340915|NCT00287677|Thymopoiesis|thymopoiesis
5340916|NCT00287677|HIV-specific responses|hiv-specific responses
5340917|NCT00287677|Treatment Experienced|treatment experienced
5340918|NCT00287664|hepatorenal syndrome|hepatorenal syndrome
5340919|NCT00287664|terlipressin|terlipressin
5340920|NCT00287664|albumin|albumin
5340921|NCT00287664|cirrhosis|cirrhosis
5340922|NCT00287651|Pulsatile intravenous insulin|pulsatile intravenous insulin
5340923|NCT00287651|Oral carbohydrate loading|oral carbohydrate loading
5340924|NCT00287651|Respiratory Quotients|respiratory quotients
5340925|NCT00287651|Hypoglycemia|hypoglycemia
5340926|NCT00287638|Obstructive sleep apnea|obstructive sleep apnea
5340927|NCT00287625|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
5340928|NCT00287625|Pulmonary rehabilitation|pulmonary rehabilitation
5340929|NCT00287612|GERD|gerd
5340930|NCT00287612|Hiatal Hernia|hiatal hernia
5340931|NCT00287612|Recurrence|recurrence
5340932|NCT00287599|Surgical wound infections|surgical wound infections
5340933|NCT00287599|Real-time PCR|real-time pcr
5340934|NCT00287599|Rapid identification of bacteria|rapid identification of bacteria
5340935|NCT00287599|Cloning|cloning
5340936|NCT00287599|16S rRNA sequencing|16s rrna sequencing
5340937|NCT00287586|Testosterone Replacement|testosterone replacement
5340938|NCT00287586|Heart Disease|heart disease
5340939|NCT00287586|Vascular Disease|vascular disease
5340940|NCT00287586|Risk Factors for Cardiovascular Disease|risk factors for cardiovascular disease
5340941|NCT00287586|Cholesterol|cholesterol
5340942|NCT00287586|Obesity|obesity
5340943|NCT00287586|Blood pressure|blood pressure
5340944|NCT00287586|Quality of Life|quality of life
5340945|NCT00287534|Early Breast Cancer|early breast cancer
5340946|NCT00287521|open|open
5340947|NCT00287521|angle|angle
5340948|NCT00287521|glaucoma|glaucoma
5340949|NCT00287521|ocular|ocular
5340950|NCT00287521|hypertension|hypertension
5340951|NCT00287508|Carotid stenting|carotid stenting
5340952|NCT00287508|Carotid endarterectomy|carotid endarterectomy
5340953|NCT00287508|Carotid artery disease with severe narrowing of the artery|carotid artery disease with severe narrowing of the artery
5340954|NCT00287508|Stroke prevention|stroke prevention
5340955|NCT00287508|cerebral infarction|cerebral infarction
5340956|NCT00287495|AIDS|aids
5340957|NCT00287495|HIV|hiv
5340958|NCT00287495|Antiangiogenesis|antiangiogenesis
5340959|NCT00287495|VEGF|vegf
5340960|NCT00287495|AIDS Malignancy|aids malignancy
5340961|NCT00287495|Kaposi Sarcoma|kaposi sarcoma
5340962|NCT00287495|KS|ks
5340963|NCT00287482|Treatment side effects|treatment side effects
5340964|NCT00287482|Quality of Life|quality of life
5340965|NCT00287482|Transition|transition
5340966|NCT00287482|Survivorship|survivorship
5340967|NCT00287469|Hepatitis E|hepatitis e
5340968|NCT00287469|clinical hepatitis|clinical hepatitis
5340969|NCT00287469|vaccine|vaccine
5340970|NCT00287469|efficacy|efficacy
5340971|NCT00287469|Nepal|nepal
5340972|NCT00287417|Nucal translucency|nucal translucency
5340973|NCT00287417|Down syndrome|down syndrome
5340974|NCT00287417|MSS|mss
5340975|NCT00287417|Risk assessment|risk assessment
5340976|NCT00287404|type 2 diabetes|type 2 diabetes
5340977|NCT00287404|hyperlipidemia|hyperlipidemia
5340978|NCT00287404|dyslipidemia|dyslipidemia
5340979|NCT00287404|fasting lipids|fasting lipids
5340980|NCT00287404|postprandial lipids|postprandial lipids
5340981|NCT00287404|Non-HDL cholesterol|non-hdl cholesterol
5340982|NCT00287404|NMR lipoanalysis|nmr lipoanalysis
5340983|NCT00287404|ATP III guidelines|atp iii guidelines
5340984|NCT00287391|Insomnia|insomnia
5340985|NCT00287391|Gastroesophageal Reflux Disease (GERD)|gastroesophageal reflux disease (gerd)
5340986|NCT00287391|Sleep Disturbance|sleep disturbance
5340987|NCT00287352|First episode psychosis|first episode psychosis
5340988|NCT00287339|Cough|cough
5340989|NCT00287339|GERD|gerd
5340990|NCT00287326|Epidural|epidural
5340991|NCT00287326|Bupivacaine|bupivacaine
5340992|NCT00287326|Clonidine|clonidine
5340993|NCT00287313|Unstable INRs|unstable inrs
5340994|NCT00287313|Warfarin|warfarin
5340995|NCT00287313|Vitamin K|vitamin k
5340996|NCT00287300|Malaria|malaria
5340997|NCT00287300|Pregnancy|pregnancy
5340998|NCT00287300|Efficacy|efficacy
5340999|NCT00287300|Azithromycin|azithromycin
5341000|NCT00287300|Artesunate|artesunate
5341001|NCT00287287|Lenalidomide|lenalidomide
5341002|NCT00287287|Clinical Trials phase II|clinical trials phase ii
5341003|NCT00287287|Carcinomas, thyroid|carcinomas, thyroid
5341004|NCT00287287|Radioiodine-Unresponsive Papillary & Follicular Thyroid Carcinomas|radioiodine-unresponsive papillary & follicular thyroid carcinomas
5341005|NCT00287261|myelofibrosis|myelofibrosis
5341006|NCT00287261|D009191|d009191
5341007|NCT00287248|Alzheimer|alzheimer
5341008|NCT00287248|Alzheimer disease|alzheimer disease
5341009|NCT00287248|Alzheimer disease (AD)|alzheimer disease (ad)
5341010|NCT00287235|Hepatic Encephalopathy|hepatic encephalopathy
5341011|NCT00287235|End Stage Liver Disease|end stage liver disease
5341012|NCT00287235|Cirrhosis|cirrhosis
5341013|NCT00287235|MARS|mars
5341014|NCT00287235|Albumin Dialysis|albumin dialysis
5341015|NCT00287222|Inoperable and Metastatic Hepatocellular Carcinoma|inoperable and metastatic hepatocellular carcinoma
5341016|NCT00287209|RASCABG 1 - study|rascabg 1 - study
5341017|NCT00287209|Postoperative atrial fibrillation|postoperative atrial fibrillation
5341018|NCT00287209|Randomized, controlled trial|randomized, controlled trial
5341019|NCT00287209|Amiodarone|amiodarone
5341020|NCT00287196|Melanoma|melanoma
5341021|NCT00287196|Lymph node disease|lymph node disease
5341022|NCT00287196|Adjuvant radiotherapy|adjuvant radiotherapy
5341023|NCT00287196|Lymphoedema|lymphoedema
5341024|NCT00287170|Crohn's Disease|crohn's disease
5341025|NCT00287170|Local Ileal Delivery|local ileal delivery
5341026|NCT00287170|Delayed-Release Formulations|delayed-release formulations
5341027|NCT00287170|6-Mercaptopurine|6-mercaptopurine
5341028|NCT00287170|Calcitriol|calcitriol
5341029|NCT00287157|Traumatic Brain Injury|traumatic brain injury
5341030|NCT00287157|Actigraphy|actigraphy
5341031|NCT00287157|Spasticity, Cognition and Functioning|spasticity, cognition and functioning
5341032|NCT00287144|Hypothyroidism|hypothyroidism
5341033|NCT00287131|melanoma|melanoma
5341034|NCT00287131|metastatic melanoma|metastatic melanoma
5341035|NCT00287131|adoptive immunotherapy|adoptive immunotherapy
5341036|NCT00287131|IL-2|il-2
5341037|NCT00287105|Chemotherapy|chemotherapy
5341038|NCT00287105|Leukemia|leukemia
5341039|NCT00287105|Children|children
5341040|NCT00287105|Philadelphia chromosome|philadelphia chromosome
5341041|NCT00287105|Protein-tyrosine kinase inhibitor|protein-tyrosine kinase inhibitor
5341042|NCT00287092|Haemophilus influenzae type b;|haemophilus influenzae type b;
5341043|NCT00287092|Corynebacterium diphtheriae;|corynebacterium diphtheriae;
5341044|NCT00287092|Clostridium tetani;|clostridium tetani;
5341045|NCT00287092|Bordetella pertussis;|bordetella pertussis;
5341046|NCT00287092|poliovirus types 1, 2 and 3;|poliovirus types 1, 2 and 3;
5341047|NCT00287092|Vero cell;|vero cell;
5341048|NCT00287092|Influenza;|influenza;
5341049|NCT00287092|Diphtheria|diphtheria
5341050|NCT00287053|divalproex sodium|divalproex sodium
5341051|NCT00287053|valproic acid|valproic acid
5341052|NCT00287053|food intake|food intake
5341053|NCT00287053|energy expenditure|energy expenditure
5341054|NCT00287053|posture allocation|posture allocation
5341055|NCT00287053|None, the population of study is healthy|none, the population of study is healthy
5341056|NCT00287040|Breast Cancer|breast cancer
5341057|NCT00287040|Mammography|mammography
5341058|NCT00287027|psychotic disorders|psychotic disorders
5341059|NCT00287027|family burden|family burden
5341060|NCT00287027|long acting injectible antipsychotic medication|long acting injectible antipsychotic medication
5341061|NCT00287014|Rift valley fever, Kenya|rift valley fever, kenya
5341062|NCT00287001|Acquired bilateral nevus of Ota-like macules|acquired bilateral nevus of ota-like macules
5341063|NCT00287001|Postinflammatory hyperpigmentation|postinflammatory hyperpigmentation
5341064|NCT00287001|Cold air cooling|cold air cooling
5341065|NCT00286988|Preventative|preventative
5341066|NCT00286988|Open-Label|open-label
5341067|NCT00286988|Safety/Efficacy|safety/efficacy
5341068|NCT00286975|Leadership skills|leadership skills
5341069|NCT00286975|Management skills|management skills
5341070|NCT00286975|Postgraduate medical education|postgraduate medical education
5341071|NCT00286962|Diabetes mellitus, type 1|diabetes mellitus, type 1
5341072|NCT00286962|insulin infusion systems|insulin infusion systems
5341073|NCT00286962|continuous intraperitoneal insulin infusion|continuous intraperitoneal insulin infusion
5341074|NCT00286962|cross-over studies|cross-over studies
5341075|NCT00286949|Parkinson's disease|parkinson's disease
5341076|NCT00286949|executive dysfunction|executive dysfunction
5341077|NCT00286949|impairment|impairment
5341078|NCT00286949|motor skills|motor skills
5341079|NCT00286949|cognitive|cognitive
5341080|NCT00286936|Hip fracture|hip fracture
5341081|NCT00286936|delirium|delirium
5341284|NCT00286078|Migraine|migraine
5341082|NCT00286936|sleep disturbance|sleep disturbance
5341083|NCT00286936|hypnotic|hypnotic
5341084|NCT00286923|migraine|migraine
5341085|NCT00286923|chronic headache|chronic headache
5341086|NCT00286923|hyperexcitability|hyperexcitability
5341087|NCT00286923|Magnetic stimulation|magnetic stimulation
5341088|NCT00286910|AQP-2|aqp-2
5341089|NCT00286910|NPHS2-gene|nphs2-gene
5341090|NCT00286845|Chemosensitivity|chemosensitivity
5341091|NCT00286845|Acute Myeloid Leukemia|acute myeloid leukemia
5341092|NCT00286845|Apoptosis|apoptosis
5341093|NCT00286845|MiCK Assay|mick assay
5341094|NCT00286832|Non-Hodgkin's lymphoma|non-hodgkin's lymphoma
5341095|NCT00286832|Diffuse large B-cell lymphoma|diffuse large b-cell lymphoma
5341096|NCT00286832|PET|pet
5341097|NCT00286832|Prognosis|prognosis
5341098|NCT00286819|early breast cancer,|early breast cancer,
5341099|NCT00286819|Fluorouracil|fluorouracil
5341100|NCT00286793|at-101|at-101
5341101|NCT00286793|at101|at101
5341102|NCT00286793|cancer|cancer
5341103|NCT00286793|hormone refractory|hormone refractory
5341104|NCT00286793|prostate|prostate
5341105|NCT00286793|docetaxel|docetaxel
5341106|NCT00286793|prednisone|prednisone
5341107|NCT00286780|AT101|at101
5341108|NCT00286780|AT-101|at-101
5341109|NCT00286780|cancer|cancer
5341110|NCT00286780|lymphoctic|lymphoctic
5341111|NCT00286780|lukemia|lukemia
5341112|NCT00286780|Rituximab|rituximab
5341113|NCT00286767|Opportunistic Infections|opportunistic infections
5341114|NCT00286767|Immune Restoration Disease|immune restoration disease
5341115|NCT00286767|Mycobacterial Infections|mycobacterial infections
5341116|NCT00286767|HIV-1 Infection|hiv-1 infection
5341117|NCT00286767|HIV|hiv
5341118|NCT00286767|ART Naive|art naive
5341119|NCT00286754|Hypertension|hypertension
5341120|NCT00286754|Behavior modification|behavior modification
5341121|NCT00286754|Randomized controlled trial|randomized controlled trial
5341122|NCT00286754|Treatment effectiveness|treatment effectiveness
5341123|NCT00286754|Telemedicine|telemedicine
5341124|NCT00286754|Prevention|prevention
5341125|NCT00286741|Diabetes|diabetes
5341126|NCT00286741|Hypertension|hypertension
5341127|NCT00286741|Randomized controlled trials|randomized controlled trials
5341128|NCT00286741|cost-effectiveness|cost-effectiveness
5341129|NCT00286741|health services|health services
5341130|NCT00286728|self-help groups|self-help groups
5341131|NCT00286728|referral and consultation|referral and consultation
5341132|NCT00286702|splints|splints
5341133|NCT00286702|Occupational Therapy|occupational therapy
5341134|NCT00286663|AIH, Autoimmune Hepatitis|aih, autoimmune hepatitis
5341135|NCT00286650|Paracetamol|paracetamol
5341136|NCT00286637|OCT|oct
5341137|NCT00286637|CSLO|cslo
5341138|NCT00286637|SLP|slp
5341139|NCT00286637|Perimetry|perimetry
5341140|NCT00286637|electrophysiology|electrophysiology
5341141|NCT00286637|glaucoma|glaucoma
5341142|NCT00286637|macular degeneration|macular degeneration
5341143|NCT00286637|retinopathy|retinopathy
5341144|NCT00286637|diabetes|diabetes
5341145|NCT00286637|macular hole|macular hole
5341146|NCT00286611|Amifostine|amifostine
5341147|NCT00286598|foot ulcer|foot ulcer
5341148|NCT00286598|diabetes mellitus|diabetes mellitus
5341149|NCT00286598|motor activity|motor activity
5341150|NCT00286598|randomized controlled trial|randomized controlled trial
5341151|NCT00286598|prevention|prevention
5341152|NCT00286585|preconditioning|preconditioning
5341153|NCT00286585|cardiac protection|cardiac protection
5341154|NCT00286585|morbidity|morbidity
5341155|NCT00286585|mortality|mortality
5341156|NCT00286585|major non-cardiac surgery|major non-cardiac surgery
5341157|NCT00286585|cardiac mortality and morbidity|cardiac mortality and morbidity
5341158|NCT00286585|high cardiac perioperative risk|high cardiac perioperative risk
5341159|NCT00286572|insulin-dependent diabetes mellitus|insulin-dependent diabetes mellitus
5341160|NCT00286572|non-insulin-dependent diabetes mellitus|non-insulin-dependent diabetes mellitus
5341161|NCT00286572|coronary artery disease|coronary artery disease
5341162|NCT00286572|long-term mortality|long-term mortality
5341163|NCT00286559|Coronary artery disease|coronary artery disease
5341164|NCT00286559|Coronary artery bypass graft surgery|coronary artery bypass graft surgery
5341165|NCT00286559|SPECT|spect
5341166|NCT00286559|Adenosin|adenosin
5341167|NCT00286546|Testosterone|testosterone
5341168|NCT00286546|Major Depression|major depression
5341169|NCT00286546|Men|men
5341170|NCT00286533|Implant|implant
5341171|NCT00286520|Constipation|constipation
5341172|NCT00286520|Fecal incontinence|fecal incontinence
5341173|NCT00286520|Spinal cord injury|spinal cord injury
5341174|NCT00286520|transanal irrigation|transanal irrigation
5341175|NCT00286520|quality of life|quality of life
5341176|NCT00286507|Full thickness macular hole|full thickness macular hole
5341177|NCT00286507|Internal limiting membrane (ILM)|internal limiting membrane (ilm)
5341178|NCT00286507|Vitreo retinal surgery|vitreo retinal surgery
5341179|NCT00286507|Vitrectomy|vitrectomy
5341180|NCT00286494|Glucose Metabolism Disorder|glucose metabolism disorder
5341181|NCT00286494|Dysmetabolic Syndrome|dysmetabolic syndrome
5341182|NCT00286494|Type II Diabetes|type ii diabetes
5341183|NCT00286494|Diabetes Mellitus|diabetes mellitus
5341184|NCT00286494|Lipoatrophic|lipoatrophic
5341185|NCT00286494|Dyslipidemia|dyslipidemia
5341186|NCT00286494|Drug Therapy|drug therapy
5341187|NCT00286481|Hyperlipidemia|hyperlipidemia
5341188|NCT00286481|Drug Therapy|drug therapy
5341189|NCT00286468|Glucose Metabolism Disorder|glucose metabolism disorder
5341190|NCT00286468|Dysmetabolic Syndrome|dysmetabolic syndrome
5341191|NCT00286468|Type II Diabetes|type ii diabetes
5341192|NCT00286468|Diabetes Mellitus|diabetes mellitus
5341193|NCT00286468|Lipoatrophic|lipoatrophic
5341194|NCT00286468|Dyslipidemia|dyslipidemia
5341195|NCT00286468|Drug Therapy|drug therapy
5341196|NCT00286455|Glucose Metabolism Disorder|glucose metabolism disorder
5341197|NCT00286455|Dysmetabolic Syndrome|dysmetabolic syndrome
5341198|NCT00286455|Type II Diabetes; Diabetes Mellitus|type ii diabetes; diabetes mellitus
5341199|NCT00286455|Lipoatrophic|lipoatrophic
5341200|NCT00286455|Dyslipidemia|dyslipidemia
5341201|NCT00286455|Drug Therapy|drug therapy
5341202|NCT00286442|Glucose Metabolism Disorder|glucose metabolism disorder
5341203|NCT00286442|Dysmetabolic Syndrome|dysmetabolic syndrome
5341204|NCT00286442|Type II Diabetes|type ii diabetes
5341205|NCT00286442|Diabetes Mellitus|diabetes mellitus
5341206|NCT00286442|Lipoatrophic|lipoatrophic
5341207|NCT00286442|Dyslipidemia|dyslipidemia
5341208|NCT00286442|Drug Therapy|drug therapy
5341209|NCT00286429|Glucose Metabolism Disorder|glucose metabolism disorder
5341210|NCT00286429|Dysmetabolic Syndrome|dysmetabolic syndrome
5341211|NCT00286429|Type II Diabetes|type ii diabetes
5341212|NCT00286429|Diabetes Mellitus|diabetes mellitus
5341213|NCT00286429|Lipoatrophic|lipoatrophic
5341214|NCT00286429|Dyslipidemia|dyslipidemia
5341215|NCT00286429|Drug Therapy|drug therapy
5341216|NCT00286416|AERD|aerd
5341217|NCT00286416|aspirin|aspirin
5341218|NCT00286416|allergy|allergy
5341219|NCT00286416|omalizumab|omalizumab
5341220|NCT00286403|Acute Tubular Necrosis|acute tubular necrosis
5341221|NCT00286403|antioxidants|antioxidants
5341222|NCT00286403|Fenoldopam|fenoldopam
5341223|NCT00286338|Fluid therapy|fluid therapy
5341224|NCT00286338|Monitoring|monitoring
5341225|NCT00286312|Acute myocardial infarction|acute myocardial infarction
5341226|NCT00286312|Primary angioplasty|primary angioplasty
5341227|NCT00286312|Reperfusion damage|reperfusion damage
5341228|NCT00286312|Atorvastatin|atorvastatin
5341229|NCT00286312|Placebo|placebo
5341230|NCT00286312|Early left ventricular remodelling|early left ventricular remodelling
5341231|NCT00286312|Late left ventricular remodelling|late left ventricular remodelling
5341232|NCT00286312|Cardiac MRI|cardiac mri
5341233|NCT00286312|Statin|statin
5341234|NCT00286312|Transluminal, Percutaneous Coronary|transluminal, percutaneous coronary
5341235|NCT00286312|Angioplasty|angioplasty
5341236|NCT00286299|Schizophrenia|schizophrenia
5341237|NCT00286299|Cardiovascular disease|cardiovascular disease
5341238|NCT00286299|Aerobic capacity|aerobic capacity
5341239|NCT00286299|Mortality|mortality
5341240|NCT00286299|Exercise|exercise
5341241|NCT00286286|Laparoscopy|laparoscopy
5341242|NCT00286286|Laparoscopic Surgical Procedures|laparoscopic surgical procedures
5341243|NCT00286286|Laparoscopic Surgery|laparoscopic surgery
5341244|NCT00286286|Gastric Bypass|gastric bypass
5341245|NCT00286286|Drug Delivery Systems|drug delivery systems
5341246|NCT00286286|Pain Measurement|pain measurement
5341247|NCT00286273|kidney failure, acute|kidney failure, acute
5341248|NCT00286273|venovenous hemofiltration|venovenous hemofiltration
5341249|NCT00286273|hemorrhage|hemorrhage
5341250|NCT00286273|heparin, low-molecular-weight|heparin, low-molecular-weight
5341251|NCT00286273|nadroparin|nadroparin
5341252|NCT00286273|citrates|citrates
5341253|NCT00286260|polyneuropathy|polyneuropathy
5341254|NCT00286260|neuropathic pain|neuropathic pain
5341255|NCT00286260|levetiracetam|levetiracetam
5341256|NCT00286234|triglycerides|triglycerides
5341257|NCT00286234|HDL-cholesterol|hdl-cholesterol
5341258|NCT00286234|insulin resistance|insulin resistance
5341259|NCT00286234|omega-3 fatty acids|omega-3 fatty acids
5341260|NCT00286234|niacin|niacin
5341261|NCT00286208|Medical abortion|medical abortion
5341262|NCT00286208|mifepristone|mifepristone
5341263|NCT00286208|misoprostol|misoprostol
5341264|NCT00286182|Heart Failure|heart failure
5341265|NCT00286182|Elderly|elderly
5341266|NCT00286182|Diastolic Dysfunction|diastolic dysfunction
5341267|NCT00286182|Anemia|anemia
5341268|NCT00286182|Ventricular End Diastolic Volume|ventricular end diastolic volume
5341269|NCT00286182|Aged|aged
5341270|NCT00286169|Extensive-disease small-cell lung cancer (ED-SCLC)|extensive-disease small-cell lung cancer (ed-sclc)
5341271|NCT00286156|ADPKD|adpkd
5341272|NCT00286130|metastatic colorectal cancer|metastatic colorectal cancer
5341273|NCT00286130|FOLFOX 6|folfox 6
5341274|NCT00286130|FOLFIRI|folfiri
5341275|NCT00286117|Breast Cancer|breast cancer
5341276|NCT00286104|Ventriculitis|ventriculitis
5341277|NCT00286104|External ventricular catheter|external ventricular catheter
5341278|NCT00286104|Antibiotic-impregnated|antibiotic-impregnated
5341279|NCT00286091|Hormone refractory prostate cancer|hormone refractory prostate cancer
5341280|NCT00286091|androgen independent|androgen independent
5341281|NCT00286091|ADT|adt
5341282|NCT00286091|bone metastasis|bone metastasis
5341285|NCT00286078|Refractory|refractory
5341286|NCT00286078|Chronic|chronic
5341287|NCT00286078|Pain|pain
5341288|NCT00286065|Pain|pain
5341289|NCT00286065|Fentanyl|fentanyl
5341290|NCT00286065|Analgesics|analgesics
5341291|NCT00286065|Opioid|opioid
5341292|NCT00286065|Inhalation|inhalation
5341293|NCT00286026|Chlamydia trachomatis|chlamydia trachomatis
5341294|NCT00285961|Fractures of the wrist, forearm, elbow, ankle, foot|fractures of the wrist, forearm, elbow, ankle, foot
5341295|NCT00285961|Distortions of the wrist, elbow, ankle|distortions of the wrist, elbow, ankle
5341296|NCT00285961|Wounds without tendon injuries|wounds without tendon injuries
5341297|NCT00285935|Major Depressive Disorder|major depressive disorder
5341298|NCT00285935|MDD|mdd
5341299|NCT00285935|Neurobiology|neurobiology
5341300|NCT00285935|Selective Serotonin Reuptake Inhibitor|selective serotonin reuptake inhibitor
5341301|NCT00285935|SSRI|ssri
5341302|NCT00285935|Depression|depression
5341303|NCT00285922|myocardial infarction|myocardial infarction
5341304|NCT00285922|electrocardiography|electrocardiography
5341305|NCT00285922|myocardial ischemia|myocardial ischemia
5341306|NCT00285922|emergency medicine|emergency medicine
5341307|NCT00285922|monitoring, physiologic|monitoring, physiologic
5341308|NCT00285909|Moderate alcohol consumption|moderate alcohol consumption
5341309|NCT00285909|Alcohol dehydrogenase 1c polymorphism|alcohol dehydrogenase 1c polymorphism
5341310|NCT00285909|PPAR-gamma activated gene expression|ppar-gamma activated gene expression
5341311|NCT00285896|GLP-1|glp-1
5341312|NCT00285896|fasting|fasting
5341313|NCT00285896|hypoglycaemia|hypoglycaemia
5341314|NCT00285883|Invirase|invirase
5341316|NCT00285883|DOT|dot
5341317|NCT00285883|Treatment Experienced|treatment experienced
5341318|NCT00285857|duct cytology|duct cytology
5341319|NCT00285844|obesity|obesity
5341320|NCT00285844|insulin resistance|insulin resistance
5341321|NCT00285844|thiazolidinedione|thiazolidinedione
5341322|NCT00285844|weight loss|weight loss
5341323|NCT00285844|adipose tissue|adipose tissue
5341324|NCT00285844|metabolic syndrome|metabolic syndrome
5341325|NCT00285844|diabetes prevention|diabetes prevention
5341326|NCT00285844|cardiovascular disease prevention|cardiovascular disease prevention
5341327|NCT00285805|Rosiglitazone|rosiglitazone
5341328|NCT00285805|Furosemide|furosemide
5341329|NCT00285805|Amiloride|amiloride
5341330|NCT00285805|Epithelial sodium channel|epithelial sodium channel
5341331|NCT00285805|Sodium excretion|sodium excretion
5341332|NCT00285792|Preschool, Physical Activity|preschool, physical activity
5341333|NCT00285766|Depression|depression
5341334|NCT00285753|psychosocial intervention|psychosocial intervention
5341335|NCT00285753|mild cognitive impairment|mild cognitive impairment
5341336|NCT00285753|support group|support group
5341337|NCT00285753|caregivers|caregivers
5341338|NCT00285753|Mild Cognitive Impairment (MCI)|mild cognitive impairment (mci)
5341339|NCT00285753|Cognitive Impairment No Dementia (CIND)|cognitive impairment no dementia (cind)
5341340|NCT00285714|3D computer assisted imaging|3d computer assisted imaging
5341341|NCT00285714|maxillofacial surgery|maxillofacial surgery
5341342|NCT00285714|cephalometry|cephalometry
5341343|NCT00285714|normative value|normative value
5341344|NCT00285688|H. Pylori, Clarithromycin resistant, gene|h. pylori, clarithromycin resistant, gene
5341345|NCT00285675|Calcitriol, DN-101, Androgen Independent Prostate Cancer (AIPC), Prostate Cancer, Non Small Cell Lung Cancer (NSCLC)|calcitriol, dn-101, androgen independent prostate cancer (aipc), prostate cancer, non small cell lung cancer (nsclc)
5341346|NCT00285662|IPTi|ipti
5341347|NCT00285662|Malaria|malaria
5341348|NCT00285662|Anemia|anemia
5341349|NCT00285662|Prevention|prevention
5341350|NCT00285662|Infant|infant
5341351|NCT00285662|Artesunate|artesunate
5341352|NCT00285662|SP|sp
5341353|NCT00285662|Amodiaquine|amodiaquine
5341354|NCT00285662|Papua New Guinea|papua new guinea
5341355|NCT00285649|Spinal Manipulation|spinal manipulation
5341356|NCT00285636|Long Term Follow-Up|long term follow-up
5341357|NCT00285623|Collection of all thromboembolic events,|collection of all thromboembolic events,
5341358|NCT00285623|immunological events and drug interactions leading to thromboembolic events or major|immunological events and drug interactions leading to thromboembolic events or major
5341359|NCT00285623|bleeding after exposure to TachoSil®.|bleeding after exposure to tachosil®.
5341360|NCT00285584|HIV infection|hiv infection
5341361|NCT00285584|Depression|depression
5341362|NCT00285584|Men who have sex with men|men who have sex with men
5341363|NCT00285584|Drug abuse|drug abuse
5341364|NCT00285558|obesity|obesity
5341365|NCT00285558|adolescent|adolescent
5341366|NCT00285558|weight loss|weight loss
5341367|NCT00285558|body mass index|body mass index
5341368|NCT00285558|evaluation studies|evaluation studies
5341369|NCT00285558|peer group|peer group
5341370|NCT00285558|behavior therapy|behavior therapy
5341371|NCT00285558|diet|diet
5341372|NCT00285558|exercise|exercise
5341373|NCT00285558|self efficacy|self efficacy
5341374|NCT00285558|parents|parents
5341375|NCT00285545|Blood Supply|blood supply
5341376|NCT00285545|Mesentery|mesentery
5341377|NCT00285532|Blood Lead|blood lead
5341378|NCT00285532|Pesticides|pesticides
5341379|NCT00285532|Community-based|community-based
5341380|NCT00285532|Sampling Kits|sampling kits
5341381|NCT00285519|Morning hypertension|morning hypertension
5341382|NCT00285506|Healthy Volunteers|healthy volunteers
5341383|NCT00285493|low back pain|low back pain
5341384|NCT00285467|kidney, parathyroid hormone, vitamin d|kidney, parathyroid hormone, vitamin d
5341385|NCT00285441|HIV|hiv
5341386|NCT00285428|treatment|treatment
5341387|NCT00285428|NHL|nhl
5341388|NCT00285428|CD20+ B-cell NHL|cd20+ b-cell nhl
5341389|NCT00285428|Lymphoma|lymphoma
5341390|NCT00285415|Advanced endometrial adenocarcinoma, stage III A, B, C|advanced endometrial adenocarcinoma, stage iii a, b, c
5341391|NCT00285402|Migraine|migraine
5341392|NCT00285402|Migraine prophylaxis|migraine prophylaxis
5341393|NCT00285402|Migraine prevention|migraine prevention
5341394|NCT00285402|Chronic migraine treatment|chronic migraine treatment
5341395|NCT00285389|Mantle cell lymphoma|mantle cell lymphoma
5341396|NCT00285389|Chemotherapy|chemotherapy
5341397|NCT00285389|Autologous PBSCT|autologous pbsct
5341398|NCT00285389|Molecular evaluation|molecular evaluation
5341399|NCT00285376|Depression. Genetics, Pharmacogenetics|depression. genetics, pharmacogenetics
5341400|NCT00285363|cancer|cancer
5341401|NCT00285363|quality of life|quality of life
5341402|NCT00285363|adolescents|adolescents
5341403|NCT00285350|myasthenia gravis|myasthenia gravis
5341404|NCT00285337|Myelopathy|myelopathy
5341405|NCT00285337|Laminectomy|laminectomy
5341406|NCT00285337|Laminoplasty|laminoplasty
5341407|NCT00285337|Decompression of Spinal Cord|decompression of spinal cord
5341408|NCT00285337|Cervical Spondylosis|cervical spondylosis
5341409|NCT00285324|Glioma|glioma
5341410|NCT00285324|Glioblastoma Multiforme|glioblastoma multiforme
5341411|NCT00285324|Brain Cancer|brain cancer
5341412|NCT00285324|Diffusion-Weighted Magnetic Resonance Imaging|diffusion-weighted magnetic resonance imaging
5341413|NCT00285324|Brain Tumor|brain tumor
5341414|NCT00285298|proteinuria|proteinuria
5341415|NCT00285298|Kidney failure, chronic|kidney failure, chronic
5341416|NCT00285285|Point-of-care Testing|point-of-care testing
5341417|NCT00285285|Pediatric Emergency Department|pediatric emergency department
5341418|NCT00285285|Length of Stay|length of stay
5341419|NCT00285285|Efficiency|efficiency
5341420|NCT00285259|cytomegalovirus infection|cytomegalovirus infection
5341421|NCT00285259|infectious disease|infectious disease
5341422|NCT00285259|viremia|viremia
5341423|NCT00285259|cytomegalovirus disease|cytomegalovirus disease
5341424|NCT00285259|stem cell transplant|stem cell transplant
5341425|NCT00285259|allogeneic|allogeneic
5341426|NCT00285259|bone marrow transplant|bone marrow transplant
5341427|NCT00285259|hematopoietic cell transplant|hematopoietic cell transplant
5341428|NCT00285259|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
5341429|NCT00285259|Chronic Myelogenous Leukemia|chronic myelogenous leukemia
5341430|NCT00285259|Acute Myelogenous Leukemia|acute myelogenous leukemia
5341431|NCT00285259|Hodgkin's Lymphoma|hodgkin's lymphoma
5341432|NCT00285259|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
5341433|NCT00285259|Myelodysplastic Syndrome|myelodysplastic syndrome
5341434|NCT00285246|combat disorders|combat disorders
5341435|NCT00285246|stress, psychological|stress, psychological
5341436|NCT00285246|somatoform disorders|somatoform disorders
5341437|NCT00285246|life change events|life change events
5341438|NCT00285246|utilization|utilization
5341439|NCT00285207|Cervical Intraepithelial Neoplasia (CIN)|cervical intraepithelial neoplasia (cin)
5341440|NCT00285207|High-grade Cervical Intraepithelial Neoplasia|high-grade cervical intraepithelial neoplasia
5341441|NCT00285207|High-grade Squamous Intraepithelial Lesions (HSIL)|high-grade squamous intraepithelial lesions (hsil)
5341442|NCT00285207|Human Papilloma Virus (HPV)|human papilloma virus (hpv)
5341443|NCT00285207|High-Grade Cervical Intraepithelial Lesions (CIN 2/3)|high-grade cervical intraepithelial lesions (cin 2/3)
5341444|NCT00285181|persons|persons
5341445|NCT00285168|Osteoporosis|osteoporosis
5341446|NCT00285168|Fractures, Bone|fractures, bone
5341447|NCT00285168|Bone Mineral Density|bone mineral density
5341448|NCT00285155|bupropion|bupropion
5341449|NCT00285155|repeated dose|repeated dose
5341450|NCT00285155|healthy volunteers|healthy volunteers
5341451|NCT00285155|cognitive function|cognitive function
5341452|NCT00285155|behaviour|behaviour
5341453|NCT00285155|tolerance|tolerance
5341454|NCT00285155|Persons|persons
5341455|NCT00285142|rosiglitazone|rosiglitazone
5341456|NCT00285142|insulin secretion|insulin secretion
5341457|NCT00285142|clinical trial|clinical trial
5341458|NCT00285142|healthy|healthy
5341459|NCT00285142|persons|persons
5341460|NCT00285103|Antisense, mRNA antagonist, Bcl-2, CLL|antisense, mrna antagonist, bcl-2, cll
5341461|NCT00285090|Burn Injury|burn injury
5341462|NCT00285090|Calcium|calcium
5341463|NCT00285090|Vitamin D|vitamin d
5341464|NCT00285090|Bone Mineral Density|bone mineral density
5341465|NCT00285077|Alzheimer disease|alzheimer disease
5341466|NCT00285077|nerve growth factors|nerve growth factors
5341467|NCT00285077|Clinical Trial|clinical trial
5341468|NCT00285064|MDCT|mdct
5341469|NCT00285064|viability|viability
5341470|NCT00285051|emesis, nausea,|emesis, nausea,
5341471|NCT00285038|Deep vein thrombosis|deep vein thrombosis
5341472|NCT00285038|Gynecological cancer|gynecological cancer
5341473|NCT00285025|Alzheimer disease|alzheimer disease
5341474|NCT00285025|nerve growth factors|nerve growth factors
5341475|NCT00285025|Clinical Trial|clinical trial
5341476|NCT00285012|smoking cessation|smoking cessation
5341477|NCT00285012|smoking cessation in COPD|smoking cessation in copd
5341478|NCT00284986|GVHD|gvhd
5341479|NCT00284986|Graft vs Host Disease|graft vs host disease
5341480|NCT00284986|Graft versus Host Disease|graft versus host disease
5341481|NCT00284973|malaria|malaria
5341482|NCT00284960|erectile dysfunction|erectile dysfunction
5341483|NCT00284960|metabolic syndrome|metabolic syndrome
5341484|NCT00284960|insulin resistance|insulin resistance
5341485|NCT00284960|etiology|etiology
5341486|NCT00284947|Side effects|side effects
5341487|NCT00284947|calcineurin inhibitors|calcineurin inhibitors
5341488|NCT00284947|maintenance|maintenance
5341489|NCT00284947|basiliximab|basiliximab
5341490|NCT00284947|Kidney maintenance transplant|kidney maintenance transplant
5341491|NCT00284934|Dose optimization|dose optimization
5341492|NCT00284934|immune suppressive regimen|immune suppressive regimen
5341493|NCT00284934|enteric-coated mycophenolate sodium|enteric-coated mycophenolate sodium
5341494|NCT00284934|EC-MPS|ec-mps
5341495|NCT00284934|renal transplantation|renal transplantation
5341496|NCT00284934|kidney|kidney
5341497|NCT00284934|transplant|transplant
5341498|NCT00284934|maintenance patients|maintenance patients
5341499|NCT00284934|Renal transplantation in maintenance|renal transplantation in maintenance
5341500|NCT00284921|kidney transplant, hepatitis C, enteric-coated mycophenolate sodium|kidney transplant, hepatitis c, enteric-coated mycophenolate sodium
5341501|NCT00284908|S-Tenatoprazole-Na|s-tenatoprazole-na
5341502|NCT00284908|Pharmacokinetic|pharmacokinetic
5341503|NCT00284908|intragastric pH recording|intragastric ph recording
5341504|NCT00284908|dose-response|dose-response
5341505|NCT00284895|Obesity|obesity
5341506|NCT00284895|Bariatric Surgery|bariatric surgery
5341507|NCT00284895|Weight Loss Surgery|weight loss surgery
5341508|NCT00284895|Asthma|asthma
5341509|NCT00284882|Streptococcus, Fiji, pyoderma, pharyngitis, scabies|streptococcus, fiji, pyoderma, pharyngitis, scabies
5341510|NCT00284869|LPS|lps
5341511|NCT00284869|ethnicity|ethnicity
5341512|NCT00284869|neutrophils|neutrophils
5341513|NCT00284869|TNF|tnf
5341514|NCT00284843|Streptococcus, Fiji, pyoderma, scabies, rheumatic disease|streptococcus, fiji, pyoderma, scabies, rheumatic disease
5341515|NCT00284830|Right Ventricular Pacing|right ventricular pacing
5341516|NCT00284830|Persistent Atrial Fibrillation|persistent atrial fibrillation
5341517|NCT00284830|Atrioventricular Conduction|atrioventricular conduction
5341518|NCT00284830|Heart Failure Hospitalization|heart failure hospitalization
5341519|NCT00284830|Cardiovascular Health Care Utilization|cardiovascular health care utilization
5341520|NCT00284830|Sinus-node Disease|sinus-node disease
5341521|NCT00284830|Minimized Ventricular Pacing|minimized ventricular pacing
5341522|NCT00284804|relapsed or refractory Hodgkin's Disease|relapsed or refractory hodgkin's disease
5341523|NCT00284778|lung cancer|lung cancer
5341524|NCT00284778|second line treatment|second line treatment
5341525|NCT00284778|cost-minimization trial|cost-minimization trial
5341526|NCT00284778|Pharmaco-economic study|pharmaco-economic study
5341527|NCT00284778|docetaxel|docetaxel
5341528|NCT00284778|pemetrexed|pemetrexed
5341529|NCT00284752|Prostate|prostate
5341530|NCT00284752|Cancer|cancer
5341531|NCT00284752|Metastatic|metastatic
5341532|NCT00284726|Cytokines in lung transplantation|cytokines in lung transplantation
5341533|NCT00284726|Cold storage solutions|cold storage solutions
5341534|NCT00284726|Ischemic reperfusion injury|ischemic reperfusion injury
5341535|NCT00284700|Helicobacter pylori|helicobacter pylori
5341536|NCT00284700|Iron deficiency anemia|iron deficiency anemia
5341537|NCT00284700|children|children
5341538|NCT00284687|bone marrow transplantation|bone marrow transplantation
5341539|NCT00284687|CMV disease|cmv disease
5341540|NCT00284661|Meniscal repair|meniscal repair
5341541|NCT00284661|Meniscal suturing|meniscal suturing
5341542|NCT00284661|Meniscal tear|meniscal tear
5341543|NCT00284648|Achilles tendon|achilles tendon
5341544|NCT00284648|Rupture|rupture
5341545|NCT00284648|Non-operative|non-operative
5341546|NCT00284648|Operative|operative
5341547|NCT00284622|HTO|hto
5341548|NCT00284622|Arthroscopy|arthroscopy
5341549|NCT00284622|Osteoarthritis|osteoarthritis
5341550|NCT00284622|Alignement|alignement
5341551|NCT00284622|Varus gonarthrosis|varus gonarthrosis
5341552|NCT00284609|Type 2 diabetes,|type 2 diabetes,
5341553|NCT00284609|rehabilitation,|rehabilitation,
5341554|NCT00284609|quality of life,|quality of life,
5341555|NCT00284609|glycaemic control,|glycaemic control,
5341556|NCT00284609|lifestyle intervention,|lifestyle intervention,
5341557|NCT00284609|patient education,|patient education,
5341558|NCT00284609|physical training,|physical training,
5341559|NCT00284609|group visits,|group visits,
5341560|NCT00284609|reminders|reminders
5341561|NCT00284596|Opening wedge high tibial osteotomy|opening wedge high tibial osteotomy
5341562|NCT00284596|Radio Sterometric Analysis|radio sterometric analysis
5341563|NCT00284596|Locking screw fixation|locking screw fixation
5341564|NCT00284583|Morton's Neuroma|morton's neuroma
5341565|NCT00284583|Alcohol|alcohol
5341566|NCT00284583|Steroid|steroid
5341567|NCT00284570|pediatrics|pediatrics
5341568|NCT00284570|congenital heart disease|congenital heart disease
5341569|NCT00284570|cardiac|cardiac
5341570|NCT00284570|cardiopulmonary bypass|cardiopulmonary bypass
5341571|NCT00284570|infection|infection
5341572|NCT00284570|sepsis|sepsis
5341573|NCT00284570|postoperative|postoperative
5341574|NCT00284570|marker for infection|marker for infection
5341575|NCT00284570|inflammation|inflammation
5341576|NCT00284570|cardiac surgery|cardiac surgery
5341577|NCT00284557|Behavioral/Social|behavioral/social
5341578|NCT00284557|Obesity|obesity
5341579|NCT00284557|Pediatrics|pediatrics
5341580|NCT00284557|Preventive Medicine|preventive medicine
5341581|NCT00284531|cardiac transplantation|cardiac transplantation
5341582|NCT00284531|allograft rejection|allograft rejection
5341583|NCT00284531|anti-CD25|anti-cd25
5341584|NCT00284505|cytokine|cytokine
5341585|NCT00284505|arachnoiditis|arachnoiditis
5341586|NCT00284505|neuropathic pain|neuropathic pain
5341587|NCT00284505|tumor necrosis factor|tumor necrosis factor
5341588|NCT00284492|Women|women
5341589|NCT00284492|Acupuncture|acupuncture
5341590|NCT00284492|Menopause|menopause
5341591|NCT00284492|Hot flashes|hot flashes
5341592|NCT00284492|Health related quality of life|health related quality of life
5341593|NCT00284479|walking intervention|walking intervention
5341594|NCT00284479|cardiovascular risk|cardiovascular risk
5341595|NCT00284479|inflammatory markers|inflammatory markers
5341596|NCT00284479|aerobic fitness|aerobic fitness
5341597|NCT00284479|fatness|fatness
5341598|NCT00284466|coronary artery disease|coronary artery disease
5341599|NCT00284466|cardiac catheterization|cardiac catheterization
5341600|NCT00284466|CT coronary angiography|ct coronary angiography
5341601|NCT00284466|coronary angiography|coronary angiography
5341602|NCT00284453|ventricular|ventricular
5341603|NCT00284453|arrhythmias|arrhythmias
5341605|NCT00284453|VT storm|vt storm
5341606|NCT00284453|ICD patients with VT storm|icd patients with vt storm
5341607|NCT00284440|Visual field progression|visual field progression
5341608|NCT00284440|Choroidal blood flow|choroidal blood flow
5341609|NCT00284401|Reversed prosthesis|reversed prosthesis
5341610|NCT00284336|breast cancer|breast cancer
5341611|NCT00284336|elderly|elderly
5341612|NCT00284336|adjuvant chemotherapy|adjuvant chemotherapy
5341613|NCT00284336|Caelyx|caelyx
5341614|NCT00284323|Acute Myocardial Infarction|acute myocardial infarction
5341615|NCT00284323|PCI|pci
5341616|NCT00284323|Adenosine|adenosine
5341617|NCT00284323|Postconditioning|postconditioning
5341618|NCT00284310|Wrist surgery: 4-corner arthrodesis or proximal row carpectomy|wrist surgery: 4-corner arthrodesis or proximal row carpectomy
5341619|NCT00284271|Hodgkin´s Lymphoma|hodgkin´s lymphoma
5341620|NCT00284271|eldery patients|eldery patients
5341621|NCT00284271|primary diagnosis|primary diagnosis
5341622|NCT00284258|Colorectal Cancer|colorectal cancer
5341623|NCT00284245|Chronic Pain|chronic pain
5341624|NCT00284245|Pain|pain
5341625|NCT00284245|Computer Analysis|computer analysis
5341626|NCT00284245|Pain Diagrams|pain diagrams
5341627|NCT00284232|HbA1c|hba1c
5341628|NCT00284232|Self-monitoring blood glucose (SMBG)|self-monitoring blood glucose (smbg)
5341629|NCT00284232|Diabetes treatment|diabetes treatment
5341630|NCT00284232|quality of care|quality of care
5341631|NCT00284219|rTMS, smoking, dopamine, acotinine|rtms, smoking, dopamine, acotinine
5341632|NCT00284206|methamphetamine, cognition, outpatient, risperidone|methamphetamine, cognition, outpatient, risperidone
5341633|NCT00284180|Breast Neoplasms|breast neoplasms
5341634|NCT00284180|Breast Cancer|breast cancer
5341635|NCT00284180|Vinflunine|vinflunine
5341636|NCT00284180|Vinca Alkaloid|vinca alkaloid
5341637|NCT00284180|Javlor|javlor
5341638|NCT00284167|tailored|tailored
5341639|NCT00284167|web-based|web-based
5341640|NCT00284167|weight management|weight management
5341641|NCT00284167|obesity|obesity
5341642|NCT00284167|efficacy|efficacy
5341643|NCT00284154|Extensive stage|extensive stage
5341644|NCT00284154|Relapsed|relapsed
5341645|NCT00284141|lung|lung
5341646|NCT00284141|cancer|cancer
5341647|NCT00284141|non-small-cell lung cancer|non-small-cell lung cancer
5341648|NCT00284141|metastatic|metastatic
5341649|NCT00284141|carcinoma|carcinoma
5341650|NCT00284141|lung neoplasm|lung neoplasm
5341651|NCT00284141|lung diseases|lung diseases
5341652|NCT00284141|angiogenesis|angiogenesis
5341653|NCT00284141|anti-angiogenesis|anti-angiogenesis
5341654|NCT00284141|anti-angiogenesis inhibitors|anti-angiogenesis inhibitors
5341655|NCT00284141|cancer and other neoplasms|cancer and other neoplasms
5341656|NCT00284141|respiratory tract|respiratory tract
5341657|NCT00284141|(lung and bronchial) diseases|(lung and bronchial) diseases
5341658|NCT00284128|Cardiovascular Disease C14|cardiovascular disease c14
5341659|NCT00284128|vascular disease C14.907|vascular disease c14.907
5341660|NCT00284128|hypertension C14.907.489|hypertension c14.907.489
5341661|NCT00284115|Gait trainer|gait trainer
5341662|NCT00284115|Hemiplegia|hemiplegia
5341663|NCT00284115|Rehabilitation|rehabilitation
5341664|NCT00284115|Stroke|stroke
5341665|NCT00284102|gas exchange|gas exchange
5341666|NCT00284102|dead space|dead space
5341667|NCT00284102|respiratory failure|respiratory failure
5341668|NCT00284102|ALI/ARDS patients|ali/ards patients
5341669|NCT00284089|Subfoveal CNV, AMD, ranibizumab|subfoveal cnv, amd, ranibizumab
5341670|NCT00284063|spinal manipulation, zygapophysial joints|spinal manipulation, zygapophysial joints
5341671|NCT00284050|DME|dme
5341672|NCT00284050|Diabetic macular edema|diabetic macular edema
5341673|NCT00284050|ranibizumab|ranibizumab
5341674|NCT00284050|Diabetic macular edema with center involvement|diabetic macular edema with center involvement
5341675|NCT00284037|obstructive sleep apnea,|obstructive sleep apnea,
5341676|NCT00284037|baroreceptors|baroreceptors
5341677|NCT00284024|breastfeeding|breastfeeding
5341678|NCT00284024|domperidone|domperidone
5341679|NCT00284024|efficacy|efficacy
5341680|NCT00284024|randomized controlled trial|randomized controlled trial
5341681|NCT00284024|compliance|compliance
5341682|NCT00284011|SAMe|same
5341683|NCT00284011|AdoMet|adomet
5341684|NCT00284011|Methylation|methylation
5341685|NCT00284011|Homocysteine|homocysteine
5341686|NCT00284011|Dietary Supplement|dietary supplement
5341687|NCT00284011|S-Adenosyl-L-Methionine|s-adenosyl-l-methionine
5341688|NCT00283998|Odontoid|odontoid
5341689|NCT00283998|Type II fractures|type ii fractures
5341690|NCT00283998|Elderly patients|elderly patients
5341691|NCT00283998|Surgical vs. conservative treatment|surgical vs. conservative treatment
5341692|NCT00283985|NK/T-cell lymphoma|nk/t-cell lymphoma
5341693|NCT00283985|Lymphoma|lymphoma
5341694|NCT00283985|L-asparaginase|l-asparaginase
5341695|NCT00283985|Nasal NK-cell lymphoma|nasal nk-cell lymphoma
5341696|NCT00283985|Nasal-type NK-cell Lymphoma|nasal-type nk-cell lymphoma
5341697|NCT00283972|Health Outcome Study|health outcome study
5341698|NCT00283946|zolpidem|zolpidem
5341699|NCT00283946|sleep initiation and maintenance disorders Hypnotics and sedatives|sleep initiation and maintenance disorders hypnotics and sedatives
5341700|NCT00283946|double-blind study|double-blind study
5341701|NCT00283946|comparative study|comparative study
5341702|NCT00283933|Amicus Therapeutics|amicus therapeutics
5341703|NCT00283933|AT1001|at1001
5341704|NCT00283933|Migalastat|migalastat
5341705|NCT00283933|Pharmacokinetics|pharmacokinetics
5341706|NCT00283933|Substrate|substrate
5341707|NCT00283920|Pharmacokinetics|pharmacokinetics
5341708|NCT00283920|Compartmental Analysis|compartmental analysis
5341709|NCT00283920|Distribution Volume|distribution volume
5341710|NCT00283920|Identitiability|identitiability
5341711|NCT00283920|Healthy Volunteer|healthy volunteer
5341712|NCT00283920|HV|hv
5341713|NCT00283907|Electroencephalogram (EEG)|electroencephalogram (eeg)
5341714|NCT00283907|Sense of Agency|sense of agency
5341715|NCT00283907|Coherence|coherence
5341716|NCT00283907|Voluntary Movement|voluntary movement
5341717|NCT00283907|Self-Agency|self-agency
5341718|NCT00283907|Healthy Volunteer|healthy volunteer
5341719|NCT00283907|HV|hv
5341720|NCT00283894|Obesity|obesity
5341721|NCT00283894|Leptin|leptin
5341722|NCT00283894|Sleep Attacks|sleep attacks
5341723|NCT00283894|Energy Metabolism|energy metabolism
5341724|NCT00283894|Healthy Control|healthy control
5341725|NCT00283894|Narcolepsy|narcolepsy
5341726|NCT00283894|Healthy Volunteer|healthy volunteer
5341727|NCT00283894|HV|hv
5341728|NCT00283881|Haptic Skills|haptic skills
5341729|NCT00283881|Implicit Tactile Learning|implicit tactile learning
5341730|NCT00283881|Functional Magnetic Resonance Imaging (fMRI)|functional magnetic resonance imaging (fmri)
5341731|NCT00283881|Transcranial Magnetic Stimulation (TMS)|transcranial magnetic stimulation (tms)
5341732|NCT00283881|Transcranial Direct Current Stimulation (tDCS)|transcranial direct current stimulation (tdcs)
5341733|NCT00283881|Stroke|stroke
5341734|NCT00283881|Healthy Volunteer|healthy volunteer
5341735|NCT00283881|HV|hv
5341736|NCT00283868|stroke|stroke
5341737|NCT00283868|digital video|digital video
5341738|NCT00283868|SPOTRIAS|spotrias
5341739|NCT00283855|Rheumatoid Arthritis|rheumatoid arthritis
5341740|NCT00283855|Self-Management|self-management
5341741|NCT00283855|Internet|internet
5341742|NCT00283842|neuropathic pain|neuropathic pain
5341743|NCT00283842|diabetic peripheral neuropathy|diabetic peripheral neuropathy
5341744|NCT00283829|Immunotherapy|immunotherapy
5341745|NCT00283816|Polycystic Ovary Syndrome|polycystic ovary syndrome
5341746|NCT00283816|Overweight Adolescent Girls|overweight adolescent girls
5341747|NCT00283816|Irregular Menstrual Cycles|irregular menstrual cycles
5341748|NCT00283777|insulin|insulin
5341749|NCT00283777|glucose|glucose
5341750|NCT00283777|body weight|body weight
5341751|NCT00283777|chromium|chromium
5341752|NCT00283738|migraine|migraine
5341753|NCT00283738|aura|aura
5341754|NCT00283738|Patent Foramen Ovale (PFO)|patent foramen ovale (pfo)
5341755|NCT00283738|cardiac defects|cardiac defects
5341756|NCT00283738|Heart Septal Defects, Atrial|heart septal defects, atrial
5341757|NCT00283738|Cephalalgia|cephalalgia
5341758|NCT00283725|Dementia|dementia
5341759|NCT00283725|Alzheimer's Disease|alzheimer's disease
5341760|NCT00283725|Acetylcholinesterase inhibitor|acetylcholinesterase inhibitor
5341761|NCT00283725|Galantamine|galantamine
5341762|NCT00283725|Nursing Home Admission|nursing home admission
5341763|NCT00283712|Skin Diseases|skin diseases
5341764|NCT00283712|Autoimmune Diseases|autoimmune diseases
5341765|NCT00283699|neurocysticercosis|neurocysticercosis
5341766|NCT00283699|albendazole|albendazole
5341767|NCT00283699|tape worm|tape worm
5341768|NCT00283686|polycystic kidney disease|polycystic kidney disease
5341769|NCT00283686|polycystic|polycystic
5341770|NCT00283686|kidney|kidney
5341771|NCT00283686|disease|disease
5341772|NCT00283686|adpkd|adpkd
5341773|NCT00283686|halt|halt
5341774|NCT00283686|pkd|pkd
5341775|NCT00283686|blood pressure|blood pressure
5341776|NCT00283686|bp|bp
5341777|NCT00283686|hypertension|hypertension
5341778|NCT00283686|renal|renal
5341779|NCT00283686|renin-angiotensin-aldosterone-system|renin-angiotensin-aldosterone-system
5341780|NCT00283686|RAAS|raas
5341781|NCT00283660|Zinc|zinc
5341782|NCT00283660|Dietary Supplements|dietary supplements
5341783|NCT00283660|Nutritional Supplements|nutritional supplements
5341784|NCT00283660|Child|child
5341785|NCT00283660|Mental Health|mental health
5341786|NCT00283660|School|school
5341787|NCT00283660|Guatemala|guatemala
5341788|NCT00283647|lead exposure|lead exposure
5341789|NCT00283647|magnetic resonance imaging|magnetic resonance imaging
5341790|NCT00283647|magnetic resonance spectroscopy|magnetic resonance spectroscopy
5341791|NCT00283647|functional magnetic resonance|functional magnetic resonance
5341792|NCT00283647|brain development|brain development
5341793|NCT00283621|Aranesp|aranesp
5341794|NCT00283621|Darbepoetin Alfa|darbepoetin alfa
5341795|NCT00283621|Pegfilgrastim|pegfilgrastim
5341796|NCT00283621|Neulasta|neulasta
5341797|NCT00283621|Sarcoma|sarcoma
5341798|NCT00283621|Adriamycin|adriamycin
5341799|NCT00283621|Doxorubicin Hydrocholoride|doxorubicin hydrocholoride
5341800|NCT00283621|Adriamycin PFS|adriamycin pfs
5341801|NCT00283621|Adriamycin RDF|adriamycin rdf
5341802|NCT00283621|Ifosfamide|ifosfamide
5341803|NCT00283608|stage I breast cancer|stage i breast cancer
5341804|NCT00283608|stage II breast cancer|stage ii breast cancer
5341805|NCT00283608|stage IIIA breast cancer|stage iiia breast cancer
5341806|NCT00283608|stage IIIB breast cancer|stage iiib breast cancer
5341807|NCT00283608|stage IIIC breast cancer|stage iiic breast cancer
5341808|NCT00283595|Anorexia Nervosa|anorexia nervosa
5341809|NCT00283595|Eating disorder|eating disorder
5341810|NCT00283595|Bone|bone
5341811|NCT00283595|Growth hormone|growth hormone
5341812|NCT00283595|Osteopenia|osteopenia
5341813|NCT00283595|Osteoporosis|osteoporosis
5341814|NCT00283569|Glioma|glioma
5341815|NCT00283556|High Dose Irinotecan|high dose irinotecan
5341816|NCT00283556|CPT-11|cpt-11
5341817|NCT00283556|Camptosar|camptosar
5341818|NCT00283556|Malignant Glioma|malignant glioma
5341819|NCT00283556|Unresectable|unresectable
5341820|NCT00283543|Glioma|glioma
5341821|NCT00283543|Gliadel Wafer|gliadel wafer
5341822|NCT00283530|Cancer|cancer
5341823|NCT00283530|Cancer receiving chemotherapy|cancer receiving chemotherapy
5341824|NCT00283530|Tumor biopsy|tumor biopsy
5341825|NCT00283517|Risperidone long-acting injection|risperidone long-acting injection
5341826|NCT00283517|Antipsychotic medication|antipsychotic medication
5341827|NCT00283517|Schizophrenia|schizophrenia
5341828|NCT00283517|Treatment retention|treatment retention
5341829|NCT00283517|Observational study|observational study
5341830|NCT00283491|Iron absorption|iron absorption
5341831|NCT00283491|Organic acids|organic acids
5341832|NCT00283491|Lactobacillus|lactobacillus
5341833|NCT00283491|Probiotic|probiotic
5341834|NCT00283478|Advanced stage|advanced stage
5341835|NCT00283478|Lung cancer|lung cancer
5341836|NCT00283465|Anemia|anemia
5341837|NCT00283465|cancer|cancer
5341838|NCT00283465|neoplasm|neoplasm
5341839|NCT00283465|transfusion|transfusion
5341840|NCT00283465|quality of life|quality of life
5341841|NCT00283465|tumor response|tumor response
5341842|NCT00283465|survival|survival
5341843|NCT00283465|chemotherapy|chemotherapy
5341844|NCT00283465|hemoglobin|hemoglobin
5341845|NCT00283465|standard care|standard care
5341846|NCT00283465|epoetin alfa|epoetin alfa
5341847|NCT00283465|epoetin|epoetin
5341848|NCT00283465|erythropoietin|erythropoietin
5341849|NCT00283452|Physical activity maintenance|physical activity maintenance
5341850|NCT00283452|Interactive phone and mail-based intervention|interactive phone and mail-based intervention
5341851|NCT00283452|Older adults|older adults
5341852|NCT00283439|NHL|nhl
5341853|NCT00283439|chemotherapy induced thrombocytopenia|chemotherapy induced thrombocytopenia
5341854|NCT00283439|CIT|cit
5341855|NCT00283439|ICE|ice
5341856|NCT00283439|RICE|rice
5341857|NCT00283439|Hodgkin's Lymphoma|hodgkin's lymphoma
5341858|NCT00283439|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
5341859|NCT00283439|CHOP|chop
5341860|NCT00283439|ESHAP|eshap
5341861|NCT00283439|DHAP|dhap
5341862|NCT00283439|R-CHOP|r-chop
5341863|NCT00283439|R-ESHAP|r-eshap
5341864|NCT00283439|R-DHAP|r-dhap
5341865|NCT00283413|Covered Stent System|covered stent system
5341866|NCT00283413|Saphenous Vein Graft|saphenous vein graft
5341867|NCT00283413|Coronary Artery Bypass[MeSH]|coronary artery bypass[mesh]
5341868|NCT00283413|Stents[MeSH]|stents[mesh]
5341869|NCT00283400|subarachnoid hemorrhage|subarachnoid hemorrhage
5341870|NCT00283400|SAH|sah
5341871|NCT00283400|human albumin|human albumin
5341872|NCT00283400|HA|ha
5341873|NCT00283400|cerebral vasospasm|cerebral vasospasm
5341874|NCT00283400|aneurysm|aneurysm
5341875|NCT00283400|neuroprotective|neuroprotective
5341876|NCT00283387|Primary Hyperoxaluria|primary hyperoxaluria
5341877|NCT00283374|Metabolic Syndrome|metabolic syndrome
5341878|NCT00283374|Obesity|obesity
5341879|NCT00283374|Nonalcoholic fatty liver disease|nonalcoholic fatty liver disease
5341880|NCT00283374|Nonalcoholic steatohepatitis|nonalcoholic steatohepatitis
5341881|NCT00283374|Bariatric Surgery|bariatric surgery
5341882|NCT00283348|Renal Transplantation|renal transplantation
5341883|NCT00283348|Immunosuppression|immunosuppression
5341884|NCT00283348|Chronic Rejection|chronic rejection
5341885|NCT00283322|Heparin Induced Thrombocytopenia|heparin induced thrombocytopenia
5341886|NCT00283322|HIT|hit
5341887|NCT00283322|HITT|hitt
5341888|NCT00283322|Thrombosis|thrombosis
5341889|NCT00283322|Thromboembolism|thromboembolism
5341890|NCT00283309|Corticosteroids|corticosteroids
5341891|NCT00283309|Riluzole|riluzole
5341892|NCT00283309|Memantine|memantine
5341893|NCT00283309|Memory|memory
5341894|NCT00283296|manual wheelchair|manual wheelchair
5341895|NCT00283296|assistive technology|assistive technology
5341896|NCT00283296|travel wheelchair|travel wheelchair
5341897|NCT00283283|Influenza|influenza
5341898|NCT00283270|Mental health|mental health
5341899|NCT00283270|Screening|screening
5341900|NCT00283270|Elderly|elderly
5341901|NCT00283270|Chinese|chinese
5341902|NCT00283270|Problem-solving counselling|problem-solving counselling
5341903|NCT00283257|Problem solving|problem solving
5341904|NCT00283257|psychosocial support|psychosocial support
5341905|NCT00283244|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5341906|NCT00283244|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5341907|NCT00283231|Hot Flashes|hot flashes
5341908|NCT00283231|Menopausal Symptoms|menopausal symptoms
5341909|NCT00283231|Paced respiration|paced respiration
5341910|NCT00283231|RESPeRATE|resperate
5341911|NCT00283205|Menopausal Symptoms|menopausal symptoms
5341912|NCT00283205|Hot Flashes|hot flashes
5341913|NCT00283205|Yoga|yoga
5341914|NCT00283192|Menopausal Symptoms|menopausal symptoms
5341915|NCT00283192|Hot flashes|hot flashes
5341916|NCT00283179|Aripiprazole|aripiprazole
5341917|NCT00283179|Risperidone|risperidone
5341918|NCT00283179|Schizophrenia|schizophrenia
5341919|NCT00283179|Schizoaffective disorder|schizoaffective disorder
5341920|NCT00283166|Palliative Care|palliative care
5341921|NCT00283153|Traumatic Brain Injury|traumatic brain injury
5341922|NCT00283153|Stroke|stroke
5341923|NCT00283153|Emotion Recognition|emotion recognition
5341924|NCT00283153|Affect|affect
5341925|NCT00283153|Interventions|interventions
5341926|NCT00283127|Chlamydia trachomatis|chlamydia trachomatis
5341927|NCT00283127|Mass screening|mass screening
5341928|NCT00283127|Home sampling|home sampling
5341929|NCT00283127|Urine test|urine test
5341930|NCT00283114|Lintuzumab|lintuzumab
5341931|NCT00283114|Antigens, CD33|antigens, cd33
5341932|NCT00283114|Antibodies, Monoclonal|antibodies, monoclonal
5341933|NCT00283114|Leukemia, Myeloid, Acute|leukemia, myeloid, acute
5341934|NCT00283114|Myelodysplastic Syndromes|myelodysplastic syndromes
5341935|NCT00283114|Hematologic Diseases|hematologic diseases
5341936|NCT00283114|Myeloproliferative Disorders|myeloproliferative disorders
5341937|NCT00283114|Leukemia|leukemia
5341938|NCT00283101|Antigens, CD40|antigens, cd40
5341939|NCT00283101|Antibody, Monoclonal|antibody, monoclonal
5341940|NCT00283101|Leukemia, Lymphocytic, Chronic, B-Cell|leukemia, lymphocytic, chronic, b-cell
5341941|NCT00283101|Hematologic Diseases|hematologic diseases
5341942|NCT00283101|Immunoproliferatic Disorders|immunoproliferatic disorders
5341943|NCT00283101|Lymphatic Diseases|lymphatic diseases
5341944|NCT00283101|Lymphoproliferative Disorders|lymphoproliferative disorders
5341945|NCT00283101|Leukemia|leukemia
5341946|NCT00283088|stroke|stroke
5341947|NCT00283088|hypothermia|hypothermia
5341948|NCT00283088|cooling|cooling
5341949|NCT00283088|tissue plasminogen activator|tissue plasminogen activator
5341950|NCT00283088|tPA|tpa
5341951|NCT00283088|thrombolysis|thrombolysis
5341952|NCT00283075|intraabdominal cancer (carcinomas)|intraabdominal cancer (carcinomas)
5341953|NCT00283075|agarose macrobeads|agarose macrobeads
5341954|NCT00283075|mouse kidney cancer cells|mouse kidney cancer cells
5341955|NCT00283075|cancer cell growth inhibition|cancer cell growth inhibition
5341956|NCT00283023|All selective craniotomy|all selective craniotomy
5341957|NCT00283010|cognitive enhancement|cognitive enhancement
5341958|NCT00283010|memory|memory
5341959|NCT00283010|auditory memory|auditory memory
5341960|NCT00283010|speech|speech
5341961|NCT00283010|computerized|computerized
5341962|NCT00283010|cognitive decline|cognitive decline
5341963|NCT00282971|Type 2 diabetes melllitus|type 2 diabetes melllitus
5341964|NCT00282893|aneurysm|aneurysm
5341965|NCT00282893|vasospasm|vasospasm
5341966|NCT00282893|subarachnoid hemorrhage|subarachnoid hemorrhage
5341967|NCT00282893|transluminal ballooning|transluminal ballooning
5341968|NCT00282867|stroke|stroke
5341969|NCT00282867|acute ischemic stroke|acute ischemic stroke
5341970|NCT00282867|hyperglycemia|hyperglycemia
5341971|NCT00282867|glucose|glucose
5341972|NCT00282867|insulin|insulin
5341973|NCT00282867|insulin and potassium therapy|insulin and potassium therapy
5341974|NCT00282867|GIK|gik
5341975|NCT00282854|epilepsy|epilepsy
5341976|NCT00282854|Rolandic epilepsy|rolandic epilepsy
5341977|NCT00282841|stroke|stroke
5341978|NCT00282841|ultrasound|ultrasound
5341979|NCT00282841|occlusion|occlusion
5341980|NCT00282841|blockage|blockage
5341981|NCT00282841|contrast solution|contrast solution
5341982|NCT00282828|Social Anxiety Disorder|social anxiety disorder
5341983|NCT00282828|Pharmacotherapy|pharmacotherapy
5341984|NCT00282828|Genetics|genetics
5341985|NCT00282828|Treatment Refractory|treatment refractory
5341986|NCT00282815|obstructive sleep apnea|obstructive sleep apnea
5341987|NCT00282815|stroke|stroke
5341988|NCT00282815|OSA|osa
5341989|NCT00282815|CPAP|cpap
5341990|NCT00282815|continuous positive airway pressure|continuous positive airway pressure
5341991|NCT00282802|Parkinson's Disease|parkinson's disease
5341992|NCT00282802|twins|twins
5341993|NCT00282802|SPECT|spect
5341994|NCT00282802|National Academy of Sciences/National Resource Council (NAS/NRC) World War II Veteran Twins Cohort Registry|national academy of sciences/national resource council (nas/nrc) world war ii veteran twins cohort registry
5341995|NCT00282802|NAS/NRC|nas/nrc
5341996|NCT00282802|World War II Veteran Twins|world war ii veteran twins
5341997|NCT00282776|Postpartum Depression|postpartum depression
5341998|NCT00282776|Telephone Care Management|telephone care management
5341999|NCT00282776|Screening for Postpartum Depression|screening for postpartum depression
5342000|NCT00282750|"Surgery[MeSH]"|"surgery[mesh]"
5342001|NCT00282750|"Surgical Sponges[MeSH]"|"surgical sponges[mesh]"
5342002|NCT00282750|"Automatic Data Processing[MeSH]"|"automatic data processing[mesh]"
5342003|NCT00282724|Lamellar ichthyosis|lamellar ichthyosis
5342004|NCT00282724|Liarozole|liarozole
5342005|NCT00282724|Investigator's Global Assessment|investigator's global assessment
5342006|NCT00282724|Scaling|scaling
5342007|NCT00282711|Diagnostic Techniques, Radioisotope|diagnostic techniques, radioisotope
5342008|NCT00282711|Radionuclide Imaging|radionuclide imaging
5342009|NCT00282711|Diagnostic Techniques, Cardiovascular|diagnostic techniques, cardiovascular
5342010|NCT00282711|Heart Function tests|heart function tests
5342011|NCT00282685|Patients with symmetric peripheral diabetic neuropathy|patients with symmetric peripheral diabetic neuropathy
5342012|NCT00282672|Barrett's Esophagus|barrett's esophagus
5342013|NCT00282672|Dysplasia|dysplasia
5342014|NCT00282672|Radiofrequency Ablation|radiofrequency ablation
5342015|NCT00282659|Hemodynamics|hemodynamics
5342016|NCT00282659|Hypertension|hypertension
5342017|NCT00282659|Dyslipidemia|dyslipidemia
5342018|NCT00282659|Diabetes|diabetes
5342019|NCT00282659|Implantable Cardioverter Defibrillator|implantable cardioverter defibrillator
5342020|NCT00282659|Blood Pressure|blood pressure
5342021|NCT00282646|critical limb ischemia|critical limb ischemia
5342022|NCT00282646|peripheral arterial occlusive disease|peripheral arterial occlusive disease
5342023|NCT00282646|[C14.907.137]|[c14.907.137]
5342024|NCT00282633|Cesarean Delivery|cesarean delivery
5342025|NCT00282633|Wound closure|wound closure
5342026|NCT00282633|Suture|suture
5342027|NCT00282633|Alternative therapy|alternative therapy
5342028|NCT00282633|Surgery|surgery
5342029|NCT00282620|Implantable Cardioverter Defibrillator|implantable cardioverter defibrillator
5342030|NCT00282620|Magnesium|magnesium
5342031|NCT00282620|Electrocardiogram|electrocardiogram
5342032|NCT00282620|Ventricular Arrhythmia|ventricular arrhythmia
5342033|NCT00282607|Erectile Dysfunction|erectile dysfunction
5342034|NCT00282594|Intensive Insulin Therapy|intensive insulin therapy
5342035|NCT00282594|General Surgical|general surgical
5342036|NCT00282594|Vascular Surgical|vascular surgical
5342037|NCT00282594|Tight Glycemic Control|tight glycemic control
5342038|NCT00282581|HIV|hiv
5342039|NCT00282581|Smallpox|smallpox
5342040|NCT00282581|MVA|mva
5342041|NCT00282568|Pharmacokinetics|pharmacokinetics
5342042|NCT00282568|Therapy|therapy
5342043|NCT00282568|Immunosuppression|immunosuppression
5342044|NCT00282568|Drugs, Investigational|drugs, investigational
5342045|NCT00282568|Adult|adult
5342046|NCT00282555|Esophagitis, Reflux|esophagitis, reflux
5342047|NCT00282555|S-Tenatoprazole-Na|s-tenatoprazole-na
5342048|NCT00282555|Heartburn|heartburn
5342049|NCT00282555|Esophageal endoscopy|esophageal endoscopy
5342050|NCT00282542|Hepatocytes|hepatocytes
5342051|NCT00282529|lymphedema, screening, treatment|lymphedema, screening, treatment
5342052|NCT00282516|asthma|asthma
5342053|NCT00282516|telemedicine|telemedicine
5342054|NCT00282516|case management|case management
5342055|NCT00282516|clinic|clinic
5342056|NCT00282516|children|children
5342057|NCT00282516|pediatric|pediatric
5342058|NCT00282503|aGvHD|agvhd
5342059|NCT00282490|Overactive bladder|overactive bladder
5342060|NCT00282490|Children|children
5342061|NCT00282490|Nerve stimulation|nerve stimulation
5342062|NCT00282490|TENS|tens
5342063|NCT00282477|cyclist|cyclist
5342064|NCT00282464|Bipolar I Depression|bipolar i depression
5342065|NCT00282399|Myelodysplastic Syndrome|myelodysplastic syndrome
5342066|NCT00282399|MGI Pharma|mgi pharma
5342067|NCT00282399|Decitabine|decitabine
5342068|NCT00282399|Dacogen|dacogen
5342069|NCT00282360|coronary artery disease|coronary artery disease
5342070|NCT00282360|diabetes mellitus|diabetes mellitus
5342071|NCT00282347|Class IV LN|class iv ln
5342072|NCT00282347|Lupus|lupus
5342073|NCT00282347|LUNAR|lunar
5342075|NCT00282334|Telemedicine|telemedicine
5342076|NCT00282334|Blood pressure|blood pressure
5342077|NCT00282334|Quality of life|quality of life
5342078|NCT00282334|Cost-effectiveness|cost-effectiveness
5342079|NCT00282308|RA|ra
5342080|NCT00282308|Rituxan|rituxan
5342081|NCT00282308|SIERRA|sierra
5342082|NCT00282295|tetanus|tetanus
5342083|NCT00282295|pertussis|pertussis
5342084|NCT00282295|Prophylaxis|prophylaxis
5342085|NCT00282295|meningococcus|meningococcus
5342086|NCT00282295|diptheria|diptheria
5342087|NCT00282282|non-myeloablative peripheral blood stem cell|non-myeloablative peripheral blood stem cell
5342088|NCT00282282|PBSCT|pbsct
5342089|NCT00282282|tacrolimus|tacrolimus
5342090|NCT00282282|sirolimus|sirolimus
5342091|NCT00282269|Traumatic Brain Injury|traumatic brain injury
5342092|NCT00282269|Children|children
5342093|NCT00282269|Hypothermia|hypothermia
5342094|NCT00282269|Outcome|outcome
5342095|NCT00282269|Intensive Care|intensive care
5342096|NCT00282269|Magnetic resonance Imaging|magnetic resonance imaging
5342097|NCT00282256|Child|child
5342098|NCT00282256|Pharmacokinetics|pharmacokinetics
5342099|NCT00282256|Immunosuppression Drugs|immunosuppression drugs
5342100|NCT00282256|Hepatic transplant|hepatic transplant
5342101|NCT00282256|Liver Transplantation|liver transplantation
5342102|NCT00282243|Pharmacokinetics|pharmacokinetics
5342103|NCT00282243|Therapy|therapy
5342104|NCT00282243|Immunosuppression|immunosuppression
5342105|NCT00282243|Drugs, Investigational|drugs, investigational
5342106|NCT00282243|Adult|adult
5342107|NCT00282230|Malononitrilamide|malononitrilamide
5342108|NCT00282230|immunosuppression|immunosuppression
5342109|NCT00282230|treatment efficacy|treatment efficacy
5342110|NCT00282230|treatment outcome|treatment outcome
5342111|NCT00282217|Kidney Failure|kidney failure
5342112|NCT00282217|Kidney Transplant|kidney transplant
5342113|NCT00282217|Graft Rejection|graft rejection
5342114|NCT00282217|Kidney Transplantation|kidney transplantation
5342115|NCT00282204|Hypnosis|hypnosis
5342116|NCT00282204|Hypnotherapy|hypnotherapy
5342117|NCT00282204|Childbirth|childbirth
5342118|NCT00282204|Analgesia|analgesia
5342119|NCT00282191|spasticity|spasticity
5342120|NCT00282191|mental retardation|mental retardation
5342121|NCT00282178|Metabolic|metabolic
5342122|NCT00282178|Hypertension|hypertension
5342123|NCT00282178|Abdominal obesity|abdominal obesity
5342124|NCT00282178|Insulin sensitivity|insulin sensitivity
5342125|NCT00282178|Hyperinsulinemic euglycemic clamp|hyperinsulinemic euglycemic clamp
5342126|NCT00282152|Early Stage Parkinson's Disease|early stage parkinson's disease
5342127|NCT00282152|Parkinson's Disease|parkinson's disease
5342128|NCT00282152|Deep Brain Stimulation|deep brain stimulation
5342129|NCT00282152|PD|pd
5342130|NCT00282152|DBS|dbs
5342131|NCT00282126|Calcium balance|calcium balance
5342132|NCT00282113|Probiotic|probiotic
5342133|NCT00282113|Prebiotic|prebiotic
5342134|NCT00282113|NEC|nec
5342135|NCT00282113|Premature infants|premature infants
5342136|NCT00282113|commensal flora|commensal flora
5342137|NCT00282087|early stage|early stage
5342138|NCT00282087|high grade|high grade
5342139|NCT00282087|uterine leiomyosarcoma|uterine leiomyosarcoma
5342140|NCT00282087|adjuvant treatment|adjuvant treatment
5342141|NCT00282061|3 conditions in a within-subject design:|3 conditions in a within-subject design:
5342142|NCT00282061|1-ad-lib sleep wake|1-ad-lib sleep wake
5342143|NCT00282061|2-forced morning wake-up|2-forced morning wake-up
5342144|NCT00282061|3- ad-lib sleep wake after treatment with melatonin|3- ad-lib sleep wake after treatment with melatonin
5342145|NCT00282035|breast cancer|breast cancer
5342146|NCT00282035|breast tumour|breast tumour
5342147|NCT00282035|DCIS|dcis
5342148|NCT00282035|female|female
5342149|NCT00282035|breast conserving surgery|breast conserving surgery
5342150|NCT00282035|irradiation|irradiation
5342151|NCT00282035|whole breast irradiation|whole breast irradiation
5342152|NCT00282035|3D CRT accelerated partial breast irradiation|3d crt accelerated partial breast irradiation
5342153|NCT00282035|cosmetic outcome|cosmetic outcome
5342154|NCT00282035|quality of life|quality of life
5342155|NCT00282022|recurrent small cell lung cancer|recurrent small cell lung cancer
5342156|NCT00282022|extensive stage small cell lung cancer|extensive stage small cell lung cancer
5342157|NCT00282022|limited stage small cell lung cancer|limited stage small cell lung cancer
5342158|NCT00282009|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5342159|NCT00281996|recurrent pancreatic cancer|recurrent pancreatic cancer
5342160|NCT00281996|stage III pancreatic cancer|stage iii pancreatic cancer
5342161|NCT00281996|stage IV pancreatic cancer|stage iv pancreatic cancer
5342162|NCT00281983|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
5342163|NCT00281983|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5342164|NCT00281983|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5342165|NCT00281983|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5342166|NCT00281983|Waldenström macroglobulinemia|waldenström macroglobulinemia
5342167|NCT00281970|stage I non-small cell lung cancer|stage i non-small cell lung cancer
5342168|NCT00281970|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
5342169|NCT00281970|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5342170|NCT00281970|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5342171|NCT00281931|prolymphocytic leukemia|prolymphocytic leukemia
5342172|NCT00281918|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
5342767|NCT00280527|Obesity|obesity
5342173|NCT00281918|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
5342174|NCT00281918|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
5342175|NCT00281918|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5342176|NCT00281918|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5342177|NCT00281905|untreated childhood brain stem glioma|untreated childhood brain stem glioma
5342178|NCT00281905|childhood high-grade cerebral astrocytoma|childhood high-grade cerebral astrocytoma
5342179|NCT00281905|childhood low-grade cerebral astrocytoma|childhood low-grade cerebral astrocytoma
5342180|NCT00281905|untreated childhood cerebellar astrocytoma|untreated childhood cerebellar astrocytoma
5342181|NCT00281905|childhood choroid plexus tumor|childhood choroid plexus tumor
5342182|NCT00281905|childhood infratentorial ependymoma|childhood infratentorial ependymoma
5342183|NCT00281905|childhood supratentorial ependymoma|childhood supratentorial ependymoma
5342184|NCT00281905|newly diagnosed childhood ependymoma|newly diagnosed childhood ependymoma
5342185|NCT00281905|untreated childhood medulloblastoma|untreated childhood medulloblastoma
5342186|NCT00281905|childhood oligodendroglioma|childhood oligodendroglioma
5342187|NCT00281905|untreated childhood supratentorial primitive neuroectodermal tumor|untreated childhood supratentorial primitive neuroectodermal tumor
5342188|NCT00281905|disseminated neuroblastoma|disseminated neuroblastoma
5342189|NCT00281905|localized resectable neuroblastoma|localized resectable neuroblastoma
5342190|NCT00281905|localized unresectable neuroblastoma|localized unresectable neuroblastoma
5342191|NCT00281905|regional neuroblastoma|regional neuroblastoma
5342192|NCT00281905|stage 4S neuroblastoma|stage 4s neuroblastoma
5342193|NCT00281892|anemia|anemia
5342194|NCT00281892|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5342195|NCT00281892|stage 0 chronic lymphocytic leukemia|stage 0 chronic lymphocytic leukemia
5342196|NCT00281892|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
5342197|NCT00281892|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
5342198|NCT00281892|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5342199|NCT00281892|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5342200|NCT00281879|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5342201|NCT00281879|L1 adult acute lymphoblastic leukemia|l1 adult acute lymphoblastic leukemia
5342202|NCT00281879|L2 adult acute lymphoblastic leukemia|l2 adult acute lymphoblastic leukemia
5342203|NCT00281879|L3 adult acute lymphoblastic leukemia|l3 adult acute lymphoblastic leukemia
5342204|NCT00281879|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5342205|NCT00281879|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5342206|NCT00281879|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5342207|NCT00281879|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5342208|NCT00281879|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5342209|NCT00281879|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
5342210|NCT00281879|L1 childhood acute lymphoblastic leukemia|l1 childhood acute lymphoblastic leukemia
5342211|NCT00281879|L2 childhood acute lymphoblastic leukemia|l2 childhood acute lymphoblastic leukemia
5342212|NCT00281879|L3 childhood acute lymphoblastic leukemia|l3 childhood acute lymphoblastic leukemia
5342213|NCT00281879|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5342214|NCT00281879|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5342215|NCT00281879|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
5342216|NCT00281879|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5342217|NCT00281879|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
5342218|NCT00281879|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5342219|NCT00281879|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5342220|NCT00281879|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5342221|NCT00281879|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5342222|NCT00281879|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
5342223|NCT00281879|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5342224|NCT00281879|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5342225|NCT00281879|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
5342226|NCT00281879|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5342227|NCT00281879|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5342228|NCT00281879|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5342229|NCT00281879|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
5342230|NCT00281879|refractory anemia with excess blasts|refractory anemia with excess blasts
5342231|NCT00281879|refractory anemia|refractory anemia
5342232|NCT00281879|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5342233|NCT00281879|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
5342234|NCT00281879|chronic eosinophilic leukemia|chronic eosinophilic leukemia
5342235|NCT00281879|primary myelofibrosis|primary myelofibrosis
5342236|NCT00281879|chronic neutrophilic leukemia|chronic neutrophilic leukemia
5342237|NCT00281879|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5342958|NCT00279682|depression|depression
5342238|NCT00281879|atypical chronic myeloid leukemia, BCR-ABL negative|atypical chronic myeloid leukemia, bcr-abl negative
5342239|NCT00281879|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5342240|NCT00281879|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
5342241|NCT00281879|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5342242|NCT00281879|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
5342243|NCT00281879|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5342244|NCT00281879|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
5342245|NCT00281879|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
5342246|NCT00281879|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
5342247|NCT00281879|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
5342248|NCT00281879|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5342249|NCT00281879|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5342250|NCT00281879|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5342251|NCT00281879|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5342252|NCT00281879|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
5342253|NCT00281879|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
5342254|NCT00281879|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5342255|NCT00281879|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5342256|NCT00281879|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5342257|NCT00281879|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5342258|NCT00281879|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5342259|NCT00281879|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5342260|NCT00281879|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
5342261|NCT00281879|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
5342262|NCT00281879|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
5342263|NCT00281879|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5342264|NCT00281879|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5342265|NCT00281879|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5342266|NCT00281879|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5342267|NCT00281879|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5342268|NCT00281879|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5342269|NCT00281879|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5342270|NCT00281879|refractory hairy cell leukemia|refractory hairy cell leukemia
5342271|NCT00281879|refractory multiple myeloma|refractory multiple myeloma
5342272|NCT00281879|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5342273|NCT00281879|stage I multiple myeloma|stage i multiple myeloma
5342274|NCT00281879|stage II multiple myeloma|stage ii multiple myeloma
5342275|NCT00281879|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5342276|NCT00281879|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5342277|NCT00281879|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5342278|NCT00281879|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5342279|NCT00281879|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5342280|NCT00281879|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5342281|NCT00281879|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5342282|NCT00281879|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5342283|NCT00281879|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5342284|NCT00281879|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5342285|NCT00281879|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5342286|NCT00281879|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5342287|NCT00281879|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5342288|NCT00281879|stage III multiple myeloma|stage iii multiple myeloma
5342289|NCT00281879|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5342290|NCT00281879|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5342291|NCT00281879|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5342292|NCT00281879|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5342293|NCT00281879|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5342294|NCT00281879|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5342295|NCT00281879|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5342296|NCT00281879|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5342297|NCT00281879|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5342298|NCT00281879|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5342299|NCT00281879|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5342300|NCT00281879|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5342301|NCT00281879|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5342302|NCT00281879|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5342303|NCT00281879|stage III childhood Hodgkin lymphoma|stage iii childhood hodgkin lymphoma
5342304|NCT00281879|stage III childhood large cell lymphoma|stage iii childhood large cell lymphoma
5342305|NCT00281879|stage III childhood lymphoblastic lymphoma|stage iii childhood lymphoblastic lymphoma
5342306|NCT00281879|stage III childhood small noncleaved cell lymphoma|stage iii childhood small noncleaved cell lymphoma
5342307|NCT00281879|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
5342308|NCT00281879|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
5342309|NCT00281879|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
5342310|NCT00281879|unusual cancers of childhood|unusual cancers of childhood
5342311|NCT00281879|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
5342312|NCT00281866|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5342313|NCT00281866|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5342314|NCT00281866|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5342315|NCT00281866|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
5342316|NCT00281866|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5342317|NCT00281866|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
5342318|NCT00281866|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
5342319|NCT00281866|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
5342320|NCT00281866|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
5342321|NCT00281866|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
5342322|NCT00281866|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
5342323|NCT00281866|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
5342324|NCT00281866|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
5342325|NCT00281866|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
5342326|NCT00281853|neurotoxicity|neurotoxicity
5342327|NCT00281853|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5342328|NCT00281840|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
5342329|NCT00281840|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5342330|NCT00281840|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
5342331|NCT00281840|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5342332|NCT00281840|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
5342333|NCT00281840|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5342334|NCT00281840|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
5342335|NCT00281840|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
5342336|NCT00281840|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
5342337|NCT00281840|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5342338|NCT00281827|adenocarcinoma of the lung|adenocarcinoma of the lung
5342339|NCT00281827|squamous cell lung cancer|squamous cell lung cancer
5342340|NCT00281827|large cell lung cancer|large cell lung cancer
5342341|NCT00281827|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
5342342|NCT00281827|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5342343|NCT00281814|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
5342344|NCT00281814|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5342345|NCT00281814|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5342346|NCT00281814|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5342347|NCT00281814|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5342348|NCT00281814|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5342349|NCT00281814|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5342350|NCT00281814|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5342351|NCT00281814|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5342352|NCT00281814|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
5342353|NCT00281814|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5342354|NCT00281814|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
5342355|NCT00281814|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5342356|NCT00281814|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5342357|NCT00281814|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5342959|NCT00279682|suicide|suicide
5342358|NCT00281814|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5342359|NCT00281814|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
5342555|NCT00281619|Kidney Transplant|kidney transplant
5342360|NCT00281814|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5342361|NCT00281814|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
5342362|NCT00281814|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5342363|NCT00281814|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
5342364|NCT00281814|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
5342365|NCT00281814|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
5342366|NCT00281814|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
5342367|NCT00281814|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5342368|NCT00281814|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5342369|NCT00281814|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5342370|NCT00281814|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5342371|NCT00281814|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
5342372|NCT00281814|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
5342373|NCT00281814|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5342374|NCT00281814|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5342375|NCT00281814|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5342376|NCT00281814|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5342377|NCT00281814|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5342378|NCT00281814|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5342379|NCT00281814|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5342380|NCT00281814|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5342381|NCT00281814|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5342382|NCT00281814|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5342383|NCT00281814|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5342384|NCT00281814|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5342385|NCT00281814|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5342386|NCT00281814|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5342387|NCT00281814|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5342388|NCT00281814|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5342389|NCT00281814|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5342390|NCT00281814|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5342391|NCT00281814|refractory hairy cell leukemia|refractory hairy cell leukemia
5342392|NCT00281814|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5342393|NCT00281814|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5342394|NCT00281814|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5342395|NCT00281814|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5342396|NCT00281814|stage I multiple myeloma|stage i multiple myeloma
5342397|NCT00281814|stage II multiple myeloma|stage ii multiple myeloma
5342398|NCT00281814|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5342399|NCT00281814|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5342400|NCT00281814|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5342401|NCT00281814|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5342402|NCT00281814|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5342403|NCT00281814|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5342404|NCT00281814|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5342405|NCT00281814|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5342406|NCT00281814|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5342407|NCT00281814|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5342408|NCT00281814|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5342409|NCT00281814|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5342410|NCT00281814|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5342411|NCT00281814|stage III multiple myeloma|stage iii multiple myeloma
5342412|NCT00281814|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5342413|NCT00281814|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5342414|NCT00281814|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5342415|NCT00281814|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5342416|NCT00281814|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5342417|NCT00281814|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5342418|NCT00281814|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5342419|NCT00281814|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5342420|NCT00281814|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5342421|NCT00281814|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5342422|NCT00281814|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5342423|NCT00281814|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5342424|NCT00281814|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5342425|NCT00281814|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5342426|NCT00281814|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5342427|NCT00281801|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
5342428|NCT00281801|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5342429|NCT00281801|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5342430|NCT00281801|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5342431|NCT00281801|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5342432|NCT00281801|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5342433|NCT00281801|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5342434|NCT00281801|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5342435|NCT00281801|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5342436|NCT00281801|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
5342437|NCT00281801|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5342438|NCT00281801|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
5342439|NCT00281801|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5342440|NCT00281801|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5342441|NCT00281801|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5342442|NCT00281801|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5342443|NCT00281801|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
5342444|NCT00281801|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5342445|NCT00281801|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
5342446|NCT00281801|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5342447|NCT00281801|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
5342448|NCT00281801|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
5342449|NCT00281801|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
5342450|NCT00281801|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
5342451|NCT00281801|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5342452|NCT00281801|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5342453|NCT00281801|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5342454|NCT00281801|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5342455|NCT00281801|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
5342456|NCT00281801|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
5342457|NCT00281801|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5342458|NCT00281801|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5342459|NCT00281801|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5342460|NCT00281801|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5342461|NCT00281801|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5342462|NCT00281801|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5342463|NCT00281801|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5342464|NCT00281801|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5342465|NCT00281801|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5342466|NCT00281801|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5342467|NCT00281801|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5342468|NCT00281801|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5342469|NCT00281801|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5342470|NCT00281801|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5342471|NCT00281801|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5342472|NCT00281801|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5342473|NCT00281801|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5342474|NCT00281801|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5342475|NCT00281801|refractory hairy cell leukemia|refractory hairy cell leukemia
5342476|NCT00281801|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5342477|NCT00281801|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5342478|NCT00281801|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5342960|NCT00279682|geriatric|geriatric
5342479|NCT00281801|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5342480|NCT00281801|stage I multiple myeloma|stage i multiple myeloma
5342481|NCT00281801|stage II multiple myeloma|stage ii multiple myeloma
5342482|NCT00281801|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5342483|NCT00281801|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5342484|NCT00281801|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5342485|NCT00281801|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5342486|NCT00281801|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5342487|NCT00281801|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5342488|NCT00281801|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5342489|NCT00281801|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5342490|NCT00281801|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5342491|NCT00281801|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5342492|NCT00281801|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5342493|NCT00281801|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5342494|NCT00281801|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5342495|NCT00281801|stage III multiple myeloma|stage iii multiple myeloma
5342496|NCT00281801|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5342497|NCT00281801|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5342498|NCT00281801|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5342499|NCT00281801|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5342500|NCT00281801|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5342501|NCT00281801|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5342502|NCT00281801|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5342503|NCT00281801|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5342504|NCT00281801|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5342505|NCT00281801|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5342506|NCT00281801|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5342507|NCT00281801|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5342508|NCT00281801|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5342509|NCT00281801|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5342510|NCT00281801|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5342511|NCT00281788|stage I esophageal cancer|stage i esophageal cancer
5342512|NCT00281788|stage II esophageal cancer|stage ii esophageal cancer
5342513|NCT00281788|stage III esophageal cancer|stage iii esophageal cancer
5342514|NCT00281762|AQP-2|aqp-2
5342515|NCT00281762|NSAID|nsaid
5342516|NCT00281762|Urinary concentrating ability|urinary concentrating ability
5342517|NCT00281749|ALZHEIMER'S D-SE|alzheimer's d-se
5342518|NCT00281749|PARKINSON'S D-SE|parkinson's d-se
5342519|NCT00281749|FRAILTY|frailty
5342520|NCT00281736|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
5342521|NCT00281736|recurrent esophageal cancer|recurrent esophageal cancer
5342522|NCT00281736|stage 0 esophageal cancer|stage 0 esophageal cancer
5342523|NCT00281736|stage I esophageal cancer|stage i esophageal cancer
5342524|NCT00281736|precancerous condition|precancerous condition
5342525|NCT00281723|Aphthous|aphthous
5342526|NCT00281723|oral|oral
5342527|NCT00281710|AQP-2|aqp-2
5342528|NCT00281710|Methylprednisolone|methylprednisolone
5342529|NCT00281710|Urinary concentrating ability|urinary concentrating ability
5342530|NCT00281697|Ribbon 2|ribbon 2
5342531|NCT00281697|Avastin|avastin
5342532|NCT00281697|MBC|mbc
5342533|NCT00281697|Breast cancer|breast cancer
5342534|NCT00281684|Acute Pain|acute pain
5342535|NCT00281684|Dental Pain|dental pain
5342536|NCT00281684|Vanilloid|vanilloid
5342537|NCT00281684|VR1|vr1
5342538|NCT00281684|TRPV1|trpv1
5342539|NCT00281684|Inflammation|inflammation
5342540|NCT00281671|Nesiritide|nesiritide
5342541|NCT00281671|Natriuretic Peptide, Brain|natriuretic peptide, brain
5342542|NCT00281671|Heart Defects, Congenital|heart defects, congenital
5342543|NCT00281671|Cardiopulmonary Bypass|cardiopulmonary bypass
5342544|NCT00281671|Diuretics|diuretics
5342545|NCT00281658|ErbB2 positive|erbb2 positive
5342546|NCT00281658|Her2+|her2+
5342547|NCT00281658|metastatic breast cancer|metastatic breast cancer
5342548|NCT00281658|FISH positive|fish positive
5342549|NCT00281658|Stage IV|stage iv
5342550|NCT00281632|Pazopanib|pazopanib
5342551|NCT00281632|Fallopian tube cancer|fallopian tube cancer
5342552|NCT00281632|Ovarian epithelial cancer|ovarian epithelial cancer
5342553|NCT00281632|Peritoneal cancer|peritoneal cancer
5342554|NCT00281619|Pediatric Kidney Transplant|pediatric kidney transplant
5342556|NCT00281619|CellCept|cellcept
5342557|NCT00281619|Mycophenolate mofetil|mycophenolate mofetil
5342558|NCT00281619|Mycophenolic Acid|mycophenolic acid
5342560|NCT00281606|Lopinavir|lopinavir
5342561|NCT00281606|antiretroviral therapy|antiretroviral therapy
5342562|NCT00281606|cross-over|cross-over
5342563|NCT00281606|tolerability|tolerability
5342564|NCT00281554|Investigational Therapies|investigational therapies
5342565|NCT00281554|Atrial Fibrillation|atrial fibrillation
5342566|NCT00281554|Treatment Efficacy|treatment efficacy
5342567|NCT00281554|Treatment Effectiveness|treatment effectiveness
5342568|NCT00281554|Safety|safety
5342569|NCT00281554|RSD1235|rsd1235
5342570|NCT00281541|Treatment Efficacy|treatment efficacy
5342571|NCT00281541|Treatment Effectiveness|treatment effectiveness
5342572|NCT00281541|Disease Management|disease management
5342573|NCT00281541|Treatment|treatment
5342574|NCT00281541|Safety|safety
5342575|NCT00281541|Malignant Melanoma|malignant melanoma
5342576|NCT00281528|First Line Metastatic Breast Cancer|first line metastatic breast cancer
5342577|NCT00281502|Hepatic Encephalopathy|hepatic encephalopathy
5342578|NCT00281502|Hepatitis C|hepatitis c
5342579|NCT00281502|Liver Cirrhosis|liver cirrhosis
5342580|NCT00281502|Bacterial Overgrowth|bacterial overgrowth
5342581|NCT00281489|Recall|recall
5342582|NCT00281489|Awareness|awareness
5342583|NCT00281489|BIS|bis
5342584|NCT00281489|Anesthesia|anesthesia
5342585|NCT00281489|Explicit Recall|explicit recall
5342586|NCT00281476|multiple myeloma|multiple myeloma
5342587|NCT00281476|statins|statins
5342588|NCT00281476|bone|bone
5342589|NCT00281463|wheelchair|wheelchair
5342590|NCT00281463|spinal cord injury|spinal cord injury
5342591|NCT00281463|rehabilitation|rehabilitation
5342592|NCT00281437|exercise|exercise
5342593|NCT00281437|adherence|adherence
5342594|NCT00281437|lifestyle|lifestyle
5342595|NCT00281437|choice|choice
5342596|NCT00281437|autonomy|autonomy
5342597|NCT00281424|exercise adherence|exercise adherence
5342598|NCT00281424|cardiac patients|cardiac patients
5342599|NCT00281424|walking|walking
5342600|NCT00281411|Blood Vessel Prosthesis Implantation|blood vessel prosthesis implantation
5342601|NCT00281411|Endovascular aneurysm repair|endovascular aneurysm repair
5342602|NCT00281411|Magnetic Resonance Angiography|magnetic resonance angiography
5342603|NCT00281411|Computed Tomography Angiography|computed tomography angiography
5342604|NCT00281411|Endoleak|endoleak
5342605|NCT00281398|homelessness|homelessness
5342606|NCT00281398|Attitudes of medical trainees towards the homeless|attitudes of medical trainees towards the homeless
5342607|NCT00281385|adherence|adherence
5342608|NCT00281385|lifestyle|lifestyle
5342609|NCT00281385|exercise|exercise
5342610|NCT00281385|pedometer|pedometer
5342611|NCT00281385|training|training
5342612|NCT00281372|sexual dysfunction|sexual dysfunction
5342613|NCT00281372|male|male
5342614|NCT00281372|female|female
5342615|NCT00281372|dental care|dental care
5342616|NCT00281372|need of control|need of control
5342617|NCT00281359|cerebral palsy|cerebral palsy
5342618|NCT00281359|dynamic splinting|dynamic splinting
5342619|NCT00281359|contractures|contractures
5342620|NCT00281359|heat therapy|heat therapy
5342621|NCT00281346|Doppler echocardiography|doppler echocardiography
5342622|NCT00281346|coronary stenosis|coronary stenosis
5342623|NCT00281346|Coronary angiography|coronary angiography
5342624|NCT00281307|Rhinitis|rhinitis
5342625|NCT00281307|Vitamin E|vitamin e
5342626|NCT00281307|Intranasal|intranasal
5342627|NCT00281294|Arthritis, Rheumatoid|arthritis, rheumatoid
5342628|NCT00281281|Extracorporeal Membrane Oxygenation|extracorporeal membrane oxygenation
5342629|NCT00281281|vancomycin|vancomycin
5342630|NCT00281242|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5342631|NCT00281242|COPD|copd
5342632|NCT00281229|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5342633|NCT00281229|COPD|copd
5342634|NCT00281216|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5342635|NCT00281216|COPD|copd
5342636|NCT00281203|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5342637|NCT00281203|COPD|copd
5342638|NCT00281190|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5342639|NCT00281190|COPD|copd
5342640|NCT00281125|Non-Small Cell Lung Cancer|non-small cell lung cancer
5342641|NCT00281125|Pleural Mesothelioma|pleural mesothelioma
5342642|NCT00281099|ICD|icd
5342643|NCT00281099|Pacing|pacing
5342644|NCT00281099|Heart Failure|heart failure
5342645|NCT00281073|Intra-Cardiac Echocardiography|intra-cardiac echocardiography
5342646|NCT00281073|Cardioversion|cardioversion
5342647|NCT00281060|endovascular|endovascular
5342648|NCT00281060|balloon angioplasty|balloon angioplasty
5342649|NCT00281060|stents|stents
5342650|NCT00281047|Helicobacter pylori (H. pylori)|helicobacter pylori (h. pylori)
5342651|NCT00281047|FP-10|fp-10
5342652|NCT00281047|amoxicillin|amoxicillin
5342653|NCT00281047|clarithromycin|clarithromycin
5342654|NCT00281047|lansoprazole|lansoprazole
5342655|NCT00281034|brain infarction|brain infarction
5342656|NCT00281034|SF-36|sf-36
5342657|NCT00281034|HRQOL|hrqol
5342658|NCT00281034|Japan|japan
5342659|NCT00281034|Post-stroke syndrome|post-stroke syndrome
5342660|NCT00281021|non-small cell lung cancer|non-small cell lung cancer
5342661|NCT00281021|Erlotinib|erlotinib
5342662|NCT00281021|Digoxin|digoxin
5342663|NCT00281008|LDL-cholesterol|ldl-cholesterol
5342664|NCT00281008|apoB-100|apob-100
5342665|NCT00281008|Heterozygous Familial Hypercholesterolemia|heterozygous familial hypercholesterolemia
5342666|NCT00280995|LDL-cholesterol|ldl-cholesterol
5342667|NCT00280995|apoB-100|apob-100
5342668|NCT00280995|Homozygous Familial Hypercholesterolemia|homozygous familial hypercholesterolemia
5342669|NCT00280982|dendritic cells, immunotherapy, vaccination, mesothelioma|dendritic cells, immunotherapy, vaccination, mesothelioma
5342670|NCT00280969|HIV infection|hiv infection
5342671|NCT00280969|treatment|treatment
5342672|NCT00280969|efavirenz|efavirenz
5342673|NCT00280969|atazanavir|atazanavir
5342674|NCT00280969|ritonavir|ritonavir
5342675|NCT00280943|All NC LTC facilities having ten residents with a hip fracture or osteoporosis on the MDS will be invited to participate in the trial|all nc ltc facilities having ten residents with a hip fracture or osteoporosis on the mds will be invited to participate in the trial
5342676|NCT00280930|letrozole|letrozole
5342677|NCT00280930|breast cancer|breast cancer
5342678|NCT00280930|menopause|menopause
5342679|NCT00280917|Rheumatoid Arthritis|rheumatoid arthritis
5342680|NCT00280917|RA|ra
5342681|NCT00280904|Hydrocephalus|hydrocephalus
5342682|NCT00280904|Shunt|shunt
5342683|NCT00280891|head and neck|head and neck
5342684|NCT00280891|cancer|cancer
5342685|NCT00280891|palliation|palliation
5342686|NCT00280891|radiotherapy|radiotherapy
5342687|NCT00280878|Lymphoma|lymphoma
5342688|NCT00280878|CD20+|cd20+
5342689|NCT00280865|Tesaglitazar|tesaglitazar
5342690|NCT00280865|type 2 diabetes|type 2 diabetes
5342691|NCT00280852|anaplastic thyroid cancer|anaplastic thyroid cancer
5342692|NCT00280852|chemotherapy|chemotherapy
5342693|NCT00280852|radiotherapy|radiotherapy
5342695|NCT00280826|Retinal Disease|retinal disease
5342696|NCT00280826|Adhesion Molecule|adhesion molecule
5342697|NCT00280826|Ocular Inflammation|ocular inflammation
5342698|NCT00280826|Raptiva|raptiva
5342699|NCT00280826|Macular Edema|macular edema
5342700|NCT00280826|Uveitis|uveitis
5342701|NCT00280826|Immunosuppression|immunosuppression
5342702|NCT00280813|treatment|treatment
5342703|NCT00280813|dual diagnosis|dual diagnosis
5342704|NCT00280800|randomized|randomized
5342705|NCT00280800|controlled|controlled
5342706|NCT00280800|double blind|double blind
5342707|NCT00280800|effectiveness|effectiveness
5342708|NCT00280800|auto CPAP|auto cpap
5342709|NCT00280800|treatment|treatment
5342710|NCT00280800|sleep apnea|sleep apnea
5342711|NCT00280787|unresectable|unresectable
5342712|NCT00280787|induction|induction
5342713|NCT00280787|radiotherapy|radiotherapy
5342714|NCT00280787|ZD1839|zd1839
5342715|NCT00280774|corticosteroid|corticosteroid
5342716|NCT00280774|prednisone|prednisone
5342717|NCT00280774|memantine|memantine
5342718|NCT00280774|Patients who are taking a corticosteroid for a|patients who are taking a corticosteroid for a
5342719|NCT00280774|pulmonary illness|pulmonary illness
5342720|NCT00280774|rheumatic illness|rheumatic illness
5342721|NCT00280774|kidney transplant|kidney transplant
5342722|NCT00280761|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5342723|NCT00280761|recurrent rectal cancer|recurrent rectal cancer
5342724|NCT00280761|stage II rectal cancer|stage ii rectal cancer
5342725|NCT00280761|stage III rectal cancer|stage iii rectal cancer
5342726|NCT00280761|stage IV rectal cancer|stage iv rectal cancer
5342727|NCT00280748|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5342728|NCT00280748|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5342729|NCT00280748|tumors metastatic to brain|tumors metastatic to brain
5342730|NCT00280735|stage I non-small cell lung cancer|stage i non-small cell lung cancer
5342731|NCT00280735|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
5342732|NCT00280735|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5342733|NCT00280722|Randomised|randomised
5342734|NCT00280722|Intervention|intervention
5342735|NCT00280722|Leaflet|leaflet
5342736|NCT00280722|Information|information
5342737|NCT00280722|Awareness|awareness
5342738|NCT00280722|Behaviour|behaviour
5342739|NCT00280722|Research|research
5342740|NCT00280709|Bile duct|bile duct
5342741|NCT00280709|Bile duct obstruction|bile duct obstruction
5342742|NCT00280709|Biliary stent|biliary stent
5342743|NCT00280709|Metal stent|metal stent
5342744|NCT00280709|ERCP|ercp
5342745|NCT00280709|Patency|patency
5342746|NCT00280709|Complication|complication
5342747|NCT00280709|Stent occlusion|stent occlusion
5342748|NCT00280696|Epilepsies, Partial,|epilepsies, partial,
5342749|NCT00280696|Keppra, levetiracetam|keppra, levetiracetam
5342750|NCT00280683|Airway Inflammation|airway inflammation
5342751|NCT00280683|Moderate persistent asthma|moderate persistent asthma
5342752|NCT00280683|Severe Persistent Asthma|severe persistent asthma
5342753|NCT00280657|Acne papulopustulosa|acne papulopustulosa
5342754|NCT00280592|Prophylaxis|prophylaxis
5342755|NCT00280592|Cranberry|cranberry
5342756|NCT00280592|Neurogenic bladder|neurogenic bladder
5342757|NCT00280553|analgesia|analgesia
5342758|NCT00280553|laparoscopic surgical procedures|laparoscopic surgical procedures
5342759|NCT00280553|length of stay|length of stay
5342760|NCT00280540|Hypertension|hypertension
5342761|NCT00280540|High blood pressure|high blood pressure
5342762|NCT00280540|Blood pressure control|blood pressure control
5342763|NCT00280540|Blood pressure reduction|blood pressure reduction
5342764|NCT00280540|Valsartan|valsartan
5342765|NCT00280527|NAFLD|nafld
5342766|NCT00280527|NASH|nash
5342768|NCT00280527|Bariatric Surgery|bariatric surgery
5342769|NCT00280527|Weight Reduction|weight reduction
5342770|NCT00280514|abscess|abscess
5342771|NCT00280514|penetration|penetration
5342772|NCT00280514|antibiotics|antibiotics
5342773|NCT00280514|cefpirome|cefpirome
5342774|NCT00280514|moxifloxacin|moxifloxacin
5342775|NCT00280514|abdominal cyst|abdominal cyst
5342776|NCT00280501|Sulpiride|sulpiride
5342777|NCT00280501|Quetiapine|quetiapine
5342778|NCT00280501|Light/dark transition|light/dark transition
5342779|NCT00280501|Choroidal blood flow|choroidal blood flow
5342780|NCT00280488|Motivational Interviewing|motivational interviewing
5342781|NCT00280488|Alcohol Abuse|alcohol abuse
5342782|NCT00280488|Alcohol Dependence|alcohol dependence
5342783|NCT00280488|Emergency Care Setting|emergency care setting
5342784|NCT00280475|Randomized Controlled Trials|randomized controlled trials
5342785|NCT00280475|Brain Neoplasms/Secondary|brain neoplasms/secondary
5342786|NCT00280475|Brain Neoplasms/Radiotherapy|brain neoplasms/radiotherapy
5342787|NCT00280475|Radiosurgery|radiosurgery
5342788|NCT00280462|Nifedipine|nifedipine
5342789|NCT00280462|Choroidal blood flow|choroidal blood flow
5342790|NCT00280462|Choroidal autoregulation|choroidal autoregulation
5342791|NCT00280462|Isometric exercise|isometric exercise
5342792|NCT00280449|people living with HIV|people living with hiv
5342793|NCT00280449|quality of life|quality of life
5342794|NCT00280436|Polysomnography|polysomnography
5342795|NCT00280436|Electroencephalography|electroencephalography
5342796|NCT00280436|Primary Insomnia|primary insomnia
5342797|NCT00280436|Cognition|cognition
5342798|NCT00280436|Sleep|sleep
5342799|NCT00280423|Cognition|cognition
5342800|NCT00280423|Polysomnography|polysomnography
5342801|NCT00280423|Primary Insomnia|primary insomnia
5342802|NCT00280423|Electroencephalography|electroencephalography
5342803|NCT00280423|Sleep|sleep
5342804|NCT00280397|Cancer, solid tumors|cancer, solid tumors
5342805|NCT00280371|COPD|copd
5342806|NCT00280371|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5342807|NCT00280371|formoterol|formoterol
5342808|NCT00280358|Fluticasone|fluticasone
5342809|NCT00280358|Formoterol|formoterol
5342810|NCT00280358|PK Study|pk study
5342811|NCT00280358|Pharmacokinetics|pharmacokinetics
5342812|NCT00280345|pigmentary glaucoma|pigmentary glaucoma
5342813|NCT00280345|primary open angle glaucoma|primary open angle glaucoma
5342814|NCT00280345|cataract|cataract
5342815|NCT00280345|trabeculectomy|trabeculectomy
5342816|NCT00280345|cataract surgery|cataract surgery
5342817|NCT00280332|colonic adenoma, colonic advanced neoplasm|colonic adenoma, colonic advanced neoplasm
5342818|NCT00280319|randomized controlled trial|randomized controlled trial
5342819|NCT00280319|depression|depression
5342820|NCT00280319|Uganda|uganda
5342821|NCT00280319|adolescents|adolescents
5342822|NCT00280293|Bipolar Disorder|bipolar disorder
5342823|NCT00280293|Cocaine Dependence|cocaine dependence
5342824|NCT00280293|Dual Diagnosis|dual diagnosis
5342825|NCT00280280|spasticity|spasticity
5342826|NCT00280280|Botox|botox
5342827|NCT00280280|baclofen|baclofen
5342828|NCT00280267|hip fracture|hip fracture
5342829|NCT00280267|testosterone|testosterone
5342830|NCT00280267|muscle weakness|muscle weakness
5342831|NCT00280267|frail elderly|frail elderly
5342832|NCT00280267|aging|aging
5342833|NCT00280254|Heart Failure|heart failure
5342834|NCT00280254|Hemodynamics|hemodynamics
5342835|NCT00280254|Echocardiography|echocardiography
5342836|NCT00280241|Chronic|chronic
5342837|NCT00280241|Lymphocytic|lymphocytic
5342838|NCT00280241|Leukemia|leukemia
5342839|NCT00280241|Fludarabine|fludarabine
5342840|NCT00280241|Cyclophosphamide|cyclophosphamide
5342841|NCT00280241|Rituximab|rituximab
5342842|NCT00280228|ADHD|adhd
5342843|NCT00280228|Oppositional Defiant Disorder|oppositional defiant disorder
5342844|NCT00280228|Conduct Disorder|conduct disorder
5342845|NCT00280228|Substance Use|substance use
5342846|NCT00280228|Drug and Alcohol Use|drug and alcohol use
5342847|NCT00280215|Primary Hyperoxaluria|primary hyperoxaluria
5342848|NCT00280202|Non-small cell lung cancer|non-small cell lung cancer
5342849|NCT00280202|Carcinogenesis|carcinogenesis
5342850|NCT00280202|Genomic changes leading to malignant phenotypes in NSCLC.|genomic changes leading to malignant phenotypes in nsclc.
5342851|NCT00280202|Simultaneous mutagenesis of epithelial cells.|simultaneous mutagenesis of epithelial cells.
5342852|NCT00280202|Chromosomal abnormalities/mutations in bronchial tissues.|chromosomal abnormalities/mutations in bronchial tissues.
5342853|NCT00280202|Detect micrometastases in histologically neg. lymph nodes|detect micrometastases in histologically neg. lymph nodes
5342854|NCT00280189|Radiofrequency ablation|radiofrequency ablation
5342855|NCT00280189|Pulmonary malignancies|pulmonary malignancies
5342856|NCT00280189|Primary lung cancer|primary lung cancer
5342857|NCT00280189|Pulmonary metastasis|pulmonary metastasis
5342858|NCT00280189|Primary lung tumors|primary lung tumors
5342859|NCT00280189|Secondary lung tumors|secondary lung tumors
5342860|NCT00280189|Coagulation necrosis of soft tissue tumors|coagulation necrosis of soft tissue tumors
5342861|NCT00280176|recurrent rectal cancer|recurrent rectal cancer
5342862|NCT00280176|stage II rectal cancer|stage ii rectal cancer
5342863|NCT00280176|stage III rectal cancer|stage iii rectal cancer
5342864|NCT00280176|stage IV rectal cancer|stage iv rectal cancer
5342865|NCT00280176|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5342866|NCT00280163|Genomics, cardiac surgery|genomics, cardiac surgery
5342867|NCT00280150|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5342868|NCT00280150|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5342869|NCT00280150|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5342870|NCT00280150|squamous cell lung cancer|squamous cell lung cancer
5342871|NCT00280137|Quality of Life|quality of life
5342872|NCT00280137|Pediatric Systemic Lupus Erythematosus|pediatric systemic lupus erythematosus
5342873|NCT00280111|rotavirus|rotavirus
5342874|NCT00280111|vaccine|vaccine
5342875|NCT00280111|safety|safety
5342876|NCT00280111|immunogenicity|immunogenicity
5342877|NCT00280111|infants|infants
5342878|NCT00280072|Renal Failure, Acute|renal failure, acute
5342879|NCT00280072|Acute Kidney Failure|acute kidney failure
5342880|NCT00280072|Acute Renal Failure|acute renal failure
5342881|NCT00280072|Acute Tubular Necrosis|acute tubular necrosis
5342882|NCT00280072|Anuria|anuria
5342883|NCT00280072|Renal Dialysis|renal dialysis
5342884|NCT00280072|Acute Kidney Injury|acute kidney injury
5342885|NCT00280059|Epilepsy|epilepsy
5342886|NCT00280059|partial seizures|partial seizures
5342887|NCT00280059|pregabalin monotherapy|pregabalin monotherapy
5342888|NCT00280059|lamotrigine comparator|lamotrigine comparator
5342889|NCT00280059|double-blind and randomized trial|double-blind and randomized trial
5342890|NCT00280033|H5N1, Influenza, vaccine, parent protocol|h5n1, influenza, vaccine, parent protocol
5342891|NCT00280020|sleep disorders|sleep disorders
5342892|NCT00280020|meditation|meditation
5342893|NCT00280020|cognitive behavior therapy|cognitive behavior therapy
5342894|NCT00280007|hepatocellular carcinoma|hepatocellular carcinoma
5342895|NCT00280007|TACE|tace
5342896|NCT00280007|transarterial chemoembolisation|transarterial chemoembolisation
5342897|NCT00280007|portal hypertension|portal hypertension
5342898|NCT00280007|angiogenesis|angiogenesis
5342899|NCT00280007|VEGF|vegf
5342900|NCT00280007|bevacizumab|bevacizumab
5342901|NCT00279994|Intermittent claudication|intermittent claudication
5342902|NCT00279994|Exercise therapy|exercise therapy
5342903|NCT00279994|Therapy feedback|therapy feedback
5342904|NCT00279994|Accelerometer|accelerometer
5342905|NCT00279994|Physiotherapy|physiotherapy
5342906|NCT00279994|PAD;|pad;
5342907|NCT00279994|peripheral arterial disease according to Fontaine stage II)|peripheral arterial disease according to fontaine stage ii)
5342908|NCT00279981|Atrial fibrillation|atrial fibrillation
5342909|NCT00279981|Stroke|stroke
5342910|NCT00279981|Pacemaker|pacemaker
5342911|NCT00279981|Implantable Cardiac Defibrillator|implantable cardiac defibrillator
5342912|NCT00279981|Resynchronization systems|resynchronization systems
5342913|NCT00279968|ICD|icd
5342914|NCT00279968|Registry|registry
5342915|NCT00279968|Ventricular tachycardia|ventricular tachycardia
5342916|NCT00279968|Ventricular Fibrillation|ventricular fibrillation
5342917|NCT00279955|Heart Failure, Congestive|heart failure, congestive
5342918|NCT00279955|Implantable Cardioverter-Defibrillators|implantable cardioverter-defibrillators
5342919|NCT00279942|Fibromyalgia|fibromyalgia
5342920|NCT00279942|Dietary Supplements|dietary supplements
5342921|NCT00279942|Rheumatologic Diseases|rheumatologic diseases
5342922|NCT00279942|Complementary and Alternative Medicine|complementary and alternative medicine
5342923|NCT00279851|idiopathic seizure|idiopathic seizure
5342924|NCT00279851|hypoglycemia|hypoglycemia
5342925|NCT00279851|hyperammonemia/hyperinsulinism syndrome|hyperammonemia/hyperinsulinism syndrome
5342926|NCT00279812|Immune response|immune response
5342927|NCT00279812|Selenomethionine|selenomethionine
5342928|NCT00279812|Selenium enriched foods|selenium enriched foods
5342929|NCT00279812|Selenium status|selenium status
5342930|NCT00279812|Selenium biomarkers|selenium biomarkers
5342931|NCT00279799|Sexually Transmitted Diseases, HIV, condom use, adolescents|sexually transmitted diseases, hiv, condom use, adolescents
5342932|NCT00279786|pediatric|pediatric
5342933|NCT00279773|Acute|acute
5342934|NCT00279773|Myeloid|myeloid
5342935|NCT00279773|Leukemia|leukemia
5342936|NCT00279734|Rheumatoid Arthritis|rheumatoid arthritis
5342937|NCT00279721|thyroid neoplasms|thyroid neoplasms
5342938|NCT00279721|intensity modulated radiation|intensity modulated radiation
5342939|NCT00279721|radiotherapy|radiotherapy
5342940|NCT00279708|Granulomatous Inflammation|granulomatous inflammation
5342941|NCT00279708|Steroid-Sparing|steroid-sparing
5342942|NCT00279708|Pulmonary Function|pulmonary function
5342943|NCT00279708|Sarcoidosis, Pulmonary|sarcoidosis, pulmonary
5342944|NCT00279708|Statins (Atorvastatin)|statins (atorvastatin)
5342945|NCT00279708|Biomarkers|biomarkers
5342946|NCT00279708|Nitric Oxide|nitric oxide
5342947|NCT00279708|Disease Activity|disease activity
5342948|NCT00279708|Quality of Life|quality of life
5342949|NCT00279708|Corticosteroids|corticosteroids
5342950|NCT00279708|Pulmonary Sarcoidosis|pulmonary sarcoidosis
5342951|NCT00279708|Sarcoidosis|sarcoidosis
5342952|NCT00279695|Glaucoma|glaucoma
5342953|NCT00279695|Accommodation|accommodation
5342954|NCT00279695|Ocular Tumors|ocular tumors
5342955|NCT00279695|Age-Related Macular Degeneration|age-related macular degeneration
5342956|NCT00279695|Ultrasound|ultrasound
5342957|NCT00279695|Eye|eye
5342961|NCT00279682|elderly|elderly
5342962|NCT00279682|primary care|primary care
5342963|NCT00279669|Retinopathy of Prematurity|retinopathy of prematurity
5342964|NCT00279669|Ultrasound|ultrasound
5342965|NCT00279669|Eye|eye
5342966|NCT00279656|Frail elderly|frail elderly
5342967|NCT00279656|Pharmaceutical services|pharmaceutical services
5342968|NCT00279656|Drug therapy|drug therapy
5342969|NCT00279656|Geriatrics|geriatrics
5342970|NCT00279656|Randomized controlled trial|randomized controlled trial
5342971|NCT00279656|Hospitals, teaching|hospitals, teaching
5342972|NCT00279643|Laser|laser
5342973|NCT00279643|immunohistochemical staining|immunohistochemical staining
5342974|NCT00279643|Laser Hair Removal|laser hair removal
5342975|NCT00279643|follicular stem cells|follicular stem cells
5342976|NCT00279643|keratin 15|keratin 15
5342977|NCT00279630|Tibialis Posterior Tendinopathy|tibialis posterior tendinopathy
5342978|NCT00279578|haemophilia A|haemophilia a
5342979|NCT00279578|thrombelastography|thrombelastography
5342980|NCT00279578|recombinant factor VIII|recombinant factor viii
5342981|NCT00279578|thrombin generation|thrombin generation
5342982|NCT00279565|buprenorphine|buprenorphine
5342983|NCT00279565|methadone|methadone
5342984|NCT00279565|Peg-Intron|peg-intron
5342985|NCT00279565|Rebetol|rebetol
5342986|NCT00279552|Vitamin B12 deficiency|vitamin b12 deficiency
5342987|NCT00279552|Vitamin B12 malabsorption|vitamin b12 malabsorption
5342988|NCT00279552|Intrinsic factor|intrinsic factor
5342989|NCT00279552|Holotranscobalamin|holotranscobalamin
5342990|NCT00279539|Cardiovascular|cardiovascular
5342991|NCT00279539|Gene Therapy|gene therapy
5342992|NCT00279539|DNA|dna
5342993|NCT00279539|Stem Cells|stem cells
5342994|NCT00279539|Congestive Heart Failure|congestive heart failure
5342995|NCT00279539|Coronary Artery Disease|coronary artery disease
5342996|NCT00279539|CHF|chf
5342997|NCT00279539|Cardiomyopathy|cardiomyopathy
5342998|NCT00279526|Depression|depression
5342999|NCT00279526|Health services utilization|health services utilization
5343000|NCT00279526|Elderly|elderly
5343001|NCT00279526|Primary Care|primary care
5343002|NCT00279513|homeopathy|homeopathy
5343003|NCT00279513|hallux valgus|hallux valgus
5343004|NCT00279513|pain|pain
5343005|NCT00279513|traumeel s|traumeel s
5343006|NCT00279487|Patients undergoing total knee replacement who received pain management by the following modality:|patients undergoing total knee replacement who received pain management by the following modality:
5343007|NCT00279487|IV PCA opioid|iv pca opioid
5343008|NCT00279487|Local femoral nerve block with 1.5% Mepivacaine & 0.5% Ropivacaine|local femoral nerve block with 1.5% mepivacaine & 0.5% ropivacaine
5343009|NCT00279474|cancer patients|cancer patients
5343010|NCT00279474|family|family
5343011|NCT00279474|cognitive behavior|cognitive behavior
5343012|NCT00279474|distress|distress
5343013|NCT00279461|Rheumatoid Arthritis|rheumatoid arthritis
5343014|NCT00279461|Vitamin D|vitamin d
5343015|NCT00279435|Intravenous, Steroid-Refractory, Ulcerative Colitis|intravenous, steroid-refractory, ulcerative colitis
5343016|NCT00279422|Intravenous, Steroid-Refractory, Ulcerative Colitis|intravenous, steroid-refractory, ulcerative colitis
5343017|NCT00279409|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
5343018|NCT00279409|ADHD|adhd
5343019|NCT00279409|Treatment resistant|treatment resistant
5343020|NCT00279409|Partial responder|partial responder
5343021|NCT00279409|Non-responder|non-responder
5343022|NCT00279409|Atypical Antipsychotic|atypical antipsychotic
5343023|NCT00279383|Intra-operatively treated patients with hemostatic supporting agents/techniques in addition to the standard surgical procedures|intra-operatively treated patients with hemostatic supporting agents/techniques in addition to the standard surgical procedures
5343024|NCT00279370|SSRI Exposure|ssri exposure
5343025|NCT00279370|Pregnancy|pregnancy
5343026|NCT00279370|Infant Development|infant development
5343027|NCT00279357|NBI|nbi
5343028|NCT00279357|high risk group for adenomas|high risk group for adenomas
5343029|NCT00279331|HIV Seronegativity|hiv seronegativity
5343030|NCT00279331|Men who have Sex with Men|men who have sex with men
5343031|NCT00279331|MSM|msm
5343032|NCT00279331|Peru|peru
5343033|NCT00279331|Ecuador|ecuador
5343034|NCT00279331|Incidence|incidence
5343035|NCT00279331|Prevalence|prevalence
5343036|NCT00279331|Drug resistance, viral|drug resistance, viral
5343037|NCT00279318|Environment|environment
5343038|NCT00279318|Exposures|exposures
5343039|NCT00279318|Diet|diet
5343040|NCT00279318|Toxins|toxins
5343041|NCT00279318|Psychosocial|psychosocial
5343042|NCT00279318|Infectious Agents|infectious agents
5343043|NCT00279318|Bacterial|bacterial
5343044|NCT00279318|Viral|viral
5343045|NCT00279318|Immunizations|immunizations
5343046|NCT00279318|Autoantibody|autoantibody
5343047|NCT00279305|Newly diagnosed type 1 diabetes|newly diagnosed type 1 diabetes
5343048|NCT00279305|New Onset type 1 diabetes|new onset type 1 diabetes
5343049|NCT00279305|Preservation of insulin secretion|preservation of insulin secretion
5343050|NCT00279305|Type 1 diabetes|type 1 diabetes
5343051|NCT00279305|Juvenile Onset Diabetes|juvenile onset diabetes
5343052|NCT00279305|Insulin Dependent Diabetes|insulin dependent diabetes
5343053|NCT00279305|T1D|t1d
5343054|NCT00279292|Pancreatic neoplasm|pancreatic neoplasm
5343055|NCT00279279|Implantable cardioverter defibrillator (ICD)|implantable cardioverter defibrillator (icd)
5343056|NCT00279279|Sudden Cardiac Death|sudden cardiac death
5343057|NCT00279279|Primary Prevention|primary prevention
5343058|NCT00279266|Diabetic Peripheral Neuropathy|diabetic peripheral neuropathy
5343059|NCT00279266|Peripheral Neuropathy|peripheral neuropathy
5343060|NCT00279266|Diabetes Mellitus|diabetes mellitus
5343061|NCT00279253|clonidine|clonidine
5343062|NCT00279253|glaucoma|glaucoma
5343063|NCT00279240|Impaired glucose tolerance|impaired glucose tolerance
5343064|NCT00279240|Intervention|intervention
5343065|NCT00279240|Prevention|prevention
5343066|NCT00279227|coronary artery disease|coronary artery disease
5343067|NCT00279227|epicardial adipose tissue|epicardial adipose tissue
5343068|NCT00279227|epicardial fat|epicardial fat
5343069|NCT00279227|obesity|obesity
5343070|NCT00279201|diabetes|diabetes
5343071|NCT00279201|type 2|type 2
5343072|NCT00279188|Bronchial hyperresponsiveness|bronchial hyperresponsiveness
5343073|NCT00279188|Atopy|atopy
5343074|NCT00279188|Inhaled steroids|inhaled steroids
5343075|NCT00279188|Exacerbations|exacerbations
5343076|NCT00279188|Lung function decline|lung function decline
5343077|NCT00279188|Prognosis|prognosis
5343078|NCT00279175|Acute myocardial infarction|acute myocardial infarction
5343079|NCT00279149|Telemedicine|telemedicine
5343080|NCT00279149|TELESTROKE|telestroke
5343081|NCT00279149|symptoms of ischemic stroke since less than 3 hours|symptoms of ischemic stroke since less than 3 hours
5343082|NCT00279136|Bronchial hyperresponsiveness,|bronchial hyperresponsiveness,
5343083|NCT00279136|lung function,|lung function,
5343084|NCT00279136|airway inflammation,|airway inflammation,
5343085|NCT00279136|deep inspiration,|deep inspiration,
5343086|NCT00279136|bronchial biopsies|bronchial biopsies
5343087|NCT00279136|airway smooth muscle|airway smooth muscle
5343088|NCT00279110|HIV|hiv
5343089|NCT00279110|Antiretroviral therapy|antiretroviral therapy
5343090|NCT00279110|Heroin dependence|heroin dependence
5343091|NCT00279110|Methadone|methadone
5343092|NCT00279110|Buprenorphine|buprenorphine
5343093|NCT00279097|Intracranial pressure|intracranial pressure
5343094|NCT00279097|High Frequency Chest Wall Oscillation|high frequency chest wall oscillation
5343095|NCT00279097|Neurosurgery|neurosurgery
5343096|NCT00279084|Anaemia|anaemia
5343097|NCT00279084|Chronic kidney disease|chronic kidney disease
5343098|NCT00279084|Type 2 diabetes|type 2 diabetes
5343099|NCT00279084|Randomized trial|randomized trial
5343100|NCT00279071|dystocia|dystocia
5343101|NCT00279071|stimulation|stimulation
5343102|NCT00279071|acupuncture|acupuncture
5343103|NCT00279071|oxytocin|oxytocin
5343104|NCT00279045|type 2 diabetes monotherapy treatment naive|type 2 diabetes monotherapy treatment naive
5343105|NCT00279032|GW406381|gw406381
5343106|NCT00279032|peripheral nerve injury|peripheral nerve injury
5343107|NCT00279032|patients|patients
5343108|NCT00279032|allodynia|allodynia
5343109|NCT00279032|hyperalgesia|hyperalgesia
5343110|NCT00279032|randomised|randomised
5343111|NCT00279032|placebo-controlled|placebo-controlled
5343112|NCT00279019|GSK233705|gsk233705
5343113|NCT00279019|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
5343114|NCT00279019|COPD|copd
5343115|NCT00279006|DES (drug eluting stents)|des (drug eluting stents)
5343116|NCT00279006|CAD (cornary artery disease)|cad (cornary artery disease)
5343117|NCT00279006|stent retrieval|stent retrieval
5343118|NCT00278993|Prostate cancer|prostate cancer
5343119|NCT00278993|metastatic disease|metastatic disease
5343120|NCT00278967|colonoscopy|colonoscopy
5343121|NCT00278967|preparation|preparation
5343122|NCT00278954|Primary Antibody Deficiency|primary antibody deficiency
5343123|NCT00278954|Common variable hypogammaglobulinemia|common variable hypogammaglobulinemia
5343124|NCT00278954|X-linked hypogammaglobulinemia|x-linked hypogammaglobulinemia
5343125|NCT00278954|Hypogammaglobulinemia|hypogammaglobulinemia
5343126|NCT00278954|Immunodeficiency with hyper-IgM|immunodeficiency with hyper-igm
5343127|NCT00278954|Wiskott-Aldrich Syndrome|wiskott-aldrich syndrome
5343128|NCT00278941|Seroquel SR™|seroquel sr™
5343129|NCT00278941|Major Depressive Disorder|major depressive disorder
5343130|NCT00278928|Hypertriglyceridemia|hypertriglyceridemia
5343131|NCT00278928|Infant, Premature|infant, premature
5343132|NCT00278915|Progressive Precocious Puberty|progressive precocious puberty
5343133|NCT00278915|PPP|ppp
5343134|NCT00278915|McCune-Albright Syndrome|mccune-albright syndrome
5343135|NCT00278915|MAS|mas
5343136|NCT00278902|ErbB2+ Breast Cancer|erbb2+ breast cancer
5343137|NCT00278902|HER2+ Breast Cancer|her2+ breast cancer
5343138|NCT00278889|Colorectal Cancer|colorectal cancer
5343139|NCT00278889|phase II|phase ii
5343140|NCT00278889|metastatic colorectal cancer|metastatic colorectal cancer
5343141|NCT00278889|AZD2171|azd2171
5343142|NCT00278889|RECENTIN|recentin
5343143|NCT00278876|GIST|gist
5343144|NCT00278876|Imatinib|imatinib
5343145|NCT00278876|Adjuvant therapy|adjuvant therapy
5343146|NCT00278876|Kit mutation|kit mutation
5343147|NCT00278863|Stomach cancer|stomach cancer
5343148|NCT00278863|Palliative chemotherapy|palliative chemotherapy
5343149|NCT00278863|Capecitabine|capecitabine
5343150|NCT00278863|S-1|s-1
5343151|NCT00278850|Vulvar vestibulitis|vulvar vestibulitis
5343152|NCT00278850|Treatment|treatment
5343153|NCT00278850|Education|education
5343154|NCT00278837|Meditation|meditation
5343155|NCT00278837|Stress-reduction|stress-reduction
5343156|NCT00278837|Cognitive-affective behavior learning|cognitive-affective behavior learning
5343157|NCT00278824|Chronic Pain|chronic pain
5343158|NCT00278824|Pain|pain
5343159|NCT00278811|Mental Health Services|mental health services
5343160|NCT00278811|Suicide|suicide
5343161|NCT00278811|Suicide ideation|suicide ideation
5343162|NCT00278798|tracehelectomy|tracehelectomy
5343163|NCT00278798|radical hysterectomy|radical hysterectomy
5343164|NCT00278785|interviews|interviews
5343165|NCT00278785|brief intervention|brief intervention
5343166|NCT00278785|drinking|drinking
5343167|NCT00278785|alcohol|alcohol
5343168|NCT00278785|injuries|injuries
5343169|NCT00278785|wounds|wounds
5343170|NCT00278785|intervention studies|intervention studies
5343171|NCT00278759|rapid viral diagnosis|rapid viral diagnosis
5343172|NCT00278759|respiratory infection|respiratory infection
5343173|NCT00278759|pediatric emergency department|pediatric emergency department
5343174|NCT00278759|febrile respiratory infection|febrile respiratory infection
5343175|NCT00278746|zinc|zinc
5343176|NCT00278746|diarrhea|diarrhea
5343177|NCT00278746|cluster randomization|cluster randomization
5343178|NCT00278746|hospitalization|hospitalization
5343179|NCT00278733|Randomized controlled trial|randomized controlled trial
5343180|NCT00278733|brief intervention|brief intervention
5343181|NCT00278733|university students|university students
5343182|NCT00278733|physician advice|physician advice
5343183|NCT00278733|high risk drinking|high risk drinking
5343184|NCT00278707|Canavan Disease|canavan disease
5343185|NCT00278707|Aspartoacylase Deficiency|aspartoacylase deficiency
5343186|NCT00278707|NAA|naa
5343187|NCT00278707|Acetate|acetate
5343188|NCT00278707|Glyceryltriacetate|glyceryltriacetate
5343189|NCT00278694|Oxaliplatin, radiation|oxaliplatin, radiation
5343190|NCT00278681|zinc|zinc
5343191|NCT00278681|diarrhea|diarrhea
5343192|NCT00278681|hospitalization|hospitalization
5343193|NCT00278681|programme|programme
5343194|NCT00278538|Stem cell, Autoimmune disease, Systemic Lupus Erythematosus|stem cell, autoimmune disease, systemic lupus erythematosus
5343195|NCT00278473|Primarily Inattentive|primarily inattentive
5343196|NCT00278473|Hyperactive Impulsive Type|hyperactive impulsive type
5343197|NCT00278473|Combined Type|combined type
5343198|NCT00278473|ADHD|adhd
5343199|NCT00278473|Adults|adults
5343200|NCT00278473|Psychological|psychological
5343201|NCT00278473|Cognitive Behavioral Therapy|cognitive behavioral therapy
5343202|NCT00278473|CBT|cbt
5343203|NCT00278460|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5343204|NCT00278460|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5343205|NCT00278460|adenocarcinoma of the lung|adenocarcinoma of the lung
5343206|NCT00278460|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
5343207|NCT00278460|large cell lung cancer|large cell lung cancer
5343208|NCT00278460|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5343209|NCT00278460|squamous cell lung cancer|squamous cell lung cancer
5343210|NCT00278447|Alcohol|alcohol
5343211|NCT00278447|Alcohol use|alcohol use
5343212|NCT00278447|Alcohol dependence|alcohol dependence
5343213|NCT00278447|Drug|drug
5343214|NCT00278447|Drug use|drug use
5343215|NCT00278447|Drug dependence|drug dependence
5343216|NCT00278447|Utilization|utilization
5343217|NCT00278447|Hospitalization|hospitalization
5343218|NCT00278447|Primary care|primary care
5343219|NCT00278447|Chronic disease management|chronic disease management
5343220|NCT00278447|Care management|care management
5343221|NCT00278447|Comorbidity|comorbidity
5343222|NCT00278434|cervical cancer|cervical cancer
5343223|NCT00278434|cervical intraepithelial neoplasia grade 2|cervical intraepithelial neoplasia grade 2
5343224|NCT00278434|cervical intraepithelial neoplasia grade 3|cervical intraepithelial neoplasia grade 3
5343225|NCT00278421|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
5343226|NCT00278421|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5343227|NCT00278421|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
5343228|NCT00278421|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
5343229|NCT00278421|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
5343230|NCT00278421|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5343231|NCT00278421|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
5343232|NCT00278421|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
5343233|NCT00278421|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
5343234|NCT00278421|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5343235|NCT00278421|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5343236|NCT00278421|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
5343237|NCT00278421|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
5343238|NCT00278421|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
5343239|NCT00278421|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
5343240|NCT00278421|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
5343241|NCT00278421|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
5343242|NCT00278421|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5343243|NCT00278421|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
5343244|NCT00278421|stage I mantle cell lymphoma|stage i mantle cell lymphoma
5343245|NCT00278421|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
5343246|NCT00278421|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
5343247|NCT00278421|stage I marginal zone lymphoma|stage i marginal zone lymphoma
5343248|NCT00278421|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5343249|NCT00278421|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5343250|NCT00278421|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5343251|NCT00278421|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5343252|NCT00278421|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5343253|NCT00278421|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5343254|NCT00278421|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5343255|NCT00278421|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5343256|NCT00278421|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5343257|NCT00278421|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5343258|NCT00278421|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5343259|NCT00278421|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5343260|NCT00278421|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5343261|NCT00278421|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5343262|NCT00278408|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
5343263|NCT00278408|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5343264|NCT00278408|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
5343265|NCT00278408|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5343266|NCT00278408|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5343267|NCT00278408|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
5343268|NCT00278408|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
5343269|NCT00278408|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5343270|NCT00278408|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
5343271|NCT00278408|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
5343272|NCT00278408|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
5343273|NCT00278408|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5343274|NCT00278408|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5343275|NCT00278408|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5343276|NCT00278408|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5343277|NCT00278408|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5343278|NCT00278408|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5343279|NCT00278408|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
5343280|NCT00278408|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
5343281|NCT00278408|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
5343282|NCT00278408|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5343283|NCT00278408|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5343284|NCT00278408|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
5343285|NCT00278408|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
5343286|NCT00278408|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
5343287|NCT00278408|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5343288|NCT00278408|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
5343289|NCT00278408|stage I mantle cell lymphoma|stage i mantle cell lymphoma
5343290|NCT00278408|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5343291|NCT00278408|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5343292|NCT00278408|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5343293|NCT00278408|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5343294|NCT00278408|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
5343295|NCT00278408|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
5343296|NCT00278408|stage I marginal zone lymphoma|stage i marginal zone lymphoma
5343297|NCT00278408|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5343298|NCT00278408|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5343299|NCT00278369|recurrent renal cell cancer|recurrent renal cell cancer
5343300|NCT00278369|stage IV renal cell cancer|stage iv renal cell cancer
5343301|NCT00278369|clear cell renal cell carcinoma|clear cell renal cell carcinoma
5343302|NCT00278304|cervical adenocarcinoma|cervical adenocarcinoma
5343303|NCT00278304|cervical adenosquamous cell carcinoma|cervical adenosquamous cell carcinoma
5343304|NCT00278304|cervical squamous cell carcinoma|cervical squamous cell carcinoma
5343305|NCT00278304|stage IB cervical cancer|stage ib cervical cancer
5343306|NCT00278304|stage IIA cervical cancer|stage iia cervical cancer
5343307|NCT00278304|stage IIB cervical cancer|stage iib cervical cancer
5343308|NCT00278304|stage III cervical cancer|stage iii cervical cancer
5343309|NCT00278304|stage IVA cervical cancer|stage iva cervical cancer
5343310|NCT00278304|stage IVB cervical cancer|stage ivb cervical cancer
5343311|NCT00278278|untreated childhood brain stem glioma|untreated childhood brain stem glioma
5343312|NCT00278278|untreated childhood cerebellar astrocytoma|untreated childhood cerebellar astrocytoma
5343313|NCT00278278|childhood high-grade cerebral astrocytoma|childhood high-grade cerebral astrocytoma
5343314|NCT00278278|childhood spinal cord neoplasm|childhood spinal cord neoplasm
5343315|NCT00278265|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
5343316|NCT00278265|anemia|anemia
5343317|NCT00278265|neutropenia|neutropenia
5343318|NCT00278252|recurrent childhood ependymoma|recurrent childhood ependymoma
5343319|NCT00278252|childhood infratentorial ependymoma|childhood infratentorial ependymoma
5343320|NCT00278252|childhood supratentorial ependymoma|childhood supratentorial ependymoma
5343321|NCT00278239|long-term effects secondary to cancer therapy in children|long-term effects secondary to cancer therapy in children
5343322|NCT00278239|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
5343323|NCT00278239|cognitive/functional effects|cognitive/functional effects
5343324|NCT00278239|childhood supratentorial primitive neuroectodermal tumor|childhood supratentorial primitive neuroectodermal tumor
5343325|NCT00278226|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5343326|NCT00278213|prolymphocytic leukemia|prolymphocytic leukemia
5343327|NCT00278213|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5343328|NCT00278213|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
5343329|NCT00278213|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
5343330|NCT00278213|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5343331|NCT00278213|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5343332|NCT00278213|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
5343333|NCT00278200|post-transplant lymphoproliferative disorder|post-transplant lymphoproliferative disorder
5343334|NCT00278187|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5343335|NCT00278187|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5343336|NCT00278187|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5343337|NCT00278174|stage IV renal cell cancer|stage iv renal cell cancer
5343338|NCT00278174|recurrent renal cell cancer|recurrent renal cell cancer
5343339|NCT00278174|clear cell renal cell carcinoma|clear cell renal cell carcinoma
5343340|NCT00278161|stage 0 chronic lymphocytic leukemia|stage 0 chronic lymphocytic leukemia
5343341|NCT00278161|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
5343342|NCT00278161|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
5343343|NCT00278161|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5343344|NCT00278161|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5343345|NCT00278161|small lymphocytic lymphoma|small lymphocytic lymphoma
5343346|NCT00278161|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
5343347|NCT00278161|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5343348|NCT00278161|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5343349|NCT00278161|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
5343350|NCT00278161|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5343351|NCT00278161|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5343352|NCT00278161|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5343353|NCT00278161|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
5343354|NCT00278161|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
5343355|NCT00278161|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5343356|NCT00278161|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5343357|NCT00278161|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5343358|NCT00278161|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5343359|NCT00278161|stage I mantle cell lymphoma|stage i mantle cell lymphoma
5343360|NCT00278161|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5343361|NCT00278161|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5343362|NCT00278161|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
5343363|NCT00278161|prolymphocytic leukemia|prolymphocytic leukemia
5343364|NCT00278161|stage I marginal zone lymphoma|stage i marginal zone lymphoma
5343365|NCT00278161|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
5343366|NCT00278161|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
5343367|NCT00278161|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
5343368|NCT00278161|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
5343369|NCT00278161|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
5343370|NCT00278161|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
5343463|NCT00277875|Isolated Systolic Hypertension|isolated systolic hypertension
5343371|NCT00278161|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
5343372|NCT00278161|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5343373|NCT00278161|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5343374|NCT00278161|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5343375|NCT00278161|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
5343376|NCT00278161|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
5343377|NCT00278161|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5343378|NCT00278161|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5343379|NCT00278161|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5343380|NCT00278161|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5343381|NCT00278161|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5343382|NCT00278161|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5343383|NCT00278161|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5343384|NCT00278161|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5343385|NCT00278148|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5343386|NCT00278148|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5343387|NCT00278135|Cognition|cognition
5343388|NCT00278135|Memory|memory
5343389|NCT00278135|Nutrition|nutrition
5343390|NCT00278135|Omega-3|omega-3
5343391|NCT00278135|DHA|dha
5343392|NCT00278122|stage III melanoma|stage iii melanoma
5343393|NCT00278122|stage IV melanoma|stage iv melanoma
5343394|NCT00278122|recurrent melanoma|recurrent melanoma
5343395|NCT00278109|stage I breast cancer|stage i breast cancer
5343396|NCT00278109|stage II breast cancer|stage ii breast cancer
5343397|NCT00278096|disability|disability
5343398|NCT00278096|occupational therapy|occupational therapy
5343399|NCT00278083|Pharmacology|pharmacology
5343400|NCT00278083|Asthma|asthma
5343401|NCT00278083|TNF-alpha|tnf-alpha
5343402|NCT00278070|Metronomic-therapy|metronomic-therapy
5343403|NCT00278070|vinorelbine|vinorelbine
5343404|NCT00278070|Recurrent Breast Cancer|recurrent breast cancer
5343405|NCT00278070|Recurrent Non Small Cell Lung Cancer|recurrent non small cell lung cancer
5343406|NCT00278070|Metastatic prostate cancer|metastatic prostate cancer
5343407|NCT00278057|Blood pressure;|blood pressure;
5343408|NCT00278057|chronic renal failure;|chronic renal failure;
5343409|NCT00278057|diabetes mellitus;|diabetes mellitus;
5343410|NCT00278057|dialysis fluid; glucose;|dialysis fluid; glucose;
5343411|NCT00278057|hemodialysis;|hemodialysis;
5343412|NCT00278057|hypertension;|hypertension;
5343413|NCT00278057|uremia.|uremia.
5343414|NCT00278044|Search as text words in Annotation & Scope Note|search as text words in annotation & scope note
5343415|NCT00278031|Retinoblastoma|retinoblastoma
5343416|NCT00278031|Quality of life|quality of life
5343417|NCT00278005|pediatric|pediatric
5343418|NCT00278005|DiGeorge Syndrome|digeorge syndrome
5343419|NCT00278005|Congenital heart defects|congenital heart defects
5343420|NCT00278005|Infections|infections
5343421|NCT00278005|Cardiac surgery|cardiac surgery
5343422|NCT00277992|Pediatric|pediatric
5343423|NCT00277992|Cardiac|cardiac
5343424|NCT00277992|Norwood operation modification|norwood operation modification
5343425|NCT00277992|GT/Nissen operation|gt/nissen operation
5343426|NCT00277992|Po feed|po feed
5343427|NCT00277992|GT fed|gt fed
5343428|NCT00277979|pediatric|pediatric
5343429|NCT00277979|cardiac|cardiac
5343430|NCT00277979|Infantile Pompe's Disease|infantile pompe's disease
5343431|NCT00277979|3D Echocardiography|3d echocardiography
5343432|NCT00277966|Pediatric|pediatric
5343433|NCT00277966|Cardiac Catheterization|cardiac catheterization
5343434|NCT00277966|Fluoroscopy time|fluoroscopy time
5343435|NCT00277953|Pediatric|pediatric
5343436|NCT00277953|Cardiac|cardiac
5343437|NCT00277953|Tracheal Dimensions|tracheal dimensions
5343438|NCT00277953|MRI|mri
5343439|NCT00277940|Pediatric|pediatric
5343440|NCT00277940|Cardiac|cardiac
5343441|NCT00277940|Neoaortic Elastic Properties|neoaortic elastic properties
5343442|NCT00277940|Aortic Arch Reconstruction|aortic arch reconstruction
5343443|NCT00277927|Pediatric|pediatric
5343444|NCT00277927|Cardiac|cardiac
5343445|NCT00277927|Valvar Pulmonary Stenosis|valvar pulmonary stenosis
5343446|NCT00277901|cardiac|cardiac
5343447|NCT00277901|pediatric|pediatric
5343448|NCT00277901|MRI|mri
5343449|NCT00277901|Tetralogy of Fallot TOF|tetralogy of fallot tof
5343450|NCT00277901|Aortic Coarctation|aortic coarctation
5343451|NCT00277888|Dialysis|dialysis
5343452|NCT00277888|Hemodialysis|hemodialysis
5343453|NCT00277888|Catheterization|catheterization
5343454|NCT00277875|Cardiovascular|cardiovascular
5343455|NCT00277875|Flow-Mediated Vasodilation (FMD)|flow-mediated vasodilation (fmd)
5343456|NCT00277875|Pulse Perfusion-Mediated Vasodilation (PPMV)|pulse perfusion-mediated vasodilation (ppmv)
5343457|NCT00277875|Endothelial Function|endothelial function
5343458|NCT00277875|Heart Failure|heart failure
5343459|NCT00277875|Local Distensibility|local distensibility
5343460|NCT00277875|Arterial Stiffening|arterial stiffening
5343461|NCT00277875|Augmentation Index (AI)|augmentation index (ai)
5343462|NCT00277875|Aging|aging
5343464|NCT00277875|Advanced Glycation Endproducts|advanced glycation endproducts
5343465|NCT00277875|Vascular Stiffness|vascular stiffness
5343466|NCT00277862|chronic hepatitis C;|chronic hepatitis c;
5343467|NCT00277862|peg-interferon alfa-2b;|peg-interferon alfa-2b;
5343468|NCT00277862|ribavirin,|ribavirin,
5343469|NCT00277862|rapid virologic response,|rapid virologic response,
5343470|NCT00277862|sustained virological response|sustained virological response
5343471|NCT00277849|Sickle|sickle
5343472|NCT00277849|Hemoglobinopathy|hemoglobinopathy
5343473|NCT00277849|Thalassemia|thalassemia
5343474|NCT00277849|G6PD|g6pd
5343475|NCT00277849|Plasmodium|plasmodium
5343476|NCT00277849|Erythrocyte Variant|erythrocyte variant
5343477|NCT00277849|Hemoglobin Variant|hemoglobin variant
5343478|NCT00277849|Healthy Volunteer|healthy volunteer
5343479|NCT00277849|HV|hv
5343480|NCT00277836|malignant tumor|malignant tumor
5343481|NCT00277823|Depression|depression
5343482|NCT00277823|Adult|adult
5343483|NCT00277823|Outpatients|outpatients
5343484|NCT00277810|Alzheimer's Disease|alzheimer's disease
5343485|NCT00277810|Cholinesterase Inhibitors|cholinesterase inhibitors
5343486|NCT00277810|Outpatients|outpatients
5343487|NCT00277797|Low Back Pain|low back pain
5343488|NCT00277784|Age Related Macular Degeneration|age related macular degeneration
5343489|NCT00277784|Ultrasound|ultrasound
5343490|NCT00277784|OCT|oct
5343491|NCT00277784|Eye|eye
5343492|NCT00277771|technology in weight loss|technology in weight loss
5343493|NCT00277771|standard behavioral therapy for obesity|standard behavioral therapy for obesity
5343494|NCT00277758|Interleukin-2|interleukin-2
5343495|NCT00277745|periodontitis|periodontitis
5343496|NCT00277745|microfluidics|microfluidics
5343497|NCT00277745|saliva diagnostics|saliva diagnostics
5343498|NCT00277706|periodontitis|periodontitis
5343499|NCT00277706|bone regeneration|bone regeneration
5343500|NCT00277706|Parathyroid Hormone|parathyroid hormone
5343501|NCT00277706|moderate to advanced periodontitis|moderate to advanced periodontitis
5343502|NCT00277693|hemodialysis|hemodialysis
5343503|NCT00277693|aldosterone|aldosterone
5343504|NCT00277693|heart failure|heart failure
5343505|NCT00277693|spironolactone|spironolactone
5343506|NCT00277680|uterine fibroids|uterine fibroids
5343507|NCT00277680|leiomyoma|leiomyoma
5343508|NCT00277680|laparoscopy|laparoscopy
5343509|NCT00277680|menorrhagia|menorrhagia
5343510|NCT00277667|currently experiencing hypomania or mild mania|currently experiencing hypomania or mild mania
5343511|NCT00277654|Bipolar Disorder with Concurrent Moderately Severe Anxiety and Lifetime Panic or Generalized Anxiety Disorder|bipolar disorder with concurrent moderately severe anxiety and lifetime panic or generalized anxiety disorder
5343512|NCT00277641|Binge Eating Disorder Associated with Obesity|binge eating disorder associated with obesity
5343513|NCT00277615|Children|children
5343514|NCT00277615|Bladder volume|bladder volume
5343515|NCT00277615|Ultrasound|ultrasound
5343516|NCT00277576|DNA vaccine|dna vaccine
5343517|NCT00277576|immunotherapy|immunotherapy
5343518|NCT00277576|Hepatitis B Virus|hepatitis b virus
5343519|NCT00277576|Particle Mediated Epidermal Delivery|particle mediated epidermal delivery
5343520|NCT00277563|Carpal Tunnel Syndrome|carpal tunnel syndrome
5343521|NCT00277563|Neuropathic Pain|neuropathic pain
5343522|NCT00277563|Neuromodulation|neuromodulation
5343523|NCT00277563|PEMF|pemf
5343524|NCT00277563|Magnetic Field Therapy|magnetic field therapy
5343525|NCT00277563|Magnetotherapy|magnetotherapy
5343526|NCT00277550|Constipation, Tegaserod, Dyspepsia|constipation, tegaserod, dyspepsia
5343527|NCT00277537|Mannitol|mannitol
5343528|NCT00277524|Pacemaker|pacemaker
5343529|NCT00277524|Defibrillator|defibrillator
5343530|NCT00277524|Cardiac Resynchronization|cardiac resynchronization
5343531|NCT00277524|Dysynchrony|dysynchrony
5343532|NCT00277524|Heart failure|heart failure
5343533|NCT00277524|Arrhythmia|arrhythmia
5343534|NCT00277524|Tachycardia|tachycardia
5343535|NCT00277524|Bradycardia|bradycardia
5343536|NCT00277472|Hypertension|hypertension
5343537|NCT00277472|High blood pressure|high blood pressure
5343538|NCT00277472|diuretics|diuretics
5343539|NCT00277472|valsartan|valsartan
5343540|NCT00277446|Asthma|asthma
5343541|NCT00277446|Soy isoflavones|soy isoflavones
5343542|NCT00277446|Eosinophils|eosinophils
5343543|NCT00277446|Exhaled nitric oxide|exhaled nitric oxide
5343544|NCT00277433|Atopic Dermatitis|atopic dermatitis
5343545|NCT00277433|Eczema|eczema
5343546|NCT00277433|Genetics|genetics
5343547|NCT00277433|Histamine|histamine
5343548|NCT00277407|NAET|naet
5343549|NCT00277407|Chiropractic procedures|chiropractic procedures
5343550|NCT00277407|Acupuncture/acupressure|acupuncture/acupressure
5343551|NCT00277407|Treatment of Autism by holistic procedures|treatment of autism by holistic procedures
5343552|NCT00277407|Food and Vaccination allergy|food and vaccination allergy
5343553|NCT00277394|Acute, symptomatic and objectively confirmed DVT|acute, symptomatic and objectively confirmed dvt
5343554|NCT00277381|Adherence|adherence
5343555|NCT00277381|Hypertension|hypertension
5343556|NCT00277381|Telemedicine|telemedicine
5343557|NCT00277368|Epilepsy|epilepsy
5343558|NCT00277368|Headache|headache
5343559|NCT00277368|Seizure|seizure
5343560|NCT00277355|Study of Minocycline in Huntington's Disease|study of minocycline in huntington's disease
5344697|NCT00272415|Temodar|temodar
5343561|NCT00277342|lipid induced hepatic insulin resistance|lipid induced hepatic insulin resistance
5343562|NCT00277342|polymorphisms liver fatty-acid-binding-protein|polymorphisms liver fatty-acid-binding-protein
5343563|NCT00277342|gluconeogenesis|gluconeogenesis
5343564|NCT00277342|glycogenolysis|glycogenolysis
5343565|NCT00277342|endogenous glucose production|endogenous glucose production
5343566|NCT00277316|Kidney cancer|kidney cancer
5343567|NCT00277316|Metastatic|metastatic
5343568|NCT00277303|Colon Cancer|colon cancer
5343569|NCT00277290|Cancer|cancer
5343570|NCT00277290|Recurrent|recurrent
5343571|NCT00277290|Platinum-resistant|platinum-resistant
5343572|NCT00277290|Platinum-sensitive|platinum-sensitive
5343573|NCT00277277|Telemedicine|telemedicine
5343574|NCT00277277|Biobehavioral weight loss program|biobehavioral weight loss program
5343575|NCT00277277|Body Mass Index|body mass index
5343576|NCT00277277|Blood Glucose|blood glucose
5343577|NCT00277277|Diabetes Management|diabetes management
5343578|NCT00277251|Crohn's disease|crohn's disease
5343579|NCT00277251|systemic-onset juvenile rheumatoid arthritis|systemic-onset juvenile rheumatoid arthritis
5343580|NCT00277251|juvenile dermatomyositis|juvenile dermatomyositis
5343581|NCT00277251|systemic lupus erythematosus (SLE)|systemic lupus erythematosus (sle)
5343582|NCT00277251|Mixed connective tissue disease (MCTD)|mixed connective tissue disease (mctd)
5343583|NCT00277251|vasculitis|vasculitis
5343584|NCT00277238|HCV|hcv
5343585|NCT00277238|Hepatitis c virus|hepatitis c virus
5343586|NCT00277238|Virus diseases|virus diseases
5343587|NCT00277238|Interferon-alpha|interferon-alpha
5343588|NCT00277238|Interferons|interferons
5343589|NCT00277238|Liver diseases|liver diseases
5343590|NCT00277212|Bipolar I Disorder with a recent manic or mixed episode|bipolar i disorder with a recent manic or mixed episode
5343591|NCT00277186|Arthroplasty|arthroplasty
5343592|NCT00277186|Health services research|health services research
5343593|NCT00277186|Intent to treat|intent to treat
5343594|NCT00277186|Randomized|randomized
5343595|NCT00277186|Controlled|controlled
5343596|NCT00277173|Medication Safety|medication safety
5343597|NCT00277173|Adverse Drug Events|adverse drug events
5343598|NCT00277173|Preventable Adverse Drug Events|preventable adverse drug events
5343599|NCT00277173|Culture of Safety|culture of safety
5343600|NCT00277173|Failure Modes and Effects Analysis|failure modes and effects analysis
5343601|NCT00277173|Teambuilding|teambuilding
5343602|NCT00277147|Typhoid Fever|typhoid fever
5343603|NCT00277147|Immunogenicity|immunogenicity
5343604|NCT00277147|Safety|safety
5343605|NCT00277147|Vaccine|vaccine
5343606|NCT00277147|Conjugate|conjugate
5343607|NCT00277147|Healthy Volunteer|healthy volunteer
5343608|NCT00277121|Lipid disorder|lipid disorder
5343609|NCT00277121|Gene mutation|gene mutation
5343610|NCT00277108|postpartum depression|postpartum depression
5343611|NCT00277108|postnatal depression|postnatal depression
5343612|NCT00277108|PPD|ppd
5343613|NCT00277095|Urinary Incontinence|urinary incontinence
5343614|NCT00277082|Metastatic or Recurrent Cancer of the Endometrium or the Lung (NSCLC)|metastatic or recurrent cancer of the endometrium or the lung (nsclc)
5343615|NCT00277082|Aerosolized Liposomal 9-Nitro 20|aerosolized liposomal 9-nitro 20
5343616|NCT00277082|Camptothecin (L9NC)|camptothecin (l9nc)
5343617|NCT00277069|Breast metastatic|breast metastatic
5343618|NCT00277056|leukemia|leukemia
5343619|NCT00277043|Taxane|taxane
5343620|NCT00277043|Test Dose|test dose
5343621|NCT00277030|Respiratory Distress Syndrome|respiratory distress syndrome
5343622|NCT00277030|Surfactant|surfactant
5343623|NCT00277030|Nasal CPAP|nasal cpap
5343624|NCT00277017|Combination Therapy|combination therapy
5343625|NCT00277017|5-Fluorouracil|5-fluorouracil
5343626|NCT00277017|Interferon-a Interleukin-2|interferon-a interleukin-2
5343627|NCT00277017|Thalidomide|thalidomide
5343628|NCT00277017|Renal Cell Carcinoma|renal cell carcinoma
5343629|NCT00276991|Prolonged Viral Suppression|prolonged viral suppression
5343630|NCT00276991|HIV Infections|hiv infections
5343631|NCT00276978|Therapy-resistant Depression|therapy-resistant depression
5343632|NCT00276978|add-on therapy depression|add-on therapy depression
5343633|NCT00276965|Bipolar II Depression|bipolar ii depression
5343634|NCT00276952|Gonyautoxins|gonyautoxins
5343635|NCT00276952|Tension-type Headache|tension-type headache
5343636|NCT00276952|Human Treatment|human treatment
5343637|NCT00276939|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
5343638|NCT00276939|Diet, Vegetarian|diet, vegetarian
5343639|NCT00276939|Diet, Fat-Restricted|diet, fat-restricted
5343640|NCT00276939|Glycemic Index|glycemic index
5343641|NCT00276926|Hypereosinophilic Syndrome|hypereosinophilic syndrome
5343642|NCT00276926|Eosinophilic leukemias|eosinophilic leukemias
5343643|NCT00276926|STI571 (Gleevec)|sti571 (gleevec)
5343644|NCT00276926|PDGF receptor alpha|pdgf receptor alpha
5343645|NCT00276926|Familiar hypereosinophilia|familiar hypereosinophilia
5343646|NCT00276926|Myeloproliferative disorder (MPD) with eosinophilia|myeloproliferative disorder (mpd) with eosinophilia
5343647|NCT00276926|myeloproliferative disorders/myelodysplastic syndromes|myeloproliferative disorders/myelodysplastic syndromes
5343648|NCT00276900|Postpartum Depression|postpartum depression
5343649|NCT00276900|Recurrent Depression|recurrent depression
5343650|NCT00276887|Somatization Disorder|somatization disorder
5343651|NCT00276887|Multiple Medically Unexplained Symptoms|multiple medically unexplained symptoms
5343652|NCT00276887|Cognitive Behavior Therapy|cognitive behavior therapy
5343653|NCT00276887|Mental Health|mental health
5343654|NCT00276874|Cocaine Addiction|cocaine addiction
5343655|NCT00276874|Cocaine Dependence|cocaine dependence
5343656|NCT00276861|adenocarcinoma of the colon|adenocarcinoma of the colon
5343657|NCT00276861|recurrent colon cancer|recurrent colon cancer
5343658|NCT00276861|stage IV colon cancer|stage iv colon cancer
5343659|NCT00276848|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5343660|NCT00276848|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5343661|NCT00276835|recurrent renal cell cancer|recurrent renal cell cancer
5343662|NCT00276835|clear cell renal cell carcinoma|clear cell renal cell carcinoma
5343663|NCT00276835|stage IV renal cell cancer|stage iv renal cell cancer
5343664|NCT00276835|recurrent melanoma|recurrent melanoma
5343665|NCT00276835|stage IV melanoma|stage iv melanoma
5343666|NCT00276822|stage I breast cancer|stage i breast cancer
5343667|NCT00276822|stage II breast cancer|stage ii breast cancer
5343668|NCT00276822|stage IIIA breast cancer|stage iiia breast cancer
5343669|NCT00276822|stage IIIB breast cancer|stage iiib breast cancer
5343670|NCT00276822|stage IIIC breast cancer|stage iiic breast cancer
5343671|NCT00276822|stage IV breast cancer|stage iv breast cancer
5343672|NCT00276809|stage 0 chronic lymphocytic leukemia|stage 0 chronic lymphocytic leukemia
5343673|NCT00276809|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
5343674|NCT00276809|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
5343675|NCT00276809|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5343676|NCT00276809|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5343677|NCT00276796|cervical squamous cell carcinoma|cervical squamous cell carcinoma
5343678|NCT00276796|stage III cervical cancer|stage iii cervical cancer
5343679|NCT00276796|recurrent cervical cancer|recurrent cervical cancer
5343680|NCT00276796|cervical adenocarcinoma|cervical adenocarcinoma
5343681|NCT00276796|cervical adenosquamous cell carcinoma|cervical adenosquamous cell carcinoma
5343682|NCT00276796|cervical small cell carcinoma|cervical small cell carcinoma
5343683|NCT00276796|stage IVA cervical cancer|stage iva cervical cancer
5343684|NCT00276796|stage IVB cervical cancer|stage ivb cervical cancer
5343685|NCT00276783|primary central nervous system lymphoma|primary central nervous system lymphoma
5343686|NCT00276783|tumors metastatic to brain|tumors metastatic to brain
5343687|NCT00276783|recurrent adult brain tumor|recurrent adult brain tumor
5343688|NCT00276783|adult giant cell glioblastoma|adult giant cell glioblastoma
5343689|NCT00276783|adult gliosarcoma|adult gliosarcoma
5343690|NCT00276783|adult mixed glioma|adult mixed glioma
5343691|NCT00276783|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5343692|NCT00276783|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
5343693|NCT00276783|adult glioblastoma|adult glioblastoma
5343694|NCT00276770|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5343695|NCT00276770|adult anaplastic ependymoma|adult anaplastic ependymoma
5343696|NCT00276770|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
5343697|NCT00276770|adult diffuse astrocytoma|adult diffuse astrocytoma
5343698|NCT00276770|adult glioblastoma|adult glioblastoma
5343699|NCT00276770|adult giant cell glioblastoma|adult giant cell glioblastoma
5343700|NCT00276770|adult gliosarcoma|adult gliosarcoma
5343701|NCT00276770|adult ependymoma|adult ependymoma
5343702|NCT00276770|adult oligodendroglioma|adult oligodendroglioma
5343703|NCT00276770|recurrent adult brain tumor|recurrent adult brain tumor
5343704|NCT00276770|adult mixed glioma|adult mixed glioma
5343705|NCT00276757|childhood Langerhans cell histiocytosis|childhood langerhans cell histiocytosis
5343706|NCT00276744|recurrent pancreatic cancer|recurrent pancreatic cancer
5343707|NCT00276744|stage III pancreatic cancer|stage iii pancreatic cancer
5343708|NCT00276744|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
5343709|NCT00276744|stage I pancreatic cancer|stage i pancreatic cancer
5343710|NCT00276744|stage II pancreatic cancer|stage ii pancreatic cancer
5343711|NCT00276731|localized resectable neuroblastoma|localized resectable neuroblastoma
5343712|NCT00276731|localized unresectable neuroblastoma|localized unresectable neuroblastoma
5343713|NCT00276731|regional neuroblastoma|regional neuroblastoma
5343714|NCT00276718|childhood malignant ovarian germ cell tumor|childhood malignant ovarian germ cell tumor
5343715|NCT00276718|childhood malignant testicular germ cell tumor|childhood malignant testicular germ cell tumor
5343716|NCT00276718|childhood central nervous system germ cell tumor|childhood central nervous system germ cell tumor
5343717|NCT00276718|childhood extragonadal germ cell tumor|childhood extragonadal germ cell tumor
5343718|NCT00276718|childhood teratoma|childhood teratoma
5343719|NCT00276705|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
5343720|NCT00276705|childhood hepatocellular carcinoma|childhood hepatocellular carcinoma
5343721|NCT00276705|advanced adult primary liver cancer|advanced adult primary liver cancer
5343722|NCT00276705|localized resectable adult primary liver cancer|localized resectable adult primary liver cancer
5343723|NCT00276705|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
5343724|NCT00276705|stage I childhood liver cancer|stage i childhood liver cancer
5343725|NCT00276705|stage II childhood liver cancer|stage ii childhood liver cancer
5343726|NCT00276705|stage III childhood liver cancer|stage iii childhood liver cancer
5343727|NCT00276705|stage IV childhood liver cancer|stage iv childhood liver cancer
5343796|NCT00276276|topotecan (HYCAMTIN)|topotecan (hycamtin)
5343728|NCT00276692|metastatic Ewing sarcoma/peripheral primitive neuroectodermal tumor|metastatic ewing sarcoma/peripheral primitive neuroectodermal tumor
5343729|NCT00276679|recurrent neuroblastoma|recurrent neuroblastoma
5343730|NCT00276679|disseminated neuroblastoma|disseminated neuroblastoma
5343731|NCT00276679|localized unresectable neuroblastoma|localized unresectable neuroblastoma
5343732|NCT00276666|untreated childhood medulloblastoma|untreated childhood medulloblastoma
5343733|NCT00276640|recurrent childhood brain stem glioma|recurrent childhood brain stem glioma
5343734|NCT00276640|untreated childhood brain stem glioma|untreated childhood brain stem glioma
5343735|NCT00276640|recurrent childhood cerebellar astrocytoma|recurrent childhood cerebellar astrocytoma
5343736|NCT00276640|untreated childhood cerebellar astrocytoma|untreated childhood cerebellar astrocytoma
5343737|NCT00276640|childhood low-grade cerebral astrocytoma|childhood low-grade cerebral astrocytoma
5343738|NCT00276640|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
5343739|NCT00276640|childhood oligodendroglioma|childhood oligodendroglioma
5343740|NCT00276640|recurrent childhood visual pathway and hypothalamic glioma|recurrent childhood visual pathway and hypothalamic glioma
5343741|NCT00276640|untreated childhood visual pathway and hypothalamic glioma|untreated childhood visual pathway and hypothalamic glioma
5343742|NCT00276640|childhood spinal cord neoplasm|childhood spinal cord neoplasm
5343743|NCT00276627|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5343744|NCT00276614|stage IV renal cell cancer|stage iv renal cell cancer
5343745|NCT00276614|recurrent renal cell cancer|recurrent renal cell cancer
5343746|NCT00276614|papillary renal cell carcinoma|papillary renal cell carcinoma
5343747|NCT00276601|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
5343748|NCT00276601|untreated childhood acute myeloid leukemia and other myeloid malignancies|untreated childhood acute myeloid leukemia and other myeloid malignancies
5343749|NCT00276601|adult acute promyelocytic leukemia (M3)|adult acute promyelocytic leukemia (m3)
5343750|NCT00276601|childhood acute promyelocytic leukemia (M3)|childhood acute promyelocytic leukemia (m3)
5343751|NCT00276601|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5343752|NCT00276588|adenocarcinoma of the lung|adenocarcinoma of the lung
5343753|NCT00276588|adenosquamous cell lung cancer|adenosquamous cell lung cancer
5343754|NCT00276588|large cell lung cancer|large cell lung cancer
5343755|NCT00276588|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5343756|NCT00276588|squamous cell lung cancer|squamous cell lung cancer
5343757|NCT00276588|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5343758|NCT00276588|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5343759|NCT00276575|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5343760|NCT00276549|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5343761|NCT00276549|stage IV prostate cancer|stage iv prostate cancer
5343762|NCT00276536|stage IV melanoma|stage iv melanoma
5343763|NCT00276536|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5343764|NCT00276523|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
5343765|NCT00276523|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
5343766|NCT00276523|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5343767|NCT00276523|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
5343768|NCT00276523|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
5343769|NCT00276523|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5343770|NCT00276523|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
5343771|NCT00276523|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
5343772|NCT00276523|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5343773|NCT00276523|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
5343774|NCT00276523|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
5343775|NCT00276523|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5343776|NCT00276523|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
5343777|NCT00276523|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
5343778|NCT00276523|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
5343779|NCT00276523|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
5343780|NCT00276497|Impaired glucose tolerance|impaired glucose tolerance
5343781|NCT00276497|Intervention|intervention
5343782|NCT00276497|Prevention|prevention
5343783|NCT00276445|allergy|allergy
5343784|NCT00276445|Allergy conjunctivitis|allergy conjunctivitis
5343785|NCT00276445|beta-1-3glucan|beta-1-3glucan
5343786|NCT00276445|Th1/Th2|th1/th2
5343787|NCT00276341|cognitive impairment|cognitive impairment
5343788|NCT00276289|nephrolithiasis|nephrolithiasis
5343789|NCT00276289|hypercalciuria|hypercalciuria
5343790|NCT00276289|hypokalemia|hypokalemia
5343791|NCT00276289|thiazide diuretics|thiazide diuretics
5343792|NCT00276276|relapsed|relapsed
5343793|NCT00276276|lung cancer|lung cancer
5343794|NCT00276276|resistant|resistant
5343795|NCT00276276|small cel|small cel
5343900|NCT00275561|Dysphagia|dysphagia
5343797|NCT00276263|Schizophrenia prodrome|schizophrenia prodrome
5343798|NCT00276263|Sarcosine|sarcosine
5343799|NCT00276263|Psychosis|psychosis
5343800|NCT00276263|NMDA receptor|nmda receptor
5343801|NCT00276263|Prevention|prevention
5343802|NCT00276237|Congenital Heart Disease|congenital heart disease
5343803|NCT00276237|Pulmonary Valve Replacement|pulmonary valve replacement
5343804|NCT00276224|iron deficiency schistosomiasis soil transmitted helminths|iron deficiency schistosomiasis soil transmitted helminths
5343805|NCT00276211|MRI diffusion mamma cancer|mri diffusion mamma cancer
5343806|NCT00276198|Clinical trial, controlled|clinical trial, controlled
5343807|NCT00276198|Micronutrients|micronutrients
5343808|NCT00276198|Dietary Supplementation|dietary supplementation
5343809|NCT00276198|Infants|infants
5343810|NCT00276185|spasticity ;|spasticity ;
5343811|NCT00276185|Botulinum toxin ;|botulinum toxin ;
5343812|NCT00276185|Upper limb ;|upper limb ;
5343813|NCT00276185|motor function.|motor function.
5343814|NCT00276185|spastic hemiplegia after stoke|spastic hemiplegia after stoke
5343815|NCT00276159|Leukemia|leukemia
5343816|NCT00276159|Lymphoma|lymphoma
5343817|NCT00276159|Myeloma|myeloma
5343818|NCT00276159|Hematology|hematology
5343819|NCT00276159|852A|852a
5343820|NCT00276159|IRM|irm
5343821|NCT00276159|Oncology|oncology
5343822|NCT00276146|dipyridamole|dipyridamole
5343823|NCT00276146|magnesium|magnesium
5343824|NCT00276146|sickle cell|sickle cell
5343825|NCT00276146|anemia|anemia
5343826|NCT00276146|red blood cells|red blood cells
5343827|NCT00276133|small dense LDL|small dense ldl
5343828|NCT00276120|Breast|breast
5343829|NCT00276120|Cancer|cancer
5343830|NCT00276120|Young|young
5343831|NCT00276120|Women|women
5343832|NCT00276107|Vaccine|vaccine
5343833|NCT00276107|Healthy Infants|healthy infants
5343834|NCT00276094|Urogenital atrophy|urogenital atrophy
5343835|NCT00276094|Vaginal atrophy|vaginal atrophy
5343836|NCT00276094|Vulvar and vaginal atrophy in postmenopausal women|vulvar and vaginal atrophy in postmenopausal women
5343837|NCT00276094|Menopausal symptoms|menopausal symptoms
5343838|NCT00276081|Hot flashes|hot flashes
5343839|NCT00276081|postmenopausal|postmenopausal
5343840|NCT00276081|climacteric symptoms|climacteric symptoms
5343841|NCT00276081|hormone replacement therapy|hormone replacement therapy
5343842|NCT00276081|gabapentin|gabapentin
5343843|NCT00276068|Vulvar vestibulitis|vulvar vestibulitis
5343844|NCT00276068|Vulvodynia|vulvodynia
5343845|NCT00276068|Desipramine|desipramine
5343846|NCT00276068|Lidocaine|lidocaine
5343847|NCT00276068|Genetics|genetics
5343848|NCT00276055|Soft Tissue Sarcoma|soft tissue sarcoma
5343849|NCT00276055|Phase I|phase i
5343850|NCT00276055|Gemcitabine|gemcitabine
5343851|NCT00276055|Docetaxel|docetaxel
5343852|NCT00276055|Bevacizumab|bevacizumab
5343853|NCT00276055|vascular endothelial growth factor|vascular endothelial growth factor
5343854|NCT00276042|AOM|aom
5343855|NCT00276029|Asthma|asthma
5343856|NCT00276029|Refractory|refractory
5343857|NCT00276003|Lymphoma-Non Hodgkins|lymphoma-non hodgkins
5343858|NCT00276003|Phase II|phase ii
5343859|NCT00276003|Gemcitabine|gemcitabine
5343860|NCT00276003|Irinotecan|irinotecan
5343861|NCT00275990|coronary thrombectomy|coronary thrombectomy
5343862|NCT00275990|thrombectomy for acute myocardial infarction|thrombectomy for acute myocardial infarction
5343863|NCT00275990|C14.280.647.500|c14.280.647.500
5343864|NCT00275990|C14.907.553.355.500|c14.907.553.355.500
5343865|NCT00275977|"Stem cell"|"stem cell"
5343866|NCT00275977|"autologous bone marrow transplantation"|"autologous bone marrow transplantation"
5343867|NCT00275977|"Myocardial infarction"|"myocardial infarction"
5343868|NCT00275951|Combination|combination
5343869|NCT00275951|Chemotherapy|chemotherapy
5343870|NCT00275951|Gastric cancer|gastric cancer
5343871|NCT00275938|hepatitis B virus|hepatitis b virus
5343872|NCT00275938|e antigen|e antigen
5343873|NCT00275938|interferon|interferon
5343874|NCT00275938|ribavirin|ribavirin
5343875|NCT00275925|partial epilepsy, oxcarbazepine, adults|partial epilepsy, oxcarbazepine, adults
5343876|NCT00275834|obesity treatment|obesity treatment
5343877|NCT00275834|weight loss|weight loss
5343878|NCT00275834|antiobesity drugs|antiobesity drugs
5343879|NCT00275834|zonisamide|zonisamide
5343880|NCT00275821|Age-related macular degeneration, ranibizumab|age-related macular degeneration, ranibizumab
5343881|NCT00275795|NST-NAET testing|nst-naet testing
5343882|NCT00275795|Food Ssensitivities|food ssensitivities
5343883|NCT00275795|Eczema|eczema
5343884|NCT00275795|Acne|acne
5343885|NCT00275795|Indigestion|indigestion
5343886|NCT00275769|Arrhythmia|arrhythmia
5343887|NCT00275769|Bradycardia|bradycardia
5343888|NCT00275769|Cardiac Pacemaker Artificial|cardiac pacemaker artificial
5343889|NCT00275756|Ocular Physiology|ocular physiology
5343890|NCT00275756|Brimonidine|brimonidine
5343891|NCT00275756|Timoptic|timoptic
5343892|NCT00275756|Dorzolamide|dorzolamide
5343893|NCT00275756|ocular blood flow|ocular blood flow
5343894|NCT00275756|Regional Blood Flow|regional blood flow
5343895|NCT00275730|indometacine|indometacine
5343896|NCT00275730|retinal blood flow|retinal blood flow
5343897|NCT00275730|choroidal blood flow|choroidal blood flow
5343898|NCT00275561|Eosinophilic Esophagitis|eosinophilic esophagitis
5343899|NCT00275561|Fluticasone|fluticasone
5343901|NCT00275535|kidney transplantation|kidney transplantation
5343902|NCT00275535|immunosuppression|immunosuppression
5343903|NCT00275535|calcineurin inhibitor|calcineurin inhibitor
5343904|NCT00275535|sirolimus|sirolimus
5343905|NCT00275535|chronic allograft nephropathy|chronic allograft nephropathy
5343906|NCT00275509|kidney|kidney
5343907|NCT00275509|transplantation|transplantation
5343908|NCT00275509|positive crossmatch|positive crossmatch
5343909|NCT00275509|antibody mediated rejection|antibody mediated rejection
5343910|NCT00275509|rejection|rejection
5343911|NCT00275509|induction|induction
5343912|NCT00275509|therapy|therapy
5343913|NCT00275509|trial|trial
5343914|NCT00275496|SLND|slnd
5343915|NCT00275496|Sentinel|sentinel
5343916|NCT00275496|Melanoma|melanoma
5343917|NCT00275496|Surgical|surgical
5343918|NCT00275431|cancer|cancer
5343919|NCT00275431|AT-101|at-101
5343920|NCT00275431|AT101|at101
5343921|NCT00275431|B-cell malignancies|b-cell malignancies
5343922|NCT00275431|Non-Hodgkin|non-hodgkin
5343923|NCT00275431|lymphoma|lymphoma
5343924|NCT00275431|lukemia|lukemia
5343925|NCT00275418|Crohn's disease|crohn's disease
5343926|NCT00275418|remission|remission
5343927|NCT00275418|beta carotene|beta carotene
5343928|NCT00275405|Effects of Garlic|effects of garlic
5343929|NCT00275392|Dizziness|dizziness
5343930|NCT00275392|Geriatrics|geriatrics
5343931|NCT00275392|Rehabilitation|rehabilitation
5343932|NCT00275392|Vestibular rehabilitation|vestibular rehabilitation
5343933|NCT00275379|Cystitis|cystitis
5343934|NCT00275366|cuff, rotator|cuff, rotator
5343935|NCT00275366|Rotator cuff|rotator cuff
5343936|NCT00275340|Pain|pain
5343937|NCT00275340|Depressive Symptoms|depressive symptoms
5343938|NCT00275340|Coronary Artery Bypass|coronary artery bypass
5343939|NCT00275340|Convalescence|convalescence
5343940|NCT00275340|Quality of Life|quality of life
5343941|NCT00275340|Human Activities|human activities
5343942|NCT00275327|antibiotics|antibiotics
5343943|NCT00275314|transplantation|transplantation
5343944|NCT00275301|Borderline Personality Disorder|borderline personality disorder
5343945|NCT00275301|BPD|bpd
5343946|NCT00275301|PET|pet
5343947|NCT00275301|olanzapine|olanzapine
5343948|NCT00275301|brain|brain
5343949|NCT00275288|Borderline Personality Disorder|borderline personality disorder
5343950|NCT00275288|BPD|bpd
5343951|NCT00275288|amygdala|amygdala
5343952|NCT00275288|facial expression response|facial expression response
5343953|NCT00275288|MRI|mri
5343954|NCT00275275|PD|pd
5343955|NCT00275275|Parkinson's|parkinson's
5343956|NCT00275262|Bone marrow transplantation|bone marrow transplantation
5343957|NCT00275262|Hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
5343958|NCT00275262|Hodgkin's disease|hodgkin's disease
5343959|NCT00275262|non-Hodgkin's lymphoma|non-hodgkin's lymphoma
5343960|NCT00275262|multiple myeloma|multiple myeloma
5343961|NCT00275249|Chronic Pain|chronic pain
5343962|NCT00275236|Idiopthic Restless Legs Syndrome|idiopthic restless legs syndrome
5343963|NCT00275223|adipose tissue|adipose tissue
5343964|NCT00275223|adipocytokines|adipocytokines
5343965|NCT00275210|Oxaliplatin|oxaliplatin
5343966|NCT00275210|Chemotherapy,adjuvant|chemotherapy,adjuvant
5343967|NCT00275210|Colonic Neoplasms|colonic neoplasms
5343968|NCT00275184|Bowel preparation|bowel preparation
5343969|NCT00275184|capsule endoscopy|capsule endoscopy
5343970|NCT00275184|randomised|randomised
5343971|NCT00275184|Citramag|citramag
5343972|NCT00275184|Senna|senna
5343973|NCT00275184|Metoclopramide|metoclopramide
5343974|NCT00275184|Patients referred for Capsule endoscopy|patients referred for capsule endoscopy
5343975|NCT00275184|occult/overt gastrointestinal bleeding|occult/overt gastrointestinal bleeding
5343976|NCT00275184|other suspected small bowel pathology|other suspected small bowel pathology
5343977|NCT00275171|Nontoxic nodular goiter|nontoxic nodular goiter
5343978|NCT00275171|131I therapy|131i therapy
5343979|NCT00275171|thyroid radioiodine uptake|thyroid radioiodine uptake
5343980|NCT00275171|optimal time-interval|optimal time-interval
5343981|NCT00275171|reduced 131I activity|reduced 131i activity
5343982|NCT00275171|goiter reduction|goiter reduction
5343983|NCT00275158|Pre-Eclampsia|pre-eclampsia
5343984|NCT00275158|Glomerular Filtration Rate (GFR)|glomerular filtration rate (gfr)
5343985|NCT00275158|Inulin clearance|inulin clearance
5343986|NCT00275158|Hypertension|hypertension
5343987|NCT00275158|L-Arginine|l-arginine
5343988|NCT00275158|Nitric Oxide|nitric oxide
5343989|NCT00275158|cGMP|cgmp
5343990|NCT00275158|Endothelin|endothelin
5343991|NCT00275158|ADMA|adma
5343992|NCT00275132|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5343993|NCT00275132|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5343994|NCT00275119|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
5343995|NCT00275119|stage II pancreatic cancer|stage ii pancreatic cancer
5343996|NCT00275119|stage III pancreatic cancer|stage iii pancreatic cancer
5343997|NCT00275119|recurrent pancreatic cancer|recurrent pancreatic cancer
5343998|NCT00275106|stage I childhood lymphoblastic lymphoma|stage i childhood lymphoblastic lymphoma
5343999|NCT00275106|stage II childhood lymphoblastic lymphoma|stage ii childhood lymphoblastic lymphoma
5344300|NCT00274300|immunotherapy|immunotherapy
5344000|NCT00275106|stage III childhood lymphoblastic lymphoma|stage iii childhood lymphoblastic lymphoma
5344001|NCT00275106|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
5344002|NCT00275067|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5344003|NCT00275067|adult gliosarcoma|adult gliosarcoma
5344004|NCT00275067|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
5344005|NCT00275067|adult mixed glioma|adult mixed glioma
5344006|NCT00275067|adult glioblastoma|adult glioblastoma
5344007|NCT00275067|adult giant cell glioblastoma|adult giant cell glioblastoma
5344008|NCT00275067|recurrent adult brain tumor|recurrent adult brain tumor
5344009|NCT00275054|stage 0 chronic lymphocytic leukemia|stage 0 chronic lymphocytic leukemia
5344010|NCT00275054|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
5344011|NCT00275054|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
5344012|NCT00275054|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
5344013|NCT00275041|recurrent breast cancer|recurrent breast cancer
5344014|NCT00275041|stage IV breast cancer|stage iv breast cancer
5344015|NCT00275041|male breast cancer|male breast cancer
5344016|NCT00275015|stage 0 chronic lymphocytic leukemia|stage 0 chronic lymphocytic leukemia
5344017|NCT00275015|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
5344018|NCT00275015|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
5344019|NCT00275015|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5344020|NCT00275015|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5344021|NCT00275015|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5344022|NCT00275002|recurrent childhood brain stem glioma|recurrent childhood brain stem glioma
5344023|NCT00275002|recurrent childhood brain tumor|recurrent childhood brain tumor
5344024|NCT00274989|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
5344025|NCT00274989|relapsed refractory chronic lymphocytic leukemia|relapsed refractory chronic lymphocytic leukemia
5344026|NCT00274989|previously untreated chronic lymphocytic leukemia|previously untreated chronic lymphocytic leukemia
5344027|NCT00274976|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5344028|NCT00274976|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5344029|NCT00274976|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5344030|NCT00274963|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
5344031|NCT00274963|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5344032|NCT00274950|childhood extragonadal germ cell tumor|childhood extragonadal germ cell tumor
5344033|NCT00274950|childhood malignant ovarian germ cell tumor|childhood malignant ovarian germ cell tumor
5344034|NCT00274950|childhood malignant testicular germ cell tumor|childhood malignant testicular germ cell tumor
5344035|NCT00274950|recurrent childhood malignant germ cell tumor|recurrent childhood malignant germ cell tumor
5344036|NCT00274950|childhood teratoma|childhood teratoma
5344037|NCT00274950|childhood extracranial germ cell tumor|childhood extracranial germ cell tumor
5344038|NCT00274924|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
5344039|NCT00274924|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5344040|NCT00274924|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5344041|NCT00274924|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5344042|NCT00274911|untreated childhood supratentorial primitive neuroectodermal tumor|untreated childhood supratentorial primitive neuroectodermal tumor
5344043|NCT00274898|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
5344044|NCT00274898|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5344045|NCT00274898|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5344046|NCT00274898|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5344047|NCT00274885|neurotoxicity|neurotoxicity
5344048|NCT00274885|carcinoma of the appendix|carcinoma of the appendix
5344049|NCT00274885|recurrent anal cancer|recurrent anal cancer
5344050|NCT00274885|stage I anal cancer|stage i anal cancer
5344051|NCT00274885|stage II anal cancer|stage ii anal cancer
5344052|NCT00274885|stage IIIA anal cancer|stage iiia anal cancer
5344053|NCT00274885|stage IIIB anal cancer|stage iiib anal cancer
5344054|NCT00274885|stage IV anal cancer|stage iv anal cancer
5344055|NCT00274885|localized extrahepatic bile duct cancer|localized extrahepatic bile duct cancer
5344056|NCT00274885|recurrent extrahepatic bile duct cancer|recurrent extrahepatic bile duct cancer
5344057|NCT00274885|unresectable extrahepatic bile duct cancer|unresectable extrahepatic bile duct cancer
5344058|NCT00274885|localized gallbladder cancer|localized gallbladder cancer
5344059|NCT00274885|recurrent gallbladder cancer|recurrent gallbladder cancer
5344060|NCT00274885|unresectable gallbladder cancer|unresectable gallbladder cancer
5344061|NCT00274885|recurrent gastric cancer|recurrent gastric cancer
5344062|NCT00274885|stage IV gastric cancer|stage iv gastric cancer
5344063|NCT00274885|recurrent colon cancer|recurrent colon cancer
5344064|NCT00274885|recurrent rectal cancer|recurrent rectal cancer
5344065|NCT00274885|recurrent esophageal cancer|recurrent esophageal cancer
5344066|NCT00274885|localized gastrointestinal carcinoid tumor|localized gastrointestinal carcinoid tumor
5344274|NCT00274495|Metabolic syndrome|metabolic syndrome
5344067|NCT00274885|metastatic gastrointestinal carcinoid tumor|metastatic gastrointestinal carcinoid tumor
5344068|NCT00274885|recurrent gastrointestinal carcinoid tumor|recurrent gastrointestinal carcinoid tumor
5344694|NCT00272415|INO4136g|ino4136g
5344069|NCT00274885|regional gastrointestinal carcinoid tumor|regional gastrointestinal carcinoid tumor
5344070|NCT00274885|gastrointestinal stromal tumor|gastrointestinal stromal tumor
5344071|NCT00274885|advanced adult primary liver cancer|advanced adult primary liver cancer
5344072|NCT00274885|localized resectable adult primary liver cancer|localized resectable adult primary liver cancer
5344073|NCT00274885|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
5344074|NCT00274885|recurrent adult primary liver cancer|recurrent adult primary liver cancer
5344075|NCT00274885|recurrent pancreatic cancer|recurrent pancreatic cancer
5344076|NCT00274885|stage I pancreatic cancer|stage i pancreatic cancer
5344077|NCT00274885|stage II pancreatic cancer|stage ii pancreatic cancer
5344078|NCT00274885|stage III pancreatic cancer|stage iii pancreatic cancer
5344079|NCT00274885|recurrent small intestine cancer|recurrent small intestine cancer
5344080|NCT00274885|small intestine adenocarcinoma|small intestine adenocarcinoma
5344081|NCT00274885|small intestine leiomyosarcoma|small intestine leiomyosarcoma
5344082|NCT00274885|small intestine lymphoma|small intestine lymphoma
5344083|NCT00274885|stage IV pancreatic cancer|stage iv pancreatic cancer
5344084|NCT00274885|metastatic extrahepatic bile duct cancer|metastatic extrahepatic bile duct cancer
5344085|NCT00274885|metastatic gallbladder cancer|metastatic gallbladder cancer
5344086|NCT00274885|stage IA gastric cancer|stage ia gastric cancer
5344087|NCT00274885|stage IB gastric cancer|stage ib gastric cancer
5344088|NCT00274885|stage IIA gastric cancer|stage iia gastric cancer
5344089|NCT00274885|stage IIB gastric cancer|stage iib gastric cancer
5344090|NCT00274885|stage IIIA gastric cancer|stage iiia gastric cancer
5344091|NCT00274885|stage IIIB gastric cancer|stage iiib gastric cancer
5344092|NCT00274885|stage IIIC gastric cancer|stage iiic gastric cancer
5344093|NCT00274885|stage I colon cancer|stage i colon cancer
5344094|NCT00274885|stage IIA colon cancer|stage iia colon cancer
5344095|NCT00274885|stage IIB colon cancer|stage iib colon cancer
5344096|NCT00274885|stage IIIA colon cancer|stage iiia colon cancer
5344097|NCT00274885|stage IIIB colon cancer|stage iiib colon cancer
5344098|NCT00274885|stage IIIC colon cancer|stage iiic colon cancer
5344099|NCT00274885|stage IVA colon cancer|stage iva colon cancer
5344100|NCT00274885|stage IVB colon cancer|stage ivb colon cancer
5344101|NCT00274885|stage I rectal cancer|stage i rectal cancer
5344102|NCT00274885|stage IIA rectal cancer|stage iia rectal cancer
5344103|NCT00274885|stage IIB rectal cancer|stage iib rectal cancer
5344104|NCT00274885|stage IIC rectal cancer|stage iic rectal cancer
5344105|NCT00274885|stage IIIA rectal cancer|stage iiia rectal cancer
5344106|NCT00274885|stage IIIB rectal cancer|stage iiib rectal cancer
5344107|NCT00274885|stage IIIC rectal cancer|stage iiic rectal cancer
5344108|NCT00274885|stage IVA rectal cancer|stage iva rectal cancer
5344109|NCT00274885|stage IVB rectal cancer|stage ivb rectal cancer
5344110|NCT00274885|stage IA esophageal cancer|stage ia esophageal cancer
5344111|NCT00274885|stage IB esophageal cancer|stage ib esophageal cancer
5344112|NCT00274885|stage IIA esophageal cancer|stage iia esophageal cancer
5344113|NCT00274885|stage IIB esophageal cancer|stage iib esophageal cancer
5344114|NCT00274885|stage IIIA esophageal cancer|stage iiia esophageal cancer
5344115|NCT00274885|stage IIIB esophageal cancer|stage iiib esophageal cancer
5344116|NCT00274885|stage IIIC esophageal cancer|stage iiic esophageal cancer
5344117|NCT00274885|stage IV esophageal cancer|stage iv esophageal cancer
5344118|NCT00274872|recurrent rectal cancer|recurrent rectal cancer
5344119|NCT00274872|stage IV rectal cancer|stage iv rectal cancer
5344120|NCT00274872|recurrent colon cancer|recurrent colon cancer
5344121|NCT00274872|stage IV colon cancer|stage iv colon cancer
5344122|NCT00274872|adenocarcinoma of the colon|adenocarcinoma of the colon
5344123|NCT00274872|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5344124|NCT00274859|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5344125|NCT00274846|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5344126|NCT00274846|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5344127|NCT00274846|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5344128|NCT00274846|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5344129|NCT00274846|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5344130|NCT00274846|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5344131|NCT00274846|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5344132|NCT00274846|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5344133|NCT00274833|adult glioblastoma|adult glioblastoma
5344134|NCT00274833|adult giant cell glioblastoma|adult giant cell glioblastoma
5344135|NCT00274833|adult gliosarcoma|adult gliosarcoma
5344136|NCT00274820|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
5344137|NCT00274820|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5344138|NCT00274820|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
5344139|NCT00274820|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
5344140|NCT00274820|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5344141|NCT00274820|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5344142|NCT00274820|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5344143|NCT00274807|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
5344144|NCT00274807|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5344145|NCT00274807|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5344146|NCT00274807|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5344147|NCT00274807|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5344148|NCT00274807|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5344149|NCT00274794|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
5344150|NCT00274794|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5344151|NCT00274794|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5344152|NCT00274794|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5344153|NCT00274794|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5344154|NCT00274794|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5344155|NCT00274794|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
5344156|NCT00274794|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
5344157|NCT00274794|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5344158|NCT00274794|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5344159|NCT00274794|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5344160|NCT00274794|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5344161|NCT00274794|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5344162|NCT00274794|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5344163|NCT00274794|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5344164|NCT00274794|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5344165|NCT00274794|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5344166|NCT00274794|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
5344167|NCT00274794|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5344168|NCT00274794|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5344169|NCT00274794|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5344170|NCT00274794|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
5344171|NCT00274794|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5344172|NCT00274794|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5344173|NCT00274794|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5344174|NCT00274794|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5344175|NCT00274794|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5344176|NCT00274794|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5344177|NCT00274794|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5344178|NCT00274794|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5344179|NCT00274794|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5344180|NCT00274794|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5344181|NCT00274794|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5344182|NCT00274794|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5344183|NCT00274794|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5344184|NCT00274794|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5344185|NCT00274794|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5344186|NCT00274794|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5344187|NCT00274794|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5344188|NCT00274794|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5344189|NCT00274794|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5344190|NCT00274794|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
5344191|NCT00274794|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5344192|NCT00274794|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5344193|NCT00274794|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5344194|NCT00274794|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5344195|NCT00274794|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
5344196|NCT00274794|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5344197|NCT00274794|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5344198|NCT00274794|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5344199|NCT00274781|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
5344200|NCT00274781|refractory anemia with excess blasts|refractory anemia with excess blasts
5344201|NCT00274781|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5344202|NCT00274781|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5344203|NCT00274781|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5344695|NCT00272415|inotek|inotek
5344204|NCT00274781|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5344205|NCT00274781|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5344206|NCT00274768|stage IV breast cancer|stage iv breast cancer
5344207|NCT00274768|male breast cancer|male breast cancer
5344208|NCT00274768|recurrent breast cancer|recurrent breast cancer
5344209|NCT00274755|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5344210|NCT00274755|adult diffuse astrocytoma|adult diffuse astrocytoma
5344211|NCT00274755|adult glioblastoma|adult glioblastoma
5344212|NCT00274755|adult giant cell glioblastoma|adult giant cell glioblastoma
5344213|NCT00274755|adult gliosarcoma|adult gliosarcoma
5344214|NCT00274755|adult pilocytic astrocytoma|adult pilocytic astrocytoma
5344215|NCT00274755|adult anaplastic ependymoma|adult anaplastic ependymoma
5344216|NCT00274755|adult ependymoma|adult ependymoma
5344217|NCT00274755|adult myxopapillary ependymoma|adult myxopapillary ependymoma
5344218|NCT00274755|adult subependymoma|adult subependymoma
5344219|NCT00274755|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
5344220|NCT00274755|adult oligodendroglioma|adult oligodendroglioma
5344221|NCT00274755|adult mixed glioma|adult mixed glioma
5344222|NCT00274742|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
5344223|NCT00274742|Cancer immunotherapy|cancer immunotherapy
5344224|NCT00274742|Monoclonal antibody|monoclonal antibody
5344225|NCT00274742|anti-CD19|anti-cd19
5344226|NCT00274742|anti-CD3|anti-cd3
5344227|NCT00274742|BiTE|bite
5344228|NCT00274742|Blinatumomab|blinatumomab
5344229|NCT00274729|Dietary intervention|dietary intervention
5344230|NCT00274729|High-carbohydrate diet|high-carbohydrate diet
5344231|NCT00274729|High-fat diet|high-fat diet
5344232|NCT00274729|Moderate-fat diet|moderate-fat diet
5344233|NCT00274729|Obesity|obesity
5344234|NCT00274729|Weight maintenance|weight maintenance
5344235|NCT00274729|Body composition|body composition
5344236|NCT00274729|Glucose metabolism|glucose metabolism
5344237|NCT00274729|Cardiovascular disease|cardiovascular disease
5344238|NCT00274729|Appetite regulation|appetite regulation
5344239|NCT00274729|Energy expenditure|energy expenditure
5344240|NCT00274703|anti IL-5|anti il-5
5344241|NCT00274703|oesophagitis|oesophagitis
5344242|NCT00274703|eosinophils|eosinophils
5344243|NCT00274703|mepolizumab|mepolizumab
5344244|NCT00274703|adults|adults
5344245|NCT00274690|Neurokinin-1 Receptor Antagonist|neurokinin-1 receptor antagonist
5344246|NCT00274690|GW679769|gw679769
5344247|NCT00274690|Post-operative Nausea|post-operative nausea
5344248|NCT00274690|NK-1 Receptor Antagonist|nk-1 receptor antagonist
5344249|NCT00274690|PONV|ponv
5344250|NCT00274690|Post-discharge Nausea and Vomiting|post-discharge nausea and vomiting
5344251|NCT00274690|PDNV|pdnv
5344252|NCT00274690|Vomiting|vomiting
5344253|NCT00274677|Bipolar Disorder|bipolar disorder
5344254|NCT00274664|Amblyopia|amblyopia
5344255|NCT00274664|Occlusion dose monitoring|occlusion dose monitoring
5344256|NCT00274664|Refractive adaptation|refractive adaptation
5344257|NCT00274664|Dose-response|dose-response
5344258|NCT00274651|CTCL|ctcl
5344259|NCT00274651|PTCL|ptcl
5344260|NCT00274651|lymphoma|lymphoma
5344261|NCT00274651|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
5344262|NCT00274651|Cutaneous T-Cell Lymphomas (CTCL)|cutaneous t-cell lymphomas (ctcl)
5344263|NCT00274651|Peripheral T-Cell Lymphomas (PTCL)|peripheral t-cell lymphomas (ptcl)
5344264|NCT00274651|Other Types of Non-Hodgkin's Lymphoma|other types of non-hodgkin's lymphoma
5344265|NCT00274651|belinostat|belinostat
5344266|NCT00274625|Biomaterials|biomaterials
5344267|NCT00274625|Bariatric Surgery|bariatric surgery
5344268|NCT00274625|Hernia, Prevention of|hernia, prevention of
5344269|NCT00274625|Obesity|obesity
5344270|NCT00274625|Bypass Surgery|bypass surgery
5344271|NCT00274625|Incisional Hernia|incisional hernia
5344272|NCT00274625|Ventral Hernia|ventral hernia
5344273|NCT00274495|Genotype 1|genotype 1
5344275|NCT00274495|Insulin resistance|insulin resistance
5344276|NCT00274469|oncology|oncology
5344277|NCT00274469|cancer|cancer
5344278|NCT00274469|breast cancer|breast cancer
5344279|NCT00274456|Metastatic breast cancer, nab paclitaxel, docetaxel,|metastatic breast cancer, nab paclitaxel, docetaxel,
5344280|NCT00274404|infectious mononucleosis|infectious mononucleosis
5344281|NCT00274404|Epstein-Barr virus|epstein-barr virus
5344282|NCT00274404|valacyclovir|valacyclovir
5344283|NCT00274404|quantitative PCR|quantitative pcr
5344284|NCT00274378|radius fracture|radius fracture
5344285|NCT00274378|fracture fixation|fracture fixation
5344286|NCT00274378|homologous bone transplantation|homologous bone transplantation
5344287|NCT00274365|general practitioners, psychiatry, videoconference|general practitioners, psychiatry, videoconference
5344288|NCT00274352|sarcoidosis|sarcoidosis
5344289|NCT00274352|adalimumab|adalimumab
5344290|NCT00274352|skin diseases|skin diseases
5344291|NCT00274339|Laryngopharyngeal Reflux|laryngopharyngeal reflux
5344292|NCT00274339|Prevacid|prevacid
5344293|NCT00274339|Lifestyle changes|lifestyle changes
5344294|NCT00274339|Reflux Finding Score|reflux finding score
5344295|NCT00274339|Reflux Symptom Index|reflux symptom index
5344296|NCT00274339|Laryngoscopy|laryngoscopy
5344297|NCT00274326|Hyponatremia|hyponatremia
5344298|NCT00274313|Cystic Fibrosis|cystic fibrosis
5344299|NCT00274300|DNA vaccine|dna vaccine
5344301|NCT00274300|Herpes Simplex Virus Type 2 (HSV2)|herpes simplex virus type 2 (hsv2)
5344302|NCT00274300|Particle Mediated Epidermal Delivery|particle mediated epidermal delivery
5344303|NCT00274261|contraception|contraception
5344304|NCT00274235|Malaria|malaria
5344305|NCT00274235|Prevention|prevention
5344306|NCT00274235|Pregnancy|pregnancy
5344307|NCT00274235|Low birthweight|low birthweight
5344308|NCT00274235|Anemia|anemia
5344309|NCT00274235|Africa|africa
5344310|NCT00274222|COPD, nebulized budesonide, systemic corticosteroids|copd, nebulized budesonide, systemic corticosteroids
5344311|NCT00274209|Ulcerative colitis|ulcerative colitis
5344312|NCT00274209|Crohn's disease|crohn's disease
5344313|NCT00274209|Chromoendoscopy|chromoendoscopy
5344314|NCT00274209|Dysplasia|dysplasia
5344315|NCT00274209|Neoplasia|neoplasia
5344316|NCT00274196|fractures, occult|fractures, occult
5344317|NCT00274196|hip|hip
5344318|NCT00274196|ultrasound examination|ultrasound examination
5344319|NCT00274196|MRI|mri
5344320|NCT00274196|sensitivity|sensitivity
5344321|NCT00274196|specificity|specificity
5344322|NCT00274170|Migraine|migraine
5344323|NCT00274170|Octreotide|octreotide
5344324|NCT00274170|Prochlorperazine|prochlorperazine
5344325|NCT00274157|Peripheral Vascular Disease|peripheral vascular disease
5344326|NCT00274157|Intermittent Claudication|intermittent claudication
5344327|NCT00274157|Catheter-based Arterial Revascularization|catheter-based arterial revascularization
5344328|NCT00274157|Peripheral angioplasty|peripheral angioplasty
5344329|NCT00274157|Peripheral stenting|peripheral stenting
5344330|NCT00274157|Functional capacity|functional capacity
5344331|NCT00274157|Quality of life|quality of life
5344332|NCT00273949|Lactulose|lactulose
5344333|NCT00273949|Prebiotics|prebiotics
5344334|NCT00273949|Nosocomial infection|nosocomial infection
5344335|NCT00273949|children|children
5344336|NCT00273949|infants|infants
5344337|NCT00273910|Disease Free Survival|disease free survival
5344338|NCT00273910|gp 100:209-217 (210m)|gp 100:209-217 (210m)
5344339|NCT00273910|Immunologic Response|immunologic response
5344340|NCT00273910|Adjuvant Therapy|adjuvant therapy
5344341|NCT00273910|Cutaneous Melanoma|cutaneous melanoma
5344342|NCT00273910|Melanoma|melanoma
5344343|NCT00273897|Dementia Treatment|dementia treatment
5344344|NCT00273897|Hand Function|hand function
5344345|NCT00273897|Clinical Trials|clinical trials
5344346|NCT00273897|Dementia|dementia
5344347|NCT00273897|Cortical Syndrome|cortical syndrome
5344348|NCT00273897|CBS|cbs
5344349|NCT00273897|Apraxia|apraxia
5344350|NCT00273884|AML|aml
5344351|NCT00273884|Secondary AML|secondary aml
5344352|NCT00273884|Leukemia|leukemia
5344353|NCT00273871|kidney transplant|kidney transplant
5344354|NCT00273858|Rheumatoid Arthritis|rheumatoid arthritis
5344355|NCT00273858|Ankylosing Spondylitis|ankylosing spondylitis
5344356|NCT00273858|Psoriatic Arthritis|psoriatic arthritis
5344357|NCT00273845|case management|case management
5344358|NCT00273845|substance abuse treatment|substance abuse treatment
5344359|NCT00273845|linkage|linkage
5344360|NCT00273832|Chest pain|chest pain
5344361|NCT00273832|Angina pectoris|angina pectoris
5344362|NCT00273832|Emergency medicine|emergency medicine
5344363|NCT00273832|Spiral computed tomography|spiral computed tomography
5344364|NCT00273832|Length of stay|length of stay
5344365|NCT00273832|Cost analysis|cost analysis
5344366|NCT00273819|Congestive heart failure, LV dysfunction|congestive heart failure, lv dysfunction
5344367|NCT00273806|Behavioral risk factors|behavioral risk factors
5344368|NCT00273806|Primary Care|primary care
5344369|NCT00273806|Health services research|health services research
5344370|NCT00273780|Patient compliance|patient compliance
5344371|NCT00273767|troponin T|troponin t
5344372|NCT00273767|CK-MB|ck-mb
5344373|NCT00273767|protein S-100|protein s-100
5344374|NCT00273767|Cardiopulmonary Bypass|cardiopulmonary bypass
5344375|NCT00273767|Erythropoietin|erythropoietin
5344376|NCT00273754|Obstructive Sleep Apnea (OSA)|obstructive sleep apnea (osa)
5344377|NCT00273754|Tonsillectomy and Adenoidectomy (T&A)|tonsillectomy and adenoidectomy (t&a)
5344378|NCT00273754|Postoperative Complications|postoperative complications
5344379|NCT00273754|Recovery|recovery
5344380|NCT00273741|palliative care|palliative care
5344381|NCT00273741|methylphenidate|methylphenidate
5344382|NCT00273728|Hydroxyethyl Starch|hydroxyethyl starch
5344383|NCT00273728|shock, septic|shock, septic
5344384|NCT00273728|infusion, intravenous|infusion, intravenous
5344385|NCT00273728|mortality|mortality
5344386|NCT00273715|Comparative|comparative
5344387|NCT00273715|Randomized|randomized
5344388|NCT00273715|Suture|suture
5344389|NCT00273715|Staples, surgical|staples, surgical
5344390|NCT00273715|Skin|skin
5344391|NCT00273715|Surgical procedures, operative|surgical procedures, operative
5344392|NCT00273715|Orthopedics|orthopedics
5344393|NCT00273715|Joint, hip|joint, hip
5344394|NCT00273715|Surgical procedures of Hip, Operative|surgical procedures of hip, operative
5344395|NCT00273702|Gambling|gambling
5344396|NCT00273702|Gambler|gambler
5344397|NCT00273702|Gamble|gamble
5344398|NCT00273702|Pathological|pathological
5344399|NCT00273676|Community-acquired pneumonia|community-acquired pneumonia
5344400|NCT00273676|Treatment|treatment
5344401|NCT00273676|Antibiotics|antibiotics
5344402|NCT00273663|cerebral blood flow|cerebral blood flow
5344403|NCT00273663|electrical stimulation|electrical stimulation
5344404|NCT00273663|Computed Tomography Scanner, X-Ray|computed tomography scanner, x-ray
5344405|NCT00273663|Brain Mapping|brain mapping
5344406|NCT00273650|Autism|autism
5344407|NCT00273650|Placebo|placebo
5344408|NCT00273650|B12|b12
5344409|NCT00273650|Controlled|controlled
5344410|NCT00273650|Complementary Alternative Medicine|complementary alternative medicine
5344411|NCT00273650|Vitamin Supplement|vitamin supplement
5344412|NCT00273637|heart failure|heart failure
5344413|NCT00273637|peripartum cardiomyopathy|peripartum cardiomyopathy
5344414|NCT00273637|pregnancy-associated cardiomyopathy|pregnancy-associated cardiomyopathy
5344415|NCT00273637|pregnancy complications|pregnancy complications
5344416|NCT00273637|nonischemic cardiomyopathy|nonischemic cardiomyopathy
5344417|NCT00273624|Therapy-resistant depression|therapy-resistant depression
5344418|NCT00273624|add-on therapy depression|add-on therapy depression
5344419|NCT00273611|vitamin D deficiency|vitamin d deficiency
5344420|NCT00273611|geriatric patients|geriatric patients
5344421|NCT00273598|Scoliosis|scoliosis
5344422|NCT00273598|spinal disease|spinal disease
5344423|NCT00273598|pediatrics|pediatrics
5344424|NCT00273598|Adolescents|adolescents
5344425|NCT00273598|Universal Spinal Instrumentation System|universal spinal instrumentation system
5344426|NCT00273598|Moss Miami Spinal Instrumentation System|moss miami spinal instrumentation system
5344427|NCT00273598|Orthopedic Surgery|orthopedic surgery
5344428|NCT00273585|Fecal occult blood testing|fecal occult blood testing
5344429|NCT00273585|Flexible sigmoidoscopy|flexible sigmoidoscopy
5344430|NCT00273585|Colonoscopy|colonoscopy
5344431|NCT00273585|Self-efficacy|self-efficacy
5344432|NCT00273572|Obesity|obesity
5344433|NCT00273572|Women|women
5344434|NCT00273572|Arab|arab
5344435|NCT00273572|Metabolic syndrome|metabolic syndrome
5344436|NCT00273572|Lifestyle intervention|lifestyle intervention
5344437|NCT00273572|Quality of life|quality of life
5344438|NCT00273559|Renal Transplantation|renal transplantation
5344439|NCT00273546|Head and Neck Cancer|head and neck cancer
5344440|NCT00273546|Induction|induction
5344441|NCT00273546|Chemotherapy|chemotherapy
5344442|NCT00273546|Chemoradiotherapy|chemoradiotherapy
5344443|NCT00273507|Non-small cell lung cancer|non-small cell lung cancer
5344444|NCT00273507|neoadjuvant|neoadjuvant
5344445|NCT00273507|resection|resection
5344446|NCT00273494|N2 disease|n2 disease
5344447|NCT00273494|Non-small cell lung cancer|non-small cell lung cancer
5344448|NCT00273494|Surgery|surgery
5344449|NCT00273494|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
5344450|NCT00273403|HIV|hiv
5344451|NCT00273403|Minority Groups|minority groups
5344452|NCT00273403|Health Services Accessibility|health services accessibility
5344453|NCT00273403|Quality of Life|quality of life
5344454|NCT00273377|Anesthesia|anesthesia
5344455|NCT00273377|Oxygen|oxygen
5344456|NCT00273377|Carbon dioxide|carbon dioxide
5344457|NCT00273377|Hypercapnia|hypercapnia
5344458|NCT00273377|Hypercarbia|hypercarbia
5344459|NCT00273377|Dexamethasone|dexamethasone
5344460|NCT00273377|Steroid|steroid
5344461|NCT00273377|Postoperative nausea and vomiting (PONV)|postoperative nausea and vomiting (ponv)
5344462|NCT00273364|stem cell, autoimmune disease, multiple sclerosis|stem cell, autoimmune disease, multiple sclerosis
5344463|NCT00273351|Parkinson|parkinson
5344464|NCT00273351|family history|family history
5344465|NCT00273351|diagnosis|diagnosis
5344466|NCT00273338|Androgen-independent Prostate Cancer (AIPC)|androgen-independent prostate cancer (aipc)
5344467|NCT00273338|Prostate Cancer|prostate cancer
5344468|NCT00273338|DN-101|dn-101
5344469|NCT00273338|calcitriol|calcitriol
5344470|NCT00273338|Taxotere|taxotere
5344471|NCT00273338|docetaxel|docetaxel
5344472|NCT00273325|NICHD Neonatal Research Network|nichd neonatal research network
5344473|NCT00273325|Very Low Birth Weight (VLBW)|very low birth weight (vlbw)
5344474|NCT00273325|Extremely Low Birth Weight (ELBW)|extremely low birth weight (elbw)
5344475|NCT00273325|Prematurity|prematurity
5344476|NCT00273325|Pneumococcal Vaccines|pneumococcal vaccines
5344477|NCT00273325|Vaccines, Conjugate|vaccines, conjugate
5344478|NCT00273325|Immunogenicity|immunogenicity
5344479|NCT00273325|Vaccine Response|vaccine response
5344480|NCT00273325|Heptavalent pneumococcal conjugate vaccine (PCV-7)|heptavalent pneumococcal conjugate vaccine (pcv-7)
5344481|NCT00273325|pneumococcal polysaccharide, type 6B|pneumococcal polysaccharide, type 6b
5344482|NCT00273325|Pneumococcal polysaccharide, type 14|pneumococcal polysaccharide, type 14
5344483|NCT00273325|Pneumococcal polysaccharide, type 19F,|pneumococcal polysaccharide, type 19f,
5344484|NCT00273325|Pneumococcal polysaccharide, 23F|pneumococcal polysaccharide, 23f
5344485|NCT00273325|Pneumococcal polysaccharide, 18C|pneumococcal polysaccharide, 18c
5344486|NCT00273325|Pneumococcal polysaccharide, 4|pneumococcal polysaccharide, 4
5344487|NCT00273325|Pneumococcal polysaccharide, 9V|pneumococcal polysaccharide, 9v
5344488|NCT00273312|Advanced unresectable metastatic hepatocellular carcinoma|advanced unresectable metastatic hepatocellular carcinoma
5344489|NCT00273312|Liver cancer|liver cancer
5344490|NCT00273299|hypertension|hypertension
5344491|NCT00273299|high blood pressure|high blood pressure
5344492|NCT00273299|valsartan/hydrochlorozide|valsartan/hydrochlorozide
5344493|NCT00273299|severe hypertension|severe hypertension
5344696|NCT00272415|Parp|parp
5344494|NCT00273286|Diabetes Mellitus, Insulin-Dependent|diabetes mellitus, insulin-dependent
5344495|NCT00273286|Diabetes Mellitus, Juvenile-Onset|diabetes mellitus, juvenile-onset
5344496|NCT00273286|IDDM|iddm
5344497|NCT00273286|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
5344498|NCT00273273|HIV|hiv
5344499|NCT00273273|Atazanavir|atazanavir
5344500|NCT00273273|ritonavir|ritonavir
5344501|NCT00273273|tenofovir|tenofovir
5344502|NCT00273273|Adolescent|adolescent
5344503|NCT00273273|Treatment Experienced|treatment experienced
5344504|NCT00273234|Venous|venous
5344505|NCT00273234|Ulcer|ulcer
5344506|NCT00273234|autologous|autologous
5344507|NCT00273234|platelet|platelet
5344508|NCT00273234|healing|healing
5344509|NCT00273221|Glaucoma|glaucoma
5344510|NCT00273221|Cataract|cataract
5344511|NCT00273208|breast cancer|breast cancer
5344512|NCT00273208|fatigue|fatigue
5344513|NCT00273195|Implantable Cardioverter Defibrillator, Anti-tachycardia pacing (ATP)|implantable cardioverter defibrillator, anti-tachycardia pacing (atp)
5344514|NCT00273182|Heart Failure|heart failure
5344515|NCT00273182|Cardiomyopathy|cardiomyopathy
5344516|NCT00273182|Cardiac pacing|cardiac pacing
5344517|NCT00273182|Cardiac resynchronization therapy|cardiac resynchronization therapy
5344518|NCT00273130|transnasal gastroscopy, stress response, ischaemia|transnasal gastroscopy, stress response, ischaemia
5344519|NCT00273117|transnasal gastroscopy|transnasal gastroscopy
5344520|NCT00273117|tachycardia|tachycardia
5344521|NCT00273117|hypoxemia|hypoxemia
5344522|NCT00273078|Speech,|speech,
5344523|NCT00273078|tongue,|tongue,
5344524|NCT00273078|pressure,|pressure,
5344525|NCT00273078|transducer,|transducer,
5344526|NCT00273078|complete denture|complete denture
5344527|NCT00273065|Local Anesthetic|local anesthetic
5344528|NCT00273065|Neosaxitoxin|neosaxitoxin
5344529|NCT00273052|hypertension|hypertension
5344530|NCT00273039|Social Anxiety Disorder|social anxiety disorder
5344531|NCT00273039|Anxiety|anxiety
5344532|NCT00273039|Psychiatry|psychiatry
5344533|NCT00273026|Asthma Advair|asthma advair
5344534|NCT00273013|asthma|asthma
5344535|NCT00273013|allergen challenge|allergen challenge
5344536|NCT00272987|trastuzumab|trastuzumab
5344537|NCT00272987|ErbB2|erbb2
5344538|NCT00272987|paclitaxel|paclitaxel
5344539|NCT00272987|Herceptin|herceptin
5344540|NCT00272987|Taxol|taxol
5344541|NCT00272987|ErbB1|erbb1
5344542|NCT00272987|metastatic breast cancer|metastatic breast cancer
5344543|NCT00272987|Stage IV breast cancer|stage iv breast cancer
5344544|NCT00272987|lapatinib|lapatinib
5344545|NCT00272974|AE adverse event|ae adverse event
5344546|NCT00272974|DCF data collection forms|dcf data collection forms
5344547|NCT00272974|IRB Institutional Review Board|irb institutional review board
5344548|NCT00272974|SAE serious adverse event|sae serious adverse event
5344549|NCT00272948|Venoocclusive disease|venoocclusive disease
5344550|NCT00272948|Pediatric|pediatric
5344551|NCT00272948|myeloablative conditioning|myeloablative conditioning
5344552|NCT00272948|stem cell transplant|stem cell transplant
5344553|NCT00272935|menopause|menopause
5344554|NCT00272935|vasomotor symptoms|vasomotor symptoms
5344555|NCT00272922|Biomaterials|biomaterials
5344556|NCT00272922|Paraesophageal Hernia|paraesophageal hernia
5344557|NCT00272922|Laparoscopy|laparoscopy
5344558|NCT00272909|Acute Ischemic Stroke|acute ischemic stroke
5344559|NCT00272909|9-Hour window MRI|9-hour window mri
5344560|NCT00272909|Serotonin receptor agonist|serotonin receptor agonist
5344561|NCT00272896|Migraine|migraine
5344562|NCT00272896|VIP|vip
5344563|NCT00272896|Transcranial Doppler|transcranial doppler
5344564|NCT00272896|Headache|headache
5344565|NCT00272883|central core|central core
5344566|NCT00272883|centronuclear|centronuclear
5344567|NCT00272883|multiminicore|multiminicore
5344568|NCT00272883|multicore|multicore
5344569|NCT00272883|minicore|minicore
5344570|NCT00272883|congenital fiber type disproportion|congenital fiber type disproportion
5344571|NCT00272883|myotubular|myotubular
5344572|NCT00272883|nemaline|nemaline
5344573|NCT00272883|congenital myopathy|congenital myopathy
5344574|NCT00272883|neuromuscular|neuromuscular
5344575|NCT00272883|rigid spine|rigid spine
5344576|NCT00272844|cholesterol|cholesterol
5344577|NCT00272844|Smith-Lemli-Opitz syndrome|smith-lemli-opitz syndrome
5344578|NCT00272844|mental retardation|mental retardation
5344579|NCT00272844|sterols|sterols
5344580|NCT00272844|congenital anomalies|congenital anomalies
5344581|NCT00272831|Diabetic nephropathy|diabetic nephropathy
5344582|NCT00272831|Macroalbuminuria|macroalbuminuria
5344583|NCT00272831|Pletaal|pletaal
5344584|NCT00272818|Colitis|colitis
5344585|NCT00272818|Esophagitis|esophagitis
5344586|NCT00272818|CD23|cd23
5344587|NCT00272805|chronic heart failure|chronic heart failure
5344588|NCT00272805|left ventricular systolic dysfunction|left ventricular systolic dysfunction
5344589|NCT00272779|HIV|hiv
5344590|NCT00272779|Treatment Naive|treatment naive
5344591|NCT00272766|Ocular histoplasmosis|ocular histoplasmosis
5344592|NCT00272766|Macugen|macugen
5344593|NCT00272766|Photodynamic therapy with Visudyne|photodynamic therapy with visudyne
5344594|NCT00272766|Best-corrected visual acuity scores between 20/40-20/200|best-corrected visual acuity scores between 20/40-20/200
5344595|NCT00272766|classic or occult choroidal neovascularization|classic or occult choroidal neovascularization
5344596|NCT00272740|breast cancer|breast cancer
5344597|NCT00272740|fulvestrant|fulvestrant
5344598|NCT00272740|Faslodex|faslodex
5344599|NCT00272740|hormonotherapy|hormonotherapy
5344600|NCT00272740|aromatase inhibitor failure|aromatase inhibitor failure
5344601|NCT00272740|Advanced breast cancer|advanced breast cancer
5344602|NCT00272727|Asthma|asthma
5344603|NCT00272727|dialog tool|dialog tool
5344604|NCT00272727|compliance|compliance
5344605|NCT00272714|breast pain, tenderness, benign breast conditions|breast pain, tenderness, benign breast conditions
5344606|NCT00272675|Nosocomial infection,|nosocomial infection,
5344607|NCT00272675|Decontamination,|decontamination,
5344608|NCT00272675|Randomized placebo-controlled trial,|randomized placebo-controlled trial,
5344609|NCT00272675|Cardiac surgery,|cardiac surgery,
5344610|NCT00272675|Chlorhexidine,|chlorhexidine,
5344611|NCT00272675|Prevention|prevention
5344612|NCT00272662|anemia|anemia
5344613|NCT00272662|cancer|cancer
5344614|NCT00272662|chemotherapy|chemotherapy
5344615|NCT00272662|chemotherapy induced anemia|chemotherapy induced anemia
5344616|NCT00272662|CIA|cia
5344617|NCT00272662|hemoglobin|hemoglobin
5344618|NCT00272662|Hb|hb
5344619|NCT00272662|Hgb|hgb
5344620|NCT00272662|erythropoietin|erythropoietin
5344621|NCT00272662|EPO|epo
5344622|NCT00272662|erythropoiesis stimulating agent|erythropoiesis stimulating agent
5344623|NCT00272662|ESA|esa
5344624|NCT00272662|Hematide|hematide
5344625|NCT00272662|Omontys|omontys
5344626|NCT00272662|peginesatide|peginesatide
5344627|NCT00272662|red blood cell|red blood cell
5344628|NCT00272662|red blood cell production|red blood cell production
5344629|NCT00272649|Kidney cancer|kidney cancer
5344630|NCT00272649|Renal cancer|renal cancer
5344631|NCT00272636|atrial fibrillation|atrial fibrillation
5344632|NCT00272636|catheter ablation|catheter ablation
5344633|NCT00272636|amiodarone|amiodarone
5344634|NCT00272636|cardioversion|cardioversion
5344635|NCT00272623|Catheter, Indwelling|catheter, indwelling
5344636|NCT00272623|Indwelling Catheter|indwelling catheter
5344637|NCT00272623|Indwelling Catheters|indwelling catheters
5344638|NCT00272623|Implantable Catheters|implantable catheters
5344639|NCT00272623|Catheter, Implantable|catheter, implantable
5344640|NCT00272623|Catheters, Implantable|catheters, implantable
5344641|NCT00272623|Implantable Catheter|implantable catheter
5344642|NCT00272623|In-Dwelling Catheters|in-dwelling catheters
5344643|NCT00272623|Catheter, In-Dwelling|catheter, in-dwelling
5344644|NCT00272623|Catheters, In-Dwelling|catheters, in-dwelling
5344645|NCT00272623|In Dwelling Catheters|in dwelling catheters
5344646|NCT00272623|In-Dwelling Catheter|in-dwelling catheter
5344647|NCT00272623|Venous Reservoirs|venous reservoirs
5344648|NCT00272623|Reservoir, Venous|reservoir, venous
5344649|NCT00272623|Reservoirs, Venous|reservoirs, venous
5344650|NCT00272623|Venous Reservoir|venous reservoir
5344651|NCT00272623|Vascular Access Ports|vascular access ports
5344652|NCT00272623|Access Port, Vascular|access port, vascular
5344653|NCT00272623|Access Ports, Vascular|access ports, vascular
5344654|NCT00272623|Port, Vascular Access|port, vascular access
5344655|NCT00272623|Ports, Vascular Access|ports, vascular access
5344656|NCT00272623|Vascular Access Port|vascular access port
5344657|NCT00272610|Skin Aging|skin aging
5344658|NCT00272610|Bateman's Purpura|bateman's purpura
5344659|NCT00272597|Psychosis|psychosis
5344660|NCT00272597|schizophrenia|schizophrenia
5344661|NCT00272597|schizoaffective|schizoaffective
5344662|NCT00272597|risperidone|risperidone
5344663|NCT00272584|Psychosis, schizophrenia, schizoaffective, clozapine, risperidone|psychosis, schizophrenia, schizoaffective, clozapine, risperidone
5344664|NCT00272571|ECPT, endothelial progenitor cells|ecpt, endothelial progenitor cells
5344665|NCT00272558|Malignant Pleural Mesothelioma|malignant pleural mesothelioma
5344666|NCT00272558|Chemotherapy|chemotherapy
5344667|NCT00272545|Anorexia Nervosa|anorexia nervosa
5344668|NCT00272545|Bulimia Nervosa|bulimia nervosa
5344669|NCT00272545|Cognitive Behavioral Therapy|cognitive behavioral therapy
5344671|NCT00272519|AIDS|aids
5344672|NCT00272519|Adolescent|adolescent
5344673|NCT00272519|HIV Positive|hiv positive
5344674|NCT00272493|Treatment Experienced|treatment experienced
5344675|NCT00272493|Treatment Naive|treatment naive
5344676|NCT00272480|HAM/TSP|ham/tsp
5344677|NCT00272480|HTLV-I-associated myelopathy|htlv-i-associated myelopathy
5344678|NCT00272480|zidovudine|zidovudine
5344679|NCT00272480|lamivudine|lamivudine
5344680|NCT00272480|antiretroviral therapy|antiretroviral therapy
5344681|NCT00272467|Helicobacter pylori|helicobacter pylori
5344682|NCT00272467|Stomach ulcer|stomach ulcer
5344683|NCT00272467|Rebamipide|rebamipide
5344684|NCT00272467|Omeprazole|omeprazole
5344685|NCT00272454|cilostazol|cilostazol
5344686|NCT00272454|aspirin|aspirin
5344687|NCT00272454|cerebral infarction|cerebral infarction
5344688|NCT00272428|Prevention trial|prevention trial
5344689|NCT00272428|Antioxydant vitamins and minerals|antioxydant vitamins and minerals
5344690|NCT00272428|Cancer|cancer
5344691|NCT00272428|Ischemic disease|ischemic disease
5344692|NCT00272428|Mortality|mortality
5344693|NCT00272428|Health related quality of life|health related quality of life
5344698|NCT00272402|physician decision support|physician decision support
5344699|NCT00272402|diabetes mellitus|diabetes mellitus
5344700|NCT00272402|electronic medical records|electronic medical records
5344701|NCT00272402|office systems redesign|office systems redesign
5344702|NCT00272376|Myopia|myopia
5344703|NCT00272376|Nearsightedness|nearsightedness
5344704|NCT00272363|Glaucoma|glaucoma
5344705|NCT00272350|Brain|brain
5344706|NCT00272350|Tumor|tumor
5344707|NCT00272350|Therapy|therapy
5344708|NCT00272350|Progression|progression
5344709|NCT00272350|Antiangiogenesis|antiangiogenesis
5344710|NCT00272350|Brain Tumor|brain tumor
5344711|NCT00272350|Malignant Glioma|malignant glioma
5344712|NCT00272337|Cardiovascular diseases|cardiovascular diseases
5344713|NCT00272337|Aspirin|aspirin
5344714|NCT00272337|Atherosclerosis|atherosclerosis
5344715|NCT00272337|Myocardial Infarction|myocardial infarction
5344716|NCT00272324|Colorectal neoplasms|colorectal neoplasms
5344717|NCT00272324|Adenomatous polyps|adenomatous polyps
5344718|NCT00272311|Primary prevention|primary prevention
5344719|NCT00272311|Cardiovascular diseases|cardiovascular diseases
5344720|NCT00272311|Aspirin|aspirin
5344721|NCT00272311|Metabolic Syndrome X|metabolic syndrome x
5344722|NCT00272311|Atherosclerosis|atherosclerosis
5344723|NCT00272285|Serotonin antagonists|serotonin antagonists
5344724|NCT00272285|Randomized controlled trial|randomized controlled trial
5344725|NCT00272285|Combination drug therapy|combination drug therapy
5344726|NCT00272285|Double-blind method|double-blind method
5344727|NCT00272272|Fall Prevention, Music Therapy, Geriatric, Nursing Home|fall prevention, music therapy, geriatric, nursing home
5344728|NCT00272246|dystonia|dystonia
5344729|NCT00272233|Inflammation Mediators [D23.469]|inflammation mediators [d23.469]
5344730|NCT00272233|Cardiovascular Physiologic Phenomena [G09.330.553]|cardiovascular physiologic phenomena [g09.330.553]
5344731|NCT00272220|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5344732|NCT00272220|Antiretroviral Therapy, Highly Active|antiretroviral therapy, highly active
5344733|NCT00272220|Randomized Controlled Trials|randomized controlled trials
5344734|NCT00272220|Africa|africa
5344735|NCT00272220|Adherence|adherence
5344736|NCT00272220|Treatment Naive|treatment naive
5344737|NCT00272207|Fibromyalgia|fibromyalgia
5344738|NCT00272207|Cannabinoids|cannabinoids
5344739|NCT00272207|Nabilone|nabilone
5344740|NCT00272207|Cesamet|cesamet
5344741|NCT00272207|Pain|pain
5344742|NCT00272194|Endotracheal Intubation|endotracheal intubation
5344743|NCT00272194|Supraglottic Airway|supraglottic airway
5344744|NCT00272168|Cognitive behavioral therapy|cognitive behavioral therapy
5344745|NCT00272168|Social Skills training|social skills training
5344746|NCT00272168|Vocational Rehabilitation|vocational rehabilitation
5344747|NCT00272142|mortality|mortality
5344748|NCT00272142|hospitalization|hospitalization
5344749|NCT00272142|diarrhea|diarrhea
5344750|NCT00272142|respiratory infection|respiratory infection
5344751|NCT00272142|low birth weight|low birth weight
5344752|NCT00272142|morbidity|morbidity
5344753|NCT00272116|zinc|zinc
5344754|NCT00272116|diarrhea|diarrhea
5344755|NCT00272116|severe diarrhea|severe diarrhea
5344756|NCT00272116|recurrent diarrhea|recurrent diarrhea
5344757|NCT00272116|acute lower respiratory infection|acute lower respiratory infection
5344758|NCT00272116|pneumonia|pneumonia
5344759|NCT00272103|functional dyspepsia|functional dyspepsia
5344760|NCT00272103|non ulcer dyspepsia|non ulcer dyspepsia
5344761|NCT00272103|drug treatment|drug treatment
5344762|NCT00272051|Neurotoxicity syndromes|neurotoxicity syndromes
5344763|NCT00272051|Paresthesia|paresthesia
5344764|NCT00272051|Oxaliplatin|oxaliplatin
5344765|NCT00272051|Xaliproden|xaliproden
5344766|NCT00272025|Bipolar Depression|bipolar depression
5344767|NCT00272025|Escitalopram|escitalopram
5344768|NCT00272025|Mood Stabilizer|mood stabilizer
5344769|NCT00272025|Atypical Antipsychotic|atypical antipsychotic
5344770|NCT00271999|randomized controlled clinical trial|randomized controlled clinical trial
5344771|NCT00271999|hemodialysis|hemodialysis
5344772|NCT00271999|End Stage Renal Disease|end stage renal disease
5344773|NCT00271986|Peritoneal microdialysis|peritoneal microdialysis
5344774|NCT00271986|Low anterior resection|low anterior resection
5344775|NCT00271986|Recto-sigmoid cancer|recto-sigmoid cancer
5344776|NCT00271986|Anastomotic leakage|anastomotic leakage
5344777|NCT00271960|Pregnancy|pregnancy
5344778|NCT00271960|Birth Weight|birth weight
5344779|NCT00271960|Gestational Age|gestational age
5344780|NCT00271960|Preterm Delivery|preterm delivery
5344781|NCT00271960|HIV Seronegativity|hiv seronegativity
5344782|NCT00271921|eating disorders|eating disorders
5344783|NCT00271921|anorexia nervosa|anorexia nervosa
5344784|NCT00271921|body fat distribution|body fat distribution
5344785|NCT00271921|metabolic syndrome|metabolic syndrome
5344786|NCT00271921|visceral adipose tissue|visceral adipose tissue
5344787|NCT00271908|HIV|hiv
5344788|NCT00271908|AIDS|aids
5344789|NCT00271908|Adolescent|adolescent
5344790|NCT00271908|Community|community
5344791|NCT00271908|Structural Changes|structural changes
5344792|NCT00271908|HIV Seronegativity|hiv seronegativity
5344793|NCT00271882|Adolescent Females|adolescent females
5344794|NCT00271882|HIV positive|hiv positive
5344795|NCT00271882|PTSD|ptsd
5344796|NCT00271882|Sexual Abuse|sexual abuse
5344797|NCT00271869|hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
5344798|NCT00271869|graft-versus-host disease|graft-versus-host disease
5344799|NCT00271869|treatment|treatment
5344800|NCT00271856|HIV|hiv
5344801|NCT00271856|Meditation|meditation
5344802|NCT00271856|Stress|stress
5344803|NCT00271856|Randomized Controlled Trial|randomized controlled trial
5344804|NCT00271856|Complementary Therapies|complementary therapies
5344805|NCT00271856|MBSR|mbsr
5344806|NCT00271856|Not on ART medications|not on art medications
5344807|NCT00271830|renal|renal
5344808|NCT00271830|transplant|transplant
5344809|NCT00271830|sexual dysfunction|sexual dysfunction
5344810|NCT00271830|male|male
5344811|NCT00271830|dialysis free|dialysis free
5344812|NCT00271804|Myelodysplastic syndrome|myelodysplastic syndrome
5344813|NCT00271804|Myelodysplasia|myelodysplasia
5344814|NCT00271804|MDS|mds
5344815|NCT00271804|Velcade|velcade
5344816|NCT00271804|Thalidomide|thalidomide
5344817|NCT00271804|Bortezomib|bortezomib
5344818|NCT00271791|Vestibular Neuronitis|vestibular neuronitis
5344819|NCT00271791|Vestibular Function Tests|vestibular function tests
5344820|NCT00271791|Vestibular Adaptation|vestibular adaptation
5344821|NCT00271791|Steroids|steroids
5344822|NCT00271778|Otitis media suppurative|otitis media suppurative
5344823|NCT00271778|surgery ear|surgery ear
5344824|NCT00271765|Myocardial infarction|myocardial infarction
5344825|NCT00271765|Coronary angioplasty|coronary angioplasty
5344826|NCT00271765|PARP inhibitor|parp inhibitor
5344827|NCT00271765|PARP inhibition|parp inhibition
5344828|NCT00271765|Heart Attack|heart attack
5344829|NCT00271752|Procalcitonin|procalcitonin
5344830|NCT00271752|Sepsis|sepsis
5344831|NCT00271752|Intensive Care Unit|intensive care unit
5344832|NCT00271752|Sepsis and Complications|sepsis and complications
5344833|NCT00271752|Organ Failure|organ failure
5344834|NCT00271739|Telemedicine|telemedicine
5344835|NCT00271739|Diabetes Mellitus|diabetes mellitus
5344836|NCT00271726|distal radius fracture|distal radius fracture
5344837|NCT00271726|extraarticular Colles fracture|extraarticular colles fracture
5344838|NCT00271713|bone structure|bone structure
5344839|NCT00271713|ibandronate|ibandronate
5344840|NCT00271700|Diabetes Mellitus|diabetes mellitus
5344841|NCT00271700|Outcome Assessment (Healthcare)|outcome assessment (healthcare)
5344842|NCT00271700|Inpatients|inpatients
5344843|NCT00271700|Hospital Information Systems|hospital information systems
5344844|NCT00271700|Education|education
5344845|NCT00271687|exercise|exercise
5344846|NCT00271687|exercise therapy|exercise therapy
5344847|NCT00271687|activities of daily living|activities of daily living
5344848|NCT00271687|quality of life|quality of life
5344849|NCT00271661|presbyopia; breast cancer survivors|presbyopia; breast cancer survivors
5344850|NCT00271635|Charcot-Marie-Tooth Disease|charcot-marie-tooth disease
5344851|NCT00271635|Hereditary Motor and Sensory Neuropathies|hereditary motor and sensory neuropathies
5344852|NCT00271635|Ascorbic Acid|ascorbic acid
5344853|NCT00271635|Vitamin C|vitamin c
5344854|NCT00271622|Screening|screening
5344855|NCT00271622|Pediatric|pediatric
5344856|NCT00271622|Pervasive Developmental Disorder|pervasive developmental disorder
5344857|NCT00271622|Early Development|early development
5344858|NCT00271622|Children|children
5344859|NCT00271622|Autism Spectrum Disorders|autism spectrum disorders
5344860|NCT00271622|Healthy Volunteer|healthy volunteer
5344861|NCT00271622|HV|hv
5344862|NCT00271609|AVASTIN|avastin
5344863|NCT00271609|Recurrence|recurrence
5344864|NCT00271609|Chemotherapy|chemotherapy
5344865|NCT00271609|Anti-Angiogenesis|anti-angiogenesis
5344866|NCT00271609|Radiotherapy|radiotherapy
5344867|NCT00271609|Brain Tumor|brain tumor
5344868|NCT00271609|Malignant Glioma|malignant glioma
5344869|NCT00271596|Huntington Disease|huntington disease
5344870|NCT00271596|Citalopram|citalopram
5344871|NCT00271596|Celexa|celexa
5344872|NCT00271596|Chorea|chorea
5344873|NCT00271596|Focus|focus
5344874|NCT00271596|ADD|add
5344875|NCT00271596|ADHD|adhd
5344876|NCT00271596|HD|hd
5344877|NCT00271596|SSRI|ssri
5344878|NCT00271583|emergency contraception|emergency contraception
5344879|NCT00271583|antiprogestin|antiprogestin
5344880|NCT00271557|Heart Failure|heart failure
5344881|NCT00271557|Renal Dysfunction|renal dysfunction
5344882|NCT00271557|Cardiomyopathy|cardiomyopathy
5344883|NCT00271557|Heart Decompensation|heart decompensation
5344884|NCT00271557|Dyspnea Paroxysmal.|dyspnea paroxysmal.
5344885|NCT00271544|heart failure|heart failure
5344886|NCT00271544|cardiac pacing|cardiac pacing
5344887|NCT00271544|left ventricular lead|left ventricular lead
5344888|NCT00271544|cardiac resynchronization therapy|cardiac resynchronization therapy
5344889|NCT00271531|bacterial infection, pneumonia, ventilation, children|bacterial infection, pneumonia, ventilation, children
5344890|NCT00271505|Non-Small Cell Lung Cancer|non-small cell lung cancer
5344891|NCT00271505|Lung Cancer|lung cancer
5344892|NCT00271505|Bevacizumab|bevacizumab
5344893|NCT00271505|Carboplatin|carboplatin
5344894|NCT00271505|Docetaxel|docetaxel
5344895|NCT00271505|Avastin|avastin
5344896|NCT00271505|NSCLC|nsclc
5344897|NCT00271505|Anti-VEGF monoclonal antibody|anti-vegf monoclonal antibody
5344898|NCT00271505|rhuMAb-VEGF|rhumab-vegf
5344899|NCT00271505|Paraplatin®|paraplatin®
5344900|NCT00271505|Taxotere|taxotere
5344901|NCT00271479|Meningitis|meningitis
5344902|NCT00271479|Dose-Response Relationship, Immunologic|dose-response relationship, immunologic
5344903|NCT00271479|Neisseria meningitidis|neisseria meningitidis
5344904|NCT00271479|Outbreaks|outbreaks
5344905|NCT00271479|Vaccine|vaccine
5344906|NCT00271479|Africa|africa
5344907|NCT00271479|Uganda|uganda
5344908|NCT00271479|Prevention of Neisseria meningitidis infections|prevention of neisseria meningitidis infections
5344909|NCT00271479|In outbreak contexts in developing countries|in outbreak contexts in developing countries
5344910|NCT00271466|opioid|opioid
5344911|NCT00271466|fentanyl|fentanyl
5344912|NCT00271466|Duragesic|duragesic
5344913|NCT00271466|transdermal|transdermal
5344914|NCT00271466|chronic pain|chronic pain
5344915|NCT00271466|morphine|morphine
5344916|NCT00271453|chronic pain|chronic pain
5344917|NCT00271453|opioid|opioid
5344918|NCT00271453|fentanyl|fentanyl
5344919|NCT00271453|transdermal|transdermal
5344920|NCT00271453|Durogesic|durogesic
5344921|NCT00271453|morphine|morphine
5344922|NCT00271440|chlorhexidine|chlorhexidine
5344923|NCT00271440|neonatal|neonatal
5344924|NCT00271440|skin flora|skin flora
5344925|NCT00271440|skin cleansing|skin cleansing
5344926|NCT00271440|bacterial colonization|bacterial colonization
5344927|NCT00271427|Thyroiditis|thyroiditis
5344928|NCT00271427|Autoimmune|autoimmune
5344929|NCT00271427|Hashimoto's|hashimoto's
5344930|NCT00271427|TPOAb|tpoab
5344931|NCT00271427|Selenium|selenium
5344932|NCT00271414|chronic pain|chronic pain
5344933|NCT00271414|opioid|opioid
5344934|NCT00271414|fentanyl|fentanyl
5344935|NCT00271414|transdermal|transdermal
5344936|NCT00271414|Duragesic|duragesic
5344937|NCT00271414|morphine|morphine
5344938|NCT00271401|Stents|stents
5344939|NCT00271401|Angioplasty, Transluminal, Percutaneous Coronary|angioplasty, transluminal, percutaneous coronary
5344940|NCT00271388|Galvanic Vestibular Stimulation|galvanic vestibular stimulation
5344941|NCT00271388|Hemispatial Neglect|hemispatial neglect
5344942|NCT00271388|Stroke|stroke
5344943|NCT00271375|Age|age
5344944|NCT00271375|Caregivers|caregivers
5344945|NCT00271375|Family|family
5344946|NCT00271375|Intervention Studies|intervention studies
5344947|NCT00271362|Exercise|exercise
5344948|NCT00271362|Physical function|physical function
5344949|NCT00271362|Prosthetic mobility|prosthetic mobility
5344950|NCT00271362|Rehabilitation|rehabilitation
5344951|NCT00271349|Eosinophilic Esophagitis|eosinophilic esophagitis
5344952|NCT00271349|Budesonide|budesonide
5344953|NCT00271336|NEC|nec
5344954|NCT00271336|Premature Infants|premature infants
5344955|NCT00271336|TNF|tnf
5344956|NCT00271336|Pentoxifylline|pentoxifylline
5344957|NCT00271297|pelvic floor|pelvic floor
5344958|NCT00271297|exercise therapy|exercise therapy
5344959|NCT00271297|prevention|prevention
5344960|NCT00271297|ultrasonography|ultrasonography
5344961|NCT00271297|risk factors|risk factors
5344962|NCT00271245|cirrhosis|cirrhosis
5344963|NCT00271245|liver disease|liver disease
5344964|NCT00271245|selenium|selenium
5344965|NCT00271245|selenoproteins|selenoproteins
5344966|NCT00271245|selenoprotein P|selenoprotein p
5344967|NCT00271245|biomarkers|biomarkers
5344968|NCT00271232|Heart Failure, Cardiac Resynchronization|heart failure, cardiac resynchronization
5344969|NCT00271219|opiate addiction|opiate addiction
5344970|NCT00271219|opiate dependence|opiate dependence
5344971|NCT00271219|substance abuse|substance abuse
5344972|NCT00271219|addiction|addiction
5344973|NCT00271219|substance addiction|substance addiction
5344974|NCT00271219|pregnancy|pregnancy
5344975|NCT00271219|buprenorphine|buprenorphine
5344976|NCT00271219|methadone|methadone
5344977|NCT00271219|fetal|fetal
5344978|NCT00271219|neonatal|neonatal
5344979|NCT00271219|post-partum|post-partum
5344980|NCT00271206|Nicotine Dependence|nicotine dependence
5344981|NCT00271206|Tobacco Dependence|tobacco dependence
5344982|NCT00271180|Cardiac Pacing|cardiac pacing
5344983|NCT00271180|Implantable Cardioverter Defibrillator|implantable cardioverter defibrillator
5344984|NCT00271180|pacemaker|pacemaker
5344985|NCT00271180|Sinus Bradycardia|sinus bradycardia
5344986|NCT00271167|Cardiac surgery|cardiac surgery
5344987|NCT00271167|PARP inhibitor|parp inhibitor
5344988|NCT00271167|PARP inhibition|parp inhibition
5344989|NCT00271167|Bypass surgery|bypass surgery
5344990|NCT00271167|CPB surgery|cpb surgery
5344991|NCT00271167|Cardiopulmonary bypass|cardiopulmonary bypass
5344992|NCT00271167|Coronary revascularization|coronary revascularization
5344993|NCT00271167|Cardiac valve replacement|cardiac valve replacement
5344994|NCT00271154|Heart Failure|heart failure
5344995|NCT00271154|Implantable Cardioverter Defibrillator|implantable cardioverter defibrillator
5344996|NCT00271154|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
5344997|NCT00271141|Parkinson's disease|parkinson's disease
5344998|NCT00271141|Oxidative stress|oxidative stress
5344999|NCT00271141|Marker|marker
5345000|NCT00271128|NT-proBNP|nt-probnp
5345001|NCT00271128|Heart failure|heart failure
5345002|NCT00271128|Dyspnea|dyspnea
5345003|NCT00271115|Kangaroo holding|kangaroo holding
5345004|NCT00271115|Kangaroo care|kangaroo care
5345005|NCT00271115|Maternal stress levels|maternal stress levels
5345006|NCT00271115|Premature birth|premature birth
5345007|NCT00271102|Cystocele, prolapse, anterior repair, colporrhaphy|cystocele, prolapse, anterior repair, colporrhaphy
5345008|NCT00271076|CAD|cad
5345009|NCT00271076|CEA|cea
5345010|NCT00271076|CAS|cas
5345011|NCT00271076|IVUS|ivus
5345012|NCT00271076|symptomatic|symptomatic
5345013|NCT00271076|asymptomatic|asymptomatic
5345014|NCT00271076|Cerebral Protection Device|cerebral protection device
5345015|NCT00271076|TIA|tia
5345016|NCT00271076|Stroke|stroke
5345017|NCT00271076|plaque morphology|plaque morphology
5345018|NCT00271063|Refractory or Relapsed Acute Lymphocytic Leukemia|refractory or relapsed acute lymphocytic leukemia
5345019|NCT00271050|non-Hodgkin's lymphoma|non-hodgkin's lymphoma
5345020|NCT00271050|external beam radiotherapy (EBRT)|external beam radiotherapy (ebrt)
5345021|NCT00271050|radio-immunotherapy (RIT)|radio-immunotherapy (rit)
5345022|NCT00271050|Zevalin|zevalin
5345023|NCT00271037|Pelvic organ prolapse|pelvic organ prolapse
5345024|NCT00271037|Stress urinary incontinence|stress urinary incontinence
5345025|NCT00271037|Surgery|surgery
5345026|NCT00271037|Colpocleisis|colpocleisis
5345027|NCT00271037|Urinary retention|urinary retention
5345028|NCT00271024|Smoking|smoking
5345029|NCT00271024|Smoking Cessation|smoking cessation
5345030|NCT00270998|Stress urinary incontinence|stress urinary incontinence
5345031|NCT00270985|almonds|almonds
5345032|NCT00270985|pre-diabetes|pre-diabetes
5345033|NCT00270985|inflammatory|inflammatory
5345034|NCT00270985|CRP|crp
5345035|NCT00270972|Venous leg ulcer|venous leg ulcer
5345036|NCT00270972|Venous insufficiency|venous insufficiency
5345037|NCT00270972|OrCel|orcel
5345038|NCT00270959|PTSD|ptsd
5345039|NCT00270946|Venous leg ulcer|venous leg ulcer
5345040|NCT00270946|OrCel|orcel
5345041|NCT00270946|Compression therapy|compression therapy
5345042|NCT00270933|defibrillators|defibrillators
5345043|NCT00270933|LLECG|llecg
5345044|NCT00270933|ventricular tachycardia|ventricular tachycardia
5345045|NCT00270933|ventricular fibrillation|ventricular fibrillation
5345046|NCT00270920|Initiation, Maintenance, Breastfeeding|initiation, maintenance, breastfeeding
5345047|NCT00270907|Metastatic Breast Cancer|metastatic breast cancer
5345048|NCT00270907|Breast Cancer|breast cancer
5345049|NCT00270907|CT-2103|ct-2103
5345050|NCT00270907|Gemcitabine|gemcitabine
5345051|NCT00270907|Xyotax|xyotax
5345052|NCT00270907|Gemzar|gemzar
5345053|NCT00270894|neoadjuvant chemotherapy|neoadjuvant chemotherapy
5345054|NCT00270894|HER2 positive breast cancer|her2 positive breast cancer
5345055|NCT00270894|stage II - III breast cancer|stage ii - iii breast cancer
5345056|NCT00270881|cord blood transplantation|cord blood transplantation
5345057|NCT00270881|myeloablative regimen|myeloablative regimen
5345058|NCT00270881|hematologic malignancies|hematologic malignancies
5345059|NCT00270868|Double guide wire technique|double guide wire technique
5345060|NCT00270868|Difficult selective biliary cannulation|difficult selective biliary cannulation
5345061|NCT00270868|ERCP|ercp
5345062|NCT00270868|Attempts of cannulation|attempts of cannulation
5345063|NCT00270868|Post-ERCP complications.|post-ercp complications.
5345064|NCT00270855|Body Composition|body composition
5345065|NCT00270855|Exercise|exercise
5345066|NCT00270855|Glucose Tolerance|glucose tolerance
5345067|NCT00270855|Insulin Sensitivity|insulin sensitivity
5345068|NCT00270855|Functional Electric Stimulation|functional electric stimulation
5345069|NCT00270842|Education|education
5345070|NCT00270842|Exercise|exercise
5345071|NCT00270842|Gait|gait
5345072|NCT00270842|Peripheral Nervous System|peripheral nervous system
5345073|NCT00270842|Postural Balance|postural balance
5345074|NCT00270842|Self Efficacy|self efficacy
5345075|NCT00270842|Tai Chi Chuan|tai chi chuan
5345076|NCT00270829|renal function|renal function
5345077|NCT00270816|Multiple Sclerosis|multiple sclerosis
5345078|NCT00270816|Interferon-ß-1b|interferon-ß-1b
5345079|NCT00270816|Therapy|therapy
5345080|NCT00270803|Marijuana, FDG, PET, maze, THC, motor coordination.|marijuana, fdg, pet, maze, thc, motor coordination.
5345081|NCT00270790|Head and Neck cancer|head and neck cancer
5345082|NCT00270777|Controlled trial|controlled trial
5345083|NCT00270777|Snake bite|snake bite
5345084|NCT00270777|Safety|safety
5345085|NCT00270777|Antivenom|antivenom
5345086|NCT00270764|HIV/AIDS|hiv/aids
5345087|NCT00270764|Antiretroviral therapy|antiretroviral therapy
5345088|NCT00270764|Quality of life|quality of life
5345089|NCT00270764|South Africa|south africa
5345090|NCT00270764|Treatment Naive|treatment naive
5345091|NCT00270751|Video-Assisted Thoracoscopic Surgery|video-assisted thoracoscopic surgery
5345092|NCT00270751|Spontaneous pneumothorax|spontaneous pneumothorax
5345093|NCT00270751|Pleurectomy|pleurectomy
5345094|NCT00270751|Pleural abrasion|pleural abrasion
5345095|NCT00270751|Minocycline|minocycline
5345096|NCT00270738|urinary incontinence|urinary incontinence
5345097|NCT00270738|transversus abdominis|transversus abdominis
5345098|NCT00270738|pelvic floor muscles|pelvic floor muscles
5345099|NCT00270738|randomized controlled trial|randomized controlled trial
5345100|NCT00270725|HIV|hiv
5345101|NCT00270725|AIDS|aids
5345102|NCT00270725|Labor productivity|labor productivity
5345103|NCT00270725|Antiretroviral therapy|antiretroviral therapy
5345104|NCT00270725|South Africa|south africa
5345105|NCT00270712|kidney|kidney
5345106|NCT00270712|transplant|transplant
5345107|NCT00270712|dysfunction|dysfunction
5345108|NCT00270712|chronic|chronic
5345109|NCT00270712|deterioration|deterioration
5345110|NCT00270712|loss of function|loss of function
5345111|NCT00270699|Dengue Vaccine|dengue vaccine
5345112|NCT00270699|Dengue Virus|dengue virus
5345113|NCT00270699|Dengue Hemorrhagic Fever|dengue hemorrhagic fever
5345114|NCT00270699|Dengue Shock Syndrome|dengue shock syndrome
5345115|NCT00270686|Ehlers-Danlos Syndrome|ehlers-danlos syndrome
5345116|NCT00270686|Stickler Syndrome|stickler syndrome
5345117|NCT00270686|Marfan Syndrome|marfan syndrome
5345118|NCT00270686|Genetics|genetics
5345119|NCT00270686|Aneurysm|aneurysm
5345120|NCT00270673|Lactate|lactate
5345121|NCT00270673|Tissue hypoxia|tissue hypoxia
5345122|NCT00270673|Intensive care|intensive care
5345123|NCT00270673|Goal- directed therapy|goal- directed therapy
5345124|NCT00270660|retraction pockets ear|retraction pockets ear
5345125|NCT00270660|unsafe otitis media|unsafe otitis media
5345126|NCT00270660|otitis media complications|otitis media complications
5345127|NCT00270647|cancer|cancer
5345128|NCT00270647|prostate cancer|prostate cancer
5345129|NCT00270647|colorectal cancer|colorectal cancer
5345130|NCT00270647|cardiovascular disease|cardiovascular disease
5345131|NCT00270647|eye disease|eye disease
5345132|NCT00270647|cognitive decline|cognitive decline
5345133|NCT00270634|Randomized Controlled Trials|randomized controlled trials
5345134|NCT00270634|Immunosuppression|immunosuppression
5345135|NCT00270634|Adult|adult
5345136|NCT00270634|Kidney Transplantation|kidney transplantation
5345137|NCT00270634|Treatment Outcome|treatment outcome
5345138|NCT00270608|Hypertension|hypertension
5345139|NCT00270608|Peripheral vascular disease|peripheral vascular disease
5345140|NCT00270608|Diabetes|diabetes
5345141|NCT00270608|Total body fat percentage|total body fat percentage
5345142|NCT00270556|Treatment Experienced|treatment experienced
5345143|NCT00270543|Stomach Neoplasms|stomach neoplasms
5345144|NCT00270530|Malaria|malaria
5345145|NCT00270530|Placental diseases|placental diseases
5345146|NCT00270530|Birth complications|birth complications
5345147|NCT00270530|Plasmodium falciparum|plasmodium falciparum
5345148|NCT00270530|Zambia|zambia
5345149|NCT00270530|HIV-seropositive|hiv-seropositive
5345150|NCT00270530|HIV|hiv
5345151|NCT00270504|Memokath|memokath
5345152|NCT00270504|Urethral stricture|urethral stricture
5345153|NCT00270504|urethral stent|urethral stent
5345154|NCT00270504|Bulbar urethral stricture|bulbar urethral stricture
5345155|NCT00270478|Erythropoietin Therapy|erythropoietin therapy
5345156|NCT00270478|Fetal Hemoglobin Induction|fetal hemoglobin induction
5345157|NCT00270478|Sickle Cell Disease|sickle cell disease
5345158|NCT00270478|Pulmonary Hypertension|pulmonary hypertension
5345159|NCT00270478|Chronic Kidney Disease|chronic kidney disease
5345160|NCT00270478|SCD|scd
5345161|NCT00270465|HIV-positive|hiv-positive
5345162|NCT00270465|Treatment Interruption|treatment interruption
5345163|NCT00270465|Therapeutic Vaccine|therapeutic vaccine
5345164|NCT00270465|HIV/AIDS|hiv/aids
5345165|NCT00270465|Virologic Response|virologic response
5345166|NCT00270465|HIV Positive|hiv positive
5345167|NCT00270452|Myelodyplastic Syndrome (MDS)|myelodyplastic syndrome (mds)
5345168|NCT00270452|Wilm's tumor-1|wilm's tumor-1
5345169|NCT00270452|Proteinase-3|proteinase-3
5345170|NCT00270452|Vaccine Therapy|vaccine therapy
5345171|NCT00270452|Acute Myeloid Leukemia|acute myeloid leukemia
5345172|NCT00270452|Chronic Myeloid Leukemias|chronic myeloid leukemias
5345173|NCT00270452|Myelodysplastic Syndrome|myelodysplastic syndrome
5345174|NCT00270452|MDS|mds
5345175|NCT00270439|Obesity|obesity
5345176|NCT00270439|Omentectomy|omentectomy
5345177|NCT00270439|Diabetes Mellitus Type 2|diabetes mellitus type 2
5345178|NCT00270439|Laparoscopic|laparoscopic
5345179|NCT00270439|Dyslipidemia|dyslipidemia
5345180|NCT00270426|Advanced Chronic Renal Insufficiency|advanced chronic renal insufficiency
5345181|NCT00270426|Benazepril|benazepril
5345182|NCT00270413|breast cancer|breast cancer
5345183|NCT00270413|metastatic|metastatic
5345184|NCT00270413|taxanes|taxanes
5345185|NCT00270413|SU11248|su11248
5345186|NCT00270400|Heart Failure|heart failure
5345187|NCT00270400|Renal Dysfunction|renal dysfunction
5345188|NCT00270400|Cardiomyopathy|cardiomyopathy
5345189|NCT00270400|Heart Decompensation|heart decompensation
5345190|NCT00270400|Dyspnea Paroxsymal.|dyspnea paroxsymal.
5345191|NCT00270387|Acutely Decompensated Congestive Heart Failure|acutely decompensated congestive heart failure
5345192|NCT00270387|Heart Failure|heart failure
5345193|NCT00270387|Renal Impairment|renal impairment
5345194|NCT00270387|Kidney Failure|kidney failure
5345195|NCT00270387|Myocardial Infarction.|myocardial infarction.
5345196|NCT00270374|Congestive heart failure|congestive heart failure
5345197|NCT00270374|CHF|chf
5345198|NCT00270374|Left-sided heart failure|left-sided heart failure
5345199|NCT00270374|Right-sided heart failure|right-sided heart failure
5345200|NCT00270374|Systolic Heart Failure|systolic heart failure
5345201|NCT00270361|Heart Failure|heart failure
5345202|NCT00270361|Renal Dysfunction|renal dysfunction
5345203|NCT00270361|Cardiomyopathy|cardiomyopathy
5345204|NCT00270361|Heart Decompensation|heart decompensation
5345205|NCT00270361|Dyspnea Paroxsymal|dyspnea paroxsymal
5345206|NCT00270361|Outpatient Therapy.|outpatient therapy.
5345207|NCT00270348|Asthma|asthma
5345208|NCT00270348|Safety|safety
5345209|NCT00270348|Pediatrics|pediatrics
5345210|NCT00270322|total knee replacement|total knee replacement
5345211|NCT00270322|orthopedic surgery|orthopedic surgery
5345212|NCT00270322|post operative analgesia|post operative analgesia
5345213|NCT00270322|continuous epidural|continuous epidural
5345214|NCT00270322|patients controlled analgesia|patients controlled analgesia
5345215|NCT00270322|morphine|morphine
5345216|NCT00270322|combined spinal epidural anesthesia|combined spinal epidural anesthesia
5345217|NCT00270322|anesthesia|anesthesia
5345218|NCT00270322|analgesia|analgesia
5345219|NCT00270322|epidural marcaine|epidural marcaine
5345220|NCT00270322|epidural fentanyl|epidural fentanyl
5345221|NCT00270322|pain|pain
5345222|NCT00270309|lower urinary tract symptoms, self-management|lower urinary tract symptoms, self-management
5345223|NCT00270296|Treatment Naive|treatment naive
5345224|NCT00270296|MTCT|mtct
5345225|NCT00270296|HIV Seronegativity|hiv seronegativity
5345226|NCT00270283|Anemia|anemia
5345227|NCT00270283|AIDS|aids
5345228|NCT00270283|erythropoietin|erythropoietin
5345229|NCT00270283|epoetin alfa|epoetin alfa
5345230|NCT00270283|Quality of Life|quality of life
5345231|NCT00270283|Zidovudine|zidovudine
5345232|NCT00270283|HIV|hiv
5345233|NCT00270270|erythropoietin|erythropoietin
5345234|NCT00270270|Anemia|anemia
5345235|NCT00270270|Quality of Life|quality of life
5345236|NCT00270270|epoetin alfa|epoetin alfa
5345237|NCT00270270|HIV|hiv
5345238|NCT00270270|Zidovudine|zidovudine
5345239|NCT00270270|AIDS|aids
5345240|NCT00270257|HIV Seronegativity|hiv seronegativity
5345241|NCT00270257|Opiate Addiction|opiate addiction
5345242|NCT00270257|Opiate Dependence|opiate dependence
5345243|NCT00270244|Major Depression|major depression
5345244|NCT00270244|Dysthymic Disorder|dysthymic disorder
5345245|NCT00270244|Adjustment Disorder With Depressed Mood|adjustment disorder with depressed mood
5345246|NCT00270244|Depressive Disorder Not Otherwise Specified|depressive disorder not otherwise specified
5345247|NCT00270244|Adolescent|adolescent
5345248|NCT00270244|Psychotherapy|psychotherapy
5345249|NCT00270231|within-subjects, crossover, laboratory study|within-subjects, crossover, laboratory study
5345250|NCT00270231|Naltrexone vs. Placebo|naltrexone vs. placebo
5345251|NCT00270218|HIV Seronegativity|hiv seronegativity
5345252|NCT00270218|Adenoviral Vector Vaccine|adenoviral vector vaccine
5345253|NCT00270218|DNA Plasmid Vaccine|dna plasmid vaccine
5345254|NCT00270205|Treatment Experienced|treatment experienced
5345255|NCT00270205|HIV Therapeutic Vaccine|hiv therapeutic vaccine
5345256|NCT00270192|Breastfeeding|breastfeeding
5345257|NCT00270192|exclusive|exclusive
5345258|NCT00270192|education|education
5345259|NCT00270192|counseling|counseling
5345260|NCT00270179|Anemia|anemia
5345261|NCT00270179|blood transfusion|blood transfusion
5345262|NCT00270179|epoetin alfa|epoetin alfa
5345263|NCT00270179|erythropoietin|erythropoietin
5345264|NCT00270179|surgery|surgery
5345265|NCT00270179|self-blood donation|self-blood donation
5345266|NCT00270166|cancer|cancer
5345267|NCT00270166|malignancy|malignancy
5345268|NCT00270166|red cell transfusion|red cell transfusion
5345269|NCT00270166|epoetin alfa|epoetin alfa
5345270|NCT00270166|epoetin|epoetin
5345271|NCT00270166|erythropoietin|erythropoietin
5345272|NCT00270166|red blood cells|red blood cells
5345273|NCT00270153|renal transplant, ACE inhibitor|renal transplant, ace inhibitor
5345274|NCT00270140|anemia|anemia
5345275|NCT00270140|blood transfusion|blood transfusion
5345276|NCT00270140|epoetin alfa|epoetin alfa
5345277|NCT00270140|erythropoietin|erythropoietin
5345278|NCT00270140|surgery|surgery
5345279|NCT00270140|blood donation|blood donation
5345280|NCT00270140|blood|blood
5345281|NCT00270127|Anemia|anemia
5345282|NCT00270127|cancer|cancer
5345283|NCT00270127|quality of life|quality of life
5345284|NCT00270127|chemotherapy|chemotherapy
5345285|NCT00270127|hemoglobin|hemoglobin
5345286|NCT00270127|transfusion|transfusion
5345287|NCT00270127|epoetin alfa|epoetin alfa
5345288|NCT00270127|epoetin|epoetin
5345289|NCT00270127|erythropoietin|erythropoietin
5345290|NCT00270114|Anemia|anemia
5345291|NCT00270114|blood transfusion, autologous|blood transfusion, autologous
5345292|NCT00270114|epoetin alfa|epoetin alfa
5345293|NCT00270114|epogen|epogen
5345294|NCT00270114|erythropoietin|erythropoietin
5345295|NCT00270114|orthopedic procedures|orthopedic procedures
5345296|NCT00270114|orthopedic surgery|orthopedic surgery
5345297|NCT00270101|anemia|anemia
5345298|NCT00270101|cancer|cancer
5345299|NCT00270101|quality of life|quality of life
5345300|NCT00270101|chemotherapy|chemotherapy
5345301|NCT00270101|hemoglobin|hemoglobin
5345302|NCT00270101|multiple myeloma|multiple myeloma
5345303|NCT00270101|transfusion|transfusion
5345304|NCT00270101|epoetin alfa|epoetin alfa
5345305|NCT00270101|epoetin|epoetin
5345306|NCT00270101|erythropoietin|erythropoietin
5345307|NCT00270088|Anemia|anemia
5345308|NCT00270088|blood transfusion|blood transfusion
5345309|NCT00270088|epoetin alfa|epoetin alfa
5345310|NCT00270088|epogen|epogen
5345311|NCT00270088|erythropoietin|erythropoietin
5345312|NCT00270088|orthopedic procedures|orthopedic procedures
5345313|NCT00270088|orthopedic surgery|orthopedic surgery
5345314|NCT00270075|epogen|epogen
5345315|NCT00270075|erythropoietin|erythropoietin
5345316|NCT00270075|orthopedic procedures|orthopedic procedures
5345317|NCT00270075|orthopedic surgery|orthopedic surgery
5345318|NCT00270075|cardiovascular surgical procedures|cardiovascular surgical procedures
5345319|NCT00270075|Blood transfusion|blood transfusion
5345320|NCT00270075|epoetin alfa|epoetin alfa
5345321|NCT00270062|anemia|anemia
5345322|NCT00270062|blood transfusion|blood transfusion
5345323|NCT00270062|epoetin alfa|epoetin alfa
5345324|NCT00270062|erythropoietin|erythropoietin
5345325|NCT00270062|surgery|surgery
5345326|NCT00270062|blood donation|blood donation
5345327|NCT00270062|blood|blood
5345328|NCT00270049|Anemia|anemia
5345329|NCT00270049|cancer|cancer
5345330|NCT00270049|leukemia|leukemia
5345331|NCT00270049|chronic lymphocytic leukemia|chronic lymphocytic leukemia
5345332|NCT00270049|lymphocytic leukemia|lymphocytic leukemia
5345333|NCT00270049|epoetin alfa|epoetin alfa
5345334|NCT00270049|erythropoietin|erythropoietin
5345335|NCT00270049|red blood cells|red blood cells
5345336|NCT00270049|transfusions|transfusions
5345337|NCT00270049|quality of life|quality of life
5345338|NCT00270036|Blood transfusion|blood transfusion
5345339|NCT00270036|epoetin alfa|epoetin alfa
5345340|NCT00270036|epogen|epogen
5345341|NCT00270036|erythropoietin|erythropoietin
5345342|NCT00270036|orthopedic procedures|orthopedic procedures
5345343|NCT00270036|orthopedic surgery|orthopedic surgery
5345344|NCT00270023|Blood transfusion|blood transfusion
5345345|NCT00270023|epoetin alfa|epoetin alfa
5345346|NCT00270023|epogen|epogen
5345347|NCT00270023|erythropoietin|erythropoietin
5345348|NCT00270023|orthopedic procedures|orthopedic procedures
5345349|NCT00270023|orthopedic surgery|orthopedic surgery
5345350|NCT00270023|cardiovascular surgical procedures|cardiovascular surgical procedures
5345351|NCT00270023|breast reduction|breast reduction
5345352|NCT00270010|Anemia|anemia
5345353|NCT00270010|AIDS|aids
5345354|NCT00270010|HIV|hiv
5345355|NCT00270010|Zidovudine|zidovudine
5345356|NCT00270010|Quality of Life|quality of life
5345357|NCT00270010|erythropoietin|erythropoietin
5345358|NCT00270010|epoetin alfa|epoetin alfa
5345359|NCT00269997|Anemia|anemia
5345360|NCT00269997|chemotherapy|chemotherapy
5345361|NCT00269997|epoetin alfa|epoetin alfa
5345362|NCT00269997|epogen|epogen
5345363|NCT00269997|erythropoietin|erythropoietin
5345364|NCT00269997|neoplasms|neoplasms
5345365|NCT00269997|cancer|cancer
5345366|NCT00269984|Anemia|anemia
5345367|NCT00269984|Blood transfusion|blood transfusion
5345368|NCT00269984|Epoetin alfa|epoetin alfa
5345369|NCT00269984|Erythropoietin|erythropoietin
5345370|NCT00269984|Neoplasm|neoplasm
5345371|NCT00269984|Epogen|epogen
5345372|NCT00269984|Cancer|cancer
5345373|NCT00269971|hip replacement|hip replacement
5345374|NCT00269971|hip replacement surgery|hip replacement surgery
5345375|NCT00269971|surgery|surgery
5345376|NCT00269971|anemia|anemia
5345377|NCT00269971|transfusions|transfusions
5345378|NCT00269971|blood|blood
5345379|NCT00269971|blood transfusions|blood transfusions
5345380|NCT00269958|hip replacement|hip replacement
5345381|NCT00269958|hip replacement surgery|hip replacement surgery
5345382|NCT00269958|surgery|surgery
5345383|NCT00269958|anemia|anemia
5345384|NCT00269958|transfusions|transfusions
5345385|NCT00269958|blood transfusions|blood transfusions
5345386|NCT00269945|Anemia|anemia
5345387|NCT00269945|AIDS|aids
5345388|NCT00269945|HIV|hiv
5345389|NCT00269945|Zidovudine|zidovudine
5345390|NCT00269945|Quality of Life|quality of life
5345391|NCT00269945|erythropoietin|erythropoietin
5345392|NCT00269945|epoetin alfa|epoetin alfa
5345393|NCT00269932|Bronchitis|bronchitis
5345394|NCT00269932|chronic bronchitis|chronic bronchitis
5345395|NCT00269932|lung diseases|lung diseases
5345396|NCT00269932|respiratory tract infections|respiratory tract infections
5345397|NCT00269932|bronchial diseases|bronchial diseases
5345398|NCT00269932|antibacterial agents|antibacterial agents
5345399|NCT00269932|quinolones|quinolones
5345400|NCT00269932|levofloxacin|levofloxacin
5345401|NCT00269919|Schizophrenia|schizophrenia
5345402|NCT00269919|Risperidone|risperidone
5345403|NCT00269919|Risperidal Consta|risperidal consta
5345404|NCT00269906|Angina, unstable|angina, unstable
5345405|NCT00269906|Angioplasty, transluminal, percutaneous coronary|angioplasty, transluminal, percutaneous coronary
5345406|NCT00269906|Abciximab|abciximab
5345407|NCT00269893|Abciximab|abciximab
5345408|NCT00269893|Angina, unstable|angina, unstable
5345409|NCT00269893|Angioplasty, transluminal, Percutaneous coronary|angioplasty, transluminal, percutaneous coronary
5345410|NCT00269880|Angioplasty, Transluminal, Percutaneous coronary|angioplasty, transluminal, percutaneous coronary
5345411|NCT00269867|Rheumatoid Arthritis|rheumatoid arthritis
5345412|NCT00269867|infliximab|infliximab
5345413|NCT00269867|methotrexate|methotrexate
5345414|NCT00269854|Crohn's Disease|crohn's disease
5345415|NCT00269841|fistulae|fistulae
5345416|NCT00269841|Crohn's Disease|crohn's disease
5345417|NCT00269828|Non-small cell lung cancer|non-small cell lung cancer
5345418|NCT00269828|NSCLC|nsclc
5345419|NCT00269828|PS 2|ps 2
5345420|NCT00269828|female|female
5345421|NCT00269828|chemotherapy|chemotherapy
5345422|NCT00269815|ADHD|adhd
5345423|NCT00269815|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
5345424|NCT00269815|OROS®|oros®
5345425|NCT00269815|children|children
5345426|NCT00269815|methylphenidate|methylphenidate
5345427|NCT00269802|ADHD|adhd
5345428|NCT00269802|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
5345429|NCT00269802|OROS®|oros®
5345430|NCT00269802|Ritalin®|ritalin®
5345431|NCT00269802|children|children
5345432|NCT00269802|methylphenidate|methylphenidate
5345433|NCT00269789|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
5345434|NCT00269789|OROS®|oros®
5345435|NCT00269789|Ritalin®|ritalin®
5345436|NCT00269789|children|children
5345437|NCT00269789|methylphenidate|methylphenidate
5345438|NCT00269789|ADHD|adhd
5345439|NCT00269776|ADHD|adhd
5345440|NCT00269776|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
5345441|NCT00269776|OROS|oros
5345442|NCT00269776|children|children
5345443|NCT00269776|methylphenidate|methylphenidate
5345444|NCT00269776|Ritalin|ritalin
5345445|NCT00269763|patch|patch
5345446|NCT00269763|pain|pain
5345447|NCT00269763|fentanyl|fentanyl
5345448|NCT00269763|narcotic|narcotic
5345449|NCT00269763|Cancer|cancer
5345450|NCT00269750|Ditropan®|ditropan®
5345451|NCT00269750|OROS®|oros®
5345452|NCT00269750|urge|urge
5345453|NCT00269750|oxybutynin|oxybutynin
5345454|NCT00269750|mixed urinary incontinence|mixed urinary incontinence
5345455|NCT00269737|fentanyl|fentanyl
5345456|NCT00269737|pain|pain
5345457|NCT00269737|Cancer|cancer
5345458|NCT00269737|patch|patch
5345459|NCT00269724|urinary incontinence|urinary incontinence
5345460|NCT00269724|oxybutynin|oxybutynin
5345461|NCT00269724|OROS®|oros®
5345462|NCT00269685|Septic shock|septic shock
5345463|NCT00269685|catecholamine|catecholamine
5345464|NCT00269685|vasopressin|vasopressin
5345465|NCT00269685|tonometria|tonometria
5345466|NCT00269685|lactate|lactate
5345467|NCT00269672|vaccine|vaccine
5345468|NCT00269659|Left Bundle Branch Block|left bundle branch block
5345469|NCT00269659|Regional cardiac function|regional cardiac function
5345470|NCT00269659|Global cardiac function|global cardiac function
5345471|NCT00269659|Mechanical asynchrony|mechanical asynchrony
5345472|NCT00269659|Echocardiography|echocardiography
5345473|NCT00269659|2D echocardiography|2d echocardiography
5345474|NCT00269659|Tissue Doppler Imaging|tissue doppler imaging
5345475|NCT00269659|Real-time 3D echocardiography|real-time 3d echocardiography
5345476|NCT00269659|Cardiovascular Magnetic Resonance Imaging-tagging|cardiovascular magnetic resonance imaging-tagging
5345477|NCT00269646|Diet|diet
5345478|NCT00269646|Low-carbohydrate|low-carbohydrate
5345479|NCT00269646|Insulin|insulin
5345480|NCT00269646|Dietary fiber|dietary fiber
5345481|NCT00269646|Diabetes|diabetes
5345482|NCT00269646|Cardiovascular disease|cardiovascular disease
5345483|NCT00269633|Seasonal Affective Disorder|seasonal affective disorder
5345484|NCT00269620|contraceptive vaginal ring|contraceptive vaginal ring
5345485|NCT00269620|contraceptive patch|contraceptive patch
5345486|NCT00269620|oral contraceptives|oral contraceptives
5345487|NCT00269620|acceptability|acceptability
5345488|NCT00269607|Substance abuse|substance abuse
5345489|NCT00269607|Treatment|treatment
5345490|NCT00269607|Relapse prevention|relapse prevention
5345491|NCT00269607|opioid antagonist|opioid antagonist
5345492|NCT00269594|Skin|skin
5345493|NCT00269594|Picking|picking
5345494|NCT00269594|Pick|pick
5345495|NCT00269594|Neurotic Excoriation|neurotic excoriation
5345496|NCT00269581|migraine|migraine
5345497|NCT00269581|tension headaches|tension headaches
5345498|NCT00269581|chronic daily headaches|chronic daily headaches
5345499|NCT00269568|medical abortion|medical abortion
5345500|NCT00269568|mifepristone|mifepristone
5345501|NCT00269568|misoprostol|misoprostol
5345502|NCT00269555|Prostate|prostate
5345503|NCT00269555|Cancer|cancer
5345504|NCT00269555|Prostate Specific Antigen|prostate specific antigen
5345505|NCT00269555|C04.588.945.440.770|c04.588.945.440.770
5345506|NCT00269542|zinc supplementation|zinc supplementation
5345507|NCT00269542|hospitalisations|hospitalisations
5345508|NCT00269542|children|children
5345509|NCT00269542|mortality|mortality
5345510|NCT00269542|iron folic acid|iron folic acid
5345511|NCT00269529|postoperative pain|postoperative pain
5345512|NCT00269529|knee arthroplasty|knee arthroplasty
5345513|NCT00269529|analgesia|analgesia
5345514|NCT00269529|infiltration|infiltration
5345515|NCT00269529|femoral nerve block|femoral nerve block
5345516|NCT00269516|Parkinson's disease|parkinson's disease
5345517|NCT00269490|Post-Traumatic Stress Disorder|post-traumatic stress disorder
5345518|NCT00269490|Yoga Nidra|yoga nidra
5345519|NCT00269477|Meningitis|meningitis
5345520|NCT00269477|Meningococcal infection|meningococcal infection
5345521|NCT00269477|Neisseria meningitidis|neisseria meningitidis
5345522|NCT00269477|Menactra®|menactra®
5345523|NCT00269477|Menomune®|menomune®
5345524|NCT00269425|Cardiovascular disease|cardiovascular disease
5345525|NCT00269425|Nutrition|nutrition
5345526|NCT00269425|Mediterranean diet|mediterranean diet
5345527|NCT00269425|Low fat diet|low fat diet
5345528|NCT00269425|American Heart Association diet|american heart association diet
5345529|NCT00269425|Monounsaturated fats|monounsaturated fats
5345530|NCT00269425|Omega-3 fats|omega-3 fats
5345531|NCT00269425|Outcomes|outcomes
5345532|NCT00269412|Irritable bowel syndrome|irritable bowel syndrome
5345533|NCT00269399|Clostridium difficile-associated Diarrhea (CDAD)|clostridium difficile-associated diarrhea (cdad)
5345534|NCT00269399|CDAD|cdad
5345535|NCT00269399|C diff|c diff
5345536|NCT00269386|Clarithromycin|clarithromycin
5345537|NCT00269386|Crohn's|crohn's
5345538|NCT00269373|Unknown primary tumor|unknown primary tumor
5345539|NCT00269373|PET-CT|pet-ct
5345540|NCT00269360|Chiropractic|chiropractic
5345541|NCT00269360|Manual Therapies|manual therapies
5345542|NCT00269360|Exercise|exercise
5345543|NCT00269360|Randomized|randomized
5345544|NCT00269360|Clinical Trial|clinical trial
5345545|NCT00269360|Neck Pain|neck pain
5345546|NCT00269347|Chiropractic|chiropractic
5345547|NCT00269347|Manual Therapy|manual therapy
5345548|NCT00269347|Exercise|exercise
5345549|NCT00269347|Randomized|randomized
5345550|NCT00269347|Clinical Trial|clinical trial
5345551|NCT00269347|Back Pain|back pain
5345552|NCT00269334|antidepressant,major depression,CYP2D6,CYP2C19,SSRI|antidepressant,major depression,cyp2d6,cyp2c19,ssri
5345553|NCT00269321|Randomized|randomized
5345554|NCT00269321|Clinical Trial|clinical trial
5345555|NCT00269321|Low Back Pain|low back pain
5345556|NCT00269321|Chiropractic|chiropractic
5345557|NCT00269321|Manual Therapies|manual therapies
5345558|NCT00269321|Exercise|exercise
5345559|NCT00269308|Randomized|randomized
5345560|NCT00269308|Clinical Trial|clinical trial
5345561|NCT00269308|Neck Pain|neck pain
5345562|NCT00269308|Chiropractic|chiropractic
5345563|NCT00269308|Manual Therapies|manual therapies
5345564|NCT00269308|Exercise|exercise
5345565|NCT00269295|Typhoid fever, S typhi, vaccine|typhoid fever, s typhi, vaccine
5345566|NCT00269230|cardiac resynchronization therapy, left ventricular Lead, Heart Failure|cardiac resynchronization therapy, left ventricular lead, heart failure
5345567|NCT00269191|Arcoxia|arcoxia
5345568|NCT00269178|malaria|malaria
5345569|NCT00269178|knowledge attitudes and practice (KAP)|knowledge attitudes and practice (kap)
5345570|NCT00269178|bednets|bednets
5345571|NCT00269178|peer health education|peer health education
5345572|NCT00269139|Behavioral crisis|behavioral crisis
5345573|NCT00269139|Perception of social crisis|perception of social crisis
5345574|NCT00269139|Repetition compulsion|repetition compulsion
5345575|NCT00269139|Intrusive mental events|intrusive mental events
5345576|NCT00269139|Uncontrollable urges|uncontrollable urges
5345577|NCT00269126|COPD|copd
5345578|NCT00269126|Chronic Bronchitis|chronic bronchitis
5345579|NCT00269126|Emphysema|emphysema
5345580|NCT00269100|Debridement|debridement
5345581|NCT00269087|Chronic Bronchitis|chronic bronchitis
5345582|NCT00269087|COPD|copd
5345583|NCT00269087|Emphysema|emphysema
5345584|NCT00269061|pioglitazone|pioglitazone
5345585|NCT00269061|diabetes|diabetes
5345586|NCT00269061|fluid|fluid
5345587|NCT00269048|CHD|chd
5345588|NCT00269048|Lp-PLA2|lp-pla2
5345589|NCT00269048|SB-480848|sb-480848
5345590|NCT00269035|SB-773812|sb-773812
5345591|NCT00269035|SPECT|spect
5345592|NCT00269035|D2 RO|d2 ro
5345593|NCT00269035|pharmacokinetics|pharmacokinetics
5345594|NCT00269035|schizophrenic patients|schizophrenic patients
5345595|NCT00269035|5HT2A RO|5ht2a ro
5345596|NCT00269022|SB-705498 acute migraine single dose TRPV1 combination inpatient outpatient study|sb-705498 acute migraine single dose trpv1 combination inpatient outpatient study
5345597|NCT00269009|Tobacco use|tobacco use
5345598|NCT00268996|Coronary artery disease|coronary artery disease
5345599|NCT00268996|Lipoprotein-associated Phospholipase A2|lipoprotein-associated phospholipase a2
5345600|NCT00268996|palpography|palpography
5345601|NCT00268996|hs-CRP|hs-crp
5345602|NCT00268996|endothelial function|endothelial function
5345603|NCT00268996|intravascular ultrasound|intravascular ultrasound
5345604|NCT00268983|rituximab|rituximab
5345605|NCT00268983|tositumomab and iodine I 131 tositumomab|tositumomab and iodine i 131 tositumomab
5345606|NCT00268983|non-Hodgkins lymphoma|non-hodgkins lymphoma
5345607|NCT00268983|radioimmunotherapy|radioimmunotherapy
5345608|NCT00268983|anti-B1 antibody|anti-b1 antibody
5345609|NCT00268983|Bexxar|bexxar
5345610|NCT00268983|NHL|nhl
5345611|NCT00268983|Tositumomab|tositumomab
5345612|NCT00268970|Advanced non-small cell lung cancer (NSCLC)|advanced non-small cell lung cancer (nsclc)
5345613|NCT00268957|Chronic|chronic
5345614|NCT00268957|Hemodialysis|hemodialysis
5345615|NCT00268957|Kidney|kidney
5345616|NCT00268957|Hyperphosphatemia|hyperphosphatemia
5345617|NCT00268957|Chronic kidney disease|chronic kidney disease
5345618|NCT00268957|Chronic Renal Insufficiency|chronic renal insufficiency
5345619|NCT00268944|Glycogen Storage Disease Type II|glycogen storage disease type ii
5345620|NCT00268944|GSD-II|gsd-ii
5345621|NCT00268944|Pompe Disease|pompe disease
5345622|NCT00268931|premature birth|premature birth
5345623|NCT00268931|motor skills|motor skills
5345624|NCT00268931|learning|learning
5345625|NCT00268931|reaching|reaching
5345626|NCT00268918|PTK787|ptk787
5345627|NCT00268918|Metastatic breast cancer|metastatic breast cancer
5345628|NCT00268918|Refractory gynecological cancer|refractory gynecological cancer
5345629|NCT00268892|Prostate Cancer|prostate cancer
5345630|NCT00268892|Androgen ablation therapy|androgen ablation therapy
5345631|NCT00268879|Irritable bowel syndrome|irritable bowel syndrome
5345632|NCT00268879|Constipation-predominant irritable bowel syndrome|constipation-predominant irritable bowel syndrome
5345633|NCT00268853|lymphoma|lymphoma
5345634|NCT00268853|NHL|nhl
5345635|NCT00268853|large cell|large cell
5345636|NCT00268853|phase II|phase ii
5345637|NCT00268853|CHOP R|chop r
5345638|NCT00268853|CPOP R|cpop r
5345639|NCT00268853|non Hodgkins|non hodgkins
5345640|NCT00268840|Pancreas or biliary cancer|pancreas or biliary cancer
5345641|NCT00268827|Kaletra|kaletra
5345642|NCT00268827|Comparison|comparison
5345643|NCT00268827|Quality of Life|quality of life
5345644|NCT00268827|African American|african american
5345645|NCT00268788|multifocal motor neuropathy|multifocal motor neuropathy
5345646|NCT00268788|subcutaneous|subcutaneous
5345647|NCT00268788|IVIG|ivig
5345648|NCT00268788|gammaglobulin|gammaglobulin
5345649|NCT00268775|community pharmacy services|community pharmacy services
5345650|NCT00268775|patient care|patient care
5345651|NCT00268775|outcome assessment|outcome assessment
5345652|NCT00268775|benzodiazepines therapeutic use|benzodiazepines therapeutic use
5345653|NCT00268762|stroke|stroke
5345654|NCT00268762|thrombin inhibition|thrombin inhibition
5345655|NCT00268762|thrombolysis|thrombolysis
5345656|NCT00268762|bleeding|bleeding
5345657|NCT00268762|outcome|outcome
5345658|NCT00268697|Hyperlipidemia|hyperlipidemia
5345659|NCT00268697|Drug Therapy|drug therapy
5345660|NCT00268658|Arthroplasty, Replacement, Hip|arthroplasty, replacement, hip
5345661|NCT00268658|Arthroplasty, Replacement, Knee|arthroplasty, replacement, knee
5345662|NCT00268658|Arthroscopy|arthroscopy
5345663|NCT00268606|fibromyalgia|fibromyalgia
5345664|NCT00268606|cognitive-behavioral therapy|cognitive-behavioral therapy
5345665|NCT00268606|tailored treatment|tailored treatment
5345666|NCT00268593|heparanase|heparanase
5345667|NCT00268593|angiogenesis|angiogenesis
5345668|NCT00268580|Asthma|asthma
5345669|NCT00268580|Care map|care map
5345670|NCT00268580|Clinical pathway|clinical pathway
5345671|NCT00268580|Education|education
5345672|NCT00268580|Emergency department|emergency department
5345673|NCT00268554|adenosine|adenosine
5345674|NCT00268554|caffeine|caffeine
5345675|NCT00268554|dipyridamole|dipyridamole
5345676|NCT00268541|exercise|exercise
5345677|NCT00268541|physical activity|physical activity
5345678|NCT00268541|insulin resistance|insulin resistance
5345679|NCT00268541|adipose tissue|adipose tissue
5345680|NCT00268541|gene expression|gene expression
5345681|NCT00268502|fatigue|fatigue
5345682|NCT00268502|depression|depression
5345683|NCT00268502|spiritual concerns|spiritual concerns
5345684|NCT00268502|sexual dysfunction|sexual dysfunction
5345685|NCT00268502|sleep disorders|sleep disorders
5345686|NCT00268502|cancer survivor|cancer survivor
5345687|NCT00268502|stage IA breast cancer|stage ia breast cancer
5345688|NCT00268502|stage IB breast cancer|stage ib breast cancer
5345689|NCT00268502|stage II breast cancer|stage ii breast cancer
5345690|NCT00268502|stage IIIA breast cancer|stage iiia breast cancer
5345691|NCT00268502|stage IIIB breast cancer|stage iiib breast cancer
5345692|NCT00268502|stage IIIC breast cancer|stage iiic breast cancer
5345693|NCT00268489|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5345694|NCT00268489|squamous cell lung cancer|squamous cell lung cancer
5345695|NCT00268489|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5345696|NCT00268489|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5345697|NCT00268476|Stage III Prostate Cancer|stage iii prostate cancer
5345698|NCT00268476|Stage IV Prostate Cancer|stage iv prostate cancer
5345699|NCT00268476|Recurrent Prostate Cancer|recurrent prostate cancer
5345700|NCT00268476|Adenocarcinoma of the prostate|adenocarcinoma of the prostate
5345701|NCT00268463|liver metastases|liver metastases
5345702|NCT00268463|stage IV colon cancer|stage iv colon cancer
5345703|NCT00268463|stage IV rectal cancer|stage iv rectal cancer
5345704|NCT00268463|adenocarcinoma of the colon|adenocarcinoma of the colon
5345705|NCT00268463|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5345706|NCT00268450|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
5345707|NCT00268450|stage III bladder cancer|stage iii bladder cancer
5345708|NCT00268450|stage II bladder cancer|stage ii bladder cancer
5345709|NCT00268450|recurrent bladder cancer|recurrent bladder cancer
5345710|NCT00268437|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
5345711|NCT00268437|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
5345712|NCT00268437|stage III esophageal cancer|stage iii esophageal cancer
5345713|NCT00268437|stage II esophageal cancer|stage ii esophageal cancer
5345714|NCT00268411|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
5345715|NCT00268411|stage IV pancreatic cancer|stage iv pancreatic cancer
5345716|NCT00268398|adenocarcinoma of the colon|adenocarcinoma of the colon
5345717|NCT00268398|stage IV colon cancer|stage iv colon cancer
5345718|NCT00268398|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5345719|NCT00268398|stage IV rectal cancer|stage iv rectal cancer
5345720|NCT00268398|resectable metastases|resectable metastases
5345721|NCT00268372|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
5345722|NCT00268372|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5345723|NCT00268359|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5345724|NCT00268359|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
5345725|NCT00268359|adult glioblastoma|adult glioblastoma
5345726|NCT00268359|adult gliosarcoma|adult gliosarcoma
5345727|NCT00268359|recurrent adult brain tumor|recurrent adult brain tumor
5345728|NCT00268359|adult giant cell glioblastoma|adult giant cell glioblastoma
5345729|NCT00268346|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
5345730|NCT00268346|recurrent esophageal cancer|recurrent esophageal cancer
5345731|NCT00268346|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
5345732|NCT00268346|stage IV esophageal cancer|stage iv esophageal cancer
5345733|NCT00268333|adenocarcinoma of the colon|adenocarcinoma of the colon
5345734|NCT00268333|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5345735|NCT00268333|stage IV colon cancer|stage iv colon cancer
5345736|NCT00268333|stage III colon cancer|stage iii colon cancer
5345737|NCT00268333|stage III rectal cancer|stage iii rectal cancer
5345738|NCT00268333|stage IV rectal cancer|stage iv rectal cancer
5345739|NCT00268320|congestive heart failure, atrial arrhythmia, cardiac resynchronization therapy, implantable cardioverter defibrillator|congestive heart failure, atrial arrhythmia, cardiac resynchronization therapy, implantable cardioverter defibrillator
5345740|NCT00268307|Cell therapy|cell therapy
5345741|NCT00268294|cardiac resynchronization therapy, atrial arrhythmia|cardiac resynchronization therapy, atrial arrhythmia
5345742|NCT00268281|cardiac resynchronization therapy|cardiac resynchronization therapy
5345743|NCT00268255|stage I non-small cell lung cancer|stage i non-small cell lung cancer
5345744|NCT00268255|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
5345745|NCT00268255|adenosquamous cell lung cancer|adenosquamous cell lung cancer
5345746|NCT00268255|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
5345747|NCT00268255|large cell lung cancer|large cell lung cancer
5345748|NCT00268255|squamous cell lung cancer|squamous cell lung cancer
5345749|NCT00268255|adenocarcinoma of the lung|adenocarcinoma of the lung
5345750|NCT00268242|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5345751|NCT00268242|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5345752|NCT00268242|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5345753|NCT00268242|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5345754|NCT00268242|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5345755|NCT00268242|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
5345756|NCT00268242|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
5345757|NCT00268242|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
5345758|NCT00268242|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
5345759|NCT00268242|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
5345760|NCT00268242|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
5345761|NCT00268242|adult erythroleukemia (M6a)|adult erythroleukemia (m6a)
5345762|NCT00268242|adult pure erythroid leukemia (M6b)|adult pure erythroid leukemia (m6b)
5345763|NCT00268242|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
5345764|NCT00268229|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5345765|NCT00268229|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5345766|NCT00268229|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5345767|NCT00268229|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5345768|NCT00268229|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5345769|NCT00268229|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
5345770|NCT00268229|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
5345771|NCT00268229|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
5345772|NCT00268229|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
5345773|NCT00268229|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
5345774|NCT00268229|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
5345775|NCT00268229|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
5345776|NCT00268229|adult erythroleukemia (M6a)|adult erythroleukemia (m6a)
5345777|NCT00268229|adult pure erythroid leukemia (M6b)|adult pure erythroid leukemia (m6b)
5345778|NCT00268216|mortality|mortality
5345779|NCT00268216|TORCH|torch
5345780|NCT00268216|SERETIDE|seretide
5345781|NCT00268216|ADVAIR|advair
5345782|NCT00268216|COPD|copd
5345783|NCT00268203|expanded access study|expanded access study
5345784|NCT00268203|refractory low-grade non-Hodgkin's Lymphoma|refractory low-grade non-hodgkin's lymphoma
5345785|NCT00268203|Bexxar®|bexxar®
5345786|NCT00268203|Iodine I 131 Tositumomab|iodine i 131 tositumomab
5345787|NCT00268203|EAP|eap
5345788|NCT00268203|relapsed low-grade non-Hodgkin's lymphoma|relapsed low-grade non-hodgkin's lymphoma
5345789|NCT00268177|Airways|airways
5345790|NCT00268177|Pulmonary|pulmonary
5345791|NCT00268177|Obstructive|obstructive
5345792|NCT00268177|Chronic|chronic
5345793|NCT00268177|inflammation|inflammation
5345794|NCT00268177|salmeterol/fluticasone propionate|salmeterol/fluticasone propionate
5345795|NCT00268151|non-small cell lung cancer|non-small cell lung cancer
5345796|NCT00268151|oxaliplatin|oxaliplatin
5345797|NCT00268151|capecitabine|capecitabine
5345798|NCT00268151|XELOX-RT|xelox-rt
5345799|NCT00268138|amine fluoride|amine fluoride
5345800|NCT00268138|white spot lesions|white spot lesions
5345801|NCT00268138|qlf|qlf
5345802|NCT00268125|Breast Neoplasm|breast neoplasm
5345803|NCT00268125|FEC100|fec100
5345804|NCT00268125|Chemotherapy|chemotherapy
5345805|NCT00268125|acupression|acupression
5345806|NCT00268125|bracelet|bracelet
5345807|NCT00268125|nausea|nausea
5345808|NCT00268125|vomiting|vomiting
5345809|NCT00268112|pediatric|pediatric
5345810|NCT00268112|cardiac|cardiac
5345811|NCT00268112|ALCAPA|alcapa
5345812|NCT00268112|Tissue Doppler Imaging|tissue doppler imaging
5345813|NCT00268099|pediatric|pediatric
5345814|NCT00268099|cardiac|cardiac
5345815|NCT00268099|repair of right to left shunt lesions|repair of right to left shunt lesions
5345816|NCT00268099|Tetralogy of Fallot defects|tetralogy of fallot defects
5345817|NCT00268086|constrictive pericarditis|constrictive pericarditis
5345818|NCT00268086|adult congenital patients|adult congenital patients
5345819|NCT00268086|pulmonary insufficiency|pulmonary insufficiency
5345820|NCT00268073|Pediatric|pediatric
5345821|NCT00268073|cardiac|cardiac
5345822|NCT00268073|neo-aortic insufficience|neo-aortic insufficience
5345823|NCT00268073|Norwood standard Stage I procedure|norwood standard stage i procedure
5345824|NCT00268073|Norwood Sano procedure|norwood sano procedure
5345825|NCT00268060|pediatric|pediatric
5345826|NCT00268060|cardiac|cardiac
5345827|NCT00268060|Long QT Syndrome|long qt syndrome
5345828|NCT00268060|Pacemaker|pacemaker
5345829|NCT00268060|Herg mutation|herg mutation
5345830|NCT00268047|pediatric|pediatric
5345831|NCT00268047|cardiac|cardiac
5345832|NCT00268047|surgery|surgery
5345833|NCT00268047|transplantation|transplantation
5345834|NCT00268047|pulmonary vascular resistance in Fontan patients|pulmonary vascular resistance in fontan patients
5345835|NCT00268034|pediatric|pediatric
5345836|NCT00268034|cardiac|cardiac
5345837|NCT00268034|aneurysms|aneurysms
5345838|NCT00268034|left ventricular aneurysms|left ventricular aneurysms
5345839|NCT00268034|surgical repair for LV aneurysms|surgical repair for lv aneurysms
5345840|NCT00268021|pediatric|pediatric
5345841|NCT00268021|biventricular pacemaker|biventricular pacemaker
5345842|NCT00268021|automated implantable cardioverter defibrillator|automated implantable cardioverter defibrillator
5345843|NCT00268021|AICD|aicd
5345844|NCT00268008|aortic valve replacement|aortic valve replacement
5345845|NCT00268008|mitral valve replacement|mitral valve replacement
5345846|NCT00268008|valvular stenosis|valvular stenosis
5345847|NCT00268008|Ross procedure|ross procedure
5345848|NCT00268008|Homograft valves|homograft valves
5345849|NCT00268008|Bio-prosthetic valves|bio-prosthetic valves
5345850|NCT00268008|Mechanical valves|mechanical valves
5345851|NCT00267995|Pediatric|pediatric
5345852|NCT00267995|cardiac|cardiac
5345853|NCT00267995|Ross procedure|ross procedure
5345854|NCT00267995|Aortic valve replacement|aortic valve replacement
5345855|NCT00267995|Proximal buttressing technique|proximal buttressing technique
5345856|NCT00267982|pediatric|pediatric
5345857|NCT00267982|cardiac|cardiac
5345858|NCT00267982|Radiofrequency Ablation|radiofrequency ablation
5345859|NCT00267982|Ectopic Atrial Tachycardia|ectopic atrial tachycardia
5345860|NCT00267969|Ustekinumab|ustekinumab
5345861|NCT00267969|CNTO1275|cnto1275
5345862|NCT00267969|Plaque type Psoriasis|plaque type psoriasis
5345863|NCT00267969|Interleukin-23|interleukin-23
5345864|NCT00267969|IL-23|il-23
5345865|NCT00267969|Psoriasis|psoriasis
5345866|NCT00267969|Interleukin 12|interleukin 12
5345867|NCT00267969|IL-12|il-12
5345868|NCT00267956|Psoriatic arthritis|psoriatic arthritis
5345869|NCT00267956|CNTO 1275|cnto 1275
5345870|NCT00267956|Ustekinumab|ustekinumab
5345871|NCT00267956|Interleukin-23, IL-12, IL-23|interleukin-23, il-12, il-23
5345872|NCT00267956|Monoclonal antibodies|monoclonal antibodies
5345873|NCT00267930|AFib|afib
5345874|NCT00267930|AF|af
5345875|NCT00267904|Normal Physiology|normal physiology
5345876|NCT00267904|Catecholamines|catecholamines
5345877|NCT00267904|Catechols|catechols
5345878|NCT00267904|Healthy Volunteer|healthy volunteer
5345879|NCT00267904|HV|hv
5345880|NCT00267891|Healthy Control Subjects|healthy control subjects
5345881|NCT00267891|Aggression|aggression
5345882|NCT00267891|Prefrontal Cortex Function|prefrontal cortex function
5345883|NCT00267891|Children and Adolescents|children and adolescents
5345884|NCT00267891|Healthy Volunteer|healthy volunteer
5345885|NCT00267891|HV|hv
5345886|NCT00267865|HIV|hiv
5345887|NCT00267865|AIDS-Related-Primary Central Nervous System Lymphoma|aids-related-primary central nervous system lymphoma
5345888|NCT00267865|High Dose Methotrexate|high dose methotrexate
5345889|NCT00267865|Rituximab|rituximab
5345890|NCT00267865|Highly Active Antiretroviral Therapy|highly active antiretroviral therapy
5345891|NCT00267865|AIDS Related-Primary Central Nervous System Lymphoma|aids related-primary central nervous system lymphoma
5345892|NCT00267865|AR-PCNSL|ar-pcnsl
5345893|NCT00267852|Arthritis|arthritis
5345894|NCT00267839|exercise|exercise
5345895|NCT00267839|intervention|intervention
5345896|NCT00267839|elderly woman|elderly woman
5345897|NCT00267839|risk factors|risk factors
5345898|NCT00267839|health costs|health costs
5345899|NCT00267839|Osteoporosis|osteoporosis
5345900|NCT00267839|cardiovascular diseases|cardiovascular diseases
5345901|NCT00267839|diabetes|diabetes
5345902|NCT00267839|Higher Age|higher age
5345903|NCT00267826|Anti-CD20 antibody treatment|anti-cd20 antibody treatment
5345904|NCT00267826|Atopic dermatitis|atopic dermatitis
5345905|NCT00267826|B cells|b cells
5345906|NCT00267826|Cytokines|cytokines
5345907|NCT00267826|Immunopathology|immunopathology
5345908|NCT00267813|craving|craving
5345909|NCT00267813|nicotine|nicotine
5345910|NCT00267813|imaging|imaging
5345911|NCT00267813|FDG|fdg
5345912|NCT00267813|PET|pet
5345913|NCT00267813|smoking|smoking
5345914|NCT00267813|Bupropion|bupropion
5345915|NCT00267800|Lung disease, Interstitial|lung disease, interstitial
5345916|NCT00267800|Sarcoidosis|sarcoidosis
5345917|NCT00267800|Pulmonary fibrosis|pulmonary fibrosis
5345918|NCT00267735|pregnancy|pregnancy
5345919|NCT00267735|repeat cesarean|repeat cesarean
5345920|NCT00267735|vaginal birth after cesarean|vaginal birth after cesarean
5345921|NCT00267696|ovarian cancer|ovarian cancer
5345922|NCT00267696|platinum sensitive cancer|platinum sensitive cancer
5345923|NCT00267696|fallopian tube cancer|fallopian tube cancer
5345924|NCT00267696|peritoneal cancer|peritoneal cancer
5345925|NCT00267670|Fatty Liver Disease|fatty liver disease
5345926|NCT00267670|Liver|liver
5345927|NCT00267670|NASH|nash
5345928|NCT00267670|Nonalcoholic Steatohepatitis|nonalcoholic steatohepatitis
5345929|NCT00267670|Nonalcoholic Fatty Liver Disease (NAFLD)|nonalcoholic fatty liver disease (nafld)
5345930|NCT00267670|Pentoxifylline|pentoxifylline
5345931|NCT00267644|Children, dehydration, Ultrasound|children, dehydration, ultrasound
5345932|NCT00267631|children, obesity, emergency medicine|children, obesity, emergency medicine
5345933|NCT00267553|Atamestane|atamestane
5345934|NCT00267553|Breast neoplasms|breast neoplasms
5345935|NCT00267553|Combined hormonal therapy|combined hormonal therapy
5345936|NCT00267553|Complete estrogen blockade|complete estrogen blockade
5345937|NCT00267553|Ductal breast carcinoma|ductal breast carcinoma
5345938|NCT00267553|Estrogen blocker|estrogen blocker
5345939|NCT00267553|Fareston®|fareston®
5345940|NCT00267553|Femara®|femara®
5345941|NCT00267553|First line therapy|first line therapy
5345942|NCT00267553|Letrozole|letrozole
5345943|NCT00267553|Lobular breast carcinoma|lobular breast carcinoma
5345944|NCT00267553|Locally advanced breast cancer|locally advanced breast cancer
5345945|NCT00267553|Locally recurrent breast cancer|locally recurrent breast cancer
5345946|NCT00267553|Maximal estrogen inhibition|maximal estrogen inhibition
5345947|NCT00267553|Metastatic breast cancer|metastatic breast cancer
5345948|NCT00267553|Neoplasms, Hormone-dependent|neoplasms, hormone-dependent
5345949|NCT00267553|Receptor-positive|receptor-positive
5345950|NCT00267553|Stage IIIA breast cancer|stage iiia breast cancer
5345951|NCT00267553|Stage IIIB breast cancer|stage iiib breast cancer
5345952|NCT00267553|Stage IV breast cancer|stage iv breast cancer
5345953|NCT00267553|Toremifene|toremifene
5345954|NCT00267540|Vitamin D|vitamin d
5345955|NCT00267540|adolescent girls|adolescent girls
5345956|NCT00267540|bone accretion|bone accretion
5345957|NCT00267540|bone turn over|bone turn over
5345958|NCT00267540|vitamin D status|vitamin d status
5345959|NCT00267540|Vitamin D insufficiency in young girls|vitamin d insufficiency in young girls
5345960|NCT00267527|Treatment Experienced|treatment experienced
5345961|NCT00267527|HIV Visceral Obesity|hiv visceral obesity
5345962|NCT00267514|Hemodialysis|hemodialysis
5345963|NCT00267501|Eosinophilic Disorders|eosinophilic disorders
5345964|NCT00267488|Hycamtin|hycamtin
5345965|NCT00267488|endometrial cancer|endometrial cancer
5345966|NCT00267488|topotecan|topotecan
5345967|NCT00267475|eosinophilic esophagitis|eosinophilic esophagitis
5345968|NCT00267475|eosinophilic gastritis|eosinophilic gastritis
5345969|NCT00267475|eosinophilic enteritis|eosinophilic enteritis
5345970|NCT00267475|eosinophilic colitis|eosinophilic colitis
5345971|NCT00267475|eosinophilic gastroenteritis|eosinophilic gastroenteritis
5345972|NCT00267462|pediatric|pediatric
5345973|NCT00267462|cardiac|cardiac
5345974|NCT00267462|hypertrophic Myopathy|hypertrophic myopathy
5345975|NCT00267449|Spectroscopy, Near-Infrared|spectroscopy, near-infrared
5345976|NCT00267449|Mammography|mammography
5345977|NCT00267449|Breast Cancer|breast cancer
5345978|NCT00267436|adaptation|adaptation
5345979|NCT00267436|HIV prevention|hiv prevention
5345980|NCT00267436|HIV positive|hiv positive
5345981|NCT00267436|evidence based interventions|evidence based interventions
5345982|NCT00267436|HIV Seronegativity|hiv seronegativity
5345983|NCT00267423|pediatric|pediatric
5345984|NCT00267423|cardiac|cardiac
5345985|NCT00267423|electrophysiology|electrophysiology
5345986|NCT00267423|epicardial biventricular pacing|epicardial biventricular pacing
5345987|NCT00267410|HIV|hiv
5345988|NCT00267410|Adaptation|adaptation
5345989|NCT00267410|Behavioral interventions|behavioral interventions
5345990|NCT00267410|Seropositive|seropositive
5345991|NCT00267410|MSM|msm
5345992|NCT00267410|HIV Seronegativity|hiv seronegativity
5345993|NCT00267397|infant|infant
5345994|NCT00267397|prenatal|prenatal
5345995|NCT00267397|birth defects|birth defects
5345996|NCT00267397|22Q11 deletion|22q11 deletion
5345997|NCT00267384|Aminoglycosides|aminoglycosides
5345998|NCT00267371|Migraine headache|migraine headache
5345999|NCT00267371|Patent Foramen Ovale|patent foramen ovale
5346000|NCT00267371|Patent Foramen Ovale Closure|patent foramen ovale closure
5346001|NCT00267332|Sedation|sedation
5346002|NCT00267332|Pain|pain
5346003|NCT00267332|modafinil|modafinil
5346004|NCT00267332|opioids|opioids
5346005|NCT00267293|fever treatment|fever treatment
5346006|NCT00267293|children|children
5346007|NCT00267241|ARDS|ards
5346008|NCT00267241|ALI|ali
5346009|NCT00267241|respiratory mechanics|respiratory mechanics
5346010|NCT00267241|gas exchange|gas exchange
5346011|NCT00267241|assisted ventilation|assisted ventilation
5346012|NCT00267228|Anorexia Nervosa|anorexia nervosa
5346013|NCT00267228|Eating disorder|eating disorder
5346014|NCT00267228|Quality of life|quality of life
5346015|NCT00267215|Lumiracoxib|lumiracoxib
5346016|NCT00267215|osteoarthritis|osteoarthritis
5346017|NCT00267202|Allergic Asthma, IgE, immunotherapy, omalizumab|allergic asthma, ige, immunotherapy, omalizumab
5346018|NCT00267189|Liver transplantation, everolimus, calcineurin inhibitor, renal function|liver transplantation, everolimus, calcineurin inhibitor, renal function
5346019|NCT00267176|Osteoarthritis,|osteoarthritis,
5346020|NCT00267176|hypertension,|hypertension,
5346021|NCT00267176|lumiracoxib,|lumiracoxib,
5346022|NCT00267176|ibuprofen,|ibuprofen,
5346023|NCT00267176|24-hour blood pressure profile|24-hour blood pressure profile
5346024|NCT00267163|Alzheimer's disease|alzheimer's disease
5346025|NCT00267163|Mild Cognitive Impairment|mild cognitive impairment
5346026|NCT00267150|Simultaneous Pancreas-Kidney Transplantation|simultaneous pancreas-kidney transplantation
5346027|NCT00267150|mycophenolate|mycophenolate
5346028|NCT00267150|GI problems|gi problems
5346029|NCT00267137|Pacemaker, Atrial Fibrillation/Therapy|pacemaker, atrial fibrillation/therapy
5346030|NCT00267124|cognitive decline|cognitive decline
5346031|NCT00267124|dementia|dementia
5346032|NCT00267124|neuroimaging|neuroimaging
5346033|NCT00267111|Infant,newborn|infant,newborn
5346034|NCT00267111|Topical anesthesia|topical anesthesia
5346035|NCT00267111|Intramuscular injection|intramuscular injection
5346036|NCT00267098|Atrioventricular block|atrioventricular block
5346037|NCT00267098|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
5346038|NCT00267098|Pacemaker|pacemaker
5346039|NCT00267098|Defibrillator|defibrillator
5346040|NCT00267098|NYHA Class I, II or III Heart failure|nyha class i, ii or iii heart failure
5346041|NCT00267085|Chronic Myeloid Leukemia|chronic myeloid leukemia
5346042|NCT00267085|Minimal Residual Disease|minimal residual disease
5346043|NCT00267085|Peptide Vaccine|peptide vaccine
5346044|NCT00267072|Ovarian Cancer|ovarian cancer
5346045|NCT00267059|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
5346046|NCT00267059|Lenalidomide|lenalidomide
5346047|NCT00267059|Revlimid|revlimid
5346048|NCT00267059|CLL|cll
5346049|NCT00267046|Sarcoma|sarcoma
5346050|NCT00267046|Soft Tissue Sarcoma|soft tissue sarcoma
5346051|NCT00267046|Oral Mucositis|oral mucositis
5346052|NCT00267046|Doxorubicin|doxorubicin
5346053|NCT00267046|Adriamycin|adriamycin
5346054|NCT00267046|Ifosfamide|ifosfamide
5346055|NCT00267046|Palifermin|palifermin
5346056|NCT00267046|Vincristine|vincristine
5346057|NCT00267046|Cisplatin|cisplatin
5346058|NCT00267046|Placebo|placebo
5346059|NCT00267033|Neoplasm Metastasis|neoplasm metastasis
5346060|NCT00267033|Bone Neoplasms|bone neoplasms
5346061|NCT00267033|Pain|pain
5346062|NCT00267033|Radiotherapy|radiotherapy
5346063|NCT00267033|Vertebroplasty|vertebroplasty
5346064|NCT00267033|Combined modality therapy|combined modality therapy
5346065|NCT00267007|Peripheral neuropathy|peripheral neuropathy
5346066|NCT00267007|Chemotherapy-induced|chemotherapy-induced
5346067|NCT00267007|Hemoglobin level|hemoglobin level
5346068|NCT00267007|Cancer|cancer
5346069|NCT00267007|Taxane|taxane
5346070|NCT00267007|Platinum-based chemotherapy|platinum-based chemotherapy
5346071|NCT00266994|Thrombosis|thrombosis
5346072|NCT00266968|pediatric|pediatric
5346073|NCT00266968|cardiac|cardiac
5346074|NCT00266968|single ventricle|single ventricle
5346075|NCT00266955|pediatric|pediatric
5346076|NCT00266955|cardiac|cardiac
5346077|NCT00266955|ADHD|adhd
5346078|NCT00266955|Adderall|adderall
5346079|NCT00266955|Straterra|straterra
5346080|NCT00266942|Fontan procedure|fontan procedure
5346081|NCT00266942|single ventricle physiology|single ventricle physiology
5346082|NCT00266942|intra-atrial|intra-atrial
5346083|NCT00266942|extracardiac technique|extracardiac technique
5346084|NCT00266929|odontoid fx|odontoid fx
5346085|NCT00266929|surgical intervention|surgical intervention
5346086|NCT00266929|conservative treatment|conservative treatment
5346087|NCT00266929|nonunion|nonunion
5346088|NCT00266929|odontoid fractures|odontoid fractures
5346089|NCT00266929|surgical treatment|surgical treatment
5346090|NCT00266916|adult|adult
5346091|NCT00266916|congenital heart disease|congenital heart disease
5346092|NCT00266916|percutaneous occlusion|percutaneous occlusion
5346093|NCT00266916|percutaneous balloon valvotomy|percutaneous balloon valvotomy
5346094|NCT00266916|balloon angioplasty|balloon angioplasty
5346095|NCT00266916|complex cyanotic congenital heart defects (CCHD)|complex cyanotic congenital heart defects (cchd)
5346096|NCT00266903|adult|adult
5346097|NCT00266903|congenital heart disease|congenital heart disease
5346098|NCT00266903|Eisenmenger's Syndrome|eisenmenger's syndrome
5346099|NCT00266903|Bosentan|bosentan
5346100|NCT00266903|Sitaxsetan|sitaxsetan
5346101|NCT00266903|Sildenafil|sildenafil
5346102|NCT00266877|Lung Cancer|lung cancer
5346103|NCT00266877|HKI-272|hki-272
5346104|NCT00266877|Neratinib|neratinib
5346105|NCT00266877|Nerlynx|nerlynx
5346106|NCT00266864|Spinal Cord Injury|spinal cord injury
5346107|NCT00266864|Testosterone Replacement Therapy|testosterone replacement therapy
5346108|NCT00266864|Dual Energy X ray Absorptiometry|dual energy x ray absorptiometry
5346109|NCT00266864|Lean Tissue Mass|lean tissue mass
5346110|NCT00266851|Randomized clinical trial|randomized clinical trial
5346111|NCT00266851|Asthma|asthma
5346112|NCT00266851|Adults|adults
5346113|NCT00266851|Azithromycin|azithromycin
5346114|NCT00266838|Lacrimal Obstruction|lacrimal obstruction
5346115|NCT00266838|Epiphora|epiphora
5346116|NCT00266812|temozolomide|temozolomide
5346117|NCT00266812|radiotherapy|radiotherapy
5346118|NCT00266773|Chronic Pain|chronic pain
5346119|NCT00266773|Cognitive Therapy|cognitive therapy
5346120|NCT00266773|Cognitive Behavioral Therapy|cognitive behavioral therapy
5346121|NCT00266773|Recurrence|recurrence
5346122|NCT00266773|Relapse Prevention|relapse prevention
5346123|NCT00266773|Educational Technology|educational technology
5346124|NCT00266773|CBT|cbt
5346125|NCT00266773|CST|cst
5346126|NCT00266773|IVR|ivr
5346127|NCT00266773|TIVR|tivr
5346128|NCT00266747|Anxiety|anxiety
5346129|NCT00266747|Anti-Anxiety Agents|anti-anxiety agents
5346130|NCT00266747|Controlled Clinical Trial|controlled clinical trial
5346131|NCT00266734|Adenoviral conjunctivitis|adenoviral conjunctivitis
5346132|NCT00266734|Viral conjunctivitis|viral conjunctivitis
5346133|NCT00266734|conjunctivitis|conjunctivitis
5346134|NCT00266721|Pancrelipase|pancrelipase
5346135|NCT00266721|Abdominal bloating|abdominal bloating
5346136|NCT00266721|Abdominal pain|abdominal pain
5346137|NCT00266721|Eructation|eructation
5346138|NCT00266708|renal transplant|renal transplant
5346139|NCT00266708|post-transplant osteoporosis|post-transplant osteoporosis
5346140|NCT00266682|Bradycardia|bradycardia
5346141|NCT00266669|Raynaud's Phenomenon|raynaud's phenomenon
5346142|NCT00266669|Raynaud's Disease|raynaud's disease
5346143|NCT00266669|Scleroderma|scleroderma
5346144|NCT00266669|Raynaud's Disease Secondary to Scleroderma|raynaud's disease secondary to scleroderma
5346145|NCT00266669|Raynaud's Disease Secondary to Other Autoimmune Disease|raynaud's disease secondary to other autoimmune disease
5346146|NCT00266617|Anemia|anemia
5346147|NCT00266617|chemotherapy|chemotherapy
5346148|NCT00266617|epoetin alfa|epoetin alfa
5346149|NCT00266617|epogen|epogen
5346150|NCT00266617|erythropoietin|erythropoietin
5346151|NCT00266617|neoplasms|neoplasms
5346152|NCT00266617|cancer|cancer
5346153|NCT00266604|Epilepsy|epilepsy
5346154|NCT00266604|seizures|seizures
5346155|NCT00266604|new-onset epilepsy|new-onset epilepsy
5346156|NCT00266604|epilepsy relapse|epilepsy relapse
5346157|NCT00266604|epilepsy monotherapy|epilepsy monotherapy
5346158|NCT00266591|Epilepsy|epilepsy
5346159|NCT00266591|Seizures|seizures
5346160|NCT00266591|Topiramate|topiramate
5346161|NCT00266591|Prophylaxis|prophylaxis
5346162|NCT00266591|Antiepileptic|antiepileptic
5346163|NCT00266591|Epileptic seizures|epileptic seizures
5346164|NCT00266591|Partial seizure disorder|partial seizure disorder
5346165|NCT00266591|Brain disease|brain disease
5346166|NCT00266578|Eosinophilic Esophagitis|eosinophilic esophagitis
5346167|NCT00266552|conduct disorder|conduct disorder
5346168|NCT00266552|oppositional defiant disorder|oppositional defiant disorder
5346169|NCT00266552|disruptive behavior disorder not otherwise specified|disruptive behavior disorder not otherwise specified
5346170|NCT00266552|ADHD|adhd
5346171|NCT00266552|risperidone|risperidone
5346172|NCT00266552|antipsychotropic agents|antipsychotropic agents
5346173|NCT00266552|children|children
5346174|NCT00266539|Postoperative pain|postoperative pain
5346175|NCT00266539|patient-controlled analgesia|patient-controlled analgesia
5346176|NCT00266526|Allergy|allergy
5346177|NCT00266526|Birch pollen|birch pollen
5346178|NCT00266526|Recombinant|recombinant
5346179|NCT00266513|CD40 Ligand|cd40 ligand
5346180|NCT00266513|Nemo|nemo
5346181|NCT00266513|Genetics|genetics
5346182|NCT00266513|Hyper-IGM|hyper-igm
5346183|NCT00266513|Ectodermal Dysplasia|ectodermal dysplasia
5346184|NCT00266513|CVID|cvid
5346185|NCT00266513|Hyper-IgM Syndrome|hyper-igm syndrome
5346186|NCT00266513|Primary Immune Deficiency Disorders|primary immune deficiency disorders
5346187|NCT00266513|Common Variable Immune Deficiency|common variable immune deficiency
5346188|NCT00266500|Adipose Tissue|adipose tissue
5346189|NCT00266500|Weight Gain|weight gain
5346190|NCT00266500|Overweight|overweight
5346191|NCT00266500|Thermogenesis|thermogenesis
5346192|NCT00266500|Deep Body Temperature|deep body temperature
5346193|NCT00266500|Adult|adult
5346194|NCT00266500|Exercise|exercise
5346195|NCT00266487|Homocysteine|homocysteine
5346196|NCT00266487|B vitamins|b vitamins
5346197|NCT00266487|Folic acid|folic acid
5346198|NCT00266487|Randomized trial|randomized trial
5346199|NCT00266487|Secondary prevention|secondary prevention
5346200|NCT00266474|Cystic Fibrosis with Chronic Rhinosinusitis|cystic fibrosis with chronic rhinosinusitis
5346201|NCT00266461|Postoperative Ileus|postoperative ileus
5346202|NCT00266448|MRSA|mrsa
5346203|NCT00266448|eradication|eradication
5346204|NCT00266448|chlorhexidine|chlorhexidine
5346205|NCT00266435|Asymptomatic subjects|asymptomatic subjects
5346206|NCT00266435|Moderate to high risk for cardiovascular event|moderate to high risk for cardiovascular event
5346207|NCT00266396|Total Hip Arthroplasty|total hip arthroplasty
5346208|NCT00266396|THA|tha
5346209|NCT00266396|Total Knee Arthroplasty|total knee arthroplasty
5346210|NCT00266396|TKA|tka
5346211|NCT00266396|Total Hip Replacement|total hip replacement
5346212|NCT00266396|THR|thr
5346213|NCT00266396|Total Knee Replacement|total knee replacement
5346214|NCT00266396|TKR|tkr
5346215|NCT00266331|Breast cancer|breast cancer
5346216|NCT00266331|Radiation skin protection|radiation skin protection
5346217|NCT00266318|Hepatitis C Nonresponder|hepatitis c nonresponder
5346218|NCT00266318|Genotype 1|genotype 1
5346219|NCT00266318|Interferon Alfacon-1|interferon alfacon-1
5346220|NCT00266318|Consensus Interferon|consensus interferon
5346221|NCT00266318|CIFN|cifn
5346222|NCT00266318|Infergen|infergen
5346223|NCT00266318|Ribavirin|ribavirin
5346224|NCT00266305|n-3 LCPUFA|n-3 lcpufa
5346225|NCT00266305|Infant development|infant development
5346226|NCT00266305|Visual acuity|visual acuity
5346227|NCT00266305|Immune function|immune function
5346228|NCT00266305|Breast milk|breast milk
5346229|NCT00266292|Fish oil|fish oil
5346230|NCT00266292|Polyunsaturated fatty acid|polyunsaturated fatty acid
5346231|NCT00266292|Immune function|immune function
5346232|NCT00266292|Endothelial function|endothelial function
5346233|NCT00266292|Cardiovascular risk factors|cardiovascular risk factors
5346234|NCT00266266|Human Papilloma Virus|human papilloma virus
5346235|NCT00266214|lidocaine patch 5%|lidocaine patch 5%
5346236|NCT00266214|Lidoderm|lidoderm
5346237|NCT00266214|carpal tunnel syndrome|carpal tunnel syndrome
5346238|NCT00266214|pain|pain
5346239|NCT00266214|nerve compression injury|nerve compression injury
5346240|NCT00266214|topical analgesic|topical analgesic
5346241|NCT00266201|Heart Defects, Congenital|heart defects, congenital
5346242|NCT00266201|Right Ventricular Dysfunction|right ventricular dysfunction
5346243|NCT00266201|Low Cardiac Output|low cardiac output
5346244|NCT00266201|Biochemical markers|biochemical markers
5346245|NCT00266201|Neurohumoral activity|neurohumoral activity
5346246|NCT00266188|Heart Defects, Congenital|heart defects, congenital
5346247|NCT00266188|Tetralogy of Fallot|tetralogy of fallot
5346248|NCT00266188|Heart Septal Defects, Ventricular|heart septal defects, ventricular
5346249|NCT00266188|Pulmonary Valve Diseases|pulmonary valve diseases
5346250|NCT00266188|Magnetic Resonance Imaging|magnetic resonance imaging
5346251|NCT00266188|Heart Catheterization|heart catheterization
5346252|NCT00266188|Echocardiography|echocardiography
5346253|NCT00266175|Pulmonary heart disease|pulmonary heart disease
5346254|NCT00266175|Pulmonary hypertension|pulmonary hypertension
5346255|NCT00266175|Stent implantation|stent implantation
5346256|NCT00266175|Balloon dilatation|balloon dilatation
5346257|NCT00266175|Surgery|surgery
5346258|NCT00266162|Heart Defects, Congenital|heart defects, congenital
5346259|NCT00266162|Eisenmenger Complex|eisenmenger complex
5346260|NCT00266162|Hypertension, Pulmonary|hypertension, pulmonary
5346261|NCT00266162|Pulmonary Heart Disease|pulmonary heart disease
5346262|NCT00266162|Pulmonary Circulation|pulmonary circulation
5346263|NCT00266162|Vascular Resistance|vascular resistance
5346264|NCT00266149|Pharmacokinetics|pharmacokinetics
5346265|NCT00266149|Lamotrigine|lamotrigine
5346266|NCT00266149|Oral Contraceptives|oral contraceptives
5346267|NCT00266149|UGT|ugt
5346268|NCT00266149|Glucuronidation.|glucuronidation.
5346269|NCT00266136|AML treatment, de-novo, secondary, high-risk MDS, chemotherapy, autologous SCT, adult|aml treatment, de-novo, secondary, high-risk mds, chemotherapy, autologous sct, adult
5346270|NCT00266123|Kidney Failure|kidney failure
5346271|NCT00266123|Kidney Transplant|kidney transplant
5346272|NCT00266110|stage IV breast cancer|stage iv breast cancer
5346273|NCT00266110|recurrent breast cancer|recurrent breast cancer
5346274|NCT00266097|stage III pancreatic cancer|stage iii pancreatic cancer
5346275|NCT00266097|stage IV pancreatic cancer|stage iv pancreatic cancer
5346499|NCT00265590|Keratopathy|keratopathy
5346276|NCT00266097|unresectable extrahepatic bile duct cancer|unresectable extrahepatic bile duct cancer
5346277|NCT00266097|unresectable gallbladder cancer|unresectable gallbladder cancer
5346278|NCT00266097|adenocarcinoma of the extrahepatic bile duct|adenocarcinoma of the extrahepatic bile duct
5346279|NCT00266097|adenocarcinoma of the gallbladder|adenocarcinoma of the gallbladder
5346280|NCT00266097|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
5346281|NCT00266097|recurrent pancreatic cancer|recurrent pancreatic cancer
5346282|NCT00266097|recurrent extrahepatic bile duct cancer|recurrent extrahepatic bile duct cancer
5346283|NCT00266097|recurrent gallbladder cancer|recurrent gallbladder cancer
5346284|NCT00266084|Cervix|cervix
5346285|NCT00266084|Uterus|uterus
5346286|NCT00266084|Dysplasia|dysplasia
5346287|NCT00266084|Cancer|cancer
5346288|NCT00266084|Collector|collector
5346289|NCT00266071|skin|skin
5346290|NCT00266071|pressure|pressure
5346291|NCT00266071|age|age
5346292|NCT00266058|healthy|healthy
5346293|NCT00266058|controls|controls
5346294|NCT00266058|research|research
5346295|NCT00266058|clinical|clinical
5346296|NCT00266058|study|study
5346297|NCT00266058|pharmacokinetic|pharmacokinetic
5346298|NCT00266058|PK|pk
5346299|NCT00266058|HIV|hiv
5346300|NCT00266058|malaria|malaria
5346301|NCT00266045|Deep Vein Thrombosis|deep vein thrombosis
5346302|NCT00266045|Pulmonary Embolism|pulmonary embolism
5346303|NCT00266045|D-dimer|d-dimer
5346304|NCT00266045|Recurrence|recurrence
5346305|NCT00266045|Duration of Anticoagulation|duration of anticoagulation
5346306|NCT00266045|Vitamin K Antagonists|vitamin k antagonists
5346307|NCT00266019|nonalcoholic steatohepatitis|nonalcoholic steatohepatitis
5346308|NCT00266019|nonalcoholic fatty liver disease|nonalcoholic fatty liver disease
5346309|NCT00266019|Fatty liver|fatty liver
5346310|NCT00266019|Cirrhosis|cirrhosis
5346311|NCT00266019|Obesity|obesity
5346312|NCT00266019|Weight Reduction|weight reduction
5346313|NCT00266019|Weight Management|weight management
5346314|NCT00265980|Leptin|leptin
5346315|NCT00265980|Obesity|obesity
5346316|NCT00265980|Energy|energy
5346317|NCT00265980|Autonomics|autonomics
5346318|NCT00265980|Neuroendocrine|neuroendocrine
5346319|NCT00265941|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
5346320|NCT00265941|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5346321|NCT00265941|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
5346322|NCT00265941|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5346323|NCT00265941|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
5346324|NCT00265941|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5346325|NCT00265928|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5346326|NCT00265928|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5346327|NCT00265928|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5346328|NCT00265928|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5346329|NCT00265928|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5346330|NCT00265928|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5346331|NCT00265928|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5346332|NCT00265928|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5346333|NCT00265928|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5346334|NCT00265928|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5346335|NCT00265928|Waldenstrom's macroglobulinemia|waldenstrom's macroglobulinemia
5346336|NCT00265915|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
5346337|NCT00265915|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5346338|NCT00265915|stage 0 chronic lymphocytic leukemia|stage 0 chronic lymphocytic leukemia
5346339|NCT00265915|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
5346340|NCT00265915|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
5346341|NCT00265915|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5346342|NCT00265915|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5346343|NCT00265902|Kaposi sarcoma|kaposi sarcoma
5346344|NCT00265889|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5346345|NCT00265889|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5346346|NCT00265889|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5346347|NCT00265876|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
5346348|NCT00265876|stage III pancreatic cancer|stage iii pancreatic cancer
5346349|NCT00265876|recurrent pancreatic cancer|recurrent pancreatic cancer
5346350|NCT00265876|stage IV pancreatic cancer|stage iv pancreatic cancer
5346351|NCT00265863|malignant ascites|malignant ascites
5346352|NCT00265850|recurrent colon cancer|recurrent colon cancer
5346353|NCT00265850|stage III colon cancer|stage iii colon cancer
5346354|NCT00265850|stage III rectal cancer|stage iii rectal cancer
5346355|NCT00265850|stage IV colon cancer|stage iv colon cancer
5346356|NCT00265850|recurrent rectal cancer|recurrent rectal cancer
5346357|NCT00265850|stage IV rectal cancer|stage iv rectal cancer
5346358|NCT00265850|adenocarcinoma of the colon|adenocarcinoma of the colon
5346359|NCT00265850|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5346360|NCT00265837|graft versus host disease|graft versus host disease
5346361|NCT00265837|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5346362|NCT00265837|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5346363|NCT00265837|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5346364|NCT00265837|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5346365|NCT00265837|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5346366|NCT00265837|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5346367|NCT00265837|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5346368|NCT00265837|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5346369|NCT00265837|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
5346370|NCT00265837|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5346371|NCT00265837|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5346372|NCT00265837|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
5346373|NCT00265837|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5346374|NCT00265837|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5346375|NCT00265837|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5346376|NCT00265837|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
5346377|NCT00265837|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5346378|NCT00265837|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5346379|NCT00265837|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5346380|NCT00265837|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5346381|NCT00265837|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5346382|NCT00265837|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5346383|NCT00265837|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5346384|NCT00265837|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
5346385|NCT00265837|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
5346386|NCT00265837|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
5346387|NCT00265837|Philadelphia chromosome negative chronic myelogenous leukemia|philadelphia chromosome negative chronic myelogenous leukemia
5346388|NCT00265837|stage I multiple myeloma|stage i multiple myeloma
5346389|NCT00265837|stage II multiple myeloma|stage ii multiple myeloma
5346390|NCT00265837|stage III multiple myeloma|stage iii multiple myeloma
5346391|NCT00265837|refractory multiple myeloma|refractory multiple myeloma
5346392|NCT00265837|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5346393|NCT00265837|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5346394|NCT00265837|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5346395|NCT00265837|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5346396|NCT00265837|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
5346397|NCT00265837|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5346398|NCT00265837|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
5346399|NCT00265837|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
5346400|NCT00265837|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
5346401|NCT00265837|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
5346402|NCT00265837|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5346403|NCT00265837|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5346404|NCT00265837|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5346405|NCT00265837|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5346406|NCT00265837|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
5346407|NCT00265837|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5346408|NCT00265837|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5346409|NCT00265837|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5346410|NCT00265837|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5346411|NCT00265837|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5346412|NCT00265837|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5346413|NCT00265837|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5346414|NCT00265837|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
5346415|NCT00265837|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
5346416|NCT00265837|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
5346417|NCT00265837|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
5346418|NCT00265837|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5346696|NCT00264641|CalCAP|calcap
5346419|NCT00265837|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5346420|NCT00265837|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5346421|NCT00265837|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5346422|NCT00265837|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5346423|NCT00265837|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5346424|NCT00265837|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5346425|NCT00265837|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5346426|NCT00265837|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5346427|NCT00265837|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5346428|NCT00265837|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5346429|NCT00265837|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5346430|NCT00265837|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5346431|NCT00265837|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5346432|NCT00265837|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5346433|NCT00265837|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5346434|NCT00265837|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5346435|NCT00265837|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5346436|NCT00265837|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5346437|NCT00265837|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5346438|NCT00265837|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5346439|NCT00265837|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5346440|NCT00265837|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5346441|NCT00265837|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5346442|NCT00265837|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5346443|NCT00265837|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5346444|NCT00265837|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5346445|NCT00265837|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5346446|NCT00265837|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5346447|NCT00265837|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5346448|NCT00265837|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
5346449|NCT00265824|stage IV colon cancer|stage iv colon cancer
5346450|NCT00265824|stage IV rectal cancer|stage iv rectal cancer
5346451|NCT00265824|adenocarcinoma of the colon|adenocarcinoma of the colon
5346452|NCT00265824|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5346453|NCT00265824|chemotherapy|chemotherapy
5346454|NCT00265811|stage III colon cancer|stage iii colon cancer
5346455|NCT00265811|adenocarcinoma of the colon|adenocarcinoma of the colon
5346456|NCT00265785|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
5346457|NCT00265785|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5346458|NCT00265785|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5346459|NCT00265785|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5346460|NCT00265772|enteral nutrition|enteral nutrition
5346461|NCT00265772|steroids|steroids
5346462|NCT00265772|mucosal healing|mucosal healing
5346463|NCT00265759|stage II breast cancer|stage ii breast cancer
5346464|NCT00265759|stage IIIA breast cancer|stage iiia breast cancer
5346465|NCT00265759|stage IIIB breast cancer|stage iiib breast cancer
5346466|NCT00265759|stage IIIC breast cancer|stage iiic breast cancer
5346467|NCT00265759|estrogen receptor-positive breast cancer|estrogen receptor-positive breast cancer
5346468|NCT00265746|metformin|metformin
5346469|NCT00265746|gestational diabetes|gestational diabetes
5346470|NCT00265746|lifestyle|lifestyle
5346471|NCT00265733|male breast cancer|male breast cancer
5346472|NCT00265733|recurrent breast cancer|recurrent breast cancer
5346473|NCT00265733|stage IV breast cancer|stage iv breast cancer
5346474|NCT00265720|African Americans|african americans
5346599|NCT00265148|cognition|cognition
5346475|NCT00265720|Colorectal Cancer Screening|colorectal cancer screening
5346476|NCT00265720|Colorectal Cancer|colorectal cancer
5346477|NCT00265720|Colorectal Cancer and African Americans|colorectal cancer and african americans
5346478|NCT00265720|Cancer Disparities|cancer disparities
5346479|NCT00265707|Hypertension|hypertension
5346480|NCT00265707|Hypotension|hypotension
5346481|NCT00265681|smokeless tobacco cessation|smokeless tobacco cessation
5346482|NCT00265681|chewing tobacco|chewing tobacco
5346483|NCT00265681|oral tobacco|oral tobacco
5346484|NCT00265681|smokeless tobacco|smokeless tobacco
5346485|NCT00265681|telephone|telephone
5346486|NCT00265681|counseling|counseling
5346487|NCT00265642|Hepatitis C, Chronic|hepatitis c, chronic
5346488|NCT00265642|irbesartan|irbesartan
5346489|NCT00265629|Atrial fibrillation|atrial fibrillation
5346490|NCT00265616|Refractory status epilepticus,|refractory status epilepticus,
5346491|NCT00265616|coma-induction,|coma-induction,
5346492|NCT00265616|treatment,|treatment,
5346493|NCT00265616|propofol,|propofol,
5346494|NCT00265616|barbiturates,|barbiturates,
5346495|NCT00265616|efficacy,|efficacy,
5346496|NCT00265616|safety.|safety.
5346497|NCT00265590|Aniridia|aniridia
5346498|NCT00265590|PAX6|pax6
5346500|NCT00265590|Limbal Stem Cell Deficiency|limbal stem cell deficiency
5346501|NCT00265590|Molecular Genetics|molecular genetics
5346502|NCT00265564|outcomes assessment|outcomes assessment
5346503|NCT00265564|substance use disorders|substance use disorders
5346504|NCT00265564|stress disorders, post-traumatic|stress disorders, post-traumatic
5346505|NCT00265564|screening|screening
5346506|NCT00265551|Schizophrenia|schizophrenia
5346507|NCT00265538|Hypertension|hypertension
5346508|NCT00265538|Diuretics|diuretics
5346509|NCT00265538|Drug Therapy|drug therapy
5346510|NCT00265538|Anti-Hypertensive Agents|anti-hypertensive agents
5346511|NCT00265538|Patient Intervention|patient intervention
5346512|NCT00265525|Randomized Control Trial|randomized control trial
5346513|NCT00265525|Exercise Intervention|exercise intervention
5346514|NCT00265525|Prevention|prevention
5346515|NCT00265525|Rehabilitation|rehabilitation
5346516|NCT00265512|Telemedicine|telemedicine
5346517|NCT00265512|Aftercare|aftercare
5346518|NCT00265499|Coronary Artery Bypass|coronary artery bypass
5346519|NCT00265499|Skeletonization|skeletonization
5346520|NCT00265499|Internal Thoracic Artery|internal thoracic artery
5346521|NCT00265499|Flow|flow
5346522|NCT00265499|Length|length
5346523|NCT00265499|Pain|pain
5346524|NCT00265486|Divers|divers
5346525|NCT00265486|Brain|brain
5346526|NCT00265486|Flow|flow
5346527|NCT00265486|Blood|blood
5346529|NCT00265486|Dive|dive
5346530|NCT00265486|reflex|reflex
5346531|NCT00265460|smoking cessation,|smoking cessation,
5346532|NCT00265460|nicotine,|nicotine,
5346533|NCT00265460|smokeless tobacco,|smokeless tobacco,
5346534|NCT00265460|cigarettes|cigarettes
5346535|NCT00265447|knee osteoarthritis|knee osteoarthritis
5346536|NCT00265447|exercise|exercise
5346537|NCT00265447|aerobic exercise|aerobic exercise
5346538|NCT00265447|strengthening exercise|strengthening exercise
5346539|NCT00265447|exercise prescription|exercise prescription
5346540|NCT00265447|rehabilitation|rehabilitation
5346541|NCT00265447|physical disability|physical disability
5346542|NCT00265447|physical function|physical function
5346543|NCT00265447|physical activity|physical activity
5346544|NCT00265447|physical fitness|physical fitness
5346545|NCT00265421|Suture Techniques|suture techniques
5346546|NCT00265408|Cervicocephalic Arterial Dissection|cervicocephalic arterial dissection
5346547|NCT00265382|Adolescent Subjects|adolescent subjects
5346548|NCT00265356|Positron Emission Tomography (PET)|positron emission tomography (pet)
5346549|NCT00265356|Diagnostic Investigation|diagnostic investigation
5346550|NCT00265356|Colorectal cancer|colorectal cancer
5346551|NCT00265356|Liver metastases|liver metastases
5346552|NCT00265356|Liver surgery|liver surgery
5346553|NCT00265330|Children And Adolescents With Bipolar I Disorder (Manic Or Mixed)|children and adolescents with bipolar i disorder (manic or mixed)
5346554|NCT00265317|Non-small cell lung cancer|non-small cell lung cancer
5346555|NCT00265317|sunitinib|sunitinib
5346556|NCT00265317|erlotinib|erlotinib
5346557|NCT00265317|Phase 2|phase 2
5346558|NCT00265304|Osteoarthritis|osteoarthritis
5346559|NCT00265291|Depression|depression
5346560|NCT00265291|mood disorders|mood disorders
5346561|NCT00265291|affective disorders|affective disorders
5346562|NCT00265291|pharmacogenetics|pharmacogenetics
5346563|NCT00265291|pharmacogenomics|pharmacogenomics
5346564|NCT00265265|Cocaine Dependence|cocaine dependence
5346565|NCT00265252|osteonecrosis|osteonecrosis
5346566|NCT00265252|total hip replacement|total hip replacement
5346567|NCT00265239|Edaravone|edaravone
5346568|NCT00265239|Randomized Control Trial|randomized control trial
5346569|NCT00265239|ST-Elevation Myocardial Infarction|st-elevation myocardial infarction
5346570|NCT00265239|Coronary Angioplasty|coronary angioplasty
5346571|NCT00265226|India|india
5346572|NCT00265226|Pulmonary Tuberculosis|pulmonary tuberculosis
5346573|NCT00265226|Category-II tuberculosis|category-ii tuberculosis
5346574|NCT00265226|Immunomodulator|immunomodulator
5346575|NCT00265226|Mycobacterium w|mycobacterium w
5346576|NCT00265226|Revised National Tuberculosis Control Programme|revised national tuberculosis control programme
5346577|NCT00265226|Category-II Pulmonary Tuberculosis|category-ii pulmonary tuberculosis
5346578|NCT00265213|breast conservative surgery|breast conservative surgery
5346579|NCT00265213|shoulder functional outcome questionnaire|shoulder functional outcome questionnaire
5346580|NCT00265213|disability questionnaire|disability questionnaire
5346581|NCT00265200|Zometa|zometa
5346582|NCT00265200|bone metastasis|bone metastasis
5346583|NCT00265200|lung cancer|lung cancer
5346584|NCT00265200|non-small cell lung cancer|non-small cell lung cancer
5346585|NCT00265200|small cell lung cancer|small cell lung cancer
5346586|NCT00265200|bone metabolic markers|bone metabolic markers
5346587|NCT00265200|tartrate resistant acid phosphatase|tartrate resistant acid phosphatase
5346588|NCT00265187|child, bronchiolitis,|child, bronchiolitis,
5346589|NCT00265174|SERUM DNA|serum dna
5346590|NCT00265174|LOH|loh
5346591|NCT00265174|METHYLATION|methylation
5346592|NCT00265174|GLIOMA|glioma
5346593|NCT00265174|MGMT|mgmt
5346594|NCT00265161|influenza vaccine|influenza vaccine
5346595|NCT00265161|effectiveness|effectiveness
5346596|NCT00265161|health care worker|health care worker
5346597|NCT00265161|OBSERVATIONAL STUDY|observational study
5346889|NCT00263627|Allergovit|allergovit
5346598|NCT00265148|rosiglitazone|rosiglitazone
5346600|NCT00265148|cerebral glucose metabolism|cerebral glucose metabolism
5346601|NCT00265148|positron emission tomography (PET)|positron emission tomography (pet)
5346602|NCT00265148|Alzheimer's Disease|alzheimer's disease
5346603|NCT00265135|Renal cell carcinoma|renal cell carcinoma
5346604|NCT00265135|CNTO 328|cnto 328
5346605|NCT00265135|Infusions|infusions
5346606|NCT00265135|Renal cell cancer|renal cell cancer
5346607|NCT00265122|Crohn Disease|crohn disease
5346608|NCT00265122|Biologic|biologic
5346609|NCT00265122|Infusion|infusion
5346610|NCT00265122|Injection|injection
5346611|NCT00265122|CNTO 1275|cnto 1275
5346612|NCT00265122|Ustekinumab|ustekinumab
5346613|NCT00265122|C01275|c01275
5346614|NCT00265122|IL-12p40|il-12p40
5346615|NCT00265109|body dysmorphic disorder|body dysmorphic disorder
5346616|NCT00265109|levetiracetam|levetiracetam
5346617|NCT00265096|Psoriatic Arthritis|psoriatic arthritis
5346618|NCT00265096|Spondyloarthritis|spondyloarthritis
5346619|NCT00265096|Spondyloarthropathy|spondyloarthropathy
5346620|NCT00265096|subcutaneous injection|subcutaneous injection
5346621|NCT00265083|Spondylitis|spondylitis
5346622|NCT00265083|subcutaneous injection|subcutaneous injection
5346623|NCT00265083|Bechterew's Disease|bechterew's disease
5346624|NCT00265083|Spondyloarthritis|spondyloarthritis
5346625|NCT00265083|Spondyloarthropathy|spondyloarthropathy
5346626|NCT00265057|Cancer;|cancer;
5346627|NCT00265057|Tumors;|tumors;
5346628|NCT00265057|Neoplasms;|neoplasms;
5346629|NCT00265057|Anticarcinogenic Agents;|anticarcinogenic agents;
5346630|NCT00265057|Antineoplastic Agents;|antineoplastic agents;
5346631|NCT00265057|Cadherins;|cadherins;
5346632|NCT00265057|Non-Small-Cell Lung Carcinoma;|non-small-cell lung carcinoma;
5346633|NCT00265057|Ovarian Cancer|ovarian cancer
5346634|NCT00265044|Behavior Change|behavior change
5346635|NCT00265044|patient Education|patient education
5346636|NCT00265031|Hodgkin´s Lymphoma|hodgkin´s lymphoma
5346637|NCT00265031|advanced stages|advanced stages
5346638|NCT00265018|Hodgkin´s lymphoma|hodgkin´s lymphoma
5346639|NCT00265018|early stages|early stages
5346640|NCT00265005|alteplase|alteplase
5346641|NCT00265005|occluded central venous catheter|occluded central venous catheter
5346642|NCT00265005|occluded arterial catheter|occluded arterial catheter
5346643|NCT00265005|occluded PICC|occluded picc
5346644|NCT00265005|neonates|neonates
5346645|NCT00265005|infants|infants
5346646|NCT00264992|embryo implantation, in vitro fertilization,|embryo implantation, in vitro fertilization,
5346647|NCT00264992|cytokine expression|cytokine expression
5346648|NCT00264979|Colorectal cancer|colorectal cancer
5346649|NCT00264979|Sequential or simultaneous surgery|sequential or simultaneous surgery
5346650|NCT00264979|Synchronous hepatic metastases|synchronous hepatic metastases
5346651|NCT00264966|Mild asthma|mild asthma
5346652|NCT00264953|Hodgkin´s lymphoma|hodgkin´s lymphoma
5346653|NCT00264953|intermediate stages|intermediate stages
5346654|NCT00264927|Inappropriate ADH Syndrome|inappropriate adh syndrome
5346655|NCT00264927|Hyponatremia|hyponatremia
5346656|NCT00264914|Inappropriate ADH Syndrome|inappropriate adh syndrome
5346657|NCT00264914|Hyponatremia|hyponatremia
5346658|NCT00264888|Duchenne muscular dystrophy|duchenne muscular dystrophy
5346659|NCT00264888|Nonsense mutation|nonsense mutation
5346660|NCT00264888|Premature stop codon|premature stop codon
5346661|NCT00264849|Asthma|asthma
5346662|NCT00264849|omalizumab|omalizumab
5346663|NCT00264849|Severe persistent allergic asthma|severe persistent allergic asthma
5346664|NCT00264823|HIV|hiv
5346665|NCT00264823|Mental Illness|mental illness
5346666|NCT00264810|Responsive Stimulation|responsive stimulation
5346667|NCT00264810|Brain Stimulator|brain stimulator
5346668|NCT00264810|Epilepsy|epilepsy
5346669|NCT00264810|Seizures|seizures
5346670|NCT00264784|Streptococcus, Group A, Fiji, epidemiology|streptococcus, group a, fiji, epidemiology
5346671|NCT00264771|Fiji, Group A streptococcus, rheumatic, glomerulonephritis|fiji, group a streptococcus, rheumatic, glomerulonephritis
5346672|NCT00264758|randomized controlled clinical trial|randomized controlled clinical trial
5346673|NCT00264758|hemodialysis|hemodialysis
5346674|NCT00264758|end stage renal disease|end stage renal disease
5346675|NCT00264745|Caregiver|caregiver
5346676|NCT00264745|Stroke|stroke
5346677|NCT00264732|cervical lesions|cervical lesions
5346678|NCT00264732|cervical dysplasia|cervical dysplasia
5346679|NCT00264732|Human papilloma virus|human papilloma virus
5346680|NCT00264732|abnormal Pap|abnormal pap
5346681|NCT00264732|High-grade cervical intraepithelial lesions (CIN 2/3)|high-grade cervical intraepithelial lesions (cin 2/3)
5346682|NCT00264719|A drug is administered to initiate breastfeeding|a drug is administered to initiate breastfeeding
5346683|NCT00264680|quality of life|quality of life
5346684|NCT00264680|qolie-10|qolie-10
5346685|NCT00264680|epilepsy|epilepsy
5346686|NCT00264680|lamotrigine|lamotrigine
5346687|NCT00264680|Validation of questionnaire|validation of questionnaire
5346688|NCT00264667|Dyslipidaemia|dyslipidaemia
5346689|NCT00264654|Social|social
5346690|NCT00264654|(SAD)|(sad)
5346691|NCT00264654|Anxiety|anxiety
5346692|NCT00264654|Disorder|disorder
5346693|NCT00264641|Hypoglycemia|hypoglycemia
5346694|NCT00264641|Cognitive impairment|cognitive impairment
5346695|NCT00264641|PET|pet
5346697|NCT00264628|NK1-antagonist|nk1-antagonist
5346698|NCT00264628|Depression|depression
5346699|NCT00264628|Fibromyalgia|fibromyalgia
5346700|NCT00264628|GW679769|gw679769
5346701|NCT00264628|Outpatient|outpatient
5346702|NCT00264615|once daily dosing|once daily dosing
5346703|NCT00264615|seizure|seizure
5346704|NCT00264615|pharmacokinetics|pharmacokinetics
5346705|NCT00264615|epilepsy|epilepsy
5346706|NCT00264602|Lymphatic mapping|lymphatic mapping
5346707|NCT00264602|nodal targeting|nodal targeting
5346708|NCT00264602|indocyanine green|indocyanine green
5346709|NCT00264602|near infrared imaging|near infrared imaging
5346710|NCT00264589|vascular function|vascular function
5346711|NCT00264589|cardiac function|cardiac function
5346712|NCT00264589|individualized training|individualized training
5346713|NCT00264589|ultrasonography|ultrasonography
5346714|NCT00264589|body composition|body composition
5346715|NCT00264576|influenza|influenza
5346716|NCT00264576|flu|flu
5346717|NCT00264550|Rheumatoid Arthritis|rheumatoid arthritis
5346718|NCT00264550|Golimumab|golimumab
5346719|NCT00264550|Methotrexate|methotrexate
5346720|NCT00264550|Fully Human anti-TNFa monoclonal antibody|fully human anti-tnfa monoclonal antibody
5346721|NCT00264550|Simpony|simpony
5346722|NCT00264537|Rheumatoid Arthritis|rheumatoid arthritis
5346723|NCT00264537|Methotrexate Naïve|methotrexate naïve
5346724|NCT00264537|subcutaneous injection|subcutaneous injection
5346725|NCT00264524|Rheumatic heart disease, HLA, Genetics, Taiwan|rheumatic heart disease, hla, genetics, taiwan
5346726|NCT00264511|Hyperbaric oxygen|hyperbaric oxygen
5346727|NCT00264511|Crush injury|crush injury
5346728|NCT00264511|Tibial fracture|tibial fracture
5346729|NCT00264511|Gustillo 3|gustillo 3
5346730|NCT00264511|soft tissue injury|soft tissue injury
5346731|NCT00264511|complications|complications
5346732|NCT00264511|outcomes|outcomes
5346733|NCT00264511|randomised controlled trial|randomised controlled trial
5346734|NCT00264498|Non-Small-Cell Lung Cancer|non-small-cell lung cancer
5346735|NCT00264498|NSCLC|nsclc
5346736|NCT00264498|Lung Cancer|lung cancer
5346737|NCT00264485|Postoperative pain|postoperative pain
5346738|NCT00264485|patient-controlled analgesia|patient-controlled analgesia
5346739|NCT00264472|Cancer|cancer
5346740|NCT00264472|Tumors|tumors
5346741|NCT00264472|Neoplasms|neoplasms
5346742|NCT00264472|Anticarcinogenic Agents|anticarcinogenic agents
5346743|NCT00264472|Antineoplastic Agents|antineoplastic agents
5346744|NCT00264472|Dihydrouracil Dehydrogenase (NADP)|dihydrouracil dehydrogenase (nadp)
5346745|NCT00264459|Sublingual immunotherapy|sublingual immunotherapy
5346746|NCT00264459|Rhinoconjunctivitis|rhinoconjunctivitis
5346747|NCT00264459|Rhinitis|rhinitis
5346748|NCT00264459|Asthma|asthma
5346749|NCT00264446|Cancer; Tumors; Neoplasms; Anticarcinogenic Agents; Antineoplastic Agents;|cancer; tumors; neoplasms; anticarcinogenic agents; antineoplastic agents;
5346750|NCT00264446|Dihydrouracil dehydrogenase (NADP); Colorectal Carcinoma; Liver Cancer|dihydrouracil dehydrogenase (nadp); colorectal carcinoma; liver cancer
5346751|NCT00264433|Cancer; Tumors; Neoplasms; Anticarcinogenic Agents; Antineoplastic Agents|cancer; tumors; neoplasms; anticarcinogenic agents; antineoplastic agents
5346752|NCT00264433|Cadherins; Non-Small-Cell Lung Carcinoma; Esophageal Cancer; Gastric Cancer; Renal Cell Carcinoma; Hepatocellular Carcinoma; Adrenocortical Carcinoma|cadherins; non-small-cell lung carcinoma; esophageal cancer; gastric cancer; renal cell carcinoma; hepatocellular carcinoma; adrenocortical carcinoma
5346753|NCT00264420|bone metastases|bone metastases
5346754|NCT00264420|breast cancer|breast cancer
5346755|NCT00264420|lung cancer|lung cancer
5346756|NCT00264420|prostate cancer|prostate cancer
5346757|NCT00264420|zoledronic acid|zoledronic acid
5346758|NCT00264420|radiation therapy|radiation therapy
5346759|NCT00264407|Hearing Loss, Central|hearing loss, central
5346760|NCT00264407|Presbycusis|presbycusis
5346761|NCT00264407|Hearing Loss, Sensorineural|hearing loss, sensorineural
5346762|NCT00264407|Hearing Loss, Cochlear|hearing loss, cochlear
5346763|NCT00264407|Hearing Loss, Bilateral|hearing loss, bilateral
5346764|NCT00264407|Sex Steroid Hormones|sex steroid hormones
5346765|NCT00264407|Estradiol|estradiol
5346766|NCT00264394|Computer generated reminder system|computer generated reminder system
5346767|NCT00264394|quality control|quality control
5346768|NCT00264394|dyslipidemia|dyslipidemia
5346769|NCT00264394|antiretroviral therapy|antiretroviral therapy
5346770|NCT00264394|HIV infection|hiv infection
5346771|NCT00264381|Superficial Thrombophlebitis|superficial thrombophlebitis
5346772|NCT00264381|STP|stp
5346773|NCT00264381|Fragmin|fragmin
5346774|NCT00264381|Ibuprofen|ibuprofen
5346775|NCT00264381|Superficial Thrombus|superficial thrombus
5346776|NCT00264381|Superficial Phlebitis|superficial phlebitis
5346777|NCT00264381|phlebitis|phlebitis
5346778|NCT00264368|Renal replacement therapy|renal replacement therapy
5346779|NCT00264368|CMV disease|cmv disease
5346780|NCT00264355|cyclosporine|cyclosporine
5346781|NCT00264355|metabolites|metabolites
5346782|NCT00264355|metabolic pattern|metabolic pattern
5346783|NCT00264355|genotypes|genotypes
5346784|NCT00264342|Smoking|smoking
5346785|NCT00264342|Tobacco|tobacco
5346786|NCT00264342|Nicotine|nicotine
5346787|NCT00264316|bone marrow cell transfer|bone marrow cell transfer
5346788|NCT00264316|acute myocardial infarction|acute myocardial infarction
5346789|NCT00264316|left ventricular function|left ventricular function
5346790|NCT00264303|Chronic Idiopathic Urticaria|chronic idiopathic urticaria
5346791|NCT00264303|CUTE Levocetirizine Xyzal®|cute levocetirizine xyzal®
5346792|NCT00264290|HIV|hiv
5346793|NCT00264290|CMV|cmv
5346794|NCT00264290|T Cell activation|t cell activation
5346795|NCT00264290|Valganciclovir|valganciclovir
5346796|NCT00264277|D-dimer|d-dimer
5346797|NCT00264277|Recurrence|recurrence
5346798|NCT00264277|Venous Thromboembolism|venous thromboembolism
5346799|NCT00264277|Anticoagulation|anticoagulation
5346800|NCT00264277|Duration|duration
5346801|NCT00264264|Closure device|closure device
5346802|NCT00264264|Stenting|stenting
5346803|NCT00264264|Percutaneous coronary intervention|percutaneous coronary intervention
5346804|NCT00264251|HIV|hiv
5346805|NCT00264251|Body composition|body composition
5346806|NCT00264251|Weight reduction|weight reduction
5346807|NCT00264251|Insulin resistance/sensitivity|insulin resistance/sensitivity
5346808|NCT00264251|Exercise|exercise
5346809|NCT00264251|Diet|diet
5346810|NCT00264251|Visceral adiposity|visceral adiposity
5346811|NCT00264225|osteoarthritis, pain|osteoarthritis, pain
5346812|NCT00264199|Chronic Congestive heart failure|chronic congestive heart failure
5346813|NCT00264199|Ischemic heart disease|ischemic heart disease
5346814|NCT00264199|insulin resistance|insulin resistance
5346815|NCT00264160|AMN107|amn107
5346816|NCT00264160|CML|cml
5346817|NCT00264160|Bcr Abl|bcr abl
5346818|NCT00264160|cytogenetic response|cytogenetic response
5346819|NCT00264160|Chronic Myelogenous Leukemia (CML)|chronic myelogenous leukemia (cml)
5346820|NCT00264160|imatinib mesylate|imatinib mesylate
5346821|NCT00264147|Arcoxia|arcoxia
5346822|NCT00264134|Non-Small Cell Lung Cancer|non-small cell lung cancer
5346823|NCT00264121|congenital, high scrotal|congenital, high scrotal
5346824|NCT00264108|Antineoplastic agents|antineoplastic agents
5346825|NCT00264108|Chemotherapy|chemotherapy
5346826|NCT00264108|Cost-effectiveness|cost-effectiveness
5346827|NCT00264108|Epoetin alfa|epoetin alfa
5346828|NCT00264108|Darbepoetin alfa|darbepoetin alfa
5346829|NCT00264095|Anemia|anemia
5346830|NCT00264095|Blood loss|blood loss
5346831|NCT00264095|Transfusion|transfusion
5346832|NCT00264095|Blood transfusion|blood transfusion
5346833|NCT00264095|Erythropoietin|erythropoietin
5346834|NCT00264095|Surgery|surgery
5346835|NCT00264095|Surgical blood loss|surgical blood loss
5346836|NCT00264095|Tumor|tumor
5346837|NCT00264095|Cancer|cancer
5346838|NCT00264095|Surgical resection|surgical resection
5346839|NCT00264095|Tumor resection|tumor resection
5346840|NCT00264069|Adherence|adherence
5346841|NCT00264069|Compliance|compliance
5346842|NCT00264069|Schizophrenia|schizophrenia
5346843|NCT00264069|Bipolar Disorder|bipolar disorder
5346844|NCT00264069|Depression|depression
5346845|NCT00264069|Personality Disorders|personality disorders
5346846|NCT00264069|Registry|registry
5346847|NCT00264056|malignant melanoma|malignant melanoma
5346848|NCT00264056|hyperthermia|hyperthermia
5346849|NCT00264056|chemotherapy|chemotherapy
5346850|NCT00264004|Advanced Solid Tumours|advanced solid tumours
5346851|NCT00264004|phase II|phase ii
5346852|NCT00264004|Hypertension|hypertension
5346853|NCT00264004|RECENTIN|recentin
5346854|NCT00263978|Venous occlusive disease|venous occlusive disease
5346855|NCT00263978|VOD|vod
5346856|NCT00263952|Bee venom allergy|bee venom allergy
5346857|NCT00263952|Specific immunotherapy|specific immunotherapy
5346858|NCT00263939|chronic disease|chronic disease
5346859|NCT00263939|patient education|patient education
5346860|NCT00263939|self-efficacy|self-efficacy
5346861|NCT00263939|self-management|self-management
5346862|NCT00263926|Wasp venom allergy,|wasp venom allergy,
5346863|NCT00263926|specific immunotherapy|specific immunotherapy
5346864|NCT00263900|Influenza A|influenza a
5346865|NCT00263900|Influenza B|influenza b
5346866|NCT00263900|RSV|rsv
5346867|NCT00263887|alpha 1 proteinase inhibitor|alpha 1 proteinase inhibitor
5346868|NCT00263887|alpha1 proteinase inhibitor|alpha1 proteinase inhibitor
5346869|NCT00263887|congenital emphysema|congenital emphysema
5346870|NCT00263887|replacement therapy|replacement therapy
5346871|NCT00263861|neurotoxicity|neurotoxicity
5346872|NCT00263861|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5346873|NCT00263822|stage I ovarian epithelial cancer|stage i ovarian epithelial cancer
5346874|NCT00263822|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
5346875|NCT00263822|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5346876|NCT00263822|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5346877|NCT00263822|primary peritoneal cavity cancer|primary peritoneal cavity cancer
5346878|NCT00263822|fallopian tube cancer|fallopian tube cancer
5346879|NCT00263731|lung cancer|lung cancer
5346880|NCT00263731|non-small cell lung cancer|non-small cell lung cancer
5346881|NCT00263731|small cell lung cancer|small cell lung cancer
5346882|NCT00263731|cancer metabolism|cancer metabolism
5346883|NCT00263640|House dust mite|house dust mite
5346884|NCT00263640|Bronchial Asthma|bronchial asthma
5346885|NCT00263640|Allergy|allergy
5346886|NCT00263640|House Dust Mite Allergy|house dust mite allergy
5346887|NCT00263627|specific immunotherapy|specific immunotherapy
5346888|NCT00263627|birch pollen allergy|birch pollen allergy
5346890|NCT00263601|Allergovit|allergovit
5346891|NCT00263601|Grass pollen allergy|grass pollen allergy
5346892|NCT00263588|breast cancer brain metastases ErbB2 positive HER2 positive|breast cancer brain metastases erbb2 positive her2 positive
5346893|NCT00263575|EN3267|en3267
5346894|NCT00263575|Breakthrough Pain|breakthrough pain
5346895|NCT00263575|Safety Study|safety study
5346896|NCT00263575|Fentanyl Tablets|fentanyl tablets
5346897|NCT00263562|Sickle cell disease|sickle cell disease
5346898|NCT00263562|vaso-occlusive crisis|vaso-occlusive crisis
5346899|NCT00263562|steroid treatment|steroid treatment
5346900|NCT00263549|House dust mite,|house dust mite,
5346901|NCT00263549|Allergy|allergy
5346902|NCT00263536|Obesity|obesity
5346903|NCT00263536|Adiposity|adiposity
5346904|NCT00263536|Binge Eating|binge eating
5346905|NCT00263536|Social Functioning|social functioning
5346906|NCT00263536|Eating Disorders|eating disorders
5346907|NCT00263536|Prevention|prevention
5346908|NCT00263536|Adolescence|adolescence
5346909|NCT00263536|Adolescent Weight Gain|adolescent weight gain
5346910|NCT00263536|Overweight|overweight
5346911|NCT00263523|Serotonin|serotonin
5346912|NCT00263523|Positron Emission Tomograhy|positron emission tomograhy
5346913|NCT00263523|Brain|brain
5346914|NCT00263523|Neurochemistry|neurochemistry
5346915|NCT00263523|Neurotransmitter|neurotransmitter
5346916|NCT00263523|Healthy Volunteer|healthy volunteer
5346917|NCT00263523|HV|hv
5346918|NCT00263497|Postinjury chronic pain|postinjury chronic pain
5346919|NCT00263497|Transtibial amputation|transtibial amputation
5346920|NCT00263497|Physical rehabilitation|physical rehabilitation
5346921|NCT00263497|Immediate temporary prosthesis|immediate temporary prosthesis
5346922|NCT00263484|Steroids, Fluorinated|steroids, fluorinated
5346923|NCT00263484|Thalidomide|thalidomide
5346924|NCT00263484|Bisphosphonates|bisphosphonates
5346925|NCT00263458|HIV|hiv
5346926|NCT00263458|acquired immunodeficiency syndrome|acquired immunodeficiency syndrome
5346927|NCT00263458|buprenorphine|buprenorphine
5346928|NCT00263458|opioid dependence|opioid dependence
5346929|NCT00263458|opioid-related disorders|opioid-related disorders
5346930|NCT00263458|integrated care|integrated care
5346931|NCT00263458|primary care|primary care
5346932|NCT00263445|Growth hormone dosing|growth hormone dosing
5346933|NCT00263445|IGF-I|igf-i
5346934|NCT00263419|Diabetes Type 2|diabetes type 2
5346935|NCT00263419|Late Complications|late complications
5346936|NCT00263419|Stress relief management|stress relief management
5346937|NCT00263419|psychosocial stress|psychosocial stress
5346938|NCT00263393|Myocardial Infarction|myocardial infarction
5346939|NCT00263393|Angina Pectoris|angina pectoris
5346940|NCT00263393|Cerebrovascular Accident|cerebrovascular accident
5346941|NCT00263393|Diabetes Mellitus|diabetes mellitus
5346942|NCT00263393|Cluster randomized design|cluster randomized design
5346943|NCT00263393|Community-based intervention trial|community-based intervention trial
5346944|NCT00263393|Primary Healthcare intervention|primary healthcare intervention
5346945|NCT00263393|Lifestyle advice|lifestyle advice
5346946|NCT00263380|COPD|copd
5346947|NCT00263380|cytokines|cytokines
5346948|NCT00263380|corticosteroids|corticosteroids
5346949|NCT00263380|beta agonists|beta agonists
5346950|NCT00263380|synergistic effect|synergistic effect
5346951|NCT00263367|Autism|autism
5346952|NCT00263367|Oxidative Stress|oxidative stress
5346953|NCT00263367|Hyperbaric Oxygen|hyperbaric oxygen
5346954|NCT00263367|Reduced Glutathione|reduced glutathione
5346955|NCT00263367|Lipid Peroxides|lipid peroxides
5346956|NCT00263341|Contraceptive agents|contraceptive agents
5346957|NCT00263341|Female contraception|female contraception
5346958|NCT00263341|Progestins|progestins
5346959|NCT00263328|immunosuppression|immunosuppression
5346960|NCT00263328|JAK3 inhibitor|jak3 inhibitor
5346961|NCT00263328|kidney transplant|kidney transplant
5346962|NCT00263328|tofacitinib|tofacitinib
5346963|NCT00263328|Xeljanz|xeljanz
5346964|NCT00263328|CP-690|cp-690
5346965|NCT00263328|550|550
5346966|NCT00263328|tacromilus|tacromilus
5346967|NCT00263328|mycophenolate mofetil|mycophenolate mofetil
5346968|NCT00263315|aspergillosis|aspergillosis
5346969|NCT00263315|mycosis|mycosis
5346970|NCT00263315|neutropenia|neutropenia
5346971|NCT00263315|primary prevention|primary prevention
5346972|NCT00263315|hematologic diseases|hematologic diseases
5346973|NCT00263315|amphotericin B|amphotericin b
5346974|NCT00263315|AmBisome|ambisome
5346975|NCT00263315|liposomal amphotericin B|liposomal amphotericin b
5346976|NCT00263302|dexamethasone, diuretic, congestive heart failure|dexamethasone, diuretic, congestive heart failure
5346977|NCT00263250|inguinal hernia|inguinal hernia
5346978|NCT00263250|asymptomatic|asymptomatic
5346979|NCT00263250|watchful waiting|watchful waiting
5346980|NCT00263250|tension-free hernia repair|tension-free hernia repair
5346982|NCT00263237|Lymphocyte|lymphocyte
5346983|NCT00263237|Lamina Propria|lamina propria
5346984|NCT00263237|Malabsorption|malabsorption
5346985|NCT00263237|Colonoscopy|colonoscopy
5346986|NCT00263237|Common Variable Immunodeficiency|common variable immunodeficiency
5346987|NCT00263237|CVID|cvid
5346988|NCT00263237|Gastrointestinal Inflammation|gastrointestinal inflammation
5346989|NCT00263211|Breast Cancer|breast cancer
5346990|NCT00263211|Metastatic|metastatic
5346991|NCT00263211|Platelet|platelet
5346992|NCT00263172|internet|internet
5346993|NCT00263172|weight management|weight management
5346994|NCT00263172|behavior therapy|behavior therapy
5346995|NCT00263172|self-help|self-help
5346996|NCT00263172|commercial program|commercial program
5346997|NCT00263172|obesity|obesity
5346998|NCT00263133|Depression|depression
5346999|NCT00263133|SSRI|ssri
5347000|NCT00263133|Sertraline|sertraline
5347001|NCT00263133|synaptic plasticity|synaptic plasticity
5347002|NCT00263133|visually evoked potentials|visually evoked potentials
5347003|NCT00263107|telerounding|telerounding
5347004|NCT00263107|minimally invasive surgery|minimally invasive surgery
5347005|NCT00263094|Fasting|fasting
5347006|NCT00263094|Headache|headache
5347007|NCT00263094|Cox 2 Inhibitors|cox 2 inhibitors
5347008|NCT00263094|Pain|pain
5347009|NCT00263094|Prophylaxis|prophylaxis
5347010|NCT00263081|Hyperlipidemia|hyperlipidemia
5347011|NCT00263081|Dyslipidemia|dyslipidemia
5347012|NCT00263081|Drug Therapy|drug therapy
5347013|NCT00263068|IDIOPATHIC RESTLESS LEGS SYNDROME|idiopathic restless legs syndrome
5347014|NCT00263042|Myocardial infarction|myocardial infarction
5347015|NCT00263042|cerebrovascular accident|cerebrovascular accident
5347016|NCT00263042|obesity|obesity
5347017|NCT00262990|Epithelial ovarian cancer|epithelial ovarian cancer
5347018|NCT00262990|fallopian tube cancer|fallopian tube cancer
5347019|NCT00262990|peritoneal cancer|peritoneal cancer
5347020|NCT00262990|primary cancer|primary cancer
5347021|NCT00262990|recurrent cancer|recurrent cancer
5347022|NCT00262990|doxorubicin|doxorubicin
5347023|NCT00262990|taxane chemotherapy|taxane chemotherapy
5347024|NCT00262990|platinum chemotherapy|platinum chemotherapy
5347025|NCT00262990|Patupilone|patupilone
5347026|NCT00262990|taxane platinum resistant|taxane platinum resistant
5347027|NCT00262977|diabetes mellitus|diabetes mellitus
5347028|NCT00262977|cardiovascular diseases|cardiovascular diseases
5347029|NCT00262977|aspirin|aspirin
5347030|NCT00262977|quality of healthcare|quality of healthcare
5347031|NCT00262964|non-alcoholic fatty liver disease|non-alcoholic fatty liver disease
5347032|NCT00262964|obesity|obesity
5347033|NCT00262964|fatty liver disease|fatty liver disease
5347034|NCT00262951|stage I pancreatic cancer|stage i pancreatic cancer
5347035|NCT00262951|stage II pancreatic cancer|stage ii pancreatic cancer
5347036|NCT00262951|stage III pancreatic cancer|stage iii pancreatic cancer
5347037|NCT00262951|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
5347038|NCT00262938|stage I endometrial carcinoma|stage i endometrial carcinoma
5347039|NCT00262938|stage II endometrial carcinoma|stage ii endometrial carcinoma
5347040|NCT00262938|weight changes|weight changes
5347041|NCT00262925|MOAD|moad
5347042|NCT00262925|Methotrexate|methotrexate
5347043|NCT00262925|Vincristine|vincristine
5347044|NCT00262925|L-asparaginase|l-asparaginase
5347045|NCT00262925|Dexamethasone|dexamethasone
5347046|NCT00262925|Subcutaneous Campath|subcutaneous campath
5347047|NCT00262899|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
5347048|NCT00262899|ductal breast carcinoma in situ|ductal breast carcinoma in situ
5347049|NCT00262899|breast cancer in situ|breast cancer in situ
5347050|NCT00262899|stage IA breast cancer|stage ia breast cancer
5347051|NCT00262899|stage IB breast cancer|stage ib breast cancer
5347052|NCT00262899|stage II breast cancer|stage ii breast cancer
5347053|NCT00262899|stage IIIA breast cancer|stage iiia breast cancer
5347054|NCT00262886|recurrent renal cell cancer|recurrent renal cell cancer
5347055|NCT00262886|stage IV renal cell cancer|stage iv renal cell cancer
5347056|NCT00262873|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5347057|NCT00262873|refractory anemia with excess blasts|refractory anemia with excess blasts
5347058|NCT00262873|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
5347059|NCT00262873|refractory anemia|refractory anemia
5347060|NCT00262873|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5347061|NCT00262873|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5347062|NCT00262860|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5347063|NCT00262808|stage II colon cancer|stage ii colon cancer
5347064|NCT00262808|stage III colon cancer|stage iii colon cancer
5347065|NCT00262808|adenocarcinoma of the colon|adenocarcinoma of the colon
5347066|NCT00262795|stage 0 chronic lymphocytic leukemia|stage 0 chronic lymphocytic leukemia
5347067|NCT00262795|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
5347068|NCT00262795|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
5347069|NCT00262795|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5347070|NCT00262795|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5347071|NCT00262782|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
5347072|NCT00262782|stage 0 chronic lymphocytic leukemia|stage 0 chronic lymphocytic leukemia
5347073|NCT00262782|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
5347074|NCT00262782|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
5347075|NCT00262769|cholangiocarcinoma of the extrahepatic bile duct|cholangiocarcinoma of the extrahepatic bile duct
5347076|NCT00262769|recurrent extrahepatic bile duct cancer|recurrent extrahepatic bile duct cancer
5347077|NCT00262769|unresectable extrahepatic bile duct cancer|unresectable extrahepatic bile duct cancer
5347078|NCT00262769|cholangiocarcinoma of the gallbladder|cholangiocarcinoma of the gallbladder
5347079|NCT00262769|recurrent gallbladder cancer|recurrent gallbladder cancer
5347080|NCT00262769|unresectable gallbladder cancer|unresectable gallbladder cancer
5347081|NCT00262769|metastatic extrahepatic bile duct cancer|metastatic extrahepatic bile duct cancer
5347082|NCT00262769|metastatic gallbladder cancer|metastatic gallbladder cancer
5347083|NCT00262743|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
5347084|NCT00262743|stage 0 chronic lymphocytic leukemia|stage 0 chronic lymphocytic leukemia
5347085|NCT00262743|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
5347086|NCT00262743|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
5347087|NCT00262730|adult glioblastoma|adult glioblastoma
5347088|NCT00262730|adult giant cell glioblastoma|adult giant cell glioblastoma
5347089|NCT00262730|adult gliosarcoma|adult gliosarcoma
5347090|NCT00262717|HIV drug resistance testing|hiv drug resistance testing
5347091|NCT00262717|Treatment Experienced|treatment experienced
5347092|NCT00262704|physician intervention|physician intervention
5347093|NCT00262704|diabetes mellitus|diabetes mellitus
5347094|NCT00262704|primary care|primary care
5347095|NCT00262704|quality improvement|quality improvement
5347096|NCT00262704|disease management|disease management
5347097|NCT00262652|sodium pyruvate|sodium pyruvate
5347098|NCT00262652|anti-inflammatory|anti-inflammatory
5347099|NCT00262652|bronchodilation|bronchodilation
5347100|NCT00262652|asthma|asthma
5347101|NCT00262652|asthmatics|asthmatics
5347102|NCT00262639|Alcoholism|alcoholism
5347103|NCT00262639|Alcohol Dependence|alcohol dependence
5347104|NCT00262639|Alcohol Withdrawal|alcohol withdrawal
5347105|NCT00262639|Treatment|treatment
5347106|NCT00262639|Pharmacotherapy|pharmacotherapy
5347107|NCT00262613|Sodium Pyruvate|sodium pyruvate
5347108|NCT00262613|COPD|copd
5347109|NCT00262613|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5347110|NCT00262587|Sport|sport
5347111|NCT00262587|Asthma|asthma
5347112|NCT00262587|Treatment|treatment
5347113|NCT00262587|Airway inflammation|airway inflammation
5347114|NCT00262574|endothelial disfunction|endothelial disfunction
5347115|NCT00262574|BNP|bnp
5347116|NCT00262574|PCI|pci
5347117|NCT00262574|coronary artery disease|coronary artery disease
5347118|NCT00262561|Intermittent Claudication|intermittent claudication
5347119|NCT00262561|Aspirin resistance|aspirin resistance
5347120|NCT00262561|Clopidogrel resistance|clopidogrel resistance
5347121|NCT00262548|Obesity|obesity
5347122|NCT00262548|Menopause|menopause
5347123|NCT00262522|Human Immunodeficiency Virus Infections|human immunodeficiency virus infections
5347124|NCT00262509|Rehabilitation|rehabilitation
5347125|NCT00262509|Sensory Aid|sensory aid
5347126|NCT00262496|Botox|botox
5347127|NCT00262496|Overactive bladder|overactive bladder
5347128|NCT00262496|Incontinence|incontinence
5347129|NCT00262496|Spinal Cord Injury|spinal cord injury
5347130|NCT00262470|tachycardia|tachycardia
5347131|NCT00262470|sinus tachycardia|sinus tachycardia
5347132|NCT00262470|postural tachycardia syndrome (POTS)|postural tachycardia syndrome (pots)
5347133|NCT00262457|electrical stimulation|electrical stimulation
5347134|NCT00262457|Pressure Ulcers|pressure ulcers
5347135|NCT00262457|Spinal Cord Injury|spinal cord injury
5347136|NCT00262431|Tracheostomy|tracheostomy
5347137|NCT00262431|Tracheostomy timing|tracheostomy timing
5347138|NCT00262431|Ventilator associated pneumonia|ventilator associated pneumonia
5347139|NCT00262431|Mechanical ventilation|mechanical ventilation
5347140|NCT00262392|heterotopic ossification,|heterotopic ossification,
5347141|NCT00262392|prevention,|prevention,
5347142|NCT00262392|high risk,|high risk,
5347143|NCT00262392|bisphosphonates,|bisphosphonates,
5347144|NCT00262392|radiotherapy|radiotherapy
5347145|NCT00262379|Chronic hepatitis C|chronic hepatitis c
5347146|NCT00262379|peginterferon|peginterferon
5347147|NCT00262379|ribavirin|ribavirin
5347148|NCT00262379|epoetin beta|epoetin beta
5347149|NCT00262340|Asthma|asthma
5347150|NCT00262340|Pediatrics|pediatrics
5347151|NCT00262340|Airway|airway
5347152|NCT00262340|Inflammation|inflammation
5347153|NCT00262327|antiangiogenesis|antiangiogenesis
5347154|NCT00262327|endostatin|endostatin
5347155|NCT00262327|adenovirus|adenovirus
5347156|NCT00262327|gene therapy|gene therapy
5347157|NCT00262327|cancer|cancer
5347158|NCT00262236|Hypertension, Aliskiren, Atenolol, Blood Pressure|hypertension, aliskiren, atenolol, blood pressure
5347159|NCT00262223|Co-morbid alcohol dependence and PTSD|co-morbid alcohol dependence and ptsd
5347160|NCT00262223|Alcohol and other drug use disorders|alcohol and other drug use disorders
5347161|NCT00262223|Treatment outcome|treatment outcome
5347162|NCT00262197|Diabetes mellitus|diabetes mellitus
5347163|NCT00262197|Medical error rates|medical error rates
5347164|NCT00262197|Pharmacotherapy|pharmacotherapy
5347165|NCT00262184|Post-Menopausal osteopenia|post-menopausal osteopenia
5347166|NCT00262158|smoking status|smoking status
5347167|NCT00262158|cigarette consumption|cigarette consumption
5347168|NCT00262145|glucose|glucose
5347169|NCT00262145|lipid|lipid
5347170|NCT00262145|diabetes|diabetes
5347171|NCT00262145|overweight|overweight
5347172|NCT00262119|Physiological pacing|physiological pacing
5347173|NCT00262119|Antitachycardia pacing therapies|antitachycardia pacing therapies
5347174|NCT00262106|Administration, intravaginal|administration, intravaginal
5347175|NCT00262106|Anti-infective agents|anti-infective agents
5347176|NCT00262106|Double blind method|double blind method
5347177|NCT00262106|Drug evaluation|drug evaluation
5347178|NCT00262106|Female|female
5347179|NCT00262106|Gels|gels
5347180|NCT00262106|HIV infections/prevention and control|hiv infections/prevention and control
5347181|NCT00262106|Microbicide|microbicide
5347182|NCT00262106|Naphthalenesulfonates/administration and dosage|naphthalenesulfonates/administration and dosage
5347183|NCT00262106|Polymers/administration and dosage|polymers/administration and dosage
5347184|NCT00262106|Sexual behavior|sexual behavior
5347185|NCT00262106|Vaginal creams, foams and jellies|vaginal creams, foams and jellies
5347186|NCT00262106|HIV Seronegativity|hiv seronegativity
5347187|NCT00262106|Genital Herpes Infections|genital herpes infections
5347188|NCT00262093|preeclampsia|preeclampsia
5347189|NCT00262093|sFlt1|sflt1
5347190|NCT00262093|PlGF|plgf
5347191|NCT00262093|parity|parity
5347192|NCT00262093|angiogenesis|angiogenesis
5347193|NCT00262054|coronary disease|coronary disease
5347194|NCT00261989|pulse oximetry readings|pulse oximetry readings
5347195|NCT00261989|pediatrics|pediatrics
5347196|NCT00261989|cardiac|cardiac
5347197|NCT00261989|congenital heart disease|congenital heart disease
5347198|NCT00261976|Rheumatoid arthritis|rheumatoid arthritis
5347199|NCT00261976|Crohn's disease|crohn's disease
5347200|NCT00261976|Psoriasis|psoriasis
5347201|NCT00261950|Cinacalcet HCl, Cinacalcet, Amgen (AMG) 073, Sensipar, Mimpara, Calcimimetic|cinacalcet hcl, cinacalcet, amgen (amg) 073, sensipar, mimpara, calcimimetic
5347202|NCT00261924|Thrombocytopenic patients|thrombocytopenic patients
5347203|NCT00261911|Meridia|meridia
5347204|NCT00261911|Sibutramine|sibutramine
5347205|NCT00261911|Obesity|obesity
5347206|NCT00261911|Adolescent|adolescent
5347207|NCT00261911|BMI|bmi
5347208|NCT00261898|Sleep Deprivation|sleep deprivation
5347209|NCT00261898|Obesity|obesity
5347210|NCT00261898|Metabolic Syndrome|metabolic syndrome
5347211|NCT00261898|Hormones|hormones
5347212|NCT00261898|Public Health|public health
5347213|NCT00261898|Overweight|overweight
5347214|NCT00261898|Sleep|sleep
5347215|NCT00261872|Alcoholism|alcoholism
5347216|NCT00261872|Attention Deficit Disorder|attention deficit disorder
5347217|NCT00261872|ADHD|adhd
5347218|NCT00261859|hazardous drinking|hazardous drinking
5347219|NCT00261846|Leukemia|leukemia
5347220|NCT00261846|tyrosine kinase inhibitor|tyrosine kinase inhibitor
5347221|NCT00261846|philadelphia chromosome|philadelphia chromosome
5347222|NCT00261846|Myeloid|myeloid
5347223|NCT00261846|Philadelphia Positive|philadelphia positive
5347224|NCT00261833|Alpha1-proteinase inhibitor deficiency|alpha1-proteinase inhibitor deficiency
5347225|NCT00261833|Emphysema|emphysema
5347226|NCT00261833|Chronic augmentation and maintenance therapy|chronic augmentation and maintenance therapy
5347227|NCT00261820|Kidney Transplant|kidney transplant
5347228|NCT00261807|severe|severe
5347229|NCT00261807|skin|skin
5347230|NCT00261807|infections|infections
5347231|NCT00261794|cognition|cognition
5347232|NCT00261794|schizophrenia|schizophrenia
5347233|NCT00261794|treatment|treatment
5347234|NCT00261781|Treadmill|treadmill
5347235|NCT00261781|Walking|walking
5347236|NCT00261781|Exercise|exercise
5347237|NCT00261781|Automaticity|automaticity
5347238|NCT00261781|Quality of Life|quality of life
5347239|NCT00261768|Aging|aging
5347240|NCT00261768|hearing aids|hearing aids
5347241|NCT00261768|hearing loss, sensorineural|hearing loss, sensorineural
5347242|NCT00261768|speech recognition|speech recognition
5347243|NCT00261755|Acupuncture|acupuncture
5347244|NCT00261755|pain relief|pain relief
5347245|NCT00261755|labour|labour
5347246|NCT00261755|randomized controlled trial|randomized controlled trial
5347247|NCT00261755|TENS|tens
5347248|NCT00261742|perianal|perianal
5347249|NCT00261742|dermatitis|dermatitis
5347250|NCT00261742|streptococcus pyogenes|streptococcus pyogenes
5347251|NCT00261729|Paroxetine|paroxetine
5347252|NCT00261729|Prazosin|prazosin
5347253|NCT00261729|Sleep Disorders|sleep disorders
5347254|NCT00261729|Stress Disorders, Post-Traumatic|stress disorders, post-traumatic
5347255|NCT00261716|clinical trial|clinical trial
5347256|NCT00261716|employment|employment
5347257|NCT00261716|schizoaffective disorder|schizoaffective disorder
5347258|NCT00261716|schizophrenia|schizophrenia
5347259|NCT00261690|Virtual Reality Distraction|virtual reality distraction
5347260|NCT00261677|Anemia|anemia
5347261|NCT00261677|cancer|cancer
5347262|NCT00261677|solid tumor|solid tumor
5347263|NCT00261677|Hodgkin's Disease|hodgkin's disease
5347264|NCT00261677|Acute Lymphocytic Leukemia (ALL)|acute lymphocytic leukemia (all)
5347265|NCT00261677|Non-Hodgkin's Lymphoma (NHL)|non-hodgkin's lymphoma (nhl)
5347266|NCT00261677|Quality of Life|quality of life
5347267|NCT00261677|hemoglobin|hemoglobin
5347268|NCT00261677|Epoetin alfa|epoetin alfa
5347269|NCT00261638|Mental Health Promotion|mental health promotion
5347270|NCT00261638|Mental Health Index|mental health index
5347271|NCT00261638|Taiwan Mental Health Index scale|taiwan mental health index scale
5347272|NCT00261638|psychophysical health|psychophysical health
5347273|NCT00261638|education years over 9 years|education years over 9 years
5347274|NCT00261638|normal people, especially joining Mental Health Foundation Promotions|normal people, especially joining mental health foundation promotions
5347275|NCT00261625|peritoneal dialysis|peritoneal dialysis
5347276|NCT00261625|artery calcification|artery calcification
5347277|NCT00261625|bone mineral density|bone mineral density
5347278|NCT00261612|relapsed or chemotherapy-refractory disease|relapsed or chemotherapy-refractory disease
5347279|NCT00261599|Colonoscopy|colonoscopy
5347280|NCT00261599|Sedation|sedation
5347281|NCT00261599|AQUAVAN|aquavan
5347282|NCT00261599|Fospropofol disodium|fospropofol disodium
5347283|NCT00261599|Colon polyps|colon polyps
5347284|NCT00261599|Endoscopic outcomes|endoscopic outcomes
5347285|NCT00261599|Endoscopic sedation|endoscopic sedation
5347286|NCT00261599|Endoscopy|endoscopy
5347287|NCT00261586|aspirin|aspirin
5347288|NCT00261586|analgesics|analgesics
5347289|NCT00261586|cyclooxygenase activity|cyclooxygenase activity
5347290|NCT00261586|non-steroidal antiinflammatory drugs|non-steroidal antiinflammatory drugs
5347291|NCT00261573|"Alzheimer's disease with cerebrovascular disease (mixed dementia)"|"alzheimer's disease with cerebrovascular disease (mixed dementia)"
5347292|NCT00261573|probable vascular dementia|probable vascular dementia
5347293|NCT00261573|galantamine|galantamine
5347294|NCT00261560|ankle sprain|ankle sprain
5347295|NCT00261560|acetaminophen extended release, ibuprofen|acetaminophen extended release, ibuprofen
5347296|NCT00261547|Kidney transplantation|kidney transplantation
5347297|NCT00261547|HLA|hla
5347298|NCT00261534|Chemotherapy|chemotherapy
5347299|NCT00261521|Kidney failure, Chronic|kidney failure, chronic
5347300|NCT00261521|End-stage renal disease|end-stage renal disease
5347301|NCT00261521|Kidney failure|kidney failure
5347302|NCT00261521|Anemia|anemia
5347303|NCT00261521|Dialysis|dialysis
5347304|NCT00261521|Epoetin|epoetin
5347305|NCT00261521|Erythropoetin|erythropoetin
5347306|NCT00261521|Epoetin alfa|epoetin alfa
5347307|NCT00261508|Risperidone|risperidone
5347308|NCT00261508|child development disorders|child development disorders
5347309|NCT00261508|pervasive development disorders|pervasive development disorders
5347310|NCT00261508|autistic disorder|autistic disorder
5347311|NCT00261508|autism|autism
5347312|NCT00261508|developmental disabilities|developmental disabilities
5347313|NCT00261508|antipsychotropic agents|antipsychotropic agents
5347314|NCT00261495|chronic noncancer pain|chronic noncancer pain
5347315|NCT00261495|pain|pain
5347316|NCT00261495|analgesia|analgesia
5347317|NCT00261495|analgesic opioid|analgesic opioid
5347318|NCT00261495|oxycodone|oxycodone
5347319|NCT00261495|hydromorphone|hydromorphone
5347320|NCT00261482|contraception|contraception
5347321|NCT00261482|female contraception|female contraception
5347322|NCT00261482|hormonal contraception|hormonal contraception
5347323|NCT00261482|transdermal contraception|transdermal contraception
5347324|NCT00261482|EVRA|evra
5347325|NCT00261482|estrogen|estrogen
5347326|NCT00261482|progestin|progestin
5347327|NCT00261482|ethinyl estradiol|ethinyl estradiol
5347328|NCT00261482|norelgestromin|norelgestromin
5347329|NCT00261469|Migraine|migraine
5347330|NCT00261469|Headache|headache
5347331|NCT00261456|Prostate cancer|prostate cancer
5347332|NCT00261456|BRCA1|brca1
5347333|NCT00261456|BRCA2|brca2
5347334|NCT00261456|prostate screening|prostate screening
5347335|NCT00261456|PSA|psa
5347336|NCT00261456|prostate biopsy|prostate biopsy
5347337|NCT00261443|Bipolar I Disorder with a recent manic or mixed episode|bipolar i disorder with a recent manic or mixed episode
5347338|NCT00261430|Schizophrenia|schizophrenia
5347339|NCT00261430|acceptance|acceptance
5347340|NCT00261430|motivational enhancement therapy|motivational enhancement therapy
5347341|NCT00261430|long-acting risperidone|long-acting risperidone
5347342|NCT00261430|intramuscular injection|intramuscular injection
5347343|NCT00261430|Treatment Guidebook|treatment guidebook
5347344|NCT00261430|GAIN Acceptance Approach|gain acceptance approach
5347345|NCT00261391|Arteriovenous Malformation|arteriovenous malformation
5347346|NCT00261391|Lymphatic Malformation|lymphatic malformation
5347347|NCT00261391|Gorham|gorham
5347348|NCT00261378|Hepatocellular Carcinoma (HCC)|hepatocellular carcinoma (hcc)
5347349|NCT00261339|Gastroesophageal Reflux|gastroesophageal reflux
5347350|NCT00261339|Gastroesophageal Reflux Disease|gastroesophageal reflux disease
5347351|NCT00261339|Pantoprazole|pantoprazole
5347352|NCT00261326|Simvastatin|simvastatin
5347353|NCT00261326|Optic Neuritis|optic neuritis
5347354|NCT00261326|Multiple Sclerosis|multiple sclerosis
5347355|NCT00261313|Breast cancer|breast cancer
5347356|NCT00261313|Doses dense chemotherapy|doses dense chemotherapy
5347357|NCT00261313|Growth factor support|growth factor support
5347358|NCT00261313|Adjuvant Breast Cancer|adjuvant breast cancer
5347359|NCT00261300|Gastric acid|gastric acid
5347360|NCT00261300|GERD|gerd
5347361|NCT00261300|Gastroesophageal reflux disease|gastroesophageal reflux disease
5347362|NCT00261300|Pantoprazole|pantoprazole
5347363|NCT00261300|Proton pump inhibitor|proton pump inhibitor
5347364|NCT00261287|Hay Fever|hay fever
5347365|NCT00261287|Allergic Rhinitis|allergic rhinitis
5347366|NCT00261287|Perennial Allergic Rhinitis|perennial allergic rhinitis
5347367|NCT00261287|Ciclesonide|ciclesonide
5347368|NCT00261274|transfusion; red blood cells|transfusion; red blood cells
5347369|NCT00261261|children|children
5347370|NCT00261261|anxiety|anxiety
5347371|NCT00261261|behavioral preparation|behavioral preparation
5347372|NCT00261261|family|family
5347373|NCT00261261|surgery|surgery
5347374|NCT00261261|parents|parents
5347375|NCT00261248|Phase 2|phase 2
5347376|NCT00261248|Vaccine|vaccine
5347377|NCT00261248|Urinary Tract Infection|urinary tract infection
5347378|NCT00261248|Vaginal Mucosal|vaginal mucosal
5347379|NCT00261235|Rehabilitation, Vocational|rehabilitation, vocational
5347380|NCT00261235|Virtues|virtues
5347381|NCT00261235|Employment, supported|employment, supported
5347382|NCT00261235|veterans|veterans
5347383|NCT00261235|Mentally Ill Persons|mentally ill persons
5347384|NCT00261222|Amodiaquine|amodiaquine
5347385|NCT00261222|Efficacy|efficacy
5347386|NCT00261222|Malaria|malaria
5347387|NCT00261222|Burkina Faso|burkina faso
5347388|NCT00261209|Flexor Tendon Adhesions|flexor tendon adhesions
5347389|NCT00261209|Zone II of the Hand|zone ii of the hand
5347390|NCT00261196|Frozen Shoulder|frozen shoulder
5347391|NCT00261170|smoking|smoking
5347392|NCT00261157|nephrectomy|nephrectomy
5347393|NCT00261157|Safety|safety
5347394|NCT00261157|Laparoscopy|laparoscopy
5347395|NCT00261157|telerounding|telerounding
5347396|NCT00261157|prostatectomy|prostatectomy
5347397|NCT00261131|cerebral palsy|cerebral palsy
5347398|NCT00261131|spasticity|spasticity
5347399|NCT00261131|diplegia|diplegia
5347400|NCT00261118|colitis|colitis
5347401|NCT00261118|rituximab|rituximab
5347402|NCT00261066|Functional outcome|functional outcome
5347403|NCT00261066|Orthopaedic surgery|orthopaedic surgery
5347404|NCT00261040|Osteoarthritis|osteoarthritis
5347405|NCT00261040|Total Hip Arthroplasty|total hip arthroplasty
5347406|NCT00261040|Minimally Invasive Surgery|minimally invasive surgery
5347407|NCT00261027|ovarian cancer|ovarian cancer
5347408|NCT00261014|Recurrent|recurrent
5347409|NCT00261014|Idiopathic|idiopathic
5347410|NCT00261014|Deep Vein Thrombosis|deep vein thrombosis
5347411|NCT00261014|Pulmonary Embolism|pulmonary embolism
5347412|NCT00261014|Clinical Prediction Rule|clinical prediction rule
5347413|NCT00261014|Venous Thromboembolism|venous thromboembolism
5347414|NCT00261014|Risk Factors|risk factors
5347415|NCT00261001|Transcutaneous|transcutaneous
5347416|NCT00261001|Vaccination|vaccination
5347417|NCT00261001|Safety|safety
5347418|NCT00261001|Immunogenicity|immunogenicity
5347419|NCT00261001|HIV|hiv
5347420|NCT00261001|Treatment Experienced|treatment experienced
5347421|NCT00260988|Prophylaxis|prophylaxis
5347422|NCT00260988|Thromboembolic disease|thromboembolic disease
5347423|NCT00260988|End stage renal disease|end stage renal disease
5347424|NCT00260988|Hemodialysis|hemodialysis
5347425|NCT00260988|Pharmacokinetics|pharmacokinetics
5347426|NCT00260988|Low Molecular Weight Heparin|low molecular weight heparin
5347427|NCT00260988|Innohep|innohep
5347428|NCT00260988|Tinzaparin|tinzaparin
5347429|NCT00260988|Fragmin|fragmin
5347430|NCT00260988|Dalteparin|dalteparin
5347431|NCT00260988|Anti Xa|anti xa
5347432|NCT00260988|INR|inr
5347433|NCT00260988|Oral anticoagulation|oral anticoagulation
5347434|NCT00260988|warfarin|warfarin
5347435|NCT00260988|Coumadin|coumadin
5347436|NCT00260975|breast cancer|breast cancer
5347437|NCT00260975|chemotherapy|chemotherapy
5347438|NCT00260975|hormonal therapy|hormonal therapy
5347439|NCT00260975|cognitive function|cognitive function
5347440|NCT00260975|chemo fog|chemo fog
5347441|NCT00260962|Pilot Project,|pilot project,
5347442|NCT00260962|Clinical Trial,|clinical trial,
5347443|NCT00260962|Treatment Outcome,|treatment outcome,
5347444|NCT00260962|Psychopharmacology|psychopharmacology
5347445|NCT00260949|rotator cuff tear|rotator cuff tear
5347446|NCT00260949|arthroscopic repair|arthroscopic repair
5347447|NCT00260936|HIV|hiv
5347448|NCT00260936|AIDS|aids
5347449|NCT00260936|Adolescent Males|adolescent males
5347450|NCT00260936|HIV positive|hiv positive
5347451|NCT00260936|Treatment Naive|treatment naive
5347452|NCT00260936|Treatment Experienced|treatment experienced
5347453|NCT00260923|hypertension|hypertension
5347454|NCT00260923|aliskiren|aliskiren
5347455|NCT00260923|blood pressure|blood pressure
5347456|NCT00260897|avascular necrosis of the femoral head|avascular necrosis of the femoral head
5347457|NCT00260897|genotyping|genotyping
5347458|NCT00260897|linkage analysis|linkage analysis
5347459|NCT00260897|pathogenesis|pathogenesis
5347460|NCT00260897|therapy|therapy
5347461|NCT00260871|lung adenocarcinoma|lung adenocarcinoma
5347462|NCT00260871|genetic epidemiology|genetic epidemiology
5347463|NCT00260871|environmental factors|environmental factors
5347464|NCT00260871|genetic map|genetic map
5347465|NCT00260871|coordination center|coordination center
5347466|NCT00260858|Glycemic index|glycemic index
5347467|NCT00260858|Nutrition|nutrition
5347468|NCT00260858|Carbohydrates|carbohydrates
5347469|NCT00260858|Glycemic responses|glycemic responses
5347470|NCT00260858|Methodology|methodology
5347471|NCT00260858|Healthy human subjects|healthy human subjects
5347472|NCT00260832|Acute Myeloid Leukemia|acute myeloid leukemia
5347473|NCT00260832|Dacogen|dacogen
5347474|NCT00260832|Decitabine|decitabine
5347475|NCT00260832|Poor or intermediate-risk cytogenetics|poor or intermediate-risk cytogenetics
5347476|NCT00260819|Hypoxia-induced pulmonary artery hypertension|hypoxia-induced pulmonary artery hypertension
5347477|NCT00260819|High-altitude pulmonary oedema|high-altitude pulmonary oedema
5347478|NCT00260819|ETA receptor antagonist|eta receptor antagonist
5347479|NCT00260793|Ropinirole|ropinirole
5347480|NCT00260793|Parkinson's disease|parkinson's disease
5347481|NCT00260793|dopamine agonist|dopamine agonist
5347482|NCT00260780|sexually transmitted diseases|sexually transmitted diseases
5347483|NCT00260780|Risk Behavior|risk behavior
5347484|NCT00260754|Risk behavior|risk behavior
5347485|NCT00260754|Sexually transmitted diseases|sexually transmitted diseases
5347486|NCT00260741|cannabis|cannabis
5347487|NCT00260741|marijuana|marijuana
5347488|NCT00260741|Multiple Sclerosis|multiple sclerosis
5347489|NCT00260741|Spasticity|spasticity
5347490|NCT00260728|vascular access|vascular access
5347491|NCT00260728|hemodialysis|hemodialysis
5347492|NCT00260715|Risk behavior|risk behavior
5347493|NCT00260715|Sexually Transmitted Diseases|sexually transmitted diseases
5347494|NCT00260702|Phenotype|phenotype
5347495|NCT00260702|Monoclonal|monoclonal
5347496|NCT00260702|Immunoglobulin|immunoglobulin
5347497|NCT00260702|Immunodeficiency|immunodeficiency
5347498|NCT00260702|Dermatitis|dermatitis
5347499|NCT00260702|Job's Syndrome|job's syndrome
5347500|NCT00260702|Hyper-IgE Syndrome|hyper-ige syndrome
5347501|NCT00260702|HIES|hies
5347502|NCT00260689|Immunosuppression|immunosuppression
5347503|NCT00260689|T-cells|t-cells
5347504|NCT00260689|Hematopoiesis|hematopoiesis
5347505|NCT00260689|Autoimmunity|autoimmunity
5347506|NCT00260689|Thrombocytopenia|thrombocytopenia
5347507|NCT00260689|Severe Aplastic Anemia|severe aplastic anemia
5347508|NCT00260689|SAA|saa
5347509|NCT00260676|brain death|brain death
5347510|NCT00260676|lung transplantation|lung transplantation
5347511|NCT00260676|organ donors|organ donors
5347512|NCT00260676|potential organ donors|potential organ donors
5347513|NCT00260663|Hearing Impaired Rehabilitation|hearing impaired rehabilitation
5347514|NCT00260663|Hearing Aids|hearing aids
5347515|NCT00260663|Randomized Controlled Trials|randomized controlled trials
5347516|NCT00260663|Cost Effectiveness|cost effectiveness
5347517|NCT00260663|Quality of life|quality of life
5347518|NCT00260663|Patient Compliance|patient compliance
5347519|NCT00260650|heart failure, congestive|heart failure, congestive
5347520|NCT00260650|self-care|self-care
5347521|NCT00260650|quality of life|quality of life
5347522|NCT00260650|health behavior|health behavior
5347523|NCT00260637|Prostatitis|prostatitis
5347524|NCT00260624|agitation|agitation
5347525|NCT00260624|dementia|dementia
5347526|NCT00260624|Alzheimer's Disease|alzheimer's disease
5347527|NCT00260611|prostate|prostate
5347528|NCT00260598|Non-small cell lung cancer|non-small cell lung cancer
5347529|NCT00260598|Head and neck squamous cell cancer|head and neck squamous cell cancer
5347530|NCT00260598|White light bronchoscopy|white light bronchoscopy
5347531|NCT00260598|Imaging Elastic Scattering Spectroscopy (IESS)|imaging elastic scattering spectroscopy (iess)
5347532|NCT00260598|Fluorescence Bronchoscopy|fluorescence bronchoscopy
5347533|NCT00260598|COPD|copd
5347534|NCT00260598|Helium-Cadmium Laser Bronchoscopy|helium-cadmium laser bronchoscopy
5347535|NCT00260598|Autofluorescence spectra of dysplasia & cancer in situ (CIS)|autofluorescence spectra of dysplasia & cancer in situ (cis)
5347536|NCT00260598|Severe Chronic Obstructive Pulmonary Disorders(COPD)|severe chronic obstructive pulmonary disorders(copd)
5347537|NCT00260585|gastroesophageal reflux disease|gastroesophageal reflux disease
5347538|NCT00260585|GERD|gerd
5347539|NCT00260585|hiatal hernia|hiatal hernia
5347540|NCT00260585|achalasia|achalasia
5347541|NCT00260585|Barrett's metaplasia|barrett's metaplasia
5347542|NCT00260585|Anti-Reflux Surgery|anti-reflux surgery
5347543|NCT00260585|Known/suspected esophageal/gastroesophageal junction tumor|known/suspected esophageal/gastroesophageal junction tumor
5347544|NCT00260585|Esophageal disorders such as Barrett's metaplasia|esophageal disorders such as barrett's metaplasia
5347545|NCT00260585|Symptomatic gastroesophageal reflux disease|symptomatic gastroesophageal reflux disease
5347546|NCT00260572|GERD|gerd
5347547|NCT00260572|nissen|nissen
5347548|NCT00260572|fundoplication|fundoplication
5347549|NCT00260572|reflux|reflux
5347550|NCT00260572|toupet|toupet
5347551|NCT00260572|QOL|qol
5347552|NCT00260572|dyspepsia|dyspepsia
5347553|NCT00260572|heartburn|heartburn
5347554|NCT00260572|Patients with reflux symptoms for at least 6 months|patients with reflux symptoms for at least 6 months
5347555|NCT00260572|Patients scheduled for lap nissen or toupet fundoplication|patients scheduled for lap nissen or toupet fundoplication
5347556|NCT00260572|Reflux diagnosed by either endoscopy, upper GI, or 24hr. pH (numeric scale used to specify the acidity of gastric contents)|reflux diagnosed by either endoscopy, upper gi, or 24hr. ph (numeric scale used to specify the acidity of gastric contents)
5347557|NCT00260572|On or starting treatment with PPI or pro-motility agents|on or starting treatment with ppi or pro-motility agents
5347558|NCT00260559|Esophagectomy|esophagectomy
5347559|NCT00260559|Esophageal Cancer|esophageal cancer
5347560|NCT00260559|Quality of Life|quality of life
5347561|NCT00260559|Minimally Invasive Esophagectomy|minimally invasive esophagectomy
5347562|NCT00260559|Laparoscopic Transhiatal Esophagectomy|laparoscopic transhiatal esophagectomy
5347563|NCT00260559|Open Esophagectomy|open esophagectomy
5347564|NCT00260559|Karnofsky Score|karnofsky score
5347565|NCT00260559|Dysphagia score|dysphagia score
5347566|NCT00260559|Heartburn Scale|heartburn scale
5347567|NCT00260559|Nutrition Score|nutrition score
5347568|NCT00260546|Ventricular dyssynchrony|ventricular dyssynchrony
5347569|NCT00260520|Low molecular weight heparin|low molecular weight heparin
5347570|NCT00260520|Preeclampsia|preeclampsia
5347571|NCT00260520|Fetal Growth Restriction|fetal growth restriction
5347572|NCT00260520|Thrombophilia|thrombophilia
5347573|NCT00260520|Factor V Leiden|factor v leiden
5347574|NCT00260520|G20210A prothrombin gene mutation|g20210a prothrombin gene mutation
5347575|NCT00260494|Cardiac Surgical Procedures|cardiac surgical procedures
5347576|NCT00260494|open saphenous vein graft harvest wounds|open saphenous vein graft harvest wounds
5347577|NCT00260494|Postoperative Complications|postoperative complications
5347578|NCT00260494|Surgical Wound Infection|surgical wound infection
5347579|NCT00260494|Surgical Wound Dehiscence|surgical wound dehiscence
5347580|NCT00260481|Methamphetamine Dependence|methamphetamine dependence
5347581|NCT00260481|Pharmacotherapy|pharmacotherapy
5347582|NCT00260468|Major depression|major depression
5347583|NCT00260468|Magnetic resonance imaging|magnetic resonance imaging
5347584|NCT00260468|White matter lesions|white matter lesions
5347585|NCT00260468|Perfusion|perfusion
5347586|NCT00260468|Diffusion|diffusion
5347587|NCT00260468|Magnetization transfer|magnetization transfer
5347588|NCT00260468|Vascular risk factors|vascular risk factors
5347589|NCT00260442|sarcopenia|sarcopenia
5347590|NCT00260442|resistance training|resistance training
5347591|NCT00260442|strength training|strength training
5347592|NCT00260442|skeletal muscle|skeletal muscle
5347593|NCT00260442|elderly|elderly
5347594|NCT00260442|cholesterol|cholesterol
5347595|NCT00260442|aging|aging
5347596|NCT00260442|cardiovascular disease|cardiovascular disease
5347597|NCT00260442|nutrition|nutrition
5347598|NCT00260442|inflammation|inflammation
5347599|NCT00260442|lipids|lipids
5347600|NCT00260429|Dupuytren's contracture|dupuytren's contracture
5347601|NCT00260429|fixed flexion contracture|fixed flexion contracture
5347602|NCT00260416|Acute myocardial infarction|acute myocardial infarction
5347603|NCT00260416|Symptom duration|symptom duration
5347604|NCT00260416|Primary angioplasty|primary angioplasty
5347605|NCT00260416|Infarct size|infarct size
5347606|NCT00260416|Myocardial scintigraphy|myocardial scintigraphy
5347607|NCT00260390|Dysthymic Disorder|dysthymic disorder
5347608|NCT00260390|HPG hypofunctioning|hpg hypofunctioning
5347609|NCT00260390|Testosterone replacement|testosterone replacement
5347610|NCT00260377|Aspirin treatment|aspirin treatment
5347611|NCT00260377|Aspirin resistance|aspirin resistance
5347612|NCT00260377|Coronary bypass surgery|coronary bypass surgery
5347613|NCT00260364|Recurrent carcinoma of the pancreas|recurrent carcinoma of the pancreas
5347614|NCT00260364|Adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
5347615|NCT00260364|Stage II carcinoma of the pancreas|stage ii carcinoma of the pancreas
5347616|NCT00260364|Stage III carcinoma of the pancreas|stage iii carcinoma of the pancreas
5347617|NCT00260364|Stage IVA carcinoma of the pancreas|stage iva carcinoma of the pancreas
5347618|NCT00260364|Stage IVB carcinoma of the pancreas|stage ivb carcinoma of the pancreas
5347619|NCT00260351|rabies;|rabies;
5347620|NCT00260351|rabies post-exposure;|rabies post-exposure;
5347621|NCT00260351|category III|category iii
5347622|NCT00260338|myocardial ischemia|myocardial ischemia
5347623|NCT00260338|stem cell|stem cell
5347624|NCT00260338|mesenchymal|mesenchymal
5347625|NCT00260338|myocardial perfusion|myocardial perfusion
5347626|NCT00260325|pretreatment|pretreatment
5347627|NCT00260325|healthy volunteers|healthy volunteers
5347628|NCT00260312|inactived|inactived
5347629|NCT00260312|polio|polio
5347630|NCT00260312|vaccine|vaccine
5347631|NCT00260312|cuba|cuba
5347632|NCT00260312|trial|trial
5347633|NCT00260312|randomized|randomized
5347634|NCT00260312|eradication|eradication
5347635|NCT00260299|cholesterol defects|cholesterol defects
5347636|NCT00260299|Mevalonic Aciduria|mevalonic aciduria
5347637|NCT00260299|Mevalonate Kinase Deficiency|mevalonate kinase deficiency
5347638|NCT00260299|HIDS|hids
5347639|NCT00260299|Hyperimmunoglobulinemia with periodic fever syndrome|hyperimmunoglobulinemia with periodic fever syndrome
5347640|NCT00260299|MKD|mkd
5347641|NCT00260299|Lipid Metabolism, Inborn Errors|lipid metabolism, inborn errors
5347642|NCT00260299|Periodic Fever Syndromes, hereditary|periodic fever syndromes, hereditary
5347643|NCT00260299|mevalonic acid|mevalonic acid
5347644|NCT00260299|mevalonate kinase|mevalonate kinase
5347645|NCT00260299|cholesterol, dietary|cholesterol, dietary
5347646|NCT00260299|Hyper IgD|hyper igd
5347647|NCT00260299|Multiple malformations|multiple malformations
5347648|NCT00260299|Fever|fever
5347649|NCT00260286|LH pulsatility|lh pulsatility
5347650|NCT00260286|energy availability|energy availability
5347651|NCT00260286|exercise|exercise
5347652|NCT00260286|diet|diet
5347653|NCT00260286|gynecological age|gynecological age
5347654|NCT00260273|Preventive Therapy|preventive therapy
5347655|NCT00260273|Psychoses|psychoses
5347656|NCT00260273|Cognitive Behaviour Therapy|cognitive behaviour therapy
5347657|NCT00260247|CYP3A4|cyp3a4
5347658|NCT00260247|Induction|induction
5347659|NCT00260247|Oxcarbazepine|oxcarbazepine
5347660|NCT00260247|Carbamazepine|carbamazepine
5347661|NCT00260247|Quinidine|quinidine
5347662|NCT00260247|Human|human
5347663|NCT00260247|In vivo|in vivo
5347664|NCT00260234|Transplantation, Pancreatic Islets|transplantation, pancreatic islets
5347665|NCT00260234|Diabetes Mellitus, Type 1|diabetes mellitus, type 1
5347666|NCT00260234|Insulin Dependent|insulin dependent
5347667|NCT00260234|Islet Transplant|islet transplant
5347668|NCT00260221|Virtual Reality Hypnosis|virtual reality hypnosis
5347669|NCT00260208|Liver transplant, adults, hepatitis C, liver fibrosis, cyclosporine microemulsion, tacrolimus|liver transplant, adults, hepatitis c, liver fibrosis, cyclosporine microemulsion, tacrolimus
5347670|NCT00260195|Trauma|trauma
5347671|NCT00260195|Violence|violence
5347672|NCT00260195|Adolescent|adolescent
5347673|NCT00260195|Schools|schools
5347674|NCT00260195|Cognitive behavioral therapy|cognitive behavioral therapy
5347675|NCT00260182|Depressive Disorder|depressive disorder
5347676|NCT00260182|Family|family
5347677|NCT00260182|Genetics|genetics
5347678|NCT00260169|Treatment Preferences|treatment preferences
5347679|NCT00260169|Public sector|public sector
5347680|NCT00260169|Latino|latino
5347681|NCT00260156|Type 2 diabetes|type 2 diabetes
5347682|NCT00260156|vildagliptin|vildagliptin
5347683|NCT00260143|HIV+ men|hiv+ men
5347684|NCT00260143|Treatment Experienced|treatment experienced
5347685|NCT00260130|obesity|obesity
5347686|NCT00260130|food intake|food intake
5347687|NCT00260130|human|human
5347688|NCT00260130|energy balance|energy balance
5347689|NCT00260130|beverage|beverage
5347690|NCT00260117|Exercise|exercise
5347691|NCT00260117|Physical activity|physical activity
5347692|NCT00260117|walking|walking
5347693|NCT00260117|running|running
5347694|NCT00260091|Infertility|infertility
5347695|NCT00260091|Advanced maternal age|advanced maternal age
5347696|NCT00260091|Pregnancy|pregnancy
5347697|NCT00260091|Reproductive health|reproductive health
5347698|NCT00260091|Fertility treatment|fertility treatment
5347699|NCT00260091|Reproduction|reproduction
5347700|NCT00260078|Treatment Experienced|treatment experienced
5347701|NCT00260078|Pharmacokinetics|pharmacokinetics
5347702|NCT00260078|PK|pk
5347703|NCT00260065|Myelodysplastic Syndrome|myelodysplastic syndrome
5347704|NCT00260065|Decitabine|decitabine
5347705|NCT00260065|Dacogen|dacogen
5347706|NCT00260065|MGI Pharma|mgi pharma
5347707|NCT00260052|traumatic brain injury|traumatic brain injury
5347708|NCT00260026|Lung Cancer|lung cancer
5347709|NCT00260013|chronic mental illness|chronic mental illness
5347710|NCT00260000|mild PKU|mild pku
5347711|NCT00260000|Y414C|y414c
5347712|NCT00260000|5,6,7,8-tetrahydrobiopterin, BH4|5,6,7,8-tetrahydrobiopterin, bh4
5347713|NCT00260000|treatment without protein restriction|treatment without protein restriction
5347714|NCT00259987|relapsed adenocarcinoma|relapsed adenocarcinoma
5347715|NCT00259987|esophagus|esophagus
5347716|NCT00259987|tumors|tumors
5347717|NCT00259987|GE junction|ge junction
5347718|NCT00259987|cancer|cancer
5347719|NCT00259987|lapatinib|lapatinib
5347720|NCT00259987|gastric cardia|gastric cardia
5347721|NCT00259974|Anti-MAG monoclonal gammopathy|anti-mag monoclonal gammopathy
5347722|NCT00259974|Polyneuropathy|polyneuropathy
5347723|NCT00259974|Rituximab|rituximab
5347724|NCT00259948|HR variability, CVA, Myocardial infarction, aerobic exercise training|hr variability, cva, myocardial infarction, aerobic exercise training
5347725|NCT00259935|Any Solid Tumor|any solid tumor
5347726|NCT00259922|constipation|constipation
5347727|NCT00259922|gastrointestinal|gastrointestinal
5347728|NCT00259922|opioids|opioids
5347729|NCT00259922|pain|pain
5347730|NCT00259922|non-cancer pain|non-cancer pain
5347731|NCT00259922|opioid-induced|opioid-induced
5347732|NCT00259922|bowel dysfunction|bowel dysfunction
5347733|NCT00259909|Patient reported outcomes|patient reported outcomes
5347734|NCT00259909|COPD|copd
5347735|NCT00259909|acute exacerbation of chronic obstructive pulmonary disease (AECOPD)|acute exacerbation of chronic obstructive pulmonary disease (aecopd)
5347736|NCT00259896|exenatide|exenatide
5347737|NCT00259896|pharmacokinetics|pharmacokinetics
5347738|NCT00259896|pharmacodynamics|pharmacodynamics
5347739|NCT00259883|depressive episodes|depressive episodes
5347740|NCT00259883|paroxetine|paroxetine
5347741|NCT00259883|PAXIL|paxil
5347742|NCT00259883|depression|depression
5347743|NCT00259883|benzodiazepine|benzodiazepine
5347744|NCT00259883|combination|combination
5347745|NCT00259870|Schizophrenia|schizophrenia
5347746|NCT00259870|PANSS|panss
5347747|NCT00259870|Acute|acute
5347748|NCT00259870|Cognition|cognition
5347749|NCT00259857|Fracture|fracture
5347750|NCT00259857|Bone Mineral Density|bone mineral density
5347751|NCT00259857|DXA|dxa
5347752|NCT00259844|Colorectal|colorectal
5347753|NCT00259844|Liver Metastases|liver metastases
5347754|NCT00259844|Vaccine|vaccine
5347755|NCT00259844|Colorectal Liver Metastases|colorectal liver metastases
5347756|NCT00259831|cold|cold
5347757|NCT00259831|influenza|influenza
5347758|NCT00259818|Refractory|refractory
5347759|NCT00259818|Solid Tumors|solid tumors
5347760|NCT00259805|encephalitis|encephalitis
5347761|NCT00259805|epilepsy|epilepsy
5347762|NCT00259805|Rasmussens|rasmussens
5347763|NCT00259805|rituximab|rituximab
5347764|NCT00259805|autoimmune|autoimmune
5347765|NCT00259779|COPD|copd
5347766|NCT00259753|Wet Age-Related Macular Degeneration|wet age-related macular degeneration
5347767|NCT00259740|Multiple Myeloma, Relapsed, Plateau-Phase|multiple myeloma, relapsed, plateau-phase
5347768|NCT00259727|Amprenavir|amprenavir
5347769|NCT00259727|Glucagon|glucagon
5347770|NCT00259727|HIV Protease inhibitors|hiv protease inhibitors
5347771|NCT00259727|Indinavir|indinavir
5347772|NCT00259727|Lopinavir|lopinavir
5347773|NCT00259727|Ritonavir|ritonavir
5347774|NCT00259714|hypertension|hypertension
5347775|NCT00259714|hemodialysis|hemodialysis
5347776|NCT00259714|sodium|sodium
5347777|NCT00259714|dialysate|dialysate
5347778|NCT00259714|hemodynamics|hemodynamics
5347779|NCT00259701|endothelium|endothelium
5347780|NCT00259701|iontophoresis|iontophoresis
5347781|NCT00259701|acetylcholine|acetylcholine
5347782|NCT00259701|nitroglycerin|nitroglycerin
5347783|NCT00259701|vasodilation|vasodilation
5347784|NCT00259688|Preeclampsia|preeclampsia
5347785|NCT00259688|Sleep Apnea|sleep apnea
5347786|NCT00259688|CPAP|cpap
5347787|NCT00259662|cancer--ovarian|cancer--ovarian
5347788|NCT00259662|cancer--endometria|cancer--endometria
5347789|NCT00259662|deep vein thrombosis|deep vein thrombosis
5347790|NCT00259662|statin therapy in perioperative period|statin therapy in perioperative period
5347791|NCT00259623|Cardiac surgery|cardiac surgery
5347792|NCT00259623|Radiofrequency ablation|radiofrequency ablation
5347793|NCT00259623|Atrial fibrillation|atrial fibrillation
5347794|NCT00259610|RA|ra
5347795|NCT00259610|painful joints|painful joints
5347796|NCT00259610|swollen joints|swollen joints
5347797|NCT00259597|nuclear morphology|nuclear morphology
5347798|NCT00259597|image analysis|image analysis
5347799|NCT00259597|lipid peroxidation|lipid peroxidation
5347800|NCT00259597|diet|diet
5347801|NCT00259597|proliferative breast disease|proliferative breast disease
5347802|NCT00259571|remission|remission
5347803|NCT00259571|mesalazin|mesalazin
5347804|NCT00259571|non-inferiority study|non-inferiority study
5347805|NCT00259571|relapse|relapse
5347806|NCT00259558|Ulcerative Colitis|ulcerative colitis
5347807|NCT00259558|Dose Finding|dose finding
5347808|NCT00259558|Phosphatidylcholine|phosphatidylcholine
5347809|NCT00259545|retarded phosphatidylcholine|retarded phosphatidylcholine
5347810|NCT00259545|chronic active|chronic active
5347811|NCT00259545|steroid|steroid
5347812|NCT00259519|premature or preterm birth|premature or preterm birth
5347813|NCT00259519|chorioamnionitis|chorioamnionitis
5347814|NCT00259519|neonatal sepsis|neonatal sepsis
5347815|NCT00259519|labour|labour
5347816|NCT00259519|Cesarean Section|cesarean section
5347817|NCT00259519|delivery|delivery
5347818|NCT00259519|length of stay|length of stay
5347819|NCT00259519|pregnancy|pregnancy
5347820|NCT00259506|Recurrent depression|recurrent depression
5347821|NCT00259506|Mental Health|mental health
5347822|NCT00259493|Coronary Artery Disease|coronary artery disease
5347823|NCT00259493|Coronary Artery Bypass Graft Surgery|coronary artery bypass graft surgery
5347824|NCT00259493|Off-pump CABG|off-pump cabg
5347825|NCT00259493|Cardiac CT|cardiac ct
5347826|NCT00259493|Bypass Graft CT angiography|bypass graft ct angiography
5347827|NCT00259467|Activity, Dementia, Caregiving|activity, dementia, caregiving
5347828|NCT00259454|Caregivers|caregivers
5347829|NCT00259454|in-home care occupational therapy|in-home care occupational therapy
5347830|NCT00259441|Kidney failure|kidney failure
5347831|NCT00259441|Contrast media|contrast media
5347832|NCT00259441|Prevention|prevention
5347833|NCT00259441|Simvastatin|simvastatin
5347834|NCT00259428|Atrial Fibrillation|atrial fibrillation
5347835|NCT00259428|Atrial Flutter|atrial flutter
5347836|NCT00259428|Arrhythmia|arrhythmia
5347837|NCT00259428|Anti-Arrhythmia agents|anti-arrhythmia agents
5347838|NCT00259415|Support groups|support groups
5347839|NCT00259415|Alzheimer's Disease|alzheimer's disease
5347840|NCT00259389|Treatment Experienced|treatment experienced
5347841|NCT00259389|Adherence|adherence
5347842|NCT00259389|Compliance|compliance
5347843|NCT00259389|Directly Observed Therapy|directly observed therapy
5347844|NCT00259389|DOT|dot
5347845|NCT00259389|Treatment Naive|treatment naive
5347846|NCT00259376|Atrial Fibrillation|atrial fibrillation
5347847|NCT00259376|Atrial Flutter|atrial flutter
5347848|NCT00259376|Arrhythmia|arrhythmia
5347849|NCT00259376|Anti-Arrhythmia agents|anti-arrhythmia agents
5347850|NCT00259350|Central venous catheter|central venous catheter
5347851|NCT00259350|Skin disinfection|skin disinfection
5347852|NCT00259350|Antisepsis|antisepsis
5347853|NCT00259350|Nosocomial infection|nosocomial infection
5347854|NCT00259350|Catheter infection|catheter infection
5347855|NCT00259337|Diphteria|diphteria
5347856|NCT00259337|Tetanus|tetanus
5347857|NCT00259337|Polio|polio
5347858|NCT00259337|Acellular Pertussis|acellular pertussis
5347859|NCT00259337|Hib|hib
5347860|NCT00259337|Haemophilus influenzae type B|haemophilus influenzae type b
5347861|NCT00259259|Appetite regulation|appetite regulation
5347862|NCT00259259|Hormones|hormones
5347863|NCT00259259|Energy intake|energy intake
5347864|NCT00259220|Bleeding|bleeding
5347865|NCT00259220|Endoscopy|endoscopy
5347866|NCT00259220|Gastric tube|gastric tube
5347867|NCT00259220|Erythromycin|erythromycin
5347868|NCT00259220|Randomized|randomized
5347869|NCT00259207|Pulmonary valve regurgitation|pulmonary valve regurgitation
5347870|NCT00259207|Valve replacement|valve replacement
5347871|NCT00259207|Hybrid procedure|hybrid procedure
5347872|NCT00259194|Coronary angiography|coronary angiography
5347873|NCT00259194|Complications|complications
5347874|NCT00259194|Observation|observation
5347875|NCT00259181|chlorhexidine gluconate|chlorhexidine gluconate
5347876|NCT00259181|polymethylmethacrylate|polymethylmethacrylate
5347877|NCT00259181|Anti-Bacterial Agents|anti-bacterial agents
5347878|NCT00259168|Postprandial endothelial function|postprandial endothelial function
5347879|NCT00259155|Irritable bowel syndrome, Bacterial overgrowth|irritable bowel syndrome, bacterial overgrowth
5347880|NCT00259142|home management of fever, malaria, Uganda|home management of fever, malaria, uganda
5347881|NCT00259116|Congestive heart failure|congestive heart failure
5347882|NCT00259116|Relaxin|relaxin
5347883|NCT00259116|Cardiac hemodynamics|cardiac hemodynamics
5347884|NCT00259103|relaxin|relaxin
5347885|NCT00259103|pregnancy|pregnancy
5347886|NCT00259103|cervical ripening|cervical ripening
5347887|NCT00259103|normal pregnancy at least at 40 weeks of gestation|normal pregnancy at least at 40 weeks of gestation
5347888|NCT00259038|Carperitide|carperitide
5347889|NCT00259038|Atrial Natriuretic Peptide|atrial natriuretic peptide
5347890|NCT00259038|Treatment efficacy|treatment efficacy
5347891|NCT00259038|Safety|safety
5347892|NCT00259038|Heart failure, Congestive|heart failure, congestive
5347893|NCT00259038|Pulmonary Artery Catheterization|pulmonary artery catheterization
5347894|NCT00259025|Renal failure, chronic|renal failure, chronic
5347895|NCT00259025|Death, sudden, cardiac|death, sudden, cardiac
5347896|NCT00259025|Heart rate variability|heart rate variability
5347897|NCT00259025|Tachycardia, ventricular|tachycardia, ventricular
5347898|NCT00259025|Ventricular premature complexes|ventricular premature complexes
5347899|NCT00259025|Ventricular repolarization|ventricular repolarization
5347900|NCT00259025|Eicosapentaenoic acid|eicosapentaenoic acid
5347901|NCT00259025|Docosahexaenoic acid|docosahexaenoic acid
5347902|NCT00259012|GERD|gerd
5347903|NCT00259012|Infant|infant
5347904|NCT00258999|Skin Cholesterol|skin cholesterol
5347905|NCT00258999|Carotid Plaque|carotid plaque
5347906|NCT00258999|Carotid Intima-Media Thickness|carotid intima-media thickness
5347907|NCT00258986|Living donors|living donors
5347908|NCT00258986|Nephrectomy|nephrectomy
5347909|NCT00258986|Kidney transplantation|kidney transplantation
5347910|NCT00258986|Randomized Controlled Trial|randomized controlled trial
5347911|NCT00258986|Laparoscopy|laparoscopy
5347912|NCT00258973|Hand held Ultrasound|hand held ultrasound
5347913|NCT00258973|Office practice|office practice
5347914|NCT00258973|Atherosclerosis prevention|atherosclerosis prevention
5347915|NCT00258973|Ultrasound training|ultrasound training
5347916|NCT00258960|HER2 positive breast cancer|her2 positive breast cancer
5347917|NCT00258960|Metastatic breast cancer|metastatic breast cancer
5347918|NCT00258947|Smallpox|smallpox
5347919|NCT00258947|Orthopoxvirus|orthopoxvirus
5347920|NCT00258947|Poxvirus|poxvirus
5347921|NCT00258947|Vaccina Virus|vaccina virus
5347922|NCT00258947|LISTER Strain|lister strain
5347923|NCT00258947|Bioterrorism|bioterrorism
5347924|NCT00258934|Influenza|influenza
5347925|NCT00258934|Orthomyxoviruses|orthomyxoviruses
5347926|NCT00258934|Inactivated|inactivated
5347927|NCT00258934|Split-virion influenza vaccine|split-virion influenza vaccine
5347928|NCT00258934|adults|adults
5347929|NCT00258934|Myxovirus Infection|myxovirus infection
5347930|NCT00258934|Orthomyxovirus Infection|orthomyxovirus infection
5347931|NCT00258908|ADACEL™|adacel™
5347932|NCT00258908|Tetanus|tetanus
5347933|NCT00258908|Diphteria|diphteria
5347934|NCT00258908|Acellular pertussis|acellular pertussis
5347935|NCT00258895|DAPTACEL®|daptacel®
5347936|NCT00258895|Pentacel™|pentacel™
5347937|NCT00258895|Diphtheria|diphtheria
5347938|NCT00258895|Tetanus|tetanus
5347939|NCT00258895|Pertussis|pertussis
5347940|NCT00258895|Whooping cough|whooping cough
5347941|NCT00258895|Acellular Pertussis Vaccine Adsorbed|acellular pertussis vaccine adsorbed
5347942|NCT00258882|Tetanus Toxoid,|tetanus toxoid,
5347943|NCT00258882|acellular pertussis,|acellular pertussis,
5347944|NCT00258882|diphtheria toxoid|diphtheria toxoid
5347945|NCT00258869|prospective studies|prospective studies
5347946|NCT00258869|biological assay|biological assay
5347947|NCT00258869|body weights and measures|body weights and measures
5347948|NCT00258869|chemistry, analytical|chemistry, analytical
5347949|NCT00258869|microchip analytical procedures|microchip analytical procedures
5347950|NCT00258869|spectrum analysis, mass|spectrum analysis, mass
5347951|NCT00258869|molecular diagnostic techniques|molecular diagnostic techniques
5347952|NCT00258869|microbiological techniques|microbiological techniques
5347953|NCT00258869|drug administration schedule|drug administration schedule
5347954|NCT00258869|data collection|data collection
5347955|NCT00258869|statistics|statistics
5347956|NCT00258869|gene expression profiling|gene expression profiling
5347957|NCT00258869|sequence analysis|sequence analysis
5347958|NCT00258869|human experimentation|human experimentation
5347959|NCT00258869|immunoassay|immunoassay
5347960|NCT00258869|Trauma severity indices|trauma severity indices
5347961|NCT00258869|Glasgow Coma score|glasgow coma score
5347962|NCT00258869|Outcome assessment|outcome assessment
5347963|NCT00258869|mortality|mortality
5347964|NCT00258869|computer models|computer models
5347965|NCT00258869|decision modeling|decision modeling
5347966|NCT00258869|linear models|linear models
5347967|NCT00258869|logistic models|logistic models
5347968|NCT00258869|immunologic model|immunologic model
5347969|NCT00258869|mathematical model|mathematical model
5347970|NCT00258869|non-linear models|non-linear models
5347971|NCT00258869|early diagnosis|early diagnosis
5347972|NCT00258869|diagnosis, computer assisted|diagnosis, computer assisted
5347973|NCT00258869|medical informatics|medical informatics
5347974|NCT00258869|prognosis|prognosis
5347975|NCT00258869|registries|registries
5347976|NCT00258869|computational biology|computational biology
5347977|NCT00258869|systems biology|systems biology
5347978|NCT00258856|Meningitis|meningitis
5347979|NCT00258856|Meningococcal infection|meningococcal infection
5347980|NCT00258856|Neisseria meningitidis|neisseria meningitidis
5347981|NCT00258856|Menactra®|menactra®
5347982|NCT00258856|Menomune®|menomune®
5347983|NCT00258843|IMOVAX;|imovax;
5347984|NCT00258843|poliomyelitis|poliomyelitis
5347985|NCT00258830|Influenza vaccine|influenza vaccine
5347986|NCT00258817|Fluzone®|fluzone®
5347987|NCT00258817|Influenza Virus Vaccine|influenza virus vaccine
5347988|NCT00258791|Psychiatric disorders|psychiatric disorders
5347989|NCT00258791|ECT|ect
5347990|NCT00258791|Headache|headache
5347991|NCT00258791|Ibuprofen|ibuprofen
5347992|NCT00258765|zoledronic acid|zoledronic acid
5347993|NCT00258765|prostate cancer|prostate cancer
5347994|NCT00258765|high risk|high risk
5347995|NCT00258765|PSA|psa
5347996|NCT00258765|docetaxel|docetaxel
5347997|NCT00258752|Prevention|prevention
5347998|NCT00258752|Adolescent|adolescent
5347999|NCT00258726|Measels, Mumps, Varicella, Rubella, vaccine, children|measels, mumps, varicella, rubella, vaccine, children
5348000|NCT00258713|Randomized Controlled Trials|randomized controlled trials
5348001|NCT00258713|Immunosuppression|immunosuppression
5348002|NCT00258713|Adult|adult
5348003|NCT00258713|Chronic Disease|chronic disease
5348004|NCT00258713|Dermatologic Agents|dermatologic agents
5348005|NCT00258713|Female|female
5348006|NCT00258713|Humans|humans
5348007|NCT00258713|Male|male
5348008|NCT00258713|Middle Aged|middle aged
5348009|NCT00258713|Severity of Illness Index|severity of illness index
5348010|NCT00258713|Treatment Outcome|treatment outcome
5348011|NCT00258713|Quality of Life|quality of life
5348012|NCT00258713|Double-Blind Method|double-blind method
5348013|NCT00258687|GVAX|gvax
5348014|NCT00258687|GM-CSF|gm-csf
5348015|NCT00258687|Adenoviral mediated gene transfer|adenoviral mediated gene transfer
5348016|NCT00258687|Pediatric Melanoma|pediatric melanoma
5348017|NCT00258674|Diabetes|diabetes
5348018|NCT00258674|Care coordination|care coordination
5348019|NCT00258674|Case management|case management
5348020|NCT00258674|Physician profiling|physician profiling
5348021|NCT00258661|Pneumonia|pneumonia
5348022|NCT00258661|Osteopathic|osteopathic
5348023|NCT00258661|Manipulation|manipulation
5348024|NCT00258661|Multi-center|multi-center
5348025|NCT00258661|Elderly|elderly
5348026|NCT00258635|Allergy|allergy
5348027|NCT00258635|Specific Immunotherapy|specific immunotherapy
5348028|NCT00258622|Peripheral neuropathic pain|peripheral neuropathic pain
5348029|NCT00258622|Neuropathic pain|neuropathic pain
5348030|NCT00258622|Chronic pain|chronic pain
5348031|NCT00258609|Botulinum toxin type A,|botulinum toxin type a,
5348032|NCT00258609|Dysport®,Dysport|dysport®,dysport
5348033|NCT00258609|Migraine without aura,|migraine without aura,
5348034|NCT00258609|Migraine prophylaxis.|migraine prophylaxis.
5348035|NCT00258596|drug-eluting stent|drug-eluting stent
5348036|NCT00258596|chronic total occlusion|chronic total occlusion
5348037|NCT00258596|sirolimus-eluting stent|sirolimus-eluting stent
5348038|NCT00258596|zotarolimus-eluting stent|zotarolimus-eluting stent
5348039|NCT00258596|QCA|qca
5348040|NCT00258583|"Lung[A04.400]"|"lung[a04.400]"
5348041|NCT00258570|"Lung[A04.400]"|"lung[a04.400]"
5348042|NCT00258557|HIV|hiv
5348043|NCT00258557|Anti-Retroviral agents|anti-retroviral agents
5348044|NCT00258557|HIV-1|hiv-1
5348045|NCT00258557|TMC114/r|tmc114/r
5348046|NCT00258557|Treatment naïve patients|treatment naïve patients
5348047|NCT00258544|Lung|lung
5348048|NCT00258544|Fibrosis|fibrosis
5348049|NCT00258544|Idiopathic|idiopathic
5348050|NCT00258544|Microarray|microarray
5348051|NCT00258544|Tissue|tissue
5348052|NCT00258544|Biopsy|biopsy
5348053|NCT00258518|Critically ill patients|critically ill patients
5348054|NCT00258505|Spreading depression|spreading depression
5348055|NCT00258505|Seizures|seizures
5348056|NCT00258505|Blood-brain barrier|blood-brain barrier
5348057|NCT00258492|Restless legs syndrome|restless legs syndrome
5348058|NCT00258492|Insomnia|insomnia
5348059|NCT00258492|Daytime sleepiness|daytime sleepiness
5348060|NCT00258492|Exercise|exercise
5348061|NCT00258479|Nicotine Dependence|nicotine dependence
5348062|NCT00258479|Nicotine Use Disorder|nicotine use disorder
5348063|NCT00258479|Tobacco Dependence|tobacco dependence
5348064|NCT00258466|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5348065|NCT00258466|stage I prostate cancer|stage i prostate cancer
5348066|NCT00258466|stage II prostate cancer|stage ii prostate cancer
5348067|NCT00258466|stage III prostate cancer|stage iii prostate cancer
5348068|NCT00258453|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
5348069|NCT00258453|long-term effects secondary to cancer therapy in children|long-term effects secondary to cancer therapy in children
5348070|NCT00258453|perioperative/postoperative complications|perioperative/postoperative complications
5348071|NCT00258453|weight changes|weight changes
5348072|NCT00258453|childhood craniopharyngioma|childhood craniopharyngioma
5348073|NCT00258440|fatigue|fatigue
5348074|NCT00258440|anemia|anemia
5348075|NCT00258440|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5348076|NCT00258427|Fanconi anemia|fanconi anemia
5348077|NCT00258401|diarrhea|diarrhea
5348078|NCT00258401|radiation toxicity|radiation toxicity
5348079|NCT00258401|recurrent uterine sarcoma|recurrent uterine sarcoma
5348080|NCT00258401|stage I uterine sarcoma|stage i uterine sarcoma
5348081|NCT00258401|stage II uterine sarcoma|stage ii uterine sarcoma
5348082|NCT00258401|stage III uterine sarcoma|stage iii uterine sarcoma
5348083|NCT00258401|stage IV uterine sarcoma|stage iv uterine sarcoma
5348084|NCT00258401|recurrent prostate cancer|recurrent prostate cancer
5348085|NCT00258401|stage I prostate cancer|stage i prostate cancer
5348086|NCT00258401|stage II prostate cancer|stage ii prostate cancer
5348087|NCT00258401|stage III prostate cancer|stage iii prostate cancer
5348088|NCT00258401|stage IV prostate cancer|stage iv prostate cancer
5348089|NCT00258401|recurrent cervical cancer|recurrent cervical cancer
5348090|NCT00258401|stage 0 cervical cancer|stage 0 cervical cancer
5348091|NCT00258401|stage IA cervical cancer|stage ia cervical cancer
5348092|NCT00258401|stage IB cervical cancer|stage ib cervical cancer
5348093|NCT00258401|stage IIA cervical cancer|stage iia cervical cancer
5348094|NCT00258401|stage IIB cervical cancer|stage iib cervical cancer
5348095|NCT00258401|stage III cervical cancer|stage iii cervical cancer
5348096|NCT00258401|stage IVA cervical cancer|stage iva cervical cancer
5348097|NCT00258401|stage IVB cervical cancer|stage ivb cervical cancer
5348098|NCT00258388|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5348099|NCT00258388|recurrent prostate cancer|recurrent prostate cancer
5348100|NCT00258388|stage IV prostate cancer|stage iv prostate cancer
5348101|NCT00258375|stage IIIA breast cancer|stage iiia breast cancer
5348102|NCT00258375|stage IIIB breast cancer|stage iiib breast cancer
5348103|NCT00258375|stage IIIC breast cancer|stage iiic breast cancer
5348104|NCT00258375|stage IV breast cancer|stage iv breast cancer
5348105|NCT00258375|recurrent breast cancer|recurrent breast cancer
5348106|NCT00258362|recurrent endometrial carcinoma|recurrent endometrial carcinoma
5348107|NCT00258362|stage III endometrial carcinoma|stage iii endometrial carcinoma
5348108|NCT00258362|stage IV endometrial carcinoma|stage iv endometrial carcinoma
5348109|NCT00258336|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5348110|NCT00258336|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5348111|NCT00258336|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5348112|NCT00258336|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5348113|NCT00258336|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5348114|NCT00258336|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5348115|NCT00258336|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
5348116|NCT00258336|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
5348117|NCT00258336|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5348118|NCT00258336|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5348119|NCT00258336|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
5348120|NCT00258336|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
5348121|NCT00258323|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
5348122|NCT00258323|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
5348123|NCT00258323|stage II esophageal cancer|stage ii esophageal cancer
5348124|NCT00258323|stage III esophageal cancer|stage iii esophageal cancer
5348125|NCT00258323|stage IV esophageal cancer|stage iv esophageal cancer
5348126|NCT00258310|stage I squamous cell carcinoma of the hypopharynx|stage i squamous cell carcinoma of the hypopharynx
5348127|NCT00258310|stage I squamous cell carcinoma of the larynx|stage i squamous cell carcinoma of the larynx
5348128|NCT00258310|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
5348129|NCT00258310|stage I squamous cell carcinoma of the nasopharynx|stage i squamous cell carcinoma of the nasopharynx
5348130|NCT00258310|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
5348131|NCT00258310|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
5348132|NCT00258310|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
5348133|NCT00258310|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
5348134|NCT00258310|stage II squamous cell carcinoma of the nasopharynx|stage ii squamous cell carcinoma of the nasopharynx
5348135|NCT00258310|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
5348136|NCT00258310|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
5348137|NCT00258310|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
5348138|NCT00258310|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
5348139|NCT00258310|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
5348140|NCT00258310|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
5348141|NCT00258310|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5348142|NCT00258310|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5348143|NCT00258310|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5348144|NCT00258310|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
5348145|NCT00258310|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5348146|NCT00258297|stage I esophageal cancer|stage i esophageal cancer
5348147|NCT00258297|stage II esophageal cancer|stage ii esophageal cancer
5348148|NCT00258297|stage III esophageal cancer|stage iii esophageal cancer
5348149|NCT00258297|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
5348150|NCT00258297|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
5348151|NCT00258284|recurrent prostate cancer|recurrent prostate cancer
5348152|NCT00258284|stage IV prostate cancer|stage iv prostate cancer
5348153|NCT00258284|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5348154|NCT00258271|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5348155|NCT00258271|adult acute basophilic leukemia|adult acute basophilic leukemia
5348156|NCT00258271|adult acute eosinophilic leukemia|adult acute eosinophilic leukemia
5348157|NCT00258271|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
5348158|NCT00258271|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
5348159|NCT00258271|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
5348160|NCT00258271|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
5348161|NCT00258271|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
5348162|NCT00258271|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
5348163|NCT00258271|adult erythroleukemia (M6a)|adult erythroleukemia (m6a)
5348164|NCT00258271|adult pure erythroid leukemia (M6b)|adult pure erythroid leukemia (m6b)
5348165|NCT00258271|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5348166|NCT00258271|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5348167|NCT00258258|refractory multiple myeloma|refractory multiple myeloma
5348168|NCT00258245|stage II multiple myeloma|stage ii multiple myeloma
5348169|NCT00258245|stage III multiple myeloma|stage iii multiple myeloma
5348170|NCT00258245|refractory multiple myeloma|refractory multiple myeloma
5348171|NCT00258245|stage I multiple myeloma|stage i multiple myeloma
5348172|NCT00258232|adenocarcinoma of the colon|adenocarcinoma of the colon
5348173|NCT00258232|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5348174|NCT00258232|recurrent colon cancer|recurrent colon cancer
5348175|NCT00258232|recurrent rectal cancer|recurrent rectal cancer
5348176|NCT00258232|stage IV colon cancer|stage iv colon cancer
5348177|NCT00258232|stage IV rectal cancer|stage iv rectal cancer
5348178|NCT00258206|stage I multiple myeloma|stage i multiple myeloma
5348179|NCT00258206|stage II multiple myeloma|stage ii multiple myeloma
5348180|NCT00258206|stage III multiple myeloma|stage iii multiple myeloma
5348181|NCT00258206|refractory multiple myeloma|refractory multiple myeloma
5348182|NCT00258193|C-IBS|c-ibs
5348183|NCT00258193|IBS-C|ibs-c
5348184|NCT00258193|Constipation-predominant Irritable Bowel Syndrome|constipation-predominant irritable bowel syndrome
5348185|NCT00258193|Constipation Predominant Irritable Bowel Syndrome|constipation predominant irritable bowel syndrome
5348186|NCT00258193|Irritable Bowel Syndrome|irritable bowel syndrome
5348187|NCT00258193|IBS|ibs
5348188|NCT00258193|Transit|transit
5348189|NCT00258193|Scintigraphy|scintigraphy
5348190|NCT00258193|Gastroenterology|gastroenterology
5348191|NCT00258193|Gastrointestinal|gastrointestinal
5348192|NCT00258193|GC|gc
5348193|NCT00258193|MD-1100 Acetate|md-1100 acetate
5348194|NCT00258193|MD-1100|md-1100
5348195|NCT00258193|linaclotide|linaclotide
5348196|NCT00258193|linaclotide acetate|linaclotide acetate
5348197|NCT00258180|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
5348198|NCT00258180|gastrointestinal complications|gastrointestinal complications
5348199|NCT00258180|diarrhea|diarrhea
5348200|NCT00258167|Family members|family members
5348201|NCT00258167|Illness burden|illness burden
5348202|NCT00258167|Mental Disorders|mental disorders
5348203|NCT00258167|Family intervention|family intervention
5348204|NCT00258115|Obesity|obesity
5348205|NCT00258115|Metabolic Syndrome|metabolic syndrome
5348206|NCT00258115|Diabetes|diabetes
5348207|NCT00258115|Inflammation|inflammation
5348208|NCT00258102|levofloxacin|levofloxacin
5348209|NCT00258102|urinary tract infections|urinary tract infections
5348210|NCT00258102|bacterial infections|bacterial infections
5348211|NCT00258102|bacteriuria|bacteriuria
5348212|NCT00258102|urinary anti-infective agents|urinary anti-infective agents
5348213|NCT00258102|urinary infections|urinary infections
5348214|NCT00258102|quinolones|quinolones
5348215|NCT00258089|levofloxacin|levofloxacin
5348216|NCT00258089|urinary tract infections|urinary tract infections
5348217|NCT00258089|bacterial infections|bacterial infections
5348218|NCT00258089|bacteriuria|bacteriuria
5348219|NCT00258089|urinary anti-infective agents|urinary anti-infective agents
5348220|NCT00258089|urinary infections|urinary infections
5348221|NCT00258089|quinolones|quinolones
5348222|NCT00258076|Transdermal contraception|transdermal contraception
5348223|NCT00258076|contraceptive|contraceptive
5348224|NCT00258076|hormonal, steroid contraception|hormonal, steroid contraception
5348225|NCT00258076|ethinyl estradiol|ethinyl estradiol
5348226|NCT00258076|progesterone|progesterone
5348227|NCT00258076|EVRA|evra
5348228|NCT00258063|Transdermal contraception|transdermal contraception
5348229|NCT00258063|contraceptive|contraceptive
5348230|NCT00258063|hormonal, steroid contraception|hormonal, steroid contraception
5348231|NCT00258063|ethinyl estradiol|ethinyl estradiol
5348232|NCT00258063|progesterone|progesterone
5348233|NCT00258063|EVRA|evra
5348234|NCT00258063|CILEST|cilest
5348235|NCT00258063|ORTHO EVRA|ortho evra
5348236|NCT00258050|midazolam|midazolam
5348237|NCT00258050|pharmacokinetics|pharmacokinetics
5348238|NCT00258050|lapatinib|lapatinib
5348239|NCT00258037|Physiotherapy|physiotherapy
5348240|NCT00258037|Stroke|stroke
5348241|NCT00258037|Urinary Incontinence|urinary incontinence
5348242|NCT00258037|quality of Life|quality of life
5348243|NCT00258024|IPT-SP, pregnancy, malaria,Ghana|ipt-sp, pregnancy, malaria,ghana
5348244|NCT00258011|MPS I Disease|mps i disease
5348245|NCT00257985|Familial hemiplegic migraine type 1 and 2|familial hemiplegic migraine type 1 and 2
5348246|NCT00257985|GTN|gtn
5348247|NCT00257985|middle cerebral artery|middle cerebral artery
5348248|NCT00257985|superficial temporal artery|superficial temporal artery
5348249|NCT00257985|headache|headache
5348250|NCT00257985|genotype|genotype
5348251|NCT00257972|Bipolar Mania|bipolar mania
5348252|NCT00257946|Diaphragm|diaphragm
5348253|NCT00257946|Hernia|hernia
5348254|NCT00257946|Congenital|congenital
5348255|NCT00257933|Corticosteroids|corticosteroids
5348256|NCT00257933|Treatment|treatment
5348257|NCT00257933|Pediatric|pediatric
5348258|NCT00257920|Stage 5 Chronic Kidney Disease (CKD)|stage 5 chronic kidney disease (ckd)
5348259|NCT00257907|Latent Tuberculosis|latent tuberculosis
5348260|NCT00257907|PPD|ppd
5348261|NCT00257907|Antigen Specific T-Cells|antigen specific t-cells
5348262|NCT00257907|Lymphocyte Proliferation Assay|lymphocyte proliferation assay
5348263|NCT00257907|HIV|hiv
5348264|NCT00257907|LPA|lpa
5348265|NCT00257894|Baclofen|baclofen
5348266|NCT00257894|Conditioning, Classical|conditioning, classical
5348267|NCT00257894|Nicotine|nicotine
5348268|NCT00257894|Smoking|smoking
5348269|NCT00257881|Tumor|tumor
5348270|NCT00257855|Secondary Progressive Multiple Sclerosis|secondary progressive multiple sclerosis
5348271|NCT00257855|Neuroprotection|neuroprotection
5348272|NCT00257855|Axonal loss|axonal loss
5348273|NCT00257855|Brain atrophy|brain atrophy
5348274|NCT00257855|MRI|mri
5348275|NCT00257855|Lamotrigine|lamotrigine
5348276|NCT00257855|Sodium Channel Blockers|sodium channel blockers
5348277|NCT00257829|Cervical Cancer|cervical cancer
5348278|NCT00257816|Cervical Cancer|cervical cancer
5348279|NCT00257816|Topotecan|topotecan
5348280|NCT00257816|Cisplatin|cisplatin
5348281|NCT00257803|Oxytocin, bolus, postpartum hemorrhage|oxytocin, bolus, postpartum hemorrhage
5348282|NCT00257790|Fever|fever
5348283|NCT00257790|Neutropenia|neutropenia
5348284|NCT00257790|Tobramycin|tobramycin
5348285|NCT00257790|Aminoglycoside|aminoglycoside
5348286|NCT00257790|Penicillin|penicillin
5348287|NCT00257764|Swallowing disorder|swallowing disorder
5348288|NCT00257764|Stroke|stroke
5348289|NCT00257764|Standardized swallowing therapy|standardized swallowing therapy
5348290|NCT00257764|Randomized controlled trial|randomized controlled trial
5348291|NCT00257725|ADHD|adhd
5348292|NCT00257725|Attention-deficit/hyperactivity disorder (ADHD)|attention-deficit/hyperactivity disorder (adhd)
5348293|NCT00257712|Alzheimer's disease|alzheimer's disease
5348294|NCT00257712|cognition disorders|cognition disorders
5348295|NCT00257699|Crohn's Disease|crohn's disease
5348296|NCT00257699|Randomized|randomized
5348297|NCT00257699|Ciprofloxacin|ciprofloxacin
5348298|NCT00257699|Metronidazole|metronidazole
5348299|NCT00257699|Antibiotic|antibiotic
5348300|NCT00257686|Kowa|kowa
5348301|NCT00257686|Hypercholesterolemia|hypercholesterolemia
5348302|NCT00257686|combined|combined
5348303|NCT00257686|dyslipidemia|dyslipidemia
5348304|NCT00257686|elderly|elderly
5348305|NCT00257686|pitavastatin|pitavastatin
5348306|NCT00257686|NK-104|nk-104
5348307|NCT00257673|Cognition|cognition
5348308|NCT00257673|Alzheimer's|alzheimer's
5348309|NCT00257673|Cognitive impairment|cognitive impairment
5348310|NCT00257634|lateral epicondylitis|lateral epicondylitis
5348311|NCT00257634|iontophoresis|iontophoresis
5348312|NCT00257634|dexamethasone|dexamethasone
5348313|NCT00257621|HIV-1 protease inhibitor GW640385 ritonavir RTV|hiv-1 protease inhibitor gw640385 ritonavir rtv
5348314|NCT00257608|NSCLC|nsclc
5348315|NCT00257608|Lung Cancer|lung cancer
5348316|NCT00257608|ATLAS|atlas
5348317|NCT00257608|Avastin|avastin
5348318|NCT00257608|Tarceva|tarceva
5348518|NCT00256685|Menopause|menopause
5348319|NCT00257595|Perennial Allergic Rhinitis pediatric|perennial allergic rhinitis pediatric
5348320|NCT00257582|cetirizine|cetirizine
5348321|NCT00257582|various type of cutaneous disease accompanied with Pruritus|various type of cutaneous disease accompanied with pruritus
5348322|NCT00257582|pediatrics|pediatrics
5348323|NCT00257569|Atopic|atopic
5348324|NCT00257569|Pediatric|pediatric
5348325|NCT00257569|Dermatitis|dermatitis
5348326|NCT00257543|sickle cell disease|sickle cell disease
5348327|NCT00257543|bone marrow transplant|bone marrow transplant
5348328|NCT00257517|Congenital heart disease|congenital heart disease
5348329|NCT00257517|Single ventricle|single ventricle
5348330|NCT00257517|Infant feeding|infant feeding
5348331|NCT00257478|Treatment Efficacy|treatment efficacy
5348332|NCT00257478|Treatment Effectiveness|treatment effectiveness
5348333|NCT00257478|Disease Management|disease management
5348334|NCT00257478|Treatment|treatment
5348335|NCT00257478|Safety|safety
5348336|NCT00257465|melanoma|melanoma
5348337|NCT00257465|metastatic|metastatic
5348338|NCT00257465|vaccine|vaccine
5348339|NCT00257465|immunotherapy|immunotherapy
5348340|NCT00257465|autologous|autologous
5348341|NCT00257439|Vitamin B12|vitamin b12
5348342|NCT00257439|Folic Acid|folic acid
5348343|NCT00257426|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
5348344|NCT00257426|advanced adult primary liver cancer|advanced adult primary liver cancer
5348345|NCT00257426|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
5348346|NCT00257426|recurrent adult primary liver cancer|recurrent adult primary liver cancer
5348347|NCT00257400|major depressive disorder|major depressive disorder
5348348|NCT00257400|psychotherapy|psychotherapy
5348349|NCT00257400|childhood sexual abuse|childhood sexual abuse
5348350|NCT00257400|trauma|trauma
5348351|NCT00257387|Kidney|kidney
5348352|NCT00257387|Kidney Transplant|kidney transplant
5348353|NCT00257348|Advanced Cervical Carcinoma|advanced cervical carcinoma
5348354|NCT00257348|Recurrent Cervical Carcinoma|recurrent cervical carcinoma
5348355|NCT00257335|Carcinoma of the head and neck|carcinoma of the head and neck
5348356|NCT00257322|Metastatic colon cancer|metastatic colon cancer
5348357|NCT00257322|Metastatic rectal cancer|metastatic rectal cancer
5348358|NCT00257309|Acute myocardial infarction|acute myocardial infarction
5348359|NCT00257309|Elderly|elderly
5348360|NCT00257309|Thrombolysis|thrombolysis
5348361|NCT00257309|Primary angioplasty|primary angioplasty
5348362|NCT00257309|Randomized trial|randomized trial
5348363|NCT00257309|Efficacy|efficacy
5348364|NCT00257309|Safety|safety
5348365|NCT00257283|Chronic renal failure|chronic renal failure
5348366|NCT00257283|Hemodialysis|hemodialysis
5348367|NCT00257283|OMACOR (omega-3-acid ethyl ester 90)|omacor (omega-3-acid ethyl ester 90)
5348368|NCT00257283|intervention study|intervention study
5348369|NCT00257283|cardiovascular events|cardiovascular events
5348370|NCT00257283|mortality|mortality
5348371|NCT00257270|Chronic|chronic
5348372|NCT00257270|Tinnitus|tinnitus
5348373|NCT00257270|Acoustic trauma|acoustic trauma
5348374|NCT00257270|Psychophysics|psychophysics
5348375|NCT00257270|Loudness match|loudness match
5348376|NCT00257270|gabapentin|gabapentin
5348377|NCT00257257|Type 2 diabetes mellitus|type 2 diabetes mellitus
5348378|NCT00257244|Immunity, innate|immunity, innate
5348379|NCT00257244|Inflammation|inflammation
5348380|NCT00257244|Genomics|genomics
5348381|NCT00257244|Proteomics|proteomics
5348382|NCT00257231|Immunity, innate|immunity, innate
5348383|NCT00257231|Inflammation|inflammation
5348384|NCT00257231|Genomics|genomics
5348385|NCT00257231|Proteomics|proteomics
5348386|NCT00257192|Adolescent Subjects With Schizophrenia|adolescent subjects with schizophrenia
5348387|NCT00257179|Tissue factor|tissue factor
5348388|NCT00257179|Lung cancer|lung cancer
5348389|NCT00257179|Tissue factor protein inhibitor|tissue factor protein inhibitor
5348390|NCT00257179|Factor VII|factor vii
5348391|NCT00257179|Factor X|factor x
5348392|NCT00257153|Acute myocardial infarction|acute myocardial infarction
5348393|NCT00257153|primary angioplasty|primary angioplasty
5348394|NCT00257153|myocardial reperfusion|myocardial reperfusion
5348395|NCT00257153|thrombus aspiration|thrombus aspiration
5348396|NCT00257140|Bronchitis|bronchitis
5348397|NCT00257140|chronic bronchitis|chronic bronchitis
5348398|NCT00257140|lung diseases|lung diseases
5348399|NCT00257140|respiratory tract infections|respiratory tract infections
5348400|NCT00257140|bronchial diseases|bronchial diseases
5348401|NCT00257140|antibacterial agents|antibacterial agents
5348402|NCT00257140|quinolones|quinolones
5348403|NCT00257140|levofloxacin|levofloxacin
5348404|NCT00257127|Vaccination|vaccination
5348405|NCT00257114|Multiple Myeloma|multiple myeloma
5348406|NCT00257114|Retreatment|retreatment
5348407|NCT00257114|VELCADE|velcade
5348408|NCT00257088|development|development
5348409|NCT00257088|epidemiology|epidemiology
5348410|NCT00257088|risk factors|risk factors
5348411|NCT00257088|randomized field trials|randomized field trials
5348412|NCT00257075|risperidone|risperidone
5348413|NCT00257075|antipsychotic agents|antipsychotic agents
5348414|NCT00257075|bipolar disorders|bipolar disorders
5348415|NCT00257075|manic episode|manic episode
5348416|NCT00257062|Infectious skin diseases|infectious skin diseases
5348417|NCT00257062|skin diseases|skin diseases
5348418|NCT00257062|bacterial skin diseases|bacterial skin diseases
5348419|NCT00257062|antibacterial agents|antibacterial agents
5348420|NCT00257062|quinolones|quinolones
5348421|NCT00257062|levofloxacin|levofloxacin
5348422|NCT00257049|Pneumonia|pneumonia
5348423|NCT00257049|lung inflammation|lung inflammation
5348424|NCT00257049|bacterial pneumonia|bacterial pneumonia
5348425|NCT00257049|lung diseases|lung diseases
5348426|NCT00257049|respiratory tract infections|respiratory tract infections
5348427|NCT00257049|antibacterial agents|antibacterial agents
5348428|NCT00257049|quinolones|quinolones
5348429|NCT00257049|levofloxacin|levofloxacin
5348430|NCT00257036|Infectious skin diseases|infectious skin diseases
5348431|NCT00257036|skin diseases|skin diseases
5348432|NCT00257036|bacterial skin diseases|bacterial skin diseases
5348433|NCT00257036|cellulitis|cellulitis
5348434|NCT00257036|quinolones|quinolones
5348435|NCT00257036|levofloxacin|levofloxacin
5348436|NCT00257023|Schizophrenia|schizophrenia
5348437|NCT00257023|Risperidone|risperidone
5348438|NCT00257023|Positive and Negative Syndrome Scale (PANSS)|positive and negative syndrome scale (panss)
5348439|NCT00257023|Clinical Global Impression (CGI)|clinical global impression (cgi)
5348440|NCT00257023|Positron Emission Tomography (PET)|positron emission tomography (pet)
5348441|NCT00257010|Migraine|migraine
5348442|NCT00257010|Almotriptan Malate|almotriptan malate
5348443|NCT00257010|Headache|headache
5348444|NCT00257010|Triptan|triptan
5348445|NCT00256997|Schizophrenia|schizophrenia
5348446|NCT00256997|Risperidone|risperidone
5348447|NCT00256997|Risperdal Consta|risperdal consta
5348448|NCT00256984|Obstructive Defecation Syndrome|obstructive defecation syndrome
5348449|NCT00256984|Colorectal Surgery|colorectal surgery
5348450|NCT00256984|Defecography|defecography
5348451|NCT00256984|Constipation|constipation
5348452|NCT00256984|Rectocele|rectocele
5348453|NCT00256984|Intussusception|intussusception
5348454|NCT00256984|Quality of Life|quality of life
5348455|NCT00256945|biofilm formation|biofilm formation
5348456|NCT00256945|dental plaque|dental plaque
5348457|NCT00256945|surface roughness|surface roughness
5348458|NCT00256945|dental restoration|dental restoration
5348459|NCT00256945|dental materials|dental materials
5348460|NCT00256932|bowel dysfunction|bowel dysfunction
5348461|NCT00256932|constipation|constipation
5348462|NCT00256932|gastrointestinal|gastrointestinal
5348463|NCT00256932|opioids|opioids
5348464|NCT00256932|pain|pain
5348465|NCT00256932|non-cancer pain|non-cancer pain
5348466|NCT00256932|Opioid-induced|opioid-induced
5348467|NCT00256919|GW856553|gw856553
5348468|NCT00256919|biomarkers|biomarkers
5348469|NCT00256919|CRP|crp
5348470|NCT00256919|rheumatoid arthritis|rheumatoid arthritis
5348471|NCT00256906|lateral ventricles|lateral ventricles
5348472|NCT00256906|fetal ventriculomegaly|fetal ventriculomegaly
5348473|NCT00256893|pain intensity|pain intensity
5348474|NCT00256893|numerical rating scale|numerical rating scale
5348475|NCT00256893|fibromyalgia|fibromyalgia
5348476|NCT00256880|Pazopanib(GW786034)|pazopanib(gw786034)
5348477|NCT00256880|Solid Tumors|solid tumors
5348478|NCT00256880|Myeloma|myeloma
5348479|NCT00256867|Type 2 diabetes Type II|type 2 diabetes type ii
5348480|NCT00256854|RLS|rls
5348481|NCT00256854|Ropinirole|ropinirole
5348482|NCT00256854|Restless Legs Syndrome|restless legs syndrome
5348483|NCT00256841|Hypofractionated Chest Radiation|hypofractionated chest radiation
5348484|NCT00256841|Taxotere|taxotere
5348485|NCT00256841|5-FU|5-fu
5348486|NCT00256828|HIV infection|hiv infection
5348487|NCT00256828|Highly active antiretroviral therapy|highly active antiretroviral therapy
5348488|NCT00256828|Treatment Naive|treatment naive
5348489|NCT00256815|Hypofractionated chest radiation|hypofractionated chest radiation
5348490|NCT00256815|Oral Navelbine|oral navelbine
5348491|NCT00256802|Headache|headache
5348492|NCT00256802|migraine|migraine
5348493|NCT00256802|MR-angiography|mr-angiography
5348494|NCT00256802|healthy volunteers|healthy volunteers
5348495|NCT00256802|GTN|gtn
5348496|NCT00256802|Middle cerebral artery|middle cerebral artery
5348497|NCT00256789|NSCLC, Non-Small Cell Lung Cancer,Weekly Radiation, Taxotere|nsclc, non-small cell lung cancer,weekly radiation, taxotere
5348498|NCT00256776|Multiple Myeloma|multiple myeloma
5348499|NCT00256776|Velcade|velcade
5348500|NCT00256776|Autologous transplantation|autologous transplantation
5348501|NCT00256776|Relapse|relapse
5348502|NCT00256776|Disease progress|disease progress
5348503|NCT00256737|Maintenance of healed erosive esophagitis|maintenance of healed erosive esophagitis
5348504|NCT00256724|hypotension|hypotension
5348505|NCT00256724|hypovolemia|hypovolemia
5348506|NCT00256724|dehydration|dehydration
5348507|NCT00256724|sepsis|sepsis
5348508|NCT00256724|blood loss|blood loss
5348509|NCT00256711|Locally advanced or metastatic NSCLC.|locally advanced or metastatic nsclc.
5348510|NCT00256711|Stage IIIb or Stage IV lung cancer|stage iiib or stage iv lung cancer
5348511|NCT00256698|Hormone|hormone
5348512|NCT00256698|receptor|receptor
5348513|NCT00256698|positive|positive
5348514|NCT00256698|breast|breast
5348515|NCT00256698|cancer|cancer
5348516|NCT00256698|first|first
5348517|NCT00256698|relapse|relapse
5348519|NCT00256672|Spinal Cord Injury|spinal cord injury
5348520|NCT00256672|TLSO brace|tlso brace
5348521|NCT00256672|Spine curvature|spine curvature
5348522|NCT00256672|Child|child
5348523|NCT00256672|Effectiveness of bracing|effectiveness of bracing
5348524|NCT00256659|Medical inpatients|medical inpatients
5348525|NCT00256659|Social Work|social work
5348526|NCT00256659|Physical therapy|physical therapy
5348527|NCT00256659|Occupational therapy|occupational therapy
5348528|NCT00256659|Psychiatry|psychiatry
5348529|NCT00256659|Early intervention|early intervention
5348530|NCT00256659|Iatrogenic complications|iatrogenic complications
5348531|NCT00256620|Cardiopulmonary bypass|cardiopulmonary bypass
5348532|NCT00256620|Coronary artery disease|coronary artery disease
5348533|NCT00256620|Cardiac morbidity|cardiac morbidity
5348534|NCT00256620|Neurologic morbidity|neurologic morbidity
5348535|NCT00256620|Neurocognitive function|neurocognitive function
5348536|NCT00256620|Autoregulation|autoregulation
5348537|NCT00256594|Medical Errors|medical errors
5348538|NCT00256594|Medication Errors|medication errors
5348539|NCT00256594|Prescriptions, Drug|prescriptions, drug
5348540|NCT00256581|myocardial perfusion|myocardial perfusion
5348541|NCT00256581|Imaging|imaging
5348542|NCT00256568|Medical Errors|medical errors
5348543|NCT00256568|Medication Errors|medication errors
5348544|NCT00256568|Prescriptions, Drug|prescriptions, drug
5348545|NCT00256568|Pharmacies|pharmacies
5348546|NCT00256568|Ambulatory Care Facilities|ambulatory care facilities
5348547|NCT00256542|interstitial cystitis|interstitial cystitis
5348548|NCT00256542|pelvic pain|pelvic pain
5348549|NCT00256542|urgency|urgency
5348550|NCT00256542|frequency|frequency
5348551|NCT00256542|Pelvic Pain and/or Urgency of Bladder Origin|pelvic pain and/or urgency of bladder origin
5348552|NCT00256529|dysphagia|dysphagia
5348553|NCT00256529|eosinophilic esophagitis|eosinophilic esophagitis
5348554|NCT00256516|Diet Therapy|diet therapy
5348555|NCT00256503|Primary Insomnia|primary insomnia
5348556|NCT00256503|Insomnia|insomnia
5348557|NCT00256503|Sleep|sleep
5348558|NCT00256490|Diffuse large B cells lymphoma|diffuse large b cells lymphoma
5348560|NCT00256490|FDG|fdg
5348561|NCT00256464|PTSD|ptsd
5348562|NCT00256451|Naltrexone|naltrexone
5348563|NCT00256451|Endophenotype|endophenotype
5348564|NCT00256438|Depression|depression
5348565|NCT00256438|Transcranial Direct Current Stimulation|transcranial direct current stimulation
5348566|NCT00256425|glioma|glioma
5348567|NCT00256425|brain tumor|brain tumor
5348568|NCT00256425|cognit|cognit
5348569|NCT00256425|neuropsycholog|neuropsycholog
5348570|NCT00256425|attention|attention
5348571|NCT00256425|memory|memory
5348572|NCT00256425|executive function|executive function
5348573|NCT00256425|rehabilitation|rehabilitation
5348574|NCT00256425|remediation|remediation
5348575|NCT00256425|training|training
5348576|NCT00256386|Baseline|baseline
5348577|NCT00256386|Laboratory|laboratory
5348578|NCT00256386|Drug|drug
5348579|NCT00256373|Low Back Pain|low back pain
5348580|NCT00256373|Dynamic Back-Muscle exercise Treatment|dynamic back-muscle exercise treatment
5348581|NCT00256373|Interdisciplinary Treatment|interdisciplinary treatment
5348582|NCT00256373|Roland Morris Disability Questionnaire|roland morris disability questionnaire
5348583|NCT00256373|SF-36|sf-36
5348584|NCT00256373|Low Back Pain Rating Scale|low back pain rating scale
5348585|NCT00256360|breast cancer|breast cancer
5348586|NCT00256360|adjuvant|adjuvant
5348587|NCT00256360|dose dense|dose dense
5348588|NCT00256360|docetaxel|docetaxel
5348589|NCT00256360|pegfilgrastim|pegfilgrastim
5348590|NCT00256334|Colon Cancer|colon cancer
5348591|NCT00256334|Resveratrol|resveratrol
5348592|NCT00256334|Clinical Trial|clinical trial
5348593|NCT00256334|WnT signaling|wnt signaling
5348594|NCT00256334|Grapes|grapes
5348595|NCT00256334|Cancer prevention|cancer prevention
5348596|NCT00256321|Gastric Carcinoma|gastric carcinoma
5348597|NCT00256321|Gastroesophageal junction Carcinoma|gastroesophageal junction carcinoma
5348598|NCT00256308|Head and Neck Cancer|head and neck cancer
5348599|NCT00256308|oxaliplatin|oxaliplatin
5348600|NCT00256308|resected squamous cell carcinoma|resected squamous cell carcinoma
5348601|NCT00256308|Eloxatin™|eloxatin™
5348602|NCT00256295|Cancer of the Head and Neck|cancer of the head and neck
5348603|NCT00256282|Metastatic Melanoma|metastatic melanoma
5348604|NCT00256269|Esophageal Cancer|esophageal cancer
5348605|NCT00256269|Gastroesophageal junction cancer|gastroesophageal junction cancer
5348606|NCT00256269|Oxaliplatin|oxaliplatin
5348607|NCT00256269|Irinotecan|irinotecan
5348608|NCT00256256|type 2 diabetes|type 2 diabetes
5348609|NCT00256256|GLP-1|glp-1
5348610|NCT00256256|PET|pet
5348611|NCT00256256|brain|brain
5348612|NCT00256256|heart|heart
5348613|NCT00256204|Parkinson's|parkinson's
5348614|NCT00256204|Rasagiline Mesylate|rasagiline mesylate
5348615|NCT00256191|taxanes|taxanes
5348616|NCT00256191|multidrug resistance|multidrug resistance
5348617|NCT00256191|mutant tubulin binding|mutant tubulin binding
5348618|NCT00256191|Hodgkin's or Non-Hodgkin's Lymphoma|hodgkin's or non-hodgkin's lymphoma
5348619|NCT00256178|Hyperlipidemia|hyperlipidemia
5348620|NCT00256178|Drug Therapy|drug therapy
5348621|NCT00256165|Aortic valve replacement|aortic valve replacement
5348622|NCT00256152|Atrial fibrillation|atrial fibrillation
5348623|NCT00256152|Pacemaker|pacemaker
5348624|NCT00256152|AF suppression pacing|af suppression pacing
5348625|NCT00256152|Indications for Pacemaker Implantation due to sinus node or atrio-ventricular node disease|indications for pacemaker implantation due to sinus node or atrio-ventricular node disease
5348626|NCT00256113|depression|depression
5348627|NCT00256113|antidepressive agents|antidepressive agents
5348628|NCT00256113|controlled clinical trial|controlled clinical trial
5348629|NCT00256087|Nosocomial rates in critically ill patients|nosocomial rates in critically ill patients
5348630|NCT00256009|Late abortion|late abortion
5348631|NCT00255983|bronchitis|bronchitis
5348632|NCT00255983|AECB|aecb
5348633|NCT00255970|Periodontal Treatment of Intraosseous Vertical Defects|periodontal treatment of intraosseous vertical defects
5348634|NCT00255957|Stroke, HES, Coagulation, Kinetics, Hemorehology|stroke, hes, coagulation, kinetics, hemorehology
5348635|NCT00255944|HIV Prevention|hiv prevention
5348636|NCT00255944|Internet Intervention|internet intervention
5348637|NCT00255944|STDs|stds
5348638|NCT00255931|Heart Failure|heart failure
5348639|NCT00255931|Biofeedback-Relaxation|biofeedback-relaxation
5348640|NCT00255931|Cognitive Behavioral Therapy|cognitive behavioral therapy
5348641|NCT00255918|Evoked Potentials|evoked potentials
5348642|NCT00255918|3-(2,4-dimethoxybenzylidene)anabaseine|3-(2,4-dimethoxybenzylidene)anabaseine
5348643|NCT00255918|DMXB-A|dmxb-a
5348644|NCT00255918|Receptors, Nicotinic|receptors, nicotinic
5348645|NCT00255905|Depression|depression
5348646|NCT00255905|Insomnia|insomnia
5348647|NCT00255892|HIV|hiv
5348648|NCT00255879|Schizophrenia|schizophrenia
5348649|NCT00255879|Neuroleptic|neuroleptic
5348650|NCT00255879|Tardive dyskinesia|tardive dyskinesia
5348651|NCT00255866|Assisted Living Facilities|assisted living facilities
5348652|NCT00255866|Aged|aged
5348653|NCT00255866|Elderly|elderly
5348654|NCT00255866|Caregivers|caregivers
5348655|NCT00255840|Treatment Naive|treatment naive
5348656|NCT00255814|liver metastases|liver metastases
5348657|NCT00255801|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
5348658|NCT00255801|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
5348659|NCT00255801|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
5348660|NCT00255801|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
5348661|NCT00255801|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5348662|NCT00255801|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
5348663|NCT00255801|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
5348664|NCT00255801|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
5348665|NCT00255801|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
5348666|NCT00255801|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5348667|NCT00255788|recurrent breast cancer|recurrent breast cancer
5348668|NCT00255788|stage IV breast cancer|stage iv breast cancer
5348669|NCT00255788|male breast cancer|male breast cancer
5348670|NCT00255775|non-small cell lung cancer|non-small cell lung cancer
5348671|NCT00255775|small cell lung cancer|small cell lung cancer
5348672|NCT00255749|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5348673|NCT00255749|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
5348674|NCT00255749|stage 0 chronic lymphocytic leukemia|stage 0 chronic lymphocytic leukemia
5348675|NCT00255749|anemia|anemia
5348676|NCT00255749|extramedullary plasmacytoma|extramedullary plasmacytoma
5348677|NCT00255749|isolated plasmacytoma of bone|isolated plasmacytoma of bone
5348678|NCT00255749|refractory multiple myeloma|refractory multiple myeloma
5348679|NCT00255749|monoclonal gammopathy of undetermined significance|monoclonal gammopathy of undetermined significance
5348680|NCT00255749|primary systemic amyloidosis|primary systemic amyloidosis
5348681|NCT00255749|stage I multiple myeloma|stage i multiple myeloma
5348682|NCT00255749|stage II multiple myeloma|stage ii multiple myeloma
5348683|NCT00255749|stage III multiple myeloma|stage iii multiple myeloma
5348684|NCT00255749|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
5348685|NCT00255749|AIDS-related primary CNS lymphoma|aids-related primary cns lymphoma
5348686|NCT00255749|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5348687|NCT00255749|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
5348688|NCT00255749|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5348689|NCT00255749|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5348690|NCT00255749|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5348691|NCT00255749|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5348692|NCT00255749|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5348693|NCT00255749|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5348694|NCT00255749|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5348695|NCT00255749|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5348696|NCT00255749|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5348697|NCT00255749|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
5349346|NCT00254007|depression|depression
5348698|NCT00255749|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5348699|NCT00255749|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5348700|NCT00255749|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5348701|NCT00255749|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5348702|NCT00255749|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5348703|NCT00255749|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5348704|NCT00255749|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5348705|NCT00255749|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5348706|NCT00255749|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5348707|NCT00255749|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5348708|NCT00255749|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5348709|NCT00255749|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5348710|NCT00255749|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5348711|NCT00255749|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5348712|NCT00255749|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5348713|NCT00255749|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5348714|NCT00255749|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
5348715|NCT00255749|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
5348716|NCT00255749|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5348717|NCT00255749|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5348718|NCT00255749|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5348719|NCT00255749|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5348720|NCT00255749|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5348721|NCT00255749|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
5348722|NCT00255749|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5348723|NCT00255749|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5348724|NCT00255749|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5348725|NCT00255749|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5348726|NCT00255749|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5348727|NCT00255749|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5348728|NCT00255749|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5348729|NCT00255749|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5348730|NCT00255749|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
5348731|NCT00255749|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
5348732|NCT00255749|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5348733|NCT00255749|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5348734|NCT00255749|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5348735|NCT00255749|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5348736|NCT00255749|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5348737|NCT00255749|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
5348738|NCT00255749|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5348739|NCT00255749|Waldenström macroglobulinemia|waldenström macroglobulinemia
5348740|NCT00255749|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
5348741|NCT00255749|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
5348742|NCT00255749|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
5348743|NCT00255749|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
5348744|NCT00255749|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
5348745|NCT00255749|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
5348746|NCT00255749|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
5348747|NCT00255749|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
5348748|NCT00255749|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
5348749|NCT00255749|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
5348750|NCT00255749|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
5348751|NCT00255749|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
5348752|NCT00255749|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
5348753|NCT00255749|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5348754|NCT00255749|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
5348755|NCT00255749|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
5348756|NCT00255749|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
5348757|NCT00255749|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
5348758|NCT00255749|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5348759|NCT00255749|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5348760|NCT00255749|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5348761|NCT00255749|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5348762|NCT00255749|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
5348763|NCT00255749|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
5348764|NCT00255749|post-transplant lymphoproliferative disorder|post-transplant lymphoproliferative disorder
5348765|NCT00255749|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
5348766|NCT00255749|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
5348767|NCT00255749|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
5349199|NCT00254579|malignant melanoma|malignant melanoma
5348768|NCT00255749|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
5348769|NCT00255749|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
5348770|NCT00255749|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
5348771|NCT00255749|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
5348772|NCT00255749|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
5348773|NCT00255749|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
5348774|NCT00255749|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
5348775|NCT00255749|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
5348776|NCT00255749|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
5348777|NCT00255749|stage I mantle cell lymphoma|stage i mantle cell lymphoma
5348778|NCT00255749|stage I marginal zone lymphoma|stage i marginal zone lymphoma
5348779|NCT00255749|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
5348780|NCT00255749|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
5348781|NCT00255749|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
5348782|NCT00255749|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
5348783|NCT00255749|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
5348784|NCT00255749|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
5348785|NCT00255749|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5348786|NCT00255749|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5348787|NCT00255749|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
5348788|NCT00255749|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
5348789|NCT00255749|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5348790|NCT00255749|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5348791|NCT00255749|refractory hairy cell leukemia|refractory hairy cell leukemia
5348792|NCT00255749|prolymphocytic leukemia|prolymphocytic leukemia
5348793|NCT00255749|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5348794|NCT00255749|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
5348795|NCT00255723|adult lymphocyte depletion Hodgkin lymphoma|adult lymphocyte depletion hodgkin lymphoma
5348796|NCT00255723|adult mixed cellularity Hodgkin lymphoma|adult mixed cellularity hodgkin lymphoma
5348797|NCT00255723|adult nodular sclerosis Hodgkin lymphoma|adult nodular sclerosis hodgkin lymphoma
5348798|NCT00255723|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5348799|NCT00255710|graft versus host disease|graft versus host disease
5348800|NCT00255710|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5348801|NCT00255710|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5348802|NCT00255710|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5348803|NCT00255710|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5348804|NCT00255710|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5348805|NCT00255710|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5348806|NCT00255710|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5348807|NCT00255710|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
5348808|NCT00255710|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5348809|NCT00255710|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5348810|NCT00255710|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
5348811|NCT00255710|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5348812|NCT00255710|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5348813|NCT00255710|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5348814|NCT00255710|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5348815|NCT00255710|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5348816|NCT00255710|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5348817|NCT00255710|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5348818|NCT00255710|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5348819|NCT00255710|stage II multiple myeloma|stage ii multiple myeloma
5348820|NCT00255710|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5349137|NCT00254852|Lumbar fusion|lumbar fusion
5348821|NCT00255710|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5348822|NCT00255710|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5348823|NCT00255710|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5348824|NCT00255710|stage III multiple myeloma|stage iii multiple myeloma
5348825|NCT00255710|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5348826|NCT00255710|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5348827|NCT00255710|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5348828|NCT00255710|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5348829|NCT00255710|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5348830|NCT00255710|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5348831|NCT00255710|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
5348832|NCT00255710|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
5348833|NCT00255710|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
5348834|NCT00255710|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
5348835|NCT00255710|refractory anemia with excess blasts|refractory anemia with excess blasts
5348836|NCT00255710|refractory cytopenia with multilineage dysplasia|refractory cytopenia with multilineage dysplasia
5348837|NCT00255710|primary systemic amyloidosis|primary systemic amyloidosis
5348838|NCT00255710|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5348839|NCT00255710|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5348840|NCT00255710|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5348841|NCT00255710|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
5348842|NCT00255697|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
5348843|NCT00255697|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5348844|NCT00255684|graft versus host disease|graft versus host disease
5348845|NCT00255684|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5348846|NCT00255684|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5348847|NCT00255684|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5348848|NCT00255684|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5348849|NCT00255684|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5348850|NCT00255684|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
5348851|NCT00255684|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5348852|NCT00255684|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5348853|NCT00255684|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5348854|NCT00255684|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
5348855|NCT00255684|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5348856|NCT00255684|acute undifferentiated leukemia|acute undifferentiated leukemia
5348857|NCT00255684|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5348858|NCT00255684|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5348859|NCT00255684|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
5348860|NCT00255684|refractory anemia with excess blasts|refractory anemia with excess blasts
5348861|NCT00255684|refractory anemia|refractory anemia
5348862|NCT00255684|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5348863|NCT00255684|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
5348864|NCT00255684|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
5348865|NCT00255684|primary myelofibrosis|primary myelofibrosis
5348866|NCT00255684|refractory hairy cell leukemia|refractory hairy cell leukemia
5348867|NCT00255684|stage I multiple myeloma|stage i multiple myeloma
5348868|NCT00255684|stage II multiple myeloma|stage ii multiple myeloma
5348869|NCT00255684|stage III multiple myeloma|stage iii multiple myeloma
5348870|NCT00255684|refractory multiple myeloma|refractory multiple myeloma
5348871|NCT00255684|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5348872|NCT00255684|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5348873|NCT00255684|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5348874|NCT00255684|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
5348875|NCT00255684|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5348876|NCT00255684|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5348877|NCT00255684|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5348878|NCT00255684|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5348879|NCT00255684|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5348880|NCT00255684|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5348881|NCT00255684|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5348882|NCT00255684|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5348883|NCT00255684|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5348884|NCT00255684|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5349345|NCT00254020|citalopram|citalopram
5348885|NCT00255684|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5348886|NCT00255684|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5348887|NCT00255684|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5348888|NCT00255684|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5348889|NCT00255684|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5348890|NCT00255684|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5348891|NCT00255684|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5348892|NCT00255684|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5348893|NCT00255684|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5348894|NCT00255684|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5348895|NCT00255684|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5348896|NCT00255684|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5348897|NCT00255684|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5348898|NCT00255684|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5348899|NCT00255684|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5348900|NCT00255684|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5348901|NCT00255684|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5348902|NCT00255684|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5348903|NCT00255684|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5348904|NCT00255684|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5348905|NCT00255684|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5348906|NCT00255684|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5348907|NCT00255684|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
5348908|NCT00255684|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
5348909|NCT00255684|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
5348910|NCT00255684|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5348911|NCT00255684|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5348912|NCT00255684|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5348913|NCT00255684|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5348914|NCT00255684|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5348915|NCT00255684|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5348916|NCT00255684|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5348917|NCT00255684|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5348918|NCT00255684|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5348919|NCT00255684|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5348920|NCT00255684|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5348921|NCT00255684|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5348922|NCT00255684|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5348923|NCT00255684|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
5348924|NCT00255684|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5348925|NCT00255684|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5348926|NCT00255684|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5348927|NCT00255684|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5348928|NCT00255684|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
5348929|NCT00255684|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5348930|NCT00255684|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
5348931|NCT00255684|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
5348932|NCT00255684|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
5348933|NCT00255684|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
5348934|NCT00255684|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5348935|NCT00255684|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5348936|NCT00255684|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5348937|NCT00255684|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5348938|NCT00255684|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
5348939|NCT00255684|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
5348940|NCT00255684|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
5348941|NCT00255671|radiation toxicity|radiation toxicity
5348942|NCT00255671|tumors metastatic to brain|tumors metastatic to brain
5348943|NCT00255671|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5348944|NCT00255671|adult anaplastic ependymoma|adult anaplastic ependymoma
5348945|NCT00255671|adult anaplastic meningioma|adult anaplastic meningioma
5348946|NCT00255671|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
5348947|NCT00255671|adult brain stem glioma|adult brain stem glioma
5348948|NCT00255671|adult central nervous system germ cell tumor|adult central nervous system germ cell tumor
5348949|NCT00255671|adult choroid plexus tumor|adult choroid plexus tumor
5348950|NCT00255671|adult craniopharyngioma|adult craniopharyngioma
5348951|NCT00255671|adult diffuse astrocytoma|adult diffuse astrocytoma
5348952|NCT00255671|adult ependymoblastoma|adult ependymoblastoma
5348953|NCT00255671|adult ependymoma|adult ependymoma
5348954|NCT00255671|adult giant cell glioblastoma|adult giant cell glioblastoma
5348955|NCT00255671|adult gliosarcoma|adult gliosarcoma
5348956|NCT00255671|adult medulloblastoma|adult medulloblastoma
5348957|NCT00255671|adult melanocytic lesion|adult melanocytic lesion
5348958|NCT00255671|adult meningeal hemangiopericytoma|adult meningeal hemangiopericytoma
5348959|NCT00255671|adult meningioma|adult meningioma
5348960|NCT00255671|adult myxopapillary ependymoma|adult myxopapillary ependymoma
5348961|NCT00255671|adult oligodendroglioma|adult oligodendroglioma
5348962|NCT00255671|adult papillary meningioma|adult papillary meningioma
5348963|NCT00255671|adult pineoblastoma|adult pineoblastoma
5348964|NCT00255671|adult pineocytoma|adult pineocytoma
5348965|NCT00255671|adult subependymoma|adult subependymoma
5348966|NCT00255671|adult supratentorial primitive neuroectodermal tumor (PNET)|adult supratentorial primitive neuroectodermal tumor (pnet)
5348967|NCT00255671|adult grade I meningioma|adult grade i meningioma
5348968|NCT00255671|adult grade II meningioma|adult grade ii meningioma
5348969|NCT00255671|adult grade III meningioma|adult grade iii meningioma
5348970|NCT00255671|adult mixed glioma|adult mixed glioma
5348971|NCT00255671|recurrent adult brain tumor|recurrent adult brain tumor
5348972|NCT00255671|adult pilocytic astrocytoma|adult pilocytic astrocytoma
5348973|NCT00255671|adult glioblastoma|adult glioblastoma
5348974|NCT00255671|ACTH-producing pituitary tumor|acth-producing pituitary tumor
5348975|NCT00255671|growth hormone-producing pituitary tumor|growth hormone-producing pituitary tumor
5348976|NCT00255671|nonfunctioning pituitary tumor|nonfunctioning pituitary tumor
5348977|NCT00255671|prolactin-producing pituitary tumor|prolactin-producing pituitary tumor
5348978|NCT00255671|recurrent pituitary tumor|recurrent pituitary tumor
5348979|NCT00255671|TSH producing pituitary tumor|tsh producing pituitary tumor
5348980|NCT00255619|Continuous ambulatory peritoneal dialysis (CAPD)|continuous ambulatory peritoneal dialysis (capd)
5348981|NCT00255619|Peritonitis|peritonitis
5348982|NCT00255619|ANDY-disc® (Fresenius Medical care)|andy-disc® (fresenius medical care)
5348983|NCT00255619|Ultra® (Baxter)|ultra® (baxter)
5348984|NCT00255619|Twin bag System|twin bag system
5348985|NCT00255606|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5348986|NCT00255606|stage IV prostate cancer|stage iv prostate cancer
5348987|NCT00255606|recurrent prostate cancer|recurrent prostate cancer
5348988|NCT00255593|Kidney|kidney
5348989|NCT00255593|Transplantation|transplantation
5348990|NCT00255593|Immunosuppression|immunosuppression
5348991|NCT00255593|Rituximab|rituximab
5348992|NCT00255580|neuropathy|neuropathy
5348993|NCT00255580|cannabis|cannabis
5348994|NCT00255580|marijuana|marijuana
5348995|NCT00255580|HIV|hiv
5348996|NCT00255580|DSPN|dspn
5348997|NCT00255567|Visceral Leishmaniasis|visceral leishmaniasis
5348998|NCT00255567|Combination|combination
5348999|NCT00255554|Borderline Personality Disorder|borderline personality disorder
5349000|NCT00255554|BPD|bpd
5349001|NCT00255554|Dialectical Behavior Therapy|dialectical behavior therapy
5349002|NCT00255554|DBT|dbt
5349003|NCT00255554|Escitalopram|escitalopram
5349004|NCT00255554|Lexapro|lexapro
5349005|NCT00255528|Pediatric hypertension|pediatric hypertension
5349006|NCT00255502|Pediatric hypertension|pediatric hypertension
5349007|NCT00255450|anemia|anemia
5349008|NCT00255411|Conversion Disorder|conversion disorder
5349009|NCT00255411|Somatoform Disorder|somatoform disorder
5349010|NCT00255411|Involuntary Movement|involuntary movement
5349011|NCT00255411|Childhood Abuse|childhood abuse
5349012|NCT00255411|Depression|depression
5349013|NCT00255411|Psychogenic Movement Disorder|psychogenic movement disorder
5349014|NCT00255411|PMD|pmd
5349015|NCT00255411|Non-Epileptic Seizure|non-epileptic seizure
5349016|NCT00255411|NES|nes
5349017|NCT00255411|Healthy Volunteer|healthy volunteer
5349018|NCT00255411|HV|hv
5349019|NCT00255398|Focal Segmental Glomerulosclerosis|focal segmental glomerulosclerosis
5349020|NCT00255398|Minimal Change Disease|minimal change disease
5349021|NCT00255398|Diabetic Nephropathy|diabetic nephropathy
5349022|NCT00255398|Mass Spectrometry|mass spectrometry
5349023|NCT00255398|Proteinuria|proteinuria
5349024|NCT00255398|Idiopathic Nephrotic Syndrome|idiopathic nephrotic syndrome
5349025|NCT00255398|Glomerular Disease|glomerular disease
5349026|NCT00255398|FSG|fsg
5349027|NCT00255398|Kidney Disease|kidney disease
5349028|NCT00255385|Zinc|zinc
5349029|NCT00255385|Iron|iron
5349030|NCT00255385|Probiotics|probiotics
5349031|NCT00255385|Prebiotics|prebiotics
5349032|NCT00255385|Child health|child health
5349033|NCT00255385|Milk fortification|milk fortification
5349034|NCT00255385|Randomized controlled trial|randomized controlled trial
5349035|NCT00255346|targeted therapy|targeted therapy
5349036|NCT00255346|leukemia|leukemia
5349037|NCT00255346|Acute myeloid leukemia (AML)|acute myeloid leukemia (aml)
5349038|NCT00255346|Myelodysplastic syndrome (MDS)|myelodysplastic syndrome (mds)
5349039|NCT00255346|Agnogenic myeloid metaplasia - myelofibrosis (MMM)|agnogenic myeloid metaplasia - myelofibrosis (mmm)
5349040|NCT00255346|Hypereosinophilic syndrome (HES)|hypereosinophilic syndrome (hes)
5349041|NCT00255346|Polycythemia vera (PV)|polycythemia vera (pv)
5349042|NCT00255346|Mastocytosis|mastocytosis
5349043|NCT00255346|CMML|cmml
5349044|NCT00255320|healthy volunteers, headache, migraine, hemodynamics, VIP, SPECT, ultrasound|healthy volunteers, headache, migraine, hemodynamics, vip, spect, ultrasound
5349045|NCT00255307|cold|cold
5349046|NCT00255307|flu|flu
5349047|NCT00255307|respiratory tract infection|respiratory tract infection
5349048|NCT00255255|Asthma|asthma
5349049|NCT00255242|Cystic Fibrosis|cystic fibrosis
5349050|NCT00255242|Airway Inflammation|airway inflammation
5349051|NCT00255242|Cytokines|cytokines
5349052|NCT00255242|Simvastatin|simvastatin
5349053|NCT00255242|HMG-CoA reductase inhibitors|hmg-coa reductase inhibitors
5349054|NCT00255242|Rho GTP-ase|rho gtp-ase
5349055|NCT00255229|irinotecan|irinotecan
5349056|NCT00255229|5FU|5fu
5349057|NCT00255229|amino acids|amino acids
5349058|NCT00255229|heat shock protein|heat shock protein
5349059|NCT00255190|Gastroesophageal Reflux Disease|gastroesophageal reflux disease
5349060|NCT00255177|Hepatitis C|hepatitis c
5349061|NCT00255164|Erosive Esophagitis|erosive esophagitis
5349062|NCT00255151|Erosive Esophagitis|erosive esophagitis
5349063|NCT00255138|Cancer|cancer
5349064|NCT00255138|Cognitive Late Effects|cognitive late effects
5349065|NCT00255138|Stimulants|stimulants
5349066|NCT00255138|Atomoxetine|atomoxetine
5349067|NCT00255138|Attention|attention
5349068|NCT00255138|Children|children
5349069|NCT00255125|Estrogen Receptor|estrogen receptor
5349070|NCT00255125|Isoflavones|isoflavones
5349071|NCT00255125|Prostate Neoplasm|prostate neoplasm
5349072|NCT00255125|Soy Supplementation|soy supplementation
5349073|NCT00255112|SAD|sad
5349074|NCT00255112|treatment|treatment
5349075|NCT00255112|cognitive behavior therapy|cognitive behavior therapy
5349076|NCT00255112|family|family
5349077|NCT00255112|children|children
5349078|NCT00255112|anxiety|anxiety
5349079|NCT00255099|HIV|hiv
5349080|NCT00255099|HIV-1|hiv-1
5349081|NCT00255099|TMC125|tmc125
5349082|NCT00255047|Pertussis|pertussis
5349083|NCT00255047|Whooping cough|whooping cough
5349084|NCT00255047|Filamentous Haemagglutinin|filamentous haemagglutinin
5349085|NCT00255047|Fimbriae Types 2 and 3;|fimbriae types 2 and 3;
5349086|NCT00255047|Pertactin|pertactin
5349087|NCT00255047|Diphtheria|diphtheria
5349088|NCT00255047|Tetanus|tetanus
5349089|NCT00255047|Poliovirus Types 1, 2, and 3.|poliovirus types 1, 2, and 3.
5349090|NCT00255034|chronic hepatitis C|chronic hepatitis c
5349091|NCT00255034|pegylated interferon alfa-2b|pegylated interferon alfa-2b
5349092|NCT00255034|ribavirin|ribavirin
5349093|NCT00255034|Australia|australia
5349094|NCT00255021|Diphteria|diphteria
5349095|NCT00255021|Tetanus|tetanus
5349096|NCT00255021|Pertussis|pertussis
5349097|NCT00255021|Poliomyelitis|poliomyelitis
5349098|NCT00255021|Haemophilus influenzae type b|haemophilus influenzae type b
5349099|NCT00255021|acellular|acellular
5349100|NCT00255008|chronic hepatitis C|chronic hepatitis c
5349101|NCT00255008|pegylated interferon alfa-2b|pegylated interferon alfa-2b
5349102|NCT00255008|ribavirin|ribavirin
5349103|NCT00255008|Asia|asia
5349104|NCT00254995|Meningitis|meningitis
5349105|NCT00254995|Meningococcal disease|meningococcal disease
5349106|NCT00254995|Menactra vaccine|menactra vaccine
5349107|NCT00254969|Diphteria|diphteria
5349108|NCT00254969|tetanus|tetanus
5349109|NCT00254969|haemophilus influenzae type b|haemophilus influenzae type b
5349110|NCT00254969|poliomyelitis|poliomyelitis
5349111|NCT00254969|pertussis|pertussis
5349112|NCT00254956|Diseases|diseases
5349113|NCT00254956|respiratory tract diseases|respiratory tract diseases
5349114|NCT00254956|respiratory hypersensitivity|respiratory hypersensitivity
5349115|NCT00254956|asthma|asthma
5349116|NCT00254930|learning disorder|learning disorder
5349117|NCT00254930|children|children
5349118|NCT00254930|behaviour disorder|behaviour disorder
5349119|NCT00254930|risperidone|risperidone
5349120|NCT00254917|Pentaxim|pentaxim
5349121|NCT00254904|advanced carcinoma, non-small cell lung, Phase III, Gemcitabine, Gemzar, Cisplatin, Platinol, PF-3512676, immunotherapy, immune modulator|advanced carcinoma, non-small cell lung, phase iii, gemcitabine, gemzar, cisplatin, platinol, pf-3512676, immunotherapy, immune modulator
5349122|NCT00254891|advanced carcinoma, non-small cell lung, Phase III, Paclitaxel, Taxol, Carboplatin, Paraplatin, PF-3512676, immunotherapy, immune modulator|advanced carcinoma, non-small cell lung, phase iii, paclitaxel, taxol, carboplatin, paraplatin, pf-3512676, immunotherapy, immune modulator
5349123|NCT00254878|ADHD, Methylphenidate hydrochloride, modified-release|adhd, methylphenidate hydrochloride, modified-release
5349124|NCT00254865|Transdermal contraception|transdermal contraception
5349125|NCT00254865|contraceptive|contraceptive
5349126|NCT00254865|hormonal, steroid contraception|hormonal, steroid contraception
5349127|NCT00254865|ethinyl estradiol|ethinyl estradiol
5349128|NCT00254865|progesterone|progesterone
5349129|NCT00254865|EVRA|evra
5349130|NCT00254865|CILEST|cilest
5349131|NCT00254852|Primary lumbar fusion|primary lumbar fusion
5349132|NCT00254852|Demineralized Bone Matrix|demineralized bone matrix
5349133|NCT00254852|DBM|dbm
5349134|NCT00254852|Optecure|optecure
5349135|NCT00254852|Allograft|allograft
5349136|NCT00254852|Autograft|autograft
5349138|NCT00254852|Interbody fusion|interbody fusion
5349139|NCT00254852|Instrumented fusion|instrumented fusion
5349140|NCT00254852|Non-instrumented fusion|non-instrumented fusion
5349141|NCT00254852|Exactech|exactech
5349142|NCT00254852|Spinal fusion|spinal fusion
5349143|NCT00254839|Oral malodor|oral malodor
5349144|NCT00254839|Dental implants|dental implants
5349145|NCT00254826|Yellow Fever Virus Vaccination|yellow fever virus vaccination
5349146|NCT00254813|Schizophrenia|schizophrenia
5349147|NCT00254813|Schizoaffective disorder|schizoaffective disorder
5349148|NCT00254800|diabetes|diabetes
5349149|NCT00254800|exenatide|exenatide
5349150|NCT00254800|Amylin|amylin
5349151|NCT00254800|Lilly|lilly
5349152|NCT00254787|Schizophrenia|schizophrenia
5349153|NCT00254774|Bipolar Disorder I or II with Rapid Cycling|bipolar disorder i or ii with rapid cycling
5349154|NCT00254761|cannabis|cannabis
5349155|NCT00254761|marijuana|marijuana
5349156|NCT00254761|neuropathy|neuropathy
5349157|NCT00254761|antinociception|antinociception
5349158|NCT00254761|mood|mood
5349159|NCT00254761|cognition|cognition
5349160|NCT00254748|Borderline personality disorder|borderline personality disorder
5349161|NCT00254735|Obsessive Compulsive Disorder (OCD)|obsessive compulsive disorder (ocd)
5349162|NCT00254722|Traumatic Brain Injury|traumatic brain injury
5349163|NCT00254722|Stem Cell|stem cell
5349164|NCT00254709|kidney transplant|kidney transplant
5349165|NCT00254709|elderly|elderly
5349166|NCT00254696|bacterial infection|bacterial infection
5349167|NCT00254683|Rectal Cancer|rectal cancer
5349168|NCT00254683|Positron Emission Tomography|positron emission tomography
5349169|NCT00254683|Fluorodeoxyglucose F18|fluorodeoxyglucose f18
5349170|NCT00254683|Computed Tomography|computed tomography
5349171|NCT00254683|Neoadjuvant Therapy|neoadjuvant therapy
5349172|NCT00254683|Chemotherapy|chemotherapy
5349173|NCT00254683|Radiotherapy|radiotherapy
5349174|NCT00254670|Alcohol|alcohol
5349175|NCT00254670|Naltrexone|naltrexone
5349176|NCT00254657|Fibromyalgia|fibromyalgia
5349177|NCT00254657|Fibro|fibro
5349178|NCT00254657|Keppra|keppra
5349179|NCT00254657|Levetiracetam|levetiracetam
5349180|NCT00254644|phonological treatment|phonological treatment
5349181|NCT00254644|language|language
5349182|NCT00254644|fMRI|fmri
5349183|NCT00254631|long bone fracture|long bone fracture
5349184|NCT00254631|open fractures|open fractures
5349185|NCT00254631|closed fractures|closed fractures
5349186|NCT00254631|trauma|trauma
5349187|NCT00254618|ulcerative colitis; pharmacokinetics; pediatrics|ulcerative colitis; pharmacokinetics; pediatrics
5349188|NCT00254605|imaging|imaging
5349189|NCT00254605|adaptive optics scanning laser ophthalmoscope|adaptive optics scanning laser ophthalmoscope
5349190|NCT00254605|optical coherence tomography|optical coherence tomography
5349191|NCT00254605|electroretinography|electroretinography
5349192|NCT00254592|Inflammatory|inflammatory
5349193|NCT00254592|Breast Cancer|breast cancer
5349194|NCT00254592|Female|female
5349195|NCT00254592|Neo-adjuvant|neo-adjuvant
5349196|NCT00254592|HER-2 positive|her-2 positive
5349197|NCT00254592|Hormone receptor|hormone receptor
5349198|NCT00254579|refractory melanoma|refractory melanoma
5349200|NCT00254566|Azithromycin SR; Moxifloxacin; Acute exacerbation of chronic bronchitis (AECB)|azithromycin sr; moxifloxacin; acute exacerbation of chronic bronchitis (aecb)
5349201|NCT00254540|Ph2, RCC, SU011248, SUNITINIB|ph2, rcc, su011248, sunitinib
5349202|NCT00254527|Methicillin Resistant Staphylococcus aureus|methicillin resistant staphylococcus aureus
5349203|NCT00254527|Children|children
5349204|NCT00254527|Colonization|colonization
5349205|NCT00254527|Risk Factor|risk factor
5349206|NCT00254501|diabetes|diabetes
5349207|NCT00254475|Valsartan|valsartan
5349208|NCT00254475|simvastatin|simvastatin
5349209|NCT00254475|hypertension|hypertension
5349210|NCT00254475|hypercholesterolemia|hypercholesterolemia
5349211|NCT00254475|angiotensin II receptor blocker|angiotensin ii receptor blocker
5349212|NCT00254462|ADHD|adhd
5349213|NCT00254462|Atomoxetine|atomoxetine
5349214|NCT00254436|Epoetin Alfa|epoetin alfa
5349215|NCT00254436|Epogen|epogen
5349216|NCT00254436|Erythropoietin|erythropoietin
5349217|NCT00254423|Chronic Myelogenous Leukemia|chronic myelogenous leukemia
5349218|NCT00254423|CML|cml
5349219|NCT00254423|Dasatinib|dasatinib
5349220|NCT00254423|BMS-354825|bms-354825
5349221|NCT00254410|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
5349222|NCT00254410|Untreated|untreated
5349223|NCT00254410|Fludarabine|fludarabine
5349224|NCT00254410|Fludara|fludara
5349225|NCT00254410|Cyclophosphamide|cyclophosphamide
5349226|NCT00254410|Cytoxan|cytoxan
5349227|NCT00254410|Mitoxantrone|mitoxantrone
5349228|NCT00254410|Novantrone|novantrone
5349229|NCT00254410|Rituximab|rituximab
5349230|NCT00254410|Rituxan|rituxan
5349231|NCT00254410|Pegylated Filgrastim|pegylated filgrastim
5349232|NCT00254410|Neupogen|neupogen
5349233|NCT00254397|Melanoma|melanoma
5349234|NCT00254397|Uveal Melanoma|uveal melanoma
5349235|NCT00254397|Peptide Vaccine|peptide vaccine
5349236|NCT00254397|LHRH-agonist|lhrh-agonist
5349237|NCT00254397|Leuprolide|leuprolide
5349238|NCT00254397|Lupron|lupron
5349239|NCT00254397|MAGE-3 Peptide|mage-3 peptide
5349240|NCT00254397|MAGE-3|mage-3
5349241|NCT00254397|GP100 Peptide|gp100 peptide
5349242|NCT00254397|Melanoma vaccines|melanoma vaccines
5349243|NCT00254397|Tumor fighting immune cells|tumor fighting immune cells
5349244|NCT00254397|T cells|t cells
5349245|NCT00254397|Skin Cancer|skin cancer
5349246|NCT00254397|Eye Cancer|eye cancer
5349247|NCT00254384|Non-Small Cell Lung Cancer|non-small cell lung cancer
5349248|NCT00254384|Lung Cancer|lung cancer
5349249|NCT00254384|Cisplatin|cisplatin
5349250|NCT00254384|Platinol|platinol
5349251|NCT00254384|Platinol-AQ|platinol-aq
5349252|NCT00254384|CDDP|cddp
5349253|NCT00254384|Docetaxel|docetaxel
5349254|NCT00254384|Taxotere|taxotere
5349255|NCT00254384|Erlotinib|erlotinib
5349256|NCT00254384|Tarceva|tarceva
5349257|NCT00254384|OSI-774|osi-774
5349258|NCT00254384|NSCLC|nsclc
5349259|NCT00254358|Nicotine|nicotine
5349260|NCT00254358|Dopamine|dopamine
5349261|NCT00254358|IBZM|ibzm
5349262|NCT00254345|biofilm|biofilm
5349263|NCT00254345|adhesion|adhesion
5349264|NCT00254345|liquid polish|liquid polish
5349265|NCT00254345|bonding resin|bonding resin
5349266|NCT00254345|PMMA Polymethylmetacrylate|pmma polymethylmetacrylate
5349267|NCT00254345|provisional crown|provisional crown
5349268|NCT00254345|no antibiotics treatment three months prior to experiment|no antibiotics treatment three months prior to experiment
5349269|NCT00254345|no mouth rinse with oral solutions one month prior to experiment|no mouth rinse with oral solutions one month prior to experiment
5349270|NCT00254332|Cutaneous T-cell Lymphoma|cutaneous t-cell lymphoma
5349271|NCT00254332|Sezary Syndrome|sezary syndrome
5349272|NCT00254332|Mycosis Fungoides|mycosis fungoides
5349273|NCT00254332|Denileukin Diftitox|denileukin diftitox
5349274|NCT00254306|Ecstasy|ecstasy
5349275|NCT00254306|D2 Dopamine Receptor|d2 dopamine receptor
5349276|NCT00254306|IBZM|ibzm
5349277|NCT00254306|MDMA|mdma
5349278|NCT00254280|Warts|warts
5349279|NCT00254280|Intense pulsed light|intense pulsed light
5349280|NCT00254280|RCT|rct
5349281|NCT00254280|Recalcitrant hand and foot warts|recalcitrant hand and foot warts
5349282|NCT00254267|Gastrointestinal Stromal Tumor, Imatinib Mesylate Resistance, Phase2 study, AMG 706|gastrointestinal stromal tumor, imatinib mesylate resistance, phase2 study, amg 706
5349283|NCT00254254|diabetes|diabetes
5349284|NCT00254254|adolescents|adolescents
5349285|NCT00254254|exenatide|exenatide
5349286|NCT00254254|Amylin|amylin
5349287|NCT00254254|Lilly|lilly
5349288|NCT00254241|Schizophrenia|schizophrenia
5349289|NCT00254228|Balance|balance
5349290|NCT00254228|Vestibular|vestibular
5349291|NCT00254228|Electrotactile|electrotactile
5349292|NCT00254228|BrainPort|brainport
5349293|NCT00254228|Sensory substitution|sensory substitution
5349294|NCT00254228|Tongue|tongue
5349295|NCT00254215|overweight|overweight
5349296|NCT00254215|obesity|obesity
5349297|NCT00254215|glycemic index|glycemic index
5349298|NCT00254215|glycemic load|glycemic load
5349299|NCT00254215|high protein diet|high protein diet
5349300|NCT00254215|blood cholesterol|blood cholesterol
5349301|NCT00254202|Schizophrenia|schizophrenia
5349302|NCT00254202|Atypical antipsychotic|atypical antipsychotic
5349303|NCT00254202|psychosis|psychosis
5349304|NCT00254189|Ovulation|ovulation
5349305|NCT00254189|Oral Contraceptive|oral contraceptive
5349306|NCT00254176|Neonate|neonate
5349307|NCT00254176|Glutathione|glutathione
5349308|NCT00254176|Cysteine|cysteine
5349309|NCT00254176|Sepsis|sepsis
5349310|NCT00254176|Stable Isotope|stable isotope
5349311|NCT00254137|capecitabine|capecitabine
5349312|NCT00254137|irinotecan|irinotecan
5349313|NCT00254137|cetuximab|cetuximab
5349314|NCT00254137|oxaliplatin|oxaliplatin
5349315|NCT00254137|colorectal cancer|colorectal cancer
5349316|NCT00254124|obesity|obesity
5349317|NCT00254124|type 2 diabetes mellitus|type 2 diabetes mellitus
5349318|NCT00254124|portion control|portion control
5349319|NCT00254111|osteoarthritis|osteoarthritis
5349320|NCT00254111|hand|hand
5349321|NCT00254111|laser|laser
5349322|NCT00254111|device|device
5349323|NCT00254111|hand pain|hand pain
5349324|NCT00254111|stiffness|stiffness
5349325|NCT00254085|Type 2 diabtes|type 2 diabtes
5349326|NCT00254085|Postprandial hyperglycemia|postprandial hyperglycemia
5349327|NCT00254085|Insulin treatment|insulin treatment
5349328|NCT00254072|Morbid Obesity|morbid obesity
5349329|NCT00254072|Laparoscopic Gastric Bypass|laparoscopic gastric bypass
5349330|NCT00254072|Staple Line Hemorrhage|staple line hemorrhage
5349331|NCT00254059|OSAHS, OSA, CPAP, polysomnography, overnight oximetry, Obstructive sleep apnea, apnea hypopnea index, AHI, Obstructive Sleep Apnea Hypopnea Syndrome|osahs, osa, cpap, polysomnography, overnight oximetry, obstructive sleep apnea, apnea hypopnea index, ahi, obstructive sleep apnea hypopnea syndrome
5349333|NCT00254046|HIV-1|hiv-1
5349334|NCT00254046|TMC125|tmc125
5349335|NCT00254033|Alzheimer's Disease|alzheimer's disease
5349336|NCT00254033|Apathy|apathy
5349337|NCT00254033|Brain Reward System|brain reward system
5349338|NCT00254033|Dopamine|dopamine
5349339|NCT00254033|Dextroamphetamine Challenge|dextroamphetamine challenge
5349340|NCT00254033|Methylphenidate|methylphenidate
5349341|NCT00254020|stroke|stroke
5349342|NCT00254020|depression|depression
5349343|NCT00254020|cytokines|cytokines
5349344|NCT00254020|serotonin|serotonin
5349347|NCT00254007|traumatic brain injury|traumatic brain injury
5349348|NCT00254007|serotonin transporter|serotonin transporter
5349349|NCT00254007|genetic polymorphisms|genetic polymorphisms
5349350|NCT00254007|citalopram|citalopram
5349351|NCT00253981|Pain, Intractable|pain, intractable
5349352|NCT00253981|Infrared Rays|infrared rays
5349353|NCT00253981|Leg|leg
5349354|NCT00253968|Primary Insomnia|primary insomnia
5349355|NCT00253968|Sleeplessness|sleeplessness
5349356|NCT00253968|Early Awakening|early awakening
5349357|NCT00253968|Chronic Insomnia|chronic insomnia
5349358|NCT00253929|adenosine|adenosine
5349359|NCT00253929|polymorphisms|polymorphisms
5349360|NCT00253929|blood flow|blood flow
5349361|NCT00253929|adenosine A2a receptor|adenosine a2a receptor
5349362|NCT00253929|AMP deaminase|amp deaminase
5349363|NCT00253903|Primary Insomnia|primary insomnia
5349364|NCT00253903|Sleeplessness|sleeplessness
5349365|NCT00253903|Early Awakening|early awakening
5349366|NCT00253903|Chronic Insomnia|chronic insomnia
5349367|NCT00253890|sleep quality|sleep quality
5349368|NCT00253890|methadone|methadone
5349369|NCT00253890|substance use|substance use
5349370|NCT00253877|osteoarthritis|osteoarthritis
5349371|NCT00253877|hip resurfacing|hip resurfacing
5349372|NCT00253864|shoulder surgery|shoulder surgery
5349373|NCT00253864|prospective database|prospective database
5349374|NCT00253864|long term outcome|long term outcome
5349375|NCT00253851|DVT|dvt
5349376|NCT00253851|Osteoarthritis|osteoarthritis
5349377|NCT00253851|Total Knee Arthroplasty|total knee arthroplasty
5349378|NCT00253838|revision hip arthroplasty|revision hip arthroplasty
5349379|NCT00253838|bone mineral density|bone mineral density
5349380|NCT00253812|colonoscopy, sigmoidoscopy, chromoendoscopy, autofluorescence, narrow band imaging, colorectal cancer, polyp, adenoma,rectal remnant, FAP|colonoscopy, sigmoidoscopy, chromoendoscopy, autofluorescence, narrow band imaging, colorectal cancer, polyp, adenoma,rectal remnant, fap
5349381|NCT00253786|diabetes|diabetes
5349382|NCT00253786|nephropathy|nephropathy
5349383|NCT00253773|sulfer amino acids|sulfer amino acids
5349384|NCT00253773|redox status|redox status
5349385|NCT00253760|redox|redox
5349386|NCT00253760|sulfur amino acids|sulfur amino acids
5349387|NCT00253760|glutathione|glutathione
5349388|NCT00253760|aging|aging
5349389|NCT00253734|Influenza|influenza
5349390|NCT00253721|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5349391|NCT00253721|adult brain stem glioma|adult brain stem glioma
5349392|NCT00253721|adult diffuse astrocytoma|adult diffuse astrocytoma
5349393|NCT00253721|adult central nervous system germ cell tumor|adult central nervous system germ cell tumor
5349394|NCT00253721|adult medulloblastoma|adult medulloblastoma
5349395|NCT00253721|adult supratentorial primitive neuroectodermal tumor (PNET)|adult supratentorial primitive neuroectodermal tumor (pnet)
5349396|NCT00253721|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
5349397|NCT00253721|adult oligodendroglioma|adult oligodendroglioma
5349398|NCT00253721|adult pineoblastoma|adult pineoblastoma
5349399|NCT00253721|tumors metastatic to brain|tumors metastatic to brain
5349400|NCT00253721|adult mixed glioma|adult mixed glioma
5349401|NCT00253721|recurrent adult brain tumor|recurrent adult brain tumor
5349402|NCT00253721|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
5349403|NCT00253708|depression|depression
5349404|NCT00253708|nausea and vomiting|nausea and vomiting
5349405|NCT00253708|pain|pain
5349406|NCT00253708|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
5349407|NCT00253708|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5349408|NCT00253708|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5349409|NCT00253708|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5349410|NCT00253708|extensive stage small cell lung cancer|extensive stage small cell lung cancer
5349411|NCT00253708|stage III gastric cancer|stage iii gastric cancer
5349412|NCT00253708|stage III esophageal cancer|stage iii esophageal cancer
5349413|NCT00253708|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
5349414|NCT00253708|stage III colon cancer|stage iii colon cancer
5349415|NCT00253708|stage IV renal cell cancer|stage iv renal cell cancer
5349416|NCT00253708|stage IV bladder cancer|stage iv bladder cancer
5349417|NCT00253708|stage IV prostate cancer|stage iv prostate cancer
5349418|NCT00253708|stage IV breast cancer|stage iv breast cancer
5349419|NCT00253708|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5349420|NCT00253708|advanced adult primary liver cancer|advanced adult primary liver cancer
5349421|NCT00253708|stage IV melanoma|stage iv melanoma
5349422|NCT00253708|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
5349423|NCT00253708|ovarian sarcoma|ovarian sarcoma
5349424|NCT00253708|ovarian stromal cancer|ovarian stromal cancer
5349425|NCT00253708|recurrent small cell lung cancer|recurrent small cell lung cancer
5349426|NCT00253708|recurrent adult primary liver cancer|recurrent adult primary liver cancer
5349427|NCT00253708|recurrent colon cancer|recurrent colon cancer
5349428|NCT00253708|recurrent esophageal cancer|recurrent esophageal cancer
5349429|NCT00253708|recurrent gastric cancer|recurrent gastric cancer
5349430|NCT00253708|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5349431|NCT00253708|recurrent bladder cancer|recurrent bladder cancer
5349432|NCT00253708|recurrent breast cancer|recurrent breast cancer
5349433|NCT00253708|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5349434|NCT00253708|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
5349435|NCT00253708|recurrent prostate cancer|recurrent prostate cancer
5349436|NCT00253708|recurrent renal cell cancer|recurrent renal cell cancer
5349437|NCT00253708|recurrent melanoma|recurrent melanoma
5349438|NCT00253669|thromboembolism|thromboembolism
5349439|NCT00253669|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5349440|NCT00253669|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
5349441|NCT00253669|adult glioblastoma|adult glioblastoma
5349442|NCT00253669|adult giant cell glioblastoma|adult giant cell glioblastoma
5349443|NCT00253669|adult gliosarcoma|adult gliosarcoma
5349444|NCT00253643|prostate cancer|prostate cancer
5349445|NCT00253643|precancerous condition|precancerous condition
5349446|NCT00253591|stage I non-small cell lung cancer|stage i non-small cell lung cancer
5349447|NCT00253591|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
5349448|NCT00253591|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5349449|NCT00253591|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5349450|NCT00253565|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5349451|NCT00253552|graft versus host disease|graft versus host disease
5349452|NCT00253552|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5349453|NCT00253552|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5349454|NCT00253552|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5349455|NCT00253552|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5349456|NCT00253552|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5349457|NCT00253552|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5349458|NCT00253552|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5349459|NCT00253552|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5349460|NCT00253552|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
5349461|NCT00253552|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5349462|NCT00253552|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
5349463|NCT00253552|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
5349464|NCT00253552|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
5349465|NCT00253552|chronic eosinophilic leukemia|chronic eosinophilic leukemia
5349466|NCT00253552|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
5349467|NCT00253552|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5349468|NCT00253552|chronic neutrophilic leukemia|chronic neutrophilic leukemia
5349469|NCT00253552|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5349470|NCT00253552|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5349471|NCT00253552|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5349472|NCT00253552|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
5349473|NCT00253552|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
5349474|NCT00253552|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5349475|NCT00253552|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
5349476|NCT00253552|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5349477|NCT00253552|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
5349478|NCT00253552|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
5349479|NCT00253552|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
5349480|NCT00253552|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
5349481|NCT00253552|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5349482|NCT00253552|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5349483|NCT00253552|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5349484|NCT00253552|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5349485|NCT00253552|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
5349486|NCT00253552|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
5349487|NCT00253552|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5349488|NCT00253552|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5349489|NCT00253552|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5349490|NCT00253552|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5349491|NCT00253552|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5349492|NCT00253552|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5349493|NCT00253552|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5349494|NCT00253552|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5349495|NCT00253552|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5349496|NCT00253552|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5349497|NCT00253552|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
5349498|NCT00253552|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5349499|NCT00253552|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5349500|NCT00253552|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
5349501|NCT00253552|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
5349502|NCT00253552|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
5349503|NCT00253552|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
5349504|NCT00253552|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5349505|NCT00253552|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5349506|NCT00253552|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5349507|NCT00253552|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5349508|NCT00253552|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5349509|NCT00253552|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5349510|NCT00253552|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5349511|NCT00253552|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5349512|NCT00253552|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5349513|NCT00253552|refractory hairy cell leukemia|refractory hairy cell leukemia
5349514|NCT00253552|refractory multiple myeloma|refractory multiple myeloma
5349515|NCT00253552|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5349516|NCT00253552|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5349517|NCT00253552|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5349518|NCT00253552|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5349519|NCT00253552|stage I multiple myeloma|stage i multiple myeloma
5349520|NCT00253552|stage II multiple myeloma|stage ii multiple myeloma
5349521|NCT00253552|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5349522|NCT00253552|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5349523|NCT00253552|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5349524|NCT00253552|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5349525|NCT00253552|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5349526|NCT00253552|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5349527|NCT00253552|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5349528|NCT00253552|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5349529|NCT00253552|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5349530|NCT00253552|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5349531|NCT00253552|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5349532|NCT00253552|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5349533|NCT00253552|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5349534|NCT00253552|stage III multiple myeloma|stage iii multiple myeloma
5349535|NCT00253552|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5349536|NCT00253552|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5349537|NCT00253552|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5349538|NCT00253552|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5349539|NCT00253552|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5349540|NCT00253552|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5349541|NCT00253552|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5349542|NCT00253552|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5349543|NCT00253552|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5349544|NCT00253552|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5349545|NCT00253552|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5349546|NCT00253552|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5349547|NCT00253552|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5349548|NCT00253552|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5349549|NCT00253552|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5349550|NCT00253552|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
5349551|NCT00253539|hereditary breast/ovarian cancer (BRCA1, BRCA2)|hereditary breast/ovarian cancer (brca1, brca2)
5349552|NCT00253539|breast cancer|breast cancer
5349553|NCT00253513|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5349554|NCT00253513|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5349555|NCT00253513|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
5349556|NCT00253513|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5349557|NCT00253513|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5349558|NCT00253513|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5349559|NCT00253513|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5349560|NCT00253513|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5349561|NCT00253513|myelodysplastic syndromes|myelodysplastic syndromes
5349562|NCT00253513|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
5349563|NCT00253500|stage II breast cancer|stage ii breast cancer
5349564|NCT00253500|stage I breast cancer|stage i breast cancer
5349565|NCT00253500|stage IIIA breast cancer|stage iiia breast cancer
5349566|NCT00253500|stage IIIB breast cancer|stage iiib breast cancer
5349567|NCT00253487|adult glioblastoma|adult glioblastoma
5349568|NCT00253487|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5349569|NCT00253487|childhood high-grade cerebral astrocytoma|childhood high-grade cerebral astrocytoma
5349570|NCT00253487|adult giant cell glioblastoma|adult giant cell glioblastoma
5349571|NCT00253487|adult gliosarcoma|adult gliosarcoma
5349572|NCT00253474|neoplasm of uncertain malignant potential|neoplasm of uncertain malignant potential
5349573|NCT00253474|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
5349574|NCT00253461|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5349575|NCT00253461|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
5349576|NCT00253461|extensive stage small cell lung cancer|extensive stage small cell lung cancer
5349577|NCT00253461|recurrent small cell lung cancer|recurrent small cell lung cancer
5349578|NCT00253461|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5349579|NCT00253461|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5349580|NCT00253461|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
5349581|NCT00253461|tumors metastatic to brain|tumors metastatic to brain
5349582|NCT00253448|adult glioblastoma|adult glioblastoma
5349583|NCT00253448|adult giant cell glioblastoma|adult giant cell glioblastoma
5349584|NCT00253448|adult gliosarcoma|adult gliosarcoma
5349585|NCT00253435|recurrent neuroblastoma|recurrent neuroblastoma
5349586|NCT00253422|recurrent breast cancer|recurrent breast cancer
5349587|NCT00253422|stage IV breast cancer|stage iv breast cancer
5349588|NCT00253422|stage IIIB breast cancer|stage iiib breast cancer
5349589|NCT00253422|stage IIIC breast cancer|stage iiic breast cancer
5349590|NCT00253409|localized malignant mesothelioma|localized malignant mesothelioma
5349591|NCT00253396|warfarin|warfarin
5349592|NCT00253396|clinical trial|clinical trial
5349593|NCT00253396|pain measurement|pain measurement
5349594|NCT00253396|heparin|heparin
5349595|NCT00253396|heparin, low-molecular-weight|heparin, low-molecular-weight
5349596|NCT00253396|Anticoagulants|anticoagulants
5349597|NCT00253383|transitional care planning|transitional care planning
5349598|NCT00253383|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5349599|NCT00253383|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5349600|NCT00253383|extensive stage small cell lung cancer|extensive stage small cell lung cancer
5349601|NCT00253383|stage IV breast cancer|stage iv breast cancer
5349602|NCT00253383|recurrent breast cancer|recurrent breast cancer
5349603|NCT00253383|male breast cancer|male breast cancer
5349604|NCT00253383|stage IIIB anal cancer|stage iiib anal cancer
5349605|NCT00253383|stage IV anal cancer|stage iv anal cancer
5349606|NCT00253383|carcinoma of the appendix|carcinoma of the appendix
5349607|NCT00253383|stage III colon cancer|stage iii colon cancer
5349608|NCT00253383|stage IV colon cancer|stage iv colon cancer
5349609|NCT00253383|stage III rectal cancer|stage iii rectal cancer
5349610|NCT00253383|stage IV rectal cancer|stage iv rectal cancer
5349611|NCT00253383|stage III esophageal cancer|stage iii esophageal cancer
5349612|NCT00253383|stage IV esophageal cancer|stage iv esophageal cancer
5349613|NCT00253383|unresectable extrahepatic bile duct cancer|unresectable extrahepatic bile duct cancer
5349614|NCT00253383|unresectable gallbladder cancer|unresectable gallbladder cancer
5349615|NCT00253383|stage III gastric cancer|stage iii gastric cancer
5349616|NCT00253383|stage IV gastric cancer|stage iv gastric cancer
5349617|NCT00253383|metastatic gastrointestinal carcinoid tumor|metastatic gastrointestinal carcinoid tumor
5349618|NCT00253383|regional gastrointestinal carcinoid tumor|regional gastrointestinal carcinoid tumor
5349619|NCT00253383|gastrointestinal stromal tumor|gastrointestinal stromal tumor
5349620|NCT00253383|advanced adult primary liver cancer|advanced adult primary liver cancer
5349621|NCT00253383|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
5349622|NCT00253383|stage III pancreatic cancer|stage iii pancreatic cancer
5349623|NCT00253383|recurrent small intestine cancer|recurrent small intestine cancer
5349624|NCT00253383|small intestine adenocarcinoma|small intestine adenocarcinoma
5349625|NCT00253383|small intestine leiomyosarcoma|small intestine leiomyosarcoma
5349626|NCT00253383|small intestine lymphoma|small intestine lymphoma
5349627|NCT00253383|stage IV bladder cancer|stage iv bladder cancer
5349628|NCT00253383|stage IV renal cell cancer|stage iv renal cell cancer
5349629|NCT00253383|clear cell sarcoma of the kidney|clear cell sarcoma of the kidney
5349630|NCT00253383|peripheral primitive neuroectodermal tumor of the kidney|peripheral primitive neuroectodermal tumor of the kidney
5349631|NCT00253383|rhabdoid tumor of the kidney|rhabdoid tumor of the kidney
5349632|NCT00253383|metastatic transitional cell cancer of the renal pelvis and ureter|metastatic transitional cell cancer of the renal pelvis and ureter
5349633|NCT00253383|anterior urethral cancer|anterior urethral cancer
5349634|NCT00253383|posterior urethral cancer|posterior urethral cancer
5349635|NCT00253383|urethral cancer associated with invasive bladder cancer|urethral cancer associated with invasive bladder cancer
5349636|NCT00253383|stage IV penile cancer|stage iv penile cancer
5349637|NCT00253383|stage IV prostate cancer|stage iv prostate cancer
5349839|NCT00252538|Tryptophan|tryptophan
5349638|NCT00253383|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
5349639|NCT00253383|stage IV endometrial carcinoma|stage iv endometrial carcinoma
5349640|NCT00253383|fallopian tube cancer|fallopian tube cancer
5349641|NCT00253383|ovarian sarcoma|ovarian sarcoma
5349642|NCT00253383|ovarian stromal cancer|ovarian stromal cancer
5349643|NCT00253383|stage IV pancreatic cancer|stage iv pancreatic cancer
5349644|NCT00253370|Sorafenib|sorafenib
5349645|NCT00253370|Docetaxel|docetaxel
5349646|NCT00253370|Cisplatin|cisplatin
5349647|NCT00253370|gastric cancer|gastric cancer
5349648|NCT00253370|gastroesophageal junction adenocarcinoma|gastroesophageal junction adenocarcinoma
5349649|NCT00253357|Heart Failure|heart failure
5349650|NCT00253357|Congestive Heart Failure|congestive heart failure
5349651|NCT00253357|Fluid overload|fluid overload
5349652|NCT00253357|Left sided heart failure|left sided heart failure
5349653|NCT00253357|Pacemaker|pacemaker
5349654|NCT00253357|Defibrillator|defibrillator
5349655|NCT00253344|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5349656|NCT00253331|Raynaud's|raynaud's
5349657|NCT00253331|sclerderma|sclerderma
5349658|NCT00253331|systemic sclerosis|systemic sclerosis
5349659|NCT00253331|autoimmune disease|autoimmune disease
5349660|NCT00253318|Neoplasm Metastasis|neoplasm metastasis
5349661|NCT00253318|Breast Cancer|breast cancer
5349662|NCT00253318|Docetaxel|docetaxel
5349663|NCT00253318|RAD001|rad001
5349664|NCT00253318|Taxotere|taxotere
5349665|NCT00253305|tinea unguium|tinea unguium
5349666|NCT00253305|onychomycosis|onychomycosis
5349667|NCT00253292|Burns|burns
5349668|NCT00253292|Trauma|trauma
5349669|NCT00253292|Outcomes|outcomes
5349670|NCT00253292|Quality of Life|quality of life
5349671|NCT00253279|Protein Synthesis Rate|protein synthesis rate
5349672|NCT00253279|Burn Injury|burn injury
5349673|NCT00253279|PET Scan|pet scan
5349674|NCT00253266|Treatment resistant depression|treatment resistant depression
5349675|NCT00253266|Augmentation|augmentation
5349676|NCT00253266|Pharmacogenetics|pharmacogenetics
5349677|NCT00253253|orchidopexy, long-term outcome, congenital|orchidopexy, long-term outcome, congenital
5349678|NCT00253227|Alzheimer's disease|alzheimer's disease
5349679|NCT00253227|dementia|dementia
5349680|NCT00253227|brain disease|brain disease
5349681|NCT00253227|memory loss|memory loss
5349682|NCT00253227|galantamine|galantamine
5349683|NCT00253227|placebo|placebo
5349684|NCT00253214|Alzheimer's disease|alzheimer's disease
5349685|NCT00253214|dementia|dementia
5349686|NCT00253214|galantamine hydrobromide|galantamine hydrobromide
5349687|NCT00253214|controlled-release|controlled-release
5349688|NCT00253214|once-daily dosing|once-daily dosing
5349689|NCT00253201|Alzheimer's disease|alzheimer's disease
5349690|NCT00253201|dementia|dementia
5349691|NCT00253201|brain disease|brain disease
5349692|NCT00253201|memory loss|memory loss
5349693|NCT00253201|galantamine|galantamine
5349694|NCT00253201|placebo|placebo
5349695|NCT00253201|caregiver|caregiver
5349696|NCT00253201|quality of life|quality of life
5349697|NCT00253201|resource utilization|resource utilization
5349698|NCT00253188|Alzheimer's disease|alzheimer's disease
5349699|NCT00253188|dementia|dementia
5349700|NCT00253188|brain disease|brain disease
5349701|NCT00253188|memory loss|memory loss
5349702|NCT00253188|galantamine|galantamine
5349703|NCT00253188|placebo|placebo
5349704|NCT00253188|caregiver|caregiver
5349705|NCT00253188|quality of life|quality of life
5349706|NCT00253188|resource utilization|resource utilization
5349707|NCT00253175|topiramate|topiramate
5349708|NCT00253175|migraine headache|migraine headache
5349709|NCT00253175|migraine prevention|migraine prevention
5349710|NCT00253175|migraine|migraine
5349711|NCT00253162|risperidone|risperidone
5349712|NCT00253162|antipsychotic agents|antipsychotic agents
5349713|NCT00253162|bipolar disorders|bipolar disorders
5349714|NCT00253162|manic episode|manic episode
5349715|NCT00253149|risperidone|risperidone
5349716|NCT00253149|antipsychotic agents|antipsychotic agents
5349717|NCT00253149|bipolar disorders|bipolar disorders
5349718|NCT00253149|manic episode|manic episode
5349719|NCT00253136|schizophrenia|schizophrenia
5349720|NCT00253136|schizoaffective disorder|schizoaffective disorder
5349721|NCT00253136|psychotic disorder|psychotic disorder
5349722|NCT00253136|risperidone|risperidone
5349723|NCT00253136|long-acting injectable|long-acting injectable
5349724|NCT00253136|intramuscular injection|intramuscular injection
5349725|NCT00253136|antipsychotic agents|antipsychotic agents
5349726|NCT00253123|Dementia|dementia
5349727|NCT00253123|Alzheimer's disease|alzheimer's disease
5349728|NCT00253123|vascular dementia|vascular dementia
5349729|NCT00253123|mixed dementia|mixed dementia
5349730|NCT00253123|risperidone|risperidone
5349731|NCT00253123|nursing home|nursing home
5349732|NCT00253110|Schizophrenia, Psychotic Disorders|schizophrenia, psychotic disorders
5349733|NCT00253110|Haloperidol|haloperidol
5349734|NCT00253110|Risperidone|risperidone
5349735|NCT00253110|Schizoaffective disorder|schizoaffective disorder
5349736|NCT00253097|stroke recurrence|stroke recurrence
5349737|NCT00253097|risk factors|risk factors
5349738|NCT00253097|health behavior|health behavior
5349739|NCT00253097|intervention|intervention
5349740|NCT00253097|tertiary prevention|tertiary prevention
5349741|NCT00253071|Prophylactic treatment|prophylactic treatment
5349742|NCT00253071|Pharmacological treatment|pharmacological treatment
5349743|NCT00253071|Psychological treatment|psychological treatment
5349744|NCT00253058|Allergic|allergic
5349745|NCT00253058|pediatric|pediatric
5349746|NCT00253058|Rhinitis|rhinitis
5349747|NCT00253058|Perennial|perennial
5349748|NCT00253045|Motivational Interviewing|motivational interviewing
5349749|NCT00253045|antiretroviral therapy|antiretroviral therapy
5349750|NCT00253045|medication adherence|medication adherence
5349751|NCT00253045|risk reduction behaviors|risk reduction behaviors
5349752|NCT00253045|women|women
5349753|NCT00253045|HIV|hiv
5349754|NCT00253045|AIDS|aids
5349755|NCT00253019|birth control|birth control
5349756|NCT00253019|continuation|continuation
5349757|NCT00253019|abortion|abortion
5349758|NCT00253019|contraception|contraception
5349759|NCT00253006|NO|no
5349760|NCT00253006|mRNA-expression|mrna-expression
5349761|NCT00253006|pathophysiology|pathophysiology
5349762|NCT00253006|painful bladder syndrome|painful bladder syndrome
5349763|NCT00252993|Nausea|nausea
5349764|NCT00252993|Vomiting|vomiting
5349765|NCT00252993|Chronic Functional Vomiting|chronic functional vomiting
5349766|NCT00252993|Functional Vomiting|functional vomiting
5349767|NCT00252993|Cyclic Vomiting|cyclic vomiting
5349768|NCT00252980|Cannabis|cannabis
5349769|NCT00252980|Dependence|dependence
5349770|NCT00252980|Marijuana|marijuana
5349771|NCT00252980|Substance Abuse Treatment|substance abuse treatment
5349772|NCT00252980|Psychotherapy,|psychotherapy,
5349773|NCT00252967|Reactive Oxgen Speers|reactive oxgen speers
5349774|NCT00252967|Atrial Fibrillation|atrial fibrillation
5349775|NCT00252967|Oxidative Stress|oxidative stress
5349776|NCT00252967|Inflammation|inflammation
5349777|NCT00252954|Spinal cord injury|spinal cord injury
5349778|NCT00252954|Neuropathic pain|neuropathic pain
5349779|NCT00252954|Spasms|spasms
5349780|NCT00252941|prostate cancer|prostate cancer
5349781|NCT00252941|brachytherapy|brachytherapy
5349782|NCT00252941|urethral stenting|urethral stenting
5349783|NCT00252928|sodium dichloroisocyanurate|sodium dichloroisocyanurate
5349784|NCT00252928|water purification|water purification
5349785|NCT00252928|disinfection|disinfection
5349786|NCT00252928|Ghana|ghana
5349787|NCT00252902|tobacco; emergency department; motivation; counseling|tobacco; emergency department; motivation; counseling
5349788|NCT00252889|Metastatic cancer|metastatic cancer
5349789|NCT00252889|Metastatic gastric and esophagus adenocarcinoma|metastatic gastric and esophagus adenocarcinoma
5349790|NCT00252889|Unresectable pancreatic cancer|unresectable pancreatic cancer
5349791|NCT00252889|Unresectable head and neck cancer|unresectable head and neck cancer
5349792|NCT00252889|Cancer of undetermined primary|cancer of undetermined primary
5349793|NCT00252850|Parkinson's Disease|parkinson's disease
5349794|NCT00252850|Gene Transfer|gene transfer
5349795|NCT00252798|Non Small Cell Lung Cancer|non small cell lung cancer
5349796|NCT00252785|Asthma|asthma
5349797|NCT00252746|NSCLC|nsclc
5349798|NCT00252746|Non Small Cell Lung Cancer|non small cell lung cancer
5349799|NCT00252733|Diabetes Mellitus, Insulin-Dependent|diabetes mellitus, insulin-dependent
5349800|NCT00252720|Diabetes mellitus type 1|diabetes mellitus type 1
5349801|NCT00252694|Diabetes mellitus type 2|diabetes mellitus type 2
5349802|NCT00252681|randomized|randomized
5349803|NCT00252681|controlled|controlled
5349804|NCT00252681|trial|trial
5349805|NCT00252681|necrotizing|necrotizing
5349806|NCT00252681|enterocolitis|enterocolitis
5349807|NCT00252681|premature|premature
5349808|NCT00252681|infants|infants
5349809|NCT00252681|laparotomy|laparotomy
5349810|NCT00252681|peritoneal|peritoneal
5349811|NCT00252681|drainage|drainage
5349812|NCT00252668|Rheumatoid Arthritis|rheumatoid arthritis
5349813|NCT00252642|Hepatitis C|hepatitis c
5349814|NCT00252642|Interferon|interferon
5349815|NCT00252642|Cirrhosis|cirrhosis
5349816|NCT00252642|Liver Disease|liver disease
5349817|NCT00252642|Portal Hypertension|portal hypertension
5349818|NCT00252642|Portal Pressure|portal pressure
5349819|NCT00252629|Fatigue|fatigue
5349820|NCT00252629|Functional Somatic Syndrome|functional somatic syndrome
5349821|NCT00252629|Gulf War Syndrome|gulf war syndrome
5349822|NCT00252629|Sleep apnea|sleep apnea
5349823|NCT00252629|Upper Airway Resistance Syndrome|upper airway resistance syndrome
5349824|NCT00252616|Mechanical ventilation|mechanical ventilation
5349825|NCT00252616|acute respiratory failure|acute respiratory failure
5349826|NCT00252616|early nutrition|early nutrition
5349827|NCT00252603|Autism|autism
5349828|NCT00252603|Childhood Autism|childhood autism
5349829|NCT00252590|Psychotherapy motivational intervention|psychotherapy motivational intervention
5349830|NCT00252577|Lithium|lithium
5349831|NCT00252577|Pharmacogenetics|pharmacogenetics
5349832|NCT00252551|spondylolisthesis, decompressive surgery, osteosynthesis|spondylolisthesis, decompressive surgery, osteosynthesis
5349833|NCT00252538|Cortisol|cortisol
5349834|NCT00252538|Depression|depression
5349835|NCT00252538|Hepatitis C|hepatitis c
5349836|NCT00252538|Interferon|interferon
5349837|NCT00252538|Polymorphism|polymorphism
5349838|NCT00252538|Serotonin|serotonin
5349840|NCT00252512|Contingency management interventions|contingency management interventions
5349841|NCT00252512|Substance use disorders treatment|substance use disorders treatment
5349842|NCT00252512|Treatment effectiveness|treatment effectiveness
5349843|NCT00252512|Randomized clinical trial|randomized clinical trial
5349844|NCT00252512|Behavioral research|behavioral research
5349845|NCT00252499|beta cell function|beta cell function
5349846|NCT00252499|fenofibrate|fenofibrate
5349847|NCT00252499|non-alcoholic steatohepatitis|non-alcoholic steatohepatitis
5349848|NCT00252499|rosiglitazone|rosiglitazone
5349849|NCT00252499|insulin sensitivity|insulin sensitivity
5349850|NCT00252486|Bipolar|bipolar
5349851|NCT00252486|Omega-3 Fatty acids|omega-3 fatty acids
5349852|NCT00252434|high-risk sexual behavior|high-risk sexual behavior
5349853|NCT00252434|methamphetamine use|methamphetamine use
5349854|NCT00252434|drug craving|drug craving
5349855|NCT00252434|addiction behaviors|addiction behaviors
5349856|NCT00252421|osteoporosis|osteoporosis
5349857|NCT00252421|bone mineral density|bone mineral density
5349858|NCT00252421|nitrates|nitrates
5349859|NCT00252408|Fracture|fracture
5349860|NCT00252408|Osteoporosis|osteoporosis
5349861|NCT00252408|Bone mineral density|bone mineral density
5349862|NCT00252408|Hormone replacement therapy|hormone replacement therapy
5349863|NCT00252408|Estrogen|estrogen
5349864|NCT00252408|Breast cancer|breast cancer
5349865|NCT00252395|medication error|medication error
5349866|NCT00252395|electronic prescribing|electronic prescribing
5349867|NCT00252395|patient safety|patient safety
5349868|NCT00252382|Lung|lung
5349869|NCT00252382|Squamous Cell|squamous cell
5349870|NCT00252382|Large Cell|large cell
5349871|NCT00252382|Adenocarcinoma|adenocarcinoma
5349872|NCT00252382|Carcinoma|carcinoma
5349873|NCT00252382|Cancer|cancer
5349874|NCT00252356|major depressive disorder|major depressive disorder
5349875|NCT00252356|depression|depression
5349876|NCT00252356|major depressive episode|major depressive episode
5349877|NCT00252356|antidepressive agents|antidepressive agents
5349878|NCT00252343|anxiety disorder|anxiety disorder
5349879|NCT00252330|major depressive disorder|major depressive disorder
5349880|NCT00252330|depression|depression
5349881|NCT00252330|major depressive episode|major depressive episode
5349882|NCT00252330|antidepressive agents|antidepressive agents
5349883|NCT00252317|Aortic stenosis|aortic stenosis
5349884|NCT00252317|ACE-inhibitores|ace-inhibitores
5349885|NCT00252304|Child, severe pneumonia, Zinc, Nepal, therapeutic|child, severe pneumonia, zinc, nepal, therapeutic
5349886|NCT00252291|bronchial|bronchial
5349887|NCT00252291|hyperresponsiveness|hyperresponsiveness
5349888|NCT00252239|stroke|stroke
5349889|NCT00252239|tenecteplase|tenecteplase
5349890|NCT00252239|TNK|tnk
5349891|NCT00252239|ischemic|ischemic
5349892|NCT00252239|tissue plasminogen activator|tissue plasminogen activator
5349893|NCT00252239|tPA|tpa
5349894|NCT00252226|Quetiapine|quetiapine
5349895|NCT00252226|bipolar spectrum disorders|bipolar spectrum disorders
5349896|NCT00252187|Heart failure|heart failure
5349897|NCT00252187|Natriuretic peptides|natriuretic peptides
5349898|NCT00252187|B-type natriuretic peptide|b-type natriuretic peptide
5349899|NCT00252187|Kidney|kidney
5349900|NCT00252187|Nesiritide|nesiritide
5349901|NCT00252187|Natrecor|natrecor
5349902|NCT00252187|CHF|chf
5349903|NCT00252174|MDMA|mdma
5349904|NCT00252174|cancer|cancer
5349905|NCT00252174|anxiety|anxiety
5349906|NCT00252174|psychotherapy|psychotherapy
5349907|NCT00252174|quality of life|quality of life
5349908|NCT00252161|Neoadjuvant Therapy|neoadjuvant therapy
5349909|NCT00252161|Stomach Neoplasms|stomach neoplasms
5349910|NCT00252161|Cisplatin|cisplatin
5349911|NCT00252161|S-1(combination)|s-1(combination)
5349912|NCT00252148|HIV Preventive Vaccine|hiv preventive vaccine
5349913|NCT00252135|Moderate to severe asthma|moderate to severe asthma
5349914|NCT00252109|HIV|hiv
5349915|NCT00252109|Seropositive|seropositive
5349916|NCT00252109|MSM|msm
5349917|NCT00252109|African American|african american
5349918|NCT00252109|Popular Opinion Leader|popular opinion leader
5349919|NCT00252096|Diagnosis|diagnosis
5349920|NCT00252096|Chlamydia trachomatis|chlamydia trachomatis
5349921|NCT00252096|Neisseria gonorrhoeae|neisseria gonorrhoeae
5349922|NCT00252096|Nucleic acid amplification test|nucleic acid amplification test
5349923|NCT00252096|Rectum|rectum
5349924|NCT00252096|Pharynx|pharynx
5349925|NCT00252083|Seropositive|seropositive
5349926|NCT00252083|MSM|msm
5349927|NCT00252083|Hispanic|hispanic
5349928|NCT00252083|Popular Opinion Leader|popular opinion leader
5349929|NCT00252083|HIV|hiv
5349930|NCT00252070|arthritis|arthritis
5349931|NCT00252070|exercise|exercise
5349932|NCT00252070|function|function
5349933|NCT00252070|pain|pain
5349934|NCT00252057|rehospitalization|rehospitalization
5349935|NCT00252057|readmission|readmission
5349936|NCT00252057|adverse events|adverse events
5349937|NCT00252057|discharge|discharge
5349938|NCT00252031|Borderline Personality Disorder|borderline personality disorder
5349939|NCT00252031|BPD|bpd
5349940|NCT00252031|Dialectical Behavior Therapy|dialectical behavior therapy
5349941|NCT00252031|DBT|dbt
5349942|NCT00252018|Nutritional supplement|nutritional supplement
5349943|NCT00252018|Prevention|prevention
5349944|NCT00252018|Endothelial function|endothelial function
5349945|NCT00252018|Flow mediated dilation|flow mediated dilation
5349946|NCT00251966|Prevention of gastroduodenal lesions|prevention of gastroduodenal lesions
5349947|NCT00251966|erosive oesophagitis|erosive oesophagitis
5349948|NCT00251966|upper GI symptoms|upper gi symptoms
5349949|NCT00251927|Acid reflux disease|acid reflux disease
5349950|NCT00251927|Gastroesophageal Reflux Disease|gastroesophageal reflux disease
5349951|NCT00251901|Gastroesophageal reflux disease|gastroesophageal reflux disease
5349952|NCT00251901|GERD|gerd
5349953|NCT00251888|cervix cancer|cervix cancer
5349954|NCT00251888|advanced cervix cancer|advanced cervix cancer
5349955|NCT00251888|radiochemotherapy|radiochemotherapy
5349956|NCT00251888|pelvic radiotherapy|pelvic radiotherapy
5349957|NCT00251888|campto|campto
5349958|NCT00251888|cisplatin|cisplatin
5349959|NCT00251888|irinotecan|irinotecan
5349960|NCT00251888|cisplatyl|cisplatyl
5349961|NCT00251888|maximum dose search|maximum dose search
5349962|NCT00251875|patient portals|patient portals
5349963|NCT00251875|electronic health records|electronic health records
5349964|NCT00251875|family history|family history
5349965|NCT00251875|health maintenance|health maintenance
5349966|NCT00251875|medications|medications
5349967|NCT00251875|diabetes|diabetes
5349968|NCT00251862|Colorectal cancer screening|colorectal cancer screening
5349969|NCT00251862|Shared decision-making|shared decision-making
5349970|NCT00251862|Decision aid|decision aid
5349971|NCT00251849|Intermittent Claudication|intermittent claudication
5349972|NCT00251836|Kidney donation|kidney donation
5349973|NCT00251836|Organ Donation|organ donation
5349974|NCT00251836|Vascular anatomy|vascular anatomy
5349975|NCT00251836|Adrenal Insufficiency|adrenal insufficiency
5349976|NCT00251823|ST-Elevation Myocardial Infarction|st-elevation myocardial infarction
5349977|NCT00251810|general anaesthesia|general anaesthesia
5349978|NCT00251810|depth of hypnosis|depth of hypnosis
5349979|NCT00251810|Cerebral State Monitor|cerebral state monitor
5349980|NCT00251810|CSM|csm
5349981|NCT00251810|Bispectral Index|bispectral index
5349982|NCT00251810|BIS|bis
5349983|NCT00251797|Phase I|phase i
5349984|NCT00251797|Brain cancer|brain cancer
5349985|NCT00251797|Recurrent CNS tumors|recurrent cns tumors
5349986|NCT00251771|Thrombolytic therapy|thrombolytic therapy
5349987|NCT00251771|Postphlebitic syndrome|postphlebitic syndrome
5349988|NCT00251771|Venous thrombosis|venous thrombosis
5349989|NCT00251758|Non-Erosive Gastroesophageal Reflux Disease(GERD),heartburn|non-erosive gastroesophageal reflux disease(gerd),heartburn
5349990|NCT00251745|Non-Erosive Gastroesophageal Reflux Disease (GERD)|non-erosive gastroesophageal reflux disease (gerd)
5349991|NCT00251745|Heartburn|heartburn
5349992|NCT00251732|acid reflux studies|acid reflux studies
5349993|NCT00251732|efficacy of PPI therapy|efficacy of ppi therapy
5349994|NCT00251732|failing PPI therapy|failing ppi therapy
5349995|NCT00251732|GERD|gerd
5349996|NCT00251732|Acid Reflux Disease|acid reflux disease
5349997|NCT00251719|Erosive Esophagitis|erosive esophagitis
5349998|NCT00251706|atrial fibrillation|atrial fibrillation
5349999|NCT00251706|atrial flutter|atrial flutter
5350000|NCT00251706|amiodarone|amiodarone
5350001|NCT00251706|post-operative|post-operative
5350002|NCT00251706|coronary artery bypass surgery|coronary artery bypass surgery
5350003|NCT00251706|valve replacement or repair|valve replacement or repair
5350004|NCT00251693|Erosive Esophagitis|erosive esophagitis
5350005|NCT00251680|Hyperlipidemia|hyperlipidemia
5350006|NCT00251680|Drug Therapy|drug therapy
5350007|NCT00251654|complications|complications
5350008|NCT00251654|adverse events|adverse events
5350009|NCT00251654|regional anesthesia|regional anesthesia
5350010|NCT00251654|adverse effects|adverse effects
5350011|NCT00251628|Tonsils|tonsils
5350012|NCT00251628|Tonsillectomy|tonsillectomy
5350013|NCT00251615|vascular surgery|vascular surgery
5350014|NCT00251615|vascular aging|vascular aging
5350015|NCT00251615|arterial aging|arterial aging
5350016|NCT00251615|surgical tissue|surgical tissue
5350017|NCT00251615|Aging|aging
5350018|NCT00251602|heart rate variability|heart rate variability
5350019|NCT00251602|gene response|gene response
5350020|NCT00251589|Relapsed Non-Small-Cell Lung Cancer|relapsed non-small-cell lung cancer
5350021|NCT00251589|Refractory Non-Small-Cell Lung Cancer|refractory non-small-cell lung cancer
5350022|NCT00251563|Cancer,Risk factors|cancer,risk factors
5350023|NCT00251537|Pilot study|pilot study
5350024|NCT00251537|Randomized|randomized
5350025|NCT00251537|Placebo-controlled|placebo-controlled
5350026|NCT00251537|Double-blind|double-blind
5350027|NCT00251537|Effect on viral load|effect on viral load
5350028|NCT00251537|LTB4|ltb4
5350029|NCT00251537|HIV-1 infection|hiv-1 infection
5350030|NCT00251498|Metastatic 1st line NSCLC|metastatic 1st line nsclc
5350031|NCT00251485|Metastatic 1st line colorectal cancer|metastatic 1st line colorectal cancer
5350032|NCT00251459|SAILOR|sailor
5350034|NCT00251459|AMD|amd
5350035|NCT00251459|CNV secondary to AMD|cnv secondary to amd
5350036|NCT00251433|ErbB1|erbb1
5350037|NCT00251433|ErbB2|erbb2
5350038|NCT00251433|trastuzumab (Herceptin)|trastuzumab (herceptin)
5350039|NCT00251433|lapatinib|lapatinib
5350040|NCT00251433|Stage IV breast cancer|stage iv breast cancer
5350141|NCT00251147|open|open
5350041|NCT00251433|metastatic breast cancer|metastatic breast cancer
5350042|NCT00251433|overexpression of ErbB2 receptors|overexpression of erbb2 receptors
5350043|NCT00251433|docetaxel (Taxotere)|docetaxel (taxotere)
5350044|NCT00251420|copd|copd
5350045|NCT00251420|asthma|asthma
5350046|NCT00251420|QoL|qol
5350047|NCT00251420|Perceived health status|perceived health status
5350048|NCT00251420|Trait anxiety|trait anxiety
5350049|NCT00251407|Advanced solid tumor malignancy|advanced solid tumor malignancy
5350050|NCT00251407|cisplatin|cisplatin
5350051|NCT00251407|CPT-11|cpt-11
5350052|NCT00251407|taxotere|taxotere
5350053|NCT00251394|B-Cell follicular non-Hodgkin's lymphoma|b-cell follicular non-hodgkin's lymphoma
5350054|NCT00251394|Rituxan|rituxan
5350055|NCT00251394|Rituximab|rituximab
5350056|NCT00251394|1018 ISS|1018 iss
5350057|NCT00251394|CD 20 +|cd 20 +
5350058|NCT00251381|Oropharyngeal Neoplasms|oropharyngeal neoplasms
5350059|NCT00251381|Cetuximab|cetuximab
5350060|NCT00251381|Concomitant-boost accelerated radiotherapy|concomitant-boost accelerated radiotherapy
5350061|NCT00251368|leukemia|leukemia
5350062|NCT00251368|9-Aminocamptothecin|9-aminocamptothecin
5350063|NCT00251368|AML|aml
5350064|NCT00251368|ALL|all
5350065|NCT00251368|refractory leukemia|refractory leukemia
5350066|NCT00251368|relapsed leukemia|relapsed leukemia
5350067|NCT00251355|gemcitabine|gemcitabine
5350068|NCT00251355|5-fluorouracil|5-fluorouracil
5350069|NCT00251355|5-FU|5-fu
5350070|NCT00251355|unresectable pancreatic cancer|unresectable pancreatic cancer
5350071|NCT00251355|non-metastatic pancreatic cancer|non-metastatic pancreatic cancer
5350072|NCT00251342|Postnatal depression|postnatal depression
5350073|NCT00251342|Randomized controlled trial|randomized controlled trial
5350074|NCT00251342|Screening|screening
5350075|NCT00251342|Outcome|outcome
5350076|NCT00251342|Edinburgh Postnatal Depression Scale|edinburgh postnatal depression scale
5350077|NCT00251329|Neoadjuvant|neoadjuvant
5350078|NCT00251329|Breast Cancer|breast cancer
5350079|NCT00251329|pCR|pcr
5350080|NCT00251329|Capecitabine|capecitabine
5350081|NCT00251329|Carboplatin|carboplatin
5350082|NCT00251329|Docetaxel|docetaxel
5350083|NCT00251316|Thyroid Neoplasm|thyroid neoplasm
5350084|NCT00251316|I-131|i-131
5350085|NCT00251316|Radiation Dose|radiation dose
5350086|NCT00251316|Radiation Effect|radiation effect
5350087|NCT00251316|Pharmaceutical Adjuvant|pharmaceutical adjuvant
5350088|NCT00251316|Thyroid Cancer|thyroid cancer
5350089|NCT00251303|Clinical Trial|clinical trial
5350090|NCT00251303|Glutamate Antagonist|glutamate antagonist
5350091|NCT00251303|Pediatrics|pediatrics
5350092|NCT00251303|Basal Ganglia|basal ganglia
5350093|NCT00251303|Neuropsychological|neuropsychological
5350094|NCT00251303|Obsessive Compulsive Disorder|obsessive compulsive disorder
5350095|NCT00251303|OCD|ocd
5350096|NCT00251303|Riluzole|riluzole
5350097|NCT00251303|Rilutek|rilutek
5350098|NCT00251290|transient ischemic attack|transient ischemic attack
5350099|NCT00251290|sleep apnea|sleep apnea
5350100|NCT00251277|Thrombotic Thrombocytopenic Purpura|thrombotic thrombocytopenic purpura
5350101|NCT00251277|TTP|ttp
5350102|NCT00251277|Hematology|hematology
5350103|NCT00251264|Shoulder instability|shoulder instability
5350104|NCT00251264|Traumatic|traumatic
5350105|NCT00251264|Anterior|anterior
5350106|NCT00251264|Unidirectional|unidirectional
5350107|NCT00251264|Open stabilization|open stabilization
5350108|NCT00251264|Arthroscopic|arthroscopic
5350109|NCT00251264|Bankart repair|bankart repair
5350110|NCT00251264|Shoulder instability, traumatic|shoulder instability, traumatic
5350111|NCT00251264|Anterior, unidirectional instability|anterior, unidirectional instability
5350112|NCT00251264|Bankart|bankart
5350113|NCT00251251|Congestive heart failure|congestive heart failure
5350114|NCT00251251|Multicentre randomized controlled trial|multicentre randomized controlled trial
5350115|NCT00251251|Defibrillator|defibrillator
5350116|NCT00251251|Cardiac resynchronization|cardiac resynchronization
5350117|NCT00251251|Sudden death/mortality|sudden death/mortality
5350118|NCT00251251|Hospitalization|hospitalization
5350119|NCT00251251|ICD indication|icd indication
5350120|NCT00251251|NYHA Class II|nyha class ii
5350121|NCT00251251|LVEF </equal to 30%|lvef </equal to 30%
5350122|NCT00251251|QRS >/equal to 120 ms|qrs >/equal to 120 ms
5350123|NCT00251238|Raynaud´s phenomenon|raynaud´s phenomenon
5350124|NCT00251238|Vasospastic attacks|vasospastic attacks
5350125|NCT00251238|Ginkgo biloba|ginkgo biloba
5350126|NCT00251225|prostate|prostate
5350127|NCT00251212|Alcohol|alcohol
5350128|NCT00251212|Violence|violence
5350129|NCT00251212|Alcohol consumption|alcohol consumption
5350130|NCT00251212|Alcohol, drinking|alcohol, drinking
5350131|NCT00251160|Multi-directional instability|multi-directional instability
5350132|NCT00251160|MDI|mdi
5350133|NCT00251160|Ligamentous laxity|ligamentous laxity
5350134|NCT00251160|Multi-directional laxity|multi-directional laxity
5350135|NCT00251160|MDL-AII|mdl-aii
5350136|NCT00251160|Shoulder instability|shoulder instability
5350137|NCT00251160|electrothermal capsulorrhaphy, ETAC|electrothermal capsulorrhaphy, etac
5350138|NCT00251160|inferior capsular shift, ICS|inferior capsular shift, ics
5350139|NCT00251160|capsular redundancy|capsular redundancy
5350140|NCT00251147|rotator cuff|rotator cuff
5350142|NCT00251147|arthroscopic|arthroscopic
5350143|NCT00251147|mini-open|mini-open
5350144|NCT00251147|acromioplasty|acromioplasty
5350145|NCT00251147|quality of life|quality of life
5350146|NCT00251147|shoulder|shoulder
5350147|NCT00251134|myocardial infarction|myocardial infarction
5350148|NCT00251134|omega 3-fatty acids|omega 3-fatty acids
5350149|NCT00251121|Electrophysiological study|electrophysiological study
5350150|NCT00251121|paroxysmal tachycardia|paroxysmal tachycardia
5350151|NCT00251108|'traumatic brain injury'|'traumatic brain injury'
5350152|NCT00251108|'head injury'|'head injury'
5350153|NCT00251108|'brain injuries'|'brain injuries'
5350154|NCT00251108|'exercise therapy'|'exercise therapy'
5350155|NCT00251108|'physical fitness'|'physical fitness'
5350156|NCT00251095|Metastatic Breast Cancer|metastatic breast cancer
5350157|NCT00251082|hormone replacement|hormone replacement
5350158|NCT00251082|vasomotoric symptoms|vasomotoric symptoms
5350159|NCT00251082|bleeding pattern|bleeding pattern
5350160|NCT00251069|glucosamine sulphate, osteoarthritis, cholesterol,|glucosamine sulphate, osteoarthritis, cholesterol,
5350161|NCT00251043|Pregnancy|pregnancy
5350162|NCT00251043|Antepartum Depression|antepartum depression
5350163|NCT00251043|Major Depression|major depression
5350164|NCT00251017|single nucleotide polymorphisms (SNPs)|single nucleotide polymorphisms (snps)
5350165|NCT00251017|personalized medicines|personalized medicines
5350166|NCT00251017|Subjects 16 years of age or older, of either sex.|subjects 16 years of age or older, of either sex.
5350167|NCT00251017|Subjects have a medication including vancomycin|subjects have a medication including vancomycin
5350168|NCT00251004|Renal transplantation, kidney, and organ transplant|renal transplantation, kidney, and organ transplant
5350169|NCT00251004|Renal transplant rejection|renal transplant rejection
5350170|NCT00250991|stroke|stroke
5350171|NCT00250991|integrilin|integrilin
5350172|NCT00250991|eptifibatide|eptifibatide
5350173|NCT00250991|activase|activase
5350174|NCT00250991|recombinant tissue plasminogen activator|recombinant tissue plasminogen activator
5350175|NCT00250991|rt-PA|rt-pa
5350176|NCT00250991|recombinant t-PA|recombinant t-pa
5350177|NCT00250991|SPOTRIAS|spotrias
5350178|NCT00250978|Advanced Non Small Cell Lung Cancer|advanced non small cell lung cancer
5350179|NCT00250952|Clinical Practice Variations|clinical practice variations
5350180|NCT00250939|Glycogen Storage Disease Type II|glycogen storage disease type ii
5350181|NCT00250939|GSD-II|gsd-ii
5350182|NCT00250939|Pompe Disease|pompe disease
5350183|NCT00250926|bortezomib|bortezomib
5350184|NCT00250926|dexamethasone|dexamethasone
5350185|NCT00250926|rituximab|rituximab
5350186|NCT00250913|motor activity|motor activity
5350187|NCT00250913|determinants|determinants
5350188|NCT00250913|psychology|psychology
5350189|NCT00250913|health care costs|health care costs
5350190|NCT00250913|quality of life|quality of life
5350191|NCT00250913|Angioplasty|angioplasty
5350192|NCT00250900|Otitis|otitis
5350193|NCT00250900|Antibiotic|antibiotic
5350194|NCT00250900|Prescription|prescription
5350195|NCT00250887|recurrent Glioblastoma, Gefitinib|recurrent glioblastoma, gefitinib
5350196|NCT00250848|Lung Diseases|lung diseases
5350197|NCT00250848|Cancer|cancer
5350198|NCT00250835|Resectable Rectal Cancer|resectable rectal cancer
5350199|NCT00250835|Radiation|radiation
5350200|NCT00250835|Neoadjuvant|neoadjuvant
5350201|NCT00250835|Rectum|rectum
5350202|NCT00250835|GI - Colorectal Neoadjuvant|gi - colorectal neoadjuvant
5350203|NCT00250835|Cancer|cancer
5350204|NCT00250822|Liver|liver
5350205|NCT00250822|hepatocellular|hepatocellular
5350206|NCT00250822|Gem-Ox|gem-ox
5350207|NCT00250822|Cancer|cancer
5350208|NCT00250796|Phase II|phase ii
5350209|NCT00250796|Hepatocellular carcinoma|hepatocellular carcinoma
5350210|NCT00250783|Corpus Uteri|corpus uteri
5350211|NCT00250783|Endometrium|endometrium
5350212|NCT00250783|Cancer|cancer
5350213|NCT00250770|Corpus Uteri|corpus uteri
5350214|NCT00250770|Endometrium|endometrium
5350215|NCT00250770|Cancer|cancer
5350216|NCT00250757|prostate|prostate
5350217|NCT00250757|NMR Spectroscopy|nmr spectroscopy
5350218|NCT00250744|delayed nausea and vomiting|delayed nausea and vomiting
5350219|NCT00250744|Emetogenic Chemotherapy|emetogenic chemotherapy
5350220|NCT00250744|Pilot Trial|pilot trial
5350221|NCT00250731|diabetes|diabetes
5350222|NCT00250731|relationship|relationship
5350223|NCT00250731|social support|social support
5350224|NCT00250731|behavior change|behavior change
5350225|NCT00250731|telemedicine|telemedicine
5350226|NCT00250718|Non Hodgkin's Lymphoma|non hodgkin's lymphoma
5350227|NCT00250718|Phase II|phase ii
5350228|NCT00250718|Lymphoid malignancies|lymphoid malignancies
5350229|NCT00250705|Aripiprazole|aripiprazole
5350230|NCT00250679|COPD|copd
5350231|NCT00250679|chronic bronchitis|chronic bronchitis
5350232|NCT00250679|emphysema|emphysema
5350233|NCT00250666|Biological Markers|biological markers
5350234|NCT00250666|Procalcitonin|procalcitonin
5350235|NCT00250666|Critical Care|critical care
5350236|NCT00250666|Diagnosis, Differential|diagnosis, differential
5350237|NCT00250666|Prospective Study|prospective study
5350238|NCT00250666|Sepsis|sepsis
5350239|NCT00250666|Antibiotic stewardship|antibiotic stewardship
5350240|NCT00250666|Antimicrobial resistance|antimicrobial resistance
5350241|NCT00250653|depression|depression
5350242|NCT00250653|antidepressive agents|antidepressive agents
5350243|NCT00250653|clinical trial|clinical trial
5350244|NCT00250640|Primary Pulmonary hypertension|primary pulmonary hypertension
5350245|NCT00250627|depression|depression
5350246|NCT00250627|antidepressive agents|antidepressive agents
5350247|NCT00250627|controlled clinical trial|controlled clinical trial
5350248|NCT00250614|depression|depression
5350249|NCT00250614|antidepressive agents|antidepressive agents
5350250|NCT00250614|controlled clinical trial|controlled clinical trial
5350251|NCT00250601|depression|depression
5350252|NCT00250601|antidepressive agents|antidepressive agents
5350253|NCT00250601|controlled clinical trial|controlled clinical trial
5350254|NCT00250588|Asthma|asthma
5350255|NCT00250588|Child|child
5350256|NCT00250588|Problem-solving|problem-solving
5350257|NCT00250588|Quality of Life|quality of life
5350258|NCT00250588|Barriers to Care|barriers to care
5350259|NCT00250575|Schizophrenia, treatment-resistant, clozapine|schizophrenia, treatment-resistant, clozapine
5350260|NCT00250562|Hypertension|hypertension
5350261|NCT00250562|Angiotensin II receptor blocker|angiotensin ii receptor blocker
5350262|NCT00250562|fixed combination|fixed combination
5350263|NCT00250562|diuretics|diuretics
5350264|NCT00250549|HIV|hiv
5350265|NCT00250549|Prevention|prevention
5350266|NCT00250549|Rapid HIV testing|rapid hiv testing
5350267|NCT00250523|trauma|trauma
5350268|NCT00250523|critical illness|critical illness
5350269|NCT00250523|injury|injury
5350270|NCT00250510|Obesity treatment|obesity treatment
5350271|NCT00250510|Insurance reimbursement|insurance reimbursement
5350272|NCT00250510|Health care utilization|health care utilization
5350273|NCT00250510|Health care costs|health care costs
5350274|NCT00250497|Adolescent|adolescent
5350275|NCT00250497|Girls|girls
5350276|NCT00250497|Physical Activity|physical activity
5350277|NCT00250497|Exercise|exercise
5350278|NCT00250497|Diet|diet
5350279|NCT00250497|Body image|body image
5350280|NCT00250484|analgesia|analgesia
5350281|NCT00250484|electric stimulation therapy|electric stimulation therapy
5350282|NCT00250484|electric stimulation|electric stimulation
5350283|NCT00250484|pain|pain
5350284|NCT00250484|safety|safety
5350285|NCT00250471|GP IIb/IIIa inhibitors|gp iib/iiia inhibitors
5350286|NCT00250471|eptifibatide|eptifibatide
5350287|NCT00250471|Anti-thrombotic agents|anti-thrombotic agents
5350288|NCT00250445|Arcoxia|arcoxia
5350289|NCT00250406|urolithiasis|urolithiasis
5350290|NCT00250406|ureteral stent|ureteral stent
5350291|NCT00250406|triclosan|triclosan
5350292|NCT00250406|drug eluting|drug eluting
5350293|NCT00250393|Parkinson's disease|parkinson's disease
5350294|NCT00250393|monotherapy|monotherapy
5350295|NCT00250380|Aspirin|aspirin
5350296|NCT00250380|Platelet Aggregation Inhibitors|platelet aggregation inhibitors
5350297|NCT00250367|risperidone|risperidone
5350298|NCT00250367|antipsychotic agents|antipsychotic agents
5350299|NCT00250367|bipolar disorders|bipolar disorders
5350300|NCT00250367|manic episode|manic episode
5350301|NCT00250354|conduct disorder|conduct disorder
5350302|NCT00250354|oppositional deficit disorder|oppositional deficit disorder
5350303|NCT00250354|disruptive behavior disorder not otherwise specified|disruptive behavior disorder not otherwise specified
5350304|NCT00250354|ADHD|adhd
5350305|NCT00250354|risperidone|risperidone
5350306|NCT00250354|antipsychotropic agents|antipsychotropic agents
5350307|NCT00250354|children|children
5350308|NCT00250289|malodor|malodor
5350309|NCT00250289|halitosis|halitosis
5350310|NCT00250289|herbal formulation|herbal formulation
5350311|NCT00250289|natural medicinals|natural medicinals
5350312|NCT00250289|slow release delivery system|slow release delivery system
5350313|NCT00250263|rhinitis|rhinitis
5350314|NCT00250263|asthma|asthma
5350315|NCT00250263|atopy|atopy
5350316|NCT00250263|house dust mite|house dust mite
5350317|NCT00250263|immunotherapy|immunotherapy
5350318|NCT00250263|SLIT|slit
5350319|NCT00250237|Post-operative delirium|post-operative delirium
5350320|NCT00250237|hip fracture|hip fracture
5350321|NCT00250224|Radiotherapy|radiotherapy
5350322|NCT00250224|image guided|image guided
5350323|NCT00250224|marker|marker
5350324|NCT00250211|magnetic resonance imaging, functional|magnetic resonance imaging, functional
5350325|NCT00250211|radiation therapy|radiation therapy
5350326|NCT00250211|temozolomide|temozolomide
5350327|NCT00250211|functional imaging|functional imaging
5350328|NCT00250211|concurrent chemoradiation|concurrent chemoradiation
5350329|NCT00250198|T Cell|t cell
5350330|NCT00250198|Lymphocyte|lymphocyte
5350331|NCT00250198|Lamina Propria|lamina propria
5350332|NCT00250198|Colonoscopy|colonoscopy
5350333|NCT00250198|Placebo|placebo
5350334|NCT00250198|Crohn's Disease|crohn's disease
5350335|NCT00250198|Crohns Disease|crohns disease
5350336|NCT00250185|Ischemia Tolerance|ischemia tolerance
5350337|NCT00250185|Endothelial Function|endothelial function
5350338|NCT00250185|Forearm Blood Flow|forearm blood flow
5350339|NCT00250185|Muscle Recovery|muscle recovery
5350340|NCT00250185|Inflammation|inflammation
5350341|NCT00250185|Healthy Volunteer|healthy volunteer
5350343|NCT00250172|Dosimetry|dosimetry
5350344|NCT00250172|Pharmacokinetics|pharmacokinetics
5350345|NCT00250172|Compartment Analysis|compartment analysis
5350346|NCT00250172|Reproducibility|reproducibility
5350347|NCT00250172|Healthy Volunteer|healthy volunteer
5350348|NCT00250172|HV|hv
5350349|NCT00250159|Congenital Adrenal Hyperplasia (CAH)|congenital adrenal hyperplasia (cah)
5350350|NCT00250159|Familial Male Precocious Puberty (FMPP)|familial male precocious puberty (fmpp)
5350351|NCT00250159|21-hydroxylast deficiency|21-hydroxylast deficiency
5350352|NCT00250159|Congenital Adrenal Hyperplasia|congenital adrenal hyperplasia
5350353|NCT00250159|CAH|cah
5350354|NCT00250159|Familial Male Precocious Puberty|familial male precocious puberty
5350355|NCT00250159|FMPP|fmpp
5350356|NCT00250146|Celiac Disease|celiac disease
5350357|NCT00250146|Gluten|gluten
5350358|NCT00250146|Toxicity|toxicity
5350359|NCT00250146|Small bowel morphometry|small bowel morphometry
5350360|NCT00250133|selective decontamination of the digestive tract|selective decontamination of the digestive tract
5350361|NCT00250120|NSCLC|nsclc
5350362|NCT00250120|L9NC|l9nc
5350363|NCT00250120|Aerosolized Liposomal 9-Nitro-20 (S)-Camptothecin|aerosolized liposomal 9-nitro-20 (s)-camptothecin
5350364|NCT00250094|Phase I|phase i
5350365|NCT00250094|Ovarian Cancer|ovarian cancer
5350366|NCT00250094|Ovary|ovary
5350367|NCT00250094|Cancer|cancer
5350368|NCT00250081|Cerebral Palsy|cerebral palsy
5350369|NCT00250081|Tendon Transfer|tendon transfer
5350370|NCT00250081|Botulinum Toxin Type A|botulinum toxin type a
5350371|NCT00250081|Occupational Therapy|occupational therapy
5350372|NCT00250081|Child|child
5350373|NCT00250068|Phase II|phase ii
5350374|NCT00250068|Aerosol Delivery|aerosol delivery
5350375|NCT00250068|NSCLC|nsclc
5350376|NCT00250068|9-Nitrocamptothecin|9-nitrocamptothecin
5350377|NCT00250055|NIH|nih
5350378|NCT00250055|Non-Invasive diagnosis of cervical tissue|non-invasive diagnosis of cervical tissue
5350379|NCT00250055|Los Alamos/NIH|los alamos/nih
5350380|NCT00250029|Colorectal Cancer|colorectal cancer
5350381|NCT00250029|Pilot Study|pilot study
5350382|NCT00250029|Oxaliplatin|oxaliplatin
5350383|NCT00250016|Endometrium|endometrium
5350384|NCT00250016|Tissue|tissue
5350385|NCT00250016|L9NC|l9nc
5350386|NCT00250003|Elderly|elderly
5350387|NCT00250003|Preventive home visits|preventive home visits
5350388|NCT00249990|Uterus|uterus
5350389|NCT00249990|Recurrent disease|recurrent disease
5350390|NCT00249990|Treatment|treatment
5350391|NCT00249990|9-Nitrocamptothecin|9-nitrocamptothecin
5350392|NCT00249990|Endometrium|endometrium
5350393|NCT00249977|Phase I|phase i
5350394|NCT00249977|solid tumors|solid tumors
5350395|NCT00249977|DNA repair|dna repair
5350396|NCT00249964|Extensive or recurrent small cell lung cancer Phase I|extensive or recurrent small cell lung cancer phase i
5350397|NCT00249964|Paclitaxel, Carboplatin, Temozolomide|paclitaxel, carboplatin, temozolomide
5350398|NCT00249951|nephrocalcinosis|nephrocalcinosis
5350399|NCT00249951|premature infants|premature infants
5350400|NCT00249951|hypocitraturia|hypocitraturia
5350401|NCT00249951|alcaline citrate therapy|alcaline citrate therapy
5350402|NCT00249951|Nephrocalcinosis in premature infants|nephrocalcinosis in premature infants
5350403|NCT00249938|Antilipemic agents|antilipemic agents
5350404|NCT00249938|hyperlipidemia|hyperlipidemia
5350405|NCT00249925|Home modification|home modification
5350406|NCT00249925|Occupational Therapy|occupational therapy
5350407|NCT00249925|Physical Therapy|physical therapy
5350408|NCT00249925|Home care|home care
5350409|NCT00249912|Hyperlipidemia|hyperlipidemia
5350410|NCT00249912|Drug Therapy|drug therapy
5350411|NCT00249899|Hyperlipidemia|hyperlipidemia
5350412|NCT00249899|Drug Therapy|drug therapy
5350413|NCT00249873|Atrial fibrillation|atrial fibrillation
5350414|NCT00249873|Anticoagulant therapy|anticoagulant therapy
5350415|NCT00249873|Thromboembolic prevention|thromboembolic prevention
5350416|NCT00249860|Subjects with chronic hepatitis C who have never previously received interferon therapy.|subjects with chronic hepatitis c who have never previously received interferon therapy.
5350417|NCT00249847|Hot flashes, vasomotor symptoms, estrogen, paroxetine|hot flashes, vasomotor symptoms, estrogen, paroxetine
5350418|NCT00249834|Assisted Reproductive Technology (ART)|assisted reproductive technology (art)
5350419|NCT00249834|Infertility|infertility
5350420|NCT00249834|Ovarian stimulation|ovarian stimulation
5350421|NCT00249808|Candidates for systemic therapy for psoriasis|candidates for systemic therapy for psoriasis
5350422|NCT00249795|Atrial fibrillation|atrial fibrillation
5350423|NCT00249795|Cardiovascular disease|cardiovascular disease
5350424|NCT00249795|angiotensin II blocker|angiotensin ii blocker
5350425|NCT00249782|rosacea, Papulopustular Rosacea,erythema, dapsone|rosacea, papulopustular rosacea,erythema, dapsone
5350426|NCT00249769|Japanese Encephalitis|japanese encephalitis
5350427|NCT00249769|Japanese B Encephalitis|japanese b encephalitis
5350428|NCT00249769|Japanese B Viral Encephalitis|japanese b viral encephalitis
5350429|NCT00249769|Viral Encephalitis, Japanese B|viral encephalitis, japanese b
5350430|NCT00249756|Criminal Justice|criminal justice
5350431|NCT00249743|fall prevention|fall prevention
5350432|NCT00249743|fall risk management|fall risk management
5350433|NCT00249743|RCT|rct
5350434|NCT00249743|cost|cost
5350435|NCT00249717|Contingency management|contingency management
5350436|NCT00249717|Substance abuse treatment|substance abuse treatment
5350437|NCT00249691|cocaine addiction|cocaine addiction
5350438|NCT00249691|cocaine dependence|cocaine dependence
5350439|NCT00249678|Behavior Therapy|behavior therapy
5350440|NCT00249678|methamphetamine|methamphetamine
5350441|NCT00249652|End stage liver disease|end stage liver disease
5350442|NCT00249652|End stage renal disease|end stage renal disease
5350443|NCT00249652|Substance-Related Disorders|substance-related disorders
5350444|NCT00249639|Contingency Management|contingency management
5350445|NCT00249639|Substance Abuse Treatment|substance abuse treatment
5350446|NCT00249626|Contingency management|contingency management
5350447|NCT00249626|substance abuse treatment|substance abuse treatment
5350448|NCT00249613|gender-responsive substance abuse treatment|gender-responsive substance abuse treatment
5350449|NCT00249600|contingency management|contingency management
5350450|NCT00249600|substance abuse|substance abuse
5350451|NCT00249574|heroin addiction|heroin addiction
5350452|NCT00249548|contingency management|contingency management
5350453|NCT00249548|substance abuse|substance abuse
5350454|NCT00249535|Substance Abuse|substance abuse
5350455|NCT00249535|Contingency Management|contingency management
5350456|NCT00249522|contingency management|contingency management
5350457|NCT00249522|substance abuse treatment|substance abuse treatment
5350458|NCT00249509|marijuana dependence|marijuana dependence
5350459|NCT00249496|cocaine|cocaine
5350460|NCT00249496|opioids|opioids
5350461|NCT00249496|contingency management|contingency management
5350462|NCT00249496|sexual risk|sexual risk
5350463|NCT00249496|HIV|hiv
5350464|NCT00249483|Cocaine Addiction|cocaine addiction
5350465|NCT00249483|Cocaine Dependence|cocaine dependence
5350466|NCT00249470|HIV|hiv
5350467|NCT00249470|HIV risk behaviors|hiv risk behaviors
5350468|NCT00249470|Heroin|heroin
5350469|NCT00249470|Cocaine|cocaine
5350470|NCT00249470|Methadone|methadone
5350471|NCT00249470|Opioid Dependence|opioid dependence
5350472|NCT00249470|Cocaine Abuse|cocaine abuse
5350473|NCT00249470|Contingency management|contingency management
5350474|NCT00249470|alcohol & drug use|alcohol & drug use
5350475|NCT00249470|sexual risk behaviors|sexual risk behaviors
5350476|NCT00249457|Behavior Therapy|behavior therapy
5350477|NCT00249457|Cocaine Abuse|cocaine abuse
5350478|NCT00249457|Cocaine Dependence|cocaine dependence
5350479|NCT00249457|Contingency Management|contingency management
5350480|NCT00249457|Heroin Dependence|heroin dependence
5350481|NCT00249457|Methadone|methadone
5350482|NCT00249457|Opioid Dependence|opioid dependence
5350483|NCT00249444|cocaine dependence|cocaine dependence
5350484|NCT00249444|mirtazipine|mirtazipine
5350485|NCT00249431|Gambling|gambling
5350486|NCT00249431|Alcohol|alcohol
5350487|NCT00249418|Contingency Management|contingency management
5350488|NCT00249418|Substance Abuse Treatment|substance abuse treatment
5350489|NCT00249405|Clinical trial|clinical trial
5350490|NCT00249405|Alcoholism|alcoholism
5350491|NCT00249405|Alcohol|alcohol
5350492|NCT00249405|Pharmacogenetics|pharmacogenetics
5350493|NCT00249405|Citalopram|citalopram
5350494|NCT00249405|Genotype|genotype
5350495|NCT00249405|Therapy compliance|therapy compliance
5350496|NCT00249405|Serotonin inhibitor|serotonin inhibitor
5350497|NCT00249405|Alcoholism/alcohol abuse therapy|alcoholism/alcohol abuse therapy
5350498|NCT00249392|ocular diseases|ocular diseases
5350499|NCT00249392|risk factors|risk factors
5350500|NCT00249392|genetic factors|genetic factors
5350501|NCT00249379|Alcohol dependence|alcohol dependence
5350502|NCT00249379|Acamprosate(drug)|acamprosate(drug)
5350503|NCT00249379|Drug Court|drug court
5350504|NCT00249379|Probation|probation
5350505|NCT00249379|Parole|parole
5350506|NCT00249379|Criminal justice|criminal justice
5350507|NCT00249366|Alcohol withdrawal|alcohol withdrawal
5350508|NCT00249366|Symptom-triggered therapy|symptom-triggered therapy
5350509|NCT00249366|Fixed-schedule therapy|fixed-schedule therapy
5350510|NCT00249366|CIWA-Ar|ciwa-ar
5350511|NCT00249366|Lorazepam (drug)|lorazepam (drug)
5350512|NCT00249353|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
5350513|NCT00249353|ADHD|adhd
5350514|NCT00249353|Concerta|concerta
5350515|NCT00249340|behavioral weight loss treatment|behavioral weight loss treatment
5350516|NCT00249340|brief behavioral treatment|brief behavioral treatment
5350517|NCT00249340|commercial weight loss programs|commercial weight loss programs
5350518|NCT00249340|Weight Watchers|weight watchers
5350519|NCT00249327|HIV testing|hiv testing
5350520|NCT00249327|HIV disclosure|hiv disclosure
5350521|NCT00249327|HIV Seronegativity|hiv seronegativity
5350522|NCT00249314|South Asians|south asians
5350523|NCT00249314|European Caucasians|european caucasians
5350524|NCT00249314|ethnic differences|ethnic differences
5350525|NCT00249314|body composition|body composition
5350526|NCT00249314|body fat distribution|body fat distribution
5350527|NCT00249314|adipose tissue|adipose tissue
5350528|NCT00249314|visceral fat|visceral fat
5350529|NCT00249314|myocellular lipids|myocellular lipids
5350530|NCT00249314|skeletal muscle|skeletal muscle
5350531|NCT00249301|Breast Cancer|breast cancer
5350532|NCT00249301|Colon Cancer|colon cancer
5350533|NCT00249301|Pancreatic Cancer|pancreatic cancer
5350534|NCT00249301|Bladder Cancer|bladder cancer
5350535|NCT00249288|Schizophrenia|schizophrenia
5350536|NCT00249288|Negative Symptoms|negative symptoms
5350537|NCT00249288|Folate|folate
5350538|NCT00249275|significant refractive errors|significant refractive errors
5350539|NCT00249275|children|children
5350540|NCT00249275|spectacles|spectacles
5350541|NCT00249275|Africa|africa
5350542|NCT00249249|hypercholesterolemia|hypercholesterolemia
5350543|NCT00249249|dyslipidemia|dyslipidemia
5350544|NCT00249249|kowa|kowa
5350545|NCT00249249|KRE|kre
5350546|NCT00249249|pitavastatin|pitavastatin
5350547|NCT00249249|NK-104|nk-104
5350548|NCT00249236|risperidone|risperidone
5350549|NCT00249236|antipsychotic agents|antipsychotic agents
5350550|NCT00249236|bipolar disorders|bipolar disorders
5350551|NCT00249236|manic episode|manic episode
5350552|NCT00249223|chronic schizophrenia, psychotic disorder, risperidone, long-acting injectable, intramuscular injection, antipsychotic agents|chronic schizophrenia, psychotic disorder, risperidone, long-acting injectable, intramuscular injection, antipsychotic agents
5350553|NCT00249210|Sinusitis|sinusitis
5350554|NCT00249210|respiratory tract diseases|respiratory tract diseases
5350555|NCT00249210|nose diseases|nose diseases
5350556|NCT00249210|respiratory tract infections|respiratory tract infections
5350557|NCT00249210|paranasal sinus diseases|paranasal sinus diseases
5350558|NCT00249210|antibacterial agents|antibacterial agents
5350559|NCT00249210|quinolones|quinolones
5350560|NCT00249210|levofloxacin|levofloxacin
5350561|NCT00249197|skin infection|skin infection
5350562|NCT00249197|bacterial infection|bacterial infection
5350563|NCT00249197|levofloxacin|levofloxacin
5350564|NCT00249197|quinolones|quinolones
5350565|NCT00249197|skin|skin
5350566|NCT00249197|infection|infection
5350567|NCT00249171|acute schizophrenia|acute schizophrenia
5350568|NCT00249171|psychosis|psychosis
5350569|NCT00249171|risperidone|risperidone
5350570|NCT00249171|lorazepam, antipsychotic agents|lorazepam, antipsychotic agents
5350571|NCT00249171|emergency treatment|emergency treatment
5350572|NCT00249158|Dementia|dementia
5350573|NCT00249158|Alzheimer's Disease|alzheimer's disease
5350574|NCT00249158|vascular dementia|vascular dementia
5350575|NCT00249158|mixed dementia|mixed dementia
5350576|NCT00249158|risperidone|risperidone
5350577|NCT00249158|nursing home|nursing home
5350578|NCT00249145|Dementia|dementia
5350579|NCT00249145|Alzheimer's Disease|alzheimer's disease
5350580|NCT00249145|vascular dementia|vascular dementia
5350581|NCT00249145|mixed dementia, risperidone|mixed dementia, risperidone
5350582|NCT00249145|nursing home|nursing home
5350583|NCT00249132|chronic schizophrenia|chronic schizophrenia
5350584|NCT00249132|psychotic disorder|psychotic disorder
5350585|NCT00249132|risperidone|risperidone
5350586|NCT00249132|antipsychotic agents|antipsychotic agents
5350587|NCT00249119|chronic schizophrenia|chronic schizophrenia
5350588|NCT00249119|psychotic disorders|psychotic disorders
5350589|NCT00249119|risperidone|risperidone
5350590|NCT00249119|antipsychotic agents|antipsychotic agents
5350591|NCT00249080|3T MRI|3t mri
5350592|NCT00249080|neurodegenerative disease|neurodegenerative disease
5350593|NCT00249080|Alzheimer's disease|alzheimer's disease
5350594|NCT00249080|spectroscopy|spectroscopy
5350595|NCT00249080|Normal, healthy subject without memory complaint|normal, healthy subject without memory complaint
5350596|NCT00249080|Not pregnant|not pregnant
5350597|NCT00249080|MR compatible|mr compatible
5350598|NCT00249067|Congestive Heart Failure, Left-to-Right Shunt|congestive heart failure, left-to-right shunt
5350599|NCT00249041|Rheumatoid Arthritis, Enbrel liquid, antibodies|rheumatoid arthritis, enbrel liquid, antibodies
5350600|NCT00249015|aerobic exercise|aerobic exercise
5350601|NCT00249015|resistance exercise|resistance exercise
5350602|NCT00249015|physical fitness|physical fitness
5350603|NCT00249015|body composition|body composition
5350604|NCT00249015|quality of life|quality of life
5350605|NCT00249015|rehabilitation|rehabilitation
5350606|NCT00249015|psychosocial oncology|psychosocial oncology
5350607|NCT00249015|adherence|adherence
5350608|NCT00249002|Vascular Access Graft Failure|vascular access graft failure
5350609|NCT00249002|Venous Neointimal Hyperplasia(VNH)|venous neointimal hyperplasia(vnh)
5350610|NCT00249002|Hemodialysis|hemodialysis
5350611|NCT00248989|Skin aging|skin aging
5350612|NCT00248989|Menopausal symptoms|menopausal symptoms
5350613|NCT00248976|Angioplasty|angioplasty
5350614|NCT00248976|Motivating behavior change|motivating behavior change
5350615|NCT00248976|Reducing risk factors|reducing risk factors
5350616|NCT00248976|Enhancing quality of life|enhancing quality of life
5350617|NCT00248976|Improving treatment outcomes|improving treatment outcomes
5350618|NCT00248963|Oral Contraceptive|oral contraceptive
5350619|NCT00248950|Angioplasty|angioplasty
5350620|NCT00248950|Behavior Change|behavior change
5350621|NCT00248937|African-American|african-american
5350622|NCT00248937|Hypertension|hypertension
5350623|NCT00248937|Medication adherence|medication adherence
5350624|NCT00248937|Risk reduction|risk reduction
5350625|NCT00248924|Social service intervention|social service intervention
5350626|NCT00248924|Social support|social support
5350627|NCT00248924|Elderly|elderly
5350628|NCT00248924|Homebound|homebound
5350629|NCT00248924|Quality of life|quality of life
5350630|NCT00248911|Breast cancer|breast cancer
5350631|NCT00248911|Gynecologic cancers|gynecologic cancers
5350632|NCT00248911|Meditation|meditation
5350633|NCT00248911|Stress-reduction|stress-reduction
5350634|NCT00248911|Cognitive-affective behavioral learning|cognitive-affective behavioral learning
5350635|NCT00248898|nonagenarians|nonagenarians
5350636|NCT00248898|quality of life|quality of life
5350637|NCT00248898|cardiothoracic surgery|cardiothoracic surgery
5350638|NCT00248898|long term survival|long term survival
5350639|NCT00248885|Coronary artery bypass graft surgery|coronary artery bypass graft surgery
5350640|NCT00248885|Perioperative complications|perioperative complications
5350641|NCT00248885|Neurocognitive function|neurocognitive function
5350642|NCT00248885|Quality of life|quality of life
5350643|NCT00248885|Blood pressure|blood pressure
5350644|NCT00248872|African-American|african-american
5350645|NCT00248872|Hypertension|hypertension
5350646|NCT00248872|Medication adherence|medication adherence
5350647|NCT00248872|Risk reduction|risk reduction
5350648|NCT00248859|Coronary artery disease|coronary artery disease
5350649|NCT00248859|Depressive symptoms|depressive symptoms
5350650|NCT00248859|Latino American|latino american
5350651|NCT00248846|Angioplasty patients|angioplasty patients
5350652|NCT00248846|Behavior change|behavior change
5350653|NCT00248846|Physical activity|physical activity
5350654|NCT00248846|Risk reduction|risk reduction
5350655|NCT00248820|Contrast-enhanced Ultrasound|contrast-enhanced ultrasound
5350656|NCT00248820|Ultrasound Contrast agent, microbubbles|ultrasound contrast agent, microbubbles
5350657|NCT00248820|Ovarian tumor|ovarian tumor
5350658|NCT00248820|vascularization|vascularization
5350659|NCT00248807|Blood Pressure, Low|blood pressure, low
5350660|NCT00248807|Hypotension, Postural|hypotension, postural
5350661|NCT00248807|Injuries, Spinal Cord|injuries, spinal cord
5350662|NCT00248807|Spinal Cord Transection|spinal cord transection
5350663|NCT00248807|Spinal Cord Trauma|spinal cord trauma
5350664|NCT00248794|Cognitive Impairment|cognitive impairment
5350665|NCT00248794|Rehabilitation|rehabilitation
5350666|NCT00248781|Activities of daily living|activities of daily living
5350667|NCT00248781|Aging|aging
5350668|NCT00248781|Exercise|exercise
5350669|NCT00248781|Weight lifting|weight lifting
5350670|NCT00248768|Depression|depression
5350671|NCT00248768|Parkinson Disease|parkinson disease
5350672|NCT00248768|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
5350673|NCT00248755|cystic fibrosis|cystic fibrosis
5350674|NCT00248755|mucociliary clearance|mucociliary clearance
5350675|NCT00248755|nuclear medicine|nuclear medicine
5350676|NCT00248742|IBD, psychological, stress management|ibd, psychological, stress management
5350677|NCT00248703|Disseminating tumor cells,breast cancer,docetaxel,adjuvant|disseminating tumor cells,breast cancer,docetaxel,adjuvant
5350678|NCT00248690|Subarachnoid hemorrhage|subarachnoid hemorrhage
5350679|NCT00248690|Intracranial hypertension|intracranial hypertension
5350680|NCT00248690|Intracranial pressure|intracranial pressure
5350681|NCT00248690|Diagnostic techniques and procedures|diagnostic techniques and procedures
5350682|NCT00248690|Compliance|compliance
5350683|NCT00248690|Treatment outcome|treatment outcome
5350684|NCT00248690|Intensive care, surgical|intensive care, surgical
5350685|NCT00248664|Cystitis, Interstitial|cystitis, interstitial
5350686|NCT00248664|Case-Control Studies|case-control studies
5350687|NCT00248664|Risk Factors|risk factors
5350688|NCT00248651|Bloating|bloating
5350689|NCT00248651|Early Fullness|early fullness
5350690|NCT00248651|Nausea|nausea
5350691|NCT00248651|Upper Abdominal Discomfort|upper abdominal discomfort
5350692|NCT00248651|dyspepsia|dyspepsia
5350693|NCT00248651|stomach pain|stomach pain
5350694|NCT00248651|stomach discomfort|stomach discomfort
5350695|NCT00248625|acute liver failure|acute liver failure
5350696|NCT00248625|hepatic encephalopathy|hepatic encephalopathy
5350697|NCT00248625|acetaminophen toxicity|acetaminophen toxicity
5350698|NCT00248625|N-acetylcysteine|n-acetylcysteine
5350699|NCT00248612|Venlafaxine|venlafaxine
5350700|NCT00248612|Alcoholism|alcoholism
5350701|NCT00248612|Anxiety Disorders|anxiety disorders
5350702|NCT00248612|Alcohol-Use Disorders|alcohol-use disorders
5350703|NCT00248612|Alcohol Abuse|alcohol abuse
5350704|NCT00248612|Alcohol Dependence|alcohol dependence
5350705|NCT00248612|Cognitive Behavioral Treatment|cognitive behavioral treatment
5350706|NCT00248560|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
5350707|NCT00248560|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5350708|NCT00248560|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
5350709|NCT00248560|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5350710|NCT00248560|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
5350711|NCT00248560|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5350712|NCT00248560|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
5350713|NCT00248560|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
5350714|NCT00248560|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
5350715|NCT00248560|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
5350847|NCT00248430|graft versus host disease|graft versus host disease
5350716|NCT00248560|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
5350717|NCT00248560|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5350718|NCT00248560|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
5350719|NCT00248560|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
5350720|NCT00248547|nausea and vomiting|nausea and vomiting
5350721|NCT00248547|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5350722|NCT00248547|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5350723|NCT00248547|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5350724|NCT00248547|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5350725|NCT00248547|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5350726|NCT00248547|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5350727|NCT00248547|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5350728|NCT00248547|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5350729|NCT00248547|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
5350730|NCT00248547|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5350731|NCT00248547|chronic eosinophilic leukemia|chronic eosinophilic leukemia
5350732|NCT00248547|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
5350733|NCT00248547|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5350734|NCT00248547|chronic neutrophilic leukemia|chronic neutrophilic leukemia
5350735|NCT00248547|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5350736|NCT00248547|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5350737|NCT00248547|disseminated neuroblastoma|disseminated neuroblastoma
5350738|NCT00248547|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5350739|NCT00248547|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
5350740|NCT00248547|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5350741|NCT00248547|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
5350836|NCT00248469|Youth-friendly health services|youth-friendly health services
5350742|NCT00248547|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5350743|NCT00248547|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
5350744|NCT00248547|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
5350745|NCT00248547|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
5350746|NCT00248547|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
5350747|NCT00248547|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5350748|NCT00248547|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5350749|NCT00248547|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5350750|NCT00248547|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5350751|NCT00248547|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
5350752|NCT00248547|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
5350753|NCT00248547|poor prognosis metastatic gestational trophoblastic tumor|poor prognosis metastatic gestational trophoblastic tumor
5350754|NCT00248547|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5350755|NCT00248547|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5350756|NCT00248547|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5350757|NCT00248547|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5350758|NCT00248547|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5350759|NCT00248547|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5350760|NCT00248547|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5350761|NCT00248547|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5350762|NCT00248547|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5350763|NCT00248547|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5350764|NCT00248547|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5350765|NCT00248547|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5350766|NCT00248547|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5350767|NCT00248547|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5350768|NCT00248547|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5350769|NCT00248547|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5350770|NCT00248547|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5350771|NCT00248547|recurrent neuroblastoma|recurrent neuroblastoma
5350772|NCT00248547|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5350773|NCT00248547|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
5351023|NCT00247754|Therapy|therapy
5350774|NCT00248547|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5350775|NCT00248547|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
5350776|NCT00248547|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5350777|NCT00248547|refractory hairy cell leukemia|refractory hairy cell leukemia
5350778|NCT00248547|refractory multiple myeloma|refractory multiple myeloma
5350779|NCT00248547|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5350780|NCT00248547|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5350781|NCT00248547|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5350782|NCT00248547|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5350783|NCT00248547|stage I multiple myeloma|stage i multiple myeloma
5350784|NCT00248547|stage II multiple myeloma|stage ii multiple myeloma
5350785|NCT00248547|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
5350786|NCT00248547|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5350787|NCT00248547|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5350788|NCT00248547|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5350789|NCT00248547|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5350790|NCT00248547|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5350791|NCT00248547|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5350792|NCT00248547|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5350793|NCT00248547|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5350794|NCT00248547|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5350795|NCT00248547|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5350796|NCT00248547|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5350797|NCT00248547|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5350798|NCT00248547|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5350799|NCT00248547|stage III multiple myeloma|stage iii multiple myeloma
5350800|NCT00248547|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5350801|NCT00248547|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5350802|NCT00248547|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
5350803|NCT00248547|stage IIIA breast cancer|stage iiia breast cancer
5350804|NCT00248547|stage IIIB breast cancer|stage iiib breast cancer
5350805|NCT00248547|stage IIIC breast cancer|stage iiic breast cancer
5350806|NCT00248547|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5350807|NCT00248547|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5350808|NCT00248547|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5350809|NCT00248547|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5350810|NCT00248547|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5350811|NCT00248547|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5350812|NCT00248547|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5350813|NCT00248547|stage IV breast cancer|stage iv breast cancer
5350814|NCT00248547|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5350815|NCT00248547|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5350816|NCT00248547|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5350817|NCT00248547|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5350818|NCT00248547|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5350819|NCT00248547|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5350820|NCT00248547|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5350821|NCT00248547|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5350822|NCT00248547|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5350823|NCT00248534|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
5350824|NCT00248521|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5350825|NCT00248495|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5350826|NCT00248495|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5350827|NCT00248495|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
5350828|NCT00248495|stage I non-small cell lung cancer|stage i non-small cell lung cancer
5350829|NCT00248482|extensive stage small cell lung cancer|extensive stage small cell lung cancer
5350830|NCT00248482|recurrent small cell lung cancer|recurrent small cell lung cancer
5350831|NCT00248469|Community randomised trial|community randomised trial
5350832|NCT00248469|Sexual behavior|sexual behavior
5350833|NCT00248469|Intervention|intervention
5350834|NCT00248469|Evaluation|evaluation
5350835|NCT00248469|Sexual health education|sexual health education
5350837|NCT00248469|Adolescents|adolescents
5350838|NCT00248469|Behavior change|behavior change
5350839|NCT00248469|HIV Seronegativity|hiv seronegativity
5350841|NCT00248443|Haematology and cancer patients|haematology and cancer patients
5350842|NCT00248443|Acute respiratory failure|acute respiratory failure
5350843|NCT00248443|Bronchoalveolar lavage|bronchoalveolar lavage
5350844|NCT00248443|Non invasive diagnostic tools|non invasive diagnostic tools
5350845|NCT00248443|Mechanical ventilation|mechanical ventilation
5350846|NCT00248443|Intensive Care|intensive care
5350848|NCT00248430|stage II multiple myeloma|stage ii multiple myeloma
5350849|NCT00248430|stage III multiple myeloma|stage iii multiple myeloma
5350850|NCT00248430|refractory multiple myeloma|refractory multiple myeloma
5350851|NCT00248430|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5350852|NCT00248430|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5350853|NCT00248430|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5350854|NCT00248430|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5350855|NCT00248430|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5350856|NCT00248430|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5350857|NCT00248430|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5350858|NCT00248430|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5350859|NCT00248430|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5350860|NCT00248430|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5350861|NCT00248430|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5350862|NCT00248430|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5350863|NCT00248430|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5350864|NCT00248430|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5350865|NCT00248430|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5350866|NCT00248430|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5350867|NCT00248430|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5350868|NCT00248430|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5350869|NCT00248404|colorectal cancer|colorectal cancer
5350870|NCT00248404|ovarian cancer|ovarian cancer
5350871|NCT00248404|lung cancer|lung cancer
5350872|NCT00248404|breast cancer|breast cancer
5350873|NCT00248404|small bowel cancer|small bowel cancer
5350874|NCT00248404|Advanced, recurrent, or metastatic solid tumors of any type|advanced, recurrent, or metastatic solid tumors of any type
5350875|NCT00248404|TS overexpression confirmed by fresh biopsy (RTPCR)|ts overexpression confirmed by fresh biopsy (rtpcr)
5350876|NCT00248404|Suitable for experimental monotherapy|suitable for experimental monotherapy
5350877|NCT00248391|adenoid hypertrophy|adenoid hypertrophy
5350878|NCT00248391|feeding position|feeding position
5350879|NCT00248391|supine|supine
5350880|NCT00248391|upright|upright
5350881|NCT00248391|pneumonia|pneumonia
5350882|NCT00248391|wheezing|wheezing
5350883|NCT00248391|otitis|otitis
5350884|NCT00248391|adenoid|adenoid
5350885|NCT00248391|tonsil|tonsil
5350886|NCT00248391|caries|caries
5350887|NCT00248378|Multiple Sclerosis|multiple sclerosis
5350888|NCT00248378|Cannabis|cannabis
5350889|NCT00248378|Spasticity|spasticity
5350890|NCT00248378|Tolerability|tolerability
5350891|NCT00248365|Chronic GvHD|chronic gvhd
5350892|NCT00248365|Extensive chronic GvHD|extensive chronic gvhd
5350893|NCT00248365|Resistant chronic GvHD|resistant chronic gvhd
5350894|NCT00248352|Coronary Artery Disease|coronary artery disease
5350895|NCT00248352|Diabetes Mellitus|diabetes mellitus
5350896|NCT00248352|Type 2|type 2
5350897|NCT00248352|Chronic Disease|chronic disease
5350898|NCT00248339|Hepatitis C|hepatitis c
5350899|NCT00248339|Peginterferon|peginterferon
5350900|NCT00248339|Ribavirin|ribavirin
5350901|NCT00248339|Procrit|procrit
5350902|NCT00248339|Epoetin-alpha|epoetin-alpha
5350903|NCT00248326|atrial fibrillation|atrial fibrillation
5350904|NCT00248326|genetics|genetics
5350905|NCT00248326|genetic polymorphisms|genetic polymorphisms
5350906|NCT00248313|Kidney Disease|kidney disease
5350907|NCT00248300|ventilator-associated pneumonia|ventilator-associated pneumonia
5350908|NCT00248300|hospital acquired pneumonia|hospital acquired pneumonia
5350909|NCT00248274|atrial fibrillation|atrial fibrillation
5350910|NCT00248274|genetics|genetics
5350911|NCT00248261|ziprasidone, sertraline, PTSD|ziprasidone, sertraline, ptsd
5350912|NCT00248248|Consolidation|consolidation
5350913|NCT00248248|Ovarian cancer|ovarian cancer
5350914|NCT00248248|DOXIL|doxil
5350915|NCT00248248|Hand-foot syndrome|hand-foot syndrome
5350916|NCT00248235|exercise|exercise
5350917|NCT00248235|rehabilitation|rehabilitation
5350918|NCT00248235|head and neck neoplasms|head and neck neoplasms
5350919|NCT00248222|Exercise|exercise
5350920|NCT00248222|Rehabilitation|rehabilitation
5350921|NCT00248222|Aerobic training|aerobic training
5350922|NCT00248209|Female Orgasmic Disorder|female orgasmic disorder
5350923|NCT00248209|Female Sexual Dysfunction|female sexual dysfunction
5350924|NCT00248170|Breast cancer|breast cancer
5350925|NCT00248170|letrozole|letrozole
5350926|NCT00248170|anastrozole|anastrozole
5350927|NCT00248170|adjuvant|adjuvant
5350928|NCT00248170|postmenopausal|postmenopausal
5350929|NCT00248170|FACE|face
5350930|NCT00248157|Diabetic retinopathy|diabetic retinopathy
5350931|NCT00248157|Octreotide acetate in microspheres|octreotide acetate in microspheres
5350932|NCT00248144|Herpes labialis|herpes labialis
5350933|NCT00248131|Diabetic retinopathy, octreotide acetate in microspheres|diabetic retinopathy, octreotide acetate in microspheres
5350934|NCT00248118|Randomized|randomized
5350935|NCT00248118|Double-blind|double-blind
5350936|NCT00248118|Placebo-controlled|placebo-controlled
5350937|NCT00248105|Arthritis|arthritis
5351024|NCT00247754|Behaviour|behaviour
5350938|NCT00248105|Physical Activity|physical activity
5350939|NCT00248092|d-Amphetamine|d-amphetamine
5350940|NCT00248092|Diethylpropion|diethylpropion
5350941|NCT00248092|Diethylpropion Hydrochloride|diethylpropion hydrochloride
5350942|NCT00248092|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
5350943|NCT00248092|Attention Deficit Disorders with Hyperactivity|attention deficit disorders with hyperactivity
5350944|NCT00248092|Attention Deficit Hyperactivity Disorders|attention deficit hyperactivity disorders
5350945|NCT00248092|Amphetamine Abuse|amphetamine abuse
5350946|NCT00248092|Amphetamine Dependence|amphetamine dependence
5350947|NCT00248092|Amphetamine Addiction|amphetamine addiction
5350948|NCT00248092|Amphetamine Users|amphetamine users
5350949|NCT00248092|Drug Abuse|drug abuse
5350950|NCT00248092|Drug Addiction|drug addiction
5350951|NCT00248092|Drug Dependence|drug dependence
5350952|NCT00248092|Drug Habituation|drug habituation
5350953|NCT00248092|Drug Use Disorders|drug use disorders
5350954|NCT00248092|Substance Abuse|substance abuse
5350955|NCT00248092|Substance Dependence|substance dependence
5350956|NCT00248092|Substance Use Disorders|substance use disorders
5350957|NCT00248092|Drug Usage|drug usage
5350958|NCT00248092|Substance Addiction|substance addiction
5350959|NCT00248079|Coronary Disease|coronary disease
5350960|NCT00248066|Coronary artery disease|coronary artery disease
5350961|NCT00248066|Restenosis|restenosis
5350962|NCT00248066|Coronary stent restenosis|coronary stent restenosis
5350963|NCT00248053|Familial adenomatous polyposis patient with 5 or more adenomatous polyps in the colon or ileoanal pouch|familial adenomatous polyposis patient with 5 or more adenomatous polyps in the colon or ileoanal pouch
5350964|NCT00248040|Kidney transplantation|kidney transplantation
5350965|NCT00248040|Reperfusion Injury|reperfusion injury
5350966|NCT00248040|Survival|survival
5350967|NCT00248027|early intervention,program evaluation|early intervention,program evaluation
5350968|NCT00248014|CLASS II|class ii
5350969|NCT00248014|FUNCTIONAL APPLIANCE|functional appliance
5350970|NCT00248014|MANDIBULAR ADVANCEMENT STABILITY|mandibular advancement stability
5350971|NCT00247988|Ovarian|ovarian
5350972|NCT00247988|Relapsed|relapsed
5350973|NCT00247975|L-carnitine|l-carnitine
5350974|NCT00247975|Breast cancer|breast cancer
5350975|NCT00247975|Anthracycline Cardiotoxicity|anthracycline cardiotoxicity
5350976|NCT00247975|Primary prevention|primary prevention
5350977|NCT00247975|Anthracycline induced cardiotoxicity|anthracycline induced cardiotoxicity
5350978|NCT00247975|Left Ventricular Ejection Fraction|left ventricular ejection fraction
5350979|NCT00247962|Ankylosing Spondylitis (AS)|ankylosing spondylitis (as)
5350980|NCT00247949|carbon dioxide|carbon dioxide
5350981|NCT00247949|monitoring|monitoring
5350982|NCT00247949|major surgery|major surgery
5350983|NCT00247949|repeated blood gas testing|repeated blood gas testing
5350984|NCT00247949|carbon dioxide monitoring|carbon dioxide monitoring
5350985|NCT00247936|Adenocarcinoma, Esophagectomy|adenocarcinoma, esophagectomy
5350986|NCT00247923|Endometrial polyps.|endometrial polyps.
5350987|NCT00247923|Angiogenesis.|angiogenesis.
5350988|NCT00247923|Asymptomatic.|asymptomatic.
5350989|NCT00247923|Symptoms.|symptoms.
5350990|NCT00247923|Malignancy.|malignancy.
5350991|NCT00247923|Treatment efficiency.|treatment efficiency.
5350992|NCT00247923|Vaginal bleeding.|vaginal bleeding.
5350993|NCT00247910|hypertension, ambulatory BP, office resting BP, hydrochlorothiazide, stress reduction, self-help, psychotherapy, efficacy|hypertension, ambulatory bp, office resting bp, hydrochlorothiazide, stress reduction, self-help, psychotherapy, efficacy
5350994|NCT00247884|Injection drug users|injection drug users
5350995|NCT00247884|pegylated interferon|pegylated interferon
5350996|NCT00247884|ribavirin,|ribavirin,
5350997|NCT00247884|HCV|hcv
5350998|NCT00247871|MRSA, USA300, CMRSA-10, CMRSA-6, soft tissue abscesses|mrsa, usa300, cmrsa-10, cmrsa-6, soft tissue abscesses
5350999|NCT00247858|MRSA, USA300, CMRSA-10, CMRSA-6, soft tissue abscesses|mrsa, usa300, cmrsa-10, cmrsa-6, soft tissue abscesses
5351000|NCT00247845|HIV|hiv
5351001|NCT00247845|Atazanavir|atazanavir
5351002|NCT00247845|quality of life|quality of life
5351003|NCT00247845|Treatment Experienced|treatment experienced
5351004|NCT00247832|Monitoring, early mobilization, motivation modality, visitation rate, step rates, anxiety, pain|monitoring, early mobilization, motivation modality, visitation rate, step rates, anxiety, pain
5351005|NCT00247832|Elective lobectomy|elective lobectomy
5351006|NCT00247819|Substance abuse|substance abuse
5351007|NCT00247806|Pilot, pediatric, stem cell transplant, lactose intolerance|pilot, pediatric, stem cell transplant, lactose intolerance
5351008|NCT00247793|immunonutrition|immunonutrition
5351009|NCT00247793|preoperative optimization|preoperative optimization
5351010|NCT00247793|preoperative enteral nutritional supplement|preoperative enteral nutritional supplement
5351011|NCT00247793|high risk|high risk
5351012|NCT00247793|cardiac surgery|cardiac surgery
5351013|NCT00247793|arginine|arginine
5351014|NCT00247793|omega-3 polyunsaturated fatty acids|omega-3 polyunsaturated fatty acids
5351015|NCT00247793|nucleotides|nucleotides
5351016|NCT00247793|glycine|glycine
5351017|NCT00247793|immune enhancing nutritional supplement|immune enhancing nutritional supplement
5351018|NCT00247793|immune enhancing formula|immune enhancing formula
5351019|NCT00247780|Atrial fibrillation|atrial fibrillation
5351020|NCT00247780|Pulmonary vein isolation|pulmonary vein isolation
5351021|NCT00247780|Tissue Doppler echocardiography|tissue doppler echocardiography
5351022|NCT00247754|Anxiety|anxiety
5351025|NCT00247741|spinal anesthesia|spinal anesthesia
5351026|NCT00247741|lidocaine|lidocaine
5351027|NCT00247741|articaine|articaine
5351028|NCT00247741|intrathecal|intrathecal
5351029|NCT00247728|PI-88|pi-88
5351030|NCT00247728|post resection hepatoma|post resection hepatoma
5351031|NCT00247728|adjuvant therapy|adjuvant therapy
5351032|NCT00247728|hepatectomy|hepatectomy
5351033|NCT00247728|hepatoma|hepatoma
5351034|NCT00247715|uninvestigated dyspepsia|uninvestigated dyspepsia
5351035|NCT00247715|cost effectiveness|cost effectiveness
5351036|NCT00247715|acid suppressive medicine|acid suppressive medicine
5351037|NCT00247715|primary care|primary care
5351038|NCT00247715|gastrointestinal complaints|gastrointestinal complaints
5351039|NCT00247715|Gastrointestinal drugs|gastrointestinal drugs
5351040|NCT00247702|CYP2C9|cyp2c9
5351041|NCT00247702|VKORC1|vkorc1
5351042|NCT00247702|polymorphism|polymorphism
5351043|NCT00247702|warfarin|warfarin
5351044|NCT00247689|Ritalin|ritalin
5351045|NCT00247689|Substance Abuse|substance abuse
5351046|NCT00247689|Allelic Variants|allelic variants
5351047|NCT00247689|Genotype|genotype
5351048|NCT00247689|Addiction-Associated Human Gene Variants|addiction-associated human gene variants
5351049|NCT00247689|Methylphenidate|methylphenidate
5351050|NCT00247676|Liver neoplasms, sunitinib, Phase 2|liver neoplasms, sunitinib, phase 2
5351051|NCT00247663|Aromatase inhibitor|aromatase inhibitor
5351052|NCT00247663|letrozole|letrozole
5351053|NCT00247663|breast cancer|breast cancer
5351054|NCT00247650|neoadjuvant, postmenopausal women, breast cancer, hormonal therapy, bisphosphonate|neoadjuvant, postmenopausal women, breast cancer, hormonal therapy, bisphosphonate
5351055|NCT00247637|Mental Health|mental health
5351056|NCT00247637|Psychosis|psychosis
5351057|NCT00247637|Genetics|genetics
5351058|NCT00247637|Heredity|heredity
5351059|NCT00247624|Depression|depression
5351060|NCT00247624|Hypnotics|hypnotics
5351061|NCT00247624|Sleep|sleep
5351062|NCT00247624|Quality of Life|quality of life
5351063|NCT00247624|Insomnia|insomnia
5351064|NCT00247624|Suicide|suicide
5351065|NCT00247611|HIV|hiv
5351066|NCT00247611|AIDS|aids
5351067|NCT00247611|Antiretroviral Medication Adherence|antiretroviral medication adherence
5351068|NCT00247585|Alcohol|alcohol
5351069|NCT00247585|Alcohol abuse|alcohol abuse
5351070|NCT00247585|Alcohol consumption|alcohol consumption
5351071|NCT00247585|Unhealthy alcohol use|unhealthy alcohol use
5351072|NCT00247585|Residual effects|residual effects
5351073|NCT00247585|Sleep Stages|sleep stages
5351074|NCT00247585|Respiratory Physiology|respiratory physiology
5351075|NCT00247572|d-Amphetamine|d-amphetamine
5351076|NCT00247572|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
5351077|NCT00247572|Attention Deficit Disorders with Hyperactivity|attention deficit disorders with hyperactivity
5351078|NCT00247572|Attention Deficit Hyperactivity Disorders|attention deficit hyperactivity disorders
5351079|NCT00247572|Amphetamine Abuse|amphetamine abuse
5351080|NCT00247572|Amphetamine Dependence|amphetamine dependence
5351081|NCT00247572|Amphetamine Addiction|amphetamine addiction
5351082|NCT00247572|Amphetamine Users|amphetamine users
5351083|NCT00247572|Drug Abuse|drug abuse
5351084|NCT00247572|Drug Addiction|drug addiction
5351085|NCT00247572|Drug Dependence|drug dependence
5351086|NCT00247572|Drug Habituation|drug habituation
5351087|NCT00247572|Drug Use Disorders|drug use disorders
5351088|NCT00247572|Substance Abuse|substance abuse
5351089|NCT00247572|Substance Dependence|substance dependence
5351090|NCT00247572|Substance Use Disorders|substance use disorders
5351091|NCT00247572|Drug Usage|drug usage
5351092|NCT00247572|Substance Addiction|substance addiction
5351093|NCT00247572|Drug Abuse, Intravenous|drug abuse, intravenous
5351094|NCT00247572|Intravenous Drug Abuse|intravenous drug abuse
5351095|NCT00247559|crow's feet|crow's feet
5351096|NCT00247559|cosmesis|cosmesis
5351097|NCT00247559|ageing|ageing
5351098|NCT00247546|Falls|falls
5351099|NCT00247546|Accidental falls|accidental falls
5351100|NCT00247546|Prevention|prevention
5351101|NCT00247546|Aged|aged
5351102|NCT00247546|Multifactorial trial|multifactorial trial
5351103|NCT00247533|coronary disease|coronary disease
5351104|NCT00247533|cerebrovascular disorders|cerebrovascular disorders
5351105|NCT00247533|angiography|angiography
5351106|NCT00247533|cerebral ischemia|cerebral ischemia
5351107|NCT00247533|intracranial atherosclerosis|intracranial atherosclerosis
5351108|NCT00247533|Coronary artery disease|coronary artery disease
5351109|NCT00247533|cerebral artery stenosis|cerebral artery stenosis
5351110|NCT00247533|percutaneous coronary balloon angioplasty|percutaneous coronary balloon angioplasty
5351111|NCT00247533|coronary artery bypass surgery|coronary artery bypass surgery
5351112|NCT00247533|ischemic stroke|ischemic stroke
5351113|NCT00247533|electrocardiograph|electrocardiograph
5351114|NCT00247533|electroencephalograph|electroencephalograph
5351115|NCT00247533|Nuclear brain scan|nuclear brain scan
5351116|NCT00247533|cognition decline|cognition decline
5351117|NCT00247533|atrial fibrillation|atrial fibrillation
5351118|NCT00247533|undetermined ischemic stroke|undetermined ischemic stroke
5351119|NCT00247520|Seasonal allergic rhinitis (SAR), rhinoconjunctivitis, allergy|seasonal allergic rhinitis (sar), rhinoconjunctivitis, allergy
5351120|NCT00247507|Anemia|anemia
5351997|NCT00244491|geriatric|geriatric
5351121|NCT00247507|atherosclerosis|atherosclerosis
5351122|NCT00247507|End-stage renal disease|end-stage renal disease
5351123|NCT00247507|Erythropoietin|erythropoietin
5351124|NCT00247507|Hemodialysis|hemodialysis
5351125|NCT00247507|Oxidative stress|oxidative stress
5351126|NCT00247507|Pro-inflammation|pro-inflammation
5351127|NCT00247494|HIV-1|hiv-1
5351128|NCT00247494|atherosclerosis|atherosclerosis
5351129|NCT00247494|immunomodulation|immunomodulation
5351130|NCT00247481|Metastatic Breast Cancer|metastatic breast cancer
5351131|NCT00247455|Human nutrition|human nutrition
5351132|NCT00247455|Dietary fibre|dietary fibre
5351133|NCT00247455|Insulin resistance|insulin resistance
5351134|NCT00247455|Obesity|obesity
5351135|NCT00247455|Glucose|glucose
5351136|NCT00247455|Colonic fermentation|colonic fermentation
5351137|NCT00247455|Short chain fatty acids|short chain fatty acids
5351138|NCT00247455|GLP-1|glp-1
5351139|NCT00247455|Appetite|appetite
5351140|NCT00247455|Abdominal fat|abdominal fat
5351141|NCT00247442|Mammography screening|mammography screening
5351142|NCT00247442|Breast cancer screening|breast cancer screening
5351143|NCT00247442|Screening outcomes|screening outcomes
5351144|NCT00247442|Decision aid|decision aid
5351145|NCT00247442|Decision support tool|decision support tool
5351146|NCT00247442|Informed choice|informed choice
5351147|NCT00247429|depression|depression
5351148|NCT00247429|anxiety|anxiety
5351149|NCT00247429|elderly|elderly
5351150|NCT00247416|Untreated|untreated
5351151|NCT00247416|Lung|lung
5351152|NCT00247416|Cancer|cancer
5351153|NCT00247416|non-small cell|non-small cell
5351154|NCT00247416|gemcitabine|gemcitabine
5351155|NCT00247416|gemzar|gemzar
5351156|NCT00247416|carboplatin|carboplatin
5351157|NCT00247416|dexamethasone|dexamethasone
5351158|NCT00247403|Intracranial cancer|intracranial cancer
5351159|NCT00247403|Cancer|cancer
5351160|NCT00247403|2DG|2dg
5351161|NCT00247403|2-deoxyglucose|2-deoxyglucose
5351162|NCT00247403|Intracranial metastatic cancer|intracranial metastatic cancer
5351163|NCT00247390|Chronic Insomnia|chronic insomnia
5351164|NCT00247390|Sleep Initiation and Maintenance Disorder|sleep initiation and maintenance disorder
5351165|NCT00247390|Drug Therapy|drug therapy
5351166|NCT00247377|Morbid Obesity|morbid obesity
5351167|NCT00247377|Laparoscopic Gastric Bypass|laparoscopic gastric bypass
5351168|NCT00247377|Laparoscopic Gastric Banding|laparoscopic gastric banding
5351169|NCT00247364|RLS|rls
5351170|NCT00247338|parenteral nutrition|parenteral nutrition
5351171|NCT00247338|low calorie|low calorie
5351172|NCT00247338|low nitrogen|low nitrogen
5351173|NCT00247338|gastrointestinal neoplasms|gastrointestinal neoplasms
5351174|NCT00247338|gastrointestinal diseases|gastrointestinal diseases
5351175|NCT00247338|gastrectomy|gastrectomy
5351176|NCT00247338|colectomy|colectomy
5351177|NCT00247338|rectectomy|rectectomy
5351178|NCT00247338|operations|operations
5351179|NCT00247325|Kidney failure|kidney failure
5351180|NCT00247325|Contrast media|contrast media
5351181|NCT00247325|Iodixanol|iodixanol
5351182|NCT00247325|Ioxaglate|ioxaglate
5351183|NCT00247312|Prostate cancer|prostate cancer
5351184|NCT00247312|brachytherapy|brachytherapy
5351185|NCT00247312|palladium 103|palladium 103
5351186|NCT00247312|I-125|i-125
5351187|NCT00247299|Vascular lesions|vascular lesions
5351188|NCT00247299|Intense pulse light|intense pulse light
5351189|NCT00247299|phototermolysis|phototermolysis
5351190|NCT00247299|wavelength|wavelength
5351191|NCT00247299|filters|filters
5351192|NCT00247299|non coherent|non coherent
5351193|NCT00247286|urodynamic stress incontinence|urodynamic stress incontinence
5351194|NCT00247286|weighted vaginal cones|weighted vaginal cones
5351195|NCT00247286|pelvic floor biofeedback|pelvic floor biofeedback
5351196|NCT00247286|randomized controlled trial|randomized controlled trial
5351197|NCT00247273|randomized controlled trial, osteoporosis, risedronate|randomized controlled trial, osteoporosis, risedronate
5351198|NCT00247260|HCC|hcc
5351199|NCT00247260|Primary Liver Cancer|primary liver cancer
5351200|NCT00247221|Alcohol|alcohol
5351201|NCT00247221|Substance abuse|substance abuse
5351202|NCT00247221|Adolescent|adolescent
5351203|NCT00247221|Family functioning|family functioning
5351204|NCT00247208|Coronary artery bypass|coronary artery bypass
5351205|NCT00247208|Stents|stents
5351206|NCT00247208|Angioplasty, Transluminal, Percutaneous Coronary|angioplasty, transluminal, percutaneous coronary
5351207|NCT00247208|Coronary Restenosis|coronary restenosis
5351208|NCT00247208|Paclitaxel|paclitaxel
5351209|NCT00247195|Major Depression|major depression
5351210|NCT00247195|MDD|mdd
5351211|NCT00247195|Hispanic|hispanic
5351212|NCT00247195|Primary Care|primary care
5351213|NCT00247195|Cultural Congruence|cultural congruence
5351214|NCT00247182|Stepped Care|stepped care
5351215|NCT00247182|Brief Motivational Intervention|brief motivational intervention
5351216|NCT00247182|Minimal Intervention|minimal intervention
5351217|NCT00247182|Treatment response|treatment response
5351218|NCT00247182|College Students|college students
5351219|NCT00247169|cervical intraepithelial neoplasia (CIN)|cervical intraepithelial neoplasia (cin)
5351220|NCT00247169|progesterone|progesterone
5351221|NCT00247156|Autism|autism
5351222|NCT00247156|eye contact|eye contact
5351223|NCT00247156|Noncommunicable|noncommunicable
5351224|NCT00247143|Protease Inhibitor|protease inhibitor
5351225|NCT00247143|Antiretroviral Agents|antiretroviral agents
5351226|NCT00247143|Treatment Experienced|treatment experienced
5351227|NCT00247130|Omeprazole|omeprazole
5351228|NCT00247130|Ranitidine|ranitidine
5351229|NCT00247130|Endoscopic treatment|endoscopic treatment
5351230|NCT00247130|Hemostasis|hemostasis
5351231|NCT00247130|Peptic ulcer|peptic ulcer
5351232|NCT00247117|non-alcoholic fatty liver disease|non-alcoholic fatty liver disease
5351233|NCT00247117|insulin resistance|insulin resistance
5351234|NCT00247117|metformin|metformin
5351235|NCT00247104|Urinary tract infection|urinary tract infection
5351236|NCT00247104|Endometritis|endometritis
5351237|NCT00247104|Respiratory Distress Syndrome|respiratory distress syndrome
5351238|NCT00247104|Necrotizing enterocolitis|necrotizing enterocolitis
5351239|NCT00247104|Intraventricular hemorrhage|intraventricular hemorrhage
5351240|NCT00247104|Latent period|latent period
5351241|NCT00247104|Neonatal infection|neonatal infection
5351242|NCT00247091|HIV|hiv
5351243|NCT00247091|measles|measles
5351244|NCT00247091|measles vaccine|measles vaccine
5351245|NCT00247091|children|children
5351246|NCT00247091|Zambia|zambia
5351247|NCT00247078|black|black
5351248|NCT00247078|widow|widow
5351249|NCT00247078|spider|spider
5351250|NCT00247078|antivenom|antivenom
5351251|NCT00247052|post operative pericardial effusion|post operative pericardial effusion
5351252|NCT00247052|NSAID|nsaid
5351253|NCT00247039|neutropenia|neutropenia
5351254|NCT00247039|fever|fever
5351255|NCT00247039|garlic|garlic
5351256|NCT00247039|infection|infection
5351257|NCT00247026|myelodysplasia|myelodysplasia
5351258|NCT00247026|curcumin|curcumin
5351259|NCT00247026|coenzyme Q10|coenzyme q10
5351260|NCT00247026|cytopenia|cytopenia
5351261|NCT00247013|automated telephone system|automated telephone system
5351262|NCT00247013|breast cancer|breast cancer
5351263|NCT00247013|cancer prevention|cancer prevention
5351264|NCT00247013|intervention|intervention
5351265|NCT00247013|mammography|mammography
5351266|NCT00247013|screening|screening
5351267|NCT00247000|Cardiovascular Diseases|cardiovascular diseases
5351268|NCT00247000|Heart Disease|heart disease
5351269|NCT00247000|Heart Failure,Congestive|heart failure,congestive
5351270|NCT00247000|Health Outcomes|health outcomes
5351271|NCT00247000|Disease Management|disease management
5351272|NCT00247000|Telehomecare|telehomecare
5351273|NCT00247000|Home Telehealth|home telehealth
5351274|NCT00246974|bladder cancer|bladder cancer
5351275|NCT00246974|Transitionel cell cancer of the urothelium|transitionel cell cancer of the urothelium
5351276|NCT00246961|Adjuvant|adjuvant
5351277|NCT00246948|Physical therapy|physical therapy
5351278|NCT00246935|COPD|copd
5351279|NCT00246935|Phosphodiesterase 4 inhibitor|phosphodiesterase 4 inhibitor
5351280|NCT00246935|Roflumilast|roflumilast
5351281|NCT00246922|Asthma|asthma
5351282|NCT00246922|Roflumilast|roflumilast
5351283|NCT00246922|phosphodiesterase 4 inhibitor|phosphodiesterase 4 inhibitor
5351284|NCT00246909|Gastroesophageal Reflux|gastroesophageal reflux
5351285|NCT00246909|Gastroesophageal Reflux Disease|gastroesophageal reflux disease
5351286|NCT00246909|Pantoprazole|pantoprazole
5351287|NCT00246883|Endothelial Progenitor Cells|endothelial progenitor cells
5351288|NCT00246883|Nitric Oxide|nitric oxide
5351289|NCT00246883|Brachial Artery Reactivity|brachial artery reactivity
5351290|NCT00246883|Physical Fitness|physical fitness
5351291|NCT00246883|C-reactive Protein|c-reactive protein
5351292|NCT00246883|Exercise|exercise
5351293|NCT00246883|Vascular Function|vascular function
5351294|NCT00246870|Seizures|seizures
5351295|NCT00246870|Development|development
5351296|NCT00246870|Pediatric|pediatric
5351297|NCT00246870|Benzodiazepine Receptors|benzodiazepine receptors
5351298|NCT00246870|Neurotransmission|neurotransmission
5351299|NCT00246870|Succinic Semialdehyde Dehydrogenase|succinic semialdehyde dehydrogenase
5351300|NCT00246870|Deficiency|deficiency
5351301|NCT00246870|SSADH Deficiency|ssadh deficiency
5351302|NCT00246870|Healthy Volunteer|healthy volunteer
5351303|NCT00246870|HV|hv
5351304|NCT00246857|Apoptosis|apoptosis
5351305|NCT00246857|T-cell|t-cell
5351306|NCT00246857|Autoimmunity|autoimmunity
5351307|NCT00246857|Immunodeficiency|immunodeficiency
5351308|NCT00246857|B-Cell|b-cell
5351309|NCT00246857|Inherited Lymphhocyte Homeostasis|inherited lymphhocyte homeostasis
5351310|NCT00246857|Genetic Disease|genetic disease
5351311|NCT00246844|Transplant|transplant
5351312|NCT00246844|Diabetes|diabetes
5351313|NCT00246844|C-Peptide|c-peptide
5351314|NCT00246844|B Cell|b cell
5351315|NCT00246844|Immunosuppression|immunosuppression
5351316|NCT00246844|Type 1 Diabetes|type 1 diabetes
5351317|NCT00246844|Pancreas Transplant|pancreas transplant
5351318|NCT00246831|fMRI|fmri
5351319|NCT00246831|Self-Agency|self-agency
5351320|NCT00246831|Functional Magnetic Resonance Imaging (fMRI)|functional magnetic resonance imaging (fmri)
5351321|NCT00246831|Voluntary Movement|voluntary movement
5351322|NCT00246831|Healthy Volunteer|healthy volunteer
5351323|NCT00246831|HV|hv
5351324|NCT00246818|Mind-Body|mind-body
5351325|NCT00246818|Stress Reduction|stress reduction
5351326|NCT00246818|Complementary Medicine|complementary medicine
5351327|NCT00246818|Quality of Life|quality of life
5351328|NCT00246818|Well-being|well-being
5351329|NCT00246818|Psychoneuroimmunology|psychoneuroimmunology
5351330|NCT00246818|Tai Chi|tai chi
5351331|NCT00246818|Aerobic Exercise|aerobic exercise
5351332|NCT00246818|Cancer Survivor|cancer survivor
5351333|NCT00246805|Permanent atrial fibrillation|permanent atrial fibrillation
5351334|NCT00246805|VVI(R) pacing|vvi(r) pacing
5351335|NCT00246805|rate regularization|rate regularization
5351336|NCT00246792|School-based intervention|school-based intervention
5351337|NCT00246792|Learning disabilities|learning disabilities
5351338|NCT00246792|ecological intervention|ecological intervention
5351339|NCT00246779|transfusion|transfusion
5351340|NCT00246779|cardiac surgery|cardiac surgery
5351341|NCT00246779|modified ultrafiltration|modified ultrafiltration
5351342|NCT00246779|Cardiopulmonary bypass|cardiopulmonary bypass
5351343|NCT00246766|Maternal's movements recorded by a specific sensor|maternal's movements recorded by a specific sensor
5351344|NCT00246766|Parameters of fetal distress (umbilical and cerebral Doppler) and new-born parameters.|parameters of fetal distress (umbilical and cerebral doppler) and new-born parameters.
5351345|NCT00246753|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5351346|NCT00246753|recurrent prostate cancer|recurrent prostate cancer
5351347|NCT00246753|stage I prostate cancer|stage i prostate cancer
5351348|NCT00246753|stage II prostate cancer|stage ii prostate cancer
5351349|NCT00246753|stage III prostate cancer|stage iii prostate cancer
5351350|NCT00246753|stage IV prostate cancer|stage iv prostate cancer
5351351|NCT00246740|Doxycycline|doxycycline
5351352|NCT00246740|coronary artery bypass grafting|coronary artery bypass grafting
5351353|NCT00246714|endotoxin tolerance|endotoxin tolerance
5351354|NCT00246714|humans|humans
5351355|NCT00246714|cross-tolerance|cross-tolerance
5351356|NCT00246714|pro and anti-inflammatory cytokines|pro and anti-inflammatory cytokines
5351357|NCT00246701|omega-3-acid ethyl esters|omega-3-acid ethyl esters
5351358|NCT00246701|simvastatin|simvastatin
5351359|NCT00246701|Lovaza|lovaza
5351360|NCT00246701|High triglycerides|high triglycerides
5351361|NCT00246662|Leukemia|leukemia
5351362|NCT00246662|Hematologic|hematologic
5351363|NCT00246662|Blood|blood
5351364|NCT00246662|Cancer|cancer
5351365|NCT00246662|Malignancy|malignancy
5351366|NCT00246662|Myelodysplastic Syndromes|myelodysplastic syndromes
5351367|NCT00246636|Very high triglycerides|very high triglycerides
5351368|NCT00246636|omega-3-acid ethyl esters|omega-3-acid ethyl esters
5351369|NCT00246636|fenofibrate|fenofibrate
5351370|NCT00246636|Lovaza|lovaza
5351371|NCT00246610|Non-randomized open-label single-arm study of Nelfinavir plus Combivir in pregnant females infected with HIV-1 virus.|non-randomized open-label single-arm study of nelfinavir plus combivir in pregnant females infected with hiv-1 virus.
5351372|NCT00246597|Anemia|anemia
5351373|NCT00246597|Breast cancer|breast cancer
5351374|NCT00246597|Hemoglobin|hemoglobin
5351375|NCT00246597|Quality of Life|quality of life
5351376|NCT00246597|Adjuvant Chemotherapy|adjuvant chemotherapy
5351377|NCT00246597|Pure red cell aplasia (PRCA)|pure red cell aplasia (prca)
5351378|NCT00246597|Cognitive and executive function|cognitive and executive function
5351379|NCT00246584|Hypertension|hypertension
5351380|NCT00246584|angiotensin|angiotensin
5351381|NCT00246584|renin|renin
5351382|NCT00246584|aliskiren|aliskiren
5351383|NCT00246558|Tight Achilles Tendon|tight achilles tendon
5351384|NCT00246558|Hyperpronation of the foot|hyperpronation of the foot
5351385|NCT00246519|hypertension|hypertension
5351386|NCT00246519|pharmacogenetics|pharmacogenetics
5351387|NCT00246519|pharmacogenomics|pharmacogenomics
5351388|NCT00246519|beta-blocker|beta-blocker
5351389|NCT00246519|atenolol|atenolol
5351390|NCT00246519|diuretic|diuretic
5351391|NCT00246519|hydrochlorothiazide|hydrochlorothiazide
5351392|NCT00246519|blood pressure|blood pressure
5351393|NCT00246519|metabolic adverse effects|metabolic adverse effects
5351394|NCT00246506|Infertility|infertility
5351395|NCT00246506|Fertility|fertility
5351396|NCT00246506|Reproduction|reproduction
5351397|NCT00246506|Advanced Maternal Age|advanced maternal age
5351398|NCT00246506|Reproductive Medicine|reproductive medicine
5351399|NCT00246506|Reproductive Techniques|reproductive techniques
5351400|NCT00246506|Pregnancy|pregnancy
5351401|NCT00246493|Coronary|coronary
5351402|NCT00246493|Endothelial|endothelial
5351403|NCT00246493|Vascular|vascular
5351404|NCT00246493|Atherosclerosis|atherosclerosis
5351405|NCT00246493|Arterial|arterial
5351406|NCT00246480|Respiratory Syncytial Virus Infections, RSV, elderly|respiratory syncytial virus infections, rsv, elderly
5351407|NCT00246467|plague|plague
5351408|NCT00246454|circadian|circadian
5351409|NCT00246454|advanced sleep phase|advanced sleep phase
5351410|NCT00246454|delayed sleep phase|delayed sleep phase
5351411|NCT00246441|Pharmacotherapy|pharmacotherapy
5351412|NCT00246441|Self medication|self medication
5351413|NCT00246428|Motivational Interviewing|motivational interviewing
5351414|NCT00246428|Alcohol Abuse|alcohol abuse
5351415|NCT00246428|Alcohol Dependence|alcohol dependence
5351416|NCT00246428|Emergency Care Setting|emergency care setting
5351417|NCT00246415|Alcohol Dependence|alcohol dependence
5351418|NCT00246415|Alcohol Abuse|alcohol abuse
5351419|NCT00246415|Memantine|memantine
5351420|NCT00246415|Alcohol Treatment|alcohol treatment
5351421|NCT00246389|muscle spasm|muscle spasm
5351422|NCT00246389|cyclobenzaprine hydrochloride|cyclobenzaprine hydrochloride
5351423|NCT00246363|HIV|hiv
5351424|NCT00246363|Hepatitis C|hepatitis c
5351425|NCT00246350|Headaches|headaches
5351426|NCT00246350|Spinal manipulation|spinal manipulation
5351427|NCT00246350|Massage|massage
5351428|NCT00246350|chiropractic|chiropractic
5351429|NCT00246298|Anemia|anemia
5351430|NCT00246298|erythropoetin|erythropoetin
5351431|NCT00246298|Epoetin alfa|epoetin alfa
5351432|NCT00246298|erythropoietin recombinant|erythropoietin recombinant
5351433|NCT00246298|HIV infection|hiv infection
5351434|NCT00246298|HIV|hiv
5351435|NCT00246298|AIDS|aids
5351436|NCT00246285|schizophrenia|schizophrenia
5351437|NCT00246285|antipsychotic agents|antipsychotic agents
5351438|NCT00246285|risperidone|risperidone
5351439|NCT00246285|adolescents|adolescents
5351440|NCT00246272|risperidone|risperidone
5351441|NCT00246272|schizophrenia|schizophrenia
5351442|NCT00246272|rapidly-dissolving|rapidly-dissolving
5351443|NCT00246259|Schizophrenia|schizophrenia
5351444|NCT00246259|Schizoaffective disorder|schizoaffective disorder
5351445|NCT00246259|Schizophreniform disorder|schizophreniform disorder
5351446|NCT00246259|Risperidone|risperidone
5351447|NCT00246259|Risperdal Consta|risperdal consta
5351448|NCT00246246|risperidone|risperidone
5351449|NCT00246246|long-acting injectable|long-acting injectable
5351450|NCT00246246|bipolar disorder|bipolar disorder
5351451|NCT00246246|intramuscular injection|intramuscular injection
5351452|NCT00246233|methylphenidate hydrochloride|methylphenidate hydrochloride
5351453|NCT00246233|oral tablets|oral tablets
5351454|NCT00246233|Major Depressive Disorder|major depressive disorder
5351455|NCT00246220|Attention deficit/hyperactivity disorder|attention deficit/hyperactivity disorder
5351456|NCT00246220|methylphenidate|methylphenidate
5351457|NCT00246220|central nervous system stimulants|central nervous system stimulants
5351458|NCT00246207|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
5351459|NCT00246207|once-day oral tablets|once-day oral tablets
5351460|NCT00246194|Schizophrenia|schizophrenia
5351461|NCT00246194|Mental disorder|mental disorder
5351462|NCT00246194|DSM-IV|dsm-iv
5351463|NCT00246194|RISPERDAL CONSTA|risperdal consta
5351464|NCT00246194|Risperidone|risperidone
5351465|NCT00246194|Long-acting risperidone|long-acting risperidone
5351466|NCT00246194|Disorganized|disorganized
5351467|NCT00246194|Catatonic|catatonic
5351468|NCT00246194|Paranoid|paranoid
5351469|NCT00246181|Lung cancer|lung cancer
5351470|NCT00246181|stereotactic body radiotherapy|stereotactic body radiotherapy
5351471|NCT00246168|Rheumatoid arthritis|rheumatoid arthritis
5351472|NCT00246168|NSAID add-on therapy|nsaid add-on therapy
5351473|NCT00246168|tramadol|tramadol
5351474|NCT00246168|acetaminophen|acetaminophen
5351475|NCT00246155|chronic|chronic
5351476|NCT00246155|muscular|muscular
5351477|NCT00246129|Kidney Transplantation|kidney transplantation
5351478|NCT00246129|Kidney Disease|kidney disease
5351479|NCT00246129|Kidney Failure|kidney failure
5351480|NCT00246129|Graft Rejection|graft rejection
5351481|NCT00246116|Lung Cancer|lung cancer
5351482|NCT00246116|Radiation Oncology|radiation oncology
5351483|NCT00246116|Treated with Stereostatic Body Radiation|treated with stereostatic body radiation
5351484|NCT00246103|Valproic Acid|valproic acid
5351485|NCT00246103|Epirubicin|epirubicin
5351486|NCT00246103|Solid Tumor|solid tumor
5351487|NCT00246103|Malignancies|malignancies
5351488|NCT00246077|chronic transfusion therapy|chronic transfusion therapy
5351489|NCT00246077|quality of life|quality of life
5351490|NCT00246064|Rheumatoid Arthritis|rheumatoid arthritis
5351491|NCT00246064|Infliximab infusions|infliximab infusions
5351492|NCT00246064|Methotrexate|methotrexate
5351493|NCT00246064|Remicade|remicade
5351494|NCT00246051|Police|police
5351495|NCT00246051|Sleep|sleep
5351496|NCT00246051|Fatigue|fatigue
5351497|NCT00246051|Work Hours|work hours
5351498|NCT00246051|Sleep disorder|sleep disorder
5351499|NCT00246051|Performance|performance
5351500|NCT00246038|Abdominal Aortic Aneurysm|abdominal aortic aneurysm
5351501|NCT00246038|Aortic Aneurysm|aortic aneurysm
5351502|NCT00246038|AAA|aaa
5351503|NCT00246038|Endovascular|endovascular
5351504|NCT00246038|Stent Graft|stent graft
5351505|NCT00246038|Endograft|endograft
5351506|NCT00246038|Vascular Prostheses|vascular prostheses
5351507|NCT00246012|Melanoma|melanoma
5351508|NCT00246012|Neoplasm|neoplasm
5351509|NCT00246012|CNTO 95|cnto 95
5351510|NCT00246012|Dacarbazine|dacarbazine
5351511|NCT00246012|Intetumumab|intetumumab
5351512|NCT00245986|Pharmacokinetics|pharmacokinetics
5351513|NCT00245986|Cytochrome P450|cytochrome p450
5351514|NCT00245986|HIV Resistance|hiv resistance
5351515|NCT00245986|Drug Interaction|drug interaction
5351516|NCT00245986|Non-Nucleoside Reverse Transcriptase Inhibitors|non-nucleoside reverse transcriptase inhibitors
5351517|NCT00245986|HIV Positive|hiv positive
5351518|NCT00245986|Healthy Volunteer|healthy volunteer
5351519|NCT00245986|HV|hv
5351520|NCT00245960|Psoriatic Arthritis|psoriatic arthritis
5351521|NCT00245960|Skin Disease|skin disease
5351522|NCT00245960|Joint Disease|joint disease
5351523|NCT00245947|Crohn's Disease|crohn's disease
5351524|NCT00245947|Inflammation|inflammation
5351525|NCT00245934|Rheumatoid Arthritis|rheumatoid arthritis
5351526|NCT00245921|contraception|contraception
5351527|NCT00245908|Asthma|asthma
5351528|NCT00245908|Chlamydia pneumoniae|chlamydia pneumoniae
5351529|NCT00245908|Chlamydophila pneumoniae|chlamydophila pneumoniae
5351530|NCT00245908|Azithromycin|azithromycin
5351531|NCT00245895|Anemia,|anemia,
5351532|NCT00245895|Prostate Cancer|prostate cancer
5351533|NCT00245882|Telehealth|telehealth
5351534|NCT00245882|Veterans|veterans
5351535|NCT00245882|Glycemic control|glycemic control
5351536|NCT00245882|Active care management|active care management
5351537|NCT00245882|Care coordination|care coordination
5351538|NCT00245869|Contrast-enhanced Ultrasound|contrast-enhanced ultrasound
5351539|NCT00245869|Ultrasound Contrast agents, microbubbles|ultrasound contrast agents, microbubbles
5351540|NCT00245869|breast cancer|breast cancer
5351541|NCT00245869|chemotherapy|chemotherapy
5351542|NCT00245869|vascularization|vascularization
5351543|NCT00245856|Upper Extremity Deep-Vein Thrombosis|upper extremity deep-vein thrombosis
5351544|NCT00245856|DVT|dvt
5351545|NCT00245856|Fragmin|fragmin
5351546|NCT00245856|Deep-Vein Thrombosis|deep-vein thrombosis
5351547|NCT00245856|Thrombosis|thrombosis
5351548|NCT00245843|Premature birth|premature birth
5351549|NCT00245843|moderate preterm|moderate preterm
5351550|NCT00245843|late preterm|late preterm
5351551|NCT00245843|Joint attention|joint attention
5351552|NCT00245843|Social interaction|social interaction
5351553|NCT00245843|Child development|child development
5351554|NCT00245843|Parent|parent
5351555|NCT00245843|infant|infant
5351556|NCT00245830|Ischemia/reperfusion of the liver|ischemia/reperfusion of the liver
5351557|NCT00245830|Ischemic Preconditioning|ischemic preconditioning
5351558|NCT00245830|Cadaver organ donor|cadaver organ donor
5351559|NCT00245817|Anxiety. Depression. HRQOL. Psycho-educative intervention|anxiety. depression. hrqol. psycho-educative intervention
5351560|NCT00245791|Complicated Urinary Infection|complicated urinary infection
5351561|NCT00245765|chronic plaque psoriasis, anti TNFα|chronic plaque psoriasis, anti tnfα
5351562|NCT00245765|CDP870, Cimzia|cdp870, cimzia
5351563|NCT00245752|post term pregnancy|post term pregnancy
5351564|NCT00245752|acupuncture|acupuncture
5351565|NCT00245752|induction|induction
5351566|NCT00245739|HIV infections|hiv infections
5351567|NCT00245739|HIV-1|hiv-1
5351568|NCT00245739|TMC114|tmc114
5351569|NCT00245739|Early access|early access
5351570|NCT00245739|Highly antiretroviral treatment experienced patients|highly antiretroviral treatment experienced patients
5351571|NCT00245739|Anti-retroviral agents|anti-retroviral agents
5351572|NCT00245713|Levetiracetam, adult, partial-onset epilepsy, antiepileptic|levetiracetam, adult, partial-onset epilepsy, antiepileptic
5351573|NCT00245687|feeding tube, nutrition, gastric, jejunal|feeding tube, nutrition, gastric, jejunal
5351574|NCT00245661|COPD|copd
5351575|NCT00245661|respiratory|respiratory
5351576|NCT00245661|sleep quality|sleep quality
5351577|NCT00245661|temazepam|temazepam
5351578|NCT00245661|dyspnea|dyspnea
5351579|NCT00245635|Body Dysmorphic Disorder|body dysmorphic disorder
5351580|NCT00245635|BDD|bdd
5351581|NCT00245635|BDD treatment|bdd treatment
5351582|NCT00245635|delusionality variant|delusionality variant
5351583|NCT00245635|OCD|ocd
5351584|NCT00245622|Phase 2b Tovaxin|phase 2b tovaxin
5351585|NCT00245622|Clinically Isolated Syndrome (CIS)|clinically isolated syndrome (cis)
5351586|NCT00245622|Relapse-Remitting Multiple Sclerosis (RR-MS)|relapse-remitting multiple sclerosis (rr-ms)
5351587|NCT00245583|Pathological Gambling|pathological gambling
5351588|NCT00245583|Compulsive Gambling|compulsive gambling
5351589|NCT00245583|Gambling|gambling
5351590|NCT00245583|topiramate|topiramate
5351591|NCT00245557|Depression|depression
5351592|NCT00245557|Geriatric|geriatric
5351593|NCT00245557|MRI|mri
5351594|NCT00245557|Sertraline|sertraline
5351595|NCT00245531|endocrine abnormalities|endocrine abnormalities
5351596|NCT00245531|cognitive performance|cognitive performance
5351597|NCT00245518|prostate cancer|prostate cancer
5351598|NCT00245518|soy|soy
5351599|NCT00245518|androgen deprivation|androgen deprivation
5351600|NCT00245518|quality of life|quality of life
5351601|NCT00245518|isoflavones|isoflavones
5351602|NCT00245492|Colonoscopy|colonoscopy
5351603|NCT00245492|Chromoscopy|chromoscopy
5351604|NCT00245492|Prevention|prevention
5351605|NCT00245479|Primary nocturnal enuresis|primary nocturnal enuresis
5351606|NCT00245466|Prostate Cancer|prostate cancer
5351607|NCT00245466|Androgen ablation therapy|androgen ablation therapy
5351608|NCT00245453|pneumonia|pneumonia
5351609|NCT00245453|Spneumoniae|spneumoniae
5351610|NCT00245453|bronchitis|bronchitis
5351611|NCT00245453|telithromycin|telithromycin
5351612|NCT00245453|azithromycin|azithromycin
5351613|NCT00245440|S.pneumonia|s.pneumonia
5351614|NCT00245440|sinusitis|sinusitis
5351615|NCT00245440|ams|ams
5351616|NCT00245440|azithromycin|azithromycin
5351617|NCT00245427|beta-lactam|beta-lactam
5351618|NCT00245427|macrolide|macrolide
5351619|NCT00245427|antibiotics|antibiotics
5351620|NCT00245388|Mixed Dyslipidemia|mixed dyslipidemia
5351621|NCT00245375|Outpatient Surgery for:|outpatient surgery for:
5352192|NCT00243594|Peptides|peptides
5351622|NCT00245375|inguinal hernia repair|inguinal hernia repair
5351623|NCT00245375|abdominal hernia repair|abdominal hernia repair
5351624|NCT00245375|umbilical hernia repair|umbilical hernia repair
5351625|NCT00245362|cancer vaccine|cancer vaccine
5351626|NCT00245362|pancreatic cancer|pancreatic cancer
5351627|NCT00245362|metastatic pancreatic cancer|metastatic pancreatic cancer
5351628|NCT00245362|unresectable pancreatic cancer|unresectable pancreatic cancer
5351629|NCT00245362|immunotherapy|immunotherapy
5351630|NCT00245349|Head and Neck cancer|head and neck cancer
5351631|NCT00245349|Squamous cell carcinoma|squamous cell carcinoma
5351632|NCT00245349|FLT|flt
5351633|NCT00245349|Fluorothymidine|fluorothymidine
5351634|NCT00245349|F-18|f-18
5351635|NCT00245336|hemostasis|hemostasis
5351636|NCT00245336|surgery|surgery
5351637|NCT00245336|hemostatics|hemostatics
5351638|NCT00245336|randomized controlled trial|randomized controlled trial
5351639|NCT00245336|phase 3|phase 3
5351640|NCT00245323|smoking|smoking
5351641|NCT00245310|ICG clearance|icg clearance
5351642|NCT00245310|liver cirrhosis|liver cirrhosis
5351643|NCT00245310|acute liver failure|acute liver failure
5351644|NCT00245310|prognosis|prognosis
5351645|NCT00245297|Bleeding disorder|bleeding disorder
5351646|NCT00245297|severe Haemophilia A|severe haemophilia a
5351647|NCT00245297|Prophylaxis|prophylaxis
5351648|NCT00245271|Knee|knee
5351649|NCT00245271|Musculoskeletal System|musculoskeletal system
5351650|NCT00245271|Ligament|ligament
5351651|NCT00245271|ACL reconstruction|acl reconstruction
5351652|NCT00245245|hemophilia A|hemophilia a
5351653|NCT00245245|inhibitor|inhibitor
5351654|NCT00245245|treatment|treatment
5351655|NCT00245232|PTSD|ptsd
5351656|NCT00245232|Cognitive therapy|cognitive therapy
5351657|NCT00245232|Rape|rape
5351658|NCT00245206|Antipsychotic|antipsychotic
5351659|NCT00245206|Diabetes|diabetes
5351660|NCT00245206|Hyperlipidemia|hyperlipidemia
5351661|NCT00245206|Stroke|stroke
5351662|NCT00245193|Major Depression|major depression
5351663|NCT00245154|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5351664|NCT00245154|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5351665|NCT00245141|embryonal childhood rhabdomyosarcoma|embryonal childhood rhabdomyosarcoma
5351666|NCT00245141|embryonal-botryoid childhood rhabdomyosarcoma|embryonal-botryoid childhood rhabdomyosarcoma
5351667|NCT00245141|previously untreated childhood rhabdomyosarcoma|previously untreated childhood rhabdomyosarcoma
5351668|NCT00245128|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
5351669|NCT00245128|polycythemia vera|polycythemia vera
5351670|NCT00245128|essential thrombocythemia|essential thrombocythemia
5351671|NCT00245115|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
5351672|NCT00245115|childhood acute myeloblastic leukemia without maturation (M1)|childhood acute myeloblastic leukemia without maturation (m1)
5351673|NCT00245115|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
5351674|NCT00245115|childhood acute myeloblastic leukemia with maturation (M2)|childhood acute myeloblastic leukemia with maturation (m2)
5351675|NCT00245115|adult acute promyelocytic leukemia (M3)|adult acute promyelocytic leukemia (m3)
5351676|NCT00245115|childhood acute promyelocytic leukemia (M3)|childhood acute promyelocytic leukemia (m3)
5351677|NCT00245115|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
5351678|NCT00245115|childhood acute myelomonocytic leukemia (M4)|childhood acute myelomonocytic leukemia (m4)
5351679|NCT00245115|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
5351680|NCT00245115|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
5351681|NCT00245115|childhood acute monoblastic leukemia (M5a)|childhood acute monoblastic leukemia (m5a)
5351682|NCT00245115|childhood acute monocytic leukemia (M5b)|childhood acute monocytic leukemia (m5b)
5351683|NCT00245115|adult erythroleukemia (M6a)|adult erythroleukemia (m6a)
5351684|NCT00245115|adult pure erythroid leukemia (M6b)|adult pure erythroid leukemia (m6b)
5351685|NCT00245115|childhood acute erythroleukemia (M6)|childhood acute erythroleukemia (m6)
5351686|NCT00245115|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
5351687|NCT00245115|childhood acute megakaryocytic leukemia (M7)|childhood acute megakaryocytic leukemia (m7)
5351688|NCT00245115|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5351689|NCT00245115|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5351690|NCT00245115|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
5351691|NCT00245115|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
5351692|NCT00245115|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5351693|NCT00245115|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5351694|NCT00245115|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5351695|NCT00245115|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5351696|NCT00245115|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5351697|NCT00245115|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5351698|NCT00245089|embryonal childhood rhabdomyosarcoma|embryonal childhood rhabdomyosarcoma
5351699|NCT00245089|embryonal-botryoid childhood rhabdomyosarcoma|embryonal-botryoid childhood rhabdomyosarcoma
5352193|NCT00243594|MRI|mri
5351700|NCT00245089|previously untreated childhood rhabdomyosarcoma|previously untreated childhood rhabdomyosarcoma
5351701|NCT00245076|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5351702|NCT00245050|drug/agent toxicity by tissue/organ|drug/agent toxicity by tissue/organ
5351703|NCT00245050|fallopian tube cancer|fallopian tube cancer
5351704|NCT00245050|peritoneal cavity cancer|peritoneal cavity cancer
5351705|NCT00245050|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5351706|NCT00245050|recurrent endometrial carcinoma|recurrent endometrial carcinoma
5351707|NCT00245050|stage III endometrial carcinoma|stage iii endometrial carcinoma
5351708|NCT00245050|stage IV endometrial carcinoma|stage iv endometrial carcinoma
5351709|NCT00245050|stage IV breast cancer|stage iv breast cancer
5351710|NCT00245050|male breast cancer|male breast cancer
5351711|NCT00245050|recurrent breast cancer|recurrent breast cancer
5351712|NCT00245037|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5351713|NCT00245037|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5351714|NCT00245037|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5351715|NCT00245037|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5351716|NCT00245037|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5351717|NCT00245037|atypical chronic myeloid leukemia, breakpoint cluster region-Abelson (BCR-ABL) negative|atypical chronic myeloid leukemia, breakpoint cluster region-abelson (bcr-abl) negative
5351718|NCT00245037|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5351719|NCT00245037|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5351720|NCT00245037|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5351721|NCT00245037|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5351722|NCT00245037|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5351723|NCT00245037|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5351724|NCT00245037|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5351725|NCT00245037|stage II multiple myeloma|stage ii multiple myeloma
5351726|NCT00245037|stage III multiple myeloma|stage iii multiple myeloma
5351727|NCT00245037|primary systemic amyloidosis|primary systemic amyloidosis
5351728|NCT00245037|refractory multiple myeloma|refractory multiple myeloma
5351729|NCT00245037|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
5351730|NCT00245037|chronic eosinophilic leukemia|chronic eosinophilic leukemia
5351731|NCT00245037|primary myelofibrosis|primary myelofibrosis
5351732|NCT00245037|chronic neutrophilic leukemia|chronic neutrophilic leukemia
5351733|NCT00245037|essential thrombocythemia|essential thrombocythemia
5351734|NCT00245037|polycythemia vera|polycythemia vera
5351735|NCT00245037|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5351736|NCT00245037|acute undifferentiated leukemia|acute undifferentiated leukemia
5351737|NCT00245037|extramedullary plasmacytoma|extramedullary plasmacytoma
5351738|NCT00245037|isolated plasmacytoma of bone|isolated plasmacytoma of bone
5351739|NCT00245037|monoclonal gammopathy of undetermined significance|monoclonal gammopathy of undetermined significance
5351740|NCT00245037|stage I multiple myeloma|stage i multiple myeloma
5351741|NCT00245037|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5351742|NCT00245037|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5351743|NCT00245037|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5351744|NCT00245037|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5351745|NCT00245037|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5351746|NCT00245037|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5351747|NCT00245037|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5351748|NCT00245037|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
5351749|NCT00245037|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5351750|NCT00245037|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
5351751|NCT00245037|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
5351752|NCT00245037|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
5351753|NCT00245037|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
5351754|NCT00245037|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5351755|NCT00245037|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5351756|NCT00245037|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5351757|NCT00245037|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5351758|NCT00245037|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
5351759|NCT00245037|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
5351760|NCT00245037|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5351761|NCT00245037|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5351762|NCT00245037|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5351763|NCT00245037|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5351764|NCT00245037|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5351765|NCT00245037|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5351766|NCT00245037|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5351767|NCT00245037|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5351768|NCT00245037|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5351769|NCT00245037|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5351770|NCT00245037|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5351771|NCT00245037|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5351772|NCT00245037|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5351773|NCT00245037|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5351774|NCT00245037|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5351775|NCT00245037|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5351776|NCT00245037|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5351777|NCT00245037|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5351778|NCT00245037|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5351779|NCT00245037|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5351780|NCT00245037|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5351781|NCT00245037|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5351782|NCT00245037|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5351783|NCT00245037|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5351784|NCT00245037|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5351785|NCT00245037|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5351786|NCT00245037|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5351787|NCT00245037|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5351788|NCT00245037|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5351789|NCT00245037|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5351790|NCT00245037|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5351791|NCT00245037|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5351792|NCT00245037|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5351793|NCT00245037|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5351794|NCT00245037|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5351795|NCT00245037|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5351796|NCT00245037|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5351797|NCT00245037|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5351798|NCT00245037|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5351799|NCT00245037|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5351800|NCT00245037|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5351801|NCT00245037|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5351802|NCT00245024|breast cancer|breast cancer
5351803|NCT00245024|ductal breast carcinoma in situ|ductal breast carcinoma in situ
5351804|NCT00245024|lobular breast carcinoma in situ|lobular breast carcinoma in situ
5351805|NCT00245024|breast cancer in situ|breast cancer in situ
5351806|NCT00245011|recurrent osteosarcoma|recurrent osteosarcoma
5351807|NCT00245011|metastatic osteosarcoma|metastatic osteosarcoma
5351808|NCT00245011|localized osteosarcoma|localized osteosarcoma
5351809|NCT00244998|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5351810|NCT00244998|stage III prostate cancer|stage iii prostate cancer
5351811|NCT00244998|stage IV prostate cancer|stage iv prostate cancer
5351812|NCT00244985|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5351813|NCT00244985|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5351814|NCT00244985|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5351815|NCT00244985|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5351816|NCT00244985|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5351817|NCT00244985|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5351818|NCT00244985|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5351819|NCT00244985|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5351820|NCT00244985|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5351821|NCT00244985|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5351822|NCT00244985|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5351823|NCT00244959|stage I breast cancer|stage i breast cancer
5351824|NCT00244959|stage II breast cancer|stage ii breast cancer
5351825|NCT00244959|stage IIIA breast cancer|stage iiia breast cancer
5351826|NCT00244959|stage IIIB breast cancer|stage iiib breast cancer
5351827|NCT00244959|stage IIIC breast cancer|stage iiic breast cancer
5351828|NCT00244959|ductal breast carcinoma in situ|ductal breast carcinoma in situ
5351829|NCT00244959|breast cancer in situ|breast cancer in situ
5351830|NCT00244946|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5351831|NCT00244946|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5351832|NCT00244946|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5351833|NCT00244946|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5351834|NCT00244946|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5351835|NCT00244946|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5351836|NCT00244946|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5351837|NCT00244946|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5351838|NCT00244946|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5351839|NCT00244946|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5351840|NCT00244946|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5351841|NCT00244946|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5351842|NCT00244946|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5351843|NCT00244946|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5351844|NCT00244946|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5351845|NCT00244946|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5351846|NCT00244946|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5351847|NCT00244946|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5351848|NCT00244946|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5351849|NCT00244946|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5351850|NCT00244946|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5351851|NCT00244946|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5351852|NCT00244946|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5351853|NCT00244946|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5351854|NCT00244946|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5351855|NCT00244946|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5351856|NCT00244946|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5351857|NCT00244946|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5351858|NCT00244946|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5351859|NCT00244946|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5351860|NCT00244946|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5351861|NCT00244946|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5351862|NCT00244946|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5351863|NCT00244946|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5351864|NCT00244946|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5351865|NCT00244946|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5351866|NCT00244946|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5351867|NCT00244946|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5351868|NCT00244946|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
5351869|NCT00244946|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5351870|NCT00244946|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
5351871|NCT00244946|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
5351872|NCT00244946|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
5351873|NCT00244946|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
5351874|NCT00244946|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5351875|NCT00244946|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5351876|NCT00244946|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5351877|NCT00244946|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5351878|NCT00244946|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
5351879|NCT00244946|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
5351880|NCT00244933|stage IV breast cancer|stage iv breast cancer
5351881|NCT00244933|recurrent breast cancer|recurrent breast cancer
5351882|NCT00244920|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5351883|NCT00244920|stage III prostate cancer|stage iii prostate cancer
5351884|NCT00244907|Bone Resorption|bone resorption
5351885|NCT00244907|Phytoestrogens|phytoestrogens
5351886|NCT00244907|Calcium|calcium
5351887|NCT00244907|Genistein|genistein
5351888|NCT00244907|Equol|equol
5351889|NCT00244894|fatigue|fatigue
5351890|NCT00244894|recurrent prostate cancer|recurrent prostate cancer
5351891|NCT00244894|stage II prostate cancer|stage ii prostate cancer
5351892|NCT00244894|stage III prostate cancer|stage iii prostate cancer
5351893|NCT00244894|stage IV prostate cancer|stage iv prostate cancer
5351894|NCT00244894|hot flashes|hot flashes
5351895|NCT00244868|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5351896|NCT00244868|metastatic cancer|metastatic cancer
5351897|NCT00244842|Randomized Controlled Trials|randomized controlled trials
5351898|NCT00244842|Immunosuppression|immunosuppression
5351899|NCT00244842|Adult|adult
5351900|NCT00244842|Chronic Disease|chronic disease
5351901|NCT00244842|Dermatologic Agents|dermatologic agents
5351902|NCT00244842|Female|female
5351903|NCT00244842|Humans|humans
5351904|NCT00244842|Male|male
5351905|NCT00244842|Middle Aged|middle aged
5351906|NCT00244842|Severity of Illness Index|severity of illness index
5351907|NCT00244842|Treatment Outcome|treatment outcome
5351908|NCT00244842|Quality of Life|quality of life
5351909|NCT00244842|Double-Blind Method|double-blind method
5351910|NCT00244829|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5351911|NCT00244829|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5351912|NCT00244829|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
5351913|NCT00244829|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5351914|NCT00244829|Philadelphia chromosome positive chronic myelogenous leukemia|philadelphia chromosome positive chronic myelogenous leukemia
5351915|NCT00244829|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5351916|NCT00244829|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
5351917|NCT00244803|Human Immunodeficiency Virus|human immunodeficiency virus
5351918|NCT00244803|FRAM 1|fram 1
5351919|NCT00244790|glomerular hyperfiltration|glomerular hyperfiltration
5351920|NCT00244790|proteinuria|proteinuria
5351921|NCT00244777|Seizure|seizure
5351922|NCT00244777|Altered consciousness|altered consciousness
5351923|NCT00244777|Hyponatraemia|hyponatraemia
5351924|NCT00244777|Diarrhoea|diarrhoea
5351925|NCT00244777|Hypo osmolar ORS|hypo osmolar ors
5351926|NCT00244764|Angiogenesis|angiogenesis
5351927|NCT00244764|Renal Cell Carcinoma|renal cell carcinoma
5351928|NCT00244764|Solid tumors|solid tumors
5351929|NCT00244764|Pazopanib(GW786034)|pazopanib(gw786034)
5351930|NCT00244751|Hepatitis C liver fibrosis|hepatitis c liver fibrosis
5351931|NCT00244738|pregnancy|pregnancy
5351932|NCT00244738|post-date|post-date
5351933|NCT00244738|induction of labor|induction of labor
5351934|NCT00244738|castor oil|castor oil
5351935|NCT00244725|deep vein thrombosis|deep vein thrombosis
5351936|NCT00244725|total knee replacement|total knee replacement
5351937|NCT00244725|PE|pe
5351938|NCT00244725|Venous thromboembolism|venous thromboembolism
5351939|NCT00244725|DVT|dvt
5351940|NCT00244725|pulmonary embolism|pulmonary embolism
5351941|NCT00244725|VTE|vte
5351942|NCT00244712|HEAT|heat
5351943|NCT00244712|Antiretroviral-naive|antiretroviral-naive
5351944|NCT00244712|HIV|hiv
5351945|NCT00244712|EPZICOM|epzicom
5351946|NCT00244712|TRUVADA|truvada
5351947|NCT00244712|KALETRA|kaletra
5351948|NCT00244712|once-daily|once-daily
5351949|NCT00244699|youth|youth
5351950|NCT00244699|drug addiction|drug addiction
5351951|NCT00244699|substance abuse|substance abuse
5351952|NCT00244699|mindfulness|mindfulness
5351953|NCT00244699|motivational interviewing|motivational interviewing
5351954|NCT00244699|brief treatment|brief treatment
5351955|NCT00244699|skills training|skills training
5351956|NCT00244699|group therapy|group therapy
5351957|NCT00244699|emotion regulation|emotion regulation
5351958|NCT00244686|Hypereosinophilic Syndrome|hypereosinophilic syndrome
5351959|NCT00244686|Mepo|mepo
5351960|NCT00244686|HES|hes
5351961|NCT00244686|Compassionate Use|compassionate use
5351962|NCT00244686|Mepolizumab|mepolizumab
5351963|NCT00244673|Vaccination|vaccination
5351964|NCT00244673|DTP|dtp
5351965|NCT00244673|Child mortality|child mortality
5351966|NCT00244673|Sex|sex
5351967|NCT00244673|Non-specific effects|non-specific effects
5351968|NCT00244647|restenosis|restenosis
5351969|NCT00244647|in-stent restenosis|in-stent restenosis
5351970|NCT00244621|Pediatric hypertension|pediatric hypertension
5351971|NCT00244595|Pediatric hypertension|pediatric hypertension
5351972|NCT00244595|Hypertension in children|hypertension in children
5351973|NCT00244582|Central Nervous System|central nervous system
5351974|NCT00244582|Enzyme Replacement Therapy|enzyme replacement therapy
5351975|NCT00244582|Convection|convection
5351976|NCT00244582|Gaucher Disease|gaucher disease
5351977|NCT00244582|Neuronopathic Gaucher Disease|neuronopathic gaucher disease
5351978|NCT00244582|Type 2 Gaucher Disease|type 2 gaucher disease
5351979|NCT00244569|Nonalcoholic Fatty Liver Disease|nonalcoholic fatty liver disease
5351980|NCT00244569|Nonalcoholic Steatohepatitis|nonalcoholic steatohepatitis
5351981|NCT00244569|Liver Function|liver function
5351982|NCT00244569|Metabolism|metabolism
5351983|NCT00244569|Cirrhosis|cirrhosis
5351984|NCT00244569|Fibrosis|fibrosis
5351985|NCT00244569|Liver|liver
5351986|NCT00244556|Rheumatoid Arthritis|rheumatoid arthritis
5351987|NCT00244543|ocular, allergic conjunctivitis, ophthalmic|ocular, allergic conjunctivitis, ophthalmic
5351988|NCT00244530|Preventive Therapy|preventive therapy
5351989|NCT00244530|Calcium Channel Blockers|calcium channel blockers
5351990|NCT00244530|Kidney Failure, Chronic|kidney failure, chronic
5351991|NCT00244530|Coronary Artery Bypass|coronary artery bypass
5351992|NCT00244530|Heart Valve Prosthesis Implantation|heart valve prosthesis implantation
5351993|NCT00244517|ventricular function|ventricular function
5351994|NCT00244517|diastolic function|diastolic function
5351995|NCT00244517|inhalative anaesthetics|inhalative anaesthetics
5351996|NCT00244491|care transitions|care transitions
5351998|NCT00244491|care coordination|care coordination
5351999|NCT00244491|self-management|self-management
5352000|NCT00244491|chronic illness|chronic illness
5352001|NCT00244491|patient-centered care|patient-centered care
5352002|NCT00244465|Narcolepsy|narcolepsy
5352003|NCT00244465|Cataplexy|cataplexy
5352004|NCT00244465|Oxybate|oxybate
5352005|NCT00244465|Xyrem|xyrem
5352006|NCT00244465|Misuse|misuse
5352007|NCT00244465|Safety|safety
5352008|NCT00244452|Endometriosis|endometriosis
5352009|NCT00244452|Cetrorelix|cetrorelix
5352010|NCT00244452|Hormone|hormone
5352011|NCT00244452|Symptoms relief|symptoms relief
5352012|NCT00244452|Safety|safety
5352013|NCT00244452|Tolerability|tolerability
5352014|NCT00244452|Pharmacodynamic|pharmacodynamic
5352015|NCT00244452|Pharmacokinetic|pharmacokinetic
5352016|NCT00244439|Head Lice|head lice
5352017|NCT00244439|Pediculosis capitis|pediculosis capitis
5352018|NCT00244426|Prevention of thromboembolic events in patients with non valvular atrial fibrillation|prevention of thromboembolic events in patients with non valvular atrial fibrillation
5352019|NCT00244413|Myotonia|myotonia
5352020|NCT00244413|Paramyotonia Congenita|paramyotonia congenita
5352021|NCT00244413|Thomsen's Disease|thomsen's disease
5352022|NCT00244400|Femur Head Necrosis|femur head necrosis
5352023|NCT00244400|CYP3A|cyp3a
5352024|NCT00244387|advanced stage idiopathic Parkinson's disease|advanced stage idiopathic parkinson's disease
5352025|NCT00244361|opsoclonus|opsoclonus
5352026|NCT00244361|myoclonus|myoclonus
5352027|NCT00244348|hepatic artery infusion|hepatic artery infusion
5352028|NCT00244348|colorectal cancer|colorectal cancer
5352029|NCT00244348|liver metastasis|liver metastasis
5352030|NCT00244348|oxaliplatin|oxaliplatin
5352031|NCT00244348|5 fluorouracil|5 fluorouracil
5352032|NCT00244335|Post-Traumatic Stress Disorders|post-traumatic stress disorders
5352033|NCT00244335|PTSD|ptsd
5352034|NCT00244309|brachytherapy|brachytherapy
5352035|NCT00244309|urinary symptoms|urinary symptoms
5352036|NCT00244283|Myocardial preconditioning|myocardial preconditioning
5352037|NCT00244283|anesthetics|anesthetics
5352038|NCT00244283|epidural anesthesia|epidural anesthesia
5352039|NCT00244283|sevoflurane|sevoflurane
5352040|NCT00244283|NT proBNP|nt probnp
5352041|NCT00244270|totally implantable vascular access devices|totally implantable vascular access devices
5352042|NCT00244270|thromboembolism|thromboembolism
5352043|NCT00244270|genetic susceptibility to venous thrombosis.|genetic susceptibility to venous thrombosis.
5352044|NCT00244257|idiopathic thrombocytopenia purpura|idiopathic thrombocytopenia purpura
5352045|NCT00244231|Niacin|niacin
5352046|NCT00244231|Hyperlipidemia|hyperlipidemia
5352047|NCT00244218|phenylketonuria|phenylketonuria
5352048|NCT00244218|hyperphenylalaninemia|hyperphenylalaninemia
5352049|NCT00244192|COPD|copd
5352050|NCT00244192|infliximab|infliximab
5352051|NCT00244192|Remicade|remicade
5352052|NCT00244192|inflammation|inflammation
5352053|NCT00244192|cachexia|cachexia
5352054|NCT00244192|fat-free mass|fat-free mass
5352055|NCT00244192|health status|health status
5352056|NCT00244192|exercise capacity|exercise capacity
5352057|NCT00244179|reactive arthritis|reactive arthritis
5352058|NCT00244179|trial|trial
5352059|NCT00244179|interferon-gamma|interferon-gamma
5352060|NCT00244179|infliximab|infliximab
5352061|NCT00244179|chronic|chronic
5352062|NCT00244179|tnf-blocker|tnf-blocker
5352063|NCT00244166|treatment|treatment
5352064|NCT00244166|ankylosing spondylitis|ankylosing spondylitis
5352065|NCT00244166|prednisolone|prednisolone
5352066|NCT00244166|trial|trial
5352067|NCT00244166|steroid|steroid
5352068|NCT00244153|intraarticular morphine, steroids, arthroscopy|intraarticular morphine, steroids, arthroscopy
5352069|NCT00244140|Ultravist 370|ultravist 370
5352070|NCT00244140|CECT|cect
5352071|NCT00244140|CT Scan|ct scan
5352072|NCT00244114|Hemophilia B|hemophilia b
5352073|NCT00244114|Allergic Reaction|allergic reaction
5352074|NCT00244101|Prematurity|prematurity
5352075|NCT00244101|respiratory distress syndrome|respiratory distress syndrome
5352076|NCT00244101|surfactant|surfactant
5352077|NCT00244101|nasal continuous positive airway pressure|nasal continuous positive airway pressure
5352078|NCT00244088|Abdominal infection|abdominal infection
5352079|NCT00244023|Erectile Dysfunction|erectile dysfunction
5352080|NCT00244023|Testosterone|testosterone
5352081|NCT00244023|Testosterone Therapy|testosterone therapy
5352082|NCT00244023|PDE V Inhibitor|pde v inhibitor
5352083|NCT00244023|Tadalafil|tadalafil
5352084|NCT00244010|Aplastic anemia|aplastic anemia
5352085|NCT00244010|Amegakaryocytic thrombocytopenia|amegakaryocytic thrombocytopenia
5352086|NCT00244010|Diamond-Blackfan Anemia|diamond-blackfan anemia
5352087|NCT00244010|Kostmann syndrome|kostmann syndrome
5352088|NCT00244010|Allogeneic stem cell transplantation|allogeneic stem cell transplantation
5352089|NCT00244010|Haploidentical stem cell transplant|haploidentical stem cell transplant
5352090|NCT00244010|T-cell depletion|t-cell depletion
5352091|NCT00244010|Partially matched family member donor transplant|partially matched family member donor transplant
5352092|NCT00244010|Refractory cytopenia|refractory cytopenia
5352093|NCT00243997|parents|parents
5352094|NCT00243997|fathers|fathers
5352095|NCT00243997|mothers|mothers
5352096|NCT00243984|metabolic syndrome|metabolic syndrome
5352097|NCT00243984|type 2 diabetes|type 2 diabetes
5352098|NCT00243984|topiramate|topiramate
5352099|NCT00243984|weight loss|weight loss
5352100|NCT00243971|EARLY-STAGE, IDIOPATHIC PARKINSON'S DISEASE|early-stage, idiopathic parkinson's disease
5352101|NCT00243932|amyotrophic lateral sclerosis|amyotrophic lateral sclerosis
5352102|NCT00243932|ALS|als
5352103|NCT00243932|Lou Gehrig's disease|lou gehrig's disease
5352104|NCT00243932|CoQ10|coq10
5352105|NCT00243932|coenzyme Q10|coenzyme q10
5352106|NCT00243932|antioxidants|antioxidants
5352107|NCT00243932|free radicals|free radicals
5352108|NCT00243932|mitochondrial dysfunction|mitochondrial dysfunction
5352109|NCT00243919|stroke|stroke
5352110|NCT00243919|locomotor|locomotor
5352111|NCT00243919|exercise|exercise
5352112|NCT00243919|walking|walking
5352113|NCT00243919|training program|training program
5352114|NCT00243919|body weight support training|body weight support training
5352115|NCT00243919|physical therapy|physical therapy
5352116|NCT00243906|acute ischemic stroke|acute ischemic stroke
5352117|NCT00243906|stroke|stroke
5352118|NCT00243906|rt-PA|rt-pa
5352119|NCT00243906|thrombolytic|thrombolytic
5352120|NCT00243906|recombinant tissue plasminogen activator|recombinant tissue plasminogen activator
5352121|NCT00243893|giant aneurysms|giant aneurysms
5352122|NCT00243893|arteriovenous malformations|arteriovenous malformations
5352123|NCT00243893|minocycline|minocycline
5352124|NCT00243893|doxycycline|doxycycline
5352125|NCT00243893|BAVM|bavm
5352126|NCT00243880|acute ischemic stroke|acute ischemic stroke
5352127|NCT00243880|lovastatin|lovastatin
5352128|NCT00243880|statin|statin
5352129|NCT00243880|neuroprotection|neuroprotection
5352130|NCT00243880|SPOTRIAS|spotrias
5352131|NCT00243867|Advanced Non-Small Cell Lung Cancer|advanced non-small cell lung cancer
5352132|NCT00243854|Pancreatic Cancer|pancreatic cancer
5352133|NCT00243854|Resectable Pancreatic Cancer|resectable pancreatic cancer
5352134|NCT00243854|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
5352135|NCT00243828|Noninvasive Mechanical Ventilation|noninvasive mechanical ventilation
5352136|NCT00243828|Acute Respiratory Failure|acute respiratory failure
5352137|NCT00243828|Intubation|intubation
5352138|NCT00243815|randomized controlled trial|randomized controlled trial
5352139|NCT00243815|prophylactic nonsteroidal antiflammatory drug|prophylactic nonsteroidal antiflammatory drug
5352140|NCT00243815|IUD removal|iud removal
5352141|NCT00243802|Atrial Fibrillation|atrial fibrillation
5352142|NCT00243802|Oxidative Stress|oxidative stress
5352143|NCT00243802|Atrial Flutter|atrial flutter
5352144|NCT00243789|Duchenne|duchenne
5352145|NCT00243789|Genetic|genetic
5352146|NCT00243789|Muscular Dystrophy|muscular dystrophy
5352147|NCT00243789|DMD|dmd
5352148|NCT00243763|Refractory Multiple Myeloma or|refractory multiple myeloma or
5352149|NCT00243763|Relapsed Multiple Myeloma|relapsed multiple myeloma
5352150|NCT00243750|ankylosing spondylitis|ankylosing spondylitis
5352151|NCT00243750|trial|trial
5352152|NCT00243750|methotrexate|methotrexate
5352153|NCT00243737|Malaria|malaria
5352154|NCT00243737|falciparum|falciparum
5352155|NCT00243737|Mefloquine|mefloquine
5352156|NCT00243737|Artesunate|artesunate
5352157|NCT00243737|Artemisinin|artemisinin
5352158|NCT00243724|immunohistochemical|immunohistochemical
5352159|NCT00243724|erosive esophagitis|erosive esophagitis
5352160|NCT00243724|Acid reflux disease|acid reflux disease
5352161|NCT00243698|Contrast-enhanced Ultrasound Sonography|contrast-enhanced ultrasound sonography
5352162|NCT00243698|Ultrasound Contrast agents, microbubbles|ultrasound contrast agents, microbubbles
5352163|NCT00243698|Breast tumors|breast tumors
5352164|NCT00243685|Chemosensitivity|chemosensitivity
5352165|NCT00243685|Chemotherapy|chemotherapy
5352166|NCT00243685|Lung cancer|lung cancer
5352167|NCT00243685|Ovarian Cancer|ovarian cancer
5352168|NCT00243685|Breast Cancer|breast cancer
5352169|NCT00243685|Sarcoma|sarcoma
5352170|NCT00243685|Apoptosis|apoptosis
5352171|NCT00243685|MiCK Assay|mick assay
5352172|NCT00243685|New Technology|new technology
5352173|NCT00243685|Patients with pathological diagnoses of breast, lung, and ovarian adenocarcinomas and soft tissue sarcoma|patients with pathological diagnoses of breast, lung, and ovarian adenocarcinomas and soft tissue sarcoma
5352174|NCT00243659|Hemophilia A|hemophilia a
5352175|NCT00243659|bleeding disorder|bleeding disorder
5352176|NCT00243646|Radiation therapy|radiation therapy
5352177|NCT00243646|Brachytherapy|brachytherapy
5352178|NCT00243646|Prostatic neoplasm|prostatic neoplasm
5352179|NCT00243633|focal liver lesions|focal liver lesions
5352180|NCT00243633|contrast-enhanced ultrasound sonography|contrast-enhanced ultrasound sonography
5352181|NCT00243633|cirrhosis|cirrhosis
5352182|NCT00243633|suspected liver metastases|suspected liver metastases
5352183|NCT00243633|suspected liver cirrhosis|suspected liver cirrhosis
5352184|NCT00243620|Chronic leg ulcers; wound healing; wound care; Vacuum Assisted Closure; topical negative Pressure|chronic leg ulcers; wound healing; wound care; vacuum assisted closure; topical negative pressure
5352185|NCT00243607|climacteric symptoms|climacteric symptoms
5352186|NCT00243607|breast cancer|breast cancer
5352187|NCT00243607|hydrotherapy|hydrotherapy
5352188|NCT00243594|Dendritic cells|dendritic cells
5352189|NCT00243594|Immunotherapy|immunotherapy
5352190|NCT00243594|Vaccination|vaccination
5352191|NCT00243594|Melanoma|melanoma
5352194|NCT00243594|Scintigraphy|scintigraphy
5352195|NCT00243594|Immune response|immune response
5352196|NCT00243568|HIV Infections|hiv infections
5352197|NCT00243568|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5352198|NCT00243568|CCR5/CXCR4 mixed tropism|ccr5/cxcr4 mixed tropism
5352199|NCT00243568|R5/X4 mixed tropism|r5/x4 mixed tropism
5352200|NCT00243568|CCR5 inhibitor|ccr5 inhibitor
5352201|NCT00243568|vicriviroc|vicriviroc
5352202|NCT00243568|treatment-experienced|treatment-experienced
5352203|NCT00243555|peanut hypersensitivity|peanut hypersensitivity
5352204|NCT00243555|chemokines|chemokines
5352205|NCT00243555|cytokines|cytokines
5352206|NCT00243555|RNA,messenger|rna,messenger
5352207|NCT00243555|monocytes|monocytes
5352208|NCT00243542|Acne, G6PD deficiency, Dapsone|acne, g6pd deficiency, dapsone
5352209|NCT00243529|Dendritic cells|dendritic cells
5352210|NCT00243529|Melanoma|melanoma
5352211|NCT00243529|Vaccine|vaccine
5352212|NCT00243529|Immunotherapy|immunotherapy
5352213|NCT00243529|RNA|rna
5352214|NCT00243529|Peptides|peptides
5352215|NCT00243516|Acute Coronary Syndrome|acute coronary syndrome
5352216|NCT00243516|Emergency Department|emergency department
5352217|NCT00243516|Chest Pain Evaluation Unit|chest pain evaluation unit
5352218|NCT00243516|Overtesting|overtesting
5352219|NCT00243516|Chest Pain Protocol|chest pain protocol
5352220|NCT00243516|Myocardial Infarction|myocardial infarction
5352221|NCT00243516|Medical Malpractice|medical malpractice
5352222|NCT00243503|Breast Cancer Metastatic|breast cancer metastatic
5352223|NCT00243490|Photodynamic therapy|photodynamic therapy
5352224|NCT00243490|Malignant glioma|malignant glioma
5352225|NCT00243490|Photosan|photosan
5352226|NCT00243477|Coronary Artery Bypass|coronary artery bypass
5352227|NCT00243477|Surgery|surgery
5352228|NCT00243425|Major Depressive Disorder;|major depressive disorder;
5352229|NCT00243425|African Americans;|african americans;
5352230|NCT00243425|Disparities;|disparities;
5352231|NCT00243425|Quality Improvement;|quality improvement;
5352232|NCT00243425|Patient Centered Care;|patient centered care;
5352233|NCT00243425|Primary Care;|primary care;
5352234|NCT00243425|Patient-Physician Relationship;|patient-physician relationship;
5352235|NCT00243412|Rituxan|rituxan
5352236|NCT00243412|RA|ra
5352237|NCT00243399|Fanconi anemia|fanconi anemia
5352238|NCT00243399|FA|fa
5352239|NCT00243373|Patient safety|patient safety
5352240|NCT00243373|Medication safety|medication safety
5352241|NCT00243373|Barcode technology|barcode technology
5352242|NCT00243360|Urinary tract infections,|urinary tract infections,
5352243|NCT00243360|antibiotic use,|antibiotic use,
5352244|NCT00243360|long term care facilities|long term care facilities
5352245|NCT00243347|RECENTIN|recentin
5352246|NCT00243334|Ambulatory Care Information Systems|ambulatory care information systems
5352247|NCT00243334|Clinical Decision Support Systems|clinical decision support systems
5352248|NCT00243334|Medication Systems|medication systems
5352249|NCT00243334|Medication Errors|medication errors
5352250|NCT00243334|Reminder Systems|reminder systems
5352251|NCT00243334|Drug Monitoring|drug monitoring
5352252|NCT00243334|Preventive Health Services|preventive health services
5352253|NCT00243334|Time and Motion Studies|time and motion studies
5352254|NCT00243334|Efficiency|efficiency
5352255|NCT00243334|Cost-Benefit Analysis|cost-benefit analysis
5352256|NCT00243321|brachytherapy|brachytherapy
5352257|NCT00243321|intensity-modulated radiation therapy|intensity-modulated radiation therapy
5352258|NCT00243321|prostate specific antigen|prostate specific antigen
5352259|NCT00243308|Anti-inflammatory agents|anti-inflammatory agents
5352260|NCT00243308|unstable plaque|unstable plaque
5352261|NCT00243308|acute coronary syndrome|acute coronary syndrome
5352262|NCT00243295|osteoarthritis|osteoarthritis
5352263|NCT00243295|deformity of knee|deformity of knee
5352264|NCT00243282|Complementary Therapies|complementary therapies
5352265|NCT00243282|Dyspnea|dyspnea
5352266|NCT00243282|Palliative Care|palliative care
5352267|NCT00243282|Meditation|meditation
5352268|NCT00243282|Quality of Life|quality of life
5352269|NCT00243269|nausea, acupressure bands, relaxation|nausea, acupressure bands, relaxation
5352270|NCT00243243|Burns|burns
5352271|NCT00243204|Stage IIIb/IV non-small cell lung cancer|stage iiib/iv non-small cell lung cancer
5352272|NCT00243204|NSCLC|nsclc
5352273|NCT00243204|Lung Cancer|lung cancer
5352274|NCT00243191|newly diagnosed or recurrent|newly diagnosed or recurrent
5352275|NCT00243178|Atrial fibrillation|atrial fibrillation
5352276|NCT00243178|Anticoagulant therapy|anticoagulant therapy
5352277|NCT00243178|Thromboembolic prevention|thromboembolic prevention
5352278|NCT00243165|breast cancer|breast cancer
5352279|NCT00243165|honey|honey
5352280|NCT00243165|myelosuppression|myelosuppression
5352281|NCT00243165|chemotherapy|chemotherapy
5352282|NCT00243152|pain|pain
5352283|NCT00243152|neuropathic|neuropathic
5352284|NCT00243152|face|face
5352285|NCT00243152|trigeminal|trigeminal
5352286|NCT00243139|Oral appliances|oral appliances
5352287|NCT00243139|Obstructive sleep apnea|obstructive sleep apnea
5352288|NCT00243139|Epworth Sleepiness Scale|epworth sleepiness scale
5352289|NCT00243139|SF-36|sf-36
5352290|NCT00243126|HIV prevention|hiv prevention
5352291|NCT00243126|HIV Seronegativity|hiv seronegativity
5352292|NCT00243126|HIV negative|hiv negative
5352293|NCT00243113|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
5352294|NCT00243113|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
5352295|NCT00243113|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
5352296|NCT00243113|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
5352297|NCT00243087|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5352298|NCT00243087|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5352299|NCT00243087|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5352300|NCT00243087|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5352301|NCT00243087|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5352302|NCT00243087|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5352303|NCT00243087|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5352304|NCT00243087|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5352305|NCT00243087|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5352306|NCT00243087|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5352307|NCT00243087|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5352308|NCT00243087|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
5352309|NCT00243087|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
5352310|NCT00243087|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5352311|NCT00243087|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5352312|NCT00243087|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5352313|NCT00243087|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
5352314|NCT00243087|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5352315|NCT00243087|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5352316|NCT00243048|stage I prostate cancer|stage i prostate cancer
5352317|NCT00243048|stage II prostate cancer|stage ii prostate cancer
5352318|NCT00243022|cerebral edema|cerebral edema
5352319|NCT00243022|adult glioblastoma|adult glioblastoma
5352320|NCT00243022|adult giant cell glioblastoma|adult giant cell glioblastoma
5352321|NCT00243022|adult gliosarcoma|adult gliosarcoma
5352322|NCT00243022|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5352323|NCT00243022|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
5352324|NCT00243009|recurrent renal cell cancer|recurrent renal cell cancer
5352325|NCT00243009|stage IV renal cell cancer|stage iv renal cell cancer
5352326|NCT00243009|clear cell renal cell carcinoma|clear cell renal cell carcinoma
5352327|NCT00242996|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5352328|NCT00242983|adenocarcinoma of the lung|adenocarcinoma of the lung
5352329|NCT00242983|large cell lung cancer|large cell lung cancer
5352330|NCT00242983|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5352331|NCT00242983|squamous cell lung cancer|squamous cell lung cancer
5352332|NCT00242983|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5352333|NCT00242983|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5352334|NCT00242957|HIV/AIDS|hiv/aids
5352335|NCT00242957|Gender Based Violence|gender based violence
5352336|NCT00242957|Structural Interventions|structural interventions
5352337|NCT00242957|South Africa|south africa
5352338|NCT00242957|HIV Seronegativity|hiv seronegativity
5352339|NCT00242944|Acute coronary syndrome|acute coronary syndrome
5352340|NCT00242944|Hypercholesterolemia|hypercholesterolemia
5352341|NCT00242944|Primary coronary intervention|primary coronary intervention
5352342|NCT00242944|Hydroxymethylglutaryl-CoA reductase inhibitors|hydroxymethylglutaryl-coa reductase inhibitors
5352343|NCT00242944|coronary plaque|coronary plaque
5352344|NCT00242944|Angioplasty, Transluminal, Percutaneous Coronary|angioplasty, transluminal, percutaneous coronary
5352345|NCT00242944|Ultrasonography, Interventional|ultrasonography, interventional
5352346|NCT00242931|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5352347|NCT00242931|recurrent prostate cancer|recurrent prostate cancer
5352348|NCT00242931|stage IV prostate cancer|stage iv prostate cancer
5352349|NCT00242918|High risk|high risk
5352350|NCT00242918|adenocarcinoma|adenocarcinoma
5352351|NCT00242918|prostate cancer|prostate cancer
5352352|NCT00242918|neoadjuvant|neoadjuvant
5352353|NCT00242905|Memory|memory
5352354|NCT00242905|Epilepsy|epilepsy
5352355|NCT00242905|Children|children
5352356|NCT00242905|Magnetic resonance imaging|magnetic resonance imaging
5352357|NCT00242905|Functional magnetic resonance imaging|functional magnetic resonance imaging
5352358|NCT00242892|Deployment stent optimisation|deployment stent optimisation
5352359|NCT00242892|Fractional Flow Reserve|fractional flow reserve
5352360|NCT00242892|Stent|stent
5352361|NCT00242892|Restenosis|restenosis
5352362|NCT00242892|Coronary|coronary
5352363|NCT00242879|treatment-experienced|treatment-experienced
5352364|NCT00242879|RTV|rtv
5352365|NCT00242879|protease inhibitor|protease inhibitor
5352366|NCT00242879|ritonavir|ritonavir
5352367|NCT00242879|GW640385|gw640385
5352368|NCT00242879|HIV-1|hiv-1
5352369|NCT00242866|Productivity|productivity
5352370|NCT00242866|Efficacy|efficacy
5352371|NCT00242866|without aura|without aura
5352372|NCT00242866|iNOS|inos
5352373|NCT00242866|Safety|safety
5352374|NCT00242866|Nitric Oxide|nitric oxide
5352375|NCT00242866|Pharmacokinetics|pharmacokinetics
5352376|NCT00242866|GW274150|gw274150
5352377|NCT00242866|with aura|with aura
5352378|NCT00242866|Migraine|migraine
5352379|NCT00242866|Prophylaxis|prophylaxis
5352380|NCT00242866|Quality of Life|quality of life
5352381|NCT00242853|iNOS|inos
5352382|NCT00242853|Rheumatoid arthritis|rheumatoid arthritis
5352383|NCT00242853|Exhaled NO|exhaled no
5352384|NCT00242840|protease inhibitor|protease inhibitor
5352385|NCT00242840|ritonavir|ritonavir
5352386|NCT00242840|GW433908|gw433908
5352387|NCT00242840|HIV-1|hiv-1
5352388|NCT00242840|fosamprenavir|fosamprenavir
5352389|NCT00242788|Colorectal Cancer|colorectal cancer
5352390|NCT00242775|Asthma|asthma
5352391|NCT00242762|Head and Neck Neoplasms|head and neck neoplasms
5352392|NCT00242762|Cancer of Head and Neck|cancer of head and neck
5352393|NCT00242762|Head and Neck Cancer|head and neck cancer
5352394|NCT00242762|Head Cancer|head cancer
5352395|NCT00242762|Neck Cancer|neck cancer
5352396|NCT00242749|Head and Neck Cancer Disease|head and neck cancer disease
5352397|NCT00242749|Head Cancer|head cancer
5352398|NCT00242749|Neck Cancer|neck cancer
5352399|NCT00242749|Cancer of Head|cancer of head
5352400|NCT00242749|Cancer of Neck|cancer of neck
5352401|NCT00242749|Cancer of the Head|cancer of the head
5352402|NCT00242749|Cancer of the Head and Neck|cancer of the head and neck
5352403|NCT00242749|Cancer of the Neck|cancer of the neck
5352404|NCT00242749|Neoplasms, Head and Neck|neoplasms, head and neck
5352405|NCT00242723|Lung Cancers|lung cancers
5352406|NCT00242723|Esophageal Cancer|esophageal cancer
5352407|NCT00242723|Malignant Pleural Mesothelioma|malignant pleural mesothelioma
5352408|NCT00242723|Biopsy|biopsy
5352409|NCT00242723|Staging Studies|staging studies
5352410|NCT00242723|Lung Cancer|lung cancer
5352411|NCT00242710|Endometrium|endometrium
5352412|NCT00242710|Uterus|uterus
5352413|NCT00242710|Menopause|menopause
5352414|NCT00242697|coronary artery bypass surgery|coronary artery bypass surgery
5352415|NCT00242697|anesthesia, general|anesthesia, general
5352416|NCT00242697|anesthesia, spinal|anesthesia, spinal
5352417|NCT00242697|heart-lung machine|heart-lung machine
5352418|NCT00242684|Aging|aging
5352419|NCT00242684|Undernutrition|undernutrition
5352420|NCT00242684|Inflammation|inflammation
5352421|NCT00242684|Frail Elderly|frail elderly
5352422|NCT00242671|general anesthesia, hyperventilation, carbon dioxide, isocapnic hyperponea|general anesthesia, hyperventilation, carbon dioxide, isocapnic hyperponea
5352423|NCT00242658|Physical Activity|physical activity
5352424|NCT00242658|Wellness Programs|wellness programs
5352425|NCT00242658|Health Promotion|health promotion
5352426|NCT00242658|Blood Pressure, High|blood pressure, high
5352427|NCT00242645|Doctor-Patient relation|doctor-patient relation
5352428|NCT00242645|Physician-Patient relation|physician-patient relation
5352429|NCT00242645|Diabetes|diabetes
5352430|NCT00242645|Office visits|office visits
5352431|NCT00242645|Comparative Study|comparative study
5352432|NCT00242645|Health behavior|health behavior
5352433|NCT00242645|Randomized controlled trials|randomized controlled trials
5352434|NCT00242645|Health Promotion|health promotion
5352435|NCT00242645|Health Education|health education
5352436|NCT00242645|Computer-tailor information|computer-tailor information
5352437|NCT00242606|Newly diagnosed epilepsy|newly diagnosed epilepsy
5352438|NCT00242606|Initial monotherapy|initial monotherapy
5352439|NCT00242606|Levetiracetam|levetiracetam
5352440|NCT00242606|Lamotrigine|lamotrigine
5352441|NCT00242593|cognition disorders|cognition disorders
5352442|NCT00242593|Alzheimer's disease|alzheimer's disease
5352443|NCT00242593|memory|memory
5352444|NCT00242580|AMD|amd
5352445|NCT00242580|age-related macular degeneration|age-related macular degeneration
5352446|NCT00242580|choroidal neovascularization|choroidal neovascularization
5352447|NCT00242567|zoledronic acid|zoledronic acid
5352448|NCT00242567|bone metastases|bone metastases
5352449|NCT00242567|prostate cancer|prostate cancer
5352450|NCT00242567|hormone-sensitive|hormone-sensitive
5352451|NCT00242554|Prostate Cancer|prostate cancer
5352452|NCT00242554|Bone Metastases|bone metastases
5352453|NCT00242554|Zoledronic acid|zoledronic acid
5352454|NCT00242541|microadenoma|microadenoma
5352455|NCT00242541|macroadenoma|macroadenoma
5352456|NCT00242528|Bone Lesions|bone lesions
5352457|NCT00242528|Multiple Myeloma|multiple myeloma
5352458|NCT00242528|zoledronic acid|zoledronic acid
5352459|NCT00242515|High risk Myelodysplastic Syndrome (MDS)|high risk myelodysplastic syndrome (mds)
5352460|NCT00242502|Hepatocellular Carcinoma|hepatocellular carcinoma
5352461|NCT00242502|Liver Cancer|liver cancer
5352462|NCT00242502|Bevacizumab|bevacizumab
5352463|NCT00242502|Anti-VEGF monoclonal antibody|anti-vegf monoclonal antibody
5352464|NCT00242502|rhuMAb-VEGF|rhumab-vegf
5352465|NCT00242502|Erlotinib Hydrochloride|erlotinib hydrochloride
5352466|NCT00242502|OSI-774|osi-774
5352467|NCT00242502|Tarceva|tarceva
5352468|NCT00242502|Erlotinib|erlotinib
5352469|NCT00242502|Avastin|avastin
5352470|NCT00242489|Arcoxia|arcoxia
5352471|NCT00242463|malnutrition|malnutrition
5352472|NCT00242463|anabolic steroids|anabolic steroids
5352473|NCT00242463|intensive care unit|intensive care unit
5352474|NCT00242463|rehabilitation|rehabilitation
5352475|NCT00242450|metoclopramide|metoclopramide
5352476|NCT00242450|feeding|feeding
5352477|NCT00242450|very low birthweightnewborn|very low birthweightnewborn
5352478|NCT00242424|influenza vaccine|influenza vaccine
5352479|NCT00242424|infants|infants
5352480|NCT00242424|safety|safety
5352481|NCT00242424|immunogenicity|immunogenicity
5352482|NCT00242398|Intensive care unit|intensive care unit
5352483|NCT00242398|Patients with bleeding high risk|patients with bleeding high risk
5352484|NCT00242398|Intermittent hemodialysis without anticoagulation|intermittent hemodialysis without anticoagulation
5352485|NCT00242398|Blood lost|blood lost
5352614|NCT00241410|Sublingual Immunotherapy|sublingual immunotherapy
5352486|NCT00242385|Severe congenital Alpha1-Proteinase Inhibitor (Alpha1-PI) deficiency|severe congenital alpha1-proteinase inhibitor (alpha1-pi) deficiency
5352487|NCT00242372|Insulin dependent Type 2 diabetes|insulin dependent type 2 diabetes
5352488|NCT00242346|Hypertension|hypertension
5352489|NCT00242333|COPD|copd
5352490|NCT00242333|COAD|coad
5352491|NCT00242333|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
5352492|NCT00242333|emphysema|emphysema
5352493|NCT00242333|chronic bronchitis|chronic bronchitis
5352494|NCT00242320|COPD|copd
5352495|NCT00242320|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
5352496|NCT00242320|Roflumilast|roflumilast
5352497|NCT00242307|Asthma|asthma
5352498|NCT00242307|Roflumilast|roflumilast
5352499|NCT00242307|phosphodiesterase 4 inhibitor|phosphodiesterase 4 inhibitor
5352500|NCT00242294|COPD|copd
5352501|NCT00242294|Phosphodiesterase 4 inhibitor|phosphodiesterase 4 inhibitor
5352502|NCT00242294|Roflumilast|roflumilast
5352503|NCT00242281|Sore Throat|sore throat
5352504|NCT00242281|Pharyngitis|pharyngitis
5352505|NCT00242281|Tonsillitis|tonsillitis
5352506|NCT00242255|Histone|histone
5352507|NCT00242255|Chromatin|chromatin
5352508|NCT00242255|Epigenome|epigenome
5352509|NCT00242255|Senescence|senescence
5352510|NCT00242255|Acetylation|acetylation
5352511|NCT00242255|Aging|aging
5352512|NCT00242255|Tissue Sample|tissue sample
5352513|NCT00242242|Stroke|stroke
5352514|NCT00242242|BCI|bci
5352515|NCT00242242|Healthy Volunteer|healthy volunteer
5352516|NCT00242242|HV|hv
5352517|NCT00242229|Depression|depression
5352518|NCT00242216|HIV-1 infected people|hiv-1 infected people
5352519|NCT00242216|Antiretroviral treatment-naïve|antiretroviral treatment-naïve
5352520|NCT00242216|Atazanavir|atazanavir
5352521|NCT00242216|Fosamprenavir|fosamprenavir
5352522|NCT00242216|ARV Treatment Naive|arv treatment naive
5352523|NCT00242203|Breast Cancer|breast cancer
5352524|NCT00242203|Neoadjuvant|neoadjuvant
5352525|NCT00242203|Micrometastasis|micrometastasis
5352526|NCT00242190|drug therapy|drug therapy
5352527|NCT00242190|radiotherapy|radiotherapy
5352528|NCT00242190|clinical trial|clinical trial
5352529|NCT00242177|Multiple Sclerosis|multiple sclerosis
5352530|NCT00242177|Relapsing, Remitting|relapsing, remitting
5352531|NCT00242177|Autoimmune disease|autoimmune disease
5352532|NCT00242164|Hemodialysis|hemodialysis
5352533|NCT00242164|Magnesium|magnesium
5352534|NCT00242164|Arrhythmia|arrhythmia
5352535|NCT00242164|QTc interval|qtc interval
5352536|NCT00242164|QT dispersion|qt dispersion
5352537|NCT00242151|Delirium, Confusion, Cardiac Surgery, Organic Brain Injury, Diffusion Weighted Magnetic Resonance Imaging (DW-MRI)|delirium, confusion, cardiac surgery, organic brain injury, diffusion weighted magnetic resonance imaging (dw-mri)
5352538|NCT00242125|Primary biliary Cirrhosis|primary biliary cirrhosis
5352539|NCT00242125|genes|genes
5352540|NCT00242125|DNA|dna
5352541|NCT00242099|liver transplant|liver transplant
5352542|NCT00242099|HHV-6|hhv-6
5352543|NCT00242099|HHV-7|hhv-7
5352544|NCT00242099|Human Herpesvirus-6|human herpesvirus-6
5352545|NCT00242099|Human Herpesvirus-7|human herpesvirus-7
5352546|NCT00242047|Tuberculosis.|tuberculosis.
5352547|NCT00242047|Children.|children.
5352548|NCT00242047|Vaccine.|vaccine.
5352549|NCT00242047|BCG.|bcg.
5352550|NCT00242021|Satiety, ad libitum food intake, fatty acids, hormones|satiety, ad libitum food intake, fatty acids, hormones
5352551|NCT00242008|IDIOPATHIC PARKINSON'S DISEASE|idiopathic parkinson's disease
5352552|NCT00241982|rheumatoid arthritis|rheumatoid arthritis
5352553|NCT00241982|long circulating liposomes|long circulating liposomes
5352554|NCT00241969|nutrition therapy|nutrition therapy
5352555|NCT00241969|preschool children|preschool children
5352556|NCT00241969|cystic fibrosis|cystic fibrosis
5352557|NCT00241943|Hepatitis C|hepatitis c
5352558|NCT00241943|Heroin|heroin
5352559|NCT00241943|Populations at risk|populations at risk
5352560|NCT00241943|testing|testing
5352561|NCT00241943|vaccination|vaccination
5352562|NCT00241930|Heroin|heroin
5352563|NCT00241930|HIV|hiv
5352564|NCT00241930|buprenorphine|buprenorphine
5352565|NCT00241930|integration|integration
5352566|NCT00241930|drug treatment|drug treatment
5352567|NCT00241917|hepatitis C|hepatitis c
5352568|NCT00241917|heroin|heroin
5352569|NCT00241917|populations at risk|populations at risk
5352570|NCT00241917|testing|testing
5352571|NCT00241917|vaccination|vaccination
5352572|NCT00241722|bowel dysfunction|bowel dysfunction
5352573|NCT00241722|constipation|constipation
5352879|NCT00240188|Ventral|ventral
5352574|NCT00241722|gastrointestinal|gastrointestinal
5352575|NCT00241722|opioids|opioids
5352576|NCT00241722|pain|pain
5352577|NCT00241722|non-cancer pain|non-cancer pain
5352578|NCT00241722|opioid-induced|opioid-induced
5352579|NCT00241644|Rotavirus gastroenteritis|rotavirus gastroenteritis
5352580|NCT00241644|HRV vaccine|hrv vaccine
5352581|NCT00241618|Clinical trial|clinical trial
5352582|NCT00241618|Randomized|randomized
5352583|NCT00241618|Treatment|treatment
5352584|NCT00241618|Prospective|prospective
5352585|NCT00241618|Parallel Assignment|parallel assignment
5352586|NCT00241618|Efficacy Safety Study|efficacy safety study
5352587|NCT00241605|Metformin|metformin
5352588|NCT00241605|AVANDAMET|avandamet
5352589|NCT00241605|Type 2 diabetes|type 2 diabetes
5352590|NCT00241592|Cannabis|cannabis
5352591|NCT00241592|Marijuana|marijuana
5352592|NCT00241592|Vaporization|vaporization
5352593|NCT00241592|Volcano|volcano
5352594|NCT00241592|THC|thc
5352595|NCT00241579|Pain|pain
5352596|NCT00241579|Cannabis|cannabis
5352597|NCT00241579|Analgesic|analgesic
5352598|NCT00241566|Neuropathic pain|neuropathic pain
5352599|NCT00241566|Electric cortical stimulation|electric cortical stimulation
5352600|NCT00241566|Economic Medical evaluation|economic medical evaluation
5352601|NCT00241540|NSAIDs|nsaids
5352602|NCT00241540|Upper GI symptoms|upper gi symptoms
5352603|NCT00241514|NSAIDs|nsaids
5352604|NCT00241514|Upper GI symptoms|upper gi symptoms
5352605|NCT00241475|Cancer of the Prostate|cancer of the prostate
5352606|NCT00241462|Advanced Breast Cancer|advanced breast cancer
5352607|NCT00241449|Locally advanced breast cancer or metastatic breast cancer|locally advanced breast cancer or metastatic breast cancer
5352608|NCT00241423|exenatide|exenatide
5352609|NCT00241423|diabetes|diabetes
5352610|NCT00241423|Amylin|amylin
5352611|NCT00241423|Lilly|lilly
5352612|NCT00241410|Allergy|allergy
5352613|NCT00241410|Specific Immunotherapy|specific immunotherapy
5352615|NCT00241397|pain|pain
5352616|NCT00241397|depression|depression
5352617|NCT00241397|anxiety disorder|anxiety disorder
5352618|NCT00241384|Prostatic Cancer|prostatic cancer
5352619|NCT00241384|Brachytherapy|brachytherapy
5352620|NCT00241384|Prostatic neoplasm|prostatic neoplasm
5352621|NCT00241384|Radiation therapy|radiation therapy
5352622|NCT00241371|Multiple Myeloma|multiple myeloma
5352623|NCT00241358|Plerixafor|plerixafor
5352624|NCT00241358|Stem cell transplantation|stem cell transplantation
5352625|NCT00241358|Stem cells|stem cells
5352626|NCT00241358|Mobilization|mobilization
5352627|NCT00241345|post transplant|post transplant
5352628|NCT00241345|Any patient receiving an allogeneic bone marrow or peripheral blood stem cell transplant at Washington University Medical Center|any patient receiving an allogeneic bone marrow or peripheral blood stem cell transplant at washington university medical center
5352629|NCT00241332|pain|pain
5352630|NCT00241332|hyperalgesia|hyperalgesia
5352631|NCT00241332|drug tolerance|drug tolerance
5352632|NCT00241332|remifentanil|remifentanil
5352633|NCT00241332|fentanyl|fentanyl
5352634|NCT00241332|Anterior Cruciate Ligament|anterior cruciate ligament
5352635|NCT00241332|Posterior Cruciate Ligament|posterior cruciate ligament
5352636|NCT00241332|Medial Collateral Ligament, Knee|medial collateral ligament, knee
5352637|NCT00241319|ocular, allergic conjunctivitis, ophthalmic|ocular, allergic conjunctivitis, ophthalmic
5352638|NCT00241306|aging|aging
5352639|NCT00241306|language|language
5352640|NCT00241306|gender|gender
5352641|NCT00241293|language|language
5352642|NCT00241267|Pulmonary|pulmonary
5352643|NCT00241267|Neoplasms|neoplasms
5352644|NCT00241267|Endobronchial|endobronchial
5352645|NCT00241267|Ultrasonography|ultrasonography
5352646|NCT00241267|Primary|primary
5352647|NCT00241254|Multiple Sclerosis, Chronic Progressive|multiple sclerosis, chronic progressive
5352648|NCT00241254|Cyclophosphamide|cyclophosphamide
5352649|NCT00241254|Methylprednisolone|methylprednisolone
5352650|NCT00241254|Randomized Controlled Trials|randomized controlled trials
5352651|NCT00241254|Double-Blind Study|double-blind study
5352652|NCT00241241|myeloproliferative disorder|myeloproliferative disorder
5352653|NCT00241241|polycythemia vera|polycythemia vera
5352654|NCT00241241|interferon|interferon
5352655|NCT00241228|Shock, Septic|shock, septic
5352656|NCT00241228|Renal Failure, Acute|renal failure, acute
5352657|NCT00241228|Venovenous Hemofiltration|venovenous hemofiltration
5352658|NCT00241228|Randomized Controlled Trial|randomized controlled trial
5352659|NCT00241228|Multicenter Study|multicenter study
5352660|NCT00241228|Mortality|mortality
5352661|NCT00241215|Botulinum toxin serotype A|botulinum toxin serotype a
5352662|NCT00241215|Cervicobrachial syndrome|cervicobrachial syndrome
5352663|NCT00241215|Myofascial pain|myofascial pain
5352664|NCT00241215|Cervicothoracic myofascial pain|cervicothoracic myofascial pain
5352665|NCT00241215|Propulsion|propulsion
5352666|NCT00241215|Postural abnormality|postural abnormality
5352667|NCT00241202|signs and symptoms|signs and symptoms
5352668|NCT00241202|self care|self care
5352669|NCT00241202|patient compliance|patient compliance
5352670|NCT00241202|quality of life|quality of life
5352671|NCT00241189|Systemic sclerosis|systemic sclerosis
5352672|NCT00241189|Scleroderma|scleroderma
5352673|NCT00241189|Rapamycin|rapamycin
5352674|NCT00241189|Methotrexate|methotrexate
5352675|NCT00241176|Psychiatric|psychiatric
5352676|NCT00241176|Clinical Trial|clinical trial
5352677|NCT00241176|Pediatrics|pediatrics
5352678|NCT00241176|Tourette's Disorder|tourette's disorder
5352679|NCT00241176|Tic Disorder|tic disorder
5352680|NCT00241150|valsartan|valsartan
5352681|NCT00241150|hypertension|hypertension
5352682|NCT00241150|metabolic syndrome|metabolic syndrome
5352683|NCT00241150|endothelial function|endothelial function
5352684|NCT00241137|hypertension|hypertension
5352685|NCT00241137|valsartan|valsartan
5352686|NCT00241124|hypertension|hypertension
5352687|NCT00241124|valsartan|valsartan
5352688|NCT00241124|morning/evening dosing|morning/evening dosing
5352689|NCT00241124|lisinopril|lisinopril
5352690|NCT00241111|Prostate|prostate
5352691|NCT00241111|cancer|cancer
5352692|NCT00241111|bone metastasis|bone metastasis
5352693|NCT00241111|zoledronic acid|zoledronic acid
5352694|NCT00241098|HYPERTENSION|hypertension
5352695|NCT00241098|HEART FAILURE|heart failure
5352696|NCT00241098|PEPTIDE|peptide
5352697|NCT00241098|valsartan|valsartan
5352698|NCT00241085|proteinuria|proteinuria
5352699|NCT00241085|hypertension|hypertension
5352700|NCT00241085|valsartan|valsartan
5352701|NCT00241085|type 2 diabetes|type 2 diabetes
5352702|NCT00241059|Renal transplantation, maintenance patients, tolerability, EC-MPS|renal transplantation, maintenance patients, tolerability, ec-mps
5352703|NCT00241046|Breast cancer|breast cancer
5352704|NCT00241046|Machine learning techniques|machine learning techniques
5352705|NCT00241046|Aromatase inhibitors|aromatase inhibitors
5352706|NCT00241046|1st line treatment|1st line treatment
5352707|NCT00241046|2nd line treatment|2nd line treatment
5352708|NCT00241020|hepatocellular carcinoma|hepatocellular carcinoma
5352709|NCT00241020|Octreotide|octreotide
5352710|NCT00241007|HYPERTENSION, VALSARTAN|hypertension, valsartan
5352711|NCT00240994|End stage renal disease|end stage renal disease
5352712|NCT00240994|Kidney transplantation|kidney transplantation
5352713|NCT00240994|Renal transplantation|renal transplantation
5352714|NCT00240994|Kidney failure|kidney failure
5352715|NCT00240994|Pediatric renal transplant recipients|pediatric renal transplant recipients
5352716|NCT00240994|Alemtuzumab|alemtuzumab
5352717|NCT00240994|Campath|campath
5352718|NCT00240994|Mycophenolate mofetil|mycophenolate mofetil
5352719|NCT00240994|MMF|mmf
5352720|NCT00240994|CellCept|cellcept
5352721|NCT00240994|Tacrolimus|tacrolimus
5352722|NCT00240994|Prograf|prograf
5352723|NCT00240994|Sirolimus|sirolimus
5352724|NCT00240994|Rapamycin|rapamycin
5352725|NCT00240981|Andropause|andropause
5352726|NCT00240981|frailty|frailty
5352727|NCT00240981|hormone replacement therapy|hormone replacement therapy
5352728|NCT00240981|Aging|aging
5352729|NCT00240968|Avian influenza, vaccine, A/H5N1, sub-study|avian influenza, vaccine, a/h5n1, sub-study
5352730|NCT00240955|Renal/Kidney, Transplantation, steroids, EC-MPS|renal/kidney, transplantation, steroids, ec-mps
5352731|NCT00240942|Endometriosis|endometriosis
5352732|NCT00240942|GnRH analog|gnrh analog
5352733|NCT00240942|Aromataseinhibitor|aromataseinhibitor
5352734|NCT00240942|Letrozole|letrozole
5352735|NCT00240903|revaccination, vaccination, influenza, H5N1 vaccine|revaccination, vaccination, influenza, h5n1 vaccine
5352736|NCT00240864|postoperative dental pain|postoperative dental pain
5352737|NCT00240864|acetaminophen|acetaminophen
5352738|NCT00240864|ibuprofen|ibuprofen
5352739|NCT00240851|muscle ache|muscle ache
5352740|NCT00240851|pain|pain
5352741|NCT00240851|soreness|soreness
5352742|NCT00240851|acetaminophen|acetaminophen
5352743|NCT00240838|muscle soreness|muscle soreness
5352744|NCT00240838|pain, acetaminophen|pain, acetaminophen
5352745|NCT00240838|ibuprofen|ibuprofen
5352746|NCT00240825|postoperative dental pain|postoperative dental pain
5352747|NCT00240825|acetaminophen|acetaminophen
5352748|NCT00240825|ibuprofen|ibuprofen
5352749|NCT00240812|nocturnal enuresis|nocturnal enuresis
5352750|NCT00240812|bedwetting|bedwetting
5352751|NCT00240812|ibuprofen|ibuprofen
5352752|NCT00240799|osteoarthritis hip|osteoarthritis hip
5352753|NCT00240799|osteoarthritis knee|osteoarthritis knee
5352754|NCT00240799|acetaminophen|acetaminophen
5352755|NCT00240786|osteoarthritis hip|osteoarthritis hip
5352756|NCT00240786|osteoarthritis knee|osteoarthritis knee
5352757|NCT00240786|acetaminophen|acetaminophen
5352758|NCT00240773|osteoarthritis hip|osteoarthritis hip
5352759|NCT00240773|osteoarthritis knee|osteoarthritis knee
5352760|NCT00240773|acetaminophen, naproxen|acetaminophen, naproxen
5352761|NCT00240760|Memantine|memantine
5352762|NCT00240760|Down syndrome|down syndrome
5352763|NCT00240760|Dementia|dementia
5352764|NCT00240760|learning Disability|learning disability
5352765|NCT00240760|Treatment of Dementia|treatment of dementia
5352766|NCT00240734|Anemia|anemia
5352767|NCT00240734|Chronic renal failure|chronic renal failure
5352768|NCT00240734|pre-dialysis|pre-dialysis
5352769|NCT00240734|diabetic|diabetic
5352770|NCT00240721|topiramate|topiramate
5352771|NCT00240721|bipolar disorders|bipolar disorders
5352772|NCT00240721|mood disorders|mood disorders
5352773|NCT00240721|manic state|manic state
5352774|NCT00240721|depression|depression
5352775|NCT00240721|manic-depressive psychoses|manic-depressive psychoses
5352776|NCT00240708|Schizophrenia|schizophrenia
5352777|NCT00240708|intramuscular injection|intramuscular injection
5352778|NCT00240708|antipsychotic agents|antipsychotic agents
5352779|NCT00240708|risperidone|risperidone
5352780|NCT00240708|long-acting injectable|long-acting injectable
5352781|NCT00240695|Alzheimer's disease|alzheimer's disease
5352782|NCT00240695|Dementia|dementia
5352783|NCT00240695|Brain Disease|brain disease
5352784|NCT00240695|Memory Loss|memory loss
5352785|NCT00240695|galantamine|galantamine
5352786|NCT00240695|Nervous System Diseases|nervous system diseases
5352787|NCT00240695|open-label|open-label
5352788|NCT00240695|elderly|elderly
5352789|NCT00240682|Carcinoma, Squamous Cell|carcinoma, squamous cell
5352790|NCT00240682|Skin|skin
5352791|NCT00240682|cetuximab|cetuximab
5352792|NCT00240682|epidermal growth factor receptor|epidermal growth factor receptor
5352793|NCT00240669|Maxillo facial surgery,|maxillo facial surgery,
5352794|NCT00240669|osteosynthesis,|osteosynthesis,
5352795|NCT00240669|resorbable device|resorbable device
5352796|NCT00240656|aldosterone antagonists, spironolactone, captopril carvedilol|aldosterone antagonists, spironolactone, captopril carvedilol
5352797|NCT00240643|non valvular atrial fibrillation|non valvular atrial fibrillation
5352798|NCT00240643|stroke|stroke
5352799|NCT00240643|aspirin|aspirin
5352800|NCT00240630|acute migraine|acute migraine
5352801|NCT00240630|consistency of response|consistency of response
5352802|NCT00240630|satisfaction|satisfaction
5352803|NCT00240630|migraine|migraine
5352804|NCT00240630|early intervention|early intervention
5352805|NCT00240617|consistency of response|consistency of response
5352806|NCT00240617|migraine|migraine
5352807|NCT00240617|satisfaction|satisfaction
5352808|NCT00240617|early intervention|early intervention
5352809|NCT00240604|corticosteroid treatment|corticosteroid treatment
5352810|NCT00240604|inflammatory diseases|inflammatory diseases
5352811|NCT00240591|BEXXAR|bexxar
5352812|NCT00240591|Tositumomab|tositumomab
5352813|NCT00240591|Iodine I 131 Tositumomab|iodine i 131 tositumomab
5352814|NCT00240591|low-grade follicular lymphomas|low-grade follicular lymphomas
5352815|NCT00240578|Long-Term Follow-up|long-term follow-up
5352816|NCT00240578|BEXXAR|bexxar
5352817|NCT00240578|Iodine I 131 Tositumomab|iodine i 131 tositumomab
5352818|NCT00240578|Low-grade lymphoma|low-grade lymphoma
5352819|NCT00240565|BEXXAR|bexxar
5352820|NCT00240565|non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
5352821|NCT00240565|tositumomab|tositumomab
5352822|NCT00240565|I-131|i-131
5352823|NCT00240552|protease inhibitor|protease inhibitor
5352824|NCT00240552|Treatment Experienced|treatment experienced
5352825|NCT00240552|amprenavir|amprenavir
5352826|NCT00240552|fosamprenavir|fosamprenavir
5352827|NCT00240552|GW433908|gw433908
5352828|NCT00240552|HIV|hiv
5352829|NCT00240552|pro drug|pro drug
5352830|NCT00240539|Hepatitis B|hepatitis b
5352831|NCT00240526|Hepatitis B immunoglobulin|hepatitis b immunoglobulin
5352832|NCT00240526|Hepatitis B antibody persistence|hepatitis b antibody persistence
5352833|NCT00240513|Acne|acne
5352834|NCT00240500|Long-term follow-up|long-term follow-up
5352835|NCT00240500|Hepatitis B antibody persistence|hepatitis b antibody persistence
5352836|NCT00240487|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
5352837|NCT00240487|ARDS|ards
5352838|NCT00240487|Nitric Oxide|nitric oxide
5352839|NCT00240461|respiratory|respiratory
5352840|NCT00240461|infection|infection
5352841|NCT00240461|influenza|influenza
5352842|NCT00240396|fracture|fracture
5352843|NCT00240396|Tibia|tibia
5352844|NCT00240396|femur|femur
5352845|NCT00240396|humerus|humerus
5352846|NCT00240396|narcotics|narcotics
5352847|NCT00240396|bimodal|bimodal
5352848|NCT00240396|analgesia|analgesia
5352849|NCT00240396|long-bone|long-bone
5352850|NCT00240396|NSAIDS|nsaids
5352851|NCT00240344|High risk patients|high risk patients
5352852|NCT00240344|Crestor|crestor
5352853|NCT00240344|Rosuvastatin|rosuvastatin
5352854|NCT00240344|LDL cholesterol|ldl cholesterol
5352855|NCT00240344|observational|observational
5352856|NCT00240331|End Stage Renal Failure|end stage renal failure
5352857|NCT00240318|Coronary Artery Disease|coronary artery disease
5352858|NCT00240305|Metabolic Syndrome|metabolic syndrome
5352859|NCT00240305|Dyslipidaemia|dyslipidaemia
5352860|NCT00240292|Ischaemic or non-ischaemic systolic congestive heart failure|ischaemic or non-ischaemic systolic congestive heart failure
5352861|NCT00240279|high blood cholesterol levels|high blood cholesterol levels
5352862|NCT00240266|Metabolic Syndrome|metabolic syndrome
5352863|NCT00240266|Dyslipaemia|dyslipaemia
5352864|NCT00240253|diabetes|diabetes
5352865|NCT00240253|Amylin|amylin
5352866|NCT00240253|Symlin|symlin
5352867|NCT00240253|pramlintide|pramlintide
5352868|NCT00240253|insulin glargine|insulin glargine
5352869|NCT00240227|Alcoholism|alcoholism
5352870|NCT00240227|Cocaine Dependence|cocaine dependence
5352871|NCT00240227|Prazosin|prazosin
5352872|NCT00240227|Substance use disorders|substance use disorders
5352873|NCT00240214|Kidney transplants|kidney transplants
5352874|NCT00240188|Hernia|hernia
5352875|NCT00240188|Incisional|incisional
5352876|NCT00240188|Laparoscopic|laparoscopic
5352877|NCT00240188|Mesh|mesh
5352878|NCT00240188|Repair|repair
5352880|NCT00240162|Myeloma|myeloma
5352881|NCT00240162|PTK|ptk
5352882|NCT00240136|Early, severe|early, severe
5352883|NCT00240123|ERCP|ercp
5352884|NCT00240123|EUS|eus
5352885|NCT00240110|Bipolar|bipolar
5352886|NCT00240110|Cocaine|cocaine
5352887|NCT00240110|Comorbidity|comorbidity
5352888|NCT00240071|Breast cancer|breast cancer
5352889|NCT00240071|Metastatic breast cancer|metastatic breast cancer
5352890|NCT00240071|Hormonal therapy|hormonal therapy
5352891|NCT00240071|Bevacizumab|bevacizumab
5352892|NCT00240058|Blood Pressure|blood pressure
5352893|NCT00240058|Nitric Oxide|nitric oxide
5352894|NCT00240058|L-NMMA|l-nmma
5352895|NCT00240058|Phenylephrine|phenylephrine
5352896|NCT00240058|Nitroprusside|nitroprusside
5352897|NCT00240058|Vasoreactivity|vasoreactivity
5352898|NCT00240045|Hepatorenal syndrome|hepatorenal syndrome
5352899|NCT00240045|Refractory ascites|refractory ascites
5352900|NCT00240045|Midodrine|midodrine
5352901|NCT00240045|Octreotide|octreotide
5352902|NCT00240045|Albumin|albumin
5352903|NCT00240045|Cirrhosis|cirrhosis
5352904|NCT00240006|Multiple Sclerosis|multiple sclerosis
5352905|NCT00240006|Copaxone®|copaxone®
5352906|NCT00240006|Shared Solutions®|shared solutions®
5352907|NCT00239980|antineoplastic agent|antineoplastic agent
5352908|NCT00239980|ovarian cancer|ovarian cancer
5352909|NCT00239980|fragmin|fragmin
5352910|NCT00239980|dalteparin|dalteparin
5352911|NCT00239967|dyslipidemia|dyslipidemia
5352912|NCT00239967|obesity|obesity
5352913|NCT00239928|Long-Term Study For Pegaptanib Sodium In Patients With Subfoveal Choroidal Neovascularization Secondary To Age-Related Macular Degeneration|long-term study for pegaptanib sodium in patients with subfoveal choroidal neovascularization secondary to age-related macular degeneration
5352914|NCT00239902|Transplantation, kidney, and organ transplantation|transplantation, kidney, and organ transplantation
5352915|NCT00239889|Forearm fracture|forearm fracture
5352916|NCT00239889|Postmenopausal women|postmenopausal women
5352917|NCT00239889|Pain|pain
5352918|NCT00239889|Grip strength|grip strength
5352919|NCT00239889|Salmon calcitonin|salmon calcitonin
5352920|NCT00239876|Transplantation, kidney, and organ transplant|transplantation, kidney, and organ transplant
5352921|NCT00239863|Transplantation, kidney,organ transplant|transplantation, kidney,organ transplant
5352922|NCT00239850|obesity|obesity
5352923|NCT00239850|lifestyle|lifestyle
5352924|NCT00239850|treatment|treatment
5352925|NCT00239850|Complications|complications
5352926|NCT00239850|endocrine changes|endocrine changes
5352927|NCT00239850|Lipids|lipids
5352928|NCT00239850|C18.654.726.500.495|c18.654.726.500.495
5352929|NCT00239837|Adolescent|adolescent
5352930|NCT00239837|Foster Care|foster care
5352931|NCT00239837|Female|female
5352932|NCT00239824|urinary incontinence|urinary incontinence
5352933|NCT00239824|pelvic floor muscle training|pelvic floor muscle training
5352934|NCT00239824|radical prostatectomy|radical prostatectomy
5352935|NCT00239824|physiotherapy|physiotherapy
5352936|NCT00239811|Transplantation, kidney, and organ transplant.|transplantation, kidney, and organ transplant.
5352937|NCT00239798|Transplantation, kidney, organ transplant|transplantation, kidney, organ transplant
5352938|NCT00239785|Transplantation, kidney, and organ transplant.|transplantation, kidney, and organ transplant.
5352939|NCT00239772|Cognitive Therapy|cognitive therapy
5352940|NCT00239772|PTSD|ptsd
5352941|NCT00239772|Females|females
5352942|NCT00239772|Rape|rape
5352943|NCT00239772|Trauma|trauma
5352944|NCT00239759|Epidemiological study|epidemiological study
5352945|NCT00239746|Nonsteroidal Anti-inflammatories|nonsteroidal anti-inflammatories
5352946|NCT00239746|NSAIDS|nsaids
5352947|NCT00239733|HIV|hiv
5352948|NCT00239733|HCV|hcv
5352949|NCT00239733|Hepatitis C|hepatitis c
5352950|NCT00239733|Thrombocytopenia|thrombocytopenia
5352951|NCT00239720|Psoriatic Arthritis|psoriatic arthritis
5352952|NCT00239720|Arthritis|arthritis
5352953|NCT00239720|Psoriasis|psoriasis
5352954|NCT00239720|Psoriatic|psoriatic
5352955|NCT00239720|PsA|psa
5352956|NCT00239707|insulin sensitivity|insulin sensitivity
5352957|NCT00239707|blood sugar|blood sugar
5352958|NCT00239694|Immune response|immune response
5352959|NCT00239694|Antibody response|antibody response
5352960|NCT00239681|Primary prevention|primary prevention
5352961|NCT00239681|Cardiovascular disease|cardiovascular disease
5352962|NCT00239681|Statin therapy|statin therapy
5352963|NCT00239681|C-reactive protein|c-reactive protein
5352964|NCT00239668|Burns|burns
5352965|NCT00239668|Functional|functional
5352966|NCT00239668|Psychosocial|psychosocial
5352967|NCT00239668|Recovery|recovery
5352968|NCT00239668|Long-term|long-term
5352969|NCT00239668|Pediatric|pediatric
5352970|NCT00239668|Surgical|surgical
5352971|NCT00239668|Outcomes|outcomes
5352972|NCT00239668|Benchmarking|benchmarking
5352973|NCT00239642|Iron|iron
5352974|NCT00239642|Anemia|anemia
5352975|NCT00239642|CKD|ckd
5352976|NCT00239616|Anemia|anemia
5352977|NCT00239616|Pharmacokinetics|pharmacokinetics
5352978|NCT00239603|OV-Watch|ov-watch
5352979|NCT00239603|fertility monitor|fertility monitor
5352980|NCT00239603|ovulation induction|ovulation induction
5352981|NCT00239603|clomiphene citrate|clomiphene citrate
5352982|NCT00239603|anovulation|anovulation
5352983|NCT00239603|infertility|infertility
5352984|NCT00239577|Dengue infection|dengue infection
5352985|NCT00239564|IPX054|ipx054
5352986|NCT00239564|Parkinson disease|parkinson disease
5352987|NCT00239564|Levodopa|levodopa
5352988|NCT00239551|gastric stress ulcer|gastric stress ulcer
5352989|NCT00239551|Prevacid|prevacid
5352990|NCT00239551|Prostaglandin|prostaglandin
5352991|NCT00239525|Cerebrovascular Accident|cerebrovascular accident
5352992|NCT00239525|Intracranial Hypertension|intracranial hypertension
5352993|NCT00239512|PDA|pda
5352994|NCT00239512|VLBW infants|vlbw infants
5352995|NCT00239512|Indomethacin|indomethacin
5352996|NCT00239512|Ibuprofen|ibuprofen
5352997|NCT00239330|high blood cholesterol levels|high blood cholesterol levels
5352998|NCT00239317|tamsulosin|tamsulosin
5352999|NCT00239317|urinary tract diseases|urinary tract diseases
5353000|NCT00239317|male|male
5353001|NCT00239304|Stage III Head and Neck Cancer|stage iii head and neck cancer
5353002|NCT00239304|Stage IV Head and Neck Cancer|stage iv head and neck cancer
5353003|NCT00239265|tamsulosin|tamsulosin
5353004|NCT00239265|urinary tract diseases|urinary tract diseases
5353005|NCT00239265|female|female
5353006|NCT00239252|Interferon alfacon-1|interferon alfacon-1
5353007|NCT00239252|Virus disease|virus disease
5353008|NCT00239252|Hepatitis C|hepatitis c
5353009|NCT00239239|Non-myeloid malignancy|non-myeloid malignancy
5353010|NCT00239239|Chemotherapy-induced anemia|chemotherapy-induced anemia
5353011|NCT00239239|Oncology|oncology
5353012|NCT00239239|Clinical Trials|clinical trials
5353013|NCT00239239|Pharmacokinetics|pharmacokinetics
5353014|NCT00239239|Darbepoetin alfa|darbepoetin alfa
5353015|NCT00239239|Aranesp|aranesp
5353016|NCT00239239|Amgen|amgen
5353017|NCT00239226|atrial fibrillation|atrial fibrillation
5353018|NCT00239226|interatrial septum|interatrial septum
5353019|NCT00239226|atrial pacing|atrial pacing
5353020|NCT00239226|symptomatic sinus node dysfunction,|symptomatic sinus node dysfunction,
5353021|NCT00239226|pacemaker indication class I|pacemaker indication class i
5353022|NCT00239213|catechins|catechins
5353023|NCT00239213|gargling|gargling
5353024|NCT00239213|healthy volunteers|healthy volunteers
5353025|NCT00239187|Type 2 diabetes|type 2 diabetes
5353026|NCT00239174|obesity|obesity
5353027|NCT00239161|Pyelonephritis|pyelonephritis
5353028|NCT00239148|Type 1 diabetes|type 1 diabetes
5353029|NCT00239135|Actinic Keratosis|actinic keratosis
5353030|NCT00239135|Topical|topical
5353031|NCT00239135|Maximum Tolerated Dose|maximum tolerated dose
5353032|NCT00239135|Solar Keratosis|solar keratosis
5353033|NCT00239135|Sun Spots|sun spots
5353034|NCT00239135|Dermatology|dermatology
5353035|NCT00239122|Cognitive Therapy|cognitive therapy
5353036|NCT00239122|Psychotic Disorders|psychotic disorders
5353037|NCT00239122|Treatment Outcome|treatment outcome
5353038|NCT00239096|alcoholic liver cirrhosis|alcoholic liver cirrhosis
5353039|NCT00239096|ascites|ascites
5353040|NCT00239096|sodium retention|sodium retention
5353041|NCT00239083|MYFORMS, Kidney Transplantation, Enteric-Coated Mycophenolate Sodium (EC-MPS), Cyclosporine microemulsion (CsA-ME)|myforms, kidney transplantation, enteric-coated mycophenolate sodium (ec-mps), cyclosporine microemulsion (csa-me)
5353042|NCT00239070|EC-MPS, renal transplantation, de novo patients|ec-mps, renal transplantation, de novo patients
5353043|NCT00239057|Renal transplantation, EC-MPS|renal transplantation, ec-mps
5353044|NCT00239044|Kidney transplant recipients; Enteric-coated Mycophenolate sodium (EC-MPS)|kidney transplant recipients; enteric-coated mycophenolate sodium (ec-mps)
5353045|NCT00239031|Renal transplantation, EC-MPS|renal transplantation, ec-mps
5353046|NCT00239018|Enteric-Coated Mycophenolate Sodium (EC-MPS), de novo, kidney transplantation, long-term safety.|enteric-coated mycophenolate sodium (ec-mps), de novo, kidney transplantation, long-term safety.
5353047|NCT00239005|QoL|qol
5353048|NCT00239005|GI Side Effects|gi side effects
5353049|NCT00239005|MPA|mpa
5353050|NCT00238992|Kidney, de novo transplant, steroid withdrawal, adults, EC-MPS and cyclosporine|kidney, de novo transplant, steroid withdrawal, adults, ec-mps and cyclosporine
5353051|NCT00238979|Renal transplantation, Enteric-coated mycophenolate sodium|renal transplantation, enteric-coated mycophenolate sodium
5353052|NCT00238966|Renal transplantation, Enteric-Coated Mycophenolate Sodium (EC-MPS)|renal transplantation, enteric-coated mycophenolate sodium (ec-mps)
5353053|NCT00238953|Kidney transplantation|kidney transplantation
5353054|NCT00238953|enteric-coated mycophenolate sodium|enteric-coated mycophenolate sodium
5353055|NCT00238940|Renal transplantation, Enteric-Coated Mycophenolate Sodium (EC-MPS)|renal transplantation, enteric-coated mycophenolate sodium (ec-mps)
5353056|NCT00238927|asthma|asthma
5353057|NCT00238927|preschool|preschool
5353058|NCT00238927|viral|viral
5353059|NCT00238927|upper respiratory track infection|upper respiratory track infection
5353060|NCT00238927|fluticasone|fluticasone
5353061|NCT00238927|inhaled corticosteroids|inhaled corticosteroids
5353062|NCT00238927|placebo|placebo
5353063|NCT00238927|exacerbations|exacerbations
5353064|NCT00238927|severity|severity
5353065|NCT00238927|safety|safety
5353066|NCT00238927|growth|growth
5353067|NCT00238927|bone mineral density|bone mineral density
5353068|NCT00238927|adrenal function|adrenal function
5353069|NCT00238927|rescue beta2-agonists|rescue beta2-agonists
5353070|NCT00238901|Liver transplant, HCV+, steroid free|liver transplant, hcv+, steroid free
5353071|NCT00238888|asthma|asthma
5353072|NCT00238888|children|children
5353073|NCT00238888|adolescent|adolescent
5353074|NCT00238888|education|education
5353075|NCT00238888|medical review|medical review
5353076|NCT00238888|asthma control|asthma control
5353077|NCT00238888|questionnaire|questionnaire
5353078|NCT00238888|quality of life|quality of life
5353079|NCT00238888|emergency department visit|emergency department visit
5353080|NCT00238888|use of medication|use of medication
5353081|NCT00238888|adherence to treatment|adherence to treatment
5353082|NCT00238875|stereotactic body radiation therapy|stereotactic body radiation therapy
5353083|NCT00238875|T1N0M0 non-small cell lung cancer|t1n0m0 non-small cell lung cancer
5353084|NCT00238875|radiotherapy|radiotherapy
5353085|NCT00238862|Diabetes|diabetes
5353086|NCT00238862|Corneal transplant|corneal transplant
5353087|NCT00238862|Neurotrophic keratitis|neurotrophic keratitis
5353088|NCT00238862|Post-bacterial keratitis|post-bacterial keratitis
5353089|NCT00238862|Metaherpetic keratitis|metaherpetic keratitis
5353090|NCT00238849|Non-small cell lung cancer|non-small cell lung cancer
5353091|NCT00238823|cryoablation|cryoablation
5353092|NCT00238823|radiofrequency ablation|radiofrequency ablation
5353093|NCT00238823|pediatrics|pediatrics
5353094|NCT00238823|cardiology|cardiology
5353095|NCT00238810|BNP|bnp
5353096|NCT00238810|Pediatrics|pediatrics
5353097|NCT00238810|Congenital heart disease|congenital heart disease
5353098|NCT00238810|b-type natriuretic peptide|b-type natriuretic peptide
5353099|NCT00238797|Glioblastoma multiforme|glioblastoma multiforme
5353100|NCT00238797|Brain tumour|brain tumour
5353101|NCT00238758|Mood Disorder|mood disorder
5353102|NCT00238745|Postmenopausal Osteoporosis|postmenopausal osteoporosis
5353103|NCT00238732|Vaginal Atrophy|vaginal atrophy
5353104|NCT00238732|Postmenopause|postmenopause
5353105|NCT00238719|Social Anxiety|social anxiety
5353106|NCT00238719|Children Disorders|children disorders
5353107|NCT00238706|Radiofrequency catheter ablation|radiofrequency catheter ablation
5353108|NCT00238706|Atrial fibrillation|atrial fibrillation
5353109|NCT00238706|Randomized trial|randomized trial
5353110|NCT00238693|transplant|transplant
5353111|NCT00238693|transplantation of liver, kidney, pancreas|transplantation of liver, kidney, pancreas
5353112|NCT00238680|Overactive bladder|overactive bladder
5353113|NCT00238680|Children|children
5353114|NCT00238680|Bladder rehabilitation|bladder rehabilitation
5353115|NCT00238667|Extracranial carotid artery dissection|extracranial carotid artery dissection
5353116|NCT00238667|Dissection and stroke|dissection and stroke
5353117|NCT00238550|Diabetes|diabetes
5353118|NCT00238550|Pain|pain
5353119|NCT00238550|Peripheral neuropathy|peripheral neuropathy
5353120|NCT00238537|Stroke|stroke
5353121|NCT00238537|Thrombolysis|thrombolysis
5353122|NCT00238537|MRI|mri
5353123|NCT00238537|Echoplanar|echoplanar
5353124|NCT00238537|Penumbra|penumbra
5353125|NCT00238524|painful distal diabetic neuropathy|painful distal diabetic neuropathy
5353126|NCT00238498|Type 2 diabetes|type 2 diabetes
5353127|NCT00238498|vildagliptin|vildagliptin
5353128|NCT00238498|HbA1c|hba1c
5353129|NCT00238485|Bipolar I Disorder|bipolar i disorder
5353130|NCT00238472|Type 2 diabetes|type 2 diabetes
5353131|NCT00238472|nateglinide|nateglinide
5353132|NCT00238459|Immunity to HIV|immunity to hiv
5353133|NCT00238459|Acute Infection|acute infection
5353134|NCT00238459|Treatment Naive|treatment naive
5353135|NCT00238459|Treatment Interruption|treatment interruption
5353136|NCT00238459|Structured Treatment Interruption|structured treatment interruption
5353137|NCT00238459|STI|sti
5353138|NCT00238446|Enteric-coated mycophenolate sodium, heart transplant recipients, long term safety|enteric-coated mycophenolate sodium, heart transplant recipients, long term safety
5353139|NCT00238433|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5353140|NCT00238433|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5353141|NCT00238433|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5353142|NCT00238433|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5353143|NCT00238433|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5353144|NCT00238433|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5353145|NCT00238433|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5353146|NCT00238433|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5353147|NCT00238433|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5353148|NCT00238433|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5353149|NCT00238433|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5353150|NCT00238433|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5353151|NCT00238433|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5353152|NCT00238433|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5353153|NCT00238433|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5353154|NCT00238433|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5353155|NCT00238433|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5353156|NCT00238433|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5353157|NCT00238433|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5353158|NCT00238433|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5353159|NCT00238433|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5353160|NCT00238433|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5353161|NCT00238433|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5353162|NCT00238433|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5353163|NCT00238433|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5353164|NCT00238433|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5353165|NCT00238433|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5353166|NCT00238433|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5353167|NCT00238433|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5353168|NCT00238433|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5353169|NCT00238433|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5353170|NCT00238433|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5353171|NCT00238433|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
5353172|NCT00238433|stage III childhood Hodgkin lymphoma|stage iii childhood hodgkin lymphoma
5353173|NCT00238433|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
5353174|NCT00238433|recurrent childhood anaplastic large cell lymphoma|recurrent childhood anaplastic large cell lymphoma
5353175|NCT00238433|stage III childhood anaplastic large cell lymphoma|stage iii childhood anaplastic large cell lymphoma
5353176|NCT00238433|stage IV childhood anaplastic large cell lymphoma|stage iv childhood anaplastic large cell lymphoma
5353177|NCT00238433|childhood grade III lymphomatoid granulomatosis|childhood grade iii lymphomatoid granulomatosis
5353178|NCT00238433|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
5353179|NCT00238433|stage III childhood large cell lymphoma|stage iii childhood large cell lymphoma
5353180|NCT00238433|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
5353181|NCT00238433|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
5353182|NCT00238433|stage III childhood lymphoblastic lymphoma|stage iii childhood lymphoblastic lymphoma
5353183|NCT00238433|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
5353184|NCT00238433|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
5353185|NCT00238433|stage III childhood small noncleaved cell lymphoma|stage iii childhood small noncleaved cell lymphoma
5353186|NCT00238433|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
5353187|NCT00238433|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5353188|NCT00238433|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
5353189|NCT00238433|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
5353190|NCT00238407|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
5353191|NCT00238407|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
5353192|NCT00238407|stage III esophageal cancer|stage iii esophageal cancer
5353193|NCT00238407|stage IV esophageal cancer|stage iv esophageal cancer
5353194|NCT00238381|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5353195|NCT00238381|stage 0 rectal cancer|stage 0 rectal cancer
5353196|NCT00238381|stage I rectal cancer|stage i rectal cancer
5353197|NCT00238381|stage II rectal cancer|stage ii rectal cancer
5353198|NCT00238381|stage III rectal cancer|stage iii rectal cancer
5353199|NCT00238381|stage IV rectal cancer|stage iv rectal cancer
5353200|NCT00238381|recurrent rectal cancer|recurrent rectal cancer
5353201|NCT00238368|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
5353202|NCT00238368|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5353203|NCT00238368|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
5353204|NCT00238368|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5353205|NCT00238368|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5353206|NCT00238368|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
5353207|NCT00238368|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5353208|NCT00238368|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
5353209|NCT00238368|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5353210|NCT00238368|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5353211|NCT00238368|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5353212|NCT00238368|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
5353213|NCT00238368|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
5353214|NCT00238368|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
5353215|NCT00238368|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
5353216|NCT00238355|infection|infection
5353217|NCT00238355|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5353218|NCT00238342|stage I ovarian epithelial cancer|stage i ovarian epithelial cancer
5353219|NCT00238342|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
5353220|NCT00238342|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5353221|NCT00238342|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5353222|NCT00238342|fallopian tube cancer|fallopian tube cancer
5353223|NCT00238342|ovarian clear cell cystadenocarcinoma|ovarian clear cell cystadenocarcinoma
5353224|NCT00238342|ovarian endometrioid adenocarcinoma|ovarian endometrioid adenocarcinoma
5353225|NCT00238342|ovarian mucinous cystadenocarcinoma|ovarian mucinous cystadenocarcinoma
5353226|NCT00238342|ovarian serous cystadenocarcinoma|ovarian serous cystadenocarcinoma
5353227|NCT00238342|ovarian undifferentiated adenocarcinoma|ovarian undifferentiated adenocarcinoma
5353228|NCT00238329|recurrent melanoma|recurrent melanoma
5353229|NCT00238329|stage IV melanoma|stage iv melanoma
5353230|NCT00238329|ciliary body and choroid melanoma, medium/large size|ciliary body and choroid melanoma, medium/large size
5353231|NCT00238329|extraocular extension melanoma|extraocular extension melanoma
5353232|NCT00238329|iris melanoma|iris melanoma
5353233|NCT00238329|recurrent intraocular melanoma|recurrent intraocular melanoma
5353234|NCT00238316|breast cancer|breast cancer
5353235|NCT00238290|recurrent breast cancer|recurrent breast cancer
5353236|NCT00238290|stage IIIA breast cancer|stage iiia breast cancer
5353237|NCT00238290|stage IIIB breast cancer|stage iiib breast cancer
5353238|NCT00238290|stage IIIC breast cancer|stage iiic breast cancer
5353239|NCT00238290|stage IV breast cancer|stage iv breast cancer
5353240|NCT00238277|adult glioblastoma|adult glioblastoma
5353241|NCT00238277|adult giant cell glioblastoma|adult giant cell glioblastoma
5353242|NCT00238277|adult gliosarcoma|adult gliosarcoma
5353243|NCT00238264|childhood oligodendroglioma|childhood oligodendroglioma
5353244|NCT00238264|recurrent childhood cerebellar astrocytoma|recurrent childhood cerebellar astrocytoma
5353245|NCT00238264|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
5353246|NCT00238264|childhood low-grade cerebral astrocytoma|childhood low-grade cerebral astrocytoma
5353247|NCT00238264|recurrent childhood visual pathway and hypothalamic glioma|recurrent childhood visual pathway and hypothalamic glioma
5353248|NCT00238264|untreated childhood cerebellar astrocytoma|untreated childhood cerebellar astrocytoma
5353249|NCT00238264|untreated childhood visual pathway and hypothalamic glioma|untreated childhood visual pathway and hypothalamic glioma
5353250|NCT00238251|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5353251|NCT00238251|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5353252|NCT00238251|tumors metastatic to brain|tumors metastatic to brain
5353253|NCT00238238|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5353254|NCT00238238|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5353255|NCT00238238|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5353256|NCT00238225|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5353257|NCT00238199|stage III pancreatic cancer|stage iii pancreatic cancer
5353258|NCT00238199|stage IV pancreatic cancer|stage iv pancreatic cancer
5353259|NCT00238173|drug/agent toxicity by tissue/organ|drug/agent toxicity by tissue/organ
5353260|NCT00238173|bone marrow suppression|bone marrow suppression
5353261|NCT00238173|long-term effects secondary to cancer therapy in children|long-term effects secondary to cancer therapy in children
5353262|NCT00238173|recurrent childhood brain stem glioma|recurrent childhood brain stem glioma
5353263|NCT00238173|untreated childhood brain stem glioma|untreated childhood brain stem glioma
5353264|NCT00238173|childhood central nervous system germ cell tumor|childhood central nervous system germ cell tumor
5353265|NCT00238173|recurrent childhood supratentorial primitive neuroectodermal tumor|recurrent childhood supratentorial primitive neuroectodermal tumor
5353266|NCT00238173|recurrent childhood visual pathway and hypothalamic glioma|recurrent childhood visual pathway and hypothalamic glioma
5353267|NCT00238173|recurrent childhood brain tumor|recurrent childhood brain tumor
5353268|NCT00238173|recurrent childhood cerebellar astrocytoma|recurrent childhood cerebellar astrocytoma
5353269|NCT00238173|childhood high-grade cerebral astrocytoma|childhood high-grade cerebral astrocytoma
5353270|NCT00238173|childhood low-grade cerebral astrocytoma|childhood low-grade cerebral astrocytoma
5353271|NCT00238173|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
5353272|NCT00238173|recurrent childhood medulloblastoma|recurrent childhood medulloblastoma
5353273|NCT00238173|childhood oligodendroglioma|childhood oligodendroglioma
5353274|NCT00238173|childhood infratentorial ependymoma|childhood infratentorial ependymoma
5353275|NCT00238173|childhood supratentorial ependymoma|childhood supratentorial ependymoma
5353276|NCT00238173|recurrent childhood ependymoma|recurrent childhood ependymoma
5353277|NCT00238173|childhood central nervous system choriocarcinoma|childhood central nervous system choriocarcinoma
5353278|NCT00238173|childhood central nervous system embryonal tumor|childhood central nervous system embryonal tumor
5353279|NCT00238173|childhood central nervous system germinoma|childhood central nervous system germinoma
5353280|NCT00238173|childhood central nervous system mixed germ cell tumor|childhood central nervous system mixed germ cell tumor
5353281|NCT00238173|childhood central nervous system teratoma|childhood central nervous system teratoma
5353282|NCT00238173|childhood central nervous system yolk sac tumor|childhood central nervous system yolk sac tumor
5353283|NCT00238173|recurrent childhood central nervous system embryonal tumor|recurrent childhood central nervous system embryonal tumor
5353284|NCT00238147|stage II esophageal cancer|stage ii esophageal cancer
5353285|NCT00238147|stage III esophageal cancer|stage iii esophageal cancer
5353286|NCT00238108|Sleep disorders|sleep disorders
5353287|NCT00238108|High blood pressure|high blood pressure
5353288|NCT00238082|COPD|copd
5353289|NCT00238082|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5353290|NCT00238082|Emphysema|emphysema
5353291|NCT00238082|Chronic Bronchitis|chronic bronchitis
5353292|NCT00238069|Asthma|asthma
5353293|NCT00238069|Sleep Apnea|sleep apnea
5353294|NCT00238069|Obesity|obesity
5353295|NCT00238069|CPAP|cpap
5353296|NCT00238056|Domperidone, QT, prematurity|domperidone, qt, prematurity
5353297|NCT00238043|Biogeneric Epoetin treatment|biogeneric epoetin treatment
5353298|NCT00238043|Renal anaemia|renal anaemia
5353299|NCT00238043|Chronic Kidney Disease|chronic kidney disease
5353300|NCT00238043|Pure Red Blood Cell Aplasia|pure red blood cell aplasia
5353301|NCT00238043|Hemodialysis|hemodialysis
5353302|NCT00238030|organ donation|organ donation
5353303|NCT00238030|thyroid replacement|thyroid replacement
5353304|NCT00238017|malaria, amodiaquine, artesunate, safety, efficacy|malaria, amodiaquine, artesunate, safety, efficacy
5353305|NCT00238004|Niacin|niacin
5353306|NCT00237965|Skin Self Examination|skin self examination
5353307|NCT00237965|Mole Mapping Diagram|mole mapping diagram
5353308|NCT00237965|Melanoma|melanoma
5353309|NCT00237926|Sleep|sleep
5353310|NCT00237926|Fatigue|fatigue
5353311|NCT00237926|Exercise tolerance|exercise tolerance
5353312|NCT00237926|Quality of life|quality of life
5353313|NCT00237926|Health status|health status
5353314|NCT00237887|Psoriasis|psoriasis
5353315|NCT00237887|adalimumab|adalimumab
5353316|NCT00237874|prodrome|prodrome
5353317|NCT00237874|ultra high risk|ultra high risk
5353318|NCT00237874|aripiprazole|aripiprazole
5353319|NCT00237822|Treatment Adherence|treatment adherence
5353320|NCT00237822|Co-Occurring Disorders|co-occurring disorders
5353321|NCT00237822|Motivational Enhancement Therapy|motivational enhancement therapy
5353322|NCT00237822|Contingency Management|contingency management
5353323|NCT00237822|MEMS Caps|mems caps
5353324|NCT00237796|Behavioral|behavioral
5353325|NCT00237796|Cognitive|cognitive
5353326|NCT00237796|Functioning|functioning
5353328|NCT00237796|CBT|cbt
5353329|NCT00237796|Rehabilitation|rehabilitation
5353330|NCT00237796|Schizophrenia|schizophrenia
5353331|NCT00237796|Skills|skills
5353332|NCT00237796|Social|social
5353333|NCT00237796|Training|training
5353334|NCT00237783|Renal dialysis|renal dialysis
5353335|NCT00237783|Hypotension|hypotension
5353336|NCT00237783|Dialysis solutions|dialysis solutions
5353337|NCT00237770|Blood Pressure|blood pressure
5353338|NCT00237770|Cardiovascular Autonomic Control|cardiovascular autonomic control
5353339|NCT00237770|Nitric Oxide|nitric oxide
5353340|NCT00237770|NOS Inhibitor|nos inhibitor
5353341|NCT00237770|Orthostatic Hypotension|orthostatic hypotension
5353342|NCT00237770|Spinal Cord Injury|spinal cord injury
5353343|NCT00237770|Tetraplegia|tetraplegia
5353344|NCT00237757|Patient Care Team|patient care team
5353345|NCT00237757|Rehabilitation outcomes|rehabilitation outcomes
5353346|NCT00237757|Treatment outcomes|treatment outcomes
5353347|NCT00237744|Motor Learning|motor learning
5353348|NCT00237744|Rehabilitation|rehabilitation
5353349|NCT00237744|Robotics|robotics
5353350|NCT00237744|Therapeutic Electric Stimulation|therapeutic electric stimulation
5353351|NCT00237731|Acute pain|acute pain
5353352|NCT00237731|Morphine titration|morphine titration
5353353|NCT00237731|Analgesia|analgesia
5353354|NCT00237731|Pre-hospital care|pre-hospital care
5353355|NCT00237705|Headache|headache
5353356|NCT00237705|Concussion|concussion
5353357|NCT00237705|Post concussive syndrome|post concussive syndrome
5353358|NCT00237705|Head trauma|head trauma
5353359|NCT00237692|Telemedicine|telemedicine
5353360|NCT00237692|Adherence|adherence
5353361|NCT00237692|Tailored Nurse Intervention|tailored nurse intervention
5353362|NCT00237692|Home Blood Pressure Monitoring|home blood pressure monitoring
5353363|NCT00237692|cardiovascular disease|cardiovascular disease
5353364|NCT00237679|behavior therapy|behavior therapy
5353365|NCT00237679|combination therapy|combination therapy
5353366|NCT00237679|gastrointestinal disorder chemotherapy|gastrointestinal disorder chemotherapy
5353367|NCT00237679|human therapy evaluation|human therapy evaluation
5353368|NCT00237679|larynx disorder|larynx disorder
5353369|NCT00237679|middle childhood (6-11)|middle childhood (6-11)
5353370|NCT00237679|lansoprazole|lansoprazole
5353371|NCT00237679|reflux esophagitis|reflux esophagitis
5353372|NCT00237679|quality of life|quality of life
5353373|NCT00237679|clinical research|clinical research
5353374|NCT00237679|human subject|human subject
5353375|NCT00237679|laryngoscopy|laryngoscopy
5353376|NCT00237679|patient oriented research|patient oriented research
5353377|NCT00237679|questionnaire|questionnaire
5353378|NCT00237666|Bipolar II Disorder|bipolar ii disorder
5353379|NCT00237666|Major Depressive Episode|major depressive episode
5353380|NCT00237653|Valganciclovir|valganciclovir
5353381|NCT00237653|Cytomegalovirus|cytomegalovirus
5353382|NCT00237653|Cryptogenic inflammatory bowel diseases|cryptogenic inflammatory bowel diseases
5353383|NCT00237653|Crohn Disease|crohn disease
5353384|NCT00237653|colitis, ulcerative|colitis, ulcerative
5353385|NCT00237640|Cinnamon|cinnamon
5353386|NCT00237640|Diabetes mellitus|diabetes mellitus
5353387|NCT00237640|Hyperlipidemia|hyperlipidemia
5353388|NCT00237640|Insulin Resistance|insulin resistance
5353389|NCT00237627|stage IIIA breast cancer|stage iiia breast cancer
5353390|NCT00237627|stage IIIB breast cancer|stage iiib breast cancer
5353391|NCT00237627|stage IIIC breast cancer|stage iiic breast cancer
5353392|NCT00237627|stage IV breast cancer|stage iv breast cancer
5353393|NCT00237627|male breast cancer|male breast cancer
5353641|NCT00237003|women|women
5353394|NCT00237627|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5353395|NCT00237627|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5353396|NCT00237627|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5353397|NCT00237627|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5353398|NCT00237627|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5353399|NCT00237627|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5353400|NCT00237627|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5353401|NCT00237627|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5353402|NCT00237627|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5353403|NCT00237627|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5353404|NCT00237627|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5353405|NCT00237627|mast cell leukemia|mast cell leukemia
5353406|NCT00237627|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5353407|NCT00237627|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5353408|NCT00237627|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5353409|NCT00237627|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
5353410|NCT00237627|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
5353411|NCT00237627|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5353412|NCT00237627|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5353413|NCT00237627|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5353414|NCT00237627|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
5353415|NCT00237627|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5353416|NCT00237627|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5353417|NCT00237627|refractory hairy cell leukemia|refractory hairy cell leukemia
5353418|NCT00237627|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
5353419|NCT00237627|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
5353420|NCT00237627|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
5353421|NCT00237627|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
5353422|NCT00237627|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5353423|NCT00237627|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5353424|NCT00237627|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5353425|NCT00237627|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5353426|NCT00237627|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
5353427|NCT00237627|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
5353428|NCT00237627|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
5353429|NCT00237627|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
5353430|NCT00237627|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
5353431|NCT00237627|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5353432|NCT00237627|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5353433|NCT00237627|adult grade III lymphomatoid granulomatosis|adult grade iii lymphomatoid granulomatosis
5353434|NCT00237627|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
5353435|NCT00237627|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
5353436|NCT00237627|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5353437|NCT00237627|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5353438|NCT00237627|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5353439|NCT00237627|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5353440|NCT00237627|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5353441|NCT00237627|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5353442|NCT00237627|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5353443|NCT00237627|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5353444|NCT00237627|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5353445|NCT00237627|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5353446|NCT00237627|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5353447|NCT00237627|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5353448|NCT00237627|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5353449|NCT00237627|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5353450|NCT00237627|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5353451|NCT00237627|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5353452|NCT00237627|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5353453|NCT00237627|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5353454|NCT00237627|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5353455|NCT00237627|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5353456|NCT00237627|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5353848|NCT00236496|tremor|tremor
5353457|NCT00237627|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5353458|NCT00237627|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5353459|NCT00237627|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5353460|NCT00237627|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5353461|NCT00237627|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5353462|NCT00237627|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5353463|NCT00237627|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5353464|NCT00237627|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5353465|NCT00237627|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5353466|NCT00237627|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
5353467|NCT00237627|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5353468|NCT00237627|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5353469|NCT00237627|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5353470|NCT00237627|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5353471|NCT00237627|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5353472|NCT00237627|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5353473|NCT00237627|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5353474|NCT00237627|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5353475|NCT00237627|intraocular lymphoma|intraocular lymphoma
5353476|NCT00237627|primary central nervous system lymphoma|primary central nervous system lymphoma
5353477|NCT00237627|stage III multiple myeloma|stage iii multiple myeloma
5353478|NCT00237627|stage II multiple myeloma|stage ii multiple myeloma
5353479|NCT00237627|refractory multiple myeloma|refractory multiple myeloma
5353480|NCT00237627|cutaneous B-cell non-Hodgkin lymphoma|cutaneous b-cell non-hodgkin lymphoma
5353481|NCT00237627|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
5353482|NCT00237627|stage III ovarian germ cell tumor|stage iii ovarian germ cell tumor
5353483|NCT00237627|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
5353484|NCT00237627|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5353485|NCT00237627|recurrent breast cancer|recurrent breast cancer
5353486|NCT00237627|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5353487|NCT00237614|Contrast-induced nephropathy|contrast-induced nephropathy
5353488|NCT00237614|Acute myocardial infarction|acute myocardial infarction
5353489|NCT00237614|Primary coronary angioplasty|primary coronary angioplasty
5353490|NCT00237601|Home birth|home birth
5353491|NCT00237601|Hospital birth|hospital birth
5353492|NCT00237601|Midwifery|midwifery
5353493|NCT00237601|Effectivity|effectivity
5353494|NCT00237601|Efficiency|efficiency
5353495|NCT00237588|Angiotensin II Type I Receptor Blockers|angiotensin ii type i receptor blockers
5353496|NCT00237588|Amlodipine|amlodipine
5353497|NCT00237588|Calcium Channel Blockers|calcium channel blockers
5353498|NCT00237588|Diabetes Mellitus|diabetes mellitus
5353499|NCT00237588|Hypertension|hypertension
5353500|NCT00237588|Insulin Resistance|insulin resistance
5353501|NCT00237588|Losartan|losartan
5353502|NCT00237575|urothelial|urothelial
5353503|NCT00237575|bladder|bladder
5353504|NCT00237575|gemcitabine|gemcitabine
5353505|NCT00237575|cisplatin|cisplatin
5353506|NCT00237575|leukine|leukine
5353507|NCT00237575|neupogen|neupogen
5353508|NCT00237575|filgrastim|filgrastim
5353509|NCT00237575|sargramostim|sargramostim
5353510|NCT00237575|metastatic|metastatic
5353511|NCT00237575|Regionally Advanced|regionally advanced
5353512|NCT00237575|Advanced|advanced
5353513|NCT00237549|Type 2 diabetes|type 2 diabetes
5353514|NCT00237549|Screening|screening
5353515|NCT00237549|Intensive treatment|intensive treatment
5353516|NCT00237549|Polypharmacy|polypharmacy
5353517|NCT00237549|Primary care|primary care
5353518|NCT00237536|Benign Prostatic Hyperplasia|benign prostatic hyperplasia
5353519|NCT00237536|BPH|bph
5353520|NCT00237536|Enlarged Prostate|enlarged prostate
5353521|NCT00237523|Breast pain|breast pain
5353522|NCT00237523|Mastalgia|mastalgia
5353523|NCT00237523|Cyclic mastalgia|cyclic mastalgia
5353524|NCT00237523|Periodic mastalgia|periodic mastalgia
5353525|NCT00237523|Non-cyclic mastalgia|non-cyclic mastalgia
5353526|NCT00237523|Fibrosis|fibrosis
5353527|NCT00237523|Nodularity|nodularity
5353528|NCT00237523|Cysts|cysts
5353529|NCT00237523|Fibrocystic breast disease|fibrocystic breast disease
5353530|NCT00237523|Fibrocystic breast condition|fibrocystic breast condition
5353531|NCT00237523|Fibocystic breast syndrome|fibocystic breast syndrome
5353532|NCT00237510|Antidepressant induced excessive sweating|antidepressant induced excessive sweating
5353533|NCT00237497|Insomnia|insomnia
5353534|NCT00237497|Center of Pressure|center of pressure
5353535|NCT00237497|Postural Sway|postural sway
5353536|NCT00237497|Drug Therapy|drug therapy
5353537|NCT00237497|Balance and Stability|balance and stability
5353538|NCT00237484|pegylated interferon alfa-2b|pegylated interferon alfa-2b
5353539|NCT00237484|ribavirin|ribavirin
5353540|NCT00237484|infliximab|infliximab
5353541|NCT00237484|chronic hepatitis C|chronic hepatitis c
5353542|NCT00237471|Acute Myocardial Infarction|acute myocardial infarction
5353543|NCT00237471|Hyperglycaemia|hyperglycaemia
5353544|NCT00237471|Insulin Infusion|insulin infusion
5353545|NCT00237419|Ankylosing spondylitis|ankylosing spondylitis
5353546|NCT00237419|Long-term therapy with infliximab|long-term therapy with infliximab
5353547|NCT00237419|Radiographic progression|radiographic progression
5353548|NCT00237406|IVR, methadone|ivr, methadone
5353549|NCT00237406|methadone maintenance|methadone maintenance
5353550|NCT00237393|PTSD|ptsd
5353551|NCT00237393|Posttraumatic stress disorder|posttraumatic stress disorder
5353552|NCT00237393|Treatment|treatment
5353553|NCT00237393|Quetiapine|quetiapine
5353554|NCT00237380|Cystic fibrosis|cystic fibrosis
5353555|NCT00237380|Nonsense mutation|nonsense mutation
5353556|NCT00237380|Premature stop codon|premature stop codon
5353557|NCT00237367|Gastroesophageal Reflux|gastroesophageal reflux
5353558|NCT00237367|GERD|gerd
5353559|NCT00237367|Nighttime heartburn|nighttime heartburn
5353560|NCT00237367|heartburn|heartburn
5353561|NCT00237367|esophagus|esophagus
5353562|NCT00237367|esophageal acid exposure|esophageal acid exposure
5353563|NCT00237367|EAE|eae
5353564|NCT00237367|Aciphex|aciphex
5353565|NCT00237367|Pariet|pariet
5353566|NCT00237367|rabeprazole|rabeprazole
5353567|NCT00237367|Protonix|protonix
5353568|NCT00237367|pantoprazole|pantoprazole
5353569|NCT00237354|Recurrent soft tissue breast carcinoma|recurrent soft tissue breast carcinoma
5353570|NCT00237341|chronic low back pain|chronic low back pain
5353571|NCT00237341|opioid|opioid
5353572|NCT00237341|fentanyl|fentanyl
5353573|NCT00237328|Heparin resistance|heparin resistance
5353574|NCT00237328|Blood clotting|blood clotting
5353575|NCT00237328|Heart surgery|heart surgery
5353576|NCT00237328|Cardiopulmonary bypass|cardiopulmonary bypass
5353577|NCT00237315|Urea|urea
5353578|NCT00237315|Inherited metabolic disorders|inherited metabolic disorders
5353579|NCT00237302|pediatric migraine|pediatric migraine
5353580|NCT00237302|migraine headache|migraine headache
5353581|NCT00237302|migraine prophylaxis|migraine prophylaxis
5353582|NCT00237302|migraine prevention|migraine prevention
5353583|NCT00237302|migraine|migraine
5353584|NCT00237289|Manic depression|manic depression
5353585|NCT00237289|Mania|mania
5353586|NCT00237289|Depression|depression
5353587|NCT00237289|Bipolar disorder|bipolar disorder
5353588|NCT00237289|Psychosis|psychosis
5353589|NCT00237276|colonoscopy, chromoendoscopy, autoflurescence, narrow band imaging, high definition endoscopy, colorectal cancer, colitis, polyp, DALM, adenoma, video|colonoscopy, chromoendoscopy, autoflurescence, narrow band imaging, high definition endoscopy, colorectal cancer, colitis, polyp, dalm, adenoma, video
5353590|NCT00237263|Parkinson's disease, end-of -dose wearing-off, entacapone|parkinson's disease, end-of -dose wearing-off, entacapone
5353591|NCT00237250|Pre-diabetes|pre-diabetes
5353592|NCT00237250|vildagliptin|vildagliptin
5353593|NCT00237250|IGT|igt
5353594|NCT00237237|Type 2 diabetes|type 2 diabetes
5353595|NCT00237237|vildagliptin|vildagliptin
5353596|NCT00237224|Breast Cancer, ER and/or PgR positive, Letrozole|breast cancer, er and/or pgr positive, letrozole
5353597|NCT00237211|Aromatase inhibitor|aromatase inhibitor
5353598|NCT00237211|letrozole|letrozole
5353599|NCT00237211|breast cancer|breast cancer
5353600|NCT00237198|Aromatase inhibitor|aromatase inhibitor
5353601|NCT00237198|letrozole|letrozole
5353602|NCT00237198|breast cancer|breast cancer
5353603|NCT00237185|GIST|gist
5353604|NCT00237185|c-kit|c-kit
5353605|NCT00237185|imatinib mesylate|imatinib mesylate
5353606|NCT00237172|GIST|gist
5353607|NCT00237172|Imatinib|imatinib
5353608|NCT00237172|STI571|sti571
5353609|NCT00237172|Gastrointestinal Stromal Tumors|gastrointestinal stromal tumors
5353610|NCT00237159|Prostate cancer|prostate cancer
5353611|NCT00237159|Bone metastasis|bone metastasis
5353612|NCT00237159|Skeletal related event|skeletal related event
5353613|NCT00237146|Prostate cancer|prostate cancer
5353614|NCT00237146|Zoledronic acid|zoledronic acid
5353615|NCT00237146|Bone metastasis|bone metastasis
5353616|NCT00237133|Breast cancer,|breast cancer,
5353617|NCT00237133|Letrozole,|letrozole,
5353618|NCT00237133|Hormonal receptors|hormonal receptors
5353619|NCT00237120|Chronic Myelogenous Leukemia|chronic myelogenous leukemia
5353620|NCT00237120|Imatinib|imatinib
5353621|NCT00237120|CML|cml
5353622|NCT00237107|Cytoreduction Surgical Procedures|cytoreduction surgical procedures
5353623|NCT00237107|Curretage|curretage
5353624|NCT00237107|Photochemotherapy|photochemotherapy
5353625|NCT00237094|Diabetes|diabetes
5353626|NCT00237094|Self Management|self management
5353627|NCT00237094|Interdisciplinary team|interdisciplinary team
5353628|NCT00237081|Interstitial Cystitis|interstitial cystitis
5353629|NCT00237081|Painful Bladder Syndrome|painful bladder syndrome
5353630|NCT00237081|Genetics|genetics
5353631|NCT00237081|Risk factors|risk factors
5353632|NCT00237081|Family history|family history
5353633|NCT00237068|Gastroesophageal Reflux|gastroesophageal reflux
5353634|NCT00237055|Children|children
5353635|NCT00237055|Crohn's disease|crohn's disease
5353636|NCT00237055|Inflammatory bowel disease|inflammatory bowel disease
5353637|NCT00237055|Infectious agents|infectious agents
5353638|NCT00237055|Colonoscopy|colonoscopy
5353639|NCT00237042|Temporomandibular Disorders|temporomandibular disorders
5353640|NCT00237042|TMJ Disorders|tmj disorders
5353642|NCT00237003|incarceration|incarceration
5353643|NCT00237003|alcohol use|alcohol use
5353644|NCT00237003|motivational interviewing|motivational interviewing
5353645|NCT00236990|prostatitis|prostatitis
5353646|NCT00236990|Elmiron|elmiron
5353647|NCT00236990|pentosan polysulfate sodium|pentosan polysulfate sodium
5353648|NCT00236977|CKD|ckd
5353649|NCT00236977|iron|iron
5353650|NCT00236977|anemia|anemia
5353651|NCT00236964|Anemia|anemia
5353652|NCT00236964|Chronic Kidney Disease|chronic kidney disease
5353653|NCT00236951|Anemia|anemia
5353654|NCT00236951|Cancer|cancer
5353655|NCT00236951|Chemotherapy|chemotherapy
5353656|NCT00236938|iron|iron
5353657|NCT00236938|peritoneal dialysis|peritoneal dialysis
5353658|NCT00236938|anemia|anemia
5353659|NCT00236925|Fibromyalgia|fibromyalgia
5353660|NCT00236925|Cortisol|cortisol
5353661|NCT00236925|Hydrocortisone|hydrocortisone
5353662|NCT00236925|Stress|stress
5353663|NCT00236912|complicated appendicitis|complicated appendicitis
5353664|NCT00236912|antibiotics|antibiotics
5353665|NCT00236912|appendicitis|appendicitis
5353666|NCT00236912|infection|infection
5353667|NCT00236886|Epilepsy|epilepsy
5353668|NCT00236886|Partial Epilepsy|partial epilepsy
5353669|NCT00236886|Secondary Generalized Epilepsy|secondary generalized epilepsy
5353670|NCT00236886|Primary Generalized Epilepsy|primary generalized epilepsy
5353671|NCT00236886|Tonic-Clonic Seizures|tonic-clonic seizures
5353672|NCT00236886|Topiramate|topiramate
5353673|NCT00236886|Weight Loss|weight loss
5353674|NCT00236873|topiramate|topiramate
5353675|NCT00236873|epilepsy|epilepsy
5353676|NCT00236873|partial epilepsies|partial epilepsies
5353677|NCT00236873|partial epilepsy|partial epilepsy
5353678|NCT00236873|seizures|seizures
5353679|NCT00236873|epileptic seizures|epileptic seizures
5353680|NCT00236873|partial seizure disorder|partial seizure disorder
5353681|NCT00236873|brain diseases|brain diseases
5353682|NCT00236860|partial seizure disorder|partial seizure disorder
5353683|NCT00236860|brain diseases|brain diseases
5353684|NCT00236860|topiramate|topiramate
5353685|NCT00236860|epilepsy|epilepsy
5353686|NCT00236860|partial epilepsies|partial epilepsies
5353687|NCT00236860|partial epilepsy|partial epilepsy
5353688|NCT00236860|seizures|seizures
5353689|NCT00236860|epileptic seizures|epileptic seizures
5353690|NCT00236847|topiramate|topiramate
5353691|NCT00236847|epilepsy|epilepsy
5353692|NCT00236847|partial epilepsy|partial epilepsy
5353693|NCT00236847|seizures|seizures
5353694|NCT00236847|epileptic seizures|epileptic seizures
5353695|NCT00236847|partial seizure disorder|partial seizure disorder
5353696|NCT00236847|brain diseases|brain diseases
5353697|NCT00236834|respiratory tract diseases|respiratory tract diseases
5353698|NCT00236834|levofloxacin|levofloxacin
5353699|NCT00236834|pneumonia|pneumonia
5353700|NCT00236834|quinolones, hospital-acquired pneumonia|quinolones, hospital-acquired pneumonia
5353701|NCT00236834|lung diseases|lung diseases
5353702|NCT00236821|respiratory tract diseases|respiratory tract diseases
5353703|NCT00236821|pneumonia|pneumonia
5353704|NCT00236821|levofloxacin|levofloxacin
5353705|NCT00236821|community-acquired pneumonia|community-acquired pneumonia
5353706|NCT00236821|lung diseases|lung diseases
5353707|NCT00236821|quinolones|quinolones
5353708|NCT00236808|quinolones, ciprofloxacin|quinolones, ciprofloxacin
5353709|NCT00236808|levofloxacin|levofloxacin
5353710|NCT00236808|chronic bacterial prostatitis|chronic bacterial prostatitis
5353711|NCT00236808|inflammation|inflammation
5353712|NCT00236808|chronic prostatitis|chronic prostatitis
5353713|NCT00236808|prostatitis|prostatitis
5353714|NCT00236808|prostate|prostate
5353715|NCT00236808|antibiotic|antibiotic
5353716|NCT00236795|contraception|contraception
5353717|NCT00236795|hormonal contraception|hormonal contraception
5353718|NCT00236795|oral contraception|oral contraception
5353719|NCT00236795|steroid, ethinyl estradiol, horgestimate, levonorgestrel contraception|steroid, ethinyl estradiol, horgestimate, levonorgestrel contraception
5353720|NCT00236795|transdermal.|transdermal.
5353721|NCT00236782|contraception|contraception
5353722|NCT00236782|hormonal contraception|hormonal contraception
5353723|NCT00236782|oral contraception|oral contraception
5353724|NCT00236782|steroid, ethinyl estradiol, progestin contraception|steroid, ethinyl estradiol, progestin contraception
5353725|NCT00236782|transdermal.|transdermal.
5353726|NCT00236769|contraception|contraception
5353727|NCT00236769|transdermal contraception|transdermal contraception
5353728|NCT00236769|hormonal, steroidal contraception|hormonal, steroidal contraception
5353729|NCT00236769|ethinyl estradiol|ethinyl estradiol
5353730|NCT00236769|progesterone|progesterone
5353731|NCT00236756|Epilepsy|epilepsy
5353732|NCT00236756|Seizures|seizures
5353733|NCT00236756|Topiramate|topiramate
5353734|NCT00236756|Prophylaxis|prophylaxis
5353735|NCT00236756|Antiepileptic|antiepileptic
5353736|NCT00236756|Lennox-Gastaut syndrome|lennox-gastaut syndrome
5353737|NCT00236756|Seizures, tonic|seizures, tonic
5353738|NCT00236743|topiramate|topiramate
5353739|NCT00236743|epilepsy|epilepsy
5353740|NCT00236743|partial epilepsies|partial epilepsies
5353741|NCT00236743|partial epilepsy|partial epilepsy
5353742|NCT00236743|seizures|seizures
5353743|NCT00236743|epileptic seizures|epileptic seizures
5353744|NCT00236743|partial seizure disorder|partial seizure disorder
5353745|NCT00236743|children|children
5353746|NCT00236743|pediatric|pediatric
5353747|NCT00236730|topiramate|topiramate
5353748|NCT00236730|epilepsy|epilepsy
5353749|NCT00236730|partial epilepsies|partial epilepsies
5353750|NCT00236730|partial epilepsy|partial epilepsy
5353751|NCT00236730|seizures|seizures
5353752|NCT00236730|epileptic seizures|epileptic seizures
5353753|NCT00236730|partial seizure disorder|partial seizure disorder
5353754|NCT00236730|brain diseases|brain diseases
5353755|NCT00236717|Epilepsy|epilepsy
5353756|NCT00236717|Seizures|seizures
5353757|NCT00236717|Topiramate|topiramate
5353758|NCT00236717|Prophylaxis|prophylaxis
5353759|NCT00236717|Antiepileptic|antiepileptic
5353760|NCT00236704|Epilepsy|epilepsy
5353761|NCT00236704|Seizures|seizures
5353762|NCT00236704|Topiramate|topiramate
5353763|NCT00236704|Prophylaxis|prophylaxis
5353764|NCT00236704|Antiepileptic|antiepileptic
5353765|NCT00236704|Tonic-clonic seizures|tonic-clonic seizures
5353766|NCT00236704|Grand mal seizures|grand mal seizures
5353767|NCT00236691|topiramate|topiramate
5353768|NCT00236691|epilepsy|epilepsy
5353769|NCT00236691|partial epilepsies|partial epilepsies
5353770|NCT00236691|partial epilepsy|partial epilepsy
5353771|NCT00236691|seizures|seizures
5353772|NCT00236691|epileptic seizures|epileptic seizures
5353773|NCT00236691|partial seizure disorder|partial seizure disorder
5353774|NCT00236691|brain diseases|brain diseases
5353775|NCT00236678|Anemia|anemia
5353776|NCT00236678|Rheumatoid arthritis|rheumatoid arthritis
5353777|NCT00236678|Hemoglobin level|hemoglobin level
5353778|NCT00236665|Obesity|obesity
5353779|NCT00236665|Essential Hypertension|essential hypertension
5353780|NCT00236665|Mild Hypertension|mild hypertension
5353781|NCT00236665|Moderate Hypertension|moderate hypertension
5353782|NCT00236665|High Blood Pressure|high blood pressure
5353783|NCT00236652|Maxillary Sinusitis|maxillary sinusitis
5353784|NCT00236652|Infection|infection
5353785|NCT00236639|Obesity|obesity
5353786|NCT00236639|Hypertension|hypertension
5353787|NCT00236639|Hyperlipidemia|hyperlipidemia
5353788|NCT00236639|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
5353789|NCT00236639|Body Mass Index|body mass index
5353790|NCT00236626|Type 2 Diabetes|type 2 diabetes
5353791|NCT00236626|Obesity|obesity
5353792|NCT00236626|Insulin Resistance|insulin resistance
5353793|NCT00236626|Body Mass Index|body mass index
5353794|NCT00236626|Hypertension|hypertension
5353795|NCT00236626|Hyperlipidemia|hyperlipidemia
5353796|NCT00236626|Sulfonylurea|sulfonylurea
5353797|NCT00236626|Topiramate|topiramate
5353798|NCT00236626|Adult-Onset Diabetes Mellitus|adult-onset diabetes mellitus
5353799|NCT00236626|Metabolic Syndrome|metabolic syndrome
5353800|NCT00236613|Obesity|obesity
5353801|NCT00236613|Hypertension|hypertension
5353802|NCT00236613|Hyperlipidemia|hyperlipidemia
5353803|NCT00236613|Body Mass Index|body mass index
5353804|NCT00236600|Obesity|obesity
5353805|NCT00236600|Hypertension|hypertension
5353806|NCT00236600|Hyperlipidemia|hyperlipidemia
5353807|NCT00236600|Type 2 Diabetes|type 2 diabetes
5353808|NCT00236600|Life style modification|life style modification
5353809|NCT00236587|Schizophrenia|schizophrenia
5353810|NCT00236587|Intramuscular injection|intramuscular injection
5353811|NCT00236587|Antipsychotic agents|antipsychotic agents
5353812|NCT00236587|Long-acting risperidone|long-acting risperidone
5353813|NCT00236574|Dementia|dementia
5353814|NCT00236574|Alzheimer disease|alzheimer disease
5353815|NCT00236574|Mild cognitive impairment|mild cognitive impairment
5353816|NCT00236574|Galantamine hydrobromide|galantamine hydrobromide
5353817|NCT00236574|Memory disorder|memory disorder
5353818|NCT00236561|Migraine|migraine
5353819|NCT00236561|Common Migraine|common migraine
5353820|NCT00236561|Classic Migraine|classic migraine
5353821|NCT00236561|Headache|headache
5353822|NCT00236561|Topiramate|topiramate
5353823|NCT00236561|Propranolol|propranolol
5353824|NCT00236561|Prophylaxis|prophylaxis
5353825|NCT00236561|Prevention|prevention
5353826|NCT00236548|Schizophrenia|schizophrenia
5353827|NCT00236548|schizoaffective disorder|schizoaffective disorder
5353828|NCT00236548|patient compliance|patient compliance
5353829|NCT00236548|long-acting risperidone|long-acting risperidone
5353830|NCT00236548|intramuscular injection|intramuscular injection
5353831|NCT00236548|Treatment Guidebook|treatment guidebook
5353832|NCT00236535|musculoskeletal|musculoskeletal
5353833|NCT00236535|Pain|pain
5353834|NCT00236535|sprained ankle|sprained ankle
5353835|NCT00236535|ligament|ligament
5353836|NCT00236535|sprain|sprain
5353837|NCT00236535|ankle|ankle
5353838|NCT00236522|sinus infection|sinus infection
5353839|NCT00236522|acute bacterial sinusitis|acute bacterial sinusitis
5353840|NCT00236522|sinusitis|sinusitis
5353841|NCT00236522|bacterial sinus infection|bacterial sinus infection
5353842|NCT00236509|Migraine|migraine
5353843|NCT00236509|Common Migraine|common migraine
5353844|NCT00236509|Classic Migraine|classic migraine
5353845|NCT00236509|Headache|headache
5353846|NCT00236509|Topiramate|topiramate
5353847|NCT00236509|Prophylaxis|prophylaxis
5353849|NCT00236496|essential tremor|essential tremor
5353850|NCT00236483|Oral Surgery|oral surgery
5353851|NCT00236483|Analgesics|analgesics
5353852|NCT00236483|Postoperative Pain|postoperative pain
5353853|NCT00236483|dental|dental
5353854|NCT00236470|Disruptive behavior disorder|disruptive behavior disorder
5353855|NCT00236470|risperidone|risperidone
5353856|NCT00236470|antipsychotropic agents|antipsychotropic agents
5353857|NCT00236470|child|child
5353858|NCT00236470|adolescent|adolescent
5353859|NCT00236457|Schizophrenia|schizophrenia
5353860|NCT00236457|Intramuscular injection|intramuscular injection
5353861|NCT00236457|Antipsychotic agents|antipsychotic agents
5353862|NCT00236457|Long-acting risperidone|long-acting risperidone
5353863|NCT00236457|Olanzapine|olanzapine
5353864|NCT00236444|Child|child
5353865|NCT00236444|adolescent|adolescent
5353866|NCT00236444|disruptive behavior disorders|disruptive behavior disorders
5353867|NCT00236444|risperidone|risperidone
5353868|NCT00236444|antipsychotropic agents|antipsychotropic agents
5353869|NCT00236431|Mild cognitive impairment|mild cognitive impairment
5353870|NCT00236431|Galantamine hydrobromide|galantamine hydrobromide
5353871|NCT00236431|Memory disorders|memory disorders
5353872|NCT00236418|Epilepsy|epilepsy
5353873|NCT00236418|Seizures|seizures
5353874|NCT00236418|Topiramate|topiramate
5353875|NCT00236418|Prophylaxis|prophylaxis
5353876|NCT00236418|Antiepileptic|antiepileptic
5353877|NCT00236418|Tonic-clonic seizures|tonic-clonic seizures
5353878|NCT00236418|Grand mal seizures|grand mal seizures
5353879|NCT00236405|Anemia|anemia
5353880|NCT00236405|erythropoetin|erythropoetin
5353881|NCT00236405|quality-of-life outcomes|quality-of-life outcomes
5353882|NCT00236392|Gastroesophageal reflux|gastroesophageal reflux
5353883|NCT00236392|Heartburn|heartburn
5353884|NCT00236392|Rabeprazole|rabeprazole
5353885|NCT00236392|Anti-ulcer agents|anti-ulcer agents
5353886|NCT00236392|GERD|gerd
5353887|NCT00236392|Proton pump inhibitor|proton pump inhibitor
5353888|NCT00236392|GORD|gord
5353889|NCT00236392|Non-Erosive Reflux Disease|non-erosive reflux disease
5353890|NCT00236392|NERD|nerd
5353891|NCT00236379|schizophrenia|schizophrenia
5353892|NCT00236379|blood glucose|blood glucose
5353893|NCT00236379|glucose metabolism|glucose metabolism
5353894|NCT00236379|diabetes mellitus|diabetes mellitus
5353895|NCT00236379|risperidone|risperidone
5353896|NCT00236379|olanzapine|olanzapine
5353897|NCT00236366|Fentanyl|fentanyl
5353898|NCT00236366|opioid analgesics|opioid analgesics
5353899|NCT00236366|osteoarthritis|osteoarthritis
5353900|NCT00236366|arthritis|arthritis
5353901|NCT00236366|transdermal administration|transdermal administration
5353902|NCT00236353|schizophrenia|schizophrenia
5353903|NCT00236353|schizoaffective disorder|schizoaffective disorder
5353904|NCT00236353|long-acting risperidone|long-acting risperidone
5353905|NCT00236353|intramuscular injection|intramuscular injection
5353906|NCT00236340|Amniodrainage|amniodrainage
5353907|NCT00236340|Pregnancy|pregnancy
5353908|NCT00236340|Amniocentesis|amniocentesis
5353909|NCT00236327|Fentanyl|fentanyl
5353910|NCT00236327|Analgesia|analgesia
5353911|NCT00236327|Pain|pain
5353912|NCT00236327|Cancer pain|cancer pain
5353913|NCT00236327|Opioid analgesia|opioid analgesia
5353914|NCT00236327|Transdermal fentanyl|transdermal fentanyl
5353915|NCT00236327|Patient-controlled analgesia|patient-controlled analgesia
5353916|NCT00236301|Hormone|hormone
5353917|NCT00236301|Menopause|menopause
5353918|NCT00236301|Inflammation|inflammation
5353919|NCT00236301|Dose effects|dose effects
5353920|NCT00236301|Apoptosis|apoptosis
5353921|NCT00236288|Cancer treatment and tobacco abuse|cancer treatment and tobacco abuse
5353922|NCT00236275|Comparison of imaging modalities|comparison of imaging modalities
5353923|NCT00236275|predict the effectiveness of neoadjuvant chemotherapy|predict the effectiveness of neoadjuvant chemotherapy
5353924|NCT00236262|SDRA|sdra
5353925|NCT00236262|Distress|distress
5353926|NCT00236262|Expiratory|expiratory
5353927|NCT00236262|Pressure|pressure
5353928|NCT00236262|Ventilatory|ventilatory
5353929|NCT00236249|Double blind method|double blind method
5353930|NCT00236249|Prospective study|prospective study
5353931|NCT00236249|Lidocaine/administration and dosage/therapeutic use|lidocaine/administration and dosage/therapeutic use
5353932|NCT00236249|Anaesthetics local/administration and dosage|anaesthetics local/administration and dosage
5353933|NCT00236249|Opioids/administration and dosage|opioids/administration and dosage
5353934|NCT00236249|Pain, postoperative|pain, postoperative
5353935|NCT00236249|Perioperative care|perioperative care
5353936|NCT00236249|Postoperative care|postoperative care
5353937|NCT00236249|Analgesia, Patient-controlled|analgesia, patient-controlled
5353938|NCT00236249|Length of stay|length of stay
5353939|NCT00236249|Survival analysis|survival analysis
5353940|NCT00236249|Patient satisfaction|patient satisfaction
5353941|NCT00236249|Surgery|surgery
5353942|NCT00236249|Middle age|middle age
5353943|NCT00236249|Adult|adult
5353944|NCT00236249|Aged|aged
5353945|NCT00236223|Primary hip replacement|primary hip replacement
5353946|NCT00236223|Gabapentin|gabapentin
5353947|NCT00236223|Dexamethasone|dexamethasone
5353948|NCT00236223|Ketamine|ketamine
5354049|NCT00235560|AML|aml
5353949|NCT00236223|Multimodal postoperative analgesia.|multimodal postoperative analgesia.
5353950|NCT00236210|Vascular Intervention Program|vascular intervention program
5353951|NCT00236210|Vascular Disease|vascular disease
5353952|NCT00236210|Coronary Artery Disease|coronary artery disease
5353953|NCT00236210|Diabetes|diabetes
5353954|NCT00236210|Lifestyle Modification|lifestyle modification
5353955|NCT00236210|Modifiable Risk Factors|modifiable risk factors
5353956|NCT00236197|Heartburn|heartburn
5353957|NCT00236197|Rabeprazole|rabeprazole
5353958|NCT00236171|topical therapy|topical therapy
5353959|NCT00236171|Psoriasis Plaque Test|psoriasis plaque test
5353960|NCT00236145|BTP|btp
5353961|NCT00236145|Break through pain|break through pain
5353962|NCT00236145|breakthrough pain|breakthrough pain
5353963|NCT00236093|Sickle Cell|sickle cell
5353964|NCT00236041|Breakthrough Pain|breakthrough pain
5353965|NCT00236041|Cancer|cancer
5353966|NCT00236041|Sickle Cell|sickle cell
5353967|NCT00236041|Severe Burns|severe burns
5353968|NCT00236041|Children|children
5353969|NCT00236041|Adolescents|adolescents
5353970|NCT00236041|Analgesia|analgesia
5353971|NCT00236041|Sickle Cell Disease|sickle cell disease
5353972|NCT00236041|Non-Cancer|non-cancer
5353973|NCT00236028|Early Rheumatoid Arthritis|early rheumatoid arthritis
5353974|NCT00235989|Relapsing multiple sclerosis|relapsing multiple sclerosis
5353975|NCT00235989|interferon beta 1b|interferon beta 1b
5353976|NCT00235989|Betaferon|betaferon
5353977|NCT00235989|Betaseron|betaseron
5353978|NCT00235976|Neuromuscular Blocking Agent|neuromuscular blocking agent
5353979|NCT00235976|Anesthesia|anesthesia
5353980|NCT00235976|Succinylcholine|succinylcholine
5353981|NCT00235976|Tracheal Intubation|tracheal intubation
5353982|NCT00235976|Adjunct for tracheal intubation|adjunct for tracheal intubation
5353983|NCT00235950|Coronary Heart Disease|coronary heart disease
5353984|NCT00235950|Percutaeous Coronary Intervention (PCI)|percutaeous coronary intervention (pci)
5353985|NCT00235937|Premenopausal|premenopausal
5353986|NCT00235937|Advanced Breast Cancer|advanced breast cancer
5353987|NCT00235937|Metastatic Breast Cancer|metastatic breast cancer
5353988|NCT00235924|menopause|menopause
5353989|NCT00235924|isoflavone|isoflavone
5353990|NCT00235924|endometrial safety|endometrial safety
5353991|NCT00235924|breast innocuity assessment|breast innocuity assessment
5353992|NCT00235924|hot flushes|hot flushes
5353993|NCT00235885|Psoriatic Arthritis|psoriatic arthritis
5353994|NCT00235885|adalimumab|adalimumab
5353995|NCT00235872|Rheumatoid arthritis|rheumatoid arthritis
5353996|NCT00235859|Rheumatoid Arthritis|rheumatoid arthritis
5353997|NCT00235859|adalimumab|adalimumab
5353998|NCT00235846|Endoscopic vein harvesting|endoscopic vein harvesting
5353999|NCT00235846|Saphenous vein|saphenous vein
5354000|NCT00235833|Rheumatoid Arthritis|rheumatoid arthritis
5354001|NCT00235820|Psoriasis|psoriasis
5354002|NCT00235820|adalimumab|adalimumab
5354003|NCT00235807|Audiology|audiology
5354004|NCT00235807|Rehabilitation|rehabilitation
5354005|NCT00235807|Tinnitus|tinnitus
5354006|NCT00235781|Kidney Transplantation|kidney transplantation
5354007|NCT00235781|Antilymphocyte Serum|antilymphocyte serum
5354008|NCT00235781|Induction|induction
5354009|NCT00235781|Graft Rejection|graft rejection
5354010|NCT00235768|Ecstasy|ecstasy
5354011|NCT00235768|MDMA|mdma
5354012|NCT00235768|Cognition|cognition
5354013|NCT00235768|Brain function|brain function
5354014|NCT00235768|Neuroimaging|neuroimaging
5354015|NCT00235755|Partial Seizures|partial seizures
5354016|NCT00235755|Complex Partial Seizures|complex partial seizures
5354017|NCT00235755|Epilepsy|epilepsy
5354018|NCT00235755|Potassium Channels|potassium channels
5354019|NCT00235755|Anticonvulsant|anticonvulsant
5354020|NCT00235729|Opiate addiction|opiate addiction
5354021|NCT00235729|Opiate dependence|opiate dependence
5354022|NCT00235729|Withdrawal symptoms|withdrawal symptoms
5354023|NCT00235716|Alzheimer's Disease|alzheimer's disease
5354024|NCT00235716|clinical trial|clinical trial
5354025|NCT00235716|randomized controlled trial|randomized controlled trial
5354026|NCT00235716|alpha-tocopherol|alpha-tocopherol
5354027|NCT00235716|vitamin E|vitamin e
5354028|NCT00235716|Namenda|namenda
5354029|NCT00235716|memantine|memantine
5354030|NCT00235677|Endoscopic antireflux treatment|endoscopic antireflux treatment
5354031|NCT00235677|GERD|gerd
5354032|NCT00235677|Sham-controlled|sham-controlled
5354033|NCT00235677|Endocinch|endocinch
5354034|NCT00235664|liver transplant recipients|liver transplant recipients
5354035|NCT00235664|intestinal transplant recipients|intestinal transplant recipients
5354036|NCT00235664|multivisceral transplant recipients|multivisceral transplant recipients
5354037|NCT00235651|Lung transplant recipient|lung transplant recipient
5354038|NCT00235625|Alternative Medicine|alternative medicine
5354039|NCT00235625|Psoriasis|psoriasis
5354040|NCT00235625|Turmeric|turmeric
5354041|NCT00235625|Curcumin|curcumin
5354042|NCT00235625|Dermatology|dermatology
5354043|NCT00235599|Growth|growth
5354044|NCT00235599|Hormone|hormone
5354045|NCT00235599|Deficiency|deficiency
5354046|NCT00235586|vitamin D deficiency postmenopausal women|vitamin d deficiency postmenopausal women
5354047|NCT00235573|Vitamin B12 absorption|vitamin b12 absorption
5354048|NCT00235573|Holo-transcobalamin|holo-transcobalamin
5354050|NCT00235560|Rapamycin|rapamycin
5354051|NCT00235560|Elderly|elderly
5354052|NCT00235560|Elderly patients not eligible for intensive chemotherapy|elderly patients not eligible for intensive chemotherapy
5354053|NCT00235547|abortion|abortion
5354054|NCT00235547|randomized|randomized
5354055|NCT00235547|contraception|contraception
5354056|NCT00235547|pregnancy|pregnancy
5354057|NCT00235547|compliance|compliance
5354058|NCT00235547|continuation|continuation
5354059|NCT00235547|contraceptive patch|contraceptive patch
5354060|NCT00235547|transdermal hormonal contraception|transdermal hormonal contraception
5354061|NCT00235534|abortion|abortion
5354062|NCT00235534|randomized|randomized
5354063|NCT00235534|contraception|contraception
5354064|NCT00235534|pregnancy|pregnancy
5354065|NCT00235534|compliance|compliance
5354066|NCT00235534|continuation|continuation
5354067|NCT00235534|oral contraceptive pills|oral contraceptive pills
5354068|NCT00235521|Pulmonary hypertension|pulmonary hypertension
5354069|NCT00235521|Cardiac Surgery|cardiac surgery
5354070|NCT00235521|Children|children
5354071|NCT00235521|Pediatric Patients|pediatric patients
5354072|NCT00235521|Iloprost|iloprost
5354073|NCT00235521|NO|no
5354074|NCT00235521|nitric oxide|nitric oxide
5354075|NCT00235521|Pulmonary hypertension after cardiac surgery in pediatric patients, 0 - 2 years old|pulmonary hypertension after cardiac surgery in pediatric patients, 0 - 2 years old
5354076|NCT00235508|Insomnia|insomnia
5354077|NCT00235508|Anxiety|anxiety
5354078|NCT00235508|Generalized Anxiety Disorder|generalized anxiety disorder
5354079|NCT00235495|stroke|stroke
5354080|NCT00235469|PAINFUL DISTAL DIABETIC NEUROPATHY|painful distal diabetic neuropathy
5354081|NCT00235456|oxygen|oxygen
5354082|NCT00235456|surgical complications|surgical complications
5354083|NCT00235456|colo-rectal resections|colo-rectal resections
5354084|NCT00235443|Painful Distal Diabetic Neuropathy|painful distal diabetic neuropathy
5354085|NCT00235417|Bone Marrow Transplantation|bone marrow transplantation
5354086|NCT00235404|Treatment of elderly.|treatment of elderly.
5354087|NCT00235404|Nursing home.|nursing home.
5354088|NCT00235404|Rehabilitation.|rehabilitation.
5354089|NCT00235404|Readmissions.|readmissions.
5354090|NCT00235391|Deferasirox|deferasirox
5354091|NCT00235391|Congenital Anemias|congenital anemias
5354092|NCT00235391|Anemias|anemias
5354093|NCT00235391|Red Blood Cell Disorders|red blood cell disorders
5354094|NCT00235391|Chronic Iron Overload|chronic iron overload
5354095|NCT00235391|Transfusional Iron Overload|transfusional iron overload
5354096|NCT00235391|Iron Chelators|iron chelators
5354097|NCT00235391|Oral Iron Chelators|oral iron chelators
5354098|NCT00235391|Thalassemia|thalassemia
5354099|NCT00235391|Sickle Cell Disease|sickle cell disease
5354100|NCT00235391|Diamond Blackfan Anemia|diamond blackfan anemia
5354101|NCT00235391|Myelofibrosis|myelofibrosis
5354102|NCT00235391|ICL670A|icl670a
5354103|NCT00235378|Lupus|lupus
5354104|NCT00235378|SLE|sle
5354105|NCT00235352|Schizphrenia|schizphrenia
5354106|NCT00235352|Cognition|cognition
5354107|NCT00235352|Negative Symptoms|negative symptoms
5354108|NCT00235339|Oxygen Consumption|oxygen consumption
5354109|NCT00235339|Exercise|exercise
5354110|NCT00235339|Rehabilitation|rehabilitation
5354111|NCT00235326|residents of Walkerton ontario at outbreak|residents of walkerton ontario at outbreak
5354112|NCT00235313|Nicotine replacement therapies|nicotine replacement therapies
5354113|NCT00235313|Smoking|smoking
5354114|NCT00235313|Smoking related diseases|smoking related diseases
5354115|NCT00235313|Saliva cotinine|saliva cotinine
5354116|NCT00235313|Dose adjustment|dose adjustment
5354117|NCT00235313|Smoker; patients with smoking related disease conditions|smoker; patients with smoking related disease conditions
5354118|NCT00235300|Anti-T cells antibodies|anti-t cells antibodies
5354119|NCT00235300|Cadaveric Donor Renal Transplantation|cadaveric donor renal transplantation
5354120|NCT00235300|Acute Renal Allograft Rejection|acute renal allograft rejection
5354121|NCT00235300|Induction Therapy|induction therapy
5354122|NCT00235287|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors
5354123|NCT00235287|type 1 angiotensin receptor antagonists|type 1 angiotensin receptor antagonists
5354124|NCT00235287|blood pressure|blood pressure
5354125|NCT00235274|Schizophrenia|schizophrenia
5354126|NCT00235274|Secretin|secretin
5354127|NCT00235261|Total hip replacement|total hip replacement
5354128|NCT00235261|Pregablin|pregablin
5354129|NCT00235261|Dexamethasone|dexamethasone
5354130|NCT00235261|Multimodal postoperative analgesia.|multimodal postoperative analgesia.
5354131|NCT00235248|TIA/Brain infarct|tia/brain infarct
5354132|NCT00235248|and plaque>4mm in the aortic arch|and plaque>4mm in the aortic arch
5354133|NCT00235248|Or peripheral embolism|or peripheral embolism
5354134|NCT00235248|and plaque>4 mm in the thoracic aorta|and plaque>4 mm in the thoracic aorta
5354135|NCT00235222|Stavudine|stavudine
5354136|NCT00235222|Reduced dose of stavudine|reduced dose of stavudine
5354137|NCT00235222|Viral load|viral load
5354138|NCT00235222|Peripheral neuropathy|peripheral neuropathy
5354139|NCT00235222|Treatment Experienced|treatment experienced
5354140|NCT00235183|plasma|plasma
5354141|NCT00235183|bleeding|bleeding
5354142|NCT00235183|liver transplantation|liver transplantation
5354143|NCT00235131|Peripheral Artery Occlusive Disease|peripheral artery occlusive disease
5354357|NCT00234091|NVP|nvp
5354144|NCT00235105|early ankylosing spondylitis|early ankylosing spondylitis
5354145|NCT00235105|spondyloarthritis|spondyloarthritis
5354146|NCT00235105|trial|trial
5354147|NCT00235105|adalimumab|adalimumab
5354148|NCT00235079|Pericarditis|pericarditis
5354149|NCT00235079|Recurrence|recurrence
5354150|NCT00235079|Therapeutics|therapeutics
5354151|NCT00235079|Prevention|prevention
5354152|NCT00235079|Colchicine|colchicine
5354153|NCT00235053|asthma|asthma
5354154|NCT00235053|candidiasis, oral|candidiasis, oral
5354155|NCT00235053|voice disorders|voice disorders
5354156|NCT00235040|Upper Respiratory Infections|upper respiratory infections
5354157|NCT00235040|Respiratory Tract Infections|respiratory tract infections
5354158|NCT00235040|Tree Number C01.539.739|tree number c01.539.739
5354159|NCT00235040|Tree Number C08.730|tree number c08.730
5354160|NCT00235040|Unique ID D012141|unique id d012141
5354161|NCT00235014|hypertension|hypertension
5354162|NCT00235014|diabetes|diabetes
5354163|NCT00235014|trandolapril|trandolapril
5354164|NCT00235014|verapamil|verapamil
5354165|NCT00235014|albuminuria|albuminuria
5354166|NCT00235001|Hypertension|hypertension
5354167|NCT00235001|Tarka|tarka
5354168|NCT00234988|Sibutramine|sibutramine
5354169|NCT00234988|Obesity|obesity
5354170|NCT00234975|Lopinavir|lopinavir
5354171|NCT00234975|Ritonavir|ritonavir
5354172|NCT00234975|Phase 4|phase 4
5354173|NCT00234975|HIV|hiv
5354174|NCT00234962|HIV Infection|hiv infection
5354175|NCT00234962|HAART|haart
5354176|NCT00234962|Lopinavir|lopinavir
5354177|NCT00234962|Ritonavir|ritonavir
5354178|NCT00234962|Treatment Experienced|treatment experienced
5354179|NCT00234962|Treatment Naive|treatment naive
5354180|NCT00234949|Cefdinir|cefdinir
5354181|NCT00234949|Cephalexin|cephalexin
5354182|NCT00234949|Skin Infection|skin infection
5354183|NCT00234936|rheumatoid arthritis|rheumatoid arthritis
5354184|NCT00234936|adalimumab|adalimumab
5354185|NCT00234936|quality of life|quality of life
5354186|NCT00234923|HIV Infection|hiv infection
5354187|NCT00234923|Kaletra|kaletra
5354188|NCT00234923|Lopinavir|lopinavir
5354189|NCT00234923|Ritonavir|ritonavir
5354190|NCT00234923|Treatment Naive|treatment naive
5354191|NCT00234910|Lopinavir|lopinavir
5354192|NCT00234910|Ritonavir|ritonavir
5354193|NCT00234910|Kaletra|kaletra
5354194|NCT00234910|Tenofovir|tenofovir
5354195|NCT00234910|HIV infection|hiv infection
5354196|NCT00234910|Treatment Naive|treatment naive
5354197|NCT00234897|adalimumab|adalimumab
5354198|NCT00234897|rheumatoid arthritis|rheumatoid arthritis
5354199|NCT00234884|rheumatoid arthritis|rheumatoid arthritis
5354200|NCT00234884|adalimumab|adalimumab
5354201|NCT00234871|Hypertension|hypertension
5354202|NCT00234871|Diabetes|diabetes
5354203|NCT00234871|Proteinuria|proteinuria
5354204|NCT00234871|Tarka|tarka
5354205|NCT00234871|Lotrel|lotrel
5354206|NCT00234858|Hypertension|hypertension
5354207|NCT00234858|Metabolic Syndrome|metabolic syndrome
5354208|NCT00234858|Tarka|tarka
5354209|NCT00234858|Hyzaar|hyzaar
5354210|NCT00234832|Obesity|obesity
5354211|NCT00234832|Sibutramine|sibutramine
5354212|NCT00234819|Menopause|menopause
5354213|NCT00234806|telehealth|telehealth
5354214|NCT00234806|telemedicine|telemedicine
5354215|NCT00234793|childhood cancer|childhood cancer
5354216|NCT00234793|intervention|intervention
5354217|NCT00234793|maternal coping|maternal coping
5354218|NCT00234793|problem solving skills|problem solving skills
5354219|NCT00234793|anxiety|anxiety
5354220|NCT00234793|cope|cope
5354221|NCT00234793|problem solving|problem solving
5354222|NCT00234780|acute home care|acute home care
5354223|NCT00234767|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
5354224|NCT00234767|ARDS|ards
5354225|NCT00234767|Acute Lung Injury|acute lung injury
5354226|NCT00234767|ALI|ali
5354227|NCT00234767|Cost-effectiveness|cost-effectiveness
5354228|NCT00234767|Pharmacoeconomics|pharmacoeconomics
5354229|NCT00234767|Long-term follow-up|long-term follow-up
5354230|NCT00234754|Incontinence|incontinence
5354231|NCT00234754|Surgery|surgery
5354232|NCT00234754|Trans-vaginal tape|trans-vaginal tape
5354233|NCT00234754|Trans-obturator tape|trans-obturator tape
5354234|NCT00234728|psoriasis|psoriasis
5354235|NCT00234728|hydrogel|hydrogel
5354236|NCT00234728|occlusive dressing|occlusive dressing
5354237|NCT00234728|occlusion|occlusion
5354238|NCT00234728|hydrocortisone|hydrocortisone
5354239|NCT00234728|tacrolimus|tacrolimus
5354240|NCT00234728|Protopic|protopic
5354241|NCT00234728|triamcinolone|triamcinolone
5354242|NCT00234728|calcipotriene|calcipotriene
5354243|NCT00234728|Dovonex|dovonex
5354244|NCT00234728|halobetasol|halobetasol
5354245|NCT00234728|Ultravate|ultravate
5354246|NCT00234715|Breast Cancer|breast cancer
5354247|NCT00234715|Breast Cancer Risk|breast cancer risk
5354248|NCT00234715|Breast Cancer Risk Assessment|breast cancer risk assessment
5354249|NCT00234715|Psychosocial|psychosocial
5354250|NCT00234715|Acceptance|acceptance
5354251|NCT00234676|Parkinson disease|parkinson disease
5354252|NCT00234676|women|women
5354253|NCT00234676|postmenopause|postmenopause
5354254|NCT00234676|estrogen replacement therapy|estrogen replacement therapy
5354255|NCT00234676|clinical trials|clinical trials
5354256|NCT00234663|Cystic fibrosis|cystic fibrosis
5354257|NCT00234663|Nonsense mutation|nonsense mutation
5354258|NCT00234663|Premature stop codon|premature stop codon
5354259|NCT00234650|position change|position change
5354260|NCT00234650|adenoma|adenoma
5354261|NCT00234650|colonoscopy|colonoscopy
5354262|NCT00234637|Alzheimer's disease,|alzheimer's disease,
5354263|NCT00234637|switch,|switch,
5354264|NCT00234637|rivastigmine,|rivastigmine,
5354265|NCT00234637|memantine|memantine
5354266|NCT00234598|Pneumonia|pneumonia
5354267|NCT00234598|Dental Health|dental health
5354268|NCT00234598|Critical Care|critical care
5354269|NCT00234559|Angiogenesis|angiogenesis
5354270|NCT00234559|Post surgical dehisced wounds of the lower extremity|post surgical dehisced wounds of the lower extremity
5354271|NCT00234533|growth|growth
5354272|NCT00234533|child development|child development
5354273|NCT00234533|growth hormone|growth hormone
5354274|NCT00234533|inadequate growth hormone secretion|inadequate growth hormone secretion
5354275|NCT00234533|growth failure|growth failure
5354276|NCT00234468|Locally Advanced Non Small Cell Lung Cancer (Stage IIIA and IIIB)|locally advanced non small cell lung cancer (stage iiia and iiib)
5354277|NCT00234442|Non symptomatic brain metastases|non symptomatic brain metastases
5354278|NCT00234442|Iressa|iressa
5354279|NCT00234429|Colorectal carcinoma advanced disease|colorectal carcinoma advanced disease
5354280|NCT00234416|Pancreatic Cancer|pancreatic cancer
5354281|NCT00234416|EGF-R|egf-r
5354282|NCT00234403|Advanced breast cancer|advanced breast cancer
5354283|NCT00234403|Metastatic breast cancer|metastatic breast cancer
5354284|NCT00234403|ER positive breast cancer|er positive breast cancer
5354285|NCT00234403|PR positive breast cancer|pr positive breast cancer
5354286|NCT00234377|Schizophrenia|schizophrenia
5354287|NCT00234364|Pergolide|pergolide
5354288|NCT00234364|Ergotamine derivates|ergotamine derivates
5354289|NCT00234364|Valvular heart disease|valvular heart disease
5354290|NCT00234338|Children|children
5354291|NCT00234338|Vaccine|vaccine
5354292|NCT00234338|Prevenar|prevenar
5354293|NCT00234312|Depressive Disorders|depressive disorders
5354294|NCT00234299|Cancer|cancer
5354295|NCT00234299|Prostate|prostate
5354296|NCT00234299|Preventive Therapy|preventive therapy
5354297|NCT00234286|Palliative Care|palliative care
5354298|NCT00234286|Terminal Care|terminal care
5354299|NCT00234286|Hospice Care|hospice care
5354300|NCT00234286|Patient Care Planning|patient care planning
5354301|NCT00234286|Nursing Care Plans|nursing care plans
5354302|NCT00234286|Quality of Health Care|quality of health care
5354303|NCT00234286|Inpatients|inpatients
5354304|NCT00234286|Professional education|professional education
5354305|NCT00234286|Resuscitation orders|resuscitation orders
5354306|NCT00234286|Pastoral Care|pastoral care
5354307|NCT00234273|Adapted Physical Activity|adapted physical activity
5354308|NCT00234273|Quality of life|quality of life
5354309|NCT00234273|cardiovascular risk|cardiovascular risk
5354310|NCT00234273|teaching|teaching
5354311|NCT00234273|Directly Observed Therapy|directly observed therapy
5354312|NCT00234273|Physical activity|physical activity
5354313|NCT00234260|Genetics|genetics
5354314|NCT00234234|Biologics|biologics
5354315|NCT00234208|Complicated parapneumonic effusion|complicated parapneumonic effusion
5354316|NCT00234208|Pleural empyema|pleural empyema
5354317|NCT00234208|Intervention|intervention
5354318|NCT00234208|Medical thoracoscopy|medical thoracoscopy
5354319|NCT00234208|Chest tube drainage|chest tube drainage
5354320|NCT00234195|Breast Cancer|breast cancer
5354321|NCT00234195|Major Depressive Disorder|major depressive disorder
5354322|NCT00234182|liver cancer|liver cancer
5354323|NCT00234182|hepatectomy|hepatectomy
5354324|NCT00234182|survival|survival
5354325|NCT00234182|recurrence|recurrence
5354326|NCT00234169|Multiple Myeloma|multiple myeloma
5354327|NCT00234169|Lymphoma|lymphoma
5354328|NCT00234156|Fructose|fructose
5354329|NCT00234156|Lipogenesis|lipogenesis
5354330|NCT00234156|Triglycerides|triglycerides
5354331|NCT00234156|Dialysis|dialysis
5354332|NCT00234143|MDS|mds
5354333|NCT00234143|EPO|epo
5354334|NCT00234143|G-CSF|g-csf
5354335|NCT00234143|REGiM|regim
5354336|NCT00234130|Dialysis|dialysis
5354337|NCT00234130|Cytokines|cytokines
5354338|NCT00234130|Triglycerides|triglycerides
5354339|NCT00234130|Insulin|insulin
5354340|NCT00234104|OPC-41061|opc-41061
5354341|NCT00234104|Tolvaptan|tolvaptan
5354342|NCT00234104|Heart Failure|heart failure
5354343|NCT00234104|Edema|edema
5354344|NCT00234104|Extracellular volume expansion|extracellular volume expansion
5354345|NCT00234091|Treatment Naive|treatment naive
5354346|NCT00234091|Treatment Initiation|treatment initiation
5354347|NCT00234091|Infant|infant
5354348|NCT00234091|Preschool Child|preschool child
5354349|NCT00234091|Child|child
5354350|NCT00234091|Zidovudine|zidovudine
5354351|NCT00234091|AZT|azt
5354352|NCT00234091|Retrovir|retrovir
5354353|NCT00234091|3TC|3tc
5354354|NCT00234091|Lamivudine|lamivudine
5354355|NCT00234091|Epivir|epivir
5354356|NCT00234091|Nevirapine|nevirapine
5354358|NCT00234091|Viramune|viramune
5354359|NCT00234091|Efavirenz|efavirenz
5354360|NCT00234091|EFV|efv
5354361|NCT00234091|Sustiva|sustiva
5354362|NCT00234091|Lopinavir/Ritonavir|lopinavir/ritonavir
5354363|NCT00234091|LPV/r|lpv/r
5354364|NCT00234091|Kaletra|kaletra
5354365|NCT00234091|Nelfinavir|nelfinavir
5354366|NCT00234091|NFV|nfv
5354367|NCT00234091|Viracept|viracept
5354368|NCT00234091|ABC|abc
5354369|NCT00234091|Abacavir|abacavir
5354370|NCT00234091|Ziagen|ziagen
5354371|NCT00234078|OPC-12759|opc-12759
5354372|NCT00234078|Dry eye syndromes|dry eye syndromes
5354373|NCT00234052|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5354374|NCT00234052|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5354375|NCT00234052|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5354376|NCT00234052|adenocarcinoma of the lung|adenocarcinoma of the lung
5354377|NCT00234052|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
5354378|NCT00234052|large cell lung cancer|large cell lung cancer
5354379|NCT00234039|recurrent bladder cancer|recurrent bladder cancer
5354380|NCT00234039|stage 0 bladder cancer|stage 0 bladder cancer
5354381|NCT00234039|stage I bladder cancer|stage i bladder cancer
5354382|NCT00234039|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
5354383|NCT00234026|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5354384|NCT00234026|stage I mantle cell lymphoma|stage i mantle cell lymphoma
5354385|NCT00234026|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
5354386|NCT00234026|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5354387|NCT00234026|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5354388|NCT00234026|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5354389|NCT00234000|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
5354390|NCT00234000|refractory anemia with excess blasts|refractory anemia with excess blasts
5354391|NCT00234000|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
5354392|NCT00234000|refractory anemia|refractory anemia
5354393|NCT00234000|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5354394|NCT00234000|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5354395|NCT00234000|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5354396|NCT00234000|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5354397|NCT00233987|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5354398|NCT00233974|stage IIIA breast cancer|stage iiia breast cancer
5354399|NCT00233974|stage IIIB breast cancer|stage iiib breast cancer
5354400|NCT00233974|stage IIIC breast cancer|stage iiic breast cancer
5354401|NCT00233974|stage IV breast cancer|stage iv breast cancer
5354402|NCT00233961|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5354403|NCT00233922|orbit|orbit
5354404|NCT00233922|orbital|orbital
5354405|NCT00233922|trauma|trauma
5354406|NCT00233922|fractures|fractures
5354407|NCT00233922|facial|facial
5354408|NCT00233909|Leukemia, Myeloid|leukemia, myeloid
5354409|NCT00233909|Relapse|relapse
5354410|NCT00233909|Chemotherapy|chemotherapy
5354411|NCT00233909|Zosuquidar|zosuquidar
5354412|NCT00233909|gemtuzumab ozogamicin (GO)|gemtuzumab ozogamicin (go)
5354413|NCT00233896|Hematopoietic cell transplant|hematopoietic cell transplant
5354414|NCT00233896|Acute graft-vs.-host disease|acute graft-vs.-host disease
5354415|NCT00233896|Gastrointestinal tract|gastrointestinal tract
5354416|NCT00233896|Randomized trial|randomized trial
5354417|NCT00233896|Topical corticosteroid|topical corticosteroid
5354418|NCT00233896|Beclomethasone dipropionate|beclomethasone dipropionate
5354419|NCT00233896|Prednisone|prednisone
5354420|NCT00233896|Survival|survival
5354421|NCT00233857|Acute pain|acute pain
5354422|NCT00233857|postoperative pain|postoperative pain
5354423|NCT00233857|auricular acupuncture|auricular acupuncture
5354424|NCT00233844|Acute pain|acute pain
5354425|NCT00233844|pain on venipuncture|pain on venipuncture
5354426|NCT00233844|"cough-trick"|"cough-trick"
5354427|NCT00233844|distraction|distraction
5354428|NCT00233831|Postoperative pain|postoperative pain
5354429|NCT00233831|analgesia|analgesia
5354430|NCT00233831|total knee arthroplasty|total knee arthroplasty
5354431|NCT00233753|Intracranial|intracranial
5354432|NCT00233753|Wide-neck|wide-neck
5354433|NCT00233753|Saccular|saccular
5354434|NCT00233753|Aneurysms|aneurysms
5354435|NCT00233727|cervical cancer|cervical cancer
5354436|NCT00233727|cervical intraepithelial neoplasia|cervical intraepithelial neoplasia
5354437|NCT00233727|prevention|prevention
5354438|NCT00233727|cryotherapy|cryotherapy
5354439|NCT00233727|HPV testing|hpv testing
5354440|NCT00233727|cytology|cytology
5354441|NCT00233701|NPH|nph
5354442|NCT00233701|Hydrocephalus|hydrocephalus
5354443|NCT00233636|Squamous Cell Carcinoma of Head and Neck|squamous cell carcinoma of head and neck
5354444|NCT00233636|Inoperable locally advanced Squamous Cell Carcinoma of Head and Neck|inoperable locally advanced squamous cell carcinoma of head and neck
5354445|NCT00233623|Metastatic Colorectal Cancer|metastatic colorectal cancer
5354446|NCT00233610|Casodex monotherapy|casodex monotherapy
5354447|NCT00233597|anemia|anemia
5354448|NCT00233597|iron|iron
5354652|NCT00232375|SPIDDM|spiddm
5354449|NCT00233584|Children of asthmatic mothers|children of asthmatic mothers
5354450|NCT00233545|cutaneous|cutaneous
5354451|NCT00233545|leishmaniasis|leishmaniasis
5354452|NCT00233545|drug|drug
5354453|NCT00233545|miltefosine|miltefosine
5354454|NCT00233532|Hypertension|hypertension
5354455|NCT00233532|Trandolapril|trandolapril
5354456|NCT00233506|CpG 7909|cpg 7909
5354457|NCT00233506|CLL|cll
5354458|NCT00233493|dermatophytes|dermatophytes
5354459|NCT00233480|Randomized Controlled Trial|randomized controlled trial
5354460|NCT00233480|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors
5354461|NCT00233480|Sympathetic Nervous System|sympathetic nervous system
5354462|NCT00233480|Ventricular Remodeling|ventricular remodeling
5354463|NCT00233480|Chemokines|chemokines
5354464|NCT00233467|antipsychotics|antipsychotics
5354465|NCT00233467|PTSD|ptsd
5354466|NCT00233467|posttraumatic stress disorder|posttraumatic stress disorder
5354467|NCT00233441|Atrial Fibrillation|atrial fibrillation
5354468|NCT00233441|Atrial Flutter|atrial flutter
5354469|NCT00233441|Arrhythmia|arrhythmia
5354470|NCT00233441|Anti-Arrhythmia Agents|anti-arrhythmia agents
5354471|NCT00233428|Healthy volunteers|healthy volunteers
5354472|NCT00233402|Bladder Cancer|bladder cancer
5354473|NCT00233402|Hexvix|hexvix
5354474|NCT00233402|Fluorescence|fluorescence
5354475|NCT00233402|Cystoscopy|cystoscopy
5354476|NCT00233376|Decision support system|decision support system
5354477|NCT00233376|Causal probabilistic network|causal probabilistic network
5354478|NCT00233376|Antibiotics|antibiotics
5354479|NCT00233376|Antibiotic resistance|antibiotic resistance
5354480|NCT00233376|Community-acquired infections|community-acquired infections
5354481|NCT00233376|Cross-infections|cross-infections
5354482|NCT00233350|Neuronavigation|neuronavigation
5354483|NCT00233350|Ultrasound|ultrasound
5354484|NCT00233350|Brain tumour surgery|brain tumour surgery
5354485|NCT00233350|Biopsy|biopsy
5354486|NCT00233350|Histopathology|histopathology
5354487|NCT00233350|Intraoperative imaging|intraoperative imaging
5354488|NCT00233350|3D ultrasound imaging|3d ultrasound imaging
5354489|NCT00233337|Malaria, non-immune travelers|malaria, non-immune travelers
5354490|NCT00233324|NICHD Neonatal Research Network|nichd neonatal research network
5354491|NCT00233324|Extremely Low Birth Weight (ELBW)|extremely low birth weight (elbw)
5354492|NCT00233324|Very Low Birth Weight (VLBW)|very low birth weight (vlbw)
5354493|NCT00233324|Prematurity|prematurity
5354494|NCT00233324|Mechanical ventilation|mechanical ventilation
5354495|NCT00233324|Surfactant|surfactant
5354496|NCT00233324|Intubation|intubation
5354497|NCT00233324|Neurodevelopmental impairment|neurodevelopmental impairment
5354498|NCT00233324|Pulse oximetry|pulse oximetry
5354499|NCT00233324|Oxygen saturation|oxygen saturation
5354500|NCT00233324|Positive-Pressure Respiration|positive-pressure respiration
5354501|NCT00233311|high fat diet|high fat diet
5354502|NCT00233311|inflammation|inflammation
5354503|NCT00233311|inflammatory markers|inflammatory markers
5354504|NCT00233311|C-reactive protein|c-reactive protein
5354505|NCT00233311|Aging|aging
5354506|NCT00233298|Hypoglycemia|hypoglycemia
5354507|NCT00233298|Blood Sugar|blood sugar
5354508|NCT00233298|Blood Glucose Level|blood glucose level
5354509|NCT00233298|Insulin Sensitivity|insulin sensitivity
5354510|NCT00233298|Metabolism|metabolism
5354511|NCT00233298|Type 2 Diabetes|type 2 diabetes
5354512|NCT00233298|Healthy|healthy
5354513|NCT00233272|Frailty|frailty
5354514|NCT00233272|Disease Processes|disease processes
5354515|NCT00233155|Analgesics|analgesics
5354516|NCT00233155|Capsaicin|capsaicin
5354517|NCT00233155|Neuropathic pain|neuropathic pain
5354518|NCT00233155|Neuropathy|neuropathy
5354519|NCT00233155|PHN|phn
5354520|NCT00233155|Shingles|shingles
5354521|NCT00233142|Diabetes|diabetes
5354522|NCT00233142|Emotions|emotions
5354523|NCT00233142|Blood glucose|blood glucose
5354524|NCT00233142|Expressive Writing|expressive writing
5354525|NCT00233129|Day treatment|day treatment
5354526|NCT00233129|executive function|executive function
5354527|NCT00233129|problem solving|problem solving
5354528|NCT00233129|attention|attention
5354529|NCT00233129|participation|participation
5354530|NCT00233129|TBI|tbi
5354531|NCT00233129|brain injury|brain injury
5354532|NCT00233129|traumatic brain injury|traumatic brain injury
5354533|NCT00233103|Sertraline|sertraline
5354534|NCT00233103|TBI|tbi
5354535|NCT00233103|depression|depression
5354536|NCT00233103|SSRI|ssri
5354537|NCT00233103|brain injury|brain injury
5354538|NCT00233090|Fatigue|fatigue
5354539|NCT00233090|TBI|tbi
5354540|NCT00233090|brain injury|brain injury
5354541|NCT00233090|Modafinil|modafinil
5354542|NCT00233090|traumatic brain injury|traumatic brain injury
5354543|NCT00233077|breast cancer|breast cancer
5354544|NCT00233077|adjuvant treatment|adjuvant treatment
5354545|NCT00233077|racial disparities|racial disparities
5354546|NCT00233051|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
5354547|NCT00233051|Emphysema|emphysema
5354548|NCT00233051|Chronic Bronchitis|chronic bronchitis
5354549|NCT00233051|Inhaled Steroid|inhaled steroid
5354550|NCT00233051|Salmeterol|salmeterol
5354551|NCT00233038|Pancreatic cancer|pancreatic cancer
5354552|NCT00233038|Pancreatic adenoma|pancreatic adenoma
5354553|NCT00233038|Ethanol|ethanol
5354554|NCT00233038|Endoscopic ultrasound|endoscopic ultrasound
5354555|NCT00233038|Cyst ablation|cyst ablation
5354556|NCT00233012|Refractory partial-onset seizures|refractory partial-onset seizures
5354557|NCT00233012|Infants aged 1-24 months|infants aged 1-24 months
5354558|NCT00233012|Pharmacokinetics|pharmacokinetics
5354559|NCT00233012|Topiramate|topiramate
5354560|NCT00232999|Allergic asthma|allergic asthma
5354561|NCT00232999|Allergen challenge|allergen challenge
5354562|NCT00232999|Bronchial hyperresponsiveness|bronchial hyperresponsiveness
5354563|NCT00232960|oral and oropharynx carcinoma|oral and oropharynx carcinoma
5354564|NCT00232960|surgery|surgery
5354565|NCT00232960|postoperative radiotherapy|postoperative radiotherapy
5354566|NCT00232960|molecular analysis|molecular analysis
5354567|NCT00232960|microsatellite instability|microsatellite instability
5354568|NCT00232947|vaccine|vaccine
5354569|NCT00232947|elderly|elderly
5354570|NCT00232947|immunogenicity|immunogenicity
5354571|NCT00232947|safety|safety
5354572|NCT00232934|Myeloma|myeloma
5354573|NCT00232934|Thalidomide|thalidomide
5354574|NCT00232934|Diagnosis|diagnosis
5354575|NCT00232934|Elderly patients|elderly patients
5354576|NCT00232882|Hypertension|hypertension
5354577|NCT00232882|Blood pressure|blood pressure
5354578|NCT00232882|Antihypertensive drugs|antihypertensive drugs
5354579|NCT00232882|Clinical Pharmacology|clinical pharmacology
5354580|NCT00232882|Autonomic nervous system|autonomic nervous system
5354581|NCT00232882|Renin angiotensin system|renin angiotensin system
5354582|NCT00232882|Oxidative stress|oxidative stress
5354583|NCT00232882|Inflammatory markers|inflammatory markers
5354584|NCT00232843|Peripheral Artery Occlusive Disease|peripheral artery occlusive disease
5354585|NCT00232817|Postoperative pain|postoperative pain
5354586|NCT00232726|Malignant melanoma|malignant melanoma
5354587|NCT00232726|CP-4055|cp-4055
5354588|NCT00232726|Chemotherapy-naïve patients|chemotherapy-naïve patients
5354589|NCT00232726|Phase II|phase ii
5354590|NCT00232726|Chemotherapy-naive patients|chemotherapy-naive patients
5354591|NCT00232726|Metastatic malignant melanoma|metastatic malignant melanoma
5354592|NCT00232713|Birth Defects|birth defects
5354593|NCT00232713|Pregnancy|pregnancy
5354594|NCT00232713|Uterine Fibroids|uterine fibroids
5354595|NCT00232713|Fibroids|fibroids
5354596|NCT00232700|Major depressive disorder|major depressive disorder
5354597|NCT00232700|Repetitive transcranial magnetic stimulation|repetitive transcranial magnetic stimulation
5354598|NCT00232674|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5354599|NCT00232635|RSV|rsv
5354600|NCT00232635|HSCT|hsct
5354601|NCT00232635|HEMATOPOIETIC STEM CELL TRANSPL|hematopoietic stem cell transpl
5354602|NCT00232622|Prosthetic valve thrombosis|prosthetic valve thrombosis
5354603|NCT00232622|Fibrinolysis|fibrinolysis
5354604|NCT00232622|Streptokinase|streptokinase
5354605|NCT00232609|Wheelchair|wheelchair
5354606|NCT00232609|Exercise|exercise
5354607|NCT00232609|Cardiovascular Disease|cardiovascular disease
5354608|NCT00232596|Partial Seizures|partial seizures
5354609|NCT00232596|Anticonvulsant|anticonvulsant
5354610|NCT00232596|Complex Partial Seizures|complex partial seizures
5354611|NCT00232596|Potassium Channels|potassium channels
5354612|NCT00232596|Epilepsy|epilepsy
5354613|NCT00232583|TYpe 2 diabetes mellitus|type 2 diabetes mellitus
5354614|NCT00232583|Newly diagnosed|newly diagnosed
5354615|NCT00232583|Beta-cell function|beta-cell function
5354616|NCT00232570|sleep disturbance|sleep disturbance
5354617|NCT00232570|dementia|dementia
5354618|NCT00232557|Asthma|asthma
5354619|NCT00232557|Disease Management|disease management
5354620|NCT00232557|Telecommunications|telecommunications
5354621|NCT00232557|Health Services|health services
5354622|NCT00232557|Quality of Life|quality of life
5354623|NCT00232557|Patient Compliance|patient compliance
5354624|NCT00232544|sleep apnea, obstructive|sleep apnea, obstructive
5354625|NCT00232544|Quality of Life|quality of life
5354626|NCT00232544|Depression|depression
5354627|NCT00232544|Patient Compliance|patient compliance
5354628|NCT00232518|immune system|immune system
5354629|NCT00232518|infection|infection
5354630|NCT00232518|allergic rhinitis|allergic rhinitis
5354631|NCT00232505|recurrent breast cancer|recurrent breast cancer
5354632|NCT00232505|stage IV breast cancer|stage iv breast cancer
5354633|NCT00232492|Wisdom|wisdom
5354634|NCT00232492|Tooth|tooth
5354635|NCT00232492|Teeth|teeth
5354636|NCT00232492|Third|third
5354637|NCT00232492|Molar|molar
5354638|NCT00232466|Vertebroplasty|vertebroplasty
5354639|NCT00232466|Vertebral fracture|vertebral fracture
5354640|NCT00232466|Actonel|actonel
5354641|NCT00232466|Osteoporotic|osteoporotic
5354642|NCT00232466|vertebral|vertebral
5354643|NCT00232466|fractures|fractures
5354644|NCT00232427|Liver cirrhosis|liver cirrhosis
5354645|NCT00232427|Hemodynamics|hemodynamics
5354646|NCT00232427|Fluid balance|fluid balance
5354647|NCT00232414|bipolar|bipolar
5354648|NCT00232414|with acute depressive episode|with acute depressive episode
5354649|NCT00232401|urine|urine
5354650|NCT00232401|circadian rhythm|circadian rhythm
5354651|NCT00232388|Ejection Fraction <35%|ejection fraction <35%
5354653|NCT00232375|LADA|lada
5354654|NCT00232375|GAD antibody|gad antibody
5354655|NCT00232375|Beta cell function|beta cell function
5354656|NCT00232375|Insulin|insulin
5354657|NCT00232349|schizophrenia|schizophrenia
5354658|NCT00232349|galantamine|galantamine
5354659|NCT00232349|cholinesterase inhibitors|cholinesterase inhibitors
5354660|NCT00232349|quality of life|quality of life
5354661|NCT00232349|cognition|cognition
5354662|NCT00232336|cocaine|cocaine
5354663|NCT00232336|drug|drug
5354664|NCT00232336|substance|substance
5354665|NCT00232336|abuse|abuse
5354666|NCT00232336|addiction|addiction
5354667|NCT00232336|dependence|dependence
5354668|NCT00232336|quetiapine|quetiapine
5354669|NCT00232336|antipsychotic|antipsychotic
5354670|NCT00232336|treatment|treatment
5354671|NCT00232323|intensive care|intensive care
5354672|NCT00232323|stress|stress
5354673|NCT00232323|education|education
5354674|NCT00232323|simulation|simulation
5354675|NCT00232310|Atrial Fibrillation|atrial fibrillation
5354676|NCT00232310|Atrial Flutter|atrial flutter
5354677|NCT00232310|Electric Countershock|electric countershock
5354678|NCT00232297|Tachycardia, Ventricular|tachycardia, ventricular
5354679|NCT00232297|Ventricular Fibrillation|ventricular fibrillation
5354680|NCT00232297|Defibrillators Implantable|defibrillators implantable
5354681|NCT00232297|Arrhythmia|arrhythmia
5354682|NCT00232297|Anti-arrhythmia agents|anti-arrhythmia agents
5354683|NCT00232258|NK1 Antagonist|nk1 antagonist
5354684|NCT00232258|Inflammatory Bowel Disease|inflammatory bowel disease
5354685|NCT00232258|Mesalamine|mesalamine
5354686|NCT00232232|Atrial mechanical stunning and|atrial mechanical stunning and
5354687|NCT00232232|atrial electrical remodeling|atrial electrical remodeling
5354688|NCT00232206|NSCLC|nsclc
5354689|NCT00232206|Lung|lung
5354690|NCT00232206|Cancer|cancer
5354691|NCT00232206|Metastatic|metastatic
5354692|NCT00232206|Neoadjuvant|neoadjuvant
5354693|NCT00232206|Stage IB Non-Small Cell Lung Cancer (NSCLC)|stage ib non-small cell lung cancer (nsclc)
5354694|NCT00232206|IIA Non-Small Cell Lung Cancer (NSCLC)|iia non-small cell lung cancer (nsclc)
5354695|NCT00232206|IIB Non-Small Cell Lung Cancer (NSCLC)|iib non-small cell lung cancer (nsclc)
5354696|NCT00232206|Some IIIA Non-Small Cell Lung Cancer (NSCLC)|some iiia non-small cell lung cancer (nsclc)
5354697|NCT00232193|Multiple Sclerosis|multiple sclerosis
5354698|NCT00232193|Interferon Beta 1-a|interferon beta 1-a
5354699|NCT00232193|Pulsed steroids|pulsed steroids
5354700|NCT00232180|Open-label|open-label
5354701|NCT00232180|single arm mortality/morbidity trial eplerenone chronic systolic heart failure|single arm mortality/morbidity trial eplerenone chronic systolic heart failure
5354702|NCT00232115|Perioral Dermatitis, pimecrolimus cream|perioral dermatitis, pimecrolimus cream
5354703|NCT00232102|Dyspepsia, gastrointestinal, tegaserod|dyspepsia, gastrointestinal, tegaserod
5354704|NCT00232089|Dyspepsia, gastrointestinal, tegaserod|dyspepsia, gastrointestinal, tegaserod
5354705|NCT00232076|Atopic Dermatitis, Ciclosporin,|atopic dermatitis, ciclosporin,
5354706|NCT00232063|Atopic Dermatitis, Ciclosporin,|atopic dermatitis, ciclosporin,
5354707|NCT00232050|Asthma, IgE, Omalizumab|asthma, ige, omalizumab
5354708|NCT00232037|Dyspepsia, gastrointestinal, tegaserod|dyspepsia, gastrointestinal, tegaserod
5354709|NCT00232024|Dyspepsia, gastrointestinal, tegaserod|dyspepsia, gastrointestinal, tegaserod
5354710|NCT00232011|Atopic dermatitis, ASM981, pimecrolimus|atopic dermatitis, asm981, pimecrolimus
5354711|NCT00231998|Atopic dermatitis, ASM981, pimecrolimus|atopic dermatitis, asm981, pimecrolimus
5354712|NCT00231985|Habit-reversal Therapy|habit-reversal therapy
5354713|NCT00231985|Behavior Therapy|behavior therapy
5354714|NCT00231985|Supportive Therapy|supportive therapy
5354715|NCT00231972|HIV|hiv
5354716|NCT00231972|MSM|msm
5354717|NCT00231959|Depression, Treatment-Resistant|depression, treatment-resistant
5354718|NCT00231946|gonadotropins|gonadotropins
5354719|NCT00231946|hormone therapy|hormone therapy
5354720|NCT00231946|HRT|hrt
5354721|NCT00231946|Antigonadotropin|antigonadotropin
5354722|NCT00231946|Leuprolide|leuprolide
5354723|NCT00231933|Person-centered Care|person-centered care
5354724|NCT00231933|Recovery|recovery
5354725|NCT00231933|Disparities|disparities
5354726|NCT00231933|Culturally Responsive Care|culturally responsive care
5354727|NCT00231933|Psychosis|psychosis
5354728|NCT00231920|Influenza, Vaccine, Infants|influenza, vaccine, infants
5354729|NCT00231907|influenza, vaccine, TIV, LAIV, booster, children|influenza, vaccine, tiv, laiv, booster, children
5354730|NCT00231894|atypical antipsychotics|atypical antipsychotics
5354731|NCT00231894|hyperglycemia|hyperglycemia
5354732|NCT00231894|triglycerides|triglycerides
5354733|NCT00231894|HDL|hdl
5354734|NCT00231894|cholesterol|cholesterol
5354735|NCT00231894|insulin resistance|insulin resistance
5354736|NCT00231894|schizophrenia|schizophrenia
5354737|NCT00231894|verbal memory|verbal memory
5354738|NCT00231881|GORD – Oesophageal sensitivity- Oesophageal permeability|gord – oesophageal sensitivity- oesophageal permeability
5354739|NCT00231868|Uterine Papillary Serous Carcinoma|uterine papillary serous carcinoma
5354740|NCT00231868|UPSC|upsc
5354741|NCT00231868|Radiation Therapy|radiation therapy
5354742|NCT00231868|Chemotherapy|chemotherapy
5354743|NCT00231855|Epithelial Ovarian Cancer|epithelial ovarian cancer
5354744|NCT00231855|Uterine Cancer|uterine cancer
5354745|NCT00231855|Prior Therapy|prior therapy
5354746|NCT00231855|Chemotherapy|chemotherapy
5354747|NCT00231855|Recurrence|recurrence
5354748|NCT00231842|Mixed Mesodermal Tumor|mixed mesodermal tumor
5354749|NCT00231842|MMT|mmt
5354750|NCT00231842|Uterine Cancer|uterine cancer
5354751|NCT00231842|Radiation Therapy|radiation therapy
5354752|NCT00231842|Chemotherapy|chemotherapy
5354753|NCT00231829|Treatment|treatment
5354754|NCT00231829|Uterine Papillary Serous Carcinoma|uterine papillary serous carcinoma
5354755|NCT00231829|Clear Cell Carcinoma|clear cell carcinoma
5354756|NCT00231829|COX-2 Inhibitors|cox-2 inhibitors
5354757|NCT00231816|Prevention of Herpes Zoster|prevention of herpes zoster
5354758|NCT00231764|Renal transplantation|renal transplantation
5354759|NCT00231764|Immunosuppression|immunosuppression
5354760|NCT00231764|Daclizumab|daclizumab
5354761|NCT00231764|GFR|gfr
5354762|NCT00231751|Hemophilia A|hemophilia a
5354763|NCT00231751|Inhibitors|inhibitors
5354764|NCT00231738|Eicosapentaenoic acid|eicosapentaenoic acid
5354765|NCT00231738|Coronary artery disease|coronary artery disease
5354766|NCT00231712|prospective analysis of immune function,|prospective analysis of immune function,
5354767|NCT00231712|spectratype|spectratype
5354768|NCT00231712|immunoscope|immunoscope
5354769|NCT00231712|TREC analysis|trec analysis
5354770|NCT00231712|solid tumor|solid tumor
5354771|NCT00231699|Prevention of Hypothermia|prevention of hypothermia
5354772|NCT00231699|Pediatric Patient|pediatric patient
5354773|NCT00231699|Cotton|cotton
5354774|NCT00231699|Plastic wrap|plastic wrap
5354775|NCT00231686|Lung function test|lung function test
5354776|NCT00231686|Physical conditioning, human|physical conditioning, human
5354777|NCT00231686|Physical fitness|physical fitness
5354778|NCT00231686|Quality of life|quality of life
5354779|NCT00231673|Diabetic peripheral polyneuropathy|diabetic peripheral polyneuropathy
5354780|NCT00231673|Electrophysiology|electrophysiology
5354781|NCT00231673|Nerve Conduction Study|nerve conduction study
5354782|NCT00231673|Neurological Examination|neurological examination
5354783|NCT00231673|Quantitative Sensory Testing|quantitative sensory testing
5354784|NCT00231673|Topiramate|topiramate
5354785|NCT00231660|Type 2 Diabetes|type 2 diabetes
5354786|NCT00231660|Obesity|obesity
5354787|NCT00231660|Metformin|metformin
5354788|NCT00231660|Hemoglobin A1c|hemoglobin a1c
5354789|NCT00231660|Adult-Onset Diabetes Mellitus (AODM)|adult-onset diabetes mellitus (aodm)
5354790|NCT00231647|Obesity|obesity
5354791|NCT00231647|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
5354792|NCT00231647|Metformin|metformin
5354793|NCT00231647|Diabetic Diet|diabetic diet
5354794|NCT00231647|Topiramate|topiramate
5354795|NCT00231647|Adult-Onset Diabetes Mellitus (AODM)|adult-onset diabetes mellitus (aodm)
5354796|NCT00231634|Obesity|obesity
5354797|NCT00231634|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
5354798|NCT00231634|HbA1c|hba1c
5354799|NCT00231634|Sulfonylurea|sulfonylurea
5354800|NCT00231634|Topiramate|topiramate
5354801|NCT00231634|Adult-Onset Diabetes Mellitus (AODM)|adult-onset diabetes mellitus (aodm)
5354802|NCT00231621|Obesity|obesity
5354803|NCT00231621|Dyslipidemia|dyslipidemia
5354804|NCT00231621|Hyperlipidemia|hyperlipidemia
5354805|NCT00231621|Triglyceride|triglyceride
5354806|NCT00231621|HDL|hdl
5354807|NCT00231621|LDL|ldl
5354808|NCT00231621|Diabetes|diabetes
5354809|NCT00231608|Obesity|obesity
5354810|NCT00231608|Abdominal Obesity|abdominal obesity
5354811|NCT00231608|Visceral Fat|visceral fat
5354812|NCT00231608|Subcutaneous Fat|subcutaneous fat
5354813|NCT00231608|Dislipidemia|dislipidemia
5354814|NCT00231608|Hypertension|hypertension
5354815|NCT00231608|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
5354816|NCT00231595|Migraine|migraine
5354817|NCT00231595|Common Migraine|common migraine
5354818|NCT00231595|Classic Migraine|classic migraine
5354819|NCT00231595|Headache|headache
5354820|NCT00231595|Topiramate|topiramate
5354821|NCT00231595|Prophylaxis|prophylaxis
5354822|NCT00231595|Prevention|prevention
5354823|NCT00231582|High-dose with autologous germ-cell tumors|high-dose with autologous germ-cell tumors
5354824|NCT00231569|LDL-cholesterol|ldl-cholesterol
5354825|NCT00231569|apoB-100|apob-100
5354826|NCT00231569|apoB-48|apob-48
5354827|NCT00231556|Epilepsy|epilepsy
5354828|NCT00231556|Seizures|seizures
5354829|NCT00231556|Parital Epilepsies|parital epilepsies
5354830|NCT00231556|Generalized Epilepsy|generalized epilepsy
5354831|NCT00231556|Tonic-Clonic Epilepsy|tonic-clonic epilepsy
5354832|NCT00231556|Topiramate|topiramate
5354833|NCT00231530|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
5354834|NCT00231530|Obesity|obesity
5354835|NCT00231530|Diabetic Diet|diabetic diet
5354836|NCT00231530|Hypertension|hypertension
5354837|NCT00231530|Hyperlipidemia|hyperlipidemia
5354838|NCT00231530|Adult-Onset Diabetes Mellitus(AODM)|adult-onset diabetes mellitus(aodm)
5354839|NCT00231504|Polymorphism P1|polymorphism p1
5354840|NCT00231504|Polymorphism P2|polymorphism p2
5354841|NCT00231504|FSH Receptor|fsh receptor
5354842|NCT00231504|Antral follicle count|antral follicle count
5354843|NCT00231504|FSH receptor polymorphism|fsh receptor polymorphism
5354844|NCT00231491|Overactive bladder|overactive bladder
5354845|NCT00231491|Urgency|urgency
5354846|NCT00231491|Urge incontinence|urge incontinence
5354847|NCT00231491|Botulinum toxin A|botulinum toxin a
5354848|NCT00231491|Quality of life|quality of life
5354849|NCT00231465|elderly|elderly
5354850|NCT00231465|malignant pleural effusion|malignant pleural effusion
5354851|NCT00231452|natural acquired immunity,|natural acquired immunity,
5354852|NCT00231452|clinical malaria,|clinical malaria,
5354853|NCT00231452|P. falciparum,|p. falciparum,
5354854|NCT00231452|age,|age,
5354855|NCT00231452|exposure,|exposure,
5354856|NCT00231452|neonatal immunology,|neonatal immunology,
5354857|NCT00231452|infants|infants
5354858|NCT00231439|Post-polio syndrome|post-polio syndrome
5354859|NCT00231439|IvIg|ivig
5354860|NCT00231400|Glycogen Storage Disease Type II (GSD-II)|glycogen storage disease type ii (gsd-ii)
5354861|NCT00231400|GSD-II|gsd-ii
5354862|NCT00231400|Pompe Disease|pompe disease
5354863|NCT00231400|Pompe Disease (late-onset)|pompe disease (late-onset)
5354864|NCT00231400|Acid Maltase Deficiency Disease|acid maltase deficiency disease
5354865|NCT00231400|Glycogenosis II|glycogenosis ii
5354866|NCT00231387|diabetes rosiglitazone plaque|diabetes rosiglitazone plaque
5354867|NCT00231374|cerebrospinal fluid|cerebrospinal fluid
5354868|NCT00231374|pain in cervical spine|pain in cervical spine
5354869|NCT00231374|pain in lumbar spine|pain in lumbar spine
5354870|NCT00231374|myelogram|myelogram
5354871|NCT00231348|Social anxiety disorder|social anxiety disorder
5354872|NCT00231348|social phobia|social phobia
5354873|NCT00231348|positron emission tomography (PET|positron emission tomography (pet
5354874|NCT00231348|regional cerebral blood flow (rCBF)|regional cerebral blood flow (rcbf)
5354875|NCT00231348|nefazodone|nefazodone
5354876|NCT00231348|amygdala|amygdala
5354877|NCT00231335|schizophrenia|schizophrenia
5354878|NCT00231335|depression|depression
5354879|NCT00231335|anxiety|anxiety
5354880|NCT00231335|negative symptoms|negative symptoms
5354881|NCT00231322|Schistosoma haematobium|schistosoma haematobium
5354882|NCT00231322|haematuria|haematuria
5354883|NCT00231322|ultrasonography|ultrasonography
5354884|NCT00231322|Uganda|uganda
5354885|NCT00231322|Vesical polyps|vesical polyps
5354886|NCT00231309|G-CSF|g-csf
5354887|NCT00231309|Bone Marrow|bone marrow
5354888|NCT00231309|Hematologic malignancies|hematologic malignancies
5354889|NCT00231309|Non-malignancies|non-malignancies
5354890|NCT00231309|Matched sibling donor|matched sibling donor
5354891|NCT00231309|Allogeneic BMT|allogeneic bmt
5354892|NCT00231296|cryoablation|cryoablation
5354893|NCT00231296|atrial fibrillation|atrial fibrillation
5354894|NCT00231218|vitamin c|vitamin c
5354895|NCT00231218|echinacea|echinacea
5354896|NCT00231218|propolis|propolis
5354897|NCT00231218|upper respiratory tract infection|upper respiratory tract infection
5354898|NCT00231218|common cold|common cold
5354899|NCT00231218|gastroenteritis|gastroenteritis
5354900|NCT00231218|dietary supplement|dietary supplement
5354901|NCT00231218|herbal remedy|herbal remedy
5354902|NCT00231205|viability|viability
5354903|NCT00231205|myocardium|myocardium
5354904|NCT00231205|preejection velocity|preejection velocity
5354905|NCT00231205|CAD|cad
5354906|NCT00231205|echocardiography|echocardiography
5354907|NCT00231205|tissue Doppler|tissue doppler
5354908|NCT00231192|Diabetes|diabetes
5354909|NCT00231192|Adolescents|adolescents
5354910|NCT00231192|Cystic Fibrosis|cystic fibrosis
5354911|NCT00231192|Insulin|insulin
5354912|NCT00231192|Repaglinide|repaglinide
5354913|NCT00231179|child, preschool|child, preschool
5354914|NCT00231179|intelligence|intelligence
5354915|NCT00231179|environment|environment
5354916|NCT00231179|home visiting|home visiting
5354917|NCT00231166|dose-finding|dose-finding
5354918|NCT00231166|monoclonal antibody|monoclonal antibody
5354919|NCT00231166|Multiple Myeloma|multiple myeloma
5354920|NCT00231153|catheter site infection|catheter site infection
5354921|NCT00231153|catheter colonization|catheter colonization
5354922|NCT00231153|catheter related blood stream infection|catheter related blood stream infection
5354923|NCT00231153|patients with central venous catheters|patients with central venous catheters
5354924|NCT00231140|ALS, motor neuron disease|als, motor neuron disease
5354925|NCT00231127|COPD|copd
5354926|NCT00231127|Osteoporosis|osteoporosis
5354927|NCT00231127|Osteopenia|osteopenia
5354928|NCT00231127|Glucocorticoids|glucocorticoids
5354929|NCT00231127|GOLD|gold
5354930|NCT00231127|BODE|bode
5354931|NCT00231114|Asthma|asthma
5354932|NCT00231101|Smoking|smoking
5354933|NCT00231101|Schizophrenia|schizophrenia
5354934|NCT00231075|Epithelial ovary cancer F.I.G.O. stages III or IV|epithelial ovary cancer f.i.g.o. stages iii or iv
5354935|NCT00231075|70 years or older|70 years or older
5354936|NCT00231062|sinusitis|sinusitis
5354937|NCT00231062|rhinitis|rhinitis
5354938|NCT00231062|sinus surgery|sinus surgery
5354939|NCT00231062|maxillary|maxillary
5354940|NCT00231062|ethmoid|ethmoid
5354941|NCT00231062|sphenoid|sphenoid
5354942|NCT00231062|frontal|frontal
5354943|NCT00231062|FESS|fess
5354944|NCT00231062|sinuplasty|sinuplasty
5354945|NCT00231049|Genital Herpes|genital herpes
5354946|NCT00231049|HSV-2 Seropositive|hsv-2 seropositive
5354947|NCT00231049|Vaccine|vaccine
5354948|NCT00231023|Anterior Subtenon|anterior subtenon
5354949|NCT00231023|Posterior Peribulbar|posterior peribulbar
5354950|NCT00231023|Laser Photocoagulation|laser photocoagulation
5354951|NCT00231023|Diabetes|diabetes
5354952|NCT00231023|Diabetic Retinopathy|diabetic retinopathy
5354953|NCT00231023|Diabetic Macular Edema|diabetic macular edema
5354954|NCT00231023|DME|dme
5354955|NCT00231010|Retnitis Pigmentosa|retnitis pigmentosa
5354956|NCT00231010|Retinal Degeneration|retinal degeneration
5354957|NCT00231010|Retinitis Pigmentosa|retinitis pigmentosa
5354958|NCT00231010|RP|rp
5354959|NCT00231010|Usher Syndrome|usher syndrome
5354960|NCT00231010|USH|ush
5354961|NCT00231010|Bietti Crystalline Dystrophy|bietti crystalline dystrophy
5354962|NCT00231010|BCD|bcd
5354963|NCT00230997|Galantamine|galantamine
5354964|NCT00230997|Dementia with Lewy Bodies|dementia with lewy bodies
5354965|NCT00230997|Treatment|treatment
5354966|NCT00230984|Chronic Respiratory Failure|chronic respiratory failure
5354967|NCT00230984|Pulmonary Rehabilitation|pulmonary rehabilitation
5354968|NCT00230984|Nutritional Depletion|nutritional depletion
5354969|NCT00230984|Home|home
5354970|NCT00230984|COPD|copd
5354971|NCT00230984|Oral Dietary Supplements|oral dietary supplements
5354972|NCT00230984|Therapeutic Education|therapeutic education
5354973|NCT00230984|Androgens|androgens
5354974|NCT00230984|Exacerbation|exacerbation
5354975|NCT00230984|Survival|survival
5354976|NCT00230971|Intra-Abdominal Infections|intra-abdominal infections
5354977|NCT00230971|Abscess|abscess
5354978|NCT00230958|Viramidine|viramidine
5354979|NCT00230958|Ribavirin|ribavirin
5354980|NCT00230958|Valeant|valeant
5354981|NCT00230958|Hepatitis C|hepatitis c
5354982|NCT00230958|Pegylated interferon alfa-2b|pegylated interferon alfa-2b
5354983|NCT00230932|Veterans|veterans
5354984|NCT00230932|Pain|pain
5354985|NCT00230932|Palliative Care|palliative care
5354986|NCT00230932|Cardiology|cardiology
5354987|NCT00230932|Reproducibility of Results|reproducibility of results
5354988|NCT00230932|Health Personnel|health personnel
5354989|NCT00230932|Heart Failure, Congestive|heart failure, congestive
5354990|NCT00230919|Obesity,|obesity,
5354991|NCT00230919|weight loss,|weight loss,
5354992|NCT00230919|diet counseling|diet counseling
5354993|NCT00230919|low-glycemic load|low-glycemic load
5354994|NCT00230893|Antipsychotics|antipsychotics
5354995|NCT00230893|PTSD|ptsd
5354996|NCT00230893|Post Traumatic Stress Disorder|post traumatic stress disorder
5354997|NCT00230893|monotherapy|monotherapy
5354998|NCT00230893|adjunct therapy|adjunct therapy
5354999|NCT00230880|Contraception behavior|contraception behavior
5355000|NCT00230880|Condoms|condoms
5355001|NCT00230880|Unsafe sex|unsafe sex
5355002|NCT00230880|Pregnancy unwanted|pregnancy unwanted
5355003|NCT00230880|Adolescent pregnancy|adolescent pregnancy
5355004|NCT00230880|Condom use|condom use
5355005|NCT00230880|Unprotected sex|unprotected sex
5355006|NCT00230880|Unintended pregnancy|unintended pregnancy
5355007|NCT00230867|herpes labialis|herpes labialis
5355008|NCT00230867|cold sore|cold sore
5355009|NCT00230867|acyclovir|acyclovir
5355010|NCT00230867|iontophoresis|iontophoresis
5355011|NCT00230867|topical|topical
5355012|NCT00230854|hepatitis C|hepatitis c
5355013|NCT00230854|genotype 1|genotype 1
5355014|NCT00230854|non-responders|non-responders
5355015|NCT00230854|viral hepatitis|viral hepatitis
5355016|NCT00230841|croup|croup
5355017|NCT00230841|humidity therapy|humidity therapy
5355018|NCT00230841|pediatrics|pediatrics
5355019|NCT00230815|Oligoanovulatory infertility|oligoanovulatory infertility
5355020|NCT00230815|Follitropin alfa|follitropin alfa
5355021|NCT00230815|Pen device|pen device
5355022|NCT00230815|Gonal-f®|gonal-f®
5355023|NCT00230815|Recombinant Human Choriogonadotropin (r-hCG)|recombinant human choriogonadotropin (r-hcg)
5355024|NCT00230815|Ovidrel®|ovidrel®
5355025|NCT00230802|pregnancy|pregnancy
5355026|NCT00230802|hypothyroidism|hypothyroidism
5355027|NCT00230802|levothyroxine|levothyroxine
5355028|NCT00230750|influenza, elderly, vaccine, H5N1, parent protocol|influenza, elderly, vaccine, h5n1, parent protocol
5355029|NCT00230737|Aged|aged
5355030|NCT00230737|Sleep|sleep
5355031|NCT00230737|Insomnia|insomnia
5355032|NCT00230737|Melatonin|melatonin
5355033|NCT00230737|Neurobehavioral Manifestations|neurobehavioral manifestations
5355034|NCT00230737|Circadian Rhythms|circadian rhythms
5355035|NCT00230737|Human|human
5355036|NCT00230737|Polysomnography|polysomnography
5355037|NCT00230737|Elderly|elderly
5355038|NCT00230724|Exercise maintenance|exercise maintenance
5355039|NCT00230711|Physical activity|physical activity
5355040|NCT00230711|Cancer follow-up care|cancer follow-up care
5355041|NCT00230698|Epilepsy|epilepsy
5355042|NCT00230698|Partial Epilepsies|partial epilepsies
5355043|NCT00230698|Seizures|seizures
5355044|NCT00230698|Topiramate|topiramate
5355045|NCT00230685|Pulmonary arteriovenous malformations|pulmonary arteriovenous malformations
5355046|NCT00230646|cancer recovery|cancer recovery
5355047|NCT00230646|physical activity|physical activity
5355048|NCT00230607|alpha Galactosidase A|alpha galactosidase a
5355049|NCT00230607|aGAL|agal
5355050|NCT00230607|rh aGAL|rh agal
5355051|NCT00230607|Fabry|fabry
5355053|NCT00230607|Fabrazyme|fabrazyme
5355054|NCT00230607|Lysosomal Storage Disorder|lysosomal storage disorder
5355055|NCT00230607|Enzyme Replacement Therapy (ERT)|enzyme replacement therapy (ert)
5355056|NCT00230581|IBS-d, IBS|ibs-d, ibs
5355057|NCT00230568|Mild to Moderate Alzheimer's Disease|mild to moderate alzheimer's disease
5355058|NCT00230568|Hispanic|hispanic
5355059|NCT00230568|Latino|latino
5355060|NCT00230568|Spanish-speaking|spanish-speaking
5355061|NCT00230555|child, preschool|child, preschool
5355062|NCT00230555|environment|environment
5355063|NCT00230555|intelligence|intelligence
5355064|NCT00230542|platinum-sensitive recurrence|platinum-sensitive recurrence
5355065|NCT00230542|carboplatin|carboplatin
5355066|NCT00230542|pemetrexed|pemetrexed
5355067|NCT00230529|Plaque-type Psoriasis|plaque-type psoriasis
5355068|NCT00230529|infliximab|infliximab
5355069|NCT00230529|Remicade|remicade
5355070|NCT00230529|biologics|biologics
5355071|NCT00230516|N/A this study is being conducted with healthy volunteers|n/a this study is being conducted with healthy volunteers
5355072|NCT00230503|Hepatitis B, Chronic|hepatitis b, chronic
5355073|NCT00230503|Hepatitis B Virus|hepatitis b virus
5355074|NCT00230503|Pradefovir Mesylate|pradefovir mesylate
5355075|NCT00230503|Adefovir Dipivoxyl|adefovir dipivoxyl
5355076|NCT00230490|Hepatitis B, Chronic|hepatitis b, chronic
5355077|NCT00230490|Hepatitis B Virus|hepatitis b virus
5355078|NCT00230490|Pradefovir Mesylate|pradefovir mesylate
5355079|NCT00230490|Adefovir Dipivoxyl|adefovir dipivoxyl
5355080|NCT00230477|Hepatitis B|hepatitis b
5355081|NCT00230464|diabetes|diabetes
5355082|NCT00230464|rate of appearance of glucose|rate of appearance of glucose
5355083|NCT00230464|insulin secretion|insulin secretion
5355084|NCT00230464|glucagon|glucagon
5355085|NCT00230425|Alcohol Abuse|alcohol abuse
5355086|NCT00230425|Anxiety Disorders|anxiety disorders
5355087|NCT00230425|Mood Disorders|mood disorders
5355088|NCT00230412|Kidney Failure, Acute|kidney failure, acute
5355089|NCT00230412|Acute Renal Failure|acute renal failure
5355090|NCT00230412|Kidney Failure|kidney failure
5355091|NCT00230412|Heat-Shock Proteins|heat-shock proteins
5355092|NCT00230412|Children|children
5355093|NCT00230373|Localized scleroderma|localized scleroderma
5355094|NCT00230360|constipation|constipation
5355095|NCT00230360|fecal incontinence|fecal incontinence
5355096|NCT00230360|diagnosis|diagnosis
5355097|NCT00230360|children|children
5355098|NCT00230308|Head and Neck Cancer|head and neck cancer
5355099|NCT00230243|Aspergillosis|aspergillosis
5355100|NCT00230243|CandidiasisMucormycosis|candidiasismucormycosis
5355101|NCT00230243|FusariosisCryptococcosis|fusariosiscryptococcosis
5355102|NCT00230243|Endemic Fungal infections|endemic fungal infections
5355103|NCT00230243|Phaeohyphomycosis|phaeohyphomycosis
5355104|NCT00230217|Relapse|relapse
5355105|NCT00230217|Refracturing|refracturing
5355106|NCT00230217|Leukemia|leukemia
5355107|NCT00230217|Lymphoma|lymphoma
5355108|NCT00230217|Solid Tumor|solid tumor
5355109|NCT00230204|Multiple sclerosis|multiple sclerosis
5355110|NCT00230204|Antibodies|antibodies
5355111|NCT00230204|Serum|serum
5355112|NCT00230204|Infectious agents|infectious agents
5355113|NCT00230204|Immunoglobulin G|immunoglobulin g
5355114|NCT00230204|Immunoglobulin M|immunoglobulin m
5355115|NCT00230191|Oral|oral
5355116|NCT00230191|Mucositis|mucositis
5355117|NCT00230191|Stomatitis|stomatitis
5355118|NCT00230191|Head and Neck Cancer|head and neck cancer
5355119|NCT00230178|Hyperuricemia|hyperuricemia
5355120|NCT00230178|Tumor lysis syndrome|tumor lysis syndrome
5355121|NCT00230178|Leukemia|leukemia
5355122|NCT00230178|Lymphoma|lymphoma
5355123|NCT00230178|Myelodysplastic Syndromes|myelodysplastic syndromes
5355124|NCT00230178|Solid tumor cancers|solid tumor cancers
5355125|NCT00230178|Solid Tumor cancers with hyperuricemia Hyperuricemia (cancer patients only)|solid tumor cancers with hyperuricemia hyperuricemia (cancer patients only)
5355126|NCT00230178|Tumor lysis syndrome (cancer patients only)|tumor lysis syndrome (cancer patients only)
5355127|NCT00230165|Platelets|platelets
5355128|NCT00230165|Erythrocytes|erythrocytes
5355129|NCT00230165|Leukocytes|leukocytes
5355130|NCT00230165|Coagulation|coagulation
5355131|NCT00230165|Thrombosis|thrombosis
5355132|NCT00230126|African Americans|african americans
5355133|NCT00230113|NAFLD|nafld
5355134|NCT00230113|NASH|nash
5355135|NCT00230113|Fatty Liver Disease|fatty liver disease
5355136|NCT00230113|Omega-3 Fatty Acid|omega-3 fatty acid
5355137|NCT00230113|Fish oil|fish oil
5355138|NCT00230100|Gender differences|gender differences
5355139|NCT00230100|Women|women
5355140|NCT00230100|Substance use disorders|substance use disorders
5355141|NCT00230100|Alcohol use disorders|alcohol use disorders
5355142|NCT00230100|Treatment outcomes|treatment outcomes
5355143|NCT00230100|Group therapy|group therapy
5355144|NCT00230087|diabetes|diabetes
5355145|NCT00230087|nafld|nafld
5355146|NCT00230087|nash|nash
5355147|NCT00230087|phlebotomy|phlebotomy
5355148|NCT00230074|Amyotrophic Lateral Sclerosis; ALS|amyotrophic lateral sclerosis; als
5355149|NCT00230061|HIV|hiv
5355150|NCT00230009|child abuse, child neglect, substance use, violence exposure, brief intervention|child abuse, child neglect, substance use, violence exposure, brief intervention
5355151|NCT00229996|endometriosis|endometriosis
5355152|NCT00229996|pelvic pain|pelvic pain
5355153|NCT00229996|treatment|treatment
5355154|NCT00229983|Substance use disorders|substance use disorders
5355155|NCT00229983|Substance abuse|substance abuse
5355156|NCT00229983|Alcohol abuse|alcohol abuse
5355157|NCT00229983|Drug abuse|drug abuse
5355158|NCT00229957|Occupational therapy|occupational therapy
5355159|NCT00229957|Physical therapy techniques|physical therapy techniques
5355160|NCT00229957|Primary health care|primary health care
5355161|NCT00229957|Chronic disease|chronic disease
5355162|NCT00229957|Rehabilitation|rehabilitation
5355163|NCT00229957|Disease management|disease management
5355164|NCT00229957|Self care|self care
5355165|NCT00229944|Azithromycin|azithromycin
5355166|NCT00229944|V. cholerae O1 / O139|v. cholerae o1 / o139
5355167|NCT00229944|adults|adults
5355168|NCT00229944|Bangladesh|bangladesh
5355169|NCT00229944|Clinical trial|clinical trial
5355170|NCT00229931|CATARACT EXTRACTION|cataract extraction
5355171|NCT00229931|MACULAR EDEMA|macular edema
5355172|NCT00229931|DIABETES|diabetes
5355173|NCT00229931|FOCAL LASER|focal laser
5355174|NCT00229931|TRIAMCINOLONE|triamcinolone
5355175|NCT00229918|Diabetic macular edema|diabetic macular edema
5355176|NCT00229918|Clinically significant macular edema|clinically significant macular edema
5355177|NCT00229905|pediatric health|pediatric health
5355178|NCT00229905|children|children
5355179|NCT00229905|single case study|single case study
5355180|NCT00229892|pediatric health|pediatric health
5355181|NCT00229892|cardiac|cardiac
5355182|NCT00229892|small incisions|small incisions
5355183|NCT00229892|operations|operations
5355184|NCT00229892|minimally invasive|minimally invasive
5355185|NCT00229879|pediatric health|pediatric health
5355186|NCT00229879|rare tumor|rare tumor
5355187|NCT00229879|children|children
5355188|NCT00229879|cardiac|cardiac
5355189|NCT00229866|newborn|newborn
5355190|NCT00229866|pediatric health|pediatric health
5355191|NCT00229866|Feeding difficulty|feeding difficulty
5355192|NCT00229866|discharge with a NG tube|discharge with a ng tube
5355193|NCT00229866|G-tube placement|g-tube placement
5355194|NCT00229866|Nissen fundoplication|nissen fundoplication
5355195|NCT00229853|Children's Healthcare of Atlanta|children's healthcare of atlanta
5355196|NCT00229853|pediatric|pediatric
5355197|NCT00229853|Thoracoscopic Vascular ring|thoracoscopic vascular ring
5355198|NCT00229853|diverticulopexy|diverticulopexy
5355199|NCT00229853|Vascular Ring Division|vascular ring division
5355200|NCT00229840|MRI, fMRI, Epilepsy, Pediatric|mri, fmri, epilepsy, pediatric
5355201|NCT00229827|pediatric health|pediatric health
5355202|NCT00229827|cardiac|cardiac
5355203|NCT00229827|pediatric population|pediatric population
5355204|NCT00229827|congenital heart surgery|congenital heart surgery
5355205|NCT00229827|left to right shunt lesions|left to right shunt lesions
5355206|NCT00229827|heart surgery|heart surgery
5355207|NCT00229827|Atrioventricular canal defects|atrioventricular canal defects
5355208|NCT00229814|Tectal Plate Glioma|tectal plate glioma
5355209|NCT00229814|Tumor|tumor
5355210|NCT00229814|Brain|brain
5355212|NCT00229814|Spectroscopy|spectroscopy
5355213|NCT00229801|Renal Function, MRI|renal function, mri
5355214|NCT00229788|orthotopic heart transplantation|orthotopic heart transplantation
5355215|NCT00229775|Plasmodium falciparum malaria|plasmodium falciparum malaria
5355216|NCT00229775|malaria|malaria
5355217|NCT00229775|artemether lumafantrine|artemether lumafantrine
5355218|NCT00229775|chloroquine|chloroquine
5355219|NCT00229775|sulfadoxine pyrimethamine|sulfadoxine pyrimethamine
5355220|NCT00229775|Coartem|coartem
5355221|NCT00229762|pneumococcal vaccination coverage with no disease or efficacy outcomes recorded|pneumococcal vaccination coverage with no disease or efficacy outcomes recorded
5355222|NCT00229749|HCV|hcv
5355223|NCT00229723|Head and Neck Squamous Cell Carcinoma|head and neck squamous cell carcinoma
5355224|NCT00229723|Head and Neck Squamous Cell Cancer|head and neck squamous cell cancer
5355225|NCT00229723|Squamous Cell Carcinoma|squamous cell carcinoma
5355226|NCT00229723|Squamous Cell Cancer|squamous cell cancer
5355227|NCT00229710|Diabetes Mellitus, Type II|diabetes mellitus, type ii
5355228|NCT00229710|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
5355229|NCT00229697|Breast cancer|breast cancer
5355230|NCT00229697|metastatic breast cancer|metastatic breast cancer
5355231|NCT00229684|Type 2 Diabetes|type 2 diabetes
5355232|NCT00229658|diabetes|diabetes
5355233|NCT00229658|pramlintide|pramlintide
5355234|NCT00229658|Symlin|symlin
5355235|NCT00229658|Amylin|amylin
5355236|NCT00229658|phase 4|phase 4
5355237|NCT00229645|Major Depression|major depression
5355238|NCT00229645|Anxiety|anxiety
5355239|NCT00229632|Friedreich's Ataxia|friedreich's ataxia
5355240|NCT00229632|Idebenone|idebenone
5355241|NCT00229632|Ataxia|ataxia
5355242|NCT00229632|Drug Trial|drug trial
5355243|NCT00229632|Randomized Trial|randomized trial
5355244|NCT00229632|Friedreich Ataxia|friedreich ataxia
5355245|NCT00229632|FA|fa
5355246|NCT00229619|rituxan|rituxan
5355247|NCT00229619|Immunosuppression|immunosuppression
5355248|NCT00229619|Bone Marrow Failure|bone marrow failure
5355249|NCT00229619|Monoclonal Antibody Therapy|monoclonal antibody therapy
5355250|NCT00229619|Diamond Blackfan Anemia (DBA)|diamond blackfan anemia (dba)
5355251|NCT00229619|T -Cells|t -cells
5355252|NCT00229619|B-Cells|b-cells
5355253|NCT00229619|Hematopoiesis|hematopoiesis
5355254|NCT00229619|Moderate Aplastic Anemia (MAA)|moderate aplastic anemia (maa)
5355255|NCT00229619|Diamond-Blackfan Anemia|diamond-blackfan anemia
5355256|NCT00229619|DBA|dba
5355257|NCT00229619|Pure Red Cell Aplasia|pure red cell aplasia
5355258|NCT00229619|PRCA|prca
5355259|NCT00229593|Male contraception|male contraception
5355260|NCT00229593|Androgen|androgen
5355261|NCT00229593|Progestin|progestin
5355262|NCT00229593|Spermatogenesis|spermatogenesis
5355263|NCT00229593|Gonadotropin suppression|gonadotropin suppression
5355264|NCT00229593|Testosterone|testosterone
5355265|NCT00229593|Nestorone|nestorone
5355266|NCT00229580|Brief Intervention|brief intervention
5355267|NCT00229580|Motivational Interviewing|motivational interviewing
5355268|NCT00229580|Health Psychology|health psychology
5355269|NCT00229580|Alcohol|alcohol
5355270|NCT00229580|Hepatitis C|hepatitis c
5355271|NCT00229580|Patient Education|patient education
5355272|NCT00229567|ketamine|ketamine
5355273|NCT00229567|lidocaine|lidocaine
5355274|NCT00229567|postoperative ileus|postoperative ileus
5355275|NCT00229567|randomized controlled trial|randomized controlled trial
5355276|NCT00229567|acute postoperative pain|acute postoperative pain
5355277|NCT00229554|health surveys|health surveys
5355278|NCT00229554|questionnaires|questionnaires
5355279|NCT00229541|Medical in-patient rehabilitation|medical in-patient rehabilitation
5355280|NCT00229541|Gainfully employed|gainfully employed
5355281|NCT00229541|Work incapacity|work incapacity
5355282|NCT00229515|Myocardial infarction|myocardial infarction
5355283|NCT00229515|Revascularization|revascularization
5355284|NCT00229515|Stent|stent
5355285|NCT00229515|ST segment elevation|st segment elevation
5355286|NCT00229476|Depression|depression
5355287|NCT00229476|EEG|eeg
5355288|NCT00229476|QEEG|qeeg
5355289|NCT00229476|cordance|cordance
5355290|NCT00229476|Zoloft|zoloft
5355291|NCT00229476|sertraline|sertraline
5355292|NCT00229476|placebo|placebo
5355293|NCT00229476|electroencephalogram|electroencephalogram
5355294|NCT00229476|brain|brain
5355295|NCT00229476|antidepressants|antidepressants
5355296|NCT00229463|Depression|depression
5355297|NCT00229463|genetic|genetic
5355298|NCT00229463|gene|gene
5355299|NCT00229463|antidepressant|antidepressant
5355300|NCT00229463|research|research
5355301|NCT00229450|depression|depression
5355302|NCT00229450|menopause|menopause
5355303|NCT00229450|perimenopause|perimenopause
5355304|NCT00229450|mood|mood
5355305|NCT00229450|memory|memory
5355306|NCT00229450|perimenopausal|perimenopausal
5355307|NCT00229450|antidepressant|antidepressant
5355308|NCT00229450|estrogen|estrogen
5355309|NCT00229437|Diabetic Mononeuropathy|diabetic mononeuropathy
5355310|NCT00229437|Diabetic Neuralgia|diabetic neuralgia
5355311|NCT00229437|Mononeuropathy, Diabetic|mononeuropathy, diabetic
5355312|NCT00229437|Neuralgia, Diabetic|neuralgia, diabetic
5355313|NCT00229437|Diabetic Polyneuropathy|diabetic polyneuropathy
5355314|NCT00229437|Drug Therapy|drug therapy
5355315|NCT00229424|lafutidine|lafutidine
5355316|NCT00229424|reflux oesophagitis|reflux oesophagitis
5355317|NCT00229424|Gastroesophageal Reflux|gastroesophageal reflux
5355318|NCT00229424|famotidine|famotidine
5355319|NCT00229424|Double Blind|double blind
5355320|NCT00229424|Controlled Study|controlled study
5355321|NCT00229424|H2 receptor antagonist|h2 receptor antagonist
5355322|NCT00229424|H2-blocker|h2-blocker
5355323|NCT00229411|intensive care|intensive care
5355324|NCT00229411|teamwork|teamwork
5355325|NCT00229411|medical errors|medical errors
5355326|NCT00229411|education|education
5355327|NCT00229411|simulation|simulation
5355328|NCT00229333|Escitalopram|escitalopram
5355329|NCT00229333|Depression|depression
5355330|NCT00229333|Dementia|dementia
5355331|NCT00229333|Treatment|treatment
5355332|NCT00229333|Depressive Syndrome in Alzheimer’s Disease|depressive syndrome in alzheimer’s disease
5355333|NCT00229333|Depressive Syndrome in Vascular Dementia|depressive syndrome in vascular dementia
5355334|NCT00229333|Depressive Syndrome in Mixed Vascular and Alzheimer’s Dementia|depressive syndrome in mixed vascular and alzheimer’s dementia
5355335|NCT00229307|Post traumatic stress disorder|post traumatic stress disorder
5355336|NCT00229268|Healthy Volunteers|healthy volunteers
5355337|NCT00229255|Non-Alcoholic hepatic steatosis|non-alcoholic hepatic steatosis
5355338|NCT00229242|Ambulatory blood pressure monitoring|ambulatory blood pressure monitoring
5355339|NCT00229242|Echocardiography|echocardiography
5355340|NCT00229242|Diastolic function|diastolic function
5355341|NCT00229242|Left ventricular mass regression|left ventricular mass regression
5355342|NCT00229229|Obesity|obesity
5355343|NCT00229229|Cardiovascular Disease|cardiovascular disease
5355344|NCT00229229|Metabolic Syndrome|metabolic syndrome
5355345|NCT00229229|Canada Food Guide|canada food guide
5355346|NCT00229229|Glycemic Index|glycemic index
5355347|NCT00229229|Glycemic Load|glycemic load
5355348|NCT00229203|Myeloma|myeloma
5355349|NCT00229203|Aplidin|aplidin
5355350|NCT00229203|Plitidepsin|plitidepsin
5355351|NCT00229203|PharmaMar|pharmamar
5355352|NCT00229190|Nasal lavage fluid|nasal lavage fluid
5355353|NCT00229190|Eosinophils|eosinophils
5355354|NCT00229190|Reproducibility of results|reproducibility of results
5355355|NCT00229177|ONO-2506|ono-2506
5355356|NCT00229177|stroke|stroke
5355357|NCT00229177|Acute ischemic stroke|acute ischemic stroke
5355358|NCT00229164|Primary Dysmenorrhea,|primary dysmenorrhea,
5355359|NCT00229164|Transcutaneous Electric Nerve Stimulation|transcutaneous electric nerve stimulation
5355360|NCT00229138|De novo kidney recipients,|de novo kidney recipients,
5355361|NCT00229138|EC-MPS,|ec-mps,
5355362|NCT00229138|tacrolimus,|tacrolimus,
5355363|NCT00229138|efficacy,|efficacy,
5355364|NCT00229138|safety,|safety,
5355365|NCT00229138|glomerular filtration rate|glomerular filtration rate
5355366|NCT00229138|Treatment in de novo kidney recipients|treatment in de novo kidney recipients
5355367|NCT00229125|Alcohol Withdrawal Syndrome|alcohol withdrawal syndrome
5355368|NCT00229125|CIWA-Ar|ciwa-ar
5355369|NCT00229125|Acoustic Startle Procedure|acoustic startle procedure
5355370|NCT00229125|Rebound Effect|rebound effect
5355371|NCT00229073|dapoxetine|dapoxetine
5355372|NCT00229073|premature ejaculation|premature ejaculation
5355373|NCT00229073|ejaculation|ejaculation
5355374|NCT00229073|sexual dysfunction|sexual dysfunction
5355375|NCT00229073|orgasmic disorder|orgasmic disorder
5355376|NCT00229073|sexual intercourse|sexual intercourse
5355377|NCT00229060|Complicated Intra-Abdominal Infections|complicated intra-abdominal infections
5355378|NCT00229060|Appendicitis|appendicitis
5355379|NCT00229060|Cholecystitis|cholecystitis
5355380|NCT00229060|Peritonitis|peritonitis
5355381|NCT00229047|Ischemic Preconditioning|ischemic preconditioning
5355382|NCT00229047|Microvascular Perfusion|microvascular perfusion
5355383|NCT00229047|Inflammation|inflammation
5355384|NCT00229047|Ischemia and Reperfusion|ischemia and reperfusion
5355385|NCT00229047|Chronic Limb Ischemia|chronic limb ischemia
5355386|NCT00229034|Systemic Inflammation|systemic inflammation
5355387|NCT00229034|Microvascular Perfusion|microvascular perfusion
5355388|NCT00229034|Septic Shock|septic shock
5355389|NCT00229021|Complicated Urinary Tract Infection|complicated urinary tract infection
5355390|NCT00229021|Pyelonephritis|pyelonephritis
5355391|NCT00229008|Ceftobiprole medocaril|ceftobiprole medocaril
5355392|NCT00229008|Nosocomial Pneumonia|nosocomial pneumonia
5355393|NCT00229008|Ventilator-Associated Pneumonia|ventilator-associated pneumonia
5355394|NCT00229008|Cephalosporins|cephalosporins
5355395|NCT00229008|Methicillin-Resistant Staphylococcus Aureus|methicillin-resistant staphylococcus aureus
5355396|NCT00228995|Anemia|anemia
5355397|NCT00228995|Subcutaneous injection|subcutaneous injection
5355398|NCT00228995|PROCRIT|procrit
5355399|NCT00228995|Erythropoietin|erythropoietin
5355400|NCT00228995|Epoetin Alfa|epoetin alfa
5355401|NCT00228995|Hemoglobin Level|hemoglobin level
5355402|NCT00228995|Elderly|elderly
5355403|NCT00228982|Complicated Skin Infections|complicated skin infections
5355404|NCT00228982|Infectious Skin Diseases|infectious skin diseases
5355405|NCT00228982|Bacterial Skin Diseases|bacterial skin diseases
5355406|NCT00228982|Staphylococcal Skin Infections|staphylococcal skin infections
5355407|NCT00228982|Cephalosporin|cephalosporin
5355408|NCT00228956|Breast Cancer|breast cancer
5355409|NCT00228956|Aromatase Inhibitor|aromatase inhibitor
5355410|NCT00228956|Letrozole|letrozole
5355411|NCT00228956|Exemestane|exemestane
5355412|NCT00228943|Breast cancer survivorship|breast cancer survivorship
5355413|NCT00228943|Hot Flashes|hot flashes
5355414|NCT00228943|Serotonin|serotonin
5355415|NCT00228930|Breast Cancer|breast cancer
5355416|NCT00228930|Tamoxifen|tamoxifen
5355417|NCT00228930|Prevention|prevention
5355418|NCT00228917|Hib & Neisseria meningitidis serogroups A & C diseases|hib & neisseria meningitidis serogroups a & c diseases
5355419|NCT00228904|Pulsatile intravenous insulin|pulsatile intravenous insulin
5355420|NCT00228904|Oral carbohydrate loading|oral carbohydrate loading
5355421|NCT00228904|Respiratory Quotients|respiratory quotients
5355422|NCT00228904|Hypoglycemia|hypoglycemia
5355423|NCT00228904|Diabetic Neuropathy|diabetic neuropathy
5355424|NCT00228904|Diabetes Mellitus, with complications|diabetes mellitus, with complications
5355425|NCT00228891|Pulsatile intravenous insulin|pulsatile intravenous insulin
5355426|NCT00228891|Oral carbohydrate loading|oral carbohydrate loading
5355427|NCT00228891|Respiratory Quotients|respiratory quotients
5355428|NCT00228891|Hypoglycemia|hypoglycemia
5355429|NCT00228891|Diabetic Neuropathy|diabetic neuropathy
5355430|NCT00228878|Diabetes|diabetes
5355431|NCT00228878|Pulsatile intravenous insulin|pulsatile intravenous insulin
5355432|NCT00228878|Oral carbohydrate loading|oral carbohydrate loading
5355433|NCT00228878|Respiratory Quotients|respiratory quotients
5355434|NCT00228878|Hypoglycemia|hypoglycemia
5355435|NCT00228878|Diabetes Mellitus, with complications|diabetes mellitus, with complications
5355436|NCT00228865|Pulsatile intravenous insulin|pulsatile intravenous insulin
5355437|NCT00228865|Oral carbohydrate loading|oral carbohydrate loading
5355438|NCT00228865|Mindstream testing|mindstream testing
5355439|NCT00228865|Wechsler Memory Scale II|wechsler memory scale ii
5355440|NCT00228865|Respiratory Quotients|respiratory quotients
5355441|NCT00228865|Hypoglycemia|hypoglycemia
5355442|NCT00228865|Diabetes Mellitus with cognitive impairment|diabetes mellitus with cognitive impairment
5355443|NCT00228865|Diabetes Mellitus with complications|diabetes mellitus with complications
5355444|NCT00228852|Patients with severe T-cell immune deficiency diseases|patients with severe t-cell immune deficiency diseases
5355445|NCT00228839|Recipients of an allogeneic hematopoietic stem cell transplant who have acute GVHD|recipients of an allogeneic hematopoietic stem cell transplant who have acute gvhd
5355446|NCT00228696|late effects|late effects
5355447|NCT00228670|Idiopathic Pulmonary Fibrosis|idiopathic pulmonary fibrosis
5355448|NCT00228670|herpesvirus|herpesvirus
5355449|NCT00228670|lung biopsy|lung biopsy
5355450|NCT00228670|Having diagnosed lung disease|having diagnosed lung disease
5355451|NCT00228670|Scheduled to have a lung biopsy as part of the evaluation for your lung disease|scheduled to have a lung biopsy as part of the evaluation for your lung disease
5355452|NCT00228644|oxidative stress|oxidative stress
5355453|NCT00228644|amino acids|amino acids
5355454|NCT00228644|acetaminophen|acetaminophen
5355455|NCT00228644|dietary requirements|dietary requirements
5355456|NCT00228631|sickle|sickle
5355457|NCT00228631|cell|cell
5355458|NCT00228618|oxidative stress|oxidative stress
5355459|NCT00228618|amino acids|amino acids
5355460|NCT00228618|dietary requirements|dietary requirements
5355461|NCT00228605|Pain|pain
5355462|NCT00228605|Sudden Pain|sudden pain
5355463|NCT00228605|Flares|flares
5355464|NCT00228605|noncancer|noncancer
5355465|NCT00228605|low back pain|low back pain
5355466|NCT00228605|neuropathic pain|neuropathic pain
5355467|NCT00228605|osteoarthritis pain|osteoarthritis pain
5355468|NCT00228605|migraine|migraine
5355469|NCT00228605|chronic headache|chronic headache
5355470|NCT00228605|diabetic peripheral neuropathy|diabetic peripheral neuropathy
5355471|NCT00228579|diabetes|diabetes
5355472|NCT00228579|insulin resistance|insulin resistance
5355473|NCT00228488|advanced non-nasopharyngeal head and neck carcinoma|advanced non-nasopharyngeal head and neck carcinoma
5355474|NCT00228462|Schizophrenia|schizophrenia
5355475|NCT00228449|anemia|anemia
5355476|NCT00228449|chronic kidney disease|chronic kidney disease
5355477|NCT00228449|CKD|ckd
5355478|NCT00228449|chronic renal failure|chronic renal failure
5355479|NCT00228449|CRF|crf
5355480|NCT00228449|dialysis|dialysis
5355481|NCT00228449|erythropoietin|erythropoietin
5355482|NCT00228449|EPO|epo
5355483|NCT00228449|erythropoiesis stimulating agent|erythropoiesis stimulating agent
5355484|NCT00228449|ESA|esa
5355485|NCT00228449|Hematide™|hematide™
5355486|NCT00228449|hemodialysis|hemodialysis
5355487|NCT00228449|hemoglobin|hemoglobin
5355488|NCT00228449|Hb|hb
5355489|NCT00228449|Hgb|hgb
5355490|NCT00228449|Omontys|omontys
5355491|NCT00228449|peginesatide|peginesatide
5355492|NCT00228449|red blood cell|red blood cell
5355493|NCT00228449|red blood cell production|red blood cell production
5355494|NCT00228436|anemia|anemia
5355495|NCT00228436|chronic kidney disease|chronic kidney disease
5355496|NCT00228436|CKD|ckd
5355497|NCT00228436|chronic renal failure|chronic renal failure
5355498|NCT00228436|CRF|crf
5355499|NCT00228436|dialysis|dialysis
5355500|NCT00228436|erythropoietin|erythropoietin
5355501|NCT00228436|EPO|epo
5355502|NCT00228436|erythropoiesis stimulating agent|erythropoiesis stimulating agent
5355503|NCT00228436|ESA|esa
5355504|NCT00228436|Hematide™|hematide™
5355505|NCT00228436|hemoglobin|hemoglobin
5355506|NCT00228436|Hb|hb
5355507|NCT00228436|Hgb|hgb
5355508|NCT00228436|Omontys|omontys
5355509|NCT00228436|peginesatide|peginesatide
5355510|NCT00228436|red blood cell|red blood cell
5355511|NCT00228436|red blood cell production|red blood cell production
5355512|NCT00228423|Saphenous vein|saphenous vein
5355513|NCT00228423|Intimal hyperplasia|intimal hyperplasia
5355514|NCT00228423|Coronary artery bypass graft surgery|coronary artery bypass graft surgery
5355515|NCT00228423|Antiplatelet therapy|antiplatelet therapy
5355516|NCT00228423|Clopidogrel|clopidogrel
5355517|NCT00228423|Saphenous vein graft disease|saphenous vein graft disease
5355518|NCT00228410|Skin Infections|skin infections
5355519|NCT00228410|Skin Disease|skin disease
5355520|NCT00228397|Multiple Sclerosis|multiple sclerosis
5355521|NCT00228371|Epilepsy|epilepsy
5355522|NCT00228371|deep brain stimulation|deep brain stimulation
5355523|NCT00228371|Subthalamic nucleus|subthalamic nucleus
5355524|NCT00228371|Drug resistant epilepsy|drug resistant epilepsy
5355525|NCT00228345|Idiopathic Axonal Polyneuropathy|idiopathic axonal polyneuropathy
5355526|NCT00228345|abnormal OGTT|abnormal ogtt
5355527|NCT00228293|cardiac arrest|cardiac arrest
5355528|NCT00228293|CPR|cpr
5355529|NCT00228280|Apicoectomy|apicoectomy
5355530|NCT00228280|Retrograde|retrograde
5355531|NCT00228280|MTA|mta
5355532|NCT00228267|Chronic Headache|chronic headache
5355533|NCT00228267|Analgesic Rebound Headache|analgesic rebound headache
5355534|NCT00228267|Chronic Daily Headache|chronic daily headache
5355535|NCT00228267|Headache, Intractable|headache, intractable
5355536|NCT00228267|Randomised controlled trial|randomised controlled trial
5355537|NCT00228267|Propofol|propofol
5355538|NCT00228254|acute respiratory infection|acute respiratory infection
5355539|NCT00228254|acute lower respiratory infection|acute lower respiratory infection
5355540|NCT00228254|diarrhea|diarrhea
5355541|NCT00228241|Sick sinus syndrome|sick sinus syndrome
5355542|NCT00228241|AV-block|av-block
5355543|NCT00228228|Multiple Sclerosis|multiple sclerosis
5355544|NCT00228228|T-cell vaccination|t-cell vaccination
5355545|NCT00228228|Autoreactive T cells|autoreactive t cells
5355546|NCT00228215|sleep|sleep
5355547|NCT00228215|neonates|neonates
5355549|NCT00228215|behavioural intervention|behavioural intervention
5355550|NCT00228202|cytomegalovirus|cytomegalovirus
5355551|NCT00228202|CMV|cmv
5355552|NCT00228202|pregnancy|pregnancy
5355553|NCT00228202|amniotic fluid|amniotic fluid
5355554|NCT00228202|bone marrow|bone marrow
5355555|NCT00228202|transplantation|transplantation
5355556|NCT00228202|viral load|viral load
5355557|NCT00228202|glycoprotein B|glycoprotein b
5355558|NCT00228202|genotyping|genotyping
5355559|NCT00228202|PCR|pcr
5355560|NCT00228202|real-time PCR|real-time pcr
5355561|NCT00228202|CMV disease|cmv disease
5355562|NCT00228202|Congenital CMV infection|congenital cmv infection
5355563|NCT00228189|Dendritic cells|dendritic cells
5355564|NCT00228189|Colorectal cancer|colorectal cancer
5355565|NCT00228189|Carcinoembryonic antigen|carcinoembryonic antigen
5355566|NCT00228189|Vaccine|vaccine
5355567|NCT00228189|Immunotherapy|immunotherapy
5355568|NCT00228176|Metabolic syndrome|metabolic syndrome
5355569|NCT00228176|Carotid Atherosclerosis|carotid atherosclerosis
5355570|NCT00228163|Multiple Sclerosis Relapsing Remitting|multiple sclerosis relapsing remitting
5355571|NCT00228163|Secondary Progressive|secondary progressive
5355572|NCT00228163|Progressive Relapsing|progressive relapsing
5355573|NCT00228150|Parkinson Disease|parkinson disease
5355574|NCT00228150|levodopa|levodopa
5355575|NCT00228150|dopamine agonists|dopamine agonists
5355576|NCT00228124|Prostate cancer|prostate cancer
5355577|NCT00228124|Continuous androgen suppression|continuous androgen suppression
5355578|NCT00228124|Intermittent androgen suppression|intermittent androgen suppression
5355579|NCT00228124|Bone loss|bone loss
5355580|NCT00228124|Osteoporosis|osteoporosis
5355581|NCT00228111|Computed tomography|computed tomography
5355582|NCT00228111|wounds and injuries,non penetrating|wounds and injuries,non penetrating
5355583|NCT00228111|algorithms|algorithms
5355584|NCT00228111|Blunt trauma of the thorax and abdomen|blunt trauma of the thorax and abdomen
5355585|NCT00228072|Hyperhidrosis|hyperhidrosis
5355586|NCT00228072|Axillary|axillary
5355587|NCT00228072|Excision|excision
5355588|NCT00228072|Suction-curettage|suction-curettage
5355589|NCT00228072|Outcome|outcome
5355590|NCT00228059|Bipolar disorder, manic episode/treatment/licarbazepine|bipolar disorder, manic episode/treatment/licarbazepine
5355591|NCT00228046|ADHD|adhd
5355592|NCT00228046|ODD|odd
5355593|NCT00228046|Conduct Disorder|conduct disorder
5355594|NCT00228046|CD|cd
5355595|NCT00228033|Calcium|calcium
5355596|NCT00228033|Pregnancy|pregnancy
5355597|NCT00228033|Postpartum Depression|postpartum depression
5355598|NCT00228033|Depression|depression
5355599|NCT00228020|pediatric, kidney transplantation, basiliximab|pediatric, kidney transplantation, basiliximab
5355600|NCT00228007|Injection Drug Use|injection drug use
5355601|NCT00228007|HIV Risk Behavior|hiv risk behavior
5355602|NCT00228007|HIV Seronegativity|hiv seronegativity
5355603|NCT00227994|Cholinesterase Inhibitors|cholinesterase inhibitors
5355604|NCT00227994|Elderly|elderly
5355605|NCT00227994|Stroke|stroke
5355606|NCT00227994|Cognition|cognition
5355607|NCT00227981|Depression Relapse|depression relapse
5355608|NCT00227981|Maintenance Therapy|maintenance therapy
5355609|NCT00227968|Manic-depressive psychosis|manic-depressive psychosis
5355610|NCT00227968|Depression, bipolar|depression, bipolar
5355611|NCT00227955|Major depression|major depression
5355612|NCT00227942|Women|women
5355613|NCT00227942|Menopause|menopause
5355614|NCT00227942|Depression|depression
5355615|NCT00227942|Hot flash|hot flash
5355616|NCT00227942|Insomnia|insomnia
5355617|NCT00227942|Sleep Disruption|sleep disruption
5355618|NCT00227942|Estrogen Replacement Therapy|estrogen replacement therapy
5355619|NCT00227929|Major Depressive Disorder|major depressive disorder
5355620|NCT00227929|MDD|mdd
5355621|NCT00227916|alcohol, marijuana|alcohol, marijuana
5355622|NCT00227890|substance abuse|substance abuse
5355623|NCT00227877|alcohol abuse|alcohol abuse
5355624|NCT00227877|substance abuse|substance abuse
5355625|NCT00227877|substance related disorders|substance related disorders
5355626|NCT00227864|marijuana|marijuana
5355627|NCT00227864|sexual risk|sexual risk
5355628|NCT00227838|substance abuse|substance abuse
5355629|NCT00227825|Behavioral Intervention|behavioral intervention
5355630|NCT00227812|cocaine dependence|cocaine dependence
5355631|NCT00227786|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5355632|NCT00227786|tobacco use disorder|tobacco use disorder
5355633|NCT00227773|localized gastrointestinal carcinoid tumor|localized gastrointestinal carcinoid tumor
5355634|NCT00227773|metastatic gastrointestinal carcinoid tumor|metastatic gastrointestinal carcinoid tumor
5355635|NCT00227773|recurrent gastrointestinal carcinoid tumor|recurrent gastrointestinal carcinoid tumor
5355636|NCT00227773|regional gastrointestinal carcinoid tumor|regional gastrointestinal carcinoid tumor
5355637|NCT00227773|recurrent islet cell carcinoma|recurrent islet cell carcinoma
5355638|NCT00227773|gastrinoma|gastrinoma
5355639|NCT00227773|insulinoma|insulinoma
5355640|NCT00227773|WDHA syndrome|wdha syndrome
5355641|NCT00227773|glucagonoma|glucagonoma
5355642|NCT00227773|pancreatic polypeptide tumor|pancreatic polypeptide tumor
5355643|NCT00227773|somatostatinoma|somatostatinoma
5355644|NCT00227747|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5355645|NCT00227747|stage II rectal cancer|stage ii rectal cancer
5355646|NCT00227747|stage III rectal cancer|stage iii rectal cancer
5355647|NCT00227734|stage IV colon cancer|stage iv colon cancer
5355648|NCT00227734|stage IV rectal cancer|stage iv rectal cancer
5355649|NCT00227734|recurrent colon cancer|recurrent colon cancer
5355650|NCT00227734|recurrent rectal cancer|recurrent rectal cancer
5355651|NCT00227721|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5355652|NCT00227721|peritoneal cavity cancer|peritoneal cavity cancer
5355653|NCT00227708|adenocarcinoma of the lung|adenocarcinoma of the lung
5355654|NCT00227708|adenosquamous cell lung cancer|adenosquamous cell lung cancer
5355655|NCT00227708|large cell lung cancer|large cell lung cancer
5355656|NCT00227708|squamous cell lung cancer|squamous cell lung cancer
5355657|NCT00227708|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5355658|NCT00227708|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5355659|NCT00227708|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5355660|NCT00227695|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
5355661|NCT00227695|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
5355662|NCT00227695|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
5355663|NCT00227695|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5355664|NCT00227695|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5355665|NCT00227695|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5355666|NCT00227695|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5355667|NCT00227695|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5355668|NCT00227695|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5355669|NCT00227695|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
5355670|NCT00227695|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
5355671|NCT00227695|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
5355672|NCT00227695|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5355673|NCT00227695|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5355674|NCT00227695|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5355675|NCT00227695|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5355676|NCT00227695|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5355677|NCT00227695|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5355678|NCT00227682|refractory multiple myeloma|refractory multiple myeloma
5355679|NCT00227669|uterine leiomyosarcoma|uterine leiomyosarcoma
5355680|NCT00227669|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
5355681|NCT00227669|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
5355682|NCT00227669|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
5355683|NCT00227669|stage III uterine sarcoma|stage iii uterine sarcoma
5355684|NCT00227669|stage IV uterine sarcoma|stage iv uterine sarcoma
5355685|NCT00227669|recurrent uterine sarcoma|recurrent uterine sarcoma
5355686|NCT00227669|adult leiomyosarcoma|adult leiomyosarcoma
5355687|NCT00227656|stage IV breast cancer|stage iv breast cancer
5355688|NCT00227656|recurrent breast cancer|recurrent breast cancer
5355689|NCT00227656|male breast cancer|male breast cancer
5355690|NCT00227656|tumors metastatic to brain|tumors metastatic to brain
5355691|NCT00227630|epithelial mesothelioma|epithelial mesothelioma
5355692|NCT00227630|sarcomatous mesothelioma|sarcomatous mesothelioma
5355693|NCT00227630|localized malignant mesothelioma|localized malignant mesothelioma
5355694|NCT00227630|recurrent malignant mesothelioma|recurrent malignant mesothelioma
5355695|NCT00227617|recurrent gastrointestinal carcinoid tumor|recurrent gastrointestinal carcinoid tumor
5355696|NCT00227617|regional gastrointestinal carcinoid tumor|regional gastrointestinal carcinoid tumor
5355697|NCT00227617|pulmonary carcinoid tumor|pulmonary carcinoid tumor
5355698|NCT00227617|gastrinoma|gastrinoma
5355699|NCT00227617|insulinoma|insulinoma
5355700|NCT00227617|WDHA syndrome|wdha syndrome
5355701|NCT00227617|glucagonoma|glucagonoma
5355702|NCT00227617|pancreatic polypeptide tumor|pancreatic polypeptide tumor
5355703|NCT00227617|somatostatinoma|somatostatinoma
5355704|NCT00227617|recurrent islet cell carcinoma|recurrent islet cell carcinoma
5355705|NCT00227617|metastatic gastrointestinal carcinoid tumor|metastatic gastrointestinal carcinoid tumor
5355706|NCT00227565|extensive stage small cell lung cancer|extensive stage small cell lung cancer
5355707|NCT00227539|stage I non-small cell lung cancer|stage i non-small cell lung cancer
5355708|NCT00227539|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
5355709|NCT00227539|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5355710|NCT00227539|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5355711|NCT00227526|Colon|colon
5355712|NCT00227526|Surgery|surgery
5355713|NCT00227526|Prehabilitation|prehabilitation
5355714|NCT00227526|Exercise|exercise
5355715|NCT00227500|Hyperlipidaemia|hyperlipidaemia
5355716|NCT00227500|Lipid metabolism|lipid metabolism
5355717|NCT00227500|Glucose metabolism|glucose metabolism
5355718|NCT00227500|HMG CoA reductase inhibitors|hmg coa reductase inhibitors
5355719|NCT00227500|Lipodystrophy|lipodystrophy
5355720|NCT00227500|Cardiovascular disease|cardiovascular disease
5355721|NCT00227500|Treatment Experienced|treatment experienced
5355723|NCT00227487|autism|autism
5355724|NCT00227487|intestine|intestine
5355725|NCT00227487|disaccharidases|disaccharidases
5355726|NCT00227487|inflammation|inflammation
5355727|NCT00227487|permeability|permeability
5355728|NCT00227474|stage IIIB breast cancer|stage iiib breast cancer
5355729|NCT00227474|stage IIIC breast cancer|stage iiic breast cancer
5355730|NCT00227474|stage IV breast cancer|stage iv breast cancer
5355731|NCT00227461|Aphasia|aphasia
5355732|NCT00227461|Stroke|stroke
5355733|NCT00227448|Ischemic|ischemic
5355734|NCT00227448|Stroke|stroke
5355735|NCT00227422|Neisseria meningitidis serogroups A & C diseases|neisseria meningitidis serogroups a & c diseases
5355736|NCT00227422|Hib diseases|hib diseases
5355737|NCT00227409|Repeated chelation therapy|repeated chelation therapy
5355738|NCT00227409|Progressive renal insufficiency|progressive renal insufficiency
5355739|NCT00227409|Body lead burden|body lead burden
5355740|NCT00227409|Long-term outcome|long-term outcome
5355741|NCT00227409|Glomerular filtration rate|glomerular filtration rate
5355742|NCT00227383|Diabetes|diabetes
5355743|NCT00227383|gastroparesis|gastroparesis
5355744|NCT00227383|electroacupuncture|electroacupuncture
5355745|NCT00227370|Acute rejection|acute rejection
5355746|NCT00227370|Non-CMV infections|non-cmv infections
5355747|NCT00227370|Resistance|resistance
5355748|NCT00227357|HIV|hiv
5355749|NCT00227357|AIDS|aids
5355750|NCT00227357|Buprenorphine|buprenorphine
5355751|NCT00227357|Methadone|methadone
5355752|NCT00227357|Primary care|primary care
5355753|NCT00227357|dual diagnosis|dual diagnosis
5355754|NCT00227357|ptsd|ptsd
5355755|NCT00227331|Pneumonia|pneumonia
5355756|NCT00227305|Schizophrenia|schizophrenia
5355757|NCT00227305|Bipolar I Disorder|bipolar i disorder
5355758|NCT00227292|Low back pain|low back pain
5355759|NCT00227292|Depression|depression
5355760|NCT00227279|Grass pollen allergy|grass pollen allergy
5355761|NCT00227279|Hayfever|hayfever
5355762|NCT00227279|Allergen immunotherapy|allergen immunotherapy
5355763|NCT00227279|Specific immunotherapy|specific immunotherapy
5355764|NCT00227266|Spinal Muscular Atrophy (SMA)|spinal muscular atrophy (sma)
5355765|NCT00227266|SMA Type 2|sma type 2
5355766|NCT00227266|SMA Type 3|sma type 3
5355767|NCT00227253|Phenotype|phenotype
5355768|NCT00227253|Growth|growth
5355769|NCT00227253|Genotype|genotype
5355770|NCT00227253|Chromosome 18|chromosome 18
5355771|NCT00227201|African-American|african-american
5355772|NCT00227201|Hypertension|hypertension
5355773|NCT00227201|Complementary medicine|complementary medicine
5355774|NCT00227201|Medication adherence|medication adherence
5355775|NCT00227175|African American|african american
5355776|NCT00227175|Hypertension|hypertension
5355777|NCT00227175|Medication adherence|medication adherence
5355778|NCT00227175|Risk reduction|risk reduction
5355779|NCT00227162|Asthma|asthma
5355780|NCT00227162|Behavior change|behavior change
5355781|NCT00227162|Physical activity|physical activity
5355782|NCT00227162|Risk reduction|risk reduction
5355783|NCT00227149|C06.552.380.705.440|c06.552.380.705.440
5355784|NCT00227136|5Hydroxytryptamine|5hydroxytryptamine
5355785|NCT00227136|Chromogranin A|chromogranin a
5355787|NCT00227136|carcinoid|carcinoid
5355788|NCT00227123|Bipolar, cocaine, methamphetamine,quetiapine,risperidone|bipolar, cocaine, methamphetamine,quetiapine,risperidone
5355789|NCT00227110|NASH, IGT, T2DM|nash, igt, t2dm
5355790|NCT00227097|therapeutic education|therapeutic education
5355791|NCT00227097|thrombi embolic disease|thrombi embolic disease
5355792|NCT00227084|Mammary glands|mammary glands
5355793|NCT00227084|hemostasis|hemostasis
5355794|NCT00227084|Mammaplasty|mammaplasty
5355795|NCT00227071|accidental falls|accidental falls
5355796|NCT00227071|osteoporosis|osteoporosis
5355797|NCT00227071|risk factors|risk factors
5355798|NCT00227058|allergic rhinitis|allergic rhinitis
5355799|NCT00227045|Kidney Transplantation|kidney transplantation
5355800|NCT00227032|adult giant cell glioblastoma|adult giant cell glioblastoma
5355801|NCT00227032|adult gliosarcoma|adult gliosarcoma
5355802|NCT00227032|adult glioblastoma|adult glioblastoma
5355803|NCT00227032|recurrent adult brain tumor|recurrent adult brain tumor
5355804|NCT00226915|ovarian neoplasms|ovarian neoplasms
5355805|NCT00226915|randomized controlled trial|randomized controlled trial
5355806|NCT00226915|paclitaxel|paclitaxel
5355807|NCT00226915|carboplatin|carboplatin
5355808|NCT00226902|Diabetes|diabetes
5355809|NCT00226902|Hemoglobin|hemoglobin
5355810|NCT00226902|Dialysis|dialysis
5355811|NCT00226902|Vascular reactivity|vascular reactivity
5355812|NCT00226889|Scleroderma|scleroderma
5355813|NCT00226889|Fibrosis|fibrosis
5355814|NCT00226889|Therapy|therapy
5355815|NCT00226889|Bosentan|bosentan
5355816|NCT00226889|Endothelin-1|endothelin-1
5355817|NCT00226876|dreaming|dreaming
5355818|NCT00226876|anaesthesia|anaesthesia
5355819|NCT00226876|electroencephalography|electroencephalography
5355820|NCT00226876|bispectral index|bispectral index
5355821|NCT00226876|awareness|awareness
5355822|NCT00226824|Tourette's disorder|tourette's disorder
5355823|NCT00226824|tic|tic
5355824|NCT00226772|Anterior cruciate ligament reconstruction|anterior cruciate ligament reconstruction
5355825|NCT00226772|ACL reconstruction|acl reconstruction
5355826|NCT00226759|Anterior cruciate ligament reconstruction|anterior cruciate ligament reconstruction
5355827|NCT00226759|ACL reconstruction|acl reconstruction
5355828|NCT00226746|Pancreatic Cancer|pancreatic cancer
5355829|NCT00226746|Hyperfractionated Radiation Therapy|hyperfractionated radiation therapy
5355830|NCT00226746|Gemcitabine|gemcitabine
5355831|NCT00226746|Paclitaxel|paclitaxel
5355832|NCT00226746|Carcinoma, Pancreatic Ductal|carcinoma, pancreatic ductal
5355833|NCT00226733|Coronary Artery Bypass (E04.928.220.520.220)|coronary artery bypass (e04.928.220.520.220)
5355834|NCT00226733|Exercise Test [E01.370.370.380.250]|exercise test [e01.370.370.380.250]
5355835|NCT00226733|Echocardiography [E01.370.370.380.220]|echocardiography [e01.370.370.380.220]
5355836|NCT00226733|Quality of Life [K01.752.400.750]|quality of life [k01.752.400.750]
5355837|NCT00226720|alcoholism|alcoholism
5355838|NCT00226720|Alcohol dependence|alcohol dependence
5355839|NCT00226720|Detoxification|detoxification
5355840|NCT00226720|Abstinence maintain|abstinence maintain
5355841|NCT00226720|Efficacy|efficacy
5355842|NCT00226720|Ambulatory detoxification|ambulatory detoxification
5355843|NCT00226707|Chronic hand dermatitis, pimecrolimus, dermatitis|chronic hand dermatitis, pimecrolimus, dermatitis
5355844|NCT00226694|Alcoholism|alcoholism
5355845|NCT00226694|Stress|stress
5355846|NCT00226694|Gender Differences|gender differences
5355847|NCT00226694|Addiction|addiction
5355848|NCT00226694|Alcohol Dependence|alcohol dependence
5355849|NCT00226668|peritumoral brain edema|peritumoral brain edema
5355850|NCT00226668|edema|edema
5355851|NCT00226668|malignant brain tumor|malignant brain tumor
5355852|NCT00226668|astrocytoma|astrocytoma
5355853|NCT00226668|brain tumor|brain tumor
5355854|NCT00226668|dexamethasone|dexamethasone
5355855|NCT00226668|Decadron|decadron
5355856|NCT00226655|peritumoral brain edema|peritumoral brain edema
5355857|NCT00226655|edema|edema
5355858|NCT00226655|malignant brain tumor|malignant brain tumor
5355859|NCT00226655|astrocytoma|astrocytoma
5355860|NCT00226655|brain tumor|brain tumor
5355861|NCT00226655|dexamethasone|dexamethasone
5355862|NCT00226655|Decadron|decadron
5355863|NCT00226642|depression|depression
5355864|NCT00226642|primary care|primary care
5355865|NCT00226616|Zinc|zinc
5355866|NCT00226616|cholera|cholera
5355867|NCT00226616|children|children
5355868|NCT00226616|Bangladesh|bangladesh
5355869|NCT00226603|groin injury|groin injury
5355870|NCT00226603|football|football
5355871|NCT00226603|prevention|prevention
5355872|NCT00226603|traing programme|traing programme
5355873|NCT00226603|cluster randomized study|cluster randomized study
5355874|NCT00226590|non-small cell lung cancer|non-small cell lung cancer
5355875|NCT00226590|carcinoma|carcinoma
5355876|NCT00226590|unresectable|unresectable
5355877|NCT00226590|Stage IIIA|stage iiia
5355878|NCT00226590|Stage IIIB|stage iiib
5355879|NCT00226590|thoracic radiation|thoracic radiation
5355880|NCT00226577|Non-Small-Cell Lung Cancer|non-small-cell lung cancer
5355881|NCT00226577|resectable|resectable
5355882|NCT00226577|NSCLC|nsclc
5355883|NCT00226525|Restenosis, skin metal allergy|restenosis, skin metal allergy
5355884|NCT00226473|malignant Melanoma|malignant melanoma
5355885|NCT00226473|Chemotherapy|chemotherapy
5355886|NCT00226473|Metastasis|metastasis
5355887|NCT00226473|standard palliative care|standard palliative care
5355888|NCT00226473|best supportive care|best supportive care
5355889|NCT00226447|Chronic Hepatitis B|chronic hepatitis b
5355890|NCT00226447|Pegylated Interferon|pegylated interferon
5355891|NCT00226447|Lamivudine|lamivudine
5355892|NCT00226434|HIV infection|hiv infection
5355893|NCT00226434|Tuberculosis|tuberculosis
5355894|NCT00226434|Paradoxical reaction|paradoxical reaction
5355895|NCT00226434|Treatment Naive|treatment naive
5355896|NCT00226421|opioid|opioid
5355897|NCT00226421|oxymorphone|oxymorphone
5355898|NCT00226421|chronic pain|chronic pain
5355899|NCT00226421|randomized, double-blind trial|randomized, double-blind trial
5355900|NCT00226421|low back pain|low back pain
5355901|NCT00226408|melanoma,adjuvant therapy,stageIII Interferon|melanoma,adjuvant therapy,stageiii interferon
5355902|NCT00226408|high dose|high dose
5355903|NCT00226395|oxymorphone|oxymorphone
5355904|NCT00226395|acute pain|acute pain
5355905|NCT00226395|abdominal surgery|abdominal surgery
5355906|NCT00226395|opioids|opioids
5355907|NCT00226382|Chronic Hepatitis B|chronic hepatitis b
5355908|NCT00226382|Pegylated Interferon-alfa-2a|pegylated interferon-alfa-2a
5355909|NCT00226382|Pegasys|pegasys
5355910|NCT00226369|Pediatric|pediatric
5355911|NCT00226369|Cardiopulmonary bypass|cardiopulmonary bypass
5355912|NCT00226369|Congenital heart disease|congenital heart disease
5355913|NCT00226369|Reperfusion injury|reperfusion injury
5355914|NCT00226330|Patients diagnosed with type 2 diabetes who have participated in and completed the randomized, double-blind, parallel-group, multi-center study GALLANT 6.|patients diagnosed with type 2 diabetes who have participated in and completed the randomized, double-blind, parallel-group, multi-center study gallant 6.
5355915|NCT00226304|Focal Brain Lesions|focal brain lesions
5355916|NCT00226304|AIDS|aids
5355917|NCT00226304|Lymphoma|lymphoma
5355918|NCT00226304|EBV|ebv
5355919|NCT00226304|FDG-PET|fdg-pet
5355920|NCT00226304|HIV Infection|hiv infection
5355921|NCT00226304|Brain Lesion|brain lesion
5355922|NCT00226291|EBM|ebm
5355923|NCT00226291|evidence based medicine|evidence based medicine
5355924|NCT00226291|informationist|informationist
5356030|NCT00225797|safety|safety
5355925|NCT00226291|clinical medical librarian|clinical medical librarian
5355926|NCT00226265|Cardiac surgery patients|cardiac surgery patients
5355927|NCT00226265|Quality of Life|quality of life
5355928|NCT00226265|Recall bias|recall bias
5355929|NCT00226265|Aortic valve replacement|aortic valve replacement
5355930|NCT00226265|Mitral valve replacement|mitral valve replacement
5355931|NCT00226265|Tricuspid valve replacement|tricuspid valve replacement
5355932|NCT00226265|Coronary artery bypass graft surgery|coronary artery bypass graft surgery
5355933|NCT00226252|Wheelchair|wheelchair
5355934|NCT00226252|Propulsion|propulsion
5355935|NCT00226252|Biomechanics|biomechanics
5355936|NCT00226239|head|head
5355937|NCT00226239|neck|neck
5355938|NCT00226200|Allergic|allergic
5355939|NCT00226200|Non allergic|non allergic
5355940|NCT00226187|Fatty acids|fatty acids
5355941|NCT00226187|Human milk|human milk
5355942|NCT00226187|Infant development|infant development
5355943|NCT00226187|Very low birthweight infants|very low birthweight infants
5355944|NCT00226174|Curcuminoids|curcuminoids
5355945|NCT00226174|Oral Lichen Planus|oral lichen planus
5355946|NCT00226148|Implant|implant
5355947|NCT00226148|Immediate placement|immediate placement
5355948|NCT00226148|Molar tooth|molar tooth
5355949|NCT00226135|Bipolar disorder|bipolar disorder
5355950|NCT00226135|Treatment|treatment
5355951|NCT00226135|Long-term|long-term
5355952|NCT00226135|Lithium|lithium
5355953|NCT00226135|Lamotrigine|lamotrigine
5355954|NCT00226135|Randomised Clinical Trial|randomised clinical trial
5355955|NCT00226122|Enuresis|enuresis
5355956|NCT00226122|Nocturnal|nocturnal
5355957|NCT00226122|Monosymptomatic|monosymptomatic
5355958|NCT00226122|DDAVP|ddavp
5355959|NCT00226122|Indomethacin|indomethacin
5355960|NCT00226122|Randomized|randomized
5355961|NCT00226109|Alcoholism|alcoholism
5355962|NCT00226109|cardiomyopathy|cardiomyopathy
5355963|NCT00226109|skeletal muscle|skeletal muscle
5355964|NCT00226109|spironolactone|spironolactone
5355965|NCT00226109|Na,K-pumps|na,k-pumps
5355966|NCT00226109|Magnesium|magnesium
5355967|NCT00226096|Clinical Trial|clinical trial
5355968|NCT00226096|Blood Pressure|blood pressure
5355969|NCT00226096|CVA (Cerebrovascular Accident)|cva (cerebrovascular accident)
5355970|NCT00226070|selfrated health,|selfrated health,
5355971|NCT00226070|SF-36,|sf-36,
5355972|NCT00226070|rehabilitation,|rehabilitation,
5355973|NCT00226070|total hip replacement,|total hip replacement,
5355974|NCT00226070|patients above 65|patients above 65
5355975|NCT00226057|Atopic dermatitis|atopic dermatitis
5355976|NCT00226057|Raptiva|raptiva
5355977|NCT00226044|Omeprazole, suppository, infants|omeprazole, suppository, infants
5355978|NCT00226031|Osteoporosis|osteoporosis
5355979|NCT00226031|Wrist fractures|wrist fractures
5355980|NCT00226031|Knowledge translation|knowledge translation
5355981|NCT00226031|Implementation|implementation
5355982|NCT00226031|Educational reminder|educational reminder
5355983|NCT00226005|pancreas|pancreas
5355984|NCT00226005|adenocarcinoma|adenocarcinoma
5355985|NCT00226005|cancer|cancer
5355986|NCT00226005|metastatic|metastatic
5355987|NCT00226005|advanced cancer|advanced cancer
5355988|NCT00226005|Phase II|phase ii
5355989|NCT00226005|growth factor|growth factor
5355990|NCT00226005|VEGF|vegf
5355991|NCT00226005|angiogenesis|angiogenesis
5355992|NCT00225979|Acromegaly|acromegaly
5355993|NCT00225979|Untreated|untreated
5355994|NCT00225979|Newly diagnosed|newly diagnosed
5355995|NCT00225979|Octreotide LAR|octreotide lar
5355996|NCT00225979|Pituitary surgery|pituitary surgery
5355997|NCT00225966|Urinary urgency-frequency|urinary urgency-frequency
5355998|NCT00225927|invasive breast cancer|invasive breast cancer
5355999|NCT00225927|in situ breast cancer|in situ breast cancer
5356000|NCT00225927|radioguided seed localization|radioguided seed localization
5356001|NCT00225927|nonpalpable tumour|nonpalpable tumour
5356002|NCT00225927|needle localization|needle localization
5356003|NCT00225927|margin status|margin status
5356004|NCT00225914|Menopause|menopause
5356005|NCT00225914|Hormone Therapy|hormone therapy
5356006|NCT00225914|Paxil|paxil
5356007|NCT00225914|Hot Flash|hot flash
5356008|NCT00225914|Sleep Disturbance|sleep disturbance
5356009|NCT00225914|Night Sweats|night sweats
5356010|NCT00225914|Antidepressants|antidepressants
5356011|NCT00225888|Diabetes|diabetes
5356012|NCT00225888|Nutrition|nutrition
5356013|NCT00225888|Digital photography|digital photography
5356014|NCT00225888|Self-management|self-management
5356015|NCT00225875|Autoimmune thrombocytopenic purpura|autoimmune thrombocytopenic purpura
5356016|NCT00225875|Rituximab|rituximab
5356017|NCT00225862|RLS|rls
5356018|NCT00225862|Restless Legs Syndrome|restless legs syndrome
5356019|NCT00225849|Aspirin|aspirin
5356020|NCT00225849|Primary prevention|primary prevention
5356021|NCT00225836|Dysmenorrhoea|dysmenorrhoea
5356022|NCT00225836|Women|women
5356023|NCT00225836|Pain|pain
5356024|NCT00225836|TENS|tens
5356025|NCT00225823|Seasonal Allergic Rhinitis Intranasal Corticosteroid|seasonal allergic rhinitis intranasal corticosteroid
5356026|NCT00225797|chronic pain|chronic pain
5356027|NCT00225797|lower back|lower back
5356028|NCT00225797|opioid|opioid
5356029|NCT00225797|efficacy|efficacy
5356031|NCT00225784|Stage I, II, III pancreatic adenocarcinoma|stage i, ii, iii pancreatic adenocarcinoma
5356032|NCT00225784|Radiographically measurable disease|radiographically measurable disease
5356033|NCT00225758|breast cancer|breast cancer
5356034|NCT00225758|endocrine therapy|endocrine therapy
5356035|NCT00225758|drug resistance|drug resistance
5356036|NCT00225758|lapatinib|lapatinib
5356037|NCT00225758|epidermal growth factor receptor|epidermal growth factor receptor
5356038|NCT00225745|Ghrelin|ghrelin
5356039|NCT00225693|coronary artery|coronary artery
5356040|NCT00225693|restenosis|restenosis
5356041|NCT00225693|patency|patency
5356042|NCT00225693|drug eluting|drug eluting
5356043|NCT00225693|stent|stent
5356044|NCT00225680|coronary artery|coronary artery
5356045|NCT00225680|stent|stent
5356046|NCT00225680|drug eluting|drug eluting
5356047|NCT00225680|patency|patency
5356048|NCT00225680|restenosis|restenosis
5356049|NCT00225667|Atrial Fibrillation|atrial fibrillation
5356050|NCT00225667|Arrhythmia|arrhythmia
5356051|NCT00225667|Pacemaker, Artificial|pacemaker, artificial
5356052|NCT00225667|Atrial High Rate Episodes|atrial high rate episodes
5356053|NCT00225667|Electrophysiology|electrophysiology
5356054|NCT00225667|Renin-Angiotensin System|renin-angiotensin system
5356055|NCT00225667|Hypertension|hypertension
5356056|NCT00225667|Cardiac Remodeling|cardiac remodeling
5356057|NCT00225654|coronary artery|coronary artery
5356058|NCT00225654|stent|stent
5356059|NCT00225654|drug eluting|drug eluting
5356060|NCT00225654|patency|patency
5356061|NCT00225654|restenosis|restenosis
5356062|NCT00225641|Follow-up|follow-up
5356063|NCT00225628|Computerized clinical decision support|computerized clinical decision support
5356064|NCT00225628|Patient Safety|patient safety
5356065|NCT00225628|Quality of Care|quality of care
5356066|NCT00225628|Electronic Medical Records|electronic medical records
5356067|NCT00225628|Chronic Disease Management|chronic disease management
5356068|NCT00225628|Drug Monitoring|drug monitoring
5356069|NCT00225628|Guideline Adherence|guideline adherence
5356070|NCT00225628|Reminder Systems|reminder systems
5356071|NCT00225615|Phenylalanine Hydroxylase|phenylalanine hydroxylase
5356072|NCT00225602|Schizophrenia|schizophrenia
5356073|NCT00225602|Assertive community treatment|assertive community treatment
5356074|NCT00225589|Hypercholesteremia|hypercholesteremia
5356075|NCT00225576|medication errors|medication errors
5356076|NCT00225576|adverse drug events|adverse drug events
5356077|NCT00225576|electronic health records|electronic health records
5356078|NCT00225563|Electronic medical records|electronic medical records
5356079|NCT00225563|Electronic prescribing|electronic prescribing
5356080|NCT00225563|Quality measures|quality measures
5356081|NCT00225550|Cancer;|cancer;
5356082|NCT00225550|Tumors;|tumors;
5356083|NCT00225550|Neoplasms;|neoplasms;
5356084|NCT00225550|Anticarcinogenic Agents;|anticarcinogenic agents;
5356085|NCT00225550|Antineoplastic Agents;|antineoplastic agents;
5356086|NCT00225550|Cadherins|cadherins
5356087|NCT00225537|hcv|hcv
5356088|NCT00225537|hbv|hbv
5356089|NCT00225537|methylumbelliferone|methylumbelliferone
5356090|NCT00225537|liver|liver
5356091|NCT00225537|hepatitis|hepatitis
5356092|NCT00225537|viral|viral
5356093|NCT00225537|heparvit|heparvit
5356094|NCT00225537|hiv|hiv
5356095|NCT00225537|aids|aids
5356096|NCT00225524|Depression|depression
5356097|NCT00225511|Depression|depression
5356098|NCT00225485|Depression|depression
5356099|NCT00225459|Religious psychology|religious psychology
5356100|NCT00225459|Anxiety disorder|anxiety disorder
5356101|NCT00225459|Mood disorder|mood disorder
5356102|NCT00225459|Suicide|suicide
5356103|NCT00225446|Orthognathic surgery.|orthognathic surgery.
5356104|NCT00225446|optic repositioning system.|optic repositioning system.
5356105|NCT00225433|infertility|infertility
5356106|NCT00225433|in vitro fertilization|in vitro fertilization
5356107|NCT00225420|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5356108|NCT00225420|stage I prostate cancer|stage i prostate cancer
5356109|NCT00225420|stage II prostate cancer|stage ii prostate cancer
5356110|NCT00225420|stage III prostate cancer|stage iii prostate cancer
5356111|NCT00225420|stage IV prostate cancer|stage iv prostate cancer
5356112|NCT00225407|Cannabis|cannabis
5356113|NCT00225407|Tetrahydrocannabinol|tetrahydrocannabinol
5356114|NCT00225407|Pharmacokinetics|pharmacokinetics
5356115|NCT00225407|Psychomotor tests|psychomotor tests
5356116|NCT00225407|Event related potentials|event related potentials
5356117|NCT00225394|CMV|cmv
5356118|NCT00225394|Kidney Transplant|kidney transplant
5356119|NCT00225394|Pancreas Transplant|pancreas transplant
5356120|NCT00225394|Ganciclovir-resistance|ganciclovir-resistance
5356121|NCT00225394|Valganciclovir|valganciclovir
5356122|NCT00225394|CMV Disease|cmv disease
5356123|NCT00225381|Oxygen consumption|oxygen consumption
5356124|NCT00225381|CO2 production|co2 production
5356125|NCT00225381|Indirect calorimetry|indirect calorimetry
5356126|NCT00225381|Non steady state|non steady state
5356127|NCT00225381|Anesthesia monitoring|anesthesia monitoring
5356128|NCT00225381|Critical events during anesthesia|critical events during anesthesia
5356129|NCT00225381|Acid base balance|acid base balance
5356130|NCT00225381|Metabolism during anesthesia|metabolism during anesthesia
5356131|NCT00225368|Malaria|malaria
5356132|NCT00225368|All-cause mortality|all-cause mortality
5356133|NCT00225368|Africa|africa
5356134|NCT00225368|Burkina Faso|burkina faso
5356135|NCT00225355|Angina pectoris|angina pectoris
5356136|NCT00225355|Metabolic syndrome|metabolic syndrome
5356137|NCT00225355|Ischaemic heart disease|ischaemic heart disease
5356138|NCT00225342|Angina|angina
5356139|NCT00225342|Ischaemic heart disease|ischaemic heart disease
5356140|NCT00225342|Diabetes|diabetes
5356141|NCT00225329|RCT|rct
5356142|NCT00225329|intervention study|intervention study
5356143|NCT00225329|labour management|labour management
5356144|NCT00225329|assessment|assessment
5356145|NCT00225316|RCT|rct
5356146|NCT00225316|intervention study|intervention study
5356147|NCT00225316|addiction|addiction
5356148|NCT00225316|substance use|substance use
5356149|NCT00225316|pregnancy|pregnancy
5356150|NCT00225303|HIV infection|hiv infection
5356151|NCT00225303|TMC125|tmc125
5356152|NCT00225303|Non-Nucleoside reverse transcriptase inhibitor|non-nucleoside reverse transcriptase inhibitor
5356153|NCT00225303|Protease inhibitor|protease inhibitor
5356154|NCT00225303|TMC125-C227|tmc125-c227
5356155|NCT00225290|Phase III|phase iii
5356156|NCT00225290|Hepatocellular Carcinoma|hepatocellular carcinoma
5356157|NCT00225277|Glucose Metabolism Disorder|glucose metabolism disorder
5356158|NCT00225277|Dysmetabolic Syndrome|dysmetabolic syndrome
5356159|NCT00225277|Type II Diabetes|type ii diabetes
5356160|NCT00225277|Diabetes Mellitus, Lipoatrophic|diabetes mellitus, lipoatrophic
5356161|NCT00225277|Dyslipidemia|dyslipidemia
5356162|NCT00225277|Drug Therapy|drug therapy
5356163|NCT00225277|Atherosclerosis|atherosclerosis
5356164|NCT00225264|Glucose Metabolism Disorder|glucose metabolism disorder
5356165|NCT00225264|Dysmetabolic Syndrome|dysmetabolic syndrome
5356166|NCT00225264|Type II Diabetes|type ii diabetes
5356167|NCT00225264|Diabetes Mellitus, Lipoatrophic|diabetes mellitus, lipoatrophic
5356168|NCT00225264|Dyslipidemia|dyslipidemia
5356169|NCT00225264|Drug Therapy|drug therapy
5356170|NCT00225251|Dysthymic Disorder|dysthymic disorder
5356171|NCT00225251|Dysthymia|dysthymia
5356172|NCT00225251|Depression|depression
5356173|NCT00225251|Chronic Depression|chronic depression
5356174|NCT00225251|Wellbutrin XL|wellbutrin xl
5356175|NCT00225238|colonoscopy prep|colonoscopy prep
5356176|NCT00225212|non-Hodgkin's lymphoma|non-hodgkin's lymphoma
5356177|NCT00225212|diffuse large cell lymphoma|diffuse large cell lymphoma
5356178|NCT00225212|mantle cell lymphoma|mantle cell lymphoma
5356179|NCT00225212|transformed lymphoma|transformed lymphoma
5356180|NCT00225212|other subtypes of B cell lymphoma|other subtypes of b cell lymphoma
5356181|NCT00225212|recurrent lymphoma|recurrent lymphoma
5356182|NCT00225173|nodular sclerosis|nodular sclerosis
5356183|NCT00225173|lymphocyte rich|lymphocyte rich
5356184|NCT00225173|lymphocyte depleted|lymphocyte depleted
5356185|NCT00225173|mixed cellularity|mixed cellularity
5356186|NCT00225160|HIV|hiv
5356187|NCT00225160|poly neuropathy|poly neuropathy
5356188|NCT00225160|acetyl L-carnitine|acetyl l-carnitine
5356189|NCT00225160|treatment naïve|treatment naïve
5356190|NCT00225160|combination antiretroviral therapy|combination antiretroviral therapy
5356191|NCT00225160|Lipid abnormalities|lipid abnormalities
5356192|NCT00225108|Deep vein thrombosis|deep vein thrombosis
5356193|NCT00225108|bleeding|bleeding
5356194|NCT00225095|meniscectomy|meniscectomy
5356195|NCT00225095|Chondrogen|chondrogen
5356196|NCT00225095|Mesenchymal Stem Cells|mesenchymal stem cells
5356197|NCT00225095|Osiris|osiris
5356198|NCT00225082|Lipoatrophy|lipoatrophy
5356199|NCT00225082|Mitochondrial function|mitochondrial function
5356200|NCT00225082|Nucleoside analogue switch|nucleoside analogue switch
5356201|NCT00225082|Treatment Experienced|treatment experienced
5356202|NCT00225069|Facial blushing|facial blushing
5356203|NCT00225069|Sympathectomy|sympathectomy
5356204|NCT00225017|Atazanavir|atazanavir
5356205|NCT00225017|Endothelial function|endothelial function
5356206|NCT00225017|Treatment Experienced|treatment experienced
5356207|NCT00225004|Colles Fracture|colles fracture
5356208|NCT00225004|Osteoporosis|osteoporosis
5356209|NCT00225004|BMD|bmd
5356210|NCT00225004|Quality assurance|quality assurance
5356211|NCT00224991|osteoporosis|osteoporosis
5356212|NCT00224991|fall frequency|fall frequency
5356213|NCT00224991|medical treatment|medical treatment
5356214|NCT00224991|compliance|compliance
5356215|NCT00224991|quality of life|quality of life
5356216|NCT00224991|systematic education|systematic education
5356217|NCT00224965|nicotine dependence|nicotine dependence
5356218|NCT00224952|seizures|seizures
5356219|NCT00224952|Epilepsy|epilepsy
5356220|NCT00224926|Tinea Capitis|tinea capitis
5356221|NCT00224913|osteoarthritis|osteoarthritis
5356222|NCT00224913|quadriceps|quadriceps
5356223|NCT00224913|inhibition|inhibition
5356224|NCT00224913|functional outcome|functional outcome
5356225|NCT00224913|electrical stimulation|electrical stimulation
5356226|NCT00224900|Perinatally-acquired HIV infection|perinatally-acquired hiv infection
5356227|NCT00224900|Life Skills|life skills
5356228|NCT00224900|Focus Group|focus group
5356229|NCT00224900|Young adolescents|young adolescents
5356230|NCT00224900|Caregivers|caregivers
5356231|NCT00224874|Acute Graft vs Host Disease|acute graft vs host disease
5356232|NCT00224874|GVHD|gvhd
5356233|NCT00224822|Psychiatry|psychiatry
5356234|NCT00224822|Antipsychotic|antipsychotic
5356235|NCT00224822|Psychopharmacology|psychopharmacology
5356236|NCT00224822|Clinical Trial|clinical trial
5356237|NCT00224822|Open Label|open label
5356238|NCT00224822|Schizophrenia|schizophrenia
5356239|NCT00224822|Schizoaffective Disorder|schizoaffective disorder
5356240|NCT00224822|Bipolar Disorder|bipolar disorder
5356241|NCT00224822|Metabolic Syndrome|metabolic syndrome
5356242|NCT00224796|Wound closure|wound closure
5356243|NCT00224796|Foot salvage|foot salvage
5356244|NCT00224796|Accelerated healing|accelerated healing
5356245|NCT00224796|Amputation Wounds of the Diabetic Foot|amputation wounds of the diabetic foot
5356246|NCT00224757|Echocardiography|echocardiography
5356247|NCT00224744|Vulvar Neoplasms|vulvar neoplasms
5356248|NCT00224744|Skin Neoplasms|skin neoplasms
5356249|NCT00224744|Ultracision|ultracision
5356250|NCT00224744|Lymphadenectomy|lymphadenectomy
5356251|NCT00224731|Attention disorder with hyperactivity|attention disorder with hyperactivity
5356252|NCT00224731|sleep|sleep
5356253|NCT00224731|stimulants|stimulants
5356254|NCT00224731|actigraphy|actigraphy
5356255|NCT00224718|Abdominal aortic aneurysm|abdominal aortic aneurysm
5356256|NCT00224718|Endograft|endograft
5356257|NCT00224718|Open repair|open repair
5356258|NCT00224718|Endovascular repair|endovascular repair
5356259|NCT00224718|AAA|aaa
5356260|NCT00224705|Albumin dialysis|albumin dialysis
5356261|NCT00224705|MARS system|mars system
5356262|NCT00224705|Extracorporeal artificial liver support|extracorporeal artificial liver support
5356263|NCT00224705|Fulminant hepatitis|fulminant hepatitis
5356264|NCT00224705|Subfulminant hepatitis|subfulminant hepatitis
5356265|NCT00224705|Acute liver failure|acute liver failure
5356266|NCT00224692|Mucositis|mucositis
5356267|NCT00224692|Pain|pain
5356268|NCT00224692|Morphine|morphine
5356269|NCT00224692|Ketamine|ketamine
5356270|NCT00224679|Colon cancer|colon cancer
5356271|NCT00224679|Aspirin|aspirin
5356272|NCT00224679|Adenomas|adenomas
5356273|NCT00224679|Prevention|prevention
5356274|NCT00224666|Cortex stimulation ,Rebel neuropathic pains|cortex stimulation ,rebel neuropathic pains
5356275|NCT00224653|Obesity.|obesity.
5356276|NCT00224653|Respiration. Respiration, artificial.|respiration. respiration, artificial.
5356277|NCT00224653|Ventilation. Pressure controlled. Volume controlled.|ventilation. pressure controlled. volume controlled.
5356278|NCT00224640|Iron-chelating treatment|iron-chelating treatment
5356279|NCT00224627|Randomized study|randomized study
5356280|NCT00224627|Capsule endoscopy|capsule endoscopy
5356281|NCT00224627|Push enteroscopy|push enteroscopy
5356282|NCT00224627|Occult gastrointestinal bleeding|occult gastrointestinal bleeding
5356283|NCT00224627|Endoscopy|endoscopy
5356284|NCT00224614|stem cell transplantation|stem cell transplantation
5356285|NCT00224614|reduced-intensity conditioning regimen|reduced-intensity conditioning regimen
5356286|NCT00224614|acute myeloid leukemia|acute myeloid leukemia
5356287|NCT00224601|Colorectal cancer|colorectal cancer
5356288|NCT00224601|HNPCC|hnpcc
5356289|NCT00224601|Diagnosis|diagnosis
5356290|NCT00224601|Coloscopy|coloscopy
5356291|NCT00224601|Chromoscopy|chromoscopy
5356292|NCT00224601|Indigo carmine|indigo carmine
5356293|NCT00224601|Colorectal Neoplasms|colorectal neoplasms
5356294|NCT00224601|Hereditary Nonpolyposis|hereditary nonpolyposis
5356295|NCT00224588|Ketamine|ketamine
5356296|NCT00224588|Chronic post thoracotomy pain|chronic post thoracotomy pain
5356297|NCT00224588|NMDA|nmda
5356298|NCT00224588|Post operative|post operative
5356299|NCT00224575|Veterans|veterans
5356300|NCT00224562|TNF alpha antagonists|tnf alpha antagonists
5356301|NCT00224562|infections|infections
5356302|NCT00224562|lymphoma|lymphoma
5356303|NCT00224562|safety|safety
5356304|NCT00224549|Resistant hypertension|resistant hypertension
5356305|NCT00224549|Combined diuretic therapy|combined diuretic therapy
5356306|NCT00224549|Combined RAS blockers|combined ras blockers
5356307|NCT00224536|Myocardial infarction|myocardial infarction
5356308|NCT00224536|Bone marrow cells|bone marrow cells
5356309|NCT00224536|Intracoronary|intracoronary
5356310|NCT00224523|perennial allergic rhinitis|perennial allergic rhinitis
5356311|NCT00224523|nasal biopsy|nasal biopsy
5356312|NCT00224523|GW685698X|gw685698x
5356313|NCT00224510|bipolar disorder bipolar depression lamotrigine|bipolar disorder bipolar depression lamotrigine
5356314|NCT00224497|Alzheimer's disease|alzheimer's disease
5356315|NCT00224497|cognition global functioning|cognition global functioning
5356316|NCT00224497|symptomatic|symptomatic
5356317|NCT00224497|B-742457|b-742457
5356318|NCT00224484|Herpes Simplex vaccine|herpes simplex vaccine
5356319|NCT00224484|Safety|safety
5356320|NCT00224484|Adolescents|adolescents
5356321|NCT00224484|Immunogenicity|immunogenicity
5356322|NCT00224471|Adolescents|adolescents
5356323|NCT00224471|Immunogenicity|immunogenicity
5356324|NCT00224471|Safety|safety
5356325|NCT00224471|Herpes Simplex vaccine|herpes simplex vaccine
5356326|NCT00224458|Treatment Experienced|treatment experienced
5356327|NCT00224458|HIV-1|hiv-1
5356328|NCT00224445|Treatment Naive|treatment naive
5356329|NCT00224445|HIV-1|hiv-1
5356330|NCT00224432|Atopic Dermatitis|atopic dermatitis
5356331|NCT00224432|SCORAD|scorad
5356332|NCT00224432|probiotics|probiotics
5356333|NCT00224432|cytokines|cytokines
5356334|NCT00224432|Infant|infant
5356335|NCT00224419|Smoking cessation|smoking cessation
5356336|NCT00224419|Pregnancy|pregnancy
5356337|NCT00224419|Nicotine replacement therapy|nicotine replacement therapy
5356338|NCT00224419|Motivational interviewing|motivational interviewing
5356339|NCT00224406|Lung transplantation|lung transplantation
5356340|NCT00224406|Reperfusion Injury|reperfusion injury
5356341|NCT00224406|Survival|survival
5356342|NCT00224393|Amyloidosis|amyloidosis
5356343|NCT00224393|Enbrel|enbrel
5356344|NCT00224380|Serious mental illness|serious mental illness
5356345|NCT00224380|medication adherence|medication adherence
5356346|NCT00224367|fracture|fracture
5356348|NCT00224367|ambulation|ambulation
5356349|NCT00224354|LYMPHOCYTIC|lymphocytic
5356350|NCT00224354|B-LEUKEMIA|b-leukemia
5356351|NCT00224354|B-CLL|b-cll
5356352|NCT00224341|Pacemaker|pacemaker
5356353|NCT00224341|Atrial Fibrillation|atrial fibrillation
5356354|NCT00224341|Prevention pacing|prevention pacing
5356355|NCT00224341|Algorithms|algorithms
5356356|NCT00224341|Sick sinus syndrome + Atrial Fibrillation|sick sinus syndrome + atrial fibrillation
5356357|NCT00224328|Tissue Oxygen Saturation|tissue oxygen saturation
5356358|NCT00224328|Peripheral Arterial Disease|peripheral arterial disease
5356359|NCT00224328|Critical Limb Ischemia|critical limb ischemia
5356360|NCT00224328|Near-infrared Spectroscopy|near-infrared spectroscopy
5356361|NCT00224315|Schizophrenia,|schizophrenia,
5356362|NCT00224315|schizoaffective disorder,|schizoaffective disorder,
5356363|NCT00224315|treatment resistancy|treatment resistancy
5356364|NCT00224315|clozapine,|clozapine,
5356365|NCT00224315|ziprasidone|ziprasidone
5356366|NCT00224315|risperidone|risperidone
5356367|NCT00224315|combination|combination
5356368|NCT00224302|Schizophrenia,|schizophrenia,
5356369|NCT00224302|schizoaffective disorder,|schizoaffective disorder,
5356370|NCT00224302|major depressive episode,|major depressive episode,
5356371|NCT00224302|combination,|combination,
5356372|NCT00224302|duloxetine|duloxetine
5356373|NCT00224289|Latanoprost|latanoprost
5356374|NCT00224289|Glaucoma|glaucoma
5356375|NCT00224289|Intraocular pressure|intraocular pressure
5356376|NCT00224263|Traditional Chinese Medicine|traditional chinese medicine
5356377|NCT00224263|Lingzhi|lingzhi
5356378|NCT00224237|Latino patients|latino patients
5356379|NCT00224237|Health practices|health practices
5356380|NCT00224237|Culture influences|culture influences
5356381|NCT00224224|Clinical performance|clinical performance
5356382|NCT00224224|Continuity of care|continuity of care
5356383|NCT00224224|Utilization of resources|utilization of resources
5356384|NCT00224185|Healthy individuals|healthy individuals
5356385|NCT00224185|smokers|smokers
5356386|NCT00224185|ex-smokers|ex-smokers
5356387|NCT00224185|non-smokers|non-smokers
5356388|NCT00224172|Pre-hospitalization characteristics|pre-hospitalization characteristics
5356389|NCT00224172|Post-hospitalization characteristics|post-hospitalization characteristics
5356390|NCT00224172|Psychosocial measures|psychosocial measures
5356391|NCT00224172|Predict re-hospitalization|predict re-hospitalization
5356392|NCT00224159|Statin therapy|statin therapy
5356393|NCT00224159|Dietary behavior|dietary behavior
5356394|NCT00224159|Attitudes and beliefs|attitudes and beliefs
5356395|NCT00224159|Self efficacy|self efficacy
5356396|NCT00224146|Oxytrol(r)|oxytrol(r)
5356397|NCT00224146|transdermal oxybutynin|transdermal oxybutynin
5356398|NCT00224146|overactive bladder|overactive bladder
5356399|NCT00224133|benign prostatic hyperplasia, alpha blocker|benign prostatic hyperplasia, alpha blocker
5356400|NCT00224120|Benign prostatic hyperplasia, alpha blocker|benign prostatic hyperplasia, alpha blocker
5356401|NCT00224107|Benign prostatic hyperplasia, BPH, alpha blocker|benign prostatic hyperplasia, bph, alpha blocker
5356402|NCT00224094|Menopause|menopause
5356403|NCT00224094|Testosterone|testosterone
5356404|NCT00224094|Androgens|androgens
5356405|NCT00224094|Sex Hormone Binding Globulin|sex hormone binding globulin
5356406|NCT00224094|Thyroid function|thyroid function
5356407|NCT00224094|Cortisol|cortisol
5356408|NCT00224081|iron deficiency anemia|iron deficiency anemia
5356409|NCT00224081|ferritin|ferritin
5356410|NCT00224081|hemodialysis|hemodialysis
5356411|NCT00224081|sodium ferric gluconate|sodium ferric gluconate
5356412|NCT00224081|epoetin alfa|epoetin alfa
5356413|NCT00224068|Iron deficiency|iron deficiency
5356414|NCT00224068|Sodium ferric gluconate|sodium ferric gluconate
5356415|NCT00224068|anemia|anemia
5356416|NCT00224068|cancer chemotherapy|cancer chemotherapy
5356417|NCT00224068|epoetin alfa|epoetin alfa
5356418|NCT00224068|Anemia/drug therapy|anemia/drug therapy
5356419|NCT00224068|Anemia, Iron-Deficiency/drug therapy/etiology|anemia, iron-deficiency/drug therapy/etiology
5356420|NCT00224068|Hematinics/administration & dosage/pharmacology|hematinics/administration & dosage/pharmacology
5356421|NCT00224068|Antineoplastic Agents/adverse effects|antineoplastic agents/adverse effects
5356422|NCT00224068|Erythropoietin, Recombinant/therapeutic use/adverse effects|erythropoietin, recombinant/therapeutic use/adverse effects
5356423|NCT00224055|Iron deficiency|iron deficiency
5356424|NCT00224055|Anemia|anemia
5356425|NCT00224055|Chronic kidney disease|chronic kidney disease
5356426|NCT00224055|Sodium Ferric Gluconate|sodium ferric gluconate
5357109|NCT00221208|Diabetes|diabetes
5356427|NCT00224055|Anemia, Iron-Deficiency/drug therapy/etiology|anemia, iron-deficiency/drug therapy/etiology
5356428|NCT00224055|Kidney Failure, Chronic/blood/complications/therapy|kidney failure, chronic/blood/complications/therapy
5356429|NCT00224042|Iron deficiency|iron deficiency
5356430|NCT00224042|Anemia|anemia
5356431|NCT00224042|Chronic kidney disease|chronic kidney disease
5356432|NCT00224042|Erythropoietic agents|erythropoietic agents
5356433|NCT00224042|Sodium Ferric Gluconate|sodium ferric gluconate
5356434|NCT00224042|Anemia, Iron-Deficiency/drug therapy/etiology|anemia, iron-deficiency/drug therapy/etiology
5356435|NCT00224042|Kidney Failure, Chronic/blood/complications/therapy|kidney failure, chronic/blood/complications/therapy
5356436|NCT00224042|Erythropoietin, Recombinant/adverse effects/therapeutic use|erythropoietin, recombinant/adverse effects/therapeutic use
5356437|NCT00224003|Anemia|anemia
5356438|NCT00223990|Plasmodium|plasmodium
5356439|NCT00223990|falciparum|falciparum
5356440|NCT00223990|malaria|malaria
5356441|NCT00223990|vaccine|vaccine
5356442|NCT00223990|AS02A adjuvant|as02a adjuvant
5356443|NCT00223990|FMP1|fmp1
5356444|NCT00223990|Merozoite surface protein-1|merozoite surface protein-1
5356445|NCT00223977|Anemia.|anemia.
5356446|NCT00223964|Iron Deficiency|iron deficiency
5356447|NCT00223964|Anemia in Pediatric Hemodialysis|anemia in pediatric hemodialysis
5356448|NCT00223951|Healthy volunteers, safety, ocular, allergic conjunctivitis, ophthalmic|healthy volunteers, safety, ocular, allergic conjunctivitis, ophthalmic
5356449|NCT00223925|Stem cell transplantation|stem cell transplantation
5356450|NCT00223925|Allogeneic transplantation|allogeneic transplantation
5356451|NCT00223912|Cardiovascular Disease|cardiovascular disease
5356452|NCT00223912|Exercise|exercise
5356453|NCT00223912|Functional electrical stimulation|functional electrical stimulation
5356454|NCT00223912|hemostasis|hemostasis
5356455|NCT00223912|Spinal cord injury|spinal cord injury
5356456|NCT00223899|Melanoma|melanoma
5356457|NCT00223899|Electroporation|electroporation
5356458|NCT00223899|IL-2|il-2
5356459|NCT00223873|Penile Vibratory Stimulation|penile vibratory stimulation
5356460|NCT00223873|Muscles Spasticity|muscles spasticity
5356461|NCT00223873|Spasms|spasms
5356462|NCT00223873|Ferti Care Vibrator|ferti care vibrator
5356463|NCT00223873|Antispasmotic treatment|antispasmotic treatment
5356464|NCT00223860|Hypogonadal|hypogonadal
5356465|NCT00223860|Hypothalamus|hypothalamus
5356466|NCT00223860|Pituitary|pituitary
5356467|NCT00223860|Spinal Cord Injury|spinal cord injury
5356468|NCT00223860|Testes|testes
5356469|NCT00223860|Testosterone|testosterone
5356470|NCT00223847|Aphasia rehabilitation|aphasia rehabilitation
5356471|NCT00223847|Aphasia therapy|aphasia therapy
5356472|NCT00223847|Constraint therapy|constraint therapy
5356473|NCT00223847|Language therapy|language therapy
5356474|NCT00223834|Counseling|counseling
5356475|NCT00223834|Motivation|motivation
5356476|NCT00223834|Psychotherapy, brief|psychotherapy, brief
5356477|NCT00223821|Behavior Therapy|behavior therapy
5356478|NCT00223821|Behavioral Medicine|behavioral medicine
5356479|NCT00223821|Behavioral Research|behavioral research
5356480|NCT00223821|Behavioral Sciences|behavioral sciences
5356481|NCT00223821|Combined Modality Therapy|combined modality therapy
5356482|NCT00223821|Drug Therapy|drug therapy
5356483|NCT00223821|Overactive bladder|overactive bladder
5356484|NCT00223821|Treatment Outcome|treatment outcome
5356485|NCT00223821|Urge incontinence|urge incontinence
5356486|NCT00223821|Urinary incontinence|urinary incontinence
5356487|NCT00223808|Rehabilitation|rehabilitation
5356488|NCT00223808|Robotics|robotics
5356489|NCT00223795|Cane|cane
5356490|NCT00223795|Gait|gait
5356491|NCT00223795|Obesity|obesity
5356492|NCT00223795|Osteoarthritis|osteoarthritis
5356493|NCT00223795|Walking Aids|walking aids
5356494|NCT00223782|Diabetes|diabetes
5356495|NCT00223782|Peripheral Neuropathy|peripheral neuropathy
5356496|NCT00223782|Walking|walking
5356497|NCT00223769|oxandrolone|oxandrolone
5356498|NCT00223769|oxandrin|oxandrin
5356499|NCT00223769|lean body mass|lean body mass
5356500|NCT00223769|functional recovery|functional recovery
5356501|NCT00223769|resistance training|resistance training
5356502|NCT00223756|Vision, Low|vision, low
5356503|NCT00223743|essential tremor|essential tremor
5356504|NCT00223743|zonisamide|zonisamide
5356505|NCT00223743|clinical trial|clinical trial
5356506|NCT00223730|Peripheral Blood Stem Cell Transplant|peripheral blood stem cell transplant
5356507|NCT00223730|Bone Marrow Transplant|bone marrow transplant
5356508|NCT00223730|Citrulline|citrulline
5356509|NCT00223730|Urea Cycle|urea cycle
5356510|NCT00223730|Hepatic Injury|hepatic injury
5356511|NCT00223730|Allogeneic PBSCT|allogeneic pbsct
5356512|NCT00223730|Matched-Unrelated PBSCT|matched-unrelated pbsct
5356513|NCT00223717|Supine Hypertension|supine hypertension
5356514|NCT00223717|Hypertension|hypertension
5356515|NCT00223717|Treatment|treatment
5356516|NCT00223717|Autonomic failure|autonomic failure
5356517|NCT00223717|Pure autonomic failure|pure autonomic failure
5356518|NCT00223717|Multiple System Atrophy|multiple system atrophy
5356519|NCT00223717|Shy-Drager Syndrome|shy-drager syndrome
5356520|NCT00223704|Coronary Artery Bypass|coronary artery bypass
5356521|NCT00223704|Blood Transfusion|blood transfusion
5356522|NCT00223704|Bradykinin Receptor Antagonism|bradykinin receptor antagonism
5357691|NCT00217763|Dementia|dementia
5356523|NCT00223704|Anti-Inflammatory Agents|anti-inflammatory agents
5356524|NCT00223704|Antifibrinolytic Agents|antifibrinolytic agents
5356525|NCT00223691|orthostatic hypotension|orthostatic hypotension
5356526|NCT00223691|autonomic failure|autonomic failure
5356527|NCT00223665|Intermittent Hormone Therapy|intermittent hormone therapy
5356528|NCT00223665|Intermittent Androgen Suppression|intermittent androgen suppression
5356529|NCT00223665|Biochemical Relapsed Prostate Cancer|biochemical relapsed prostate cancer
5356530|NCT00223665|Androgen Deprivation Therapy|androgen deprivation therapy
5356531|NCT00223665|Localized Prostate Cancer|localized prostate cancer
5356532|NCT00223652|Cognitive-Behavioral Therapy|cognitive-behavioral therapy
5356533|NCT00223652|Telephone psychotherapy|telephone psychotherapy
5356534|NCT00223652|Clinical Trial|clinical trial
5356535|NCT00223652|Primary Care Clinic|primary care clinic
5356536|NCT00223652|Treatment for Depression|treatment for depression
5356537|NCT00223639|alcoholism /alcohol abuse|alcoholism /alcohol abuse
5356538|NCT00223639|alcoholism antagonist|alcoholism antagonist
5356539|NCT00223639|anticonvulsant|anticonvulsant
5356540|NCT00223639|cognition|cognition
5356541|NCT00223639|neuropharmacology|neuropharmacology
5356542|NCT00223639|substance abuse related behavior|substance abuse related behavior
5356543|NCT00223639|craving|craving
5356544|NCT00223639|euphoria|euphoria
5356545|NCT00223639|relapse /recurrence|relapse /recurrence
5356546|NCT00223639|patient oriented research|patient oriented research
5356547|NCT00223626|Cocaine Addiction|cocaine addiction
5356548|NCT00223626|Cocaine Dependence|cocaine dependence
5356549|NCT00223613|diabetes|diabetes
5356550|NCT00223613|juvenile diabetes|juvenile diabetes
5356551|NCT00223613|insulin deficiency|insulin deficiency
5356552|NCT00223600|lipids|lipids
5356553|NCT00223600|lipoproproteins|lipoproproteins
5356554|NCT00223600|growth|growth
5356555|NCT00223600|neurological development|neurological development
5356556|NCT00223600|vascular wall|vascular wall
5356557|NCT00223600|blood pressure|blood pressure
5356558|NCT00223600|nutrient intake|nutrient intake
5356559|NCT00223587|driving|driving
5356560|NCT00223587|memory|memory
5356561|NCT00223561|adult|adult
5356562|NCT00223548|prophylaxis|prophylaxis
5356563|NCT00223548|contrast-induced nephropathy|contrast-induced nephropathy
5356564|NCT00223548|mesna|mesna
5356565|NCT00223548|acute renal failure|acute renal failure
5356566|NCT00223535|Schizophrenia|schizophrenia
5356567|NCT00223535|Cognitive Remediation|cognitive remediation
5356568|NCT00223535|Social Skills Training|social skills training
5356569|NCT00223535|Psychosocial|psychosocial
5356570|NCT00223522|Schizophrenia|schizophrenia
5356571|NCT00223522|Schizoaffective|schizoaffective
5356572|NCT00223522|MEMS|mems
5356573|NCT00223522|adherence to antipsychotic medication|adherence to antipsychotic medication
5356574|NCT00223509|mixed mania|mixed mania
5356575|NCT00223509|lamotrigine|lamotrigine
5356576|NCT00223496|Bipolar Depression|bipolar depression
5356577|NCT00223496|Refractory|refractory
5356578|NCT00223483|Hematologic Diseases|hematologic diseases
5356579|NCT00223483|Genomics|genomics
5356580|NCT00223483|Cytokines|cytokines
5356581|NCT00223483|Chemokines|chemokines
5356582|NCT00223483|Receptors|receptors
5356583|NCT00223470|pain|pain
5356584|NCT00223457|multiple sclerosis|multiple sclerosis
5356585|NCT00223457|compliance|compliance
5356586|NCT00223457|adherence|adherence
5356587|NCT00223457|disease modifying therapy|disease modifying therapy
5356588|NCT00223457|depression|depression
5356589|NCT00223457|hope|hope
5356590|NCT00223457|quality of life|quality of life
5356591|NCT00223444|alcohol|alcohol
5356592|NCT00223444|GABA|gaba
5356593|NCT00223444|genetic variation|genetic variation
5356594|NCT00223418|aripiprazole|aripiprazole
5356595|NCT00223418|olanzapine|olanzapine
5356596|NCT00223418|vocational|vocational
5356597|NCT00223418|learning|learning
5356598|NCT00223418|cognition|cognition
5356599|NCT00223418|cognitive|cognitive
5356600|NCT00223405|enamel wear against ceramic crowns|enamel wear against ceramic crowns
5356601|NCT00223379|Apical Periodontitis, Root Canal Therapy, Apical Preparation|apical periodontitis, root canal therapy, apical preparation
5356602|NCT00223366|Pain in teeth|pain in teeth
5356603|NCT00223353|Biomechanics|biomechanics
5356604|NCT00223353|Gait|gait
5356605|NCT00223353|Balance|balance
5356606|NCT00223340|patient activation|patient activation
5356607|NCT00223340|primary care|primary care
5356608|NCT00223340|diabetes|diabetes
5356609|NCT00223340|cardiovascular risk|cardiovascular risk
5356610|NCT00223327|pain|pain
5356611|NCT00223327|Normal pulp and normal periodontal status|normal pulp and normal periodontal status
5356612|NCT00223327|Chronic apical periodontitis of pulpal origin|chronic apical periodontitis of pulpal origin
5356613|NCT00223314|HIV|hiv
5356614|NCT00223314|Sexually Transmitted Diseases|sexually transmitted diseases
5356615|NCT00223314|Pregnancy|pregnancy
5356616|NCT00223314|HIV Seronegativity|hiv seronegativity
5356617|NCT00223275|Bipolar Disorder|bipolar disorder
5356618|NCT00223275|Alcohol Dependence|alcohol dependence
5356619|NCT00223275|Dual Diagnosis|dual diagnosis
5356620|NCT00223275|Naltrexone|naltrexone
5356621|NCT00223210|bipolar disorder|bipolar disorder
5357868|NCT00216866|Thrombosis|thrombosis
5356622|NCT00223210|cocaine dependence|cocaine dependence
5356623|NCT00223210|quetiapine|quetiapine
5356624|NCT00223197|Bipolar with depression|bipolar with depression
5356625|NCT00223197|Recurrent major depressive disorder|recurrent major depressive disorder
5356626|NCT00223197|substance abuse dependence|substance abuse dependence
5356627|NCT00223171|Stage T3 T4|stage t3 t4
5356628|NCT00223171|PSA > 20|psa > 20
5356629|NCT00223171|Gleason Score > 7|gleason score > 7
5356630|NCT00223158|Thyroid cancer|thyroid cancer
5356631|NCT00223158|Hypothyroidism|hypothyroidism
5356632|NCT00223158|Whole Body Scintigraphy|whole body scintigraphy
5356633|NCT00223158|Liothyronine|liothyronine
5356634|NCT00223158|TSH elevation|tsh elevation
5356635|NCT00223145|Prostate adenocarcinoma|prostate adenocarcinoma
5356636|NCT00223145|Gleason score <= 6 and PSA 10-20|gleason score <= 6 and psa 10-20
5356637|NCT00223145|Gleason score = 7 and PSA <=20|gleason score = 7 and psa <=20
5356638|NCT00223132|bariatric surgery|bariatric surgery
5356639|NCT00223132|body contouring|body contouring
5356640|NCT00223132|skin laxity|skin laxity
5356641|NCT00223132|plastic surgery|plastic surgery
5356642|NCT00223132|suture granuloma|suture granuloma
5356643|NCT00223132|absorbable sutures|absorbable sutures
5356644|NCT00223119|perineal trauma|perineal trauma
5356645|NCT00223119|perineal laceration|perineal laceration
5356646|NCT00223119|persistent perineal pain|persistent perineal pain
5356647|NCT00223106|urge incontinence|urge incontinence
5356648|NCT00223106|urinary incontinence|urinary incontinence
5356649|NCT00223106|vault prolapse|vault prolapse
5356650|NCT00223106|stess incontinence|stess incontinence
5356651|NCT00223106|mixed incontinence|mixed incontinence
5356652|NCT00223106|urine leakage|urine leakage
5356653|NCT00223106|enterocele|enterocele
5356654|NCT00223106|rectocele|rectocele
5356655|NCT00223106|cystocele|cystocele
5356656|NCT00223093|renal transplantation, TAIZ-moncytes|renal transplantation, taiz-moncytes
5356657|NCT00223080|HIV Seronegativity|hiv seronegativity
5356658|NCT00223067|renal transplantation|renal transplantation
5356659|NCT00223067|TAIZ|taiz
5356660|NCT00223054|cyclosporin A|cyclosporin a
5356661|NCT00223054|Tacrolimus|tacrolimus
5356662|NCT00223054|Everolimus|everolimus
5356663|NCT00223054|Sirolimus|sirolimus
5356664|NCT00223054|Fluvastatin|fluvastatin
5356665|NCT00223041|renal transplantation|renal transplantation
5356666|NCT00223041|cardiovasculary disease|cardiovasculary disease
5356667|NCT00223041|statin|statin
5356668|NCT00223028|fluvastain|fluvastain
5356669|NCT00223028|sirolimus|sirolimus
5356670|NCT00223028|mycophenolat mofetil|mycophenolat mofetil
5356671|NCT00223028|renal transplantation|renal transplantation
5356672|NCT00223015|renal transplantation|renal transplantation
5356673|NCT00223015|pharmacokinetics|pharmacokinetics
5356674|NCT00223015|Fluvastatin|fluvastatin
5356675|NCT00223015|Mycophenolat mofetil|mycophenolat mofetil
5356676|NCT00223015|tacrolimus|tacrolimus
5356677|NCT00222989|GERD|gerd
5356678|NCT00222989|PPI|ppi
5356679|NCT00222989|Functional heartburn|functional heartburn
5356680|NCT00222963|Obesity|obesity
5356681|NCT00222963|Obstructive Sleep Apnea Syndrome|obstructive sleep apnea syndrome
5356682|NCT00222963|Children|children
5356683|NCT00222963|Adolescents|adolescents
5356684|NCT00222963|Adenotonsillectomy|adenotonsillectomy
5356685|NCT00222950|plant sterols, serum, aortic valve cusps|plant sterols, serum, aortic valve cusps
5356686|NCT00222937|Voice Problems|voice problems
5356687|NCT00222937|Voice Disorders|voice disorders
5356688|NCT00222924|Mitochondria|mitochondria
5356689|NCT00222911|plantar fasciitis|plantar fasciitis
5356690|NCT00222911|heel pain|heel pain
5356691|NCT00222911|heel spur|heel spur
5356692|NCT00222911|night splint|night splint
5356693|NCT00222911|arch support|arch support
5356694|NCT00222911|foot orthosis|foot orthosis
5356695|NCT00222911|physical therapy|physical therapy
5356696|NCT00222898|Pancreatic Cyst|pancreatic cyst
5356697|NCT00222898|PANDA Study|panda study
5356698|NCT00222885|PET imaging|pet imaging
5356699|NCT00222885|Skeletal muscle|skeletal muscle
5356700|NCT00222885|In vivo insulin-stimulated tissue perfusion|in vivo insulin-stimulated tissue perfusion
5356701|NCT00222885|Glucose transport|glucose transport
5356702|NCT00222885|Glucose phosphorylation|glucose phosphorylation
5356703|NCT00222872|Endocrine System Diseases|endocrine system diseases
5356704|NCT00222872|MusculoSkeletal System Diseases|musculoskeletal system diseases
5356705|NCT00222872|Hormone|hormone
5356706|NCT00222872|Postmenopausal Women|postmenopausal women
5356707|NCT00222859|HIV|hiv
5356708|NCT00222859|HCV|hcv
5356709|NCT00222846|Clinical trial|clinical trial
5356710|NCT00222846|Behavioral research|behavioral research
5356711|NCT00222846|Patient compliance|patient compliance
5356712|NCT00222833|Schizophrenia|schizophrenia
5356713|NCT00222833|Schizoaffective disorder|schizoaffective disorder
5356714|NCT00222833|Aripiprazole|aripiprazole
5356715|NCT00222833|Obese|obese
5356716|NCT00222833|Overweight|overweight
5356717|NCT00222833|Heart Health|heart health
5356718|NCT00222833|Antipsychotic|antipsychotic
5356719|NCT00222833|Heart Health Factors|heart health factors
5356720|NCT00222833|Cardiovascular Health Indices|cardiovascular health indices
5356721|NCT00222833|Cardiovascular health|cardiovascular health
5356722|NCT00222807|schizophrenia, psychosis, type 2 diabetes mellitus|schizophrenia, psychosis, type 2 diabetes mellitus
5356723|NCT00222794|Schizophrenia|schizophrenia
5356724|NCT00222794|Schizo-Affective Disorder|schizo-affective disorder
5356725|NCT00222794|Negative Symptoms|negative symptoms
5356726|NCT00222794|Atomoxetine|atomoxetine
5356727|NCT00222794|Strattera|strattera
5356728|NCT00222781|Skeletal muscle|skeletal muscle
5356729|NCT00222781|Triple-tracer PET imaging|triple-tracer pet imaging
5356730|NCT00222768|Adipose tissue|adipose tissue
5356731|NCT00222768|PET imaging|pet imaging
5356732|NCT00222755|Mood disorders-bipolar|mood disorders-bipolar
5356733|NCT00222755|Disease management|disease management
5356734|NCT00222755|Quality of care|quality of care
5356735|NCT00222742|hypothermia|hypothermia
5356736|NCT00222742|pediatric TBI|pediatric tbi
5356737|NCT00222729|head|head
5356738|NCT00222729|neck|neck
5356739|NCT00222716|Treatment adherence|treatment adherence
5356740|NCT00222716|HIV|hiv
5356741|NCT00222716|Self-efficacy|self-efficacy
5356742|NCT00222716|Treatment Experienced|treatment experienced
5356743|NCT00222703|nicotine addiction|nicotine addiction
5356744|NCT00222703|relapse|relapse
5356745|NCT00222703|smoking|smoking
5356746|NCT00222703|chronic disorders|chronic disorders
5356747|NCT00222703|randomized controlled trial|randomized controlled trial
5356748|NCT00222703|intervention|intervention
5356749|NCT00222690|qualitative interview|qualitative interview
5356750|NCT00222690|symptom triggers|symptom triggers
5356751|NCT00222690|activity and participation|activity and participation
5356752|NCT00222677|venous thromboembolism|venous thromboembolism
5356753|NCT00222677|deep vein thrombosis|deep vein thrombosis
5356754|NCT00222677|pulmonary embolism|pulmonary embolism
5356755|NCT00222677|antithrombotic agents|antithrombotic agents
5356756|NCT00222664|hepatitis B|hepatitis b
5356757|NCT00222664|hepatocellular carcinoma|hepatocellular carcinoma
5356758|NCT00222664|prevention|prevention
5356759|NCT00222664|vaccination|vaccination
5356760|NCT00222651|pulmonary embolism|pulmonary embolism
5356761|NCT00222651|right ventricular dysfunction|right ventricular dysfunction
5356762|NCT00222651|thrombolysis|thrombolysis
5356763|NCT00222651|echocardiography|echocardiography
5356764|NCT00222638|Oral anticoagulants|oral anticoagulants
5356765|NCT00222638|Influenza virus|influenza virus
5356766|NCT00222638|Influenza vaccine|influenza vaccine
5356767|NCT00222638|Pharmacological interference|pharmacological interference
5356768|NCT00222625|Intracerebral Hemorrhage|intracerebral hemorrhage
5356769|NCT00222625|Oral Anticoagulants|oral anticoagulants
5356770|NCT00222625|Antiplatelet Agents|antiplatelet agents
5356771|NCT00222625|Recombinant Activated Factor VII|recombinant activated factor vii
5356772|NCT00222573|clopidogrel|clopidogrel
5356773|NCT00222573|metoprolol|metoprolol
5356774|NCT00222573|myocardial infarction|myocardial infarction
5356775|NCT00222573|randomised trial|randomised trial
5356776|NCT00222560|physical activity counselling|physical activity counselling
5356777|NCT00222560|physical activity behavior change intervention|physical activity behavior change intervention
5356778|NCT00222560|prevention|prevention
5356779|NCT00222560|collaborative health care|collaborative health care
5356780|NCT00222560|physical inactivity|physical inactivity
5356781|NCT00222560|motivation|motivation
5356782|NCT00222560|fitness|fitness
5356783|NCT00222560|randomized controlled trial|randomized controlled trial
5356784|NCT00222534|Respiratory Insufficiency|respiratory insufficiency
5356785|NCT00222534|Alkalosis|alkalosis
5356786|NCT00222521|Cystic Fibrosis|cystic fibrosis
5356787|NCT00222521|Diabetes|diabetes
5356788|NCT00222508|Cystic Fibrosis|cystic fibrosis
5356789|NCT00222508|Diabetes|diabetes
5356790|NCT00222508|Complications|complications
5356791|NCT00222495|Psychotic Disorders in adolescents|psychotic disorders in adolescents
5356792|NCT00222495|Schizophrenia in adolescents|schizophrenia in adolescents
5356793|NCT00222495|Schizophreniform Disorders in adolescents|schizophreniform disorders in adolescents
5356794|NCT00222495|Schizoaffective Disorders in adolescents|schizoaffective disorders in adolescents
5356795|NCT00222482|Borderline Personality Disorder|borderline personality disorder
5356796|NCT00222469|pancreatic cancer|pancreatic cancer
5356797|NCT00222469|unresectable pancreatic cancer|unresectable pancreatic cancer
5356798|NCT00222469|metastatic pancreatic cancer|metastatic pancreatic cancer
5356799|NCT00222469|bevacizumab|bevacizumab
5356800|NCT00222469|oxaliplatin|oxaliplatin
5356801|NCT00222469|gemcitabine|gemcitabine
5356802|NCT00222469|1st line treatment|1st line treatment
5356803|NCT00222469|first line treatment|first line treatment
5356804|NCT00222469|locally advanced (unresectable) pancreatic cancer|locally advanced (unresectable) pancreatic cancer
5356805|NCT00222456|preterm infants|preterm infants
5356806|NCT00222456|early intervention|early intervention
5356807|NCT00222456|outcome|outcome
5356808|NCT00222456|behavioral problems|behavioral problems
5356809|NCT00222456|parenting stress|parenting stress
5356810|NCT00222443|Recurrent solid tumors|recurrent solid tumors
5356811|NCT00222443|recurrent lymphomas|recurrent lymphomas
5356812|NCT00222443|Pediatrics|pediatrics
5356813|NCT00222443|Adolescents|adolescents
5356814|NCT00222430|Fluoroscopy|fluoroscopy
5356815|NCT00222430|Femoral Artery|femoral artery
5356816|NCT00222430|Arterial Vascular Access|arterial vascular access
5356817|NCT00222404|Carcinoma, Non-Small-Cell Lung|carcinoma, non-small-cell lung
5356818|NCT00222404|Pharmacogenomic|pharmacogenomic
5356819|NCT00222378|Crohn's disease|crohn's disease
5356820|NCT00222378|ulcerative colitis|ulcerative colitis
5356821|NCT00222378|cytomegalovirus|cytomegalovirus
5356822|NCT00222378|Epstein Bar Virus|epstein bar virus
5356823|NCT00222378|Human Herpes virus 6|human herpes virus 6
5356824|NCT00222365|homeopathy|homeopathy
5356825|NCT00222365|assessment|assessment
5356826|NCT00222365|pain|pain
5356827|NCT00222365|ligamentoplasty|ligamentoplasty
5356828|NCT00222352|Unstable Angina|unstable angina
5356829|NCT00222352|Non-ST-segment Myocardial Infarction|non-st-segment myocardial infarction
5356830|NCT00222352|Myocardial Necrosis|myocardial necrosis
5356831|NCT00222352|Troponin I|troponin i
5356832|NCT00222339|Stroke|stroke
5356833|NCT00222339|Hand function|hand function
5356834|NCT00222339|Task-specific training|task-specific training
5356835|NCT00222326|Hysterectomy,|hysterectomy,
5356836|NCT00222326|Prolapse,|prolapse,
5356837|NCT00222326|Pelvic floor muscles,|pelvic floor muscles,
5356838|NCT00222326|Bladder,|bladder,
5356839|NCT00222326|Bowel.|bowel.
5356840|NCT00222300|Total hip replacement|total hip replacement
5356841|NCT00222300|Strength training|strength training
5356842|NCT00222300|Gait analysis|gait analysis
5356843|NCT00222287|Feldenkrais Method|feldenkrais method
5356844|NCT00222287|movement class|movement class
5356845|NCT00222287|balance|balance
5356846|NCT00222287|Four square step test|four square step test
5356847|NCT00222287|Activities Specific Balance Confidence Scale|activities specific balance confidence scale
5356848|NCT00222287|systems theory|systems theory
5356849|NCT00222274|fibromyalgia|fibromyalgia
5356850|NCT00222274|pain|pain
5356851|NCT00222274|biofeedback|biofeedback
5356852|NCT00222274|heart rate variability|heart rate variability
5356853|NCT00222261|antiplatelet therapy|antiplatelet therapy
5356854|NCT00222261|aspirin non-responders|aspirin non-responders
5356855|NCT00222261|aspirin resistance|aspirin resistance
5356856|NCT00222261|clopidogrel|clopidogrel
5356857|NCT00222261|coronary heart disease|coronary heart disease
5356858|NCT00222261|stable angina pectoris|stable angina pectoris
5356859|NCT00222248|Stress urinary incontinence|stress urinary incontinence
5356860|NCT00222248|Pelvic floor muscle training|pelvic floor muscle training
5356861|NCT00222248|Bladder training|bladder training
5356862|NCT00222248|Older women|older women
5356863|NCT00222235|schizophrenia|schizophrenia
5356864|NCT00222235|schizoaffective disorder|schizoaffective disorder
5356865|NCT00222235|negative symptoms|negative symptoms
5356866|NCT00222235|cognitive impairments|cognitive impairments
5356867|NCT00222222|severe sepsis|severe sepsis
5356868|NCT00222222|prognostic markers|prognostic markers
5356869|NCT00222222|polymorphisms|polymorphisms
5356870|NCT00222222|SIRS|sirs
5356871|NCT00222209|Experimental study|experimental study
5356872|NCT00222209|chronic pain|chronic pain
5356873|NCT00222209|operant learning|operant learning
5356874|NCT00222209|comorbidity|comorbidity
5356875|NCT00222209|stress|stress
5356876|NCT00222209|Fibromyalgia w visceral hypersensitivity|fibromyalgia w visceral hypersensitivity
5356877|NCT00222209|Fibromyalgia w/o visceral hypersensitivity|fibromyalgia w/o visceral hypersensitivity
5356878|NCT00222196|atherosclerosis|atherosclerosis
5356879|NCT00222196|quality of life|quality of life
5356880|NCT00222196|pain-score|pain-score
5356881|NCT00222196|biomarkers|biomarkers
5356882|NCT00222183|Lupus erythematodes|lupus erythematodes
5356883|NCT00222183|Elidel|elidel
5356884|NCT00222183|Pimecrolimus|pimecrolimus
5356885|NCT00222183|Chronic discoid lupus erythematosus (dLE)|chronic discoid lupus erythematosus (dle)
5356886|NCT00222183|subacute cutaneous lupus erythematosus (scLE)|subacute cutaneous lupus erythematosus (scle)
5356887|NCT00222131|Epigastric Pain|epigastric pain
5356888|NCT00222131|Non-Ulcer Dyspepsia (NUD)|non-ulcer dyspepsia (nud)
5356889|NCT00222092|post-ERCP pancreatitis|post-ercp pancreatitis
5356890|NCT00222092|prophylaxis|prophylaxis
5356891|NCT00222092|prognosis|prognosis
5356892|NCT00222092|natural course|natural course
5356893|NCT00222092|molecular markers|molecular markers
5356894|NCT00222066|Aspiration|aspiration
5356895|NCT00222066|Fetal ovarian cyst|fetal ovarian cyst
5356896|NCT00222066|Ovarian torsion|ovarian torsion
5356897|NCT00222053|Myeloma|myeloma
5356898|NCT00222053|Autologous transplantation|autologous transplantation
5356899|NCT00222053|Maintenance therapy|maintenance therapy
5356900|NCT00222053|Thalidomide|thalidomide
5356901|NCT00222040|Stroke|stroke
5356902|NCT00222040|thrombolysis|thrombolysis
5356903|NCT00222040|ultrasound|ultrasound
5356904|NCT00222040|microbubbles|microbubbles
5356905|NCT00222040|alteplase|alteplase
5356906|NCT00222027|Acute lymphoblastic leukemia|acute lymphoblastic leukemia
5356907|NCT00222027|adult patient|adult patient
5356908|NCT00222027|chemotherapy|chemotherapy
5356909|NCT00222027|stem cell transplantation|stem cell transplantation
5356910|NCT00222027|Young adult patients|young adult patients
5356911|NCT00222014|Refractory ascites|refractory ascites
5356912|NCT00222014|Cirrhosis|cirrhosis
5356913|NCT00222014|Paracentesesis|paracentesesis
5356914|NCT00221988|Elderly|elderly
5356915|NCT00221988|Epilepsy|epilepsy
5356916|NCT00221988|Cognition|cognition
5356917|NCT00221988|Health Outcome|health outcome
5356918|NCT00221962|ADHD|adhd
5356919|NCT00221923|Primary open angle glaucoma|primary open angle glaucoma
5356920|NCT00221923|African American|african american
5356921|NCT00221923|Glaucoma/pathology|glaucoma/pathology
5356922|NCT00221923|Glaucoma/ physiopathology|glaucoma/ physiopathology
5356923|NCT00221923|Nerve Fibers/pathology|nerve fibers/pathology
5356924|NCT00221923|Risk factor glaucoma|risk factor glaucoma
5356925|NCT00221897|Primary open angle glaucoma|primary open angle glaucoma
5356926|NCT00221897|Glaucoma/pathology|glaucoma/pathology
5356927|NCT00221897|Glaucoma/physiopathology|glaucoma/physiopathology
5356928|NCT00221897|Nerve Fibers/pathology|nerve fibers/pathology
5356929|NCT00221897|Risk factors glaucoma|risk factors glaucoma
5356930|NCT00221845|Ramipril|ramipril
5356931|NCT00221845|Hypertension|hypertension
5356932|NCT00221845|Chronic renal failure|chronic renal failure
5356933|NCT00221845|Disease progression|disease progression
5356934|NCT00221845|Left ventricular hypertrophy|left ventricular hypertrophy
5356935|NCT00221845|Intima media thickness|intima media thickness
5356936|NCT00221845|Cardiovascular disease|cardiovascular disease
5356937|NCT00221845|Biomarkers|biomarkers
5356938|NCT00221845|Gene polymorphisms|gene polymorphisms
5356939|NCT00221832|Long QT Syndrome|long qt syndrome
5356940|NCT00221832|Hypertrophic cardiomyopathy|hypertrophic cardiomyopathy
5356941|NCT00221832|arrhythmogenic right ventricular dysplasia|arrhythmogenic right ventricular dysplasia
5356942|NCT00221832|Short QT Syndrome|short qt syndrome
5356943|NCT00221832|Brugada Syndrome|brugada syndrome
5356944|NCT00221819|Humidification|humidification
5356945|NCT00221819|Heat and moisture exchanger|heat and moisture exchanger
5356946|NCT00221819|Heated humidifier, non invasive ventilation|heated humidifier, non invasive ventilation
5356947|NCT00221806|Arteritis, femoro popliteal bypass, endothelialised prosthesis, saphenous vein graft, permeability, Doppler echography|arteritis, femoro popliteal bypass, endothelialised prosthesis, saphenous vein graft, permeability, doppler echography
5356948|NCT00221793|Parkinson|parkinson
5356949|NCT00221793|deep subthalamic stimulation|deep subthalamic stimulation
5356950|NCT00221793|pharmacological treatment|pharmacological treatment
5356951|NCT00221780|Heart failure|heart failure
5356952|NCT00221780|Cardiomyopathy, dilated|cardiomyopathy, dilated
5356953|NCT00221780|Coronary disease|coronary disease
5356954|NCT00221780|Cardiac Pacing, Artificial|cardiac pacing, artificial
5356955|NCT00221780|Hemodynamics|hemodynamics
5356956|NCT00221780|Randomized Controlled Trials|randomized controlled trials
5356957|NCT00221780|Single-Blind Study|single-blind study
5356958|NCT00221767|Neurogenic bladder|neurogenic bladder
5356959|NCT00221767|electric stimulation therapy|electric stimulation therapy
5356960|NCT00221767|urinary tract infection|urinary tract infection
5356961|NCT00221767|urinary incontinence|urinary incontinence
5356962|NCT00221767|spinal cord injuries|spinal cord injuries
5356963|NCT00221767|spinal nerve roots|spinal nerve roots
5356964|NCT00221767|nonRandomized Controlled Trials|nonrandomized controlled trials
5356965|NCT00221767|open Study|open study
5356966|NCT00221754|HIV,|hiv,
5356967|NCT00221754|protease inhibitors|protease inhibitors
5356968|NCT00221754|pravastatin|pravastatin
5356969|NCT00221754|Treatment Experienced|treatment experienced
5356970|NCT00221741|Heart surgery|heart surgery
5356971|NCT00221741|Blood Loss, Surgical|blood loss, surgical
5356972|NCT00221741|Mortality|mortality
5356973|NCT00221741|Blood Transfusion|blood transfusion
5356974|NCT00221741|Cohort Studies|cohort studies
5356975|NCT00221728|Kidney Neoplasms|kidney neoplasms
5356976|NCT00221728|Surgery|surgery
5356977|NCT00221728|Catheter Ablation|catheter ablation
5356978|NCT00221728|Randomized controlled trials|randomized controlled trials
5356979|NCT00221728|Kidney Failure, Chronic|kidney failure, chronic
5356980|NCT00221715|arteritis|arteritis
5356981|NCT00221715|lower limb ischemia|lower limb ischemia
5356982|NCT00221715|femoropopliteal artery bypass|femoropopliteal artery bypass
5356983|NCT00221715|blood vessel prothesis implantation|blood vessel prothesis implantation
5356984|NCT00221715|saphenous vein|saphenous vein
5356985|NCT00221715|vascular permeability|vascular permeability
5356986|NCT00221715|doppler ultrasonography|doppler ultrasonography
5356987|NCT00221715|randomized clinical trials|randomized clinical trials
5356988|NCT00221715|efficacy study|efficacy study
5356989|NCT00221702|Melanoma|melanoma
5356990|NCT00221702|Neoplasm metastasis|neoplasm metastasis
5356991|NCT00221702|Interferon alfa-2b|interferon alfa-2b
5356992|NCT00221702|Adjuvants|adjuvants
5356993|NCT00221702|Randomized clinical trial|randomized clinical trial
5356994|NCT00221702|Disease-free survival time|disease-free survival time
5356995|NCT00221702|Safety|safety
5356996|NCT00221702|Drug toxicity|drug toxicity
5356997|NCT00221702|Quality of life|quality of life
5356998|NCT00221689|Severe brain injury|severe brain injury
5356999|NCT00221689|Coma|coma
5357000|NCT00221689|Hypertonia|hypertonia
5357001|NCT00221689|Dysautonomia|dysautonomia
5357002|NCT00221689|Baclofen|baclofen
5357003|NCT00221689|Randomized Controlled Trials|randomized controlled trials
5357004|NCT00221676|influenza vaccine|influenza vaccine
5357005|NCT00221676|general practitioner|general practitioner
5357006|NCT00221663|Cardiac surgery|cardiac surgery
5357007|NCT00221663|Aortic valve replacement|aortic valve replacement
5357970|NCT00216476|Quetiapine|quetiapine
5357008|NCT00221663|Minimally invasive surgery|minimally invasive surgery
5357009|NCT00221663|Perioperative course|perioperative course
5357010|NCT00221650|Hepatitis C, Chronic|hepatitis c, chronic
5357011|NCT00221650|HCV infection|hcv infection
5357012|NCT00221650|HIV infection|hiv infection
5357013|NCT00221650|Treatment Failure|treatment failure
5357014|NCT00221650|PEG interferon|peg interferon
5357015|NCT00221650|Interferons/therapeutic use|interferons/therapeutic use
5357016|NCT00221650|Interferon Alfa-2a/adverse effects|interferon alfa-2a/adverse effects
5357017|NCT00221650|Ribavirin/therapeutic use|ribavirin/therapeutic use
5357018|NCT00221650|Ribavirin/adverse effects|ribavirin/adverse effects
5357019|NCT00221650|Drug Therapy, Combination|drug therapy, combination
5357020|NCT00221650|Treatment Experienced|treatment experienced
5357021|NCT00221650|Treatment Naive|treatment naive
5357022|NCT00221637|Neuralgia|neuralgia
5357023|NCT00221637|Valproate|valproate
5357024|NCT00221637|Anticonvulsant Drugs|anticonvulsant drugs
5357025|NCT00221637|Pain Measurement|pain measurement
5357026|NCT00221637|Randomized Controlled Trials|randomized controlled trials
5357027|NCT00221624|Hepatitis C, chronic|hepatitis c, chronic
5357028|NCT00221624|HCV infection|hcv infection
5357029|NCT00221624|Treatment failure|treatment failure
5357030|NCT00221624|PEG Interferon|peg interferon
5357031|NCT00221624|(Interferons/therapeutic use|(interferons/therapeutic use
5357032|NCT00221624|Interferon Alfa-2a/adverse effects)|interferon alfa-2a/adverse effects)
5357033|NCT00221624|ribavirin|ribavirin
5357034|NCT00221624|(Ribavirin/therapeutic use|(ribavirin/therapeutic use
5357035|NCT00221624|Ribavirin/adverse effects)|ribavirin/adverse effects)
5357036|NCT00221624|Amantadine|amantadine
5357037|NCT00221624|Drug Therapy, Combination|drug therapy, combination
5357038|NCT00221520|Sedation, mechanical ventilation|sedation, mechanical ventilation
5357039|NCT00221507|Vaccination|vaccination
5357040|NCT00221507|Prevention & Control|prevention & control
5357041|NCT00221494|depression|depression
5357042|NCT00221481|Bipolar|bipolar
5357043|NCT00221481|Alcohol|alcohol
5357044|NCT00221468|Adolescents|adolescents
5357045|NCT00221455|Diabetes Mellitus|diabetes mellitus
5357046|NCT00221455|Chronic disease management|chronic disease management
5357047|NCT00221455|Patient portal|patient portal
5357048|NCT00221455|Patient empowerment|patient empowerment
5357049|NCT00221442|Adults|adults
5357050|NCT00221442|Binge eating disorder|binge eating disorder
5357051|NCT00221442|Blood draw|blood draw
5357052|NCT00221442|E.Coli enterprotoxin|e.coli enterprotoxin
5357053|NCT00221442|Eating disorders|eating disorders
5357054|NCT00221442|Electrocardiogram|electrocardiogram
5357055|NCT00221442|Females|females
5357056|NCT00221442|Males|males
5357057|NCT00221442|Physical exam|physical exam
5357058|NCT00221442|Psychiatric evaluation|psychiatric evaluation
5357059|NCT00221442|Questionnaire|questionnaire
5357060|NCT00221429|child|child
5357061|NCT00221429|adolescent|adolescent
5357062|NCT00221416|child|child
5357063|NCT00221416|adolescent|adolescent
5357064|NCT00221403|child|child
5357065|NCT00221403|adolescent|adolescent
5357066|NCT00221403|bipolar disorder|bipolar disorder
5357067|NCT00221390|stroke|stroke
5357068|NCT00221390|Chronic stroke with hemiparesis|chronic stroke with hemiparesis
5357069|NCT00221377|intubation|intubation
5357070|NCT00221377|trachea|trachea
5357071|NCT00221377|tube|tube
5357072|NCT00221377|cuff|cuff
5357073|NCT00221377|children|children
5357074|NCT00221364|Trachoma|trachoma
5357075|NCT00221364|Chlamydia|chlamydia
5357076|NCT00221364|Azithromycin|azithromycin
5357077|NCT00221351|cough|cough
5357078|NCT00221351|acute bronchitis|acute bronchitis
5357079|NCT00221351|upper respiratory tract infection|upper respiratory tract infection
5357080|NCT00221351|pneumonia|pneumonia
5357081|NCT00221351|lower respiratory tract infection|lower respiratory tract infection
5357082|NCT00221338|gabapentin|gabapentin
5357083|NCT00221338|pain|pain
5357084|NCT00221338|surgery|surgery
5357085|NCT00221338|delirium|delirium
5357086|NCT00221338|cognitive decline|cognitive decline
5357087|NCT00221325|Phase I Clinical Trial|phase i clinical trial
5357088|NCT00221325|Pharmacokinetics|pharmacokinetics
5357089|NCT00221325|Pharmacodynamics|pharmacodynamics
5357090|NCT00221325|CNS Lymphoma|cns lymphoma
5357091|NCT00221325|Ocular Lymphoma|ocular lymphoma
5357092|NCT00221312|Perimenopausal bone loss|perimenopausal bone loss
5357093|NCT00221299|Osteoporosis|osteoporosis
5357094|NCT00221299|Steroids|steroids
5357095|NCT00221299|Prednisone|prednisone
5357096|NCT00221286|chronic hepatitis B|chronic hepatitis b
5357097|NCT00221286|human immunodeficiency virus|human immunodeficiency virus
5357098|NCT00221286|pegylated interferon|pegylated interferon
5357099|NCT00221286|tenofovir DF|tenofovir df
5357100|NCT00221286|emtricitabine|emtricitabine
5357101|NCT00221260|Analgesia|analgesia
5357102|NCT00221260|anesthesia|anesthesia
5357103|NCT00221247|cerebral palsy; acupuncture|cerebral palsy; acupuncture
5357104|NCT00221234|Diabetes|diabetes
5357105|NCT00221234|Physical Activity|physical activity
5357106|NCT00221221|breast cancer survivors|breast cancer survivors
5357107|NCT00221221|physical activity|physical activity
5357108|NCT00221221|health promotion|health promotion
5357110|NCT00221208|Resistance Training|resistance training
5357111|NCT00221182|Angina|angina
5357112|NCT00221182|Heart diseases|heart diseases
5357113|NCT00221182|Pain|pain
5357114|NCT00221182|Vascular diseases|vascular diseases
5357115|NCT00221169|Non-small cell lung cancer|non-small cell lung cancer
5357116|NCT00221169|Positron emission tomography|positron emission tomography
5357117|NCT00221169|Gross tumor volume|gross tumor volume
5357118|NCT00221169|Radiation therapy|radiation therapy
5357119|NCT00221156|Abnormal Glucose Tolerance|abnormal glucose tolerance
5357120|NCT00221156|coronary artery disease|coronary artery disease
5357121|NCT00221156|diabetes mellitus|diabetes mellitus
5357122|NCT00221156|clinical outcome|clinical outcome
5357123|NCT00221143|Ulcer/ gangrene|ulcer/ gangrene
5357124|NCT00221143|Leg diseases|leg diseases
5357125|NCT00221143|Pain|pain
5357126|NCT00221143|Vascular diseases|vascular diseases
5357127|NCT00221143|Chronic limb ischemia|chronic limb ischemia
5357128|NCT00221143|Peripheral artery disease|peripheral artery disease
5357129|NCT00221130|Regenerative medicine|regenerative medicine
5357130|NCT00221130|Periodontal tissue|periodontal tissue
5357131|NCT00221117|Spinal Cord Injuries|spinal cord injuries
5357132|NCT00221104|stroke|stroke
5357133|NCT00221104|brain ischemia|brain ischemia
5357134|NCT00221104|cerebrovascular accident|cerebrovascular accident
5357135|NCT00221104|statin|statin
5357136|NCT00221104|hydroxymethylglutaryl-CoA reductase inhibitors|hydroxymethylglutaryl-coa reductase inhibitors
5357137|NCT00221104|cholesterol|cholesterol
5357138|NCT00221104|hypercholesterolemia|hypercholesterolemia
5357139|NCT00221104|hyperlipidemia|hyperlipidemia
5357140|NCT00221104|multicenter studies|multicenter studies
5357141|NCT00221104|prospective studies|prospective studies
5357142|NCT00221104|endpoint determination|endpoint determination
5357143|NCT00221104|randomized controlled trials|randomized controlled trials
5357144|NCT00221104|recurrence|recurrence
5357145|NCT00221104|pravastatin|pravastatin
5357146|NCT00221091|idiopathic normal pressure hydrocephalus|idiopathic normal pressure hydrocephalus
5357147|NCT00221091|shunt|shunt
5357148|NCT00221078|Cerebrovascular Accident|cerebrovascular accident
5357149|NCT00221078|Stroke|stroke
5357150|NCT00221065|Sleep Apnea Syndromes|sleep apnea syndromes
5357151|NCT00221065|Cerebrovascular Accident|cerebrovascular accident
5357152|NCT00221039|ECP|ecp
5357153|NCT00221039|Photopheresis|photopheresis
5357154|NCT00221039|CTCL|ctcl
5357155|NCT00221039|Cutaneous T Cell Lymphoma|cutaneous t cell lymphoma
5357156|NCT00221039|Mycosis Fungoides|mycosis fungoides
5357157|NCT00221013|Acute Renal Failure|acute renal failure
5357158|NCT00221013|Continuous Renal Replacement Therapy|continuous renal replacement therapy
5357159|NCT00221013|Continuous Veno-Venous Haemofiltration|continuous veno-venous haemofiltration
5357160|NCT00221013|Continuous Veno-Venous Haemodiafiltration|continuous veno-venous haemodiafiltration
5357161|NCT00221013|Renal Replacement Therapy|renal replacement therapy
5357162|NCT00221000|Rheumatoid Arthritis|rheumatoid arthritis
5357163|NCT00220987|Hyperglycemia in the critically ill patient|hyperglycemia in the critically ill patient
5357164|NCT00220987|Intensive Insulin Therapy|intensive insulin therapy
5357165|NCT00220987|Conventional insulin therapy|conventional insulin therapy
5357166|NCT00220987|Hypoglycaemia|hypoglycaemia
5357167|NCT00220961|Impaired Glucose Tolerance|impaired glucose tolerance
5357168|NCT00220961|Type 2 Diabetes|type 2 diabetes
5357169|NCT00220961|Prevention|prevention
5357170|NCT00220961|Pioglitazone|pioglitazone
5357171|NCT00220948|discogenic pain|discogenic pain
5357172|NCT00220948|myoelectric activity|myoelectric activity
5357173|NCT00220935|Randomized controlled clinical trial|randomized controlled clinical trial
5357174|NCT00220922|Copaxone|copaxone
5357175|NCT00220909|Gastric erosions|gastric erosions
5357176|NCT00220909|Proton pump inhibitors|proton pump inhibitors
5357177|NCT00220896|Delirium|delirium
5357178|NCT00220896|Prevention|prevention
5357179|NCT00220896|Donepezil|donepezil
5357180|NCT00220883|Functional Dyspepsia|functional dyspepsia
5357181|NCT00220883|Electrogastrography|electrogastrography
5357182|NCT00220870|schizophrenia|schizophrenia
5357183|NCT00220870|shared decision making|shared decision making
5357184|NCT00220870|compliance|compliance
5357185|NCT00220870|maintenance therapy|maintenance therapy
5357186|NCT00220857|Rabeprazole|rabeprazole
5357187|NCT00220857|Nonsteroidal Antiinflammatory Drugs|nonsteroidal antiinflammatory drugs
5357188|NCT00220857|Gastric erosions|gastric erosions
5357189|NCT00220831|Diabetes|diabetes
5357190|NCT00220831|MI|mi
5357191|NCT00220831|CVD disease|cvd disease
5357192|NCT00220818|Pediatric GERD|pediatric gerd
5357193|NCT00220818|Pediatric Gastroesophageal Reflux Disease|pediatric gastroesophageal reflux disease
5357194|NCT00220818|lansoprazole|lansoprazole
5357195|NCT00220792|Primary breast cancer|primary breast cancer
5357196|NCT00220792|support groups|support groups
5357197|NCT00220792|mood disturbance|mood disturbance
5357198|NCT00220766|Primary Immune Deficiency|primary immune deficiency
5357199|NCT00220766|IGIV|igiv
5357200|NCT00220766|Immunoglobulin G|immunoglobulin g
5357201|NCT00220753|Dog allergy|dog allergy
5357202|NCT00220753|Pet allergy|pet allergy
5357203|NCT00220753|Air cleaners|air cleaners
5357204|NCT00220753|HEPA filters|hepa filters
5358574|NCT00213174|fractures|fractures
5357205|NCT00220753|Air filtration|air filtration
5357206|NCT00220753|Can f1|can f1
5357207|NCT00220753|Asthma|asthma
5357208|NCT00220753|Children|children
5357209|NCT00220753|Adolescents|adolescents
5357210|NCT00220753|Indoor environment|indoor environment
5357211|NCT00220753|Indoor allergy|indoor allergy
5357212|NCT00220753|Perennial allergy|perennial allergy
5357213|NCT00220740|Immunoglobulin G|immunoglobulin g
5357214|NCT00220727|Idiopathic (Immune) Thrombocytopenic Purpura|idiopathic (immune) thrombocytopenic purpura
5357215|NCT00220727|Immunoglobulin G|immunoglobulin g
5357216|NCT00220714|schizophrenia|schizophrenia
5357217|NCT00220714|first-episode|first-episode
5357218|NCT00220714|patient compliance|patient compliance
5357219|NCT00220714|long-acting risperidone|long-acting risperidone
5357220|NCT00220714|relapse|relapse
5357221|NCT00220701|Dysthymic Disorder|dysthymic disorder
5357222|NCT00220701|Depression|depression
5357223|NCT00220701|Chronic Depression|chronic depression
5357224|NCT00220701|Escitalopram|escitalopram
5357225|NCT00220688|nausea|nausea
5357226|NCT00220688|vomiting|vomiting
5357227|NCT00220688|palliative|palliative
5357228|NCT00220688|acupressure|acupressure
5357229|NCT00220675|Malignant extradural spinal cord compression|malignant extradural spinal cord compression
5357230|NCT00220675|Erythropoietin|erythropoietin
5357231|NCT00220675|Neuroprotectant|neuroprotectant
5357232|NCT00220675|Radiotherapy|radiotherapy
5357233|NCT00220675|Palliation|palliation
5357234|NCT00220662|anorexia nervosa|anorexia nervosa
5357235|NCT00220662|bulimia nervosa|bulimia nervosa
5357236|NCT00220662|readiness and motivation|readiness and motivation
5357237|NCT00220649|solid tumors or adenocarcinoma of the exocrine pancreas|solid tumors or adenocarcinoma of the exocrine pancreas
5357238|NCT00220636|Major Depression|major depression
5357239|NCT00220636|Depression|depression
5357240|NCT00220636|Unipolar Depression|unipolar depression
5357241|NCT00220636|Treatment Resistant Depression|treatment resistant depression
5357242|NCT00220636|Adjunctive treatment|adjunctive treatment
5357243|NCT00220623|major depression|major depression
5357244|NCT00220623|psychotherapy|psychotherapy
5357245|NCT00220623|antidepressant medications|antidepressant medications
5357246|NCT00220623|clincial trial|clincial trial
5357247|NCT00220597|group therapy|group therapy
5357248|NCT00220597|sexual revictimization|sexual revictimization
5357249|NCT00220597|risky sex|risky sex
5357250|NCT00220597|addiction|addiction
5357251|NCT00220571|AMI|ami
5357252|NCT00220571|stent|stent
5357253|NCT00220571|PTCA|ptca
5357254|NCT00220571|abciximab|abciximab
5357255|NCT00220571|reteplase|reteplase
5357256|NCT00220571|combo therapy|combo therapy
5357257|NCT00220558|Percutaneous Transluminal Coronary Angioplasty|percutaneous transluminal coronary angioplasty
5357258|NCT00220558|Bare metal stents|bare metal stents
5357259|NCT00220558|drug eluting stents|drug eluting stents
5357260|NCT00220545|Polycystic ovarY|polycystic ovary
5357261|NCT00220545|Laparoscopic ovarian diathermy|laparoscopic ovarian diathermy
5357262|NCT00220545|Induction of ovulation|induction of ovulation
5357263|NCT00220545|Clomiphene citrate|clomiphene citrate
5357264|NCT00220532|Randomised placebo controlled intervention trial|randomised placebo controlled intervention trial
5357265|NCT00220532|Folic acid|folic acid
5357266|NCT00220532|Riboflavin|riboflavin
5357267|NCT00220532|cervical cancer|cervical cancer
5357268|NCT00220506|provigil|provigil
5357269|NCT00220506|fatigue|fatigue
5357270|NCT00220506|Multiple Sclerosis|multiple sclerosis
5357271|NCT00220506|cognition|cognition
5357272|NCT00220493|MS|ms
5357273|NCT00220493|RITALIN|ritalin
5357274|NCT00220493|PASAT|pasat
5357275|NCT00220493|COGNITION|cognition
5357276|NCT00220493|ATTENTION|attention
5357277|NCT00220493|Relapsing remitting|relapsing remitting
5357278|NCT00220493|Secondary progressive|secondary progressive
5357279|NCT00220493|Primary progressive|primary progressive
5357281|NCT00220467|aging|aging
5357282|NCT00220467|cognition|cognition
5357283|NCT00220467|exercise|exercise
5357284|NCT00220467|aerobic|aerobic
5357285|NCT00220467|insulin|insulin
5357286|NCT00220454|cognition|cognition
5357287|NCT00220454|estradiol|estradiol
5357288|NCT00220454|cortisol|cortisol
5357289|NCT00220454|postmenopause|postmenopause
5357290|NCT00220441|IGT|igt
5357291|NCT00220441|exercise|exercise
5357292|NCT00220441|cognition|cognition
5357293|NCT00220441|insulin|insulin
5357294|NCT00220441|aging|aging
5357295|NCT00220441|aerobic|aerobic
5357296|NCT00220428|T cell|t cell
5357297|NCT00220350|arousal|arousal
5357298|NCT00220350|sex offender|sex offender
5357299|NCT00220350|suppression of arousal|suppression of arousal
5357300|NCT00220350|pedohilia|pedohilia
5357301|NCT00220350|leuprolide acetate|leuprolide acetate
5357302|NCT00220324|Contraception|contraception
5357303|NCT00220285|Antigen|antigen
5357304|NCT00220285|CD20|cd20
5357305|NCT00220272|Parkinson Disease|parkinson disease
5357306|NCT00220272|5-fluorodopa|5-fluorodopa
5357307|NCT00220259|Cystic Fibrosis, inhaled corticosteroids|cystic fibrosis, inhaled corticosteroids
5357308|NCT00220246|Hereditary colorectal cancer|hereditary colorectal cancer
5357309|NCT00220246|Microsatellite instability|microsatellite instability
5357310|NCT00220246|Chromosomal instability|chromosomal instability
5357311|NCT00220207|Diabetes|diabetes
5357312|NCT00220207|Health Education|health education
5357313|NCT00220207|Information Technology|information technology
5357314|NCT00220207|African Americans|african americans
5357315|NCT00220207|Disease Management|disease management
5357316|NCT00220207|Internet|internet
5357317|NCT00220207|Patient Education|patient education
5357318|NCT00220181|Nutritional status|nutritional status
5357319|NCT00220181|Bowel symptoms|bowel symptoms
5357320|NCT00220181|Radical radiotherapy to pelvis|radical radiotherapy to pelvis
5357321|NCT00220181|Gynaecological, urological or rectal cancer|gynaecological, urological or rectal cancer
5357322|NCT00220090|Irritable Bowel Syndrome|irritable bowel syndrome
5357323|NCT00220090|Cholecystokinin|cholecystokinin
5357324|NCT00220090|Dexloxiglumide|dexloxiglumide
5357325|NCT00220090|Randomized/withdrawal|randomized/withdrawal
5357326|NCT00219999|Hepatitis|hepatitis
5357327|NCT00219999|Hepacivirus|hepacivirus
5357328|NCT00219999|B Lymphocytes|b lymphocytes
5357329|NCT00219999|Chemokines|chemokines
5357330|NCT00219999|Antibodies|antibodies
5357331|NCT00219986|Treatment Experienced|treatment experienced
5357332|NCT00219986|HIV|hiv
5357333|NCT00219973|venous thromboembolism|venous thromboembolism
5357334|NCT00219973|deep vein thrombosis|deep vein thrombosis
5357335|NCT00219973|pulmonary embolism|pulmonary embolism
5357336|NCT00219973|bleeding|bleeding
5357337|NCT00219973|low-molecular-weight heparin|low-molecular-weight heparin
5357338|NCT00219973|cancer|cancer
5357339|NCT00219973|surgery|surgery
5357340|NCT00219960|Hypertension|hypertension
5357341|NCT00219960|Blood Pressure|blood pressure
5357342|NCT00219960|Ambulatory Blood Pressure Monitoring|ambulatory blood pressure monitoring
5357343|NCT00219960|Complementary and Alternative Medicine|complementary and alternative medicine
5357344|NCT00219960|Herbal|herbal
5357345|NCT00219960|North American Ginseng|north american ginseng
5357346|NCT00219960|Panax Quinquefolius|panax quinquefolius
5357347|NCT00219947|HIV Infection|hiv infection
5357348|NCT00219947|Acute HIV Infection|acute hiv infection
5357349|NCT00219947|Primary HIV Infection|primary hiv infection
5357350|NCT00219947|Acute Seroconversion Syndrome|acute seroconversion syndrome
5357351|NCT00219934|New HIV Infection|new hiv infection
5357352|NCT00219934|Acute HIV Infection|acute hiv infection
5357353|NCT00219934|Primary HIV Infection|primary hiv infection
5357354|NCT00219934|Acute Seroconversion Syndrome|acute seroconversion syndrome
5357355|NCT00219921|total hip replacement|total hip replacement
5357356|NCT00219921|pain treatment|pain treatment
5357357|NCT00219908|Multiple sclerosis|multiple sclerosis
5357358|NCT00219908|Mitoxantrone|mitoxantrone
5357359|NCT00219908|Methylprednisolone|methylprednisolone
5357360|NCT00219908|Interferon beta1b|interferon beta1b
5357361|NCT00219908|Relapse|relapse
5357362|NCT00219908|MRI|mri
5357363|NCT00219908|EDSS|edss
5357364|NCT00219895|Cystic Fibrosis|cystic fibrosis
5357365|NCT00219895|Anti-inflammatory Agents|anti-inflammatory agents
5357366|NCT00219895|Ibuprofen|ibuprofen
5357367|NCT00219882|Cystic Fibrosis|cystic fibrosis
5357368|NCT00219882|curcuminoids|curcuminoids
5357369|NCT00219882|turmeric root extract|turmeric root extract
5357370|NCT00219882|nasal potential difference (NPD)|nasal potential difference (npd)
5357371|NCT00219882|sweat chloride|sweat chloride
5357372|NCT00219869|Post|post
5357373|NCT00219869|Traumatic|traumatic
5357374|NCT00219869|Headache|headache
5357375|NCT00219869|Cognitive|cognitive
5357376|NCT00219856|Propofol|propofol
5357377|NCT00219856|Hepatectomy|hepatectomy
5357378|NCT00219856|Oxidative stress|oxidative stress
5357379|NCT00219843|Stage III and IV melanoma|stage iii and iv melanoma
5357380|NCT00219830|Cardiac Rehabilitation|cardiac rehabilitation
5357381|NCT00219830|Walking|walking
5357382|NCT00219830|Acute Myocardial Infarction|acute myocardial infarction
5357383|NCT00219830|Secondary Prevention|secondary prevention
5357384|NCT00219817|Anorexia|anorexia
5357385|NCT00219817|Cachexia|cachexia
5357386|NCT00219791|methotrexate|methotrexate
5357387|NCT00219791|delayed elimination|delayed elimination
5357388|NCT00219791|renal insufficiency|renal insufficiency
5357389|NCT00219791|CPG2|cpg2
5357390|NCT00219791|Voraxaze|voraxaze
5357391|NCT00219765|CML|cml
5357392|NCT00219765|Acute Phase|acute phase
5357393|NCT00219765|Imatinib mesylate|imatinib mesylate
5357394|NCT00219765|Cytarabine|cytarabine
5357395|NCT00219765|Daunorubicine|daunorubicine
5357396|NCT00219752|CML - ederly patients - Imatinib mesylate|cml - ederly patients - imatinib mesylate
5357397|NCT00219739|CML|cml
5357398|NCT00219739|Imatinib|imatinib
5357399|NCT00219739|Interferon|interferon
5357400|NCT00219739|Cytarabine|cytarabine
5357401|NCT00219726|CML|cml
5357402|NCT00219726|Imatinib mesylate|imatinib mesylate
5357403|NCT00219726|Stem cell transplantation|stem cell transplantation
5357404|NCT00219713|Nitrous oxide and oxygen|nitrous oxide and oxygen
5357405|NCT00219713|Pain|pain
5357406|NCT00219713|Bone marrow biopsy|bone marrow biopsy
5357407|NCT00219713|Bone marrow aspiration|bone marrow aspiration
5357408|NCT00219700|NSAID-PC|nsaid-pc
5357409|NCT00219700|IBU-PC|ibu-pc
5357410|NCT00219687|Heart arrest|heart arrest
5357411|NCT00219687|Cardiopulmonary resuscitation|cardiopulmonary resuscitation
5357412|NCT00219687|Dispatcher|dispatcher
5357413|NCT00219674|education|education
5357414|NCT00219674|training, defibrillators|training, defibrillators
5357415|NCT00219674|home defibrillators|home defibrillators
5357416|NCT00219674|automated external defibrillators|automated external defibrillators
5357417|NCT00219674|psychological adjustment|psychological adjustment
5357418|NCT00219661|randomised control trial|randomised control trial
5357419|NCT00219661|intensive care unit|intensive care unit
5357420|NCT00219661|mechanical ventilation|mechanical ventilation
5357421|NCT00219661|ventilator-associated pneumonia|ventilator-associated pneumonia
5357422|NCT00219661|drainage of subglottic secretions|drainage of subglottic secretions
5357423|NCT00219557|Randomized Phase 2 Study of AG-013736 in Combination with Gemcitabine versus Gemcitabine Alone in Advanced Pancreatic Cancer|randomized phase 2 study of ag-013736 in combination with gemcitabine versus gemcitabine alone in advanced pancreatic cancer
5357424|NCT00219531|functional MRI|functional mri
5357425|NCT00219531|pain perception|pain perception
5357426|NCT00219531|anxiety|anxiety
5357427|NCT00219531|brain-gut axis|brain-gut axis
5357428|NCT00219518|Defecography|defecography
5357429|NCT00219518|Pelvic floor dyssynergia|pelvic floor dyssynergia
5357430|NCT00219518|Anismus|anismus
5357431|NCT00219505|Diarrhea-predominant irritable bowel syndrome|diarrhea-predominant irritable bowel syndrome
5357432|NCT00219505|Acupuncture|acupuncture
5357433|NCT00219505|abdominal pain|abdominal pain
5357434|NCT00219492|NCCP, mast cell, esophagus|nccp, mast cell, esophagus
5357435|NCT00219479|seizure prophylaxis|seizure prophylaxis
5357436|NCT00219479|enteral nutrition|enteral nutrition
5357437|NCT00219453|Pilot Projects|pilot projects
5357438|NCT00219453|Injections, Jet|injections, jet
5357439|NCT00219453|Injections, Jet/instrumentation|injections, jet/instrumentation
5357440|NCT00219453|Equipment Contamination/prevention and control|equipment contamination/prevention and control
5357441|NCT00219453|Blood-Borne Pathogens|blood-borne pathogens
5357442|NCT00219453|Disease Transmission, Horizontal|disease transmission, horizontal
5357443|NCT00219427|Low vision|low vision
5357444|NCT00219401|Pneumococcal vaccine|pneumococcal vaccine
5357445|NCT00219401|Antibody responses|antibody responses
5357446|NCT00219401|Cellular immunology|cellular immunology
5357447|NCT00219401|Th1/Th2 immune responses|th1/th2 immune responses
5357448|NCT00219401|Paediatric|paediatric
5357449|NCT00219401|Neonatal|neonatal
5357450|NCT00219401|Infectious diseases|infectious diseases
5357451|NCT00219401|Papua New Guinea|papua new guinea
5357452|NCT00219388|Safety|safety
5357453|NCT00219388|Efficacy|efficacy
5357454|NCT00219388|Levosimendan|levosimendan
5357455|NCT00219388|Dobutamine|dobutamine
5357456|NCT00219388|Intravenous|intravenous
5357457|NCT00219388|Invasive hemodynamics|invasive hemodynamics
5357458|NCT00219388|Decompensated Heart Failure|decompensated heart failure
5357459|NCT00219375|sivelestat sodium hydrate|sivelestat sodium hydrate
5357460|NCT00219375|acute lung injury|acute lung injury
5357461|NCT00219375|systemic inflammatory response syndrome|systemic inflammatory response syndrome
5357462|NCT00219375|Elaspol|elaspol
5357463|NCT00219375|Acute Lung Injury (ALI) Associated With Systemic Inflammatory Response Syndrome (SIRS)|acute lung injury (ali) associated with systemic inflammatory response syndrome (sirs)
5357464|NCT00219362|HIV-1 infection|hiv-1 infection
5357465|NCT00219362|therapeutic vaccine|therapeutic vaccine
5357466|NCT00219362|Treatment Experienced|treatment experienced
5357467|NCT00219349|Anxiety Disorders|anxiety disorders
5357468|NCT00219349|Anxiety Neuroses|anxiety neuroses
5357469|NCT00219349|Behavior Therapy, Cognitive|behavior therapy, cognitive
5357470|NCT00219349|Escitalopram|escitalopram
5357471|NCT00219336|Prevent Alcohol Exposed Pregnancies|prevent alcohol exposed pregnancies
5357472|NCT00219336|Reduced Alcohol Used|reduced alcohol used
5357473|NCT00219336|Self-Guided Motivational Intervention|self-guided motivational intervention
5357474|NCT00219336|Effective Contraception|effective contraception
5357475|NCT00219336|Contraception|contraception
5357476|NCT00219336|College Students|college students
5357477|NCT00219323|Asthma, IgE, Omalizumab|asthma, ige, omalizumab
5357478|NCT00219310|Recurrent Genital Herpes (RGH), famciclovir, episodic treatment, suppressive treatment, Polymerase Chain Reaction (PCR).|recurrent genital herpes (rgh), famciclovir, episodic treatment, suppressive treatment, polymerase chain reaction (pcr).
5357479|NCT00219297|EPO|epo
5357480|NCT00219297|EPO906|epo906
5357481|NCT00219297|Brain cancer|brain cancer
5357482|NCT00219297|Brain metastasis|brain metastasis
5357483|NCT00219297|Lung cancer|lung cancer
5357484|NCT00219297|Lung metastasis|lung metastasis
5357485|NCT00219297|Brain metastasis from non-small cell lung cancer|brain metastasis from non-small cell lung cancer
5357486|NCT00219284|Parkinson's disease, tremor|parkinson's disease, tremor
5357487|NCT00219271|Prostate cancer|prostate cancer
5357488|NCT00219271|molecular staging|molecular staging
5357489|NCT00219271|antitumor potential|antitumor potential
5357490|NCT00219245|Traumatic brain injury, head trauma, rivastigmine, cognitive deficits|traumatic brain injury, head trauma, rivastigmine, cognitive deficits
5357491|NCT00219232|Alzheimer's disease|alzheimer's disease
5357492|NCT00219232|Dementia|dementia
5357493|NCT00219219|zoledronic acid|zoledronic acid
5357494|NCT00219219|prostate cancer|prostate cancer
5357495|NCT00219219|SRE|sre
5357496|NCT00219193|Hypertension, aliskiren, blood pressure, valsartan, HCTZ|hypertension, aliskiren, blood pressure, valsartan, hctz
5357497|NCT00219180|Hypertension, Aliskiren|hypertension, aliskiren
5357498|NCT00219167|hypertension|hypertension
5357499|NCT00219167|aliskiren|aliskiren
5357500|NCT00219167|age|age
5357501|NCT00219128|Hypertension, aliskiren, blood pressure, placebo|hypertension, aliskiren, blood pressure, placebo
5357502|NCT00219115|Hypertension, aliskiren, blood pressure, irbesartan, amlodipine, hydrochlorothiazide|hypertension, aliskiren, blood pressure, irbesartan, amlodipine, hydrochlorothiazide
5357503|NCT00219102|Hypertension,|hypertension,
5357504|NCT00219102|diabetes,|diabetes,
5357505|NCT00219102|aliskiren,|aliskiren,
5357506|NCT00219102|blood pressure,|blood pressure,
5357507|NCT00219102|valsartan,|valsartan,
5357508|NCT00219102|hydrochlorothiazide|hydrochlorothiazide
5357509|NCT00219089|Hypertension, aliskiren, blood pressure, diabetes mellitus, ramipril|hypertension, aliskiren, blood pressure, diabetes mellitus, ramipril
5357510|NCT00219076|Hypertension, aliskiren, blood pressure, amlodipine|hypertension, aliskiren, blood pressure, amlodipine
5357511|NCT00219063|Hypertension, aliskiren, blood pressure, Ramipril, hydrochlorothiazide|hypertension, aliskiren, blood pressure, ramipril, hydrochlorothiazide
5357512|NCT00219037|Hypertension, blood pressure, aliskiren|hypertension, blood pressure, aliskiren
5357513|NCT00219024|Hypertension, aliskiren, blood pressure, hydrochlorothiazide (HCTZ).|hypertension, aliskiren, blood pressure, hydrochlorothiazide (hctz).
5357514|NCT00219011|Aliskiren, heart failure,hypertension|aliskiren, heart failure,hypertension
5357515|NCT00218998|Exercise|exercise
5357516|NCT00218998|Exercise therapy|exercise therapy
5357517|NCT00218985|Aerobic capacity|aerobic capacity
5357518|NCT00218985|Exercise training|exercise training
5357519|NCT00218985|CABG|cabg
5357520|NCT00218985|Endothelial function|endothelial function
5357521|NCT00218972|Hypertension|hypertension
5357522|NCT00218972|endurance training|endurance training
5357523|NCT00218972|endothelial function|endothelial function
5357524|NCT00218972|left ventricular function|left ventricular function
5357525|NCT00218972|Echocardiography|echocardiography
5357526|NCT00218972|Quality of life|quality of life
5357527|NCT00218972|Essential hypertension grade 1 - 2|essential hypertension grade 1 - 2
5357528|NCT00218959|PTSD|ptsd
5357529|NCT00218959|trauma treatment|trauma treatment
5357530|NCT00218959|refugees|refugees
5357531|NCT00218959|randomized controlled|randomized controlled
5357532|NCT00218946|pain|pain
5357533|NCT00218946|infant, premature|infant, premature
5357534|NCT00218946|intubation, gastrointestinal|intubation, gastrointestinal
5357535|NCT00218946|Neonatal nursing|neonatal nursing
5357536|NCT00218933|Interval training|interval training
5357537|NCT00218933|Endothelial dysfunction|endothelial dysfunction
5357538|NCT00218933|Aerobic capacity|aerobic capacity
5357539|NCT00218933|Exercise|exercise
5357540|NCT00218920|aerobic capacity|aerobic capacity
5357541|NCT00218920|endothelial function|endothelial function
5357542|NCT00218920|exercise|exercise
5357543|NCT00218907|HIV prevention|hiv prevention
5357544|NCT00218907|HIV counseling|hiv counseling
5357545|NCT00218907|HIV testing|hiv testing
5357546|NCT00218907|Emergency Medicine|emergency medicine
5357547|NCT00218907|HIV Seronegativity|hiv seronegativity
5357548|NCT00218894|Effect|effect
5357549|NCT00218894|Balance|balance
5357550|NCT00218894|Gait|gait
5357551|NCT00218894|Falls|falls
5357552|NCT00218881|HIV prevention|hiv prevention
5357553|NCT00218881|HIV screening|hiv screening
5357554|NCT00218881|Emergency Medicine|emergency medicine
5357555|NCT00218881|HIV counseling and Testing|hiv counseling and testing
5357556|NCT00218881|HIV Seronegativity|hiv seronegativity
5357557|NCT00218868|Cytodiagnosis|cytodiagnosis
5357558|NCT00218868|Skin Scrape|skin scrape
5357559|NCT00218868|Touch Imprint|touch imprint
5357560|NCT00218868|Papanicolaou|papanicolaou
5357561|NCT00218868|May-Grunvald-Giemsa|may-grunvald-giemsa
5357562|NCT00218855|Multiple Myeloma|multiple myeloma
5357563|NCT00218855|Phase 3, randomised, double blind study|phase 3, randomised, double blind study
5357564|NCT00218855|thalidomide|thalidomide
5357565|NCT00218842|exercise|exercise
5357566|NCT00218842|functioning|functioning
5357567|NCT00218842|frail elderly|frail elderly
5357568|NCT00218829|Photodynamic treatment|photodynamic treatment
5357569|NCT00218829|Basal cell carcinoma|basal cell carcinoma
5357570|NCT00218829|DMSO|dmso
5357571|NCT00218790|Sleep|sleep
5357572|NCT00218790|Renal failure|renal failure
5357573|NCT00218790|Dialysis|dialysis
5357574|NCT00218777|Chronic tic disorder|chronic tic disorder
5357575|NCT00218777|Motor tics|motor tics
5357576|NCT00218777|Vocal tics|vocal tics
5357577|NCT00218751|Child abuse|child abuse
5357578|NCT00218751|Neglect|neglect
5357579|NCT00218751|Home Visitation|home visitation
5357580|NCT00218751|Program Evaluation|program evaluation
5357581|NCT00218725|Cognitive Therapy|cognitive therapy
5357582|NCT00218725|Suicide|suicide
5357583|NCT00218725|Addictions|addictions
5357584|NCT00218725|Substance Abuse|substance abuse
5357585|NCT00218712|HIV|hiv
5357586|NCT00218712|AIDS|aids
5357587|NCT00218712|MSM|msm
5357588|NCT00218712|Cognitive-Behavioral|cognitive-behavioral
5357589|NCT00218712|HIV Seronegativity|hiv seronegativity
5357590|NCT00218699|HIV|hiv
5357591|NCT00218699|MSM Men Who Have Sex with Men|msm men who have sex with men
5357592|NCT00218699|Men Who Have Sex With Men|men who have sex with men
5357593|NCT00218699|Cognitive-Behavioral|cognitive-behavioral
5357594|NCT00218699|HIV Counseling and Testing|hiv counseling and testing
5357595|NCT00218699|HIV Seronegativity|hiv seronegativity
5357596|NCT00218686|HIV|hiv
5357597|NCT00218686|injection drug use|injection drug use
5357598|NCT00218686|social networks|social networks
5357599|NCT00218673|HIV|hiv
5357600|NCT00218673|injection drug use|injection drug use
5357601|NCT00218673|social networks|social networks
5357602|NCT00218621|Buprenorphine|buprenorphine
5357603|NCT00218621|Methadone|methadone
5357604|NCT00218608|Cocaine Abuse|cocaine abuse
5357605|NCT00218582|12 step groups|12 step groups
5357606|NCT00218582|self help|self help
5357607|NCT00218582|psychiatric day treatment|psychiatric day treatment
5357608|NCT00218582|co-occurring disorders|co-occurring disorders
5357609|NCT00218582|dual diagnosis|dual diagnosis
5357610|NCT00218569|Alcohol Dependence|alcohol dependence
5357611|NCT00218569|Cocaine Dependence|cocaine dependence
5357612|NCT00218556|Hepatitis C, Depressive Symptoms|hepatitis c, depressive symptoms
5357613|NCT00218543|ADHD|adhd
5357614|NCT00218543|Cocaine Abuse|cocaine abuse
5357615|NCT00218517|cannabis use disorder|cannabis use disorder
5357616|NCT00218465|Drugs, Investigational|drugs, investigational
5357617|NCT00218465|Therapies for Relapse to Nicotine|therapies for relapse to nicotine
5357618|NCT00218465|Relapse Prevention|relapse prevention
5357619|NCT00218465|Nicotine Cessation Therapies|nicotine cessation therapies
5357620|NCT00218465|Smoking Cessation|smoking cessation
5357621|NCT00218465|Nicotine Dependence|nicotine dependence
5357622|NCT00218452|Tobacco use cessation|tobacco use cessation
5357623|NCT00218439|Smoking|smoking
5357624|NCT00218413|Vaccine|vaccine
5357625|NCT00218413|Immunogenicity|immunogenicity
5357626|NCT00218413|Randomized Controlled Trial|randomized controlled trial
5357627|NCT00218413|Addiction|addiction
5357628|NCT00218374|Opiate Addiction|opiate addiction
5357629|NCT00218374|Opiate Dependence|opiate dependence
5357630|NCT00218361|Behavioral economics|behavioral economics
5357631|NCT00218361|Drug self administration|drug self administration
5357632|NCT00218361|Opioid|opioid
5357633|NCT00218348|Cocaine Abuse|cocaine abuse
5357634|NCT00218348|Dextro-Amphetamine Sulfate|dextro-amphetamine sulfate
5357635|NCT00218335|HIV prevention Intervention, injection drug user,peer-oriented, randomized controlled trial, social network|hiv prevention intervention, injection drug user,peer-oriented, randomized controlled trial, social network
5357636|NCT00218309|opiate dependence|opiate dependence
5357637|NCT00218296|Nicotine Dependence|nicotine dependence
5357638|NCT00218296|Tobacco Dependence|tobacco dependence
5357639|NCT00218283|Nicotine Dependence|nicotine dependence
5357640|NCT00218283|Tobacco Dependence|tobacco dependence
5357641|NCT00218270|Smokeless tobacco, harm reduction|smokeless tobacco, harm reduction
5357642|NCT00218257|Cocaine|cocaine
5357643|NCT00218244|Brand Switching, smokeless tobacco use|brand switching, smokeless tobacco use
5357644|NCT00218231|schizophrenia|schizophrenia
5357645|NCT00218231|tobacco dependence|tobacco dependence
5357646|NCT00218231|nicotine|nicotine
5357647|NCT00218218|Nicotine Dependence|nicotine dependence
5357648|NCT00218218|Tobacco Dependence|tobacco dependence
5357649|NCT00218205|Epirubicin|epirubicin
5357650|NCT00218205|Estramustine Phosphate|estramustine phosphate
5357651|NCT00218205|Celecoxib|celecoxib
5357652|NCT00218205|Hormone Refractory Prostate Cancer|hormone refractory prostate cancer
5357653|NCT00218192|hepatitis c|hepatitis c
5357654|NCT00218192|injection drug use|injection drug use
5357655|NCT00218179|Lung Cancer|lung cancer
5357656|NCT00218179|Cotinine|cotinine
5357657|NCT00218179|NNAL|nnal
5357658|NCT00218179|Carcinogens|carcinogens
5357659|NCT00218179|Case-control|case-control
5357660|NCT00218179|SNPs|snps
5357661|NCT00218166|cocaine|cocaine
5357662|NCT00218166|tiagabine|tiagabine
5357663|NCT00218166|baclofen|baclofen
5357664|NCT00218153|nicotine dependence|nicotine dependence
5357665|NCT00218140|tobacco|tobacco
5357666|NCT00218127|Heroin dependence|heroin dependence
5357667|NCT00218114|ADHD, disruptive behavior disorder, marijuana abuse|adhd, disruptive behavior disorder, marijuana abuse
5357668|NCT00218101|opioid dependence|opioid dependence
5357669|NCT00218075|Cocaine addiction|cocaine addiction
5357670|NCT00218075|cocaine treatment|cocaine treatment
5357671|NCT00218036|Cocaine Abuse|cocaine abuse
5357672|NCT00218036|Opiate Abuse|opiate abuse
5357673|NCT00218023|cocaine|cocaine
5357674|NCT00218023|cocaine addiction|cocaine addiction
5357675|NCT00218023|cocaine abuse|cocaine abuse
5357676|NCT00218023|relapse prevention|relapse prevention
5357677|NCT00218010|methadone|methadone
5357678|NCT00218010|lactation|lactation
5357679|NCT00218010|breastfeeding|breastfeeding
5357680|NCT00218010|maternal opioid dependency|maternal opioid dependency
5357681|NCT00217997|cocaine abuse|cocaine abuse
5357682|NCT00217997|Cocaine-Related Disorders|cocaine-related disorders
5357683|NCT00217984|Tobacco use disorder|tobacco use disorder
5357684|NCT00217984|Alcohol dependence|alcohol dependence
5357685|NCT00217971|cannabis dependence|cannabis dependence
5357686|NCT00217971|dronabinol|dronabinol
5357687|NCT00217971|treatment|treatment
5357688|NCT00217932|Behavioral Disorders|behavioral disorders
5357689|NCT00217854|asthma, corticosteroids|asthma, corticosteroids
5357690|NCT00217841|MRSA|mrsa
5357692|NCT00217763|Alzheimer's disease|alzheimer's disease
5357693|NCT00217724|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5357694|NCT00217724|pain|pain
5357695|NCT00217711|stage III colon cancer|stage iii colon cancer
5357696|NCT00217711|stage IV colon cancer|stage iv colon cancer
5357697|NCT00217711|stage III rectal cancer|stage iii rectal cancer
5357698|NCT00217711|stage IV rectal cancer|stage iv rectal cancer
5357699|NCT00217698|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5357700|NCT00217698|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5357701|NCT00217698|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5357702|NCT00217698|adenocarcinoma of the lung|adenocarcinoma of the lung
5357703|NCT00217698|large cell lung cancer|large cell lung cancer
5357704|NCT00217698|squamous cell lung cancer|squamous cell lung cancer
5357705|NCT00217672|stage IV breast cancer|stage iv breast cancer
5357706|NCT00217672|recurrent breast cancer|recurrent breast cancer
5357707|NCT00217659|male breast cancer|male breast cancer
5357708|NCT00217659|recurrent breast cancer|recurrent breast cancer
5357709|NCT00217659|stage IV breast cancer|stage iv breast cancer
5357710|NCT00217620|adult angiosarcoma|adult angiosarcoma
5357711|NCT00217620|adult leiomyosarcoma|adult leiomyosarcoma
5357712|NCT00217620|adult liposarcoma|adult liposarcoma
5357713|NCT00217620|adult malignant hemangiopericytoma|adult malignant hemangiopericytoma
5357714|NCT00217620|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
5357715|NCT00217620|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
5357716|NCT00217620|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
5357717|NCT00217607|adult angiosarcoma|adult angiosarcoma
5357718|NCT00217607|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
5357719|NCT00217607|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
5357720|NCT00217607|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
5357721|NCT00217594|Immunosuppression|immunosuppression
5357722|NCT00217594|T Cells|t cells
5357723|NCT00217594|Hematopoiesis|hematopoiesis
5357724|NCT00217594|Anti-CD52|anti-cd52
5357725|NCT00217594|Monoclonal Antibody Therapy|monoclonal antibody therapy
5357726|NCT00217581|recurrent gastric cancer|recurrent gastric cancer
5357727|NCT00217581|stage III gastric cancer|stage iii gastric cancer
5357728|NCT00217581|stage IV gastric cancer|stage iv gastric cancer
5357729|NCT00217581|recurrent esophageal cancer|recurrent esophageal cancer
5357730|NCT00217581|stage III esophageal cancer|stage iii esophageal cancer
5357731|NCT00217581|stage IV esophageal cancer|stage iv esophageal cancer
5357732|NCT00217581|adenocarcinoma of the stomach|adenocarcinoma of the stomach
5357733|NCT00217568|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5357734|NCT00217568|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5357735|NCT00217568|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5357736|NCT00217568|peritoneal cavity cancer|peritoneal cavity cancer
5357737|NCT00217555|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5357738|NCT00217555|fallopian tube cancer|fallopian tube cancer
5357739|NCT00217555|peritoneal cavity cancer|peritoneal cavity cancer
5357740|NCT00217529|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5357741|NCT00217529|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5357742|NCT00217529|peritoneal cavity cancer|peritoneal cavity cancer
5357743|NCT00217529|ovarian clear cell cystadenocarcinoma|ovarian clear cell cystadenocarcinoma
5357744|NCT00217529|ovarian endometrioid adenocarcinoma|ovarian endometrioid adenocarcinoma
5357745|NCT00217529|ovarian undifferentiated adenocarcinoma|ovarian undifferentiated adenocarcinoma
5357746|NCT00217529|ovarian mucinous cystadenocarcinoma|ovarian mucinous cystadenocarcinoma
5357747|NCT00217529|ovarian serous cystadenocarcinoma|ovarian serous cystadenocarcinoma
5357748|NCT00217529|Brenner tumor|brenner tumor
5357749|NCT00217529|fallopian tube cancer|fallopian tube cancer
5357750|NCT00217529|ovarian mixed epithelial carcinoma|ovarian mixed epithelial carcinoma
5357751|NCT00217516|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5357752|NCT00217516|stage I prostate cancer|stage i prostate cancer
5357753|NCT00217516|stage II prostate cancer|stage ii prostate cancer
5357754|NCT00217503|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
5357755|NCT00217490|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5357756|NCT00217477|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5357757|NCT00217464|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5357758|NCT00217464|recurrent prostate cancer|recurrent prostate cancer
5357759|NCT00217451|Malaria|malaria
5357760|NCT00217451|Fosmidomycin|fosmidomycin
5357761|NCT00217451|Clindamycin|clindamycin
5357762|NCT00217451|Gabon|gabon
5357763|NCT00217425|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5357764|NCT00217425|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
5357765|NCT00217425|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
5357766|NCT00217425|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
5357767|NCT00217425|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
5357768|NCT00217425|peripheral T-cell lymphoma|peripheral t-cell lymphoma
5357769|NCT00217386|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5357770|NCT00217386|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5357771|NCT00217386|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5357772|NCT00217386|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
5357773|NCT00217386|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
5357774|NCT00217347|Gastroesophageal reflux|gastroesophageal reflux
5357775|NCT00217347|Dyspepsia|dyspepsia
5357776|NCT00217347|Esophageal Capsule Endoscopy|esophageal capsule endoscopy
5357777|NCT00217334|Hypertension|hypertension
5357778|NCT00217334|Cardiovascular diseases|cardiovascular diseases
5357779|NCT00217334|Randomized controlled trial|randomized controlled trial
5357780|NCT00217334|Cluster randomization|cluster randomization
5357781|NCT00217334|Primary care|primary care
5357782|NCT00217321|Parkinson's disease|parkinson's disease
5357783|NCT00217321|Parkinson disease|parkinson disease
5357784|NCT00217321|Registry|registry
5357785|NCT00217321|quality of life|quality of life
5357786|NCT00217321|database|database
5357787|NCT00217295|Relapsing-remitting multiple sclerosis|relapsing-remitting multiple sclerosis
5357788|NCT00217295|Brain atrophy|brain atrophy
5357789|NCT00217295|Disease progression|disease progression
5357790|NCT00217269|Restenosis|restenosis
5357791|NCT00217256|Restenosis|restenosis
5357792|NCT00217243|Pain|pain
5357793|NCT00217243|Magnetoencephalography|magnetoencephalography
5357794|NCT00217243|Median|median
5357795|NCT00217243|Ulnar|ulnar
5357796|NCT00217243|Causalgia|causalgia
5357797|NCT00217243|Complex regional pain syndrome|complex regional pain syndrome
5357798|NCT00217243|Evoked fields|evoked fields
5357799|NCT00217243|Nerve injury|nerve injury
5357800|NCT00217243|Neuropathic pain|neuropathic pain
5357801|NCT00217217|non-pharmaceutical|non-pharmaceutical
5357802|NCT00217217|alternative|alternative
5357803|NCT00217217|imaging|imaging
5357804|NCT00217217|magnetic resonance imaging|magnetic resonance imaging
5357805|NCT00217217|low field magnetic stimulation|low field magnetic stimulation
5357806|NCT00217217|bipolar disorder|bipolar disorder
5357807|NCT00217217|depression|depression
5357808|NCT00217217|bipolar depression|bipolar depression
5357809|NCT00217204|Cystic fibrosis|cystic fibrosis
5357810|NCT00217204|Pancreatic insufficiency|pancreatic insufficiency
5357811|NCT00217204|Steatorrhea|steatorrhea
5357812|NCT00217204|Fat malabsorption|fat malabsorption
5357813|NCT00217204|Pancrelipase|pancrelipase
5357814|NCT00217191|Premature Infants|premature infants
5357815|NCT00217191|Patent ductus arteriosus|patent ductus arteriosus
5357816|NCT00217191|Renal function|renal function
5357817|NCT00217191|Ibuprofen|ibuprofen
5357818|NCT00217178|Atherosclerosis|atherosclerosis
5357819|NCT00217178|CV Risk Factors|cv risk factors
5357820|NCT00217178|Homocysteine|homocysteine
5357821|NCT00217178|CV disease|cv disease
5357822|NCT00217178|Cardiovascular disease|cardiovascular disease
5357823|NCT00217165|bipolar|bipolar
5357824|NCT00217165|mania|mania
5357825|NCT00217165|depression|depression
5357826|NCT00217165|taurine|taurine
5357827|NCT00217165|alternative|alternative
5357828|NCT00217152|Kidney Transplant|kidney transplant
5357829|NCT00217139|Hepatitis C|hepatitis c
5357830|NCT00217139|Celgosivir|celgosivir
5357831|NCT00217139|HCV|hcv
5357832|NCT00217139|Genotype 1|genotype 1
5357833|NCT00217139|Non-responders|non-responders
5357834|NCT00217139|Early Viral Response|early viral response
5357835|NCT00217139|EVR|evr
5357836|NCT00217035|parenteral nutrition|parenteral nutrition
5357837|NCT00217035|burn injury|burn injury
5357838|NCT00217035|stable isotopes|stable isotopes
5357839|NCT00217035|Proline Metabolic Kinetics|proline metabolic kinetics
5357840|NCT00217035|Ornithine Metabolic Kinetics|ornithine metabolic kinetics
5357841|NCT00217035|Glutamate Metabolic Kinetics|glutamate metabolic kinetics
5357842|NCT00217035|Glutamine Metabolic Kinetics|glutamine metabolic kinetics
5357843|NCT00217022|Lymphocytic Colitis|lymphocytic colitis
5357844|NCT00217022|diarrhea|diarrhea
5357845|NCT00217022|budesonide|budesonide
5357846|NCT00216996|parenteral nutrition|parenteral nutrition
5357847|NCT00216996|burn injury|burn injury
5357848|NCT00216996|stable isotopes|stable isotopes
5357849|NCT00216996|Glutamate Metabolic Kinetics|glutamate metabolic kinetics
5357850|NCT00216996|Glutamine Metabolic Kinetics|glutamine metabolic kinetics
5357851|NCT00216983|parenteral nutrition|parenteral nutrition
5357852|NCT00216983|burn injury|burn injury
5357853|NCT00216983|stable isotopes|stable isotopes
5357854|NCT00216983|Proline Metabolic Kinetics|proline metabolic kinetics
5357855|NCT00216983|Ornithine Metabolic Kinetics|ornithine metabolic kinetics
5357856|NCT00216983|Glutamate Metabolic Kinetics|glutamate metabolic kinetics
5357857|NCT00216983|Glutamine Metabolic Kinetics|glutamine metabolic kinetics
5357858|NCT00216970|parenteral nutrition|parenteral nutrition
5357859|NCT00216970|burn injury|burn injury
5357860|NCT00216970|stable isotopes|stable isotopes
5357861|NCT00216970|Arginine Metabolic Kinetics|arginine metabolic kinetics
5357862|NCT00216970|Nitric Oxide Formation|nitric oxide formation
5357863|NCT00216970|Glutamine Metabolic Kinetics|glutamine metabolic kinetics
5357864|NCT00216944|Intubation|intubation
5357865|NCT00216944|premedication|premedication
5357866|NCT00216905|Patients with alcoholism according to ICD-10 after detoxification|patients with alcoholism according to icd-10 after detoxification
5357867|NCT00216866|Embolism|embolism
5357869|NCT00216814|antiangiogenic effects of bcg treatment and prognosis|antiangiogenic effects of bcg treatment and prognosis
5357870|NCT00216801|Upper Tract Transitional Cell (TCC)|upper tract transitional cell (tcc)
5357871|NCT00216788|Sucrose|sucrose
5357872|NCT00216788|Barrett's esophagus|barrett's esophagus
5357873|NCT00216788|Esophagitis|esophagitis
5357874|NCT00216788|GERD|gerd
5357875|NCT00216788|Reflux|reflux
5357876|NCT00216788|Esophagus|esophagus
5357877|NCT00216788|Esomeprazole|esomeprazole
5357878|NCT00216762|Urticaria|urticaria
5357879|NCT00216762|Hives|hives
5357880|NCT00216749|Cerebral Infarction Prevention|cerebral infarction prevention
5357881|NCT00216749|Cilostazol|cilostazol
5357882|NCT00216736|Migraine|migraine
5357883|NCT00216736|Headache|headache
5357884|NCT00216736|Rebound headache|rebound headache
5357885|NCT00216723|Aripiprazole|aripiprazole
5357886|NCT00216723|Schizophrenia|schizophrenia
5357887|NCT00216723|Bipolar Disorder|bipolar disorder
5357888|NCT00216710|Child abuse|child abuse
5357889|NCT00216710|Neglect|neglect
5357890|NCT00216710|Home visitation|home visitation
5357891|NCT00216710|Program evaluation|program evaluation
5357892|NCT00216697|Multiple myeloma|multiple myeloma
5357893|NCT00216697|Proteasome inhibitor|proteasome inhibitor
5357894|NCT00216697|Ubiquitin|ubiquitin
5357895|NCT00216697|Boronic acids|boronic acids
5357896|NCT00216697|Bortezomib|bortezomib
5357897|NCT00216684|Fentanyl, Chronic intractable pain, Japanese patients|fentanyl, chronic intractable pain, japanese patients
5357898|NCT00216671|Schizophrenia|schizophrenia
5357899|NCT00216671|intramuscular injection|intramuscular injection
5357900|NCT00216671|antipsychotic agents|antipsychotic agents
5357901|NCT00216671|long-acting risperidone|long-acting risperidone
5357902|NCT00216658|Fentanyl|fentanyl
5357903|NCT00216658|Cancer pain|cancer pain
5357904|NCT00216658|Japanese patients|japanese patients
5357905|NCT00216645|Müllerian Carcinoma|müllerian carcinoma
5357906|NCT00216645|Doxil|doxil
5357907|NCT00216645|Japanese Patients|japanese patients
5357908|NCT00216632|Schizophrenia, Schizoaffective disorder|schizophrenia, schizoaffective disorder
5357909|NCT00216632|antipsychotic agents|antipsychotic agents
5357910|NCT00216632|long-acting risperidone|long-acting risperidone
5357911|NCT00216632|intramuscular injection|intramuscular injection
5357912|NCT00216619|chronic migraine|chronic migraine
5357913|NCT00216619|Topiramate|topiramate
5357914|NCT00216619|migraine|migraine
5357915|NCT00216619|headache|headache
5357916|NCT00216619|chronic headache|chronic headache
5357917|NCT00216606|Chronic migraine|chronic migraine
5357918|NCT00216606|Migraine|migraine
5357919|NCT00216606|Headache|headache
5357920|NCT00216606|Migraine headache|migraine headache
5357921|NCT00216606|Topiramate|topiramate
5357922|NCT00216593|dementia|dementia
5357923|NCT00216593|cognition function|cognition function
5357924|NCT00216593|Alzheimer disease|alzheimer disease
5357925|NCT00216593|behavioral symptoms|behavioral symptoms
5357926|NCT00216593|galantamine hydrobromide|galantamine hydrobromide
5357927|NCT00216580|Schizophrenia|schizophrenia
5357928|NCT00216580|Intramuscular injection|intramuscular injection
5357929|NCT00216580|Antipsychotic agents|antipsychotic agents
5357930|NCT00216580|Long-acting risperidone|long-acting risperidone
5357931|NCT00216580|Schizophreniform disorders|schizophreniform disorders
5357932|NCT00216580|Schizoaffective disorder|schizoaffective disorder
5357933|NCT00216567|Benign rolandic epilepsy|benign rolandic epilepsy
5357934|NCT00216567|Topiramate|topiramate
5357935|NCT00216554|Bipolar|bipolar
5357936|NCT00216554|risperidone|risperidone
5357937|NCT00216554|Adjunctive therapy|adjunctive therapy
5357938|NCT00216541|Anemia|anemia
5357939|NCT00216541|cancer|cancer
5357940|NCT00216541|transfusion|transfusion
5357941|NCT00216541|chemotherapy|chemotherapy
5357942|NCT00216541|hemoglobin|hemoglobin
5357943|NCT00216541|standard care|standard care
5357944|NCT00216541|epoetin alfa|epoetin alfa
5357945|NCT00216541|epoetin|epoetin
5357946|NCT00216541|erythropoietin|erythropoietin
5357947|NCT00216528|Schizophrenia|schizophrenia
5357948|NCT00216528|risperidone|risperidone
5357949|NCT00216528|Intramuscular injection, long-acting risperidone|intramuscular injection, long-acting risperidone
5357950|NCT00216515|Alzheimer's disease|alzheimer's disease
5357951|NCT00216515|galantamine|galantamine
5357952|NCT00216515|attention|attention
5357953|NCT00216515|executive function|executive function
5357954|NCT00216502|Alzheimer's disease|alzheimer's disease
5357955|NCT00216502|Dementia|dementia
5357956|NCT00216502|galantamine|galantamine
5357957|NCT00216502|placebo|placebo
5357958|NCT00216502|Caregiver|caregiver
5357959|NCT00216502|Brain disease|brain disease
5357960|NCT00216502|Memory loss|memory loss
5357961|NCT00216489|gastroesophageal reflux|gastroesophageal reflux
5357962|NCT00216489|heartburn|heartburn
5357963|NCT00216489|rabeprazole|rabeprazole
5357964|NCT00216489|GERD|gerd
5357965|NCT00216489|anti-ulcer agents|anti-ulcer agents
5357966|NCT00216489|proton pump inhibitor|proton pump inhibitor
5357967|NCT00216476|Schizophrenia, relapse prevention|schizophrenia, relapse prevention
5357968|NCT00216476|Antipsychotic agents|antipsychotic agents
5357969|NCT00216476|Long-acting risperidone|long-acting risperidone
5357971|NCT00216476|Aripiprazole|aripiprazole
5357972|NCT00216463|LDL-cholesterol|ldl-cholesterol
5357973|NCT00216463|apoB-100|apob-100
5357974|NCT00216463|apoB-48|apob-48
5357975|NCT00216450|rabeprazole|rabeprazole
5357976|NCT00216450|proton pump inhibitor|proton pump inhibitor
5357977|NCT00216450|Helicobacter infections|helicobacter infections
5357978|NCT00216450|Helicobacter pylori|helicobacter pylori
5357979|NCT00216450|H pylori|h pylori
5357980|NCT00216450|bacterial infections|bacterial infections
5357981|NCT00216437|Liver cancer|liver cancer
5357982|NCT00216424|Colon cancer|colon cancer
5357983|NCT00216424|Rectal cancer|rectal cancer
5357984|NCT00216398|acromegaly|acromegaly
5357985|NCT00216398|growth hormone|growth hormone
5357986|NCT00216385|Tuberculosis|tuberculosis
5357987|NCT00216385|Treatment|treatment
5357988|NCT00216385|Quinolone|quinolone
5357989|NCT00216385|Short course chemotherapy|short course chemotherapy
5357990|NCT00216372|carcinomatosis|carcinomatosis
5357991|NCT00216359|Treatment Experienced|treatment experienced
5357992|NCT00216333|tuberculosis|tuberculosis
5357993|NCT00216333|fixed dose combination|fixed dose combination
5357994|NCT00216333|DOT|dot
5357995|NCT00216333|shot-course chemotherapy|shot-course chemotherapy
5357996|NCT00216320|electrical stimulation|electrical stimulation
5357997|NCT00216294|Obsessive Compulsive Disorder|obsessive compulsive disorder
5357998|NCT00216294|RG 1068 (Synthetic Human Secretin)|rg 1068 (synthetic human secretin)
5357999|NCT00216281|Schizophrenia|schizophrenia
5358000|NCT00216281|Clozapine|clozapine
5358001|NCT00216281|Atomoxetine|atomoxetine
5358002|NCT00216255|Persistent Developmental Stuttering|persistent developmental stuttering
5358003|NCT00216242|influenza|influenza
5358004|NCT00216242|vaccine|vaccine
5358005|NCT00216242|efficacy|efficacy
5358006|NCT00216242|safety|safety
5358007|NCT00216242|immunogenicity|immunogenicity
5358008|NCT00216229|combined hepatitis A and B vaccine|combined hepatitis a and b vaccine
5358009|NCT00216229|hepatitis B virus|hepatitis b virus
5358010|NCT00216229|immunity|immunity
5358011|NCT00216203|Non-Small Cell Lung Cancer|non-small cell lung cancer
5358012|NCT00216190|Sedation, ICU, Anesthesia, Dexmedetomidine, Midazolam|sedation, icu, anesthesia, dexmedetomidine, midazolam
5358013|NCT00216164|Lymphoma|lymphoma
5358014|NCT00216151|Multiple Myeloma|multiple myeloma
5358015|NCT00216151|Bisphosphonates|bisphosphonates
5358016|NCT00216138|Head and Neck Cancer|head and neck cancer
5358017|NCT00216125|Non-Small Cell Lung Cancer|non-small cell lung cancer
5358018|NCT00216112|Ovarian Cancer|ovarian cancer
5358019|NCT00216099|Prostate Cancer|prostate cancer
5358020|NCT00216086|Rectal Cancer|rectal cancer
5358021|NCT00216073|Breast Cancer|breast cancer
5358022|NCT00216047|Breast Cancer|breast cancer
5358023|NCT00216034|Gastric Cancer|gastric cancer
5358024|NCT00216034|TS-1|ts-1
5358025|NCT00216034|PSK|psk
5358026|NCT00216034|Disease-free survival|disease-free survival
5358027|NCT00216034|Overall survival|overall survival
5358028|NCT00216021|Breast Cancer|breast cancer
5358029|NCT00215995|esophageal cancer|esophageal cancer
5358030|NCT00215995|esophagogastric cancer|esophagogastric cancer
5358031|NCT00215995|gastric cancer|gastric cancer
5358032|NCT00215982|advanced|advanced
5358033|NCT00215982|colon|colon
5358034|NCT00215982|rectal|rectal
5358035|NCT00215969|Pre-eclampsia|pre-eclampsia
5358036|NCT00215969|Pregnancy|pregnancy
5358037|NCT00215969|Hypercoagulation|hypercoagulation
5358038|NCT00215969|Screening|screening
5358039|NCT00215969|Cardiovascular complications|cardiovascular complications
5358040|NCT00215956|Topotecan|topotecan
5358041|NCT00215956|Rectal Neoplasms|rectal neoplasms
5358042|NCT00215956|Radiosensitizing|radiosensitizing
5358043|NCT00215943|hematologic malignancy|hematologic malignancy
5358044|NCT00215930|malignant pleural effusion|malignant pleural effusion
5358045|NCT00215917|Schizophrenia|schizophrenia
5358046|NCT00215917|NMDA|nmda
5358047|NCT00215917|D-serine|d-serine
5358048|NCT00215891|Treatment Experienced|treatment experienced
5358049|NCT00215852|Alferon LDO|alferon ldo
5358050|NCT00215852|Low Dose Oral Interferon|low dose oral interferon
5358051|NCT00215852|Alfa-n3|alfa-n3
5358052|NCT00215852|Human Leukocyte Derived|human leukocyte derived
5358053|NCT00215852|HIV|hiv
5358054|NCT00215852|Asymptomatic HIV|asymptomatic hiv
5358055|NCT00215852|Treatment Experienced|treatment experienced
5358056|NCT00215839|Treatment Experienced|treatment experienced
5358057|NCT00215826|SARS|sars
5358058|NCT00215826|Alferon LDO|alferon ldo
5358059|NCT00215826|Low Dose Oral Interferon ALFA-n3|low dose oral interferon alfa-n3
5358060|NCT00215826|Human Leukocyte Derived|human leukocyte derived
5358061|NCT00215826|Exposure to SARS|exposure to sars
5358062|NCT00215826|Possible SARS|possible sars
5358063|NCT00215813|Chronic Fatigue Syndrome|chronic fatigue syndrome
5358064|NCT00215813|CFS|cfs
5358065|NCT00215813|ME|me
5358066|NCT00215813|Ampligen|ampligen
5358067|NCT00215813|poly I:poly C12U|poly i:poly c12u
5358068|NCT00215813|Rintatolimod|rintatolimod
5358069|NCT00215800|Chronic Fatigue Syndrome|chronic fatigue syndrome
5358070|NCT00215800|Myalgic Encephalomyelitis|myalgic encephalomyelitis
5358071|NCT00215800|CFS|cfs
5358072|NCT00215800|Ampligen|ampligen
5358073|NCT00215800|Poly I:ploy C12U|poly i:ploy c12u
5358074|NCT00215787|Nasal polyps|nasal polyps
5358075|NCT00215787|Gastroesophageal Reflux|gastroesophageal reflux
5358076|NCT00215774|Atrial fibrillation|atrial fibrillation
5358077|NCT00215761|Atrial fibrillation|atrial fibrillation
5358078|NCT00215761|Preventive stimulation|preventive stimulation
5358079|NCT00215761|Pacemaker|pacemaker
5358080|NCT00215748|Elderly|elderly
5358081|NCT00215748|Weekly|weekly
5358082|NCT00215735|diabetes|diabetes
5358083|NCT00215735|Ulcer|ulcer
5358084|NCT00215735|APC|apc
5358085|NCT00215709|elderly|elderly
5358086|NCT00215683|Prostate Cancer|prostate cancer
5358087|NCT00215683|Androgen ablation therapy|androgen ablation therapy
5358088|NCT00215670|AMD|amd
5358089|NCT00215670|Macugen|macugen
5358090|NCT00215670|Pharmacokinetics|pharmacokinetics
5358091|NCT00215670|Age-Related Macular Degeneration|age-related macular degeneration
5358092|NCT00215670|PK|pk
5358093|NCT00215644|Esophagus|esophagus
5358094|NCT00215644|Gastric|gastric
5358095|NCT00215644|Adenocarcinoma|adenocarcinoma
5358096|NCT00215644|EGFR|egfr
5358097|NCT00215644|matuzumab|matuzumab
5358098|NCT00215644|EMD 72000|emd 72000
5358099|NCT00215644|randomized|randomized
5358100|NCT00215644|Epirubicin|epirubicin
5358101|NCT00215644|cisplatin|cisplatin
5358102|NCT00215644|capecitabine|capecitabine
5358103|NCT00215644|Metastatic Esophago-Gastric cancer|metastatic esophago-gastric cancer
5358104|NCT00215631|prostate cancer|prostate cancer
5358105|NCT00215631|radiotherapy|radiotherapy
5358106|NCT00215631|erectile dysfunction|erectile dysfunction
5358107|NCT00215631|tadalafil|tadalafil
5358108|NCT00215605|Advanced Malignancies|advanced malignancies
5358109|NCT00215605|Solid Tumor|solid tumor
5358110|NCT00215605|Medullary Thyroid Cancer|medullary thyroid cancer
5358111|NCT00215566|IBS|ibs
5358112|NCT00215566|IBS-c|ibs-c
5358113|NCT00215540|Double-blind|double-blind
5358114|NCT00215540|Low Birth Weight|low birth weight
5358115|NCT00215540|Surfactant|surfactant
5358116|NCT00215540|Placebo-Controlled|placebo-controlled
5358117|NCT00215540|Premature Birth|premature birth
5358118|NCT00215527|mucopolysaccharidosis|mucopolysaccharidosis
5358119|NCT00215527|Hurler-Scheie|hurler-scheie
5358120|NCT00215527|Scheie|scheie
5358121|NCT00215527|laronidase|laronidase
5358122|NCT00215527|spinal cord compression|spinal cord compression
5358123|NCT00215527|central nervous system|central nervous system
5358124|NCT00215527|enzyme replacement therapy|enzyme replacement therapy
5358125|NCT00215527|intrathecal|intrathecal
5358126|NCT00215527|LA Biomed|la biomed
5358127|NCT00215514|adjuvant chemoradiation|adjuvant chemoradiation
5358128|NCT00215514|GE junction|ge junction
5358129|NCT00215514|epirubicin|epirubicin
5358130|NCT00215501|advanced solid tumor malignancy|advanced solid tumor malignancy
5358131|NCT00215501|capecitabine|capecitabine
5358132|NCT00215501|continuous infusion|continuous infusion
5358133|NCT00215501|5-FU|5-fu
5358134|NCT00215501|irinotecan|irinotecan
5358135|NCT00215501|5-fluorouracil|5-fluorouracil
5358136|NCT00215501|cisplatin|cisplatin
5358137|NCT00215462|gastric adenocarcinoma|gastric adenocarcinoma
5358138|NCT00215462|esophageal adenocarcinoma|esophageal adenocarcinoma
5358139|NCT00215462|vinorelbine|vinorelbine
5358140|NCT00215449|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5358141|NCT00215449|COPD|copd
5358142|NCT00215449|formoterol|formoterol
5358143|NCT00215449|formoterol fumarate|formoterol fumarate
5358144|NCT00215436|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5358145|NCT00215436|COPD|copd
5358146|NCT00215436|formoterol|formoterol
5358147|NCT00215423|COPD|copd
5358148|NCT00215423|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5358149|NCT00215423|Formoterol Fumarate|formoterol fumarate
5358150|NCT00215423|Formoterol|formoterol
5358151|NCT00215410|Asthma|asthma
5358152|NCT00215410|Formoterol|formoterol
5358153|NCT00215410|Fumarate|fumarate
5358154|NCT00215397|Asthma|asthma
5358155|NCT00215397|Formoterol|formoterol
5358156|NCT00215397|Fumarate|fumarate
5358157|NCT00215384|COPD|copd
5358158|NCT00215384|formoterol|formoterol
5358159|NCT00215371|Asthma|asthma
5358160|NCT00215371|Pediatric|pediatric
5358161|NCT00215371|Formoterol Fumarate|formoterol fumarate
5358162|NCT00215371|Foradil|foradil
5358163|NCT00215358|Asthma|asthma
5358164|NCT00215358|Formoterol|formoterol
5358165|NCT00215358|Fumarate|fumarate
5358166|NCT00215358|Foradil|foradil
5358167|NCT00215345|Celecoxib|celecoxib
5358168|NCT00215345|Taxotere|taxotere
5358169|NCT00215345|Hormone Refractory Prostate Cancer|hormone refractory prostate cancer
5358170|NCT00215332|arthroplasty|arthroplasty
5358171|NCT00215332|lumbar|lumbar
5358172|NCT00215332|disc|disc
5358173|NCT00215319|Degenerative disc disease at up to 2 levels (L2-S1)|degenerative disc disease at up to 2 levels (l2-s1)
5358174|NCT00215306|arthroplasty|arthroplasty
5358175|NCT00215306|lumbar|lumbar
5358176|NCT00215306|spine|spine
5358177|NCT00215293|fusion|fusion
5358178|NCT00215293|cervical|cervical
5358179|NCT00215293|spine|spine
5358180|NCT00215280|Mansonella perstans|mansonella perstans
5358181|NCT00215280|microfilaraemia|microfilaraemia
5358182|NCT00215280|ivermectin|ivermectin
5358183|NCT00215280|albendazole|albendazole
5358184|NCT00215280|Uganda|uganda
5358185|NCT00215267|Schistosoma mansoni|schistosoma mansoni
5358186|NCT00215267|hepatosplenomegaly|hepatosplenomegaly
5358187|NCT00215267|malaria|malaria
5358188|NCT00215267|Uganda|uganda
5358189|NCT00215254|quetiapine|quetiapine
5358190|NCT00215254|social anxiety disorder|social anxiety disorder
5358191|NCT00215254|antipsychotic|antipsychotic
5358192|NCT00215254|pilot study|pilot study
5358193|NCT00215241|PTSD|ptsd
5358194|NCT00215241|sertraline|sertraline
5358195|NCT00215241|risperidone|risperidone
5358196|NCT00215241|antidepressant|antidepressant
5358197|NCT00215241|antipsychotic|antipsychotic
5358198|NCT00215241|anxiety|anxiety
5358199|NCT00215241|trauma|trauma
5358200|NCT00215215|Vagus Nerve Stimulation Therapy|vagus nerve stimulation therapy
5358201|NCT00215215|Epilepsies, Partial|epilepsies, partial
5358202|NCT00215215|Seizures|seizures
5358203|NCT00215215|Antiepileptic Drugs|antiepileptic drugs
5358204|NCT00215215|Refractory Partial Seizures|refractory partial seizures
5358205|NCT00215202|Adrenocortical Cancer|adrenocortical cancer
5358206|NCT00215202|Iressa|iressa
5358207|NCT00215202|Adrenal Cancer|adrenal cancer
5358208|NCT00215189|health|health
5358209|NCT00215189|mental illness|mental illness
5358210|NCT00215189|fitness|fitness
5358211|NCT00215176|atypical depression|atypical depression
5358212|NCT00215176|psychostimulants|psychostimulants
5358213|NCT00215176|modafinil|modafinil
5358214|NCT00215163|PTSD|ptsd
5358215|NCT00215163|Anxiety|anxiety
5358216|NCT00215163|CBT|cbt
5358217|NCT00215163|Exposure|exposure
5358218|NCT00215163|Paroxetine|paroxetine
5358219|NCT00215163|Paroxetine-CR|paroxetine-cr
5358220|NCT00215150|anxiety disorder|anxiety disorder
5358221|NCT00215150|SAD|sad
5358222|NCT00215150|ziprasidone|ziprasidone
5358223|NCT00215150|sertraline|sertraline
5358224|NCT00215150|antidepressant|antidepressant
5358225|NCT00215150|antipsychotic|antipsychotic
5358226|NCT00215137|OCD|ocd
5358227|NCT00215137|SSRI|ssri
5358228|NCT00215137|escitalopram|escitalopram
5358229|NCT00215137|relapse|relapse
5358230|NCT00215111|childhood obesity|childhood obesity
5358231|NCT00215111|weight management|weight management
5358232|NCT00215111|dietary interventions|dietary interventions
5358233|NCT00215111|cardiovascular disease risk factors|cardiovascular disease risk factors
5358234|NCT00215098|pediatric health|pediatric health
5358235|NCT00215098|cardiac|cardiac
5358236|NCT00215098|congenital heart surgery|congenital heart surgery
5358237|NCT00215098|post-operative chylous effusions|post-operative chylous effusions
5358238|NCT00215098|heart defects|heart defects
5358239|NCT00215098|children|children
5358240|NCT00215085|pediatric health|pediatric health
5358241|NCT00215085|cardiac|cardiac
5358242|NCT00215085|cardiac tumor|cardiac tumor
5358243|NCT00215085|children|children
5358244|NCT00215072|Death after heart surgery|death after heart surgery
5358245|NCT00215072|surgical mortality|surgical mortality
5358246|NCT00215072|post-operative mortality|post-operative mortality
5358247|NCT00215072|pediatric health|pediatric health
5358248|NCT00215072|cardiac|cardiac
5358249|NCT00215059|angiogenic related growth factor|angiogenic related growth factor
5358250|NCT00215046|vinblastine|vinblastine
5358251|NCT00215046|methotrexate|methotrexate
5358252|NCT00215033|Epstein-Barr virus|epstein-barr virus
5358253|NCT00215033|pediatric health|pediatric health
5358254|NCT00215033|cardiac|cardiac
5358255|NCT00215033|heart transplant|heart transplant
5358256|NCT00215033|lymphoproliferative disease|lymphoproliferative disease
5358257|NCT00215033|post-transplant|post-transplant
5358258|NCT00215033|pediatric transplant|pediatric transplant
5358259|NCT00215020|Isoprostanes|isoprostanes
5358260|NCT00214981|ADHD|adhd
5358261|NCT00214981|Attention Deficit/Hyperactivity Disorder|attention deficit/hyperactivity disorder
5358262|NCT00214929|Pulmonary Embolism|pulmonary embolism
5358263|NCT00214929|Therapy|therapy
5358264|NCT00214929|Home Nursing|home nursing
5358265|NCT00214929|Economics|economics
5358266|NCT00214916|Tight glycemic control with|tight glycemic control with
5358267|NCT00214916|intensive insulin treatment|intensive insulin treatment
5358268|NCT00214916|versus conventional glycemic control|versus conventional glycemic control
5358269|NCT00214916|in infant or child in ICU|in infant or child in icu
5358270|NCT00214903|Postmenopause|postmenopause
5358271|NCT00214903|HRT|hrt
5358272|NCT00214890|HIV|hiv
5358273|NCT00214890|nucleoside pharmacology|nucleoside pharmacology
5358274|NCT00214890|drug-drug interaction|drug-drug interaction
5358275|NCT00214890|Treatment Naive|treatment naive
5358276|NCT00214890|Drug resistance|drug resistance
5358277|NCT00214890|Drug pharmacokinetics|drug pharmacokinetics
5358278|NCT00214877|methylene blue for cognitive dysfunction in bipolar disorder|methylene blue for cognitive dysfunction in bipolar disorder
5358279|NCT00214864|Metastatic Breast Cancer|metastatic breast cancer
5358280|NCT00214864|Taxotere (docetaxel)|taxotere (docetaxel)
5358281|NCT00214864|Xeloda (capecitabine)|xeloda (capecitabine)
5358282|NCT00214851|Familial Cold Urticaria|familial cold urticaria
5358283|NCT00214851|Kineret (anakinra)|kineret (anakinra)
5358284|NCT00214851|Interleukin 1 beta|interleukin 1 beta
5358285|NCT00214851|C-Reactive Protein|c-reactive protein
5358286|NCT00214851|Serum Amyloid A protein|serum amyloid a protein
5358287|NCT00214838|cancer, atiprimod|cancer, atiprimod
5358288|NCT00214812|HIV Seronegativity|hiv seronegativity
5358289|NCT00214812|HIV|hiv
5358290|NCT00214786|Diabetes Mellitus|diabetes mellitus
5358291|NCT00214786|Hypoglycemia|hypoglycemia
5358292|NCT00214786|Hyperglycemia|hyperglycemia
5358293|NCT00214760|Hip prosthesis|hip prosthesis
5358294|NCT00214760|Centralizer|centralizer
5358295|NCT00214760|Uncemented|uncemented
5358296|NCT00214747|HIV Seronegativity|hiv seronegativity
5358297|NCT00214747|HIV|hiv
5358298|NCT00214708|Tuberculosis|tuberculosis
5358299|NCT00214708|Screening|screening
5358300|NCT00214708|Heaf|heaf
5358301|NCT00214708|BCG|bcg
5358302|NCT00214682|Depression|depression
5358303|NCT00214682|Cognition|cognition
5358304|NCT00214682|Depressive disorder|depressive disorder
5358305|NCT00214682|Mental health literacy|mental health literacy
5358306|NCT00214682|Older adults|older adults
5358307|NCT00214682|Randomzed controlled trial|randomzed controlled trial
5358308|NCT00214669|ethnicity|ethnicity
5358309|NCT00214669|primary care|primary care
5358310|NCT00214669|education|education
5358311|NCT00214656|Cardiac surgical procedures|cardiac surgical procedures
5358312|NCT00214656|Surgical blood loss|surgical blood loss
5358313|NCT00214656|Surgical haemostasis|surgical haemostasis
5358314|NCT00214656|Factor VIIa|factor viia
5358315|NCT00214656|Anaesthesia|anaesthesia
5358316|NCT00214643|Malaria|malaria
5358317|NCT00214643|Fosmidomycin|fosmidomycin
5358318|NCT00214643|Clindamycin|clindamycin
5358319|NCT00214643|Chemotherapy|chemotherapy
5358320|NCT00214643|Gabon|gabon
5358321|NCT00214617|hypercholesterolemia|hypercholesterolemia
5358322|NCT00214617|HMG CoA Reductase Inhibtors|hmg coa reductase inhibtors
5358323|NCT00214617|tracer kinetics|tracer kinetics
5358324|NCT00214617|Apolipoproteins|apolipoproteins
5358325|NCT00214591|Type 2 diabetes|type 2 diabetes
5358326|NCT00214578|Schizophrenia|schizophrenia
5358327|NCT00214565|Type 2 diabetes|type 2 diabetes
5358328|NCT00214552|GERD|gerd
5358329|NCT00214552|Gastroesophageal reflux disease|gastroesophageal reflux disease
5358330|NCT00214552|Asthma symptoms|asthma symptoms
5358331|NCT00214539|Asthma|asthma
5358332|NCT00214539|Bronchial Thermoplasty|bronchial thermoplasty
5358333|NCT00214526|Asthma|asthma
5358334|NCT00214526|Bronchial Thermoplasty|bronchial thermoplasty
5358335|NCT00214526|Airway Hyperresponsiveness|airway hyperresponsiveness
5358336|NCT00214487|Myopia Progression|myopia progression
5358337|NCT00214487|Myopia Control|myopia control
5358338|NCT00214487|Bifocal Contact Lenses|bifocal contact lenses
5358339|NCT00214487|Esophoria|esophoria
5358340|NCT00214487|Fixation Disparity|fixation disparity
5358341|NCT00214474|Disease Management|disease management
5358342|NCT00214474|Health Literacy|health literacy
5358343|NCT00214474|Telephone Care|telephone care
5358344|NCT00214474|Group Medical Visits|group medical visits
5358345|NCT00214474|Type 2 Diabetes|type 2 diabetes
5358346|NCT00214474|Access to Care|access to care
5358347|NCT00214474|Technology|technology
5358348|NCT00214474|Language Barriers|language barriers
5358349|NCT00214461|Clostridium difficile|clostridium difficile
5358350|NCT00214448|Multiple genetic conditions will be studied|multiple genetic conditions will be studied
5358351|NCT00214435|HIV infection|hiv infection
5358352|NCT00214435|AIDS|aids
5358353|NCT00214435|Adherence|adherence
5358354|NCT00214435|MEMS caps|mems caps
5358355|NCT00214435|Treatment Experienced|treatment experienced
5358356|NCT00214422|Prostate|prostate
5358357|NCT00214422|Radiation|radiation
5358358|NCT00214422|Cancer|cancer
5358359|NCT00214422|Prostate Cancer|prostate cancer
5358360|NCT00214383|pediatric asthma|pediatric asthma
5358361|NCT00214370|pediatric|pediatric
5358362|NCT00214370|acute leukemia/lymphoma|acute leukemia/lymphoma
5358363|NCT00214344|dying|dying
5358364|NCT00214227|patient who will undergo definitive radiotherapy|patient who will undergo definitive radiotherapy
5358365|NCT00214175|low grade gliomas and benign CNS lesions|low grade gliomas and benign cns lesions
5358366|NCT00214045|Bladder cancer surveillance|bladder cancer surveillance
5358367|NCT00214045|Voiding dysfunction|voiding dysfunction
5358368|NCT00214045|Cystoscopy|cystoscopy
5358369|NCT00214032|lymphedema of the arm in breast cancer survivors|lymphedema of the arm in breast cancer survivors
5358370|NCT00213980|bone mineral density|bone mineral density
5358371|NCT00213980|postmenopausal women|postmenopausal women
5358372|NCT00213967|Influenza vaccine|influenza vaccine
5358373|NCT00213954|Nerve block anaesthesia|nerve block anaesthesia
5358374|NCT00213954|ultrasound-guidance|ultrasound-guidance
5358375|NCT00213941|transient tachypnoea of the newborn|transient tachypnoea of the newborn
5358376|NCT00213941|surfactant deficiency|surfactant deficiency
5358377|NCT00213941|persistant pulmonary hypertension of the neonate|persistant pulmonary hypertension of the neonate
5358378|NCT00213941|lung maturity tests|lung maturity tests
5358379|NCT00213915|L-arginine|l-arginine
5358380|NCT00213915|exercise capacity|exercise capacity
5358381|NCT00213915|renal function|renal function
5358382|NCT00213915|nitric oxide|nitric oxide
5358471|NCT00213616|phrenic nerve|phrenic nerve
5358383|NCT00213915|exercise capacity using a maximal exercise test|exercise capacity using a maximal exercise test
5358384|NCT00213915|urinary elimination of a saline load using blood and urinary samples|urinary elimination of a saline load using blood and urinary samples
5358385|NCT00213902|Heart failure|heart failure
5358386|NCT00213902|Diastolic|diastolic
5358387|NCT00213902|functionClonidine|functionclonidine
5358388|NCT00213902|Left ventricular diastolic dysfunction with preserved ejection fraction|left ventricular diastolic dysfunction with preserved ejection fraction
5358389|NCT00213889|Facial clefting|facial clefting
5358390|NCT00213889|twist|twist
5358391|NCT00213889|craniofacial development genes|craniofacial development genes
5358392|NCT00213889|Human cleft lip and palate|human cleft lip and palate
5358393|NCT00213889|cleft lip and palate|cleft lip and palate
5358394|NCT00213876|Brain tumours|brain tumours
5358395|NCT00213876|oligodendrogliomas|oligodendrogliomas
5358396|NCT00213876|allelotyping|allelotyping
5358397|NCT00213876|SAGE|sage
5358398|NCT00213876|Presence of molecular abnormalities statistically linked to survival or response to chemotherapy|presence of molecular abnormalities statistically linked to survival or response to chemotherapy
5358399|NCT00213863|porous titanium implants|porous titanium implants
5358400|NCT00213863|thyroplasty|thyroplasty
5358401|NCT00213863|vocal cord paralysis|vocal cord paralysis
5358402|NCT00213863|male or female more than 18 years old|male or female more than 18 years old
5358403|NCT00213850|Interrupter technique|interrupter technique
5358404|NCT00213850|Respiratory resistance|respiratory resistance
5358405|NCT00213850|Normal adults|normal adults
5358406|NCT00213837|porous titanium implants|porous titanium implants
5358407|NCT00213837|thyroplasty|thyroplasty
5358408|NCT00213837|vocal cord paralysis|vocal cord paralysis
5358409|NCT00213837|male or female more than 18 years old|male or female more than 18 years old
5358410|NCT00213824|Amyotrophic lateral sclerosis|amyotrophic lateral sclerosis
5358411|NCT00213824|Nogo gene|nogo gene
5358412|NCT00213824|reticulon genes|reticulon genes
5358413|NCT00213811|Bardet-Biedl syndrome, retinitis pigmentosa, obesity, genes|bardet-biedl syndrome, retinitis pigmentosa, obesity, genes
5358414|NCT00213798|Lung cancer|lung cancer
5358415|NCT00213798|plasma DNA|plasma dna
5358416|NCT00213798|allelotyping|allelotyping
5358417|NCT00213798|follow-up|follow-up
5358418|NCT00213798|Prospective Study|prospective study
5358419|NCT00213798|Non-Small Cell Lung Cancer|non-small cell lung cancer
5358420|NCT00213798|Small Cell Lung Cancer|small cell lung cancer
5358421|NCT00213785|AreET1|areet1
5358423|NCT00213785|BNP pronostic markers of stroke|bnp pronostic markers of stroke
5358424|NCT00213772|Porphyria cutanea tarda|porphyria cutanea tarda
5358425|NCT00213772|hepatitis C|hepatitis c
5358426|NCT00213772|hemochromatosis|hemochromatosis
5358427|NCT00213759|neutropenia|neutropenia
5358428|NCT00213759|prematurity|prematurity
5358429|NCT00213759|nosocomial infection|nosocomial infection
5358430|NCT00213759|G-CSF|g-csf
5358431|NCT00213746|Coronary Arteriosclerosis|coronary arteriosclerosis
5358432|NCT00213746|Heart Failure, Congestive|heart failure, congestive
5358433|NCT00213746|Myocardial Infarction|myocardial infarction
5358434|NCT00213746|Myocardial Revascularization|myocardial revascularization
5358435|NCT00213746|Tomography, Emission-Computed, Single-Photon|tomography, emission-computed, single-photon
5358436|NCT00213746|Dobutamine|dobutamine
5358437|NCT00213746|Myocardial Stunning|myocardial stunning
5358438|NCT00213746|Myocardial Hibernation|myocardial hibernation
5358439|NCT00213733|Lung cancer patients|lung cancer patients
5358440|NCT00213733|non-small cell lung cancer|non-small cell lung cancer
5358441|NCT00213733|molecular marker|molecular marker
5358442|NCT00213733|lymph node completed resected|lymph node completed resected
5358443|NCT00213733|Lung cancer samples and paired lymph node resected|lung cancer samples and paired lymph node resected
5358444|NCT00213720|Hyperthyroidism|hyperthyroidism
5358445|NCT00213720|atrial fibrillation|atrial fibrillation
5358446|NCT00213720|quality of life|quality of life
5358447|NCT00213720|radioiodine treatment|radioiodine treatment
5358448|NCT00213707|Dendritic cells|dendritic cells
5358449|NCT00213707|liver transplantation|liver transplantation
5358450|NCT00213707|hepatitis C virus|hepatitis c virus
5358451|NCT00213707|quasispecies|quasispecies
5358452|NCT00213707|virological markers|virological markers
5358453|NCT00213707|biochemical markers|biochemical markers
5358454|NCT00213707|immunological markers|immunological markers
5358455|NCT00213707|clinical markers|clinical markers
5358456|NCT00213681|Pulmonary edema, respiratory failure, pressure support ventilation, continuous positive pressure|pulmonary edema, respiratory failure, pressure support ventilation, continuous positive pressure
5358457|NCT00213668|glutamine|glutamine
5358458|NCT00213668|premature neonate|premature neonate
5358459|NCT00213668|gastric emptying|gastric emptying
5358460|NCT00213642|Technetium Tc 99m Mertiatide|technetium tc 99m mertiatide
5358461|NCT00213642|Radionuclide Imaging|radionuclide imaging
5358462|NCT00213642|Cisplatin|cisplatin
5358463|NCT00213642|Kidney failure|kidney failure
5358464|NCT00213642|Drug Toxicity|drug toxicity
5358465|NCT00213642|Cancer|cancer
5358466|NCT00213629|myositis|myositis
5358467|NCT00213629|cDNA arrays|cdna arrays
5358468|NCT00213629|Genes, T-Cell Receptor beta|genes, t-cell receptor beta
5358469|NCT00213616|bilateral vocal cord paralysis|bilateral vocal cord paralysis
5358470|NCT00213616|reinnervation|reinnervation
5358472|NCT00213603|precancerous lesions|precancerous lesions
5358473|NCT00213603|Lung cancer|lung cancer
5358474|NCT00213603|Follow-up|follow-up
5358475|NCT00213603|Randomized study|randomized study
5358476|NCT00213603|Autofluorescence endoscopy|autofluorescence endoscopy
5358477|NCT00213603|precancerous conditions|precancerous conditions
5358478|NCT00213577|overactive neurogenic bladder|overactive neurogenic bladder
5358479|NCT00213499|Mechanical ventilation|mechanical ventilation
5358480|NCT00213499|Weaning|weaning
5358481|NCT00213499|Noninvasive ventilation|noninvasive ventilation
5358482|NCT00213499|Acute on chronic respiratory failure|acute on chronic respiratory failure
5358483|NCT00213473|acquired haemophilia|acquired haemophilia
5358484|NCT00213434|prospective|prospective
5358485|NCT00213434|randomized|randomized
5358486|NCT00213434|polysomnography|polysomnography
5358487|NCT00213434|orthodontic appliance, removable|orthodontic appliance, removable
5358488|NCT00213408|Arrhythmia|arrhythmia
5358489|NCT00213408|atrial flutter|atrial flutter
5358490|NCT00213408|catheter ablation|catheter ablation
5358491|NCT00213395|Noninvasive ventilation|noninvasive ventilation
5358492|NCT00213395|Acute hypercapnic respiratory failure|acute hypercapnic respiratory failure
5358493|NCT00213395|Cephalic mask|cephalic mask
5358494|NCT00213395|Facial Mask|facial mask
5358495|NCT00213382|swallowing|swallowing
5358496|NCT00213382|ventilation|ventilation
5358497|NCT00213382|pressure|pressure
5358498|NCT00213382|EMG|emg
5358499|NCT00213382|cortical magnetic stimulation|cortical magnetic stimulation
5358500|NCT00213382|Brain Mapping|brain mapping
5358501|NCT00213369|aspiration|aspiration
5358502|NCT00213369|stroke|stroke
5358503|NCT00213369|motor evoked potential|motor evoked potential
5358504|NCT00213369|cortical evoked potential|cortical evoked potential
5358505|NCT00213369|neuromodulation|neuromodulation
5358636|NCT00213005|HIV|hiv
5358506|NCT00213356|spinal cord injuries - anal sphincter - evoked potentials|spinal cord injuries - anal sphincter - evoked potentials
5358507|NCT00213343|aspiration|aspiration
5358508|NCT00213343|phrenic nerve|phrenic nerve
5358509|NCT00213343|magnetic stimulation|magnetic stimulation
5358510|NCT00213330|cerebral activity|cerebral activity
5358511|NCT00213330|rectal distension|rectal distension
5358512|NCT00213330|colitis ulcerative|colitis ulcerative
5358513|NCT00213330|irritable bowel syndrome|irritable bowel syndrome
5358514|NCT00213330|magnetic resonance imaging|magnetic resonance imaging
5358515|NCT00213317|sacral magnetic stimulation|sacral magnetic stimulation
5358516|NCT00213317|fecal incontinence|fecal incontinence
5358517|NCT00213317|constipation|constipation
5358518|NCT00213304|organ transplantation|organ transplantation
5358519|NCT00213304|immunosuppression|immunosuppression
5358520|NCT00213304|vaccine|vaccine
5358521|NCT00213304|varicella|varicella
5358522|NCT00213304|pediatrics|pediatrics
5358523|NCT00213291|chronic kidney failure|chronic kidney failure
5358524|NCT00213291|darbepoetin|darbepoetin
5358525|NCT00213291|pediatrics|pediatrics
5358526|NCT00213291|anemia|anemia
5358527|NCT00213278|glioma|glioma
5358528|NCT00213278|brain tumour|brain tumour
5358529|NCT00213278|cancer|cancer
5358530|NCT00213278|pediatrics|pediatrics
5358531|NCT00213278|vinblastine sulfate|vinblastine sulfate
5358532|NCT00213265|organ transplantation|organ transplantation
5358533|NCT00213265|immunosuppression|immunosuppression
5358534|NCT00213265|vaccine|vaccine
5358535|NCT00213265|pneumococcal conjugate vaccine|pneumococcal conjugate vaccine
5358536|NCT00213265|pediatrics|pediatrics
5358537|NCT00213252|asthma, randomized trial, pediatrics|asthma, randomized trial, pediatrics
5358538|NCT00213239|spinal puncture|spinal puncture
5358539|NCT00213239|remifentanil|remifentanil
5358540|NCT00213239|propofol|propofol
5358541|NCT00213239|anesthesia|anesthesia
5358542|NCT00213239|dose finding|dose finding
5358543|NCT00213239|pediatrics|pediatrics
5358544|NCT00213226|bronchiolitis|bronchiolitis
5358545|NCT00213226|pediatrics|pediatrics
5358546|NCT00213226|corticosteroids|corticosteroids
5358547|NCT00213213|sucrose|sucrose
5358548|NCT00213213|analgesia|analgesia
5358549|NCT00213213|pain|pain
5358550|NCT00213213|neonates|neonates
5358551|NCT00213213|diabetes|diabetes
5358552|NCT00213200|pain|pain
5358553|NCT00213200|analgesia|analgesia
5358554|NCT00213200|morphine|morphine
5358555|NCT00213200|amethocaine|amethocaine
5358556|NCT00213200|neonate|neonate
5358557|NCT00213187|Juvenile Rheumatoid Arthritis,|juvenile rheumatoid arthritis,
5358558|NCT00213187|Randomized Control Trial,|randomized control trial,
5358559|NCT00213187|attention placebo,|attention placebo,
5358560|NCT00213187|exercise testing,|exercise testing,
5358561|NCT00213187|aerobics,|aerobics,
5358562|NCT00213187|Qi Gong,|qi gong,
5358563|NCT00213187|exercise video,|exercise video,
5358564|NCT00213187|activities of daily living,|activities of daily living,
5358565|NCT00213187|quality of life,|quality of life,
5358566|NCT00213187|economy of walking,|economy of walking,
5358567|NCT00213187|fitness|fitness
5358568|NCT00213187|pediatrics|pediatrics
5358569|NCT00213174|pediatrics|pediatrics
5358570|NCT00213174|injury|injury
5358571|NCT00213174|arm fractures|arm fractures
5358572|NCT00213174|trauma|trauma
5358573|NCT00213174|playground surfaces|playground surfaces
5358575|NCT00213161|anemia|anemia
5358576|NCT00213161|iron deficiency|iron deficiency
5358577|NCT00213161|iron drops|iron drops
5358578|NCT00213161|iron supplement|iron supplement
5358579|NCT00213161|malnutrition|malnutrition
5358580|NCT00213161|pediatrics|pediatrics
5358581|NCT00213122|alpha-glucosidase inhibitor,Insulin|alpha-glucosidase inhibitor,insulin
5358582|NCT00213109|alpha-glucosidase inhibitor,Insulin|alpha-glucosidase inhibitor,insulin
5358583|NCT00213096|Contraceptive agents|contraceptive agents
5358584|NCT00213096|female|female
5358585|NCT00213083|Microbicide|microbicide
5358586|NCT00213083|HIV|hiv
5358587|NCT00213083|AIDS|aids
5358588|NCT00213083|STIs|stis
5358589|NCT00213083|STDs|stds
5358590|NCT00213083|Efficacy|efficacy
5358591|NCT00213083|HSV|hsv
5358592|NCT00213083|Women|women
5358593|NCT00213083|South Africa|south africa
5358594|NCT00213083|seroconversion|seroconversion
5358595|NCT00213083|condom|condom
5358596|NCT00213083|safe-sex|safe-sex
5358597|NCT00213083|vaginal intercourse|vaginal intercourse
5358598|NCT00213083|prevention|prevention
5358599|NCT00213083|HIV Seronegativity|hiv seronegativity
5358600|NCT00213070|alpha-glucosidase inhibitor,Insulin|alpha-glucosidase inhibitor,insulin
5358601|NCT00213057|Microbicides|microbicides
5358602|NCT00213057|HIV prevention|hiv prevention
5358603|NCT00213057|sexually transmitted infections|sexually transmitted infections
5358604|NCT00213057|carrageenan|carrageenan
5358605|NCT00213057|sero-concordant couples|sero-concordant couples
5358606|NCT00213057|HIV Seronegativity|hiv seronegativity
5358607|NCT00213057|HIV|hiv
5358608|NCT00213044|Microbicides|microbicides
5358609|NCT00213044|HIV prevention|hiv prevention
5358610|NCT00213044|HIV-positive women|hiv-positive women
5358611|NCT00213044|safety|safety
5358612|NCT00213044|carrageenan|carrageenan
5358613|NCT00213044|HIV|hiv
5358614|NCT00213031|microbicides|microbicides
5358615|NCT00213031|HIV prevention|hiv prevention
5358616|NCT00213031|sexually transmitted infections|sexually transmitted infections
5358617|NCT00213031|female-initiated protection|female-initiated protection
5358618|NCT00213031|carrageenan|carrageenan
5358619|NCT00213031|expanded safety trial|expanded safety trial
5358620|NCT00213031|HIV Seronegativity|hiv seronegativity
5358621|NCT00213031|HIV|hiv
5358622|NCT00213018|microbicides|microbicides
5358623|NCT00213018|HIV prevention|hiv prevention
5358624|NCT00213018|sexually transmitted infections|sexually transmitted infections
5358625|NCT00213018|female-initiated protection|female-initiated protection
5358626|NCT00213018|carrageenan|carrageenan
5358627|NCT00213018|expanded safety trial|expanded safety trial
5358628|NCT00213018|HIV Seronegativity|hiv seronegativity
5358629|NCT00213018|HIV|hiv
5358630|NCT00213005|Microbicides|microbicides
5358631|NCT00213005|HIV prevention|hiv prevention
5358632|NCT00213005|HIV positive|hiv positive
5358633|NCT00213005|carrageenan|carrageenan
5358634|NCT00213005|safety trial|safety trial
5358635|NCT00213005|Treatment Experienced|treatment experienced
5358637|NCT00212992|defibrillation|defibrillation
5358638|NCT00212992|ventricular fibrillation|ventricular fibrillation
5358639|NCT00212992|heart arrest|heart arrest
5358640|NCT00212979|glomerular filtration rate|glomerular filtration rate
5358641|NCT00212979|cystatin C|cystatin c
5358642|NCT00212979|creatinine|creatinine
5358643|NCT00212966|psychosocial|psychosocial
5358644|NCT00212953|Chest Pain,|chest pain,
5358645|NCT00212953|Shortness of breath,|shortness of breath,
5358646|NCT00212953|Injury,|injury,
5358647|NCT00212953|Trauma|trauma
5358648|NCT00212940|Treatment Naive|treatment naive
5358649|NCT00212940|HIV|hiv
5358650|NCT00212901|Diabetes|diabetes
5358651|NCT00212901|Proteinuria|proteinuria
5358652|NCT00212901|Angiotensin converting enzyme inhibitors|angiotensin converting enzyme inhibitors
5358653|NCT00212901|Angiotensin receptor antagonists|angiotensin receptor antagonists
5358654|NCT00212888|HIV|hiv
5358655|NCT00212888|Vaccination|vaccination
5358656|NCT00212875|Chronic Kidney disease|chronic kidney disease
5358657|NCT00212875|anemia|anemia
5358658|NCT00212862|Anemia|anemia
5358659|NCT00212862|Cancer|cancer
5358660|NCT00212862|Epoetin alfa|epoetin alfa
5358661|NCT00212862|Darbepoetin alfa|darbepoetin alfa
5358662|NCT00212862|Registry|registry
5358663|NCT00212849|Articular Cartilage Lesions|articular cartilage lesions
5358664|NCT00212849|Patellar lesions|patellar lesions
5358665|NCT00212849|Trochlear lesions|trochlear lesions
5358666|NCT00212849|Patellofemoral joint|patellofemoral joint
5358667|NCT00212849|Carticel|carticel
5358668|NCT00212849|Autologous Chondrocyte Implantation|autologous chondrocyte implantation
5358669|NCT00212823|Migraine|migraine
5358670|NCT00212810|Migraine|migraine
5358671|NCT00212810|Headache|headache
5358672|NCT00212810|Migraine Headache|migraine headache
5358673|NCT00212758|Short stature|short stature
5358674|NCT00212758|children|children
5358675|NCT00212758|kidney failure, chronic|kidney failure, chronic
5358676|NCT00212758|Growth|growth
5358677|NCT00212745|Behavior Therapy|behavior therapy
5358678|NCT00212745|Relaxation Techniques|relaxation techniques
5358679|NCT00212732|ONO-8025, KRP-197, overactive bladder, antimuscarinic|ono-8025, krp-197, overactive bladder, antimuscarinic
5358680|NCT00212719|ONO-5920, osteoporosis, bisphosphonate|ono-5920, osteoporosis, bisphosphonate
5358681|NCT00212706|ONO-8025, KRP-197, overactive bladder, antimuscarinic|ono-8025, krp-197, overactive bladder, antimuscarinic
5358682|NCT00212693|ONO-2506PO, Parkinson's disease|ono-2506po, parkinson's disease
5358683|NCT00212680|ONO-1101,Landiolol Hydrochloride, Postoperative, Supraventricular Tachyarrhythmia|ono-1101,landiolol hydrochloride, postoperative, supraventricular tachyarrhythmia
5358684|NCT00212667|ONO-5920, osteoporosis, bisphosphonate|ono-5920, osteoporosis, bisphosphonate
5358685|NCT00212654|ONO-1101|ono-1101
5358686|NCT00212654|Landiolol Hydrochloride|landiolol hydrochloride
5358687|NCT00212654|Postoperative|postoperative
5358688|NCT00212654|supraventricular tachyarrhythmia|supraventricular tachyarrhythmia
5358689|NCT00212628|ONO-5920|ono-5920
5358690|NCT00212628|osteoporosis|osteoporosis
5358691|NCT00212628|bisphosphonate|bisphosphonate
5358692|NCT00212615|Colorectal neoplasm|colorectal neoplasm
5358693|NCT00212615|Capecitabine (Xeloda)|capecitabine (xeloda)
5358694|NCT00212615|Oxaliplatin (Eloxatin)|oxaliplatin (eloxatin)
5358695|NCT00212615|Advanced disease|advanced disease
5358696|NCT00212615|Metastatic disease|metastatic disease
5358697|NCT00212615|First-line treatment|first-line treatment
5358698|NCT00212615|Phase II study|phase ii study
5358699|NCT00212602|ONO-7436, Aprepitant, Vomiting, Nausea|ono-7436, aprepitant, vomiting, nausea
5358700|NCT00212589|Patients preference|patients preference
5358701|NCT00212589|Colorectal cancer|colorectal cancer
5358702|NCT00212589|Capecitabine|capecitabine
5358703|NCT00212589|Fluorouracil + folinic acid|fluorouracil + folinic acid
5358704|NCT00212589|Cross-over study|cross-over study
5358705|NCT00212576|Child development|child development
5358706|NCT00212576|Language Development|language development
5358707|NCT00212576|Parenting|parenting
5358708|NCT00212537|Asthma and normal|asthma and normal
5358709|NCT00212485|Hemophilia|hemophilia
5358710|NCT00212485|Factor Deficiency|factor deficiency
5358711|NCT00212485|synovitis|synovitis
5358712|NCT00212485|sonogram|sonogram
5358713|NCT00212459|Bleeding logs|bleeding logs
5358714|NCT00212459|Factor Infusions|factor infusions
5358715|NCT00212446|Tocolysis|tocolysis
5358716|NCT00212446|Electrical Pacemaker|electrical pacemaker
5358717|NCT00212433|colorectal neoplasia|colorectal neoplasia
5358718|NCT00212433|CT colonography|ct colonography
5358719|NCT00212433|faecal tagging|faecal tagging
5358720|NCT00212420|fistula; enterocutaneous; nutrition;enteral; parenteral; TPN|fistula; enterocutaneous; nutrition;enteral; parenteral; tpn
5358721|NCT00212407|Cord blood transplantation|cord blood transplantation
5358722|NCT00212407|bone marrow transplantation|bone marrow transplantation
5358723|NCT00212394|Tourniquet|tourniquet
5358724|NCT00212394|paresis|paresis
5358725|NCT00212381|cervical dysplasia, diindolylmethane, pap smear|cervical dysplasia, diindolylmethane, pap smear
5358726|NCT00212329|Type 1 Diabetes|type 1 diabetes
5358727|NCT00212329|Juvenile Onset Diabetes|juvenile onset diabetes
5358728|NCT00212329|Insulin Dependent Diabetes|insulin dependent diabetes
5358729|NCT00212329|T1D|t1d
5358730|NCT00212316|Huntington's Disease|huntington's disease
5358731|NCT00212316|phenylbutyrate|phenylbutyrate
5358732|NCT00212316|HDAC inhibitors|hdac inhibitors
5358733|NCT00212316|transcription|transcription
5358734|NCT00212303|type 2 diabetes|type 2 diabetes
5358735|NCT00212303|hypertension|hypertension
5358736|NCT00212303|exercise training|exercise training
5358737|NCT00212303|cardiac, peripheral|cardiac, peripheral
5358738|NCT00212303|body composition|body composition
5358739|NCT00212303|physical fitness|physical fitness
5358740|NCT00212303|inflammation|inflammation
5358741|NCT00212290|impaired glucose tolerance|impaired glucose tolerance
5358742|NCT00212264|urinary incontinence|urinary incontinence
5358743|NCT00212264|therapy|therapy
5358744|NCT00212264|prostatectomy|prostatectomy
5358745|NCT00212264|prostate cancer|prostate cancer
5358746|NCT00212251|obesity|obesity
5358747|NCT00212251|postpartum period|postpartum period
5358748|NCT00212251|exercise|exercise
5358749|NCT00212251|diet|diet
5358750|NCT00212251|motivation|motivation
5358751|NCT00212238|obesity|obesity
5358752|NCT00212238|weight loss|weight loss
5358753|NCT00212238|Internet|internet
5358754|NCT00212238|cognitive behavior therapy|cognitive behavior therapy
5358755|NCT00212238|computer assisted patient care|computer assisted patient care
5358756|NCT00212238|human therapy evaluation|human therapy evaluation
5358757|NCT00212238|physical activity|physical activity
5358758|NCT00212238|clinical trial|clinical trial
5358882|NCT00211783|fMRI|fmri
5358759|NCT00212238|nutrient intake activity|nutrient intake activity
5358760|NCT00212238|outcomes research|outcomes research
5358761|NCT00212238|personal log /diary|personal log /diary
5358762|NCT00212238|reinforcer|reinforcer
5358763|NCT00212238|self care|self care
5358764|NCT00212238|social support network|social support network
5358765|NCT00212238|weight control|weight control
5358766|NCT00212238|behavioral /social science research tag|behavioral /social science research tag
5358767|NCT00212238|clinical research|clinical research
5358768|NCT00212238|human subject|human subject
5358769|NCT00212238|questionnaire|questionnaire
5358770|NCT00212225|gastric disease|gastric disease
5358771|NCT00212225|H. pylori|h. pylori
5358772|NCT00212225|children|children
5359967|NCT00207064|PPI|ppi
5358773|NCT00212225|Helicobacter pylori|helicobacter pylori
5358774|NCT00212225|child|child
5358775|NCT00212225|epidemiology|epidemiology
5358776|NCT00212212|selenium supplements|selenium supplements
5358777|NCT00212212|selenate|selenate
5358778|NCT00212212|selenomethionine|selenomethionine
5358779|NCT00212212|biomarkers|biomarkers
5358780|NCT00212212|plasma selenium concentration|plasma selenium concentration
5358781|NCT00212212|plasma glutathione peroxidase|plasma glutathione peroxidase
5358782|NCT00212212|selenoprotein P|selenoprotein p
5358783|NCT00212199|Obesity Treatment|obesity treatment
5358784|NCT00212199|Effectiveness of weight management treatment|effectiveness of weight management treatment
5358785|NCT00212199|Counseling for weight management|counseling for weight management
5358786|NCT00212173|Adolescent|adolescent
5358787|NCT00212173|Weight Management|weight management
5358788|NCT00212173|Obesity Treatment|obesity treatment
5358789|NCT00212173|Behavioral Treatment|behavioral treatment
5358790|NCT00212147|cobalamin|cobalamin
5358791|NCT00212147|anesthesia|anesthesia
5358792|NCT00212147|cognition|cognition
5358793|NCT00212134|cataract surgery|cataract surgery
5358794|NCT00212134|intraocular lens|intraocular lens
5358795|NCT00212134|contact lens|contact lens
5358796|NCT00212134|infants|infants
5358797|NCT00212134|aphakia|aphakia
5358798|NCT00212121|breast cancer|breast cancer
5358799|NCT00212121|radiotherapy|radiotherapy
5358800|NCT00212121|microarrays|microarrays
5358801|NCT00212108|celecoxib, NPC, gefitinib|celecoxib, npc, gefitinib
5358802|NCT00212095|breast cancer|breast cancer
5358803|NCT00212095|docetaxel|docetaxel
5358804|NCT00212095|gene expression|gene expression
5358805|NCT00212095|proteomics|proteomics
5358806|NCT00212082|breast cancer|breast cancer
5358807|NCT00212082|chemotherapy response|chemotherapy response
5358808|NCT00212082|gene expression profiles|gene expression profiles
5358809|NCT00212082|proteomics|proteomics
5358810|NCT00212069|breast cancer|breast cancer
5358811|NCT00212069|serum proteomics|serum proteomics
5358812|NCT00212069|gemcitabine|gemcitabine
5358813|NCT00212069|carboplatin|carboplatin
5358814|NCT00212069|chemotherapy sensitivity|chemotherapy sensitivity
5358815|NCT00212056|Acute myocardial infarction|acute myocardial infarction
5358816|NCT00212056|Atrial natriuretic peptide|atrial natriuretic peptide
5358817|NCT00212056|Data mining|data mining
5358818|NCT00212056|Randomized clinical trial|randomized clinical trial
5358819|NCT00212056|SNPs|snps
5358820|NCT00212043|randomised phase II trial gemcitabine and carboplatin|randomised phase ii trial gemcitabine and carboplatin
5358821|NCT00212030|Acute myocardial infarction|acute myocardial infarction
5358822|NCT00212030|Data mining|data mining
5358823|NCT00212030|Nicorandil|nicorandil
5358824|NCT00212030|Randomized clinical trial|randomized clinical trial
5358825|NCT00212030|SNPs|snps
5358826|NCT00212017|IGT|igt
5358827|NCT00212017|Myocardial Infarction|myocardial infarction
5358828|NCT00212017|alpha-glucosidase inhibitor|alpha-glucosidase inhibitor
5358829|NCT00212017|re-infarction prevention|re-infarction prevention
5358830|NCT00212004|diabetes mellitus|diabetes mellitus
5358831|NCT00212004|myocardial infarction|myocardial infarction
5358832|NCT00212004|pioglitazone|pioglitazone
5358833|NCT00211978|PhosLo (Calcium acetate)|phoslo (calcium acetate)
5358834|NCT00211965|Knee replacement surgery|knee replacement surgery
5358835|NCT00211965|hip replacement surgery|hip replacement surgery
5358836|NCT00211965|nosocomial infections|nosocomial infections
5358837|NCT00211965|Arthroplasty|arthroplasty
5358838|NCT00211939|PhosLo (Calcium acetate)|phoslo (calcium acetate)
5358839|NCT00211939|Renagel (sevelamer, polyallylamine HCL)|renagel (sevelamer, polyallylamine hcl)
5358840|NCT00211939|kidney dialysis|kidney dialysis
5358841|NCT00211939|hyperphosphatemia|hyperphosphatemia
5358842|NCT00211939|Kidney failure|kidney failure
5358843|NCT00211926|vaccine|vaccine
5358844|NCT00211926|Staphylococcus aureus vaccine|staphylococcus aureus vaccine
5358845|NCT00211887|Multiple Sclerosis|multiple sclerosis
5358846|NCT00211887|Clinical trial|clinical trial
5358847|NCT00211887|treatment trial|treatment trial
5358848|NCT00211887|autoimmune disease|autoimmune disease
5358849|NCT00211887|Relapsing Remitting|relapsing remitting
5358850|NCT00211887|MS Treatment|ms treatment
5358851|NCT00211887|interferon beta-1a|interferon beta-1a
5358852|NCT00211887|glatiramer acetate|glatiramer acetate
5358853|NCT00211874|Congestive heart failure|congestive heart failure
5358854|NCT00211874|nurse management|nurse management
5358855|NCT00211874|effectiveness trial|effectiveness trial
5358856|NCT00211874|quality improvement|quality improvement
5358857|NCT00211874|minority communities|minority communities
5358858|NCT00211874|disease management|disease management
5358859|NCT00211848|Chemical Compounds-drugs|chemical compounds-drugs
5358860|NCT00211848|Human Subjects- adults|human subjects- adults
5358861|NCT00211848|Gastrointestinal System-liver|gastrointestinal system-liver
5358862|NCT00211848|Pathology|pathology
5358863|NCT00211835|TBI|tbi
5358864|NCT00211835|traumatic brain injury|traumatic brain injury
5358865|NCT00211835|depression|depression
5358866|NCT00211835|cognitive behavioral therapy|cognitive behavioral therapy
5358867|NCT00211835|supportive psychotherapy|supportive psychotherapy
5358868|NCT00211835|psychotherapy|psychotherapy
5358869|NCT00211822|Pathological Gambling|pathological gambling
5358870|NCT00211822|Obsessive-Compulsive Disorder|obsessive-compulsive disorder
5358871|NCT00211822|Go No-go|go no-go
5358872|NCT00211822|Monetary incentives delay|monetary incentives delay
5358873|NCT00211822|fMRI|fmri
5358874|NCT00211809|Body Dysmorphic Disorder|body dysmorphic disorder
5358875|NCT00211809|SRIs|sris
5358876|NCT00211809|Cognitive Behavioral Therapy|cognitive behavioral therapy
5358877|NCT00211796|autism|autism
5358878|NCT00211796|divalproex sodium ER|divalproex sodium er
5358879|NCT00211796|aggression|aggression
5358880|NCT00211796|irritability|irritability
5358881|NCT00211783|autism|autism
5358883|NCT00211783|response inhibition|response inhibition
5358884|NCT00211783|face processing|face processing
5358885|NCT00211783|linguistic processing|linguistic processing
5358886|NCT00211770|Autism|autism
5358887|NCT00211770|Functional Behavioral Assessment|functional behavioral assessment
5358888|NCT00211770|Citalopram|citalopram
5358889|NCT00211757|autism|autism
5358890|NCT00211757|aggression|aggression
5358891|NCT00211757|irritability|irritability
5358892|NCT00211757|divalproex sodium|divalproex sodium
5358893|NCT00211744|OCD|ocd
5358894|NCT00211744|Obsessive-Compulsive Disorder|obsessive-compulsive disorder
5358895|NCT00211744|OCD treatment|ocd treatment
5358896|NCT00211731|Acute stroke|acute stroke
5358897|NCT00211731|recurrent stroke preventive measures|recurrent stroke preventive measures
5358898|NCT00211731|racial disparities|racial disparities
5358899|NCT00211718|shoulder pain|shoulder pain
5358900|NCT00211718|arthritis|arthritis
5358901|NCT00211718|intra-articular botulinum toxin a|intra-articular botulinum toxin a
5358902|NCT00211718|joint pain|joint pain
5358903|NCT00211705|Hyperlipidemia|hyperlipidemia
5358904|NCT00211705|coronary heart disease|coronary heart disease
5358905|NCT00211705|prevention|prevention
5358906|NCT00211705|stroke|stroke
5358907|NCT00211705|pravastatin|pravastatin
5358908|NCT00211692|Hepatitis C|hepatitis c
5358909|NCT00211692|interferon alfa|interferon alfa
5358910|NCT00211692|ribavirin|ribavirin
5358911|NCT00211692|interferon alfacon-1|interferon alfacon-1
5358912|NCT00211692|antiviral therapy|antiviral therapy
5358913|NCT00211679|Joint pain|joint pain
5358914|NCT00211679|Knee Pain|knee pain
5358915|NCT00211679|Arthritis|arthritis
5358916|NCT00211679|Intra-articular Botulinum Toxin Type A|intra-articular botulinum toxin type a
5358917|NCT00211666|Hypertension|hypertension
5358918|NCT00211666|blood pressure|blood pressure
5358919|NCT00211666|self management|self management
5358920|NCT00211666|nurse management|nurse management
5358921|NCT00211666|racial disparities|racial disparities
5358922|NCT00211666|cardiovascular disease|cardiovascular disease
5358923|NCT00211653|Kidney failure|kidney failure
5358924|NCT00211653|Thoracic surgery|thoracic surgery
5358925|NCT00211653|Acetylcysteine|acetylcysteine
5358926|NCT00211614|Obstructive Sleep Apnea|obstructive sleep apnea
5358927|NCT00211614|Gastroesophageal Reflux|gastroesophageal reflux
5358928|NCT00211614|Proton Pump Inhibitor|proton pump inhibitor
5358929|NCT00211614|Lansoprazole (Prevacid)|lansoprazole (prevacid)
5358930|NCT00211614|Quality of Life|quality of life
5358931|NCT00211588|cognition|cognition
5358932|NCT00211562|weight gain|weight gain
5358933|NCT00211562|weight gain supplementation|weight gain supplementation
5358934|NCT00211562|antioxidants|antioxidants
5358935|NCT00211562|olanzapine|olanzapine
5358936|NCT00211549|Osteoarthritis|osteoarthritis
5358937|NCT00211536|Diabetes|diabetes
5358938|NCT00211536|Implantable Insulin Pump|implantable insulin pump
5358939|NCT00211536|Intraperitoneal Insulin Delivery|intraperitoneal insulin delivery
5358940|NCT00211523|acne|acne
5358941|NCT00211523|acne vulgaris|acne vulgaris
5358942|NCT00211523|MBI 226|mbi 226
5358943|NCT00211523|Propionibacterium acnes|propionibacterium acnes
5358944|NCT00211523|lesion counts|lesion counts
5358945|NCT00211523|lesions|lesions
5358946|NCT00211523|inflammatory|inflammatory
5358947|NCT00211523|non-inflammatory|non-inflammatory
5358948|NCT00211523|topical|topical
5358949|NCT00211510|Diabetes|diabetes
5358950|NCT00211510|Continuous Glucose Monitoring|continuous glucose monitoring
5358951|NCT00211510|Glycemic Control|glycemic control
5358952|NCT00211497|acne vulgaris|acne vulgaris
5358953|NCT00211497|acne|acne
5358954|NCT00211497|Propionibacterium acnes|propionibacterium acnes
5358955|NCT00211497|topical|topical
5358956|NCT00211497|inflammatory|inflammatory
5358957|NCT00211497|non-inflammatory|non-inflammatory
5358958|NCT00211497|lesion counts|lesion counts
5358959|NCT00211497|lesions|lesions
5358960|NCT00211458|Age-Related Macular Degeneration|age-related macular degeneration
5358961|NCT00211419|Exudative Age-Related Macular Degeneration|exudative age-related macular degeneration
5358962|NCT00211419|AMD|amd
5358963|NCT00211380|cognition|cognition
5358964|NCT00211380|schizophrenia|schizophrenia
5358965|NCT00211380|schizoaffective disorder|schizoaffective disorder
5358966|NCT00211367|Radiation Retinopathy|radiation retinopathy
5358967|NCT00211341|Pregnancy|pregnancy
5358968|NCT00211341|Mortality|mortality
5358969|NCT00211341|Maternal|maternal
5358970|NCT00211341|Vitamin A|vitamin a
5358971|NCT00211302|Cognition|cognition
5358972|NCT00211302|Schizophrenia|schizophrenia
5358973|NCT00211302|Schizoaffective disorder|schizoaffective disorder
5358974|NCT00211289|Educational Interventions|educational interventions
5358975|NCT00211289|Heart Failure|heart failure
5358976|NCT00211289|Compliance|compliance
5358977|NCT00211263|Bipolar Disorder|bipolar disorder
5358978|NCT00211250|Depakote Er and Valproic Acid|depakote er and valproic acid
5358979|NCT00211237|Balloon Kyphoplasty|balloon kyphoplasty
5358980|NCT00211237|Cancer|cancer
5358981|NCT00211237|Vertebral Compression Fracture|vertebral compression fracture
5358982|NCT00211237|Back Pain|back pain
5358983|NCT00211237|Spine|spine
5358984|NCT00211224|multiple system atrophy|multiple system atrophy
5358985|NCT00211224|progressive supranuclear palsy|progressive supranuclear palsy
5358986|NCT00211224|riluzole|riluzole
5358987|NCT00211224|MSA|msa
5358988|NCT00211224|PSP|psp
5358989|NCT00211211|Osteopenia|osteopenia
5358990|NCT00211211|Osteoporosis|osteoporosis
5358991|NCT00211211|Multiple Myeloma|multiple myeloma
5358992|NCT00211211|Osteolytic Metastatic Tumors|osteolytic metastatic tumors
5358993|NCT00211211|Vertebral Compression Fracture|vertebral compression fracture
5358994|NCT00211211|Back Pain|back pain
5358995|NCT00211211|Spine|spine
5358996|NCT00211198|Cutaneous|cutaneous
5358997|NCT00211198|T-cell lymphoma|t-cell lymphoma
5358998|NCT00211198|ONTAK|ontak
5358999|NCT00211198|CD25|cd25
5359000|NCT00211172|Acute Myocardial Infarction (AMI)|acute myocardial infarction (ami)
5359001|NCT00211172|Heart Attack|heart attack
5359002|NCT00211172|Adherence|adherence
5359003|NCT00211172|Beta-blocker|beta-blocker
5359004|NCT00211172|Behavior change|behavior change
5359005|NCT00211159|Alzheimer's disease|alzheimer's disease
5359006|NCT00211159|Omega-3 fatty acid|omega-3 fatty acid
5359007|NCT00211159|Dietary supplementation|dietary supplementation
5359008|NCT00211159|Cognition|cognition
5359009|NCT00211159|Safety|safety
5359134|NCT00210821|analgesics|analgesics
5359010|NCT00211146|Anemia, erythropoetin, PROCRIT, deep vein thrombosis, thrombovascular event|anemia, erythropoetin, procrit, deep vein thrombosis, thrombovascular event
5359011|NCT00211133|Anemia|anemia
5359012|NCT00211133|Breast Cancer|breast cancer
5359013|NCT00211133|Breast Tumor|breast tumor
5359014|NCT00211133|Quality of Life|quality of life
5359015|NCT00211133|Women|women
5359016|NCT00211133|Female|female
5359017|NCT00211133|Chemotherapy|chemotherapy
5359018|NCT00211133|Hemoglobin|hemoglobin
5359019|NCT00211133|Survival|survival
5359020|NCT00211133|Epoetin|epoetin
5359021|NCT00211133|Epoetin alfa|epoetin alfa
5359022|NCT00211133|erythropoietin|erythropoietin
5359023|NCT00211120|Anemia|anemia
5359024|NCT00211120|Low Blood Count|low blood count
5359025|NCT00211120|Chronic Kidney Failure|chronic kidney failure
5359026|NCT00211120|Chronic Kidney Disease|chronic kidney disease
5359027|NCT00211107|dapoxetine|dapoxetine
5359028|NCT00211107|rapid ejaculation|rapid ejaculation
5359029|NCT00211107|premature ejaculation|premature ejaculation
5359030|NCT00211107|ejaculation|ejaculation
5359031|NCT00211107|sexual dysfunction|sexual dysfunction
5359032|NCT00211107|orgasmic disorder|orgasmic disorder
5359033|NCT00211107|sexual intercourse|sexual intercourse
5359034|NCT00211094|dapoxetine|dapoxetine
5359035|NCT00211094|premature ejaculation|premature ejaculation
5359036|NCT00211094|ejaculation|ejaculation
5359037|NCT00211094|sexual dysfunction|sexual dysfunction
5359038|NCT00211094|orgasmic disorder|orgasmic disorder
5359039|NCT00211094|sexual intercourse|sexual intercourse
5359040|NCT00211081|Congenital Heart Disease|congenital heart disease
5359041|NCT00211081|Spironolactone|spironolactone
5359042|NCT00211081|>17 years old|>17 years old
5359043|NCT00211081|undergone Fontan procedure|undergone fontan procedure
5359044|NCT00211081|endothelial function|endothelial function
5359045|NCT00211068|Pure red-cell aplasia|pure red-cell aplasia
5359046|NCT00211068|Chronic kidney failure|chronic kidney failure
5359047|NCT00211068|Epoetin alfa (Eprex)|epoetin alfa (eprex)
5359048|NCT00211068|Erythropoietin|erythropoietin
5359049|NCT00211068|Kidney disease|kidney disease
5359050|NCT00211068|Anemia|anemia
5359051|NCT00211055|Critically Ill|critically ill
5359052|NCT00211055|Intensive Care Unit|intensive care unit
5359053|NCT00211055|Blood transfusion|blood transfusion
5359054|NCT00211055|Blood loss|blood loss
5359055|NCT00211055|Pediatric|pediatric
5359056|NCT00211055|Children|children
5359057|NCT00211055|Anemia, Pediatric Intensive Care Unit|anemia, pediatric intensive care unit
5359058|NCT00211055|Hemoglobin|hemoglobin
5359059|NCT00211055|Transfusion|transfusion
5359060|NCT00211042|Pure red-cell aplasia|pure red-cell aplasia
5359061|NCT00211042|Anemia|anemia
5359062|NCT00211042|Red blood cells|red blood cells
5359063|NCT00211042|Epoetin alfa (Eprex)|epoetin alfa (eprex)
5359064|NCT00211042|Anti-erythropoietin antibodies|anti-erythropoietin antibodies
5359065|NCT00211042|Recombinant human erythropoietin|recombinant human erythropoietin
5359066|NCT00211029|Anemia, Hemoglobin, Red Blood Cells, Epoetin alfa|anemia, hemoglobin, red blood cells, epoetin alfa
5359067|NCT00211029|Epoetin|epoetin
5359068|NCT00211029|erythropoietin|erythropoietin
5359069|NCT00211029|Red Cell Aplasia, Pure Red Cell Aplasia|red cell aplasia, pure red cell aplasia
5359070|NCT00211029|Chronic Renal Failure|chronic renal failure
5359071|NCT00211029|Kidney Failure|kidney failure
5359072|NCT00211016|Ventilator-Associated Pneumonia|ventilator-associated pneumonia
5359073|NCT00211003|Hospital-Acquired Pneumonia|hospital-acquired pneumonia
5359074|NCT00211003|Mechanical Ventilation|mechanical ventilation
5359075|NCT00210990|Complicated Urinary Tract Infections|complicated urinary tract infections
5359076|NCT00210990|Pyelonephritis|pyelonephritis
5359077|NCT00210977|Anemia|anemia
5359078|NCT00210977|Erythropoietin|erythropoietin
5359079|NCT00210977|Epoetin alfa|epoetin alfa
5359080|NCT00210977|Erythropoietin receptor agonist (ERA) therapy|erythropoietin receptor agonist (era) therapy
5359081|NCT00210977|Anti-erythropoietin antibodies (anti-EPO Ab)|anti-erythropoietin antibodies (anti-epo ab)
5359082|NCT00210977|Recombinant human erythropoietin|recombinant human erythropoietin
5359083|NCT00210977|Pure red cell aplasia|pure red cell aplasia
5359084|NCT00210977|Darbepoetin|darbepoetin
5359085|NCT00210964|Ceftobiprole medocaril|ceftobiprole medocaril
5359086|NCT00210964|Nosocominal Pneumonia|nosocominal pneumonia
5359087|NCT00210964|Ventilator-Associated Pneumonia|ventilator-associated pneumonia
5359088|NCT00210964|Cephalosporins|cephalosporins
5359089|NCT00210964|Methicillin-Resistant Staphylococcus Aureus|methicillin-resistant staphylococcus aureus
5359090|NCT00210951|Epoetin alfa|epoetin alfa
5359091|NCT00210951|Erythropoietin|erythropoietin
5359092|NCT00210951|Red Cell Aplasia, Pure|red cell aplasia, pure
5359093|NCT00210951|Chronic Renal Failure|chronic renal failure
5359094|NCT00210938|Complicated Intra-Abdominal Infections|complicated intra-abdominal infections
5359095|NCT00210938|Appendicitis|appendicitis
5359096|NCT00210938|Cholecystitis|cholecystitis
5359097|NCT00210938|Peritonitis|peritonitis
5359098|NCT00210925|alcoholism|alcoholism
5359099|NCT00210925|alcohol dependence|alcohol dependence
5359100|NCT00210925|medication treatment.|medication treatment.
5359101|NCT00210912|prevention|prevention
5359102|NCT00210912|Migraine|migraine
5359103|NCT00210912|chronic|chronic
5359104|NCT00210912|headache|headache
5359105|NCT00210899|Complicated Skin Infections|complicated skin infections
5359106|NCT00210899|Infectious Skin Diseases|infectious skin diseases
5359107|NCT00210899|Bacterial Skin Diseases|bacterial skin diseases
5359108|NCT00210899|Staphylococcal Skin Infections|staphylococcal skin infections
5359109|NCT00210899|Cephalosporin|cephalosporin
5359110|NCT00210886|complicated urinary tract infection|complicated urinary tract infection
5359111|NCT00210886|urinary tract infection|urinary tract infection
5359112|NCT00210886|acute pyelonephritis|acute pyelonephritis
5359113|NCT00210886|pyelonephritis|pyelonephritis
5359114|NCT00210886|kidney infection|kidney infection
5359115|NCT00210886|bladder infection|bladder infection
5359116|NCT00210873|Migraine|migraine
5359117|NCT00210873|headache|headache
5359118|NCT00210873|chronic|chronic
5359119|NCT00210873|prevention|prevention
5359120|NCT00210860|chronic|chronic
5359121|NCT00210860|headache|headache
5359122|NCT00210860|prevention|prevention
5359123|NCT00210860|Migraine|migraine
5359124|NCT00210847|peripheral neuropathy|peripheral neuropathy
5359125|NCT00210847|Diabetic neuropathy|diabetic neuropathy
5359126|NCT00210847|pain|pain
5359127|NCT00210847|diabetes|diabetes
5359128|NCT00210847|extremities|extremities
5359129|NCT00210847|neuropathy|neuropathy
5359130|NCT00210847|diabetic|diabetic
5359131|NCT00210834|PROCRIT, Erythropoietin, Epoetin alfa, Hemoglobin level|procrit, erythropoietin, epoetin alfa, hemoglobin level
5359132|NCT00210821|migraine|migraine
5359133|NCT00210821|headache|headache
5359135|NCT00210821|prophylaxis|prophylaxis
5359136|NCT00210821|prevention|prevention
5359137|NCT00210808|Binge-Eating Disorder|binge-eating disorder
5359138|NCT00210808|medication treatment|medication treatment
5359139|NCT00210808|obesity|obesity
5359140|NCT00210808|bingeing|bingeing
5359141|NCT00210795|Anemia|anemia
5359142|NCT00210795|Subcutaneous injection|subcutaneous injection
5359143|NCT00210795|PROCRIT|procrit
5359144|NCT00210795|Erythropoietin|erythropoietin
5359145|NCT00210795|Epoetin Alfa|epoetin alfa
5359146|NCT00210795|Hemoglobin Level|hemoglobin level
5359147|NCT00210795|Elderly|elderly
5359148|NCT00210782|epilepsy|epilepsy
5359149|NCT00210782|seizures|seizures
5359150|NCT00210782|epileptic seizures|epileptic seizures
5359151|NCT00210782|complex partial seizures|complex partial seizures
5359152|NCT00210782|generalized tonic-clonic seizures|generalized tonic-clonic seizures
5359153|NCT00210769|schizophrenia|schizophrenia
5359154|NCT00210769|extended release|extended release
5359155|NCT00210769|oral administration|oral administration
5359156|NCT00210769|antipsychotic agents|antipsychotic agents
5359157|NCT00210769|dementia praecox|dementia praecox
5359158|NCT00210769|mental disorders|mental disorders
5359159|NCT00210769|paliperidone|paliperidone
5359160|NCT00210769|PANSS|panss
5359161|NCT00210756|Anemia|anemia
5359162|NCT00210756|pharmacokinetics|pharmacokinetics
5359163|NCT00210756|erythropoetin|erythropoetin
5359164|NCT00210756|Epoetin alfa|epoetin alfa
5359165|NCT00210756|erythropoetin recombinant|erythropoetin recombinant
5359166|NCT00210756|Critical care|critical care
5359167|NCT00210756|critical illness, intensive care,|critical illness, intensive care,
5359168|NCT00210743|Anemia|anemia
5359169|NCT00210743|chronic kidney disease|chronic kidney disease
5359170|NCT00210743|erythropoetin, Epoetin alfa|erythropoetin, epoetin alfa
5359171|NCT00210743|erythropoetin recombinant|erythropoetin recombinant
5359172|NCT00210743|pre-dialysis|pre-dialysis
5359173|NCT00210730|Anemia|anemia
5359174|NCT00210730|Neoplasm|neoplasm
5359175|NCT00210730|Hemoglobin Level|hemoglobin level
5359176|NCT00210717|schizophrenia|schizophrenia
5359177|NCT00210717|intramuscular injection|intramuscular injection
5359178|NCT00210717|antipsychotic agents|antipsychotic agents
5359179|NCT00210717|risperidone|risperidone
5359180|NCT00210717|paliperidone palmitate|paliperidone palmitate
5359181|NCT00210717|dementia praecox|dementia praecox
5359182|NCT00210717|mental disorders|mental disorders
5359183|NCT00210717|PANSS|panss
5359184|NCT00210704|dapoxetine|dapoxetine
5359185|NCT00210704|premature ejaculation|premature ejaculation
5359186|NCT00210704|ejaculation|ejaculation
5359187|NCT00210704|sexual dysfunction|sexual dysfunction
5359188|NCT00210704|orgasmic disorder|orgasmic disorder
5359189|NCT00210704|sexual intercourse|sexual intercourse
5359190|NCT00210691|Schizophrenia|schizophrenia
5359191|NCT00210691|intramuscular injection|intramuscular injection
5359192|NCT00210691|psychotropic agents|psychotropic agents
5359193|NCT00210691|long-acting risperidone|long-acting risperidone
5359194|NCT00210678|Erectile Dysfunction|erectile dysfunction
5359195|NCT00210678|Dapoxetine|dapoxetine
5359196|NCT00210678|Premature ejaculation|premature ejaculation
5359197|NCT00210678|Ejaculation|ejaculation
5359198|NCT00210678|Sexual dysfunction|sexual dysfunction
5359199|NCT00210678|Orgasmic disorder|orgasmic disorder
5359200|NCT00210665|Sarcoma|sarcoma
5359201|NCT00210665|Soft tissue sarcoma|soft tissue sarcoma
5359202|NCT00210665|Standard care|standard care
5359203|NCT00210665|Trabectedin|trabectedin
5359204|NCT00210665|Antitumor agent|antitumor agent
5359205|NCT00210665|Safety|safety
5359206|NCT00210652|Epilepsy|epilepsy
5359207|NCT00210652|Refractory partial epilepsy|refractory partial epilepsy
5359208|NCT00210652|seizure disorder|seizure disorder
5359209|NCT00210652|antiepileptic drugs|antiepileptic drugs
5359210|NCT00210639|Musculoskeletal Diseases|musculoskeletal diseases
5359211|NCT00210639|Musculoskeletal Disorders|musculoskeletal disorders
5359212|NCT00210639|Childhood Disease|childhood disease
5359213|NCT00210639|Bone Diseases|bone diseases
5359214|NCT00210639|Joint Diseases|joint diseases
5359215|NCT00210639|Levofloxacin|levofloxacin
5359216|NCT00210639|Quinolones|quinolones
5359217|NCT00210639|Bacterial infections|bacterial infections
5359218|NCT00210626|Anemia, erythropoetin, Epoetin alfa, erythropoetin recombinant, Critical care, critical illness, intensive care|anemia, erythropoetin, epoetin alfa, erythropoetin recombinant, critical care, critical illness, intensive care
5359219|NCT00210613|dapoxetine|dapoxetine
5359220|NCT00210613|premature ejaculation|premature ejaculation
5359221|NCT00210613|sexual dysfunction|sexual dysfunction
5359222|NCT00210613|orgasmic disorder|orgasmic disorder
5359223|NCT00210613|sexual intercourse|sexual intercourse
5359224|NCT00210613|ejaculation|ejaculation
5359225|NCT00210600|Anemia|anemia
5359226|NCT00210600|Hemoglobin level|hemoglobin level
5359227|NCT00210587|Anemia|anemia
5359228|NCT00210587|Neoplasms|neoplasms
5359229|NCT00210587|hemoglobin level|hemoglobin level
5359230|NCT00210574|childhood absence epilepsy|childhood absence epilepsy
5359231|NCT00210574|epilepsy|epilepsy
5359232|NCT00210574|seizures|seizures
5359233|NCT00210574|absence seizures|absence seizures
5359234|NCT00210561|Pain|pain
5359235|NCT00210561|Acute Low Back Pain|acute low back pain
5359236|NCT00210561|Back|back
5359237|NCT00210561|Lower back|lower back
5359238|NCT00210548|schizophrenia|schizophrenia
5359239|NCT00210548|intramuscular injection|intramuscular injection
5359240|NCT00210548|antipsychotic agents|antipsychotic agents
5359241|NCT00210548|dementia praecox|dementia praecox
5359242|NCT00210548|paliperidone palmitate|paliperidone palmitate
5359243|NCT00210548|mental disorders|mental disorders
5359244|NCT00210548|PANSS.|panss.
5359245|NCT00210535|Topiramate|topiramate
5359246|NCT00210535|Migraine|migraine
5359247|NCT00210535|Migraine headache|migraine headache
5359248|NCT00210535|Migraine prevention|migraine prevention
5359249|NCT00210535|Pediatric|pediatric
5359250|NCT00210522|RWJ-333369|rwj-333369
5359251|NCT00210522|Anticonvulsants|anticonvulsants
5359252|NCT00210522|Epilepsy|epilepsy
5359253|NCT00210522|Refractory partial epilepsy|refractory partial epilepsy
5359254|NCT00210522|Seizure disorder|seizure disorder
5359255|NCT00210522|Antiepileptic drugs|antiepileptic drugs
5359256|NCT00210509|aura|aura
5359257|NCT00210509|Migraine|migraine
5359258|NCT00210509|pain|pain
5359259|NCT00210509|headache|headache
5359260|NCT00210496|Migraine headache|migraine headache
5359261|NCT00210496|Topiramate, Almotriptan malate|topiramate, almotriptan malate
5359262|NCT00210483|pain|pain
5359263|NCT00210483|Migraine|migraine
5359264|NCT00210483|aura|aura
5359265|NCT00210483|headache|headache
5359266|NCT00210470|Head and Neck Cancer|head and neck cancer
5359267|NCT00210470|Immunotherapy|immunotherapy
5359268|NCT00210470|IRX-2|irx-2
5359269|NCT00210470|Mouth Cancer|mouth cancer
5359270|NCT00210470|Throat Cancer|throat cancer
5359271|NCT00210418|Malnutrition|malnutrition
5359272|NCT00210418|Infant nutrition|infant nutrition
5359273|NCT00210418|Food, fortified|food, fortified
5359274|NCT00210418|Growth|growth
5359275|NCT00210418|Randomized controlled trials|randomized controlled trials
5359276|NCT00210418|Evaluation studies|evaluation studies
5359277|NCT00210418|Haiti|haiti
5359278|NCT00210405|Anemia|anemia
5359279|NCT00210405|Infant nutrition|infant nutrition
5359280|NCT00210405|Dietary supplements|dietary supplements
5359281|NCT00210405|Randomized controlled trials|randomized controlled trials
5359282|NCT00210405|Evaluation studies|evaluation studies
5359283|NCT00210405|Haiti|haiti
5359284|NCT00210301|MS|ms
5359285|NCT00210301|cognition|cognition
5359286|NCT00210301|attention|attention
5359287|NCT00210301|fatigue|fatigue
5359288|NCT00210288|Healthy Volunteer|healthy volunteer
5359289|NCT00210288|Shigella|shigella
5359290|NCT00210288|Oral Vaccine|oral vaccine
5359291|NCT00210288|Double Blind|double blind
5359292|NCT00210288|Placebo|placebo
5359293|NCT00210288|Immunogenicity|immunogenicity
5359294|NCT00210288|Safety|safety
5359295|NCT00210249|Cancer|cancer
5359296|NCT00210249|elderly|elderly
5359297|NCT00210249|geriatric evaluation|geriatric evaluation
5359298|NCT00210249|safety|safety
5359299|NCT00210249|chemotherapy|chemotherapy
5359300|NCT00210236|Breast neoplasms|breast neoplasms
5359301|NCT00210236|Local recurrence|local recurrence
5359302|NCT00210236|Survival|survival
5359303|NCT00210236|Surgery|surgery
5359304|NCT00210223|Radiofrequency|radiofrequency
5359305|NCT00210223|Percutaneous technique|percutaneous technique
5359306|NCT00210223|breast cancer|breast cancer
5359307|NCT00210223|tolerance|tolerance
5359308|NCT00210210|Post-operative-pain|post-operative-pain
5359309|NCT00210210|Breast cancer|breast cancer
5359310|NCT00210210|Morphine|morphine
5359311|NCT00210210|Analgesia|analgesia
5359312|NCT00210197|Hypercoagulability|hypercoagulability
5359313|NCT00210197|Plasma coagulation parameters|plasma coagulation parameters
5359314|NCT00210197|Breast cancer|breast cancer
5359315|NCT00210184|Chemotherapy|chemotherapy
5359316|NCT00210184|gastric cancer|gastric cancer
5359317|NCT00210184|geriatric evaluation|geriatric evaluation
5359318|NCT00210184|efficacy|efficacy
5359319|NCT00210184|safety|safety
5359320|NCT00210171|Carcinoma|carcinoma
5359321|NCT00210171|Stage IIIA Non Small Cell Lung|stage iiia non small cell lung
5359322|NCT00210171|Stage IIIB Non-Small-Cell Lung|stage iiib non-small-cell lung
5359323|NCT00210171|Concomitant chemo-radiotherapy|concomitant chemo-radiotherapy
5359324|NCT00210171|Consolidation chemotherapy|consolidation chemotherapy
5359325|NCT00210158|Current opioid treatment|current opioid treatment
5359326|NCT00210158|Nitrous oxide|nitrous oxide
5359327|NCT00210158|Chronic pain|chronic pain
5359328|NCT00210158|Opioid therapy|opioid therapy
5359329|NCT00210158|Postoperative hyperalgesia|postoperative hyperalgesia
5359330|NCT00210158|Acute opioid tolerance|acute opioid tolerance
5359331|NCT00210145|Aesthetic care,|aesthetic care,
5359332|NCT00210145|Mastectomy,|mastectomy,
5359333|NCT00210145|Breast cancer,|breast cancer,
5359334|NCT00210145|Quality of life,|quality of life,
5359335|NCT00210145|Body image,|body image,
5359336|NCT00210145|Psychological adjustment|psychological adjustment
5359337|NCT00210132|Thoracic surgery|thoracic surgery
5359338|NCT00210132|postoperative pain|postoperative pain
5359339|NCT00210132|ropivacaine|ropivacaine
5359340|NCT00210132|inter pleural analgesia|inter pleural analgesia
5359341|NCT00210119|Chronic myeloid leukemia|chronic myeloid leukemia
5359342|NCT00210119|imatinib mesylate|imatinib mesylate
5359343|NCT00210119|zoledronate|zoledronate
5359344|NCT00210119|molecular response|molecular response
5359345|NCT00210106|Radiofrequency ablation|radiofrequency ablation
5359346|NCT00210106|Colorectal cancer|colorectal cancer
5359347|NCT00210106|Liver metastases|liver metastases
5359348|NCT00210041|Genital Neoplasms, Male|genital neoplasms, male
5359349|NCT00210028|Breast Neoplasms|breast neoplasms
5359350|NCT00210028|Zarnestra|zarnestra
5359351|NCT00210028|Tamoxifen|tamoxifen
5359352|NCT00210028|estrogen receptor|estrogen receptor
5359353|NCT00210028|progesterone receptor|progesterone receptor
5359354|NCT00210002|Neoplasms|neoplasms
5359355|NCT00210002|Solid|solid
5359356|NCT00210002|Anemia|anemia
5359357|NCT00210002|darbepoetin alfa|darbepoetin alfa
5359358|NCT00210002|ferric saccharose|ferric saccharose
5359359|NCT00210002|Venofer®|venofer®
5359360|NCT00210002|Aranesp®|aranesp®
5359361|NCT00209989|Glioblastoma Multiforme|glioblastoma multiforme
5359362|NCT00209989|Zarnestra|zarnestra
5359363|NCT00209989|Radiation therapy|radiation therapy
5359364|NCT00209963|Primary insomnia|primary insomnia
5359365|NCT00209950|Primary insomnia|primary insomnia
5359366|NCT00209937|Primary insomnia|primary insomnia
5359367|NCT00209924|Primary insomnia|primary insomnia
5359368|NCT00209911|atrial volume|atrial volume
5359369|NCT00209911|ventricular volume|ventricular volume
5359370|NCT00209911|atrial function|atrial function
5359371|NCT00209911|ventricular function|ventricular function
5359372|NCT00209911|magnetic resonance imaging|magnetic resonance imaging
5359373|NCT00209911|cardioversion|cardioversion
5359374|NCT00209911|natriuretic peptides|natriuretic peptides
5359375|NCT00209898|Chronic hepatits C|chronic hepatits c
5359376|NCT00209898|peginterferon|peginterferon
5359377|NCT00209898|ribavirin|ribavirin
5359378|NCT00209898|inmate|inmate
5359379|NCT00209898|fast initiation procedure|fast initiation procedure
5359380|NCT00209846|Primary insomnia|primary insomnia
5359381|NCT00209820|low back pain|low back pain
5359382|NCT00209820|randomized clinical trial|randomized clinical trial
5359383|NCT00209820|Nordic walking|nordic walking
5359384|NCT00209820|supervision|supervision
5359385|NCT00209820|Advice to stay active|advice to stay active
5359386|NCT00209807|major depression|major depression
5359387|NCT00209807|pain|pain
5359388|NCT00209807|escitalopram|escitalopram
5359389|NCT00209807|reboxetine|reboxetine
5359390|NCT00209807|visceral sensitivity|visceral sensitivity
5359391|NCT00209807|somatic sensitivity|somatic sensitivity
5359392|NCT00209768|pediatric intensive care|pediatric intensive care
5359393|NCT00209768|critically ill children|critically ill children
5359394|NCT00209768|in-line filtration|in-line filtration
5359395|NCT00209768|prospective randomized study|prospective randomized study
5359396|NCT00209768|complications|complications
5359397|NCT00209768|sepsis|sepsis
5359398|NCT00209768|SIRS|sirs
5359399|NCT00209768|thrombosis|thrombosis
5359400|NCT00209768|organ failure|organ failure
5359401|NCT00209755|chronic hepatitis C|chronic hepatitis c
5359402|NCT00209742|Colorectal Cancer,UFT,LV,Krestin,adjuvant therapy,phase III|colorectal cancer,uft,lv,krestin,adjuvant therapy,phase iii
5359403|NCT00209729|Docetaxel|docetaxel
5359404|NCT00209729|S-1|s-1
5359405|NCT00209729|Elderly Patients|elderly patients
5359406|NCT00209729|Gastric cancer|gastric cancer
5359407|NCT00209664|Irinotecan, S-1, Phase II, gastric cancer|irinotecan, s-1, phase ii, gastric cancer
5359408|NCT00209651|Irinotecan, S-1, Phase II, colorectal cancer,|irinotecan, s-1, phase ii, colorectal cancer,
5359409|NCT00209638|Irinotecan,|irinotecan,
5359410|NCT00209638|S-1,|s-1,
5359411|NCT00209638|Phase I/II,|phase i/ii,
5359412|NCT00209638|gastric cancer|gastric cancer
5359413|NCT00209625|Irinotecan, leucovorin, fluorouracil, PhaseI/II, colorectal cancer,|irinotecan, leucovorin, fluorouracil, phasei/ii, colorectal cancer,
5359414|NCT00209599|Colonoscopy|colonoscopy
5359415|NCT00209599|Seadation|seadation
5359416|NCT00209586|Bronchoscopy|bronchoscopy
5359417|NCT00209586|Sedation|sedation
5359418|NCT00209573|Colonoscopy|colonoscopy
5359419|NCT00209573|Sedation|sedation
5359420|NCT00209560|AQUAVAN® Injection|aquavan® injection
5359421|NCT00209560|Midazolam|midazolam
5359422|NCT00209560|Minor surgical procedures|minor surgical procedures
5359423|NCT00209560|Sedation|sedation
5359424|NCT00209547|AQUAVAN® Injection|aquavan® injection
5359425|NCT00209547|Midazolam|midazolam
5359426|NCT00209547|Angioplasty|angioplasty
5359427|NCT00209547|Coronary catheterization|coronary catheterization
5359428|NCT00209521|Coronary Artery Bypass Surgery|coronary artery bypass surgery
5359429|NCT00209521|AQUAVAN® Injection|aquavan® injection
5359430|NCT00209521|DISOPRIVAN® Injectable Emulsion.|disoprivan® injectable emulsion.
5359431|NCT00209521|ischemic coronary artery disease|ischemic coronary artery disease
5359432|NCT00209508|Parkinson's Disease|parkinson's disease
5359433|NCT00209508|SPECT Scanning|spect scanning
5359434|NCT00209495|Abdominal hysterectomy|abdominal hysterectomy
5359435|NCT00209495|Pregabalin|pregabalin
5359436|NCT00209495|Dexamethasone|dexamethasone
5359437|NCT00209495|Multimodal postoperative analgesia|multimodal postoperative analgesia
5359438|NCT00209456|Lewy Body Dementia|lewy body dementia
5359439|NCT00209456|non-DLB dementia|non-dlb dementia
5359440|NCT00209456|Dopamine Transporter|dopamine transporter
5359441|NCT00209456|Striatal Uptake|striatal uptake
5359442|NCT00209443|Aorto-iliac Stenosis|aorto-iliac stenosis
5359443|NCT00209443|Occlusion|occlusion
5359444|NCT00209443|Diagnostic Imaging|diagnostic imaging
5359445|NCT00209443|Omniscan|omniscan
5359446|NCT00209443|Magnetic Resonance Angiography|magnetic resonance angiography
5359447|NCT00209443|Contrast Media|contrast media
5359448|NCT00209430|Iodixanol|iodixanol
5359449|NCT00209430|Iopamidol|iopamidol
5359450|NCT00209430|coronary angiography|coronary angiography
5359451|NCT00209430|Contrast media-induced nephropathy|contrast media-induced nephropathy
5359452|NCT00209417|Iodixanol|iodixanol
5359453|NCT00209417|Iopamidol|iopamidol
5359454|NCT00209417|computed tomography|computed tomography
5359455|NCT00209417|Patients with pre-existing renal impairment and diabetes|patients with pre-existing renal impairment and diabetes
5359456|NCT00209404|MDCT|mdct
5359457|NCT00209404|Coronary Artery|coronary artery
5359458|NCT00209404|Heart Rate|heart rate
5359459|NCT00209404|Image Quality|image quality
5359460|NCT00209404|Diagnostic Quality|diagnostic quality
5359461|NCT00209391|Renal Artery Stenosis|renal artery stenosis
5359462|NCT00209391|Occlusion|occlusion
5359463|NCT00209391|Diagnostic Imaging|diagnostic imaging
5359464|NCT00209391|Omniscan|omniscan
5359465|NCT00209391|Magnetic Resonance Angiography|magnetic resonance angiography
5359466|NCT00209391|Contrast Media|contrast media
5359467|NCT00209378|Continuous venovenous hemofiltration (CVVH)|continuous venovenous hemofiltration (cvvh)
5359468|NCT00209378|Continuous renal replacement therapy (CRRT)|continuous renal replacement therapy (crrt)
5359469|NCT00209378|Acute Kidney Injury|acute kidney injury
5359968|NCT00207064|P300|p300
5359470|NCT00209378|Regional citrate anticoagulation|regional citrate anticoagulation
5359471|NCT00209378|filter survival|filter survival
5359472|NCT00209378|trisodium citrate|trisodium citrate
5359473|NCT00209378|bleeding complication|bleeding complication
5359474|NCT00209378|Hemofiltration|hemofiltration
5359475|NCT00209352|Varicella Zoster Virus Infection|varicella zoster virus infection
5359476|NCT00209352|VZV infection|vzv infection
5359477|NCT00209352|Oral Acyclovir|oral acyclovir
5359478|NCT00209352|Allogeneic Bone Marrow Transplantation|allogeneic bone marrow transplantation
5359479|NCT00209352|Allogeneic Hematopoietic Cell Transplantation|allogeneic hematopoietic cell transplantation
5359480|NCT00209339|Mitral Valve Insufficiency|mitral valve insufficiency
5359481|NCT00209339|Mitral Valve Regurgitation|mitral valve regurgitation
5359482|NCT00209339|Mitral Valve Incompetence|mitral valve incompetence
5359483|NCT00209339|Mitral Regurgitation|mitral regurgitation
5359484|NCT00209339|Mitral Insufficiency|mitral insufficiency
5359485|NCT00209339|Mitral Valve|mitral valve
5359486|NCT00209339|MR|mr
5359487|NCT00209339|Mitral Valve Prolapse|mitral valve prolapse
5359488|NCT00209339|E2E - Edge to Edge|e2e - edge to edge
5359489|NCT00209339|Alfieri Technique|alfieri technique
5359490|NCT00209339|MitraClip|mitraclip
5359491|NCT00209339|Functional MR|functional mr
5359492|NCT00209339|Degenerative MR|degenerative mr
5359493|NCT00209339|Echocardiogram|echocardiogram
5359494|NCT00209339|CAD - Coronary Artery Disease|cad - coronary artery disease
5359495|NCT00209339|Heart Failure|heart failure
5359496|NCT00209339|Heart Attack|heart attack
5359497|NCT00209339|EVEREST|everest
5359498|NCT00209339|EVEREST I|everest i
5359499|NCT00209339|EVEREST II|everest ii
5359500|NCT00209313|HIV-1|hiv-1
5359501|NCT00209313|HSV-2|hsv-2
5359502|NCT00209313|Coinfection|coinfection
5359503|NCT00209313|Africa|africa
5359504|NCT00209313|Cameroon|cameroon
5359505|NCT00209300|Ulcerative Colitis for Maintenance of Remission|ulcerative colitis for maintenance of remission
5359506|NCT00209287|Ulcerative Colitis for Maintenance of Remission|ulcerative colitis for maintenance of remission
5359507|NCT00209274|Mitral Valve Insufficiency|mitral valve insufficiency
5359508|NCT00209274|Mitral Valve Regurgitation|mitral valve regurgitation
5359509|NCT00209274|Mitral Valve Incompetence|mitral valve incompetence
5359510|NCT00209274|Mitral Regurgitation|mitral regurgitation
5359511|NCT00209274|Mitral Insufficiency|mitral insufficiency
5359512|NCT00209274|Mitral Valve|mitral valve
5359513|NCT00209274|MR|mr
5359514|NCT00209274|Mitral Valve Prolapse|mitral valve prolapse
5359515|NCT00209274|Edge to Edge (E2E)|edge to edge (e2e)
5359516|NCT00209274|Alfieri Technique|alfieri technique
5359517|NCT00209274|MitraClip|mitraclip
5359518|NCT00209274|Functional MR|functional mr
5359519|NCT00209274|Degenerative MR|degenerative mr
5359520|NCT00209274|Echocardiogram|echocardiogram
5359521|NCT00209274|CAD - Coronary Artery Disease|cad - coronary artery disease
5359522|NCT00209274|Heart Failure|heart failure
5359523|NCT00209274|Heart Attack|heart attack
5359524|NCT00209274|EVEREST|everest
5359525|NCT00209274|EVEREST I|everest i
5359526|NCT00209274|EVEREST II|everest ii
5359527|NCT00209274|REALISM|realism
5359528|NCT00209235|Pseudohypoparathyroidism Type 1A (PHP 1A)|pseudohypoparathyroidism type 1a (php 1a)
5359529|NCT00209235|Albright Hereditary Osteodystrophy|albright hereditary osteodystrophy
5359530|NCT00209235|Growth Hormone Deficiency|growth hormone deficiency
5359531|NCT00209222|Lymphoma, Mantle-Cell|lymphoma, mantle-cell
5359532|NCT00209222|younger patients|younger patients
5359533|NCT00209222|chemotherapy|chemotherapy
5359534|NCT00209222|high dose therapy|high dose therapy
5359535|NCT00209222|C04.557.386.480.300.725.500|c04.557.386.480.300.725.500
5359536|NCT00209222|C15.604.515.569.480.300.725.500|c15.604.515.569.480.300.725.500
5359537|NCT00209222|C20.683.515.761.480.300.725.500|c20.683.515.761.480.300.725.500
5359538|NCT00209209|Lymphoma, Mantle-Cell|lymphoma, mantle-cell
5359539|NCT00209209|Elderly patients|elderly patients
5359540|NCT00209209|Chemotherapy|chemotherapy
5359541|NCT00209209|Maintenance therapy|maintenance therapy
5359542|NCT00209209|C04.557.386.480.300.725.500|c04.557.386.480.300.725.500
5359543|NCT00209209|C15.604.515.569.480.300.725.500|c15.604.515.569.480.300.725.500
5359544|NCT00209209|C20.683.515.761.480.300.725.500|c20.683.515.761.480.300.725.500
5359545|NCT00209196|pediatric|pediatric
5359546|NCT00209196|transplantation|transplantation
5359547|NCT00209196|psychosocial|psychosocial
5359548|NCT00209196|kidney transplant recipient|kidney transplant recipient
5359549|NCT00209196|liver transplant recipient|liver transplant recipient
5359550|NCT00209196|heart transplant recipient|heart transplant recipient
5359551|NCT00209196|lung transplant recipient|lung transplant recipient
5359552|NCT00209196|heart-lung transplant recipient|heart-lung transplant recipient
5359553|NCT00209144|Inflammation|inflammation
5359554|NCT00209144|Thrombosis|thrombosis
5359555|NCT00209144|Hyperglycemia|hyperglycemia
5359556|NCT00209144|Myocardial Infarction|myocardial infarction
5359557|NCT00209144|Angioplasty|angioplasty
5359558|NCT00209131|urolithiasis|urolithiasis
5359559|NCT00209118|Hepatitis C|hepatitis c
5359560|NCT00209118|Interferon-alpha associated side effects|interferon-alpha associated side effects
5359561|NCT00209118|Antidepressants|antidepressants
5359562|NCT00209118|Prevention|prevention
5359563|NCT00209105|Child Abuse|child abuse
5359564|NCT00209105|Hypothalamic-Pituitary-Adrenal Axis|hypothalamic-pituitary-adrenal axis
5359565|NCT00209105|Brain Imaging|brain imaging
5359566|NCT00209105|Depression|depression
5359567|NCT00209092|Breast Cancer|breast cancer
5359568|NCT00209079|Gastric Adenocarcinoma|gastric adenocarcinoma
5359569|NCT00209066|Major Depressive Disorder|major depressive disorder
5359570|NCT00209066|Electroconvulsive Therapy|electroconvulsive therapy
5359571|NCT00209066|Platelet Activation|platelet activation
5359572|NCT00209040|PTSD|ptsd
5359573|NCT00209040|Acoustic startle|acoustic startle
5359574|NCT00209027|schizophrenia|schizophrenia
5359575|NCT00209027|reward|reward
5359576|NCT00209027|fMRI|fmri
5359577|NCT00209014|B-Cell Lymphoma|b-cell lymphoma
5359578|NCT00209014|Hodgkin's Disease|hodgkin's disease
5359579|NCT00209001|Breast Cancer|breast cancer
5359580|NCT00208988|Health literacy|health literacy
5359581|NCT00208988|Physician-Patient Relationship|physician-patient relationship
5359582|NCT00208988|Prostate Cancer|prostate cancer
5359583|NCT00208975|Lymphoma|lymphoma
5359584|NCT00208962|Hematologic Diseases|hematologic diseases
5359585|NCT00208949|Hematologic Diseases|hematologic diseases
5359586|NCT00208936|Esophageal Diseases|esophageal diseases
5359587|NCT00208923|Hematologic Malignancies|hematologic malignancies
5359588|NCT00208910|Anxiety|anxiety
5359589|NCT00208910|Mental Health|mental health
5359590|NCT00208897|Early Life Stress|early life stress
5359591|NCT00208897|HPA-axis|hpa-axis
5359592|NCT00208897|CRF|crf
5359593|NCT00208884|pediatric|pediatric
5359594|NCT00208884|orthotopic heart transplantation|orthotopic heart transplantation
5359595|NCT00208884|graft failure|graft failure
5359596|NCT00208871|Stereoscopic digital mammography|stereoscopic digital mammography
5359597|NCT00208871|Breast cancer detection|breast cancer detection
5359598|NCT00208871|Reduced rate of recall|reduced rate of recall
5359599|NCT00208871|Focal abnormalities detection|focal abnormalities detection
5359600|NCT00208832|Medication Compliance|medication compliance
5359601|NCT00208832|Health Literacy|health literacy
5359602|NCT00208819|Alzheimer's Disease|alzheimer's disease
5359603|NCT00208819|Geriatric|geriatric
5359604|NCT00208819|Dementia|dementia
5359605|NCT00208819|Agitation|agitation
5359606|NCT00208819|Behavioral Disturbances|behavioral disturbances
5359607|NCT00208819|Psychosis|psychosis
5359608|NCT00208806|Dilated Cardiomyopathy|dilated cardiomyopathy
5359609|NCT00208806|Pediatric|pediatric
5359610|NCT00208806|Bi-ventricular Pacemaker|bi-ventricular pacemaker
5359611|NCT00208793|colonic polyps|colonic polyps
5359612|NCT00208793|adenomatous polyps|adenomatous polyps
5359613|NCT00208793|colon cancer prevention|colon cancer prevention
5359614|NCT00208793|dietary supplements|dietary supplements
5359615|NCT00208780|Oxidative Stress|oxidative stress
5359616|NCT00208780|Endothelium|endothelium
5359617|NCT00208767|Angiotensin receptor blockade|angiotensin receptor blockade
5359618|NCT00208767|Oxidative stress|oxidative stress
5359619|NCT00208767|Endothelial dysfunction|endothelial dysfunction
5359620|NCT00208754|heart defects|heart defects
5359621|NCT00208754|cardiology|cardiology
5359622|NCT00208754|adults who have congenital heart defects|adults who have congenital heart defects
5359623|NCT00208741|Social Anxiety Disorder|social anxiety disorder
5359624|NCT00208741|Mental Health|mental health
5359625|NCT00208728|pediatric|pediatric
5359626|NCT00208728|congenital heart disease|congenital heart disease
5359627|NCT00208728|cardiac surgery|cardiac surgery
5359628|NCT00208715|Depression|depression
5359629|NCT00208702|Major Depressive Disorder|major depressive disorder
5359630|NCT00208702|Mental Health|mental health
5359631|NCT00208702|Depression|depression
5359632|NCT00208689|pediatric|pediatric
5359633|NCT00208689|congenital heart disease|congenital heart disease
5359634|NCT00208676|heart defects|heart defects
5359635|NCT00208676|pediatrics|pediatrics
5359636|NCT00208650|pediatrics|pediatrics
5359637|NCT00208650|transplant|transplant
5359638|NCT00208650|cardiac|cardiac
5359639|NCT00208637|Maori|maori
5359640|NCT00208637|insulin sensitivity|insulin sensitivity
5359641|NCT00208637|cardiovascular risk|cardiovascular risk
5359642|NCT00208637|diabetes prevention|diabetes prevention
5359643|NCT00208637|diet modification|diet modification
5359644|NCT00208624|arrhythmia|arrhythmia
5359645|NCT00208624|pediatrics|pediatrics
5359646|NCT00208624|cardiac|cardiac
5359647|NCT00208598|Maori|maori
5359648|NCT00208598|Body Composition|body composition
5359649|NCT00208598|DEXA|dexa
5359650|NCT00208598|Cardiovascular disease|cardiovascular disease
5359651|NCT00208598|Diabetes|diabetes
5359652|NCT00208572|Traumatic Brain Injury; Anxiety Disorders; SRI Treatment|traumatic brain injury; anxiety disorders; sri treatment
5359653|NCT00208559|Autism|autism
5359654|NCT00208559|Pervasive Developmental Disorder|pervasive developmental disorder
5359655|NCT00208559|Ziprasidone|ziprasidone
5359656|NCT00208559|Adolescents|adolescents
5359657|NCT00208546|capecitabine|capecitabine
5359658|NCT00208546|oxaliplatin|oxaliplatin
5359659|NCT00208546|bevacizumab|bevacizumab
5359660|NCT00208546|cetuximab|cetuximab
5359661|NCT00208546|advanced colorectal cancer|advanced colorectal cancer
5359662|NCT00208533|Autism|autism
5359663|NCT00208533|Pervasive developmental disorder|pervasive developmental disorder
5359664|NCT00208533|Aripiprazole|aripiprazole
5359665|NCT00208533|Antipsychotic medication|antipsychotic medication
5359666|NCT00208533|Adolescents|adolescents
5359667|NCT00208520|Epilepsy|epilepsy
5359668|NCT00208520|Valproate|valproate
5359669|NCT00208520|Levetiracetam|levetiracetam
5359670|NCT00208520|Lamotrigine|lamotrigine
5359671|NCT00208520|Carbamazepine|carbamazepine
5359672|NCT00208507|Joint Diseases|joint diseases
5359673|NCT00208507|Non-Inflammatory Degenerative Joint Disease|non-inflammatory degenerative joint disease
5359674|NCT00208494|Non-Inflammatory Degenerative Joint Disease|non-inflammatory degenerative joint disease
5359676|NCT00208468|Cementless|cementless
5359677|NCT00208455|Arthroplasty|arthroplasty
5359678|NCT00208455|Replacement|replacement
5359679|NCT00208455|Hip|hip
5359680|NCT00208455|Conservative|conservative
5359681|NCT00208455|Anatomic|anatomic
5359682|NCT00208455|Cementless|cementless
5359683|NCT00208442|Hip|hip
5359684|NCT00208442|Cemented|cemented
5359685|NCT00208429|Hip|hip
5359686|NCT00208429|Cementless|cementless
5359687|NCT00208416|Hip|hip
5359688|NCT00208416|Surgical Technique|surgical technique
5359689|NCT00208403|Hip|hip
5359690|NCT00208403|Cement|cement
5359691|NCT00208390|Hip|hip
5359692|NCT00208390|Cementless|cementless
5359693|NCT00208377|Hip|hip
5359694|NCT00208377|Conservative|conservative
5359695|NCT00208377|Metal-on-Metal|metal-on-metal
5359696|NCT00208377|Resurfacing|resurfacing
5359697|NCT00208364|Hip|hip
5359698|NCT00208364|Cementless|cementless
5359699|NCT00208364|Metal-on-Metal|metal-on-metal
5359700|NCT00208351|Hip|hip
5359701|NCT00208351|Cemented|cemented
5359702|NCT00208338|Rotator cuff tear repair|rotator cuff tear repair
5359703|NCT00208312|Lexiscan|lexiscan
5359704|NCT00208312|Regadenoson|regadenoson
5359705|NCT00208312|Adenoscan®|adenoscan®
5359706|NCT00208312|Adenosine|adenosine
5359707|NCT00208312|SPECT Myocardial Perfusion Imaging|spect myocardial perfusion imaging
5359708|NCT00208312|Reversible Perfusion Defect|reversible perfusion defect
5359709|NCT00208299|Lexiscan|lexiscan
5359710|NCT00208299|Regadenoson|regadenoson
5359711|NCT00208299|Adenoscan®|adenoscan®
5359712|NCT00208299|Adenosine|adenosine
5359713|NCT00208299|SPECT Myocardial Perfusion Imaging|spect myocardial perfusion imaging
5359714|NCT00208299|Reversible Perfusion Defect|reversible perfusion defect
5359715|NCT00208273|Postmenopausal breast cancer, radiohormonotherapy sequences|postmenopausal breast cancer, radiohormonotherapy sequences
5359716|NCT00208273|ER+ and/or PgR+,|er+ and/or pgr+,
5359717|NCT00208273|Postmenopausal Breast cancer,|postmenopausal breast cancer,
5359718|NCT00208273|Adjuvant setting|adjuvant setting
5359719|NCT00208234|asthma|asthma
5359720|NCT00208221|Hypertension|hypertension
5359721|NCT00208221|Diabetes|diabetes
5359722|NCT00208221|Microalbuminuria|microalbuminuria
5359723|NCT00208221|Blood pressure|blood pressure
5359724|NCT00208208|Posttraumatic Stress Disorder|posttraumatic stress disorder
5359725|NCT00208208|Post-traumatic Stress Disorder|post-traumatic stress disorder
5359726|NCT00208208|PTSD|ptsd
5359727|NCT00208208|Geodon|geodon
5359728|NCT00208208|Ziprasidone|ziprasidone
5359729|NCT00208195|Bipolar Disorder|bipolar disorder
5359730|NCT00208195|Mania|mania
5359731|NCT00208195|Substance Abuse|substance abuse
5359732|NCT00208195|Substance Dependence|substance dependence
5359733|NCT00208195|Comorbid|comorbid
5359734|NCT00208169|Comorbid substance abuse/dependence|comorbid substance abuse/dependence
5359735|NCT00208169|Comorbid diagnoses|comorbid diagnoses
5359736|NCT00208169|Substance abuse and/or dependence|substance abuse and/or dependence
5359737|NCT00208156|Depression|depression
5359738|NCT00208156|Major Depression|major depression
5359739|NCT00208156|Psychotic Major Depression|psychotic major depression
5359740|NCT00208156|PMD|pmd
5359741|NCT00208156|Psychosis|psychosis
5359742|NCT00208143|Cocaine Abuse|cocaine abuse
5359743|NCT00208143|Cocaine Dependence|cocaine dependence
5359744|NCT00208143|Amphetamine Abuse|amphetamine abuse
5359745|NCT00208143|Amphetamine Dependence|amphetamine dependence
5359746|NCT00208143|Schizophrenia|schizophrenia
5359747|NCT00208143|Comorbid|comorbid
5359748|NCT00208143|Schizoaffective Disorder|schizoaffective disorder
5359749|NCT00208130|PTSD|ptsd
5359750|NCT00208130|trauma|trauma
5359751|NCT00208117|depression|depression
5359752|NCT00208117|inflammation|inflammation
5359753|NCT00208117|heart disease|heart disease
5359754|NCT00208117|randomized clinical trial|randomized clinical trial
5359755|NCT00208117|sertraline|sertraline
5359756|NCT00208117|simvastatin|simvastatin
5359757|NCT00208117|placebo|placebo
5359758|NCT00208104|Hypertension|hypertension
5359759|NCT00208104|African Americans|african americans
5359760|NCT00208104|Adherence|adherence
5359761|NCT00208104|Motivational Interviewing|motivational interviewing
5359762|NCT00208091|Myloboc|myloboc
5359763|NCT00208091|Botulinum Toxin Type B|botulinum toxin type b
5359764|NCT00208091|Focal Dystonia|focal dystonia
5359765|NCT00208091|Musicians|musicians
5359766|NCT00208091|Muscle Relaxants|muscle relaxants
5359767|NCT00208091|Motor Impairments|motor impairments
5359768|NCT00208091|Motor Performance|motor performance
5359769|NCT00208091|Tremor|tremor
5359770|NCT00208091|Abnormal Postures|abnormal postures
5359771|NCT00208078|Hypercapnia|hypercapnia
5359772|NCT00208078|Non-Invasive Ventilation|non-invasive ventilation
5359773|NCT00208065|migraine|migraine
5359774|NCT00208065|biological markers|biological markers
5359775|NCT00208065|rhinosinusitis|rhinosinusitis
5359776|NCT00208065|CGRP|cgrp
5359777|NCT00208065|histamine|histamine
5359778|NCT00208065|VIP|vip
5359779|NCT00208039|Prematurity|prematurity
5359780|NCT00208039|Lung Disease|lung disease
5359781|NCT00208039|Hyaline Membrane|hyaline membrane
5359782|NCT00208039|Surfactant|surfactant
5359783|NCT00208013|resting energy expenditure|resting energy expenditure
5359784|NCT00208013|cachexia|cachexia
5359785|NCT00208013|advanced cancer|advanced cancer
5359786|NCT00208013|advanced cancer patients|advanced cancer patients
5359787|NCT00207987|controlled hypotension|controlled hypotension
5359788|NCT00207974|Hyperuricemia, Anserine, Pharmacokinetic|hyperuricemia, anserine, pharmacokinetic
5359789|NCT00207948|Human Immunodeficiency Virus|human immunodeficiency virus
5359790|NCT00207948|Protease Inhibitors|protease inhibitors
5359791|NCT00207948|Pharmacogenetics|pharmacogenetics
5359792|NCT00207948|Genes, MDR1, Cytochrome P-450 enzymes|genes, mdr1, cytochrome p-450 enzymes
5359793|NCT00207948|Pharmacokinetics|pharmacokinetics
5359794|NCT00207948|Pediatrics|pediatrics
5359795|NCT00207948|Treatment Experienced|treatment experienced
5359796|NCT00207935|Seizures|seizures
5359797|NCT00207935|Depakote|depakote
5359798|NCT00207935|Developmental Delay|developmental delay
5359799|NCT00207935|Mental Retardation|mental retardation
5359800|NCT00207935|Swallow|swallow
5359801|NCT00207922|cytokine|cytokine
5359802|NCT00207922|T-cell|t-cell
5359803|NCT00207922|chemokine|chemokine
5359804|NCT00207922|graft-versus-host disease|graft-versus-host disease
5359805|NCT00207909|Acute Renal Failure|acute renal failure
5359806|NCT00207909|Contiuous Veno Venous Hemofiltration|contiuous veno venous hemofiltration
5359807|NCT00207896|Pediatric Intensive Care|pediatric intensive care
5359808|NCT00207896|Neuroendocrine Dysfunction|neuroendocrine dysfunction
5359809|NCT00207883|Vascular Access|vascular access
5359810|NCT00207883|Ultrasound|ultrasound
5359811|NCT00207883|Pediatric|pediatric
5359812|NCT00207883|Pediatric intensive care patient|pediatric intensive care patient
5359813|NCT00207870|Type II Supracondylar Fracture|type ii supracondylar fracture
5359814|NCT00207870|Orthopaedics|orthopaedics
5359815|NCT00207857|Duchenne's Muscular Dystrophy|duchenne's muscular dystrophy
5359816|NCT00207857|Scoliosis|scoliosis
5359817|NCT00207844|Selenium|selenium
5359818|NCT00207844|Oxidative stress|oxidative stress
5359819|NCT00207844|Septic shock|septic shock
5359820|NCT00207844|Sodium selenite|sodium selenite
5359821|NCT00207831|rectal cancer|rectal cancer
5359822|NCT00207831|neoadjuvant therapy|neoadjuvant therapy
5359823|NCT00207831|UFT|uft
5359824|NCT00207831|radiochemotherapy|radiochemotherapy
5359825|NCT00207818|tissue engineered wound dressing; autologous skin substitute; biological dressing; wound care|tissue engineered wound dressing; autologous skin substitute; biological dressing; wound care
5359826|NCT00207792|Granulocyte colony stimulating factor|granulocyte colony stimulating factor
5359827|NCT00207779|central venous catheter|central venous catheter
5359828|NCT00207779|catheter related bloodstream infection|catheter related bloodstream infection
5359829|NCT00207779|heparin|heparin
5359830|NCT00207766|Crohn's Disease|crohn's disease
5359831|NCT00207766|infusions|infusions
5359832|NCT00207753|ascaris|ascaris
5359833|NCT00207753|trichuris|trichuris
5359834|NCT00207753|strongyloides|strongyloides
5359835|NCT00207753|hookworm|hookworm
5359836|NCT00207753|head lice|head lice
5359837|NCT00207740|Asthma|asthma
5359838|NCT00207740|Severe Persistent Asthma|severe persistent asthma
5359839|NCT00207740|Subcutaneous injections|subcutaneous injections
5359840|NCT00207740|Immunology disorder|immunology disorder
5359841|NCT00207740|Breathlesness|breathlesness
5359842|NCT00207727|Multiple Sclerosis|multiple sclerosis
5359843|NCT00207714|Rheumatoid Arthritis|rheumatoid arthritis
5359844|NCT00207714|CNTO 148|cnto 148
5359845|NCT00207714|Methotrexate|methotrexate
5359846|NCT00207714|Joint pain|joint pain
5359847|NCT00207714|Arthritis|arthritis
5359848|NCT00207701|Ankylosing Spondylitis|ankylosing spondylitis
5359849|NCT00207701|infusion|infusion
5359850|NCT00207688|Ulcerative Colitis|ulcerative colitis
5359851|NCT00207688|Infliximab|infliximab
5359852|NCT00207688|Remicade|remicade
5359853|NCT00207688|Safety|safety
5359854|NCT00207675|Crohn's Disease|crohn's disease
5359855|NCT00207675|pediatric Crohn's Disease|pediatric crohn's disease
5359856|NCT00207662|Crohn's Disease|crohn's disease
5359857|NCT00207649|shared decision-making|shared decision-making
5359858|NCT00207649|prostate cancer screening|prostate cancer screening
5359859|NCT00207649|evidence-based medicine|evidence-based medicine
5359860|NCT00207649|computer-assisted learning tools|computer-assisted learning tools
5359861|NCT00207649|standardized patients|standardized patients
5359862|NCT00207649|randomized controlled trial|randomized controlled trial
5359863|NCT00207649|educational intervention|educational intervention
5359864|NCT00207649|patient education|patient education
5359865|NCT00207649|physician education|physician education
5359969|NCT00207064|P50 gating|p50 gating
5359866|NCT00207636|Computer-Assisted Decision Making|computer-assisted decision making
5359867|NCT00207636|Workplace|workplace
5359868|NCT00207636|Screening|screening
5359869|NCT00207623|arthritis|arthritis
5359870|NCT00207623|self management|self management
5359871|NCT00207623|patient education|patient education
5359872|NCT00207610|Anemia|anemia
5359873|NCT00207610|Postpartum|postpartum
5359874|NCT00207610|iron|iron
5359875|NCT00207610|supplements|supplements
5359876|NCT00207571|computer|computer
5359877|NCT00207571|video|video
5359878|NCT00207571|partner notification|partner notification
5359879|NCT00207519|overweight|overweight
5359880|NCT00207519|obesity|obesity
5359881|NCT00207519|adolescent|adolescent
5359882|NCT00207506|Latino|latino
5359883|NCT00207506|Lay Health|lay health
5359884|NCT00207506|Access|access
5359885|NCT00207506|Prevention|prevention
5359886|NCT00207506|HIV Seronegativity|hiv seronegativity
5359887|NCT00207506|HIV|hiv
5359888|NCT00207493|sexually transmitted disease|sexually transmitted disease
5359889|NCT00207493|structural intervention|structural intervention
5359890|NCT00207493|behavioral intervention|behavioral intervention
5359891|NCT00207467|patient-delivered partner treatment|patient-delivered partner treatment
5359892|NCT00207467|partner referral|partner referral
5359893|NCT00207467|sexually transmitted diseases|sexually transmitted diseases
5359894|NCT00207454|Partner Referral|partner referral
5359895|NCT00207454|Social Cognitive Intervention|social cognitive intervention
5359896|NCT00207454|Partner Delivered Medication|partner delivered medication
5359897|NCT00207441|arthritis|arthritis
5359898|NCT00207441|chronic disease|chronic disease
5359899|NCT00207441|self management|self management
5359900|NCT00207441|self efficacy|self efficacy
5359901|NCT00207428|Bronchial asthma|bronchial asthma
5359902|NCT00207428|Carbamazepine|carbamazepine
5359903|NCT00207428|Efficacy|efficacy
5359904|NCT00207415|arthritis|arthritis
5359905|NCT00207415|self management|self management
5359906|NCT00207402|Hepatitis C|hepatitis c
5359907|NCT00207402|Insulin resistance|insulin resistance
5359908|NCT00207389|Incretins:GIP , GLP-1|incretins:gip , glp-1
5359909|NCT00207389|Gastric bypass surgery|gastric bypass surgery
5359910|NCT00207389|Laparoscopic gastric bypass surgery|laparoscopic gastric bypass surgery
5359911|NCT00207389|Postprandial expression of GIP|postprandial expression of gip
5359912|NCT00207363|Hepatitis C|hepatitis c
5359913|NCT00207350|Brain Tumor|brain tumor
5359914|NCT00207337|COPD (Chronic Obstructive Pulmonary Disease)|copd (chronic obstructive pulmonary disease)
5359915|NCT00207337|Emphysema|emphysema
5359916|NCT00207337|Minimally invasive|minimally invasive
5359917|NCT00207311|Hepatitis C|hepatitis c
5359918|NCT00207311|Fatty Liver|fatty liver
5359919|NCT00207311|NASH|nash
5359920|NCT00207311|Steatohepatitis|steatohepatitis
5359921|NCT00207285|Police|police
5359922|NCT00207285|Sleep|sleep
5359923|NCT00207285|Fatigue|fatigue
5359924|NCT00207285|Work Hours|work hours
5359925|NCT00207285|Sleep disorder|sleep disorder
5359926|NCT00207285|Performance|performance
5359927|NCT00207272|Hypocaloric MCT oil liquid diet|hypocaloric mct oil liquid diet
5359928|NCT00207272|Hypocaloric LCT oil liquid diet|hypocaloric lct oil liquid diet
5359929|NCT00207272|Visceral and omental adipose tissue|visceral and omental adipose tissue
5359930|NCT00207272|Subcutaneous abdominal adipose tissue|subcutaneous abdominal adipose tissue
5359931|NCT00207272|Gastric bypass surgery|gastric bypass surgery
5359932|NCT00207259|Prostate Cancer|prostate cancer
5359933|NCT00207259|Reiki|reiki
5359934|NCT00207259|Relaxation Response|relaxation response
5359935|NCT00207259|Cognitive Restructuring|cognitive restructuring
5359936|NCT00207259|Feasibility|feasibility
5359937|NCT00207233|Weight loss|weight loss
5359938|NCT00207233|MCT oil hypocaloric liquid diet|mct oil hypocaloric liquid diet
5359939|NCT00207233|LCT oil hypocaloric liquid diet|lct oil hypocaloric liquid diet
5359940|NCT00207233|Gastric Bypass|gastric bypass
5359941|NCT00207220|heart failure|heart failure
5359942|NCT00207220|preserved ejection fraction|preserved ejection fraction
5359943|NCT00207220|vascular stiffness|vascular stiffness
5359944|NCT00207207|Alternate Site|alternate site
5359945|NCT00207207|Blood Glucose Testing|blood glucose testing
5359946|NCT00207207|Blood Sugar Testing|blood sugar testing
5359947|NCT00207207|Hemoglobin A1C|hemoglobin a1c
5359948|NCT00207181|Cancer prevention|cancer prevention
5359949|NCT00207181|Physical activity|physical activity
5359950|NCT00207181|Self-report|self-report
5359951|NCT00207181|Paper diary|paper diary
5359952|NCT00207181|Electronic|electronic
5359953|NCT00207181|Computerized|computerized
5359954|NCT00207181|Measurement|measurement
5359955|NCT00207181|PDA|pda
5359956|NCT00207181|Accelerometer|accelerometer
5359957|NCT00207142|Treatment Naive|treatment naive
5359958|NCT00207142|HIV-1 infected treatment naive patients|hiv-1 infected treatment naive patients
5359959|NCT00207116|Metastatic Non Small Cell Lung Cancer|metastatic non small cell lung cancer
5359960|NCT00207103|Advanced metastatic or solid tumors|advanced metastatic or solid tumors
5359961|NCT00207077|Advanced Solid Tumors|advanced solid tumors
5359962|NCT00207064|first-episode|first-episode
5359963|NCT00207064|altanserin|altanserin
5359964|NCT00207064|5-HT2A receptors|5-ht2a receptors
5359965|NCT00207064|MRI|mri
5359966|NCT00207064|fMRI|fmri
5359970|NCT00207064|endophenotypes|endophenotypes
5359971|NCT00207064|vulnerability indicators|vulnerability indicators
5359972|NCT00207064|quetiapine|quetiapine
5359973|NCT00207051|Advanced Gastrointestinal Malignancies|advanced gastrointestinal malignancies
5359974|NCT00207038|Asthma|asthma
5359975|NCT00207038|Airway inflammation|airway inflammation
5359976|NCT00207038|Sport|sport
5359977|NCT00207025|Patients with advanced solid tumors|patients with advanced solid tumors
5359978|NCT00206999|Psychophysiology|psychophysiology
5359979|NCT00206999|PPI|ppi
5359980|NCT00206999|P50 suppression|p50 suppression
5359981|NCT00206999|Imipramine|imipramine
5359982|NCT00206986|Schizophrenia|schizophrenia
5359983|NCT00206986|Information processing|information processing
5359984|NCT00206986|PPI|ppi
5359985|NCT00206986|P50 gating|p50 gating
5359986|NCT00206986|P300|p300
5359987|NCT00206986|mismatch negativity|mismatch negativity
5359988|NCT00206986|clonidine|clonidine
5359989|NCT00206960|drug-naive|drug-naive
5359990|NCT00206960|epidepride|epidepride
5359991|NCT00206960|single tomography|single tomography
5359992|NCT00206960|D2 receptor|d2 receptor
5359993|NCT00206960|information processing|information processing
5359994|NCT00206960|PPI|ppi
5359995|NCT00206960|antipsychotic treatment|antipsychotic treatment
5359996|NCT00206960|MRI|mri
5359997|NCT00206960|fMRI|fmri
5359998|NCT00206960|cognitive disturbances|cognitive disturbances
5359999|NCT00206947|Cognitive deficits|cognitive deficits
5360000|NCT00206947|Cholinergic Augmentation|cholinergic augmentation
5360001|NCT00206947|Schizophrenia|schizophrenia
5360002|NCT00206934|PPI|ppi
5360003|NCT00206934|P50 suppression|p50 suppression
5360004|NCT00206934|P300|p300
5360005|NCT00206934|mismatch negativity|mismatch negativity
5360006|NCT00206934|escitalopram|escitalopram
5360007|NCT00206921|Telangiectasia|telangiectasia
5360008|NCT00206921|Skin redness|skin redness
5360009|NCT00206882|sunburn|sunburn
5360010|NCT00206882|corticosteroids|corticosteroids
5360011|NCT00206791|bone substitutes|bone substitutes
5360012|NCT00206791|Bone Replacement Materials|bone replacement materials
5360013|NCT00206791|bone void filler|bone void filler
5360014|NCT00206791|Grafting, Bone|grafting, bone
5360015|NCT00206791|Bone Cysts|bone cysts
5360016|NCT00206778|Mixed mania|mixed mania
5360017|NCT00206778|Bipolar Disorder|bipolar disorder
5360018|NCT00206765|panic|panic
5360019|NCT00206739|Malaria|malaria
5360020|NCT00206739|Anemia|anemia
5360021|NCT00206739|IPTi|ipti
5360022|NCT00206739|Intermittent Preventive Treatment in Infants|intermittent preventive treatment in infants
5360023|NCT00206739|Sulfadoxine-Pyrimethamine|sulfadoxine-pyrimethamine
5360024|NCT00206739|Chemoprophylaxis|chemoprophylaxis
5360025|NCT00206739|Ghana|ghana
5360026|NCT00206713|Crohn Disease|crohn disease
5360027|NCT00206674|Morbus Crohn|morbus crohn
5360028|NCT00206674|Sargramostim|sargramostim
5360029|NCT00206674|Phase III|phase iii
5360030|NCT00206674|Placebo Controlled|placebo controlled
5360031|NCT00206661|Crohn Disease|crohn disease
5360032|NCT00206609|Cancer|cancer
5360033|NCT00206609|palliative care|palliative care
5360034|NCT00206609|dyspnoea|dyspnoea
5360035|NCT00206609|oxygen|oxygen
5360036|NCT00206570|Schizophrenia|schizophrenia
5360037|NCT00206570|Gender differences|gender differences
5360038|NCT00206570|Hormones|hormones
5360039|NCT00206570|Estradiol|estradiol
5360040|NCT00206570|PANSS|panss
5360041|NCT00206557|Schizophrenia|schizophrenia
5360042|NCT00206557|Mental Illness|mental illness
5360043|NCT00206557|Hormone Therapy|hormone therapy
5360044|NCT00206557|Post-menopausal|post-menopausal
5360045|NCT00206557|SERM|serm
5360046|NCT00206557|Raloxifene|raloxifene
5360047|NCT00206544|Bipolar Affective Disorder|bipolar affective disorder
5360048|NCT00206544|Mania|mania
5360049|NCT00206544|Anti-Estrogen|anti-estrogen
5360050|NCT00206544|Schizoaffective Disorder|schizoaffective disorder
5360051|NCT00206544|Mood|mood
5360052|NCT00206531|HIV-1|hiv-1
5360053|NCT00206531|Naive T-cells|naive t-cells
5360054|NCT00206531|CD31|cd31
5360055|NCT00206531|Treatment Naive|treatment naive
5360056|NCT00206518|Breast|breast
5360057|NCT00206518|Cancer|cancer
5360058|NCT00206518|Taxotere|taxotere
5360060|NCT00206518|Validation|validation
5360061|NCT00206518|Neoadjuvant|neoadjuvant
5360062|NCT00206505|Breast|breast
5360063|NCT00206505|Cancer|cancer
5360064|NCT00206505|Neoadjuvant|neoadjuvant
5360065|NCT00206505|Taxotere|taxotere
5360066|NCT00206492|Breast|breast
5360067|NCT00206492|Cancer|cancer
5360068|NCT00206492|Neoadjuvant|neoadjuvant
5360069|NCT00206492|HER2|her2
5360070|NCT00206492|Overexpressing|overexpressing
5360071|NCT00206466|neoadjuvant|neoadjuvant
5360072|NCT00206466|chemosensitivity|chemosensitivity
5360073|NCT00206466|chemotherapy|chemotherapy
5360074|NCT00206466|breast cancer|breast cancer
5360075|NCT00206466|tumor|tumor
5360076|NCT00206466|taxotere|taxotere
5360077|NCT00206466|AC|ac
5360078|NCT00206453|Breast|breast
5360079|NCT00206453|Cancer|cancer
5360080|NCT00206453|Gene|gene
5360081|NCT00206453|Expression|expression
5360082|NCT00206453|Taxotere|taxotere
5360083|NCT00206440|chemotherapy|chemotherapy
5360084|NCT00206440|nausea|nausea
5360085|NCT00206440|vomiting|vomiting
5360086|NCT00206440|breast cancer|breast cancer
5360087|NCT00206427|Advanced|advanced
5360088|NCT00206427|Breast|breast
5360089|NCT00206427|Cancer|cancer
5360090|NCT00206427|Neoadjuvant|neoadjuvant
5360091|NCT00206427|HER2|her2
5360092|NCT00206414|HORMONE RECEPTOR POSITIVE BREAST CANCER|hormone receptor positive breast cancer
5360093|NCT00206401|Adolescents|adolescents
5360094|NCT00206401|Lantus|lantus
5360095|NCT00206388|NEUROBLASTOMA|neuroblastoma
5360096|NCT00206388|RECURRENT|recurrent
5360097|NCT00206388|REFRACTORY|refractory
5360098|NCT00206388|CORTICAL|cortical
5360099|NCT00206388|BONE|bone
5360100|NCT00206375|Hypothyroidism|hypothyroidism
5360101|NCT00206375|Growth hormone|growth hormone
5360102|NCT00206362|Depression|depression
5360103|NCT00206362|Socioeconomic status|socioeconomic status
5360104|NCT00206362|Type 1 diabetes mellitus|type 1 diabetes mellitus
5360105|NCT00206362|Children|children
5360106|NCT00206362|Adolescents|adolescents
5360107|NCT00206349|Depression|depression
5360108|NCT00206349|Socioeconomic status|socioeconomic status
5360109|NCT00206349|Type 1 diabetes mellitus|type 1 diabetes mellitus
5360110|NCT00206349|Children|children
5360111|NCT00206349|Adolescents|adolescents
5360112|NCT00206297|Type 1 diabetes|type 1 diabetes
5360113|NCT00206297|hypoglycemia|hypoglycemia
5360114|NCT00206297|hyperglycemia|hyperglycemia
5360115|NCT00206284|GERD without erosive esophagitis|gerd without erosive esophagitis
5360116|NCT00206271|whiplash injuries|whiplash injuries
5360117|NCT00206271|neck pain|neck pain
5360118|NCT00206271|exercise movement techniques|exercise movement techniques
5360119|NCT00206271|immobilisation|immobilisation
5360120|NCT00206258|type 1 diabetes|type 1 diabetes
5360121|NCT00206258|hypoglycemia|hypoglycemia
5360122|NCT00206258|hyperglycemia|hyperglycemia
5360123|NCT00206245|GERD with erosive esophagitis|gerd with erosive esophagitis
5360124|NCT00206232|Diastolic Heart Failure|diastolic heart failure
5360125|NCT00206219|Squamous cell carcinoma of the head and neck|squamous cell carcinoma of the head and neck
5360126|NCT00206193|termination of pregnancy|termination of pregnancy
5360127|NCT00206141|Bipolar disorder|bipolar disorder
5360128|NCT00206141|bipolar depression|bipolar depression
5360129|NCT00206141|depression|depression
5360130|NCT00206128|Schizophrenia|schizophrenia
5360131|NCT00206115|Schizophrenic disorder|schizophrenic disorder
5360132|NCT00206102|Schizophrenia|schizophrenia
5360133|NCT00206102|Schizoaffective Disorder|schizoaffective disorder
5360134|NCT00206089|Prevention of venous thromboembolic events in patients undergoing elective hip replacement or hip fracture surgery|prevention of venous thromboembolic events in patients undergoing elective hip replacement or hip fracture surgery
5360135|NCT00206076|Liver transplantation|liver transplantation
5360136|NCT00206076|Calcineurin inhibitor withdraw|calcineurin inhibitor withdraw
5360137|NCT00206076|mycophenolate mofetil|mycophenolate mofetil
5360138|NCT00206076|Immunosuppression side effects|immunosuppression side effects
5360139|NCT00206076|Graft rejection|graft rejection
5360140|NCT00206037|Tibia osteotomy|tibia osteotomy
5360141|NCT00206037|Bone healing|bone healing
5360142|NCT00206037|Bone filler|bone filler
5360143|NCT00206037|Equine Protein|equine protein
5360144|NCT00206037|COLLOSS E|colloss e
5360145|NCT00206037|TomoFix|tomofix
5360146|NCT00206011|Condylar neck|condylar neck
5360147|NCT00206011|fractures|fractures
5360148|NCT00206011|endoscopic|endoscopic
5360149|NCT00206011|Helkimo Dysfunction index|helkimo dysfunction index
5360150|NCT00205998|Locking Compression Plate|locking compression plate
5360151|NCT00205998|Conservative treatment|conservative treatment
5360152|NCT00205998|Surgical treatment|surgical treatment
5360153|NCT00205998|Radius fractures|radius fractures
5360154|NCT00205998|AO 23|ao 23
5360155|NCT00205985|Return to work|return to work
5360156|NCT00205985|Scaphoid fracture|scaphoid fracture
5360157|NCT00205985|Operative treatment|operative treatment
5360158|NCT00205985|Activity level|activity level
5360159|NCT00205972|Fractures|fractures
5360160|NCT00205972|Humerus|humerus
5360161|NCT00205972|Conservative treatment|conservative treatment
5360162|NCT00205972|Operative treatment|operative treatment
5360163|NCT00205959|Humerus|humerus
5360164|NCT00205959|Fractures|fractures
5360165|NCT00205959|Locking Plates|locking plates
5360166|NCT00205959|Nail System|nail system
5360167|NCT00205946|Reward Processing|reward processing
5360168|NCT00205946|Wellbutrin|wellbutrin
5360169|NCT00205946|Bupropion|bupropion
5360170|NCT00205933|Depression|depression
5360171|NCT00205933|Bipolar Disorder|bipolar disorder
5360172|NCT00205933|Reward Processing|reward processing
5360173|NCT00205920|emphysema|emphysema
5360174|NCT00205920|pulmonary emphysema|pulmonary emphysema
5360175|NCT00205920|COPD|copd
5360176|NCT00205920|COLD|cold
5360177|NCT00205920|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
5360178|NCT00205907|BLVR|blvr
5360179|NCT00205907|emphysema|emphysema
5360180|NCT00205907|COPD|copd
5360181|NCT00205907|COLD|cold
5360182|NCT00205907|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
5360377|NCT00204438|follicle|follicle
5360183|NCT00205907|pulmonary emphysema|pulmonary emphysema
5360184|NCT00205894|Headache|headache
5360185|NCT00205894|Chronic headache|chronic headache
5360186|NCT00205894|Migraine|migraine
5360187|NCT00205894|Pain|pain
5360188|NCT00205894|Cluster headache|cluster headache
5360189|NCT00205881|HiResolution Bionic Ear|hiresolution bionic ear
5360190|NCT00205881|severe to profound hearing loss|severe to profound hearing loss
5360191|NCT00205881|bilateral implantation|bilateral implantation
5360192|NCT00205868|Back Pain|back pain
5360193|NCT00205868|Low Back Pain|low back pain
5360194|NCT00205868|Chronic Pain|chronic pain
5360195|NCT00205868|Spinal Cord Stimulation|spinal cord stimulation
5360196|NCT00205855|Pain|pain
5360197|NCT00205855|Chronic Pain|chronic pain
5360198|NCT00205855|Neurostimulation|neurostimulation
5360199|NCT00205829|Chronic headaches|chronic headaches
5360200|NCT00205829|greater occipital nerve stimulation|greater occipital nerve stimulation
5360201|NCT00205816|Bacterial Infections|bacterial infections
5360202|NCT00205803|Infant Vaccine|infant vaccine
5360203|NCT00205777|Osteoporosis|osteoporosis
5360204|NCT00205777|Postmenopause|postmenopause
5360205|NCT00205764|Multiple Myeloma|multiple myeloma
5360206|NCT00205764|first line tretment|first line tretment
5360207|NCT00205764|high dose chemotherapy|high dose chemotherapy
5360208|NCT00205764|stem cell transplantation|stem cell transplantation
5360209|NCT00205764|maintenance therapy|maintenance therapy
5360210|NCT00205751|Multiple Myeloma|multiple myeloma
5360211|NCT00205751|first line treatment|first line treatment
5360212|NCT00205751|thalidomide|thalidomide
5360213|NCT00205751|melphalan|melphalan
5360214|NCT00205738|Schizophrenia|schizophrenia
5360215|NCT00205738|BMI|bmi
5360216|NCT00205738|T2DM|t2dm
5360217|NCT00205725|Schizophrenia|schizophrenia
5360218|NCT00205725|BMI|bmi
5360219|NCT00205725|T2DM|t2dm
5360220|NCT00205712|NMDA antagonist-induced psychosis|nmda antagonist-induced psychosis
5360221|NCT00205712|Children|children
5360222|NCT00205712|Memory Impairment|memory impairment
5360223|NCT00205712|Decreased cognitive function|decreased cognitive function
5360224|NCT00205712|Increased memory impairment|increased memory impairment
5360225|NCT00205699|Antipsychotic treatment|antipsychotic treatment
5360226|NCT00205699|Insulin action/secretion|insulin action/secretion
5360227|NCT00205699|Abdominal fat mass, total body fat|abdominal fat mass, total body fat
5360228|NCT00205699|Aggression|aggression
5360229|NCT00205699|Resting metabolic rates|resting metabolic rates
5360230|NCT00205686|Aging, dhea, bone density, muscle mass, insulin action|aging, dhea, bone density, muscle mass, insulin action
5360231|NCT00205660|Schizophrenia|schizophrenia
5360232|NCT00205660|Obesity|obesity
5360233|NCT00205660|Hyperglycemia|hyperglycemia
5360234|NCT00205660|Dyslipidemia|dyslipidemia
5360235|NCT00205660|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
5360236|NCT00205647|Chronic Bronchitis|chronic bronchitis
5360237|NCT00205647|N-acetylcysteine (NAC)|n-acetylcysteine (nac)
5360238|NCT00205647|Quality of Life|quality of life
5360239|NCT00205647|Mucus|mucus
5360240|NCT00205634|Cystic Fibrosis (CF)|cystic fibrosis (cf)
5360241|NCT00205634|Macrolide antiobiotics|macrolide antiobiotics
5360242|NCT00205634|airway inflammation|airway inflammation
5360243|NCT00205621|Alzheimer's disease|alzheimer's disease
5360244|NCT00205621|amyloid|amyloid
5360245|NCT00205621|PET|pet
5360246|NCT00205621|PIB|pib
5360247|NCT00205621|FDDNP|fddnp
5360248|NCT00205608|schizophrenia|schizophrenia
5360249|NCT00205608|microglia|microglia
5360250|NCT00205608|PET|pet
5360251|NCT00205595|microglia|microglia
5360252|NCT00205595|PET|pet
5360253|NCT00205595|PK11195|pk11195
5360254|NCT00205582|Traumatic Brain Injury|traumatic brain injury
5360255|NCT00205582|PET|pet
5360256|NCT00205582|microglia|microglia
5360257|NCT00205569|brain injury, acute rehabilitation|brain injury, acute rehabilitation
5360258|NCT00205556|online hemodiafiltration|online hemodiafiltration
5360259|NCT00205556|low flux hemodialysis|low flux hemodialysis
5360260|NCT00205556|cardiovascular disease|cardiovascular disease
5360261|NCT00205556|endothelial dysfunction|endothelial dysfunction
5360262|NCT00205556|uremic toxicity|uremic toxicity
5360263|NCT00205556|quality of life|quality of life
5360264|NCT00205556|nutritional status|nutritional status
5360265|NCT00205543|obstructive sleep apnea|obstructive sleep apnea
5360266|NCT00205543|airway obstruction|airway obstruction
5360267|NCT00205543|sleep-disordered breathing|sleep-disordered breathing
5360268|NCT00205530|brain injury, family treatment|brain injury, family treatment
5360269|NCT00205504|Inflammatory markers, oral contraceptions, obesity, metabolic syndrome X|inflammatory markers, oral contraceptions, obesity, metabolic syndrome x
5360270|NCT00205491|depression after brain injury|depression after brain injury
5360271|NCT00205491|traumatic brain injury|traumatic brain injury
5360272|NCT00205491|Venlafaxine|venlafaxine
5360273|NCT00205426|Pulmonary hypertension in lung transplant recipients|pulmonary hypertension in lung transplant recipients
5360274|NCT00205413|surveillance for lung cancer|surveillance for lung cancer
5360275|NCT00205387|echocardiography|echocardiography
5360276|NCT00205387|cardiac elastography|cardiac elastography
5360277|NCT00205387|Normal volunteers|normal volunteers
5360278|NCT00205309|intubated patients|intubated patients
5360279|NCT00205283|HIV|hiv
5360280|NCT00205270|Pre or post-lung transplant|pre or post-lung transplant
5360281|NCT00205270|Healthy|healthy
5360282|NCT00205231|HIV|hiv
5360283|NCT00205192|Heart Failure|heart failure
5360284|NCT00205192|Cardiac resynchronization|cardiac resynchronization
5360285|NCT00205192|echocardiography|echocardiography
5360286|NCT00205166|adenosine tracer scans|adenosine tracer scans
5360287|NCT00205166|coronary artery disease|coronary artery disease
5360288|NCT00205166|caffeine|caffeine
5360289|NCT00205153|hypertension in African Americans|hypertension in african americans
5360290|NCT00205127|Cardiac PET imaging|cardiac pet imaging
5360291|NCT00205127|Radiopharmaceutical tracers|radiopharmaceutical tracers
5360292|NCT00205101|Transforaminal lumbar interbody fusion|transforaminal lumbar interbody fusion
5360293|NCT00205101|Posterior lumbar interbody fusion|posterior lumbar interbody fusion
5360294|NCT00205101|Isthmic spondylolisthesis, degenerative spondylolisthesis|isthmic spondylolisthesis, degenerative spondylolisthesis
5360295|NCT00205101|Pseudoarthritis|pseudoarthritis
5360296|NCT00205101|Severe Foraminal Stenosis|severe foraminal stenosis
5360297|NCT00205049|acute alcoholic hepatitis|acute alcoholic hepatitis
5360298|NCT00204997|Cervical Cancer|cervical cancer
5360299|NCT00204997|Squamous Cell|squamous cell
5360300|NCT00204997|Laparoscopy|laparoscopy
5360301|NCT00204997|Ovarian Function|ovarian function
5360302|NCT00204984|arterial stiffness|arterial stiffness
5360303|NCT00204984|echocardiography|echocardiography
5360304|NCT00204984|nesiritide|nesiritide
5360305|NCT00204958|bone marrow transplant (BMT)|bone marrow transplant (bmt)
5360306|NCT00204958|hematopoietic stem cell transplant (HSCT)|hematopoietic stem cell transplant (hsct)
5360307|NCT00204945|arterial stiffness|arterial stiffness
5360308|NCT00204945|echocardiography|echocardiography
5360309|NCT00204945|nesiritide|nesiritide
5360310|NCT00204945|high heart pressures|high heart pressures
5360311|NCT00204945|cardiac catheterization|cardiac catheterization
5360312|NCT00204919|osteoporosis|osteoporosis
5360313|NCT00204919|vitamin D deficiency|vitamin d deficiency
5360314|NCT00204867|colorectal|colorectal
5360315|NCT00204867|polyps|polyps
5360316|NCT00204763|manometry catheters|manometry catheters
5360317|NCT00204763|diffuse esophageal spasm or hypertensive LES|diffuse esophageal spasm or hypertensive les
5360318|NCT00204763|incontinence|incontinence
5360319|NCT00204750|lower esophageal ring|lower esophageal ring
5360320|NCT00204750|dysphagia|dysphagia
5360321|NCT00204750|electrosurgical incision|electrosurgical incision
5360322|NCT00204750|bougie dilation|bougie dilation
5360323|NCT00204750|GERD|gerd
5360324|NCT00204711|patients having outpatient surgery with sedation|patients having outpatient surgery with sedation
5360325|NCT00204711|patients having procedures with sedation|patients having procedures with sedation
5360326|NCT00204672|Asthma|asthma
5360327|NCT00204659|Rituximab|rituximab
5360328|NCT00204659|CHOP|chop
5360329|NCT00204659|DLBCL|dlbcl
5360330|NCT00204659|gastric lymphoma|gastric lymphoma
5360331|NCT00204594|mRNA|mrna
5360332|NCT00204594|vaccination|vaccination
5360333|NCT00204594|melanoma|melanoma
5360334|NCT00204581|Melanoma|melanoma
5360335|NCT00204581|Soft tissue metastases|soft tissue metastases
5360336|NCT00204581|Interleukin-2|interleukin-2
5360337|NCT00204555|nodular basal cell carcinoma|nodular basal cell carcinoma
5360338|NCT00204555|Imiquimod|imiquimod
5360339|NCT00204555|topical treatment|topical treatment
5360340|NCT00204555|Adjuvants, Immunologic|adjuvants, immunologic
5360341|NCT00204555|Antineoplastic Agents|antineoplastic agents
5360342|NCT00204555|Interferon Inducers|interferon inducers
5360343|NCT00204542|actinic keratosis|actinic keratosis
5360344|NCT00204542|diclofenac sodium|diclofenac sodium
5360345|NCT00204529|malignant melanoma|malignant melanoma
5360346|NCT00204529|adjuvant therapy|adjuvant therapy
5360347|NCT00204529|Adjuvants, Immunologic|adjuvants, immunologic
5360348|NCT00204516|vaccination|vaccination
5360349|NCT00204516|mRNA|mrna
5360350|NCT00204503|Bipolar I or II|bipolar i or ii
5360351|NCT00204503|Depression|depression
5360352|NCT00204503|Alcohol Abuse or Dependence|alcohol abuse or dependence
5360353|NCT00204503|Mental Health Issues|mental health issues
5360354|NCT00204490|soy|soy
5360355|NCT00204490|isoflavones|isoflavones
5360356|NCT00204490|phytoestrogens|phytoestrogens
5360357|NCT00204490|prevention|prevention
5360358|NCT00204490|mammographic density|mammographic density
5360359|NCT00204490|bone density|bone density
5360360|NCT00204477|soy diet|soy diet
5360361|NCT00204477|breast cancer|breast cancer
5360362|NCT00204477|ovarian hormones|ovarian hormones
5360363|NCT00204477|breast density|breast density
5360364|NCT00204477|prevention|prevention
5360365|NCT00204464|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
5360366|NCT00204464|Exercise|exercise
5360367|NCT00204451|emergency contraception|emergency contraception
5360368|NCT00204451|follicle|follicle
5360369|NCT00204451|ovulation|ovulation
5360370|NCT00204451|blood pressure|blood pressure
5360371|NCT00204451|Fertility Control|fertility control
5360372|NCT00204451|Inhibition of fertilization|inhibition of fertilization
5360373|NCT00204438|female contraception|female contraception
5360374|NCT00204438|oral contraceptive|oral contraceptive
5360375|NCT00204438|emergency contraceptive|emergency contraceptive
5360376|NCT00204438|ovary|ovary
5360378|NCT00204438|ovulation|ovulation
5360379|NCT00204425|Osteoporosis|osteoporosis
5360380|NCT00204425|Bone|bone
5360381|NCT00204425|Exercise|exercise
5360382|NCT00204425|Soy|soy
5360383|NCT00204425|Isoflavone|isoflavone
5360384|NCT00204425|Phytoestrogen|phytoestrogen
5360385|NCT00204425|Menopause|menopause
5360386|NCT00204425|Lipids|lipids
5360387|NCT00204412|Cholesterol|cholesterol
5360388|NCT00204412|High density lipoprotein|high density lipoprotein
5360389|NCT00204412|Low density lipoprotein|low density lipoprotein
5360390|NCT00204412|Triglyceride|triglyceride
5360391|NCT00204412|Glucose|glucose
5360392|NCT00204412|Exercise|exercise
5360393|NCT00204412|Fitness|fitness
5360394|NCT00204412|Flax|flax
5360395|NCT00204412|Lignan|lignan
5360396|NCT00204412|Phytoestrogen|phytoestrogen
5360397|NCT00204412|bone|bone
5360398|NCT00204386|Posttraumatic Stress Disorder|posttraumatic stress disorder
5360399|NCT00204360|epilepsy|epilepsy
5360400|NCT00204347|risperidone|risperidone
5360401|NCT00204334|Kidney transplantation|kidney transplantation
5360402|NCT00204334|anemia|anemia
5360403|NCT00204334|vascular endothelium|vascular endothelium
5360404|NCT00204334|monocytes|monocytes
5360405|NCT00204334|apoptosis|apoptosis
5360406|NCT00204321|rejection|rejection
5360407|NCT00204321|vesselwall function|vesselwall function
5360408|NCT00204321|endothelial cell function|endothelial cell function
5360409|NCT00204321|monocytes|monocytes
5360410|NCT00204308|HIV|hiv
5360411|NCT00204308|Pregnancy|pregnancy
5360412|NCT00204308|Mother-to-child transmission of HIV|mother-to-child transmission of hiv
5360413|NCT00204308|Drug resistance|drug resistance
5360414|NCT00204308|Nevirapine resistance|nevirapine resistance
5360415|NCT00204308|NNRTI resistance|nnrti resistance
5360416|NCT00204295|Brain neoplasms|brain neoplasms
5360417|NCT00204295|Positron-Emission Tomography|positron-emission tomography
5360418|NCT00204295|Amino Acids|amino acids
5360419|NCT00204295|Magnetic Resonance Imaging|magnetic resonance imaging
5360420|NCT00204282|Diabetes prevention|diabetes prevention
5360421|NCT00204269|Hypogonadism|hypogonadism
5360422|NCT00204269|Testosterone|testosterone
5360423|NCT00204269|Substitution|substitution
5360424|NCT00204256|chronic kidney disease|chronic kidney disease
5360425|NCT00204256|anemia|anemia
5360426|NCT00204256|intravenous iron|intravenous iron
5360427|NCT00204256|recombinant human erythropoetin|recombinant human erythropoetin
5360428|NCT00204243|naltrexone implant|naltrexone implant
5360429|NCT00204243|methadone|methadone
5360430|NCT00204243|inmates|inmates
5360431|NCT00204243|randomized controlled trial|randomized controlled trial
5360432|NCT00204230|Kidney Failure, Chronic|kidney failure, chronic
5360433|NCT00204230|Kidney Transplantation|kidney transplantation
5360434|NCT00204217|cardiac arrest|cardiac arrest
5360435|NCT00204217|resuscitation|resuscitation
5360436|NCT00204217|ventilation|ventilation
5360437|NCT00204217|impedance|impedance
5360438|NCT00204204|multiple trauma|multiple trauma
5360439|NCT00204204|traffic accident|traffic accident
5360440|NCT00204204|outcome|outcome
5360441|NCT00204204|safety|safety
5360442|NCT00204204|injury severity|injury severity
5360443|NCT00204191|kidney transplantation|kidney transplantation
5360444|NCT00204191|Immunosuppression|immunosuppression
5360445|NCT00204191|Cyclosporine|cyclosporine
5360446|NCT00204191|Tacrolimus|tacrolimus
5360447|NCT00204178|Kidney transplantation|kidney transplantation
5360448|NCT00204178|Reperfusion injury|reperfusion injury
5360449|NCT00204152|Early onset depression|early onset depression
5360450|NCT00204152|early adversity|early adversity
5360451|NCT00204126|exercise testing|exercise testing
5360452|NCT00204126|treadmill|treadmill
5360453|NCT00204126|incomplete spinal cord injury|incomplete spinal cord injury
5360454|NCT00204126|novel methods|novel methods
5360455|NCT00204113|spinal cord injury|spinal cord injury
5360456|NCT00204113|standing|standing
5360457|NCT00204113|balance|balance
5360458|NCT00204113|functional electrical stimulation|functional electrical stimulation
5360459|NCT00204100|paraplegia|paraplegia
5360460|NCT00204100|spinal cord injury|spinal cord injury
5360461|NCT00204100|functional electrical stimulation|functional electrical stimulation
5360462|NCT00204100|cycling|cycling
5360463|NCT00204100|exercise|exercise
5360464|NCT00204100|cardiopulmonary fitness|cardiopulmonary fitness
5360465|NCT00204087|Schizophrenia|schizophrenia
5360466|NCT00204087|Psychosis|psychosis
5360467|NCT00204087|Prodrome|prodrome
5360468|NCT00204087|Early Initial Prodromal State|early initial prodromal state
5360469|NCT00204087|Early Intervention|early intervention
5360470|NCT00204087|Cognitive Behavioral Therapy|cognitive behavioral therapy
5360471|NCT00204074|Migraine|migraine
5360472|NCT00204074|Menstrual cycle|menstrual cycle
5360473|NCT00204074|17 beta-estradiol|17 beta-estradiol
5360474|NCT00204074|Transdermal administration|transdermal administration
5360475|NCT00204061|schizophrenia|schizophrenia
5360476|NCT00204061|psychosis|psychosis
5360477|NCT00204061|ultra high risk|ultra high risk
5360478|NCT00204061|prodromal state|prodromal state
5360479|NCT00204061|early intervention|early intervention
5360480|NCT00204061|amisulpride|amisulpride
5360481|NCT00204048|Hospitalists|hospitalists
5360482|NCT00204035|Training early achievers for careers in health|training early achievers for careers in health
5360483|NCT00204022|Lupus nephritis|lupus nephritis
5360484|NCT00204022|Treatment|treatment
5360485|NCT00204022|Maintenance therapy|maintenance therapy
5360486|NCT00204022|Mycophenolate mofetil|mycophenolate mofetil
5360487|NCT00204022|Azathioprine|azathioprine
5360488|NCT00204009|children and adolescents|children and adolescents
5360489|NCT00204009|epidemiology|epidemiology
5360490|NCT00203996|polycystic ovary syndrome|polycystic ovary syndrome
5360491|NCT00203996|metabolic syndrome|metabolic syndrome
5360492|NCT00203996|obstructive sleep apnea|obstructive sleep apnea
5360493|NCT00203996|impaired glucose tolerance|impaired glucose tolerance
5360494|NCT00203996|insulin resistance|insulin resistance
5360495|NCT00203970|Thrombosis|thrombosis
5360496|NCT00203970|Low Molecular Weight Heparin|low molecular weight heparin
5360497|NCT00203957|Parkinson's Disease|parkinson's disease
5360498|NCT00203944|Adoption|adoption
5360499|NCT00203944|Stress Response|stress response
5360500|NCT00203944|Child Development|child development
5360501|NCT00203931|Non-small cell lung cancer|non-small cell lung cancer
5360502|NCT00203918|Prostate Cancer|prostate cancer
5360503|NCT00203918|Cost-Effectiveness Analysis|cost-effectiveness analysis
5360504|NCT00203918|Utility Assessment|utility assessment
5360505|NCT00203905|Head and Neck Cancer|head and neck cancer
5360506|NCT00203892|Adenocarcinoma|adenocarcinoma
5360507|NCT00203892|Pancreas|pancreas
5360508|NCT00203879|metastatic melanoma|metastatic melanoma
5360509|NCT00203866|Metastatic Renal Cell Carcinoma|metastatic renal cell carcinoma
5360510|NCT00203853|HIV|hiv
5360511|NCT00203853|HAART|haart
5360512|NCT00203853|medication adherance|medication adherance
5360513|NCT00203853|pillbox|pillbox
5360514|NCT00203853|wristwatch|wristwatch
5360515|NCT00203840|Sleep Disorders|sleep disorders
5360516|NCT00203827|Sleep Disorders|sleep disorders
5360517|NCT00203814|Malaria|malaria
5360518|NCT00203814|Efficacy|efficacy
5360519|NCT00203814|Pharmacokinetic|pharmacokinetic
5360520|NCT00203814|Gametocyte|gametocyte
5360521|NCT00203814|Molecular markers|molecular markers
5360522|NCT00203814|Sulfadoxine-pyrimethamine|sulfadoxine-pyrimethamine
5360523|NCT00203814|Artesunate|artesunate
5360524|NCT00203814|Artemisinin|artemisinin
5360525|NCT00203801|Malaria|malaria
5360526|NCT00203801|Efficacy|efficacy
5360527|NCT00203801|Pharmacokinetic|pharmacokinetic
5360528|NCT00203801|Gametocyte|gametocyte
5360529|NCT00203801|Molecular markers|molecular markers
5360530|NCT00203801|Sulfadoxine-pyrimethamine|sulfadoxine-pyrimethamine
5360531|NCT00203801|Artesunate|artesunate
5360532|NCT00203801|Artemisinin|artemisinin
5360533|NCT00203788|work outcome|work outcome
5360534|NCT00203788|supported employment|supported employment
5360535|NCT00203788|social skills training|social skills training
5360536|NCT00203788|risperidone|risperidone
5360537|NCT00203788|cognition|cognition
5360538|NCT00203788|first-episode schizophrenia|first-episode schizophrenia
5360539|NCT00203762|Pragmatic cluster non-randomized controlled trial|pragmatic cluster non-randomized controlled trial
5360540|NCT00203762|antiretroviral treatment|antiretroviral treatment
5360541|NCT00203762|tuberculosis|tuberculosis
5360542|NCT00203762|childhood immunization|childhood immunization
5360543|NCT00203762|primary care|primary care
5360544|NCT00203762|resource-restricted settings|resource-restricted settings
5360545|NCT00203749|HIV|hiv
5360546|NCT00203749|Testing|testing
5360547|NCT00203749|Counseling|counseling
5360548|NCT00203736|Malaria|malaria
5360549|NCT00203736|Efficacy|efficacy
5360550|NCT00203736|Pharmacokinetic|pharmacokinetic
5360551|NCT00203736|Gametocyte|gametocyte
5360552|NCT00203736|Molecular Markers|molecular markers
5360553|NCT00203736|Sulfadoxine-pyrimethamine|sulfadoxine-pyrimethamine
5360554|NCT00203736|Artesunate|artesunate
5360555|NCT00203736|Artemisinin|artemisinin
5360556|NCT00203723|mood disorder|mood disorder
5360557|NCT00203723|affective disorder|affective disorder
5360558|NCT00203723|depression|depression
5360559|NCT00203723|treatment-resistant|treatment-resistant
5360560|NCT00203710|Concentric Retriever Device|concentric retriever device
5360561|NCT00203710|embolectomy|embolectomy
5360562|NCT00203710|acute ischemic stroke|acute ischemic stroke
5360563|NCT00203710|treatment|treatment
5360564|NCT00203697|Eric Kleerup|eric kleerup
5360565|NCT00203697|Idiopathic Pulmonary Fibrosis|idiopathic pulmonary fibrosis
5360566|NCT00203671|renal|renal
5360567|NCT00203671|transplant|transplant
5360568|NCT00203671|kidney|kidney
5360569|NCT00203671|rejection|rejection
5360570|NCT00203671|MMF|mmf
5360571|NCT00203671|Mycophenolate Mofetil|mycophenolate mofetil
5360572|NCT00203671|outcomes|outcomes
5360573|NCT00203671|Kidney Transplantation|kidney transplantation
5360574|NCT00203645|Problem gambling|problem gambling
5360575|NCT00203645|Self-help manual|self-help manual
5360576|NCT00203645|Motivation enhancement|motivation enhancement
5360577|NCT00203645|Telephone support|telephone support
5360578|NCT00203645|Treatment|treatment
5360579|NCT00203645|Pathological gambling|pathological gambling
5360580|NCT00203632|diabetes mellitus|diabetes mellitus
5360581|NCT00203632|endothelium|endothelium
5360582|NCT00203632|thiazolidinediones|thiazolidinediones
5360583|NCT00203632|atherosclerosis|atherosclerosis
5360584|NCT00203593|exercise|exercise
5360585|NCT00203593|total peripheral resistance|total peripheral resistance
5360586|NCT00203593|venoconstriction|venoconstriction
5360587|NCT00203593|blood volume expansion|blood volume expansion
5360588|NCT00203593|orthostatic tolerance|orthostatic tolerance
5360589|NCT00203580|venous thromboembolism|venous thromboembolism
5360590|NCT00203580|low-molecular-weight heparin|low-molecular-weight heparin
5360591|NCT00203567|bipolar depression|bipolar depression
5360592|NCT00203567|carbamazepine ER|carbamazepine er
5360593|NCT00203567|Equetro|equetro
5360594|NCT00203554|osteoporosis|osteoporosis
5360595|NCT00203554|vertebra|vertebra
5360596|NCT00203554|fracture|fracture
5360597|NCT00203554|pain|pain
5360598|NCT00203554|percutaneous|percutaneous
5360599|NCT00203554|vertebroplasty|vertebroplasty
5360600|NCT00203554|polymethylmetacrylate|polymethylmetacrylate
5360601|NCT00203528|divalproex sodium|divalproex sodium
5360602|NCT00203528|risperidone|risperidone
5360603|NCT00203528|dual diagnosis|dual diagnosis
5360604|NCT00203528|substance use|substance use
5360605|NCT00203528|bipolar|bipolar
5360606|NCT00203515|Urinary Catheterization|urinary catheterization
5360607|NCT00203502|Operable and Locally advanced Breast Cancer|operable and locally advanced breast cancer
5360608|NCT00203476|ezetimibe|ezetimibe
5360609|NCT00203476|niacin|niacin
5360610|NCT00203476|colestipol|colestipol
5360611|NCT00203476|hyperlipidemia|hyperlipidemia
5360612|NCT00203476|adjunct therapy|adjunct therapy
5360613|NCT00203476|zetia|zetia
5360614|NCT00203463|topiramate|topiramate
5360615|NCT00203463|PTSD|ptsd
5360616|NCT00203463|posttraumatic stress disorder|posttraumatic stress disorder
5360617|NCT00203463|topamax|topamax
5360618|NCT00203450|obesity|obesity
5360619|NCT00203450|zonisamide|zonisamide
5360620|NCT00203450|zonegran|zonegran
5360621|NCT00203450|psychotropic weight gain|psychotropic weight gain
5360622|NCT00203450|psychotropic|psychotropic
5360623|NCT00203385|divalproex sodium, depakote, ptsd, long-term ptsd treatments|divalproex sodium, depakote, ptsd, long-term ptsd treatments
5360624|NCT00203333|Epilepsy|epilepsy
5360625|NCT00203281|renal transplantation|renal transplantation
5360626|NCT00203268|migraine|migraine
5360627|NCT00203268|cutaneous allodynia|cutaneous allodynia
5360628|NCT00203255|Menstrually-Associated Migraine|menstrually-associated migraine
5360629|NCT00203229|Double-Blind|double-blind
5360630|NCT00203229|Placebo-Controlled|placebo-controlled
5360631|NCT00203203|Autologous|autologous
5360632|NCT00203203|Cardiac|cardiac
5360633|NCT00203203|Stem Cell|stem cell
5360634|NCT00203203|Transplant|transplant
5360635|NCT00203047|Multiple Sclerosis|multiple sclerosis
5360636|NCT00203047|brain atrophy|brain atrophy
5360637|NCT00203047|Glatiramer Acetate|glatiramer acetate
5360638|NCT00203047|Copaxone|copaxone
5360639|NCT00203047|Steroids|steroids
5360640|NCT00203047|Prednisone|prednisone
5360641|NCT00202969|Stomach cancer|stomach cancer
5360642|NCT00202943|TCRFVR, LAUP, Snorer|tcrfvr, laup, snorer
5360643|NCT00202930|neuroblastoma|neuroblastoma
5360644|NCT00202930|Opsoclonus-myoclonus|opsoclonus-myoclonus
5360645|NCT00202930|rituximab|rituximab
5360646|NCT00202917|haploidentical transplantation|haploidentical transplantation
5360647|NCT00202917|immunomagnetic cell sorting|immunomagnetic cell sorting
5360648|NCT00202917|allogeneic hematopoietic cell transplantation|allogeneic hematopoietic cell transplantation
5360649|NCT00202917|dose reduced conditioning|dose reduced conditioning
5360650|NCT00202904|ezetimibe|ezetimibe
5360651|NCT00202904|atorvastatin|atorvastatin
5360652|NCT00202904|hypercholesterolemia|hypercholesterolemia
5360653|NCT00202904|coronary heart disease|coronary heart disease
5360654|NCT00202891|pyoderma|pyoderma
5360655|NCT00202891|sisomicin|sisomicin
5360656|NCT00202891|nadifloxacin|nadifloxacin
5360657|NCT00202878|hypercholesterolemia|hypercholesterolemia
5360658|NCT00202878|myocardial infarction|myocardial infarction
5360659|NCT00202878|cholesterol|cholesterol
5360660|NCT00202878|randomized controlled trials|randomized controlled trials
5360661|NCT00202878|acute coronary syndrome|acute coronary syndrome
5360662|NCT00202878|angina|angina
5360664|NCT00202813|central venous catheter|central venous catheter
5360665|NCT00202813|infection|infection
5360666|NCT00202813|bloodstream infection|bloodstream infection
5360667|NCT00202813|catheter infection|catheter infection
5360668|NCT00202813|pediatric|pediatric
5360669|NCT00202813|children|children
5360670|NCT00202813|antibiotic impregnated catheters|antibiotic impregnated catheters
5360671|NCT00202800|Pancreatic Cancer|pancreatic cancer
5360672|NCT00202800|Gemcitabine/Etoposide|gemcitabine/etoposide
5360673|NCT00202800|Ras-mutation|ras-mutation
5360674|NCT00202787|colorectal cancer|colorectal cancer
5360675|NCT00202787|cetuximab|cetuximab
5360676|NCT00202787|FOLFOX4|folfox4
5360677|NCT00202774|colorectal cancer, capecitabine, oxaliplatin, 5-fluorouracil|colorectal cancer, capecitabine, oxaliplatin, 5-fluorouracil
5360678|NCT00202761|Cerebral palsy|cerebral palsy
5360679|NCT00202761|Functional training|functional training
5360680|NCT00202761|preschool children|preschool children
5360681|NCT00202761|Gross Motor Functional Classification Level|gross motor functional classification level
5360781|NCT00202306|prodrome|prodrome
5360682|NCT00202761|Gross motor functional Measure test|gross motor functional measure test
5360683|NCT00202761|Pediatric Evaluation of Disability Inventory|pediatric evaluation of disability inventory
5360684|NCT00202761|Parental Stress Index|parental stress index
5360685|NCT00202748|metabolic syndrome|metabolic syndrome
5360686|NCT00202748|lifestyle|lifestyle
5360687|NCT00202748|obesity|obesity
5360688|NCT00202735|shoulder dislocation|shoulder dislocation
5360689|NCT00202735|anterior|anterior
5360690|NCT00202735|traumatic|traumatic
5360691|NCT00202735|primary|primary
5360692|NCT00202735|first time|first time
5360693|NCT00202735|initial|initial
5360694|NCT00202735|immobilization|immobilization
5360695|NCT00202735|external|external
5360696|NCT00202735|rotation|rotation
5360697|NCT00202722|Remifentanil, parenteral opioids, obstetric analgesia, IVPCA|remifentanil, parenteral opioids, obstetric analgesia, ivpca
5360698|NCT00202709|Anxiety disorder|anxiety disorder
5360699|NCT00202709|Thought Field Therapy|thought field therapy
5360700|NCT00202709|Psychotherapy|psychotherapy
5360701|NCT00202709|Agoraphobia|agoraphobia
5360702|NCT00202709|Social Phobia|social phobia
5360703|NCT00202709|Post Traumatic Stress Disorder|post traumatic stress disorder
5360704|NCT00202683|Altitude|altitude
5360705|NCT00202683|Anoxemia|anoxemia
5360706|NCT00202683|Mitochondria|mitochondria
5360707|NCT00202683|Reflex|reflex
5360708|NCT00202683|Genetic research|genetic research
5360709|NCT00202670|coronary artery disease|coronary artery disease
5360710|NCT00202670|stress myocardial scintigraphy|stress myocardial scintigraphy
5360711|NCT00202670|stress echocardiography|stress echocardiography
5360712|NCT00202657|parkinson's disease|parkinson's disease
5360713|NCT00202657|pergolide|pergolide
5360714|NCT00202657|heart valve disease|heart valve disease
5360715|NCT00202631|tetraplegia|tetraplegia
5360716|NCT00202631|quadriplegia|quadriplegia
5360717|NCT00202631|spinal cord injury|spinal cord injury
5360718|NCT00202631|functional electrical stimulation|functional electrical stimulation
5360719|NCT00202631|abdominal stimulation|abdominal stimulation
5360720|NCT00202618|Hypertension|hypertension
5360721|NCT00202618|Type 2 diabetes mellitus|type 2 diabetes mellitus
5360722|NCT00202618|Microalbuminuria|microalbuminuria
5360723|NCT00202618|Amlodipine|amlodipine
5360724|NCT00202618|Calcium channel blocker|calcium channel blocker
5360725|NCT00202618|Valsartan|valsartan
5360726|NCT00202618|Angiotensin type 2 receptor blocker|angiotensin type 2 receptor blocker
5360727|NCT00202527|Sleep apnea|sleep apnea
5360728|NCT00202527|Hypertension|hypertension
5360729|NCT00202527|CPAP|cpap
5360730|NCT00202514|alcoholism|alcoholism
5360731|NCT00202514|alcohol related disorders|alcohol related disorders
5360732|NCT00202514|mood disorders|mood disorders
5360733|NCT00202514|anticonvulsants|anticonvulsants
5360734|NCT00202514|divalproex sodium|divalproex sodium
5360735|NCT00202488|anemia, iron-deficiency|anemia, iron-deficiency
5360736|NCT00202488|Helicobacter pylori|helicobacter pylori
5360737|NCT00202475|Dubble eerythrocytapheresis|dubble eerythrocytapheresis
5360738|NCT00202462|testosterone|testosterone
5360739|NCT00202462|depression|depression
5360740|NCT00202462|subsyndromal depression|subsyndromal depression
5360741|NCT00202462|quality of life|quality of life
5360742|NCT00202449|Prazosin|prazosin
5360743|NCT00202449|Paroxetine|paroxetine
5360744|NCT00202449|Stress Disorders, Post-Traumatic|stress disorders, post-traumatic
5360745|NCT00202449|Sleep Disorders|sleep disorders
5360746|NCT00202423|Multiple sclerosis|multiple sclerosis
5360747|NCT00202423|Cannabinoids|cannabinoids
5360748|NCT00202423|Spasticity|spasticity
5360749|NCT00202423|fMRI|fmri
5360750|NCT00202423|TMS|tms
5360751|NCT00202410|Multiple Sclerosis|multiple sclerosis
5360752|NCT00202410|Tuberculosis vaccine|tuberculosis vaccine
5360753|NCT00202410|Therapy|therapy
5360754|NCT00202397|cerebellar ataxia|cerebellar ataxia
5360755|NCT00202397|deep cerebellar nuclei (DCN)|deep cerebellar nuclei (dcn)
5360756|NCT00202397|small-conductance calcium-activated potassium(SK)channels|small-conductance calcium-activated potassium(sk)channels
5360757|NCT00202397|riluzole|riluzole
5360758|NCT00202397|Sporadic ataxia|sporadic ataxia
5360759|NCT00202397|Multiple system atrophy type C|multiple system atrophy type c
5360760|NCT00202384|Multiple Sclerosis|multiple sclerosis
5360761|NCT00202384|microarrays|microarrays
5360762|NCT00202371|MDS, Fatigue, RBC transfusion|mds, fatigue, rbc transfusion
5360763|NCT00202358|perioperative|perioperative
5360764|NCT00202358|beta-blockers|beta-blockers
5360765|NCT00202358|inflammation|inflammation
5360766|NCT00202358|outcomes|outcomes
5360767|NCT00202345|Creatinine Clearance|creatinine clearance
5360768|NCT00202345|Hemoglobin|hemoglobin
5360769|NCT00202345|Iron sucrose|iron sucrose
5360770|NCT00202345|Oral iron therapy|oral iron therapy
5360771|NCT00202345|Ferritin|ferritin
5360772|NCT00202345|Transferrin saturation|transferrin saturation
5360773|NCT00202345|Iron|iron
5360774|NCT00202319|sedation|sedation
5360775|NCT00202319|mechanical ventilation|mechanical ventilation
5360776|NCT00202319|sedation protocols|sedation protocols
5360777|NCT00202319|critical care|critical care
5360778|NCT00202319|intensive care outcomes|intensive care outcomes
5360779|NCT00202319|staffing|staffing
5360780|NCT00202306|at risk mental state|at risk mental state
5360782|NCT00202306|ultra high risk|ultra high risk
5360783|NCT00202306|first episode psychosis|first episode psychosis
5360784|NCT00202306|schizophrenia|schizophrenia
5360785|NCT00202306|bipolar disorder|bipolar disorder
5360786|NCT00202293|Bipolar|bipolar
5360787|NCT00202293|Mania|mania
5360788|NCT00202293|Drug treatment|drug treatment
5360789|NCT00202293|First episode|first episode
5360790|NCT00202293|Psychosis|psychosis
5360791|NCT00202293|Therapy|therapy
5360792|NCT00202293|Antipsychotic|antipsychotic
5360793|NCT00202267|leg ulcer, compression, bandage, APBI, venous insufficiency|leg ulcer, compression, bandage, apbi, venous insufficiency
5360794|NCT00202254|Mulitple Sclerosis|mulitple sclerosis
5360795|NCT00202254|MS|ms
5360796|NCT00202241|HIV|hiv
5360797|NCT00202241|AIDS|aids
5360798|NCT00202241|testosterone|testosterone
5360799|NCT00202241|anabolic steroid|anabolic steroid
5360800|NCT00202241|body composition|body composition
5360801|NCT00202241|lipodystrophy|lipodystrophy
5360802|NCT00202241|MRI|mri
5360803|NCT00202241|BIA|bia
5360804|NCT00202241|skinfold measurements|skinfold measurements
5360805|NCT00202241|protease inhibitors|protease inhibitors
5360806|NCT00202228|HIV|hiv
5360807|NCT00202228|HIV/AIDS|hiv/aids
5360808|NCT00202228|Lactic Acidosis|lactic acidosis
5360809|NCT00202228|Supplementation|supplementation
5360810|NCT00202228|Lactate Clearance|lactate clearance
5360811|NCT00202228|Mitochondrial Toxicity|mitochondrial toxicity
5360812|NCT00202228|HAART|haart
5360813|NCT00202215|Day hospital treatment|day hospital treatment
5360814|NCT00202202|personality disorder|personality disorder
5360815|NCT00202202|user satisfaction|user satisfaction
5360816|NCT00202189|COPD|copd
5360817|NCT00202189|Pulmicort|pulmicort
5360818|NCT00202189|Budesonide|budesonide
5360819|NCT00202189|Chronic|chronic
5360820|NCT00202189|Obstructive|obstructive
5360821|NCT00202189|Pulmonary|pulmonary
5360822|NCT00202189|Disease|disease
5360823|NCT00202189|Exercise|exercise
5360824|NCT00202189|Emphysema|emphysema
5360825|NCT00202176|Chronic|chronic
5360826|NCT00202176|Obstructive|obstructive
5360827|NCT00202176|Pulmonary|pulmonary
5360828|NCT00202176|Disease|disease
5360829|NCT00202176|COPD|copd
5360830|NCT00202176|Atrovent|atrovent
5360831|NCT00202176|Ipratropium|ipratropium
5360832|NCT00202176|Bromide|bromide
5360833|NCT00202176|Exercise|exercise
5360834|NCT00202176|Dyspnea|dyspnea
5360835|NCT00202163|ED|ed
5360836|NCT00202163|DHEA|dhea
5360837|NCT00202163|testosterone|testosterone
5360838|NCT00202150|Advanced chronic diseases|advanced chronic diseases
5360839|NCT00202150|Heart failure|heart failure
5360840|NCT00202150|Chronic obstructive lung disease|chronic obstructive lung disease
5360841|NCT00202150|primary care|primary care
5360842|NCT00202150|Chronic Care|chronic care
5360843|NCT00202137|Home Blood Pressure, Hypertension, Blood Pressure Control|home blood pressure, hypertension, blood pressure control
5360844|NCT00202111|Clinical Trial|clinical trial
5360845|NCT00202111|Colonic Neoplasms|colonic neoplasms
5360846|NCT00202111|Laparoscopic Surgery|laparoscopic surgery
5360847|NCT00202111|Morbidity|morbidity
5360848|NCT00202111|Port Site Metastasis|port site metastasis
5360849|NCT00202111|Disease-Free Survival|disease-free survival
5360850|NCT00202098|ARDS|ards
5360851|NCT00202098|mechanical ventilation|mechanical ventilation
5360852|NCT00202098|variable ventilation|variable ventilation
5360853|NCT00202098|chaotic ventilation|chaotic ventilation
5360854|NCT00202072|lung|lung
5360855|NCT00202072|airway|airway
5360856|NCT00202072|pulmonary exacerbation|pulmonary exacerbation
5360857|NCT00202072|mucus|mucus
5360858|NCT00202059|Breast cancer|breast cancer
5360859|NCT00202059|Bone mineral density|bone mineral density
5360860|NCT00202059|Chemotherapy|chemotherapy
5360861|NCT00202046|Breast cancer|breast cancer
5360862|NCT00202046|Lymphedema|lymphedema
5360863|NCT00202046|Quality of life|quality of life
5360864|NCT00202033|referred to|referred to
5360865|NCT00202033|comprehensive|comprehensive
5360866|NCT00202033|diabetes|diabetes
5360867|NCT00202033|education|education
5360868|NCT00202033|program|program
5360869|NCT00202020|Cerebral infarction|cerebral infarction
5360870|NCT00202020|Prevention|prevention
5360871|NCT00202020|Cilostazol|cilostazol
5360872|NCT00202020|Aspirin|aspirin
5360873|NCT00202020|Stroke|stroke
5360874|NCT00202020|Clinical trial|clinical trial
5360875|NCT00202007|Aripiprazole|aripiprazole
5360876|NCT00202007|Schizophrenia|schizophrenia
5360877|NCT00202007|Clinical trial|clinical trial
5360878|NCT00202007|Risperidone|risperidone
5360879|NCT00201994|Sodium|sodium
5360880|NCT00201994|SIADH|siadh
5360881|NCT00201994|Vasopressin|vasopressin
5360882|NCT00201994|CHF|chf
5360883|NCT00201994|Cirrhosis|cirrhosis
5360884|NCT00201994|salt|salt
5360885|NCT00201994|water|water
5360886|NCT00201994|electrolyte|electrolyte
5360887|NCT00201981|dry eye|dry eye
5360888|NCT00201981|keratoconjunctivitis sicca|keratoconjunctivitis sicca
5360889|NCT00201955|dry eye|dry eye
5360890|NCT00201955|keratoconjunctivitis sicca|keratoconjunctivitis sicca
5360891|NCT00201942|Breast Cancer|breast cancer
5360892|NCT00201942|Diagnosis|diagnosis
5360893|NCT00201942|PET|pet
5360894|NCT00201942|Positronic Emission Tomography|positronic emission tomography
5360895|NCT00201942|fluorodeoxyglucose|fluorodeoxyglucose
5360896|NCT00201929|breast cancer|breast cancer
5360897|NCT00201929|decision aid|decision aid
5360898|NCT00201929|Decision Board|decision board
5360899|NCT00201929|information transfer|information transfer
5360900|NCT00201916|prostate cancer|prostate cancer
5360901|NCT00201916|prostate specific antigen|prostate specific antigen
5360902|NCT00201916|PSA|psa
5360903|NCT00201916|radiation fractionation|radiation fractionation
5360904|NCT00201903|venous thromboembolism|venous thromboembolism
5360905|NCT00201903|brain tumours|brain tumours
5360906|NCT00201903|glioma|glioma
5360907|NCT00201903|tissue factor|tissue factor
5360908|NCT00201903|blood coagulation|blood coagulation
5360909|NCT00201903|tumour progression|tumour progression
5360910|NCT00201903|low molecular weight heparin|low molecular weight heparin
5360911|NCT00201890|Breast Cancer|breast cancer
5360912|NCT00201890|Lymphedema|lymphedema
5360913|NCT00201890|Treatment|treatment
5360914|NCT00201890|Massage|massage
5360915|NCT00201890|Randomized|randomized
5360916|NCT00201890|DLT therapy|dlt therapy
5360917|NCT00201890|Quality of Life|quality of life
5360918|NCT00201890|Decongestive Therapy|decongestive therapy
5360919|NCT00201890|Breast Cancer related Lymphedema|breast cancer related lymphedema
5360920|NCT00201877|Relapsed/Refractory|relapsed/refractory
5360921|NCT00201877|NHL|nhl
5360922|NCT00201877|Follicular|follicular
5360923|NCT00201877|Mantle Cell|mantle cell
5360924|NCT00201877|non-Hodgkin's lymphoma|non-hodgkin's lymphoma
5360925|NCT00201864|Postmenopausal|postmenopausal
5360926|NCT00201864|Women|women
5360927|NCT00201851|Asian|asian
5360928|NCT00201851|Premenopausal|premenopausal
5360929|NCT00201851|Women|women
5360930|NCT00201851|Oophorectomy|oophorectomy
5360931|NCT00201838|Advanced Stage|advanced stage
5360932|NCT00201838|Chemotherapy Naive|chemotherapy naive
5360933|NCT00201825|Previously Untreated|previously untreated
5360934|NCT00201825|Advanced|advanced
5360935|NCT00201812|Advanced Solid Tumors|advanced solid tumors
5360936|NCT00201799|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
5360937|NCT00201786|Corticosteroids|corticosteroids
5360938|NCT00201773|Post-Menopause|post-menopause
5360939|NCT00201773|Neoadjuvant Therapy|neoadjuvant therapy
5360940|NCT00201760|metastatic|metastatic
5360941|NCT00201747|Advanced|advanced
5360942|NCT00201734|Adenocarcinoma|adenocarcinoma
5360943|NCT00201721|Previously Untreated|previously untreated
5360944|NCT00201708|Adjuvant Trial|adjuvant trial
5360945|NCT00201708|Dose-Dense|dose-dense
5360946|NCT00201708|Axillary Node-Positive|axillary node-positive
5360947|NCT00201695|Untreated Patients|untreated patients
5360948|NCT00201695|Symptomatic|symptomatic
5360949|NCT00201682|Leukemia|leukemia
5360950|NCT00201682|Lymphoma|lymphoma
5360951|NCT00201669|Aggressive|aggressive
5360952|NCT00201669|Clofarabine|clofarabine
5360953|NCT00201656|PPROM|pprom
5360954|NCT00201656|Cerclage|cerclage
5360955|NCT00201656|Preterm Premature Rupture of the Membranes with Cerclage|preterm premature rupture of the membranes with cerclage
5360956|NCT00201643|Preterm Labor|preterm labor
5360957|NCT00201643|Preterm delivery|preterm delivery
5360958|NCT00201630|Prostate|prostate
5360959|NCT00201630|cancer|cancer
5360960|NCT00201630|Brachytherapy|brachytherapy
5360961|NCT00201630|Alpha Blocker|alpha blocker
5360962|NCT00201617|Unilateral hearing loss|unilateral hearing loss
5360963|NCT00201617|Unilateral deafness|unilateral deafness
5360964|NCT00201617|Bone anchored hearing aid|bone anchored hearing aid
5360965|NCT00201591|Coronary artery disease|coronary artery disease
5360966|NCT00201591|Exercise training|exercise training
5360967|NCT00201591|Intensity|intensity
5360968|NCT00201591|Randomized|randomized
5360969|NCT00201591|echocardiography|echocardiography
5360970|NCT00201591|Aerobic Exercise|aerobic exercise
5360971|NCT00201578|Herbal Drugs|herbal drugs
5360972|NCT00201578|Alternative medicine|alternative medicine
5360973|NCT00201565|pulse wave velocity|pulse wave velocity
5360974|NCT00201565|cardiovascular disease|cardiovascular disease
5360975|NCT00201539|analgesics, opioid/pharmacokinetics|analgesics, opioid/pharmacokinetics
5360976|NCT00201539|humans|humans
5360977|NCT00201539|morphine/therapeutic use*|morphine/therapeutic use*
5360978|NCT00201539|neoplasms|neoplasms
5360979|NCT00201539|pain/drugtherapy|pain/drugtherapy
5360980|NCT00201526|Bipolar Disorder|bipolar disorder
5360981|NCT00201513|Muscle, Skeletal|muscle, skeletal
5360982|NCT00201513|Neuromuscular control|neuromuscular control
5360983|NCT00201513|Stability|stability
5360984|NCT00201513|Exercise|exercise
5360985|NCT00201513|Anticipatory muscle control|anticipatory muscle control
5360986|NCT00201474|brief depressive episodes|brief depressive episodes
5360987|NCT00201474|affective disorders|affective disorders
5360988|NCT00201474|EEG and QEEG|eeg and qeeg
5360989|NCT00201474|epilepsy|epilepsy
5360990|NCT00201474|organic brain disorders|organic brain disorders
5360991|NCT00201474|acute psychiatry|acute psychiatry
5360992|NCT00201461|Patent Foramen Ovale|patent foramen ovale
5360993|NCT00201461|STARFlex|starflex
5360994|NCT00201461|CLOSURE I|closure i
5360995|NCT00201461|Septal Closure System|septal closure system
5360996|NCT00201461|Stroke|stroke
5360997|NCT00201461|Cerebrovascular Accident|cerebrovascular accident
5360998|NCT00201461|Transient Ischemic Attack|transient ischemic attack
5360999|NCT00201461|Heart Septal Defects, Atrial|heart septal defects, atrial
5361000|NCT00201448|CMV, cytomegalovirus, vaccine, Towne strain|cmv, cytomegalovirus, vaccine, towne strain
5361001|NCT00201435|Breast|breast
5361002|NCT00201435|Cancer|cancer
5361003|NCT00201435|Paclitaxel|paclitaxel
5361004|NCT00201435|Docetaxel|docetaxel
5361005|NCT00201435|Qulaity of life|qulaity of life
5361006|NCT00201422|MALT lymphoma|malt lymphoma
5361007|NCT00201422|diffuse large B-cell lymphoma,|diffuse large b-cell lymphoma,
5361008|NCT00201422|stomach|stomach
5361009|NCT00201422|Helicobacter pylori|helicobacter pylori
5361010|NCT00201422|antibiotic therapy|antibiotic therapy
5361011|NCT00201396|A Multicenter Phase III Trial|a multicenter phase iii trial
5361012|NCT00201396|Induction Chemotherapy|induction chemotherapy
5361013|NCT00201396|Concurrent Chemoradiotherapy|concurrent chemoradiotherapy
5361014|NCT00201396|Stage IV Nasopharyngeal Carcinoma (NPC)|stage iv nasopharyngeal carcinoma (npc)
5361015|NCT00201396|randomization|randomization
5361016|NCT00201396|disease-free survival|disease-free survival
5361017|NCT00201370|cervical neoplasia;|cervical neoplasia;
5361018|NCT00201370|human papillomavirus,|human papillomavirus,
5361019|NCT00201370|PCR,|pcr,
5361020|NCT00201370|risk factors,|risk factors,
5361021|NCT00201370|Taiwan|taiwan
5361022|NCT00201357|hormone-refractory prostate cancer|hormone-refractory prostate cancer
5361023|NCT00201357|thalidomide|thalidomide
5361024|NCT00201357|quality of life|quality of life
5361025|NCT00201344|Radiotherapy|radiotherapy
5361026|NCT00201344|Adjuvant chemotherapy|adjuvant chemotherapy
5361027|NCT00201344|Chemtherapy|chemtherapy
5361028|NCT00201344|Nasopharyngeal Carcinoma|nasopharyngeal carcinoma
5361029|NCT00201292|Metabolic syndrome|metabolic syndrome
5361030|NCT00201292|Diabetes|diabetes
5361031|NCT00201292|Insulin resistance|insulin resistance
5361032|NCT00201292|pharmacogenetics|pharmacogenetics
5361033|NCT00201201|Older Adults|older adults
5361034|NCT00201201|Primary Care|primary care
5361035|NCT00201201|Hypertension|hypertension
5361036|NCT00201201|Adherence|adherence
5361037|NCT00201136|Behavioral intervention|behavioral intervention
5361038|NCT00201136|Lifestyle modification|lifestyle modification
5361039|NCT00201136|Guidelines|guidelines
5361040|NCT00201110|African Americans|african americans
5361042|NCT00201058|adolescents|adolescents
5361043|NCT00201058|African American|african american
5361044|NCT00201058|web-based|web-based
5361045|NCT00201058|computer tailoring|computer tailoring
5361046|NCT00201058|school based|school based
5361047|NCT00201045|Hypertension management|hypertension management
5361048|NCT00201045|Pharmacist management|pharmacist management
5361049|NCT00201045|Physician pharmacist collaboration|physician pharmacist collaboration
5361050|NCT00201045|Blood pressure control|blood pressure control
5361051|NCT00200954|prospective|prospective
5361052|NCT00200954|intervention|intervention
5361053|NCT00200954|randomised|randomised
5361054|NCT00200954|probiotics|probiotics
5361055|NCT00200954|atopy|atopy
5361056|NCT00200941|Restless Legs Syndrome|restless legs syndrome
5361057|NCT00200941|Topiramate|topiramate
5361058|NCT00200941|Actigraphy|actigraphy
5361059|NCT00200941|Polysomnography|polysomnography
5361060|NCT00200928|prospective|prospective
5361061|NCT00200928|randomised|randomised
5361062|NCT00200928|intervention|intervention
5361063|NCT00200928|BCG|bcg
5361064|NCT00200928|atopy|atopy
5361065|NCT00200902|Major depressive disorder|major depressive disorder
5361066|NCT00200902|MDD|mdd
5361067|NCT00200902|Antidepressant|antidepressant
5361068|NCT00200889|Acupuncture|acupuncture
5361069|NCT00200889|Magnetic Resonance Imaging, Functional|magnetic resonance imaging, functional
5361070|NCT00200889|Brain Mapping|brain mapping
5361071|NCT00200889|healthy volunteers|healthy volunteers
5361072|NCT00200889|Neuromodulation|neuromodulation
5361073|NCT00200876|Positron-Emission Tomography|positron-emission tomography
5361074|NCT00200876|Endorphins|endorphins
5361075|NCT00200876|Pain Relief|pain relief
5361076|NCT00200876|Opioid Receptors|opioid receptors
5361077|NCT00200876|Stress|stress
5361078|NCT00200876|Analgesia|analgesia
5361079|NCT00200863|light|light
5361080|NCT00200863|wavelength|wavelength
5361081|NCT00200863|action spectrum|action spectrum
5361082|NCT00200863|circadian|circadian
5361083|NCT00200863|melatonin|melatonin
5361084|NCT00200863|alertness|alertness
5361085|NCT00200863|performance|performance
5361086|NCT00200863|arousal|arousal
5361087|NCT00200850|Breathing|breathing
5361088|NCT00200850|Allergy|allergy
5361089|NCT00200850|Mites, House Dust|mites, house dust
5361090|NCT00200837|oral mucosal pain|oral mucosal pain
5361091|NCT00200837|oral inflammations|oral inflammations
5361092|NCT00200837|anisillo|anisillo
5361093|NCT00200837|cordonsillo|cordonsillo
5361094|NCT00200837|Piperaceae|piperaceae
5361095|NCT00200837|oral ulcers|oral ulcers
5361096|NCT00200837|oral tumors|oral tumors
5361097|NCT00200837|mucosal pain|mucosal pain
5361098|NCT00200837|mucosal inflammations|mucosal inflammations
5361099|NCT00200837|cordoncillo|cordoncillo
5361100|NCT00200824|isoflavones|isoflavones
5361101|NCT00200824|soy|soy
5361102|NCT00200824|postmenopausal|postmenopausal
5361103|NCT00200824|men|men
5361104|NCT00200824|prostate|prostate
5361105|NCT00200824|breast|breast
5361106|NCT00200824|bone|bone
5361107|NCT00200798|Milk Thistle|milk thistle
5361108|NCT00200798|Silymarin|silymarin
5361109|NCT00200798|pharmacokinetics|pharmacokinetics
5361110|NCT00200798|drug interactions|drug interactions
5361111|NCT00200798|Normal volunteers|normal volunteers
5361112|NCT00200785|garlic|garlic
5361113|NCT00200759|Vaccinium macrocarpon|vaccinium macrocarpon
5361114|NCT00200759|Antioxidants|antioxidants
5361115|NCT00200759|Drug Interactions|drug interactions
5361116|NCT00200746|Hepatitis|hepatitis
5361117|NCT00200746|Liver Diseases|liver diseases
5361118|NCT00200746|Alcoholism|alcoholism
5361119|NCT00200746|Arginine|arginine
5361120|NCT00200733|acupuncture|acupuncture
5361121|NCT00200733|patient narratives|patient narratives
5361122|NCT00200733|qualitative methods|qualitative methods
5361123|NCT00200720|Diet|diet
5361124|NCT00200720|Carbohydrates|carbohydrates
5361125|NCT00200720|Weight Loss|weight loss
5361126|NCT00200707|Cell therapy|cell therapy
5361127|NCT00200707|bone marrow mononuclear cells|bone marrow mononuclear cells
5361128|NCT00200707|myocardial infarction|myocardial infarction
5361129|NCT00200694|Proteinuria|proteinuria
5361130|NCT00200694|ACEI|acei
5361131|NCT00200694|ARB|arb
5361132|NCT00200694|diuretics|diuretics
5361133|NCT00200694|blood pressure|blood pressure
5361134|NCT00200694|renal failure|renal failure
5361135|NCT00200681|Secretory Multiple Myeloma|secretory multiple myeloma
5361136|NCT00200681|First line treatment|first line treatment
5361137|NCT00200681|Velcade®|velcade®
5361138|NCT00200681|autograft|autograft
5361139|NCT00200681|Newly diagnosed secretory Multiple Myeloma (MM)|newly diagnosed secretory multiple myeloma (mm)
5361140|NCT00200642|Gastroesophageal reflux. PPI. Radiofrequency|gastroesophageal reflux. ppi. radiofrequency
5361141|NCT00200629|Women|women
5361142|NCT00200629|Diagnostic Testing|diagnostic testing
5361143|NCT00200629|Radionuclide Imaging|radionuclide imaging
5361144|NCT00200629|Stress Testing|stress testing
5361145|NCT00200629|Adenosine|adenosine
5361146|NCT00200616|Urinary tract infection|urinary tract infection
5361147|NCT00200616|Vesico-renal reflux|vesico-renal reflux
5361148|NCT00200616|Child|child
5361149|NCT00200616|Antimicrobial prophylaxis|antimicrobial prophylaxis
5361150|NCT00200616|Recurrence of urinary tract infection|recurrence of urinary tract infection
5361151|NCT00200603|Calcium phosphate ceramic|calcium phosphate ceramic
5361152|NCT00200603|tibial osteotomy|tibial osteotomy
5361153|NCT00200603|osteoarthritis|osteoarthritis
5361154|NCT00200590|prostaglandin|prostaglandin
5361155|NCT00200590|analgesia|analgesia
5361156|NCT00200590|congenital|congenital
5361157|NCT00200590|heart|heart
5361158|NCT00200590|defect|defect
5361159|NCT00200590|induced|induced
5361160|NCT00200577|Adjuvant therapy|adjuvant therapy
5361161|NCT00200577|immunotherapy|immunotherapy
5361162|NCT00200577|TIL|til
5361163|NCT00200577|melanoma|melanoma
5361164|NCT00200564|Pediatrics|pediatrics
5361165|NCT00200564|ketamine|ketamine
5361166|NCT00200564|postoperative analgesia|postoperative analgesia
5361167|NCT00200564|nalbuphine|nalbuphine
5361168|NCT00200564|Postoperative analgesia in children|postoperative analgesia in children
5361169|NCT00200538|frontotemporal dementia|frontotemporal dementia
5361170|NCT00200538|Mémantine|mémantine
5361171|NCT00200538|Patients with frontotemporal dementia|patients with frontotemporal dementia
5361172|NCT00200499|Nebivolol|nebivolol
5361173|NCT00200499|Hypertension|hypertension
5361174|NCT00200499|Beta-Blocker|beta-blocker
5361175|NCT00200486|genetic microarray|genetic microarray
5361176|NCT00200486|head and neck cancer|head and neck cancer
5361177|NCT00200473|Nebivolol|nebivolol
5361178|NCT00200473|Hypertension|hypertension
5361179|NCT00200473|Beta-Blockers|beta-blockers
5361180|NCT00200460|Nebivolol|nebivolol
5361181|NCT00200460|Hypertension|hypertension
5361182|NCT00200460|Beta-Blocker|beta-blocker
5361183|NCT00200447|Parkinson|parkinson
5361184|NCT00200447|brain imaging|brain imaging
5361185|NCT00200434|Nebivolol|nebivolol
5361186|NCT00200434|Beta-Blocker|beta-blocker
5361187|NCT00200434|Hypertension|hypertension
5361188|NCT00200421|Nebivolol|nebivolol
5361189|NCT00200421|Atenolol|atenolol
5361190|NCT00200421|Exercise|exercise
5361191|NCT00200421|Hypertension|hypertension
5361192|NCT00200408|cancer of head and neck|cancer of head and neck
5361193|NCT00200408|smoking|smoking
5361194|NCT00200369|HIV|hiv
5361195|NCT00200369|Adherence|adherence
5361196|NCT00200369|Antiretroviral therapy|antiretroviral therapy
5361197|NCT00200369|Protease inhibitor|protease inhibitor
5361198|NCT00200369|Lopinavir|lopinavir
5361199|NCT00200343|Chronic hepatitis C, Ursodeoxycholic acid|chronic hepatitis c, ursodeoxycholic acid
5361200|NCT00200330|weight loss|weight loss
5361201|NCT00200330|physical activity|physical activity
5361202|NCT00200330|diet|diet
5361203|NCT00200330|home environment|home environment
5361204|NCT00200317|Exercise|exercise
5361205|NCT00200317|Internet|internet
5361206|NCT00200317|Print|print
5361207|NCT00200317|Randomized Controlled Trial|randomized controlled trial
5361208|NCT00200317|Exercise Intervention|exercise intervention
5361209|NCT00200304|Obesity|obesity
5361210|NCT00200304|Weight loss|weight loss
5361211|NCT00200304|Internet|internet
5361212|NCT00200278|Exercise|exercise
5361213|NCT00200278|Intervention studies|intervention studies
5361214|NCT00200278|Decision-making|decision-making
5361215|NCT00200278|computer assisted Expert systems|computer assisted expert systems
5361216|NCT00200278|telephone|telephone
5361217|NCT00200252|oxytocin|oxytocin
5361218|NCT00200252|third stage|third stage
5361219|NCT00200252|dose|dose
5361220|NCT00200252|route|route
5361221|NCT00200252|blood loss|blood loss
5361222|NCT00200226|pain/discomfort|pain/discomfort
5361223|NCT00200226|cervical dilatation|cervical dilatation
5361224|NCT00200226|side effects|side effects
5361225|NCT00200200|BEVACIZUMAB (AVASTIN)|bevacizumab (avastin)
5361226|NCT00200200|DEXAMETHASONE|dexamethasone
5361227|NCT00200200|FLOXURIDINE|floxuridine
5361228|NCT00200200|FLUOROURACIL|fluorouracil
5361229|NCT00200200|IRINOTECAN (CPT-11) CAMPTOSAR|irinotecan (cpt-11) camptosar
5361230|NCT00200200|LEUCOVORIN|leucovorin
5361231|NCT00200200|OXALIPLATIN|oxaliplatin
5361232|NCT00200200|Colon|colon
5361233|NCT00200200|Rectal|rectal
5361234|NCT00200200|04-086|04-086
5361235|NCT00200200|Adjuvant postoperative chemo for CLM|adjuvant postoperative chemo for clm
5361236|NCT00200187|Prostatectomy|prostatectomy
5361237|NCT00200187|Anesthesia|anesthesia
5361238|NCT00200187|Blood Loss|blood loss
5361239|NCT00200174|Breast cancer|breast cancer
5361240|NCT00200174|estrogen|estrogen
5361241|NCT00200174|postmenopausal|postmenopausal
5361242|NCT00200148|Pancreaticoduodenectomy|pancreaticoduodenectomy
5361243|NCT00200148|Hepatectomy|hepatectomy
5361244|NCT00200148|Major Hepatic resection|major hepatic resection
5361245|NCT00200148|Acute Normovolemic Hemodilution|acute normovolemic hemodilution
5361246|NCT00200135|motorcycle accident|motorcycle accident
5361247|NCT00200135|helmet|helmet
5361248|NCT00200135|traumatic brain injury|traumatic brain injury
5361249|NCT00200135|financial burden|financial burden
5361250|NCT00200096|Cancer|cancer
5361251|NCT00200096|Fatigue|fatigue
5361252|NCT00200083|Obesity|obesity
5361253|NCT00200083|Morbid Obesity|morbid obesity
5361254|NCT00200083|SHAPE|shape
5361255|NCT00200083|IGS|igs
5361256|NCT00200083|Implantable Gastric Stimulator|implantable gastric stimulator
5361257|NCT00200070|Angina Pectoris Pain|angina pectoris pain
5361258|NCT00200057|Fecal Incontinence|fecal incontinence
5361259|NCT00200057|InterStim|interstim
5361260|NCT00200044|GERD|gerd
5361261|NCT00200018|Obesity|obesity
5361262|NCT00200018|Morbid obesity|morbid obesity
5361263|NCT00200018|Diabetes|diabetes
5361264|NCT00200005|Slow transit constipation|slow transit constipation
5361265|NCT00200005|Fecal incontinence|fecal incontinence
5361266|NCT00200005|Constipation|constipation
5361267|NCT00200005|Idiopathic slow transit constipation|idiopathic slow transit constipation
5361268|NCT00200005|Chronic constipation|chronic constipation
5361269|NCT00199992|acute wounds|acute wounds
5361270|NCT00199992|wounds|wounds
5361271|NCT00199992|platelets|platelets
5361272|NCT00199992|platelet gel|platelet gel
5361273|NCT00199979|Antiretroviral Therapy|antiretroviral therapy
5361274|NCT00199979|Nevirapine|nevirapine
5361275|NCT00199979|HIV Viral Load|hiv viral load
5361276|NCT00199979|Adherence|adherence
5361277|NCT00199979|Quality of Life|quality of life
5361278|NCT00199979|Resistance Mutations|resistance mutations
5361279|NCT00199966|Bipolar Disorder; Pediatric Bipolar Disorder; Depakote ER|bipolar disorder; pediatric bipolar disorder; depakote er
5361280|NCT00199953|Postnasal drainage|postnasal drainage
5361281|NCT00199953|Extraesophageal reflux|extraesophageal reflux
5361282|NCT00199940|Schizophrenia|schizophrenia
5361283|NCT00199940|Pediatric psychotic disorders|pediatric psychotic disorders
5361284|NCT00199940|Ziprasidone|ziprasidone
5361285|NCT00199914|Diathermy|diathermy
5361286|NCT00199914|Short-wave therapy|short-wave therapy
5361287|NCT00199914|Osteoarthritis|osteoarthritis
5361288|NCT00199914|Knee|knee
5361289|NCT00199901|Phase II|phase ii
5361290|NCT00199901|Randomized Controlled Trial|randomized controlled trial
5361291|NCT00199901|Double-Blind|double-blind
5361292|NCT00199901|Cancer Vaccine|cancer vaccine
5361293|NCT00199901|NY-ESO-1 protein, human|ny-eso-1 protein, human
5361294|NCT00199901|ISCOMATRIX, immunological adjuvant|iscomatrix, immunological adjuvant
5361295|NCT00199888|Kidney Cancer|kidney cancer
5361296|NCT00199888|Renal Cancer|renal cancer
5361297|NCT00199888|Neoplasms, Kidney|neoplasms, kidney
5361298|NCT00199888|cG250|cg250
5361299|NCT00199888|antibody|antibody
5361300|NCT00199888|Iodine 124|iodine 124
5361301|NCT00199875|antibody|antibody
5361302|NCT00199875|renal cell carcinoma|renal cell carcinoma
5361303|NCT00199875|advanced renal cancer|advanced renal cancer
5361304|NCT00199875|cG250|cg250
5361305|NCT00199875|90Y|90y
5361306|NCT00199862|huA33|hua33
5361307|NCT00199862|antibody|antibody
5361308|NCT00199862|colorectal cancer|colorectal cancer
5361309|NCT00199862|Iodine 124|iodine 124
5361310|NCT00199862|124I|124i
5361311|NCT00199862|03-124|03-124
5361312|NCT00199849|NY-ESO-1|ny-eso-1
5361313|NCT00199849|DNA|dna
5361314|NCT00199836|cancer vaccine|cancer vaccine
5361315|NCT00199836|NY-ESO-1b peptide|ny-eso-1b peptide
5361316|NCT00199836|CpG 7909|cpg 7909
5361317|NCT00199836|Montanide ISA-51|montanide isa-51
5361318|NCT00199836|LAGE-1|lage-1
5361319|NCT00199836|immune response|immune response
5361320|NCT00199836|safety|safety
5361321|NCT00199823|Myocardial infarction|myocardial infarction
5361322|NCT00199823|bone marrow cells|bone marrow cells
5361323|NCT00199823|cell transplantation|cell transplantation
5361324|NCT00199810|Cardiac output|cardiac output
5361325|NCT00199810|Preeclamptic women|preeclamptic women
5361326|NCT00199810|systemic vascular resistance|systemic vascular resistance
5361327|NCT00199810|blood pressure|blood pressure
5361328|NCT00199797|Colorectal Cancer|colorectal cancer
5361329|NCT00199797|huA33|hua33
5361330|NCT00199797|antibody|antibody
5361331|NCT00199797|chemotherapy|chemotherapy
5361332|NCT00199784|Hemodynamic|hemodynamic
5361333|NCT00199784|Hypotension|hypotension
5361334|NCT00199784|Spinal|spinal
5361335|NCT00199784|Anesthesia|anesthesia
5361336|NCT00199784|Healthy pregnant women for elective cesarean section|healthy pregnant women for elective cesarean section
5361337|NCT00199771|Cardiac Surgery|cardiac surgery
5361338|NCT00199771|Infant|infant
5361339|NCT00199771|Infant, Newborn|infant, newborn
5361340|NCT00199771|Hypertonic Solutions|hypertonic solutions
5361341|NCT00199771|Saline Solution, Hypertonic|saline solution, hypertonic
5361342|NCT00199771|Capillary leak|capillary leak
5361343|NCT00199771|Inflammation Mediators|inflammation mediators
5361344|NCT00199758|Non small cell lung carcinoma|non small cell lung carcinoma
5361345|NCT00199758|Cisplatin|cisplatin
5361346|NCT00199758|Gemcitabine|gemcitabine
5361347|NCT00199758|Paclitaxel|paclitaxel
5361348|NCT00199745|statin|statin
5361349|NCT00199745|statins|statins
5361350|NCT00199745|statin therapy|statin therapy
5361351|NCT00199745|adverse events|adverse events
5361352|NCT00199745|side effect|side effect
5361353|NCT00199745|Myotoxicity|myotoxicity
5361354|NCT00199745|atorvastatin|atorvastatin
5361355|NCT00199745|Atorvastatin Therapy|atorvastatin therapy
5361356|NCT00199732|Chronic hepatitis B|chronic hepatitis b
5361357|NCT00199732|CCC DNA kinetics|ccc dna kinetics
5361358|NCT00199732|Total HBV DNA kinetics|total hbv dna kinetics
5361359|NCT00199732|Adefovir-Dipovixil|adefovir-dipovixil
5361360|NCT00199732|Peg interferon alpha 2a|peg interferon alpha 2a
5361361|NCT00199719|drug monitoring|drug monitoring
5361362|NCT00199719|ribavirin-pharmacokinetic|ribavirin-pharmacokinetic
5361363|NCT00199719|pharmacodynamics|pharmacodynamics
5361364|NCT00199719|chronic hepatitis C|chronic hepatitis c
5361365|NCT00199719|non 2 non 3 genotype|non 2 non 3 genotype
5361366|NCT00199706|Intracranial Pressure|intracranial pressure
5361367|NCT00199706|Intracranial Hypertension|intracranial hypertension
5361368|NCT00199706|Hypertonic Solutions|hypertonic solutions
5361369|NCT00199706|Saline Solutions, Hypertonic|saline solutions, hypertonic
5361370|NCT00199693|Hemodynamic and respiratory changes and pregnancy|hemodynamic and respiratory changes and pregnancy
5361371|NCT00199693|Healthy pregnant women|healthy pregnant women
5361372|NCT00199680|PETscan, cervical cancer|petscan, cervical cancer
5361373|NCT00199667|MMF, Monitoring, area under curve (AUC), kidney transplantation|mmf, monitoring, area under curve (auc), kidney transplantation
5361374|NCT00199654|colorectal cancer stage II and III|colorectal cancer stage ii and iii
5361375|NCT00199628|fetomaternal tissular alloimmunization|fetomaternal tissular alloimmunization
5361376|NCT00199628|Mothers having a child suffering from:|mothers having a child suffering from:
5361377|NCT00199628|neonatal membranous glomerulonephritis|neonatal membranous glomerulonephritis
5361378|NCT00199628|unexplained neonatal tubular defect|unexplained neonatal tubular defect
5361379|NCT00199628|unexplained thrombotic microangiopathy|unexplained thrombotic microangiopathy
5361380|NCT00199628|neonatal hemochromatosis|neonatal hemochromatosis
5361381|NCT00199615|lung cancer, 18 FDG, PET|lung cancer, 18 fdg, pet
5361382|NCT00199589|Spastic equinovarus|spastic equinovarus
5361383|NCT00199589|Botox|botox
5361384|NCT00199589|Ankle foot orthosis|ankle foot orthosis
5361385|NCT00199576|Corticosteroids|corticosteroids
5361386|NCT00199576|Laryngotracheal injury|laryngotracheal injury
5361387|NCT00199576|Intubation-extubation|intubation-extubation
5361388|NCT00199563|Viagra|viagra
5361389|NCT00199563|sildenafil|sildenafil
5361390|NCT00199550|Transurethral Resection of Prostate|transurethral resection of prostate
5361391|NCT00199550|TURP|turp
5361392|NCT00199524|ureteroscopy|ureteroscopy
5361393|NCT00199524|stone free|stone free
5361394|NCT00199511|Brain Tumor|brain tumor
5361395|NCT00199511|Intracranial Pressure|intracranial pressure
5361396|NCT00199511|Osmolarity|osmolarity
5361397|NCT00199511|Seric|seric
5361398|NCT00199511|Hypertonic Solution|hypertonic solution
5361399|NCT00199498|Permanent Pacemaker Implantation- Lead Position|permanent pacemaker implantation- lead position
5361400|NCT00199485|prostate cancer|prostate cancer
5361401|NCT00199485|Luteinizing Hormone Releasing Hormone|luteinizing hormone releasing hormone
5361402|NCT00199485|LHRH|lhrh
5361403|NCT00199459|calculi|calculi
5361404|NCT00199459|proteomics|proteomics
5361405|NCT00199446|Sleep -Sleep Disorder|sleep -sleep disorder
5361406|NCT00199446|Sleep- Restless Legs Syndrome|sleep- restless legs syndrome
5361407|NCT00199446|Clinical Trial|clinical trial
5361408|NCT00199433|Parkinson's Disease|parkinson's disease
5361409|NCT00199433|Movement Disorder|movement disorder
5361410|NCT00199433|Neurology,|neurology,
5361411|NCT00199433|Clinical Trial|clinical trial
5361412|NCT00199420|levodopa|levodopa
5361413|NCT00199420|end of dose wearing off|end of dose wearing off
5361414|NCT00199420|OFF time|off time
5361415|NCT00199407|Parkinson's disease|parkinson's disease
5361416|NCT00199407|levodopa|levodopa
5361417|NCT00199407|end of dose wearing off|end of dose wearing off
5361418|NCT00199407|OFF time|off time
5361419|NCT00199394|KW-6002 (istradefylline)|kw-6002 (istradefylline)
5361420|NCT00199394|Entacapone|entacapone
5361421|NCT00199394|Placebo|placebo
5361422|NCT00199394|Parkinson's Disease|parkinson's disease
5361423|NCT00199394|Motor Response Complications|motor response complications
5361424|NCT00199394|Levodopa Therapy|levodopa therapy
5361425|NCT00199381|Parkinson's Disease|parkinson's disease
5361426|NCT00199381|levodopa|levodopa
5361427|NCT00199381|end of dose wearing off|end of dose wearing off
5361428|NCT00199381|OFF time|off time
5361429|NCT00199368|Parkinson's disease|parkinson's disease
5361430|NCT00199368|levodopa|levodopa
5361431|NCT00199368|end of dose wearing off|end of dose wearing off
5361432|NCT00199368|OFF time|off time
5361433|NCT00199355|Parkinson's Disease|parkinson's disease
5361434|NCT00199355|levodopa|levodopa
5361435|NCT00199355|end of dose wearing off|end of dose wearing off
5361436|NCT00199355|OFF time|off time
5361437|NCT00199342|Melanoma|melanoma
5361438|NCT00199342|Monoclonal Antibody|monoclonal antibody
5361439|NCT00199342|Anti-GD-3|anti-gd-3
5361440|NCT00199329|ondansetron|ondansetron
5361442|NCT00199316|patient who recieve kidney surgery and Patient controlled anesthesia with spinal morphine, intrathecal|patient who recieve kidney surgery and patient controlled anesthesia with spinal morphine, intrathecal
5361443|NCT00199303|NMDAreceptor antagonist, dextromethorphan|nmdareceptor antagonist, dextromethorphan
5361444|NCT00199303|pain, post-operative|pain, post-operative
5361445|NCT00199303|opioid consumption, morphine|opioid consumption, morphine
5361446|NCT00199290|Trafermin|trafermin
5361447|NCT00199290|Periodontitis|periodontitis
5361448|NCT00199264|antifungal oral therapy|antifungal oral therapy
5361449|NCT00199264|efficacy acute candidiasis vulvaginitis|efficacy acute candidiasis vulvaginitis
5361450|NCT00199251|URTICARIA, WHEALS, FLARE, ANTIHISTAMINE, ANTIHISTAMINE|urticaria, wheals, flare, antihistamine, antihistamine
5361451|NCT00199238|ANTIHISTAMINE|antihistamine
5361452|NCT00199238|RUPATADINE|rupatadine
5361453|NCT00199238|WHEAL|wheal
5361454|NCT00199238|FLARE|flare
5361455|NCT00199238|DERMATOLOGY|dermatology
5361456|NCT00199225|Thorough study QT/QTc|thorough study qt/qtc
5361457|NCT00199225|Cardiac repolarization|cardiac repolarization
5361458|NCT00199225|QT prolongation|qt prolongation
5361459|NCT00199212|HER-2 positive|her-2 positive
5361460|NCT00199212|metastatic breast cancer patients|metastatic breast cancer patients
5361461|NCT00199173|colorectal cancer|colorectal cancer
5361462|NCT00199173|liver metastasis|liver metastasis
5361463|NCT00199173|intraarterial hepatic injection|intraarterial hepatic injection
5361464|NCT00199173|yttrium loaded microspheres|yttrium loaded microspheres
5361465|NCT00199173|colorectal neoplasm metastatic to the liver|colorectal neoplasm metastatic to the liver
5361466|NCT00199160|local recurrence and or metastatic disease|local recurrence and or metastatic disease
5361467|NCT00199160|Previously treated with platinum|previously treated with platinum
5361468|NCT00199160|carcinoma of the head and neck|carcinoma of the head and neck
5361469|NCT00199134|neoadjuvant treatment|neoadjuvant treatment
5361470|NCT00199108|CNS relapse|cns relapse
5361471|NCT00199108|ALL|all
5361472|NCT00199108|Treatment|treatment
5361473|NCT00199095|ALL|all
5361474|NCT00199095|Elderly|elderly
5361475|NCT00199095|Chemotherapy|chemotherapy
5361476|NCT00199082|High-grade NHL|high-grade nhl
5361477|NCT00199082|De novo|de novo
5361478|NCT00199082|Mature B-ALL|mature b-all
5361479|NCT00199082|Burkitt'S NHL|burkitt's nhl
5361480|NCT00199082|Chemotherapy|chemotherapy
5361481|NCT00199082|Rituximab|rituximab
5361482|NCT00199082|Primary mediastinal diffuse large cell lymphoma|primary mediastinal diffuse large cell lymphoma
5361483|NCT00199082|B-precursor lymphoblastic lymphoma|b-precursor lymphoblastic lymphoma
5361484|NCT00199069|ALL|all
5361485|NCT00199069|Treatment|treatment
5361486|NCT00199069|De Novo|de novo
5361487|NCT00199069|Adult|adult
5361488|NCT00199056|ALL|all
5361489|NCT00199056|Treatment|treatment
5361490|NCT00199056|De Novo|de novo
5361491|NCT00199056|Adult|adult
5361492|NCT00199030|Relapse|relapse
5361493|NCT00199030|T-ALL|t-all
5361494|NCT00199030|T-LBL|t-lbl
5361495|NCT00199030|MabCampath|mabcampath
5361496|NCT00199030|Minimal residual disease|minimal residual disease
5361497|NCT00199030|Lymphoma, lymphoblastic, T-cell|lymphoma, lymphoblastic, t-cell
5361498|NCT00199017|T-LBL|t-lbl
5361499|NCT00199017|Treatment|treatment
5361500|NCT00199017|De novo|de novo
5361501|NCT00199017|Chemotherapy|chemotherapy
5361502|NCT00199017|Adult|adult
5361802|NCT00197561|Selenium|selenium
5361503|NCT00199017|Lymphoma, lymphoblastic, T-cell|lymphoma, lymphoblastic, t-cell
5361504|NCT00199004|ALL|all
5361505|NCT00199004|Treatment|treatment
5361506|NCT00199004|De novo|de novo
5361507|NCT00199004|Minimal residual disease|minimal residual disease
5361508|NCT00199004|Rituximab|rituximab
5361509|NCT00199004|Adult|adult
5361510|NCT00198991|ALL|all
5361511|NCT00198991|Treatment|treatment
5361512|NCT00198991|de novo|de novo
5361513|NCT00198991|Minimal residual disease|minimal residual disease
5361514|NCT00198991|Adult|adult
5361515|NCT00198978|ALL|all
5361516|NCT00198978|Treatment|treatment
5361517|NCT00198978|Elderly|elderly
5361518|NCT00198978|De novo|de novo
5361519|NCT00198939|drug prevention|drug prevention
5361520|NCT00198939|adolescence|adolescence
5361521|NCT00198939|middle school|middle school
5361522|NCT00198939|randomized trial|randomized trial
5361523|NCT00198939|family therapy|family therapy
5361524|NCT00198939|cognitive-behavioral|cognitive-behavioral
5361525|NCT00198939|efficacy|efficacy
5361526|NCT00198939|selected youth|selected youth
5361527|NCT00198939|indicated youth|indicated youth
5361528|NCT00198887|newborn|newborn
5361529|NCT00198887|operations research|operations research
5361530|NCT00198887|newborn survival|newborn survival
5361531|NCT00198887|Neonatal illness/mortality|neonatal illness/mortality
5361532|NCT00198887|Delivery complications|delivery complications
5361533|NCT00198874|drug abuse|drug abuse
5361534|NCT00198874|drug dependence|drug dependence
5361535|NCT00198874|treatment|treatment
5361536|NCT00198874|randomized trial|randomized trial
5361537|NCT00198874|stage II study|stage ii study
5361538|NCT00198874|adolescents|adolescents
5361539|NCT00198874|young adults|young adults
5361540|NCT00198874|efficacy study|efficacy study
5361541|NCT00198861|HIV Epidemiology|hiv epidemiology
5361542|NCT00198861|Neurology|neurology
5361543|NCT00198861|Neuropsychological|neuropsychological
5361544|NCT00198861|HIV Risk Factors|hiv risk factors
5361545|NCT00198861|Cognitive Risk Factors|cognitive risk factors
5361546|NCT00198861|HIV|hiv
5361547|NCT00198848|Iron deficiency anemia|iron deficiency anemia
5361548|NCT00198848|Adolescent girls|adolescent girls
5361549|NCT00198848|India|india
5361550|NCT00198835|malnutrition|malnutrition
5361551|NCT00198835|anemia|anemia
5361552|NCT00198835|infants|infants
5361553|NCT00198835|children|children
5361554|NCT00198835|India|india
5361555|NCT00198822|Maternal mortality|maternal mortality
5361556|NCT00198822|Infant mortality|infant mortality
5361557|NCT00198822|Vitamin A|vitamin a
5361558|NCT00198822|Beta-carotene|beta-carotene
5361559|NCT00198822|Micronutrients|micronutrients
5361560|NCT00198822|Bangladesh|bangladesh
5361561|NCT00198822|Neonatal mortality|neonatal mortality
5361562|NCT00198731|maternal health|maternal health
5361563|NCT00198731|Bangladesh|bangladesh
5361564|NCT00198731|care seeking|care seeking
5361565|NCT00198718|Vitamin A supplementation|vitamin a supplementation
5361566|NCT00198718|HIV|hiv
5361567|NCT00198718|Mother to child transmission of HIV|mother to child transmission of hiv
5361568|NCT00198718|Breastfeeding|breastfeeding
5361569|NCT00198692|amputation|amputation
5361570|NCT00198692|depression|depression
5361571|NCT00198692|pain|pain
5361572|NCT00198692|anxiety|anxiety
5361573|NCT00198692|self-management|self-management
5361574|NCT00198692|secondary conditions|secondary conditions
5361575|NCT00198679|skin cleansing|skin cleansing
5361576|NCT00198679|Bangladesh|bangladesh
5361577|NCT00198679|Skin Flora|skin flora
5361578|NCT00198679|Newborn|newborn
5361579|NCT00198679|infectious disease|infectious disease
5361580|NCT00198679|chlorhexidine|chlorhexidine
5361581|NCT00198666|Pneumonia|pneumonia
5361582|NCT00198666|zinc|zinc
5361583|NCT00198653|Hypothermia|hypothermia
5361584|NCT00198653|Newborn|newborn
5361585|NCT00198653|India|india
5361586|NCT00198653|Maternal/Child Health|maternal/child health
5361587|NCT00198653|Infant|infant
5361588|NCT00198653|Kangaroo Mother Care|kangaroo mother care
5361589|NCT00198640|animal antibiotics|animal antibiotics
5361590|NCT00198640|human antibiotics|human antibiotics
5361591|NCT00198627|Neonatal bacterial infection|neonatal bacterial infection
5361592|NCT00198614|Adrenergic beta-Antagonists|adrenergic beta-antagonists
5361593|NCT00198614|Carvedilol|carvedilol
5361594|NCT00198614|Metoprolol|metoprolol
5361595|NCT00198614|Coronary Artery Bypass|coronary artery bypass
5361596|NCT00198614|Atrial Fibrillation|atrial fibrillation
5361597|NCT00198601|meningitis|meningitis
5361598|NCT00198601|neonatal deaths|neonatal deaths
5361599|NCT00198601|gentamicin|gentamicin
5361600|NCT00198601|Uniject|uniject
5361601|NCT00198601|aminoglycoside|aminoglycoside
5361602|NCT00198588|heparin-induced thrombocytopenia|heparin-induced thrombocytopenia
5361603|NCT00198588|argatroban|argatroban
5361604|NCT00198588|cardiac surgery|cardiac surgery
5361605|NCT00198588|acute coronary syndrome|acute coronary syndrome
5361606|NCT00198588|thrombosis|thrombosis
5361607|NCT00198588|amputation|amputation
5361608|NCT00198588|anticoagulation|anticoagulation
5361609|NCT00198575|heparin-induced thrombocytopenia|heparin-induced thrombocytopenia
5361610|NCT00198575|cardiovascular surgery|cardiovascular surgery
5361611|NCT00198575|percutaneous coronary intervention|percutaneous coronary intervention
5361612|NCT00198562|Antihypertensive therapy|antihypertensive therapy
5361613|NCT00198562|Home blood pressure|home blood pressure
5361614|NCT00198562|Systolic blood pressure|systolic blood pressure
5361615|NCT00198562|Morning blood pressure|morning blood pressure
5361616|NCT00198562|Calcium antagonist|calcium antagonist
5361617|NCT00198562|Angiotensin receptor antagonist|angiotensin receptor antagonist
5361618|NCT00198549|Adjuvants, Anesthesia|adjuvants, anesthesia
5361619|NCT00198549|hyaluronate lyase|hyaluronate lyase
5361620|NCT00198523|Cataract Extraction|cataract extraction
5361621|NCT00198523|Anti-Bacterial Agents|anti-bacterial agents
5361622|NCT00198523|Steroids|steroids
5361623|NCT00198484|Adjuvants, Anesthesia|adjuvants, anesthesia
5361624|NCT00198484|Spreading Factor|spreading factor
5361625|NCT00198445|Cataract Extraction|cataract extraction
5361626|NCT00198445|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal
5361627|NCT00198393|stage IIIB/IV NSCLC|stage iiib/iv nsclc
5361628|NCT00198393|patients with performance status 2 or 3.|patients with performance status 2 or 3.
5361629|NCT00198380|Adenocarcinoma, Bronchiolo-Alveolar|adenocarcinoma, bronchiolo-alveolar
5361630|NCT00198367|operable and resectable stage IIIA (T1-3, N2) NSCLC|operable and resectable stage iiia (t1-3, n2) nsclc
5361631|NCT00198341|Post-surgical Non-small cell lung cancer|post-surgical non-small cell lung cancer
5361632|NCT00198328|Squamous Cell Carcinoma|squamous cell carcinoma
5361633|NCT00198328|carcinoma|carcinoma
5361634|NCT00198328|head and neck cancer|head and neck cancer
5361635|NCT00198328|larynx|larynx
5361636|NCT00198328|electroporation|electroporation
5361637|NCT00198328|medpulser|medpulser
5361638|NCT00198328|bleomycin|bleomycin
5361639|NCT00198328|cancer|cancer
5361640|NCT00198328|Locally recurrent or second primary squamous cell carcinoma of the base of the tongue, posterior lateral pharyngeal wall, hypopharynx, or larynx|locally recurrent or second primary squamous cell carcinoma of the base of the tongue, posterior lateral pharyngeal wall, hypopharynx, or larynx
5361641|NCT00198315|Squamous Cell Carcinoma|squamous cell carcinoma
5361642|NCT00198315|Carcinoma|carcinoma
5361643|NCT00198315|Head and Neck Cancer|head and neck cancer
5361644|NCT00198315|Oral|oral
5361645|NCT00198315|Soft Palate|soft palate
5361646|NCT00198315|Cancer|cancer
5361647|NCT00198315|Medpulser|medpulser
5361648|NCT00198315|Electroporation|electroporation
5361649|NCT00198315|Local recurrent or second primary squamous cell carcinoma of anterior oral cavity, soft palate, or tonsil|local recurrent or second primary squamous cell carcinoma of anterior oral cavity, soft palate, or tonsil
5361650|NCT00198302|staphylococcus aureus|staphylococcus aureus
5361651|NCT00198302|bacteremia|bacteremia
5361652|NCT00198302|sepsis|sepsis
5361653|NCT00198289|Cystic Fibrosis|cystic fibrosis
5361654|NCT00198289|Staphylococcus aureus|staphylococcus aureus
5361655|NCT00198289|lungs|lungs
5361656|NCT00198276|cancer|cancer
5361657|NCT00198276|cutaneous|cutaneous
5361658|NCT00198276|subcutaneous|subcutaneous
5361659|NCT00198276|MedPulser|medpulser
5361660|NCT00198276|bleomycin|bleomycin
5361661|NCT00198276|electroporation|electroporation
5361662|NCT00198276|Cutaneous or subcutaneous cancer|cutaneous or subcutaneous cancer
5361663|NCT00198263|head and neck cancer|head and neck cancer
5361664|NCT00198263|cancer|cancer
5361665|NCT00198263|bleomycin|bleomycin
5361666|NCT00198263|medpulser|medpulser
5361667|NCT00198263|electroporation|electroporation
5361668|NCT00198263|primary oral cavity, primary pharyngeal, primary laryngeal, salivary gland, limited recurrent and second primary tumors|primary oral cavity, primary pharyngeal, primary laryngeal, salivary gland, limited recurrent and second primary tumors
5361669|NCT00198250|Breast cancer survivorship|breast cancer survivorship
5361670|NCT00198250|hot flashes|hot flashes
5361671|NCT00198250|treatment|treatment
5361672|NCT00198237|Breast Cancer|breast cancer
5361673|NCT00198237|Stage II Breast Cancer|stage ii breast cancer
5361674|NCT00198237|Stage III Breast Cancer|stage iii breast cancer
5361675|NCT00198224|immunosuppression|immunosuppression
5361676|NCT00198185|Full Thickness Tendon Defect of Rotator Cuff|full thickness tendon defect of rotator cuff
5361677|NCT00198172|Germ Cell Tumor|germ cell tumor
5361678|NCT00198172|Refractory Germ Cell Tumors|refractory germ cell tumors
5361679|NCT00198172|Cisplatin plus Epirubicin Salvage Chemotherapy|cisplatin plus epirubicin salvage chemotherapy
5361680|NCT00198159|Refractory Germ Cell Tumors|refractory germ cell tumors
5361681|NCT00198159|Germ Cell Tumors|germ cell tumors
5361682|NCT00198133|Thymoma|thymoma
5361683|NCT00198133|Thymic Carcinoma|thymic carcinoma
5361684|NCT00198120|Autistic Disorder|autistic disorder
5361685|NCT00198120|cycloserine|cycloserine
5361686|NCT00198120|pharmacology|pharmacology
5361687|NCT00198120|glutamatergic agents|glutamatergic agents
5361688|NCT00198120|communication|communication
5361689|NCT00198120|social interaction|social interaction
5361690|NCT00198120|Double-Blind Method|double-blind method
5361691|NCT00198107|Children|children
5361692|NCT00198107|Adolescents|adolescents
5361693|NCT00198107|Aripiprazole|aripiprazole
5361694|NCT00198107|Cycloserine|cycloserine
5361695|NCT00198107|Aggression|aggression
5361696|NCT00198107|Irritability|irritability
5361697|NCT00198107|Self-Injurious Behavior|self-injurious behavior
5361698|NCT00198107|Social Interaction|social interaction
5361699|NCT00198107|Antipsychotics|antipsychotics
5361700|NCT00198107|Pharmacology|pharmacology
5361701|NCT00198107|Glutamatergic Agents|glutamatergic agents
5361702|NCT00198081|celecoxib for pancreas lesions|celecoxib for pancreas lesions
5361703|NCT00198068|Pregnancy outcomes|pregnancy outcomes
5361704|NCT00198068|Systemic lupus erythematosus|systemic lupus erythematosus
5361705|NCT00198068|Antiphospholipid syndrome|antiphospholipid syndrome
5361706|NCT00198055|Aggression|aggression
5361707|NCT00198055|Behavioral symptoms|behavioral symptoms
5361708|NCT00198042|ACL|acl
5361709|NCT00198042|Tunnel|tunnel
5361710|NCT00198042|Widening|widening
5361711|NCT00198029|Osteoarthritis|osteoarthritis
5361712|NCT00198029|Hyaluronan|hyaluronan
5361713|NCT00198029|Carpometacarpal|carpometacarpal
5361714|NCT00198029|Outcomes|outcomes
5361715|NCT00198016|coronary fistulas.|coronary fistulas.
5361716|NCT00198016|coils embolization.|coils embolization.
5361717|NCT00198003|hip arthritis|hip arthritis
5361718|NCT00198003|total hip arthroplasty|total hip arthroplasty
5361719|NCT00198003|expectations|expectations
5361720|NCT00198003|education|education
5361721|NCT00197990|total hip arthroplasty|total hip arthroplasty
5361722|NCT00197990|expectations|expectations
5361723|NCT00197990|satisfaction|satisfaction
5361724|NCT00197990|quality of life|quality of life
5361725|NCT00197977|knee arthritis|knee arthritis
5361726|NCT00197977|total knee arthroplasty|total knee arthroplasty
5361727|NCT00197977|expectations|expectations
5361728|NCT00197977|education|education
5361729|NCT00197964|Self-management|self-management
5361730|NCT00197964|Self-efficacy|self-efficacy
5361731|NCT00197964|Quality of life|quality of life
5361732|NCT00197964|Resource utilization|resource utilization
5361733|NCT00197951|Psychiatric symptoms associated to alcoholism recovery|psychiatric symptoms associated to alcoholism recovery
5361734|NCT00197951|Alcoholism treatment|alcoholism treatment
5361735|NCT00197951|Alcohol craving|alcohol craving
5361736|NCT00197951|Relapse to heavy drinking|relapse to heavy drinking
5361737|NCT00197951|Abuse of other substances during alcoholism recovery|abuse of other substances during alcoholism recovery
5361738|NCT00197925|breast cancer|breast cancer
5361739|NCT00197925|dendritic cells|dendritic cells
5361740|NCT00197925|vaccine|vaccine
5361741|NCT00197912|dendritic cell|dendritic cell
5361742|NCT00197912|cancer vaccine|cancer vaccine
5361743|NCT00197912|cyclophosphamide|cyclophosphamide
5361744|NCT00197912|melanoma|melanoma
5361745|NCT00197873|colorectal cancer|colorectal cancer
5361746|NCT00197873|probiotics|probiotics
5361747|NCT00197873|chemotherapy|chemotherapy
5361748|NCT00197873|prevention|prevention
5361749|NCT00197873|adverse effects|adverse effects
5361750|NCT00197873|diarrhoea|diarrhoea
5361751|NCT00197860|dendritic cell|dendritic cell
5361752|NCT00197860|vaccine|vaccine
5361753|NCT00197860|renal cell carcinoma|renal cell carcinoma
5361754|NCT00197834|Depakote|depakote
5361755|NCT00197834|Agitation|agitation
5361756|NCT00197834|Dementia|dementia
5361757|NCT00197834|Atypical antipsychotic|atypical antipsychotic
5361758|NCT00197834|Behavioral Symptoms|behavioral symptoms
5361759|NCT00197834|Psychiatric Symptoms|psychiatric symptoms
5361760|NCT00197834|Psychological Symptoms|psychological symptoms
5361761|NCT00197834|Geriatric|geriatric
5361762|NCT00197834|Behavioral and Psychological Symptoms|behavioral and psychological symptoms
5361763|NCT00197808|Streptococcus pneumoniae|streptococcus pneumoniae
5361764|NCT00197808|Neisseria meningitidis|neisseria meningitidis
5361765|NCT00197756|HIV|hiv
5361766|NCT00197756|Breastfeeding|breastfeeding
5361767|NCT00197756|Vitamins|vitamins
5361768|NCT00197756|Tanzania|tanzania
5361769|NCT00197756|Children|children
5361770|NCT00197743|HIV|hiv
5361771|NCT00197743|Multivitamins|multivitamins
5361772|NCT00197743|Pregnancy outcomes|pregnancy outcomes
5361773|NCT00197743|Tanzania|tanzania
5361774|NCT00197743|Women|women
5361775|NCT00197730|Birth Outcomes|birth outcomes
5361776|NCT00197730|Nutrition|nutrition
5361777|NCT00197730|HIV|hiv
5361778|NCT00197730|AIDS|aids
5361779|NCT00197730|Vitamins|vitamins
5361780|NCT00197730|Multivitamins|multivitamins
5361781|NCT00197730|Maternal and child health outcomes|maternal and child health outcomes
5361782|NCT00197730|Tanzania|tanzania
5361783|NCT00197730|Africa|africa
5361784|NCT00197704|Tuberculosis|tuberculosis
5361785|NCT00197704|HIV|hiv
5361786|NCT00197704|Tanzania|tanzania
5361787|NCT00197704|multivitamins|multivitamins
5361788|NCT00197691|HIV infected mothers|hiv infected mothers
5361789|NCT00197691|Infants at risk of HIV-infection|infants at risk of hiv-infection
5361915|NCT00196976|Conjugate vaccine|conjugate vaccine
5361790|NCT00197691|Infant lower respiratory tract disease|infant lower respiratory tract disease
5361791|NCT00197691|Infant bloodstream infection|infant bloodstream infection
5361793|NCT00197678|AIDS|aids
5361794|NCT00197678|Multivitamins|multivitamins
5361795|NCT00197678|Pregnancy Outcomes|pregnancy outcomes
5361796|NCT00197678|Women|women
5361797|NCT00197678|Tanzania|tanzania
5361798|NCT00197678|Africa|africa
5361799|NCT00197652|Prevention of Mother-Infant HIV Transmission|prevention of mother-infant hiv transmission
5361800|NCT00197639|indinavir, HIV, ritonavir, pharmacokinetics, Thailand|indinavir, hiv, ritonavir, pharmacokinetics, thailand
5361801|NCT00197561|HIV|hiv
5361803|NCT00197561|Nutrition|nutrition
5361804|NCT00197561|Women|women
5361805|NCT00197561|Pregnancy|pregnancy
5361806|NCT00197561|Tanzania|tanzania
5361807|NCT00197561|Maternal and child health outcomes|maternal and child health outcomes
5361808|NCT00197561|HIV/AIDS|hiv/aids
5361809|NCT00197561|Pregnancy Outcome|pregnancy outcome
5361810|NCT00197548|Women|women
5361811|NCT00197548|Pregnancy Outcomes|pregnancy outcomes
5361812|NCT00197548|Nutrition|nutrition
5361813|NCT00197548|Vitamins|vitamins
5361814|NCT00197548|Tanzania|tanzania
5361815|NCT00197548|Maternal and Child Health Outcomes|maternal and child health outcomes
5361816|NCT00197522|breast cancer|breast cancer
5361817|NCT00197522|vaccination|vaccination
5361818|NCT00197522|dendritic cells|dendritic cells
5361819|NCT00197522|HER-2|her-2
5361820|NCT00197522|CD34+ stem cells|cd34+ stem cells
5361821|NCT00197509|Long-Term Care|long-term care
5361822|NCT00197509|Clinical Protocols|clinical protocols
5361823|NCT00197509|Sit-To-Stand|sit-to-stand
5361824|NCT00197483|Pergolide|pergolide
5361825|NCT00197483|Dopamine D1|dopamine d1
5361826|NCT00197483|Schizophrenia|schizophrenia
5361827|NCT00197483|Cognitive disturbance|cognitive disturbance
5361828|NCT00197483|Negative symptoms|negative symptoms
5361829|NCT00197444|esophageal cancer|esophageal cancer
5361830|NCT00197444|Nedaplatin|nedaplatin
5361831|NCT00197444|5-FU|5-fu
5361832|NCT00197444|chemotherapy|chemotherapy
5361833|NCT00197444|radiation|radiation
5361834|NCT00197444|chemoradiotherapy|chemoradiotherapy
5361835|NCT00197418|H. pylori infection|h. pylori infection
5361836|NCT00197392|Ventriculostomy|ventriculostomy
5361837|NCT00197392|EVD|evd
5361838|NCT00197379|androgenetic alopecia|androgenetic alopecia
5361839|NCT00197379|roxitromycin|roxitromycin
5361840|NCT00197379|apoptosis|apoptosis
5361841|NCT00197366|pregnancy|pregnancy
5361842|NCT00197366|HIV-positive|hiv-positive
5361843|NCT00197366|HIV resistance|hiv resistance
5361844|NCT00197366|HIV|hiv
5361845|NCT00197353|Anesthesia, Epidural|anesthesia, epidural
5361846|NCT00197353|Pharmacology|pharmacology
5361847|NCT00197353|Dose-Response Relationship, Drug|dose-response relationship, drug
5361848|NCT00197353|Sympathectomy|sympathectomy
5361849|NCT00197353|Photoplethysmography|photoplethysmography
5361850|NCT00197340|Pre-Eclampsia|pre-eclampsia
5361851|NCT00197340|Fetal Growth Retardation|fetal growth retardation
5361852|NCT00197340|Anesthesia, Epidural|anesthesia, epidural
5361853|NCT00197340|Placental Circulation|placental circulation
5361854|NCT00197340|Dose-Response Relationship, Drug|dose-response relationship, drug
5361855|NCT00197327|Labor Pain|labor pain
5361856|NCT00197327|Analgesia, Obstetrical|analgesia, obstetrical
5361857|NCT00197327|Pharmacology|pharmacology
5361858|NCT00197327|Treatment Outcome|treatment outcome
5361859|NCT00197314|Urinary stress incontinence|urinary stress incontinence
5361860|NCT00197314|Randomized trial|randomized trial
5361861|NCT00197314|circular muscle training|circular muscle training
5361862|NCT00197314|pelvic floor training|pelvic floor training
5361863|NCT00197314|bioequivalence|bioequivalence
5361864|NCT00197301|Intranasal vaccination, Influenza|intranasal vaccination, influenza
5361865|NCT00197288|Prophylaxis: Influenza virus infection|prophylaxis: influenza virus infection
5361866|NCT00197275|Haemophilus influenzae type b|haemophilus influenzae type b
5361867|NCT00197275|diphtheria|diphtheria
5361868|NCT00197275|tetanus|tetanus
5361869|NCT00197275|Prophylaxis diphtheria|prophylaxis diphtheria
5361870|NCT00197275|pertussis|pertussis
5361871|NCT00197275|hepatitis B|hepatitis b
5361872|NCT00197275|meningococcal serogroups A & C diseases|meningococcal serogroups a & c diseases
5361873|NCT00197262|Seasonal Allergic Rhinitis|seasonal allergic rhinitis
5361874|NCT00197262|GW685698X|gw685698x
5361875|NCT00197262|allergic rhinitis|allergic rhinitis
5361876|NCT00197262|Hayfever|hayfever
5361877|NCT00197249|Hepatitis A & B|hepatitis a & b
5361878|NCT00197249|Typhoid|typhoid
5361879|NCT00197236|Hepatitis A|hepatitis a
5361880|NCT00197197|HIV-1 GW873140 CCR5 antagonist treatment experienced|hiv-1 gw873140 ccr5 antagonist treatment experienced
5361881|NCT00197184|Combined hepatitis A and B vaccine|combined hepatitis a and b vaccine
5361882|NCT00197184|Twinrix™|twinrix™
5361883|NCT00197145|HIV-1 GW873140 CCR5 antagonist experienced|hiv-1 gw873140 ccr5 antagonist experienced
5361884|NCT00197132|Insulin resistance vasodilatory response|insulin resistance vasodilatory response
5361885|NCT00197119|Hepatitis B|hepatitis b
5361886|NCT00197119|TWINRIX™ Adult|twinrix™ adult
5361887|NCT00197119|Hepatitis A|hepatitis a
5361888|NCT00197119|TWINRIX™ Junior|twinrix™ junior
5361889|NCT00197106|salmeterol/fluticasone combination|salmeterol/fluticasone combination
5361890|NCT00197106|Asthma|asthma
5361891|NCT00197106|bronchial hyperresponsiveness|bronchial hyperresponsiveness
5361892|NCT00197106|Children|children
5361893|NCT00197106|symptom control|symptom control
5361894|NCT00197093|Schizophrenia|schizophrenia
5361895|NCT00197093|safety|safety
5361896|NCT00197093|tolerability|tolerability
5361897|NCT00197093|pharmacokinetics|pharmacokinetics
5361898|NCT00197080|Restless Legs Syndrome|restless legs syndrome
5361899|NCT00197080|RLS|rls
5361900|NCT00196989|Efficacy|efficacy
5361901|NCT00196989|PPARpan|pparpan
5362404|NCT00194441|outcome|outcome
5361902|NCT00196989|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
5361903|NCT00196989|Phase IIb|phase iib
5361904|NCT00196989|Safety|safety
5361905|NCT00196989|Pharmacokinetics|pharmacokinetics
5361906|NCT00196989|GW677954|gw677954
5361907|NCT00196989|Pharmacodynamics|pharmacodynamics
5361908|NCT00196989|Tolerability|tolerability
5361909|NCT00196989|Dose-Ranging|dose-ranging
5361910|NCT00196976|Safety|safety
5361911|NCT00196976|Meningococcal vaccine|meningococcal vaccine
5361912|NCT00196976|Dose selection|dose selection
5361913|NCT00196976|Toddlers|toddlers
5361914|NCT00196976|Immunogenicity|immunogenicity
5361916|NCT00196976|Reactogenicity|reactogenicity
5361917|NCT00196976|Children|children
5361918|NCT00196937|HPV Vaccine Safety|hpv vaccine safety
5361919|NCT00196898|Parkinson´s disease|parkinson´s disease
5361920|NCT00196898|fibrotic valvular heart fibrosis|fibrotic valvular heart fibrosis
5361921|NCT00196898|ergot dopamine agonists|ergot dopamine agonists
5361922|NCT00196898|non-ergot dopamine agonists|non-ergot dopamine agonists
5361923|NCT00196885|cancer cachexia|cancer cachexia
5361924|NCT00196885|muscle wasting|muscle wasting
5361925|NCT00196885|weight loss|weight loss
5361926|NCT00196885|proteolysis|proteolysis
5361927|NCT00196872|dose dense sequence|dose dense sequence
5361928|NCT00196872|dose dense combination|dose dense combination
5361929|NCT00196872|node positive disease|node positive disease
5361930|NCT00196859|Early Breast Cancer in elderly Patients|early breast cancer in elderly patients
5361931|NCT00196859|Ibandronate plus/minus Capecitabine in elderly patients|ibandronate plus/minus capecitabine in elderly patients
5361932|NCT00196846|hormone insensitive breast cancer|hormone insensitive breast cancer
5361933|NCT00196846|Prevention of Chemotherapy induced ovarian failure|prevention of chemotherapy induced ovarian failure
5361934|NCT00196846|P.O.F.|p.o.f.
5361935|NCT00196846|GnRH-Agonist Goserelin|gnrh-agonist goserelin
5361936|NCT00196833|Breast Cancer in Pregnancy|breast cancer in pregnancy
5361937|NCT00196833|Prospective and Retrospective Register|prospective and retrospective register
5361938|NCT00196833|Study|study
5361939|NCT00196820|Metastatic breast cancer|metastatic breast cancer
5361940|NCT00196820|HER2 negative, medium-risk, metastatic breast cancer|her2 negative, medium-risk, metastatic breast cancer
5361941|NCT00196807|prostate cancer screening|prostate cancer screening
5361942|NCT00196807|medical decision making|medical decision making
5361943|NCT00196807|informed decision making|informed decision making
5361944|NCT00196807|patient education|patient education
5361945|NCT00196807|male|male
5361946|NCT00196794|Pseudomembranous Colitis|pseudomembranous colitis
5361947|NCT00196794|Clostridium difficile-associated diarrhea|clostridium difficile-associated diarrhea
5361948|NCT00196794|C. difficile|c. difficile
5361949|NCT00196794|CDAD|cdad
5361950|NCT00196781|prostate cancer treatment|prostate cancer treatment
5361951|NCT00196781|medical decision making|medical decision making
5361952|NCT00196781|informed decision making|informed decision making
5361953|NCT00196781|shared decision making|shared decision making
5361954|NCT00196781|decision aid|decision aid
5361955|NCT00196781|patient education|patient education
5361956|NCT00196768|relapsed|relapsed
5361957|NCT00196768|acute promyelocytic leukemia|acute promyelocytic leukemia
5361958|NCT00196768|arsenic|arsenic
5361959|NCT00196742|alpha Galactosidase A|alpha galactosidase a
5361960|NCT00196742|aGAL (alpha-galactosidase)|agal (alpha-galactosidase)
5361961|NCT00196742|Fabry|fabry
5361962|NCT00196742|GL3 (globotriaosylceramide)|gl3 (globotriaosylceramide)
5361963|NCT00196742|Anderson-Fabry Disease|anderson-fabry disease
5361964|NCT00196742|angiokeratomas|angiokeratomas
5361965|NCT00196742|GLA deficiency (gene deficiency)|gla deficiency (gene deficiency)
5361966|NCT00196742|errors in metabolism|errors in metabolism
5361967|NCT00196716|alpha Galactosidase A|alpha galactosidase a
5361968|NCT00196716|aGAL|agal
5361969|NCT00196716|rh aGAL|rh agal
5361970|NCT00196716|Fabry|fabry
5361971|NCT00196716|GL3|gl3
5361972|NCT00196716|Fabrazyme|fabrazyme
5361973|NCT00196703|Aphasia|aphasia
5361974|NCT00196703|Memantine|memantine
5361975|NCT00196703|Constraint-induced language therapy|constraint-induced language therapy
5361976|NCT00196703|Event-related potentials|event-related potentials
5361977|NCT00196690|Aphasia|aphasia
5361978|NCT00196690|Donepezil|donepezil
5361979|NCT00196664|Chronic Hepatitis C|chronic hepatitis c
5361980|NCT00196664|Paroxetine|paroxetine
5361981|NCT00196664|Depression|depression
5361982|NCT00196651|HIV infection|hiv infection
5361983|NCT00196651|AIDS Vaccines|aids vaccines
5361984|NCT00196651|ALVAC vaccine|alvac vaccine
5361985|NCT00196651|Interleukin-2|interleukin-2
5361986|NCT00196651|Antiretroviral Therapy, Highly Active|antiretroviral therapy, highly active
5361987|NCT00196638|HIV infections|hiv infections
5361988|NCT00196638|Primary acute infection|primary acute infection
5361989|NCT00196638|Interferon-alpha|interferon-alpha
5361990|NCT00196625|HIV infections|hiv infections
5361991|NCT00196625|Salvage therapy|salvage therapy
5361992|NCT00196625|Amprenavir|amprenavir
5361993|NCT00196625|Lopinavir|lopinavir
5361994|NCT00196625|Ritonavir|ritonavir
5361995|NCT00196612|HIV Infections|hiv infections
5361996|NCT00196612|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5361997|NCT00196612|Treatment simplification|treatment simplification
5361998|NCT00196599|HIV infections|hiv infections
5361999|NCT00196599|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5362000|NCT00196586|Chronic Hepatitis C|chronic hepatitis c
5362001|NCT00196586|HIV infection|hiv infection
5362002|NCT00196586|Interleukin-2|interleukin-2
5362003|NCT00196586|Pegylated interferon alpha 2 a|pegylated interferon alpha 2 a
5362004|NCT00196586|ribavirin|ribavirin
5362005|NCT00196573|Rotator Cuff|rotator cuff
5362006|NCT00196573|Tendinosis|tendinosis
5362007|NCT00196573|Impingement Syndrome|impingement syndrome
5362008|NCT00196573|Partial Thickness Tears|partial thickness tears
5362009|NCT00196573|Rotator Cuff Tendinosis|rotator cuff tendinosis
5362010|NCT00196573|Partial Thickness Rotator Cuff Tears|partial thickness rotator cuff tears
5362011|NCT00196560|Immobilization in External Rotation|immobilization in external rotation
5362012|NCT00196560|Acute primary anterior shoulder dislocation|acute primary anterior shoulder dislocation
5362013|NCT00196547|Asthma|asthma
5362014|NCT00196547|Respiratory viral infections|respiratory viral infections
5362015|NCT00196547|Exacerbations|exacerbations
5362016|NCT00196547|Pediatric|pediatric
5362017|NCT00196547|Leukotriene receptor antagonists|leukotriene receptor antagonists
5362018|NCT00196547|School|school
5362019|NCT00196508|Childbirth|childbirth
5362020|NCT00196482|growth|growth
5362021|NCT00196482|oral feeding|oral feeding
5362022|NCT00196482|nutrition|nutrition
5362023|NCT00196456|Photodynamic lasertherapy|photodynamic lasertherapy
5362024|NCT00196456|Periodontol disease|periodontol disease
5362025|NCT00196417|heparin-induced thrombocytopenia|heparin-induced thrombocytopenia
5362026|NCT00196417|HIT|hit
5362027|NCT00196417|unfractionated heparin|unfractionated heparin
5362028|NCT00196417|UFH|ufh
5362029|NCT00196417|low-molecular-weight heparin|low-molecular-weight heparin
5362030|NCT00196417|LMWH|lmwh
5362031|NCT00196417|thrombosis prophylaxis|thrombosis prophylaxis
5362032|NCT00196417|HIT-antibody|hit-antibody
5362033|NCT00196404|overactive bladder|overactive bladder
5362034|NCT00196404|urge incontinence|urge incontinence
5362035|NCT00196404|urinary incontinence|urinary incontinence
5362036|NCT00196391|secondary amenorrhea|secondary amenorrhea
5362037|NCT00196391|progesterone|progesterone
5362038|NCT00196378|vaginal atrophy|vaginal atrophy
5362039|NCT00196378|vaginal dryness|vaginal dryness
5362040|NCT00196378|vaginal itching|vaginal itching
5362041|NCT00196378|vaginal pain|vaginal pain
5362042|NCT00196378|dyspareunia|dyspareunia
5362043|NCT00196365|cyclic pelvic pain|cyclic pelvic pain
5362044|NCT00196365|dysmenorrhea|dysmenorrhea
5362045|NCT00196352|oral contraceptives|oral contraceptives
5362046|NCT00196352|birth control|birth control
5362047|NCT00196352|ethinyl estradiol|ethinyl estradiol
5362048|NCT00196352|pregnancy prevention|pregnancy prevention
5362049|NCT00196339|prostate cancer|prostate cancer
5362050|NCT00196339|hot flashes|hot flashes
5362051|NCT00196339|hot flushes|hot flushes
5362052|NCT00196339|vasomotor symptoms|vasomotor symptoms
5362053|NCT00196326|pregnancy prevention|pregnancy prevention
5362054|NCT00196326|oral contraceptives|oral contraceptives
5362055|NCT00196313|cyclic pelvic pain|cyclic pelvic pain
5362056|NCT00196313|dysmenorrhea|dysmenorrhea
5362057|NCT00196313|oral contraceptives|oral contraceptives
5362058|NCT00196300|Assessment, Risk|assessment, risk
5362059|NCT00196300|Autonomic nervous system|autonomic nervous system
5362060|NCT00196300|Aged|aged
5362061|NCT00196287|Assessment, risk|assessment, risk
5362062|NCT00196287|autonomic nervous system|autonomic nervous system
5362063|NCT00196287|Gender|gender
5362064|NCT00196274|AUTONOMIC NERVOUS SYSTEM|autonomic nervous system
5362065|NCT00196274|Assessment, Risk|assessment, risk
5362066|NCT00196261|Assessment, Risk|assessment, risk
5362067|NCT00196261|Autonomic nervous system|autonomic nervous system
5362068|NCT00196235|Assessment, Risk|assessment, risk
5362069|NCT00196235|Diabetes mellitus|diabetes mellitus
5362070|NCT00196235|Autonomic nervous system|autonomic nervous system
5362071|NCT00196209|atrial fibrillation|atrial fibrillation
5362072|NCT00196209|catheter ablation|catheter ablation
5362073|NCT00196196|Hydrocephalus|hydrocephalus
5362074|NCT00196196|Codman Hakim Programmable Valve|codman hakim programmable valve
5362075|NCT00196196|Programmable Valve|programmable valve
5362076|NCT00196196|Shunt System|shunt system
5362077|NCT00196131|morphine|morphine
5362078|NCT00196131|head injury|head injury
5362079|NCT00196131|SAH|sah
5362080|NCT00196118|Pulmonary Embolism|pulmonary embolism
5362081|NCT00196118|Venous Thromboembolism|venous thromboembolism
5362082|NCT00196118|Inferior Vena Cava Filter|inferior vena cava filter
5362083|NCT00196118|IVC|ivc
5362084|NCT00196118|PE|pe
5362085|NCT00196105|Stents|stents
5362086|NCT00196105|Stent-graft|stent-graft
5362087|NCT00196105|Minimally invasive|minimally invasive
5362088|NCT00196105|Biliary Tract Cancer|biliary tract cancer
5362089|NCT00196105|Pancreatic Cancer|pancreatic cancer
5362090|NCT00196105|Jaundice|jaundice
5362091|NCT00196105|Biliary Tract Neoplasms|biliary tract neoplasms
5362092|NCT00196105|Pancreatic Neoplasms|pancreatic neoplasms
5362093|NCT00196105|Jaundice, Obstructive|jaundice, obstructive
5362094|NCT00196105|Zilver|zilver
5362095|NCT00196079|coronary artery|coronary artery
5362096|NCT00196079|stenosis|stenosis
5362097|NCT00196079|drug eluting stent|drug eluting stent
5362098|NCT00196079|stent|stent
5362099|NCT00196053|Intrathecal pain management|intrathecal pain management
5362100|NCT00196053|constant flow pump|constant flow pump
5362101|NCT00196014|Registered Nurses|registered nurses
5362102|NCT00196014|Workload|workload
5362103|NCT00196014|Clinical staff nurses that are currently working|clinical staff nurses that are currently working
5362104|NCT00196001|Adrenal sufficiency|adrenal sufficiency
5362105|NCT00196001|Low-dose ACTH stimulation|low-dose acth stimulation
5362106|NCT00196001|G proteins|g proteins
5362107|NCT00195988|immunosuppression,|immunosuppression,
5362108|NCT00195988|steroid avoidance,|steroid avoidance,
5362109|NCT00195988|liver transplantation,|liver transplantation,
5362110|NCT00195988|children|children
5362111|NCT00195975|Abdominal Pain|abdominal pain
5362112|NCT00195975|Functional Gastrointestinal Disorders|functional gastrointestinal disorders
5362113|NCT00195975|Stress|stress
5362114|NCT00195975|Anxiety|anxiety
5362115|NCT00195975|Autonomic Nervous System|autonomic nervous system
5362116|NCT00195962|Breastfeeding|breastfeeding
5362117|NCT00195962|Post-partum mothers of healthy breast-fed newborns|post-partum mothers of healthy breast-fed newborns
5362118|NCT00195949|Pyloric Stenosis|pyloric stenosis
5362119|NCT00195949|Laparoscopy|laparoscopy
5362120|NCT00195949|Idiopathic Hypertrophic Pyloric Stenosis|idiopathic hypertrophic pyloric stenosis
5362121|NCT00195936|Cinacalcet|cinacalcet
5362122|NCT00195936|PTH|pth
5362123|NCT00195936|XLH|xlh
5362124|NCT00195936|children and adolescents with hypophosphatemic rickets (XLH)|children and adolescents with hypophosphatemic rickets (xlh)
5362125|NCT00195923|appendicitis|appendicitis
5362126|NCT00195923|perforation|perforation
5362127|NCT00195910|Acute|acute
5362128|NCT00195910|Pain|pain
5362129|NCT00195910|Emergency Department|emergency department
5362130|NCT00195910|Morphine|morphine
5362131|NCT00195910|Hydromorphone|hydromorphone
5362132|NCT00195910|Dilaudid|dilaudid
5362133|NCT00195910|oligoanalgesia|oligoanalgesia
5362134|NCT00195897|Lymphoma|lymphoma
5362135|NCT00195897|Anthracyclines|anthracyclines
5362136|NCT00195897|Heart Failure|heart failure
5362137|NCT00195897|Radionuclide|radionuclide
5362138|NCT00195897|Magnetic Resonance Imaging|magnetic resonance imaging
5362139|NCT00195897|Troponin|troponin
5362140|NCT00195897|Natriuretic Peptide, Brain|natriuretic peptide, brain
5362141|NCT00195884|Diabetes Mellitus|diabetes mellitus
5362142|NCT00195884|Type 2 Diabetes|type 2 diabetes
5362143|NCT00195884|Aerobic|aerobic
5362144|NCT00195884|Resistance|resistance
5362145|NCT00195884|weight training|weight training
5362146|NCT00195884|Exercise|exercise
5362147|NCT00195871|Non-Hodgkin|non-hodgkin
5362148|NCT00195871|Lymphoma|lymphoma
5362149|NCT00195871|Lymphoblastic|lymphoblastic
5362150|NCT00195858|Youth|youth
5362151|NCT00195858|Exercise|exercise
5362152|NCT00195858|Physical Activity|physical activity
5362153|NCT00195858|Aerobic|aerobic
5362154|NCT00195858|Resistance|resistance
5362155|NCT00195858|Overweight|overweight
5362156|NCT00195858|obese|obese
5362157|NCT00195858|Canada|canada
5362158|NCT00195858|Sigal|sigal
5362159|NCT00195819|ankylosing spondylitis|ankylosing spondylitis
5362160|NCT00195819|adalimumab|adalimumab
5362161|NCT00195806|Migraine|migraine
5362162|NCT00195806|Depakote ER|depakote er
5362163|NCT00195806|Divalproex sodium|divalproex sodium
5362164|NCT00195793|Hyperlipidemia|hyperlipidemia
5362165|NCT00195793|fenofibrate|fenofibrate
5362166|NCT00195793|ezetimibe|ezetimibe
5362167|NCT00195793|atorvastatin|atorvastatin
5362168|NCT00195780|Bipolar I Disorder|bipolar i disorder
5362169|NCT00195780|Depakote|depakote
5362170|NCT00195767|Bipolar I Disorder|bipolar i disorder
5362171|NCT00195767|Depakote ER|depakote er
5362172|NCT00195767|divalproex sodium|divalproex sodium
5362173|NCT00195754|Migraines|migraines
5362174|NCT00195754|Depakote ER|depakote er
5362175|NCT00195754|divalproex sodium|divalproex sodium
5362176|NCT00195741|Migraine|migraine
5362177|NCT00195741|Depakote ER|depakote er
5362178|NCT00195728|Hydrocodone/Acetaminophen|hydrocodone/acetaminophen
5362179|NCT00195728|Vicodin CR|vicodin cr
5362180|NCT00195702|Rheumatoid Arthritis|rheumatoid arthritis
5362181|NCT00195663|Early Rheumatoid Arthritis|early rheumatoid arthritis
5362182|NCT00195650|Rheumatoid Arthritis|rheumatoid arthritis
5362183|NCT00195637|GNE Gene|gne gene
5362184|NCT00195637|Alpha-Dystroglycan|alpha-dystroglycan
5362185|NCT00195637|Sialic Acid|sialic acid
5362186|NCT00195637|Glycosylation|glycosylation
5362187|NCT00195637|Dystroglycanopathy|dystroglycanopathy
5362188|NCT00195637|Hereditary Inclusion Body Myopathy|hereditary inclusion body myopathy
5362189|NCT00195637|Immune Globulin|immune globulin
5362190|NCT00195637|HIBM|hibm
5362191|NCT00195624|Immunosuppression|immunosuppression
5362192|NCT00195624|Alemtuzumab/Campath|alemtuzumab/campath
5362193|NCT00195624|Severe Aplastic Anemia|severe aplastic anemia
5362194|NCT00195624|T-cells|t-cells
5362195|NCT00195624|Hematopoiesis|hematopoiesis
5362196|NCT00195624|Autoimmunity|autoimmunity
5362197|NCT00195624|Thrombocytopenia|thrombocytopenia
5362198|NCT00195624|Neutropenia|neutropenia
5362199|NCT00195624|SAA|saa
5362698|NCT00192595|Hepatitis B|hepatitis b
5362200|NCT00195611|Middle Ear Infection|middle ear infection
5362201|NCT00195598|Panic Disorders|panic disorders
5362202|NCT00195585|Colon Cancer|colon cancer
5362203|NCT00195572|Gastric Cancer|gastric cancer
5362204|NCT00195572|Advanced/Recurrent Gastric Cancer|advanced/recurrent gastric cancer
5362205|NCT00195559|Premenstrual Syndrome (PMS)|premenstrual syndrome (pms)
5362206|NCT00195559|Hormone Therapy|hormone therapy
5362207|NCT00195546|Menopause|menopause
5362208|NCT00195533|Leukemia|leukemia
5362209|NCT00195533|Lymphoma|lymphoma
5362210|NCT00195533|Myeloma|myeloma
5362211|NCT00195520|Menopause|menopause
5362212|NCT00195520|Sleep Disorder|sleep disorder
5362213|NCT00195520|Hot Flashes|hot flashes
5362214|NCT00195507|Psoriasis|psoriasis
5362215|NCT00195494|Rheumatoid Arthritis|rheumatoid arthritis
5362216|NCT00195481|Kidney|kidney
5362217|NCT00195481|Transplant|transplant
5362218|NCT00195468|Kidney Failure|kidney failure
5362219|NCT00195468|Transplant|transplant
5362220|NCT00195455|Postmenopause|postmenopause
5362221|NCT00195442|Hemophilia A|hemophilia a
5362222|NCT00195429|Kidney|kidney
5362223|NCT00195429|Transplant|transplant
5362224|NCT00195416|Ankylosing Spondylitis|ankylosing spondylitis
5362225|NCT00195403|Rheumatoid Arthritis|rheumatoid arthritis
5362226|NCT00195390|Vaccine|vaccine
5362227|NCT00195390|heptavalent pneumococcal conjugate vaccine|heptavalent pneumococcal conjugate vaccine
5362228|NCT00195364|Rheumatoid Arthritis|rheumatoid arthritis
5362229|NCT00195351|Complicated intra-abdominal infection|complicated intra-abdominal infection
5362230|NCT00195351|Appendicitis with abscess|appendicitis with abscess
5362231|NCT00195351|Perforated diverticulitis|perforated diverticulitis
5362232|NCT00195351|Purulent peritonitis|purulent peritonitis
5362233|NCT00195351|Complicated cholecystitis|complicated cholecystitis
5362234|NCT00195338|Rheumatoid Arthritis|rheumatoid arthritis
5362235|NCT00195325|Advanced Malignant Solid Tumors|advanced malignant solid tumors
5362236|NCT00195312|HIV|hiv
5362237|NCT00195312|Vaccine|vaccine
5362238|NCT00195312|Treatment Experienced|treatment experienced
5362239|NCT00195299|Carcinoma|carcinoma
5362240|NCT00195299|Head|head
5362241|NCT00195299|Neck|neck
5362242|NCT00195286|Urinary Infections|urinary infections
5362243|NCT00195273|Kidney|kidney
5362244|NCT00195273|Transplant|transplant
5362245|NCT00195260|Solid tumors|solid tumors
5362246|NCT00195247|Tumors|tumors
5362247|NCT00195247|Advanced malignant solid tumors|advanced malignant solid tumors
5362248|NCT00195234|HIV|hiv
5362249|NCT00195234|Treatment Experienced|treatment experienced
5362250|NCT00195221|Hemophilia B|hemophilia b
5362251|NCT00195208|Gastroesophageal Reflux Disease (GERD)|gastroesophageal reflux disease (gerd)
5362252|NCT00195195|Transplantation|transplantation
5362253|NCT00195182|Hypertension|hypertension
5362254|NCT00195182|African-American|african-american
5362255|NCT00195182|Perceived Racism|perceived racism
5362256|NCT00195182|Psychological Stress|psychological stress
5362257|NCT00195182|Medication Adherence|medication adherence
5362258|NCT00195169|Myocardial Infarction|myocardial infarction
5362259|NCT00195169|Social support|social support
5362260|NCT00195156|Solid Tumor Malignancies|solid tumor malignancies
5362261|NCT00195143|Parkinson's disease|parkinson's disease
5362262|NCT00195143|GABA|gaba
5362263|NCT00195143|Subthalamic nucleus|subthalamic nucleus
5362264|NCT00195143|Adeno-associated virus|adeno-associated virus
5362265|NCT00195143|AAV|aav
5362266|NCT00195143|Gene therapy|gene therapy
5362267|NCT00195130|prognosis|prognosis
5362268|NCT00195130|risk of death|risk of death
5362269|NCT00195130|morbidity|morbidity
5362270|NCT00195130|mortality|mortality
5362271|NCT00195130|quality of life|quality of life
5362272|NCT00195117|Asthma|asthma
5362273|NCT00195117|Behavior change|behavior change
5362274|NCT00195117|Physical activity|physical activity
5362275|NCT00195117|Risk reduction|risk reduction
5362276|NCT00195104|Myelodysplastic Syndrome|myelodysplastic syndrome
5362277|NCT00195078|head and neck cancer|head and neck cancer
5362278|NCT00195078|squamous cell carcinoma of the oral cavity|squamous cell carcinoma of the oral cavity
5362279|NCT00195078|squamous cell carcinoma of the oropharynx|squamous cell carcinoma of the oropharynx
5362280|NCT00195078|squamous cell carcinoma of the larynx|squamous cell carcinoma of the larynx
5362281|NCT00195078|squamous cell carcinoma of the hypopharynx|squamous cell carcinoma of the hypopharynx
5362282|NCT00195065|Asthma|asthma
5362283|NCT00195065|Behavior change|behavior change
5362284|NCT00195065|Physical activity|physical activity
5362285|NCT00195065|Risk reduction|risk reduction
5362286|NCT00195052|epilepsy|epilepsy
5362287|NCT00195052|optical imaging|optical imaging
5362288|NCT00195052|optical mapping|optical mapping
5362289|NCT00195039|Prostate Cancer|prostate cancer
5362290|NCT00195000|Acute Myeloid Leukemia|acute myeloid leukemia
5362291|NCT00195000|Myelodysplastic Syndrome|myelodysplastic syndrome
5362292|NCT00194987|Alloimmune thrombocytopenia|alloimmune thrombocytopenia
5362293|NCT00194987|Fetal alloimmune thrombocytopenia|fetal alloimmune thrombocytopenia
5362294|NCT00194974|pregnancy|pregnancy
5362295|NCT00194974|chronic hypertension|chronic hypertension
5362296|NCT00194974|Toxemia|toxemia
5362297|NCT00194974|Blood Pressure|blood pressure
5362298|NCT00194961|Chronic Kidney Disease|chronic kidney disease
5362299|NCT00194961|Growth Failure|growth failure
5362300|NCT00194961|Cytokines|cytokines
5362301|NCT00194961|leptin|leptin
5362302|NCT00194935|Ovarian Cancer|ovarian cancer
5362303|NCT00194935|Cancer of the Ovary|cancer of the ovary
5362304|NCT00194896|type 2 diabetes mellitus|type 2 diabetes mellitus
5362305|NCT00194896|autoantibodies|autoantibodies
5362306|NCT00194896|islet proteins|islet proteins
5362307|NCT00194896|rosiglitazone|rosiglitazone
5362308|NCT00194896|glyburide|glyburide
5362309|NCT00194896|c-peptide|c-peptide
5362310|NCT00194883|Recombinant Human Growth Hormone|recombinant human growth hormone
5362311|NCT00194883|Leptin|leptin
5362312|NCT00194883|Cytokines|cytokines
5362313|NCT00194883|Chronic Renal Insufficiency|chronic renal insufficiency
5362314|NCT00194883|Children|children
5362315|NCT00194870|EEG|eeg
5362316|NCT00194870|DBS|dbs
5362317|NCT00194857|anemia|anemia
5362318|NCT00194857|dose reduction|dose reduction
5362319|NCT00194857|neutropenia|neutropenia
5362320|NCT00194857|hepatitis C virus|hepatitis c virus
5362321|NCT00194857|human immunodeficiency virus|human immunodeficiency virus
5362322|NCT00194844|caring|caring
5362323|NCT00194844|miscarriage|miscarriage
5362324|NCT00194844|grief|grief
5362325|NCT00194844|couples|couples
5362326|NCT00194844|counseling|counseling
5362327|NCT00194805|Internet|internet
5362328|NCT00194805|Diabetes|diabetes
5362329|NCT00194805|Education|education
5362330|NCT00194805|Social Support|social support
5362331|NCT00194766|Breast cancer|breast cancer
5362332|NCT00194766|Soft tissue sarcoma|soft tissue sarcoma
5362333|NCT00194753|Breast cancer|breast cancer
5362334|NCT00194740|Breast cancer|breast cancer
5362335|NCT00194727|Breast cancer|breast cancer
5362336|NCT00194701|heart failure|heart failure
5362337|NCT00194701|sleep|sleep
5362338|NCT00194701|exercise|exercise
5362339|NCT00194701|heart rate variability|heart rate variability
5362340|NCT00194688|ammonia|ammonia
5362341|NCT00194675|androgen deficiency|androgen deficiency
5362342|NCT00194675|testosterone|testosterone
5362343|NCT00194675|Benign Prostatic Hyperplasia|benign prostatic hyperplasia
5362344|NCT00194675|hypogonadism|hypogonadism
5362345|NCT00194675|prostate|prostate
5362346|NCT00194675|BPH|bph
5362347|NCT00194649|Glycosphingolipids (GSL)|glycosphingolipids (gsl)
5362348|NCT00194636|Prostatitis|prostatitis
5362349|NCT00194636|Chronic Male Pelvic Pain Syndrome|chronic male pelvic pain syndrome
5362350|NCT00194623|prostatitis|prostatitis
5362351|NCT00194597|Prostatitis|prostatitis
5362352|NCT00194584|children|children
5362353|NCT00194584|chronic illness|chronic illness
5362354|NCT00194584|parent education|parent education
5362355|NCT00194584|parent support|parent support
5362356|NCT00194571|breast cancer,|breast cancer,
5362357|NCT00194571|child functioning,|child functioning,
5362358|NCT00194571|parenting,|parenting,
5362359|NCT00194571|self-efficacy,|self-efficacy,
5362360|NCT00194571|psychoeducational intervention|psychoeducational intervention
5362361|NCT00194571|counseling|counseling
5362362|NCT00194558|Diabetes|diabetes
5362363|NCT00194558|Health Education|health education
5362364|NCT00194558|Information Technology|information technology
5362365|NCT00194558|Disease Management|disease management
5362366|NCT00194558|Internet|internet
5362367|NCT00194558|Patient Education|patient education
5362368|NCT00194545|HIV-1|hiv-1
5362369|NCT00194545|pediatric adherence|pediatric adherence
5362370|NCT00194545|medication diaries|medication diaries
5362371|NCT00194545|HAART|haart
5362372|NCT00194545|Treatment Naive|treatment naive
5362373|NCT00194532|UTI|uti
5362374|NCT00194519|HIV infection|hiv infection
5362375|NCT00194519|HIV transmission|hiv transmission
5362376|NCT00194519|genital herpes|genital herpes
5362377|NCT00194519|sexual intercourse|sexual intercourse
5362378|NCT00194519|sexual transmitted infection|sexual transmitted infection
5362379|NCT00194519|acyclovir|acyclovir
5362380|NCT00194519|HIV Seronegativity|hiv seronegativity
5362381|NCT00194519|Treatment Naive|treatment naive
5362382|NCT00194519|HIV-discordant couples|hiv-discordant couples
5362383|NCT00194519|HIV serodiagnosis|hiv serodiagnosis
5362384|NCT00194506|Diabetes|diabetes
5362385|NCT00194506|Health Education|health education
5362386|NCT00194506|Information Technology|information technology
5362387|NCT00194506|Disease Management|disease management
5362388|NCT00194506|Internet|internet
5362389|NCT00194506|Patient Education|patient education
5362390|NCT00194493|Cancer|cancer
5362391|NCT00194493|Quality of Life|quality of life
5362392|NCT00194493|Signs and Symptoms|signs and symptoms
5362393|NCT00194493|Computers|computers
5362394|NCT00194493|Patient-Reported Outcomes|patient-reported outcomes
5362395|NCT00194480|Hepatitis C, peg-Interferon, drug abuse|hepatitis c, peg-interferon, drug abuse
5362396|NCT00194454|Depressive symptoms|depressive symptoms
5362397|NCT00194454|Behavior and behavior mechanisms|behavior and behavior mechanisms
5362398|NCT00194454|Recovery|recovery
5362399|NCT00194441|cerebral circulation|cerebral circulation
5362400|NCT00194441|monitoring, physiologic|monitoring, physiologic
5362401|NCT00194441|informatics|informatics
5362402|NCT00194441|nursing care|nursing care
5362403|NCT00194441|physiologic variability|physiologic variability
5362405|NCT00194441|quality adjusted life years|quality adjusted life years
5362406|NCT00194428|Obesity,|obesity,
5362407|NCT00194428|Metabolic Syndrome,|metabolic syndrome,
5362408|NCT00194428|BMI|bmi
5362409|NCT00194402|cholesterol|cholesterol
5362410|NCT00194402|dyslipidemia|dyslipidemia
5362411|NCT00194402|hypercholesterolemia|hypercholesterolemia
5362412|NCT00194402|C-reactive protein|c-reactive protein
5362413|NCT00194363|breast cancer|breast cancer
5362414|NCT00194363|breast cancer survivors|breast cancer survivors
5362415|NCT00194363|lymphedema|lymphedema
5362416|NCT00194363|strength training|strength training
5362417|NCT00194363|breast cancer survivorship|breast cancer survivorship
5362418|NCT00194350|Infertility|infertility
5362419|NCT00194350|Factor V Leiden|factor v leiden
5362420|NCT00194337|stage I breast cancer|stage i breast cancer
5362421|NCT00194337|stage II breast cancer|stage ii breast cancer
5362422|NCT00194337|stage IIIA breast cancer|stage iiia breast cancer
5362423|NCT00194337|stage IIIB breast cancer|stage iiib breast cancer
5362424|NCT00194337|stage IIIC breast cancer|stage iiic breast cancer
5362425|NCT00194337|stage IV breast cancer|stage iv breast cancer
5362426|NCT00194311|HPV|hpv
5362427|NCT00194311|Pregnancy|pregnancy
5362428|NCT00194298|diabetic foot disease|diabetic foot disease
5362429|NCT00194298|osteomyelitis|osteomyelitis
5362430|NCT00194298|charcot|charcot
5362431|NCT00194298|neuropathy|neuropathy
5362432|NCT00194298|hypoxia|hypoxia
5362433|NCT00194298|[18 F] Fluorodeoxyglucose|[18 f] fluorodeoxyglucose
5362434|NCT00194298|Positron Emission Tomography Imaging|positron emission tomography imaging
5362435|NCT00194285|Prosthesis|prosthesis
5362436|NCT00194285|[18 F] Fluorodeoxyglucose|[18 f] fluorodeoxyglucose
5362437|NCT00194285|Positron Emission Tomography Imaging|positron emission tomography imaging
5362438|NCT00194272|Ectopic pregnancy|ectopic pregnancy
5362439|NCT00194272|Methotrexate|methotrexate
5362440|NCT00194233|Endometriosis|endometriosis
5362441|NCT00194220|Infertility|infertility
5362442|NCT00194220|Oxidative stress|oxidative stress
5362443|NCT00194207|Ectopic pregnancy|ectopic pregnancy
5362444|NCT00194194|BMI|bmi
5362445|NCT00194194|RMR|rmr
5362446|NCT00194194|Personal Computer|personal computer
5362447|NCT00194181|dialysis|dialysis
5362448|NCT00194181|fibrin|fibrin
5362449|NCT00194181|sheath|sheath
5362450|NCT00194181|clot|clot
5362451|NCT00194181|tpa|tpa
5362452|NCT00194168|ectopic pregnancy|ectopic pregnancy
5362453|NCT00194155|cytomegalovirus|cytomegalovirus
5362454|NCT00194155|pregnancy|pregnancy
5362455|NCT00194155|placenta|placenta
5362456|NCT00194142|Pregnancy|pregnancy
5362457|NCT00194142|Cytomegalovirus|cytomegalovirus
5362458|NCT00194090|pain|pain
5362459|NCT00194090|osteoarthritis|osteoarthritis
5362460|NCT00194051|obesity|obesity
5362461|NCT00194051|gait biomechanics|gait biomechanics
5362462|NCT00194051|knee osteoarthritis|knee osteoarthritis
5362463|NCT00194038|Bipolar Disorder|bipolar disorder
5362464|NCT00194038|Geriatric Psychiatry|geriatric psychiatry
5362465|NCT00194038|Aripiprazole|aripiprazole
5362466|NCT00194025|Schizophrenia|schizophrenia
5362467|NCT00194025|Anticonvulsants|anticonvulsants
5362468|NCT00194025|Valproic Acid|valproic acid
5362469|NCT00194025|Valproate|valproate
5362470|NCT00194012|bipolar disorder|bipolar disorder
5362471|NCT00193999|Nasogastric Tubes|nasogastric tubes
5362472|NCT00193999|Nausea|nausea
5362473|NCT00193999|Vomiting|vomiting
5362474|NCT00193999|Cardiac surgery|cardiac surgery
5362475|NCT00193986|Prepulse|prepulse
5362476|NCT00193986|Defibrillator|defibrillator
5362477|NCT00193973|Lymphoma|lymphoma
5362478|NCT00193973|PCNSL|pcnsl
5362479|NCT00193973|Primary CNS lymphoma|primary cns lymphoma
5362480|NCT00193960|Seton surgery, glaucoma, Ahmed valve, intraocular pressure|seton surgery, glaucoma, ahmed valve, intraocular pressure
5362481|NCT00193934|Women's Health|women's health
5362482|NCT00193934|Multidisciplinary, multicentre prospective study|multidisciplinary, multicentre prospective study
5362483|NCT00193934|Cancer:mechanisms of growth, invasion, metastases|cancer:mechanisms of growth, invasion, metastases
5362484|NCT00193934|Figo Stages cervical cancer|figo stages cervical cancer
5362485|NCT00193934|Advances in diagnosis using radiological methods|advances in diagnosis using radiological methods
5362486|NCT00193934|Quantitative Magnetic Resonance Imaging|quantitative magnetic resonance imaging
5362487|NCT00193934|Patient Management Strategies|patient management strategies
5362488|NCT00193934|Selecting patients for therapy|selecting patients for therapy
5362489|NCT00193921|Chemoradiotherapy|chemoradiotherapy
5362490|NCT00193921|High dose|high dose
5362491|NCT00193921|palliative radiotherapy|palliative radiotherapy
5362492|NCT00193921|Quality of life|quality of life
5362493|NCT00193908|Skin care|skin care
5362494|NCT00193908|Radiotherapy|radiotherapy
5362495|NCT00193895|Skin cancer|skin cancer
5362496|NCT00193895|radiotherapy|radiotherapy
5362497|NCT00193895|chemotherapy|chemotherapy
5362498|NCT00193895|surgery|surgery
5362499|NCT00193882|Oesophageal|oesophageal
5362500|NCT00193882|Dysphagia|dysphagia
5362501|NCT00193882|Palliation|palliation
5362502|NCT00193882|Quality of Life|quality of life
5362503|NCT00193882|Radiotherapy|radiotherapy
5362504|NCT00193882|Chemotherapy|chemotherapy
5362505|NCT00193869|Radiotherapy|radiotherapy
5362506|NCT00193869|Dose fractionation|dose fractionation
5362507|NCT00193856|Prostate Cancer|prostate cancer
5362508|NCT00193856|Androgen Deprivation|androgen deprivation
5362509|NCT00193856|Hormone Therapy|hormone therapy
5362510|NCT00193856|RadiotherapyBisphosphonate|radiotherapybisphosphonate
5362511|NCT00193856|Prostate Specific Antigen (PSA)|prostate specific antigen (psa)
5362512|NCT00193843|Oral cancer|oral cancer
5362513|NCT00193843|Head and neck surgery|head and neck surgery
5362514|NCT00193843|Accelerated radiotherapy|accelerated radiotherapy
5362515|NCT00193843|Chemo-radiotherapy|chemo-radiotherapy
5362516|NCT00193830|Cervical Cancer|cervical cancer
5362517|NCT00193830|High Dose Rate (HDR) Brachytherapy|high dose rate (hdr) brachytherapy
5362518|NCT00193830|Low Dose Rate (LDR) Brachytherapy|low dose rate (ldr) brachytherapy
5362519|NCT00193830|Acute Toxicities|acute toxicities
5362520|NCT00193830|Late Radiation Sequelae|late radiation sequelae
5362521|NCT00193817|Cancer|cancer
5362522|NCT00193817|Esophagus|esophagus
5362523|NCT00193817|Lymphadenectomy|lymphadenectomy
5362524|NCT00193804|Cervical Cancer|cervical cancer
5362525|NCT00193804|FIGO STAGE IIB|figo stage iib
5362526|NCT00193804|CHEMORADIATION|chemoradiation
5362527|NCT00193804|Intensity Modulated Radiation Therapy(IMRT)|intensity modulated radiation therapy(imrt)
5362528|NCT00193804|Conventional Radiation Therapy|conventional radiation therapy
5362529|NCT00193804|Cancer of the Cervix|cancer of the cervix
5362530|NCT00193804|Cervix Cancer|cervix cancer
5362531|NCT00193791|Carcinoma Cervix|carcinoma cervix
5362532|NCT00193791|FIGO Stage IIIB|figo stage iiib
5362533|NCT00193791|Radiation therapy|radiation therapy
5362534|NCT00193791|Chemoradiation|chemoradiation
5362535|NCT00193791|Treatment related toxicities|treatment related toxicities
5362536|NCT00193791|Cervical Cancer|cervical cancer
5362537|NCT00193791|Cervix Cancer|cervix cancer
5362538|NCT00193778|Metastatic breast cancer|metastatic breast cancer
5362539|NCT00193778|Locoregional treatment|locoregional treatment
5362540|NCT00193778|Survival|survival
5362541|NCT00193765|neck dissection|neck dissection
5362542|NCT00193765|survival|survival
5362543|NCT00193765|early oral cancer|early oral cancer
5362544|NCT00193765|Early oral cavity squamous cancer with node negative neck|early oral cavity squamous cancer with node negative neck
5362545|NCT00193752|FDG-PET Imaging|fdg-pet imaging
5362546|NCT00193752|Cervical Cancer|cervical cancer
5362547|NCT00193752|Post-treatment evaluation|post-treatment evaluation
5362548|NCT00193752|Para-aortic Nodal Staging|para-aortic nodal staging
5362549|NCT00193752|Extended field Radiation|extended field radiation
5362550|NCT00193752|Extended field IMRT|extended field imrt
5362551|NCT00193739|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
5362552|NCT00193739|Surgery|surgery
5362553|NCT00193739|Cervix cancer|cervix cancer
5362554|NCT00193739|Concurrent chemoradiation|concurrent chemoradiation
5362555|NCT00193726|Estrogen|estrogen
5362556|NCT00193726|Priming|priming
5362557|NCT00193726|Adjuvant chemotherapy|adjuvant chemotherapy
5362558|NCT00193726|Breast cancer|breast cancer
5362559|NCT00193713|double-blind study in the treatment of schizophrenia|double-blind study in the treatment of schizophrenia
5362560|NCT00193700|Hypogonadism|hypogonadism
5362561|NCT00193687|open-label study in the treatment of schizophrenia|open-label study in the treatment of schizophrenia
5362562|NCT00193674|Pregnancy|pregnancy
5362563|NCT00193674|Immunology|immunology
5362564|NCT00193674|Unexplained recurrent miscarriage|unexplained recurrent miscarriage
5362565|NCT00193661|Hypogonadism|hypogonadism
5362566|NCT00193648|FSGS|fsgs
5362567|NCT00193648|Pharmacokinetics|pharmacokinetics
5362568|NCT00193648|Rosiglitazone|rosiglitazone
5362569|NCT00193648|PPAR-gamma agonist|ppar-gamma agonist
5362570|NCT00193648|Adalimumab|adalimumab
5362571|NCT00193648|TNF-alpha antagonist|tnf-alpha antagonist
5362572|NCT00193648|Steroid and immunosuppressive drug resistance|steroid and immunosuppressive drug resistance
5362573|NCT00193648|Resistant primary FSGS|resistant primary fsgs
5362574|NCT00193635|Congenital uropathies|congenital uropathies
5362575|NCT00193635|Mycophenolate mofetil|mycophenolate mofetil
5362576|NCT00193635|GFR|gfr
5362577|NCT00193635|Iothalamate clearance|iothalamate clearance
5362578|NCT00193635|Urine cytometry|urine cytometry
5362579|NCT00193635|Children|children
5362580|NCT00193635|Congenital urological abnormalities which represent stuctural defects in the genitourinary system|congenital urological abnormalities which represent stuctural defects in the genitourinary system
5362581|NCT00193609|Neoplasms, Unknown Primary|neoplasms, unknown primary
5362582|NCT00193596|Neoplasms, Unknown Primary|neoplasms, unknown primary
5362583|NCT00193492|Lymphoma|lymphoma
5362584|NCT00193492|Bevacizumab|bevacizumab
5362585|NCT00193492|Rituximab|rituximab
5362586|NCT00193453|Lung Cancer|lung cancer
5362587|NCT00193336|NSCLC Lung Cancer|nsclc lung cancer
5362588|NCT00193336|Non Small Cell Lung Cancer|non small cell lung cancer
5362589|NCT00193297|Ovary Cancer|ovary cancer
5362590|NCT00193258|Recurrent clear cell renal cell carcinoma|recurrent clear cell renal cell carcinoma
5362591|NCT00193258|Bevacizumab|bevacizumab
5362592|NCT00193258|Erlotinib|erlotinib
5362593|NCT00193258|Imatinib|imatinib
5362594|NCT00193219|Colon Cancer|colon cancer
5362595|NCT00193206|Locally Advanced Breast Cancer|locally advanced breast cancer
5362596|NCT00193206|Inflammatory Breast Cancer|inflammatory breast cancer
5362597|NCT00193206|Breast Cancer|breast cancer
5362598|NCT00193206|Abraxane|abraxane
5362599|NCT00193206|nab Paclitaxel|nab paclitaxel
5362600|NCT00193206|Epirubicin|epirubicin
5362601|NCT00193206|Gemcitabine|gemcitabine
5362602|NCT00193206|Gemzar|gemzar
5362603|NCT00193180|Breast Cancer|breast cancer
5362604|NCT00193154|Kidney Cancer|kidney cancer
5362605|NCT00193128|Esophagus Cancer|esophagus cancer
5362606|NCT00193037|Breast Cancer|breast cancer
5362607|NCT00192998|Affective disorder|affective disorder
5362608|NCT00192998|Alzheimer dementia|alzheimer dementia
5362609|NCT00192998|healthy controls|healthy controls
5362610|NCT00192972|Catheter ablation|catheter ablation
5362611|NCT00192972|Atrial fibrillation|atrial fibrillation
5362612|NCT00192959|Anaesthesia|anaesthesia
5362613|NCT00192959|Surgery|surgery
5362614|NCT00192959|Postoperative|postoperative
5362615|NCT00192959|Neuropsychological test|neuropsychological test
5362616|NCT00192946|Cardiac resynchronization|cardiac resynchronization
5362617|NCT00192946|Heart failure|heart failure
5362618|NCT00192946|open heart surgery|open heart surgery
5362619|NCT00192946|surgery|surgery
5362620|NCT00192881|Percutaneous coronary intervention|percutaneous coronary intervention
5362621|NCT00192881|Balloon angioplasty|balloon angioplasty
5362622|NCT00192881|Restenosis|restenosis
5362623|NCT00192881|Stents|stents
5362624|NCT00192868|primary PCI|primary pci
5362625|NCT00192868|distal protection|distal protection
5362626|NCT00192868|drug eluting stent|drug eluting stent
5362627|NCT00192868|restenosis|restenosis
5362628|NCT00192855|schizophrenia|schizophrenia
5362629|NCT00192855|negative symptoms|negative symptoms
5362630|NCT00192855|entacapone|entacapone
5362631|NCT00192842|carcinoma|carcinoma
5362632|NCT00192842|pancreas|pancreas
5362633|NCT00192842|gemcitabine|gemcitabine
5362634|NCT00192842|curcumin|curcumin
5362635|NCT00192829|Lung cancer|lung cancer
5362636|NCT00192829|Thrombosis|thrombosis
5362637|NCT00192829|Hypercoagulable|hypercoagulable
5362638|NCT00192803|niddm|niddm
5362639|NCT00192803|ace2|ace2
5362640|NCT00192803|NIDDM patients|niddm patients
5362641|NCT00192790|Therma,pain, Silent myocardial ischemia, catastrophizing|therma,pain, silent myocardial ischemia, catastrophizing
5362642|NCT00192777|Solid Tumors|solid tumors
5362643|NCT00192777|Bone Metastases|bone metastases
5362644|NCT00192777|Radiotherapy|radiotherapy
5362645|NCT00192777|Xeloda|xeloda
5362646|NCT00192777|Concurrent|concurrent
5362647|NCT00192777|Radiosensitization|radiosensitization
5362648|NCT00192764|large cell lymphoma|large cell lymphoma
5362649|NCT00192764|CHOP|chop
5362650|NCT00192764|cyclophosphamide|cyclophosphamide
5362651|NCT00192764|high-dose|high-dose
5362652|NCT00192751|Schizophrenia|schizophrenia
5362653|NCT00192751|Major depression|major depression
5362654|NCT00192751|Bipolar disorder|bipolar disorder
5362655|NCT00192751|Compliance|compliance
5362656|NCT00192751|Relapse prevention|relapse prevention
5362657|NCT00192738|telephone,|telephone,
5362658|NCT00192738|internal medicine,|internal medicine,
5362659|NCT00192738|readmission,|readmission,
5362660|NCT00192738|patients' satisfaction|patients' satisfaction
5362661|NCT00192725|bipolar disorder|bipolar disorder
5362662|NCT00192725|acute mania|acute mania
5362663|NCT00192725|tryptophan depletion|tryptophan depletion
5362664|NCT00192725|placebo controlled add-on|placebo controlled add-on
5362665|NCT00192725|Bipolar disorder- manic type|bipolar disorder- manic type
5362666|NCT00192712|carcinoma|carcinoma
5362667|NCT00192712|pancreas|pancreas
5362668|NCT00192712|chemotherapy|chemotherapy
5362669|NCT00192712|radiotherapy|radiotherapy
5362670|NCT00192699|Osteoarthritis|osteoarthritis
5362671|NCT00192673|Asparaginase|asparaginase
5362672|NCT00192673|intramuscular administration|intramuscular administration
5362673|NCT00192673|Silent antibodies|silent antibodies
5362674|NCT00192673|Childhood acute lymphoblastic leukemia|childhood acute lymphoblastic leukemia
5362675|NCT00192673|Side effects|side effects
5362676|NCT00192673|5-year EFS|5-year efs
5362677|NCT00192660|HIV|hiv
5362678|NCT00192660|Metabolic abnormality|metabolic abnormality
5362679|NCT00192660|Lipodystrophy|lipodystrophy
5362680|NCT00192660|Cardiovascular disease|cardiovascular disease
5362681|NCT00192660|Treatment Naive|treatment naive
5362682|NCT00192660|Treatment Experienced|treatment experienced
5362683|NCT00192660|HIV Infections|hiv infections
5362684|NCT00192634|HIV|hiv
5362685|NCT00192634|Antiretroviral therapy|antiretroviral therapy
5362686|NCT00192634|nucleoside analogue reverse transcriptase|nucleoside analogue reverse transcriptase
5362687|NCT00192634|fixed dose combination|fixed dose combination
5362688|NCT00192634|Treatment Experienced|treatment experienced
5362689|NCT00192621|HIV negative healthy subjects|hiv negative healthy subjects
5362690|NCT00192621|Lipid metabolism|lipid metabolism
5362691|NCT00192621|Glucose metabolism|glucose metabolism
5362692|NCT00192621|Metabolic abnormality|metabolic abnormality
5362693|NCT00192621|Lipodystrophy|lipodystrophy
5362694|NCT00192621|Cardiovascular disease|cardiovascular disease
5362695|NCT00192621|Treatment Naive|treatment naive
5362696|NCT00192621|HIV|hiv
5362697|NCT00192608|Pharmacokinetics, atazanavir, saquinavir, ritonavir, HIV|pharmacokinetics, atazanavir, saquinavir, ritonavir, hiv
5362699|NCT00192595|HIV|hiv
5362700|NCT00192595|Treatment Naive|treatment naive
5362701|NCT00192582|Motivational interview|motivational interview
5362702|NCT00192582|Care plan|care plan
5362703|NCT00192582|Relapse prevention|relapse prevention
5362704|NCT00192582|Psychoeducation|psychoeducation
5362705|NCT00192582|Indigenous mental health|indigenous mental health
5362706|NCT00192569|Acute Hepatitis C|acute hepatitis c
5362707|NCT00192556|tuberculosis|tuberculosis
5362708|NCT00192556|nutrition|nutrition
5362709|NCT00192556|directly observed therapy|directly observed therapy
5362710|NCT00192556|Timor Leste|timor leste
5362711|NCT00192556|cost-effectiveness|cost-effectiveness
5362712|NCT00192543|dialysis|dialysis
5362713|NCT00192543|omega-3 fatty acids|omega-3 fatty acids
5362714|NCT00192543|antioxidants|antioxidants
5362715|NCT00192543|cardiovascular markers|cardiovascular markers
5362716|NCT00192543|Mortality|mortality
5362717|NCT00192543|End-stage renal disease|end-stage renal disease
5362718|NCT00191971|Transitional cell carcinoma of urothelium|transitional cell carcinoma of urothelium
5362719|NCT00191282|diabetes|diabetes
5362720|NCT00191282|MI|mi
5362721|NCT00191282|heart attack|heart attack
5362722|NCT00191269|after|after
5362723|NCT00191269|anthracycline|anthracycline
5362724|NCT00191269|taxane|taxane
5362725|NCT00191269|regimen|regimen
5362726|NCT00191243|breast cancer|breast cancer
5362727|NCT00191113|syndrome|syndrome
5362728|NCT00191113|Turner|turner
5362729|NCT00191113|Turner's|turner's
5362730|NCT00191113|height|height
5362731|NCT00191113|growth|growth
5362732|NCT00191113|growth hormone|growth hormone
5362733|NCT00191113|somatropin|somatropin
5362734|NCT00191113|short stature|short stature
5362735|NCT00191113|short|short
5362736|NCT00191113|hearing|hearing
5362737|NCT00191113|glucose metabolism|glucose metabolism
5362738|NCT00190671|Advanced Breast Cancer|advanced breast cancer
5362739|NCT00190580|CKD|ckd
5362740|NCT00190580|chronic kidney disease|chronic kidney disease
5362741|NCT00190580|hypertension|hypertension
5362742|NCT00190580|angiotensin II receptor blocker|angiotensin ii receptor blocker
5362743|NCT00190580|cardiovascular disease|cardiovascular disease
5362744|NCT00190580|valsartan|valsartan
5362745|NCT00190580|KVT|kvt
5362746|NCT00190554|esophageal cancer|esophageal cancer
5362747|NCT00190554|squamous cell carcinoma|squamous cell carcinoma
5362748|NCT00190554|esophagectomy|esophagectomy
5362749|NCT00190554|neoadjuvant chemotherapy|neoadjuvant chemotherapy
5362750|NCT00190554|esophageal squamous cell carcinoma|esophageal squamous cell carcinoma
5362751|NCT00190541|Rectal Cancer|rectal cancer
5362752|NCT00190541|Lymph Node Dissection|lymph node dissection
5362753|NCT00190541|Rectal Surgery|rectal surgery
5362754|NCT00190541|Autonomic Nerves|autonomic nerves
5362755|NCT00190541|Stage II, III lower rectal cancer|stage ii, iii lower rectal cancer
5362756|NCT00190528|cervical cancer|cervical cancer
5362757|NCT00190528|drug therapy|drug therapy
5362758|NCT00190528|cisplatin|cisplatin
5362759|NCT00190528|bleomycin|bleomycin
5362760|NCT00190528|mitomycin|mitomycin
5362761|NCT00190528|vincristine|vincristine
5362762|NCT00190515|adjuvant chemotherapy|adjuvant chemotherapy
5362763|NCT00190515|Stage III colorectal cancer|stage iii colorectal cancer
5362764|NCT00190515|5-FU+l-LV|5-fu+l-lv
5362765|NCT00190515|UFT+LV|uft+lv
5362766|NCT00190515|randomized controlled trial|randomized controlled trial
5362767|NCT00190502|Type 1 diabetes mellitus|type 1 diabetes mellitus
5362768|NCT00190502|Immune intervention|immune intervention
5362769|NCT00190502|Polyclonal antibodies|polyclonal antibodies
5362770|NCT00190502|Type 1 diabetes of recent onset|type 1 diabetes of recent onset
5362771|NCT00190502|C-peptide level 0.3 pmol/l or higher|c-peptide level 0.3 pmol/l or higher
5362772|NCT00190502|Positivity of at least one marker of autoimmunity (diabetes)|positivity of at least one marker of autoimmunity (diabetes)
5362773|NCT00190489|metastatic breast cancer|metastatic breast cancer
5362774|NCT00190489|drug therapy|drug therapy
5362775|NCT00190489|doxorubicin|doxorubicin
5362776|NCT00190489|docetaxel|docetaxel
5362777|NCT00190476|Elderly|elderly
5362778|NCT00190476|advanced|advanced
5362779|NCT00190476|non-small-cell lung cancer|non-small-cell lung cancer
5362780|NCT00190476|cisplatin|cisplatin
5362781|NCT00190476|docetaxel|docetaxel
5362782|NCT00190476|weekly|weekly
5362783|NCT00190476|combination|combination
5362784|NCT00190476|chemotherapy|chemotherapy
5362785|NCT00190476|randomized trial|randomized trial
5362786|NCT00190463|aspergillosis|aspergillosis
5362787|NCT00190463|antifungal therapy|antifungal therapy
5362788|NCT00190463|empirical antifungal treatment|empirical antifungal treatment
5362789|NCT00190450|Huntington|huntington
5362790|NCT00190450|graft|graft
5362791|NCT00190450|cellular therapy|cellular therapy
5362792|NCT00190450|striatum|striatum
5362793|NCT00190437|Chronic Obstructive Lung Disease (COLD)|chronic obstructive lung disease (cold)
5362794|NCT00190437|Randomized Clinical Trial|randomized clinical trial
5362795|NCT00190437|Antibiotics|antibiotics
5362796|NCT00190437|Acute Exacerbation|acute exacerbation
5362797|NCT00190437|Mechanical|mechanical
5362798|NCT00190437|Ventilation|ventilation
5362799|NCT00190437|Intensive Care|intensive care
5362800|NCT00190437|Length of Stay|length of stay
5362801|NCT00190437|Mortality|mortality
5362802|NCT00190424|Glioblastoma|glioblastoma
5362803|NCT00190424|Immunotherapy|immunotherapy
5362804|NCT00190411|Arteries|arteries
5362805|NCT00190411|ultrasonography|ultrasonography
5362806|NCT00190411|Ehlers Danlos syndrome|ehlers danlos syndrome
5362807|NCT00190411|Cardiovascular disease|cardiovascular disease
5362808|NCT00190411|beta adrenergic antagonists|beta adrenergic antagonists
5362809|NCT00190398|Prospective|prospective
5362810|NCT00190398|Randomised|randomised
5362811|NCT00190398|Open|open
5362812|NCT00190398|Blinded End-point|blinded end-point
5362813|NCT00190398|PROBE Study|probe study
5362814|NCT00190398|Ischemic stroke|ischemic stroke
5362815|NCT00190385|Cirrhosis|cirrhosis
5362816|NCT00190385|Hepatocellular carcinoma|hepatocellular carcinoma
5362817|NCT00190385|Screening|screening
5362818|NCT00190385|Randomized|randomized
5362819|NCT00190385|HBV|hbv
5362820|NCT00190385|HCV|hcv
5362821|NCT00190385|alcohol|alcohol
5362822|NCT00190385|hemochromatosis|hemochromatosis
5362823|NCT00190372|Alzheimer's disease training programme|alzheimer's disease training programme
5362824|NCT00190372|educational programme caregivers carers dementia treatment|educational programme caregivers carers dementia treatment
5362825|NCT00190372|Dementia Cognitive disorder|dementia cognitive disorder
5362826|NCT00190359|heart failure|heart failure
5362827|NCT00190359|hormones|hormones
5362828|NCT00190359|growth substances|growth substances
5362829|NCT00190346|Acute respiratory distress|acute respiratory distress
5362830|NCT00190346|with hypercapnia|with hypercapnia
5362831|NCT00190346|with hypoxemia|with hypoxemia
5362832|NCT00190346|requiring NIV|requiring niv
5362833|NCT00190333|pulmonary hypertension|pulmonary hypertension
5362834|NCT00190333|6 minutes walking test|6 minutes walking test
5362835|NCT00190333|serotonin|serotonin
5362836|NCT00190333|primary or associated pulmonary hypertension|primary or associated pulmonary hypertension
5362837|NCT00190320|Fetal macrosomia|fetal macrosomia
5362838|NCT00190320|Neonatal traumatism|neonatal traumatism
5362839|NCT00190320|Maternal morbidity|maternal morbidity
5362840|NCT00190307|Long term antiplatelet therapy|long term antiplatelet therapy
5362841|NCT00190307|Scheduled surgery|scheduled surgery
5362842|NCT00190294|Pregnancy Complications|pregnancy complications
5362843|NCT00190281|FUNCTIONAL STUDY|functional study
5362844|NCT00190281|CONTRAST-ENHANCED US|contrast-enhanced us
5362845|NCT00190281|PERFUSION|perfusion
5362846|NCT00190268|multiple sclerosis|multiple sclerosis
5362847|NCT00190268|fatigue|fatigue
5362848|NCT00190268|3,4-diaminopyridine|3,4-diaminopyridine
5362849|NCT00190255|gastrointestinal haemorrhage|gastrointestinal haemorrhage
5362850|NCT00190255|stomach ulcer|stomach ulcer
5362851|NCT00190255|anti-inflammatory agents, non-steroidal|anti-inflammatory agents, non-steroidal
5362852|NCT00190255|CYP2C9 protein, human|cyp2c9 protein, human
5362853|NCT00190255|genotype|genotype
5362854|NCT00190255|pharmacogenetics|pharmacogenetics
5362855|NCT00190242|HIV|hiv
5362856|NCT00190242|hepatitis A|hepatitis a
5362857|NCT00190242|vaccine|vaccine
5362858|NCT00190242|HBV and/or HCV co-infection|hbv and/or hcv co-infection
5362859|NCT00190229|Vasculitis|vasculitis
5362860|NCT00190229|Cyclophosphamide|cyclophosphamide
5362861|NCT00190229|Renal failure|renal failure
5362862|NCT00190216|Resistant depression|resistant depression
5362863|NCT00190216|Transcranial Magnetic Stimulation,|transcranial magnetic stimulation,
5362864|NCT00190216|Neuroimaging|neuroimaging
5362865|NCT00190203|Malignant middle cerebral artery infarction|malignant middle cerebral artery infarction
5362866|NCT00190203|Decompressive surgery|decompressive surgery
5362867|NCT00190203|Hemicraniectomy|hemicraniectomy
5362868|NCT00190203|Brain edema|brain edema
5362869|NCT00190190|Macular hole|macular hole
5362870|NCT00190190|internal limiting membrane|internal limiting membrane
5362871|NCT00190190|retina|retina
5362872|NCT00190190|surgery|surgery
5362873|NCT00190164|Macular hole|macular hole
5362874|NCT00190164|Vitrectomy|vitrectomy
5362875|NCT00190164|positioning|positioning
5362876|NCT00190164|retina|retina
5362877|NCT00190164|surgery|surgery
5362878|NCT00190151|ciprofloxacin|ciprofloxacin
5362879|NCT00190151|commensal flora|commensal flora
5362880|NCT00190151|resistance|resistance
5362881|NCT00190151|Pharmacokinetic|pharmacokinetic
5362882|NCT00190138|Bi-ventricular pacing|bi-ventricular pacing
5362883|NCT00190138|ventricular resynchronization|ventricular resynchronization
5362884|NCT00190138|baroreflex sensitivity|baroreflex sensitivity
5362885|NCT00190138|heart rate variability|heart rate variability
5362886|NCT00190125|Hemodialysis|hemodialysis
5362887|NCT00190125|Malnutrition|malnutrition
5362888|NCT00190125|Inflammation|inflammation
5362889|NCT00190099|In-stent restenosis,|in-stent restenosis,
5362890|NCT00190099|Drug eluting stent,|drug eluting stent,
5362891|NCT00190099|dexamethasone,|dexamethasone,
5362892|NCT00190099|Acute coronary syndrome|acute coronary syndrome
5362893|NCT00190073|Epidermal nerves;protein gene product 9.5; ethanol|epidermal nerves;protein gene product 9.5; ethanol
5362894|NCT00190060|Frailty|frailty
5362895|NCT00190060|Muscle strength|muscle strength
5362896|NCT00190060|Physical performance|physical performance
5362897|NCT00190060|Bone mineral density|bone mineral density
5362898|NCT00190060|Quality of life|quality of life
5362899|NCT00190047|Cerebral Ischemia|cerebral ischemia
5362900|NCT00190047|Ischemic Brain Injury|ischemic brain injury
5362901|NCT00190047|Brain Infarction|brain infarction
5362902|NCT00190047|Brain Ischemia|brain ischemia
5362903|NCT00190034|Acetylcysteine|acetylcysteine
5362904|NCT00190034|cardiac surgery|cardiac surgery
5362905|NCT00190034|cardiopulmonary bypass|cardiopulmonary bypass
5362906|NCT00190034|acute renal insufficiency|acute renal insufficiency
5362907|NCT00190021|Alzheimer's type dementia|alzheimer's type dementia
5362908|NCT00190021|donepezil|donepezil
5362909|NCT00190021|double-blind|double-blind
5362910|NCT00190008|tardive dyskinesia|tardive dyskinesia
5362911|NCT00190008|piracetam|piracetam
5362912|NCT00189995|schizophrenia|schizophrenia
5362913|NCT00189995|aggression|aggression
5362914|NCT00189995|clozapine|clozapine
5362915|NCT00189995|efficacy|efficacy
5362916|NCT00189995|double-blind|double-blind
5362917|NCT00189982|Factor VIII Deficiency|factor viii deficiency
5362918|NCT00189930|Treatment Experienced|treatment experienced
5362919|NCT00189904|HIV|hiv
5362920|NCT00189878|chronic idiopathic urticaria|chronic idiopathic urticaria
5362921|NCT00189878|methotrexate|methotrexate
5362922|NCT00189852|Telecare|telecare
5362923|NCT00189852|chronic|chronic
5362924|NCT00189852|older people|older people
5362925|NCT00189852|heart failure|heart failure
5362926|NCT00189839|Tacrolimus|tacrolimus
5362927|NCT00189839|Kidney transplantation|kidney transplantation
5362928|NCT00189839|Transplantation, kidney|transplantation, kidney
5362929|NCT00189839|Renal Transplantation|renal transplantation
5362930|NCT00189839|Transplantation, renal|transplantation, renal
5362931|NCT00189826|Tacrolimus|tacrolimus
5362932|NCT00189826|Liver transplantation|liver transplantation
5362933|NCT00189813|Irritable Bowel Syndrome|irritable bowel syndrome
5362934|NCT00189813|Diarrhea|diarrhea
5362935|NCT00189813|Nasea®|nasea®
5362936|NCT00189813|Irribow®|irribow®
5362937|NCT00189813|ramosetron|ramosetron
5362938|NCT00189800|Solifenacin|solifenacin
5362939|NCT00189800|tolterodine|tolterodine
5362940|NCT00189800|randomized controlled trial|randomized controlled trial
5362941|NCT00189800|double-blind method|double-blind method
5362942|NCT00189787|Tacrolimus|tacrolimus
5362943|NCT00189787|Immunosuppressant|immunosuppressant
5362944|NCT00189787|Anti-asthmatic drug|anti-asthmatic drug
5362945|NCT00189787|Administration, inhalation|administration, inhalation
5362946|NCT00189774|nateglinide|nateglinide
5362947|NCT00189774|pioglitazone|pioglitazone
5362948|NCT00189774|combination drug therapy|combination drug therapy
5362949|NCT00189774|treatment|treatment
5362950|NCT00189761|Tacrolimus|tacrolimus
5362951|NCT00189761|Immunosuppression|immunosuppression
5362952|NCT00189761|Bone Marrow Transplantation|bone marrow transplantation
5362953|NCT00189761|Graft versus Host Disease|graft versus host disease
5362954|NCT00189748|Tacrolimus|tacrolimus
5362955|NCT00189748|Immunosuppression|immunosuppression
5362956|NCT00189748|Bone Marrow Transplantation|bone marrow transplantation
5362957|NCT00189748|Graft versus Host Disease|graft versus host disease
5362958|NCT00189735|Treatment Efficacy|treatment efficacy
5362959|NCT00189735|Treatment Effectiveness|treatment effectiveness
5362960|NCT00189735|Anti-rejection therapy|anti-rejection therapy
5362961|NCT00189735|Immunosuppression|immunosuppression
5362962|NCT00189735|Antirejection|antirejection
5362963|NCT00189735|Malononitrilamide|malononitrilamide
5362964|NCT00189722|Tacrolimus|tacrolimus
5362965|NCT00189722|Immunosuppressant|immunosuppressant
5362966|NCT00189722|Anti-asthmatic drug|anti-asthmatic drug
5362967|NCT00189722|Administration, inhalation|administration, inhalation
5362968|NCT00189709|micafungin|micafungin
5362969|NCT00189709|fluconazole|fluconazole
5362970|NCT00189709|invasive candidiasis|invasive candidiasis
5362971|NCT00189709|candidemia|candidemia
5362972|NCT00189696|Irritable Bowel Syndrome, Diarrhea|irritable bowel syndrome, diarrhea
5362973|NCT00189618|Peripheral vascular disease|peripheral vascular disease
5362974|NCT00189618|Peripheral arterial disease|peripheral arterial disease
5362975|NCT00189618|Walking Capacity|walking capacity
5362976|NCT00189618|Aspirin|aspirin
5362977|NCT00189618|Clopidogrel|clopidogrel
5362978|NCT00189605|Plasma disc decompression|plasma disc decompression
5362979|NCT00189605|Intradiscal Pressure|intradiscal pressure
5362980|NCT00189605|Steroid Injection|steroid injection
5362981|NCT00189605|Epidural Steroid Injection|epidural steroid injection
5362982|NCT00189605|Selective Nerve Root Injection|selective nerve root injection
5362983|NCT00189605|Leg Pain|leg pain
5362984|NCT00189605|Radicular Pain|radicular pain
5362985|NCT00189605|Coblation|coblation
5362986|NCT00189605|SNRI|snri
5362987|NCT00189592|plantar fascia|plantar fascia
5362988|NCT00189592|plantar fasciitis|plantar fasciitis
5362989|NCT00189592|Coblation|coblation
5362990|NCT00189592|fasciotomy|fasciotomy
5362991|NCT00189592|conventional surgical fasciotomy|conventional surgical fasciotomy
5362992|NCT00189592|heel spur|heel spur
5362993|NCT00189592|heel pain|heel pain
5362994|NCT00189592|aponeurosis|aponeurosis
5362995|NCT00189592|plasma based radiofrequency|plasma based radiofrequency
5362996|NCT00189592|angiogenesis|angiogenesis
5362997|NCT00189579|HERCEPTIN|herceptin
5362998|NCT00189579|Carboplatin|carboplatin
5362999|NCT00189579|Paclitaxel|paclitaxel
5363000|NCT00189579|Relapse|relapse
5363001|NCT00189566|Relapse within 6 months|relapse within 6 months
5363002|NCT00189566|Previously received taxane derivative|previously received taxane derivative
5363003|NCT00189553|Extra-ovarian papillary serous tumors|extra-ovarian papillary serous tumors
5363004|NCT00189553|Relapse over 6 months|relapse over 6 months
5363005|NCT00189553|Previously received taxane derivative|previously received taxane derivative
5363006|NCT00189540|Ischemic ulcers|ischemic ulcers
5363007|NCT00189540|Critical Limb Ischemia|critical limb ischemia
5363008|NCT00189514|obesity|obesity
5363009|NCT00189514|weight loss|weight loss
5363010|NCT00189514|Amylin|amylin
5363011|NCT00189514|pramlintide|pramlintide
5363012|NCT00189501|Chronic Kidney Disease, CKD,|chronic kidney disease, ckd,
5363013|NCT00189501|Secondary Hyperparathyroidism, HPT|secondary hyperparathyroidism, hpt
5363014|NCT00189488|Hematological Malignancies|hematological malignancies
5363015|NCT00189488|Graft-versus-host-disease|graft-versus-host-disease
5363016|NCT00189488|Oral Mucositis|oral mucositis
5363017|NCT00189488|Allogeneic Transplantation|allogeneic transplantation
5363018|NCT00189475|Cold|cold
5363019|NCT00189475|Upper Respiratory Infection|upper respiratory infection
5363020|NCT00189462|Ear Infections|ear infections
5363021|NCT00189462|Otitis Media|otitis media
5363022|NCT00189449|Allergic Rhinitis|allergic rhinitis
5363023|NCT00189449|Allergy|allergy
5363024|NCT00189449|Growth|growth
5363025|NCT00189436|Asthma|asthma
5363026|NCT00189423|Heart Arrest|heart arrest
5363027|NCT00189423|Cardiac Arrest|cardiac arrest
5363028|NCT00189423|Cardiopulmonary Resuscitation|cardiopulmonary resuscitation
5363029|NCT00189423|Impedance Threshold Device|impedance threshold device
5363030|NCT00189423|Active Compression Decompression|active compression decompression
5363031|NCT00189423|ResQPOD|resqpod
5363032|NCT00189423|ResQPump|resqpump
5363033|NCT00189423|Survival|survival
5363034|NCT00189423|Out-of-hospital|out-of-hospital
5363035|NCT00189423|Prehospital|prehospital
5363036|NCT00189423|ResQCPR System|resqcpr system
5363037|NCT00189397|Parthenium dermatitis|parthenium dermatitis
5363038|NCT00189384|Neonatal sepsis|neonatal sepsis
5363039|NCT00189384|Neonatal pneumonia|neonatal pneumonia
5363040|NCT00189384|Bacterial infections|bacterial infections
5363041|NCT00189384|Young infants|young infants
5363042|NCT00189384|Neonate|neonate
5363043|NCT00189384|Community|community
5363044|NCT00189384|Developing country|developing country
5363045|NCT00189358|cancer|cancer
5363046|NCT00189358|cancer alternative therapies|cancer alternative therapies
5363047|NCT00189358|ovarian cancer|ovarian cancer
5363048|NCT00189358|tyrosine kinase inhibitor|tyrosine kinase inhibitor
5363049|NCT00189345|Cancer|cancer
5363050|NCT00189345|Cancer alternative therapies|cancer alternative therapies
5363051|NCT00189345|ovarian cancer|ovarian cancer
5363052|NCT00189332|Oncology|oncology
5363053|NCT00189332|Melanoma|melanoma
5363054|NCT00189319|Tambocor|tambocor
5363055|NCT00189319|Paroxysmal Atrial Fibrillation|paroxysmal atrial fibrillation
5363056|NCT00189319|Quality of Life|quality of life
5363057|NCT00189306|Superficial Basal Cell Carcinoma|superficial basal cell carcinoma
5363058|NCT00189306|Aldara|aldara
5363059|NCT00189293|External Ano-Genital Warts|external ano-genital warts
5363060|NCT00189293|Ablative Therapy|ablative therapy
5363061|NCT00189293|Aldara|aldara
5363062|NCT00189280|Aldara, sBCC|aldara, sbcc
5363063|NCT00189267|Aldara|aldara
5363064|NCT00189267|Actinic Keratosis|actinic keratosis
5363065|NCT00189267|Graft Recipients|graft recipients
5363066|NCT00189254|1 year follow up|1 year follow up
5363067|NCT00189241|Aldara|aldara
5363068|NCT00189241|Superficial Basal Cell Carcinoma|superficial basal cell carcinoma
5363069|NCT00189241|Long-Term Study|long-term study
5363070|NCT00189215|coronary artery disease|coronary artery disease
5363071|NCT00189215|cardiopulmonary bypass|cardiopulmonary bypass
5363072|NCT00189215|cognition disorders|cognition disorders
5363073|NCT00189189|prevention|prevention
5363074|NCT00189189|oppositional defiant disorder|oppositional defiant disorder
5363075|NCT00189189|conduct disorder|conduct disorder
5363076|NCT00189163|Hepatitis C|hepatitis c
5363077|NCT00189163|Genotype 1|genotype 1
5363078|NCT00189163|Insulin Resistance|insulin resistance
5363079|NCT00189163|Pioglitazone|pioglitazone
5363080|NCT00189150|Valganciclovir|valganciclovir
5363081|NCT00189150|Mycophenolate Mofetil|mycophenolate mofetil
5363082|NCT00189150|Pharmacokinetic|pharmacokinetic
5363083|NCT00189150|Interaction|interaction
5363084|NCT00189150|MPA|mpa
5363085|NCT00189124|Systemic Lupus Erythematosus|systemic lupus erythematosus
5363086|NCT00189124|Dehydroepiandrosterone (DHEA)|dehydroepiandrosterone (dhea)
5363087|NCT00189124|DHEA|dhea
5363088|NCT00189124|SLE|sle
5363089|NCT00189124|Lupus|lupus
5363090|NCT00189111|peripheral arterial disease|peripheral arterial disease
5363091|NCT00189111|computed tomography|computed tomography
5363092|NCT00189111|cardiac asymptomatic|cardiac asymptomatic
5363093|NCT00189111|dobutamine magnetic resonance imaging|dobutamine magnetic resonance imaging
5363094|NCT00189085|Metabolic syndrome|metabolic syndrome
5363095|NCT00189072|gabapentin|gabapentin
5363096|NCT00189072|neuropathic pain|neuropathic pain
5363097|NCT00189072|driving|driving
5363098|NCT00189072|attention|attention
5363099|NCT00189059|neuropathic pain|neuropathic pain
5363100|NCT00189059|erp|erp
5363101|NCT00189059|driving|driving
5363102|NCT00189059|attention|attention
5363103|NCT00189059|amitriptyline|amitriptyline
5363104|NCT00189046|driving, chronic pain, attention|driving, chronic pain, attention
5363105|NCT00189033|Irritable Bowel Syndrome|irritable bowel syndrome
5363106|NCT00189033|Diet Therapy|diet therapy
5363107|NCT00189033|Dietary Fiber|dietary fiber
5363108|NCT00189033|Randomized Controlled Trial|randomized controlled trial
5363109|NCT00189033|Family Practice|family practice
5363110|NCT00189020|pneumococcal conjugate vaccination|pneumococcal conjugate vaccination
5363111|NCT00189020|nasopharyngeal carriage|nasopharyngeal carriage
5363112|NCT00189020|herd immunity|herd immunity
5363113|NCT00189020|antipneumococcal antibodies|antipneumococcal antibodies
5363114|NCT00189020|respiratory tract infections|respiratory tract infections
5363115|NCT00189020|National infant vaccination program|national infant vaccination program
5363116|NCT00189007|allopurinol|allopurinol
5363117|NCT00189007|neuroprotection|neuroprotection
5363118|NCT00189007|reperfusion injury|reperfusion injury
5363119|NCT00189007|fetal hypoxia|fetal hypoxia
5363120|NCT00189007|post hypoxic-ischemic reperfusion damage|post hypoxic-ischemic reperfusion damage
5363121|NCT00188994|Myocardial Protection|myocardial protection
5363122|NCT00188994|Myocardial Metabolism|myocardial metabolism
5363123|NCT00188994|Ventricular Function|ventricular function
5363124|NCT00188994|Cardiovascular Disease|cardiovascular disease
5363125|NCT00188994|Cardioplegic Additives|cardioplegic additives
5363126|NCT00188981|psychosis|psychosis
5363127|NCT00188981|high risk|high risk
5363128|NCT00188981|prodrome|prodrome
5363129|NCT00188981|Multiple Complex Developmental Disorder|multiple complex developmental disorder
5363130|NCT00188968|Xanthines|xanthines
5363131|NCT00188968|Reintubation|reintubation
5363132|NCT00188968|Nasal Intermittent Ventilation|nasal intermittent ventilation
5363133|NCT00188968|Nasal continous positive airway pressure|nasal continous positive airway pressure
5363134|NCT00188955|pediatric|pediatric
5363135|NCT00188955|chronic allograft nephropathy|chronic allograft nephropathy
5363136|NCT00188955|chronic rejection|chronic rejection
5363137|NCT00188955|interstitial fibrosis|interstitial fibrosis
5363138|NCT00188942|Magnetic Resonance Imaging|magnetic resonance imaging
5363139|NCT00188942|Diagnostic Imaging|diagnostic imaging
5363140|NCT00188942|Mood Disorders|mood disorders
5363141|NCT00188942|Major Depressive Disorder|major depressive disorder
5363142|NCT00188942|Antipsychotic|antipsychotic
5363143|NCT00188942|Olanzapine|olanzapine
5363144|NCT00188942|Fluoxetine|fluoxetine
5363145|NCT00188916|Bronchial blockers|bronchial blockers
5363146|NCT00188916|Lung isolation|lung isolation
5363147|NCT00188916|Thoracic Anesthesia|thoracic anesthesia
5363148|NCT00188903|Cardiac Surgery|cardiac surgery
5363149|NCT00188903|Diastolic Dysfunction|diastolic dysfunction
5363150|NCT00188903|Atrial Fibrillation|atrial fibrillation
5363151|NCT00188890|Lung Cancer|lung cancer
5363152|NCT00188890|Mesothelioma|mesothelioma
5363153|NCT00188890|Asbestos|asbestos
5363154|NCT00188890|Screening|screening
5363155|NCT00188890|Early Diagnosis|early diagnosis
5363156|NCT00188851|HIV|hiv
5363157|NCT00188851|salvage regimen|salvage regimen
5363158|NCT00188851|virologic failure|virologic failure
5363159|NCT00188851|treatment interruption|treatment interruption
5363160|NCT00188851|ARV experienced|arv experienced
5363161|NCT00188838|Bipolar Disorder|bipolar disorder
5363162|NCT00188838|Psychosocial Factors|psychosocial factors
5363163|NCT00188838|Mania|mania
5363164|NCT00188838|Depression|depression
5363165|NCT00188838|Social Adjustment|social adjustment
5363166|NCT00188838|Coping Skills|coping skills
5363167|NCT00188825|Lung|lung
5363168|NCT00188825|Transplant|transplant
5363169|NCT00188825|Rejection|rejection
5363170|NCT00188825|BOS|bos
5363171|NCT00188812|dementia|dementia
5363172|NCT00188812|stroke|stroke
5363173|NCT00188773|n-acetylcysteine,|n-acetylcysteine,
5363174|NCT00188773|free fatty acid,|free fatty acid,
5363175|NCT00188773|glucose stimulated insulin secretion,|glucose stimulated insulin secretion,
5363176|NCT00188773|insulin resistance syndrome|insulin resistance syndrome
5363177|NCT00188773|antioxidant therapy|antioxidant therapy
5363178|NCT00188773|Insulin Resistance|insulin resistance
5363179|NCT00188760|Breast Transillumination Spectroscopy|breast transillumination spectroscopy
5363180|NCT00188760|Optical Transillumination Spectroscopy|optical transillumination spectroscopy
5363181|NCT00188760|Breast Cancer Risk|breast cancer risk
5363182|NCT00188747|Coagulopathy|coagulopathy
5363183|NCT00188747|Cardiac Surgery|cardiac surgery
5363184|NCT00188747|Point of Care|point of care
5363185|NCT00188747|Monitoring|monitoring
5363186|NCT00188734|Lung Cancer|lung cancer
5363187|NCT00188734|Eary Diagnosis|eary diagnosis
5363188|NCT00188734|Screening|screening
5363189|NCT00188721|Breast Cancer Risk|breast cancer risk
5363190|NCT00188721|Optical Transillumination Spectroscopy|optical transillumination spectroscopy
5363191|NCT00188721|Transillumination Breast Spectroscopy|transillumination breast spectroscopy
5363192|NCT00188682|Optical Transillumination Spectroscopy|optical transillumination spectroscopy
5363193|NCT00188682|Transillumination Breast Spectroscopy|transillumination breast spectroscopy
5363194|NCT00188682|Breast Cancer Risk|breast cancer risk
5363195|NCT00188643|Bipolar Disorder, Depression, Anticonvulsants, Antidepressants|bipolar disorder, depression, anticonvulsants, antidepressants
5363196|NCT00188630|Cardiac Surgery|cardiac surgery
5363197|NCT00188630|Acute Renal Failure|acute renal failure
5363198|NCT00188630|N-acetylcysteine|n-acetylcysteine
5363199|NCT00188630|Cardiopulmonary bypass|cardiopulmonary bypass
5363200|NCT00188617|LUNG CANCER|lung cancer
5363201|NCT00188617|IRESSA|iressa
5363202|NCT00188617|GEFITINIB|gefitinib
5363203|NCT00188617|STAGE 1A & 1B|stage 1a & 1b
5363204|NCT00188617|NEOADJUVANT|neoadjuvant
5363205|NCT00188617|PHASE 2|phase 2
5363206|NCT00188591|Optical Transillumination Spectroscopy|optical transillumination spectroscopy
5363207|NCT00188591|Breast Cancer Risk|breast cancer risk
5363208|NCT00188500|epilepsy|epilepsy
5363209|NCT00188500|atkins diet|atkins diet
5363210|NCT00188396|Major Depressive Disorder|major depressive disorder
5363211|NCT00188396|Women's Mental Health|women's mental health
5363212|NCT00188396|Hormones|hormones
5363213|NCT00188396|Citalopram|citalopram
5363214|NCT00188396|Antidepressive agents|antidepressive agents
5363215|NCT00188396|Mental Health|mental health
5363216|NCT00188383|Hyperalgesia|hyperalgesia
5363217|NCT00188383|Quantitative Sensory Testing|quantitative sensory testing
5363218|NCT00188383|Pain|pain
5363219|NCT00188383|Opioid use|opioid use
5363220|NCT00188383|Elderly|elderly
5363221|NCT00188344|laparoscopic myotomy|laparoscopic myotomy
5363222|NCT00188344|pneumatic dilatation|pneumatic dilatation
5363223|NCT00188344|motility disorder|motility disorder
5363224|NCT00188344|dysphasia|dysphasia
5363225|NCT00188344|health-related quality of life|health-related quality of life
5363226|NCT00188331|cognitive function|cognitive function
5363227|NCT00188331|fatigue|fatigue
5363228|NCT00188331|colorectal cancer|colorectal cancer
5363229|NCT00188331|chemotherapy|chemotherapy
5363230|NCT00188331|cognitive impairment|cognitive impairment
5363231|NCT00188305|Risk counselling|risk counselling
5363232|NCT00188305|Health education|health education
5363233|NCT00188305|Prevention|prevention
5363234|NCT00188305|Behavioral|behavioral
5363235|NCT00188305|Screening|screening
5363236|NCT00188305|Intervention|intervention
5363237|NCT00188305|Telephone vs in person|telephone vs in person
5363238|NCT00188292|Human Papillomavirus|human papillomavirus
5363239|NCT00188292|Anal|anal
5363240|NCT00188292|Cancer screening|cancer screening
5363241|NCT00188292|Immunodeficiency|immunodeficiency
5363242|NCT00188292|HIV|hiv
5363243|NCT00188279|ct|ct
5363244|NCT00188279|scan|scan
5363245|NCT00188279|lung|lung
5363246|NCT00188279|follow-up|follow-up
5363247|NCT00188253|Nasopharyngeal carcinoma|nasopharyngeal carcinoma
5363248|NCT00188253|PET scan|pet scan
5363249|NCT00188253|MRI|mri
5363250|NCT00188253|EBV virus|ebv virus
5363251|NCT00188240|hepatitis C|hepatitis c
5363252|NCT00188240|insulin resistance|insulin resistance
5363253|NCT00188240|antiviral therapy|antiviral therapy
5363254|NCT00188227|Bone marrow puncture|bone marrow puncture
5363255|NCT00188227|Pain|pain
5363256|NCT00188214|perfusion|perfusion
5363257|NCT00188214|CT|ct
5363258|NCT00188214|CAT|cat
5363259|NCT00188214|non-small|non-small
5363260|NCT00188214|lung|lung
5363261|NCT00188201|Hepatitis C|hepatitis c
5363262|NCT00188201|neucognitive functions|neucognitive functions
5363263|NCT00188201|neuropsychological testing|neuropsychological testing
5363264|NCT00188201|antiviral treatment|antiviral treatment
5363265|NCT00188188|Endothelial|endothelial
5363266|NCT00188188|Dysfunction|dysfunction
5363267|NCT00188188|Systemic|systemic
5363268|NCT00188188|Lupus|lupus
5363269|NCT00188149|Hodgkin's Lymphoma|hodgkin's lymphoma
5363270|NCT00188149|Chemotherapy|chemotherapy
5363271|NCT00188149|Radiation therapy|radiation therapy
5363272|NCT00188149|PET|pet
5363273|NCT00188136|AML, allogeneic transplantation, high-risk, karyotype|aml, allogeneic transplantation, high-risk, karyotype
5363274|NCT00188123|Myocardial infarction|myocardial infarction
5363275|NCT00188123|MRI late enhancement|mri late enhancement
5363276|NCT00188123|Atrial fibrillation|atrial fibrillation
5363277|NCT00188110|Water-Enema Computed Tomography|water-enema computed tomography
5363278|NCT00188110|colon tumor|colon tumor
5363279|NCT00188110|coloscopy|coloscopy
5363280|NCT00188110|suspicion of colon tumor|suspicion of colon tumor
5363281|NCT00188110|coloscopy or surgery|coloscopy or surgery
5363282|NCT00188071|medical abortion|medical abortion
5363283|NCT00188071|analgesia|analgesia
5363284|NCT00188058|Acute respiratory distress syndrome|acute respiratory distress syndrome
5363285|NCT00188058|Positive end-expiratory pressure|positive end-expiratory pressure
5363286|NCT00188058|Acute lung injury|acute lung injury
5363287|NCT00188058|Mechanical ventilation|mechanical ventilation
5363288|NCT00188058|Randomized controlled trial|randomized controlled trial
5363289|NCT00188045|Portal hypertension, alcoholic cirrhosis, Hepatic venous pressure gradient, hemodynamic, spironolactone, propranolol|portal hypertension, alcoholic cirrhosis, hepatic venous pressure gradient, hemodynamic, spironolactone, propranolol
5363290|NCT00188032|pulmonary embolism|pulmonary embolism
5363291|NCT00188032|clinical practice|clinical practice
5363292|NCT00188032|quality of health care|quality of health care
5363293|NCT00188032|diagnostic criteria|diagnostic criteria
5363294|NCT00188032|Computer-Assisted Decision Support|computer-assisted decision support
5363295|NCT00188032|reminders|reminders
5363296|NCT00188006|cardiopulmonary bypass, inflammatory response|cardiopulmonary bypass, inflammatory response
5363297|NCT00188006|neurologic injury|neurologic injury
5363298|NCT00188006|neurocognitive deficit|neurocognitive deficit
5363299|NCT00188006|biomaterials|biomaterials
5363300|NCT00188006|coronary artery bypass surgery|coronary artery bypass surgery
5363301|NCT00187993|growth hormone deficiency|growth hormone deficiency
5363302|NCT00187993|growth hormone|growth hormone
5363303|NCT00187993|energy expenditure|energy expenditure
5363304|NCT00187993|body composition|body composition
5363305|NCT00187954|women|women
5363306|NCT00187954|chest pain|chest pain
5363307|NCT00187954|microvascular dysfunction|microvascular dysfunction
5363308|NCT00187954|retinal photography|retinal photography
5363309|NCT00187954|Retinal vascular function|retinal vascular function
5363310|NCT00187941|transplant|transplant
5363311|NCT00187941|renal|renal
5363312|NCT00187941|Cellcept|cellcept
5363313|NCT00187941|therapeutic drug level|therapeutic drug level
5363315|NCT00187941|MPA|mpa
5363316|NCT00187941|immunosuppression|immunosuppression
5363317|NCT00187928|Obsessive-Compulsive Disorder|obsessive-compulsive disorder
5363318|NCT00187928|Obsessions|obsessions
5363319|NCT00187928|Compulsions|compulsions
5363320|NCT00187928|Adjunctive treatment|adjunctive treatment
5363321|NCT00187915|Renal transplant|renal transplant
5363322|NCT00187915|Cellcept|cellcept
5363323|NCT00187915|Therapeutic drug level|therapeutic drug level
5363324|NCT00187915|Mycophenolate mofetil (MMF)|mycophenolate mofetil (mmf)
5363325|NCT00187915|Mycophenolate Acid (MPA)|mycophenolate acid (mpa)
5363326|NCT00187915|Oral Bioavailability|oral bioavailability
5363327|NCT00187915|Immunosuppression|immunosuppression
5363328|NCT00187902|Sexually Transmitted Diseases|sexually transmitted diseases
5363329|NCT00187902|Chlamydia trachomatis|chlamydia trachomatis
5363330|NCT00187902|Neisseria gonorrhoeae|neisseria gonorrhoeae
5363331|NCT00187889|Microvascular Disease|microvascular disease
5363332|NCT00187889|Women|women
5363333|NCT00187889|Ischemic Heart Disease|ischemic heart disease
5363334|NCT00187889|WISE|wise
5363335|NCT00187850|Pulp capping|pulp capping
5363336|NCT00187850|partial pulpotomy|partial pulpotomy
5363337|NCT00187850|Exposure of the pulp|exposure of the pulp
5363338|NCT00187837|Stepwise excavation|stepwise excavation
5363339|NCT00187824|prospective|prospective
5363340|NCT00187824|observational|observational
5363341|NCT00187824|hormonal|hormonal
5363342|NCT00187824|inflammatory|inflammatory
5363343|NCT00187824|vioenergetic|vioenergetic
5363344|NCT00187824|immune|immune
5363345|NCT00187824|sepsis|sepsis
5363346|NCT00187811|Angioplasty,|angioplasty,
5363347|NCT00187811|Restenosis,|restenosis,
5363348|NCT00187811|Photodynamic therapy|photodynamic therapy
5363349|NCT00187798|Healthy Control Twins|healthy control twins
5363350|NCT00187785|Hispanic|hispanic
5363351|NCT00187785|communication|communication
5363352|NCT00187772|domestic violence|domestic violence
5363353|NCT00187772|preschoolers|preschoolers
5363354|NCT00187772|trauma|trauma
5363355|NCT00187772|intervention|intervention
5363356|NCT00187759|Abscess|abscess
5363357|NCT00187759|Antibitoics|antibitoics
5363358|NCT00187759|Methicillin-resistant Staphylococcus aureus|methicillin-resistant staphylococcus aureus
5363359|NCT00187746|Healthy Control|healthy control
5363360|NCT00187733|L-carnitine|l-carnitine
5363361|NCT00187720|Healthy Control|healthy control
5363362|NCT00187681|Healthy controls|healthy controls
5363363|NCT00187668|Healthy Cohort|healthy cohort
5363364|NCT00187655|Healthy volunteers willing to be dosed with cefotaxime|healthy volunteers willing to be dosed with cefotaxime
5363365|NCT00187616|adverse events|adverse events
5363366|NCT00187616|clinical trial methodology|clinical trial methodology
5363367|NCT00187603|tobacco|tobacco
5363368|NCT00187603|cessation|cessation
5363369|NCT00187603|smoking|smoking
5363370|NCT00187603|smoking cessation|smoking cessation
5363371|NCT00187590|HIV|hiv
5363372|NCT00187590|case management|case management
5363373|NCT00187577|Alopecia areata|alopecia areata
5363374|NCT00187577|Eyelash growth|eyelash growth
5363375|NCT00187577|Latanoprost|latanoprost
5363376|NCT00187577|Bimatoprost|bimatoprost
5363377|NCT00187564|Diabetes Mellitus, Type 1|diabetes mellitus, type 1
5363378|NCT00187564|lipoic acid|lipoic acid
5363379|NCT00187564|oxidative stress|oxidative stress
5363380|NCT00187551|enfuvirtide|enfuvirtide
5363381|NCT00187551|T20|t20
5363382|NCT00187551|Fuzeon|fuzeon
5363383|NCT00187551|Treatment|treatment
5363384|NCT00187551|Interruption|interruption
5363385|NCT00187551|Resistance|resistance
5363386|NCT00187551|HIV Drug Resistance|hiv drug resistance
5363387|NCT00187551|Antiretroviral Agents|antiretroviral agents
5363388|NCT00187551|Salvage Therapy|salvage therapy
5363389|NCT00187551|Drug Resistance, Multiple|drug resistance, multiple
5363390|NCT00187551|Human Immunodeficiency virus|human immunodeficiency virus
5363391|NCT00187512|HIV|hiv
5363392|NCT00187512|Antiretroviral Agents|antiretroviral agents
5363393|NCT00187512|Drug Resistance, Multiple|drug resistance, multiple
5363788|NCT00184444|hyperoxia|hyperoxia
5363394|NCT00187512|Long Term Non Progression|long term non progression
5363395|NCT00187512|Long Term Non Progressor|long term non progressor
5363396|NCT00187512|Elite Suppression|elite suppression
5363397|NCT00187512|Elite Suppressor|elite suppressor
5363398|NCT00187512|Natural History|natural history
5363399|NCT00187512|Observational|observational
5363400|NCT00187499|Asthma|asthma
5363401|NCT00187499|Corticosteroid|corticosteroid
5363402|NCT00187499|Gene expression|gene expression
5363403|NCT00187486|Glioblastoma Multiforme|glioblastoma multiforme
5363404|NCT00187486|Gliosarcoma|gliosarcoma
5363405|NCT00187486|GBM|gbm
5363406|NCT00187486|GS|gs
5363407|NCT00187486|Tarceva|tarceva
5363408|NCT00187486|Temodar|temodar
5363409|NCT00187486|Radiation|radiation
5363410|NCT00187486|Newly Diagnosed|newly diagnosed
5363411|NCT00187473|hepatitis C|hepatitis c
5363412|NCT00187473|HCV|hcv
5363413|NCT00187473|natural history|natural history
5363414|NCT00187460|Acute myocardial infarction|acute myocardial infarction
5363415|NCT00187460|Congestive heart failure|congestive heart failure
5363416|NCT00187460|Quality of care|quality of care
5363417|NCT00187460|Reperfusion|reperfusion
5363418|NCT00187460|Report cards|report cards
5363419|NCT00187460|Quality indicators|quality indicators
5363420|NCT00187447|prematurity|prematurity
5363421|NCT00187447|chronic lung disease|chronic lung disease
5363422|NCT00187447|necrotizing enterocolitis|necrotizing enterocolitis
5363423|NCT00187447|indomethacin|indomethacin
5363424|NCT00187447|ductus arteriosus|ductus arteriosus
5363425|NCT00187434|premature infant|premature infant
5363426|NCT00187434|supporting extubation|supporting extubation
5363427|NCT00187421|coronary disease|coronary disease
5363428|NCT00187421|angiography|angiography
5363429|NCT00187421|intraoperative care|intraoperative care
5363430|NCT00187421|vascular patency|vascular patency
5363431|NCT00187408|Thrombosis|thrombosis
5363432|NCT00187408|Pulmonary Embolism|pulmonary embolism
5363433|NCT00187408|Low Molecular Weight Heparin|low molecular weight heparin
5363434|NCT00187408|Tibial Fractures|tibial fractures
5363435|NCT00187395|hypertension|hypertension
5363436|NCT00187395|blood pressure|blood pressure
5363437|NCT00187395|pregnancy|pregnancy
5363438|NCT00187382|antenatal corticosteroids|antenatal corticosteroids
5363439|NCT00187382|preterm birth|preterm birth
5363440|NCT00187382|multiple versus single doses|multiple versus single doses
5363441|NCT00187382|follow-up|follow-up
5363442|NCT00187369|twins|twins
5363443|NCT00187369|twin births|twin births
5363444|NCT00187369|multiples|multiples
5363445|NCT00187356|Coronary Bypass Surgery|coronary bypass surgery
5363446|NCT00187356|Coronary Artery Disease|coronary artery disease
5363447|NCT00187356|Angiography|angiography
5363448|NCT00187356|Arterial Grafts|arterial grafts
5363449|NCT00187356|Radial Artery|radial artery
5363450|NCT00187356|Saphenous Vein|saphenous vein
5363451|NCT00187343|Radiotherapy|radiotherapy
5363452|NCT00187343|IMRT|imrt
5363453|NCT00187330|cardiopulmonary bypass|cardiopulmonary bypass
5363454|NCT00187330|renal insufficiency|renal insufficiency
5363455|NCT00187330|cardiac surgery|cardiac surgery
5363456|NCT00187330|n-acetylcysteine|n-acetylcysteine
5363457|NCT00187317|Exercise|exercise
5363458|NCT00187317|Rehabilitation|rehabilitation
5363459|NCT00187317|Postural Balance|postural balance
5363460|NCT00187317|Accidental Falls|accidental falls
5363461|NCT00187317|Geriatrics|geriatrics
5363462|NCT00187291|T-Wave Alternans|t-wave alternans
5363463|NCT00187291|ICD|icd
5363464|NCT00187291|Primary Prevention|primary prevention
5363465|NCT00187278|Standard pacing indication|standard pacing indication
5363466|NCT00187252|Ventricular Dyssynchrony|ventricular dyssynchrony
5363467|NCT00187239|ICDs|icds
5363468|NCT00187239|Ventricular pacing|ventricular pacing
5363469|NCT00187239|Patient has been implanted with a dual chamber SJM ICD with AICS for 1 month (± 2 weeks).|patient has been implanted with a dual chamber sjm icd with aics for 1 month (± 2 weeks).
5363470|NCT00187239|At the time of enrollment, patient is paced in the RV ≤25% of the time as determined by the device diagnostics.|at the time of enrollment, patient is paced in the rv ≤25% of the time as determined by the device diagnostics.
5363471|NCT00187239|Patient is medically stable.|patient is medically stable.
5363472|NCT00187226|Brain neoplasm|brain neoplasm
5363473|NCT00187226|Brain cancer|brain cancer
5363474|NCT00187226|Neoplasm intracranial|neoplasm intracranial
5363475|NCT00187213|Ventricular Dyssynchrony|ventricular dyssynchrony
5363476|NCT00187174|Brain tumors|brain tumors
5363477|NCT00187174|Soft Tissue Sarcomas|soft tissue sarcomas
5363478|NCT00187174|Refractory solid tumors|refractory solid tumors
5363479|NCT00187174|Recurrent or Refractory Rhabdomyosarcomatous Soft Tissue and Non-Rhabdomyosarcoma Soft Tissue Sarcomas|recurrent or refractory rhabdomyosarcomatous soft tissue and non-rhabdomyosarcoma soft tissue sarcomas
5363480|NCT00187161|Mature B-Cell Leukemia|mature b-cell leukemia
5363481|NCT00187161|Non-Hodgkin Lymphoma|non-hodgkin lymphoma
5363482|NCT00187161|Burkitt's lymphoma|burkitt's lymphoma
5363483|NCT00187161|Small noncleaved cell non Hodgkin lymphoma|small noncleaved cell non hodgkin lymphoma
5363484|NCT00187161|Large cell lymphoma|large cell lymphoma
5363485|NCT00187148|Vaccine|vaccine
5363486|NCT00187148|Prevention|prevention
5363487|NCT00187148|HIV|hiv
5363488|NCT00187148|AIDS|aids
5363489|NCT00187135|Pain Management|pain management
5363490|NCT00187135|Bone Marrow Aspiration|bone marrow aspiration
5363491|NCT00187122|Non-Hodgkin|non-hodgkin
5363492|NCT00187122|Lymphoma|lymphoma
5363493|NCT00187109|Thrombocytopenia|thrombocytopenia
5363494|NCT00187109|Platelets|platelets
5363495|NCT00187109|Thrombopoietin|thrombopoietin
5363496|NCT00187096|Leukemia|leukemia
5363497|NCT00187096|Myeloid|myeloid
5363498|NCT00187096|Acute|acute
5363499|NCT00187083|Leukemia|leukemia
5363500|NCT00187083|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
5363501|NCT00187083|Refractory Acute Lymphoblastic Leukemia|refractory acute lymphoblastic leukemia
5363502|NCT00187083|Relapsed Acute Lymphoblastic Leukemia|relapsed acute lymphoblastic leukemia
5363503|NCT00187057|Ataxia|ataxia
5363504|NCT00187057|alphafetoprotein|alphafetoprotein
5363505|NCT00187044|Vaccine|vaccine
5363506|NCT00187044|Prevention|prevention
5363507|NCT00187044|HIV|hiv
5363508|NCT00187044|AIDS|aids
5363509|NCT00187031|Wilms Tumor|wilms tumor
5363510|NCT00187018|Collagen Disease|collagen disease
5363511|NCT00187005|Leukemia|leukemia
5363512|NCT00186992|Sarcoma|sarcoma
5363513|NCT00186992|radiation therapy|radiation therapy
5363514|NCT00186992|Other musculoskeletal tumors|other musculoskeletal tumors
5363515|NCT00186979|Refractory Childhood Solid Tumors|refractory childhood solid tumors
5363516|NCT00186953|Ultrasound|ultrasound
5363517|NCT00186953|Abdominal tumors|abdominal tumors
5363518|NCT00186953|Pelvic tumors|pelvic tumors
5363519|NCT00186940|leukemia|leukemia
5363520|NCT00186927|Vaccine|vaccine
5363521|NCT00186927|Sendai virus vaccine|sendai virus vaccine
5363522|NCT00186914|Bone marrow transplant|bone marrow transplant
5363523|NCT00186914|bone marrow stromal cells|bone marrow stromal cells
5363524|NCT00186914|allogeneic transplant|allogeneic transplant
5363525|NCT00186914|Osteodysplasia|osteodysplasia
5363526|NCT00186914|Osteogenesis imperfecta|osteogenesis imperfecta
5363527|NCT00186914|Gene marking|gene marking
5363528|NCT00186914|Stromal cell|stromal cell
5363529|NCT00186901|Bone Density|bone density
5363530|NCT00186888|Cancer of the Eye|cancer of the eye
5363531|NCT00186888|Eye Enucleation|eye enucleation
5363532|NCT00186875|Leukemia|leukemia
5363533|NCT00186875|Lymphoblastic|lymphoblastic
5363534|NCT00186875|Acute|acute
5363535|NCT00186875|Lymphoma|lymphoma
5363536|NCT00186875|Non-Hodgkin's|non-hodgkin's
5363537|NCT00186862|Neuroblastoma|neuroblastoma
5363538|NCT00186862|Immunotherapy|immunotherapy
5363539|NCT00186862|Gene therapy|gene therapy
5363540|NCT00186849|Neuroblastoma|neuroblastoma
5363541|NCT00186836|Hepatitis A|hepatitis a
5363542|NCT00186836|Hepatitis B|hepatitis b
5363543|NCT00186836|Hemodialysis|hemodialysis
5363544|NCT00186836|Vaccine|vaccine
5363545|NCT00186823|Haploidentical stem cell transplant|haploidentical stem cell transplant
5363546|NCT00186823|Allogeneic stem cell transplant|allogeneic stem cell transplant
5363547|NCT00186823|Mismatched family member stem cell donor transplant|mismatched family member stem cell donor transplant
5363548|NCT00186823|Bone marrow transplantHigh risk hematologic malignancies|bone marrow transplanthigh risk hematologic malignancies
5363549|NCT00186810|Anemia|anemia
5363550|NCT00186810|Sickle Cell|sickle cell
5363551|NCT00186797|Aplastic Anemia|aplastic anemia
5363552|NCT00186784|Repetitive Transcranial Magnetic Stimulation|repetitive transcranial magnetic stimulation
5363554|NCT00186771|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
5363555|NCT00186771|Paired Pulse|paired pulse
5363556|NCT00186758|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
5363557|NCT00186758|TMS|tms
5363558|NCT00186745|Venous thrombosis|venous thrombosis
5363559|NCT00186745|Pulmonary embolism|pulmonary embolism
5363560|NCT00186745|Kidney failure|kidney failure
5363561|NCT00186745|Anticoagulants|anticoagulants
5363562|NCT00186745|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight
5363563|NCT00186732|wound closure|wound closure
5363564|NCT00186732|Pfannenstiel incision|pfannenstiel incision
5363565|NCT00186732|surgical staples|surgical staples
5363566|NCT00186732|subcuticular suture|subcuticular suture
5363567|NCT00186719|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5363568|NCT00186719|Smoking Related Disease|smoking related disease
5363569|NCT00186719|Immune System Changes|immune system changes
5363570|NCT00186706|Selenium|selenium
5363571|NCT00186706|Chronic Obstructive Pulmonaary Disease|chronic obstructive pulmonaary disease
5363572|NCT00186706|Cardiovascular Disease|cardiovascular disease
5363573|NCT00186706|Anti-oxidant|anti-oxidant
5363574|NCT00186706|Pulmonary|pulmonary
5363575|NCT00186693|Airway remodeling|airway remodeling
5363576|NCT00186693|Asthma|asthma
5363577|NCT00186693|Hyper-responsiveness|hyper-responsiveness
5363578|NCT00186641|chronic Graft vs Host Disease|chronic graft vs host disease
5363579|NCT00186537|Insulin resistance|insulin resistance
5363580|NCT00186537|Insulin resistance syndrome|insulin resistance syndrome
5363581|NCT00186537|dyslipidemia|dyslipidemia
5363582|NCT00186537|atherogenic dyslipidemia|atherogenic dyslipidemia
5363583|NCT00186537|triglyceride/HDL-C ratio|triglyceride/hdl-c ratio
5363584|NCT00186420|Prostate Cancer|prostate cancer
5363585|NCT00186420|Taxotere|taxotere
5363586|NCT00186368|Prostate cancer|prostate cancer
5363587|NCT00186368|Gene expression|gene expression
5363588|NCT00186368|tumor markers|tumor markers
5363589|NCT00186368|microarray analysis|microarray analysis
5363590|NCT00186329|Vasodilation|vasodilation
5363591|NCT00186329|Congestive heart failure|congestive heart failure
5363592|NCT00186329|Renal insufficiency|renal insufficiency
5363593|NCT00186329|Diuresis|diuresis
5363594|NCT00186329|Serum creatinine|serum creatinine
5363595|NCT00186199|voiding patterns|voiding patterns
5363596|NCT00186199|flow rate|flow rate
5363597|NCT00186199|ultrasound|ultrasound
5363598|NCT00186173|Obesity|obesity
5363599|NCT00186173|Physical activity|physical activity
5363600|NCT00186134|Physical Activity|physical activity
5363601|NCT00186134|Walking|walking
5363602|NCT00186134|Primary Schools|primary schools
5363603|NCT00186134|Transportation|transportation
5363604|NCT00186108|Oral Triamcinalone|oral triamcinalone
5363605|NCT00186108|Prostate Cancer|prostate cancer
5363606|NCT00186095|Amyloidosis|amyloidosis
5363607|NCT00186095|nonmyeloablative|nonmyeloablative
5363608|NCT00186095|hematopoietic|hematopoietic
5363609|NCT00186095|cell transplantation|cell transplantation
5363610|NCT00186030|HIV|hiv
5363611|NCT00186030|AIDS|aids
5363612|NCT00186030|PTSD|ptsd
5363613|NCT00186030|Prevention|prevention
5363614|NCT00185978|obesity prevention|obesity prevention
5363615|NCT00185978|preadolescents|preadolescents
5363616|NCT00185978|schools|schools
5363617|NCT00185965|non-Hodgkin|non-hodgkin
5363618|NCT00185965|lymphoma|lymphoma
5363619|NCT00185965|mycosis|mycosis
5363620|NCT00185965|fungoides|fungoides
5363621|NCT00185939|dog bites|dog bites
5363622|NCT00185939|infection|infection
5363623|NCT00185939|prophylactic antibiotics|prophylactic antibiotics
5363624|NCT00185939|cost effectiveness|cost effectiveness
5363625|NCT00185783|Sepsis|sepsis
5363626|NCT00185783|Adrenal Insufficiency|adrenal insufficiency
5363627|NCT00185783|Hydrocortisone|hydrocortisone
5363628|NCT00185783|Gene Expression|gene expression
5363629|NCT00185783|Microarray|microarray
5363630|NCT00185783|RNA|rna
5363631|NCT00185783|Critically Ill|critically ill
5363632|NCT00185770|Obesity prevention|obesity prevention
5363633|NCT00185770|Television|television
5363634|NCT00185770|Screen time|screen time
5363635|NCT00185770|Schools|schools
5363636|NCT00185770|Preadolescents|preadolescents
5363637|NCT00185705|Insulin resistance|insulin resistance
5363638|NCT00185705|obesity|obesity
5363639|NCT00185705|hypertension|hypertension
5363640|NCT00185705|adolescents|adolescents
5363641|NCT00185705|telmisartan|telmisartan
5363642|NCT00185705|lifestyle intervention|lifestyle intervention
5363643|NCT00185562|Osteoarthritis|osteoarthritis
5363644|NCT00185549|Cystic Fibrosis;|cystic fibrosis;
5363645|NCT00185549|patient education,|patient education,
5363646|NCT00185549|Internet|internet
5363647|NCT00185536|Taste|taste
5363648|NCT00185536|preschool children|preschool children
5363649|NCT00185536|fast food|fast food
5363650|NCT00185484|Oral contraception|oral contraception
5363651|NCT00185445|Non Hodgkin Lymphoma|non hodgkin lymphoma
5363652|NCT00185393|Follicular Non Hodgkin lymphoma|follicular non hodgkin lymphoma
5363653|NCT00185354|FC patch|fc patch
5363654|NCT00185354|comparator study|comparator study
5363655|NCT00185341|Endometriosis associated pelvic pain|endometriosis associated pelvic pain
5363656|NCT00185328|Postmenopause|postmenopause
5363657|NCT00185302|Non-resectable metastatic melanoma|non-resectable metastatic melanoma
5363658|NCT00185276|Structural abnormalities of the infrarenal aorta and peripheral arteries|structural abnormalities of the infrarenal aorta and peripheral arteries
5363659|NCT00185263|angina|angina
5363660|NCT00185263|FGF-4|fgf-4
5363661|NCT00185263|angiogenesis|angiogenesis
5363662|NCT00185263|adenovector|adenovector
5363663|NCT00185263|growth factor|growth factor
5363664|NCT00185263|myocardial ischemia|myocardial ischemia
5363665|NCT00185263|revascularization|revascularization
5363666|NCT00185250|Cardiomyopathy|cardiomyopathy
5363667|NCT00185250|idiopathic chronic heart failure|idiopathic chronic heart failure
5363668|NCT00185250|Adenovirus|adenovirus
5363669|NCT00185250|Enterovirus|enterovirus
5363670|NCT00185250|Parvovirus|parvovirus
5363671|NCT00185237|Menopause|menopause
5363672|NCT00185198|Partial androgen deficiency of aging males (PADAM)|partial androgen deficiency of aging males (padam)
5363673|NCT00185159|Microalbuminuria|microalbuminuria
5363674|NCT00185133|Treatment of high blood pressure in mild to severe hypertensive patients|treatment of high blood pressure in mild to severe hypertensive patients
5363675|NCT00185120|Hypertension|hypertension
5363676|NCT00185120|angiotensin receptor blocker|angiotensin receptor blocker
5363677|NCT00185120|calcium channel blocker|calcium channel blocker
5363678|NCT00185120|angiotensin converting enzyme inhibitor hydroclorothiazide|angiotensin converting enzyme inhibitor hydroclorothiazide
5363679|NCT00185107|Safety|safety
5363680|NCT00185107|Efficacy|efficacy
5363681|NCT00185107|WelChol®|welchol®
5363682|NCT00185107|Zocor®|zocor®
5363683|NCT00185107|Zetia®|zetia®
5363684|NCT00185081|colon cancer|colon cancer
5363685|NCT00185081|radioimmunoscintigraphy|radioimmunoscintigraphy
5363686|NCT00185081|colon-specific antigen,|colon-specific antigen,
5363687|NCT00185081|radioimmunotherapy,|radioimmunotherapy,
5363688|NCT00185081|radioimmunodetection|radioimmunodetection
5363789|NCT00184444|endurance training|endurance training
5363689|NCT00185068|Systolic hypertension, Angiotensin receptor blocker|systolic hypertension, angiotensin receptor blocker
5363690|NCT00185055|olmesartan|olmesartan
5363691|NCT00185055|valsartan|valsartan
5363692|NCT00185055|irbesartan|irbesartan
5363693|NCT00185055|renin-angiotensin-aldosterone system|renin-angiotensin-aldosterone system
5363694|NCT00185042|Atherosclerosis, intravascular ultrasound|atherosclerosis, intravascular ultrasound
5363695|NCT00185029|prostate|prostate
5363696|NCT00185029|ferumoxtran-10|ferumoxtran-10
5363697|NCT00185029|lymph nodes|lymph nodes
5363698|NCT00185029|USPIO|uspio
5363699|NCT00185016|intimate partner abuse|intimate partner abuse
5363700|NCT00185016|gender|gender
5363701|NCT00185016|education|education
5363702|NCT00185016|attitude|attitude
5363703|NCT00185016|family doctor|family doctor
5363704|NCT00185016|health care utilisation|health care utilisation
5363705|NCT00185016|abused women|abused women
5363706|NCT00185003|Endotoxemia|endotoxemia
5363707|NCT00185003|vascular potassium channels|vascular potassium channels
5363708|NCT00185003|cytokine|cytokine
5363709|NCT00185003|norepinephrine|norepinephrine
5363710|NCT00185003|regional blood flow,|regional blood flow,
5363711|NCT00185003|inflammation,|inflammation,
5363712|NCT00185003|ion channels,|ion channels,
5363713|NCT00185003|nitric oxide synthase,|nitric oxide synthase,
5363714|NCT00185003|pharmacology.|pharmacology.
5363715|NCT00184990|Endotoxemia|endotoxemia
5363716|NCT00184990|Aminoguanidine|aminoguanidine
5363717|NCT00184977|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
5363718|NCT00184977|Randomized Controlled Trial|randomized controlled trial
5363719|NCT00184977|Family Practice|family practice
5363720|NCT00184977|Respiratory Function Tests|respiratory function tests
5363721|NCT00184977|Health Status|health status
5363722|NCT00184951|HIV|hiv
5363723|NCT00184938|opioids|opioids
5363724|NCT00184938|ischemic preconditioning|ischemic preconditioning
5363725|NCT00184938|morphine|morphine
5363726|NCT00184899|free fatty acids|free fatty acids
5363727|NCT00184899|vasodilation|vasodilation
5363728|NCT00184899|sympathetic activity|sympathetic activity
5363729|NCT00184873|randomized controlled trial|randomized controlled trial
5363730|NCT00184873|health-counseling|health-counseling
5363731|NCT00184873|multi-center study|multi-center study
5363732|NCT00184847|acetylcholine|acetylcholine
5363733|NCT00184847|adenosine|adenosine
5363734|NCT00184847|caffeine|caffeine
5363735|NCT00184847|ischemic preconditioning|ischemic preconditioning
5363736|NCT00184834|colorectal|colorectal
5363737|NCT00184834|liver|liver
5363738|NCT00184834|metastases|metastases
5363739|NCT00184834|health-related quality of life|health-related quality of life
5363740|NCT00184834|surgery|surgery
5363741|NCT00184821|Diabetes|diabetes
5363742|NCT00184821|Ischemia|ischemia
5363743|NCT00184821|Annexin A5 scintigraphy|annexin a5 scintigraphy
5363744|NCT00184795|Hot flashes|hot flashes
5363745|NCT00184782|colorectal cancer|colorectal cancer
5363746|NCT00184782|liver metastases|liver metastases
5363747|NCT00184782|metabolic activity|metabolic activity
5363748|NCT00184587|prophylactic|prophylactic
5363749|NCT00184587|episodic|episodic
5363750|NCT00184587|cluster|cluster
5363751|NCT00184587|candesartan|candesartan
5363752|NCT00184587|angiotensin II receptor blocker|angiotensin ii receptor blocker
5363753|NCT00184587|randomized placebo controlled parallel study|randomized placebo controlled parallel study
5363754|NCT00184587|headache diary|headache diary
5363755|NCT00184535|Low back pain|low back pain
5363756|NCT00184535|Neuromuscular control|neuromuscular control
5363757|NCT00184535|Anticipatory motor control|anticipatory motor control
5363758|NCT00184535|Musculoskeletal Physiologic Processes|musculoskeletal physiologic processes
5363759|NCT00184535|Muscle, Skeletal|muscle, skeletal
5363760|NCT00184535|Ultrasonography|ultrasonography
5363761|NCT00184535|Electromyography|electromyography
5363762|NCT00184522|Gastroesophageal Reflux|gastroesophageal reflux
5363763|NCT00184522|Esomeprazole|esomeprazole
5363764|NCT00184522|Drug treatment|drug treatment
5363765|NCT00184509|schizophrenia|schizophrenia
5363766|NCT00184509|psychosocial treatment|psychosocial treatment
5363767|NCT00184509|outcome|outcome
5363768|NCT00184496|Analgesics, Opioid/pharmacokinetics|analgesics, opioid/pharmacokinetics
5363769|NCT00184496|Humans|humans
5363770|NCT00184496|Methadone/therapeutic use|methadone/therapeutic use
5363771|NCT00184496|Neoplasms/complications|neoplasms/complications
5363772|NCT00184496|pain/drug therapy|pain/drug therapy
5363773|NCT00184483|Surgery|surgery
5363774|NCT00184483|Lichtenstein|lichtenstein
5363775|NCT00184483|Prolene Hernia System|prolene hernia system
5363776|NCT00184483|Postoperative pain|postoperative pain
5363777|NCT00184483|Recurrence|recurrence
5363778|NCT00184470|Adult|adult
5363779|NCT00184470|Child|child
5363780|NCT00184470|Hospitalization/statistics & numerical data|hospitalization/statistics & numerical data
5363781|NCT00184470|Retrospective studies|retrospective studies
5363782|NCT00184457|Cardiac heart failure|cardiac heart failure
5363783|NCT00184457|Leg press|leg press
5363784|NCT00184457|Maximal strength training|maximal strength training
5363785|NCT00184457|Serum testosterone|serum testosterone
5363786|NCT00184457|Work economy|work economy
5363787|NCT00184444|angina pectoris|angina pectoris
5363790|NCT00184444|stroke volume|stroke volume
5363791|NCT00184444|cardiac perfusion|cardiac perfusion
5363792|NCT00184431|Cerebrovascular Accident|cerebrovascular accident
5363793|NCT00184431|Physical Therapy Techniques|physical therapy techniques
5363794|NCT00184431|Musculoskeletal Equilibrium|musculoskeletal equilibrium
5363795|NCT00184431|Rehabilitation|rehabilitation
5363796|NCT00184418|Immunity|immunity
5363797|NCT00184418|Immune System|immune system
5363798|NCT00184418|Cytokines|cytokines
5363799|NCT00184418|Psychophysiology|psychophysiology
5363800|NCT00184418|Psychoneuroimmunology|psychoneuroimmunology
5363801|NCT00184405|Parents with psychiatric or addictive problems|parents with psychiatric or addictive problems
5363802|NCT00184392|Sinus surgery|sinus surgery
5363803|NCT00184392|endoscopic|endoscopic
5363804|NCT00184392|postoperative care|postoperative care
5363805|NCT00184392|debridement|debridement
5363806|NCT00184392|randomized|randomized
5363807|NCT00184392|acute recurrent rhinosinusitis|acute recurrent rhinosinusitis
5363808|NCT00184392|chronic rhinosinusitis|chronic rhinosinusitis
5363809|NCT00184392|nasal polyps|nasal polyps
5363810|NCT00184392|Chronic rhinosinusitis with nasal polyps|chronic rhinosinusitis with nasal polyps
5363811|NCT00184392|Chronic rhinosinusitis without nasal polyps|chronic rhinosinusitis without nasal polyps
5363812|NCT00184379|Family|family
5363813|NCT00184379|Coping Skills|coping skills
5363814|NCT00184379|Psychoeducation|psychoeducation
5363815|NCT00184379|Stress, Psychological|stress, psychological
5363816|NCT00184379|Health Education|health education
5363817|NCT00184366|drug therapy|drug therapy
5363818|NCT00184366|efalizumab|efalizumab
5363819|NCT00184353|brain metastasis|brain metastasis
5363820|NCT00184353|signal to noise ratio|signal to noise ratio
5363821|NCT00184353|spectral resolution|spectral resolution
5363822|NCT00184340|eTherapy supplementary|etherapy supplementary
5363823|NCT00184327|Severe and longstanding psychiatric symptoms in children|severe and longstanding psychiatric symptoms in children
5363824|NCT00184301|Eating disorders|eating disorders
5363825|NCT00184301|Anorexia nervosa|anorexia nervosa
5363826|NCT00184301|Bulimia nervosa|bulimia nervosa
5363827|NCT00184301|Personality disorders|personality disorders
5363828|NCT00184301|In-patient treatment|in-patient treatment
5363829|NCT00184301|out-patient treatment|out-patient treatment
5363830|NCT00184301|group therapy|group therapy
5363831|NCT00184288|Lipid|lipid
5363832|NCT00184288|choline|choline
5363833|NCT00184288|metastasis|metastasis
5363834|NCT00184288|magnetic resonance spectroscopy|magnetic resonance spectroscopy
5363835|NCT00184288|treatment response|treatment response
5363836|NCT00184275|Brain metastasis|brain metastasis
5363837|NCT00184275|HR MAS spectroscopy|hr mas spectroscopy
5363838|NCT00184275|Tissue micro array|tissue micro array
5363839|NCT00184275|DNA micro array|dna micro array
5363840|NCT00184249|Catheter ablation|catheter ablation
5363841|NCT00184249|Heart/surgery|heart/surgery
5363842|NCT00184249|Cardial surgical procedures|cardial surgical procedures
5363843|NCT00184236|Exercise Training|exercise training
5363844|NCT00184236|Cardiovascular diseases|cardiovascular diseases
5363845|NCT00184236|Risk factors|risk factors
5363846|NCT00184223|Motivational Interviewing|motivational interviewing
5363847|NCT00184223|Substance abuse|substance abuse
5363848|NCT00184223|Acuteley admitted psychiatric patients|acuteley admitted psychiatric patients
5363849|NCT00184223|Emergency Services, Psychiatric|emergency services, psychiatric
5363850|NCT00184210|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
5363851|NCT00184197|Injection|injection
5363852|NCT00184197|Headache|headache
5363853|NCT00184197|Cervical muscles|cervical muscles
5363854|NCT00184184|Emergency Services, Psychiatric|emergency services, psychiatric
5363855|NCT00184184|Tobacco use cessation|tobacco use cessation
5363856|NCT00184184|Coffee use cessation|coffee use cessation
5363857|NCT00184184|substance use detection|substance use detection
5363858|NCT00184184|Substance Abuse Detection|substance abuse detection
5363859|NCT00184171|Microscopic colitis|microscopic colitis
5363860|NCT00184171|Drug treatment|drug treatment
5363861|NCT00184171|Diarrhoea|diarrhoea
5363862|NCT00184158|Cubital tunnel|cubital tunnel
5363863|NCT00184158|treatment|treatment
5363864|NCT00184158|nerve compression|nerve compression
5363865|NCT00184145|Specific (Animal) Phobia|specific (animal) phobia
5363866|NCT00184145|EMDR|emdr
5363867|NCT00184145|Exposure therapy|exposure therapy
5363868|NCT00184132|Intensive care units|intensive care units
5363869|NCT00184132|Emergency services, psychiatric|emergency services, psychiatric
5363870|NCT00184132|Interior Design and Furnishings|interior design and furnishings
5363871|NCT00184132|Intensive Care|intensive care
5363872|NCT00184119|Emergency services, psychiatric|emergency services, psychiatric
5363873|NCT00184119|Intensive care units|intensive care units
5363874|NCT00184119|Hospitals, psychiatric|hospitals, psychiatric
5363875|NCT00184119|Aggression|aggression
5363876|NCT00184119|Violence|violence
5363877|NCT00184106|Phobic disorders|phobic disorders
5363878|NCT00184106|Therapy, cognitive|therapy, cognitive
5363879|NCT00184106|Paroxetine|paroxetine
5363880|NCT00184093|Cervical Carcinoma|cervical carcinoma
5363881|NCT00183976|Diffuse mixed NHL|diffuse mixed nhl
5363882|NCT00183976|Diffuse or follicular large B-cell NHL|diffuse or follicular large b-cell nhl
5364469|NCT00181870|Equetro|equetro
5363883|NCT00183976|Immunoblastic NHL|immunoblastic nhl
5363884|NCT00183976|Burkitt or Burkitt-like lymphomas|burkitt or burkitt-like lymphomas
5363885|NCT00183898|Gastroesophageal Junction Cancer|gastroesophageal junction cancer
5363886|NCT00183872|Gastroesophageal cancer|gastroesophageal cancer
5363887|NCT00183872|Gastric Adenocarcinoma|gastric adenocarcinoma
5363888|NCT00183872|Gastroesophageal Junction Adenocarcinoma|gastroesophageal junction adenocarcinoma
5363889|NCT00183859|solid tumor|solid tumor
5363890|NCT00183859|phase I|phase i
5363891|NCT00183859|phase one|phase one
5363892|NCT00183846|pancreas|pancreas
5363893|NCT00183846|stomach|stomach
5363894|NCT00183846|common bile duct cancer|common bile duct cancer
5363895|NCT00183846|ampulla of Vater cancer|ampulla of vater cancer
5363896|NCT00183833|phase 1|phase 1
5363897|NCT00183833|phase I|phase i
5363898|NCT00183833|phase one|phase one
5363899|NCT00183833|colon cancer|colon cancer
5363900|NCT00183833|colorectal cancer|colorectal cancer
5363901|NCT00183820|Testicular|testicular
5363902|NCT00183820|Extra gonadal germ cell neoplasm|extra gonadal germ cell neoplasm
5363903|NCT00183794|Primary Peritoneal|primary peritoneal
5363904|NCT00183781|HIV|hiv
5363905|NCT00183781|Telephone intervention|telephone intervention
5363906|NCT00183768|Cognitive Behavioral Treatment For Depression|cognitive behavioral treatment for depression
5363907|NCT00183768|Antidepressant Psychopharmacology|antidepressant psychopharmacology
5363908|NCT00183768|HIV Risk Behavior|hiv risk behavior
5363909|NCT00183768|Injection Drug Use|injection drug use
5363910|NCT00183755|Reward Processing|reward processing
5363911|NCT00183755|Anhedonia|anhedonia
5363912|NCT00183755|Major Depressive Disorder|major depressive disorder
5363913|NCT00183755|Depression|depression
5363914|NCT00183742|Phase 1|phase 1
5363915|NCT00183742|Phase I|phase i
5363916|NCT00183742|Phase one|phase one
5363917|NCT00183742|Solid tumor|solid tumor
5363918|NCT00183729|Major depressive disorder|major depressive disorder
5363919|NCT00183729|Rehabilitating|rehabilitating
5363920|NCT00183729|Elderly|elderly
5363921|NCT00183729|Apathy|apathy
5363922|NCT00183716|PTSD|ptsd
5363923|NCT00183716|Physical Abuse|physical abuse
5363924|NCT00183716|Sexual Abuse|sexual abuse
5363925|NCT00183716|Women|women
5363926|NCT00183716|Trauma|trauma
5363927|NCT00183716|Group Therapy|group therapy
5363928|NCT00183716|Substance Abuse|substance abuse
5363929|NCT00183703|Depression, Bipolar|depression, bipolar
5363930|NCT00183703|Manic-Depressive Psychosis|manic-depressive psychosis
5363931|NCT00183690|PTSD|ptsd
5363932|NCT00183690|Anxiety Disorder|anxiety disorder
5363933|NCT00183690|Trauma|trauma
5363934|NCT00183690|Adolescents|adolescents
5363935|NCT00183690|Cognitive Behavioral Therapy|cognitive behavioral therapy
5363936|NCT00183677|Brain Bioenergetic Metabolism|brain bioenergetic metabolism
5363937|NCT00183677|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
5363938|NCT00183677|Major Depressive Disorder|major depressive disorder
5363939|NCT00183677|Treatment Response|treatment response
5363940|NCT00183651|Suicide|suicide
5363941|NCT00183651|Women|women
5363942|NCT00183651|Emotions|emotions
5363943|NCT00183651|Psychotherapy, Group|psychotherapy, group
5363944|NCT00183638|Internet|internet
5363945|NCT00183638|Interactive Computer Program|interactive computer program
5363946|NCT00183638|HIV Prevention|hiv prevention
5363947|NCT00183625|Antipsychotic Agents|antipsychotic agents
5363948|NCT00183625|Employment|employment
5363949|NCT00183612|Child|child
5363950|NCT00183612|Adolescent|adolescent
5363951|NCT00183612|Mental Health|mental health
5363952|NCT00183612|Olanzapine|olanzapine
5363953|NCT00183612|Pharmacokinetics|pharmacokinetics
5363954|NCT00183612|Pharmacology|pharmacology
5363955|NCT00183599|Brief interventions|brief interventions
5363956|NCT00183599|Motivational Enhancement Therapy|motivational enhancement therapy
5363957|NCT00183599|Cognitive Behavioral Therapy|cognitive behavioral therapy
5363958|NCT00183586|Treatment outcomes study|treatment outcomes study
5363959|NCT00183586|Anorexia|anorexia
5363960|NCT00183586|Anorexia nervosa|anorexia nervosa
5363961|NCT00183573|STDs|stds
5363962|NCT00183573|Sexual Behavior|sexual behavior
5363963|NCT00183573|Health Behavior|health behavior
5363964|NCT00183573|HIV Seronegativity|hiv seronegativity
5363965|NCT00183560|Depression Recurrence|depression recurrence
5363966|NCT00183560|Drug Therapy|drug therapy
5363967|NCT00183560|Cognitive Therapy|cognitive therapy
5363968|NCT00183560|Relapse|relapse
5363969|NCT00183560|Antidepressants|antidepressants
5363970|NCT00183547|Postpartum Depression|postpartum depression
5363971|NCT00183547|Postpartum Period|postpartum period
5363972|NCT00183547|Indians, North American|indians, north american
5363973|NCT00183547|Adolescent|adolescent
5363974|NCT00183547|Female|female
5363975|NCT00183547|CBT|cbt
5363976|NCT00183521|Hyperventilation|hyperventilation
5363977|NCT00183521|Breathing Exercises|breathing exercises
5363978|NCT00183521|Carbon Dioxide|carbon dioxide
5363979|NCT00183521|Panic Attack|panic attack
5363980|NCT00183508|PTSD|ptsd
5363981|NCT00183508|Occupational Health|occupational health
5363982|NCT00183508|Trauma|trauma
5363983|NCT00183508|Job|job
5363984|NCT00183508|CBT|cbt
5364470|NCT00181857|ADHD NOS|adhd nos
5363985|NCT00183495|Depression, Bipolar|depression, bipolar
5363986|NCT00183495|Manic-Depressive Psychosis|manic-depressive psychosis
5363987|NCT00183482|Parents|parents
5363988|NCT00183482|Child|child
5363989|NCT00183482|Stress|stress
5363990|NCT00183482|CBT|cbt
5363991|NCT00183469|Lamotrigine|lamotrigine
5363992|NCT00183469|Divalproex|divalproex
5363993|NCT00183469|Antidepressant|antidepressant
5363994|NCT00183456|Sex Education|sex education
5363995|NCT00183456|Peer Group|peer group
5363996|NCT00183456|Social Identity Theory|social identity theory
5363997|NCT00183456|HIV Seronegativity|hiv seronegativity
5363998|NCT00183456|Intervention|intervention
5363999|NCT00183456|women|women
5364000|NCT00183456|Social Networks|social networks
5364001|NCT00183456|Peer Education|peer education
5364002|NCT00183443|Mania|mania
5364003|NCT00183443|Manic-depressive|manic-depressive
5364004|NCT00183443|Psychotic disorder|psychotic disorder
5364005|NCT00183430|Prazosin|prazosin
5364006|NCT00183430|Sleep Disorders|sleep disorders
5364007|NCT00183417|Adolescent|adolescent
5364008|NCT00183417|CBT|cbt
5364009|NCT00183404|Drug Treatment|drug treatment
5364010|NCT00183404|Child|child
5364011|NCT00183404|Olanzapine|olanzapine
5364012|NCT00183391|ADHD|adhd
5364013|NCT00183391|Child|child
5364014|NCT00183391|Adolescent|adolescent
5364015|NCT00183391|School|school
5364016|NCT00183378|Alzheimer's Disease|alzheimer's disease
5364017|NCT00183378|Insomnia|insomnia
5364018|NCT00183378|Sleep Problems|sleep problems
5364019|NCT00183378|Elderly|elderly
5364020|NCT00183378|Caregivers|caregivers
5364021|NCT00183365|Family|family
5364022|NCT00183365|Parenting|parenting
5364023|NCT00183365|Depression|depression
5364024|NCT00183365|Group Intervention|group intervention
5364025|NCT00183352|Women|women
5364026|NCT00183352|Mood|mood
5364027|NCT00183352|Menarche|menarche
5364028|NCT00183352|Menstruation|menstruation
5364029|NCT00183339|Autism|autism
5364030|NCT00183326|Posttraumatic Stress Disorder|posttraumatic stress disorder
5364031|NCT00183326|Domestic Violence|domestic violence
5364032|NCT00183326|Children|children
5364033|NCT00183326|Cognitive Behavioral Therapy|cognitive behavioral therapy
5364034|NCT00183326|CBT|cbt
5364035|NCT00183313|Mental Health|mental health
5364036|NCT00183313|Primary health care|primary health care
5364037|NCT00183313|Case management|case management
5364038|NCT00183300|Post-traumatic stress disorder|post-traumatic stress disorder
5364039|NCT00183300|PTSD|ptsd
5364040|NCT00183300|Prolonged Exposure|prolonged exposure
5364041|NCT00183300|Cognitive-Behavior Therapy|cognitive-behavior therapy
5364042|NCT00183274|Generalized Anxiety Disorder|generalized anxiety disorder
5364043|NCT00183274|Chronic Mediation Treatment|chronic mediation treatment
5364044|NCT00183274|Double-Blind|double-blind
5364045|NCT00183274|Placebo Controlled|placebo controlled
5364046|NCT00183274|Venlafaxine XR|venlafaxine xr
5364047|NCT00183274|Relapse|relapse
5364048|NCT00183261|Treatment Interruption|treatment interruption
5364049|NCT00183261|HIV Therapeutic Vaccine|hiv therapeutic vaccine
5364050|NCT00183261|Acute Infection|acute infection
5364051|NCT00183261|Acute Retroviral Syndrome|acute retroviral syndrome
5364052|NCT00183248|kidney|kidney
5364053|NCT00183248|kidney transplant|kidney transplant
5364054|NCT00183248|kidney transplantation|kidney transplantation
5364055|NCT00183248|transplant|transplant
5364056|NCT00183248|transplantation|transplantation
5364057|NCT00183248|renal|renal
5364058|NCT00183248|renal transplant|renal transplant
5364059|NCT00183248|renal transplantation|renal transplantation
5364060|NCT00183248|kidney disease|kidney disease
5364061|NCT00183248|chronic|chronic
5364062|NCT00183248|renal failure|renal failure
5364063|NCT00183248|kidney failure|kidney failure
5364064|NCT00183235|Alcohol dependence|alcohol dependence
5364065|NCT00183235|Alcoholism|alcoholism
5364066|NCT00183235|Craving|craving
5364067|NCT00183222|Alcohol dependence|alcohol dependence
5364068|NCT00183222|Alcoholism|alcoholism
5364069|NCT00183222|Craving|craving
5364070|NCT00183209|Substance use disorders|substance use disorders
5364071|NCT00183209|Parent child relationship|parent child relationship
5364072|NCT00183196|Alcohol dependence|alcohol dependence
5364073|NCT00183196|Alcoholism|alcoholism
5364074|NCT00183196|Heavy drinking|heavy drinking
5364075|NCT00183183|Alcohol Abuse|alcohol abuse
5364076|NCT00183183|Harm Reduction|harm reduction
5364077|NCT00183183|Motivational Interviewing|motivational interviewing
5364078|NCT00183183|Emergency Department|emergency department
5364079|NCT00183183|Risky Drinking|risky drinking
5364080|NCT00183183|Prevention|prevention
5364081|NCT00183170|Alcohol abuse|alcohol abuse
5364082|NCT00183170|Alcoholic beverages (beer)|alcoholic beverages (beer)
5364083|NCT00183170|Residual effects|residual effects
5364084|NCT00183170|Psychomotor performance|psychomotor performance
5364085|NCT00183170|Psychomotor vigilance test|psychomotor vigilance test
5364086|NCT00183170|Neurobehavioral Evaluation System|neurobehavioral evaluation system
5364087|NCT00183170|Family history of alcohol use|family history of alcohol use
5364088|NCT00183170|Alcoholic Consumption|alcoholic consumption
5364089|NCT00183170|Unhealthy alcohol use|unhealthy alcohol use
5364090|NCT00183170|Alcohol|alcohol
5364091|NCT00183157|High risk drinking|high risk drinking
5364092|NCT00183157|Alcohol dependence|alcohol dependence
5364093|NCT00183157|Alcohol related injury|alcohol related injury
5364094|NCT00183144|contingency management|contingency management
5364095|NCT00183144|reinforcement|reinforcement
5364096|NCT00183144|employment|employment
5364097|NCT00183144|Therapeutic Workplace|therapeutic workplace
5364098|NCT00183131|Alcohol|alcohol
5364099|NCT00183131|Alcohol abuse|alcohol abuse
5364100|NCT00183131|Alcohol dependence|alcohol dependence
5364101|NCT00183131|Alcohol consumption|alcohol consumption
5364102|NCT00183131|Unhealthy alcohol use|unhealthy alcohol use
5364103|NCT00183131|Screening|screening
5364104|NCT00183131|Brief Intervention|brief intervention
5364105|NCT00183131|Effectiveness|effectiveness
5364106|NCT00183131|Electronic intervention|electronic intervention
5364107|NCT00183131|Web-based intervention|web-based intervention
5364108|NCT00183131|College students|college students
5364109|NCT00183118|HIV|hiv
5364110|NCT00183118|Russia|russia
5364111|NCT00183118|Prevention|prevention
5364112|NCT00183118|Behavioral intervention|behavioral intervention
5364113|NCT00183118|Alcohol dependence|alcohol dependence
5364114|NCT00183105|Alcohol|alcohol
5364115|NCT00183105|Alcohol abuse|alcohol abuse
5364116|NCT00183105|Alcohol dependence|alcohol dependence
5364117|NCT00183105|Utilization|utilization
5364118|NCT00183105|Alcohol consumption|alcohol consumption
5364119|NCT00183105|Unhealthy alcohol use|unhealthy alcohol use
5364120|NCT00183105|Hospitalization|hospitalization
5364121|NCT00183105|Screening|screening
5364122|NCT00183105|Brief Intervention|brief intervention
5364123|NCT00183105|Motivational Interviewing|motivational interviewing
5364124|NCT00183105|Randomized trial|randomized trial
5364125|NCT00183105|Effectiveness|effectiveness
5364126|NCT00183105|Unhealthy alcohol use (Risky alcohol consumption amounts, problem alcohol use, hazardous alcohol use, alcohol abuse and alcohol dependence)|unhealthy alcohol use (risky alcohol consumption amounts, problem alcohol use, hazardous alcohol use, alcohol abuse and alcohol dependence)
5364127|NCT00183092|dementia|dementia
5364128|NCT00183092|spongiform encephalopathy|spongiform encephalopathy
5364129|NCT00183092|nervous system disorder|nervous system disorder
5364130|NCT00183092|acridine|acridine
5364131|NCT00183092|prion|prion
5364132|NCT00183092|neuropharmacologic agent|neuropharmacologic agent
5364133|NCT00183079|Depression|depression
5364134|NCT00183079|Alcohol Use|alcohol use
5364135|NCT00183079|Motivational Interviewing|motivational interviewing
5364136|NCT00183053|Hospitalization|hospitalization
5364137|NCT00183053|Fall Risk|fall risk
5364138|NCT00183053|Frailty|frailty
5364139|NCT00183040|andropause|andropause
5364140|NCT00183040|hormone therapy|hormone therapy
5364141|NCT00183040|HRT|hrt
5364142|NCT00183027|Dietary restriction|dietary restriction
5364143|NCT00183027|Caloric restriction|caloric restriction
5364144|NCT00183014|behavior therapy|behavior therapy
5364145|NCT00183014|exercise|exercise
5364146|NCT00183014|gait|gait
5364147|NCT00183014|physical activity|physical activity
5364148|NCT00183001|nutritional supplement|nutritional supplement
5364149|NCT00183001|dietary supplement|dietary supplement
5364150|NCT00183001|vitamin therapy|vitamin therapy
5364151|NCT00183001|Vitamin K deficiency|vitamin k deficiency
5364152|NCT00183001|bone density|bone density
5364153|NCT00182988|communication behavior|communication behavior
5364154|NCT00182988|coping|coping
5364155|NCT00182988|functional ability|functional ability
5364156|NCT00182988|quality of life|quality of life
5364157|NCT00182988|caregiving|caregiving
5364158|NCT00182975|Metabolic syndrome|metabolic syndrome
5364159|NCT00182962|Activities of Daily Living|activities of daily living
5364160|NCT00182962|Low-income|low-income
5364161|NCT00182962|geriatric medicine|geriatric medicine
5364162|NCT00182962|computer assisted patient care|computer assisted patient care
5364163|NCT00182949|Epidemiology|epidemiology
5364164|NCT00182949|Genetics|genetics
5364165|NCT00182949|Aging|aging
5364166|NCT00182949|Sardinian Population|sardinian population
5364167|NCT00182949|Cardiovascular Diseases|cardiovascular diseases
5364168|NCT00182949|Personality Traits|personality traits
5364169|NCT00182949|Frailty|frailty
5364170|NCT00182936|Cognition disorder|cognition disorder
5364171|NCT00182936|organic brain syndrome|organic brain syndrome
5364172|NCT00182936|patient care management|patient care management
5364173|NCT00182936|long term care|long term care
5364174|NCT00182936|extended care facility|extended care facility
5364175|NCT00182923|Blood pressure|blood pressure
5364176|NCT00182923|genetics|genetics
5364177|NCT00182897|caregiver|caregiver
5364178|NCT00182897|home health care|home health care
5364179|NCT00182897|coping|coping
5364180|NCT00182884|Hospital acquired complications|hospital acquired complications
5364181|NCT00182884|adverse effects|adverse effects
5364182|NCT00182884|Cognitive Impairment|cognitive impairment
5364183|NCT00182884|Aging|aging
5364184|NCT00182871|geriatric medicine|geriatric medicine
5364185|NCT00182871|hormone therapy|hormone therapy
5364186|NCT00182871|HT|ht
5364187|NCT00182871|andropause|andropause
5364188|NCT00182858|Tissue|tissue
5364189|NCT00182858|Procurement|procurement
5364190|NCT00182858|Exploratory Methods|exploratory methods
5364191|NCT00182858|Disease Correlation|disease correlation
5364192|NCT00182858|Sampling|sampling
5364193|NCT00182845|dementia|dementia
5364194|NCT00182845|MCI|mci
5364195|NCT00182845|Aricept|aricept
5364196|NCT00182845|Adverse Effects|adverse effects
5364197|NCT00182845|Hospital Acquired Complications|hospital acquired complications
5364198|NCT00182845|Cognitive Impairment|cognitive impairment
5364199|NCT00182845|Aging|aging
5364200|NCT00182832|Physician Behavior|physician behavior
5364201|NCT00182832|Hospital Acquired Complications|hospital acquired complications
5364202|NCT00182832|MCI|mci
5364203|NCT00182832|Mild Cognitive Impairment|mild cognitive impairment
5364204|NCT00182819|adult oligodendroglioma|adult oligodendroglioma
5364205|NCT00182819|adult diffuse astrocytoma|adult diffuse astrocytoma
5364206|NCT00182819|adult mixed glioma|adult mixed glioma
5364207|NCT00182806|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5364208|NCT00182806|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5364209|NCT00182806|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5364210|NCT00182806|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5364211|NCT00182793|stage IIIB breast cancer|stage iiib breast cancer
5364212|NCT00182793|stage IIIC breast cancer|stage iiic breast cancer
5364213|NCT00182793|stage IV breast cancer|stage iv breast cancer
5364214|NCT00182793|inflammatory breast cancer|inflammatory breast cancer
5364215|NCT00182793|male breast cancer|male breast cancer
5364216|NCT00182793|recurrent breast cancer|recurrent breast cancer
5364217|NCT00182793|invasive ductal breast carcinoma with predominant intraductal component|invasive ductal breast carcinoma with predominant intraductal component
5364218|NCT00182793|invasive ductal breast carcinoma|invasive ductal breast carcinoma
5364219|NCT00182793|medullary ductal breast carcinoma with lymphocytic infiltrate|medullary ductal breast carcinoma with lymphocytic infiltrate
5364220|NCT00182793|mucinous ductal breast carcinoma|mucinous ductal breast carcinoma
5364221|NCT00182793|Paget disease of the breast with invasive ductal carcinoma|paget disease of the breast with invasive ductal carcinoma
5364222|NCT00182793|papillary ductal breast carcinoma|papillary ductal breast carcinoma
5364223|NCT00182793|tubular ductal breast carcinoma|tubular ductal breast carcinoma
5364224|NCT00182793|invasive lobular breast carcinoma with predominant in situ component|invasive lobular breast carcinoma with predominant in situ component
5364225|NCT00182793|invasive lobular breast carcinoma|invasive lobular breast carcinoma
5364226|NCT00182793|comedo ductal breast carcinoma|comedo ductal breast carcinoma
5364227|NCT00182780|fatigue|fatigue
5364228|NCT00182780|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5364229|NCT00182754|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5364230|NCT00182754|malignant ascites|malignant ascites
5364231|NCT00182741|recurrent prostate cancer|recurrent prostate cancer
5364232|NCT00182741|stage IV prostate cancer|stage iv prostate cancer
5364233|NCT00182728|invasive ductal breast carcinoma|invasive ductal breast carcinoma
5364234|NCT00182728|stage I breast cancer|stage i breast cancer
5364235|NCT00182728|stage II breast cancer|stage ii breast cancer
5364236|NCT00182715|adenocarcinoma of the colon|adenocarcinoma of the colon
5364237|NCT00182715|stage IV colon cancer|stage iv colon cancer
5364238|NCT00182715|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5364239|NCT00182715|stage IV rectal cancer|stage iv rectal cancer
5364240|NCT00182650|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5364241|NCT00182650|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5364242|NCT00182650|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5364243|NCT00182637|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5364244|NCT00182637|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
5364245|NCT00182637|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
5364246|NCT00182637|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
5364247|NCT00182637|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
5364248|NCT00182637|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
5364249|NCT00182637|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
5364250|NCT00182637|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
5364251|NCT00182637|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
5364252|NCT00182637|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5364253|NCT00182624|Prostate Cancer|prostate cancer
5364254|NCT00182624|Magnetic Resonance Imaging|magnetic resonance imaging
5364255|NCT00182624|Spectroscopy|spectroscopy
5364256|NCT00182611|stage III gastric cancer|stage iii gastric cancer
5364257|NCT00182611|adenocarcinoma of the stomach|adenocarcinoma of the stomach
5364258|NCT00182598|buprenorphine|buprenorphine
5364259|NCT00182598|computer|computer
5364260|NCT00182598|treatment|treatment
5364261|NCT00182598|opioid|opioid
5364262|NCT00182598|heroin|heroin
5364263|NCT00182585|HIV|hiv
5364264|NCT00182585|hepatitis|hepatitis
5364265|NCT00182585|STDs|stds
5364266|NCT00182585|adolescents|adolescents
5364267|NCT00182585|addiction|addiction
5364268|NCT00182585|treatment|treatment
5364269|NCT00182585|prevention|prevention
5364362|NCT00182234|unmet supportive care needs|unmet supportive care needs
5364270|NCT00182585|HIV and related risk behavior among youth in drug treatment|hiv and related risk behavior among youth in drug treatment
5364271|NCT00182572|heroin|heroin
5364272|NCT00182572|opiate|opiate
5364273|NCT00182572|addiction|addiction
5364274|NCT00182572|adolescent|adolescent
5364275|NCT00182572|treatment|treatment
5364276|NCT00182559|kidney|kidney
5364277|NCT00182559|transplantation|transplantation
5364278|NCT00182559|tacrolimus|tacrolimus
5364279|NCT00182559|cyclosporine|cyclosporine
5364280|NCT00182559|conversion|conversion
5364281|NCT00182546|Pulmonary Embolism|pulmonary embolism
5364282|NCT00182546|DVT|dvt
5364283|NCT00182546|Venous Thrombosis|venous thrombosis
5364284|NCT00182546|D dimer|d dimer
5364285|NCT00182546|DD|dd
5364286|NCT00182546|Thrombosis|thrombosis
5364287|NCT00182546|Diagnosis|diagnosis
5364288|NCT00182533|Generalized social phobia|generalized social phobia
5364289|NCT00182533|Comorbid panic disorder with agoraphobia|comorbid panic disorder with agoraphobia
5364290|NCT00182533|Comorbid obsessive compulsive disorder|comorbid obsessive compulsive disorder
5364291|NCT00182533|Comorbid generalized anxiety disorder|comorbid generalized anxiety disorder
5364292|NCT00182533|Comorbid major depressive disorder/Dysthymia|comorbid major depressive disorder/dysthymia
5364293|NCT00182520|Treatment Refractory Obsessive Compulsive Disorder|treatment refractory obsessive compulsive disorder
5364294|NCT00182494|Schizophrenia, Diabetes, Weight gain, Antipsychotic drugs|schizophrenia, diabetes, weight gain, antipsychotic drugs
5364295|NCT00182481|asthma treatment|asthma treatment
5364296|NCT00182481|induced sputum cell counts|induced sputum cell counts
5364297|NCT00182481|asthma exacerbations|asthma exacerbations
5364298|NCT00182481|eosinophilic bronchitis|eosinophilic bronchitis
5364299|NCT00182481|non-eosinophilic bronchitis|non-eosinophilic bronchitis
5364300|NCT00182468|Domestic violence|domestic violence
5364301|NCT00182468|Spouse Abuse|spouse abuse
5364302|NCT00182455|Treatment Refractory Generalized Social Phobia|treatment refractory generalized social phobia
5364303|NCT00182442|Cognitive deficits|cognitive deficits
5364304|NCT00182442|Psychosocial functioning|psychosocial functioning
5364305|NCT00182442|Quality of Life|quality of life
5364306|NCT00182429|Antibiotic associated diarrhea|antibiotic associated diarrhea
5364307|NCT00182429|C. difficile|c. difficile
5364308|NCT00182429|Metronidazole|metronidazole
5364309|NCT00182429|Rifampin|rifampin
5364310|NCT00182416|pacemakers|pacemakers
5364311|NCT00182416|atrial fibrillation|atrial fibrillation
5364312|NCT00182416|stroke|stroke
5364313|NCT00182416|cardiovascular death|cardiovascular death
5364314|NCT00182403|Unfractionated Heparin|unfractionated heparin
5364315|NCT00182403|Low Molecular Weight Heparin|low molecular weight heparin
5364316|NCT00182403|Venous Thromboembolism|venous thromboembolism
5364317|NCT00182403|APTT|aptt
5364318|NCT00182403|Treatment|treatment
5364319|NCT00182390|ELBW premature infants|elbw premature infants
5364320|NCT00182390|neonatal transfusion|neonatal transfusion
5364321|NCT00182390|bronchopulmonary dysplasia|bronchopulmonary dysplasia
5364322|NCT00182390|periventricular leukomalacia|periventricular leukomalacia
5364323|NCT00182390|ventriculomegaly|ventriculomegaly
5364324|NCT00182390|retinopathy of prematurity|retinopathy of prematurity
5364325|NCT00182377|patients undergoing cardiac surgery requiring cardiopulmonary bypass|patients undergoing cardiac surgery requiring cardiopulmonary bypass
5364326|NCT00182364|Critically Ill|critically ill
5364327|NCT00182364|Deep Venous Thrombosis|deep venous thrombosis
5364328|NCT00182364|Randomized Control Trial|randomized control trial
5364329|NCT00182364|Pilot Study|pilot study
5364330|NCT00182351|deep vein thrombosis|deep vein thrombosis
5364331|NCT00182351|d-dimer|d-dimer
5364332|NCT00182351|serial compression ultrasound|serial compression ultrasound
5364333|NCT00182338|cardiovascular outcomes|cardiovascular outcomes
5364334|NCT00182338|congestive heart failure|congestive heart failure
5364335|NCT00182338|Peritoneal Membrane transport properties|peritoneal membrane transport properties
5364336|NCT00182338|Arterial stiffening|arterial stiffening
5364337|NCT00182338|Inflammatory markers|inflammatory markers
5364338|NCT00182325|medical record|medical record
5364339|NCT00182325|pregnancy|pregnancy
5364340|NCT00182325|Internet|internet
5364341|NCT00182312|preterm infants|preterm infants
5364342|NCT00182312|very low birthweight|very low birthweight
5364343|NCT00182312|apnea of prematurity|apnea of prematurity
5364344|NCT00182312|methylxanthines|methylxanthines
5364345|NCT00182312|developmental disabilities|developmental disabilities
5364346|NCT00182286|Diabetes|diabetes
5364347|NCT00182286|Continuity of Care|continuity of care
5364348|NCT00182286|Patient Perspective|patient perspective
5364349|NCT00182286|Health Service Organization|health service organization
5364350|NCT00182273|Benign paroxysmal positional vertigo|benign paroxysmal positional vertigo
5364351|NCT00182273|Canalith repositioning maneuver|canalith repositioning maneuver
5364352|NCT00182273|Dizziness|dizziness
5364353|NCT00182273|Primary Care|primary care
5364354|NCT00182247|deep vein thrombosis|deep vein thrombosis
5364355|NCT00182247|DVT|dvt
5364356|NCT00182247|pulmonary embolism|pulmonary embolism
5364357|NCT00182247|PE|pe
5364358|NCT00182247|venous thromboembolism|venous thromboembolism
5364359|NCT00182247|VTE|vte
5364360|NCT00182247|d-dimer|d-dimer
5364361|NCT00182247|IPG|ipg
5364468|NCT00181870|mania|mania
5364363|NCT00182221|Pulmonary Embolism|pulmonary embolism
5364364|NCT00182221|Deep Vein Thrombosis|deep vein thrombosis
5364365|NCT00182221|MDA D-Dimer Testing|mda d-dimer testing
5364366|NCT00182221|Diagnostic Algorithm|diagnostic algorithm
5364367|NCT00182208|PTS|pts
5364368|NCT00182208|Post phlebitic Syndrome|post phlebitic syndrome
5364369|NCT00182208|Activities of Daily Living|activities of daily living
5364370|NCT00182208|Quality of Life|quality of life
5364371|NCT00182182|Heart Failure|heart failure
5364372|NCT00182182|Family physicians|family physicians
5364373|NCT00182182|academic detailing|academic detailing
5364374|NCT00182182|process of care|process of care
5364375|NCT00182169|Severe heart failure|severe heart failure
5364376|NCT00182169|Growth hormone|growth hormone
5364377|NCT00182169|exercise capacity|exercise capacity
5364378|NCT00182169|quality of life|quality of life
5364379|NCT00182169|cardiac function|cardiac function
5364380|NCT00182156|hemodialysis|hemodialysis
5364381|NCT00182156|platelet function analyzer|platelet function analyzer
5364382|NCT00182156|bioimpedance|bioimpedance
5364383|NCT00182156|pulse wave velocity|pulse wave velocity
5364384|NCT00182156|end stage renal disease|end stage renal disease
5364385|NCT00182143|Critically Ill|critically ill
5364386|NCT00182143|Deep Venous ThromboEmbolism|deep venous thromboembolism
5364387|NCT00182143|Randomized Controlled Trial|randomized controlled trial
5364388|NCT00182130|rectal cancer|rectal cancer
5364389|NCT00182130|surgery|surgery
5364390|NCT00182130|physician behaviour|physician behaviour
5364391|NCT00182130|knowledge translation|knowledge translation
5364392|NCT00182117|bleeding|bleeding
5364393|NCT00182117|end stage renal disease|end stage renal disease
5364394|NCT00182117|antiplatelet therapy|antiplatelet therapy
5364395|NCT00182117|anticoagulant therapy|anticoagulant therapy
5364396|NCT00182117|hemodialysis|hemodialysis
5364397|NCT00182104|Fontan procedure|fontan procedure
5364398|NCT00182104|Anticoagulation|anticoagulation
5364399|NCT00182104|Thrombosis|thrombosis
5364400|NCT00182104|Thromboembolism|thromboembolism
5364401|NCT00182104|Prevention|prevention
5364402|NCT00182091|Acromegaly|acromegaly
5364403|NCT00182091|Growth Hormone Deficiency|growth hormone deficiency
5364404|NCT00182091|Cardiovascular Risk|cardiovascular risk
5364405|NCT00182091|Pituitary|pituitary
5364406|NCT00182091|Hypothalamic|hypothalamic
5364407|NCT00182078|sertraline|sertraline
5364408|NCT00182078|children|children
5364409|NCT00182078|adolescents|adolescents
5364410|NCT00182078|posttraumatic stress disorder|posttraumatic stress disorder
5364411|NCT00182078|depression|depression
5364412|NCT00182078|prevention|prevention
5364414|NCT00182078|injuries|injuries
5364415|NCT00182065|Heart failure|heart failure
5364416|NCT00182065|Functional decline|functional decline
5364417|NCT00182065|Cognitive impairment|cognitive impairment
5364418|NCT00182065|Neuropsychiatric health|neuropsychiatric health
5364419|NCT00182065|Longitudinal|longitudinal
5364420|NCT00182065|Long-term care|long-term care
5364421|NCT00182065|Elderly|elderly
5364422|NCT00182052|rosiglitazone|rosiglitazone
5364423|NCT00182052|Avandia|avandia
5364424|NCT00182052|androgen dependant prostate cancer|androgen dependant prostate cancer
5364425|NCT00182039|randomized controlled trial|randomized controlled trial
5364426|NCT00182039|blinded|blinded
5364427|NCT00182039|noncardiac surgery|noncardiac surgery
5364428|NCT00182039|cardiovascular events|cardiovascular events
5364429|NCT00182026|diabetes|diabetes
5364430|NCT00182026|community intervention|community intervention
5364431|NCT00182026|self-management|self-management
5364432|NCT00182026|prevention|prevention
5364433|NCT00182000|OCD|ocd
5364434|NCT00181987|ADHD|adhd
5364435|NCT00181987|bipolar disorder|bipolar disorder
5364436|NCT00181987|children|children
5364437|NCT00181987|Concerta|concerta
5364438|NCT00181974|burns|burns
5364439|NCT00181974|hemostasis|hemostasis
5364440|NCT00181974|skin graft|skin graft
5364441|NCT00181974|Surgical Hemostasis|surgical hemostasis
5364442|NCT00181974|Grafting, Skin|grafting, skin
5364443|NCT00181961|antidepressant-induced sexual dysfunction|antidepressant-induced sexual dysfunction
5364444|NCT00181948|ADHD|adhd
5364445|NCT00181948|children|children
5364446|NCT00181948|stimulant non-responders|stimulant non-responders
5364447|NCT00181948|Strattera|strattera
5364448|NCT00181935|bipolar disorder|bipolar disorder
5364449|NCT00181935|preschoolers|preschoolers
5364450|NCT00181935|risperdal|risperdal
5364451|NCT00181935|zyprexa|zyprexa
5364452|NCT00181922|bipolar disorder|bipolar disorder
5364453|NCT00181922|children|children
5364454|NCT00181922|ziprasidone|ziprasidone
5364455|NCT00181922|mania|mania
5364456|NCT00181909|Pregnancy|pregnancy
5364457|NCT00181909|Smoking cessation|smoking cessation
5364458|NCT00181896|depression|depression
5364459|NCT00181896|bipolar disorder|bipolar disorder
5364460|NCT00181896|children|children
5364461|NCT00181896|bupropion SR|bupropion sr
5364462|NCT00181883|children|children
5364463|NCT00181883|bipolar disorder|bipolar disorder
5364464|NCT00181883|quetiapine|quetiapine
5364465|NCT00181883|preschoolers|preschoolers
5364466|NCT00181870|bipolar disorder|bipolar disorder
5364467|NCT00181870|children|children
5364471|NCT00181857|familial risk|familial risk
5364472|NCT00181857|children|children
5364473|NCT00181844|bipolar disorder|bipolar disorder
5364474|NCT00181844|lamotrigine|lamotrigine
5364475|NCT00181844|children|children
5364476|NCT00181844|mania|mania
5364477|NCT00181831|SPECT|spect
5364478|NCT00181831|bipolar disorder|bipolar disorder
5364479|NCT00181831|ADHD|adhd
5364480|NCT00181831|children|children
5364481|NCT00181818|Smoking cessation|smoking cessation
5364482|NCT00181818|Bupropion SR|bupropion sr
5364483|NCT00181818|Hospital intervention|hospital intervention
5364484|NCT00181818|Myocardial infarction|myocardial infarction
5364485|NCT00181818|Unstable angina|unstable angina
5364486|NCT00181805|GER|ger
5364487|NCT00181792|ADHD|adhd
5364488|NCT00181792|smoking|smoking
5364489|NCT00181792|familial risk|familial risk
5364490|NCT00181779|mania|mania
5364491|NCT00181779|Abilify|abilify
5364492|NCT00181779|children|children
5364493|NCT00181779|bipolar disorder|bipolar disorder
5364494|NCT00181766|ADHD NOS|adhd nos
5364495|NCT00181766|Adults|adults
5364496|NCT00181766|Strattera (atomoxetine)|strattera (atomoxetine)
5364497|NCT00181766|Open-Label|open-label
5364498|NCT00181753|glutamine metabolic kinetics|glutamine metabolic kinetics
5364499|NCT00181753|glutamate metabolic kinetics|glutamate metabolic kinetics
5364500|NCT00181753|enteral nutrition|enteral nutrition
5364501|NCT00181753|parenteral nutrition|parenteral nutrition
5364502|NCT00181753|burn injury|burn injury
5364503|NCT00181753|stable isotopes|stable isotopes
5364504|NCT00181740|ADHD NOS|adhd nos
5364505|NCT00181740|Adults|adults
5364506|NCT00181740|Concerta|concerta
5364507|NCT00181740|Open-Label|open-label
5364508|NCT00181727|bipolar disorder|bipolar disorder
5364509|NCT00181727|mania|mania
5364510|NCT00181727|depakote ER|depakote er
5364511|NCT00181727|children|children
5364512|NCT00181714|cigarette smoking|cigarette smoking
5364513|NCT00181714|ADHD|adhd
5364514|NCT00181714|adolescents|adolescents
5364515|NCT00181714|Concerta|concerta
5364516|NCT00181701|Ovarian cancer|ovarian cancer
5364517|NCT00181701|Epithelial carcinoma of mullerian origin|epithelial carcinoma of mullerian origin
5364518|NCT00181701|Intraperitoneal paclitaxel|intraperitoneal paclitaxel
5364519|NCT00181701|Intraperitoneal carboplatin|intraperitoneal carboplatin
5364520|NCT00181701|Primary peritoneal carcinoma|primary peritoneal carcinoma
5364521|NCT00181701|Tubal carcinoma|tubal carcinoma
5364522|NCT00181688|Iressa|iressa
5364523|NCT00181688|ZD1839|zd1839
5364524|NCT00181688|Anastrozole|anastrozole
5364525|NCT00181688|Arimidex|arimidex
5364526|NCT00181675|Adult|adult
5364527|NCT00181675|ADHD|adhd
5364528|NCT00181675|galantamine|galantamine
5364529|NCT00181675|double-blind|double-blind
5364530|NCT00181662|Curcumin|curcumin
5364531|NCT00181662|Piperine|piperine
5364532|NCT00181662|Silybin|silybin
5364533|NCT00181662|Healthy volunteer|healthy volunteer
5364534|NCT00181662|Female|female
5364535|NCT00181649|Lactation|lactation
5364536|NCT00181649|Breastfeeding|breastfeeding
5364537|NCT00181649|Adoptive mothers|adoptive mothers
5364538|NCT00181649|Prolactin|prolactin
5364539|NCT00181649|Relative lactation insufficiency|relative lactation insufficiency
5364540|NCT00181623|Lactation|lactation
5364541|NCT00181623|Breastfeeding|breastfeeding
5364542|NCT00181623|Prolactin|prolactin
5364543|NCT00181623|Primary lactation insufficiency|primary lactation insufficiency
5364544|NCT00181610|Lactation|lactation
5364545|NCT00181610|Breastfeeding|breastfeeding
5364546|NCT00181610|Premature infants|premature infants
5364547|NCT00181610|Prolactin|prolactin
5364548|NCT00181610|Primary lactation insufficiency|primary lactation insufficiency
5364549|NCT00181597|Trilostane|trilostane
5364550|NCT00181597|Androgen-independent prostate cancer|androgen-independent prostate cancer
5364551|NCT00181584|Androgen deprivation therapy|androgen deprivation therapy
5364552|NCT00181584|bone loss|bone loss
5364553|NCT00181584|prostate cancer|prostate cancer
5364554|NCT00181584|Zoledronic Acid|zoledronic acid
5364555|NCT00181584|Zometa|zometa
5364556|NCT00181571|ADHD|adhd
5364557|NCT00181571|Adults|adults
5364558|NCT00181571|Concerta|concerta
5364559|NCT00181571|Double-Blind|double-blind
5364560|NCT00181558|Prostate Cancer|prostate cancer
5364561|NCT00181558|bone metastases|bone metastases
5364562|NCT00181558|Atrasentan|atrasentan
5364563|NCT00181558|Zometa|zometa
5364564|NCT00181558|Androgen Independent Prostate Cancer|androgen independent prostate cancer
5364565|NCT00181545|Non-small cell lung carcinoma|non-small cell lung carcinoma
5364566|NCT00181545|radiotherapy|radiotherapy
5364567|NCT00181545|mean lung dose|mean lung dose
5364568|NCT00181532|NSCLC|nsclc
5364569|NCT00181532|cox-2-inhibitor|cox-2-inhibitor
5364570|NCT00181532|radiosensitizer|radiosensitizer
5364571|NCT00181532|radiotherapy|radiotherapy
5364572|NCT00181506|radiotherapy|radiotherapy
5364573|NCT00181506|radiation dose|radiation dose
5364574|NCT00181506|lung cancer|lung cancer
5364575|NCT00181363|Breast cancer|breast cancer
5364576|NCT00181363|Breast conserving surgery|breast conserving surgery
5364577|NCT00181363|Radiotherapy|radiotherapy
5364578|NCT00181363|Pendulous breasts|pendulous breasts
5364579|NCT00181350|brain tumor|brain tumor
5364580|NCT00181350|fractionated stereotactic radiotherapy|fractionated stereotactic radiotherapy
5364581|NCT00181350|fixationsystems|fixationsystems
5364582|NCT00181350|repositioning|repositioning
5364583|NCT00181311|vaginal hysterectomy|vaginal hysterectomy
5364584|NCT00181311|abdominal hysterectomy|abdominal hysterectomy
5364585|NCT00181311|complications|complications
5364586|NCT00181311|physical well being|physical well being
5364587|NCT00181311|mental well being|mental well being
5364588|NCT00181298|Memantine|memantine
5364589|NCT00181298|SLE|sle
5364590|NCT00181298|Anti NR2|anti nr2
5364591|NCT00181298|ANAM|anam
5364592|NCT00181298|Cognitive functioning|cognitive functioning
5364593|NCT00181272|chronic obstructive pulmonary disease (COPD)|chronic obstructive pulmonary disease (copd)
5364594|NCT00181272|undifferentiated asthma/COPD|undifferentiated asthma/copd
5364595|NCT00181246|Neuropathic pain|neuropathic pain
5364596|NCT00181246|Efficacy|efficacy
5364597|NCT00181207|COPD|copd
5364598|NCT00181194|Asthma|asthma
5364599|NCT00181181|Hypertension|hypertension
5364600|NCT00181168|thyroid cancer|thyroid cancer
5364601|NCT00181168|PET scan|pet scan
5364602|NCT00181168|recombinant thyrotropin|recombinant thyrotropin
5364603|NCT00181168|thyroglobulin|thyroglobulin
5364604|NCT00181168|Thyroid cancer, differentiated epithelial|thyroid cancer, differentiated epithelial
5364605|NCT00181155|metabolism|metabolism
5364606|NCT00181155|congestive heart failure|congestive heart failure
5364607|NCT00181155|allopurinol|allopurinol
5364608|NCT00181155|Adenosine triphosphate (ATP)|adenosine triphosphate (atp)
5364609|NCT00181142|Induciton therapy, Daclizumab, Thymoglobulin, lung transplantation|induciton therapy, daclizumab, thymoglobulin, lung transplantation
5364610|NCT00181129|Fatigue|fatigue
5364611|NCT00181129|Cancer treatment|cancer treatment
5364612|NCT00181116|Epilepsy|epilepsy
5364613|NCT00181116|Benign rolandic|benign rolandic
5364614|NCT00181116|Levetiracetam|levetiracetam
5364615|NCT00181090|Epilepsy|epilepsy
5364616|NCT00181090|Ketosis|ketosis
5364617|NCT00181090|Atkins|atkins
5364618|NCT00181090|seizures|seizures
5364619|NCT00181077|preeclampsia, hypertonic saline, diuresis|preeclampsia, hypertonic saline, diuresis
5364620|NCT00181064|headache|headache
5364621|NCT00181064|Atkins|atkins
5364622|NCT00181064|ketosis|ketosis
5364623|NCT00181064|intractable|intractable
5364624|NCT00181038|Oro-Pharyngeal Carcinoma Surgery|oro-pharyngeal carcinoma surgery
5364625|NCT00181025|Limbs’ girdle|limbs’ girdle
5364626|NCT00181012|Cancer Related Visceral Pain Resistant to Morphinics|cancer related visceral pain resistant to morphinics
5364627|NCT00180947|Soft parts tissue|soft parts tissue
5364628|NCT00180921|Adenoid cystic carcinoma of the head and neck|adenoid cystic carcinoma of the head and neck
5364629|NCT00180908|Osteosarcoma|osteosarcoma
5364630|NCT00180895|Burkitt lymphoma|burkitt lymphoma
5364631|NCT00180895|B-cell non Hodgkin lymphoma|b-cell non hodgkin lymphoma
5364632|NCT00180895|B-cell ALL|b-cell all
5364633|NCT00180895|Refractory|refractory
5364634|NCT00180895|Relapse|relapse
5364635|NCT00180895|Rituximab|rituximab
5364636|NCT00180895|Children|children
5364637|NCT00180869|cancer|cancer
5364638|NCT00180869|peroperative transfusion|peroperative transfusion
5364639|NCT00180869|allogeneic red blood cell concentrate|allogeneic red blood cell concentrate
5364640|NCT00180869|leuko-reduced red blood cell concentrate|leuko-reduced red blood cell concentrate
5364641|NCT00180856|Lung metastasis|lung metastasis
5364642|NCT00180856|Lung cancer|lung cancer
5364643|NCT00180856|Radiofrequency ablation|radiofrequency ablation
5364644|NCT00180791|Brain PNET|brain pnet
5364645|NCT00180765|Leukocytes|leukocytes
5364646|NCT00180765|Eosinophils|eosinophils
5364647|NCT00180765|Neutrophils|neutrophils
5364648|NCT00180765|Chronic Obstructive Airway Disease|chronic obstructive airway disease
5364649|NCT00180765|Apoptosis|apoptosis
5364650|NCT00180765|Signal Transduction|signal transduction
5364651|NCT00180739|MR guided FUS|mr guided fus
5364652|NCT00180739|Uterine Fibroids|uterine fibroids
5364653|NCT00180739|Fertility|fertility
5364654|NCT00180739|Pregnancy|pregnancy
5364655|NCT00180726|asthma, inflammatory, corticosteroid|asthma, inflammatory, corticosteroid
5364656|NCT00180713|Pulmonary hypertension|pulmonary hypertension
5364657|NCT00180713|Simvastatin|simvastatin
5364658|NCT00180713|Statins|statins
5364659|NCT00180700|HIV|hiv
5364660|NCT00180700|Stress|stress
5364661|NCT00180700|Psychoneuroimmunology|psychoneuroimmunology
5364662|NCT00180700|stress management|stress management
5364663|NCT00180700|hypnosis|hypnosis
5364664|NCT00180700|Johrei|johrei
5364665|NCT00180700|psychological intervention|psychological intervention
5364666|NCT00180687|Pain|pain
5364667|NCT00180687|Nebulisation|nebulisation
5364668|NCT00180687|Cholecystectomy|cholecystectomy
5364669|NCT00180687|Laparoscopic|laparoscopic
5364670|NCT00180687|Bupivacaine|bupivacaine
5364671|NCT00180687|Local Anaesthetic|local anaesthetic
5364672|NCT00180674|Hepatic fibrosis|hepatic fibrosis
5364673|NCT00180674|anticoagulation|anticoagulation
5364674|NCT00180674|Coumarin|coumarin
5364675|NCT00180674|Warfarin|warfarin
5364676|NCT00180674|Chronic hepatitis C virus infection|chronic hepatitis c virus infection
5364677|NCT00180661|Severe asthma|severe asthma
5364678|NCT00180661|corticosteroid responsiveness|corticosteroid responsiveness
5364679|NCT00180648|Short Bowel Syndrome|short bowel syndrome
5364680|NCT00180648|Intestinal Failure|intestinal failure
5364681|NCT00180648|Glucagon Like Peptide 2|glucagon like peptide 2
5364682|NCT00180648|Parenteral Nutrition|parenteral nutrition
5364683|NCT00180518|Carotid artery disease|carotid artery disease
5364684|NCT00180518|High risk|high risk
5364685|NCT00180518|High surgical risk|high surgical risk
5364686|NCT00180505|Peripheral Artery Disease|peripheral artery disease
5364687|NCT00180505|Restenosis Rate|restenosis rate
5364688|NCT00180505|Patency Rates|patency rates
5364689|NCT00180505|Self-Expandable Nitinol Stents|self-expandable nitinol stents
5364690|NCT00180505|Stent Fractures|stent fractures
5364691|NCT00180492|Atherosclerotic disease|atherosclerotic disease
5364692|NCT00180479|Everolimus|everolimus
5364693|NCT00180466|drug eluting stents|drug eluting stents
5364694|NCT00180466|stents|stents
5364695|NCT00180466|angioplasty|angioplasty
5364696|NCT00180466|coronary artery disease|coronary artery disease
5364697|NCT00180466|total coronary occlusion|total coronary occlusion
5364698|NCT00180466|coronary artery restenosis|coronary artery restenosis
5364699|NCT00180466|stent thrombosis|stent thrombosis
5364700|NCT00180466|vascular disease|vascular disease
5364701|NCT00180466|myocardial ischemia|myocardial ischemia
5364702|NCT00180466|coronary artery stenosis|coronary artery stenosis
5364703|NCT00180453|Cardiovascular disease|cardiovascular disease
5364704|NCT00180453|Ischemia|ischemia
5364705|NCT00180414|heart failure|heart failure
5364706|NCT00180388|cardiovascular system|cardiovascular system
5364707|NCT00180388|veins|veins
5364708|NCT00180388|saphenous vein|saphenous vein
5364709|NCT00180336|Heart Failure|heart failure
5364710|NCT00180336|Tachycardia|tachycardia
5364711|NCT00180336|Atrial Fibrillation|atrial fibrillation
5364712|NCT00180336|Atrial Flutter|atrial flutter
5364713|NCT00180336|Ventricular Fibrillation|ventricular fibrillation
5364714|NCT00180310|drug eluting stents|drug eluting stents
5364715|NCT00180310|stents|stents
5364716|NCT00180310|angioplasty|angioplasty
5364717|NCT00180310|coronary artery disease|coronary artery disease
5364718|NCT00180310|total coronary occlusion|total coronary occlusion
5364719|NCT00180310|coronary artery restenosis|coronary artery restenosis
5364720|NCT00180310|stent thrombosis|stent thrombosis
5364721|NCT00180310|vascular disease|vascular disease
5364722|NCT00180310|myocardial ischemia|myocardial ischemia
5364723|NCT00180310|coronary artery stenosis|coronary artery stenosis
5364724|NCT00180284|Pacemaker leads|pacemaker leads
5364725|NCT00180284|Electrodes, implantable|electrodes, implantable
5364726|NCT00180284|Cardiac pacing, aritificial|cardiac pacing, aritificial
5364727|NCT00180271|Defibrillator|defibrillator
5364728|NCT00180271|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
5364729|NCT00180271|MADIT|madit
5364730|NCT00180258|Cardiac Resynchronization Therapy (CRT)|cardiac resynchronization therapy (crt)
5364731|NCT00180258|Heart Failure|heart failure
5364732|NCT00180258|Defibrillator|defibrillator
5364733|NCT00180258|Pacemaker|pacemaker
5364734|NCT00180245|Radiation therapy|radiation therapy
5364735|NCT00180245|F-18-FDG|f-18-fdg
5364736|NCT00180219|G08.520.769.550.408|g08.520.769.550.408
5364737|NCT00180219|G08.520.769.550.490|g08.520.769.550.490
5364738|NCT00180219|G08.520.769.550.520|g08.520.769.550.520
5364739|NCT00180206|Arthritis|arthritis
5364740|NCT00180206|Hip|hip
5364741|NCT00180206|Hip arthroplasty|hip arthroplasty
5364742|NCT00180206|Hip resurfacing arthroplasty|hip resurfacing arthroplasty
5364743|NCT00180193|Radiotherapy|radiotherapy
5364744|NCT00180193|F-18-OMFD|f-18-omfd
5364745|NCT00180180|head-and-neck cancer|head-and-neck cancer
5364746|NCT00180180|radiation therapy|radiation therapy
5364747|NCT00180180|F-18-FMISO|f-18-fmiso
5364748|NCT00180167|Chemotherapy|chemotherapy
5364749|NCT00180167|elderly|elderly
5364750|NCT00180154|radiation therapy|radiation therapy
5364751|NCT00180154|F-18-FDG|f-18-fdg
5364752|NCT00180154|NSCLC|nsclc
5364753|NCT00180141|Atopic dermatitis on both lower arm.|atopic dermatitis on both lower arm.
5364754|NCT00180128|acute promyelocytic leukemia|acute promyelocytic leukemia
5364755|NCT00180128|risk adapted therapy|risk adapted therapy
5364756|NCT00180115|acute myeloid leukemia|acute myeloid leukemia
5364757|NCT00180115|cytarabine postremission dosage|cytarabine postremission dosage
5364758|NCT00180115|risk adapted treatment strategy|risk adapted treatment strategy
5364759|NCT00180115|allogeneic stem cell transplantation|allogeneic stem cell transplantation
5364760|NCT00180115|autologous stem cell transplantation|autologous stem cell transplantation
5364761|NCT00180102|acute myeloid leukemia|acute myeloid leukemia
5364762|NCT00180102|risk adapted treatment|risk adapted treatment
5364763|NCT00180102|early allogeneic stem cell transplantation|early allogeneic stem cell transplantation
5364764|NCT00180102|autologous stem cell transplantation|autologous stem cell transplantation
5364765|NCT00180089|graft-versus-host disease|graft-versus-host disease
5364766|NCT00180089|budesonide|budesonide
5364767|NCT00180089|stem cell transplantation|stem cell transplantation
5364768|NCT00180076|collagenous colitis|collagenous colitis
5364769|NCT00180076|microscopic colitis|microscopic colitis
5364770|NCT00180076|budesonide|budesonide
5364771|NCT00180050|lymphocytic colitis|lymphocytic colitis
5364772|NCT00180050|microscopic colitis|microscopic colitis
5364773|NCT00180050|budesonide|budesonide
5364774|NCT00180037|Parkinson's disease|parkinson's disease
5364775|NCT00180037|Coenzyme Q10|coenzyme q10
5364776|NCT00180037|Treatment|treatment
5364777|NCT00180037|Neuroprotection|neuroprotection
5364778|NCT00180024|AT1-receptor|at1-receptor
5364779|NCT00180024|AT2-receptor|at2-receptor
5364780|NCT00180024|human pharmacology|human pharmacology
5364781|NCT00180011|omalizumab|omalizumab
5364782|NCT00180011|severe asthma|severe asthma
5364783|NCT00180011|moderate asthma|moderate asthma
5364784|NCT00180011|injectable asthma medication|injectable asthma medication
5364785|NCT00180011|Xolair|xolair
5364786|NCT00179998|Cystic fibrosis|cystic fibrosis
5364787|NCT00179998|Infants|infants
5364788|NCT00179998|Children|children
5364789|NCT00179998|Pulmozyme|pulmozyme
5364790|NCT00179998|Pulmonary function|pulmonary function
5364791|NCT00179998|Computed tomography|computed tomography
5364792|NCT00179985|Developmental Care|developmental care
5364793|NCT00179985|Neonatal Intensive Care Unit (NICU)|neonatal intensive care unit (nicu)
5364794|NCT00179972|Pulse oximetry|pulse oximetry
5364795|NCT00179972|Pulse oximetry sensors|pulse oximetry sensors
5364796|NCT00179972|Skin Integrity|skin integrity
5364797|NCT00179972|Prematurity|prematurity
5364798|NCT00179972|Neonatal Intensive Care Unit|neonatal intensive care unit
5364799|NCT00179972|Infant, premature|infant, premature
5364800|NCT00179933|developmental care|developmental care
5364801|NCT00179933|Neonatal Intensive Care Unit|neonatal intensive care unit
5364802|NCT00179894|ADHD|adhd
5364803|NCT00179894|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
5364804|NCT00179881|Brain stem glioma|brain stem glioma
5364805|NCT00179868|cancer|cancer
5364806|NCT00179868|leukemia|leukemia
5364807|NCT00179868|stem cell transplant|stem cell transplant
5364808|NCT00179868|complications|complications
5364809|NCT00179855|graft versus host disease|graft versus host disease
5364810|NCT00179855|ECP|ecp
5364811|NCT00179855|extracorporeal photopheresis|extracorporeal photopheresis
5364812|NCT00179855|allogeneic transplantation|allogeneic transplantation
5364813|NCT00179829|leukemia|leukemia
5364814|NCT00179829|acute lymphocytic leukemia|acute lymphocytic leukemia
5364815|NCT00179829|chronic myelogenous leukemia|chronic myelogenous leukemia
5364816|NCT00179829|acute myelogenous leukemia|acute myelogenous leukemia
5364817|NCT00179816|wilm's tumor|wilm's tumor
5364818|NCT00179816|stem cell transplantation|stem cell transplantation
5364819|NCT00179816|solid tumor|solid tumor
5364820|NCT00179803|brain tumor|brain tumor
5364821|NCT00179803|medulloblastoma|medulloblastoma
5364822|NCT00179803|germ cell tumor|germ cell tumor
5364823|NCT00179803|CNS tumor|cns tumor
5364824|NCT00179803|glioblastoma|glioblastoma
5364825|NCT00179803|astrocytoma|astrocytoma
5364826|NCT00179803|pineoblastoma|pineoblastoma
5364827|NCT00179803|rhabdoid tumor|rhabdoid tumor
5364828|NCT00179803|supratentorial PNET|supratentorial pnet
5364829|NCT00179803|high grade astrocytoma|high grade astrocytoma
5364830|NCT00179790|cancer|cancer
5364831|NCT00179790|hemoglobinopathy|hemoglobinopathy
5364832|NCT00179790|immune deficiency|immune deficiency
5364833|NCT00179790|photopheresis|photopheresis
5364834|NCT00179790|ECP|ecp
5364835|NCT00179790|extracorporeal photopheresis|extracorporeal photopheresis
5364836|NCT00179777|Diabetes Mellitus, Type 1|diabetes mellitus, type 1
5364837|NCT00179777|Genetic Predisposition to Disease|genetic predisposition to disease
5364838|NCT00179777|Infant Nutrition|infant nutrition
5364839|NCT00179777|Primary Prevention|primary prevention
5364840|NCT00179764|Patients with recurrent solid tumors|patients with recurrent solid tumors
5364841|NCT00179764|Patients with malignant melanoma|patients with malignant melanoma
5364842|NCT00179764|Patients with hematological malignancies|patients with hematological malignancies
5364843|NCT00179764|Acute lymphoblastic leukemia (ALL)|acute lymphoblastic leukemia (all)
5364844|NCT00179764|Acute myelogenous leukemia (AML)|acute myelogenous leukemia (aml)
5364845|NCT00179751|cc-5013|cc-5013
5364846|NCT00179751|revlimid|revlimid
5364847|NCT00179751|pancreatic cancer|pancreatic cancer
5364848|NCT00179738|Androgen Independent Prostate Cancer|androgen independent prostate cancer
5364849|NCT00179725|cc-5013|cc-5013
5364850|NCT00179725|revlimid|revlimid
5364851|NCT00179725|ovarian cancer|ovarian cancer
5364852|NCT00179725|celgene|celgene
5364853|NCT00179712|cc-5013|cc-5013
5364854|NCT00179712|revlimid|revlimid
5364855|NCT00179712|ovarian cancer|ovarian cancer
5364856|NCT00179712|celgene|celgene
5364857|NCT00179699|cc-5013|cc-5013
5364858|NCT00179699|Non Small Cell Lung Cancer|non small cell lung cancer
5364859|NCT00179699|revlimid|revlimid
5364860|NCT00179699|celgene|celgene
5364861|NCT00179699|cc5013|cc5013
5364862|NCT00179686|celgene|celgene
5364863|NCT00179686|cc-5013|cc-5013
5364864|NCT00179686|NSCLC|nsclc
5364865|NCT00179686|CC5013|cc5013
5364866|NCT00179686|Revlimid|revlimid
5364867|NCT00179686|Non-Small Cell Lung Cancer|non-small cell lung cancer
5364868|NCT00179673|NHL|nhl
5364869|NCT00179673|CC5013|cc5013
5364870|NCT00179673|Non-Hodgkins Lymphoma|non-hodgkins lymphoma
5364871|NCT00179673|revlimid|revlimid
5364872|NCT00179673|cc-5013|cc-5013
5364873|NCT00179673|celgene|celgene
5364874|NCT00179660|celgene|celgene
5364875|NCT00179660|cc-5013|cc-5013
5364876|NCT00179660|CC5013|cc5013
5364877|NCT00179660|NHL|nhl
5364878|NCT00179660|Non-Hodgkins Lymphoma|non-hodgkins lymphoma
5364879|NCT00179660|Revlimid|revlimid
5364880|NCT00179647|Multiple Myeloma|multiple myeloma
5364881|NCT00179647|MM|mm
5364882|NCT00179647|Revlimid|revlimid
5364883|NCT00179647|CC5013|cc5013
5364884|NCT00179647|celgene|celgene
5364885|NCT00179647|cc-5013|cc-5013
5364886|NCT00179647|relapsed/refractory|relapsed/refractory
5364887|NCT00179647|lenalidomide|lenalidomide
5364888|NCT00179647|dexamethasone|dexamethasone
5364889|NCT00179647|Decadron|decadron
5364890|NCT00179634|Mastectomy|mastectomy
5364891|NCT00179634|Randomized Controlled Trial|randomized controlled trial
5364892|NCT00179634|Imagery|imagery
5364893|NCT00179621|MDS|mds
5364894|NCT00179621|transfusion dependent|transfusion dependent
5364895|NCT00179621|anaemia|anaemia
5364896|NCT00179621|cytogenetic abnormality 5q-|cytogenetic abnormality 5q-
5364897|NCT00179621|erythroid response|erythroid response
5364898|NCT00179621|leukaemia|leukaemia
5364899|NCT00179621|CC-5013|cc-5013
5364900|NCT00179621|Celgene|celgene
5364901|NCT00179621|revlimid|revlimid
5364902|NCT00179621|lenalidomide|lenalidomide
5364903|NCT00179608|CC-5013|cc-5013
5364904|NCT00179608|CC5013|cc5013
5364905|NCT00179608|celgene|celgene
5364906|NCT00179608|Melanoma|melanoma
5364907|NCT00179608|Revlimid|revlimid
5364908|NCT00179608|Metastatic Malignant Melanoma|metastatic malignant melanoma
5364909|NCT00179608|Lenalidomide|lenalidomide
5364910|NCT00179595|nitric oxide, volumetric oxygen consumption|nitric oxide, volumetric oxygen consumption
5364911|NCT00179582|IBS|ibs
5364912|NCT00179582|Functional bowel disorder|functional bowel disorder
5364913|NCT00179582|Diarrhea|diarrhea
5364914|NCT00179582|probiotic|probiotic
5364915|NCT00179556|Hot flashes|hot flashes
5364916|NCT00179556|Menopausal symptoms|menopausal symptoms
5364917|NCT00179556|Soybean germ|soybean germ
5364918|NCT00179556|Aglycones|aglycones
5364919|NCT00179556|Menopause|menopause
5364920|NCT00179517|Seizure|seizure
5364921|NCT00179517|Epilepsy|epilepsy
5364922|NCT00179517|Testosterone|testosterone
5364923|NCT00179517|Hormone|hormone
5364924|NCT00179517|Sexual Dysfunction|sexual dysfunction
5364925|NCT00179517|Hypogonadism|hypogonadism
5364926|NCT00179517|Men|men
5364927|NCT00179491|coronary artery bypass grafting surgery|coronary artery bypass grafting surgery
5364928|NCT00179478|Multiple sclerosis|multiple sclerosis
5364929|NCT00179478|Interferon Beta|interferon beta
5364930|NCT00179478|MRI|mri
5364931|NCT00179478|Optic neuritis|optic neuritis
5364932|NCT00179478|Transverse Myelitis|transverse myelitis
5364933|NCT00179465|Treatment|treatment
5364934|NCT00179465|fMRI|fmri
5364935|NCT00179465|Cognition|cognition
5364936|NCT00179465|Brain development|brain development
5364937|NCT00179452|epilepsy, yoga|epilepsy, yoga
5364938|NCT00179439|PSC|psc
5364939|NCT00179439|IBD|ibd
5364940|NCT00179439|CFTR|cftr
5364941|NCT00179426|Seizure Disorder|seizure disorder
5364942|NCT00179426|Hypogonadism|hypogonadism
5364943|NCT00179426|Sexual Function|sexual function
5364944|NCT00179426|Epilepsy|epilepsy
5364945|NCT00179413|hepatitis C|hepatitis c
5364946|NCT00179413|cirrhosis|cirrhosis
5364947|NCT00179413|interferon|interferon
5364948|NCT00179413|colchicine|colchicine
5364949|NCT00179387|Neoplasms|neoplasms
5364950|NCT00179387|Needs Assessment|needs assessment
5364951|NCT00179387|Adaptation Psychological|adaptation psychological
5364952|NCT00179387|Minority Groups|minority groups
5364953|NCT00179387|Psychotherapy, Group|psychotherapy, group
5364954|NCT00179387|Program Evaluation|program evaluation
5364955|NCT00179387|Spirituality|spirituality
5364956|NCT00179387|Spiritual Therapies|spiritual therapies
5364957|NCT00179374|Medication adherence|medication adherence
5364958|NCT00179374|Self-care behaviors|self-care behaviors
5364959|NCT00179374|Telephonic intervention|telephonic intervention
5364960|NCT00179374|Diabetes|diabetes
5364961|NCT00179374|Nutrition|nutrition
5364962|NCT00179374|Exercise|exercise
5364963|NCT00179335|Regular lopinavir/ritonavir or Efavirenz use|regular lopinavir/ritonavir or efavirenz use
5364964|NCT00179335|Age >/= 55 y or </= 35 y|age >/= 55 y or </= 35 y
5364965|NCT00179335|HIV+|hiv+
5364966|NCT00179322|Sleep Architecture|sleep architecture
5364967|NCT00179322|Sleep Measures|sleep measures
5364968|NCT00179322|Speech Articulation|speech articulation
5364969|NCT00179322|Cerebral Perfusion|cerebral perfusion
5364970|NCT00179322|Neuroimaging|neuroimaging
5364971|NCT00179322|Healthy Volunteer|healthy volunteer
5364972|NCT00179322|HV|hv
5364973|NCT00179309|CEA|cea
5364974|NCT00179309|MUC-1|muc-1
5364975|NCT00179309|Immunotherapy|immunotherapy
5364976|NCT00179309|GM-CSF|gm-csf
5364977|NCT00179309|Vaccine|vaccine
5364978|NCT00179309|Breast Cancer|breast cancer
5364979|NCT00179309|Metastatic Breast Cancer|metastatic breast cancer
5364980|NCT00179257|Failure to Escitalopram|failure to escitalopram
5364981|NCT00179244|Treatment Resistant Depression|treatment resistant depression
5364982|NCT00179192|End Stage Renal Disease|end stage renal disease
5364983|NCT00179192|ESRD|esrd
5364984|NCT00179192|Chronic Maintenance Hemodialysis|chronic maintenance hemodialysis
5364985|NCT00179127|Pediatrics|pediatrics
5364986|NCT00179127|Diabetes|diabetes
5364987|NCT00179127|Emergency Care|emergency care
5364988|NCT00179127|Endocrinology|endocrinology
5364989|NCT00179127|Critical Care|critical care
5364990|NCT00179114|Spasticity|spasticity
5364991|NCT00179114|Developmental Disabilities|developmental disabilities
5364992|NCT00179114|Intrathecal baclofen (ITB)|intrathecal baclofen (itb)
5364993|NCT00179114|Botulinum Toxin Type A (Botox)|botulinum toxin type a (botox)
5364994|NCT00179101|Parkinson's Disease|parkinson's disease
5364995|NCT00179101|Depression|depression
5364996|NCT00179101|Quality of Life|quality of life
5364997|NCT00179101|Deep Brain Stimulation|deep brain stimulation
5364998|NCT00179088|Weight-Bearing|weight-bearing
5364999|NCT00179088|Total Hip Replacement|total hip replacement
5365000|NCT00179088|Non-cemented|non-cemented
5365001|NCT00179088|Randomized|randomized
5365002|NCT00179088|Fiber-Metal-Taper-Stem|fiber-metal-taper-stem
5365003|NCT00179088|Hip|hip
5365004|NCT00179088|Osteoarthritis|osteoarthritis
5365005|NCT00179075|T-Lymphocyte Subsets|t-lymphocyte subsets
5365006|NCT00179062|major depression with psychotic features|major depression with psychotic features
5365007|NCT00179062|bipolar disorder with psychotic features|bipolar disorder with psychotic features
5365008|NCT00179049|T-Lymphocyte Subsets|t-lymphocyte subsets
5365009|NCT00179036|Blood supply|blood supply
5365010|NCT00179036|Mesentery|mesentery
5365011|NCT00179023|OBESITY|obesity
5365012|NCT00179023|RESTING ENERGY EXPENDITURE|resting energy expenditure
5365013|NCT00179023|SYMPATHETIC NERVOUS SYSTEM|sympathetic nervous system
5365014|NCT00179023|HYPERTENSION|hypertension
5365015|NCT00179023|AUTONOMIC FAILURE|autonomic failure
5365016|NCT00179010|Adenosine|adenosine
5365017|NCT00179010|AMP|amp
5365018|NCT00179010|Microdialysis|microdialysis
5365019|NCT00179010|Blood Flow|blood flow
5365020|NCT00178997|Blood supply|blood supply
5365021|NCT00178997|Mesentery|mesentery
5365022|NCT00178984|Blood supply|blood supply
5365023|NCT00178984|Mesentery|mesentery
5365024|NCT00178919|Endothelial Nitric Oxide|endothelial nitric oxide
5365025|NCT00178919|L-NMMA|l-nmma
5365026|NCT00178919|Trimethaphan|trimethaphan
5365027|NCT00178919|Autonomic Nervous System|autonomic nervous system
5365028|NCT00178919|Nitric Oxide Inhibition|nitric oxide inhibition
5365029|NCT00178906|depression|depression
5365030|NCT00178906|suicide|suicide
5365031|NCT00178906|voice|voice
5365032|NCT00178880|depression|depression
5365033|NCT00178880|MRI|mri
5365034|NCT00178880|imaging|imaging
5365035|NCT00178841|Cutaneous T-cell Lymphoma|cutaneous t-cell lymphoma
5365036|NCT00178841|CTCL|ctcl
5365037|NCT00178841|Mycosis Fungoides|mycosis fungoides
5365038|NCT00178841|Sezary Syndrome|sezary syndrome
5365039|NCT00178841|Bexarotene|bexarotene
5365040|NCT00178841|Targretin|targretin
5365041|NCT00178841|Rosiglitazone|rosiglitazone
5365042|NCT00178841|Avandia|avandia
5365043|NCT00178828|Depression|depression
5365044|NCT00178828|antidepressant|antidepressant
5365045|NCT00178828|SSRI|ssri
5365046|NCT00178802|breast cancer|breast cancer
5365047|NCT00178802|endometrial cancer|endometrial cancer
5365048|NCT00178802|cervical cancer|cervical cancer
5365049|NCT00178802|ovarian cancer|ovarian cancer
5365050|NCT00178789|Deep Venous Thrombosis|deep venous thrombosis
5365051|NCT00178789|Blood Clot|blood clot
5365052|NCT00178789|Lower Extremity|lower extremity
5365053|NCT00178789|Sonography|sonography
5365054|NCT00178776|Group|group
5365055|NCT00178776|Therapy|therapy
5365056|NCT00178776|Cocaine|cocaine
5365057|NCT00178776|Drugs|drugs
5365058|NCT00178776|Trial|trial
5365059|NCT00178776|Outcome|outcome
5365060|NCT00178776|Study|study
5365061|NCT00178776|Feasibility|feasibility
5365062|NCT00178776|Transtheoretical|transtheoretical
5365063|NCT00178776|Stages|stages
5365064|NCT00178776|Motivation|motivation
5365065|NCT00178776|Change|change
5365066|NCT00178763|Cancer|cancer
5365067|NCT00178763|Pancreatic Cancer|pancreatic cancer
5365068|NCT00178763|Pancreas|pancreas
5365069|NCT00178763|Neoplasms|neoplasms
5365070|NCT00178750|Epidural placement|epidural placement
5365071|NCT00178750|CompuFlo®|compuflo®
5365072|NCT00178724|spinal cord injury|spinal cord injury
5365073|NCT00178724|SCI|sci
5365074|NCT00178724|traumatic spinal cord injury|traumatic spinal cord injury
5365075|NCT00178724|acute spinal cord injury|acute spinal cord injury
5365076|NCT00178724|paralysis|paralysis
5365077|NCT00178711|Traumatic Brain Injury|traumatic brain injury
5365078|NCT00178711|Hypothermia|hypothermia
5365079|NCT00178698|thermochemotherapy|thermochemotherapy
5365080|NCT00178698|fever range whole body|fever range whole body
5365081|NCT00178698|cisplatin|cisplatin
5365082|NCT00178698|gemcitabine|gemcitabine
5365083|NCT00178698|daily low dose interferon alpha|daily low dose interferon alpha
5365084|NCT00178685|Self-determination|self-determination
5365085|NCT00178685|motivation|motivation
5365086|NCT00178685|adherence|adherence
5365087|NCT00178685|competence|competence
5365088|NCT00178685|autonomy|autonomy
5365089|NCT00178685|tobacco dependence|tobacco dependence
5365090|NCT00178685|Tobacco use and dependence|tobacco use and dependence
5365091|NCT00178685|Behavior change|behavior change
5365092|NCT00178672|CVA|cva
5365093|NCT00178672|TIA|tia
5365094|NCT00178672|Carotid disease|carotid disease
5365095|NCT00178672|Stroke|stroke
5365096|NCT00178672|Neurology|neurology
5365097|NCT00178672|Carotid Stenting|carotid stenting
5365098|NCT00178659|Traumatic Brain Injury|traumatic brain injury
5365099|NCT00178659|TBI (Traumatic Brain Injury)|tbi (traumatic brain injury)
5365100|NCT00178659|Proteomics|proteomics
5365101|NCT00178646|Stroke|stroke
5365102|NCT00178646|Brain Injuries|brain injuries
5365103|NCT00178646|Spasticity|spasticity
5365104|NCT00178646|Botulinum Toxins|botulinum toxins
5365105|NCT00178633|Obesity|obesity
5365106|NCT00178633|Insulin Resistance|insulin resistance
5365107|NCT00178633|Free Fatty Acids|free fatty acids
5365108|NCT00178633|Heart Failure|heart failure
5365109|NCT00178620|Heart Disease|heart disease
5365110|NCT00178620|Heart Attack|heart attack
5365111|NCT00178620|Myocardial Infarction|myocardial infarction
5365112|NCT00178620|Thrombolytic Therapy|thrombolytic therapy
5365113|NCT00178620|Emergency Medicine|emergency medicine
5365114|NCT00178607|Inhibitors|inhibitors
5365115|NCT00178594|Hereditary Bleeding disorder|hereditary bleeding disorder
5365116|NCT00178594|Thrombotic Disorder|thrombotic disorder
5365117|NCT00178581|Trauma|trauma
5365118|NCT00178581|Critical Illness|critical illness
5365119|NCT00178581|Shock|shock
5365120|NCT00178581|Enteral Nutrition|enteral nutrition
5365121|NCT00178581|Glutamine|glutamine
5365122|NCT00178568|Caregiving|caregiving
5365123|NCT00178568|Spousal|spousal
5365124|NCT00178568|Sleep disturbances|sleep disturbances
5365125|NCT00178568|Progressive dementia|progressive dementia
5365126|NCT00178568|Stress|stress
5365127|NCT00178568|Health outcomes|health outcomes
5365128|NCT00178568|Intervention|intervention
5365129|NCT00178568|Affective self-management|affective self-management
5365130|NCT00178568|Caregivers M01.526.485.200|caregivers m01.526.485.200
5365131|NCT00178568|Spouses F01.829.263.500.660|spouses f01.829.263.500.660
5365132|NCT00178568|Alzheimer's disease C10.574.945.249|alzheimer's disease c10.574.945.249
5365133|NCT00178568|Parkinson's disease C10.574.812|parkinson's disease c10.574.812
5365134|NCT00178568|Sleep disorder C10.886.425.800.800|sleep disorder c10.886.425.800.800
5365135|NCT00178555|Endotracheal Intubation, Video Laryngoscopy|endotracheal intubation, video laryngoscopy
5365136|NCT00178542|von Willebrand Disease|von willebrand disease
5365137|NCT00178542|Healthy Women and Women with von Willebrand Disease|healthy women and women with von willebrand disease
5365138|NCT00178529|Stroke|stroke
5365139|NCT00178529|Caregivers|caregivers
5365140|NCT00178516|male|male
5365141|NCT00178516|infertility|infertility
5365142|NCT00178490|Neurocognitive Function|neurocognitive function
5365143|NCT00178464|sickle cell disease|sickle cell disease
5365144|NCT00178464|hemoglobin SS disease|hemoglobin ss disease
5365145|NCT00178464|hemoglobin S Beta-0 Thalassemia|hemoglobin s beta-0 thalassemia
5365146|NCT00178464|silent infarction in sickle cell disease|silent infarction in sickle cell disease
5365147|NCT00178464|overt stroke in sickle cell disease|overt stroke in sickle cell disease
5365148|NCT00178464|aspirin|aspirin
5365149|NCT00178464|transcranial Doppler ultrasound|transcranial doppler ultrasound
5365150|NCT00178464|neurocognitive testing|neurocognitive testing
5365151|NCT00178438|capsule endoscopy in small bowel|capsule endoscopy in small bowel
5365152|NCT00178425|mycophenolate mofetil hydrochloride|mycophenolate mofetil hydrochloride
5365153|NCT00178425|pharmacokinetics|pharmacokinetics
5365154|NCT00178425|tacrolimus|tacrolimus
5365155|NCT00178412|Hospitalized elders|hospitalized elders
5365156|NCT00178412|Family caregivers|family caregivers
5365157|NCT00178412|Acute care|acute care
5365158|NCT00178386|cancer|cancer
5365159|NCT00178386|education|education
5365160|NCT00178386|learning|learning
5365161|NCT00178386|brain tumor|brain tumor
5365162|NCT00178386|school|school
5365163|NCT00178373|cancer-related fatigue|cancer-related fatigue
5365164|NCT00178373|chemotherapy|chemotherapy
5365165|NCT00178373|modafinil|modafinil
5365166|NCT00178360|Huntington's Disease, Music Therapy, quality of life|huntington's disease, music therapy, quality of life
5365167|NCT00178321|Sleep|sleep
5365168|NCT00178321|Criticall Ill|criticall ill
5365169|NCT00178321|Children|children
5365170|NCT00178321|Earplugs|earplugs
5365171|NCT00178217|Botulinum Toxin|botulinum toxin
5365172|NCT00178217|Music Therapy|music therapy
5365173|NCT00178217|Cerebral Palsy|cerebral palsy
5365174|NCT00178217|Procedural Support|procedural support
5365175|NCT00178204|delta sleep|delta sleep
5365176|NCT00178204|Cancer-related fatigue|cancer-related fatigue
5365177|NCT00178204|Sleep Disturbance|sleep disturbance
5365178|NCT00178204|chemotherapy|chemotherapy
5365179|NCT00178178|anterior cruciate ligament reconstruction|anterior cruciate ligament reconstruction
5365180|NCT00178178|Pain Care 3000|pain care 3000
5365181|NCT00178178|Catheter Placement|catheter placement
5365182|NCT00178178|Pain|pain
5365183|NCT00178178|Breg, Inc|breg, inc
5365184|NCT00178165|Family Caregivers|family caregivers
5365185|NCT00178165|Dementia|dementia
5365287|NCT00177567|Late-Life|late-life
5365186|NCT00178165|Alzheimer Disease|alzheimer disease
5365187|NCT00178165|Randomized Controlled Trial|randomized controlled trial
5365188|NCT00178165|Intervention Studies|intervention studies
5365189|NCT00178139|Music Therapy|music therapy
5365190|NCT00178139|Mechanical ventilation|mechanical ventilation
5365191|NCT00178139|Weaning from mechanical ventilation|weaning from mechanical ventilation
5365192|NCT00178139|complementary and alternative therapy|complementary and alternative therapy
5365193|NCT00178126|pressure ulcer|pressure ulcer
5365194|NCT00178113|Prostatic Intraepithelial Neoplasia|prostatic intraepithelial neoplasia
5365195|NCT00178113|Prostate-Specific Antigen|prostate-specific antigen
5365196|NCT00178113|lycopene|lycopene
5365197|NCT00178100|Depression|depression
5365198|NCT00178100|Elderly|elderly
5365199|NCT00178100|Late Life|late life
5365200|NCT00178087|late-life depression|late-life depression
5365201|NCT00178087|mild cognitive impairment|mild cognitive impairment
5365202|NCT00178087|dementia|dementia
5365203|NCT00178074|depression|depression
5365204|NCT00178074|imaging|imaging
5365205|NCT00178074|PET|pet
5365206|NCT00178074|elderly|elderly
5365207|NCT00178074|late life|late life
5365208|NCT00178074|sleep deprivation|sleep deprivation
5365209|NCT00178048|primary insomnia|primary insomnia
5365210|NCT00178048|insomnia|insomnia
5365211|NCT00178048|depression|depression
5365212|NCT00178048|late life|late life
5365213|NCT00178048|elderly|elderly
5365214|NCT00178048|sleep disorders|sleep disorders
5365215|NCT00178035|Depression|depression
5365216|NCT00178035|Unipolar Depression|unipolar depression
5365217|NCT00178035|Elderly depression|elderly depression
5365218|NCT00178035|Late-Life|late-life
5365219|NCT00178022|tbi|tbi
5365220|NCT00178022|intervention|intervention
5365221|NCT00178022|depression|depression
5365222|NCT00178022|anxiety|anxiety
5365223|NCT00178009|computer-assisted instruction|computer-assisted instruction
5365224|NCT00178009|instruction (video)|instruction (video)
5365225|NCT00177996|depression|depression
5365226|NCT00177996|anxiety|anxiety
5365227|NCT00177983|Schizophrenia|schizophrenia
5365228|NCT00177983|Relapse|relapse
5365229|NCT00177983|Psychological distress|psychological distress
5365230|NCT00177957|Gram negative bacteremia|gram negative bacteremia
5365231|NCT00177944|invasive fungal infection|invasive fungal infection
5365232|NCT00177931|Liver transplant|liver transplant
5365233|NCT00177931|cefepime|cefepime
5365234|NCT00177931|antibiotics|antibiotics
5365235|NCT00177918|Lung Transplant|lung transplant
5365236|NCT00177892|Sleep fragmentation|sleep fragmentation
5365237|NCT00177892|Intermittent hypoxia|intermittent hypoxia
5365238|NCT00177892|Obstructive Sleep Apnea|obstructive sleep apnea
5365239|NCT00177892|Metabolic Syndrome|metabolic syndrome
5365240|NCT00177892|Insulin resistance|insulin resistance
5365241|NCT00177879|website|website
5365242|NCT00177879|comparison|comparison
5365243|NCT00177853|Locally advanced pancreatic cancer|locally advanced pancreatic cancer
5365244|NCT00177853|invasion of major arteries and veins around pancreas|invasion of major arteries and veins around pancreas
5365245|NCT00177853|No prior radiation or chemo|no prior radiation or chemo
5365246|NCT00177840|cancer-related fatigue|cancer-related fatigue
5365247|NCT00177840|acupuncture|acupuncture
5365248|NCT00177840|breast cancer|breast cancer
5365249|NCT00177814|pipercillin|pipercillin
5365250|NCT00177814|gram negative bacteria infections|gram negative bacteria infections
5365251|NCT00177788|liver transplant|liver transplant
5365252|NCT00177788|voriconazole prophylaxis|voriconazole prophylaxis
5365253|NCT00177788|liver transplantation|liver transplantation
5365254|NCT00177788|voriconazole|voriconazole
5365255|NCT00177749|invasive fungal infections|invasive fungal infections
5365256|NCT00177736|ventilator associated pneumonia|ventilator associated pneumonia
5365257|NCT00177723|receiving antibiotic Linezolid clinically|receiving antibiotic linezolid clinically
5365258|NCT00177671|Depression|depression
5365259|NCT00177671|Dementia|dementia
5365260|NCT00177671|Alzheimer's Disease|alzheimer's disease
5365261|NCT00177671|Cognitive|cognitive
5365262|NCT00177671|Donepezil|donepezil
5365263|NCT00177671|Memory|memory
5365264|NCT00177671|Function|function
5365265|NCT00177671|Elderly|elderly
5365266|NCT00177671|Late-Life|late-life
5365267|NCT00177658|Salmonella|salmonella
5365268|NCT00177645|cystic fibrosis|cystic fibrosis
5365269|NCT00177645|mucus clearance|mucus clearance
5365270|NCT00177619|Prostatic neoplasms|prostatic neoplasms
5365271|NCT00177619|Bisphosphonates|bisphosphonates
5365272|NCT00177619|Hypogonadism|hypogonadism
5365273|NCT00177606|withdrawal|withdrawal
5365274|NCT00177606|life-sustaining|life-sustaining
5365275|NCT00177606|treatments|treatments
5365276|NCT00177606|UNOS|unos
5365277|NCT00177606|organ donation|organ donation
5365278|NCT00177580|schizophrenia|schizophrenia
5365279|NCT00177580|schizoaffective disorder|schizoaffective disorder
5365280|NCT00177580|positive symptoms|positive symptoms
5365281|NCT00177580|negative symptoms|negative symptoms
5365282|NCT00177580|cognitive functioning|cognitive functioning
5365283|NCT00177580|pravastatin|pravastatin
5365284|NCT00177567|Bipolar Disorder|bipolar disorder
5365285|NCT00177567|Manic Depression|manic depression
5365286|NCT00177567|Elderly|elderly
5365288|NCT00177554|Non-Hodgkin Lymphoma|non-hodgkin lymphoma
5365289|NCT00177541|urge incontinence|urge incontinence
5365290|NCT00177541|biofeedback|biofeedback
5365291|NCT00177541|pelvic floor muscle training|pelvic floor muscle training
5365292|NCT00177541|behavior modification|behavior modification
5365293|NCT00177528|Elderly|elderly
5365294|NCT00177515|emergency contraception|emergency contraception
5365295|NCT00177515|folic acid|folic acid
5365296|NCT00177515|education|education
5365297|NCT00177515|preventive health|preventive health
5365298|NCT00177489|Family Caregivers|family caregivers
5365299|NCT00177489|Dementia|dementia
5365300|NCT00177489|Alzheimer Disease|alzheimer disease
5365301|NCT00177489|Randomized Controlled Trial|randomized controlled trial
5365302|NCT00177489|Intervention Studies|intervention studies
5365303|NCT00177463|L-carnosine|l-carnosine
5365304|NCT00177463|Bipolar I disorder|bipolar i disorder
5365305|NCT00177463|Cognitive enhancement|cognitive enhancement
5365306|NCT00177424|Rehabilitation|rehabilitation
5365307|NCT00177411|Endocrine System Diseases|endocrine system diseases
5365308|NCT00177411|MusculoSkeletal System Diseases|musculoskeletal system diseases
5365309|NCT00177411|Hormone|hormone
5365310|NCT00177411|Postmenopausal Women|postmenopausal women
5365311|NCT00177398|Type 2 diabetes|type 2 diabetes
5365312|NCT00177398|Hyperglycemia|hyperglycemia
5365313|NCT00177398|Enteral nutrition|enteral nutrition
5365314|NCT00177385|Sleep|sleep
5365315|NCT00177385|Sleep Hygiene|sleep hygiene
5365316|NCT00177385|Modest sleep deprivation|modest sleep deprivation
5365317|NCT00177385|Healthy Aging and sleep|healthy aging and sleep
5365318|NCT00177385|Health Promotion|health promotion
5365319|NCT00177359|gait impairment|gait impairment
5365320|NCT00177333|Abortion, Induced|abortion, induced
5365321|NCT00177333|Doxycycline|doxycycline
5365322|NCT00177333|Antibiotic Prophylaxis|antibiotic prophylaxis
5365323|NCT00177333|Vomiting|vomiting
5365324|NCT00177333|Abortion, Therapeutic|abortion, therapeutic
5365325|NCT00177320|Rheumatic Disorders|rheumatic disorders
5365326|NCT00177320|Computer Use|computer use
5365327|NCT00177307|colon|colon
5365328|NCT00177307|rectum|rectum
5365329|NCT00177294|Elderly|elderly
5365330|NCT00177294|Remission|remission
5365331|NCT00177294|Escitalopram|escitalopram
5365332|NCT00177294|Interpersonal Psychotherapy|interpersonal psychotherapy
5365333|NCT00177294|Psychotherapy|psychotherapy
5365334|NCT00177294|Caregiving|caregiving
5365335|NCT00177294|Late-Life|late-life
5365336|NCT00177268|Cutaneous T-cell Lymphoma|cutaneous t-cell lymphoma
5365337|NCT00177268|Sezary Syndrome|sezary syndrome
5365338|NCT00177268|Mycosis Fungoides|mycosis fungoides
5365339|NCT00177268|Blood/tissue banking|blood/tissue banking
5365340|NCT00177268|eczema|eczema
5365341|NCT00177268|atopic dermatitis|atopic dermatitis
5365342|NCT00177255|gastric|gastric
5365343|NCT00177255|stomach|stomach
5365344|NCT00177255|esophagus|esophagus
5365345|NCT00177255|esophageal|esophageal
5365346|NCT00177242|pancreas|pancreas
5365347|NCT00177242|pancreatic|pancreatic
5365348|NCT00177216|Primary Insomnia|primary insomnia
5365349|NCT00177216|Insomnia|insomnia
5365350|NCT00177216|Placebo-Controlled|placebo-controlled
5365351|NCT00177216|Double-Blind|double-blind
5365352|NCT00177216|Polysomnography|polysomnography
5365353|NCT00177216|PET Studies|pet studies
5365354|NCT00177216|Escitalopram|escitalopram
5365355|NCT00177216|Zolpidem|zolpidem
5365356|NCT00177203|Insomnia|insomnia
5365357|NCT00177203|Sleep Disorders|sleep disorders
5365358|NCT00177203|Sleeplessness|sleeplessness
5365359|NCT00177203|Chronic Insomnia|chronic insomnia
5365360|NCT00177203|Sleep Studies|sleep studies
5365361|NCT00177203|Disorders of Initiating and Maintaining Sleep|disorders of initiating and maintaining sleep
5365362|NCT00177203|Primary Care|primary care
5365363|NCT00177190|Cutaneous T-cell Lymphoma|cutaneous t-cell lymphoma
5365364|NCT00177190|Sezary Syndrome|sezary syndrome
5365365|NCT00177190|Mycosis Fungoides|mycosis fungoides
5365366|NCT00177190|Immune Responses|immune responses
5365367|NCT00177177|L-carnosine|l-carnosine
5365368|NCT00177177|Schizophrenia|schizophrenia
5365369|NCT00177177|Schizoaffective disorder|schizoaffective disorder
5365370|NCT00177177|Cognitive enhancement|cognitive enhancement
5365371|NCT00177164|Bipolar I Disorder|bipolar i disorder
5365372|NCT00177164|Risperidone Consta - Long Acting Injection|risperidone consta - long acting injection
5365373|NCT00177164|Oral second generation antipsychotic agents|oral second generation antipsychotic agents
5365374|NCT00177138|Campath Study|campath study
5365375|NCT00177138|Pancreas After Kidney Transplantation|pancreas after kidney transplantation
5365376|NCT00177138|Alemtuzumab|alemtuzumab
5365377|NCT00177112|Cystoscopy|cystoscopy
5365378|NCT00177047|stem cell transplantation|stem cell transplantation
5365379|NCT00177047|chemotherapy|chemotherapy
5365380|NCT00177047|multiple myeloma|multiple myeloma
5365381|NCT00177047|autologous|autologous
5365382|NCT00177034|Keratinocyte|keratinocyte
5365383|NCT00177008|Schizophrenia|schizophrenia
5365384|NCT00177008|Schizoaffective Disorder|schizoaffective disorder
5365385|NCT00177008|Social Anxiety Disorder|social anxiety disorder
5365386|NCT00176982|treatment of alopecia areata|treatment of alopecia areata
5365556|NCT00176293|metastatic|metastatic
5365387|NCT00176956|Post Pediatric Heart Transplant|post pediatric heart transplant
5365388|NCT00176930|stem cell transplant|stem cell transplant
5365389|NCT00176930|chronic leukemia|chronic leukemia
5365390|NCT00176930|acute leukemia|acute leukemia
5365391|NCT00176930|irradiation|irradiation
5365392|NCT00176930|chemotherapy|chemotherapy
5365393|NCT00176917|stem cell transplant|stem cell transplant
5365394|NCT00176917|storage disease|storage disease
5365395|NCT00176917|errors of metabolism|errors of metabolism
5365396|NCT00176904|Inborn errors|inborn errors
5365397|NCT00176904|Storage disease|storage disease
5365398|NCT00176904|errors of metabolism|errors of metabolism
5365399|NCT00176904|stem cell transplant|stem cell transplant
5365400|NCT00176891|Laronidase ERT|laronidase ert
5365401|NCT00176891|Stem cell transplant|stem cell transplant
5365402|NCT00176891|storage disease|storage disease
5365403|NCT00176891|inborn errors of metabolism|inborn errors of metabolism
5365404|NCT00176891|hurler syndrome|hurler syndrome
5365405|NCT00176891|glycosaminoglycans|glycosaminoglycans
5365406|NCT00176891|enzyme replacement|enzyme replacement
5365407|NCT00176878|Stem cell transplant|stem cell transplant
5365408|NCT00176878|T-cell depletion|t-cell depletion
5365409|NCT00176878|TLI|tli
5365410|NCT00176878|bone marrow failure disorders|bone marrow failure disorders
5365411|NCT00176865|Stem cell transplant|stem cell transplant
5365412|NCT00176865|immunodeficiency|immunodeficiency
5365413|NCT00176865|donor lymphocyte infusion|donor lymphocyte infusion
5365414|NCT00176852|high risk hemoglobinopathy|high risk hemoglobinopathy
5365415|NCT00176852|stem cell transplant|stem cell transplant
5365416|NCT00176852|donor lymphocyte infusion|donor lymphocyte infusion
5365417|NCT00176852|transfusion dependent|transfusion dependent
5365418|NCT00176852|stem cell donor|stem cell donor
5365419|NCT00176852|cord blood|cord blood
5365420|NCT00176852|marrow|marrow
5365421|NCT00176852|transfusion dependent non-malignant hematologic disorders|transfusion dependent non-malignant hematologic disorders
5365422|NCT00176839|Stem Cell transplant|stem cell transplant
5365423|NCT00176839|retransplant|retransplant
5365424|NCT00176839|hematological malignancies|hematological malignancies
5365425|NCT00176826|Stem Cell Transplant|stem cell transplant
5365426|NCT00176826|T-cell depletion|t-cell depletion
5365427|NCT00176826|immune deficiencies|immune deficiencies
5365428|NCT00176826|Busulfan pharmacokinetics|busulfan pharmacokinetics
5365429|NCT00176826|Non-Malignant Hematological Disorders|non-malignant hematological disorders
5365430|NCT00176722|Spine Surgery|spine surgery
5365431|NCT00176722|Intraocular Pressure|intraocular pressure
5365432|NCT00176722|lumbar or thoracic Spine Surgery in the prone position|lumbar or thoracic spine surgery in the prone position
5365433|NCT00176722|and its association with visual change|and its association with visual change
5365434|NCT00176696|general anesthesia|general anesthesia
5365435|NCT00176696|pain|pain
5365436|NCT00176696|depth of anesthesia|depth of anesthesia
5365437|NCT00176683|intubation|intubation
5365438|NCT00176683|capnography|capnography
5365439|NCT00176670|presurgical anxiety, children,|presurgical anxiety, children,
5365440|NCT00176657|cardiac surgery|cardiac surgery
5365441|NCT00176657|transfusion|transfusion
5365442|NCT00176644|prostate cancer|prostate cancer
5365443|NCT00176631|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5365444|NCT00176631|recurrent prostate cancer|recurrent prostate cancer
5365445|NCT00176631|stage IV prostate cancer|stage iv prostate cancer
5365446|NCT00176618|Aberrant Crypt Foci|aberrant crypt foci
5365447|NCT00176605|prostate cancer|prostate cancer
5365448|NCT00176605|recurrent prostate cancer|recurrent prostate cancer
5365449|NCT00176605|stage IV prostate cancer|stage iv prostate cancer
5365450|NCT00176592|Multiple Sclerosis|multiple sclerosis
5365451|NCT00176592|Brain|brain
5365452|NCT00176592|Betaseron|betaseron
5365453|NCT00176592|Copaxone|copaxone
5365454|NCT00176592|MRI|mri
5365455|NCT00176579|osteoporosis|osteoporosis
5365456|NCT00176579|stage I prostate cancer|stage i prostate cancer
5365457|NCT00176566|oral leukoplakia|oral leukoplakia
5365458|NCT00176553|methotrexate neurotoxicity|methotrexate neurotoxicity
5365459|NCT00176540|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5365460|NCT00176540|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
5365461|NCT00176540|fatigue|fatigue
5365462|NCT00176527|recurrent prostate cancer|recurrent prostate cancer
5365463|NCT00176527|stage IV prostate cancer|stage iv prostate cancer
5365464|NCT00176514|mucositis|mucositis
5365465|NCT00176501|recurrent renal cell cancer|recurrent renal cell cancer
5365466|NCT00176501|clear cell renal cell carcinoma|clear cell renal cell carcinoma
5365467|NCT00176501|stage IV renal cell cancer|stage iv renal cell cancer
5365468|NCT00176488|recurrent breast cancer|recurrent breast cancer
5365469|NCT00176488|stage II breast cancer|stage ii breast cancer
5365470|NCT00176488|stage IIIA breast cancer|stage iiia breast cancer
5365471|NCT00176488|stage IIIB breast cancer|stage iiib breast cancer
5365472|NCT00176488|stage IV breast cancer|stage iv breast cancer
5365473|NCT00176488|male breast cancer|male breast cancer
5365474|NCT00176475|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5365475|NCT00176475|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5365476|NCT00176475|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5365477|NCT00176475|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5365478|NCT00176475|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5365479|NCT00176475|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5365480|NCT00176475|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5365481|NCT00176475|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5365482|NCT00176475|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5365483|NCT00176475|refractory hairy cell leukemia|refractory hairy cell leukemia
5365484|NCT00176475|prolymphocytic leukemia|prolymphocytic leukemia
5365485|NCT00176475|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5365486|NCT00176475|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5365487|NCT00176475|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5365488|NCT00176475|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5365489|NCT00176475|refractory multiple myeloma|refractory multiple myeloma
5365490|NCT00176475|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5365491|NCT00176475|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
5365492|NCT00176475|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
5365493|NCT00176475|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5365494|NCT00176475|stage II multiple myeloma|stage ii multiple myeloma
5365495|NCT00176475|stage III multiple myeloma|stage iii multiple myeloma
5365496|NCT00176475|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5365497|NCT00176475|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5365498|NCT00176475|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5365499|NCT00176475|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5365500|NCT00176475|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5365501|NCT00176475|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5365502|NCT00176475|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5365503|NCT00176475|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5365504|NCT00176475|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5365505|NCT00176475|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5365506|NCT00176475|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5365507|NCT00176475|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5365508|NCT00176475|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5365509|NCT00176475|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5365510|NCT00176475|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5365511|NCT00176475|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5365512|NCT00176475|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5365513|NCT00176475|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5365514|NCT00176475|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5365515|NCT00176475|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5365516|NCT00176475|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5365517|NCT00176475|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5365518|NCT00176475|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
5365519|NCT00176462|Acute Lymphocytic Leukemia|acute lymphocytic leukemia
5365520|NCT00176462|Leukemia|leukemia
5365521|NCT00176449|Nicotine Dependence|nicotine dependence
5365522|NCT00176449|Nicotine Use Disorder|nicotine use disorder
5365523|NCT00176449|Tobacco Dependence|tobacco dependence
5365524|NCT00176449|Tobacco-Use Disorder|tobacco-use disorder
5365525|NCT00176449|Smoking Cessation|smoking cessation
5365526|NCT00176436|Weight loss|weight loss
5365527|NCT00176436|Support group|support group
5365528|NCT00176436|Exercise|exercise
5365529|NCT00176436|Atomoxetine|atomoxetine
5365530|NCT00176423|schizophrenia|schizophrenia
5365531|NCT00176423|acetylcholine|acetylcholine
5365532|NCT00176423|cognitive impairments|cognitive impairments
5365533|NCT00176423|attention|attention
5365534|NCT00176423|processing speed|processing speed
5365535|NCT00176423|sensory gating|sensory gating
5365536|NCT00176423|eye-tracking|eye-tracking
5365537|NCT00176410|aortic valve stenosis|aortic valve stenosis
5365538|NCT00176410|statin therapy|statin therapy
5365539|NCT00176397|left main coronary artery|left main coronary artery
5365540|NCT00176397|coronary artery disease|coronary artery disease
5365541|NCT00176384|chronic heart failure|chronic heart failure
5365542|NCT00176384|exercise training|exercise training
5365543|NCT00176371|Physical fitness|physical fitness
5365544|NCT00176345|exercise training|exercise training
5365545|NCT00176345|endothelial function|endothelial function
5365546|NCT00176332|chronic heart failure|chronic heart failure
5365547|NCT00176332|rosuvastatin|rosuvastatin
5365548|NCT00176332|endothelial function|endothelial function
5365549|NCT00176332|skeletal muscle|skeletal muscle
5365550|NCT00176319|heart failure|heart failure
5365551|NCT00176319|ageing|ageing
5365552|NCT00176293|prostate|prostate
5365553|NCT00176293|prostate cancer|prostate cancer
5365554|NCT00176293|doxil|doxil
5365555|NCT00176293|dexamethasone|dexamethasone
5365557|NCT00176293|hormone refractory|hormone refractory
5365558|NCT00176280|Renal|renal
5365559|NCT00176280|Carcinoma|carcinoma
5365560|NCT00176280|Renal Cell Carcinoma|renal cell carcinoma
5365561|NCT00176280|RCC|rcc
5365562|NCT00176280|Leukine|leukine
5365563|NCT00176280|Dexamethasone|dexamethasone
5365564|NCT00176280|Gemcitabine|gemcitabine
5365565|NCT00176280|5 Fluorouracil|5 fluorouracil
5365566|NCT00176280|5 FU|5 fu
5365567|NCT00176280|Metastatic|metastatic
5365568|NCT00176267|head and neck|head and neck
5365569|NCT00176267|squamous cell carcinoma|squamous cell carcinoma
5365570|NCT00176267|squamous cell|squamous cell
5365571|NCT00176267|carcinoma|carcinoma
5365572|NCT00176267|paclitaxel|paclitaxel
5365573|NCT00176267|carboplatin|carboplatin
5365574|NCT00176267|radiotherapy|radiotherapy
5365575|NCT00176267|induction therapy|induction therapy
5365576|NCT00176254|head and neck|head and neck
5365577|NCT00176254|squamous cell carcinoma|squamous cell carcinoma
5365578|NCT00176254|squamous cell|squamous cell
5365579|NCT00176254|carcinoma|carcinoma
5365580|NCT00176254|paclitaxel|paclitaxel
5365581|NCT00176254|carboplatin|carboplatin
5365582|NCT00176254|radiotherapy|radiotherapy
5365583|NCT00176254|induction therapy|induction therapy
5365584|NCT00176241|head and neck|head and neck
5365585|NCT00176241|Gemcitabine|gemcitabine
5365586|NCT00176241|Paclitaxel|paclitaxel
5365587|NCT00176241|radiation|radiation
5365588|NCT00176241|low-dose radiation|low-dose radiation
5365589|NCT00176241|recurrent|recurrent
5365590|NCT00176241|metastatic|metastatic
5365591|NCT00176189|FPD, all-ceramic|fpd, all-ceramic
5365592|NCT00176176|cerebral circulation|cerebral circulation
5365593|NCT00176163|Fibromyalgia|fibromyalgia
5365594|NCT00176163|Back pain|back pain
5365595|NCT00176163|Behavior Therapy|behavior therapy
5365596|NCT00176163|Operant learning|operant learning
5365597|NCT00176163|Tetrahydrocannabinol|tetrahydrocannabinol
5365598|NCT00176150|anorexia nervosa|anorexia nervosa
5365599|NCT00176150|multidrug resistance|multidrug resistance
5365600|NCT00176150|cholesterol metabolism|cholesterol metabolism
5365601|NCT00176137|multimodality treatment|multimodality treatment
5365602|NCT00176124|leukocyte depletion, autologous transfusion,|leukocyte depletion, autologous transfusion,
5365603|NCT00176124|infection|infection
5365604|NCT00176124|bacterial infection|bacterial infection
5365605|NCT00176124|sepsis, antibiotics|sepsis, antibiotics
5365606|NCT00176111|peripheral nerve stimulation|peripheral nerve stimulation
5365607|NCT00176111|saline|saline
5365608|NCT00176111|local anesthestics|local anesthestics
5365609|NCT00176111|regional anesthestia|regional anesthestia
5365610|NCT00176111|nerve damage|nerve damage
5365611|NCT00176098|Cataract surgery|cataract surgery
5365612|NCT00176098|Hypnosis|hypnosis
5365613|NCT00176098|C11.510.245|c11.510.245
5365614|NCT00176098|F04.754.424.771|f04.754.424.771
5365615|NCT00176098|Suggestion|suggestion
5365616|NCT00176059|immunoglobulins, intravenous|immunoglobulins, intravenous
5365617|NCT00176059|kidney transplantation|kidney transplantation
5365618|NCT00176059|acute rejection|acute rejection
5365619|NCT00176059|chronic rejection|chronic rejection
5365620|NCT00176059|regulatory autoantibodies|regulatory autoantibodies
5365621|NCT00176059|Th1|th1
5365622|NCT00176059|Th2|th2
5365623|NCT00176059|B Cell|b cell
5365624|NCT00176059|Monokines|monokines
5365625|NCT00176059|Cytokine promoter gene polymorphisms|cytokine promoter gene polymorphisms
5365626|NCT00176046|breast cancer|breast cancer
5365627|NCT00176046|mistletoe|mistletoe
5365628|NCT00176046|complementary therapy|complementary therapy
5365629|NCT00176046|quality of life|quality of life
5365630|NCT00176046|immune function|immune function
5365631|NCT00176046|breast cancer (UICC stage I/II)|breast cancer (uicc stage i/ii)
5365632|NCT00176033|ritonavir|ritonavir
5365633|NCT00176033|lopinavir|lopinavir
5365634|NCT00176033|HIV Infections|hiv infections
5365635|NCT00176020|nicotinic acid|nicotinic acid
5365636|NCT00176020|flush symptom|flush symptom
5365637|NCT00176020|pharmacodynamic|pharmacodynamic
5365638|NCT00176020|pharmacokinetic|pharmacokinetic
5365639|NCT00175994|voriconazole|voriconazole
5365640|NCT00175994|genotype|genotype
5365641|NCT00175994|bioavailability|bioavailability
5365642|NCT00175994|metabolic clearance|metabolic clearance
5365643|NCT00175955|Neuroleptic-induced tardive dyskinesia|neuroleptic-induced tardive dyskinesia
5365644|NCT00175955|Keppra, Levetiracetam|keppra, levetiracetam
5365645|NCT00175942|acute myocardial infarction|acute myocardial infarction
5365646|NCT00175942|ventricular fibrillation|ventricular fibrillation
5365647|NCT00175942|coagulation|coagulation
5365648|NCT00175942|inflammation|inflammation
5365649|NCT00175929|Epilepsy|epilepsy
5365650|NCT00175929|Focal Epilepsy|focal epilepsy
5365651|NCT00175929|Partial Onset Seizures|partial onset seizures
5365652|NCT00175929|Brivaracetam|brivaracetam
5365653|NCT00175916|Brivaracetam|brivaracetam
5365654|NCT00175916|Epilepsy|epilepsy
5365655|NCT00175916|long term|long term
5365656|NCT00175903|Newly Diagnosed Epilepsy|newly diagnosed epilepsy
5365657|NCT00175903|Levetiracetam|levetiracetam
5365658|NCT00175903|Keppra|keppra
5365659|NCT00175903|Carbamazepine|carbamazepine
5365660|NCT00175903|Valproate|valproate
5365661|NCT00175890|Partial Onset Seizure|partial onset seizure
5365662|NCT00175890|levetiracetam|levetiracetam
5365663|NCT00175890|Video Electroencephalogram|video electroencephalogram
5365664|NCT00175890|Keppra|keppra
5365665|NCT00175877|Rheumatoid Arthritis|rheumatoid arthritis
5365666|NCT00175877|CDP870|cdp870
5365667|NCT00175877|Certolizumab Pegol|certolizumab pegol
5365668|NCT00175877|Cimzia|cimzia
5365669|NCT00175864|Partial Onset, Primary Generalized Seizures, Seletracetam|partial onset, primary generalized seizures, seletracetam
5365670|NCT00175851|Partial onset, primary generalized seizures, seletracetam|partial onset, primary generalized seizures, seletracetam
5365671|NCT00175838|Primary Thrombocythmeia|primary thrombocythmeia
5365672|NCT00175838|Hydroxyurea|hydroxyurea
5365673|NCT00175838|Randomised|randomised
5365674|NCT00175838|Thrombosis|thrombosis
5365675|NCT00175838|Haemorrhage|haemorrhage
5365676|NCT00175825|Epilepsy: partial onset seizures|epilepsy: partial onset seizures
5365677|NCT00175825|brivaracetam|brivaracetam
5365678|NCT00175812|Acute myelogenous leukemia|acute myelogenous leukemia
5365679|NCT00175812|Differentiation|differentiation
5365680|NCT00175812|All trans retinoic acid|all trans retinoic acid
5365681|NCT00175812|Valproic acid|valproic acid
5365682|NCT00175812|Theophyllamin|theophyllamin
5365683|NCT00175799|Observational study of physiological status at entry into PICU as a predictor of outcome, comparison of two commonly used scores (PRISM and PIM)|observational study of physiological status at entry into picu as a predictor of outcome, comparison of two commonly used scores (prism and pim)
5365684|NCT00175799|Data from children admitted to a Paediatric Intensive Care unit|data from children admitted to a paediatric intensive care unit
5365685|NCT00175786|Glaucoma|glaucoma
5365686|NCT00175786|Normal Tensions Glaucoma|normal tensions glaucoma
5365687|NCT00175786|Neuroradiology|neuroradiology
5365688|NCT00175786|Tumor|tumor
5365689|NCT00175786|MRI|mri
5365690|NCT00175786|Magnetic Resonance Imaging|magnetic resonance imaging
5365691|NCT00175786|Compressive Lesion|compressive lesion
5365692|NCT00175773|Orthostatic stress|orthostatic stress
5365693|NCT00175760|TTG|ttg
5365694|NCT00175760|pediatric|pediatric
5365695|NCT00175760|comparison study|comparison study
5365696|NCT00175747|dysplasia|dysplasia
5365697|NCT00175747|lung cancer|lung cancer
5365698|NCT00175747|chemoprevention|chemoprevention
5365699|NCT00175734|Vascular Reactivity|vascular reactivity
5365700|NCT00175734|Anemia Correction Therapy|anemia correction therapy
5365701|NCT00175734|Hemodialysis patients|hemodialysis patients
5365702|NCT00175734|Diabetic and non-diabetic patients|diabetic and non-diabetic patients
5365703|NCT00175734|Diabetes in Hemodialysis patients|diabetes in hemodialysis patients
5365704|NCT00175721|Combined Clinic|combined clinic
5365705|NCT00175721|Chronic Kidney Disease|chronic kidney disease
5365706|NCT00175721|Diabetes|diabetes
5365707|NCT00175708|Evaluation of an outcome tool|evaluation of an outcome tool
5365708|NCT00175708|clubfoot|clubfoot
5365709|NCT00175708|foot pressure profiles|foot pressure profiles
5365710|NCT00175708|pedobarographs|pedobarographs
5365711|NCT00175682|Autonomic Dysreflexia|autonomic dysreflexia
5365712|NCT00175682|SCI|sci
5365713|NCT00175682|Vibrostimulation|vibrostimulation
5365714|NCT00175682|Ejaculation|ejaculation
5365715|NCT00175669|Randomized control trial; placebo-control study|randomized control trial; placebo-control study
5365716|NCT00175656|Femur fracture|femur fracture
5365717|NCT00175656|titanium elastic nails|titanium elastic nails
5365718|NCT00175643|actinic keratoses|actinic keratoses
5365719|NCT00175643|imiquimod|imiquimod
5365720|NCT00175643|pre-malignant|pre-malignant
5365721|NCT00175643|squamous cell carcinoma|squamous cell carcinoma
5365722|NCT00175643|immunosuppression|immunosuppression
5365723|NCT00175630|ACL reconstruction|acl reconstruction
5365724|NCT00175630|morphine sparing|morphine sparing
5365725|NCT00175630|preemptive analgesia|preemptive analgesia
5365726|NCT00175630|Post-operative pain and post- operative opioid use|post-operative pain and post- operative opioid use
5365727|NCT00175604|Botox|botox
5365728|NCT00175604|torticollis|torticollis
5365729|NCT00175604|Congenital Muscular Torticollis (CMT)|congenital muscular torticollis (cmt)
5365730|NCT00175591|Femur fracture|femur fracture
5365731|NCT00175591|morphine sparing|morphine sparing
5365732|NCT00175591|preemptive analgesia|preemptive analgesia
5365733|NCT00175591|Post-operative pain and post- operative opioid use|post-operative pain and post- operative opioid use
5365734|NCT00175578|Early stage (0/I) non-small cell lung cancer|early stage (0/i) non-small cell lung cancer
5365735|NCT00175565|inflammation|inflammation
5365736|NCT00175565|trial|trial
5365737|NCT00175565|fluticasone|fluticasone
5365738|NCT00175552|Depression|depression
5365739|NCT00175552|Adolescents|adolescents
5365740|NCT00175552|IPT|ipt
5365741|NCT00175552|Knowledge translation|knowledge translation
5365742|NCT00175552|Psychotherapy|psychotherapy
5365743|NCT00175539|sexual dysfunction|sexual dysfunction
5365744|NCT00175539|group treatment|group treatment
5365745|NCT00175513|Psychosis|psychosis
5365746|NCT00175513|early psychosis|early psychosis
5365747|NCT00175513|first episode psychosis|first episode psychosis
5365748|NCT00175513|schizophrenia|schizophrenia
5365749|NCT00175513|schizoaffective|schizoaffective
5365750|NCT00175513|schizophreniform|schizophreniform
5365751|NCT00175513|bipolar disorder|bipolar disorder
5365752|NCT00175513|valtrex|valtrex
5365753|NCT00175513|valacyclovir.|valacyclovir.
5365754|NCT00175500|Post-Arthroplasty Hip Dislocation|post-arthroplasty hip dislocation
5365755|NCT00175487|Osteoarthritis/Avascular Necrosis|osteoarthritis/avascular necrosis
5365756|NCT00175487|Hip|hip
5365757|NCT00175435|Topical Immune Modulator|topical immune modulator
5365758|NCT00175435|resiquimod gel|resiquimod gel
5365759|NCT00175435|Hepatitis B booster response|hepatitis b booster response
5365760|NCT00175435|Vaccine Evaluation|vaccine evaluation
5365761|NCT00175435|Prevention of Hepatitis B disease|prevention of hepatitis b disease
5365762|NCT00175422|Prevention|prevention
5365763|NCT00175422|Randomized controlled trial|randomized controlled trial
5365764|NCT00175422|Community education|community education
5365765|NCT00175422|Shaken Baby Syndrome|shaken baby syndrome
5365766|NCT00175422|Crying|crying
5365767|NCT00175422|Colic|colic
5365768|NCT00175409|Pain Response|pain response
5365769|NCT00175396|ASCENDE-RT|ascende-rt
5365770|NCT00175383|Prostate cancer, LHRH, hormone therapy, testosterone level|prostate cancer, lhrh, hormone therapy, testosterone level
5365771|NCT00175370|Vancomycin|vancomycin
5365772|NCT00175370|Coagulase Negative Staphylococcus|coagulase negative staphylococcus
5365773|NCT00175370|Central Venous Catheter|central venous catheter
5365774|NCT00175370|Bloodstream infection|bloodstream infection
5365775|NCT00175370|CNS bloodstream infection|cns bloodstream infection
5365776|NCT00175357|Opiate addiction|opiate addiction
5365777|NCT00175357|medical heroin|medical heroin
5365778|NCT00175357|methadoneRCT|methadonerct
5365779|NCT00175344|Breast cancer|breast cancer
5365780|NCT00175344|scar massage|scar massage
5365781|NCT00175344|breast conserving surgery|breast conserving surgery
5365782|NCT00175344|scar pain|scar pain
5365783|NCT00175344|quality of life|quality of life
5365784|NCT00175344|Breast cancer treated with breast conserving surgery with or without axillary dissection or sentinel node sampling.|breast cancer treated with breast conserving surgery with or without axillary dissection or sentinel node sampling.
5365785|NCT00175318|Motivational interviewing|motivational interviewing
5365786|NCT00175318|behavioural modification|behavioural modification
5365787|NCT00175318|maternal counseling|maternal counseling
5365788|NCT00175305|Prader-Willi Syndrome|prader-willi syndrome
5365789|NCT00175305|Somatostatin|somatostatin
5365790|NCT00175305|Ghrelin|ghrelin
5365791|NCT00175305|Obesity|obesity
5365792|NCT00175305|Hyperphagia|hyperphagia
5365793|NCT00175305|Hyperphagia in Prader-Willi syndrome|hyperphagia in prader-willi syndrome
5365794|NCT00175279|coronary disease|coronary disease
5365795|NCT00175279|heart failure|heart failure
5365796|NCT00175279|quality improvement|quality improvement
5365797|NCT00175279|knowledge translation|knowledge translation
5365798|NCT00175279|opinion leaders|opinion leaders
5365799|NCT00175266|islet|islet
5365800|NCT00175266|transplantation|transplantation
5365801|NCT00175253|islet|islet
5365802|NCT00175253|transplantation|transplantation
5365803|NCT00175240|Coronary disease|coronary disease
5365804|NCT00175240|quality improvement|quality improvement
5365805|NCT00175240|knowledge translation|knowledge translation
5365806|NCT00175227|contrast-induced nephropathy|contrast-induced nephropathy
5365807|NCT00175227|prevention|prevention
5365808|NCT00175227|renal failure|renal failure
5365809|NCT00175227|cardiac angiogram|cardiac angiogram
5365810|NCT00175214|osteoporosis|osteoporosis
5365811|NCT00175214|wrist fractures|wrist fractures
5365812|NCT00175214|quality improvement|quality improvement
5365813|NCT00175214|knowledge translation|knowledge translation
5365814|NCT00175188|RSA|rsa
5365815|NCT00175188|DEXA|dexa
5365816|NCT00175188|Osteoarthritis|osteoarthritis
5365817|NCT00175188|Finger implant|finger implant
5365818|NCT00175188|Micromotion|micromotion
5365819|NCT00175188|Bone density|bone density
5365820|NCT00175188|Cement|cement
5365821|NCT00175175|osteoporosis treatment|osteoporosis treatment
5365822|NCT00175175|osteoporosis testing|osteoporosis testing
5365823|NCT00175175|hip fracture|hip fracture
5365824|NCT00175175|quality improvement|quality improvement
5365825|NCT00175162|RSA|rsa
5365826|NCT00175162|DEXA|dexa
5365827|NCT00175162|Genoarthrosis|genoarthrosis
5365828|NCT00175162|Knee Arthroplasty|knee arthroplasty
5365829|NCT00175162|Micromotion of polyethylene liner|micromotion of polyethylene liner
5365830|NCT00175162|Cement|cement
5365831|NCT00175149|CKD 3-4|ckd 3-4
5365832|NCT00175136|RSA|rsa
5365833|NCT00175136|DEXA|dexa
5365834|NCT00175136|Gonarthrosis|gonarthrosis
5365835|NCT00175136|Knee Arthroplasty|knee arthroplasty
5365836|NCT00175136|Micromotion of polyethylen liner|micromotion of polyethylen liner
5365837|NCT00175136|Stem arthroplasty design|stem arthroplasty design
5365838|NCT00175123|Myelomeningocele|myelomeningocele
5365839|NCT00175123|Neurogenic Bladder|neurogenic bladder
5365840|NCT00175123|Intervention|intervention
5365841|NCT00175123|Botulinum A toxin|botulinum a toxin
5365842|NCT00175123|Oxybutynin|oxybutynin
5365843|NCT00175110|pre-hypertension|pre-hypertension
5365844|NCT00175110|mild hypertension|mild hypertension
5365845|NCT00175097|soy protein|soy protein
5365846|NCT00175097|lipids|lipids
5365847|NCT00175097|lipoproteins|lipoproteins
5365848|NCT00175097|apolipoproteins|apolipoproteins
5365849|NCT00175097|cholesterol|cholesterol
5365850|NCT00175097|endothelial function|endothelial function
5365851|NCT00175058|Heart Attack|heart attack
5365852|NCT00175045|Intravenous|intravenous
5365853|NCT00175045|gastric acid secretion|gastric acid secretion
5365854|NCT00175045|Lansoprazole|lansoprazole
5365855|NCT00175045|Esophagitis|esophagitis
5365856|NCT00175045|reflux|reflux
5365857|NCT00175032|Low dose aspirin|low dose aspirin
5365858|NCT00175032|Peptic Ulcer|peptic ulcer
5365859|NCT00175032|gastric ulcer|gastric ulcer
5365860|NCT00175032|duodenal ulcer|duodenal ulcer
5365861|NCT00175032|NSAIDs|nsaids
5365862|NCT00175019|uric acid|uric acid
5365863|NCT00175019|xanthine oxidase|xanthine oxidase
5365864|NCT00175019|hyperuricemia|hyperuricemia
5365865|NCT00175019|tophi|tophi
5365866|NCT00175019|Drug Therapy|drug therapy
5365867|NCT00175006|Hyperuricemia|hyperuricemia
5365868|NCT00175006|Tophi|tophi
5365869|NCT00175006|Tophus|tophus
5365870|NCT00175006|Drug Therapy|drug therapy
5365871|NCT00174993|Glucose Metabolism Disorder|glucose metabolism disorder
5365872|NCT00174993|Dysmetabolic Syndrome|dysmetabolic syndrome
5365873|NCT00174993|Type II Diabetes; Diabetes Mellitus|type ii diabetes; diabetes mellitus
5365874|NCT00174993|Lipoatrophic|lipoatrophic
5365875|NCT00174993|Dyslipidemia|dyslipidemia
5365876|NCT00174993|Drug Therapy|drug therapy
5365877|NCT00174980|Oxycyte|oxycyte
5365878|NCT00174980|perfluorocarbon oxygen carrier|perfluorocarbon oxygen carrier
5365879|NCT00174980|brain oxygen tension|brain oxygen tension
5365880|NCT00174967|Uric Acid|uric acid
5365881|NCT00174967|xanthine oxidase|xanthine oxidase
5365882|NCT00174967|tophi|tophi
5365883|NCT00174967|Drug Therapy|drug therapy
5365884|NCT00174954|Gout|gout
5365885|NCT00174954|Tophus|tophus
5365886|NCT00174954|MRI|mri
5365887|NCT00174941|Uric acid|uric acid
5365888|NCT00174941|xanthine oxidase|xanthine oxidase
5365889|NCT00174941|tophi|tophi
5365890|NCT00174941|Drug Therapy|drug therapy
5365891|NCT00174928|Pediatric GERD|pediatric gerd
5365892|NCT00174928|Pediatric Gastroesophageal Reflux Disease|pediatric gastroesophageal reflux disease
5365893|NCT00174928|Neonates|neonates
5365894|NCT00174928|lansoprazole|lansoprazole
5365895|NCT00174915|Uric Acid, gout, xanthine oxidase, febuxostat, tophi|uric acid, gout, xanthine oxidase, febuxostat, tophi
5365896|NCT00174902|Randomized controlled trial|randomized controlled trial
5365897|NCT00174902|Blood platelets|blood platelets
5365898|NCT00174902|Hemostasis|hemostasis
5365899|NCT00174902|Stress, psychological|stress, psychological
5365900|NCT00174902|Adrenergic beta-antagonists|adrenergic beta-antagonists
5365901|NCT00174902|Aspirin|aspirin
5365902|NCT00174902|Endothelium|endothelium
5365903|NCT00174902|Arteriosclerosis|arteriosclerosis
5365904|NCT00174889|Schizophrenia|schizophrenia
5365905|NCT00174889|Pregnenolone|pregnenolone
5365906|NCT00174889|Neurosteroids|neurosteroids
5365907|NCT00174876|depression|depression
5365908|NCT00174850|anxiety|anxiety
5365909|NCT00174850|sexual dysfunction|sexual dysfunction
5365910|NCT00174850|ssri|ssri
5365911|NCT00174837|Tirapazamine|tirapazamine
5365912|NCT00174837|Head and Neck Cancer|head and neck cancer
5365913|NCT00174837|Cisplatin|cisplatin
5365914|NCT00174837|Radiation|radiation
5365915|NCT00174824|Diabetes|diabetes
5365916|NCT00174824|Diabetic Retinopathy|diabetic retinopathy
5365917|NCT00174811|acute otitis media|acute otitis media
5365918|NCT00174811|controlled clinical trial|controlled clinical trial
5365919|NCT00174811|telithromycin|telithromycin
5365920|NCT00174811|cefuroxime axetil|cefuroxime axetil
5365921|NCT00174811|middle ear infections|middle ear infections
5365922|NCT00174811|tympanocentecis|tympanocentecis
5365923|NCT00174798|Cystometry NK1 Antagonist SSR240600C|cystometry nk1 antagonist ssr240600c
5365924|NCT00174785|Mortality, Hospitalization|mortality, hospitalization
5365925|NCT00174746|Glucocorticosteroid; Dose response; Bronchospasm|glucocorticosteroid; dose response; bronchospasm
5365926|NCT00174733|Glucocorticosteroid. Bronchospasm|glucocorticosteroid. bronchospasm
5365927|NCT00174720|Glucocorticosteroid. Bronchospasm|glucocorticosteroid. bronchospasm
5365928|NCT00174603|depression|depression
5365929|NCT00174603|psychosis|psychosis
5365930|NCT00174590|depression|depression
5365931|NCT00174538|codeine|codeine
5365932|NCT00174538|pain|pain
5365933|NCT00174538|CYP2D6|cyp2d6
5365934|NCT00174538|genotype|genotype
5365935|NCT00174538|morphine|morphine
5365936|NCT00174538|sickle cell|sickle cell
5365937|NCT00174538|pharmacokinetic|pharmacokinetic
5365938|NCT00174525|Alzheimer's Caregivers|alzheimer's caregivers
5365939|NCT00174525|Alzheimer disease|alzheimer disease
5365940|NCT00174499|Tooth stain|tooth stain
5365941|NCT00174213|iliotibial tract|iliotibial tract
5365942|NCT00174161|Premenstrual Syndrome,Health Related Quality of Life|premenstrual syndrome,health related quality of life
5365943|NCT00174135|Sarcopenia|sarcopenia
5365944|NCT00174135|exercise|exercise
5365945|NCT00174122|Emergency department|emergency department
5365946|NCT00174122|Blood culture|blood culture
5365947|NCT00174122|Antimicrobial therapy|antimicrobial therapy
5365948|NCT00174109|arecoline, oral cancer, MAP2, cell migration|arecoline, oral cancer, map2, cell migration
5365949|NCT00174096|laryngeal cancer|laryngeal cancer
5367210|NCT00168025|Children|children
5365950|NCT00174096|hypopharyngeal cancer|hypopharyngeal cancer
5365951|NCT00174096|CXCR4|cxcr4
5365952|NCT00174096|stromal-cell-derived factor-1(SDF-1)|stromal-cell-derived factor-1(sdf-1)
5365953|NCT00174096|metastasis|metastasis
5365954|NCT00174083|Tuberculosis, TB-ELISPOT, active tuberculosis latent infection interferon|tuberculosis, tb-elispot, active tuberculosis latent infection interferon
5365955|NCT00174070|Respiratory failure|respiratory failure
5365956|NCT00174070|Community|community
5365957|NCT00174057|Graves' ophthalmopathy|graves' ophthalmopathy
5365958|NCT00174057|real time PCR|real time pcr
5365959|NCT00174057|cytokines|cytokines
5365960|NCT00174057|Tsh receptor|tsh receptor
5365961|NCT00174031|baseball|baseball
5365962|NCT00174031|injury|injury
5365963|NCT00174018|subacrominal space|subacrominal space
5365964|NCT00174005|muscle|muscle
5365965|NCT00174005|tendon|tendon
5365966|NCT00173992|Stroke|stroke
5365967|NCT00173992|Balance|balance
5365968|NCT00173992|Proactive control|proactive control
5365969|NCT00173992|Reactive control|reactive control
5365970|NCT00173992|Recovery|recovery
5365971|NCT00173992|Training|training
5365972|NCT00173992|Fall|fall
5365973|NCT00173979|muscle|muscle
5365974|NCT00173979|tendon|tendon
5365975|NCT00173953|H. pylori、immune response、lymphocytic subsets、cytokine|h. pylori、immune response、lymphocytic subsets、cytokine
5365976|NCT00173940|chronic diseases, such as hypertension, diabetes, obesity, chronic renal failure, and so on|chronic diseases, such as hypertension, diabetes, obesity, chronic renal failure, and so on
5365977|NCT00173927|extracranial atherosclerosis|extracranial atherosclerosis
5365978|NCT00173927|imaging|imaging
5365979|NCT00173927|biomarkers|biomarkers
5365980|NCT00173914|1. Transplant vasculopathy|1. transplant vasculopathy
5365981|NCT00173914|2. Endothelial dysfunction|2. endothelial dysfunction
5365982|NCT00173914|3. Myocardial perfusion imaging|3. myocardial perfusion imaging
5365983|NCT00173914|4. Intravascular vascular ultrasound|4. intravascular vascular ultrasound
5365984|NCT00173901|ceftazidime|ceftazidime
5365985|NCT00173901|safety|safety
5365986|NCT00173901|infection|infection
5365987|NCT00173888|Combination, Chemotherapy,non-small cell lung cancer|combination, chemotherapy,non-small cell lung cancer
5365988|NCT00173875|EGFR Non-small cell lung cancer|egfr non-small cell lung cancer
5365989|NCT00173862|Combination, Chemotherapy,transitional cell carcinoma|combination, chemotherapy,transitional cell carcinoma
5365990|NCT00173849|oral cancer|oral cancer
5365991|NCT00173849|CXCR4|cxcr4
5365992|NCT00173849|stromal-cell-derived factor-1(SDF-1)|stromal-cell-derived factor-1(sdf-1)
5365993|NCT00173849|metastasis|metastasis
5365994|NCT00173836|Nasopharyngeal carcinoma|nasopharyngeal carcinoma
5365995|NCT00173836|Saliva|saliva
5365996|NCT00173836|Swallowing|swallowing
5365997|NCT00173836|Videofluoroscopy|videofluoroscopy
5365998|NCT00173836|Radiation|radiation
5365999|NCT00173810|stroke|stroke
5366000|NCT00173810|movement|movement
5366001|NCT00173810|psychomterics|psychomterics
5366002|NCT00173797|depression|depression
5366003|NCT00173797|psychometrics|psychometrics
5366004|NCT00173784|psychometrics|psychometrics
5366005|NCT00173784|activities of daily living|activities of daily living
5366006|NCT00173771|stroke|stroke
5366007|NCT00173771|activities of daily living|activities of daily living
5366008|NCT00173771|psychometrics|psychometrics
5366009|NCT00173758|IL-15|il-15
5366010|NCT00173758|IL-15 receptor|il-15 receptor
5366011|NCT00173758|decidual natural killer cells|decidual natural killer cells
5366012|NCT00173758|endometrium|endometrium
5366013|NCT00173745|cerebral palsy|cerebral palsy
5366014|NCT00173745|drooling|drooling
5366015|NCT00173745|botulinum toxin|botulinum toxin
5366016|NCT00173732|Preimplantation genetic diagnosis (PGD)|preimplantation genetic diagnosis (pgd)
5366017|NCT00173732|single cell|single cell
5366018|NCT00173732|Multiple displacement amplification (MDA)|multiple displacement amplification (mda)
5366019|NCT00173719|Hemiplegia|hemiplegia
5366020|NCT00173719|Assisstive device|assisstive device
5366021|NCT00173719|Walking|walking
5366022|NCT00173719|Dynamic equilibrium|dynamic equilibrium
5366023|NCT00173719|Reaction time|reaction time
5366024|NCT00173719|Attention|attention
5366025|NCT00173719|Dual task|dual task
5366026|NCT00173706|L-Carnitine|l-carnitine
5366027|NCT00173706|hemodialysis|hemodialysis
5366028|NCT00173706|cardiac complications|cardiac complications
5366029|NCT00173706|impaired exercise and functional capacities|impaired exercise and functional capacities
5366030|NCT00173706|muscle symptoms|muscle symptoms
5366031|NCT00173706|intradialytic hypotension|intradialytic hypotension
5366032|NCT00173706|erythropoietin-resistant anemia|erythropoietin-resistant anemia
5366033|NCT00173693|CEA, Osteoporosis, Fracture, Prevention, Exercise|cea, osteoporosis, fracture, prevention, exercise
5366034|NCT00173615|ECMO|ecmo
5366035|NCT00173615|CPR|cpr
5366036|NCT00173602|Peritoneal Dialysis|peritoneal dialysis
5366037|NCT00173563|Immunology|immunology
5366038|NCT00173550|Menopause, premature|menopause, premature
5366039|NCT00173550|Hysterectomy|hysterectomy
5366040|NCT00173550|Ovariectomy|ovariectomy
5366041|NCT00173550|Estrogen Replacement Therapy|estrogen replacement therapy
5366042|NCT00173550|Knowledge|knowledge
5366043|NCT00173550|Perception|perception
5366044|NCT00173550|Attitude|attitude
5366142|NCT00173069|Candidate Genes|candidate genes
5366045|NCT00173537|idiopathic pulmonary artery hypertension|idiopathic pulmonary artery hypertension
5366046|NCT00173524|EGFR Non-small cell lung cancer|egfr non-small cell lung cancer
5366047|NCT00173498|atopic dermatitis, skin test|atopic dermatitis, skin test
5366048|NCT00173485|peritonitis, peritoneal dialysis, dialysate|peritonitis, peritoneal dialysis, dialysate
5366049|NCT00173472|colorectal cancer, MSI, TS, DPD, EGFR, chemotherapy.|colorectal cancer, msi, ts, dpd, egfr, chemotherapy.
5366050|NCT00173446|Normal part of the adrenal gland|normal part of the adrenal gland
5366051|NCT00173433|tuberculosis|tuberculosis
5366052|NCT00173433|relapse|relapse
5366053|NCT00173433|reinfection|reinfection
5366054|NCT00173433|reactivation|reactivation
5366055|NCT00173433|dormancy|dormancy
5366056|NCT00173433|tuberculin skin test|tuberculin skin test
5366057|NCT00173420|Normal Controls|normal controls
5366058|NCT00173407|Ovarian endometrioid carcinoma|ovarian endometrioid carcinoma
5366059|NCT00173407|invasion|invasion
5366060|NCT00173407|IGFBP-3|igfbp-3
5366061|NCT00173407|transfection|transfection
5366062|NCT00173407|signal transduction|signal transduction
5366063|NCT00173407|PTEN|pten
5366064|NCT00173407|methylation|methylation
5366065|NCT00173394|ovarian cancer|ovarian cancer
5366066|NCT00173394|immunotherapy|immunotherapy
5366067|NCT00173394|mesothelin|mesothelin
5366068|NCT00173394|normal volunteer|normal volunteer
5366069|NCT00173381|lymphangiogenesis|lymphangiogenesis
5366070|NCT00173381|head and neck squamous cell carcinoma (HNSCC)|head and neck squamous cell carcinoma (hnscc)
5366071|NCT00173381|vascular endothelial growth factor-C (VEGF-C)|vascular endothelial growth factor-c (vegf-c)
5366072|NCT00173381|cyclooxygenase-2 (COX-2)|cyclooxygenase-2 (cox-2)
5366073|NCT00173381|interleukin-6 (IL-6)|interleukin-6 (il-6)
5366074|NCT00173368|Sphincterotomy|sphincterotomy
5366075|NCT00173368|needle knife|needle knife
5366076|NCT00173368|hemorrhage|hemorrhage
5366077|NCT00173368|complication|complication
5366078|NCT00173355|pediatric Dermatofibrosarcoma Protuberans|pediatric dermatofibrosarcoma protuberans
5366079|NCT00173342|Right bundle branch block|right bundle branch block
5366080|NCT00173342|Electrocardiography|electrocardiography
5366081|NCT00173342|Ion channel|ion channel
5366082|NCT00173329|HIV|hiv
5366083|NCT00173316|vascular endothelial growth factor-C|vascular endothelial growth factor-c
5366084|NCT00173316|VEGF-CR|vegf-cr
5366085|NCT00173316|lymphangiogenesis|lymphangiogenesis
5366086|NCT00173316|host inflammatory responses|host inflammatory responses
5366087|NCT00173316|oral carcinogenesis|oral carcinogenesis
5366088|NCT00173316|oral cancers|oral cancers
5366089|NCT00173316|oral premalignant lesions|oral premalignant lesions
5366090|NCT00173303|Breast neoplasms|breast neoplasms
5366091|NCT00173303|Breast radiography|breast radiography
5366092|NCT00173303|Cancer screening|cancer screening
5366093|NCT00173290|Cervical cancer|cervical cancer
5366094|NCT00173290|Breast cancer|breast cancer
5366095|NCT00173290|T lymphocyte|t lymphocyte
5366096|NCT00173290|NK receptor|nk receptor
5366097|NCT00173277|colorectal cancer screening|colorectal cancer screening
5366098|NCT00173277|colonoscopy|colonoscopy
5366099|NCT00173238|atherosclerosis|atherosclerosis
5366100|NCT00173238|optical coherence tomography|optical coherence tomography
5366101|NCT00173238|polarization|polarization
5366102|NCT00173238|phase retardation|phase retardation
5366103|NCT00173238|birefringence|birefringence
5366104|NCT00173225|nociceptin|nociceptin
5366105|NCT00173225|sunstance P|sunstance p
5366106|NCT00173225|asthma|asthma
5366107|NCT00173225|COPD|copd
5366108|NCT00173225|cough|cough
5366109|NCT00173212|adenomyosis|adenomyosis
5366110|NCT00173212|cell proliferation|cell proliferation
5366111|NCT00173212|Immunocytochemistry|immunocytochemistry
5366112|NCT00173186|ventricular septal defect|ventricular septal defect
5366113|NCT00173186|aortic regurgitation|aortic regurgitation
5366114|NCT00173173|Gifted dance students|gifted dance students
5366115|NCT00173173|eating disorders|eating disorders
5366116|NCT00173173|prevalence|prevalence
5366117|NCT00173173|risk factors|risk factors
5366118|NCT00173173|BITE|bite
5366119|NCT00173160|Eating disorders|eating disorders
5366120|NCT00173160|risk factors|risk factors
5366121|NCT00173160|prospective study|prospective study
5366122|NCT00173160|case-controled study|case-controled study
5366123|NCT00173160|outcome|outcome
5366124|NCT00173160|gifted dance students|gifted dance students
5366125|NCT00173134|diabetes|diabetes
5366126|NCT00173134|erectile dysfunction|erectile dysfunction
5366127|NCT00173134|erectile dysfunction related quality of life|erectile dysfunction related quality of life
5366128|NCT00173121|enterovirus, environment, aerosol, air|enterovirus, environment, aerosol, air
5366129|NCT00173108|Prematurity|prematurity
5366130|NCT00173108|Early intervention|early intervention
5366131|NCT00173108|Neurodevelopment|neurodevelopment
5366132|NCT00173108|Cost-effectiveness|cost-effectiveness
5366133|NCT00173082|primary aldosteronism|primary aldosteronism
5366134|NCT00173082|Insulin resistance|insulin resistance
5366135|NCT00173082|Metabolic syndrome|metabolic syndrome
5366136|NCT00173082|OGTT|ogtt
5366137|NCT00173069|Schizophrenia|schizophrenia
5366138|NCT00173069|PPI|ppi
5366139|NCT00173069|P50I|p50i
5366140|NCT00173069|MRS|mrs
5366141|NCT00173069|Niacin|niacin
5366143|NCT00173056|Peritoneal dialysis|peritoneal dialysis
5366144|NCT00173017|N95 mask|n95 mask
5366145|NCT00173017|medical staff|medical staff
5366146|NCT00173017|hypoxemia|hypoxemia
5366147|NCT00173017|hypercapnia|hypercapnia
5366148|NCT00173017|neurological study|neurological study
5366149|NCT00172965|Optic coherence tomography|optic coherence tomography
5366150|NCT00172965|oral cancer|oral cancer
5366151|NCT00172965|oral precancers|oral precancers
5366152|NCT00172952|high myopia, genomic|high myopia, genomic
5366153|NCT00172926|Physical Constitution|physical constitution
5366154|NCT00172926|Disease Pattern|disease pattern
5366155|NCT00172926|Laboratory Data|laboratory data
5366156|NCT00172926|Integrative Chinese Medicine and Western Medicine|integrative chinese medicine and western medicine
5366157|NCT00172913|Wavefront Aberration|wavefront aberration
5366158|NCT00172913|LASIK|lasik
5366159|NCT00172913|Contrast Sensitivity|contrast sensitivity
5366160|NCT00172913|Visual Performance|visual performance
5366161|NCT00172913|Ablation Profile|ablation profile
5366162|NCT00172900|Diffusion tensor imaging|diffusion tensor imaging
5366163|NCT00172900|MR spectroscopy|mr spectroscopy
5366164|NCT00172900|dementia|dementia
5366165|NCT00172900|white matter|white matter
5366166|NCT00172887|Psychiatrists|psychiatrists
5366167|NCT00172874|cross-cultural,|cross-cultural,
5366168|NCT00172874|eating disorders,|eating disorders,
5366169|NCT00172874|EDI,|edi,
5366170|NCT00172874|psychometrics|psychometrics
5366171|NCT00172861|gastric cancer, cyclooxygenase-2, microarray|gastric cancer, cyclooxygenase-2, microarray
5366172|NCT00172835|pleural effusion|pleural effusion
5366173|NCT00172835|procalcitonin|procalcitonin
5366174|NCT00172822|appendicitis|appendicitis
5366175|NCT00172809|Chronic Hepatitis C|chronic hepatitis c
5366176|NCT00172809|End stage renal disease|end stage renal disease
5366177|NCT00172809|Hemodialysis|hemodialysis
5366178|NCT00172809|Interferon|interferon
5366179|NCT00172809|Pegylated interferon|pegylated interferon
5366180|NCT00172796|Metabolic syndrome|metabolic syndrome
5366181|NCT00172783|TB|tb
5366182|NCT00172783|PPD|ppd
5366183|NCT00172783|ELISPOT|elispot
5366184|NCT00172783|BCG|bcg
5366185|NCT00172757|MSI, TS, Colorectal Cancer, DM.|msi, ts, colorectal cancer, dm.
5366186|NCT00172744|stem cells|stem cells
5366187|NCT00172744|periodontal cells|periodontal cells
5366188|NCT00172744|mechanical stress|mechanical stress
5366189|NCT00172744|differentiation|differentiation
5366190|NCT00172744|periodontal ligament|periodontal ligament
5366191|NCT00172692|Chewing efficiency,|chewing efficiency,
5366192|NCT00172692|Gum chewing|gum chewing
5366193|NCT00172692|Chewing velocity|chewing velocity
5366194|NCT00172692|Occlusal surface area|occlusal surface area
5366195|NCT00172692|EMG|emg
5366196|NCT00172692|Jaw movement|jaw movement
5366197|NCT00172679|Tai Chi|tai chi
5366198|NCT00172679|NK Cells|nk cells
5366199|NCT00172679|T lymphocytes|t lymphocytes
5366200|NCT00172679|Exercise|exercise
5366201|NCT00172666|SLE|sle
5366202|NCT00172666|healthy subjects|healthy subjects
5366203|NCT00172653|shoulder, reliability, validity|shoulder, reliability, validity
5366204|NCT00172614|metabolic syndrome|metabolic syndrome
5366205|NCT00172588|adenomyosis|adenomyosis
5366206|NCT00172588|apoptosis|apoptosis
5366207|NCT00172588|flowcytometry|flowcytometry
5366208|NCT00172575|Lung neoplasms|lung neoplasms
5366209|NCT00172575|Magnetic resonance imaging|magnetic resonance imaging
5366210|NCT00172562|acute myeloid leukemia|acute myeloid leukemia
5366211|NCT00172562|age and sex matched normal subjects|age and sex matched normal subjects
5366212|NCT00172562|dynamic MRI|dynamic mri
5366213|NCT00172562|bone marrow perfusion|bone marrow perfusion
5366214|NCT00172562|tumor angiogenesis|tumor angiogenesis
5366215|NCT00172497|aggressive acts|aggressive acts
5366216|NCT00172484|cerebrovascular accident|cerebrovascular accident
5366217|NCT00172484|stroke center|stroke center
5366218|NCT00172484|stroke team|stroke team
5366219|NCT00172484|intensive care of stroke|intensive care of stroke
5366220|NCT00172484|rehabilitation of stroke|rehabilitation of stroke
5366221|NCT00172419|statin, inflammation, FDG, positron emission tomography|statin, inflammation, fdg, positron emission tomography
5366222|NCT00172393|EV71,|ev71,
5366223|NCT00172393|CNS,|cns,
5366224|NCT00172393|Outcome,|outcome,
5366225|NCT00172393|Neurological,|neurological,
5366226|NCT00172393|Psychiatric|psychiatric
5366227|NCT00172367|Urothelial carcinoma|urothelial carcinoma
5366228|NCT00172367|Lycopene|lycopene
5366229|NCT00172367|uremia|uremia
5366230|NCT00172367|prevention|prevention
5366231|NCT00172367|biomarker|biomarker
5366232|NCT00172367|progression|progression
5366233|NCT00172367|anti-oxidant|anti-oxidant
5366234|NCT00172328|Hepatitis B|hepatitis b
5366235|NCT00172328|vaccine|vaccine
5366236|NCT00172315|acquired immunodeficiency syndrome|acquired immunodeficiency syndrome
5366237|NCT00172315|lipodystrophy|lipodystrophy
5366238|NCT00172315|MR spectroscopy|mr spectroscopy
5366239|NCT00172289|pulse wave velocity|pulse wave velocity
5366240|NCT00172289|sympathetic nerve activity|sympathetic nerve activity
5366241|NCT00172289|spinal cord injury|spinal cord injury
5366242|NCT00172289|cerebrovascular accident|cerebrovascular accident
5366243|NCT00172263|Immunology|immunology
5366244|NCT00172237|eye-head coordination|eye-head coordination
5366245|NCT00172237|proprioception|proprioception
5366246|NCT00172237|cervical spine with degenerative disease|cervical spine with degenerative disease
5366247|NCT00172237|degenerated cervical spine|degenerated cervical spine
5366248|NCT00172224|osteoporosis|osteoporosis
5366249|NCT00172224|compression fracture|compression fracture
5366250|NCT00172224|bone marrow perfusion|bone marrow perfusion
5366251|NCT00172224|MR spectroscopy|mr spectroscopy
5366252|NCT00172224|hormone therapy|hormone therapy
5366253|NCT00172211|Physioneal|physioneal
5366254|NCT00172211|Peritoneal dialysis|peritoneal dialysis
5366255|NCT00172211|Oxidative stress|oxidative stress
5366256|NCT00172211|insulin resistance|insulin resistance
5366257|NCT00172198|w-3 fish oil|w-3 fish oil
5366258|NCT00172198|Nutrition|nutrition
5366259|NCT00172198|immune|immune
5366260|NCT00172198|intensive care|intensive care
5366261|NCT00172198|patients|patients
5366262|NCT00172185|Short Bowel Syndrome|short bowel syndrome
5366263|NCT00172185|Parenteral Nutrition|parenteral nutrition
5366264|NCT00172185|SBS|sbs
5366265|NCT00172185|Teduglutide|teduglutide
5366266|NCT00172172|Post-menopausal|post-menopausal
5366267|NCT00172172|Osteoporosis|osteoporosis
5366268|NCT00172172|Parathyroid Hormone|parathyroid hormone
5366269|NCT00172172|PTH|pth
5366270|NCT00172172|ALX1-11|alx1-11
5366271|NCT00172159|Colorectal cancer|colorectal cancer
5366272|NCT00172159|Chemotherapy|chemotherapy
5366273|NCT00172159|Surgery|surgery
5366274|NCT00172159|Liver metastasis|liver metastasis
5366275|NCT00172146|Hemiplegia|hemiplegia
5366276|NCT00172146|Regular cane|regular cane
5366277|NCT00172146|Volitional stepping|volitional stepping
5366278|NCT00172146|Dynamic equilibrium|dynamic equilibrium
5366279|NCT00172146|Attention|attention
5366280|NCT00172146|Dual task|dual task
5366281|NCT00172133|Post-menopausal|post-menopausal
5366282|NCT00172133|Osteoporosis|osteoporosis
5366283|NCT00172133|Parathyroid Hormone|parathyroid hormone
5366284|NCT00172133|PTH|pth
5366285|NCT00172133|ALX1-11|alx1-11
5366286|NCT00172120|Post-menopausal|post-menopausal
5366287|NCT00172120|Osteoporosis|osteoporosis
5366288|NCT00172120|Parathyroid Hormone|parathyroid hormone
5366289|NCT00172120|PTH|pth
5366290|NCT00172120|ALX1-11|alx1-11
5366291|NCT00172107|Post-menopausal|post-menopausal
5366292|NCT00172107|Osteoporosis|osteoporosis
5366293|NCT00172107|Parathyroid Hormone|parathyroid hormone
5366294|NCT00172107|PTH|pth
5366295|NCT00172107|ALX1-11|alx1-11
5366296|NCT00172094|Migraine|migraine
5366297|NCT00172081|Post-menopausal|post-menopausal
5366298|NCT00172081|Osteoporosis|osteoporosis
5366299|NCT00172081|Parathyroid Hormone|parathyroid hormone
5366300|NCT00172081|PTH|pth
5366301|NCT00172081|ALX1-11|alx1-11
5366302|NCT00172068|Primary breast cancer|primary breast cancer
5366303|NCT00172068|Bone metastases|bone metastases
5366304|NCT00172068|Minimal residual disease|minimal residual disease
5366305|NCT00172068|Bisphosphonates|bisphosphonates
5366306|NCT00172055|Zoledronic acid|zoledronic acid
5366307|NCT00172055|Zometa|zometa
5366308|NCT00172055|prostate cancer|prostate cancer
5366309|NCT00172055|osteoporosis|osteoporosis
5366310|NCT00172042|Non-Small-Cell Lung Cancer|non-small-cell lung cancer
5366311|NCT00172042|Bisphosphonates|bisphosphonates
5366312|NCT00172042|Zoledronic acid|zoledronic acid
5366313|NCT00172042|Bone metastases|bone metastases
5366314|NCT00172042|Prevention of bone metastases|prevention of bone metastases
5366315|NCT00172029|Zoledronic acid|zoledronic acid
5366316|NCT00172029|Radiotherapy|radiotherapy
5366317|NCT00172029|Bone pain|bone pain
5366318|NCT00172029|Breast cancer|breast cancer
5366319|NCT00172016|Zoledronic acid|zoledronic acid
5366320|NCT00172016|SRE|sre
5366321|NCT00172016|Prostate cancer|prostate cancer
5366322|NCT00172003|Renal Cell Cancer|renal cell cancer
5366323|NCT00172003|Bone metastasis|bone metastasis
5366324|NCT00172003|Skeletal related event|skeletal related event
5366325|NCT00172003|Renal Cell Cancer patients with bone metastasis|renal cell cancer patients with bone metastasis
5366326|NCT00171990|genital herpes|genital herpes
5366327|NCT00171990|herpes|herpes
5366328|NCT00171990|famciclovir|famciclovir
5366329|NCT00171977|GIST|gist
5366330|NCT00171977|Imatinib|imatinib
5366331|NCT00171977|Postoperative Adjuvant|postoperative adjuvant
5366332|NCT00171964|Pain|pain
5366333|NCT00171964|Bone metastasis|bone metastasis
5366334|NCT00171964|Analgesic consumption|analgesic consumption
5366335|NCT00171964|Cancer patients|cancer patients
5366336|NCT00171964|Cancer patients with painful bone metastasis|cancer patients with painful bone metastasis
5366337|NCT00171951|Cushing's disease|cushing's disease
5366338|NCT00171951|ACTH|acth
5366339|NCT00171951|Cortisol|cortisol
5366340|NCT00171951|ACTH dependent Cushing's disease|acth dependent cushing's disease
5366341|NCT00171938|Glioblastoma|glioblastoma
5366342|NCT00171938|Brain tumors|brain tumors
5366343|NCT00171938|Imatinib|imatinib
5366344|NCT00171938|PDGFR|pdgfr
5366345|NCT00171925|Multiple Myeloma|multiple myeloma
5366346|NCT00171925|Stage I|stage i
5366347|NCT00171925|Zoledronic acid|zoledronic acid
5366348|NCT00171925|Progression|progression
5366349|NCT00171912|Imatinib mesylate|imatinib mesylate
5366350|NCT00171912|tyrosine kinases|tyrosine kinases
5366351|NCT00171912|imatinib sensitivity|imatinib sensitivity
5366352|NCT00171912|Diverse malignancies either associated with|diverse malignancies either associated with
5366353|NCT00171912|or thought to be associated with|or thought to be associated with
5366354|NCT00171912|activated tyrosine kinase enzymes|activated tyrosine kinase enzymes
5366355|NCT00171912|including hypereosinophilic syndrome|including hypereosinophilic syndrome
5366356|NCT00171912|systemic mastocytosis|systemic mastocytosis
5366357|NCT00171912|chronic myelomonocytic leukaemia,|chronic myelomonocytic leukaemia,
5366358|NCT00171912|dermatofibrosarcoma protuberans and other diseases.|dermatofibrosarcoma protuberans and other diseases.
5366359|NCT00171912|Not included:|not included:
5366360|NCT00171912|patients with chronic myeloid leukemia,|patients with chronic myeloid leukemia,
5366361|NCT00171912|some other types of leukemias (abl-mutated)|some other types of leukemias (abl-mutated)
5366362|NCT00171912|some types of gastrointestinal stromal tumours (c-KIT-positive),|some types of gastrointestinal stromal tumours (c-kit-positive),
5366363|NCT00171912|some systemic mastocytosis (if c-KIT D816V mutation),|some systemic mastocytosis (if c-kit d816v mutation),
5366364|NCT00171912|brain,|brain,
5366365|NCT00171912|prostate,|prostate,
5366366|NCT00171912|breast or lung cancers.|breast or lung cancers.
5366367|NCT00171899|Chronic Myelogenous Leukemia|chronic myelogenous leukemia
5366368|NCT00171899|Complete cytogenetic response|complete cytogenetic response
5366369|NCT00171899|Imatinib mesylate|imatinib mesylate
5366370|NCT00171899|Major molecular response|major molecular response
5366371|NCT00171899|Chronic phase Ph+ Chronic Myelogenous Leukemia|chronic phase ph+ chronic myelogenous leukemia
5366372|NCT00171886|Acromegaly|acromegaly
5366373|NCT00171886|Otreotide|otreotide
5366374|NCT00171886|Tumor reduction|tumor reduction
5366375|NCT00171873|Double blind|double blind
5366376|NCT00171873|Phase III|phase iii
5366377|NCT00171873|Disease|disease
5366378|NCT00171873|Clinical trial|clinical trial
5366379|NCT00171873|Octreotide|octreotide
5366380|NCT00171873|Neuroendocrine tumor|neuroendocrine tumor
5366381|NCT00171873|Cancer|cancer
5366382|NCT00171873|Tumor|tumor
5366383|NCT00171873|Midgut|midgut
5366384|NCT00171860|Hypereosinophilic syndrome|hypereosinophilic syndrome
5366385|NCT00171860|Imatinib|imatinib
5366386|NCT00171847|Breast cancer|breast cancer
5366387|NCT00171847|Metastatic|metastatic
5366388|NCT00171847|Trastuzumab|trastuzumab
5366389|NCT00171847|Letrozole|letrozole
5366390|NCT00171834|EPO|epo
5366391|NCT00171834|EPO906|epo906
5366392|NCT00171834|Brain metastasis|brain metastasis
5366393|NCT00171834|Lung cancer|lung cancer
5366394|NCT00171834|Lung metastasis|lung metastasis
5366395|NCT00171834|NSCLC|nsclc
5366396|NCT00171821|Thalassemia|thalassemia
5366397|NCT00171821|Myelodysplastic Syndrome|myelodysplastic syndrome
5366398|NCT00171821|MDS|mds
5366399|NCT00171821|Sickle cell|sickle cell
5366400|NCT00171821|Diamond-Blackfan anemia|diamond-blackfan anemia
5366401|NCT00171821|Transfusion|transfusion
5366402|NCT00171821|Anemia|anemia
5366403|NCT00171821|Fanconi|fanconi
5366404|NCT00171821|Chelation|chelation
5366405|NCT00171821|Deferasirox|deferasirox
5366406|NCT00171808|Endometrial Cancer|endometrial cancer
5366407|NCT00171808|Aromatase inhibitor|aromatase inhibitor
5366408|NCT00171808|Advanced or recurrent|advanced or recurrent
5366409|NCT00171808|hormone receptor positive|hormone receptor positive
5366410|NCT00171795|Traumatic brain injury,|traumatic brain injury,
5366411|NCT00171795|cognitive impairment,|cognitive impairment,
5366412|NCT00171795|rivastigmine|rivastigmine
5366413|NCT00171782|HYPERTENSION|hypertension
5366414|NCT00171782|VALSARTAN|valsartan
5366415|NCT00171782|VALSARTAN AND HYDROCHLOROTHIAZIDE|valsartan and hydrochlorothiazide
5366416|NCT00171782|RISK FACTORS|risk factors
5366417|NCT00171756|hypertension|hypertension
5366418|NCT00171756|valsartan|valsartan
5366419|NCT00171743|Adults|adults
5366420|NCT00171743|Post transplant diabetes|post transplant diabetes
5366421|NCT00171730|Acromegaly|acromegaly
5366422|NCT00171730|Pasireotide|pasireotide
5366423|NCT00171730|GH|gh
5366424|NCT00171730|IGF-1|igf-1
5366425|NCT00171717|Cyclosporine, liver transplantation, maintenance, diabetes|cyclosporine, liver transplantation, maintenance, diabetes
5366426|NCT00171704|Breast Cancer|breast cancer
5366427|NCT00171704|Letrozole|letrozole
5366428|NCT00171704|Bone Mineral Density|bone mineral density
5366429|NCT00171704|Bone Markers|bone markers
5366430|NCT00171704|Serum lipid|serum lipid
5366431|NCT00171704|Postmenopausal|postmenopausal
5366432|NCT00171691|Knee osteoarthritis, Topical NSAID, Diclofenac sodium|knee osteoarthritis, topical nsaid, diclofenac sodium
5366433|NCT00171678|Knee osteoarthritis, Topical NSAID, Diclofenac sodium|knee osteoarthritis, topical nsaid, diclofenac sodium
5366434|NCT00171665|Hand osteoarthritis, Topical NSAID, Diclofenac sodium|hand osteoarthritis, topical nsaid, diclofenac sodium
5366435|NCT00171652|Hand osteoarthritis, Topical NSAID, Diclofenac sodium|hand osteoarthritis, topical nsaid, diclofenac sodium
5366436|NCT00171626|Knee osteoarthritis, Topical NSAID, Diclofenac sodium|knee osteoarthritis, topical nsaid, diclofenac sodium
5366437|NCT00171613|Obesity|obesity
5366438|NCT00171600|valsartan|valsartan
5366439|NCT00171600|lisinopril|lisinopril
5366440|NCT00171600|albuminuria|albuminuria
5366441|NCT00171600|diabetic nephropathy|diabetic nephropathy
5367111|NCT00168545|Cytokines|cytokines
5366442|NCT00171587|Metastatic solid tumors|metastatic solid tumors
5366443|NCT00171587|PTK787/ZK 222584|ptk787/zk 222584
5366444|NCT00171587|Vatalanib|vatalanib
5366445|NCT00171587|Capecitabine|capecitabine
5366446|NCT00171587|VEGF (vascular endothelial growth factor)|vegf (vascular endothelial growth factor)
5366447|NCT00171587|Histologically confirmed metastatic solid tumors|histologically confirmed metastatic solid tumors
5366448|NCT00171574|valsartan|valsartan
5366449|NCT00171574|lisinopril|lisinopril
5366450|NCT00171574|antiproteinuric|antiproteinuric
5366451|NCT00171574|diabetic nephropathy|diabetic nephropathy
5366452|NCT00171561|hypertension|hypertension
5366453|NCT00171561|diabetes|diabetes
5366454|NCT00171561|albuminuria|albuminuria
5366455|NCT00171561|valsartan|valsartan
5366456|NCT00171561|hydrochlorothiazide|hydrochlorothiazide
5366457|NCT00171561|amlodipine|amlodipine
5366458|NCT00171548|Metabolic syndrome, cardiovascular risk reduction|metabolic syndrome, cardiovascular risk reduction
5366459|NCT00171535|hypertension|hypertension
5366460|NCT00171535|high blood pressure|high blood pressure
5366461|NCT00171535|valsartan|valsartan
5366462|NCT00171535|amlodipine|amlodipine
5366463|NCT00171522|Constipation|constipation
5366464|NCT00171522|Tegaserod|tegaserod
5366465|NCT00171522|Polyethylene Glycol 3350|polyethylene glycol 3350
5366466|NCT00171522|PEG|peg
5366467|NCT00171509|Liver transplant, adults, once a day administration, Immunosuppressants|liver transplant, adults, once a day administration, immunosuppressants
5366468|NCT00171496|Kidney transplant, adults, NODM, immunosuppressants|kidney transplant, adults, nodm, immunosuppressants
5366469|NCT00171483|GERD|gerd
5366470|NCT00171483|PPI|ppi
5366471|NCT00171483|heartburn|heartburn
5366472|NCT00171483|regurgitation|regurgitation
5366473|NCT00171470|dyspepsia|dyspepsia
5366474|NCT00171470|hearburn|hearburn
5366475|NCT00171470|female|female
5366476|NCT00171470|PPI|ppi
5366477|NCT00171457|functional heartburn|functional heartburn
5366478|NCT00171457|dyspepsia|dyspepsia
5366479|NCT00171457|male|male
5366480|NCT00171457|female|female
5366481|NCT00171457|visceral sensitivity|visceral sensitivity
5366482|NCT00171444|hypertension,|hypertension,
5366483|NCT00171444|valsartan+hydrochlorothiazide|valsartan+hydrochlorothiazide
5366484|NCT00171431|IBS-C|ibs-c
5366485|NCT00171431|female|female
5366486|NCT00171418|GERD|gerd
5366487|NCT00171418|PPI|ppi
5366488|NCT00171405|hypertension|hypertension
5366489|NCT00171405|aliskiren|aliskiren
5366490|NCT00171405|hydrochlorothiazide|hydrochlorothiazide
5366491|NCT00171392|Kidney transplantation; acute rejection; gastrointestinal adverse events; quality of life; mycophenolate sodium, tacrolimus.|kidney transplantation; acute rejection; gastrointestinal adverse events; quality of life; mycophenolate sodium, tacrolimus.
5366492|NCT00171379|Kidney transplantation; acute rejection; gastrointestinal adverse events; quality of life; mycophenolate sodium.|kidney transplantation; acute rejection; gastrointestinal adverse events; quality of life; mycophenolate sodium.
5366493|NCT00171366|amlodipine|amlodipine
5366494|NCT00171366|benazepril|benazepril
5366495|NCT00171366|hypertension|hypertension
5366496|NCT00171366|diastolic|diastolic
5366497|NCT00171353|arterial hypertension|arterial hypertension
5366498|NCT00171353|albuminuria|albuminuria
5366499|NCT00171353|valsartan|valsartan
5366500|NCT00171340|Bone Loss|bone loss
5366501|NCT00171340|Osteopenia|osteopenia
5366502|NCT00171340|Breast cancer|breast cancer
5366503|NCT00171340|letrozole|letrozole
5366504|NCT00171340|zoledronic acid|zoledronic acid
5366505|NCT00171340|postmenopausal|postmenopausal
5366506|NCT00171327|arterial hypertension|arterial hypertension
5366507|NCT00171327|dyslipidemia|dyslipidemia
5366508|NCT00171327|valsartan|valsartan
5366509|NCT00171327|fluvastatin|fluvastatin
5366510|NCT00171314|breast cancer|breast cancer
5366511|NCT00171314|letrozole|letrozole
5366512|NCT00171314|zoledronic acid|zoledronic acid
5366513|NCT00171314|adjuvant|adjuvant
5366514|NCT00171314|postmenopausal|postmenopausal
5366515|NCT00171301|Transfusional hemosiderosis|transfusional hemosiderosis
5366516|NCT00171301|Beta-thalassemia major|beta-thalassemia major
5366517|NCT00171301|Deferasirox|deferasirox
5366518|NCT00171301|iron overload|iron overload
5366519|NCT00171301|rare anemia|rare anemia
5366520|NCT00171301|iron overload due to transfusion|iron overload due to transfusion
5366521|NCT00171288|Dyslipidemia, ezetimibe, inflammatory markers, fluvastatin|dyslipidemia, ezetimibe, inflammatory markers, fluvastatin
5366522|NCT00171275|Coronary disease|coronary disease
5366523|NCT00171275|Myocardial infarction|myocardial infarction
5366524|NCT00171275|Statins|statins
5366525|NCT00171262|Dyslipidemia, chronic renal disease, fluvastatin|dyslipidemia, chronic renal disease, fluvastatin
5366526|NCT00171249|Chronic Myelogenous Leukemia|chronic myelogenous leukemia
5366527|NCT00171249|CML|cml
5366528|NCT00171249|Philadelphia Chromosome|philadelphia chromosome
5366529|NCT00171249|Accelerated phase|accelerated phase
5366530|NCT00171249|Acute Myelogenous Leukemia|acute myelogenous leukemia
5366531|NCT00171249|AML|aml
5366532|NCT00171249|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
5366533|NCT00171249|ALL|all
5366534|NCT00171249|Imatinib mesylate|imatinib mesylate
5366535|NCT00171236|Heterozygous familial hypercholesterolemia|heterozygous familial hypercholesterolemia
5366536|NCT00171236|mixed dyslipidemia|mixed dyslipidemia
5366537|NCT00171223|Chronic Myelogenous Leukemia|chronic myelogenous leukemia
5366538|NCT00171223|CML|cml
5366539|NCT00171223|Philadelphia Chromosome|philadelphia chromosome
5366540|NCT00171223|Accelerated phase|accelerated phase
5366541|NCT00171223|Acute Myelogenous Leukemia|acute myelogenous leukemia
5366542|NCT00171223|AML|aml
5366543|NCT00171223|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
5366544|NCT00171223|ALL|all
5366545|NCT00171223|Imatinib mesylate|imatinib mesylate
5366546|NCT00171210|β-thalassemia|β-thalassemia
5366547|NCT00171210|iron overload|iron overload
5366548|NCT00171210|deferasirox|deferasirox
5366549|NCT00171184|Overactive bladder, Darifenacin, M3 muscarinic receptor antagonist, elderly population|overactive bladder, darifenacin, m3 muscarinic receptor antagonist, elderly population
5366550|NCT00171171|Thalassemia (beta-thal. major)|thalassemia (beta-thal. major)
5366551|NCT00171171|Transfusional hemosiderosis|transfusional hemosiderosis
5366552|NCT00171171|Deferasirox|deferasirox
5366553|NCT00171171|Beta-thalassemia major patients|beta-thalassemia major patients
5366554|NCT00171171|Unable to be chelated with deferoxamine or deferiprone|unable to be chelated with deferoxamine or deferiprone
5366555|NCT00171158|Chronic Myelogenous Leukemia|chronic myelogenous leukemia
5366556|NCT00171158|CML|cml
5366557|NCT00171158|Philadelphia Chromosome|philadelphia chromosome
5366558|NCT00171158|Blast crisis|blast crisis
5366559|NCT00171158|Imatinib mesylate|imatinib mesylate
5366560|NCT00171145|Overactive Bladder, incontinence, antimuscarinic, warning time, darifenacin|overactive bladder, incontinence, antimuscarinic, warning time, darifenacin
5366561|NCT00171132|Postmenopausal|postmenopausal
5366562|NCT00171132|women|women
5366563|NCT00171132|overweight|overweight
5366564|NCT00171132|hypertension|hypertension
5366565|NCT00171132|impaired|impaired
5366566|NCT00171132|exercise|exercise
5366567|NCT00171132|capacity|capacity
5366568|NCT00171132|valsartan|valsartan
5366569|NCT00171132|atenolol|atenolol
5366570|NCT00171132|hydrochlorothiazide|hydrochlorothiazide
5366571|NCT00171119|HYPERTENSION|hypertension
5366572|NCT00171119|DIABETES MELLITUS TYPE II|diabetes mellitus type ii
5366573|NCT00171119|VALSARTAN|valsartan
5366574|NCT00171119|BENAZAPRIL|benazapril
5366575|NCT00171106|diastolic dysfunction|diastolic dysfunction
5366576|NCT00171106|heart failure|heart failure
5366577|NCT00171106|exercise tolerance|exercise tolerance
5366578|NCT00171106|valsartan|valsartan
5366579|NCT00171093|HYPERTENSION|hypertension
5366580|NCT00171093|HYPERCHOLESTEROLEMIA|hypercholesterolemia
5366581|NCT00171093|BLOOD PRESSURE|blood pressure
5366582|NCT00171093|CHOLESTEROL|cholesterol
5366583|NCT00171093|VALSARTAN|valsartan
5366584|NCT00171093|SIMVASTATIN|simvastatin
5366585|NCT00171080|Hypertension|hypertension
5366586|NCT00171080|Valsartan|valsartan
5366587|NCT00171080|Dialysis|dialysis
5366588|NCT00171080|Renal Disease|renal disease
5366589|NCT00171067|Microalbuminuria, urinary albumin excretion, urinary albumin creatinine ratio, hypertension, valsartan, lisinopril, combination|microalbuminuria, urinary albumin excretion, urinary albumin creatinine ratio, hypertension, valsartan, lisinopril, combination
5366590|NCT00171054|hypertension|hypertension
5366591|NCT00171054|postmenopausal|postmenopausal
5366592|NCT00171054|valsartan|valsartan
5366593|NCT00171054|amlodipine|amlodipine
5366594|NCT00171054|hydrochlorothiazide|hydrochlorothiazide
5366595|NCT00171041|PEDIATRIC HYPERTENSION|pediatric hypertension
5366596|NCT00171041|PEDIATRIC|pediatric
5366597|NCT00171041|VALSARTAN|valsartan
5366598|NCT00171028|PEDIATRIC HYPERTENSION|pediatric hypertension
5366599|NCT00171028|PEDIATRIC|pediatric
5366600|NCT00171028|VALSARTAN|valsartan
5366601|NCT00171015|VALSARTAN|valsartan
5366602|NCT00171015|HYDROCHLOROTHIAZIDE|hydrochlorothiazide
5366603|NCT00171015|OLMESARTAN|olmesartan
5366604|NCT00171015|HYPERTENSION|hypertension
5366605|NCT00171002|Hypertension, high blood pressure, valsartan, amlodipine|hypertension, high blood pressure, valsartan, amlodipine
5366606|NCT00170989|hypertension|hypertension
5366607|NCT00170989|high blood pressure|high blood pressure
5366608|NCT00170989|valsartan|valsartan
5366609|NCT00170989|hydrochlorothiazide|hydrochlorothiazide
5366610|NCT00170976|HYPERTENSION, VALSARTAN, AMLODIPINE< SAFETY|hypertension, valsartan, amlodipine< safety
5366611|NCT00170963|Hypertension, high blood pressure, valsartan, amlodipine|hypertension, high blood pressure, valsartan, amlodipine
5366612|NCT00170950|cardiovascular morbidity|cardiovascular morbidity
5366613|NCT00170950|cardiovascular mortality|cardiovascular mortality
5366614|NCT00170950|benazepril|benazepril
5366615|NCT00170950|amlodipine|amlodipine
5366616|NCT00170950|high risk population|high risk population
5366617|NCT00170937|METABOLIC SYNDROME, VALSARTAN, HYDROCHLOROTHIAZIDE, HYPERTENSION,|metabolic syndrome, valsartan, hydrochlorothiazide, hypertension,
5366618|NCT00170924|Hypertension, High Blood Pressure, Diastolic Dysfunction,|hypertension, high blood pressure, diastolic dysfunction,
5366619|NCT00170924|Heart Disease|heart disease
5366620|NCT00170911|Osteoporosis|osteoporosis
5366621|NCT00170911|Postmenopausal women|postmenopausal women
5366622|NCT00170911|Cathepsin K inhibitor|cathepsin k inhibitor
5366623|NCT00170898|Musculoskeletal pain|musculoskeletal pain
5366624|NCT00170898|cyclooxygenase-2 inhibitors|cyclooxygenase-2 inhibitors
5366625|NCT00170898|lumiracoxib|lumiracoxib
5366626|NCT00170898|naproxen|naproxen
5366627|NCT00170885|acute rejection|acute rejection
5366628|NCT00170885|renal function|renal function
5366629|NCT00170885|everolimus|everolimus
5366630|NCT00170885|cyclosporine microemulsion|cyclosporine microemulsion
5366631|NCT00170872|Osteoarthritis|osteoarthritis
5366632|NCT00170872|Rheumatoid Arthritis|rheumatoid arthritis
5366633|NCT00170872|Cox-2|cox-2
5366634|NCT00170872|lumiracoxib|lumiracoxib
5366635|NCT00170859|everolimus|everolimus
5366636|NCT00170859|cyclosporine microemulsion|cyclosporine microemulsion
5366637|NCT00170859|renal function|renal function
5366638|NCT00170846|Renal transplantation, everolimus, calcineurin inhibitors, GFR|renal transplantation, everolimus, calcineurin inhibitors, gfr
5366639|NCT00170833|Renal/Kidney, transplantation, everolimus, calcineurin sparing|renal/kidney, transplantation, everolimus, calcineurin sparing
5366640|NCT00170820|Renal transplantation, maintenance, switch, everolimus, CNI-free|renal transplantation, maintenance, switch, everolimus, cni-free
5366641|NCT00170794|cardiac transplantation, everolimus, cyclosporine microemulsion, GFR|cardiac transplantation, everolimus, cyclosporine microemulsion, gfr
5366642|NCT00170781|Pain, acute gout, arthritis, cyclooxygenase-2 inhibitors, lumiracoxib, indomethacin|pain, acute gout, arthritis, cyclooxygenase-2 inhibitors, lumiracoxib, indomethacin
5366643|NCT00170768|Darifenacin, oxybutynin, cognition, memory|darifenacin, oxybutynin, cognition, memory
5366644|NCT00170755|Overactive Bladder, incontinence, antimuscarinic, darifenacin, long-term treatment|overactive bladder, incontinence, antimuscarinic, darifenacin, long-term treatment
5366645|NCT00170742|Open label,|open label,
5366646|NCT00170742|phase III,|phase iii,
5366647|NCT00170742|disease,|disease,
5366648|NCT00170742|clinical trial,|clinical trial,
5366649|NCT00170742|octreotide,|octreotide,
5366650|NCT00170742|proliferative diabetic retinopathy, lasercoagulation|proliferative diabetic retinopathy, lasercoagulation
5366651|NCT00170729|Prednisolone acetate,|prednisolone acetate,
5366652|NCT00170729|efficacy,|efficacy,
5366653|NCT00170729|cataract,|cataract,
5366654|NCT00170729|eye drops,|eye drops,
5366655|NCT00170729|tolerability,|tolerability,
5366656|NCT00170729|inflammation|inflammation
5366657|NCT00170716|Motor Cortex Electrical Stimulation|motor cortex electrical stimulation
5366658|NCT00170716|Ischemic Stroke|ischemic stroke
5366659|NCT00170716|Upper Extremity Hemiparesis|upper extremity hemiparesis
5366660|NCT00170716|Rehabilitation|rehabilitation
5366661|NCT00170716|Motor Recovery|motor recovery
5366662|NCT00170716|Functional MRI|functional mri
5366663|NCT00170703|Cortical Electrical Stimulation|cortical electrical stimulation
5366664|NCT00170703|Ischemic Stroke|ischemic stroke
5366665|NCT00170703|Broca's Aphasia|broca's aphasia
5366666|NCT00170703|Speech Rehabilitation|speech rehabilitation
5366667|NCT00170703|Functional MRI|functional mri
5366668|NCT00170664|Ovarian neoplasms|ovarian neoplasms
5366669|NCT00170664|paclitaxel, carboplatin|paclitaxel, carboplatin
5366670|NCT00170664|clinical trials, phase II|clinical trials, phase ii
5366671|NCT00170664|first-line chemotherapy|first-line chemotherapy
5366672|NCT00170664|weekly therapy schedule|weekly therapy schedule
5366673|NCT00170638|Tuberculosis, children, infants|tuberculosis, children, infants
5366674|NCT00170625|platin-resistant|platin-resistant
5366675|NCT00170612|Pneumococcal infections|pneumococcal infections
5366676|NCT00170612|Fiji|fiji
5366677|NCT00170612|infants|infants
5366678|NCT00170612|vaccine|vaccine
5366679|NCT00170586|Underglove, polyvinylidene fluoride, acrylic polymer|underglove, polyvinylidene fluoride, acrylic polymer
5366680|NCT00170573|biweekly schedule of PLD - Ovarian cancer - pegylated liposomal doxorubicin -quality of life - Toxic skin reactions|biweekly schedule of pld - ovarian cancer - pegylated liposomal doxorubicin -quality of life - toxic skin reactions
5366681|NCT00170560|hospital, acquired, infections, mortality|hospital, acquired, infections, mortality
5366682|NCT00170547|inactivated, trivalent, influenza, vaccine, Fluzone|inactivated, trivalent, influenza, vaccine, fluzone
5366683|NCT00170534|India, male, sexually transmitted infection, STI, STD|india, male, sexually transmitted infection, sti, std
5366684|NCT00170521|group A streptococci, pharyngitis, epidemiology, Streptococcus pyogenes, children, Nicaragua|group a streptococci, pharyngitis, epidemiology, streptococcus pyogenes, children, nicaragua
5366685|NCT00170508|Influenza, sub-study|influenza, sub-study
5366686|NCT00170495|respiratory illness, influenza, bronchitis, pneumonia, cold|respiratory illness, influenza, bronchitis, pneumonia, cold
5366687|NCT00170482|influenza vaccine, Fluzone, inactivated, trivalent|influenza vaccine, fluzone, inactivated, trivalent
5366688|NCT00170469|Anthrax|anthrax
5366689|NCT00170456|Anthrax vaccine|anthrax vaccine
5366690|NCT00170443|Influenza, Baculovirus, Immunogenicity, Geriatrics|influenza, baculovirus, immunogenicity, geriatrics
5366691|NCT00170430|HIV-1, sexually transmitted diseases, females, Kenya|hiv-1, sexually transmitted diseases, females, kenya
5366692|NCT00170404|HIV Infections, Tuberculosis, Malnutrition, Tanzania|hiv infections, tuberculosis, malnutrition, tanzania
5366693|NCT00170391|Insomnia|insomnia
5366694|NCT00170391|Sleep|sleep
5366695|NCT00170391|PSG|psg
5366696|NCT00170391|Behavioural treatment|behavioural treatment
5366697|NCT00170378|Enoxaparin|enoxaparin
5366698|NCT00170378|Safety|safety
5366699|NCT00170365|Stress|stress
5366700|NCT00170365|Yoga|yoga
5366701|NCT00170352|hyperbaric oxygen|hyperbaric oxygen
5366702|NCT00170352|cerebral metabolism|cerebral metabolism
5366703|NCT00170352|hyperoxia|hyperoxia
5366704|NCT00170352|traumatic brain injury|traumatic brain injury
5366705|NCT00170339|Opiate Dependence|opiate dependence
5366706|NCT00170339|Methadone Maintenance|methadone maintenance
5366707|NCT00170339|Osteoporosis|osteoporosis
5366708|NCT00170339|Hypogonadism|hypogonadism
5366709|NCT00170326|Permanent Pacing artificial internal|permanent pacing artificial internal
5366710|NCT00170313|Heart Failure|heart failure
5366711|NCT00170313|Primary Prevention of Sudden Cardiac Death|primary prevention of sudden cardiac death
5366712|NCT00170313|Secondary Prevention of Sudden Cardiac Death|secondary prevention of sudden cardiac death
5366713|NCT00170313|Cardiac Desynchronization|cardiac desynchronization
5366714|NCT00170313|CRT-D|crt-d
5366715|NCT00170313|Cardiac Dyssynchrony|cardiac dyssynchrony
5366716|NCT00170300|Cardiac resynchronisation therapy (CRT therapy),|cardiac resynchronisation therapy (crt therapy),
5366717|NCT00170300|all-cause mortality,|all-cause mortality,
5366718|NCT00170300|quality of life assesment,|quality of life assesment,
5366719|NCT00170300|echocardiographic left ventricular function,|echocardiographic left ventricular function,
5366720|NCT00170300|CRT and neurohormonal activation,|crt and neurohormonal activation,
5366721|NCT00170300|CRT and health economics|crt and health economics
5366722|NCT00170287|Unstable Ventricular Tachycardia|unstable ventricular tachycardia
5366723|NCT00170274|Indication for cardiac pacing|indication for cardiac pacing
5366724|NCT00170274|Atrial Arrhythmia|atrial arrhythmia
5366725|NCT00170274|Indication for the implantation of a pacemaker according to the German guidelines|indication for the implantation of a pacemaker according to the german guidelines
5366726|NCT00170274|Documented (ECG) atrial tachyarrhythmia within the last three months before enrollment|documented (ecg) atrial tachyarrhythmia within the last three months before enrollment
5366727|NCT00170261|Syncope of uncertain etiology|syncope of uncertain etiology
5366728|NCT00170261|Repeated presyncopes|repeated presyncopes
5366729|NCT00170248|Asthma|asthma
5366730|NCT00170248|Primary Care|primary care
5366731|NCT00170248|Computer-Based Decision Support|computer-based decision support
5366732|NCT00170248|Outcome Evaluation|outcome evaluation
5366733|NCT00170235|Breast cancer|breast cancer
5366734|NCT00170235|Prehabilitation|prehabilitation
5366735|NCT00170235|Rehabilitation|rehabilitation
5366736|NCT00170235|Exercise|exercise
5366737|NCT00170222|Acute bronchitis|acute bronchitis
5366738|NCT00170222|antibiotics|antibiotics
5366739|NCT00170209|Tuberculosis|tuberculosis
5366740|NCT00170209|Children|children
5366741|NCT00170196|pneumonia|pneumonia
5366742|NCT00170196|corticosteroids|corticosteroids
5366743|NCT00170183|Heart failure|heart failure
5366744|NCT00170183|Renal dysfunction|renal dysfunction
5366745|NCT00170170|cytomegalovirus|cytomegalovirus
5366746|NCT00170105|Age 18 years or older|age 18 years or older
5366747|NCT00170105|No cognitive impairment or altered mental status|no cognitive impairment or altered mental status
5366748|NCT00170105|Stable|stable
5366749|NCT00170105|No aphasia|no aphasia
5366750|NCT00170105|English-speaking|english-speaking
5366751|NCT00170053|Kidney Transplantation|kidney transplantation
5366752|NCT00170001|supraesophageal reflux|supraesophageal reflux
5366753|NCT00170001|laryngopharyngeal symptoms|laryngopharyngeal symptoms
5366754|NCT00170001|pharynx|pharynx
5366755|NCT00170001|esophagus|esophagus
5366756|NCT00169988|clinical high risk|clinical high risk
5366757|NCT00169988|attenuated positive symptoms|attenuated positive symptoms
5366758|NCT00169988|attenuated negative symptoms|attenuated negative symptoms
5366759|NCT00169988|cognition|cognition
5366760|NCT00169988|functional status|functional status
5366761|NCT00169988|prodromal psychosis|prodromal psychosis
5366762|NCT00169962|acute disease|acute disease
5366763|NCT00169949|early intervention|early intervention
5366764|NCT00169949|social functioning|social functioning
5366765|NCT00169949|role functioning|role functioning
5366766|NCT00169949|cognition|cognition
5366767|NCT00169910|Renal Transplantation|renal transplantation
5366768|NCT00169910|Calcineurin Inhibitor|calcineurin inhibitor
5366769|NCT00169910|Mycophenolate Mofetil|mycophenolate mofetil
5366770|NCT00169910|Cardiovascular Disease|cardiovascular disease
5366771|NCT00169897|COPD|copd
5366772|NCT00169897|Exercise|exercise
5366773|NCT00169897|Self-management|self-management
5366774|NCT00169897|Rehabilitation|rehabilitation
5366775|NCT00169897|Quality of life|quality of life
5366776|NCT00169897|Health economy|health economy
5366777|NCT00169897|Cost effectiveness|cost effectiveness
5366778|NCT00169897|Health care utilization|health care utilization
5366779|NCT00169884|Deliberate Self-Harm,|deliberate self-harm,
5366780|NCT00169884|cognitive-behavioural therapy,|cognitive-behavioural therapy,
5366781|NCT00169884|integrative approach|integrative approach
5366782|NCT00169858|Hepatitis B|hepatitis b
5366783|NCT00169858|Vaccination|vaccination
5366784|NCT00169858|Engerix-B|engerix-b
5366785|NCT00169858|Immunogenicity|immunogenicity
5366786|NCT00169858|Long-term immunity|long-term immunity
5366787|NCT00169858|Booster dose|booster dose
5366788|NCT00169858|Safety|safety
5366789|NCT00169845|chemoprevention trial|chemoprevention trial
5366790|NCT00169845|antioxidant|antioxidant
5366791|NCT00169845|alpha-tocopherol|alpha-tocopherol
5366792|NCT00169845|beta-carotene|beta-carotene
5366793|NCT00169845|second primary cancer|second primary cancer
5366794|NCT00169845|head and neck cancer|head and neck cancer
5366795|NCT00169845|adverse effect of radiation therapy|adverse effect of radiation therapy
5366796|NCT00169845|quality of life|quality of life
5366797|NCT00169845|mortality|mortality
5366798|NCT00169845|cancer free survival|cancer free survival
5366799|NCT00169845|cancer recurrence|cancer recurrence
5366800|NCT00169832|Atherosclerosis progression|atherosclerosis progression
5366801|NCT00169832|Ischemic heart disease|ischemic heart disease
5366802|NCT00169832|Saphenous vein graft|saphenous vein graft
5366803|NCT00169832|Metabolic risk factors|metabolic risk factors
5366804|NCT00169832|Rosiglitazone|rosiglitazone
5366805|NCT00169819|Same day discharge|same day discharge
5366806|NCT00169819|Trans-radial|trans-radial
5366807|NCT00169819|Coronary artery stenting|coronary artery stenting
5366808|NCT00169819|Abciximab bolus|abciximab bolus
5366809|NCT00169806|Randall's Plaque|randall's plaque
5366810|NCT00169806|Kidney stones|kidney stones
5366811|NCT00169793|Obesity|obesity
5366812|NCT00169793|Nephrolithiasis|nephrolithiasis
5366813|NCT00169780|Renal Calculi|renal calculi
5366814|NCT00169780|Radiology|radiology
5366815|NCT00169780|High Reslolution CT|high reslolution ct
5366816|NCT00169767|Enlarged Prostate|enlarged prostate
5366817|NCT00169767|BPH|bph
5366818|NCT00169754|Nephrolithiasis|nephrolithiasis
5366819|NCT00169754|Renal Calculi|renal calculi
5366820|NCT00169754|Perc|perc
5366821|NCT00169754|Attached Stones|attached stones
5366822|NCT00169741|Nephrolithiasis|nephrolithiasis
5366823|NCT00169741|Renal Calculi|renal calculi
5366824|NCT00169728|allogeneic haematopoietic stem cell transplantation|allogeneic haematopoietic stem cell transplantation
5366825|NCT00169728|bone marrow transplantation|bone marrow transplantation
5366826|NCT00169728|children|children
5366827|NCT00169728|vaccination|vaccination
5366828|NCT00169728|invasive pneumococcal disease|invasive pneumococcal disease
5366829|NCT00169728|tetanus|tetanus
5366830|NCT00169728|diphtheria|diphtheria
5366831|NCT00169728|poliomyelitis|poliomyelitis
5366832|NCT00169728|pertussis|pertussis
5366833|NCT00169728|Hepatitis B|hepatitis b
5366834|NCT00169728|Haemophilus influenzae type B infection|haemophilus influenzae type b infection
5366835|NCT00169715|Kidney stones|kidney stones
5366836|NCT00169715|renal Calculi|renal calculi
5366837|NCT00169715|Tic|tic
5366838|NCT00169715|Caliceal Diverticula|caliceal diverticula
5366839|NCT00169702|Schizophrenia, weight management programme|schizophrenia, weight management programme
5366840|NCT00169689|schizophrenia, rTMS|schizophrenia, rtms
5366841|NCT00169676|Prostate Cancer|prostate cancer
5366842|NCT00169663|Brushite Kidney Stones|brushite kidney stones
5366843|NCT00169663|Nephrolithiasis|nephrolithiasis
5366844|NCT00169650|UPJ Obstruction|upj obstruction
5366845|NCT00169650|Renal Obstruction|renal obstruction
5366846|NCT00169650|Delayed Renal Flow|delayed renal flow
5366847|NCT00169637|Short bowel syndrome|short bowel syndrome
5366848|NCT00169637|Growth hormone|growth hormone
5366849|NCT00169637|Children|children
5366850|NCT00169624|Diabetes,|diabetes,
5366851|NCT00169624|coronary endothelial dysfunction,|coronary endothelial dysfunction,
5366852|NCT00169624|metformin,|metformin,
5366853|NCT00169624|glyclazide,|glyclazide,
5366854|NCT00169624|MRI.|mri.
5366855|NCT00169611|Neurofibromatosis type 1|neurofibromatosis type 1
5366856|NCT00169611|Attention deficit with hyperactivity disorder school difficulties|attention deficit with hyperactivity disorder school difficulties
5366857|NCT00169611|methylphenidate|methylphenidate
5366858|NCT00169598|Lymphoma|lymphoma
5366859|NCT00169598|positron emission tomography|positron emission tomography
5366860|NCT00169598|stem cell transplantation|stem cell transplantation
5366861|NCT00169598|therapeutic impact|therapeutic impact
5366862|NCT00169585|diagnostic-therapeutic pathway|diagnostic-therapeutic pathway
5366863|NCT00169585|PSA|psa
5366864|NCT00169585|DRE|dre
5366865|NCT00169585|Levofloxacin|levofloxacin
5366866|NCT00169572|Nausea|nausea
5366867|NCT00169572|Vomiting|vomiting
5366868|NCT00169572|Emesis|emesis
5366869|NCT00169572|Chemotherapy-induced Nausea and Vomiting|chemotherapy-induced nausea and vomiting
5366870|NCT00169572|CINV|cinv
5366871|NCT00169559|triglycerides|triglycerides
5366872|NCT00169559|Hypertriglyceridemia|hypertriglyceridemia
5366873|NCT00169559|cholesterol|cholesterol
5366874|NCT00169559|LDL|ldl
5366875|NCT00169559|HDL|hdl
5366876|NCT00169546|Asthma|asthma
5366877|NCT00169546|inhaled corticosteroids|inhaled corticosteroids
5366878|NCT00169533|safety|safety
5366879|NCT00169533|tolerating lapatinib|tolerating lapatinib
5366880|NCT00169533|Lapatinib|lapatinib
5366881|NCT00169520|Safety|safety
5366882|NCT00169520|tolerability|tolerability
5366883|NCT00169520|dose limiting toxicity|dose limiting toxicity
5366884|NCT00169520|solid tumors|solid tumors
5366885|NCT00169520|docetaxel|docetaxel
5366886|NCT00169468|B Lymphoma|b lymphoma
5366887|NCT00169468|Velcade|velcade
5366888|NCT00169468|Chemotherapy|chemotherapy
5366889|NCT00169416|chicken pox|chicken pox
5366890|NCT00169416|varicella|varicella
5366891|NCT00169416|VZV|vzv
5366892|NCT00169416|pharmacokinetics|pharmacokinetics
5366893|NCT00169403|Idiopathic dystonia|idiopathic dystonia
5366894|NCT00169403|deep brain stimulation|deep brain stimulation
5366895|NCT00169403|globus pallidus|globus pallidus
5366896|NCT00169403|generalised Idiopathic dystonia|generalised idiopathic dystonia
5366897|NCT00169390|smoking|smoking
5366898|NCT00169390|pregnancy|pregnancy
5366899|NCT00169390|newborns|newborns
5366900|NCT00169390|monoamine oxidases|monoamine oxidases
5366901|NCT00169377|Obsessive compulsive disorder|obsessive compulsive disorder
5366902|NCT00169377|deep brain stimulation|deep brain stimulation
5366903|NCT00169377|subthalamic nucleus|subthalamic nucleus
5366904|NCT00169364|Parkinson's disease|parkinson's disease
5366905|NCT00169364|parkin mutation|parkin mutation
5366906|NCT00169364|Juvenile parkinson's disease|juvenile parkinson's disease
5366907|NCT00169364|positron emission tomography|positron emission tomography
5366908|NCT00169338|Dystonia|dystonia
5366909|NCT00169338|deep brain stimulation|deep brain stimulation
5366910|NCT00169338|globus pallidus|globus pallidus
5366911|NCT00169338|Post-anoxic dystonia|post-anoxic dystonia
5366912|NCT00169325|basal ganglia|basal ganglia
5366913|NCT00169325|loss of psychic self-activation|loss of psychic self-activation
5366914|NCT00169312|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5366915|NCT00169299|Menopause|menopause
5366916|NCT00169299|Vasomotor|vasomotor
5366917|NCT00169299|Black cohosh|black cohosh
5366918|NCT00169299|Herbs|herbs
5366919|NCT00169299|Hot flashes|hot flashes
5366920|NCT00169299|HT|ht
5366921|NCT00169299|CAM|cam
5366922|NCT00169273|Obesity|obesity
5366923|NCT00169273|Depression|depression
5366924|NCT00169273|Behavioral|behavioral
5366925|NCT00169273|Cognitive|cognitive
5366926|NCT00169273|Treatment|treatment
5366927|NCT00169260|smoking|smoking
5366928|NCT00169260|tobacco|tobacco
5366929|NCT00169260|behavior therapy|behavior therapy
5366930|NCT00169247|larynx cancer|larynx cancer
5366931|NCT00169247|hypopharynx cancer|hypopharynx cancer
5366932|NCT00169247|larynx preservation|larynx preservation
5366933|NCT00169247|concomitant radiochemotherapy|concomitant radiochemotherapy
5366934|NCT00169247|cisplatin|cisplatin
5366935|NCT00169247|cetuximab|cetuximab
5366936|NCT00169247|randomized trial|randomized trial
5366937|NCT00169234|Pneumococcal disease|pneumococcal disease
5366938|NCT00169234|Vaccination|vaccination
5366939|NCT00169234|Immunization|immunization
5366940|NCT00169234|PPV23|ppv23
5366941|NCT00169234|PCV7|pcv7
5366942|NCT00169208|relapsed/refractory.|relapsed/refractory.
5366943|NCT00169208|lymphoma, follicular|lymphoma, follicular
5366944|NCT00169208|rituximab|rituximab
5366945|NCT00169208|chemotherapy|chemotherapy
5366946|NCT00169195|B-cell lymphoma|b-cell lymphoma
5366947|NCT00169195|Salvage Therapy|salvage therapy
5366948|NCT00169195|rituximab|rituximab
5366949|NCT00169195|oxaliplatine|oxaliplatine
5366950|NCT00169195|gemcitabine|gemcitabine
5366951|NCT00169182|Larynx cancer|larynx cancer
5366952|NCT00169182|Hypopharynx cancer|hypopharynx cancer
5366953|NCT00169182|Chemotherapy|chemotherapy
5366954|NCT00169182|Randomized trial|randomized trial
5366955|NCT00169182|Larynx preservation|larynx preservation
5366956|NCT00169169|Diffuse large B cell lymphoma|diffuse large b cell lymphoma
5366957|NCT00169169|Rituximab|rituximab
5366958|NCT00169169|Autotransplant|autotransplant
5366959|NCT00169156|T-cell angioimmunoblastic lymphoma|t-cell angioimmunoblastic lymphoma
5366960|NCT00169156|Rituximab|rituximab
5366961|NCT00169143|Diffuse large B cell lymphoma|diffuse large b cell lymphoma
5366962|NCT00169143|Pegfilgrastim|pegfilgrastim
5366963|NCT00169143|Autotransplant|autotransplant
5366964|NCT00169130|lymphoma|lymphoma
5366965|NCT00169130|autologous stem cell transplant|autologous stem cell transplant
5366966|NCT00169130|chemotherapy|chemotherapy
5366967|NCT00169130|BCL2|bcl2
5366968|NCT00169117|Mosquito nets|mosquito nets
5366969|NCT00169117|Malaria prevention|malaria prevention
5366970|NCT00169117|Songs|songs
5366971|NCT00169117|Posters|posters
5366972|NCT00169117|Net repair|net repair
5366973|NCT00169117|Bednets|bednets
5366974|NCT00169104|Breast cancer|breast cancer
5366975|NCT00169104|Her-2/neu|her-2/neu
5366976|NCT00169104|Granulocyte Colony Stimulating Factor|granulocyte colony stimulating factor
5366977|NCT00169104|Trastuzumab|trastuzumab
5366978|NCT00169104|Vinorelbine|vinorelbine
5366979|NCT00169104|Antibody-dependent cellular cytotoxicity|antibody-dependent cellular cytotoxicity
5366980|NCT00169104|Effector cells|effector cells
5366981|NCT00169091|Clozapine|clozapine
5366982|NCT00169091|Haloperidol|haloperidol
5366983|NCT00169091|Schizophrenia|schizophrenia
5366984|NCT00169078|Transmission intensity|transmission intensity
5366985|NCT00169078|Insecticide-treated materials|insecticide-treated materials
5366986|NCT00169078|antimalarial drug resistance|antimalarial drug resistance
5366987|NCT00169065|Clozapine|clozapine
5366988|NCT00169065|olanzapine|olanzapine
5366989|NCT00169052|geriatric,|geriatric,
5366990|NCT00169052|older|older
5366991|NCT00169052|serious mental illness|serious mental illness
5366992|NCT00169052|SMI|smi
5366993|NCT00169039|Clozapine|clozapine
5366994|NCT00169039|Chlorpromazine|chlorpromazine
5366995|NCT00169039|Schizophrenia|schizophrenia
5366996|NCT00169039|Biochemistry|biochemistry
5366997|NCT00169026|Clozapine|clozapine
5366998|NCT00169026|Atypical Antipsychotic|atypical antipsychotic
5366999|NCT00169026|Conventional antipsychotic|conventional antipsychotic
5367000|NCT00169026|Schizophrenia|schizophrenia
5367001|NCT00169026|Dual Diagnosis|dual diagnosis
5367002|NCT00169026|Substance Abuse|substance abuse
5367003|NCT00169026|Alcohol Abuse|alcohol abuse
5367004|NCT00169000|breast cancer|breast cancer
5367005|NCT00169000|capecitabine|capecitabine
5367006|NCT00169000|docetaxel|docetaxel
5367007|NCT00169000|pharmacokinetic/pharmacodynamic|pharmacokinetic/pharmacodynamic
5367008|NCT00169000|bcl-2|bcl-2
5367009|NCT00169000|bax|bax
5367010|NCT00168987|oral nutritional supplement|oral nutritional supplement
5367011|NCT00168987|eicosapentanoic acid|eicosapentanoic acid
5367012|NCT00168987|gastroenterological tumors|gastroenterological tumors
5367013|NCT00168987|muscle function|muscle function
5367014|NCT00168987|quality of life|quality of life
5367015|NCT00168987|body composition|body composition
5367016|NCT00168961|liver cirrhosis Child B or C|liver cirrhosis child b or c
5367017|NCT00168948|Intermittent preventive treatment|intermittent preventive treatment
5367018|NCT00168948|IPTi|ipti
5367019|NCT00168948|Malaria control|malaria control
5367020|NCT00168948|Ghana|ghana
5367021|NCT00168922|recurrent SCLC|recurrent sclc
5367022|NCT00168909|osteoporosis|osteoporosis
5367023|NCT00168909|frailty|frailty
5367024|NCT00168909|falls|falls
5367025|NCT00168896|SCLC|sclc
5367026|NCT00168883|NSCLC|nsclc
5367027|NCT00168883|curative non-treatable NSCLC UICC stage IIIB and IV|curative non-treatable nsclc uicc stage iiib and iv
5367028|NCT00168870|metastatic ocular melanoma|metastatic ocular melanoma
5367029|NCT00168766|Combination therapy for multiple sclerosis|combination therapy for multiple sclerosis
5367030|NCT00168753|Extended dosing|extended dosing
5367031|NCT00168753|alefacept|alefacept
5367032|NCT00168740|rituximab|rituximab
5367033|NCT00168740|Rituxan|rituxan
5367034|NCT00168740|B-cell lymphoma|b-cell lymphoma
5367035|NCT00168740|low-grade|low-grade
5367036|NCT00168740|follicular|follicular
5367037|NCT00168740|anti-CD20 monoclonal antibody|anti-cd20 monoclonal antibody
5367038|NCT00168727|Radioimmunotherapy|radioimmunotherapy
5367039|NCT00168727|Antigens, CD20|antigens, cd20
5367040|NCT00168714|AVONEX|avonex
5367041|NCT00168714|Pregnancy|pregnancy
5367042|NCT00168701|Multiple Sclerosis|multiple sclerosis
5367043|NCT00168701|MRI|mri
5367044|NCT00168688|micronutrient supplementation|micronutrient supplementation
5367045|NCT00168688|pregnancy|pregnancy
5367046|NCT00168688|birth weight|birth weight
5367047|NCT00168688|perinatal mortality|perinatal mortality
5367048|NCT00168662|Non-specific effects of vaccines|non-specific effects of vaccines
5367049|NCT00168662|Infant mortality|infant mortality
5367050|NCT00168662|Child mortality|child mortality
5367051|NCT00168662|Mortality|mortality
5367052|NCT00168662|Morbidity|morbidity
5367053|NCT00168662|Measles vaccine|measles vaccine
5367054|NCT00168662|Measles|measles
5367055|NCT00168662|Immunisation|immunisation
5367056|NCT00168662|Low income country|low income country
5367057|NCT00168662|Guinea-Bissau|guinea-bissau
5367058|NCT00168662|Bandim Health Project|bandim health project
5367059|NCT00168662|Immunology|immunology
5367060|NCT00168649|Vitamin A|vitamin a
5367061|NCT00168649|Endotoxin|endotoxin
5367062|NCT00168649|TNF-alfa|tnf-alfa
5367063|NCT00168636|Vitamin A|vitamin a
5367064|NCT00168636|Mortality|mortality
5367065|NCT00168636|Morbidity|morbidity
5367066|NCT00168636|OPV|opv
5367067|NCT00168636|Sex|sex
5367068|NCT00168623|Vitamin A|vitamin a
5367069|NCT00168623|Vaccines|vaccines
5367070|NCT00168623|Mortality|mortality
5367071|NCT00168623|Morbidity|morbidity
5367072|NCT00168610|Vitamin A|vitamin a
5367073|NCT00168610|BCG|bcg
5367074|NCT00168610|Infant mortality|infant mortality
5367075|NCT00168610|Morbidity|morbidity
5367076|NCT00168610|Low-income country|low-income country
5367077|NCT00168610|Mortality|mortality
5367078|NCT00168597|Vitamin A|vitamin a
5367079|NCT00168597|BCG|bcg
5367080|NCT00168597|Infant mortality|infant mortality
5367081|NCT00168597|Morbidity|morbidity
5367082|NCT00168597|Low-income country|low-income country
5367083|NCT00168584|Vitamin A|vitamin a
5367084|NCT00168584|Mortality|mortality
5367085|NCT00168584|Morbidity|morbidity
5367086|NCT00168584|Doses|doses
5367087|NCT00168584|OPV|opv
5367088|NCT00168571|Measles vaccine|measles vaccine
5367089|NCT00168571|Measles|measles
5367090|NCT00168571|Measles antibodies|measles antibodies
5367091|NCT00168571|Immunisation|immunisation
5367092|NCT00168571|Low income country|low income country
5367093|NCT00168571|Guinea-Bissau|guinea-bissau
5367094|NCT00168571|Bandim Health Project|bandim health project
5367095|NCT00168571|Measles antibody level|measles antibody level
5367096|NCT00168558|Non-specific effects of vaccines|non-specific effects of vaccines
5367097|NCT00168558|Infant mortality|infant mortality
5367098|NCT00168558|Child mortality|child mortality
5367099|NCT00168558|Mortality|mortality
5367100|NCT00168558|Morbidity|morbidity
5367101|NCT00168558|Diphtheria-tetanus-pertussis vaccine|diphtheria-tetanus-pertussis vaccine
5367102|NCT00168558|Measles vaccine|measles vaccine
5367103|NCT00168558|Measles|measles
5367104|NCT00168558|Immunisation|immunisation
5367105|NCT00168558|Low income country|low income country
5367106|NCT00168558|Guinea-Bissau|guinea-bissau
5367107|NCT00168558|Bandim Health Project|bandim health project
5367108|NCT00168558|Immunology|immunology
5367109|NCT00168545|Non-specific effects of vaccines|non-specific effects of vaccines
5367110|NCT00168545|Immunology|immunology
5367112|NCT00168545|Infant mortality|infant mortality
5367113|NCT00168545|Child mortality|child mortality
5367114|NCT00168545|Mortality|mortality
5367115|NCT00168545|Morbidity|morbidity
5367116|NCT00168545|Diphtheria-tetanus-pertussis vaccine|diphtheria-tetanus-pertussis vaccine
5367117|NCT00168545|Measles vaccine|measles vaccine
5367118|NCT00168545|Measles|measles
5367119|NCT00168545|Immunisation|immunisation
5367120|NCT00168545|Low income country|low income country
5367121|NCT00168545|Guinea-Bissau|guinea-bissau
5367122|NCT00168545|Bandim Health Project|bandim health project
5367123|NCT00168545|Immunology of measles and DTP vaccination|immunology of measles and dtp vaccination
5367124|NCT00168532|Prophylactic antibiotics|prophylactic antibiotics
5367125|NCT00168532|Measles|measles
5367126|NCT00168532|Pneumonia|pneumonia
5367127|NCT00168532|Post-measles pneumonia|post-measles pneumonia
5367128|NCT00168532|Low income country|low income country
5367129|NCT00168532|Guinea-Bissau|guinea-bissau
5367130|NCT00168532|Bandim Health Project|bandim health project
5367131|NCT00168519|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
5367132|NCT00168519|Blood Glucose|blood glucose
5367133|NCT00168519|Exercise|exercise
5367134|NCT00168519|Muscle Contraction|muscle contraction
5367135|NCT00168519|Nitric Oxide|nitric oxide
5367136|NCT00168519|Nitrates|nitrates
5367137|NCT00168506|panic disorder|panic disorder
5367138|NCT00168506|cardiac risk|cardiac risk
5367139|NCT00168493|Major Depression|major depression
5367140|NCT00168493|Cardiac disease|cardiac disease
5367141|NCT00168402|Axillary Hyperhidrosis|axillary hyperhidrosis
5367142|NCT00168376|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
5367143|NCT00168376|Depression|depression
5367144|NCT00168311|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
5367145|NCT00168311|Schizophrenia|schizophrenia
5367146|NCT00168311|Negative Symptoms|negative symptoms
5367147|NCT00168285|Exercise|exercise
5367148|NCT00168285|Pulmonary rehabilitation|pulmonary rehabilitation
5367149|NCT00168285|Idiopathic pulmonary fibrosis|idiopathic pulmonary fibrosis
5367150|NCT00168285|Connective tissue disorders|connective tissue disorders
5367151|NCT00168272|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
5367152|NCT00168272|Depression|depression
5367153|NCT00168259|Treatment Naive|treatment naive
5367154|NCT00168259|HIV|hiv
5367155|NCT00168246|HIV|hiv
5367156|NCT00168233|Treatment Naive|treatment naive
5367157|NCT00168233|HIV|hiv
5367158|NCT00168220|Treatment Experienced|treatment experienced
5367159|NCT00168220|HIV|hiv
5367160|NCT00168207|Treatment Experienced|treatment experienced
5367161|NCT00168207|HIV|hiv
5367162|NCT00168194|HIV|hiv
5367163|NCT00168181|salagen|salagen
5367164|NCT00168181|gland transfer|gland transfer
5367165|NCT00168181|randomized|randomized
5367166|NCT00168181|xerostomia|xerostomia
5367167|NCT00168168|G-CSF|g-csf
5367168|NCT00168168|Filgrastim|filgrastim
5367169|NCT00168168|Engraftment time|engraftment time
5367170|NCT00168168|Autologus transplant|autologus transplant
5367171|NCT00168155|resectable liver metastases|resectable liver metastases
5367172|NCT00168155|colorectal adenocarcinoma|colorectal adenocarcinoma
5367173|NCT00168155|survival|survival
5367174|NCT00168155|neoadjuvant chemotherapy|neoadjuvant chemotherapy
5367175|NCT00168142|Helical tomotherapy|helical tomotherapy
5367176|NCT00168142|Megavoltage imaging|megavoltage imaging
5367177|NCT00168129|tomotherapy|tomotherapy
5367178|NCT00168129|bone metastases|bone metastases
5367179|NCT00168129|radiotherapy|radiotherapy
5367180|NCT00168129|intensity modulated|intensity modulated
5367181|NCT00168116|nasopharynx|nasopharynx
5367182|NCT00168116|xerostomia|xerostomia
5367183|NCT00168116|prevention|prevention
5367184|NCT00168103|C1 Inhibitor|c1 inhibitor
5367185|NCT00168103|Hereditary angioedema|hereditary angioedema
5367186|NCT00168103|Acute HAE attack|acute hae attack
5367187|NCT00168090|von Willebrand Factor|von willebrand factor
5367188|NCT00168090|Blood Coagulation Disorders|blood coagulation disorders
5367189|NCT00168090|Factor VIII|factor viii
5367190|NCT00168077|Prothrombin Complex Concentrate|prothrombin complex concentrate
5367191|NCT00168077|Anticoagulant reversal|anticoagulant reversal
5367192|NCT00168064|Mycosis Fungoides|mycosis fungoides
5367193|NCT00168064|Nitrogen Mustard|nitrogen mustard
5367194|NCT00168064|Cutaneous T-Cell Lymphoma|cutaneous t-cell lymphoma
5367195|NCT00168064|CTCL - Mycosis Fungoides|ctcl - mycosis fungoides
5367196|NCT00168051|Hemophilia A|hemophilia a
5367197|NCT00168038|Chronic Immune Thrombocytopenic Purpura|chronic immune thrombocytopenic purpura
5367198|NCT00168038|Chronic Idiopathic Thrombocytopenic Purpura|chronic idiopathic thrombocytopenic purpura
5367199|NCT00168038|Werlhofs Disease|werlhofs disease
5367200|NCT00168038|Autoimmune Thrombocytopenia|autoimmune thrombocytopenia
5367201|NCT00168038|Immunglobulin Intravenous|immunglobulin intravenous
5367202|NCT00168038|Chronic ITP|chronic itp
5367203|NCT00168038|Platelet count|platelet count
5367204|NCT00168038|Thrombocytopenia|thrombocytopenia
5367205|NCT00168025|Immunoglobulin Intravenous|immunoglobulin intravenous
5367206|NCT00168025|Agammaglobulinemia|agammaglobulinemia
5367207|NCT00168025|Hypogammaglobulinemia|hypogammaglobulinemia
5367208|NCT00168025|Common variable immunodeficiency|common variable immunodeficiency
5367209|NCT00168025|Immunoglobulin G|immunoglobulin g
5367211|NCT00168012|Immunoglobulin intravenous|immunoglobulin intravenous
5367212|NCT00168012|Agammaglobulinemia|agammaglobulinemia
5367213|NCT00168012|Hypogammaglobulinemia|hypogammaglobulinemia
5367214|NCT00168012|Common variable immunodeficiency|common variable immunodeficiency
5367215|NCT00168012|Immunoglobulin G|immunoglobulin g
5367216|NCT00168012|Children|children
5367217|NCT00167999|Bacterial Infections|bacterial infections
5367218|NCT00167986|Bacterial Infections|bacterial infections
5367219|NCT00167973|Hemophilia B|hemophilia b
5367220|NCT00167960|Bacterial Infections|bacterial infections
5367221|NCT00167947|Kidney|kidney
5367222|NCT00167947|Transplant|transplant
5367223|NCT00167934|Diabetes|diabetes
5367224|NCT00167934|Metabolic|metabolic
5367225|NCT00167895|osteoarthritis|osteoarthritis
5367226|NCT00167895|knee|knee
5367227|NCT00167895|platelet concentrate|platelet concentrate
5367228|NCT00167882|Crohn's disease|crohn's disease
5367229|NCT00167882|Ulcerative colitis|ulcerative colitis
5367230|NCT00167882|Inflammatory bowel disease|inflammatory bowel disease
5367231|NCT00167882|azathioprine|azathioprine
5367232|NCT00167882|6-mercaptopurine|6-mercaptopurine
5367233|NCT00167882|5-aminosalicylate|5-aminosalicylate
5367234|NCT00167882|metabolism|metabolism
5367235|NCT00167869|hypertension|hypertension
5367236|NCT00167869|blood pressure|blood pressure
5367237|NCT00167869|dairy peptides|dairy peptides
5367238|NCT00167869|bioactive peptides|bioactive peptides
5367239|NCT00167869|randomized controlled trial|randomized controlled trial
5367240|NCT00167856|Burning pain|burning pain
5367241|NCT00167856|Clinical trial|clinical trial
5367242|NCT00167856|Effexor|effexor
5367243|NCT00167856|Pain|pain
5367244|NCT00167856|Spinal cord injury|spinal cord injury
5367245|NCT00167856|Venalafaxine|venalafaxine
5367246|NCT00167856|Neuropathic Pain|neuropathic pain
5367247|NCT00167843|Malaria|malaria
5367248|NCT00167843|Anemia|anemia
5367249|NCT00167843|Children|children
5367250|NCT00167843|Gabon|gabon
5367251|NCT00167843|Intermittent preventive treatment|intermittent preventive treatment
5367252|NCT00167830|Pediatric Overweight,|pediatric overweight,
5367253|NCT00167830|African American;|african american;
5367254|NCT00167830|Adolescent;|adolescent;
5367255|NCT00167830|Intervention,|intervention,
5367256|NCT00167830|Teasing;|teasing;
5367257|NCT00167830|Self-esteem|self-esteem
5367258|NCT00167830|Quality of Life|quality of life
5367259|NCT00167830|Metabolic syndrome|metabolic syndrome
5367260|NCT00167830|Insulin resistance|insulin resistance
5367261|NCT00167830|Diabetes|diabetes
5367262|NCT00167830|Nutrition|nutrition
5367263|NCT00167830|Motivation|motivation
5367264|NCT00167830|Culture|culture
5367265|NCT00167830|BMI|bmi
5367266|NCT00167830|Cardiorespiratory fitness|cardiorespiratory fitness
5367267|NCT00167830|Resistance Training|resistance training
5367268|NCT00167830|Compliance|compliance
5367269|NCT00167817|Schizophrenia|schizophrenia
5367270|NCT00167817|Smoking|smoking
5367271|NCT00167817|Metabolic|metabolic
5367272|NCT00167817|Health|health
5367273|NCT00167817|Glucose|glucose
5367274|NCT00167817|Lipids|lipids
5367275|NCT00167804|Exposure Therapy|exposure therapy
5367276|NCT00167804|Post Traumatic Stress Disorder|post traumatic stress disorder
5367277|NCT00167804|Treatment Outcome|treatment outcome
5367278|NCT00167804|Veterans|veterans
5367279|NCT00167804|Virtual Reality|virtual reality
5367280|NCT00167791|transplant|transplant
5367281|NCT00167791|desensitization|desensitization
5367282|NCT00167791|kidney transplant|kidney transplant
5367283|NCT00167778|Amputation|amputation
5367284|NCT00167778|Amputee|amputee
5367285|NCT00167778|Artificial limbs|artificial limbs
5367286|NCT00167778|Gait|gait
5367287|NCT00167778|Locomotion|locomotion
5367288|NCT00167778|Walking|walking
5367289|NCT00167765|stroke, ischemic|stroke, ischemic
5367290|NCT00167765|acute ischemic stroke|acute ischemic stroke
5367291|NCT00167739|Malaria|malaria
5367292|NCT00167739|Quinine|quinine
5367293|NCT00167739|Sulfadoxine-pyrimethamine|sulfadoxine-pyrimethamine
5367294|NCT00167739|Gabon|gabon
5367295|NCT00167713|Malaria|malaria
5367296|NCT00167713|Fever|fever
5367297|NCT00167713|Ibuprofen|ibuprofen
5367298|NCT00167713|Gabon|gabon
5367299|NCT00167700|atopic disease|atopic disease
5367300|NCT00167700|probiotics|probiotics
5367301|NCT00167700|gut microbiota|gut microbiota
5367302|NCT00167700|allergy|allergy
5367303|NCT00167700|nutrition|nutrition
5367304|NCT00167700|growth|growth
5367305|NCT00167700|allergic rhinitis|allergic rhinitis
5367306|NCT00167700|atopic sensitization|atopic sensitization
5367307|NCT00167700|risk-markers of life-style related diseases|risk-markers of life-style related diseases
5367308|NCT00167687|Alcoholism|alcoholism
5367309|NCT00167687|Randomized Controlled Trial|randomized controlled trial
5367310|NCT00167674|breastmilk|breastmilk
5367311|NCT00167674|HIV-1|hiv-1
5367312|NCT00167674|antiretroviral|antiretroviral
5367313|NCT00167674|mother-to-child|mother-to-child
5367314|NCT00167674|transmission|transmission
5367315|NCT00167661|living or deceased donor renal transplant recipient|living or deceased donor renal transplant recipient
5367316|NCT00167635|Irritable Bowel Syndrome|irritable bowel syndrome
5367317|NCT00167635|Cognitive-behavioral intervention|cognitive-behavioral intervention
5367318|NCT00167635|Psychological distress|psychological distress
5367319|NCT00167635|Quality of life|quality of life
5367320|NCT00167622|Guillain Barré|guillain barré
5367321|NCT00167622|Mechanical ventilation, invasive|mechanical ventilation, invasive
5367322|NCT00167622|Mechanical ventilation, non invasive|mechanical ventilation, non invasive
5367323|NCT00167622|Pneumonia|pneumonia
5367324|NCT00167609|myotonic dystrophy|myotonic dystrophy
5367325|NCT00167609|hypersomnia|hypersomnia
5367326|NCT00167609|dehydroepiandrosterone|dehydroepiandrosterone
5367327|NCT00167596|near infrared spectroscopy|near infrared spectroscopy
5367328|NCT00167596|tissue oxygenation|tissue oxygenation
5367329|NCT00167596|organ dysfunction|organ dysfunction
5367330|NCT00167596|mortality|mortality
5367331|NCT00167583|Ocular Behcet`s disease|ocular behcet`s disease
5367332|NCT00167583|Panuveitis|panuveitis
5367333|NCT00167583|Posterior Uveitis|posterior uveitis
5367334|NCT00167583|Retinal vasculitis|retinal vasculitis
5367335|NCT00167583|Treatment|treatment
5367336|NCT00167583|Interferon-alpha|interferon-alpha
5367337|NCT00167583|Cyclosporin A|cyclosporin a
5367338|NCT00167570|Artificial Limbs|artificial limbs
5367339|NCT00167570|Amputees|amputees
5367340|NCT00167570|Computer-Aided Design|computer-aided design
5367341|NCT00167557|Liver Transplantation|liver transplantation
5367342|NCT00167544|Bronchopulmonary Dysplasia|bronchopulmonary dysplasia
5367343|NCT00167544|Encephalomalacia|encephalomalacia
5367344|NCT00167544|Brain injury|brain injury
5367345|NCT00167544|Neurosensory impairment|neurosensory impairment
5367346|NCT00167544|Corticosteroids|corticosteroids
5367347|NCT00167544|Anti-Inflammatory Agents|anti-inflammatory agents
5367348|NCT00167544|Extremely Low Birth Weight (ELBW) infants|extremely low birth weight (elbw) infants
5367349|NCT00167544|Premature Birth|premature birth
5367350|NCT00167544|Magnetic Resonance Imaging|magnetic resonance imaging
5367351|NCT00167531|Stroke|stroke
5367352|NCT00167531|health outcomes|health outcomes
5367353|NCT00167531|physiotherapy|physiotherapy
5367354|NCT00167531|rehabilitation|rehabilitation
5367355|NCT00167531|treadmill|treadmill
5367356|NCT00167518|Diabetic macular oedema|diabetic macular oedema
5367357|NCT00167518|Triamcinolone acetate|triamcinolone acetate
5367358|NCT00167518|Intravitreal injection|intravitreal injection
5367359|NCT00167518|Clinical trial|clinical trial
5367360|NCT00167518|Laser treatment|laser treatment
5367361|NCT00167505|adolescents|adolescents
5367362|NCT00167505|sexual health|sexual health
5367363|NCT00167505|HIV|hiv
5367364|NCT00167505|STD|std
5367365|NCT00167505|pregnancy prevention|pregnancy prevention
5367366|NCT00167505|abstinence education|abstinence education
5367367|NCT00167505|HIV Seronegativity|hiv seronegativity
5367368|NCT00167505|human immunodeficiency virus|human immunodeficiency virus
5367369|NCT00167479|Bipolar Anxiety|bipolar anxiety
5367370|NCT00167479|Bipolar Disorder|bipolar disorder
5367371|NCT00167479|Anxiety|anxiety
5367372|NCT00167479|Panic Disorder|panic disorder
5367373|NCT00167479|Generalized Anxiety Disorder|generalized anxiety disorder
5367374|NCT00167479|GAD|gad
5367375|NCT00167479|Risperidone|risperidone
5367376|NCT00167479|Double-Blind|double-blind
5367377|NCT00167479|Placebo Controlled|placebo controlled
5367378|NCT00167466|periodontal disease|periodontal disease
5367379|NCT00167466|toothbrush|toothbrush
5367380|NCT00167466|titanium dioxide semiconductor|titanium dioxide semiconductor
5367381|NCT00167466|mild-to-moderate periodontal disease|mild-to-moderate periodontal disease
5367382|NCT00167466|adult patients 18 to 70 years of age|adult patients 18 to 70 years of age
5367383|NCT00167453|Nervous system disease|nervous system disease
5367384|NCT00167453|movement disorder|movement disorder
5367385|NCT00167453|exercise|exercise
5367386|NCT00167453|balance|balance
5367387|NCT00167453|education|education
5367388|NCT00167440|cardiac index|cardiac index
5367389|NCT00167440|cardiac output|cardiac output
5367390|NCT00167440|indwelling central venous catheter|indwelling central venous catheter
5367391|NCT00167440|indwelling arterial catheter|indwelling arterial catheter
5367392|NCT00167414|conformal radiotherapy|conformal radiotherapy
5367393|NCT00167388|anemia|anemia
5367394|NCT00167388|prematurity|prematurity
5367395|NCT00167388|blood flow velocity|blood flow velocity
5367396|NCT00167388|superior mesenteric artery|superior mesenteric artery
5367397|NCT00167388|intestinal blood flow in premature infants|intestinal blood flow in premature infants
5367398|NCT00167375|Insomnia|insomnia
5367399|NCT00167375|polysomnography|polysomnography
5367400|NCT00167375|sleep onset|sleep onset
5367401|NCT00167375|time series analysis|time series analysis
5367402|NCT00167362|Schizophrenia|schizophrenia
5367403|NCT00167362|Cognition|cognition
5367404|NCT00167362|Enhancement|enhancement
5367405|NCT00167362|Randomized|randomized
5367406|NCT00167349|cardiac surgery|cardiac surgery
5367407|NCT00167349|cardiopulmonary bypass|cardiopulmonary bypass
5367408|NCT00167349|cytokines|cytokines
5367409|NCT00167336|Computer|computer
5367410|NCT00167336|Kinematics|kinematics
5367411|NCT00167336|Instrument development|instrument development
5367412|NCT00167336|Reliability|reliability
5367413|NCT00167336|Cumulative Trauma Disorder|cumulative trauma disorder
5367414|NCT00167323|Bipolar|bipolar
5367415|NCT00167323|Alcoholism|alcoholism
5367416|NCT00167310|Omega-3 fatty acids|omega-3 fatty acids
5367417|NCT00167310|Statins|statins
5367418|NCT00167310|Antipsychotic drug|antipsychotic drug
5367419|NCT00167310|Antidepressant drug|antidepressant drug
5367420|NCT00167310|Antimanic drug|antimanic drug
5367421|NCT00167310|Placebos|placebos
5367422|NCT00167310|Double-blind method|double-blind method
5367423|NCT00167310|Bipolar (depressed phase)|bipolar (depressed phase)
5367424|NCT00167297|atomoxetine|atomoxetine
5367425|NCT00167297|cannabis dependence|cannabis dependence
5367426|NCT00167297|treatment|treatment
5367427|NCT00167284|chronic care model, diabetes, community, diabetes education|chronic care model, diabetes, community, diabetes education
5367428|NCT00167271|Cognitive therapy|cognitive therapy
5367429|NCT00167245|Topiramate|topiramate
5367430|NCT00167245|alcoholism|alcoholism
5367431|NCT00167245|cocaine dependence|cocaine dependence
5367432|NCT00167232|naltrexone|naltrexone
5367433|NCT00167232|cocaine dependence|cocaine dependence
5367434|NCT00167232|alcohol dependence|alcohol dependence
5367435|NCT00167232|psychosocial treatment|psychosocial treatment
5367436|NCT00167219|Stem cell transplant|stem cell transplant
5367437|NCT00167219|long term survival|long term survival
5367438|NCT00167219|retinoic acid|retinoic acid
5367439|NCT00167206|Stem Cell Transplant|stem cell transplant
5367440|NCT00167206|Thymic Shielding|thymic shielding
5367441|NCT00167206|Total Body Irradiation|total body irradiation
5367442|NCT00167206|Chemotherapy|chemotherapy
5367443|NCT00167180|donor lymphocyte infusions|donor lymphocyte infusions
5367444|NCT00167180|BMT|bmt
5367445|NCT00167180|bone marrow transplant|bone marrow transplant
5367446|NCT00167167|Donor Lymphocyte Infusion|donor lymphocyte infusion
5367447|NCT00167167|relapse|relapse
5367448|NCT00167167|post-transplant|post-transplant
5367449|NCT00167154|suicidality|suicidality
5367450|NCT00167154|antipsychotic|antipsychotic
5367451|NCT00167154|antidepressant|antidepressant
5367452|NCT00167154|treatment|treatment
5367453|NCT00167141|male fertility|male fertility
5367454|NCT00167141|semen parameters|semen parameters
5367455|NCT00167128|Auditory Processing Disorder|auditory processing disorder
5367456|NCT00167128|speech-in-noise intelligibility|speech-in-noise intelligibility
5367457|NCT00167115|Alcohol|alcohol
5367458|NCT00167115|Type 2 diabetes mellitus|type 2 diabetes mellitus
5367459|NCT00167115|Plama glucose|plama glucose
5367460|NCT00167115|HDL cholesterol|hdl cholesterol
5367461|NCT00167102|Alopecia Areata|alopecia areata
5367462|NCT00167089|Stroke|stroke
5367463|NCT00167089|Hemiplegia|hemiplegia
5367464|NCT00167089|Gait|gait
5367465|NCT00167089|Ambulation training|ambulation training
5367466|NCT00167089|Neurologic physical therapy|neurologic physical therapy
5367467|NCT00167076|Stroke|stroke
5367468|NCT00167076|Foot pressure|foot pressure
5367469|NCT00167076|Walking speed|walking speed
5367470|NCT00167076|Gait|gait
5367471|NCT00167063|Stroke|stroke
5367472|NCT00167063|Fall|fall
5367473|NCT00167063|Fall prediction|fall prediction
5367474|NCT00167063|Clinical manifestations|clinical manifestations
5367475|NCT00167063|Frequent faller|frequent faller
5367476|NCT00167037|Hemiplegia|hemiplegia
5367477|NCT00167037|Waist pulling perturbation|waist pulling perturbation
5367478|NCT00167037|Reactive balance strategy|reactive balance strategy
5367479|NCT00167037|Trajectory of center of pressure|trajectory of center of pressure
5367480|NCT00167037|Parameters of center of pressure|parameters of center of pressure
5367481|NCT00167024|prostate cancer, DNA repair gene, genetic polymorphism|prostate cancer, dna repair gene, genetic polymorphism
5367482|NCT00167011|coronary artery|coronary artery
5367483|NCT00166998|Breast neoplasms|breast neoplasms
5367484|NCT00166998|diagnosis|diagnosis
5367485|NCT00166985|endometrial cancer, MRI, Doppler sonography, angiogenesis|endometrial cancer, mri, doppler sonography, angiogenesis
5367486|NCT00166972|metastasis, survival, malignancy, female, trophinin|metastasis, survival, malignancy, female, trophinin
5367487|NCT00166959|Stroke patients|stroke patients
5367488|NCT00166959|Falls|falls
5367489|NCT00166959|Reliability|reliability
5367490|NCT00166959|Validity|validity
5367491|NCT00166933|minimal erythema dose|minimal erythema dose
5367492|NCT00166933|UVB|uvb
5367493|NCT00166933|normal|normal
5367494|NCT00166907|Stroke|stroke
5367495|NCT00166907|Balance|balance
5367496|NCT00166907|Proactive control|proactive control
5367497|NCT00166907|Reactive control|reactive control
5367498|NCT00166907|Recovery|recovery
5367499|NCT00166907|Training|training
5367500|NCT00166907|Fall|fall
5367501|NCT00166894|pleural effusion|pleural effusion
5367502|NCT00166894|TREM-1|trem-1
5367503|NCT00166881|Combination, Chemotherapy, Inoperable Gastric Cancer|combination, chemotherapy, inoperable gastric cancer
5367504|NCT00166868|Biliary atresia, cholangitis, probiotics, prophylaxis|biliary atresia, cholangitis, probiotics, prophylaxis
5367505|NCT00166855|angiogenesis|angiogenesis
5367506|NCT00166855|bone marrow perfusion|bone marrow perfusion
5367507|NCT00166855|dynamic MRI|dynamic mri
5367508|NCT00166855|multiple myeloma|multiple myeloma
5367509|NCT00166855|prognosis|prognosis
5367510|NCT00166842|Pharmacokinetics|pharmacokinetics
5367511|NCT00166842|Sirolimus|sirolimus
5367512|NCT00166842|Cyclosporine|cyclosporine
5367513|NCT00166842|Tacrolimus|tacrolimus
5367514|NCT00166842|Immunosuppressive Agents|immunosuppressive agents
5367515|NCT00166842|Immunosuppression|immunosuppression
5367516|NCT00166842|Transplantation|transplantation
5367517|NCT00166842|Kidney Transplantation|kidney transplantation
5367518|NCT00166829|Tacrolimus|tacrolimus
5367519|NCT00166829|Sirolimus|sirolimus
5367520|NCT00166829|Mycophenolic acid|mycophenolic acid
5367521|NCT00166829|Immunosuppressive Agents|immunosuppressive agents
5367522|NCT00166829|Immunosuppression|immunosuppression
5367523|NCT00166829|Kidney Transplantation|kidney transplantation
5367524|NCT00166829|Transplantation|transplantation
5367525|NCT00166816|Sirolimus|sirolimus
5367526|NCT00166816|Tacrolimus|tacrolimus
5367527|NCT00166816|Cyclosporine|cyclosporine
5367528|NCT00166816|Pharmacokinetics|pharmacokinetics
5367529|NCT00166816|Immunosuppressive Agents|immunosuppressive agents
5367530|NCT00166816|Immunosuppression|immunosuppression
5367531|NCT00166816|Kidney Transplantation|kidney transplantation
5367532|NCT00166816|Transplantation|transplantation
5367533|NCT00166803|Diabetes Mellitus, PPARγ agonist, FDG PET|diabetes mellitus, pparγ agonist, fdg pet
5367534|NCT00166790|Human Chorionic Gonadotropin|human chorionic gonadotropin
5367535|NCT00166790|Dual Polarization Interferometry,|dual polarization interferometry,
5367536|NCT00166790|Gestational Trophoblastic Neoplasms|gestational trophoblastic neoplasms
5367537|NCT00166764|Psychiatric Disorders|psychiatric disorders
5367538|NCT00166764|Evaluation of Mental Health Index|evaluation of mental health index
5367539|NCT00166751|Videofluoroscopic examination,|videofluoroscopic examination,
5367540|NCT00166751|ultrasound|ultrasound
5367541|NCT00166751|laryngeal elevation|laryngeal elevation
5367542|NCT00166751|dysphagia|dysphagia
5367543|NCT00166738|Schizophrenia|schizophrenia
5367544|NCT00166738|multiple genes|multiple genes
5367545|NCT00166738|array-comparative genomic hybridization (CGH)|array-comparative genomic hybridization (cgh)
5367546|NCT00166738|genomic DNA|genomic dna
5367547|NCT00166738|Chinese Han People|chinese han people
5367548|NCT00166725|HRPC|hrpc
5367549|NCT00166725|octreotide LAR|octreotide lar
5367550|NCT00166725|CgA|cga
5367551|NCT00166712|Kidney Transplant|kidney transplant
5367552|NCT00166712|Living Donor Kidney Transplant Recipients|living donor kidney transplant recipients
5367553|NCT00166699|ultrasonography|ultrasonography
5367554|NCT00166699|obesity|obesity
5367555|NCT00166699|Cesarean Section|cesarean section
5367556|NCT00166699|Anesthesia|anesthesia
5367557|NCT00166699|Epidural|epidural
5367558|NCT00166686|Cancer|cancer
5367559|NCT00166686|Clonidine|clonidine
5367560|NCT00166686|Neurocognitive sequelae|neurocognitive sequelae
5367561|NCT00166673|Diabetes Mellitus, Insulin-Dependent|diabetes mellitus, insulin-dependent
5367562|NCT00166673|Type 1 Diabetes|type 1 diabetes
5367563|NCT00166673|Continuous Glucose Monitoring Devices|continuous glucose monitoring devices
5367564|NCT00166673|Electronic Data Collection|electronic data collection
5367565|NCT00166660|Preterm infants|preterm infants
5367566|NCT00166660|Developmental Care|developmental care
5367567|NCT00166660|NIDCAP|nidcap
5367568|NCT00166660|Fetal Growth Restriction|fetal growth restriction
5367569|NCT00166660|Neurobehavior|neurobehavior
5367570|NCT00166660|APIB|apib
5367571|NCT00166660|MRI|mri
5367572|NCT00166660|EEG|eeg
5367573|NCT00166660|Parent Stress|parent stress
5367574|NCT00166647|Cancer|cancer
5367575|NCT00166647|Chemotherapy|chemotherapy
5367576|NCT00166647|Hematological disorder|hematological disorder
5367577|NCT00166634|Hypertension|hypertension
5367578|NCT00166634|ABPM|abpm
5367579|NCT00166634|Ambulatory Blood Pressure Monitoring|ambulatory blood pressure monitoring
5367580|NCT00166621|Autism|autism
5367581|NCT00166621|Neuroplasticity|neuroplasticity
5367582|NCT00166608|acetaminophen toxicity|acetaminophen toxicity
5367583|NCT00166608|liver damage|liver damage
5367584|NCT00166608|tylenol overdose|tylenol overdose
5367585|NCT00166595|Risperidone|risperidone
5367586|NCT00166595|Autism|autism
5367587|NCT00166595|Pervasive Developmental Disorder (PDD)|pervasive developmental disorder (pdd)
5367588|NCT00166582|pediatric asthma, medication adherence, adolescents|pediatric asthma, medication adherence, adolescents
5367589|NCT00166569|Polycystic Ovary Syndrome|polycystic ovary syndrome
5367590|NCT00166543|locally advanced breast carcinoma|locally advanced breast carcinoma
5367591|NCT00166543|locally recurrent inoperable breast carcinoma|locally recurrent inoperable breast carcinoma
5367592|NCT00166543|progressive metastatic breast carcinoma|progressive metastatic breast carcinoma
5367593|NCT00166517|Gastrointestinal Rotavirus|gastrointestinal rotavirus
5367594|NCT00166439|C04.557.386|c04.557.386
5367595|NCT00166387|Hemophilia|hemophilia
5367596|NCT00166387|Inhibitors|inhibitors
5367597|NCT00166361|Extrinsic ureteral obstruction|extrinsic ureteral obstruction
5367598|NCT00166361|Memokath 051 Ureteral Stent|memokath 051 ureteral stent
5367599|NCT00166361|JJ Stent|jj stent
5367600|NCT00166361|Stent|stent
5367601|NCT00166348|Cognitive Rehabilitation|cognitive rehabilitation
5367602|NCT00166322|IBZM-SPECT|ibzm-spect
5367603|NCT00166322|Amphetamine Challenge|amphetamine challenge
5367604|NCT00166322|Schizophrenia|schizophrenia
5367605|NCT00166322|dopaminergic neurotransmission|dopaminergic neurotransmission
5367606|NCT00166322|Persons at risk for the development of schizophrenia|persons at risk for the development of schizophrenia
5367607|NCT00166322|healthy subjects|healthy subjects
5367608|NCT00166309|Hemophilia A|hemophilia a
5367609|NCT00166309|Inhibitors|inhibitors
5367610|NCT00166296|Major depressive disorder, chemically induced.|major depressive disorder, chemically induced.
5367611|NCT00166296|Peginterferon alfa-2a.|peginterferon alfa-2a.
5367612|NCT00166296|Escitalopram.|escitalopram.
5367613|NCT00166296|Chronic hepatitis C, psychology.|chronic hepatitis c, psychology.
5367614|NCT00166296|Prophylactic treatment.|prophylactic treatment.
5367615|NCT00166283|memory|memory
5367616|NCT00166283|learning|learning
5367617|NCT00166283|Multiple Sclerosis|multiple sclerosis
5367618|NCT00166283|Cognition|cognition
5367619|NCT00166283|treatment|treatment
5367620|NCT00166283|therapy|therapy
5367621|NCT00166270|Fibroids|fibroids
5367622|NCT00166270|ExAblate|exablate
5367623|NCT00166270|MrgFus|mrgfus
5367624|NCT00166270|Uterine Fibroids|uterine fibroids
5367625|NCT00166257|Paradoxical embolism, Patent foramen ovale,|paradoxical embolism, patent foramen ovale,
5367626|NCT00166244|Mycophenolate mofetil|mycophenolate mofetil
5367627|NCT00166244|Therapeutic Drug Monitoring|therapeutic drug monitoring
5367628|NCT00166244|Adult kidney transplantation|adult kidney transplantation
5367629|NCT00166244|Paediatric kidney transplantation|paediatric kidney transplantation
5367630|NCT00166231|Innocent heart murmurs|innocent heart murmurs
5367631|NCT00166231|Chest pain|chest pain
5367632|NCT00166231|pediatric Cardiology|pediatric cardiology
5367633|NCT00166231|Somatization|somatization
5367634|NCT00166231|life stress|life stress
5367635|NCT00166218|pediatrics|pediatrics
5367636|NCT00166218|cardiac defects|cardiac defects
5367637|NCT00166205|Obesity, Morbid|obesity, morbid
5367638|NCT00166205|Obesity|obesity
5367639|NCT00166205|Body Weight|body weight
5367640|NCT00166192|Melasma|melasma
5367641|NCT00166192|Jessner's solution|jessner's solution
5367642|NCT00166192|Trichloroacetic acid (TCA)|trichloroacetic acid (tca)
5367643|NCT00166179|CAD|cad
5367644|NCT00166166|hyperlipidaemia|hyperlipidaemia
5367645|NCT00166166|EDHF|edhf
5367646|NCT00166166|FMD|fmd
5367647|NCT00166153|cardiac transplantation|cardiac transplantation
5367648|NCT00166153|pediatrics|pediatrics
5367649|NCT00166153|cardiology|cardiology
5367650|NCT00166153|drug metabolism|drug metabolism
5367651|NCT00166140|pediatrics|pediatrics
5367652|NCT00166140|cardiac|cardiac
5367653|NCT00166140|surgery|surgery
5367654|NCT00166127|heart failure|heart failure
5367655|NCT00166127|cardiac surgery|cardiac surgery
5367656|NCT00166127|pharmacokinetics|pharmacokinetics
5367657|NCT00166127|pharmacodynamics|pharmacodynamics
5367658|NCT00166114|platelet function|platelet function
5367659|NCT00166114|childhood abuse|childhood abuse
5367660|NCT00166114|depression|depression
5367661|NCT00166114|antidepressants|antidepressants
5367662|NCT00166114|immune function|immune function
5367663|NCT00166114|stress response|stress response
5367664|NCT00166101|pediatric|pediatric
5367665|NCT00166101|cardiac surgery|cardiac surgery
5367666|NCT00166088|Oxidative Stress|oxidative stress
5367667|NCT00166088|Diet, Mediterranean|diet, mediterranean
5367668|NCT00166075|Suicidality|suicidality
5367669|NCT00166075|PTSD|ptsd
5367670|NCT00166075|depression|depression
5367671|NCT00166062|intimate partner violence|intimate partner violence
5367672|NCT00166062|perpetration|perpetration
5367673|NCT00166049|Heart failure|heart failure
5367674|NCT00166049|Family partnership|family partnership
5367675|NCT00166049|Patient family education|patient family education
5367676|NCT00166023|pediatric|pediatric
5367677|NCT00166023|cardiology|cardiology
5367678|NCT00166010|drug|drug
5367679|NCT00166010|pediatrics|pediatrics
5367680|NCT00166010|cardiac|cardiac
5367681|NCT00166010|Children with Cardiac Ventricular Failure|children with cardiac ventricular failure
5367682|NCT00165997|pediatrics|pediatrics
5367683|NCT00165997|cardiology|cardiology
5367684|NCT00165997|Radiofrequency ablation|radiofrequency ablation
5367685|NCT00165997|structurally normal heart|structurally normal heart
5367686|NCT00165984|cardiac|cardiac
5367687|NCT00165984|hypoplastic|hypoplastic
5367688|NCT00165984|pediatric|pediatric
5367689|NCT00165984|hypoplastic heart ventricle|hypoplastic heart ventricle
5367690|NCT00165971|Cognitive decline|cognitive decline
5367691|NCT00165971|Inflammation|inflammation
5367692|NCT00165971|Monitoring|monitoring
5367693|NCT00165971|Recovery|recovery
5367694|NCT00165971|Bispectral index|bispectral index
5367695|NCT00165958|Epidermal cyst|epidermal cyst
5367696|NCT00165958|Epidermoid cyst|epidermoid cyst
5367697|NCT00165958|Sebaceous cyst|sebaceous cyst
5367698|NCT00165958|Pilar cyst|pilar cyst
5367699|NCT00165945|pediatric, cardiology, diagnostic imaging using MRI|pediatric, cardiology, diagnostic imaging using mri
5367700|NCT00165932|tachycardia|tachycardia
5367701|NCT00165932|pediatrics|pediatrics
5367702|NCT00165919|Hepatitis C|hepatitis c
5367703|NCT00165919|HIV|hiv
5367704|NCT00165919|Immunopathogenesis|immunopathogenesis
5367705|NCT00165919|HIV-1|hiv-1
5367706|NCT00165906|neonates|neonates
5367707|NCT00165906|cardiac|cardiac
5367708|NCT00165906|non-cardiac|non-cardiac
5367709|NCT00165906|surgery|surgery
5367710|NCT00165906|anticoagulation|anticoagulation
5367711|NCT00165893|low back pain|low back pain
5367712|NCT00165893|DDD|ddd
5368892|NCT00160511|Nerve Pain|nerve pain
5367713|NCT00165841|non-erosive symptomatic GERD|non-erosive symptomatic gerd
5367714|NCT00165841|GERD|gerd
5367715|NCT00165828|Epilepsy|epilepsy
5367716|NCT00165802|Cancer|cancer
5367717|NCT00165802|malignant tumors|malignant tumors
5367718|NCT00165763|Vascular Dementia|vascular dementia
5367719|NCT00165737|Dementia cerebrovascular disease|dementia cerebrovascular disease
5367720|NCT00165698|Postmenopausal|postmenopausal
5367721|NCT00165698|osteoporosis|osteoporosis
5367722|NCT00165672|24-hour esophageal pH monitoring|24-hour esophageal ph monitoring
5367723|NCT00165672|non-erosive gastroesophageal reflux disease|non-erosive gastroesophageal reflux disease
5367724|NCT00165672|NERD|nerd
5367725|NCT00165672|proton pump inhibitor|proton pump inhibitor
5367726|NCT00165672|rabeprazole|rabeprazole
5367727|NCT00165646|non-erosive gastroesophageal reflux disease|non-erosive gastroesophageal reflux disease
5367728|NCT00165646|NERD|nerd
5367729|NCT00165646|proton pump inhibitor|proton pump inhibitor
5367730|NCT00165646|rabeprazole|rabeprazole
5367731|NCT00165633|Hepatocellular|hepatocellular
5367732|NCT00165633|Carcinoma|carcinoma
5367733|NCT00165633|Hepatitis C Virus|hepatitis c virus
5367734|NCT00165633|Hepatitis B Virus|hepatitis b virus
5367735|NCT00165633|recurrence|recurrence
5367736|NCT00165633|Vitamin K2|vitamin k2
5367737|NCT00165633|E0167|e0167
5367738|NCT00165594|gastric cancer|gastric cancer
5367739|NCT00165594|Phase I|phase i
5367740|NCT00165594|Phase IIa|phase iia
5367741|NCT00165594|E7070|e7070
5367742|NCT00165594|Indisulam|indisulam
5367743|NCT00165594|Pharmacogenomic|pharmacogenomic
5367744|NCT00165594|2C19|2c19
5367745|NCT00165581|Intracavitary brachytherapy|intracavitary brachytherapy
5367746|NCT00165581|radiation therapy|radiation therapy
5367747|NCT00165581|Stage I breast cancer|stage i breast cancer
5367748|NCT00165581|Stage II breast cancer|stage ii breast cancer
5367749|NCT00165568|Positron emission tomography|positron emission tomography
5367750|NCT00165568|PET|pet
5367751|NCT00165568|bevacizumab|bevacizumab
5367752|NCT00165568|5fluorouracil|5fluorouracil
5367753|NCT00165568|Metastatic colorectal cancer|metastatic colorectal cancer
5367754|NCT00165555|cisplatin|cisplatin
5367755|NCT00165555|pleurectomy|pleurectomy
5367756|NCT00165555|decortication|decortication
5367757|NCT00165555|heated cisplatin|heated cisplatin
5367758|NCT00165542|A-protein level|a-protein level
5367759|NCT00165542|brain tumor|brain tumor
5367760|NCT00165516|Extrapleural pneumonectomy|extrapleural pneumonectomy
5367761|NCT00165516|cisplatin|cisplatin
5367762|NCT00165516|heated cisplatin|heated cisplatin
5367763|NCT00165503|pleurectomy|pleurectomy
5367764|NCT00165503|decortication|decortication
5367765|NCT00165503|cisplatin|cisplatin
5367766|NCT00165503|ALIMTA|alimta
5367767|NCT00165490|adenocarcinoma of esophagus|adenocarcinoma of esophagus
5367768|NCT00165490|squamous cell carcinoma of esophagus|squamous cell carcinoma of esophagus
5367769|NCT00165490|combination chemotherapy|combination chemotherapy
5367770|NCT00165490|cisplatin|cisplatin
5367771|NCT00165490|irinotecan|irinotecan
5367772|NCT00165490|radiation therapy|radiation therapy
5367773|NCT00165490|resectable esophageal cancer|resectable esophageal cancer
5367774|NCT00165477|Glioblastoma|glioblastoma
5367775|NCT00165477|Gliosarcoma|gliosarcoma
5367776|NCT00165477|Malignant Gliomas|malignant gliomas
5367777|NCT00165477|Radiation Therapy|radiation therapy
5367778|NCT00165477|IMiD|imid
5367779|NCT00165477|Lenalidomide|lenalidomide
5367780|NCT00165464|Esophageal Cancer|esophageal cancer
5367781|NCT00165464|Gastric Cancer|gastric cancer
5367782|NCT00165464|GE Junction|ge junction
5367783|NCT00165464|Cisplatin|cisplatin
5367784|NCT00165464|Taxotere|taxotere
5367785|NCT00165464|CPT-11|cpt-11
5367786|NCT00165464|Irinotecan|irinotecan
5367787|NCT00165451|Relapsed tumors|relapsed tumors
5367788|NCT00165451|Progressive Poor Prognosis Tumors|progressive poor prognosis tumors
5367789|NCT00165451|Thalidomide|thalidomide
5367790|NCT00165451|Celecoxib|celecoxib
5367791|NCT00165451|Etoposide|etoposide
5367792|NCT00165451|Cyclophosphamide|cyclophosphamide
5367793|NCT00165438|Pulmonary function|pulmonary function
5367794|NCT00165438|Bleomycin-based chemotherapy|bleomycin-based chemotherapy
5367795|NCT00165438|mediastinal irradiation|mediastinal irradiation
5367796|NCT00165425|Cardiac screening|cardiac screening
5367797|NCT00165425|Cardiac stress test|cardiac stress test
5367798|NCT00165425|Echocardiogram|echocardiogram
5367799|NCT00165412|Breast screening|breast screening
5367800|NCT00165412|Breast MRI|breast mri
5367801|NCT00165412|Mammogram|mammogram
5367802|NCT00165412|Mammography|mammography
5367803|NCT00165399|Prostate cancer|prostate cancer
5367804|NCT00165399|PSA level|psa level
5367805|NCT00165399|docetaxel|docetaxel
5367806|NCT00165399|estramustine|estramustine
5367807|NCT00165399|hormone therapy|hormone therapy
5367808|NCT00165399|androgen withdrawal|androgen withdrawal
5367809|NCT00165386|MRI-guided bone marrow biopsy|mri-guided bone marrow biopsy
5367810|NCT00165373|pediatric solid tumors|pediatric solid tumors
5367811|NCT00165373|rhEndostatin|rhendostatin
5367812|NCT00165360|low-grade glioma|low-grade glioma
5367813|NCT00165360|astrocytoma|astrocytoma
5367814|NCT00165360|oligodendroglioma|oligodendroglioma
5367815|NCT00165360|oligoastrocytoma|oligoastrocytoma
5367816|NCT00165360|temozolomide|temozolomide
5367817|NCT00165360|mixed oligoastrocytoma|mixed oligoastrocytoma
5367818|NCT00165347|Multiple myeloma|multiple myeloma
5367819|NCT00165347|PTK|ptk
5367820|NCT00165347|Relapsed multiple myeloma|relapsed multiple myeloma
5367821|NCT00165347|Refractory Multiple myeloma|refractory multiple myeloma
5367822|NCT00165347|Myeloma|myeloma
5367823|NCT00165334|Non-small cell lung cancer|non-small cell lung cancer
5367824|NCT00165334|Cetuximab|cetuximab
5367825|NCT00165334|Vinorelbine|vinorelbine
5367826|NCT00165334|Navelbine|navelbine
5367827|NCT00165334|Previously untreated lung cancer|previously untreated lung cancer
5367828|NCT00165308|Hodgkin's disease|hodgkin's disease
5367829|NCT00165308|breast cancer prevention|breast cancer prevention
5367830|NCT00165308|tamoxifen|tamoxifen
5367831|NCT00165295|sildenafil citrate|sildenafil citrate
5367832|NCT00165295|Viagra|viagra
5367833|NCT00165295|Waldenstrom's macroglobulinemia|waldenstrom's macroglobulinemia
5367834|NCT00165282|Meditation|meditation
5367835|NCT00165282|Mindfulness meditation|mindfulness meditation
5367836|NCT00165282|Bone Marrow Transplant|bone marrow transplant
5367837|NCT00165282|Stem Cell Transplant|stem cell transplant
5367838|NCT00165269|Hodgkin's Disease Stage IA-IIA|hodgkin's disease stage ia-iia
5367839|NCT00165269|mantle irradiation|mantle irradiation
5367840|NCT00165256|Ductal carcinoma in situ|ductal carcinoma in situ
5367841|NCT00165256|DCIS|dcis
5367842|NCT00165256|wide excision|wide excision
5367843|NCT00165243|Axillary Dissection|axillary dissection
5367844|NCT00165243|Tangential Radiation|tangential radiation
5367845|NCT00165243|Breast Cancer|breast cancer
5367846|NCT00165230|thalidomide|thalidomide
5367847|NCT00165230|temodar|temodar
5367848|NCT00165230|metastatic neuroendocrine tumor|metastatic neuroendocrine tumor
5367849|NCT00165230|unresectable neuroendocrine tumor|unresectable neuroendocrine tumor
5367850|NCT00165217|capecitabine|capecitabine
5367851|NCT00165217|thalidomide|thalidomide
5367852|NCT00165217|colorectal cancer|colorectal cancer
5367853|NCT00165204|Tibolone|tibolone
5367854|NCT00165204|High risk women|high risk women
5367855|NCT00165204|Oophorectomy|oophorectomy
5367856|NCT00165204|Breast Density|breast density
5367857|NCT00165204|Bone Density|bone density
5367858|NCT00165191|doxorubicin|doxorubicin
5367859|NCT00165191|cisplatin|cisplatin
5367860|NCT00165191|5-fluorouracil|5-fluorouracil
5367861|NCT00165191|stomach cancer|stomach cancer
5367862|NCT00165191|esophagus cancer|esophagus cancer
5367863|NCT00165178|Acute lymphoblastic leukemia in children|acute lymphoblastic leukemia in children
5367864|NCT00165178|High Risk ALL|high risk all
5367865|NCT00165178|Standard Risk ALL|standard risk all
5367866|NCT00165178|E. coli asparaginase|e. coli asparaginase
5367867|NCT00165152|Genetic testing|genetic testing
5367868|NCT00165152|BRCA1 gene|brca1 gene
5367869|NCT00165152|BRCA2 gene|brca2 gene
5367870|NCT00165152|Counseling interventions|counseling interventions
5367871|NCT00165152|Genetic counseling|genetic counseling
5367872|NCT00165139|Stem cell transplant|stem cell transplant
5367873|NCT00165139|High-risk pediatric tumors|high-risk pediatric tumors
5367874|NCT00165126|dosimetric analysis|dosimetric analysis
5367875|NCT00165126|vaginal cuff brachytherapy|vaginal cuff brachytherapy
5367876|NCT00165100|DAT|dat
5367877|NCT00165100|imaging modality|imaging modality
5367878|NCT00165087|childhood ALL|childhood all
5367879|NCT00165087|standard risk|standard risk
5367880|NCT00165087|high risk|high risk
5367881|NCT00165087|infant/high risk|infant/high risk
5367882|NCT00165074|Prematurity|prematurity
5367883|NCT00165074|Lung Disease|lung disease
5367884|NCT00165074|Hyaline Membrane|hyaline membrane
5367885|NCT00165074|Surfactant|surfactant
5367886|NCT00165035|Percutaneous coronary intervention (PCI)|percutaneous coronary intervention (pci)
5367887|NCT00165035|Drug eluting stent (DES)|drug eluting stent (des)
5367888|NCT00165009|Bleeding Peptic Ulcer|bleeding peptic ulcer
5367889|NCT00165009|Endoscopic treatment|endoscopic treatment
5367890|NCT00164996|upper endoscopy|upper endoscopy
5367891|NCT00164996|local pharyngeal anaesthesia|local pharyngeal anaesthesia
5367892|NCT00164996|ultrathin endoscope|ultrathin endoscope
5367893|NCT00164944|Colonoscopy|colonoscopy
5367894|NCT00164944|First degree relatives|first degree relatives
5367895|NCT00164931|Peptic ulcer hemorrhage|peptic ulcer hemorrhage
5367896|NCT00164931|Omeprazole|omeprazole
5367897|NCT00164931|Scheduled second endoscopy|scheduled second endoscopy
5367898|NCT00164905|Peptic ulcer hemorrhage|peptic ulcer hemorrhage
5367899|NCT00164905|Doppler ultrasound|doppler ultrasound
5367900|NCT00164879|Obstructing|obstructing
5367901|NCT00164879|Left-sided|left-sided
5367902|NCT00164879|Colorectal neoplasms|colorectal neoplasms
5367903|NCT00164879|Obstructing left-sided colorectal cancers|obstructing left-sided colorectal cancers
5367904|NCT00164866|Peptic ulcer|peptic ulcer
5367905|NCT00164866|IVPPI prior endoscopy|ivppi prior endoscopy
5367906|NCT00164840|GERD|gerd
5367907|NCT00164788|24 hours pH monitoring|24 hours ph monitoring
5367908|NCT00164775|Functional dyspepsia, refractory, antidepressant|functional dyspepsia, refractory, antidepressant
5367910|NCT00164762|drug resistance|drug resistance
5367911|NCT00164762|nevirapine|nevirapine
5367912|NCT00164762|anti-retroviral drugs|anti-retroviral drugs
5367913|NCT00164762|mother-to-child transmission|mother-to-child transmission
5367914|NCT00164762|Treatment Naive|treatment naive
5367915|NCT00164762|pregnancy|pregnancy
5367916|NCT00164749|dementia|dementia
5367917|NCT00164749|cognition|cognition
5367918|NCT00164749|memory|memory
5367919|NCT00164749|neurodegenerative disease|neurodegenerative disease
5367920|NCT00164749|brain|brain
5367921|NCT00164736|HIV|hiv
5367922|NCT00164736|Clinical trial|clinical trial
5367923|NCT00164736|breastfeeding|breastfeeding
5367924|NCT00164736|mother-to-child-transmission|mother-to-child-transmission
5367925|NCT00164736|nutrition|nutrition
5367926|NCT00164736|HIV Seronegativity|hiv seronegativity
5367927|NCT00164723|Capsule Endoscopy|capsule endoscopy
5367928|NCT00164710|antimalarials|antimalarials
5367929|NCT00164697|Child Development|child development
5367930|NCT00164697|Parenting|parenting
5367931|NCT00164697|Child Rearing|child rearing
5367932|NCT00164697|Parent-Child Relations|parent-child relations
5367933|NCT00164684|batterers|batterers
5367934|NCT00164684|prevention|prevention
5367935|NCT00164684|African American|african american
5367936|NCT00164684|Latino|latino
5367937|NCT00164671|Male condoms|male condoms
5367938|NCT00164671|Female condoms|female condoms
5367939|NCT00164671|Self-efficacy|self-efficacy
5367940|NCT00164658|family history|family history
5367941|NCT00164658|familial risk|familial risk
5367942|NCT00164658|behavior change|behavior change
5367943|NCT00164645|Emotional outcomes|emotional outcomes
5367944|NCT00164645|health outcomes|health outcomes
5367945|NCT00164645|traumatic brain injury|traumatic brain injury
5367946|NCT00164645|caregiving|caregiving
5367947|NCT00164619|controlled clinical trial|controlled clinical trial
5367948|NCT00164619|behavioral intervention|behavioral intervention
5367949|NCT00164619|prevention intervention|prevention intervention
5367950|NCT00164606|child maltreatment|child maltreatment
5367951|NCT00164606|child abuse|child abuse
5367952|NCT00164606|prevention|prevention
5367953|NCT00164593|Youth Violence|youth violence
5367954|NCT00164593|Prevention|prevention
5367955|NCT00164580|Homosexuality, Male|homosexuality, male
5367956|NCT00164580|Adolescents|adolescents
5367957|NCT00164580|Minority Groups|minority groups
5367958|NCT00164580|Community Participation|community participation
5367959|NCT00164580|Community Surveys|community surveys
5367960|NCT00164580|HIV Seronegativity|hiv seronegativity
5367961|NCT00164580|HIV|hiv
5367962|NCT00164567|partner abuse|partner abuse
5367963|NCT00164567|screening|screening
5367964|NCT00164567|intimate partner violence|intimate partner violence
5367965|NCT00164554|treatment|treatment
5367966|NCT00164554|control|control
5367967|NCT00164541|dating violence|dating violence
5367968|NCT00164541|violence against women|violence against women
5367969|NCT00164515|obesity, mobility limitations, women, physical activity|obesity, mobility limitations, women, physical activity
5367970|NCT00164463|tuberculosis|tuberculosis
5367971|NCT00164463|TB|tb
5367972|NCT00164450|tuberculosis|tuberculosis
5367973|NCT00164450|TB|tb
5367974|NCT00164450|pharmacokinetics|pharmacokinetics
5367975|NCT00164450|children|children
5367976|NCT00164437|screening|screening
5367977|NCT00164437|community healt education|community healt education
5367978|NCT00164437|decision making|decision making
5367979|NCT00164437|computer-assisted decision making|computer-assisted decision making
5367980|NCT00164424|HSV2|hsv2
5367981|NCT00164424|genital ulcer|genital ulcer
5367982|NCT00164424|HIV|hiv
5367983|NCT00164424|South Africa|south africa
5367984|NCT00164424|Treatment|treatment
5367985|NCT00164424|Acyclovir|acyclovir
5367986|NCT00164424|Prevention|prevention
5367987|NCT00164411|Diptheria-Tetanus vaccine|diptheria-tetanus vaccine
5367988|NCT00164411|Pneumococcal vaccine|pneumococcal vaccine
5367989|NCT00164411|Adverse events following vaccination|adverse events following vaccination
5367990|NCT00164411|Immunization|immunization
5367991|NCT00164411|Immunogenicity|immunogenicity
5367992|NCT00164398|HIV|hiv
5367993|NCT00164385|HIV/AIDS|hiv/aids
5367994|NCT00164372|IV Drug users|iv drug users
5367995|NCT00164372|HIV|hiv
5367996|NCT00164372|hepatitis C virus|hepatitis c virus
5367997|NCT00164372|HIV Seronegativity|hiv seronegativity
5367998|NCT00164359|malaria, falciparum|malaria, falciparum
5367999|NCT00164359|antimalarials|antimalarials
5368000|NCT00164346|fetal alcohol syndrome (FAS)|fetal alcohol syndrome (fas)
5368001|NCT00164346|alcohol-related neurodevelopmental disorder (ARND)|alcohol-related neurodevelopmental disorder (arnd)
5368002|NCT00164281|TB|tb
5368003|NCT00164281|Tuberculosis|tuberculosis
5368004|NCT00164281|INH|inh
5368005|NCT00164281|Isoniazid|isoniazid
5368006|NCT00164281|Preventive therapy|preventive therapy
5368007|NCT00164281|HIV|hiv
5368008|NCT00164281|AIDS|aids
5368009|NCT00164281|Botswana|botswana
5368010|NCT00164281|LTBI|ltbi
5368011|NCT00164281|Latent TB Infection|latent tb infection
5368012|NCT00164268|Intimate partner violence|intimate partner violence
5368013|NCT00164268|Sexual violence|sexual violence
5368014|NCT00164268|Cultural intervention|cultural intervention
5368015|NCT00164268|Native Hawaiian|native hawaiian
5368016|NCT00164255|malaria|malaria
5368017|NCT00164255|birthweight|birthweight
5368018|NCT00164255|placental malaria|placental malaria
5368019|NCT00164255|intermittent protective treatment|intermittent protective treatment
5368020|NCT00164255|sulfadoxine/ pyrimethamine|sulfadoxine/ pyrimethamine
5368021|NCT00164255|artesuate|artesuate
5368022|NCT00164255|combination therapy|combination therapy
5368023|NCT00164255|Pregnancy|pregnancy
5368024|NCT00164242|Tardive dyskinesia|tardive dyskinesia
5368025|NCT00164242|Galantamine|galantamine
5368026|NCT00164242|Cholinesterase inhibitors|cholinesterase inhibitors
5368027|NCT00164229|treatment|treatment
5368028|NCT00164229|control|control
5368029|NCT00164216|malaria|malaria
5368030|NCT00164216|combination therapy|combination therapy
5368031|NCT00164216|mefloquine|mefloquine
5368032|NCT00164216|artesunate|artesunate
5368033|NCT00164216|Peru|peru
5368034|NCT00164216|malaria, uncomplicated|malaria, uncomplicated
5368035|NCT00164190|Myocardial Infarction|myocardial infarction
5368036|NCT00164190|Thrombolysis|thrombolysis
5368037|NCT00164190|Angioplasty|angioplasty
5368038|NCT00164190|ST Elevation Myocardial Infarction|st elevation myocardial infarction
5368039|NCT00164177|virtual colonoscopy|virtual colonoscopy
5368040|NCT00164177|colonoscopy preparation|colonoscopy preparation
5368041|NCT00164177|bowel prep|bowel prep
5368042|NCT00164164|colonoscopy preparation|colonoscopy preparation
5368043|NCT00164164|prep|prep
5368044|NCT00164151|colonoscopy preparation|colonoscopy preparation
5368045|NCT00164151|prep|prep
5368046|NCT00164138|Incontinence|incontinence
5368047|NCT00164138|physiotherapy|physiotherapy
5368048|NCT00164138|treatment|treatment
5368049|NCT00164138|pelvic floor muscle function|pelvic floor muscle function
5368050|NCT00164138|coughing|coughing
5368051|NCT00164138|forced expirations|forced expirations
5368052|NCT00164138|lung disease|lung disease
5368053|NCT00164112|Cooperstown Cocktail|cooperstown cocktail
5368054|NCT00164112|Drug Metabolizing Enzymes|drug metabolizing enzymes
5368055|NCT00164112|Drug Interactions|drug interactions
5368056|NCT00164112|Phenotyping|phenotyping
5368057|NCT00164099|Coronary Artery Bypass|coronary artery bypass
5368058|NCT00164099|Postoperative Complications|postoperative complications
5368059|NCT00164099|Probiotics|probiotics
5368060|NCT00164099|Surgical Wound infection|surgical wound infection
5368061|NCT00164099|cystitis|cystitis
5368062|NCT00164099|bacteremia|bacteremia
5368063|NCT00164099|pneumonia|pneumonia
5368064|NCT00164099|Enterocolitis, Pseudomembranous|enterocolitis, pseudomembranous
5368065|NCT00164073|HCV and microarray|hcv and microarray
5368066|NCT00164073|HCV|hcv
5368067|NCT00164060|HCV|hcv
5368068|NCT00164060|HIV co-infection|hiv co-infection
5368069|NCT00164047|Nitrous Oxide|nitrous oxide
5368070|NCT00164047|Anaesthesia|anaesthesia
5368071|NCT00164047|Anesthesia|anesthesia
5368072|NCT00164047|Recovery|recovery
5368073|NCT00164047|Quality|quality
5368074|NCT00164034|Trauma|trauma
5368075|NCT00164034|Wounds|wounds
5368076|NCT00164034|Injuries|injuries
5368077|NCT00164021|gastroesophageal reflux, gastric reflux, acid reflux, lung transplantation, physiotherapy, anti-reflux medication|gastroesophageal reflux, gastric reflux, acid reflux, lung transplantation, physiotherapy, anti-reflux medication
5368078|NCT00163995|Chronic Liver Disease|chronic liver disease
5368079|NCT00163982|HVPG > 12 mmHg|hvpg > 12 mmhg
5368080|NCT00163969|Pain|pain
5368081|NCT00163969|Wind-up|wind-up
5368082|NCT00163969|opioid|opioid
5368083|NCT00163969|ketamine|ketamine
5368084|NCT00163969|pre-emptive|pre-emptive
5368085|NCT00163956|IVC filters|ivc filters
5368086|NCT00163956|failed retrieval|failed retrieval
5368087|NCT00163943|Metabolic syndrome|metabolic syndrome
5368088|NCT00163943|Sympathetic nervous system activity|sympathetic nervous system activity
5368089|NCT00163943|Insulin sensitivity|insulin sensitivity
5368090|NCT00163943|weight loss|weight loss
5368091|NCT00163943|aerobic exercise|aerobic exercise
5368092|NCT00163930|Uterine Fibroids|uterine fibroids
5368093|NCT00163930|embolisation|embolisation
5368094|NCT00163930|pain management|pain management
5368095|NCT00163917|Hypnosis|hypnosis
5368096|NCT00163917|Analgesia|analgesia
5368097|NCT00163904|Heart Failure|heart failure
5368098|NCT00163904|Inflammatory mediators|inflammatory mediators
5368099|NCT00163904|insulin sensitivity|insulin sensitivity
5368100|NCT00163904|overweight|overweight
5368101|NCT00163904|high monounsaturated diet|high monounsaturated diet
5368102|NCT00163891|Respiratory Therapy|respiratory therapy
5368103|NCT00163891|Postoperative Care|postoperative care
5368104|NCT00163891|Treatment Outcome|treatment outcome
5368105|NCT00163878|Sensory Stimulation Programs|sensory stimulation programs
5368106|NCT00163865|Boredom|boredom
5368107|NCT00163865|Adolescent|adolescent
5368108|NCT00163865|Mental illness|mental illness
5368109|NCT00163865|Depression|depression
5368110|NCT00163865|Anxiety|anxiety
5368111|NCT00163852|Cystic fibrosis|cystic fibrosis
5368112|NCT00163852|Metabolic alkalosis|metabolic alkalosis
5368113|NCT00163852|Hypercapnia|hypercapnia
5368114|NCT00163852|Salt replacement|salt replacement
5368115|NCT00163839|Dietary Intervention|dietary intervention
5368116|NCT00163839|Pseudoallergen free diet|pseudoallergen free diet
5368117|NCT00163826|cervical spine injury|cervical spine injury
5368118|NCT00163826|multiple trauma|multiple trauma
5368119|NCT00163813|Mechanically-ventilated|mechanically-ventilated
5368120|NCT00163813|medical-surgical critically ill patients|medical-surgical critically ill patients
5368121|NCT00163813|reduced gastric motility|reduced gastric motility
5368122|NCT00163800|Outcome predictors|outcome predictors
5368123|NCT00163800|Acute brain injury|acute brain injury
5368124|NCT00163787|mobility|mobility
5368125|NCT00163787|falls|falls
5368126|NCT00163787|activity level|activity level
5368127|NCT00163761|Lymphoma|lymphoma
5368128|NCT00163748|Lymphoma|lymphoma
5368129|NCT00163735|Food allergy|food allergy
5368130|NCT00163735|wine|wine
5368131|NCT00163735|milk allergy|milk allergy
5368132|NCT00163735|egg allergy|egg allergy
5368133|NCT00163735|nut allergy|nut allergy
5368134|NCT00163735|fish allergy|fish allergy
5368135|NCT00163709|Atrial natriuretic factor.|atrial natriuretic factor.
5368136|NCT00163709|Biochemistry.|biochemistry.
5368137|NCT00163709|Cardiac failure.|cardiac failure.
5368138|NCT00163709|Randomised trials.|randomised trials.
5368139|NCT00163709|Hormones.|hormones.
5368140|NCT00163709|Systolic heart failure.|systolic heart failure.
5368141|NCT00163709|Diastolic heart failure.|diastolic heart failure.
5368142|NCT00163709|Ischaemic cardiomyopathy.|ischaemic cardiomyopathy.
5368143|NCT00163709|Ventricular hypertrophy.|ventricular hypertrophy.
5368144|NCT00163709|AMI|ami
5368145|NCT00163696|MBNW|mbnw
5368146|NCT00163696|Ventilation|ventilation
5368147|NCT00163696|small airways|small airways
5368148|NCT00163696|Lung Transplant recipients (Bronchiolitis Obliterans syndrome)|lung transplant recipients (bronchiolitis obliterans syndrome)
5368149|NCT00163683|Dietary Intervention|dietary intervention
5368150|NCT00163657|Hepatitis C Virus|hepatitis c virus
5368151|NCT00163657|Immunosuppressive Agents|immunosuppressive agents
5368152|NCT00163644|Hematological malignancies.|hematological malignancies.
5368153|NCT00163644|Bone- marrow/ haemopoetic transplant|bone- marrow/ haemopoetic transplant
5368154|NCT00163644|Exercise|exercise
5368155|NCT00163618|tick-borne encephalitis|tick-borne encephalitis
5368156|NCT00163605|Sinus augmentation|sinus augmentation
5368157|NCT00163605|Alloplastic bone substitute|alloplastic bone substitute
5368158|NCT00163605|Hydroxyl apatite|hydroxyl apatite
5368159|NCT00163592|Vascular reconstruction|vascular reconstruction
5368160|NCT00163592|Polytetraflouroethylene (PTFE) prosthesis|polytetraflouroethylene (ptfe) prosthesis
5368161|NCT00163579|premature birth|premature birth
5368162|NCT00163579|cerclage|cerclage
5368163|NCT00163579|tocolysis|tocolysis
5368164|NCT00163579|drug therapy|drug therapy
5368165|NCT00163566|libido|libido
5368166|NCT00163566|depression strength|depression strength
5368167|NCT00163566|testosterone|testosterone
5368168|NCT00163566|dihydrotestosterone|dihydrotestosterone
5368169|NCT00163553|spinal surgery|spinal surgery
5368170|NCT00163553|pethidine|pethidine
5368171|NCT00163553|analgesia|analgesia
5368172|NCT00163540|tick-borne encephalitis|tick-borne encephalitis
5368173|NCT00163527|Asthma|asthma
5368174|NCT00163527|Roflumilast|roflumilast
5368175|NCT00163527|Corticosteroids|corticosteroids
5368176|NCT00163514|Allergy|allergy
5368177|NCT00163514|Perennial Allergic Rhinitis|perennial allergic rhinitis
5368178|NCT00163514|Allergic Rhinitis|allergic rhinitis
5368179|NCT00163514|Hay Fever|hay fever
5368180|NCT00163501|Allergy|allergy
5368181|NCT00163501|Perennial Allergic Rhinitis|perennial allergic rhinitis
5368182|NCT00163501|Allergic Rhinitis|allergic rhinitis
5368183|NCT00163501|Hay Fever|hay fever
5368184|NCT00163488|Allergy|allergy
5368185|NCT00163488|Perennial Allergic Rhinitis|perennial allergic rhinitis
5368186|NCT00163488|Allergic Rhinitis|allergic rhinitis
5368187|NCT00163488|Hay Fever|hay fever
5368188|NCT00163475|Asthma|asthma
5368189|NCT00163475|Roflumilast|roflumilast
5368190|NCT00163462|Asthma|asthma
5368191|NCT00163462|Ciclesonide|ciclesonide
5368192|NCT00163462|Child|child
5368193|NCT00163462|Fluticasone propionate|fluticasone propionate
5368194|NCT00163462|Pediatric|pediatric
5368195|NCT00163449|Asthma|asthma
5368196|NCT00163449|Ciclesonide|ciclesonide
5368197|NCT00163449|Child|child
5368198|NCT00163449|Pediatric|pediatric
5368199|NCT00163436|Asthma|asthma
5368200|NCT00163436|Ciclesonide|ciclesonide
5368201|NCT00163423|Asthma|asthma
5368202|NCT00163423|Ciclesonide|ciclesonide
5368203|NCT00163423|Fluticasone propionate|fluticasone propionate
5368204|NCT00163410|Asthma|asthma
5368205|NCT00163410|Ciclesonide|ciclesonide
5368206|NCT00163410|Child|child
5368207|NCT00163410|Fluticasone propionate|fluticasone propionate
5368208|NCT00163410|Pediatric|pediatric
5368209|NCT00163397|Asthma|asthma
5368210|NCT00163397|Ciclesonide|ciclesonide
5368211|NCT00163397|Budesonide|budesonide
5368212|NCT00163384|Asthma|asthma
5368213|NCT00163384|Ciclesonide|ciclesonide
5368214|NCT00163384|Budesonide|budesonide
5368215|NCT00163371|Asthma|asthma
5368216|NCT00163371|Ciclesonide|ciclesonide
5368217|NCT00163371|Child|child
5368218|NCT00163371|Fluticasone propionate|fluticasone propionate
5368219|NCT00163371|HPA-axis|hpa-axis
5368220|NCT00163371|Pediatric|pediatric
5368221|NCT00163371|Linear growth rate|linear growth rate
5368222|NCT00163358|Asthma|asthma
5368223|NCT00163358|Ciclesonide|ciclesonide
5368224|NCT00163358|Fluticasone propionate|fluticasone propionate
5368225|NCT00163358|Salmeterol|salmeterol
5368226|NCT00163345|Asthma|asthma
5368227|NCT00163345|Ciclesonide|ciclesonide
5368228|NCT00163345|Small Airways|small airways
5368229|NCT00163332|Asthma|asthma
5368230|NCT00163332|Ciclesonide|ciclesonide
5368231|NCT00163332|Fluticasone propionate|fluticasone propionate
5368232|NCT00163319|Asthma|asthma
5368233|NCT00163319|Ciclesonide|ciclesonide
5368234|NCT00163319|Fluticasone propionate|fluticasone propionate
5368235|NCT00163306|Gastroesophageal Reflux|gastroesophageal reflux
5368236|NCT00163306|Gastroesophageal Reflux Disease|gastroesophageal reflux disease
5368237|NCT00163306|Pantoprazole|pantoprazole
5368238|NCT00163293|Asthma|asthma
5368239|NCT00163293|Ciclesonide|ciclesonide
5368240|NCT00163293|Exacerbation|exacerbation
5368241|NCT00163280|Mucositis|mucositis
5368242|NCT00163280|Peripheral blood stem cell transplant|peripheral blood stem cell transplant
5368243|NCT00163267|peripheral arterial intervention|peripheral arterial intervention
5368244|NCT00163267|atherosclerosis|atherosclerosis
5368245|NCT00163267|platelets|platelets
5368246|NCT00163267|Age above 18|age above 18
5368247|NCT00163254|Chronic limb ischemia|chronic limb ischemia
5368248|NCT00163254|Intervention|intervention
5368249|NCT00163254|Restenosis|restenosis
5368250|NCT00163254|Patients above 18 years|patients above 18 years
5368251|NCT00163228|C05.550.114.606.500|c05.550.114.606.500
5368252|NCT00163228|C05.550.114.606.508|c05.550.114.606.508
5368253|NCT00163176|cell proliferation|cell proliferation
5368254|NCT00163176|PET|pet
5368255|NCT00163176|radiotherapy|radiotherapy
5368256|NCT00163124|chiropractic|chiropractic
5368257|NCT00163124|spinal manipulation|spinal manipulation
5368258|NCT00163124|low back pain|low back pain
5368259|NCT00163072|transdermal|transdermal
5368260|NCT00163072|Megace|megace
5368261|NCT00163072|pharmacokinetics|pharmacokinetics
5368262|NCT00163033|phase I study|phase i study
5368263|NCT00163020|Preterm Birth|preterm birth
5368264|NCT00163020|Preterm Delivery|preterm delivery
5368265|NCT00163020|Multiple gestation|multiple gestation
5368266|NCT00163020|17-alpha-hydroxyprogesterone caproate|17-alpha-hydroxyprogesterone caproate
5368267|NCT00163020|Progesterone|progesterone
5368268|NCT00162994|recurrent otitis media|recurrent otitis media
5368269|NCT00162994|adenoidectomy|adenoidectomy
5368270|NCT00162994|tympanostomy|tympanostomy
5368271|NCT00162994|young children|young children
5368272|NCT00162994|prevention|prevention
5368273|NCT00162994|quality of life|quality of life
5368274|NCT00162968|polyneuropathies|polyneuropathies
5368275|NCT00162968|pain|pain
5368276|NCT00162968|drug effects|drug effects
5368277|NCT00162968|escitalopram|escitalopram
5368278|NCT00162968|serotonin uptake inhibitors|serotonin uptake inhibitors
5368279|NCT00162955|untreated adult Non-Hodgkin's Lymphoma|untreated adult non-hodgkin's lymphoma
5368280|NCT00162955|CHOP protocol|chop protocol
5368281|NCT00162955|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers
5368282|NCT00162955|Cardiomyopathy|cardiomyopathy
5368283|NCT00162942|Crohn's Disease|crohn's disease
5368284|NCT00162929|metastatic breast cancer|metastatic breast cancer
5368285|NCT00162929|locally recurrent breast cancer|locally recurrent breast cancer
5368286|NCT00162916|Traumatic Brain Injury|traumatic brain injury
5368287|NCT00162916|Depression|depression
5368288|NCT00162916|Antidepressant medication|antidepressant medication
5368289|NCT00162916|Double-Blind Study|double-blind study
5368290|NCT00162916|Brain Injuries|brain injuries
5368291|NCT00162916|Antidepressive Agents|antidepressive agents
5368292|NCT00162916|Citalopram|citalopram
5368293|NCT00162916|Double-Blind Method|double-blind method
5368294|NCT00162903|Preterm infant, Patent ductus arteriosus, Nitric oxide,Endothelin-1|preterm infant, patent ductus arteriosus, nitric oxide,endothelin-1
5368295|NCT00162890|degenerated cervical spine|degenerated cervical spine
5368296|NCT00162890|assessment|assessment
5368297|NCT00162890|physical therapy|physical therapy
5368298|NCT00162877|rabeprazole, omeprazole, CYP2C19, H. pylori, PK/PD|rabeprazole, omeprazole, cyp2c19, h. pylori, pk/pd
5368300|NCT00162864|COPD|copd
5368301|NCT00162864|montelukast sodium|montelukast sodium
5368302|NCT00162864|leukotriene modifier|leukotriene modifier
5368303|NCT00162864|older adults|older adults
5368304|NCT00162825|Psoriasis, T cell, inflammation, CD7, cytokine|psoriasis, t cell, inflammation, cd7, cytokine
5368305|NCT00162812|neoadjuvant chemotherapy|neoadjuvant chemotherapy
5368306|NCT00162812|early breast cancer|early breast cancer
5368307|NCT00162812|inflammatory breast cancer|inflammatory breast cancer
5368308|NCT00162799|insulin resistance and inflamation|insulin resistance and inflamation
5368309|NCT00162799|insulin sensitibity|insulin sensitibity
5368310|NCT00162799|obesity-induced insuline resistence|obesity-induced insuline resistence
5368311|NCT00162799|obesity-diabetes link|obesity-diabetes link
5368312|NCT00162799|salicylate|salicylate
5368313|NCT00162799|insulin resistance in obesity health adults|insulin resistance in obesity health adults
5368314|NCT00162786|Driving performance|driving performance
5368315|NCT00162786|Antihistamine|antihistamine
5368316|NCT00162773|asthma|asthma
5368317|NCT00162747|Pre-term infants|pre-term infants
5368318|NCT00162747|skin infections|skin infections
5368319|NCT00162747|infant skin|infant skin
5368320|NCT00162747|Aquaphor|aquaphor
5368321|NCT00162747|sunflower seed oil|sunflower seed oil
5368322|NCT00162747|nutrition|nutrition
5368323|NCT00162747|skin care|skin care
5368324|NCT00162734|Chronic Hepatitis C|chronic hepatitis c
5368325|NCT00162734|Liver|liver
5368326|NCT00162734|Pegylated|pegylated
5368327|NCT00162734|Interferon|interferon
5368328|NCT00162734|Alpha|alpha
5368329|NCT00162734|Ribavirin|ribavirin
5368330|NCT00162734|Combination|combination
5368331|NCT00162734|Nonresponder|nonresponder
5368332|NCT00162734|HCV|hcv
5368333|NCT00162734|Infergen|infergen
5368334|NCT00162734|SVR|svr
5368335|NCT00162721|Uterine sarcoma non metastatic|uterine sarcoma non metastatic
5368336|NCT00162708|Head and neck squamous cell carcinoma|head and neck squamous cell carcinoma
5368337|NCT00162708|Radiotherapy|radiotherapy
5368338|NCT00162708|Chemotherapy|chemotherapy
5368339|NCT00162682|HIV|hiv
5368340|NCT00162682|Highly Active Antiretroviral Therapy|highly active antiretroviral therapy
5368341|NCT00162682|Monitoring|monitoring
5368342|NCT00162682|Viral load|viral load
5368343|NCT00162682|CD4|cd4
5368344|NCT00162682|Thailand|thailand
5368345|NCT00162682|Future Drug Options|future drug options
5368346|NCT00162682|Resistance|resistance
5368347|NCT00162682|Developing Country|developing country
5368348|NCT00162682|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5368349|NCT00162669|Hepatocellular carcinoma, advanced, bevacizumab, phase II, VGEF, neovascularization|hepatocellular carcinoma, advanced, bevacizumab, phase ii, vgef, neovascularization
5368350|NCT00162656|B-Cell Lymphoma|b-cell lymphoma
5368351|NCT00162643|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5368352|NCT00162643|Antiretroviral Therapy, Highly Active|antiretroviral therapy, highly active
5368353|NCT00162643|Protease Inhibitors|protease inhibitors
5368354|NCT00162643|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5368355|NCT00162630|Hip fracture, pain, regional anaesthesia, analgesia|hip fracture, pain, regional anaesthesia, analgesia
5368356|NCT00162617|Hip fracture|hip fracture
5368357|NCT00162617|Rehabilitation|rehabilitation
5368358|NCT00162617|Transfusion|transfusion
5368359|NCT00162617|Outcome|outcome
5368360|NCT00162604|Prophylactic antibiotic|prophylactic antibiotic
5368361|NCT00162604|Postoperative infections|postoperative infections
5368362|NCT00162604|Uterine prolapse grade I - II|uterine prolapse grade i - ii
5368363|NCT00162604|cystocele|cystocele
5368364|NCT00162604|rectocele|rectocele
5368365|NCT00162604|enterocele|enterocele
5368366|NCT00162604|defects of the perineal body|defects of the perineal body
5368367|NCT00162591|Bispectral index|bispectral index
5368368|NCT00162591|sedation|sedation
5368369|NCT00162591|remifentanyl|remifentanyl
5368370|NCT00162591|Bronchoalveolar lavage|bronchoalveolar lavage
5368371|NCT00162591|Intensive care|intensive care
5368372|NCT00162591|Nociceptive stimuli|nociceptive stimuli
5368373|NCT00162591|Sedated patient|sedated patient
5368374|NCT00162591|BIS variation|bis variation
5368375|NCT00162578|pneumococcal meningitis|pneumococcal meningitis
5368376|NCT00162578|intensive care unit|intensive care unit
5368377|NCT00162578|vancomycin|vancomycin
5368378|NCT00162578|dexamethasone|dexamethasone
5368379|NCT00162578|drug diffusion in cerebrospinal fluid|drug diffusion in cerebrospinal fluid
5368380|NCT00162565|Heart Failure, Congestive|heart failure, congestive
5368381|NCT00162565|beta-Adrenergic Blockers|beta-adrenergic blockers
5368382|NCT00162552|multicenter-randomized-trial|multicenter-randomized-trial
5368383|NCT00162552|pentoxifyllinE|pentoxifylline
5368384|NCT00162552|placebo|placebo
5368385|NCT00162552|cirrhosis|cirrhosis
5368386|NCT00162552|liver failure|liver failure
5368387|NCT00162552|cytokine|cytokine
5368388|NCT00162539|foetal thyroid mensuration|foetal thyroid mensuration
5368389|NCT00162500|Metastatic solid tumors|metastatic solid tumors
5368390|NCT00162474|Healthy Volunteers|healthy volunteers
5368391|NCT00162461|Healthy Volunteers|healthy volunteers
5368392|NCT00162448|Patients requiring dual-chamber pacemakers or defibrillators|patients requiring dual-chamber pacemakers or defibrillators
5368393|NCT00162396|Albuterol|albuterol
5368394|NCT00162396|β2 Adrenergic receptor|β2 adrenergic receptor
5368395|NCT00162396|Polymorphism|polymorphism
5368396|NCT00162240|Metabolics Diabetes New Onset|metabolics diabetes new onset
5368397|NCT00162214|Advanced Solid Tumors|advanced solid tumors
5368398|NCT00162123|ipilimumab|ipilimumab
5368399|NCT00162123|previously treated|previously treated
5368400|NCT00162019|Factor VIII Deficiency|factor viii deficiency
5368401|NCT00162006|Chronic idiopathic thrombocytopenic purpura|chronic idiopathic thrombocytopenic purpura
5368402|NCT00161993|Gammaglobulin|gammaglobulin
5368403|NCT00161980|Axillary wound|axillary wound
5368404|NCT00161980|Seroma|seroma
5368405|NCT00161980|Fistulae|fistulae
5368406|NCT00161967|tick-borne encephalitis|tick-borne encephalitis
5368407|NCT00161954|Tick-Borne Encephalitis|tick-borne encephalitis
5368408|NCT00161941|Meningococcal Vaccine|meningococcal vaccine
5368409|NCT00161941|Meningococcal Meningitis, Serogroup C|meningococcal meningitis, serogroup c
5368410|NCT00161941|Neisseria Meningitidis|neisseria meningitidis
5368411|NCT00161928|Meningococcal Vaccine|meningococcal vaccine
5368412|NCT00161928|Meningococcal Meningitis, Serogroup C|meningococcal meningitis, serogroup c
5368413|NCT00161928|Neisseria Meningitidis|neisseria meningitidis
5368414|NCT00161915|Liver cirrhosis|liver cirrhosis
5368415|NCT00161902|Arthroplasty|arthroplasty
5368416|NCT00161902|Hip Prosthesis|hip prosthesis
5368417|NCT00161902|Cement Free Hip Prosthesis|cement free hip prosthesis
5368418|NCT00161902|Femur Head Necrosis|femur head necrosis
5368419|NCT00161902|Coxarthrosis|coxarthrosis
5368420|NCT00161876|tick-borne encephalitis|tick-borne encephalitis
5368421|NCT00161837|Influenza|influenza
5368422|NCT00161837|Vaccine|vaccine
5368423|NCT00161746|Tick-Borne Encephalitis|tick-borne encephalitis
5368424|NCT00161733|Cardiopulmonary bypass|cardiopulmonary bypass
5368425|NCT00161733|Median sternotomy|median sternotomy
5368426|NCT00161733|Fibrin sealant|fibrin sealant
5368427|NCT00161733|Clot|clot
5368428|NCT00161733|Cardiac surgery|cardiac surgery
5368429|NCT00161720|Severe Congenital Protein C Deficiency|severe congenital protein c deficiency
5368430|NCT00161694|pain control|pain control
5368431|NCT00161681|Levonorgestrel|levonorgestrel
5368432|NCT00161681|ethinyl estradiol|ethinyl estradiol
5368433|NCT00161681|premenstrual syndrome|premenstrual syndrome
5368434|NCT00161681|menstrual cycle related symptoms|menstrual cycle related symptoms
5368435|NCT00161668|Leukemia|leukemia
5368436|NCT00161655|Psoriasis|psoriasis
5368437|NCT00161655|Arthritis|arthritis
5368438|NCT00161642|Malignant Tumors|malignant tumors
5368439|NCT00161629|Distal Radius Fractures|distal radius fractures
5368440|NCT00161616|Open Diaphyseal Tibia Fractures|open diaphyseal tibia fractures
5368441|NCT00161603|Angioplasty|angioplasty
5368442|NCT00161603|Behavior change|behavior change
5368443|NCT00161603|Physical activity|physical activity
5368444|NCT00161603|Risk reduction|risk reduction
5368445|NCT00161590|NK cell lymphoma|nk cell lymphoma
5368446|NCT00161590|Null cell lymphoma|null cell lymphoma
5368447|NCT00161577|Ketorolac|ketorolac
5368448|NCT00161564|Idiopathic Thrombocytopenic Purpura|idiopathic thrombocytopenic purpura
5368449|NCT00161564|ITP|itp
5368450|NCT00161564|Non-Malignant Hematology|non-malignant hematology
5368451|NCT00161551|Cardiac Pacing, artificial|cardiac pacing, artificial
5368452|NCT00161551|Atrial Fibrillation|atrial fibrillation
5368453|NCT00161551|Heart Failure|heart failure
5368454|NCT00161551|Pacemaker leads|pacemaker leads
5368455|NCT00161551|Pacing Mode|pacing mode
5368456|NCT00161538|Cardiac Pacing, artificial|cardiac pacing, artificial
5368457|NCT00161538|Atrial fibrillation|atrial fibrillation
5368458|NCT00161538|Pacemaker leads|pacemaker leads
5368459|NCT00161538|Lead positions|lead positions
5368460|NCT00161525|Subretinal Hemorrhage, Perfluorocarbon gas|subretinal hemorrhage, perfluorocarbon gas
5368461|NCT00161486|Male contraception|male contraception
5368462|NCT00161486|Prostate|prostate
5368463|NCT00161486|Acyline|acyline
5368464|NCT00161486|Androgen replacement|androgen replacement
5368465|NCT00161473|double-blind|double-blind
5368466|NCT00161473|treatment|treatment
5368467|NCT00161473|prazosin|prazosin
5368468|NCT00161460|Colorectal cancer|colorectal cancer
5368469|NCT00161460|Mass screening|mass screening
5368470|NCT00161447|Male contraception|male contraception
5368471|NCT00161447|testosterone|testosterone
5368472|NCT00161447|acyline|acyline
5368473|NCT00161434|HIV-1|hiv-1
5368474|NCT00161421|Male Contraception|male contraception
5368475|NCT00161421|Testosterone|testosterone
5368476|NCT00161421|Hypogonadism|hypogonadism
5368477|NCT00161408|schizophrenia, first episode, cognitive behavioural therapy, psychoeducation|schizophrenia, first episode, cognitive behavioural therapy, psychoeducation
5368478|NCT00161395|fertility|fertility
5368479|NCT00161395|pregnancy|pregnancy
5368480|NCT00161382|HIV Seronegativity|hiv seronegativity
5368481|NCT00161382|HIV|hiv
5368482|NCT00161369|homocysteine|homocysteine
5368483|NCT00161369|asymmetric dimethylarginine|asymmetric dimethylarginine
5368484|NCT00161369|atherosclerosis|atherosclerosis
5368485|NCT00161369|cardiovascular event|cardiovascular event
5368486|NCT00161369|hemodialysis|hemodialysis
5368487|NCT00161343|HIV|hiv
5368488|NCT00161343|Prevention Intervention|prevention intervention
5368489|NCT00161343|Female|female
5368490|NCT00161343|Adolescents|adolescents
5368491|NCT00161343|STD|std
5368492|NCT00161343|HIV Seronegativity|hiv seronegativity
5368493|NCT00161330|urinary tract infection,|urinary tract infection,
5368494|NCT00161330|antibiotic treatment|antibiotic treatment
5368495|NCT00161330|childhood|childhood
5368496|NCT00161330|amoxicilline/clavulanic acid|amoxicilline/clavulanic acid
5368497|NCT00161330|ceftriaxone|ceftriaxone
5368498|NCT00161330|renal ultrasonography|renal ultrasonography
5368499|NCT00161330|renal scintigraphy|renal scintigraphy
5368500|NCT00161291|Carcinoma of the breast|carcinoma of the breast
5368501|NCT00161291|Breast cancer|breast cancer
5368502|NCT00161252|Prostate Cancer|prostate cancer
5368503|NCT00161239|T-Cell Lymphomas|t-cell lymphomas
5368504|NCT00161226|endometrial cancer|endometrial cancer
5368505|NCT00161213|recurrent pancreatic cancer|recurrent pancreatic cancer
5368506|NCT00161213|stage IV pancreatic cancer|stage iv pancreatic cancer
5368507|NCT00161213|stage III pancreatic cancer|stage iii pancreatic cancer
5368508|NCT00161213|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
5368509|NCT00161213|stage II pancreatic cancer|stage ii pancreatic cancer
5368510|NCT00161200|Esophageal Metaplasia|esophageal metaplasia
5368511|NCT00161187|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5369176|NCT00158834|Children|children
5368512|NCT00161187|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5368513|NCT00161187|prolymphocytic leukemia|prolymphocytic leukemia
5368514|NCT00161187|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5368515|NCT00161187|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5368516|NCT00161187|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5368517|NCT00161187|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5368518|NCT00161187|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5368519|NCT00161187|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5368520|NCT00161187|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5368521|NCT00161187|stage I multiple myeloma|stage i multiple myeloma
5368522|NCT00161187|stage II multiple myeloma|stage ii multiple myeloma
5368523|NCT00161187|stage III multiple myeloma|stage iii multiple myeloma
5368524|NCT00161187|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5368525|NCT00161187|childhood diffuse large cell lymphoma|childhood diffuse large cell lymphoma
5368526|NCT00161187|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5368527|NCT00161187|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5368528|NCT00161187|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
5368529|NCT00161187|recurrent childhood grade III lymphomatoid granulomatosis|recurrent childhood grade iii lymphomatoid granulomatosis
5368530|NCT00161187|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
5368531|NCT00161187|childhood nasal type extranodal NK/T-cell lymphoma|childhood nasal type extranodal nk/t-cell lymphoma
5368532|NCT00161187|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5368533|NCT00161187|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5368534|NCT00161187|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
5368535|NCT00161187|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
5368536|NCT00161187|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5368537|NCT00161187|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
5368538|NCT00161187|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5368539|NCT00161187|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5368540|NCT00161187|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
5368541|NCT00161187|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5368542|NCT00161187|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5368543|NCT00161187|recurrent renal cell cancer|recurrent renal cell cancer
5368544|NCT00161187|stage IV renal cell cancer|stage iv renal cell cancer
5368545|NCT00161187|recurrent bladder cancer|recurrent bladder cancer
5368546|NCT00161187|stage IV bladder cancer|stage iv bladder cancer
5368547|NCT00161187|recurrent prostate cancer|recurrent prostate cancer
5368548|NCT00161187|stage IV prostate cancer|stage iv prostate cancer
5368549|NCT00161187|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
5368550|NCT00161187|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
5368551|NCT00161187|recurrent gastric cancer|recurrent gastric cancer
5368552|NCT00161187|stage IV gastric cancer|stage iv gastric cancer
5368553|NCT00161187|recurrent pancreatic cancer|recurrent pancreatic cancer
5368554|NCT00161187|stage IV pancreatic cancer|stage iv pancreatic cancer
5368555|NCT00161187|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
5368556|NCT00161187|recurrent adult primary liver cancer|recurrent adult primary liver cancer
5368557|NCT00161187|recurrent childhood liver cancer|recurrent childhood liver cancer
5368558|NCT00161187|recurrent colon cancer|recurrent colon cancer
5368559|NCT00161187|stage IV colon cancer|stage iv colon cancer
5368560|NCT00161187|recurrent rectal cancer|recurrent rectal cancer
5368561|NCT00161187|stage IV rectal cancer|stage iv rectal cancer
5368562|NCT00161187|recurrent breast cancer|recurrent breast cancer
5368563|NCT00161187|stage IV breast cancer|stage iv breast cancer
5368564|NCT00161187|extensive stage small cell lung cancer|extensive stage small cell lung cancer
5368565|NCT00161187|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5368566|NCT00161187|recurrent small cell lung cancer|recurrent small cell lung cancer
5368567|NCT00161187|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5368568|NCT00161187|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5368569|NCT00161187|recurrent cervical cancer|recurrent cervical cancer
5368570|NCT00161187|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
5368571|NCT00161187|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
5368572|NCT00161187|chondrosarcoma|chondrosarcoma
5368573|NCT00161187|recurrent osteosarcoma|recurrent osteosarcoma
5368574|NCT00161187|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
5368575|NCT00161187|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
5368576|NCT00161187|ovarian sarcoma|ovarian sarcoma
5368577|NCT00161187|recurrent uterine sarcoma|recurrent uterine sarcoma
5368578|NCT00161187|stage IV uterine sarcoma|stage iv uterine sarcoma
5368579|NCT00161187|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
5368580|NCT00161187|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
5368581|NCT00161187|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
5368582|NCT00161187|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5368583|NCT00161187|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5368584|NCT00161187|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5368585|NCT00161187|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5368586|NCT00161187|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
5368587|NCT00161187|stage I childhood large cell lymphoma|stage i childhood large cell lymphoma
5368588|NCT00161187|stage II childhood large cell lymphoma|stage ii childhood large cell lymphoma
5368589|NCT00161187|stage III childhood large cell lymphoma|stage iii childhood large cell lymphoma
5368590|NCT00161187|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
5368591|NCT00161187|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
5368592|NCT00161187|advanced adult primary liver cancer|advanced adult primary liver cancer
5368593|NCT00161187|ovarian stromal cancer|ovarian stromal cancer
5368594|NCT00161187|stage IA cervical cancer|stage ia cervical cancer
5368595|NCT00161187|stage IB cervical cancer|stage ib cervical cancer
5368596|NCT00161187|stage IIA cervical cancer|stage iia cervical cancer
5368597|NCT00161187|stage IIB cervical cancer|stage iib cervical cancer
5368598|NCT00161187|stage III cervical cancer|stage iii cervical cancer
5368599|NCT00161187|stage IVA cervical cancer|stage iva cervical cancer
5368600|NCT00161187|stage IVB cervical cancer|stage ivb cervical cancer
5368601|NCT00161187|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5368602|NCT00161187|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
5368603|NCT00161187|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5368604|NCT00161187|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
5368605|NCT00161187|recurrent endometrial carcinoma|recurrent endometrial carcinoma
5368606|NCT00161187|stage I endometrial carcinoma|stage i endometrial carcinoma
5368607|NCT00161187|stage II endometrial carcinoma|stage ii endometrial carcinoma
5368608|NCT00161187|stage III endometrial carcinoma|stage iii endometrial carcinoma
5368609|NCT00161187|stage IV endometrial carcinoma|stage iv endometrial carcinoma
5368610|NCT00161187|childhood hepatocellular carcinoma|childhood hepatocellular carcinoma
5368611|NCT00161187|stage III childhood liver cancer|stage iii childhood liver cancer
5368612|NCT00161187|stage IV childhood liver cancer|stage iv childhood liver cancer
5368613|NCT00161187|previously untreated childhood rhabdomyosarcoma|previously untreated childhood rhabdomyosarcoma
5368614|NCT00161187|metastatic childhood soft tissue sarcoma|metastatic childhood soft tissue sarcoma
5368615|NCT00161187|localized Ewing sarcoma/peripheral primitive neuroectodermal tumor|localized ewing sarcoma/peripheral primitive neuroectodermal tumor
5368825|NCT00160927|neuropathy|neuropathy
5368616|NCT00161187|metastatic Ewing sarcoma/peripheral primitive neuroectodermal tumor|metastatic ewing sarcoma/peripheral primitive neuroectodermal tumor
5368617|NCT00161187|recurrent Ewing sarcoma/peripheral primitive neuroectodermal tumor|recurrent ewing sarcoma/peripheral primitive neuroectodermal tumor
5368618|NCT00161187|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
5368619|NCT00161187|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
5368620|NCT00161187|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
5368621|NCT00161187|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5368622|NCT00161187|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5368623|NCT00161187|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5368624|NCT00161187|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
5368625|NCT00161187|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
5368626|NCT00161187|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
5368627|NCT00161187|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5368628|NCT00161187|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5368629|NCT00161187|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5368630|NCT00161187|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5368631|NCT00161187|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5368632|NCT00161187|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5368633|NCT00161187|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
5368634|NCT00161187|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
5368635|NCT00161187|stage I marginal zone lymphoma|stage i marginal zone lymphoma
5368636|NCT00161187|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5368637|NCT00161187|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5368638|NCT00161187|localized osteosarcoma|localized osteosarcoma
5368639|NCT00161187|metastatic osteosarcoma|metastatic osteosarcoma
5368640|NCT00161187|stage I ovarian epithelial cancer|stage i ovarian epithelial cancer
5368641|NCT00161187|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
5368642|NCT00161187|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5368643|NCT00161187|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5368644|NCT00161187|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
5368645|NCT00161187|stage I ovarian germ cell tumor|stage i ovarian germ cell tumor
5368646|NCT00161187|stage II ovarian germ cell tumor|stage ii ovarian germ cell tumor
5368647|NCT00161187|stage III ovarian germ cell tumor|stage iii ovarian germ cell tumor
5368648|NCT00161187|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
5368649|NCT00161187|limited stage small cell lung cancer|limited stage small cell lung cancer
5368650|NCT00161187|refractory multiple myeloma|refractory multiple myeloma
5368651|NCT00161187|stage II malignant testicular germ cell tumor|stage ii malignant testicular germ cell tumor
5368652|NCT00161187|stage I adult soft tissue sarcoma|stage i adult soft tissue sarcoma
5368653|NCT00161187|stage II adult soft tissue sarcoma|stage ii adult soft tissue sarcoma
5368654|NCT00161187|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
5368655|NCT00161187|stage I bladder cancer|stage i bladder cancer
5368656|NCT00161187|stage II bladder cancer|stage ii bladder cancer
5368657|NCT00161187|stage III bladder cancer|stage iii bladder cancer
5368658|NCT00161187|male breast cancer|male breast cancer
5368659|NCT00161187|stage I breast cancer|stage i breast cancer
5368660|NCT00161187|stage II breast cancer|stage ii breast cancer
5368661|NCT00161187|stage IIIA breast cancer|stage iiia breast cancer
5368662|NCT00161187|stage IIIB breast cancer|stage iiib breast cancer
5368663|NCT00161187|stage IIIC breast cancer|stage iiic breast cancer
5368664|NCT00161187|stage I colon cancer|stage i colon cancer
5368665|NCT00161187|stage II colon cancer|stage ii colon cancer
5368666|NCT00161187|stage III colon cancer|stage iii colon cancer
5368667|NCT00161187|stage I gastric cancer|stage i gastric cancer
5368668|NCT00161187|stage II gastric cancer|stage ii gastric cancer
5368669|NCT00161187|stage III gastric cancer|stage iii gastric cancer
5368670|NCT00161187|stage I non-small cell lung cancer|stage i non-small cell lung cancer
5368671|NCT00161187|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
5368672|NCT00161187|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5368673|NCT00161187|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5368674|NCT00161187|stage I pancreatic cancer|stage i pancreatic cancer
5368675|NCT00161187|stage II pancreatic cancer|stage ii pancreatic cancer
5368676|NCT00161187|stage III pancreatic cancer|stage iii pancreatic cancer
5368677|NCT00161187|stage I prostate cancer|stage i prostate cancer
5368678|NCT00161187|stage II prostate cancer|stage ii prostate cancer
5368679|NCT00161187|stage III prostate cancer|stage iii prostate cancer
5368680|NCT00161187|stage I rectal cancer|stage i rectal cancer
5368681|NCT00161187|stage II rectal cancer|stage ii rectal cancer
5368682|NCT00161187|stage III rectal cancer|stage iii rectal cancer
5368683|NCT00161187|stage I renal cell cancer|stage i renal cell cancer
5368684|NCT00161187|stage II renal cell cancer|stage ii renal cell cancer
5368685|NCT00161187|stage III renal cell cancer|stage iii renal cell cancer
5368686|NCT00161187|stage I uterine sarcoma|stage i uterine sarcoma
5368687|NCT00161187|stage II uterine sarcoma|stage ii uterine sarcoma
5368688|NCT00161187|stage III uterine sarcoma|stage iii uterine sarcoma
5368689|NCT00161187|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
5368690|NCT00161187|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
5368691|NCT00161187|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5368692|NCT00161187|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5368693|NCT00161187|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
5368694|NCT00161187|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5368695|NCT00161187|stage I mantle cell lymphoma|stage i mantle cell lymphoma
5368696|NCT00161187|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5368697|NCT00161187|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5368698|NCT00161187|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
5368699|NCT00161187|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
5368700|NCT00161187|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5368701|NCT00161187|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
5368702|NCT00161187|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5368703|NCT00161187|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5368704|NCT00161187|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
5368705|NCT00161187|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
5368706|NCT00161187|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
5368707|NCT00161187|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5368708|NCT00161187|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5368709|NCT00161187|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
5368710|NCT00161187|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
5368711|NCT00161187|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
5368712|NCT00161187|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
5368713|NCT00161187|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5368826|NCT00160927|endothelial function|endothelial function
5368714|NCT00161187|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5368715|NCT00161187|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5368716|NCT00161187|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5368717|NCT00161187|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5368801|NCT00161057|schizoaffective disorder|schizoaffective disorder
5368718|NCT00161187|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
5368719|NCT00161187|untreated childhood acute myeloid leukemia and other myeloid malignancies|untreated childhood acute myeloid leukemia and other myeloid malignancies
5368720|NCT00161187|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5368721|NCT00161187|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5368722|NCT00161187|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5368723|NCT00161187|nonmetastatic childhood soft tissue sarcoma|nonmetastatic childhood soft tissue sarcoma
5368724|NCT00161187|recurrent childhood soft tissue sarcoma|recurrent childhood soft tissue sarcoma
5368725|NCT00161187|stage I childhood Hodgkin lymphoma|stage i childhood hodgkin lymphoma
5368726|NCT00161187|stage II childhood Hodgkin lymphoma|stage ii childhood hodgkin lymphoma
5368727|NCT00161187|stage III childhood Hodgkin lymphoma|stage iii childhood hodgkin lymphoma
5368728|NCT00161187|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
5368729|NCT00161187|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
5368730|NCT00161187|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
5368731|NCT00161187|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5368732|NCT00161187|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5368733|NCT00161187|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
5368734|NCT00161187|stage I childhood small noncleaved cell lymphoma|stage i childhood small noncleaved cell lymphoma
5368735|NCT00161187|stage II childhood small noncleaved cell lymphoma|stage ii childhood small noncleaved cell lymphoma
5368736|NCT00161187|stage III childhood small noncleaved cell lymphoma|stage iii childhood small noncleaved cell lymphoma
5368737|NCT00161187|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
5368738|NCT00161187|Burkitt lymphoma|burkitt lymphoma
5368739|NCT00161187|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
5368740|NCT00161187|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
5368741|NCT00161187|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
5368742|NCT00161187|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
5368743|NCT00161187|stage I malignant testicular germ cell tumor|stage i malignant testicular germ cell tumor
5368744|NCT00161187|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
5368745|NCT00161187|childhood renal cell carcinoma|childhood renal cell carcinoma
5368746|NCT00161187|stage IA melanoma|stage ia melanoma
5368747|NCT00161187|stage IB melanoma|stage ib melanoma
5368748|NCT00161187|stage IIA melanoma|stage iia melanoma
5368749|NCT00161187|stage IIB melanoma|stage iib melanoma
5368750|NCT00161187|stage IIC melanoma|stage iic melanoma
5368751|NCT00161187|stage IIIA melanoma|stage iiia melanoma
5368752|NCT00161187|stage IIIB melanoma|stage iiib melanoma
5368753|NCT00161187|stage IIIC melanoma|stage iiic melanoma
5368754|NCT00161187|stage IV melanoma|stage iv melanoma
5368755|NCT00161187|recurrent melanoma|recurrent melanoma
5368756|NCT00161174|testicular cancer|testicular cancer
5368757|NCT00161174|cardiovascular morbidity|cardiovascular morbidity
5368758|NCT00161174|cardiovascular risk factors|cardiovascular risk factors
5368759|NCT00161174|pharmacogenomic determinants|pharmacogenomic determinants
5368760|NCT00161161|ADHD; MRI; genetics|adhd; mri; genetics
5368761|NCT00161148|PSC|psc
5368762|NCT00161148|Liver biochemistry|liver biochemistry
5368763|NCT00161148|Probiotics|probiotics
5368764|NCT00161148|Pruritus|pruritus
5368765|NCT00161135|MRI|mri
5368766|NCT00161135|PDD-NOS, MCDD|pdd-nos, mcdd
5368767|NCT00161109|22q11.2 deletion syndrome|22q11.2 deletion syndrome
5368768|NCT00161109|Psychopathology|psychopathology
5368769|NCT00161109|Psychiatry|psychiatry
5368770|NCT00161109|Neuropsychology|neuropsychology
5368771|NCT00161109|Psychiophysiology|psychiophysiology
5368772|NCT00161109|Autism|autism
5368773|NCT00161109|Psychosis|psychosis
5368774|NCT00161109|Deletion size|deletion size
5368775|NCT00161109|Candidate genes|candidate genes
5368776|NCT00161109|Psychiatric symptoms|psychiatric symptoms
5368777|NCT00161109|Neuropsychological impairments|neuropsychological impairments
5368778|NCT00161109|Psychophysiological performance|psychophysiological performance
5368779|NCT00161096|on-demand therapy|on-demand therapy
5368780|NCT00161096|pantoprazole|pantoprazole
5368781|NCT00161096|gastro-oesophageal reflux disease|gastro-oesophageal reflux disease
5368782|NCT00161096|proton pump inhibitor|proton pump inhibitor
5368783|NCT00161096|acid suppression|acid suppression
5368784|NCT00161096|intermittent|intermittent
5368785|NCT00161083|ursodeoxycholic acid|ursodeoxycholic acid
5368786|NCT00161083|gallstone|gallstone
5368787|NCT00161083|complications|complications
5368788|NCT00161083|pancreatitis|pancreatitis
5368789|NCT00161083|gallbladder motility|gallbladder motility
5368790|NCT00161083|colic|colic
5368791|NCT00161070|secondary prevention|secondary prevention
5368792|NCT00161070|TIA / minor stroke|tia / minor stroke
5368793|NCT00161070|atherosclerotic origin|atherosclerotic origin
5368794|NCT00161070|TIA (Transient Ischemic Attack)|tia (transient ischemic attack)
5368795|NCT00161070|prevention & control|prevention & control
5368796|NCT00161057|Schizophrenia|schizophrenia
5368797|NCT00161057|Medication-naive|medication-naive
5368798|NCT00161057|Functional MRI|functional mri
5368799|NCT00161057|Working memory|working memory
5368800|NCT00161057|Language lateralization|language lateralization
5368802|NCT00161057|psychotic disorder Not Otherwise Specified|psychotic disorder not otherwise specified
5368803|NCT00161005|Acute myocardial infarction|acute myocardial infarction
5368804|NCT00161005|Fibrinolysis|fibrinolysis
5368805|NCT00161005|Health effects /Quality of life|health effects /quality of life
5368806|NCT00160992|Adoptive cell transfer|adoptive cell transfer
5368807|NCT00160992|peptide vaccination|peptide vaccination
5368808|NCT00160992|melanoma|melanoma
5368809|NCT00160992|immunosuppression and homeostatic proliferation|immunosuppression and homeostatic proliferation
5368810|NCT00160966|kidney transplantation|kidney transplantation
5368811|NCT00160966|polyoma virus associated transplant nephropathy|polyoma virus associated transplant nephropathy
5368812|NCT00160966|tacrolimus|tacrolimus
5368813|NCT00160966|mycophenolate mofetil|mycophenolate mofetil
5368814|NCT00160966|everolimus|everolimus
5368815|NCT00160966|cyclosporin A|cyclosporin a
5368816|NCT00160966|BK virus PCR|bk virus pcr
5368817|NCT00160966|viruria screening|viruria screening
5368818|NCT00160966|BK polyomavirus|bk polyomavirus
5368819|NCT00160966|immunosuppression|immunosuppression
5368820|NCT00160940|gene expression|gene expression
5368821|NCT00160940|viral hepatitis|viral hepatitis
5368822|NCT00160940|autoimmune disease|autoimmune disease
5368823|NCT00160927|microcirculation|microcirculation
5368824|NCT00160927|Laser doppler flowmetry|laser doppler flowmetry
5368827|NCT00160914|Childhood obesity|childhood obesity
5368828|NCT00160901|Breast cancer|breast cancer
5368829|NCT00160901|Chemotherapy|chemotherapy
5368830|NCT00160901|Phytotherapy|phytotherapy
5368831|NCT00160901|Nutritional counseling|nutritional counseling
5368832|NCT00160875|esophageal|esophageal
5368833|NCT00160875|esophagus|esophagus
5368834|NCT00160875|irinotecan|irinotecan
5368835|NCT00160875|CPT11|cpt11
5368836|NCT00160875|cisplatin|cisplatin
5368837|NCT00160849|Treatment Experienced|treatment experienced
5368838|NCT00160836|Tissue diagnosis|tissue diagnosis
5368839|NCT00160823|Colon cleansing|colon cleansing
5368840|NCT00160823|Quality|quality
5368841|NCT00160823|Cost-effectiveness|cost-effectiveness
5368842|NCT00160810|distal|distal
5368843|NCT00160810|radius|radius
5368844|NCT00160810|fractures|fractures
5368845|NCT00160745|endothelium, NO, renal, statins|endothelium, no, renal, statins
5368846|NCT00160732|Islet Cell Transplant|islet cell transplant
5368847|NCT00160732|Human islet cell infusion|human islet cell infusion
5368848|NCT00160732|Juvenile-onset diabetes|juvenile-onset diabetes
5368849|NCT00160693|Rheumatoid Arthritis|rheumatoid arthritis
5368850|NCT00160693|America College of Rheumatology|america college of rheumatology
5368851|NCT00160693|Disease modifying anti-rheumatic drug|disease modifying anti-rheumatic drug
5368852|NCT00160693|Certolizumab Pegol (CDP870)|certolizumab pegol (cdp870)
5368853|NCT00160680|Persistent Allergic Rhinitis, HDM, Parietaria, sneezing, rhinorrhea, ocular pruritus, Rhinasthma, inflammatory cells, ICAM-1, ATAREAL, Xyzal, Levocetirizine|persistent allergic rhinitis, hdm, parietaria, sneezing, rhinorrhea, ocular pruritus, rhinasthma, inflammatory cells, icam-1, atareal, xyzal, levocetirizine
5368854|NCT00160667|Post-herpetic Neuralgia (PHN)|post-herpetic neuralgia (phn)
5368855|NCT00160667|Brivaracetam|brivaracetam
5368856|NCT00160654|Epilepsy|epilepsy
5368857|NCT00160654|Partial Onset Seizures|partial onset seizures
5368858|NCT00160654|Keppra|keppra
5368859|NCT00160654|Levetiracetam|levetiracetam
5368860|NCT00160641|Rheumatoid Arthritis|rheumatoid arthritis
5368861|NCT00160641|CDP870|cdp870
5368862|NCT00160641|Certolizumab Pegol|certolizumab pegol
5368863|NCT00160641|Cimzia|cimzia
5368864|NCT00160628|Epilepsy|epilepsy
5368865|NCT00160628|Partial Onset Seizures|partial onset seizures
5368866|NCT00160628|Keppra|keppra
5368867|NCT00160628|Levetiracetam|levetiracetam
5368868|NCT00160615|Epilepsy, Partial,|epilepsy, partial,
5368869|NCT00160615|Keppra, levetiracetam|keppra, levetiracetam
5368870|NCT00160602|Rheumatoid Arthritis|rheumatoid arthritis
5368871|NCT00160602|Certolizumab Pegol, Cimzia|certolizumab pegol, cimzia
5368872|NCT00160589|Allergic Rhinits, Symptoms (sneezing, rhinorrhea, nasal/ocular pruritus, nasal congestion), LEADER, Xyzal, Levocetirizine|allergic rhinits, symptoms (sneezing, rhinorrhea, nasal/ocular pruritus, nasal congestion), leader, xyzal, levocetirizine
5368873|NCT00160576|Idiopathic Parkinson's Disease, levodopa induced dyskinesia,|idiopathic parkinson's disease, levodopa induced dyskinesia,
5368874|NCT00160576|Levetiracetam, Keppra|levetiracetam, keppra
5368875|NCT00160563|Pediatry|pediatry
5368876|NCT00160563|EPAAC|epaac
5368877|NCT00160563|atopic Children|atopic children
5368878|NCT00160563|prevention of asthma|prevention of asthma
5368879|NCT00160563|Levocetirizine|levocetirizine
5368880|NCT00160563|Xyzal|xyzal
5368881|NCT00160550|Idiopathic Generalized Epilepsy, tonic-clonic seizures|idiopathic generalized epilepsy, tonic-clonic seizures
5368882|NCT00160550|Levetiracetam, Keppra|levetiracetam, keppra
5368883|NCT00160537|Seasonal Allergic Rhinitis (SAR), Grass pollen, SAR Symptoms (sneezing, rhinorrhea, nasal / ocular pruritus, nasal congestion)|seasonal allergic rhinitis (sar), grass pollen, sar symptoms (sneezing, rhinorrhea, nasal / ocular pruritus, nasal congestion)
5368884|NCT00160537|POPULAR, Xyzal, Levocetirizine|popular, xyzal, levocetirizine
5368885|NCT00160524|Certolizumab Pegol|certolizumab pegol
5368886|NCT00160524|Cimzia|cimzia
5368887|NCT00160524|CDP870|cdp870
5368888|NCT00160524|CZP|czp
5368889|NCT00160511|Postherpetic Neuralgia (PHN)|postherpetic neuralgia (phn)
5368890|NCT00160511|Levetiracetam|levetiracetam
5368891|NCT00160511|Keppra|keppra
5368893|NCT00160498|Lercanidipine, calcium antagonist, hypertension, obesity|lercanidipine, calcium antagonist, hypertension, obesity
5368894|NCT00160485|Gestational Diabetes|gestational diabetes
5368895|NCT00160485|Pregnancy|pregnancy
5368896|NCT00160485|Glyburide|glyburide
5368897|NCT00160485|Insulin|insulin
5368898|NCT00160472|vasopressin|vasopressin
5368899|NCT00160472|ovarian|ovarian
5368900|NCT00160472|neoplasm|neoplasm
5368901|NCT00160459|Fibroid Uterus|fibroid uterus
5368902|NCT00160459|Leiomyoma|leiomyoma
5368903|NCT00160459|Uterine Fibroids|uterine fibroids
5368904|NCT00160459|asoprisnil|asoprisnil
5368905|NCT00160446|Pelvic pain|pelvic pain
5368906|NCT00160446|Dysmenorrhea|dysmenorrhea
5368907|NCT00160446|Dyspareunia|dyspareunia
5368908|NCT00160446|Infertility|infertility
5368909|NCT00160446|Asoprisnil|asoprisnil
5368910|NCT00160433|Pelvic pain|pelvic pain
5368911|NCT00160433|Dysmenorrhea|dysmenorrhea
5368912|NCT00160433|Dyspareunia|dyspareunia
5368913|NCT00160433|Infertility|infertility
5368914|NCT00160433|asoprisnil|asoprisnil
5368915|NCT00160420|Pelvic pain|pelvic pain
5368916|NCT00160420|Dysmenorrhea|dysmenorrhea
5368917|NCT00160420|Dyspareunia|dyspareunia
5368918|NCT00160420|Infertility|infertility
5368919|NCT00160420|asoprisnil|asoprisnil
5368920|NCT00160407|nonalcoholic steatohepatitis|nonalcoholic steatohepatitis
5368921|NCT00160407|enzyme inhibitors|enzyme inhibitors
5368922|NCT00160407|lipase|lipase
5368923|NCT00160407|obesity|obesity
5368924|NCT00160407|insulin resistance|insulin resistance
5368925|NCT00160394|Mild to Moderate|mild to moderate
5368926|NCT00160381|Symptomatic Uterine Fibroids|symptomatic uterine fibroids
5368927|NCT00160381|Excessive Uterine Bleeding|excessive uterine bleeding
5368928|NCT00160381|Uterine Hemorrhage|uterine hemorrhage
5368929|NCT00160381|asoprisnil|asoprisnil
5368930|NCT00160368|Hypertension, potassium salts|hypertension, potassium salts
5368931|NCT00160355|Wiskott-Aldrich Syndrome|wiskott-aldrich syndrome
5368932|NCT00160355|Immunodeficiency|immunodeficiency
5368933|NCT00160355|Haploidentical transplantation|haploidentical transplantation
5368934|NCT00160342|Hormone replacement therapy, hot flushes, postmenopause|hormone replacement therapy, hot flushes, postmenopause
5368935|NCT00160303|Prolotherapy|prolotherapy
5368936|NCT00160303|Lateral Epicondylitis|lateral epicondylitis
5368937|NCT00160303|Tennis Elbow|tennis elbow
5368938|NCT00160303|Corticosteroid Therapy|corticosteroid therapy
5368939|NCT00160290|lactulose|lactulose
5368940|NCT00160290|randomised clinical trial|randomised clinical trial
5368941|NCT00160290|hemorrhoids|hemorrhoids
5368942|NCT00160290|anal fissures|anal fissures
5368943|NCT00160277|Efficacy and safety of moxonidine in Indian hypertensives|efficacy and safety of moxonidine in indian hypertensives
5368944|NCT00160264|lactulose; randomised clinical trial; osteopenia; postmenopause|lactulose; randomised clinical trial; osteopenia; postmenopause
5368945|NCT00160251|PEG-Intron|peg-intron
5368946|NCT00160251|Ribavirin|ribavirin
5368947|NCT00160251|Protease Inhibitor|protease inhibitor
5368948|NCT00160238|Meniere's disease|meniere's disease
5368949|NCT00160238|Vestibular neurotomy|vestibular neurotomy
5368950|NCT00160225|blood pressure, diabetic nephropathy, proteinuria|blood pressure, diabetic nephropathy, proteinuria
5368951|NCT00160212|blood pressure|blood pressure
5368952|NCT00160199|To collect additional data on 300 and 400 mg doses of PROMETRIUM in women with secondary amenorrhea|to collect additional data on 300 and 400 mg doses of prometrium in women with secondary amenorrhea
5368953|NCT00160173|Post menopausal vasomotor symptoms|post menopausal vasomotor symptoms
5368954|NCT00160160|comparator trial|comparator trial
5368955|NCT00160160|hypertension|hypertension
5368956|NCT00160160|diabetes|diabetes
5368957|NCT00160160|blood pressure|blood pressure
5368958|NCT00160134|congestive heart failure, adenosine receptor blocker, cardiac hemodynamic|congestive heart failure, adenosine receptor blocker, cardiac hemodynamic
5368959|NCT00160095|larynx carcinoma|larynx carcinoma
5368960|NCT00160095|Tumor hypoxia|tumor hypoxia
5368961|NCT00160095|microregional imaging|microregional imaging
5368962|NCT00160095|hypoxia modifying treatment|hypoxia modifying treatment
5368963|NCT00160082|Post Polio Syndrome|post polio syndrome
5368964|NCT00160082|PPS|pps
5368965|NCT00160082|Poliomyelitis|poliomyelitis
5368966|NCT00160082|Paralylic Polio|paralylic polio
5368967|NCT00160082|Late effects of polio|late effects of polio
5368968|NCT00160082|Late onset polio sequele|late onset polio sequele
5368969|NCT00160082|Xepol|xepol
5368970|NCT00160082|IvIg|ivig
5368971|NCT00160082|Intravenous Immunoglobuline|intravenous immunoglobuline
5368972|NCT00160069|Stage IIIB or stage IV non-small-cell lung cancer.|stage iiib or stage iv non-small-cell lung cancer.
5368973|NCT00160056|Hypoglycemia unawareness|hypoglycemia unawareness
5368974|NCT00160056|Diabetes|diabetes
5368975|NCT00160056|adrenal receptor|adrenal receptor
5368976|NCT00160056|adrenerg respons|adrenerg respons
5368977|NCT00160056|adrenergic beta-agonists|adrenergic beta-agonists
5368978|NCT00160056|salbutamol|salbutamol
5368979|NCT00160017|Quality assurance health care|quality assurance health care
5368980|NCT00160017|Diabetes|diabetes
5368981|NCT00160017|Breakthrough collaborative (IHI)|breakthrough collaborative (ihi)
5368982|NCT00160017|Evaluation|evaluation
5368983|NCT00160004|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
5368984|NCT00160004|Exercise|exercise
5368985|NCT00160004|Fatigue|fatigue
5368986|NCT00160004|Quality-of-life|quality-of-life
5368987|NCT00159991|Coronary artery bypass grafting|coronary artery bypass grafting
5368988|NCT00159991|Total arterial revascularization|total arterial revascularization
5368989|NCT00159991|Internal mammary artery grafting|internal mammary artery grafting
5368990|NCT00159991|Radial artery grafting|radial artery grafting
5368991|NCT00159978|head and neck cancer|head and neck cancer
5368992|NCT00159978|hypoxia|hypoxia
5368993|NCT00159978|tumor cell proliferation|tumor cell proliferation
5368994|NCT00159978|PET|pet
5368995|NCT00159965|nonepileptic seizure|nonepileptic seizure
5368996|NCT00159965|pseudoseizure|pseudoseizure
5368997|NCT00159965|conversion disorder|conversion disorder
5368998|NCT00159965|psychogenic|psychogenic
5368999|NCT00159965|Depression|depression
5369000|NCT00159965|Anxiety|anxiety
5369001|NCT00159965|Abuse|abuse
5369002|NCT00159965|post-traumatic stress disorder|post-traumatic stress disorder
5369003|NCT00159965|sertraline|sertraline
5369004|NCT00159965|serotonin|serotonin
5369005|NCT00159965|randomized controlled trial|randomized controlled trial
5369006|NCT00159952|Sepsis|sepsis
5369007|NCT00159952|Septic shock|septic shock
5369008|NCT00159952|Hyperglycemia|hyperglycemia
5369009|NCT00159952|Fibrinolysis|fibrinolysis
5369010|NCT00159952|PAI 1|pai 1
5369011|NCT00159939|ARDS|ards
5369012|NCT00159939|prone position|prone position
5369013|NCT00159926|systemic inflammatory response syndrome|systemic inflammatory response syndrome
5369014|NCT00159926|coronary artery bypass grafting|coronary artery bypass grafting
5369015|NCT00159926|cell saver|cell saver
5369016|NCT00159926|interleukins|interleukins
5369017|NCT00159926|tumor necrosis factor alfa|tumor necrosis factor alfa
5369018|NCT00159900|Impotence|impotence
5369019|NCT00159874|children|children
5369020|NCT00159627|heart failure, congestive|heart failure, congestive
5369021|NCT00159627|diuretic|diuretic
5369022|NCT00159614|renal insufficiency|renal insufficiency
5369023|NCT00159614|diuretic|diuretic
5369024|NCT00159614|heart failure, congestive|heart failure, congestive
5369025|NCT00159601|Quality of Life|quality of life
5369026|NCT00159601|Mental health|mental health
5369027|NCT00159601|Children|children
5369028|NCT00159601|Adolescents|adolescents
5369029|NCT00159601|Normal population|normal population
5369030|NCT00159588|Medication-overuse headache|medication-overuse headache
5369031|NCT00159588|preventative medication|preventative medication
5369032|NCT00159588|controls|controls
5369033|NCT00159588|follow-up|follow-up
5369034|NCT00159588|randomized|randomized
5369035|NCT00159588|abrupt withdrawal|abrupt withdrawal
5369036|NCT00159575|Polycystic ovarian syndrome|polycystic ovarian syndrome
5369037|NCT00159575|Clinical pregnancy rate|clinical pregnancy rate
5369038|NCT00159575|Oligo- or anovulation|oligo- or anovulation
5369039|NCT00159562|Bipolar Disorder|bipolar disorder
5369040|NCT00159562|Psycho-education|psycho-education
5369041|NCT00159549|Patient education|patient education
5369042|NCT00159536|PCOS|pcos
5369043|NCT00159536|metformin|metformin
5369044|NCT00159536|pregnancy|pregnancy
5369045|NCT00159536|preeclampsia|preeclampsia
5369046|NCT00159536|diabetes|diabetes
5369047|NCT00159536|preterm delivery|preterm delivery
5369048|NCT00159523|Prevention|prevention
5369049|NCT00159523|Probiotics|probiotics
5369050|NCT00159523|Allergy|allergy
5369051|NCT00159523|Hypersensitivity|hypersensitivity
5369052|NCT00159510|sepsis, methylene blue, nitric oxide, acute lung injury|sepsis, methylene blue, nitric oxide, acute lung injury
5369053|NCT00159497|THA|tha
5369054|NCT00159484|phase 1|phase 1
5369055|NCT00159484|phase one|phase one
5369056|NCT00159484|phase I|phase i
5369057|NCT00159432|colorectal|colorectal
5369058|NCT00159432|cancer|cancer
5369059|NCT00159419|Osteogenesis Imperfecta|osteogenesis imperfecta
5369060|NCT00159419|Fractures|fractures
5369061|NCT00159419|Pediatric|pediatric
5369062|NCT00159419|Osteoporosis|osteoporosis
5369063|NCT00159419|Juvenile Pagets|juvenile pagets
5369064|NCT00159406|BPH treatment|bph treatment
5369065|NCT00159406|Laser Prostatectomy|laser prostatectomy
5369066|NCT00159406|Treatment of enlarged Prostates|treatment of enlarged prostates
5369067|NCT00159406|BPH|bph
5369068|NCT00159393|Kidney stones|kidney stones
5369069|NCT00159393|nephrolithotripsy percutaneous|nephrolithotripsy percutaneous
5369070|NCT00159380|Healthy Volunteers|healthy volunteers
5369071|NCT00159367|Neuromuscular electrical stimulation|neuromuscular electrical stimulation
5369072|NCT00159354|FDG−PET|fdg−pet
5369073|NCT00159354|pulmonary inflammation,|pulmonary inflammation,
5369074|NCT00159354|smoking,|smoking,
5369075|NCT00159354|COPD|copd
5369076|NCT00159354|steroid intervention|steroid intervention
5369077|NCT00159341|cigarette smoke|cigarette smoke
5369078|NCT00159341|nasal|nasal
5369079|NCT00159341|whole blood|whole blood
5369080|NCT00159341|cytokines|cytokines
5369081|NCT00159341|chemokines|chemokines
5369082|NCT00159341|nasal fluid|nasal fluid
5369083|NCT00159341|filter paper|filter paper
5369084|NCT00159328|Magnetic Resonance Guided Focused Ultrasound|magnetic resonance guided focused ultrasound
5369085|NCT00159328|Gonadotrophin Releasing Hormone Agonist|gonadotrophin releasing hormone agonist
5369086|NCT00159328|Uterine Fibroids|uterine fibroids
5369177|NCT00158834|Asthma|asthma
5369087|NCT00159315|Healthy Volunteers (smokers)|healthy volunteers (smokers)
5369088|NCT00159315|Healthy Volunteers (Non-smokers)|healthy volunteers (non-smokers)
5369089|NCT00159315|Asthma Patients|asthma patients
5369090|NCT00159315|COPD Patients|copd patients
5369091|NCT00159289|Mild to moderate Chronic Obstructive Pulmonary Disease (COPD)|mild to moderate chronic obstructive pulmonary disease (copd)
5369092|NCT00159289|Volunteers (healthy non-smokers)|volunteers (healthy non-smokers)
5369093|NCT00159289|Volunteers (current or ex-smokers)|volunteers (current or ex-smokers)
5369094|NCT00159250|Duchenne muscular dystrophy;|duchenne muscular dystrophy;
5369095|NCT00159250|antisense oligonucleotides;|antisense oligonucleotides;
5369096|NCT00159250|gene restoration;|gene restoration;
5369097|NCT00159250|deletion|deletion
5369098|NCT00159224|HIV|hiv
5369099|NCT00159224|Simplification|simplification
5369100|NCT00159224|Monotherapy|monotherapy
5369101|NCT00159224|Treatment Naive|treatment naive
5369102|NCT00159224|HIV-1 infection|hiv-1 infection
5369103|NCT00159211|type 2 diabetes|type 2 diabetes
5369104|NCT00159198|Amyotrophic lateral sclerosis|amyotrophic lateral sclerosis
5369105|NCT00159198|Frontotemporal dementia|frontotemporal dementia
5369106|NCT00159198|Mutations spectrum|mutations spectrum
5369107|NCT00159198|Linkage studies|linkage studies
5369108|NCT00159198|Genetic epidemiology|genetic epidemiology
5369109|NCT00159185|Arthroplasty, Replacement, Hip|arthroplasty, replacement, hip
5369110|NCT00159185|Epidemiology|epidemiology
5369111|NCT00159172|Advanced parkinson disease|advanced parkinson disease
5369112|NCT00159172|Stimulation|stimulation
5369113|NCT00159172|Motor Cortex|motor cortex
5369114|NCT00159172|Parkinson disease C10.574.812|parkinson disease c10.574.812
5369115|NCT00159172|Electric Stimulation Therapy E02.831.580.438|electric stimulation therapy e02.831.580.438
5369116|NCT00159172|Neuronavigation E05.873.249|neuronavigation e05.873.249
5369117|NCT00159159|Cardiac Transplant|cardiac transplant
5369118|NCT00159159|ciclosporine|ciclosporine
5369119|NCT00159159|immunosuppressive|immunosuppressive
5369120|NCT00159146|Major Depression|major depression
5369121|NCT00159146|Pindolol|pindolol
5369122|NCT00159146|Venlafaxine|venlafaxine
5369123|NCT00159146|Augmentation|augmentation
5369124|NCT00159146|Major depression (DSM-IVR)|major depression (dsm-ivr)
5369125|NCT00159133|Schizophrenia|schizophrenia
5369126|NCT00159133|first episode|first episode
5369127|NCT00159133|prodrome based early intervention|prodrome based early intervention
5369128|NCT00159133|antipsychotics - benzodiazepine|antipsychotics - benzodiazepine
5369129|NCT00159133|maintenance treatment|maintenance treatment
5369130|NCT00159133|drug discontinuation|drug discontinuation
5369131|NCT00159120|Schizophrenia|schizophrenia
5369132|NCT00159120|first episode|first episode
5369133|NCT00159120|neuroleptic maintenance treatment|neuroleptic maintenance treatment
5369134|NCT00159120|drug discontinuation|drug discontinuation
5369135|NCT00159120|prodrome based early intervention|prodrome based early intervention
5369136|NCT00159107|alcoholism|alcoholism
5369137|NCT00159107|abstinence enhancement|abstinence enhancement
5369138|NCT00159107|psychotherapy|psychotherapy
5369139|NCT00159107|cognitive behavior therapy vs. supportive counseling|cognitive behavior therapy vs. supportive counseling
5369140|NCT00159107|Acamprosate vs. Placebo|acamprosate vs. placebo
5369141|NCT00159107|multi-center study|multi-center study
5369142|NCT00159081|Schizophrenia|schizophrenia
5369143|NCT00159081|first episode|first episode
5369144|NCT00159081|long-term treatment|long-term treatment
5369145|NCT00159081|typical vs. atypical neuroleptics|typical vs. atypical neuroleptics
5369146|NCT00159003|drug metabolism and disposition enzymes|drug metabolism and disposition enzymes
5369147|NCT00158990|major depression|major depression
5369148|NCT00158990|bipolar disorder|bipolar disorder
5369149|NCT00158990|unipolar depression|unipolar depression
5369150|NCT00158990|sertraline|sertraline
5369151|NCT00158990|triiodothyronine|triiodothyronine
5369152|NCT00158977|heart failure|heart failure
5369153|NCT00158977|atrial fibrillation|atrial fibrillation
5369154|NCT00158977|cardiac resynchronization therapy defibrillator|cardiac resynchronization therapy defibrillator
5369155|NCT00158964|left ventricular lead|left ventricular lead
5369156|NCT00158964|pacing|pacing
5369157|NCT00158964|heart failure|heart failure
5369158|NCT00158951|Left Ventricular Lead|left ventricular lead
5369159|NCT00158951|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
5369160|NCT00158951|Congestive Heart Failure|congestive heart failure
5369161|NCT00158938|Artificial Cardiac Pacemaker|artificial cardiac pacemaker
5369162|NCT00158938|Implanted Electrodes|implanted electrodes
5369163|NCT00158925|Artificial Cardiac Pacing|artificial cardiac pacing
5369164|NCT00158925|Implanted Electrodes|implanted electrodes
5369165|NCT00158899|HDLc|hdlc
5369166|NCT00158899|high-density lipoprotein|high-density lipoprotein
5369167|NCT00158899|Dyslipidemia|dyslipidemia
5369168|NCT00158886|oral topotecan rectal cancer pelvic radiation|oral topotecan rectal cancer pelvic radiation
5369169|NCT00158873|ICU mechanical ventilation analgesia sedation|icu mechanical ventilation analgesia sedation
5369170|NCT00158860|VALTREX®|valtrex®
5369171|NCT00158860|valaciclovir|valaciclovir
5369172|NCT00158860|genital herpes|genital herpes
5369173|NCT00158860|HSV-2|hsv-2
5369174|NCT00158860|suppression|suppression
5369175|NCT00158847|COPD inflammation sputum lung function biopsy|copd inflammation sputum lung function biopsy
5369178|NCT00158834|bronchial hyperresponsiveness|bronchial hyperresponsiveness
5369179|NCT00158834|symptoms|symptoms
5369180|NCT00158821|HIV|hiv
5369181|NCT00158821|Antiretroviral|antiretroviral
5369182|NCT00158821|Treatment Experienced|treatment experienced
5369183|NCT00158821|HIV-1|hiv-1
5369184|NCT00158782|Cancer GW786034 Lapatinib Pazopanib|cancer gw786034 lapatinib pazopanib
5369185|NCT00158769|Hepatic Impairment|hepatic impairment
5369186|NCT00158769|GR270773|gr270773
5369187|NCT00158769|Emulsion|emulsion
5369188|NCT00158756|Diphtheria|diphtheria
5369189|NCT00158756|Pertussis|pertussis
5369190|NCT00158756|Prophylaxis|prophylaxis
5369191|NCT00158756|Hepatitis B diseases|hepatitis b diseases
5369192|NCT00158756|Tetanus|tetanus
5369193|NCT00158743|Pre-eclampsia|pre-eclampsia
5369194|NCT00158743|Hypertension|hypertension
5369195|NCT00158743|Endogenous digitalis-like factor|endogenous digitalis-like factor
5369196|NCT00158743|Anti-digoxin antibody|anti-digoxin antibody
5369197|NCT00158743|Digibind|digibind
5369198|NCT00158717|Chronic Hepatitis B|chronic hepatitis b
5369199|NCT00158704|Chronic Hepatitis B|chronic hepatitis b
5369200|NCT00158691|Head and Neck cancer|head and neck cancer
5369201|NCT00158691|Radiotherapy|radiotherapy
5369202|NCT00158691|Xerostomia|xerostomia
5369203|NCT00158691|Randomized trial|randomized trial
5369204|NCT00158678|oral cancer|oral cancer
5369205|NCT00158678|oropharynx cancer|oropharynx cancer
5369206|NCT00158678|hypopharynx cancer|hypopharynx cancer
5369207|NCT00158678|IMRT|imrt
5369208|NCT00158665|Influenza|influenza
5369209|NCT00158665|Vaccination|vaccination
5369210|NCT00158665|Immunization|immunization
5369212|NCT00158665|Immunogenicity|immunogenicity
5369213|NCT00158652|Head and neck squamous cell carcinoma|head and neck squamous cell carcinoma
5369214|NCT00158652|Radiotherapy|radiotherapy
5369215|NCT00158652|Chemotherapy|chemotherapy
5369216|NCT00158639|Blood Pressure Monitoring, home|blood pressure monitoring, home
5369217|NCT00158639|Pharmaceutical services|pharmaceutical services
5369218|NCT00158639|Self care|self care
5369219|NCT00158626|physical therapy|physical therapy
5369220|NCT00158626|physiotherapy|physiotherapy
5369221|NCT00158626|pelvic organ prolapse|pelvic organ prolapse
5369222|NCT00158600|Glycogen Storage Disease Type II|glycogen storage disease type ii
5369223|NCT00158600|GSD-II|gsd-ii
5369224|NCT00158600|Pompe Disease|pompe disease
5369225|NCT00158587|Vivax|vivax
5369226|NCT00158587|Treatment|treatment
5369227|NCT00158587|Primaquine|primaquine
5369228|NCT00158587|Asia|asia
5369229|NCT00158574|intermittent preventive treatment|intermittent preventive treatment
5369230|NCT00158574|malaria|malaria
5369231|NCT00158574|efficacy|efficacy
5369232|NCT00158574|safety|safety
5369233|NCT00158574|drug options|drug options
5369234|NCT00158561|vivax|vivax
5369235|NCT00158561|treatment|treatment
5369236|NCT00158561|Asia|asia
5369237|NCT00158548|Falciparum|falciparum
5369238|NCT00158548|Vivax|vivax
5369239|NCT00158548|Treatment|treatment
5369240|NCT00158548|Asia|asia
5369241|NCT00158535|Liver Transplantation|liver transplantation
5369242|NCT00158535|Hepatitis C|hepatitis c
5369243|NCT00158535|HIV Infections|hiv infections
5369244|NCT00158522|Acute hepatitis C|acute hepatitis c
5369245|NCT00158522|Genotype 4|genotype 4
5369246|NCT00158522|Pegylated Interferon|pegylated interferon
5369247|NCT00158522|Egypt|egypt
5369248|NCT00158509|Valacyclovir|valacyclovir
5369249|NCT00158509|HIV-1|hiv-1
5369250|NCT00158509|HSV-2|hsv-2
5369251|NCT00158509|genital shedding|genital shedding
5369252|NCT00158509|herpes genitalis|herpes genitalis
5369253|NCT00158509|HIV infection|hiv infection
5369254|NCT00158496|Chronic Hepatitis C|chronic hepatitis c
5369255|NCT00158496|Genotype 4|genotype 4
5369256|NCT00158496|Pegylated Interferon|pegylated interferon
5369257|NCT00158496|Ribavirin|ribavirin
5369258|NCT00158496|Egypt|egypt
5369259|NCT00158483|Genital herpes|genital herpes
5369260|NCT00158483|Cofactors of sexual transmission|cofactors of sexual transmission
5369261|NCT00158483|Syndromic treatment|syndromic treatment
5369262|NCT00158483|Genital viral load|genital viral load
5369263|NCT00158483|Ulcer|ulcer
5369264|NCT00158470|HIV infection|hiv infection
5369265|NCT00158470|injecting drug users|injecting drug users
5369266|NCT00158470|HAART|haart
5369267|NCT00158470|once daily regimen|once daily regimen
5369268|NCT00158470|Treatment Naive|treatment naive
5369269|NCT00158457|Simplification regimen|simplification regimen
5369270|NCT00158457|HIV infection|hiv infection
5369271|NCT00158457|Once a day|once a day
5369272|NCT00158457|Naive patients|naive patients
5369273|NCT00158457|Sub-saharian Africa|sub-saharian africa
5369274|NCT00158457|Treatment Naive|treatment naive
5369275|NCT00158431|osteoarthritis|osteoarthritis
5369276|NCT00158431|randomized trial|randomized trial
5369277|NCT00158431|knee|knee
5369278|NCT00158431|quality of life|quality of life
5369279|NCT00158418|osteoarthritis|osteoarthritis
5369280|NCT00158418|shoulder|shoulder
5369281|NCT00158418|randomized trial|randomized trial
5369282|NCT00158418|cement|cement
5369283|NCT00158405|HIV|hiv
5369284|NCT00158405|Structured treatment interruption|structured treatment interruption
5369285|NCT00158405|HAART|haart
5369286|NCT00158405|Sub-saharian africa|sub-saharian africa
5369287|NCT00158405|Treatment Interruption|treatment interruption
5369288|NCT00158405|Treatment Naive|treatment naive
5369289|NCT00158366|Weight Loss|weight loss
5369290|NCT00158353|Mentors|mentors
5369291|NCT00158353|Self-esteem|self-esteem
5369292|NCT00158353|Adolescent|adolescent
5369293|NCT00158353|Mental health|mental health
5369294|NCT00158353|Social support|social support
5369295|NCT00158353|Substance use|substance use
5369296|NCT00158353|Violence|violence
5369297|NCT00158353|Exercise|exercise
5369298|NCT00158353|Nutrition|nutrition
5369299|NCT00158353|Sexual behavior|sexual behavior
5369300|NCT00158353|Female|female
5369301|NCT00158340|Binge Eating|binge eating
5369302|NCT00158340|Overeating|overeating
5369303|NCT00158340|Compulsive Eating|compulsive eating
5369304|NCT00158340|Hyperphagia|hyperphagia
5369305|NCT00158327|Primary Health Care|primary health care
5369306|NCT00158314|Pathological gambling|pathological gambling
5369307|NCT00158314|Gambler's anonymous|gambler's anonymous
5369308|NCT00158314|Cognitive behavioral therapy|cognitive behavioral therapy
5369309|NCT00158314|CBT|cbt
5369310|NCT00158301|Child|child
5369311|NCT00158301|Adolescent|adolescent
5369312|NCT00158301|CBT|cbt
5369313|NCT00158301|Drug Therapy|drug therapy
5369314|NCT00158288|Substance Use Disorders|substance use disorders
5369315|NCT00158275|Cognitive behavioral therapy|cognitive behavioral therapy
5369316|NCT00158275|Problem solving therapy|problem solving therapy
5369317|NCT00158275|CBT|cbt
5369318|NCT00158262|Post-Traumatic Stress Disorder|post-traumatic stress disorder
5369319|NCT00158262|Prevention|prevention
5369320|NCT00158262|Propranolol|propranolol
5369321|NCT00158262|Psychophysiology|psychophysiology
5369322|NCT00158249|citicoline, drug abuse, marijuana|citicoline, drug abuse, marijuana
5369323|NCT00158236|Opiate Addiction|opiate addiction
5369324|NCT00158236|Opiate Dependence|opiate dependence
5369325|NCT00158223|Schizophrenia|schizophrenia
5369326|NCT00158223|Clozapine|clozapine
5369327|NCT00158223|Treatment|treatment
5369328|NCT00158223|Combination|combination
5369329|NCT00158223|Unresponsive|unresponsive
5369330|NCT00158223|Schizoaffective Disorders|schizoaffective disorders
5369331|NCT00158197|Adherence|adherence
5369332|NCT00158197|Amphetamine-Related Disorders|amphetamine-related disorders
5369333|NCT00158197|Behavior Therapy|behavior therapy
5369334|NCT00158197|Contingency management|contingency management
5369335|NCT00158197|Drug Counseling|drug counseling
5369336|NCT00158197|health behaviors|health behaviors
5369337|NCT00158197|methamphetamine|methamphetamine
5369338|NCT00158197|sexual risk behaviors|sexual risk behaviors
5369339|NCT00158197|substance dependence|substance dependence
5369340|NCT00158184|Opiate|opiate
5369341|NCT00158184|Opioid|opioid
5369342|NCT00158184|Abuse Liability|abuse liability
5369343|NCT00158184|Abuse Potential|abuse potential
5369344|NCT00158171|smoking addiction|smoking addiction
5369345|NCT00158158|smoking addiction|smoking addiction
5369346|NCT00158132|cocaine|cocaine
5369347|NCT00158119|strength training|strength training
5369348|NCT00158119|power training|power training
5369349|NCT00158119|exercise training|exercise training
5369350|NCT00158119|functional performance tasks|functional performance tasks
5369351|NCT00158106|functional communicative ability|functional communicative ability
5369352|NCT00158106|cost effectiveness|cost effectiveness
5369353|NCT00158106|service user preferences|service user preferences
5369354|NCT00158067|Epilepsy|epilepsy
5369355|NCT00158067|Neurostimulation|neurostimulation
5369356|NCT00158054|depression|depression
5369357|NCT00158054|acute coronary syndrome|acute coronary syndrome
5369358|NCT00158054|clinical trials|clinical trials
5369359|NCT00158041|Amifostine|amifostine
5369360|NCT00158041|Mucositis|mucositis
5369361|NCT00158041|Nausea|nausea
5369362|NCT00158041|Hypotension|hypotension
5369363|NCT00158041|Rash|rash
5369364|NCT00158028|Schizotypal Personality Disorder|schizotypal personality disorder
5369365|NCT00158028|Risperidone|risperidone
5369366|NCT00158028|Treatment|treatment
5369367|NCT00158028|Cognitive|cognitive
5369368|NCT00158015|Echocardiography|echocardiography
5369369|NCT00158015|tissue Doppler Imaging|tissue doppler imaging
5369370|NCT00158015|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
5369371|NCT00158002|Basilar/Hemiplegic Migraine|basilar/hemiplegic migraine
5369372|NCT00158002|Prophylaxis|prophylaxis
5369373|NCT00157989|Infant, Premature|infant, premature
5369374|NCT00157976|Macular Degeneration|macular degeneration
5369375|NCT00157976|AMD|amd
5369376|NCT00157976|Visual Acuity|visual acuity
5369377|NCT00157950|Human Papilloma Virus|human papilloma virus
5369378|NCT00157885|Falciparum|falciparum
5369379|NCT00157885|Vivax|vivax
5369380|NCT00157885|Papua|papua
5369381|NCT00157885|Amodiaquine|amodiaquine
5369382|NCT00157885|Artekin|artekin
5369383|NCT00157885|Artemisinin Combination Therapy|artemisinin combination therapy
5369384|NCT00157885|Dihydroartemisinin|dihydroartemisinin
5369385|NCT00157885|Piperaquine|piperaquine
5369386|NCT00157885|Lumefantrine|lumefantrine
5369387|NCT00157885|Artemether|artemether
5369388|NCT00157859|Falciparum|falciparum
5369389|NCT00157859|Vivax|vivax
5369390|NCT00157859|Papua|papua
5369391|NCT00157859|Chloroquine|chloroquine
5369392|NCT00157859|Sulphadoxine-pyrimethamine|sulphadoxine-pyrimethamine
5369393|NCT00157846|Heart Failure|heart failure
5369394|NCT00157846|LVEF < 35%|lvef < 35%
5369395|NCT00157846|Bradycardia|bradycardia
5369396|NCT00157833|Coartemether|coartemether
5369397|NCT00157833|Artekin|artekin
5369398|NCT00157833|Papua|papua
5369399|NCT00157833|Uncomplicated malaria|uncomplicated malaria
5369400|NCT00157820|Defibrillators, Implantable|defibrillators, implantable
5369401|NCT00157820|Atrial Fibrillation|atrial fibrillation
5369402|NCT00157820|Ventricular Tachyarrhythmias|ventricular tachyarrhythmias
5369403|NCT00157820|Clinical Trial|clinical trial
5369404|NCT00157807|Persistent Atrial Fibrillation|persistent atrial fibrillation
5369405|NCT00157807|Permanent Atrial Fibrillation|permanent atrial fibrillation
5369406|NCT00157807|Mitral Valve Defect|mitral valve defect
5369407|NCT00157807|Tricuspid Valve Defect|tricuspid valve defect
5369408|NCT00157807|Aortic Valve Defect|aortic valve defect
5369409|NCT00157794|Sinus Node Disease|sinus node disease
5369410|NCT00157794|Pacemaker|pacemaker
5369411|NCT00157794|Dual Chamber Pacemaker|dual chamber pacemaker
5369412|NCT00157781|Atrial Fibrillation|atrial fibrillation
5369413|NCT00157781|Atrial Tachyarrhythmia|atrial tachyarrhythmia
5369414|NCT00157781|Pacing|pacing
5369415|NCT00157781|Electrophysiology|electrophysiology
5369416|NCT00157768|Acute myocardial infarction|acute myocardial infarction
5369417|NCT00157768|Non-sustained ventricular tachycardia|non-sustained ventricular tachycardia
5369418|NCT00157768|Left ventricular dysfunction|left ventricular dysfunction
5369419|NCT00157768|Implantable cardioverter defibrillator|implantable cardioverter defibrillator
5369420|NCT00157768|ICD|icd
5369421|NCT00157768|Risk-stratification|risk-stratification
5369422|NCT00157755|Nausea and Vomiting|nausea and vomiting
5369423|NCT00157742|Angina Pectoris|angina pectoris
5369424|NCT00157742|Spinal Cord Stimulation (SCS)|spinal cord stimulation (scs)
5369425|NCT00157742|Percutaneous Myocardial Revascularisation (PMR)|percutaneous myocardial revascularisation (pmr)
5369426|NCT00157742|Refractory Angina Pectoris|refractory angina pectoris
5369427|NCT00157729|Hypertension|hypertension
5369428|NCT00157729|antihypertensive agents|antihypertensive agents
5369429|NCT00157729|diabetes mellitus type 2|diabetes mellitus type 2
5369430|NCT00157729|metabolic syndrome|metabolic syndrome
5369431|NCT00157716|Coronary|coronary
5369432|NCT00157716|surgery|surgery
5369433|NCT00157716|ischemia|ischemia
5369434|NCT00157716|reperfusion injury|reperfusion injury
5369435|NCT00157716|cardiac|cardiac
5369436|NCT00157716|heart|heart
5369437|NCT00157716|neurological|neurological
5369438|NCT00157716|cardiopulmonary bypass|cardiopulmonary bypass
5369439|NCT00157716|cardioprotection|cardioprotection
5369440|NCT00157703|Malignant glioma|malignant glioma
5369441|NCT00157703|Glioblastoma multiforme|glioblastoma multiforme
5369442|NCT00157703|GBM|gbm
5369443|NCT00157703|Gliosarcoma|gliosarcoma
5369444|NCT00157703|Anaplastic astrocytoma|anaplastic astrocytoma
5369445|NCT00157703|Brain cancer|brain cancer
5369446|NCT00157703|Brain tumor|brain tumor
5369447|NCT00157703|Glioma|glioma
5369448|NCT00157703|recurrent/progressive malignant glioma|recurrent/progressive malignant glioma
5369449|NCT00157690|Alendronate|alendronate
5369450|NCT00157690|Bisphosphonates|bisphosphonates
5369451|NCT00157690|Cystic Fibrosis|cystic fibrosis
5369452|NCT00157690|Osteoporosis|osteoporosis
5369453|NCT00157677|deep vein thrombosis|deep vein thrombosis
5369454|NCT00157677|pulmonary embolism|pulmonary embolism
5369455|NCT00157677|D-dimer testing|d-dimer testing
5369456|NCT00157651|end stage renal disease|end stage renal disease
5369457|NCT00157651|thrombosis|thrombosis
5369458|NCT00157651|bleeding|bleeding
5369459|NCT00157638|pharmacist|pharmacist
5369460|NCT00157638|physician|physician
5369461|NCT00157638|primary care|primary care
5369462|NCT00157638|collaboration|collaboration
5369463|NCT00157638|therapeutics|therapeutics
5369464|NCT00157625|urinary infections, catheters, bacteriuria, trial|urinary infections, catheters, bacteriuria, trial
5369465|NCT00157612|pneumonia|pneumonia
5369466|NCT00157612|lower respiratory tract infection|lower respiratory tract infection
5369467|NCT00157612|clinical pathway|clinical pathway
5369468|NCT00157612|nursing home|nursing home
5369469|NCT00157612|long-term care|long-term care
5369470|NCT00157612|randomized control trial|randomized control trial
5369471|NCT00157599|deep vein thrombosis|deep vein thrombosis
5369472|NCT00157599|DVT|dvt
5369473|NCT00157573|Asymptomatic|asymptomatic
5369474|NCT00157573|Clinical trial|clinical trial
5369475|NCT00157573|Phase II|phase ii
5369476|NCT00157573|GM-CSF|gm-csf
5369477|NCT00157573|Immunotherapy|immunotherapy
5369478|NCT00157547|Depression|depression
5369479|NCT00157547|Quantitative EEG (QEEG)|quantitative eeg (qeeg)
5369480|NCT00157547|Antidepressants|antidepressants
5369481|NCT00157534|Hepatitis C|hepatitis c
5369482|NCT00157534|Celgosivir|celgosivir
5369483|NCT00157534|HCV|hcv
5369484|NCT00157534|Genotype 1|genotype 1
5369485|NCT00157378|first episode,|first episode,
5369486|NCT00157378|schizophrenia,|schizophrenia,
5369487|NCT00157378|atypical neuroleptics,|atypical neuroleptics,
5369488|NCT00157378|negative symptoms|negative symptoms
5369489|NCT00157326|High Blood Pressure|high blood pressure
5369490|NCT00157313|Schizophrenia|schizophrenia
5369491|NCT00157313|First episode psychosis|first episode psychosis
5369492|NCT00157313|Psychosocial intervention|psychosocial intervention
5369493|NCT00157300|erythropoietin|erythropoietin
5369494|NCT00157300|kidney transplantation|kidney transplantation
5369495|NCT00157300|delayed graft function|delayed graft function
5369496|NCT00157274|Alemtuzumab|alemtuzumab
5369497|NCT00157274|Mycosis fungoides|mycosis fungoides
5369498|NCT00157274|Sezary|sezary
5369499|NCT00157222|Charcot|charcot
5369500|NCT00157222|Diabetic|diabetic
5369501|NCT00157222|osteoporosis|osteoporosis
5369502|NCT00157196|Carcinoma, Non-Small-Cell Lung, L-BLP25, Tecemotide|carcinoma, non-small-cell lung, l-blp25, tecemotide
5369503|NCT00157183|cystic fibrosis|cystic fibrosis
5369504|NCT00157183|hypoxia|hypoxia
5369505|NCT00157183|oxygen|oxygen
5369506|NCT00157183|noninvasive ventilation|noninvasive ventilation
5369507|NCT00157183|quality of life|quality of life
5369508|NCT00157170|exercise|exercise
5369509|NCT00157170|self efficacy|self efficacy
5369510|NCT00157170|quality of life|quality of life
5369511|NCT00157170|HIV|hiv
5369512|NCT00157157|Factor VIII Deficiency|factor viii deficiency
5369513|NCT00157144|Lung Transplantation|lung transplantation
5369514|NCT00157144|Heart Transplantation|heart transplantation
5369515|NCT00157131|autologous sheet skin grafts|autologous sheet skin grafts
5369516|NCT00157131|FS 4IU VH S/D|fs 4iu vh s/d
5369517|NCT00157131|skin grafts|skin grafts
5369518|NCT00157131|burn|burn
5369519|NCT00157118|Severe congenital protein C deficiency|severe congenital protein c deficiency
5369520|NCT00157079|PID|pid
5369521|NCT00157079|Immunodeficiency|immunodeficiency
5369522|NCT00157079|Immune Thrombocytopenic Purpura (ITP)|immune thrombocytopenic purpura (itp)
5369523|NCT00157079|Kawasaki syndrome|kawasaki syndrome
5369524|NCT00157066|Latent tuberculosis infection|latent tuberculosis infection
5369525|NCT00157066|Active tuberculosis infection|active tuberculosis infection
5369526|NCT00157053|Factor VIII Deficiency|factor viii deficiency
5369527|NCT00157040|Factor VIII Deficiency|factor viii deficiency
5369528|NCT00157027|Treatment Experienced|treatment experienced
5369529|NCT00157027|HIV-1 Positive by ELISA Assay|hiv-1 positive by elisa assay
5369530|NCT00157027|Confirmed by Western Blot|confirmed by western blot
5369531|NCT00157027|Refractory or intolerant to HAART|refractory or intolerant to haart
5369532|NCT00157014|Antirejection|antirejection
5369533|NCT00157014|Treatment Outcome|treatment outcome
5369534|NCT00157014|Immunosuppression|immunosuppression
5369535|NCT00157014|Treatment Effectiveness|treatment effectiveness
5369536|NCT00157014|Anti-rejection therapy|anti-rejection therapy
5369537|NCT00156988|burns|burns
5369538|NCT00156988|partial thickness|partial thickness
5369539|NCT00156988|cerium flamazine|cerium flamazine
5369540|NCT00156988|randomised clinical trial|randomised clinical trial
5369541|NCT00156975|Oxaliplatin|oxaliplatin
5369542|NCT00156975|Capecitabine|capecitabine
5369543|NCT00156975|Chemotherapy|chemotherapy
5369544|NCT00156975|Resection|resection
5369545|NCT00156975|Liver metastases|liver metastases
5369546|NCT00156975|Liver resection|liver resection
5369547|NCT00156975|Adjuvant|adjuvant
5369548|NCT00156962|Epogen|epogen
5369549|NCT00156962|Procrit|procrit
5369550|NCT00156962|Chronic Kidney Disease|chronic kidney disease
5369551|NCT00156962|Anemia Treatment|anemia treatment
5369552|NCT00156949|Epogen|epogen
5369553|NCT00156949|Procrit|procrit
5369554|NCT00156949|Chronic Kidney Disease|chronic kidney disease
5369555|NCT00156949|Anemia Treatment for Dialysis Patients|anemia treatment for dialysis patients
5369556|NCT00156923|Alcohol dependence|alcohol dependence
5369557|NCT00156897|Non-insulin-dependent diabetes mellitus|non-insulin-dependent diabetes mellitus
5369558|NCT00156897|NIDDM|niddm
5369559|NCT00156897|Type II diabetes|type ii diabetes
5369560|NCT00156897|Obesity|obesity
5369561|NCT00156897|Lipase inhibitor|lipase inhibitor
5369562|NCT00156884|prostate cancer|prostate cancer
5369563|NCT00156884|cisplatin|cisplatin
5369564|NCT00156884|strontium-89|strontium-89
5369565|NCT00156884|phase II|phase ii
5369566|NCT00156871|transplant|transplant
5369567|NCT00156871|fatigue|fatigue
5369568|NCT00156871|exercise|exercise
5369569|NCT00156871|Malignant disease|malignant disease
5369570|NCT00156858|pharmacokinetics|pharmacokinetics
5369571|NCT00156858|transplantation|transplantation
5369572|NCT00156858|busulfan|busulfan
5369573|NCT00156845|coronary artery disease|coronary artery disease
5369574|NCT00156845|ischemia|ischemia
5369575|NCT00156845|echocardiography|echocardiography
5369576|NCT00156845|cardiac imaging|cardiac imaging
5369577|NCT00156845|heart disease|heart disease
5369578|NCT00156845|myocardial contrast enhancement|myocardial contrast enhancement
5369579|NCT00156845|myocardial perfusion|myocardial perfusion
5369580|NCT00156845|wall motion|wall motion
5369581|NCT00156845|ultrasound contrast agent|ultrasound contrast agent
5369582|NCT00156819|Asthma|asthma
5369583|NCT00156819|Asthma Control|asthma control
5369584|NCT00156806|aloe|aloe
5369585|NCT00156806|radiation dermatitis|radiation dermatitis
5369586|NCT00156806|radiation therapy|radiation therapy
5369587|NCT00156793|coronary artery disease|coronary artery disease
5369588|NCT00156793|ischemia|ischemia
5369589|NCT00156793|echocardiography|echocardiography
5369590|NCT00156793|cardiac imaging|cardiac imaging
5369591|NCT00156793|heart disease|heart disease
5369592|NCT00156793|myocardial contrast enhancement|myocardial contrast enhancement
5369593|NCT00156793|myocardial perfusion|myocardial perfusion
5369594|NCT00156793|wall motion|wall motion
5369595|NCT00156793|ultrasound contrast agent|ultrasound contrast agent
5369596|NCT00156780|ultrasound contrast agent|ultrasound contrast agent
5369597|NCT00156780|pharmacokinetics|pharmacokinetics
5369598|NCT00156780|congestive heart failure|congestive heart failure
5369599|NCT00156780|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
5369600|NCT00156780|safety|safety
5369601|NCT00156767|Critical Care|critical care
5369602|NCT00156767|Adrenal Insufficiency|adrenal insufficiency
5369603|NCT00156767|Septic Shock|septic shock
5369604|NCT00156767|Cortrosyn|cortrosyn
5369605|NCT00156767|Steroids|steroids
5369606|NCT00156767|Cortisol|cortisol
5369607|NCT00156767|Critical Care Unit|critical care unit
5369608|NCT00156767|Adrenal Gland Function|adrenal gland function
5369609|NCT00156741|Refined ventricular pacing|refined ventricular pacing
5369610|NCT00156728|Pacemaker artificial, congestive heart failure and atrial fibrillation|pacemaker artificial, congestive heart failure and atrial fibrillation
5369611|NCT00156715|Quetiapine|quetiapine
5369612|NCT00156715|Seroquel|seroquel
5369613|NCT00156715|Schizophrenia|schizophrenia
5369614|NCT00156715|Dual Diagnosis|dual diagnosis
5369615|NCT00156715|Substance Abuse|substance abuse
5369616|NCT00156715|Alcohol Abuse|alcohol abuse
5369617|NCT00156702|Smoking|smoking
5369618|NCT00156702|Adolescents|adolescents
5369619|NCT00156702|Motivational Interviewing|motivational interviewing
5369620|NCT00156689|polyneuropathy|polyneuropathy
5369621|NCT00156676|Disability|disability
5369622|NCT00156676|Gait|gait
5369623|NCT00156676|Multiple Sclerosis|multiple sclerosis
5369624|NCT00156676|Rehabilitation|rehabilitation
5369625|NCT00156676|Robot|robot
5369626|NCT00156663|Women|women
5369627|NCT00156663|Veterans|veterans
5369628|NCT00156663|Delivery of Healthcare|delivery of healthcare
5369629|NCT00156663|Intervention Studies|intervention studies
5369630|NCT00156663|United States Department of Veterans Affairs|united states department of veterans affairs
5369631|NCT00156663|Women's Health|women's health
5369632|NCT00156650|Male contraception|male contraception
5369633|NCT00156650|Testosterone|testosterone
5369634|NCT00156637|schizophrenia|schizophrenia
5369635|NCT00156637|quality of health care|quality of health care
5369636|NCT00156637|quality indicators|quality indicators
5369637|NCT00156637|intervention studies|intervention studies
5369638|NCT00156624|Intervention|intervention
5369639|NCT00156624|Peripheral Vascular Disease|peripheral vascular disease
5369640|NCT00156624|Drug|drug
5369641|NCT00156624|Restenosis|restenosis
5369642|NCT00156624|18 years and above|18 years and above
5369643|NCT00156611|peripheral vascular disease|peripheral vascular disease
5369644|NCT00156611|intervention|intervention
5369645|NCT00156611|restenosis|restenosis
5369646|NCT00156611|Age above 18 years|age above 18 years
5369647|NCT00156598|metal ion concentration|metal ion concentration
5369648|NCT00156585|cerebral metastases|cerebral metastases
5369649|NCT00156585|dynamic contrast enhanced magnetic resonance imaging|dynamic contrast enhanced magnetic resonance imaging
5369650|NCT00156585|DCE-MRI|dce-mri
5369651|NCT00156585|gamma knife|gamma knife
5369652|NCT00156559|immunization|immunization
5369653|NCT00156559|vaccine|vaccine
5369654|NCT00156559|low birth weight infant|low birth weight infant
5369655|NCT00156559|premature infant|premature infant
5369656|NCT00156546|Urinary tract infections|urinary tract infections
5369657|NCT00156546|Children|children
5369658|NCT00156546|Antibiotic prophylaxis|antibiotic prophylaxis
5369659|NCT00156546|Renal scintigraphy|renal scintigraphy
5369660|NCT00156546|Vesico ureteral reflux|vesico ureteral reflux
5369661|NCT00156533|Insomnia|insomnia
5369662|NCT00156533|Sleep|sleep
5369663|NCT00156533|zolpidem|zolpidem
5369664|NCT00156533|Ambien|ambien
5369665|NCT00156533|Hypnotics|hypnotics
5369666|NCT00156455|Children|children
5369667|NCT00156455|Hypoplastic left heart syndrome|hypoplastic left heart syndrome
5369668|NCT00156455|Obstructive Sleep Apnea Syndrome|obstructive sleep apnea syndrome
5369669|NCT00156455|Single Ventricle Physiology|single ventricle physiology
5369670|NCT00156442|Obstructive Sleep Apnea Syndrome|obstructive sleep apnea syndrome
5369671|NCT00156442|Cleft lip/palate|cleft lip/palate
5369672|NCT00156442|Children|children
5369673|NCT00156429|genetic testing|genetic testing
5369674|NCT00156416|menopause|menopause
5369675|NCT00156416|hot flash|hot flash
5369676|NCT00156416|night sweat|night sweat
5369677|NCT00156416|meditation|meditation
5369678|NCT00156416|breast cancer|breast cancer
5369679|NCT00156403|pancreatitis, hereditary|pancreatitis, hereditary
5369680|NCT00156403|trypsinogen, cationic|trypsinogen, cationic
5369681|NCT00156403|pilot study|pilot study
5369682|NCT00156377|Mupirocin|mupirocin
5369683|NCT00156377|Staphylococcus aureus|staphylococcus aureus
5369684|NCT00156377|Nasal Cavity|nasal cavity
5369685|NCT00156377|Preventive measures|preventive measures
5370246|NCT00153881|Xeloda|xeloda
5369686|NCT00156364|Diabetic Nephropathy|diabetic nephropathy
5369687|NCT00156364|Kidney Transplant|kidney transplant
5369688|NCT00156364|Pancreas Transplant|pancreas transplant
5369689|NCT00156364|Renal Interstitium|renal interstitium
5369690|NCT00156364|Diabetes Mellitus|diabetes mellitus
5369691|NCT00156364|Cyclosporine|cyclosporine
5369692|NCT00156364|Tacrolimus|tacrolimus
5369693|NCT00156351|African Americans|african americans
5369694|NCT00156351|Women|women
5369695|NCT00156351|Internet|internet
5369696|NCT00156351|Telephone Counseling|telephone counseling
5369697|NCT00156338|Fluid therapy|fluid therapy
5369698|NCT00156325|Bipolar Disorder|bipolar disorder
5369699|NCT00156325|Depression|depression
5369700|NCT00156325|Hypomania|hypomania
5369701|NCT00156325|Mood Stabilizer|mood stabilizer
5369702|NCT00156299|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
5369703|NCT00156299|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
5369704|NCT00156299|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
5369705|NCT00156299|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
5369706|NCT00156299|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
5369707|NCT00156299|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
5369708|NCT00156299|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5369709|NCT00156299|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5369710|NCT00156299|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5369711|NCT00156299|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5369712|NCT00156299|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
5369713|NCT00156299|adult erythroleukemia (M6a)|adult erythroleukemia (m6a)
5369714|NCT00156299|adult pure erythroid leukemia (M6b)|adult pure erythroid leukemia (m6b)
5369715|NCT00156299|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
5369716|NCT00156247|psoriasis|psoriasis
5369717|NCT00156247|etanercept|etanercept
5369718|NCT00156247|acitretin|acitretin
5369719|NCT00156221|Autism|autism
5369720|NCT00156221|MRI|mri
5369721|NCT00156221|Developmental Disorders|developmental disorders
5369722|NCT00156208|Symptomatic Uterine Fibroids|symptomatic uterine fibroids
5369723|NCT00156208|Excessive Uterine Bleeding|excessive uterine bleeding
5369724|NCT00156208|Uterine Hemorrhage|uterine hemorrhage
5369725|NCT00156208|asoprisnil|asoprisnil
5369726|NCT00156195|Symptomatic Uterine Fibroids|symptomatic uterine fibroids
5369727|NCT00156195|Excessive Uterine Bleeding|excessive uterine bleeding
5369728|NCT00156195|Uterine Hemorrhage|uterine hemorrhage
5369729|NCT00156195|asoprisnil|asoprisnil
5369730|NCT00156182|Fibroid Uterus|fibroid uterus
5369731|NCT00156182|Leiomyoma|leiomyoma
5369732|NCT00156182|Uterine Fibroids|uterine fibroids
5369733|NCT00156182|asoprisnil|asoprisnil
5369734|NCT00156156|Symptomatic Uterine Fibroids|symptomatic uterine fibroids
5369735|NCT00156156|Excessive Uterine Bleeding|excessive uterine bleeding
5369736|NCT00156156|Uterine Hemorrhage|uterine hemorrhage
5369737|NCT00156130|Breast Cancer|breast cancer
5369738|NCT00156130|Lumpectomy|lumpectomy
5369739|NCT00156130|Radiotherapy|radiotherapy
5369740|NCT00156130|Hypofractionated Radiotherapy|hypofractionated radiotherapy
5369741|NCT00156130|Long Term Outcomes|long term outcomes
5369742|NCT00156052|Breast Cancer|breast cancer
5369743|NCT00156052|Hypofractionated Radiotherapy|hypofractionated radiotherapy
5369744|NCT00156052|Lumpectomy|lumpectomy
5369745|NCT00156039|Breast Cancer|breast cancer
5369746|NCT00156039|Follow-up Strategy|follow-up strategy
5369747|NCT00156039|Follow-up Care|follow-up care
5369748|NCT00156039|Family Physician|family physician
5369749|NCT00156039|Oncologist|oncologist
5369750|NCT00156026|CIN 1|cin 1
5369751|NCT00156026|cervical intraepithelial neoplasia|cervical intraepithelial neoplasia
5369752|NCT00156026|cervix|cervix
5369753|NCT00156026|cancer|cancer
5369754|NCT00156026|loop electrosurgical excision procedure|loop electrosurgical excision procedure
5369755|NCT00156026|LEEP|leep
5369756|NCT00156026|expectant management|expectant management
5369757|NCT00156026|human papilloma virus|human papilloma virus
5369758|NCT00156026|HPV|hpv
5369759|NCT00156026|colposcopy|colposcopy
5369760|NCT00156013|B-Cell NHL|b-cell nhl
5369761|NCT00156000|Preterm Delivery|preterm delivery
5369762|NCT00156000|Multifetal pregnancy|multifetal pregnancy
5369763|NCT00156000|Preterm Birth|preterm birth
5369764|NCT00156000|17-alpha Hydroxyprogesterone Caproate|17-alpha hydroxyprogesterone caproate
5369765|NCT00156000|Markers of Preterm Birth|markers of preterm birth
5369766|NCT00155987|Severe diffuse TBI refractory intracranial hypertension.|severe diffuse tbi refractory intracranial hypertension.
5369767|NCT00155974|Influenza|influenza
5369768|NCT00155974|Vaccination|vaccination
5369769|NCT00155974|Hard-to-Reach Populations|hard-to-reach populations
5369770|NCT00155974|Urban|urban
5369771|NCT00155974|Disadvantaged|disadvantaged
5369772|NCT00155961|Androgens|androgens
5369773|NCT00155961|Metabolic syndrome|metabolic syndrome
5369774|NCT00155961|Bone mineral density|bone mineral density
5369775|NCT00155961|Body composition|body composition
5369776|NCT00155961|Questionnaire|questionnaire
5369777|NCT00155948|Ultrasonography|ultrasonography
5369778|NCT00155948|Cervical Multifidus|cervical multifidus
5369779|NCT00155935|ovarian cancer|ovarian cancer
5369780|NCT00155935|immunotherapy|immunotherapy
5369781|NCT00155935|folate receptor|folate receptor
5369782|NCT00155935|Chemotherapy|chemotherapy
5369783|NCT00155922|Diabetes mellitus|diabetes mellitus
5369784|NCT00155922|Monocyte|monocyte
5369785|NCT00155922|Gene expression|gene expression
5369786|NCT00155922|Monocyte gene expression|monocyte gene expression
5369787|NCT00155909|Radiation Pneumonitis|radiation pneumonitis
5369788|NCT00155909|Radiotherapy Planning, Computer-Assisted|radiotherapy planning, computer-assisted
5369789|NCT00155896|BRCA1 gene, BRCA2 gene, DHPLC, genetic diagnosis|brca1 gene, brca2 gene, dhplc, genetic diagnosis
5369790|NCT00155870|laparoscopic assisted vaginal hysterectomy leiomyoma|laparoscopic assisted vaginal hysterectomy leiomyoma
5369791|NCT00155870|adenomyosis|adenomyosis
5369792|NCT00155870|quality of life|quality of life
5369793|NCT00155857|glaucoma, genetic|glaucoma, genetic
5369794|NCT00155831|Premature infants|premature infants
5369795|NCT00155831|Kicking|kicking
5369796|NCT00155831|Stepping|stepping
5369797|NCT00155831|Walking|walking
5369798|NCT00155831|Motor development|motor development
5369799|NCT00155831|Kinematics|kinematics
5369800|NCT00155818|DISC1|disc1
5369801|NCT00155818|Schizophrenia|schizophrenia
5369802|NCT00155818|Chromosome 1q|chromosome 1q
5369803|NCT00155818|Polymorphism detection|polymorphism detection
5369804|NCT00155818|Association study|association study
5369805|NCT00155818|Balanced translocation|balanced translocation
5369806|NCT00155818|DHPLC|dhplc
5369807|NCT00155805|Gastroesophageal reflux disease|gastroesophageal reflux disease
5369808|NCT00155805|reflux esophagitis|reflux esophagitis
5369809|NCT00155805|nonerosive reflux disease|nonerosive reflux disease
5369810|NCT00155805|Barrett’s esophagus|barrett’s esophagus
5369811|NCT00155805|hiatus hernia|hiatus hernia
5369812|NCT00155805|lower esophageal sphincter pressure|lower esophageal sphincter pressure
5369813|NCT00155805|24 hours esophageal pH monitor|24 hours esophageal ph monitor
5369814|NCT00155805|Helicobacter pylori|helicobacter pylori
5369815|NCT00155792|ervical cancer, human papillomavirus, immunotherapy|ervical cancer, human papillomavirus, immunotherapy
5369816|NCT00155779|adult respiratory distress syndrome|adult respiratory distress syndrome
5369817|NCT00155779|angiotensin-converting enzyme|angiotensin-converting enzyme
5369818|NCT00155779|polymorphism|polymorphism
5369819|NCT00155766|cervical cancer, immunotherapy, DC|cervical cancer, immunotherapy, dc
5369820|NCT00155753|pathological myopia, genomic|pathological myopia, genomic
5369821|NCT00155740|ovarian cancer|ovarian cancer
5369822|NCT00155740|tumor marker|tumor marker
5369823|NCT00155740|mesothelin|mesothelin
5369824|NCT00155727|colorectal cancer, laparoscopic colectomy|colorectal cancer, laparoscopic colectomy
5369825|NCT00155714|pulmonary arterial hypertension|pulmonary arterial hypertension
5369826|NCT00155714|type-5 phosphodiesterase Inhibitors|type-5 phosphodiesterase inhibitors
5369827|NCT00155714|Sildenafil|sildenafil
5369828|NCT00155701|DISC1|disc1
5369829|NCT00155701|Schizophrenia|schizophrenia
5369830|NCT00155701|Chromosome 1q|chromosome 1q
5369831|NCT00155701|Polymorphism detection|polymorphism detection
5369832|NCT00155701|Association study|association study
5369833|NCT00155701|Balanced translocation|balanced translocation
5369834|NCT00155701|DHPLC|dhplc
5369835|NCT00155688|Schizophrenia|schizophrenia
5369836|NCT00155688|linkage|linkage
5369837|NCT00155688|Taiwan|taiwan
5369838|NCT00155688|Han Chinese population|han chinese population
5369839|NCT00155662|work hardening|work hardening
5369840|NCT00155662|chronic low back pain over 3 months|chronic low back pain over 3 months
5369841|NCT00155649|schizophrenia|schizophrenia
5369842|NCT00155649|vulnerability gene|vulnerability gene
5369843|NCT00155649|positional cloning|positional cloning
5369844|NCT00155649|subtype definition|subtype definition
5369845|NCT00155649|endophenotype|endophenotype
5369846|NCT00155649|genetic marker|genetic marker
5369847|NCT00155649|genetic linkage|genetic linkage
5369848|NCT00155649|candidate genes|candidate genes
5369849|NCT00155636|Schizophrenia|schizophrenia
5369850|NCT00155623|H. pylori, 13C-urea breath test, serology, epidemiology|h. pylori, 13c-urea breath test, serology, epidemiology
5369851|NCT00155610|diabetic cystopathy|diabetic cystopathy
5369852|NCT00155610|bladder|bladder
5369853|NCT00155610|voiding dysfunction|voiding dysfunction
5369854|NCT00155610|current perception test|current perception test
5369855|NCT00155597|physical therapy|physical therapy
5369856|NCT00155597|post surgery|post surgery
5369857|NCT00155584|warts|warts
5369858|NCT00155584|photodynamic therapy|photodynamic therapy
5369859|NCT00155584|5-ALA|5-ala
5369860|NCT00155571|betel nut|betel nut
5369861|NCT00155571|periodontitis|periodontitis
5369862|NCT00155571|periodontal microbiology|periodontal microbiology
5369863|NCT00155558|Colorectal Cancer, Maximum tolerated dose|colorectal cancer, maximum tolerated dose
5369864|NCT00155545|functional scoliosis|functional scoliosis
5369865|NCT00155545|idiopathic scoliosis|idiopathic scoliosis
5369866|NCT00155545|leg length discrepancy|leg length discrepancy
5369867|NCT00155545|motion analysis|motion analysis
5369868|NCT00155545|biomechanics|biomechanics
5370061|NCT00154505|Lateral Trunk Support|lateral trunk support
5369869|NCT00155532|Peripheral neuropathy;systemic lupus erythematosus|peripheral neuropathy;systemic lupus erythematosus
5369870|NCT00155519|Schizophrenia|schizophrenia
5369871|NCT00155519|Latent Schizophrenia|latent schizophrenia
5369872|NCT00155519|Schizotypal Disorder|schizotypal disorder
5369873|NCT00155519|Psychopathology|psychopathology
5369874|NCT00155519|Neuropsychological Function|neuropsychological function
5369875|NCT00155519|Family History|family history
5369876|NCT00155519|Nosology|nosology
5369877|NCT00155519|basic symptoms|basic symptoms
5369878|NCT00155506|Schizophrenia|schizophrenia
5369879|NCT00155506|Niacin|niacin
5369880|NCT00155506|Genotyping|genotyping
5369881|NCT00155506|candidate gene|candidate gene
5369882|NCT00155506|one proband, normal parents and one normal sibling|one proband, normal parents and one normal sibling
5369883|NCT00155480|thoracic aorta|thoracic aorta
5369884|NCT00155480|finite element mesh|finite element mesh
5369885|NCT00155467|CT|ct
5369886|NCT00155467|children|children
5369887|NCT00155467|congenital|congenital
5369888|NCT00155454|Diabetic retinopathy|diabetic retinopathy
5369889|NCT00155454|Vitrectomy|vitrectomy
5369890|NCT00155454|Postoperative vitreous hemorrahge|postoperative vitreous hemorrahge
5369891|NCT00155454|Intravitreal gas injection|intravitreal gas injection
5369892|NCT00155441|sleep disorder|sleep disorder
5369893|NCT00155441|peritoneal dialysis|peritoneal dialysis
5369894|NCT00155441|cognitive-behavioral therapy|cognitive-behavioral therapy
5369895|NCT00155441|sleep disorder:C23.888.592.796|sleep disorder:c23.888.592.796
5369896|NCT00155441|peritoneal dialysis: F03.870.664|peritoneal dialysis: f03.870.664
5369897|NCT00155428|biomodel|biomodel
5369898|NCT00155428|rapid prototyping|rapid prototyping
5369899|NCT00155428|computed tomograpgy|computed tomograpgy
5369900|NCT00155415|Colonoscopy|colonoscopy
5369901|NCT00155415|Polyethylene glycol(PEG)|polyethylene glycol(peg)
5369902|NCT00155415|Colon neoplasm|colon neoplasm
5369903|NCT00155415|Colon cleansing|colon cleansing
5369904|NCT00155415|Timing|timing
5369905|NCT00155402|fibrin glue|fibrin glue
5369906|NCT00155402|corneal perforation|corneal perforation
5369907|NCT00155402|pterygium|pterygium
5369908|NCT00155402|conjunctiva|conjunctiva
5369909|NCT00155402|corneal ulcer|corneal ulcer
5369910|NCT00155389|Helicobacter pylori|helicobacter pylori
5369911|NCT00155389|Gastric cancer|gastric cancer
5369912|NCT00155389|single nucleotide polymorphism|single nucleotide polymorphism
5369913|NCT00155350|atherosclerosis|atherosclerosis
5369914|NCT00155350|calcification|calcification
5369915|NCT00155350|coronary|coronary
5369916|NCT00155350|inflammation|inflammation
5369917|NCT00155350|insulin|insulin
5369918|NCT00155350|plaque|plaque
5369919|NCT00155350|Coronary calcification|coronary calcification
5369920|NCT00155350|Plaque vulnerability|plaque vulnerability
5369921|NCT00155337|leukoplakia|leukoplakia
5369922|NCT00155337|erythroleukoplakia|erythroleukoplakia
5369923|NCT00155337|photodynamic therapy|photodynamic therapy
5369924|NCT00155324|plantar fasciitis|plantar fasciitis
5369925|NCT00155324|ultrasonographic examination|ultrasonographic examination
5369926|NCT00155311|orthodontic tooth movement|orthodontic tooth movement
5369927|NCT00155311|OPG|opg
5369928|NCT00155311|RANKL|rankl
5369929|NCT00155285|heart diseases|heart diseases
5369930|NCT00155285|congenital|congenital
5369931|NCT00155272|Hepatocellular Carcinoma|hepatocellular carcinoma
5369932|NCT00155272|Radiotherapy|radiotherapy
5369933|NCT00155272|Thalidomide|thalidomide
5369934|NCT00155272|Dynamic contrast enhanced MRI|dynamic contrast enhanced mri
5369935|NCT00155259|Breast Cancer , Neoadjuvant Chemotherapy|breast cancer , neoadjuvant chemotherapy
5369936|NCT00155246|CKD, pentoxifylline|ckd, pentoxifylline
5369937|NCT00155233|analgeisa|analgeisa
5369938|NCT00155233|postoperatve|postoperatve
5369939|NCT00155233|side effects|side effects
5369940|NCT00155207|Schizophrenia|schizophrenia
5369941|NCT00155207|endophenotype|endophenotype
5369942|NCT00155207|risk genetic mutation|risk genetic mutation
5369943|NCT00155207|vulnerability genes|vulnerability genes
5369944|NCT00155207|affected sib-pairs|affected sib-pairs
5369945|NCT00155207|case-control design|case-control design
5369946|NCT00155207|animal model|animal model
5369947|NCT00155207|functional validity|functional validity
5369948|NCT00155207|genetic epidemiological analysis|genetic epidemiological analysis
5369949|NCT00155181|Epstein-Barr virus|epstein-barr virus
5369950|NCT00155181|Nasopharyngeal carcinoma|nasopharyngeal carcinoma
5369951|NCT00155181|Carcinogenesis|carcinogenesis
5369952|NCT00155168|Spinal muscular atrophy (SMA)|spinal muscular atrophy (sma)
5369953|NCT00155168|SMN1/SMN2 gene|smn1/smn2 gene
5369954|NCT00155168|denaturing high-performance liquid chromatography (DHPLC)|denaturing high-performance liquid chromatography (dhplc)
5369955|NCT00155168|multiplex PCR|multiplex pcr
5369956|NCT00155168|gene dose|gene dose
5369957|NCT00155168|carrier test|carrier test
5369958|NCT00155129|migraine|migraine
5369959|NCT00155129|CGRP|cgrp
5369960|NCT00155129|nociceptin|nociceptin
5369961|NCT00155103|Hepatitis B|hepatitis b
5369962|NCT00155103|Carcinoma, Hepatocellular|carcinoma, hepatocellular
5369963|NCT00155103|Polymorphism, Genetic|polymorphism, genetic
5369964|NCT00155090|Magnetic resonance imaging,|magnetic resonance imaging,
5369965|NCT00155090|breast disease|breast disease
5369966|NCT00155077|cervical cancer, chemoradiotherapy, angiogenesis|cervical cancer, chemoradiotherapy, angiogenesis
5369967|NCT00155064|Primary aldosteronism|primary aldosteronism
5369968|NCT00155064|kallikrein|kallikrein
5369969|NCT00155064|aldosterone|aldosterone
5369970|NCT00155064|captopril|captopril
5369971|NCT00155038|Breast neoplasms|breast neoplasms
5369972|NCT00155038|breast radiography|breast radiography
5369973|NCT00155038|young women.|young women.
5369974|NCT00155025|Prostatic neoplasms|prostatic neoplasms
5369975|NCT00155025|Family history|family history
5369976|NCT00154999|hyperbilirubinemia|hyperbilirubinemia
5369977|NCT00154999|free radicals|free radicals
5369978|NCT00154999|Health neonate|health neonate
5369979|NCT00154986|invasion|invasion
5369980|NCT00154986|migration|migration
5369981|NCT00154986|metastasis|metastasis
5369982|NCT00154986|IGFBP-3|igfbp-3
5369983|NCT00154986|transfection|transfection
5369984|NCT00154986|signal transduction.|signal transduction.
5369985|NCT00154973|oral precancers|oral precancers
5369986|NCT00154973|oral cancer|oral cancer
5369987|NCT00154973|hypoxia-inducible factor|hypoxia-inducible factor
5369988|NCT00154960|Spinal muscular atrophy (SMA)|spinal muscular atrophy (sma)
5369989|NCT00154960|SMN1/SMN2 gene|smn1/smn2 gene
5369990|NCT00154960|denaturing high-performance liquid chromatography (DHPLC)|denaturing high-performance liquid chromatography (dhplc)
5369991|NCT00154960|multiplex PCR|multiplex pcr
5369992|NCT00154960|gene dose|gene dose
5369993|NCT00154960|carrier test|carrier test
5369994|NCT00154960|screen|screen
5369995|NCT00154960|stool|stool
5369996|NCT00154960|microsatellite|microsatellite
5369997|NCT00154895|minocycline|minocycline
5369998|NCT00154895|pleurodesis|pleurodesis
5369999|NCT00154895|thoracoscopy|thoracoscopy
5370000|NCT00154895|primary spontaneous pneumothorax|primary spontaneous pneumothorax
5370001|NCT00154895|clinical trial|clinical trial
5370002|NCT00154882|Breast Cancer|breast cancer
5370003|NCT00154882|First-line|first-line
5370004|NCT00154869|Patients with dual chronic hepatitis B and C|patients with dual chronic hepatitis b and c
5370005|NCT00154856|osteogenesis|osteogenesis
5370006|NCT00154856|Ilizarov fixator|ilizarov fixator
5370007|NCT00154856|motion analysis|motion analysis
5370008|NCT00154856|FEM|fem
5370009|NCT00154856|bone stress|bone stress
5370010|NCT00154843|Lycopene|lycopene
5370011|NCT00154843|BPH|bph
5370012|NCT00154843|PSA|psa
5370013|NCT00154843|IPSS|ipss
5370014|NCT00154817|radiotherapy|radiotherapy
5370015|NCT00154817|dynamic contrast enhanced MRI|dynamic contrast enhanced mri
5370016|NCT00154817|hepatocellular carcinoma|hepatocellular carcinoma
5370017|NCT00154804|Concurrent Chemoradiotherapy|concurrent chemoradiotherapy
5370018|NCT00154804|Esophageal Cancer|esophageal cancer
5370019|NCT00154791|Pancreatic adenocarcinoma|pancreatic adenocarcinoma
5370020|NCT00154791|Oxaliplatin|oxaliplatin
5370021|NCT00154791|Gemcitabine|gemcitabine
5370022|NCT00154791|5-FU|5-fu
5370023|NCT00154778|Combination,Chemotherapy,Advanced Gastric Cancer|combination,chemotherapy,advanced gastric cancer
5370024|NCT00154752|Rectal cancer, CCRT, Pelvic lymphadenoectomy.|rectal cancer, ccrt, pelvic lymphadenoectomy.
5370025|NCT00154739|Combination, Chemotherapy,non-small cell lung cancer|combination, chemotherapy,non-small cell lung cancer
5370026|NCT00154726|Paclitaxel-HDFL,Locally Advanced and Recurrent/Metastatic Gastric Cancer|paclitaxel-hdfl,locally advanced and recurrent/metastatic gastric cancer
5370027|NCT00154713|colorectal cancer|colorectal cancer
5370028|NCT00154713|dendritic cell|dendritic cell
5370029|NCT00154713|CEA|cea
5370030|NCT00154713|IL-2|il-2
5370031|NCT00154700|Combination,Chemotherapy,Esophageal Cancer|combination,chemotherapy,esophageal cancer
5370032|NCT00154687|Combination, Chemotherapy,transitional cell carcinoma|combination, chemotherapy,transitional cell carcinoma
5370033|NCT00154661|glomerulonephritis|glomerulonephritis
5370034|NCT00154648|MRA|mra
5370035|NCT00154648|DSA|dsa
5370036|NCT00154648|gadovist|gadovist
5370037|NCT00154648|angiography|angiography
5370038|NCT00154635|Alzheimer's disease|alzheimer's disease
5370039|NCT00154635|Fo-ti|fo-ti
5370040|NCT00154635|Chinese herbs|chinese herbs
5370041|NCT00154622|musculoskeletal disorder, work hardening, return to work|musculoskeletal disorder, work hardening, return to work
5370042|NCT00154596|etiology|etiology
5370043|NCT00154596|transmission|transmission
5370044|NCT00154596|vasculitis|vasculitis
5370045|NCT00154596|household|household
5370046|NCT00154596|etiology of disease|etiology of disease
5370047|NCT00154583|cervical cancer|cervical cancer
5370048|NCT00154583|human papillomavirus|human papillomavirus
5370049|NCT00154583|cancer vaccine|cancer vaccine
5370050|NCT00154583|normal volunteer|normal volunteer
5370051|NCT00154570|reflux esophagitis|reflux esophagitis
5370052|NCT00154570|24 hour esophageal pH|24 hour esophageal ph
5370053|NCT00154570|electrogastrography (EGG)|electrogastrography (egg)
5370054|NCT00154570|Running Spectral Analysis (RSA)|running spectral analysis (rsa)
5370055|NCT00154557|Judo, Performance, Injury|judo, performance, injury
5370056|NCT00154518|orthodontic tooth movement|orthodontic tooth movement
5370057|NCT00154518|matrix metalloproteinase|matrix metalloproteinase
5370058|NCT00154518|Orthodontics|orthodontics
5370059|NCT00154505|Scoliosis|scoliosis
5370060|NCT00154505|Spinal Cord Injury|spinal cord injury
5370062|NCT00154505|Radiography|radiography
5370063|NCT00154492|Active variceal bleeding in patients with advanced cirrhosis|active variceal bleeding in patients with advanced cirrhosis
5370064|NCT00154479|Cervical cancer|cervical cancer
5370065|NCT00154479|Human papillomavirus|human papillomavirus
5370066|NCT00154479|Human leukocyte antigen|human leukocyte antigen
5370067|NCT00154479|immunologic response|immunologic response
5370068|NCT00154479|healthy volunteers|healthy volunteers
5370069|NCT00154466|Myocardial infarction, stem cell, cardiac rehabilitation|myocardial infarction, stem cell, cardiac rehabilitation
5370070|NCT00154453|Aging|aging
5370071|NCT00154453|Orbicularis oculi|orbicularis oculi
5370072|NCT00154453|Blepharoplasty|blepharoplasty
5370073|NCT00154453|Myosin heavy chain (MHC)|myosin heavy chain (mhc)
5370074|NCT00154440|primary gastric MALT lymphoma|primary gastric malt lymphoma
5370075|NCT00154440|Helicobacter pylori|helicobacter pylori
5370076|NCT00154440|eradication therapy|eradication therapy
5370077|NCT00154440|radiation|radiation
5370078|NCT00154440|marginal zone B-cell lymphoma|marginal zone b-cell lymphoma
5370079|NCT00154440|Mucosa-associated Lymphoid Tissue|mucosa-associated lymphoid tissue
5370080|NCT00154440|B-cell Non-Hodgkin's Lymphoma of the stomach|b-cell non-hodgkin's lymphoma of the stomach
5370081|NCT00154440|primary gastric lymphoma|primary gastric lymphoma
5370082|NCT00154388|adenocarcinoma|adenocarcinoma
5370083|NCT00154388|leiomyosarcoma|leiomyosarcoma
5370084|NCT00154388|angiosarcoma|angiosarcoma
5370085|NCT00154388|synovial sarcoma|synovial sarcoma
5370086|NCT00154388|myelodysplastic syndrome/HES|myelodysplastic syndrome/hes
5370087|NCT00154388|CMML|cmml
5370088|NCT00154388|multiple myeloma|multiple myeloma
5370089|NCT00154388|embryonal rhabdomyosarcoma|embryonal rhabdomyosarcoma
5370090|NCT00154388|endometrial sarcoma|endometrial sarcoma
5370091|NCT00154388|adenoid cystic carcinoma|adenoid cystic carcinoma
5370092|NCT00154388|fibromatosis|fibromatosis
5370093|NCT00154388|ductal invasive breast carcinoma|ductal invasive breast carcinoma
5370094|NCT00154388|chondrosarcoma|chondrosarcoma
5370095|NCT00154388|pleural tumor|pleural tumor
5370096|NCT00154388|brenner tumor|brenner tumor
5370097|NCT00154388|ewing sarcoma|ewing sarcoma
5370098|NCT00154388|round cell tumor|round cell tumor
5370099|NCT00154388|seminoma|seminoma
5370100|NCT00154388|thymic carcinoma|thymic carcinoma
5370101|NCT00154388|malignant melanoma|malignant melanoma
5370102|NCT00154388|fibrosarcoma breast|fibrosarcoma breast
5370103|NCT00154388|dermatofibrosarcoma protuberans|dermatofibrosarcoma protuberans
5370104|NCT00154388|DFSP|dfsp
5370105|NCT00154388|ovarian stromal tumor|ovarian stromal tumor
5370106|NCT00154388|osteosarcoma|osteosarcoma
5370107|NCT00154388|chorioideal melanoma|chorioideal melanoma
5370108|NCT00154388|hemangiopericytoma|hemangiopericytoma
5370109|NCT00154388|myelofibrosis|myelofibrosis
5370110|NCT00154388|liposarcoma|liposarcoma
5370111|NCT00154388|SCLC|sclc
5370112|NCT00154388|small cell lung carcinoma|small cell lung carcinoma
5370113|NCT00154388|hypereosinophilic syndrome|hypereosinophilic syndrome
5370114|NCT00154388|chronic myelo-monocytic leukemia|chronic myelo-monocytic leukemia
5370115|NCT00154388|neurofibrosarcoma|neurofibrosarcoma
5370116|NCT00154388|mesothelioma|mesothelioma
5370117|NCT00154388|malignant mesenchymoma|malignant mesenchymoma
5370118|NCT00154388|malignant schwannoma|malignant schwannoma
5370119|NCT00154388|mast cell leukemia / mastocytosis|mast cell leukemia / mastocytosis
5370120|NCT00154388|renal cell carcinoma|renal cell carcinoma
5370121|NCT00154388|malignant histocytoma|malignant histocytoma
5370122|NCT00154388|chordoma|chordoma
5370123|NCT00154375|Open label|open label
5370124|NCT00154375|Imatinib mesylate|imatinib mesylate
5370125|NCT00154375|hydroxyurea|hydroxyurea
5370126|NCT00154375|temozolomide|temozolomide
5370127|NCT00154375|resistant|resistant
5370128|NCT00154375|protein tyrosine kinases|protein tyrosine kinases
5370129|NCT00154375|adenocarcinoma|adenocarcinoma
5370130|NCT00154375|glioblastoma multiforme|glioblastoma multiforme
5370131|NCT00154375|astrocytoma|astrocytoma
5370132|NCT00154375|brain tumor|brain tumor
5370133|NCT00154375|brain cancer|brain cancer
5370134|NCT00154362|Oxcarbazepine, conduct disorder, adolescents|oxcarbazepine, conduct disorder, adolescents
5370135|NCT00154349|Ph+ALL|ph+all
5370136|NCT00154349|imatinib mesylate|imatinib mesylate
5370137|NCT00154336|Rheumatoid arthritis, imatinib, methotrexate|rheumatoid arthritis, imatinib, methotrexate
5370138|NCT00154323|Oxcarbazepine, bipolar disorder|oxcarbazepine, bipolar disorder
5370139|NCT00154310|Renal transplantation, everolimus, immunosuppressants, CNI-free|renal transplantation, everolimus, immunosuppressants, cni-free
5370140|NCT00154297|Renal transplantation|renal transplantation
5370141|NCT00154297|everolimus|everolimus
5370142|NCT00154297|immunosuppressants|immunosuppressants
5370143|NCT00154297|wound-healing|wound-healing
5370144|NCT00154284|Renal transplantation,|renal transplantation,
5370145|NCT00154284|everolimus,|everolimus,
5370146|NCT00154284|immunosuppressants,|immunosuppressants,
5370147|NCT00154284|basiliximab,|basiliximab,
5370148|NCT00154284|cyclosporine microemulsion discontinuation, cyclosporine microemulsion minimization|cyclosporine microemulsion discontinuation, cyclosporine microemulsion minimization
5370149|NCT00154271|Hypertension (HTN)|hypertension (htn)
5370150|NCT00154271|High Sensitivity C-Reactive Protein|high sensitivity c-reactive protein
5370151|NCT00154258|Schizophrenia, treatment-resistant, clozapine|schizophrenia, treatment-resistant, clozapine
5370152|NCT00154245|Enteric-coated mycophenolate sodium, transplantation, de novo, cyclosporine|enteric-coated mycophenolate sodium, transplantation, de novo, cyclosporine
5370153|NCT00154232|Renal transplantation, DGF, basiliximab, EC-MPS, cyclosporine|renal transplantation, dgf, basiliximab, ec-mps, cyclosporine
5370154|NCT00154219|Osteoarthritis, Hip, Lumiracoxib, Efficacy, Safety|osteoarthritis, hip, lumiracoxib, efficacy, safety
5370155|NCT00154206|Enteric-coated mycophenolate sodium,|enteric-coated mycophenolate sodium,
5370156|NCT00154206|de novo,|de novo,
5370157|NCT00154206|renal transplantation,|renal transplantation,
5370158|NCT00154206|pediatric|pediatric
5370159|NCT00154206|De novo pediatric renal transplantation|de novo pediatric renal transplantation
5370160|NCT00154193|Heart transplant, lung transplant, renal function, cyclosporine C2 Levels|heart transplant, lung transplant, renal function, cyclosporine c2 levels
5370161|NCT00154180|Perimenopause|perimenopause
5370162|NCT00154180|Coronary Disease|coronary disease
5370163|NCT00154180|Estrogen Replacement Therapy|estrogen replacement therapy
5370164|NCT00154180|Hormone Replacement Therapy|hormone replacement therapy
5370165|NCT00154154|borderline personality disorder|borderline personality disorder
5370167|NCT00154154|treatment|treatment
5370168|NCT00154154|dialectical behavior therapy|dialectical behavior therapy
5370169|NCT00154154|DBT|dbt
5370170|NCT00154154|general Psychiatric management|general psychiatric management
5370171|NCT00154154|GPM|gpm
5370172|NCT00154154|suicide|suicide
5370173|NCT00154154|parasuicide|parasuicide
5370174|NCT00154154|randomized control trials|randomized control trials
5370175|NCT00154128|temporomandibular disorder|temporomandibular disorder
5370176|NCT00154128|craniomandibular disorder|craniomandibular disorder
5370177|NCT00154128|occlusal appliance|occlusal appliance
5370178|NCT00154128|clinical trial|clinical trial
5370179|NCT00154115|heart failure|heart failure
5370180|NCT00154115|levosimendan|levosimendan
5370181|NCT00154115|cardiac surgery|cardiac surgery
5370182|NCT00154102|Metastatic colorectal cancer|metastatic colorectal cancer
5370183|NCT00154102|EGFR|egfr
5370184|NCT00154102|Irinotecan|irinotecan
5370185|NCT00154102|cetuximab|cetuximab
5370186|NCT00154102|first-line treatment|first-line treatment
5370187|NCT00154089|cervical intraepithelial neoplasia|cervical intraepithelial neoplasia
5370188|NCT00154089|CIN|cin
5370189|NCT00154089|HPV|hpv
5370190|NCT00154050|restenosis|restenosis
5370191|NCT00154050|intima hyperproliferation|intima hyperproliferation
5370192|NCT00154050|stent angioplasty|stent angioplasty
5370193|NCT00154050|pain-free walking distance|pain-free walking distance
5370194|NCT00154037|vascular reactivity|vascular reactivity
5370195|NCT00154037|venodilation|venodilation
5370196|NCT00154037|pulse wave velocity|pulse wave velocity
5370197|NCT00154024|venoconstriction|venoconstriction
5370198|NCT00154024|venodilation|venodilation
5370199|NCT00154024|pleiotropic effects|pleiotropic effects
5370200|NCT00154011|vascular reactivity, venodilation|vascular reactivity, venodilation
5370201|NCT00153998|Cetuximab|cetuximab
5370202|NCT00153998|Oxaliplatin|oxaliplatin
5370203|NCT00153998|Irinotecan|irinotecan
5370204|NCT00153998|5-FU|5-fu
5370205|NCT00153998|Chemotherapy|chemotherapy
5370206|NCT00153998|Resection|resection
5370207|NCT00153998|Liver resection|liver resection
5370208|NCT00153998|Neoadjuvant|neoadjuvant
5370209|NCT00153985|Hemoglobinopathies|hemoglobinopathies
5370210|NCT00153985|Sickle cell anemia|sickle cell anemia
5370211|NCT00153985|sickle cell-hemoglobin C disease|sickle cell-hemoglobin c disease
5370212|NCT00153985|sickle cell-B-thalassemia|sickle cell-b-thalassemia
5370213|NCT00153985|transfusion-dependant thalassemia|transfusion-dependant thalassemia
5370214|NCT00153985|allogeneic transplant|allogeneic transplant
5370215|NCT00153985|nonmyeloablative transplant|nonmyeloablative transplant
5370216|NCT00153985|Stem cell transfusion|stem cell transfusion
5370217|NCT00153985|graft vs. host disease|graft vs. host disease
5370218|NCT00153972|Parkinson's disease|parkinson's disease
5370219|NCT00153972|Fluoro-Dopa-PET|fluoro-dopa-pet
5370220|NCT00153972|Dopamine agonists|dopamine agonists
5370221|NCT00153972|Cabergoline|cabergoline
5370222|NCT00153972|Surrogate marker|surrogate marker
5370223|NCT00153972|Dopamine turnover|dopamine turnover
5370224|NCT00153946|Free Radical Scavenger|free radical scavenger
5370225|NCT00153946|Selective Thrombin Inhibitor|selective thrombin inhibitor
5370226|NCT00153946|Acute ischemic stroke (nonlacunar and noncardioembolic)|acute ischemic stroke (nonlacunar and noncardioembolic)
5370227|NCT00153933|Multiple Myeloma|multiple myeloma
5370228|NCT00153933|bortezomib|bortezomib
5370229|NCT00153933|Revlimid|revlimid
5370230|NCT00153933|CC-5013|cc-5013
5370231|NCT00153920|multiple myeloma|multiple myeloma
5370232|NCT00153920|Velcade|velcade
5370233|NCT00153920|bortezomib|bortezomib
5370234|NCT00153907|Xeloda|xeloda
5370235|NCT00153907|Navelbine|navelbine
5370236|NCT00153907|capecitabine|capecitabine
5370237|NCT00153907|metastatic breast cancer|metastatic breast cancer
5370238|NCT00153894|Breast cancer survivor|breast cancer survivor
5370239|NCT00153894|Insulin levels|insulin levels
5370240|NCT00153894|exercise regimen|exercise regimen
5370241|NCT00153894|endurance training|endurance training
5370242|NCT00153894|strength training|strength training
5370243|NCT00153881|Esophageal Cancer|esophageal cancer
5370244|NCT00153881|Trimodality|trimodality
5370245|NCT00153881|Capecitabine|capecitabine
5370247|NCT00153881|Gastro-esophageal Neoplasm|gastro-esophageal neoplasm
5370248|NCT00153881|Carcinoma of the Esophagus|carcinoma of the esophagus
5370249|NCT00153868|Anemia|anemia
5370250|NCT00153868|Cancer|cancer
5370251|NCT00153868|Quality of life|quality of life
5370252|NCT00153868|Web-based|web-based
5370253|NCT00153868|Aranesp|aranesp
5370254|NCT00153868|Darbepoetin alfa|darbepoetin alfa
5370255|NCT00153855|etiology|etiology
5370256|NCT00153855|pathology|pathology
5370257|NCT00153842|NSCLC|nsclc
5370258|NCT00153842|Bexarotene|bexarotene
5370259|NCT00153842|Targretin|targretin
5370260|NCT00153829|Chronic Disease|chronic disease
5370261|NCT00153829|Quality of Life|quality of life
5370262|NCT00153816|Colorectal neoplasms|colorectal neoplasms
5370263|NCT00153816|Adenomatous polyps|adenomatous polyps
5370264|NCT00153803|Erlotinib|erlotinib
5370265|NCT00153803|Tarceva|tarceva
5370266|NCT00153803|Web based|web based
5370267|NCT00153803|Stage III NSCLC|stage iii nsclc
5370268|NCT00153790|green tea|green tea
5370269|NCT00153790|weight|weight
5370270|NCT00153790|women|women
5370271|NCT00153777|HIV prevention|hiv prevention
5370272|NCT00153777|Randomized controlled trial|randomized controlled trial
5370273|NCT00153777|Women|women
5370274|NCT00153777|Sexually transmitted infections|sexually transmitted infections
5370275|NCT00153777|HIV Seronegativity|hiv seronegativity
5370276|NCT00153764|supplement|supplement
5370277|NCT00153764|omega-3 fatty acid|omega-3 fatty acid
5370278|NCT00153764|Homocysteine|homocysteine
5370279|NCT00153764|LDL cholesterol|ldl cholesterol
5370280|NCT00153751|Traditional Chinese Medicine|traditional chinese medicine
5370281|NCT00153738|LDL-C, phytosterol|ldl-c, phytosterol
5370282|NCT00153712|Non-NSAID|non-nsaid
5370283|NCT00153712|Non-Hp Bleeding Peptic Ulcer|non-hp bleeding peptic ulcer
5370284|NCT00153699|Side effects|side effects
5370285|NCT00153699|Topiramate|topiramate
5370286|NCT00153686|Capsule Endoscopy|capsule endoscopy
5370287|NCT00153686|Mesenteric angiogram|mesenteric angiogram
5370288|NCT00153673|celecoxib|celecoxib
5370289|NCT00153673|arthritis|arthritis
5370290|NCT00153673|ulcer healing|ulcer healing
5370291|NCT00153634|Cystic fibrosis|cystic fibrosis
5370292|NCT00153634|Antibiotic susceptibility testing|antibiotic susceptibility testing
5370293|NCT00153634|Pseudomonas aeruginosa|pseudomonas aeruginosa
5370294|NCT00153634|Chronic bronchitis|chronic bronchitis
5370295|NCT00153634|Biofilms|biofilms
5370296|NCT00153621|Pediatrics|pediatrics
5370297|NCT00153621|Chronic Kidney Failure|chronic kidney failure
5370298|NCT00153621|HIV|hiv
5370299|NCT00153621|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5370300|NCT00153621|AIDS-Associated Nephropathy|aids-associated nephropathy
5370301|NCT00153595|Allergic rhinitis|allergic rhinitis
5370302|NCT00153595|EWO1|ewo1
5370303|NCT00153556|Haemophilus influenza type B|haemophilus influenza type b
5370304|NCT00153556|Carrier state|carrier state
5370305|NCT00153556|Bacterial Vaccines|bacterial vaccines
5370306|NCT00153556|Anti-PRP antibody|anti-prp antibody
5370307|NCT00153556|Antibody avidity|antibody avidity
5370308|NCT00153556|Serum bacteriocidal antibody|serum bacteriocidal antibody
5370309|NCT00153556|American Indians/Alaska Natives|american indians/alaska natives
5370310|NCT00153556|Case control study|case control study
5370311|NCT00153556|Adult vaccines|adult vaccines
5370312|NCT00153530|primary central nervous system lymphoma|primary central nervous system lymphoma
5370313|NCT00153517|Bacterial Vaginosis|bacterial vaginosis
5370314|NCT00153517|Metronidazole|metronidazole
5370315|NCT00153504|HIV|hiv
5370316|NCT00153504|AIDS|aids
5370317|NCT00153504|Homeless|homeless
5370318|NCT00153504|Homelessness|homelessness
5370319|NCT00153504|Housing|housing
5370320|NCT00153504|HIV seropositive|hiv seropositive
5370321|NCT00153504|HIV risk behavior|hiv risk behavior
5370322|NCT00153491|malaria|malaria
5370323|NCT00153491|artemether-lumefantrine|artemether-lumefantrine
5370324|NCT00153491|co-artem|co-artem
5370325|NCT00153491|Tanzania|tanzania
5370326|NCT00153491|adherence|adherence
5370327|NCT00153478|Alcohol-Exposed Pregnancy|alcohol-exposed pregnancy
5370328|NCT00153478|Binge drinking|binge drinking
5370329|NCT00153478|Frequent drinking|frequent drinking
5370330|NCT00153478|Unintended pregnancy|unintended pregnancy
5370331|NCT00153478|Fetal Alcohol Syndrome|fetal alcohol syndrome
5370332|NCT00153465|Parent training|parent training
5370333|NCT00153465|Child maltreatment|child maltreatment
5370334|NCT00153465|Motivation|motivation
5370335|NCT00153465|Program attrition|program attrition
5370336|NCT00153439|parenting|parenting
5370337|NCT00153439|motivation|motivation
5370338|NCT00153439|child maltreatment|child maltreatment
5370339|NCT00153439|program attrition|program attrition
5370340|NCT00153400|CVD risk|cvd risk
5370341|NCT00153361|HIV Seronegativity|hiv seronegativity
5370342|NCT00153361|HIV|hiv
5370343|NCT00153335|Health Risk Assessment|health risk assessment
5370344|NCT00153335|Behavior Change|behavior change
5370345|NCT00153335|Patient-Provider Interaction|patient-provider interaction
5370346|NCT00153335|Employee Health|employee health
5370347|NCT00153335|Absenteeism|absenteeism
5370348|NCT00153335|Tobacco Use|tobacco use
5370349|NCT00153335|Substance Use|substance use
5370350|NCT00153335|Diet|diet
5370351|NCT00153335|Exercise|exercise
5370352|NCT00153335|Medication Adherence|medication adherence
5370353|NCT00153322|Childhood Obesity|childhood obesity
5370354|NCT00153322|Community-based Participatory Research|community-based participatory research
5370355|NCT00153322|School intervention|school intervention
5370356|NCT00153322|Parental Involvement|parental involvement
5370357|NCT00153309|arthritis|arthritis
5370358|NCT00153309|exercise|exercise
5370359|NCT00153309|physical activity|physical activity
5370360|NCT00153309|physical function|physical function
5370361|NCT00153309|pain|pain
5370362|NCT00153296|Bronchial asthma|bronchial asthma
5370363|NCT00153296|Carbamazepine|carbamazepine
5370364|NCT00153296|Antiepileptic drugs|antiepileptic drugs
5370365|NCT00153296|Efficacy|efficacy
5370366|NCT00153283|Bronchial asthma|bronchial asthma
5370367|NCT00153283|Gabapentin|gabapentin
5370368|NCT00153283|Antiepileptic drug|antiepileptic drug
5370369|NCT00153283|Efficacy|efficacy
5370370|NCT00153270|Bronchial asthma|bronchial asthma
5370371|NCT00153270|Sodium valproate|sodium valproate
5370372|NCT00153270|Antiepileptic drug|antiepileptic drug
5370373|NCT00153270|Efficacy|efficacy
5370374|NCT00153244|Bronchial asthma|bronchial asthma
5370375|NCT00153244|Lamotrigine|lamotrigine
5370376|NCT00153244|Antiepileptic drug|antiepileptic drug
5370377|NCT00153244|Efficacy|efficacy
5370378|NCT00153218|Metastatic Breast Cancer|metastatic breast cancer
5370379|NCT00153218|Her2neu|her2neu
5370380|NCT00153218|trastuzumab|trastuzumab
5370381|NCT00153205|medication errors|medication errors
5370382|NCT00153205|medical records systems, computerized|medical records systems, computerized
5370383|NCT00153205|patient safety|patient safety
5370384|NCT00153192|Marinol|marinol
5370385|NCT00153192|Dronabinol|dronabinol
5370386|NCT00153192|Cannabinoid|cannabinoid
5370387|NCT00153192|Chronic Pain|chronic pain
5370388|NCT00153179|insulin resistance|insulin resistance
5370389|NCT00153179|insulin signaling|insulin signaling
5370390|NCT00153179|endothelium-dependent vasodilation|endothelium-dependent vasodilation
5370391|NCT00153166|peripheral arterial disease|peripheral arterial disease
5370392|NCT00153166|intermittent claudication|intermittent claudication
5370393|NCT00152945|intestinal lipoprotein|intestinal lipoprotein
5370394|NCT00152945|very low density lipoprotein|very low density lipoprotein
5370395|NCT00152945|free fatty acids|free fatty acids
5370396|NCT00152945|Apo B48 and Apo B100|apo b48 and apo b100
5370397|NCT00152945|triglycerides|triglycerides
5370398|NCT00152945|Intestinal lipoprotein production|intestinal lipoprotein production
5370399|NCT00152932|Glaucoma|glaucoma
5370400|NCT00152932|Intraocular pressure|intraocular pressure
5370401|NCT00152932|Ocular blood flow|ocular blood flow
5370402|NCT00152932|Laser-Doppler Flowmetry|laser-doppler flowmetry
5370403|NCT00152893|HIV|hiv
5370404|NCT00152893|blood sugar > 6.1 mmol/l|blood sugar > 6.1 mmol/l
5370405|NCT00152893|triglycerides > 2 mmol/l|triglycerides > 2 mmol/l
5370406|NCT00152893|total cholesterol > 5.5 mmol/l or HDL < 0.9 mmol/l|total cholesterol > 5.5 mmol/l or hdl < 0.9 mmol/l
5370407|NCT00152880|Hepatitis B, apoptosis|hepatitis b, apoptosis
5370408|NCT00152867|quality of life|quality of life
5370409|NCT00152867|dexamethasone|dexamethasone
5370410|NCT00152867|emesis|emesis
5370411|NCT00152854|cancer pain|cancer pain
5370412|NCT00152854|acetaminophen|acetaminophen
5370413|NCT00152854|opioids|opioids
5370414|NCT00152815|HIV|hiv
5370415|NCT00152815|non-alcoholic fatty liver disease|non-alcoholic fatty liver disease
5370416|NCT00152802|liver transplant|liver transplant
5370417|NCT00152802|antibody response|antibody response
5370418|NCT00152802|opsonophagocytic assay|opsonophagocytic assay
5370419|NCT00152802|pneumococcal conjugate vaccine|pneumococcal conjugate vaccine
5370420|NCT00152802|pneumococcal polysaccharide vaccine|pneumococcal polysaccharide vaccine
5370421|NCT00152776|menopausal symptoms|menopausal symptoms
5370422|NCT00152776|complementary medicine|complementary medicine
5370423|NCT00152763|health anxiety|health anxiety
5370424|NCT00152750|Tourette's Syndrome|tourette's syndrome
5370425|NCT00152750|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
5370426|NCT00152750|Children|children
5370427|NCT00152750|Sleep disorders|sleep disorders
5370428|NCT00152750|Aggression|aggression
5370429|NCT00152737|Intermittent Claudication|intermittent claudication
5370430|NCT00152737|Peripheral Vascular Diseases|peripheral vascular diseases
5370431|NCT00152737|Blood Gas Monitoring, Transcutaneous|blood gas monitoring, transcutaneous
5370433|NCT00152724|Physiology|physiology
5370434|NCT00152724|Microcirculation|microcirculation
5370435|NCT00152724|Laser-Doppler Flowmetry|laser-doppler flowmetry
5370436|NCT00152659|Epilepsy|epilepsy
5370437|NCT00152659|Tumor|tumor
5370438|NCT00152659|Surgery|surgery
5370439|NCT00152659|Brain|brain
5370440|NCT00152633|endothelium, hypertension, retina, AT1|endothelium, hypertension, retina, at1
5370441|NCT00152620|Inflammatory Bowel Disease (IBD)|inflammatory bowel disease (ibd)
5370442|NCT00152607|Liver Transplantation|liver transplantation
5370443|NCT00152607|Living Donors|living donors
5370444|NCT00152607|End Stage Liver Disease|end stage liver disease
5370445|NCT00152581|HCV, genotype 1, treatment, HCV kinetics, T-cells|hcv, genotype 1, treatment, hcv kinetics, t-cells
5370446|NCT00152568|Car Seat Check|car seat check
5370447|NCT00152555|SLE,|sle,
5370448|NCT00152555|exercize,|exercize,
5370449|NCT00152555|physical therapy,|physical therapy,
5370450|NCT00152555|Systemic lupus erythematosus|systemic lupus erythematosus
5370451|NCT00152555|relaxation therapy|relaxation therapy
5370452|NCT00152542|Inhaled nitric oxide,|inhaled nitric oxide,
5370453|NCT00152542|Lung recruitment,|lung recruitment,
5370454|NCT00152542|Ventilatory approach,|ventilatory approach,
5370455|NCT00152542|Neurodevelopmental outcomes,|neurodevelopmental outcomes,
5370456|NCT00152542|School age children|school age children
5370457|NCT00152529|Depression, educational site for depression|depression, educational site for depression
5370458|NCT00152516|Partial Onset Seizures|partial onset seizures
5370459|NCT00152516|levetiracetam|levetiracetam
5370460|NCT00152516|Epilepsy|epilepsy
5370461|NCT00152516|Keppra|keppra
5370462|NCT00152503|Epilepsy, Partial Onset Seizures, Seletracetam|epilepsy, partial onset seizures, seletracetam
5370463|NCT00152490|Crohn's disease, CDP870, CDAI, clinical response, remission,|crohn's disease, cdp870, cdai, clinical response, remission,
5370464|NCT00152490|Certolizumab Pegol, Cimzia|certolizumab pegol, cimzia
5370465|NCT00152477|Non-small-cell-lung cancer|non-small-cell-lung cancer
5370466|NCT00152477|carboplatin|carboplatin
5370467|NCT00152477|paclitaxel|paclitaxel
5370468|NCT00152477|VEGF|vegf
5370469|NCT00152477|monoclonal antibody|monoclonal antibody
5370470|NCT00152464|EPAAC , atopic Children, asthma, XYZAL, levocetirizine|epaac , atopic children, asthma, xyzal, levocetirizine
5370471|NCT00152451|Epilepsy: partial onset seizures, seletracetam|epilepsy: partial onset seizures, seletracetam
5370472|NCT00152438|Vasomotor symptoms|vasomotor symptoms
5370473|NCT00152438|Menopause|menopause
5370474|NCT00152425|Crohn's disease, CDP870, CDAI, clinical response, remission, Certolizumab Pegol, Cimzia|crohn's disease, cdp870, cdai, clinical response, remission, certolizumab pegol, cimzia
5370475|NCT00152412|Allergic Rhinitis, safety, levocetirizine, children|allergic rhinitis, safety, levocetirizine, children
5370476|NCT00152412|Xyzal|xyzal
5370477|NCT00152399|Peptic ulcer bleeding, upper intestinal bleeding, endoscopy, somatostatin|peptic ulcer bleeding, upper intestinal bleeding, endoscopy, somatostatin
5370478|NCT00152386|Rheumatoid Arthritis, CDP870|rheumatoid arthritis, cdp870
5370479|NCT00152386|Certolizumab pegol, Cimzia|certolizumab pegol, cimzia
5370480|NCT00152373|Epilepsy, Partial Onset Seizures; Keppra; Levetiracetam|epilepsy, partial onset seizures; keppra; levetiracetam
5370481|NCT00152360|Obesity|obesity
5370482|NCT00152360|weight loss|weight loss
5370483|NCT00152360|cardiovascular risk factors|cardiovascular risk factors
5370484|NCT00152360|Obesity and obesity related pathology|obesity and obesity related pathology
5370485|NCT00152334|Efficacy study|efficacy study
5370486|NCT00152334|assessment of patient outcomes following treatment|assessment of patient outcomes following treatment
5370487|NCT00152321|osteoporosis|osteoporosis
5370488|NCT00152321|wrist fractures|wrist fractures
5370489|NCT00152321|quality improvement|quality improvement
5370490|NCT00152321|knowledge translation|knowledge translation
5370491|NCT00152295|Postmenopausal|postmenopausal
5370492|NCT00152295|Amenorrhea|amenorrhea
5370493|NCT00152295|Hormone replacement therapy|hormone replacement therapy
5370494|NCT00152295|HRT|hrt
5370495|NCT00152295|asoprisnil|asoprisnil
5370496|NCT00152295|Estrogen Replacement Therapy, postmenopause|estrogen replacement therapy, postmenopause
5370497|NCT00152282|Postmenopausal|postmenopausal
5370498|NCT00152282|Amenorrhea|amenorrhea
5370499|NCT00152282|Hormone replacement therapy|hormone replacement therapy
5370500|NCT00152282|HRT|hrt
5370501|NCT00152282|asoprisnil|asoprisnil
5370502|NCT00152269|Symptomatic Uterine Fibroids|symptomatic uterine fibroids
5370503|NCT00152269|Excessive Uterine Bleeding|excessive uterine bleeding
5370504|NCT00152269|Uterine Hemorrhage|uterine hemorrhage
5370505|NCT00152269|asoprisnil|asoprisnil
5370506|NCT00152256|Symptomatic Uterine Fibroids|symptomatic uterine fibroids
5370507|NCT00152256|Excessive Uterine Bleeding|excessive uterine bleeding
5370508|NCT00152256|Uterine Hemorrhage|uterine hemorrhage
5370509|NCT00152243|Stomach Cancer|stomach cancer
5370510|NCT00152230|Colorectal Cancer|colorectal cancer
5370511|NCT00152217|Stomach cancer|stomach cancer
5370512|NCT00152204|Use-Effectiveness|use-effectiveness
5370513|NCT00152204|Cost Effectiveness|cost effectiveness
5370514|NCT00152204|Patient Acceptance of Health Care|patient acceptance of health care
5370515|NCT00152204|Drug Resistance|drug resistance
5370516|NCT00152204|Delivery of Health Care|delivery of health care
5370517|NCT00152191|Breast Cancer|breast cancer
5370518|NCT00152178|Breast Cancer|breast cancer
5370519|NCT00152165|spinal motion|spinal motion
5370520|NCT00152165|tantalum beads|tantalum beads
5370521|NCT00152165|DYNESYS Stabilization system|dynesys stabilization system
5370522|NCT00152165|spinal fusion|spinal fusion
5370523|NCT00152165|Radiostereometric Analysis following spinal fusion|radiostereometric analysis following spinal fusion
5370524|NCT00152165|Radiostereometric Analysis following surgery with DYNESYS Stabilization System|radiostereometric analysis following surgery with dynesys stabilization system
5370525|NCT00152152|spinal motion|spinal motion
5370526|NCT00152152|tantalum beads|tantalum beads
5370527|NCT00152139|High risk hematologic malignancies|high risk hematologic malignancies
5370528|NCT00152139|Allogeneic stem cell transplant|allogeneic stem cell transplant
5370529|NCT00152139|Matched unrelated donor transplantation|matched unrelated donor transplantation
5370530|NCT00152139|Unmanipulated stem cell graft|unmanipulated stem cell graft
5370821|NCT00150462|Lymphoma|lymphoma
5370531|NCT00152139|Bone marrow transplantation|bone marrow transplantation
5370532|NCT00152126|Autologous stem cell transplantation|autologous stem cell transplantation
5370533|NCT00152126|CD133 cell selection|cd133 cell selection
5370534|NCT00152126|CliniMACS device|clinimacs device
5370535|NCT00152126|Tumor marker|tumor marker
5370536|NCT00152126|Tumor purging|tumor purging
5370537|NCT00152113|Sickle Cell Anemia|sickle cell anemia
5370538|NCT00152113|Stem Cell Transplantation|stem cell transplantation
5370539|NCT00152113|Haploidentical stem cell transplant|haploidentical stem cell transplant
5370540|NCT00152113|T cell depletion|t cell depletion
5370541|NCT00152113|CliniMACS device|clinimacs device
5370542|NCT00152100|Severe combined immunodeficiency|severe combined immunodeficiency
5370543|NCT00152100|Transplantation|transplantation
5370544|NCT00152100|Haploidentical|haploidentical
5370545|NCT00152087|Liver cancer|liver cancer
5370546|NCT00152087|Brachytherapy|brachytherapy
5370547|NCT00152074|Blood pressure|blood pressure
5370548|NCT00152074|Sodium|sodium
5370549|NCT00152074|Dietary|dietary
5370550|NCT00152074|Hypertension or prehypertension|hypertension or prehypertension
5370551|NCT00152061|HIV|hiv
5370552|NCT00152061|Antiretroviral Drug Resistance|antiretroviral drug resistance
5370553|NCT00152061|Treatment Experienced|treatment experienced
5370554|NCT00151905|bronchiolitis|bronchiolitis
5370555|NCT00151905|hypertonic saline|hypertonic saline
5370556|NCT00151879|partial seizures with or without secondary generalization|partial seizures with or without secondary generalization
5370557|NCT00151866|Thrombopenia|thrombopenia
5370558|NCT00151866|Platelet transfusion|platelet transfusion
5370559|NCT00151866|Increment|increment
5370560|NCT00151866|Transfusion reactions|transfusion reactions
5370561|NCT00151866|Bleeding complication|bleeding complication
5370562|NCT00151853|CPB|cpb
5370563|NCT00151853|oral anticoagulant therapy|oral anticoagulant therapy
5370564|NCT00151853|plasma|plasma
5370565|NCT00151853|PCC|pcc
5370566|NCT00151840|Purpura, Thrombocytopenic, Idiopathic|purpura, thrombocytopenic, idiopathic
5370567|NCT00151840|ITP|itp
5370568|NCT00151840|Immunoglobulin, Intravenous|immunoglobulin, intravenous
5370569|NCT00151814|Olmesartan PK in children|olmesartan pk in children
5370570|NCT00151801|multiple sclerosis|multiple sclerosis
5370571|NCT00151801|estroprogestins|estroprogestins
5370572|NCT00151801|interferon-beta|interferon-beta
5370573|NCT00151801|sex hormones|sex hormones
5370574|NCT00151801|MRI|mri
5370575|NCT00151775|Treatment of hypertension or high blood pressure in children ages 1-16 years.|treatment of hypertension or high blood pressure in children ages 1-16 years.
5370576|NCT00151762|Open label, Diabetes Mellitus|open label, diabetes mellitus
5370577|NCT00151762|Long term safety study, extension study|long term safety study, extension study
5370578|NCT00151749|Diabetes mellitus|diabetes mellitus
5370579|NCT00151736|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
5370580|NCT00151736|CLL|cll
5370581|NCT00151736|Leukemia|leukemia
5370582|NCT00151723|endogenous subclinical hyperthyroidism|endogenous subclinical hyperthyroidism
5370583|NCT00151697|diabetes|diabetes
5370584|NCT00151697|failing oral treatment|failing oral treatment
5370585|NCT00151697|weight gain|weight gain
5370586|NCT00151684|Obesity|obesity
5370587|NCT00151684|Hyperinsulinism|hyperinsulinism
5370588|NCT00151684|Diazoxide|diazoxide
5370589|NCT00151671|Surgery|surgery
5370590|NCT00151671|Liver Cancer|liver cancer
5370591|NCT00151671|Cirrhosis|cirrhosis
5370592|NCT00151671|Nutrition|nutrition
5370593|NCT00151658|Coronary complex lesions|coronary complex lesions
5370594|NCT00151658|Restenosis|restenosis
5370595|NCT00151658|Drug eluting stents|drug eluting stents
5370596|NCT00151645|Immunotherapy|immunotherapy
5370597|NCT00151645|Renal cell carcinoma|renal cell carcinoma
5370598|NCT00151645|Metastasis|metastasis
5370599|NCT00151645|Lymphokine activated killers|lymphokine activated killers
5370600|NCT00151645|Cell therapy|cell therapy
5370601|NCT00151632|Immunosuppression|immunosuppression
5370602|NCT00151632|Liver transplantation|liver transplantation
5370603|NCT00151632|Acute graft rejection|acute graft rejection
5370604|NCT00151632|Treatment combination|treatment combination
5370605|NCT00151619|Calcium channel blockers|calcium channel blockers
5370606|NCT00151619|Heart failure|heart failure
5370607|NCT00151619|Hemodynamics|hemodynamics
5370608|NCT00151606|Infection prevention|infection prevention
5370609|NCT00151606|Isolation|isolation
5370610|NCT00151606|Resistant bacteria|resistant bacteria
5370611|NCT00151606|MRSA colonization|mrsa colonization
5370612|NCT00151593|Cold storage|cold storage
5370613|NCT00151593|Liver transplantation|liver transplantation
5370614|NCT00151593|Preservation solution|preservation solution
5370615|NCT00151580|Hepatitis C|hepatitis c
5370616|NCT00151580|Viral recurrence|viral recurrence
5370617|NCT00151580|Ribavirin / Interferon|ribavirin / interferon
5370618|NCT00151567|Ureterolithiasis|ureterolithiasis
5370619|NCT00151567|Alpha1-blocker|alpha1-blocker
5370620|NCT00151567|Lower ureteral stone|lower ureteral stone
5370621|NCT00151554|Anxiety|anxiety
5370622|NCT00151554|Intensive Care Unit (ICU)|intensive care unit (icu)
5370623|NCT00151554|Preoperative Information|preoperative information
5370624|NCT00151554|Randomized Controlled Trial (RCT)|randomized controlled trial (rct)
5370625|NCT00151554|Chronic heart disease|chronic heart disease
5370626|NCT00151541|Acne Vulgaris|acne vulgaris
5370627|NCT00151541|Acne|acne
5370628|NCT00151541|Dermatology|dermatology
5370629|NCT00151541|Dapsone|dapsone
5370630|NCT00151541|Dapsone Topical Gel|dapsone topical gel
5370631|NCT00151515|Alopecia, Balding|alopecia, balding
5370632|NCT00151476|Familial adenomatous polyposis|familial adenomatous polyposis
5370633|NCT00151476|celecoxib|celecoxib
5370634|NCT00151476|IRA|ira
5370635|NCT00151476|IPAA|ipaa
5370636|NCT00151411|Polycystic Ovary Syndrome (PCOS)|polycystic ovary syndrome (pcos)
5370637|NCT00151411|Anovulation|anovulation
5370638|NCT00151411|Elevated Testosterone|elevated testosterone
5370639|NCT00151346|Epidural|epidural
5370640|NCT00151346|Labour pain|labour pain
5370641|NCT00151346|Pregnant women|pregnant women
5370642|NCT00151346|Epidural anesthesia|epidural anesthesia
5370643|NCT00151346|Labour, Obstetric|labour, obstetric
5370644|NCT00151346|labor pain|labor pain
5370645|NCT00151346|labor, obstetric|labor, obstetric
5370646|NCT00151346|labor analgesia|labor analgesia
5370647|NCT00151320|diffuse large B cell|diffuse large b cell
5370648|NCT00151320|mantle cell lymphoma|mantle cell lymphoma
5370649|NCT00151307|Heart surgery|heart surgery
5370650|NCT00151307|Cerebral oxygen saturation|cerebral oxygen saturation
5370651|NCT00151307|Neuropsychological function|neuropsychological function
5370652|NCT00151294|Depression (mild to moderate)|depression (mild to moderate)
5370653|NCT00151294|Affective symptoms|affective symptoms
5370654|NCT00151294|Emotional lability|emotional lability
5370655|NCT00151294|Multiple Sclerosis|multiple sclerosis
5370656|NCT00151281|relapsed mantle cell lymphoma|relapsed mantle cell lymphoma
5370657|NCT00151268|Batten Disease|batten disease
5370658|NCT00151268|Late Infantile Neuronal Lipofuscinosis|late infantile neuronal lipofuscinosis
5370659|NCT00151268|LINCL|lincl
5370660|NCT00151255|age > 60 years|age > 60 years
5370661|NCT00151229|isolated systolic hypertension|isolated systolic hypertension
5370662|NCT00151229|valsartan|valsartan
5370663|NCT00151229|target blood pressure|target blood pressure
5370664|NCT00151216|Batten Disease|batten disease
5370665|NCT00151216|Late Infantile Neuronal Ceroid Lipofuscinosis|late infantile neuronal ceroid lipofuscinosis
5370666|NCT00151216|LINCL|lincl
5370667|NCT00151203|newly diagnosed multiple myeloma|newly diagnosed multiple myeloma
5370668|NCT00151177|ischemic stroke|ischemic stroke
5370669|NCT00151177|CPAP ventilation|cpap ventilation
5370670|NCT00151164|transplantation tolerance|transplantation tolerance
5370671|NCT00151164|thymus|thymus
5370672|NCT00151164|bone marrow|bone marrow
5370673|NCT00151164|pediatric heart transplantation|pediatric heart transplantation
5370674|NCT00151151|pregnancy prevention|pregnancy prevention
5370675|NCT00151151|STD prevention|std prevention
5370676|NCT00151151|adolescents|adolescents
5370677|NCT00151151|motivational interviewing|motivational interviewing
5370678|NCT00151151|abstinence|abstinence
5370679|NCT00151151|contraception|contraception
5370680|NCT00151151|transtheoretical model|transtheoretical model
5370681|NCT00151151|sexual behavior|sexual behavior
5370682|NCT00151138|cerebral blood flow, positron emission tomography, magnetic resonance imaging, neuropsychology|cerebral blood flow, positron emission tomography, magnetic resonance imaging, neuropsychology
5370683|NCT00151125|Von Willebrand Disease|von willebrand disease
5370684|NCT00151125|Bleeding|bleeding
5370685|NCT00151125|Coagulation|coagulation
5370686|NCT00151125|Hemostatic agent|hemostatic agent
5370687|NCT00151112|nerve block|nerve block
5370688|NCT00151112|regional anesthesia|regional anesthesia
5370689|NCT00151112|injuries|injuries
5370690|NCT00151112|diverse malformations|diverse malformations
5370691|NCT00151099|preoperative nutrition|preoperative nutrition
5370692|NCT00151099|postoperative nausea and vomiting|postoperative nausea and vomiting
5370693|NCT00151099|Dysgnathia|dysgnathia
5370694|NCT00151099|anesthesia|anesthesia
5370695|NCT00151073|Zometa|zometa
5370696|NCT00151073|Prostate Cancer|prostate cancer
5370697|NCT00151073|Metastatic Prostate Cancer|metastatic prostate cancer
5370698|NCT00151034|Urothelial Cancer|urothelial cancer
5370699|NCT00151034|Herceptin|herceptin
5370700|NCT00151034|Advanced Urothelial Cancer|advanced urothelial cancer
5370701|NCT00151021|Diabetes|diabetes
5370702|NCT00151021|Pedometer|pedometer
5370703|NCT00151021|Behavioral|behavioral
5370704|NCT00151008|psoriasis|psoriasis
5370705|NCT00151008|bexarotene|bexarotene
5370706|NCT00151008|narrow band|narrow band
5370707|NCT00151008|UVB|uvb
5370708|NCT00150982|psoriasis|psoriasis
5370709|NCT00150982|alefacept|alefacept
5370710|NCT00150969|vitamin K|vitamin k
5370711|NCT00150969|bone mineral density|bone mineral density
5370712|NCT00150969|post-menopausal women|post-menopausal women
5370713|NCT00150969|randomized double blind placebo controlled trial|randomized double blind placebo controlled trial
5370714|NCT00150969|osteoporosis|osteoporosis
5370715|NCT00150969|women's health|women's health
5370716|NCT00150943|Renal artery stenosis|renal artery stenosis
5370717|NCT00150943|Stent|stent
5370718|NCT00150943|Renal failure|renal failure
5370719|NCT00150943|Atorvastatin|atorvastatin
5370720|NCT00150943|Hypertension|hypertension
5370721|NCT00150943|Atherosclerosis|atherosclerosis
5370722|NCT00150930|psoriasis|psoriasis
5370723|NCT00150930|ultraviolet|ultraviolet
5370724|NCT00150930|UVB|uvb
5370725|NCT00150930|phototherapy|phototherapy
5370726|NCT00150930|home care|home care
5370727|NCT00150930|narrowband|narrowband
5370728|NCT00150917|Breast cancer|breast cancer
5370729|NCT00150917|Genetics|genetics
5370730|NCT00150917|Psychotherapy|psychotherapy
5370731|NCT00150917|Group counselling|group counselling
5370732|NCT00150917|Randomized control trial|randomized control trial
5370733|NCT00150917|Risk counselling|risk counselling
5370734|NCT00150917|Women's mental health|women's mental health
5370735|NCT00150917|Familial breast cancer|familial breast cancer
5370736|NCT00150904|HIV|hiv
5370737|NCT00150904|hepatitis C|hepatitis c
5370738|NCT00150904|virologic|virologic
5370739|NCT00150904|immunologic|immunologic
5370740|NCT00150904|HIV / Hepatitis C coinfection|hiv / hepatitis c coinfection
5370741|NCT00150891|Th1|th1
5370742|NCT00150891|Th2|th2
5370743|NCT00150891|B cell|b cell
5370744|NCT00150891|monokines|monokines
5370745|NCT00150891|kidney transplantation|kidney transplantation
5370746|NCT00150891|acute rejection|acute rejection
5370747|NCT00150891|chronic rejection|chronic rejection
5370748|NCT00150878|Reduced-intensity conditioning|reduced-intensity conditioning
5370749|NCT00150878|Fludarabine|fludarabine
5370750|NCT00150878|Acute myeloid Leukemia|acute myeloid leukemia
5370751|NCT00150878|Treatment-related mortality|treatment-related mortality
5370752|NCT00150865|ropivacaine|ropivacaine
5370753|NCT00150865|posterior lumbar plexus block|posterior lumbar plexus block
5370754|NCT00150865|hip arthroplasy|hip arthroplasy
5370755|NCT00150865|analgesia|analgesia
5370756|NCT00150865|postoperative|postoperative
5370757|NCT00150852|Gastrostomy|gastrostomy
5370758|NCT00150852|Wound infection|wound infection
5370759|NCT00150852|Antibiotic prophylaxis|antibiotic prophylaxis
5370760|NCT00150839|Depressive Disorder, Major|depressive disorder, major
5370761|NCT00150839|Venlafaxine|venlafaxine
5370762|NCT00150839|Mirtazapine|mirtazapine
5370763|NCT00150839|Double-blind RCT|double-blind rct
5370764|NCT00150839|Magnetic resonance imaging|magnetic resonance imaging
5370765|NCT00150839|Hippocampal volume|hippocampal volume
5370766|NCT00150826|microvascular disease|microvascular disease
5370767|NCT00150826|women|women
5370768|NCT00150826|renin angiotensin system|renin angiotensin system
5370769|NCT00150826|WISE|wise
5370770|NCT00150826|ischemic heart disease|ischemic heart disease
5370771|NCT00150813|Monotherapy, epilepsy|monotherapy, epilepsy
5370772|NCT00150813|Keppra, levetiracetam|keppra, levetiracetam
5370773|NCT00150800|Brivaracetam|brivaracetam
5370774|NCT00150800|Epilepsy|epilepsy
5370775|NCT00150800|Partial Onset Seizures|partial onset seizures
5370776|NCT00150800|open label|open label
5370777|NCT00150787|Monotherapy, epilepsy|monotherapy, epilepsy
5370778|NCT00150787|Levetiracetam|levetiracetam
5370779|NCT00150787|Keppra|keppra
5370780|NCT00150774|Idiopathic Generalized Epilepsy, Myoclonic seizures|idiopathic generalized epilepsy, myoclonic seizures
5370781|NCT00150774|Keppra - Levetiracetam|keppra - levetiracetam
5370782|NCT00150761|Nasal histamine provocation, facial thermography, levocetirizine, cetirizine,|nasal histamine provocation, facial thermography, levocetirizine, cetirizine,
5370783|NCT00150761|Xyzal, Zyrtec|xyzal, zyrtec
5370784|NCT00150748|Generalized Epilepsy, Primary Generalized Seizures|generalized epilepsy, primary generalized seizures
5370785|NCT00150748|Keppra, Levetiracetam|keppra, levetiracetam
5370786|NCT00150735|Monotherapy, epilepsy, Levetiracetam, Keppra.|monotherapy, epilepsy, levetiracetam, keppra.
5370787|NCT00150722|atherosclerosis|atherosclerosis
5370788|NCT00150722|endothelial function|endothelial function
5370789|NCT00150722|HDL|hdl
5370790|NCT00150722|Niacin|niacin
5370791|NCT00150722|statins|statins
5370792|NCT00150722|Stable Atherosclerotic Vascular Disease|stable atherosclerotic vascular disease
5370793|NCT00150709|Epilepsy, Pediatric , partial onset epilepsy,|epilepsy, pediatric , partial onset epilepsy,
5370794|NCT00150709|Levetiracetam (Keppra®)|levetiracetam (keppra®)
5370795|NCT00150696|Osteoporosis|osteoporosis
5370796|NCT00150696|Spinal Cord Injury|spinal cord injury
5370797|NCT00150683|Spinal Cord Injury.|spinal cord injury.
5370798|NCT00150683|Osteoporosis.|osteoporosis.
5370799|NCT00150683|Standing.|standing.
5370800|NCT00150683|Vibration.|vibration.
5370801|NCT00150670|Stomach cancer|stomach cancer
5370802|NCT00150644|Fibroid Uterus|fibroid uterus
5370803|NCT00150644|Leiomyoma|leiomyoma
5370804|NCT00150644|Uterine Fibroids|uterine fibroids
5370805|NCT00150644|Hysterectomy|hysterectomy
5370806|NCT00150644|Asoprisnil|asoprisnil
5370807|NCT00150631|Hypertension|hypertension
5370808|NCT00150631|Prevention|prevention
5370809|NCT00150631|Offspring|offspring
5370810|NCT00150631|Prevent or delay development of hypertension|prevent or delay development of hypertension
5370811|NCT00150527|antidepressive agents|antidepressive agents
5370812|NCT00150514|nasal biopsy grasspollen sublingual immunotherapy|nasal biopsy grasspollen sublingual immunotherapy
5370813|NCT00150488|PBS|pbs
5370814|NCT00150488|Painful Bladder Syndrome|painful bladder syndrome
5370815|NCT00150488|Interstitial Cystitis|interstitial cystitis
5370816|NCT00150488|chrondroitin sulfate|chrondroitin sulfate
5370817|NCT00150475|Severe Acute Respiratory Syndrome|severe acute respiratory syndrome
5370818|NCT00150462|Hematological|hematological
5370819|NCT00150462|Proteasome|proteasome
5370820|NCT00150462|Myeloma|myeloma
5370822|NCT00150371|(D006937)|(d006937)
5370823|NCT00150345|Neutropenia|neutropenia
5370824|NCT00150345|Fever of unknown origin|fever of unknown origin
5370825|NCT00150345|Empirical treatment|empirical treatment
5370826|NCT00150345|Voriconazole|voriconazole
5370827|NCT00150189|Pain|pain
5370828|NCT00150189|Procedural Pain|procedural pain
5370829|NCT00150189|Sucrose|sucrose
5370830|NCT00150189|Infant|infant
5370831|NCT00150189|Newborn|newborn
5370832|NCT00150163|Androgens|androgens
5370833|NCT00150163|Bone|bone
5370834|NCT00150163|Muscle|muscle
5370835|NCT00150163|Estrogens|estrogens
5370836|NCT00150163|Fat|fat
5370837|NCT00150163|Lipid and glucose metabolism|lipid and glucose metabolism
5370838|NCT00150150|Interventional ultrasound|interventional ultrasound
5370839|NCT00150150|interstitial laser theraphy|interstitial laser theraphy
5370840|NCT00150150|tumor ablation|tumor ablation
5370841|NCT00150150|nodule reduction|nodule reduction
5370842|NCT00150150|adverse effects|adverse effects
5370843|NCT00150150|patient satesfaction|patient satesfaction
5370844|NCT00150137|Radioiodine therapy|radioiodine therapy
5370845|NCT00150137|Graves’ disease|graves’ disease
5370846|NCT00150137|toxic nodular goiter|toxic nodular goiter
5370847|NCT00150137|antithyroid drugs|antithyroid drugs
5370848|NCT00150137|radioprotection|radioprotection
5370849|NCT00150124|Radioiodine therapy|radioiodine therapy
5370850|NCT00150124|Graves' disease|graves' disease
5370851|NCT00150124|toxic nodular goiter|toxic nodular goiter
5370852|NCT00150124|antithyroid drugs|antithyroid drugs
5370853|NCT00150124|levothyroxine|levothyroxine
5370854|NCT00150124|radioprotection|radioprotection
5370855|NCT00150111|Graves disease|graves disease
5370856|NCT00150111|thyroid|thyroid
5370857|NCT00150111|ophthalmopathy|ophthalmopathy
5370858|NCT00150111|autoimmunity|autoimmunity
5370859|NCT00150111|B lymphocyte depletion|b lymphocyte depletion
5370860|NCT00150111|rituximab|rituximab
5370861|NCT00150111|immunization|immunization
5370862|NCT00150098|HIV|hiv
5370863|NCT00150098|vaccines|vaccines
5370864|NCT00150098|women|women
5370865|NCT00150098|substance use|substance use
5370866|NCT00150085|diabetes, glucose, tacrolimus, cyclosporine micro-emulsion, liver, kidney, renal|diabetes, glucose, tacrolimus, cyclosporine micro-emulsion, liver, kidney, renal
5370867|NCT00150072|chordoma|chordoma
5370868|NCT00150072|imatinib|imatinib
5370869|NCT00150072|PDGFR|pdgfr
5370870|NCT00150059|atopic dermatitis, eczema, mild to moderate, children, IGA|atopic dermatitis, eczema, mild to moderate, children, iga
5370871|NCT00150046|Heart transplantation|heart transplantation
5370872|NCT00150046|Everolimus|everolimus
5370873|NCT00150046|Heart transplant recipient|heart transplant recipient
5370874|NCT00150033|thyroid disease|thyroid disease
5370875|NCT00150033|Quality of Life|quality of life
5370876|NCT00150033|Patient reported outcome|patient reported outcome
5370877|NCT00150033|questionnaire|questionnaire
5370878|NCT00150033|Quality of Life measurement|quality of life measurement
5370879|NCT00150020|Renal/Kidney|renal/kidney
5370880|NCT00150020|Transplantation|transplantation
5370881|NCT00150020|MPA|mpa
5370882|NCT00150020|EC-MPS|ec-mps
5370883|NCT00150020|Renal Transplantation Patients with GI Intolerance with MMF|renal transplantation patients with gi intolerance with mmf
5370884|NCT00150007|Kidney, maintenance transplant, GI complaints, patient reported outcome|kidney, maintenance transplant, gi complaints, patient reported outcome
5370885|NCT00149994|Liver transplant, adults, C2 monitoring|liver transplant, adults, c2 monitoring
5370886|NCT00149981|Kidney, heart, lung, liver, pancreas|kidney, heart, lung, liver, pancreas
5370887|NCT00149968|Renal transplantation|renal transplantation
5370888|NCT00149968|MMF|mmf
5370889|NCT00149968|EC-MPS|ec-mps
5370890|NCT00149968|GI problems|gi problems
5370891|NCT00149942|Enteric coated mycophenolate sodium|enteric coated mycophenolate sodium
5370892|NCT00149942|transplantation|transplantation
5370893|NCT00149942|gastrointestinal adverse events|gastrointestinal adverse events
5370894|NCT00149942|Kidney and liver transplantation patients experiencing GI AEs with current MMF treatment|kidney and liver transplantation patients experiencing gi aes with current mmf treatment
5370895|NCT00149929|Renal Transplant, adults, immunosuppressant|renal transplant, adults, immunosuppressant
5370896|NCT00149916|Renal Transplant, adults, immunosuppressants|renal transplant, adults, immunosuppressants
5370897|NCT00149890|pediatric|pediatric
5370898|NCT00149890|liver transplantation|liver transplantation
5370899|NCT00149890|Simulect|simulect
5370900|NCT00149890|Basiliximab|basiliximab
5370901|NCT00149890|ciclosporin microemulsion|ciclosporin microemulsion
5370902|NCT00149890|steroid reduction|steroid reduction
5370903|NCT00149890|pediatric liver transplantation|pediatric liver transplantation
5370904|NCT00149877|Chronic constipation, tegaserod|chronic constipation, tegaserod
5370905|NCT00149864|Renal Transplant, adults, immunosuppressant|renal transplant, adults, immunosuppressant
5370906|NCT00149851|GERD, heartburn, regurgitation, reflux disease|gerd, heartburn, regurgitation, reflux disease
5370907|NCT00149838|Electric Stimulation|electric stimulation
5370908|NCT00149838|Magnetic Stimulation|magnetic stimulation
5370909|NCT00149838|Prefrontal Cortex|prefrontal cortex
5370910|NCT00149838|Brain|brain
5370911|NCT00149825|Major Depressive Disorder|major depressive disorder
5370912|NCT00149825|Insomnia|insomnia
5370913|NCT00149825|Sleep|sleep
5370914|NCT00149825|Mental Health|mental health
5370915|NCT00149812|Depression|depression
5370916|NCT00149812|Child disruptive behavior|child disruptive behavior
5370917|NCT00149812|Family functioning|family functioning
5370918|NCT00149799|Body Dysmorphic Disorder|body dysmorphic disorder
5370919|NCT00149799|Escitalopram|escitalopram
5370920|NCT00149799|Lexapro|lexapro
5370921|NCT00149799|BDD|bdd
5370922|NCT00149799|Body Image|body image
5370923|NCT00149786|Anorexia Nervosa|anorexia nervosa
5370924|NCT00149786|Adolescents|adolescents
5370925|NCT00149786|Family therapy|family therapy
5370926|NCT00149786|Individual therapy|individual therapy
5370927|NCT00149773|Cognitive therapy|cognitive therapy
5370928|NCT00149773|Suicide|suicide
5370929|NCT00149773|Older men|older men
5370930|NCT00149773|Death ideation|death ideation
5370931|NCT00149773|Primary care|primary care
5370932|NCT00149760|Cognitive Behavior Therapy|cognitive behavior therapy
5370933|NCT00149760|Treatment Outcome|treatment outcome
5370934|NCT00149760|Health Care Utilization|health care utilization
5370935|NCT00149760|Somatization Disorder|somatization disorder
5370936|NCT00149760|Somatoform Disorder|somatoform disorder
5370937|NCT00149747|Sleep|sleep
5370938|NCT00149747|Exercise|exercise
5370939|NCT00149747|Older Adults|older adults
5370940|NCT00149734|Schizophrenia|schizophrenia
5370941|NCT00149734|Ondansetron|ondansetron
5370942|NCT00149734|P50 sensory gating|p50 sensory gating
5370943|NCT00149734|Evoked potentials|evoked potentials
5370944|NCT00149734|5-HT3 receptors|5-ht3 receptors
5370945|NCT00149734|Atypical antipsychotics|atypical antipsychotics
5370946|NCT00149721|hydrocephalus|hydrocephalus
5370947|NCT00149721|pituitary function|pituitary function
5370948|NCT00149721|shunting|shunting
5370949|NCT00149708|Growth hormone|growth hormone
5370950|NCT00149708|Deficiency|deficiency
5370951|NCT00149708|Cardiovascular risk|cardiovascular risk
5370952|NCT00149708|Body composition|body composition
5370953|NCT00149695|Obesity, beverages, weight loss, body mass index, diet|obesity, beverages, weight loss, body mass index, diet
5370954|NCT00149682|Obesity|obesity
5370955|NCT00149669|Behavior Therapy|behavior therapy
5370956|NCT00149669|Cocaine|cocaine
5370957|NCT00149669|Cocaine (IV)|cocaine (iv)
5370958|NCT00149669|Cocaine Abuse|cocaine abuse
5370959|NCT00149669|Cocaine Dependence|cocaine dependence
5370960|NCT00149669|Contingency management|contingency management
5370961|NCT00149669|HIV risk behaviors|hiv risk behaviors
5370962|NCT00149669|Heroin|heroin
5370963|NCT00149669|Naltrexone|naltrexone
5370964|NCT00149669|Opioid Dependence|opioid dependence
5370965|NCT00149669|sexual risk behaviors|sexual risk behaviors
5370966|NCT00149656|Treatment Naive|treatment naive
5370967|NCT00149656|Multivitamins|multivitamins
5370968|NCT00149656|Selenium|selenium
5370969|NCT00149656|Supplementation|supplementation
5370970|NCT00149656|HIV Disease Progression|hiv disease progression
5370971|NCT00149643|Cannabis|cannabis
5370972|NCT00149643|MDD|mdd
5370973|NCT00149630|Opioid Dependence|opioid dependence
5370974|NCT00149630|Substance Related Disorders|substance related disorders
5370975|NCT00149617|Marijuana|marijuana
5370976|NCT00149617|Mood Disorder|mood disorder
5370977|NCT00149604|metabolic syndrome|metabolic syndrome
5370978|NCT00149604|hormone therapy|hormone therapy
5370979|NCT00149604|abdominal adiposity|abdominal adiposity
5370980|NCT00149604|lipolysis|lipolysis
5370981|NCT00149591|Myocardial infarction|myocardial infarction
5370982|NCT00149591|Viability|viability
5370983|NCT00149591|Coronary angioplasty|coronary angioplasty
5370984|NCT00149591|Prevention|prevention
5370985|NCT00149591|Prognosis|prognosis
5370986|NCT00149578|pancreatic cancer|pancreatic cancer
5370987|NCT00149578|gemcitabine|gemcitabine
5370988|NCT00149578|oxaliplatin|oxaliplatin
5370989|NCT00149578|5-Fluorouracil|5-fluorouracil
5370990|NCT00149578|radiation|radiation
5370991|NCT00149552|Treatment Naive|treatment naive
5370992|NCT00149552|Treatment Experienced|treatment experienced
5370993|NCT00149461|Asthma Action Plans|asthma action plans
5370994|NCT00149461|African Americans|african americans
5370995|NCT00149461|Latinos|latinos
5370996|NCT00149461|Health Literacy|health literacy
5370997|NCT00149461|Asthma Education|asthma education
5370998|NCT00149422|NT-proBNP|nt-probnp
5370999|NCT00149396|Colorectal cancer metastases to liver|colorectal cancer metastases to liver
5371000|NCT00149396|Colorectal Cancer|colorectal cancer
5371001|NCT00149396|Colorectal Carcinoma|colorectal carcinoma
5371002|NCT00149396|Colorectal Tumors|colorectal tumors
5371003|NCT00149396|Colorectal Neoplasms|colorectal neoplasms
5371004|NCT00149396|Rectum Cancer|rectum cancer
5371005|NCT00149396|Rectum tumors|rectum tumors
5371006|NCT00149396|Rectum carcinoma|rectum carcinoma
5371007|NCT00149396|Colon cancer|colon cancer
5371008|NCT00149396|Colon tumors|colon tumors
5371009|NCT00149396|Colon carcinoma|colon carcinoma
5371010|NCT00149396|Rectum Neoplasms|rectum neoplasms
5371011|NCT00149396|Colon Neoplasms|colon neoplasms
5371012|NCT00149396|Liver Neoplasms|liver neoplasms
5371013|NCT00149396|Hepatic Neoplasms|hepatic neoplasms
5371014|NCT00149396|Liver Tumors|liver tumors
5371015|NCT00149396|Liver cancer|liver cancer
5371016|NCT00149396|Hepatic Cancer|hepatic cancer
5371017|NCT00149396|Hepatic tumors|hepatic tumors
5371018|NCT00149396|metastatic to the liver|metastatic to the liver
5371019|NCT00149383|randomized controlled trial|randomized controlled trial
5371020|NCT00149383|malaria|malaria
5371021|NCT00149383|Plasmodium falciparum|plasmodium falciparum
5371022|NCT00149383|thiazolidinediones|thiazolidinediones
5371023|NCT00149383|rosiglitazone|rosiglitazone
5371024|NCT00149383|atovaquone-proguanil|atovaquone-proguanil
5371025|NCT00149370|breast hypertrophy|breast hypertrophy
5371026|NCT00149370|breast reduction surgery|breast reduction surgery
5371027|NCT00149370|health-related quality of life|health-related quality of life
5371028|NCT00149370|Health Utilities Index|health utilities index
5371029|NCT00149370|HUI|hui
5371030|NCT00149370|prospective|prospective
5371031|NCT00149370|SF-36|sf-36
5371032|NCT00149370|quality-adjusted life years|quality-adjusted life years
5371033|NCT00149370|QALY|qaly
5371034|NCT00149357|venous thromboembolism|venous thromboembolism
5371036|NCT00149357|thrombophilia|thrombophilia
5371037|NCT00149357|fetal loss|fetal loss
5371038|NCT00149344|cost-utility analysis;|cost-utility analysis;
5371039|NCT00149344|breast reduction;|breast reduction;
5371040|NCT00149344|vertical scar mammoplasty;|vertical scar mammoplasty;
5371041|NCT00149344|pedicle reduction mammoplasty|pedicle reduction mammoplasty
5371042|NCT00149331|Diabetes, Insulin, Education|diabetes, insulin, education
5371043|NCT00149305|Gouty diathesis|gouty diathesis
5371044|NCT00149305|Acid uric nephrolithiasis|acid uric nephrolithiasis
5371045|NCT00149279|stomach neoplasms|stomach neoplasms
5371046|NCT00149279|lymph node excision|lymph node excision
5371047|NCT00149279|abdominal aorta|abdominal aorta
5371048|NCT00149266|stomach neoplasms|stomach neoplasms
5371049|NCT00149266|lymph node resection|lymph node resection
5371050|NCT00149266|cardia|cardia
5371051|NCT00149266|thoracotomy|thoracotomy
5371052|NCT00149253|Abdominal hysterectomy,|abdominal hysterectomy,
5371053|NCT00149253|Etoricoxib,|etoricoxib,
5371054|NCT00149253|morphine consumption,|morphine consumption,
5371055|NCT00149253|pre-emptive analgesia|pre-emptive analgesia
5371056|NCT00149240|DYSPORT|dysport
5371057|NCT00149240|botulinum toxin A|botulinum toxin a
5371058|NCT00149240|myofascial pain syndrome|myofascial pain syndrome
5371059|NCT00149227|High risk hypertension|high risk hypertension
5371060|NCT00149227|Ischemic heart disease|ischemic heart disease
5371061|NCT00149227|Angiotensin receptor blockers|angiotensin receptor blockers
5371062|NCT00149227|Cardiovascular mortality- morbidity|cardiovascular mortality- morbidity
5371063|NCT00149227|KYOTO HEART Study|kyoto heart study
5371064|NCT00149201|gastric cancer|gastric cancer
5371065|NCT00149201|peritoneal metastasis|peritoneal metastasis
5371066|NCT00149201|randomized trial|randomized trial
5371067|NCT00149201|5-FU|5-fu
5371068|NCT00149201|MTX|mtx
5371069|NCT00149188|Growth Hormone|growth hormone
5371070|NCT00149175|Alzheimer's disease|alzheimer's disease
5371071|NCT00149175|Dementia|dementia
5371072|NCT00149175|Phenotype-genotype correlations|phenotype-genotype correlations
5371073|NCT00149175|Candidate genes|candidate genes
5371074|NCT00149175|Related disorders|related disorders
5371075|NCT00149162|Controlled|controlled
5371076|NCT00149162|Multicenter|multicenter
5371077|NCT00149162|International|international
5371078|NCT00149162|Randomized study|randomized study
5371079|NCT00149162|Direct individual benefit|direct individual benefit
5371080|NCT00149162|complete remission after chemotherapy|complete remission after chemotherapy
5371081|NCT00149162|non allogeneic transplanted|non allogeneic transplanted
5371082|NCT00149149|Reduction in NSAID related gut damage|reduction in nsaid related gut damage
5371083|NCT00149136|Acute Lymphocytic Leukemia,|acute lymphocytic leukemia,
5371084|NCT00149136|Ph+,|ph+,
5371085|NCT00149136|elderly patients,|elderly patients,
5371086|NCT00149136|Imatinib|imatinib
5371087|NCT00149123|Burn|burn
5371088|NCT00149123|adrenal insufficiency|adrenal insufficiency
5371089|NCT00149123|hydrocortisone|hydrocortisone
5371090|NCT00149123|short corticotropin test|short corticotropin test
5371091|NCT00149110|Sleep deprivation|sleep deprivation
5371092|NCT00149110|Exercise|exercise
5371093|NCT00149110|Light therapy|light therapy
5371094|NCT00149110|Major depression|major depression
5371095|NCT00149110|Bipolar depression|bipolar depression
5371096|NCT00149110|Sleep-wake cycle|sleep-wake cycle
5371097|NCT00149084|The tailored H. pylori eradication therapy|the tailored h. pylori eradication therapy
5371098|NCT00149084|CYP2C19 genotype|cyp2c19 genotype
5371099|NCT00149084|23S rRNA|23s rrna
5371100|NCT00149084|clarithromycin|clarithromycin
5371101|NCT00149084|Lansoprazole|lansoprazole
5371102|NCT00149084|Amoxicillin|amoxicillin
5371103|NCT00149084|H. pylori infection|h. pylori infection
5371104|NCT00149071|Transcranial magnetic stimulation (TMS)|transcranial magnetic stimulation (tms)
5371105|NCT00149071|Major depression|major depression
5371106|NCT00149071|treatment resistant major depression|treatment resistant major depression
5371107|NCT00149058|acute myocardial infarction|acute myocardial infarction
5371108|NCT00149058|primary angioplasty|primary angioplasty
5371109|NCT00149045|familial peripheral Neuropathy Anticipation|familial peripheral neuropathy anticipation
5371110|NCT00149032|Metastatic solid tumor|metastatic solid tumor
5371111|NCT00149006|Metastatic solid tumor|metastatic solid tumor
5371112|NCT00149006|Mismatch allogeneic cell mediated immunotherapy|mismatch allogeneic cell mediated immunotherapy
5371113|NCT00148993|Tumor cell vaccine|tumor cell vaccine
5371114|NCT00148980|Myelodysplastic syndrome (MDS)|myelodysplastic syndrome (mds)
5371115|NCT00148980|Allogeneic stem cell transplantation|allogeneic stem cell transplantation
5371116|NCT00148980|Demineralized bone matrix (DBM)|demineralized bone matrix (dbm)
5371117|NCT00148980|Bone marrow microenvironment|bone marrow microenvironment
5371118|NCT00148967|right ventricular pacing|right ventricular pacing
5371119|NCT00148967|implantable cardioverter defibrillator|implantable cardioverter defibrillator
5371120|NCT00148915|Osteoporosis|osteoporosis
5371121|NCT00148915|bisphosphonates|bisphosphonates
5371122|NCT00148915|bone|bone
5371123|NCT00148902|tumor|tumor
5371124|NCT00148889|cervical dystonia|cervical dystonia
5371125|NCT00148889|torticollis|torticollis
5371126|NCT00148889|deep brain stimulation|deep brain stimulation
5371127|NCT00148889|pallidal stimulation|pallidal stimulation
5371128|NCT00148889|globus pallidus internus|globus pallidus internus
5371129|NCT00148876|Progression after treatment with Trastuzumab|progression after treatment with trastuzumab
5371130|NCT00148876|Metastatic Breast Cancer|metastatic breast cancer
5371131|NCT00148876|Palliative Study|palliative study
5371132|NCT00148863|Hepatitis C, Chronic|hepatitis c, chronic
5371133|NCT00148863|Interferon Alfa-2a|interferon alfa-2a
5371134|NCT00148863|Ribavirin|ribavirin
5371135|NCT00148863|Interferon-gamma, Recombinant|interferon-gamma, recombinant
5371136|NCT00148850|HIV-Associated Lipodystrophy Syndrome|hiv-associated lipodystrophy syndrome
5371137|NCT00148850|pioglitazone|pioglitazone
5371138|NCT00148850|HIV infections|hiv infections
5371139|NCT00148850|Treatment Experienced|treatment experienced
5371140|NCT00148837|Hepatitis C, Chronic|hepatitis c, chronic
5371141|NCT00148837|Fibrosis|fibrosis
5371142|NCT00148837|Interferon Alfa-2b|interferon alfa-2b
5371143|NCT00148837|Ribavirin|ribavirin
5371144|NCT00148837|Prazosin|prazosin
5371145|NCT00148824|HIV infections|hiv infections
5371146|NCT00148824|Pneumococcal vaccines|pneumococcal vaccines
5371147|NCT00148824|Treatment Experienced|treatment experienced
5371148|NCT00148824|Treatment Naive|treatment naive
5371149|NCT00148798|Cetuximab|cetuximab
5371150|NCT00148798|Non small cell lung cancer|non small cell lung cancer
5371151|NCT00148798|Lung cancer|lung cancer
5371152|NCT00148798|Cisplatin/vinorelbine|cisplatin/vinorelbine
5371153|NCT00148798|Monoclonal antibody|monoclonal antibody
5371154|NCT00148798|Erbitux|erbitux
5371155|NCT00148785|Antiretroviral drugs|antiretroviral drugs
5371156|NCT00148785|Pharmacokinetic|pharmacokinetic
5371157|NCT00148785|Indinavir|indinavir
5371158|NCT00148785|Ritonavir|ritonavir
5371159|NCT00148785|Fosamprenavir|fosamprenavir
5371160|NCT00148772|Prostate Cancer|prostate cancer
5371161|NCT00148772|Rising PSA|rising psa
5371162|NCT00148772|Erlotinib|erlotinib
5371163|NCT00148772|Tarceva|tarceva
5371164|NCT00148772|Androgen Deprivation Therapy|androgen deprivation therapy
5371165|NCT00148772|Hormone Therapy|hormone therapy
5371166|NCT00148772|Rising Prostate Specific Antigen (PSA)|rising prostate specific antigen (psa)
5371167|NCT00148772|Non-Metastatic Prostate Cancer|non-metastatic prostate cancer
5371168|NCT00148759|Sex differences|sex differences
5371169|NCT00148759|Pharmacokinetic|pharmacokinetic
5371170|NCT00148759|Lopinavir/ritonavir|lopinavir/ritonavir
5371171|NCT00148759|Treatment Experienced|treatment experienced
5371172|NCT00148759|HIV-infection|hiv-infection
5371173|NCT00148746|atopic dermatitis, atopy|atopic dermatitis, atopy
5371174|NCT00148733|Child|child
5371175|NCT00148733|pneumonia|pneumonia
5371176|NCT00148733|Zinc|zinc
5371177|NCT00148733|clinical trial|clinical trial
5371178|NCT00148733|Nepal|nepal
5371179|NCT00148733|nutrition|nutrition
5371180|NCT00148733|therapeutic|therapeutic
5371181|NCT00148720|Invasive Breast Cancer|invasive breast cancer
5371182|NCT00148720|Operable Breast Cancer|operable breast cancer
5371183|NCT00148720|Capecitabine|capecitabine
5371184|NCT00148707|Metastatic Breast Cancer|metastatic breast cancer
5371185|NCT00148707|HER2-negative Breast Cancer|her2-negative breast cancer
5371186|NCT00148707|CT-2103|ct-2103
5371187|NCT00148707|Xyotax|xyotax
5371188|NCT00148694|Cisplatin|cisplatin
5371189|NCT00148694|Early Stage Breast Cancer|early stage breast cancer
5371190|NCT00148694|ER Negative Breast Cancer|er negative breast cancer
5371191|NCT00148694|PR Negative Breast Cancer|pr negative breast cancer
5371192|NCT00148694|HER-2 Negative Breast Cancer|her-2 negative breast cancer
5371193|NCT00148681|HER-2 Positive breast cancer|her-2 positive breast cancer
5371194|NCT00148681|herceptin|herceptin
5371195|NCT00148681|navelbine|navelbine
5371196|NCT00148668|HER-2 Positive Breast Cancer|her-2 positive breast cancer
5371197|NCT00148668|herceptin|herceptin
5371198|NCT00148668|navelbine|navelbine
5371199|NCT00148668|taxotere|taxotere
5371200|NCT00148668|carboplatin|carboplatin
5371201|NCT00148668|Early stage Breast Cancer|early stage breast cancer
5371202|NCT00148655|educational intervention|educational intervention
5371203|NCT00148655|decision board|decision board
5371204|NCT00148655|DCIS|dcis
5371205|NCT00148642|ventilator-associated pneumonia|ventilator-associated pneumonia
5371206|NCT00148642|nosocomial pneumonia|nosocomial pneumonia
5371207|NCT00148629|Anemia|anemia
5371208|NCT00148629|Birth weight|birth weight
5371209|NCT00148629|Neonatal Mortality|neonatal mortality
5371210|NCT00148629|Tanzania|tanzania
5371211|NCT00148629|Pregnancy|pregnancy
5371212|NCT00148616|Memantine|memantine
5371213|NCT00148616|Negative Syndrome|negative syndrome
5371214|NCT00148616|Schizophrenia|schizophrenia
5371215|NCT00148616|Cognitive impairment|cognitive impairment
5371216|NCT00148603|dyspepsia|dyspepsia
5371217|NCT00148603|eosinophilic gastroenteritis|eosinophilic gastroenteritis
5371218|NCT00148603|montelukast|montelukast
5371219|NCT00148590|Memantine|memantine
5371220|NCT00148590|Negative syndrome|negative syndrome
5371221|NCT00148590|Schizophrenia|schizophrenia
5371222|NCT00148590|Cognitive impairment|cognitive impairment
5371223|NCT00148590|Glutamate|glutamate
5371224|NCT00148577|Pain Relief, TENS, Acupuncture Points|pain relief, tens, acupuncture points
5371225|NCT00148564|weight gain|weight gain
5371226|NCT00148564|schizophrenia|schizophrenia
5371227|NCT00148564|atypical antipsychotics|atypical antipsychotics
5371228|NCT00148551|AMD|amd
5371229|NCT00148551|Triamcinolone|triamcinolone
5371230|NCT00148551|Macular Degeneration|macular degeneration
5371231|NCT00148538|Type 1 Diabetes|type 1 diabetes
5371232|NCT00148538|Resistance Exercise|resistance exercise
5371233|NCT00148538|Aerobic Exercise|aerobic exercise
5371234|NCT00148538|Exercise & Disease|exercise & disease
5371235|NCT00148538|Exercise|exercise
5371236|NCT00148538|Diabetes|diabetes
5371237|NCT00148525|automated telephony, cancer prevention, healthy diet|automated telephony, cancer prevention, healthy diet
5371238|NCT00148473|Cervical ripening.|cervical ripening.
5371239|NCT00148473|Induction of labor.|induction of labor.
5371240|NCT00148473|Misoprostol.|misoprostol.
5371241|NCT00148447|negative symptoms|negative symptoms
5371242|NCT00148447|depression|depression
5371243|NCT00148447|ssri|ssri
5371244|NCT00148447|schizophrenia|schizophrenia
5371245|NCT00148434|hypertension|hypertension
5371246|NCT00148434|guidelines|guidelines
5371247|NCT00148434|patient empowerment|patient empowerment
5371248|NCT00148434|anxiety|anxiety
5371249|NCT00148421|Non-myeloid malignancy|non-myeloid malignancy
5371250|NCT00148421|Chemotherapy-induced anemia|chemotherapy-induced anemia
5371251|NCT00148408|Asthma|asthma
5371252|NCT00148408|Placebo|placebo
5371253|NCT00148408|Education|education
5371254|NCT00148382|Obesity|obesity
5371255|NCT00148382|Pharmacokinetics|pharmacokinetics
5371256|NCT00148382|Pharmacodynamics|pharmacodynamics
5371257|NCT00148356|drug eluting stents|drug eluting stents
5371258|NCT00148356|stents|stents
5371259|NCT00148356|angioplasty|angioplasty
5371260|NCT00148356|coronary artery disease|coronary artery disease
5371261|NCT00148356|total coronary occlusion|total coronary occlusion
5371262|NCT00148356|coronary artery restenosis|coronary artery restenosis
5371263|NCT00148356|stent thrombosis|stent thrombosis
5371264|NCT00148356|vascular disease|vascular disease
5371265|NCT00148356|myocardial ischemia|myocardial ischemia
5371266|NCT00148356|coronary artery stenosis|coronary artery stenosis
5371267|NCT00148343|hemiplegia|hemiplegia
5371268|NCT00148343|hemiparesis|hemiparesis
5371269|NCT00148343|stroke|stroke
5371270|NCT00148343|foot-drop|foot-drop
5371271|NCT00148343|electrical stimulation|electrical stimulation
5371272|NCT00148343|ankle-foot-orthosis|ankle-foot-orthosis
5371273|NCT00148330|Diabetic macular oedema|diabetic macular oedema
5371274|NCT00148330|Triamcinolone acetate|triamcinolone acetate
5371275|NCT00148330|Intravitreal injection|intravitreal injection
5371276|NCT00148330|Clinical trial|clinical trial
5371277|NCT00148330|Laser treatment|laser treatment
5371278|NCT00148304|Decision-making|decision-making
5371279|NCT00148304|Insulin|insulin
5371280|NCT00148304|Preference|preference
5371281|NCT00148304|Treatment Variation|treatment variation
5371282|NCT00148304|Provider|provider
5371283|NCT00148304|Patient|patient
5371284|NCT00148278|Catecholamines|catecholamines
5371285|NCT00148278|Septic shock|septic shock
5371286|NCT00148265|Diabetic macular oedema|diabetic macular oedema
5371287|NCT00148265|Triamcinolone acetate|triamcinolone acetate
5371288|NCT00148265|Intravitreal injection|intravitreal injection
5371289|NCT00148265|Clinical trial|clinical trial
5371290|NCT00148265|Laser treatment|laser treatment
5371291|NCT00148252|Calcineurin|calcineurin
5371292|NCT00148252|reduction|reduction
5371293|NCT00148252|immunosuppression|immunosuppression
5371294|NCT00148252|cyclosporine A|cyclosporine a
5371295|NCT00148252|mycophenolate mofetil|mycophenolate mofetil
5371296|NCT00148239|SCI|sci
5371297|NCT00148239|Caregiving|caregiving
5371298|NCT00148239|Aging|aging
5371299|NCT00148239|Disability|disability
5371300|NCT00148239|Paralysis|paralysis
5371301|NCT00148226|Decision Aid|decision aid
5371302|NCT00148226|Faecal Occult Blood Test|faecal occult blood test
5371303|NCT00148226|Colorectal Cancer Screening|colorectal cancer screening
5371304|NCT00148226|Informed Decision-making|informed decision-making
5371305|NCT00148213|differentiated thyroid carcinoma|differentiated thyroid carcinoma
5371306|NCT00148213|thyroglobulin|thyroglobulin
5371307|NCT00148213|immunoassay|immunoassay
5371308|NCT00148213|thyroidectomy|thyroidectomy
5371309|NCT00148213|radioiodine therapy|radioiodine therapy
5371310|NCT00148200|female sexual dysfunction|female sexual dysfunction
5371311|NCT00148200|desire|desire
5371312|NCT00148200|arousal|arousal
5371313|NCT00148200|lubrification|lubrification
5371314|NCT00148200|orgasm|orgasm
5371315|NCT00148200|satisfaction|satisfaction
5371316|NCT00148200|pain|pain
5371317|NCT00148187|Medication adherence|medication adherence
5371318|NCT00148187|Patient compliance|patient compliance
5371319|NCT00148187|Kidney transplant|kidney transplant
5371320|NCT00148187|Organ rejection|organ rejection
5371321|NCT00148187|Allograft loss|allograft loss
5371322|NCT00148187|Drug monitoring|drug monitoring
5371323|NCT00148174|Medication adherence|medication adherence
5371324|NCT00148174|Patient compliance|patient compliance
5371325|NCT00148174|Kidney transplant|kidney transplant
5371326|NCT00148174|Organ rejection|organ rejection
5371327|NCT00148174|Allograft loss|allograft loss
5371328|NCT00148174|Drug monitoring|drug monitoring
5371329|NCT00148161|Magnetoencephalography|magnetoencephalography
5371330|NCT00148161|Auditory cortex|auditory cortex
5371331|NCT00148161|Stuttering|stuttering
5371332|NCT00148161|Non stuttering|non stuttering
5371333|NCT00148148|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
5371334|NCT00148148|Caspofungin|caspofungin
5371335|NCT00148148|Liposomal Amphotericin B|liposomal amphotericin b
5371336|NCT00148135|Carcinoma of Unknown Primary Site (CUP)|carcinoma of unknown primary site (cup)
5371337|NCT00148122|Squamous cell cancer of the oral cavity and pharynx|squamous cell cancer of the oral cavity and pharynx
5371338|NCT00148109|Unresectable/metastatic high grade soft tissue bony sarcoma|unresectable/metastatic high grade soft tissue bony sarcoma
5371339|NCT00148096|asthma|asthma
5371340|NCT00148096|house dust mite|house dust mite
5371341|NCT00148096|allergy|allergy
5371342|NCT00148096|housing|housing
5371343|NCT00148096|avoidance|avoidance
5371344|NCT00148096|humidity|humidity
5371345|NCT00148083|Schizophrenia|schizophrenia
5371346|NCT00148083|Cognition|cognition
5371347|NCT00148083|Clinical Trial|clinical trial
5371348|NCT00148057|Diet|diet
5371349|NCT00148057|Dietary fat|dietary fat
5371350|NCT00148057|Breast cancer|breast cancer
5371351|NCT00148057|Prevention|prevention
5371352|NCT00148031|behavior modification|behavior modification
5371353|NCT00148031|health care service utilization|health care service utilization
5371354|NCT00148031|hepatitis C,|hepatitis c,
5371355|NCT00148031|injection drug use|injection drug use
5371356|NCT00148031|therapy compliance|therapy compliance
5371357|NCT00148031|alcoholism|alcoholism
5371358|NCT00148031|alcohol abuse|alcohol abuse
5371359|NCT00148031|prevention|prevention
5371360|NCT00148031|drug abuse|drug abuse
5371361|NCT00148031|liver disorder|liver disorder
5371362|NCT00148031|HCV|hcv
5371363|NCT00148031|methadone|methadone
5371364|NCT00148018|Hodgkin disease|hodgkin disease
5371365|NCT00148018|Bortezomib|bortezomib
5371366|NCT00148018|Relapse|relapse
5371367|NCT00148018|Lymphoma|lymphoma
5371368|NCT00147966|active disease despite concomitant methotrexate|active disease despite concomitant methotrexate
5371369|NCT00147953|NHL|nhl
5371370|NCT00147953|Lymphoma|lymphoma
5371371|NCT00147953|Radiotherapy|radiotherapy
5371372|NCT00147953|Rituximab|rituximab
5371373|NCT00147953|Palliative treatment|palliative treatment
5371374|NCT00147940|Allergy|allergy
5371375|NCT00147927|email|email
5371376|NCT00147927|internet|internet
5371377|NCT00147927|health promotion|health promotion
5371378|NCT00147927|behavior change|behavior change
5371379|NCT00147927|health status|health status
5371380|NCT00147927|work productivity|work productivity
5371381|NCT00147927|healthcare cost|healthcare cost
5371382|NCT00147927|employee|employee
5371383|NCT00147914|Acute bacterial sinusitis|acute bacterial sinusitis
5371384|NCT00147901|CLL|cll
5371385|NCT00147901|Immunochemotherapy|immunochemotherapy
5371386|NCT00147888|Mucosal congestion|mucosal congestion
5371387|NCT00147888|Acoustic rhinometry|acoustic rhinometry
5371388|NCT00147888|Physiology|physiology
5371389|NCT00147875|Lymphoma|lymphoma
5371390|NCT00147875|Gemcitabine|gemcitabine
5371391|NCT00147875|Advanced stages Hodgkin's lymphoma|advanced stages hodgkin's lymphoma
5371392|NCT00147875|Elderly|elderly
5371393|NCT00147862|Tranexamic Acid|tranexamic acid
5371394|NCT00147862|Antifibrinolytic Agents|antifibrinolytic agents
5371395|NCT00147862|Head and Neck Neoplasms|head and neck neoplasms
5371396|NCT00147862|Thromboelastography|thromboelastography
5371397|NCT00147849|knowledge translation|knowledge translation
5371398|NCT00147849|health care utilization|health care utilization
5371399|NCT00147849|economic analysis|economic analysis
5371400|NCT00147836|type 2 diabetes mellitus|type 2 diabetes mellitus
5371401|NCT00147836|therapy|therapy
5371402|NCT00147836|sulfonylureas|sulfonylureas
5371403|NCT00147836|metformin|metformin
5371404|NCT00147836|insulin|insulin
5371405|NCT00147823|Bone formation|bone formation
5371406|NCT00147823|Bone lesions|bone lesions
5371407|NCT00147823|Benign bone lesion|benign bone lesion
5371408|NCT00147810|telephone outreach|telephone outreach
5371409|NCT00147810|asthma care|asthma care
5371410|NCT00147797|Atherosclerosis|atherosclerosis
5371411|NCT00147797|intima media thickness|intima media thickness
5371412|NCT00147797|aortic stiffness|aortic stiffness
5371413|NCT00147797|HIV infection|hiv infection
5371414|NCT00147797|Dyslipidemia|dyslipidemia
5371415|NCT00147797|Treatment Experienced|treatment experienced
5371416|NCT00147784|Chronical Hepatitis C treatment|chronical hepatitis c treatment
5371417|NCT00147784|Methadone Maintenance Treatment|methadone maintenance treatment
5371418|NCT00147784|Pegylated Interferon and Ribavirin|pegylated interferon and ribavirin
5371419|NCT00147784|14 weeks treatment|14 weeks treatment
5371420|NCT00147784|Genotype 2 and 3|genotype 2 and 3
5371421|NCT00147771|localized scleroderma|localized scleroderma
5371422|NCT00147771|morphea|morphea
5371423|NCT00147771|imiquimod|imiquimod
5371424|NCT00147771|pediatrics|pediatrics
5371425|NCT00147758|Diabetes Mellitus|diabetes mellitus
5371426|NCT00147745|Mechanism of action insulin sensitivity|mechanism of action insulin sensitivity
5371427|NCT00147732|larynx carcinoma|larynx carcinoma
5371428|NCT00147732|radiotherapy|radiotherapy
5371429|NCT00147732|carbogen|carbogen
5371430|NCT00147732|nicotinamide|nicotinamide
5371431|NCT00147719|Diabetes Mellitus|diabetes mellitus
5371432|NCT00147706|Electronic Health Record|electronic health record
5371433|NCT00147706|Patient Portal|patient portal
5371434|NCT00147706|Chronic Diseases|chronic diseases
5371435|NCT00147693|Dementia|dementia
5371436|NCT00147693|Alzheimer Disease|alzheimer disease
5371437|NCT00147693|Lewy-Body|lewy-body
5371438|NCT00147693|Cost*|cost*
5371439|NCT00147693|Community (dwelling)|community (dwelling)
5371440|NCT00147693|Caregiver(s)|caregiver(s)
5371441|NCT00147693|Institutionalization|institutionalization
5371442|NCT00147693|Quality of life|quality of life
5371443|NCT00147693|Randomized Control Trail|randomized control trail
5371444|NCT00147693|Vascular dementia|vascular dementia
5371445|NCT00147680|Uterine Papillary Serous Carcinoma (UPSC)|uterine papillary serous carcinoma (upsc)
5371446|NCT00147667|COPD|copd
5371447|NCT00147667|EXACERBATIONS|exacerbations
5371448|NCT00147667|AIRWAY INFLAMMATION|airway inflammation
5371449|NCT00147537|non-small cell lung cancer|non-small cell lung cancer
5371450|NCT00147537|chemotherapy|chemotherapy
5371451|NCT00147537|figitumumab|figitumumab
5371452|NCT00147537|insulin-like growth 1 factor receptor|insulin-like growth 1 factor receptor
5371453|NCT00147537|IGF-IR|igf-ir
5371454|NCT00147537|monoclonal antibody|monoclonal antibody
5371455|NCT00147498|oral JAK inhibitor|oral jak inhibitor
5371456|NCT00147498|clinical trial|clinical trial
5371457|NCT00147498|joint diseases|joint diseases
5371458|NCT00147498|anti-Inflammatory agents|anti-inflammatory agents
5371459|NCT00147498|rheumatic diseases|rheumatic diseases
5371460|NCT00147498|DMARD|dmard
5371461|NCT00147498|Antirheumatic Agents|antirheumatic agents
5371462|NCT00147498|Autoimmune Diseases|autoimmune diseases
5371463|NCT00147498|Immune System Diseases|immune system diseases
5371464|NCT00147472|Head and neck|head and neck
5371465|NCT00147472|Cancer|cancer
5371466|NCT00147472|Diagnosis|diagnosis
5371467|NCT00147472|Fluorodeoxyglucose|fluorodeoxyglucose
5371468|NCT00147472|Positron-Emission Tomography|positron-emission tomography
5371469|NCT00147472|PET|pet
5371470|NCT00147472|Oncology|oncology
5371471|NCT00147459|hepatitis B virus|hepatitis b virus
5371472|NCT00147459|vaccine|vaccine
5371473|NCT00147459|booster|booster
5371474|NCT00147459|liver transplantation|liver transplantation
5371475|NCT00147446|Stress|stress
5371476|NCT00147446|Stress Management|stress management
5371477|NCT00147446|Behavioral Medicine|behavioral medicine
5371478|NCT00147446|Multiple Sclerosis|multiple sclerosis
5371479|NCT00147446|Psychoneuroimmunology|psychoneuroimmunology
5371480|NCT00147433|free thyroxine|free thyroxine
5371481|NCT00147433|pregnancy|pregnancy
5371482|NCT00147433|fetal brain development|fetal brain development
5371483|NCT00147433|thyroid stimulating hormone|thyroid stimulating hormone
5371484|NCT00147433|IQ|iq
5371485|NCT00147420|Tibet|tibet
5371486|NCT00147420|Third Stage Labor|third stage labor
5371487|NCT00147420|Post Partum Hemorrhage|post partum hemorrhage
5371488|NCT00147420|Misoprostol|misoprostol
5371489|NCT00147420|Zhi Byed 11|zhi byed 11
5371490|NCT00147420|Global Network|global network
5371491|NCT00147394|Risperidone|risperidone
5371492|NCT00147394|Autism|autism
5371493|NCT00147394|PDD|pdd
5371494|NCT00147394|Pervasive Developmental Disorder|pervasive developmental disorder
5371495|NCT00147381|Campath-1H|campath-1h
5371496|NCT00147381|Alemtuzumab|alemtuzumab
5371497|NCT00147381|Tacrolimus|tacrolimus
5371498|NCT00147381|renal transplantation|renal transplantation
5371499|NCT00147381|immunosuppression|immunosuppression
5371500|NCT00147381|prevention of acute rejection|prevention of acute rejection
5371501|NCT00147368|falciparum|falciparum
5371502|NCT00147368|malaria|malaria
5371503|NCT00147368|arginine|arginine
5371504|NCT00147355|rIL-2-toxicity|ril-2-toxicity
5371505|NCT00147355|interleukin-2 therapy|interleukin-2 therapy
5371506|NCT00147355|HIV|hiv
5371507|NCT00147355|Toxicity substudy of ESPRIT|toxicity substudy of esprit
5371508|NCT00147342|exercise|exercise
5371509|NCT00147342|hypoglycemia|hypoglycemia
5371510|NCT00147342|Diabetes Mellitus, Type I|diabetes mellitus, type i
5371511|NCT00147342|glucose monitoring|glucose monitoring
5371512|NCT00147316|acute stroke|acute stroke
5371513|NCT00147316|thrombolytic therapy|thrombolytic therapy
5371514|NCT00147316|tissue plasminogen activator|tissue plasminogen activator
5371515|NCT00147290|ATP|atp
5371516|NCT00147290|Tachycardia|tachycardia
5371517|NCT00147290|CRT-D|crt-d
5371518|NCT00147277|ATP|atp
5371519|NCT00147277|Thachy|thachy
5371520|NCT00147277|FVT|fvt
5371521|NCT00147264|insulin resistance, myocellular lipids, adipose tissue|insulin resistance, myocellular lipids, adipose tissue
5371522|NCT00147251|lowering LDL and BP below current targets|lowering ldl and bp below current targets
5371523|NCT00147251|LDL cholesterol treatment|ldl cholesterol treatment
5371524|NCT00147251|blood pressure treatment|blood pressure treatment
5371525|NCT00147251|carotid intimal medial thickness|carotid intimal medial thickness
5371526|NCT00147251|prevent progression of CVD|prevent progression of cvd
5371527|NCT00147238|Bladder Cancer|bladder cancer
5371528|NCT00147238|Genitourinary Cancer|genitourinary cancer
5371529|NCT00147238|Prostate Cancer|prostate cancer
5371530|NCT00147238|MR Lymphangiography|mr lymphangiography
5371531|NCT00147238|Ferumoxtran-10|ferumoxtran-10
5371532|NCT00147238|SPIO|spio
5371533|NCT00147238|Ultra-small superparamagnetic agent iron oxide|ultra-small superparamagnetic agent iron oxide
5371534|NCT00147225|Advanced Cancer|advanced cancer
5371535|NCT00147225|Advanced Malignancy|advanced malignancy
5371536|NCT00147225|Solid Tumors|solid tumors
5371537|NCT00147225|Thrombocytopenia|thrombocytopenia
5371538|NCT00147225|AMG 531|amg 531
5371539|NCT00147225|Romiplostim|romiplostim
5371540|NCT00147225|Carboplatin|carboplatin
5371541|NCT00147225|Paraplatin|paraplatin
5371542|NCT00147225|Platelets|platelets
5371543|NCT00147225|Adriamycin|adriamycin
5371544|NCT00147225|Doxorubicin|doxorubicin
5371545|NCT00147225|Rubex|rubex
5371546|NCT00147225|Ifosfamide|ifosfamide
5371547|NCT00147225|Ifex|ifex
5371548|NCT00147212|Advanced Prostate Cancer|advanced prostate cancer
5371549|NCT00147212|Prostate Cancer|prostate cancer
5371550|NCT00147212|Trabectedin|trabectedin
5371551|NCT00147212|ET 743|et 743
5371552|NCT00147212|Yondelis|yondelis
5371553|NCT00147199|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
5371554|NCT00147147|gastric neoplasm|gastric neoplasm
5371555|NCT00147147|gastrectomy|gastrectomy
5371556|NCT00147147|adjuvant chemotherapy|adjuvant chemotherapy
5371557|NCT00147147|randomized trial|randomized trial
5371558|NCT00147147|T3 and T4 carcinoma of the stomach/Gastric Neoplasm|t3 and t4 carcinoma of the stomach/gastric neoplasm
5371559|NCT00147134|colorectal cancer|colorectal cancer
5371560|NCT00147134|laparoscopic surgery|laparoscopic surgery
5371561|NCT00147134|randomized controlled trial|randomized controlled trial
5371562|NCT00147134|oncological outcome|oncological outcome
5371563|NCT00147121|Rituximab|rituximab
5371564|NCT00147121|CHOP|chop
5371565|NCT00147121|Bi-weekly|bi-weekly
5371566|NCT00147121|low-grade B-cell lymphoma|low-grade b-cell lymphoma
5371567|NCT00147121|advanced stage|advanced stage
5371568|NCT00147121|follicular lymphoma|follicular lymphoma
5371569|NCT00147121|G-CSF|g-csf
5371570|NCT00147121|Untreated stage III/IV low-grade B-cell lymphoma|untreated stage iii/iv low-grade b-cell lymphoma
5371571|NCT00147108|Breast Cancer|breast cancer
5371572|NCT00147095|macrophages|macrophages
5371573|NCT00147095|neutrophils|neutrophils
5371574|NCT00147095|lymphocytes|lymphocytes
5371575|NCT00147082|chemokine|chemokine
5371576|NCT00147082|chemokine receptor|chemokine receptor
5371577|NCT00147082|neutrophil|neutrophil
5371578|NCT00147082|lymphocyte|lymphocyte
5371579|NCT00147082|monocyte|monocyte
5371580|NCT00147069|sputum|sputum
5371581|NCT00147069|macrophage|macrophage
5371582|NCT00147069|neutrophil|neutrophil
5371583|NCT00147056|Brain tumor|brain tumor
5371584|NCT00147056|Brain Lesions|brain lesions
5371585|NCT00147056|Brain Cancer|brain cancer
5371586|NCT00147056|ExAblate|exablate
5371587|NCT00147043|Adult stem cells|adult stem cells
5371588|NCT00147043|Liver disease|liver disease
5371589|NCT00147043|CD34 positive cells|cd34 positive cells
5371590|NCT00147030|Hypoxia|hypoxia
5371591|NCT00147030|Ischaemia|ischaemia
5371592|NCT00147030|Encephalopathy|encephalopathy
5371593|NCT00147030|Neonatal|neonatal
5371594|NCT00147030|Hypothermia|hypothermia
5371595|NCT00147030|Perinatal|perinatal
5371596|NCT00147030|Cooling|cooling
5371597|NCT00147030|Whole/Total Body|whole/total body
5371598|NCT00147017|macrophage|macrophage
5371599|NCT00147017|inflammation|inflammation
5371600|NCT00147017|COPD|copd
5371601|NCT00147004|Septic shock|septic shock
5371602|NCT00147004|Steroids|steroids
5371603|NCT00147004|Hydrocortisone|hydrocortisone
5371604|NCT00147004|Mortality|mortality
5371605|NCT00147004|Reversal of shock|reversal of shock
5371606|NCT00147004|Adrenal insufficiency|adrenal insufficiency
5371607|NCT00146952|Hemineglects|hemineglects
5371608|NCT00146926|Propofol|propofol
5371609|NCT00146926|pain|pain
5371610|NCT00146926|general anesthesia|general anesthesia
5371611|NCT00146926|prevention|prevention
5371612|NCT00146913|Chronic myeloid leukaemia|chronic myeloid leukaemia
5371613|NCT00146913|resistant|resistant
5371614|NCT00146913|refractory|refractory
5371615|NCT00146913|Imatinib mesylate|imatinib mesylate
5371616|NCT00146900|Traumatic Events|traumatic events
5371617|NCT00146900|Post-traumatic Stress Disorder|post-traumatic stress disorder
5371618|NCT00146900|Treatment (psychological)|treatment (psychological)
5371619|NCT00146900|Treatment (pharmacological)|treatment (pharmacological)
5371620|NCT00146900|Prevention|prevention
5371621|NCT00146900|SSRIs|ssris
5371622|NCT00146887|Coronary CT|coronary ct
5371623|NCT00146887|sensitivity|sensitivity
5371624|NCT00146887|specificity|specificity
5371625|NCT00146809|Multi-System-Atrophy|multi-system-atrophy
5371626|NCT00146809|Minocycline|minocycline
5371627|NCT00146796|Malaria|malaria
5371628|NCT00146796|Diagnosis|diagnosis
5371629|NCT00146796|RDT|rdt
5371630|NCT00146796|Africa|africa
5371631|NCT00146796|Tanzania|tanzania
5371632|NCT00146783|intermittent preventive treatment|intermittent preventive treatment
5371633|NCT00146783|malaria|malaria
5371634|NCT00146783|pregnancy|pregnancy
5371635|NCT00146783|efficacy|efficacy
5371636|NCT00146783|safety|safety
5371637|NCT00146731|malaria|malaria
5371638|NCT00146731|pregnancy|pregnancy
5371639|NCT00146731|treatment|treatment
5371640|NCT00146731|Africa|africa
5371641|NCT00146731|Tanzania|tanzania
5371642|NCT00146718|malaria|malaria
5371643|NCT00146718|drug resistance|drug resistance
5371644|NCT00146718|antimalarials|antimalarials
5371645|NCT00146705|chronic HBV|chronic hbv
5371646|NCT00146705|Peginterferon|peginterferon
5371647|NCT00146705|long term follow-up|long term follow-up
5371648|NCT00146692|Malaria|malaria
5371649|NCT00146692|Cost|cost
5371650|NCT00146692|Treatment|treatment
5371651|NCT00146692|Diagnosis|diagnosis
5371652|NCT00146692|Africa|africa
5371653|NCT00146692|Ghana|ghana
5371654|NCT00146679|Heart failure|heart failure
5371655|NCT00146679|Ventricular arrhythmias|ventricular arrhythmias
5371656|NCT00146679|ICD|icd
5371657|NCT00146679|Psychoeducational intervention|psychoeducational intervention
5371658|NCT00146666|Peak walking time|peak walking time
5371659|NCT00146666|Absolute claudication distance|absolute claudication distance
5371660|NCT00146666|Claudication onset time|claudication onset time
5371661|NCT00146666|Initial claudication distance|initial claudication distance
5371662|NCT00146666|Intermittent compression|intermittent compression
5371663|NCT00146653|pediatrics|pediatrics
5371664|NCT00146653|cardiopulmonary bypass|cardiopulmonary bypass
5371665|NCT00146653|surgery|surgery
5371666|NCT00146640|active disease|active disease
5371667|NCT00146640|morning stiffness of joints|morning stiffness of joints
5371668|NCT00146640|nighttime application of prednisone|nighttime application of prednisone
5371669|NCT00146640|modified release prednisone|modified release prednisone
5371670|NCT00146627|Human African Trypanosomiasis|human african trypanosomiasis
5371671|NCT00146627|Combination|combination
5371672|NCT00146627|Trypanosoma brucei gambiense Human African Trypanosomiasis|trypanosoma brucei gambiense human african trypanosomiasis
5371673|NCT00146614|Graft versus Host Disease|graft versus host disease
5371674|NCT00146614|GVHD|gvhd
5371675|NCT00146614|Stem Cell Transplantation|stem cell transplantation
5371676|NCT00146614|Tacrolimus|tacrolimus
5371677|NCT00146614|Sirolimus|sirolimus
5371678|NCT00146614|Methotrexate|methotrexate
5371679|NCT00146614|allogeneic stem cell transplantation|allogeneic stem cell transplantation
5371680|NCT00146601|Fulvestrant|fulvestrant
5371681|NCT00146601|Advanced breast cancer|advanced breast cancer
5371682|NCT00146601|Invasive breast cancer|invasive breast cancer
5371683|NCT00146601|Stage IV Breast Cancer|stage iv breast cancer
5371684|NCT00146601|Hormone Receptor-Positive Breast Cancer|hormone receptor-positive breast cancer
5371685|NCT00146588|Breast cancer|breast cancer
5371686|NCT00146588|cytoxan|cytoxan
5371687|NCT00146588|epirubicin|epirubicin
5371688|NCT00146588|capecitabine|capecitabine
5371689|NCT00146562|adjuvant chemotherapy|adjuvant chemotherapy
5371690|NCT00146562|G-CSF|g-csf
5371691|NCT00146562|pegfilgrastim|pegfilgrastim
5371692|NCT00146562|darbepoetin alfa|darbepoetin alfa
5371693|NCT00146549|HER2-positive Breast cancer|her2-positive breast cancer
5371694|NCT00146549|HER2 overexpressing|her2 overexpressing
5371695|NCT00146549|trastuzumab|trastuzumab
5371696|NCT00146549|Herceptin|herceptin
5371697|NCT00146549|vinorelbine|vinorelbine
5371698|NCT00146549|Navelbine|navelbine
5371699|NCT00146549|Taxotere|taxotere
5371700|NCT00146549|taxol|taxol
5371701|NCT00146536|ALH|alh
5371702|NCT00146536|LCIS|lcis
5371703|NCT00146536|DCIS|dcis
5371704|NCT00146536|adjacent ipsilateral infiltrating carcinoma|adjacent ipsilateral infiltrating carcinoma
5371705|NCT00146536|core needle biopsy|core needle biopsy
5371706|NCT00146536|Lobular neoplasia of the breast|lobular neoplasia of the breast
5371707|NCT00146523|Psychotic Major Depression|psychotic major depression
5371708|NCT00146523|PMD|pmd
5371709|NCT00146523|Depression|depression
5371710|NCT00146523|Major Depression|major depression
5371711|NCT00146523|Psychosis|psychosis
5371712|NCT00146510|weight control|weight control
5371713|NCT00146510|compliance|compliance
5371714|NCT00146510|physical activity|physical activity
5371715|NCT00146510|nutrition|nutrition
5371716|NCT00146510|Health Behavior|health behavior
5371717|NCT00146510|Patient Compliance|patient compliance
5371718|NCT00146497|Respiratory distress syndrome (RDS)|respiratory distress syndrome (rds)
5371719|NCT00146497|Premature infants|premature infants
5371720|NCT00146497|Chronic lung disease (CLD)|chronic lung disease (cld)
5371721|NCT00146497|Bronchoalveolar lavage fluid (BALF)|bronchoalveolar lavage fluid (balf)
5371722|NCT00146497|Cytokines|cytokines
5371723|NCT00146484|Diabetes Mellitus, Type 1|diabetes mellitus, type 1
5371724|NCT00146484|Child|child
5371725|NCT00146484|Adolescent|adolescent
5371726|NCT00146484|Disease Management|disease management
5371727|NCT00146484|Newly Diagnosed|newly diagnosed
5371728|NCT00146484|Hemoglobin A, Glycosylated|hemoglobin a, glycosylated
5371729|NCT00146471|alcohol withdrawal|alcohol withdrawal
5371730|NCT00146471|detoxification|detoxification
5371731|NCT00146471|Inpatients|inpatients
5371732|NCT00146471|alcohol dependence according to DSM-IV/ICD-10|alcohol dependence according to dsm-iv/icd-10
5371733|NCT00146471|withdrawal symptoms|withdrawal symptoms
5371734|NCT00146458|Cervical cancer|cervical cancer
5371735|NCT00146458|FDG-PET|fdg-pet
5371736|NCT00146458|Lymph node metastasis|lymph node metastasis
5371737|NCT00146458|Radiotherapy|radiotherapy
5371738|NCT00146458|Chemotherapy|chemotherapy
5371739|NCT00146445|IV drug users|iv drug users
5371740|NCT00146419|Treatment Experienced|treatment experienced
5371741|NCT00146419|Treatment Naive|treatment naive
5371742|NCT00146406|Adolescent Health|adolescent health
5371743|NCT00146406|Sexually Transmitted Disease|sexually transmitted disease
5371744|NCT00146406|Sexual Behavior|sexual behavior
5371745|NCT00146393|exercise|exercise
5371746|NCT00146393|physical activity|physical activity
5371747|NCT00146393|physical conditioning|physical conditioning
5371748|NCT00146393|pain|pain
5371749|NCT00146393|physical function|physical function
5371750|NCT00146380|Prevention Mother-to-Child HIV transmission|prevention mother-to-child hiv transmission
5371751|NCT00146380|HIV Seronegativity|hiv seronegativity
5371752|NCT00146367|arthritis|arthritis
5371753|NCT00146367|osteoarthritis|osteoarthritis
5371754|NCT00146367|rheumatoid arthritis|rheumatoid arthritis
5371755|NCT00146367|rheumatic disease|rheumatic disease
5371756|NCT00146367|exercise|exercise
5371757|NCT00146367|physical activity|physical activity
5371758|NCT00146367|physical function|physical function
5371759|NCT00146367|disability|disability
5371760|NCT00146354|Electronic Medical Record|electronic medical record
5371761|NCT00146354|Electronic Results Tracking|electronic results tracking
5371762|NCT00146354|Patient Safety|patient safety
5371763|NCT00146354|Post-Discharge Test Results|post-discharge test results
5371764|NCT00146315|Primary Health Care|primary health care
5371765|NCT00146315|Family Practice|family practice
5371766|NCT00146315|Family Physician|family physician
5371767|NCT00146315|Exercise|exercise
5371768|NCT00146315|Coronary Heart Disease|coronary heart disease
5371769|NCT00146315|Randomized Controlled Trials|randomized controlled trials
5371770|NCT00146315|Multicenter Studies|multicenter studies
5371771|NCT00146302|Non-specific effects of vaccines|non-specific effects of vaccines
5371772|NCT00146302|Infant mortality|infant mortality
5371773|NCT00146302|Morbidity|morbidity
5371774|NCT00146302|Low income country|low income country
5371775|NCT00146302|BCG|bcg
5371776|NCT00146302|Vaccine policy|vaccine policy
5371777|NCT00146302|immunisation|immunisation
5371778|NCT00146302|Low birth weight|low birth weight
5371779|NCT00146302|Tuberculin|tuberculin
5371780|NCT00146302|Mortality|mortality
5371781|NCT00146276|bladder cancer|bladder cancer
5371782|NCT00146276|cystectomy|cystectomy
5371783|NCT00146276|gemcitabine|gemcitabine
5371784|NCT00146276|adjuvant chemotherapy|adjuvant chemotherapy
5371785|NCT00146276|locally advanced bladder cancer|locally advanced bladder cancer
5371786|NCT00146263|mild cognitive impairment|mild cognitive impairment
5371787|NCT00146263|dementia|dementia
5371788|NCT00146263|Alzheimer's Disease|alzheimer's disease
5371789|NCT00146263|cognitive training|cognitive training
5371790|NCT00146237|phenytoin|phenytoin
5371791|NCT00146237|SSRI failure|ssri failure
5371792|NCT00146237|depression|depression
5371793|NCT00146224|anemia|anemia
5371794|NCT00146224|chronic kidney disease, CKD|chronic kidney disease, ckd
5371795|NCT00146224|hemodialysis|hemodialysis
5371796|NCT00146224|epoetin|epoetin
5371797|NCT00146224|Epogen®|epogen®
5371798|NCT00146211|Trial|trial
5371799|NCT00146211|ethyl-EPA|ethyl-epa
5371800|NCT00146211|Miraxion™|miraxion™
5371801|NCT00146211|treating|treating
5371802|NCT00146211|mild|mild
5371803|NCT00146211|moderate|moderate
5371804|NCT00146211|Huntington's|huntington's
5371805|NCT00146198|Postoperative pain|postoperative pain
5371806|NCT00146198|Inguinal Hernia Repair|inguinal hernia repair
5371807|NCT00146198|Capsaicin|capsaicin
5371808|NCT00146185|Needlestick pain|needlestick pain
5371809|NCT00146185|Venipuncture pain|venipuncture pain
5371810|NCT00146185|Procedural pain|procedural pain
5371811|NCT00146172|Tumors|tumors
5371812|NCT00146172|Neratinib|neratinib
5371813|NCT00146172|HKI-272|hki-272
5371814|NCT00146172|Nerlynx|nerlynx
5371815|NCT00146159|Multiple Sclerosis|multiple sclerosis
5371816|NCT00146146|transsexualism|transsexualism
5371817|NCT00146146|testosterone|testosterone
5371818|NCT00146146|dihydrotestosterone|dihydrotestosterone
5371819|NCT00146146|estradiol|estradiol
5371820|NCT00146133|Obesity, Aging, Frailty, exercise, weight loss|obesity, aging, frailty, exercise, weight loss
5371821|NCT00146107|obesity|obesity
5371822|NCT00146107|aging|aging
5371823|NCT00146107|exercise|exercise
5371824|NCT00146107|diet|diet
5371825|NCT00146107|weight loss|weight loss
5371826|NCT00146107|physical function|physical function
5371827|NCT00146107|Obesity in the Elderly|obesity in the elderly
5371828|NCT00146094|Osteopenia|osteopenia
5371829|NCT00146094|osteoporosis|osteoporosis
5371830|NCT00146094|bone mineral density|bone mineral density
5371831|NCT00146094|HIV infection|hiv infection
5371832|NCT00146094|bone metabolism|bone metabolism
5371833|NCT00146094|Treatment Naive|treatment naive
5371834|NCT00146081|African Americans|african americans
5371835|NCT00146081|weight control|weight control
5371836|NCT00146081|social support|social support
5371837|NCT00146068|Clinically Isolated Syndrome|clinically isolated syndrome
5371838|NCT00146029|Patients who participated in UMCC 9900/9901 (Phase II Studies of Tailored-Dose Docetaxel in Metastatic Breast Cancer)|patients who participated in umcc 9900/9901 (phase ii studies of tailored-dose docetaxel in metastatic breast cancer)
5371839|NCT00146016|Chronic Hepatitis C|chronic hepatitis c
5371840|NCT00146016|Amantadine|amantadine
5371841|NCT00146016|Triple therapy|triple therapy
5371842|NCT00146003|eczema|eczema
5371843|NCT00146003|atopic dermatitis|atopic dermatitis
5371844|NCT00146003|efalizumab|efalizumab
5371845|NCT00145990|methacholine PC20|methacholine pc20
5371846|NCT00145990|dosimeter|dosimeter
5371847|NCT00145990|asthma|asthma
5371848|NCT00145977|osteoporosis|osteoporosis
5371849|NCT00145977|bone density|bone density
5371850|NCT00145977|women|women
5371851|NCT00145977|endocrine|endocrine
5371852|NCT00145977|musculoskeletal|musculoskeletal
5371853|NCT00145977|metabolic|metabolic
5371854|NCT00145964|Biliary Cirrhosis, Primary|biliary cirrhosis, primary
5371855|NCT00145964|genes|genes
5371856|NCT00145964|autoimmune disease|autoimmune disease
5371857|NCT00145938|Portopulmonary hypertension|portopulmonary hypertension
5371858|NCT00145938|PTPH|ptph
5371859|NCT00145938|pulmonary hypertension|pulmonary hypertension
5371860|NCT00145938|high blood pressure in the pulmonary arteries|high blood pressure in the pulmonary arteries
5371861|NCT00145925|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
5371862|NCT00145925|Blood Pressure|blood pressure
5371863|NCT00145925|Stroke|stroke
5371864|NCT00145925|MI|mi
5371865|NCT00145912|Depression in adolescents and young adults, depression web-base activity|depression in adolescents and young adults, depression web-base activity
5371866|NCT00145886|low bone turnover; sclerosing bone disorders,|low bone turnover; sclerosing bone disorders,
5371867|NCT00145886|osteopetrosis|osteopetrosis
5371868|NCT00145873|heart failure|heart failure
5371869|NCT00145873|nesiritide|nesiritide
5371870|NCT00145873|heart disease|heart disease
5371871|NCT00145873|cardiovascular disease|cardiovascular disease
5371872|NCT00145860|Colorectal Cancer|colorectal cancer
5371873|NCT00145847|alcohol|alcohol
5371874|NCT00145847|schizophrenia|schizophrenia
5371875|NCT00145847|naltrexone|naltrexone
5371876|NCT00145834|psychosocial factors|psychosocial factors
5371877|NCT00145834|breastfeeding|breastfeeding
5371878|NCT00145834|postnatal intervention|postnatal intervention
5371879|NCT00145834|health visitor|health visitor
5371880|NCT00145808|Ulcerative colitis|ulcerative colitis
5371881|NCT00145795|HIV|hiv
5371882|NCT00145795|HAART (Highly Active Anti-Retroviral Therapy) partial immune response|haart (highly active anti-retroviral therapy) partial immune response
5371883|NCT00145795|no immune response|no immune response
5371884|NCT00145795|Treatment Experienced|treatment experienced
5371885|NCT00145782|multiphasic screening|multiphasic screening
5371886|NCT00145782|primary health care|primary health care
5371887|NCT00145782|randomized controlled trial|randomized controlled trial
5371888|NCT00145782|Risk factors|risk factors
5371889|NCT00145769|rectal cancer|rectal cancer
5371890|NCT00145769|radiotherapy|radiotherapy
5371891|NCT00145769|chemotherapy|chemotherapy
5371892|NCT00145769|chemoradiation|chemoradiation
5371893|NCT00145769|adjuvant therapy|adjuvant therapy
5371894|NCT00145756|Sodium Chloride|sodium chloride
5371895|NCT00145756|Blood Pressure|blood pressure
5371896|NCT00145756|Cardiovascular Diseases|cardiovascular diseases
5371897|NCT00145756|Clinical Trial|clinical trial
5371898|NCT00145743|Quality of Life|quality of life
5371899|NCT00145743|Breast Cancer|breast cancer
5371900|NCT00145743|Referee's Report|referee's report
5371901|NCT00145743|Diagnostics|diagnostics
5371902|NCT00145743|Therapy|therapy
5371903|NCT00145730|osteoarthritis hip|osteoarthritis hip
5371904|NCT00145730|arthroplasty|arthroplasty
5371905|NCT00145730|ectopic bone formation|ectopic bone formation
5371906|NCT00145730|non-steroidal anti-inflammatory drugs|non-steroidal anti-inflammatory drugs
5371907|NCT00145730|disability|disability
5371908|NCT00145717|Phytosterols|phytosterols
5371909|NCT00145717|Cholesterol|cholesterol
5371910|NCT00145717|China|china
5371911|NCT00145717|Randomized controlled trial|randomized controlled trial
5371912|NCT00145704|osteopenia|osteopenia
5371913|NCT00145704|growth hormone deficiency|growth hormone deficiency
5371914|NCT00145704|pediatric malignancy|pediatric malignancy
5371915|NCT00145678|borderline|borderline
5371916|NCT00145678|alcohol|alcohol
5371917|NCT00145678|substance|substance
5371918|NCT00145678|psychodynamic|psychodynamic
5371919|NCT00145678|psychotherapy|psychotherapy
5371920|NCT00145678|psychoanalytic|psychoanalytic
5371921|NCT00145665|FLT-PET|flt-pet
5372223|NCT00143949|kidney|kidney
5371922|NCT00145665|colorectal liver metastases|colorectal liver metastases
5371923|NCT00145665|proliferation|proliferation
5371924|NCT00145665|proliferation markers|proliferation markers
5371925|NCT00145665|recurrence|recurrence
5371926|NCT00145652|erythropoetin|erythropoetin
5371927|NCT00145652|adjuvant iron therapy|adjuvant iron therapy
5371928|NCT00145652|anemia|anemia
5371929|NCT00145652|cancer|cancer
5371930|NCT00145639|Osteosarcoma|osteosarcoma
5371931|NCT00145639|Treatment, Carboplatin|treatment, carboplatin
5371932|NCT00145626|Stem cell transplantation|stem cell transplantation
5371933|NCT00145626|Stem cell transplant|stem cell transplant
5371934|NCT00145626|Haploidentical transplant|haploidentical transplant
5371935|NCT00145613|Haploidentical stem cell transplant|haploidentical stem cell transplant
5371936|NCT00145613|High risk hematologic malignancies|high risk hematologic malignancies
5371937|NCT00145613|Allogeneic stem cell transplant|allogeneic stem cell transplant
5371938|NCT00145613|Mismatched family member stem cell donor|mismatched family member stem cell donor
5371939|NCT00145600|Lymphoma|lymphoma
5371940|NCT00145600|Hodgkin Disease|hodgkin disease
5371941|NCT00145587|Osteopetrosis|osteopetrosis
5371942|NCT00145587|Autosomal recessive bone disease|autosomal recessive bone disease
5371943|NCT00145587|Haploidentical stem cell transplantation|haploidentical stem cell transplantation
5371944|NCT00145587|Allogeneic stem cell transplantation|allogeneic stem cell transplantation
5371945|NCT00145587|T-cell depletion methodology|t-cell depletion methodology
5371946|NCT00145587|Miltenyi Biotec CliniMACS stem cell selection device|miltenyi biotec clinimacs stem cell selection device
5371947|NCT00145574|Pediatric|pediatric
5371948|NCT00145574|hypercholesterolemia|hypercholesterolemia
5371949|NCT00145574|colesevelam|colesevelam
5371950|NCT00145561|HIV|hiv
5371951|NCT00145548|COPD|copd
5371952|NCT00145535|Glaucoma|glaucoma
5371953|NCT00145535|Glaucoma, open angle|glaucoma, open angle
5371954|NCT00145535|Intraocular Pressure|intraocular pressure
5371955|NCT00145535|Trabeculoplasty|trabeculoplasty
5371956|NCT00145535|laser|laser
5371957|NCT00145535|laser, surgery|laser, surgery
5371958|NCT00145522|Menopause, IGF-1, HRT|menopause, igf-1, hrt
5371959|NCT00145418|Non small Cell Lung Cancer Stage IIIb and IV|non small cell lung cancer stage iiib and iv
5371960|NCT00145405|Acromegaly|acromegaly
5371961|NCT00145405|somatostatin analogues|somatostatin analogues
5371962|NCT00145405|lanreotide|lanreotide
5371963|NCT00145405|octreotide|octreotide
5371964|NCT00145405|GH|gh
5371965|NCT00145405|IGF-I|igf-i
5371966|NCT00145405|injection site|injection site
5371967|NCT00145392|Polycystic ovary syndrome|polycystic ovary syndrome
5371968|NCT00145392|growth hormone|growth hormone
5371969|NCT00145392|insulin resistance|insulin resistance
5371970|NCT00145392|overweight|overweight
5371971|NCT00145392|glucose metabolism|glucose metabolism
5371972|NCT00145379|type 1 diabetes mellitus|type 1 diabetes mellitus
5371973|NCT00145379|insulin resistance|insulin resistance
5371974|NCT00145379|metformin|metformin
5371975|NCT00145379|randomized, controlled study|randomized, controlled study
5371976|NCT00145366|Benign nontoxic and toxic goiter|benign nontoxic and toxic goiter
5371977|NCT00145366|rhTSH|rhtsh
5371978|NCT00145366|131I|131i
5371979|NCT00145366|goiter reduction|goiter reduction
5371980|NCT00145366|131I kinetic|131i kinetic
5371981|NCT00145366|thyroid size|thyroid size
5371982|NCT00145366|patient satisfaction|patient satisfaction
5371983|NCT00145366|adverse effects|adverse effects
5371984|NCT00145366|BRT|brt
5371985|NCT00145366|Graves' disease|graves' disease
5371986|NCT00145353|type 1 diabetes mellitus|type 1 diabetes mellitus
5371987|NCT00145353|hypoglycaemia|hypoglycaemia
5371988|NCT00145353|insulin profiles|insulin profiles
5371989|NCT00145353|growth hormone|growth hormone
5371990|NCT00145353|cortisol|cortisol
5371991|NCT00145353|glucagon|glucagon
5371992|NCT00145340|polycystic ovary syndrome (PCOS)|polycystic ovary syndrome (pcos)
5371993|NCT00145340|PPARgamma|ppargamma
5371994|NCT00145340|growth hormone|growth hormone
5371995|NCT00145340|insulin resistance|insulin resistance
5371996|NCT00145340|pioglitazone|pioglitazone
5371997|NCT00145340|glucose metabolism|glucose metabolism
5371998|NCT00145340|microarray|microarray
5371999|NCT00145327|Osteoporosis, Zoledronic Acid|osteoporosis, zoledronic acid
5372000|NCT00145314|Metastatic colorectal cancer|metastatic colorectal cancer
5372001|NCT00145314|FLOX|flox
5372002|NCT00145314|Cetuximab|cetuximab
5372003|NCT00145301|Osteoarthritis, lumiracoxib, retention on treatment, efficacy, safety|osteoarthritis, lumiracoxib, retention on treatment, efficacy, safety
5372004|NCT00145288|hirsutism|hirsutism
5372005|NCT00145288|type 2 diabetes|type 2 diabetes
5372006|NCT00145288|polycystic ovary syndrome|polycystic ovary syndrome
5372007|NCT00145288|metabolism|metabolism
5372008|NCT00145275|zoledronic acid|zoledronic acid
5372009|NCT00145275|bisphosphonate|bisphosphonate
5372010|NCT00145275|Low bone mass|low bone mass
5372011|NCT00145262|critical limb ischemia|critical limb ischemia
5372012|NCT00145262|bone marrow mononuclear cells|bone marrow mononuclear cells
5372013|NCT00145262|angiogenesis|angiogenesis
5372014|NCT00145262|vasculogenesis|vasculogenesis
5372015|NCT00145262|Arteriosclerosis Obliterans (ASO)|arteriosclerosis obliterans (aso)
5372016|NCT00145262|Ischemic ulcers|ischemic ulcers
5372017|NCT00145249|Bacterial infections, HIV infection, cryptococcal meningitis|bacterial infections, hiv infection, cryptococcal meningitis
5372018|NCT00145236|Nebivolol|nebivolol
5372019|NCT00145236|Beta-Blocker|beta-blocker
5372020|NCT00145223|Wuchereria bancrofti, filariasis, Egypt|wuchereria bancrofti, filariasis, egypt
5372021|NCT00145210|Nebivolol|nebivolol
5372022|NCT00145197|breast cancer|breast cancer
5372023|NCT00145197|adjuvant treatment|adjuvant treatment
5372024|NCT00145197|racial disparities|racial disparities
5372025|NCT00145197|Early-Stage Breast Cancer|early-stage breast cancer
5372026|NCT00145184|multivitamin, supplements, tuberculosis, Tanzania|multivitamin, supplements, tuberculosis, tanzania
5372027|NCT00145158|Melanoma|melanoma
5372028|NCT00145158|Vaccine|vaccine
5372029|NCT00145158|Peptide|peptide
5372030|NCT00145158|Montanide|montanide
5372031|NCT00145145|Melanoma|melanoma
5372032|NCT00145145|Vaccine|vaccine
5372033|NCT00145145|Peptide|peptide
5372034|NCT00145145|MAGE|mage
5372035|NCT00145145|CpG|cpg
5372036|NCT00145132|depression|depression
5372037|NCT00145132|β-CIT-SPECT|β-cit-spect
5372038|NCT00145132|SERT|sert
5372039|NCT00145132|DAT|dat
5372040|NCT00145132|neurophysiology|neurophysiology
5372041|NCT00145132|LDAEP|ldaep
5372042|NCT00145132|escitalopram|escitalopram
5372043|NCT00145132|SSRI|ssri
5372044|NCT00145119|Acute myocardial infarction|acute myocardial infarction
5372045|NCT00145119|Cardiac arrhythmias|cardiac arrhythmias
5372046|NCT00145119|Left ventricular dysfunction|left ventricular dysfunction
5372047|NCT00145119|Implantable loop recorder|implantable loop recorder
5372048|NCT00145119|Risk stratifiers|risk stratifiers
5372049|NCT00145106|acne, tazarotene, minocycline, maintenance, retinoid, efficacy, combination|acne, tazarotene, minocycline, maintenance, retinoid, efficacy, combination
5372050|NCT00145093|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
5372051|NCT00145093|Chromium|chromium
5372052|NCT00145093|Saccharomyces cerevisiae|saccharomyces cerevisiae
5372053|NCT00145028|Neoplasms|neoplasms
5372054|NCT00145028|Carboplatin|carboplatin
5372055|NCT00145028|optimal exposure|optimal exposure
5372056|NCT00145028|AUC|auc
5372057|NCT00145015|Intervention|intervention
5372058|NCT00145015|Adults|adults
5372059|NCT00145015|Colorectal cancer|colorectal cancer
5372060|NCT00145015|Nutrition|nutrition
5372061|NCT00145015|Fish|fish
5372062|NCT00145015|n-3 fatty acids|n-3 fatty acids
5372063|NCT00145015|Apoptosis|apoptosis
5372064|NCT00145015|Ulcerative colitis|ulcerative colitis
5372065|NCT00145015|Polyps|polyps
5372066|NCT00145015|Gastro-intestinal tract|gastro-intestinal tract
5372067|NCT00145002|ATLL|atll
5372068|NCT00145002|chemotherapy|chemotherapy
5372069|NCT00145002|phase III study|phase iii study
5372070|NCT00145002|VCAP-AMP-VECP|vcap-amp-vecp
5372071|NCT00145002|biweekly-CHOP|biweekly-chop
5372072|NCT00144989|Small-cell lung cancer|small-cell lung cancer
5372073|NCT00144989|Limited-Stage Small-Cell Lung Cancer|limited-stage small-cell lung cancer
5372074|NCT00144989|Combined modality therapy|combined modality therapy
5372075|NCT00144989|chemotherapy|chemotherapy
5372076|NCT00144989|radiotherapy|radiotherapy
5372077|NCT00144989|Irinotecan|irinotecan
5372078|NCT00144989|Cisplatin|cisplatin
5372079|NCT00144976|Head and Neck Neoplasms|head and neck neoplasms
5372080|NCT00144976|Tarceva|tarceva
5372081|NCT00144976|ENT|ent
5372082|NCT00144911|exacerbations|exacerbations
5372083|NCT00144911|breathing|breathing
5372084|NCT00144911|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
5372085|NCT00144898|Breast cancer|breast cancer
5372086|NCT00144898|sentinel node resection|sentinel node resection
5372087|NCT00144898|survival|survival
5372088|NCT00144898|Breast cancer unifocal N0|breast cancer unifocal n0
5372089|NCT00144885|Endocarditis|endocarditis
5372090|NCT00144885|RMI|rmi
5372091|NCT00144885|Impact measure|impact measure
5372092|NCT00144872|Absence Seizures|absence seizures
5372093|NCT00144872|EEG|eeg
5372094|NCT00144872|LTG|ltg
5372095|NCT00144872|Typical Absence Epilepsy|typical absence epilepsy
5372096|NCT00144872|Epilepsy|epilepsy
5372097|NCT00144872|LAMICTAL|lamictal
5372098|NCT00144859|P38 map kinase|p38 map kinase
5372099|NCT00144859|CRP|crp
5372100|NCT00144859|COPD|copd
5372101|NCT00144859|safety|safety
5372102|NCT00144846|wheezing|wheezing
5372103|NCT00144846|bronchospasm|bronchospasm
5372104|NCT00144846|albuterol sulfate HFA|albuterol sulfate hfa
5372105|NCT00144833|Protease inhibitors-experienced HIV-1 infected patients|protease inhibitors-experienced hiv-1 infected patients
5372106|NCT00144833|Highly-resistant HIV-1|highly-resistant hiv-1
5372107|NCT00144833|Dual boosted Pis|dual boosted pis
5372108|NCT00144833|fosamprenavir|fosamprenavir
5372109|NCT00144833|lopinavir|lopinavir
5372110|NCT00144820|Hyaluronan|hyaluronan
5372111|NCT00144820|Gonarthrosis|gonarthrosis
5372112|NCT00144820|Osteoarthritis,knee|osteoarthritis,knee
5372113|NCT00144820|Double-blinded|double-blinded
5372114|NCT00144820|Placebo controlled|placebo controlled
5372115|NCT00144820|Randomised|randomised
5372116|NCT00144807|lymphoma, diffuse large B-cell|lymphoma, diffuse large b-cell
5372117|NCT00144807|rituximab|rituximab
5372118|NCT00144807|chemotherapy|chemotherapy
5372224|NCT00143949|retinopathy|retinopathy
5372119|NCT00144807|autologous stem cell transplant|autologous stem cell transplant
5372120|NCT00144794|Hurler's Syndrome|hurler's syndrome
5372121|NCT00144794|Hurler-Scheie Syndrome|hurler-scheie syndrome
5372122|NCT00144794|Scheie Syndrome|scheie syndrome
5372123|NCT00144755|lymphoma, diffuse large B-cell|lymphoma, diffuse large b-cell
5372124|NCT00144755|rituximab|rituximab
5372125|NCT00144755|chemotherapy|chemotherapy
5372126|NCT00144755|erythropoetin|erythropoetin
5372127|NCT00144755|darbepoetin alfa|darbepoetin alfa
5372128|NCT00144716|Vector Control|vector control
5372129|NCT00144716|repellent|repellent
5372130|NCT00144716|ITN's|itn's
5372131|NCT00144716|malaria|malaria
5372132|NCT00144716|Amazon|amazon
5372133|NCT00144703|Graft versus host disease|graft versus host disease
5372134|NCT00144703|GVHD|gvhd
5372135|NCT00144703|Stem cell transplantation|stem cell transplantation
5372136|NCT00144703|sirolimus|sirolimus
5372137|NCT00144703|tacrolimus|tacrolimus
5372138|NCT00144690|Epilepsy refractory partial seizures|epilepsy refractory partial seizures
5372139|NCT00144677|Graft versus Host Disease|graft versus host disease
5372140|NCT00144677|GVHD|gvhd
5372141|NCT00144677|sirolimus|sirolimus
5372142|NCT00144677|tacrolimus|tacrolimus
5372143|NCT00144677|Stem cell transplant|stem cell transplant
5372144|NCT00144443|Aerobiology|aerobiology
5372145|NCT00144443|Asthma|asthma
5372146|NCT00144443|Indoor Fungi|indoor fungi
5372147|NCT00144443|Allergen|allergen
5372148|NCT00144443|Home Remediation|home remediation
5372149|NCT00144430|chronic graft versus host disease|chronic graft versus host disease
5372150|NCT00144430|graft|graft
5372151|NCT00144430|host|host
5372152|NCT00144430|transplant|transplant
5372153|NCT00144430|stem cell|stem cell
5372154|NCT00144430|pediatric|pediatric
5372155|NCT00144430|GVH0313|gvh0313
5372156|NCT00144430|leukemia|leukemia
5372157|NCT00144417|tuberculosis|tuberculosis
5372158|NCT00144417|TB|tb
5372159|NCT00144417|treatment|treatment
5372160|NCT00144417|efficacy|efficacy
5372161|NCT00144417|safety|safety
5372162|NCT00144378|gastric cancer|gastric cancer
5372163|NCT00144378|metastatic|metastatic
5372164|NCT00144378|irinotecan|irinotecan
5372165|NCT00144365|HIV|hiv
5372166|NCT00144365|Africa|africa
5372167|NCT00144365|Adherence|adherence
5372168|NCT00144365|HIV viral load|hiv viral load
5372169|NCT00144365|Sexual behavior|sexual behavior
5372410|NCT00142597|analgesia|analgesia
5372170|NCT00144365|Voluntary counseling and testing|voluntary counseling and testing
5372172|NCT00144352|HIV|hiv
5372173|NCT00144352|AIDS|aids
5372174|NCT00144352|drug efficacy|drug efficacy
5372175|NCT00144352|Kenya|kenya
5372176|NCT00144352|Africa|africa
5372177|NCT00144352|Sulfadoxine pyirmethamine|sulfadoxine pyirmethamine
5372178|NCT00144352|fansidar|fansidar
5372179|NCT00144313|vaccine|vaccine
5372180|NCT00144313|hepatitis B|hepatitis b
5372181|NCT00144313|immune memory|immune memory
5372182|NCT00144144|Hypertension|hypertension
5372183|NCT00144144|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
5372184|NCT00144144|Calcium Channel Blocker|calcium channel blocker
5372185|NCT00144144|Angiotensin II type 1 Receptor Blocker|angiotensin ii type 1 receptor blocker
5372186|NCT00144131|Chemotherapy, Anemia|chemotherapy, anemia
5372187|NCT00144131|Aranesp®, rHuEPO|aranesp®, rhuepo
5372188|NCT00144131|Chemotherapy Induced Anemia|chemotherapy induced anemia
5372189|NCT00144131|non-myeloid malignancy|non-myeloid malignancy
5372190|NCT00144131|Non-Myeloid Malignancies|non-myeloid malignancies
5372191|NCT00144131|Chemotherapy|chemotherapy
5372192|NCT00144092|autologous and allogeneic stem cell transplantation|autologous and allogeneic stem cell transplantation
5372193|NCT00144092|low grade lymphoma|low grade lymphoma
5372194|NCT00144092|mantle cell|mantle cell
5372195|NCT00144079|Differentiated thyroid carcinoma|differentiated thyroid carcinoma
5372196|NCT00144079|radiotherapy|radiotherapy
5372197|NCT00144079|radioiodine therapy|radioiodine therapy
5372198|NCT00144079|thyroidectomy|thyroidectomy
5372199|NCT00144040|Antibiotics|antibiotics
5372200|NCT00144040|Respiratory Infections|respiratory infections
5372201|NCT00144040|Quality Assurance, Healthcare|quality assurance, healthcare
5372202|NCT00144040|Professional Education|professional education
5372203|NCT00144040|Emergency Services, Medical|emergency services, medical
5372204|NCT00144040|Education, Patient|education, patient
5372205|NCT00144027|patient non-adherence|patient non-adherence
5372206|NCT00144027|intervention studies|intervention studies
5372207|NCT00144014|Acute|acute
5372208|NCT00144014|Ischaemic|ischaemic
5372209|NCT00144014|Stroke|stroke
5372210|NCT00144001|Epilepsy|epilepsy
5372211|NCT00144001|Pharmacoepidemiology|pharmacoepidemiology
5372212|NCT00144001|Quality of Care|quality of care
5372213|NCT00144001|Outcomes|outcomes
5372214|NCT00143988|Blood Pressure|blood pressure
5372215|NCT00143988|Heart Rate|heart rate
5372216|NCT00143988|Sexual Activity|sexual activity
5372217|NCT00143975|Acute myeloid leukemia|acute myeloid leukemia
5372218|NCT00143975|gemtuzumab ozogamicin|gemtuzumab ozogamicin
5372219|NCT00143975|refractory disease|refractory disease
5372220|NCT00143962|Weight Loss|weight loss
5372221|NCT00143949|diabetes|diabetes
5372222|NCT00143949|nephropathy|nephropathy
5372225|NCT00143936|Weight Loss|weight loss
5372226|NCT00143923|Cardiovascular Diseases|cardiovascular diseases
5372227|NCT00143923|Ethnic Groups|ethnic groups
5372228|NCT00143923|Risk Factors|risk factors
5372229|NCT00143923|Sleep disordered breathing|sleep disordered breathing
5372230|NCT00143923|Environmental exposures|environmental exposures
5372231|NCT00143923|Cognitive Function|cognitive function
5372232|NCT00143910|Medication adherence|medication adherence
5372233|NCT00143910|Patient compliance|patient compliance
5372234|NCT00143910|Kidney transplant|kidney transplant
5372235|NCT00143910|Organ rejection|organ rejection
5372236|NCT00143910|Allograft loss|allograft loss
5372237|NCT00143910|Drug monitoring|drug monitoring
5372238|NCT00143858|Peripheral Pulse Volume|peripheral pulse volume
5372239|NCT00143832|fMRI|fmri
5372240|NCT00143819|psoriasis|psoriasis
5372241|NCT00143819|dry skin|dry skin
5372242|NCT00143819|eczema|eczema
5372243|NCT00143819|atopic dermatitis|atopic dermatitis
5372244|NCT00143806|psoriasis|psoriasis
5372245|NCT00143806|cyclosporine|cyclosporine
5372246|NCT00143806|transition|transition
5372247|NCT00143806|alefacept|alefacept
5372248|NCT00143793|natruretic peptides|natruretic peptides
5372249|NCT00143793|NT-proBNP|nt-probnp
5372250|NCT00143793|new biomarkers|new biomarkers
5372251|NCT00143793|congestive heart failure|congestive heart failure
5372252|NCT00143793|atrial fibrillation|atrial fibrillation
5372253|NCT00143793|acute myocardial infarction|acute myocardial infarction
5372254|NCT00143793|lung embolism|lung embolism
5372255|NCT00143780|Bone Marrow Transplant|bone marrow transplant
5372256|NCT00143780|Pneumonia|pneumonia
5372257|NCT00143780|Vaccine|vaccine
5372258|NCT00143780|Conjugate Vaccine|conjugate vaccine
5372259|NCT00143780|Polysaccharide Vaccine|polysaccharide vaccine
5372260|NCT00143767|Magnetic Resonance Imaging|magnetic resonance imaging
5372261|NCT00143741|Kidney Disease, Lipitor, Atorvastatin, Allosensitization|kidney disease, lipitor, atorvastatin, allosensitization
5372262|NCT00143728|HIV|hiv
5372263|NCT00143728|Treatment Experienced|treatment experienced
5372264|NCT00143715|Vitamin K1 (phytonadione)|vitamin k1 (phytonadione)
5372265|NCT00143715|Randomized controlled trial|randomized controlled trial
5372266|NCT00143715|Warfarin|warfarin
5372267|NCT00143715|Coagulopathy|coagulopathy
5372268|NCT00143715|Bleeding|bleeding
5372269|NCT00143715|Thrombosis|thrombosis
5372270|NCT00143715|Warfarin associated coagulopathy defined as an INR of 4.5 and 10.0 (for entry into randomized tria) or greater than 10.0 (for entry into parallel cohort study|warfarin associated coagulopathy defined as an inr of 4.5 and 10.0 (for entry into randomized tria) or greater than 10.0 (for entry into parallel cohort study
5372271|NCT00143715|Warfarin associated coagulopathy|warfarin associated coagulopathy
5372272|NCT00143702|Elevated Lactic Acid|elevated lactic acid
5372273|NCT00143676|Hyperlipidemia|hyperlipidemia
5372274|NCT00143676|Dyslipidemia|dyslipidemia
5372275|NCT00143676|Drug Therapy|drug therapy
5372276|NCT00143663|Hypercholesterolemia|hypercholesterolemia
5372277|NCT00143663|Hyperlipidemia|hyperlipidemia
5372278|NCT00143663|Drug Therapy|drug therapy
5372279|NCT00143650|Upper airway, irritation inflammation, discomfort, house dust, damp buildings, climate chamber, humans|upper airway, irritation inflammation, discomfort, house dust, damp buildings, climate chamber, humans
5372280|NCT00143637|Office dust|office dust
5372281|NCT00143637|Glucan|glucan
5372282|NCT00143637|dose-response|dose-response
5372283|NCT00143637|lung function|lung function
5372284|NCT00143637|peak expiratory flow|peak expiratory flow
5372285|NCT00143637|inflammation|inflammation
5372286|NCT00143637|perception|perception
5372287|NCT00143624|Treatment Experienced|treatment experienced
5372288|NCT00143624|HIV Metabolic Syndrome|hiv metabolic syndrome
5372289|NCT00143624|Atherosclerosis in HIV|atherosclerosis in hiv
5372290|NCT00143611|Shock, Septic|shock, septic
5372291|NCT00143611|Sepsis Syndrome|sepsis syndrome
5372292|NCT00143611|Respiratory Insufficiency|respiratory insufficiency
5372293|NCT00143611|SIRS (Systemic Inflammatory Response Syndrome)|sirs (systemic inflammatory response syndrome)
5372294|NCT00143611|Respiratory Failure|respiratory failure
5372295|NCT00143611|Drug Therapy|drug therapy
5372296|NCT00143598|Postphlebitic Syndrome|postphlebitic syndrome
5372297|NCT00143598|Post-Thrombotic Syndrome|post-thrombotic syndrome
5372298|NCT00143598|Elastic Stockings|elastic stockings
5372299|NCT00143598|Stockings, Compression|stockings, compression
5372300|NCT00143598|Randomized Controlled Trials|randomized controlled trials
5372301|NCT00143598|Quality of Life|quality of life
5372302|NCT00143585|angiogenesis|angiogenesis
5372303|NCT00143585|VEGF|vegf
5372304|NCT00143572|Hematologic Diseases|hematologic diseases
5372305|NCT00143572|Anemia, Sickle Cell|anemia, sickle cell
5372306|NCT00143559|Allogeneic stem cell transplantation|allogeneic stem cell transplantation
5372307|NCT00143559|Haploidentical stem cell transplant|haploidentical stem cell transplant
5372308|NCT00143559|Mismatched family member stem cell donor transplant|mismatched family member stem cell donor transplant
5372309|NCT00143559|Bone marrow transplant|bone marrow transplant
5372310|NCT00143559|High risk hematological malignancies|high risk hematological malignancies
5372311|NCT00143559|T-cell depletion methodology|t-cell depletion methodology
5372312|NCT00143559|Miltenyi Biotec CliniMACS stem cell selection device|miltenyi biotec clinimacs stem cell selection device
5372313|NCT00143546|Hepatic Veno-occlusive Disease|hepatic veno-occlusive disease
5372314|NCT00143533|Solid Tumors|solid tumors
5372315|NCT00143520|Placebo and active control dose response study of rivoglitazone in type 2 diabetics|placebo and active control dose response study of rivoglitazone in type 2 diabetics
5372316|NCT00143468|gas exchange|gas exchange
5372317|NCT00143468|respiratory mechanics|respiratory mechanics
5372318|NCT00143429|Primary Open Angle Glaucoma|primary open angle glaucoma
5372319|NCT00143312|Invasive Fungal Infection, Allogenic Stem Cell Transplant, prophylaxis, leukemia, voriconazole|invasive fungal infection, allogenic stem cell transplant, prophylaxis, leukemia, voriconazole
5372320|NCT00143130|phase 4, open label, seizures, epilepsy, add-on therapy, pregabalin, lyrica|phase 4, open label, seizures, epilepsy, add-on therapy, pregabalin, lyrica
5372321|NCT00143091|Major Depressive Disorder, Recurrent|major depressive disorder, recurrent
5372322|NCT00143078|Obesity|obesity
5372323|NCT00143078|Reproduction|reproduction
5372324|NCT00143078|Weight Loss|weight loss
5372325|NCT00143078|Reproductive System|reproductive system
5372326|NCT00143065|Antigens, CD5|antigens, cd5
5372327|NCT00143065|Antigens, CD19|antigens, cd19
5372328|NCT00143065|Antigens, CD20|antigens, cd20
5372329|NCT00143052|Hirsutism|hirsutism
5372330|NCT00143052|Bone status|bone status
5372331|NCT00143052|Androgens|androgens
5372332|NCT00143052|insulin|insulin
5372333|NCT00143039|NIH|nih
5372334|NCT00143039|Severe Symmetrical IUGR|severe symmetrical iugr
5372335|NCT00143039|Tandem Mass Spectrometry|tandem mass spectrometry
5372336|NCT00143039|Nonimmune Hydrops|nonimmune hydrops
5372337|NCT00143039|Severe Symmetrical Intrauterine Growth Restriction|severe symmetrical intrauterine growth restriction
5372338|NCT00143026|Parkinson's disease, levodopa, motor fluctuations|parkinson's disease, levodopa, motor fluctuations
5372339|NCT00143013|type 2 diabetes|type 2 diabetes
5372340|NCT00143013|microarray|microarray
5372341|NCT00143013|skeletal muscle|skeletal muscle
5372342|NCT00143013|bioinformatics|bioinformatics
5372343|NCT00143000|Hepatitis C Virus|hepatitis c virus
5372344|NCT00143000|Genotype 2|genotype 2
5372345|NCT00143000|Genotype 3|genotype 3
5372346|NCT00142987|Tegaserod, IBS-C, women, mixed bowel habit|tegaserod, ibs-c, women, mixed bowel habit
5372347|NCT00142974|Diabetes, tegaserod, gastropathy|diabetes, tegaserod, gastropathy
5372348|NCT00142961|cannabis abuse|cannabis abuse
5372349|NCT00142961|atomoxetine|atomoxetine
5372350|NCT00142961|ADHD|adhd
5372351|NCT00142948|Heroin Abuse|heroin abuse
5372352|NCT00142948|Heroin Addiction|heroin addiction
5372353|NCT00142935|HIV Prevention|hiv prevention
5372354|NCT00142935|Opioid-Related Disorders|opioid-related disorders
5372355|NCT00142935|Medication Assisted Treatment|medication assisted treatment
5372356|NCT00142935|Methadone|methadone
5372357|NCT00142922|Adherence|adherence
5372358|NCT00142922|self-care|self-care
5372359|NCT00142922|Behavioral intervention|behavioral intervention
5372360|NCT00142922|Diabetes|diabetes
5372361|NCT00142909|Opioid dependence|opioid dependence
5372362|NCT00142896|Opiate Addiction|opiate addiction
5372363|NCT00142896|Opiate Dependence|opiate dependence
5372364|NCT00142883|addiction, crack, cocaine|addiction, crack, cocaine
5372365|NCT00142870|marijuana|marijuana
5372366|NCT00142870|treatment|treatment
5372367|NCT00142844|cocaine|cocaine
5372368|NCT00142831|nicotine dependence|nicotine dependence
5372369|NCT00142818|Alcohol Abuse|alcohol abuse
5372370|NCT00142818|Cocaine Abuse|cocaine abuse
5372371|NCT00142805|ketones|ketones
5372372|NCT00142805|Apolipoprotein E|apolipoprotein e
5372373|NCT00142805|ApoE genotype|apoe genotype
5372374|NCT00142805|cognitive function|cognitive function
5372375|NCT00142805|glucose metabolism|glucose metabolism
5372376|NCT00142792|stroke|stroke
5372377|NCT00142792|recovery of function|recovery of function
5372378|NCT00142792|functional electrical stimulation (FES)|functional electrical stimulation (fes)
5372379|NCT00142779|Cocaine Addiction|cocaine addiction
5372380|NCT00142779|Cocaine Dependence|cocaine dependence
5372381|NCT00142779|Opiate Addiction|opiate addiction
5372382|NCT00142779|Opiate Dependence|opiate dependence
5372383|NCT00142766|Sedation|sedation
5372384|NCT00142766|Mechanical ventilation|mechanical ventilation
5372385|NCT00142766|Critical illness|critical illness
5372386|NCT00142766|Analgesic|analgesic
5372387|NCT00142766|Opioid Withdrawal|opioid withdrawal
5372388|NCT00142766|Benzodiazepine Withdrawal|benzodiazepine withdrawal
5372389|NCT00142766|Nurse|nurse
5372390|NCT00142753|Hepatitis B vaccines|hepatitis b vaccines
5372391|NCT00142753|HIV-infected adolescents|hiv-infected adolescents
5372392|NCT00142753|Hepatitis B infection|hepatitis b infection
5372393|NCT00142740|Hepatitis B vaccines|hepatitis b vaccines
5372394|NCT00142740|HIV-infected adolescents|hiv-infected adolescents
5372395|NCT00142740|Hepatitis B infection (negative)|hepatitis b infection (negative)
5372396|NCT00142740|HIV vaccine trial|hiv vaccine trial
5372397|NCT00142714|sexual response|sexual response
5372398|NCT00142714|sexual dysfunction in females|sexual dysfunction in females
5372399|NCT00142714|spinal cord injury|spinal cord injury
5372400|NCT00142636|Chronic Kideny Disease|chronic kideny disease
5372401|NCT00142636|Hypertension|hypertension
5372402|NCT00142610|alpha tocopherol|alpha tocopherol
5372403|NCT00142610|vitamin E|vitamin e
5372404|NCT00142610|ascorbate|ascorbate
5372405|NCT00142610|vitamin C|vitamin c
5372406|NCT00142610|antioxidant|antioxidant
5372407|NCT00142610|allergic|allergic
5372408|NCT00142610|asthma|asthma
5372409|NCT00142597|acupuncture|acupuncture
5372411|NCT00142597|pain|pain
5372412|NCT00142597|fibromyalgia|fibromyalgia
5372413|NCT00142597|fMRI|fmri
5372414|NCT00142597|PET|pet
5372415|NCT00142584|safety and tolerability study|safety and tolerability study
5372416|NCT00142584|hypertension|hypertension
5372417|NCT00142584|beta-blockers|beta-blockers
5372418|NCT00142571|Sarcoma, Soft Tissue|sarcoma, soft tissue
5372419|NCT00142571|Gemcitabine|gemcitabine
5372420|NCT00142571|Docetaxel|docetaxel
5372421|NCT00142558|Arcoxia|arcoxia
5372422|NCT00142532|Acupuncture|acupuncture
5372423|NCT00142532|Pain|pain
5372424|NCT00142532|Lung Cancer|lung cancer
5372425|NCT00142532|Thoracotomy|thoracotomy
5372426|NCT00142532|Surgery|surgery
5372427|NCT00142519|Pain|pain
5372428|NCT00142519|Analgesics|analgesics
5372429|NCT00142519|Retroperitoneal lymph node dissection|retroperitoneal lymph node dissection
5372430|NCT00142506|Prostate Cancer|prostate cancer
5372431|NCT00142506|Cancer of the Prostate|cancer of the prostate
5372432|NCT00142506|Prostate Neoplasms|prostate neoplasms
5372433|NCT00142506|Prostatic Cancer|prostatic cancer
5372434|NCT00142506|Viagra|viagra
5372435|NCT00142506|05-007|05-007
5372436|NCT00142493|Episodic Memory|episodic memory
5372437|NCT00142493|Amnesia|amnesia
5372438|NCT00142493|Amnesia, Temporary|amnesia, temporary
5372439|NCT00142480|locally advanced biliary adenocarcinoma|locally advanced biliary adenocarcinoma
5372440|NCT00142480|unresectable biliary adenocarcinoma|unresectable biliary adenocarcinoma
5372441|NCT00142480|gallbladder adenocarcinoma|gallbladder adenocarcinoma
5372442|NCT00142480|capecitabine|capecitabine
5372443|NCT00142480|oxaliplatin|oxaliplatin
5372444|NCT00142480|bevacizumab|bevacizumab
5372445|NCT00142480|Biliary tract adenocarcinoma|biliary tract adenocarcinoma
5372446|NCT00142467|Unresectable hepatocellular carcinoma|unresectable hepatocellular carcinoma
5372447|NCT00142467|Metastatic hepatocellular carcinoma|metastatic hepatocellular carcinoma
5372448|NCT00142467|gemcitabine|gemcitabine
5372449|NCT00142467|oxaliplatin|oxaliplatin
5372450|NCT00142467|bevacizumab|bevacizumab
5372451|NCT00142467|Avastin|avastin
5372452|NCT00142454|Malignant melanoma|malignant melanoma
5372453|NCT00142454|Stages IIB-III|stages iib-iii
5372454|NCT00142441|Pulsed dye laser|pulsed dye laser
5372455|NCT00142441|Keloids|keloids
5372456|NCT00142441|Hypertrophic scars|hypertrophic scars
5372457|NCT00142441|Pulse width|pulse width
5372458|NCT00142441|Pulse duration|pulse duration
5372459|NCT00142428|Hepatocellular carcinoma|hepatocellular carcinoma
5372460|NCT00142428|cetuximab|cetuximab
5372461|NCT00142428|Unresectable hepatocellular carcinoma|unresectable hepatocellular carcinoma
5372462|NCT00142428|Metastatic hepatocellular carcinoma|metastatic hepatocellular carcinoma
5372463|NCT00142415|Advanced Renal Cell Carcinoma|advanced renal cell carcinoma
5372464|NCT00142415|Clear Cell Renal Cell Carcinoma (CCRCC)|clear cell renal cell carcinoma (ccrcc)
5372465|NCT00142415|Lutetium-177|lutetium-177
5372466|NCT00142415|177-Lu|177-lu
5372467|NCT00142415|cG250|cg250
5372468|NCT00142415|DOTA-cG250|dota-cg250
5372469|NCT00142415|Monoclonal Antibody|monoclonal antibody
5372470|NCT00142402|Multiple Sclerosis|multiple sclerosis
5372471|NCT00142402|Memory|memory
5372472|NCT00142402|New Learning|new learning
5372473|NCT00142402|Fatigue|fatigue
5372474|NCT00142389|gestational immunization,|gestational immunization,
5372475|NCT00142389|infant antibody,|infant antibody,
5372476|NCT00142389|cord antibody|cord antibody
5372477|NCT00142363|Parkinson's disease|parkinson's disease
5372478|NCT00142363|Parkin|parkin
5372479|NCT00142363|Epilepsy|epilepsy
5372480|NCT00142363|Phenotype-genotype correlations|phenotype-genotype correlations
5372481|NCT00142363|Ionic channels|ionic channels
5372482|NCT00142350|gastric cancer|gastric cancer
5372483|NCT00142350|5-fluorouracil|5-fluorouracil
5372484|NCT00142350|irinotecan|irinotecan
5372485|NCT00142350|cisplatin|cisplatin
5372486|NCT00142350|S-1|s-1
5372487|NCT00142350|advanced or recurrent gastric cancer|advanced or recurrent gastric cancer
5372488|NCT00142337|zidovudine|zidovudine
5372489|NCT00142337|didanosine|didanosine
5372490|NCT00142337|Prevention of mother to child transmission of HIV|prevention of mother to child transmission of hiv
5372491|NCT00142337|nevirapine|nevirapine
5372492|NCT00142337|Thailand|thailand
5372493|NCT00142337|Resistance|resistance
5372494|NCT00142337|HIV|hiv
5372495|NCT00142337|Postpartum period|postpartum period
5372496|NCT00142324|Dementia|dementia
5372497|NCT00142311|Parkinson's disease|parkinson's disease
5372498|NCT00142311|Parkin mutations|parkin mutations
5372499|NCT00142311|Metabolic explorations|metabolic explorations
5372500|NCT00142311|Clinics|clinics
5372501|NCT00142311|Genetics|genetics
5372502|NCT00142285|pneumonia|pneumonia
5372503|NCT00142285|zinc|zinc
5372504|NCT00142285|treatment|treatment
5372505|NCT00142285|efficacy|efficacy
5372506|NCT00142285|children|children
5372507|NCT00142272|Ciprofloxacin|ciprofloxacin
5372508|NCT00142272|children|children
5372509|NCT00142272|V.cholerae O1 and O139|v.cholerae o1 and o139
5372510|NCT00142272|drug resistance|drug resistance
5372511|NCT00142272|Bangladesh|bangladesh
5372512|NCT00142259|deep brain stimulation|deep brain stimulation
5372513|NCT00142259|internal globus pallidus|internal globus pallidus
5372514|NCT00142259|dystonia|dystonia
5372515|NCT00142246|malaria|malaria
5372516|NCT00142246|anaemia|anaemia
5372517|NCT00142246|school performance|school performance
5372518|NCT00142246|education|education
5372519|NCT00142246|intermittent preventive treatment|intermittent preventive treatment
5372520|NCT00142246|schools|schools
5372521|NCT00142233|EUROPAC 2, ANTOX (vers)1.2, MGCT (Magnesiocard) Hereditary Pancreatitis, Idiopathic chronic pancreatitis.|europac 2, antox (vers)1.2, mgct (magnesiocard) hereditary pancreatitis, idiopathic chronic pancreatitis.
5372522|NCT00142233|Hereditary Pancreatitis|hereditary pancreatitis
5372523|NCT00142233|idiopathic chronic pancreatitis|idiopathic chronic pancreatitis
5372524|NCT00142207|malaria|malaria
5372525|NCT00142207|pregnancy|pregnancy
5372526|NCT00142207|intermittent preventive treatment|intermittent preventive treatment
5372527|NCT00142207|insecticide-treated nets|insecticide-treated nets
5372528|NCT00142194|Atrial Fibrillation|atrial fibrillation
5372529|NCT00142194|Oxidative stress|oxidative stress
5372530|NCT00142194|Cardiology|cardiology
5372531|NCT00142181|Lymphoplasmacytic lymphoma|lymphoplasmacytic lymphoma
5372532|NCT00142181|Waldenstrom's Macroglobulinemia|waldenstrom's macroglobulinemia
5372533|NCT00142181|Antibody|antibody
5372534|NCT00142181|Campath-1H|campath-1h
5372535|NCT00142168|CC-5103 (lenalidomide)|cc-5103 (lenalidomide)
5372536|NCT00142168|rituximab|rituximab
5372537|NCT00142168|Waldenstrom's macroglobulinemia|waldenstrom's macroglobulinemia
5372538|NCT00142155|monoclonal antibody|monoclonal antibody
5372539|NCT00142155|Fc gamma RIII receptor expression|fc gamma riii receptor expression
5372540|NCT00142155|rituximab|rituximab
5372541|NCT00142129|bortezomib|bortezomib
5372542|NCT00142129|Velcade|velcade
5372543|NCT00142129|Waldenstrom's macroglobulinemia|waldenstrom's macroglobulinemia
5372544|NCT00142116|thalidomide|thalidomide
5372545|NCT00142116|rituximab|rituximab
5372546|NCT00142116|Waldenstrom's|waldenstrom's
5372547|NCT00142103|Hepatitis c virus|hepatitis c virus
5372548|NCT00142103|HCV|hcv
5372549|NCT00142103|Liver|liver
5372550|NCT00142090|Brain Concussion|brain concussion
5372551|NCT00142090|Post-Concussion Syndrome|post-concussion syndrome
5372552|NCT00142090|Closed Head Injury|closed head injury
5372553|NCT00142090|Traumatic Brain Injury|traumatic brain injury
5372554|NCT00142090|Hypertonic Saline Solution|hypertonic saline solution
5372555|NCT00142077|Influenza|influenza
5372556|NCT00142077|Electronic health record|electronic health record
5372557|NCT00142077|Behavior modification|behavior modification
5372558|NCT00142064|Topical analgesia|topical analgesia
5372559|NCT00142064|Urinary catheterization|urinary catheterization
5372560|NCT00142064|FlACC Pain Scale|flacc pain scale
5372561|NCT00142064|Lidocaine jelly|lidocaine jelly
5372562|NCT00142051|sickle cell disease|sickle cell disease
5372563|NCT00142051|pain crisis|pain crisis
5372564|NCT00142051|vaso-occlusive crisis|vaso-occlusive crisis
5372565|NCT00142051|nitric oxide|nitric oxide
5372566|NCT00142038|gastric cancer|gastric cancer
5372567|NCT00142038|metastatic|metastatic
5372568|NCT00142038|locally advanced|locally advanced
5372569|NCT00142038|docetaxel|docetaxel
5372570|NCT00142038|capecitabine|capecitabine
5372571|NCT00142025|Bronchial asthma|bronchial asthma
5372572|NCT00142025|Oxcarbazepine|oxcarbazepine
5372573|NCT00142025|Antiepileptic drug|antiepileptic drug
5372574|NCT00142025|Efficacy|efficacy
5372575|NCT00142012|School-based|school-based
5372576|NCT00142012|Obesity|obesity
5372577|NCT00142012|Prevention|prevention
5372578|NCT00141999|vaccine|vaccine
5372579|NCT00141999|hepatitis|hepatitis
5372580|NCT00141986|vitamin D|vitamin d
5372581|NCT00141986|type 1 diabetes|type 1 diabetes
5372582|NCT00141986|prevention trial|prevention trial
5372583|NCT00141973|Procalcitonin|procalcitonin
5372584|NCT00141973|Sepsis|sepsis
5372585|NCT00141973|Corticosteroids|corticosteroids
5372586|NCT00141960|Treatment efficacy|treatment efficacy
5372587|NCT00141960|Treatment effectiveness|treatment effectiveness
5372588|NCT00141960|Gastrointestinal Diseases|gastrointestinal diseases
5372589|NCT00141960|Reflux, Gastroesophageal|reflux, gastroesophageal
5372590|NCT00141960|GERD|gerd
5372591|NCT00141947|bexarotene|bexarotene
5372592|NCT00141947|schizophrenia|schizophrenia
5372593|NCT00141947|psychopathology|psychopathology
5372594|NCT00141947|cognitive impairment|cognitive impairment
5372595|NCT00141947|quality of life|quality of life
5372596|NCT00141947|open lable trial|open lable trial
5372597|NCT00141934|Rheumatoid Arthritis|rheumatoid arthritis
5372598|NCT00141934|RA|ra
5372599|NCT00141934|ACR20 endpoint|acr20 endpoint
5372600|NCT00141934|Tender/swollen joints|tender/swollen joints
5372601|NCT00141934|Improvement in pain|improvement in pain
5372602|NCT00141934|Health assessment questionnaire|health assessment questionnaire
5372603|NCT00141934|Profile of mood states|profile of mood states
5372604|NCT00141921|Immunex|immunex
5372605|NCT00141921|Amgen|amgen
5372606|NCT00141921|Pediatric,|pediatric,
5372607|NCT00141921|plaque psoriasis|plaque psoriasis
5372608|NCT00141921|clinical trial|clinical trial
5372609|NCT00141908|Hydroxyprogesterone Caproate, twins, preterm delivery|hydroxyprogesterone caproate, twins, preterm delivery
5372610|NCT00141895|Intrauterine fetal death, 2nd trimester, induction|intrauterine fetal death, 2nd trimester, induction
5372611|NCT00141869|Sensory Processing|sensory processing
5372612|NCT00141869|Magnetoencephalogram|magnetoencephalogram
5372613|NCT00141869|Tourete Syndrome|tourete syndrome
5372614|NCT00141869|Trigeminal Nerve|trigeminal nerve
5372615|NCT00141869|Tics|tics
5372616|NCT00141869|TS|ts
5372617|NCT00141869|Healthy Volunteer|healthy volunteer
5372618|NCT00141869|HV|hv
5372619|NCT00141856|Dis Management|dis management
5372620|NCT00141856|Heart Decompensation|heart decompensation
5372621|NCT00141856|Hearts|hearts
5372622|NCT00141856|Veteran (M01.930)|veteran (m01.930)
5372623|NCT00141843|Hemophilia A|hemophilia a
5372624|NCT00141830|Rheumatoid Arthritis|rheumatoid arthritis
5372625|NCT00141817|Gastrointestinal Reflux Disease|gastrointestinal reflux disease
5372626|NCT00141804|renal transplantation|renal transplantation
5372627|NCT00141804|immunosuppression|immunosuppression
5372628|NCT00141804|prevention of acute rejection|prevention of acute rejection
5372629|NCT00141791|Asthma|asthma
5372630|NCT00141791|Anti-Asthmatic Agents|anti-asthmatic agents
5372631|NCT00141791|Receptors|receptors
5372632|NCT00141791|Tumor Necrosis Factor|tumor necrosis factor
5372633|NCT00141778|atrial fibrillation|atrial fibrillation
5372634|NCT00141778|cardiac surgery|cardiac surgery
5372635|NCT00141752|Cerebrovascular Accident|cerebrovascular accident
5372636|NCT00141752|Deglutition Disorders|deglutition disorders
5372637|NCT00141752|stroke|stroke
5372638|NCT00141752|dysphagia|dysphagia
5372639|NCT00141752|screening|screening
5372640|NCT00141739|Stem Cell Transplantation|stem cell transplantation
5372641|NCT00141739|Graft-Versus-Host Disease|graft-versus-host disease
5372642|NCT00141739|prophylaxis|prophylaxis
5372643|NCT00141726|Enbrel|enbrel
5372644|NCT00141726|Stem Cell Transplantation|stem cell transplantation
5372645|NCT00141726|Lung Injury|lung injury
5372646|NCT00141687|External cephalic version|external cephalic version
5372647|NCT00141687|Cesarean section|cesarean section
5372648|NCT00141687|pregnancy|pregnancy
5372649|NCT00141687|labour|labour
5372650|NCT00141687|Breech pregnancy|breech pregnancy
5372651|NCT00141674|Blood transfusion|blood transfusion
5372652|NCT00141674|Age of blood|age of blood
5372653|NCT00141674|Traumatic Brain Injury|traumatic brain injury
5372654|NCT00141674|Cerebral Oxygen Extraction Ratio|cerebral oxygen extraction ratio
5372655|NCT00141674|Age of transfused blood in traumatic brain injury|age of transfused blood in traumatic brain injury
5372656|NCT00141661|Interventional, Alzheimer, Safety and Tolerability|interventional, alzheimer, safety and tolerability
5372657|NCT00141648|Osteolymphoma|osteolymphoma
5372658|NCT00141648|Chemotherapy|chemotherapy
5372659|NCT00141648|Radiotherapy|radiotherapy
5372660|NCT00141648|Lymphoma|lymphoma
5372661|NCT00141635|Quality of Life|quality of life
5372662|NCT00141635|Breast Cancer|breast cancer
5372663|NCT00141635|Referee's Report|referee's report
5372664|NCT00141635|Diagnostics|diagnostics
5372665|NCT00141635|Therapy|therapy
5372666|NCT00141622|Endothelial dysfunction|endothelial dysfunction
5372667|NCT00141622|ADMA|adma
5372668|NCT00141622|DDAH|ddah
5372669|NCT00141622|Sodium|sodium
5372670|NCT00141609|End-stage renal failure|end-stage renal failure
5372671|NCT00141609|Haemodialysis|haemodialysis
5372672|NCT00141609|Sodium|sodium
5372673|NCT00141609|Blood Pressure|blood pressure
5372674|NCT00141596|Resistant Hypertension|resistant hypertension
5372675|NCT00141596|Extracellular Fluid Volume|extracellular fluid volume
5372676|NCT00141583|Renin-angiotensin system|renin-angiotensin system
5372677|NCT00141583|ACE Inhibitor|ace inhibitor
5372678|NCT00141583|Angiotensin Receptor Blocker|angiotensin receptor blocker
5372679|NCT00141570|Menopause; Postmenopause; Estrogen; Hormone Therapy|menopause; postmenopause; estrogen; hormone therapy
5372680|NCT00141557|Menopause; Postmenopause; Estrogen; Hormone Therapy|menopause; postmenopause; estrogen; hormone therapy
5372681|NCT00141544|Menopause; Postmenopause; Estrogen; Hormone Therapy|menopause; postmenopause; estrogen; hormone therapy
5372682|NCT00141531|Bladder cancer|bladder cancer
5372683|NCT00141531|Superficial|superficial
5372684|NCT00141531|Carcinoma in situ|carcinoma in situ
5372685|NCT00141531|Intravesical instillation|intravesical instillation
5372686|NCT00141531|Chemotherapy|chemotherapy
5372687|NCT00141531|Adjuvant|adjuvant
5372688|NCT00141518|Health economics,Quality of life|health economics,quality of life
5372689|NCT00141505|drug interaction|drug interaction
5372690|NCT00141505|pharmacokinetics|pharmacokinetics
5372691|NCT00141505|valproate|valproate
5372692|NCT00141505|bipolar|bipolar
5372693|NCT00141492|Type 2 diabetes|type 2 diabetes
5372694|NCT00141492|hypogonadism|hypogonadism
5372695|NCT00141492|testosterone|testosterone
5372696|NCT00141492|glycosylated hemoglobin A1C|glycosylated hemoglobin a1c
5372697|NCT00141479|Treatment interruption on reinitiation|treatment interruption on reinitiation
5372698|NCT00141479|Schizophrenia|schizophrenia
5372699|NCT00141479|Schizoaffective disorder|schizoaffective disorder
5372700|NCT00141466|Hereditary colorectal cancer|hereditary colorectal cancer
5372701|NCT00141466|Microsatellite instability|microsatellite instability
5372702|NCT00141466|Physician roles|physician roles
5372703|NCT00141466|Health care implementation|health care implementation
5372704|NCT00141466|Intervention|intervention
5372705|NCT00141453|angiotensin II type I receptor blockers|angiotensin ii type i receptor blockers
5372706|NCT00141453|diabetic nephropathy|diabetic nephropathy
5372707|NCT00141453|end-stage renal disease|end-stage renal disease
5372708|NCT00141453|renal failure|renal failure
5372709|NCT00141453|type 2 diabetes|type 2 diabetes
5372710|NCT00141453|olmesartan medoxomil|olmesartan medoxomil
5372711|NCT00141440|gas exchange|gas exchange
5372712|NCT00141440|pressure support ventilation|pressure support ventilation
5372713|NCT00141440|respiratory mechanics|respiratory mechanics
5372714|NCT00141440|COPD patients|copd patients
5372715|NCT00141297|Advanced cancer|advanced cancer
5372716|NCT00141271|Bipolar I Disorder|bipolar i disorder
5372717|NCT00141115|Substance-induced anxiety disorder|substance-induced anxiety disorder
5372718|NCT00141102|GI events in high risk GI arthritis patients|gi events in high risk gi arthritis patients
5372719|NCT00141089|Male patients, chronic constipation, tegaserod|male patients, chronic constipation, tegaserod
5372720|NCT00141076|obesity|obesity
5372721|NCT00141076|glycemic index|glycemic index
5372722|NCT00141076|insulin resistance|insulin resistance
5372723|NCT00141076|cardiovascular disease|cardiovascular disease
5372724|NCT00141076|diabetes|diabetes
5372725|NCT00141063|ADHD, children|adhd, children
5372726|NCT00141050|ADHD, children|adhd, children
5372727|NCT00141037|Organ Rejection|organ rejection
5372728|NCT00141037|Corticosteroids|corticosteroids
5372729|NCT00141037|Child|child
5372730|NCT00141037|Adolescent|adolescent
5372731|NCT00141037|Immunosuppression|immunosuppression
5372732|NCT00141037|Steroids|steroids
5372733|NCT00141024|HIV Seronegativity|hiv seronegativity
5372734|NCT00141024|HIV Preventive Vaccine|hiv preventive vaccine
5372735|NCT00141011|Stroke|stroke
5372736|NCT00141011|Fibrinogen|fibrinogen
5372737|NCT00141011|Reperfusion|reperfusion
5372738|NCT00141011|Thrombolysis|thrombolysis
5372739|NCT00140998|Turner syndrome|turner syndrome
5372740|NCT00140998|Hypogonadism|hypogonadism
5372742|NCT00140998|Estrogen|estrogen
5372743|NCT00140998|Estrogen Patches|estrogen patches
5372744|NCT00140998|IGF-I|igf-i
5372745|NCT00140998|Body Composition|body composition
5372746|NCT00140998|Protein Metabolism|protein metabolism
5372747|NCT00140998|Lipolysis|lipolysis
5372748|NCT00140972|Arcoxia|arcoxia
5372749|NCT00140894|Osteoarthritis|osteoarthritis
5372750|NCT00140894|Cancer Pain|cancer pain
5372751|NCT00140868|Colonic Pseudo-Obstruction|colonic pseudo-obstruction
5372752|NCT00140868|Large bowel obstruction|large bowel obstruction
5372753|NCT00140868|Stents|stents
5372754|NCT00140868|Laparotomy|laparotomy
5372755|NCT00140868|Palliative Surgery|palliative surgery
5372756|NCT00140868|Surgery, Palliative|surgery, palliative
5372757|NCT00140868|Palliative Therapy|palliative therapy
5372758|NCT00140855|synovial sarcoma|synovial sarcoma
5372759|NCT00140855|immunotherapy|immunotherapy
5372760|NCT00140855|cancer-testis antigen|cancer-testis antigen
5372761|NCT00140855|cancer-germ cell antigen|cancer-germ cell antigen
5372762|NCT00140855|soft tissue sarcoma|soft tissue sarcoma
5372763|NCT00140855|SYT-SSX chromosomal translocation|syt-ssx chromosomal translocation
5372764|NCT00140842|Obesity, adolescent, ghrelin, growth hormone, cortisol|obesity, adolescent, ghrelin, growth hormone, cortisol
5372765|NCT00140829|Cerebellar ataxias|cerebellar ataxias
5372766|NCT00140829|Spastic paraplegias|spastic paraplegias
5372767|NCT00140829|Mutations spectrum|mutations spectrum
5372768|NCT00140829|Linkage studies|linkage studies
5372769|NCT00140829|Genetic counselling|genetic counselling
5372770|NCT00140790|Cardiorenal syndrome|cardiorenal syndrome
5372771|NCT00140790|Renal dysfunction|renal dysfunction
5372772|NCT00140790|Cardiovascular events|cardiovascular events
5372773|NCT00140790|Valsartan|valsartan
5372774|NCT00140764|Genitourinary symptoms|genitourinary symptoms
5372775|NCT00140751|HIV-1|hiv-1
5372776|NCT00140751|Treatment simplification|treatment simplification
5372777|NCT00140751|Lopinavir/ritonavir|lopinavir/ritonavir
5372778|NCT00140751|Treatment Experienced|treatment experienced
5372779|NCT00140751|HIV Seropositivity|hiv seropositivity
5372780|NCT00140725|HBeAg-positive|hbeag-positive
5372781|NCT00140725|chronic|chronic
5372782|NCT00140725|Hepatitis B|hepatitis b
5372783|NCT00140725|lamivudine|lamivudine
5372784|NCT00140725|seroconversion|seroconversion
5372785|NCT00140725|Chronic Hepatitis B|chronic hepatitis b
5372786|NCT00140712|RLS|rls
5372787|NCT00140712|PLMS|plms
5372788|NCT00140712|Adolescent|adolescent
5372789|NCT00140712|Periodic Limb Movements of Sleep|periodic limb movements of sleep
5372790|NCT00140712|Ropinirole|ropinirole
5372791|NCT00140699|Children, Hearing loss, Balance control, Sensory inputs|children, hearing loss, balance control, sensory inputs
5372792|NCT00140660|lymphoma, diffuse large B-cell|lymphoma, diffuse large b-cell
5372793|NCT00140660|rituximab|rituximab
5372794|NCT00140660|chemotherapy|chemotherapy
5372795|NCT00140647|atherosclerosis|atherosclerosis
5372796|NCT00140647|carotid artery|carotid artery
5372797|NCT00140647|ramipril|ramipril
5372798|NCT00140647|rosiglitazone|rosiglitazone
5372799|NCT00140647|impaired glucose tolerance|impaired glucose tolerance
5372800|NCT00140647|impaired fasting glucose|impaired fasting glucose
5372801|NCT00140647|diabetes prevention|diabetes prevention
5372802|NCT00140621|cardiac fabry disease|cardiac fabry disease
5372803|NCT00140608|sinus|sinus
5372804|NCT00140595|Lymphoma, diffuse large B-cell|lymphoma, diffuse large b-cell
5372805|NCT00140595|rituximab|rituximab
5372806|NCT00140595|chemotherapy|chemotherapy
5372807|NCT00140582|lymphoma|lymphoma
5372808|NCT00140582|follicular|follicular
5372809|NCT00140582|maintenance|maintenance
5372810|NCT00140569|follicular lymphoma|follicular lymphoma
5372811|NCT00140569|CHVP + interferon|chvp + interferon
5372812|NCT00140569|fludarabine|fludarabine
5372813|NCT00140569|autotransplant|autotransplant
5372814|NCT00140556|head and neck cancer|head and neck cancer
5372815|NCT00140556|targeted therapy|targeted therapy
5372816|NCT00140556|bevacizumab|bevacizumab
5372817|NCT00140556|erlotinib|erlotinib
5372818|NCT00140556|Tarceva|tarceva
5372819|NCT00140556|radiotherapy|radiotherapy
5372820|NCT00140556|concurrent chemotherapy|concurrent chemotherapy
5372821|NCT00140556|pharynx cancer|pharynx cancer
5372822|NCT00140556|tonsil cancer|tonsil cancer
5372823|NCT00140556|hyperfractionation|hyperfractionation
5372824|NCT00140556|angiogenesis|angiogenesis
5372825|NCT00140556|epidermal growth factor|epidermal growth factor
5372826|NCT00140556|vascular endothelial growth factor|vascular endothelial growth factor
5372827|NCT00140556|magnetic resonance spectroscopy|magnetic resonance spectroscopy
5372828|NCT00140556|cancer of the head and neck|cancer of the head and neck
5372829|NCT00140556|upper aerodigestive tract neoplasms|upper aerodigestive tract neoplasms
5372830|NCT00140556|pharynx neoplasms|pharynx neoplasms
5372831|NCT00140543|simultaneous pancreas/kidney transplantation|simultaneous pancreas/kidney transplantation
5372832|NCT00140543|Immunosuppression|immunosuppression
5372833|NCT00140517|Plasmodium falciparum|plasmodium falciparum
5372834|NCT00140517|malaria|malaria
5372835|NCT00140517|pregnancy|pregnancy
5372836|NCT00140517|resistance|resistance
5372837|NCT00140504|Adverse drug event|adverse drug event
5372838|NCT00140504|Patient safety|patient safety
5372839|NCT00140504|Internet portal|internet portal
5372840|NCT00140504|PatientSite|patientsite
5372841|NCT00140504|Preventive health|preventive health
5372842|NCT00140504|Primary care|primary care
5372843|NCT00140491|Non-Arteritic Anterior Ischemic Optic Neuropathy|non-arteritic anterior ischemic optic neuropathy
5372844|NCT00140491|Visual Field Defect|visual field defect
5372845|NCT00140491|Neuroplasticity|neuroplasticity
5372846|NCT00140491|Rehabilitation|rehabilitation
5372847|NCT00140478|Androgen Independent Prostate Cancer|androgen independent prostate cancer
5372848|NCT00140478|Prostate Cancer|prostate cancer
5372849|NCT00140478|Mifepristone|mifepristone
5372850|NCT00140478|RU-486|ru-486
5372851|NCT00140452|ALS|als
5372852|NCT00140439|asthma|asthma
5372853|NCT00140439|emergency department|emergency department
5372854|NCT00140439|compliance|compliance
5372855|NCT00140439|randomized clinical trial|randomized clinical trial
5372856|NCT00140426|Anorexia Nervosa|anorexia nervosa
5372857|NCT00140426|Risperidone|risperidone
5372858|NCT00140426|Atypical Neuroleptics|atypical neuroleptics
5372859|NCT00140426|Dopamine|dopamine
5372860|NCT00140426|Leptin|leptin
5372861|NCT00140426|Body Image|body image
5372862|NCT00140426|Adolescents|adolescents
5372863|NCT00140413|Optic Nerve Hypoplasia|optic nerve hypoplasia
5372864|NCT00140400|Prostate|prostate
5372865|NCT00140400|Cancer|cancer
5372866|NCT00140400|Advanced prostate cancer|advanced prostate cancer
5372867|NCT00140400|Metastatic|metastatic
5372868|NCT00140400|Hormone-refractory|hormone-refractory
5372869|NCT00140400|GVAX|gvax
5372870|NCT00140400|Vaccine|vaccine
5372871|NCT00140400|Allogeneic cells|allogeneic cells
5372872|NCT00140387|Prostate|prostate
5372873|NCT00140387|Cancer|cancer
5372874|NCT00140387|GVAX|gvax
5372875|NCT00140387|Metastatic|metastatic
5372876|NCT00140387|Vaccine|vaccine
5372877|NCT00140387|Allogeneic cells|allogeneic cells
5372878|NCT00140374|Prostate|prostate
5372879|NCT00140374|Cancer|cancer
5372880|NCT00140374|Vaccine|vaccine
5372881|NCT00140374|GVAX|gvax
5372882|NCT00140374|Allogeneic cells|allogeneic cells
5372883|NCT00140361|malaria|malaria
5372884|NCT00140361|sulfadoxine-pyrimethamine|sulfadoxine-pyrimethamine
5372885|NCT00140361|sulfadoxine-pyrimethamine plus artsunate|sulfadoxine-pyrimethamine plus artsunate
5372886|NCT00140361|lumefantrine plus artemether|lumefantrine plus artemether
5372887|NCT00140361|combination therapy|combination therapy
5372888|NCT00140348|Prostate|prostate
5372889|NCT00140348|Cancer|cancer
5372890|NCT00140348|Advanced Prostate Cancer|advanced prostate cancer
5372891|NCT00140348|Metastatic|metastatic
5372892|NCT00140348|Hormone-refractory|hormone-refractory
5372893|NCT00140348|GVAX|gvax
5372894|NCT00140348|Vaccine|vaccine
5372895|NCT00140348|Allogeneic cells|allogeneic cells
5372896|NCT00140335|handwashing|handwashing
5372897|NCT00140335|communicable diseases|communicable diseases
5372898|NCT00140335|health education|health education
5372899|NCT00140322|falls|falls
5372900|NCT00140322|injury|injury
5372901|NCT00140322|elderly|elderly
5372902|NCT00140309|TB|tb
5372903|NCT00140309|Pulmonary Tuberculosis|pulmonary tuberculosis
5372904|NCT00140309|Tuberculosis|tuberculosis
5372905|NCT00140309|Pulmonary TB|pulmonary tb
5372906|NCT00140283|Effectiveness|effectiveness
5372907|NCT00140283|Educational intervention|educational intervention
5372908|NCT00140283|Primary health care|primary health care
5372909|NCT00140257|Myocardial Infarction|myocardial infarction
5372910|NCT00140244|leptin|leptin
5372911|NCT00140244|lipodystrophy|lipodystrophy
5372912|NCT00140244|insulin resistance|insulin resistance
5372913|NCT00140244|hyperlipidemia|hyperlipidemia
5372914|NCT00140244|metabolic syndrome|metabolic syndrome
5372915|NCT00140231|leptin|leptin
5372916|NCT00140231|fasting|fasting
5372917|NCT00140231|reproductive|reproductive
5372918|NCT00140231|neuroendocrine|neuroendocrine
5372919|NCT00140231|immune function|immune function
5372920|NCT00140231|energy deficiency associated with short-term fasting|energy deficiency associated with short-term fasting
5372921|NCT00140218|amyotrophic lateral sclerosis|amyotrophic lateral sclerosis
5372922|NCT00140218|pramipexole|pramipexole
5372923|NCT00140218|oxidative stress|oxidative stress
5372924|NCT00140218|neuroprotection|neuroprotection
5372925|NCT00140205|leptin|leptin
5372926|NCT00140205|fasting|fasting
5372927|NCT00140205|pharmacokinetics|pharmacokinetics
5372928|NCT00140192|creatine metabolism|creatine metabolism
5372929|NCT00140192|schizophrenia|schizophrenia
5372930|NCT00140192|energy metabolism|energy metabolism
5372931|NCT00140179|valnoctamide|valnoctamide
5372932|NCT00140179|teratogenicity|teratogenicity
5372933|NCT00140179|double-blind|double-blind
5372934|NCT00140179|mania|mania
5372935|NCT00140166|schizophrenia|schizophrenia
5372936|NCT00140166|niacinamide|niacinamide
5372937|NCT00140153|androgel|androgel
5372938|NCT00140153|female sexuale dysfunction|female sexuale dysfunction
5372939|NCT00140153|controlled double-blind|controlled double-blind
5372940|NCT00140153|testosterone|testosterone
5372941|NCT00140140|Breast cancer|breast cancer
5372942|NCT00140114|Vaginal, sublingual, misoprostol, cervical ripening|vaginal, sublingual, misoprostol, cervical ripening
5372943|NCT00140101|drug eluting stents|drug eluting stents
5372944|NCT00140101|stents|stents
5372945|NCT00140101|angioplasty|angioplasty
5372946|NCT00140101|coronary artery disease|coronary artery disease
5372947|NCT00140101|total coronary occlusion|total coronary occlusion
5372948|NCT00140101|coronary artery restenosis|coronary artery restenosis
5372949|NCT00140101|stent thrombosis|stent thrombosis
5372950|NCT00140101|vascular disease|vascular disease
5372951|NCT00140101|myocardial ischemia|myocardial ischemia
5372952|NCT00140101|coronary artery stenosis|coronary artery stenosis
5372953|NCT00140088|Needlestick pain|needlestick pain
5372954|NCT00140088|Venipuncture pain|venipuncture pain
5372955|NCT00140010|aneurysm|aneurysm
5372956|NCT00140010|autoregulation|autoregulation
5372957|NCT00140010|erythropoietion|erythropoietion
5372958|NCT00140010|stroke|stroke
5372959|NCT00140010|subarachnoid hemorrhage|subarachnoid hemorrhage
5372960|NCT00140010|vasospasm|vasospasm
5372961|NCT00139997|Major Depression|major depression
5372962|NCT00139997|Seasonal Affective Disorder (SAD)|seasonal affective disorder (sad)
5372963|NCT00139984|Hypertension|hypertension
5372964|NCT00139984|Ambulatory blood pressure monitoring|ambulatory blood pressure monitoring
5372965|NCT00139984|Blood pressure|blood pressure
5372966|NCT00139984|Risk assessment|risk assessment
5372967|NCT00139958|Acute coronary syndrome|acute coronary syndrome
5372968|NCT00139958|HIV infection|hiv infection
5372969|NCT00139958|Prognosis|prognosis
5372970|NCT00139958|Coronary heart disease|coronary heart disease
5372971|NCT00139958|Revascularization|revascularization
5372972|NCT00139919|Decreasing Titration Study|decreasing titration study
5372973|NCT00139919|Schizophrenia|schizophrenia
5372974|NCT00139919|Bipolar|bipolar
5372975|NCT00139919|Pharmacokinetic|pharmacokinetic
5372976|NCT00139906|Titration Study|titration study
5372977|NCT00139906|Schizophrenia|schizophrenia
5372978|NCT00139906|BID dosing|bid dosing
5372979|NCT00139906|Pharmacokinetic|pharmacokinetic
5372980|NCT00139841|Lymphoma, Non-Hodgkin|lymphoma, non-hodgkin
5372981|NCT00139841|Rituximab Refractory|rituximab refractory
5372982|NCT00139841|Rituximab Failure|rituximab failure
5372983|NCT00139841|Indolent Non-Hodgkins Lymphoma|indolent non-hodgkins lymphoma
5372984|NCT00139828|haemophilia B|haemophilia b
5372985|NCT00139828|factor IX|factor ix
5372986|NCT00139828|Product Surveillance, Postmarketing|product surveillance, postmarketing
5372987|NCT00139828|plasma products|plasma products
5372988|NCT00139815|unstable angina|unstable angina
5372989|NCT00139815|acute coronary syndrome|acute coronary syndrome
5372990|NCT00139815|fondaparinux sodium|fondaparinux sodium
5372991|NCT00139815|non ST segment elevation myocardial infarction|non st segment elevation myocardial infarction
5372992|NCT00139815|myocardial infarction|myocardial infarction
5372993|NCT00139776|Chronic treatment osteoarthritis, Celecoxib, Continuous Use, Intermittent Use|chronic treatment osteoarthritis, celecoxib, continuous use, intermittent use
5372994|NCT00139737|Open-label extension Ziprasidone study in Schizophrenia|open-label extension ziprasidone study in schizophrenia
5372995|NCT00139633|esophageal cancer, chemotherapy, radiation|esophageal cancer, chemotherapy, radiation
5372996|NCT00139620|advanced cancer, solid tumor|advanced cancer, solid tumor
5372997|NCT00139594|Bipolar disorder, manic episode/treatment/licarbazepine|bipolar disorder, manic episode/treatment/licarbazepine
5372998|NCT00139581|Atopic dermatitis, children, infants, pimecrolimus, bid, od|atopic dermatitis, children, infants, pimecrolimus, bid, od
5372999|NCT00139568|Chronic constipation|chronic constipation
5373000|NCT00139568|5-HT,5-HT4,|5-ht,5-ht4,
5373001|NCT00139568|functional GI|functional gi
5373002|NCT00139568|China|china
5373003|NCT00139568|tegaserod|tegaserod
5373004|NCT00139555|Hypertension|hypertension
5373005|NCT00139555|Left ventricular hypertrophy|left ventricular hypertrophy
5373006|NCT00139542|human|human
5373007|NCT00139542|ventricular fibrillation|ventricular fibrillation
5373008|NCT00139542|out-of-hospital|out-of-hospital
5373009|NCT00139542|cardiac arrest|cardiac arrest
5373010|NCT00139542|automated external defibrillators (AED)|automated external defibrillators (aed)
5373011|NCT00139542|defibrillators|defibrillators
5373012|NCT00139542|electrick countershock|electrick countershock
5373013|NCT00139542|cardiopulmonary resuscitation|cardiopulmonary resuscitation
5373014|NCT00139490|Blood Pressure, High|blood pressure, high
5373015|NCT00139451|GH|gh
5373016|NCT00139451|Delayed Growth|delayed growth
5373017|NCT00139451|Energy Expenditure|energy expenditure
5373018|NCT00139451|Puberty|puberty
5373019|NCT00139451|Nutrition|nutrition
5373020|NCT00139451|Short Stature|short stature
5373021|NCT00139399|Coronary artery bypass|coronary artery bypass
5373022|NCT00139399|Coronary arteries|coronary arteries
5373023|NCT00139399|Atherosclerosis|atherosclerosis
5373024|NCT00139399|Angiography|angiography
5373025|NCT00139399|Blood flow|blood flow
5373026|NCT00139386|Drug-eluting stent|drug-eluting stent
5373027|NCT00139386|Candesartan|candesartan
5373028|NCT00139386|Randomized control study|randomized control study
5373029|NCT00139386|Coronary Angioplasty|coronary angioplasty
5373030|NCT00139373|Progressive supranuclear palsy|progressive supranuclear palsy
5373031|NCT00139373|Frontal lobe|frontal lobe
5373032|NCT00139373|Oculomotor testing|oculomotor testing
5373033|NCT00139373|Neuropsychological scores|neuropsychological scores
5373034|NCT00139373|Motor disability (UPDRS)|motor disability (updrs)
5373035|NCT00139373|Distractibility|distractibility
5373036|NCT00139321|Gait disorders|gait disorders
5373037|NCT00139321|Postural instability|postural instability
5373038|NCT00139321|parkinsonian syndrome|parkinsonian syndrome
5373039|NCT00139321|Gait initiation|gait initiation
5373040|NCT00139321|Parkinson's disease|parkinson's disease
5373041|NCT00139321|Adults|adults
5373042|NCT00139308|Tourette's syndrome|tourette's syndrome
5373043|NCT00139308|High frequency stimulation|high frequency stimulation
5373044|NCT00139308|Globus pallidus|globus pallidus
5373045|NCT00139308|Thalamus|thalamus
5373046|NCT00139295|musculoskeletal|musculoskeletal
5373047|NCT00139295|osteoarthritis of the knee|osteoarthritis of the knee
5373048|NCT00139282|wet AMD|wet amd
5373049|NCT00139282|macular degeneration|macular degeneration
5373050|NCT00139269|Advanced Squamous Cell Carcinoma|advanced squamous cell carcinoma
5373051|NCT00139269|Squamous cell Carcinoma of Head and Neck|squamous cell carcinoma of head and neck
5373052|NCT00139269|SSCHN|sschn
5373053|NCT00139269|Docetaxel|docetaxel
5373054|NCT00139256|Glucocorticoid|glucocorticoid
5373055|NCT00139256|Antepartum Betamethasone Treatment|antepartum betamethasone treatment
5373056|NCT00139256|Elective Cesarean Section|elective cesarean section
5373057|NCT00139256|Respiratory Distress in Infants|respiratory distress in infants
5373058|NCT00139243|squamous cell carcinoma|squamous cell carcinoma
5373059|NCT00139243|Taxotere|taxotere
5373060|NCT00139243|carcinoma of head/neck|carcinoma of head/neck
5373061|NCT00139243|Cisplatin|cisplatin
5373062|NCT00139243|5-Fluorouracil|5-fluorouracil
5373063|NCT00139243|Leucovorin|leucovorin
5373064|NCT00139230|Squamous Cell Carcinoma of Head and Neck|squamous cell carcinoma of head and neck
5373065|NCT00139230|Compressed TPFL|compressed tpfl
5373066|NCT00139230|Taxotere|taxotere
5373067|NCT00139230|Growth Factor Support|growth factor support
5373068|NCT00139217|Persistent pulmonary hypertension|persistent pulmonary hypertension
5373069|NCT00139217|Non-invasive inhaled nitric oxide|non-invasive inhaled nitric oxide
5373070|NCT00139217|iNO|ino
5373071|NCT00139204|Prostate cancer|prostate cancer
5373072|NCT00139204|Hormone-refractory prostate cancer|hormone-refractory prostate cancer
5373073|NCT00139204|PET scan|pet scan
5373074|NCT00139204|C11-methionine|c11-methionine
5373075|NCT00139204|positron emission tomography|positron emission tomography
5373076|NCT00139191|Prostate Cancer|prostate cancer
5373077|NCT00139191|positron emission tomography|positron emission tomography
5373078|NCT00139191|carbon 11 acetate|carbon 11 acetate
5373079|NCT00139191|PET|pet
5373080|NCT00139191|fatty acid synthase|fatty acid synthase
5373081|NCT00139191|FAS|fas
5373082|NCT00139165|Collagenous colitis|collagenous colitis
5373083|NCT00139165|Budesonide treatment|budesonide treatment
5373084|NCT00139165|Diarrhea|diarrhea
5373085|NCT00139152|moderate to severe allergic asthma|moderate to severe allergic asthma
5373086|NCT00139139|hepatitis A|hepatitis a
5373087|NCT00139139|hepatitis A vaccine|hepatitis a vaccine
5373088|NCT00139139|immune globulin|immune globulin
5373089|NCT00139113|hepatitis A|hepatitis a
5373090|NCT00139113|hepatitis A vaccine|hepatitis a vaccine
5373091|NCT00139074|Bipolar I Disorder (DSM-IV 296.01, DSM-IV 296.4, DSM-IV 296.61)|bipolar i disorder (dsm-iv 296.01, dsm-iv 296.4, dsm-iv 296.61)
5373092|NCT00139048|informed choice|informed choice
5373093|NCT00139048|shared decision making|shared decision making
5373094|NCT00139048|decision aid|decision aid
5373095|NCT00139048|mammography screening|mammography screening
5373096|NCT00139048|decision support|decision support
5373097|NCT00139035|glucose intolerance|glucose intolerance
5373098|NCT00139035|insulin|insulin
5373099|NCT00139035|microvascular function|microvascular function
5373100|NCT00139035|genotyping|genotyping
5373101|NCT00139035|CYP3A5|cyp3a5
5373102|NCT00139035|pharmacokinetics|pharmacokinetics
5373103|NCT00139035|renal transplantation|renal transplantation
5373104|NCT00139022|sleep apnea, home monitoring, CPAP|sleep apnea, home monitoring, cpap
5373105|NCT00139009|intracellular concentration|intracellular concentration
5373106|NCT00139009|cyclosporine A|cyclosporine a
5373107|NCT00139009|renal biopsies|renal biopsies
5373108|NCT00139009|heart biopsies|heart biopsies
5373109|NCT00139009|Renal transplant recipients|renal transplant recipients
5373110|NCT00138996|cardiac arrest|cardiac arrest
5373111|NCT00138996|resuscitation|resuscitation
5373112|NCT00138996|quality|quality
5373113|NCT00138996|feedback|feedback
5373114|NCT00138996|training|training
5373115|NCT00138983|glucocorticoid-induced osteoporosis|glucocorticoid-induced osteoporosis
5373116|NCT00138983|rheumatic diseases|rheumatic diseases
5373117|NCT00138983|prevention|prevention
5373118|NCT00138983|randomized double-blind, double placebo controlled trial|randomized double-blind, double placebo controlled trial
5373119|NCT00138983|alendronate versus alfacalcidol|alendronate versus alfacalcidol
5373120|NCT00138970|Cadaveric donor|cadaveric donor
5373121|NCT00138970|Calcineurine free|calcineurine free
5373122|NCT00138957|Laparoscopic parastomal hernia repair|laparoscopic parastomal hernia repair
5373123|NCT00138957|Intraperitoneally|intraperitoneally
5373124|NCT00138957|Mesh|mesh
5373125|NCT00138957|Quality of life|quality of life
5373126|NCT00138957|Postoperative pain|postoperative pain
5373127|NCT00138957|Recurrence|recurrence
5373128|NCT00138944|Essential hypertension|essential hypertension
5373129|NCT00138931|Cardiomyopathy|cardiomyopathy
5373130|NCT00138931|Arrhythmia|arrhythmia
5373131|NCT00138931|Muscular Dystrophy|muscular dystrophy
5373132|NCT00138918|Prostate Cancer|prostate cancer
5373133|NCT00138918|Clusterin|clusterin
5373134|NCT00138918|Neoadjuvant|neoadjuvant
5373135|NCT00138918|Phase II|phase ii
5373136|NCT00138905|Base station, EMF, human exposure study,Well-being,cognitive|base station, emf, human exposure study,well-being,cognitive
5373137|NCT00138892|Quality of life|quality of life
5373138|NCT00138892|waiting time|waiting time
5373139|NCT00138892|total joint replacement|total joint replacement
5373140|NCT00138879|Citrulline|citrulline
5373141|NCT00138879|Parenteral Nutrition|parenteral nutrition
5373142|NCT00138879|functioning intestinal mass|functioning intestinal mass
5373143|NCT00138879|small bowel permeability and absorption|small bowel permeability and absorption
5373144|NCT00138879|Granulomatous Enteritis|granulomatous enteritis
5373145|NCT00138866|Spinal cord injury|spinal cord injury
5373146|NCT00138853|RSA|rsa
5373147|NCT00138853|Genoarthrosis|genoarthrosis
5373148|NCT00138853|Knee arthroplasty|knee arthroplasty
5373149|NCT00138853|Micromotion of polyethylene liner|micromotion of polyethylene liner
5373150|NCT00138840|Crohn's disease|crohn's disease
5373151|NCT00138840|Gastroenterology|gastroenterology
5373152|NCT00138827|Radiotherapy|radiotherapy
5373153|NCT00138827|Mucositis|mucositis
5373154|NCT00138827|Xerostomia|xerostomia
5373155|NCT00138814|Neoplasm recurrence, local|neoplasm recurrence, local
5373156|NCT00138814|Radiotherapy dosage|radiotherapy dosage
5373157|NCT00138814|Cosmesis|cosmesis
5373158|NCT00138814|Mastectomy, segmental|mastectomy, segmental
5373159|NCT00138801|Neuroborreliosis|neuroborreliosis
5373160|NCT00138788|Radiotherapy|radiotherapy
5373161|NCT00138788|Qualify of life|qualify of life
5373162|NCT00138788|Neoplasm metastasis of the brain|neoplasm metastasis of the brain
5373163|NCT00138775|D-serine|d-serine
5373164|NCT00138775|Negative symptoms|negative symptoms
5373165|NCT00138775|Cognition|cognition
5373166|NCT00138775|Schizophrenia|schizophrenia
5373167|NCT00138775|Amino acid|amino acid
5373168|NCT00138736|MBL-deficient|mbl-deficient
5373169|NCT00138736|chemotherapy|chemotherapy
5373170|NCT00138736|neutropenia|neutropenia
5373171|NCT00138736|chemotherapy-induced neutropenia|chemotherapy-induced neutropenia
5373172|NCT00138710|obesity|obesity
5373173|NCT00138710|Hypogonadotrophic hypogonadism|hypogonadotrophic hypogonadism
5373174|NCT00138710|aromatase inhibition|aromatase inhibition
5373175|NCT00138697|Agammaglobulinemia|agammaglobulinemia
5373176|NCT00138697|Hypogammaglobulinemia|hypogammaglobulinemia
5373177|NCT00138697|Immunoglobulins, Intravenous|immunoglobulins, intravenous
5373178|NCT00138684|insulin resistance|insulin resistance
5373179|NCT00138684|iron overload|iron overload
5373180|NCT00138684|phlebotomy|phlebotomy
5373181|NCT00138684|hepatic iron overload|hepatic iron overload
5373182|NCT00138658|NSCLC|nsclc
5373183|NCT00138658|custirsen sodium|custirsen sodium
5373184|NCT00138658|OGX-011|ogx-011
5373185|NCT00138658|Stage IIIB or IV advanced non-small cell lung cancer|stage iiib or iv advanced non-small cell lung cancer
5373186|NCT00138632|Wet Age-related macular degeneration|wet age-related macular degeneration
5373187|NCT00138632|PTK787|ptk787
5373188|NCT00138619|Type 2 diabetes|type 2 diabetes
5373189|NCT00138619|vildagliptin|vildagliptin
5373190|NCT00138606|Type 2 diabetes|type 2 diabetes
5373191|NCT00138606|vildagliptin|vildagliptin
5373192|NCT00138593|Type 2 diabetes|type 2 diabetes
5373193|NCT00138593|vildagliptin|vildagliptin
5373194|NCT00138580|Type 2 diabetes|type 2 diabetes
5373195|NCT00138580|vildagliptin|vildagliptin
5373196|NCT00138567|Type 2 diabetes|type 2 diabetes
5373197|NCT00138567|vildagliptin|vildagliptin
5373198|NCT00138554|Type 2 diabetes|type 2 diabetes
5373199|NCT00138554|vildagliptin|vildagliptin
5373200|NCT00138541|type 2 diabetes|type 2 diabetes
5373201|NCT00138541|vildagliptin|vildagliptin
5373202|NCT00138528|Metabolic Syndrome, fluvastatin|metabolic syndrome, fluvastatin
5373203|NCT00138515|Type 2 diabetes|type 2 diabetes
5373204|NCT00138515|vildagliptin|vildagliptin
5373205|NCT00138502|Candidiasis, Funguria|candidiasis, funguria
5373206|NCT00138489|Malaria, Papua New Guinea, infants, children|malaria, papua new guinea, infants, children
5373207|NCT00138476|Norovirus, calicivirus, gastroenteritis, Norwalk virus, challenge|norovirus, calicivirus, gastroenteritis, norwalk virus, challenge
5373208|NCT00138463|West Nile Virus, Neuroinvasive Disease|west nile virus, neuroinvasive disease
5373209|NCT00138450|Schistosomiasis, S. haematobium, morbidity, Kenya|schistosomiasis, s. haematobium, morbidity, kenya
5373210|NCT00138437|leprosy|leprosy
5373211|NCT00138437|Colombia|colombia
5373212|NCT00138424|Vistide®, Cidofovir, renal transplant, BK Virus Nephropathy|vistide®, cidofovir, renal transplant, bk virus nephropathy
5373213|NCT00138411|anthrax, Bacillus anthracis, monoclonal antibody, ETI-204|anthrax, bacillus anthracis, monoclonal antibody, eti-204
5373214|NCT00138398|Influenza, T cell, vaccine, Congestive heart failure|influenza, t cell, vaccine, congestive heart failure
5373215|NCT00138385|inactivated, attenuated, influenza vaccine, FluMist, Fluzone|inactivated, attenuated, influenza vaccine, flumist, fluzone
5373216|NCT00138372|malaria|malaria
5373217|NCT00138372|immunity|immunity
5373218|NCT00138372|MSP-1|msp-1
5373219|NCT00138372|Kenya|kenya
5373220|NCT00138372|infants|infants
5373221|NCT00138359|T solium, cysticercus, pig triquina, solitaria, intestinal parasites, Niclosamide, tapeworms, Taeniasis|t solium, cysticercus, pig triquina, solitaria, intestinal parasites, niclosamide, tapeworms, taeniasis
5373222|NCT00138346|hydatid disease, Echinococcus granulosus, tapeworm|hydatid disease, echinococcus granulosus, tapeworm
5373223|NCT00138333|Thimerosal, mercury levels, low birth weight, Argentina|thimerosal, mercury levels, low birth weight, argentina
5373224|NCT00138320|Herpes Simplex, vaccine, antibodies, mother|herpes simplex, vaccine, antibodies, mother
5373225|NCT00138307|malaria, children, naturally acquired immunity, Ghana|malaria, children, naturally acquired immunity, ghana
5373226|NCT00138294|influenza vaccine|influenza vaccine
5373227|NCT00138294|live attenuated influenza vaccine (LAIV or FluMist)|live attenuated influenza vaccine (laiv or flumist)
5373228|NCT00138294|inactivated influenza vaccine (IIV)|inactivated influenza vaccine (iiv)
5373229|NCT00138294|School-based influenza vaccination program|school-based influenza vaccination program
5373230|NCT00138294|children|children
5373231|NCT00138294|herd protection|herd protection
5373232|NCT00138281|influenza, vaccine, respiratory virus, Fluzone, FluMist|influenza, vaccine, respiratory virus, fluzone, flumist
5373233|NCT00138268|umbilical cord blood, vaccine, pregnant women|umbilical cord blood, vaccine, pregnant women
5373234|NCT00138242|stage I ovarian epithelial cancer|stage i ovarian epithelial cancer
5373235|NCT00138242|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
5373236|NCT00138242|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5373237|NCT00138242|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5373238|NCT00138242|fallopian tube cancer|fallopian tube cancer
5373239|NCT00138242|primary peritoneal cavity cancer|primary peritoneal cavity cancer
5373240|NCT00138229|recurrent melanoma|recurrent melanoma
5373241|NCT00138229|stage IV melanoma|stage iv melanoma
5373242|NCT00138216|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
5373243|NCT00138216|recurrent childhood cerebellar astrocytoma|recurrent childhood cerebellar astrocytoma
5373244|NCT00138216|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
5373245|NCT00138216|recurrent childhood brain stem glioma|recurrent childhood brain stem glioma
5373246|NCT00138216|recurrent childhood brain tumor|recurrent childhood brain tumor
5373247|NCT00138216|recurrent childhood ependymoma|recurrent childhood ependymoma
5373248|NCT00138216|recurrent childhood medulloblastoma|recurrent childhood medulloblastoma
5373249|NCT00138216|recurrent childhood supratentorial primitive neuroectodermal tumor|recurrent childhood supratentorial primitive neuroectodermal tumor
5373250|NCT00138216|recurrent childhood visual pathway and hypothalamic glioma|recurrent childhood visual pathway and hypothalamic glioma
5373251|NCT00138216|childhood oligodendroglioma|childhood oligodendroglioma
5373252|NCT00138216|childhood craniopharyngioma|childhood craniopharyngioma
5373253|NCT00138216|childhood choroid plexus tumor|childhood choroid plexus tumor
5373254|NCT00138216|childhood infratentorial ependymoma|childhood infratentorial ependymoma
5373255|NCT00138216|childhood supratentorial ependymoma|childhood supratentorial ependymoma
5373256|NCT00138216|childhood high-grade cerebral astrocytoma|childhood high-grade cerebral astrocytoma
5373257|NCT00138216|childhood low-grade cerebral astrocytoma|childhood low-grade cerebral astrocytoma
5373258|NCT00138216|childhood central nervous system germ cell tumor|childhood central nervous system germ cell tumor
5373259|NCT00138216|childhood grade I meningioma|childhood grade i meningioma
5373260|NCT00138216|childhood grade II meningioma|childhood grade ii meningioma
5373261|NCT00138216|childhood grade III meningioma|childhood grade iii meningioma
5373262|NCT00138216|recurrent childhood subependymal giant cell astrocytoma|recurrent childhood subependymal giant cell astrocytoma
5373263|NCT00138216|childhood atypical teratoid/rhabdoid tumor|childhood atypical teratoid/rhabdoid tumor
5373388|NCT00137657|antifolate|antifolate
5373264|NCT00138164|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5373265|NCT00138164|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5373266|NCT00138164|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5373267|NCT00138164|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5373268|NCT00138164|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5373269|NCT00138151|recurrent cervical cancer|recurrent cervical cancer
5373270|NCT00138151|stage IVB cervical cancer|stage ivb cervical cancer
5373271|NCT00138125|stage IV breast cancer|stage iv breast cancer
5373272|NCT00138125|recurrent breast cancer|recurrent breast cancer
5373273|NCT00138112|Streptococcal Sepsis|streptococcal sepsis
5373274|NCT00138112|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
5373275|NCT00138112|Hematologic Malignancies|hematologic malignancies
5373276|NCT00138112|Streptococci|streptococci
5373277|NCT00138112|Transplant|transplant
5373278|NCT00138099|Critically ill patients (ICU)|critically ill patients (icu)
5373279|NCT00138099|Deep Venous Thromboembolism prevention|deep venous thromboembolism prevention
5373280|NCT00138099|Renal Failure|renal failure
5373281|NCT00138099|Critically ill|critically ill
5373282|NCT00138086|lymphoma|lymphoma
5373283|NCT00138086|chemotherapy|chemotherapy
5373284|NCT00138086|Zevalin ( Yttrium-90 Ibritumomab Tiuxetan)|zevalin ( yttrium-90 ibritumomab tiuxetan)
5373285|NCT00138073|pulmonary artery catheter|pulmonary artery catheter
5373286|NCT00138073|waveform interpretation|waveform interpretation
5373287|NCT00138073|computer-based learning|computer-based learning
5373288|NCT00138073|medical education|medical education
5373289|NCT00138060|genotypic profile|genotypic profile
5373290|NCT00138060|metastatic colorectal cancer|metastatic colorectal cancer
5373291|NCT00138047|zinc|zinc
5373292|NCT00138047|HIV|hiv
5373293|NCT00138047|children|children
5373294|NCT00138034|Open infarct-related artery within 72 hours of thrombolysis|open infarct-related artery within 72 hours of thrombolysis
5373295|NCT00138021|Serious mental illness|serious mental illness
5373296|NCT00138021|Supported Employment|supported employment
5373297|NCT00138021|Cognitive remediation|cognitive remediation
5373298|NCT00138021|Cognitive impairments|cognitive impairments
5373299|NCT00138008|prostate cancer|prostate cancer
5373300|NCT00138008|radical prostatectomy|radical prostatectomy
5373301|NCT00138008|PSA failure|psa failure
5373302|NCT00138008|RCT|rct
5373303|NCT00138008|radiation|radiation
5373304|NCT00138008|endocrinotherapy|endocrinotherapy
5373305|NCT00137995|Lymphoma|lymphoma
5373306|NCT00137995|Chemotherapy|chemotherapy
5373307|NCT00137995|rituximab|rituximab
5373308|NCT00137982|Ectopic pregnancy|ectopic pregnancy
5373309|NCT00137982|Surgical treatment|surgical treatment
5373310|NCT00137982|Medical treatment|medical treatment
5373311|NCT00137982|Fertility|fertility
5373312|NCT00137969|Rituxan|rituxan
5373313|NCT00137969|SLE|sle
5373314|NCT00137969|Lupus|lupus
5373315|NCT00137956|Endobronchial Valve|endobronchial valve
5373316|NCT00137956|Endobronchial Valve ProcedureEBV|endobronchial valve procedureebv
5373317|NCT00137956|EBV Procedure|ebv procedure
5373318|NCT00137956|Endobronchial Lung Volume Reduction|endobronchial lung volume reduction
5373319|NCT00137956|Lung Volume Reduction|lung volume reduction
5373320|NCT00137943|Parent-child communication|parent-child communication
5373321|NCT00137943|Primary prevention|primary prevention
5373322|NCT00137943|sexual risk prevention|sexual risk prevention
5373323|NCT00137943|HIV|hiv
5373324|NCT00137930|Prophylaxis of rotavirus gastroenteritis|prophylaxis of rotavirus gastroenteritis
5373325|NCT00137917|Prophylaxis meningococcal serogroup B disease|prophylaxis meningococcal serogroup b disease
5373326|NCT00137904|multiple sclerosis|multiple sclerosis
5373327|NCT00137904|fatigue|fatigue
5373328|NCT00137904|sleep disorders|sleep disorders
5373329|NCT00137891|Multinodular goiter|multinodular goiter
5373330|NCT00137852|Esophageal Cancer|esophageal cancer
5373331|NCT00137852|Resectable Esophageal Cancer|resectable esophageal cancer
5373332|NCT00137852|Radiation Therapy|radiation therapy
5373333|NCT00137852|Celecoxib|celecoxib
5373334|NCT00137852|Irinotecan|irinotecan
5373335|NCT00137852|Cisplatin|cisplatin
5373336|NCT00137839|Tarceva|tarceva
5373337|NCT00137839|Erlotinib|erlotinib
5373338|NCT00137839|OSI-774|osi-774
5373339|NCT00137839|Adenocarcinoma|adenocarcinoma
5373340|NCT00137839|Advanced Lung Cancer|advanced lung cancer
5373341|NCT00137826|Mesothelioma|mesothelioma
5373342|NCT00137826|Avastin|avastin
5373343|NCT00137826|Bevacizumab|bevacizumab
5373344|NCT00137826|Tarceva|tarceva
5373345|NCT00137826|OSI-774|osi-774
5373346|NCT00137826|Erlotinib|erlotinib
5373347|NCT00137813|Bevacizumab|bevacizumab
5373348|NCT00137813|Docetaxel|docetaxel
5373349|NCT00137813|AvaTax|avatax
5373350|NCT00137813|Metastatic Esophagogastric Cancer|metastatic esophagogastric cancer
5373351|NCT00137800|Non-Small Cell Lung Cancer|non-small cell lung cancer
5373352|NCT00137800|Elderly Cancer Patients|elderly cancer patients
5373353|NCT00137800|Tarceva|tarceva
5373354|NCT00137800|Erlotinib|erlotinib
5373355|NCT00137800|OSI-774|osi-774
5373356|NCT00137800|Stage IIIB or IV Non-Small Cell Lung Cancer|stage iiib or iv non-small cell lung cancer
5373357|NCT00137787|febrile neutropenia|febrile neutropenia
5373358|NCT00137787|hematologic disease|hematologic disease
5373359|NCT00137774|Metastatic Neuroendocrine Tumor|metastatic neuroendocrine tumor
5373360|NCT00137774|Advanced Neuroendocrine tumor|advanced neuroendocrine tumor
5373361|NCT00137774|Bevacizumab|bevacizumab
5373362|NCT00137774|Temozolomide|temozolomide
5373363|NCT00137761|Pancreatic Carcinoma|pancreatic carcinoma
5373364|NCT00137761|Iressa|iressa
5373365|NCT00137761|Docetaxel|docetaxel
5373366|NCT00137748|Lung transplantation|lung transplantation
5373367|NCT00137735|carpal tunnel syndrome|carpal tunnel syndrome
5373368|NCT00137735|gabapentin|gabapentin
5373369|NCT00137722|Asthma|asthma
5373370|NCT00137722|Disease Management|disease management
5373371|NCT00137722|Outcomes|outcomes
5373372|NCT00137722|Utilization|utilization
5373373|NCT00137709|epilepsy|epilepsy
5373374|NCT00137709|hormone|hormone
5373375|NCT00137696|polio|polio
5373376|NCT00137696|vaccine|vaccine
5373377|NCT00137696|immunogenicity|immunogenicity
5373378|NCT00137683|screening|screening
5373379|NCT00137683|prevention|prevention
5373380|NCT00137683|community health education|community health education
5373381|NCT00137670|Intervention studies|intervention studies
5373382|NCT00137670|HIV|hiv
5373383|NCT00137657|HIV|hiv
5373384|NCT00137657|malaria|malaria
5373385|NCT00137657|E. Coli|e. coli
5373386|NCT00137657|S. pneumoniae|s. pneumoniae
5373387|NCT00137657|drug resistance|drug resistance
5373389|NCT00137657|opportunistic infections|opportunistic infections
5373390|NCT00137657|Africa|africa
5373391|NCT00137657|Kenya|kenya
5373392|NCT00137657|East Africa|east africa
5373393|NCT00137644|Adolescent|adolescent
5373394|NCT00137644|*HIV Infections/ pc [Prevention & Control]|*hiv infections/ pc [prevention & control]
5373395|NCT00137644|Male|male
5373396|NCT00137644|Humans|humans
5373397|NCT00137644|Risk-Taking|risk-taking
5373398|NCT00137644|Safe Sex|safe sex
5373399|NCT00137644|Sexual Behavior|sexual behavior
5373400|NCT00137644|HIV|hiv
5373401|NCT00137644|HIV Seronegativity|hiv seronegativity
5373402|NCT00137631|Adult|adult
5373403|NCT00137631|HIV Infections / pc [Prevention & Control]|hiv infections / pc [prevention & control]
5373404|NCT00137631|Homosexuality, Male|homosexuality, male
5373405|NCT00137631|Humans|humans
5373406|NCT00137631|Male|male
5373407|NCT00137631|Risk-Taking|risk-taking
5373408|NCT00137631|Safe Sex|safe sex
5373409|NCT00137631|Sexual Behavior|sexual behavior
5373410|NCT00137631|HIV|hiv
5373411|NCT00137618|Prostatic neoplasm|prostatic neoplasm
5373412|NCT00137618|Prostate cancer|prostate cancer
5373413|NCT00137618|Informed decision making|informed decision making
5373414|NCT00137618|Prostate cancer screening|prostate cancer screening
5373415|NCT00137618|Prostate specific antigen|prostate specific antigen
5373416|NCT00137605|HIV|hiv
5373417|NCT00137605|HIV Infections|hiv infections
5373418|NCT00137592|screening|screening
5373419|NCT00137592|community health education|community health education
5373420|NCT00137579|Influenza Vaccines|influenza vaccines
5373421|NCT00137579|Acenocoumarol|acenocoumarol
5373422|NCT00137579|Drug Administration Routes|drug administration routes
5373423|NCT00137579|Anticoagulants|anticoagulants
5373424|NCT00137566|malaria|malaria
5373425|NCT00137566|treatment|treatment
5373426|NCT00137566|paracetamol|paracetamol
5373427|NCT00137566|chloroquine|chloroquine
5373428|NCT00137566|Guinea-Bissau|guinea-bissau
5373429|NCT00137566|children|children
5373430|NCT00137566|P.falciparum|p.falciparum
5373431|NCT00137553|Children|children
5373432|NCT00137553|malaria|malaria
5373433|NCT00137553|sulfadoxine-pyrimethamine|sulfadoxine-pyrimethamine
5373434|NCT00137553|Guinea-Bissau|guinea-bissau
5373435|NCT00137553|treatment|treatment
5373436|NCT00137540|First line ablation therapy|first line ablation therapy
5373437|NCT00137527|Cardiac Surgery|cardiac surgery
5373438|NCT00137527|Cardiopulmonary Bypass|cardiopulmonary bypass
5373439|NCT00137527|Cerebral Oxygenation|cerebral oxygenation
5373440|NCT00137527|Neurologic Dysfunction|neurologic dysfunction
5373441|NCT00137527|Neurocognitive Dysfunction|neurocognitive dysfunction
5373442|NCT00137527|Neurological manifestations|neurological manifestations
5373443|NCT00137527|Memory loss|memory loss
5373444|NCT00137527|Delirium|delirium
5373445|NCT00137527|Coronary Artery Bypass|coronary artery bypass
5373446|NCT00137514|malaria|malaria
5373447|NCT00137514|Plasmodium falciparum|plasmodium falciparum
5373448|NCT00137514|chloroquine|chloroquine
5373449|NCT00137514|amodiaquine|amodiaquine
5373450|NCT00137514|treatment|treatment
5373451|NCT00137514|Guinea-Bissau|guinea-bissau
5373452|NCT00137514|children|children
5373453|NCT00137488|non-enhancing lesion|non-enhancing lesion
5373454|NCT00137488|low grade glioma|low grade glioma
5373455|NCT00137488|high risk group selection|high risk group selection
5373456|NCT00137475|IMRT|imrt
5373457|NCT00137475|head and neck cancer|head and neck cancer
5373458|NCT00137475|parotid sparing|parotid sparing
5373459|NCT00137436|First-line treatment of metastatic hormone-refractory prostate cancer SUTENT in combination with docetaxel and prednisone|first-line treatment of metastatic hormone-refractory prostate cancer sutent in combination with docetaxel and prednisone
5373460|NCT00137384|Magnetoencephalogram|magnetoencephalogram
5373461|NCT00137384|Functional Connectivity|functional connectivity
5373462|NCT00137384|Electroencephalogram (EEG)|electroencephalogram (eeg)
5373463|NCT00137384|Focal Hand Dystonia|focal hand dystonia
5373464|NCT00137384|Spectral Analysis|spectral analysis
5373465|NCT00137384|Healthy Volunteer|healthy volunteer
5373466|NCT00137384|HV|hv
5373467|NCT00137371|Postmenopause|postmenopause
5373468|NCT00137371|Vaginitis|vaginitis
5373469|NCT00137358|Cervical|cervical
5373470|NCT00137358|Uterine|uterine
5373471|NCT00137358|Para-aortic|para-aortic
5373472|NCT00137358|Nodes|nodes
5373473|NCT00137358|IMRT|imrt
5373474|NCT00137358|Cancer|cancer
5373475|NCT00137345|Randomized controlled trial|randomized controlled trial
5373476|NCT00137345|Clinical Trial Phase III|clinical trial phase iii
5373477|NCT00137345|Drug therapy|drug therapy
5373478|NCT00137345|Immunosuppression|immunosuppression
5373479|NCT00137345|Treatment outcome|treatment outcome
5373480|NCT00137345|Kidney transplantation|kidney transplantation
5373481|NCT00137345|Kidney function tests|kidney function tests
5373482|NCT00137332|Arrhythmia|arrhythmia
5373483|NCT00137332|antiarrhythmic|antiarrhythmic
5373484|NCT00137332|programmed electrical stimulation|programmed electrical stimulation
5373485|NCT00137319|inspiratory impedance threshold device|inspiratory impedance threshold device
5373486|NCT00137319|blood pressure regulation|blood pressure regulation
5373487|NCT00137319|head-up tilt test|head-up tilt test
5373488|NCT00137319|tilt table testing|tilt table testing
5373489|NCT00137319|burn injury|burn injury
5373490|NCT00137319|Burns|burns
5373491|NCT00137306|Guideline Adherence|guideline adherence
5373492|NCT00137306|Quality Assurance, Health Care|quality assurance, health care
5373493|NCT00137293|Arrhythmia, syncope, antiarrhythmic|arrhythmia, syncope, antiarrhythmic
5373494|NCT00137280|Randomized Controlled Trial|randomized controlled trial
5373495|NCT00137280|Quality of Health Care|quality of health care
5373496|NCT00137280|Health Services Research|health services research
5373497|NCT00137280|Guidelines|guidelines
5373498|NCT00137280|Medical Informatics Computing|medical informatics computing
5373499|NCT00137280|Services, Mental Health|services, mental health
5373500|NCT00137280|Medicine, Evidenced-Based|medicine, evidenced-based
5373501|NCT00137280|Quality Assurance, Healthcare|quality assurance, healthcare
5373502|NCT00137280|Quality Indicators, Health Care|quality indicators, health care
5373503|NCT00137280|Veterans|veterans
5373504|NCT00137280|Unemployment|unemployment
5373505|NCT00137280|Obesity|obesity
5373506|NCT00137280|Quality Improvement|quality improvement
5373507|NCT00137267|Schizophrenia / disorders w psychotic features|schizophrenia / disorders w psychotic features
5373508|NCT00137267|Substance-related disorders|substance-related disorders
5373509|NCT00137267|Community Mental Health Services|community mental health services
5373510|NCT00137267|Case Management|case management
5373511|NCT00137267|Health Education|health education
5373512|NCT00137254|Severe burns|severe burns
5373513|NCT00137254|Hyperinsulinemia|hyperinsulinemia
5373514|NCT00137254|Insulin|insulin
5373515|NCT00137254|Muscle protein kinetics|muscle protein kinetics
5373516|NCT00137254|Immune function|immune function
5373517|NCT00137254|Exercise|exercise
5373518|NCT00137241|health literacy|health literacy
5373519|NCT00137241|screening|screening
5373520|NCT00137241|cancer|cancer
5373521|NCT00137241|health disparities|health disparities
5373522|NCT00137228|Hand Edema|hand edema
5373523|NCT00137228|Figure of eight method|figure of eight method
5373524|NCT00137228|Measuring edema in burn patients|measuring edema in burn patients
5373525|NCT00137215|burns|burns
5373526|NCT00137215|donor site care|donor site care
5373527|NCT00137215|Silverlon dressing|silverlon dressing
5373528|NCT00137202|pruritus|pruritus
5373529|NCT00137202|burn wound|burn wound
5373530|NCT00137189|Motivation|motivation
5373531|NCT00137189|Music Therapy|music therapy
5373532|NCT00137189|Psychotherapy|psychotherapy
5373533|NCT00137176|Clinically Isolated Syndrome|clinically isolated syndrome
5373534|NCT00137163|burns|burns
5373535|NCT00137163|donor site care|donor site care
5373536|NCT00137163|Dermafill dressing|dermafill dressing
5373537|NCT00137124|Essential hypertension|essential hypertension
5373538|NCT00137111|Leukemia|leukemia
5373539|NCT00137085|procedural sedation|procedural sedation
5373540|NCT00136955|Weekly Irinotecan(60mg/sqm, D1, 8, 15) in combination with Cisplatin (60mg/sqm, D1), Squamous Cell Carcinoma Of The Uterine Cervix|weekly irinotecan(60mg/sqm, d1, 8, 15) in combination with cisplatin (60mg/sqm, d1), squamous cell carcinoma of the uterine cervix
5373541|NCT00136929|AMI|ami
5373542|NCT00136929|MI|mi
5373543|NCT00136929|Acute myocardial infarction (AMI), (MI)|acute myocardial infarction (ami), (mi)
5373544|NCT00136903|Graft vs Host Disease|graft vs host disease
5373545|NCT00136903|GVHD|gvhd
5373546|NCT00136903|Graft Versus Host Disease|graft versus host disease
5373547|NCT00136903|Bone marrow transplant|bone marrow transplant
5373548|NCT00136903|Stem cells|stem cells
5373549|NCT00136903|Mesenchymal stem cells|mesenchymal stem cells
5373550|NCT00136903|Adult stem cells|adult stem cells
5373551|NCT00136903|Leukemia|leukemia
5373552|NCT00136903|Lymphoma|lymphoma
5373553|NCT00136890|Positron-Emission Tomography|positron-emission tomography
5373554|NCT00136890|PET Scan|pet scan
5373555|NCT00136890|Lung Cancer|lung cancer
5373556|NCT00136890|Thoracic Surgery|thoracic surgery
5373557|NCT00136890|Diagnostic|diagnostic
5373558|NCT00136890|Randomized Controlled Trial|randomized controlled trial
5373559|NCT00136890|Oncology|oncology
5373560|NCT00136877|recurrent tonsillitis|recurrent tonsillitis
5373561|NCT00136877|streptococcus|streptococcus
5373562|NCT00136877|tonsillectomy|tonsillectomy
5373563|NCT00136877|prevention|prevention
5373564|NCT00136864|Positron-Emission Tomography|positron-emission tomography
5373565|NCT00136864|PET Scan|pet scan
5373566|NCT00136864|Non-Small-Cell Lung Carcinoma|non-small-cell lung carcinoma
5373567|NCT00136864|Diagnosis|diagnosis
5373568|NCT00136864|Radiation Oncology|radiation oncology
5373569|NCT00136864|Lung Cancer|lung cancer
5373570|NCT00136864|Randomized Controlled Trial|randomized controlled trial
5373571|NCT00136864|Oncology|oncology
5373572|NCT00136864|Radiation Planning|radiation planning
5373573|NCT00136851|Hypertension|hypertension
5373574|NCT00136838|tobacco use|tobacco use
5373575|NCT00136825|cocaine|cocaine
5373576|NCT00136825|treatment|treatment
5373577|NCT00136812|tobacco|tobacco
5373578|NCT00136799|Mixed Dyslipidemia|mixed dyslipidemia
5373579|NCT00136799|high cholesterol|high cholesterol
5373580|NCT00136799|adults|adults
5373581|NCT00136799|fluvastatin|fluvastatin
5373582|NCT00136786|tobacco use|tobacco use
5373583|NCT00136773|Albuminuria|albuminuria
5373584|NCT00136773|Type 2 diabetes mellitus|type 2 diabetes mellitus
5373585|NCT00136773|Hypertension|hypertension
5373586|NCT00136760|tobacco|tobacco
5373587|NCT00136747|tobacco use|tobacco use
5373588|NCT00136734|ADHD|adhd
5373589|NCT00136734|Cocaine dependence|cocaine dependence
5373590|NCT00136734|treatment|treatment
5373591|NCT00136734|methylphenidate|methylphenidate
5373592|NCT00136721|Parkinson's disease|parkinson's disease
5373593|NCT00136721|phenotype-genotype correlations|phenotype-genotype correlations
5373594|NCT00136721|mutations spectrum|mutations spectrum
5373595|NCT00136721|candidate genes|candidate genes
5373596|NCT00136708|Global Network|global network
5373597|NCT00136708|Neonatal mortality|neonatal mortality
5373598|NCT00136708|Asphyxia|asphyxia
5373599|NCT00136708|Maternal and child health|maternal and child health
5373600|NCT00136708|International|international
5373601|NCT00136708|Zambia|zambia
5373602|NCT00136708|Pakistan|pakistan
5373603|NCT00136708|India|india
5373604|NCT00136708|Democratic Republic of Congo|democratic republic of congo
5373605|NCT00136708|Uruguay|uruguay
5373606|NCT00136708|Guatemala|guatemala
5373607|NCT00136708|Argentina|argentina
5373608|NCT00136708|Neonatal resuscitation|neonatal resuscitation
5373609|NCT00136695|Aging|aging
5373610|NCT00136682|Major abdominal or pelvic surgery|major abdominal or pelvic surgery
5373611|NCT00136682|Patient-Controlled Epidural Analgesia (PCEA)|patient-controlled epidural analgesia (pcea)
5373612|NCT00136682|Length of hospital stay after surgery|length of hospital stay after surgery
5373613|NCT00136669|Acupuncture|acupuncture
5373614|NCT00136669|Pain|pain
5373615|NCT00136669|Pancreatic Neoplasms|pancreatic neoplasms
5373616|NCT00136656|infant|infant
5373617|NCT00136656|children|children
5373618|NCT00136656|pyelonephritis|pyelonephritis
5373619|NCT00136656|Renal scars|renal scars
5373620|NCT00136656|DMSA scan|dmsa scan
5373621|NCT00136643|microbicide|microbicide
5373622|NCT00136643|Women|women
5373623|NCT00136643|Prevention|prevention
5373624|NCT00136643|HIV|hiv
5373625|NCT00136643|STIs|stis
5373626|NCT00136643|HIV Seronegativity|hiv seronegativity
5373627|NCT00136643|prevention of sexually transmitted infections including HIV.|prevention of sexually transmitted infections including hiv.
5373628|NCT00136630|dominant spinocerebellar degenerations|dominant spinocerebellar degenerations
5373629|NCT00136630|new rate scales|new rate scales
5373630|NCT00136630|natural history|natural history
5373631|NCT00136630|molecular biology|molecular biology
5373632|NCT00136630|candidate genes|candidate genes
5373633|NCT00136617|Short Alcohol Withdrawal Scale|short alcohol withdrawal scale
5373634|NCT00136617|Documentation|documentation
5373635|NCT00136604|Prophylaxis diphtheria|prophylaxis diphtheria
5373636|NCT00136604|Hib & meningococcal serogroup A & C disease|hib & meningococcal serogroup a & c disease
5373637|NCT00136591|follicular lymphoma|follicular lymphoma
5373638|NCT00136591|bortezomib|bortezomib
5373639|NCT00136591|relapse|relapse
5373640|NCT00136578|solid tumors|solid tumors
5373641|NCT00136578|dose limiting toxicity|dose limiting toxicity
5373642|NCT00136578|carboplatin|carboplatin
5373643|NCT00136578|tolerability|tolerability
5373644|NCT00136578|Safety|safety
5373645|NCT00136565|peripheral T-cell lymphomas|peripheral t-cell lymphomas
5373646|NCT00136565|bortezomib|bortezomib
5373647|NCT00136565|ACVBP regimen|acvbp regimen
5373648|NCT00136552|lymphoma|lymphoma
5373649|NCT00136552|follicular|follicular
5373650|NCT00136552|B-cell|b-cell
5373651|NCT00136552|rituximab|rituximab
5373652|NCT00136552|interferon|interferon
5373653|NCT00136539|Breast Cancer|breast cancer
5373654|NCT00136539|Early Stage Breast Cancer|early stage breast cancer
5373655|NCT00136539|HER2-positive|her2-positive
5373656|NCT00136539|HER2-positive breast cancer|her2-positive breast cancer
5373657|NCT00136539|Herceptin|herceptin
5373658|NCT00136539|Taxol|taxol
5373659|NCT00136539|Stage II Breast Cancer|stage ii breast cancer
5373660|NCT00136539|Stage III Breast Cancer|stage iii breast cancer
5373661|NCT00136526|Prostate Cancer|prostate cancer
5373957|NCT00135304|Vitamin D|vitamin d
5373662|NCT00136526|Hormone refractory prostate cancer|hormone refractory prostate cancer
5373663|NCT00136526|Metastatic prostate cancer|metastatic prostate cancer
5373664|NCT00136513|Safety|safety
5373665|NCT00136513|tolerability|tolerability
5373666|NCT00136513|dose limiting toxicity|dose limiting toxicity
5373667|NCT00136513|solid tumors|solid tumors
5373668|NCT00136500|genetics|genetics
5373669|NCT00136500|biomarkers|biomarkers
5373670|NCT00136500|pre-symptomatic|pre-symptomatic
5373671|NCT00136500|natural history|natural history
5373672|NCT00136487|Prostate Cancer|prostate cancer
5373673|NCT00136487|Cancer of Prostate|cancer of prostate
5373674|NCT00136487|Cancer of the Prostate|cancer of the prostate
5373675|NCT00136487|Prostate-Specific Antigen|prostate-specific antigen
5373676|NCT00136474|Lymphoma|lymphoma
5373677|NCT00136474|Radiation therapy|radiation therapy
5373678|NCT00136474|Amifostine|amifostine
5373679|NCT00136461|AML|aml
5373680|NCT00136461|acute myelogenous leukemia|acute myelogenous leukemia
5373681|NCT00136461|MDS|mds
5373682|NCT00136461|myelodysplastic syndrome|myelodysplastic syndrome
5373683|NCT00136461|bryostatin 1|bryostatin 1
5373684|NCT00136461|all-trans retinoic acid|all-trans retinoic acid
5373685|NCT00136461|ATRA|atra
5373686|NCT00136448|AML|aml
5373687|NCT00136448|acute myelogenous leukemia|acute myelogenous leukemia
5373688|NCT00136448|cytarabine|cytarabine
5373689|NCT00136448|interleukin-2|interleukin-2
5373690|NCT00136435|ALL|all
5373691|NCT00136435|acute lymphoblastic leukemia|acute lymphoblastic leukemia
5373692|NCT00136435|chemotherapy|chemotherapy
5373693|NCT00136435|asparaginase|asparaginase
5373694|NCT00136422|AML|aml
5373695|NCT00136422|acute myelogenous leukemia|acute myelogenous leukemia
5373696|NCT00136422|MDS|mds
5373697|NCT00136422|myelodysplasia|myelodysplasia
5373698|NCT00136422|vaccine|vaccine
5373699|NCT00136409|myelofibrosis|myelofibrosis
5373700|NCT00136409|agnogenic myeloid metaplasia with myelofibrosis|agnogenic myeloid metaplasia with myelofibrosis
5373701|NCT00136409|CMML|cmml
5373702|NCT00136409|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5373703|NCT00136409|imatinib mesylate|imatinib mesylate
5373704|NCT00136409|Gleevec|gleevec
5373705|NCT00136396|Steroid-refractory Chronic Graft vs. Host Disease|steroid-refractory chronic graft vs. host disease
5373706|NCT00136396|Chronic Graft vs. Host Disease|chronic graft vs. host disease
5373707|NCT00136396|GVHD|gvhd
5373708|NCT00136396|steroid-refractory|steroid-refractory
5373709|NCT00136396|rituximab|rituximab
5373710|NCT00136370|Chlorhexidine|chlorhexidine
5373711|NCT00136370|Prevention|prevention
5373712|NCT00136370|Neonatal sepsis|neonatal sepsis
5373713|NCT00136370|Peripartum infections|peripartum infections
5373714|NCT00136357|posttraumatic stress|posttraumatic stress
5373715|NCT00136357|mind-body techniques|mind-body techniques
5373716|NCT00136357|war|war
5373717|NCT00136357|adolescents|adolescents
5373718|NCT00136344|cataract surgery|cataract surgery
5373719|NCT00136344|phacoemulsification|phacoemulsification
5373720|NCT00136344|post-operative endophthalmitis|post-operative endophthalmitis
5373721|NCT00136331|Pandemic|pandemic
5373722|NCT00136331|Influenza|influenza
5373723|NCT00136331|Prevention|prevention
5373724|NCT00136331|Vaccine|vaccine
5373725|NCT00136331|Prevention of Pandemic Influenza|prevention of pandemic influenza
5373726|NCT00136318|Pegasys-Induced depression|pegasys-induced depression
5373727|NCT00136305|pediatric asthma|pediatric asthma
5373728|NCT00136305|asthma action plans|asthma action plans
5373729|NCT00136305|patient education|patient education
5373730|NCT00136305|medication adherence|medication adherence
5373731|NCT00136292|Gram-Positive Infection|gram-positive infection
5373732|NCT00136279|adolescent behavior|adolescent behavior
5373733|NCT00136279|sexual behavior|sexual behavior
5373734|NCT00136279|smoking|smoking
5373735|NCT00136279|parents|parents
5373736|NCT00136279|communication|communication
5373737|NCT00136279|health education|health education
5373738|NCT00136279|schools|schools
5373739|NCT00136279|Sexual initiation|sexual initiation
5373740|NCT00136266|Adherence|adherence
5373741|NCT00136266|Supplements|supplements
5373742|NCT00136266|Iron|iron
5373743|NCT00136266|Iron deficiency|iron deficiency
5373744|NCT00136266|Anemia|anemia
5373745|NCT00136266|Vitamins|vitamins
5373746|NCT00136266|Minerals|minerals
5373747|NCT00136227|screening,|screening,
5373748|NCT00136227|community health education,|community health education,
5373749|NCT00136227|decision making,|decision making,
5373750|NCT00136227|computer-assisted decision making|computer-assisted decision making
5373751|NCT00136201|Peritonitis|peritonitis
5373752|NCT00136201|Community-Acquired Infections|community-acquired infections
5373753|NCT00136201|Cross Infection|cross infection
5373754|NCT00136188|Prediabetes|prediabetes
5373755|NCT00136188|Metabolic Syndrome|metabolic syndrome
5373756|NCT00136188|Healthy Controls|healthy controls
5373757|NCT00136188|Endothelial function|endothelial function
5373758|NCT00136175|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
5373759|NCT00136110|ALS|als
5373760|NCT00136110|Sodium Valproate|sodium valproate
5373761|NCT00136110|randomised trial|randomised trial
5373762|NCT00136110|Amyotrophic Lateral Sclerosis (ALS)|amyotrophic lateral sclerosis (als)
5373958|NCT00135304|Sensipar®|sensipar®
5373763|NCT00136097|colonisation of the catheter|colonisation of the catheter
5373764|NCT00136084|Leukemia,Erythroblastic, Acute|leukemia,erythroblastic, acute
5373765|NCT00136084|Erythroblastic Leukemia, Acute|erythroblastic leukemia, acute
5373766|NCT00136084|Leukemia, Myeloid, Acute|leukemia, myeloid, acute
5373767|NCT00136084|Myeloid Leukemia, Acute|myeloid leukemia, acute
5373768|NCT00136071|Stress Urinary Incontinence,|stress urinary incontinence,
5373769|NCT00136071|TOT,|tot,
5373770|NCT00136071|TVT-O|tvt-o
5373771|NCT00136058|osteoporosis|osteoporosis
5373772|NCT00136058|hip fracture|hip fracture
5373773|NCT00136045|Idiopathic RLS|idiopathic rls
5373774|NCT00136032|Growth Hormone|growth hormone
5373775|NCT00136032|Cardiovascular risk|cardiovascular risk
5373776|NCT00136032|Pituitary|pituitary
5373777|NCT00136032|Hypothalamic|hypothalamic
5373778|NCT00136032|GH Deficiency|gh deficiency
5373779|NCT00136032|Pituitary Tumor|pituitary tumor
5373780|NCT00136032|Pituitary Disease|pituitary disease
5373781|NCT00136019|Epilepsy with partial seizures|epilepsy with partial seizures
5373782|NCT00136006|Epidemiology|epidemiology
5373783|NCT00136006|Lung health|lung health
5373784|NCT00136006|lung function|lung function
5373785|NCT00136006|COPD|copd
5373786|NCT00135993|Idiopathic Restless Leg syndrome|idiopathic restless leg syndrome
5373787|NCT00135967|membranous nephropathy|membranous nephropathy
5373788|NCT00135967|mycophenolate mofetil|mycophenolate mofetil
5373789|NCT00135967|cyclophosphamide|cyclophosphamide
5373790|NCT00135967|prednisone|prednisone
5373791|NCT00135954|membranous nephropathy|membranous nephropathy
5373792|NCT00135954|cyclophosphamide|cyclophosphamide
5373793|NCT00135954|prednisone|prednisone
5373794|NCT00135941|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
5373795|NCT00135928|ST-elevation myocardial infarction|st-elevation myocardial infarction
5373796|NCT00135928|granulocyte-colony stimulating factor angiogenesis|granulocyte-colony stimulating factor angiogenesis
5373797|NCT00135928|stem cells|stem cells
5373798|NCT00135902|Preterm birth|preterm birth
5373799|NCT00135902|Progesterone|progesterone
5373800|NCT00135902|Omega-3 fatty acid|omega-3 fatty acid
5373801|NCT00135902|Pregnancy|pregnancy
5373802|NCT00135889|Total Knee Arthroplasty secondary to osteoarthritis|total knee arthroplasty secondary to osteoarthritis
5373803|NCT00135876|deep vein thrombosis|deep vein thrombosis
5373804|NCT00135876|pulmonary embolism|pulmonary embolism
5373805|NCT00135876|glioma|glioma
5373806|NCT00135876|fragmin|fragmin
5373807|NCT00135876|anticoagulant|anticoagulant
5373808|NCT00135876|prophylaxis|prophylaxis
5373809|NCT00135876|dalteparin|dalteparin
5373810|NCT00135850|Gene therapy|gene therapy
5373811|NCT00135850|VEGF|vegf
5373812|NCT00135850|Stem cells|stem cells
5373813|NCT00135850|myocardial ischemia|myocardial ischemia
5373814|NCT00135850|angiogenesis|angiogenesis
5373815|NCT00135837|Age related Macula Degeneration,|age related macula degeneration,
5373816|NCT00135837|AMD,|amd,
5373817|NCT00135837|choroidal neovascularisation (CNV),|choroidal neovascularisation (cnv),
5373818|NCT00135837|occult CNV lesion,|occult cnv lesion,
5373819|NCT00135837|verteporfin for injection,|verteporfin for injection,
5373820|NCT00135837|photodynamic therapy (PDT)|photodynamic therapy (pdt)
5373821|NCT00135824|Artificial eye drops|artificial eye drops
5373822|NCT00135824|tolerability|tolerability
5373823|NCT00135824|healthy volunteers|healthy volunteers
5373824|NCT00135824|povidone|povidone
5373825|NCT00135824|healthy subjects|healthy subjects
5373826|NCT00135811|Focal Segmental Glomerulosclerosis|focal segmental glomerulosclerosis
5373827|NCT00135798|Hepatitis C|hepatitis c
5373828|NCT00135798|Ribavirin|ribavirin
5373829|NCT00135798|PegInterferon alfa2b|peginterferon alfa2b
5373830|NCT00135772|nicotine dependence|nicotine dependence
5373831|NCT00135759|opiate dependence|opiate dependence
5373832|NCT00135746|tobacco|tobacco
5373833|NCT00135733|Lichen Planus|lichen planus
5373834|NCT00135733|Mucosal lichen planus|mucosal lichen planus
5373835|NCT00135733|Alefacept|alefacept
5373836|NCT00135733|T-cell mediated|t-cell mediated
5373837|NCT00135733|subcutaneous medication|subcutaneous medication
5373838|NCT00135733|Autoimmune disease|autoimmune disease
5373839|NCT00135720|Pemphigus Vulgaris|pemphigus vulgaris
5373840|NCT00135720|Chronic Pemphigus|chronic pemphigus
5373841|NCT00135720|Etanercept|etanercept
5373842|NCT00135720|Enbrel|enbrel
5373843|NCT00135720|anti-TNF-alpha|anti-tnf-alpha
5373844|NCT00135720|TNF-alpha antagonist|tnf-alpha antagonist
5373845|NCT00135720|biologic|biologic
5373846|NCT00135720|immunomodulator|immunomodulator
5373847|NCT00135720|subcutaneous medication|subcutaneous medication
5373848|NCT00135707|Antioxidants|antioxidants
5373849|NCT00135707|Preeclampsia|preeclampsia
5373850|NCT00135707|Pregnancy|pregnancy
5373851|NCT00135707|Hypertension|hypertension
5373852|NCT00135694|hepatitis|hepatitis
5373853|NCT00135694|hepatitis C|hepatitis c
5373854|NCT00135694|HCV|hcv
5373855|NCT00135694|liver|liver
5373856|NCT00135694|liver disease|liver disease
5373857|NCT00135694|liver transplant|liver transplant
5373858|NCT00135694|liver transplantation|liver transplantation
5373859|NCT00135694|transplant|transplant
5373860|NCT00135694|hepatic|hepatic
5373861|NCT00135694|hepatic transplantation|hepatic transplantation
5373862|NCT00135694|immunosuppression|immunosuppression
5373863|NCT00135694|rejection|rejection
5373864|NCT00135668|children|children
5373865|NCT00135668|sodium nitroprusside|sodium nitroprusside
5373866|NCT00135668|controlled hypotension|controlled hypotension
5373867|NCT00135668|dose-response|dose-response
5373868|NCT00135668|pharmacokinetics|pharmacokinetics
5373869|NCT00135668|pharmacodynamics|pharmacodynamics
5373870|NCT00135668|safety|safety
5373871|NCT00135668|efficacy|efficacy
5373872|NCT00135655|macular edema|macular edema
5373873|NCT00135655|post cataract extraction|post cataract extraction
5373874|NCT00135655|cystoid macular edema|cystoid macular edema
5373875|NCT00135655|post cataract extraction macular edema|post cataract extraction macular edema
5373876|NCT00135642|Hayfever|hayfever
5373877|NCT00135642|Subcutaneous Immunotherapy|subcutaneous immunotherapy
5373878|NCT00135642|Grass pollen immunotherapy|grass pollen immunotherapy
5373879|NCT00135642|Seasonal Allergic Rhinoconjunctivitis|seasonal allergic rhinoconjunctivitis
5373880|NCT00135629|Hayfever|hayfever
5373881|NCT00135629|Sublingual Immunotherapy|sublingual immunotherapy
5373882|NCT00135629|Grass pollen immunotherapy|grass pollen immunotherapy
5373883|NCT00135629|Late cutaneous response|late cutaneous response
5373884|NCT00135629|Intradermal allergen challenge|intradermal allergen challenge
5373885|NCT00135629|Seasonal Allergic Rhinoconjunctivitis|seasonal allergic rhinoconjunctivitis
5373886|NCT00135616|urinary incontinence|urinary incontinence
5373887|NCT00135616|stress incontinence|stress incontinence
5373888|NCT00135616|urethra|urethra
5373889|NCT00135616|gynaecologic surgical procedures|gynaecologic surgical procedures
5373890|NCT00135616|suburethral sling|suburethral sling
5373891|NCT00135603|appendicitis.|appendicitis.
5373892|NCT00135603|adult.|adult.
5373893|NCT00135603|treatment.|treatment.
5373894|NCT00135603|antibiotic therapy.|antibiotic therapy.
5373895|NCT00135603|CT scanning.|ct scanning.
5373896|NCT00135603|randomized trial|randomized trial
5373897|NCT00135603|safety|safety
5373898|NCT00135590|Protein pulse-feeding|protein pulse-feeding
5373899|NCT00135590|Nutritional supplementation|nutritional supplementation
5373900|NCT00135590|Protein-energy malnutrition|protein-energy malnutrition
5373901|NCT00135590|Elderly subjects|elderly subjects
5373902|NCT00135590|Body composition|body composition
5373903|NCT00135577|opioids|opioids
5373904|NCT00135577|constipation|constipation
5373905|NCT00135577|opioid-induced bowel dysfunction|opioid-induced bowel dysfunction
5373906|NCT00135564|Haemophilus Influenzae type b/Meningococcal (vaccine)|haemophilus influenzae type b/meningococcal (vaccine)
5373907|NCT00135564|Prophylaxis meningococcal serogroup C disease, Hib diseases|prophylaxis meningococcal serogroup c disease, hib diseases
5373908|NCT00135551|Hypertension|hypertension
5373909|NCT00135551|Multicenter clinical trial|multicenter clinical trial
5373910|NCT00135551|PROBE|probe
5373911|NCT00135551|Combination therapy|combination therapy
5373912|NCT00135551|Benidipine|benidipine
5373913|NCT00135551|Essential Hypertension|essential hypertension
5373914|NCT00135538|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
5373915|NCT00135538|Intermittent Positive-Pressure Ventilation|intermittent positive-pressure ventilation
5373916|NCT00135538|Rehabilitation|rehabilitation
5373917|NCT00135525|Generalized Anxiety Disorder|generalized anxiety disorder
5373918|NCT00135512|MDD|mdd
5373919|NCT00135499|Lymphoma|lymphoma
5373920|NCT00135499|chemotherapy|chemotherapy
5373921|NCT00135499|rituximab|rituximab
5373922|NCT00135486|Haemophilus Influenzae type b/Meningococcal vaccine|haemophilus influenzae type b/meningococcal vaccine
5373923|NCT00135486|Prophylaxis meningococcal serogroup C disease, Hib diseases|prophylaxis meningococcal serogroup c disease, hib diseases
5373924|NCT00135473|Severe sepsis|severe sepsis
5373925|NCT00135473|septic shock|septic shock
5373926|NCT00135473|volume substitution|volume substitution
5373927|NCT00135473|intensive insulin therapy|intensive insulin therapy
5373928|NCT00135473|colloids|colloids
5373929|NCT00135473|crystalloids|crystalloids
5373930|NCT00135473|outcome|outcome
5373931|NCT00135473|safety|safety
5373932|NCT00135460|HIV|hiv
5373933|NCT00135460|Lipoatrophy|lipoatrophy
5373934|NCT00135460|Lipodystrophy|lipodystrophy
5373935|NCT00135460|Treatment Naive|treatment naive
5373936|NCT00135460|HIV Infections|hiv infections
5373937|NCT00135460|Hypercholesterolemia|hypercholesterolemia
5373938|NCT00135447|HIV/AIDS|hiv/aids
5373939|NCT00135447|Treatment Experienced|treatment experienced
5373940|NCT00135408|Unresectable Stage III or IV Malignant Melanoma|unresectable stage iii or iv malignant melanoma
5373941|NCT00135395|HIV/AIDS|hiv/aids
5373942|NCT00135395|Treatment Experienced|treatment experienced
5373943|NCT00135382|HIV/AIDS|hiv/aids
5373944|NCT00135369|HIV-AIDS|hiv-aids
5373945|NCT00135356|HIV infections|hiv infections
5373946|NCT00135343|HIV/AIDS|hiv/aids
5373947|NCT00135330|diabetes|diabetes
5373948|NCT00135330|exenatide|exenatide
5373949|NCT00135330|rosiglitazone|rosiglitazone
5373950|NCT00135330|Amylin|amylin
5373951|NCT00135330|Lilly|lilly
5373952|NCT00135317|oncology|oncology
5373953|NCT00135317|darbepoetin alfa|darbepoetin alfa
5373954|NCT00135317|Aranesp®|aranesp®
5373955|NCT00135317|Amgen|amgen
5373956|NCT00135317|Non-myeloid malignancy|non-myeloid malignancy
5373959|NCT00135304|Cinacalcet HCl|cinacalcet hcl
5373960|NCT00135304|Chronic Kidney Disease|chronic kidney disease
5373961|NCT00135291|transfusion-induced immunomodulation|transfusion-induced immunomodulation
5373962|NCT00135291|leukoreduction|leukoreduction
5373963|NCT00135291|surgical site infections|surgical site infections
5373964|NCT00135291|nosocomial infections|nosocomial infections
5373965|NCT00135291|transfusion|transfusion
5373966|NCT00135291|Infection|infection
5373967|NCT00135291|Sepsis|sepsis
5373968|NCT00135291|Hemorrhage|hemorrhage
5373969|NCT00135278|Neuroprotection|neuroprotection
5373970|NCT00135278|inflammation|inflammation
5373971|NCT00135278|cytokines|cytokines
5373972|NCT00135278|CSF|csf
5373973|NCT00135265|smoking cessation|smoking cessation
5373974|NCT00135265|adolescents|adolescents
5373975|NCT00135252|developing chronic lung disease|developing chronic lung disease
5373976|NCT00135239|back|back
5373977|NCT00135239|Lower Mechanical Back Pain|lower mechanical back pain
5373978|NCT00135239|Rehabilitation|rehabilitation
5373979|NCT00135226|Diabetes Mellitus|diabetes mellitus
5373980|NCT00135226|Cardiovascular Disease|cardiovascular disease
5373981|NCT00135226|Aspirin|aspirin
5373982|NCT00135226|Omega-3 fatty acids|omega-3 fatty acids
5373983|NCT00135226|Primary prevention|primary prevention
5373984|NCT00135226|Randomized Controlled Trial|randomized controlled trial
5373985|NCT00135226|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
5373986|NCT00135226|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
5373987|NCT00135213|passive smoking|passive smoking
5373988|NCT00135213|pediatric practice|pediatric practice
5373989|NCT00135213|smoking cessation|smoking cessation
5373990|NCT00135174|Pacemaker|pacemaker
5373991|NCT00135174|routine|routine
5373992|NCT00135174|follow-up|follow-up
5373993|NCT00135174|complications|complications
5373994|NCT00135174|Quality of Life|quality of life
5373995|NCT00135161|neoplasms (squamous cell carcinoma of the head and neck region)|neoplasms (squamous cell carcinoma of the head and neck region)
5373996|NCT00135135|Cancer|cancer
5373997|NCT00135135|Childhood Tumor|childhood tumor
5373998|NCT00135135|Neoplasms|neoplasms
5373999|NCT00135122|migraine|migraine
5374000|NCT00135122|analgesics|analgesics
5374001|NCT00135122|tension type headache|tension type headache
5374002|NCT00135070|Diabetes Mellitus|diabetes mellitus
5374003|NCT00135044|taurine|taurine
5374004|NCT00135044|intestinal failure|intestinal failure
5374005|NCT00135044|HPN|hpn
5374006|NCT00135044|hepatobiliary complications|hepatobiliary complications
5374007|NCT00135044|chronic intestinal failure (CIF)|chronic intestinal failure (cif)
5374008|NCT00135005|GIST|gist
5374009|NCT00135005|AMN107|amn107
5374010|NCT00135005|Gastrointestinal Stromal Tumors|gastrointestinal stromal tumors
5374011|NCT00134992|Prednisolone acetate|prednisolone acetate
5374012|NCT00134992|eye drops|eye drops
5374013|NCT00134992|tolerability|tolerability
5374014|NCT00134992|Healthy volunteers|healthy volunteers
5374015|NCT00134979|COPD, formoterol,|copd, formoterol,
5374016|NCT00134966|Parkinson's disease, levodopa, dyskinesia|parkinson's disease, levodopa, dyskinesia
5374017|NCT00134953|Mild cognitive impairment|mild cognitive impairment
5374018|NCT00134953|Alzheimer's disease|alzheimer's disease
5374019|NCT00134953|Dementia|dementia
5374020|NCT00134953|Mild Cognitive Impairment (MCI)|mild cognitive impairment (mci)
5374021|NCT00134940|Transplantation, heart|transplantation, heart
5374022|NCT00134940|Organ transplant|organ transplant
5374023|NCT00134914|opiate dependence|opiate dependence
5374024|NCT00134901|Cocaine dependence|cocaine dependence
5374025|NCT00134901|treatment|treatment
5374026|NCT00134901|memantine|memantine
5374027|NCT00134888|Opioid Dependence|opioid dependence
5374028|NCT00134875|opioid dependence|opioid dependence
5374029|NCT00134849|hypertension|hypertension
5374030|NCT00134823|Parent Experience of Care|parent experience of care
5374031|NCT00134823|Quality Improvement|quality improvement
5374032|NCT00134823|Medication Errors|medication errors
5374033|NCT00134823|Abnormal Lab Values|abnormal lab values
5374034|NCT00134823|Guideline Adherence|guideline adherence
5374035|NCT00134810|Myofascial pain syndrome|myofascial pain syndrome
5374036|NCT00134797|GFR|gfr
5374037|NCT00134797|serum creatinine|serum creatinine
5374038|NCT00134784|parkinson|parkinson
5374039|NCT00134784|brain imaging|brain imaging
5374040|NCT00134771|Infants whose birthweight is less than the 20th centile for gestational age (UK standards)|infants whose birthweight is less than the 20th centile for gestational age (uk standards)
5374041|NCT00134771|Infants who are formula fed from birth|infants who are formula fed from birth
5374042|NCT00134771|Singletons|singletons
5374043|NCT00134771|Infants free from major congenital disease|infants free from major congenital disease
5374044|NCT00134758|Treatment of adenomas of the duodenum in FAP patients.|treatment of adenomas of the duodenum in fap patients.
5374045|NCT00134758|Adenoma|adenoma
5374046|NCT00134745|Turner Syndrome|turner syndrome
5374047|NCT00134745|Hormonal replacement therapy|hormonal replacement therapy
5374048|NCT00134745|Bone mineralization|bone mineralization
5374049|NCT00134745|Uterine size|uterine size
5374050|NCT00134745|aortic root dilatation|aortic root dilatation
5374051|NCT00134732|Prophylaxis of Rotavirus Gastroenteritis|prophylaxis of rotavirus gastroenteritis
5374052|NCT00134719|Invasive Hib & N. meningitidis diseases|invasive hib & n. meningitidis diseases
5374053|NCT00134706|Prostate Cancer|prostate cancer
5374054|NCT00134706|Cancer of the prostate|cancer of the prostate
5374055|NCT00134706|Cancer of prostate|cancer of prostate
5374056|NCT00134706|Docetaxel|docetaxel
5374057|NCT00134706|Carboplatin|carboplatin
5374058|NCT00134693|SB-681323 rheumatoid arthritis CRP biomarkers|sb-681323 rheumatoid arthritis crp biomarkers
5374059|NCT00134680|estrogen receptor positive|estrogen receptor positive
5374060|NCT00134680|progesterone receptor positive|progesterone receptor positive
5374061|NCT00134680|ErbB2 positive|erbb2 positive
5374062|NCT00134680|metastatic breast cancer|metastatic breast cancer
5374063|NCT00134667|AMD|amd
5374064|NCT00134667|Age-Related Macular Degeneration|age-related macular degeneration
5374065|NCT00134667|Macular Degeneration|macular degeneration
5374066|NCT00134667|Macugen|macugen
5374067|NCT00134667|Photodynamic Therapy|photodynamic therapy
5374068|NCT00134667|PDT|pdt
5374069|NCT00134667|Visudyne|visudyne
5374070|NCT00134667|pegaptanib sodium|pegaptanib sodium
5374071|NCT00134667|verteporfin|verteporfin
5374072|NCT00134667|Predominantly Classic|predominantly classic
5374073|NCT00134667|Age-Related Macular Degeneration (AMD)|age-related macular degeneration (amd)
5374074|NCT00134654|Androgen-independent prostate cancer|androgen-independent prostate cancer
5374075|NCT00134654|Premarin|premarin
5374076|NCT00134654|conjugated estrogen|conjugated estrogen
5374077|NCT00134641|soft tissue sarcoma|soft tissue sarcoma
5374078|NCT00134641|metastatic soft tissue sarcoma|metastatic soft tissue sarcoma
5374079|NCT00134641|gemcitabine|gemcitabine
5374080|NCT00134641|vinorelbine|vinorelbine
5374081|NCT00134628|Hyperbaric Oxygenation|hyperbaric oxygenation
5374082|NCT00134628|Radiation injuries|radiation injuries
5374083|NCT00134628|Prophylaxis|prophylaxis
5374084|NCT00134628|Proctitis|proctitis
5374085|NCT00134628|Cystitis|cystitis
5374086|NCT00134628|Enteritis|enteritis
5374087|NCT00134628|Osteoradionecrosis|osteoradionecrosis
5374088|NCT00134615|decision-making|decision-making
5374089|NCT00134615|patient activation|patient activation
5374090|NCT00134615|empowerment|empowerment
5374091|NCT00134615|mental health|mental health
5374092|NCT00134615|Depression|depression
5374093|NCT00134615|Anxiety|anxiety
5374094|NCT00134615|Other Psychiatric Disorder|other psychiatric disorder
5374095|NCT00134602|HIV infection, antiretroviral therapy, adherence, pediatric|hiv infection, antiretroviral therapy, adherence, pediatric
5374096|NCT00134589|Academic Detailing|academic detailing
5374097|NCT00134589|Decision Aid|decision aid
5374098|NCT00134589|Colorectal Cancer Screening|colorectal cancer screening
5374099|NCT00134589|RECTAL NEOPLASMS|rectal neoplasms
5374100|NCT00134589|COLONIC POLYPS|colonic polyps
5374101|NCT00134563|Multiple Sclerosis|multiple sclerosis
5374102|NCT00134563|Relapsing Remitting|relapsing remitting
5374103|NCT00134563|Secondary Progressive|secondary progressive
5374104|NCT00134563|Progressive Relapsing|progressive relapsing
5374105|NCT00134550|Diabetes Mellitus|diabetes mellitus
5374106|NCT00134550|Foot ulcers|foot ulcers
5374107|NCT00134550|Complication|complication
5374108|NCT00134550|Foot Ulcer, Diabetic|foot ulcer, diabetic
5374109|NCT00134537|Degenerative Disc Disease of the lumbar spine|degenerative disc disease of the lumbar spine
5374110|NCT00134524|Magnetics|magnetics
5374111|NCT00134524|Electromagnetics|electromagnetics
5374112|NCT00134524|Diabetic neuropathy|diabetic neuropathy
5374113|NCT00134524|Pain|pain
5374114|NCT00134472|Hypothermia, induced|hypothermia, induced
5374115|NCT00134472|Traumatic Brain injuries|traumatic brain injuries
5374116|NCT00134472|Anesthesia|anesthesia
5374117|NCT00134472|Neuro-intensive care|neuro-intensive care
5374118|NCT00134472|neurochemistry|neurochemistry
5374119|NCT00134459|Depression|depression
5374120|NCT00134459|Bipolar Disorder|bipolar disorder
5374121|NCT00134446|post traumatic stress disorder|post traumatic stress disorder
5374122|NCT00134446|PTSD|ptsd
5374123|NCT00134446|trauma|trauma
5374124|NCT00134446|transcranial magnetic stimulation|transcranial magnetic stimulation
5374125|NCT00134446|randomized clinical trial|randomized clinical trial
5374126|NCT00134433|Coronary Artery Disease, Diffuse|coronary artery disease, diffuse
5374127|NCT00134433|Coronary Artery Disease, Deemed Inoperable|coronary artery disease, deemed inoperable
5374128|NCT00134420|Growth Hormone|growth hormone
5374129|NCT00134420|Chromosomes, Human, Pair 18|chromosomes, human, pair 18
5374130|NCT00134420|Child|child
5374131|NCT00134407|Nutrition|nutrition
5374132|NCT00134407|Postoperative|postoperative
5374133|NCT00134407|oral|oral
5374134|NCT00134407|jejunal|jejunal
5374135|NCT00134407|feeding|feeding
5374136|NCT00134407|Surgery|surgery
5374137|NCT00134407|major|major
5374138|NCT00134407|abdominal|abdominal
5374139|NCT00134407|adult|adult
5374140|NCT00134394|psoriasis|psoriasis
5374141|NCT00134394|tacrolimus|tacrolimus
5374142|NCT00134394|etanercept|etanercept
5374143|NCT00134381|Normal volunteer study|normal volunteer study
5374144|NCT00134368|vitiligo|vitiligo
5374145|NCT00134368|etanercept|etanercept
5374146|NCT00134355|antiangiogenesis therapy|antiangiogenesis therapy
5374147|NCT00134355|vatalanib|vatalanib
5374148|NCT00134342|tuberculosis|tuberculosis
5374149|NCT00134342|tuberculin test|tuberculin test
5374150|NCT00134342|immunologic tests|immunologic tests
5374429|NCT00133744|pregnancy|pregnancy
5374151|NCT00134342|Latent tuberculosis|latent tuberculosis
5374152|NCT00134342|end stage renal disease|end stage renal disease
5374153|NCT00134342|solid organ transplantation|solid organ transplantation
5374154|NCT00134342|bone marrow transplantation|bone marrow transplantation
5374155|NCT00134342|rheumatologic disease|rheumatologic disease
5374156|NCT00134316|sexual dysfunction|sexual dysfunction
5374157|NCT00134251|Parkinson's disease|parkinson's disease
5374158|NCT00134251|adjunctive to L-dopa therapy|adjunctive to l-dopa therapy
5374159|NCT00134251|Advanced stage Parkinson's disease|advanced stage parkinson's disease
5374160|NCT00134225|Musculoskeletal abnormality|musculoskeletal abnormality
5374161|NCT00134225|Musculoskeletal physiology|musculoskeletal physiology
5374162|NCT00134225|Musculoskeletal disease|musculoskeletal disease
5374163|NCT00134225|Musculoskeletal dysfunction|musculoskeletal dysfunction
5374164|NCT00134212|Splanchnic perfusion, hepatic damage, oxidative stress.|splanchnic perfusion, hepatic damage, oxidative stress.
5374165|NCT00134186|Kidney cancer|kidney cancer
5374166|NCT00134186|Renal cell carcinoma|renal cell carcinoma
5374167|NCT00134186|Motexafin gadolinium|motexafin gadolinium
5374168|NCT00134160|Aged|aged
5374169|NCT00134160|Hypertension|hypertension
5374170|NCT00134160|Cardiovascular Diseases|cardiovascular diseases
5374171|NCT00134160|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers
5374172|NCT00134160|Calcium Channel Blockers|calcium channel blockers
5374173|NCT00134160|Combination Drug Therapy|combination drug therapy
5374174|NCT00134160|Diabetes Mellitus Type 2|diabetes mellitus type 2
5374175|NCT00134134|hidradenitis suppurativa|hidradenitis suppurativa
5374176|NCT00134134|efalizumab|efalizumab
5374177|NCT00134134|biologic|biologic
5374178|NCT00134134|Raptiva|raptiva
5374179|NCT00134095|adenocarcinoma of the stomach|adenocarcinoma of the stomach
5374180|NCT00134095|stage II gastric cancer|stage ii gastric cancer
5374181|NCT00134095|stage III gastric cancer|stage iii gastric cancer
5374182|NCT00134095|stage IV gastric cancer|stage iv gastric cancer
5374183|NCT00134082|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5374184|NCT00134056|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5374185|NCT00134056|stage IV prostate cancer|stage iv prostate cancer
5374186|NCT00134056|recurrent prostate cancer|recurrent prostate cancer
5374187|NCT00134056|bone metastases|bone metastases
5374188|NCT00134017|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5374189|NCT00134017|refractory anemia with excess blasts|refractory anemia with excess blasts
5374190|NCT00134017|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5374191|NCT00134017|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5374192|NCT00134017|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5374193|NCT00134017|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5374194|NCT00134017|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5374195|NCT00134017|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
5374196|NCT00134017|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5374197|NCT00134017|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5374198|NCT00134017|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5374199|NCT00134017|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5374200|NCT00134017|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5374201|NCT00134017|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
5374202|NCT00134017|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5374203|NCT00134017|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5374204|NCT00134017|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5374205|NCT00134017|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5374206|NCT00134017|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
5374207|NCT00134017|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5374208|NCT00134017|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5374209|NCT00134017|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5374210|NCT00134017|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5374211|NCT00134017|chronic eosinophilic leukemia|chronic eosinophilic leukemia
5374212|NCT00134017|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
5374213|NCT00134017|chronic neutrophilic leukemia|chronic neutrophilic leukemia
5374214|NCT00134017|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5374215|NCT00134017|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5374216|NCT00134017|stage II multiple myeloma|stage ii multiple myeloma
5374217|NCT00134017|stage III multiple myeloma|stage iii multiple myeloma
5374218|NCT00134017|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5374219|NCT00134017|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5374220|NCT00134017|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5374221|NCT00134017|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
5374222|NCT00134017|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5374223|NCT00134017|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
5374224|NCT00134017|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
5374225|NCT00134017|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
5374226|NCT00134017|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
5374227|NCT00134017|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5374228|NCT00134017|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5374229|NCT00134017|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5374230|NCT00134017|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5374231|NCT00134017|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
5374232|NCT00134017|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
5374233|NCT00134017|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5374234|NCT00134017|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5374235|NCT00134017|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5374437|NCT00133744|birthweight|birthweight
5374236|NCT00134017|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5374237|NCT00134017|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5374238|NCT00134017|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5374239|NCT00134017|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5374240|NCT00134017|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
5374241|NCT00134017|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
5374242|NCT00134017|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5374243|NCT00134017|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5374244|NCT00134017|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5374245|NCT00134017|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5374246|NCT00134017|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
5374247|NCT00134017|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
5374248|NCT00134017|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5374249|NCT00134017|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5374250|NCT00134017|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5374251|NCT00134017|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5374252|NCT00134017|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5374253|NCT00134017|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5374254|NCT00134017|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5374255|NCT00134017|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5374256|NCT00134017|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5374257|NCT00134017|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5374258|NCT00134017|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5374259|NCT00134017|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5374260|NCT00134017|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5374261|NCT00134017|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5374262|NCT00134017|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5374263|NCT00134017|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5374264|NCT00134017|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5374265|NCT00134017|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5374266|NCT00134017|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5374267|NCT00134017|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5374268|NCT00134017|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5374269|NCT00134017|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5374270|NCT00134017|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5374271|NCT00134017|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5374272|NCT00134017|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5374273|NCT00134017|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5374274|NCT00134017|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5374275|NCT00134017|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5374276|NCT00134017|refractory multiple myeloma|refractory multiple myeloma
5374277|NCT00134017|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5374278|NCT00134017|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5374279|NCT00134017|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
5374280|NCT00134004|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5374281|NCT00134004|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5374282|NCT00134004|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
5374283|NCT00134004|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
5374430|NCT00133744|vitamins|vitamins
5374284|NCT00134004|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
5374285|NCT00134004|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5374286|NCT00134004|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5374287|NCT00134004|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5374288|NCT00134004|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5374289|NCT00134004|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5374290|NCT00134004|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5374291|NCT00134004|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5374292|NCT00134004|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5374293|NCT00134004|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
5374294|NCT00134004|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5374295|NCT00134004|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5374296|NCT00134004|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5374297|NCT00134004|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
5374298|NCT00134004|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5374299|NCT00134004|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
5374300|NCT00134004|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
5374301|NCT00134004|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
5374302|NCT00134004|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
5374303|NCT00134004|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5374304|NCT00134004|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5374305|NCT00134004|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5374306|NCT00134004|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5374307|NCT00134004|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
5374308|NCT00134004|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
5374309|NCT00134004|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5374310|NCT00134004|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5374311|NCT00134004|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5374312|NCT00134004|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5374313|NCT00134004|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5374314|NCT00134004|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5374315|NCT00134004|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5374316|NCT00134004|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
5374317|NCT00134004|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
5374318|NCT00134004|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
5374319|NCT00134004|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
5374320|NCT00134004|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5374321|NCT00134004|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5374322|NCT00134004|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5374323|NCT00134004|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5374324|NCT00134004|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5374325|NCT00134004|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5374326|NCT00134004|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5374327|NCT00134004|refractory multiple myeloma|refractory multiple myeloma
5374328|NCT00134004|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5374329|NCT00134004|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5374330|NCT00134004|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5374331|NCT00134004|stage I multiple myeloma|stage i multiple myeloma
5374332|NCT00134004|stage II multiple myeloma|stage ii multiple myeloma
5374333|NCT00134004|stage III multiple myeloma|stage iii multiple myeloma
5374334|NCT00134004|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5374335|NCT00134004|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5374336|NCT00134004|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5374337|NCT00134004|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5374338|NCT00134004|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5374339|NCT00134004|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5374340|NCT00134004|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5374341|NCT00134004|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5374342|NCT00134004|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5374343|NCT00134004|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5374344|NCT00134004|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5374431|NCT00133744|minerals|minerals
5374345|NCT00134004|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5374346|NCT00134004|polycythemia vera|polycythemia vera
5374347|NCT00134004|essential thrombocythemia|essential thrombocythemia
5374348|NCT00134004|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5374349|NCT00134004|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5374350|NCT00134004|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5374351|NCT00134004|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5374352|NCT00134004|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5374353|NCT00134004|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5374354|NCT00134004|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5374355|NCT00134004|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5374356|NCT00134004|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5374357|NCT00134004|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5374358|NCT00134004|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5374359|NCT00134004|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5374360|NCT00134004|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5374361|NCT00134004|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5374362|NCT00134004|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
5374363|NCT00133991|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
5374364|NCT00133991|L3 adult acute lymphoblastic leukemia|l3 adult acute lymphoblastic leukemia
5374365|NCT00133991|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
5374366|NCT00133991|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
5374367|NCT00133991|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
5374368|NCT00133991|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5374369|NCT00133991|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5374370|NCT00133978|randomized trial|randomized trial
5374371|NCT00133978|antioxidants|antioxidants
5374372|NCT00133978|glutamine|glutamine
5374373|NCT00133978|organ failure|organ failure
5374374|NCT00133965|Advanced Cancer|advanced cancer
5374375|NCT00133965|Dignity Care|dignity care
5374376|NCT00133965|Supportive Care|supportive care
5374377|NCT00133965|Quality of Life|quality of life
5374378|NCT00133965|Psychotherapy|psychotherapy
5374379|NCT00133965|Palliative Care|palliative care
5374380|NCT00133939|Proportional assisted ventilation|proportional assisted ventilation
5374381|NCT00133939|Pressure support ventilation|pressure support ventilation
5374382|NCT00133939|Synchronism during mechanical ventilation|synchronism during mechanical ventilation
5374383|NCT00133939|Patients undergoing partial mechanical ventilation|patients undergoing partial mechanical ventilation
5374384|NCT00133926|Periodontal disease|periodontal disease
5374385|NCT00133926|Pregnancy|pregnancy
5374386|NCT00133926|Pre-term birth|pre-term birth
5374387|NCT00133926|Fetal growth|fetal growth
5374388|NCT00133926|Pre-eclampsia|pre-eclampsia
5374389|NCT00133926|Infant, Low Birth Weight|infant, low birth weight
5374390|NCT00133913|metastatic colorectal cancer|metastatic colorectal cancer
5374391|NCT00133900|hormone refractory prostate cancer|hormone refractory prostate cancer
5374392|NCT00133887|Squamous cell carcinoma|squamous cell carcinoma
5374393|NCT00133887|kidney transplant recipients|kidney transplant recipients
5374394|NCT00133887|rapamycin|rapamycin
5374395|NCT00133887|Skin cancers in kidney transplant recipients|skin cancers in kidney transplant recipients
5374396|NCT00133874|topical antibacterial|topical antibacterial
5374397|NCT00133874|topical antibiotic|topical antibiotic
5374398|NCT00133874|impetigo|impetigo
5374399|NCT00133861|cerebral palsy children|cerebral palsy children
5374400|NCT00133861|Botulinum toxin|botulinum toxin
5374401|NCT00133848|impetigo|impetigo
5374402|NCT00133848|topical antibacterial|topical antibacterial
5374403|NCT00133848|topical antibiotic|topical antibiotic
5374404|NCT00133835|Randomized controlled trial|randomized controlled trial
5374405|NCT00133835|Lithotripsy|lithotripsy
5374406|NCT00133835|Cholangiopancreatography, Endoscopic Retrograde|cholangiopancreatography, endoscopic retrograde
5374407|NCT00133835|Abdominal pain|abdominal pain
5374408|NCT00133822|Post-Traumatic Stress Disorder|post-traumatic stress disorder
5374409|NCT00133822|Sertraline|sertraline
5374410|NCT00133822|Risperidone|risperidone
5374411|NCT00133809|Type 1 Diabetes|type 1 diabetes
5374412|NCT00133809|Islet Transplantation|islet transplantation
5374413|NCT00133809|Immunology|immunology
5374414|NCT00133796|Breast Cancer|breast cancer
5374415|NCT00133796|Advanced Breast Cancer|advanced breast cancer
5374416|NCT00133783|Intermedin|intermedin
5374417|NCT00133783|estradiol|estradiol
5374418|NCT00133783|female hypertension|female hypertension
5374419|NCT00133783|Premenopausal and postmenopausal women|premenopausal and postmenopausal women
5374420|NCT00133783|Surgically-induced menopause women|surgically-induced menopause women
5374421|NCT00133783|IVF treatment patients|ivf treatment patients
5374422|NCT00133770|IV pantoprazole|iv pantoprazole
5374423|NCT00133770|Esophagitis|esophagitis
5374424|NCT00133757|Tobacco|tobacco
5374425|NCT00133757|Nicotine|nicotine
5374426|NCT00133757|Bupropion|bupropion
5374427|NCT00133757|Cue-reactivity|cue-reactivity
5374428|NCT00133757|Craving|craving
5374432|NCT00133744|supplements|supplements
5374433|NCT00133744|mortality|mortality
5374434|NCT00133744|prenatal|prenatal
5374435|NCT00133744|perinatal|perinatal
5374436|NCT00133744|anemia|anemia
5374438|NCT00133744|preterm|preterm
5374439|NCT00133744|iron|iron
5374440|NCT00133744|micronutrients|micronutrients
5374441|NCT00133744|Stillbirths|stillbirths
5374442|NCT00133744|Early neonatal deaths|early neonatal deaths
5374443|NCT00133718|Type 2 diabetes mellitus|type 2 diabetes mellitus
5374444|NCT00133718|Cardiovascular|cardiovascular
5374445|NCT00133718|Coronary artery disease|coronary artery disease
5374446|NCT00133718|Glycemic control|glycemic control
5374447|NCT00133718|Treatment|treatment
5374448|NCT00133718|Diabetes Mellitus|diabetes mellitus
5374449|NCT00133705|A benign tumor derived from smooth uterine muscle tissue.|a benign tumor derived from smooth uterine muscle tissue.
5374450|NCT00133692|Hypertension|hypertension
5374451|NCT00133692|Coronary Artery Disease|coronary artery disease
5374452|NCT00133692|INVEST|invest
5374453|NCT00133692|Diabetes|diabetes
5374454|NCT00133692|Verapamil SR|verapamil sr
5374455|NCT00133692|Trandolapril|trandolapril
5374456|NCT00133692|Atenolol|atenolol
5374457|NCT00133692|HCTZ|hctz
5374458|NCT00133679|Chronic lung disease|chronic lung disease
5374459|NCT00133679|Nitric oxide|nitric oxide
5374460|NCT00133679|cyclic guanosine monophosphate|cyclic guanosine monophosphate
5374461|NCT00133679|phosphodiesterase inhibitor|phosphodiesterase inhibitor
5374462|NCT00133653|Hypertension; Job Strain; Marital Strain; Blood Pressure|hypertension; job strain; marital strain; blood pressure
5374463|NCT00133640|Vitamin D|vitamin d
5374464|NCT00133640|Elderly|elderly
5374465|NCT00133640|Hip fracture|hip fracture
5374466|NCT00133640|Falls|falls
5374467|NCT00133640|Physical Therapy|physical therapy
5374468|NCT00133640|Disability|disability
5374469|NCT00133627|Allergic|allergic
5374470|NCT00133627|Conjunctivitis|conjunctivitis
5374471|NCT00133627|Ketotifen|ketotifen
5374472|NCT00133627|Histamine|histamine
5374473|NCT00133588|influenza, vaccine, proteomic profiling, elderly|influenza, vaccine, proteomic profiling, elderly
5374474|NCT00133575|MVA, smallpox, Acambis|mva, smallpox, acambis
5374475|NCT00133562|Malnutrition, pediatric, Brazil, alanyl-glutamine|malnutrition, pediatric, brazil, alanyl-glutamine
5374476|NCT00133549|pneumococcal vaccine, 23-valent polysaccharide vaccine, elderly|pneumococcal vaccine, 23-valent polysaccharide vaccine, elderly
5374477|NCT00133536|H5N1, Influenza, children|h5n1, influenza, children
5374478|NCT00133523|FLU-VACS, influenza, vaccine|flu-vacs, influenza, vaccine
5374479|NCT00133510|children, immunocompromised, influenza, liver transplant|children, immunocompromised, influenza, liver transplant
5374480|NCT00133497|cytomegalovirus, vaccine, women, children, parent protocol|cytomegalovirus, vaccine, women, children, parent protocol
5374481|NCT00133484|Anthrax, rPA|anthrax, rpa
5374482|NCT00133471|Influenza, vaccine, A/H9N2, MF59, adjuvant|influenza, vaccine, a/h9n2, mf59, adjuvant
5374483|NCT00133458|Albenza, Subarachnoid cysticercosis|albenza, subarachnoid cysticercosis
5374484|NCT00133445|Pentavalent vaccine, Pediarix, DTaP-Hep B-IPV vaccine|pentavalent vaccine, pediarix, dtap-hep b-ipv vaccine
5374485|NCT00133432|Pneumonia, acute respiratory infections, zinc, Tanzania, children, infants, hospitalization|pneumonia, acute respiratory infections, zinc, tanzania, children, infants, hospitalization
5374486|NCT00133419|micronutrient, supplementation, Africa, children, HIV|micronutrient, supplementation, africa, children, hiv
5374487|NCT00133406|Brazil, Child Nutrition Disorders, Deficiency Diseases|brazil, child nutrition disorders, deficiency diseases
5374488|NCT00133367|Hematologic malignancy|hematologic malignancy
5374489|NCT00133367|Cord blood transfusion|cord blood transfusion
5374490|NCT00133367|Graft versus host disease|graft versus host disease
5374491|NCT00133367|tacrolimus|tacrolimus
5374492|NCT00133367|sirolimus|sirolimus
5374493|NCT00133354|Puberty|puberty
5374494|NCT00133354|Growth hormone deficiency|growth hormone deficiency
5374495|NCT00133354|aromatase inhibitors|aromatase inhibitors
5374496|NCT00133354|estrogen|estrogen
5374497|NCT00133354|bone mineral density|bone mineral density
5374498|NCT00133354|short stature|short stature
5374499|NCT00133341|Allergic contact dermatitis,patch testing, dilution series|allergic contact dermatitis,patch testing, dilution series
5374500|NCT00133328|stroke|stroke
5374501|NCT00133328|myocardial infarction|myocardial infarction
5374502|NCT00133328|angina|angina
5374503|NCT00133328|renal damage|renal damage
5374504|NCT00133302|Non-Hodgkin's lymphoma|non-hodgkin's lymphoma
5374505|NCT00133302|intermediate-grade lymphoma|intermediate-grade lymphoma
5374506|NCT00133302|high-grade lymphoma|high-grade lymphoma
5374507|NCT00133302|CHOP protocol|chop protocol
5374508|NCT00133302|granulocyte-colony stimulating factor|granulocyte-colony stimulating factor
5374509|NCT00133276|Hepatitis C|hepatitis c
5374510|NCT00133276|Peg-interferon|peg-interferon
5374511|NCT00133276|Psychiatric side-effects|psychiatric side-effects
5374512|NCT00133263|Randomized controlled trial|randomized controlled trial
5374513|NCT00133263|Primary Care|primary care
5374514|NCT00133224|Advanced Prostate Cancer|advanced prostate cancer
5374515|NCT00133224|HRPC|hrpc
5374516|NCT00133224|Prostate|prostate
5374517|NCT00133224|Cancer|cancer
5374518|NCT00133224|Metastatic|metastatic
5374519|NCT00133224|Hormone-refractory|hormone-refractory
5374520|NCT00133224|GVAX|gvax
5374521|NCT00133224|Chemotherapy|chemotherapy
5374522|NCT00133224|Taxotere|taxotere
5374523|NCT00133224|Docetaxel|docetaxel
5374524|NCT00133224|Prednisone|prednisone
5374525|NCT00133224|Vaccine|vaccine
5374526|NCT00133224|Allogeneic cells|allogeneic cells
5374527|NCT00133211|Paroxysmal atrial fibrillation|paroxysmal atrial fibrillation
5374528|NCT00133211|Heart arrhythmia|heart arrhythmia
5374529|NCT00133211|Ablation|ablation
5374530|NCT00133211|Drug treatment|drug treatment
5374531|NCT00133172|Treatment Efficacy|treatment efficacy
5374532|NCT00133172|Treatment Effectiveness|treatment effectiveness
5374533|NCT00133172|Anti-rejection therapy|anti-rejection therapy
5374534|NCT00133172|Immunosuppression|immunosuppression
5374535|NCT00133172|Antirejection|antirejection
5374536|NCT00133172|Renal Transplantation|renal transplantation
5374537|NCT00133172|Transplantation, Renal|transplantation, renal
5374538|NCT00133172|Transplantation, Kidney|transplantation, kidney
5374539|NCT00133172|Grafting, Kidney|grafting, kidney
5374540|NCT00133159|Allergy|allergy
5374541|NCT00133159|Specific Immunotherapy|specific immunotherapy
5374542|NCT00133146|Allergy|allergy
5374543|NCT00133146|Specific Immunotherapy|specific immunotherapy
5374544|NCT00133133|Postoperative pain|postoperative pain
5374545|NCT00133133|Open cholecystectomy|open cholecystectomy
5374546|NCT00133133|Capsaicin|capsaicin
5374547|NCT00133094|Hypercholesterolemia|hypercholesterolemia
5374548|NCT00133094|Decision Support Systems, Clinical|decision support systems, clinical
5374549|NCT00133081|epilepsy|epilepsy
5374550|NCT00133081|antiepileptic drugs|antiepileptic drugs
5374551|NCT00133081|side effects|side effects
5374552|NCT00133081|quality of life|quality of life
5374553|NCT00133068|High Blood Pressure|high blood pressure
5374554|NCT00133068|Health Behaviors|health behaviors
5374555|NCT00133068|Patient Compliance|patient compliance
5374556|NCT00133055|parenting|parenting
5374557|NCT00133055|sleep problems|sleep problems
5374558|NCT00133055|behavior problems|behavior problems
5374559|NCT00133055|brief intervention|brief intervention
5374560|NCT00133055|self-help|self-help
5374561|NCT00133055|preschool-age children|preschool-age children
5374562|NCT00133055|psychosocial|psychosocial
5374563|NCT00133042|anti-IgE, omalizumab|anti-ige, omalizumab
5374564|NCT00133016|Induction of labor|induction of labor
5374565|NCT00132990|Cervical dystonia|cervical dystonia
5374566|NCT00132990|Deep brain stimulation|deep brain stimulation
5374567|NCT00132977|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
5374568|NCT00132977|Heart Failure|heart failure
5374569|NCT00132977|Mechanical Dyssynchrony|mechanical dyssynchrony
5374570|NCT00132964|pediatric|pediatric
5374571|NCT00132964|ankle fractures|ankle fractures
5374572|NCT00132964|randomized controlled trial|randomized controlled trial
5374573|NCT00132964|management|management
5374574|NCT00132925|allergic rhinitis|allergic rhinitis
5374575|NCT00132912|Platelets|platelets
5374576|NCT00132912|Platelet Aggregation Inhibitors|platelet aggregation inhibitors
5374577|NCT00132912|Protease-Activated Receptor 1|protease-activated receptor 1
5374578|NCT00132912|Hemorrhage|hemorrhage
5374579|NCT00132899|Crohn's Disease|crohn's disease
5374580|NCT00132899|multi-centre randomized placebo-controlled|multi-centre randomized placebo-controlled
5374581|NCT00132899|infliximab|infliximab
5374582|NCT00132899|methotrexate|methotrexate
5374583|NCT00132899|inflammatory bowel disease|inflammatory bowel disease
5374584|NCT00132873|Narcolepsy|narcolepsy
5374585|NCT00132873|Cataplexy|cataplexy
5374586|NCT00132847|Child|child
5374587|NCT00132847|Adolescent|adolescent
5374588|NCT00132847|Urban Health|urban health
5374589|NCT00132821|Nicotine dependence|nicotine dependence
5374590|NCT00132821|Sleep disorders|sleep disorders
5374591|NCT00132821|smoking cessation|smoking cessation
5374592|NCT00132821|Relapse|relapse
5374593|NCT00132808|Postmenopausal osteoporosis|postmenopausal osteoporosis
5374594|NCT00132808|osteopenia|osteopenia
5374595|NCT00132808|zoledronic acid|zoledronic acid
5374596|NCT00132808|Osteopenia (osteoporosis prevention)|osteopenia (osteoporosis prevention)
5374597|NCT00132795|Cognitive Therapy|cognitive therapy
5374598|NCT00132795|Recurrence|recurrence
5374599|NCT00132795|Prevention|prevention
5374600|NCT00132795|Educational Technology|educational technology
5374601|NCT00132756|Hormone Refractory|hormone refractory
5374602|NCT00132756|Taxane Refractory|taxane refractory
5374603|NCT00132704|Lung cancer metastases to the CNS (adenocarcinomas)|lung cancer metastases to the cns (adenocarcinomas)
5374604|NCT00132704|Melanoma metastases to the CNS|melanoma metastases to the cns
5374605|NCT00132704|Breast cancer metastases to the CNS (ductal carcinomas)|breast cancer metastases to the cns (ductal carcinomas)
5374606|NCT00132704|Central nervous system gliomas|central nervous system gliomas
5374607|NCT00132704|Colorectal cancers (adenocarcinomas)|colorectal cancers (adenocarcinomas)
5374608|NCT00132704|Ovarian cancers (papillary serous carcinomas)|ovarian cancers (papillary serous carcinomas)
5374609|NCT00132704|Endometrial cancers (endometrioid carcinomas)|endometrial cancers (endometrioid carcinomas)
5374610|NCT00132704|Cervical cancers (squamous cell carcinomas)|cervical cancers (squamous cell carcinomas)
5374611|NCT00132704|Sarcomas (liposarcomas and leiomyosarcomas)|sarcomas (liposarcomas and leiomyosarcomas)
5374612|NCT00132704|Thoracic mesotheliomas|thoracic mesotheliomas
5374613|NCT00132704|Colorectal cancers metastatic to the liver|colorectal cancers metastatic to the liver
5375102|NCT00130949|Capsaicin|capsaicin
5374614|NCT00132704|Primary adenocarcinomas of the lung|primary adenocarcinomas of the lung
5374615|NCT00132704|Primary squamous cell carcinomas of the lung|primary squamous cell carcinomas of the lung
5374616|NCT00132704|Pancreatic Cancers-adenocarcinoma|pancreatic cancers-adenocarcinoma
5374617|NCT00132691|uveitis|uveitis
5374618|NCT00132691|non-infectious intermediate uveitis|non-infectious intermediate uveitis
5374619|NCT00132691|non-infectious posterior uveitis|non-infectious posterior uveitis
5374620|NCT00132691|non-infectious panuveitis|non-infectious panuveitis
5374621|NCT00132678|Mood episodes|mood episodes
5374622|NCT00132678|Bipolar 1 disorder|bipolar 1 disorder
5374623|NCT00132678|Intramuscular Injectable|intramuscular injectable
5374624|NCT00132678|risperidone|risperidone
5374625|NCT00132678|safety and efficacy|safety and efficacy
5374626|NCT00132665|non-small cell lung cancer|non-small cell lung cancer
5374627|NCT00132665|elderly patients|elderly patients
5374628|NCT00132665|carboplatin|carboplatin
5374629|NCT00132665|chemoradiotherapy|chemoradiotherapy
5374630|NCT00132639|pulmonary neoplasm|pulmonary neoplasm
5374631|NCT00132639|preoperative chemotherapy|preoperative chemotherapy
5374632|NCT00132639|cisplatin, docetaxel|cisplatin, docetaxel
5374633|NCT00132639|randomized trial|randomized trial
5374634|NCT00132639|clinical stage IB or II nonsmall cell lung cancer|clinical stage ib or ii nonsmall cell lung cancer
5374635|NCT00132626|parkinson|parkinson
5374636|NCT00132626|diagnosis|diagnosis
5374637|NCT00132613|pulmonary neoplasm|pulmonary neoplasm
5374638|NCT00132613|malignant pericardial effusion|malignant pericardial effusion
5374639|NCT00132613|pericardial drainage|pericardial drainage
5374640|NCT00132613|randomized trial|randomized trial
5374641|NCT00132613|bleomycin|bleomycin
5374642|NCT00132613|intrapericardial instillation|intrapericardial instillation
5374643|NCT00132600|Allergic contact dermatitis|allergic contact dermatitis
5374644|NCT00132600|Patch testing|patch testing
5374645|NCT00132600|bacitracin|bacitracin
5374646|NCT00132587|Knee arthroplasty|knee arthroplasty
5374647|NCT00132587|Femoral loosening|femoral loosening
5374648|NCT00132587|Total Knee Arthroplasty|total knee arthroplasty
5374649|NCT00132574|acne, dairy|acne, dairy
5374650|NCT00132548|Malaria|malaria
5374651|NCT00132548|Children|children
5374652|NCT00132548|Intermittent preventive treatment|intermittent preventive treatment
5374653|NCT00132548|Senegal|senegal
5374654|NCT00132535|Malaria in pregnancy|malaria in pregnancy
5374656|NCT00132535|Sulphadoxine-pyrimethamine|sulphadoxine-pyrimethamine
5374657|NCT00132535|Chloroquine|chloroquine
5374658|NCT00132535|HIV|hiv
5374659|NCT00132535|Viral load|viral load
5374660|NCT00132535|birth weight|birth weight
5374661|NCT00132535|anaemia|anaemia
5374662|NCT00132522|EpCAM|epcam
5374663|NCT00132522|monoclonal-antibody|monoclonal-antibody
5374664|NCT00132522|targeted therapy|targeted therapy
5374665|NCT00132522|colorectal|colorectal
5374666|NCT00132522|prostate|prostate
5374667|NCT00132522|non-small cell lung cancer|non-small cell lung cancer
5374668|NCT00132522|ovarian|ovarian
5374669|NCT00132522|solid tumor|solid tumor
5374670|NCT00132509|rt-PA|rt-pa
5374671|NCT00132509|thrombolysis|thrombolysis
5374672|NCT00132509|Acute ischemic stroke|acute ischemic stroke
5374673|NCT00132496|GERD|gerd
5374674|NCT00132483|Physical activity|physical activity
5374675|NCT00132483|cerebral infarct|cerebral infarct
5374676|NCT00132457|Chlamydia|chlamydia
5374677|NCT00132457|screening|screening
5374678|NCT00132457|Sexually transmitted disease|sexually transmitted disease
5374679|NCT00132444|HIV|hiv
5374680|NCT00132444|topical microbicides|topical microbicides
5374681|NCT00132431|calcimimetic|calcimimetic
5374682|NCT00132431|cinacalcet|cinacalcet
5374683|NCT00132431|hemodialysis|hemodialysis
5374684|NCT00132431|secondary hyperparathyroidism|secondary hyperparathyroidism
5374685|NCT00132431|chronic kidney disease|chronic kidney disease
5374686|NCT00132418|rheumatoid arthritis and at least 1 qualifying comorbid condition (diabetes, chronic pulmonary disease, recent infection)|rheumatoid arthritis and at least 1 qualifying comorbid condition (diabetes, chronic pulmonary disease, recent infection)
5374687|NCT00132418|RA|ra
5374688|NCT00132418|rheumatoid arthritis|rheumatoid arthritis
5374689|NCT00132405|Needlestick pain|needlestick pain
5374690|NCT00132405|Venipuncture pain|venipuncture pain
5374691|NCT00132405|Procedural pain|procedural pain
5374692|NCT00132392|Arthroplasty|arthroplasty
5374693|NCT00132392|Total knee arthroplasty|total knee arthroplasty
5374694|NCT00132392|Capsaicin|capsaicin
5374695|NCT00132392|Pain|pain
5374696|NCT00132392|Analgesia|analgesia
5374697|NCT00132366|Neurotransmission|neurotransmission
5374698|NCT00132366|Cortical Excitability|cortical excitability
5374699|NCT00132366|GABA|gaba
5374700|NCT00132366|Seizures|seizures
5374701|NCT00132366|Succinic Semialdehyde Dehydrogenase Deficiency|succinic semialdehyde dehydrogenase deficiency
5374702|NCT00132366|SSADH|ssadh
5374703|NCT00132366|Healthy Volunteer|healthy volunteer
5374704|NCT00132366|HV|hv
5374705|NCT00132353|Magnetic Stimulation|magnetic stimulation
5374706|NCT00132353|Single Fiber EMG|single fiber emg
5374707|NCT00132353|Ultrasonography|ultrasonography
5374708|NCT00132353|Quantitative Sensory Testing|quantitative sensory testing
5374709|NCT00132353|Near-nerve recording|near-nerve recording
5375103|NCT00130936|phase I|phase i
5374710|NCT00132353|Neurological Disorders|neurological disorders
5374711|NCT00132353|Neuromuscular Transmission Disorders|neuromuscular transmission disorders
5374712|NCT00132353|Central Demyelinating Disorders|central demyelinating disorders
5374713|NCT00132353|Myelopathy|myelopathy
5374714|NCT00132353|Motor Neuron Disease|motor neuron disease
5374715|NCT00132353|Movement Disorders|movement disorders
5374716|NCT00132353|Healthy Volunteer|healthy volunteer
5374717|NCT00132340|Spasmodic Torticollis|spasmodic torticollis
5374718|NCT00132340|Treatment|treatment
5374719|NCT00132340|Physiology|physiology
5374720|NCT00132340|Surgery|surgery
5374721|NCT00132340|Cervical Dystonia|cervical dystonia
5374722|NCT00132327|Lyme Disease|lyme disease
5374723|NCT00132327|Borrelia Burgdorferi|borrelia burgdorferi
5374724|NCT00132327|Inflammation|inflammation
5374725|NCT00132327|Skin|skin
5374726|NCT00132327|Host Response|host response
5374727|NCT00132327|Erythema Migrans Rash|erythema migrans rash
5374728|NCT00132327|Healthy Volunteer|healthy volunteer
5374729|NCT00132327|HV|hv
5374730|NCT00132301|multi-site clinical trial|multi-site clinical trial
5374731|NCT00132301|prostate|prostate
5374732|NCT00132301|radical prostatectomy|radical prostatectomy
5374733|NCT00132301|randomized|randomized
5374734|NCT00132288|Aging|aging
5374735|NCT00132288|Frailty|frailty
5374736|NCT00132288|Sedentary|sedentary
5374737|NCT00132288|Falls|falls
5374738|NCT00132288|Physical Activity|physical activity
5374739|NCT00132275|bacterial|bacterial
5374740|NCT00132275|sinusitis|sinusitis
5374741|NCT00132275|treatment|treatment
5374742|NCT00132275|diagnosis|diagnosis
5374743|NCT00132275|guideline|guideline
5374744|NCT00132275|acute bacterial sinusitis|acute bacterial sinusitis
5374745|NCT00132262|Screening and Brief Intervention|screening and brief intervention
5374746|NCT00132262|Ethnic Differences|ethnic differences
5374747|NCT00132262|Trauma Center|trauma center
5374748|NCT00132249|Traumatic Brain Injury|traumatic brain injury
5374749|NCT00132249|Penetrating head wound|penetrating head wound
5374750|NCT00132249|Closed head trauma|closed head trauma
5374751|NCT00132249|Vietnam Veteran|vietnam veteran
5374752|NCT00132236|smoking cessation|smoking cessation
5374753|NCT00132236|nicotine sublingual tablets|nicotine sublingual tablets
5374754|NCT00132236|behaviour support|behaviour support
5374755|NCT00132236|smoking reduction|smoking reduction
5374756|NCT00132236|quality of life|quality of life
5374757|NCT00132236|COPD|copd
5374758|NCT00132236|weight|weight
5374759|NCT00132223|magnetic imaging|magnetic imaging
5374760|NCT00132223|angiography|angiography
5374761|NCT00132223|contrast agent|contrast agent
5374762|NCT00132223|signal/noise ratio|signal/noise ratio
5374763|NCT00132223|contrast/noise ratio|contrast/noise ratio
5374764|NCT00132223|vessel|vessel
5374765|NCT00132210|acute hepatitis C|acute hepatitis c
5374766|NCT00132210|HIV|hiv
5374767|NCT00132210|pegylated interferon|pegylated interferon
5374768|NCT00132197|Functional somatic symptoms|functional somatic symptoms
5374769|NCT00132197|Cognitive behavioral therapy|cognitive behavioral therapy
5374770|NCT00132197|somatization disorder|somatization disorder
5374771|NCT00132197|SF-36|sf-36
5374772|NCT00132197|cost-effectiveness|cost-effectiveness
5374773|NCT00132197|Medically unexplained symptoms|medically unexplained symptoms
5374774|NCT00132184|Vitamin D|vitamin d
5374775|NCT00132184|Crohns Disease|crohns disease
5374776|NCT00132171|Helicobacter pylori|helicobacter pylori
5374777|NCT00132171|Eradication|eradication
5374778|NCT00132171|Sequential therapy|sequential therapy
5374779|NCT00132171|Standard therapy|standard therapy
5374780|NCT00132145|Vascular diseases|vascular diseases
5374781|NCT00132145|Computerized decision support systems|computerized decision support systems
5374782|NCT00132145|Shared care|shared care
5374783|NCT00132145|Patient motivation|patient motivation
5374784|NCT00132145|Quality of care|quality of care
5374785|NCT00132132|BMI|bmi
5374786|NCT00132132|obesity|obesity
5374787|NCT00132132|behavioral intervention|behavioral intervention
5374788|NCT00132132|longterm randomized controlled trial|longterm randomized controlled trial
5374789|NCT00132132|exercise|exercise
5374790|NCT00132132|empowerment|empowerment
5374791|NCT00132132|nutrition|nutrition
5374792|NCT00132093|Left ventricular remodelling|left ventricular remodelling
5374793|NCT00132093|Acute myocardial infarction|acute myocardial infarction
5374794|NCT00132093|Left ventricular dysfunction|left ventricular dysfunction
5374795|NCT00132093|Eplerenone|eplerenone
5374796|NCT00132093|Cardiac Magnetic Resonance Imaging|cardiac magnetic resonance imaging
5374797|NCT00132054|extensive stage small cell lung cancer|extensive stage small cell lung cancer
5374798|NCT00132054|recurrent small cell lung cancer|recurrent small cell lung cancer
5374921|NCT00131599|thymidylate synthase|thymidylate synthase
5374799|NCT00132041|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
5374800|NCT00132041|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
5374801|NCT00132015|Waldenström macroglobulinemia|waldenström macroglobulinemia
5374802|NCT00132015|multicentric Castleman disease|multicentric castleman disease
5374803|NCT00132015|unicentric Castleman disease|unicentric castleman disease
5374804|NCT00132015|adult grade III lymphomatoid granulomatosis|adult grade iii lymphomatoid granulomatosis
5374805|NCT00132015|polycythemia vera|polycythemia vera
5374806|NCT00132015|essential thrombocythemia|essential thrombocythemia
5374807|NCT00132015|hairy cell leukemia|hairy cell leukemia
5374808|NCT00132015|monoclonal gammopathy of undetermined significance|monoclonal gammopathy of undetermined significance
5374809|NCT00132015|adult Burkitt lymphoma|adult burkitt lymphoma
5374810|NCT00132015|adult diffuse large cell lymphoma|adult diffuse large cell lymphoma
5374811|NCT00132015|adult diffuse mixed cell lymphoma|adult diffuse mixed cell lymphoma
5374812|NCT00132015|adult diffuse small cleaved cell lymphoma|adult diffuse small cleaved cell lymphoma
5374813|NCT00132015|adult immunoblastic large cell lymphoma|adult immunoblastic large cell lymphoma
5374814|NCT00132015|adult lymphoblastic lymphoma|adult lymphoblastic lymphoma
5374815|NCT00132015|grade 1 follicular lymphoma|grade 1 follicular lymphoma
5374816|NCT00132015|grade 2 follicular lymphoma|grade 2 follicular lymphoma
5374817|NCT00132015|grade 3 follicular lymphoma|grade 3 follicular lymphoma
5374818|NCT00132015|mantle cell lymphoma|mantle cell lymphoma
5374819|NCT00132015|marginal zone lymphoma|marginal zone lymphoma
5374820|NCT00132015|small lymphocytic lymphoma|small lymphocytic lymphoma
5374821|NCT00132015|precancerous condition|precancerous condition
5374822|NCT00131963|stage One A (IA) breast cancer|stage one a (ia) breast cancer
5374823|NCT00131963|stage Two (II) breast cancer|stage two (ii) breast cancer
5374824|NCT00131963|stage Three A (IIIA) breast cancer|stage three a (iiia) breast cancer
5374825|NCT00131963|stage Three B(IIIB) breast cancer|stage three b(iiib) breast cancer
5374826|NCT00131963|stage Three C(IIIC) breast cancer|stage three c(iiic) breast cancer
5374827|NCT00131963|stage One B (IB) breast cancer|stage one b (ib) breast cancer
5374828|NCT00131950|breast cancer|breast cancer
5374829|NCT00131924|recurrent breast cancer|recurrent breast cancer
5374830|NCT00131924|stage IV breast cancer|stage iv breast cancer
5374831|NCT00131898|IMRT+Surgery versus Surgery For Sarcoma|imrt+surgery versus surgery for sarcoma
5374832|NCT00131885|Menstruation|menstruation
5374833|NCT00131885|Complementary Therapies|complementary therapies
5374834|NCT00131885|Pharmacokinetics|pharmacokinetics
5374835|NCT00131885|Hypericum|hypericum
5374836|NCT00131885|St. John's wort|st. john's wort
5374837|NCT00131885|Levonorgestrel|levonorgestrel
5374838|NCT00131885|Women|women
5374839|NCT00131872|vascular access graft|vascular access graft
5374840|NCT00131872|hemodialysis|hemodialysis
5374841|NCT00131872|dialysis|dialysis
5374842|NCT00131872|end stage renal disease|end stage renal disease
5374843|NCT00131859|Perinatal brain injury|perinatal brain injury
5374844|NCT00131859|Diffusion-tensor imaging|diffusion-tensor imaging
5374845|NCT00131846|Thiazide diuretics|thiazide diuretics
5374846|NCT00131846|Essential hypertension|essential hypertension
5374847|NCT00131846|Type 2 diabetes|type 2 diabetes
5374848|NCT00131846|Randomized clinical trial|randomized clinical trial
5374849|NCT00131846|Cost-effectiveness|cost-effectiveness
5374850|NCT00131833|salmonella|salmonella
5374851|NCT00131833|typhoid vaccine|typhoid vaccine
5374852|NCT00131833|enteric fever|enteric fever
5374853|NCT00131820|Salmonella|salmonella
5374854|NCT00131820|typhoid vaccine|typhoid vaccine
5374855|NCT00131820|enteric fever|enteric fever
5374856|NCT00131820|socioeconomic costs|socioeconomic costs
5374857|NCT00131807|Blood Pressure|blood pressure
5374858|NCT00131807|HIV|hiv
5374859|NCT00131807|Antiretroviral therapy|antiretroviral therapy
5374860|NCT00131794|Malaria|malaria
5374861|NCT00131794|BCG vaccine|bcg vaccine
5374862|NCT00131794|Guinea Bissau|guinea bissau
5374863|NCT00131781|Borderline personality disorder|borderline personality disorder
5374864|NCT00131781|Controlled trials|controlled trials
5374865|NCT00131781|Cognitive Therapy|cognitive therapy
5374866|NCT00131781|Supportive Therapy|supportive therapy
5374867|NCT00131781|suicide|suicide
5374868|NCT00131781|impulsivity|impulsivity
5374869|NCT00131768|osteoarthritis of the ankle|osteoarthritis of the ankle
5374870|NCT00131768|musculoskeletal|musculoskeletal
5374871|NCT00131755|type 1 diabetes|type 1 diabetes
5374872|NCT00131755|beta cell rest|beta cell rest
5374873|NCT00131755|diazoxide|diazoxide
5374874|NCT00131755|insulin secretion|insulin secretion
5374875|NCT00131729|Amblyopia|amblyopia
5374876|NCT00131729|Occlusion therapy|occlusion therapy
5374877|NCT00131729|Compliance|compliance
5374878|NCT00131729|Risk factors|risk factors
5374879|NCT00131716|prevention|prevention
5374880|NCT00131716|recurrence|recurrence
5374881|NCT00131716|severe|severe
5374882|NCT00131716|anaemia|anaemia
5374883|NCT00131703|Screening|screening
5374884|NCT00131703|Treatment|treatment
5374885|NCT00131703|Amodiaquine|amodiaquine
5374886|NCT00131703|Sulphadoxine-pyrimethamine|sulphadoxine-pyrimethamine
5374887|NCT00131703|Malaria in pregnancy|malaria in pregnancy
5374888|NCT00131690|Caffeine|caffeine
5374889|NCT00131690|Coffee|coffee
5374890|NCT00131690|Randomized|randomized
5374891|NCT00131690|Birth weight|birth weight
5374892|NCT00131651|renal|renal
5374893|NCT00131651|cancer|cancer
5374894|NCT00131651|advanced|advanced
5374895|NCT00131651|unresectable|unresectable
5374896|NCT00131651|metastatic|metastatic
5374897|NCT00131651|recurrent|recurrent
5374898|NCT00131651|anti-angiogenic|anti-angiogenic
5374899|NCT00131651|targeted|targeted
5374900|NCT00131651|ATN-161|atn-161
5374901|NCT00131651|Recurrent renal cell cancer|recurrent renal cell cancer
5374902|NCT00131651|Renal clear cell carcinoma|renal clear cell carcinoma
5374903|NCT00131651|Advanced Renal Cell Cancer|advanced renal cell cancer
5374904|NCT00131638|Oncology|oncology
5374905|NCT00131638|KGF|kgf
5374906|NCT00131638|Palifermin|palifermin
5374907|NCT00131638|Oral mucositis|oral mucositis
5374908|NCT00131638|Clinical Trial|clinical trial
5374909|NCT00131638|Amgen|amgen
5374910|NCT00131638|head and neck|head and neck
5374911|NCT00131625|Exclusive breast-feeding|exclusive breast-feeding
5374912|NCT00131625|Mortality|mortality
5374913|NCT00131625|Morbidity|morbidity
5374914|NCT00131625|Nutrition|nutrition
5374915|NCT00131625|Low income country|low income country
5374916|NCT00131612|adjuvant therapy|adjuvant therapy
5374917|NCT00131612|epirubicin|epirubicin
5374918|NCT00131612|uridine glucuronosyl/transferase 2B7|uridine glucuronosyl/transferase 2b7
5374919|NCT00131612|pharmacogenetics|pharmacogenetics
5374920|NCT00131599|5-fluorouracil|5-fluorouracil
5374922|NCT00131599|pharmacogenetics|pharmacogenetics
5374923|NCT00131586|platinum analogues|platinum analogues
5374924|NCT00131586|cisplatin, carboplatin, oxaliplatin|cisplatin, carboplatin, oxaliplatin
5374925|NCT00131586|proteomics|proteomics
5374926|NCT00131586|hemoglobin|hemoglobin
5374927|NCT00131573|Urgency-Frequency|urgency-frequency
5374928|NCT00131573|Syndrome|syndrome
5374929|NCT00131573|Urinary|urinary
5374930|NCT00131573|Refractory|refractory
5374931|NCT00131573|Stimulation|stimulation
5374932|NCT00131573|Nerve|nerve
5374933|NCT00131573|Neuromodulation|neuromodulation
5374934|NCT00131573|Microstimulator|microstimulator
5374935|NCT00131573|bion|bion
5374936|NCT00131573|Pudendal|pudendal
5374937|NCT00131573|Overactive bladder|overactive bladder
5374938|NCT00131560|HIV, gene therapy, leukapheresis, autologous CD4 T cell, lentivector|hiv, gene therapy, leukapheresis, autologous cd4 t cell, lentivector
5374939|NCT00131547|Obesity|obesity
5374940|NCT00131547|Obstructive Sleep Apnea|obstructive sleep apnea
5374941|NCT00131534|Complex trauma|complex trauma
5374942|NCT00131534|Trauma recovery|trauma recovery
5374943|NCT00131534|Resiliency|resiliency
5374944|NCT00131534|Posttraumatic stress|posttraumatic stress
5374945|NCT00131534|Individual psychotherapy|individual psychotherapy
5374946|NCT00131534|Group psychotherapy|group psychotherapy
5374947|NCT00131521|mucus obstruction, ventilator management|mucus obstruction, ventilator management
5374948|NCT00131508|Hemoglobin S Disease|hemoglobin s disease
5374949|NCT00131508|Sickle Cell Anemia|sickle cell anemia
5374950|NCT00131495|Low Libido|low libido
5374951|NCT00131495|Low Desire|low desire
5374952|NCT00131495|Distress|distress
5374953|NCT00131482|Chrysalin|chrysalin
5374954|NCT00131482|TP508|tp508
5374955|NCT00131482|Fracture|fracture
5374956|NCT00131482|Wrist|wrist
5374957|NCT00131482|Healing|healing
5374958|NCT00131469|Osteogenesis Imperfecta|osteogenesis imperfecta
5374959|NCT00131469|Brittle Bone Disease|brittle bone disease
5374960|NCT00131469|Fragility Fractures|fragility fractures
5374961|NCT00131456|cannabis dependence|cannabis dependence
5374962|NCT00131456|depression|depression
5374963|NCT00131456|treatment|treatment
5374964|NCT00131456|venlafaxine|venlafaxine
5374965|NCT00131443|Basilar/Hemiplegic Migraine|basilar/hemiplegic migraine
5374966|NCT00131443|Prophylaxis|prophylaxis
5374967|NCT00131417|severe|severe
5374968|NCT00131417|malnutrition|malnutrition
5374969|NCT00131417|ready-to-use-therapeutic-food|ready-to-use-therapeutic-food
5374970|NCT00131417|children|children
5374971|NCT00131417|Uganda|uganda
5374972|NCT00131378|Visceral obesity|visceral obesity
5374973|NCT00131378|Growth hormone|growth hormone
5374974|NCT00131378|Cardiovascular risk|cardiovascular risk
5374975|NCT00131378|Insulin resistance|insulin resistance
5374976|NCT00131365|fibroids|fibroids
5374977|NCT00131365|Uterine Fibroids|uterine fibroids
5374978|NCT00131365|ExAblate|exablate
5374979|NCT00131365|MrgFUS|mrgfus
5374980|NCT00131352|Osteoarthritis of the knee|osteoarthritis of the knee
5374981|NCT00131352|Musculoskeletal|musculoskeletal
5374982|NCT00131339|panic disorder|panic disorder
5374983|NCT00131339|cognitive behavioral therapy|cognitive behavioral therapy
5374984|NCT00131339|D-cycloserine|d-cycloserine
5374985|NCT00131339|medication|medication
5374986|NCT00131339|treatment trial|treatment trial
5374987|NCT00131339|placebo-controlled|placebo-controlled
5374988|NCT00131339|double-blind|double-blind
5374989|NCT00131339|randomized|randomized
5374990|NCT00131326|osteoarthritis of the hip|osteoarthritis of the hip
5374991|NCT00131326|Musculoskeletal Diseases|musculoskeletal diseases
5374992|NCT00131313|Leukemia|leukemia
5374993|NCT00131313|Cancer|cancer
5374994|NCT00131313|Nipent|nipent
5374995|NCT00131313|Rituxan|rituxan
5374996|NCT00131313|Cytoxan|cytoxan
5374997|NCT00131300|Osteoarthritis of the shoulder|osteoarthritis of the shoulder
5374998|NCT00131300|Musculoskeletal|musculoskeletal
5374999|NCT00131287|Agaricus Blazei Murill|agaricus blazei murill
5375000|NCT00131287|type II DM|type ii dm
5375001|NCT00131287|insulin index|insulin index
5375002|NCT00131274|Pulmonary Fibrosis|pulmonary fibrosis
5375003|NCT00131274|Respiratory Diseases|respiratory diseases
5375004|NCT00131274|Interstitial Lung Disease|interstitial lung disease
5375104|NCT00130936|epirubicin|epirubicin
5375005|NCT00131274|Usual Interstitial Pneumonia|usual interstitial pneumonia
5375006|NCT00131261|Multiple Myeloma|multiple myeloma
5375007|NCT00131261|Neoplasms|neoplasms
5375008|NCT00131235|Malaria|malaria
5375009|NCT00131235|STI|sti
5375010|NCT00131235|Pregnancy|pregnancy
5375011|NCT00131235|Prevention|prevention
5375012|NCT00131235|Preterm birth|preterm birth
5375013|NCT00131235|Low birth weight|low birth weight
5375014|NCT00131235|Sub-Saharan Africa|sub-saharan africa
5375015|NCT00131222|Infant|infant
5375016|NCT00131222|Malnutrition|malnutrition
5375017|NCT00131222|Sub-Saharan Africa|sub-saharan africa
5375018|NCT00131222|Treatment|treatment
5375019|NCT00131222|Growth|growth
5375020|NCT00131222|Haemoglobin|haemoglobin
5375021|NCT00131222|Fortified spread|fortified spread
5375022|NCT00131222|Food supplement|food supplement
5375023|NCT00131209|Infant|infant
5375024|NCT00131209|Sub-Saharan Africa|sub-saharan africa
5375025|NCT00131209|Complementary feeding|complementary feeding
5375026|NCT00131209|Malnutrition|malnutrition
5375027|NCT00131209|Growth|growth
5375028|NCT00131209|Fortified spread|fortified spread
5375029|NCT00131209|Haemoglobin|haemoglobin
5375030|NCT00131196|pneumonia|pneumonia
5375031|NCT00131196|peritonitis|peritonitis
5375032|NCT00131196|sepsis|sepsis
5375033|NCT00131196|outcome|outcome
5375034|NCT00131196|genomics|genomics
5375035|NCT00131183|Angina Pectoris|angina pectoris
5375036|NCT00131183|Arteriosclerosis|arteriosclerosis
5375037|NCT00131183|Testosterone|testosterone
5375038|NCT00131157|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
5375039|NCT00131157|Family Practice|family practice
5375040|NCT00131157|Spirometry|spirometry
5375041|NCT00131157|Decision Support Systems|decision support systems
5375042|NCT00131157|Feedback|feedback
5375043|NCT00131144|Diabetic retinopathy,Octreotide Acetate in Microspheres|diabetic retinopathy,octreotide acetate in microspheres
5375044|NCT00131131|physical activity|physical activity
5375045|NCT00131131|cholelithiasis|cholelithiasis
5375046|NCT00131131|pregnancy complication|pregnancy complication
5375047|NCT00131118|Osteogenesis Imperfecta, Brittle bone disease, bisphosphonate, children|osteogenesis imperfecta, brittle bone disease, bisphosphonate, children
5375048|NCT00131105|Healthy|healthy
5375049|NCT00131105|Caregivers|caregivers
5375050|NCT00131105|Aging|aging
5375051|NCT00131092|exercise|exercise
5375052|NCT00131092|aging|aging
5375053|NCT00131092|physical activity|physical activity
5375054|NCT00131079|Primary Health Care|primary health care
5375055|NCT00131079|Physicians, Family|physicians, family
5375056|NCT00131079|Family Practice|family practice
5375057|NCT00131079|Health Promotion|health promotion
5375058|NCT00131079|Randomized Controlled Trials|randomized controlled trials
5375059|NCT00131079|Multicenter Studies|multicenter studies
5375060|NCT00131079|Physical Fitness|physical fitness
5375061|NCT00131079|Quality of Life|quality of life
5375062|NCT00131066|Previously enrolled on a MEDI-507 for psoriasis|previously enrolled on a medi-507 for psoriasis
5375063|NCT00131053|acute lymphoblastic leukemia|acute lymphoblastic leukemia
5375064|NCT00131053|newly diagnosed|newly diagnosed
5375065|NCT00131053|BCR-ABL-negative|bcr-abl-negative
5375066|NCT00131040|Cardiopulmonary|cardiopulmonary
5375067|NCT00131040|Surgery|surgery
5375068|NCT00131040|leukocyte|leukocyte
5375069|NCT00131040|inflammation|inflammation
5375070|NCT00131040|Coronary Artery Bypass Grafting|coronary artery bypass grafting
5375071|NCT00131027|acute lymphoblastic leukemia|acute lymphoblastic leukemia
5375072|NCT00131027|newly diagnosed|newly diagnosed
5375073|NCT00131027|BCR-ABL-negative|bcr-abl-negative
5375074|NCT00131014|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
5375075|NCT00131014|Hodgkin's disease|hodgkin's disease
5375076|NCT00131014|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
5375077|NCT00131014|Lymphoproliferative disorder|lymphoproliferative disorder
5375078|NCT00131014|Genetics|genetics
5375079|NCT00131001|Carotid artery stenosis|carotid artery stenosis
5375080|NCT00131001|cost effectiveness|cost effectiveness
5375081|NCT00131001|magnetic resonance angiography|magnetic resonance angiography
5375082|NCT00131001|computed tomography angiography|computed tomography angiography
5375083|NCT00131001|digital subtraction angiography|digital subtraction angiography
5375084|NCT00130988|Somatoform Disorders|somatoform disorders
5375085|NCT00130988|Medically unexplained symptoms|medically unexplained symptoms
5375086|NCT00130988|Physician-Patient Relations|physician-patient relations
5375087|NCT00130988|Primary Health Care|primary health care
5375088|NCT00130988|Family Physician|family physician
5375089|NCT00130988|psychosocial therapy|psychosocial therapy
5375090|NCT00130988|re-attribution of symptoms|re-attribution of symptoms
5375091|NCT00130988|cluster randomised controlled trial|cluster randomised controlled trial
5375092|NCT00130975|Atrial fibrillation.|atrial fibrillation.
5375093|NCT00130975|Cardioversion.|cardioversion.
5375094|NCT00130975|Recurrence.|recurrence.
5375095|NCT00130975|Candesartan.|candesartan.
5375096|NCT00130962|Intermetatarsal neuroma|intermetatarsal neuroma
5375097|NCT00130962|Morton's neuroma|morton's neuroma
5375098|NCT00130962|ALGRX 4975|algrx 4975
5375099|NCT00130962|capsaicin|capsaicin
5375100|NCT00130949|Acute lateral epicondylitis|acute lateral epicondylitis
5375101|NCT00130949|Tennis elbow|tennis elbow
5375105|NCT00130936|solid tumors|solid tumors
5375106|NCT00130923|Risperidone|risperidone
5375107|NCT00130923|Schizophrenia|schizophrenia
5375108|NCT00130923|Substance Use Disorder|substance use disorder
5375109|NCT00130923|Alcohol Use Disorder|alcohol use disorder
5375110|NCT00130923|Treatment|treatment
5375111|NCT00130923|Schizoaffective Disorder|schizoaffective disorder
5375113|NCT00130910|Helminthiasis|helminthiasis
5375114|NCT00130910|Co-infection|co-infection
5375115|NCT00130910|Intestinal immune activation|intestinal immune activation
5375116|NCT00130910|Treatment Naive|treatment naive
5375117|NCT00130884|levosimendan|levosimendan
5375118|NCT00130884|chronic heart failure|chronic heart failure
5375119|NCT00130884|oral administration|oral administration
5375120|NCT00130871|levosimendan|levosimendan
5375121|NCT00130871|weaning|weaning
5375122|NCT00130871|cardio-pulmonary bypass|cardio-pulmonary bypass
5375123|NCT00130858|Sarcoma, Soft Tissue|sarcoma, soft tissue
5375124|NCT00130845|Diabetic retinopathy, Octreotide Acetate in Microspheres|diabetic retinopathy, octreotide acetate in microspheres
5375125|NCT00130819|Drug Dependence|drug dependence
5375126|NCT00130819|Opiate Dependence|opiate dependence
5375127|NCT00130819|Human Immunodeficiency Viruses|human immunodeficiency viruses
5375128|NCT00130819|Buprenorphine|buprenorphine
5375129|NCT00130780|Multi-modality treatment for lung cancer|multi-modality treatment for lung cancer
5375130|NCT00130780|Carcinoma, Squamous Cell|carcinoma, squamous cell
5375131|NCT00130780|Bevacizumab|bevacizumab
5375132|NCT00130780|BEACON|beacon
5375133|NCT00130780|05-052|05-052
5375134|NCT00130767|Prostate|prostate
5375135|NCT00130767|apoptosis|apoptosis
5375136|NCT00130767|finasteride kinetics|finasteride kinetics
5375137|NCT00130728|NSCLC|nsclc
5375138|NCT00130728|Avastin|avastin
5375139|NCT00130728|Tarceva|tarceva
5375140|NCT00130728|Lung Cancer|lung cancer
5375141|NCT00130715|Patients undergoing a variety of abdominal surgical procedures|patients undergoing a variety of abdominal surgical procedures
5375142|NCT00130702|AML|aml
5375143|NCT00130702|acute myelogenous leukemia|acute myelogenous leukemia
5375144|NCT00130702|gefitinib|gefitinib
5375145|NCT00130702|Iressa|iressa
5375146|NCT00130689|Esophageal Cancer|esophageal cancer
5375147|NCT00130689|Gastric Cancer|gastric cancer
5375148|NCT00130689|Metastatic Esophageal Cancer|metastatic esophageal cancer
5375149|NCT00130689|Metastatic Gastric Cancer|metastatic gastric cancer
5375150|NCT00130689|Cetuximab|cetuximab
5375151|NCT00130689|Metastatic Esophageal and Gastric Cancer|metastatic esophageal and gastric cancer
5375152|NCT00130676|PMD|pmd
5375153|NCT00130676|Psychotic Major Depression|psychotic major depression
5375154|NCT00130676|Depression|depression
5375155|NCT00130676|Major Depression|major depression
5375156|NCT00130676|Psychosis|psychosis
5375157|NCT00130650|IV|iv
5375158|NCT00130650|cannulation|cannulation
5375159|NCT00130650|Injections, Intravenous|injections, intravenous
5375160|NCT00130637|Anterior Uveitis|anterior uveitis
5375161|NCT00130637|Arthritis, Juvenile Idiopathic|arthritis, juvenile idiopathic
5375162|NCT00130637|Daclizumab|daclizumab
5375163|NCT00130637|Iritis|iritis
5375164|NCT00130637|Immunosuppression|immunosuppression
5375165|NCT00130637|Chronic Inflammatory Eye-Disease|chronic inflammatory eye-disease
5375166|NCT00130637|Juvenile Idiopathic Arthritis|juvenile idiopathic arthritis
5375167|NCT00130624|Falls|falls
5375168|NCT00130624|Elderly|elderly
5375169|NCT00130624|multidisciplinary assessment|multidisciplinary assessment
5375170|NCT00130611|heart failure|heart failure
5375171|NCT00130611|cost effectiveness|cost effectiveness
5375172|NCT00130611|BNP|bnp
5375173|NCT00130611|private practice|private practice
5375174|NCT00130611|Acute dyspnoea|acute dyspnoea
5375175|NCT00130598|contrast nephropathy|contrast nephropathy
5375176|NCT00130598|contrast media|contrast media
5375177|NCT00130598|renal dysfunction|renal dysfunction
5375178|NCT00130585|Folate|folate
5375179|NCT00130585|Bioavailability|bioavailability
5375180|NCT00130585|Stable isotopes|stable isotopes
5375181|NCT00130559|Respiratory failure|respiratory failure
5375182|NCT00130559|BNP|bnp
5375183|NCT00130546|coronary artery disease|coronary artery disease
5375184|NCT00130546|coronary intervention|coronary intervention
5375185|NCT00130546|drug eluting stent implantation|drug eluting stent implantation
5375186|NCT00130546|Cypher - Stent|cypher - stent
5375187|NCT00130546|Sirolimus|sirolimus
5375188|NCT00130546|Taxus - Stent|taxus - stent
5375189|NCT00130546|Paclitaxel|paclitaxel
5375190|NCT00130533|TNBC Triple-Negative Early Breast Cancer|tnbc triple-negative early breast cancer
5375191|NCT00130533|Maintenance Adjuvant Chemotherapy|maintenance adjuvant chemotherapy
5375192|NCT00130533|Capecitabine|capecitabine
5375193|NCT00130533|Basal-like genotype|basal-like genotype
5375194|NCT00130520|advanced ovarian cancer|advanced ovarian cancer
5375195|NCT00130520|refractory ovarian cancer|refractory ovarian cancer
5375196|NCT00130520|primary peritoneal cancer|primary peritoneal cancer
5375197|NCT00130507|HER2 positive breast cancer.|her2 positive breast cancer.
5375198|NCT00130507|Progression to trastuzumab and taxanes.|progression to trastuzumab and taxanes.
5375199|NCT00130494|Non-symptomatic bone metastases.|non-symptomatic bone metastases.
5375200|NCT00130481|Diabetes|diabetes
5375201|NCT00130481|Children|children
5375202|NCT00130481|Adolescents|adolescents
5375203|NCT00130481|Arterial Compliance|arterial compliance
5375204|NCT00130481|Physiology Cardiovascular Endothelium|physiology cardiovascular endothelium
5375205|NCT00130442|phase II|phase ii
5375206|NCT00130442|metastatic melanoma|metastatic melanoma
5375207|NCT00130442|dacarbazine|dacarbazine
5375208|NCT00130442|combination|combination
5375209|NCT00130442|PI-88|pi-88
5375210|NCT00130429|dementia|dementia
5375211|NCT00130429|memory|memory
5375212|NCT00130429|Hopkins verbal learning test|hopkins verbal learning test
5375213|NCT00130429|paired associated learning|paired associated learning
5375214|NCT00130416|behavior|behavior
5375215|NCT00130416|randomized trial|randomized trial
5375216|NCT00130416|communication|communication
5375217|NCT00130416|patient|patient
5375218|NCT00130416|internet|internet
5375219|NCT00130416|coaching|coaching
5375220|NCT00130416|self-efficacy|self-efficacy
5375221|NCT00130416|nurse|nurse
5375222|NCT00130416|primary care|primary care
5375223|NCT00130416|physician|physician
5375224|NCT00130416|screening|screening
5375225|NCT00130416|survey|survey
5375226|NCT00130416|pain|pain
5375227|NCT00130416|mobility|mobility
5375228|NCT00130416|disability|disability
5375229|NCT00130416|depression|depression
5375230|NCT00130390|Crohn's Disease|crohn's disease
5375231|NCT00130377|Stem Cell|stem cell
5375232|NCT00130377|Heart|heart
5375233|NCT00130377|Lung|lung
5375234|NCT00130377|Vascular|vascular
5375235|NCT00130377|cell therapy registry|cell therapy registry
5375236|NCT00130364|Atopic dermatitis|atopic dermatitis
5375237|NCT00130364|T-cell|t-cell
5375238|NCT00130364|pimecrolimus|pimecrolimus
5375239|NCT00130364|children|children
5375240|NCT00130364|facial|facial
5375241|NCT00130364|Facial atopic dermatitis|facial atopic dermatitis
5375242|NCT00130351|asthma, formoterol multi-dose dry powder inhaler (MDDPI)|asthma, formoterol multi-dose dry powder inhaler (mddpi)
5375243|NCT00130338|Dementia|dementia
5375244|NCT00130338|Vascular|vascular
5375245|NCT00130338|Rivastigmine|rivastigmine
5375246|NCT00130338|Stroke|stroke
5375247|NCT00130338|Memory loss|memory loss
5375248|NCT00130325|ELISPOT,|elispot,
5375249|NCT00130325|tuberculosis,|tuberculosis,
5375250|NCT00130325|Mycobacterium tuberculosis|mycobacterium tuberculosis
5375251|NCT00130325|Isoniazid|isoniazid
5375252|NCT00130325|Clinical trial|clinical trial
5375253|NCT00130312|Diabetes|diabetes
5375254|NCT00130312|Diabetic Nephropathy|diabetic nephropathy
5375255|NCT00130312|Proteinuria|proteinuria
5375256|NCT00130286|Lipodystrophy|lipodystrophy
5375257|NCT00130286|HIV|hiv
5375258|NCT00130286|Growth hormone|growth hormone
5375259|NCT00130286|Rosiglitazone|rosiglitazone
5375260|NCT00130286|Visceral fat|visceral fat
5375261|NCT00130286|Metabolic syndrome|metabolic syndrome
5375262|NCT00130286|Treatment Experienced|treatment experienced
5375263|NCT00130286|Visceral fat accumulation|visceral fat accumulation
5375264|NCT00130286|fat accumulation|fat accumulation
5375265|NCT00130286|HIV-Associated Metabolic Syndrome|hiv-associated metabolic syndrome
5375266|NCT00130273|HIV|hiv
5375267|NCT00130273|AIDS|aids
5375268|NCT00130273|Problem Solving|problem solving
5375269|NCT00130273|Antiretroviral Therapy, Highly Active|antiretroviral therapy, highly active
5375270|NCT00130273|Patient Compliance|patient compliance
5375271|NCT00130260|Staphylococcus aureus|staphylococcus aureus
5375272|NCT00130260|Vaccine|vaccine
5375273|NCT00130260|Randomized Controlled Trial|randomized controlled trial
5375274|NCT00130247|Tuberculosis, Uganda, Brazil, Philippines|tuberculosis, uganda, brazil, philippines
5375275|NCT00130234|urticaria|urticaria
5375276|NCT00130234|hives|hives
5375277|NCT00130234|Xolair|xolair
5375278|NCT00130221|Chlorhexidine|chlorhexidine
5375279|NCT00130221|Blood stream infections|blood stream infections
5375280|NCT00130221|central venous catheter associated|central venous catheter associated
5375281|NCT00130221|Nosocomial infection|nosocomial infection
5375282|NCT00130221|Bacteremia|bacteremia
5375283|NCT00130221|sepsis|sepsis
5375284|NCT00130221|Pneumonia|pneumonia
5375285|NCT00130221|Urinary tract infection|urinary tract infection
5375286|NCT00130221|Clostridium Difficile|clostridium difficile
5375287|NCT00130221|intensive care unit|intensive care unit
5375288|NCT00130221|catheter|catheter
5375289|NCT00130221|nosocomial pneumonia|nosocomial pneumonia
5375290|NCT00130221|Infection control|infection control
5375291|NCT00130208|Diabetes|diabetes
5375292|NCT00130208|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
5375293|NCT00130208|Albuminuria|albuminuria
5375294|NCT00130208|Diabetic Nephropathy|diabetic nephropathy
5375295|NCT00130195|acute lymphoblastic leukemia|acute lymphoblastic leukemia
5375296|NCT00130195|BCR-ABL|bcr-abl
5375297|NCT00130195|Philadelphia-chromosome|philadelphia-chromosome
5375298|NCT00130195|newly diagnosed|newly diagnosed
5375299|NCT00130182|lung disease|lung disease
5375300|NCT00130169|Cancer|cancer
5375301|NCT00130169|malignant tumors|malignant tumors
5375302|NCT00130156|Blood pressure|blood pressure
5375303|NCT00130156|SBP|sbp
5375304|NCT00130156|DBP|dbp
5375305|NCT00130117|leptin|leptin
5375306|NCT00130117|hypothalamic amenorrhea|hypothalamic amenorrhea
5375407|NCT00129688|once-daily|once-daily
5375307|NCT00130117|exercise-induced amenorrhea|exercise-induced amenorrhea
5375308|NCT00130117|neuroendocrine function|neuroendocrine function
5375309|NCT00130117|bone metabolism|bone metabolism
5375310|NCT00130104|digital block|digital block
5375311|NCT00130104|regional anesthesia|regional anesthesia
5375312|NCT00130104|finger repair|finger repair
5375313|NCT00130104|Fingers|fingers
5375314|NCT00130104|Anesthesia, Conduction|anesthesia, conduction
5375315|NCT00130091|unilateral|unilateral
5375316|NCT00130091|hernia|hernia
5375317|NCT00130091|hydrocele|hydrocele
5375318|NCT00130091|pediatric|pediatric
5375319|NCT00130091|clonidine|clonidine
5375320|NCT00130091|nerve block|nerve block
5375321|NCT00130078|HIV Seronegativity|hiv seronegativity
5375322|NCT00130078|HIV transmission|hiv transmission
5375323|NCT00130065|Malaria|malaria
5375324|NCT00130065|Pregnancy|pregnancy
5375325|NCT00130065|Sulfadoxine-pyrimethamine|sulfadoxine-pyrimethamine
5375326|NCT00130065|Folic acid|folic acid
5375327|NCT00130065|Folate|folate
5375328|NCT00130039|Infarction, Cerebral|infarction, cerebral
5375329|NCT00130039|cilostazol|cilostazol
5375330|NCT00130039|stenosis|stenosis
5375331|NCT00130039|atherosclerosis|atherosclerosis
5375332|NCT00130039|clopidogrel|clopidogrel
5375333|NCT00130013|Children|children
5375334|NCT00130013|Non-severe pneumonia|non-severe pneumonia
5375335|NCT00130013|Oral amoxicillin|oral amoxicillin
5375336|NCT00130000|h5g.1|h5g.1
5375337|NCT00130000|Paroxysmal Nocturnal Hemoglobinuria|paroxysmal nocturnal hemoglobinuria
5375338|NCT00130000|SHEPHERD|shepherd
5375339|NCT00130000|PNH|pnh
5375340|NCT00129987|Asthma|asthma
5375341|NCT00129974|Lung cancer|lung cancer
5375342|NCT00129974|Phase II|phase ii
5375343|NCT00129974|Drug Therapy|drug therapy
5375344|NCT00129961|Kidney|kidney
5375345|NCT00129961|Transplant|transplant
5375346|NCT00129961|Skin Cancer|skin cancer
5375347|NCT00129948|Acute myeloid leukemia|acute myeloid leukemia
5375348|NCT00129948|AML|aml
5375349|NCT00129948|refractory|refractory
5375350|NCT00129948|relapsed|relapsed
5375351|NCT00129935|HER2 negative breast cancer|her2 negative breast cancer
5375352|NCT00129935|Node positive breast cancer|node positive breast cancer
5375353|NCT00129935|Adjuvant treatment|adjuvant treatment
5375354|NCT00129935|Oral chemotherapy|oral chemotherapy
5375355|NCT00129922|Axillary node positive breast cancer.|axillary node positive breast cancer.
5375356|NCT00129922|Sequential drug administration.|sequential drug administration.
5375357|NCT00129922|Weekly paclitaxel.|weekly paclitaxel.
5375358|NCT00129909|hypertension|hypertension
5375359|NCT00129909|family physicians|family physicians
5375360|NCT00129909|fixed dose combination therapy|fixed dose combination therapy
5375361|NCT00129909|cluster randomized controlled trial|cluster randomized controlled trial
5375362|NCT00129896|Her2neu positive breast cancer.|her2neu positive breast cancer.
5375363|NCT00129896|Neoadjuvant treatment.|neoadjuvant treatment.
5375364|NCT00129883|quality of care|quality of care
5375365|NCT00129883|antibiotic use|antibiotic use
5375366|NCT00129883|intervention|intervention
5375367|NCT00129883|lower respiratory tract infections|lower respiratory tract infections
5375368|NCT00129883|Community acquired Pneumonia|community acquired pneumonia
5375369|NCT00129883|Acute Exacerbation of Chronic Bronchitis or COPD|acute exacerbation of chronic bronchitis or copd
5375370|NCT00129844|Motexafin Gadolinium|motexafin gadolinium
5375371|NCT00129844|non-small cell, lung cancer|non-small cell, lung cancer
5375372|NCT00129844|Lung cancer|lung cancer
5375373|NCT00129844|cancer of the lung|cancer of the lung
5375374|NCT00129844|Carcinoma, Non-Small-Cell Lung|carcinoma, non-small-cell lung
5375375|NCT00129831|COPD, indacaterol, PK|copd, indacaterol, pk
5375376|NCT00129818|Genital herpes|genital herpes
5375377|NCT00129818|viral shedding|viral shedding
5375378|NCT00129818|famciclovir|famciclovir
5375379|NCT00129818|Symptomatic genital herpes|symptomatic genital herpes
5375380|NCT00129818|Asymptomatic genital herpes|asymptomatic genital herpes
5375381|NCT00129792|Blood Glucose|blood glucose
5375382|NCT00129792|Cholesterol|cholesterol
5375383|NCT00129792|Weight Loss|weight loss
5375384|NCT00129792|Insulin|insulin
5375385|NCT00129792|Complementary Therapies|complementary therapies
5375386|NCT00129779|COPD|copd
5375387|NCT00129766|Respiratory Syncytial Virus (RSV)|respiratory syncytial virus (rsv)
5375388|NCT00129766|motavizumab|motavizumab
5375389|NCT00129766|palivizumab|palivizumab
5375390|NCT00129766|Synagis|synagis
5375391|NCT00129753|Campath-1H Monoclonal Antibody|campath-1h monoclonal antibody
5375392|NCT00129753|Alemtuzumab|alemtuzumab
5375393|NCT00129753|Campath|campath
5375394|NCT00129753|Campath-1H|campath-1h
5375395|NCT00129753|Relapsed and Resistant Classical Hodgkin's Disease|relapsed and resistant classical hodgkin's disease
5375396|NCT00129753|Lymphoma|lymphoma
5375397|NCT00129740|Chronic phase CML|chronic phase cml
5375398|NCT00129740|Newly diagnosed chronic phase CML|newly diagnosed chronic phase cml
5375399|NCT00129740|AMN107|amn107
5375400|NCT00129727|Carboplatin|carboplatin
5375401|NCT00129727|Paclitaxel|paclitaxel
5375402|NCT00129727|Bevacizumab|bevacizumab
5375403|NCT00129727|Ovarian|ovarian
5375404|NCT00129727|Cancer|cancer
5375405|NCT00129714|cervical radiculopathy conservative treatment|cervical radiculopathy conservative treatment
5375406|NCT00129688|febrile neutropenia|febrile neutropenia
5375408|NCT00129688|amikacin|amikacin
5375409|NCT00129688|cloxacillin|cloxacillin
5375410|NCT00129688|children|children
5375411|NCT00129675|parkinson|parkinson
5375412|NCT00129675|diagnosis|diagnosis
5375413|NCT00129610|Agoraphobia|agoraphobia
5375414|NCT00129610|panic disorder|panic disorder
5375415|NCT00129610|Virtual Reality Therapy|virtual reality therapy
5375416|NCT00129610|Cognitive Behavior Therapy|cognitive behavior therapy
5375417|NCT00129610|cognition|cognition
5375418|NCT00129610|spatial cognition|spatial cognition
5375419|NCT00129610|PANIC DISORDER WITH AGORAPHOBIA|panic disorder with agoraphobia
5375420|NCT00129597|Ketalar|ketalar
5375421|NCT00129597|NMDA|nmda
5375422|NCT00129597|mastectomy|mastectomy
5375423|NCT00129597|postoperative chronic pain|postoperative chronic pain
5375424|NCT00129597|Chronic pain after mastectomy for breast cancer|chronic pain after mastectomy for breast cancer
5375425|NCT00129584|Endobronchial Valve (EBV) Procedure|endobronchial valve (ebv) procedure
5375426|NCT00129584|Bronchoscopic Lung Volume Reduction|bronchoscopic lung volume reduction
5375427|NCT00129545|Atrial Fibrillation|atrial fibrillation
5375428|NCT00129545|AF|af
5375429|NCT00129545|A Fib|a fib
5375430|NCT00129545|Stroke|stroke
5375431|NCT00129545|Coumadin|coumadin
5375432|NCT00129545|Warfarin|warfarin
5375433|NCT00129545|Blood thinning medication|blood thinning medication
5375434|NCT00129545|transient ischemic attack (TIA)|transient ischemic attack (tia)
5375435|NCT00129545|WATCHMAN|watchman
5375436|NCT00129545|Left atrial appendage|left atrial appendage
5375437|NCT00129545|LAA isolation|laa isolation
5375438|NCT00129545|LAA occlusion|laa occlusion
5375439|NCT00129532|HIV transmission|hiv transmission
5375440|NCT00129519|BCC curettage|bcc curettage
5375441|NCT00129506|medical abortion|medical abortion
5375442|NCT00129506|methotrexate|methotrexate
5375443|NCT00129506|misoprostol|misoprostol
5375444|NCT00129493|Practice guidelines|practice guidelines
5375445|NCT00129493|Hypertension|hypertension
5375446|NCT00129493|Primary health care|primary health care
5375447|NCT00129493|Patient-centered care|patient-centered care
5375448|NCT00129493|Healthcare quality|healthcare quality
5375449|NCT00129493|Office visits|office visits
5375450|NCT00129493|Self-efficacy|self-efficacy
5375451|NCT00129493|Self care|self care
5375452|NCT00129493|Guideline adherence|guideline adherence
5375453|NCT00129493|Patient noncompliance|patient noncompliance
5375454|NCT00129480|veterans|veterans
5375455|NCT00129480|pain and chronic disease|pain and chronic disease
5375456|NCT00129480|disease management|disease management
5375457|NCT00129480|depression|depression
5375458|NCT00129480|primary health care|primary health care
5375459|NCT00129480|practice guidelines|practice guidelines
5375460|NCT00129480|guideline adherence|guideline adherence
5375461|NCT00129480|narcotics|narcotics
5375462|NCT00129480|patient compliance|patient compliance
5375463|NCT00129480|randomized controlled trial|randomized controlled trial
5375464|NCT00129467|Depression|depression
5375465|NCT00129467|Hospice Care|hospice care
5375466|NCT00129467|Antidepressive Agents|antidepressive agents
5375467|NCT00129467|Methylphenidate|methylphenidate
5375468|NCT00129467|Central Nervous System Stimulant|central nervous system stimulant
5375469|NCT00129467|Pain|pain
5375470|NCT00129467|Caregiver Burden|caregiver burden
5375471|NCT00129467|Cancer|cancer
5375472|NCT00129454|Telemedicine|telemedicine
5375473|NCT00129454|Cognitive Behavior Therapy|cognitive behavior therapy
5375474|NCT00129454|Utilization|utilization
5375475|NCT00129454|Randomized Control Trial|randomized control trial
5375476|NCT00129454|Gulf War Illness|gulf war illness
5375477|NCT00129454|Symptom-Based Illness|symptom-based illness
5375478|NCT00129454|Multisymptom Illness|multisymptom illness
5375479|NCT00129454|High utilization|high utilization
5375480|NCT00129441|schizophrenia|schizophrenia
5375481|NCT00129428|UVB|uvb
5375482|NCT00129428|keloid|keloid
5375483|NCT00129428|scleroderma|scleroderma
5375484|NCT00129428|acne keloidalis nuchae|acne keloidalis nuchae
5375485|NCT00129428|scars|scars
5375486|NCT00129428|granuloma annulare|granuloma annulare
5375487|NCT00129415|UVA1|uva1
5375488|NCT00129415|UVB|uvb
5375489|NCT00129415|atopic dermatitis|atopic dermatitis
5375490|NCT00129415|psoriasis|psoriasis
5375491|NCT00129415|alopecia|alopecia
5375492|NCT00129415|mycosis fungoides (CTCL)|mycosis fungoides (ctcl)
5375493|NCT00129415|urticaria|urticaria
5375494|NCT00129415|inflammatory dermatoses|inflammatory dermatoses
5375495|NCT00129415|stretch marks|stretch marks
5375496|NCT00129402|cholesterol|cholesterol
5375497|NCT00129402|drugs|drugs
5375498|NCT00129402|hypercholesterolemia|hypercholesterolemia
5375499|NCT00129402|adolescent|adolescent
5375500|NCT00129402|randomized controlled trials|randomized controlled trials
5375501|NCT00129389|Node negative, high risk breast cancer.|node negative, high risk breast cancer.
5375502|NCT00129389|Prognostic gene profile.|prognostic gene profile.
5375503|NCT00129389|Saint Gallen high risk criteria.|saint gallen high risk criteria.
5375504|NCT00129389|Weekly paclitaxel.|weekly paclitaxel.
5375505|NCT00129376|Stage II and IIIA breast Cancer.|stage ii and iiia breast cancer.
5375506|NCT00129376|Neoadjuvant chemotherapy.|neoadjuvant chemotherapy.
5375507|NCT00129376|Weekly docetaxel.|weekly docetaxel.
5375508|NCT00129363|Adolescent|adolescent
5375509|NCT00129363|Adrenergic alpha-Antagonists/therapeutic use|adrenergic alpha-antagonists/therapeutic use
5375510|NCT00129363|Adrenergic alpha-Antagonists/pharmacokinetics|adrenergic alpha-antagonists/pharmacokinetics
5375511|NCT00129363|Adrenergic alpha-Antagonists/administration & dosage|adrenergic alpha-antagonists/administration & dosage
5375512|NCT00129363|Adrenergic beta-Antagonists/therapeutic use|adrenergic beta-antagonists/therapeutic use
5375513|NCT00129363|Adrenergic beta-Antagonists/pharmacokinetics|adrenergic beta-antagonists/pharmacokinetics
5375514|NCT00129363|Adrenergic beta-Antagonists/administration & dosage|adrenergic beta-antagonists/administration & dosage
5375515|NCT00129363|Age Factors|age factors
5375516|NCT00129363|Carbazoles/therapeutic use|carbazoles/therapeutic use
5375517|NCT00129363|Carbazoles/administration & dosage|carbazoles/administration & dosage
5375518|NCT00129363|Child|child
5375519|NCT00129363|Child, Preschool|child, preschool
5375520|NCT00129363|Drug Administration Schedule|drug administration schedule
5375521|NCT00129363|Female|female
5375522|NCT00129363|Heart Failure, Congestive/etiology|heart failure, congestive/etiology
5375523|NCT00129363|Heart Failure, Congestive/drug therapy|heart failure, congestive/drug therapy
5375524|NCT00129363|Heart Failure, Congestive/blood|heart failure, congestive/blood
5375525|NCT00129363|Human|human
5375526|NCT00129363|Infant|infant
5375527|NCT00129363|Infant, Newborn|infant, newborn
5375528|NCT00129363|Male|male
5375529|NCT00129363|Natriuretic Peptide, Brain/blood|natriuretic peptide, brain/blood
5375530|NCT00129363|Placebos|placebos
5375531|NCT00129363|Propanolamines/therapeutic use|propanolamines/therapeutic use
5375532|NCT00129363|Propanolamines/administration & dosage|propanolamines/administration & dosage
5375533|NCT00129363|Prospective Studies|prospective studies
5375534|NCT00129363|Support, Non-U.S. Gov't|support, non-u.s. gov't
5375535|NCT00129363|Treatment Outcome|treatment outcome
5375536|NCT00129363|Ventricular Dysfunction/drug therapy|ventricular dysfunction/drug therapy
5375537|NCT00129363|Ventricular Dysfunction/complications|ventricular dysfunction/complications
5375538|NCT00129363|Ventricular Dysfunction/blood|ventricular dysfunction/blood
5375539|NCT00129363|Ventricular Function/drug effects|ventricular function/drug effects
5375540|NCT00129363|Ventricular Remodeling/drug effects|ventricular remodeling/drug effects
5375541|NCT00129350|End Stage Fibrotic Lung Disease|end stage fibrotic lung disease
5375542|NCT00129337|monoclonal antibody|monoclonal antibody
5375543|NCT00129337|phase 1|phase 1
5375544|NCT00129337|solid tumor|solid tumor
5375545|NCT00129337|anti-angiogenesis|anti-angiogenesis
5375546|NCT00129337|refractory advanced solid tumor malignancy|refractory advanced solid tumor malignancy
5375547|NCT00129324|HOME|home
5375548|NCT00129324|Environmental Exposure|environmental exposure
5375549|NCT00129324|Neurobehavior|neurobehavior
5375550|NCT00129324|Child Development|child development
5375551|NCT00129324|Lead Exposure|lead exposure
5375552|NCT00129324|Child Injury|child injury
5375553|NCT00129324|Adolescence|adolescence
5375554|NCT00129324|Adiposity|adiposity
5375555|NCT00129324|Neuroimaging|neuroimaging
5375556|NCT00129311|Tobacco|tobacco
5375557|NCT00129298|cocaine abuse|cocaine abuse
5375558|NCT00129298|opiate dependent|opiate dependent
5375559|NCT00129298|tiagabine|tiagabine
5375560|NCT00129298|methadone|methadone
5375561|NCT00129285|cocaine|cocaine
5375562|NCT00129272|adolescents, cigarettes, smoking, tobacco|adolescents, cigarettes, smoking, tobacco
5375563|NCT00129259|T1D|t1d
5375564|NCT00129259|type 1 diabetes|type 1 diabetes
5375565|NCT00129259|type 1 diabetes mellitus|type 1 diabetes mellitus
5375566|NCT00129259|juvenile diabetes|juvenile diabetes
5375567|NCT00129259|autoimmune diabetes|autoimmune diabetes
5375568|NCT00129259|autoimmune|autoimmune
5375569|NCT00129259|anti-CD3 mAb|anti-cd3 mab
5375570|NCT00129259|mAb hOKT3g1(Ala-Ala)|mab hokt3g1(ala-ala)
5375571|NCT00129259|teplizumab|teplizumab
5375572|NCT00129246|Tobacco|tobacco
5375573|NCT00129246|Smoking|smoking
5375574|NCT00129246|Weight|weight
5375575|NCT00129246|Weight perception|weight perception
5375576|NCT00129246|Naltrexone|naltrexone
5375577|NCT00129246|Bupropion|bupropion
5375578|NCT00129233|cardiovascular disease|cardiovascular disease
5375579|NCT00129233|rennin-angiotensin system|rennin-angiotensin system
5375580|NCT00129233|calcium channel blocker|calcium channel blocker
5375581|NCT00129233|impaired glucose tolerance|impaired glucose tolerance
5375582|NCT00129220|Manic or mixed episode associated with bipolar I disorder|manic or mixed episode associated with bipolar i disorder
5375583|NCT00129207|pharmacokinetic|pharmacokinetic
5375584|NCT00129207|pharmacodynamics|pharmacodynamics
5375585|NCT00129207|VELCADE|velcade
5375586|NCT00129207|Ketoconazole|ketoconazole
5375587|NCT00129207|CYP 3A4|cyp 3a4
5375588|NCT00129207|Solid Tumor|solid tumor
5375589|NCT00129207|Advanced Solid Tumors|advanced solid tumors
5375590|NCT00129194|HIV|hiv
5375591|NCT00129194|Treatment Experienced|treatment experienced
5375592|NCT00129181|parkinson|parkinson
5375593|NCT00129181|brain imaging|brain imaging
5375594|NCT00129181|diagnosis|diagnosis
5375595|NCT00129168|Leukemia, Myeloid|leukemia, myeloid
5375596|NCT00129168|Relapse|relapse
5375597|NCT00129168|Chemotherapy|chemotherapy
5375598|NCT00129168|Zosuquidar|zosuquidar
5375599|NCT00129168|Daunorubicin|daunorubicin
5375600|NCT00129168|Cytarabine|cytarabine
5375601|NCT00129168|Acute|acute
5375602|NCT00129168|AML|aml
5375603|NCT00129168|Adult AML|adult aml
5375604|NCT00129155|Allogenic stem cell transplantation|allogenic stem cell transplantation
5375605|NCT00129155|Treosulfan|treosulfan
5375606|NCT00129155|Haematological malignancies|haematological malignancies
5375607|NCT00129155|allogeneic stem cell transplantation in patients with hematological malignancies|allogeneic stem cell transplantation in patients with hematological malignancies
5375608|NCT00129142|Prostate cancer|prostate cancer
5375609|NCT00129142|Bone Loss|bone loss
5375610|NCT00129142|Osteoporosis|osteoporosis
5375611|NCT00129142|Fractures|fractures
5375612|NCT00129142|Androgen Deprivation Therapy|androgen deprivation therapy
5375613|NCT00129129|Immunogenicity|immunogenicity
5375614|NCT00129129|Primary & booster vaccination|primary & booster vaccination
5375615|NCT00129129|Infants|infants
5375616|NCT00129129|Meningococcal vaccine|meningococcal vaccine
5375617|NCT00129129|Safety|safety
5375618|NCT00129129|Children|children
5375619|NCT00129129|Hib disease|hib disease
5375620|NCT00129129|Meningococcal disease|meningococcal disease
5375621|NCT00129116|Invasive bacterial disease caused by Hib|invasive bacterial disease caused by hib
5375622|NCT00129116|Neisseria meningitidis serogroups C & Y|neisseria meningitidis serogroups c & y
5375623|NCT00129077|Pediatric critical care|pediatric critical care
5375624|NCT00129077|neuromuscular blocking agents|neuromuscular blocking agents
5375625|NCT00129077|corneal abrasions|corneal abrasions
5375626|NCT00129064|Referrals|referrals
5375627|NCT00129064|Quality of care|quality of care
5375628|NCT00129064|Ambulatory care|ambulatory care
5375629|NCT00129064|Electronic medical record|electronic medical record
5375630|NCT00129064|Referral communication|referral communication
5375631|NCT00129051|tomotherapy|tomotherapy
5375632|NCT00129051|metastatic carcinoma|metastatic carcinoma
5375633|NCT00129025|conformal hypofractionated radiotherapy|conformal hypofractionated radiotherapy
5375634|NCT00129025|localized prostate cancer|localized prostate cancer
5375635|NCT00129012|radiation therapy|radiation therapy
5375636|NCT00129012|carcinoma|carcinoma
5375637|NCT00129012|non-small cell lung|non-small cell lung
5375638|NCT00128999|radiation therapy|radiation therapy
5375639|NCT00128986|radiotherapy|radiotherapy
5375640|NCT00128986|brain|brain
5375641|NCT00128973|CGD|cgd
5375642|NCT00128973|LAD|lad
5375643|NCT00128973|XSCID|xscid
5375644|NCT00128973|cGVHD|cgvhd
5375645|NCT00128973|Infection|infection
5375646|NCT00128973|Abnormal Immune Function|abnormal immune function
5375647|NCT00128973|Recurrent Infection|recurrent infection
5375648|NCT00128973|Chronic Granulomatous Disease|chronic granulomatous disease
5375649|NCT00128973|X-Linked Severe Combined Immune Deficiency (XSCID)|x-linked severe combined immune deficiency (xscid)
5375650|NCT00128973|Leukocyte Adhesion Deficiency 1|leukocyte adhesion deficiency 1
5375651|NCT00128973|Healthy Volunteer|healthy volunteer
5375652|NCT00128973|HV|hv
5375653|NCT00128960|Allogeneic Hematopoietic Stem Cell Transplant|allogeneic hematopoietic stem cell transplant
5375654|NCT00128960|Health Related Quality of Life|health related quality of life
5375655|NCT00128960|Symptom Experience|symptom experience
5375656|NCT00128960|Fatigue|fatigue
5375657|NCT00128960|Functional Status|functional status
5375658|NCT00128960|Survey|survey
5375659|NCT00128960|Allogeneic Stem Cell Transplant|allogeneic stem cell transplant
5375660|NCT00128947|Immunosuppresant|immunosuppresant
5375661|NCT00128947|Pharmacogenetics|pharmacogenetics
5375662|NCT00128947|Glucuronidation|glucuronidation
5375663|NCT00128947|Metabolism|metabolism
5375664|NCT00128947|UGT|ugt
5375665|NCT00128934|Premenstrual Syndrome (PMS)|premenstrual syndrome (pms)
5375666|NCT00128934|Hormone Therapy|hormone therapy
5375667|NCT00128921|Multiple Myeloma|multiple myeloma
5375668|NCT00128908|HIV-1|hiv-1
5375669|NCT00128908|HAART|haart
5375670|NCT00128908|sequential HAART|sequential haart
5375671|NCT00128908|resistance|resistance
5375672|NCT00128908|salvage therapy|salvage therapy
5375673|NCT00128908|Treatment Experienced|treatment experienced
5375674|NCT00128895|Wegener's granulomatosis, ANCA, vasculitis, proteinase 3|wegener's granulomatosis, anca, vasculitis, proteinase 3
5375675|NCT00128895|ANCA-associated vasculitis|anca-associated vasculitis
5375676|NCT00128895|ANCA|anca
5375677|NCT00128882|Idiopathic Thrombocytopenic Purpura|idiopathic thrombocytopenic purpura
5375678|NCT00128882|Treatment|treatment
5375679|NCT00128882|Anti-D|anti-d
5375680|NCT00128882|Subcutaneous|subcutaneous
5375681|NCT00128882|Clinical evaluation|clinical evaluation
5375682|NCT00128882|Platelet count|platelet count
5375683|NCT00128882|IVIG|ivig
5375684|NCT00128869|Manipulation|manipulation
5375685|NCT00128869|Mobilization|mobilization
5375686|NCT00128869|Neck Pain|neck pain
5375687|NCT00128869|Physical Therapy|physical therapy
5375688|NCT00128856|Neoadjuvant chemotherapy.|neoadjuvant chemotherapy.
5375689|NCT00128856|Stage III disease.|stage iii disease.
5375690|NCT00128843|Metastatic breast cancer|metastatic breast cancer
5375691|NCT00128843|First line of hormone treatment|first line of hormone treatment
5375692|NCT00128843|Postmenopausal women|postmenopausal women
5375693|NCT00128843|Positive hormone receptor tumours|positive hormone receptor tumours
5375694|NCT00128830|Human Immunodeficiency Virus Type 1|human immunodeficiency virus type 1
5375695|NCT00128830|HIV-1 infection|hiv-1 infection
5375696|NCT00128830|TMC125|tmc125
5375697|NCT00128830|Etravirine|etravirine
5375698|NCT00128830|Enfuvirtide|enfuvirtide
5375699|NCT00128830|Antiretroviral therapy|antiretroviral therapy
5375700|NCT00128817|neoplasm|neoplasm
5375701|NCT00128817|larynx|larynx
5375702|NCT00128817|surgery|surgery
5375703|NCT00128817|radiotherapy|radiotherapy
5375704|NCT00128817|chemotherapy|chemotherapy
5375705|NCT00128804|vitamin A|vitamin a
5375706|NCT00128804|beta Carotene|beta carotene
5375707|NCT00128804|diet|diet
5375708|NCT00128804|nutrition|nutrition
5375709|NCT00128804|nutritional requirements|nutritional requirements
5375710|NCT00128791|myocardial infarction|myocardial infarction
5375711|NCT00128791|angioplasty|angioplasty
5375712|NCT00128791|nitric oxide|nitric oxide
5375713|NCT00128791|prevention|prevention
5375714|NCT00128791|acute myocardial infarction|acute myocardial infarction
5375715|NCT00128778|Breast cancer|breast cancer
5375716|NCT00128778|Metastases|metastases
5375717|NCT00128778|Maintenance treatment|maintenance treatment
5375718|NCT00128765|chronic obstructive pulmonary disease (COPD)|chronic obstructive pulmonary disease (copd)
5375719|NCT00128765|self-management|self-management
5375720|NCT00128765|practice nurse|practice nurse
5375721|NCT00128765|cost-effectiveness|cost-effectiveness
5375722|NCT00128765|randomized controlled trial|randomized controlled trial
5375723|NCT00128752|vitamin A|vitamin a
5375724|NCT00128752|beta Carotene|beta carotene
5375725|NCT00128752|diet|diet
5375726|NCT00128752|nutrition|nutrition
5375727|NCT00128752|nutritional requirements|nutritional requirements
5375728|NCT00128726|continuous combined oral contraceptive|continuous combined oral contraceptive
5375729|NCT00128726|endometrial and ovarian suppression|endometrial and ovarian suppression
5375730|NCT00128713|Blood Transfusion|blood transfusion
5375731|NCT00128713|Blood Platelets|blood platelets
5375732|NCT00128700|adult glioblastoma|adult glioblastoma
5375733|NCT00128700|adult giant cell glioblastoma|adult giant cell glioblastoma
5375734|NCT00128700|adult gliosarcoma|adult gliosarcoma
5375735|NCT00128661|cervical intraepithelial neoplasia grade 2|cervical intraepithelial neoplasia grade 2
5375736|NCT00128661|cervical cancer|cervical cancer
5375737|NCT00128661|cervical intraepithelial neoplasia grade 3|cervical intraepithelial neoplasia grade 3
5375738|NCT00128635|adult glioblastoma|adult glioblastoma
5375739|NCT00128635|adult gliosarcoma|adult gliosarcoma
5375740|NCT00128635|adult giant cell glioblastoma|adult giant cell glioblastoma
5375741|NCT00128635|recurrent adult brain tumor|recurrent adult brain tumor
5375742|NCT00128622|male breast cancer|male breast cancer
5375743|NCT00128622|recurrent breast cancer|recurrent breast cancer
5375744|NCT00128622|stage IV breast cancer|stage iv breast cancer
5375745|NCT00128622|recurrent colon cancer|recurrent colon cancer
5375746|NCT00128622|stage IV colon cancer|stage iv colon cancer
5375747|NCT00128622|recurrent rectal cancer|recurrent rectal cancer
5375748|NCT00128622|stage IV rectal cancer|stage iv rectal cancer
5375749|NCT00128622|recurrent pancreatic cancer|recurrent pancreatic cancer
5375750|NCT00128622|extensive stage small cell lung cancer|extensive stage small cell lung cancer
5375751|NCT00128622|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5375752|NCT00128622|recurrent small cell lung cancer|recurrent small cell lung cancer
5375753|NCT00128622|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5375754|NCT00128622|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5375755|NCT00128622|stage IV pancreatic cancer|stage iv pancreatic cancer
5375756|NCT00128596|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
5375757|NCT00128596|advanced adult primary liver cancer|advanced adult primary liver cancer
5375758|NCT00128596|recurrent adult primary liver cancer|recurrent adult primary liver cancer
5375759|NCT00128583|stage III melanoma|stage iii melanoma
5375760|NCT00128570|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5375761|NCT00128557|Vitamin A|vitamin a
5375762|NCT00128557|Newborn health|newborn health
5375763|NCT00128557|Infant Mortality|infant mortality
5375764|NCT00128557|Supplementation|supplementation
5375765|NCT00128557|Micronutrients|micronutrients
5375766|NCT00128557|Bangladesh|bangladesh
5375767|NCT00128531|Phase III|phase iii
5375768|NCT00128531|open label|open label
5375769|NCT00128531|multiple dose|multiple dose
5375770|NCT00128531|safety study|safety study
5375771|NCT00128531|pharmacokinetic study|pharmacokinetic study
5375772|NCT00128531|efficacy study|efficacy study
5375773|NCT00128518|Hypertension - Drugs - Blood pressure response - Responders - pharmacogenetics|hypertension - drugs - blood pressure response - responders - pharmacogenetics
5375775|NCT00128505|Depression|depression
5375776|NCT00128505|Psychosis|psychosis
5375777|NCT00128505|Psychotic Major Depression|psychotic major depression
5375778|NCT00128505|Major Depression|major depression
5375779|NCT00128492|cystic fibrosis|cystic fibrosis
5375780|NCT00128492|Pseudomonas aeruginosa|pseudomonas aeruginosa
5375781|NCT00128479|PMD|pmd
5375782|NCT00128479|Psychotic Depression|psychotic depression
5375783|NCT00128479|Psychosis|psychosis
5375784|NCT00128479|Major Depression|major depression
5375785|NCT00128479|Depression|depression
5375786|NCT00128479|Psychotic Major Depression|psychotic major depression
5375787|NCT00128466|bubonic plague|bubonic plague
5375788|NCT00128466|pneumonic plague|pneumonic plague
5375988|NCT00127686|cough|cough
5375789|NCT00128466|septicemic plague|septicemic plague
5375790|NCT00128466|Yersinia pestis|yersinia pestis
5375791|NCT00128466|Pasteurella pestis|pasteurella pestis
5375792|NCT00128453|Pericarditis|pericarditis
5375793|NCT00128453|Recurrence|recurrence
5375794|NCT00128453|Therapeutics|therapeutics
5375795|NCT00128453|Prevention|prevention
5375796|NCT00128453|Colchicine|colchicine
5375797|NCT00128427|Postpericardiotomy Syndrome|postpericardiotomy syndrome
5375798|NCT00128427|Pericarditis|pericarditis
5375799|NCT00128427|Prevention|prevention
5375800|NCT00128427|Colchicine|colchicine
5375801|NCT00128427|Recurrence|recurrence
5375802|NCT00128414|Pericarditis|pericarditis
5375803|NCT00128414|Recurrence|recurrence
5375804|NCT00128414|Therapeutics|therapeutics
5375805|NCT00128414|Prevention|prevention
5375806|NCT00128414|Colchicine|colchicine
5375807|NCT00128401|Cognitive|cognitive
5375808|NCT00128401|Behavioral|behavioral
5375809|NCT00128401|Adolescent|adolescent
5375810|NCT00128401|Therapy|therapy
5375811|NCT00128401|Extinction|extinction
5375812|NCT00128401|Social Phobia|social phobia
5375813|NCT00128388|panic disorder,|panic disorder,
5375814|NCT00128388|psychodynamic psychotherapy,|psychodynamic psychotherapy,
5375815|NCT00128388|efficacy trial|efficacy trial
5375816|NCT00128375|Smoking Cessation|smoking cessation
5375817|NCT00128375|Work-site|work-site
5375818|NCT00128375|Incentives|incentives
5375819|NCT00128375|Cost Effectiveness|cost effectiveness
5375820|NCT00128375|Health Behavior|health behavior
5375821|NCT00128375|Smoking|smoking
5375822|NCT00128362|Sentinel node|sentinel node
5375823|NCT00128362|Axillary sampling|axillary sampling
5375824|NCT00128362|Operable breast cancer|operable breast cancer
5375825|NCT00128336|Weight|weight
5375826|NCT00128336|Diet|diet
5375827|NCT00128336|exercise|exercise
5375828|NCT00128336|maintenance|maintenance
5375829|NCT00128323|Children|children
5375830|NCT00128323|oropharyngeal candidiasis|oropharyngeal candidiasis
5375831|NCT00128323|GV solution|gv solution
5375832|NCT00128323|nystatin drops|nystatin drops
5375833|NCT00128310|Drug-resistant metastatic breast cancer|drug-resistant metastatic breast cancer
5375834|NCT00128297|Breast cancer patients with symptomatic bone metastases|breast cancer patients with symptomatic bone metastases
5375835|NCT00128284|gastroparesis|gastroparesis
5375836|NCT00128284|Digestive|digestive
5375837|NCT00128284|Gastrointestinal|gastrointestinal
5375838|NCT00128284|Stomach|stomach
5375839|NCT00128284|Motility|motility
5375840|NCT00128284|Non-Invasive|non-invasive
5375841|NCT00128284|Capsule|capsule
5375842|NCT00128284|GI|gi
5375843|NCT00128284|Device|device
5375844|NCT00128284|Digestive System Diseases|digestive system diseases
5375845|NCT00128271|HCV|hcv
5375846|NCT00128271|monoclonal antibody|monoclonal antibody
5375847|NCT00128271|phase 1|phase 1
5375848|NCT00128258|Stem Cell|stem cell
5375849|NCT00128258|Heart Failure|heart failure
5375850|NCT00128258|Bone Marrow|bone marrow
5375851|NCT00128245|KCS|kcs
5375852|NCT00128245|dry eye|dry eye
5375853|NCT00128245|pimecrolimus|pimecrolimus
5375854|NCT00128245|Keratoconjunctivitis sicca (dry eye syndrome)|keratoconjunctivitis sicca (dry eye syndrome)
5375855|NCT00128232|Acromegaly|acromegaly
5375856|NCT00128232|untreated|untreated
5375857|NCT00128232|newly diagnosed|newly diagnosed
5375858|NCT00128232|octreotide LAR|octreotide lar
5375859|NCT00128219|Group B Streptococcus, women, vaccine|group b streptococcus, women, vaccine
5375860|NCT00128206|LTBI, tuberculosis, rifampin, isoniazid, prisoners|ltbi, tuberculosis, rifampin, isoniazid, prisoners
5375861|NCT00128193|leprosy, Mycobacterium leprae, Hansen's Disease, skin test, Nepal|leprosy, mycobacterium leprae, hansen's disease, skin test, nepal
5375862|NCT00128180|hantaviruses, methylprednisolone, cardiopulmonary syndrome|hantaviruses, methylprednisolone, cardiopulmonary syndrome
5375863|NCT00128154|Chromium|chromium
5375864|NCT00128154|Chromium picolinate|chromium picolinate
5375865|NCT00128154|Blood Glucose|blood glucose
5375866|NCT00128154|Cholesterol|cholesterol
5375867|NCT00128154|Complementary Therapies|complementary therapies
5375868|NCT00128128|Vaccinium macrocarpon|vaccinium macrocarpon
5375869|NCT00128128|Cranberry|cranberry
5375870|NCT00128128|Complementary Therapies|complementary therapies
5375871|NCT00128102|Advanced malignant pleural mesothelioma|advanced malignant pleural mesothelioma
5375872|NCT00128089|Obesity|obesity
5375873|NCT00128089|Dietary treatment|dietary treatment
5375874|NCT00128089|Fasting as medical therapy|fasting as medical therapy
5375875|NCT00128076|shoulder surgery|shoulder surgery
5375876|NCT00128076|rotator cuff|rotator cuff
5375877|NCT00128076|arthroscopic repair|arthroscopic repair
5375878|NCT00128076|mini-open repair|mini-open repair
5375879|NCT00128063|HIV-1|hiv-1
5375880|NCT00128063|succinylated human serum albumin|succinylated human serum albumin
5375881|NCT00128063|Treatment Naive|treatment naive
5375882|NCT00128050|Spontaneous intracerebral hemorrhage|spontaneous intracerebral hemorrhage
5375883|NCT00128050|ICH|ich
5375884|NCT00128050|intracerebral rebleeding|intracerebral rebleeding
5375885|NCT00128050|cerebral hematoma evacuation|cerebral hematoma evacuation
5375886|NCT00128050|cerebral hematoma volume|cerebral hematoma volume
5375887|NCT00128037|pulmonary neoplasm|pulmonary neoplasm
5375888|NCT00128037|preoperative chemoradiotherapy|preoperative chemoradiotherapy
5375889|NCT00128037|surgical resection|surgical resection
5375890|NCT00128037|superior sulcus tumor|superior sulcus tumor
5375891|NCT00128037|chest wall invasion|chest wall invasion
5375892|NCT00128037|mytomicin C|mytomicin c
5375893|NCT00128037|vindesine|vindesine
5375894|NCT00128037|cisplatin|cisplatin
5375895|NCT00128024|randomized prospective study|randomized prospective study
5375896|NCT00128024|lipid-lowering therapy with any available statins|lipid-lowering therapy with any available statins
5375897|NCT00128024|multicenter study|multicenter study
5375898|NCT00128024|Japanese|japanese
5375899|NCT00128024|acute myocardial infarction|acute myocardial infarction
5375900|NCT00128024|primary percutaneous coronary intervention|primary percutaneous coronary intervention
5375901|NCT00128011|watery diarrhea|watery diarrhea
5375902|NCT00128011|cholera vaccine|cholera vaccine
5375903|NCT00127998|malaria|malaria
5375904|NCT00127998|Plasmodium falciparum|plasmodium falciparum
5375905|NCT00127998|drug resistance|drug resistance
5375906|NCT00127998|antimalarials|antimalarials
5375907|NCT00127998|genotype|genotype
5375908|NCT00127998|treatment outcome|treatment outcome
5375909|NCT00127985|multiple organ dysfunction syndrome|multiple organ dysfunction syndrome
5375910|NCT00127985|corticosteroids|corticosteroids
5375911|NCT00127985|mortality|mortality
5375912|NCT00127972|nevirapine|nevirapine
5375913|NCT00127972|efavirenz|efavirenz
5375914|NCT00127972|hiv-1|hiv-1
5375915|NCT00127972|Treatment Experienced|treatment experienced
5375916|NCT00127959|HIV-1|hiv-1
5375917|NCT00127959|HBV|hbv
5375918|NCT00127959|treatment|treatment
5375919|NCT00127959|tenofovir|tenofovir
5375920|NCT00127959|emtricitabine|emtricitabine
5375921|NCT00127959|Treatment Naive|treatment naive
5375922|NCT00127959|HIV-1 infection|hiv-1 infection
5375923|NCT00127959|Hepatitis B virus infection|hepatitis b virus infection
5375924|NCT00127907|Out-of-hospital cardiac arrest - Vasopressin - Epinephrine|out-of-hospital cardiac arrest - vasopressin - epinephrine
5375925|NCT00127881|Refractory or intolerant to Mycosis Fungoides and sezary syndrome|refractory or intolerant to mycosis fungoides and sezary syndrome
5375926|NCT00127881|Cutaneous T-cell Lymphoma|cutaneous t-cell lymphoma
5375927|NCT00127881|To evaluate the efficacy and safety of zanolimumab in Mycosis Fungoides and sezary syndrome|to evaluate the efficacy and safety of zanolimumab in mycosis fungoides and sezary syndrome
5375928|NCT00127868|Tinea Capitis|tinea capitis
5375929|NCT00127868|Children|children
5375930|NCT00127868|Pediatric|pediatric
5375931|NCT00127868|Treatment|treatment
5375932|NCT00127868|Therapy|therapy
5375933|NCT00127868|Adjunctive|adjunctive
5375934|NCT00127868|Selenium Sulfide|selenium sulfide
5375935|NCT00127868|Ciclopirox|ciclopirox
5375936|NCT00127868|Shampoo|shampoo
5375937|NCT00127855|Invasive bacterial disease caused by Hib|invasive bacterial disease caused by hib
5375938|NCT00127855|Neisseria meningitidis serogroups C & Y|neisseria meningitidis serogroups c & y
5375939|NCT00127842|Psoriatic Arthritis|psoriatic arthritis
5375940|NCT00127842|PsA|psa
5375941|NCT00127842|Commercial product|commercial product
5375942|NCT00127842|American College of Rheumatology|american college of rheumatology
5375943|NCT00127842|ACR/PASI|acr/pasi
5375944|NCT00127829|Solid Tumors|solid tumors
5375945|NCT00127816|brachytherapy|brachytherapy
5375946|NCT00127816|implant radiotherapy|implant radiotherapy
5375947|NCT00127803|Clostridium difficile|clostridium difficile
5375948|NCT00127790|Insomnia|insomnia
5375949|NCT00127790|Sleep|sleep
5375950|NCT00127790|Pain|pain
5375951|NCT00127790|Pain, Chronic|pain, chronic
5375952|NCT00127790|Behavior Therapy|behavior therapy
5375953|NCT00127790|CBT|cbt
5375954|NCT00127790|CBT-I|cbt-i
5375955|NCT00127790|cognitive-behavioral|cognitive-behavioral
5375956|NCT00127777|HCV genotype 1|hcv genotype 1
5375957|NCT00127777|peginterferon alfa-2a|peginterferon alfa-2a
5375958|NCT00127777|ribavirin|ribavirin
5375959|NCT00127777|amantadine|amantadine
5375960|NCT00127777|treatment-naive|treatment-naive
5375961|NCT00127764|pemphigus|pemphigus
5375962|NCT00127764|dexamethasone|dexamethasone
5375963|NCT00127764|glucocorticoids|glucocorticoids
5375964|NCT00127764|pulse|pulse
5375965|NCT00127764|therapy|therapy
5375966|NCT00127764|randomised|randomised
5375967|NCT00127764|placebo-controlled|placebo-controlled
5375968|NCT00127751|Risk factor reduction|risk factor reduction
5375969|NCT00127751|cardiovascular disease prevention|cardiovascular disease prevention
5375970|NCT00127738|Hypertension|hypertension
5375971|NCT00127738|Renal artery stenosis|renal artery stenosis
5375972|NCT00127738|Kidney disease|kidney disease
5375973|NCT00127738|Renal vascular disease|renal vascular disease
5375974|NCT00127738|Atherosclerosis|atherosclerosis
5375975|NCT00127725|tibia|tibia
5375976|NCT00127725|fracture|fracture
5375977|NCT00127725|PEMF|pemf
5375978|NCT00127725|electromagnetic|electromagnetic
5375979|NCT00127725|non-union|non-union
5375980|NCT00127725|revision|revision
5375981|NCT00127725|Diaphyseal fractures of the tibia|diaphyseal fractures of the tibia
5375982|NCT00127712|amiodarone|amiodarone
5375983|NCT00127712|atrial fibrillation|atrial fibrillation
5375984|NCT00127712|surgical procedures, thoracic|surgical procedures, thoracic
5375985|NCT00127699|Umbilical cord|umbilical cord
5375986|NCT00127699|Triple dye|triple dye
5375987|NCT00127699|Infant care|infant care
5375989|NCT00127686|nocturnal cough|nocturnal cough
5375990|NCT00127686|upper respiratory tract infection|upper respiratory tract infection
5375991|NCT00127686|sleep quality|sleep quality
5375992|NCT00127686|childhood cough|childhood cough
5375993|NCT00127686|Dextromethorphan|dextromethorphan
5375994|NCT00127686|Honey|honey
5375995|NCT00127673|Antidepressants|antidepressants
5375996|NCT00127673|Cognitive behavior therapy|cognitive behavior therapy
5375997|NCT00127660|Behavior|behavior
5375998|NCT00127621|ICU patients needing prolonged ventilatory support|icu patients needing prolonged ventilatory support
5375999|NCT00127595|carcinoma of the urothelial tract|carcinoma of the urothelial tract
5376000|NCT00127582|Myotonic dystrophy type 1|myotonic dystrophy type 1
5376001|NCT00127582|Sudden cardiac death|sudden cardiac death
5376002|NCT00127582|Ventricular tachyarrhythmias|ventricular tachyarrhythmias
5376003|NCT00127582|Bradyarrhythmias|bradyarrhythmias
5376004|NCT00127569|HIV infections|hiv infections
5376005|NCT00127569|Giant Lymph Node Hyperplasia|giant lymph node hyperplasia
5376006|NCT00127569|Herpesvirus 8, Human|herpesvirus 8, human
5376007|NCT00127569|Rituximab (Mabthera)|rituximab (mabthera)
5376008|NCT00127569|Antibodies, Monoclonal|antibodies, monoclonal
5376009|NCT00127556|Transfusion|transfusion
5376010|NCT00127556|Safety|safety
5376011|NCT00127543|Medication Education|medication education
5376012|NCT00127543|Pediatric|pediatric
5376013|NCT00127530|Walking Ability|walking ability
5376014|NCT00127517|Oncology|oncology
5376015|NCT00127517|Palliative Care|palliative care
5376016|NCT00127517|Advanced Cancer|advanced cancer
5376017|NCT00127517|Palliative Cancer Care|palliative cancer care
5376018|NCT00127504|Onchocerciasis|onchocerciasis
5376019|NCT00127504|Wolbachia|wolbachia
5376020|NCT00127504|Therapy|therapy
5376021|NCT00127491|Acute Lung Injury|acute lung injury
5376022|NCT00127491|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
5376023|NCT00127491|Mechanical Ventilation|mechanical ventilation
5376024|NCT00127491|Esophageal Pressures|esophageal pressures
5376025|NCT00127491|Randomized Controlled Trial|randomized controlled trial
5376026|NCT00127478|Hormone Refractory Prostate Cancer|hormone refractory prostate cancer
5376027|NCT00127478|Adenocarcinoma of the Prostate|adenocarcinoma of the prostate
5376028|NCT00127465|Medical Informatics|medical informatics
5376029|NCT00127465|Patient education|patient education
5376030|NCT00127465|Social support|social support
5376031|NCT00127465|Cancer|cancer
5376032|NCT00127465|Anxiety|anxiety
5376033|NCT00127452|alpha-linolenic acid|alpha-linolenic acid
5376034|NCT00127452|cardiovascular diseases|cardiovascular diseases
5376035|NCT00127452|coronary heart disease|coronary heart disease
5376036|NCT00127452|coronary patients|coronary patients
5376037|NCT00127452|DHA|dha
5376038|NCT00127452|dietary intervention|dietary intervention
5376039|NCT00127452|dietary supplementation|dietary supplementation
5376040|NCT00127452|docosahexaenoic acid|docosahexaenoic acid
5376041|NCT00127452|eicosapentaenoic acid|eicosapentaenoic acid
5376042|NCT00127452|EPA|epa
5376043|NCT00127452|fish oil|fish oil
5376044|NCT00127452|fish fatty acids|fish fatty acids
5376045|NCT00127452|human subjects|human subjects
5376046|NCT00127452|ischaemic heart disease|ischaemic heart disease
5376047|NCT00127452|margarine|margarine
5376048|NCT00127452|marine fatty acids|marine fatty acids
5376049|NCT00127452|mortality|mortality
5376050|NCT00127452|myocardial infarction|myocardial infarction
5376051|NCT00127452|n-3 fatty acids|n-3 fatty acids
5376052|NCT00127452|n-3 polyunsaturated fatty acids|n-3 polyunsaturated fatty acids
5376053|NCT00127452|n-3 PUFA|n-3 pufa
5376054|NCT00127452|omega-3 fatty acids|omega-3 fatty acids
5376055|NCT00127452|omega-3 polyunsaturated fatty acids|omega-3 polyunsaturated fatty acids
5376056|NCT00127452|prevention|prevention
5376057|NCT00127452|randomized controlled trial|randomized controlled trial
5376058|NCT00127452|secondary prevention|secondary prevention
5376059|NCT00127439|Ambulatory Disability|ambulatory disability
5376060|NCT00127439|Disability Ambulation|disability ambulation
5376061|NCT00127439|Locomotion Disorders|locomotion disorders
5376062|NCT00127439|Motor Activity|motor activity
5376063|NCT00127439|Rehabilitation|rehabilitation
5376064|NCT00127439|Spinal Cord Injury|spinal cord injury
5376065|NCT00127413|Chronic pain|chronic pain
5376066|NCT00127413|Co-morbid|co-morbid
5376067|NCT00127413|Intervention|intervention
5376068|NCT00127413|Posttraumatic Stress Disorder|posttraumatic stress disorder
5376069|NCT00127413|Treatment|treatment
5376070|NCT00127400|anger|anger
5376071|NCT00127400|intermittent|intermittent
5376072|NCT00127400|explosive|explosive
5376073|NCT00127387|Bone metastasis|bone metastasis
5376074|NCT00127387|Radiation therapy|radiation therapy
5376075|NCT00127387|Lung cancer|lung cancer
5376076|NCT00127387|Prostate cancer|prostate cancer
5376077|NCT00127387|Advanced lung cancer receiving radiation therapy|advanced lung cancer receiving radiation therapy
5376078|NCT00127387|Advanced prostate cancer receiving radiation therapy|advanced prostate cancer receiving radiation therapy
5376079|NCT00127387|Any cancer with bone mets receiving radiation therapy|any cancer with bone mets receiving radiation therapy
5376080|NCT00127374|Overweight; self-esteem; depression|overweight; self-esteem; depression
5376081|NCT00127361|doula|doula
5376082|NCT00127361|caregivers|caregivers
5376083|NCT00127361|labor support|labor support
5376084|NCT00127361|being with woman|being with woman
5376085|NCT00127361|continuous labor support|continuous labor support
5376086|NCT00127361|maternal outcomes|maternal outcomes
5376087|NCT00127361|Parturition|parturition
5376088|NCT00127335|rhabdomyolysis,|rhabdomyolysis,
5376089|NCT00127335|myositis,|myositis,
5376090|NCT00127335|myopathy,|myopathy,
5376091|NCT00127335|statin side effects,|statin side effects,
5376092|NCT00127335|fatty acid oxidation|fatty acid oxidation
5376093|NCT00127335|Statin induced Muscle toxicity|statin induced muscle toxicity
5376094|NCT00127322|Heart Failure, Congestive|heart failure, congestive
5376095|NCT00127322|survival|survival
5376096|NCT00127322|patient admission|patient admission
5376097|NCT00127309|hangover|hangover
5376098|NCT00127309|hangover symptoms|hangover symptoms
5376099|NCT00127270|OAB|oab
5376100|NCT00127270|Overactive Bladder|overactive bladder
5376101|NCT00127270|Bladder hyperactivity|bladder hyperactivity
5376102|NCT00127270|Urge Incontinence|urge incontinence
5376103|NCT00127270|Incontinence|incontinence
5376104|NCT00127270|Bladder|bladder
5376105|NCT00127257|Constipation|constipation
5376106|NCT00127257|Biofeedback|biofeedback
5376107|NCT00127257|Dyssynergia|dyssynergia
5376108|NCT00127257|Pelvic floor dyssynergia|pelvic floor dyssynergia
5376109|NCT00127257|Outlet dysfunction|outlet dysfunction
5376110|NCT00127231|Controlled Clinical Trials, Randomized|controlled clinical trials, randomized
5376111|NCT00127231|Alcohol Consumption|alcohol consumption
5376112|NCT00127231|Behavioral Research|behavioral research
5376113|NCT00127231|HIV|hiv
5376114|NCT00127231|Alcohol Abuse|alcohol abuse
5376115|NCT00127218|atherosclerotic plaque|atherosclerotic plaque
5376116|NCT00127218|MRI|mri
5376117|NCT00127218|inflammatory markers|inflammatory markers
5376118|NCT00127218|statins|statins
5376119|NCT00127205|stage I breast cancer|stage i breast cancer
5376120|NCT00127205|stage II breast cancer|stage ii breast cancer
5376121|NCT00127205|stage IIIA breast cancer|stage iiia breast cancer
5376122|NCT00127205|stage IIIB breast cancer|stage iiib breast cancer
5376123|NCT00127205|stage IIIC breast cancer|stage iiic breast cancer
5376124|NCT00127127|Solid tumors|solid tumors
5376125|NCT00127114|Behavioral disturbance|behavioral disturbance
5376126|NCT00127114|Frontotemporal dementia|frontotemporal dementia
5376127|NCT00127114|Dementia|dementia
5376128|NCT00127114|Amantadine|amantadine
5376129|NCT00127114|Behavioral disturbance due to frontotemporal dementia|behavioral disturbance due to frontotemporal dementia
5376130|NCT00127088|Patients with localized Gleason 7 pT2a-pT2b adenocarcinoma of the prostate|patients with localized gleason 7 pt2a-pt2b adenocarcinoma of the prostate
5376131|NCT00127075|Multiple sclerosis. Relapses. Post partum. Pregnancy. Delivery. Hormones. Progesterone. Estradiol. Clinical trial. Prevention.|multiple sclerosis. relapses. post partum. pregnancy. delivery. hormones. progesterone. estradiol. clinical trial. prevention.
5376132|NCT00127062|Exposure to Oxford Street|exposure to oxford street
5376133|NCT00127062|Exposure to Hyde Park|exposure to hyde park
5376134|NCT00127049|Patients with relapsed non-seminomatous germ-cell tumors (NSGCT)|patients with relapsed non-seminomatous germ-cell tumors (nsgct)
5376135|NCT00127036|colon|colon
5376136|NCT00127036|adenocarcinoma|adenocarcinoma
5376137|NCT00127036|adenocarcinoma-colon|adenocarcinoma-colon
5376138|NCT00127036|adenocarcinoma-rectum|adenocarcinoma-rectum
5376139|NCT00127023|Prophylaxis measles, mumps, rubella and chickenpox|prophylaxis measles, mumps, rubella and chickenpox
5376140|NCT00127010|Prophylaxis measles, mumps, rubella and chickenpox|prophylaxis measles, mumps, rubella and chickenpox
5376141|NCT00126997|Prophylaxis measles, mumps, rubella and chickenpox|prophylaxis measles, mumps, rubella and chickenpox
5376142|NCT00126984|Safety|safety
5376143|NCT00126984|Reactogenicity|reactogenicity
5376144|NCT00126984|Immunogenicity|immunogenicity
5376145|NCT00126984|Meningococcal vaccine|meningococcal vaccine
5376146|NCT00126984|Dose selection|dose selection
5376147|NCT00126984|Conjugate vaccine|conjugate vaccine
5376148|NCT00126971|malaria|malaria
5376149|NCT00126971|pregnancy|pregnancy
5376150|NCT00126971|Plasmodium falciparum|plasmodium falciparum
5376151|NCT00126971|antimalarials|antimalarials
5376152|NCT00126971|pharmacokinetics|pharmacokinetics
5376153|NCT00126971|treatment outcome|treatment outcome
5376154|NCT00126971|safety|safety
5376155|NCT00126958|superficial urothelial cell carcinoma|superficial urothelial cell carcinoma
5376156|NCT00126958|urinary analysis|urinary analysis
5376157|NCT00126958|Loss of heterozygosity|loss of heterozygosity
5376158|NCT00126958|FGFR3 mutation|fgfr3 mutation
5376159|NCT00126958|follow-up|follow-up
5376160|NCT00126945|Meningococcal serogroups A, C, W-135, Y disease|meningococcal serogroups a, c, w-135, y disease
5376161|NCT00126906|Malaria|malaria
5376162|NCT00126906|Pregnancy|pregnancy
5376163|NCT00126906|HIV|hiv
5376164|NCT00126893|Leukemia|leukemia
5376165|NCT00126893|AML|aml
5376166|NCT00126893|CC401|cc401
5376167|NCT00126893|CC-401|cc-401
5376168|NCT00126893|Celgene|celgene
5376169|NCT00126893|High Risk Myeloid Leukemia|high risk myeloid leukemia
5376170|NCT00126893|Myeloid Leukemia|myeloid leukemia
5376171|NCT00126880|Human Immunodeficiency Virus|human immunodeficiency virus
5376172|NCT00126880|anti-retroviral therapy|anti-retroviral therapy
5376173|NCT00126880|nucleoside analogue|nucleoside analogue
5376174|NCT00126880|reverse transcriptase|reverse transcriptase
5376175|NCT00126880|lamivudine|lamivudine
5376176|NCT00126880|resistance mutation|resistance mutation
5376177|NCT00126880|Treatment Experienced|treatment experienced
5376178|NCT00126867|thymidylate synthase polymers|thymidylate synthase polymers
5376179|NCT00126867|rapecitabine|rapecitabine
5376180|NCT00126867|adjuvant|adjuvant
5376181|NCT00126867|colon cancer|colon cancer
5376182|NCT00126867|toxicity|toxicity
5376183|NCT00126867|Stage II colon cancer|stage ii colon cancer
5376184|NCT00126867|Stage III colon cancer|stage iii colon cancer
5376185|NCT00126867|adenocarcinoma of the colon|adenocarcinoma of the colon
5376186|NCT00126854|brachytherapy|brachytherapy
5376187|NCT00126854|magnetic resonance spectroscopy|magnetic resonance spectroscopy
5376188|NCT00126841|radiotherapy planning CT/MR fusion|radiotherapy planning ct/mr fusion
5376189|NCT00126828|radiotherapy, conformal|radiotherapy, conformal
5376190|NCT00126828|lung neoplasm|lung neoplasm
5376191|NCT00126828|radiotherapy dosage|radiotherapy dosage
5376192|NCT00126815|prostate cancer|prostate cancer
5376193|NCT00126815|prostate specific antigen|prostate specific antigen
5376194|NCT00126815|radiotherapy|radiotherapy
5376195|NCT00126815|mathematical modeling|mathematical modeling
5376196|NCT00126802|tomotherapy|tomotherapy
5376197|NCT00126802|MRSZ|mrsz
5376198|NCT00126802|high risk prostate cancer|high risk prostate cancer
5376199|NCT00126789|Pain Cancer|pain cancer
5376200|NCT00126789|Chronic Pain|chronic pain
5376201|NCT00126776|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
5376202|NCT00126776|case management|case management
5376203|NCT00126776|self management|self management
5376204|NCT00126763|Chronic Pain|chronic pain
5376205|NCT00126763|Pain|pain
5376206|NCT00126750|Myocardial Infarction|myocardial infarction
5376207|NCT00126750|Comorbidities|comorbidities
5376208|NCT00126750|Guidelines|guidelines
5376209|NCT00126750|Computer Assisted Instruction|computer assisted instruction
5376210|NCT00126750|Physician Practice Instruction|physician practice instruction
5376211|NCT00126750|Online Systems|online systems
5376212|NCT00126737|Elderly|elderly
5376213|NCT00126737|Exercise|exercise
5376214|NCT00126737|lean body mass|lean body mass
5376215|NCT00126737|muscle strength|muscle strength
5376216|NCT00126737|Nutrition program|nutrition program
5376217|NCT00126737|Pain control|pain control
5376218|NCT00126737|stair climb|stair climb
5376219|NCT00126737|walking distance|walking distance
5376220|NCT00126737|weight loss|weight loss
5376221|NCT00126724|tgAAC94|tgaac94
5376222|NCT00126724|Rheumatoid arthritis|rheumatoid arthritis
5376223|NCT00126724|Inflammatory arthritis|inflammatory arthritis
5376224|NCT00126724|Arthritis|arthritis
5376225|NCT00126724|Gene therapy|gene therapy
5376226|NCT00126724|AAV|aav
5376227|NCT00126698|Bacteriuria|bacteriuria
5376228|NCT00126698|Urinary Catheter|urinary catheter
5376229|NCT00126698|Urinary tract infection|urinary tract infection
5376230|NCT00126698|Prophylaxis|prophylaxis
5376231|NCT00126698|Urinary catheter removal|urinary catheter removal
5376232|NCT00126685|stage IV melanoma|stage iv melanoma
5376233|NCT00126685|recurrent melanoma|recurrent melanoma
5376234|NCT00126672|angiomyolipoma|angiomyolipoma
5376235|NCT00126646|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
5376236|NCT00126646|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5376237|NCT00126646|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5376238|NCT00126646|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5376239|NCT00126646|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5376240|NCT00126646|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5376241|NCT00126646|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5376242|NCT00126646|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5376243|NCT00126646|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5376244|NCT00126646|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5376245|NCT00126646|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5376246|NCT00126646|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5376247|NCT00126646|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5376248|NCT00126646|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5376249|NCT00126646|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5376250|NCT00126646|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5376251|NCT00126646|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5376252|NCT00126646|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5376253|NCT00126646|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5376254|NCT00126646|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5376255|NCT00126646|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5376256|NCT00126646|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5376257|NCT00126646|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5376258|NCT00126646|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
5376259|NCT00126646|prolymphocytic leukemia|prolymphocytic leukemia
5376260|NCT00126633|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
5376261|NCT00126633|stage IV pancreatic cancer|stage iv pancreatic cancer
5376262|NCT00126620|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5376263|NCT00126581|A Phase II Randomized Study of OSI-774|a phase ii randomized study of osi-774
5376264|NCT00126555|squamous cell carcinoma of the skin|squamous cell carcinoma of the skin
5376265|NCT00126555|recurrent skin cancer|recurrent skin cancer
5376266|NCT00126555|non-melanomatous skin cancer|non-melanomatous skin cancer
5376267|NCT00126555|Radiation|radiation
5376268|NCT00126555|ZD1839|zd1839
5376269|NCT00126555|Iressa|iressa
5376270|NCT00126555|Gefitinib|gefitinib
5376271|NCT00126516|silent brain infarction|silent brain infarction
5376272|NCT00126516|cognitive decline|cognitive decline
5376273|NCT00126516|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers
5376274|NCT00126516|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors
5376275|NCT00126516|hypertension|hypertension
5376276|NCT00126477|quality of life|quality of life
5376277|NCT00126477|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5376278|NCT00126477|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5376279|NCT00126477|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5376280|NCT00126477|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
5376281|NCT00126477|childhood Hodgkin lymphoma|childhood hodgkin lymphoma
5376282|NCT00126477|childhood lymphoblastic lymphoma|childhood lymphoblastic lymphoma
5376283|NCT00126477|childhood large cell lymphoma|childhood large cell lymphoma
5376284|NCT00126477|childhood small noncleaved cell lymphoma|childhood small noncleaved cell lymphoma
5376285|NCT00126477|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
5376286|NCT00126477|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
5376287|NCT00126477|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
5376288|NCT00126464|ductal breast carcinoma in situ|ductal breast carcinoma in situ
5376289|NCT00126464|breast cancer in situ|breast cancer in situ
5376290|NCT00126438|Heart Failure|heart failure
5376291|NCT00126438|nuclear cardiology|nuclear cardiology
5376292|NCT00126438|sympathetic innervation|sympathetic innervation
5376293|NCT00126438|123I-mIBG|123i-mibg
5376294|NCT00126425|Heart Failure|heart failure
5376295|NCT00126425|nuclear cardiology|nuclear cardiology
5376296|NCT00126425|sympathetic innervation|sympathetic innervation
5376297|NCT00126425|123I-mIBG|123i-mibg
5376298|NCT00126412|Phaeochromocytoma|phaeochromocytoma
5376299|NCT00126412|Neuroblastoma|neuroblastoma
5376300|NCT00126412|diagnosis|diagnosis
5376301|NCT00126412|123I-mIBG|123i-mibg
5376302|NCT00126399|rosacea|rosacea
5376303|NCT00126399|acne rosacea|acne rosacea
5376304|NCT00126386|tumor induced hypercalcemia|tumor induced hypercalcemia
5376305|NCT00126386|malignant bone pain|malignant bone pain
5376306|NCT00126386|bisphosphonates|bisphosphonates
5376307|NCT00126386|cancer|cancer
5376308|NCT00126386|palliative|palliative
5376309|NCT00126386|Zometa|zometa
5376310|NCT00126386|palliative patient|palliative patient
5376311|NCT00126386|treatment in community|treatment in community
5376312|NCT00126373|Crohn disease|crohn disease
5376313|NCT00126373|TNF-alpha|tnf-alpha
5376314|NCT00126360|Breast Cancer|breast cancer
5376315|NCT00126360|Timing of Radiotherapy|timing of radiotherapy
5376316|NCT00126360|Local Control|local control
5376317|NCT00126347|betaine|betaine
5376318|NCT00126347|serine|serine
5376319|NCT00126347|folic acid|folic acid
5376320|NCT00126347|methionine load|methionine load
5376321|NCT00126347|homocysteine|homocysteine
5376322|NCT00126347|cardiovascular health|cardiovascular health
5376323|NCT00126347|vascular function|vascular function
5376324|NCT00126347|human|human
5376325|NCT00126334|Myocardial Infarction|myocardial infarction
5376326|NCT00126334|Anemia|anemia
5376327|NCT00126334|Erythrocyte Transfusion|erythrocyte transfusion
5376328|NCT00126321|AML, relapsed|aml, relapsed
5376329|NCT00126321|cladribine|cladribine
5376330|NCT00126321|chemotherapy|chemotherapy
5376331|NCT00126308|HIV|hiv
5376332|NCT00126308|Lipodystrophy|lipodystrophy
5376333|NCT00126308|Intervention|intervention
5376334|NCT00126308|Poly-L-lactic acid|poly-l-lactic acid
5376335|NCT00126308|HIV facial lipoatrophy|hiv facial lipoatrophy
5376336|NCT00126308|Treatment Experienced|treatment experienced
5376337|NCT00126282|obsessive-compulsive disorder|obsessive-compulsive disorder
5376338|NCT00126282|behavior therapy|behavior therapy
5376339|NCT00126282|D-Cycloserine|d-cycloserine
5376340|NCT00126282|medication|medication
5376341|NCT00126282|treatment trial|treatment trial
5376342|NCT00126282|placebo-controlled|placebo-controlled
5376343|NCT00126282|double-blind|double-blind
5376344|NCT00126282|randomized|randomized
5376345|NCT00126269|Patients with Carcinoma of Unknown Primary and a Predicted Favorable Prognosis|patients with carcinoma of unknown primary and a predicted favorable prognosis
5376346|NCT00126256|Colorectal cancer|colorectal cancer
5376347|NCT00126256|metastatic|metastatic
5376348|NCT00126256|chemotherapy|chemotherapy
5376349|NCT00126256|randomized trial|randomized trial
5376350|NCT00126243|AIDS related Lymphoma|aids related lymphoma
5376351|NCT00126243|chemotherapy|chemotherapy
5376352|NCT00126243|rituximab|rituximab
5376452|NCT00125918|Hypertension, Pulmonary; Pulmonary Heart Disease|hypertension, pulmonary; pulmonary heart disease
5376353|NCT00126230|hormone-refractory advanced prostate cancer who achieve a response or a stabilization to docetaxel-estramustine|hormone-refractory advanced prostate cancer who achieve a response or a stabilization to docetaxel-estramustine
5376354|NCT00126217|Non-specific effects of vaccines|non-specific effects of vaccines
5376355|NCT00126217|Infant mortality|infant mortality
5376356|NCT00126217|Morbidity|morbidity
5376357|NCT00126217|Low income country|low income country
5376358|NCT00126217|Malaria|malaria
5376359|NCT00126217|BCG|bcg
5376360|NCT00126217|immunisation|immunisation
5376361|NCT00126217|BCG revaccination|bcg revaccination
5376362|NCT00126217|Tuberculin|tuberculin
5376363|NCT00126217|Mortality|mortality
5376364|NCT00126204|endoleak|endoleak
5376365|NCT00126204|doxycycline|doxycycline
5376366|NCT00126204|matrix metalloproteinase|matrix metalloproteinase
5376367|NCT00126204|inflammation|inflammation
5376368|NCT00126204|endograft|endograft
5376369|NCT00126204|circulating markers|circulating markers
5376370|NCT00126191|Burkitt Lymphoma|burkitt lymphoma
5376371|NCT00126191|atypical Burkitt lymphoma|atypical burkitt lymphoma
5376372|NCT00126191|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
5376373|NCT00126191|rituximab|rituximab
5376374|NCT00126178|Kidney Cancer|kidney cancer
5376375|NCT00126178|Renal|renal
5376376|NCT00126178|Immunotherapy|immunotherapy
5376377|NCT00126178|Vaccine|vaccine
5376378|NCT00126165|prostate cancer|prostate cancer
5376379|NCT00126165|radiotherapy|radiotherapy
5376380|NCT00126165|hypofraction|hypofraction
5376381|NCT00126165|radiosensitivity|radiosensitivity
5376382|NCT00126165|image-guidance|image-guidance
5376383|NCT00126152|Falls|falls
5376384|NCT00126152|Exercise|exercise
5376385|NCT00126152|Fall Risk Factors|fall risk factors
5376386|NCT00126152|Older Adults|older adults
5376387|NCT00126139|stroke, ischemic|stroke, ischemic
5376388|NCT00126139|stenosis, internal carotid artery|stenosis, internal carotid artery
5376389|NCT00126139|Acute ischemic stroke|acute ischemic stroke
5376390|NCT00126139|Stenosis of extracranial internal carotid artery|stenosis of extracranial internal carotid artery
5376391|NCT00126126|Artificial Limbs|artificial limbs
5376392|NCT00126126|Evidence based medicine|evidence based medicine
5376393|NCT00126126|Exercise|exercise
5376394|NCT00126126|Outcomes research|outcomes research
5376395|NCT00126126|Physical therapy|physical therapy
5376396|NCT00126113|Audiologic rehabilitation|audiologic rehabilitation
5376397|NCT00126113|Counseling|counseling
5376398|NCT00126100|Stem Cells|stem cells
5376399|NCT00126087|dopamine|dopamine
5376400|NCT00126087|NMDA receptor|nmda receptor
5376401|NCT00126087|brain imaging|brain imaging
5376402|NCT00126087|neuroplasticity|neuroplasticity
5376403|NCT00126087|learning|learning
5376404|NCT00126087|transcranial direct current stimulation|transcranial direct current stimulation
5376405|NCT00126087|rehabilitation|rehabilitation
5376406|NCT00126087|aging|aging
5376407|NCT00126074|Atrial fibrillation, atrial flutter, anti-arrhythmic agents, conversion to normal sinus rhythm|atrial fibrillation, atrial flutter, anti-arrhythmic agents, conversion to normal sinus rhythm
5376408|NCT00126061|Atrial fibrillation|atrial fibrillation
5376409|NCT00126061|atrial flutter|atrial flutter
5376410|NCT00126061|anti-arrhythmic agents|anti-arrhythmic agents
5376411|NCT00126061|conversion to normal sinus rhythm|conversion to normal sinus rhythm
5376412|NCT00126048|Atopy|atopy
5376413|NCT00126048|Statin|statin
5376414|NCT00126048|Asthma|asthma
5376415|NCT00126048|methacholine|methacholine
5376416|NCT00126048|FEV1|fev1
5376417|NCT00126035|Acute Migraine|acute migraine
5376418|NCT00126035|Device|device
5376419|NCT00126035|Migraid|migraid
5376420|NCT00126035|Treatment|treatment
5376421|NCT00126035|Aura|aura
5376422|NCT00126022|Atrial fibrillation|atrial fibrillation
5376423|NCT00126022|atrial flutter|atrial flutter
5376424|NCT00126022|anti-arrhythmic agents|anti-arrhythmic agents
5376425|NCT00126022|conversion to normal sinus rhythm|conversion to normal sinus rhythm
5376426|NCT00125996|ANAEMIA|anaemia
5376427|NCT00125996|Iron Deficiency|iron deficiency
5376428|NCT00125983|Birth Control Pills|birth control pills
5376429|NCT00125983|Oral Contraceptives|oral contraceptives
5376430|NCT00125983|Contraceptive Patch|contraceptive patch
5376431|NCT00125983|Pharmacokinetics|pharmacokinetics
5376432|NCT00125983|Antiretroviral Therapy, Highly Active|antiretroviral therapy, highly active
5376433|NCT00125983|Protease Inhibitor|protease inhibitor
5376434|NCT00125983|Treatment Experienced|treatment experienced
5376435|NCT00125983|Treatment Naive|treatment naive
5376436|NCT00125983|Contraception|contraception
5376437|NCT00125970|HIV Seronegativity|hiv seronegativity
5376438|NCT00125970|HIV Preventive Vaccine|hiv preventive vaccine
5376439|NCT00125957|depression|depression
5376440|NCT00125957|serotonin|serotonin
5376441|NCT00125957|norepinephrine|norepinephrine
5376442|NCT00125957|SSRI|ssri
5376443|NCT00125957|Wellbutrin|wellbutrin
5376444|NCT00125957|bupropion|bupropion
5376445|NCT00125957|executive function|executive function
5376446|NCT00125957|residual symptoms|residual symptoms
5376447|NCT00125931|bipolar disorder|bipolar disorder
5376448|NCT00125931|mania|mania
5376449|NCT00125931|manic state|manic state
5376450|NCT00125931|opiate|opiate
5376451|NCT00125931|kappa|kappa
5376453|NCT00125905|Primary Care|primary care
5376454|NCT00125905|Smoking Cessation|smoking cessation
5376455|NCT00125905|Stages of Change Model|stages of change model
5376456|NCT00125905|Health Education|health education
5376457|NCT00125905|Clinical Practice guideline|clinical practice guideline
5376458|NCT00125879|Glycogen Storage Disease Type II|glycogen storage disease type ii
5376459|NCT00125879|GSD-II|gsd-ii
5376460|NCT00125879|Pompe Disease|pompe disease
5376461|NCT00125879|Pompe Disease (Late-onset)|pompe disease (late-onset)
5376462|NCT00125879|Acid Maltase Deficiency Disease|acid maltase deficiency disease
5376463|NCT00125879|Glycogenosis 2|glycogenosis 2
5376464|NCT00125879|Glycogen Storage Disease Type II (GSD-II)|glycogen storage disease type ii (gsd-ii)
5376465|NCT00125866|randomised double blind trial|randomised double blind trial
5376466|NCT00125866|blood pressure|blood pressure
5376467|NCT00125866|cocoa flavonoids|cocoa flavonoids
5376468|NCT00125853|blood pressure|blood pressure
5376469|NCT00125853|insulin sensitivity|insulin sensitivity
5376470|NCT00125853|beta blockers|beta blockers
5376471|NCT00125853|randomised double blind crossover trial|randomised double blind crossover trial
5376472|NCT00125840|CLO151|clo151
5376473|NCT00125840|Clolar|clolar
5376474|NCT00125840|Pediatric ALL and AML|pediatric all and aml
5376475|NCT00125840|Adult ALL and AML and MDS|adult all and aml and mds
5376476|NCT00125827|CLO152|clo152
5376477|NCT00125827|Clolar|clolar
5376478|NCT00125814|Interferon Alfa-2b|interferon alfa-2b
5376479|NCT00125814|HIV infections|hiv infections
5376480|NCT00125788|sickle cell disease|sickle cell disease
5376481|NCT00125788|sickle cell anemia|sickle cell anemia
5376482|NCT00125788|L-glutamine|l-glutamine
5376483|NCT00125788|Sickle Cell Anemia (homozygous)|sickle cell anemia (homozygous)
5376484|NCT00125788|Sickle ß0-Thalassemia|sickle ß0-thalassemia
5376485|NCT00125749|Dendritic|dendritic
5376486|NCT00125749|Vaccine|vaccine
5376487|NCT00125749|Melanoma|melanoma
5376488|NCT00125749|Stage IV metastatic melanoma|stage iv metastatic melanoma
5376489|NCT00125723|Phase 4 Clinical Trial|phase 4 clinical trial
5376490|NCT00125723|Chemotherapy|chemotherapy
5376491|NCT00125723|Neulasta®|neulasta®
5376492|NCT00125723|Oncology|oncology
5376493|NCT00125723|Malignancy|malignancy
5376494|NCT00125710|cryogenic analysis|cryogenic analysis
5376495|NCT00125710|oncogenes|oncogenes
5376496|NCT00125697|malignant glioma|malignant glioma
5376497|NCT00125697|spectroscopy|spectroscopy
5376498|NCT00125697|magnetic resonance|magnetic resonance
5376499|NCT00125684|transdermal morphine|transdermal morphine
5376500|NCT00125684|cancer|cancer
5376501|NCT00125684|pain|pain
5376502|NCT00125684|bioavailability|bioavailability
5376503|NCT00125684|pharmacokinetics|pharmacokinetics
5376504|NCT00125684|cancer related pain|cancer related pain
5376505|NCT00125684|stable baseline pain|stable baseline pain
5376506|NCT00125684|currently taking opioids|currently taking opioids
5376507|NCT00125671|Warfarin and Antiplatelet Vascular Evaluation|warfarin and antiplatelet vascular evaluation
5376508|NCT00125671|Peripheral vascular disease|peripheral vascular disease
5376509|NCT00125671|Atherosclerosis|atherosclerosis
5376510|NCT00125671|cardiovascular events|cardiovascular events
5376511|NCT00125671|Ischemia|ischemia
5376512|NCT00125671|oral anticoagulants|oral anticoagulants
5376513|NCT00125671|low ankle-brachial index|low ankle-brachial index
5376514|NCT00125671|moderate intensity warfarin|moderate intensity warfarin
5376515|NCT00125671|International normalized ratio [INR]|international normalized ratio [inr]
5376516|NCT00125658|biomechanics|biomechanics
5376517|NCT00125658|Cerebrovascular Accident|cerebrovascular accident
5376518|NCT00125658|electromyography|electromyography
5376519|NCT00125658|muscular weakness|muscular weakness
5376520|NCT00125658|recovery of function|recovery of function
5376521|NCT00125658|reflex variability stroke|reflex variability stroke
5376522|NCT00125658|upper-extremity kinematics|upper-extremity kinematics
5376523|NCT00125645|AMI|ami
5376524|NCT00125645|Left ventricular function|left ventricular function
5376525|NCT00125645|Myocardial performance index|myocardial performance index
5376526|NCT00125645|Acute myocardial infarction (AMI)|acute myocardial infarction (ami)
5376527|NCT00125632|Reading|reading
5376528|NCT00125632|Rehabilitation|rehabilitation
5376529|NCT00125632|Treatment Outcomes|treatment outcomes
5376530|NCT00125632|Low vision|low vision
5376531|NCT00125619|biomechanics|biomechanics
5376532|NCT00125619|stroke|stroke
5376533|NCT00125619|electromyography|electromyography
5376534|NCT00125619|Gait disability stroke|gait disability stroke
5376535|NCT00125619|locomotor therapy|locomotor therapy
5376536|NCT00125619|muscular weakness|muscular weakness
5376537|NCT00125619|reflex variability stroke|reflex variability stroke
5376538|NCT00125606|AML|aml
5376539|NCT00125606|allogeneic HSCT|allogeneic hsct
5376540|NCT00125606|reduced intensity conditioning|reduced intensity conditioning
5376541|NCT00125606|randomized trail|randomized trail
5376542|NCT00125593|Kidney Disease, Chronic|kidney disease, chronic
5376543|NCT00125593|LDL cholesterol|ldl cholesterol
5376544|NCT00125593|simvastatin|simvastatin
5376545|NCT00125593|ezetimibe|ezetimibe
5376546|NCT00125593|cardiovascular disease|cardiovascular disease
5376547|NCT00125593|atherosclerosis|atherosclerosis
5376548|NCT00125580|Obesity|obesity
5376831|NCT00124358|Drug Abuse|drug abuse
5376549|NCT00125580|Childhood Obesity|childhood obesity
5376550|NCT00125580|Infant Sleep|infant sleep
5376551|NCT00125580|Infant growth|infant growth
5376552|NCT00125580|Infant feeding|infant feeding
5376553|NCT00125554|Clinical trial|clinical trial
5376554|NCT00125554|double-blind|double-blind
5376555|NCT00125554|randomized placebo-controlled trial|randomized placebo-controlled trial
5376556|NCT00125554|metyrapone|metyrapone
5376557|NCT00125554|Major Depression|major depression
5376558|NCT00125541|MeSH: angioneurotic edema, complement 1 inactivators|mesh: angioneurotic edema, complement 1 inactivators
5376559|NCT00125541|Hereditary Angioedema Type I or II, Acquired Angioedema|hereditary angioedema type i or ii, acquired angioedema
5376560|NCT00125528|chronic pain|chronic pain
5376561|NCT00125528|low back pain|low back pain
5376562|NCT00125528|D-cycloserine|d-cycloserine
5376563|NCT00125515|Heroin|heroin
5376564|NCT00125515|Opiates|opiates
5376565|NCT00125515|naltrexone|naltrexone
5376566|NCT00125515|memantine|memantine
5376567|NCT00125502|CMV, Cytomegalovirus, vaccine, women, postpartum|cmv, cytomegalovirus, vaccine, women, postpartum
5376568|NCT00125489|chloroquine, malaria, sulfadoxine/pyrimethamine, Malawi|chloroquine, malaria, sulfadoxine/pyrimethamine, malawi
5376569|NCT00125476|Postmenopause|postmenopause
5376570|NCT00125463|Hypertension|hypertension
5376571|NCT00125463|clinical trial|clinical trial
5376572|NCT00125463|Candesartan Antihypertensive Survival Evaluation in Japan trial|candesartan antihypertensive survival evaluation in japan trial
5376573|NCT00125463|candesartan cilexetil|candesartan cilexetil
5376574|NCT00125463|amlodipine besilate|amlodipine besilate
5376575|NCT00125450|Acute Bronchiolitis|acute bronchiolitis
5376576|NCT00125450|Chest Physiotherapy|chest physiotherapy
5376577|NCT00125450|Forced Expiratory Techniques|forced expiratory techniques
5376578|NCT00125450|Double Blind Trial|double blind trial
5376579|NCT00125450|Children|children
5376580|NCT00125450|Pediatric|pediatric
5376581|NCT00125450|RESPIRATORY SYNCYTIAL VIRUS|respiratory syncytial virus
5376582|NCT00125437|aldosterone antagonists|aldosterone antagonists
5376583|NCT00125437|spironolactone|spironolactone
5376584|NCT00125437|left ventricular remodeling|left ventricular remodeling
5376585|NCT00125424|Colonoscopy|colonoscopy
5376586|NCT00125424|Sedation|sedation
5376587|NCT00125424|AQUAVAN|aquavan
5376588|NCT00125424|(fospropofol disodium)|(fospropofol disodium)
5376589|NCT00125424|Endoscopic sedation|endoscopic sedation
5376590|NCT00125424|Endoscopic outcomes|endoscopic outcomes
5376591|NCT00125424|Endoscopy|endoscopy
5376592|NCT00125411|satraplatin|satraplatin
5376593|NCT00125411|docetaxel|docetaxel
5376594|NCT00125411|cancer|cancer
5376595|NCT00125411|Phase I|phase i
5376596|NCT00125411|advanced solid tumors|advanced solid tumors
5376597|NCT00125398|AQUAVAN|aquavan
5376598|NCT00125398|GPI 15715|gpi 15715
5376599|NCT00125398|ICU|icu
5376600|NCT00125398|Sedation|sedation
5376601|NCT00125385|IPF|ipf
5376602|NCT00125385|Idiopathic|idiopathic
5376603|NCT00125385|Pulmonary|pulmonary
5376604|NCT00125385|Fibrosis|fibrosis
5376605|NCT00125372|tarceva|tarceva
5376606|NCT00125372|targretin|targretin
5376607|NCT00125372|non-small cell lung cancer|non-small cell lung cancer
5376608|NCT00125372|carcinoma, non-small cell lung cancer|carcinoma, non-small cell lung cancer
5376609|NCT00125372|nsclc|nsclc
5376610|NCT00125359|tarceva|tarceva
5376611|NCT00125359|targretin|targretin
5376612|NCT00125359|non-small cell lung cancer|non-small cell lung cancer
5376613|NCT00125359|Carcinoma, non-small cell lung cancer|carcinoma, non-small cell lung cancer
5376614|NCT00125359|NSCLC|nsclc
5376615|NCT00125346|Tobramycin Inhalation Powder|tobramycin inhalation powder
5376616|NCT00125333|atopic dermatitis, eczema|atopic dermatitis, eczema
5376617|NCT00125320|Treatment|treatment
5376618|NCT00125307|SLE|sle
5376619|NCT00125307|glomerulonephritis|glomerulonephritis
5376620|NCT00125307|immunosuppressive therapy|immunosuppressive therapy
5376621|NCT00125307|type V (membranous) lupus nephritis|type v (membranous) lupus nephritis
5376622|NCT00125294|cancer pain|cancer pain
5376623|NCT00125294|breakthrough pain|breakthrough pain
5376624|NCT00125294|methadone|methadone
5376625|NCT00125294|dose titration|dose titration
5376626|NCT00125294|sublingual route of administration|sublingual route of administration
5376627|NCT00125294|Cancer related pain|cancer related pain
5376628|NCT00125294|currently taking narcotics|currently taking narcotics
5376629|NCT00125281|Fatigue|fatigue
5376630|NCT00125281|Cirrhosis|cirrhosis
5376631|NCT00125281|S-Adenosyl Methionine|s-adenosyl methionine
5376632|NCT00125281|Primary Biliary Cirrhosis|primary biliary cirrhosis
5376633|NCT00125281|Pruritus|pruritus
5376634|NCT00125281|Symptomatic Releif|symptomatic releif
5376635|NCT00125281|Serum Liver-Related Enzymes|serum liver-related enzymes
5376636|NCT00125281|PBC|pbc
5376637|NCT00125281|Liver Disease|liver disease
5376638|NCT00125268|painful|painful
5376639|NCT00125268|peripheral|peripheral
5376640|NCT00125268|neuropathy|neuropathy
5376641|NCT00125268|light|light
5376642|NCT00125268|therapy|therapy
5376643|NCT00125242|Aphasia|aphasia
5376644|NCT00125242|Language therapy|language therapy
5376889|NCT00124176|Children|children
5376645|NCT00125242|Rehabilitation of speech and language disorders|rehabilitation of speech and language disorders
5376646|NCT00125242|Speech-language pathology|speech-language pathology
5376647|NCT00125229|Hypertonic Saline|hypertonic saline
5376648|NCT00125229|Mannitol|mannitol
5376649|NCT00125229|Intracranial hypertension|intracranial hypertension
5376650|NCT00125229|Cerebral blood flow|cerebral blood flow
5376651|NCT00125229|Traumatic brain injury|traumatic brain injury
5376652|NCT00125216|Aphasia|aphasia
5376653|NCT00125216|Language Therapy|language therapy
5376654|NCT00125216|Rehabilitation of speech and language disorders|rehabilitation of speech and language disorders
5376655|NCT00125216|Speech-language pathology|speech-language pathology
5376656|NCT00125203|ALS|als
5376657|NCT00125203|Lou Gehrig's Disease|lou gehrig's disease
5376658|NCT00125203|Motor Neuron Disease|motor neuron disease
5376659|NCT00125203|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
5376660|NCT00125203|Sialorrhea|sialorrhea
5376661|NCT00125203|Hypersalivation|hypersalivation
5376662|NCT00125203|Excessive Drooling|excessive drooling
5376663|NCT00125203|Myobloc|myobloc
5376664|NCT00125203|botulinum toxin type B|botulinum toxin type b
5376665|NCT00125203|Clostridium botulinum B toxin|clostridium botulinum b toxin
5376666|NCT00125203|botulinum B toxin|botulinum b toxin
5376667|NCT00125203|botulinum neurotoxin B|botulinum neurotoxin b
5376668|NCT00125203|NeuroBloc|neurobloc
5376669|NCT00125190|Primary IGF-1 Deficiency|primary igf-1 deficiency
5376670|NCT00125190|IGF-1|igf-1
5376671|NCT00125177|pelvic muscle therapy|pelvic muscle therapy
5376672|NCT00125177|urinary incontinence therapy|urinary incontinence therapy
5376673|NCT00125177|stress incontinence intervention|stress incontinence intervention
5376674|NCT00125177|incontinence intervention|incontinence intervention
5376675|NCT00125177|Incontinence|incontinence
5376676|NCT00125177|SUI|sui
5376677|NCT00125177|Stress Incontinence|stress incontinence
5376678|NCT00125164|Primary IGF-1 Deficiency|primary igf-1 deficiency
5376679|NCT00125151|MeSH: angioneurotic edema, complement 1 inactivators|mesh: angioneurotic edema, complement 1 inactivators
5376680|NCT00125151|Hereditary angioedema type I or II, Acquired angioedema|hereditary angioedema type i or ii, acquired angioedema
5376681|NCT00125125|Dyslipidemia, adults, fluvastatin|dyslipidemia, adults, fluvastatin
5376682|NCT00125112|binge eating|binge eating
5376683|NCT00125112|weight loss|weight loss
5376684|NCT00125112|obesity|obesity
5376685|NCT00125099|Acute Infection|acute infection
5376686|NCT00125099|Treatment Experienced|treatment experienced
5376687|NCT00125099|Treatment Interruption|treatment interruption
5376688|NCT00125099|HIV Therapeutic Vaccine|hiv therapeutic vaccine
5376689|NCT00125086|wounds|wounds
5376690|NCT00125086|healing|healing
5376691|NCT00125086|Acute wounds healing by secondary intention|acute wounds healing by secondary intention
5376692|NCT00125073|Standard Care|standard care
5376693|NCT00125073|Nutritional Counseling|nutritional counseling
5376694|NCT00125060|Aorta|aorta
5376695|NCT00125060|Atherosclerosis|atherosclerosis
5376696|NCT00125060|MRI|mri
5376697|NCT00125060|statin|statin
5376698|NCT00125060|inflammatory markers|inflammatory markers
5376699|NCT00125047|Salmonellosis|salmonellosis
5376700|NCT00125047|typhoid vaccine|typhoid vaccine
5376701|NCT00125047|enteric fever|enteric fever
5376702|NCT00125034|FOLFOX-4|folfox-4
5376703|NCT00125034|Cetuximab|cetuximab
5376704|NCT00125034|First-line mCRC|first-line mcrc
5376705|NCT00125034|EGFR positive|egfr positive
5376706|NCT00125034|metastatic CRC|metastatic crc
5376707|NCT00125021|Second Line Therapy|second line therapy
5376708|NCT00125021|Gemcitabine Refractory|gemcitabine refractory
5376709|NCT00125021|Pancreatic Cancer|pancreatic cancer
5376710|NCT00125021|Capecitabine|capecitabine
5376711|NCT00125021|Tarceva|tarceva
5376712|NCT00125021|OSI-774|osi-774
5376713|NCT00125021|Metastatic Pancreatic Cancer|metastatic pancreatic cancer
5376714|NCT00125008|Salmonella|salmonella
5376715|NCT00125008|Typhoid vaccine|typhoid vaccine
5376716|NCT00125008|enteric fever|enteric fever
5376717|NCT00124969|End-stage renal disease, hemodialysis|end-stage renal disease, hemodialysis
5376718|NCT00124943|Prevention of Instent Restenosis|prevention of instent restenosis
5376719|NCT00124930|olanzapine|olanzapine
5376720|NCT00124930|haldol|haldol
5376721|NCT00124930|cancer|cancer
5376722|NCT00124930|nausea|nausea
5376723|NCT00124930|second line treatment|second line treatment
5376724|NCT00124930|refractory nausea|refractory nausea
5376725|NCT00124917|Prostate Cancer|prostate cancer
5376726|NCT00124917|MRI|mri
5376727|NCT00124917|Fiducial Marker|fiducial marker
5376728|NCT00124917|IMRT|imrt
5376729|NCT00124904|Biofeedback|biofeedback
5376730|NCT00124904|Incontinence|incontinence
5376731|NCT00124891|Arrhythmias|arrhythmias
5376732|NCT00124878|HIV|hiv
5376733|NCT00124878|STDs|stds
5376734|NCT00124878|Male circumcision|male circumcision
5376735|NCT00124878|HIV+ males|hiv+ males
5376736|NCT00124878|HIV-negative males|hiv-negative males
5376737|NCT00124878|Female partners|female partners
5376738|NCT00124878|STDs such as the following:|stds such as the following:
5376739|NCT00124878|HPV|hpv
5376740|NCT00124878|HSV-2|hsv-2
5376741|NCT00124878|HIV Seronegativity|hiv seronegativity
5376742|NCT00124865|Campylobacter|campylobacter
5376743|NCT00124865|Bacterial enteritis|bacterial enteritis
5376744|NCT00124852|cognition|cognition
5376745|NCT00124852|depression|depression
5376746|NCT00124852|elderly|elderly
5376747|NCT00124839|Dissociation|dissociation
5376748|NCT00124839|Flashbacks|flashbacks
5376749|NCT00124839|Self-injurious behavior|self-injurious behavior
5376750|NCT00124826|stroke|stroke
5376751|NCT00124826|cerebrovascular disease|cerebrovascular disease
5376752|NCT00124826|hyperglycemia|hyperglycemia
5376753|NCT00124826|magnetic resonance imaging|magnetic resonance imaging
5376754|NCT00124826|acute ischemic stroke|acute ischemic stroke
5376755|NCT00124800|tinnitus|tinnitus
5376756|NCT00124774|hernia|hernia
5376757|NCT00124774|nucleoplasty|nucleoplasty
5376758|NCT00124774|radicular pain|radicular pain
5376759|NCT00124774|Contained lumbar herniated disc|contained lumbar herniated disc
5376760|NCT00124761|Radiosurgery|radiosurgery
5376761|NCT00124761|Brain metastases|brain metastases
5376762|NCT00124761|Whole Brain Radiotherapy|whole brain radiotherapy
5376763|NCT00124761|Neurosurgery|neurosurgery
5376764|NCT00124761|Solitary Brain Metastases|solitary brain metastases
5376765|NCT00124761|Adult Tumours Metastatic to Brain|adult tumours metastatic to brain
5376766|NCT00124748|CML|cml
5376767|NCT00124748|Philadelphia positive|philadelphia positive
5376768|NCT00124748|Bcr-abl|bcr-abl
5376769|NCT00124748|imatinib mesylate|imatinib mesylate
5376770|NCT00124748|Chronic myeloid leukemia (CML) in chronic phase|chronic myeloid leukemia (cml) in chronic phase
5376771|NCT00124709|Atopic, dermatitis, asthma, children, modification|atopic, dermatitis, asthma, children, modification
5376772|NCT00124709|Atopic dermatitis/atopy|atopic dermatitis/atopy
5376773|NCT00124696|cocaine dependence|cocaine dependence
5376774|NCT00124683|nicotine dependence|nicotine dependence
5376775|NCT00124657|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5376776|NCT00124657|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
5376777|NCT00124657|adult glioblastoma|adult glioblastoma
5376778|NCT00124657|adult giant cell glioblastoma|adult giant cell glioblastoma
5376779|NCT00124657|adult gliosarcoma|adult gliosarcoma
5376780|NCT00124657|adult mixed glioma|adult mixed glioma
5376781|NCT00124657|childhood mixed glioma|childhood mixed glioma
5376782|NCT00124657|untreated childhood cerebellar astrocytoma|untreated childhood cerebellar astrocytoma
5376783|NCT00124657|childhood high-grade cerebral astrocytoma|childhood high-grade cerebral astrocytoma
5376784|NCT00124657|childhood low-grade cerebral astrocytoma|childhood low-grade cerebral astrocytoma
5376785|NCT00124657|childhood oligodendroglioma|childhood oligodendroglioma
5376786|NCT00124657|childhood spinal cord neoplasm|childhood spinal cord neoplasm
5376787|NCT00124644|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5376788|NCT00124644|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5376789|NCT00124644|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
5376790|NCT00124644|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5376791|NCT00124618|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5376792|NCT00124618|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5376793|NCT00124579|stage I multiple myeloma|stage i multiple myeloma
5376794|NCT00124579|stage II multiple myeloma|stage ii multiple myeloma
5376795|NCT00124579|stage III multiple myeloma|stage iii multiple myeloma
5376796|NCT00124579|refractory multiple myeloma|refractory multiple myeloma
5376797|NCT00124566|Irofulven|irofulven
5376798|NCT00124566|Docetaxel|docetaxel
5376799|NCT00124566|Taxotere|taxotere
5376800|NCT00124553|Type 2 diabetes|type 2 diabetes
5376801|NCT00124553|cardiovascular risk|cardiovascular risk
5376802|NCT00124553|glycaemic control|glycaemic control
5376803|NCT00124553|dietary modification|dietary modification
5376804|NCT00124540|Misoprostol|misoprostol
5376805|NCT00124540|Active management|active management
5376806|NCT00124540|Postpartum hemorrhage|postpartum hemorrhage
5376807|NCT00124540|Maternal morbidity|maternal morbidity
5376808|NCT00124540|Anemia|anemia
5376809|NCT00124540|Developing countries|developing countries
5376810|NCT00124527|Irofulven, Thyroid Cancer|irofulven, thyroid cancer
5376811|NCT00124514|SLE|sle
5376812|NCT00124514|Lupus|lupus
5376813|NCT00124514|Ovarian damage|ovarian damage
5376814|NCT00124514|Menopause|menopause
5376815|NCT00124501|Biofeedback|biofeedback
5376816|NCT00124488|radiotherapy planning|radiotherapy planning
5376817|NCT00124488|computer assisted radiotherapy|computer assisted radiotherapy
5376818|NCT00124488|conformal|conformal
5376819|NCT00124475|Chronic Hand Dermatitis|chronic hand dermatitis
5376820|NCT00124436|Patients who have been enrolled in study protocol BAP089, and whose severe chronic hand dermatitis responded with mild or moderate disease, or who relapsed|patients who have been enrolled in study protocol bap089, and whose severe chronic hand dermatitis responded with mild or moderate disease, or who relapsed
5376821|NCT00124423|brachytherapy megavoltage CT imaging|brachytherapy megavoltage ct imaging
5376822|NCT00124410|prostate cancer|prostate cancer
5376823|NCT00124410|androgen suppression therapy (hormone therapy)|androgen suppression therapy (hormone therapy)
5376824|NCT00124410|osteoporosis|osteoporosis
5376825|NCT00124384|primary insomnia, stimulants, cognitive behavioral therapy|primary insomnia, stimulants, cognitive behavioral therapy
5376826|NCT00124371|coronary artery bypass surgery|coronary artery bypass surgery
5376827|NCT00124371|risk factors|risk factors
5376828|NCT00124371|nurse-led secondary prevention|nurse-led secondary prevention
5376829|NCT00124371|prehabilitation|prehabilitation
5376830|NCT00124371|waiting period|waiting period
5376832|NCT00124358|Drug Addiction|drug addiction
5376833|NCT00124358|Drug Dependence|drug dependence
5376834|NCT00124358|Drug Use Disorders|drug use disorders
5376835|NCT00124358|Drug Use Disorder|drug use disorder
5376836|NCT00124358|Substance Abuse|substance abuse
5376837|NCT00124358|Substance Use Disorder|substance use disorder
5376838|NCT00124358|Buprenorphine|buprenorphine
5376839|NCT00124358|Opiate Addiction|opiate addiction
5376840|NCT00124358|Substance-related disorders|substance-related disorders
5376841|NCT00124358|HIV|hiv
5376842|NCT00124345|temperature|temperature
5376843|NCT00124345|humidity|humidity
5376844|NCT00124345|non invasive mechanical ventilation|non invasive mechanical ventilation
5376845|NCT00124319|Biomechanics|biomechanics
5376846|NCT00124319|Neuromuscular|neuromuscular
5376847|NCT00124319|Lower limb|lower limb
5376848|NCT00124319|Injury|injury
5376849|NCT00124319|ACL|acl
5376850|NCT00124319|Anterior Cruciate Ligament injury|anterior cruciate ligament injury
5376851|NCT00124306|painful bladder syndrome|painful bladder syndrome
5376852|NCT00124306|interstitial cystitis|interstitial cystitis
5376853|NCT00124306|newly diagnosed|newly diagnosed
5376854|NCT00124280|Lung cancer|lung cancer
5376855|NCT00124280|non-small cell|non-small cell
5376856|NCT00124280|everolimus|everolimus
5376857|NCT00124280|Non-small cell lung cancer (NSCLC)|non-small cell lung cancer (nsclc)
5376858|NCT00124267|Cerebral|cerebral
5376859|NCT00124267|malaria|malaria
5376860|NCT00124267|intra-rectal|intra-rectal
5376861|NCT00124267|quinine|quinine
5376862|NCT00124267|children|children
5376863|NCT00124267|Uganda|uganda
5376864|NCT00124267|efficacy|efficacy
5376865|NCT00124267|safety|safety
5376866|NCT00124254|Metacarpophalangeal Joint|metacarpophalangeal joint
5376867|NCT00124254|Arthroplasty|arthroplasty
5376868|NCT00124254|Outcomes|outcomes
5376869|NCT00124254|Michigan Hand Outcomes Questionnaire|michigan hand outcomes questionnaire
5376870|NCT00124254|Joint Replacement|joint replacement
5376871|NCT00124228|Cirrhosis|cirrhosis
5376872|NCT00124228|Infection|infection
5376873|NCT00124228|Sepsis|sepsis
5376874|NCT00124228|Renal failure|renal failure
5376875|NCT00124215|Hepatitis|hepatitis
5376876|NCT00124215|HCV|hcv
5376877|NCT00124215|vaccine|vaccine
5376878|NCT00124215|Hepatitis C Infection|hepatitis c infection
5376879|NCT00124202|a fatty meal|a fatty meal
5376880|NCT00124202|ERCP|ercp
5376881|NCT00124189|Chronic lymphocytic leukemia|chronic lymphocytic leukemia
5376882|NCT00124189|T-cell prolymphocytic leukemia|t-cell prolymphocytic leukemia
5376883|NCT00124189|Chronic lymphoproliferative diseases|chronic lymphoproliferative diseases
5376884|NCT00124189|Telomerase|telomerase
5376885|NCT00124189|Telomerase Inhibition|telomerase inhibition
5376886|NCT00124176|Asthma|asthma
5376887|NCT00124176|Levalbuterol|levalbuterol
5376888|NCT00124176|Albuterol|albuterol
5376890|NCT00124163|CT Virtual Colonoscopy|ct virtual colonoscopy
5376891|NCT00124163|Optical Colonoscopy|optical colonoscopy
5376892|NCT00124163|Stool Tagging|stool tagging
5376893|NCT00124163|Patient Preparation|patient preparation
5376894|NCT00124150|subarachnoid hemorrhage|subarachnoid hemorrhage
5376895|NCT00124150|magnesium sulfate|magnesium sulfate
5376896|NCT00124137|Ultrafiltration|ultrafiltration
5376897|NCT00124137|acute decompensated heart failure|acute decompensated heart failure
5376898|NCT00124137|fluid overload|fluid overload
5376899|NCT00124137|pulmonary congestion|pulmonary congestion
5376900|NCT00124111|clinical trial|clinical trial
5376901|NCT00124111|pegfilgrastim|pegfilgrastim
5376902|NCT00124111|haematopoietic growth factor|haematopoietic growth factor
5376903|NCT00124111|neutropenia|neutropenia
5376905|NCT00124111|Cancer|cancer
5376906|NCT00124098|Chronic Kidney Disease (CKD)|chronic kidney disease (ckd)
5376907|NCT00124098|anemia, clinical trial|anemia, clinical trial
5376908|NCT00124098|darbepoetin alfa|darbepoetin alfa
5376909|NCT00124098|Aranesp®|aranesp®
5376910|NCT00124098|Amgen|amgen
5376911|NCT00124072|Myocardial infarction|myocardial infarction
5376912|NCT00124072|Coronary heart disease|coronary heart disease
5376913|NCT00124072|Cholesterol|cholesterol
5376914|NCT00124072|Stroke|stroke
5376915|NCT00124059|alcohol dependence|alcohol dependence
5376916|NCT00124046|Urinary Incontinence in Children|urinary incontinence in children
5376917|NCT00124046|Surgical Section of the Filum Terminale|surgical section of the filum terminale
5376918|NCT00124046|Occult Tethered Cord Syndrome|occult tethered cord syndrome
5376919|NCT00124046|Urodynamic Scale|urodynamic scale
5376920|NCT00124046|Enuresis-Specific Quality of Life Scale|enuresis-specific quality of life scale
5376921|NCT00124033|Cholecystectomy|cholecystectomy
5376922|NCT00124033|Cholangiopancreatography, Endoscopic Retrograde|cholangiopancreatography, endoscopic retrograde
5376923|NCT00124007|HIV Seronegativity|hiv seronegativity
5376924|NCT00124007|HIV Preventive Vaccine|hiv preventive vaccine
5376925|NCT00123994|TaiChi|taichi
5376926|NCT00123994|Hydrotherapy|hydrotherapy
5376927|NCT00123994|Exercise|exercise
5376928|NCT00123994|Joint pain|joint pain
5376929|NCT00123994|Disability|disability
5376930|NCT00123981|Off-pump Coronary Artery By-pass Grafting|off-pump coronary artery by-pass grafting
5376931|NCT00123981|Randomization|randomization
5376932|NCT00123981|stroke|stroke
5376933|NCT00123981|myocardial infarction|myocardial infarction
5376934|NCT00123981|mortality|mortality
5376935|NCT00123981|graft patency|graft patency
5376936|NCT00123981|quality of life|quality of life
5376937|NCT00123968|HIV Seronegativity|hiv seronegativity
5376938|NCT00123968|HIV Preventive Vaccine|hiv preventive vaccine
5376939|NCT00123942|CD2+ Lymphoproliferative disorder|cd2+ lymphoproliferative disorder
5376940|NCT00123929|breast cancer|breast cancer
5376941|NCT00123929|neoadjuvant chemotherapy|neoadjuvant chemotherapy
5376942|NCT00123929|genetic signature|genetic signature
5376943|NCT00123929|doxorubicin|doxorubicin
5376944|NCT00123929|docetaxel|docetaxel
5376945|NCT00123916|Chagas Disease|chagas disease
5376946|NCT00123916|Trypanosomiasis|trypanosomiasis
5376947|NCT00123916|Benznidazole|benznidazole
5376948|NCT00123916|Chronic Heart disease|chronic heart disease
5376949|NCT00123916|Trypanosoma Cruzi|trypanosoma cruzi
5376950|NCT00123903|hypertension|hypertension
5376951|NCT00123903|urine albumin:creatinine ratio|urine albumin:creatinine ratio
5376952|NCT00123903|microalbuminuria|microalbuminuria
5376953|NCT00123890|HIV-1 GW873140 CCR5 antagonist experienced|hiv-1 gw873140 ccr5 antagonist experienced
5376954|NCT00123877|Breast|breast
5376955|NCT00123877|Cancer|cancer
5376956|NCT00123877|Metastasis|metastasis
5376957|NCT00123864|intensity modulated radiation therapy|intensity modulated radiation therapy
5376958|NCT00123864|parotid|parotid
5376959|NCT00123864|nasopharyngeal carcinoma|nasopharyngeal carcinoma
5376960|NCT00123851|Colorectal|colorectal
5376961|NCT00123851|Metastatic Colorectal Cancer|metastatic colorectal cancer
5376962|NCT00123851|Oxaliplatin|oxaliplatin
5376963|NCT00123851|Tarceva|tarceva
5376964|NCT00123851|Capecitabine|capecitabine
5376965|NCT00123851|Xeloda|xeloda
5376966|NCT00123838|Prostate|prostate
5376967|NCT00123838|Cancer|cancer
5376968|NCT00123838|Radiotherapy|radiotherapy
5376969|NCT00123838|Neoplasm|neoplasm
5376970|NCT00123838|Localization|localization
5376971|NCT00123838|Tracking|tracking
5376972|NCT00123838|Cancer of Prostate|cancer of prostate
5376973|NCT00123838|Neoplasms, Prostate|neoplasms, prostate
5376974|NCT00123825|Gallbladder|gallbladder
5376975|NCT00123825|Biliary Tract|biliary tract
5376976|NCT00123825|Cholangiocarcinoma|cholangiocarcinoma
5376977|NCT00123812|quality assurance|quality assurance
5376978|NCT00123812|frequency of port films|frequency of port films
5376979|NCT00123799|positron emission tomography|positron emission tomography
5376980|NCT00123799|fluorodeoxyglucose F18|fluorodeoxyglucose f18
5376981|NCT00123799|sentinel lymph node biopsy|sentinel lymph node biopsy
5376982|NCT00123786|positron emission tomography|positron emission tomography
5376983|NCT00123786|fluorodeoxyglucose F18|fluorodeoxyglucose f18
5376984|NCT00123786|tomography scanners, x-ray computed|tomography scanners, x-ray computed
5376985|NCT00123773|positron emission tomography|positron emission tomography
5376986|NCT00123773|fluorodeoxyglucose F18|fluorodeoxyglucose f18
5376987|NCT00123773|Tomography scanners, x-ray computed|tomography scanners, x-ray computed
5376988|NCT00123760|Positron-Emission Tomography|positron-emission tomography
5376989|NCT00123760|Fluorodeoxyglucose F18|fluorodeoxyglucose f18
5376990|NCT00123760|Tomography scanners, X-Ray computed|tomography scanners, x-ray computed
5376991|NCT00123747|Positron Emission Tomography|positron emission tomography
5376992|NCT00123747|Fluorodeoxyglucose F18|fluorodeoxyglucose f18
5376993|NCT00123747|Tomography scanners, X-Ray Computed|tomography scanners, x-ray computed
5376994|NCT00123708|Spasticity|spasticity
5376995|NCT00123708|Dystonia|dystonia
5376996|NCT00123708|Movement Disorders|movement disorders
5376997|NCT00123708|Walking|walking
5376998|NCT00123708|Muscle Weakness|muscle weakness
5376999|NCT00123708|Resistance|resistance
5377000|NCT00123708|Gait|gait
5377001|NCT00123708|Cerebral Palsy|cerebral palsy
5377002|NCT00123708|CP|cp
5377003|NCT00123695|Subarachnoid hemorrhage|subarachnoid hemorrhage
5377004|NCT00123695|Takotsubo cardiomyopathy|takotsubo cardiomyopathy
5377005|NCT00123695|Cardiac abnormalities|cardiac abnormalities
5377006|NCT00123695|outcome|outcome
5377007|NCT00123682|Smoking Cessation|smoking cessation
5377008|NCT00123682|Care Management|care management
5377009|NCT00123682|Substance Use Disorder QUERI|substance use disorder queri
5377010|NCT00123682|Primary Care|primary care
5377011|NCT00123682|Regional Expansion|regional expansion
5377012|NCT00123682|Telephone|telephone
5377013|NCT00123669|Cancer of the Breast|cancer of the breast
5377014|NCT00123669|Neoplasm|neoplasm
5377015|NCT00123656|Eosinophilic esophagitis|eosinophilic esophagitis
5377016|NCT00123656|esomeprazole|esomeprazole
5377017|NCT00123656|fluticasone|fluticasone
5377018|NCT00123643|thiazolidinedione|thiazolidinedione
5377019|NCT00123643|sulfonylurea|sulfonylurea
5377020|NCT00123643|endothelial function|endothelial function
5377021|NCT00123630|eosinophilic esophagitis|eosinophilic esophagitis
5377022|NCT00123630|omalizumab|omalizumab
5377023|NCT00123617|Chest pain|chest pain
5377024|NCT00123617|Women|women
5377025|NCT00123617|Syndrome X|syndrome x
5377026|NCT00123617|Cardiac rehabilitation|cardiac rehabilitation
5377027|NCT00123617|Psychological morbidity|psychological morbidity
5377028|NCT00123617|Cardiovascular risk factors|cardiovascular risk factors
5377029|NCT00123604|beta-blockers|beta-blockers
5377030|NCT00123604|endothelial function|endothelial function
5377882|NCT00120458|Anxiety|anxiety
5377031|NCT00123565|Coronary Disease|coronary disease
5377032|NCT00123552|Uganda, malaria, combination antimalarial therapy|uganda, malaria, combination antimalarial therapy
5377033|NCT00123487|Accelerated Phase Chronic Myeloid Leukemia|accelerated phase chronic myeloid leukemia
5377034|NCT00123487|Lymphoid Blast Phase Chronic Myeloid Leukemia|lymphoid blast phase chronic myeloid leukemia
5377035|NCT00123487|Myeloid Blast Phase Chronic Myeloid Leukemia|myeloid blast phase chronic myeloid leukemia
5377036|NCT00123487|Philadelphia Positive Acute Lymphoblastic Leukemia|philadelphia positive acute lymphoblastic leukemia
5377037|NCT00123474|Chronic Phase Chronic Myelogenous Leukemia|chronic phase chronic myelogenous leukemia
5377038|NCT00123448|Mirror Neurons|mirror neurons
5377039|NCT00123448|fMRI|fmri
5377040|NCT00123448|Premotor Cortex|premotor cortex
5377041|NCT00123448|gesture|gesture
5377042|NCT00123448|Healthy Volunteer|healthy volunteer
5377044|NCT00123435|Behavioral Research|behavioral research
5377045|NCT00123435|Nutritional management|nutritional management
5377046|NCT00123435|Physical activity|physical activity
5377047|NCT00123435|Prevention|prevention
5377048|NCT00123435|Randomized control trial|randomized control trial
5377049|NCT00123435|walking program|walking program
5377050|NCT00123435|Weight loss|weight loss
5377051|NCT00123435|World wide web|world wide web
5377052|NCT00123422|Breathing exercise|breathing exercise
5377053|NCT00123422|Exercise Therapy|exercise therapy
5377054|NCT00123422|Helium|helium
5377055|NCT00123422|Oxygen inhalation therapy|oxygen inhalation therapy
5377056|NCT00123422|Pulmonary emphysema|pulmonary emphysema
5377057|NCT00123422|Pulmonary ventilation|pulmonary ventilation
5377058|NCT00123422|Rehabilitation|rehabilitation
5377059|NCT00123409|Primary Care|primary care
5377060|NCT00123409|Telephone|telephone
5377061|NCT00123409|Quality of Life|quality of life
5377062|NCT00123396|Bioterrorism|bioterrorism
5377063|NCT00123396|Education, Medical, Continuing|education, medical, continuing
5377064|NCT00123396|Internet|internet
5377065|NCT00123383|Modafinil|modafinil
5377066|NCT00123383|Cocaine Dependence|cocaine dependence
5377067|NCT00123383|Randomised placebo-controlled trial|randomised placebo-controlled trial
5377068|NCT00123370|Modafinil|modafinil
5377069|NCT00123370|Amphetamine Dependence|amphetamine dependence
5377070|NCT00123370|Randomised placebo-controlled trial|randomised placebo-controlled trial
5377071|NCT00123344|symptomatic bradycardia|symptomatic bradycardia
5377072|NCT00123344|paroxysmal atrial fibrillation|paroxysmal atrial fibrillation
5377073|NCT00123344|antitachycardia pacing therapies|antitachycardia pacing therapies
5377074|NCT00123344|prevention algorithms|prevention algorithms
5377075|NCT00123331|Heart transplantation|heart transplantation
5377076|NCT00123331|Renal failure|renal failure
5377077|NCT00123331|Cyclosporine|cyclosporine
5377078|NCT00123331|Rapamycin|rapamycin
5377079|NCT00123318|Gastric cancer|gastric cancer
5377080|NCT00123318|Radiotherapy|radiotherapy
5377081|NCT00123318|Chemotherapy|chemotherapy
5377082|NCT00123318|Chemoradiation|chemoradiation
5377083|NCT00123305|Stroke|stroke
5377084|NCT00123305|Acute Ischemic Stroke|acute ischemic stroke
5377085|NCT00123292|arterial occlusion|arterial occlusion
5377086|NCT00123292|thromboembolism|thromboembolism
5377087|NCT00123292|Acute Peripheral Arterial Occlusion|acute peripheral arterial occlusion
5377088|NCT00123279|diabetic macular edema|diabetic macular edema
5377089|NCT00123279|macular hole|macular hole
5377090|NCT00123279|vitreomacular traction syndrome|vitreomacular traction syndrome
5377091|NCT00123266|stroke|stroke
5377092|NCT00123266|vertebrobasilar|vertebrobasilar
5377093|NCT00123266|basilar|basilar
5377094|NCT00123266|Acute vertebrobasilar artery occlusion|acute vertebrobasilar artery occlusion
5377095|NCT00123253|HIV|hiv
5377096|NCT00123253|Lipodystrophy|lipodystrophy
5377097|NCT00123253|Abdominal fat accumulation|abdominal fat accumulation
5377098|NCT00123253|Growth hormone releasing factor/Growth hormone releasing hormone|growth hormone releasing factor/growth hormone releasing hormone
5377099|NCT00123253|Treatment Experienced|treatment experienced
5377100|NCT00123240|overweight|overweight
5377101|NCT00123240|obese|obese
5377102|NCT00123240|diet|diet
5377103|NCT00123227|Randomised controlled trial|randomised controlled trial
5377104|NCT00123227|Rosiglitazone|rosiglitazone
5377105|NCT00123227|Cardiovascular magnetic resonance|cardiovascular magnetic resonance
5377106|NCT00123227|Diabetes Mellitus|diabetes mellitus
5377107|NCT00123227|Vascular Diseases|vascular diseases
5377108|NCT00123227|Hypertension|hypertension
5377109|NCT00123214|Diet|diet
5377110|NCT00123214|Chronic sleep deprivation|chronic sleep deprivation
5377111|NCT00123214|Weight|weight
5377112|NCT00123214|Cognitive impairment|cognitive impairment
5377113|NCT00123214|Lipids|lipids
5377114|NCT00123214|Inflammation|inflammation
5377115|NCT00123214|Resting metabolic rate|resting metabolic rate
5377116|NCT00123214|Weight Gain|weight gain
5377117|NCT00123214|Percent Body Fat|percent body fat
5377118|NCT00123214|Hyperlipidemia|hyperlipidemia
5377119|NCT00123201|efficacy & safety, migraine headache, placebo-controlled|efficacy & safety, migraine headache, placebo-controlled
5377120|NCT00123201|migraine headache with or without aura|migraine headache with or without aura
5377121|NCT00123175|Endometrial Hyperplasia without atypia|endometrial hyperplasia without atypia
5377122|NCT00123162|Sildenafil|sildenafil
5377123|NCT00123149|Anemia|anemia
5377124|NCT00123149|Rheumatoid arthritis|rheumatoid arthritis
5377125|NCT00123149|Hemoglobin level|hemoglobin level
5377126|NCT00123136|pulsed magnetic field therapy|pulsed magnetic field therapy
5377127|NCT00123136|diabetic peripheral neuropathy|diabetic peripheral neuropathy
5377128|NCT00123136|neuromodulation|neuromodulation
5377129|NCT00123136|diabetic peripheral neuropathic pain|diabetic peripheral neuropathic pain
5377130|NCT00123136|sleep benefit|sleep benefit
5377131|NCT00123136|diabetic peripheral neuropathic functioning|diabetic peripheral neuropathic functioning
5377132|NCT00123123|Ventilator-associated pneumonia|ventilator-associated pneumonia
5377133|NCT00123097|Facial Neoplasms|facial neoplasms
5377134|NCT00123097|Head and Neck Neoplasms|head and neck neoplasms
5377135|NCT00123097|Head Injuries, Penetrating|head injuries, penetrating
5377136|NCT00123097|Birth Injuries|birth injuries
5377137|NCT00123084|Parkinson's disease|parkinson's disease
5377138|NCT00123084|Swallowing difficulties|swallowing difficulties
5377139|NCT00123084|speech|speech
5377140|NCT00123084|voice|voice
5377141|NCT00123058|Hypertension|hypertension
5377142|NCT00123058|Cariovascular Diseases|cariovascular diseases
5377143|NCT00123058|Health Illiteracy|health illiteracy
5377144|NCT00122980|Blood Diseases|blood diseases
5377145|NCT00122954|Fatty Acids, Omega-3|fatty acids, omega-3
5377146|NCT00122954|Fish Oils|fish oils
5377147|NCT00122954|Complementary Therapies|complementary therapies
5377148|NCT00122941|multiple|multiple
5377149|NCT00122941|micronutrients|micronutrients
5377150|NCT00122941|supplementation|supplementation
5377151|NCT00122941|HIV|hiv
5377152|NCT00122941|children|children
5377153|NCT00122941|randomised|randomised
5377154|NCT00122941|trial|trial
5377155|NCT00122941|mortality|mortality
5377156|NCT00122941|morbidity|morbidity
5377157|NCT00122941|growth|growth
5377158|NCT00122941|Uganda|uganda
5377159|NCT00122928|Worksite|worksite
5377160|NCT00122928|Workplace|workplace
5377161|NCT00122928|Return on Investment|return on investment
5377162|NCT00122928|Financial Impact|financial impact
5377163|NCT00122915|Motor Cortex Stimulation|motor cortex stimulation
5377164|NCT00122915|Pain treatment|pain treatment
5377165|NCT00122915|Central post-stroke pain (CPSP)|central post-stroke pain (cpsp)
5377166|NCT00122915|Trigeminal neuropathic pain (TGN)|trigeminal neuropathic pain (tgn)
5377167|NCT00122915|Facial pain|facial pain
5377168|NCT00122915|Neurostimuation|neurostimuation
5377169|NCT00122915|Cortical lead|cortical lead
5377170|NCT00122915|Neuropathic pain|neuropathic pain
5377171|NCT00122902|HIV|hiv
5377172|NCT00122902|AIDS|aids
5377173|NCT00122902|Spirituality|spirituality
5377174|NCT00122889|Drug Interactions|drug interactions
5377175|NCT00122889|Pharmacokinetics|pharmacokinetics
5377176|NCT00122889|Garlic|garlic
5377177|NCT00122889|Complementary Therapies|complementary therapies
5377178|NCT00122889|Complementary and Alternative Medicine|complementary and alternative medicine
5377179|NCT00122876|Hepatocellular Carcinoma|hepatocellular carcinoma
5377180|NCT00122876|HCC|hcc
5377181|NCT00122876|Photodynamic therapy|photodynamic therapy
5377182|NCT00122876|Talaporfin Sodium (LS11)|talaporfin sodium (ls11)
5377183|NCT00122876|Light emitting diodes (LEDs)|light emitting diodes (leds)
5377184|NCT00122876|Litx|litx
5377185|NCT00122876|Light Infusion Technology|light infusion technology
5377186|NCT00122811|Aged|aged
5377187|NCT00122811|Hypertension|hypertension
5377188|NCT00122811|Stroke|stroke
5377189|NCT00122798|Stroke, stroke treatment, atrial fibrillation, medication, rehabilitation|stroke, stroke treatment, atrial fibrillation, medication, rehabilitation
5377190|NCT00122785|bronchiolitis|bronchiolitis
5377191|NCT00122785|wheezing|wheezing
5377192|NCT00122785|dexamethasone|dexamethasone
5377193|NCT00122785|young children|young children
5377194|NCT00122759|Mechanical ventilation|mechanical ventilation
5377195|NCT00122759|Agitation|agitation
5377196|NCT00122746|Cervical Cancer|cervical cancer
5377197|NCT00122746|AIDS|aids
5377198|NCT00122746|External Beam Radiotherapy|external beam radiotherapy
5377199|NCT00122746|Brachytherapy|brachytherapy
5377200|NCT00122746|Cisplatin|cisplatin
5377201|NCT00122733|Mechanical ventilation|mechanical ventilation
5377202|NCT00122733|Agitation|agitation
5377203|NCT00122733|Difficult weaning|difficult weaning
5377204|NCT00122720|colorectal cancer|colorectal cancer
5377205|NCT00122720|erythropoietin|erythropoietin
5377206|NCT00122720|rehabilitation|rehabilitation
5377207|NCT00122720|physical capacity|physical capacity
5377208|NCT00122707|catheter-related infection|catheter-related infection
5377209|NCT00122707|mechanical complications of catheters|mechanical complications of catheters
5377210|NCT00122694|carbon monoxide|carbon monoxide
5377211|NCT00122694|COPD|copd
5377212|NCT00122694|inflammation|inflammation
5377213|NCT00122694|sputum induction|sputum induction
5377214|NCT00122694|stable COPD|stable copd
5377215|NCT00122668|HIV Protease Inhibitors|hiv protease inhibitors
5377216|NCT00122668|HIV-Associated Lipodystrophy Syndrome|hiv-associated lipodystrophy syndrome
5377217|NCT00122668|HIV infections|hiv infections
5377218|NCT00122655|HIV infections|hiv infections
5377219|NCT00122655|HIV Lipodystrophy Syndrome|hiv lipodystrophy syndrome
5377220|NCT00122642|catheterization|catheterization
5377221|NCT00122642|Catheters, Indwelling|catheters, indwelling
5377222|NCT00122629|Hepatitis C, Chronic|hepatitis c, chronic
5377223|NCT00122629|peginterferon alfa-2b|peginterferon alfa-2b
5377224|NCT00122629|ribavirin|ribavirin
5377225|NCT00122629|Amantadine|amantadine
5377226|NCT00122616|HIV infections|hiv infections
5377227|NCT00122616|peginterferon alfa-2a|peginterferon alfa-2a
5377228|NCT00122616|Treatment Failure|treatment failure
5377229|NCT00122616|Hepatitis C, Chronic|hepatitis c, chronic
5377230|NCT00122616|Treatment Experienced|treatment experienced
5377231|NCT00122603|HIV Protease Inhibitors|hiv protease inhibitors
5377232|NCT00122603|HIV infections|hiv infections
5377233|NCT00122603|Atazanavir|atazanavir
5377234|NCT00122603|Saquinavir|saquinavir
5377235|NCT00122603|Fosamprenavir|fosamprenavir
5377236|NCT00122603|ritonavir|ritonavir
5377237|NCT00122603|Treatment Naive|treatment naive
5377238|NCT00122590|protease inhibitors|protease inhibitors
5377239|NCT00122590|nelfinavir|nelfinavir
5377240|NCT00122590|lopinavir|lopinavir
5377241|NCT00122590|indinavir|indinavir
5377242|NCT00122590|Pharmacokinetics|pharmacokinetics
5377243|NCT00122577|HIV infections|hiv infections
5377244|NCT00122577|Treatment Failure|treatment failure
5377245|NCT00122577|tenofovir|tenofovir
5377246|NCT00122577|atazanavir|atazanavir
5377247|NCT00122564|HIV Vaccines|hiv vaccines
5377248|NCT00122564|HIV Seronegativity|hiv seronegativity
5377249|NCT00122551|HIV infections|hiv infections
5377250|NCT00122538|HAART|haart
5377251|NCT00122538|once-daily|once-daily
5377252|NCT00122538|child|child
5377253|NCT00122538|africa|africa
5377254|NCT00122538|HIV|hiv
5377255|NCT00122538|AIDS|aids
5377256|NCT00122538|Treatment Naive|treatment naive
5377257|NCT00122525|HIV|hiv
5377258|NCT00122525|Male circumcision|male circumcision
5377259|NCT00122525|Prevention|prevention
5377260|NCT00122525|HSV-2|hsv-2
5377261|NCT00122525|Africa|africa
5377262|NCT00122525|Sexual behavior|sexual behavior
5377263|NCT00122512|AE adverse event|ae adverse event
5377264|NCT00122512|AIDS acquired immunodeficiency syndrome|aids acquired immunodeficiency syndrome
5377265|NCT00122512|ALT (SGPT) alanine aminotransferase|alt (sgpt) alanine aminotransferase
5377266|NCT00122512|ART antiretroviral therapy|art antiretroviral therapy
5377267|NCT00122512|AST (SGOT) aspartate aminotransferase|ast (sgot) aspartate aminotransferase
5377268|NCT00122512|DCF data collection forms|dcf data collection forms
5377269|NCT00122512|DMC Data Monitoring Committee|dmc data monitoring committee
5377270|NCT00122512|FDA (U.S.) Food and Drug Administration|fda (u.s.) food and drug administration
5377271|NCT00122512|GCP Good Clinical Practice guidelines|gcp good clinical practice guidelines
5377272|NCT00122512|HB sAg Hepatitis B surface antigen|hb sag hepatitis b surface antigen
5377273|NCT00122512|ICH International Conference of Harmonisation|ich international conference of harmonisation
5377274|NCT00122512|IND Investigational New Drug Application|ind investigational new drug application
5377275|NCT00122512|IRB Institutional Review Board|irb institutional review board
5377276|NCT00122512|IU international units|iu international units
5377277|NCT00122512|mg milligram(s)|mg milligram(s)
5377278|NCT00122512|mm3 cubic millimeter(s)|mm3 cubic millimeter(s)
5377279|NCT00122512|PCR polymerase chain reaction|pcr polymerase chain reaction
5377280|NCT00122512|SAE serious adverse event|sae serious adverse event
5377281|NCT00122512|TDF tenofovir disoproxil fumarate, GS-4331-05, PMPA prodrug|tdf tenofovir disoproxil fumarate, gs-4331-05, pmpa prodrug
5377282|NCT00122512|µg microgram|µg microgram
5377283|NCT00122512|ULN upper limit of the normal range|uln upper limit of the normal range
5377284|NCT00122512|WB Western Blot|wb western blot
5377285|NCT00122512|Human Immunodeficiency Virus|human immunodeficiency virus
5377286|NCT00122512|HIV Seronegativity|hiv seronegativity
5377287|NCT00122499|Prostate cancer|prostate cancer
5377288|NCT00122499|Radiotherapy|radiotherapy
5377289|NCT00122499|Erectile dysfunction|erectile dysfunction
5377290|NCT00122499|Tadalafil|tadalafil
5377291|NCT00122486|AE adverse event|ae adverse event
5377292|NCT00122486|AIDS acquired immunodeficiency syndrome|aids acquired immunodeficiency syndrome
5377293|NCT00122486|ALT (SGPT) alanine aminotransferase|alt (sgpt) alanine aminotransferase
5377294|NCT00122486|ART antiretroviral therapy|art antiretroviral therapy
5377295|NCT00122486|AST (SGOT) aspartate aminotransferase|ast (sgot) aspartate aminotransferase
5377296|NCT00122486|DCF data collection forms|dcf data collection forms
5377297|NCT00122486|DMC Data Monitoring Committee|dmc data monitoring committee
5377298|NCT00122486|FDA (U.S.) Food and Drug Administration|fda (u.s.) food and drug administration
5377299|NCT00122486|GCP Good Clinical Practice guidelines|gcp good clinical practice guidelines
5377300|NCT00122486|HB sAg Hepatitis B surface antigen|hb sag hepatitis b surface antigen
5377301|NCT00122486|ICH International Conference of Harmonisation|ich international conference of harmonisation
5377302|NCT00122486|IND Investigational New Drug Application|ind investigational new drug application
5377303|NCT00122486|IRB Institutional Review Board|irb institutional review board
5377304|NCT00122486|IU international units|iu international units
5377305|NCT00122486|mg milligram(s)|mg milligram(s)
5377306|NCT00122486|mm3 cubic millimeter(s)|mm3 cubic millimeter(s)
5377307|NCT00122486|PCR polymerase chain reaction|pcr polymerase chain reaction
5377308|NCT00122486|SAE serious adverse event|sae serious adverse event
5377309|NCT00122486|µg microgram|µg microgram
5377310|NCT00122486|ULN upper limit of the normal range|uln upper limit of the normal range
5377311|NCT00122486|WB Western Blot|wb western blot
5377312|NCT00122486|Human Immunodeficiency Virus|human immunodeficiency virus
5377313|NCT00122473|Dermatofibrosarcoma|dermatofibrosarcoma
5377314|NCT00122473|Imatinib|imatinib
5377315|NCT00122473|Tyrosine Kinase Inhibitor|tyrosine kinase inhibitor
5377316|NCT00122460|Head and Neck Cancer|head and neck cancer
5377317|NCT00122447|Prediabetic state|prediabetic state
5377318|NCT00122447|Cardiovascular disease|cardiovascular disease
5377319|NCT00122447|Diabetes|diabetes
5377320|NCT00122447|Glucose intolerance|glucose intolerance
5377321|NCT00122421|diabetes|diabetes
5377322|NCT00122421|quality of care|quality of care
5377323|NCT00122421|pharmacist recommendations|pharmacist recommendations
5377324|NCT00122408|ventilator-associated pneumonia|ventilator-associated pneumonia
5377325|NCT00122408|probiotic|probiotic
5377326|NCT00122408|mechanical ventilation|mechanical ventilation
5377327|NCT00122408|intensive care|intensive care
5377328|NCT00122395|Domestic violence|domestic violence
5377329|NCT00122395|Screening|screening
5377330|NCT00122395|Emergency department|emergency department
5377331|NCT00122382|abatacept, methotrexate, erosive RA|abatacept, methotrexate, erosive ra
5377332|NCT00122369|Breast|breast
5377333|NCT00122369|Biopsy|biopsy
5377334|NCT00122369|Hypnosis|hypnosis
5377335|NCT00122369|Relaxation|relaxation
5377336|NCT00122369|Anxiety|anxiety
5377337|NCT00122369|Pain|pain
5377338|NCT00122369|Medical and Surgical Procedures|medical and surgical procedures
5377339|NCT00122343|Endometrial|endometrial
5377340|NCT00122343|Cancer|cancer
5377341|NCT00122317|transfusion dependent|transfusion dependent
5377342|NCT00122317|paroxysmal nocturnal hemoglobinuria|paroxysmal nocturnal hemoglobinuria
5377343|NCT00122317|hemolytic|hemolytic
5377344|NCT00122291|preoperative|preoperative
5377345|NCT00122291|chemotherapy|chemotherapy
5377346|NCT00122291|radiation therapy|radiation therapy
5377347|NCT00122291|rectal cancer|rectal cancer
5377348|NCT00122291|transmural rectal wall invasion|transmural rectal wall invasion
5377349|NCT00122291|nodal metastasis|nodal metastasis
5377350|NCT00122278|migraine, emergency department, dexamethasone|migraine, emergency department, dexamethasone
5377351|NCT00122278|Migraine with or without aura or probable migraine without aura as defined by ICHD, 2nd edition|migraine with or without aura or probable migraine without aura as defined by ichd, 2nd edition
5377352|NCT00122265|prostate cancer|prostate cancer
5377353|NCT00122265|radiotherapy|radiotherapy
5377354|NCT00122265|radiation toxicity|radiation toxicity
5377355|NCT00122265|single nucleotide polymorphism|single nucleotide polymorphism
5377356|NCT00122252|prostate cancer|prostate cancer
5377357|NCT00122252|radiotherapy|radiotherapy
5377358|NCT00122252|biological imaging|biological imaging
5377359|NCT00122239|radiotherapy|radiotherapy
5377360|NCT00122239|radiation toxicity|radiation toxicity
5377361|NCT00122239|single nucleotide polymorphism|single nucleotide polymorphism
5377362|NCT00122239|breast carcinoma|breast carcinoma
5377363|NCT00122239|prostate carcinoma|prostate carcinoma
5377364|NCT00122239|squamous cell carcinoma of the head and neck|squamous cell carcinoma of the head and neck
5377365|NCT00122239|lung carcinoma (non-small cell)|lung carcinoma (non-small cell)
5377366|NCT00122226|HIV|hiv
5377367|NCT00122226|HIV-associated lipodystrophy syndrome|hiv-associated lipodystrophy syndrome
5377368|NCT00122213|Prevention|prevention
5377369|NCT00122213|Retirement|retirement
5377370|NCT00122213|Physical activity|physical activity
5377371|NCT00122213|Diet|diet
5377372|NCT00122213|Weight gain|weight gain
5377373|NCT00122213|Body composition|body composition
5377374|NCT00122187|cancer|cancer
5377375|NCT00122187|colonoscopy|colonoscopy
5377376|NCT00122187|mass screening|mass screening
5377377|NCT00122187|colorectal cancer|colorectal cancer
5377378|NCT00122187|colorectal carcinoma|colorectal carcinoma
5377379|NCT00122187|reminder systems|reminder systems
5377380|NCT00122187|rectal cancers|rectal cancers
5377381|NCT00122187|colorectal tumor|colorectal tumor
5377382|NCT00122187|guidelines|guidelines
5377383|NCT00122187|CRC secondary prevention|crc secondary prevention
5377384|NCT00122187|colorectal neoplasms|colorectal neoplasms
5377385|NCT00122187|colonic neoplasms|colonic neoplasms
5377386|NCT00122187|colonic diseases|colonic diseases
5377387|NCT00122187|hemoccult testing|hemoccult testing
5377388|NCT00122174|Caregivers|caregivers
5377389|NCT00122174|Stress|stress
5377390|NCT00122174|Coping|coping
5377391|NCT00122174|Immune|immune
5377392|NCT00122174|Relaxation|relaxation
5377393|NCT00122174|Biofeedback|biofeedback
5377394|NCT00122174|Bioinstrumentation|bioinstrumentation
5377395|NCT00122174|Homecare|homecare
5377396|NCT00122161|Drug therapy|drug therapy
5377397|NCT00122161|Practice guidelines|practice guidelines
5377398|NCT00122161|Reminder systems|reminder systems
5377399|NCT00122161|Ambulatory care|ambulatory care
5377400|NCT00122161|Hypertension|hypertension
5377401|NCT00122161|Clinical protocols|clinical protocols
5377402|NCT00122161|Quality Assurance, Health Care|quality assurance, health care
5377403|NCT00122148|Quality of health care|quality of health care
5377404|NCT00122148|Feedback|feedback
5377405|NCT00122135|end-of-life care|end-of-life care
5377406|NCT00122135|clinical decision-making|clinical decision-making
5377407|NCT00122135|values inventory|values inventory
5377408|NCT00122135|racial disparities|racial disparities
5377409|NCT00122109|Posttraumatic Stress Disorder|posttraumatic stress disorder
5377410|NCT00122109|Anger Management|anger management
5377411|NCT00122109|Telemedicine modality|telemedicine modality
5377412|NCT00122096|neurosurgery|neurosurgery
5377413|NCT00122096|COX-2|cox-2
5377414|NCT00122096|inflammation|inflammation
5377415|NCT00122096|pain|pain
5377416|NCT00122083|Depression|depression
5377417|NCT00122083|Students|students
5377418|NCT00122083|Health education|health education
5377419|NCT00122070|Borderline Personality Disorder|borderline personality disorder
5377420|NCT00122070|Personality Disorder|personality disorder
5377421|NCT00122070|Quetiapine|quetiapine
5377422|NCT00122070|Atypical Antipsychotics|atypical antipsychotics
5377423|NCT00122070|Seroquel|seroquel
5377424|NCT00122070|Antipsychotics|antipsychotics
5377425|NCT00122057|ventilator-associated tracheobronchitis|ventilator-associated tracheobronchitis
5377426|NCT00122057|nosocomial tracheobronchitis|nosocomial tracheobronchitis
5377427|NCT00122044|childhood|childhood
5377428|NCT00122044|cerebral palsy|cerebral palsy
5377429|NCT00122044|dystonia|dystonia
5377430|NCT00122044|secondary|secondary
5377431|NCT00122044|trihexyphenidyl|trihexyphenidyl
5377432|NCT00122044|pediatric dystonia|pediatric dystonia
5377433|NCT00122031|Major Depression|major depression
5377434|NCT00122031|Treatment Refractory Major Depression|treatment refractory major depression
5377435|NCT00122018|Kidney failure|kidney failure
5377436|NCT00122018|Cardiac Surgery|cardiac surgery
5377437|NCT00122018|Fenoldopam|fenoldopam
5377438|NCT00122018|N-acetylcysteine|n-acetylcysteine
5377439|NCT00122005|Metastatic|metastatic
5377440|NCT00122005|Prostate|prostate
5377441|NCT00122005|Advanced|advanced
5377442|NCT00122005|Cancer|cancer
5377443|NCT00122005|GVAX|gvax
5377444|NCT00122005|Vaccine|vaccine
5377445|NCT00121992|High risk node negative breast cancer|high risk node negative breast cancer
5377446|NCT00121992|Disease-Free survival|disease-free survival
5377447|NCT00121992|Quality of life|quality of life
5377448|NCT00121979|HIV|hiv
5377449|NCT00121979|treatment-experienced|treatment-experienced
5377450|NCT00121979|lamivudine|lamivudine
5377451|NCT00121979|3TC|3tc
5377452|NCT00121966|Type 2 diabetes|type 2 diabetes
5377453|NCT00121966|Insulin Aspart|insulin aspart
5377454|NCT00121966|Insulin NPH|insulin nph
5377455|NCT00121966|Metformin|metformin
5377456|NCT00121966|Rosiglitazone|rosiglitazone
5377457|NCT00121953|Endometriosis|endometriosis
5377458|NCT00121953|Peritoneal fluid|peritoneal fluid
5377459|NCT00121953|Cytokines|cytokines
5377460|NCT00121953|Peroxisome Proliferator-Activated Receptors|peroxisome proliferator-activated receptors
5377461|NCT00121940|Chronic Disease|chronic disease
5377462|NCT00121940|Nurses|nurses
5377463|NCT00121940|Caregivers|caregivers
5377464|NCT00121940|Support Groups|support groups
5377465|NCT00121927|intractable|intractable
5377466|NCT00121927|ketogenic|ketogenic
5377467|NCT00121927|ketosis|ketosis
5377468|NCT00121927|Atkins|atkins
5377469|NCT00121914|Carcinoma, Hepatocellular,|carcinoma, hepatocellular,
5377470|NCT00121914|percutaneous ethanol instillation|percutaneous ethanol instillation
5377471|NCT00121914|long-acting somatostatin|long-acting somatostatin
5377472|NCT00121901|Pancreatitis|pancreatitis
5377473|NCT00121901|Cholangiopancreatograpy, Endoscopic Retrograde/adverse|cholangiopancreatograpy, endoscopic retrograde/adverse
5377474|NCT00121901|Nitroglycerin|nitroglycerin
5377475|NCT00121901|Randomized Controlled Trial,|randomized controlled trial,
5377476|NCT00121888|post traumatic stress disorder|post traumatic stress disorder
5377477|NCT00121888|Prolonged Exposure Therapy|prolonged exposure therapy
5377478|NCT00121888|pharmacotherapy|pharmacotherapy
5377479|NCT00121888|double-blind|double-blind
5377480|NCT00121888|Anxiety Disorder|anxiety disorder
5377481|NCT00121875|short stature|short stature
5377482|NCT00121875|insulin resistance|insulin resistance
5377483|NCT00121875|body composition|body composition
5377484|NCT00121875|Turner syndrome|turner syndrome
5377485|NCT00121875|intramyocellular lipid|intramyocellular lipid
5377486|NCT00121875|glucose tolerance|glucose tolerance
5377487|NCT00121862|Leishmaniasis|leishmaniasis
5377488|NCT00121862|Subunit Vaccine|subunit vaccine
5377489|NCT00121862|Prevention|prevention
5377490|NCT00121862|T cell|t cell
5377491|NCT00121849|Leishmaniasis,|leishmaniasis,
5377492|NCT00121849|Subunit Vaccine,|subunit vaccine,
5377493|NCT00121849|Prevention,|prevention,
5377494|NCT00121849|T cell|t cell
5377495|NCT00121823|Malaria|malaria
5377496|NCT00121823|PCR|pcr
5377497|NCT00121823|Vaccines|vaccines
5377498|NCT00121823|Acceptability|acceptability
5377499|NCT00121797|Postpartum Period|postpartum period
5377500|NCT00121771|Malaria|malaria
5377501|NCT00121771|Vaccines|vaccines
5377502|NCT00121771|Safety|safety
5377503|NCT00121771|Immunogenicity|immunogenicity
5377504|NCT00121758|HIV Vaccines|hiv vaccines
5377505|NCT00121758|HIV Seronegativity|hiv seronegativity
5377506|NCT00121745|gene transfer|gene transfer
5377507|NCT00121745|cell cycle control|cell cycle control
5377508|NCT00121745|cancer gene therapy|cancer gene therapy
5377509|NCT00121745|pathotropic targeting|pathotropic targeting
5377510|NCT00121745|tumor targeted retroviral vector|tumor targeted retroviral vector
5377511|NCT00121719|Resistant and refractory solid tumors|resistant and refractory solid tumors
5377512|NCT00121719|lymphomas|lymphomas
5377513|NCT00121719|hodgkins disease|hodgkins disease
5377514|NCT00121719|non-hodgkins lymphoma|non-hodgkins lymphoma
5377515|NCT00121719|neoplasms|neoplasms
5377516|NCT00121693|Fall prevention|fall prevention
5377517|NCT00121693|posturography|posturography
5377518|NCT00121693|music therapy|music therapy
5377519|NCT00121680|cancer|cancer
5377520|NCT00121654|Angina pectoris|angina pectoris
5377521|NCT00121654|Spinal cord stimulation|spinal cord stimulation
5377522|NCT00121654|Refractory angina pectoris|refractory angina pectoris
5377523|NCT00121628|Thyroid cancer|thyroid cancer
5377524|NCT00121628|Advanced thyroid cancer|advanced thyroid cancer
5377525|NCT00121628|Metastatic thyroid cancer|metastatic thyroid cancer
5377526|NCT00121628|Medullary thyroid cancer|medullary thyroid cancer
5377527|NCT00121628|Follicular thyroid cancer|follicular thyroid cancer
5377528|NCT00121628|Papillary thyroid cancer|papillary thyroid cancer
5377529|NCT00121628|Hurthle cell thyroid cancer|hurthle cell thyroid cancer
5377530|NCT00121628|Thyroid cancer treatments|thyroid cancer treatments
5377531|NCT00121628|Differentiated thyroid cancer and medullary thyroid cancer|differentiated thyroid cancer and medullary thyroid cancer
5377532|NCT00121615|Clinical Trials|clinical trials
5377533|NCT00121602|Hemodialysis|hemodialysis
5377534|NCT00121602|Darbepoetin Alfa|darbepoetin alfa
5377535|NCT00121602|Clinical Trials|clinical trials
5377536|NCT00121602|Nephrology|nephrology
5377537|NCT00121602|Amgen|amgen
5377538|NCT00121602|Chronic Kidney Disease (CKD)|chronic kidney disease (ckd)
5377539|NCT00121589|AMD|amd
5377540|NCT00121589|Macular Pigment|macular pigment
5377541|NCT00121589|Serum Lutein Levels|serum lutein levels
5377542|NCT00121589|Vitamin Supplementation|vitamin supplementation
5377543|NCT00121589|Carotenoids|carotenoids
5377544|NCT00121589|Lutein|lutein
5377545|NCT00121589|Zeaxanthin|zeaxanthin
5377546|NCT00121589|DHA|dha
5377547|NCT00121589|Age Related Macular Degeneration|age related macular degeneration
5377548|NCT00121563|Cytokines|cytokines
5377549|NCT00121563|Inflammation|inflammation
5377550|NCT00121563|Pain|pain
5377551|NCT00121563|Injury|injury
5377552|NCT00121563|Peripheral|peripheral
5377553|NCT00121563|Wisdom Teeth|wisdom teeth
5377554|NCT00121563|Third Molar Extraction|third molar extraction
5377555|NCT00121550|Coronary heart disease|coronary heart disease
5377556|NCT00121550|Clarithromycin|clarithromycin
5377557|NCT00121550|Macrolides|macrolides
5377558|NCT00121550|Cardiovascular mortality|cardiovascular mortality
5377559|NCT00121550|Chlamydia pneumoniae|chlamydia pneumoniae
5377560|NCT00121537|wounds-open|wounds-open
5377561|NCT00121524|cardiac arrest|cardiac arrest
5377562|NCT00121524|resuscitation|resuscitation
5377563|NCT00121524|epinephrine|epinephrine
5377564|NCT00121524|intravenous|intravenous
5377565|NCT00121524|survival|survival
5377566|NCT00121511|photoaging|photoaging
5377567|NCT00121511|Actinic Keratoses|actinic keratoses
5377568|NCT00121511|Efudex|efudex
5377569|NCT00121511|5 fluorouracil|5 fluorouracil
5377570|NCT00121498|Pain|pain
5377571|NCT00121498|Hysterectomy|hysterectomy
5377572|NCT00121498|Preemptive|preemptive
5377573|NCT00121498|Lidocaine|lidocaine
5377574|NCT00121485|Heart-assist devices|heart-assist devices
5377575|NCT00121472|Heart-assist devices|heart-assist devices
5377576|NCT00121459|Diaphragm|diaphragm
5377577|NCT00121459|HIV prevention|hiv prevention
5377578|NCT00121459|Southern/South Africa, Zimbabwe|southern/south africa, zimbabwe
5377579|NCT00121459|female-controlled methods|female-controlled methods
5377580|NCT00121459|Replens|replens
5377581|NCT00121459|STI prevention|sti prevention
5377582|NCT00121459|HIV Seronegativity|hiv seronegativity
5377583|NCT00121446|Heart Attack|heart attack
5377584|NCT00121446|ST Elevation Myocardial Infarction|st elevation myocardial infarction
5377585|NCT00121446|fibrinolytic therapy|fibrinolytic therapy
5377586|NCT00121446|percutaneous coronary intervention|percutaneous coronary intervention
5377587|NCT00121446|Acute Myocardial Infarction|acute myocardial infarction
5377588|NCT00121420|Brain Neoplasms/secondary|brain neoplasms/secondary
5377589|NCT00121420|Brain neoplasms/radiotherapy|brain neoplasms/radiotherapy
5377590|NCT00121420|Brain metastasis|brain metastasis
5377591|NCT00121420|Neoplasm metastasis|neoplasm metastasis
5377592|NCT00121420|Cranial irradiation|cranial irradiation
5377593|NCT00121420|Radiosurgery|radiosurgery
5377594|NCT00121420|Lung Neoplasms|lung neoplasms
5377595|NCT00121420|Breast Neoplasms|breast neoplasms
5377596|NCT00121420|Kidney Neoplasms|kidney neoplasms
5377597|NCT00121420|Melanoma|melanoma
5377598|NCT00121420|Radiotherapy|radiotherapy
5377599|NCT00121420|Carcinoma, non-small cell lung|carcinoma, non-small cell lung
5377600|NCT00121407|Age Related Macular Degeneration (AMD)|age related macular degeneration (amd)
5377601|NCT00121407|Photodynamic Therapy (PDT)|photodynamic therapy (pdt)
5377602|NCT00121407|Visudyne|visudyne
5377603|NCT00121394|Chlorhexidine|chlorhexidine
5377604|NCT00121394|Vaginal wash|vaginal wash
5377605|NCT00121394|Neonatal mortality|neonatal mortality
5377606|NCT00121394|Sepsis|sepsis
5377607|NCT00121394|Global Network|global network
5377608|NCT00121394|Maternal and child health|maternal and child health
5377609|NCT00121394|Women's Health|women's health
5377610|NCT00121394|International|international
5377611|NCT00121394|Pakistan|pakistan
5377612|NCT00121381|Atopic dermatitis|atopic dermatitis
5377613|NCT00121381|T-cell|t-cell
5377614|NCT00121381|pimecrolimus|pimecrolimus
5377615|NCT00121381|children|children
5377616|NCT00121381|topical corticosteroids|topical corticosteroids
5377617|NCT00121368|Global Network|global network
5377618|NCT00121368|Maternal and child health|maternal and child health
5377619|NCT00121368|International|international
5377620|NCT00121368|Women's health|women's health
5377621|NCT00121368|Tobacco|tobacco
5377622|NCT00121368|Smoking|smoking
5377623|NCT00121368|Africa|africa
5377624|NCT00121368|Latin America|latin america
5377625|NCT00121368|South America|south america
5377626|NCT00121368|Guatemala|guatemala
5377627|NCT00121368|Zambia|zambia
5377628|NCT00121368|India|india
5377629|NCT00121368|Argentina|argentina
5377630|NCT00121368|Democratic Republic of the Congo|democratic republic of the congo
5377631|NCT00121329|Pain with procedures|pain with procedures
5377632|NCT00121316|Atopic dermatitis|atopic dermatitis
5377633|NCT00121316|pimecrolimus|pimecrolimus
5377634|NCT00121303|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
5377635|NCT00121303|adult erythroleukemia (M6a)|adult erythroleukemia (m6a)
5377636|NCT00121303|adult pure erythroid leukemia (M6b)|adult pure erythroid leukemia (m6b)
5377637|NCT00121303|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
5377638|NCT00121303|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
5377639|NCT00121303|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
5377640|NCT00121303|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
5377641|NCT00121303|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
5377642|NCT00121303|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
5377643|NCT00121303|refractory anemia with excess blasts|refractory anemia with excess blasts
5377644|NCT00121303|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5377645|NCT00121303|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
5377646|NCT00121303|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5377647|NCT00121303|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
5377648|NCT00121303|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5377649|NCT00121303|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5377650|NCT00121303|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5377651|NCT00121303|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5377652|NCT00121303|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5377653|NCT00121277|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5377654|NCT00121212|stage I prostate cancer|stage i prostate cancer
5377655|NCT00121212|stage IIB prostate cancer|stage iib prostate cancer
5377656|NCT00121212|stage IIA prostate cancer|stage iia prostate cancer
5377657|NCT00121212|stage III prostate cancer|stage iii prostate cancer
5377658|NCT00121186|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5377659|NCT00121186|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5377660|NCT00121186|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5377661|NCT00121186|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5377662|NCT00121186|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5377663|NCT00121186|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5377664|NCT00121186|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5377665|NCT00121173|cervical cancer|cervical cancer
5377666|NCT00121173|cervical intraepithelial neoplasia grade 2|cervical intraepithelial neoplasia grade 2
5377667|NCT00121173|cervical intraepithelial neoplasia grade 3|cervical intraepithelial neoplasia grade 3
5377668|NCT00121160|immune response to vaccines|immune response to vaccines
5377669|NCT00121160|stress management|stress management
5377670|NCT00121160|breast cancer|breast cancer
5377671|NCT00121147|glaucoma|glaucoma
5377672|NCT00121147|pseudoexfoliation|pseudoexfoliation
5377673|NCT00121134|Bevacizumab|bevacizumab
5377674|NCT00121134|Metronomic Chemotherapy|metronomic chemotherapy
5377675|NCT00121134|Breast Cancer Stages II-III|breast cancer stages ii-iii
5377676|NCT00121134|Invasive breast cancer stages II-III|invasive breast cancer stages ii-iii
5377677|NCT00121121|HIV Vaccines|hiv vaccines
5377678|NCT00121121|HIV Seronegativity|hiv seronegativity
5377679|NCT00121095|prostate cancer|prostate cancer
5377680|NCT00121069|specific phobia|specific phobia
5377681|NCT00121069|anxiety|anxiety
5377682|NCT00121069|SSRI|ssri
5377683|NCT00121069|clinical trial|clinical trial
5377684|NCT00121069|escitalopram|escitalopram
5377685|NCT00121043|Rheumatoid Arthritis, Inflammation|rheumatoid arthritis, inflammation
5377686|NCT00121043|Interleukin-1 (IL-1), r-metHuIL-1ra|interleukin-1 (il-1), r-methuil-1ra
5377687|NCT00121043|Autoimmune, Kineret®|autoimmune, kineret®
5377688|NCT00121043|Anakinra, Immunex|anakinra, immunex
5377689|NCT00121043|Amgen, Clinical Trials|amgen, clinical trials
5377690|NCT00121030|uterine cancer|uterine cancer
5377691|NCT00121030|ovarian cancer|ovarian cancer
5377692|NCT00121030|darbepoetin alfa|darbepoetin alfa
5377693|NCT00121030|Amgen|amgen
5377694|NCT00121030|Gynecological Malignancies|gynecological malignancies
5377695|NCT00121017|HCV Infection|hcv infection
5377696|NCT00121017|Treatment Naive|treatment naive
5377697|NCT00121004|Advance Directive|advance directive
5377698|NCT00121004|Living Will|living will
5377699|NCT00121004|Terminal Illness|terminal illness
5377700|NCT00120991|Coronary artery bypass grafting|coronary artery bypass grafting
5377701|NCT00120991|OPCAB|opcab
5377702|NCT00120978|Clinical Trial; C-reactive protein; fluticasone; salmeterol|clinical trial; c-reactive protein; fluticasone; salmeterol
5377703|NCT00120965|Cardiac arrest|cardiac arrest
5377704|NCT00120965|OOH-cardiac arrest|ooh-cardiac arrest
5377705|NCT00120965|CPR|cpr
5377706|NCT00120965|Chest compressions|chest compressions
5377707|NCT00120965|Chest compression device|chest compression device
5377708|NCT00120952|RSA|rsa
5377709|NCT00120952|Osteoarthritis|osteoarthritis
5377710|NCT00120952|Hip arthroplasty|hip arthroplasty
5377711|NCT00120952|DEXA|dexa
5377712|NCT00120952|Titanium|titanium
5377713|NCT00120952|Cobalt chromium|cobalt chromium
5377714|NCT00120952|Bone cement|bone cement
5377715|NCT00120939|Lung Cancer|lung cancer
5377716|NCT00120939|Breast Cancer|breast cancer
5377717|NCT00120939|Prostate Cancer|prostate cancer
5377718|NCT00120939|Ovarian Cancer|ovarian cancer
5377719|NCT00120939|Head and Neck Cancer|head and neck cancer
5377720|NCT00120939|Gastrointestinal Cancer|gastrointestinal cancer
5377721|NCT00120939|Metastatic Cancer|metastatic cancer
5377722|NCT00120939|Advanced Cancer|advanced cancer
5377723|NCT00120939|Genitourinary Cancer|genitourinary cancer
5377724|NCT00120939|Glioblastoma Multiforme|glioblastoma multiforme
5377725|NCT00120939|Recurrent Cancer|recurrent cancer
5377726|NCT00120939|Colon Cancer|colon cancer
5377727|NCT00120939|Gastric Cancer|gastric cancer
5377728|NCT00120939|Stomach Cancer|stomach cancer
5377729|NCT00120939|Pancreatic Cancer|pancreatic cancer
5377730|NCT00120939|Esophageal Cancer|esophageal cancer
5377731|NCT00120939|Throat Cancer|throat cancer
5377732|NCT00120939|Bladder Cancer|bladder cancer
5377733|NCT00120939|Kidney Cancer|kidney cancer
5377734|NCT00120939|Renal Cancer|renal cancer
5377735|NCT00120939|Cervical Cancer|cervical cancer
5377736|NCT00120939|Endometrial Cancer|endometrial cancer
5377737|NCT00120939|Colorectal Cancer|colorectal cancer
5377738|NCT00120926|Premature neonate|premature neonate
5377739|NCT00120926|Parenteral nutrition|parenteral nutrition
5377740|NCT00120926|Growth|growth
5377741|NCT00120926|Amino Acids|amino acids
5377742|NCT00120926|Nutrition|nutrition
5377743|NCT00120913|Breakthrough bleeding while taking continuously dosed oral contraceptives|breakthrough bleeding while taking continuously dosed oral contraceptives
5377744|NCT00120900|COX-2 inhibitor|cox-2 inhibitor
5377745|NCT00120900|Knee osteoarthritis|knee osteoarthritis
5377746|NCT00120887|Atherosclerosis, SLE, statins|atherosclerosis, sle, statins
5377747|NCT00120874|Alzheimer's disease|alzheimer's disease
5377748|NCT00120874|caregiver training|caregiver training
5377749|NCT00120874|caregiver counseling|caregiver counseling
5377750|NCT00120874|individualized management|individualized management
5377751|NCT00120874|memantine|memantine
5377752|NCT00120874|dementia|dementia
5377753|NCT00120861|Genotype-1|genotype-1
5377754|NCT00120861|Previously failed treatment|previously failed treatment
5377755|NCT00120848|HPV vaccine efficacy|hpv vaccine efficacy
5377756|NCT00120848|Prophylaxis HPV 16/18 infections|prophylaxis hpv 16/18 infections
5377757|NCT00120835|Genotype-1|genotype-1
5377758|NCT00120835|Treatment-Naive|treatment-naive
5377759|NCT00120822|Malaria|malaria
5377760|NCT00120822|Pregnancy|pregnancy
5377761|NCT00120822|Folic acid|folic acid
5377762|NCT00120822|Sulfadoxine-pyrimethamine|sulfadoxine-pyrimethamine
5377763|NCT00120809|Malaria|malaria
5377764|NCT00120809|Pregnancy|pregnancy
5377765|NCT00120809|Multigravidae|multigravidae
5377766|NCT00120809|Intermittent preventative treatment|intermittent preventative treatment
5377767|NCT00120809|Sulfadoxine-pyrimethamine|sulfadoxine-pyrimethamine
5377768|NCT00120796|Hepatitis B|hepatitis b
5377769|NCT00120796|Hepatitis B Vaccines|hepatitis b vaccines
5377770|NCT00120796|Lamivudine|lamivudine
5377771|NCT00120783|Treatment Failure|treatment failure
5377772|NCT00120783|HIV infections|hiv infections
5377773|NCT00120770|AE adverse event|ae adverse event
5377774|NCT00120770|AIDS acquired immunodeficiency syndrome|aids acquired immunodeficiency syndrome
5377775|NCT00120770|ALT (SGPT) alanine aminotransferase|alt (sgpt) alanine aminotransferase
5377776|NCT00120770|ART antiretroviral therapy|art antiretroviral therapy
5377777|NCT00120770|AST (SGOT) aspartate aminotransferase|ast (sgot) aspartate aminotransferase
5377778|NCT00120770|DCF data collection forms|dcf data collection forms
5377779|NCT00120770|DMC Data Monitoring Committee|dmc data monitoring committee
5377780|NCT00120770|FDA (U.S.) Food and Drug Administration|fda (u.s.) food and drug administration
5377781|NCT00120770|GCP Good Clinical Practice guidelines|gcp good clinical practice guidelines
5377782|NCT00120770|HB sAg Hepatitis B surface antigen|hb sag hepatitis b surface antigen
5377783|NCT00120770|ICH International Conference of Harmonisation|ich international conference of harmonisation
5377784|NCT00120770|IND Investigational New Drug Application|ind investigational new drug application
5377785|NCT00120770|IRB Institutional Review Board|irb institutional review board
5377786|NCT00120770|IU international units|iu international units
5377787|NCT00120770|mg milligram(s)|mg milligram(s)
5377788|NCT00120770|mm3 cubic millimeter(s)|mm3 cubic millimeter(s)
5377789|NCT00120770|PCR polymerase chain reaction|pcr polymerase chain reaction
5377790|NCT00120770|SAE serious adverse event|sae serious adverse event
5377791|NCT00120770|µg microgram|µg microgram
5377792|NCT00120770|ULN upper limit of the normal range|uln upper limit of the normal range
5377793|NCT00120770|WB Western Blot|wb western blot
5377794|NCT00120770|Human Immunodeficiency Virus|human immunodeficiency virus
5377795|NCT00120770|Neisseria gonorrhoeae|neisseria gonorrhoeae
5377796|NCT00120770|Chlamydia trachomatis|chlamydia trachomatis
5377797|NCT00120770|HIV Seronegativity|hiv seronegativity
5377798|NCT00120757|Osteoporosis|osteoporosis
5377799|NCT00120731|Recurrent nephrolithiasis|recurrent nephrolithiasis
5377800|NCT00120731|Potassium Citrate|potassium citrate
5377801|NCT00120731|Hypercalciuria|hypercalciuria
5377802|NCT00120731|Distal Renal Tubular Acidosis|distal renal tubular acidosis
5377803|NCT00120731|Nephrolithiasis in children|nephrolithiasis in children
5377804|NCT00120705|anemia|anemia
5377805|NCT00120705|darbepoetin alfa|darbepoetin alfa
5377806|NCT00120705|Amgen|amgen
5377807|NCT00120705|Non-myeloid Malignancies|non-myeloid malignancies
5377808|NCT00120692|breast cancer|breast cancer
5377809|NCT00120692|darbepoetin alfa|darbepoetin alfa
5377810|NCT00120692|Amgen|amgen
5377811|NCT00120679|non-small cell lung cancer|non-small cell lung cancer
5377812|NCT00120679|darbepoetin alfa|darbepoetin alfa
5377813|NCT00120679|Amgen|amgen
5377814|NCT00120666|Exercise|exercise
5377815|NCT00120666|Stimulation|stimulation
5377816|NCT00120666|Nerve|nerve
5377817|NCT00120666|Electrical|electrical
5377818|NCT00120666|Muscle|muscle
5377819|NCT00120666|Healthy Volunteer|healthy volunteer
5377820|NCT00120666|HV|hv
5377821|NCT00120653|Reglan|reglan
5377822|NCT00120653|Prolactin|prolactin
5377823|NCT00120653|MDS|mds
5377824|NCT00120653|Metoclopramide|metoclopramide
5377825|NCT00120653|Myelodysplastic Syndrome|myelodysplastic syndrome
5377826|NCT00120640|Premature birth|premature birth
5377827|NCT00120640|Premature labor|premature labor
5377828|NCT00120640|Progesterone|progesterone
5377829|NCT00120627|Randomized Controlled Trial|randomized controlled trial
5377830|NCT00120627|Intervention Study|intervention study
5377831|NCT00120627|Mindfulness|mindfulness
5377832|NCT00120627|Complementary Therapy|complementary therapy
5377833|NCT00120627|Mind-Body Relations (Metaphysics)|mind-body relations (metaphysics)
5377834|NCT00120627|Spiritual Therapy|spiritual therapy
5377835|NCT00120627|Meditation|meditation
5377836|NCT00120627|Qualitative Analysis|qualitative analysis
5377837|NCT00120614|Premature Infant|premature infant
5377838|NCT00120614|Premature Birth|premature birth
5377839|NCT00120614|Parenting Interventions|parenting interventions
5377840|NCT00120614|NICU Interventional studies|nicu interventional studies
5377841|NCT00120614|Parental coping|parental coping
5377842|NCT00120614|Low birthweight infant|low birthweight infant
5377843|NCT00120614|Coping Behavior|coping behavior
5377844|NCT00120614|Infant, Premature|infant, premature
5377845|NCT00120601|treatment|treatment
5377846|NCT00120601|alcohol|alcohol
5377847|NCT00120601|dependence|dependence
5377848|NCT00120601|medication|medication
5377849|NCT00120588|brain protection|brain protection
5377850|NCT00120588|white matter injury|white matter injury
5377851|NCT00120588|neurodevelopmental sequelae|neurodevelopmental sequelae
5377852|NCT00120588|magnesium sulfate|magnesium sulfate
5377853|NCT00120588|intraventricular hemorrhage|intraventricular hemorrhage
5377854|NCT00120575|Hemofiltration|hemofiltration
5377855|NCT00120575|Pediatrics|pediatrics
5377856|NCT00120562|weight loss surgery|weight loss surgery
5377857|NCT00120562|gastric bypass surgery|gastric bypass surgery
5377858|NCT00120549|Assisted Hatching|assisted hatching
5377859|NCT00120549|Cleavage Stage, Ovum|cleavage stage, ovum
5377860|NCT00120549|Embryo Transfer|embryo transfer
5377861|NCT00120549|Pregnancy|pregnancy
5377862|NCT00120549|Embryo Implantation|embryo implantation
5377863|NCT00120536|Type 2 diabetes|type 2 diabetes
5377864|NCT00120536|vildagliptin|vildagliptin
5377990|NCT00120016|olive oil|olive oil
5377865|NCT00120523|Atopic dermatitis, children, infants, pimecrolimus|atopic dermatitis, children, infants, pimecrolimus
5377866|NCT00120510|Treatment Naive|treatment naive
5377867|NCT00120510|TB|tb
5377868|NCT00120497|short stature|short stature
5377869|NCT00120497|intrauterine growth restriction|intrauterine growth restriction
5377870|NCT00120497|insulin resistance|insulin resistance
5377871|NCT00120497|intramyocellular lipid|intramyocellular lipid
5377872|NCT00120497|small for gestational age|small for gestational age
5377873|NCT00120497|glucose tolerance|glucose tolerance
5377874|NCT00120484|Circadian Rhythm|circadian rhythm
5377875|NCT00120484|Biological Clock|biological clock
5377876|NCT00120484|Complementary and Alternative Medicine|complementary and alternative medicine
5377877|NCT00120471|Perinatal Transmission|perinatal transmission
5377878|NCT00120471|MTCT|mtct
5377879|NCT00120471|HIV Seronegativity|hiv seronegativity
5377880|NCT00120458|Black Cohosh|black cohosh
5377881|NCT00120458|Cimicifuga|cimicifuga
5377883|NCT00120458|Women|women
5377884|NCT00120458|Complementary and Alternative Medicine|complementary and alternative medicine
5377885|NCT00120445|retinal detachment|retinal detachment
5377886|NCT00120445|pneumatic retinopexy|pneumatic retinopexy
5377887|NCT00120432|single dose|single dose
5377888|NCT00120432|mydriatic drug|mydriatic drug
5377889|NCT00120432|pupillary dilation|pupillary dilation
5377890|NCT00120419|HIV-1 infection|hiv-1 infection
5377891|NCT00120419|immunomodulatory therapy|immunomodulatory therapy
5377892|NCT00120419|Treatment Naive|treatment naive
5377893|NCT00120406|Peripheral Arterial Disease (PAD)|peripheral arterial disease (pad)
5377894|NCT00120406|Peripheral Vascular Disease|peripheral vascular disease
5377895|NCT00120406|Drug-Eluting Stent|drug-eluting stent
5377896|NCT00120406|Drug-Coated Stent|drug-coated stent
5377897|NCT00120393|Treatment Experienced|treatment experienced
5377898|NCT00120380|Idiopathic pulmonary arterial hypertension|idiopathic pulmonary arterial hypertension
5377899|NCT00120367|Leukoencephalopathy, Progressive Multifocal|leukoencephalopathy, progressive multifocal
5377900|NCT00120367|HIV infections|hiv infections
5377901|NCT00120367|HIV Fusion Inhibitors|hiv fusion inhibitors
5377902|NCT00120354|Hepatitis B Virus|hepatitis b virus
5377903|NCT00120354|Antiviral Resistance|antiviral resistance
5377904|NCT00120354|Drug Withdrawal|drug withdrawal
5377905|NCT00120354|Immune Response|immune response
5377906|NCT00120354|Hepatitis B Surface Antigen|hepatitis b surface antigen
5377907|NCT00120354|Liver Biopsy|liver biopsy
5377908|NCT00120354|Hepatitis B|hepatitis b
5377909|NCT00120328|serum creatinine|serum creatinine
5377910|NCT00120328|end stage renal disease|end stage renal disease
5377911|NCT00120328|cardiovascular mortality|cardiovascular mortality
5377912|NCT00120328|cardiovascular morbidity|cardiovascular morbidity
5377913|NCT00120328|non-cardiovascular mortality|non-cardiovascular mortality
5377914|NCT00120328|non-cardiovascular morbidity|non-cardiovascular morbidity
5377915|NCT00120315|dyspepsia|dyspepsia
5377916|NCT00120315|discontinuation|discontinuation
5377917|NCT00120315|Primary health care|primary health care
5377918|NCT00120315|Helicobacter pylori|helicobacter pylori
5377919|NCT00120315|Proton Pump Inhibitor|proton pump inhibitor
5377920|NCT00120315|Histamine-2-receptor-antagonist|histamine-2-receptor-antagonist
5377921|NCT00120302|Randomised|randomised
5377922|NCT00120302|Placebo-controlled|placebo-controlled
5377923|NCT00120302|Elidel|elidel
5377924|NCT00120302|Quality of Life|quality of life
5377925|NCT00120302|Atopic Eczema|atopic eczema
5377926|NCT00120276|Functional Mitral Regurgitation (FMR)|functional mitral regurgitation (fmr)
5377927|NCT00120276|Ischemic Mitral Regurgitation|ischemic mitral regurgitation
5377928|NCT00120276|Less invasive repair|less invasive repair
5377929|NCT00120276|Surgical MV repair|surgical mv repair
5377930|NCT00120276|Mitral Valve Repair|mitral valve repair
5377931|NCT00120276|Heart Failure|heart failure
5377932|NCT00120276|Left Ventricular Dysfunction|left ventricular dysfunction
5377933|NCT00120263|Plasma Exchange|plasma exchange
5377934|NCT00120263|Myeloma|myeloma
5377935|NCT00120263|Acute renal failure|acute renal failure
5377936|NCT00120263|Light Chains|light chains
5377937|NCT00120263|Bence Jones Proteins|bence jones proteins
5377938|NCT00120263|Kidney Function|kidney function
5377939|NCT00120250|PTSD|ptsd
5377940|NCT00120250|Sleep disturbance|sleep disturbance
5377941|NCT00120250|Eszopiclone|eszopiclone
5377942|NCT00120250|Double-blind|double-blind
5377943|NCT00120250|Crossover|crossover
5377944|NCT00120237|Postpartum hemorrhage|postpartum hemorrhage
5377945|NCT00120237|Misoprostol|misoprostol
5377946|NCT00120237|Maternal morbidity|maternal morbidity
5377947|NCT00120237|Developing countries|developing countries
5377948|NCT00120237|Traditional birth attendants|traditional birth attendants
5377949|NCT00120224|Mifepristone|mifepristone
5377950|NCT00120224|Medical abortion|medical abortion
5377951|NCT00120224|Ultrasound|ultrasound
5377952|NCT00120198|NHL|nhl
5377953|NCT00120198|elderly|elderly
5377954|NCT00120185|HIV Infections|hiv infections
5377955|NCT00120185|Interleukin-2|interleukin-2
5377956|NCT00120172|colorectal|colorectal
5377957|NCT00120172|metastatic|metastatic
5377958|NCT00120172|elderly|elderly
5377959|NCT00120172|metastatic colorectal cancer|metastatic colorectal cancer
5377960|NCT00120159|Necrotizing Enterocolitis|necrotizing enterocolitis
5377961|NCT00120133|Osteoporosis|osteoporosis
5377962|NCT00120133|Bisphosphonates|bisphosphonates
5377963|NCT00120133|Atorvastatin|atorvastatin
5377964|NCT00120120|Radiculopathy|radiculopathy
5377965|NCT00120120|Back Pain|back pain
5377966|NCT00120120|Lumbar Pain|lumbar pain
5377967|NCT00120120|CC-5013|cc-5013
5377968|NCT00120120|Revlimid|revlimid
5377969|NCT00120120|Lenalidomide|lenalidomide
5377970|NCT00120094|Syncope|syncope
5377971|NCT00120094|Electrocardiographic monitoring|electrocardiographic monitoring
5377972|NCT00120081|Vaccine|vaccine
5377973|NCT00120081|Hookworm|hookworm
5377974|NCT00120081|Phase 1|phase 1
5377975|NCT00120081|Human Hookworm Infection|human hookworm infection
5377976|NCT00120081|Na-ASP-2|na-asp-2
5377977|NCT00120042|Abortion|abortion
5377978|NCT00120042|Retained placenta|retained placenta
5377979|NCT00120042|Hemorrhage|hemorrhage
5377980|NCT00120042|Postpartum ultrasound|postpartum ultrasound
5377981|NCT00120029|weight loss|weight loss
5377982|NCT00120029|survivorship|survivorship
5377983|NCT00120029|breast ductal lavage|breast ductal lavage
5377984|NCT00120029|exercise|exercise
5377985|NCT00120029|diet|diet
5377986|NCT00120016|cancer prevention|cancer prevention
5377987|NCT00120016|diet|diet
5377988|NCT00120016|nutrition|nutrition
5377989|NCT00120016|polyunsaturated fat|polyunsaturated fat
5377991|NCT00120003|Acute stroke|acute stroke
5377992|NCT00120003|Elevated blood pressure|elevated blood pressure
5377993|NCT00120003|Blood pressure lowering treatment|blood pressure lowering treatment
5377994|NCT00119990|vasopressin|vasopressin
5377995|NCT00119990|icodextrin|icodextrin
5377996|NCT00119990|cardiac output|cardiac output
5377997|NCT00119977|cartilage thickness|cartilage thickness
5377998|NCT00119977|RSA|rsa
5377999|NCT00119977|DEXA|dexa
5378000|NCT00119977|ultra sound|ultra sound
5378001|NCT00119977|MRI|mri
5378002|NCT00119977|osteoarthritis|osteoarthritis
5378003|NCT00119977|periacetabular osteotomy|periacetabular osteotomy
5378004|NCT00119951|Behavioral|behavioral
5378005|NCT00119938|Disease management|disease management
5378006|NCT00119938|Patient access to records|patient access to records
5378007|NCT00119938|Medical records systems, computerized|medical records systems, computerized
5378008|NCT00119938|Questionnaires|questionnaires
5378009|NCT00119938|Physician-patient relations|physician-patient relations
5378010|NCT00119938|Medical records|medical records
5378011|NCT00119925|infertility|infertility
5378012|NCT00119925|guideline|guideline
5378013|NCT00119925|health care implementation|health care implementation
5378014|NCT00119925|intervention|intervention
5378015|NCT00119925|gynecology|gynecology
5378016|NCT00119912|screening|screening
5378017|NCT00119912|flexible sigmoidoscopy|flexible sigmoidoscopy
5378018|NCT00119912|fecal occult blood|fecal occult blood
5378019|NCT00119912|cancer|cancer
5378020|NCT00119912|colon|colon
5378021|NCT00119912|rectum|rectum
5378022|NCT00119899|Colorectal Cancer;|colorectal cancer;
5378023|NCT00119899|Liver;|liver;
5378024|NCT00119899|Metastases;|metastases;
5378025|NCT00119899|Resection;|resection;
5378026|NCT00119899|Fluorodeoxyglucose;|fluorodeoxyglucose;
5378027|NCT00119899|Tomography;|tomography;
5378028|NCT00119899|Positron-Emission|positron-emission
5378029|NCT00119873|HIV Preventive Vaccine|hiv preventive vaccine
5378030|NCT00119873|AIDS Vaccines|aids vaccines
5378031|NCT00119873|Adenoviridae|adenoviridae
5378032|NCT00119847|Stents, myocardial infarction|stents, myocardial infarction
5378033|NCT00119834|Heart Failure|heart failure
5378034|NCT00119834|Intermacs|intermacs
5378035|NCT00119834|Pedimacs|pedimacs
5378036|NCT00119834|Mechanical Circulatory Support|mechanical circulatory support
5378037|NCT00119834|Ventricular Assist Device|ventricular assist device
5378038|NCT00119769|HIV|hiv
5378039|NCT00119769|immune stimulation|immune stimulation
5378040|NCT00119769|lipodystrophy|lipodystrophy
5378041|NCT00119769|growth hormone|growth hormone
5378042|NCT00119769|recombinant growth hormone|recombinant growth hormone
5378043|NCT00119769|Treatment Experienced|treatment experienced
5378044|NCT00119756|Schizophrenia|schizophrenia
5378045|NCT00119756|Intramuscular injection|intramuscular injection
5378046|NCT00119756|Deltoid muscle|deltoid muscle
5378047|NCT00119756|Gluteus muscle|gluteus muscle
5378048|NCT00119756|Paliperidone palmitate|paliperidone palmitate
5378049|NCT00119743|Prophylaxis pneumococcal vaccine|prophylaxis pneumococcal vaccine
5378050|NCT00119730|Fludarabine|fludarabine
5378051|NCT00119730|Mitoxantrone|mitoxantrone
5378052|NCT00119730|Rituximab|rituximab
5378053|NCT00119730|Zevalin|zevalin
5378054|NCT00119730|Mantle Cell Lymphoma|mantle cell lymphoma
5378055|NCT00119730|Relapsed Mantle Cell Lymphoma|relapsed mantle cell lymphoma
5378056|NCT00119717|acute|acute
5378057|NCT00119717|ischemic|ischemic
5378058|NCT00119717|stroke|stroke
5378059|NCT00119717|randomized|randomized
5378060|NCT00119717|device|device
5378061|NCT00119717|treatment|treatment
5378062|NCT00119678|SLE|sle
5378063|NCT00119665|Postmenopausal symptoms|postmenopausal symptoms
5378064|NCT00119665|Hot Flashes|hot flashes
5378065|NCT00119665|Postmenopausal Hot Flashes|postmenopausal hot flashes
5378066|NCT00119652|Bipolar disorder|bipolar disorder
5378067|NCT00119652|bipolar depression|bipolar depression
5378068|NCT00119652|depression|depression
5378069|NCT00119626|Stroke, Acute|stroke, acute
5378070|NCT00119626|Cerebrovascular Stroke|cerebrovascular stroke
5378071|NCT00119613|Oncology|oncology
5378072|NCT00119613|Clinical Trial|clinical trial
5378073|NCT00119613|Hemoglobin|hemoglobin
5378074|NCT00119613|Darbepoetin alfa|darbepoetin alfa
5378075|NCT00119613|Survival|survival
5378076|NCT00119613|Carboplatin|carboplatin
5378077|NCT00119613|Cisplatin|cisplatin
5378078|NCT00119613|Etoposide|etoposide
5378079|NCT00119613|Extensive Stage Small Cell Lung Cancer|extensive stage small cell lung cancer
5378080|NCT00119600|Non-myeloid malignancy|non-myeloid malignancy
5378081|NCT00119600|Clinical Trial|clinical trial
5378082|NCT00119587|Hemodialysis|hemodialysis
5378083|NCT00119587|darbepoetin alfa|darbepoetin alfa
5378084|NCT00119587|Clinical Trial|clinical trial
5378085|NCT00119587|Amgen|amgen
5378086|NCT00119574|Randomized Controlled Trial|randomized controlled trial
5378087|NCT00119574|Quality of Health Care|quality of health care
5378088|NCT00119574|Health Services Research|health services research
5378089|NCT00119574|Guidelines|guidelines
5378090|NCT00119574|Medical Informatics Computing|medical informatics computing
5378091|NCT00119574|Services, Mental Health|services, mental health
5378092|NCT00119574|Medicine, Evidence-Based|medicine, evidence-based
5378093|NCT00119574|Quality Assurance, Healthcare|quality assurance, healthcare
5378094|NCT00119574|Quality Indicators, Health Care|quality indicators, health care
5378095|NCT00119574|Veterans|veterans
5378096|NCT00119561|Caregiver|caregiver
5378097|NCT00119561|Dementia|dementia
5378098|NCT00119561|Alzheimer Disease|alzheimer disease
5378099|NCT00119561|Telephone|telephone
5378100|NCT00119561|Randomized Controlled Trials|randomized controlled trials
5378101|NCT00119548|HIV Rapid Testing|hiv rapid testing
5378102|NCT00119548|Cost-effectiveness|cost-effectiveness
5378103|NCT00119548|HIV Seronegativity|hiv seronegativity
5378104|NCT00119535|Diabetes mellitus|diabetes mellitus
5378105|NCT00119535|Diabetic retinopathy|diabetic retinopathy
5378106|NCT00119535|Organizational change|organizational change
5378107|NCT00119535|Quality improvement|quality improvement
5378108|NCT00119535|Quasi-experimental|quasi-experimental
5378109|NCT00119522|wheelchairs|wheelchairs
5378110|NCT00119522|falls|falls
5378111|NCT00119522|spinal cord injury|spinal cord injury
5378112|NCT00119522|accidental falls|accidental falls
5378113|NCT00119522|safety|safety
5378114|NCT00119509|Cervix Neoplasms|cervix neoplasms
5378115|NCT00119509|Vaginal smears|vaginal smears
5378116|NCT00119509|Papillomavirus - Human|papillomavirus - human
5378117|NCT00119496|Corticosteroid|corticosteroid
5378118|NCT00119496|Rosiglitazone|rosiglitazone
5378119|NCT00119496|Theophylline|theophylline
5378120|NCT00119496|Beclomethasone|beclomethasone
5378121|NCT00119496|Inflammation|inflammation
5378123|NCT00119496|Smoking|smoking
5378124|NCT00119496|Pulmonary|pulmonary
5378125|NCT00119483|Men|men
5378126|NCT00119483|testosterone|testosterone
5378127|NCT00119483|hypogonadal|hypogonadal
5378128|NCT00119483|aging|aging
5378129|NCT00119483|body composition|body composition
5378130|NCT00119483|quality og life|quality og life
5378131|NCT00119483|Muscle strength|muscle strength
5378132|NCT00119483|Aging male|aging male
5378133|NCT00119457|antithrombotic agents|antithrombotic agents
5378134|NCT00119457|anticoagulants|anticoagulants
5378135|NCT00119457|prophylaxis|prophylaxis
5378136|NCT00119457|embolism|embolism
5378137|NCT00119457|deep vein thrombosis|deep vein thrombosis
5378138|NCT00119457|hip fracture|hip fracture
5378139|NCT00119444|PET|pet
5378140|NCT00119444|Periacetabular osteotomy|periacetabular osteotomy
5378141|NCT00119431|Hereditary angioedema type I (MeSH: angioneurotic edema, complement 1 inactivators)|hereditary angioedema type i (mesh: angioneurotic edema, complement 1 inactivators)
5378142|NCT00119418|hot flash|hot flash
5378143|NCT00119418|menopause|menopause
5378144|NCT00119418|herbal medicine|herbal medicine
5378145|NCT00119418|kampo|kampo
5378146|NCT00119418|alternative medicine|alternative medicine
5378147|NCT00119405|Lipoatrophy|lipoatrophy
5378148|NCT00119405|Mitochondria|mitochondria
5378149|NCT00119405|Treatment Naive|treatment naive
5378150|NCT00119379|lipoatrophy|lipoatrophy
5378151|NCT00119379|mitochondria|mitochondria
5378152|NCT00119379|HIV|hiv
5378153|NCT00119379|treatment experienced|treatment experienced
5378154|NCT00119340|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5378155|NCT00119340|Philadelphia chromosome positive chronic myelogenous leukemia|philadelphia chromosome positive chronic myelogenous leukemia
5378156|NCT00119340|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5378157|NCT00119340|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5378158|NCT00119314|newly diagnosed carcinoma of unknown primary|newly diagnosed carcinoma of unknown primary
5378159|NCT00119314|recurrent carcinoma of unknown primary|recurrent carcinoma of unknown primary
5378160|NCT00119301|recurrent osteosarcoma|recurrent osteosarcoma
5378161|NCT00119210|Tobacco use cessation|tobacco use cessation
5378162|NCT00119210|Bupropion|bupropion
5378163|NCT00119210|Zyban|zyban
5378164|NCT00119210|Puerperium|puerperium
5378165|NCT00119197|watery diarrhea|watery diarrhea
5378166|NCT00119197|cholera vaccine|cholera vaccine
5378167|NCT00119184|anesthesia|anesthesia
5378168|NCT00119184|breech|breech
5378169|NCT00119184|external cephalic version|external cephalic version
5378170|NCT00119184|spinal|spinal
5378171|NCT00119184|success|success
5378172|NCT00119184|anesthesia,spinal|anesthesia,spinal
5378173|NCT00119171|Safety|safety
5378174|NCT00119171|tolerability|tolerability
5378175|NCT00119171|dose limiting toxicity|dose limiting toxicity
5378176|NCT00119171|solid tumors|solid tumors
5378177|NCT00119171|capecitabine|capecitabine
5378178|NCT00119158|THerapy for acute moderate to severe flares|therapy for acute moderate to severe flares
5378179|NCT00119145|antimalarial drugs|antimalarial drugs
5378180|NCT00119145|efficacy|efficacy
5378181|NCT00119145|safety|safety
5378182|NCT00119145|trial|trial
5378183|NCT00119132|intermittent preventive treatment|intermittent preventive treatment
5378184|NCT00119132|effectiveness|effectiveness
5378185|NCT00119132|malaria|malaria
5378186|NCT00119119|Hepatitis C|hepatitis c
5378187|NCT00119119|Liver Cirrhosis|liver cirrhosis
5378188|NCT00119119|Tocopherols|tocopherols
5378189|NCT00119106|HIV|hiv
5378190|NCT00119106|Prevention|prevention
5378191|NCT00119106|Tenofovir|tenofovir
5378192|NCT00119106|HIV Seronegativity|hiv seronegativity
5378193|NCT00119093|Antiretroviral therapy|antiretroviral therapy
5378194|NCT00119093|HIV|hiv
5378195|NCT00119093|Adherence|adherence
5378196|NCT00119093|Viral Load|viral load
5378197|NCT00119093|Opportunistic illness|opportunistic illness
5378198|NCT00119080|Meningococcal carriage|meningococcal carriage
5378199|NCT00119080|Conjugate vaccine|conjugate vaccine
5378200|NCT00119067|Anthrax|anthrax
5378201|NCT00119067|Vaccine|vaccine
5378202|NCT00119067|Immunogenicity|immunogenicity
5378203|NCT00119067|Reactogenicity|reactogenicity
5378204|NCT00119054|Hypertension|hypertension
5378205|NCT00119054|Diabetes Mellitus|diabetes mellitus
5378206|NCT00119054|Telemedicine|telemedicine
5378207|NCT00119054|Nursing Care|nursing care
5378208|NCT00119041|Diabetes Mellitus|diabetes mellitus
5378209|NCT00119041|Telemedicine|telemedicine
5378210|NCT00119041|Referral|referral
5378211|NCT00119041|Consultation|consultation
5378212|NCT00119028|Quality Improvement|quality improvement
5378213|NCT00119028|Cluster Randomized Trial|cluster randomized trial
5378214|NCT00119028|Care Model|care model
5378215|NCT00119015|perennial allergic rhinitis|perennial allergic rhinitis
5378216|NCT00119002|randomized clinical trial|randomized clinical trial
5378217|NCT00119002|placebo-controlled|placebo-controlled
5378218|NCT00119002|double-blind|double-blind
5378219|NCT00119002|double-masked|double-masked
5378220|NCT00119002|infant|infant
5378221|NCT00119002|dexamethasone|dexamethasone
5378222|NCT00119002|wheezing|wheezing
5378223|NCT00118989|Curcumin|curcumin
5378224|NCT00118989|chemoprevention|chemoprevention
5378225|NCT00118989|adenomatous polyps|adenomatous polyps
5378226|NCT00118989|colorectal cancer|colorectal cancer
5378227|NCT00118976|diabetic nephropathy|diabetic nephropathy
5378228|NCT00118976|type 1 diabetes|type 1 diabetes
5378229|NCT00118976|albuminuria|albuminuria
5378230|NCT00118976|hypertension|hypertension
5378231|NCT00118924|Dengue Vaccine|dengue vaccine
5378232|NCT00118924|Tick-Borne Illnesses|tick-borne illnesses
5378233|NCT00118924|Flavivirus|flavivirus
5378234|NCT00118911|Adult|adult
5378235|NCT00118911|ADHD|adhd
5378236|NCT00118911|ADD|add
5378237|NCT00118911|CBT|cbt
5378238|NCT00118911|Relaxation Techniques|relaxation techniques
5378239|NCT00118911|Education|education
5378240|NCT00118898|Treatment Naive|treatment naive
5378241|NCT00118885|Shingles|shingles
5378242|NCT00118885|depression|depression
5378243|NCT00118885|varicella zoster virus|varicella zoster virus
5378244|NCT00118885|alternative medicine|alternative medicine
5378245|NCT00118885|psychoneuroimmunology|psychoneuroimmunology
5378246|NCT00118872|Growth and Development|growth and development
5378247|NCT00118872|Pakistan|pakistan
5378248|NCT00118872|Weaning|weaning
5378249|NCT00118872|Probiotics|probiotics
5378250|NCT00118872|Infant|infant
5378251|NCT00118872|Lactobacillus GG|lactobacillus gg
5378252|NCT00118859|Back Pain|back pain
5378253|NCT00118859|Integrative Care|integrative care
5378254|NCT00118859|Acupuncture|acupuncture
5378255|NCT00118859|Chiropractic|chiropractic
5378256|NCT00118859|Exercise|exercise
5378257|NCT00118859|Massage Therapy|massage therapy
5378258|NCT00118859|Mind-Body Therapy|mind-body therapy
5378259|NCT00118859|Nutritional Counseling|nutritional counseling
5378260|NCT00118859|Complementary Therapies|complementary therapies
5378261|NCT00118859|Complementary and Alternative Medicine|complementary and alternative medicine
5378262|NCT00118846|Women|women
5378263|NCT00118846|Complementary and Alternative Medicine|complementary and alternative medicine
5378264|NCT00118846|CAM|cam
5378265|NCT00118833|Social Anxiety Disorder|social anxiety disorder
5378266|NCT00118833|Social Phobia|social phobia
5378267|NCT00118833|Generalized Anxiety Disorder|generalized anxiety disorder
5378268|NCT00118833|Hypericum|hypericum
5378269|NCT00118833|St. John's wort|st. john's wort
5378270|NCT00118833|Medicine, Herbal|medicine, herbal
5378271|NCT00118833|Complementary Therapies|complementary therapies
5378272|NCT00118820|Dry socket|dry socket
5378273|NCT00118820|Third molar|third molar
5378274|NCT00118820|Infection|infection
5378275|NCT00118820|postop-infection|postop-infection
5378276|NCT00118820|Antibiotic efficacy|antibiotic efficacy
5378277|NCT00118820|Infection characterized by pus,erythema,edema and pain|infection characterized by pus,erythema,edema and pain
5378278|NCT00118807|malaria treatment|malaria treatment
5378279|NCT00118807|artemisinin based combination therapy|artemisinin based combination therapy
5378280|NCT00118807|Plasmodium falciparum|plasmodium falciparum
5378281|NCT00118807|pragmatic trial|pragmatic trial
5378282|NCT00118807|effectiveness|effectiveness
5378283|NCT00118794|uncomplicated malaria|uncomplicated malaria
5378284|NCT00118794|G6PD deficiency|g6pd deficiency
5378285|NCT00118794|haemolytic anaemia|haemolytic anaemia
5378286|NCT00118794|Lapdap|lapdap
5378392|NCT00118430|Knee Pain|knee pain
5378287|NCT00118794|Artemsinin based combination treatment|artemsinin based combination treatment
5378288|NCT00118794|compliance|compliance
5378289|NCT00118794|pragmatic trials|pragmatic trials
5378290|NCT00118781|ventilator-associated pneumonia|ventilator-associated pneumonia
5378291|NCT00118781|VAP|vap
5378292|NCT00118781|pneumonia|pneumonia
5378293|NCT00118781|ICU infection|icu infection
5378294|NCT00118768|Genotype-1, Chronic Hepatitis C|genotype-1, chronic hepatitis c
5378295|NCT00118729|Ragweed|ragweed
5378296|NCT00118729|GW685698X|gw685698x
5378297|NCT00118729|seasonal allergic rhinitis|seasonal allergic rhinitis
5378298|NCT00118729|onset|onset
5378299|NCT00118716|asthma|asthma
5378300|NCT00118716|bronchospasm|bronchospasm
5378301|NCT00118703|nonallergic rhinitis|nonallergic rhinitis
5378302|NCT00118703|GW685698X|gw685698x
5378303|NCT00118703|VMR|vmr
5378304|NCT00118703|vasomotor rhinitis|vasomotor rhinitis
5378305|NCT00118690|bronchospasm|bronchospasm
5378306|NCT00118690|asthma|asthma
5378307|NCT00118677|HIV Infections|hiv infections
5378308|NCT00118664|Septic Shock|septic shock
5378309|NCT00118664|Thrombocytopenia|thrombocytopenia
5378310|NCT00118664|Multiple Organ Failure|multiple organ failure
5378311|NCT00118664|Pediatric|pediatric
5378312|NCT00118651|pneumonia|pneumonia
5378313|NCT00118651|chest x-ray|chest x-ray
5378314|NCT00118651|diagnosis|diagnosis
5378315|NCT00118638|Non-myeloid malignancy|non-myeloid malignancy
5378316|NCT00118638|Darbepoetin alfa|darbepoetin alfa
5378317|NCT00118638|Clinical Trial|clinical trial
5378318|NCT00118625|Allergy|allergy
5378319|NCT00118625|Specific Immunotherapy|specific immunotherapy
5378320|NCT00118625|Adjuvant|adjuvant
5378321|NCT00118625|Allergy Vaccination|allergy vaccination
5378322|NCT00118625|Allergenicity|allergenicity
5378323|NCT00118612|Allergy|allergy
5378324|NCT00118612|Specific Immunotherapy|specific immunotherapy
5378325|NCT00118612|Allergy Vaccination|allergy vaccination
5378326|NCT00118612|Allergenicity|allergenicity
5378327|NCT00118586|Neuroanatomy|neuroanatomy
5378328|NCT00118586|Brain Damage|brain damage
5378329|NCT00118586|Dystonia|dystonia
5378330|NCT00118586|Pathology|pathology
5378331|NCT00118586|Brain Imaging|brain imaging
5378332|NCT00118586|Spasmodic Dysphonia|spasmodic dysphonia
5378333|NCT00118586|SD|sd
5378334|NCT00118586|Focal Dystonia|focal dystonia
5378335|NCT00118586|Healthy Volunteer|healthy volunteer
5378336|NCT00118586|HV|hv
5378337|NCT00118573|abdominal aortic aneurysm|abdominal aortic aneurysm
5378338|NCT00118573|randomized controlled trial|randomized controlled trial
5378339|NCT00118573|endovascular aneurysm repair|endovascular aneurysm repair
5378340|NCT00118560|Collateral Circulation|collateral circulation
5378341|NCT00118560|Exercise Therapy|exercise therapy
5378342|NCT00118560|Microcirculation|microcirculation
5378343|NCT00118560|Oxygen|oxygen
5378344|NCT00118560|Positron-emission tomography|positron-emission tomography
5378345|NCT00118560|Walking|walking
5378346|NCT00118547|Adherence|adherence
5378347|NCT00118547|Medication|medication
5378348|NCT00118547|Multiple Sclerosis|multiple sclerosis
5378349|NCT00118534|addictive disorders|addictive disorders
5378350|NCT00118534|clinical trial|clinical trial
5378351|NCT00118534|cost effectiveness|cost effectiveness
5378352|NCT00118534|mental health|mental health
5378353|NCT00118534|military or environmental exposure|military or environmental exposure
5378354|NCT00118534|multi-site trial|multi-site trial
5378355|NCT00118534|nicotine|nicotine
5378356|NCT00118534|nicotine replacement|nicotine replacement
5378357|NCT00118534|post traumatic stress|post traumatic stress
5378358|NCT00118534|post traumatic stress disorder|post traumatic stress disorder
5378359|NCT00118534|psychiatric|psychiatric
5378360|NCT00118534|psychological|psychological
5378361|NCT00118534|PTSD|ptsd
5378362|NCT00118534|smoking cessation|smoking cessation
5378363|NCT00118534|smoking cessation medications|smoking cessation medications
5378364|NCT00118534|substance abuse|substance abuse
5378365|NCT00118521|Anterior Knee Pain|anterior knee pain
5378366|NCT00118495|female sexual dysfunction|female sexual dysfunction
5378367|NCT00118495|FSD|fsd
5378368|NCT00118495|arousal|arousal
5378369|NCT00118495|orgasm|orgasm
5378370|NCT00118495|desire|desire
5378371|NCT00118495|Zestra|zestra
5378372|NCT00118495|Mixed FSD|mixed fsd
5378373|NCT00118495|Hypoactive sexual desire disorder|hypoactive sexual desire disorder
5378374|NCT00118495|Sexual arousal disorder|sexual arousal disorder
5378375|NCT00118495|Orgasmic disorder|orgasmic disorder
5378376|NCT00118482|vasovagal syncope|vasovagal syncope
5378377|NCT00118482|randomized clinical trial|randomized clinical trial
5378378|NCT00118482|quality of life|quality of life
5378379|NCT00118469|Adolescent|adolescent
5378380|NCT00118469|CBT|cbt
5378381|NCT00118469|Parents|parents
5378382|NCT00118456|Advanced cancers|advanced cancers
5378383|NCT00118456|EGFR|egfr
5378384|NCT00118456|Her2|her2
5378385|NCT00118456|VEGFR|vegfr
5378386|NCT00118443|Suicide Prevention|suicide prevention
5378387|NCT00118443|Depression|depression
5378388|NCT00118443|Adolescent|adolescent
5378389|NCT00118443|Students|students
5378390|NCT00118443|School Teachers|school teachers
5378391|NCT00118430|Back Pain|back pain
5378393|NCT00118430|Hip Pain|hip pain
5378394|NCT00118430|Stepped Care|stepped care
5378395|NCT00118430|Antidepressant|antidepressant
5378396|NCT00118430|Relaxation Techniques|relaxation techniques
5378397|NCT00118430|Exercise|exercise
5378398|NCT00118417|Selective serotonin reuptake inhibitor|selective serotonin reuptake inhibitor
5378399|NCT00118417|Anxiety|anxiety
5378400|NCT00118417|Pharmacotherapy|pharmacotherapy
5378401|NCT00118417|Cognitive behavioral therapy|cognitive behavioral therapy
5378402|NCT00118417|CBT|cbt
5378403|NCT00118404|Cognitive therapy|cognitive therapy
5378404|NCT00118404|Antidepressants|antidepressants
5378405|NCT00118404|Psychotherapy|psychotherapy
5378406|NCT00118391|Pathological Gambling|pathological gambling
5378407|NCT00118391|CBT|cbt
5378408|NCT00118391|CM|cm
5378409|NCT00118378|HIV|hiv
5378410|NCT00118378|AIDS|aids
5378411|NCT00118378|Modafinil|modafinil
5378412|NCT00118378|Depression|depression
5378413|NCT00118339|oral complications|oral complications
5378414|NCT00118339|drug/agent toxicity by tissue/organ|drug/agent toxicity by tissue/organ
5378415|NCT00118339|stage I multiple myeloma|stage i multiple myeloma
5378416|NCT00118339|stage II multiple myeloma|stage ii multiple myeloma
5378417|NCT00118339|stage III multiple myeloma|stage iii multiple myeloma
5378418|NCT00118326|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5378419|NCT00118326|disseminated neuroblastoma|disseminated neuroblastoma
5378420|NCT00118326|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5378421|NCT00118326|recurrent neuroblastoma|recurrent neuroblastoma
5378422|NCT00118326|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5378423|NCT00118326|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
5378424|NCT00118326|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
5378425|NCT00118326|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
5378426|NCT00118326|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
5378427|NCT00118326|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
5378428|NCT00118326|recurrent Wilms tumor and other childhood kidney tumors|recurrent wilms tumor and other childhood kidney tumors
5378429|NCT00118326|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
5378430|NCT00118326|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5378431|NCT00118326|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5378432|NCT00118326|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
5378433|NCT00118326|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
5378434|NCT00118326|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
5378435|NCT00118326|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
5378436|NCT00118326|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
5378437|NCT00118326|untreated childhood acute myeloid leukemia and other myeloid malignancies|untreated childhood acute myeloid leukemia and other myeloid malignancies
5378438|NCT00118313|stage II melanoma|stage ii melanoma
5378439|NCT00118313|stage III melanoma|stage iii melanoma
5378440|NCT00118313|stage IV melanoma|stage iv melanoma
5378441|NCT00118300|stage III cervical cancer|stage iii cervical cancer
5378442|NCT00118300|stage IVA cervical cancer|stage iva cervical cancer
5378443|NCT00118300|recurrent cervical cancer|recurrent cervical cancer
5378444|NCT00118300|stage III endometrial carcinoma|stage iii endometrial carcinoma
5378445|NCT00118300|recurrent endometrial carcinoma|recurrent endometrial carcinoma
5378446|NCT00118300|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5378447|NCT00118300|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5378448|NCT00118300|stage III ovarian germ cell tumor|stage iii ovarian germ cell tumor
5378449|NCT00118300|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
5378450|NCT00118300|stage III vaginal cancer|stage iii vaginal cancer
5378451|NCT00118300|stage IVA vaginal cancer|stage iva vaginal cancer
5378452|NCT00118300|recurrent vaginal cancer|recurrent vaginal cancer
5378453|NCT00118300|ovarian sarcoma|ovarian sarcoma
5378454|NCT00118300|ovarian stromal cancer|ovarian stromal cancer
5378455|NCT00118300|stage IV endometrial carcinoma|stage iv endometrial carcinoma
5378456|NCT00118300|stage IB cervical cancer|stage ib cervical cancer
5378457|NCT00118300|stage IIA cervical cancer|stage iia cervical cancer
5378458|NCT00118300|stage IIB cervical cancer|stage iib cervical cancer
5378459|NCT00118300|stage II vaginal cancer|stage ii vaginal cancer
5378460|NCT00118300|stage I vaginal cancer|stage i vaginal cancer
5378461|NCT00118274|stage II melanoma|stage ii melanoma
5378462|NCT00118274|stage III melanoma|stage iii melanoma
5378463|NCT00118274|stage IV melanoma|stage iv melanoma
5378464|NCT00118261|stage IV rectal cancer|stage iv rectal cancer
5378465|NCT00118261|stage IV colon cancer|stage iv colon cancer
5378466|NCT00118261|recurrent rectal cancer|recurrent rectal cancer
5378467|NCT00118261|recurrent colon cancer|recurrent colon cancer
5378468|NCT00118222|adult mixed glioma|adult mixed glioma
5378469|NCT00118222|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5378470|NCT00118222|recurrent adult brain tumor|recurrent adult brain tumor
5378471|NCT00118222|adult giant cell glioblastoma|adult giant cell glioblastoma
5378472|NCT00118222|adult gliosarcoma|adult gliosarcoma
5378557|NCT00117845|Denileukin Diftitox (Ontak)|denileukin diftitox (ontak)
5378473|NCT00118196|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5378474|NCT00118196|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5378475|NCT00118196|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5378476|NCT00118196|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5378477|NCT00118131|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5378478|NCT00118131|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5378479|NCT00118131|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5378480|NCT00118105|recurrent colon cancer|recurrent colon cancer
5378481|NCT00118105|stage IV colon cancer|stage iv colon cancer
5378482|NCT00118105|recurrent rectal cancer|recurrent rectal cancer
5378483|NCT00118105|stage IV rectal cancer|stage iv rectal cancer
5378484|NCT00118105|liver metastases|liver metastases
5378485|NCT00118066|prostate cancer|prostate cancer
5378486|NCT00118066|high grade prostatic intraepithelial neoplasia|high grade prostatic intraepithelial neoplasia
5378487|NCT00118053|inflammatory breast cancer|inflammatory breast cancer
5378488|NCT00118053|stage II breast cancer|stage ii breast cancer
5378489|NCT00118053|stage IIIA breast cancer|stage iiia breast cancer
5378490|NCT00118053|stage IIIB breast cancer|stage iiib breast cancer
5378491|NCT00118053|stage IIIC breast cancer|stage iiic breast cancer
5378492|NCT00118027|Malaria in pregnancy|malaria in pregnancy
5378494|NCT00118027|Low birth weight|low birth weight
5378495|NCT00118014|Trichotillomania|trichotillomania
5378496|NCT00118014|Habit Reversal Training|habit reversal training
5378497|NCT00118014|Sertraline|sertraline
5378498|NCT00118014|Zoloft|zoloft
5378499|NCT00118001|Psychotherapy|psychotherapy
5378500|NCT00118001|Generalized Anxiety Disorder|generalized anxiety disorder
5378501|NCT00118001|randomized-controlled trial|randomized-controlled trial
5378502|NCT00118001|worry exposure|worry exposure
5378503|NCT00118001|applied relaxation|applied relaxation
5378504|NCT00117975|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
5378505|NCT00117975|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
5378506|NCT00117975|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5378507|NCT00117975|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5378508|NCT00117975|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5378509|NCT00117975|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5378510|NCT00117975|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5378511|NCT00117975|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5378512|NCT00117975|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5378513|NCT00117975|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5378514|NCT00117975|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5378515|NCT00117975|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
5378516|NCT00117962|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5378517|NCT00117962|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5378518|NCT00117962|squamous cell lung cancer|squamous cell lung cancer
5378519|NCT00117962|large cell lung cancer|large cell lung cancer
5378520|NCT00117962|adenocarcinoma of the lung|adenocarcinoma of the lung
5378521|NCT00117962|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
5378522|NCT00117949|Prostate Cancer|prostate cancer
5378523|NCT00117949|Androgen ablation therapy|androgen ablation therapy
5378524|NCT00117936|Angiogenesis|angiogenesis
5378525|NCT00117936|No-option heart patients|no-option heart patients
5378526|NCT00117936|Blocked coronary artery|blocked coronary artery
5378527|NCT00117936|Revascularization|revascularization
5378528|NCT00117936|FGF-1|fgf-1
5378529|NCT00117936|growth factor|growth factor
5378530|NCT00117923|Warts|warts
5378531|NCT00117923|Adults|adults
5378532|NCT00117923|Common Warts|common warts
5378533|NCT00117923|Resiquimod|resiquimod
5378534|NCT00117910|Aged, Granulocyte Colony-Stimulating Factor|aged, granulocyte colony-stimulating factor
5378535|NCT00117910|Combined Modality Therapy, Neutropenia|combined modality therapy, neutropenia
5378536|NCT00117910|pegfilgrastim, Neulasta®|pegfilgrastim, neulasta®
5378537|NCT00117910|FEC-100, Antineoplastic Agents|fec-100, antineoplastic agents
5378538|NCT00117910|Breast Cancer, Female|breast cancer, female
5378539|NCT00117897|non-Hodgkin's lymphoma|non-hodgkin's lymphoma
5378540|NCT00117897|R-CHOP-14|r-chop-14
5378541|NCT00117897|pegfilgrastim|pegfilgrastim
5378542|NCT00117897|neutropenia, clinical trial|neutropenia, clinical trial
5378543|NCT00117897|haematopoietic growth factor|haematopoietic growth factor
5378544|NCT00117884|Papillomavirus infections;|papillomavirus infections;
5378545|NCT00117884|Cervix Dysplasia|cervix dysplasia
5378546|NCT00117871|Warts|warts
5378547|NCT00117871|Adults|adults
5378548|NCT00117871|Common Warts|common warts
5378549|NCT00117871|Resiquimod|resiquimod
5378550|NCT00117858|Frontal Lobe|frontal lobe
5378551|NCT00117858|Language|language
5378552|NCT00117858|Behavior|behavior
5378553|NCT00117858|Degenerative Diseases|degenerative diseases
5378554|NCT00117858|Pick's Disease|pick's disease
5378555|NCT00117858|Frontotemporal Dementia|frontotemporal dementia
5378556|NCT00117858|FTP|ftp
5378949|NCT00116545|IDDM|iddm
5378558|NCT00117845|Recombinant Immunotoxin|recombinant immunotoxin
5378559|NCT00117845|Human T-Cell Lymphotropic Virus (HTLV1)|human t-cell lymphotropic virus (htlv1)
5378560|NCT00117845|CD25 Positive|cd25 positive
5378561|NCT00117845|IL-2R|il-2r
5378562|NCT00117845|ATL|atl
5378563|NCT00117845|Ontak|ontak
5378564|NCT00117845|Adult T-Cell Leukemia|adult t-cell leukemia
5378565|NCT00117845|Lymphoproliferative Disorders|lymphoproliferative disorders
5378566|NCT00117832|allergic rhinitis|allergic rhinitis
5378567|NCT00117819|parkinson|parkinson
5378568|NCT00117819|family history|family history
5378569|NCT00117819|diagnosis|diagnosis
5378570|NCT00117806|Adult|adult
5378571|NCT00117806|Depression|depression
5378572|NCT00117806|Employment, supported|employment, supported
5378573|NCT00117806|Health Service/ut|health service/ut
5378574|NCT00117806|Humans|humans
5378575|NCT00117806|Outcomes|outcomes
5378576|NCT00117806|Quality of life|quality of life
5378577|NCT00117806|Veterans/rh (rehabilitation)|veterans/rh (rehabilitation)
5378578|NCT00117806|Workplace|workplace
5378579|NCT00117806|Spinal Cord Injuries|spinal cord injuries
5378580|NCT00117793|Amputee|amputee
5378581|NCT00117793|Artificial limbs|artificial limbs
5378582|NCT00117793|Gait|gait
5378583|NCT00117793|Walking|walking
5378584|NCT00117767|Terbinafine, Tinea capitis, pediatric, antifungal|terbinafine, tinea capitis, pediatric, antifungal
5378585|NCT00117754|Terbinafine, Tinea capitis, pediatric, antifungal|terbinafine, tinea capitis, pediatric, antifungal
5378586|NCT00117741|Opiate Dependence|opiate dependence
5378587|NCT00117741|DBT|dbt
5378588|NCT00117741|Dialectical Behavior Therapy|dialectical behavior therapy
5378589|NCT00117741|Drug Counseling|drug counseling
5378590|NCT00117741|Therapy, Cognitive Behavior|therapy, cognitive behavior
5378591|NCT00117728|Non-nucleoside reverse transcriptase inhibitor|non-nucleoside reverse transcriptase inhibitor
5378592|NCT00117728|Drug Resistance|drug resistance
5378593|NCT00117728|HIV Seronegativity|hiv seronegativity
5378594|NCT00117728|Treatment Naive|treatment naive
5378595|NCT00117715|Developmental regulation of CYPs 1A2, 2D6, 3A4|developmental regulation of cyps 1a2, 2d6, 3a4
5378596|NCT00117715|Ontogeny|ontogeny
5378597|NCT00117715|pharmacokinetics|pharmacokinetics
5378598|NCT00117715|drug biotransformation|drug biotransformation
5378599|NCT00117715|enzymatic biotransformation of drugs|enzymatic biotransformation of drugs
5378600|NCT00117702|GvHD|gvhd
5378601|NCT00117702|Tacrolimus|tacrolimus
5378602|NCT00117702|Everolimus|everolimus
5378603|NCT00117702|Stem cell transplantation|stem cell transplantation
5378604|NCT00117689|Anti-T cell antibodies|anti-t cell antibodies
5378605|NCT00117689|Primary Liver Transplantation and Renal Dysfunction|primary liver transplantation and renal dysfunction
5378606|NCT00117689|Liver Transplant Rejection|liver transplant rejection
5378607|NCT00117689|Induction Therapy with reduction of Calcineurin inhibitors|induction therapy with reduction of calcineurin inhibitors
5378608|NCT00117689|Primary Liver Transplantation|primary liver transplantation
5378609|NCT00117689|Primary Transplant Rejection|primary transplant rejection
5378610|NCT00117689|Transplantation, Liver|transplantation, liver
5378611|NCT00117689|Rejection, Transplant|rejection, transplant
5378612|NCT00117676|tenofovir|tenofovir
5378613|NCT00117676|adefovir|adefovir
5378614|NCT00117676|hepatitis B virus|hepatitis b virus
5378615|NCT00117676|HBeAg Negative|hbeag negative
5378616|NCT00117663|Randomized controlled trial|randomized controlled trial
5378617|NCT00117663|Mammography|mammography
5378618|NCT00117663|health care setting|health care setting
5378619|NCT00117663|hormone replacement therapy|hormone replacement therapy
5378620|NCT00117663|breast density|breast density
5378621|NCT00117663|mammography performance|mammography performance
5378622|NCT00117663|Breast Carcinoma|breast carcinoma
5378623|NCT00117650|leg pain|leg pain
5378624|NCT00117650|gene transfer|gene transfer
5378625|NCT00117650|angiogenesis|angiogenesis
5378626|NCT00117650|Phase 2|phase 2
5378627|NCT00117650|Genzyme|genzyme
5378628|NCT00117650|peripheral arterial disease|peripheral arterial disease
5378629|NCT00117637|Renal Cell Cancer|renal cell cancer
5378630|NCT00117637|RCC|rcc
5378631|NCT00117637|Cancer|cancer
5378632|NCT00117624|Non-myeloid malignancy|non-myeloid malignancy
5378633|NCT00117624|Darbepoetin alfa|darbepoetin alfa
5378634|NCT00117624|Clinical Trial|clinical trial
5378635|NCT00117611|chronic sinusitis|chronic sinusitis
5378636|NCT00117598|Lymphoma|lymphoma
5378637|NCT00117585|Aging|aging
5378638|NCT00117585|Blood pressure|blood pressure
5378639|NCT00117585|Hypotension|hypotension
5378640|NCT00117585|Orthostatic|orthostatic
5378641|NCT00117585|Rehabilitation|rehabilitation
5378642|NCT00117572|Cancer of the Pharynx (Nasopharynx, Oropharynx, Hypopharynx)|cancer of the pharynx (nasopharynx, oropharynx, hypopharynx)
5378643|NCT00117572|Cancer of the Nasal Cavity and Paranasal Sinuses|cancer of the nasal cavity and paranasal sinuses
5378644|NCT00117559|Psychotherapy,group|psychotherapy,group
5378645|NCT00117559|Rehabilitation|rehabilitation
5378646|NCT00117559|Telecommunications|telecommunications
5378647|NCT00117546|CAPACITY trial|capacity trial
5378648|NCT00117546|preeclampsia|preeclampsia
5378649|NCT00117546|plasma volume|plasma volume
5378650|NCT00117546|sympathetic activity|sympathetic activity
5378651|NCT00117546|hypertension|hypertension
5378652|NCT00117546|cardiovascular system|cardiovascular system
5378653|NCT00117533|chronic hepatitis B;|chronic hepatitis b;
5378654|NCT00117533|chronic hepatitis delta;|chronic hepatitis delta;
5378655|NCT00117533|treatment;|treatment;
5378656|NCT00117533|pegylated interferon alfa-2b;|pegylated interferon alfa-2b;
5378657|NCT00117533|ribavirin|ribavirin
5378658|NCT00117520|caffeine, endurance, postural stability, elderly|caffeine, endurance, postural stability, elderly
5378659|NCT00117507|MDS|mds
5378660|NCT00117507|Myelodysplastic Syndrome|myelodysplastic syndrome
5378661|NCT00117507|ICL-670|icl-670
5378662|NCT00117507|ICL-670 and Myelodysplastic Syndrome|icl-670 and myelodysplastic syndrome
5378663|NCT00117494|Hyperlipidemia|hyperlipidemia
5378664|NCT00117494|HIV infections|hiv infections
5378665|NCT00117494|STATINS, HMG-COA|statins, hmg-coa
5378666|NCT00117494|Protease Inhibitor|protease inhibitor
5378667|NCT00117494|Treatment Experienced|treatment experienced
5378668|NCT00117481|endometriosis|endometriosis
5378669|NCT00117481|pelvic pain|pelvic pain
5378670|NCT00117481|hormonal treatment|hormonal treatment
5378671|NCT00117468|luteal phase replacement|luteal phase replacement
5378672|NCT00117468|oocyte donation|oocyte donation
5378673|NCT00117468|infertility|infertility
5378674|NCT00117468|progesterone|progesterone
5378675|NCT00117455|ICE|ice
5378676|NCT00117455|BEAM|beam
5378677|NCT00117455|PBPC transplant|pbpc transplant
5378678|NCT00117442|solid tumour|solid tumour
5378679|NCT00117442|unknown primary tumour|unknown primary tumour
5378680|NCT00117442|carboplatin|carboplatin
5378681|NCT00117442|paclitaxel|paclitaxel
5378682|NCT00117429|HIV-1|hiv-1
5378683|NCT00117429|therapeutic vaccination|therapeutic vaccination
5378684|NCT00117429|cellular immunity|cellular immunity
5378685|NCT00117429|humoral immunity|humoral immunity
5378686|NCT00117429|HAART|haart
5378687|NCT00117429|chronic HIV-1 infection|chronic hiv-1 infection
5378688|NCT00117429|Treatment Experienced|treatment experienced
5378689|NCT00117429|HIV Therapeutic Vaccine|hiv therapeutic vaccine
5378690|NCT00117403|dementia|dementia
5378691|NCT00117403|anti-oxidant|anti-oxidant
5378692|NCT00117403|biomarkers|biomarkers
5378693|NCT00117403|alpha-tocopherol|alpha-tocopherol
5378694|NCT00117403|CoQ|coq
5378695|NCT00117377|Atopic dermatitis, pimecrolimus, cellular, molecular|atopic dermatitis, pimecrolimus, cellular, molecular
5378696|NCT00117364|chronic ulcer|chronic ulcer
5378697|NCT00117364|poor healing|poor healing
5378698|NCT00117364|The patients with a poorly healed wound, in which skin graft is clinically indicated, are included in this study|the patients with a poorly healed wound, in which skin graft is clinically indicated, are included in this study
5378699|NCT00117351|Adenocarcinoma|adenocarcinoma
5378700|NCT00117351|Bronchiolo-Alveolar|bronchiolo-alveolar
5378701|NCT00117351|Carcinoma, Bronchioloalveolar|carcinoma, bronchioloalveolar
5378702|NCT00117351|Carcinoma, Non-Small-Cell Lung|carcinoma, non-small-cell lung
5378703|NCT00117351|Carcinoma, Bronchiolo-Alveolar|carcinoma, bronchiolo-alveolar
5378704|NCT00117325|Vasomotor Rhinitis|vasomotor rhinitis
5378705|NCT00117325|VMR|vmr
5378706|NCT00117325|nonallergic rhinitis|nonallergic rhinitis
5378707|NCT00117325|GW685698X|gw685698x
5378708|NCT00117312|Prostate Cancer|prostate cancer
5378709|NCT00117312|Androgen ablation therapy|androgen ablation therapy
5378710|NCT00117299|Gastrointestinal stromal tumor|gastrointestinal stromal tumor
5378711|NCT00117299|GIST|gist
5378712|NCT00117299|Sarcoma|sarcoma
5378713|NCT00117299|PTK787|ptk787
5378714|NCT00117299|ZK 222584|zk 222584
5378715|NCT00117299|Tyrosine kinase inhibitor|tyrosine kinase inhibitor
5378716|NCT00117299|Tyrosine kinase|tyrosine kinase
5378717|NCT00117299|VEGF|vegf
5378718|NCT00117299|Vascular endothelial growth factor|vascular endothelial growth factor
5378719|NCT00117299|VEGFR|vegfr
5378720|NCT00117299|Vascular endothelial growth factor receptor|vascular endothelial growth factor receptor
5378721|NCT00117299|KDR|kdr
5378722|NCT00117299|KIT|kit
5378723|NCT00117299|c-KIT|c-kit
5378724|NCT00117299|Platelet derived growth factor receptor|platelet derived growth factor receptor
5378725|NCT00117299|PDGFR|pdgfr
5378726|NCT00117286|Prostate Cancer|prostate cancer
5378727|NCT00117286|Androgen ablation therapy|androgen ablation therapy
5378728|NCT00117260|osteopenia|osteopenia
5378729|NCT00117260|bone mineral density|bone mineral density
5378730|NCT00117260|amenorrhea|amenorrhea
5378731|NCT00117260|adolescents|adolescents
5378732|NCT00117247|Heart Failure|heart failure
5378733|NCT00117234|chronic heart failure|chronic heart failure
5378734|NCT00117234|congestive heart failure|congestive heart failure
5378735|NCT00117234|low hemoglobin|low hemoglobin
5378736|NCT00117234|anemia|anemia
5378737|NCT00117234|CHF|chf
5378738|NCT00117234|Symptomatic Congestive Heart Failure (CHF)|symptomatic congestive heart failure (chf)
5378739|NCT00117221|Magnetic Resonance Imaging|magnetic resonance imaging
5378740|NCT00117221|Functional Imaging|functional imaging
5378741|NCT00117221|Cerebral Blood Flow|cerebral blood flow
5378742|NCT00117221|BOLD Effect|bold effect
5378743|NCT00117221|Sleep|sleep
5378744|NCT00117208|cystic fibrosis|cystic fibrosis
5378745|NCT00117195|parkinson|parkinson
5378746|NCT00117195|diagnosis|diagnosis
5378747|NCT00117195|screening|screening
5378748|NCT00117169|Pulmonary embolism|pulmonary embolism
5378749|NCT00117169|multi-detector helical computed tomography clinical probability|multi-detector helical computed tomography clinical probability
5378750|NCT00117169|clinical score|clinical score
5378751|NCT00117156|Fludarabine|fludarabine
5378752|NCT00117156|Rituximab|rituximab
5378753|NCT00117156|Marginal Zone Lymphoma|marginal zone lymphoma
5378754|NCT00117156|MALT lymphoma|malt lymphoma
5378755|NCT00117143|Immune Thrombocytopenic Purpura|immune thrombocytopenic purpura
5378756|NCT00117143|Idiopathic Thrombocytopenic Purpura|idiopathic thrombocytopenic purpura
5378757|NCT00117143|ITP|itp
5378758|NCT00117143|Thrombocytopenia|thrombocytopenia
5378759|NCT00117130|Kidney disease, Renal, CKD (Chronic Kidney Disease)|kidney disease, renal, ckd (chronic kidney disease)
5378760|NCT00117130|CRI (Chronic Renal Insufficiency), Pre-dialysis, Amgen|cri (chronic renal insufficiency), pre-dialysis, amgen
5378761|NCT00117130|Aranesp®, Darbepoetin alfa, QW dosing|aranesp®, darbepoetin alfa, qw dosing
5378762|NCT00117130|Q2W dosing, Q4W dosing|q2w dosing, q4w dosing
5378763|NCT00117130|Patient preference, Subject preference|patient preference, subject preference
5378764|NCT00117117|Chemotherapy induced anemia|chemotherapy induced anemia
5378765|NCT00117117|Amgen|amgen
5378766|NCT00117117|Aranesp®|aranesp®
5378767|NCT00117117|darbepoetin alfa|darbepoetin alfa
5378768|NCT00117104|End Stage Renal Disease (ESRD)|end stage renal disease (esrd)
5378769|NCT00117104|Kidney Disease, Dialysis|kidney disease, dialysis
5378770|NCT00117104|Aranesp®, rHuEPO|aranesp®, rhuepo
5378771|NCT00117104|Anemia, Hemoglobin|anemia, hemoglobin
5378772|NCT00117104|Dosing, Amgen|dosing, amgen
5378773|NCT00117091|Rheumatoid Arthritis|rheumatoid arthritis
5378774|NCT00117091|RA|ra
5378775|NCT00117091|Anakinra (Kineret®)|anakinra (kineret®)
5378776|NCT00117078|Kidney disease, Renal, CKD (Chronic Kidney Disease)|kidney disease, renal, ckd (chronic kidney disease)
5378777|NCT00117078|CRI (Chronic Renal Insufficiency), Pre-dialysis, Amgen|cri (chronic renal insufficiency), pre-dialysis, amgen
5378778|NCT00117078|Aranesp®, Darbepoetin alfa, QW dosing|aranesp®, darbepoetin alfa, qw dosing
5378779|NCT00117078|Q2W dosing, Q4W dosing|q2w dosing, q4w dosing
5378780|NCT00117078|Patient preference, Subject preference|patient preference, subject preference
5378781|NCT00117065|Kidney transplant, Renal transplant|kidney transplant, renal transplant
5378782|NCT00117065|Aranesp®, Darbepoetin alfa|aranesp®, darbepoetin alfa
5378783|NCT00117065|Amgen, Q2W dosing, Q4W dosing|amgen, q2w dosing, q4w dosing
5378784|NCT00117052|Clinical trial|clinical trial
5378785|NCT00117052|Amgen|amgen
5378786|NCT00117052|Secondary HyperParaThyroidism (SHPT)|secondary hyperparathyroidism (shpt)
5378787|NCT00117052|Dialysis|dialysis
5378788|NCT00117052|End Stage Renal Disease (ESRD)|end stage renal disease (esrd)
5378789|NCT00117052|KDOQI|kdoqi
5378790|NCT00117052|Cinacalcet|cinacalcet
5378791|NCT00117039|anemia|anemia
5378792|NCT00117039|fatigue|fatigue
5378793|NCT00117039|Aranesp®|aranesp®
5378794|NCT00117039|clinical trial|clinical trial
5378795|NCT00117026|Diabetes Complications|diabetes complications
5378796|NCT00117026|benfotiamine|benfotiamine
5378797|NCT00117026|type 1 diabetes|type 1 diabetes
5378798|NCT00117026|elevated urinary albumin excretion|elevated urinary albumin excretion
5378799|NCT00117026|nerve function|nerve function
5378800|NCT00117026|advanced glycation end products|advanced glycation end products
5378801|NCT00117013|Phase I|phase i
5378802|NCT00117013|Antiangiogenesis|antiangiogenesis
5378803|NCT00117013|Targeted Therapy|targeted therapy
5378804|NCT00117013|Chronic Schedule|chronic schedule
5378805|NCT00117013|VEGF|vegf
5378806|NCT00117013|Cancer|cancer
5378807|NCT00117013|Metastatic Solid Tumor|metastatic solid tumor
5378808|NCT00117000|testosterone|testosterone
5378809|NCT00117000|food, formulated|food, formulated
5378810|NCT00117000|malnutrition|malnutrition
5378811|NCT00117000|undernutrition|undernutrition
5378812|NCT00117000|aging|aging
5378813|NCT00117000|aged|aged
5378814|NCT00117000|aged, 80 and over|aged, 80 and over
5378815|NCT00117000|frail elderly|frail elderly
5378816|NCT00116987|physiologic pacing|physiologic pacing
5378817|NCT00116987|ventricular pacing|ventricular pacing
5378818|NCT00116987|hospitalizations|hospitalizations
5378819|NCT00116974|Dental scaling|dental scaling
5378820|NCT00116948|Osteoarthrosis|osteoarthrosis
5378821|NCT00116948|RSA|rsa
5378822|NCT00116948|DEXA|dexa
5378823|NCT00116948|Hip arthroplasty|hip arthroplasty
5378824|NCT00116948|Metal ion|metal ion
5378825|NCT00116948|Inflammatory response|inflammatory response
5378826|NCT00116948|Gait analysis|gait analysis
5378827|NCT00116935|Gastrointestinal stromal tumor|gastrointestinal stromal tumor
5378828|NCT00116935|GIST|gist
5378829|NCT00116935|Sarcoma|sarcoma
5378830|NCT00116935|Imatinib|imatinib
5378831|NCT00116935|Adjuvant therapy|adjuvant therapy
5378832|NCT00116935|KIT|kit
5378833|NCT00116935|PDGFRA|pdgfra
5378834|NCT00116935|Receptor tyrosine kinase|receptor tyrosine kinase
5378835|NCT00116935|Tyrosine kinase inhibitor|tyrosine kinase inhibitor
5378836|NCT00116922|Diabetes|diabetes
5378837|NCT00116922|Prevention.|prevention.
5378838|NCT00116922|Rosiglitazone|rosiglitazone
5378839|NCT00116922|Metformin|metformin
5378840|NCT00116922|Lifestyle|lifestyle
5378841|NCT00116922|Impaired glucose Tolerance|impaired glucose tolerance
5378842|NCT00116883|GW685698X|gw685698x
5378843|NCT00116883|perennial allergic rhinitis|perennial allergic rhinitis
5378844|NCT00116883|pediatric|pediatric
5378845|NCT00116883|intranasal corticosteroid|intranasal corticosteroid
5378846|NCT00116883|HPA axis function|hpa axis function
5378847|NCT00116870|CAD|cad
5378848|NCT00116870|familial hypercholesterolemia|familial hypercholesterolemia
5378849|NCT00116844|viral shedding|viral shedding
5378850|NCT00116844|Recurrent|recurrent
5378851|NCT00116844|herpes|herpes
5378852|NCT00116844|genital herpes|genital herpes
5378853|NCT00116831|atheroma|atheroma
5378854|NCT00116831|IVUS|ivus
5378855|NCT00116831|Intravascular ultrasound|intravascular ultrasound
5378856|NCT00116831|atherosclerosis|atherosclerosis
5378857|NCT00116818|perennial allergic rhinitis|perennial allergic rhinitis
5378858|NCT00116818|intranasal corticosteroid|intranasal corticosteroid
5378859|NCT00116818|HPA axis function|hpa axis function
5378860|NCT00116818|GW685698X|gw685698x
5378861|NCT00116805|tenofovir|tenofovir
5378862|NCT00116805|adefovir|adefovir
5378863|NCT00116805|hepatitis B|hepatitis b
5378864|NCT00116805|HBeAg Positive|hbeag positive
5378865|NCT00116792|CAD|cad
5378866|NCT00116792|Diabetes Mellitus|diabetes mellitus
5378867|NCT00116792|Restenosis|restenosis
5378868|NCT00116792|ppar gamma|ppar gamma
5378869|NCT00116792|glitazone|glitazone
5378870|NCT00116779|Prostate Cancer|prostate cancer
5378871|NCT00116779|Androgen ablation therapy|androgen ablation therapy
5378872|NCT00116766|mosquitoes|mosquitoes
5378873|NCT00116766|malaria|malaria
5378874|NCT00116766|vector control|vector control
5378875|NCT00116766|plant-based|plant-based
5378876|NCT00116753|Prostate Cancer|prostate cancer
5378877|NCT00116753|Androgen ablation therapy|androgen ablation therapy
5378878|NCT00116740|Serotonin|serotonin
5378879|NCT00116740|5-HT2c|5-ht2c
5378880|NCT00116740|Satiety|satiety
5378881|NCT00116740|Obesity|obesity
5378882|NCT00116740|Appetite suppressant|appetite suppressant
5378883|NCT00116740|Weight Loss|weight loss
5378884|NCT00116740|Overweight|overweight
5378885|NCT00116727|Rheumatoid Arthritis|rheumatoid arthritis
5378886|NCT00116727|DMARD|dmard
5378887|NCT00116714|rheumatoid arthritis|rheumatoid arthritis
5378888|NCT00116714|RA|ra
5378889|NCT00116714|DMARD|dmard
5378890|NCT00116701|Chronic Kidney Disease (CKD)|chronic kidney disease (ckd)
5378891|NCT00116701|Haemoglobin (Hb)|haemoglobin (hb)
5378892|NCT00116701|Erthropoetin (EPO)|erthropoetin (epo)
5378893|NCT00116701|End Stage Renal Disease (ESRD)|end stage renal disease (esrd)
5378894|NCT00116701|Recombinant Human Erthropoetic (rHuEPO)|recombinant human erthropoetic (rhuepo)
5378895|NCT00116701|Anaemia|anaemia
5378896|NCT00116701|Darbepoetin Alfa, Aranesp®|darbepoetin alfa, aranesp®
5378897|NCT00116701|Haemodialysis|haemodialysis
5378898|NCT00116701|Clinical Trial|clinical trial
5378899|NCT00116688|Immune (Idiopathic) Thrombocytopenic Purpura (ITP)|immune (idiopathic) thrombocytopenic purpura (itp)
5378900|NCT00116688|Thrombocytopenic|thrombocytopenic
5378901|NCT00116675|Common Wart(s)|common wart(s)
5378902|NCT00116675|Pediatric|pediatric
5378903|NCT00116675|Wart(s)|wart(s)
5378904|NCT00116675|Children|children
5378905|NCT00116675|3M Pharmaceuticals|3m pharmaceuticals
5378906|NCT00116675|Resiquimod|resiquimod
5378907|NCT00116662|Wart(s)|wart(s)
5378908|NCT00116662|Common Wart(s)|common wart(s)
5378909|NCT00116662|Children|children
5378910|NCT00116662|Pediatric|pediatric
5378911|NCT00116662|3M Pharmaceuticals|3m pharmaceuticals
5378912|NCT00116662|Resiquimod|resiquimod
5378913|NCT00116649|actinic keratosis lesions large head torso extremities|actinic keratosis lesions large head torso extremities
5378914|NCT00116649|actinic keratosis|actinic keratosis
5378915|NCT00116636|HIV|hiv
5378916|NCT00116636|Treatment Naive|treatment naive
5378917|NCT00116610|small cell lung cancer|small cell lung cancer
5378918|NCT00116610|resistant|resistant
5378919|NCT00116610|refractory|refractory
5378920|NCT00116610|platinum|platinum
5378921|NCT00116610|chemotherapy|chemotherapy
5378922|NCT00116610|second-line|second-line
5378923|NCT00116610|relapse|relapse
5378924|NCT00116610|sensitive|sensitive
5378925|NCT00116597|Active Specific Immunotherapy|active specific immunotherapy
5378926|NCT00116597|Intranodal|intranodal
5378927|NCT00116597|Cancer|cancer
5378928|NCT00116597|Melanoma stages IIb to IV|melanoma stages iib to iv
5378929|NCT00116597|Gene Therapy|gene therapy
5378930|NCT00116597|Recombinant Vaccinia virus|recombinant vaccinia virus
5378931|NCT00116597|HLA-A2|hla-a2
5378932|NCT00116597|Mart-1/Melan-A, Gp-100, tyrosinase|mart-1/melan-a, gp-100, tyrosinase
5378933|NCT00116597|Clinical Trial|clinical trial
5378934|NCT00116597|Phase I/II|phase i/ii
5378935|NCT00116584|heliox|heliox
5378936|NCT00116584|bronchiolitis|bronchiolitis
5378937|NCT00116584|racemic epinephrine|racemic epinephrine
5378938|NCT00116571|Benign Prostatic Hyperplasia (BPH)|benign prostatic hyperplasia (bph)
5378939|NCT00116571|Photodynamic Therapy (PDT)|photodynamic therapy (pdt)
5378940|NCT00116571|Lower Urinary Tract Symptoms (LUTS)|lower urinary tract symptoms (luts)
5378941|NCT00116558|amyotrophic lateral sclerosis|amyotrophic lateral sclerosis
5378942|NCT00116558|ALS|als
5378943|NCT00116558|Lou Gehrig's disease|lou gehrig's disease
5378944|NCT00116558|nutrition|nutrition
5378945|NCT00116558|NIPPV|nippv
5378946|NCT00116558|non-invasive positive pressure ventilation|non-invasive positive pressure ventilation
5378947|NCT00116558|percutaneous endoscopic gastrostomy|percutaneous endoscopic gastrostomy
5378948|NCT00116558|PEG|peg
5378950|NCT00116545|Insulin|insulin
5378951|NCT00116545|cardiovascular disease|cardiovascular disease
5378952|NCT00116532|Obsessive Compulsive Disorder|obsessive compulsive disorder
5378953|NCT00116532|Escitalopram|escitalopram
5378954|NCT00116532|SSRI|ssri
5378955|NCT00116532|Open Label|open label
5378956|NCT00116506|Metastatic Colorectal Cancer|metastatic colorectal cancer
5378957|NCT00116506|Bevacizumab|bevacizumab
5378958|NCT00116506|Erlotinib|erlotinib
5378959|NCT00116506|FOLFOX|folfox
5378960|NCT00116493|severe anemia|severe anemia
5378961|NCT00116493|anthelminthic|anthelminthic
5378962|NCT00116493|multivitamins|multivitamins
5378963|NCT00116493|pregnancy|pregnancy
5378964|NCT00116493|children|children
5378965|NCT00116493|Pakistan|pakistan
5378966|NCT00116480|Postpartum Haemorrhage|postpartum haemorrhage
5378967|NCT00116480|Misoprostol|misoprostol
5378968|NCT00116467|AML|aml
5378969|NCT00116467|Acute Myelogenous Leukemia|acute myelogenous leukemia
5378970|NCT00116467|GVAX|gvax
5378971|NCT00116467|Vaccine|vaccine
5378972|NCT00116467|Stem Cell Transplant|stem cell transplant
5378973|NCT00116467|Autologous|autologous
5378974|NCT00116454|Carcinoma, Hepatocellular|carcinoma, hepatocellular
5378975|NCT00116454|Viral Hepatitis, Alcoholic Hepatitis|viral hepatitis, alcoholic hepatitis
5378976|NCT00116441|Multiple Myeloma|multiple myeloma
5378977|NCT00116441|Cancer|cancer
5378978|NCT00116441|PSCT|psct
5378979|NCT00116441|Peripheral Stem Cell Transplant|peripheral stem cell transplant
5378980|NCT00116441|Chemotherapy|chemotherapy
5378981|NCT00116441|GVAX|gvax
5378982|NCT00116428|Atrial Fibrillation|atrial fibrillation
5378983|NCT00116428|Paroxysmal Atrial Fibrillation|paroxysmal atrial fibrillation
5378984|NCT00116415|HIV/AIDS|hiv/aids
5378985|NCT00116402|COPD|copd
5378986|NCT00116402|Chronic Obstructive|chronic obstructive
5378987|NCT00116402|Pulmonary Disease|pulmonary disease
5378988|NCT00116402|Inhaled Corticosteroids|inhaled corticosteroids
5378989|NCT00116402|Airway Inflammation|airway inflammation
5378990|NCT00116402|Bronchoscopy|bronchoscopy
5378991|NCT00116389|pancreatic cancer|pancreatic cancer
5378992|NCT00116389|cancer of the pancreas|cancer of the pancreas
5378993|NCT00116389|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
5378994|NCT00116389|pancreatic neoplasms|pancreatic neoplasms
5378995|NCT00116389|Metastatic pancreatic cancer (Stage IV)|metastatic pancreatic cancer (stage iv)
5378996|NCT00116389|Stage IV Adenocarcinoma of the Pancreas|stage iv adenocarcinoma of the pancreas
5378998|NCT00116376|recurrent/relapse|recurrent/relapse
5378999|NCT00116376|EGFR|egfr
5379000|NCT00116376|VEGFR|vegfr
5379001|NCT00116363|gene therapy|gene therapy
5379002|NCT00116363|melanoma|melanoma
5379003|NCT00116363|adenovirus|adenovirus
5379004|NCT00116363|in-transit melanoma|in-transit melanoma
5379005|NCT00116363|metastatic melanoma|metastatic melanoma
5379006|NCT00116350|Postpartum hemorrhage|postpartum hemorrhage
5379007|NCT00116350|Misoprostol|misoprostol
5379008|NCT00116350|Developing countries|developing countries
5379009|NCT00116350|Maternal morbidity|maternal morbidity
5379010|NCT00116350|Randomized controlled trial|randomized controlled trial
5379011|NCT00116337|spinal cord injury|spinal cord injury
5379012|NCT00116337|paralysis|paralysis
5379013|NCT00116337|cough|cough
5379014|NCT00116337|cervical spinal cord injury|cervical spinal cord injury
5379015|NCT00116337|thoracic spinal cord injury|thoracic spinal cord injury
5379016|NCT00116324|Asthma|asthma
5379017|NCT00116324|Leukotriene receptor antagonist|leukotriene receptor antagonist
5379018|NCT00116324|Hypertonic saline challenge|hypertonic saline challenge
5379019|NCT00116311|Adenosine receptors|adenosine receptors
5379020|NCT00116311|asthma|asthma
5379021|NCT00116311|sputum|sputum
5379022|NCT00116311|peripheral blood|peripheral blood
5379023|NCT00116311|healthy|healthy
5379024|NCT00116298|Antivirals|antivirals
5379025|NCT00116298|HIV|hiv
5379026|NCT00116285|allergy|allergy
5379027|NCT00116285|skin prick test|skin prick test
5379028|NCT00116285|allergoid|allergoid
5379029|NCT00116285|allergenicity|allergenicity
5379030|NCT00116285|specific immunotherapy|specific immunotherapy
5379031|NCT00116272|pregnancy|pregnancy
5379032|NCT00116272|Autoimmune Disease|autoimmune disease
5379033|NCT00116259|clinical trial|clinical trial
5379034|NCT00116259|aripiprazole|aripiprazole
5379035|NCT00116259|Bipolar Disorder|bipolar disorder
5379036|NCT00116259|Attention-Deficit Hyperactivity Disorder|attention-deficit hyperactivity disorder
5379037|NCT00116259|ADHD|adhd
5379038|NCT00116246|Labour|labour
5379039|NCT00116246|vaginal delivery|vaginal delivery
5379040|NCT00116246|primigravida|primigravida
5379041|NCT00116246|McRobert's Manoeuvre|mcrobert's manoeuvre
5379042|NCT00116246|operative delivery|operative delivery
5379043|NCT00116233|post operative adhesions|post operative adhesions
5379044|NCT00116220|Prostate Cancer|prostate cancer
5379045|NCT00116220|Total Androgen Suppression|total androgen suppression
5379046|NCT00116220|endorectal coil MRI|endorectal coil mri
5379047|NCT00116220|External Beam Radiation Therapy|external beam radiation therapy
5379048|NCT00116220|Prostate Cancer- High Risk, clinically Organ-Confined|prostate cancer- high risk, clinically organ-confined
5379049|NCT00116207|Type 1 Diabetes|type 1 diabetes
5379050|NCT00116207|Oxidative Stress|oxidative stress
5379051|NCT00116207|Diabetic Complications|diabetic complications
5379052|NCT00116207|Neuropathy|neuropathy
5379053|NCT00116194|exercise|exercise
5379054|NCT00116194|activities of daily living|activities of daily living
5379055|NCT00116194|ADL|adl
5379056|NCT00116194|loss of mobility|loss of mobility
5379057|NCT00116194|risk of disability|risk of disability
5379058|NCT00116194|physical activity|physical activity
5379059|NCT00116194|mobility disability|mobility disability
5379060|NCT00116155|Hormone Refractory Metastatic Prostate Cancer|hormone refractory metastatic prostate cancer
5379061|NCT00116142|Prostate Cancer|prostate cancer
5379062|NCT00116142|Hormone Refractory|hormone refractory
5379063|NCT00116142|Metastatic|metastatic
5379064|NCT00116142|Localized|localized
5379065|NCT00116142|Locally Advanced|locally advanced
5379066|NCT00116142|Prostate Cancer - High Risk Localized or Locally Advanced|prostate cancer - high risk localized or locally advanced
5379067|NCT00116129|Fibromyalgia|fibromyalgia
5379068|NCT00116129|Treatment|treatment
5379069|NCT00116129|Growth hormone|growth hormone
5379070|NCT00116129|IGF-1|igf-1
5379071|NCT00116129|MK-0677|mk-0677
5379072|NCT00116129|Oral growth hormone secretagogue|oral growth hormone secretagogue
5379073|NCT00116116|HIV/AIDS|hiv/aids
5379074|NCT00116103|Treatment Effectiveness|treatment effectiveness
5379075|NCT00116103|Treatment Efficacy|treatment efficacy
5379076|NCT00116103|Investigational, Therapies|investigational, therapies
5379077|NCT00116103|Asthma|asthma
5379078|NCT00116103|Antiasthmatics|antiasthmatics
5379079|NCT00116103|Antiasthmatic agents|antiasthmatic agents
5379080|NCT00116090|Uveitis|uveitis
5379081|NCT00116090|Immunosuppression|immunosuppression
5379082|NCT00116090|Cancer|cancer
5379083|NCT00116090|Infections|infections
5379084|NCT00116090|Mortality|mortality
5379085|NCT00116090|Ocular Inflammatory Disease|ocular inflammatory disease
5379086|NCT00116090|Scleritis|scleritis
5379087|NCT00116090|Mucous Membranes Pemphigoid|mucous membranes pemphigoid
5379088|NCT00116077|PET|pet
5379089|NCT00116077|[C-11] NNC-112|[c-11] nnc-112
5379090|NCT00116077|[F-18] Fallypride|[f-18] fallypride
5379091|NCT00116077|Dopamine Receptors|dopamine receptors
5379092|NCT00116077|Mood Disorders|mood disorders
5379093|NCT00116077|DA Receptors|da receptors
5379094|NCT00116077|Major Depressive Disorder|major depressive disorder
5379095|NCT00116077|Bipolar Disorder|bipolar disorder
5379096|NCT00116077|MDD|mdd
5379097|NCT00116077|Bipolar Depression|bipolar depression
5379098|NCT00116077|Healthy Volunteer|healthy volunteer
5379099|NCT00116077|HV|hv
5379100|NCT00116064|intranasal|intranasal
5379101|NCT00116064|lorazepam|lorazepam
5379102|NCT00116064|paediatric|paediatric
5379103|NCT00116064|convulsions|convulsions
5379104|NCT00116051|RSA|rsa
5379105|NCT00116051|DEXA|dexa
5379106|NCT00116051|Osteoarthritis|osteoarthritis
5379107|NCT00116051|Hip arthroplasty|hip arthroplasty
5379108|NCT00116038|RSA|rsa
5379109|NCT00116038|Osteoarthritis|osteoarthritis
5379110|NCT00116038|Hip arthroplasty|hip arthroplasty
5379111|NCT00116038|DEXA|dexa
5379112|NCT00116012|acute coronary syndrome|acute coronary syndrome
5379113|NCT00116012|rNAPc2|rnapc2
5379114|NCT00116012|unstable angina|unstable angina
5379115|NCT00116012|Non-STE myocardial infarction|non-ste myocardial infarction
5379116|NCT00116012|ST elevation|st elevation
5379117|NCT00116012|cardiac enzymes|cardiac enzymes
5379118|NCT00116012|acute coronary syndromes|acute coronary syndromes
5379119|NCT00116012|factor VIIa|factor viia
5379120|NCT00116012|tissue factor|tissue factor
5379121|NCT00116012|nematode anticoagulant protein c2|nematode anticoagulant protein c2
5379122|NCT00116012|anticoagulants|anticoagulants
5379123|NCT00116012|thrombin inhibitors|thrombin inhibitors
5379124|NCT00116012|thrombosis|thrombosis
5379125|NCT00115999|PAO|pao
5379126|NCT00115999|acute peripheral arterial occlusion|acute peripheral arterial occlusion
5379127|NCT00115999|thrombolysis|thrombolysis
5379128|NCT00115999|blood clot|blood clot
5379129|NCT00115999|leg attack|leg attack
5379130|NCT00115999|alfimeprase|alfimeprase
5379131|NCT00115999|thrombus|thrombus
5379132|NCT00115999|embolism|embolism
5379133|NCT00115999|thromboembolism|thromboembolism
5379134|NCT00115999|claudication|claudication
5379135|NCT00115999|thrombolytic|thrombolytic
5379136|NCT00115999|thrombosis|thrombosis
5379137|NCT00115999|plasminogen activator|plasminogen activator
5379138|NCT00115999|arterial flow|arterial flow
5379139|NCT00115986|A/H5N1, Influenza, Vaccine, parent protocol|a/h5n1, influenza, vaccine, parent protocol
5379140|NCT00115973|Pump|pump
5379141|NCT00115973|Diabetes|diabetes
5379142|NCT00115960|IL-12|il-12
5379143|NCT00115960|IL-15|il-15
5379144|NCT00115960|HIV Seronegativity|hiv seronegativity
5379145|NCT00115960|HIV Preventive Vaccine|hiv preventive vaccine
5379146|NCT00115921|Home-based care|home-based care
5379147|NCT00115921|Malaria|malaria
5379148|NCT00115921|Africa|africa
5379149|NCT00115908|Hepatitis C|hepatitis c
5379150|NCT00115895|radioiodine|radioiodine
5379151|NCT00115895|serum thyroglobulin|serum thyroglobulin
5379152|NCT00115895|whole body radioiodine scanning|whole body radioiodine scanning
5379153|NCT00115882|Adolescent|adolescent
5379154|NCT00115882|smoking|smoking
5380341|NCT00111956|TNF|tnf
5379155|NCT00115882|smoking cessation|smoking cessation
5379156|NCT00115882|counseling|counseling
5379157|NCT00115869|smoking prevention|smoking prevention
5379158|NCT00115869|tobacco use prevention|tobacco use prevention
5379159|NCT00115869|adolescent tobacco use|adolescent tobacco use
5379160|NCT00115869|prevention intervention|prevention intervention
5379161|NCT00115856|Arterial Disease|arterial disease
5379162|NCT00115843|Atrial fibrillation|atrial fibrillation
5379163|NCT00115843|Arrhythmia|arrhythmia
5379164|NCT00115843|Tachycardia|tachycardia
5379165|NCT00115804|Fibromyalgia|fibromyalgia
5379166|NCT00115804|Juvenile|juvenile
5379167|NCT00115791|Atrial Flutters|atrial flutters
5379168|NCT00115791|Atrial Fibrillations|atrial fibrillations
5379169|NCT00115791|RSD1235|rsd1235
5379170|NCT00115778|Hypogammaglobulinemia|hypogammaglobulinemia
5379171|NCT00115778|Lung Transplantation|lung transplantation
5379172|NCT00115765|Panitumumab Advanced Colorectal Cancer Evaluation Study (PACCE Study)|panitumumab advanced colorectal cancer evaluation study (pacce study)
5379173|NCT00115765|Colorectal, Colon, Rectal Cancer, Metastatic Colorectal|colorectal, colon, rectal cancer, metastatic colorectal
5379174|NCT00115765|Cancer|cancer
5379175|NCT00115765|EGFr, Clinical Trial|egfr, clinical trial
5379176|NCT00115765|Panitumumab, ABX-EGF|panitumumab, abx-egf
5379177|NCT00115765|Immunex, Abgenix, Amgen|immunex, abgenix, amgen
5379178|NCT00115765|Metastatic Colorectal Cancer|metastatic colorectal cancer
5379179|NCT00115765|Oncology|oncology
5379180|NCT00115752|Single Nucleotide Polymorphism|single nucleotide polymorphism
5379181|NCT00115752|Analgesic Efficacy|analgesic efficacy
5379182|NCT00115752|Oral Surgery Model|oral surgery model
5379183|NCT00115752|Cyclooxygenase Inhibitor|cyclooxygenase inhibitor
5379184|NCT00115752|Gene Expression Profile|gene expression profile
5379185|NCT00115752|Wisdom Teeth|wisdom teeth
5379186|NCT00115752|Third Molar Extraction|third molar extraction
5379187|NCT00115739|Anaplastic Thyroid Cancer|anaplastic thyroid cancer
5379188|NCT00115726|anesthesia|anesthesia
5379189|NCT00115726|hypotension|hypotension
5379190|NCT00115726|furosemide|furosemide
5379191|NCT00115726|blood pressure|blood pressure
5379192|NCT00115726|peripheral edema|peripheral edema
5379193|NCT00115726|diuretic|diuretic
5379194|NCT00115726|surgery|surgery
5379195|NCT00115726|congestive heart failure|congestive heart failure
5379196|NCT00115713|Aerobic Exercise|aerobic exercise
5379197|NCT00115713|Weight Lifting|weight lifting
5379198|NCT00115713|Breast Cancer|breast cancer
5379199|NCT00115713|Quality of Life|quality of life
5379200|NCT00115700|Radiotherapy|radiotherapy
5379201|NCT00115700|Chemotherapy|chemotherapy
5379202|NCT00115700|Rituximab|rituximab
5379203|NCT00115700|Randomised Trial|randomised trial
5379204|NCT00115700|Stage I-II low grade follicular lymphoma|stage i-ii low grade follicular lymphoma
5379205|NCT00115687|nicotine addiction|nicotine addiction
5379206|NCT00115661|Peroxisome Proliferator-Activated Receptors|peroxisome proliferator-activated receptors
5379207|NCT00115661|treatment of endometriosis|treatment of endometriosis
5379208|NCT00115648|HIV|hiv
5379209|NCT00115648|MTCT|mtct
5379210|NCT00115648|Infants|infants
5379211|NCT00115648|africa|africa
5379212|NCT00115648|HIV Seronegativity|hiv seronegativity
5379213|NCT00115635|Hormonal refractory, chemotherapy, docetaxel, gemcitabine|hormonal refractory, chemotherapy, docetaxel, gemcitabine
5379214|NCT00115622|GW685698X|gw685698x
5379215|NCT00115622|once daily|once daily
5379216|NCT00115622|mountain cedar|mountain cedar
5379217|NCT00115622|allergic rhinitis|allergic rhinitis
5379218|NCT00115622|fluticasone furoate|fluticasone furoate
5379219|NCT00115609|HIV infections|hiv infections
5379220|NCT00115609|tuberculosis|tuberculosis
5379221|NCT00115609|tuberculosis agents|tuberculosis agents
5379222|NCT00115609|Anti HIV agents|anti hiv agents
5379223|NCT00115609|Treatment Naive|treatment naive
5379224|NCT00115596|Procedure|procedure
5379225|NCT00115596|Training|training
5379226|NCT00115596|Simulation|simulation
5379227|NCT00115596|Pediatrics|pediatrics
5379228|NCT00115596|Curriculum|curriculum
5379229|NCT00115596|Evaluation|evaluation
5379230|NCT00115570|Diabetes,Insulin-Dependent, pediatric,rapid acting injection|diabetes,insulin-dependent, pediatric,rapid acting injection
5379231|NCT00115557|translational research|translational research
5379232|NCT00115557|prevention|prevention
5379233|NCT00115557|primary care|primary care
5379234|NCT00115557|practice-based research network|practice-based research network
5379235|NCT00115544|neonatal|neonatal
5379236|NCT00115544|jaundice|jaundice
5379237|NCT00115544|hyperbilirubinemia|hyperbilirubinemia
5379238|NCT00115531|Elderly, influenza, vaccine, parent protocol|elderly, influenza, vaccine, parent protocol
5379239|NCT00115505|stage IA breast cancer|stage ia breast cancer
5379240|NCT00115505|stage II breast cancer|stage ii breast cancer
5379241|NCT00115505|stage IB breast cancer|stage ib breast cancer
5379242|NCT00115505|estrogen receptor-negative breast cancer|estrogen receptor-negative breast cancer
5379243|NCT00115505|estrogen receptor-positive breast cancer|estrogen receptor-positive breast cancer
5379244|NCT00115505|progesterone receptor-negative breast cancer|progesterone receptor-negative breast cancer
5379245|NCT00115505|progesterone receptor-positive breast cancer|progesterone receptor-positive breast cancer
5379246|NCT00115492|Breathing|breathing
5379247|NCT00115492|Exacerbation|exacerbation
5379248|NCT00115492|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5379249|NCT00115479|critical illness|critical illness
5379250|NCT00115479|intensive care|intensive care
5379251|NCT00115479|outcome|outcome
5379252|NCT00115479|insulin|insulin
5379253|NCT00115479|blood glucose|blood glucose
5379254|NCT00115466|ASCs (adult stem cells derived from adipose tissue)|ascs (adult stem cells derived from adipose tissue)
5379255|NCT00115466|Fistula|fistula
5379256|NCT00115466|Cell Therapy|cell therapy
5379257|NCT00115466|Complex perianal fistula|complex perianal fistula
5379258|NCT00115453|glioblastoma|glioblastoma
5379259|NCT00115453|boron neutron capture therapy|boron neutron capture therapy
5379260|NCT00115453|boronophenylalanine|boronophenylalanine
5379261|NCT00115453|brain tumor|brain tumor
5379262|NCT00115440|glioblastoma|glioblastoma
5379263|NCT00115440|anaplastic astrocytoma|anaplastic astrocytoma
5379264|NCT00115440|boron neutron capture therapy|boron neutron capture therapy
5379265|NCT00115440|radiation therapy|radiation therapy
5379266|NCT00115440|boronophenylalanine|boronophenylalanine
5379267|NCT00115427|Bilateral, Idiopathic Parkinson's Disease|bilateral, idiopathic parkinson's disease
5379268|NCT00115414|Neulasta®|neulasta®
5379269|NCT00115414|Chemotherapy|chemotherapy
5379270|NCT00115414|TAC|tac
5379271|NCT00115414|Amgen|amgen
5379272|NCT00019500|breast cancer|breast cancer
5379273|NCT00115401|Walking|walking
5379274|NCT00115401|Compensation|compensation
5379275|NCT00115401|Leg Weakness|leg weakness
5379276|NCT00115401|Orthotics|orthotics
5379277|NCT00115401|Joint Impairment|joint impairment
5379278|NCT00115401|Healthy Volunteer|healthy volunteer
5379279|NCT00115401|HV|hv
5379280|NCT00115401|Joint Inmpairment|joint inmpairment
5379281|NCT00115388|Pelvic inflammatory disease|pelvic inflammatory disease
5379282|NCT00115388|Chlamydia trachomatis|chlamydia trachomatis
5379283|NCT00115388|Screening|screening
5379284|NCT00115375|THROMBOSIS|thrombosis
5379285|NCT00115375|PLATELET AGGREGATION|platelet aggregation
5379286|NCT00115375|Pediatrics|pediatrics
5379287|NCT00115362|functional dyspepsia;|functional dyspepsia;
5379288|NCT00115362|Serotonin Uptake Inhibitors;|serotonin uptake inhibitors;
5379289|NCT00115362|Antidepressive Agents.|antidepressive agents.
5379290|NCT00115336|Blood Diseases|blood diseases
5379291|NCT00115336|Sickle Cell Anemia|sickle cell anemia
5379292|NCT00115310|dermal assessment|dermal assessment
5379293|NCT00115310|pain measurement|pain measurement
5379294|NCT00115310|diary|diary
5379295|NCT00115310|PHN|phn
5379296|NCT00115310|shingles|shingles
5379297|NCT00115310|neuropathy|neuropathy
5379298|NCT00115310|analgesics|analgesics
5379299|NCT00115310|capsaicin|capsaicin
5379300|NCT00115310|postherpetic neuralgia|postherpetic neuralgia
5379301|NCT00115284|Asthma|asthma
5379302|NCT00115284|Education, Medical, Continuing|education, medical, continuing
5379303|NCT00115284|American Board of Internal Medicine|american board of internal medicine
5379304|NCT00115284|Recertification|recertification
5379305|NCT00115284|Continuous Professional Development|continuous professional development
5379306|NCT00115284|Practice improvement|practice improvement
5379307|NCT00115271|Micronutrients|micronutrients
5379308|NCT00115271|Supplementation|supplementation
5379309|NCT00115271|Pregnancy|pregnancy
5379310|NCT00115271|Birth weight|birth weight
5379311|NCT00115271|Infant mortality|infant mortality
5379312|NCT00115258|Nutrition, Parenteral|nutrition, parenteral
5379313|NCT00115258|Body Composition|body composition
5379314|NCT00115258|Energy Expenditure|energy expenditure
5379315|NCT00115232|cardiovascular disease|cardiovascular disease
5379316|NCT00115232|metabolic syndrome|metabolic syndrome
5379317|NCT00115232|hypercholesterolemia|hypercholesterolemia
5379318|NCT00115232|child|child
5379319|NCT00115232|family history|family history
5379320|NCT00115232|inflammation|inflammation
5379321|NCT00115219|Rheumatoid Arthritis, RA|rheumatoid arthritis, ra
5379322|NCT00115219|Enbrel® (etanercept)|enbrel® (etanercept)
5379323|NCT00115219|Clinical Trials, Amgen|clinical trials, amgen
5379324|NCT00115219|Immunex, Methotrexate (MTX)|immunex, methotrexate (mtx)
5379325|NCT00115219|Rheumatoid Arthritis (RA)|rheumatoid arthritis (ra)
5379326|NCT00115206|Non Small Cell Lung Cancer|non small cell lung cancer
5379327|NCT00115206|NSCLC|nsclc
5379328|NCT00115206|Fever|fever
5379329|NCT00115206|Neutropenia|neutropenia
5379330|NCT00115206|Neulasta®|neulasta®
5379331|NCT00115206|Quality of Life|quality of life
5379332|NCT00115206|Chemotherapy|chemotherapy
5379333|NCT00115206|Amgen|amgen
5379334|NCT00115193|Oncology|oncology
5379335|NCT00115193|NHL|nhl
5379336|NCT00115193|Mantle cell|mantle cell
5379337|NCT00115193|Diffuse large B-cell|diffuse large b-cell
5379338|NCT00115193|Chemotherapy|chemotherapy
5379339|NCT00115193|RCHOP|rchop
5379340|NCT00115193|Neulasta®|neulasta®
5379341|NCT00115193|Neutropenia|neutropenia
5379342|NCT00115193|Pegfilgrastim|pegfilgrastim
5379343|NCT00115193|Amgen|amgen
5379344|NCT00115180|analgesia|analgesia
5379345|NCT00115180|adult|adult
5379346|NCT00115180|opioid|opioid
5379347|NCT00115180|Long Bone Fractures|long bone fractures
5379348|NCT00115167|Oncology|oncology
5379349|NCT00115167|Cancer-related anemia|cancer-related anemia
5379350|NCT00115154|Actinic Keratosis|actinic keratosis
5379351|NCT00115154|AK|ak
5379352|NCT00115154|3M Pharmaceuticals|3m pharmaceuticals
5379353|NCT00115154|Aldara|aldara
5379354|NCT00115154|Imiquimod|imiquimod
5379355|NCT00115154|Actinic Keratosis (AK)|actinic keratosis (ak)
5379356|NCT00115141|Wart(s)|wart(s)
5379357|NCT00115141|Adults|adults
5379358|NCT00115141|Common Wart(s)|common wart(s)
5379359|NCT00115128|normal PBPC donors|normal pbpc donors
5379360|NCT00115115|Donor dopamine|donor dopamine
5379361|NCT00115115|Immediate graft function|immediate graft function
5379362|NCT00115115|Kidney transplantation|kidney transplantation
5379363|NCT00115102|Atypical odontalgia|atypical odontalgia
5379364|NCT00115102|capsaicin|capsaicin
5379365|NCT00115102|pain|pain
5379366|NCT00115102|neuropathic pain|neuropathic pain
5379367|NCT00115089|Allergic Rhinitis|allergic rhinitis
5379368|NCT00115089|Nasal Spray|nasal spray
5379369|NCT00115089|Seasonal Allergic Rhinitis|seasonal allergic rhinitis
5379370|NCT00115076|skin|skin
5379371|NCT00115076|psoriasis|psoriasis
5379372|NCT00115063|obesity|obesity
5379373|NCT00115063|Low Calorie Diet|low calorie diet
5379374|NCT00115063|Obesity Pharmacotherapy|obesity pharmacotherapy
5379375|NCT00115063|Pragmatic Clinical Trial|pragmatic clinical trial
5379376|NCT00115050|HIV infections|hiv infections
5379377|NCT00115050|Antiretroviral|antiretroviral
5379378|NCT00115050|TMC114|tmc114
5379379|NCT00115050|Ritonavir|ritonavir
5379380|NCT00115050|Safety, TMC114-C209|safety, tmc114-c209
5379381|NCT00115037|Alcoholism|alcoholism
5379382|NCT00115037|alcohol abuse|alcohol abuse
5379383|NCT00115037|therapy|therapy
5379384|NCT00115037|drug resistance|drug resistance
5379385|NCT00115037|naltrexone|naltrexone
5379386|NCT00115037|patient care management|patient care management
5379387|NCT00115037|human subject|human subject
5379388|NCT00115024|cardiovascular disease|cardiovascular disease
5379389|NCT00115024|CVD|cvd
5379390|NCT00115024|estrogen|estrogen
5379391|NCT00115024|cholesterol|cholesterol
5379392|NCT00115024|LDL|ldl
5379393|NCT00115024|lipids|lipids
5379394|NCT00115024|postmenopausal|postmenopausal
5379395|NCT00115011|Skin Picking|skin picking
5379396|NCT00115011|Escitalopram|escitalopram
5379397|NCT00115011|Lexapro|lexapro
5379398|NCT00115011|Body Focused Repetitive Behaviors|body focused repetitive behaviors
5379399|NCT00115011|Obsessive Compulsive Spectrum Disorders|obsessive compulsive spectrum disorders
5379400|NCT00114985|Total Androgen Suppression|total androgen suppression
5379401|NCT00114985|Simulation|simulation
5379402|NCT00114985|3-D Conformal External Beam Radiation Therapy|3-d conformal external beam radiation therapy
5379403|NCT00114985|Intra-rectal immobilization device|intra-rectal immobilization device
5379404|NCT00114985|Quality of Life Assessment Questionnaire|quality of life assessment questionnaire
5379405|NCT00114985|Rectal Bleeding|rectal bleeding
5379406|NCT00114985|Late effects|late effects
5379407|NCT00114972|Three-vessel coronary artery disease|three-vessel coronary artery disease
5379408|NCT00114972|Left main coronary artery disease|left main coronary artery disease
5379409|NCT00114959|ChemGenex Pharmaceuticals, Ltd|chemgenex pharmaceuticals, ltd
5379410|NCT00114959|ChemGenex Pharmaceuticals|chemgenex pharmaceuticals
5379411|NCT00114959|ChemGenex|chemgenex
5379412|NCT00114959|Chronic Myeloid Leukemia|chronic myeloid leukemia
5379413|NCT00114959|Myeloid Leukemia, Chronic|myeloid leukemia, chronic
5379414|NCT00114959|Leukemia|leukemia
5379415|NCT00114959|Myeloid Leukemia|myeloid leukemia
5379416|NCT00114959|Chronic Phase|chronic phase
5379417|NCT00114959|Accelerated Phase|accelerated phase
5379418|NCT00114959|Blast Phase|blast phase
5379419|NCT00114959|Myeloid, Leukemia, Chronic, Accelerated Phase|myeloid, leukemia, chronic, accelerated phase
5379420|NCT00114959|Myeloid, Leukemia, Chronic|myeloid, leukemia, chronic
5379421|NCT00114959|Leukemia, Myeloid, Chronic|leukemia, myeloid, chronic
5379422|NCT00114959|Leukemia, Myeloid, Chronic-Phase|leukemia, myeloid, chronic-phase
5379423|NCT00114959|Leukemia, Myeloid, Chronic Phase|leukemia, myeloid, chronic phase
5379424|NCT00114959|Leukemia, Myeloid, Accelerated-Phase|leukemia, myeloid, accelerated-phase
5379425|NCT00114959|Myeloid, Leukemia, Chronic, Chronic Phase|myeloid, leukemia, chronic, chronic phase
5379426|NCT00114959|Leukemia, Myeloid, Accelerated Phase|leukemia, myeloid, accelerated phase
5379427|NCT00114959|Homoharringtonine|homoharringtonine
5379428|NCT00114959|Omacetaxine|omacetaxine
5379429|NCT00114946|Metastatic Colorectal Cancer OASIS|metastatic colorectal cancer oasis
5379430|NCT00114933|HIV|hiv
5379431|NCT00114933|AIDS|aids
5379432|NCT00114933|Treatment Experienced|treatment experienced
5379433|NCT00114920|Wart(s)|wart(s)
5379434|NCT00114920|Adults|adults
5379435|NCT00114920|Common Wart(s)|common wart(s)
5379436|NCT00114907|Tea|tea
5379437|NCT00114907|Oxidative stress markers|oxidative stress markers
5379438|NCT00114907|cardiovascular disease|cardiovascular disease
5379439|NCT00114907|polyphenolics|polyphenolics
5379440|NCT00114907|double blind|double blind
5379441|NCT00114907|Ischaemic cardiac disease|ischaemic cardiac disease
5379442|NCT00114894|Jellyfish|jellyfish
5379443|NCT00114894|Stings|stings
5379444|NCT00114894|Marine|marine
5379445|NCT00114894|Envenomation|envenomation
5379446|NCT00114894|Jellyfish stings|jellyfish stings
5379447|NCT00114881|Children|children
5379448|NCT00114881|Urban Health|urban health
5379449|NCT00114881|Pregnancy|pregnancy
5379450|NCT00114881|Asthma|asthma
5379451|NCT00114868|vitamin A|vitamin a
5379452|NCT00114868|mortality|mortality
5379453|NCT00114868|newborn|newborn
5379454|NCT00114868|liveborn infants|liveborn infants
5379455|NCT00114855|Hypocol|hypocol
5379456|NCT00114855|Red yeast rice|red yeast rice
5379457|NCT00114855|Patients with mild Type IIa, Type IIb or IV hyperlipidaemia (LDL-cholesterol >3.0 mmol/L< 6.0 mmol/L.|patients with mild type iia, type iib or iv hyperlipidaemia (ldl-cholesterol >3.0 mmol/l< 6.0 mmol/l.
5379458|NCT00114855|Mildly elevated blood glucose|mildly elevated blood glucose
5379459|NCT00114842|colorectal polyps|colorectal polyps
5379460|NCT00114842|colorectal cancer|colorectal cancer
5379461|NCT00114842|Virtual colonoscopy|virtual colonoscopy
5379462|NCT00114842|Fecal tagging|fecal tagging
5379463|NCT00114842|MR colonography|mr colonography
5379464|NCT00114829|Colorectal cancer|colorectal cancer
5379465|NCT00114829|Colorectal tumor|colorectal tumor
5379466|NCT00114829|Dynamic contrast uptake|dynamic contrast uptake
5379467|NCT00114829|MR colonography|mr colonography
5379468|NCT00114816|breast cancer|breast cancer
5379469|NCT00114816|chemotherapy|chemotherapy
5379470|NCT00114816|adjuvant|adjuvant
5379471|NCT00114816|capecitabine|capecitabine
5379472|NCT00114816|docetaxel|docetaxel
5379473|NCT00114803|bone mineral density|bone mineral density
5379474|NCT00114803|osteoporosis|osteoporosis
5379475|NCT00114803|osteopenia|osteopenia
5379476|NCT00114803|children|children
5379477|NCT00114803|adolescents|adolescents
5379478|NCT00114803|DXA|dxa
5379479|NCT00114790|head and neck cancer|head and neck cancer
5379480|NCT00114790|boron neutron capture therapy|boron neutron capture therapy
5379481|NCT00114790|radiation therapy|radiation therapy
5379482|NCT00114790|boronophenylalanine|boronophenylalanine
5379483|NCT00114764|Acute myeloid leukaemia|acute myeloid leukaemia
5379484|NCT00114764|Pegfilgrastim|pegfilgrastim
5379485|NCT00114764|Neulasta®|neulasta®
5379486|NCT00114764|Neutropenia|neutropenia
5379487|NCT00114764|Induction chemotherapy|induction chemotherapy
5379488|NCT00114764|Consolidation|consolidation
5379489|NCT00114738|Proteasome Inhibition|proteasome inhibition
5379490|NCT00114738|NF-Kappa-B|nf-kappa-b
5379491|NCT00114738|Gene Expression Signature|gene expression signature
5379492|NCT00114738|Cyclin D1|cyclin d1
5379493|NCT00114738|Translational Studies|translational studies
5379494|NCT00114738|Lymphoma|lymphoma
5379495|NCT00114738|Mantle Cell Lymphoma|mantle cell lymphoma
5379496|NCT00114738|MCL|mcl
5379497|NCT00114725|In Vitro Fertilization|in vitro fertilization
5379498|NCT00114725|Intracytoplasmic Sperm Injection|intracytoplasmic sperm injection
5379499|NCT00114725|Oocytes|oocytes
5379500|NCT00114725|Zona Pellucida|zona pellucida
5379501|NCT00114725|Oolemma|oolemma
5379502|NCT00114725|Fertilization|fertilization
5379503|NCT00114725|Preimplantation Embryo Development|preimplantation embryo development
5379504|NCT00114712|Birth Defects|birth defects
5379505|NCT00114712|Pregnancy|pregnancy
5379506|NCT00114712|Ribavirin|ribavirin
5379507|NCT00114712|Hepatitis C|hepatitis c
5379508|NCT00114699|HIV|hiv
5379509|NCT00114699|Treatment Naive|treatment naive
5379510|NCT00114686|Bipolar I Disorder|bipolar i disorder
5379511|NCT00114686|Alcohol Dependency|alcohol dependency
5379512|NCT00114673|Uneven skin color|uneven skin color
5379513|NCT00114673|Wrinkles|wrinkles
5379514|NCT00114673|Wrinkles and uneven skin color in the area around the eyes|wrinkles and uneven skin color in the area around the eyes
5379515|NCT00114660|striae gravidarum|striae gravidarum
5379516|NCT00114660|stretch marks|stretch marks
5379517|NCT00114660|cocoa butter|cocoa butter
5379518|NCT00114660|prevention|prevention
5379519|NCT00114647|Plasmapheresis|plasmapheresis
5379520|NCT00114647|Leukapheresis|leukapheresis
5379521|NCT00114647|Lymphocytes|lymphocytes
5379522|NCT00114647|Apheresis|apheresis
5379523|NCT00114634|SLOS|slos
5379524|NCT00114634|RSH syndrome|rsh syndrome
5379525|NCT00114634|ABC Checklist|abc checklist
5379526|NCT00114634|Cholesterol supplementation|cholesterol supplementation
5379527|NCT00114634|Egg yolk|egg yolk
5379528|NCT00114634|Smith-Lemli-Opitz Syndrome|smith-lemli-opitz syndrome
5379529|NCT00114621|PA|pa
5379530|NCT00114621|Phase I|phase i
5379531|NCT00114621|Phase 2|phase 2
5379532|NCT00114621|Safety|safety
5379533|NCT00114621|Immunogenicity|immunogenicity
5379534|NCT00114608|Electrical foot stimulation|electrical foot stimulation
5379535|NCT00114608|Intermittent pneumatic compression|intermittent pneumatic compression
5379536|NCT00114608|Venous thromboembolism|venous thromboembolism
5379537|NCT00114608|Immobilization|immobilization
5379538|NCT00114608|Total hip replacement|total hip replacement
5379539|NCT00114608|Prolonged travel|prolonged travel
5379540|NCT00114608|Venous thromboembolic disease (VTE)|venous thromboembolic disease (vte)
5379541|NCT00114608|Deep vein thrombosis (DVT)|deep vein thrombosis (dvt)
5379542|NCT00114608|Pulmonary embolism (PE)|pulmonary embolism (pe)
5379543|NCT00114595|eicosapentaenoic acid|eicosapentaenoic acid
5379544|NCT00114595|tardive dyskinesia|tardive dyskinesia
5379545|NCT00114595|omega-3|omega-3
5379546|NCT00114595|schizophrenia|schizophrenia
5379547|NCT00114582|family style dinner|family style dinner
5379548|NCT00114582|quality of life|quality of life
5379549|NCT00114582|nutritional status|nutritional status
5379550|NCT00114582|nursing home residents|nursing home residents
5379551|NCT00114569|children|children
5379552|NCT00114569|status epilepticus|status epilepticus
5379553|NCT00114569|lorazepam|lorazepam
5379554|NCT00114569|safety|safety
5379555|NCT00114569|pharmacokinetics|pharmacokinetics
5379556|NCT00114569|status epilepticus in children|status epilepticus in children
5379557|NCT00114556|osteoporosis|osteoporosis
5379558|NCT00114556|liver transplantation|liver transplantation
5379559|NCT00114543|NICHD Neonatal Research Network|nichd neonatal research network
5379560|NCT00114543|Bilirubin|bilirubin
5379561|NCT00114543|Phototherapy|phototherapy
5379562|NCT00114543|Very Low Birth Weight (VLBW)|very low birth weight (vlbw)
5379563|NCT00114543|Extremely Low Birth Weight (ELBW)|extremely low birth weight (elbw)
5379564|NCT00114543|Prematurity|prematurity
5379565|NCT00114543|Neurodevelopmental outcome|neurodevelopmental outcome
5379566|NCT00114530|systemic sclerosis|systemic sclerosis
5379567|NCT00114530|hematopoietic stem cell transplant|hematopoietic stem cell transplant
5379568|NCT00114530|clinical trial|clinical trial
5379569|NCT00114530|global rank composite score|global rank composite score
5379570|NCT00114517|atherosclerosis|atherosclerosis
5379571|NCT00114517|CAD|cad
5379572|NCT00114517|cardiac computed tomography|cardiac computed tomography
5379573|NCT00114517|cardiovascular disease|cardiovascular disease
5379574|NCT00114517|carotid artery intima-media thickness|carotid artery intima-media thickness
5379575|NCT00114517|cognitive function|cognitive function
5379576|NCT00114517|computed tomography|computed tomography
5379577|NCT00114517|coronary artery calcium|coronary artery calcium
5379578|NCT00114517|coronary artery disease|coronary artery disease
5379579|NCT00114517|coronary artery lesions|coronary artery lesions
5379580|NCT00114517|CVD|cvd
5379581|NCT00114517|estrogen|estrogen
5379582|NCT00114517|estrogen therapy|estrogen therapy
5379583|NCT00114517|hormone therapy|hormone therapy
5379584|NCT00114517|postmenopausal|postmenopausal
5379585|NCT00114517|subclinical vascular disease|subclinical vascular disease
5379586|NCT00114517|timing hypothesis|timing hypothesis
5379587|NCT00114517|ultrasonography|ultrasonography
5379588|NCT00114504|atherosclerosis|atherosclerosis
5379589|NCT00114504|inflammation|inflammation
5379590|NCT00114504|statins|statins
5379591|NCT00114504|PET|pet
5379592|NCT00114504|carotid ultrasonography|carotid ultrasonography
5379593|NCT00114491|Aortic Stenosis|aortic stenosis
5379594|NCT00114491|Statins|statins
5379595|NCT00114491|Hypercholesterolemia|hypercholesterolemia
5379596|NCT00114478|Bronchiolitis|bronchiolitis
5379597|NCT00114478|disposition|disposition
5379598|NCT00114478|pediatric|pediatric
5379599|NCT00114478|epinephrine|epinephrine
5379600|NCT00114478|albuterol|albuterol
5379601|NCT00114465|Randomized|randomized
5379602|NCT00114465|Double-Blind|double-blind
5379603|NCT00114465|Probiotic|probiotic
5379604|NCT00114465|Remission|remission
5379605|NCT00114465|Crohn's Disease|crohn's disease
5379606|NCT00114452|Acute Myocardial Infarction|acute myocardial infarction
5379607|NCT00114452|Heart Attack|heart attack
5379608|NCT00114452|Cardiovascular Disease|cardiovascular disease
5379609|NCT00114452|Stem cells|stem cells
5379610|NCT00114452|Congestive Heart Failure|congestive heart failure
5379611|NCT00114452|Heart Attack Repair|heart attack repair
5379612|NCT00114439|cannabis withdrawal|cannabis withdrawal
5379613|NCT00114439|lithium|lithium
5379614|NCT00114439|Cannabis withdrawal syndrome|cannabis withdrawal syndrome
5379615|NCT00114426|randomized controlled trial; COPD|randomized controlled trial; copd
5379616|NCT00114413|Exhaled Nitric Oxide|exhaled nitric oxide
5379617|NCT00114413|Lung|lung
5379618|NCT00114413|Urban Health|urban health
5379619|NCT00114413|Child|child
5379620|NCT00114413|Adolescent|adolescent
5379621|NCT00114400|cardiovascular disease|cardiovascular disease
5379623|NCT00114387|vitamin E|vitamin e
5379624|NCT00114374|Acute Stress Disorder|acute stress disorder
5379625|NCT00114374|Posttraumatic Stress Disorder|posttraumatic stress disorder
5379626|NCT00114374|Escitalopram|escitalopram
5379627|NCT00114374|Double-Blind|double-blind
5379628|NCT00114361|HBeAg-negative|hbeag-negative
5379629|NCT00114361|chronic|chronic
5379630|NCT00114361|hepatitis B|hepatitis b
5379631|NCT00114361|viral|viral
5379632|NCT00114348|non-B ALL|non-b all
5379633|NCT00114348|relapse|relapse
5379634|NCT00114348|treatment|treatment
5379635|NCT00114348|Relapsed non-B ALL or non-B non-Hodgkin lymphoma|relapsed non-b all or non-b non-hodgkin lymphoma
5379636|NCT00114335|low molecular weight heparin|low molecular weight heparin
5379637|NCT00114335|unfractionated heparin|unfractionated heparin
5379638|NCT00114309|High grade recurrent glioma|high grade recurrent glioma
5379639|NCT00114309|Phase II|phase ii
5379640|NCT00114309|Multi-Center|multi-center
5379641|NCT00114309|Open label|open label
5379642|NCT00114309|Multiple dose|multiple dose
5379643|NCT00114309|Brain Cancer|brain cancer
5379644|NCT00114309|Brain Tumor|brain tumor
5379645|NCT00114309|GBM|gbm
5379646|NCT00114309|glioma|glioma
5379647|NCT00114296|breast cancer|breast cancer
5379648|NCT00114270|breast cancer|breast cancer
5379649|NCT00114270|osteoporosis|osteoporosis
5379650|NCT00114257|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5379651|NCT00114257|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5379652|NCT00114257|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5379653|NCT00114257|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5379654|NCT00114257|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5379655|NCT00114257|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5379656|NCT00114257|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5379657|NCT00114257|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5379658|NCT00114257|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
5379659|NCT00114257|adult acute promyelocytic leukemia (M3)|adult acute promyelocytic leukemia (m3)
5379660|NCT00114257|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5379661|NCT00114257|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5379662|NCT00114257|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5379663|NCT00114257|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
5379664|NCT00114257|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5379665|NCT00114257|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5379666|NCT00114257|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
5379667|NCT00114257|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5379668|NCT00114257|chronic eosinophilic leukemia|chronic eosinophilic leukemia
5379669|NCT00114257|primary myelofibrosis|primary myelofibrosis
5379670|NCT00114257|chronic neutrophilic leukemia|chronic neutrophilic leukemia
5379671|NCT00114257|essential thrombocythemia|essential thrombocythemia
5379672|NCT00114257|polycythemia vera|polycythemia vera
5379673|NCT00114257|Philadelphia chromosome negative chronic myelogenous leukemia|philadelphia chromosome negative chronic myelogenous leukemia
5379674|NCT00114257|chronic myelogenous leukemia, BCR-ABL1 positive|chronic myelogenous leukemia, bcr-abl1 positive
5379675|NCT00114257|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
5379676|NCT00114257|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
5379677|NCT00114257|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
5379678|NCT00114257|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
5379679|NCT00114257|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
5379680|NCT00114257|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
5379681|NCT00114257|adult erythroleukemia (M6a)|adult erythroleukemia (m6a)
5379682|NCT00114257|adult pure erythroid leukemia (M6b)|adult pure erythroid leukemia (m6b)
5379683|NCT00114257|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
5379684|NCT00114257|adult acute basophilic leukemia|adult acute basophilic leukemia
5379685|NCT00114257|adult acute eosinophilic leukemia|adult acute eosinophilic leukemia
5379686|NCT00114231|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5379687|NCT00114231|stage I rectal cancer|stage i rectal cancer
5379688|NCT00114205|malignant pleural effusion|malignant pleural effusion
5379689|NCT00114192|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5379690|NCT00114192|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5379691|NCT00114192|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5379692|NCT00114192|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5379693|NCT00114166|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5379694|NCT00114166|fallopian tube cancer|fallopian tube cancer
5379695|NCT00114166|primary peritoneal cavity cancer|primary peritoneal cavity cancer
5379696|NCT00114153|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
5379697|NCT00114153|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
5379698|NCT00114153|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
5379699|NCT00114153|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5379700|NCT00114153|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5379701|NCT00114153|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5379702|NCT00114140|adult diffuse astrocytoma|adult diffuse astrocytoma
5379703|NCT00114140|adult oligodendroglioma|adult oligodendroglioma
5379704|NCT00114140|adult mixed glioma|adult mixed glioma
5379705|NCT00114127|social anxiety disorder|social anxiety disorder
5379706|NCT00114127|social phobia|social phobia
5379707|NCT00114127|duloxetine|duloxetine
5379708|NCT00114127|serotonin norepinephrine reuptake inhibitor|serotonin norepinephrine reuptake inhibitor
5379709|NCT00114127|SNRI|snri
5379710|NCT00114127|double blind|double blind
5379711|NCT00114114|Testosterone|testosterone
5379712|NCT00114114|Bone turnover|bone turnover
5379713|NCT00114114|Aging|aging
5379714|NCT00114114|Body composition|body composition
5379715|NCT00114114|Hypogonadism|hypogonadism
5379716|NCT00114114|Sexual function|sexual function
5379717|NCT00114088|Hysterectomy,|hysterectomy,
5379718|NCT00114088|Endometrial ablation,|endometrial ablation,
5379719|NCT00114088|Ovulatory dysfunctional uterine bleeding,|ovulatory dysfunctional uterine bleeding,
5379720|NCT00114088|Anovulatory dysfucntional uterine bleeding,|anovulatory dysfucntional uterine bleeding,
5379721|NCT00114088|DUB|dub
5379722|NCT00114088|Dysfunctional uterine bleeding|dysfunctional uterine bleeding
5379723|NCT00114075|gait|gait
5379724|NCT00114075|walking|walking
5379725|NCT00114075|orthopedic surgery|orthopedic surgery
5379726|NCT00114075|orthopaedic surgery|orthopaedic surgery
5379727|NCT00114062|uveitis|uveitis
5379728|NCT00114062|macular edema|macular edema
5379729|NCT00114062|uveitis associated macular edema|uveitis associated macular edema
5379730|NCT00114049|Dental Pain|dental pain
5379731|NCT00114049|Dental Surgery|dental surgery
5379732|NCT00114049|Cox-2 inhibitor|cox-2 inhibitor
5379733|NCT00114036|Antibiotic prophylaxis|antibiotic prophylaxis
5379734|NCT00114036|Surgical wound infections|surgical wound infections
5379735|NCT00114023|AK|ak
5379736|NCT00114023|Imiquimod 5% cream|imiquimod 5% cream
5379737|NCT00114023|3M Pharmaceuticals|3m pharmaceuticals
5379738|NCT00114023|Aldara|aldara
5379739|NCT00114023|Actinic Keratosis|actinic keratosis
5379740|NCT00114010|B Cells|b cells
5379741|NCT00114010|T Cells|t cells
5379742|NCT00114010|Erythrocyte Stage|erythrocyte stage
5379743|NCT00114010|Antibody|antibody
5379744|NCT00114010|Immunogenicity|immunogenicity
5379745|NCT00114010|Healthy Volunteer|healthy volunteer
5379746|NCT00113997|Anticoagulant|anticoagulant
5379747|NCT00113997|Antidote|antidote
5379748|NCT00113997|Pharmacokinetics|pharmacokinetics
5379749|NCT00113997|Pharmacodynamics|pharmacodynamics
5379750|NCT00113997|Healthy Volunteer|healthy volunteer
5379751|NCT00113997|HV|hv
5379752|NCT00113984|Monoclonal Antibody|monoclonal antibody
5379753|NCT00113984|Vaccine|vaccine
5379754|NCT00113984|Cytokines|cytokines
5379755|NCT00113984|Immunotherapy|immunotherapy
5379756|NCT00113984|Elispot Assay|elispot assay
5379757|NCT00113984|Prostate Cancer|prostate cancer
5379758|NCT00113984|Metastatic Prostate Cancer|metastatic prostate cancer
5379759|NCT00113971|study of epratuzumab in systemic lupus erythematosus|study of epratuzumab in systemic lupus erythematosus
5379760|NCT00113971|systemic lupus erythematosus|systemic lupus erythematosus
5379761|NCT00113971|SLE|sle
5379762|NCT00113958|End Stage Renal Disease (ESRD)|end stage renal disease (esrd)
5379763|NCT00113958|secondary hyperparathyroidism (SHPT)|secondary hyperparathyroidism (shpt)
5379764|NCT00113958|hemodialysis|hemodialysis
5379765|NCT00113958|biPTH|bipth
5379766|NCT00113958|AMG 073, Amgen|amg 073, amgen
5379767|NCT00113945|End Stage Renal Disease (ESRD)|end stage renal disease (esrd)
5379768|NCT00113945|secondary hyperparathyroidism|secondary hyperparathyroidism
5379769|NCT00113945|hemodialysis, biPTH|hemodialysis, bipth
5379770|NCT00113945|AMG 073, Amgen|amg 073, amgen
5379771|NCT00113932|Myeloma|myeloma
5379772|NCT00113919|Myeloma, MM|myeloma, mm
5379773|NCT00113906|melatonin,|melatonin,
5379774|NCT00113906|fatigue,|fatigue,
5379775|NCT00113906|sleep quality,|sleep quality,
5379776|NCT00113906|circadian,|circadian,
5379777|NCT00113906|postoperative|postoperative
5379778|NCT00113906|Postoperative fatigue|postoperative fatigue
5379779|NCT00113906|postoperative sleep disturbance|postoperative sleep disturbance
5379780|NCT00113906|general wellbeing|general wellbeing
5379781|NCT00113893|Myelodysplastic syndromes|myelodysplastic syndromes
5379782|NCT00113893|p38 MAP kinase|p38 map kinase
5379783|NCT00113893|Bone marrow diseases|bone marrow diseases
5379784|NCT00113893|SCIO-469|scio-469
5379785|NCT00113867|IVF|ivf
5379786|NCT00113867|in vitro fertilization|in vitro fertilization
5379787|NCT00113867|hormones|hormones
5379788|NCT00113867|stress|stress
5379789|NCT00113867|memory|memory
5379790|NCT00113867|Cognitive Function|cognitive function
5379791|NCT00113867|adoption|adoption
5379792|NCT00113854|cerebral|cerebral
5379793|NCT00113854|malaria|malaria
5379794|NCT00113854|children|children
5379795|NCT00113854|mannitol|mannitol
5379796|NCT00113854|adjunct|adjunct
5379797|NCT00113854|therapy|therapy
5379798|NCT00113854|Uganda|uganda
5379799|NCT00113841|Multiple Myeloma|multiple myeloma
5379800|NCT00113841|Diferuloylmethane Derivative|diferuloylmethane derivative
5379801|NCT00113841|Curcumin|curcumin
5379802|NCT00113841|Bioperine|bioperine
5379803|NCT00113828|Non-Myeloablative|non-myeloablative
5379804|NCT00113828|Stem Cell Transplantation|stem cell transplantation
5379805|NCT00113828|T-cell Depletion|t-cell depletion
5379806|NCT00113828|HLA-Matched|hla-matched
5379807|NCT00113815|Partial seizure disorder|partial seizure disorder
5379808|NCT00113815|Topiramate|topiramate
5379809|NCT00113815|Epilepsy|epilepsy
5379810|NCT00113815|Infants|infants
5379811|NCT00113802|Epratuzumab (hLL2- anti-CD22 humanized antibody)|epratuzumab (hll2- anti-cd22 humanized antibody)
5379812|NCT00113802|Waldenstrom's Macroglobulinemia|waldenstrom's macroglobulinemia
5379813|NCT00113802|Waldenstrom Macroglobulinemia|waldenstrom macroglobulinemia
5379814|NCT00113802|Hematologic Disease|hematologic disease
5379815|NCT00113802|Hematologic Diseases|hematologic diseases
5379816|NCT00113802|Paraproteinemias|paraproteinemias
5379817|NCT00113802|Vascular Hemostatic Disorders|vascular hemostatic disorders
5379818|NCT00113802|Lymphoproliferative Disorders|lymphoproliferative disorders
5379819|NCT00113789|ovarian cancer|ovarian cancer
5379820|NCT00113789|topotecan|topotecan
5379821|NCT00113789|neutropenia|neutropenia
5379822|NCT00113789|Neulasta®|neulasta®
5379823|NCT00113776|Metastatic Colorectal Cancer, Colon|metastatic colorectal cancer, colon
5379824|NCT00113776|Colorectal, Rectal Cancer, EGFr|colorectal, rectal cancer, egfr
5379825|NCT00113776|Metastatic, Cancer, ABX-EGF|metastatic, cancer, abx-egf
5379826|NCT00113776|Panitumumab, Clinical Trial|panitumumab, clinical trial
5379827|NCT00113776|Immunex, Abgenix, Amgen|immunex, abgenix, amgen
5379828|NCT00113763|Metastatic Colorectal Cancer, Colon|metastatic colorectal cancer, colon
5379829|NCT00113763|Colorectal, Rectal Cancer, Cancer|colorectal, rectal cancer, cancer
5379830|NCT00113763|Metastatic, EGFr, Clinical Trial|metastatic, egfr, clinical trial
5379831|NCT00113763|Panitumumab, ABX-EGF|panitumumab, abx-egf
5379832|NCT00113763|Immunex, Abgenix, Amgen|immunex, abgenix, amgen
5379833|NCT00113750|Allergy|allergy
5379834|NCT00113750|Allergoid|allergoid
5379835|NCT00113750|Specific Immunotherapy|specific immunotherapy
5379836|NCT00113724|taxane|taxane
5379837|NCT00113724|multi-drug resistance|multi-drug resistance
5379838|NCT00113724|mutant tubulin binding|mutant tubulin binding
5379839|NCT00113724|Advanced malignancies|advanced malignancies
5379840|NCT00113724|Hodgkin's or Non-Hodgkin's Lymphoma|hodgkin's or non-hodgkin's lymphoma
5379841|NCT00113659|Asthma|asthma
5379842|NCT00113659|Probiotics|probiotics
5379843|NCT00113659|Prevention|prevention
5379844|NCT00113659|Eczema|eczema
5379845|NCT00113646|Non-Myeloablative|non-myeloablative
5379846|NCT00113646|T-cell Depleted|t-cell depleted
5379847|NCT00113646|Mismatched|mismatched
5379848|NCT00113646|Stem Cell Transplantation|stem cell transplantation
5379849|NCT00113633|Asthma|asthma
5379850|NCT00113633|Emergency|emergency
5379851|NCT00113633|Primary Care|primary care
5379852|NCT00113633|Children|children
5379853|NCT00113620|distal symmetrical|distal symmetrical
5379854|NCT00113620|pain|pain
5379855|NCT00113620|lower extremities|lower extremities
5379856|NCT00113620|dextromethorphan|dextromethorphan
5379857|NCT00113607|Ovarian cancer|ovarian cancer
5379858|NCT00113607|Trabectedin|trabectedin
5379859|NCT00113607|Yondelis|yondelis
5379860|NCT00113607|Advanced Relapsed Ovarian Cancer|advanced relapsed ovarian cancer
5379861|NCT00113607|DOXIL|doxil
5379862|NCT00113607|CAELYX|caelyx
5379863|NCT00113581|EMD 72000|emd 72000
5379864|NCT00113581|matuzumab|matuzumab
5379865|NCT00113581|Esophageal adenocarcinoma|esophageal adenocarcinoma
5379866|NCT00113581|Gastric adenocarcinoma|gastric adenocarcinoma
5379867|NCT00113568|Menorrhagia|menorrhagia
5379868|NCT00113568|Heavy Menstrual Bleeding|heavy menstrual bleeding
5379869|NCT00113555|urinary incontinence|urinary incontinence
5379870|NCT00113542|Psoriasis|psoriasis
5379871|NCT00113542|Tetrathiomolybdate|tetrathiomolybdate
5379872|NCT00113516|Lung Neoplasms|lung neoplasms
5379873|NCT00113503|Inflammatory Bowel Disease, Crohn's disease, Crohn's Colitis|inflammatory bowel disease, crohn's disease, crohn's colitis
5379874|NCT00113490|motavizumab, palivizumab, synagis|motavizumab, palivizumab, synagis
5379875|NCT00113490|Rezield, MEDI-524|rezield, medi-524
5379876|NCT00113477|Q10|q10
5379877|NCT00113477|CoQ10|coq10
5379878|NCT00113477|Coenzyme Q10|coenzyme q10
5379879|NCT00113477|selen|selen
5379880|NCT00113477|selenoprotein|selenoprotein
5379881|NCT00113477|selenoproteins|selenoproteins
5379882|NCT00113477|adverse events|adverse events
5379883|NCT00113477|adverse effects|adverse effects
5379884|NCT00113477|AE|ae
5379885|NCT00113477|myalgia|myalgia
5379886|NCT00113477|muscle|muscle
5379887|NCT00113477|statin therapy|statin therapy
5379888|NCT00113477|Indication for statin therapy|indication for statin therapy
5379889|NCT00113464|SCID (Severe Combined Immunodeficiency)|scid (severe combined immunodeficiency)
5379890|NCT00113464|TREC (T cell Receptor Excision Circle)|trec (t cell receptor excision circle)
5379891|NCT00113464|Bone Marrow Transplant|bone marrow transplant
5379892|NCT00113464|Dried Blood Spots|dried blood spots
5379893|NCT00113464|Early Detection|early detection
5379894|NCT00113464|T Cell Immunodeficiency Diseases|t cell immunodeficiency diseases
5379895|NCT00113464|Immunodeficiency Diseases|immunodeficiency diseases
5379896|NCT00113464|Primary Immunodeficiency|primary immunodeficiency
5379897|NCT00113464|T Cell Immunodeficiency Disease|t cell immunodeficiency disease
5379898|NCT00113464|Severe Combined Immunodeficiency|severe combined immunodeficiency
5379899|NCT00113464|SCID|scid
5379900|NCT00113451|radial artery|radial artery
5379901|NCT00113451|angina pectoris|angina pectoris
5379902|NCT00113451|infarction|infarction
5379903|NCT00113451|bypass|bypass
5379904|NCT00113451|angiography|angiography
5379905|NCT00113438|cancer|cancer
5379906|NCT00113438|tumor|tumor
5379907|NCT00113438|imageable|imageable
5379908|NCT00113438|CA4P|ca4p
5379909|NCT00113438|Combretastatin|combretastatin
5379910|NCT00113438|Combretastatin A4 Phosphate|combretastatin a4 phosphate
5379911|NCT00113438|Combretastatin A-4 Phosphate|combretastatin a-4 phosphate
5379912|NCT00113438|Carboplatin|carboplatin
5379913|NCT00113438|Paclitaxel|paclitaxel
5379914|NCT00113438|carbo|carbo
5379915|NCT00113438|taxol|taxol
5379916|NCT00113425|non-ablative laser|non-ablative laser
5379917|NCT00113425|acne|acne
5379918|NCT00113425|photosensitizer|photosensitizer
5379919|NCT00113425|photodynamic therapy|photodynamic therapy
5379920|NCT00113412|HIV|hiv
5379921|NCT00113412|Treatment Experienced|treatment experienced
5379922|NCT00113399|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
5379923|NCT00113399|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
5379924|NCT00113399|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
5379925|NCT00113399|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
5379926|NCT00113399|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
5379927|NCT00113399|recurrent lymphoepithelioma of the oropharynx|recurrent lymphoepithelioma of the oropharynx
5379928|NCT00113386|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5379929|NCT00113386|adenocarcinoma of the lung|adenocarcinoma of the lung
5379930|NCT00113386|large cell lung cancer|large cell lung cancer
5379931|NCT00113386|squamous cell lung cancer|squamous cell lung cancer
5379932|NCT00113386|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
5379933|NCT00113360|Neuroendocrine Carcinoma|neuroendocrine carcinoma
5379934|NCT00113360|Low Grade Neuroendocrine Carcinoma|low grade neuroendocrine carcinoma
5379935|NCT00113360|Neuroendocrine Carcinoid|neuroendocrine carcinoid
5379936|NCT00113360|Islet Cell Carcinoma|islet cell carcinoma
5379937|NCT00113360|RAD001|rad001
5379938|NCT00113360|Everolimus|everolimus
5379939|NCT00113360|Octreotide Depot|octreotide depot
5379940|NCT00113360|Sandostatin LAR|sandostatin lar
5379941|NCT00113360|Octreotide long-acting release (LAR)|octreotide long-acting release (lar)
5379942|NCT00113360|Octreotide LAR|octreotide lar
5379943|NCT00113347|Head and Neck Cancer|head and neck cancer
5379944|NCT00113347|Squamous Cell Carcinoma|squamous cell carcinoma
5379945|NCT00113347|Erlotinib|erlotinib
5379946|NCT00113347|Docetaxel|docetaxel
5379947|NCT00113347|Radiation|radiation
5379948|NCT00113347|Radiotherapy|radiotherapy
5379949|NCT00113347|Concomitant Boost Radiation|concomitant boost radiation
5379950|NCT00113334|Head and Neck Cancer|head and neck cancer
5379951|NCT00113334|Thrombospondin Analogue|thrombospondin analogue
5379952|NCT00113334|ABT-510|abt-510
5379953|NCT00113334|Antiangiogenic agent|antiangiogenic agent
5379954|NCT00113334|Lung|lung
5379955|NCT00113334|Skin|skin
5379956|NCT00113334|Thyroid|thyroid
5379957|NCT00113321|Myelodysplastic Syndrome|myelodysplastic syndrome
5379958|NCT00113321|Chronic Myelomonocytic Leukemia|chronic myelomonocytic leukemia
5379959|NCT00113321|Azacytidine Failure|azacytidine failure
5379960|NCT00113321|Decitabine|decitabine
5379961|NCT00113308|Rheumatoid Arthritis|rheumatoid arthritis
5379962|NCT00113308|COX-2 Inhibitor|cox-2 inhibitor
5379963|NCT00113295|generalized anxiety disorder|generalized anxiety disorder
5379964|NCT00113295|pharmacotherapy|pharmacotherapy
5379965|NCT00113295|treatment refractory|treatment refractory
5379966|NCT00113295|double-blind|double-blind
5379967|NCT00113282|Treatment failure|treatment failure
5379968|NCT00113282|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5379969|NCT00113282|Interleukin-2|interleukin-2
5379970|NCT00113282|Treatment Experienced|treatment experienced
5379971|NCT00113269|Treatment Effectiveness|treatment effectiveness
5379972|NCT00113269|Treatment Efficacy|treatment efficacy
5379973|NCT00113269|Anti-rejection therapy|anti-rejection therapy
5379974|NCT00113269|Immunosuppression|immunosuppression
5379975|NCT00113269|Therapy, antirejection|therapy, antirejection
5379976|NCT00113269|Renal Transplantation|renal transplantation
5379977|NCT00113269|Transplantation, Kidney|transplantation, kidney
5379978|NCT00113269|Transplantation, Renal|transplantation, renal
5379979|NCT00113269|Grafting, Kidney|grafting, kidney
5379980|NCT00113256|rubitecan|rubitecan
5379981|NCT00113256|Orathecin|orathecin
5379982|NCT00113256|9-nitrocamptothecin|9-nitrocamptothecin
5379983|NCT00113256|gemcitabine|gemcitabine
5379984|NCT00113256|Gemzar|gemzar
5379985|NCT00113256|pancreatic cancer|pancreatic cancer
5379986|NCT00113256|adenocarcinoma|adenocarcinoma
5379987|NCT00113256|RFS 2000|rfs 2000
5379988|NCT00113230|Rectal Cancer|rectal cancer
5379989|NCT00113230|Bevacizumab|bevacizumab
5379990|NCT00113230|RHUMAB VEGF|rhumab vegf
5379991|NCT00113230|Avastin|avastin
5379992|NCT00113230|Capecitabine|capecitabine
5379993|NCT00113230|Neoadjuvant Concurrent Capecitabine|neoadjuvant concurrent capecitabine
5379994|NCT00113230|Xeloda|xeloda
5379995|NCT00113230|Radiation|radiation
5379996|NCT00113230|Radiotherapy|radiotherapy
5379997|NCT00113230|Radiation Therapy|radiation therapy
5379998|NCT00113230|XRT|xrt
5379999|NCT00113217|Renal Cell Carcinoma|renal cell carcinoma
5380000|NCT00113217|Kidney Cancer|kidney cancer
5380001|NCT00113217|Bevacizumab|bevacizumab
5380002|NCT00113217|Avastin|avastin
5380003|NCT00113217|RCC|rcc
5380004|NCT00113204|Multiple myeloma|multiple myeloma
5380005|NCT00113204|Relapsed|relapsed
5380006|NCT00113204|Relapsed refractory|relapsed refractory
5380007|NCT00113204|Hematologic cancer|hematologic cancer
5380008|NCT00113204|hematologic disease|hematologic disease
5380009|NCT00113204|plasma cells|plasma cells
5380010|NCT00113191|late onset sepsis|late onset sepsis
5380011|NCT00113191|premature infants|premature infants
5380645|NCT00110838|ICD|icd
5380012|NCT00113191|staphylococcus|staphylococcus
5380013|NCT00113191|candida|candida
5380014|NCT00113191|prevention|prevention
5380015|NCT00113178|atrial flutter|atrial flutter
5380016|NCT00113178|cryoablation|cryoablation
5380017|NCT00113165|partial seizures|partial seizures
5380018|NCT00113165|Epilepsy|epilepsy
5380019|NCT00113165|antiepileptic drugs|antiepileptic drugs
5380020|NCT00113165|anticonvulsants|anticonvulsants
5380021|NCT00113165|LAMICTAL|lamictal
5380022|NCT00113165|seizures|seizures
5380023|NCT00113165|lamotrigine|lamotrigine
5380024|NCT00113152|Cardiac Arrhythmias|cardiac arrhythmias
5380025|NCT00113152|Diastolic Dysfunction|diastolic dysfunction
5380026|NCT00113152|Pulmonary Hypertension|pulmonary hypertension
5380027|NCT00113152|Sickle Cell Anemia|sickle cell anemia
5380028|NCT00113152|Sudden Death|sudden death
5380029|NCT00113152|Thalassemia|thalassemia
5380030|NCT00113126|Scheduled treatment interruptions|scheduled treatment interruptions
5380031|NCT00113126|STI|sti
5380032|NCT00113113|rubitecan|rubitecan
5380033|NCT00113113|Orathecin|orathecin
5380034|NCT00113113|9-nitrocamptothecin|9-nitrocamptothecin
5380035|NCT00113113|solid tumors|solid tumors
5380036|NCT00113113|organ dysfunction|organ dysfunction
5380037|NCT00113113|renal dysfunction|renal dysfunction
5380038|NCT00113113|hepatic dysfunction|hepatic dysfunction
5380039|NCT00113113|RFS 2000|rfs 2000
5380040|NCT00113100|skin|skin
5380041|NCT00113100|estrogen|estrogen
5380042|NCT00113100|sun damage|sun damage
5380043|NCT00113100|Photodamaged Skin|photodamaged skin
5380044|NCT00113061|Coronary Heart Disease Risk Reduction|coronary heart disease risk reduction
5380045|NCT00113048|CD52 Expressing Hematologic Malignancies|cd52 expressing hematologic malignancies
5380046|NCT00113035|Glycogen Storage Disease Type II|glycogen storage disease type ii
5380047|NCT00113035|GSD-II|gsd-ii
5380048|NCT00113035|Pompe Disease|pompe disease
5380049|NCT00113035|Pompe Disease (Late-Onset)|pompe disease (late-onset)
5380050|NCT00113035|Glycogen Storage Disease Type II (GSD-II)|glycogen storage disease type ii (gsd-ii)
5380051|NCT00113035|Acid Maltase Deficiency|acid maltase deficiency
5380052|NCT00113035|Glycogenosis 2|glycogenosis 2
5380053|NCT00113022|Depression|depression
5380054|NCT00113022|Glutamate|glutamate
5380055|NCT00113022|Ampakine|ampakine
5380056|NCT00113022|Treatment|treatment
5380057|NCT00113022|Memory|memory
5380058|NCT00113022|Major Depressive Disorder|major depressive disorder
5380059|NCT00113022|AMPA Receptor Activation|ampa receptor activation
5380060|NCT00113022|BDNF|bdnf
5380061|NCT00113009|Peripheral arterial disease|peripheral arterial disease
5380062|NCT00112996|neurotoxicity|neurotoxicity
5380063|NCT00112996|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5380064|NCT00112996|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
5380065|NCT00112983|adult acute lymphoblastic leukemia|adult acute lymphoblastic leukemia
5380066|NCT00112983|adult acute myeloid leukemia|adult acute myeloid leukemia
5380067|NCT00112957|fallopian tube cancer|fallopian tube cancer
5380068|NCT00112957|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
5380069|NCT00112957|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5380070|NCT00112957|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5380071|NCT00112957|peritoneal cavity cancer|peritoneal cavity cancer
5380072|NCT00112931|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5380073|NCT00112931|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5380074|NCT00112931|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5380075|NCT00112931|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5380076|NCT00112931|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5380077|NCT00112931|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5380078|NCT00112931|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5380079|NCT00112931|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5380080|NCT00112931|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5380081|NCT00112931|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
5380082|NCT00112931|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
5380083|NCT00112931|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
5380084|NCT00112918|stage II colon cancer|stage ii colon cancer
5380085|NCT00112918|stage III colon cancer|stage iii colon cancer
5380086|NCT00112892|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5380087|NCT00112775|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5380088|NCT00112775|chronic myelogenous leukemia, BCR-ABL1 positive|chronic myelogenous leukemia, bcr-abl1 positive
5380089|NCT00112775|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5380090|NCT00112749|stage I breast cancer|stage i breast cancer
5380091|NCT00112749|stage II breast cancer|stage ii breast cancer
5380092|NCT00112749|breast cancer in situ|breast cancer in situ
5380093|NCT00112749|fatigue|fatigue
5380094|NCT00112710|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5380095|NCT00112710|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5380646|NCT00110838|human|human
5380096|NCT00112697|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
5380097|NCT00112697|stage IV pancreatic cancer|stage iv pancreatic cancer
5380098|NCT00112658|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
5380099|NCT00112658|stage IV pancreatic cancer|stage iv pancreatic cancer
5380100|NCT00112645|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
5380101|NCT00112645|recurrent neuroblastoma|recurrent neuroblastoma
5380102|NCT00112645|recurrent Ewing sarcoma/peripheral primitive neuroectodermal tumor|recurrent ewing sarcoma/peripheral primitive neuroectodermal tumor
5380103|NCT00112645|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
5380104|NCT00112632|gastrointestinal stromal tumor|gastrointestinal stromal tumor
5380105|NCT00112619|AIDS-related diffuse large cell lymphoma|aids-related diffuse large cell lymphoma
5380106|NCT00112619|AIDS-related diffuse mixed cell lymphoma|aids-related diffuse mixed cell lymphoma
5380107|NCT00112619|AIDS-related diffuse small cleaved cell lymphoma|aids-related diffuse small cleaved cell lymphoma
5380108|NCT00112619|AIDS-related immunoblastic large cell lymphoma|aids-related immunoblastic large cell lymphoma
5380109|NCT00112619|AIDS-related lymphoblastic lymphoma|aids-related lymphoblastic lymphoma
5380110|NCT00112619|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
5380111|NCT00112619|AIDS-related primary CNS lymphoma|aids-related primary cns lymphoma
5380112|NCT00112619|AIDS-related small noncleaved cell lymphoma|aids-related small noncleaved cell lymphoma
5380113|NCT00112619|HIV-associated Hodgkin lymphoma|hiv-associated hodgkin lymphoma
5380114|NCT00112619|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
5380115|NCT00112619|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
5380116|NCT00112619|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
5380117|NCT00112619|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
5380118|NCT00112619|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
5380119|NCT00112619|primary central nervous system Hodgkin lymphoma|primary central nervous system hodgkin lymphoma
5380120|NCT00112619|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5380121|NCT00112619|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5380122|NCT00112619|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
5380123|NCT00112619|childhood grade I meningioma|childhood grade i meningioma
5380124|NCT00112619|childhood grade II meningioma|childhood grade ii meningioma
5380125|NCT00112619|childhood grade III meningioma|childhood grade iii meningioma
5380126|NCT00112619|recurrent childhood cerebellar astrocytoma|recurrent childhood cerebellar astrocytoma
5380127|NCT00112619|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
5380128|NCT00112619|childhood high-grade cerebral astrocytoma|childhood high-grade cerebral astrocytoma
5380129|NCT00112619|childhood low-grade cerebral astrocytoma|childhood low-grade cerebral astrocytoma
5380130|NCT00112619|childhood choroid plexus tumor|childhood choroid plexus tumor
5380131|NCT00112619|childhood craniopharyngioma|childhood craniopharyngioma
5380132|NCT00112619|childhood infratentorial ependymoma|childhood infratentorial ependymoma
5380133|NCT00112619|childhood supratentorial ependymoma|childhood supratentorial ependymoma
5380134|NCT00112619|recurrent childhood ependymoma|recurrent childhood ependymoma
5380135|NCT00112619|recurrent childhood medulloblastoma|recurrent childhood medulloblastoma
5380136|NCT00112619|childhood oligodendroglioma|childhood oligodendroglioma
5380137|NCT00112619|recurrent childhood supratentorial primitive neuroectodermal tumor|recurrent childhood supratentorial primitive neuroectodermal tumor
5380138|NCT00112619|leptomeningeal metastases|leptomeningeal metastases
5380139|NCT00112619|recurrent carcinoma of unknown primary|recurrent carcinoma of unknown primary
5380140|NCT00112619|childhood central nervous system germ cell tumor|childhood central nervous system germ cell tumor
5380141|NCT00112619|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
5380142|NCT00112619|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
5380143|NCT00112619|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
5380144|NCT00112619|recurrent childhood grade III lymphomatoid granulomatosis|recurrent childhood grade iii lymphomatoid granulomatosis
5380145|NCT00112619|recurrent childhood visual pathway and hypothalamic glioma|recurrent childhood visual pathway and hypothalamic glioma
5380146|NCT00112619|childhood atypical teratoid/rhabdoid tumor|childhood atypical teratoid/rhabdoid tumor
5380147|NCT00112619|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
5380148|NCT00112619|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
5380149|NCT00112619|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
5380150|NCT00112619|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5380151|NCT00112619|recurrent childhood pineoblastoma|recurrent childhood pineoblastoma
5380152|NCT00112619|recurrent childhood subependymal giant cell astrocytoma|recurrent childhood subependymal giant cell astrocytoma
5380153|NCT00112619|meningeal leukemia|meningeal leukemia
5380154|NCT00112619|secondary central nervous system Hodgkin lymphoma|secondary central nervous system hodgkin lymphoma
5380155|NCT00112619|secondary central nervous system non-Hodgkin lymphoma|secondary central nervous system non-hodgkin lymphoma
5380156|NCT00112593|HIV|hiv
5380157|NCT00112593|Lymphoma|lymphoma
5380158|NCT00112593|Leukemia|leukemia
5380159|NCT00112580|recurrent pancreatic cancer|recurrent pancreatic cancer
5380160|NCT00112580|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
5380161|NCT00112580|stage IV pancreatic cancer|stage iv pancreatic cancer
5380162|NCT00112567|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5380163|NCT00112567|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
5380164|NCT00112567|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
5380165|NCT00112567|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5380166|NCT00112567|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
5380167|NCT00112567|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5380168|NCT00112567|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5380169|NCT00112567|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5380170|NCT00112567|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
5380171|NCT00112567|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5380172|NCT00112567|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5380289|NCT00112151|hypogonadism|hypogonadism
5380173|NCT00112567|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5380174|NCT00112567|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5380175|NCT00112554|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5380176|NCT00112554|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5380177|NCT00112554|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5380178|NCT00112554|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5380179|NCT00112554|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5380180|NCT00112554|adult acute basophilic leukemia|adult acute basophilic leukemia
5380181|NCT00112554|adult acute eosinophilic leukemia|adult acute eosinophilic leukemia
5380182|NCT00112554|adult erythroleukemia (M6a)|adult erythroleukemia (m6a)
5380183|NCT00112554|adult pure erythroid leukemia (M6b)|adult pure erythroid leukemia (m6b)
5380184|NCT00112554|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
5380185|NCT00112554|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
5380186|NCT00112554|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
5380187|NCT00112554|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
5380188|NCT00112554|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
5380189|NCT00112554|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
5380190|NCT00112554|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
5380191|NCT00112528|duct cell adenocarcinoma of the pancreas|duct cell adenocarcinoma of the pancreas
5380192|NCT00112528|recurrent pancreatic cancer|recurrent pancreatic cancer
5380193|NCT00112528|stage IV pancreatic cancer|stage iv pancreatic cancer
5380194|NCT00112515|depression|depression
5380195|NCT00112515|cognitive/functional effects|cognitive/functional effects
5380196|NCT00112515|fatigue|fatigue
5380197|NCT00112515|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5380198|NCT00112502|adult giant cell glioblastoma|adult giant cell glioblastoma
5380199|NCT00112502|adult gliosarcoma|adult gliosarcoma
5380200|NCT00112502|adult glioblastoma|adult glioblastoma
5380201|NCT00112489|recurrent uterine sarcoma|recurrent uterine sarcoma
5380202|NCT00112489|stage III uterine sarcoma|stage iii uterine sarcoma
5380203|NCT00112489|stage IV uterine sarcoma|stage iv uterine sarcoma
5380204|NCT00112489|uterine carcinosarcoma|uterine carcinosarcoma
5380205|NCT00112424|Superior cavo-pulmonary anastomosis|superior cavo-pulmonary anastomosis
5380206|NCT00112424|Glenn operation|glenn operation
5380207|NCT00112424|Congenital heart defects|congenital heart defects
5380208|NCT00112424|Cardiac magnetic resonance imaging|cardiac magnetic resonance imaging
5380209|NCT00112398|Head injuries|head injuries
5380210|NCT00112398|Prehospital|prehospital
5380211|NCT00112398|Advanced Interventions|advanced interventions
5380212|NCT00112385|dermatomyositis|dermatomyositis
5380213|NCT00112385|etanercept|etanercept
5380214|NCT00112385|tumor necrosis factor alpha|tumor necrosis factor alpha
5380215|NCT00112372|unresectable|unresectable
5380216|NCT00112372|metastatic|metastatic
5380217|NCT00112372|cancer|cancer
5380218|NCT00112372|recurrent|recurrent
5380219|NCT00112372|malignancies|malignancies
5380220|NCT00112372|progressive|progressive
5380221|NCT00112359|Cystic Fibrosis|cystic fibrosis
5380222|NCT00112359|Pseudomonas aeruginosa|pseudomonas aeruginosa
5380223|NCT00112359|Pulmonary Cystic Fibrosis|pulmonary cystic fibrosis
5380224|NCT00112346|Non-Small Lung Cancer|non-small lung cancer
5380225|NCT00112333|Dyspepsia, fMRI|dyspepsia, fmri
5380226|NCT00112320|Pulmonary Valve Regurgitation|pulmonary valve regurgitation
5380227|NCT00112320|Right Ventricular Dysfunction|right ventricular dysfunction
5380228|NCT00112320|Heart Diseases|heart diseases
5380229|NCT00112307|MRI|mri
5380230|NCT00112307|Brachytherapy|brachytherapy
5380231|NCT00112307|Carcinoma|carcinoma
5380232|NCT00112307|Cervix|cervix
5380233|NCT00112307|Uterus|uterus
5380234|NCT00112307|Vagina|vagina
5380235|NCT00112307|Vulva|vulva
5380236|NCT00112307|Carcinoma of the cervix|carcinoma of the cervix
5380237|NCT00112307|Carcinoma of the uterus|carcinoma of the uterus
5380238|NCT00112307|Carcinoma of the vagina|carcinoma of the vagina
5380239|NCT00112307|Carcinoma of the vulva|carcinoma of the vulva
5380240|NCT00112294|Non-Small Cell Lung Cancer|non-small cell lung cancer
5380241|NCT00112281|"shock, cardiogenic, myocardial infarction"|"shock, cardiogenic, myocardial infarction"
5380242|NCT00112268|randomized controlled trial|randomized controlled trial
5380243|NCT00112268|primary health care|primary health care
5380244|NCT00112268|smoking cessation|smoking cessation
5380245|NCT00112255|Chlamydia trachomatis|chlamydia trachomatis
5380246|NCT00112255|Chlamydia infections|chlamydia infections
5380247|NCT00112255|Randomized controlled trials|randomized controlled trials
5380248|NCT00112255|Contact tracing|contact tracing
5380249|NCT00112255|Family practice|family practice
5380250|NCT00112242|Immunotherapy|immunotherapy
5380251|NCT00112242|Vaccination|vaccination
5380252|NCT00112242|Melanoma|melanoma
5380253|NCT00112242|Melan-A/Mart-1 peptide|melan-a/mart-1 peptide
5380254|NCT00112242|MAGE-A10 peptide|mage-a10 peptide
5380255|NCT00112242|NY-ESO-1 peptide|ny-eso-1 peptide
5380256|NCT00112242|Montanide|montanide
5380257|NCT00112229|Immunotherapy|immunotherapy
5380258|NCT00112229|Vaccination|vaccination
5380259|NCT00112229|Melanoma|melanoma
5380260|NCT00112229|Melan-A/Mart-1 peptide|melan-a/mart-1 peptide
5380261|NCT00112229|Tyrosinase peptide|tyrosinase peptide
5380262|NCT00112229|CpG|cpg
5380263|NCT00112229|Montanide|montanide
5380264|NCT00112216|Immunotherapy|immunotherapy
5380265|NCT00112216|Vaccination|vaccination
5380266|NCT00112216|Melanoma|melanoma
5380267|NCT00112216|Melan-A/Mart-1 peptide|melan-a/mart-1 peptide
5380268|NCT00112216|Flu peptide|flu peptide
5380269|NCT00112216|Mage-A10 peptide|mage-a10 peptide
5380270|NCT00112216|SB AS-2 adjuvant|sb as-2 adjuvant
5380271|NCT00112216|Montanide adjuvant|montanide adjuvant
5380272|NCT00112203|Abdominal Symptom Relief|abdominal symptom relief
5380273|NCT00112203|Fullness|fullness
5380274|NCT00112203|Bloating|bloating
5380275|NCT00112203|Indigestion|indigestion
5380276|NCT00112203|Functional dyspepsia|functional dyspepsia
5380277|NCT00112190|Functional dyspepsia|functional dyspepsia
5380278|NCT00112190|Abdominal Symptom relief|abdominal symptom relief
5380279|NCT00112190|Fullness|fullness
5380280|NCT00112190|Bloating|bloating
5380281|NCT00112190|Indigestion|indigestion
5380282|NCT00112177|Functional dyspepsia|functional dyspepsia
5380283|NCT00112177|Abdominal Symptom relief|abdominal symptom relief
5380284|NCT00112177|Fullness|fullness
5380285|NCT00112177|Bloating|bloating
5380286|NCT00112177|Indigestion|indigestion
5380287|NCT00112164|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
5380288|NCT00112151|andropause|andropause
5380290|NCT00112151|AndroGel|androgel
5380291|NCT00112151|exercise|exercise
5380292|NCT00112151|PRT|prt
5380293|NCT00112151|Testosterone|testosterone
5380294|NCT00112151|T supplementation|t supplementation
5380295|NCT00112138|gabapentin|gabapentin
5380296|NCT00112138|hot flashes or flushes|hot flashes or flushes
5380297|NCT00112138|menopause|menopause
5380298|NCT00112125|cardiac contractility modulation|cardiac contractility modulation
5380299|NCT00112125|heart failure|heart failure
5380300|NCT00112125|cardiopulmonary exercise test|cardiopulmonary exercise test
5380301|NCT00112125|chronic heart disease|chronic heart disease
5380302|NCT00112112|cancer, pediatric, influenza, vaccine|cancer, pediatric, influenza, vaccine
5380303|NCT00112099|gastric neoplasm|gastric neoplasm
5380304|NCT00112099|gastrectomy|gastrectomy
5380305|NCT00112099|splenectomy|splenectomy
5380306|NCT00112099|randomized trial|randomized trial
5380307|NCT00112099|T2, T3 and T4 carcinoma in the proximal third of the stomach|t2, t3 and t4 carcinoma in the proximal third of the stomach
5380308|NCT00112086|ovarian neoplasms|ovarian neoplasms
5380309|NCT00112086|laparoscopy|laparoscopy
5380310|NCT00112086|neoadjuvant therapy|neoadjuvant therapy
5380311|NCT00112086|interval cytoreductive surgery|interval cytoreductive surgery
5380312|NCT00112073|Alzheimer's disease|alzheimer's disease
5380313|NCT00112073|immunotherapy|immunotherapy
5380314|NCT00112073|beta amyloid|beta amyloid
5380315|NCT00112060|Talotrexin|talotrexin
5380316|NCT00112060|PT-523|pt-523
5380317|NCT00112060|Non-Small Cell Lung Carcinoma (NSCLC)|non-small cell lung carcinoma (nsclc)
5380318|NCT00112047|Human Immunodeficiency Virus|human immunodeficiency virus
5380319|NCT00112034|Multiple Sclerosis|multiple sclerosis
5380320|NCT00112034|Relapsing-Remitting|relapsing-remitting
5380321|NCT00112034|AVONEX|avonex
5380322|NCT00112034|Combination|combination
5380323|NCT00112034|Methotrexate|methotrexate
5380324|NCT00112034|IV Methylprednisolone|iv methylprednisolone
5380325|NCT00112034|IVMP|ivmp
5380326|NCT00112034|ACT|act
5380327|NCT00112034|MTX|mtx
5380328|NCT00112021|obesity|obesity
5380329|NCT00112021|weight loss|weight loss
5380330|NCT00112021|Amylin|amylin
5380331|NCT00112021|pramlintide|pramlintide
5380332|NCT00112021|Symlin|symlin
5380333|NCT00112008|Anemia|anemia
5380334|NCT00111995|Chronic Renal Failure (CRF)|chronic renal failure (crf)
5380335|NCT00111995|Anemia|anemia
5380336|NCT00111982|bilateral, idiopathic Parkinson's Disease|bilateral, idiopathic parkinson's disease
5380337|NCT00111969|Heart failure|heart failure
5380338|NCT00111969|Immune modulation therapy|immune modulation therapy
5380339|NCT00111969|Inflammation|inflammation
5380340|NCT00111969|Chronic systolic heart failure|chronic systolic heart failure
5380342|NCT00111956|metabolic syndrome|metabolic syndrome
5380343|NCT00111956|inflammation|inflammation
5380344|NCT00111956|CRP|crp
5380345|NCT00111956|adiponectin|adiponectin
5380346|NCT00111943|Anti-Infective Agents, Local|anti-infective agents, local
5380347|NCT00111943|HIV Seronegativity|hiv seronegativity
5380348|NCT00111943|Tenofovir|tenofovir
5380349|NCT00111943|Vaginal gel|vaginal gel
5380350|NCT00111943|Microbicide|microbicide
5380351|NCT00111943|Vaginal Microbicide|vaginal microbicide
5380352|NCT00111943|PMPA|pmpa
5380353|NCT00111930|dehydroepiandrosterone|dehydroepiandrosterone
5380354|NCT00111930|DHEAS|dheas
5380355|NCT00111930|bone mineral density|bone mineral density
5380356|NCT00111930|body composition|body composition
5380357|NCT00111930|lean mass|lean mass
5380358|NCT00111930|fat mass|fat mass
5380359|NCT00111930|bone mass|bone mass
5380360|NCT00111930|decreased DHEAS levels|decreased dheas levels
5380361|NCT00111917|Chronic Beryllium Disease|chronic beryllium disease
5380362|NCT00111917|Berylliosis|berylliosis
5380363|NCT00111917|Beryllium Disease|beryllium disease
5380364|NCT00111917|CBD|cbd
5380365|NCT00111917|Infliximab|infliximab
5380366|NCT00111904|stage III pancreatic cancer|stage iii pancreatic cancer
5380367|NCT00111904|recurrent pancreatic cancer|recurrent pancreatic cancer
5380368|NCT00111904|stage IV pancreatic cancer|stage iv pancreatic cancer
5380369|NCT00111878|Respiratory Syncytial Virus (RSV) and Parainfluenza Virus Type 3 (PIV3)|respiratory syncytial virus (rsv) and parainfluenza virus type 3 (piv3)
5380370|NCT00111865|physical exercise|physical exercise
5380371|NCT00111865|quality of life|quality of life
5380372|NCT00111865|lymphoma|lymphoma
5380373|NCT00111852|Desmoteplase|desmoteplase
5380374|NCT00111852|Acute Ischemic Stroke|acute ischemic stroke
5380375|NCT00111852|Stroke, Acute|stroke, acute
5380376|NCT00111839|Lung cancer|lung cancer
5380377|NCT00111826|Intermittent Claudication|intermittent claudication
5380378|NCT00111826|Peripheral Arterial Disease|peripheral arterial disease
5380379|NCT00111826|Immune modulation therapy|immune modulation therapy
5380380|NCT00111826|Inflammation|inflammation
5380381|NCT00111800|NIDDM|niddm
5380382|NCT00111787|breast cancer|breast cancer
5380383|NCT00111774|Colon Cancer, Rectal Cancer|colon cancer, rectal cancer
5380384|NCT00111774|Colorectal Carcinoma, EGFr|colorectal carcinoma, egfr
5380385|NCT00111774|Metastatic Cancer, ABX-EGF|metastatic cancer, abx-egf
5380386|NCT00111774|Panitumumab, Abgenix|panitumumab, abgenix
5380387|NCT00111774|Clinical Trial, Immunex, Amgen|clinical trial, immunex, amgen
5380388|NCT00111774|Metastatic Colorectal|metastatic colorectal
5380389|NCT00111761|Immunex|immunex
5380390|NCT00111761|Panitumumab|panitumumab
5380391|NCT00111761|ABX-EGF|abx-egf
5380392|NCT00111761|Abgenix|abgenix
5380393|NCT00111748|Myeloma|myeloma
5380394|NCT00111683|Myelodysplastic Syndrome[Refractory Anemia with|myelodysplastic syndrome[refractory anemia with
5380395|NCT00111683|Excess Blasts-1 or 2 (WHO Classification)]|excess blasts-1 or 2 (who classification)]
5380396|NCT00111683|Chronic Myelogenous Leukemia in blast crisis|chronic myelogenous leukemia in blast crisis
5380397|NCT00111657|Gout|gout
5380398|NCT00111657|Tophi|tophi
5380399|NCT00111657|Tophaceous gout|tophaceous gout
5380400|NCT00111657|Allergy to allopurinol|allergy to allopurinol
5380401|NCT00111657|Post-transplant gout|post-transplant gout
5380402|NCT00111618|vascular disrupting agent|vascular disrupting agent
5380403|NCT00111618|safety|safety
5380404|NCT00111618|tolerability|tolerability
5380405|NCT00111618|efficacy|efficacy
5380406|NCT00111618|hormone refractory prostate cancer|hormone refractory prostate cancer
5380407|NCT00111605|AIDS Vaccines|aids vaccines
5380408|NCT00111605|HIV Vaccines|hiv vaccines
5380409|NCT00111605|HIV Preventive Vaccine|hiv preventive vaccine
5380410|NCT00111605|HIV Seronegativity|hiv seronegativity
5380411|NCT00111592|BPH|bph
5380412|NCT00111592|benign prostatic hyperplasia|benign prostatic hyperplasia
5380413|NCT00111566|Percutaneous Coronary Intervention (PCI)|percutaneous coronary intervention (pci)
5380414|NCT00111566|Glycoprotein IIb/IIIa blockade|glycoprotein iib/iiia blockade
5380415|NCT00111566|Ischemic complications following PCI|ischemic complications following pci
5380416|NCT00111553|Leishmaniasis|leishmaniasis
5380417|NCT00111553|Subunit vaccine|subunit vaccine
5380418|NCT00111553|Therapeutic|therapeutic
5380419|NCT00111553|T cell|t cell
5380420|NCT00111553|Antimony|antimony
5380421|NCT00111540|exenatide|exenatide
5380422|NCT00111540|diabetes|diabetes
5380423|NCT00111540|Amylin|amylin
5380424|NCT00111540|exendin-4|exendin-4
5380425|NCT00111527|Heart failure|heart failure
5380426|NCT00111527|Atrial fibrillation|atrial fibrillation
5380427|NCT00111527|Cardiac resynchronization|cardiac resynchronization
5380428|NCT00111527|Cardiac pacing|cardiac pacing
5380429|NCT00111527|Catheter ablation|catheter ablation
5380430|NCT00111527|Quality of life|quality of life
5380431|NCT00111527|Echocardiography|echocardiography
5380432|NCT00111514|Leishmaniasis|leishmaniasis
5380433|NCT00111514|Subunit vaccine|subunit vaccine
5380434|NCT00111514|therapeutic|therapeutic
5380435|NCT00111514|T-cell|t-cell
5380436|NCT00111514|pentavalent antimony|pentavalent antimony
5380437|NCT00111501|smoking|smoking
5380438|NCT00111501|tobacco|tobacco
5380439|NCT00111488|atrial fibrillation|atrial fibrillation
5381756|NCT00107874|Maternal|maternal
5380440|NCT00111475|Immune Thrombocytopenic Purpura|immune thrombocytopenic purpura
5380441|NCT00111475|Idiopathic Thrombocytopenic Purpura|idiopathic thrombocytopenic purpura
5380442|NCT00111475|Thrombocytopenic|thrombocytopenic
5380443|NCT00111475|Thrombocytopenia|thrombocytopenia
5380444|NCT00111475|ITP|itp
5380445|NCT00111462|non-myeloid malignancy|non-myeloid malignancy
5380446|NCT00111462|chemotherapy-induced anemia|chemotherapy-induced anemia
5380447|NCT00111449|Psoriasis, adults|psoriasis, adults
5380448|NCT00111449|skin, Phase 3|skin, phase 3
5380449|NCT00111449|clinical trial, Amgen|clinical trial, amgen
5380450|NCT00111449|etanercept, Enbrel®|etanercept, enbrel®
5380451|NCT00111449|moderate, severe|moderate, severe
5380452|NCT00111436|Psoriasis, adults, skin|psoriasis, adults, skin
5380453|NCT00111436|Phase 3, clinical trial|phase 3, clinical trial
5380454|NCT00111436|Amgen, etanercept|amgen, etanercept
5380455|NCT00111436|Enbrel®, moderate|enbrel®, moderate
5380456|NCT00111436|severe, extension|severe, extension
5380457|NCT00111423|Rheumatoid Arthritis, Inflammation|rheumatoid arthritis, inflammation
5380458|NCT00111423|Pegsunercept, PEG sTNF-RI|pegsunercept, peg stnf-ri
5380459|NCT00111423|Autoimmune, Amgen|autoimmune, amgen
5380460|NCT00111423|Clinical Trials|clinical trials
5380461|NCT00111410|Rheumatoid Arthritis, Inflammation|rheumatoid arthritis, inflammation
5380462|NCT00111410|Interleukin-1 (IL-1), r-metHuIL-1ra|interleukin-1 (il-1), r-methuil-1ra
5380463|NCT00111410|Autoimmune, Kineret®|autoimmune, kineret®
5380464|NCT00111410|Anakinra, Immunex|anakinra, immunex
5380465|NCT00111410|Amgen, Clinical Trials|amgen, clinical trials
5380466|NCT00111397|Mycobacterial|mycobacterial
5380467|NCT00111397|Interferon|interferon
5380468|NCT00111397|GM-CSF|gm-csf
5380469|NCT00111397|Microarray|microarray
5380470|NCT00111397|Proteomics|proteomics
5380471|NCT00111397|Mycobacterium Avium Complex Infection|mycobacterium avium complex infection
5380472|NCT00111397|MAC|mac
5380473|NCT00111384|Phenotype|phenotype
5380474|NCT00111384|NF1-associated tumors|nf1-associated tumors
5380475|NCT00111384|NF1|nf1
5380476|NCT00111384|EQTL|eqtl
5380477|NCT00111384|Modifier Genes|modifier genes
5380478|NCT00111384|Neurofibroma|neurofibroma
5380479|NCT00111384|Neurofibromatosis Type 1|neurofibromatosis type 1
5380480|NCT00111371|artificial grammar learning|artificial grammar learning
5380481|NCT00111371|dyslexia|dyslexia
5380482|NCT00111371|healthy subjects|healthy subjects
5380483|NCT00111371|levodopa|levodopa
5380484|NCT00111371|drug|drug
5380485|NCT00111371|treatment|treatment
5380486|NCT00111371|intervention|intervention
5380487|NCT00111358|HIV, AIDS, metabolic syndrome|hiv, aids, metabolic syndrome
5380488|NCT00111345|Acute|acute
5380489|NCT00111345|myeloid|myeloid
5380490|NCT00111345|leukemia|leukemia
5380491|NCT00111345|Acute myeloid leukemia|acute myeloid leukemia
5380492|NCT00111319|Front Line|front line
5380493|NCT00111319|Multiple Myeloma|multiple myeloma
5380494|NCT00111319|Untreated|untreated
5380495|NCT00111306|Lupus|lupus
5380496|NCT00111306|Antibody|antibody
5380497|NCT00111306|B-cell immunotherapy|b-cell immunotherapy
5380498|NCT00111293|Attention|attention
5380499|NCT00111293|Executive Function|executive function
5380500|NCT00111293|Vision|vision
5380501|NCT00111293|fMRI|fmri
5380502|NCT00111293|Top-Down|top-down
5380503|NCT00111293|Visual Processing|visual processing
5380504|NCT00111293|Lesion|lesion
5380505|NCT00111293|Prefrontal|prefrontal
5380506|NCT00111293|Parietal|parietal
5380507|NCT00111293|Focal Brain Lesion|focal brain lesion
5380508|NCT00111293|Healthy Volunteer|healthy volunteer
5380509|NCT00111280|HIV infection|hiv infection
5380510|NCT00111280|TMC125|tmc125
5380511|NCT00111280|Nucleoside reverse transcriptase inhibitors (NRTIs)|nucleoside reverse transcriptase inhibitors (nrtis)
5380512|NCT00111280|roll-over trial|roll-over trial
5380513|NCT00111280|antiretrovirals (ARVs)|antiretrovirals (arvs)
5380514|NCT00111267|vitamin B12|vitamin b12
5380515|NCT00111267|cognitive function|cognitive function
5380516|NCT00111267|oral supplementation|oral supplementation
5380517|NCT00111267|elderly|elderly
5380518|NCT00111254|microdermabrasion|microdermabrasion
5380519|NCT00111254|skin|skin
5380520|NCT00111254|wrinkles|wrinkles
5380521|NCT00111254|collagen|collagen
5380522|NCT00111254|photoaging|photoaging
5380523|NCT00111254|wrinkled skin|wrinkled skin
5380524|NCT00111241|bone fracture|bone fracture
5380525|NCT00111241|cartilage|cartilage
5380526|NCT00111241|osteoporosis|osteoporosis
5380527|NCT00111241|breast cancer|breast cancer
5380528|NCT00111241|aromatase inhibitors|aromatase inhibitors
5380529|NCT00111241|knee articular cartilage volume|knee articular cartilage volume
5380530|NCT00111228|Diabetes|diabetes
5380531|NCT00111215|Menorrhagia|menorrhagia
5380532|NCT00111215|Von Willebrand's Disease|von willebrand's disease
5380533|NCT00111215|Platelet Disorder|platelet disorder
5380534|NCT00111202|Genetic counseling|genetic counseling
5380535|NCT00111202|Genetic counselling|genetic counselling
5380536|NCT00111202|Genetics|genetics
5380537|NCT00111202|Schizophrenia|schizophrenia
5380538|NCT00111189|Schizophrenia|schizophrenia
5380539|NCT00111189|Paliperidone palmitate|paliperidone palmitate
5380540|NCT00111189|R092670|r092670
5380541|NCT00111189|antipsychotic|antipsychotic
5380542|NCT00111189|recurrence prevention|recurrence prevention
5380543|NCT00111176|Thoracic Aortic Aneurysm|thoracic aortic aneurysm
5380544|NCT00111176|Descending|descending
5380545|NCT00111176|minimally invasive|minimally invasive
5380546|NCT00111176|endovascular|endovascular
5380547|NCT00111176|rupture|rupture
5380548|NCT00111176|back pain|back pain
5380549|NCT00111176|stent graft|stent graft
5380550|NCT00111176|endovascular aneurysm repair|endovascular aneurysm repair
5380551|NCT00111176|aortic aneurysm|aortic aneurysm
5380552|NCT00111176|thoracic|thoracic
5380553|NCT00111163|malaria|malaria
5380554|NCT00111163|anemia|anemia
5380555|NCT00111163|Plasmodium falciparum|plasmodium falciparum
5380556|NCT00111163|infants|infants
5380557|NCT00111163|prevention|prevention
5380558|NCT00111163|safety|safety
5380559|NCT00111163|efficacy|efficacy
5380560|NCT00111163|antimalarials|antimalarials
5380561|NCT00111150|HIV incidence|hiv incidence
5380562|NCT00111150|HIV prevention|hiv prevention
5380563|NCT00111137|darbepoetin alfa|darbepoetin alfa
5380564|NCT00111137|anemia|anemia
5380565|NCT00111137|Amgen|amgen
5380566|NCT00111137|Chemotherapy|chemotherapy
5380567|NCT00111124|psoriasis|psoriasis
5380568|NCT00111124|arthritis|arthritis
5380569|NCT00111124|Enbrel®|enbrel®
5380570|NCT00111124|etanercept|etanercept
5380571|NCT00111111|Psoriasis|psoriasis
5380572|NCT00111098|Anemia|anemia
5380573|NCT00111098|Chronic Kidney Disease (CKD)|chronic kidney disease (ckd)
5380574|NCT00111085|delayed ischemic neurological deficits (DIND)|delayed ischemic neurological deficits (dind)
5380575|NCT00111085|vasospasm|vasospasm
5380576|NCT00111085|clazosentan|clazosentan
5380577|NCT00111085|cerebral vasospasm|cerebral vasospasm
5380578|NCT00111085|computer tomography scan (CT scan)|computer tomography scan (ct scan)
5380579|NCT00111085|digital subtraction angiography (DSA)|digital subtraction angiography (dsa)
5380580|NCT00111085|endothelin A receptor|endothelin a receptor
5380581|NCT00111085|aneurysmal subarachnoid hemorrhage (aSAH)|aneurysmal subarachnoid hemorrhage (asah)
5380582|NCT00111059|obesity|obesity
5380583|NCT00111059|cardiovascular disease|cardiovascular disease
5380584|NCT00111059|depression|depression
5380585|NCT00111059|stress|stress
5380586|NCT00111046|Pain Relief|pain relief
5380587|NCT00111046|Choroidal melanoma|choroidal melanoma
5380588|NCT00111046|plaque radiotherapy|plaque radiotherapy
5380589|NCT00110981|psoriasis|psoriasis
5380590|NCT00110981|dermatology|dermatology
5380591|NCT00110981|plaque psoriasis|plaque psoriasis
5380592|NCT00110981|skin|skin
5380593|NCT00110981|etanercept|etanercept
5380594|NCT00110981|ENBREL|enbrel
5380595|NCT00110981|NB-UVB, narrow-band UVB, phototherapy|nb-uvb, narrow-band uvb, phototherapy
5380596|NCT00110981|combination therapy, 50 mg prefilled syringes|combination therapy, 50 mg prefilled syringes
5380597|NCT00110968|Abdominal Symptom relief|abdominal symptom relief
5380598|NCT00110968|Fullness|fullness
5380599|NCT00110968|Bloating|bloating
5380600|NCT00110968|Indigestion|indigestion
5380601|NCT00110968|Functional dyspepsia|functional dyspepsia
5380602|NCT00110955|Non-myeloid malignancy|non-myeloid malignancy
5380603|NCT00110955|Chemotherapy-induced anemia|chemotherapy-induced anemia
5380604|NCT00110942|Intra-articular|intra-articular
5380605|NCT00110942|Osteoarthritis|osteoarthritis
5380606|NCT00110942|OA|oa
5380607|NCT00110942|anakinra|anakinra
5380608|NCT00110942|Amgen|amgen
5380609|NCT00110929|Sensipar®|sensipar®
5380610|NCT00110929|Secondary HPT|secondary hpt
5380611|NCT00110929|Mimpara®|mimpara®
5380612|NCT00110929|Cinacalcet|cinacalcet
5380613|NCT00110929|calcimimetic|calcimimetic
5380614|NCT00110929|End-Stage Renal Disease (ESRD)|end-stage renal disease (esrd)
5380615|NCT00110916|Intra-articular|intra-articular
5380616|NCT00110916|Osteoarthritis|osteoarthritis
5380617|NCT00110916|OA|oa
5380618|NCT00110916|anakinra|anakinra
5380619|NCT00110916|Amgen|amgen
5380620|NCT00110903|Rheumatoid arthritis|rheumatoid arthritis
5380621|NCT00110903|RA|ra
5380622|NCT00110903|etanercept|etanercept
5380623|NCT00110903|Immunex|immunex
5380624|NCT00110903|Amgen|amgen
5380625|NCT00110890|Secondary HyperParaThyroidism (SHPT)|secondary hyperparathyroidism (shpt)
5380626|NCT00110890|Dialysis, End Stage Renal Disease (ESRD)|dialysis, end stage renal disease (esrd)
5380627|NCT00110890|KDOQI, Cinacalcet|kdoqi, cinacalcet
5380628|NCT00110890|Clinical Trial, Amgen|clinical trial, amgen
5380629|NCT00111072|Mucosal Disease|mucosal disease
5380630|NCT00111072|Topical Steroids|topical steroids
5380631|NCT00111072|Salivary Diagnostics|salivary diagnostics
5380632|NCT00111072|Oral Pain|oral pain
5380633|NCT00111072|Quality of Life Indicators|quality of life indicators
5380634|NCT00111072|Oral Lichen Planus|oral lichen planus
5380635|NCT00110877|Human Immunodeficiency Virus|human immunodeficiency virus
5380636|NCT00110877|Treatment Experienced|treatment experienced
5380637|NCT00110877|TMC114-C214|tmc114-c214
5380638|NCT00110864|diabetes, type 2|diabetes, type 2
5380639|NCT00110851|diabetes, type 2|diabetes, type 2
5380640|NCT00110838|fish oil|fish oil
5380641|NCT00110838|n-3 fatty acids|n-3 fatty acids
5380642|NCT00110838|n-3 PUFA|n-3 pufa
5380643|NCT00110838|omega-3 fatty acids|omega-3 fatty acids
5380644|NCT00110838|arrhythmia|arrhythmia
5380647|NCT00110838|Patients with an implantable cardioverter defibrillator|patients with an implantable cardioverter defibrillator
5380648|NCT00110812|Treatment Naive|treatment naive
5380649|NCT00110812|IL-2|il-2
5380650|NCT00110812|rIL-2|ril-2
5380651|NCT00110799|thrombopoietin|thrombopoietin
5380652|NCT00110799|platelets|platelets
5380653|NCT00110799|Hepatitis C-related thrombocytopenia|hepatitis c-related thrombocytopenia
5380654|NCT00110799|Hepatitis C|hepatitis c
5380655|NCT00110786|Allergy|allergy
5380656|NCT00110786|Specific Immunotherapy|specific immunotherapy
5380657|NCT00110786|Ragweed|ragweed
5380658|NCT00110786|Environmental Exposure Chamber|environmental exposure chamber
5380659|NCT00110721|colorectal cancer|colorectal cancer
5380660|NCT00110721|DAVANAT|davanat
5380661|NCT00110721|5-fluorouracil|5-fluorouracil
5380662|NCT00110708|autism|autism
5380663|NCT00110708|gastrointestinal dysfunction|gastrointestinal dysfunction
5380664|NCT00110708|autistic disorder|autistic disorder
5380665|NCT00110708|diarrhea|diarrhea
5380666|NCT00110708|constipation|constipation
5380667|NCT00110708|abdominal pain|abdominal pain
5380668|NCT00110708|gastrointestinal problems associated with autism|gastrointestinal problems associated with autism
5380669|NCT00110708|immune globulin|immune globulin
5380670|NCT00110708|immunoglobulin|immunoglobulin
5380671|NCT00110708|Immunoglobulins, Intravenous|immunoglobulins, intravenous
5380672|NCT00110708|Intestinal Mucosa/immunology/pathology|intestinal mucosa/immunology/pathology
5380673|NCT00110708|Administration, Oral|administration, oral
5380674|NCT00110708|Autistic Disorder/*drug therapy|autistic disorder/*drug therapy
5380675|NCT00110708|Child Behavior/*drug effects|child behavior/*drug effects
5380676|NCT00110708|Constipation/drug therapy|constipation/drug therapy
5380677|NCT00110708|Diarrhea/drug therapy|diarrhea/drug therapy
5380678|NCT00110708|Gastrointestinal Agents/*therapeutic use|gastrointestinal agents/*therapeutic use
5380679|NCT00110695|NSABP|nsabp
5380680|NCT00110695|Abraxis|abraxis
5380681|NCT00110695|Abraxane|abraxane
5380682|NCT00110695|Locally advanced breast cancer|locally advanced breast cancer
5380683|NCT00110695|Fluorouracil|fluorouracil
5380684|NCT00110695|Epirubicin|epirubicin
5380685|NCT00110695|Cyclophosphamide|cyclophosphamide
5380686|NCT00110695|FEC|fec
5380687|NCT00110682|Actinic Keratosis|actinic keratosis
5380688|NCT00110682|Cryotherapy|cryotherapy
5380689|NCT00110682|Imiquimod|imiquimod
5380690|NCT00110669|Muscular dystrophy, Duchenne and Beckers|muscular dystrophy, duchenne and beckers
5380691|NCT00110669|Beckers Muscular dystrophy|beckers muscular dystrophy
5380692|NCT00110656|Kidney transplant|kidney transplant
5380693|NCT00110643|Acne|acne
5380694|NCT00110643|laser|laser
5380695|NCT00110630|nicotine dependence|nicotine dependence
5380696|NCT00110617|Sickle Cell Disease|sickle cell disease
5380697|NCT00110617|Iron Overload from Repeated Blood Transfusions|iron overload from repeated blood transfusions
5380698|NCT00110617|Iron Overload|iron overload
5380699|NCT00110617|Blood Transfusions|blood transfusions
5380700|NCT00110604|Folic acid|folic acid
5380701|NCT00110604|Atherosclerosis|atherosclerosis
5380702|NCT00110604|Cognitive function|cognitive function
5380703|NCT00110604|Hearing|hearing
5380704|NCT00110604|Inflammation|inflammation
5380705|NCT00110604|Hemostasis|hemostasis
5380706|NCT00110604|Arterial stiffness|arterial stiffness
5380707|NCT00110578|Treatment Naive|treatment naive
5380708|NCT00110578|Treatment Experienced|treatment experienced
5380709|NCT00110565|Magnetics|magnetics
5380710|NCT00110565|Pulsed Magnetic Pad|pulsed magnetic pad
5380711|NCT00110565|Magnetic Field|magnetic field
5380712|NCT00110565|Electromagnetic Field|electromagnetic field
5380713|NCT00110565|Women|women
5380714|NCT00110565|Pulsed Magnetic Field|pulsed magnetic field
5380715|NCT00110539|Medicine, Herbal|medicine, herbal
5380716|NCT00110539|Dietary Supplements|dietary supplements
5380717|NCT00110539|Complementary and Alternative Medicine|complementary and alternative medicine
5380718|NCT00110539|Physicians|physicians
5380719|NCT00110526|Prostate Cancer|prostate cancer
5380720|NCT00110526|Radiation Therapy|radiation therapy
5380721|NCT00110526|Local recurrence|local recurrence
5380722|NCT00110526|Gene Therapy|gene therapy
5380723|NCT00110513|Antithrombin Deficiency, Congenital or Hereditary|antithrombin deficiency, congenital or hereditary
5380724|NCT00110513|Antithrombin III Deficiency|antithrombin iii deficiency
5380725|NCT00110513|ATIII|atiii
5380726|NCT00110513|Hereditary Antithrombin Deficiency (HD)|hereditary antithrombin deficiency (hd)
5380727|NCT00110500|Diabetes|diabetes
5380728|NCT00110500|Neuropathy|neuropathy
5380729|NCT00110487|Endometriosis|endometriosis
5380730|NCT00110474|Glucosamine sulfate|glucosamine sulfate
5380731|NCT00110474|Osteoarthritis|osteoarthritis
5380732|NCT00110474|Acetaminophen|acetaminophen
5380733|NCT00110474|Paracetamol|paracetamol
5380734|NCT00110474|Clinical trial|clinical trial
5380735|NCT00110461|Aripiprazole|aripiprazole
5380736|NCT00110461|Bipolar I Disorder, Manic or Mixed Episode with or without Psychotic Features|bipolar i disorder, manic or mixed episode with or without psychotic features
5380737|NCT00110448|type 2 diabetes|type 2 diabetes
5380738|NCT00110448|coronary heart diseases|coronary heart diseases
5380739|NCT00110448|primary prevention|primary prevention
5380740|NCT00110448|atherosclerosis|atherosclerosis
5380741|NCT00110448|aspirin|aspirin
5381757|NCT00107874|morbidity|morbidity
5380742|NCT00110422|Metabolic Syndrome|metabolic syndrome
5380743|NCT00110396|Multiple Sclerosis|multiple sclerosis
5380744|NCT00110396|Relapsing forms of multiple sclerosis|relapsing forms of multiple sclerosis
5380745|NCT00110344|Cancer|cancer
5380746|NCT00110331|Encephalopathy|encephalopathy
5380747|NCT00110331|Neuroimaging|neuroimaging
5380748|NCT00110331|Cognition|cognition
5380749|NCT00110331|Neuroinflammation|neuroinflammation
5380750|NCT00110331|Opportunistic Infections|opportunistic infections
5380751|NCT00110331|HIV|hiv
5380752|NCT00110331|Central Nervous System Disease|central nervous system disease
5380753|NCT00110331|Bipolar Disorder|bipolar disorder
5380754|NCT00110331|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
5380755|NCT00110331|ADHD|adhd
5380756|NCT00110331|Major Depression|major depression
5380757|NCT00110331|Psychosis|psychosis
5380758|NCT00110318|Tennis Elbow|tennis elbow
5380759|NCT00110318|Physical Therapy Techniques|physical therapy techniques
5380760|NCT00110318|Evidence-Based Medicine|evidence-based medicine
5380761|NCT00110318|Primary Health Care|primary health care
5380762|NCT00110305|Human Immunodeficiency Virus Type 1|human immunodeficiency virus type 1
5380763|NCT00110305|Human immunodeficiency virus (HIV)|human immunodeficiency virus (hiv)
5380764|NCT00110305|Antiretroviral|antiretroviral
5380765|NCT00110305|Antiviral|antiviral
5380766|NCT00110305|ARV|arv
5380767|NCT00110305|TMC278|tmc278
5380768|NCT00110305|Efavirenz|efavirenz
5380769|NCT00110305|Combivir|combivir
5380770|NCT00110305|Truvada|truvada
5380771|NCT00110305|Zidovudine|zidovudine
5380772|NCT00110305|Lamivudine|lamivudine
5380773|NCT00110305|Tenofovir disoproxil fumarate|tenofovir disoproxil fumarate
5380774|NCT00110305|Emtricitabine|emtricitabine
5380775|NCT00110292|Public health|public health
5380776|NCT00110292|Primary care|primary care
5380777|NCT00110292|Parenting education|parenting education
5380778|NCT00110292|Child rearing|child rearing
5380779|NCT00110292|Parenting newsletters|parenting newsletters
5380780|NCT00110292|Child development|child development
5380781|NCT00110292|Language delay|language delay
5380782|NCT00110279|Bird Flu|bird flu
5380783|NCT00110266|ICL670|icl670
5380784|NCT00110266|Deferasirox|deferasirox
5380785|NCT00110266|Iron chelation|iron chelation
5380786|NCT00110266|Chelator|chelator
5380787|NCT00110266|Desferal|desferal
5380788|NCT00110240|Type 2 diabetes|type 2 diabetes
5380789|NCT00110240|vildagliptin|vildagliptin
5380790|NCT00110227|Complementary Therapies|complementary therapies
5380791|NCT00110227|Tai Chi|tai chi
5380792|NCT00110201|Acute renal failure|acute renal failure
5380793|NCT00110201|Nesiritide|nesiritide
5380794|NCT00110201|Cardiovascular surgery|cardiovascular surgery
5380795|NCT00110188|prostate|prostate
5380797|NCT00110175|Cortical Reorganization|cortical reorganization
5380798|NCT00110175|Motor Function|motor function
5380799|NCT00110175|Somatosensory Stimulation|somatosensory stimulation
5380800|NCT00110175|Rehabilitation|rehabilitation
5380801|NCT00110175|Transcranial Direct Current Stimulation (tDCS)|transcranial direct current stimulation (tdcs)
5380802|NCT00110175|Direct Current Stimulation|direct current stimulation
5380803|NCT00110175|Stroke|stroke
5380804|NCT00110175|Healthy Volunteer|healthy volunteer
5380805|NCT00110162|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5380806|NCT00110162|stage I prostate cancer|stage i prostate cancer
5380807|NCT00110162|stage IIB prostate cancer|stage iib prostate cancer
5380808|NCT00110162|stage IIA prostate cancer|stage iia prostate cancer
5380809|NCT00110162|stage III prostate cancer|stage iii prostate cancer
5380810|NCT00110162|stage IV prostate cancer|stage iv prostate cancer
5380811|NCT00110162|recurrent prostate cancer|recurrent prostate cancer
5380812|NCT00110149|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
5380813|NCT00110149|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5380814|NCT00110149|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
5380815|NCT00110149|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5380816|NCT00110149|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5380817|NCT00110149|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
5380818|NCT00110149|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5380819|NCT00110149|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
5380820|NCT00110149|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5380821|NCT00110149|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5380822|NCT00110149|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
5380823|NCT00110149|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
5380824|NCT00110149|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5380825|NCT00110149|stage I marginal zone lymphoma|stage i marginal zone lymphoma
5380826|NCT00110149|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5380827|NCT00110149|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5380828|NCT00110149|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5380829|NCT00110149|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5381243|NCT00109616|newborn cleansing|newborn cleansing
5380830|NCT00110149|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
5380831|NCT00110149|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
5380832|NCT00110149|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
5380833|NCT00110149|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5380834|NCT00110149|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5380835|NCT00110136|recurrent breast cancer|recurrent breast cancer
5380836|NCT00110136|stage I breast cancer|stage i breast cancer
5380837|NCT00110136|stage II breast cancer|stage ii breast cancer
5380838|NCT00110136|stage IIIA breast cancer|stage iiia breast cancer
5380839|NCT00110136|stage IIIB breast cancer|stage iiib breast cancer
5380840|NCT00110136|breast cancer in situ|breast cancer in situ
5380841|NCT00110136|ductal breast carcinoma in situ|ductal breast carcinoma in situ
5380842|NCT00110136|hot flashes|hot flashes
5380843|NCT00110123|liver metastases|liver metastases
5380844|NCT00110123|ciliary body and choroid melanoma, medium/large size|ciliary body and choroid melanoma, medium/large size
5380845|NCT00110123|iris melanoma|iris melanoma
5380846|NCT00110123|extraocular extension melanoma|extraocular extension melanoma
5380847|NCT00110123|recurrent intraocular melanoma|recurrent intraocular melanoma
5380848|NCT00110123|metastatic intraocular melanoma|metastatic intraocular melanoma
5380849|NCT00110110|intraocular retinoblastoma|intraocular retinoblastoma
5380850|NCT00110084|recurrent breast cancer|recurrent breast cancer
5380851|NCT00110084|stage IV breast cancer|stage iv breast cancer
5380852|NCT00110058|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5380853|NCT00110058|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
5380854|NCT00110058|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5380855|NCT00110058|Philadelphia chromosome positive chronic myelogenous leukemia|philadelphia chromosome positive chronic myelogenous leukemia
5380856|NCT00110058|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5380857|NCT00110045|infection|infection
5380858|NCT00110045|ataxia-telangiectasia|ataxia-telangiectasia
5380859|NCT00110045|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5380860|NCT00110045|acute undifferentiated leukemia|acute undifferentiated leukemia
5380861|NCT00110045|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5380862|NCT00110045|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
5380863|NCT00110045|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5380864|NCT00110045|chronic eosinophilic leukemia|chronic eosinophilic leukemia
5380865|NCT00110045|primary myelofibrosis|primary myelofibrosis
5380866|NCT00110045|chronic neutrophilic leukemia|chronic neutrophilic leukemia
5380867|NCT00110045|essential thrombocythemia|essential thrombocythemia
5380868|NCT00110045|polycythemia vera|polycythemia vera
5380869|NCT00110045|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5380870|NCT00110045|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5380871|NCT00110045|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5380872|NCT00110045|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5380873|NCT00110045|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5380874|NCT00110045|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5380875|NCT00110045|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5380876|NCT00110045|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5380877|NCT00110045|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
5380878|NCT00110045|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
5380879|NCT00110045|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
5380880|NCT00110045|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
5380881|NCT00110045|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
5380882|NCT00110045|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5380883|NCT00110045|stage 0 chronic lymphocytic leukemia|stage 0 chronic lymphocytic leukemia
5380884|NCT00110045|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
5380885|NCT00110045|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
5380886|NCT00110045|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5380887|NCT00110045|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5380888|NCT00110045|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
5380889|NCT00110045|refractory hairy cell leukemia|refractory hairy cell leukemia
5380890|NCT00110045|prolymphocytic leukemia|prolymphocytic leukemia
5380891|NCT00110045|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5380892|NCT00110045|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
5380893|NCT00110045|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
5380894|NCT00110045|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5380895|NCT00110045|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5380896|NCT00110045|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5380897|NCT00110045|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
5380898|NCT00110045|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5381758|NCT00107874|mortality|mortality
5380899|NCT00110045|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
5380900|NCT00110045|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
5380901|NCT00110045|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
5380902|NCT00110045|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
5380903|NCT00110045|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5380904|NCT00110045|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
5380905|NCT00110045|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
5380906|NCT00110045|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
5380907|NCT00110045|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
5380908|NCT00110045|adult grade III lymphomatoid granulomatosis|adult grade iii lymphomatoid granulomatosis
5380909|NCT00110045|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
5380910|NCT00110045|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
5380911|NCT00110045|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5380912|NCT00110045|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5380913|NCT00110045|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5380914|NCT00110045|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5380915|NCT00110045|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5380916|NCT00110045|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5380917|NCT00110045|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5380918|NCT00110045|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5380919|NCT00110045|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5380920|NCT00110045|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5380921|NCT00110045|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5380922|NCT00110045|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5380923|NCT00110045|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5380924|NCT00110045|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5380925|NCT00110045|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
5380926|NCT00110045|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
5380927|NCT00110045|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
5380928|NCT00110045|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5380929|NCT00110045|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5380930|NCT00110045|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
5380931|NCT00110045|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5380932|NCT00110045|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
5380933|NCT00110045|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5380934|NCT00110045|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5380935|NCT00110045|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
5380936|NCT00110045|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
5380937|NCT00110045|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
5380938|NCT00110045|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5380939|NCT00110045|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5380940|NCT00110045|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
5380941|NCT00110045|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
5380942|NCT00110045|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
5380943|NCT00110045|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5380944|NCT00110045|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5380945|NCT00110045|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
5380946|NCT00110045|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
5380947|NCT00110045|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
5380948|NCT00110045|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5380949|NCT00110045|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5380950|NCT00110045|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
5380951|NCT00110045|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5380952|NCT00110045|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
5380953|NCT00110045|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5380954|NCT00110045|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5380955|NCT00110045|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
5380956|NCT00110045|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5380957|NCT00110045|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
5380958|NCT00110045|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5380959|NCT00110045|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5380960|NCT00110045|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
5380961|NCT00110045|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5380962|NCT00110045|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
5380963|NCT00110045|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5380964|NCT00110045|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5380965|NCT00110045|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
5380966|NCT00110045|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5380967|NCT00110045|stage I mantle cell lymphoma|stage i mantle cell lymphoma
5380968|NCT00110045|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5380969|NCT00110045|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5380970|NCT00110045|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
5380971|NCT00110045|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
5380972|NCT00110045|stage I marginal zone lymphoma|stage i marginal zone lymphoma
5380973|NCT00110045|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5380974|NCT00110045|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5380975|NCT00110045|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5380976|NCT00110045|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
5380977|NCT00110045|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
5380978|NCT00110045|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
5380979|NCT00110045|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5380980|NCT00110045|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5380981|NCT00110045|intraocular lymphoma|intraocular lymphoma
5380982|NCT00110045|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
5380983|NCT00110045|post-transplant lymphoproliferative disorder|post-transplant lymphoproliferative disorder
5380984|NCT00110045|extramedullary plasmacytoma|extramedullary plasmacytoma
5380985|NCT00110045|isolated plasmacytoma of bone|isolated plasmacytoma of bone
5380986|NCT00110045|monoclonal gammopathy of undetermined significance|monoclonal gammopathy of undetermined significance
5380987|NCT00110045|stage I multiple myeloma|stage i multiple myeloma
5380988|NCT00110045|stage II multiple myeloma|stage ii multiple myeloma
5380989|NCT00110045|stage III multiple myeloma|stage iii multiple myeloma
5380990|NCT00110045|primary systemic amyloidosis|primary systemic amyloidosis
5380991|NCT00110045|refractory multiple myeloma|refractory multiple myeloma
5380992|NCT00110045|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5380993|NCT00110045|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
5380994|NCT00110045|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5380995|NCT00110045|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5380996|NCT00110045|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
5380997|NCT00110045|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5380998|NCT00110045|disseminated neuroblastoma|disseminated neuroblastoma
5380999|NCT00110045|high risk metastatic gestational trophoblastic tumor|high risk metastatic gestational trophoblastic tumor
5381000|NCT00110045|recurrent neuroblastoma|recurrent neuroblastoma
5381001|NCT00110045|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5381002|NCT00110045|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
5381003|NCT00110045|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5381004|NCT00110045|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5381005|NCT00110045|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
5381006|NCT00110045|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
5381007|NCT00110045|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
5381008|NCT00110045|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5381009|NCT00110045|stage IIIA breast cancer|stage iiia breast cancer
5381010|NCT00110045|stage IIIB breast cancer|stage iiib breast cancer
5381011|NCT00110045|stage IIIC breast cancer|stage iiic breast cancer
5381012|NCT00110045|stage IV breast cancer|stage iv breast cancer
5381013|NCT00110045|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5381014|NCT00110045|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
5381015|NCT00110045|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
5381016|NCT00110045|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5381017|NCT00110045|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
5381018|NCT00110045|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5381019|NCT00110045|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5381020|NCT00110045|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
5381021|NCT00110006|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
5381022|NCT00110006|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5381023|NCT00110006|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
5381244|NCT00109616|umbilical cord care|umbilical cord care
5381024|NCT00110006|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5381025|NCT00110006|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5381026|NCT00110006|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
5381027|NCT00110006|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5381028|NCT00110006|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
5381029|NCT00110006|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5381030|NCT00110006|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5381031|NCT00110006|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
5381032|NCT00110006|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5381033|NCT00110006|stage I mantle cell lymphoma|stage i mantle cell lymphoma
5381034|NCT00110006|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5381035|NCT00110006|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5381036|NCT00110006|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5381037|NCT00109993|graft versus host disease|graft versus host disease
5381038|NCT00109993|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5381039|NCT00109993|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5381040|NCT00109993|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5381041|NCT00109993|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5381042|NCT00109993|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5381043|NCT00109993|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5381044|NCT00109993|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5381045|NCT00109993|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5381046|NCT00109993|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
5381047|NCT00109993|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5381048|NCT00109993|chronic eosinophilic leukemia|chronic eosinophilic leukemia
5381049|NCT00109993|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
5381050|NCT00109993|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5381051|NCT00109993|chronic neutrophilic leukemia|chronic neutrophilic leukemia
5381052|NCT00109993|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5381053|NCT00109993|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5381054|NCT00109993|disseminated neuroblastoma|disseminated neuroblastoma
5381055|NCT00109993|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5381056|NCT00109993|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
5381057|NCT00109993|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5381058|NCT00109993|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
5381059|NCT00109993|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5381060|NCT00109993|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
5381061|NCT00109993|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
5381062|NCT00109993|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
5381063|NCT00109993|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
5381064|NCT00109993|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5381065|NCT00109993|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5381066|NCT00109993|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5381067|NCT00109993|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5381068|NCT00109993|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
5381069|NCT00109993|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
5381070|NCT00109993|poor prognosis metastatic gestational trophoblastic tumor|poor prognosis metastatic gestational trophoblastic tumor
5381071|NCT00109993|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5381072|NCT00109993|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5381073|NCT00109993|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5381074|NCT00109993|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5381075|NCT00109993|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5381076|NCT00109993|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5381077|NCT00109993|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5381078|NCT00109993|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5381079|NCT00109993|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5381080|NCT00109993|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5381081|NCT00109993|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5381082|NCT00109993|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5381083|NCT00109993|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5381084|NCT00109993|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5381085|NCT00109993|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5381086|NCT00109993|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5381087|NCT00109993|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5381088|NCT00109993|recurrent neuroblastoma|recurrent neuroblastoma
5381089|NCT00109993|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5381090|NCT00109993|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
5381091|NCT00109993|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5381092|NCT00109993|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
5381093|NCT00109993|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5381094|NCT00109993|refractory multiple myeloma|refractory multiple myeloma
5381095|NCT00109993|refractory hairy cell leukemia|refractory hairy cell leukemia
5381096|NCT00109993|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5381097|NCT00109993|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5381098|NCT00109993|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5381099|NCT00109993|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5381100|NCT00109993|stage I multiple myeloma|stage i multiple myeloma
5381101|NCT00109993|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5381102|NCT00109993|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5381103|NCT00109993|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5381104|NCT00109993|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5381105|NCT00109993|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5381106|NCT00109993|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5381107|NCT00109993|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
5381108|NCT00109993|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5381109|NCT00109993|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5381110|NCT00109993|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5381111|NCT00109993|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5381112|NCT00109993|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5381113|NCT00109993|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5381114|NCT00109993|stage III multiple myeloma|stage iii multiple myeloma
5381115|NCT00109993|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5381116|NCT00109993|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5381117|NCT00109993|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
5381118|NCT00109993|stage IIIA breast cancer|stage iiia breast cancer
5381119|NCT00109993|stage IIIB breast cancer|stage iiib breast cancer
5381120|NCT00109993|stage IIIC breast cancer|stage iiic breast cancer
5381121|NCT00109993|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5381122|NCT00109993|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5381123|NCT00109993|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5381124|NCT00109993|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5381125|NCT00109993|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5381126|NCT00109993|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5381127|NCT00109993|stage IV breast cancer|stage iv breast cancer
5381128|NCT00109993|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5381129|NCT00109993|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5381130|NCT00109993|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5381131|NCT00109993|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5381132|NCT00109993|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5381133|NCT00109993|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5381134|NCT00109993|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5381135|NCT00109993|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5381136|NCT00109980|Complementary Therapies|complementary therapies
5381137|NCT00109980|Plants, Medicinal|plants, medicinal
5381138|NCT00109980|Dominican Republic|dominican republic
5381139|NCT00109980|Hispanic Americans|hispanic americans
5381140|NCT00109954|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
5381141|NCT00109954|advanced adult primary liver cancer|advanced adult primary liver cancer
5381142|NCT00109954|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
5381143|NCT00109954|recurrent adult primary liver cancer|recurrent adult primary liver cancer
5381144|NCT00109941|recurrent pancreatic cancer|recurrent pancreatic cancer
5381145|NCT00109941|stage III pancreatic cancer|stage iii pancreatic cancer
5381146|NCT00109941|stage IV pancreatic cancer|stage iv pancreatic cancer
5381147|NCT00109928|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5381148|NCT00109928|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5381149|NCT00109928|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
5381150|NCT00109928|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
5381151|NCT00109928|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
5381152|NCT00109928|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5381153|NCT00109928|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5381154|NCT00109928|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5381155|NCT00109928|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5381156|NCT00109889|extramedullary plasmacytoma|extramedullary plasmacytoma
5381157|NCT00109889|isolated plasmacytoma of bone|isolated plasmacytoma of bone
5381158|NCT00109876|stage I non-small cell lung cancer|stage i non-small cell lung cancer
5381159|NCT00109863|recurrent melanoma|recurrent melanoma
5381160|NCT00109863|stage IV melanoma|stage iv melanoma
5381161|NCT00109850|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
5381162|NCT00109850|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
5381163|NCT00109850|stage III esophageal cancer|stage iii esophageal cancer
5381164|NCT00109837|L1 adult acute lymphoblastic leukemia|l1 adult acute lymphoblastic leukemia
5381165|NCT00109837|L2 adult acute lymphoblastic leukemia|l2 adult acute lymphoblastic leukemia
5381166|NCT00109837|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
5381167|NCT00109798|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
5381168|NCT00109798|primary central nervous system Hodgkin lymphoma|primary central nervous system hodgkin lymphoma
5381169|NCT00109785|stage IIIA breast cancer|stage iiia breast cancer
5381170|NCT00109785|stage IIIB breast cancer|stage iiib breast cancer
5381297|NCT00109486|children|children
5381171|NCT00109785|stage IIIC breast cancer|stage iiic breast cancer
5381172|NCT00109785|male breast cancer|male breast cancer
5381173|NCT00109772|CRPS|crps
5381174|NCT00109772|RSDS|rsds
5381175|NCT00109772|Pain|pain
5381176|NCT00109772|CC-5013|cc-5013
5381177|NCT00109772|Revlimid|revlimid
5381178|NCT00109772|Complex Regional Pain Syndrome|complex regional pain syndrome
5381179|NCT00109772|Reflex Sympathy Dystrophy Syndrome|reflex sympathy dystrophy syndrome
5381180|NCT00109772|Lenalidomide|lenalidomide
5381181|NCT00109772|CRPS Type I|crps type i
5381182|NCT00109772|Celgene|celgene
5381183|NCT00109759|allergy|allergy
5381184|NCT00109759|allergoid|allergoid
5381185|NCT00109759|specific immunotherapy|specific immunotherapy
5381186|NCT00109759|ragweed|ragweed
5381187|NCT00109746|HIV|hiv
5381188|NCT00109746|Treatment Experienced|treatment experienced
5381189|NCT00109746|Anti-Retroviral Agents|anti-retroviral agents
5381190|NCT00109746|Antiretroviral Therapy, Highly Active|antiretroviral therapy, highly active
5381191|NCT00109746|Picolinic acid|picolinic acid
5381192|NCT00109746|Dietary Supplements|dietary supplements
5381193|NCT00109733|Childhood-onset growth hormone deficiency (COGHD)|childhood-onset growth hormone deficiency (coghd)
5381194|NCT00109733|Saizen®|saizen®
5381195|NCT00109720|Diabetes|diabetes
5381196|NCT00109720|Self Management|self management
5381197|NCT00109720|Type 2 diabetes|type 2 diabetes
5381198|NCT00109707|CML in blast crisis|cml in blast crisis
5381199|NCT00109707|CML in chronic phase|cml in chronic phase
5381200|NCT00109707|CML in accelerated phase|cml in accelerated phase
5381201|NCT00109707|Gleevec resistance|gleevec resistance
5381202|NCT00109707|Gleevec intolerant|gleevec intolerant
5381203|NCT00109707|Gleevec and CML|gleevec and cml
5381204|NCT00109707|imatinib resistance|imatinib resistance
5381205|NCT00109707|imatinib intolerant|imatinib intolerant
5381206|NCT00109707|Hypereosinophilic Syndrome|hypereosinophilic syndrome
5381207|NCT00109707|Systemic Mastocytosis|systemic mastocytosis
5381208|NCT00109707|Chronic eosinophilic syndrome|chronic eosinophilic syndrome
5381209|NCT00109707|Philadelphia chromosome positive acute lymphoblastic leukemia|philadelphia chromosome positive acute lymphoblastic leukemia
5381210|NCT00109707|HES|hes
5381211|NCT00109707|CEL|cel
5381212|NCT00109707|CML|cml
5381213|NCT00109707|SM|sm
5381214|NCT00109707|Ph+ ALL refractory to standard therapy|ph+ all refractory to standard therapy
5381215|NCT00109707|Ph+ALL relapsed|ph+all relapsed
5381216|NCT00109707|AMN107A|amn107a
5381217|NCT00109681|ACTIVE|active
5381218|NCT00109681|iloprost|iloprost
5381219|NCT00109681|idiopathic pulmonary fibrosis|idiopathic pulmonary fibrosis
5381220|NCT00109681|pulmonary arterial hypertension|pulmonary arterial hypertension
5381221|NCT00109655|Superficial Transitional Cell Carcinoma|superficial transitional cell carcinoma
5381222|NCT00109655|Bacillus Calmette-Guerin (BCG)|bacillus calmette-guerin (bcg)
5381223|NCT00109655|Superficial Bladder Cancer|superficial bladder cancer
5381224|NCT00109655|Gene Therapy|gene therapy
5381225|NCT00109655|Vaccine|vaccine
5381226|NCT00109655|Adenovirus|adenovirus
5381227|NCT00109655|Carcinoma in situ|carcinoma in situ
5381228|NCT00109642|Amygdala|amygdala
5381229|NCT00109642|Orbitofrontal Cortex|orbitofrontal cortex
5381230|NCT00109642|Yohimbine|yohimbine
5381231|NCT00109642|Emotion|emotion
5381232|NCT00109642|Guanfacine|guanfacine
5381233|NCT00109642|Norepinephrine|norepinephrine
5381234|NCT00109642|Healthy Volunteer|healthy volunteer
5381235|NCT00109629|HIV-Negative|hiv-negative
5381236|NCT00109629|Healthy|healthy
5381237|NCT00109629|Immunity|immunity
5381238|NCT00109629|Preventive|preventive
5381239|NCT00109629|Virus|virus
5381240|NCT00109629|Healthy Volunteer|healthy volunteer
5381241|NCT00109616|neonatal mortality|neonatal mortality
5381242|NCT00109616|chlorhexidine|chlorhexidine
5381245|NCT00109616|community-based trial|community-based trial
5381246|NCT00109616|prevention trial|prevention trial
5381247|NCT00109616|omphalitis|omphalitis
5381248|NCT00109603|Treatment Experienced|treatment experienced
5381249|NCT00109603|TDF|tdf
5381250|NCT00109590|HIV Seronegativity|hiv seronegativity
5381251|NCT00109590|Treatment Naive|treatment naive
5381252|NCT00109590|Pregnancy|pregnancy
5381253|NCT00109590|Perinatal Transmission|perinatal transmission
5381254|NCT00109590|Vertical Transmission|vertical transmission
5381255|NCT00109590|Mother-To-Child Transmission|mother-to-child transmission
5381256|NCT00109590|MTCT|mtct
5381257|NCT00109577|bipolar disorder|bipolar disorder
5381258|NCT00109577|mood disorders|mood disorders
5381259|NCT00109577|manic depression|manic depression
5381260|NCT00109577|nutrition|nutrition
5381261|NCT00109564|AAMI|aami
5381262|NCT00109564|Memory Impairment|memory impairment
5381263|NCT00109564|Decline in Cognitive Function|decline in cognitive function
5381264|NCT00109564|Age Associated Memory Impairment|age associated memory impairment
5381265|NCT00109551|zinc|zinc
5381266|NCT00109551|child mortality|child mortality
5381267|NCT00109551|child morbidity|child morbidity
5381268|NCT00109551|community trial|community trial
5381269|NCT00109551|prevention trial|prevention trial
5381270|NCT00109551|dietary supplement|dietary supplement
5381271|NCT00109538|Lonafarnib|lonafarnib
5381272|NCT00109525|NICHD Neonatal Research Network|nichd neonatal research network
5381273|NCT00109525|Fungal Infection|fungal infection
5381274|NCT00109525|Mycosis|mycosis
5381275|NCT00109525|Extremely Low Birth Weight (ELBW)|extremely low birth weight (elbw)
5381276|NCT00109525|Prematurity|prematurity
5381277|NCT00109525|Clinical Judgement|clinical judgement
5381278|NCT00109525|Polymerase chain reaction (PCR) testing|polymerase chain reaction (pcr) testing
5381279|NCT00109525|Beta-glucan assay|beta-glucan assay
5381280|NCT00109525|Mass Spectrometry|mass spectrometry
5381281|NCT00109525|Lumbar puncture|lumbar puncture
5381282|NCT00109512|endometriosis|endometriosis
5381283|NCT00109512|pelvic pain|pelvic pain
5381284|NCT00109512|painful periods|painful periods
5381285|NCT00109512|dysmenorrhea|dysmenorrhea
5381286|NCT00109512|painful menstruation|painful menstruation
5381287|NCT00109512|GnRH|gnrh
5381288|NCT00109512|agonist|agonist
5381289|NCT00109512|antagonist|antagonist
5381290|NCT00109512|menstrual pain|menstrual pain
5381291|NCT00109499|Wet Age-Related Macular Degeneration|wet age-related macular degeneration
5381292|NCT00109499|Age-Related Maculopathies|age-related maculopathies
5381293|NCT00109486|GW685698X|gw685698x
5381294|NCT00109486|seasonal allergic rhinitis|seasonal allergic rhinitis
5381295|NCT00109486|perennial allergic rhinitis|perennial allergic rhinitis
5381296|NCT00109486|knemometry|knemometry
5381298|NCT00109473|Pediatric Crohn's disease|pediatric crohn's disease
5381299|NCT00109473|Pediatric|pediatric
5381300|NCT00109473|Crohn's Disease|crohn's disease
5381301|NCT00024635|Screening|screening
5381302|NCT00024635|Psychiatric History|psychiatric history
5381303|NCT00024635|Medical History|medical history
5381304|NCT00024635|Diagnostic Evaluation|diagnostic evaluation
5381305|NCT00024635|Natural History|natural history
5381307|NCT00024635|HV|hv
5381308|NCT00024635|Healthy Volunteer|healthy volunteer
5381309|NCT00024635|Normal Control|normal control
5381310|NCT00024635|Mood Disorder|mood disorder
5381311|NCT00024635|PTSD|ptsd
5381312|NCT00024635|Post-Traumatic Stress Disorder|post-traumatic stress disorder
5381313|NCT00109460|Tobacco|tobacco
5381314|NCT00109434|exercise|exercise
5381315|NCT00109434|hypoglycemia|hypoglycemia
5381316|NCT00109434|Diabetes Mellitus, Type I|diabetes mellitus, type i
5381317|NCT00109434|glucose monitoring|glucose monitoring
5381318|NCT00109421|adolescent|adolescent
5381319|NCT00109421|female|female
5381320|NCT00109421|community-based|community-based
5381321|NCT00109421|social network|social network
5381322|NCT00109421|HIV/STI intervention|hiv/sti intervention
5381323|NCT00109421|High HIV-risk African American adolescent females|high hiv-risk african american adolescent females
5381324|NCT00109395|Lorazepam|lorazepam
5381325|NCT00109395|Midazolam|midazolam
5381326|NCT00109395|Best Pharmaceuticals for Children Act|best pharmaceuticals for children act
5381327|NCT00109395|Critically ill|critically ill
5381328|NCT00109395|pediatrics|pediatrics
5381329|NCT00109395|mechanical ventilation|mechanical ventilation
5381330|NCT00109395|sedation|sedation
5381331|NCT00109382|Transient Ischemic Attack|transient ischemic attack
5381332|NCT00109382|Stroke|stroke
5381333|NCT00109382|Stroke Prevention|stroke prevention
5381334|NCT00109382|Recurrence|recurrence
5381335|NCT00109382|Neuroprotection|neuroprotection
5381336|NCT00109382|Antiplatelet Therapy|antiplatelet therapy
5381337|NCT00109382|Statins|statins
5381338|NCT00109369|Chronic Disease|chronic disease
5381339|NCT00109369|Multi-Hospital Information Systems|multi-hospital information systems
5381340|NCT00109369|Clinical Decision Support Systems|clinical decision support systems
5381341|NCT00109369|Reminder Systems|reminder systems
5381342|NCT00109369|Registries|registries
5381343|NCT00109369|Quality of Healthcare|quality of healthcare
5381344|NCT00109369|Guideline Adherence|guideline adherence
5381345|NCT00109369|Outcome and Process Assessment (Health Care)|outcome and process assessment (health care)
5381346|NCT00109369|Technology Assessment, Biomedical|technology assessment, biomedical
5381347|NCT00109369|Primary Health Care|primary health care
5381348|NCT00109369|Hypercholesterolemia|hypercholesterolemia
5381349|NCT00109369|Hypertension|hypertension
5381350|NCT00109369|Hyperglycemia|hyperglycemia
5381351|NCT00109356|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
5381352|NCT00109356|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
5381353|NCT00109356|Small Lymphocytic Leukemia|small lymphocytic leukemia
5381354|NCT00109330|Prevention of Diphtheria, Tetanus, Pertussis|prevention of diphtheria, tetanus, pertussis
5381355|NCT00109317|Moderate Plaque Psoriasis|moderate plaque psoriasis
5381356|NCT00109317|Severe Plaque Psoriasis|severe plaque psoriasis
5381357|NCT00109317|Topical|topical
5381358|NCT00109304|Venezuelan Equine Encephalitis|venezuelan equine encephalitis
5381359|NCT00109304|VEE|vee
5381360|NCT00109304|Vaccine|vaccine
5381361|NCT00109304|Provide protective immunity against VEE subtypes IA/B|provide protective immunity against vee subtypes ia/b
5381362|NCT00109291|anemia|anemia
5381363|NCT00109291|chronic kidney disease|chronic kidney disease
5381364|NCT00109291|CKD|ckd
5381365|NCT00109291|chronic renal failure|chronic renal failure
5381366|NCT00109291|CRF|crf
5381367|NCT00109291|dialysis|dialysis
5381368|NCT00109291|erythropoietin|erythropoietin
5381369|NCT00109291|EPO|epo
5381370|NCT00109291|erythropoiesis stimulating agent|erythropoiesis stimulating agent
5381371|NCT00109291|ESA|esa
5381372|NCT00109291|Hematide™|hematide™
5381373|NCT00109291|hemoglobin|hemoglobin
5381374|NCT00109291|Hb|hb
5381375|NCT00109291|Hgb|hgb
5381376|NCT00109291|Omontys|omontys
5381377|NCT00109291|peginesatide|peginesatide
5381378|NCT00109291|red blood cell|red blood cell
5381379|NCT00109291|red blood cell production|red blood cell production
5381380|NCT00109278|Prevention of Measles|prevention of measles
5381381|NCT00109265|Advanced Breast Cancer|advanced breast cancer
5381382|NCT00109265|Metastatic Breast Cancer|metastatic breast cancer
5381383|NCT00109265|Cancer|cancer
5381384|NCT00109252|Plaque Psoriasis|plaque psoriasis
5381385|NCT00109252|Topical|topical
5381386|NCT00109239|Metastatic Breast Cancer|metastatic breast cancer
5381387|NCT00109239|Metastatic|metastatic
5381388|NCT00109239|Cancer|cancer
5381389|NCT00109226|Metastatic Colorectal Cancer|metastatic colorectal cancer
5381390|NCT00109226|Cancer|cancer
5381391|NCT00109213|Spinal Stenosis|spinal stenosis
5381392|NCT00109213|Lumbar Spine|lumbar spine
5381393|NCT00109213|Decompression|decompression
5381394|NCT00109213|Fusion|fusion
5381395|NCT00109213|Spondylolisthesis|spondylolisthesis
5381396|NCT00109213|Prospective, randomized clinical trial|prospective, randomized clinical trial
5381397|NCT00109200|Allergic Asthma|allergic asthma
5381398|NCT00109200|Severe Allergic Asthma|severe allergic asthma
5381399|NCT00109187|Moderate Persistent Asthma|moderate persistent asthma
5381400|NCT00109187|Severe Persistent Asthma|severe persistent asthma
5381401|NCT00109174|Glutamate|glutamate
5381402|NCT00109174|Excitatory Amino Acid|excitatory amino acid
5381403|NCT00109174|Neurochemistry|neurochemistry
5381404|NCT00109174|GABA|gaba
5381405|NCT00109174|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
5381406|NCT00109161|Multiple Sclerosis, MS, CNS, Daclizumab|multiple sclerosis, ms, cns, daclizumab
5381407|NCT00109148|Obesity and obesity-related medical conditions|obesity and obesity-related medical conditions
5381408|NCT00109083|Migraine|migraine
5381409|NCT00109083|Headaches|headaches
5381410|NCT00109083|Migraine headaches|migraine headaches
5381411|NCT00109083|Head pain|head pain
5381412|NCT00109070|Metastatic|metastatic
5381413|NCT00109057|Cancer|cancer
5381414|NCT00109057|Advanced malignancies|advanced malignancies
5381415|NCT00109044|Depression|depression
5381416|NCT00109044|Major Depressive Disorder|major depressive disorder
5381417|NCT00109044|Escitalopram|escitalopram
5381418|NCT00109031|Cancer|cancer
5381419|NCT00109031|Oncology|oncology
5381420|NCT00109018|Risk Assessment|risk assessment
5381421|NCT00109018|Coronary Heart Disease|coronary heart disease
5381422|NCT00109018|Vascular Function|vascular function
5381423|NCT00109018|Nitric Oxide Metabolites|nitric oxide metabolites
5381424|NCT00109018|Blood Tests|blood tests
5381425|NCT00109018|Nitrite|nitrite
5381426|NCT00109018|Flow-Mediated Dilation|flow-mediated dilation
5381427|NCT00109018|Biomarker|biomarker
5381428|NCT00109018|Endothelial Dysfunction|endothelial dysfunction
5381429|NCT00109018|Coronary Artery Disease|coronary artery disease
5381430|NCT00109018|CAD|cad
5381431|NCT00109018|Coronary Artery Disease At Risk|coronary artery disease at risk
5381432|NCT00109018|Healthy Volunteer|healthy volunteer
5381433|NCT00109005|Response Rate|response rate
5381434|NCT00109005|Toxicity|toxicity
5381435|NCT00109005|Progression-Free Survival|progression-free survival
5381436|NCT00109005|Overall Survival|overall survival
5381437|NCT00109005|Pharmacokinetic|pharmacokinetic
5381438|NCT00109005|Ocular Melanoma|ocular melanoma
5381439|NCT00108992|topical NSAID|topical nsaid
5381440|NCT00108992|topical diclofenac|topical diclofenac
5381441|NCT00108979|Depression|depression
5381442|NCT00108979|Major Depressive Disorder|major depressive disorder
5381443|NCT00108979|Escitalopram|escitalopram
5381444|NCT00108953|Cancer|cancer
5381445|NCT00108953|Liver Cancer|liver cancer
5381446|NCT00108953|Hepatocellular carcinoma|hepatocellular carcinoma
5381447|NCT00108953|HCC|hcc
5381448|NCT00108940|stroke|stroke
5381449|NCT00108940|ischemic stroke|ischemic stroke
5381450|NCT00108940|siblings|siblings
5381451|NCT00108927|Clinical trial|clinical trial
5381452|NCT00108927|Diabetes|diabetes
5381453|NCT00108927|Quality Improvement|quality improvement
5381454|NCT00108914|Perennial allergic rhinitis|perennial allergic rhinitis
5381455|NCT00108914|pediatric|pediatric
5381456|NCT00108901|prevention|prevention
5381457|NCT00108901|children|children
5381458|NCT00108901|diabetes|diabetes
5381459|NCT00108901|overweight|overweight
5381460|NCT00108901|obesity|obesity
5381461|NCT00108901|metabolic syndrome|metabolic syndrome
5381462|NCT00108901|exercise|exercise
5381463|NCT00108901|insulin resistance|insulin resistance
5381464|NCT00108901|female|female
5381465|NCT00108901|male|male
5381466|NCT00108901|black, African-American|black, african-american
5381467|NCT00108901|white, Caucasian|white, caucasian
5381468|NCT00108901|cognition|cognition
5381469|NCT00108901|executive function|executive function
5381470|NCT00108875|Peptide vaccine therapy|peptide vaccine therapy
5381471|NCT00108875|Survivin|survivin
5381472|NCT00108862|Treatment Naive|treatment naive
5381473|NCT00108862|TB|tb
5381474|NCT00108862|HIV|hiv
5381475|NCT00108862|Antiretroviral Agents|antiretroviral agents
5381476|NCT00108862|Strategy Study|strategy study
5381477|NCT00108836|GAD|gad
5381478|NCT00108836|Anxiety|anxiety
5381479|NCT00108836|XBD173|xbd173
5381480|NCT00108836|Generalized Anxiety Disorder|generalized anxiety disorder
5381481|NCT00108810|Pain|pain
5381482|NCT00108810|Osteoarthritis|osteoarthritis
5381483|NCT00108810|OA|oa
5381484|NCT00108810|Mild to Moderate Osteoarthritis (OA) Pain of the Knee|mild to moderate osteoarthritis (oa) pain of the knee
5381485|NCT00108784|reduced-energy-density diet|reduced-energy-density diet
5381486|NCT00108784|fat-restricted diet|fat-restricted diet
5381487|NCT00108784|fruit|fruit
5381488|NCT00108784|vegetables|vegetables
5381489|NCT00108784|ad libitum intake|ad libitum intake
5381490|NCT00108784|weight loss|weight loss
5381491|NCT00108784|obesity|obesity
5381492|NCT00108771|Pain|pain
5381493|NCT00108771|Chronic Pain|chronic pain
5381494|NCT00108771|Osteoarthritis Pain|osteoarthritis pain
5381495|NCT00108771|Osteoarthritis|osteoarthritis
5381496|NCT00108706|Acute Stroke|acute stroke
5381497|NCT00108706|Cerebrovascular Accident|cerebrovascular accident
5381498|NCT00108706|Ischaemic Stroke|ischaemic stroke
5381499|NCT00108706|Candesartan|candesartan
5381500|NCT00108706|Angiotensin Receptor Blocker|angiotensin receptor blocker
5381501|NCT00108680|Hemiparesis|hemiparesis
5381502|NCT00108680|Rehabilitation|rehabilitation
5381503|NCT00108680|Reaching|reaching
5381504|NCT00108680|Interlimb Coupling|interlimb coupling
5381505|NCT00108680|Cortical Excitability|cortical excitability
5381506|NCT00108680|Stroke|stroke
5381507|NCT00108667|Parkinson's Disease|parkinson's disease
5381508|NCT00108667|AMPA Antagonist|ampa antagonist
5381509|NCT00108667|Dyskinesias|dyskinesias
5381510|NCT00108667|Glutamate Antagonist|glutamate antagonist
5381511|NCT00108667|Parkinson Disease|parkinson disease
5381512|NCT00108667|PD|pd
5381513|NCT00108654|HIV-Negative|hiv-negative
5381514|NCT00108654|Healthy|healthy
5381515|NCT00108654|Immunity|immunity
5381516|NCT00108654|Preventive|preventive
5381517|NCT00108654|Virus|virus
5381518|NCT00108654|Healthy Volunteer|healthy volunteer
5381519|NCT00108628|Imagery|imagery
5381520|NCT00108628|Nightmares|nightmares
5381521|NCT00108628|Post-Traumatic Stress Disorder|post-traumatic stress disorder
5381522|NCT00108628|Psychotherapy|psychotherapy
5381523|NCT00108602|sleep apnea|sleep apnea
5381524|NCT00108602|stroke|stroke
5381525|NCT00108602|ventilatory control|ventilatory control
5381526|NCT00108589|s-adenosylmethionine|s-adenosylmethionine
5381527|NCT00108589|fatty liver|fatty liver
5381528|NCT00108589|obesity|obesity
5381529|NCT00108589|Non-alcoholic steatohepatitis|non-alcoholic steatohepatitis
5381530|NCT00108576|anticonvulsant|anticonvulsant
5381531|NCT00108576|anxiety|anxiety
5381532|NCT00108576|divalproex|divalproex
5381533|NCT00108576|PTSD|ptsd
5381534|NCT00108563|Hepatitis C|hepatitis c
5381535|NCT00108563|Depression|depression
5381536|NCT00108563|Interferon-alpha|interferon-alpha
5381537|NCT00108563|Citalopram|citalopram
5381538|NCT00108563|ribavirin|ribavirin
5381539|NCT00108563|antidepressive agents|antidepressive agents
5381540|NCT00108550|analgesia|analgesia
5381541|NCT00108550|antidepressant agents|antidepressant agents
5381542|NCT00108550|back pain|back pain
5381543|NCT00108550|pain|pain
5381544|NCT00108537|smoking|smoking
5381545|NCT00108537|nicotine|nicotine
5381546|NCT00108537|drug therapy|drug therapy
5381547|NCT00108537|smoking cessation|smoking cessation
5381548|NCT00108524|anti-obesity agents|anti-obesity agents
5381549|NCT00108524|diet therapy|diet therapy
5381550|NCT00108524|diet, reducing|diet, reducing
5381551|NCT00108524|obesity|obesity
5381552|NCT00108524|overweight|overweight
5381553|NCT00108524|risk factors|risk factors
5381554|NCT00108524|weight loss|weight loss
5381555|NCT00108511|hypertriglyceridemia|hypertriglyceridemia
5381556|NCT00108511|lipoproteins|lipoproteins
5381557|NCT00108511|triglycerides|triglycerides
5381558|NCT00108511|serum GPI-PLD (glycosylphosphatidylinositol-specific phospholipase D)|serum gpi-pld (glycosylphosphatidylinositol-specific phospholipase d)
5381559|NCT00108498|sleep apnea|sleep apnea
5381560|NCT00108498|mirtazapine|mirtazapine
5381561|NCT00108498|sleep|sleep
5381562|NCT00108485|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
5381563|NCT00108485|Kidney Failure, Chronic|kidney failure, chronic
5381564|NCT00108485|Hyperlipidemia|hyperlipidemia
5381565|NCT00108485|Randomized Controlled Trials|randomized controlled trials
5381566|NCT00108459|Obesity|obesity
5381567|NCT00108459|Type 2 Diabetes|type 2 diabetes
5381568|NCT00108459|Hyperlipidemia|hyperlipidemia
5381569|NCT00108459|Insulin resistance|insulin resistance
5381570|NCT00108446|Irritable Bowel Syndrome|irritable bowel syndrome
5381571|NCT00108446|visceral hypersensitivity|visceral hypersensitivity
5381572|NCT00108446|cutaneous hypersensitivity|cutaneous hypersensitivity
5381573|NCT00108446|lidocaine|lidocaine
5381574|NCT00108420|Prazosin|prazosin
5381575|NCT00108420|Stress Disorders, Post-traumatic|stress disorders, post-traumatic
5381576|NCT00108407|Alcohol Abuse/Dependence|alcohol abuse/dependence
5381577|NCT00108407|Alcohol Use Disorders|alcohol use disorders
5381578|NCT00108407|Cannabis Abuse/Dependence|cannabis abuse/dependence
5381579|NCT00108407|Depression|depression
5381580|NCT00108407|Dual diagnosis|dual diagnosis
5381581|NCT00108407|Dysthymia|dysthymia
5381582|NCT00108407|Stimulant Abuse/Dependence|stimulant abuse/dependence
5381583|NCT00108407|Substance Use Disorders|substance use disorders
5381584|NCT00108394|Uremia|uremia
5381585|NCT00108394|Dialysis|dialysis
5381586|NCT00108394|Clinical Trials|clinical trials
5381587|NCT00108394|Bone Diseases, Metabolic|bone diseases, metabolic
5381588|NCT00108394|adynamic bone disease|adynamic bone disease
5381589|NCT00108394|low bone turnover|low bone turnover
5381590|NCT00108381|chronic back pain|chronic back pain
5381591|NCT00108381|cognitive-behavioral|cognitive-behavioral
5381592|NCT00108381|pain|pain
5381593|NCT00108381|stages of change|stages of change
5381594|NCT00108368|schizophrenia|schizophrenia
5381595|NCT00108368|cognition|cognition
5381596|NCT00108368|antipsychotic medication|antipsychotic medication
5381597|NCT00108368|information processing|information processing
5381598|NCT00108368|social cognition|social cognition
5381599|NCT00108368|Psychotic|psychotic
5381600|NCT00108355|albumin|albumin
5381601|NCT00108355|ascites|ascites
5381602|NCT00108355|paracentesis|paracentesis
5381603|NCT00108342|nicotine|nicotine
5381604|NCT00108342|drug therapy|drug therapy
5381605|NCT00108342|Smoking Cessation|smoking cessation
5381606|NCT00108329|aging|aging
5381607|NCT00108329|exercise|exercise
5381608|NCT00108329|metabolic syndrome|metabolic syndrome
5381609|NCT00108329|insulin resistance|insulin resistance
5381610|NCT00108316|Depressive Disorder|depressive disorder
5381611|NCT00108316|DNA|dna
5381612|NCT00108316|Serotonin|serotonin
5381613|NCT00108303|schizophrenia|schizophrenia
5381614|NCT00108290|Prostate cancer|prostate cancer
5381615|NCT00108290|chemotherapy|chemotherapy
5381616|NCT00108290|hormone therapy|hormone therapy
5381617|NCT00108290|surgery|surgery
5381618|NCT00108290|PSA|psa
5381619|NCT00108290|Gleason score|gleason score
5381620|NCT00108277|Anxiety|anxiety
5381621|NCT00108277|Breathing Training|breathing training
5381622|NCT00108277|Respiratory Dysregulation|respiratory dysregulation
5381623|NCT00108264|Prostatic Neoplasms|prostatic neoplasms
5381624|NCT00108264|Neoplasm Metastasis|neoplasm metastasis
5381625|NCT00108264|Immunotherapy|immunotherapy
5381626|NCT00108264|Active|active
5381627|NCT00108264|Dendritic Cells|dendritic cells
5381628|NCT00108251|controlled clinical trial|controlled clinical trial
5381629|NCT00108251|Diastole|diastole
5381630|NCT00108251|Echocardiography|echocardiography
5381631|NCT00108251|exercise tolerance|exercise tolerance
5381632|NCT00108251|Heart Failure, Congestive|heart failure, congestive
5381633|NCT00108251|Receptors, Aldosterone|receptors, aldosterone
5381634|NCT00108238|endothelial function|endothelial function
5381635|NCT00108238|hormone replacement therapy|hormone replacement therapy
5381636|NCT00108238|coronary flow reserve|coronary flow reserve
5381637|NCT00108238|posmenopausal women|posmenopausal women
5381638|NCT00108238|women's cardiovascular heatlh|women's cardiovascular heatlh
5381639|NCT00108225|Cholesterol|cholesterol
5381640|NCT00108225|Creatinine Clearance|creatinine clearance
5381641|NCT00108225|Diabetes|diabetes
5381642|NCT00108225|Glycohemoglobin|glycohemoglobin
5381643|NCT00108225|High Protein Diet|high protein diet
5381644|NCT00108212|Diet|diet
5381645|NCT00108212|triglyceride|triglyceride
5381646|NCT00108212|inflammation|inflammation
5381647|NCT00108212|Genetic polymorphism|genetic polymorphism
5381648|NCT00108199|Schizophrenia|schizophrenia
5381649|NCT00108199|vocational rehabilitation|vocational rehabilitation
5381650|NCT00108199|neuropsychology|neuropsychology
5381651|NCT00108186|cyclooxygenase 2|cyclooxygenase 2
5381652|NCT00108186|lung cancer|lung cancer
5381653|NCT00108186|lymphocytes|lymphocytes
5381654|NCT00108186|non small cell|non small cell
5381655|NCT00108186|therapeutics|therapeutics
5381656|NCT00108173|Position Emission Tomography (PET)|position emission tomography (pet)
5381657|NCT00108173|Nicotine dependence|nicotine dependence
5381658|NCT00108173|functional magnetic resonance imaging|functional magnetic resonance imaging
5381659|NCT00108173|cigarette cues|cigarette cues
5381660|NCT00108160|mupirocin|mupirocin
5381661|NCT00108160|prevention and control|prevention and control
5381662|NCT00108160|s. aureus|s. aureus
5381663|NCT00108147|Aged|aged
5381664|NCT00108147|Congestive Heart Failure|congestive heart failure
5381665|NCT00108147|Exercise|exercise
5381666|NCT00108134|Superficial basal cell carcinoma|superficial basal cell carcinoma
5381667|NCT00108134|basal cell carcinoma|basal cell carcinoma
5381668|NCT00108134|sBCC|sbcc
5381669|NCT00108134|BCC|bcc
5381670|NCT00108134|PEP005|pep005
5381671|NCT00108134|Topical|topical
5381672|NCT00108134|Dermatology|dermatology
5381673|NCT00108121|Nodular basal cell carcinoma|nodular basal cell carcinoma
5381674|NCT00108121|basal cell carcinoma|basal cell carcinoma
5381675|NCT00108121|nBCC|nbcc
5381676|NCT00108121|BCC|bcc
5381677|NCT00108121|PEP005|pep005
5381678|NCT00108121|Topical|topical
5381679|NCT00108121|Dermatology|dermatology
5381680|NCT00108108|Lymphocytic Leukemia|lymphocytic leukemia
5381681|NCT00108095|emesis|emesis
5381682|NCT00108095|nausea|nausea
5381683|NCT00108095|post operative nausea and vomiting|post operative nausea and vomiting
5381684|NCT00108095|vomiting|vomiting
5381685|NCT00108095|PONV|ponv
5381686|NCT00108082|left ventricular hypertrophy (LVH)|left ventricular hypertrophy (lvh)
5381687|NCT00108082|echocardiogram|echocardiogram
5381688|NCT00108082|left ventricular mass regression|left ventricular mass regression
5381689|NCT00108082|cardiac MRI|cardiac mri
5381690|NCT00108082|left ventricular mass index (LVMI)hypertension|left ventricular mass index (lvmi)hypertension
5381691|NCT00108069|Brain|brain
5381692|NCT00108069|Tumor|tumor
5381693|NCT00108069|Malignant|malignant
5381694|NCT00108069|Therapy|therapy
5381695|NCT00108069|Progression|progression
5381696|NCT00108069|Chemotherapy|chemotherapy
5381697|NCT00108069|Antiangiogenesis|antiangiogenesis
5381698|NCT00108069|Radiation|radiation
5381699|NCT00108069|Malignant Brain Tumor|malignant brain tumor
5381700|NCT00108069|Malignant Glioma|malignant glioma
5381701|NCT00108069|Glioma|glioma
5381702|NCT00108056|Brain|brain
5381703|NCT00108056|Tumor|tumor
5381704|NCT00108056|Malignant|malignant
5381705|NCT00108056|Therapy|therapy
5381706|NCT00108056|Progression|progression
5381707|NCT00108056|Malignant Brain Tumor|malignant brain tumor
5381708|NCT00108056|Malignant Glioma|malignant glioma
5381709|NCT00108056|Glioma|glioma
5381710|NCT00108043|Functional Electrical Stimulation|functional electrical stimulation
5381711|NCT00108043|Gait|gait
5381712|NCT00108043|Blood pressure|blood pressure
5381713|NCT00108043|Orthostatic Hypotension|orthostatic hypotension
5381714|NCT00108043|Cardiovascular responses|cardiovascular responses
5381715|NCT00108043|Near-infra red spectroscopy|near-infra red spectroscopy
5381716|NCT00108030|PBWST training|pbwst training
5381717|NCT00108030|Strength training|strength training
5381718|NCT00108030|6-min walking endurance|6-min walking endurance
5381719|NCT00108030|Cardiovascular fitness|cardiovascular fitness
5381720|NCT00108030|Psychosocial attributes|psychosocial attributes
5381721|NCT00108017|Ocular hypertension (excessive pressure in the eye)|ocular hypertension (excessive pressure in the eye)
5381722|NCT00108004|Diabetes|diabetes
5381723|NCT00108004|Amylin|amylin
5381724|NCT00108004|Symlin|symlin
5381725|NCT00108004|pramlintide acetate|pramlintide acetate
5381726|NCT00107991|clinical trial; efficacy; etanercept; hidradenitis suppurativa; quality of life; safety; tnf|clinical trial; efficacy; etanercept; hidradenitis suppurativa; quality of life; safety; tnf
5381727|NCT00107978|cSSSI (complicated Skin and Skin Structure Infections)|csssi (complicated skin and skin structure infections)
5381728|NCT00107978|Staph (Staphylococcus)|staph (staphylococcus)
5381729|NCT00107978|MRSA (Methicillin-resistant Staphylococcus Aureus)|mrsa (methicillin-resistant staphylococcus aureus)
5381730|NCT00107965|Actinic Keratosis|actinic keratosis
5381731|NCT00107965|Solar Keratosis|solar keratosis
5381732|NCT00107965|AK|ak
5381733|NCT00107965|Sun spots|sun spots
5381734|NCT00107965|PEP005|pep005
5381735|NCT00107965|Topical|topical
5381736|NCT00107965|Dermatology|dermatology
5381737|NCT00107952|Nosocomial pneumonia|nosocomial pneumonia
5381738|NCT00107952|MRSA|mrsa
5381739|NCT00107939|bipolar disorder|bipolar disorder
5381740|NCT00107939|manic episode|manic episode
5381741|NCT00107939|treatment|treatment
5381742|NCT00107939|licarbazepine|licarbazepine
5381743|NCT00107926|bipolar disorder|bipolar disorder
5381744|NCT00107926|manic episode|manic episode
5381745|NCT00107926|treatment|treatment
5381746|NCT00107926|licarbazepine|licarbazepine
5381747|NCT00107913|Immune Thrombocytopenic Purpura|immune thrombocytopenic purpura
5381748|NCT00107900|Deep Vein Thrombosis,|deep vein thrombosis,
5381749|NCT00107900|Anticoagulant,|anticoagulant,
5381750|NCT00107900|Venous thromboembolic|venous thromboembolic
5381751|NCT00107887|TST|tst
5381752|NCT00107887|isoniazid|isoniazid
5381753|NCT00107887|HAART|haart
5381754|NCT00107887|Brazil|brazil
5381755|NCT00107887|HIV|hiv
5381759|NCT00107874|pregnancy|pregnancy
5381760|NCT00107874|postpartum hemorrhage|postpartum hemorrhage
5381761|NCT00107874|Cesarean Section|cesarean section
5381762|NCT00107848|Pediatric Narcolepsy|pediatric narcolepsy
5381763|NCT00107848|Pediatric OSA|pediatric osa
5381764|NCT00107848|CPAP|cpap
5381765|NCT00107848|Pediatric Narcolepsy or OSAHS|pediatric narcolepsy or osahs
5381766|NCT00107835|Pain|pain
5381767|NCT00107822|Pain|pain
5381768|NCT00107809|Pediatric Obstructive sleep Apnea|pediatric obstructive sleep apnea
5381769|NCT00107809|Excessive sleepiness|excessive sleepiness
5381770|NCT00107809|CPAP|cpap
5381771|NCT00107809|Pediatric OSAHS|pediatric osahs
5381772|NCT00107796|Pediatric Narcolepsy|pediatric narcolepsy
5381773|NCT00107796|Excessive sleepiness|excessive sleepiness
5381774|NCT00107783|Arthritis|arthritis
5381775|NCT00107783|Homogentisic Acid|homogentisic acid
5381776|NCT00107783|Corneal Damage|corneal damage
5381777|NCT00107783|Tyrosine|tyrosine
5381778|NCT00107783|Alkaptonuria|alkaptonuria
5381779|NCT00107783|Photophobia|photophobia
5381780|NCT00107783|Nitisinone|nitisinone
5381781|NCT00107770|ALS|als
5381782|NCT00107770|histone deacetylase inhibition|histone deacetylase inhibition
5381783|NCT00107770|open label|open label
5381784|NCT00107770|safety study|safety study
5381785|NCT00107770|sodium phenylbutyrate|sodium phenylbutyrate
5381786|NCT00107757|pediatric|pediatric
5381787|NCT00107757|Seasonal allergic rhinitis|seasonal allergic rhinitis
5381788|NCT00107744|Blood Pressure; Lipids; Dietary Protein|blood pressure; lipids; dietary protein
5381789|NCT00107731|Bipolar I Disorder|bipolar i disorder
5381790|NCT00107731|Manic Depressive Disorder|manic depressive disorder
5381791|NCT00107731|Manic Depression|manic depression
5381792|NCT00107718|IL-18|il-18
5381793|NCT00107718|treatment naive|treatment naive
5381794|NCT00107718|Phase 2|phase 2
5381795|NCT00107718|melanoma|melanoma
5381796|NCT00107705|allergy|allergy
5381797|NCT00107705|skin prick test|skin prick test
5381798|NCT00107705|allergoid|allergoid
5381799|NCT00107705|allergenicity|allergenicity
5381800|NCT00107705|specific immunotherapy|specific immunotherapy
5381801|NCT00107692|Child Obesity|child obesity
5381802|NCT00107692|Physical activity|physical activity
5381803|NCT00107692|community intervention study|community intervention study
5381804|NCT00107692|competence|competence
5381805|NCT00107692|diet and nutrition|diet and nutrition
5381806|NCT00107692|Nutrition|nutrition
5381807|NCT00107679|Treatment Experienced|treatment experienced
5381808|NCT00107679|HIV|hiv
5381809|NCT00107679|HPV|hpv
5381810|NCT00107679|Antiretroviral Therapy, Highly Active|antiretroviral therapy, highly active
5381811|NCT00107679|Papillomavirus, Human|papillomavirus, human
5381812|NCT00107666|Coronary artery bypass grafting|coronary artery bypass grafting
5381813|NCT00107666|Heart valve prosthesis implantation|heart valve prosthesis implantation
5381814|NCT00107666|Cardiopulmonary bypass|cardiopulmonary bypass
5381815|NCT00107666|Oxidative stress|oxidative stress
5381816|NCT00107666|Inflammation|inflammation
5381817|NCT00107666|Endotoxemia|endotoxemia
5381818|NCT00107640|At-risk drinking|at-risk drinking
5381819|NCT00107640|Alcohol education|alcohol education
5381820|NCT00107640|Effectiveness|effectiveness
5381821|NCT00107640|Cost-effectiveness|cost-effectiveness
5381822|NCT00107627|Gynaecological Cancer|gynaecological cancer
5381823|NCT00107627|Surgical Staples|surgical staples
5381824|NCT00107627|Subcuticular Sutures|subcuticular sutures
5381825|NCT00107614|Waldenstrom|waldenstrom
5381826|NCT00107601|Glucose|glucose
5381827|NCT00107601|Glucose Control|glucose control
5381828|NCT00107601|Insulin|insulin
5381829|NCT00107601|Insulin therapy|insulin therapy
5381830|NCT00107601|Critically ill|critically ill
5381831|NCT00107601|Intensive Care|intensive care
5381832|NCT00107588|marijuana dependence|marijuana dependence
5381833|NCT00107588|self-efficacy|self-efficacy
5381834|NCT00107588|coping skills|coping skills
5381835|NCT00107588|attendance|attendance
5381836|NCT00107588|marijuana abstinence|marijuana abstinence
5381837|NCT00107575|tobacco|tobacco
5381838|NCT00107575|alcohol|alcohol
5381839|NCT00107562|risk behavior|risk behavior
5381840|NCT00107562|social networks|social networks
5381841|NCT00107562|behavior|behavior
5381842|NCT00107549|Treatment Experienced|treatment experienced
5381843|NCT00107549|HIV Therapeutic Vaccine|hiv therapeutic vaccine
5381844|NCT00107523|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5381845|NCT00107523|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5381846|NCT00107523|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5381847|NCT00107523|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5381848|NCT00107523|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5381849|NCT00107523|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5381850|NCT00107523|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
5381851|NCT00107510|stage II breast cancer|stage ii breast cancer
5381852|NCT00107510|stage IIIA breast cancer|stage iiia breast cancer
5381853|NCT00107510|stage IIIB breast cancer|stage iiib breast cancer
5382120|NCT00106561|aldosterone|aldosterone
5381854|NCT00107510|stage IIIC breast cancer|stage iiic breast cancer
5381855|NCT00107510|male breast cancer|male breast cancer
5381856|NCT00107497|stage I breast cancer|stage i breast cancer
5381857|NCT00107497|stage II breast cancer|stage ii breast cancer
5381858|NCT00107484|stage IV breast cancer|stage iv breast cancer
5381859|NCT00107484|stage I breast cancer|stage i breast cancer
5381860|NCT00107484|stage II breast cancer|stage ii breast cancer
5381861|NCT00107484|stage IIIA breast cancer|stage iiia breast cancer
5381862|NCT00107484|stage IIIB breast cancer|stage iiib breast cancer
5381863|NCT00107484|stage IIIC breast cancer|stage iiic breast cancer
5381864|NCT00107484|male breast cancer|male breast cancer
5381865|NCT00107471|untreated childhood brain stem glioma|untreated childhood brain stem glioma
5381866|NCT00107458|recurrent childhood brain stem glioma|recurrent childhood brain stem glioma
5381867|NCT00107458|recurrent childhood brain tumor|recurrent childhood brain tumor
5381868|NCT00107458|recurrent childhood cerebellar astrocytoma|recurrent childhood cerebellar astrocytoma
5381869|NCT00107458|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
5381870|NCT00107458|recurrent childhood ependymoma|recurrent childhood ependymoma
5381871|NCT00107458|recurrent childhood medulloblastoma|recurrent childhood medulloblastoma
5381872|NCT00107458|recurrent childhood supratentorial primitive neuroectodermal tumor|recurrent childhood supratentorial primitive neuroectodermal tumor
5381873|NCT00107458|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
5381874|NCT00107458|recurrent childhood visual pathway and hypothalamic glioma|recurrent childhood visual pathway and hypothalamic glioma
5381875|NCT00107458|childhood high-grade cerebral astrocytoma|childhood high-grade cerebral astrocytoma
5381876|NCT00107458|childhood low-grade cerebral astrocytoma|childhood low-grade cerebral astrocytoma
5381877|NCT00107458|childhood infratentorial ependymoma|childhood infratentorial ependymoma
5381878|NCT00107458|childhood supratentorial ependymoma|childhood supratentorial ependymoma
5381879|NCT00107458|childhood spinal cord neoplasm|childhood spinal cord neoplasm
5381880|NCT00107458|childhood grade I meningioma|childhood grade i meningioma
5381881|NCT00107458|childhood grade II meningioma|childhood grade ii meningioma
5381882|NCT00107458|childhood grade III meningioma|childhood grade iii meningioma
5381883|NCT00107458|childhood craniopharyngioma|childhood craniopharyngioma
5381884|NCT00107458|childhood central nervous system germ cell tumor|childhood central nervous system germ cell tumor
5381885|NCT00107419|chondrosarcoma|chondrosarcoma
5381886|NCT00107393|recurrent breast cancer|recurrent breast cancer
5381887|NCT00107393|stage IV breast cancer|stage iv breast cancer
5381888|NCT00107380|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
5381889|NCT00107380|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5381890|NCT00107380|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5381891|NCT00107380|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5381892|NCT00107367|tumors metastatic to brain|tumors metastatic to brain
5381893|NCT00107354|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5381894|NCT00107354|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5381895|NCT00107354|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5381896|NCT00107354|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5381897|NCT00107354|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5381898|NCT00107354|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
5381899|NCT00107354|refractory anemia with excess blasts|refractory anemia with excess blasts
5381900|NCT00107354|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5381901|NCT00107354|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5381902|NCT00107354|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5381903|NCT00107354|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5381904|NCT00107354|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5381905|NCT00107354|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5381906|NCT00107354|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5381907|NCT00107354|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5381908|NCT00107354|T-cell adult acute lymphoblastic leukemia|t-cell adult acute lymphoblastic leukemia
5381909|NCT00107354|T-cell childhood acute lymphoblastic leukemia|t-cell childhood acute lymphoblastic leukemia
5381910|NCT00107354|B-cell adult acute lymphoblastic leukemia|b-cell adult acute lymphoblastic leukemia
5381911|NCT00107354|B-cell childhood acute lymphoblastic leukemia|b-cell childhood acute lymphoblastic leukemia
5381912|NCT00107354|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
5381913|NCT00107341|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
5381914|NCT00107341|stage IV esophageal cancer|stage iv esophageal cancer
5381915|NCT00107341|recurrent esophageal cancer|recurrent esophageal cancer
5381916|NCT00107315|recurrent colon cancer|recurrent colon cancer
5381917|NCT00107315|stage IV colon cancer|stage iv colon cancer
5381918|NCT00107315|recurrent rectal cancer|recurrent rectal cancer
5381919|NCT00107315|stage IV rectal cancer|stage iv rectal cancer
5381920|NCT00107289|metastatic pheochromocytoma|metastatic pheochromocytoma
5381921|NCT00107289|recurrent pheochromocytoma|recurrent pheochromocytoma
5382320|NCT00105625|Geriatrics|geriatrics
5381922|NCT00107289|regional pheochromocytoma|regional pheochromocytoma
5381923|NCT00107289|recurrent neuroblastoma|recurrent neuroblastoma
5381924|NCT00107289|04-148|04-148
5381925|NCT00107276|stage IV breast cancer|stage iv breast cancer
5381926|NCT00107276|recurrent breast cancer|recurrent breast cancer
5381927|NCT00107263|osteoporosis|osteoporosis
5381928|NCT00107263|stage I breast cancer|stage i breast cancer
5381929|NCT00107263|stage II breast cancer|stage ii breast cancer
5381930|NCT00107263|stage IIIA breast cancer|stage iiia breast cancer
5381931|NCT00107250|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5381932|NCT00107250|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5381933|NCT00107250|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5381934|NCT00107250|stage IV colon cancer|stage iv colon cancer
5381935|NCT00107250|stage IV rectal cancer|stage iv rectal cancer
5381936|NCT00107250|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5381937|NCT00107237|adult glioblastoma|adult glioblastoma
5381938|NCT00107237|recurrent adult brain tumor|recurrent adult brain tumor
5381939|NCT00107237|adult giant cell glioblastoma|adult giant cell glioblastoma
5381940|NCT00107237|adult gliosarcoma|adult gliosarcoma
5381941|NCT00107211|ductal breast carcinoma in situ|ductal breast carcinoma in situ
5381942|NCT00107211|breast cancer in situ|breast cancer in situ
5381943|NCT00107185|childhood high-grade cerebral astrocytoma|childhood high-grade cerebral astrocytoma
5381944|NCT00107185|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
5381945|NCT00107185|childhood oligodendroglioma|childhood oligodendroglioma
5381946|NCT00107172|stage I non-small cell lung cancer|stage i non-small cell lung cancer
5381947|NCT00107159|recurrent melanoma|recurrent melanoma
5381948|NCT00107159|stage III melanoma|stage iii melanoma
5381949|NCT00107159|stage IV melanoma|stage iv melanoma
5381950|NCT00107120|Major Depressive Disorder|major depressive disorder
5381951|NCT00107120|Depression|depression
5381952|NCT00107120|Adolescents|adolescents
5381953|NCT00107120|Escitalopram|escitalopram
5381954|NCT00107120|Pediatrics|pediatrics
5381955|NCT00107107|Diabetes|diabetes
5381956|NCT00107107|Amylin|amylin
5381957|NCT00107107|pramlintide|pramlintide
5381958|NCT00107107|Symlin|symlin
5381959|NCT00107094|Breast Cancer|breast cancer
5381960|NCT00107094|Adriamycin|adriamycin
5381961|NCT00107094|Cyclophosphamide|cyclophosphamide
5381962|NCT00107094|Abraxane|abraxane
5381963|NCT00107081|children|children
5381964|NCT00107081|oral antibiotics|oral antibiotics
5381965|NCT00107081|outpatient treatment|outpatient treatment
5381966|NCT00107081|fever and neutropenia|fever and neutropenia
5381967|NCT00107068|Stroke|stroke
5381968|NCT00107068|Exercise|exercise
5381969|NCT00107068|Aerobic|aerobic
5381970|NCT00107068|PRT|prt
5381971|NCT00107068|Walking ability|walking ability
5381972|NCT00107055|Herniated nucleus pulposus|herniated nucleus pulposus
5381973|NCT00107055|Lumbosacral radiculopathy|lumbosacral radiculopathy
5381974|NCT00107055|Anti-TNF alpha|anti-tnf alpha
5381975|NCT00107055|Tumor necrosis factor alpha|tumor necrosis factor alpha
5381976|NCT00107042|Hepatitis B|hepatitis b
5381977|NCT00107042|HIV vaccine trial|hiv vaccine trial
5381978|NCT00107029|HIV infection|hiv infection
5381979|NCT00107029|CD8+ T-cells|cd8+ t-cells
5381980|NCT00107029|HIV-1 genotype|hiv-1 genotype
5381981|NCT00107016|Breast Cancer|breast cancer
5381982|NCT00107016|Cancer of the Breast|cancer of the breast
5381983|NCT00107016|Neo-adjuvant|neo-adjuvant
5381984|NCT00107016|Primary breast cancer|primary breast cancer
5381985|NCT00107016|postmenopausal|postmenopausal
5381986|NCT00107016|pre-operative|pre-operative
5381987|NCT00107003|Brain|brain
5381988|NCT00107003|Tumor|tumor
5381989|NCT00107003|Surgery|surgery
5381990|NCT00107003|Therapy|therapy
5381991|NCT00107003|Trial|trial
5381992|NCT00107003|Brain Tumor|brain tumor
5381993|NCT00107003|Glioblastoma Multiforme|glioblastoma multiforme
5381994|NCT00107003|GBM|gbm
5381995|NCT00107003|Gliosarcoma|gliosarcoma
5381996|NCT00107003|GS|gs
5381997|NCT00106977|Craniosynostosis|craniosynostosis
5381998|NCT00106977|Hearing Loss|hearing loss
5381999|NCT00106977|Genectic Disorders|genectic disorders
5382000|NCT00106977|Muenke Syndrome|muenke syndrome
5382001|NCT00106964|Hepatitis B vaccines|hepatitis b vaccines
5382002|NCT00106964|HIV-infected adolescents|hiv-infected adolescents
5382003|NCT00106964|Hepatitis B infection (negative)|hepatitis b infection (negative)
5382004|NCT00106951|Surveillance|surveillance
5382005|NCT00106951|coronary heart disease|coronary heart disease
5382006|NCT00106951|neighborhood SES|neighborhood ses
5382007|NCT00106938|Carotid stenting|carotid stenting
5382008|NCT00106938|Carotid endarterectomy|carotid endarterectomy
5382009|NCT00106938|Carotid artery disease with severe narrowing of the artery|carotid artery disease with severe narrowing of the artery
5382010|NCT00106938|Stroke prevention|stroke prevention
5382011|NCT00106925|Peripheral Blood Stem Cells|peripheral blood stem cells
5382012|NCT00106925|Graft-Versus Leukemia/Myeloma|graft-versus leukemia/myeloma
5382013|NCT00106925|Graft-Versus-Host Disease|graft-versus-host disease
5382014|NCT00106925|Whole Body Irradiation|whole body irradiation
5382015|NCT00106925|Leukemic Relapse|leukemic relapse
5382121|NCT00106509|Clostridium Enterocolitis|clostridium enterocolitis
5382016|NCT00106925|Allogeneic Stem Cell Transplantation Recipient|allogeneic stem cell transplantation recipient
5382017|NCT00106912|Genetic|genetic
5382018|NCT00106912|Stroke|stroke
5382019|NCT00106912|Heart|heart
5382020|NCT00106912|Lysosomal|lysosomal
5382021|NCT00106912|Glycolipid|glycolipid
5382022|NCT00106912|Fabry Disease|fabry disease
5382023|NCT00106899|neuroimaging|neuroimaging
5382024|NCT00106899|brain metabolism|brain metabolism
5382025|NCT00106899|biomarkers|biomarkers
5382026|NCT00106899|cognition disorder|cognition disorder
5382027|NCT00106899|Mild Cognitive Impairment|mild cognitive impairment
5382028|NCT00106886|homocysteine|homocysteine
5382029|NCT00106886|folic acid|folic acid
5382030|NCT00106886|micronutrients|micronutrients
5382031|NCT00106886|multivitamins|multivitamins
5382032|NCT00106886|vitamin supplements|vitamin supplements
5382033|NCT00106860|Anxiety|anxiety
5382034|NCT00106860|Generalized Anxiety Disorder|generalized anxiety disorder
5382035|NCT00106847|plaque-type psoriasis|plaque-type psoriasis
5382036|NCT00106847|psoriasis|psoriasis
5382037|NCT00106847|drug safety|drug safety
5382038|NCT00106847|drug efficacy|drug efficacy
5382039|NCT00106847|maintenance therapy|maintenance therapy
5382040|NCT00106847|induction therapy|induction therapy
5382041|NCT00106847|remicade|remicade
5382042|NCT00106834|Psoriasis|psoriasis
5382043|NCT00106834|Infliximab|infliximab
5382044|NCT00106834|Remicade|remicade
5382045|NCT00106808|Type 2 Diabetes|type 2 diabetes
5382046|NCT00106795|Antiretrovirals|antiretrovirals
5382047|NCT00106795|Adipocytes|adipocytes
5382048|NCT00106795|Skeletal Muscle|skeletal muscle
5382049|NCT00106795|Fatigue|fatigue
5382050|NCT00106795|HIV|hiv
5382051|NCT00106795|AIDS|aids
5382052|NCT00106795|Lymphocytes|lymphocytes
5382053|NCT00106795|Lipodystrophy|lipodystrophy
5382054|NCT00106795|HIV Positive|hiv positive
5382055|NCT00106795|Healthy Volunteer|healthy volunteer
5382056|NCT00106795|HV|hv
5382057|NCT00106782|Electrical|electrical
5382058|NCT00106782|Stimulation|stimulation
5382059|NCT00106782|Dystonia|dystonia
5382060|NCT00106782|Brain|brain
5382061|NCT00106782|Focal Hand Dystonia|focal hand dystonia
5382062|NCT00106782|FHD|fhd
5382063|NCT00106769|Flavivirus|flavivirus
5382064|NCT00106769|Mosquito|mosquito
5382065|NCT00106769|Immunity|immunity
5382066|NCT00106769|Preventive|preventive
5382067|NCT00106769|Virus|virus
5382068|NCT00106769|West Nile Fever|west nile fever
5382069|NCT00106769|Healthy Volunteer|healthy volunteer
5382070|NCT00106769|HV|hv
5382071|NCT00106756|Exudation|exudation
5382072|NCT00106756|Avascular Retina|avascular retina
5382073|NCT00106756|Retina Fold|retina fold
5382074|NCT00106743|Usher Syndrome|usher syndrome
5382075|NCT00106743|Retinitis Pigmentosa|retinitis pigmentosa
5382076|NCT00106743|Congenital Deafness|congenital deafness
5382077|NCT00106717|Cancer pain|cancer pain
5382078|NCT00106717|Quality of life|quality of life
5382079|NCT00106717|Narrative medicine|narrative medicine
5382080|NCT00106717|Pain relief|pain relief
5382081|NCT00106691|neoplasia|neoplasia
5382082|NCT00106691|chemoprevention|chemoprevention
5382083|NCT00106691|cancer|cancer
5382084|NCT00106691|premalignant|premalignant
5382085|NCT00106691|precancerous|precancerous
5382086|NCT00106691|Chemoprophylaxis|chemoprophylaxis
5382087|NCT00106691|Intraepithelial Prostatic Neoplasia|intraepithelial prostatic neoplasia
5382088|NCT00106691|Neoplasia, Prostatic Intraepithelial|neoplasia, prostatic intraepithelial
5382089|NCT00106678|HIV|hiv
5382090|NCT00106678|Antiretroviral therapy (ART)|antiretroviral therapy (art)
5382091|NCT00106678|HAART|haart
5382092|NCT00106678|Adherence|adherence
5382093|NCT00106678|Barriers|barriers
5382094|NCT00106665|ICU acquired weakness|icu acquired weakness
5382095|NCT00106665|Critical care polyneuropathy|critical care polyneuropathy
5382096|NCT00106665|Critical care myopathy|critical care myopathy
5382097|NCT00106652|autism|autism
5382098|NCT00106652|neurodevelopment|neurodevelopment
5382099|NCT00106652|neurotoxicology|neurotoxicology
5382100|NCT00106652|perinatology|perinatology
5382101|NCT00106652|teratology|teratology
5382102|NCT00106639|tofacitinib|tofacitinib
5382103|NCT00106639|CP-690550|cp-690550
5382104|NCT00106639|kidney transplant|kidney transplant
5382105|NCT00106626|Advanced solid tumors including MPM and NSCLC|advanced solid tumors including mpm and nsclc
5382106|NCT00106613|Renal Cell Carcinoma|renal cell carcinoma
5382107|NCT00106613|Metastatic Cancer|metastatic cancer
5382108|NCT00106613|Metastatic Renal Cell Carcinoma|metastatic renal cell carcinoma
5382109|NCT00106600|Relapsed|relapsed
5382110|NCT00106600|Refractory|refractory
5382111|NCT00106587|in stent restenosis|in stent restenosis
5382112|NCT00106587|paclitaxel coated balloon catheter|paclitaxel coated balloon catheter
5382113|NCT00106587|paccocath|paccocath
5382114|NCT00106587|drug eluting balloon|drug eluting balloon
5382115|NCT00106561|spironolactone|spironolactone
5382116|NCT00106561|proteinuria|proteinuria
5382117|NCT00106561|angiotensin converting enzyme inhibitor|angiotensin converting enzyme inhibitor
5382118|NCT00106561|angiotensin receptor blocker|angiotensin receptor blocker
5382119|NCT00106561|renin angiotensin aldosterone system|renin angiotensin aldosterone system
5382122|NCT00106509|Pseudomembranous Colitis|pseudomembranous colitis
5382123|NCT00106509|Clostridium difficile-associated diarrhea|clostridium difficile-associated diarrhea
5382124|NCT00106509|C. difficile|c. difficile
5382125|NCT00106509|CDAD|cdad
5382126|NCT00106496|Treatment Effectiveness|treatment effectiveness
5382127|NCT00106496|Treatment Efficacy|treatment efficacy
5382128|NCT00106496|Immunomodulator, Topical|immunomodulator, topical
5382129|NCT00106496|Tacrolimus, Topical|tacrolimus, topical
5382130|NCT00106496|Dermatitis, Atopic|dermatitis, atopic
5382131|NCT00106496|Eczema, Atopic|eczema, atopic
5382132|NCT00106496|Atopic Dermatitis|atopic dermatitis
5382133|NCT00106483|Cardiovascular Diseases|cardiovascular diseases
5382134|NCT00106483|Coronary Disease|coronary disease
5382135|NCT00106483|Heart Diseases|heart diseases
5382136|NCT00106470|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5382137|NCT00106431|romidepsin|romidepsin
5382138|NCT00106418|Prostate Cancer|prostate cancer
5382139|NCT00106418|Androgen independent metastatic prostate cancer patients with rising PSA|androgen independent metastatic prostate cancer patients with rising psa
5382140|NCT00106418|romidepsin|romidepsin
5382141|NCT00106405|Bipolar I Disorder|bipolar i disorder
5382142|NCT00106405|Mania|mania
5382143|NCT00106405|Memantine HCl|memantine hcl
5382144|NCT00106392|Treatment effectiveness|treatment effectiveness
5382145|NCT00106392|Treatment efficacy|treatment efficacy
5382146|NCT00106392|Investigational, Therapies|investigational, therapies
5382147|NCT00106392|Immunosuppressant|immunosuppressant
5382148|NCT00106392|Erectile dysfunction|erectile dysfunction
5382149|NCT00106392|Prostatectomy|prostatectomy
5382150|NCT00106379|HIV-1|hiv-1
5382151|NCT00106379|Treatment Naive|treatment naive
5382152|NCT00106379|Treatment Experienced|treatment experienced
5382153|NCT00106366|Diabetes, Type 2|diabetes, type 2
5382154|NCT00106353|Pediatric Tumors|pediatric tumors
5382155|NCT00106340|type 2 diabetes|type 2 diabetes
5382156|NCT00106340|vildagliptin|vildagliptin
5382157|NCT00106314|Dehydroepiandrosterone|dehydroepiandrosterone
5382158|NCT00106314|DHEA|dhea
5382159|NCT00106314|Crohn's disease|crohn's disease
5382160|NCT00106314|C-reactive protein|c-reactive protein
5382161|NCT00106314|CRP|crp
5382162|NCT00106314|Crohn's Disease Activity Index|crohn's disease activity index
5382163|NCT00106314|CDAI|cdai
5382164|NCT00106314|Inflammatory Bowel Disease Questionnaire|inflammatory bowel disease questionnaire
5382165|NCT00106314|IBDQ|ibdq
5382166|NCT00106301|FK228|fk228
5382167|NCT00106301|Hormone Refractory Prostate Cancer|hormone refractory prostate cancer
5382168|NCT00106288|Candidaemia|candidaemia
5382169|NCT00106288|Micafungin|micafungin
5382170|NCT00106275|Fibromyalgia|fibromyalgia
5382171|NCT00106275|Meditation|meditation
5382172|NCT00106275|Stress, Psychological|stress, psychological
5382173|NCT00106275|Monitoring, Ambulatory|monitoring, ambulatory
5382174|NCT00106275|Electrocardiographie, Ambulatory|electrocardiographie, ambulatory
5382175|NCT00106275|Psychophysiology|psychophysiology
5382176|NCT00106262|advanced cervical cancer|advanced cervical cancer
5382177|NCT00106262|metastatic cervical cancer|metastatic cervical cancer
5382178|NCT00106249|TMS, Supplementary Motor Area, Obsessive-Compulsive Disorder|tms, supplementary motor area, obsessive-compulsive disorder
5382179|NCT00106236|Exercise|exercise
5382180|NCT00106236|Fitness Club|fitness club
5382181|NCT00106236|Randomized Controlled Trial|randomized controlled trial
5382182|NCT00106236|Cardiovascular Risk Factor|cardiovascular risk factor
5382183|NCT00106236|Overweight|overweight
5382184|NCT00106236|Inactivity|inactivity
5382185|NCT00106223|Cognitive Behavioral Therapy|cognitive behavioral therapy
5382186|NCT00106223|CBT|cbt
5382187|NCT00106223|BDD|bdd
5382188|NCT00106223|Body dysmorphic disorder|body dysmorphic disorder
5382189|NCT00106210|Child|child
5382190|NCT00106197|Sleep, REM|sleep, rem
5382191|NCT00106197|Antidepressant|antidepressant
5382192|NCT00106197|Adolescent|adolescent
5382193|NCT00106197|Cortisol|cortisol
5382194|NCT00106184|rituximab|rituximab
5382195|NCT00106184|myositis|myositis
5382196|NCT00106184|dermatomyositis|dermatomyositis
5382197|NCT00106184|polymyositis|polymyositis
5382198|NCT00106184|refractory|refractory
5382199|NCT00106184|Juvenile Dermatomyositis|juvenile dermatomyositis
5382200|NCT00106171|HIV|hiv
5382201|NCT00106171|Acute/Early Seroconverters|acute/early seroconverters
5382202|NCT00106171|Acute Infection|acute infection
5382203|NCT00106171|Treatment Naive|treatment naive
5382204|NCT00106171|Primary HIV Infection|primary hiv infection
5382205|NCT00106158|cancer/testis antigen|cancer/testis antigen
5382206|NCT00106158|cancer vaccine|cancer vaccine
5382207|NCT00106158|recombinant protein|recombinant protein
5382208|NCT00106145|Advanced Breast Cancer|advanced breast cancer
5382209|NCT00106145|Solid Tumors|solid tumors
5382210|NCT00106145|Advanced Solid Tumors|advanced solid tumors
5382211|NCT00106132|Macular Edema|macular edema
5382212|NCT00106132|Steroid|steroid
5382213|NCT00106132|Fluorescein Angiogram|fluorescein angiogram
5382214|NCT00106132|Ocular Coherence Tomography|ocular coherence tomography
5382215|NCT00106132|Laser|laser
5382216|NCT00106132|Retinal Vein Occlusion|retinal vein occlusion
5382217|NCT00106119|Levothyroxine|levothyroxine
5382218|NCT00106119|Liothyronine|liothyronine
5382219|NCT00106119|Lipid Metabolism|lipid metabolism
5382220|NCT00106119|Gluconeogensis|gluconeogensis
5382221|NCT00106119|Thyrotropin Releasing Hormone|thyrotropin releasing hormone
5382222|NCT00106119|Deiodinase|deiodinase
5382223|NCT00106119|Replacement Thyroid Hormone Therapy|replacement thyroid hormone therapy
5382224|NCT00106119|Thyroidectomy|thyroidectomy
5382225|NCT00106119|Near Total Thyroidectomy|near total thyroidectomy
5382226|NCT00106106|Alcoholism|alcoholism
5382227|NCT00106106|Acamprosate|acamprosate
5382228|NCT00106106|Withdrawal|withdrawal
5382229|NCT00106106|Glutamate|glutamate
5382230|NCT00106106|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
5382231|NCT00106106|Alcohol Dependence|alcohol dependence
5382232|NCT00106106|Healthy Volunteer|healthy volunteer
5382233|NCT00106106|HV|hv
5382234|NCT00106093|Alcohol|alcohol
5382235|NCT00106093|Alcohol Treatment|alcohol treatment
5382236|NCT00106093|DNA|dna
5382237|NCT00106093|Treatment|treatment
5382238|NCT00106093|Alcohol Dependence|alcohol dependence
5382239|NCT00106093|Alcoholism|alcoholism
5382240|NCT00106093|Alcohol Drinking Related Problems|alcohol drinking related problems
5382241|NCT00106080|Communication|communication
5382242|NCT00106080|Palliative Care|palliative care
5382243|NCT00106067|aging|aging
5382244|NCT00106067|behavioral research|behavioral research
5382245|NCT00106067|quality of life|quality of life
5382246|NCT00106067|end of life|end of life
5382247|NCT00106067|family relations|family relations
5382248|NCT00106067|supportive care|supportive care
5382249|NCT00106067|advanced care|advanced care
5382250|NCT00106067|bereavement|bereavement
5382251|NCT00106041|end of life care|end of life care
5382252|NCT00106041|evaluation studies|evaluation studies
5382253|NCT00106041|quality of death and dying|quality of death and dying
5382254|NCT00106041|palliative care|palliative care
5382255|NCT00106041|coordination of care|coordination of care
5382256|NCT00106041|satisfaction with care|satisfaction with care
5382257|NCT00106041|healthcare cost|healthcare cost
5382258|NCT00106041|utilization of healthcare resources|utilization of healthcare resources
5382259|NCT00106041|caregivers|caregivers
5382260|NCT00106041|veterans|veterans
5382261|NCT00106028|Primary disease: Osteogenesis Imperfecta|primary disease: osteogenesis imperfecta
5382262|NCT00106015|inherited pure red cell aplasia|inherited pure red cell aplasia
5382263|NCT00105963|abuse|abuse
5382264|NCT00105950|ErbB2 overexpressing|erbb2 overexpressing
5382265|NCT00105950|ErbB1 expressing|erbb1 expressing
5382266|NCT00105950|relapsed breast cancer|relapsed breast cancer
5382267|NCT00105950|refractory inflammatory breast cancer|refractory inflammatory breast cancer
5382268|NCT00105937|Cancer|cancer
5382269|NCT00105937|Pain|pain
5382270|NCT00105911|Cognitive Behavioral Therapy|cognitive behavioral therapy
5382271|NCT00105898|Diabetes mellitus|diabetes mellitus
5382272|NCT00105898|Hypertension|hypertension
5382273|NCT00105898|Telemedicine|telemedicine
5382274|NCT00105898|Case management|case management
5382275|NCT00105885|Telephone|telephone
5382276|NCT00105885|Telemedicine|telemedicine
5382277|NCT00105885|Psychopharmacology|psychopharmacology
5382278|NCT00105872|insomnia|insomnia
5382279|NCT00105872|cognitive behavior therapy|cognitive behavior therapy
5382280|NCT00105820|Evaluation|evaluation
5382281|NCT00105820|Quality improvement|quality improvement
5382282|NCT00105820|Cluster randomized trial|cluster randomized trial
5382283|NCT00105820|Care model|care model
5382284|NCT00105820|Collaborative care|collaborative care
5382285|NCT00105820|Informatics|informatics
5382286|NCT00105794|advance directives|advance directives
5382287|NCT00105794|advance directive adherence|advance directive adherence
5382288|NCT00105794|patient-centered care|patient-centered care
5382289|NCT00105794|patient satisfaction|patient satisfaction
5382290|NCT00105794|coercion|coercion
5382291|NCT00105794|informed consent|informed consent
5382292|NCT00105794|commitment of mentally ill|commitment of mentally ill
5382293|NCT00105794|physician-patient relations|physician-patient relations
5382295|NCT00105781|Telephone|telephone
5382296|NCT00105781|Counseling|counseling
5382297|NCT00105781|Exercise|exercise
5382298|NCT00105755|Activity Cycles|activity cycles
5382299|NCT00105755|Amputation|amputation
5382300|NCT00105755|Prevention|prevention
5382301|NCT00105755|Temperature|temperature
5382302|NCT00105729|Self-help groups|self-help groups
5382303|NCT00105729|Referral and consultation|referral and consultation
5382304|NCT00105716|hypertension|hypertension
5382305|NCT00105716|adherence|adherence
5382306|NCT00105716|cardiovascular diseases|cardiovascular diseases
5382307|NCT00105703|Nurse practitioners|nurse practitioners
5382308|NCT00105703|Case management|case management
5382309|NCT00105677|Racial/ethnic health disparities|racial/ethnic health disparities
5382310|NCT00105677|Attitudes|attitudes
5382311|NCT00105677|Osteoarthritis Management|osteoarthritis management
5382312|NCT00105677|Patient Perceptions|patient perceptions
5382313|NCT00105664|Outcomes Assessment|outcomes assessment
5382314|NCT00105664|Primary Health Care|primary health care
5382315|NCT00105664|Group Process|group process
5382316|NCT00105638|Intervention studies|intervention studies
5382317|NCT00105638|Health Care Costs|health care costs
5382318|NCT00105638|Telephone|telephone
5382319|NCT00105638|Caregivers|caregivers
5382321|NCT00105625|Nutrition|nutrition
5382322|NCT00105625|Immune function|immune function
5382323|NCT00105625|Infection|infection
5382324|NCT00105625|Rehabilitation|rehabilitation
5382325|NCT00105625|Inpatient|inpatient
5382326|NCT00105612|Informed Consent|informed consent
5382327|NCT00105612|Memory Aid|memory aid
5382328|NCT00105586|Anxiety|anxiety
5382329|NCT00105586|Elderly|elderly
5382330|NCT00105586|Aged|aged
5382331|NCT00105586|Serotonin Reuptake Inhibitors|serotonin reuptake inhibitors
5382332|NCT00105586|SSRI|ssri
5382333|NCT00105586|SERT|sert
5382334|NCT00105573|Mother-Child Relations|mother-child relations
5382335|NCT00105573|Infant|infant
5382336|NCT00105573|Child Development|child development
5382337|NCT00105573|Poverty|poverty
5382338|NCT00105560|long-term effects secondary to cancer therapy in children|long-term effects secondary to cancer therapy in children
5382339|NCT00105560|untreated childhood medulloblastoma|untreated childhood medulloblastoma
5382340|NCT00105560|untreated childhood pineoblastoma|untreated childhood pineoblastoma
5382341|NCT00105547|Alzheimer's|alzheimer's
5382342|NCT00105547|Dementia|dementia
5382343|NCT00105547|Dementia of Alzheimer Type|dementia of alzheimer type
5382344|NCT00105534|Bacterial Conjunctivitis|bacterial conjunctivitis
5382345|NCT00105534|Pink Eye|pink eye
5382346|NCT00105534|Conjunctivitis|conjunctivitis
5382347|NCT00105534|Eye Infection|eye infection
5382348|NCT00105534|Eye Discharge|eye discharge
5382349|NCT00105521|Parkinson's Disease|parkinson's disease
5382350|NCT00105521|Dyskinesia|dyskinesia
5382351|NCT00105521|Dyskinesia associated with dopaminergic treatment|dyskinesia associated with dopaminergic treatment
5382352|NCT00105508|Parkinson's Disease|parkinson's disease
5382353|NCT00105508|Dyskinesia|dyskinesia
5382354|NCT00105508|Dyskinesia associated with dopaminergic treatment|dyskinesia associated with dopaminergic treatment
5382355|NCT00105495|Iron Overload|iron overload
5382356|NCT00105495|Thalassemia|thalassemia
5382357|NCT00105495|Haemosiderosis|haemosiderosis
5382358|NCT00105495|Cardiac|cardiac
5382359|NCT00105495|Deferiprone|deferiprone
5382360|NCT00105495|Chelation|chelation
5382361|NCT00105482|Tobacco|tobacco
5382362|NCT00105482|Smoking|smoking
5382363|NCT00105482|Weight|weight
5382364|NCT00105482|Weight perception|weight perception
5382365|NCT00105482|Naltrexone|naltrexone
5382366|NCT00105469|Bacterial Conjunctivitis|bacterial conjunctivitis
5382367|NCT00105469|Pink Eye|pink eye
5382368|NCT00105469|Conjunctivitis|conjunctivitis
5382369|NCT00105469|Eye Infection|eye infection
5382370|NCT00105456|HER2-Positive Metastatic Breast Cancer|her2-positive metastatic breast cancer
5382371|NCT00105456|HER2|her2
5382372|NCT00105443|Liver Cancer|liver cancer
5382373|NCT00105443|Cancer|cancer
5382374|NCT00105430|Surgery|surgery
5382375|NCT00105430|Treatment|treatment
5382376|NCT00105430|Physiology|physiology
5382377|NCT00105430|Pediatric|pediatric
5382378|NCT00105430|Neurosurgery|neurosurgery
5382379|NCT00105430|Generalized Primary Dystonia|generalized primary dystonia
5382380|NCT00105417|Immune Reconstitution|immune reconstitution
5382381|NCT00105417|Thymus|thymus
5382382|NCT00105417|Cytokines|cytokines
5382383|NCT00105417|HIV|hiv
5382384|NCT00105404|Steroid|steroid
5382385|NCT00105404|Diabetic Macular Edema|diabetic macular edema
5382386|NCT00105404|DME|dme
5382387|NCT00105378|health care services research|health care services research
5382388|NCT00105378|frail elderly|frail elderly
5382389|NCT00105378|intermediate care|intermediate care
5382390|NCT00105378|patient centered care|patient centered care
5382391|NCT00105378|comprehensive health care|comprehensive health care
5382392|NCT00105378|geriatric nursing|geriatric nursing
5382393|NCT00105378|Behavioral symptoms|behavioral symptoms
5382394|NCT00105365|lateral wedge inserts|lateral wedge inserts
5382395|NCT00105365|shoe inserts|shoe inserts
5382396|NCT00105352|Type 1 Diabetes Study Group|type 1 diabetes study group
5382397|NCT00105352|TrialNet|trialnet
5382398|NCT00105352|type 1 diabetes|type 1 diabetes
5382399|NCT00105352|juvenile onset diabetes|juvenile onset diabetes
5382400|NCT00105339|consent form, vaccine trial|consent form, vaccine trial
5382401|NCT00105339|Simplified consent form|simplified consent form
5382402|NCT00105326|Schizophrenia|schizophrenia
5382403|NCT00105326|Schizophrenia-related insomnia|schizophrenia-related insomnia
5382404|NCT00105326|insomnia|insomnia
5382405|NCT00105326|paliperidone|paliperidone
5382406|NCT00105326|placebo|placebo
5382407|NCT00105326|polysomnography|polysomnography
5382408|NCT00105287|cancer|cancer
5382409|NCT00105287|pain|pain
5382410|NCT00105287|Breakthrough Pain in cancer patients|breakthrough pain in cancer patients
5382411|NCT00105274|Velocardiofacial Syndrome|velocardiofacial syndrome
5382412|NCT00105274|Susceptibility Genes|susceptibility genes
5382413|NCT00105274|Neuroimaging|neuroimaging
5382414|NCT00105274|22q11.2|22q11.2
5382415|NCT00105274|Psychosis|psychosis
5382416|NCT00105274|Mircodeletion|mircodeletion
5382417|NCT00105274|DiGeorge Syndrome|digeorge syndrome
5382418|NCT00105274|22q11.2 Syndrome|22q11.2 syndrome
5382419|NCT00105248|acute repiratory infections|acute repiratory infections
5382420|NCT00105248|antibiotic therapy|antibiotic therapy
5382421|NCT00105248|patient-centred communication|patient-centred communication
5382422|NCT00105248|randomized controlled trial|randomized controlled trial
5382423|NCT00105235|transplantation|transplantation
5382424|NCT00105235|liver transplant|liver transplant
5382425|NCT00105235|rejection|rejection
5382426|NCT00105235|tolerance|tolerance
5382427|NCT00105235|antibody induction|antibody induction
5382428|NCT00105222|Cycle Ergometer|cycle ergometer
5382429|NCT00105222|Exercise Physiology|exercise physiology
5382430|NCT00105222|Nitric Oxide|nitric oxide
5382431|NCT00105222|Sodium Nitrite|sodium nitrite
5382432|NCT00105222|Healthy Volunteers|healthy volunteers
5382433|NCT00105222|Normal Volunteer|normal volunteer
5382434|NCT00105222|Healthy Volunteer|healthy volunteer
5382435|NCT00105222|HV|hv
5382436|NCT00105209|Platelets|platelets
5382437|NCT00105196|Single or recurrent|single or recurrent
5382438|NCT00105196|non-psychotic episode of Major Depressive Disorder|non-psychotic episode of major depressive disorder
5382439|NCT00105183|pulmonary transplantation|pulmonary transplantation
5382440|NCT00105183|Pulmonary Allograft Rejection|pulmonary allograft rejection
5382441|NCT00105170|Monoclonal antibody|monoclonal antibody
5382442|NCT00105170|Advanced solid tumors|advanced solid tumors
5382443|NCT00105170|Tumors|tumors
5382444|NCT00105170|hCBE-11|hcbe-11
5382445|NCT00105144|Treatment Effectiveness|treatment effectiveness
5382446|NCT00105144|Treatment Efficacy|treatment efficacy
5382447|NCT00105144|Investigational, Therapies|investigational, therapies
5382448|NCT00105144|Antifungal, Systemic|antifungal, systemic
5382449|NCT00105144|Antibiotics, Antifungal|antibiotics, antifungal
5382450|NCT00105144|Micafungin|micafungin
5382451|NCT00105131|Parkinson's Disease|parkinson's disease
5382452|NCT00105131|Movement Disorders|movement disorders
5382453|NCT00105131|Tremor|tremor
5382454|NCT00105131|Alpha-Synuclein|alpha-synuclein
5382455|NCT00105131|Lewy Bodies|lewy bodies
5382456|NCT00105131|Parkinson Disease|parkinson disease
5382457|NCT00105131|PD|pd
5382458|NCT00105131|Movement Disorder|movement disorder
5382459|NCT00105131|Healthy Volunteer|healthy volunteer
5382460|NCT00105131|HV|hv
5382461|NCT00105118|Cognition|cognition
5382462|NCT00105118|Alpha|alpha
5382463|NCT00105118|Schizophrenia|schizophrenia
5382464|NCT00105118|Functional Connectivity|functional connectivity
5382465|NCT00105118|Oscillatory Potential|oscillatory potential
5382466|NCT00105105|Alzheimers|alzheimers
5382467|NCT00105105|cognition|cognition
5382468|NCT00105105|acetyl cholinesterase inhibitor|acetyl cholinesterase inhibitor
5382469|NCT00105105|GR-II antagonist|gr-ii antagonist
5382470|NCT00105066|Metabolic Syndrome|metabolic syndrome
5382471|NCT00105066|triglycerides|triglycerides
5382472|NCT00105066|HDL|hdl
5382473|NCT00105066|LDL|ldl
5382474|NCT00105066|High Blood Pressure|high blood pressure
5382475|NCT00105066|High Cholesterol|high cholesterol
5382476|NCT00105066|High Blood Sugar|high blood sugar
5382477|NCT00105040|Partial onset seizures|partial onset seizures
5382478|NCT00105040|epilepsy|epilepsy
5382479|NCT00105040|levetiracetam|levetiracetam
5382480|NCT00105040|Keppra|keppra
5382481|NCT00105040|cognition|cognition
5382482|NCT00105040|behavior|behavior
5382483|NCT00105040|pediatry|pediatry
5382484|NCT00105027|macular edema|macular edema
5382485|NCT00105027|central retinal vein occlusion (CRVO)|central retinal vein occlusion (crvo)
5382486|NCT00105027|branch retinal vein occlusion (BRVO)|branch retinal vein occlusion (brvo)
5382487|NCT00104988|stage IV melanoma|stage iv melanoma
5382488|NCT00104975|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5382489|NCT00104975|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5382490|NCT00104975|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5382491|NCT00104975|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5382492|NCT00104975|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5382493|NCT00104975|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5382494|NCT00104975|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5382495|NCT00104975|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
5382496|NCT00104975|refractory anemia with excess blasts|refractory anemia with excess blasts
5382497|NCT00104975|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5382498|NCT00104975|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5382499|NCT00104975|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5382500|NCT00104975|chronic eosinophilic leukemia|chronic eosinophilic leukemia
5382501|NCT00104975|primary myelofibrosis|primary myelofibrosis
5382502|NCT00104975|chronic neutrophilic leukemia|chronic neutrophilic leukemia
5382503|NCT00104975|essential thrombocythemia|essential thrombocythemia
5382504|NCT00104975|polycythemia vera|polycythemia vera
5382505|NCT00104975|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5382506|NCT00104975|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5382507|NCT00104975|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5382508|NCT00104975|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5382509|NCT00104975|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5383120|NCT00102752|Solid|solid
5382510|NCT00104975|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5382511|NCT00104975|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5382512|NCT00104975|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5382513|NCT00104975|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5382514|NCT00104975|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5382515|NCT00104975|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5382516|NCT00104975|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5382517|NCT00104975|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5382518|NCT00104975|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
5382519|NCT00104975|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5382520|NCT00104975|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5382521|NCT00104975|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
5382522|NCT00104949|adult synovial sarcoma|adult synovial sarcoma
5382523|NCT00104949|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
5382524|NCT00104949|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
5382525|NCT00104949|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
5382526|NCT00104936|adult grade I meningioma|adult grade i meningioma
5382527|NCT00104923|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5382528|NCT00104923|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5382529|NCT00104923|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5382530|NCT00104923|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5382531|NCT00104923|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5382532|NCT00104923|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5382533|NCT00104923|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5382534|NCT00104923|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5382535|NCT00104923|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5382536|NCT00104923|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5382537|NCT00104923|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
5382538|NCT00104923|adult grade III lymphomatoid granulomatosis|adult grade iii lymphomatoid granulomatosis
5382539|NCT00104923|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
5382540|NCT00104923|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5382541|NCT00104923|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5382542|NCT00104923|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5382543|NCT00104923|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5382544|NCT00104923|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5382545|NCT00104923|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5382546|NCT00104923|refractory multiple myeloma|refractory multiple myeloma
5382547|NCT00104923|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5382548|NCT00104923|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5382549|NCT00104923|chronic eosinophilic leukemia|chronic eosinophilic leukemia
5382550|NCT00104923|primary myelofibrosis|primary myelofibrosis
5382551|NCT00104923|chronic neutrophilic leukemia|chronic neutrophilic leukemia
5382552|NCT00104923|essential thrombocythemia|essential thrombocythemia
5382553|NCT00104923|polycythemia vera|polycythemia vera
5382554|NCT00104923|stage II multiple myeloma|stage ii multiple myeloma
5382555|NCT00104923|stage III multiple myeloma|stage iii multiple myeloma
5382556|NCT00104923|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5382557|NCT00104923|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5382558|NCT00104923|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5382559|NCT00104923|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5382560|NCT00104923|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5382561|NCT00104923|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5382562|NCT00104923|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5382563|NCT00104923|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5382564|NCT00104897|recurrent melanoma|recurrent melanoma
5382565|NCT00104897|stage IV melanoma|stage iv melanoma
5382566|NCT00104884|stage III melanoma|stage iii melanoma
5382567|NCT00104884|stage IV melanoma|stage iv melanoma
5382568|NCT00104884|Depsipeptide|depsipeptide
5382569|NCT00104871|National Thyroid Cancer Treatment Cooperative Study Group|national thyroid cancer treatment cooperative study group
5382570|NCT00104871|NTCTCSG|ntctcsg
5382571|NCT00104871|bortezomib|bortezomib
5382572|NCT00104871|velcade|velcade
5382573|NCT00104871|metastatic differentiated thyroid carcinoma|metastatic differentiated thyroid carcinoma
5382574|NCT00104871|Differentiated thyroid carcinoma|differentiated thyroid carcinoma
5382575|NCT00104871|follicular epithelial thyroid cells|follicular epithelial thyroid cells
5382576|NCT00104871|papillary|papillary
5382577|NCT00104871|oxyphilic cell|oxyphilic cell
5382578|NCT00104871|Hurthle cell|hurthle cell
5382579|NCT00104871|insular cell|insular cell
5382580|NCT00104871|columnar cell|columnar cell
5382581|NCT00104871|tall cell|tall cell
5382582|NCT00104845|stage II melanoma|stage ii melanoma
5382583|NCT00104845|stage III melanoma|stage iii melanoma
5382584|NCT00104845|stage IV melanoma|stage iv melanoma
5382585|NCT00104845|recurrent melanoma|recurrent melanoma
5382586|NCT00104819|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5382587|NCT00104819|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5382588|NCT00104819|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5382589|NCT00104806|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5382590|NCT00104806|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
5382591|NCT00104806|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5382592|NCT00104806|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5382593|NCT00104806|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
5382594|NCT00104806|refractory anemia with excess blasts|refractory anemia with excess blasts
5382595|NCT00104806|refractory anemia|refractory anemia
5382596|NCT00104806|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
5382597|NCT00104806|refractory cytopenia with multilineage dysplasia|refractory cytopenia with multilineage dysplasia
5382598|NCT00104806|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5382599|NCT00104806|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
5382600|NCT00104793|extensive stage small cell lung cancer|extensive stage small cell lung cancer
5382601|NCT00104780|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5382602|NCT00104780|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5382603|NCT00104780|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5382604|NCT00104767|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5382605|NCT00104767|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5382606|NCT00104767|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5382607|NCT00104754|extensive stage small cell lung cancer|extensive stage small cell lung cancer
5382608|NCT00104754|limited stage small cell lung cancer|limited stage small cell lung cancer
5382609|NCT00104754|recurrent small cell lung cancer|recurrent small cell lung cancer
5382610|NCT00104741|stage IIB prostate cancer|stage iib prostate cancer
5382611|NCT00104741|stage IIA prostate cancer|stage iia prostate cancer
5382612|NCT00104741|stage III prostate cancer|stage iii prostate cancer
5382613|NCT00104728|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
5382614|NCT00104728|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5382615|NCT00104728|stage IA non-small cell lung cancer|stage ia non-small cell lung cancer
5382616|NCT00104728|stage IB non-small cell lung cancer|stage ib non-small cell lung cancer
5382617|NCT00104715|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5382618|NCT00104715|recurrent prostate cancer|recurrent prostate cancer
5382619|NCT00104715|stage IV prostate cancer|stage iv prostate cancer
5382620|NCT00104702|stage I breast cancer|stage i breast cancer
5382621|NCT00104702|stage II breast cancer|stage ii breast cancer
5382622|NCT00104689|stage IV colon cancer|stage iv colon cancer
5382623|NCT00104689|stage IV rectal cancer|stage iv rectal cancer
5382624|NCT00104689|adenocarcinoma of the colon|adenocarcinoma of the colon
5382625|NCT00104689|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5382626|NCT00104676|stage II malignant testicular germ cell tumor|stage ii malignant testicular germ cell tumor
5382627|NCT00104676|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
5382628|NCT00104676|testicular choriocarcinoma and embryonal carcinoma|testicular choriocarcinoma and embryonal carcinoma
5382629|NCT00104676|testicular choriocarcinoma and teratoma|testicular choriocarcinoma and teratoma
5382630|NCT00104676|testicular choriocarcinoma and yolk sac tumor|testicular choriocarcinoma and yolk sac tumor
5382631|NCT00104676|testicular choriocarcinoma|testicular choriocarcinoma
5382632|NCT00104676|testicular embryonal carcinoma and teratoma|testicular embryonal carcinoma and teratoma
5382633|NCT00104676|testicular embryonal carcinoma and yolk sac tumor|testicular embryonal carcinoma and yolk sac tumor
5382634|NCT00104676|testicular embryonal carcinoma|testicular embryonal carcinoma
5382635|NCT00104676|testicular yolk sac tumor and teratoma|testicular yolk sac tumor and teratoma
5382636|NCT00104676|testicular yolk sac tumor|testicular yolk sac tumor
5382637|NCT00104676|stage II extragonadal non-seminomatous germ cell tumor|stage ii extragonadal non-seminomatous germ cell tumor
5382638|NCT00104676|stage III extragonadal non-seminomatous germ cell tumor|stage iii extragonadal non-seminomatous germ cell tumor
5382639|NCT00104676|testicular immature teratoma|testicular immature teratoma
5382640|NCT00104676|testicular mature teratoma|testicular mature teratoma
5382641|NCT00104676|adult teratoma|adult teratoma
5382642|NCT00104663|Creutzfeldt-Jakob disease|creutzfeldt-jakob disease
5382643|NCT00104663|inherited|inherited
5382644|NCT00104663|sporadic|sporadic
5382645|NCT00104663|acquired|acquired
5382646|NCT00104663|new variant CJD|new variant cjd
5382647|NCT00104650|Bone Metastases|bone metastases
5382648|NCT00104650|AMG 162|amg 162
5382649|NCT00104650|Bisphosphonates|bisphosphonates
5382650|NCT00104650|Solid Tumor Carcinomas|solid tumor carcinomas
5382651|NCT00104650|Advanced|advanced
5382652|NCT00104637|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5382653|NCT00104637|Emphysema|emphysema
5382654|NCT00104637|Phosphodiesterase inhibitors|phosphodiesterase inhibitors
5382655|NCT00104637|Sildenafil|sildenafil
5382656|NCT00104637|Exercise testing|exercise testing
5382657|NCT00104637|Quality of life|quality of life
5382658|NCT00104624|stage IV breast cancer|stage iv breast cancer
5382659|NCT00104624|recurrent breast cancer|recurrent breast cancer
5382660|NCT00104611|Major Depressive Disorder|major depressive disorder
5382661|NCT00104611|Repetitive Transcranial Magnetic Stimulation|repetitive transcranial magnetic stimulation
5382662|NCT00104611|rTMS|rtms
5382663|NCT00104611|Non-invasive Neuromodulation|non-invasive neuromodulation
5382664|NCT00104611|Antidepressant|antidepressant
5382665|NCT00104585|Parkinson's disease|parkinson's disease
5382667|NCT00104585|gene|gene
5382668|NCT00104585|environment|environment
5382669|NCT00104585|early-onset Parkinson's disease|early-onset parkinson's disease
5382670|NCT00104572|Estrogen|estrogen
5382671|NCT00104572|Glucose Tolerance|glucose tolerance
5382672|NCT00104572|Bone Density|bone density
5382673|NCT00104572|Quality-of-Life|quality-of-life
5382674|NCT00104572|Sarcopenia|sarcopenia
5382675|NCT00104559|HIV|hiv
5382676|NCT00104559|Informed Consent|informed consent
5382677|NCT00104546|Dysmenorrhea|dysmenorrhea
5382678|NCT00104546|Acupuncture|acupuncture
5382679|NCT00104546|Vitamin K|vitamin k
5382680|NCT00104546|Medicine, Chinese Traditional|medicine, chinese traditional
5382681|NCT00104546|Women|women
5382682|NCT00104546|Menstruation|menstruation
5382683|NCT00104546|Pain, Menstrual|pain, menstrual
5382684|NCT00104546|China|china
5382685|NCT00104533|Static magnetic therapy|static magnetic therapy
5382686|NCT00104533|Pain|pain
5382687|NCT00104533|Analgesia|analgesia
5382688|NCT00104533|Opioids|opioids
5382689|NCT00104520|Cystic Fibrosis|cystic fibrosis
5382690|NCT00104520|Pseudomonas aeruginosa|pseudomonas aeruginosa
5382691|NCT00104520|Pulmonary Cystic Fibrosis|pulmonary cystic fibrosis
5382692|NCT00104507|Serotonin|serotonin
5382693|NCT00104507|5-HT2c|5-ht2c
5382694|NCT00104507|Satiety|satiety
5382695|NCT00104507|Obesity|obesity
5382696|NCT00104507|Appetite suppressant|appetite suppressant
5382697|NCT00104507|Weight Loss|weight loss
5382698|NCT00104507|Overweight|overweight
5382699|NCT00104494|Cystic Fibrosis|cystic fibrosis
5382700|NCT00104494|Zinc supplementation|zinc supplementation
5382701|NCT00104494|Nutrition|nutrition
5382702|NCT00104494|Zinc absorption|zinc absorption
5382703|NCT00104494|Zinc excretion|zinc excretion
5382704|NCT00104494|Zinc status|zinc status
5382705|NCT00104481|cognitive behavior therapy|cognitive behavior therapy
5382706|NCT00104481|coping|coping
5382707|NCT00104481|smoking cessation|smoking cessation
5382708|NCT00104481|acceptance|acceptance
5382709|NCT00104481|expectancies|expectancies
5382710|NCT00104481|quit smoking|quit smoking
5382711|NCT00104481|quitting smoking|quitting smoking
5382712|NCT00104468|Single-arm, open-label, multi-center, dose escalation, continuous infusion, multi-dose, acute myeloid leukemia|single-arm, open-label, multi-center, dose escalation, continuous infusion, multi-dose, acute myeloid leukemia
5382713|NCT00104468|Acute myelogenous leukemia (AML) that has been refractory to prior therapy and/or is unlikely to benefit from known therapies|acute myelogenous leukemia (aml) that has been refractory to prior therapy and/or is unlikely to benefit from known therapies
5382714|NCT00104455|rFVIIa|rfviia
5382715|NCT00104455|Punch Biopsy|punch biopsy
5382716|NCT00104455|Dose Response|dose response
5382717|NCT00104455|Healthy People Programs|healthy people programs
5382718|NCT00104442|Alzheimer's disease|alzheimer's disease
5382719|NCT00104442|memory loss|memory loss
5382720|NCT00104442|dementia|dementia
5382721|NCT00104442|senility|senility
5382722|NCT00104442|forgetful|forgetful
5382723|NCT00104442|geriatric|geriatric
5382724|NCT00104442|behavior|behavior
5382725|NCT00104442|mood swings|mood swings
5382726|NCT00104429|HIV infections|hiv infections
5382727|NCT00104429|therapy naive|therapy naive
5382728|NCT00104416|antiepileptic drugs|antiepileptic drugs
5382729|NCT00104416|seizures|seizures
5382730|NCT00104416|primary generalized tonic-clonic seizures|primary generalized tonic-clonic seizures
5382731|NCT00104416|Epilepsy|epilepsy
5382732|NCT00104416|lamotrigine|lamotrigine
5382733|NCT00104416|anticonvulsants|anticonvulsants
5382734|NCT00104416|LAMICTAL|lamictal
5382735|NCT00104403|Vomiting|vomiting
5382736|NCT00104403|CINV|cinv
5382737|NCT00104403|Emesis|emesis
5382738|NCT00104403|Nausea|nausea
5382739|NCT00104403|Chemotherapy-Induced Nausea and Vomiting|chemotherapy-induced nausea and vomiting
5382740|NCT00104390|allergy|allergy
5382741|NCT00104390|skin prick test|skin prick test
5382742|NCT00104390|allergoid|allergoid
5382743|NCT00104390|allergenicity|allergenicity
5382744|NCT00104390|specific immunotherapy|specific immunotherapy
5382745|NCT00104377|Allergy|allergy
5382746|NCT00104377|Allergoid|allergoid
5382747|NCT00104377|Specific Immunotherapy|specific immunotherapy
5382748|NCT00104338|Investigational Therapies|investigational therapies
5382749|NCT00104338|Treatment Effectiveness|treatment effectiveness
5382750|NCT00104338|Treatment Efficacy|treatment efficacy
5382751|NCT00104338|Immunosuppressant|immunosuppressant
5382752|NCT00104338|BK Nephropathy|bk nephropathy
5382753|NCT00104338|Polyomavirus, BK|polyomavirus, bk
5383121|NCT00102752|Tumor|tumor
5382754|NCT00104338|Human Polyomavirus BK|human polyomavirus bk
5382755|NCT00104338|Polyomavirus hominis 1|polyomavirus hominis 1
5382756|NCT00104325|Cytapheresis|cytapheresis
5382757|NCT00104325|Blood Collection|blood collection
5382758|NCT00104325|Volunteer Donor|volunteer donor
5382759|NCT00104325|White Blood Cells|white blood cells
5382760|NCT00104312|Knee Osteoarthritis|knee osteoarthritis
5382761|NCT00104312|Muscle|muscle
5382762|NCT00104312|Cytokine|cytokine
5382763|NCT00104312|Mobility|mobility
5382764|NCT00104312|Function|function
5382765|NCT00104299|ANCA|anca
5382766|NCT00104299|Vasculitis|vasculitis
5382767|NCT00104299|Wegener's Granulomatosis|wegener's granulomatosis
5382768|NCT00104299|microscopic polyangiitis|microscopic polyangiitis
5382769|NCT00104299|ANCA-positive|anca-positive
5382770|NCT00104299|ANCA-associated|anca-associated
5382771|NCT00104299|ANCA-associated vasculitis|anca-associated vasculitis
5382773|NCT00104273|Dementia, Alzheimer's Disease|dementia, alzheimer's disease
5382774|NCT00104247|Phenylalanine Hydroxylase|phenylalanine hydroxylase
5382775|NCT00104195|Anxiety|anxiety
5382776|NCT00104195|Adolescence|adolescence
5382777|NCT00104195|Generalized Anxiety Disorder|generalized anxiety disorder
5382778|NCT00104169|Anemia|anemia
5382779|NCT00104169|Frailty|frailty
5382780|NCT00104169|Epoetin|epoetin
5382781|NCT00104169|Erythropoietin|erythropoietin
5382782|NCT00104169|EPO|epo
5382783|NCT00104156|Knee pain|knee pain
5382784|NCT00104156|Arthritis|arthritis
5382785|NCT00104156|Qigong|qigong
5382786|NCT00104156|Qi|qi
5382787|NCT00104156|Meditation|meditation
5382788|NCT00104156|Breathing Exercises|breathing exercises
5382789|NCT00104130|prostate|prostate
5382790|NCT00104104|Z-MAX, multiple myeloma, zoledronic acid, bone metastases|z-max, multiple myeloma, zoledronic acid, bone metastases
5382791|NCT00104091|Gross Total Resection|gross total resection
5382792|NCT00104091|Convection Enhanced Delivery|convection enhanced delivery
5382793|NCT00104091|Recurrent Glioblastoma Multiforme|recurrent glioblastoma multiforme
5382794|NCT00104065|oral mucositis|oral mucositis
5382795|NCT00104065|oncology - supportive care|oncology - supportive care
5382796|NCT00104065|mouth diseases|mouth diseases
5382797|NCT00104039|Amygdala|amygdala
5382798|NCT00104039|Orbital Frontal Cortex|orbital frontal cortex
5382799|NCT00104039|Serotonin|serotonin
5382800|NCT00104039|Orbitofrontal Cortex|orbitofrontal cortex
5382801|NCT00104039|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
5382802|NCT00104039|ADHD|adhd
5382803|NCT00104039|Anti-Social Behavior|anti-social behavior
5382804|NCT00104039|Healthy Volunteer|healthy volunteer
5382805|NCT00104039|HV|hv
5382806|NCT00104026|Periodontal Disease|periodontal disease
5382807|NCT00104026|Dilantin|dilantin
5382808|NCT00104026|Cyclosporin|cyclosporin
5382809|NCT00104026|Calcium-Channel Blockers|calcium-channel blockers
5382810|NCT00104026|Genetics|genetics
5382811|NCT00104026|Hereditary Gingival Fibromatosis|hereditary gingival fibromatosis
5382812|NCT00104026|HGF|hgf
5382813|NCT00104026|Gingival Overgrowth|gingival overgrowth
5382814|NCT00104026|Gum Overgrowth|gum overgrowth
5382815|NCT00104000|Neuromuscular|neuromuscular
5382816|NCT00104000|Elevation|elevation
5382817|NCT00104000|Current|current
5382818|NCT00104000|Videofluoroscopy|videofluoroscopy
5382819|NCT00104000|Nasoendoscopy|nasoendoscopy
5382820|NCT00104000|Healthy Volunteer|healthy volunteer
5382821|NCT00104000|HV|hv
5382822|NCT00103987|Panic Disorder|panic disorder
5382823|NCT00103987|Norepinephrine|norepinephrine
5382824|NCT00103987|Yohimbine|yohimbine
5382825|NCT00103987|Genes|genes
5382826|NCT00103987|Pathophysiology|pathophysiology
5382827|NCT00103987|Noradrenergic Mechanisms|noradrenergic mechanisms
5382828|NCT00103987|PET Imaging|pet imaging
5382829|NCT00103987|PD|pd
5382830|NCT00103987|Healthy Volunteer|healthy volunteer
5382831|NCT00103987|HV|hv
5382832|NCT00103974|multiple sclerosis|multiple sclerosis
5382833|NCT00103974|relapsing-remitting|relapsing-remitting
5382834|NCT00103974|secondary progressive|secondary progressive
5382835|NCT00103961|Acute Infection|acute infection
5382836|NCT00103961|HIV|hiv
5382837|NCT00103961|AIDS|aids
5382838|NCT00103961|Acute HIV|acute hiv
5382839|NCT00103961|Early HIV|early hiv
5382840|NCT00103935|diabetes|diabetes
5382841|NCT00103935|exenatide|exenatide
5382842|NCT00103935|long acting release|long acting release
5382843|NCT00103935|Amylin|amylin
5382844|NCT00103935|Lilly|lilly
5382845|NCT00103922|smokers cough|smokers cough
5382846|NCT00103896|High-risk youth|high-risk youth
5382847|NCT00103896|HIV infected youth|hiv infected youth
5382848|NCT00103896|Community mobilization|community mobilization
5382849|NCT00103896|HIV serosurveys|hiv serosurveys
5382850|NCT00103883|HIV|hiv
5382851|NCT00103883|Detuned Assay|detuned assay
5382852|NCT00103883|Enzyme Immunoassay (EIA)|enzyme immunoassay (eia)
5382853|NCT00103883|HIV Incidence|hiv incidence
5382854|NCT00103883|Laboratory assay|laboratory assay
5382855|NCT00103883|Sensitive/Less sensitive Assay|sensitive/less sensitive assay
5382856|NCT00103883|Acute Infection|acute infection
5382857|NCT00103870|Music Therapy|music therapy
5382858|NCT00103870|Electric Stimulation|electric stimulation
5382859|NCT00103870|Electric Shock|electric shock
5382860|NCT00103870|Analgesics|analgesics
5382861|NCT00103870|Distraction|distraction
5382862|NCT00103844|Chronic Phase Philadelphia chromosome Positive (Ph+) chronic myeloid leukemia|chronic phase philadelphia chromosome positive (ph+) chronic myeloid leukemia
5382863|NCT00103831|NSCLC - non-small cell lung cancer|nsclc - non-small cell lung cancer
5382864|NCT00103805|language acquisition|language acquisition
5382865|NCT00103805|plasticity|plasticity
5382866|NCT00103805|stroke recovery|stroke recovery
5382867|NCT00103805|associative learning|associative learning
5382868|NCT00103792|Induction therapy|induction therapy
5382869|NCT00103792|ANCA-associated vasculitis|anca-associated vasculitis
5382870|NCT00103792|Wegener's granulomatosis|wegener's granulomatosis
5382871|NCT00103792|microscopic polyangiitis|microscopic polyangiitis
5382872|NCT00103792|mycophenolate mofetil|mycophenolate mofetil
5382873|NCT00103792|cyclophosphamide|cyclophosphamide
5382874|NCT00103779|Antigens, CD40|antigens, cd40
5382875|NCT00103779|Antibody, Monoclonal|antibody, monoclonal
5382876|NCT00103779|Lymphoma, Non-Hodgkin|lymphoma, non-hodgkin
5382877|NCT00103779|Lymphoma, B-Cell|lymphoma, b-cell
5382878|NCT00103779|Hematologic Diseases|hematologic diseases
5382879|NCT00103779|Immunoproliferative Disorders|immunoproliferative disorders
5382880|NCT00103779|Lymphatic Diseases|lymphatic diseases
5382881|NCT00103779|Lymphoproliferative Disorders|lymphoproliferative disorders
5382882|NCT00103779|Lymphoma|lymphoma
5382883|NCT00103766|Alteplase|alteplase
5382884|NCT00103766|Empyema|empyema
5382885|NCT00103766|Complicated Parapneumonic Effusion|complicated parapneumonic effusion
5382886|NCT00103753|Randomized Controlled Trial|randomized controlled trial
5382887|NCT00103753|Deferiprone|deferiprone
5382888|NCT00103753|Deferoxamine|deferoxamine
5382889|NCT00103753|Iron chelation|iron chelation
5382890|NCT00103753|Beta Thalassemia Major|beta thalassemia major
5382891|NCT00103740|Zoledronic acid, risedronate, Paget's disease of bone|zoledronic acid, risedronate, paget's disease of bone
5382892|NCT00103727|paranoid|paranoid
5382893|NCT00103727|catatonic|catatonic
5382894|NCT00103727|undifferentiated types|undifferentiated types
5382895|NCT00103727|disorganized|disorganized
5382896|NCT00103714|lung disease|lung disease
5382897|NCT00103701|Chronic myelogenous leukemia (CML) chronic, accelerated, blast phase|chronic myelogenous leukemia (cml) chronic, accelerated, blast phase
5382898|NCT00103701|Philadelphia chromosome positive acute (Ph+ALL)|philadelphia chromosome positive acute (ph+all)
5382899|NCT00103675|Acupuncture|acupuncture
5382900|NCT00103636|Phlebitis/etiology|phlebitis/etiology
5382901|NCT00103636|Infusions|infusions
5382902|NCT00103636|Intravenous/adverse effects|intravenous/adverse effects
5382903|NCT00103636|Randomised controlled trial|randomised controlled trial
5382904|NCT00103636|Phlebitis/prevention|phlebitis/prevention
5382905|NCT00103636|Adult|adult
5382906|NCT00103636|Time factors|time factors
5382907|NCT00103623|Advanced|advanced
5382908|NCT00103623|Symptomatic|symptomatic
5382909|NCT00103623|Prostate|prostate
5382910|NCT00103623|Cancer|cancer
5382911|NCT00103623|Advanced Symptomatic Prostate Cancer|advanced symptomatic prostate cancer
5382912|NCT00103610|Non-Hodgkin's lymphoma|non-hodgkin's lymphoma
5382913|NCT00103610|Stem cell mobilization|stem cell mobilization
5382914|NCT00103597|Orthostatic hypotension|orthostatic hypotension
5382915|NCT00103597|Parkinson's Disease|parkinson's disease
5382916|NCT00103545|Ovarian Cancer|ovarian cancer
5382917|NCT00103545|ACA 125|aca 125
5382918|NCT00103545|6 or 9 vaccinations|6 or 9 vaccinations
5382919|NCT00103545|immune response|immune response
5382920|NCT00103545|Fallopian tube cancer|fallopian tube cancer
5382921|NCT00103545|Peritoneal cancer|peritoneal cancer
5382922|NCT00103532|motivational enhancement|motivational enhancement
5382923|NCT00103532|health behaviors|health behaviors
5382924|NCT00103532|risk behaviors|risk behaviors
5382925|NCT00103519|Heart Failure, DITPA|heart failure, ditpa
5382926|NCT00103506|Multiple Myeloma|multiple myeloma
5382927|NCT00103506|Doxil|doxil
5382928|NCT00103506|Caelyx|caelyx
5382929|NCT00103506|Doxorubicin|doxorubicin
5382930|NCT00103506|Velcade|velcade
5382931|NCT00103506|Bortezomib|bortezomib
5382932|NCT00103454|allergic rhinitis|allergic rhinitis
5382933|NCT00103454|GW685698X|gw685698x
5382934|NCT00103454|Perennial Allergic Rhinitis|perennial allergic rhinitis
5382935|NCT00103428|chemotherapy|chemotherapy
5382936|NCT00103428|prostate cancer|prostate cancer
5382937|NCT00103428|cancer|cancer
5382938|NCT00103428|metastatic|metastatic
5382939|NCT00103428|hormone refractory|hormone refractory
5382940|NCT00103428|chemotherapy naive|chemotherapy naive
5382941|NCT00103428|dose escalation|dose escalation
5382942|NCT00103415|Depression|depression
5382943|NCT00103415|Exercise|exercise
5382944|NCT00103415|Job|job
5382945|NCT00103402|Prostatitis|prostatitis
5382946|NCT00103402|Non-bacterial Prostatitis|non-bacterial prostatitis
5382947|NCT00103402|Prostatodynia|prostatodynia
5382948|NCT00103402|Alfuzosin|alfuzosin
5382949|NCT00103402|Alpha-adrenergic blocker|alpha-adrenergic blocker
5382950|NCT00103389|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5382951|NCT00103389|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5382952|NCT00103389|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5382953|NCT00103376|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5382954|NCT00103376|recurrent prostate cancer|recurrent prostate cancer
5382955|NCT00103363|non-small cell lung cancer|non-small cell lung cancer
5382956|NCT00103363|small cell lung cancer|small cell lung cancer
5382957|NCT00103350|myocardial infarction|myocardial infarction
5382958|NCT00103350|infarct size|infarct size
5382959|NCT00103350|angioplasty|angioplasty
5382960|NCT00103350|percutaneous coronary intervention|percutaneous coronary intervention
5382961|NCT00103350|Acute Myocardial Infarction|acute myocardial infarction
5382962|NCT00103298|recurrent colon cancer|recurrent colon cancer
5382963|NCT00103298|stage IV colon cancer|stage iv colon cancer
5382964|NCT00103298|recurrent rectal cancer|recurrent rectal cancer
5382965|NCT00103298|stage IV rectal cancer|stage iv rectal cancer
5382966|NCT00103298|liver metastases|liver metastases
5382967|NCT00103246|skin cancer|skin cancer
5382968|NCT00103246|squamous cell carcinoma of the skin|squamous cell carcinoma of the skin
5382969|NCT00103246|basal cell carcinoma of the skin|basal cell carcinoma of the skin
5382970|NCT00103246|recurrent skin cancer|recurrent skin cancer
5382971|NCT00103246|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5382972|NCT00103246|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
5382973|NCT00103246|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
5382974|NCT00103246|actinic keratosis|actinic keratosis
5382975|NCT00103246|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5382976|NCT00103246|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
5382977|NCT00103246|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
5382978|NCT00103233|stage IV breast cancer|stage iv breast cancer
5382979|NCT00103233|recurrent breast cancer|recurrent breast cancer
5382980|NCT00103207|bronchioalveolar carcinoma (BAC)|bronchioalveolar carcinoma (bac)
5382981|NCT00103207|adenocarcinoma with BAC features|adenocarcinoma with bac features
5382982|NCT00103207|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5382983|NCT00103207|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5382984|NCT00103207|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5382985|NCT00103207|cetuximab|cetuximab
5382986|NCT00103181|stage II breast cancer|stage ii breast cancer
5382987|NCT00103181|ductal breast carcinoma in situ|ductal breast carcinoma in situ
5382988|NCT00103181|breast cancer in situ|breast cancer in situ
5382989|NCT00103181|stage IA breast cancer|stage ia breast cancer
5382990|NCT00103181|stage IB breast cancer|stage ib breast cancer
5382991|NCT00103168|gastrointestinal stromal tumor|gastrointestinal stromal tumor
5382992|NCT00103155|stage I papillary thyroid cancer|stage i papillary thyroid cancer
5382993|NCT00103142|liver metastases|liver metastases
5382994|NCT00103142|adenocarcinoma of the colon|adenocarcinoma of the colon
5382995|NCT00103142|recurrent colon cancer|recurrent colon cancer
5382996|NCT00103142|stage IV colon cancer|stage iv colon cancer
5382997|NCT00103142|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5382998|NCT00103142|recurrent rectal cancer|recurrent rectal cancer
5382999|NCT00103142|stage IV rectal cancer|stage iv rectal cancer
5383000|NCT00103142|lung metastases|lung metastases
5383001|NCT00103116|stage I non-small cell lung cancer|stage i non-small cell lung cancer
5383002|NCT00103116|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
5383003|NCT00103116|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5383004|NCT00103116|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5383005|NCT00103116|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
5383006|NCT00103103|recurrent gastric cancer|recurrent gastric cancer
5383007|NCT00103103|stage IV gastric cancer|stage iv gastric cancer
5383008|NCT00103103|adenocarcinoma of the stomach|adenocarcinoma of the stomach
5383009|NCT00103090|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
5383010|NCT00103090|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
5383011|NCT00103090|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5383012|NCT00103090|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
5383013|NCT00103090|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
5383014|NCT00103090|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5383015|NCT00103090|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
5383016|NCT00103090|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
5383017|NCT00103090|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5383018|NCT00103090|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
5383019|NCT00103090|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
5383020|NCT00103090|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
5383021|NCT00103090|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
5383022|NCT00103090|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
5383023|NCT00103090|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5383122|NCT00102752|Advanced Solid Tumors|advanced solid tumors
5383024|NCT00103090|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
5383025|NCT00103090|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
5383026|NCT00103090|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
5383027|NCT00103090|recurrent salivary gland cancer|recurrent salivary gland cancer
5383028|NCT00103090|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
5383029|NCT00103090|stage III salivary gland cancer|stage iii salivary gland cancer
5383030|NCT00103090|stage IV salivary gland cancer|stage iv salivary gland cancer
5383031|NCT00103090|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
5383032|NCT00103090|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
5383033|NCT00103051|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5383034|NCT00103025|Vasodilation|vasodilation
5383035|NCT00103025|Hypotension|hypotension
5383036|NCT00103025|Hypertension|hypertension
5383037|NCT00103025|EDRF|edrf
5383038|NCT00103025|Methemoglobinemia|methemoglobinemia
5383039|NCT00103025|Healthy Volunteer|healthy volunteer
5383040|NCT00103025|HV|hv
5383041|NCT00103012|Antiretrovirals|antiretrovirals
5383042|NCT00103012|Protease Inhibitors|protease inhibitors
5383043|NCT00103012|Herbal Supplements|herbal supplements
5383044|NCT00103012|Drug Interactions|drug interactions
5383045|NCT00103012|Metabolism|metabolism
5383046|NCT00103012|Healthy Volunteer|healthy volunteer
5383047|NCT00103012|HV|hv
5383048|NCT00102999|Learning|learning
5383049|NCT00102999|PAS|pas
5383050|NCT00102999|Upper Limb|upper limb
5383051|NCT00102999|TMS|tms
5383052|NCT00102999|Somatosensory|somatosensory
5383053|NCT00102999|Dystonia|dystonia
5383054|NCT00102999|Upper Limb Dystonia|upper limb dystonia
5383055|NCT00102999|Healthy Volunteer|healthy volunteer
5383056|NCT00102999|HV|hv
5383057|NCT00102986|Kaletra|kaletra
5383058|NCT00102986|Treatment Experienced|treatment experienced
5383059|NCT00102973|Ovary|ovary
5383060|NCT00102960|Infant|infant
5383061|NCT00102960|Perinatal|perinatal
5383062|NCT00102960|HIV|hiv
5383063|NCT00102960|Disease Transmission, Vertical|disease transmission, vertical
5383064|NCT00102960|Anti-Retroviral Agents|anti-retroviral agents
5383065|NCT00102960|Treatment Interruption|treatment interruption
5383066|NCT00102960|Treatment Naive|treatment naive
5383067|NCT00102960|Acute Infection|acute infection
5383068|NCT00102960|Mother-to-Child Transmission|mother-to-child transmission
5383069|NCT00102947|renal impairment|renal impairment
5383070|NCT00102947|daptomycin|daptomycin
5383071|NCT00102947|Cubist|cubist
5383072|NCT00102947|complicated skin and skin structure infections|complicated skin and skin structure infections
5383073|NCT00102934|HIV|hiv
5383074|NCT00102934|Drug Resistance|drug resistance
5383075|NCT00102934|Viral Fitness|viral fitness
5383076|NCT00102934|HIV Specific Immunity|hiv specific immunity
5383077|NCT00102934|T Cell Activation|t cell activation
5383078|NCT00102934|Drug Resistant Viremia|drug resistant viremia
5383079|NCT00102934|Treatment Experienced|treatment experienced
5383080|NCT00102921|Crohn Disease|crohn disease
5383081|NCT00102921|oral medication|oral medication
5383082|NCT00102908|Bone Metabolism|bone metabolism
5383083|NCT00102908|Osteopenia|osteopenia
5383084|NCT00102908|Osteoporosis|osteoporosis
5383085|NCT00102908|Treatment Experienced|treatment experienced
5383086|NCT00102882|genotype|genotype
5383087|NCT00102882|Salmeterol|salmeterol
5383088|NCT00102882|ADVAIR|advair
5383089|NCT00102869|language acquisition|language acquisition
5383090|NCT00102869|plasticity|plasticity
5383091|NCT00102869|stroke recovery|stroke recovery
5383092|NCT00102869|aphasia treatment|aphasia treatment
5383093|NCT00102869|naming|naming
5383094|NCT00102869|levodopa|levodopa
5383095|NCT00102869|stroke|stroke
5383096|NCT00102856|language acquisition|language acquisition
5383097|NCT00102856|plasticity|plasticity
5383098|NCT00102856|stroke recovery|stroke recovery
5383099|NCT00102856|associative learning|associative learning
5383100|NCT00102843|folic acid|folic acid
5383101|NCT00102843|betaine|betaine
5383102|NCT00102843|homocysteine|homocysteine
5383823|NCT00100334|Alzheimer's Disease|alzheimer's disease
5383103|NCT00102843|cardiovascular disease prevention|cardiovascular disease prevention
5383104|NCT00102843|human|human
5383105|NCT00102843|Cardiovascular health|cardiovascular health
5383106|NCT00102830|Solid Tumor|solid tumor
5383107|NCT00102830|Metastatic Cancer|metastatic cancer
5383108|NCT00102830|Advanced Solid Tumors|advanced solid tumors
5383109|NCT00102817|Growth Hormone Disorder|growth hormone disorder
5383110|NCT00102791|Sickle Cell Anemia|sickle cell anemia
5383111|NCT00102778|HIV infected|hiv infected
5383112|NCT00102778|therapy-naive subjects|therapy-naive subjects
5383113|NCT00102765|asthma exacerbation|asthma exacerbation
5383114|NCT00102765|asthma|asthma
5383115|NCT00102752|Pancreas|pancreas
5383116|NCT00102752|Cancer|cancer
5383117|NCT00102752|Metastatic|metastatic
5383118|NCT00102752|Glufosfamide|glufosfamide
5383119|NCT00102752|Advanced|advanced
5383123|NCT00102752|Pancreatic Adenocarcinoma|pancreatic adenocarcinoma
5383124|NCT00102739|thrombopoietin|thrombopoietin
5383125|NCT00102739|immune thrombocytopenic purpura|immune thrombocytopenic purpura
5383126|NCT00102739|platelets|platelets
5383127|NCT00102739|chronic thrombocytopenia|chronic thrombocytopenia
5383128|NCT00102726|chemotherapy|chemotherapy
5383129|NCT00102726|thrombopoietin|thrombopoietin
5383130|NCT00102726|platelets|platelets
5383131|NCT00102726|chemotherapy induced|chemotherapy induced
5383132|NCT00102713|Partial Seizures|partial seizures
5383133|NCT00102700|cancer|cancer
5383134|NCT00102700|solid tumor|solid tumor
5383135|NCT00102700|advanced solid tumor|advanced solid tumor
5383136|NCT00102700|pancreas|pancreas
5383137|NCT00102700|pancreatic cancer|pancreatic cancer
5383138|NCT00102700|cancer of the pancreas|cancer of the pancreas
5383139|NCT00102674|cangrelor|cangrelor
5383140|NCT00102674|clopidogrel|clopidogrel
5383141|NCT00102648|Glioblastoma Multiforme|glioblastoma multiforme
5383142|NCT00102648|Gliosarcoma|gliosarcoma
5383143|NCT00102648|Brain Tumors|brain tumors
5383144|NCT00102648|Sarasar|sarasar
5383145|NCT00102648|Temodar|temodar
5383146|NCT00102648|Temozolomide|temozolomide
5383147|NCT00102648|Lonafarnib|lonafarnib
5383148|NCT00102648|SCH 66336|sch 66336
5383149|NCT00102635|apoptotic activity|apoptotic activity
5383150|NCT00102635|4-HPR|4-hpr
5383151|NCT00102635|FTI|fti
5383152|NCT00102635|Fenretinide|fenretinide
5383153|NCT00102635|SCH66336|sch66336
5383154|NCT00102635|Farnesyl Transferase Inhibitor|farnesyl transferase inhibitor
5383155|NCT00102635|HNC|hnc
5383156|NCT00102622|Ovary|ovary
5383157|NCT00102622|ovarian cancer|ovarian cancer
5383158|NCT00102622|biologic therapy|biologic therapy
5383159|NCT00102622|platinum-resistant|platinum-resistant
5383160|NCT00102622|platinum-refractory ovarian cancer|platinum-refractory ovarian cancer
5383161|NCT00102622|platinum-resistant ovarian cancer|platinum-resistant ovarian cancer
5383162|NCT00102622|paclitaxel|paclitaxel
5383163|NCT00102622|tgDCC-E1A|tgdcc-e1a
5383164|NCT00102622|E1A|e1a
5383165|NCT00102622|Taxol|taxol
5383166|NCT00102609|Doxorubicin|doxorubicin
5383167|NCT00102609|Adriamycin|adriamycin
5383168|NCT00102609|Trabectedin|trabectedin
5383169|NCT00102609|Yondelis|yondelis
5383170|NCT00102609|Ecteinascidin 743|ecteinascidin 743
5383171|NCT00102609|Filgrastim, Antineoplastic|filgrastim, antineoplastic
5383172|NCT00102609|Antineoplastic Agents|antineoplastic agents
5383173|NCT00102609|Pharmacologic Actions|pharmacologic actions
5383174|NCT00102609|Alkylating Agents|alkylating agents
5383175|NCT00102596|Ethanol|ethanol
5383176|NCT00102596|Alcohol Responsive|alcohol responsive
5383177|NCT00102596|Movement Disorder|movement disorder
5383178|NCT00102596|Gas Chromatography|gas chromatography
5383179|NCT00102596|Bioavailability|bioavailability
5383180|NCT00102596|Pharmacokinetics|pharmacokinetics
5383181|NCT00102596|Essential Tremor|essential tremor
5383182|NCT00102583|Dry Eye|dry eye
5383183|NCT00102583|Lacrimal Gland|lacrimal gland
5383184|NCT00102583|Tear Deficiency|tear deficiency
5383185|NCT00102583|Keratitis Sicca|keratitis sicca
5383186|NCT00102583|GVHD|gvhd
5383187|NCT00102583|Ocular GVHD|ocular gvhd
5383188|NCT00102583|Ocular Graft Vs Host Disease|ocular graft vs host disease
5383189|NCT00102570|Pediatric|pediatric
5383190|NCT00102570|Atopic|atopic
5383191|NCT00102570|Asthma|asthma
5383192|NCT00102570|Rhinitis|rhinitis
5383193|NCT00102570|Outpatient|outpatient
5383194|NCT00102570|Allergy|allergy
5383195|NCT00102570|Pediatric Allergy|pediatric allergy
5383196|NCT00102570|Food Allergy|food allergy
5383197|NCT00102570|Stinging Insect Allergy|stinging insect allergy
5383198|NCT00102570|Atopic Dermatitis|atopic dermatitis
5383199|NCT00102570|Insect Sting|insect sting
5383200|NCT00102557|Vesiculobullous|vesiculobullous
5383201|NCT00102557|Mucosal Lesions|mucosal lesions
5383202|NCT00102557|Oral Health|oral health
5383203|NCT00102557|Dermatology|dermatology
5383204|NCT00102557|Plaquenil|plaquenil
5383205|NCT00102557|Oral Lichen Planus|oral lichen planus
5383206|NCT00102557|Mouth Lesions|mouth lesions
5383207|NCT00102557|Oral Lesions|oral lesions
5383208|NCT00102544|CT-Guided|ct-guided
5383209|NCT00102544|Electromagnetic Tracking|electromagnetic tracking
5383210|NCT00102544|Ultrasound-Guided Biopsy|ultrasound-guided biopsy
5383211|NCT00102544|Ablation|ablation
5383212|NCT00102544|Surgical Navigation|surgical navigation
5383213|NCT00102531|Osteosarcoma|osteosarcoma
5383214|NCT00102531|relapsed|relapsed
5383215|NCT00102531|progressive|progressive
5383216|NCT00102531|metastatic|metastatic
5383217|NCT00102531|lung|lung
5383218|NCT00102518|Open Label|open label
5383219|NCT00102518|Aripiprazole|aripiprazole
5383220|NCT00102518|Bipolar I Disorder, Manic or Mixed Episode|bipolar i disorder, manic or mixed episode
5383221|NCT00102505|Non-Small Cell Lung Cancer|non-small cell lung cancer
5383222|NCT00102505|Lung Cancer|lung cancer
5383223|NCT00102505|Metastatic lung cancer|metastatic lung cancer
5383224|NCT00102505|Inoperable lung cancer|inoperable lung cancer
5383225|NCT00102505|Advanced lung cancer|advanced lung cancer
5383226|NCT00102505|Large-cell lung cancer|large-cell lung cancer
5383227|NCT00102505|Adenocarcinoma, lung|adenocarcinoma, lung
5383228|NCT00102505|Squamous cell carcinoma, lung|squamous cell carcinoma, lung
5383229|NCT00102505|Squamous cell lung cancer|squamous cell lung cancer
5383230|NCT00102505|Large cell carcinoma, lung|large cell carcinoma, lung
5383231|NCT00102505|Bronchogenic|bronchogenic
5383232|NCT00102492|Major Depressive Disorder|major depressive disorder
5383233|NCT00102492|Major Depression|major depression
5383234|NCT00102492|Mood Disorders|mood disorders
5383235|NCT00102492|Major Depressive Episode|major depressive episode
5383236|NCT00102479|Pharmacokinetics,|pharmacokinetics,
5383237|NCT00102479|Aripiprazole|aripiprazole
5383238|NCT00102479|acute mania in pediatric populations|acute mania in pediatric populations
5383239|NCT00102466|type 2 diabetes|type 2 diabetes
5383240|NCT00102466|vildagliptin|vildagliptin
5383241|NCT00102453|Duchenne|duchenne
5383242|NCT00102453|Genetics|genetics
5383243|NCT00102440|uric Acid|uric acid
5383244|NCT00102440|xanthine oxidase|xanthine oxidase
5383246|NCT00102440|Drug Therapy|drug therapy
5383247|NCT00102427|Anxiety|anxiety
5383248|NCT00102427|Panic|panic
5383249|NCT00102427|Generalized Anxiety Disorder|generalized anxiety disorder
5383250|NCT00102414|Ovarian cancer|ovarian cancer
5383251|NCT00102414|Recurrence or progression|recurrence or progression
5383252|NCT00102414|Gemcitabine plus Carboplatin vs Carboplatin|gemcitabine plus carboplatin vs carboplatin
5383253|NCT00102401|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
5383254|NCT00102401|Pulmonary Disease, chronic obstructive|pulmonary disease, chronic obstructive
5383255|NCT00102401|Lung disease, obstructive|lung disease, obstructive
5383256|NCT00102401|Self-care|self-care
5383257|NCT00102401|Self-management|self-management
5383258|NCT00102401|Patient education|patient education
5383259|NCT00102388|type 2 diabetes|type 2 diabetes
5383260|NCT00102388|vildagliptin|vildagliptin
5383261|NCT00102375|Ovarian Cancer|ovarian cancer
5383262|NCT00102375|first-line|first-line
5383263|NCT00102375|Topotecan|topotecan
5383264|NCT00102362|behavioral intervention|behavioral intervention
5383265|NCT00102349|behavioral intervention|behavioral intervention
5383266|NCT00102336|immune (idiopathic) thrombocytopenic purpura|immune (idiopathic) thrombocytopenic purpura
5383267|NCT00102336|pre-splenectomy|pre-splenectomy
5383268|NCT00102336|ITP|itp
5383269|NCT00102336|Thrombopenia|thrombopenia
5383270|NCT00102323|immune (idiopathic) thrombocytopenic purpura|immune (idiopathic) thrombocytopenic purpura
5383271|NCT00102323|post-splenectomy|post-splenectomy
5383272|NCT00102323|ITP|itp
5383273|NCT00102323|Thrombopenia|thrombopenia
5383274|NCT00102310|Nausea|nausea
5383275|NCT00102310|Indigestion|indigestion
5383276|NCT00102310|Bloating|bloating
5383277|NCT00102310|Functional Dyspepsia|functional dyspepsia
5383278|NCT00102310|Fullness after Meals|fullness after meals
5383279|NCT00102297|Incipient Nephropathy|incipient nephropathy
5383280|NCT00102297|Type 1 or Type 2 Diabetes|type 1 or type 2 diabetes
5383281|NCT00102284|language acquisition|language acquisition
5383282|NCT00102284|plasticity|plasticity
5383283|NCT00102284|stroke recovery|stroke recovery
5383284|NCT00102284|associative learning|associative learning
5383285|NCT00102271|Sodium Nitrite|sodium nitrite
5383286|NCT00102271|Oxypurinol|oxypurinol
5383287|NCT00102271|Ascorbic Acid|ascorbic acid
5383288|NCT00102271|Hypoxic Gas|hypoxic gas
5383289|NCT00102271|Forearm Blood Flow|forearm blood flow
5383290|NCT00102271|Healthy Volunteer|healthy volunteer
5383291|NCT00102271|HV|hv
5383292|NCT00102258|Short Stature|short stature
5383293|NCT00102258|Constitutional Delay of Growth and Development|constitutional delay of growth and development
5383294|NCT00102258|Body Composition|body composition
5383295|NCT00102258|Energy Expenditure|energy expenditure
5383296|NCT00102258|Dietary Supplements|dietary supplements
5383297|NCT00102258|Constitutional Delay of Growth|constitutional delay of growth
5383298|NCT00102258|CDGM|cdgm
5383299|NCT00102245|Hemoglobin|hemoglobin
5383300|NCT00102245|Hemoglobinapathies|hemoglobinapathies
5383301|NCT00102245|Human Genome|human genome
5383302|NCT00102245|Recombinant DNA Technology|recombinant dna technology
5383303|NCT00102245|Sequencing|sequencing
5383304|NCT00102245|Erythrocyte|erythrocyte
5383305|NCT00102232|phosphatidylcholine|phosphatidylcholine
5383306|NCT00102232|choline|choline
5383307|NCT00102232|homocysteine|homocysteine
5383308|NCT00102232|cardiovascular disease prevention|cardiovascular disease prevention
5383309|NCT00102232|human|human
5383310|NCT00102232|cardiovascular health|cardiovascular health
5383311|NCT00102206|Treatment Experienced|treatment experienced
5383312|NCT00102206|Child|child
5383313|NCT00102193|Ulcerative Colitis, Apheresis|ulcerative colitis, apheresis
5383314|NCT00102141|Postmenopausal|postmenopausal
5383315|NCT00102141|vasomotor symptoms|vasomotor symptoms
5383316|NCT00102141|essential hypertension|essential hypertension
5383317|NCT00102115|Macular disease|macular disease
5383318|NCT00102115|Wet AMD|wet amd
5383319|NCT00102115|AMD|amd
5383320|NCT00102115|Age-Related Macular Disease|age-related macular disease
5383321|NCT00102115|PDT|pdt
5383322|NCT00102115|Photodynamic Therapy|photodynamic therapy
5383323|NCT00102102|Substance P|substance p
5383324|NCT00102102|Neurokinin|neurokinin
5383325|NCT00102102|Tachykinin|tachykinin
5383326|NCT00102102|Anxiety|anxiety
5383327|NCT00102102|Neuroreceptor Imaging|neuroreceptor imaging
5383328|NCT00102102|Post-Traumatic Stress Disorder|post-traumatic stress disorder
5383329|NCT00102102|PTSD|ptsd
5383330|NCT00102102|Healthy Volunteer|healthy volunteer
5383331|NCT00102102|HV|hv
5383332|NCT00102089|HIV-Negative|hiv-negative
5383333|NCT00102089|Healthy|healthy
5383334|NCT00102089|Immunity|immunity
5383335|NCT00102089|Preventive|preventive
5383336|NCT00102089|Virus|virus
5383337|NCT00102089|Healthy Volunteer|healthy volunteer
5383338|NCT00102089|HV|hv
5383339|NCT00102076|Minimal|minimal
5383340|NCT00102076|Risk|risk
5383341|NCT00102076|Regulations|regulations
5383342|NCT00102076|Parents|parents
5383343|NCT00102076|IRB|irb
5383344|NCT00102076|Surgery|surgery
5383345|NCT00102076|Assent Requirement|assent requirement
5383346|NCT00102063|Schizophrenia|schizophrenia
5383347|NCT00102063|Aripiprazole|aripiprazole
5383348|NCT00102050|NM-702 tablets|nm-702 tablets
5383349|NCT00102050|intermittent claudication|intermittent claudication
5383350|NCT00102050|peripheral|peripheral
5383351|NCT00102050|arterial|arterial
5383352|NCT00102050|vascular|vascular
5383353|NCT00102050|peripheral arterial disease|peripheral arterial disease
5383354|NCT00102024|Metastatic Colorectal Adenocarcinoma|metastatic colorectal adenocarcinoma
5383355|NCT00102024|Anti TAG-72|anti tag-72
5383356|NCT00102024|Monoclonal Antibody|monoclonal antibody
5383357|NCT00102011|colon cancer|colon cancer
5383358|NCT00102011|rectal cancer|rectal cancer
5383359|NCT00101998|OBD (Induced Bowel Dysfunction)|obd (induced bowel dysfunction)
5383360|NCT00101998|cancer pain|cancer pain
5383361|NCT00101998|pain medication|pain medication
5383362|NCT00101998|constipation|constipation
5383363|NCT00101998|bowel|bowel
5383364|NCT00101998|bowel dysfunction|bowel dysfunction
5383365|NCT00101985|Quality of Life|quality of life
5383366|NCT00101985|Irritable bowel syndrome|irritable bowel syndrome
5383367|NCT00101985|IBS|ibs
5383368|NCT00101985|SB223412|sb223412
5383369|NCT00101985|Qol|qol
5383370|NCT00101972|adenocarcinoma of the bladder|adenocarcinoma of the bladder
5383371|NCT00101972|adenocarcinoma of the colon|adenocarcinoma of the colon
5383372|NCT00101972|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
5383373|NCT00101972|adenocarcinoma of the extrahepatic bile duct|adenocarcinoma of the extrahepatic bile duct
5383374|NCT00101972|adenocarcinoma of the gallbladder|adenocarcinoma of the gallbladder
5383375|NCT00101972|adenocarcinoma of the lung|adenocarcinoma of the lung
5383376|NCT00101972|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
5383377|NCT00101972|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5383378|NCT00101972|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5383379|NCT00101972|adenocarcinoma of the stomach|adenocarcinoma of the stomach
5383380|NCT00101972|adenocarcinoma with squamous metaplasia of the gallbladder|adenocarcinoma with squamous metaplasia of the gallbladder
5383381|NCT00101972|cervical adenocarcinoma|cervical adenocarcinoma
5383382|NCT00101972|endometrial adenocarcinoma|endometrial adenocarcinoma
5383383|NCT00101972|ovarian endometrioid adenocarcinoma|ovarian endometrioid adenocarcinoma
5383384|NCT00101972|ovarian undifferentiated adenocarcinoma|ovarian undifferentiated adenocarcinoma
5383385|NCT00101972|salivary gland adenocarcinoma|salivary gland adenocarcinoma
5383386|NCT00101972|small intestine adenocarcinoma|small intestine adenocarcinoma
5383387|NCT00101972|vaginal adenocarcinoma|vaginal adenocarcinoma
5383388|NCT00101972|vaginal clear cell adenocarcinoma|vaginal clear cell adenocarcinoma
5383389|NCT00101972|ovarian clear cell cystadenocarcinoma|ovarian clear cell cystadenocarcinoma
5383390|NCT00101972|ovarian mucinous cystadenocarcinoma|ovarian mucinous cystadenocarcinoma
5383391|NCT00101972|ovarian serous cystadenocarcinoma|ovarian serous cystadenocarcinoma
5383392|NCT00101972|stage IV bladder cancer|stage iv bladder cancer
5383393|NCT00101972|stage IV breast cancer|stage iv breast cancer
5383394|NCT00101972|stage IV colon cancer|stage iv colon cancer
5383395|NCT00101972|stage IV endometrial carcinoma|stage iv endometrial carcinoma
5383396|NCT00101972|stage IV esophageal cancer|stage iv esophageal cancer
5383397|NCT00101972|stage IV gastric cancer|stage iv gastric cancer
5383398|NCT00101972|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5383399|NCT00101972|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5383400|NCT00101972|stage IV prostate cancer|stage iv prostate cancer
5383401|NCT00101972|stage IV rectal cancer|stage iv rectal cancer
5383402|NCT00101972|stage IV renal cell cancer|stage iv renal cell cancer
5383403|NCT00101972|stage IV salivary gland cancer|stage iv salivary gland cancer
5383404|NCT00101972|stage IVA cervical cancer|stage iva cervical cancer
5383405|NCT00101972|stage IVA vaginal cancer|stage iva vaginal cancer
5383406|NCT00101972|stage IVB cervical cancer|stage ivb cervical cancer
5383407|NCT00101972|stage IVB vaginal cancer|stage ivb vaginal cancer
5383408|NCT00101972|recurrent bladder cancer|recurrent bladder cancer
5383409|NCT00101972|recurrent breast cancer|recurrent breast cancer
5383410|NCT00101972|recurrent cervical cancer|recurrent cervical cancer
5383411|NCT00101972|recurrent colon cancer|recurrent colon cancer
5383412|NCT00101972|recurrent endometrial carcinoma|recurrent endometrial carcinoma
5383413|NCT00101972|recurrent esophageal cancer|recurrent esophageal cancer
5383414|NCT00101972|recurrent extrahepatic bile duct cancer|recurrent extrahepatic bile duct cancer
5383415|NCT00101972|recurrent gallbladder cancer|recurrent gallbladder cancer
5383511|NCT00101582|Oropharynx|oropharynx
5383416|NCT00101972|recurrent gastric cancer|recurrent gastric cancer
5383417|NCT00101972|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5383418|NCT00101972|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5383419|NCT00101972|recurrent pancreatic cancer|recurrent pancreatic cancer
5383420|NCT00101972|recurrent prostate cancer|recurrent prostate cancer
5383421|NCT00101972|recurrent rectal cancer|recurrent rectal cancer
5383422|NCT00101972|recurrent renal cell cancer|recurrent renal cell cancer
5383423|NCT00101972|recurrent salivary gland cancer|recurrent salivary gland cancer
5383424|NCT00101972|recurrent small intestine cancer|recurrent small intestine cancer
5383425|NCT00101972|recurrent vaginal cancer|recurrent vaginal cancer
5383426|NCT00101972|unresectable extrahepatic bile duct cancer|unresectable extrahepatic bile duct cancer
5383427|NCT00101972|unresectable gallbladder cancer|unresectable gallbladder cancer
5383428|NCT00101972|stage IV pancreatic cancer|stage iv pancreatic cancer
5383429|NCT00101946|CD|cd
5383430|NCT00101946|Crohn's Disease|crohn's disease
5383431|NCT00101933|Deep brain stimulation, DBS, SANTE|deep brain stimulation, dbs, sante
5383432|NCT00101907|Advanced Cancer|advanced cancer
5383433|NCT00101907|AMG 706|amg 706
5383434|NCT00101907|Panitumumab|panitumumab
5383435|NCT00101907|Gemcitabine-Cisplatin|gemcitabine-cisplatin
5383436|NCT00101894|AMG 706|amg 706
5383437|NCT00101894|Panitumumab|panitumumab
5383438|NCT00101881|Cardiac arrest|cardiac arrest
5383439|NCT00101881|Defibrillation|defibrillation
5383440|NCT00101881|Biphasic defibrillation|biphasic defibrillation
5383441|NCT00101881|Monophasic defibrillation|monophasic defibrillation
5383442|NCT00101881|Ventricular fibrillation|ventricular fibrillation
5383443|NCT00101868|Aged|aged
5383444|NCT00101868|Hospitalists|hospitalists
5383445|NCT00101868|Outcome and process assessment (health care)|outcome and process assessment (health care)
5383446|NCT00101868|Human|human
5383447|NCT00101868|Hospitals, teaching|hospitals, teaching
5383448|NCT00101868|Physicians, family|physicians, family
5383449|NCT00101868|Medical records|medical records
5383450|NCT00101868|Quality assurance, health care|quality assurance, health care
5383451|NCT00101868|Medical errors|medical errors
5383452|NCT00101855|prevention|prevention
5383453|NCT00101855|internet|internet
5383454|NCT00101855|quality of care|quality of care
5383455|NCT00101829|Autoimmune Diseases|autoimmune diseases
5383456|NCT00101816|Myeloid blast phase Chronic Myeloid Leukemia (CML)|myeloid blast phase chronic myeloid leukemia (cml)
5383457|NCT00101803|type 2 diabetes|type 2 diabetes
5383458|NCT00101803|vildagliptin|vildagliptin
5383459|NCT00101790|low back pain|low back pain
5383460|NCT00101790|pamidronate|pamidronate
5383461|NCT00101777|Anxiety|anxiety
5383462|NCT00101777|Ventilation|ventilation
5383463|NCT00101777|Panic Disorder|panic disorder
5383464|NCT00101777|Children|children
5383465|NCT00101777|Healthy Volunteer|healthy volunteer
5383466|NCT00101777|HV|hv
5383467|NCT00101777|Normal Control|normal control
5383468|NCT00101764|AMD|amd
5383469|NCT00101764|CRVO|crvo
5383470|NCT00101764|BRVO|brvo
5383471|NCT00101764|Uveitis|uveitis
5383472|NCT00101764|Choroidal Neovascularization|choroidal neovascularization
5383473|NCT00101764|Age-Related Macular Degeneration (AMD)|age-related macular degeneration (amd)
5383474|NCT00101764|Macular Edema|macular edema
5383475|NCT00101764|Central Retinal Vein Occlusion|central retinal vein occlusion
5383476|NCT00101764|Branch Retinal Vein Occlusion|branch retinal vein occlusion
5383477|NCT00101764|Inflammation|inflammation
5383478|NCT00101764|Age Related Macular Degeneration|age related macular degeneration
5383479|NCT00101764|Retinal Disorder|retinal disorder
5383480|NCT00101738|MPA|mpa
5383481|NCT00101738|Kidney Transplantation|kidney transplantation
5383482|NCT00101738|Acute rejection|acute rejection
5383483|NCT00101738|Kidney function|kidney function
5383484|NCT00101725|Diarrhea|diarrhea
5383485|NCT00101725|IBS|ibs
5383486|NCT00101725|Irritable Bowel Syndrome|irritable bowel syndrome
5383487|NCT00101725|Abdominal pain|abdominal pain
5383488|NCT00101712|type 2 diabetes|type 2 diabetes
5383489|NCT00101712|vildagliptin|vildagliptin
5383490|NCT00101699|Women|women
5383491|NCT00101699|Soy Foods|soy foods
5383492|NCT00101699|Middle Aged|middle aged
5383493|NCT00101673|type 2 diabetes|type 2 diabetes
5383494|NCT00101673|vildagliptin|vildagliptin
5383495|NCT00101660|Chronic phase Philadelphia chromosome chronic myeloid leukemia (Ph+CML)|chronic phase philadelphia chromosome chronic myeloid leukemia (ph+cml)
5383496|NCT00101647|Chronic myelogenous leukemia (CML): Accelerated phase|chronic myelogenous leukemia (cml): accelerated phase
5383497|NCT00101634|Schizophrenia|schizophrenia
5383498|NCT00101634|Paliperidone palmitate|paliperidone palmitate
5383499|NCT00101634|R092670|r092670
5383500|NCT00101634|antipsychotic|antipsychotic
5383501|NCT00101621|cancer|cancer
5383502|NCT00101621|pain|pain
5383503|NCT00101621|Cancers, Pain|cancers, pain
5383504|NCT00101608|urothelium|urothelium
5383505|NCT00101595|Lymphoid blast phase chronic myeloid leukemia|lymphoid blast phase chronic myeloid leukemia
5383506|NCT00101595|Philadelphia chromosome positive acute lymphoblastic leukemia|philadelphia chromosome positive acute lymphoblastic leukemia
5383507|NCT00101582|SCCHN|scchn
5383508|NCT00101582|Palifermin|palifermin
5383509|NCT00101582|Mucositis|mucositis
5383510|NCT00101582|Oral Cavity|oral cavity
5383512|NCT00101582|Nasopharynx|nasopharynx
5383513|NCT00101582|Hypopharynx|hypopharynx
5383514|NCT00101582|Larynx|larynx
5383515|NCT00101582|Mouth Pain|mouth pain
5383516|NCT00101582|Mouth Sores|mouth sores
5383517|NCT00101582|Radiation Therapy|radiation therapy
5383518|NCT00101582|Radiotherapy|radiotherapy
5383519|NCT00101582|Radiochemotherapy|radiochemotherapy
5383520|NCT00101582|Concurrent Chemotherapy|concurrent chemotherapy
5383521|NCT00101582|Xerostomia|xerostomia
5383522|NCT00101582|Stomatitis|stomatitis
5383523|NCT00101582|Mucosa|mucosa
5383524|NCT00101582|KGF|kgf
5383525|NCT00101582|rHuKGF|rhukgf
5383526|NCT00101582|Keratinocyte Growth Factor|keratinocyte growth factor
5383527|NCT00101582|HNC|hnc
5383528|NCT00101582|Head and Neck Cancer|head and neck cancer
5383529|NCT00101582|Oral Mucositis|oral mucositis
5383530|NCT00101543|Gait Training|gait training
5383531|NCT00101543|Motor learning|motor learning
5383532|NCT00101543|Electrical stimulation|electrical stimulation
5383533|NCT00101543|Body Weight supported Treadmill Training|body weight supported treadmill training
5383534|NCT00101543|Cerebrovascular Accident|cerebrovascular accident
5383535|NCT00101465|Heart Failure|heart failure
5383536|NCT00101452|Depression|depression
5383537|NCT00101452|Antidepressive Agents|antidepressive agents
5383538|NCT00101452|Complementary Therapies|complementary therapies
5383539|NCT00101439|Primary Hypercholesterolemia|primary hypercholesterolemia
5383540|NCT00101426|Diabetic sensorimotor polyneuropathy|diabetic sensorimotor polyneuropathy
5383541|NCT00101426|Diabetic Neuropathy|diabetic neuropathy
5383542|NCT00101413|NSCLC|nsclc
5383543|NCT00101400|Cancer|cancer
5383544|NCT00101387|Aged|aged
5383545|NCT00101387|Acupuncture|acupuncture
5383546|NCT00101374|Immunomodulatory Drug|immunomodulatory drug
5383547|NCT00101374|Antiviral|antiviral
5383548|NCT00101374|Ki67+|ki67+
5383549|NCT00101374|Immune Activation|immune activation
5383550|NCT00101374|T Cell Proliferation|t cell proliferation
5383551|NCT00101374|HIV|hiv
5383552|NCT00101374|Activated CD4+T-cell|activated cd4+t-cell
5383553|NCT00101374|Proliferation|proliferation
5383554|NCT00101361|dermatologic|dermatologic
5383555|NCT00101361|skin|skin
5383556|NCT00101361|clinical trial|clinical trial
5383557|NCT00101361|androgen/anabolic|androgen/anabolic
5383558|NCT00101335|hypopharyngeal cancer|hypopharyngeal cancer
5383559|NCT00101335|lip and oral cavity cancer|lip and oral cavity cancer
5383560|NCT00101335|nasopharyngeal cancer|nasopharyngeal cancer
5383561|NCT00101335|oropharyngeal cancer|oropharyngeal cancer
5383562|NCT00101335|tongue cancer|tongue cancer
5383563|NCT00101335|oral leukoplakia|oral leukoplakia
5383564|NCT00101309|recurrent neuroblastoma|recurrent neuroblastoma
5383565|NCT00101309|recurrent Ewing sarcoma/peripheral primitive neuroectodermal tumor|recurrent ewing sarcoma/peripheral primitive neuroectodermal tumor
5383566|NCT00101283|advanced malignant mesothelioma|advanced malignant mesothelioma
5383567|NCT00101283|recurrent malignant mesothelioma|recurrent malignant mesothelioma
5383568|NCT00101257|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5383569|NCT00101257|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5383570|NCT00101257|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5383571|NCT00101257|peritoneal cavity cancer|peritoneal cavity cancer
5383572|NCT00101192|recurrent cervical cancer|recurrent cervical cancer
5383573|NCT00101192|cervical adenocarcinoma|cervical adenocarcinoma
5383574|NCT00101192|cervical adenosquamous cell carcinoma|cervical adenosquamous cell carcinoma
5383575|NCT00101192|cervical small cell carcinoma|cervical small cell carcinoma
5383576|NCT00101192|cervical squamous cell carcinoma|cervical squamous cell carcinoma
5383577|NCT00101192|stage III cervical cancer|stage iii cervical cancer
5383578|NCT00101192|stage IVA cervical cancer|stage iva cervical cancer
5383579|NCT00101192|stage IVB cervical cancer|stage ivb cervical cancer
5383580|NCT00101166|recurrent melanoma|recurrent melanoma
5383581|NCT00101166|stage III melanoma|stage iii melanoma
5383582|NCT00101166|stage IV melanoma|stage iv melanoma
5383583|NCT00101153|adult acute basophilic leukemia|adult acute basophilic leukemia
5383584|NCT00101153|adult acute eosinophilic leukemia|adult acute eosinophilic leukemia
5383585|NCT00101153|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
5383586|NCT00101153|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
5383587|NCT00101153|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
5383588|NCT00101153|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
5383589|NCT00101153|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
5383590|NCT00101153|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
5383591|NCT00101153|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5383592|NCT00101153|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5383593|NCT00101153|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5383594|NCT00101153|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5383595|NCT00101153|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
5383596|NCT00101153|adult erythroleukemia (M6a)|adult erythroleukemia (m6a)
5383867|NCT00100204|HV|hv
5383597|NCT00101153|adult pure erythroid leukemia (M6b)|adult pure erythroid leukemia (m6b)
5383598|NCT00101153|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
5383599|NCT00101140|adult erythroleukemia (M6a)|adult erythroleukemia (m6a)
5383600|NCT00101140|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
5383601|NCT00101140|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
5383602|NCT00101140|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
5383603|NCT00101140|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
5383604|NCT00101140|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
5383605|NCT00101140|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5383606|NCT00101140|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5383607|NCT00101140|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5383608|NCT00101140|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5383609|NCT00101140|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5383610|NCT00101140|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
5383611|NCT00101127|recurrent uterine sarcoma|recurrent uterine sarcoma
5383612|NCT00101127|stage III uterine sarcoma|stage iii uterine sarcoma
5383613|NCT00101127|stage IV uterine sarcoma|stage iv uterine sarcoma
5383614|NCT00101127|uterine leiomyosarcoma|uterine leiomyosarcoma
5383615|NCT00101101|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5383616|NCT00101101|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
5383617|NCT00101101|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5383618|NCT00101101|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5383619|NCT00101101|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5383620|NCT00101075|high-grade salivary gland mucoepidermoid carcinoma|high-grade salivary gland mucoepidermoid carcinoma
5383621|NCT00101075|low-grade salivary gland mucoepidermoid carcinoma|low-grade salivary gland mucoepidermoid carcinoma
5383622|NCT00101075|salivary gland acinic cell tumor|salivary gland acinic cell tumor
5383623|NCT00101075|salivary gland adenocarcinoma|salivary gland adenocarcinoma
5383624|NCT00101075|salivary gland adenoid cystic carcinoma|salivary gland adenoid cystic carcinoma
5383625|NCT00101075|salivary gland malignant mixed cell type tumor|salivary gland malignant mixed cell type tumor
5383626|NCT00101075|salivary gland poorly differentiated carcinoma|salivary gland poorly differentiated carcinoma
5383627|NCT00101075|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
5383628|NCT00101075|recurrent salivary gland cancer|recurrent salivary gland cancer
5383629|NCT00101075|stage III salivary gland cancer|stage iii salivary gland cancer
5383630|NCT00101075|stage IV salivary gland cancer|stage iv salivary gland cancer
5383631|NCT00101062|stage IIIA breast cancer|stage iiia breast cancer
5383632|NCT00101062|stage IIIB breast cancer|stage iiib breast cancer
5383633|NCT00101062|stage IIIC breast cancer|stage iiic breast cancer
5383634|NCT00101062|stage IV breast cancer|stage iv breast cancer
5383635|NCT00101062|recurrent breast cancer|recurrent breast cancer
5383636|NCT00101010|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
5383637|NCT00101010|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5383638|NCT00101010|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5383639|NCT00101010|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5383640|NCT00100997|chronic myelogenous leukemia, BCR-ABL1 positive|chronic myelogenous leukemia, bcr-abl1 positive
5383641|NCT00100997|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5383642|NCT00100997|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5383643|NCT00100971|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5383644|NCT00100971|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5383645|NCT00100971|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5383646|NCT00100971|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5383647|NCT00100971|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5383648|NCT00100971|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5383649|NCT00100958|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5383650|NCT00100945|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
5383651|NCT00100945|stage II esophageal cancer|stage ii esophageal cancer
5383652|NCT00100919|Kinesithesia|kinesithesia
5383653|NCT00100919|Sensorimotor Function|sensorimotor function
5383654|NCT00100919|Somatosensory|somatosensory
5383655|NCT00100919|Muscle Spindles|muscle spindles
5383656|NCT00100919|Sensory Feedback|sensory feedback
5383657|NCT00100919|Healthy Volunteer|healthy volunteer
5383659|NCT00100906|stage IV renal cell cancer|stage iv renal cell cancer
5383660|NCT00100906|recurrent renal cell cancer|recurrent renal cell cancer
5383661|NCT00100906|clear cell renal cell carcinoma|clear cell renal cell carcinoma
5383662|NCT00100893|breast cancer|breast cancer
5383663|NCT00100867|Perinatal Transmission|perinatal transmission
5383664|NCT00100867|Mother-to-Child Transmission|mother-to-child transmission
5383764|NCT00100542|Psychopathology|psychopathology
5383665|NCT00100854|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5383666|NCT00100854|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5383667|NCT00100854|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5383668|NCT00100828|thyroid gland medullary carcinoma|thyroid gland medullary carcinoma
5383669|NCT00100828|recurrent thyroid cancer|recurrent thyroid cancer
5383670|NCT00100815|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
5383671|NCT00100815|recurrent pancreatic cancer|recurrent pancreatic cancer
5383672|NCT00100815|stage IV pancreatic cancer|stage iv pancreatic cancer
5383673|NCT00100802|childhood high-grade cerebral astrocytoma|childhood high-grade cerebral astrocytoma
5383674|NCT00100802|childhood spinal cord neoplasm|childhood spinal cord neoplasm
5383675|NCT00100789|Recurrent|recurrent
5383676|NCT00100789|stage IV|stage iv
5383677|NCT00100789|squamous cell carcinoma|squamous cell carcinoma
5383678|NCT00100789|hypopharynx|hypopharynx
5383679|NCT00100789|larynx|larynx
5383680|NCT00100789|lip|lip
5383681|NCT00100789|oral cavity|oral cavity
5383682|NCT00100789|nasopharynx|nasopharynx
5383683|NCT00100789|oropharynx|oropharynx
5383684|NCT00100789|paranasal|paranasal
5383685|NCT00100789|nasal cavity|nasal cavity
5383686|NCT00100789|metastatic|metastatic
5383687|NCT00100789|neck cancer|neck cancer
5383688|NCT00100737|non-hodgkins lymphoma|non-hodgkins lymphoma
5383689|NCT00100737|interleukin-2|interleukin-2
5383690|NCT00100737|rituximab|rituximab
5383691|NCT00100737|CD20+ follicular B-cell non-hodgkins lymphoma (grade I, II,III)|cd20+ follicular b-cell non-hodgkins lymphoma (grade i, ii,iii)
5383692|NCT00100724|Anthrax|anthrax
5383693|NCT00100724|rPA102|rpa102
5383694|NCT00100724|vaccine|vaccine
5383695|NCT00100711|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
5383696|NCT00100711|Small Lymphocytic Lymphoma|small lymphocytic lymphoma
5383697|NCT00100711|Leukemia|leukemia
5383698|NCT00100711|Lymphoma|lymphoma
5383699|NCT00100711|Motexafin Gadolinium|motexafin gadolinium
5383700|NCT00100711|Relapsed Chronic Lymphocytic Leukemia|relapsed chronic lymphocytic leukemia
5383701|NCT00100711|Relapsed Chronic Lymphocycic Lymphoma|relapsed chronic lymphocycic lymphoma
5383702|NCT00100711|Refractory Chronic Lymphocytic Leukemia|refractory chronic lymphocytic leukemia
5383703|NCT00100711|Refractory Small Lymphocytic Lymphoma|refractory small lymphocytic lymphoma
5383704|NCT00100698|HIV|hiv
5383705|NCT00100698|lipodystrophy|lipodystrophy
5383706|NCT00100698|growth hormone|growth hormone
5383707|NCT00100698|visceral fat|visceral fat
5383708|NCT00100698|IGF-I|igf-i
5383709|NCT00100698|Treatment Experienced|treatment experienced
5383710|NCT00100685|Kidney|kidney
5383711|NCT00100685|renal|renal
5383712|NCT00100685|cancer|cancer
5383713|NCT00100685|carcinoma|carcinoma
5383714|NCT00100685|cell|cell
5383715|NCT00100685|metastatic|metastatic
5383716|NCT00100685|metastatic renal cell carcinoma|metastatic renal cell carcinoma
5383717|NCT00100685|RCC|rcc
5383718|NCT00100672|LErafAON-ETU|lerafaon-etu
5383719|NCT00100672|Signal transduction|signal transduction
5383720|NCT00100672|Neoplasm|neoplasm
5383721|NCT00100672|Cancer|cancer
5383722|NCT00100672|NeoPharm|neopharm
5383723|NCT00100672|Liposomes|liposomes
5383724|NCT00100672|Antisense|antisense
5383725|NCT00100672|Anti-cancer|anti-cancer
5383726|NCT00100672|Advanced neoplasm|advanced neoplasm
5383727|NCT00100672|Advanced cancer|advanced cancer
5383728|NCT00100672|Chemotherapy|chemotherapy
5383729|NCT00100672|Refractory cancer|refractory cancer
5383730|NCT00100672|Metastatic cancer|metastatic cancer
5383731|NCT00100659|pediatric|pediatric
5383732|NCT00100659|hepatitis|hepatitis
5383733|NCT00100659|children|children
5383734|NCT00100659|HCV|hcv
5383735|NCT00100659|PEG|peg
5383736|NCT00100659|PEG-2a|peg-2a
5383737|NCT00100659|peginterferon alfa-2a|peginterferon alfa-2a
5383738|NCT00100659|Pegylated Interferon|pegylated interferon
5383739|NCT00100659|RV|rv
5383740|NCT00100659|ribavirin|ribavirin
5383741|NCT00100659|Pegasys|pegasys
5383742|NCT00100659|CHC|chc
5383743|NCT00100659|chronic hepatitis C|chronic hepatitis c
5383744|NCT00100659|chronic hepatitis C virus|chronic hepatitis c virus
5383745|NCT00100659|hepatitis c|hepatitis c
5383746|NCT00100659|pediatric hepatitis|pediatric hepatitis
5383747|NCT00100659|pediatric HCV|pediatric hcv
5383748|NCT00100646|Treatment Interruption|treatment interruption
5383749|NCT00100646|Treatment Naive|treatment naive
5383750|NCT00100633|Hepatitis B Vaccine|hepatitis b vaccine
5383751|NCT00100633|Treatment Experienced|treatment experienced
5383752|NCT00100633|Treatment Naive|treatment naive
5383753|NCT00100620|Corticosteroid induced osteoporosis|corticosteroid induced osteoporosis
5383754|NCT00100620|prevention|prevention
5383755|NCT00100620|treatment|treatment
5383756|NCT00100620|zoledronic acid|zoledronic acid
5383757|NCT00100607|osteoporosis/osteopenia, BMD, postmenopausal|osteoporosis/osteopenia, bmd, postmenopausal
5383758|NCT00100594|Treatment Naive|treatment naive
5383759|NCT00100581|Treatment Naive|treatment naive
5383760|NCT00100568|Treatment Naive|treatment naive
5383761|NCT00100555|Osteoporosis, osteopenia, post-menopausal, zoledronic acid|osteoporosis, osteopenia, post-menopausal, zoledronic acid
5383762|NCT00100542|Treatment Experienced|treatment experienced
5383763|NCT00100542|Treatment Naive|treatment naive
5383765|NCT00100542|Anti-Retroviral Agents|anti-retroviral agents
5383766|NCT00100542|Child|child
5383767|NCT00100542|Adolescent|adolescent
5383768|NCT00100529|Facial Imaging|facial imaging
5383769|NCT00100529|Genetics|genetics
5383770|NCT00100529|Growth|growth
5383771|NCT00100529|Development|development
5383772|NCT00100529|Diagnostics|diagnostics
5383773|NCT00100529|Craniofacial Dysmorphologies|craniofacial dysmorphologies
5383774|NCT00100529|Facial Features|facial features
5383775|NCT00100516|Renal|renal
5383776|NCT00100516|Allografts|allografts
5383777|NCT00100516|Nephrectomy|nephrectomy
5383778|NCT00100516|Pneumoperitoneum|pneumoperitoneum
5383779|NCT00100516|LaparoscopIC|laparoscopic
5383780|NCT00100516|Kidney Donation|kidney donation
5383781|NCT00100503|Rehabilitation|rehabilitation
5383782|NCT00100503|Forced Use|forced use
5383783|NCT00100503|Hemiplegia|hemiplegia
5383784|NCT00100503|Magnetic Resonance Imaging|magnetic resonance imaging
5383785|NCT00100503|TMS|tms
5383786|NCT00100503|Cerebral Palsy|cerebral palsy
5383787|NCT00100503|Spastic Hemiplegia|spastic hemiplegia
5383788|NCT00100503|Healthy Volunteer|healthy volunteer
5383789|NCT00100503|HV|hv
5383790|NCT00100477|Multiple Myeloma|multiple myeloma
5383791|NCT00100477|Lymphoma|lymphoma
5383792|NCT00100477|Leukemia|leukemia
5383793|NCT00100477|Etoposide|etoposide
5383794|NCT00100477|Drug Therapy|drug therapy
5383795|NCT00100477|Clinical Trials|clinical trials
5383796|NCT00100464|Serotonin|serotonin
5383797|NCT00100464|Sleep Apnea Syndrome|sleep apnea syndrome
5383798|NCT00100464|Pharyngeal Muscles|pharyngeal muscles
5383799|NCT00100451|Adipose tissue|adipose tissue
5383800|NCT00100451|Aging|aging
5383801|NCT00100451|Exercise|exercise
5383802|NCT00100451|Lipolysis|lipolysis
5383803|NCT00100451|Estrogens|estrogens
5383804|NCT00100425|Irritable Bowel Syndrome|irritable bowel syndrome
5383805|NCT00100425|Visceral Hypersensitivity|visceral hypersensitivity
5383806|NCT00100425|Visceral Pain|visceral pain
5383807|NCT00100399|influenza, flu, Fluarix, vaccine, GSK, immunogenicity|influenza, flu, fluarix, vaccine, gsk, immunogenicity
5383808|NCT00100386|Hand hygiene, antibiotic resistance, contact precautions|hand hygiene, antibiotic resistance, contact precautions
5383809|NCT00100373|Respiratory Syncytial Virus Infections|respiratory syncytial virus infections
5383810|NCT00100360|Gonadal Steroids|gonadal steroids
5383811|NCT00100360|GnRH Agonist|gnrh agonist
5383812|NCT00100360|Depression|depression
5383813|NCT00100360|Menstrual Cycle|menstrual cycle
5383814|NCT00100360|Menstrually Related Mood Disorder|menstrually related mood disorder
5383815|NCT00100360|MRMD|mrmd
5383816|NCT00100360|Healthy Volunteer|healthy volunteer
5383817|NCT00100360|HV|hv
5383818|NCT00100347|non-Hodgkin lymphoma|non-hodgkin lymphoma
5383819|NCT00100347|non-Hodgkin’s lymphoma|non-hodgkin’s lymphoma
5383820|NCT00100347|NHL|nhl
5383821|NCT00100347|MetAP2|metap2
5383822|NCT00100347|Solid Tumors|solid tumors
5383824|NCT00100321|Tumor Antigen Identification|tumor antigen identification
5383825|NCT00100321|Standard Treatment|standard treatment
5383826|NCT00100321|Tissue Acquisition|tissue acquisition
5383827|NCT00100321|Surgery|surgery
5383828|NCT00100321|Adjuvant Chemotherapy|adjuvant chemotherapy
5383829|NCT00100321|Pancreatic Cancer|pancreatic cancer
5383830|NCT00100321|Pancreatic Tumor|pancreatic tumor
5383831|NCT00100308|sepsis|sepsis
5383832|NCT00100308|Randomized clinical trial|randomized clinical trial
5383833|NCT00100308|Heparin|heparin
5383834|NCT00100308|Therapy|therapy
5383835|NCT00100295|Adolescent|adolescent
5383836|NCT00100295|Child|child
5383837|NCT00100295|Phytotherapy|phytotherapy
5383838|NCT00100282|Mild-moderate Alzheimer's disease|mild-moderate alzheimer's disease
5383839|NCT00100269|Male infertility|male infertility
5383840|NCT00100269|sperm|sperm
5383841|NCT00100269|pregnancy|pregnancy
5383842|NCT00100269|IVF (in vitro fertilisation)|ivf (in vitro fertilisation)
5383843|NCT00100269|oxidative stress|oxidative stress
5383844|NCT00100269|free radicals|free radicals
5383845|NCT00100269|DNA damage|dna damage
5383846|NCT00100256|Advanced or recurrent stage IIIb or IV non small cell lung cancer|advanced or recurrent stage iiib or iv non small cell lung cancer
5383847|NCT00100256|Disseminated or recurrent small cell lung cancer|disseminated or recurrent small cell lung cancer
5383848|NCT00100243|androgen-independent|androgen-independent
5383849|NCT00100243|prostate cancer|prostate cancer
5383850|NCT00100230|retina|retina
5383851|NCT00100230|electroretinography|electroretinography
5383852|NCT00100230|clinical trial|clinical trial
5383853|NCT00100230|docosahexaenoic acid|docosahexaenoic acid
5383854|NCT00100230|omega-3 fatty acid|omega-3 fatty acid
5383855|NCT00100230|x-linked inheritance|x-linked inheritance
5383856|NCT00100217|Training|training
5383857|NCT00100217|Critical Care|critical care
5383858|NCT00100217|Heart Failure|heart failure
5383859|NCT00100217|Pulmonary Hypertension|pulmonary hypertension
5383860|NCT00100217|Infectious Diseases|infectious diseases
5383861|NCT00100204|Head and Neck Radiation|head and neck radiation
5383862|NCT00100204|Diabetes|diabetes
5383863|NCT00100204|Sarcoidosis|sarcoidosis
5383864|NCT00100204|Sjogren's Syndrome|sjogren's syndrome
5383865|NCT00100204|Caries|caries
5383866|NCT00100204|Healthy Volunteer|healthy volunteer
5383868|NCT00100204|Saliva Sample|saliva sample
5383869|NCT00100191|hysterectomy|hysterectomy
5383870|NCT00100191|fibroids|fibroids
5383871|NCT00100191|uterine artery embolization|uterine artery embolization
5383872|NCT00100191|therapeutic embolization|therapeutic embolization
5383873|NCT00100191|uterus|uterus
5383874|NCT00100191|menorrhagia|menorrhagia
5383875|NCT00100178|immunosuppressive therapy|immunosuppressive therapy
5383876|NCT00100178|Type 1 Diabetes TrialNet|type 1 diabetes trialnet
5383877|NCT00100178|TrialNet|trialnet
5383878|NCT00100178|POPPII|poppii
5383879|NCT00100178|POPPII-1|poppii-1
5383880|NCT00100165|Schizophrenia|schizophrenia
5383881|NCT00100152|Relapsed or refractory T-cell ALL acute lymphoblastic/leukemia|relapsed or refractory t-cell all acute lymphoblastic/leukemia
5383882|NCT00100152|Relapsed/refractory T-cell acute Lymphoblastic/leukemia|relapsed/refractory t-cell acute lymphoblastic/leukemia
5383883|NCT00100152|Acute/chronic myelogenous leukemia|acute/chronic myelogenous leukemia
5383884|NCT00100152|Poor-risk myelodysplasia|poor-risk myelodysplasia
5383885|NCT00100139|Neoplasm|neoplasm
5383886|NCT00100139|Cancer|cancer
5383887|NCT00100139|NeoPharm|neopharm
5383888|NCT00100139|Liposomes|liposomes
5383889|NCT00100139|Taxol|taxol
5383890|NCT00100139|Paclitaxel|paclitaxel
5383891|NCT00100139|Anti-cancer|anti-cancer
5383892|NCT00100139|Advanced neoplasm|advanced neoplasm
5383893|NCT00100139|Advanced cancer|advanced cancer
5383894|NCT00100139|Chemotherapy|chemotherapy
5383895|NCT00100139|Refractory cancer|refractory cancer
5383896|NCT00100139|Metastatic cancer|metastatic cancer
5383897|NCT00100126|Pharyngitis|pharyngitis
5383898|NCT00100126|Strep throat|strep throat
5383899|NCT00100113|cocaine dependence|cocaine dependence
5383900|NCT00100100|cocaine dependence|cocaine dependence
5383901|NCT00100087|macular degeneration|macular degeneration
5383902|NCT00100087|brachytherapy|brachytherapy
5383903|NCT00100087|choroidal neovascularization|choroidal neovascularization
5383904|NCT00100087|retinal degeneration|retinal degeneration
5383905|NCT00100087|retinal diseases|retinal diseases
5383906|NCT00100061|Cranberry|cranberry
5383907|NCT00100061|Vaccinium macrocarpon|vaccinium macrocarpon
5383908|NCT00100035|Caregivers|caregivers
5383909|NCT00100035|Complementary Therapies|complementary therapies
5383910|NCT00100009|Steroid|steroid
5383911|NCT00100009|Inflammation|inflammation
5383912|NCT00100009|Choroidal Neovascularization|choroidal neovascularization
5383913|NCT00100009|Intravitreal Injection|intravitreal injection
5383914|NCT00100009|Verteporfin|verteporfin
5383915|NCT00100009|Age-Related Macular Degeneration|age-related macular degeneration
5383916|NCT00100009|Photodynamic Therapy|photodynamic therapy
5383917|NCT00100009|Age Related Macular Degeneration|age related macular degeneration
5383918|NCT00100009|AMD|amd
5383919|NCT00099996|Sitosterolemia|sitosterolemia
5383920|NCT00099996|Sitosterol|sitosterol
5383921|NCT00099996|Ezetimibe|ezetimibe
5383922|NCT00099996|Absorption|absorption
5383923|NCT00099996|Intestine|intestine
5383924|NCT00099996|Cholesterol|cholesterol
5383925|NCT00099996|Atherosclerosis|atherosclerosis
5383926|NCT00099996|Homozygous Sitosterolemia|homozygous sitosterolemia
5383927|NCT00099983|PTSD|ptsd
5383928|NCT00099970|Solid tumors|solid tumors
5383929|NCT00099970|Metastatic melanoma|metastatic melanoma
5383930|NCT00099957|type 2 diabetes|type 2 diabetes
5383931|NCT00099957|vildagliptin|vildagliptin
5383932|NCT00099944|type 2 diabetes|type 2 diabetes
5383933|NCT00099944|vildagliptin|vildagliptin
5383934|NCT00099931|type 2 diabetes|type 2 diabetes
5383935|NCT00099931|vildagliptin|vildagliptin
5383936|NCT00099918|type 2 diabetes|type 2 diabetes
5383937|NCT00099918|vildagliptin|vildagliptin
5383938|NCT00099905|type 2 diabetes|type 2 diabetes
5383939|NCT00099905|vildagliptin|vildagliptin
5383940|NCT00099892|type 2 diabetes|type 2 diabetes
5383941|NCT00099892|vildagliptin|vildagliptin
5383942|NCT00099866|type 2 diabetes|type 2 diabetes
5383943|NCT00099866|vildagliptin|vildagliptin
5383944|NCT00099853|type 2 diabetes|type 2 diabetes
5383945|NCT00099853|vildagliptin|vildagliptin
5383946|NCT00099840|common cold|common cold
5383947|NCT00099840|pharyngitis|pharyngitis
5383948|NCT00099840|tonsillitis|tonsillitis
5383949|NCT00099840|rhinosinusitis|rhinosinusitis
5383950|NCT00099840|tracheo-bronchitis|tracheo-bronchitis
5383951|NCT00099840|otitis media|otitis media
5383952|NCT00099840|acute exacerbations of asthma|acute exacerbations of asthma
5383953|NCT00099840|acute exacerbations of chronic pulmonary disease|acute exacerbations of chronic pulmonary disease
5383954|NCT00099840|community acquired pneumonia|community acquired pneumonia
5383955|NCT00099827|Depression|depression
5383956|NCT00099814|tooth movement|tooth movement
5383957|NCT00099814|orthodontics|orthodontics
5383958|NCT00099814|force|force
5383959|NCT00099814|humans|humans
5383960|NCT00099814|clinical trial|clinical trial
5383961|NCT00099801|Kidney, Transplantation, Rejection, Immunosuppression|kidney, transplantation, rejection, immunosuppression
5383962|NCT00099788|Acute Coronary Syndrome|acute coronary syndrome
5383963|NCT00099788|Myocardial Infarction|myocardial infarction
5383964|NCT00099788|Heart Attack|heart attack
5383965|NCT00099788|Angina|angina
5383966|NCT00099788|Chest pain|chest pain
5383967|NCT00099788|Ischemia|ischemia
5383968|NCT00099788|Non-ST Elevation Acute Coronary Syndrome|non-st elevation acute coronary syndrome
5383969|NCT00099775|Mycoses|mycoses
5383970|NCT00099775|Candida|candida
5383971|NCT00099775|Echinocandin|echinocandin
5383972|NCT00099775|Immunocompromised Host|immunocompromised host
5383973|NCT00099775|Invasive Fungal Infection|invasive fungal infection
5383974|NCT00099775|Fungal Infection|fungal infection
5383975|NCT00099762|Tumor Induced Osteomalacia|tumor induced osteomalacia
5383976|NCT00099762|FGF-23|fgf-23
5383977|NCT00099762|Phosphatonin|phosphatonin
5383978|NCT00099762|Hypophosphatemia|hypophosphatemia
5383979|NCT00099762|Oncogenic Osteomalacia|oncogenic osteomalacia
5383980|NCT00099762|Phosphaturic Mesenchymal Tumor|phosphaturic mesenchymal tumor
5383981|NCT00099762|TIO|tio
5383982|NCT00099762|Osteogenic Osteomalacia|osteogenic osteomalacia
5383983|NCT00099762|OOM|oom
5383984|NCT00099749|Kidney, immunosuppression, transplant, rejection|kidney, immunosuppression, transplant, rejection
5383985|NCT00099736|Kidney, transplantation, rejection, immunosuppression|kidney, transplantation, rejection, immunosuppression
5383986|NCT00099723|Hepatic steatosis|hepatic steatosis
5383987|NCT00099723|adult-onset diabetes|adult-onset diabetes
5383988|NCT00099723|Non-alcoholic fatty liver disease|non-alcoholic fatty liver disease
5383989|NCT00099710|Curcumin|curcumin
5383990|NCT00099710|Turmeric|turmeric
5383991|NCT00099710|Curry|curry
5383992|NCT00099710|NSAID|nsaid
5383993|NCT00099710|anti-inflammatory|anti-inflammatory
5383994|NCT00099710|Cholesterol|cholesterol
5383995|NCT00099710|anti-oxidant|anti-oxidant
5383996|NCT00099697|abdominal fat|abdominal fat
5383997|NCT00099697|dehydroepiandrosterone|dehydroepiandrosterone
5383998|NCT00099697|Insulin sensitivity|insulin sensitivity
5383999|NCT00099684|Treatment Experienced|treatment experienced
5384000|NCT00099671|Treatment Experienced|treatment experienced
5384001|NCT00099658|MTCT|mtct
5384002|NCT00099645|Mifepristone|mifepristone
5384003|NCT00099645|Mifeprex|mifeprex
5384004|NCT00099645|RU486|ru486
5384005|NCT00099645|VGX-410|vgx-410
5384006|NCT00099645|Abortion Pill|abortion pill
5384007|NCT00099645|Investigational Drug|investigational drug
5384008|NCT00099632|Treatment Naive|treatment naive
5384009|NCT00099619|exenatide|exenatide
5384010|NCT00099619|exendin-4|exendin-4
5384011|NCT00099619|diabetes|diabetes
5384012|NCT00099619|Amylin|amylin
5384013|NCT00099619|Lilly|lilly
5384014|NCT00099593|Cutaneous T-cell lymphoma (CTCL)|cutaneous t-cell lymphoma (ctcl)
5384015|NCT00099593|Sezary Syndrome|sezary syndrome
5384016|NCT00099593|Mycosis Fungoides|mycosis fungoides
5384017|NCT00099593|Vaccine|vaccine
5384018|NCT00099580|Congestive Heart Failure|congestive heart failure
5384019|NCT00099580|AC2592|ac2592
5384020|NCT00099580|GLP-1|glp-1
5384021|NCT00099580|Amylin|amylin
5384022|NCT00099580|metabolic abnormality|metabolic abnormality
5384023|NCT00099567|Metabolic Syndrome|metabolic syndrome
5384024|NCT00099567|Alzheimer's Disease|alzheimer's disease
5384025|NCT00099567|Cognitive Impairment|cognitive impairment
5384026|NCT00099567|Inflammation|inflammation
5384027|NCT00099541|Lung Cancer|lung cancer
5384028|NCT00099541|Bone Metastases|bone metastases
5384029|NCT00099541|Bone Markers|bone markers
5384030|NCT00099541|NTX|ntx
5384031|NCT00099541|zoledronic acid|zoledronic acid
5384032|NCT00099541|Registry|registry
5384033|NCT00099541|Unresectable Stage IV Non Small-cell Lung Cancer (NSCLC)|unresectable stage iv non small-cell lung cancer (nsclc)
5384034|NCT00099541|Unresectable Stage IIIB NSCLC with Pleural Effusion|unresectable stage iiib nsclc with pleural effusion
5384035|NCT00099528|Post-herpetic neuralgia|post-herpetic neuralgia
5384036|NCT00099528|Shingles|shingles
5384037|NCT00099528|Herpes Zoster|herpes zoster
5384038|NCT00099528|Neuropathic pain|neuropathic pain
5384039|NCT00099528|Neuralgia|neuralgia
5384040|NCT00099528|Anti-TNF agents|anti-tnf agents
5384041|NCT00099528|Inflammatory cytokines|inflammatory cytokines
5384042|NCT00099528|Hyperalgesia|hyperalgesia
5384043|NCT00099528|Allodynia|allodynia
5384044|NCT00099528|Irritable nociceptor|irritable nociceptor
5384045|NCT00099502|Relapsing multiple sclerosis|relapsing multiple sclerosis
5384046|NCT00099502|interferon beta 1b|interferon beta 1b
5384047|NCT00099502|Betaferon|betaferon
5384048|NCT00099502|Betaseron|betaseron
5384049|NCT00099489|Chronic Inflammatory Demyelinating Polyradiculoneuropathy|chronic inflammatory demyelinating polyradiculoneuropathy
5384050|NCT00099489|CIDP|cidp
5384051|NCT00099489|IVIg|ivig
5384052|NCT00099489|AVONEX|avonex
5384053|NCT00099476|Epicatechin|epicatechin
5384054|NCT00099476|Polyphenols|polyphenols
5384055|NCT00099476|Chocolate|chocolate
5384056|NCT00099476|Insulin Resistance|insulin resistance
5384057|NCT00099476|Endothelial Dysfunction|endothelial dysfunction
5384058|NCT00099476|Hypertension|hypertension
5384059|NCT00099463|Coronavirus|coronavirus
5384060|NCT00099463|Healthy|healthy
5384061|NCT00099463|Immunity|immunity
5384062|NCT00099463|Preventive|preventive
5384063|NCT00099463|Virus|virus
5384064|NCT00099463|Healthy Volunteer|healthy volunteer
5384065|NCT00099463|HV|hv
5384066|NCT00099450|bleeding|bleeding
5384067|NCT00099450|blood transfusion|blood transfusion
5384068|NCT00099450|surgeries|surgeries
5384389|NCT00098202|Maize|maize
5384069|NCT00099437|Advanced Breast Cancer|advanced breast cancer
5384070|NCT00099437|Metastatic Breast Cancer|metastatic breast cancer
5384071|NCT00099424|exercise training|exercise training
5384072|NCT00099424|resistance training|resistance training
5384073|NCT00099424|endurance training|endurance training
5384074|NCT00099424|Boeck's Sarcoid|boeck's sarcoid
5384075|NCT00099424|Besnier-Boeck Disease|besnier-boeck disease
5384076|NCT00099385|social development|social development
5384077|NCT00099385|risk behaviors|risk behaviors
5384078|NCT00099385|social emotional education|social emotional education
5384079|NCT00099385|classroom instruction|classroom instruction
5384080|NCT00099372|sacrocolpopexy|sacrocolpopexy
5384081|NCT00099372|abdominal sacrocolpopexy|abdominal sacrocolpopexy
5384082|NCT00099372|surgical procedure, prolapse|surgical procedure, prolapse
5384083|NCT00099372|pelvic organ prolapse|pelvic organ prolapse
5384084|NCT00099372|urinary incontinence|urinary incontinence
5384085|NCT00099372|stress urinary incontinence|stress urinary incontinence
5384086|NCT00099359|HIV|hiv
5384087|NCT00099359|Perinatal|perinatal
5384088|NCT00099359|Prevention|prevention
5384089|NCT00099359|Transmission|transmission
5384090|NCT00099359|Nevirapine|nevirapine
5384091|NCT00099359|Epivir|epivir
5384092|NCT00099359|Zidovudine|zidovudine
5384093|NCT00099359|Nelfinavir|nelfinavir
5384094|NCT00099359|ZDV|zdv
5384095|NCT00099359|NVP|nvp
5384096|NCT00099359|3TC|3tc
5384097|NCT00099359|NFV|nfv
5384098|NCT00099359|Viracept|viracept
5384099|NCT00099359|Viramune|viramune
5384100|NCT00099359|HIV Seronegativity|hiv seronegativity
5384101|NCT00099359|Treatment Naive|treatment naive
5384102|NCT00099333|exenatide|exenatide
5384103|NCT00099333|exendin-4|exendin-4
5384104|NCT00099333|Amylin|amylin
5384105|NCT00099333|Eli Lilly|eli lilly
5384106|NCT00099333|diabetes|diabetes
5384107|NCT00099320|exenatide|exenatide
5384108|NCT00099320|exendin-4|exendin-4
5384109|NCT00099320|diabetes|diabetes
5384110|NCT00099320|Amylin|amylin
5384111|NCT00099320|Lilly|lilly
5384112|NCT00099307|White Matter|white matter
5384113|NCT00099307|Grey Matter|grey matter
5384114|NCT00099307|Brain|brain
5384115|NCT00099307|Disability|disability
5384116|NCT00099307|Lesions|lesions
5384117|NCT00099307|Multiple Sclerosis|multiple sclerosis
5384118|NCT00099307|MS|ms
5384119|NCT00099307|Healthy Volunteer|healthy volunteer
5384120|NCT00099307|HV|hv
5384121|NCT00099294|Pancreas|pancreas
5384122|NCT00099294|Cancer|cancer
5384123|NCT00099294|Pancreatic Adenocarcinoma|pancreatic adenocarcinoma
5384124|NCT00099294|Metastatic|metastatic
5384125|NCT00099294|Glufosfamide|glufosfamide
5384126|NCT00099281|Metastatic breast cancer|metastatic breast cancer
5384127|NCT00099268|Parkinson's disease, levodopa therapy, dyskinesia|parkinson's disease, levodopa therapy, dyskinesia
5384128|NCT00099255|Keyword?|keyword?
5384129|NCT00099255|Primary Cutaneous Anaplastic Large Cell Lymphoma|primary cutaneous anaplastic large cell lymphoma
5384130|NCT00099255|Large Cell Transformation of Mycosis Fungoides|large cell transformation of mycosis fungoides
5384131|NCT00099255|Lymphomatoid Papulosis|lymphomatoid papulosis
5384132|NCT00099242|Alzheimer's Disease|alzheimer's disease
5384133|NCT00099242|Dementia|dementia
5384134|NCT00099229|bipolar disorder|bipolar disorder
5384135|NCT00099229|manic episode|manic episode
5384136|NCT00099229|treatment|treatment
5384137|NCT00099229|licarbazepine|licarbazepine
5384138|NCT00099216|Dementia,vascular,rivastigmine,stroke,memory loss|dementia,vascular,rivastigmine,stroke,memory loss
5384139|NCT00099190|cancer|cancer
5384140|NCT00099190|solid tumor|solid tumor
5384141|NCT00099190|advanced solid tumor|advanced solid tumor
5384142|NCT00099164|preterm birth|preterm birth
5384143|NCT00099164|pregnancy|pregnancy
5384144|NCT00099164|multifetal|multifetal
5384145|NCT00099164|Progesterone|progesterone
5384146|NCT00099151|Longevity|longevity
5384147|NCT00099151|Dietary restriction|dietary restriction
5384148|NCT00099151|Physical activity|physical activity
5384149|NCT00099151|Weight Loss|weight loss
5384150|NCT00099151|Diabetes|diabetes
5384151|NCT00099138|Diet|diet
5384152|NCT00099138|Caloric Restriction|caloric restriction
5384153|NCT00099138|Exercise|exercise
5384154|NCT00099138|Energy Metabolism|energy metabolism
5384155|NCT00099138|Primary Aging|primary aging
5384156|NCT00099138|Secondary Aging|secondary aging
5384157|NCT00099125|adult giant cell glioblastoma|adult giant cell glioblastoma
5384158|NCT00099125|adult gliosarcoma|adult gliosarcoma
5384159|NCT00099125|adult glioblastoma|adult glioblastoma
5384160|NCT00099112|basal cell carcinoma of the skin|basal cell carcinoma of the skin
5384161|NCT00099112|squamous cell carcinoma of the skin|squamous cell carcinoma of the skin
5384162|NCT00099112|actinic keratosis|actinic keratosis
5384163|NCT00099099|Longevity|longevity
5384164|NCT00099099|Calorie restriction|calorie restriction
5384165|NCT00099099|Physical activity|physical activity
5384166|NCT00099099|Weight loss|weight loss
5384167|NCT00099086|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5384168|NCT00099086|stage IIB prostate cancer|stage iib prostate cancer
5384169|NCT00099086|stage IIA prostate cancer|stage iia prostate cancer
5384170|NCT00099086|stage III prostate cancer|stage iii prostate cancer
5384171|NCT00099086|stage IV prostate cancer|stage iv prostate cancer
5384172|NCT00099060|adult giant cell glioblastoma|adult giant cell glioblastoma
5384173|NCT00099060|adult gliosarcoma|adult gliosarcoma
5384174|NCT00099060|recurrent adult brain tumor|recurrent adult brain tumor
5384175|NCT00099008|breast cancer|breast cancer
5384176|NCT00099008|endometrial cancer|endometrial cancer
5384177|NCT00098995|stage IB cervical cancer|stage ib cervical cancer
5384178|NCT00098995|stage IIA cervical cancer|stage iia cervical cancer
5384179|NCT00098995|stage IIB cervical cancer|stage iib cervical cancer
5384180|NCT00098995|stage III cervical cancer|stage iii cervical cancer
5384181|NCT00098995|stage IVA cervical cancer|stage iva cervical cancer
5384182|NCT00098995|cervical adenocarcinoma|cervical adenocarcinoma
5384183|NCT00098995|cervical adenosquamous cell carcinoma|cervical adenosquamous cell carcinoma
5384184|NCT00098995|cervical squamous cell carcinoma|cervical squamous cell carcinoma
5384185|NCT00098982|stage III colon cancer|stage iii colon cancer
5384186|NCT00098982|stage IV colon cancer|stage iv colon cancer
5384187|NCT00098982|stage III rectal cancer|stage iii rectal cancer
5384188|NCT00098982|stage IV rectal cancer|stage iv rectal cancer
5384189|NCT00098982|recurrent colon cancer|recurrent colon cancer
5384190|NCT00098982|recurrent rectal cancer|recurrent rectal cancer
5384191|NCT00098969|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5384192|NCT00098943|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5384193|NCT00098943|stage IV renal cell cancer|stage iv renal cell cancer
5384194|NCT00098943|recurrent renal cell cancer|recurrent renal cell cancer
5384195|NCT00098943|stage IV colon cancer|stage iv colon cancer
5384196|NCT00098943|recurrent colon cancer|recurrent colon cancer
5384197|NCT00098943|anaplastic thyroid cancer|anaplastic thyroid cancer
5384198|NCT00098943|insular thyroid cancer|insular thyroid cancer
5384199|NCT00098943|thyroid gland medullary carcinoma|thyroid gland medullary carcinoma
5384200|NCT00098943|stage IV follicular thyroid cancer|stage iv follicular thyroid cancer
5384201|NCT00098943|stage IV papillary thyroid cancer|stage iv papillary thyroid cancer
5384202|NCT00098943|recurrent thyroid cancer|recurrent thyroid cancer
5384203|NCT00098943|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
5384204|NCT00098943|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
5384205|NCT00098943|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
5384206|NCT00098943|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
5384207|NCT00098943|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
5384208|NCT00098943|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
5384209|NCT00098943|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5384210|NCT00098943|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5384211|NCT00098943|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5384212|NCT00098943|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
5384213|NCT00098943|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5384214|NCT00098943|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
5384215|NCT00098943|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
5384216|NCT00098943|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
5384217|NCT00098943|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
5384218|NCT00098943|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
5384219|NCT00098943|recurrent adenoid cystic carcinoma of the oral cavity|recurrent adenoid cystic carcinoma of the oral cavity
5384220|NCT00098943|stage IV adenoid cystic carcinoma of the oral cavity|stage iv adenoid cystic carcinoma of the oral cavity
5384221|NCT00098943|recurrent basal cell carcinoma of the lip|recurrent basal cell carcinoma of the lip
5384222|NCT00098943|stage IV basal cell carcinoma of the lip|stage iv basal cell carcinoma of the lip
5384223|NCT00098943|recurrent mucoepidermoid carcinoma of the oral cavity|recurrent mucoepidermoid carcinoma of the oral cavity
5384224|NCT00098943|stage IV mucoepidermoid carcinoma of the oral cavity|stage iv mucoepidermoid carcinoma of the oral cavity
5384225|NCT00098943|recurrent lymphoepithelioma of the nasopharynx|recurrent lymphoepithelioma of the nasopharynx
5384226|NCT00098943|recurrent lymphoepithelioma of the oropharynx|recurrent lymphoepithelioma of the oropharynx
5384227|NCT00098943|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
5384228|NCT00098943|stage IV lymphoepithelioma of the oropharynx|stage iv lymphoepithelioma of the oropharynx
5384229|NCT00098943|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity
5384230|NCT00098943|stage IV esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iv esthesioneuroblastoma of the paranasal sinus and nasal cavity
5384231|NCT00098943|recurrent inverted papilloma of the paranasal sinus and nasal cavity|recurrent inverted papilloma of the paranasal sinus and nasal cavity
5384232|NCT00098943|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity
5384233|NCT00098943|stage IV inverted papilloma of the paranasal sinus and nasal cavity|stage iv inverted papilloma of the paranasal sinus and nasal cavity
5384234|NCT00098943|stage IV midline lethal granuloma of the paranasal sinus and nasal cavity|stage iv midline lethal granuloma of the paranasal sinus and nasal cavity
5384235|NCT00098943|metastatic parathyroid cancer|metastatic parathyroid cancer
5384236|NCT00098943|recurrent parathyroid cancer|recurrent parathyroid cancer
5384237|NCT00098943|recurrent salivary gland cancer|recurrent salivary gland cancer
5384238|NCT00098943|stage IV salivary gland cancer|stage iv salivary gland cancer
5384239|NCT00098917|stage I non-small cell lung cancer|stage i non-small cell lung cancer
5384240|NCT00098917|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
5384241|NCT00098917|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5384242|NCT00098878|stage I ovarian epithelial cancer|stage i ovarian epithelial cancer
5384243|NCT00098878|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
5384244|NCT00098878|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5384245|NCT00098878|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5384246|NCT00098878|fallopian tube cancer|fallopian tube cancer
5384247|NCT00098878|primary peritoneal cavity cancer|primary peritoneal cavity cancer
5384248|NCT00098852|recurrent thyroid cancer|recurrent thyroid cancer
5384249|NCT00098852|stage II follicular thyroid cancer|stage ii follicular thyroid cancer
5384250|NCT00098852|stage IV follicular thyroid cancer|stage iv follicular thyroid cancer
5384251|NCT00098852|stage II papillary thyroid cancer|stage ii papillary thyroid cancer
5384252|NCT00098852|stage IV papillary thyroid cancer|stage iv papillary thyroid cancer
5384253|NCT00098800|ovarian epithelial cancer|ovarian epithelial cancer
5384254|NCT00098800|BRCA1 mutation carrier|brca1 mutation carrier
5384255|NCT00098800|BRCA2 mutation carrier|brca2 mutation carrier
5384256|NCT00098787|recurrent colon cancer|recurrent colon cancer
5384257|NCT00098787|stage IV colon cancer|stage iv colon cancer
5384258|NCT00098787|recurrent rectal cancer|recurrent rectal cancer
5384259|NCT00098787|stage IV rectal cancer|stage iv rectal cancer
5384260|NCT00098787|adenocarcinoma of the colon|adenocarcinoma of the colon
5384261|NCT00098787|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5384262|NCT00098774|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
5384263|NCT00098761|recurrent childhood brain stem glioma|recurrent childhood brain stem glioma
5384264|NCT00098761|recurrent childhood visual pathway and hypothalamic glioma|recurrent childhood visual pathway and hypothalamic glioma
5384265|NCT00098761|recurrent childhood cerebellar astrocytoma|recurrent childhood cerebellar astrocytoma
5384266|NCT00098761|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
5384267|NCT00098761|recurrent childhood ependymoma|recurrent childhood ependymoma
5384268|NCT00098761|recurrent childhood medulloblastoma|recurrent childhood medulloblastoma
5384269|NCT00098761|recurrent childhood supratentorial primitive neuroectodermal tumor|recurrent childhood supratentorial primitive neuroectodermal tumor
5384270|NCT00098761|childhood central nervous system germ cell tumor|childhood central nervous system germ cell tumor
5384271|NCT00098761|childhood choroid plexus tumor|childhood choroid plexus tumor
5384272|NCT00098761|childhood craniopharyngioma|childhood craniopharyngioma
5384273|NCT00098761|childhood infratentorial ependymoma|childhood infratentorial ependymoma
5384274|NCT00098761|childhood grade I meningioma|childhood grade i meningioma
5384275|NCT00098761|childhood grade II meningioma|childhood grade ii meningioma
5384276|NCT00098761|childhood grade III meningioma|childhood grade iii meningioma
5384277|NCT00098761|childhood high-grade cerebral astrocytoma|childhood high-grade cerebral astrocytoma
5384278|NCT00098761|childhood low-grade cerebral astrocytoma|childhood low-grade cerebral astrocytoma
5384279|NCT00098735|Kidney,Transplantation, rejection, immunosuppression|kidney,transplantation, rejection, immunosuppression
5384280|NCT00098709|pregnancy|pregnancy
5384281|NCT00098709|labor, obstetric|labor, obstetric
5384282|NCT00098709|fetal monitoring|fetal monitoring
5384283|NCT00098709|oximetry|oximetry
5384284|NCT00098709|fetal heart rate|fetal heart rate
5384285|NCT00098709|cardiotocography|cardiotocography
5384286|NCT00098683|refractory anemia with excess blasts|refractory anemia with excess blasts
5384287|NCT00098683|refractory anemia|refractory anemia
5384288|NCT00098683|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
5384289|NCT00098683|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5384401|NCT00098124|fibromyalgia|fibromyalgia
5384290|NCT00098683|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
5384291|NCT00098683|refractory cytopenia with multilineage dysplasia|refractory cytopenia with multilineage dysplasia
5384292|NCT00098566|quality of life|quality of life
5384293|NCT00098566|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5384294|NCT00098566|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5384295|NCT00098566|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5384296|NCT00098566|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5384297|NCT00098566|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5384298|NCT00098566|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5384299|NCT00098566|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5384300|NCT00098566|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5384301|NCT00098566|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5384302|NCT00098566|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5384591|NCT00097409|Recurrent|recurrent
5384303|NCT00098566|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5384304|NCT00098566|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5384305|NCT00098566|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
5384306|NCT00098566|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
5384307|NCT00098566|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5384308|NCT00098566|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5384309|NCT00098566|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5384310|NCT00098553|stage IV melanoma|stage iv melanoma
5384311|NCT00098553|recurrent melanoma|recurrent melanoma
5384312|NCT00098514|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5384313|NCT00098462|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5384314|NCT00098462|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5384315|NCT00098462|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5384316|NCT00098436|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5384317|NCT00098436|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5384318|NCT00098436|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5384319|NCT00098436|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5384320|NCT00098436|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5384321|NCT00098436|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5384322|NCT00098436|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5384323|NCT00098436|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5384324|NCT00098436|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5384325|NCT00098436|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5384326|NCT00098384|Travelers’ diarrhea|travelers’ diarrhea
5384327|NCT00098384|rifaximin|rifaximin
5384328|NCT00098384|prophylaxis|prophylaxis
5384329|NCT00098384|enterotoxigenic E. coli|enterotoxigenic e. coli
5384330|NCT00098358|Leukotrienes|leukotrienes
5384331|NCT00098358|inflammation|inflammation
5384332|NCT00098345|Caprelsa (vandetanib)|caprelsa (vandetanib)
5384333|NCT00098345|ZD6474|zd6474
5384334|NCT00098332|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5384335|NCT00098332|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
5384336|NCT00098332|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
5384337|NCT00098332|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
5384338|NCT00098332|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5384339|NCT00098332|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
5384340|NCT00098332|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
5384341|NCT00098332|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
5384342|NCT00098319|Cleft palate|cleft palate
5384343|NCT00098319|Cleft lip|cleft lip
5384344|NCT00098319|Folic acid|folic acid
5384345|NCT00098319|Global Network|global network
5384346|NCT00098319|Maternal and child health|maternal and child health
5384347|NCT00098319|International|international
5384348|NCT00098319|Women's health|women's health
5384349|NCT00098319|Brazil|brazil
5384350|NCT00098319|Brasil|brasil
5384351|NCT00098319|Latin America|latin america
5384352|NCT00098319|ECLAMC|eclamc
5384353|NCT00098319|Congenital defects|congenital defects
5384354|NCT00098319|Pregnancy|pregnancy
5384355|NCT00098293|Aids|aids
5384356|NCT00098293|HIV|hiv
5384357|NCT00098280|H5g1|h5g1
5384358|NCT00098280|PNH|pnh
5384359|NCT00098280|TRIUMPH|triumph
5384360|NCT00098280|Paroxysmal Nocturnal Hemoglobinuria|paroxysmal nocturnal hemoglobinuria
5384361|NCT00098267|Bacteria|bacteria
5384362|NCT00098267|Biofilm Formation|biofilm formation
5384363|NCT00098267|Secretory Antibodies|secretory antibodies
5384364|NCT00098267|Teeth|teeth
5384365|NCT00098267|Health and Disease|health and disease
5384366|NCT00098254|Non-Small Cell|non-small cell
5384367|NCT00098254|Molecular|molecular
5384368|NCT00098254|Targeted|targeted
5384369|NCT00098254|Therapies|therapies
5384370|NCT00098254|Cancer|cancer
5384371|NCT00098254|Non-Small Cell Lung Cancer|non-small cell lung cancer
5384372|NCT00098254|NSCLC|nsclc
5384373|NCT00098241|pediatric|pediatric
5384374|NCT00098241|renal|renal
5384375|NCT00098241|transplant recipients|transplant recipients
5384376|NCT00098241|de novo|de novo
5384377|NCT00098241|De novo renal pediatric transplant|de novo renal pediatric transplant
5384378|NCT00098228|COPD, adults, QAB149|copd, adults, qab149
5384379|NCT00098215|Residency training|residency training
5384380|NCT00098202|Global Network|global network
5384381|NCT00098202|Micronutrients|micronutrients
5384382|NCT00098202|Zinc|zinc
5384383|NCT00098202|Maternal and child health|maternal and child health
5384384|NCT00098202|Women's health|women's health
5384385|NCT00098202|International|international
5384386|NCT00098202|Guatemala|guatemala
5384387|NCT00098202|Nutrition|nutrition
5384388|NCT00098202|Corn|corn
5384390|NCT00098189|Safety, psoriasis, adverse event, SAE, extension|safety, psoriasis, adverse event, sae, extension
5384391|NCT00098163|HIV Seronegativity|hiv seronegativity
5384392|NCT00098163|HIV Preventive Vaccine|hiv preventive vaccine
5384393|NCT00098150|Safety, atopic dermatitis, adverse event, SAE, extension|safety, atopic dermatitis, adverse event, sae, extension
5384394|NCT00098137|atrial fibrillation|atrial fibrillation
5384395|NCT00098137|angiotensin II|angiotensin ii
5384396|NCT00098137|angiotensin receptor antagonist|angiotensin receptor antagonist
5384397|NCT00098137|drug|drug
5384398|NCT00098137|controlled clinical trial|controlled clinical trial
5384399|NCT00098124|NSRI|nsri
5384400|NCT00098124|milnacipran|milnacipran
5384402|NCT00098111|Crohn's disease|crohn's disease
5384403|NCT00098111|inflammatory bowel disease|inflammatory bowel disease
5384404|NCT00098111|IMURAN|imuran
5384405|NCT00098111|azathioprine|azathioprine
5384406|NCT00098098|Botulinum|botulinum
5384407|NCT00098098|Recombinant Botulinum Vaccine|recombinant botulinum vaccine
5384408|NCT00098098|botulinum neurotoxins|botulinum neurotoxins
5384409|NCT00098085|Lung cancer|lung cancer
5384410|NCT00098085|Non-small cell lung cancer|non-small cell lung cancer
5384411|NCT00098085|Pulmonary|pulmonary
5384412|NCT00098085|Immunotherapy|immunotherapy
5384413|NCT00098085|Vaccine|vaccine
5384414|NCT00098072|Cytometry|cytometry
5384415|NCT00098072|Genes|genes
5384416|NCT00098072|Hypertension|hypertension
5384417|NCT00098072|Lung|lung
5384418|NCT00098072|Proteomics|proteomics
5384419|NCT00098072|Primary Pulmonary Hypertenion|primary pulmonary hypertenion
5384420|NCT00098072|PPH|pph
5384421|NCT00098072|Healthy Volunteers|healthy volunteers
5384422|NCT00098072|HV|hv
5384423|NCT00098059|herpes simplex|herpes simplex
5384424|NCT00098059|cold sores|cold sores
5384425|NCT00098059|fever blisters|fever blisters
5384426|NCT00098059|children|children
5384427|NCT00098059|Famvir|famvir
5384428|NCT00098059|famciclovir|famciclovir
5384429|NCT00098046|chickenpox|chickenpox
5384430|NCT00098046|herpes zoster|herpes zoster
5384431|NCT00098046|children|children
5384432|NCT00098046|Famvir|famvir
5384433|NCT00098046|varicella zoster virus|varicella zoster virus
5384434|NCT00098033|clinical|clinical
5384435|NCT00098033|pharmacodynamics|pharmacodynamics
5384436|NCT00098033|investigational drug clofarabine|investigational drug clofarabine
5384437|NCT00098033|AML, ALL, CML-accelerated phase, CML-blastic phase|aml, all, cml-accelerated phase, cml-blastic phase
5384438|NCT00098033|Chronic Myelogenous Leukemia - accelerated phase|chronic myelogenous leukemia - accelerated phase
5384439|NCT00098033|Chronic Myelogenous Leukemia - blastic phase|chronic myelogenous leukemia - blastic phase
5384440|NCT00098020|Glomerulosclerosis|glomerulosclerosis
5384441|NCT00098020|Proteinuria|proteinuria
5384442|NCT00098020|Fibrosis|fibrosis
5384443|NCT00098020|Chronic Kidney Disease|chronic kidney disease
5384444|NCT00098020|Nephrotic Syndrome|nephrotic syndrome
5384445|NCT00098007|Heart transplantation|heart transplantation
5384446|NCT00098007|Everolimus|everolimus
5384447|NCT00098007|De novo heart transplant patients|de novo heart transplant patients
5384448|NCT00097994|Menopause|menopause
5384449|NCT00097994|Quality of Life|quality of life
5384450|NCT00097994|Health Services|health services
5384451|NCT00097994|Complementary Therapies|complementary therapies
5384452|NCT00097981|Multiple myeloma|multiple myeloma
5384453|NCT00097981|Newly diagnosed multiple myeloma|newly diagnosed multiple myeloma
5384454|NCT00097981|Thalidomide|thalidomide
5384455|NCT00097981|Dexamethasone|dexamethasone
5384456|NCT00097981|DOXIL|doxil
5384457|NCT00097981|Pegylated liposomal hydrochloride doxorubicin injection|pegylated liposomal hydrochloride doxorubicin injection
5384458|NCT00097968|transplant, heart, adult, everolimus|transplant, heart, adult, everolimus
5384459|NCT00097968|allograft rejection|allograft rejection
5384460|NCT00097955|diabetes|diabetes
5384461|NCT00097955|nephropathy|nephropathy
5384462|NCT00097955|hypertension|hypertension
5384463|NCT00097955|aliskiren|aliskiren
5384464|NCT00097955|losartan|losartan
5384465|NCT00097942|memantine|memantine
5384466|NCT00097942|adjunctive therapy|adjunctive therapy
5384467|NCT00097942|schizophrenia|schizophrenia
5384468|NCT00097929|Relapsed Diffuse Large B-cell Lymphoma|relapsed diffuse large b-cell lymphoma
5384469|NCT00097916|memantine HCl|memantine hcl
5384470|NCT00097916|Dementia|dementia
5384471|NCT00097916|Agitation|agitation
5384472|NCT00097916|Alzheimer Disease|alzheimer disease
5384473|NCT00097903|Carcinoma, Non-Small-Cell Lung|carcinoma, non-small-cell lung
5384474|NCT00097903|Solid Tumors|solid tumors
5384475|NCT00097903|Oral|oral
5384476|NCT00097890|Lysosomes|lysosomes
5384477|NCT00097890|Storage|storage
5384478|NCT00097890|Glycolipid|glycolipid
5384479|NCT00097890|Fabry Disease|fabry disease
5384480|NCT00097890|Stroke|stroke
5384481|NCT00097877|Type 2 Diabetes|type 2 diabetes
5384482|NCT00097851|second-line|second-line
5384483|NCT00097851|combination|combination
5384484|NCT00097851|chemotherapy|chemotherapy
5384485|NCT00097851|anti-angiogenic|anti-angiogenic
5384486|NCT00097838|HIV Seronegativity|hiv seronegativity
5384487|NCT00097838|HIV Preventive Vaccine|hiv preventive vaccine
5384488|NCT00097825|Male Osteoporosis|male osteoporosis
5384592|NCT00097396|plague|plague
5384489|NCT00097812|osteoporosis, osteopenia, post-menopausal, zoledronic acid|osteoporosis, osteopenia, post-menopausal, zoledronic acid
5384490|NCT00097786|Prevention|prevention
5384491|NCT00097786|Diabetes type 2|diabetes type 2
5384492|NCT00097786|valsartan|valsartan
5384493|NCT00097786|nateglinide|nateglinide
5384494|NCT00097773|Lung Diseases|lung diseases
5384495|NCT00097773|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5384496|NCT00097760|Multiple Sclerosis|multiple sclerosis
5384497|NCT00097760|MS|ms
5384498|NCT00097747|anemia|anemia
5384499|NCT00097747|chronic kidney disease|chronic kidney disease
5384500|NCT00097747|CKD|ckd
5384501|NCT00097747|chronic renal failure|chronic renal failure
5384502|NCT00097747|CRF|crf
5384503|NCT00097747|erythropoietin|erythropoietin
5384504|NCT00097747|EPO|epo
5384505|NCT00097747|erythropoiesis stimulating agent|erythropoiesis stimulating agent
5384506|NCT00097747|ESA|esa
5384507|NCT00097747|Hematide™|hematide™
5384508|NCT00097747|hemoglobin|hemoglobin
5384509|NCT00097747|Hb|hb
5384510|NCT00097747|Hgb|hgb
5384511|NCT00097747|Omontys|omontys
5384512|NCT00097747|peginesatide|peginesatide
5384513|NCT00097747|red blood cell|red blood cell
5384514|NCT00097747|red blood cell production|red blood cell production
5384515|NCT00097734|diverticulitis|diverticulitis
5384516|NCT00097734|Invanz|invanz
5384517|NCT00097734|Ertapenem|ertapenem
5384518|NCT00097734|acute attacks|acute attacks
5384519|NCT00097734|sigmoid diverticulitis|sigmoid diverticulitis
5384520|NCT00097734|Acute attacks of sigmoid diverticulitis|acute attacks of sigmoid diverticulitis
5384521|NCT00097721|breast neoplasm|breast neoplasm
5384522|NCT00097721|breast cancer|breast cancer
5384523|NCT00097721|breast tumor|breast tumor
5384524|NCT00097708|Double Blind, Placebo controlled, Safety and Efficacy|double blind, placebo controlled, safety and efficacy
5384525|NCT00097708|Generalized Anxiety Disorder|generalized anxiety disorder
5384526|NCT00097695|Hereditary Angioedema|hereditary angioedema
5384527|NCT00097695|C1 inhibitor deficiency|c1 inhibitor deficiency
5384528|NCT00097695|HAE|hae
5384529|NCT00097695|Icatibant|icatibant
5384530|NCT00097695|Bradykinin antagonist|bradykinin antagonist
5384531|NCT00097695|acute attack|acute attack
5384532|NCT00097695|subcutaneous|subcutaneous
5384533|NCT00097682|Financial Ties|financial ties
5384534|NCT00097682|Institution|institution
5384535|NCT00097682|Research Doctor|research doctor
5384536|NCT00097682|Oncology|oncology
5384537|NCT00097682|Attitudes|attitudes
5384538|NCT00097682|Cancer|cancer
5384539|NCT00097682|Survey|survey
5384540|NCT00097669|VITATOPS|vitatops
5384541|NCT00097669|stroke|stroke
5384542|NCT00097669|prevention|prevention
5384543|NCT00097669|multivitamins|multivitamins
5384544|NCT00097669|homocysteine|homocysteine
5384545|NCT00097643|exercise|exercise
5384546|NCT00097643|health promotion|health promotion
5384547|NCT00097643|independent living|independent living
5384548|NCT00097643|affective aspects|affective aspects
5384549|NCT00097630|mechanical ventilation|mechanical ventilation
5384550|NCT00097630|delirium|delirium
5384551|NCT00097630|sedation scoring|sedation scoring
5384552|NCT00097630|cognitive impairment|cognitive impairment
5384553|NCT00097630|ventilation weaning|ventilation weaning
5384554|NCT00097604|Sleep|sleep
5384555|NCT00097604|Aged|aged
5384556|NCT00097604|Valerian|valerian
5384557|NCT00097604|Complementary Therapies|complementary therapies
5384558|NCT00097604|Medicine, Herbal|medicine, herbal
5384559|NCT00097565|Follicular Non-Hodgkin's Lymphoma|follicular non-hodgkin's lymphoma
5384560|NCT00097539|Pediatric growth disorders|pediatric growth disorders
5384561|NCT00097526|Growth Hormone Deficiency|growth hormone deficiency
5384562|NCT00097513|Pubertal Growth Hormone Deficiency|pubertal growth hormone deficiency
5384563|NCT00097500|diabetes|diabetes
5384564|NCT00097500|exenatide|exenatide
5384565|NCT00097500|exendin-4|exendin-4
5384566|NCT00097500|Amylin|amylin
5384567|NCT00097500|Lilly|lilly
5384568|NCT00097487|Metastatic Breast Cancer|metastatic breast cancer
5384569|NCT00097474|Cortisol|cortisol
5384570|NCT00097474|Travel|travel
5384571|NCT00097474|Saliva|saliva
5384572|NCT00097474|Body Clock|body clock
5384573|NCT00097474|Sleep|sleep
5384574|NCT00097474|Healthy Volunteer|healthy volunteer
5384575|NCT00097474|HV|hv
5384576|NCT00097474|Jet Lag|jet lag
5384577|NCT00097461|Employee Health|employee health
5384578|NCT00097461|Insurance Benefit|insurance benefit
5384579|NCT00097461|Fringe Benefit|fringe benefit
5384580|NCT00097461|Health Status|health status
5384581|NCT00097461|Socioeconomic Factors|socioeconomic factors
5384582|NCT00097448|sudden hearing loss|sudden hearing loss
5384583|NCT00097448|unilateral sudden sensorineural hearing loss|unilateral sudden sensorineural hearing loss
5384584|NCT00097448|sudden sensorineural hearing loss|sudden sensorineural hearing loss
5384585|NCT00097448|sudden unilateral hearing loss|sudden unilateral hearing loss
5384586|NCT00097422|CDAD, diarrhea|cdad, diarrhea
5384587|NCT00097422|Clostridium difficile-Associated Diarrhea|clostridium difficile-associated diarrhea
5384588|NCT00097409|ovarian cancer|ovarian cancer
5384589|NCT00097409|platinum/taxane-refractory chemotherapy|platinum/taxane-refractory chemotherapy
5384590|NCT00097409|Persistent|persistent
5384593|NCT00097396|recombinant plague vaccine|recombinant plague vaccine
5384594|NCT00097396|vaccine|vaccine
5384595|NCT00097396|plague vaccine|plague vaccine
5384596|NCT00097396|Protection against pneumonic plague|protection against pneumonic plague
5384597|NCT00097370|Mepolizumab|mepolizumab
5384598|NCT00097370|Open-label|open-label
5384599|NCT00097370|Anti-IL-5|anti-il-5
5384600|NCT00097370|Hypereosinophilic Syndrome|hypereosinophilic syndrome
5384601|NCT00097370|Hypereosinophilia|hypereosinophilia
5384602|NCT00097357|Prevention of deep vein thrombosis and pulmonary embolism|prevention of deep vein thrombosis and pulmonary embolism
5384603|NCT00097357|Preventive therapy|preventive therapy
5384604|NCT00097344|Aromatase inhibitor|aromatase inhibitor
5384605|NCT00097344|Atamestane|atamestane
5384606|NCT00097344|Breast neoplasms|breast neoplasms
5384607|NCT00097344|Combined hormonal therapy|combined hormonal therapy
5384608|NCT00097344|Complete estrogen blockade|complete estrogen blockade
5384609|NCT00097344|Ductal breast carcinoma|ductal breast carcinoma
5384610|NCT00097344|Estrogen blocker|estrogen blocker
5384611|NCT00097344|Fareston®|fareston®
5384612|NCT00097344|Femara®|femara®
5384613|NCT00097344|First line therapy|first line therapy
5384614|NCT00097344|Letrozole|letrozole
5384615|NCT00097344|Lobular breast carcinoma|lobular breast carcinoma
5384616|NCT00097344|Locally advanced breast cancer|locally advanced breast cancer
5384617|NCT00097344|Locally recurrent breast cancer|locally recurrent breast cancer
5384618|NCT00097344|Maximal estrogen inhibition|maximal estrogen inhibition
5384619|NCT00097344|Metastatic breast cancer|metastatic breast cancer
5384620|NCT00097344|Neoplasms, Hormone-dependent|neoplasms, hormone-dependent
5384621|NCT00097344|Receptor-positive|receptor-positive
5384622|NCT00097344|Stage IIIA breast cancer|stage iiia breast cancer
5384623|NCT00097344|Stage IIIB breast cancer|stage iiib breast cancer
5384624|NCT00097344|Stage IV breast cancer|stage iv breast cancer
5384625|NCT00097344|Toremifene|toremifene
5384626|NCT00097331|multiple sclerosis|multiple sclerosis
5384627|NCT00097331|relapsing|relapsing
5384628|NCT00097331|remitting|remitting
5384629|NCT00097331|Relapsing-Remitting MS (RRMS)|relapsing-remitting ms (rrms)
5384630|NCT00097318|Ischemic|ischemic
5384631|NCT00097318|Brain|brain
5384632|NCT00097318|Inflammation|inflammation
5384633|NCT00097318|Clinical Trial|clinical trial
5384634|NCT00097318|Stroke|stroke
5384635|NCT00097305|Mental Health|mental health
5384636|NCT00097305|Psychotherapy|psychotherapy
5384637|NCT00097292|"at risk for developing type 1 diabetes"|"at risk for developing type 1 diabetes"
5384638|NCT00097292|T1DM|t1dm
5384639|NCT00097292|T1D|t1d
5384640|NCT00097292|juvenile diabetes|juvenile diabetes
5384641|NCT00097292|Type 1 Diabetes TrialNet|type 1 diabetes trialnet
5384642|NCT00097292|TrialNet|trialnet
5384643|NCT00097266|Bipolar Mania|bipolar mania
5384644|NCT00097253|Aromatherapy|aromatherapy
5384645|NCT00097253|Smell|smell
5384646|NCT00097240|FOLLOW|follow
5384647|NCT00097240|Psoriasis|psoriasis
5384648|NCT00097240|Pregnancy|pregnancy
5384649|NCT00097227|NSCLC|nsclc
5384650|NCT00097227|non-small|non-small
5384651|NCT00097227|lung|lung
5384652|NCT00097227|IIIb|iiib
5384653|NCT00097227|IV|iv
5384654|NCT00097227|Carboplatin|carboplatin
5384655|NCT00097227|Paclitaxel|paclitaxel
5384656|NCT00097227|Cetuximab|cetuximab
5384657|NCT00097227|Stage IIIB Non-Small Cell Lung Cancer|stage iiib non-small cell lung cancer
5384658|NCT00097227|Stage IV Non-Small Cell Lung Cancer|stage iv non-small cell lung cancer
5384659|NCT00097214|NSCLC|nsclc
5384660|NCT00097214|Non-small|non-small
5384661|NCT00097214|Lung|lung
5384662|NCT00097214|IIIB|iiib
5384664|NCT00097214|Carboplatin|carboplatin
5384665|NCT00097214|Cetuximab|cetuximab
5384666|NCT00097214|Stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5384667|NCT00097214|Stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5384668|NCT00097188|Relapsing remitting multiple sclerosis|relapsing remitting multiple sclerosis
5384669|NCT00097175|Major Depressive Disorder|major depressive disorder
5384670|NCT00097175|Serotonin|serotonin
5384671|NCT00097175|Functional MRI|functional mri
5384672|NCT00097175|Genotype|genotype
5384673|NCT00097175|Negative Affect|negative affect
5384674|NCT00097175|MDD|mdd
5384675|NCT00097175|Healthy Volunteer|healthy volunteer
5384676|NCT00097175|HV|hv
5384677|NCT00097162|Anisometropia|anisometropia
5384678|NCT00097162|Strabismus|strabismus
5384679|NCT00097162|Cortical Suppression|cortical suppression
5384680|NCT00097162|Impaired Vision|impaired vision
5384681|NCT00097162|Cortical Plasticity|cortical plasticity
5384682|NCT00097162|Amblyopia|amblyopia
5384683|NCT00097162|Adult Amblyopia|adult amblyopia
5384684|NCT00097149|Congenital birth defects|congenital birth defects
5384685|NCT00097149|Cleft lip|cleft lip
5384686|NCT00097149|Cleft palate|cleft palate
5384687|NCT00097149|Global Network|global network
5384688|NCT00097149|Neurodevelopmental outcome|neurodevelopmental outcome
5384689|NCT00097149|Maternal and child health|maternal and child health
5384690|NCT00097149|International|international
5384691|NCT00097149|Women's health|women's health
5384692|NCT00097149|Brazil|brazil
5384693|NCT00097149|Brasil|brasil
5384694|NCT00097149|Latin America|latin america
5384695|NCT00097149|ECLAMC|eclamc
5384696|NCT00097149|Argentina|argentina
5384697|NCT00097149|Bolivia|bolivia
5384698|NCT00097149|Chile|chile
5384699|NCT00097149|Colombia|colombia
5384700|NCT00097149|Ecuador|ecuador
5384701|NCT00097149|Venezuela|venezuela
5384702|NCT00097123|Acute postpartum hemorrhage|acute postpartum hemorrhage
5384703|NCT00097123|PPH|pph
5384704|NCT00097123|Misoprostol|misoprostol
5384705|NCT00097123|Global Network|global network
5384706|NCT00097123|Uterotonics|uterotonics
5384707|NCT00097123|India|india
5384708|NCT00097123|Maternal and child health|maternal and child health
5384709|NCT00097123|International|international
5384710|NCT00097123|Women's health|women's health
5384711|NCT00097110|Vitamin C|vitamin c
5384712|NCT00097110|Vitamin E|vitamin e
5384713|NCT00097110|Preeclampsia|preeclampsia
5384714|NCT00097110|Antioxidants|antioxidants
5384715|NCT00097110|Global Network|global network
5384716|NCT00097110|Preterm birth|preterm birth
5384717|NCT00097110|Low birth weight infants|low birth weight infants
5384718|NCT00097110|Brazil|brazil
5384719|NCT00097110|Brasil|brasil
5384720|NCT00097110|Maternal and child health|maternal and child health
5384721|NCT00097110|International|international
5384722|NCT00097110|Women's health|women's health
5384723|NCT00097097|Asphyxia|asphyxia
5384724|NCT00097097|Neonatal mortality|neonatal mortality
5384725|NCT00097097|Neonatal morbidity|neonatal morbidity
5384726|NCT00097097|Hypoxic ischemic encephalopathy|hypoxic ischemic encephalopathy
5384727|NCT00097097|Neurodevelopmental impairment|neurodevelopmental impairment
5384728|NCT00097097|Neonatal resuscitation|neonatal resuscitation
5384729|NCT00097097|Global Network|global network
5384730|NCT00097097|Zambia|zambia
5384731|NCT00097097|Africa|africa
5384732|NCT00097097|Cerebral palsy|cerebral palsy
5384733|NCT00097097|Child health|child health
5384734|NCT00097097|International|international
5384735|NCT00097071|Diabetes, Type 1|diabetes, type 1
5384736|NCT00097058|Aging|aging
5384737|NCT00097058|Menopause|menopause
5384738|NCT00097058|Estrogen Replacement Therapy|estrogen replacement therapy
5384739|NCT00097058|Cognitive Decline|cognitive decline
5384740|NCT00097045|Hepatitis C|hepatitis c
5384741|NCT00097045|HCV|hcv
5384742|NCT00097045|Omega Interferon|omega interferon
5384743|NCT00097045|Interferon|interferon
5384744|NCT00097045|HCV genotype 1|hcv genotype 1
5384745|NCT00097032|Bipolar I Disorder|bipolar i disorder
5384746|NCT00097032|risperidone|risperidone
5384747|NCT00097032|quetiapine|quetiapine
5384748|NCT00097032|sedation|sedation
5384749|NCT00097032|cognition|cognition
5384750|NCT00097019|Recurrent ovarian cancer|recurrent ovarian cancer
5384751|NCT00097019|Refractory ovarian cancer|refractory ovarian cancer
5384752|NCT00096993|Omnitarg|omnitarg
5384753|NCT00096993|Cancer|cancer
5384754|NCT00096993|Platinum-Resistant|platinum-resistant
5384755|NCT00096967|Metastatic breast cancer|metastatic breast cancer
5384756|NCT00096967|Metastatic colorectal cancer|metastatic colorectal cancer
5384757|NCT00096954|Omalizumab (Xolair)|omalizumab (xolair)
5384758|NCT00096954|Atopic Asthma|atopic asthma
5384759|NCT00096941|Advanced solid cancers|advanced solid cancers
5384760|NCT00096941|HER2|her2
5384761|NCT00096941|EGFR|egfr
5384762|NCT00096928|Plaque Psoriasis|plaque psoriasis
5384763|NCT00096928|RESPONSE|response
5384764|NCT00096928|Raptiva|raptiva
5384765|NCT00096928|efalizumab|efalizumab
5384766|NCT00096915|chronic kidney disease, CKD|chronic kidney disease, ckd
5384767|NCT00096915|renal failure|renal failure
5384768|NCT00096915|anemia|anemia
5384769|NCT00096915|hemodialysis|hemodialysis
5384770|NCT00096915|peritoneal dialysis|peritoneal dialysis
5384771|NCT00096915|Aranesp®, Darbepoetin Alfa|aranesp®, darbepoetin alfa
5384772|NCT00096902|Orthostatic Intolerance|orthostatic intolerance
5384773|NCT00096902|Hypnosis|hypnosis
5384774|NCT00096902|Cold Pressor|cold pressor
5384775|NCT00096902|Isometric Exercise|isometric exercise
5384776|NCT00096902|Behavior|behavior
5384777|NCT00096902|Neurocardiogenic Syncope|neurocardiogenic syncope
5384778|NCT00096876|Parkinsonian syndrome|parkinsonian syndrome
5384779|NCT00096863|Delirium|delirium
5384780|NCT00096863|Cognition Disorders|cognition disorders
5384781|NCT00096863|Antipsychotics|antipsychotics
5384782|NCT00096863|Mechanical Ventilation|mechanical ventilation
5384783|NCT00096863|Critical Illness|critical illness
5384784|NCT00096850|HIV Seronegativity|hiv seronegativity
5384785|NCT00096850|Antitubercular agents|antitubercular agents
5384786|NCT00096837|Myeloma|myeloma
5384787|NCT00096837|Multiple Myeloma|multiple myeloma
5384788|NCT00096837|Relapsed Multiple Myeloma|relapsed multiple myeloma
5384789|NCT00096837|Refractory Multiple Myeloma|refractory multiple myeloma
5384790|NCT00096824|Acute Infection|acute infection
5384791|NCT00096824|Treatment Naive|treatment naive
5384792|NCT00096798|Fatty Acids, Omega-3|fatty acids, omega-3
5384793|NCT00096798|Antidepressive Agents|antidepressive agents
5384794|NCT00096798|Eicosapentanoic Acid|eicosapentanoic acid
5384795|NCT00096785|chronic hepatitis B infection|chronic hepatitis b infection
5384796|NCT00096772|Genetic Testing|genetic testing
5384797|NCT00096772|Genomics|genomics
5384798|NCT00096772|Human Genetic Factors|human genetic factors
5384799|NCT00096759|Arthritis|arthritis
5384800|NCT00096759|Tai Chi|tai chi
5384801|NCT00096759|Meditation|meditation
5384802|NCT00096759|Relaxation Techniques|relaxation techniques
5384803|NCT00096746|Treatment Experienced|treatment experienced
5384804|NCT00096733|Living donors|living donors
5384805|NCT00096733|Organ procurement|organ procurement
5384806|NCT00096733|Liver transplantation|liver transplantation
5384807|NCT00096733|Hepatitis C|hepatitis c
5384808|NCT00096733|Hepatocellular carcinoma|hepatocellular carcinoma
5384809|NCT00096733|Hepatectomy|hepatectomy
5384810|NCT00096733|Liver regeneration|liver regeneration
5384811|NCT00096733|Graft rejection|graft rejection
5384812|NCT00096733|Quality of life|quality of life
5384813|NCT00096733|Informed consent|informed consent
5384814|NCT00096720|parkinson|parkinson
5384815|NCT00096720|brain imaging|brain imaging
5384816|NCT00096720|diagnosis|diagnosis
5384817|NCT00096707|advanced solid tumors|advanced solid tumors
5384818|NCT00096707|cancer|cancer
5384819|NCT00096707|docetaxel|docetaxel
5384820|NCT00096707|2-deoxy-D-glucose (2DG)|2-deoxy-d-glucose (2dg)
5384821|NCT00096707|phase 1|phase 1
5384822|NCT00096694|Intrauterine Device|intrauterine device
5384823|NCT00096694|IUD|iud
5384824|NCT00096694|Contraceptive|contraceptive
5384825|NCT00096694|Levonorgestrel|levonorgestrel
5384826|NCT00096668|Breast cancer|breast cancer
5384827|NCT00096668|TOCOSOL Paclitaxel|tocosol paclitaxel
5384828|NCT00096655|Ulcerative colitis|ulcerative colitis
5384829|NCT00096655|Infliximab|infliximab
5384830|NCT00096655|Remicade|remicade
5384831|NCT00096642|cognitive behavioral therapy|cognitive behavioral therapy
5384832|NCT00096642|depression|depression
5384833|NCT00096642|group therapy|group therapy
5384834|NCT00096642|parenting|parenting
5384835|NCT00096642|children and adolescents|children and adolescents
5384836|NCT00096629|recurrent renal cell cancer|recurrent renal cell cancer
5384837|NCT00096629|stage I renal cell cancer|stage i renal cell cancer
5384838|NCT00096629|stage II renal cell cancer|stage ii renal cell cancer
5384839|NCT00096629|stage III renal cell cancer|stage iii renal cell cancer
5384840|NCT00096629|stage IV renal cell cancer|stage iv renal cell cancer
5384841|NCT00096603|Moderate to severe plaque psoriasis|moderate to severe plaque psoriasis
5384842|NCT00096590|thromboembolism|thromboembolism
5384843|NCT00096590|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5384844|NCT00096564|Mirror Neuron|mirror neuron
5384845|NCT00096564|Urge|urge
5384846|NCT00096564|Statistical Parametric Mapping|statistical parametric mapping
5384847|NCT00096564|Healthy Volunteer|healthy volunteer
5384848|NCT00096564|HV|hv
5384849|NCT00096551|Biochemical Failure|biochemical failure
5384850|NCT00096551|Immunotherapy|immunotherapy
5384851|NCT00096551|TRICOM|tricom
5384852|NCT00096551|Pox-virus|pox-virus
5384853|NCT00096551|Fowlpox|fowlpox
5384854|NCT00096551|Prostate Cancer|prostate cancer
5384855|NCT00096538|classic Kaposi sarcoma|classic kaposi sarcoma
5384856|NCT00096538|recurrent Kaposi sarcoma|recurrent kaposi sarcoma
5384857|NCT00096525|recurrent renal cell cancer|recurrent renal cell cancer
5384858|NCT00096525|stage III renal cell cancer|stage iii renal cell cancer
5384859|NCT00096525|stage IV renal cell cancer|stage iv renal cell cancer
5384860|NCT00096486|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5384861|NCT00096486|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5384862|NCT00096486|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5384863|NCT00096473|Alzheimer's Disease|alzheimer's disease
5384864|NCT00096473|dementia|dementia
5384865|NCT00096473|acetylcholinesterase|acetylcholinesterase
5384866|NCT00096473|donepezil|donepezil
5384867|NCT00096473|Aricept|aricept
5384868|NCT00096473|memory loss|memory loss
5384869|NCT00096473|Severe dementia of the Alzheimer's type|severe dementia of the alzheimer's type
5384870|NCT00096421|Critical illness|critical illness
5384871|NCT00096421|Critical care|critical care
5384872|NCT00096421|Hyperglycemia|hyperglycemia
5384873|NCT00096421|Intensive care|intensive care
5384874|NCT00096421|Intensive Care Units|intensive care units
5384875|NCT00096421|Insulin resistance|insulin resistance
5384876|NCT00096421|Intensive insulin therapy|intensive insulin therapy
5384877|NCT00096421|Conventional insulin therapy|conventional insulin therapy
5384878|NCT00096408|Endometrial|endometrial
5384879|NCT00096408|Endometrium|endometrium
5384880|NCT00096408|Uterus|uterus
5384881|NCT00096408|Cancer|cancer
5384882|NCT00096408|Carcinoma|carcinoma
5384883|NCT00096408|Adenocarcinoma|adenocarcinoma
5384884|NCT00096408|Stage 1|stage 1
5384885|NCT00096408|Hysterectomy|hysterectomy
5384886|NCT00096408|Laparoscopy|laparoscopy
5384887|NCT00096408|Abdominal|abdominal
5384888|NCT00096408|Total|total
5384889|NCT00096408|Surgery|surgery
5384890|NCT00096408|Quality of Life|quality of life
5384891|NCT00096408|Disease-free survival|disease-free survival
5384892|NCT00096382|stage IV melanoma|stage iv melanoma
5384893|NCT00096382|recurrent melanoma|recurrent melanoma
5384894|NCT00096369|breast cancer|breast cancer
5384895|NCT00096369|lobular breast carcinoma in situ|lobular breast carcinoma in situ
5384896|NCT00096369|breast cancer in situ|breast cancer in situ
5384897|NCT00096356|fatigue|fatigue
5385468|NCT00094367|GR109714|gr109714
5384898|NCT00096356|stage I breast cancer|stage i breast cancer
5384899|NCT00096356|stage II breast cancer|stage ii breast cancer
5384900|NCT00096356|stage IIIA breast cancer|stage iiia breast cancer
5384901|NCT00096356|stage IIIB breast cancer|stage iiib breast cancer
5384902|NCT00096356|stage IIIC breast cancer|stage iiic breast cancer
5384903|NCT00096356|stage IV breast cancer|stage iv breast cancer
5384904|NCT00096343|invasive ductal breast carcinoma|invasive ductal breast carcinoma
5384905|NCT00096343|invasive lobular breast carcinoma|invasive lobular breast carcinoma
5384906|NCT00096343|stage II breast cancer|stage ii breast cancer
5384907|NCT00096343|stage IIIA breast cancer|stage iiia breast cancer
5384908|NCT00096343|stage IIIB breast cancer|stage iiib breast cancer
5384909|NCT00096343|inflammatory breast cancer|inflammatory breast cancer
5384910|NCT00096330|colon cancer|colon cancer
5384911|NCT00096330|rectal cancer|rectal cancer
5384912|NCT00096317|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5384913|NCT00096304|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5384914|NCT00096304|recurrent prostate cancer|recurrent prostate cancer
5384915|NCT00096304|stage IV prostate cancer|stage iv prostate cancer
5384916|NCT00096291|stage II breast cancer|stage ii breast cancer
5384917|NCT00096291|stage IIIA breast cancer|stage iiia breast cancer
5384918|NCT00096291|stage IIIB breast cancer|stage iiib breast cancer
5384919|NCT00096291|stage IIIC breast cancer|stage iiic breast cancer
5384920|NCT00096239|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5384921|NCT00096239|primary peritoneal cavity cancer|primary peritoneal cavity cancer
5384922|NCT00096239|fallopian tube cancer|fallopian tube cancer
5384923|NCT00096226|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5384924|NCT00096226|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5384925|NCT00096213|chondrosarcoma|chondrosarcoma
5384926|NCT00096187|low risk metastatic gestational trophoblastic tumor|low risk metastatic gestational trophoblastic tumor
5384927|NCT00096187|recurrent gestational trophoblastic tumor|recurrent gestational trophoblastic tumor
5384928|NCT00096187|nonmetastatic gestational trophoblastic tumor|nonmetastatic gestational trophoblastic tumor
5384929|NCT00096174|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5384930|NCT00096174|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5384931|NCT00096174|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5384932|NCT00096174|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5384933|NCT00096135|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5384934|NCT00096135|B-cell childhood acute lymphoblastic leukemia|b-cell childhood acute lymphoblastic leukemia
5384935|NCT00096135|T-cell childhood acute lymphoblastic leukemia|t-cell childhood acute lymphoblastic leukemia
5384936|NCT00096135|TdT positive childhood acute lymphoblastic leukemia|tdt positive childhood acute lymphoblastic leukemia
5384937|NCT00096096|graft versus host disease|graft versus host disease
5384938|NCT00096096|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5384939|NCT00096096|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5384940|NCT00096096|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5384941|NCT00096096|refractory multiple myeloma|refractory multiple myeloma
5384942|NCT00096096|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5384943|NCT00096096|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
5384944|NCT00096096|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5384945|NCT00096096|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5384946|NCT00096096|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5384947|NCT00096096|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5384948|NCT00096096|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5384949|NCT00096096|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5384950|NCT00096096|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5384951|NCT00096096|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5384952|NCT00096096|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5384953|NCT00096096|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5384954|NCT00096096|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5384955|NCT00096096|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5384956|NCT00096096|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5384957|NCT00096096|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5384958|NCT00096096|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5384959|NCT00096096|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
5384960|NCT00096096|refractory anemia with excess blasts|refractory anemia with excess blasts
5384961|NCT00096096|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
5384962|NCT00096096|refractory hairy cell leukemia|refractory hairy cell leukemia
5384963|NCT00096096|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
5384964|NCT00096096|chronic eosinophilic leukemia|chronic eosinophilic leukemia
5384965|NCT00096096|chronic neutrophilic leukemia|chronic neutrophilic leukemia
5384966|NCT00096096|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5384967|NCT00096096|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5384968|NCT00096096|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5384969|NCT00096096|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5384970|NCT00096096|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5384971|NCT00096096|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
5384972|NCT00096096|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
5384973|NCT00096096|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
5384974|NCT00096096|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5384975|NCT00096096|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5384976|NCT00096096|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5384977|NCT00096096|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
5384978|NCT00096096|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5384979|NCT00096096|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5384980|NCT00096096|refractory cytopenia with multilineage dysplasia|refractory cytopenia with multilineage dysplasia
5384981|NCT00096096|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5384982|NCT00096096|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5384983|NCT00096096|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5384984|NCT00096096|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
5384985|NCT00096096|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5384986|NCT00096096|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5384987|NCT00096096|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5384988|NCT00096096|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5384989|NCT00096096|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5384990|NCT00096096|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
5384991|NCT00096096|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
5384992|NCT00096096|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5384993|NCT00096096|stage I multiple myeloma|stage i multiple myeloma
5384994|NCT00096096|stage II multiple myeloma|stage ii multiple myeloma
5384995|NCT00096096|stage III multiple myeloma|stage iii multiple myeloma
5384996|NCT00096096|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
5384997|NCT00096096|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5384998|NCT00096096|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5384999|NCT00096096|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5385000|NCT00096096|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
5385329|NCT00094887|Pain Crisis|pain crisis
5385001|NCT00096096|stage III childhood large cell lymphoma|stage iii childhood large cell lymphoma
5385002|NCT00096096|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
5385003|NCT00096096|stage III childhood lymphoblastic lymphoma|stage iii childhood lymphoblastic lymphoma
5385004|NCT00096096|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
5385005|NCT00096096|stage III childhood small noncleaved cell lymphoma|stage iii childhood small noncleaved cell lymphoma
5385006|NCT00096096|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
5385007|NCT00096096|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5385008|NCT00096096|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5385009|NCT00096096|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5385010|NCT00096096|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5385011|NCT00096096|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5385012|NCT00096096|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5385013|NCT00096096|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5385014|NCT00096096|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5385015|NCT00096096|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5385016|NCT00096096|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5385017|NCT00096096|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5385018|NCT00096096|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5385019|NCT00096096|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5385020|NCT00096096|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5385021|NCT00096096|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5385022|NCT00096096|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5385023|NCT00096096|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5385024|NCT00096096|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5385025|NCT00096096|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5385026|NCT00096096|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5385027|NCT00096096|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5385028|NCT00096096|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5385029|NCT00096096|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5385030|NCT00096096|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5385031|NCT00096096|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
5385032|NCT00096083|advanced adult primary liver cancer|advanced adult primary liver cancer
5385033|NCT00096083|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
5385034|NCT00096083|recurrent adult primary liver cancer|recurrent adult primary liver cancer
5385035|NCT00096083|liver metastases|liver metastases
5385036|NCT00096083|adenocarcinoma of the colon|adenocarcinoma of the colon
5385037|NCT00096083|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
5385038|NCT00096083|adenocarcinoma of the extrahepatic bile duct|adenocarcinoma of the extrahepatic bile duct
5385039|NCT00096083|adenocarcinoma of the gallbladder|adenocarcinoma of the gallbladder
5385040|NCT00096083|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
5385041|NCT00096083|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5385042|NCT00096083|adenocarcinoma of the stomach|adenocarcinoma of the stomach
5385043|NCT00096083|carcinoma of the appendix|carcinoma of the appendix
5385044|NCT00096083|recurrent gallbladder cancer|recurrent gallbladder cancer
5385045|NCT00096083|unresectable gallbladder cancer|unresectable gallbladder cancer
5385046|NCT00096083|recurrent colon cancer|recurrent colon cancer
5385047|NCT00096083|stage IV colon cancer|stage iv colon cancer
5385048|NCT00096083|recurrent esophageal cancer|recurrent esophageal cancer
5385049|NCT00096083|stage IV esophageal cancer|stage iv esophageal cancer
5385050|NCT00096083|recurrent extrahepatic bile duct cancer|recurrent extrahepatic bile duct cancer
5385051|NCT00096083|unresectable extrahepatic bile duct cancer|unresectable extrahepatic bile duct cancer
5385052|NCT00096083|recurrent gastric cancer|recurrent gastric cancer
5385053|NCT00096083|stage IV gastric cancer|stage iv gastric cancer
5385054|NCT00096083|recurrent rectal cancer|recurrent rectal cancer
5385055|NCT00096083|stage IV rectal cancer|stage iv rectal cancer
5385056|NCT00096083|small intestine adenocarcinoma|small intestine adenocarcinoma
5385057|NCT00096083|recurrent small intestine cancer|recurrent small intestine cancer
5385058|NCT00096083|recurrent islet cell carcinoma|recurrent islet cell carcinoma
5385059|NCT00096083|recurrent pheochromocytoma|recurrent pheochromocytoma
5385060|NCT00096083|metastatic pheochromocytoma|metastatic pheochromocytoma
5385061|NCT00096083|pulmonary carcinoid tumor|pulmonary carcinoid tumor
5385062|NCT00096083|thyroid gland medullary carcinoma|thyroid gland medullary carcinoma
5385063|NCT00096083|metastatic gastrointestinal carcinoid tumor|metastatic gastrointestinal carcinoid tumor
5385064|NCT00096083|recurrent gastrointestinal carcinoid tumor|recurrent gastrointestinal carcinoid tumor
5385065|NCT00096083|recurrent pancreatic cancer|recurrent pancreatic cancer
5385066|NCT00096083|insulinoma|insulinoma
5385067|NCT00096083|WDHA syndrome|wdha syndrome
5385068|NCT00096083|glucagonoma|glucagonoma
5385069|NCT00096083|pancreatic polypeptide tumor|pancreatic polypeptide tumor
5385070|NCT00096083|somatostatinoma|somatostatinoma
5385071|NCT00096083|stage IV pancreatic cancer|stage iv pancreatic cancer
5385072|NCT00096083|intraocular melanoma|intraocular melanoma
5385073|NCT00096083|conjunctival melanoma|conjunctival melanoma
5385074|NCT00096083|iris melanoma|iris melanoma
5385075|NCT00096083|recurrent melanoma|recurrent melanoma
5385076|NCT00096083|stage IV melanoma|stage iv melanoma
5385077|NCT00096057|recurrent breast cancer|recurrent breast cancer
5385078|NCT00096057|stage IIIA breast cancer|stage iiia breast cancer
5385079|NCT00096057|stage IIIB breast cancer|stage iiib breast cancer
5385080|NCT00096057|stage IIIC breast cancer|stage iiic breast cancer
5385081|NCT00096057|stage IV breast cancer|stage iv breast cancer
5385082|NCT00096044|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5385083|NCT00096031|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
5385084|NCT00096031|recurrent esophageal cancer|recurrent esophageal cancer
5385085|NCT00096031|stage IV esophageal cancer|stage iv esophageal cancer
5385086|NCT00096018|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
5385087|NCT00096018|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
5385088|NCT00096018|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5385089|NCT00096018|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5385090|NCT00096018|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
5385091|NCT00095992|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
5385092|NCT00095992|advanced adult primary liver cancer|advanced adult primary liver cancer
5385093|NCT00095992|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
5385094|NCT00095992|recurrent adult primary liver cancer|recurrent adult primary liver cancer
5385095|NCT00095953|recurrent melanoma|recurrent melanoma
5385096|NCT00095953|stage IV melanoma|stage iv melanoma
5385097|NCT00095927|radiation toxicity|radiation toxicity
5385098|NCT00095927|chemotherapeutic agent toxicity|chemotherapeutic agent toxicity
5385099|NCT00095927|mucositis|mucositis
5385100|NCT00095927|xerostomia|xerostomia
5385101|NCT00095927|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
5385330|NCT00094887|Sickle Cell Anemia|sickle cell anemia
5385102|NCT00095927|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
5385170|NCT00095550|Moderate Hypertension|moderate hypertension
5385103|NCT00095927|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5385104|NCT00095927|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
5385105|NCT00095927|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
5385106|NCT00095927|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5385107|NCT00095927|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
5385108|NCT00095927|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
5385109|NCT00095927|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5385110|NCT00095927|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
5385111|NCT00095927|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
5385112|NCT00095927|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5385113|NCT00095927|stage II squamous cell carcinoma of the paranasal sinus and nasal cavity|stage ii squamous cell carcinoma of the paranasal sinus and nasal cavity
5385114|NCT00095927|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
5385115|NCT00095927|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
5385116|NCT00095927|untreated metastatic squamous neck cancer with occult primary|untreated metastatic squamous neck cancer with occult primary
5385117|NCT00095927|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
5385118|NCT00095914|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5385119|NCT00095901|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
5385120|NCT00095901|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
5385121|NCT00095901|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
5385122|NCT00095901|stage II squamous cell carcinoma of the nasopharynx|stage ii squamous cell carcinoma of the nasopharynx
5385123|NCT00095875|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
5385124|NCT00095875|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
5385125|NCT00095875|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
5385126|NCT00095875|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
5385127|NCT00095875|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5385128|NCT00095875|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5385129|NCT00095875|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5385130|NCT00095875|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5385131|NCT00095862|recurrent breast cancer|recurrent breast cancer
5385132|NCT00095862|stage IV breast cancer|stage iv breast cancer
5385133|NCT00095862|male breast cancer|male breast cancer
5385134|NCT00095862|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5385135|NCT00095836|recurrent thyroid cancer|recurrent thyroid cancer
5385136|NCT00095836|stage III follicular thyroid cancer|stage iii follicular thyroid cancer
5385137|NCT00095836|stage III papillary thyroid cancer|stage iii papillary thyroid cancer
5385138|NCT00095836|stage IV follicular thyroid cancer|stage iv follicular thyroid cancer
5385139|NCT00095836|stage IV papillary thyroid cancer|stage iv papillary thyroid cancer
5385140|NCT00095836|anaplastic thyroid cancer|anaplastic thyroid cancer
5385141|NCT00095836|thyroid gland medullary carcinoma|thyroid gland medullary carcinoma
5385142|NCT00095810|Psychosis, Parkinson's Disease|psychosis, parkinson's disease
5385143|NCT00095771|untreated childhood brain stem glioma|untreated childhood brain stem glioma
5385144|NCT00095771|childhood high-grade cerebral astrocytoma|childhood high-grade cerebral astrocytoma
5385145|NCT00095732|Pancreatic Insufficiency|pancreatic insufficiency
5385146|NCT00095732|Cystic Fibrosis|cystic fibrosis
5385147|NCT00095732|Enzymes|enzymes
5385148|NCT00095719|Acute agitation in patients diagnosed with Dementia|acute agitation in patients diagnosed with dementia
5385149|NCT00095706|Metastatic breast cancer|metastatic breast cancer
5385150|NCT00095706|HER2|her2
5385151|NCT00095706|Trastuzumab|trastuzumab
5385152|NCT00095706|Herceptin|herceptin
5385153|NCT00095706|VEGF|vegf
5385154|NCT00095706|Bevacizumab|bevacizumab
5385155|NCT00095706|Avastin|avastin
5385156|NCT00095680|Multiple Myeloma|multiple myeloma
5385157|NCT00095680|SCIO-469|scio-469
5385158|NCT00095680|Bortezomib|bortezomib
5385159|NCT00095680|p38 MAP kinase|p38 map kinase
5385160|NCT00095654|diabetes prevention|diabetes prevention
5385161|NCT00095654|ramipril|ramipril
5385162|NCT00095654|rosiglitazone|rosiglitazone
5385163|NCT00095654|impaired glucose tolerance|impaired glucose tolerance
5385164|NCT00095654|isolated impaired fasting glucose|isolated impaired fasting glucose
5385165|NCT00095654|Isolated Impaired Glucose Tolerance|isolated impaired glucose tolerance
5385166|NCT00095589|bladder cancer|bladder cancer
5385167|NCT00095589|stage 0 bladder cancer|stage 0 bladder cancer
5385168|NCT00095589|stage I bladder cancer|stage i bladder cancer
5385169|NCT00095589|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
5385269|NCT00095186|Oral|oral
5385171|NCT00095537|Solid tumors|solid tumors
5385172|NCT00095537|cancer|cancer
5385173|NCT00095537|HER-2-expressing tumors|her-2-expressing tumors
5385174|NCT00095524|Patient weight change|patient weight change
5385175|NCT00095524|changes in metabolic status|changes in metabolic status
5385176|NCT00095511|Bipolar Mania|bipolar mania
5385177|NCT00095498|arthritis|arthritis
5385178|NCT00095498|joint pain|joint pain
5385179|NCT00095498|Methotrexate|methotrexate
5385180|NCT00095485|Activity Level|activity level
5385181|NCT00095485|Musculoskeletal|musculoskeletal
5385182|NCT00095485|Healthy Volunteer|healthy volunteer
5385183|NCT00095485|Physical Activity|physical activity
5385184|NCT00095472|Blood Flow|blood flow
5385185|NCT00095472|Nitric Oxide|nitric oxide
5385186|NCT00095472|Vascular Function|vascular function
5385187|NCT00095472|Vasodilation|vasodilation
5385188|NCT00095472|Vaso-Occlusive Pain Crisis|vaso-occlusive pain crisis
5385189|NCT00095472|Sickle Cell Disease|sickle cell disease
5385190|NCT00095459|Raf-Kinase Inhibitor|raf-kinase inhibitor
5385191|NCT00095459|Combinatorial Therapy|combinatorial therapy
5385192|NCT00095459|Pathway Profiling|pathway profiling
5385193|NCT00095459|VEGFR|vegfr
5385194|NCT00095459|Bevacizumab|bevacizumab
5385195|NCT00095459|Sorafenib|sorafenib
5385196|NCT00095459|Advanced Solid Tumors|advanced solid tumors
5385197|NCT00095459|Angiogenesis|angiogenesis
5385198|NCT00095459|Targeted Therapy|targeted therapy
5385199|NCT00095459|VEGF|vegf
5385200|NCT00095459|Cancer|cancer
5385201|NCT00095459|Solid Tumor|solid tumor
5385202|NCT00095459|Metastatic Uresectable Solid Tumors|metastatic uresectable solid tumors
5385203|NCT00095446|Diabetes Mellitus|diabetes mellitus
5385204|NCT00095446|Diabetes|diabetes
5385205|NCT00095433|AMD|amd
5385206|NCT00095433|Neovascular age-related macular degeneration|neovascular age-related macular degeneration
5385207|NCT00095420|Interpersonal Relationships|interpersonal relationships
5385208|NCT00095420|Child|child
5385209|NCT00095407|Social Cognition|social cognition
5385210|NCT00095407|Semantic Memory|semantic memory
5385211|NCT00095407|Prefrontal Cortex|prefrontal cortex
5385212|NCT00095407|Temporal Cortex|temporal cortex
5385213|NCT00095407|Conceptual Self|conceptual self
5385214|NCT00095394|Severe Hypertension|severe hypertension
5385215|NCT00095381|Leukemia, Lymphocytic, T-Cell|leukemia, lymphocytic, t-cell
5385216|NCT00095381|Entry Term Lymphocytic Leukemia, T-Cell|entry term lymphocytic leukemia, t-cell
5385217|NCT00095381|T-Cell Leukemia|t-cell leukemia
5385218|NCT00095381|T-Lymphocytic Leukemia|t-lymphocytic leukemia
5385219|NCT00095381|Leukemia, Lymphocytic, T Cell|leukemia, lymphocytic, t cell
5385220|NCT00095381|T Lymphocytic Leukemia|t lymphocytic leukemia
5385221|NCT00095381|BCX-1777|bcx-1777
5385222|NCT00095381|forodesine hydrochloride|forodesine hydrochloride
5385223|NCT00095381|BioCryst|biocryst
5385224|NCT00095368|Pharyngitis|pharyngitis
5385225|NCT00095368|Tonsillitis|tonsillitis
5385226|NCT00095355|BDNF|bdnf
5385227|NCT00095355|Lithium|lithium
5385228|NCT00095355|Divalproex|divalproex
5385229|NCT00095355|Huntington Disease|huntington disease
5385230|NCT00095355|HD|hd
5385231|NCT00095329|relapsing-remitting MS|relapsing-remitting ms
5385232|NCT00095329|nonresponsive to standard of care MS|nonresponsive to standard of care ms
5385233|NCT00095329|sirolimus|sirolimus
5385234|NCT00095316|candidiasis, caspofungin, fungal infection, prophylaxis|candidiasis, caspofungin, fungal infection, prophylaxis
5385235|NCT00095303|BSFT|bsft
5385236|NCT00095303|Family Therapy|family therapy
5385237|NCT00095303|Adolescents|adolescents
5385238|NCT00095303|Substance Abuse|substance abuse
5385239|NCT00095290|Albuminuria|albuminuria
5385240|NCT00095290|Hypertension|hypertension
5385241|NCT00095290|Elevated Cardiovascular Risk|elevated cardiovascular risk
5385242|NCT00095290|Albuminuria in Hypertensive Subjects at Elevated Cardiovascular Risk|albuminuria in hypertensive subjects at elevated cardiovascular risk
5385243|NCT00095277|non-myeloid malignancies|non-myeloid malignancies
5385244|NCT00095277|myeloma|myeloma
5385245|NCT00095277|Anemia of Cancer|anemia of cancer
5385246|NCT00095264|Myelodysplastic Syndrome|myelodysplastic syndrome
5385247|NCT00095251|Delirium|delirium
5385248|NCT00095251|Hypnotics and Sedatives|hypnotics and sedatives
5385249|NCT00095251|Adrenergic alpha-Agonists|adrenergic alpha-agonists
5385250|NCT00095251|efficacy of sedation|efficacy of sedation
5385251|NCT00095251|cognitive impairment|cognitive impairment
5385252|NCT00095225|Recurrent or refractory non-small cell lung cancer|recurrent or refractory non-small cell lung cancer
5385253|NCT00095212|HIV|hiv
5385254|NCT00095212|women|women
5385255|NCT00095212|androgen|androgen
5385256|NCT00095212|Treatment Experienced|treatment experienced
5385257|NCT00095199|Recurrent or Progressive Non-Small Cell Lung Cancer|recurrent or progressive non-small cell lung cancer
5385258|NCT00095199|Second-line therapy|second-line therapy
5385259|NCT00095199|Docetaxel|docetaxel
5385260|NCT00095199|Pemetrexed|pemetrexed
5385261|NCT00095199|Cetuximab|cetuximab
5385262|NCT00095199|Failed platinum-based therapy|failed platinum-based therapy
5385263|NCT00095199|NSCLC|nsclc
5385264|NCT00095186|Cancer|cancer
5385265|NCT00095186|Metastatic|metastatic
5385266|NCT00095186|Kidney|kidney
5385267|NCT00095186|Refractive|refractive
5385268|NCT00095186|Lactoferrin|lactoferrin
5385270|NCT00095173|Juvenile Idiopathic Arthritis|juvenile idiopathic arthritis
5385271|NCT00095160|Solid Organ Tumors|solid organ tumors
5385272|NCT00095121|Hepatitis B|hepatitis b
5385273|NCT00095121|Children|children
5385274|NCT00095121|Pediatric|pediatric
5385275|NCT00095121|Adefovir Dipivoxil|adefovir dipivoxil
5385276|NCT00095108|Metastatic Melanoma|metastatic melanoma
5385277|NCT00095108|Metastatic Renal Cell Carcinoma|metastatic renal cell carcinoma
5385278|NCT00095095|Spine|spine
5385279|NCT00095095|Lumbar spine|lumbar spine
5385280|NCT00095095|Spinal fusion|spinal fusion
5385281|NCT00095095|Low back pain|low back pain
5385282|NCT00095095|Fusion cage|fusion cage
5385283|NCT00095095|Posterior lumbar interbody fusion|posterior lumbar interbody fusion
5385284|NCT00095095|Bioresorbable|bioresorbable
5385285|NCT00095095|Peek|peek
5385286|NCT00095082|Diabetes Mellitus, Type I|diabetes mellitus, type i
5385287|NCT00095056|Type 2 Diabetes Mellitus and Chronic Renal Insufficiency|type 2 diabetes mellitus and chronic renal insufficiency
5385288|NCT00095030|Diabetes|diabetes
5385289|NCT00095017|Arcoxia|arcoxia
5385290|NCT00094991|Type 2 diabetes|type 2 diabetes
5385291|NCT00094978|Apoptosis|apoptosis
5385292|NCT00094978|Toxicity|toxicity
5385293|NCT00094978|Pharmacokinetic|pharmacokinetic
5385294|NCT00094978|Gene Induction|gene induction
5385295|NCT00094978|Maximally Tolerated Dose|maximally tolerated dose
5385296|NCT00094978|Small Cell Lung Cancer|small cell lung cancer
5385297|NCT00094978|SCLC|sclc
5385298|NCT00094978|Non-Small Cell Lung Cancer|non-small cell lung cancer
5385299|NCT00094978|NSCLC|nsclc
5385300|NCT00094978|Esophageal Cancer|esophageal cancer
5385301|NCT00094978|Pleural Mesothelioma|pleural mesothelioma
5385302|NCT00094965|Advanced Gastrointestinal tumors and normal to severely abnormal renal function|advanced gastrointestinal tumors and normal to severely abnormal renal function
5385303|NCT00094952|Mild Cognitive Impairment|mild cognitive impairment
5385304|NCT00094952|Alzheimer's disease|alzheimer's disease
5385305|NCT00094952|magnetic resonance imaging|magnetic resonance imaging
5385306|NCT00094952|cerebrospinal fluid (CSF) biomarkers|cerebrospinal fluid (csf) biomarkers
5385307|NCT00094939|mild cognitive impairment|mild cognitive impairment
5385308|NCT00094939|Alzheimer disease|alzheimer disease
5385309|NCT00094939|magnetic resonance imaging|magnetic resonance imaging
5385310|NCT00094939|CSF tau protein|csf tau protein
5385311|NCT00094939|Hippocampus|hippocampus
5385312|NCT00094926|Risperidal CONSTA|risperidal consta
5385313|NCT00094926|Bipolar disorder|bipolar disorder
5385314|NCT00094926|mood episodes|mood episodes
5385315|NCT00094926|Safety and efficacy, adjuvant therapy|safety and efficacy, adjuvant therapy
5385316|NCT00094913|Aging|aging
5385317|NCT00094913|Mild Cognitive Impairment|mild cognitive impairment
5385318|NCT00094913|Alzheimer disease, preclinical|alzheimer disease, preclinical
5385319|NCT00094913|Hippocampal formation|hippocampal formation
5385320|NCT00094913|Glucose metabolism|glucose metabolism
5385321|NCT00094900|Muckle Wells Syndrome|muckle wells syndrome
5385322|NCT00094900|NOMID|nomid
5385323|NCT00094900|Adult Stills Disease|adult stills disease
5385324|NCT00094900|Familial Mediterranean|familial mediterranean
5385325|NCT00094900|Treatment Trial/Fever|treatment trial/fever
5385326|NCT00094900|Autoinflammatory Disease|autoinflammatory disease
5385327|NCT00094887|Blood Flow|blood flow
5385328|NCT00094887|Nitric Oxide|nitric oxide
5385331|NCT00094887|Vaso-Occlusive Crisis|vaso-occlusive crisis
5385332|NCT00094887|Sickle Cell Disease|sickle cell disease
5385333|NCT00094887|SCD|scd
5385334|NCT00094874|pelvic pain, bladder pain, urgency, frequency, nocturia|pelvic pain, bladder pain, urgency, frequency, nocturia
5385335|NCT00094861|dysphagia|dysphagia
5385336|NCT00094861|palifermin, KGF|palifermin, kgf
5385337|NCT00094861|chemoradiotherapy|chemoradiotherapy
5385338|NCT00094861|NSCLC, non-small cell lung cancer|nsclc, non-small cell lung cancer
5385339|NCT00094861|lung cancer|lung cancer
5385340|NCT00094861|supportive care|supportive care
5385341|NCT00094861|clinical trial|clinical trial
5385342|NCT00094861|consolidation chemotherapy|consolidation chemotherapy
5385343|NCT00094861|radiotherapy|radiotherapy
5385344|NCT00094835|Lung cancer, Non-small cell lung cancer, NSCLC|lung cancer, non-small cell lung cancer, nsclc
5385345|NCT00094835|Clinical Trial, Panitumumab, AMG 706|clinical trial, panitumumab, amg 706
5385346|NCT00094835|Anti-angiogenesis|anti-angiogenesis
5385347|NCT00094835|Immunex, Abgenix, Amgen|immunex, abgenix, amgen
5385348|NCT00094835|Stage IIIB, Stage IV, Unresectable|stage iiib, stage iv, unresectable
5385349|NCT00094822|Metastatic Cancer|metastatic cancer
5385350|NCT00094822|Neulasta®|neulasta®
5385351|NCT00094822|pegfilgrastim|pegfilgrastim
5385352|NCT00094809|Neulasta®|neulasta®
5385353|NCT00094809|pegfilgrastim|pegfilgrastim
5385354|NCT00094809|Advanced|advanced
5385355|NCT00094809|Chemotherapy|chemotherapy
5385356|NCT00094796|Insulin Resistance|insulin resistance
5385357|NCT00094796|Brachial Artery Reactivity|brachial artery reactivity
5385358|NCT00094796|Endothelial Progenitor Cells|endothelial progenitor cells
5385359|NCT00094796|Metabolic Stress Test|metabolic stress test
5385360|NCT00094796|Mitochondrial Function|mitochondrial function
5385361|NCT00094796|Type 2 Diabetes|type 2 diabetes
5385362|NCT00094796|T2DM|t2dm
5385363|NCT00094796|Pre-Diabetes|pre-diabetes
5385364|NCT00094783|Magnetic Resonance Imaging|magnetic resonance imaging
5385365|NCT00094783|Interventional MRI|interventional mri
5385366|NCT00094783|Arterial Stenosis|arterial stenosis
5385367|NCT00094783|Revascularization|revascularization
5385368|NCT00094783|Lllac Artery Stenosis|lllac artery stenosis
5385369|NCT00094783|Peripheral Arterial Disease|peripheral arterial disease
5385370|NCT00094783|Cardiovascular Disease|cardiovascular disease
5385371|NCT00094731|Aging|aging
5385372|NCT00094731|Memory|memory
5385373|NCT00094731|Mental Recall|mental recall
5385374|NCT00094731|Mental Processes|mental processes
5385375|NCT00094718|Chimeric Virus Vaccine|chimeric virus vaccine
5385376|NCT00094718|West Nile Virus|west nile virus
5385377|NCT00094718|Dengue Virus|dengue virus
5385378|NCT00094705|Dengue Vaccine|dengue vaccine
5385379|NCT00094705|Dengue Virus|dengue virus
5385380|NCT00094705|Dengue Hemorrhagic Fever|dengue hemorrhagic fever
5385381|NCT00094705|Dengue Shock Syndrome|dengue shock syndrome
5385382|NCT00094692|Amblyopia|amblyopia
5385383|NCT00094692|Patching|patching
5385384|NCT00094692|Spectacles|spectacles
5385385|NCT00094653|melanoma|melanoma
5385386|NCT00094653|metastatic melanoma|metastatic melanoma
5385387|NCT00094653|skin cancer|skin cancer
5385388|NCT00094601|Positron Emission Tomograhy|positron emission tomograhy
5385389|NCT00094601|[18F] FDOPA|[18f] fdopa
5385390|NCT00094601|[11C] NNC-112|[11c] nnc-112
5385391|NCT00094601|Dopamine|dopamine
5385392|NCT00094601|Molecular Imaging|molecular imaging
5385393|NCT00094601|Dopamine D1 Receptor|dopamine d1 receptor
5385394|NCT00094601|PET|pet
5385395|NCT00094601|Parkinson's Disease|parkinson's disease
5385396|NCT00094601|Cognition|cognition
5385397|NCT00094601|Parkinson Disease|parkinson disease
5385398|NCT00094601|PD|pd
5385399|NCT00094601|Healthy Volunteer|healthy volunteer
5385400|NCT00094601|HV|hv
5385401|NCT00094575|Abdominal|abdominal
5385402|NCT00094575|Aortic Aneurysm|aortic aneurysm
5385403|NCT00094575|cost of AAA repair|cost of aaa repair
5385404|NCT00094575|Endovascular Repair|endovascular repair
5385405|NCT00094575|Grafts|grafts
5385406|NCT00094575|Long-term survival|long-term survival
5385407|NCT00094575|secondary outcomes|secondary outcomes
5385408|NCT00094562|Cancer|cancer
5385409|NCT00094562|Cancer Cachexia|cancer cachexia
5385410|NCT00094562|Weight Loss|weight loss
5385411|NCT00094562|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5385412|NCT00094562|Chronic Heart Failure|chronic heart failure
5385413|NCT00094562|Rheumatoid Arthritis|rheumatoid arthritis
5385414|NCT00094536|Menorrhagia|menorrhagia
5385415|NCT00094536|Excessive Uterine Bleeding|excessive uterine bleeding
5385416|NCT00094536|Cryoablation|cryoablation
5385417|NCT00094536|Menstrual disorder|menstrual disorder
5385418|NCT00094536|Endometrial ablation|endometrial ablation
5385419|NCT00094536|Abnormal uterine bleeding|abnormal uterine bleeding
5385420|NCT00094536|Dysfunctional uterine bleeding|dysfunctional uterine bleeding
5385421|NCT00094523|fosamprenavir LEXIVA non-inferiority safety tolerability|fosamprenavir lexiva non-inferiority safety tolerability
5385422|NCT00094510|Prefrontal GABA|prefrontal gaba
5385423|NCT00094510|Stress|stress
5385424|NCT00094510|Emotion Recognition|emotion recognition
5385425|NCT00094510|Differential Reward|differential reward
5385426|NCT00094510|Gabapentin|gabapentin
5385427|NCT00094510|GABA|gaba
5385428|NCT00094510|Prefrontal Cortex|prefrontal cortex
5385429|NCT00094510|Emotional Processing|emotional processing
5385430|NCT00094510|Healthy Humans|healthy humans
5385431|NCT00094510|Healthy Volunteer|healthy volunteer
5385432|NCT00094510|HV|hv
5385433|NCT00094484|Sensipar®|sensipar®
5385434|NCT00094484|Mimpara®|mimpara®
5385435|NCT00094484|Cinacalcet|cinacalcet
5385436|NCT00094484|Calcimimetic|calcimimetic
5385437|NCT00094484|Chronic Kidney Disease|chronic kidney disease
5385438|NCT00094458|Crohn's Disease|crohn's disease
5385439|NCT00094458|infliximab|infliximab
5385440|NCT00094458|azathioprine|azathioprine
5385441|NCT00094458|Remicade|remicade
5385442|NCT00094458|SONIC|sonic
5385443|NCT00094445|Pancreatic Cancer|pancreatic cancer
5385444|NCT00094445|Adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
5385445|NCT00094445|Alternative therapy|alternative therapy
5385446|NCT00094445|Pancreas|pancreas
5385447|NCT00094445|Pancreatic Neoplasm|pancreatic neoplasm
5385448|NCT00094445|Cancer of the pancreas|cancer of the pancreas
5385449|NCT00094432|depressed|depressed
5385450|NCT00094419|Complementary Therapies|complementary therapies
5385451|NCT00094406|Lung Permeability|lung permeability
5385452|NCT00094406|Endotoxin Tolerance|endotoxin tolerance
5385453|NCT00094406|Bronchoscopy|bronchoscopy
5385454|NCT00094406|Carbon Monoxide Inhalation|carbon monoxide inhalation
5385455|NCT00094393|Ageing|ageing
5385456|NCT00094393|Atherosclerosis|atherosclerosis
5385457|NCT00094393|Lamin A|lamin a
5385458|NCT00094393|Lipodystrophy|lipodystrophy
5385459|NCT00094393|Growth Impairment|growth impairment
5385460|NCT00094393|Premature Aging|premature aging
5385461|NCT00094393|Hutchinson-Gilford Progeria Syndrome|hutchinson-gilford progeria syndrome
5385462|NCT00094393|HGPS|hgps
5385464|NCT00094380|Lupus|lupus
5385465|NCT00094380|Systemic Lupus Erythematosus|systemic lupus erythematosus
5385466|NCT00094380|Lupus Nephritis|lupus nephritis
5385467|NCT00094367|1592U89|1592u89
5385469|NCT00094367|abacavir|abacavir
5385470|NCT00094367|lamivudine|lamivudine
5385471|NCT00094367|fixed-dose combination|fixed-dose combination
5385472|NCT00094367|once-daily|once-daily
5385473|NCT00094367|twice-daily|twice-daily
5385474|NCT00094367|HIV infection|hiv infection
5385475|NCT00094367|naive|naive
5385476|NCT00094354|HIV infected former Plasma Donors|hiv infected former plasma donors
5385477|NCT00094354|Needs assessment|needs assessment
5385478|NCT00094354|HIV-related stigma and discrimination|hiv-related stigma and discrimination
5385479|NCT00094354|In-depth interview|in-depth interview
5385480|NCT00094354|Focus Groups|focus groups
5385481|NCT00094341|Arthritis|arthritis
5385482|NCT00094341|Rheumatology|rheumatology
5385483|NCT00094328|Testotoxicosis|testotoxicosis
5385484|NCT00094328|Familial Male-limited Precocious Puberty (FMPP)|familial male-limited precocious puberty (fmpp)
5385485|NCT00094302|Heart Failure|heart failure
5385486|NCT00094302|Diastolic Heart Failure|diastolic heart failure
5385487|NCT00094302|Preserved Ejection Fraction|preserved ejection fraction
5385488|NCT00094172|Early Multiple Sclerosis|early multiple sclerosis
5385489|NCT00094172|MS|ms
5385490|NCT00094172|Clinically Isolated Syndrome|clinically isolated syndrome
5385491|NCT00094146|Primary Insulin Hypersecretion|primary insulin hypersecretion
5385492|NCT00094146|PIH|pih
5385493|NCT00094146|Obesity|obesity
5385494|NCT00094133|cancer survivor|cancer survivor
5385495|NCT00094133|stage IA breast cancer|stage ia breast cancer
5385496|NCT00094133|stage IB breast cancer|stage ib breast cancer
5385497|NCT00094133|stage II breast cancer|stage ii breast cancer
5385498|NCT00094133|stage IIIA breast cancer|stage iiia breast cancer
5385499|NCT00094133|stage IIIB breast cancer|stage iiib breast cancer
5385500|NCT00094133|stage IIIC breast cancer|stage iiic breast cancer
5385501|NCT00094133|stage IV breast cancer|stage iv breast cancer
5385502|NCT00094133|breast cancer in situ|breast cancer in situ
5385503|NCT00094133|inflammatory breast cancer|inflammatory breast cancer
5385504|NCT00094133|hot flashes|hot flashes
5385505|NCT00094120|Age-Related Macular Degeneration - Wet Type|age-related macular degeneration - wet type
5385506|NCT00094107|melanoma|melanoma
5385507|NCT00094107|antiangiogenesis|antiangiogenesis
5385508|NCT00094081|squamous cell carcinoma|squamous cell carcinoma
5385509|NCT00094081|oropharynx|oropharynx
5385510|NCT00094081|oral cavity|oral cavity
5385511|NCT00094081|larynx|larynx
5385512|NCT00094081|hypopharynx|hypopharynx
5385513|NCT00091468|Age-Related Memory Loss|age-related memory loss
5385514|NCT00091468|Nicotine|nicotine
5385515|NCT00091468|Mild Cognitive Impairment (MCI)|mild cognitive impairment (mci)
5385516|NCT00094068|Gray Matter|gray matter
5385517|NCT00094068|White Matter|white matter
5385518|NCT00094068|Cerebral Blood Flow|cerebral blood flow
5385519|NCT00094068|Cerebral Blood Volume|cerebral blood volume
5385520|NCT00094068|Lesion|lesion
5385521|NCT00094068|MRI|mri
5385522|NCT00094068|Multiple Sclerosis|multiple sclerosis
5385523|NCT00094068|Perfusion|perfusion
5385524|NCT00094068|Imaging|imaging
5385525|NCT00094068|Sildenafil|sildenafil
5385526|NCT00094068|MS|ms
5385527|NCT00094068|Healthy Volunteer|healthy volunteer
5385528|NCT00094068|HV|hv
5385529|NCT00094042|Socioeconomic Factors|socioeconomic factors
5385530|NCT00094042|Dietary Supplementation|dietary supplementation
5385531|NCT00094003|Liver metastases|liver metastases
5385532|NCT00094003|Colorectal cancer|colorectal cancer
5385533|NCT00094003|Gastric cancer|gastric cancer
5385534|NCT00094003|Esophagus cancer|esophagus cancer
5385535|NCT00094003|Breast cancer|breast cancer
5385536|NCT00094003|Lung cancer|lung cancer
5385537|NCT00094003|Skin cancer|skin cancer
5385538|NCT00094003|Renal Cancer|renal cancer
5385539|NCT00094003|Liver metastasis|liver metastasis
5385540|NCT00093990|Myeloid leukemia acute disease|myeloid leukemia acute disease
5385541|NCT00093990|Tipifarnib|tipifarnib
5385542|NCT00093990|Bone marrow aspirate|bone marrow aspirate
5385543|NCT00093977|Chronic Kidney Disease|chronic kidney disease
5385544|NCT00093977|Dialysis|dialysis
5385545|NCT00093977|Anemia|anemia
5385546|NCT00093977|Nephrology|nephrology
5385547|NCT00093964|brain cancer|brain cancer
5385548|NCT00093964|brain tumor|brain tumor
5385549|NCT00093951|Alzheimer disease|alzheimer disease
5385550|NCT00093951|memory|memory
5385551|NCT00093951|cognition|cognition
5385552|NCT00093951|GABA(B)receptor antagonist|gaba(b)receptor antagonist
5385553|NCT00093938|Vaccinium macrocarpon|vaccinium macrocarpon
5385554|NCT00093938|Asymptomatic Bacteriuria|asymptomatic bacteriuria
5385555|NCT00093925|Postoperative hypertension|postoperative hypertension
5385556|NCT00093912|Perioperative Hypertension|perioperative hypertension
5385557|NCT00093899|Mixed Hyperlipidemia|mixed hyperlipidemia
5385558|NCT00093886|Preoperative hypertension|preoperative hypertension
5385559|NCT00093873|Cancer|cancer
5385560|NCT00093873|antiangiogenesis|antiangiogenesis
5385561|NCT00093873|Solid Tumors|solid tumors
5385562|NCT00093847|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors
5385563|NCT00093847|S-adenosyl Methionine|s-adenosyl methionine
5385564|NCT00093847|SSRI|ssri
5385565|NCT00093847|SAMe|same
5385566|NCT00093834|stage IV breast cancer|stage iv breast cancer
5385567|NCT00093834|recurrent breast cancer|recurrent breast cancer
5385568|NCT00093808|recurrent breast cancer|recurrent breast cancer
5385569|NCT00093808|stage IV breast cancer|stage iv breast cancer
5385570|NCT00093808|male breast cancer|male breast cancer
5385571|NCT00093795|stage II breast cancer|stage ii breast cancer
5385572|NCT00093795|stage IIIA breast cancer|stage iiia breast cancer
5385573|NCT00093795|stage IIIC breast cancer|stage iiic breast cancer
5385574|NCT00093769|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5385575|NCT00093769|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5385576|NCT00093769|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5385577|NCT00093769|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5385578|NCT00093769|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5385579|NCT00093769|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5385580|NCT00093769|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5385581|NCT00093730|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5385582|NCT00093704|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5385583|NCT00093704|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5385584|NCT00093704|post-transplant lymphoproliferative disorder|post-transplant lymphoproliferative disorder
5385585|NCT00093704|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
5385586|NCT00093704|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
5385587|NCT00093704|adult grade III lymphomatoid granulomatosis|adult grade iii lymphomatoid granulomatosis
5385588|NCT00093678|pain|pain
5385589|NCT00093678|cachexia|cachexia
5385590|NCT00093678|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5385591|NCT00093678|recurrent uterine sarcoma|recurrent uterine sarcoma
5385592|NCT00093678|stage III uterine sarcoma|stage iii uterine sarcoma
5385593|NCT00093678|stage IV uterine sarcoma|stage iv uterine sarcoma
5385594|NCT00093678|ovarian sarcoma|ovarian sarcoma
5385595|NCT00093678|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
5385596|NCT00093678|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
5385597|NCT00093678|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
5385598|NCT00093678|recurrent melanoma|recurrent melanoma
5385599|NCT00093678|stage III melanoma|stage iii melanoma
5385600|NCT00093678|stage IV melanoma|stage iv melanoma
5385601|NCT00093678|chondrosarcoma|chondrosarcoma
5385602|NCT00093678|metastatic osteosarcoma|metastatic osteosarcoma
5385603|NCT00093678|recurrent osteosarcoma|recurrent osteosarcoma
5385604|NCT00093678|classic Kaposi sarcoma|classic kaposi sarcoma
5385605|NCT00093678|AIDS-related Kaposi sarcoma|aids-related kaposi sarcoma
5385606|NCT00093678|recurrent Kaposi sarcoma|recurrent kaposi sarcoma
5385607|NCT00093678|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5385608|NCT00093678|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5385609|NCT00093678|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5385610|NCT00093678|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5385611|NCT00093678|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5385612|NCT00093678|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5385613|NCT00093678|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5385614|NCT00093678|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5385615|NCT00093678|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5385616|NCT00093678|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5385617|NCT00093678|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5385618|NCT00093678|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5385619|NCT00093678|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5385620|NCT00093678|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5385621|NCT00093678|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5385622|NCT00093678|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5385623|NCT00093678|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5385624|NCT00093678|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5385625|NCT00093678|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5385626|NCT00093678|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5385627|NCT00093678|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5385628|NCT00093678|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5385629|NCT00093678|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5385630|NCT00093678|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5385631|NCT00093678|intraocular lymphoma|intraocular lymphoma
5385632|NCT00093678|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5385633|NCT00093678|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5385634|NCT00093678|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5385635|NCT00093678|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5385636|NCT00093678|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5385637|NCT00093678|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5385638|NCT00093678|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5385639|NCT00093678|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5385640|NCT00093678|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5385641|NCT00093678|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5385642|NCT00093678|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5385643|NCT00093678|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5385644|NCT00093678|primary central nervous system lymphoma|primary central nervous system lymphoma
5385645|NCT00093678|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5385646|NCT00093678|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5385647|NCT00093678|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5385648|NCT00093678|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5385649|NCT00093678|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
5385650|NCT00093678|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
5385651|NCT00093678|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5385652|NCT00093678|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
5385653|NCT00093678|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
5385654|NCT00093678|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5385655|NCT00093678|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5385656|NCT00093678|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5385657|NCT00093678|adult grade III lymphomatoid granulomatosis|adult grade iii lymphomatoid granulomatosis
5385658|NCT00093678|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
5385659|NCT00093678|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5385660|NCT00093678|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
5385661|NCT00093678|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
5385662|NCT00093678|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
5385663|NCT00093678|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
5385664|NCT00093678|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
5385665|NCT00093678|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
5385666|NCT00093678|AIDS-related primary CNS lymphoma|aids-related primary cns lymphoma
5385667|NCT00093678|immunosuppressive treatment related Kaposi sarcoma|immunosuppressive treatment related kaposi sarcoma
5385668|NCT00093665|stage II lymphoepithelioma of the nasopharynx|stage ii lymphoepithelioma of the nasopharynx
5385669|NCT00093665|stage III lymphoepithelioma of the nasopharynx|stage iii lymphoepithelioma of the nasopharynx
5385670|NCT00093665|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
5385671|NCT00093665|stage II squamous cell carcinoma of the nasopharynx|stage ii squamous cell carcinoma of the nasopharynx
5385672|NCT00093665|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
5385673|NCT00093665|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
5385674|NCT00093652|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
5385675|NCT00093652|recurrent esophageal cancer|recurrent esophageal cancer
5385676|NCT00093652|stage II esophageal cancer|stage ii esophageal cancer
5385677|NCT00093652|stage III esophageal cancer|stage iii esophageal cancer
5385678|NCT00093652|stage IV esophageal cancer|stage iv esophageal cancer
5385679|NCT00093652|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
5385680|NCT00093639|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5385681|NCT00093639|chronic myelogenous leukemia, BCR-ABL1 positive|chronic myelogenous leukemia, bcr-abl1 positive
5385682|NCT00093600|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5385683|NCT00093600|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5385684|NCT00093600|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5385685|NCT00093600|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5385686|NCT00093600|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5385687|NCT00093600|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
5385688|NCT00093587|graft versus host disease|graft versus host disease
5385689|NCT00093587|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5385690|NCT00093587|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5385691|NCT00093587|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5385692|NCT00093587|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5385693|NCT00093587|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5385694|NCT00093587|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5385695|NCT00093587|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5385696|NCT00093587|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5385697|NCT00093561|prostate cancer|prostate cancer
5385698|NCT00093548|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
5385699|NCT00093548|advanced adult primary liver cancer|advanced adult primary liver cancer
5385780|NCT00093184|ST-Segment Elevation|st-segment elevation
5385700|NCT00093548|localized resectable adult primary liver cancer|localized resectable adult primary liver cancer
5385701|NCT00093548|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
5385702|NCT00093522|recurrent renal cell cancer|recurrent renal cell cancer
5385703|NCT00093522|stage IV renal cell cancer|stage iv renal cell cancer
5385704|NCT00093509|stage I adult soft tissue sarcoma|stage i adult soft tissue sarcoma
5385705|NCT00093509|stage II adult soft tissue sarcoma|stage ii adult soft tissue sarcoma
5385706|NCT00093509|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
5385707|NCT00093509|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
5385708|NCT00093483|adult acute basophilic leukemia|adult acute basophilic leukemia
5385709|NCT00093483|adult acute eosinophilic leukemia|adult acute eosinophilic leukemia
5385710|NCT00093483|adult erythroleukemia (M6a)|adult erythroleukemia (m6a)
5385711|NCT00093483|adult pure erythroid leukemia (M6b)|adult pure erythroid leukemia (m6b)
5385712|NCT00093483|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
5385713|NCT00093483|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
5385714|NCT00093483|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
5385715|NCT00093483|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
5385716|NCT00093483|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
5385717|NCT00093483|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
5385718|NCT00093483|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
5385719|NCT00093483|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5385720|NCT00093483|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5385721|NCT00093483|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5385722|NCT00093483|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5385723|NCT00093483|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
5385724|NCT00093483|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5385725|NCT00093457|recurrent prostate cancer|recurrent prostate cancer
5385726|NCT00093457|stage IV prostate cancer|stage iv prostate cancer
5385727|NCT00093457|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5385728|NCT00093444|advanced adult primary liver cancer|advanced adult primary liver cancer
5385729|NCT00093444|liver metastases|liver metastases
5385730|NCT00093444|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
5385731|NCT00093444|recurrent adult primary liver cancer|recurrent adult primary liver cancer
5385732|NCT00093405|recurrent renal cell cancer|recurrent renal cell cancer
5385733|NCT00093405|stage IV renal cell cancer|stage iv renal cell cancer
5385734|NCT00093405|clear cell renal cell carcinoma|clear cell renal cell carcinoma
5385735|NCT00093379|stage II anal cancer|stage ii anal cancer
5385736|NCT00093379|stage IIIA anal cancer|stage iiia anal cancer
5385737|NCT00093379|stage IIIB anal cancer|stage iiib anal cancer
5385738|NCT00093379|squamous cell carcinoma of the anus|squamous cell carcinoma of the anus
5385739|NCT00093379|Capecitabine|capecitabine
5385740|NCT00093379|Xeloda|xeloda
5385741|NCT00093379|Oxaliplatin|oxaliplatin
5385742|NCT00093379|Eloxatin|eloxatin
5385743|NCT00093379|Radiotherapy|radiotherapy
5385745|NCT00093366|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5385746|NCT00093366|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5385747|NCT00093366|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5385748|NCT00093366|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
5385749|NCT00093366|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
5385750|NCT00093366|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5385751|NCT00093353|diarrhea|diarrhea
5385752|NCT00093353|drug/agent toxicity by tissue/organ|drug/agent toxicity by tissue/organ
5385753|NCT00093353|disseminated neuroblastoma|disseminated neuroblastoma
5385754|NCT00093353|recurrent neuroblastoma|recurrent neuroblastoma
5385755|NCT00093314|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
5385756|NCT00093314|B-cell Lymphoma|b-cell lymphoma
5385757|NCT00093860|Adrenaline|adrenaline
5385758|NCT00093860|Norepinephrine|norepinephrine
5385759|NCT00093860|Sympathetic Nervous System|sympathetic nervous system
5385760|NCT00093860|Fainting|fainting
5385761|NCT00093860|Hypotension|hypotension
5385762|NCT00093860|Beta-Adrenoceptors|beta-adrenoceptors
5385763|NCT00093860|Neurocardiogenic Syncope|neurocardiogenic syncope
5385764|NCT00093860|Chronic Orthostatic Intolerance|chronic orthostatic intolerance
5385765|NCT00093860|Sympathoadrenal Imbalance|sympathoadrenal imbalance
5385766|NCT00093860|SAI|sai
5385767|NCT00093860|Children|children
5385768|NCT00093301|Shock|shock
5385769|NCT00093301|Levosimendan|levosimendan
5385770|NCT00093301|Inotropes|inotropes
5385771|NCT00093301|Dobutamine|dobutamine
5385772|NCT00093301|Heart failure|heart failure
5385773|NCT00093301|Sepsis|sepsis
5385774|NCT00093288|MDD|mdd
5385775|NCT00093288|bupropion|bupropion
5385776|NCT00093288|Depression|depression
5385777|NCT00093262|Postoperative Hypertension|postoperative hypertension
5385778|NCT00093249|Pre-operative hypertension|pre-operative hypertension
5385779|NCT00093223|In-Stent Restenosis|in-stent restenosis
5385781|NCT00093184|Acute Myocardial Infarction|acute myocardial infarction
5385782|NCT00093184|PCI|pci
5385783|NCT00093184|Percutaneous Coronary Intervention|percutaneous coronary intervention
5385784|NCT00093158|Acute Coronary Syndromes|acute coronary syndromes
5385785|NCT00093145|Advanced Breast Cancer|advanced breast cancer
5385786|NCT00002543|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
5385787|NCT00002543|recurrent childhood brain tumor|recurrent childhood brain tumor
5385788|NCT00002543|recurrent neuroblastoma|recurrent neuroblastoma
5385789|NCT00002543|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
5385790|NCT00002543|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
5385791|NCT00002543|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
5385792|NCT00002543|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
5385793|NCT00002524|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
5385794|NCT00002524|AIDS-related primary CNS lymphoma|aids-related primary cns lymphoma
5385795|NCT00002524|AIDS-related diffuse large cell lymphoma|aids-related diffuse large cell lymphoma
5385796|NCT00002524|AIDS-related immunoblastic large cell lymphoma|aids-related immunoblastic large cell lymphoma
5385797|NCT00002524|AIDS-related small noncleaved cell lymphoma|aids-related small noncleaved cell lymphoma
5385798|NCT00002524|AIDS-related diffuse mixed cell lymphoma|aids-related diffuse mixed cell lymphoma
5385799|NCT00002524|AIDS-related diffuse small cleaved cell lymphoma|aids-related diffuse small cleaved cell lymphoma
5385800|NCT00093132|Non-Small Cell Lung Cancer (stage II or III)|non-small cell lung cancer (stage ii or iii)
5385801|NCT00093132|NSCLC|nsclc
5385802|NCT00093132|Squamous Cell Lung Cancer|squamous cell lung cancer
5385803|NCT00093132|adenocarcinoma of the lung|adenocarcinoma of the lung
5385804|NCT00093132|adenosquamous cell lung cancer|adenosquamous cell lung cancer
5385805|NCT00093132|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
5385806|NCT00093132|carcinoma, non-small cell lung|carcinoma, non-small cell lung
5385807|NCT00093119|Metastatic Melanoma|metastatic melanoma
5385808|NCT00093093|Viramidine|viramidine
5385809|NCT00093093|Ribavirin|ribavirin
5385810|NCT00093093|Valeant|valeant
5385811|NCT00093093|Hepatitis C|hepatitis c
5385812|NCT00093093|Pegylated interferon alfa-2a|pegylated interferon alfa-2a
5385813|NCT00093080|Metastatic and/or unresectable soft tissue or|metastatic and/or unresectable soft tissue or
5385814|NCT00093067|Gram-positive bacterial infections|gram-positive bacterial infections
5385815|NCT00093067|Staph Aureus|staph aureus
5385816|NCT00093067|endocarditis|endocarditis
5385817|NCT00093067|bacteremia|bacteremia
5385818|NCT00093067|Cubist|cubist
5385819|NCT00093054|Vaccinium macrocarpon|vaccinium macrocarpon
5385820|NCT00093041|Head and neck cancer|head and neck cancer
5385821|NCT00093041|squamous cell carcinoma of the head and neck|squamous cell carcinoma of the head and neck
5385822|NCT00093028|Myeloma|myeloma
5385823|NCT00093028|Revlimid|revlimid
5385824|NCT00093028|bortezomib|bortezomib
5385825|NCT00093028|CC-5013|cc-5013
5385826|NCT00093028|Dexamethasone|dexamethasone
5385827|NCT00091520|Congestive heart failure|congestive heart failure
5385828|NCT00091520|Nesiritide|nesiritide
5385829|NCT00093002|Early Breast Cancer|early breast cancer
5385830|NCT00093002|neoadjuvant therapy|neoadjuvant therapy
5385831|NCT00093002|hormonal treatment|hormonal treatment
5385832|NCT00093002|newly diagnosed breast cancer|newly diagnosed breast cancer
5385833|NCT00093002|Estrogen Receptor Positive Breast Cancer|estrogen receptor positive breast cancer
5385834|NCT00093002|treatment naïve|treatment naïve
5385835|NCT00093002|neoadjuvant treatment|neoadjuvant treatment
5385836|NCT00093002|neoadjuvant setting|neoadjuvant setting
5385837|NCT00093002|invasive breast cancer|invasive breast cancer
5385838|NCT00092976|Hemophilia A|hemophilia a
5385839|NCT00092898|Sitosterolemia|sitosterolemia
5385840|NCT00092846|High Blood Cholesterol Levels|high blood cholesterol levels
5385841|NCT00092820|Homozygous Sitosterolemia|homozygous sitosterolemia
5385842|NCT00092807|Homozygous Sitosterolemia|homozygous sitosterolemia
5385843|NCT00092781|Arcoxia|arcoxia
5385844|NCT00092768|Arcoxia|arcoxia
5385845|NCT00092755|Arcoxia|arcoxia
5385846|NCT00092742|Arcoxia|arcoxia
5385847|NCT00092703|Arcoxia|arcoxia
5385848|NCT00092664|Primary hypercholesterolemia|primary hypercholesterolemia
5385849|NCT00092651|Primary hypercholesterolemia|primary hypercholesterolemia
5385850|NCT00092573|Mixed hyperlipidemia (high cholesterol and high triglycerides)|mixed hyperlipidemia (high cholesterol and high triglycerides)
5385851|NCT00092560|mixed hyperlipidemia|mixed hyperlipidemia
5385852|NCT00092560|high cholesterol|high cholesterol
5385853|NCT00092560|high triglycerides|high triglycerides
5385854|NCT00092508|Ulcerative Colitis Remission|ulcerative colitis remission
5385855|NCT00092508|ulcerative|ulcerative
5385856|NCT00092508|colitis|colitis
5385857|NCT00092508|remission|remission
5385858|NCT00092508|relapse|relapse
5385859|NCT00092508|Asacol®|asacol®
5385860|NCT00092508|maintain|maintain
5385861|NCT00092508|maintenance|maintenance
5385862|NCT00092508|flare|flare
5385863|NCT00092508|rectal|rectal
5385864|NCT00092508|bleeding|bleeding
5385865|NCT00092508|bowel|bowel
5385866|NCT00092300|dental surgery|dental surgery
5385867|NCT00092300|molar removal|molar removal
5385868|NCT00092950|Exercise|exercise
5385869|NCT00092950|Pedometer|pedometer
5385870|NCT00092950|Physician Prescription|physician prescription
5385871|NCT00092950|Biomarkers|biomarkers
5385872|NCT00092950|Compliance|compliance
5385873|NCT00092950|Breast Cancer Survivor|breast cancer survivor
5385874|NCT00092950|Breast Cancer Risk|breast cancer risk
5385875|NCT00092937|Chronic Granulomatous Disease|chronic granulomatous disease
5385876|NCT00092937|Nonmyeloablative|nonmyeloablative
5385877|NCT00092937|CD34 Positive Cells|cd34 positive cells
5385878|NCT00092937|Donor Engraftment|donor engraftment
5385879|NCT00092937|Myeloid Chimerism|myeloid chimerism
5385880|NCT00092638|Elevated Cholesterol|elevated cholesterol
5385881|NCT00092625|Elevated Cholesterol|elevated cholesterol
5385882|NCT00092612|Elevated Cholesterol|elevated cholesterol
5385883|NCT00092599|Elevated Cholesterol|elevated cholesterol
5385884|NCT00092378|Bunionectomy|bunionectomy
5385885|NCT00092339|dental surgery|dental surgery
5385886|NCT00092339|molar removal|molar removal
5385887|NCT00092326|dental surgery|dental surgery
5385888|NCT00092326|molar removal|molar removal
5385889|NCT00092313|dental surgery|dental surgery
5385890|NCT00092313|molar removal|molar removal
5385891|NCT00092287|Carcinoid Syndrome|carcinoid syndrome
5385892|NCT00092287|Neuroendocrine Tumuors|neuroendocrine tumuors
5385893|NCT00092274|Follicular Lymphoma|follicular lymphoma
5385894|NCT00092274|Non Hodgkin´s Lymphoma|non hodgkin´s lymphoma
5385895|NCT00092001|Non-small cell lung cancer, carcinoma, sunitinib, Phase 2|non-small cell lung cancer, carcinoma, sunitinib, phase 2
5385896|NCT00092196|Chemotherapy-Induced Nausea and Vomiting|chemotherapy-induced nausea and vomiting
5385897|NCT00092183|Chemotherapy-Induced Nausea and Vomiting|chemotherapy-induced nausea and vomiting
5385898|NCT00092170|Intra-abdominal infections|intra-abdominal infections
5385899|NCT00092170|Acute pelvic infections|acute pelvic infections
5385900|NCT00092157|High cholesterol|high cholesterol
5385901|NCT00092105|Rhinitis, Allergic|rhinitis, allergic
5385902|NCT00092053|Postmenopausal|postmenopausal
5385903|NCT00092053|Osteoporosis|osteoporosis
5385904|NCT00092235|cGVHD-associated graft-versus-tumor effects (GVT)|cgvhd-associated graft-versus-tumor effects (gvt)
5385905|NCT00092235|Allo-HSCT controls|allo-hsct controls
5385906|NCT00092235|Leukapheresis|leukapheresis
5385907|NCT00092235|Chronic Graft-Versus-Host Disease|chronic graft-versus-host disease
5385909|NCT00092222|HHV-8|hhv-8
5385910|NCT00092222|HIV|hiv
5385911|NCT00092222|Malignancy|malignancy
5385912|NCT00092222|Lymphoproliferation|lymphoproliferation
5385913|NCT00092222|Lymph Node Hyperplasia|lymph node hyperplasia
5385914|NCT00092222|Multicentric Castleman DIsease|multicentric castleman disease
5385915|NCT00092222|MCD|mcd
5385916|NCT00092222|KSHV-MCD|kshv-mcd
5385917|NCT00092222|KSHV Associated MCD|kshv associated mcd
5385918|NCT00092222|HIV Infections|hiv infections
5385919|NCT00092222|Herpes Viruses|herpes viruses
5385920|NCT00091988|Urinary Incontinence|urinary incontinence
5385921|NCT00091988|Weight Loss|weight loss
5385922|NCT00091988|Obesity|obesity
5385923|NCT00091988|Motivation|motivation
5385924|NCT00091975|Chronic Kidney Disease|chronic kidney disease
5385925|NCT00091949|stroke|stroke
5385926|NCT00091949|heart attack|heart attack
5385927|NCT00091949|diabetes|diabetes
5385928|NCT00091949|pioglitazone|pioglitazone
5385929|NCT00091949|insulin resistance|insulin resistance
5385930|NCT00091936|Treatment Naive|treatment naive
5385931|NCT00091936|Directly Observed Therapy|directly observed therapy
5385932|NCT00091936|DOT|dot
5385933|NCT00091936|TB|tb
5385934|NCT00091910|Anemia|anemia
5385935|NCT00091910|Epoetin alfa|epoetin alfa
5385936|NCT00091910|Erythropoietin|erythropoietin
5385937|NCT00091910|Blood transfusion|blood transfusion
5385938|NCT00091910|Intensive care units|intensive care units
5385939|NCT00091858|Cancer-related anemia|cancer-related anemia
5385940|NCT00091845|West Nile Fever Myelitis|west nile fever myelitis
5385941|NCT00091845|West Nile Fever Encephalitis|west nile fever encephalitis
5385942|NCT00091845|West Nile Fever Meningitis|west nile fever meningitis
5385943|NCT00091845|West Nile Fever Meningoencephalitis|west nile fever meningoencephalitis
5385944|NCT00091832|Breast Cancer|breast cancer
5385945|NCT00091832|Cancer|cancer
5385946|NCT00091819|staph|staph
5385947|NCT00091819|MRSA|mrsa
5385948|NCT00091819|cSSSI|csssi
5385949|NCT00091806|Targeted Therapy|targeted therapy
5385950|NCT00091806|Solid tumors|solid tumors
5385951|NCT00091806|ABX-EGF, panitumumab|abx-egf, panitumumab
5385952|NCT00091806|EGFr|egfr
5385953|NCT00091806|Immunex, Abgenix, Amgen|immunex, abgenix, amgen
5385954|NCT00091806|Monoclonal Antibody|monoclonal antibody
5385955|NCT00091793|Osteoporosis|osteoporosis
5385956|NCT00091793|Postmenopausal|postmenopausal
5385957|NCT00091897|RITUXAN|rituxan
5385958|NCT00091897|GABA|gaba
5385959|NCT00091897|B Cells|b cells
5385960|NCT00091897|Humanized Monoclonal Antibodies|humanized monoclonal antibodies
5385961|NCT00091897|GAD|gad
5385962|NCT00091897|Stiff Person Syndrome|stiff person syndrome
5385963|NCT00091897|SPS|sps
5385964|NCT00091884|HIV|hiv
5385965|NCT00091884|Immune Recovery|immune recovery
5385966|NCT00091884|Reactivation|reactivation
5385967|NCT00091884|Anti-Viral Medication|anti-viral medication
5385968|NCT00091884|HAART|haart
5385969|NCT00091884|CMV Retinitis|cmv retinitis
5385970|NCT00091884|Retinal Disease|retinal disease
5385971|NCT00091871|Genetic|genetic
5385972|NCT00091871|Eosinophils|eosinophils
5385973|NCT00091871|Familial Hypereosinophilia|familial hypereosinophilia
5385974|NCT00091871|Hypereosinophilia|hypereosinophilia
5385975|NCT00091871|FE|fe
5385976|NCT00091741|HIV|hiv
5385977|NCT00091741|Treatment Experienced|treatment experienced
5385978|NCT00091741|Complementary Therapies|complementary therapies
5385979|NCT00091728|epidemiology|epidemiology
5385980|NCT00091728|relative risk|relative risk
5385981|NCT00091728|cervical ectopy|cervical ectopy
5385982|NCT00091728|hormonal contraceptives|hormonal contraceptives
5385983|NCT00091728|sexually transmitted infections|sexually transmitted infections
5385984|NCT00091715|Pulmonary arterial hypertension|pulmonary arterial hypertension
5385985|NCT00091715|PAH|pah
5385986|NCT00091715|PPH|pph
5385987|NCT00091715|bosentan|bosentan
5385988|NCT00091715|early|early
5385989|NCT00091702|FluMist|flumist
5385990|NCT00091702|Influenza Vaccine|influenza vaccine
5385991|NCT00091702|Adolescent|adolescent
5385992|NCT00091702|Treatment Experienced|treatment experienced
5385993|NCT00091689|Advanced Metastatic Melanoma|advanced metastatic melanoma
5385994|NCT00091676|follicular|follicular
5385995|NCT00091676|lymphoma|lymphoma
5385996|NCT00091676|Non-Hodgkins|non-hodgkins
5385997|NCT00091676|idiotype|idiotype
5385998|NCT00091676|vaccine|vaccine
5385999|NCT00091676|indolent follicular Non-Hodgkins Lymphoma|indolent follicular non-hodgkins lymphoma
5386000|NCT00091676|tumor-derived|tumor-derived
5386001|NCT00091676|B-cell|b-cell
5386002|NCT00091676|cancer|cancer
5386003|NCT00091663|Advanced non-small cell lung cancer|advanced non-small cell lung cancer
5386004|NCT00004905|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5386005|NCT00004905|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5386006|NCT00004905|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5386007|NCT00004905|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5386008|NCT00004905|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5386009|NCT00004905|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5386010|NCT00004209|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5386011|NCT00004209|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5386012|NCT00004195|stage I colon cancer|stage i colon cancer
5386013|NCT00004195|stage II colon cancer|stage ii colon cancer
5386014|NCT00004195|stage III colon cancer|stage iii colon cancer
5386015|NCT00004195|stage IV colon cancer|stage iv colon cancer
5386016|NCT00004195|stage I rectal cancer|stage i rectal cancer
5386017|NCT00004195|stage II rectal cancer|stage ii rectal cancer
5386018|NCT00004195|stage III rectal cancer|stage iii rectal cancer
5386019|NCT00004195|stage IV rectal cancer|stage iv rectal cancer
5386020|NCT00004195|recurrent colon cancer|recurrent colon cancer
5386021|NCT00004195|recurrent rectal cancer|recurrent rectal cancer
5386022|NCT00004194|graft versus host disease|graft versus host disease
5386023|NCT00004184|stage III melanoma|stage iii melanoma
5386024|NCT00004184|stage IV melanoma|stage iv melanoma
5386025|NCT00004184|recurrent melanoma|recurrent melanoma
5386026|NCT00004172|stage IV breast cancer|stage iv breast cancer
5386027|NCT00004172|stage IIIA breast cancer|stage iiia breast cancer
5386028|NCT00004172|recurrent breast cancer|recurrent breast cancer
5386029|NCT00004172|stage IIIB breast cancer|stage iiib breast cancer
5386030|NCT00091624|CC-5013|cc-5013
5386031|NCT00091624|CC5013|cc5013
5386032|NCT00091624|Revlimid|revlimid
5386033|NCT00091624|Lenalidomide|lenalidomide
5386034|NCT00091624|Multiple myeloma|multiple myeloma
5386035|NCT00091598|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
5386036|NCT00091572|Metastatic Melanoma|metastatic melanoma
5386037|NCT00091559|CTCL|ctcl
5386038|NCT00004089|anaplastic thyroid cancer|anaplastic thyroid cancer
5386039|NCT00004083|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5386040|NCT00004083|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5386041|NCT00004014|recurrent prostate cancer|recurrent prostate cancer
5386042|NCT00003956|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5386043|NCT00003956|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5386044|NCT00003956|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5386045|NCT00003956|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5386046|NCT00003956|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5386047|NCT00003956|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5386048|NCT00003956|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5386049|NCT00003956|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5386050|NCT00003956|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5386051|NCT00003956|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5386052|NCT00003956|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5386053|NCT00003956|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5386054|NCT00003956|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5386055|NCT00003956|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5386056|NCT00003956|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5386057|NCT00003956|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5386058|NCT00003956|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5386059|NCT00003956|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5386060|NCT00003956|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5386061|NCT00003956|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5386062|NCT00003956|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5386063|NCT00003956|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
5386064|NCT00003956|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
5386065|NCT00003956|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
5386066|NCT00003956|AIDS-related primary CNS lymphoma|aids-related primary cns lymphoma
5386067|NCT00003956|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5386068|NCT00003956|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5386069|NCT00003956|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
5386070|NCT00003956|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5386071|NCT00003956|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5386072|NCT00003956|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5386073|NCT00003956|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5386074|NCT00003956|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5386075|NCT00003956|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5386076|NCT00003956|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5386077|NCT00003956|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5386078|NCT00003858|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5386079|NCT00003858|stage I prostate cancer|stage i prostate cancer
5386080|NCT00003858|stage IIB prostate cancer|stage iib prostate cancer
5386081|NCT00003858|stage IIA prostate cancer|stage iia prostate cancer
5386082|NCT00003858|stage III prostate cancer|stage iii prostate cancer
5386083|NCT00003858|stage IV prostate cancer|stage iv prostate cancer
5386084|NCT00003842|recurrent adult brain tumor|recurrent adult brain tumor
5386085|NCT00003842|adult glioblastoma|adult glioblastoma
5386086|NCT00003842|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5386087|NCT00003842|adult giant cell glioblastoma|adult giant cell glioblastoma
5386088|NCT00003842|adult gliosarcoma|adult gliosarcoma
5386089|NCT00003780|stage II pancreatic cancer|stage ii pancreatic cancer
5386090|NCT00003780|stage III pancreatic cancer|stage iii pancreatic cancer
5386091|NCT00003780|stage IV pancreatic cancer|stage iv pancreatic cancer
5386092|NCT00003775|recurrent adult brain tumor|recurrent adult brain tumor
5386093|NCT00003775|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5386094|NCT00003775|adult mixed glioma|adult mixed glioma
5386095|NCT00003714|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
5386096|NCT00003714|advanced adult primary liver cancer|advanced adult primary liver cancer
5386097|NCT00003714|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
5386098|NCT00003714|liver metastases|liver metastases
5386099|NCT00003711|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5386100|NCT00091611|Clinical Response|clinical response
5386101|NCT00091611|Intravenous|intravenous
5386102|NCT00091611|Intra-Arterial|intra-arterial
5386103|NCT00091611|Lymphodepletion|lymphodepletion
5386104|NCT00091611|Traffic of Cells|traffic of cells
5386105|NCT00091611|T-Cell Transfer|t-cell transfer
5386106|NCT00091611|Renal Cell Carcinoma|renal cell carcinoma
5386107|NCT00091611|Metastatic Renal Cell Cancer|metastatic renal cell cancer
5386108|NCT00091507|Acute Coronary Syndrome|acute coronary syndrome
5386109|NCT00091481|Stage V Chronic Kidney Disease|stage v chronic kidney disease
5386110|NCT00091442|Breast Cancer|breast cancer
5386111|NCT00091442|Advanced breast cancer|advanced breast cancer
5386112|NCT00091442|Breast Tumors|breast tumors
5386113|NCT00091442|Cancer of Breast|cancer of breast
5386114|NCT00091442|Human Mammary Carcinoma|human mammary carcinoma
5386115|NCT00091442|Mammary Neoplasms, Human|mammary neoplasms, human
5386116|NCT00091442|DOXIL|doxil
5386117|NCT00091442|Docetaxel|docetaxel
5386118|NCT00004057|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5386119|NCT00004057|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5386120|NCT00004057|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5386121|NCT00004057|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5386122|NCT00004057|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5386123|NCT00004057|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5386124|NCT00004057|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5386125|NCT00004057|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5386126|NCT00004057|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5386127|NCT00004057|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5386128|NCT00004057|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5386129|NCT00004057|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
5386130|NCT00004057|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5386131|NCT00004057|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
5386132|NCT00004057|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5386133|NCT00004057|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5386134|NCT00004057|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5386135|NCT00004057|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5386136|NCT00004057|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5386137|NCT00004057|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5386138|NCT00004036|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5386139|NCT00004036|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5386140|NCT00004036|monoclonal gammopathy of undetermined significance|monoclonal gammopathy of undetermined significance
5386141|NCT00004036|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5386142|NCT00004036|isolated plasmacytoma of bone|isolated plasmacytoma of bone
5386143|NCT00004036|extramedullary plasmacytoma|extramedullary plasmacytoma
5386144|NCT00004036|refractory multiple myeloma|refractory multiple myeloma
5386145|NCT00004036|Waldenström macroglobulinemia|waldenström macroglobulinemia
5386146|NCT00004036|stage III multiple myeloma|stage iii multiple myeloma
5386147|NCT00004036|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5386148|NCT00004036|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5386149|NCT00004036|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5386150|NCT00004036|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5386151|NCT00004036|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5386152|NCT00004036|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5386153|NCT00004036|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5386154|NCT00004036|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5386155|NCT00004036|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5386156|NCT00004036|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5386157|NCT00004036|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
5386158|NCT00004036|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
5386159|NCT00004036|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
5386160|NCT00004036|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5386161|NCT00004036|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5386162|NCT00004036|polycythemia vera|polycythemia vera
5386163|NCT00004036|primary myelofibrosis|primary myelofibrosis
5386164|NCT00004036|essential thrombocythemia|essential thrombocythemia
5386165|NCT00004036|untreated hairy cell leukemia|untreated hairy cell leukemia
5386166|NCT00004036|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
5386167|NCT00004036|refractory hairy cell leukemia|refractory hairy cell leukemia
5386168|NCT00004036|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5386169|NCT00004036|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
5386170|NCT00004036|acute undifferentiated leukemia|acute undifferentiated leukemia
5386171|NCT00004036|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5386172|NCT00004036|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5386173|NCT00004036|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5386174|NCT00004036|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5386175|NCT00004036|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5386176|NCT00004036|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5386177|NCT00004036|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5386178|NCT00004036|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5386179|NCT00004036|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5386180|NCT00004036|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5386181|NCT00004036|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5386182|NCT00004036|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5386183|NCT00004036|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5386184|NCT00004036|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5386185|NCT00004036|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5386186|NCT00004036|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5386187|NCT00004036|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5386188|NCT00004036|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5386189|NCT00004036|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5386190|NCT00004036|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5386191|NCT00004036|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5386192|NCT00004036|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5386193|NCT00004036|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5386194|NCT00004036|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5386623|NCT00090831|Serotonin|serotonin
5386195|NCT00004036|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5386196|NCT00004036|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5386197|NCT00004036|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5386198|NCT00004036|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
5386199|NCT00004036|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
5386200|NCT00004036|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
5386201|NCT00004036|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5386202|NCT00004036|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5386203|NCT00004036|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5386204|NCT00004036|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5386205|NCT00004036|drug/agent toxicity by tissue/organ|drug/agent toxicity by tissue/organ
5386206|NCT00004036|prolymphocytic leukemia|prolymphocytic leukemia
5386207|NCT00004036|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
5386208|NCT00004036|AIDS-related primary CNS lymphoma|aids-related primary cns lymphoma
5386209|NCT00004036|primary systemic amyloidosis|primary systemic amyloidosis
5386210|NCT00004036|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5386211|NCT00004036|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5386212|NCT00004036|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5386213|NCT00004036|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
5386214|NCT00004036|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5386215|NCT00004036|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5386216|NCT00004036|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5386217|NCT00004036|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5386218|NCT00004036|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5386219|NCT00004036|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5386220|NCT00004036|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5386221|NCT00004036|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5386222|NCT00004036|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5386223|NCT00004036|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5386224|NCT00004022|stage III melanoma|stage iii melanoma
5386225|NCT00004022|stage IV melanoma|stage iv melanoma
5386226|NCT00004022|recurrent melanoma|recurrent melanoma
5386227|NCT00003673|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5386228|NCT00003671|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
5386229|NCT00003671|B-cell childhood acute lymphoblastic leukemia|b-cell childhood acute lymphoblastic leukemia
5386230|NCT00003666|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5386231|NCT00003666|squamous cell lung cancer|squamous cell lung cancer
5386232|NCT00003666|large cell lung cancer|large cell lung cancer
5386233|NCT00003666|adenocarcinoma of the lung|adenocarcinoma of the lung
5386234|NCT00003666|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
5386235|NCT00003634|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5386236|NCT00003634|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5386237|NCT00003634|fallopian tube cancer|fallopian tube cancer
5386238|NCT00003634|primary peritoneal cavity cancer|primary peritoneal cavity cancer
5386239|NCT00003625|untreated childhood brain stem glioma|untreated childhood brain stem glioma
5386240|NCT00003599|non-small cell lung cancer|non-small cell lung cancer
5386241|NCT00003599|small cell lung cancer|small cell lung cancer
5386242|NCT00003591|stage I pancreatic cancer|stage i pancreatic cancer
5386243|NCT00003591|stage II pancreatic cancer|stage ii pancreatic cancer
5386244|NCT00003591|stage III pancreatic cancer|stage iii pancreatic cancer
5386245|NCT00003591|recurrent pancreatic cancer|recurrent pancreatic cancer
5386246|NCT00003591|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
5386247|NCT00003587|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5386248|NCT00003587|squamous cell lung cancer|squamous cell lung cancer
5386249|NCT00003587|large cell lung cancer|large cell lung cancer
5386250|NCT00003587|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5386251|NCT00003587|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5386252|NCT00003587|adenocarcinoma of the lung|adenocarcinoma of the lung
5386253|NCT00003564|recurrent adult brain tumor|recurrent adult brain tumor
5386254|NCT00003564|adult glioblastoma|adult glioblastoma
5386255|NCT00003564|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5386256|NCT00003564|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
5386257|NCT00003564|adult mixed glioma|adult mixed glioma
5386258|NCT00003564|adult giant cell glioblastoma|adult giant cell glioblastoma
5386259|NCT00003564|adult gliosarcoma|adult gliosarcoma
5386260|NCT00003551|stage III renal cell cancer|stage iii renal cell cancer
5386261|NCT00003551|stage IV renal cell cancer|stage iv renal cell cancer
5386262|NCT00003551|recurrent renal cell cancer|recurrent renal cell cancer
5386263|NCT00003546|stage I pancreatic cancer|stage i pancreatic cancer
5386264|NCT00003546|stage II pancreatic cancer|stage ii pancreatic cancer
5386265|NCT00003546|stage III pancreatic cancer|stage iii pancreatic cancer
5386266|NCT00003546|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
5386267|NCT00003451|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5386268|NCT00003451|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5386269|NCT00003451|monoclonal gammopathy of undetermined significance|monoclonal gammopathy of undetermined significance
5386270|NCT00003451|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5386271|NCT00003451|isolated plasmacytoma of bone|isolated plasmacytoma of bone
5386272|NCT00003451|extramedullary plasmacytoma|extramedullary plasmacytoma
5386273|NCT00003451|refractory multiple myeloma|refractory multiple myeloma
5386274|NCT00003451|Waldenström macroglobulinemia|waldenström macroglobulinemia
5386275|NCT00003451|stage III multiple myeloma|stage iii multiple myeloma
5386276|NCT00003451|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5386277|NCT00003451|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5386278|NCT00003451|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5386279|NCT00003451|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5386280|NCT00003451|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5386281|NCT00003451|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5386282|NCT00003451|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5386283|NCT00003451|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5386284|NCT00003451|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5386285|NCT00003451|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
5386286|NCT00003451|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
5386287|NCT00003451|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
5386288|NCT00003451|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5386289|NCT00003451|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5386290|NCT00003451|polycythemia vera|polycythemia vera
5386291|NCT00003451|primary myelofibrosis|primary myelofibrosis
5386292|NCT00003451|essential thrombocythemia|essential thrombocythemia
5386293|NCT00003451|untreated hairy cell leukemia|untreated hairy cell leukemia
5386294|NCT00003451|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
5386295|NCT00003451|refractory hairy cell leukemia|refractory hairy cell leukemia
5386296|NCT00003451|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5386297|NCT00003451|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
5386298|NCT00003451|acute undifferentiated leukemia|acute undifferentiated leukemia
5386299|NCT00003451|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5386300|NCT00003451|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5386301|NCT00003451|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5386302|NCT00003451|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5386303|NCT00003451|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5386304|NCT00003451|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5386305|NCT00003451|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5386306|NCT00003451|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5386307|NCT00003451|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5386308|NCT00003451|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5386309|NCT00003451|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5386310|NCT00003451|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5386311|NCT00003451|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5386312|NCT00003451|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5386313|NCT00003451|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5386314|NCT00003451|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5386315|NCT00003451|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5386316|NCT00003451|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5386317|NCT00003451|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5386318|NCT00003451|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5386319|NCT00003451|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5386320|NCT00003451|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5386321|NCT00003451|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5386322|NCT00003451|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5386323|NCT00003451|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5386324|NCT00003451|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5386325|NCT00003451|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5386326|NCT00003451|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
5386327|NCT00003451|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
5386328|NCT00003451|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
5386329|NCT00003451|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5386330|NCT00003451|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5386331|NCT00003451|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5386332|NCT00003451|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5386333|NCT00003451|prolymphocytic leukemia|prolymphocytic leukemia
5386334|NCT00003451|primary systemic amyloidosis|primary systemic amyloidosis
5386335|NCT00003451|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5386336|NCT00003451|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5386337|NCT00003451|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5386338|NCT00003451|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
5386339|NCT00003451|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5386340|NCT00003451|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5386341|NCT00003451|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5386342|NCT00003451|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5386343|NCT00003451|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5386344|NCT00003451|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5386345|NCT00003451|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5386346|NCT00003451|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5386347|NCT00003451|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5386348|NCT00003451|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5386349|NCT00003451|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
5386350|NCT00003441|stage IV colon cancer|stage iv colon cancer
5386351|NCT00003441|stage IV rectal cancer|stage iv rectal cancer
5386352|NCT00003441|recurrent colon cancer|recurrent colon cancer
5386353|NCT00003441|recurrent rectal cancer|recurrent rectal cancer
5386354|NCT00003441|adenocarcinoma of the colon|adenocarcinoma of the colon
5386355|NCT00003441|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5386356|NCT00003441|6-hydroxymethylacylfulvene|6-hydroxymethylacylfulvene
5386357|NCT00003441|MGI-114|mgi-114
5386358|NCT00003441|Irofulven|irofulven
5386359|NCT00003430|recurrent nasopharyngeal cancer|recurrent nasopharyngeal cancer
5386360|NCT00003430|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5386361|NCT00003430|recurrent lip and oral cavity cancer|recurrent lip and oral cavity cancer
5386362|NCT00003430|recurrent hypopharyngeal cancer|recurrent hypopharyngeal cancer
5386363|NCT00003430|recurrent laryngeal cancer|recurrent laryngeal cancer
5386364|NCT00003430|recurrent paranasal sinus and nasal cavity cancer|recurrent paranasal sinus and nasal cavity cancer
5386365|NCT00003430|recurrent oropharyngeal cancer|recurrent oropharyngeal cancer
5386366|NCT00003428|stage IV breast cancer|stage iv breast cancer
5386367|NCT00003428|recurrent breast cancer|recurrent breast cancer
5386368|NCT00003353|primary systemic amyloidosis|primary systemic amyloidosis
5386369|NCT00003344|stage II colon cancer|stage ii colon cancer
5386370|NCT00003344|stage III colon cancer|stage iii colon cancer
5386371|NCT00003344|stage II rectal cancer|stage ii rectal cancer
5386372|NCT00003344|stage III rectal cancer|stage iii rectal cancer
5386373|NCT00003344|recurrent colon cancer|recurrent colon cancer
5386374|NCT00003344|recurrent rectal cancer|recurrent rectal cancer
5386375|NCT00003339|recurrent intraocular melanoma|recurrent intraocular melanoma
5386376|NCT00003339|stage III melanoma|stage iii melanoma
5386377|NCT00003339|stage IV melanoma|stage iv melanoma
5386378|NCT00003339|recurrent melanoma|recurrent melanoma
5386379|NCT00003331|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5386380|NCT00003331|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5386381|NCT00003331|monoclonal gammopathy of undetermined significance|monoclonal gammopathy of undetermined significance
5386382|NCT00003331|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5386383|NCT00003331|isolated plasmacytoma of bone|isolated plasmacytoma of bone
5386384|NCT00003331|extramedullary plasmacytoma|extramedullary plasmacytoma
5386385|NCT00003331|refractory multiple myeloma|refractory multiple myeloma
5386386|NCT00003331|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
5386387|NCT00003331|stage III multiple myeloma|stage iii multiple myeloma
5386388|NCT00003331|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5386389|NCT00003331|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5386390|NCT00003331|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5386391|NCT00003331|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5386392|NCT00003331|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5386393|NCT00003331|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5386394|NCT00003331|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5386395|NCT00003331|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5386396|NCT00003331|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5386397|NCT00003331|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
5386398|NCT00003331|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
5386399|NCT00003331|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
5386400|NCT00003331|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5386401|NCT00003331|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5386402|NCT00003331|polycythemia vera|polycythemia vera
5386403|NCT00003331|primary myelofibrosis|primary myelofibrosis
5386404|NCT00003331|essential thrombocythemia|essential thrombocythemia
5386405|NCT00003331|untreated hairy cell leukemia|untreated hairy cell leukemia
5386625|NCT00090831|HV|hv
5386406|NCT00003331|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
5386407|NCT00003331|refractory hairy cell leukemia|refractory hairy cell leukemia
5386408|NCT00003331|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5386409|NCT00003331|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
5386410|NCT00003331|acute undifferentiated leukemia|acute undifferentiated leukemia
5386411|NCT00003331|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5386412|NCT00003331|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5386413|NCT00003331|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5386414|NCT00003331|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5386415|NCT00003331|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5386416|NCT00003331|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5386417|NCT00003331|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5386418|NCT00003331|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5386419|NCT00003331|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5386420|NCT00003331|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5386421|NCT00003331|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5386422|NCT00003331|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5386423|NCT00003331|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5386424|NCT00003331|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5386425|NCT00003331|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5386426|NCT00003331|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5386427|NCT00003331|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5386428|NCT00003331|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5386429|NCT00003331|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5386430|NCT00003331|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5386431|NCT00003331|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5386432|NCT00003331|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5386433|NCT00003331|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5386434|NCT00003331|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5386435|NCT00003331|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5386436|NCT00003331|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5386437|NCT00003331|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5386438|NCT00003331|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
5386439|NCT00003331|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
5386440|NCT00003331|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
5386441|NCT00003331|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5386442|NCT00003331|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5386443|NCT00003331|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5386444|NCT00003331|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5386445|NCT00003331|prolymphocytic leukemia|prolymphocytic leukemia
5386446|NCT00003331|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
5386447|NCT00003331|AIDS-related primary CNS lymphoma|aids-related primary cns lymphoma
5386448|NCT00003331|primary systemic amyloidosis|primary systemic amyloidosis
5386449|NCT00003331|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5386450|NCT00003331|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5386451|NCT00003331|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5386452|NCT00003331|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
5386453|NCT00003331|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5386454|NCT00003331|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5386455|NCT00003331|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5386456|NCT00003331|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5386457|NCT00003331|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5386458|NCT00003331|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5386459|NCT00003331|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5386460|NCT00003331|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5386461|NCT00003331|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5386462|NCT00003331|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5386463|NCT00003288|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
5386464|NCT00003263|localized malignant mesothelioma|localized malignant mesothelioma
5386466|NCT00091533|Mirror Neuron System|mirror neuron system
5386467|NCT00091533|Bimodal Neurons|bimodal neurons
5386468|NCT00091533|Somatosensory Cortex|somatosensory cortex
5386469|NCT00091533|Rehabilitation|rehabilitation
5386470|NCT00091533|Healthy Volunteer|healthy volunteer
5386471|NCT00091533|HV|hv
5386472|NCT00091429|Angina|angina
5386473|NCT00091429|Chest Pain|chest pain
5386474|NCT00091429|Coronary Artery Disease|coronary artery disease
5386475|NCT00091429|Heart Disease|heart disease
5386476|NCT00003257|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
5386477|NCT00003257|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
5386478|NCT00003257|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
5386479|NCT00003257|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
5386480|NCT00003257|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
5386481|NCT00003257|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
5386482|NCT00003257|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
5386483|NCT00003252|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5386484|NCT00003252|drug/agent toxicity by tissue/organ|drug/agent toxicity by tissue/organ
5386485|NCT00003248|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
5386486|NCT00003248|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
5386487|NCT00003248|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5386488|NCT00003248|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5386489|NCT00003248|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
5386490|NCT00003241|recurrent childhood brain tumor|recurrent childhood brain tumor
5386491|NCT00003241|childhood high-grade cerebral astrocytoma|childhood high-grade cerebral astrocytoma
5386492|NCT00003241|untreated childhood brain stem glioma|untreated childhood brain stem glioma
5386493|NCT00003241|recurrent childhood brain stem glioma|recurrent childhood brain stem glioma
5386494|NCT00003241|recurrent childhood supratentorial primitive neuroectodermal tumor|recurrent childhood supratentorial primitive neuroectodermal tumor
5386495|NCT00003241|recurrent childhood cerebellar astrocytoma|recurrent childhood cerebellar astrocytoma
5386496|NCT00003241|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
5386497|NCT00003241|recurrent childhood medulloblastoma|recurrent childhood medulloblastoma
5386498|NCT00003241|recurrent childhood ependymoma|recurrent childhood ependymoma
5386499|NCT00003223|lip and oral cavity cancer|lip and oral cavity cancer
5386500|NCT00091416|HIV Seronegativity|hiv seronegativity
5386501|NCT00091416|HIV Preventive Vaccine|hiv preventive vaccine
5386502|NCT00091390|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5386503|NCT00091390|stage IIB prostate cancer|stage iib prostate cancer
5386504|NCT00091390|stage IIA prostate cancer|stage iia prostate cancer
5386505|NCT00091390|stage III prostate cancer|stage iii prostate cancer
5386506|NCT00091377|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5386507|NCT00091377|fallopian tube cancer|fallopian tube cancer
5386508|NCT00091377|primary peritoneal cavity cancer|primary peritoneal cavity cancer
5386509|NCT00091351|adult alveolar soft-part sarcoma|adult alveolar soft-part sarcoma
5386510|NCT00091351|adult angiosarcoma|adult angiosarcoma
5386511|NCT00091351|adult epithelioid sarcoma|adult epithelioid sarcoma
5386512|NCT00091351|adult fibrosarcoma|adult fibrosarcoma
5386513|NCT00091351|adult leiomyosarcoma|adult leiomyosarcoma
5386514|NCT00091351|adult liposarcoma|adult liposarcoma
5386515|NCT00091351|adult neurofibrosarcoma|adult neurofibrosarcoma
5386516|NCT00091351|adult synovial sarcoma|adult synovial sarcoma
5386517|NCT00091351|adult malignant fibrous histiocytoma|adult malignant fibrous histiocytoma
5386518|NCT00091351|stage I adult soft tissue sarcoma|stage i adult soft tissue sarcoma
5386519|NCT00091351|stage II adult soft tissue sarcoma|stage ii adult soft tissue sarcoma
5386520|NCT00091351|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
5386521|NCT00091338|recurrent melanoma|recurrent melanoma
5386522|NCT00091338|stage IV melanoma|stage iv melanoma
5386523|NCT00091325|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5386524|NCT00091312|stage II colon cancer|stage ii colon cancer
5386525|NCT00091312|adenocarcinoma of the colon|adenocarcinoma of the colon
5386526|NCT00091299|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5386527|NCT00091286|recurrent colon cancer|recurrent colon cancer
5386528|NCT00091286|stage IIB colon cancer|stage iib colon cancer
5386529|NCT00091286|stage IIIA colon cancer|stage iiia colon cancer
5386530|NCT00091286|stage IIIB colon cancer|stage iiib colon cancer
5386531|NCT00091286|stage IIIC colon cancer|stage iiic colon cancer
5386532|NCT00091286|stage IVA colon cancer|stage iva colon cancer
5386533|NCT00091286|stage IVB colon cancer|stage ivb colon cancer
5386534|NCT00091286|recurrent rectal cancer|recurrent rectal cancer
5386535|NCT00091286|stage IIB rectal cancer|stage iib rectal cancer
5386536|NCT00091286|stage IIIA rectal cancer|stage iiia rectal cancer
5386537|NCT00091286|stage IIIB rectal cancer|stage iiib rectal cancer
5386538|NCT00091286|stage IIIC rectal cancer|stage iiic rectal cancer
5386539|NCT00091286|stage IVA rectal cancer|stage iva rectal cancer
5386540|NCT00091286|stage IVB rectal cancer|stage ivb rectal cancer
5386541|NCT00091273|stage I ovarian epithelial cancer|stage i ovarian epithelial cancer
5386542|NCT00091273|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
5386543|NCT00091273|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5386544|NCT00091273|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5386545|NCT00091273|primary peritoneal cavity cancer|primary peritoneal cavity cancer
5386546|NCT00091260|primary systemic amyloidosis|primary systemic amyloidosis
5386624|NCT00090831|Healthy Volunteer|healthy volunteer
5386547|NCT00091247|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5386548|NCT00091234|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5386549|NCT00091234|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5386550|NCT00091234|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5386551|NCT00091234|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5386552|NCT00091234|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
5386553|NCT00091234|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5386554|NCT00091234|adult acute basophilic leukemia|adult acute basophilic leukemia
5386555|NCT00091234|adult acute eosinophilic leukemia|adult acute eosinophilic leukemia
5386556|NCT00091234|adult erythroleukemia (M6a)|adult erythroleukemia (m6a)
5386557|NCT00091234|adult pure erythroid leukemia (M6b)|adult pure erythroid leukemia (m6b)
5386558|NCT00091234|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
5386559|NCT00091234|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
5386560|NCT00091234|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
5386561|NCT00091234|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
5386562|NCT00091234|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
5386563|NCT00091234|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
5386564|NCT00091234|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
5386565|NCT00091169|fatigue|fatigue
5386566|NCT00091169|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5386567|NCT00091169|levocarnitine|levocarnitine
5386568|NCT00091169|depression|depression
5386569|NCT00091169|pain|pain
5386570|NCT00091169|carnitine deficiency|carnitine deficiency
5386571|NCT00091156|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5386572|NCT00091156|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5386573|NCT00091143|recurrent melanoma|recurrent melanoma
5386574|NCT00091143|stage III melanoma|stage iii melanoma
5386575|NCT00091143|stage IV melanoma|stage iv melanoma
5386576|NCT00091104|stage IV melanoma|stage iv melanoma
5386577|NCT00091104|recurrent melanoma|recurrent melanoma
5386578|NCT00091091|long-term effects secondary to cancer therapy in children|long-term effects secondary to cancer therapy in children
5386579|NCT00091091|stage I childhood Hodgkin lymphoma|stage i childhood hodgkin lymphoma
5386580|NCT00091091|stage II childhood Hodgkin lymphoma|stage ii childhood hodgkin lymphoma
5386581|NCT00091091|stage III childhood Hodgkin lymphoma|stage iii childhood hodgkin lymphoma
5386582|NCT00091091|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
5386583|NCT00091052|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5386584|NCT00091039|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5386585|NCT00091039|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5386586|NCT00090987|AIDS-related Kaposi sarcoma|aids-related kaposi sarcoma
5386587|NCT00090987|recurrent Kaposi sarcoma|recurrent kaposi sarcoma
5386588|NCT00090974|stage I breast cancer|stage i breast cancer
5386589|NCT00090974|stage II breast cancer|stage ii breast cancer
5386590|NCT00090974|stage IIIA breast cancer|stage iiia breast cancer
5386591|NCT00090961|pulmonary complications|pulmonary complications
5386592|NCT00090961|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5386593|NCT00090961|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5386594|NCT00090961|squamous cell lung cancer|squamous cell lung cancer
5386595|NCT00090961|large cell lung cancer|large cell lung cancer
5386596|NCT00090961|adenocarcinoma of the lung|adenocarcinoma of the lung
5386597|NCT00090961|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
5386598|NCT00090961|limited stage small cell lung cancer|limited stage small cell lung cancer
5386599|NCT00090909|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5386600|NCT00090896|recurrent melanoma|recurrent melanoma
5386601|NCT00090896|stage III melanoma|stage iii melanoma
5386602|NCT00090896|stage IV melanoma|stage iv melanoma
5386603|NCT00090870|stage IV renal cell cancer|stage iv renal cell cancer
5386604|NCT00090857|breast cancer|breast cancer
5386605|NCT00090857|stage I breast cancer|stage i breast cancer
5386606|NCT00090857|stage II breast cancer|stage ii breast cancer
5386607|NCT00090857|stage IIIA breast cancer|stage iiia breast cancer
5386608|NCT00090857|stage IIIB breast cancer|stage iiib breast cancer
5386609|NCT00090857|stage IIIC breast cancer|stage iiic breast cancer
5386610|NCT00090857|stage IV breast cancer|stage iv breast cancer
5386611|NCT00090857|breast cancer in situ|breast cancer in situ
5386612|NCT00090857|ductal breast carcinoma in situ|ductal breast carcinoma in situ
5386613|NCT00090844|drug/agent toxicity by tissue/organ|drug/agent toxicity by tissue/organ
5386614|NCT00090844|hormone changes|hormone changes
5386615|NCT00090844|stage I breast cancer|stage i breast cancer
5386616|NCT00090844|stage II breast cancer|stage ii breast cancer
5386617|NCT00090831|Emotional Learning|emotional learning
5386618|NCT00090831|Neurotransmitter|neurotransmitter
5386619|NCT00090831|Neural Systems|neural systems
5386620|NCT00090831|Response Control|response control
5386621|NCT00090831|Orbitofrontal Cortex|orbitofrontal cortex
5386622|NCT00090831|Amygdala|amygdala
5386626|NCT00090818|Dental Abnormalities|dental abnormalities
5386627|NCT00090818|Lichen Planus|lichen planus
5386628|NCT00090818|Oral Mucosal Disease|oral mucosal disease
5386629|NCT00090818|Genetic Disease|genetic disease
5386630|NCT00090818|Amelogensis Imperfecta|amelogensis imperfecta
5386631|NCT00090818|Maxillofacial Abnormalities|maxillofacial abnormalities
5386632|NCT00090818|Craniofacial Abnormalities|craniofacial abnormalities
5386633|NCT00090818|Craniofacial Genetic Abnormalities|craniofacial genetic abnormalities
5386634|NCT00090779|Acute Infection|acute infection
5386635|NCT00090779|Treatment Naive|treatment naive
5386636|NCT00090727|diffuse|diffuse
5386637|NCT00090727|follicular|follicular
5386638|NCT00090727|chronic lymphocytic leukemia|chronic lymphocytic leukemia
5386639|NCT00090727|colorectal cancer|colorectal cancer
5386640|NCT00090727|pancreatic cancer|pancreatic cancer
5386641|NCT00090727|acute myelogenous leukemia|acute myelogenous leukemia
5386642|NCT00090727|head and neck cancer|head and neck cancer
5386643|NCT00090727|breast cancer|breast cancer
5386644|NCT00090727|prostate cancer|prostate cancer
5386645|NCT00090727|ovarian cancer|ovarian cancer
5386646|NCT00090727|bladder cancer|bladder cancer
5386647|NCT00090727|hypoxia|hypoxia
5386648|NCT00090727|refractory|refractory
5386649|NCT00090727|metastatic|metastatic
5386650|NCT00090714|DNA|dna
5386651|NCT00090714|Circular|circular
5386652|NCT00090714|Gene Therapy|gene therapy
5386653|NCT00003217|childhood Burkitt lymphoma|childhood burkitt lymphoma
5386654|NCT00003217|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
5386655|NCT00003217|B-cell childhood acute lymphoblastic leukemia|b-cell childhood acute lymphoblastic leukemia
5386656|NCT00003217|stage III childhood small noncleaved cell lymphoma|stage iii childhood small noncleaved cell lymphoma
5386657|NCT00003217|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
5386658|NCT00003172|stage III gastric cancer|stage iii gastric cancer
5386659|NCT00003172|stage IV gastric cancer|stage iv gastric cancer
5386660|NCT00003172|recurrent gastric cancer|recurrent gastric cancer
5386661|NCT00003139|oral complications|oral complications
5386662|NCT00003139|lip and oral cavity squamous cell carcinoma|lip and oral cavity squamous cell carcinoma
5386663|NCT00003139|oropharyngeal squamous cell carcinoma|oropharyngeal squamous cell carcinoma
5386664|NCT00003134|recurrent adult brain tumor|recurrent adult brain tumor
5386665|NCT00003134|adult brain stem glioma|adult brain stem glioma
5386666|NCT00003134|adult oligodendroglioma|adult oligodendroglioma
5386667|NCT00003134|adult mixed glioma|adult mixed glioma
5386668|NCT00003134|adult diffuse astrocytoma|adult diffuse astrocytoma
5386669|NCT00003100|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5386670|NCT00003088|stage II breast cancer|stage ii breast cancer
5386671|NCT00003088|stage IIIA breast cancer|stage iiia breast cancer
5386672|NCT00003072|stage III non-small cell lung cancer|stage iii non-small cell lung cancer
5386673|NCT00003072|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5386674|NCT00003072|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5386675|NCT00003072|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5386676|NCT00003072|neurotoxicity|neurotoxicity
5386677|NCT00003048|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5386678|NCT00003048|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5386679|NCT00003048|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5386680|NCT00003048|Amifostine|amifostine
5386681|NCT00003048|Ethyol|ethyol
5386682|NCT00003048|Ethiofos|ethiofos
5386683|NCT00003048|Gammaphos|gammaphos
5386684|NCT00003039|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5386685|NCT00003039|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5386686|NCT00003039|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5386687|NCT00003039|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5386688|NCT00003039|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5386689|NCT00003039|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5386690|NCT00003039|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5386691|NCT00003039|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5386692|NCT00090688|diarrhea|diarrhea
5386693|NCT00003005|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5386694|NCT00003005|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5386695|NCT00003005|TdT positive adult acute lymphoblastic leukemia|tdt positive adult acute lymphoblastic leukemia
5386696|NCT00002993|stage III uterine sarcoma|stage iii uterine sarcoma
5386697|NCT00002993|stage IV uterine sarcoma|stage iv uterine sarcoma
5386698|NCT00002993|recurrent uterine sarcoma|recurrent uterine sarcoma
5386699|NCT00002980|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5386700|NCT00002980|monoclonal gammopathy of undetermined significance|monoclonal gammopathy of undetermined significance
5386701|NCT00002980|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5386702|NCT00002980|isolated plasmacytoma of bone|isolated plasmacytoma of bone
5386703|NCT00002980|extramedullary plasmacytoma|extramedullary plasmacytoma
5386704|NCT00002980|refractory multiple myeloma|refractory multiple myeloma
5386705|NCT00002980|Waldenström macroglobulinemia|waldenström macroglobulinemia
5388805|NCT00088751|Stimulant|stimulant
5386706|NCT00002980|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5386707|NCT00002980|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5386708|NCT00002980|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5386709|NCT00002980|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5386710|NCT00002980|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5386711|NCT00002980|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5386712|NCT00002980|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5386713|NCT00002980|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5386714|NCT00002980|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5386715|NCT00002980|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
5386716|NCT00002980|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
5386717|NCT00002980|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5386718|NCT00002980|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5386719|NCT00002980|polycythemia vera|polycythemia vera
5386720|NCT00002980|primary myelofibrosis|primary myelofibrosis
5386721|NCT00002980|essential thrombocythemia|essential thrombocythemia
5386722|NCT00002980|untreated hairy cell leukemia|untreated hairy cell leukemia
5386723|NCT00002980|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
5386724|NCT00002980|refractory hairy cell leukemia|refractory hairy cell leukemia
5386725|NCT00002980|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5386726|NCT00002980|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
5387516|NCT00089895|ischemia|ischemia
5386727|NCT00002980|acute undifferentiated leukemia|acute undifferentiated leukemia
5386728|NCT00002980|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5386729|NCT00002980|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5386730|NCT00002980|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5386731|NCT00002980|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5386732|NCT00002980|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5386733|NCT00002980|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5386734|NCT00002980|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5386735|NCT00002980|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5386736|NCT00002980|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5386737|NCT00002980|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5386738|NCT00002980|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5386739|NCT00002980|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5386740|NCT00002980|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5386741|NCT00002980|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5386742|NCT00002980|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5386743|NCT00002980|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5386744|NCT00002980|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5386745|NCT00002980|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5386746|NCT00002980|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
5386747|NCT00002980|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
5386748|NCT00002980|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5386749|NCT00002980|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5386750|NCT00002980|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5386751|NCT00002980|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5386752|NCT00002980|prolymphocytic leukemia|prolymphocytic leukemia
5386753|NCT00002980|primary systemic amyloidosis|primary systemic amyloidosis
5386754|NCT00002980|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5386755|NCT00002980|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5386756|NCT00002980|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
5386757|NCT00002980|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5386758|NCT00002980|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5386759|NCT00002980|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5386760|NCT00002980|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5386761|NCT00002980|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5386762|NCT00002980|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5386763|NCT00002980|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5386764|NCT00002980|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5386765|NCT00002967|stage I breast cancer|stage i breast cancer
5386766|NCT00002967|stage II breast cancer|stage ii breast cancer
5386767|NCT00002967|invasive ductal breast carcinoma|invasive ductal breast carcinoma
5386768|NCT00002946|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
5386769|NCT00002946|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
5386770|NCT00002946|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5386771|NCT00002946|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5386772|NCT00002946|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5386773|NCT00002946|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5386774|NCT00002946|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
5386775|NCT00002946|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
5386776|NCT00002946|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
5386777|NCT00002946|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
5386778|NCT00002946|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
5386779|NCT00002946|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
5386780|NCT00002946|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
5386781|NCT00002946|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
5386782|NCT00002946|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
5386783|NCT00002946|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5386784|NCT00002946|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5386785|NCT00002946|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5386786|NCT00002946|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5386787|NCT00002946|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5386788|NCT00002946|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5386789|NCT00002946|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5386790|NCT00002946|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5386791|NCT00002946|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5386792|NCT00002946|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5386793|NCT00002946|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5386794|NCT00002946|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5386795|NCT00002946|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5386796|NCT00002946|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5386797|NCT00002946|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5386798|NCT00002946|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5386799|NCT00002946|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5386800|NCT00002946|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5386801|NCT00002946|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5386802|NCT00002946|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5386803|NCT00002946|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5386804|NCT00002946|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5386805|NCT00002946|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5386806|NCT00002946|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5386807|NCT00002946|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5386808|NCT00002946|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5386809|NCT00002946|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5386810|NCT00002946|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
5386811|NCT00002946|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
5386812|NCT00002946|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
5386813|NCT00002946|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
5386814|NCT00002946|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
5386815|NCT00002946|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
5386816|NCT00002946|AIDS-related primary CNS lymphoma|aids-related primary cns lymphoma
5386817|NCT00002946|stage I mantle cell lymphoma|stage i mantle cell lymphoma
5386818|NCT00002946|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
5386819|NCT00002946|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
5386820|NCT00002946|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
5386821|NCT00002946|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
5386822|NCT00002946|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
5386823|NCT00002946|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
5386824|NCT00002946|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
5386825|NCT00002946|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
5386826|NCT00002946|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
5386827|NCT00002946|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
5386828|NCT00002946|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5386829|NCT00002946|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5386830|NCT00002946|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5386831|NCT00002946|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
5386832|NCT00002946|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5386833|NCT00002946|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
5386834|NCT00002946|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
5386835|NCT00002946|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5386836|NCT00002946|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
5386837|NCT00002946|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
5386838|NCT00002946|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5386839|NCT00002946|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5386840|NCT00002946|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5386841|NCT00002946|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
5386842|NCT00002946|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5386843|NCT00002946|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
5386844|NCT00002946|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
5386845|NCT00002946|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5386846|NCT00002946|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5386847|NCT00002946|stage I marginal zone lymphoma|stage i marginal zone lymphoma
5386848|NCT00002946|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
5386849|NCT00002946|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5386850|NCT00002946|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5386851|NCT00002946|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5386852|NCT00002946|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5386853|NCT00002946|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
5386854|NCT00002946|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
5386855|NCT00002946|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5386856|NCT00002946|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5386857|NCT00002946|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5386858|NCT00002942|stage II breast cancer|stage ii breast cancer
5386859|NCT00002942|stage IV breast cancer|stage iv breast cancer
5386860|NCT00002942|stage IIIA breast cancer|stage iiia breast cancer
5386861|NCT00002942|stage IIIB breast cancer|stage iiib breast cancer
5386862|NCT00002937|recurrent breast cancer|recurrent breast cancer
5386863|NCT00002932|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5386864|NCT00002932|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5386865|NCT00002932|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5386866|NCT00002932|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5386867|NCT00002904|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5386868|NCT00002897|stage II esophageal cancer|stage ii esophageal cancer
5386869|NCT00002897|stage III esophageal cancer|stage iii esophageal cancer
5386870|NCT00002897|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
5386871|NCT00090662|Normal Volunteer|normal volunteer
5386872|NCT00090662|Eosinophilopoiesis|eosinophilopoiesis
5386873|NCT00090662|Healthy Volunteer|healthy volunteer
5386874|NCT00090662|HV|hv
5386875|NCT00002873|stage I breast cancer|stage i breast cancer
5386876|NCT00002873|stage II breast cancer|stage ii breast cancer
5386877|NCT00002873|medullary ductal breast carcinoma with lymphocytic infiltrate|medullary ductal breast carcinoma with lymphocytic infiltrate
5386878|NCT00002873|mucinous ductal breast carcinoma|mucinous ductal breast carcinoma
5386879|NCT00002873|invasive ductal breast carcinoma|invasive ductal breast carcinoma
5386880|NCT00002873|papillary ductal breast carcinoma|papillary ductal breast carcinoma
5386881|NCT00002873|tubular ductal breast carcinoma|tubular ductal breast carcinoma
5386882|NCT00002872|malignant pleural effusion|malignant pleural effusion
5386883|NCT00002811|actinic keratosis|actinic keratosis
5386884|NCT00002805|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5386885|NCT00002805|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5386886|NCT00002805|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
5386887|NCT00002793|stage IV colon cancer|stage iv colon cancer
5386888|NCT00002793|stage IV rectal cancer|stage iv rectal cancer
5386889|NCT00002793|recurrent colon cancer|recurrent colon cancer
5386890|NCT00002793|recurrent rectal cancer|recurrent rectal cancer
5386891|NCT00002793|liver metastases|liver metastases
5386892|NCT00002791|stage II adult soft tissue sarcoma|stage ii adult soft tissue sarcoma
5386893|NCT00002791|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
5386894|NCT00002791|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
5386895|NCT00002790|childhood acute lymphoblastic leukemia|childhood acute lymphoblastic leukemia
5386896|NCT00002790|chronic lymphocytic leukemia|chronic lymphocytic leukemia
5386897|NCT00002790|adult acute lymphoblastic leukemia|adult acute lymphoblastic leukemia
5386898|NCT00002790|adult acute myeloid leukemia|adult acute myeloid leukemia
5386899|NCT00002790|chronic myelogenous leukemia|chronic myelogenous leukemia
5386900|NCT00002790|childhood acute myeloid leukemia/other myeloid malignancies|childhood acute myeloid leukemia/other myeloid malignancies
5386901|NCT00002790|myelodysplastic syndromes|myelodysplastic syndromes
5388806|NCT00088751|Apathy|apathy
5386902|NCT00002790|graft versus host disease|graft versus host disease
5386903|NCT00002790|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
5386904|NCT00002781|stage III melanoma|stage iii melanoma
5386905|NCT00002781|recurrent melanoma|recurrent melanoma
5386906|NCT00002775|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5386907|NCT00002775|stage IV prostate cancer|stage iv prostate cancer
5386908|NCT00002775|recurrent prostate cancer|recurrent prostate cancer
5386909|NCT00002767|stage IV melanoma|stage iv melanoma
5386910|NCT00002767|recurrent melanoma|recurrent melanoma
5386911|NCT00090623|Subfoveal neovascular|subfoveal neovascular
5386912|NCT00090623|Age-related macular degeneration|age-related macular degeneration
5386913|NCT00090623|AMD|amd
5386914|NCT00090623|Wet AMD|wet amd
5386915|NCT00002744|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
5386916|NCT00002744|L1 childhood acute lymphoblastic leukemia|l1 childhood acute lymphoblastic leukemia
5386917|NCT00002744|L2 childhood acute lymphoblastic leukemia|l2 childhood acute lymphoblastic leukemia
5386918|NCT00002735|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
5386919|NCT00002735|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5386920|NCT00002735|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
5386921|NCT00002735|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5386922|NCT00002730|recurrent neuroblastoma|recurrent neuroblastoma
5386923|NCT00002703|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5386924|NCT00002703|stage I prostate cancer|stage i prostate cancer
5386925|NCT00002703|stage IIB prostate cancer|stage iib prostate cancer
5386926|NCT00002703|stage IIA prostate cancer|stage iia prostate cancer
5386927|NCT00090610|Relapsed ovarian cancer|relapsed ovarian cancer
5386928|NCT00090584|Urge urinary incontinence (UUI)|urge urinary incontinence (uui)
5386929|NCT00090584|Drug/Behavior treatment|drug/behavior treatment
5386930|NCT00090493|Myeloma|myeloma
5386931|NCT00090493|Mage-A3|mage-a3
5386932|NCT00090493|Transplant|transplant
5386933|NCT00090493|Peptide|peptide
5386934|NCT00090493|DTPACE|dtpace
5386935|NCT00090493|vaccines|vaccines
5386936|NCT00090493|Immunotherapy|immunotherapy
5386937|NCT00090493|NY-ESO-1|ny-eso-1
5386938|NCT00090480|Cancer|cancer
5386939|NCT00002659|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
5386940|NCT00002659|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
5386941|NCT00002659|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
5386942|NCT00002659|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
5386943|NCT00002659|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
5386944|NCT00002659|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
5386945|NCT00002631|stage I esophageal cancer|stage i esophageal cancer
5386946|NCT00002631|stage II esophageal cancer|stage ii esophageal cancer
5386947|NCT00002631|stage III esophageal cancer|stage iii esophageal cancer
5386948|NCT00002631|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
5386949|NCT00002631|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
5386950|NCT00002628|stage IV breast cancer|stage iv breast cancer
5386951|NCT00002628|recurrent breast cancer|recurrent breast cancer
5386952|NCT00002622|malignant pleural effusion|malignant pleural effusion
5386953|NCT00002616|stage IV breast cancer|stage iv breast cancer
5386954|NCT00002616|recurrent breast cancer|recurrent breast cancer
5386955|NCT00002616|stage IIIB breast cancer|stage iiib breast cancer
5386956|NCT00002616|inflammatory breast cancer|inflammatory breast cancer
5386957|NCT00002593|stage II colon cancer|stage ii colon cancer
5386958|NCT00002593|stage III colon cancer|stage iii colon cancer
5386959|NCT00002570|stage III colon cancer|stage iii colon cancer
5386960|NCT00002570|stage IV colon cancer|stage iv colon cancer
5386961|NCT00002570|stage III rectal cancer|stage iii rectal cancer
5386962|NCT00002570|stage IV rectal cancer|stage iv rectal cancer
5386963|NCT00002570|recurrent colon cancer|recurrent colon cancer
5386964|NCT00002570|recurrent rectal cancer|recurrent rectal cancer
5386965|NCT00002554|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5386966|NCT00002554|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5386967|NCT00002527|colon cancer|colon cancer
5386968|NCT00002527|rectal cancer|rectal cancer
5386969|NCT00002509|stage II breast cancer|stage ii breast cancer
5386970|NCT00002509|stage IV breast cancer|stage iv breast cancer
5386971|NCT00002509|stage IIIA breast cancer|stage iiia breast cancer
5386972|NCT00002509|recurrent breast cancer|recurrent breast cancer
5386973|NCT00002509|stage IIIB breast cancer|stage iiib breast cancer
5386974|NCT00090571|JRA ASPs|jra asps
5386975|NCT00090571|Genomics|genomics
5386976|NCT00090376|Erectile Dysfunction|erectile dysfunction
5386977|NCT00090376|Impotence|impotence
5386978|NCT00090376|Prostate Cancer|prostate cancer
5386979|NCT00090376|Prostatectomy|prostatectomy
5386980|NCT00090363|rising PSA|rising psa
5386981|NCT00090363|bone metastases|bone metastases
5386982|NCT00090363|Clinical study|clinical study
5386983|NCT00090363|pain-free or mildly symptomatic|pain-free or mildly symptomatic
5386984|NCT00090324|Schizophrenia|schizophrenia
5386985|NCT00090311|Bipolar I Mania|bipolar i mania
5386986|NCT00004915|recurrent endometrial carcinoma|recurrent endometrial carcinoma
5386987|NCT00004201|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5386988|NCT00004201|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5386989|NCT00004201|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5386990|NCT00004090|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5386991|NCT00004029|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5386992|NCT00004029|stage IV prostate cancer|stage iv prostate cancer
5386993|NCT00004029|recurrent prostate cancer|recurrent prostate cancer
5386994|NCT00002489|stage II ovarian germ cell tumor|stage ii ovarian germ cell tumor
5386995|NCT00002489|stage III ovarian germ cell tumor|stage iii ovarian germ cell tumor
5386996|NCT00002489|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
5386997|NCT00002489|ovarian teratoma|ovarian teratoma
5386998|NCT00002489|extragonadal germ cell tumor|extragonadal germ cell tumor
5386999|NCT00002488|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5387000|NCT00002488|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5387001|NCT00002488|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5387002|NCT00002488|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5387003|NCT00002488|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5387004|NCT00002488|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5387005|NCT00002488|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5387006|NCT00002487|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5387007|NCT00002471|childhood Burkitt lymphoma|childhood burkitt lymphoma
5387008|NCT00002471|L3 childhood acute lymphoblastic leukemia|l3 childhood acute lymphoblastic leukemia
5387009|NCT00002471|B-cell childhood acute lymphoblastic leukemia|b-cell childhood acute lymphoblastic leukemia
5387010|NCT00002471|L3 adult acute lymphoblastic leukemia|l3 adult acute lymphoblastic leukemia
5387011|NCT00002471|B-cell adult acute lymphoblastic leukemia|b-cell adult acute lymphoblastic leukemia
5387012|NCT00002471|recurrent adult non-Hodgkin lymphoma|recurrent adult non-hodgkin lymphoma
5387013|NCT00002471|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5387014|NCT00002471|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5387015|NCT00002471|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5387016|NCT00002471|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5387017|NCT00002471|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5387018|NCT00002471|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5387019|NCT00002471|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5387020|NCT00002471|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5387021|NCT00002471|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5387022|NCT00002471|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5387023|NCT00002471|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5387024|NCT00002471|stage III childhood small noncleaved cell lymphoma|stage iii childhood small noncleaved cell lymphoma
5387025|NCT00002471|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
5387026|NCT00002471|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
5387027|NCT00002471|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
5387028|NCT00002471|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
5387029|NCT00002458|disseminated neuroblastoma|disseminated neuroblastoma
5387030|NCT00002458|recurrent neuroblastoma|recurrent neuroblastoma
5387031|NCT00090558|Atherosclerosis|atherosclerosis
5387032|NCT00090558|Bone Marrow|bone marrow
5387033|NCT00090558|Exercise|exercise
5387034|NCT00090558|Endothelium|endothelium
5387035|NCT00090558|Nitroglycerin|nitroglycerin
5387036|NCT00090558|Coronary Artery Disease|coronary artery disease
5387037|NCT00090558|CAD|cad
5387038|NCT00090545|Hormone-Refractory|hormone-refractory
5387039|NCT00090545|Proteomics|proteomics
5387040|NCT00090545|Angiogenesis|angiogenesis
5387041|NCT00090545|VEGFR|vegfr
5387042|NCT00090545|Prostate Cancer|prostate cancer
5387043|NCT00090545|Metastatic Prostate Cancer|metastatic prostate cancer
5387044|NCT00090506|Yoga|yoga
5387045|NCT00090506|Meditation|meditation
5387046|NCT00090428|Autism|autism
5387047|NCT00090428|Applied Behavioral Analysis|applied behavioral analysis
5387048|NCT00090428|Gluten|gluten
5387049|NCT00090428|Casein|casein
5387050|NCT00090415|Autism|autism
5387051|NCT00090415|Developmental Delay Disorders|developmental delay disorders
5387052|NCT00090285|anogenital warts|anogenital warts
5387053|NCT00090181|Arcoxia|arcoxia
5387054|NCT00004026|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5387055|NCT00004026|stage IV prostate cancer|stage iv prostate cancer
5387056|NCT00004026|recurrent prostate cancer|recurrent prostate cancer
5387057|NCT00004009|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5387058|NCT00004009|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5387059|NCT00004009|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5387060|NCT00004009|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5387061|NCT00004009|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
5387062|NCT00004009|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
5387063|NCT00004009|adult acute promyelocytic leukemia (M3)|adult acute promyelocytic leukemia (m3)
5387064|NCT00004009|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5387065|NCT00003989|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5387066|NCT00003989|stage III melanoma|stage iii melanoma
5387067|NCT00003989|stage IV melanoma|stage iv melanoma
5387068|NCT00003989|recurrent melanoma|recurrent melanoma
5387069|NCT00003989|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5387070|NCT00003989|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5387071|NCT00003989|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5387072|NCT00003962|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5387073|NCT00003962|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5387074|NCT00003962|refractory multiple myeloma|refractory multiple myeloma
5387075|NCT00003962|stage I multiple myeloma|stage i multiple myeloma
5387076|NCT00003962|stage II multiple myeloma|stage ii multiple myeloma
5387077|NCT00003962|stage III multiple myeloma|stage iii multiple myeloma
5387078|NCT00003962|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
5387079|NCT00003962|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5387080|NCT00003962|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5387081|NCT00003962|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5387082|NCT00003962|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
5387083|NCT00003962|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5387084|NCT00003962|acute undifferentiated leukemia|acute undifferentiated leukemia
5387085|NCT00003962|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5387086|NCT00003962|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5387087|NCT00003962|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5387088|NCT00003962|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5387089|NCT00003962|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5387090|NCT00003962|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5387091|NCT00003962|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5387092|NCT00003962|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5387093|NCT00003962|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
5387094|NCT00003962|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5387095|NCT00003962|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
5387096|NCT00003962|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
5387097|NCT00003962|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
5387098|NCT00003962|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5387099|NCT00003962|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5387100|NCT00003962|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5387101|NCT00003962|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5387102|NCT00003962|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5387103|NCT00003962|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5387104|NCT00003778|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
5387105|NCT00003778|stage IV uterine sarcoma|stage iv uterine sarcoma
5387106|NCT00003778|recurrent uterine sarcoma|recurrent uterine sarcoma
5387107|NCT00003778|ovarian sarcoma|ovarian sarcoma
5387108|NCT00003778|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
5387109|NCT00090402|Fish Oils|fish oils
5387110|NCT00090402|Thioctic Acid|thioctic acid
5387111|NCT00090402|Antioxidants|antioxidants
5387112|NCT00090402|Dietary Supplements|dietary supplements
5387113|NCT00090389|Acupuncture|acupuncture
5387114|NCT00090389|Medicine, Chinese Traditional|medicine, chinese traditional
5387115|NCT00090337|pain|pain
5387116|NCT00090337|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
5387117|NCT00090337|stage I squamous cell carcinoma of the hypopharynx|stage i squamous cell carcinoma of the hypopharynx
5387118|NCT00090337|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
5387119|NCT00090337|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
5387120|NCT00090337|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5387121|NCT00090337|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
5387122|NCT00090337|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
5387123|NCT00090337|stage I squamous cell carcinoma of the larynx|stage i squamous cell carcinoma of the larynx
5387124|NCT00090337|stage I verrucous carcinoma of the larynx|stage i verrucous carcinoma of the larynx
5387125|NCT00090337|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
5387126|NCT00090337|stage II verrucous carcinoma of the larynx|stage ii verrucous carcinoma of the larynx
5387127|NCT00090337|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
5387128|NCT00090337|stage III verrucous carcinoma of the larynx|stage iii verrucous carcinoma of the larynx
5387129|NCT00090337|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5387130|NCT00090337|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
5387131|NCT00090337|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
5387132|NCT00090337|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
5387133|NCT00090337|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
5387134|NCT00090337|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
5387135|NCT00090337|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5387136|NCT00090337|recurrent basal cell carcinoma of the lip|recurrent basal cell carcinoma of the lip
5387137|NCT00090337|stage I basal cell carcinoma of the lip|stage i basal cell carcinoma of the lip
5387138|NCT00090337|stage II basal cell carcinoma of the lip|stage ii basal cell carcinoma of the lip
5387139|NCT00090337|stage III basal cell carcinoma of the lip|stage iii basal cell carcinoma of the lip
5387140|NCT00090337|stage IV basal cell carcinoma of the lip|stage iv basal cell carcinoma of the lip
5387141|NCT00090337|recurrent adenoid cystic carcinoma of the oral cavity|recurrent adenoid cystic carcinoma of the oral cavity
5387142|NCT00090337|recurrent mucoepidermoid carcinoma of the oral cavity|recurrent mucoepidermoid carcinoma of the oral cavity
5387143|NCT00090337|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
5387144|NCT00090337|stage I adenoid cystic carcinoma of the oral cavity|stage i adenoid cystic carcinoma of the oral cavity
5387145|NCT00090337|stage I mucoepidermoid carcinoma of the oral cavity|stage i mucoepidermoid carcinoma of the oral cavity
5387146|NCT00090337|stage I verrucous carcinoma of the oral cavity|stage i verrucous carcinoma of the oral cavity
5387147|NCT00090337|stage II adenoid cystic carcinoma of the oral cavity|stage ii adenoid cystic carcinoma of the oral cavity
5387148|NCT00090337|stage II mucoepidermoid carcinoma of the oral cavity|stage ii mucoepidermoid carcinoma of the oral cavity
5387149|NCT00090337|stage II verrucous carcinoma of the oral cavity|stage ii verrucous carcinoma of the oral cavity
5387150|NCT00090337|stage III adenoid cystic carcinoma of the oral cavity|stage iii adenoid cystic carcinoma of the oral cavity
5387151|NCT00090337|stage III mucoepidermoid carcinoma of the oral cavity|stage iii mucoepidermoid carcinoma of the oral cavity
5387152|NCT00090337|stage III verrucous carcinoma of the oral cavity|stage iii verrucous carcinoma of the oral cavity
5387153|NCT00090337|stage IV adenoid cystic carcinoma of the oral cavity|stage iv adenoid cystic carcinoma of the oral cavity
5387154|NCT00090337|stage IV mucoepidermoid carcinoma of the oral cavity|stage iv mucoepidermoid carcinoma of the oral cavity
5387155|NCT00090337|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
5387156|NCT00090337|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
5387157|NCT00090337|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
5387158|NCT00090337|recurrent lymphoepithelioma of the nasopharynx|recurrent lymphoepithelioma of the nasopharynx
5387159|NCT00090337|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
5387160|NCT00090337|stage I lymphoepithelioma of the nasopharynx|stage i lymphoepithelioma of the nasopharynx
5387161|NCT00090337|stage I squamous cell carcinoma of the nasopharynx|stage i squamous cell carcinoma of the nasopharynx
5387162|NCT00090337|stage II lymphoepithelioma of the nasopharynx|stage ii lymphoepithelioma of the nasopharynx
5387163|NCT00090337|stage II squamous cell carcinoma of the nasopharynx|stage ii squamous cell carcinoma of the nasopharynx
5387164|NCT00090337|stage III lymphoepithelioma of the nasopharynx|stage iii lymphoepithelioma of the nasopharynx
5387165|NCT00090337|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
5387166|NCT00090337|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
5387167|NCT00090337|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
5387168|NCT00090337|recurrent lymphoepithelioma of the oropharynx|recurrent lymphoepithelioma of the oropharynx
5387169|NCT00090337|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
5387170|NCT00090337|stage I lymphoepithelioma of the oropharynx|stage i lymphoepithelioma of the oropharynx
5387171|NCT00090337|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
5387172|NCT00090337|stage II lymphoepithelioma of the oropharynx|stage ii lymphoepithelioma of the oropharynx
5387173|NCT00090337|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
5387174|NCT00090337|stage III lymphoepithelioma of the oropharynx|stage iii lymphoepithelioma of the oropharynx
5387175|NCT00090337|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
5387176|NCT00090337|stage IV lymphoepithelioma of the oropharynx|stage iv lymphoepithelioma of the oropharynx
5387177|NCT00090337|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5387178|NCT00090337|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity
5387179|NCT00090337|recurrent inverted papilloma of the paranasal sinus and nasal cavity|recurrent inverted papilloma of the paranasal sinus and nasal cavity
5387180|NCT00090337|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity
5387249|NCT00003406|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5387181|NCT00090337|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
5387182|NCT00090337|stage I esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage i esthesioneuroblastoma of the paranasal sinus and nasal cavity
5387183|NCT00090337|stage I inverted papilloma of the paranasal sinus and nasal cavity|stage i inverted papilloma of the paranasal sinus and nasal cavity
5387184|NCT00090337|stage I midline lethal granuloma of the paranasal sinus and nasal cavity|stage i midline lethal granuloma of the paranasal sinus and nasal cavity
5387185|NCT00090337|stage I squamous cell carcinoma of the paranasal sinus and nasal cavity|stage i squamous cell carcinoma of the paranasal sinus and nasal cavity
5387186|NCT00090337|stage II esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage ii esthesioneuroblastoma of the paranasal sinus and nasal cavity
5387187|NCT00090337|stage II inverted papilloma of the paranasal sinus and nasal cavity|stage ii inverted papilloma of the paranasal sinus and nasal cavity
5387188|NCT00090337|stage II midline lethal granuloma of the paranasal sinus and nasal cavity|stage ii midline lethal granuloma of the paranasal sinus and nasal cavity
5387189|NCT00090337|stage II squamous cell carcinoma of the paranasal sinus and nasal cavity|stage ii squamous cell carcinoma of the paranasal sinus and nasal cavity
5387190|NCT00090337|stage III esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iii esthesioneuroblastoma of the paranasal sinus and nasal cavity
5387191|NCT00090337|stage III inverted papilloma of the paranasal sinus and nasal cavity|stage iii inverted papilloma of the paranasal sinus and nasal cavity
5387192|NCT00090337|stage III midline lethal granuloma of the paranasal sinus and nasal cavity|stage iii midline lethal granuloma of the paranasal sinus and nasal cavity
5387193|NCT00090337|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
5387194|NCT00090337|stage IV esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iv esthesioneuroblastoma of the paranasal sinus and nasal cavity
5387195|NCT00090337|stage IV inverted papilloma of the paranasal sinus and nasal cavity|stage iv inverted papilloma of the paranasal sinus and nasal cavity
5387196|NCT00090337|stage IV midline lethal granuloma of the paranasal sinus and nasal cavity|stage iv midline lethal granuloma of the paranasal sinus and nasal cavity
5387197|NCT00090337|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
5387198|NCT00090337|recurrent salivary gland cancer|recurrent salivary gland cancer
5387199|NCT00090337|stage I salivary gland cancer|stage i salivary gland cancer
5387200|NCT00090337|stage II salivary gland cancer|stage ii salivary gland cancer
5387201|NCT00090337|stage III salivary gland cancer|stage iii salivary gland cancer
5387202|NCT00090337|stage IV salivary gland cancer|stage iv salivary gland cancer
5387203|NCT00090194|Kidney Transplantation|kidney transplantation
5387204|NCT00090194|Transplantation, Homologous|transplantation, homologous
5387205|NCT00090194|HLA Antigens|hla antigens
5387206|NCT00090194|Autoantibodies|autoantibodies
5387207|NCT00090194|Immunoglobulins, Intravenous|immunoglobulins, intravenous
5387208|NCT00090194|Living Donors|living donors
5387209|NCT00090194|Dose-Response Relationship, Immunologic|dose-response relationship, immunologic
5387210|NCT00090129|Psoriatic Arthritis|psoriatic arthritis
5387211|NCT00090129|Moderate plaque psoriasis|moderate plaque psoriasis
5387212|NCT00090129|severe plaque psoriasis|severe plaque psoriasis
5387213|NCT00090129|Onercept|onercept
5387214|NCT00090129|Placebo|placebo
5387215|NCT00090116|Neramexane|neramexane
5387216|NCT00090116|NMDA receptor antagonist|nmda receptor antagonist
5387217|NCT00090116|Memory Loss|memory loss
5387218|NCT00090116|Alzheimer Disease|alzheimer disease
5387219|NCT00090103|Combination Therapy|combination therapy
5387220|NCT00090103|dutasteride|dutasteride
5387221|NCT00090103|BPH|bph
5387222|NCT00090077|GW695634G|gw695634g
5387223|NCT00090077|GW695634X|gw695634x
5387224|NCT00090077|GW678248X|gw678248x
5387225|NCT00090077|pharmacokinetics|pharmacokinetics
5387226|NCT00090077|NNRTI|nnrti
5387227|NCT00090077|HIV|hiv
5387228|NCT00003654|stage I breast cancer|stage i breast cancer
5387229|NCT00003654|stage II breast cancer|stage ii breast cancer
5387230|NCT00003601|melanoma|melanoma
5387231|NCT00003588|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5387232|NCT00003588|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5387233|NCT00003519|stage II breast cancer|stage ii breast cancer
5387234|NCT00003519|stage IIIA breast cancer|stage iiia breast cancer
5387235|NCT00003519|stage IIIB breast cancer|stage iiib breast cancer
5387236|NCT00003406|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5387237|NCT00003406|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5387238|NCT00003406|monoclonal gammopathy of undetermined significance|monoclonal gammopathy of undetermined significance
5387239|NCT00003406|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5387240|NCT00003406|isolated plasmacytoma of bone|isolated plasmacytoma of bone
5387241|NCT00003406|extramedullary plasmacytoma|extramedullary plasmacytoma
5387242|NCT00003406|refractory multiple myeloma|refractory multiple myeloma
5387243|NCT00003406|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
5387244|NCT00003406|stage III multiple myeloma|stage iii multiple myeloma
5387245|NCT00003406|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5387246|NCT00003406|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5387247|NCT00003406|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5387248|NCT00003406|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5387462|NCT00002493|endometrial adenoacanthoma|endometrial adenoacanthoma
5387250|NCT00003406|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5387251|NCT00003406|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5387252|NCT00003406|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5387253|NCT00003406|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5387254|NCT00003406|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5387255|NCT00003406|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
5387256|NCT00003406|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5387257|NCT00003406|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5387258|NCT00003406|polycythemia vera|polycythemia vera
5387259|NCT00003406|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
5387260|NCT00003406|essential thrombocythemia|essential thrombocythemia
5387261|NCT00003406|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
5387262|NCT00003406|refractory hairy cell leukemia|refractory hairy cell leukemia
5387263|NCT00003406|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5387264|NCT00003406|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
5387265|NCT00003406|acute undifferentiated leukemia|acute undifferentiated leukemia
5387266|NCT00003406|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5387267|NCT00003406|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5387268|NCT00003406|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5387269|NCT00003406|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5387270|NCT00003406|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5387271|NCT00003406|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5387272|NCT00003406|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5387273|NCT00003406|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5387274|NCT00003406|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5387275|NCT00003406|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5387276|NCT00003406|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5387277|NCT00003406|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5387278|NCT00003406|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5387279|NCT00003406|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5387280|NCT00003406|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5387281|NCT00003406|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5387282|NCT00003406|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5387283|NCT00003406|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5387284|NCT00003406|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5387285|NCT00003406|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5387286|NCT00003406|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5387287|NCT00003406|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5387288|NCT00003406|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5387289|NCT00003406|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5387290|NCT00003406|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5387291|NCT00003406|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5387292|NCT00003406|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5387293|NCT00003406|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
5387294|NCT00003406|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
5387295|NCT00003406|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
5387296|NCT00003406|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5387297|NCT00003406|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5387298|NCT00003406|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5387299|NCT00003406|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5387300|NCT00003406|prolymphocytic leukemia|prolymphocytic leukemia
5387301|NCT00003406|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
5387302|NCT00003406|AIDS-related primary CNS lymphoma|aids-related primary cns lymphoma
5387303|NCT00003406|primary systemic amyloidosis|primary systemic amyloidosis
5387304|NCT00003406|non-Hodgkin lymphoma during pregnancy|non-hodgkin lymphoma during pregnancy
5387305|NCT00003406|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5387306|NCT00003406|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5387307|NCT00003406|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5387517|NCT00089895|cardiac ischemia|cardiac ischemia
5387308|NCT00003406|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
5387309|NCT00003406|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5387310|NCT00003406|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5387311|NCT00003406|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5387312|NCT00003406|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5387313|NCT00003406|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5387314|NCT00003406|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5387315|NCT00003406|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5387316|NCT00003406|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5387317|NCT00003406|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5387318|NCT00003406|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5387319|NCT00003406|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
5387320|NCT00003390|stage IV renal cell cancer|stage iv renal cell cancer
5387321|NCT00003390|recurrent renal cell cancer|recurrent renal cell cancer
5387322|NCT00003378|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5387323|NCT00003378|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5387324|NCT00003378|primary peritoneal cavity cancer|primary peritoneal cavity cancer
5387325|NCT00003362|stage III melanoma|stage iii melanoma
5387326|NCT00003362|stage IV melanoma|stage iv melanoma
5387327|NCT00003362|recurrent melanoma|recurrent melanoma
5387328|NCT00003315|infection|infection
5387329|NCT00003304|adult oligodendroglioma|adult oligodendroglioma
5387330|NCT00090064|MDMA|mdma
5387331|NCT00090064|Methylenedioxymethamphetamine|methylenedioxymethamphetamine
5387332|NCT00090064|PTSD|ptsd
5387333|NCT00090064|psychotherapy|psychotherapy
5387334|NCT00003279|limited stage small cell lung cancer|limited stage small cell lung cancer
5387335|NCT00003260|stage IV colon cancer|stage iv colon cancer
5387336|NCT00003260|stage IV rectal cancer|stage iv rectal cancer
5387337|NCT00003260|recurrent colon cancer|recurrent colon cancer
5387338|NCT00003260|recurrent rectal cancer|recurrent rectal cancer
5387339|NCT00003260|adenocarcinoma of the colon|adenocarcinoma of the colon
5387340|NCT00003260|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5387341|NCT00003237|stage II gastric cancer|stage ii gastric cancer
5387342|NCT00003237|stage III gastric cancer|stage iii gastric cancer
5387343|NCT00003237|stage II esophageal cancer|stage ii esophageal cancer
5387344|NCT00003237|stage III esophageal cancer|stage iii esophageal cancer
5387345|NCT00003237|adenocarcinoma of the stomach|adenocarcinoma of the stomach
5387346|NCT00003237|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
5387347|NCT00003229|stage IV melanoma|stage iv melanoma
5387348|NCT00003229|recurrent melanoma|recurrent melanoma
5387349|NCT00003224|stage II melanoma|stage ii melanoma
5387350|NCT00003224|stage III melanoma|stage iii melanoma
5387351|NCT00003224|stage IV melanoma|stage iv melanoma
5387352|NCT00003224|recurrent melanoma|recurrent melanoma
5387353|NCT00003151|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
5387354|NCT00003151|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
5387355|NCT00003151|stage I marginal zone lymphoma|stage i marginal zone lymphoma
5387356|NCT00003151|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
5387357|NCT00003151|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5387358|NCT00003147|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
5387359|NCT00003147|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
5387360|NCT00003136|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5387361|NCT00003136|primary peritoneal cavity cancer|primary peritoneal cavity cancer
5387362|NCT00003131|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5387363|NCT00002969|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5387364|NCT00002969|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5387365|NCT00002969|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5387366|NCT00002960|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5387367|NCT00002960|malignant ascites|malignant ascites
5387368|NCT00002960|fallopian tube cancer|fallopian tube cancer
5387369|NCT00002960|primary peritoneal cavity cancer|primary peritoneal cavity cancer
5387370|NCT00002888|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
5387371|NCT00002888|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5387372|NCT00002888|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
5387373|NCT00002888|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
5387374|NCT00002888|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5387375|NCT00002888|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
5387376|NCT00002888|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
5387377|NCT00002888|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5387378|NCT00002888|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
5387379|NCT00002888|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
5387380|NCT00002888|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5387381|NCT00002888|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
5387382|NCT00002888|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
5387383|NCT00002888|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
5387686|NCT00003312|stage I prostate cancer|stage i prostate cancer
5387384|NCT00002888|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
5387385|NCT00002881|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5387386|NCT00002881|stage IV prostate cancer|stage iv prostate cancer
5387387|NCT00002881|recurrent prostate cancer|recurrent prostate cancer
5387388|NCT00002879|mantle cell lymphoma|mantle cell lymphoma
5387389|NCT00002879|stage I mantle cell lymphoma|stage i mantle cell lymphoma
5387390|NCT00002879|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
5387391|NCT00002879|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5387392|NCT00002879|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5387393|NCT00002879|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5387394|NCT00002879|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5387395|NCT00002845|stage IV melanoma|stage iv melanoma
5387396|NCT00002845|recurrent melanoma|recurrent melanoma
5387397|NCT00002783|stage II gastric cancer|stage ii gastric cancer
5387398|NCT00002783|stage III gastric cancer|stage iii gastric cancer
5387399|NCT00002783|stage IV gastric cancer|stage iv gastric cancer
5387400|NCT00002783|adenocarcinoma of the stomach|adenocarcinoma of the stomach
5387401|NCT00002755|stage II breast cancer|stage ii breast cancer
5387402|NCT00002755|stage IIIA breast cancer|stage iiia breast cancer
5387403|NCT00002742|adult Hodgkin lymphoma|adult hodgkin lymphoma
5387404|NCT00002742|adult non-Hodgkin lymphoma|adult non-hodgkin lymphoma
5387405|NCT00002742|leukemia|leukemia
5387406|NCT00002742|childhood non-Hodgkin lymphoma|childhood non-hodgkin lymphoma
5387407|NCT00002742|chronic myeloproliferative disorders|chronic myeloproliferative disorders
5387408|NCT00002742|myelodysplastic syndromes|myelodysplastic syndromes
5387409|NCT00002742|childhood Hodgkin lymphoma|childhood hodgkin lymphoma
5387410|NCT00002742|recurrent adult non-Hodgkin lymphoma|recurrent adult non-hodgkin lymphoma
5387411|NCT00002742|infection|infection
5387412|NCT00002742|multiple myeloma and other plasma cell neoplasms|multiple myeloma and other plasma cell neoplasms
5387413|NCT00002742|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
5387414|NCT00002711|stage I esophageal cancer|stage i esophageal cancer
5387415|NCT00002711|stage II esophageal cancer|stage ii esophageal cancer
5387416|NCT00002711|stage III esophageal cancer|stage iii esophageal cancer
5387417|NCT00002711|recurrent esophageal cancer|recurrent esophageal cancer
5387418|NCT00002711|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
5387419|NCT00002711|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
5387420|NCT00090025|Advanced Biliary Cancer|advanced biliary cancer
5387421|NCT00090025|Cholangiocarcinoma|cholangiocarcinoma
5387422|NCT00090025|Gall bladder tumor|gall bladder tumor
5387423|NCT00090025|Gall bladder cancer|gall bladder cancer
5387424|NCT00090025|Bile duct tumor|bile duct tumor
5387425|NCT00090025|Tumor of biliary tree|tumor of biliary tree
5387426|NCT00089999|lapatinib|lapatinib
5387427|NCT00089999|advanced|advanced
5387428|NCT00089999|metastatic breast cancer|metastatic breast cancer
5387429|NCT00089999|GW572016|gw572016
5387430|NCT00089999|ErbB2|erbb2
5387431|NCT00089986|severe sepsis|severe sepsis
5387432|NCT00089986|septic shock|septic shock
5387433|NCT00089986|Gram-negative infection|gram-negative infection
5387434|NCT00089986|phospholipid emulsion|phospholipid emulsion
5387435|NCT00005024|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5387436|NCT00004906|stage IV breast cancer|stage iv breast cancer
5387437|NCT00004906|recurrent breast cancer|recurrent breast cancer
5387438|NCT00002674|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5387439|NCT00002674|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5387440|NCT00002674|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5387441|NCT00002674|Philadelphia chromosome positive chronic myelogenous leukemia|philadelphia chromosome positive chronic myelogenous leukemia
5387442|NCT00002634|localized resectable neuroblastoma|localized resectable neuroblastoma
5387443|NCT00002634|regional neuroblastoma|regional neuroblastoma
5387444|NCT00002634|disseminated neuroblastoma|disseminated neuroblastoma
5387445|NCT00002634|recurrent neuroblastoma|recurrent neuroblastoma
5387446|NCT00002634|localized unresectable neuroblastoma|localized unresectable neuroblastoma
5387447|NCT00002579|stage I breast cancer|stage i breast cancer
5387448|NCT00002579|stage II breast cancer|stage ii breast cancer
5387449|NCT00002579|stage IIIA breast cancer|stage iiia breast cancer
5387450|NCT00002510|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
5387451|NCT00002510|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5387452|NCT00002510|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5387453|NCT00002510|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5387454|NCT00002510|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5387455|NCT00002499|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5387456|NCT00002498|stage IV breast cancer|stage iv breast cancer
5387457|NCT00002498|recurrent breast cancer|recurrent breast cancer
5387458|NCT00002493|stage III endometrial carcinoma|stage iii endometrial carcinoma
5387459|NCT00002493|stage IV endometrial carcinoma|stage iv endometrial carcinoma
5387460|NCT00002493|endometrial adenocarcinoma|endometrial adenocarcinoma
5387461|NCT00002493|endometrial adenosquamous cell carcinoma|endometrial adenosquamous cell carcinoma
5387463|NCT00002493|endometrial papillary serous carcinoma|endometrial papillary serous carcinoma
5387464|NCT00002493|endometrial clear cell carcinoma|endometrial clear cell carcinoma
5387465|NCT00002493|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
5387466|NCT00002479|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
5387467|NCT00002479|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
5387468|NCT00002479|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
5387469|NCT00002479|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
5387470|NCT00089973|breast cancer|breast cancer
5387471|NCT00089960|GIST|gist
5387472|NCT00089947|Anti-T cell antibodies|anti-t cell antibodies
5387473|NCT00089947|Living Donor Renal Transplantation|living donor renal transplantation
5387474|NCT00089947|Acute Renal Allograft Rejection|acute renal allograft rejection
5387475|NCT00089947|Induction Therapy with Reduction of Calcineurin inhibitors|induction therapy with reduction of calcineurin inhibitors
5387476|NCT00089921|Rheumatoid Arthritis|rheumatoid arthritis
5387477|NCT00089921|DMARDs|dmards
5387478|NCT00089921|Methotrexate|methotrexate
5387479|NCT00089921|p38 kinase|p38 kinase
5387480|NCT00004900|stage IV breast cancer|stage iv breast cancer
5387481|NCT00004900|recurrent breast cancer|recurrent breast cancer
5387482|NCT00004900|stage IIIB breast cancer|stage iiib breast cancer
5387483|NCT00004182|stage IV breast cancer|stage iv breast cancer
5387484|NCT00004182|recurrent breast cancer|recurrent breast cancer
5387485|NCT00004136|stage III childhood liver cancer|stage iii childhood liver cancer
5387486|NCT00004136|stage IV childhood liver cancer|stage iv childhood liver cancer
5387487|NCT00004136|recurrent childhood liver cancer|recurrent childhood liver cancer
5387488|NCT00004136|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
5387489|NCT00004136|advanced adult primary liver cancer|advanced adult primary liver cancer
5387490|NCT00004136|recurrent adult primary liver cancer|recurrent adult primary liver cancer
5387491|NCT00004136|liver metastases|liver metastases
5387492|NCT00004042|stage III colon cancer|stage iii colon cancer
5387493|NCT00004042|stage IV colon cancer|stage iv colon cancer
5387494|NCT00004042|stage III rectal cancer|stage iii rectal cancer
5387495|NCT00004042|stage IV rectal cancer|stage iv rectal cancer
5387496|NCT00004042|recurrent colon cancer|recurrent colon cancer
5387497|NCT00004042|recurrent rectal cancer|recurrent rectal cancer
5387498|NCT00003974|stage I non-small cell lung cancer|stage i non-small cell lung cancer
5387499|NCT00003974|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
5387500|NCT00003974|localized malignant mesothelioma|localized malignant mesothelioma
5387501|NCT00003974|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5387502|NCT00089908|Dengue Vaccine|dengue vaccine
5387503|NCT00089908|Dengue Virus|dengue virus
5387504|NCT00089908|Dengue Hemorrhagic Fever|dengue hemorrhagic fever
5387505|NCT00089908|Dengue Shock Syndrome|dengue shock syndrome
5387506|NCT00089895|myocardial infarction|myocardial infarction
5387507|NCT00089895|acute coronary syndrome|acute coronary syndrome
5387508|NCT00089895|non-ST-segment elevation|non-st-segment elevation
5387509|NCT00089895|eptifibatide|eptifibatide
5387510|NCT00089895|Integrilin|integrilin
5387511|NCT00089895|glycoprotein IIb/IIIa inhibitor (GP IIb/IIIa)|glycoprotein iib/iiia inhibitor (gp iib/iiia)
5387512|NCT00089895|percutaneous coronary intervention (PCI)|percutaneous coronary intervention (pci)
5387513|NCT00089895|coronary artery bypass graph surgery (CABG)|coronary artery bypass graph surgery (cabg)
5387514|NCT00089895|catheterization|catheterization
5387515|NCT00089895|angina|angina
5387518|NCT00089895|cardiovascular disease|cardiovascular disease
5387519|NCT00089882|Alzheimer disease|alzheimer disease
5387520|NCT00089882|Apolipoproteins E (APOE)|apolipoproteins e (apoe)
5387521|NCT00089882|Genetic susceptibility testing|genetic susceptibility testing
5387522|NCT00089856|Prostate|prostate
5387523|NCT00089856|Cancer|cancer
5387524|NCT00089856|Metastatic|metastatic
5387525|NCT00089856|Hormone-refractory|hormone-refractory
5387526|NCT00089856|GVAX|gvax
5387527|NCT00089856|Chemotherapy|chemotherapy
5387528|NCT00089856|Taxotere|taxotere
5387529|NCT00089856|Docetaxel|docetaxel
5387530|NCT00089856|Prednisone|prednisone
5387531|NCT00089856|Vaccine|vaccine
5387532|NCT00089856|Allogeneic cells|allogeneic cells
5387533|NCT00089856|Advanced Prostate Cancer|advanced prostate cancer
5387534|NCT00003951|recurrent pancreatic cancer|recurrent pancreatic cancer
5387535|NCT00003951|duct cell adenocarcinoma of the pancreas|duct cell adenocarcinoma of the pancreas
5387536|NCT00003951|stage IV pancreatic cancer|stage iv pancreatic cancer
5387537|NCT00003897|stage IV melanoma|stage iv melanoma
5387538|NCT00003897|recurrent melanoma|recurrent melanoma
5387539|NCT00003885|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5387540|NCT00003885|stage I multiple myeloma|stage i multiple myeloma
5387541|NCT00003885|stage II multiple myeloma|stage ii multiple myeloma
5387542|NCT00003885|stage III multiple myeloma|stage iii multiple myeloma
5387543|NCT00003885|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5387544|NCT00003885|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5387545|NCT00003885|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5387687|NCT00003312|stage IIB prostate cancer|stage iib prostate cancer
5387546|NCT00003885|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5387547|NCT00003885|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5387548|NCT00003885|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5387549|NCT00003885|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5387550|NCT00003885|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5387551|NCT00003885|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5387552|NCT00003885|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5387553|NCT00003885|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5387554|NCT00003885|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5387555|NCT00003885|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
5387556|NCT00003885|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5387557|NCT00003885|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5387558|NCT00003885|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5387559|NCT00003885|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5387560|NCT00003885|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5387561|NCT00003885|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5387562|NCT00003885|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5387563|NCT00003776|metastatic osteosarcoma|metastatic osteosarcoma
5387564|NCT00003751|adult glioblastoma|adult glioblastoma
5387565|NCT00003751|adult giant cell glioblastoma|adult giant cell glioblastoma
5387566|NCT00003751|adult gliosarcoma|adult gliosarcoma
5387567|NCT00089843|Eating Disorders|eating disorders
5387568|NCT00089843|Osteopenia|osteopenia
5387569|NCT00089830|Subfoveal Choroidal Neovascularization|subfoveal choroidal neovascularization
5387570|NCT00089830|Squalamine Lactate|squalamine lactate
5387571|NCT00089804|Lupus|lupus
5387572|NCT00089804|Nephritis|nephritis
5387573|NCT00089804|Kidney|kidney
5387574|NCT00089804|SLE|sle
5387575|NCT00089804|Systemic Lupus Erythematosus|systemic lupus erythematosus
5387576|NCT00089804|Nephritis, Lupus|nephritis, lupus
5387577|NCT00003709|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5387578|NCT00003686|oral complications|oral complications
5387579|NCT00003686|quality of life|quality of life
5387580|NCT00003684|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5387581|NCT00003684|pulmonary complications|pulmonary complications
5387582|NCT00003684|quality of life|quality of life
5387583|NCT00003626|stage IV prostate cancer|stage iv prostate cancer
5387584|NCT00003626|recurrent prostate cancer|recurrent prostate cancer
5387585|NCT00003556|stage IV melanoma|stage iv melanoma
5387586|NCT00003556|recurrent melanoma|recurrent melanoma
5387587|NCT00089791|Postmenopausal Osteoporosis|postmenopausal osteoporosis
5387588|NCT00003555|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5387589|NCT00003543|stage IV colon cancer|stage iv colon cancer
5387590|NCT00003543|stage IV rectal cancer|stage iv rectal cancer
5387591|NCT00003543|recurrent colon cancer|recurrent colon cancer
5387592|NCT00003543|recurrent rectal cancer|recurrent rectal cancer
5387593|NCT00003400|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5387594|NCT00003400|stage IV prostate cancer|stage iv prostate cancer
5387595|NCT00003400|recurrent prostate cancer|recurrent prostate cancer
5387596|NCT00003395|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5387597|NCT00003395|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5387598|NCT00003395|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
5387599|NCT00003395|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5387600|NCT00003395|refractory multiple myeloma|refractory multiple myeloma
5387601|NCT00003395|Waldenström macroglobulinemia|waldenström macroglobulinemia
5387602|NCT00003395|stage III multiple myeloma|stage iii multiple myeloma
5387603|NCT00003395|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5387604|NCT00003395|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5387605|NCT00003395|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5387606|NCT00003395|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5387607|NCT00003395|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5387608|NCT00003395|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5387609|NCT00003395|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5387610|NCT00003395|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5387611|NCT00003395|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
5387612|NCT00003395|adult acute erythroid leukemia (M6)|adult acute erythroid leukemia (m6)
5387613|NCT00003395|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
5387614|NCT00003395|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
5387615|NCT00003395|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
5387616|NCT00003395|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
5387617|NCT00003395|adult acute eosinophilic leukemia|adult acute eosinophilic leukemia
5389737|NCT00088192|AMD|amd
5387618|NCT00003395|adult acute basophilic leukemia|adult acute basophilic leukemia
5387619|NCT00003395|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
5387620|NCT00003395|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
5387621|NCT00003395|refractory hairy cell leukemia|refractory hairy cell leukemia
5388231|NCT00089297|Paclitaxel|paclitaxel
5387622|NCT00003395|acute undifferentiated leukemia|acute undifferentiated leukemia
5387623|NCT00003395|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5387624|NCT00003395|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5387625|NCT00003395|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5387626|NCT00003395|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5387627|NCT00003395|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5387628|NCT00003395|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5387629|NCT00003395|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5387630|NCT00003395|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5387631|NCT00003395|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5387632|NCT00003395|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5387633|NCT00003395|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5387634|NCT00003395|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5387635|NCT00003395|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5387636|NCT00003395|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5387637|NCT00003395|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5387638|NCT00003395|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5387639|NCT00003395|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5387640|NCT00003395|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5387641|NCT00003395|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
5387642|NCT00003395|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
5387643|NCT00003395|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5387644|NCT00003395|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
5387645|NCT00003395|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
5387646|NCT00003395|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
5387647|NCT00003395|AIDS-related primary CNS lymphoma|aids-related primary cns lymphoma
5387648|NCT00003395|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
5387649|NCT00003395|intraocular lymphoma|intraocular lymphoma
5387650|NCT00003395|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5387651|NCT00003395|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5387652|NCT00003395|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5387653|NCT00003395|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
5387654|NCT00003395|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5387655|NCT00003395|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
5387656|NCT00003395|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5387657|NCT00003395|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5387658|NCT00003395|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5387659|NCT00003395|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5387660|NCT00003395|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5387661|NCT00003395|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5387662|NCT00003395|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5387663|NCT00003380|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5387664|NCT00003380|ovarian undifferentiated adenocarcinoma|ovarian undifferentiated adenocarcinoma
5387665|NCT00003380|ovarian mixed epithelial carcinoma|ovarian mixed epithelial carcinoma
5387666|NCT00003380|ovarian serous cystadenocarcinoma|ovarian serous cystadenocarcinoma
5387667|NCT00003380|ovarian mucinous cystadenocarcinoma|ovarian mucinous cystadenocarcinoma
5387668|NCT00003380|ovarian endometrioid adenocarcinoma|ovarian endometrioid adenocarcinoma
5387669|NCT00003380|ovarian clear cell cystadenocarcinoma|ovarian clear cell cystadenocarcinoma
5387670|NCT00003380|fallopian tube cancer|fallopian tube cancer
5387671|NCT00003380|primary peritoneal cavity cancer|primary peritoneal cavity cancer
5387672|NCT00003380|Brenner tumor|brenner tumor
5387673|NCT00003360|stage IV colon cancer|stage iv colon cancer
5387674|NCT00003360|stage IV rectal cancer|stage iv rectal cancer
5387675|NCT00003360|recurrent colon cancer|recurrent colon cancer
5387676|NCT00003360|recurrent rectal cancer|recurrent rectal cancer
5387677|NCT00003357|stage I breast cancer|stage i breast cancer
5387678|NCT00003357|stage II breast cancer|stage ii breast cancer
5387679|NCT00003357|stage III breast cancer|stage iii breast cancer
5387680|NCT00003348|recurrent adult brain tumor|recurrent adult brain tumor
5387681|NCT00003348|adult glioblastoma|adult glioblastoma
5387682|NCT00003348|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5387683|NCT00003348|adult giant cell glioblastoma|adult giant cell glioblastoma
5387684|NCT00003348|adult gliosarcoma|adult gliosarcoma
5387685|NCT00003340|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5387688|NCT00003312|stage IIA prostate cancer|stage iia prostate cancer
5387689|NCT00089778|Clinical Response|clinical response
5387690|NCT00089778|Toxicity|toxicity
5387691|NCT00089778|Immunologic Response|immunologic response
5387692|NCT00089778|Adjuvant|adjuvant
5387693|NCT00089778|IL-2|il-2
5387694|NCT00089778|Renal Cancer|renal cancer
5387695|NCT00089765|Retinal Angioma|retinal angioma
5387696|NCT00089765|Tumor|tumor
5387697|NCT00089765|Anti-VEGF|anti-vegf
5387698|NCT00089765|Monoclonal Antibody|monoclonal antibody
5387699|NCT00089765|Macular Edema|macular edema
5387700|NCT00089765|Von Hippel-Lindau Disease|von hippel-lindau disease
5387701|NCT00089765|VEGF|vegf
5387702|NCT00089765|Ranibizumab|ranibizumab
5387703|NCT00089765|VHL|vhl
5387704|NCT00003294|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5387705|NCT00003294|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5387706|NCT00003294|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5387707|NCT00003294|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5387708|NCT00003294|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5387709|NCT00003294|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5387710|NCT00003294|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5387711|NCT00003294|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5387712|NCT00003294|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5387713|NCT00003294|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5387714|NCT00003294|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5387715|NCT00003294|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5387716|NCT00003294|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5387717|NCT00003294|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
5387718|NCT00003294|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
5387719|NCT00003294|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
5387720|NCT00003294|untreated hairy cell leukemia|untreated hairy cell leukemia
5387721|NCT00003294|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
5387722|NCT00003294|refractory hairy cell leukemia|refractory hairy cell leukemia
5387723|NCT00003294|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5387724|NCT00003294|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5387725|NCT00003294|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5387726|NCT00003294|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5387727|NCT00003294|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5387728|NCT00003294|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5387729|NCT00003294|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5387730|NCT00003294|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5387731|NCT00003294|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5387732|NCT00003294|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5387733|NCT00003294|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5387734|NCT00003294|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5387735|NCT00003294|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5387736|NCT00003294|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5387737|NCT00003294|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5387738|NCT00003294|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5387739|NCT00003294|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5387740|NCT00003294|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5387741|NCT00003294|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5387742|NCT00003294|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
5387743|NCT00003294|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
5387744|NCT00003294|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
5387745|NCT00003294|prolymphocytic leukemia|prolymphocytic leukemia
5387746|NCT00003294|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
5387747|NCT00003294|AIDS-related primary CNS lymphoma|aids-related primary cns lymphoma
5387748|NCT00003294|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5387749|NCT00003294|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5387750|NCT00003294|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
5387751|NCT00003294|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5387752|NCT00003294|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5387753|NCT00003294|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5387754|NCT00003294|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5387755|NCT00003294|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5387756|NCT00003294|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5387757|NCT00003294|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5387758|NCT00003294|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5394510|NCT00083226|doxorubicin|doxorubicin
5387759|NCT00003284|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
5387760|NCT00003284|limited stage small cell lung cancer|limited stage small cell lung cancer
5387761|NCT00003284|extensive stage small cell lung cancer|extensive stage small cell lung cancer
5387762|NCT00003284|recurrent small cell lung cancer|recurrent small cell lung cancer
5387763|NCT00003284|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5387764|NCT00003284|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5387765|NCT00003284|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5387766|NCT00003251|stage III nasopharyngeal cancer|stage iii nasopharyngeal cancer
5387767|NCT00003251|stage IV nasopharyngeal cancer|stage iv nasopharyngeal cancer
5387768|NCT00003251|recurrent nasopharyngeal cancer|recurrent nasopharyngeal cancer
5387769|NCT00003251|stage III salivary gland cancer|stage iii salivary gland cancer
5387770|NCT00003251|stage IV salivary gland cancer|stage iv salivary gland cancer
5387771|NCT00003251|recurrent salivary gland cancer|recurrent salivary gland cancer
5387772|NCT00003251|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
5387773|NCT00003251|high-grade salivary gland mucoepidermoid carcinoma|high-grade salivary gland mucoepidermoid carcinoma
5387774|NCT00003251|stage III lip and oral cavity cancer|stage iii lip and oral cavity cancer
5387775|NCT00003251|stage IV lip and oral cavity cancer|stage iv lip and oral cavity cancer
5387776|NCT00003251|recurrent lip and oral cavity cancer|recurrent lip and oral cavity cancer
5387777|NCT00003251|stage III hypopharyngeal cancer|stage iii hypopharyngeal cancer
5387778|NCT00003251|stage IV hypopharyngeal cancer|stage iv hypopharyngeal cancer
5387779|NCT00003251|recurrent hypopharyngeal cancer|recurrent hypopharyngeal cancer
5387780|NCT00003251|stage III laryngeal cancer|stage iii laryngeal cancer
5387781|NCT00003251|stage IV laryngeal cancer|stage iv laryngeal cancer
5387782|NCT00003251|recurrent laryngeal cancer|recurrent laryngeal cancer
5387783|NCT00003251|stage III paranasal sinus and nasal cavity cancer|stage iii paranasal sinus and nasal cavity cancer
5387784|NCT00003251|stage IV paranasal sinus and nasal cavity cancer|stage iv paranasal sinus and nasal cavity cancer
5387785|NCT00003251|recurrent paranasal sinus and nasal cavity cancer|recurrent paranasal sinus and nasal cavity cancer
5387786|NCT00003251|stage III oropharyngeal cancer|stage iii oropharyngeal cancer
5387787|NCT00003251|stage IV oropharyngeal cancer|stage iv oropharyngeal cancer
5387788|NCT00003251|recurrent oropharyngeal cancer|recurrent oropharyngeal cancer
5387789|NCT00003251|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
5387790|NCT00003251|stage III mucoepidermoid carcinoma of the oral cavity|stage iii mucoepidermoid carcinoma of the oral cavity
5387791|NCT00003251|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5387792|NCT00003251|stage IV mucoepidermoid carcinoma of the oral cavity|stage iv mucoepidermoid carcinoma of the oral cavity
5387793|NCT00003251|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
5387794|NCT00003251|recurrent mucoepidermoid carcinoma of the oral cavity|recurrent mucoepidermoid carcinoma of the oral cavity
5387795|NCT00003251|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
5387796|NCT00003251|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5387797|NCT00003251|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
5387798|NCT00003251|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
5387799|NCT00003251|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
5387800|NCT00003251|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
5387801|NCT00003251|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
5387802|NCT00003251|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5387803|NCT00003251|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
5387804|NCT00003251|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
5387805|NCT00003251|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5387806|NCT00003251|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
5387807|NCT00003251|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
5387808|NCT00003251|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
5387809|NCT00003251|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
5387810|NCT00003251|drug/agent toxicity by tissue/organ|drug/agent toxicity by tissue/organ
5387811|NCT00003251|radiation toxicity|radiation toxicity
5387812|NCT00003220|stage IV colon cancer|stage iv colon cancer
5387813|NCT00003220|stage IV rectal cancer|stage iv rectal cancer
5387814|NCT00003220|recurrent colon cancer|recurrent colon cancer
5387815|NCT00003220|recurrent rectal cancer|recurrent rectal cancer
5388232|NCT00089297|Carboplatin|carboplatin
5387816|NCT00003220|adenocarcinoma of the colon|adenocarcinoma of the colon
5387817|NCT00003220|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5387818|NCT00003200|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
5387819|NCT00003200|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5388179|NCT00089466|Entry Inhibitors|entry inhibitors
5387820|NCT00003200|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
5387821|NCT00003200|stage III lymphoepithelioma of the oropharynx|stage iii lymphoepithelioma of the oropharynx
5387822|NCT00003200|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5387823|NCT00003200|stage IV lymphoepithelioma of the oropharynx|stage iv lymphoepithelioma of the oropharynx
5387824|NCT00003200|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
5387825|NCT00003200|stage III lymphoepithelioma of the nasopharynx|stage iii lymphoepithelioma of the nasopharynx
5387826|NCT00003200|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
5387827|NCT00003200|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
5387828|NCT00003200|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
5387829|NCT00003200|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5387830|NCT00003200|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
5387831|NCT00003200|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5387832|NCT00003200|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
5387833|NCT00003200|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
5387834|NCT00089739|Uveitis|uveitis
5387835|NCT00089739|Suppressor of Cytokine Secretion|suppressor of cytokine secretion
5387836|NCT00089739|GITR|gitr
5387837|NCT00089739|Immunosuppression|immunosuppression
5387838|NCT00089739|GITR Ligand|gitr ligand
5387839|NCT00089739|Intraocular Inflammation|intraocular inflammation
5387840|NCT00089726|cancer vaccine|cancer vaccine
5387841|NCT00089726|NSCLC|nsclc
5387842|NCT00089726|immunotherapy|immunotherapy
5387843|NCT00089713|antihypertensive agents/therapeutic use|antihypertensive agents/therapeutic use
5387844|NCT00089713|hypertension/drug therapy|hypertension/drug therapy
5387845|NCT00089713|blood pressure|blood pressure
5387846|NCT00089700|HIV|hiv
5387847|NCT00089700|AIDS|aids
5387848|NCT00089700|Treatment Experienced|treatment experienced
5387849|NCT00089700|Optimized Background Therapy|optimized background therapy
5387850|NCT00089700|HIV-1|hiv-1
5387851|NCT00003197|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5387852|NCT00003123|refractory anemia|refractory anemia
5387853|NCT00003123|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
5387854|NCT00003123|refractory anemia with excess blasts|refractory anemia with excess blasts
5387855|NCT00003123|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
5387856|NCT00003115|prostate cancer|prostate cancer
5387857|NCT00003115|pain|pain
5387858|NCT00003102|stage IV renal cell cancer|stage iv renal cell cancer
5387859|NCT00003102|recurrent renal cell cancer|recurrent renal cell cancer
5387860|NCT00003058|adult liposarcoma|adult liposarcoma
5387861|NCT00003058|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
5387862|NCT00003044|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
5387863|NCT00003025|stage I pancreatic cancer|stage i pancreatic cancer
5387864|NCT00003025|stage II pancreatic cancer|stage ii pancreatic cancer
5387865|NCT00003025|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
5387866|NCT00003003|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5387867|NCT00003003|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5387868|NCT00002955|stage IV pancreatic cancer|stage iv pancreatic cancer
5387869|NCT00002933|stage IV colon cancer|stage iv colon cancer
5387870|NCT00002933|stage IV rectal cancer|stage iv rectal cancer
5387871|NCT00002933|recurrent colon cancer|recurrent colon cancer
5387872|NCT00002933|recurrent rectal cancer|recurrent rectal cancer
5387873|NCT00002933|adenocarcinoma of the colon|adenocarcinoma of the colon
5387874|NCT00002933|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5387875|NCT00089674|Prostate Cancer|prostate cancer
5387876|NCT00089674|Bone Loss with Prostate Cancer|bone loss with prostate cancer
5387877|NCT00089674|Treatment of bone loss in patients undergoing androgen deprivation therapy (ADT) for non-metastatic prostate cancer (PC).|treatment of bone loss in patients undergoing androgen deprivation therapy (adt) for non-metastatic prostate cancer (pc).
5387878|NCT00089661|Breast Cancer|breast cancer
5387879|NCT00089661|Bone loss associated with Aromatase Inhibitor therapy (AIT) for non-metastatic BC|bone loss associated with aromatase inhibitor therapy (ait) for non-metastatic bc
5387880|NCT00089661|osteopenia|osteopenia
5387881|NCT00089661|Low bone density|low bone density
5387882|NCT00089635|Colon, Rectal Cancer|colon, rectal cancer
5387883|NCT00089635|ABX-EGF, Panitumumab, EGFr|abx-egf, panitumumab, egfr
5387884|NCT00089635|Immunex, Abgenix, Amgen|immunex, abgenix, amgen
5387885|NCT00089635|Metastatic Colorectal Cancer|metastatic colorectal cancer
5387886|NCT00089635|Vectibix|vectibix
5387887|NCT00002914|recurrent bladder cancer|recurrent bladder cancer
5387888|NCT00002914|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
5387889|NCT00002914|squamous cell carcinoma of the bladder|squamous cell carcinoma of the bladder
5387890|NCT00002914|adenocarcinoma of the bladder|adenocarcinoma of the bladder
5387891|NCT00002914|recurrent urethral cancer|recurrent urethral cancer
5387956|NCT00002749|recurrent childhood brain stem glioma|recurrent childhood brain stem glioma
5387892|NCT00002914|recurrent transitional cell cancer of the renal pelvis and ureter|recurrent transitional cell cancer of the renal pelvis and ureter
5387893|NCT00002909|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5387894|NCT00002909|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5387895|NCT00002909|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5387896|NCT00002909|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5387897|NCT00002909|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5387898|NCT00002909|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5387899|NCT00002909|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5387900|NCT00002909|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5387901|NCT00002909|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5387902|NCT00002909|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5387903|NCT00002909|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5387904|NCT00002909|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5387905|NCT00002909|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5387906|NCT00002909|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5387907|NCT00002909|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5387908|NCT00002909|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5387909|NCT00002909|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5387910|NCT00002909|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5387911|NCT00002909|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5387912|NCT00002909|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5387913|NCT00002909|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5387914|NCT00002909|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5387915|NCT00002909|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5387916|NCT00002909|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5387917|NCT00002909|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5387918|NCT00002909|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5387919|NCT00002909|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5387920|NCT00002909|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5387921|NCT00002909|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5387922|NCT00002909|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5387923|NCT00002909|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5387924|NCT00002909|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
5387925|NCT00002909|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
5387926|NCT00002909|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5387927|NCT00002909|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5387928|NCT00002909|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5387929|NCT00002909|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
5387930|NCT00002909|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5387931|NCT00002909|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5387932|NCT00002909|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5387933|NCT00002909|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5387934|NCT00002909|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5387935|NCT00002909|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5387936|NCT00002909|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5387937|NCT00002909|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5387938|NCT00002909|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5387939|NCT00002909|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5387940|NCT00002890|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5387941|NCT00002890|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5387942|NCT00002890|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5387943|NCT00002890|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5387944|NCT00002890|refractory anemia with excess blasts|refractory anemia with excess blasts
5387945|NCT00002890|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
5387946|NCT00002890|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5387947|NCT00002890|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5387948|NCT00002890|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5387949|NCT00002890|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
5387950|NCT00002865|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5387951|NCT00002749|childhood low-grade cerebral astrocytoma|childhood low-grade cerebral astrocytoma
5387952|NCT00002749|recurrent adult brain tumor|recurrent adult brain tumor
5387953|NCT00002749|adult brain stem glioma|adult brain stem glioma
5387954|NCT00002749|childhood oligodendroglioma|childhood oligodendroglioma
5387955|NCT00002749|untreated childhood brain stem glioma|untreated childhood brain stem glioma
5388177|NCT00089505|MTCT|mtct
5387957|NCT00002749|untreated childhood visual pathway glioma|untreated childhood visual pathway glioma
5387958|NCT00002749|recurrent childhood visual pathway glioma|recurrent childhood visual pathway glioma
5387959|NCT00002749|untreated childhood cerebellar astrocytoma|untreated childhood cerebellar astrocytoma
5387960|NCT00002749|recurrent childhood cerebellar astrocytoma|recurrent childhood cerebellar astrocytoma
5387961|NCT00002749|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
5387962|NCT00002749|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5387963|NCT00002749|adult oligodendroglioma|adult oligodendroglioma
5387964|NCT00002655|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
5387965|NCT00002655|recurrent adult primary liver cancer|recurrent adult primary liver cancer
5387966|NCT00002655|liver metastases|liver metastases
5387967|NCT00002635|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
5387968|NCT00002635|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
5387969|NCT00002635|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
5387970|NCT00002635|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5387971|NCT00002619|adult brain stem glioma|adult brain stem glioma
5387972|NCT00002619|adult glioblastoma|adult glioblastoma
5387973|NCT00002619|childhood high-grade cerebral astrocytoma|childhood high-grade cerebral astrocytoma
5387974|NCT00002619|untreated childhood brain stem glioma|untreated childhood brain stem glioma
5387975|NCT00002619|adult giant cell glioblastoma|adult giant cell glioblastoma
5387976|NCT00002619|adult gliosarcoma|adult gliosarcoma
5387977|NCT00002609|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5387978|NCT00002609|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
5387979|NCT00002609|adult acute promyelocytic leukemia (M3)|adult acute promyelocytic leukemia (m3)
5387980|NCT00002609|childhood acute promyelocytic leukemia (M3)|childhood acute promyelocytic leukemia (m3)
5387981|NCT00002585|stage IV breast cancer|stage iv breast cancer
5387982|NCT00002585|recurrent breast cancer|recurrent breast cancer
5387983|NCT00089596|umbilical cord blood|umbilical cord blood
5387984|NCT00089596|transplant|transplant
5387985|NCT00089596|ALL|all
5387986|NCT00089596|AML|aml
5387987|NCT00089596|MDS|mds
5387988|NCT00089596|NHL|nhl
5387989|NCT00089596|CML|cml
5387990|NCT00089583|antiretroviral therapy|antiretroviral therapy
5387991|NCT00089583|pediatrics|pediatrics
5387992|NCT00089583|AGENERASE|agenerase
5387993|NCT00089583|amprenavir|amprenavir
5387994|NCT00089583|fosamprenavir|fosamprenavir
5387995|NCT00089583|HIV Infection|hiv infection
5387996|NCT00089583|ritonavir|ritonavir
5387997|NCT00089583|protease inhibitor|protease inhibitor
5387998|NCT00089583|LEXIVA|lexiva
5387999|NCT00005626|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5388000|NCT00005626|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5388001|NCT00005626|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5388002|NCT00005626|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
5388003|NCT00005626|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
5388004|NCT00005626|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5388005|NCT00005626|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5388006|NCT00005626|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5388007|NCT00005626|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5388008|NCT00005626|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5388009|NCT00005626|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5388010|NCT00005626|prolymphocytic leukemia|prolymphocytic leukemia
5388011|NCT00005626|stage I mantle cell lymphoma|stage i mantle cell lymphoma
5388012|NCT00005626|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
5388013|NCT00005626|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
5388014|NCT00005626|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
5388015|NCT00005626|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5388016|NCT00005626|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5388017|NCT00005626|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5388018|NCT00005626|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5388019|NCT00005626|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5388020|NCT00005626|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5388021|NCT00005626|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
5388022|NCT00005626|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
5388023|NCT00005626|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5388024|NCT00005626|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5388025|NCT00005626|stage I marginal zone lymphoma|stage i marginal zone lymphoma
5388026|NCT00005626|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
5388027|NCT00005626|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5388028|NCT00005626|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5388029|NCT00005626|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5388030|NCT00005626|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5388031|NCT00005626|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
5388032|NCT00005626|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
5388033|NCT00005626|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5388034|NCT00005626|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5388035|NCT00005626|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5388036|NCT00005607|stage IV gastric cancer|stage iv gastric cancer
5388037|NCT00005607|recurrent gastric cancer|recurrent gastric cancer
5388038|NCT00005607|stage IV esophageal cancer|stage iv esophageal cancer
5388039|NCT00005607|recurrent esophageal cancer|recurrent esophageal cancer
5388040|NCT00005607|adenocarcinoma of the stomach|adenocarcinoma of the stomach
5388041|NCT00005607|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
5388042|NCT00002574|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5388043|NCT00002574|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5388044|NCT00002562|recurrent cervical cancer|recurrent cervical cancer
5388045|NCT00002562|recurrent vaginal cancer|recurrent vaginal cancer
5388046|NCT00002562|vaginal clear cell adenocarcinoma|vaginal clear cell adenocarcinoma
5388047|NCT00002562|cervical adenocarcinoma|cervical adenocarcinoma
5388048|NCT00002507|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
5388049|NCT00002507|stage I adenoid cystic carcinoma of the oral cavity|stage i adenoid cystic carcinoma of the oral cavity
5388050|NCT00002507|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
5388051|NCT00002507|stage II adenoid cystic carcinoma of the oral cavity|stage ii adenoid cystic carcinoma of the oral cavity
5388052|NCT00002507|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
5388053|NCT00002507|stage III adenoid cystic carcinoma of the oral cavity|stage iii adenoid cystic carcinoma of the oral cavity
5388054|NCT00002507|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5388055|NCT00002507|stage IV adenoid cystic carcinoma of the oral cavity|stage iv adenoid cystic carcinoma of the oral cavity
5388056|NCT00002507|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
5388057|NCT00002507|recurrent adenoid cystic carcinoma of the oral cavity|recurrent adenoid cystic carcinoma of the oral cavity
5388058|NCT00002507|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
5388059|NCT00002507|stage I lymphoepithelioma of the oropharynx|stage i lymphoepithelioma of the oropharynx
5388060|NCT00002507|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
5388061|NCT00002507|stage II lymphoepithelioma of the oropharynx|stage ii lymphoepithelioma of the oropharynx
5388062|NCT00002507|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
5388063|NCT00002507|stage III lymphoepithelioma of the oropharynx|stage iii lymphoepithelioma of the oropharynx
5388064|NCT00002507|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5388065|NCT00002507|stage IV lymphoepithelioma of the oropharynx|stage iv lymphoepithelioma of the oropharynx
5388066|NCT00002507|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
5388067|NCT00002507|recurrent lymphoepithelioma of the oropharynx|recurrent lymphoepithelioma of the oropharynx
5388068|NCT00002507|stage I squamous cell carcinoma of the nasopharynx|stage i squamous cell carcinoma of the nasopharynx
5388069|NCT00002507|stage I lymphoepithelioma of the nasopharynx|stage i lymphoepithelioma of the nasopharynx
5388070|NCT00002507|stage II squamous cell carcinoma of the nasopharynx|stage ii squamous cell carcinoma of the nasopharynx
5388071|NCT00002507|stage II lymphoepithelioma of the nasopharynx|stage ii lymphoepithelioma of the nasopharynx
5388072|NCT00002507|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
5388073|NCT00002507|stage III lymphoepithelioma of the nasopharynx|stage iii lymphoepithelioma of the nasopharynx
5388074|NCT00002507|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
5388075|NCT00002507|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
5388076|NCT00002507|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
5388077|NCT00002507|recurrent lymphoepithelioma of the nasopharynx|recurrent lymphoepithelioma of the nasopharynx
5388078|NCT00002507|stage I squamous cell carcinoma of the hypopharynx|stage i squamous cell carcinoma of the hypopharynx
5388079|NCT00002507|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
5388080|NCT00002507|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
5388081|NCT00002507|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5388082|NCT00002507|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
5388083|NCT00002507|stage I squamous cell carcinoma of the larynx|stage i squamous cell carcinoma of the larynx
5388084|NCT00002507|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
5388085|NCT00002507|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
5388086|NCT00002507|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5388087|NCT00002507|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
5388088|NCT00002507|newly diagnosed carcinoma of unknown primary|newly diagnosed carcinoma of unknown primary
5388178|NCT00089505|HIV Seronegativity|hiv seronegativity
5388089|NCT00002507|recurrent carcinoma of unknown primary|recurrent carcinoma of unknown primary
5388090|NCT00089622|Parkinson's Disease|parkinson's disease
5388091|NCT00089622|Motor Fluctuations|motor fluctuations
5388092|NCT00089622|Intravenous Levodopa|intravenous levodopa
5388093|NCT00089622|Antiparkinsonian Response|antiparkinsonian response
5388094|NCT00089622|Lisuride Patch|lisuride patch
5388095|NCT00089622|Parkinson Disease|parkinson disease
5388096|NCT00089622|PD|pd
5388097|NCT00089609|Hormones|hormones
5388098|NCT00089609|Angiogenesis|angiogenesis
5388099|NCT00089609|Markers|markers
5388100|NCT00089609|Tumor|tumor
5388101|NCT00089609|Prostate Cancer|prostate cancer
5388102|NCT00089570|hepatorenal syndrome|hepatorenal syndrome
5388103|NCT00089570|terlipressin|terlipressin
5388104|NCT00089557|Dermal assessment|dermal assessment
5388105|NCT00089557|Pain assessment|pain assessment
5388106|NCT00089557|Diary|diary
5388107|NCT00089557|Analgesics|analgesics
5388108|NCT00089557|Capsaicin|capsaicin
5388109|NCT00089557|Herpes zoster|herpes zoster
5388110|NCT00089557|Neuralgia|neuralgia
5388111|NCT00089557|Pain|pain
5388112|NCT00089557|HIV Infections|hiv infections
5388113|NCT00089557|Peripheral Nervous System Diseases|peripheral nervous system diseases
5388114|NCT00089557|Diabetic Neuropathies|diabetic neuropathies
5388115|NCT00089557|Diabetes Mellitus|diabetes mellitus
5388116|NCT00089557|Polyneuropathies|polyneuropathies
5388117|NCT00089557|Complementary Therapies|complementary therapies
5388118|NCT00005591|stage III pancreatic cancer|stage iii pancreatic cancer
5388119|NCT00005591|recurrent pancreatic cancer|recurrent pancreatic cancer
5388120|NCT00005591|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
5388121|NCT00005591|stage IV pancreatic cancer|stage iv pancreatic cancer
5388122|NCT00005076|stage III colon cancer|stage iii colon cancer
5388123|NCT00005076|stage IV colon cancer|stage iv colon cancer
5388124|NCT00005076|stage III rectal cancer|stage iii rectal cancer
5388125|NCT00005076|stage IV rectal cancer|stage iv rectal cancer
5388126|NCT00005076|recurrent colon cancer|recurrent colon cancer
5388127|NCT00005076|recurrent rectal cancer|recurrent rectal cancer
5388128|NCT00005070|recurrent cervical cancer|recurrent cervical cancer
5388129|NCT00005070|stage IVB cervical cancer|stage ivb cervical cancer
5388130|NCT00005070|cervical squamous cell carcinoma|cervical squamous cell carcinoma
5388131|NCT00005070|cervical adenocarcinoma|cervical adenocarcinoma
5388132|NCT00005070|cervical adenosquamous cell carcinoma|cervical adenosquamous cell carcinoma
5388133|NCT00005057|stage IV melanoma|stage iv melanoma
5388134|NCT00005057|recurrent melanoma|recurrent melanoma
5388135|NCT00005057|lentigo maligna malignant melanoma|lentigo maligna malignant melanoma
5388136|NCT00005057|superficial spreading malignant melanoma|superficial spreading malignant melanoma
5388137|NCT00005057|acral lentiginous malignant melanoma|acral lentiginous malignant melanoma
5388138|NCT00005057|nodular malignant melanoma|nodular malignant melanoma
5388139|NCT00005056|stage I renal cell cancer|stage i renal cell cancer
5388140|NCT00005056|stage II renal cell cancer|stage ii renal cell cancer
5388141|NCT00005056|stage III renal cell cancer|stage iii renal cell cancer
5388142|NCT00005056|stage IV renal cell cancer|stage iv renal cell cancer
5388143|NCT00005056|recurrent renal cell cancer|recurrent renal cell cancer
5388144|NCT00004937|recurrent adult brain tumor|recurrent adult brain tumor
5388145|NCT00004937|adult glioblastoma|adult glioblastoma
5388146|NCT00004937|adult giant cell glioblastoma|adult giant cell glioblastoma
5388147|NCT00004937|adult gliosarcoma|adult gliosarcoma
5388148|NCT00004219|nausea and vomiting|nausea and vomiting
5388149|NCT00004219|stage I malignant testicular germ cell tumor|stage i malignant testicular germ cell tumor
5388150|NCT00004219|testicular seminoma|testicular seminoma
5388151|NCT00004215|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
5388152|NCT00004215|adult acute erythroid leukemia (M6)|adult acute erythroid leukemia (m6)
5388153|NCT00004215|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
5388154|NCT00004215|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
5388155|NCT00004215|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
5388156|NCT00004215|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
5388157|NCT00004215|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
5388158|NCT00004215|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
5388159|NCT00004215|anemia|anemia
5388160|NCT00004215|neutropenia|neutropenia
5388161|NCT00004215|thrombocytopenia|thrombocytopenia
5388162|NCT00004215|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
5388163|NCT00004207|stage IV breast cancer|stage iv breast cancer
5388164|NCT00004207|recurrent breast cancer|recurrent breast cancer
5388165|NCT00089531|Healthy|healthy
5388166|NCT00089531|Virus|virus
5388167|NCT00089531|T-Cells|t-cells
5388168|NCT00089531|HIV-Negative|hiv-negative
5388169|NCT00089531|Immunity|immunity
5388170|NCT00089531|Healthy Volunteer|healthy volunteer
5388171|NCT00089531|HV|hv
5388172|NCT00089531|HIV Preventive Vaccine|hiv preventive vaccine
5388173|NCT00089531|HIV Seronegativity|hiv seronegativity
5388174|NCT00089518|Treatment Experienced|treatment experienced
5388175|NCT00089505|Treatment Experienced|treatment experienced
5388176|NCT00089505|Treatment Naive|treatment naive
5388180|NCT00089466|CXCR4 Entry Inhibitors|cxcr4 entry inhibitors
5388181|NCT00089466|Treatment Experienced|treatment experienced
5388182|NCT00089466|Treatment Naive|treatment naive
5388183|NCT00089453|Myeloma|myeloma
5388184|NCT00089453|Transplant|transplant
5388185|NCT00089453|Relapsed|relapsed
5388186|NCT00089453|Donor|donor
5388187|NCT00089453|Stem Cell|stem cell
5388188|NCT00089453|Thalidomide|thalidomide
5388189|NCT00089453|Dexamethasone|dexamethasone
5388190|NCT00089453|Cisplatin|cisplatin
5388191|NCT00089453|Adriamycin|adriamycin
5388192|NCT00089453|Cyclophosphamide|cyclophosphamide
5388193|NCT00089453|Etoposide|etoposide
5388194|NCT00089453|Melphalan|melphalan
5388195|NCT00089427|brain tumor|brain tumor
5388196|NCT00089427|malignant glioma|malignant glioma
5388197|NCT00089427|brain neoplasm|brain neoplasm
5388198|NCT00089427|central nervous system|central nervous system
5388199|NCT00089427|surgery|surgery
5388200|NCT00089427|resection|resection
5388201|NCT00089427|temozolomide|temozolomide
5388202|NCT00089427|infusion|infusion
5388203|NCT00089427|glioblastoma multiforme|glioblastoma multiforme
5388204|NCT00089427|anaplastic astrocytoma|anaplastic astrocytoma
5388205|NCT00089427|oligoastrocytoma|oligoastrocytoma
5388206|NCT00089427|Temodar|temodar
5388207|NCT00089427|radiation|radiation
5388208|NCT00089427|convection-enhanced delivery|convection-enhanced delivery
5388209|NCT00089427|GBM|gbm
5388210|NCT00089414|Depression|depression
5388211|NCT00089414|Menstrual Cycle|menstrual cycle
5388212|NCT00089414|Gonadal Steroids|gonadal steroids
5388213|NCT00089414|Ethinyl Estradiol|ethinyl estradiol
5388214|NCT00089414|Drospirenone|drospirenone
5388215|NCT00089414|Menstrually Related Mood Disorder|menstrually related mood disorder
5388216|NCT00089414|MRMD|mrmd
5388217|NCT00089401|recurrent colon cancer|recurrent colon cancer
5388218|NCT00089401|stage IV colon cancer|stage iv colon cancer
5388219|NCT00089401|recurrent rectal cancer|recurrent rectal cancer
5388220|NCT00089401|stage IV rectal cancer|stage iv rectal cancer
5388221|NCT00089401|liver metastases|liver metastases
5388222|NCT00089323|stage IA breast cancer|stage ia breast cancer
5388223|NCT00089323|stage II breast cancer|stage ii breast cancer
5388224|NCT00089323|stage IIIA breast cancer|stage iiia breast cancer
5388225|NCT00089323|male breast cancer|male breast cancer
5388226|NCT00089323|stage IB breast cancer|stage ib breast cancer
5388227|NCT00089310|stage I non-small cell lung cancer|stage i non-small cell lung cancer
5388228|NCT00089297|Stage III head and neck cancer|stage iii head and neck cancer
5388229|NCT00089297|Stage IV head and neck cancer|stage iv head and neck cancer
5388230|NCT00089297|Cetuximab|cetuximab
5388233|NCT00089258|localized unresectable neuroblastoma|localized unresectable neuroblastoma
5388234|NCT00089258|disseminated neuroblastoma|disseminated neuroblastoma
5388235|NCT00089258|regional neuroblastoma|regional neuroblastoma
5388236|NCT00089258|stage 4S neuroblastoma|stage 4s neuroblastoma
5388237|NCT00089258|recurrent neuroblastoma|recurrent neuroblastoma
5388238|NCT00089245|leptomeningeal metastases|leptomeningeal metastases
5388239|NCT00089245|recurrent neuroblastoma|recurrent neuroblastoma
5388240|NCT00089245|disseminated neuroblastoma|disseminated neuroblastoma
5388241|NCT00089245|recurrent adult brain tumor|recurrent adult brain tumor
5388242|NCT00089245|recurrent childhood medulloblastoma|recurrent childhood medulloblastoma
5388243|NCT00089245|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
5388244|NCT00089245|recurrent childhood soft tissue sarcoma|recurrent childhood soft tissue sarcoma
5388245|NCT00089245|recurrent osteosarcoma|recurrent osteosarcoma
5388246|NCT00089245|recurrent Ewing sarcoma/peripheral primitive neuroectodermal tumor|recurrent ewing sarcoma/peripheral primitive neuroectodermal tumor
5388247|NCT00089245|childhood atypical teratoid/rhabdoid tumor|childhood atypical teratoid/rhabdoid tumor
5388248|NCT00089245|adult medulloblastoma|adult medulloblastoma
5388249|NCT00089245|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
5388250|NCT00089245|metastatic Ewing sarcoma/peripheral primitive neuroectodermal tumor|metastatic ewing sarcoma/peripheral primitive neuroectodermal tumor
5388251|NCT00089245|metastatic osteosarcoma|metastatic osteosarcoma
5388252|NCT00089245|childhood desmoplastic small round cell tumor|childhood desmoplastic small round cell tumor
5388253|NCT00089245|metastatic childhood soft tissue sarcoma|metastatic childhood soft tissue sarcoma
5388254|NCT00089245|adult rhabdomyosarcoma|adult rhabdomyosarcoma
5388255|NCT00089245|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
5388256|NCT00089245|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
5388257|NCT00089219|stage III melanoma|stage iii melanoma
5388258|NCT00089219|stage IV melanoma|stage iv melanoma
5388259|NCT00089219|recurrent melanoma|recurrent melanoma
5388260|NCT00089219|ciliary body and choroid melanoma, medium/large size|ciliary body and choroid melanoma, medium/large size
5388261|NCT00089219|extraocular extension melanoma|extraocular extension melanoma
5388262|NCT00089219|iris melanoma|iris melanoma
5388263|NCT00089219|recurrent intraocular melanoma|recurrent intraocular melanoma
5388264|NCT00089206|stage III melanoma|stage iii melanoma
5388265|NCT00089206|stage IV melanoma|stage iv melanoma
5388266|NCT00089206|recurrent melanoma|recurrent melanoma
5388267|NCT00089206|recurrent intraocular melanoma|recurrent intraocular melanoma
5388268|NCT00089206|iris melanoma|iris melanoma
5388269|NCT00089206|extraocular extension melanoma|extraocular extension melanoma
5388270|NCT00089206|ciliary body and choroid melanoma, medium/large size|ciliary body and choroid melanoma, medium/large size
5388271|NCT00089193|stage II melanoma|stage ii melanoma
5388272|NCT00089193|stage III melanoma|stage iii melanoma
5388273|NCT00089193|stage IV melanoma|stage iv melanoma
5388274|NCT00089193|recurrent melanoma|recurrent melanoma
5388275|NCT00089167|primary systemic amyloidosis|primary systemic amyloidosis
5388276|NCT00089141|graft versus host disease|graft versus host disease
5388277|NCT00089141|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5388278|NCT00089141|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5388279|NCT00089141|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5388280|NCT00089141|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
5388281|NCT00089141|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
5388282|NCT00089141|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
5388283|NCT00089141|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5388284|NCT00089141|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
5388285|NCT00089141|chronic eosinophilic leukemia|chronic eosinophilic leukemia
5388286|NCT00089141|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
5388287|NCT00089141|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5388288|NCT00089141|chronic neutrophilic leukemia|chronic neutrophilic leukemia
5388289|NCT00089141|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5388290|NCT00089141|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5388291|NCT00089141|disseminated neuroblastoma|disseminated neuroblastoma
5388292|NCT00089141|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5388293|NCT00089141|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
5388294|NCT00089141|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
5388295|NCT00089141|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5388296|NCT00089141|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
5388297|NCT00089141|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5388298|NCT00089141|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
5388299|NCT00089141|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
5388300|NCT00089141|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
5388301|NCT00089141|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
5388302|NCT00089141|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5388303|NCT00089141|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5388304|NCT00089141|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5388305|NCT00089141|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5388306|NCT00089141|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
5388307|NCT00089141|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
5388308|NCT00089141|poor prognosis metastatic gestational trophoblastic tumor|poor prognosis metastatic gestational trophoblastic tumor
5388309|NCT00089141|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
5388310|NCT00089141|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5388311|NCT00089141|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5388312|NCT00089141|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5388313|NCT00089141|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5388314|NCT00089141|stage I multiple myeloma|stage i multiple myeloma
5388315|NCT00089141|stage II multiple myeloma|stage ii multiple myeloma
5388316|NCT00089141|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
5388317|NCT00089141|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5388318|NCT00089141|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5388319|NCT00089141|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5388320|NCT00089141|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5388321|NCT00089141|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5388322|NCT00089141|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5388323|NCT00089141|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5388324|NCT00089141|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5388325|NCT00089141|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5388326|NCT00089141|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5388327|NCT00089141|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5388328|NCT00089141|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5388329|NCT00089141|stage III multiple myeloma|stage iii multiple myeloma
5388330|NCT00089141|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5388331|NCT00089141|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5388332|NCT00089141|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
5395232|NCT00003646|solid tumor|solid tumor
5388333|NCT00089141|stage IIIA breast cancer|stage iiia breast cancer
5388334|NCT00089141|stage IIIB breast cancer|stage iiib breast cancer
5388335|NCT00089141|stage IIIC breast cancer|stage iiic breast cancer
5388336|NCT00089141|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5388337|NCT00089141|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5388338|NCT00089141|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5388339|NCT00089141|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5388340|NCT00089141|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5388341|NCT00089141|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5388342|NCT00089141|stage IV breast cancer|stage iv breast cancer
5388343|NCT00089141|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5388344|NCT00089141|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5388345|NCT00089141|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5388346|NCT00089141|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5388347|NCT00089141|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5388348|NCT00089141|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5388349|NCT00089141|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5388350|NCT00089141|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5388351|NCT00089141|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
5388352|NCT00089128|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
5388353|NCT00089128|recurrent bladder cancer|recurrent bladder cancer
5388354|NCT00089128|stage III bladder cancer|stage iii bladder cancer
5388355|NCT00089128|stage IV bladder cancer|stage iv bladder cancer
5388356|NCT00089115|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
5388357|NCT00089115|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
5388358|NCT00089115|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
5388359|NCT00089115|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5388360|NCT00089115|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5388361|NCT00089115|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5388362|NCT00089115|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
5388363|NCT00089115|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
5388364|NCT00089115|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
5388365|NCT00089115|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5388366|NCT00089115|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5388367|NCT00089115|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5388368|NCT00089115|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5388369|NCT00089115|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5388370|NCT00089115|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5388371|NCT00089115|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5388372|NCT00089115|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5388373|NCT00089115|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5388374|NCT00089102|recurrent renal cell cancer|recurrent renal cell cancer
5388375|NCT00089102|stage III renal cell cancer|stage iii renal cell cancer
5388376|NCT00089102|stage IV renal cell cancer|stage iv renal cell cancer
5388377|NCT00089050|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5388378|NCT00089050|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
5388379|NCT00089050|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
5388380|NCT00089050|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
5388381|NCT00089050|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
5388382|NCT00089050|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
5388383|NCT00089050|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
5388384|NCT00089050|adult erythroleukemia (M6a)|adult erythroleukemia (m6a)
5388385|NCT00089050|adult pure erythroid leukemia (M6b)|adult pure erythroid leukemia (m6b)
5388386|NCT00089050|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
5388387|NCT00089050|adult acute basophilic leukemia|adult acute basophilic leukemia
5388388|NCT00089050|adult acute eosinophilic leukemia|adult acute eosinophilic leukemia
5388389|NCT00089050|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5388390|NCT00089050|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5388391|NCT00089050|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5388392|NCT00089050|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5388393|NCT00089037|graft versus host disease|graft versus host disease
5388394|NCT00089037|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5388395|NCT00089037|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
5388396|NCT00089037|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5388397|NCT00089037|chronic eosinophilic leukemia|chronic eosinophilic leukemia
5388671|NCT00003786|stage IV rectal cancer|stage iv rectal cancer
5388398|NCT00089037|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
5388399|NCT00089037|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5388400|NCT00089037|chronic neutrophilic leukemia|chronic neutrophilic leukemia
5388401|NCT00089037|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
5388402|NCT00089037|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5388403|NCT00089037|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5388404|NCT00089037|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5388405|NCT00089037|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5388406|NCT00089037|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5388407|NCT00089037|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5388408|NCT00089037|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5388409|NCT00089037|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
5388410|NCT00089037|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
5388411|NCT00089037|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5388412|NCT00089037|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5388413|NCT00089037|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5388414|NCT00089037|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5388415|NCT00089037|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5388416|NCT00089037|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5388417|NCT00089037|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5388418|NCT00089037|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5388419|NCT00089037|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5388420|NCT00089037|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5388421|NCT00089037|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5388422|NCT00089037|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5388423|NCT00089037|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5388424|NCT00089037|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5388425|NCT00089037|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5388426|NCT00089037|refractory hairy cell leukemia|refractory hairy cell leukemia
5388427|NCT00089037|refractory multiple myeloma|refractory multiple myeloma
5388428|NCT00089037|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5388429|NCT00089037|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5388430|NCT00089037|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5388431|NCT00089037|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
5388432|NCT00089037|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5388433|NCT00089037|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5388434|NCT00089037|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5388435|NCT00089037|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
5388436|NCT00089037|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
5388437|NCT00089037|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
5388438|NCT00089037|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
5388439|NCT00089037|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5388440|NCT00089037|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5388441|NCT00089037|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5388442|NCT00089037|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5388443|NCT00089037|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
5388444|NCT00089037|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
5388445|NCT00089037|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5388446|NCT00089037|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5388447|NCT00089037|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5388448|NCT00089037|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5388449|NCT00089037|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5388450|NCT00089037|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5388451|NCT00089037|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5388452|NCT00089037|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5388453|NCT00089037|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5388454|NCT00089037|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5388455|NCT00089037|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5388456|NCT00089037|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5388457|NCT00089037|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5388458|NCT00089037|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5388459|NCT00089037|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5388460|NCT00089037|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5388461|NCT00089037|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5388462|NCT00089037|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5388463|NCT00089037|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5388464|NCT00089037|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5388465|NCT00089037|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
5388466|NCT00089037|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5388467|NCT00089037|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5388468|NCT00089037|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
5388469|NCT00089037|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
5388470|NCT00089037|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
5388471|NCT00089037|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
5388472|NCT00089037|untreated childhood acute myeloid leukemia and other myeloid malignancies|untreated childhood acute myeloid leukemia and other myeloid malignancies
5388473|NCT00089037|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
5388474|NCT00089037|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
5388475|NCT00089037|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5388476|NCT00089037|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
5388477|NCT00089037|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
5388478|NCT00089037|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5388479|NCT00089037|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5388480|NCT00089037|stage I multiple myeloma|stage i multiple myeloma
5388481|NCT00089037|stage II multiple myeloma|stage ii multiple myeloma
5388482|NCT00089037|stage III multiple myeloma|stage iii multiple myeloma
5388483|NCT00089037|refractory cytopenia with multilineage dysplasia|refractory cytopenia with multilineage dysplasia
5388484|NCT00089037|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5388485|NCT00089037|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5388486|NCT00089024|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
5388487|NCT00089024|stage II pancreatic cancer|stage ii pancreatic cancer
5388488|NCT00089024|stage III pancreatic cancer|stage iii pancreatic cancer
5388489|NCT00088998|male breast cancer|male breast cancer
5388490|NCT00088998|recurrent breast cancer|recurrent breast cancer
5388491|NCT00088998|stage IV breast cancer|stage iv breast cancer
5388492|NCT00088985|recurrent breast cancer|recurrent breast cancer
5388493|NCT00088985|stage IIIB breast cancer|stage iiib breast cancer
5388494|NCT00088985|stage IIIC breast cancer|stage iiic breast cancer
5388495|NCT00088985|stage IV breast cancer|stage iv breast cancer
5388496|NCT00088972|breast cancer|breast cancer
5388497|NCT00088972|breast cancer in situ|breast cancer in situ
5388498|NCT00088972|lobular breast carcinoma in situ|lobular breast carcinoma in situ
5388499|NCT00088972|ductal breast carcinoma|ductal breast carcinoma
5388500|NCT00088946|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
5388501|NCT00088946|stage 0 bladder cancer|stage 0 bladder cancer
5388502|NCT00088946|stage I bladder cancer|stage i bladder cancer
5388503|NCT00088907|docetaxel|docetaxel
5388504|NCT00088907|gefitinib|gefitinib
5388505|NCT00088907|head and neck cancer|head and neck cancer
5388506|NCT00088868|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5388507|NCT00088868|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5388508|NCT00088868|intraocular lymphoma|intraocular lymphoma
5388509|NCT00088868|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5388510|NCT00088868|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5388511|NCT00088868|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5388512|NCT00088868|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5388513|NCT00088868|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5388514|NCT00088868|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5388515|NCT00088868|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5388516|NCT00088868|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5388517|NCT00088868|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5388518|NCT00088868|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5388519|NCT00088868|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5388520|NCT00088868|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5388521|NCT00088868|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5388522|NCT00088868|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5388523|NCT00088868|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5388524|NCT00088868|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5388525|NCT00088868|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5388526|NCT00088868|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5388527|NCT00088868|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5388528|NCT00088868|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5388529|NCT00088868|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5388530|NCT00088868|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5388531|NCT00088868|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5388532|NCT00088868|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5388533|NCT00088868|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5388534|NCT00088868|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5388535|NCT00088868|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5388536|NCT00088868|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5388537|NCT00088868|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5388538|NCT00088868|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5388539|NCT00088868|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5388540|NCT00088868|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5388541|NCT00088868|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5388542|NCT00088868|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
5388543|NCT00088868|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
5388544|NCT00088868|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5388545|NCT00088868|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5388546|NCT00088868|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5388547|NCT00088868|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5388548|NCT00088868|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5388549|NCT00088868|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5388550|NCT00088868|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5388551|NCT00088868|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
5388552|NCT00088868|small intestine lymphoma|small intestine lymphoma
5388553|NCT00088868|Waldenström macroglobulinemia|waldenström macroglobulinemia
5388554|NCT00088868|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5388555|NCT00088868|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
5388556|NCT00088868|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
5388557|NCT00088868|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
5388558|NCT00088868|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
5388559|NCT00088868|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
5388560|NCT00088868|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5388561|NCT00088868|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5388562|NCT00088868|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5388563|NCT00088829|stage II breast cancer|stage ii breast cancer
5388564|NCT00088829|stage IIIA breast cancer|stage iiia breast cancer
5388565|NCT00088829|stage IIIB breast cancer|stage iiib breast cancer
5388566|NCT00088829|stage IIIC breast cancer|stage iiic breast cancer
5388567|NCT00088829|stage IV breast cancer|stage iv breast cancer
5388568|NCT00088829|stage IA breast cancer|stage ia breast cancer
5388569|NCT00088829|stage IB breast cancer|stage ib breast cancer
5388570|NCT00088829|HER2-negative breast cancer|her2-negative breast cancer
5388571|NCT00088829|HER2-positive breast cancer|her2-positive breast cancer
5388572|NCT00088816|stage IV gastric cancer|stage iv gastric cancer
5388573|NCT00088816|adenocarcinoma of the stomach|adenocarcinoma of the stomach
5388574|NCT00088803|recurrent Wilms tumor and other childhood kidney tumors|recurrent wilms tumor and other childhood kidney tumors
5388575|NCT00088803|stage I Wilms tumor|stage i wilms tumor
5388576|NCT00088803|stage II Wilms tumor|stage ii wilms tumor
5388577|NCT00088803|stage III Wilms tumor|stage iii wilms tumor
5388578|NCT00088803|stage IV Wilms tumor|stage iv wilms tumor
5388579|NCT00088803|stage V Wilms tumor|stage v wilms tumor
5388580|NCT00088790|advanced, solid, malignancies|advanced, solid, malignancies
5388581|NCT00088764|Stress|stress
5388582|NCT00088764|Coping|coping
5388583|NCT00088764|Expressive Writing|expressive writing
5388584|NCT00088764|Self-Efficacy|self-efficacy
5388585|NCT00088764|Disclosure|disclosure
5388586|NCT00004193|stage IV colon cancer|stage iv colon cancer
5388587|NCT00004193|stage IV rectal cancer|stage iv rectal cancer
5388588|NCT00004193|recurrent colon cancer|recurrent colon cancer
5388589|NCT00004193|recurrent rectal cancer|recurrent rectal cancer
5388590|NCT00004193|adenocarcinoma of the colon|adenocarcinoma of the colon
5388591|NCT00004193|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5388592|NCT00004187|stage III colon cancer|stage iii colon cancer
5388593|NCT00004187|stage IV colon cancer|stage iv colon cancer
5388594|NCT00004187|stage III rectal cancer|stage iii rectal cancer
5388595|NCT00004187|stage IV rectal cancer|stage iv rectal cancer
5388596|NCT00004187|recurrent colon cancer|recurrent colon cancer
5388597|NCT00004187|recurrent rectal cancer|recurrent rectal cancer
5388598|NCT00004186|limited stage small cell lung cancer|limited stage small cell lung cancer
5388599|NCT00004186|extensive stage small cell lung cancer|extensive stage small cell lung cancer
5388600|NCT00004186|recurrent small cell lung cancer|recurrent small cell lung cancer
5388601|NCT00004162|AIDS-related diffuse large cell lymphoma|aids-related diffuse large cell lymphoma
5388602|NCT00004162|AIDS-related immunoblastic large cell lymphoma|aids-related immunoblastic large cell lymphoma
5388603|NCT00004162|AIDS-related small noncleaved cell lymphoma|aids-related small noncleaved cell lymphoma
5388604|NCT00004162|AIDS-related diffuse mixed cell lymphoma|aids-related diffuse mixed cell lymphoma
5388605|NCT00004162|AIDS-related diffuse small cleaved cell lymphoma|aids-related diffuse small cleaved cell lymphoma
5388606|NCT00004162|AIDS-related lymphoblastic lymphoma|aids-related lymphoblastic lymphoma
5388607|NCT00004096|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5388608|NCT00004096|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5388609|NCT00004080|recurrent adult brain tumor|recurrent adult brain tumor
5388610|NCT00004080|adult glioblastoma|adult glioblastoma
5388611|NCT00004080|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5388612|NCT00004080|adult mixed glioma|adult mixed glioma
5388613|NCT00004080|adult giant cell glioblastoma|adult giant cell glioblastoma
5388614|NCT00004080|adult gliosarcoma|adult gliosarcoma
5388615|NCT00004064|stage I ovarian epithelial cancer|stage i ovarian epithelial cancer
5388616|NCT00004064|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
5388617|NCT00004064|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5388618|NCT00004064|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5388619|NCT00004064|fallopian tube cancer|fallopian tube cancer
5388620|NCT00004064|primary peritoneal cavity cancer|primary peritoneal cavity cancer
5388621|NCT00004040|stage I multiple myeloma|stage i multiple myeloma
5388622|NCT00004040|stage II multiple myeloma|stage ii multiple myeloma
5388623|NCT00004040|stage III multiple myeloma|stage iii multiple myeloma
5388624|NCT00004040|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
5388625|NCT00004040|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
5388626|NCT00004040|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5388627|NCT00004040|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5388628|NCT00004040|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
5388629|NCT00004039|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
5388630|NCT00004039|stage II grade 3 follicular lymphoma|stage ii grade 3 follicular lymphoma
5388631|NCT00004039|stage II adult diffuse small cleaved cell lymphoma|stage ii adult diffuse small cleaved cell lymphoma
5388632|NCT00004039|stage II adult diffuse mixed cell lymphoma|stage ii adult diffuse mixed cell lymphoma
5388633|NCT00004039|stage II adult diffuse large cell lymphoma|stage ii adult diffuse large cell lymphoma
5388634|NCT00004039|stage II adult immunoblastic large cell lymphoma|stage ii adult immunoblastic large cell lymphoma
5388635|NCT00004039|stage II adult Burkitt lymphoma|stage ii adult burkitt lymphoma
5388636|NCT00004039|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5388637|NCT00004039|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5388638|NCT00004039|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5388639|NCT00004039|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5388640|NCT00004039|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5388641|NCT00004039|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5388642|NCT00004039|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5388643|NCT00004039|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5388644|NCT00004039|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5388645|NCT00004039|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5388646|NCT00004039|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5388647|NCT00004039|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5388648|NCT00004039|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5388649|NCT00004039|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5388650|NCT00004039|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5388651|NCT00004039|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5388652|NCT00004039|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5388653|NCT00004039|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5388654|NCT00003957|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5388655|NCT00003957|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5388656|NCT00003957|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5388657|NCT00003957|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5388658|NCT00003892|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5388659|NCT00003892|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5388660|NCT00003828|stage IV melanoma|stage iv melanoma
5388661|NCT00003828|recurrent melanoma|recurrent melanoma
5388662|NCT00003821|recurrent endometrial carcinoma|recurrent endometrial carcinoma
5388663|NCT00003810|stage III pancreatic cancer|stage iii pancreatic cancer
5388664|NCT00003810|stage IV pancreatic cancer|stage iv pancreatic cancer
5388665|NCT00003810|recurrent pancreatic cancer|recurrent pancreatic cancer
5388666|NCT00003810|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
5388667|NCT00003798|stage II pancreatic cancer|stage ii pancreatic cancer
5388668|NCT00003798|stage III pancreatic cancer|stage iii pancreatic cancer
5388669|NCT00003798|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
5388670|NCT00003786|stage IV colon cancer|stage iv colon cancer
5388672|NCT00003786|recurrent colon cancer|recurrent colon cancer
5388673|NCT00003786|recurrent rectal cancer|recurrent rectal cancer
5388674|NCT00003786|adenocarcinoma of the colon|adenocarcinoma of the colon
5388675|NCT00003786|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5388676|NCT00003784|Waldenström macroglobulinemia|waldenström macroglobulinemia
5388677|NCT00003784|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5388678|NCT00003784|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5388679|NCT00003784|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5388680|NCT00003784|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5388681|NCT00003784|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5388682|NCT00003784|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5388683|NCT00003784|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
5388684|NCT00003784|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
5388685|NCT00003784|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
5388686|NCT00003784|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5388687|NCT00003784|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5388688|NCT00003784|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5388689|NCT00003760|stage III pancreatic cancer|stage iii pancreatic cancer
5388690|NCT00003760|stage IV pancreatic cancer|stage iv pancreatic cancer
5388691|NCT00003760|recurrent pancreatic cancer|recurrent pancreatic cancer
5388692|NCT00003760|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
5388693|NCT00003708|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5388694|NCT00003681|refractory anemia|refractory anemia
5388695|NCT00003681|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
5388696|NCT00003681|refractory anemia with excess blasts|refractory anemia with excess blasts
5388697|NCT00003681|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5388698|NCT00003681|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5388699|NCT00003681|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5388700|NCT00003681|anemia|anemia
5388701|NCT00003663|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
5388702|NCT00003663|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5388703|NCT00003663|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5388704|NCT00003663|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5388705|NCT00003663|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5388706|NCT00003663|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5388707|NCT00003663|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5388708|NCT00003663|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5388709|NCT00003663|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5388710|NCT00003663|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5388711|NCT00003663|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5388712|NCT00003663|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5388713|NCT00003663|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5388714|NCT00003663|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5388715|NCT00003663|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5388716|NCT00003663|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5388717|NCT00003663|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5388718|NCT00003663|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5388719|NCT00003663|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5388720|NCT00003662|noninvasive thymoma and thymic carcinoma|noninvasive thymoma and thymic carcinoma
5388721|NCT00003662|recurrent thymoma and thymic carcinoma|recurrent thymoma and thymic carcinoma
5388722|NCT00003662|refractory anemia|refractory anemia
5388723|NCT00003662|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
5388724|NCT00003662|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5388725|NCT00003662|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5388726|NCT00003662|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5388727|NCT00003662|graft versus host disease|graft versus host disease
5388728|NCT00003662|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
5388729|NCT00003661|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5388730|NCT00003661|stage 4S neuroblastoma|stage 4s neuroblastoma
5388731|NCT00003661|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
5388732|NCT00003661|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5388733|NCT00003661|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5388734|NCT00003661|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5388735|NCT00003661|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5388736|NCT00003661|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5388737|NCT00003661|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
5388804|NCT00088751|Atypical Antipsychotic|atypical antipsychotic
5388738|NCT00003661|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
5388739|NCT00003661|refractory anemia with excess blasts|refractory anemia with excess blasts
5388740|NCT00003661|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
5388741|NCT00003661|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5388742|NCT00003661|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5388743|NCT00003661|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5388744|NCT00003661|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5388745|NCT00003661|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5388746|NCT00003661|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5388747|NCT00003661|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5388748|NCT00003661|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5388749|NCT00003661|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5388750|NCT00003661|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5388751|NCT00003661|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5388752|NCT00003661|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5388753|NCT00003661|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5388754|NCT00003661|graft versus host disease|graft versus host disease
5388755|NCT00003661|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
5388756|NCT00003661|childhood acute minimally differentiated myeloid leukemia (M0)|childhood acute minimally differentiated myeloid leukemia (m0)
5388757|NCT00003661|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
5388758|NCT00003661|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
5388759|NCT00003661|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5388760|NCT00003661|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5388761|NCT00003661|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5388762|NCT00003661|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5388763|NCT00003661|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5388764|NCT00003661|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5388765|NCT00003661|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
5388766|NCT00003605|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
5388767|NCT00003605|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5388768|NCT00003605|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5388769|NCT00003605|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5388770|NCT00003605|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5388771|NCT00003605|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5388772|NCT00003605|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5388773|NCT00003605|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5388774|NCT00003605|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5388775|NCT00003605|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5388776|NCT00003605|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5388777|NCT00003605|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5388778|NCT00003605|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5388779|NCT00003605|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5388780|NCT00003605|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5388781|NCT00003605|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5388782|NCT00003542|stage III renal cell cancer|stage iii renal cell cancer
5388783|NCT00003542|stage IV renal cell cancer|stage iv renal cell cancer
5388784|NCT00003539|stage IV breast cancer|stage iv breast cancer
5388785|NCT00003539|recurrent breast cancer|recurrent breast cancer
5388786|NCT00003431|stage IV colon cancer|stage iv colon cancer
5388787|NCT00003431|lung metastases|lung metastases
5388788|NCT00003431|liver metastases|liver metastases
5388789|NCT00003424|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
5388790|NCT00003424|advanced adult primary liver cancer|advanced adult primary liver cancer
5388791|NCT00003424|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
5388792|NCT00088673|Alzheimer Disease|alzheimer disease
5388793|NCT00003416|Waldenström macroglobulinemia|waldenström macroglobulinemia
5388794|NCT00003415|refractory anemia with excess blasts|refractory anemia with excess blasts
5388795|NCT00003415|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
5388796|NCT00003415|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5388797|NCT00003415|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5388798|NCT00003415|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5388799|NCT00003413|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5388800|NCT00003413|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5388801|NCT00003413|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5388802|NCT00088751|Frontotemporal Dementia|frontotemporal dementia
5388803|NCT00088751|Alzheimer's Disease|alzheimer's disease
5388807|NCT00088751|Disinhibition|disinhibition
5388808|NCT00088751|Antipsychotic|antipsychotic
5388809|NCT00088751|Biomarkers|biomarkers
5388810|NCT00088751|Dementia|dementia
5388811|NCT00088751|FTD|ftd
5388812|NCT00088738|Tachykinin|tachykinin
5388813|NCT00088738|Anxiety|anxiety
5388814|NCT00088738|Neuroreceptor|neuroreceptor
5388815|NCT00088738|Internalization|internalization
5388816|NCT00088738|Carbon Dioxide|carbon dioxide
5388817|NCT00088738|Healthy Volunteer|healthy volunteer
5388818|NCT00088738|HV|hv
5388819|NCT00088738|Panic Disorder|panic disorder
5388820|NCT00088712|Behavior and Neurocognition|behavior and neurocognition
5388821|NCT00088712|Functional Brian Activity|functional brian activity
5388822|NCT00088712|Visual Perception|visual perception
5388823|NCT00088712|Selective Attention|selective attention
5388824|NCT00088712|Information Processing|information processing
5388825|NCT00088712|Age Differences|age differences
5388826|NCT00088712|Childhood Growth and Development|childhood growth and development
5388827|NCT00088712|Cognitive Development|cognitive development
5388828|NCT00088712|Brain Connectivity|brain connectivity
5388829|NCT00088712|Healthy Volunteer|healthy volunteer
5388830|NCT00088712|HV|hv
5388831|NCT00088699|Depression|depression
5388832|NCT00088699|NMDA Antagonist|nmda antagonist
5388833|NCT00088699|Treatment Resistant|treatment resistant
5388834|NCT00088699|Glutamatergic System|glutamatergic system
5388835|NCT00088699|Bipolar Disorder|bipolar disorder
5388836|NCT00088699|Major Depression|major depression
5388837|NCT00088686|Preemptive Analgesia|preemptive analgesia
5388838|NCT00088686|Vanilloid|vanilloid
5388839|NCT00088686|Capsaicin|capsaicin
5388840|NCT00088686|Acute Pain|acute pain
5388841|NCT00088686|Orofacial|orofacial
5388842|NCT00088686|Vanilloid Receptor (VR)|vanilloid receptor (vr)
5388843|NCT00088686|Visual Analog Scale (VAS)|visual analog scale (vas)
5388844|NCT00088686|Wisdom Teeth|wisdom teeth
5388845|NCT00088686|Third Molar Extraction|third molar extraction
5388846|NCT00088660|Metastatic|metastatic
5388847|NCT00088647|advanced malignant solid tumors|advanced malignant solid tumors
5388848|NCT00088647|breast cancer|breast cancer
5388849|NCT00088634|Schizophrenia|schizophrenia
5388850|NCT00088634|Latuda|latuda
5388851|NCT00088634|Lurasidone|lurasidone
5388852|NCT00088621|Schizophrenia|schizophrenia
5388853|NCT00088621|Latuda|latuda
5388854|NCT00088621|Lurasidone|lurasidone
5388855|NCT00088595|SOM230|som230
5388856|NCT00088595|Sandostatin|sandostatin
5388857|NCT00088595|Carcinoid syndrome|carcinoid syndrome
5388858|NCT00088582|Acromegaly|acromegaly
5388859|NCT00088582|SOM230|som230
5388860|NCT00088582|Sandostatin|sandostatin
5388861|NCT00003358|stage I ovarian epithelial cancer|stage i ovarian epithelial cancer
5388862|NCT00003358|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
5388863|NCT00003358|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5388864|NCT00003358|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5388865|NCT00003358|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5388866|NCT00003358|fallopian tube cancer|fallopian tube cancer
5388867|NCT00003358|primary peritoneal cavity cancer|primary peritoneal cavity cancer
5388868|NCT00003305|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5388869|NCT00003305|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5388870|NCT00003305|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5388871|NCT00003305|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5388872|NCT00003259|stage IV prostate cancer|stage iv prostate cancer
5388873|NCT00003256|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5388874|NCT00003256|stage IV prostate cancer|stage iv prostate cancer
5388875|NCT00003214|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5388876|NCT00003214|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5388877|NCT00003213|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5388878|NCT00003213|nausea and vomiting|nausea and vomiting
5388879|NCT00003182|stage III nasopharyngeal cancer|stage iii nasopharyngeal cancer
5388880|NCT00003182|stage IV nasopharyngeal cancer|stage iv nasopharyngeal cancer
5388881|NCT00003182|recurrent nasopharyngeal cancer|recurrent nasopharyngeal cancer
5388882|NCT00003182|stage III salivary gland cancer|stage iii salivary gland cancer
5388883|NCT00003182|stage IV salivary gland cancer|stage iv salivary gland cancer
5388884|NCT00003182|recurrent salivary gland cancer|recurrent salivary gland cancer
5388885|NCT00003182|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
5388886|NCT00003182|stage III lip and oral cavity cancer|stage iii lip and oral cavity cancer
5388887|NCT00003182|stage IV lip and oral cavity cancer|stage iv lip and oral cavity cancer
5388888|NCT00003182|recurrent lip and oral cavity cancer|recurrent lip and oral cavity cancer
5388889|NCT00003182|stage III hypopharyngeal cancer|stage iii hypopharyngeal cancer
5388890|NCT00003182|stage IV hypopharyngeal cancer|stage iv hypopharyngeal cancer
5388891|NCT00003182|recurrent hypopharyngeal cancer|recurrent hypopharyngeal cancer
5388892|NCT00003182|stage III laryngeal cancer|stage iii laryngeal cancer
5388893|NCT00003182|stage IV laryngeal cancer|stage iv laryngeal cancer
5388894|NCT00003182|recurrent laryngeal cancer|recurrent laryngeal cancer
5388895|NCT00003182|stage III paranasal sinus and nasal cavity cancer|stage iii paranasal sinus and nasal cavity cancer
5388896|NCT00003182|stage IV paranasal sinus and nasal cavity cancer|stage iv paranasal sinus and nasal cavity cancer
5388897|NCT00003182|recurrent paranasal sinus and nasal cavity cancer|recurrent paranasal sinus and nasal cavity cancer
5388898|NCT00003182|stage III oropharyngeal cancer|stage iii oropharyngeal cancer
5388899|NCT00003182|stage IV oropharyngeal cancer|stage iv oropharyngeal cancer
5388900|NCT00003182|recurrent oropharyngeal cancer|recurrent oropharyngeal cancer
5388901|NCT00003182|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
5388902|NCT00003182|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5388903|NCT00003182|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
5388904|NCT00003182|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
5388905|NCT00003182|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5388906|NCT00003182|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
5388907|NCT00003182|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
5388908|NCT00003182|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
5388909|NCT00003182|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
5388910|NCT00003182|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
5388911|NCT00003182|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5388912|NCT00003182|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
5388913|NCT00003182|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
5388914|NCT00003182|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5388915|NCT00003182|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
5388916|NCT00003182|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
5388917|NCT00003182|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
5388918|NCT00003182|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
5388919|NCT00003158|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5388920|NCT00003158|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5388921|NCT00003152|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5388922|NCT00003152|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5388923|NCT00003152|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5388924|NCT00003152|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5388925|NCT00003152|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5388926|NCT00003152|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5388927|NCT00003097|basal cell carcinoma of the skin|basal cell carcinoma of the skin
5388928|NCT00003097|squamous cell carcinoma of the skin|squamous cell carcinoma of the skin
5388929|NCT00003090|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5388930|NCT00003087|stage II esophageal cancer|stage ii esophageal cancer
5388931|NCT00003087|stage III esophageal cancer|stage iii esophageal cancer
5388932|NCT00003087|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
5388933|NCT00003087|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
5388934|NCT00003068|stage IV breast cancer|stage iv breast cancer
5388935|NCT00003068|stage IIIA breast cancer|stage iiia breast cancer
5388936|NCT00003068|recurrent breast cancer|recurrent breast cancer
5388937|NCT00003068|stage IIIB breast cancer|stage iiib breast cancer
5388938|NCT00003068|drug/agent toxicity by tissue/organ|drug/agent toxicity by tissue/organ
5388939|NCT00088569|Frontal Lobe|frontal lobe
5388940|NCT00088569|Working Memory|working memory
5388941|NCT00088569|Treatment|treatment
5388942|NCT00088569|Transcranial|transcranial
5388943|NCT00088569|Electrical|electrical
5388944|NCT00088569|Healthy Volunteer|healthy volunteer
5388945|NCT00088569|HV|hv
5388946|NCT00088556|Non-small cell lung cancer|non-small cell lung cancer
5388947|NCT00088543|Acute myelogenous leukemia (AML)|acute myelogenous leukemia (aml)
5388948|NCT00088543|Acute lymphocytic leukemia (ALL)|acute lymphocytic leukemia (all)
5388949|NCT00088543|Anti-T cell antibodies|anti-t cell antibodies
5388950|NCT00088543|Allogenic stem cell transplant|allogenic stem cell transplant
5388951|NCT00088543|Graft vs. Host Disease (GvHD)|graft vs. host disease (gvhd)
5388952|NCT00003055|stage III gastric cancer|stage iii gastric cancer
5388953|NCT00003055|stage IV gastric cancer|stage iv gastric cancer
5388954|NCT00003055|recurrent gastric cancer|recurrent gastric cancer
5388955|NCT00003055|stage III esophageal cancer|stage iii esophageal cancer
5388956|NCT00003055|stage IV esophageal cancer|stage iv esophageal cancer
5388957|NCT00003055|recurrent esophageal cancer|recurrent esophageal cancer
5388958|NCT00003055|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
5388959|NCT00003050|stage II breast cancer|stage ii breast cancer
5388960|NCT00003050|stage IIIA breast cancer|stage iiia breast cancer
5388961|NCT00003050|stage IIIB breast cancer|stage iiib breast cancer
5388962|NCT00003002|stage III breast cancer|stage iii breast cancer
5388963|NCT00003002|stage IV breast cancer|stage iv breast cancer
5388964|NCT00003002|stage III non-small cell lung cancer|stage iii non-small cell lung cancer
5388965|NCT00003002|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5388966|NCT00003002|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5388967|NCT00003002|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5388968|NCT00003002|adenocarcinoma of the lung|adenocarcinoma of the lung
5388969|NCT00003000|pain|pain
5388970|NCT00002984|stage II esophageal cancer|stage ii esophageal cancer
5388971|NCT00002984|stage III esophageal cancer|stage iii esophageal cancer
5388972|NCT00002984|stage IV esophageal cancer|stage iv esophageal cancer
5388973|NCT00002984|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
5388974|NCT00002984|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
5388975|NCT00002921|stage III adrenocortical carcinoma|stage iii adrenocortical carcinoma
5388976|NCT00002921|stage IV adrenocortical carcinoma|stage iv adrenocortical carcinoma
5388977|NCT00002833|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5388978|NCT00002833|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5388979|NCT00002833|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5388980|NCT00002833|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5388981|NCT00002833|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5388982|NCT00002833|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5388983|NCT00002833|Philadelphia chromosome positive chronic myelogenous leukemia|philadelphia chromosome positive chronic myelogenous leukemia
5388984|NCT00002833|refractory anemia with excess blasts|refractory anemia with excess blasts
5388985|NCT00002833|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
5388986|NCT00002833|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5388987|NCT00002833|graft versus host disease|graft versus host disease
5388988|NCT00088530|Pixantrone|pixantrone
5388989|NCT00088530|Non-Hodgkins lymphoma|non-hodgkins lymphoma
5388990|NCT00002832|Decitabine|decitabine
5388991|NCT00002832|Dacogen|dacogen
5388992|NCT00002832|Filgrastim|filgrastim
5388993|NCT00002832|G-CSF|g-csf
5388994|NCT00002832|Neupogen|neupogen
5388995|NCT00002832|Cyclosporine|cyclosporine
5388996|NCT00002832|Sandimmune|sandimmune
5388997|NCT00002832|CYA|cya
5388998|NCT00002832|Cyclosporin A|cyclosporin a
5388999|NCT00002832|Peripheral blood stem cells|peripheral blood stem cells
5389000|NCT00002832|PBSC|pbsc
5389001|NCT00002832|Allogeneic bone marrow transplantation|allogeneic bone marrow transplantation
5389002|NCT00002832|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5389003|NCT00002832|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5389004|NCT00002832|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5389005|NCT00002832|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5389006|NCT00002832|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5389007|NCT00002832|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5389008|NCT00002832|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5389009|NCT00002832|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
5389010|NCT00002831|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5389011|NCT00002831|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5389012|NCT00002831|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5389013|NCT00002824|recurrent adult brain tumor|recurrent adult brain tumor
5389014|NCT00002824|adult glioblastoma|adult glioblastoma
5389015|NCT00002824|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5389016|NCT00002824|adult giant cell glioblastoma|adult giant cell glioblastoma
5389017|NCT00002824|adult gliosarcoma|adult gliosarcoma
5389018|NCT00002784|stage II breast cancer|stage ii breast cancer
5389019|NCT00002784|stage IIIA breast cancer|stage iiia breast cancer
5389020|NCT00002779|Waldenström macroglobulinemia|waldenström macroglobulinemia
5389021|NCT00002779|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5389022|NCT00002779|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5389023|NCT00002779|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5389024|NCT00002779|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5389025|NCT00002779|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5389026|NCT00002779|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5389027|NCT00002779|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5389028|NCT00002754|recurrent adult brain tumor|recurrent adult brain tumor
5389029|NCT00002754|adult glioblastoma|adult glioblastoma
5389030|NCT00002754|stage IV melanoma|stage iv melanoma
5389031|NCT00002754|tumors metastatic to brain|tumors metastatic to brain
5389032|NCT00002754|childhood high-grade cerebral astrocytoma|childhood high-grade cerebral astrocytoma
5389033|NCT00002754|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5389034|NCT00002754|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
5389035|NCT00002754|adult mixed glioma|adult mixed glioma
5389036|NCT00002754|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
5389037|NCT00002754|adult giant cell glioblastoma|adult giant cell glioblastoma
5389038|NCT00002754|adult gliosarcoma|adult gliosarcoma
5389039|NCT00002753|childhood supratentorial ependymoma|childhood supratentorial ependymoma
5389040|NCT00002753|recurrent childhood brain tumor|recurrent childhood brain tumor
5389041|NCT00002753|recurrent adult brain tumor|recurrent adult brain tumor
5389042|NCT00002753|adult glioblastoma|adult glioblastoma
5389043|NCT00002753|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5389044|NCT00002753|adult myxopapillary ependymoma|adult myxopapillary ependymoma
5389045|NCT00002753|adult anaplastic ependymoma|adult anaplastic ependymoma
5389046|NCT00002753|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
5389047|NCT00002753|adult mixed glioma|adult mixed glioma
5389048|NCT00002753|adult ependymoblastoma|adult ependymoblastoma
5389049|NCT00002753|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
5389050|NCT00002753|recurrent childhood ependymoma|recurrent childhood ependymoma
5389051|NCT00002753|adult giant cell glioblastoma|adult giant cell glioblastoma
5389052|NCT00002753|adult gliosarcoma|adult gliosarcoma
5389053|NCT00002688|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5389054|NCT00002675|intraocular retinoblastoma|intraocular retinoblastoma
5389055|NCT00002665|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
5389056|NCT00002665|L1 adult acute lymphoblastic leukemia|l1 adult acute lymphoblastic leukemia
5389057|NCT00002665|L2 adult acute lymphoblastic leukemia|l2 adult acute lymphoblastic leukemia
5389058|NCT00002665|L3 adult acute lymphoblastic leukemia|l3 adult acute lymphoblastic leukemia
5389059|NCT00002665|neutropenia|neutropenia
5389060|NCT00002665|thrombocytopenia|thrombocytopenia
5389061|NCT00002630|refractory multiple myeloma|refractory multiple myeloma
5389062|NCT00002630|stage II multiple myeloma|stage ii multiple myeloma
5389063|NCT00002630|stage III multiple myeloma|stage iii multiple myeloma
5389064|NCT00002627|stage II breast cancer|stage ii breast cancer
5389065|NCT00002627|stage IIIA breast cancer|stage iiia breast cancer
5389066|NCT00002627|stage IIIB breast cancer|stage iiib breast cancer
5389067|NCT00002627|inflammatory breast cancer|inflammatory breast cancer
5389068|NCT00002618|childhood diffuse large cell lymphoma|childhood diffuse large cell lymphoma
5389069|NCT00002618|childhood immunoblastic large cell lymphoma|childhood immunoblastic large cell lymphoma
5389070|NCT00002618|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
5389071|NCT00002618|AIDS-related diffuse large cell lymphoma|aids-related diffuse large cell lymphoma
5389072|NCT00002618|AIDS-related immunoblastic large cell lymphoma|aids-related immunoblastic large cell lymphoma
5389073|NCT00002618|AIDS-related diffuse mixed cell lymphoma|aids-related diffuse mixed cell lymphoma
5389074|NCT00002618|stage III childhood large cell lymphoma|stage iii childhood large cell lymphoma
5389075|NCT00002618|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
5389076|NCT00002604|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5389077|NCT00002588|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5389078|NCT00002588|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5389079|NCT00002588|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5389080|NCT00002588|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5389081|NCT00002588|L1 adult acute lymphoblastic leukemia|l1 adult acute lymphoblastic leukemia
5389082|NCT00002588|L2 adult acute lymphoblastic leukemia|l2 adult acute lymphoblastic leukemia
5389083|NCT00002588|adult acute erythroid leukemia (M6)|adult acute erythroid leukemia (m6)
5389084|NCT00002588|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
5389085|NCT00002588|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
5389086|NCT00002588|adult acute promyelocytic leukemia (M3)|adult acute promyelocytic leukemia (m3)
5389087|NCT00002588|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
5389088|NCT00002588|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
5389089|NCT00002588|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
5389090|NCT00002588|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5389091|NCT00002588|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
5389092|NCT00002588|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
5389093|NCT00002572|recurrent adult brain tumor|recurrent adult brain tumor
5389094|NCT00002572|adult glioblastoma|adult glioblastoma
5389095|NCT00002572|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5389096|NCT00002572|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
5389097|NCT00002572|adult mixed glioma|adult mixed glioma
5389098|NCT00002572|adult giant cell glioblastoma|adult giant cell glioblastoma
5389099|NCT00002572|adult gliosarcoma|adult gliosarcoma
5389100|NCT00002542|stage I breast cancer|stage i breast cancer
5389101|NCT00002542|stage II breast cancer|stage ii breast cancer
5389102|NCT00002542|stage IIIA breast cancer|stage iiia breast cancer
5389103|NCT00002535|stage III melanoma|stage iii melanoma
5389104|NCT00002535|stage IV melanoma|stage iv melanoma
5389105|NCT00002535|recurrent melanoma|recurrent melanoma
5389106|NCT00002529|stage II breast cancer|stage ii breast cancer
5389107|NCT00002529|stage IIIA breast cancer|stage iiia breast cancer
5389108|NCT00088517|Biodistribution|biodistribution
5389109|NCT00088517|MIRD|mird
5389110|NCT00088517|Radiation Absorbed Dose|radiation absorbed dose
5389111|NCT00088517|Healthy|healthy
5389112|NCT00088517|Prefrontal Cortex|prefrontal cortex
5389113|NCT00088517|Radiation Exposure|radiation exposure
5389114|NCT00088517|PET|pet
5389115|NCT00088517|Dopamine D1 Receptor|dopamine d1 receptor
5389116|NCT00088517|(11C)NNC-112|(11c)nnc-112
5389117|NCT00088517|Healthy Volunteer|healthy volunteer
5389118|NCT00088517|HV|hv
5389119|NCT00088504|Hepatitis|hepatitis
5389120|NCT00088452|childhood absence epilepsy|childhood absence epilepsy
5389121|NCT00088452|CAE|cae
5389122|NCT00088452|petit mal epilepsy|petit mal epilepsy
5389123|NCT00088452|epilepsy|epilepsy
5389124|NCT00088452|seizures|seizures
5389125|NCT00088452|ethosuximide|ethosuximide
5389126|NCT00088452|lamotrigine|lamotrigine
5389127|NCT00088452|valproic acid|valproic acid
5389128|NCT00088426|Holoprosencephaly|holoprosencephaly
5389129|NCT00088426|HPE|hpe
5389130|NCT00088413|CEA|cea
5389131|NCT00088413|Vaccine|vaccine
5389132|NCT00088413|Immunotherapy|immunotherapy
5389133|NCT00088413|MUC-1|muc-1
5389134|NCT00088413|Cancer|cancer
5389135|NCT00088413|Adenocarcinoma|adenocarcinoma
5389136|NCT00088413|Metastatic Adenocarcinoma|metastatic adenocarcinoma
5389137|NCT00088400|Transferrin|transferrin
5389138|NCT00088400|Brain Tumor|brain tumor
5389139|NCT00088400|Convection|convection
5389140|NCT00088400|Immunotherapy|immunotherapy
5389141|NCT00088400|Targeted Protein Toxin|targeted protein toxin
5389142|NCT00088400|Glioblastoma Multiforme|glioblastoma multiforme
5389143|NCT00088400|GBM|gbm
5389144|NCT00088387|Tau|tau
5389145|NCT00088387|T181|t181
5389146|NCT00088387|T231|t231
5389147|NCT00088387|Amyloid Beta|amyloid beta
5389148|NCT00088387|Beta-Catenin|beta-catenin
5389149|NCT00088387|Alzheimer Disease|alzheimer disease
5389150|NCT00088387|AD|ad
5389151|NCT00088374|Kidney Cancer|kidney cancer
5389152|NCT00088374|VHL|vhl
5389153|NCT00088374|17 AAG|17 aag
5389154|NCT00088374|Chemotherapy|chemotherapy
5389155|NCT00088374|Von Hippel Lindau Disease|von hippel lindau disease
5389156|NCT00088374|Renal Tumor|renal tumor
5389157|NCT00088361|Reconstruction|reconstruction
5389158|NCT00088361|PET Artifacts|pet artifacts
5389159|NCT00088361|PET/CT Motion Artifacts|pet/ct motion artifacts
5389160|NCT00088361|Liver|liver
5389161|NCT00088361|Heart|heart
5389162|NCT00088361|Respiratory Motion|respiratory motion
5389163|NCT00088348|Cornea|cornea
5389164|NCT00088348|Conjunctiva|conjunctiva
5389165|NCT00088348|Keratitis|keratitis
5389166|NCT00088348|Ocular Surface|ocular surface
5389167|NCT00088348|Inflammation|inflammation
5389168|NCT00088348|Evaluation|evaluation
5389169|NCT00088348|Screening|screening
5389170|NCT00088348|Ocular Surface Disease|ocular surface disease
5389171|NCT00088348|Eye|eye
5389172|NCT00088348|Ocular Disease|ocular disease
5389173|NCT00088348|Anterior Segment Disease|anterior segment disease
5389174|NCT00088335|Parkinsonism|parkinsonism
5389175|NCT00088335|Biomarker|biomarker
5389176|NCT00088335|Proteomics|proteomics
5389177|NCT00088335|Parkinson's Disease|parkinson's disease
5389178|NCT00088335|Neurodegenerative Disorders|neurodegenerative disorders
5389179|NCT00088335|Parkinson Disease|parkinson disease
5389180|NCT00088335|PD|pd
5389181|NCT00088309|Drug Resistance|drug resistance
5389182|NCT00088309|HAART|haart
5389183|NCT00088309|Pamidronate|pamidronate
5389184|NCT00088309|Osteopenia|osteopenia
5389185|NCT00088309|Pediatric|pediatric
5389186|NCT00088309|HIV|hiv
5389187|NCT00088309|Pediatrics|pediatrics
5389188|NCT00088309|Treatment Experienced|treatment experienced
5389189|NCT00088296|Osteoarthritis|osteoarthritis
5389190|NCT00088296|MS Contin|ms contin
5389191|NCT00088296|Placebo|placebo
5389192|NCT00088296|Cortisol|cortisol
5389193|NCT00088296|Testosterone|testosterone
5389194|NCT00088296|Degenerative Joint Disease|degenerative joint disease
5389195|NCT00088296|OA|oa
5389196|NCT00088296|Arthritis|arthritis
5389197|NCT00088296|Joint Pain|joint pain
5389198|NCT00088296|Arthritic Pain|arthritic pain
5389199|NCT00088296|Opioid|opioid
5389200|NCT00088283|CRVO|crvo
5389201|NCT00088283|Central Retinal Vein Occlusion|central retinal vein occlusion
5389202|NCT00088283|RVO|rvo
5389203|NCT00088283|Retinal Vein Occlusion|retinal vein occlusion
5389204|NCT00005884|basal cell carcinoma of the skin|basal cell carcinoma of the skin
5389205|NCT00005884|squamous cell carcinoma of the skin|squamous cell carcinoma of the skin
5389206|NCT00005852|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5389207|NCT00005852|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5389208|NCT00005852|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5389209|NCT00005852|refractory multiple myeloma|refractory multiple myeloma
5389210|NCT00005852|stage I multiple myeloma|stage i multiple myeloma
5389211|NCT00005852|stage II multiple myeloma|stage ii multiple myeloma
5389212|NCT00005852|stage III multiple myeloma|stage iii multiple myeloma
5389213|NCT00005852|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
5389214|NCT00005852|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5389215|NCT00005852|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5389409|NCT00005614|stage IV breast cancer|stage iv breast cancer
5389216|NCT00005852|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5389217|NCT00005852|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5389218|NCT00005852|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5389219|NCT00005852|primary myelofibrosis|primary myelofibrosis
5389220|NCT00005852|childhood acute promyelocytic leukemia (M3)|childhood acute promyelocytic leukemia (m3)
5389221|NCT00005852|refractory hairy cell leukemia|refractory hairy cell leukemia
5389222|NCT00005852|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
5389223|NCT00005852|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5389224|NCT00005852|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5389225|NCT00005852|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5389226|NCT00005852|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5389227|NCT00005852|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5389228|NCT00005852|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5389229|NCT00005852|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5389230|NCT00005852|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5389231|NCT00005852|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5389232|NCT00005852|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5389233|NCT00005852|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5389234|NCT00005852|graft versus host disease|graft versus host disease
5389235|NCT00005852|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
5389236|NCT00005852|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
5389237|NCT00005852|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5389238|NCT00005852|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5389239|NCT00005852|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5389240|NCT00005852|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5389241|NCT00005852|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5389242|NCT00005852|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5389243|NCT00005852|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
5389244|NCT00005805|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
5389245|NCT00005805|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
5389246|NCT00005805|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5389247|NCT00005805|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5389248|NCT00005805|monoclonal gammopathy of undetermined significance|monoclonal gammopathy of undetermined significance
5389249|NCT00005805|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5389250|NCT00005805|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
5389251|NCT00005805|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
5389252|NCT00005805|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
5389253|NCT00005805|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
5389254|NCT00005805|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5389255|NCT00005805|childhood Burkitt lymphoma|childhood burkitt lymphoma
5389256|NCT00005805|isolated plasmacytoma of bone|isolated plasmacytoma of bone
5389257|NCT00005805|extramedullary plasmacytoma|extramedullary plasmacytoma
5389258|NCT00005805|refractory multiple myeloma|refractory multiple myeloma
5389259|NCT00005805|stage 0 chronic lymphocytic leukemia|stage 0 chronic lymphocytic leukemia
5389260|NCT00005805|Waldenström macroglobulinemia|waldenström macroglobulinemia
5389261|NCT00005805|stage I multiple myeloma|stage i multiple myeloma
5389262|NCT00005805|stage II multiple myeloma|stage ii multiple myeloma
5389263|NCT00005805|stage III multiple myeloma|stage iii multiple myeloma
5389264|NCT00005805|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
5389265|NCT00005805|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
5389266|NCT00005805|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5389267|NCT00005805|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5389268|NCT00005805|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5389269|NCT00005805|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5389270|NCT00005805|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5389271|NCT00005805|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5389272|NCT00005805|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5389273|NCT00005805|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5389274|NCT00005805|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5389275|NCT00005805|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5389276|NCT00005805|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5389277|NCT00005805|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
5389278|NCT00005805|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
5389279|NCT00005805|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
5389344|NCT00005805|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5389733|NCT00088218|ara-C|ara-c
5389280|NCT00005805|untreated childhood acute myeloid leukemia and other myeloid malignancies|untreated childhood acute myeloid leukemia and other myeloid malignancies
5389281|NCT00005805|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5389282|NCT00005805|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
5389283|NCT00005805|polycythemia vera|polycythemia vera
5389284|NCT00005805|primary myelofibrosis|primary myelofibrosis
5389285|NCT00005805|essential thrombocythemia|essential thrombocythemia
5389286|NCT00005805|untreated hairy cell leukemia|untreated hairy cell leukemia
5389287|NCT00005805|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
5389288|NCT00005805|refractory hairy cell leukemia|refractory hairy cell leukemia
5389289|NCT00005805|stage II childhood Hodgkin lymphoma|stage ii childhood hodgkin lymphoma
5389290|NCT00005805|stage I childhood Hodgkin lymphoma|stage i childhood hodgkin lymphoma
5389291|NCT00005805|stage III childhood Hodgkin lymphoma|stage iii childhood hodgkin lymphoma
5389292|NCT00005805|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
5389293|NCT00005805|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
5389294|NCT00005805|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
5389295|NCT00005805|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
5389296|NCT00005805|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
5389297|NCT00005805|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
5389298|NCT00005805|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
5389299|NCT00005805|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
5389300|NCT00005805|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
5389301|NCT00005805|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
5389302|NCT00005805|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
5389303|NCT00005805|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
5389304|NCT00005805|stage I adult non-Hodgkin lymphoma|stage i adult non-hodgkin lymphoma
5389305|NCT00005805|stage II adult non-Hodgkin lymphoma|stage ii adult non-hodgkin lymphoma
5389306|NCT00005805|stage II small lymphocytic lymphoma|stage ii small lymphocytic lymphoma
5389307|NCT00005805|stage II grade 1 follicular lymphoma|stage ii grade 1 follicular lymphoma
5389308|NCT00005805|stage II grade 2 follicular lymphoma|stage ii grade 2 follicular lymphoma
5389309|NCT00005805|stage II grade 3 follicular lymphoma|stage ii grade 3 follicular lymphoma
5389310|NCT00005805|stage II adult diffuse small cleaved cell lymphoma|stage ii adult diffuse small cleaved cell lymphoma
5389311|NCT00005805|stage II adult diffuse mixed cell lymphoma|stage ii adult diffuse mixed cell lymphoma
5389312|NCT00005805|stage II adult diffuse large cell lymphoma|stage ii adult diffuse large cell lymphoma
5389313|NCT00005805|stage II adult immunoblastic large cell lymphoma|stage ii adult immunoblastic large cell lymphoma
5389314|NCT00005805|stage II adult lymphoblastic lymphoma|stage ii adult lymphoblastic lymphoma
5389315|NCT00005805|stage II adult Burkitt lymphoma|stage ii adult burkitt lymphoma
5389316|NCT00005805|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5389317|NCT00005805|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5389318|NCT00005805|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5389319|NCT00005805|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5389320|NCT00005805|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5389321|NCT00005805|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5389322|NCT00005805|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5389323|NCT00005805|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5389324|NCT00005805|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5389325|NCT00005805|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5389326|NCT00005805|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5389327|NCT00005805|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5389328|NCT00005805|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5389329|NCT00005805|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5389330|NCT00005805|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5389331|NCT00005805|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5389332|NCT00005805|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5389333|NCT00005805|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5389334|NCT00005805|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5389335|NCT00005805|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5389336|NCT00005805|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5389337|NCT00005805|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5389338|NCT00005805|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5389339|NCT00005805|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5389340|NCT00005805|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5389341|NCT00005805|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5389342|NCT00005805|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5389343|NCT00005805|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5389345|NCT00005805|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5389346|NCT00005805|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
5389347|NCT00005805|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
5389348|NCT00005805|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
5389349|NCT00005805|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
5389350|NCT00005805|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
5389351|NCT00005805|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5389352|NCT00005805|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5389353|NCT00005805|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5389354|NCT00005805|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
5389355|NCT00005805|fatigue|fatigue
5389356|NCT00005805|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
5389357|NCT00005805|AIDS-related primary CNS lymphoma|aids-related primary cns lymphoma
5389358|NCT00005805|primary systemic amyloidosis|primary systemic amyloidosis
5389359|NCT00005805|intraocular lymphoma|intraocular lymphoma
5389360|NCT00005805|stage I mantle cell lymphoma|stage i mantle cell lymphoma
5389361|NCT00005805|contiguous stage II adult non-Hodgkin lymphoma|contiguous stage ii adult non-hodgkin lymphoma
5389362|NCT00005805|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
5389363|NCT00005805|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
5389364|NCT00005805|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
5389365|NCT00005805|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
5389366|NCT00005805|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
5389367|NCT00005805|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
5389368|NCT00005805|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
5389369|NCT00005805|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
5389370|NCT00005805|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
5389371|NCT00005805|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
5389372|NCT00005805|noncontiguous stage II adult non-Hodgkin lymphoma|noncontiguous stage ii adult non-hodgkin lymphoma
5389373|NCT00005805|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5389374|NCT00005805|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5389375|NCT00005805|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5389376|NCT00005805|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
5389377|NCT00005805|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5389378|NCT00005805|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
5389379|NCT00005805|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
5389380|NCT00005805|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5389381|NCT00005805|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
5389382|NCT00005805|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
5389383|NCT00005805|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5389384|NCT00005805|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5389385|NCT00005805|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5389386|NCT00005805|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
5389387|NCT00005805|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5389388|NCT00005805|stage II mantle cell lymphoma|stage ii mantle cell lymphoma
5389389|NCT00005805|multiple myeloma|multiple myeloma
5389390|NCT00005805|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
5389391|NCT00005805|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
5389392|NCT00005805|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5389393|NCT00005805|stage I marginal zone lymphoma|stage i marginal zone lymphoma
5389394|NCT00005805|stage II marginal zone lymphoma|stage ii marginal zone lymphoma
5389395|NCT00005805|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5389396|NCT00005805|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5389397|NCT00005805|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
5389398|NCT00005805|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
5389399|NCT00005805|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5389400|NCT00005805|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5389401|NCT00005805|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5389402|NCT00005633|stage III melanoma|stage iii melanoma
5389403|NCT00005633|stage IV melanoma|stage iv melanoma
5389404|NCT00005633|recurrent melanoma|recurrent melanoma
5389405|NCT00005624|refractory multiple myeloma|refractory multiple myeloma
5389406|NCT00005624|stage II multiple myeloma|stage ii multiple myeloma
5389407|NCT00005624|stage III multiple myeloma|stage iii multiple myeloma
5389408|NCT00005624|plasma cell neoplasm|plasma cell neoplasm
5389410|NCT00005614|recurrent breast cancer|recurrent breast cancer
5389411|NCT00005611|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5389412|NCT00004902|refractory multiple myeloma|refractory multiple myeloma
5389413|NCT00004902|stage I multiple myeloma|stage i multiple myeloma
5389414|NCT00004902|stage II multiple myeloma|stage ii multiple myeloma
5389415|NCT00004902|stage III multiple myeloma|stage iii multiple myeloma
5389416|NCT00004901|stage IV hypopharyngeal cancer|stage iv hypopharyngeal cancer
5389417|NCT00004901|recurrent hypopharyngeal cancer|recurrent hypopharyngeal cancer
5389418|NCT00004901|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5389419|NCT00004901|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
5389420|NCT00004901|stage IV mucoepidermoid carcinoma of the oral cavity|stage iv mucoepidermoid carcinoma of the oral cavity
5389421|NCT00004901|stage IV adenoid cystic carcinoma of the oral cavity|stage iv adenoid cystic carcinoma of the oral cavity
5389422|NCT00004901|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
5389423|NCT00004901|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
5389424|NCT00004901|recurrent mucoepidermoid carcinoma of the oral cavity|recurrent mucoepidermoid carcinoma of the oral cavity
5389425|NCT00004901|recurrent adenoid cystic carcinoma of the oral cavity|recurrent adenoid cystic carcinoma of the oral cavity
5389426|NCT00004901|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5389427|NCT00004901|stage IV lymphoepithelioma of the oropharynx|stage iv lymphoepithelioma of the oropharynx
5389428|NCT00004901|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
5389429|NCT00004901|recurrent lymphoepithelioma of the oropharynx|recurrent lymphoepithelioma of the oropharynx
5389430|NCT00004901|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
5389431|NCT00004901|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
5389432|NCT00004901|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
5389433|NCT00004901|recurrent lymphoepithelioma of the nasopharynx|recurrent lymphoepithelioma of the nasopharynx
5389434|NCT00004901|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5389435|NCT00004901|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
5389436|NCT00004901|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5389437|NCT00004901|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
5389438|NCT00004901|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
5389439|NCT00004901|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
5389440|NCT00004897|stage I esophageal cancer|stage i esophageal cancer
5389441|NCT00004897|stage II esophageal cancer|stage ii esophageal cancer
5389442|NCT00004897|stage III esophageal cancer|stage iii esophageal cancer
5389443|NCT00004897|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
5389444|NCT00004897|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
5389445|NCT00004875|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
5389446|NCT00004875|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
5389447|NCT00004875|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5389448|NCT00004875|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5389449|NCT00004875|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5389450|NCT00004875|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5389451|NCT00004875|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
5389452|NCT00004875|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
5389453|NCT00004875|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
5389454|NCT00004875|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
5389455|NCT00004875|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
5389456|NCT00004875|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
5389457|NCT00004875|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
5389458|NCT00004875|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
5389459|NCT00004875|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5389460|NCT00004875|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5389461|NCT00004875|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5389462|NCT00004875|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5389463|NCT00004875|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5389464|NCT00004875|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5389465|NCT00004875|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5389466|NCT00004875|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5389467|NCT00004875|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5389468|NCT00004875|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5389469|NCT00004875|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5389470|NCT00004875|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5389471|NCT00004875|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5389734|NCT00088179|CABG|cabg
5389472|NCT00004875|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5389473|NCT00004875|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5389474|NCT00004875|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5389475|NCT00004875|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5389476|NCT00004875|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5389477|NCT00004875|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5389478|NCT00004875|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5389479|NCT00004875|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5389480|NCT00004875|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5389481|NCT00004875|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5389482|NCT00004875|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5389483|NCT00004875|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
5389484|NCT00004875|AIDS-related primary CNS lymphoma|aids-related primary cns lymphoma
5389485|NCT00004875|stage I mantle cell lymphoma|stage i mantle cell lymphoma
5389486|NCT00004875|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
5389487|NCT00004875|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
5389488|NCT00004875|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
5389489|NCT00004875|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
5389490|NCT00004875|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
5389491|NCT00004875|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
5389492|NCT00004875|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
5389493|NCT00004875|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
5389494|NCT00004875|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
5389495|NCT00004875|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5389496|NCT00004875|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5389497|NCT00004875|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5389498|NCT00004875|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
5389499|NCT00004875|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5389500|NCT00004875|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
5389501|NCT00004875|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
5389502|NCT00004875|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5389503|NCT00004875|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
5389504|NCT00004875|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5389505|NCT00004875|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5389506|NCT00004875|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5389507|NCT00004875|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
5389508|NCT00004875|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5389509|NCT00004875|thromboembolism|thromboembolism
5389510|NCT00004875|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
5389511|NCT00004875|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
5389512|NCT00004875|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5389513|NCT00004875|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5389514|NCT00004875|stage I marginal zone lymphoma|stage i marginal zone lymphoma
5389515|NCT00004875|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
5389516|NCT00004875|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5389517|NCT00004875|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5389518|NCT00004875|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5389519|NCT00004875|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5389520|NCT00004875|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
5389521|NCT00004875|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
5389522|NCT00004875|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5389523|NCT00004875|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5389524|NCT00004875|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5389525|NCT00004265|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5389526|NCT00004264|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5390399|NCT00003805|infection|infection
5389527|NCT00004264|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5389528|NCT00004264|drug/agent toxicity by tissue/organ|drug/agent toxicity by tissue/organ
5389529|NCT00004263|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5389530|NCT00004263|refractory anemia with excess blasts|refractory anemia with excess blasts
5389531|NCT00004263|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
5389532|NCT00004263|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5389533|NCT00004263|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
5389534|NCT00004263|Ara-C|ara-c
5389535|NCT00004263|Cytosar|cytosar
5389536|NCT00004263|DepoCyt|depocyt
5389537|NCT00004263|Cytosine arabinosine hydrochloride|cytosine arabinosine hydrochloride
5389538|NCT00004263|cytarabine|cytarabine
5389539|NCT00004263|7-hydroxystaurosporine|7-hydroxystaurosporine
5389540|NCT00004263|UCN-01|ucn-01
5389541|NCT00004258|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5389542|NCT00004258|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5389543|NCT00004258|monoclonal gammopathy of undetermined significance|monoclonal gammopathy of undetermined significance
5389544|NCT00004258|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5389545|NCT00004258|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
5389546|NCT00004258|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
5389547|NCT00004258|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
5389548|NCT00004258|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
5389549|NCT00004258|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5389550|NCT00004258|isolated plasmacytoma of bone|isolated plasmacytoma of bone
5389551|NCT00004258|extramedullary plasmacytoma|extramedullary plasmacytoma
5389552|NCT00004258|refractory multiple myeloma|refractory multiple myeloma
5389553|NCT00004258|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
5389554|NCT00004258|stage III multiple myeloma|stage iii multiple myeloma
5389555|NCT00004258|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5389556|NCT00004258|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5389557|NCT00004258|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5389558|NCT00004258|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5389559|NCT00004258|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5389560|NCT00004258|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5389561|NCT00004258|small intestine lymphoma|small intestine lymphoma
5389562|NCT00004258|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5389563|NCT00004258|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5389564|NCT00004258|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5389565|NCT00004258|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
5389566|NCT00004258|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
5389567|NCT00004258|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
5389568|NCT00004258|polycythemia vera|polycythemia vera
5389569|NCT00004258|essential thrombocythemia|essential thrombocythemia
5389570|NCT00004258|untreated hairy cell leukemia|untreated hairy cell leukemia
5389571|NCT00004258|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
5389572|NCT00004258|refractory hairy cell leukemia|refractory hairy cell leukemia
5389573|NCT00004258|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5389574|NCT00004258|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
5389575|NCT00004258|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5389576|NCT00004258|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5389577|NCT00004258|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5389578|NCT00004258|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5389579|NCT00004258|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5389580|NCT00004258|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5389581|NCT00004258|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5389582|NCT00004258|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5389583|NCT00004258|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5389584|NCT00004258|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5389585|NCT00004258|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5389586|NCT00004258|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5389587|NCT00004258|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5389588|NCT00004258|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5389589|NCT00004258|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5389590|NCT00004258|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5389591|NCT00004258|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5389592|NCT00004258|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5389593|NCT00004258|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5389594|NCT00004258|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5389595|NCT00004258|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5389596|NCT00004258|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5389597|NCT00004258|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5389598|NCT00004258|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5389599|NCT00004258|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5389735|NCT00088179|CPB|cpb
5389736|NCT00087997|sarcoma|sarcoma
5389600|NCT00004258|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5389601|NCT00004258|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5389602|NCT00004258|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
5389603|NCT00004258|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
5389604|NCT00004258|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
5389605|NCT00004258|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5389606|NCT00004258|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5389607|NCT00004258|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5389608|NCT00004258|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5389609|NCT00004258|prolymphocytic leukemia|prolymphocytic leukemia
5389610|NCT00004258|primary systemic amyloidosis|primary systemic amyloidosis
5389611|NCT00004258|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5389612|NCT00004258|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5389613|NCT00004258|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5389614|NCT00004258|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
5389615|NCT00004258|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
5389616|NCT00004258|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5389617|NCT00004258|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5389618|NCT00004258|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5389619|NCT00004258|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5389620|NCT00004258|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5389621|NCT00004258|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5389622|NCT00004258|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5390400|NCT00003805|bone marrow suppression|bone marrow suppression
5389623|NCT00004258|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5389624|NCT00004258|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5389625|NCT00004169|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5389626|NCT00004169|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
5389627|NCT00004159|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5389628|NCT00004159|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5389629|NCT00003942|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
5389630|NCT00003942|AIDS-related diffuse large cell lymphoma|aids-related diffuse large cell lymphoma
5389631|NCT00003942|AIDS-related immunoblastic large cell lymphoma|aids-related immunoblastic large cell lymphoma
5389632|NCT00003942|AIDS-related small noncleaved cell lymphoma|aids-related small noncleaved cell lymphoma
5389633|NCT00003942|AIDS-related diffuse mixed cell lymphoma|aids-related diffuse mixed cell lymphoma
5389634|NCT00003942|AIDS-related diffuse small cleaved cell lymphoma|aids-related diffuse small cleaved cell lymphoma
5389635|NCT00003942|AIDS-related lymphoblastic lymphoma|aids-related lymphoblastic lymphoma
5389636|NCT00003936|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5389637|NCT00003929|primary central nervous system lymphoma|primary central nervous system lymphoma
5389638|NCT00003929|AIDS-related primary CNS lymphoma|aids-related primary cns lymphoma
5389639|NCT00002506|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5389640|NCT00002506|recurrent esophageal cancer|recurrent esophageal cancer
5389641|NCT00002506|recurrent cervical cancer|recurrent cervical cancer
5389642|NCT00002506|squamous cell lung cancer|squamous cell lung cancer
5389643|NCT00002506|squamous cell carcinoma of the skin|squamous cell carcinoma of the skin
5389644|NCT00002506|recurrent penile cancer|recurrent penile cancer
5389645|NCT00002506|recurrent skin cancer|recurrent skin cancer
5389646|NCT00002506|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
5389647|NCT00002506|cervical squamous cell carcinoma|cervical squamous cell carcinoma
5389648|NCT00002506|penile squamous cell carcinoma|penile squamous cell carcinoma
5389649|NCT00002506|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
5389650|NCT00002506|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
5389651|NCT00002506|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
5389652|NCT00002506|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
5389653|NCT00002506|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
5389654|NCT00002506|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
5389655|NCT00002504|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5389656|NCT00002504|monoclonal gammopathy of undetermined significance|monoclonal gammopathy of undetermined significance
5389657|NCT00002504|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5389658|NCT00002504|isolated plasmacytoma of bone|isolated plasmacytoma of bone
5389659|NCT00002504|extramedullary plasmacytoma|extramedullary plasmacytoma
5389660|NCT00002504|refractory multiple myeloma|refractory multiple myeloma
5389661|NCT00002504|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
5389662|NCT00002504|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5389663|NCT00002504|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5389664|NCT00002504|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5389665|NCT00002504|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5389666|NCT00002504|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5389667|NCT00002504|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5389668|NCT00002504|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5389669|NCT00002504|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5389670|NCT00002504|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5389671|NCT00002504|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
5389672|NCT00002504|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
5389673|NCT00002504|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
5389674|NCT00002504|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5389675|NCT00002504|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5389676|NCT00002504|polycythemia vera|polycythemia vera
5389677|NCT00002504|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
5389678|NCT00002504|essential thrombocythemia|essential thrombocythemia
5389679|NCT00002504|untreated hairy cell leukemia|untreated hairy cell leukemia
5389680|NCT00002504|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
5389681|NCT00002504|refractory hairy cell leukemia|refractory hairy cell leukemia
5389682|NCT00002504|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5389683|NCT00002504|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
5389684|NCT00002504|acute undifferentiated leukemia|acute undifferentiated leukemia
5389685|NCT00002504|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5389686|NCT00002504|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5389687|NCT00002504|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5389688|NCT00002504|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5389689|NCT00002504|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5389690|NCT00002504|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5389691|NCT00002504|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5389692|NCT00002504|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5389693|NCT00002504|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5389694|NCT00002504|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5389695|NCT00002504|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5389696|NCT00002504|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5389697|NCT00002504|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5389698|NCT00002504|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5389699|NCT00002504|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5389700|NCT00002504|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5389701|NCT00002504|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5389702|NCT00002504|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5389703|NCT00002504|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
5389704|NCT00002504|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
5389705|NCT00002504|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5389706|NCT00002504|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5389707|NCT00002504|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5389708|NCT00002504|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5389709|NCT00002504|prolymphocytic leukemia|prolymphocytic leukemia
5389710|NCT00002504|primary systemic amyloidosis|primary systemic amyloidosis
5389711|NCT00002504|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5389712|NCT00002504|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5389713|NCT00002504|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
5389714|NCT00002504|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5389715|NCT00002504|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5389716|NCT00002504|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5390492|NCT00087685|Uterine Cancer|uterine cancer
5389717|NCT00002504|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5389718|NCT00002504|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5389719|NCT00002504|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5389720|NCT00002504|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5389721|NCT00002504|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5389722|NCT00002462|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5389723|NCT00002462|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5389724|NCT00088231|Acute Myelogenous Leukemia (AML)|acute myelogenous leukemia (aml)
5389725|NCT00088231|Agnogenic Myeloid Metaplasia (AMM)|agnogenic myeloid metaplasia (amm)
5389726|NCT00088231|Chronic Myelogenous Leukemia-Blastic Phase (CML-BP)|chronic myelogenous leukemia-blastic phase (cml-bp)
5389727|NCT00088218|Acute Myeloid Leukemia|acute myeloid leukemia
5389729|NCT00088218|High-Risk Myelodysplastic Syndrome|high-risk myelodysplastic syndrome
5389730|NCT00088218|MDS|mds
5389731|NCT00088218|Clofarabine|clofarabine
5389732|NCT00088218|Cytarabine|cytarabine
5389738|NCT00088192|Age-Related Macular Degeneration|age-related macular degeneration
5389739|NCT00088192|Exudative Subfoveal Age Related Macular Degeneration with Subfoveal Choroidal Neovascularization|exudative subfoveal age related macular degeneration with subfoveal choroidal neovascularization
5389740|NCT00088166|peritumoral brain edema|peritumoral brain edema
5389741|NCT00088166|edema|edema
5389742|NCT00088166|malignant brain tumor|malignant brain tumor
5389743|NCT00088166|astrocytoma|astrocytoma
5389744|NCT00088166|brain tumor|brain tumor
5389745|NCT00088166|dexamethasone|dexamethasone
5389746|NCT00088166|Decadron|decadron
5389747|NCT00003884|hypercalcemia of malignancy|hypercalcemia of malignancy
5389748|NCT00003884|pain|pain
5389749|NCT00003884|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5389750|NCT00003884|recurrent small cell lung cancer|recurrent small cell lung cancer
5389751|NCT00003884|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5389752|NCT00003884|bone metastases|bone metastases
5389753|NCT00003812|limited stage small cell lung cancer|limited stage small cell lung cancer
5389754|NCT00003808|stage 0 chronic lymphocytic leukemia|stage 0 chronic lymphocytic leukemia
5389755|NCT00003808|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
5389756|NCT00003808|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
5389757|NCT00003808|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
5389758|NCT00003781|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5389759|NCT00003781|stage IV prostate cancer|stage iv prostate cancer
5389760|NCT00003781|recurrent prostate cancer|recurrent prostate cancer
5389761|NCT00003781|pain|pain
5389762|NCT00003763|stage I ovarian epithelial cancer|stage i ovarian epithelial cancer
5389763|NCT00003763|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
5389764|NCT00003763|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5389765|NCT00003763|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5389766|NCT00003763|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5389767|NCT00003763|ovarian stromal cancer|ovarian stromal cancer
5389768|NCT00003763|stage I ovarian germ cell tumor|stage i ovarian germ cell tumor
5389769|NCT00003763|stage II ovarian germ cell tumor|stage ii ovarian germ cell tumor
5389770|NCT00003763|stage III ovarian germ cell tumor|stage iii ovarian germ cell tumor
5389771|NCT00003763|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
5389772|NCT00003763|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
5389773|NCT00003763|borderline ovarian surface epithelial-stromal tumor|borderline ovarian surface epithelial-stromal tumor
5389774|NCT00003763|ovarian sarcoma|ovarian sarcoma
5389775|NCT00003748|stage I gastric cancer|stage i gastric cancer
5389776|NCT00003748|stage II gastric cancer|stage ii gastric cancer
5389777|NCT00003748|stage III gastric cancer|stage iii gastric cancer
5389778|NCT00003748|stage IV gastric cancer|stage iv gastric cancer
5389779|NCT00003748|recurrent gastric cancer|recurrent gastric cancer
5389780|NCT00003748|stage I esophageal cancer|stage i esophageal cancer
5389781|NCT00003748|stage II esophageal cancer|stage ii esophageal cancer
5389782|NCT00003748|stage III esophageal cancer|stage iii esophageal cancer
5389783|NCT00003748|stage IV esophageal cancer|stage iv esophageal cancer
5389784|NCT00003748|recurrent esophageal cancer|recurrent esophageal cancer
5389785|NCT00003748|adenocarcinoma of the stomach|adenocarcinoma of the stomach
5389786|NCT00003748|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
5389787|NCT00003725|stage 0 bladder cancer|stage 0 bladder cancer
5389788|NCT00003725|stage I bladder cancer|stage i bladder cancer
5389789|NCT00003725|recurrent bladder cancer|recurrent bladder cancer
5389790|NCT00003725|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
5389791|NCT00003677|recurrent pancreatic cancer|recurrent pancreatic cancer
5389792|NCT00003677|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
5389793|NCT00003677|stage IV pancreatic cancer|stage iv pancreatic cancer
5389794|NCT00003675|refractory anemia|refractory anemia
5389795|NCT00003675|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
5389796|NCT00003675|refractory anemia with excess blasts|refractory anemia with excess blasts
5389797|NCT00003675|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
5389798|NCT00003675|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5389799|NCT00003675|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5389800|NCT00003675|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5389801|NCT00003675|refractory cytopenia with multilineage dysplasia|refractory cytopenia with multilineage dysplasia
5389802|NCT00003675|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
5389803|NCT00003585|stage IV renal cell cancer|stage iv renal cell cancer
5389804|NCT00003585|recurrent renal cell cancer|recurrent renal cell cancer
5389805|NCT00003557|advanced adult primary liver cancer|advanced adult primary liver cancer
5389806|NCT00003557|recurrent adult primary liver cancer|recurrent adult primary liver cancer
5389807|NCT00003557|unresectable gallbladder cancer|unresectable gallbladder cancer
5389808|NCT00003557|recurrent gallbladder cancer|recurrent gallbladder cancer
5389809|NCT00003557|unresectable extrahepatic bile duct cancer|unresectable extrahepatic bile duct cancer
5389810|NCT00003557|recurrent extrahepatic bile duct cancer|recurrent extrahepatic bile duct cancer
5389811|NCT00003557|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
5389812|NCT00003557|cholangiocarcinoma of the gallbladder|cholangiocarcinoma of the gallbladder
5389813|NCT00003392|stage IV breast cancer|stage iv breast cancer
5389814|NCT00003392|recurrent breast cancer|recurrent breast cancer
5389815|NCT00003391|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5389816|NCT00003391|stage IV prostate cancer|stage iv prostate cancer
5389817|NCT00003391|recurrent prostate cancer|recurrent prostate cancer
5389818|NCT00003267|stage I cervical cancer|stage i cervical cancer
5389819|NCT00003267|stage II cervical cancer|stage ii cervical cancer
5389820|NCT00003267|stage I vaginal cancer|stage i vaginal cancer
5389821|NCT00003267|stage II vaginal cancer|stage ii vaginal cancer
5389822|NCT00003267|stage I endometrial carcinoma|stage i endometrial carcinoma
5389823|NCT00003267|stage II endometrial carcinoma|stage ii endometrial carcinoma
5389824|NCT00003267|infection|infection
5389825|NCT00003267|perioperative/postoperative complications|perioperative/postoperative complications
5389826|NCT00088153|Anorexia Nervosa|anorexia nervosa
5389827|NCT00088153|Amenorrhea|amenorrhea
5389828|NCT00088153|Bone Mass|bone mass
5389829|NCT00088153|Growth hormone|growth hormone
5389830|NCT00088101|Hematological Malignancies|hematological malignancies
5389831|NCT00088101|Leukemia|leukemia
5389832|NCT00088101|Lymphoma|lymphoma
5389833|NCT00088101|Metastatic|metastatic
5389834|NCT00088101|Unresectable solid tumors|unresectable solid tumors
5389835|NCT00088075|Schizophrenia|schizophrenia
5389836|NCT00088075|Risperidone|risperidone
5389837|NCT00088075|Adolescents|adolescents
5389838|NCT00088062|Crohn's Disease|crohn's disease
5389839|NCT00003238|recurrent prostate cancer|recurrent prostate cancer
5389840|NCT00003225|stage IV colon cancer|stage iv colon cancer
5389841|NCT00003225|stage IV rectal cancer|stage iv rectal cancer
5389842|NCT00003225|recurrent colon cancer|recurrent colon cancer
5389843|NCT00003225|recurrent rectal cancer|recurrent rectal cancer
5389844|NCT00088023|Solid tumors|solid tumors
5389845|NCT00087984|Kidney cancer|kidney cancer
5389846|NCT00087984|Renal cancer|renal cancer
5389847|NCT00087958|Metastatic breast cancer|metastatic breast cancer
5389848|NCT00087945|Treatment Experienced|treatment experienced
5389849|NCT00087880|smoking cessation|smoking cessation
5389850|NCT00087867|Multiple Myeloma|multiple myeloma
5389851|NCT00087867|SCIO-469|scio-469
5389852|NCT00087867|p38 MAP kinase|p38 map kinase
5389853|NCT00087867|myeloma|myeloma
5389854|NCT00087867|bone marrow|bone marrow
5389855|NCT00005996|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5389856|NCT00005806|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5389857|NCT00005806|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5389858|NCT00005806|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5389859|NCT00005806|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5389860|NCT00005632|recurrent prostate cancer|recurrent prostate cancer
5389861|NCT00005619|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
5389862|NCT00005619|refractory hairy cell leukemia|refractory hairy cell leukemia
5389863|NCT00005042|AIDS-related Kaposi sarcoma|aids-related kaposi sarcoma
5389864|NCT00005042|recurrent Kaposi sarcoma|recurrent kaposi sarcoma
5389865|NCT00005029|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5389866|NCT00005029|primary peritoneal cavity cancer|primary peritoneal cavity cancer
5389867|NCT00004199|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5389868|NCT00004199|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5389869|NCT00004164|stage II nasopharyngeal cancer|stage ii nasopharyngeal cancer
5389870|NCT00004164|stage III nasopharyngeal cancer|stage iii nasopharyngeal cancer
5389871|NCT00004164|stage IV nasopharyngeal cancer|stage iv nasopharyngeal cancer
5389872|NCT00004160|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5389873|NCT00004160|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5389874|NCT00004158|refractory multiple myeloma|refractory multiple myeloma
5389875|NCT00004158|stage I multiple myeloma|stage i multiple myeloma
5389876|NCT00004158|stage II multiple myeloma|stage ii multiple myeloma
5389877|NCT00004158|stage III multiple myeloma|stage iii multiple myeloma
5389878|NCT00004104|stage III melanoma|stage iii melanoma
5389879|NCT00004060|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5389880|NCT00004060|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5389881|NCT00004060|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5389882|NCT00004060|fallopian tube cancer|fallopian tube cancer
5389883|NCT00004060|primary peritoneal cavity cancer|primary peritoneal cavity cancer
5389884|NCT00004047|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5389885|NCT00004047|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5389886|NCT00004047|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5389887|NCT00004047|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5389888|NCT00004047|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5389889|NCT00004047|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5389890|NCT00004047|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5389891|NCT00004047|refractory anemia with excess blasts|refractory anemia with excess blasts
5389892|NCT00004047|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
5395522|NCT00082030|HV|hv
5389893|NCT00004047|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5389894|NCT00004047|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
5389895|NCT00004041|recurrent adult brain tumor|recurrent adult brain tumor
5389896|NCT00004041|adult glioblastoma|adult glioblastoma
5389897|NCT00004041|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5389898|NCT00004041|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
5389899|NCT00004041|adult mixed glioma|adult mixed glioma
5389900|NCT00004041|adult giant cell glioblastoma|adult giant cell glioblastoma
5389901|NCT00004041|adult gliosarcoma|adult gliosarcoma
5389902|NCT00003881|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5389903|NCT00003881|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5389904|NCT00003881|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5389905|NCT00003219|stage IV breast cancer|stage iv breast cancer
5389906|NCT00003219|recurrent breast cancer|recurrent breast cancer
5389907|NCT00003171|refractory anemia|refractory anemia
5389908|NCT00003171|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
5389909|NCT00003171|refractory anemia with excess blasts|refractory anemia with excess blasts
5389910|NCT00003171|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
5389911|NCT00003171|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5389912|NCT00003171|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5389913|NCT00003171|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5389914|NCT00003171|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5389915|NCT00003082|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5389916|NCT00003082|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5389917|NCT00003082|monoclonal gammopathy of undetermined significance|monoclonal gammopathy of undetermined significance
5389918|NCT00003082|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5389919|NCT00003082|isolated plasmacytoma of bone|isolated plasmacytoma of bone
5389920|NCT00003082|extramedullary plasmacytoma|extramedullary plasmacytoma
5389921|NCT00003082|refractory multiple myeloma|refractory multiple myeloma
5389922|NCT00003082|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
5389923|NCT00003082|stage III multiple myeloma|stage iii multiple myeloma
5389924|NCT00003082|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5389925|NCT00003082|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5389926|NCT00003082|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5389927|NCT00003082|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5389928|NCT00003082|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5389929|NCT00003082|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5389930|NCT00003082|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5389931|NCT00003082|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5389932|NCT00003082|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5389933|NCT00003082|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5389934|NCT00003082|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
5389935|NCT00003082|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
5389936|NCT00003082|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
5389937|NCT00003082|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5389938|NCT00003082|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5389939|NCT00003082|polycythemia vera|polycythemia vera
5389940|NCT00003082|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
5389941|NCT00003082|essential thrombocythemia|essential thrombocythemia
5389942|NCT00003082|untreated hairy cell leukemia|untreated hairy cell leukemia
5389943|NCT00003082|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
5389944|NCT00003082|refractory hairy cell leukemia|refractory hairy cell leukemia
5389945|NCT00003082|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5389946|NCT00003082|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
5389947|NCT00003082|acute undifferentiated leukemia|acute undifferentiated leukemia
5389948|NCT00003082|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5389949|NCT00003082|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5389950|NCT00003082|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5389951|NCT00003082|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5389952|NCT00003082|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5389953|NCT00003082|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5389954|NCT00003082|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5389955|NCT00003082|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5389956|NCT00003082|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5389957|NCT00003082|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5389958|NCT00003082|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5389959|NCT00003082|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5389960|NCT00003082|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5389961|NCT00003082|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5389962|NCT00003082|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5389963|NCT00003082|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5389964|NCT00003082|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5389965|NCT00003082|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5389966|NCT00003082|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5389967|NCT00003082|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5389968|NCT00003082|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5389969|NCT00003082|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5389970|NCT00003082|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5389971|NCT00003082|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5389972|NCT00003082|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5389973|NCT00003082|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5389974|NCT00003082|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5389975|NCT00003082|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
5389976|NCT00003082|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
5389977|NCT00003082|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
5389978|NCT00003082|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5389979|NCT00003082|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5389980|NCT00003082|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5389981|NCT00003082|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5389982|NCT00003082|prolymphocytic leukemia|prolymphocytic leukemia
5389983|NCT00003082|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
5389984|NCT00003082|AIDS-related primary CNS lymphoma|aids-related primary cns lymphoma
5389985|NCT00003082|primary systemic amyloidosis|primary systemic amyloidosis
5389986|NCT00003082|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5389987|NCT00003082|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5389988|NCT00003082|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5389989|NCT00003082|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
5389990|NCT00003082|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5389991|NCT00003082|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5389992|NCT00003082|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5389993|NCT00003082|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5389994|NCT00003082|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5389995|NCT00003082|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5389996|NCT00003082|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5389997|NCT00003082|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5389998|NCT00003082|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5389999|NCT00003082|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5390000|NCT00003057|colon cancer|colon cancer
5390001|NCT00003057|rectal cancer|rectal cancer
5390002|NCT00003057|diarrhea|diarrhea
5390003|NCT00002998|stage IV breast cancer|stage iv breast cancer
5390004|NCT00002998|recurrent breast cancer|recurrent breast cancer
5390005|NCT00002994|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5390006|NCT00002956|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5390007|NCT00002956|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
5390008|NCT00002956|childhood diffuse large cell lymphoma|childhood diffuse large cell lymphoma
5390009|NCT00002956|childhood immunoblastic large cell lymphoma|childhood immunoblastic large cell lymphoma
5390010|NCT00002956|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
5390011|NCT00002956|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
5390012|NCT00002956|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5390013|NCT00002956|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5390014|NCT00002956|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5390015|NCT00002956|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5390016|NCT00002956|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5390017|NCT00002956|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5390018|NCT00002956|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5390019|NCT00002956|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5390020|NCT00002956|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5390021|NCT00002956|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
5390022|NCT00002956|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
5390023|NCT00002956|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5390024|NCT00002956|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5390025|NCT00002956|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5390026|NCT00002956|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5390027|NCT00002956|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5390028|NCT00002956|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5390029|NCT00002925|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
5390030|NCT00002925|adult acute erythroid leukemia (M6)|adult acute erythroid leukemia (m6)
5390031|NCT00002925|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
5390032|NCT00002925|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
5390033|NCT00002925|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
5390034|NCT00002925|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
5390035|NCT00002925|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
5390036|NCT00002925|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
5390037|NCT00002925|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
5390038|NCT00002908|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5390039|NCT00002908|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5390040|NCT00002908|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5390041|NCT00002908|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5390042|NCT00002908|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5390043|NCT00002908|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5390044|NCT00002908|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5390045|NCT00002908|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5390046|NCT00002908|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5390047|NCT00002908|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5390048|NCT00002908|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5390049|NCT00002908|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5390050|NCT00002908|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5390051|NCT00002908|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5390052|NCT00002908|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5390053|NCT00002908|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5390054|NCT00002907|refractory multiple myeloma|refractory multiple myeloma
5390055|NCT00002862|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5390056|NCT00002862|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5390057|NCT00002862|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5390058|NCT00002862|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5390059|NCT00002862|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5390060|NCT00002862|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5390061|NCT00002862|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5390062|NCT00002862|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5390063|NCT00002862|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5390064|NCT00002862|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5390065|NCT00002862|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5390066|NCT00002862|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5390067|NCT00002862|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5390068|NCT00002862|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5390069|NCT00002862|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5390070|NCT00002862|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5390071|NCT00002862|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5390072|NCT00002862|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5390073|NCT00002862|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5390074|NCT00002862|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5390075|NCT00002862|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5390076|NCT00002862|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
5390077|NCT00002862|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
5390078|NCT00002862|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5390079|NCT00002862|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5390080|NCT00002862|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
5390081|NCT00002862|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5390082|NCT00002862|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5390083|NCT00002862|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5390084|NCT00002862|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5390085|NCT00002862|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5390086|NCT00002862|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5390087|NCT00002862|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5390088|NCT00002862|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5390089|NCT00002763|stage III melanoma|stage iii melanoma
5390090|NCT00002763|recurrent melanoma|recurrent melanoma
5396989|NCT00081497|Fabry|fabry
5390091|NCT00002760|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5390092|NCT00002760|recurrent prostate cancer|recurrent prostate cancer
5390093|NCT00002667|stage I non-small cell lung cancer|stage i non-small cell lung cancer
5390094|NCT00002620|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5390095|NCT00002563|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
5390096|NCT00002563|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
5390097|NCT00002563|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
5390098|NCT00002557|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
5390099|NCT00002557|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
5390100|NCT00002557|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5390101|NCT00002549|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
5390102|NCT00002549|adult acute erythroid leukemia (M6)|adult acute erythroid leukemia (m6)
5390103|NCT00002549|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
5390104|NCT00002549|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
5390105|NCT00002549|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
5390106|NCT00002549|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
5390107|NCT00002549|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
5390108|NCT00002549|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5390109|NCT00002549|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
5390110|NCT00002545|adult glioblastoma|adult glioblastoma
5390111|NCT00002545|adult giant cell glioblastoma|adult giant cell glioblastoma
5390112|NCT00002545|adult gliosarcoma|adult gliosarcoma
5390113|NCT00002502|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
5390114|NCT00002502|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
5390115|NCT00002502|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5390116|NCT00002502|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5390117|NCT00002502|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5390118|NCT00002502|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5390119|NCT00002502|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
5390120|NCT00002502|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
5390121|NCT00002502|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
5390122|NCT00002502|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
5390123|NCT00002502|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5390124|NCT00002502|childhood Burkitt lymphoma|childhood burkitt lymphoma
5390125|NCT00002502|refractory multiple myeloma|refractory multiple myeloma
5390126|NCT00002502|Waldenström macroglobulinemia|waldenström macroglobulinemia
5390127|NCT00002502|stage I multiple myeloma|stage i multiple myeloma
5390128|NCT00002502|stage II multiple myeloma|stage ii multiple myeloma
5390129|NCT00002502|stage III multiple myeloma|stage iii multiple myeloma
5390130|NCT00002502|stage I childhood lymphoblastic lymphoma|stage i childhood lymphoblastic lymphoma
5390131|NCT00002502|stage II childhood lymphoblastic lymphoma|stage ii childhood lymphoblastic lymphoma
5390132|NCT00002502|stage III childhood lymphoblastic lymphoma|stage iii childhood lymphoblastic lymphoma
5390133|NCT00002502|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
5390134|NCT00002502|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
5390135|NCT00002502|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5390136|NCT00002502|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5390137|NCT00002502|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5390138|NCT00002502|childhood diffuse large cell lymphoma|childhood diffuse large cell lymphoma
5390139|NCT00002502|childhood immunoblastic large cell lymphoma|childhood immunoblastic large cell lymphoma
5390140|NCT00002502|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5390141|NCT00002502|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5390142|NCT00002502|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5390143|NCT00002502|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5390144|NCT00002502|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5390145|NCT00002502|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
5390146|NCT00002502|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
5390147|NCT00002502|stage II childhood Hodgkin lymphoma|stage ii childhood hodgkin lymphoma
5390148|NCT00002502|stage I childhood Hodgkin lymphoma|stage i childhood hodgkin lymphoma
5390149|NCT00002502|stage III childhood Hodgkin lymphoma|stage iii childhood hodgkin lymphoma
5390150|NCT00002502|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
5390151|NCT00002502|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
5390152|NCT00002502|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
5390153|NCT00002502|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
5390154|NCT00002502|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
5390155|NCT00002502|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
5396990|NCT00081497|GL-3|gl-3
5390156|NCT00002502|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
5390157|NCT00002502|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
5390158|NCT00002502|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
5390159|NCT00002502|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
5390160|NCT00002502|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
5390161|NCT00002502|refractory anemia|refractory anemia
5390162|NCT00002502|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
5390163|NCT00002502|refractory anemia with excess blasts|refractory anemia with excess blasts
5390164|NCT00002502|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5390165|NCT00002502|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5390166|NCT00002502|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5390167|NCT00002502|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5390168|NCT00002502|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5390169|NCT00002502|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5390170|NCT00002502|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5390171|NCT00002502|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5390172|NCT00002502|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5390173|NCT00002502|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5390174|NCT00002502|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5390175|NCT00002502|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5390176|NCT00002502|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5390177|NCT00002502|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5390178|NCT00002502|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5390179|NCT00002502|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5390180|NCT00002502|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5390181|NCT00002502|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5390182|NCT00002502|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5390183|NCT00002502|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5390184|NCT00002502|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5390185|NCT00002502|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5390186|NCT00002502|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5390187|NCT00002502|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5390188|NCT00002502|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5390189|NCT00002502|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5390190|NCT00002502|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5390191|NCT00002502|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5390192|NCT00002502|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5390193|NCT00002502|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5390194|NCT00002502|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5390195|NCT00002502|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5390196|NCT00002502|intraocular lymphoma|intraocular lymphoma
5390197|NCT00002502|stage I childhood small noncleaved cell lymphoma|stage i childhood small noncleaved cell lymphoma
5390198|NCT00002502|stage I childhood large cell lymphoma|stage i childhood large cell lymphoma
5390199|NCT00002502|stage II childhood small noncleaved cell lymphoma|stage ii childhood small noncleaved cell lymphoma
5390200|NCT00002502|stage II childhood large cell lymphoma|stage ii childhood large cell lymphoma
5390201|NCT00002502|stage III childhood small noncleaved cell lymphoma|stage iii childhood small noncleaved cell lymphoma
5390202|NCT00002502|stage III childhood large cell lymphoma|stage iii childhood large cell lymphoma
5390203|NCT00002502|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
5390204|NCT00002502|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
5390205|NCT00002502|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
5390206|NCT00002502|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
5390207|NCT00002502|stage I mantle cell lymphoma|stage i mantle cell lymphoma
5390208|NCT00002502|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
5390209|NCT00002502|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
5390493|NCT00087672|Myelofibrosis|myelofibrosis
5390210|NCT00002502|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
5390211|NCT00002502|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
5390212|NCT00002502|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
5390213|NCT00002502|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
5390214|NCT00002502|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
5390215|NCT00002502|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
5390216|NCT00002502|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
5390477|NCT00003604|stage IV renal cell cancer|stage iv renal cell cancer
5390217|NCT00002502|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
5390218|NCT00002502|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5390219|NCT00002502|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5390220|NCT00002502|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5390221|NCT00002502|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
5390222|NCT00002502|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5390223|NCT00002502|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
5390224|NCT00002502|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
5390225|NCT00002502|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5390226|NCT00002502|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
5390227|NCT00002502|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
5390228|NCT00002502|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5390229|NCT00002502|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5390230|NCT00002502|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5390231|NCT00002502|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
5390232|NCT00002502|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5390233|NCT00002502|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
5390234|NCT00002502|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
5390235|NCT00002502|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5390236|NCT00002502|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5390237|NCT00002502|stage I marginal zone lymphoma|stage i marginal zone lymphoma
5390238|NCT00002502|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
5390239|NCT00002502|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5390240|NCT00002502|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5390241|NCT00002502|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5390242|NCT00002502|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5390243|NCT00002502|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
5390244|NCT00002502|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
5390245|NCT00002502|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5390246|NCT00002502|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5390247|NCT00002502|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5390248|NCT00002502|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
5390249|NCT00002495|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
5390250|NCT00002495|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
5390251|NCT00002465|stage IV breast cancer|stage iv breast cancer
5390252|NCT00002465|recurrent breast cancer|recurrent breast cancer
5390253|NCT00002465|advanced malignant mesothelioma|advanced malignant mesothelioma
5390254|NCT00002465|recurrent malignant mesothelioma|recurrent malignant mesothelioma
5390255|NCT00002465|stage IV endometrial carcinoma|stage iv endometrial carcinoma
5390256|NCT00002465|recurrent endometrial carcinoma|recurrent endometrial carcinoma
5390257|NCT00087932|Complementary Therapies|complementary therapies
5390258|NCT00087841|Hypnosis|hypnosis
5390259|NCT00087841|Analgesia|analgesia
5390260|NCT00087841|Embolization, Therapeutic|embolization, therapeutic
5390261|NCT00087841|Chemoembolization, Therapeutic|chemoembolization, therapeutic
5390262|NCT00087828|Vaccinium macrocarpon|vaccinium macrocarpon
5390263|NCT00087815|cognitive/functional effects|cognitive/functional effects
5390264|NCT00087815|radiation toxicity|radiation toxicity
5390265|NCT00087815|adult brain tumor|adult brain tumor
5390266|NCT00087815|childhood brain tumor|childhood brain tumor
5390267|NCT00087789|Alzheimer's Disease|alzheimer's disease
5390268|NCT00087789|Gene Transfer|gene transfer
5390270|NCT00087763|Age Related Macular Degeneration|age related macular degeneration
5390271|NCT00087763|Exudative Subfoveal Age Related Macular Degeneration with Subfoveal Choroidal Neovascularization|exudative subfoveal age related macular degeneration with subfoveal choroidal neovascularization
5390272|NCT00082511|Lupus|lupus
5390273|NCT00082511|Systemic Lupus Erythematosus|systemic lupus erythematosus
5390274|NCT00082511|SLE|sle
5390275|NCT00082511|Bone Loss|bone loss
5390276|NCT00082511|DHEA|dhea
5390277|NCT00003877|stage IV breast cancer|stage iv breast cancer
5390278|NCT00003877|recurrent breast cancer|recurrent breast cancer
5390279|NCT00003874|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5390280|NCT00003874|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
5390281|NCT00003874|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
5390282|NCT00003874|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5390283|NCT00003874|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5390284|NCT00003874|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
5390285|NCT00003874|B-cell childhood acute lymphoblastic leukemia|b-cell childhood acute lymphoblastic leukemia
5390286|NCT00003874|B-cell adult acute lymphoblastic leukemia|b-cell adult acute lymphoblastic leukemia
5396991|NCT00081497|Fabrazyme|fabrazyme
5390287|NCT00003874|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5390288|NCT00003874|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5390289|NCT00003874|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5390290|NCT00003874|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5390291|NCT00003874|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5390292|NCT00003874|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5390293|NCT00003874|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5390294|NCT00003874|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5390295|NCT00003874|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5390296|NCT00003874|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
5390297|NCT00003874|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
5390298|NCT00003874|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5390299|NCT00003874|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5390300|NCT00003874|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5390301|NCT00003874|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5390302|NCT00003874|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5390303|NCT00003874|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5390304|NCT00003853|primary systemic amyloidosis|primary systemic amyloidosis
5390305|NCT00003805|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
5390306|NCT00003805|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
5390307|NCT00003805|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5390308|NCT00003805|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5390309|NCT00003805|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5390310|NCT00003805|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5390311|NCT00003805|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
5390312|NCT00003805|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
5390313|NCT00003805|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
5390314|NCT00003805|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
5390315|NCT00003805|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5390316|NCT00003805|Burkitt lymphoma|burkitt lymphoma
5390317|NCT00003805|stage 0 chronic lymphocytic leukemia|stage 0 chronic lymphocytic leukemia
5390318|NCT00003805|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
5390319|NCT00003805|stage I multiple myeloma|stage i multiple myeloma
5390320|NCT00003805|stage II multiple myeloma|stage ii multiple myeloma
5390321|NCT00003805|stage III multiple myeloma|stage iii multiple myeloma
5390322|NCT00003805|stage I childhood lymphoblastic lymphoma|stage i childhood lymphoblastic lymphoma
5390323|NCT00003805|stage II childhood lymphoblastic lymphoma|stage ii childhood lymphoblastic lymphoma
5390324|NCT00003805|stage III childhood lymphoblastic lymphoma|stage iii childhood lymphoblastic lymphoma
5390325|NCT00003805|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
5390326|NCT00003805|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
5390327|NCT00003805|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
5390328|NCT00003805|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
5390329|NCT00003805|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5390330|NCT00003805|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5390331|NCT00003805|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5390332|NCT00003805|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5390333|NCT00003805|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5390334|NCT00003805|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5390335|NCT00003805|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5390336|NCT00003805|childhood diffuse large cell lymphoma|childhood diffuse large cell lymphoma
5390337|NCT00003805|childhood immunoblastic large cell lymphoma|childhood immunoblastic large cell lymphoma
5390338|NCT00003805|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
5390339|NCT00003805|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5390340|NCT00003805|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5390341|NCT00003805|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5390342|NCT00003805|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5390343|NCT00003805|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
5390344|NCT00003805|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5390345|NCT00003805|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5390346|NCT00003805|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
5390347|NCT00003805|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
5390348|NCT00003805|fever, sweats, and hot flashes|fever, sweats, and hot flashes
5390349|NCT00003805|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
5390350|NCT00003805|refractory hairy cell leukemia|refractory hairy cell leukemia
5390351|NCT00003805|stage II childhood Hodgkin lymphoma|stage ii childhood hodgkin lymphoma
5390352|NCT00003805|stage I childhood Hodgkin lymphoma|stage i childhood hodgkin lymphoma
5390353|NCT00003805|stage III childhood Hodgkin lymphoma|stage iii childhood hodgkin lymphoma
5390354|NCT00003805|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
5390355|NCT00003805|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
5390356|NCT00003805|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
5390357|NCT00003805|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
5390358|NCT00003805|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
5390359|NCT00003805|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
5390360|NCT00003805|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
5390361|NCT00003805|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
5390362|NCT00003805|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
5390363|NCT00003805|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
5390364|NCT00003805|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5390365|NCT00003805|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5390366|NCT00003805|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5390367|NCT00003805|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5390368|NCT00003805|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5390369|NCT00003805|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5390370|NCT00003805|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5390371|NCT00003805|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5390372|NCT00003805|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5390373|NCT00003805|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5390374|NCT00003805|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5390375|NCT00003805|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5390376|NCT00003805|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5390377|NCT00003805|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5390378|NCT00003805|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5390379|NCT00003805|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5390380|NCT00003805|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5390381|NCT00003805|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5390382|NCT00003805|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5390383|NCT00003805|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5390384|NCT00003805|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5390385|NCT00003805|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5390386|NCT00003805|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5390387|NCT00003805|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5390388|NCT00003805|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5390389|NCT00003805|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5390390|NCT00003805|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5390391|NCT00003805|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
5390392|NCT00003805|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
5390393|NCT00003805|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
5390394|NCT00003805|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
5390395|NCT00003805|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
5390396|NCT00003805|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5390397|NCT00003805|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5390398|NCT00003805|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5390401|NCT00003805|stage I childhood small noncleaved cell lymphoma|stage i childhood small noncleaved cell lymphoma
5390402|NCT00003805|stage I childhood large cell lymphoma|stage i childhood large cell lymphoma
5390403|NCT00003805|stage II childhood small noncleaved cell lymphoma|stage ii childhood small noncleaved cell lymphoma
5390404|NCT00003805|stage II childhood large cell lymphoma|stage ii childhood large cell lymphoma
5390405|NCT00003805|stage III childhood small noncleaved cell lymphoma|stage iii childhood small noncleaved cell lymphoma
5390406|NCT00003805|stage III childhood large cell lymphoma|stage iii childhood large cell lymphoma
5390407|NCT00003805|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
5390408|NCT00003805|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
5390409|NCT00003805|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
5390410|NCT00003805|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
5390411|NCT00003805|stage I mantle cell lymphoma|stage i mantle cell lymphoma
5390412|NCT00003805|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
5390413|NCT00003805|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
5390414|NCT00003805|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
5390554|NCT00087425|Waldenström macroglobulinemia|waldenström macroglobulinemia
5390415|NCT00003805|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
5390416|NCT00003805|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
5390417|NCT00003805|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
5390418|NCT00003805|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
5390419|NCT00003805|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
5390420|NCT00003805|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
5390421|NCT00003805|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
5390422|NCT00003805|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5390423|NCT00003805|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5390424|NCT00003805|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5390425|NCT00003805|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
5390426|NCT00003805|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5390427|NCT00003805|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
5390428|NCT00003805|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
5390429|NCT00003805|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5390430|NCT00003805|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
5390431|NCT00003805|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
5390432|NCT00003805|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5390433|NCT00003805|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5390434|NCT00003805|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5390435|NCT00003805|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
5390436|NCT00003805|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
5390437|NCT00003805|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
5390438|NCT00003805|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
5390439|NCT00003805|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5390440|NCT00003805|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5390441|NCT00003805|stage I marginal zone lymphoma|stage i marginal zone lymphoma
5390442|NCT00003805|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
5390443|NCT00003805|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5390444|NCT00003805|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5390445|NCT00003805|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5390446|NCT00003805|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5390447|NCT00003805|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5390448|NCT00003805|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5390449|NCT00003805|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5390450|NCT00003805|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
5390451|NCT00003804|stage I Wilms tumor|stage i wilms tumor
5390452|NCT00003792|stage IV melanoma|stage iv melanoma
5390453|NCT00003792|recurrent melanoma|recurrent melanoma
5390454|NCT00003743|disseminated neuroblastoma|disseminated neuroblastoma
5390455|NCT00003664|stage IV renal cell cancer|stage iv renal cell cancer
5390456|NCT00003664|recurrent renal cell cancer|recurrent renal cell cancer
5390457|NCT00003639|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5390458|NCT00003639|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5390459|NCT00003639|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5390460|NCT00003639|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5390461|NCT00003639|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
5390462|NCT00003639|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
5390463|NCT00003639|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5390464|NCT00003639|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5390465|NCT00003639|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
5390466|NCT00003639|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
5390467|NCT00003639|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5390468|NCT00003639|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5390469|NCT00003639|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5390470|NCT00003639|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5390471|NCT00003639|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
5390472|NCT00003639|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
5390473|NCT00003639|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5390474|NCT00003639|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5390475|NCT00003639|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5390476|NCT00003604|stage III renal cell cancer|stage iii renal cell cancer
5390478|NCT00003359|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5390479|NCT00003343|stage IV prostate cancer|stage iv prostate cancer
5390480|NCT00003328|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
5390481|NCT00003328|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5390482|NCT00003328|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
5390483|NCT00003328|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5390484|NCT00003328|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
5390485|NCT00003328|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5390486|NCT00003328|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
5390487|NCT00003328|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5390488|NCT00087685|Recurrent Endometrial Cancer|recurrent endometrial cancer
5390489|NCT00087685|Endometrial|endometrial
5390490|NCT00087685|Endometrioid|endometrioid
5390491|NCT00087685|RAD001|rad001
5390494|NCT00087672|Philadelphia negative myeloproliferative disorder|philadelphia negative myeloproliferative disorder
5390495|NCT00087672|CC-5013|cc-5013
5390496|NCT00087672|Lenalidomide|lenalidomide
5390497|NCT00087672|Revlimid|revlimid
5390498|NCT00087672|Antiangiogenesis|antiangiogenesis
5390499|NCT00087659|ADT, BMD, US63, H014|adt, bmd, us63, h014
5390500|NCT00087555|Fibromyalgia|fibromyalgia
5390501|NCT00087555|Pain|pain
5390502|NCT00087542|Hallucinosis/Psychosis|hallucinosis/psychosis
5390503|NCT00087529|PPMS|ppms
5390504|NCT00087529|Primary progressive MS|primary progressive ms
5390505|NCT00087529|Primary progressive multiple sclerosis|primary progressive multiple sclerosis
5390506|NCT00087529|Rituxan|rituxan
5390507|NCT00087529|MS|ms
5390508|NCT00087477|Malignant Melanoma, Pivanex, Histone deacetylases inhibitor|malignant melanoma, pivanex, histone deacetylases inhibitor
5390509|NCT00087464|Acute Infection|acute infection
5390510|NCT00087464|Treatment Naive|treatment naive
5390511|NCT00087464|Treatment Interruption|treatment interruption
5390512|NCT00087451|Progressive or recurrent malignant glioma|progressive or recurrent malignant glioma
5390513|NCT00086645|Autism|autism
5390514|NCT00086645|Asperger Syndrome|asperger syndrome
5390515|NCT00086645|Pervasive Developmental Disorder|pervasive developmental disorder
5390516|NCT00086645|PDD|pdd
5390517|NCT00086645|Rituals|rituals
5390518|NCT00086645|Compulsions|compulsions
5390519|NCT00086645|Stereotypy|stereotypy
5390520|NCT00086645|Routines|routines
5390521|NCT00086645|Repetitive behavior|repetitive behavior
5390522|NCT00086645|SSRI|ssri
5390523|NCT00086645|Serotonin|serotonin
5390524|NCT00003589|recurrent small cell lung cancer|recurrent small cell lung cancer
5390525|NCT00003589|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5390526|NCT00003589|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5390527|NCT00087438|stage I non-small cell lung cancer|stage i non-small cell lung cancer
5390528|NCT00087438|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
5390529|NCT00087438|squamous cell lung cancer|squamous cell lung cancer
5390530|NCT00087438|large cell lung cancer|large cell lung cancer
5390531|NCT00087438|adenocarcinoma of the lung|adenocarcinoma of the lung
5390532|NCT00087438|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
5390533|NCT00087425|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
5390534|NCT00087425|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
5390535|NCT00087425|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5390536|NCT00087425|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5390537|NCT00087425|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5390538|NCT00087425|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
5390539|NCT00087425|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5390540|NCT00087425|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5390541|NCT00087425|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5390542|NCT00087425|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5390543|NCT00087425|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
5390544|NCT00087425|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5390545|NCT00087425|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5390546|NCT00087425|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5390547|NCT00087425|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5390548|NCT00087425|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
5390549|NCT00087425|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
5390550|NCT00087425|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5390551|NCT00087425|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5390552|NCT00087425|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5390553|NCT00087425|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5390791|NCT00086476|GPS|gps
5390555|NCT00087425|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
5390556|NCT00087425|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
5390557|NCT00087425|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5390558|NCT00087425|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5390559|NCT00087425|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5390560|NCT00087399|breast cancer|breast cancer
5390561|NCT00087399|hot flashes|hot flashes
5390562|NCT00087360|colon cancer|colon cancer
5390563|NCT00087360|rectal cancer|rectal cancer
5390564|NCT00087347|recurrent prostate cancer|recurrent prostate cancer
5390565|NCT00087347|stage I prostate cancer|stage i prostate cancer
5390566|NCT00087347|stage IIB prostate cancer|stage iib prostate cancer
5390567|NCT00087347|stage IIA prostate cancer|stage iia prostate cancer
5390568|NCT00087347|stage III prostate cancer|stage iii prostate cancer
5390569|NCT00087347|stage IV prostate cancer|stage iv prostate cancer
5390570|NCT00087347|stage I breast cancer|stage i breast cancer
5390571|NCT00087347|stage II breast cancer|stage ii breast cancer
5390572|NCT00087347|stage IIIA breast cancer|stage iiia breast cancer
5390573|NCT00087347|stage IIIB breast cancer|stage iiib breast cancer
5390574|NCT00087347|stage IIIC breast cancer|stage iiic breast cancer
5390575|NCT00087347|stage IV breast cancer|stage iv breast cancer
5390576|NCT00087347|recurrent breast cancer|recurrent breast cancer
5390577|NCT00087334|recurrent colon cancer|recurrent colon cancer
5390578|NCT00087334|stage IV colon cancer|stage iv colon cancer
5390579|NCT00087334|recurrent rectal cancer|recurrent rectal cancer
5390580|NCT00087334|stage IV rectal cancer|stage iv rectal cancer
5390581|NCT00087295|recurrent bladder cancer|recurrent bladder cancer
5390582|NCT00087295|stage IV bladder cancer|stage iv bladder cancer
5390583|NCT00087295|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
5390584|NCT00087295|metastatic transitional cell cancer of the renal pelvis and ureter|metastatic transitional cell cancer of the renal pelvis and ureter
5390585|NCT00087295|recurrent transitional cell cancer of the renal pelvis and ureter|recurrent transitional cell cancer of the renal pelvis and ureter
5390586|NCT00087295|anterior urethral cancer|anterior urethral cancer
5390587|NCT00087295|posterior urethral cancer|posterior urethral cancer
5390588|NCT00087295|recurrent urethral cancer|recurrent urethral cancer
5390589|NCT00087295|urethral cancer associated with invasive bladder cancer|urethral cancer associated with invasive bladder cancer
5390590|NCT00087282|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
5390591|NCT00087282|advanced adult primary liver cancer|advanced adult primary liver cancer
5390592|NCT00087282|recurrent adult primary liver cancer|recurrent adult primary liver cancer
5390593|NCT00087256|stage I colon cancer|stage i colon cancer
5390594|NCT00087256|adenocarcinoma of the colon|adenocarcinoma of the colon
5390595|NCT00087178|stage I breast cancer|stage i breast cancer
5390596|NCT00087178|stage II breast cancer|stage ii breast cancer
5390597|NCT00087165|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5390598|NCT00087165|recurrent prostate cancer|recurrent prostate cancer
5390599|NCT00087152|stage IV breast cancer|stage iv breast cancer
5390600|NCT00087152|recurrent breast cancer|recurrent breast cancer
5390601|NCT00087126|recurrent cervical cancer|recurrent cervical cancer
5390602|NCT00087126|cervical squamous cell carcinoma|cervical squamous cell carcinoma
5390603|NCT00087113|cervical squamous cell carcinoma|cervical squamous cell carcinoma
5390604|NCT00087113|recurrent cervical cancer|recurrent cervical cancer
5390605|NCT00087113|stage III cervical cancer|stage iii cervical cancer
5390606|NCT00087113|stage IVA cervical cancer|stage iva cervical cancer
5390607|NCT00087113|stage IVB cervical cancer|stage ivb cervical cancer
5390608|NCT00087100|recurrent endometrial carcinoma|recurrent endometrial carcinoma
5390609|NCT00087100|endometrial adenocarcinoma|endometrial adenocarcinoma
5390610|NCT00087100|stage III endometrial carcinoma|stage iii endometrial carcinoma
5390611|NCT00087100|stage IV endometrial carcinoma|stage iv endometrial carcinoma
5390612|NCT00087087|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5390613|NCT00087087|primary peritoneal cavity cancer|primary peritoneal cavity cancer
5390614|NCT00087061|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
5390615|NCT00087061|recurrent adult brain tumor|recurrent adult brain tumor
5390616|NCT00087061|adult glioblastoma|adult glioblastoma
5390617|NCT00087061|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5390618|NCT00087061|adult giant cell glioblastoma|adult giant cell glioblastoma
5390619|NCT00087061|adult gliosarcoma|adult gliosarcoma
5390620|NCT00087048|extensive stage small cell lung cancer|extensive stage small cell lung cancer
5390621|NCT00087048|recurrent small cell lung cancer|recurrent small cell lung cancer
5390622|NCT00087035|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5390623|NCT00087035|recurrent prostate cancer|recurrent prostate cancer
5390624|NCT00087022|clear cell renal cell carcinoma|clear cell renal cell carcinoma
5390625|NCT00087022|stage I renal cell cancer|stage i renal cell cancer
5390626|NCT00087022|stage II renal cell cancer|stage ii renal cell cancer
5390627|NCT00087022|stage III renal cell cancer|stage iii renal cell cancer
5390628|NCT00087022|stage IV renal cell cancer|stage iv renal cell cancer
5390629|NCT00087009|post-transplant lymphoproliferative disorder|post-transplant lymphoproliferative disorder
5390630|NCT00087009|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5390792|NCT00086476|HPS|hps
5390631|NCT00087009|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
5390632|NCT00087009|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
5390633|NCT00087009|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
5390634|NCT00087009|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
5390635|NCT00087009|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
5390636|NCT00087009|AIDS-related primary CNS lymphoma|aids-related primary cns lymphoma
5390637|NCT00086996|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
5390638|NCT00086996|stage II esophageal cancer|stage ii esophageal cancer
5390639|NCT00086996|stage III esophageal cancer|stage iii esophageal cancer
5390640|NCT00086957|stage IV breast cancer|stage iv breast cancer
5390641|NCT00086957|male breast cancer|male breast cancer
5390642|NCT00086957|recurrent breast cancer|recurrent breast cancer
5390643|NCT00086931|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5390644|NCT00086931|stage III rectal cancer|stage iii rectal cancer
5390645|NCT00086931|stage II rectal cancer|stage ii rectal cancer
5390646|NCT00086892|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5390647|NCT00086892|primary peritoneal cavity cancer|primary peritoneal cavity cancer
5390648|NCT00086879|adult glioblastoma|adult glioblastoma
5390649|NCT00086879|recurrent adult brain tumor|recurrent adult brain tumor
5390650|NCT00086879|adult giant cell glioblastoma|adult giant cell glioblastoma
5390651|NCT00086879|adult gliosarcoma|adult gliosarcoma
5390652|NCT00086866|stage III melanoma|stage iii melanoma
5390653|NCT00086866|stage IV melanoma|stage iv melanoma
5390654|NCT00086866|recurrent melanoma|recurrent melanoma
5390655|NCT00086801|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
5390656|NCT00086801|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
5390657|NCT00086775|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5390658|NCT00086775|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
5390659|NCT00086762|nausea and vomiting|nausea and vomiting
5390660|NCT00086762|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5390661|NCT00086762|mindfulness relaxation|mindfulness relaxation
5390662|NCT00086749|breast cancer|breast cancer
5390663|NCT00086749|stage I breast cancer|stage i breast cancer
5390664|NCT00086749|stage II breast cancer|stage ii breast cancer
5390665|NCT00086749|stage IIIA breast cancer|stage iiia breast cancer
5390666|NCT00086749|stage IIIB breast cancer|stage iiib breast cancer
5390667|NCT00086749|stage IIIC breast cancer|stage iiic breast cancer
5390668|NCT00086736|stage I prostate cancer|stage i prostate cancer
5390669|NCT00086736|stage IIB prostate cancer|stage iib prostate cancer
5390670|NCT00086736|stage IIA prostate cancer|stage iia prostate cancer
5390671|NCT00086736|stage III prostate cancer|stage iii prostate cancer
5390672|NCT00086723|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5390673|NCT00086684|Interstitial Cystitis|interstitial cystitis
5390674|NCT00086684|Urinary Bladder Pain|urinary bladder pain
5390675|NCT00086658|Hypereosinophilic Syndrome Hypereosinophilia|hypereosinophilic syndrome hypereosinophilia
5390676|NCT00086658|mepolizumab|mepolizumab
5390677|NCT00086658|anti IL-5|anti il-5
5390678|NCT00086632|oregovomab|oregovomab
5390679|NCT00086632|ovarex|ovarex
5390680|NCT00086632|ovarian cancer|ovarian cancer
5390681|NCT00086632|ovary|ovary
5390682|NCT00086632|ovarian carcinoma|ovarian carcinoma
5390683|NCT00086632|front-line|front-line
5390684|NCT00086606|Peanut|peanut
5390685|NCT00086619|Osteoporosis|osteoporosis
5390686|NCT00086619|Parathyroid hormone|parathyroid hormone
5390687|NCT00086619|Teriparatide|teriparatide
5390688|NCT00086619|Bone formation|bone formation
5390689|NCT00086619|Bone resorption|bone resorption
5390690|NCT00086593|adjunctive|adjunctive
5390691|NCT00086593|atypical antipsychotics|atypical antipsychotics
5390692|NCT00086593|add-on|add-on
5390693|NCT00086593|Schizophrenia|schizophrenia
5390694|NCT00086593|psychosis|psychosis
5390695|NCT00003297|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5390696|NCT00003297|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5390697|NCT00003297|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5390698|NCT00003296|localized resectable adult primary liver cancer|localized resectable adult primary liver cancer
5390699|NCT00003296|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
5390700|NCT00003296|advanced adult primary liver cancer|advanced adult primary liver cancer
5390701|NCT00003296|recurrent adult primary liver cancer|recurrent adult primary liver cancer
5390702|NCT00003296|localized gallbladder cancer|localized gallbladder cancer
5390703|NCT00003296|unresectable gallbladder cancer|unresectable gallbladder cancer
5390704|NCT00003296|recurrent gallbladder cancer|recurrent gallbladder cancer
5390705|NCT00003296|localized extrahepatic bile duct cancer|localized extrahepatic bile duct cancer
5390706|NCT00003296|unresectable extrahepatic bile duct cancer|unresectable extrahepatic bile duct cancer
5390707|NCT00003296|recurrent extrahepatic bile duct cancer|recurrent extrahepatic bile duct cancer
5390708|NCT00003296|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
5390709|NCT00003296|cholangiocarcinoma of the gallbladder|cholangiocarcinoma of the gallbladder
5390710|NCT00003296|cholangiocarcinoma of the extrahepatic bile duct|cholangiocarcinoma of the extrahepatic bile duct
5390793|NCT00086476|Griscelli Disease|griscelli disease
5390711|NCT00003296|adult primary cholangiocellular carcinoma|adult primary cholangiocellular carcinoma
5390712|NCT00003230|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5390713|NCT00003230|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5390714|NCT00003230|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5390715|NCT00003230|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
5390716|NCT00003230|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
5390717|NCT00003198|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5390718|NCT00003109|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5390719|NCT00086541|Chronic Hepatitis C|chronic hepatitis c
5390720|NCT00086541|Liver|liver
5390721|NCT00086541|Pegylated|pegylated
5390722|NCT00086541|Interferon|interferon
5390723|NCT00086541|Alpha|alpha
5390724|NCT00086541|Ribavirin|ribavirin
5390725|NCT00086541|Combination|combination
5390726|NCT00086541|Nonresponder|nonresponder
5390727|NCT00086541|HCV|hcv
5390728|NCT00086541|Infergen|infergen
5390729|NCT00086541|SVR|svr
5390730|NCT00086528|Solid Tumors|solid tumors
5390731|NCT00086411|light smokers, smoking cessation treatment programs|light smokers, smoking cessation treatment programs
5390732|NCT00086385|Smoking cessation|smoking cessation
5390733|NCT00086385|Tobacco|tobacco
5390734|NCT00003091|stage IV renal cell cancer|stage iv renal cell cancer
5390735|NCT00003091|recurrent renal cell cancer|recurrent renal cell cancer
5390736|NCT00003091|stage IV melanoma|stage iv melanoma
5390737|NCT00003091|recurrent melanoma|recurrent melanoma
5390738|NCT00002953|stage IV breast cancer|stage iv breast cancer
5390739|NCT00002922|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5390740|NCT00002922|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
5390741|NCT00002922|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5390742|NCT00002922|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
5390743|NCT00002922|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
5390744|NCT00002922|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
5390745|NCT00002922|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5390746|NCT00002922|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
5390747|NCT00002922|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5390748|NCT00002922|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
5390749|NCT00002922|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
5390750|NCT00002922|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
5390751|NCT00002863|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
5390752|NCT00002863|stage I adult soft tissue sarcoma|stage i adult soft tissue sarcoma
5390753|NCT00002863|stage II adult soft tissue sarcoma|stage ii adult soft tissue sarcoma
5390754|NCT00002863|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
5390755|NCT00002863|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
5390756|NCT00002863|nonmetastatic childhood soft tissue sarcoma|nonmetastatic childhood soft tissue sarcoma
5390757|NCT00002863|recurrent childhood soft tissue sarcoma|recurrent childhood soft tissue sarcoma
5390758|NCT00002863|previously untreated childhood rhabdomyosarcoma|previously untreated childhood rhabdomyosarcoma
5390759|NCT00002863|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
5390760|NCT00086567|Blood|blood
5390761|NCT00086567|Testing|testing
5390762|NCT00086567|Gynecologic|gynecologic
5390763|NCT00086567|Urine|urine
5390764|NCT00086567|CA125|ca125
5390765|NCT00086567|Epithelial Ovarian Cancer|epithelial ovarian cancer
5390766|NCT00086567|Peritoneal Cancer|peritoneal cancer
5390767|NCT00086567|Fallopian Tube Cancer|fallopian tube cancer
5390768|NCT00086554|Surgery|surgery
5390769|NCT00086554|Intestinal Resection|intestinal resection
5390770|NCT00086554|Blood Sample|blood sample
5390771|NCT00086515|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
5390772|NCT00086489|metastatic melanoma|metastatic melanoma
5390773|NCT00086489|multiple dose|multiple dose
5390774|NCT00086463|STEP|step
5390775|NCT00086463|PAH|pah
5390776|NCT00086463|iloprost|iloprost
5390777|NCT00086463|inhalation|inhalation
5390778|NCT00086463|prostacyclin|prostacyclin
5390779|NCT00002999|stage III nasopharyngeal cancer|stage iii nasopharyngeal cancer
5390780|NCT00002999|stage IV nasopharyngeal cancer|stage iv nasopharyngeal cancer
5390781|NCT00086476|Gray Platelet Syndrome|gray platelet syndrome
5390782|NCT00086476|Hermansky-Pudlak Syndrome|hermansky-pudlak syndrome
5390783|NCT00086476|Storage Pool Deficiency|storage pool deficiency
5390784|NCT00086476|Organelle Formation|organelle formation
5390785|NCT00086476|Megakaryocyte Development|megakaryocyte development
5390786|NCT00086476|Megakaryocytes|megakaryocytes
5390787|NCT00086476|Platelets|platelets
5390788|NCT00086476|Dense Granules|dense granules
5390789|NCT00086476|Alpha Granules|alpha granules
5390790|NCT00086476|Lysosome-related Organelles|lysosome-related organelles
5390794|NCT00086476|Chediak Higashi Syndrome|chediak higashi syndrome
5390795|NCT00086476|Wiskott Aldrich Syndrome|wiskott aldrich syndrome
5390796|NCT00086476|Platelet|platelet
5390797|NCT00086476|Congenital Bleeding Disorders|congenital bleeding disorders
5390798|NCT00086476|SAC|sac
5390799|NCT00086476|Vesicle|vesicle
5390800|NCT00086346|Liver|liver
5390801|NCT00086346|Transplant|transplant
5390802|NCT00086333|Carcinoma, Non-Small-Cell Lung|carcinoma, non-small-cell lung
5390803|NCT00086333|Taxotere|taxotere
5390804|NCT00086333|docetaxel|docetaxel
5390805|NCT00086333|taxanes|taxanes
5390806|NCT00086372|Acute Infection|acute infection
5390807|NCT00086372|Treatment Experienced|treatment experienced
5390808|NCT00086372|Treatment Naive|treatment naive
5390809|NCT00086359|Treatment Naive|treatment naive
5390810|NCT00086359|Perinatal Transmission|perinatal transmission
5390811|NCT00086359|Mother-to-Child Transmission|mother-to-child transmission
5390812|NCT00086359|MTCT|mtct
5390813|NCT00086359|Treatment Experienced|treatment experienced
5390814|NCT00086320|Schizophrenia|schizophrenia
5390815|NCT00086320|paliperidone|paliperidone
5390816|NCT00086320|Risperidone|risperidone
5390817|NCT00086281|Sleep-disordered breathing|sleep-disordered breathing
5390818|NCT00086281|Obstructive sleep apnea syndrome|obstructive sleep apnea syndrome
5390819|NCT00086268|lung cancer|lung cancer
5390820|NCT00086268|ZPACT|zpact
5390821|NCT00086268|US75|us75
5390822|NCT00086268|Bone Metastases|bone metastases
5390823|NCT00002837|stage IV breast cancer|stage iv breast cancer
5390824|NCT00002837|recurrent breast cancer|recurrent breast cancer
5390825|NCT00002804|nonmetastatic childhood soft tissue sarcoma|nonmetastatic childhood soft tissue sarcoma
5390826|NCT00002804|metastatic childhood soft tissue sarcoma|metastatic childhood soft tissue sarcoma
5390827|NCT00002751|leptomeningeal metastases|leptomeningeal metastases
5390828|NCT00002733|stage IV renal cell cancer|stage iv renal cell cancer
5390829|NCT00002733|stage IV melanoma|stage iv melanoma
5390830|NCT00002733|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5390831|NCT00002705|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5390832|NCT00002705|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5390833|NCT00002705|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5390834|NCT00002704|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5390835|NCT00002704|T-cell childhood acute lymphoblastic leukemia|t-cell childhood acute lymphoblastic leukemia
5390836|NCT00002704|B-cell childhood acute lymphoblastic leukemia|b-cell childhood acute lymphoblastic leukemia
5390837|NCT00002704|TdT positive childhood acute lymphoblastic leukemia|tdt positive childhood acute lymphoblastic leukemia
5390838|NCT00002691|stage III childhood lymphoblastic lymphoma|stage iii childhood lymphoblastic lymphoma
5390839|NCT00002691|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
5390840|NCT00002691|stage III childhood small noncleaved cell lymphoma|stage iii childhood small noncleaved cell lymphoma
5390841|NCT00002691|stage III childhood large cell lymphoma|stage iii childhood large cell lymphoma
5390842|NCT00002691|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
5390843|NCT00002654|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
5390844|NCT00002654|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5390845|NCT00002654|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
5390846|NCT00002654|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5390847|NCT00002654|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
5390848|NCT00002654|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5390849|NCT00002654|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
5390850|NCT00002654|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5390851|NCT00086307|Pramipexole|pramipexole
5390852|NCT00086307|Escitalopran|escitalopran
5390853|NCT00086307|Antidepressant|antidepressant
5390854|NCT00086307|Dopaminergic Receptor Agonist|dopaminergic receptor agonist
5390855|NCT00086307|Depression|depression
5390856|NCT00086307|Major Depression|major depression
5390857|NCT00086294|Non-Dopaminergic|non-dopaminergic
5390858|NCT00086294|Dyskinesias|dyskinesias
5390859|NCT00086294|Fluctuations|fluctuations
5390860|NCT00086294|Inverse Agonist|inverse agonist
5390861|NCT00086294|ACP-103|acp-103
5390862|NCT00086294|Parkinson Disease|parkinson disease
5390863|NCT00086294|PD|pd
5390864|NCT00086255|cocaine dependence|cocaine dependence
5390865|NCT00086216|Multiple myeloma|multiple myeloma
5390866|NCT00002642|squamous cell lung cancer|squamous cell lung cancer
5390867|NCT00002642|large cell lung cancer|large cell lung cancer
5390868|NCT00002642|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5390869|NCT00002642|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5390870|NCT00002642|adenocarcinoma of the lung|adenocarcinoma of the lung
5390871|NCT00002642|adenosquamous cell lung cancer|adenosquamous cell lung cancer
5390872|NCT00002565|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
5390873|NCT00002565|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
5400389|NCT00079560|Oral THC|oral thc
5390874|NCT00002565|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
5390875|NCT00002565|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
5390876|NCT00002565|stage II grade 3 follicular lymphoma|stage ii grade 3 follicular lymphoma
5390877|NCT00002565|stage II adult diffuse mixed cell lymphoma|stage ii adult diffuse mixed cell lymphoma
5390878|NCT00002565|stage II adult diffuse large cell lymphoma|stage ii adult diffuse large cell lymphoma
5390879|NCT00002565|stage II adult immunoblastic large cell lymphoma|stage ii adult immunoblastic large cell lymphoma
5390880|NCT00002565|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5390881|NCT00002565|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5390882|NCT00002565|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5390883|NCT00002565|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5390884|NCT00002565|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5390885|NCT00002565|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5390886|NCT00002565|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5390887|NCT00002565|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5390888|NCT00002565|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
5390889|NCT00002565|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
5390890|NCT00002565|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
5390891|NCT00002565|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
5390892|NCT00002565|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5390893|NCT00002565|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
5390894|NCT00002565|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
5390895|NCT00002565|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5390896|NCT00086242|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
5390897|NCT00086242|stage IA cervical cancer|stage ia cervical cancer
5390898|NCT00086242|stage IB cervical cancer|stage ib cervical cancer
5390899|NCT00086242|stage IIA cervical cancer|stage iia cervical cancer
5390900|NCT00086242|stage IIB cervical cancer|stage iib cervical cancer
5390901|NCT00086242|stage III cervical cancer|stage iii cervical cancer
5390902|NCT00086229|Complementary Therapies|complementary therapies
5390903|NCT00086190|Parkinson disease|parkinson disease
5390904|NCT00086190|depression|depression
5390905|NCT00086190|Parkinson's disease|parkinson's disease
5390906|NCT00086190|paroxetine|paroxetine
5390907|NCT00086190|venlafaxine|venlafaxine
5390908|NCT00086190|antidepressant|antidepressant
5390909|NCT00086177|Pregnancy,|pregnancy,
5390910|NCT00086177|prevention of preterm birth,|prevention of preterm birth,
5390911|NCT00086177|prevention of preterm labor,|prevention of preterm labor,
5390912|NCT00086164|edifoligide|edifoligide
5390913|NCT00086164|E2F Decoy|e2f decoy
5390914|NCT00086164|Chronic Renal failure|chronic renal failure
5390915|NCT00086164|hemodialysis|hemodialysis
5390916|NCT00086164|AV Graft|av graft
5390917|NCT00086164|neointimal hyperplasia|neointimal hyperplasia
5390918|NCT00086138|Alzheimer's disease|alzheimer's disease
5390919|NCT00086138|Depression|depression
5390920|NCT00086125|Relapsed or refractory hematologic malignancies|relapsed or refractory hematologic malignancies
5390921|NCT00086112|Anxiety|anxiety
5390922|NCT00086112|antipsychotic|antipsychotic
5390923|NCT00006041|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5390924|NCT00006041|fallopian tube cancer|fallopian tube cancer
5390925|NCT00006041|primary peritoneal cavity cancer|primary peritoneal cavity cancer
5390926|NCT00005975|stage I breast cancer|stage i breast cancer
5390927|NCT00005975|stage II breast cancer|stage ii breast cancer
5390928|NCT00005975|hot flashes|hot flashes
5390929|NCT00005854|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5390930|NCT00005854|refractory multiple myeloma|refractory multiple myeloma
5390931|NCT00005854|stage I multiple myeloma|stage i multiple myeloma
5390932|NCT00005854|stage II multiple myeloma|stage ii multiple myeloma
5390933|NCT00005854|stage III multiple myeloma|stage iii multiple myeloma
5390934|NCT00005854|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
5390935|NCT00005854|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5390936|NCT00005854|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5390937|NCT00005854|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5390938|NCT00005854|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5390939|NCT00005854|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5390940|NCT00005854|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5390941|NCT00005854|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5390942|NCT00005854|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5390943|NCT00005854|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5390944|NCT00005854|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
5391347|NCT00085891|Schizophrenia|schizophrenia
5390945|NCT00005854|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5390946|NCT00005854|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5390947|NCT00005854|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
5390948|NCT00005854|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
5390949|NCT00005854|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5390950|NCT00005854|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5390951|NCT00005854|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5390952|NCT00005854|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5390953|NCT00005854|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5390954|NCT00005854|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5390955|NCT00005854|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5390956|NCT00005854|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5390957|NCT00005854|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5390958|NCT00005854|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5390959|NCT00005854|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5390960|NCT00005854|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5390961|NCT00005854|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5390962|NCT00005854|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
5390963|NCT00005854|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
5390964|NCT00005854|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5390965|NCT00005854|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5390966|NCT00005854|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5390967|NCT00005854|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5390968|NCT00005854|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5390969|NCT00005854|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5390970|NCT00005854|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
5390971|NCT00002505|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5390972|NCT00002482|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5390973|NCT00005613|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5390974|NCT00005613|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5390975|NCT00005613|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5390976|NCT00005613|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5390977|NCT00005613|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5390978|NCT00005613|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5390979|NCT00005613|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5390980|NCT00005613|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5390981|NCT00005613|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5390982|NCT00005613|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5390983|NCT00005613|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5390984|NCT00005613|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5390985|NCT00005613|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5390986|NCT00005613|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5390987|NCT00005613|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5390988|NCT00005613|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5390989|NCT00005613|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5390990|NCT00004202|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5390991|NCT00004202|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5390992|NCT00004202|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5390993|NCT00004197|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
5390994|NCT00004197|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
5390995|NCT00004197|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
5390996|NCT00004197|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
5390997|NCT00004197|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5390998|NCT00004197|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5390999|NCT00004197|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5391000|NCT00004197|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5391001|NCT00004197|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5391002|NCT00004197|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5391003|NCT00004197|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5391004|NCT00004197|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5391005|NCT00004197|stage I mantle cell lymphoma|stage i mantle cell lymphoma
5391006|NCT00004197|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
5391348|NCT00085891|Schizophrenic disorder|schizophrenic disorder
5391007|NCT00004197|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
5391008|NCT00004197|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
5391009|NCT00004197|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
5391010|NCT00004197|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
5391011|NCT00004197|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5391012|NCT00004197|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5391013|NCT00004197|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
5391508|NCT00085761|Complementary Therapies|complementary therapies
5391014|NCT00004197|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
5391015|NCT00004197|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5391016|NCT00004197|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5391017|NCT00004197|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5391018|NCT00004192|neutropenia|neutropenia
5391019|NCT00004192|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
5391020|NCT00004192|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5391021|NCT00004192|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5391022|NCT00004192|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5391023|NCT00004192|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5391024|NCT00004192|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5391025|NCT00004192|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5391026|NCT00004192|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5391027|NCT00004192|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5391028|NCT00004192|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5391029|NCT00004192|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5391030|NCT00004192|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5391031|NCT00004192|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5391032|NCT00004192|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5391033|NCT00004192|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5391034|NCT00004192|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5391035|NCT00003995|stage IV colon cancer|stage iv colon cancer
5391036|NCT00003995|stage IV rectal cancer|stage iv rectal cancer
5391037|NCT00003995|recurrent colon cancer|recurrent colon cancer
5391038|NCT00003995|recurrent rectal cancer|recurrent rectal cancer
5391039|NCT00003946|stage IV endometrial carcinoma|stage iv endometrial carcinoma
5391040|NCT00003946|recurrent endometrial carcinoma|recurrent endometrial carcinoma
5391041|NCT00086086|Symptomatic Congestive Heart Failure|symptomatic congestive heart failure
5391042|NCT00086086|CHF|chf
5391043|NCT00086086|Anaemia|anaemia
5391044|NCT00086086|Anemia|anemia
5391045|NCT00086073|Parkinson disease|parkinson disease
5391046|NCT00086073|Parkinson's disease|parkinson's disease
5391047|NCT00086073|PD|pd
5391048|NCT00086073|genetics|genetics
5391049|NCT00086073|genes|genes
5391050|NCT00086073|siblings|siblings
5391051|NCT00086073|family|family
5391052|NCT00003762|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5391053|NCT00003762|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5391054|NCT00003762|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5391055|NCT00003723|advanced malignant mesothelioma|advanced malignant mesothelioma
5391056|NCT00003723|epithelial mesothelioma|epithelial mesothelioma
5391057|NCT00003723|sarcomatous mesothelioma|sarcomatous mesothelioma
5391058|NCT00003691|stage III endometrial carcinoma|stage iii endometrial carcinoma
5391059|NCT00003691|stage IV endometrial carcinoma|stage iv endometrial carcinoma
5391060|NCT00003691|recurrent endometrial carcinoma|recurrent endometrial carcinoma
5391061|NCT00003667|nonmetastatic childhood soft tissue sarcoma|nonmetastatic childhood soft tissue sarcoma
5391062|NCT00003667|metastatic childhood soft tissue sarcoma|metastatic childhood soft tissue sarcoma
5391063|NCT00003667|extraosseous Ewing sarcoma/peripheral primitive neuroectodermal tumor|extraosseous ewing sarcoma/peripheral primitive neuroectodermal tumor
5391064|NCT00003667|localized Ewing sarcoma/peripheral primitive neuroectodermal tumor|localized ewing sarcoma/peripheral primitive neuroectodermal tumor
5391065|NCT00003667|metastatic Ewing sarcoma/peripheral primitive neuroectodermal tumor|metastatic ewing sarcoma/peripheral primitive neuroectodermal tumor
5391066|NCT00003630|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
5391067|NCT00003630|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5391068|NCT00003549|stage II neuroendocrine carcinoma of the skin|stage ii neuroendocrine carcinoma of the skin
5391069|NCT00003549|stage III neuroendocrine carcinoma of the skin|stage iii neuroendocrine carcinoma of the skin
5391070|NCT00003549|recurrent neuroendocrine carcinoma of the skin|recurrent neuroendocrine carcinoma of the skin
5391071|NCT00003369|stage IV cervical cancer|stage iv cervical cancer
5391072|NCT00003369|recurrent cervical cancer|recurrent cervical cancer
5391073|NCT00003369|cervical squamous cell carcinoma|cervical squamous cell carcinoma
5391074|NCT00003369|cervical adenosquamous cell carcinoma|cervical adenosquamous cell carcinoma
5391075|NCT00003317|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5391076|NCT00003127|stage IV endometrial carcinoma|stage iv endometrial carcinoma
5391077|NCT00003127|recurrent endometrial carcinoma|recurrent endometrial carcinoma
5391078|NCT00003127|endometrial adenocarcinoma|endometrial adenocarcinoma
5391079|NCT00003127|endometrial adenosquamous cell carcinoma|endometrial adenosquamous cell carcinoma
5391080|NCT00003127|endometrial clear cell carcinoma|endometrial clear cell carcinoma
5391081|NCT00086060|Internal-External Control|internal-external control
5391082|NCT00086060|Magnetic Resonance Imaging|magnetic resonance imaging
5391083|NCT00086060|fMRI|fmri
5391084|NCT00086060|Exercise|exercise
5391085|NCT00086060|Relaxation|relaxation
5391086|NCT00086047|Juvenile Fibromyalgia Syndrome|juvenile fibromyalgia syndrome
5391087|NCT00086047|JPFS|jpfs
5391088|NCT00086047|Fibromyalgia|fibromyalgia
5391089|NCT00086047|Chronic Pain|chronic pain
5391090|NCT00086047|Pediatric Pain|pediatric pain
5391091|NCT00086047|Juvenile Fibromyalgia|juvenile fibromyalgia
5391092|NCT00086034|Lymphoma|lymphoma
5391093|NCT00086034|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
5391094|NCT00086034|Indolent lymphoma|indolent lymphoma
5391095|NCT00086034|Relapsed lymphoma|relapsed lymphoma
5391096|NCT00086034|Refractory lymphoma|refractory lymphoma
5391097|NCT00086034|Motexafin gadolinium|motexafin gadolinium
5391098|NCT00003078|stage III cervical cancer|stage iii cervical cancer
5391099|NCT00003078|stage IIB cervical cancer|stage iib cervical cancer
5391100|NCT00003078|stage IVA cervical cancer|stage iva cervical cancer
5391101|NCT00003078|cervical squamous cell carcinoma|cervical squamous cell carcinoma
5391102|NCT00003078|cervical adenocarcinoma|cervical adenocarcinoma
5391103|NCT00003078|cervical adenosquamous cell carcinoma|cervical adenosquamous cell carcinoma
5391104|NCT00002844|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5391105|NCT00002844|Cyclophosphamide|cyclophosphamide
5391106|NCT00002844|Cytoxan|cytoxan
5391107|NCT00002844|Neosar|neosar
5391108|NCT00002844|Bone Marrow Transplantation|bone marrow transplantation
5391109|NCT00002844|total body irradiation|total body irradiation
5391110|NCT00002844|chronic lymphocytic leukemia|chronic lymphocytic leukemia
5391111|NCT00002844|allogeneic|allogeneic
5391112|NCT00002844|autologous|autologous
5391113|NCT00002816|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5391114|NCT00002747|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
5391115|NCT00002747|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
5391116|NCT00002747|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5391117|NCT00002725|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5391609|NCT00003254|stage IV rectal cancer|stage iv rectal cancer
5391118|NCT00002725|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5391119|NCT00002725|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5391120|NCT00002725|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5391121|NCT00002725|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5391122|NCT00002725|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5391123|NCT00002725|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5391124|NCT00002725|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5391125|NCT00002725|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5391126|NCT00002725|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5391127|NCT00002725|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5391128|NCT00002725|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5391129|NCT00002725|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5391130|NCT00002725|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5391131|NCT00002725|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5391132|NCT00086021|Headache|headache
5391133|NCT00086021|Acupuncture|acupuncture
5391134|NCT00085969|diabetes|diabetes
5391135|NCT00085969|exenatide|exenatide
5391136|NCT00085969|Amylin|amylin
5391137|NCT00085969|Lilly|lilly
5391138|NCT00006241|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5391139|NCT00006241|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5391140|NCT00006241|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5391141|NCT00006241|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5391142|NCT00006241|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5391143|NCT00006241|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5391144|NCT00006241|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5391145|NCT00006241|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5391146|NCT00006241|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5391147|NCT00006241|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5391148|NCT00006241|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5391149|NCT00006241|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5391150|NCT00006235|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5391151|NCT00006235|ovarian undifferentiated adenocarcinoma|ovarian undifferentiated adenocarcinoma
5391152|NCT00006235|ovarian mixed epithelial carcinoma|ovarian mixed epithelial carcinoma
5391153|NCT00006235|ovarian serous cystadenocarcinoma|ovarian serous cystadenocarcinoma
5391154|NCT00006235|ovarian mucinous cystadenocarcinoma|ovarian mucinous cystadenocarcinoma
5391155|NCT00006235|ovarian endometrioid adenocarcinoma|ovarian endometrioid adenocarcinoma
5391156|NCT00006235|ovarian clear cell cystadenocarcinoma|ovarian clear cell cystadenocarcinoma
5391157|NCT00006235|fallopian tube cancer|fallopian tube cancer
5391158|NCT00006235|primary peritoneal cavity cancer|primary peritoneal cavity cancer
5391159|NCT00006235|Brenner tumor|brenner tumor
5391160|NCT00006214|prostate cancer|prostate cancer
5391161|NCT00006117|stage III pancreatic cancer|stage iii pancreatic cancer
5391162|NCT00006117|stage IV pancreatic cancer|stage iv pancreatic cancer
5391163|NCT00006117|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
5391164|NCT00006116|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5391165|NCT00006116|squamous cell lung cancer|squamous cell lung cancer
5391166|NCT00006116|large cell lung cancer|large cell lung cancer
5391167|NCT00006116|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5391168|NCT00006116|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5391169|NCT00006116|adenocarcinoma of the lung|adenocarcinoma of the lung
5391170|NCT00006088|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5391171|NCT00002717|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5391172|NCT00002717|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5391173|NCT00002717|ovarian undifferentiated adenocarcinoma|ovarian undifferentiated adenocarcinoma
5391174|NCT00002717|ovarian mixed epithelial carcinoma|ovarian mixed epithelial carcinoma
5391175|NCT00002717|ovarian serous cystadenocarcinoma|ovarian serous cystadenocarcinoma
5391176|NCT00002717|ovarian mucinous cystadenocarcinoma|ovarian mucinous cystadenocarcinoma
5391177|NCT00002717|ovarian endometrioid adenocarcinoma|ovarian endometrioid adenocarcinoma
5391178|NCT00002717|ovarian clear cell cystadenocarcinoma|ovarian clear cell cystadenocarcinoma
5391179|NCT00002717|primary peritoneal cavity cancer|primary peritoneal cavity cancer
5391180|NCT00002717|Brenner tumor|brenner tumor
5391181|NCT00002657|isolated plasmacytoma of bone|isolated plasmacytoma of bone
5391182|NCT00002657|extramedullary plasmacytoma|extramedullary plasmacytoma
5391183|NCT00002657|refractory multiple myeloma|refractory multiple myeloma
5391184|NCT00002657|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
5391185|NCT00002657|stage I multiple myeloma|stage i multiple myeloma
5391186|NCT00002657|stage II multiple myeloma|stage ii multiple myeloma
5391187|NCT00002657|stage III multiple myeloma|stage iii multiple myeloma
5391188|NCT00002657|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
5391189|NCT00002657|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
5391190|NCT00002657|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
5391191|NCT00002657|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
5391192|NCT00002657|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
5391193|NCT00002657|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
5391194|NCT00002657|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
5391195|NCT00002657|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
5391196|NCT00002657|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
5391197|NCT00002657|stage II small lymphocytic lymphoma|stage ii small lymphocytic lymphoma
5391198|NCT00002657|stage II grade 1 follicular lymphoma|stage ii grade 1 follicular lymphoma
5391199|NCT00002657|stage II grade 2 follicular lymphoma|stage ii grade 2 follicular lymphoma
5391200|NCT00002657|stage II grade 3 follicular lymphoma|stage ii grade 3 follicular lymphoma
5391201|NCT00002657|stage II adult diffuse small cleaved cell lymphoma|stage ii adult diffuse small cleaved cell lymphoma
5391202|NCT00002657|stage II adult diffuse mixed cell lymphoma|stage ii adult diffuse mixed cell lymphoma
5391203|NCT00002657|stage II adult diffuse large cell lymphoma|stage ii adult diffuse large cell lymphoma
5391204|NCT00002657|stage II adult immunoblastic large cell lymphoma|stage ii adult immunoblastic large cell lymphoma
5391205|NCT00002657|stage II adult Burkitt lymphoma|stage ii adult burkitt lymphoma
5391206|NCT00002657|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5391207|NCT00002657|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5391208|NCT00002657|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5391209|NCT00002657|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5391210|NCT00002657|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5391211|NCT00002657|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5391212|NCT00002657|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5391213|NCT00002657|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5391214|NCT00002657|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5391215|NCT00002657|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5391216|NCT00002657|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5391217|NCT00002657|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5391218|NCT00002657|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5391349|NCT00085878|IL-18|il-18
5391219|NCT00002657|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5391220|NCT00002657|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5391221|NCT00002657|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5391222|NCT00002657|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5391223|NCT00002657|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5391224|NCT00002657|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5391225|NCT00002657|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5391226|NCT00002657|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5391227|NCT00002657|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5391228|NCT00002657|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5391229|NCT00002657|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5391230|NCT00002657|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5391231|NCT00002657|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5391232|NCT00002657|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5391233|NCT00002657|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
5391234|NCT00002657|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
5391235|NCT00002657|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
5391236|NCT00002657|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
5391237|NCT00002657|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
5391238|NCT00002657|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
5391239|NCT00002657|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
5391240|NCT00002657|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
5391241|NCT00002657|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5391242|NCT00002657|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5391243|NCT00002657|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5391244|NCT00002657|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
5391245|NCT00002657|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
5391246|NCT00002657|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
5391247|NCT00002657|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5391248|NCT00002657|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
5391249|NCT00002657|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
5391250|NCT00002657|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
5391251|NCT00002657|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5391252|NCT00002657|stage I marginal zone lymphoma|stage i marginal zone lymphoma
5391253|NCT00002657|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5391254|NCT00002657|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5391255|NCT00002657|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
5391256|NCT00002657|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
5391257|NCT00002657|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5391258|NCT00002657|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5391259|NCT00002657|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5391260|NCT00085995|Syndesmophyte|syndesmophyte
5391261|NCT00085995|Ankylosing Spondylitis|ankylosing spondylitis
5391262|NCT00085995|AS|as
5391263|NCT00085995|Spondyloarthropathy|spondyloarthropathy
5391264|NCT00085995|Spondyloarthritis|spondyloarthritis
5391265|NCT00085982|Rabson Mendenhall|rabson mendenhall
5391266|NCT00085982|Type B Insulin Resistance|type b insulin resistance
5391267|NCT00085982|Type A Insulin Resistance|type a insulin resistance
5391268|NCT00085982|Diabetes|diabetes
5391269|NCT00085943|ritonavir|ritonavir
5391270|NCT00085943|abacavir|abacavir
5391271|NCT00085943|HIV|hiv
5391272|NCT00085943|lopinavir|lopinavir
5391273|NCT00085943|lamivudine|lamivudine
5391274|NCT00085943|fosamprenavir|fosamprenavir
5391275|NCT00085943|Epzicom|epzicom
5391276|NCT00085930|Neuroblastoma|neuroblastoma
5391277|NCT00006035|stage III melanoma|stage iii melanoma
5391278|NCT00006035|stage IV melanoma|stage iv melanoma
5391279|NCT00006035|recurrent melanoma|recurrent melanoma
5391280|NCT00006033|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
5391281|NCT00006033|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
5391282|NCT00006033|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5391283|NCT00006033|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
5391284|NCT00006033|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
5391489|NCT00085826|Lung Cancer|lung cancer
5391285|NCT00006033|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5391286|NCT00006033|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
5391287|NCT00006033|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
5391288|NCT00006033|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
5391289|NCT00006033|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
5391290|NCT00006033|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
5391291|NCT00006033|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5391292|NCT00006033|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
5391293|NCT00006033|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
5391294|NCT00006033|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5391295|NCT00006033|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
5391296|NCT00006033|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
5391297|NCT00006033|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
5391298|NCT00006033|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
5391299|NCT00005993|stage IV breast cancer|stage iv breast cancer
5391300|NCT00005993|stage IIIA breast cancer|stage iiia breast cancer
5391301|NCT00005993|recurrent breast cancer|recurrent breast cancer
5391302|NCT00005993|stage IIIB breast cancer|stage iiib breast cancer
5391303|NCT00005993|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5391304|NCT00005993|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5391305|NCT00005993|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5391306|NCT00005993|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5391307|NCT00005993|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5391610|NCT00003254|recurrent colon cancer|recurrent colon cancer
5391308|NCT00005993|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5391309|NCT00005993|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5391310|NCT00005993|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5391311|NCT00005993|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5391312|NCT00005993|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5391313|NCT00005993|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5391314|NCT00005993|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5391315|NCT00005993|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5391316|NCT00005993|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5391317|NCT00005993|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5391318|NCT00005993|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5391319|NCT00005993|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5391320|NCT00005993|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5391321|NCT00005993|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5391322|NCT00005993|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5391323|NCT00005993|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5391324|NCT00005993|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5391325|NCT00005993|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5391326|NCT00005993|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5391327|NCT00005993|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
5391328|NCT00005993|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
5391329|NCT00005993|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5391330|NCT00005993|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
5391331|NCT00005993|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
5391332|NCT00005993|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5391333|NCT00005993|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5391334|NCT00005993|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5391335|NCT00005993|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5391336|NCT00005993|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5391337|NCT00005993|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5391338|NCT00005993|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5391339|NCT00005993|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5391340|NCT00005968|stage IV melanoma|stage iv melanoma
5391341|NCT00085904|Advanced cancer|advanced cancer
5391342|NCT00085904|IL-18|il-18
5391343|NCT00085904|repeat dosing|repeat dosing
5391344|NCT00085904|Phase 1|phase 1
5391345|NCT00085904|pharmacokinetics|pharmacokinetics
5391346|NCT00085904|oncology|oncology
5391490|NCT00085826|NSCLC|nsclc
5391350|NCT00085878|subcutaneous|subcutaneous
5391351|NCT00085878|pharmacokinetics|pharmacokinetics
5391352|NCT00085878|Phase 1|phase 1
5391353|NCT00005829|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5391354|NCT00005829|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
5391355|NCT00005826|adult glioblastoma|adult glioblastoma
5391356|NCT00005826|adult giant cell glioblastoma|adult giant cell glioblastoma
5391357|NCT00005826|adult gliosarcoma|adult gliosarcoma
5391358|NCT00005616|stage I colon cancer|stage i colon cancer
5391359|NCT00005616|stage II colon cancer|stage ii colon cancer
5391360|NCT00005616|stage III colon cancer|stage iii colon cancer
5391361|NCT00005616|stage IV colon cancer|stage iv colon cancer
5391362|NCT00005616|stage I rectal cancer|stage i rectal cancer
5391363|NCT00005616|stage II rectal cancer|stage ii rectal cancer
5391364|NCT00005616|stage III rectal cancer|stage iii rectal cancer
5391365|NCT00005616|stage IV rectal cancer|stage iv rectal cancer
5391366|NCT00005616|recurrent colon cancer|recurrent colon cancer
5391367|NCT00005616|recurrent rectal cancer|recurrent rectal cancer
5391368|NCT00005616|liver metastases|liver metastases
5391369|NCT00005093|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5391370|NCT00005093|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5391371|NCT00005093|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5391372|NCT00005093|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5391373|NCT00005073|stage I prostate cancer|stage i prostate cancer
5391374|NCT00005073|stage IIB prostate cancer|stage iib prostate cancer
5391375|NCT00005073|stage IIA prostate cancer|stage iia prostate cancer
5391376|NCT00005073|stage III prostate cancer|stage iii prostate cancer
5391377|NCT00005073|recurrent prostate cancer|recurrent prostate cancer
5391378|NCT00005048|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5391379|NCT00005048|recurrent prostate cancer|recurrent prostate cancer
5391380|NCT00005041|extensive stage small cell lung cancer|extensive stage small cell lung cancer
5391381|NCT00005041|recurrent small cell lung cancer|recurrent small cell lung cancer
5391382|NCT00004929|recurrent prostate cancer|recurrent prostate cancer
5391383|NCT00004861|stage II pancreatic cancer|stage ii pancreatic cancer
5391384|NCT00004861|stage III pancreatic cancer|stage iii pancreatic cancer
5391385|NCT00004861|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
5391386|NCT00004861|stage IV pancreatic cancer|stage iv pancreatic cancer
5391387|NCT00004260|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
5391388|NCT00004260|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
5391389|NCT00004260|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
5391390|NCT00004260|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
5391391|NCT00004260|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
5391392|NCT00004260|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
5391393|NCT00004260|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
5391394|NCT00004260|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
5391395|NCT00004260|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
5391396|NCT00004260|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5391397|NCT00004260|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5391398|NCT00004260|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5391399|NCT00004260|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5391400|NCT00004260|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5391401|NCT00004260|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5391402|NCT00004260|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5391403|NCT00004260|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5391404|NCT00004260|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5391405|NCT00004260|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5391406|NCT00004260|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5391407|NCT00004260|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5391408|NCT00004260|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5391409|NCT00004260|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5391410|NCT00004260|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5391411|NCT00004260|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5391412|NCT00004260|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5391413|NCT00004260|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5391414|NCT00004260|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5391415|NCT00004260|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5391416|NCT00004260|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5391417|NCT00004260|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5391418|NCT00004260|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5391419|NCT00004260|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5391420|NCT00004260|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5400390|NCT00079560|Appetite|appetite
5391421|NCT00004260|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5391422|NCT00004260|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5391423|NCT00004260|stage I mantle cell lymphoma|stage i mantle cell lymphoma
5391424|NCT00004260|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
5391425|NCT00004260|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
5391426|NCT00004260|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
5391427|NCT00004260|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
5391428|NCT00004260|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
5391429|NCT00004260|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
5391430|NCT00004260|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
5391431|NCT00004260|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
5391432|NCT00004260|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
5391433|NCT00004260|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
5391434|NCT00004260|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5391435|NCT00004260|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5391436|NCT00004260|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5391437|NCT00004260|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
5391438|NCT00004260|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5391439|NCT00004260|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
5391440|NCT00004260|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
5391441|NCT00004260|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5391442|NCT00004260|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
5391443|NCT00004260|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
5391444|NCT00004260|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5391445|NCT00004260|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5391446|NCT00004260|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5391447|NCT00004260|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
5391448|NCT00004260|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
5391449|NCT00004260|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5391450|NCT00004260|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5391451|NCT00004260|stage I marginal zone lymphoma|stage i marginal zone lymphoma
5391452|NCT00004260|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
5391453|NCT00004260|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5391454|NCT00004260|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5391455|NCT00004260|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5391456|NCT00004260|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5391457|NCT00004260|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
5391458|NCT00004260|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
5391459|NCT00004260|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5391460|NCT00004260|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5391461|NCT00004260|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5391462|NCT00004217|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
5391463|NCT00004217|adult acute erythroid leukemia (M6)|adult acute erythroid leukemia (m6)
5391464|NCT00004217|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
5391465|NCT00004217|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
5391466|NCT00004217|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
5391467|NCT00004217|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
5391468|NCT00004217|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
5391469|NCT00004217|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
5391470|NCT00004217|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
5391471|NCT00085917|Pegasys|pegasys
5391472|NCT00085917|Ribavirin|ribavirin
5391473|NCT00085917|Early Virological Response|early virological response
5391474|NCT00085917|Hepatitis C|hepatitis c
5391476|NCT00085852|emphysema|emphysema
5391477|NCT00085852|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
5391478|NCT00085852|lung volume reduction|lung volume reduction
5391479|NCT00085852|bronchoscopic|bronchoscopic
5391480|NCT00085852|bronchoscopy|bronchoscopy
5391481|NCT00085852|bronchoscope|bronchoscope
5391482|NCT00085839|Tarceva|tarceva
5391483|NCT00085839|NSCLC|nsclc
5391484|NCT00085839|EGFR|egfr
5391485|NCT00085839|ECOG Performance Status 2|ecog performance status 2
5391486|NCT00085839|erlotinib|erlotinib
5391487|NCT00085839|Non-Small Cell Lung Cancer|non-small cell lung cancer
5391488|NCT00085839|OSI-774|osi-774
5391491|NCT00085826|Non-small Cell Lung Cancer|non-small cell lung cancer
5391492|NCT00085813|Platinum-Refractory|platinum-refractory
5391493|NCT00085813|Platinum-Relapsed|platinum-relapsed
5391494|NCT00085813|Non-Small Cell Lung Cancer|non-small cell lung cancer
5391495|NCT00085774|albuterol|albuterol
5391496|NCT00085774|aerosol inhaler|aerosol inhaler
5391497|NCT00085774|metered-dose inhaler|metered-dose inhaler
5391498|NCT00085774|breath-actuated inhaler|breath-actuated inhaler
5391499|NCT00085774|exercise-induced bronchospasm|exercise-induced bronchospasm
5391500|NCT00085761|Dermal assessment|dermal assessment
5391501|NCT00085761|Pain measurement|pain measurement
5391502|NCT00085761|Diary|diary
5391503|NCT00085761|Neuropathy|neuropathy
5391504|NCT00085761|Analgesics/*therapeutic use|analgesics/*therapeutic use
5391505|NCT00085761|Capsaicin/*administration & dosage/adverse effects|capsaicin/*administration & dosage/adverse effects
5391506|NCT00085761|HIV Infections/*complications/*drug therapy|hiv infections/*complications/*drug therapy
5391507|NCT00085761|Pain|pain
5391509|NCT00004251|stage IV endometrial carcinoma|stage iv endometrial carcinoma
5391510|NCT00004251|recurrent endometrial carcinoma|recurrent endometrial carcinoma
5391511|NCT00004251|endometrial adenocarcinoma|endometrial adenocarcinoma
5391512|NCT00004251|endometrial adenosquamous cell carcinoma|endometrial adenosquamous cell carcinoma
5391513|NCT00004076|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5391514|NCT00004043|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5391515|NCT00004043|recurrent prostate cancer|recurrent prostate cancer
5391516|NCT00003996|adult glioblastoma|adult glioblastoma
5391517|NCT00003996|adult giant cell glioblastoma|adult giant cell glioblastoma
5391518|NCT00003996|adult gliosarcoma|adult gliosarcoma
5391519|NCT00003920|stage IV breast cancer|stage iv breast cancer
5391520|NCT00003920|recurrent breast cancer|recurrent breast cancer
5391521|NCT00003898|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
5391522|NCT00003898|oral complications|oral complications
5391523|NCT00003894|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
5391524|NCT00003894|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5391525|NCT00003894|graft versus host disease|graft versus host disease
5391526|NCT00003891|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5391527|NCT00085865|5 HT|5 ht
5391528|NCT00085865|Neuroreceptors|neuroreceptors
5391529|NCT00085865|Radiotracer|radiotracer
5391530|NCT00085865|Neuroimaging|neuroimaging
5391531|NCT00085865|Serotonin Transporter|serotonin transporter
5391532|NCT00085865|Alcoholism|alcoholism
5391533|NCT00085865|PET|pet
5391534|NCT00085865|Healthy Volunteer|healthy volunteer
5391535|NCT00085865|HV|hv
5391536|NCT00085748|schizophrenia|schizophrenia
5391537|NCT00085748|geriatric|geriatric
5391538|NCT00085748|elderly|elderly
5391539|NCT00085722|Injection Therapy|injection therapy
5391540|NCT00085709|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
5391541|NCT00085709|adult acute eosinophilic leukemia|adult acute eosinophilic leukemia
5391542|NCT00085709|adult acute basophilic leukemia|adult acute basophilic leukemia
5391543|NCT00085709|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
5391544|NCT00085709|adult acute erythroid leukemia (M6)|adult acute erythroid leukemia (m6)
5391545|NCT00085709|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
5391546|NCT00085709|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
5391547|NCT00085709|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
5391548|NCT00085709|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
5391549|NCT00085709|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
5391550|NCT00085709|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
5391551|NCT00085709|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5391552|NCT00085709|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5391553|NCT00085709|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5391554|NCT00085709|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5391555|NCT00003871|stage IV prostate cancer|stage iv prostate cancer
5391556|NCT00003871|recurrent prostate cancer|recurrent prostate cancer
5391557|NCT00003860|extensive stage small cell lung cancer|extensive stage small cell lung cancer
5391558|NCT00003847|recurrent small cell lung cancer|recurrent small cell lung cancer
5391559|NCT00003847|intermediate type small cell lung cancer|intermediate type small cell lung cancer
5391560|NCT00003829|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
5391561|NCT00003829|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
5391562|NCT00003829|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5391563|NCT00003829|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5391564|NCT00003829|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
5391565|NCT00003720|AIDS-related Kaposi sarcoma|aids-related kaposi sarcoma
5391566|NCT00003720|recurrent Kaposi sarcoma|recurrent kaposi sarcoma
5391567|NCT00003624|stage I cervical cancer|stage i cervical cancer
5391568|NCT00003624|stage II cervical cancer|stage ii cervical cancer
5391569|NCT00003624|stage III cervical cancer|stage iii cervical cancer
5391570|NCT00003624|stage IV cervical cancer|stage iv cervical cancer
5391571|NCT00003624|stage I ovarian epithelial cancer|stage i ovarian epithelial cancer
5391572|NCT00003624|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
5391573|NCT00003624|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5391574|NCT00003624|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5391575|NCT00003624|stage I endometrial carcinoma|stage i endometrial carcinoma
5391576|NCT00003624|stage II endometrial carcinoma|stage ii endometrial carcinoma
5391577|NCT00003624|stage III endometrial carcinoma|stage iii endometrial carcinoma
5391578|NCT00003624|stage IV endometrial carcinoma|stage iv endometrial carcinoma
5391579|NCT00003624|endometrial adenocarcinoma|endometrial adenocarcinoma
5391580|NCT00003624|fallopian tube cancer|fallopian tube cancer
5391581|NCT00003624|primary peritoneal cavity cancer|primary peritoneal cavity cancer
5391582|NCT00003624|stage I uterine sarcoma|stage i uterine sarcoma
5391583|NCT00003624|stage II uterine sarcoma|stage ii uterine sarcoma
5391584|NCT00003624|stage III uterine sarcoma|stage iii uterine sarcoma
5391585|NCT00003624|stage IV uterine sarcoma|stage iv uterine sarcoma
5391586|NCT00003624|neurotoxicity|neurotoxicity
5391587|NCT00003592|stage IV salivary gland cancer|stage iv salivary gland cancer
5391588|NCT00003592|recurrent salivary gland cancer|recurrent salivary gland cancer
5391589|NCT00003592|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
5391590|NCT00003592|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5391591|NCT00003592|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
5391592|NCT00003592|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5391593|NCT00003592|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
5391594|NCT00003592|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
5391595|NCT00003592|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
5391596|NCT00003592|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5391597|NCT00003592|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
5391598|NCT00003592|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5391599|NCT00003592|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
5391600|NCT00003592|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
5391601|NCT00003592|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
5391602|NCT00003574|recurrent adult brain tumor|recurrent adult brain tumor
5391603|NCT00003574|adult glioblastoma|adult glioblastoma
5391604|NCT00003574|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5391605|NCT00003574|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
5391606|NCT00003574|adult giant cell glioblastoma|adult giant cell glioblastoma
5391607|NCT00003574|adult gliosarcoma|adult gliosarcoma
5391608|NCT00003254|stage IV colon cancer|stage iv colon cancer
5391611|NCT00003254|recurrent rectal cancer|recurrent rectal cancer
5391612|NCT00003242|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5391613|NCT00003206|stage IV nasopharyngeal cancer|stage iv nasopharyngeal cancer
5391614|NCT00003206|recurrent nasopharyngeal cancer|recurrent nasopharyngeal cancer
5391615|NCT00003143|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5391616|NCT00003143|Waldenström macroglobulinemia|waldenström macroglobulinemia
5391617|NCT00003143|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5391618|NCT00003143|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5391619|NCT00003143|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5391620|NCT00003143|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5391621|NCT00003143|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5391622|NCT00003143|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5391623|NCT00003143|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5391624|NCT00003143|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5391625|NCT00003143|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5391626|NCT00003143|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5391627|NCT00003143|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5391628|NCT00003143|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5391629|NCT00003143|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5391630|NCT00003143|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5391631|NCT00003143|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5391632|NCT00003099|breast cancer|breast cancer
5391633|NCT00003099|Tamoxifen|tamoxifen
5391634|NCT00003099|Fenretinide|fenretinide
5391635|NCT00003099|Chemoprevention Therapy|chemoprevention therapy
5391636|NCT00003099|N-(4-hydroxyphenyl) Retinamide|n-(4-hydroxyphenyl) retinamide
5391637|NCT00003099|4-HPR|4-hpr
5391638|NCT00003099|Breast Neoplasia|breast neoplasia
5391639|NCT00003099|Diagnostic Core Biopsy|diagnostic core biopsy
5391640|NCT00003099|Surgery|surgery
5391641|NCT00003085|stage I pancreatic cancer|stage i pancreatic cancer
5391642|NCT00003085|stage II pancreatic cancer|stage ii pancreatic cancer
5391643|NCT00003028|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5391644|NCT00003009|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5391645|NCT00002973|stage III melanoma|stage iii melanoma
5391646|NCT00002973|stage IV melanoma|stage iv melanoma
5391647|NCT00002973|recurrent melanoma|recurrent melanoma
5391648|NCT00002949|stage II cervical cancer|stage ii cervical cancer
5391649|NCT00002949|stage III cervical cancer|stage iii cervical cancer
5391650|NCT00002949|stage IV cervical cancer|stage iv cervical cancer
5391651|NCT00002949|stage II vaginal cancer|stage ii vaginal cancer
5391652|NCT00002949|stage III vaginal cancer|stage iii vaginal cancer
5391653|NCT00002949|stage IVA vaginal cancer|stage iva vaginal cancer
5391654|NCT00002949|stage IVB vaginal cancer|stage ivb vaginal cancer
5391655|NCT00002949|stage II endometrial carcinoma|stage ii endometrial carcinoma
5391656|NCT00002949|stage III endometrial carcinoma|stage iii endometrial carcinoma
5391657|NCT00002949|stage IV endometrial carcinoma|stage iv endometrial carcinoma
5391658|NCT00002949|stage II bladder cancer|stage ii bladder cancer
5391659|NCT00002949|stage III bladder cancer|stage iii bladder cancer
5391660|NCT00002949|stage IV bladder cancer|stage iv bladder cancer
5391661|NCT00002915|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5391662|NCT00002864|stage I breast cancer|stage i breast cancer
5391663|NCT00002864|stage II breast cancer|stage ii breast cancer
5391664|NCT00002864|stage III breast cancer|stage iii breast cancer
5391665|NCT00002838|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5391666|NCT00002838|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5391667|NCT00002838|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5391668|NCT00002785|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
5391669|NCT00002740|disseminated neuroblastoma|disseminated neuroblastoma
5391670|NCT00085696|Lymphoma|lymphoma
5391671|NCT00085696|Non-Hodgkin's|non-hodgkin's
5391673|NCT00085696|B-Cell|b-cell
5391674|NCT00085696|Indolent|indolent
5391675|NCT00085683|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
5391676|NCT00085683|Lumbar Puncture|lumbar puncture
5391677|NCT00085683|Healthy Control Subjects|healthy control subjects
5391678|NCT00085683|Mesial Temporal Sclerosis|mesial temporal sclerosis
5391679|NCT00085683|Neuroexcitotoxicity|neuroexcitotoxicity
5391680|NCT00085683|Seizure Disorder|seizure disorder
5391681|NCT00085683|Epilepsy|epilepsy
5391682|NCT00085683|Healthy Volunteer|healthy volunteer
5391683|NCT00085683|HV|hv
5391684|NCT00085670|Tumor Necrosis Factor Alpha (TNF-Alpha)|tumor necrosis factor alpha (tnf-alpha)
5391685|NCT00085670|Interferon-Gamma (IFN-Gamma)|interferon-gamma (ifn-gamma)
5391686|NCT00085670|Transforming Growth Factor Beta 1 (TGF-B1)|transforming growth factor beta 1 (tgf-b1)
5391687|NCT00085670|Interleukin-10 (IL-10)|interleukin-10 (il-10)
5391688|NCT00085670|Interleukin-1 Receptor Antagonist (IL-1 Ra)|interleukin-1 receptor antagonist (il-1 ra)
5391689|NCT00085670|Vitamin D Receptor (VitD R)|vitamin d receptor (vitd r)
5391690|NCT00085670|Interleukin-6 (IL-6)|interleukin-6 (il-6)
5391691|NCT00085670|Bone Marrow Failure|bone marrow failure
5391692|NCT00085670|Aplastic Anemia|aplastic anemia
5391693|NCT00085670|Myelodysplastic Syndrome|myelodysplastic syndrome
5391694|NCT00085670|MDS|mds
5391695|NCT00085670|Pure Red Cell Aplasia|pure red cell aplasia
5391696|NCT00085670|PRCA|prca
5391697|NCT00085657|Direct Current Stimulation|direct current stimulation
5391698|NCT00085657|Cortical Reorganization|cortical reorganization
5391699|NCT00085657|Rehabilitation|rehabilitation
5391700|NCT00085657|Acute Stroke|acute stroke
5391701|NCT00085657|Stroke|stroke
5391702|NCT00085631|stage IA cervical cancer|stage ia cervical cancer
5391703|NCT00085631|stage IB cervical cancer|stage ib cervical cancer
5391704|NCT00085631|stage IIA cervical cancer|stage iia cervical cancer
5391705|NCT00085631|stage IIB cervical cancer|stage iib cervical cancer
5391706|NCT00085631|stage III cervical cancer|stage iii cervical cancer
5391707|NCT00085631|stage IVA cervical cancer|stage iva cervical cancer
5391708|NCT00085631|cervical adenocarcinoma|cervical adenocarcinoma
5391709|NCT00085631|cervical adenosquamous cell carcinoma|cervical adenosquamous cell carcinoma
5391710|NCT00085631|cervical squamous cell carcinoma|cervical squamous cell carcinoma
5391711|NCT00085579|stage III melanoma|stage iii melanoma
5391712|NCT00085579|stage IV melanoma|stage iv melanoma
5391713|NCT00085566|adult glioblastoma|adult glioblastoma
5391714|NCT00085566|recurrent prostate cancer|recurrent prostate cancer
5391715|NCT00085566|recurrent adult brain tumor|recurrent adult brain tumor
5391716|NCT00085566|stage IV prostate cancer|stage iv prostate cancer
5391717|NCT00085566|adult giant cell glioblastoma|adult giant cell glioblastoma
5391718|NCT00085566|adult gliosarcoma|adult gliosarcoma
5391719|NCT00085527|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5391720|NCT00085527|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5391721|NCT00085527|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5391722|NCT00085501|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5391723|NCT00085501|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5391724|NCT00085501|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5391725|NCT00085501|adenocarcinoma of the lung|adenocarcinoma of the lung
5391726|NCT00085501|squamous cell lung cancer|squamous cell lung cancer
5391727|NCT00085501|large cell lung cancer|large cell lung cancer
5391728|NCT00085488|recurrent melanoma|recurrent melanoma
5391729|NCT00085488|stage III melanoma|stage iii melanoma
5391730|NCT00085488|stage IV melanoma|stage iv melanoma
5391731|NCT00085475|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
5391732|NCT00085475|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
5391733|NCT00085475|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
5391734|NCT00085475|adult fibrosarcoma|adult fibrosarcoma
5391735|NCT00085475|adult malignant fibrous histiocytoma|adult malignant fibrous histiocytoma
5391736|NCT00085462|recurrent melanoma|recurrent melanoma
5391737|NCT00085462|stage IV melanoma|stage iv melanoma
5391738|NCT00085449|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5391739|NCT00085449|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5391740|NCT00085449|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5391741|NCT00085449|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5391742|NCT00085449|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
5391743|NCT00085449|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5391744|NCT00085449|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
5391745|NCT00085449|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5391746|NCT00085449|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5391747|NCT00085449|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5391748|NCT00085449|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5391749|NCT00085449|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5391750|NCT00085449|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5391751|NCT00085449|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5391752|NCT00085449|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5391753|NCT00085449|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5391754|NCT00085449|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5391755|NCT00085449|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5391756|NCT00085449|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5391757|NCT00085449|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5391758|NCT00085449|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5391759|NCT00085449|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5391760|NCT00085449|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5391761|NCT00085449|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5391762|NCT00085449|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5391763|NCT00085449|refractory multiple myeloma|refractory multiple myeloma
5391764|NCT00085449|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5391765|NCT00085449|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5391766|NCT00085449|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5391767|NCT00085449|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5391768|NCT00085449|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5391769|NCT00085449|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5391770|NCT00085449|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5391771|NCT00085436|recurrent renal cell cancer|recurrent renal cell cancer
5391772|NCT00085436|stage IV renal cell cancer|stage iv renal cell cancer
5391773|NCT00085423|recurrent melanoma|recurrent melanoma
5391774|NCT00085423|stage IV melanoma|stage iv melanoma
5391775|NCT00085397|recurrent melanoma|recurrent melanoma
5391776|NCT00085397|stage III melanoma|stage iii melanoma
5391777|NCT00085397|stage IV melanoma|stage iv melanoma
5391778|NCT00085384|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5391779|NCT00085384|peritoneal cavity cancer|peritoneal cavity cancer
5391780|NCT00085384|fallopian tube cancer|fallopian tube cancer
5391781|NCT00085332|recurrent endometrial carcinoma|recurrent endometrial carcinoma
5391782|NCT00085332|stage III endometrial carcinoma|stage iii endometrial carcinoma
5391783|NCT00085332|stage IV endometrial carcinoma|stage iv endometrial carcinoma
5391784|NCT00085306|recurrent melanoma|recurrent melanoma
5391785|NCT00085306|stage IV melanoma|stage iv melanoma
5391786|NCT00085306|iris melanoma|iris melanoma
5391787|NCT00085306|ciliary body and choroid melanoma, medium/large size|ciliary body and choroid melanoma, medium/large size
5391788|NCT00085306|extraocular extension melanoma|extraocular extension melanoma
5391789|NCT00085306|recurrent intraocular melanoma|recurrent intraocular melanoma
5391790|NCT00085228|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5391791|NCT00085228|recurrent prostate cancer|recurrent prostate cancer
5391792|NCT00085228|stage IV prostate cancer|stage iv prostate cancer
5391793|NCT00085202|untreated childhood medulloblastoma|untreated childhood medulloblastoma
5391794|NCT00085202|untreated childhood supratentorial primitive neuroectodermal tumor|untreated childhood supratentorial primitive neuroectodermal tumor
5400817|NCT00006253|cancer|cancer
5391795|NCT00085202|childhood atypical teratoid/rhabdoid tumor|childhood atypical teratoid/rhabdoid tumor
5391796|NCT00085202|untreated childhood pineoblastoma|untreated childhood pineoblastoma
5391797|NCT00085176|long-term effects secondary to cancer therapy in children|long-term effects secondary to cancer therapy in children
5391798|NCT00085176|neurotoxicity|neurotoxicity
5391799|NCT00085176|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
5391800|NCT00085176|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
5391801|NCT00085163|adenocarcinoma of the colon|adenocarcinoma of the colon
5391802|NCT00085163|stage III colon cancer|stage iii colon cancer
5391803|NCT00085150|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
5391804|NCT00085150|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5391805|NCT00085150|childhood Burkitt lymphoma|childhood burkitt lymphoma
5391806|NCT00085150|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5391807|NCT00085150|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
5391808|NCT00085150|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
5391809|NCT00085150|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5391810|NCT00085150|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5391811|NCT00085150|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
5391812|NCT00085150|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5391813|NCT00085150|acute undifferentiated leukemia|acute undifferentiated leukemia
5391814|NCT00085098|childhood central nervous system germ cell tumor|childhood central nervous system germ cell tumor
5391815|NCT00085059|stage IV melanoma|stage iv melanoma
5391816|NCT00085059|recurrent melanoma|recurrent melanoma
5391817|NCT00085020|stage IV breast cancer|stage iv breast cancer
5391818|NCT00085020|male breast cancer|male breast cancer
5391819|NCT00085020|recurrent breast cancer|recurrent breast cancer
5391820|NCT00084942|cholangiocarcinoma of the gallbladder|cholangiocarcinoma of the gallbladder
5391821|NCT00084942|recurrent gallbladder cancer|recurrent gallbladder cancer
5391822|NCT00084942|unresectable gallbladder cancer|unresectable gallbladder cancer
5391823|NCT00084942|cholangiocarcinoma of the extrahepatic bile duct|cholangiocarcinoma of the extrahepatic bile duct
5391824|NCT00084942|recurrent extrahepatic bile duct cancer|recurrent extrahepatic bile duct cancer
5391825|NCT00084942|unresectable extrahepatic bile duct cancer|unresectable extrahepatic bile duct cancer
5391826|NCT00084929|colon cancer|colon cancer
5391827|NCT00084929|rectal cancer|rectal cancer
5391828|NCT00084903|cervical cancer|cervical cancer
5391829|NCT00084903|cervical intraepithelial neoplasia|cervical intraepithelial neoplasia
5391830|NCT00084890|stage IVB cervical cancer|stage ivb cervical cancer
5391831|NCT00084890|recurrent cervical cancer|recurrent cervical cancer
5391832|NCT00084890|cervical squamous cell carcinoma|cervical squamous cell carcinoma
5391833|NCT00084864|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5391834|NCT00084864|stage II prostate cancer|stage ii prostate cancer
5391835|NCT00084864|stage III prostate cancer|stage iii prostate cancer
5391836|NCT00084838|childhood atypical teratoid/rhabdoid tumor|childhood atypical teratoid/rhabdoid tumor
5391837|NCT00084825|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5391838|NCT00084825|recurrent prostate cancer|recurrent prostate cancer
5391839|NCT00084825|stage IV prostate cancer|stage iv prostate cancer
5391840|NCT00084825|bone metastases|bone metastases
5391841|NCT00084812|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5391842|NCT00084799|recurrent small cell lung cancer|recurrent small cell lung cancer
5391843|NCT00084786|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5391844|NCT00084773|recurrent rectal cancer|recurrent rectal cancer
5391845|NCT00084773|stage II rectal cancer|stage ii rectal cancer
5391846|NCT00084773|stage III rectal cancer|stage iii rectal cancer
5391847|NCT00084773|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5391848|NCT00084747|stage II multiple myeloma|stage ii multiple myeloma
5391849|NCT00084747|stage III multiple myeloma|stage iii multiple myeloma
5391850|NCT00084734|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5391851|NCT00084721|diarrhea|diarrhea
5391852|NCT00084721|recurrent colon cancer|recurrent colon cancer
5391853|NCT00084721|stage IV colon cancer|stage iv colon cancer
5391854|NCT00084721|recurrent rectal cancer|recurrent rectal cancer
5391855|NCT00084721|stage IV rectal cancer|stage iv rectal cancer
5391856|NCT00084721|stage III colon cancer|stage iii colon cancer
5391857|NCT00084721|stage III rectal cancer|stage iii rectal cancer
5391858|NCT00084708|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5391859|NCT00084695|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
5391860|NCT00084695|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
5391861|NCT00084695|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
5391862|NCT00084695|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
5391863|NCT00084695|previously untreated childhood rhabdomyosarcoma|previously untreated childhood rhabdomyosarcoma
5391864|NCT00084695|disseminated neuroblastoma|disseminated neuroblastoma
5391865|NCT00084695|regional neuroblastoma|regional neuroblastoma
5391866|NCT00084695|recurrent neuroblastoma|recurrent neuroblastoma
5402982|NCT00076570|Antibody|antibody
5391867|NCT00084695|metastatic Ewing sarcoma/peripheral primitive neuroectodermal tumor|metastatic ewing sarcoma/peripheral primitive neuroectodermal tumor
5391868|NCT00084695|recurrent Ewing sarcoma/peripheral primitive neuroectodermal tumor|recurrent ewing sarcoma/peripheral primitive neuroectodermal tumor
5391869|NCT00084695|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5391870|NCT00084695|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
5391871|NCT00084695|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
5391872|NCT00084695|childhood Burkitt lymphoma|childhood burkitt lymphoma
5391873|NCT00084695|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
5391874|NCT00084695|stage III childhood lymphoblastic lymphoma|stage iii childhood lymphoblastic lymphoma
5391875|NCT00084695|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
5391876|NCT00084695|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
5391877|NCT00084695|stage III childhood small noncleaved cell lymphoma|stage iii childhood small noncleaved cell lymphoma
5391878|NCT00084695|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
5391879|NCT00084695|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
5391880|NCT00084695|stage III childhood large cell lymphoma|stage iii childhood large cell lymphoma
5391881|NCT00084695|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
5391882|NCT00084695|stage III childhood Hodgkin lymphoma|stage iii childhood hodgkin lymphoma
5391883|NCT00084695|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
5391884|NCT00084695|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5391885|NCT00084695|Fanconi anemia|fanconi anemia
5391886|NCT00084695|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5391887|NCT00084695|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5391888|NCT00084695|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
5391889|NCT00084695|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5391890|NCT00084695|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5391891|NCT00084695|childhood Langerhans cell histiocytosis|childhood langerhans cell histiocytosis
5391892|NCT00084695|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5391893|NCT00084695|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
5391894|NCT00084669|hot flashes|hot flashes
5391895|NCT00084669|sleep disorders|sleep disorders
5391896|NCT00084669|ductal breast carcinoma in situ|ductal breast carcinoma in situ
5391897|NCT00084669|breast cancer in situ|breast cancer in situ
5391898|NCT00084669|lobular breast carcinoma in situ|lobular breast carcinoma in situ
5391899|NCT00084669|lobular breast carcinoma|lobular breast carcinoma
5391900|NCT00084669|recurrent breast cancer|recurrent breast cancer
5391901|NCT00084669|stage I breast cancer|stage i breast cancer
5391902|NCT00084669|stage II breast cancer|stage ii breast cancer
5391903|NCT00084669|stage IIIA breast cancer|stage iiia breast cancer
5391904|NCT00084669|stage IIIB breast cancer|stage iiib breast cancer
5391905|NCT00084669|stage IIIC breast cancer|stage iiic breast cancer
5391906|NCT00084669|stage IV breast cancer|stage iv breast cancer
5391907|NCT00084656|stage III melanoma|stage iii melanoma
5391908|NCT00084656|stage IV melanoma|stage iv melanoma
5391909|NCT00084656|ciliary body and choroid melanoma, medium/large size|ciliary body and choroid melanoma, medium/large size
5391910|NCT00084656|extraocular extension melanoma|extraocular extension melanoma
5391911|NCT00084656|iris melanoma|iris melanoma
5391912|NCT00084656|recurrent melanoma|recurrent melanoma
5391913|NCT00084656|recurrent intraocular melanoma|recurrent intraocular melanoma
5391914|NCT00084656|metastatic intraocular melanoma|metastatic intraocular melanoma
5391915|NCT00084591|stage II rectal cancer|stage ii rectal cancer
5391916|NCT00084591|stage III rectal cancer|stage iii rectal cancer
5391917|NCT00084591|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5391918|NCT00084578|stage 0 bladder cancer|stage 0 bladder cancer
5391919|NCT00084578|stage I bladder cancer|stage i bladder cancer
5391920|NCT00084578|stage II bladder cancer|stage ii bladder cancer
5391921|NCT00084578|stage III bladder cancer|stage iii bladder cancer
5391922|NCT00084578|stage IV bladder cancer|stage iv bladder cancer
5391923|NCT00084578|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
5391924|NCT00084565|stage IV prostate cancer|stage iv prostate cancer
5391925|NCT00084565|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5391926|NCT00084552|sexual dysfunction|sexual dysfunction
5391927|NCT00084552|sexuality and reproductive issues|sexuality and reproductive issues
5391928|NCT00084552|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5391929|NCT00084552|stage IIB prostate cancer|stage iib prostate cancer
5391930|NCT00084552|stage IIA prostate cancer|stage iia prostate cancer
5391931|NCT00084539|stage I breast cancer|stage i breast cancer
5391932|NCT00084539|stage II breast cancer|stage ii breast cancer
5391933|NCT00084539|breast cancer in situ|breast cancer in situ
5391934|NCT00084526|recurrent prostate cancer|recurrent prostate cancer
5391935|NCT00084526|stage I prostate cancer|stage i prostate cancer
5391936|NCT00084526|stage II prostate cancer|stage ii prostate cancer
5391937|NCT00084526|stage III prostate cancer|stage iii prostate cancer
5391938|NCT00084526|stage IV prostate cancer|stage iv prostate cancer
5391939|NCT00084513|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5391940|NCT00084448|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5391941|NCT00084448|primary peritoneal cavity cancer|primary peritoneal cavity cancer
5391942|NCT00084435|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
5391943|NCT00084435|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5391944|NCT00084435|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
5391945|NCT00084435|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
5391946|NCT00084435|stage III salivary gland cancer|stage iii salivary gland cancer
5391947|NCT00084435|stage IV salivary gland cancer|stage iv salivary gland cancer
5391948|NCT00084435|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
5391949|NCT00084435|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5391950|NCT00084435|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
5391951|NCT00084435|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5391952|NCT00084435|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
5391953|NCT00084435|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5391954|NCT00084435|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
5391955|NCT00084422|recurrent neuroblastoma|recurrent neuroblastoma
5391956|NCT00084409|non-small cell lung cancer|non-small cell lung cancer
5391957|NCT00084409|squamous lung dysplasia|squamous lung dysplasia
5391958|NCT00084396|stage II breast cancer|stage ii breast cancer
5391959|NCT00084396|stage IIIA breast cancer|stage iiia breast cancer
5391960|NCT00084396|stage IIIB breast cancer|stage iiib breast cancer
5391961|NCT00084383|stage I pancreatic cancer|stage i pancreatic cancer
5391962|NCT00084383|stage II pancreatic cancer|stage ii pancreatic cancer
5391963|NCT00084383|duct cell adenocarcinoma of the pancreas|duct cell adenocarcinoma of the pancreas
5391964|NCT00084370|ovarian epithelial cancer|ovarian epithelial cancer
5391965|NCT00084370|BRCA1 mutation carrier|brca1 mutation carrier
5391966|NCT00084370|BRCA2 mutation carrier|brca2 mutation carrier
5391967|NCT00084344|breast cancer|breast cancer
5391968|NCT00084318|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
5391969|NCT00084318|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5391970|NCT00084318|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
5391971|NCT00084318|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5391972|NCT00084318|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
5391973|NCT00084318|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5391974|NCT00084318|stage III lymphoepithelioma of the oropharynx|stage iii lymphoepithelioma of the oropharynx
5391975|NCT00084318|stage IV lymphoepithelioma of the oropharynx|stage iv lymphoepithelioma of the oropharynx
5391976|NCT00084279|Chronic Hepatitis C|chronic hepatitis c
5391978|NCT00084279|Pegylated|pegylated
5391979|NCT00084279|Interferon|interferon
5391980|NCT00084279|Alpha|alpha
5391981|NCT00084279|Gamma|gamma
5391982|NCT00084279|Ribavirin|ribavirin
5391983|NCT00084279|Combination|combination
5391984|NCT00084279|Nonresponder|nonresponder
5391985|NCT00084279|Pegasys|pegasys
5391986|NCT00084279|PegIntron|pegintron
5391987|NCT00084266|Staphylococcal pneumonia|staphylococcal pneumonia
5391988|NCT00084266|Methicillin-resistant staphylococcal pneumonia|methicillin-resistant staphylococcal pneumonia
5391989|NCT00084266|healthcare-associated pneumonia|healthcare-associated pneumonia
5391990|NCT00084253|HIV|hiv
5391991|NCT00084253|Treatment Naive|treatment naive
5391992|NCT00084305|Bronchoscopy|bronchoscopy
5391993|NCT00084305|Pulmonary Fibrosis|pulmonary fibrosis
5391994|NCT00084305|Lung Biopsy (Clinically-Indicated)|lung biopsy (clinically-indicated)
5391995|NCT00084305|Hereditary Pulmonary Fibrosis|hereditary pulmonary fibrosis
5391996|NCT00084305|Healthy Volunteer|healthy volunteer
5391997|NCT00084305|HV|hv
5391998|NCT00084292|Ischemia|ischemia
5391999|NCT00084292|Pediatric|pediatric
5392000|NCT00084292|Etiology|etiology
5392001|NCT00084292|Treatment|treatment
5392002|NCT00084292|Outcome|outcome
5392003|NCT00084292|Childhood Stroke|childhood stroke
5392004|NCT00084292|Pediatric Stroke|pediatric stroke
5392005|NCT00084292|Ischemic Stroke|ischemic stroke
5392006|NCT00084292|Spastic Hemiplegia|spastic hemiplegia
5392007|NCT00084292|Hemiplegic cerebral palsy|hemiplegic cerebral palsy
5392008|NCT00084214|metastatic|metastatic
5392009|NCT00084214|increased antitumor effect|increased antitumor effect
5392010|NCT00002682|Antibiotic Treatment|antibiotic treatment
5392011|NCT00002682|Gastric Malt Lymphoma|gastric malt lymphoma
5392012|NCT00002682|stage I marginal zone lymphoma|stage i marginal zone lymphoma
5392013|NCT00002682|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5392014|NCT00002676|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
5392015|NCT00002670|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
5392079|NCT00002625|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5392016|NCT00002670|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
5392017|NCT00002670|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5392018|NCT00002670|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
5392019|NCT00002670|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
5392020|NCT00002670|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5392021|NCT00002670|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
5392022|NCT00002670|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
5392023|NCT00002670|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5392024|NCT00002670|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
5392025|NCT00002670|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
5392026|NCT00002670|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5392027|NCT00002656|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5392028|NCT00002656|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5392029|NCT00002656|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5392030|NCT00002646|stage II breast cancer|stage ii breast cancer
5392031|NCT00002646|stage IIIA breast cancer|stage iiia breast cancer
5392032|NCT00002637|recurrent prostate cancer|recurrent prostate cancer
5392033|NCT00002632|stage IV salivary gland cancer|stage iv salivary gland cancer
5392034|NCT00002632|recurrent salivary gland cancer|recurrent salivary gland cancer
5392035|NCT00002632|high-grade salivary gland mucoepidermoid carcinoma|high-grade salivary gland mucoepidermoid carcinoma
5392036|NCT00002632|salivary gland adenocarcinoma|salivary gland adenocarcinoma
5392037|NCT00002625|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5392038|NCT00002625|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5392039|NCT00002625|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5392040|NCT00002625|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5392041|NCT00002625|recurrent esophageal cancer|recurrent esophageal cancer
5392042|NCT00002625|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
5392043|NCT00002625|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
5392044|NCT00002625|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5392045|NCT00002625|recurrent small cell lung cancer|recurrent small cell lung cancer
5392046|NCT00002625|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5392047|NCT00002625|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5392048|NCT00002625|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5392049|NCT00002625|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5392050|NCT00002625|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5392051|NCT00002625|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5392052|NCT00002625|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5392053|NCT00002625|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5392054|NCT00002625|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5392055|NCT00002625|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5392056|NCT00002625|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5392057|NCT00002625|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5392058|NCT00002625|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5392059|NCT00002625|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5392060|NCT00002625|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5392061|NCT00002625|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5392062|NCT00002625|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5392063|NCT00002625|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5392064|NCT00002625|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5392065|NCT00002625|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5392066|NCT00002625|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5392067|NCT00002625|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5392068|NCT00002625|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5392069|NCT00002625|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5392070|NCT00002625|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5392071|NCT00002625|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5392072|NCT00002625|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5392073|NCT00002625|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
5392074|NCT00002625|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
5392075|NCT00002625|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
5392076|NCT00002625|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5392077|NCT00002625|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5392078|NCT00002625|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5403592|NCT00074958|Fabrazyme|fabrazyme
5392080|NCT00002625|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5392081|NCT00002625|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5392082|NCT00002625|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5392083|NCT00002625|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5392084|NCT00002625|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5392085|NCT00002625|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5392086|NCT00002625|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5392087|NCT00002625|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5392088|NCT00002551|stage II rectal cancer|stage ii rectal cancer
5392089|NCT00002551|stage III rectal cancer|stage iii rectal cancer
5392090|NCT00002551|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5392091|NCT00002538|stage I ovarian epithelial cancer|stage i ovarian epithelial cancer
5392092|NCT00002538|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
5392093|NCT00002538|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5392094|NCT00002538|ovarian undifferentiated adenocarcinoma|ovarian undifferentiated adenocarcinoma
5392095|NCT00002538|ovarian mixed epithelial carcinoma|ovarian mixed epithelial carcinoma
5392096|NCT00002538|ovarian serous cystadenocarcinoma|ovarian serous cystadenocarcinoma
5392097|NCT00002538|ovarian mucinous cystadenocarcinoma|ovarian mucinous cystadenocarcinoma
5392098|NCT00002538|ovarian endometrioid adenocarcinoma|ovarian endometrioid adenocarcinoma
5392099|NCT00002538|ovarian clear cell cystadenocarcinoma|ovarian clear cell cystadenocarcinoma
5392100|NCT00002538|fallopian tube cancer|fallopian tube cancer
5392101|NCT00002538|primary peritoneal cavity cancer|primary peritoneal cavity cancer
5392102|NCT00084201|Vaccinium macrocarpon|vaccinium macrocarpon
5392103|NCT00084188|behavioral intervention|behavioral intervention
5392104|NCT00084175|behavioral intervention|behavioral intervention
5392105|NCT00006451|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5392106|NCT00006451|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
5392107|NCT00006451|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5392108|NCT00006451|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5392109|NCT00006451|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5392110|NCT00006451|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5392111|NCT00006451|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5392112|NCT00006451|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5392113|NCT00006451|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
5392114|NCT00006451|acute undifferentiated leukemia|acute undifferentiated leukemia
5392115|NCT00006451|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5392116|NCT00006451|graft versus host disease|graft versus host disease
5392117|NCT00006387|stage IV colon cancer|stage iv colon cancer
5392118|NCT00006387|recurrent pancreatic cancer|recurrent pancreatic cancer
5392119|NCT00006387|stage IV rectal cancer|stage iv rectal cancer
5392120|NCT00006387|recurrent colon cancer|recurrent colon cancer
5392121|NCT00006387|recurrent rectal cancer|recurrent rectal cancer
5392122|NCT00006387|adenocarcinoma of the colon|adenocarcinoma of the colon
5392123|NCT00006387|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5392124|NCT00006387|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
5392125|NCT00006387|stage IV pancreatic cancer|stage iv pancreatic cancer
5392126|NCT00006382|non-small cell lung cancer|non-small cell lung cancer
5392127|NCT00006382|small cell lung cancer|small cell lung cancer
5392128|NCT00006380|stage III prostate cancer|stage iii prostate cancer
5392129|NCT00006380|stage IV prostate cancer|stage iv prostate cancer
5392130|NCT00006380|recurrent prostate cancer|recurrent prostate cancer
5392131|NCT00006378|squamous cell lung cancer|squamous cell lung cancer
5392132|NCT00006378|large cell lung cancer|large cell lung cancer
5392133|NCT00006378|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5392134|NCT00006378|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5392135|NCT00006378|adenocarcinoma of the lung|adenocarcinoma of the lung
5392136|NCT00006378|adenosquamous cell lung cancer|adenosquamous cell lung cancer
5392137|NCT00006378|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
5392138|NCT00006374|extensive stage small cell lung cancer|extensive stage small cell lung cancer
5392139|NCT00006374|recurrent small cell lung cancer|recurrent small cell lung cancer
5392140|NCT00005994|nausea and vomiting|nausea and vomiting
5392141|NCT00005994|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5392142|NCT00005790|adult brain stem glioma|adult brain stem glioma
5392143|NCT00005790|adult ependymoma|adult ependymoma
5392144|NCT00005790|adult craniopharyngioma|adult craniopharyngioma
5392145|NCT00005790|adult medulloblastoma|adult medulloblastoma
5392146|NCT00005790|adult meningioma|adult meningioma
5392147|NCT00005790|adult glioblastoma|adult glioblastoma
5392148|NCT00005790|adult oligodendroglioma|adult oligodendroglioma
5392149|NCT00005790|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5392150|NCT00005790|adult myxopapillary ependymoma|adult myxopapillary ependymoma
5392151|NCT00005790|adult anaplastic ependymoma|adult anaplastic ependymoma
5392152|NCT00005790|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
5392153|NCT00005790|adult mixed glioma|adult mixed glioma
5392154|NCT00005790|adult pineal parenchymal tumor|adult pineal parenchymal tumor
5392155|NCT00005790|adult central nervous system germ cell tumor|adult central nervous system germ cell tumor
5392156|NCT00005790|adult pilocytic astrocytoma|adult pilocytic astrocytoma
5392157|NCT00005790|adult subependymoma|adult subependymoma
5392158|NCT00005790|adult diffuse astrocytoma|adult diffuse astrocytoma
5392159|NCT00005790|adult ependymoblastoma|adult ependymoblastoma
5392160|NCT00005790|adult pineocytoma|adult pineocytoma
5392161|NCT00005790|adult pineoblastoma|adult pineoblastoma
5392162|NCT00005790|adult meningeal hemangiopericytoma|adult meningeal hemangiopericytoma
5392163|NCT00005790|adult choroid plexus tumor|adult choroid plexus tumor
5392164|NCT00005790|adult grade III meningioma|adult grade iii meningioma
5392165|NCT00005790|adult giant cell glioblastoma|adult giant cell glioblastoma
5392166|NCT00005790|adult gliosarcoma|adult gliosarcoma
5392167|NCT00005084|childhood low-grade cerebral astrocytoma|childhood low-grade cerebral astrocytoma
5392168|NCT00005084|childhood low-grade cerebellar astrocytoma|childhood low-grade cerebellar astrocytoma
5392169|NCT00005084|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
5392170|NCT00005045|stage III renal cell cancer|stage iii renal cell cancer
5392171|NCT00005045|stage IV renal cell cancer|stage iv renal cell cancer
5392172|NCT00005045|recurrent renal cell cancer|recurrent renal cell cancer
5392173|NCT00004236|stage III gastric cancer|stage iii gastric cancer
5392174|NCT00004236|stage IV gastric cancer|stage iv gastric cancer
5392175|NCT00004236|recurrent gastric cancer|recurrent gastric cancer
5392176|NCT00004236|stage III esophageal cancer|stage iii esophageal cancer
5392177|NCT00004236|stage IV esophageal cancer|stage iv esophageal cancer
5392178|NCT00004236|recurrent esophageal cancer|recurrent esophageal cancer
5392179|NCT00004236|adenocarcinoma of the stomach|adenocarcinoma of the stomach
5392180|NCT00004236|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
5392181|NCT00003992|stage II breast cancer|stage ii breast cancer
5392182|NCT00003992|stage IIIA breast cancer|stage iiia breast cancer
5392183|NCT00003859|untreated childhood supratentorial primitive neuroectodermal tumor|untreated childhood supratentorial primitive neuroectodermal tumor
5392184|NCT00003859|recurrent childhood supratentorial primitive neuroectodermal tumor|recurrent childhood supratentorial primitive neuroectodermal tumor
5392185|NCT00003733|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
5392186|NCT00003733|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5392187|NCT00003733|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5392188|NCT00003584|stage IV renal cell cancer|stage iv renal cell cancer
5392189|NCT00003584|recurrent renal cell cancer|recurrent renal cell cancer
5392190|NCT00003435|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5392191|NCT00003435|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5392192|NCT00003435|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
5392193|NCT00003435|HIV-associated Hodgkin lymphoma|hiv-associated hodgkin lymphoma
5392194|NCT00003410|adult glioblastoma|adult glioblastoma
5392195|NCT00003410|adult giant cell glioblastoma|adult giant cell glioblastoma
5392196|NCT00003410|adult gliosarcoma|adult gliosarcoma
5392197|NCT00003372|recurrent adult brain tumor|recurrent adult brain tumor
5392198|NCT00003372|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
5392199|NCT00003372|adult mixed glioma|adult mixed glioma
5392200|NCT00003236|recurrent breast cancer|recurrent breast cancer
5392201|NCT00002905|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
5392202|NCT00002496|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
5392203|NCT00002496|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5392204|NCT00002478|recurrent cervical cancer|recurrent cervical cancer
5392205|NCT00002478|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5392206|NCT00002476|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
5392207|NCT00002476|stage II verrucous carcinoma of the oral cavity|stage ii verrucous carcinoma of the oral cavity
5392208|NCT00002476|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
5392209|NCT00002476|stage III verrucous carcinoma of the oral cavity|stage iii verrucous carcinoma of the oral cavity
5392210|NCT00002476|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5392211|NCT00002476|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
5392212|NCT00002476|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
5392213|NCT00002476|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
5392214|NCT00002476|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5392215|NCT00002476|stage II squamous cell carcinoma of the nasopharynx|stage ii squamous cell carcinoma of the nasopharynx
5392216|NCT00002476|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
5392217|NCT00002476|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
5392218|NCT00002476|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
5392328|NCT00084045|Treatment Naive|treatment naive
5392219|NCT00002476|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
5392220|NCT00002476|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5392681|NCT00083538|Multiple Myeloma|multiple myeloma
5392221|NCT00002476|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
5392222|NCT00002476|stage II verrucous carcinoma of the larynx|stage ii verrucous carcinoma of the larynx
5392223|NCT00002476|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
5392224|NCT00002476|stage III verrucous carcinoma of the larynx|stage iii verrucous carcinoma of the larynx
5392225|NCT00002476|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5392226|NCT00002476|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
5392227|NCT00002476|stage II squamous cell carcinoma of the paranasal sinus and nasal cavity|stage ii squamous cell carcinoma of the paranasal sinus and nasal cavity
5392228|NCT00002476|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
5392229|NCT00002476|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
5392230|NCT00002460|stage I breast cancer|stage i breast cancer
5392231|NCT00002460|stage II breast cancer|stage ii breast cancer
5392232|NCT00002460|stage IIIA breast cancer|stage iiia breast cancer
5392233|NCT00084162|PET|pet
5392234|NCT00084162|Heart Rate Variability|heart rate variability
5392235|NCT00084162|N-Back Task|n-back task
5392236|NCT00084162|Isometric Handgrip|isometric handgrip
5392237|NCT00084162|MRI|mri
5392238|NCT00084162|Depression|depression
5392239|NCT00084162|MDD|mdd
5392240|NCT00084162|Heart|heart
5392241|NCT00084149|Acute Infection|acute infection
5392242|NCT00084149|Treatment Naive|treatment naive
5392243|NCT00084136|Treatment Naive|treatment naive
5392244|NCT00084136|Adherence|adherence
5392245|NCT00084136|Drug Resistance|drug resistance
5392246|NCT00084136|Treatment Failure|treatment failure
5392247|NCT00084123|Relaxation Techniques|relaxation techniques
5392248|NCT00084123|Radiation|radiation
5392249|NCT00084123|Drug Therapy|drug therapy
5392250|NCT00084123|Healing Touch|healing touch
5392251|NCT00084110|Aged|aged
5392252|NCT00084110|Mexican Americans|mexican americans
5392253|NCT00084110|Complementary Therapies|complementary therapies
5392254|NCT00083993|Breast Cancer|breast cancer
5392255|NCT00005960|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5392256|NCT00005960|stage I prostate cancer|stage i prostate cancer
5392257|NCT00005960|stage IIB prostate cancer|stage iib prostate cancer
5392258|NCT00005960|stage IIA prostate cancer|stage iia prostate cancer
5392259|NCT00005960|stage III prostate cancer|stage iii prostate cancer
5392260|NCT00005960|stage IV prostate cancer|stage iv prostate cancer
5392261|NCT00005960|recurrent prostate cancer|recurrent prostate cancer
5392262|NCT00005960|pain|pain
5392263|NCT00005641|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5392264|NCT00005641|refractory multiple myeloma|refractory multiple myeloma
5392265|NCT00005641|stage 0 chronic lymphocytic leukemia|stage 0 chronic lymphocytic leukemia
5392266|NCT00005641|stage I multiple myeloma|stage i multiple myeloma
5392267|NCT00005641|stage II multiple myeloma|stage ii multiple myeloma
5392268|NCT00005641|stage III multiple myeloma|stage iii multiple myeloma
5392269|NCT00005641|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
5392270|NCT00005641|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
5392271|NCT00005641|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5392272|NCT00005641|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5392273|NCT00005641|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5392274|NCT00005641|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5392275|NCT00005641|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5392276|NCT00005641|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5392277|NCT00005641|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5392278|NCT00005641|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5392279|NCT00005641|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5392280|NCT00005641|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5392281|NCT00005641|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5392282|NCT00005641|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5392283|NCT00005641|polycythemia vera|polycythemia vera
5392284|NCT00005641|primary myelofibrosis|primary myelofibrosis
5392285|NCT00005641|essential thrombocythemia|essential thrombocythemia
5392286|NCT00005641|refractory anemia|refractory anemia
5392287|NCT00005641|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
5392288|NCT00005641|refractory anemia with excess blasts|refractory anemia with excess blasts
5392289|NCT00005641|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
5392290|NCT00005641|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5392291|NCT00005641|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5392292|NCT00005641|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5392293|NCT00005641|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5392294|NCT00005641|graft versus host disease|graft versus host disease
5392295|NCT00005641|refractory cytopenia with multilineage dysplasia|refractory cytopenia with multilineage dysplasia
5392296|NCT00005641|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
5392297|NCT00005091|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5392298|NCT00005091|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5392299|NCT00005091|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5392300|NCT00005054|stage IV breast cancer|stage iv breast cancer
5392301|NCT00005054|stage IIIA breast cancer|stage iiia breast cancer
5392302|NCT00005054|recurrent breast cancer|recurrent breast cancer
5392303|NCT00005054|stage IIIB breast cancer|stage iiib breast cancer
5392304|NCT00005050|stage III colon cancer|stage iii colon cancer
5392305|NCT00005050|stage IV colon cancer|stage iv colon cancer
5392306|NCT00005050|stage III rectal cancer|stage iii rectal cancer
5392307|NCT00005050|stage IV rectal cancer|stage iv rectal cancer
5392308|NCT00005050|recurrent colon cancer|recurrent colon cancer
5392309|NCT00005050|recurrent rectal cancer|recurrent rectal cancer
5392310|NCT00084097|Allergy|allergy
5392311|NCT00084097|IgE|ige
5392312|NCT00084097|Eosinophil|eosinophil
5392313|NCT00084097|Monoclonal Antibody|monoclonal antibody
5392314|NCT00084097|Eosinophilic Gastroenteritis|eosinophilic gastroenteritis
5392315|NCT00084097|EG|eg
5392316|NCT00084084|Lysosomes|lysosomes
5392317|NCT00084084|Storage|storage
5392318|NCT00084084|Glycolipid|glycolipid
5392319|NCT00084084|Fabry disease|fabry disease
5392320|NCT00084084|Stroke|stroke
5392321|NCT00084084|Children|children
5392322|NCT00084084|Pediatrics|pediatrics
5392323|NCT00084058|Dose Intensification|dose intensification
5392324|NCT00084058|Pharmacokinetic Sampling|pharmacokinetic sampling
5392325|NCT00084058|Treatment Experienced|treatment experienced
5392326|NCT00084058|Child|child
5392327|NCT00084045|HIV Seronegativity|hiv seronegativity
5392329|NCT00084045|Pediatric HIV|pediatric hiv
5392330|NCT00084045|Perinatal Transmission|perinatal transmission
5392331|NCT00084032|Acute Infection|acute infection
5392332|NCT00084032|Treatment Interruption|treatment interruption
5392333|NCT00084032|Treatment Naive|treatment naive
5392334|NCT00084032|Primary HIV Infection|primary hiv infection
5392335|NCT00084032|PHI|phi
5392336|NCT00084019|Treatment Experienced|treatment experienced
5392337|NCT00083980|Kava|kava
5392338|NCT00083980|Complementary Therapies|complementary therapies
5392339|NCT00083980|Medicine, Herbal|medicine, herbal
5392340|NCT00083967|rhegmatogenous retinal detachment|rhegmatogenous retinal detachment
5392341|NCT00083967|detached retina|detached retina
5392342|NCT00083967|retinal tear|retinal tear
5392343|NCT00083967|retinal break|retinal break
5392344|NCT00083954|Bipolar I Disorder|bipolar i disorder
5392345|NCT00083941|Renal Cell Cancer|renal cell cancer
5392346|NCT00083941|Requiring IL-2 treatment|requiring il-2 treatment
5392347|NCT00083941|Stage IV Renal Cell Cancer|stage iv renal cell cancer
5392348|NCT00083928|Asymptomatic|asymptomatic
5392349|NCT00083928|subcutaneous|subcutaneous
5392350|NCT00083928|CA125 Progression|ca125 progression
5392351|NCT00083928|Angstrom|angstrom
5392352|NCT00083928|Ångstrom|ångstrom
5392353|NCT00083928|ovarian cancer|ovarian cancer
5392354|NCT00083915|Multiple Myeloma|multiple myeloma
5392355|NCT00083915|DTPACE|dtpace
5392356|NCT00083915|Tandem Transplant|tandem transplant
5392357|NCT00083915|Cisplatin|cisplatin
5392358|NCT00083915|Cyclophosphamide|cyclophosphamide
5392359|NCT00083915|Dexamethasone|dexamethasone
5392360|NCT00083915|Doxorubicin|doxorubicin
5392361|NCT00083915|Etoposide|etoposide
5392362|NCT00083915|Sargramostim|sargramostim
5392363|NCT00083915|Thalidomide|thalidomide
5392364|NCT00083915|Melphalan|melphalan
5392365|NCT00083902|Myeloma|myeloma
5392366|NCT00083902|Thalidomide|thalidomide
5392367|NCT00083902|Dexamethasone|dexamethasone
5392368|NCT00083876|Multiple Myeloma|multiple myeloma
5392369|NCT00083876|D.T. PACE|d.t. pace
5392370|NCT00083876|Melphalan|melphalan
5392371|NCT00083876|Transplant|transplant
5392372|NCT00083876|Thalidomide|thalidomide
5392373|NCT00083876|Dexamethasone|dexamethasone
5392374|NCT00083876|Cisplatin|cisplatin
5392375|NCT00083876|Cyclophosphamide|cyclophosphamide
5392376|NCT00083876|Doxorubicin|doxorubicin
5392377|NCT00083876|Etoposide|etoposide
5392378|NCT00083876|Filgrastim|filgrastim
5392379|NCT00083876|Interferon-alpha 2b|interferon-alpha 2b
5392380|NCT00083876|Sargramostim|sargramostim
5392381|NCT00005032|recurrent small cell lung cancer|recurrent small cell lung cancer
5392382|NCT00005030|stage IV colon cancer|stage iv colon cancer
5392383|NCT00005030|stage IV rectal cancer|stage iv rectal cancer
5392384|NCT00005030|recurrent colon cancer|recurrent colon cancer
5392385|NCT00005030|recurrent rectal cancer|recurrent rectal cancer
5392386|NCT00005030|liver metastases|liver metastases
5392387|NCT00004979|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5392388|NCT00004927|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5392389|NCT00004877|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5392390|NCT00004161|lip and oral cavity cancer|lip and oral cavity cancer
5392391|NCT00004071|stage IV prostate cancer|stage iv prostate cancer
5392392|NCT00004071|recurrent prostate cancer|recurrent prostate cancer
5392393|NCT00004070|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
5392394|NCT00004070|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
5392395|NCT00004070|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
5392396|NCT00004070|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5392397|NCT00004070|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
5392398|NCT00004070|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
5392399|NCT00004070|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5392400|NCT00004070|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
5392401|NCT00004070|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
5392402|NCT00004070|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
5392403|NCT00004070|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
5392404|NCT00004070|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
5392405|NCT00004070|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5392406|NCT00004070|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
5392407|NCT00004070|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
5392408|NCT00004070|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5392409|NCT00004070|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
5392410|NCT00004070|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
5392411|NCT00004070|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
5392412|NCT00004070|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
5392413|NCT00004062|stage IV papillary thyroid cancer|stage iv papillary thyroid cancer
5392414|NCT00004062|stage IV follicular thyroid cancer|stage iv follicular thyroid cancer
5392415|NCT00004062|recurrent thyroid cancer|recurrent thyroid cancer
5392416|NCT00083772|Heart failure|heart failure
5392417|NCT00083772|Diastolic heart failure|diastolic heart failure
5392418|NCT00083772|Congestive heart failure|congestive heart failure
5392419|NCT00083772|Nesiritide|nesiritide
5392420|NCT00083772|Natrecor|natrecor
5392421|NCT00083772|Left ventricular (LV) diastolic function|left ventricular (lv) diastolic function
5392422|NCT00083772|Fatigue|fatigue
5392423|NCT00083772|Shortness of breath|shortness of breath
5392424|NCT00083772|Edema|edema
5392425|NCT00083772|Heart disease|heart disease
5392426|NCT00004055|extensive stage small cell lung cancer|extensive stage small cell lung cancer
5392427|NCT00003998|stage I ovarian epithelial cancer|stage i ovarian epithelial cancer
5392428|NCT00003998|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
5392429|NCT00003998|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5392430|NCT00003998|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5392431|NCT00003998|primary peritoneal cavity cancer|primary peritoneal cavity cancer
5392432|NCT00003997|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5392433|NCT00003997|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5392434|NCT00003997|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5392435|NCT00003997|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5392436|NCT00003997|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5392437|NCT00003991|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5392438|NCT00003939|adult angiosarcoma|adult angiosarcoma
5392439|NCT00003939|adult fibrosarcoma|adult fibrosarcoma
5392440|NCT00003939|adult leiomyosarcoma|adult leiomyosarcoma
5392441|NCT00003939|adult liposarcoma|adult liposarcoma
5392442|NCT00003939|adult neurofibrosarcoma|adult neurofibrosarcoma
5392443|NCT00003939|adult synovial sarcoma|adult synovial sarcoma
5392444|NCT00003939|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
5392445|NCT00003939|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
5392446|NCT00003939|small intestine leiomyosarcoma|small intestine leiomyosarcoma
5392447|NCT00003939|adult alveolar soft-part sarcoma|adult alveolar soft-part sarcoma
5392448|NCT00003939|adult epithelioid sarcoma|adult epithelioid sarcoma
5392449|NCT00003939|adult malignant fibrous histiocytoma|adult malignant fibrous histiocytoma
5392450|NCT00003939|adult malignant hemangiopericytoma|adult malignant hemangiopericytoma
5392451|NCT00003939|adult malignant mesenchymoma|adult malignant mesenchymoma
5392452|NCT00003939|adult rhabdomyosarcoma|adult rhabdomyosarcoma
5392453|NCT00003939|stage IV uterine sarcoma|stage iv uterine sarcoma
5392454|NCT00003939|recurrent uterine sarcoma|recurrent uterine sarcoma
5392455|NCT00003939|uterine carcinosarcoma|uterine carcinosarcoma
5392456|NCT00003939|uterine leiomyosarcoma|uterine leiomyosarcoma
5392457|NCT00003939|endometrial stromal sarcoma|endometrial stromal sarcoma
5392458|NCT00003939|ovarian sarcoma|ovarian sarcoma
5392459|NCT00003939|adult meningeal hemangiopericytoma|adult meningeal hemangiopericytoma
5392460|NCT00003939|gastrointestinal stromal tumor|gastrointestinal stromal tumor
5392461|NCT00003856|recurrent salivary gland cancer|recurrent salivary gland cancer
5392462|NCT00003856|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
5392463|NCT00003856|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
5392464|NCT00003856|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
5392465|NCT00003856|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
5392466|NCT00003856|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
5392467|NCT00003856|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
5392468|NCT00003856|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
5392469|NCT00003850|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
5392470|NCT00003850|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
5392471|NCT00003850|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5392472|NCT00003850|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
5392473|NCT00003850|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5392474|NCT00003850|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
5392475|NCT00003850|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
5392476|NCT00003850|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
5392477|NCT00003850|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5392478|NCT00003850|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
5392479|NCT00003850|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5392480|NCT00003850|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
5392481|NCT00003850|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
5392482|NCT00003850|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
5392483|NCT00003787|stage I breast cancer|stage i breast cancer
5392484|NCT00003787|stage II breast cancer|stage ii breast cancer
5392485|NCT00003787|stage IIIA breast cancer|stage iiia breast cancer
5392486|NCT00003787|recurrent breast cancer|recurrent breast cancer
5392487|NCT00003773|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5392488|NCT00003758|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5392489|NCT00003758|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5392490|NCT00003758|adult acute monoblastic leukemia and acute monocytic leukemia (M5)|adult acute monoblastic leukemia and acute monocytic leukemia (m5)
5392491|NCT00003758|childhood acute monoblastic leukemia and acute monocytic leukemia (M5)|childhood acute monoblastic leukemia and acute monocytic leukemia (m5)
5392492|NCT00003758|adult acute erythroid leukemia (M6)|adult acute erythroid leukemia (m6)
5392493|NCT00003758|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
5392494|NCT00003758|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
5392495|NCT00003758|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
5392496|NCT00003758|adult acute eosinophilic leukemia|adult acute eosinophilic leukemia
5392497|NCT00003758|adult acute basophilic leukemia|adult acute basophilic leukemia
5392498|NCT00003758|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
5392499|NCT00003758|childhood acute myeloblastic leukemia without maturation (M1)|childhood acute myeloblastic leukemia without maturation (m1)
5392500|NCT00003758|childhood acute myeloblastic leukemia with maturation (M2)|childhood acute myeloblastic leukemia with maturation (m2)
5392501|NCT00003758|childhood acute myelomonocytic leukemia (M4)|childhood acute myelomonocytic leukemia (m4)
5392502|NCT00003758|childhood acute erythroleukemia (M6)|childhood acute erythroleukemia (m6)
5392503|NCT00003758|childhood acute eosinophilic leukemia|childhood acute eosinophilic leukemia
5392504|NCT00003758|childhood acute basophilic leukemia|childhood acute basophilic leukemia
5392505|NCT00003758|childhood acute megakaryocytic leukemia (M7)|childhood acute megakaryocytic leukemia (m7)
5392506|NCT00003758|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
5392507|NCT00003758|childhood acute minimally differentiated myeloid leukemia (M0)|childhood acute minimally differentiated myeloid leukemia (m0)
5392508|NCT00003755|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5392509|NCT00003740|stage IV prostate cancer|stage iv prostate cancer
5392510|NCT00003740|recurrent prostate cancer|recurrent prostate cancer
5392511|NCT00003443|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5392512|NCT00003443|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
5392513|NCT00003443|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5392514|NCT00003443|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
5392515|NCT00003443|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
5392516|NCT00003443|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
5392682|NCT00083538|DTPACE|dtpace
5392517|NCT00003443|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5392518|NCT00003443|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
5392519|NCT00003443|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5392520|NCT00003443|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
5392521|NCT00003443|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
5392522|NCT00003443|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
5392523|NCT00003401|refractory multiple myeloma|refractory multiple myeloma
5392524|NCT00003401|stage I multiple myeloma|stage i multiple myeloma
5392525|NCT00003401|stage II multiple myeloma|stage ii multiple myeloma
5392526|NCT00003401|stage III multiple myeloma|stage iii multiple myeloma
5392527|NCT00003399|refractory multiple myeloma|refractory multiple myeloma
5392528|NCT00003399|stage I multiple myeloma|stage i multiple myeloma
5392529|NCT00003399|stage II multiple myeloma|stage ii multiple myeloma
5392530|NCT00003399|stage III multiple myeloma|stage iii multiple myeloma
5392531|NCT00003396|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5392532|NCT00003396|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5392533|NCT00003396|refractory multiple myeloma|refractory multiple myeloma
5392534|NCT00003396|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
5392535|NCT00003396|stage I multiple myeloma|stage i multiple myeloma
5392536|NCT00003396|stage II multiple myeloma|stage ii multiple myeloma
5392537|NCT00003396|stage III multiple myeloma|stage iii multiple myeloma
5392538|NCT00003396|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
5392539|NCT00003396|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5392540|NCT00003396|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5392541|NCT00003396|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5392542|NCT00003396|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5392543|NCT00003396|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5392544|NCT00003396|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5392545|NCT00003396|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5392546|NCT00003396|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5392547|NCT00003396|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5392548|NCT00003396|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
5392549|NCT00003396|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
5392550|NCT00003396|adult acute erythroid leukemia (M6)|adult acute erythroid leukemia (m6)
5392551|NCT00003396|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
5392552|NCT00003396|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
5392553|NCT00003396|adult acute promyelocytic leukemia (M3)|adult acute promyelocytic leukemia (m3)
5392554|NCT00003396|adult acute eosinophilic leukemia|adult acute eosinophilic leukemia
5392555|NCT00003396|adult acute basophilic leukemia|adult acute basophilic leukemia
5392556|NCT00003396|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
5392557|NCT00003396|childhood acute myeloblastic leukemia without maturation (M1)|childhood acute myeloblastic leukemia without maturation (m1)
5392558|NCT00003396|childhood acute myeloblastic leukemia with maturation (M2)|childhood acute myeloblastic leukemia with maturation (m2)
5392559|NCT00003396|childhood acute promyelocytic leukemia (M3)|childhood acute promyelocytic leukemia (m3)
5392560|NCT00003396|childhood acute erythroleukemia (M6)|childhood acute erythroleukemia (m6)
5392561|NCT00003396|childhood acute eosinophilic leukemia|childhood acute eosinophilic leukemia
5392562|NCT00003396|childhood acute basophilic leukemia|childhood acute basophilic leukemia
5392563|NCT00003396|childhood acute megakaryocytic leukemia (M7)|childhood acute megakaryocytic leukemia (m7)
5392564|NCT00003396|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
5392565|NCT00003396|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5392566|NCT00003396|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5392567|NCT00003396|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5392568|NCT00003396|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5392569|NCT00003396|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5392570|NCT00003396|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5392571|NCT00003396|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5392572|NCT00003396|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5392573|NCT00003396|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5392574|NCT00003396|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5392575|NCT00003396|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
5392576|NCT00003396|childhood acute minimally differentiated myeloid leukemia (M0)|childhood acute minimally differentiated myeloid leukemia (m0)
5392577|NCT00003396|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
5392578|NCT00003396|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
5392579|NCT00003396|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5392580|NCT00003396|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5392581|NCT00003396|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5392582|NCT00003396|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5392583|NCT00003396|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5392584|NCT00003396|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5392585|NCT00003396|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
5392586|NCT00003293|recurrent adult brain tumor|recurrent adult brain tumor
5392587|NCT00003293|adult glioblastoma|adult glioblastoma
5392588|NCT00003293|adult giant cell glioblastoma|adult giant cell glioblastoma
5392589|NCT00003293|adult gliosarcoma|adult gliosarcoma
5392590|NCT00003249|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5392591|NCT00003231|squamous cell lung cancer|squamous cell lung cancer
5392592|NCT00003231|large cell lung cancer|large cell lung cancer
5392593|NCT00003231|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5392594|NCT00003231|adenocarcinoma of the lung|adenocarcinoma of the lung
5392595|NCT00083720|EGFR-undetectable|egfr-undetectable
5392596|NCT00083720|Metastatic Colorectal Cancer|metastatic colorectal cancer
5392597|NCT00083733|Gene Expression|gene expression
5392598|NCT00083733|Microarray|microarray
5392599|NCT00083733|Stem Cell|stem cell
5392600|NCT00083733|Proteomics|proteomics
5392601|NCT00083733|Metastases|metastases
5392602|NCT00083733|Breast Tissue|breast tissue
5392603|NCT00083733|Normal Breast Tissue|normal breast tissue
5392604|NCT00083733|Breast Cancer|breast cancer
5392605|NCT00083707|Macroglobulinemia|macroglobulinemia
5392606|NCT00083707|Waldenstrom|waldenstrom
5392607|NCT00083707|Thalidomide|thalidomide
5392608|NCT00083694|Leukemia|leukemia
5392609|NCT00083694|Thalidomide|thalidomide
5392610|NCT00083694|relapsed|relapsed
5392611|NCT00083681|Multiple Myeloma|multiple myeloma
5392612|NCT00083681|Thalidomide|thalidomide
5392613|NCT00083681|G-CSF|g-csf
5392614|NCT00083681|Cisplatin|cisplatin
5392615|NCT00083681|Etoposide|etoposide
5392616|NCT00083681|Dexamethasone|dexamethasone
5392617|NCT00083681|Cytoxan|cytoxan
5392618|NCT00083681|DCEP|dcep
5392619|NCT00083681|Relapse|relapse
5392620|NCT00083668|Schizophrenia|schizophrenia
5392621|NCT00083668|Paliperidone|paliperidone
5392622|NCT00083668|Olanzapine|olanzapine
5392623|NCT00083668|PANSS|panss
5392624|NCT00083668|Extended release|extended release
5392625|NCT00083668|Atypical neuroleptic|atypical neuroleptic
5392626|NCT00083616|EGFr|egfr
5392627|NCT00083616|Clinical Trial|clinical trial
5392628|NCT00083616|Panitumumab|panitumumab
5392629|NCT00083616|ABX-EGF|abx-egf
5392630|NCT00083616|Immunex|immunex
5392631|NCT00083616|Metastatic Cancer|metastatic cancer
5392632|NCT00083616|Vectibix|vectibix
5392633|NCT00083616|Abgenix|abgenix
5392634|NCT00083616|Amgen|amgen
5392635|NCT00083564|Multiple myeloma|multiple myeloma
5392636|NCT00083564|Primary refractory multiple myeloma|primary refractory multiple myeloma
5392637|NCT00083564|STR|str
5392638|NCT00083564|Skeletal Targeted Radiotherapy|skeletal targeted radiotherapy
5392639|NCT00083564|Holmium-166|holmium-166
5392640|NCT00083564|166-Ho-DOTMP|166-ho-dotmp
5392641|NCT00083642|Brain Plasticity|brain plasticity
5392642|NCT00083642|Functional MRI|functional mri
5392643|NCT00083642|Finger Movement|finger movement
5392644|NCT00083642|Rehabilitation|rehabilitation
5392645|NCT00083642|Improvement|improvement
5392646|NCT00083642|Stroke|stroke
5392647|NCT00083642|Motor Recovery|motor recovery
5392648|NCT00083642|Observation|observation
5392649|NCT00083642|fMRI|fmri
5392650|NCT00083642|Healthy Volunteer|healthy volunteer
5392651|NCT00083642|HV|hv
5392652|NCT00083629|[18F]FECNT|[18f]fecnt
5392653|NCT00083629|Biodistribution|biodistribution
5392654|NCT00083629|Dosimetry|dosimetry
5392655|NCT00083629|Dopamine Transporter|dopamine transporter
5392656|NCT00083629|MIRD|mird
5392657|NCT00083629|Kinetic Analysis|kinetic analysis
5392658|NCT00083629|Compartment Analysis|compartment analysis
5392659|NCT00083629|Healthy Volunteer|healthy volunteer
5392660|NCT00083629|HV|hv
5392661|NCT00083603|HIV Seronegativity|hiv seronegativity
5392662|NCT00083603|HIV Preventive Vaccine|hiv preventive vaccine
5392663|NCT00083603|Vaccinia vector|vaccinia vector
5392664|NCT00083603|Pox vector|pox vector
5392665|NCT00083590|Alzheimer disease|alzheimer disease
5392666|NCT00083590|Cholinesterase inhibitor|cholinesterase inhibitor
5392667|NCT00083577|Multiple Myeloma|multiple myeloma
5392668|NCT00083577|Thalidomide|thalidomide
5392669|NCT00083577|Anti-Angiogenesis|anti-angiogenesis
5392670|NCT00083551|Multiple Myeloma|multiple myeloma
5392671|NCT00083551|Cancer|cancer
5392672|NCT00083551|Therapy|therapy
5392673|NCT00083551|Thalidomide|thalidomide
5392674|NCT00083551|DTPACE|dtpace
5392675|NCT00083551|Transplant|transplant
5392676|NCT00083551|VAD|vad
5392677|NCT00083551|DCEP|dcep
5392678|NCT00083551|CAD|cad
5392679|NCT00083551|Consolidation|consolidation
5392680|NCT00083551|Melphalan|melphalan
5392683|NCT00083538|Dexamethasone|dexamethasone
5392684|NCT00083538|Thalidomide|thalidomide
5392685|NCT00083538|Cisplatin|cisplatin
5392686|NCT00083538|Cytoxan|cytoxan
5392687|NCT00083538|Doxorubicin|doxorubicin
5392688|NCT00083538|Etoposide|etoposide
5392689|NCT00083538|Dendritic Cell Vaccination|dendritic cell vaccination
5392690|NCT00083538|Leukapheresis|leukapheresis
5392691|NCT00003160|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5392692|NCT00003160|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5392693|NCT00003160|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5392694|NCT00003160|fallopian tube cancer|fallopian tube cancer
5392695|NCT00003160|primary peritoneal cavity cancer|primary peritoneal cavity cancer
5392696|NCT00003079|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5392697|NCT00003079|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5392698|NCT00003079|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5392699|NCT00003079|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5392700|NCT00003075|cervical cancer|cervical cancer
5392701|NCT00003075|cervical intraepithelial neoplasia grade 2|cervical intraepithelial neoplasia grade 2
5392702|NCT00003075|cervical intraepithelial neoplasia grade 3|cervical intraepithelial neoplasia grade 3
5392703|NCT00003031|infection|infection
5392704|NCT00003031|pulmonary complications|pulmonary complications
5392705|NCT00003015|childhood low-grade cerebral astrocytoma|childhood low-grade cerebral astrocytoma
5392706|NCT00003015|childhood oligodendroglioma|childhood oligodendroglioma
5392707|NCT00003015|untreated childhood visual pathway glioma|untreated childhood visual pathway glioma
5392708|NCT00003015|untreated childhood cerebellar astrocytoma|untreated childhood cerebellar astrocytoma
5392709|NCT00083473|Leukemia Lymphocytic Chronic,|leukemia lymphocytic chronic,
5392710|NCT00083473|Pivanex,|pivanex,
5392711|NCT00083473|Histone deacetylase inhibitor|histone deacetylase inhibitor
5392712|NCT00083460|Multiple Myeloma|multiple myeloma
5392713|NCT00083460|Thalidomide|thalidomide
5392714|NCT00083460|Velcade|velcade
5392715|NCT00083460|PS-341|ps-341
5392716|NCT00083460|Refractory|refractory
5392717|NCT00083460|Bortezomid|bortezomid
5392718|NCT00083447|brain tumor|brain tumor
5392719|NCT00083447|GBM|gbm
5392720|NCT00083447|glioblastoma|glioblastoma
5392721|NCT00083447|glioblastoma multiforme|glioblastoma multiforme
5392722|NCT00083447|brain cancer|brain cancer
5392723|NCT00083447|treatment|treatment
5392724|NCT00083434|Anemia|anemia
5392725|NCT00083434|Cancer|cancer
5392726|NCT00006877|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5392727|NCT00006877|squamous cell lung cancer|squamous cell lung cancer
5392728|NCT00006877|large cell lung cancer|large cell lung cancer
5392729|NCT00006877|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5392730|NCT00006877|adenocarcinoma of the lung|adenocarcinoma of the lung
5392731|NCT00006358|recurrent adult brain tumor|recurrent adult brain tumor
5392732|NCT00006358|adult glioblastoma|adult glioblastoma
5392733|NCT00006358|adult giant cell glioblastoma|adult giant cell glioblastoma
5392734|NCT00006358|adult gliosarcoma|adult gliosarcoma
5392735|NCT00006343|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5392736|NCT00006343|chronic myelogenous leukemia, BCR-ABL1 positive|chronic myelogenous leukemia, bcr-abl1 positive
5392737|NCT00006222|AIDS-related Kaposi sarcoma|aids-related kaposi sarcoma
5392738|NCT00006222|recurrent Kaposi sarcoma|recurrent kaposi sarcoma
5392739|NCT00006212|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
5392740|NCT00006212|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5392741|NCT00006212|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5392742|NCT00006083|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
5392743|NCT00006083|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
5392744|NCT00006083|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5392745|NCT00006083|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5392746|NCT00006083|monoclonal gammopathy of undetermined significance|monoclonal gammopathy of undetermined significance
5392747|NCT00006083|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5392748|NCT00006083|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
5392749|NCT00006083|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
5392750|NCT00006083|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
5392751|NCT00006083|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
5392752|NCT00006083|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5392753|NCT00006083|stage IB cervical cancer|stage ib cervical cancer
5392754|NCT00006083|Burkitt lymphoma|burkitt lymphoma
5392755|NCT00006083|isolated plasmacytoma of bone|isolated plasmacytoma of bone
5392756|NCT00006083|extramedullary plasmacytoma|extramedullary plasmacytoma
5392757|NCT00006083|refractory multiple myeloma|refractory multiple myeloma
5392758|NCT00006083|stage 0 chronic lymphocytic leukemia|stage 0 chronic lymphocytic leukemia
5392759|NCT00006083|stage I multiple myeloma|stage i multiple myeloma
5392760|NCT00006083|stage II multiple myeloma|stage ii multiple myeloma
5392761|NCT00006083|stage III multiple myeloma|stage iii multiple myeloma
5392762|NCT00006083|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
5403684|NCT00074711|Calcium|calcium
5392763|NCT00006083|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
5392764|NCT00006083|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5392765|NCT00006083|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5392766|NCT00006083|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5392767|NCT00006083|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5392768|NCT00006083|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5392769|NCT00006083|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5392770|NCT00006083|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5392771|NCT00006083|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5392772|NCT00006083|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5392773|NCT00006083|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
5392774|NCT00006083|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
5392775|NCT00006083|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
5392776|NCT00006083|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5392777|NCT00006083|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5392778|NCT00006083|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
5392779|NCT00006083|essential thrombocythemia|essential thrombocythemia
5392780|NCT00006083|untreated hairy cell leukemia|untreated hairy cell leukemia
5392781|NCT00006083|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
5392782|NCT00006083|refractory hairy cell leukemia|refractory hairy cell leukemia
5392783|NCT00006083|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
5392784|NCT00006083|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
5392785|NCT00006083|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
5392786|NCT00006083|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
5392787|NCT00006083|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
5392788|NCT00006083|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
5392789|NCT00006083|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
5392790|NCT00006083|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
5392791|NCT00006083|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
5392792|NCT00006083|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5392793|NCT00006083|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
5392794|NCT00006083|acute undifferentiated leukemia|acute undifferentiated leukemia
5392795|NCT00006083|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5392796|NCT00006083|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5392797|NCT00006083|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5392798|NCT00006083|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5392799|NCT00006083|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5392800|NCT00006083|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5392801|NCT00006083|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5392802|NCT00006083|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5392803|NCT00006083|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5392804|NCT00006083|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5392805|NCT00006083|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5392806|NCT00006083|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5392807|NCT00006083|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5392808|NCT00006083|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5392809|NCT00006083|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5392810|NCT00006083|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5392811|NCT00006083|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5392812|NCT00006083|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5392813|NCT00006083|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5392814|NCT00006083|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5392815|NCT00006083|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5392816|NCT00006083|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5392817|NCT00006083|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5392818|NCT00006083|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5392819|NCT00006083|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5392820|NCT00006083|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5392821|NCT00006083|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5392822|NCT00006083|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
5392823|NCT00006083|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
5392824|NCT00006083|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
5392825|NCT00006083|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
5392891|NCT00005939|stage III prostate cancer|stage iii prostate cancer
5392826|NCT00006083|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
5392827|NCT00006083|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5392828|NCT00006083|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5392829|NCT00006083|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5392830|NCT00006083|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5392831|NCT00006083|primary central nervous system lymphoma|primary central nervous system lymphoma
5392832|NCT00006083|prolymphocytic leukemia|prolymphocytic leukemia
5392833|NCT00006083|primary systemic amyloidosis|primary systemic amyloidosis
5392834|NCT00006083|veno-occlusive disease|veno-occlusive disease
5392835|NCT00006083|stage I mantle cell lymphoma|stage i mantle cell lymphoma
5392836|NCT00006083|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
5392837|NCT00006083|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
5392838|NCT00006083|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
5392839|NCT00006083|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
5392840|NCT00006083|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
5392841|NCT00006083|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
5392842|NCT00006083|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
5392843|NCT00006083|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
5392844|NCT00006083|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
5392845|NCT00006083|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
5392846|NCT00006083|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5392847|NCT00006083|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5392848|NCT00006083|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5392849|NCT00006083|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
5392850|NCT00006083|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5392851|NCT00006083|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
5392852|NCT00006083|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
5392853|NCT00006083|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5392854|NCT00006083|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
5392855|NCT00006083|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
5392856|NCT00006083|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5392857|NCT00006083|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5392858|NCT00006083|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5392859|NCT00006083|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
5392860|NCT00006083|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5392861|NCT00006083|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
5392862|NCT00006083|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
5392863|NCT00006083|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5392864|NCT00006083|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5392865|NCT00006083|stage I marginal zone lymphoma|stage i marginal zone lymphoma
5392866|NCT00006083|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
5392867|NCT00006083|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5392868|NCT00006083|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5392869|NCT00006083|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5392870|NCT00006083|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5392871|NCT00006083|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
5392872|NCT00006083|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
5392873|NCT00006083|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5392874|NCT00006083|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5392875|NCT00006083|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5392876|NCT00006079|cervical cancer|cervical cancer
5392877|NCT00006079|cervical intraepithelial neoplasia grade 2|cervical intraepithelial neoplasia grade 2
5392878|NCT00006079|cervical intraepithelial neoplasia grade 3|cervical intraepithelial neoplasia grade 3
5392879|NCT00006079|Eflornithine|eflornithine
5392880|NCT00006001|stage III colon cancer|stage iii colon cancer
5392881|NCT00006001|stage IV colon cancer|stage iv colon cancer
5392882|NCT00006001|stage III rectal cancer|stage iii rectal cancer
5392883|NCT00006001|stage IV rectal cancer|stage iv rectal cancer
5392884|NCT00006001|recurrent colon cancer|recurrent colon cancer
5392885|NCT00006001|recurrent rectal cancer|recurrent rectal cancer
5392886|NCT00006001|adenocarcinoma of the colon|adenocarcinoma of the colon
5392887|NCT00006001|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5392888|NCT00005939|stage I prostate cancer|stage i prostate cancer
5392889|NCT00005939|stage IIB prostate cancer|stage iib prostate cancer
5392890|NCT00005939|stage IIA prostate cancer|stage iia prostate cancer
5404066|NCT00073853|tetraplegia|tetraplegia
5392892|NCT00005939|recurrent prostate cancer|recurrent prostate cancer
5392893|NCT00005841|iris melanoma|iris melanoma
5392894|NCT00005841|ciliary body and choroid melanoma, small size|ciliary body and choroid melanoma, small size
5392895|NCT00005841|ciliary body and choroid melanoma, medium/large size|ciliary body and choroid melanoma, medium/large size
5392896|NCT00005841|extraocular extension melanoma|extraocular extension melanoma
5392897|NCT00005841|recurrent intraocular melanoma|recurrent intraocular melanoma
5392898|NCT00005841|stage III melanoma|stage iii melanoma
5392899|NCT00005841|stage IV melanoma|stage iv melanoma
5392900|NCT00005841|recurrent melanoma|recurrent melanoma
5392901|NCT00005645|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5392902|NCT00005645|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5392903|NCT00005645|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5392904|NCT00005645|liver metastases|liver metastases
5392905|NCT00005645|malignant pericardial effusion|malignant pericardial effusion
5392906|NCT00005645|malignant pleural effusion|malignant pleural effusion
5392907|NCT00005645|malignant ascites|malignant ascites
5392908|NCT00005645|fallopian tube cancer|fallopian tube cancer
5392909|NCT00005645|primary peritoneal cavity cancer|primary peritoneal cavity cancer
5392910|NCT00005640|stage I colon cancer|stage i colon cancer
5392911|NCT00005640|stage II colon cancer|stage ii colon cancer
5392912|NCT00005640|stage III colon cancer|stage iii colon cancer
5392913|NCT00005640|stage I rectal cancer|stage i rectal cancer
5392914|NCT00005640|stage II rectal cancer|stage ii rectal cancer
5392915|NCT00005640|stage III rectal cancer|stage iii rectal cancer
5392916|NCT00005636|localized malignant mesothelioma|localized malignant mesothelioma
5392917|NCT00005636|advanced malignant mesothelioma|advanced malignant mesothelioma
5392918|NCT00005636|recurrent malignant mesothelioma|recurrent malignant mesothelioma
5392919|NCT00005578|stage II childhood Hodgkin lymphoma|stage ii childhood hodgkin lymphoma
5392920|NCT00005578|stage I childhood Hodgkin lymphoma|stage i childhood hodgkin lymphoma
5392921|NCT00005578|stage III childhood Hodgkin lymphoma|stage iii childhood hodgkin lymphoma
5392922|NCT00005578|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
5392923|NCT00005578|cardiac toxicity|cardiac toxicity
5392924|NCT00005088|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
5392925|NCT00005088|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5392926|NCT00005088|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
5392927|NCT00005088|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5392928|NCT00005088|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
5392929|NCT00005088|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5392930|NCT00005088|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
5392931|NCT00005088|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5392932|NCT00005069|stage IV renal cell cancer|stage iv renal cell cancer
5392933|NCT00005069|recurrent renal cell cancer|recurrent renal cell cancer
5392934|NCT00005059|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5392935|NCT00005059|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5392936|NCT00002923|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5392937|NCT00002917|stage 0 bladder cancer|stage 0 bladder cancer
5392938|NCT00002917|stage I bladder cancer|stage i bladder cancer
5392939|NCT00002917|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
5392940|NCT00002911|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5392941|NCT00002911|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5392942|NCT00002829|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
5392943|NCT00002829|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5392944|NCT00002829|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5392945|NCT00002829|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5392946|NCT00002829|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5392947|NCT00002829|extranodal marginal zone B-cell lymphoma|extranodal marginal zone b-cell lymphoma
5392948|NCT00002829|mucosa-associated lymphoid tissue|mucosa-associated lymphoid tissue
5392949|NCT00002829|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5392950|NCT00002829|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5392951|NCT00002827|stage II childhood Hodgkin lymphoma|stage ii childhood hodgkin lymphoma
5392952|NCT00002827|stage I childhood Hodgkin lymphoma|stage i childhood hodgkin lymphoma
5392953|NCT00002827|stage III childhood Hodgkin lymphoma|stage iii childhood hodgkin lymphoma
5392954|NCT00002827|cardiac toxicity|cardiac toxicity
5392955|NCT00002819|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5392956|NCT00002819|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5392957|NCT00002819|ovarian undifferentiated adenocarcinoma|ovarian undifferentiated adenocarcinoma
5392958|NCT00002819|ovarian mixed epithelial carcinoma|ovarian mixed epithelial carcinoma
5392959|NCT00002819|ovarian serous cystadenocarcinoma|ovarian serous cystadenocarcinoma
5392960|NCT00002819|ovarian mucinous cystadenocarcinoma|ovarian mucinous cystadenocarcinoma
5392961|NCT00002819|ovarian endometrioid adenocarcinoma|ovarian endometrioid adenocarcinoma
5392962|NCT00002819|ovarian clear cell cystadenocarcinoma|ovarian clear cell cystadenocarcinoma
5392963|NCT00002819|Brenner tumor|brenner tumor
5392964|NCT00002806|adult diffuse astrocytoma|adult diffuse astrocytoma
5392965|NCT00002721|recurrent prostate cancer|recurrent prostate cancer
5392966|NCT00002639|recurrent adult brain tumor|recurrent adult brain tumor
5392967|NCT00002639|adult glioblastoma|adult glioblastoma
5392968|NCT00002639|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5392969|NCT00002639|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
5392970|NCT00002639|adult mixed glioma|adult mixed glioma
5392971|NCT00002639|adult giant cell glioblastoma|adult giant cell glioblastoma
5392972|NCT00002639|adult gliosarcoma|adult gliosarcoma
5392973|NCT00002602|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5392974|NCT00002602|stage IIB prostate cancer|stage iib prostate cancer
5392975|NCT00002602|stage IIA prostate cancer|stage iia prostate cancer
5392976|NCT00002602|stage III prostate cancer|stage iii prostate cancer
5392977|NCT00002555|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
5392978|NCT00002555|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5392979|NCT00002555|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
5392980|NCT00002555|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5392981|NCT00002555|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
5392982|NCT00002555|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5392983|NCT00002555|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
5392984|NCT00002555|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5392985|NCT00002477|stage I ovarian epithelial cancer|stage i ovarian epithelial cancer
5392986|NCT00002477|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
5392987|NCT00083512|Blood|blood
5392988|NCT00083512|Urine|urine
5392989|NCT00083512|GBM|gbm
5392990|NCT00083512|Radiation|radiation
5392991|NCT00083512|Glioblastoma Multiforme|glioblastoma multiforme
5392992|NCT00083499|Pental of Cantrell|pental of cantrell
5392993|NCT00083499|TAS Syndrome|tas syndrome
5392994|NCT00083499|Midline Defects|midline defects
5392995|NCT00083499|Contractile Proteins|contractile proteins
5392996|NCT00083499|Herniation|herniation
5392997|NCT00083499|Nonmuscle Myosin IIC|nonmuscle myosin iic
5392998|NCT00083499|Pentalogy of Cantrell|pentalogy of cantrell
5392999|NCT00083499|Non-muscle Myosin Heavy Chain Genes|non-muscle myosin heavy chain genes
5393000|NCT00083408|Multiple Myeloma|multiple myeloma
5393001|NCT00083408|Pamidronate|pamidronate
5393002|NCT00083408|Thalidomide|thalidomide
5393003|NCT00083408|refractory myeloma|refractory myeloma
5393004|NCT00083408|bisphosphonates|bisphosphonates
5393005|NCT00083408|Aredia|aredia
5393006|NCT00004881|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5393007|NCT00004200|adult glioblastoma|adult glioblastoma
5393008|NCT00004200|adult giant cell glioblastoma|adult giant cell glioblastoma
5393009|NCT00004200|adult gliosarcoma|adult gliosarcoma
5393010|NCT00004190|stage III pancreatic cancer|stage iii pancreatic cancer
5393011|NCT00004190|recurrent pancreatic cancer|recurrent pancreatic cancer
5393012|NCT00004190|duct cell adenocarcinoma of the pancreas|duct cell adenocarcinoma of the pancreas
5393013|NCT00004190|stage IV pancreatic cancer|stage iv pancreatic cancer
5393014|NCT00004176|limited stage small cell lung cancer|limited stage small cell lung cancer
5393015|NCT00004176|drug/agent toxicity by tissue/organ|drug/agent toxicity by tissue/organ
5393016|NCT00004176|radiation toxicity|radiation toxicity
5393017|NCT00004139|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5393018|NCT00004139|squamous cell lung cancer|squamous cell lung cancer
5393019|NCT00004139|large cell lung cancer|large cell lung cancer
5393020|NCT00004139|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5393021|NCT00004139|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5393022|NCT00004139|adenocarcinoma of the lung|adenocarcinoma of the lung
5393023|NCT00004139|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
5393024|NCT00004112|stage II adult diffuse small cleaved cell lymphoma|stage ii adult diffuse small cleaved cell lymphoma
5393025|NCT00004112|stage II adult diffuse mixed cell lymphoma|stage ii adult diffuse mixed cell lymphoma
5393026|NCT00004112|stage II adult diffuse large cell lymphoma|stage ii adult diffuse large cell lymphoma
5393027|NCT00004112|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5393028|NCT00004112|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5393029|NCT00004112|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5393030|NCT00004112|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5393031|NCT00004112|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5393032|NCT00004112|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5393033|NCT00004112|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5393034|NCT00004112|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5393035|NCT00004112|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5393036|NCT00004112|stage II mantle cell lymphoma|stage ii mantle cell lymphoma
5393037|NCT00004112|stage II small lymphocytic lymphoma|stage ii small lymphocytic lymphoma
5393038|NCT00004112|stage II marginal zone lymphoma|stage ii marginal zone lymphoma
5393039|NCT00004112|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5393040|NCT00004112|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5393041|NCT00004112|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5393042|NCT00004112|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5393043|NCT00004112|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5393044|NCT00004112|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5393045|NCT00004112|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5393046|NCT00004105|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5393047|NCT00004105|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5393048|NCT00004105|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5393049|NCT00004105|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5393050|NCT00004105|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5393051|NCT00004105|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5393052|NCT00004105|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5393053|NCT00004105|childhood fibrosarcoma|childhood fibrosarcoma
5393054|NCT00004105|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5393055|NCT00004105|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5393056|NCT00004105|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5393057|NCT00004105|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5393058|NCT00004105|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5393059|NCT00004105|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5393060|NCT00004105|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5393061|NCT00004105|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5393062|NCT00004105|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5393063|NCT00004105|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5393064|NCT00004105|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5393065|NCT00004105|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5393066|NCT00004105|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5393067|NCT00004105|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5393068|NCT00004105|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5393069|NCT00004105|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5393070|NCT00004105|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5393071|NCT00004105|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5393072|NCT00004105|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5393073|NCT00004105|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5393074|NCT00004105|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5393075|NCT00004105|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5393076|NCT00004105|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5393077|NCT00004105|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5393078|NCT00004105|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5393079|NCT00004105|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5393080|NCT00004105|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5393081|NCT00004105|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
5393082|NCT00004105|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
5393083|NCT00004105|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
5393084|NCT00004105|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5393085|NCT00004105|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5393086|NCT00004105|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5393087|NCT00004105|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5393088|NCT00004105|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5393089|NCT00004105|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5393090|NCT00004105|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5393091|NCT00004105|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5393092|NCT00004105|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5393093|NCT00004105|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5393094|NCT00004105|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5393095|NCT00004105|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5393096|NCT00004061|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
5393097|NCT00004061|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
5393098|NCT00004061|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5393099|NCT00004061|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5393100|NCT00004061|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5393101|NCT00004061|stage 0 chronic lymphocytic leukemia|stage 0 chronic lymphocytic leukemia
5393102|NCT00004061|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
5393103|NCT00004061|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
5393104|NCT00004061|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5393105|NCT00004061|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5393106|NCT00004061|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5393107|NCT00004061|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5393108|NCT00004061|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5393109|NCT00004061|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5393110|NCT00004061|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5393111|NCT00004061|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5393112|NCT00004061|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5393113|NCT00004061|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
5393114|NCT00004061|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
5393115|NCT00004061|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
5393116|NCT00004061|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5393117|NCT00004061|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5393118|NCT00004061|oral complications|oral complications
5393119|NCT00004061|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
5393120|NCT00004061|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
5393121|NCT00004061|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
5393122|NCT00004061|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
5393123|NCT00004061|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
5393124|NCT00004061|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
5393125|NCT00004061|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
5393126|NCT00004061|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
5393127|NCT00004061|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
5393128|NCT00004061|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5393129|NCT00004061|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5393130|NCT00004061|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5393131|NCT00004061|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5393132|NCT00004061|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5393133|NCT00004061|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5393134|NCT00004061|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5393135|NCT00004061|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5393136|NCT00004061|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5393137|NCT00004061|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5393138|NCT00004061|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5393139|NCT00004061|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5393140|NCT00004061|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5393141|NCT00004061|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5393142|NCT00004061|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5393143|NCT00004061|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5393144|NCT00004061|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5393145|NCT00004061|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5393146|NCT00004061|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5393147|NCT00004061|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5393148|NCT00004061|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5393149|NCT00004061|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5393150|NCT00004061|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5393151|NCT00004061|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5393152|NCT00004061|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5393153|NCT00004061|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5393154|NCT00004061|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5393155|NCT00004061|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5393156|NCT00004061|stage I mantle cell lymphoma|stage i mantle cell lymphoma
5393157|NCT00004061|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
5393158|NCT00004061|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
5393159|NCT00004061|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
5393160|NCT00004061|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
5393161|NCT00004061|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
5393162|NCT00004061|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
5393163|NCT00004061|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
5393164|NCT00004061|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
5393165|NCT00004061|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
5393166|NCT00004061|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
5393167|NCT00004061|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5393168|NCT00004061|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5393169|NCT00004061|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5393170|NCT00004061|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
5393171|NCT00004061|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5393172|NCT00004061|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
5393173|NCT00004061|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
5393174|NCT00004061|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5393175|NCT00004061|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
5393176|NCT00004061|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
5393177|NCT00004061|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5393178|NCT00004061|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5393179|NCT00004061|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5393180|NCT00004061|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
5393181|NCT00004061|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
5393182|NCT00004061|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5393183|NCT00004061|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5393184|NCT00004061|stage I marginal zone lymphoma|stage i marginal zone lymphoma
5393185|NCT00004061|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
5393186|NCT00004061|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5393187|NCT00004061|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5393188|NCT00004061|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5393189|NCT00004061|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5393190|NCT00004061|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
5393191|NCT00004061|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
5393192|NCT00004061|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5393193|NCT00004061|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5393194|NCT00004061|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5393195|NCT00004030|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5393196|NCT00004012|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5393197|NCT00004012|fallopian tube cancer|fallopian tube cancer
5393198|NCT00004012|primary peritoneal cavity cancer|primary peritoneal cavity cancer
5393199|NCT00003985|non-small cell lung cancer|non-small cell lung cancer
5393200|NCT00003985|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5393201|NCT00003984|refractory anemia with excess blasts|refractory anemia with excess blasts
5393202|NCT00003984|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
5393203|NCT00003984|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5393204|NCT00003984|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5393205|NCT00003984|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5393206|NCT00003982|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5393207|NCT00003982|testicular embryonal carcinoma and yolk sac tumor|testicular embryonal carcinoma and yolk sac tumor
5393208|NCT00003980|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5393209|NCT00003944|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5393210|NCT00003944|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5393211|NCT00003944|ovarian undifferentiated adenocarcinoma|ovarian undifferentiated adenocarcinoma
5393212|NCT00003944|ovarian mixed epithelial carcinoma|ovarian mixed epithelial carcinoma
5393213|NCT00003944|ovarian serous cystadenocarcinoma|ovarian serous cystadenocarcinoma
5393214|NCT00003944|ovarian mucinous cystadenocarcinoma|ovarian mucinous cystadenocarcinoma
5393215|NCT00003944|ovarian endometrioid adenocarcinoma|ovarian endometrioid adenocarcinoma
5393216|NCT00003944|ovarian clear cell cystadenocarcinoma|ovarian clear cell cystadenocarcinoma
5393217|NCT00003944|fallopian tube cancer|fallopian tube cancer
5393218|NCT00003944|peritoneal cavity cancer|peritoneal cavity cancer
5393219|NCT00003846|regional neuroblastoma|regional neuroblastoma
5393220|NCT00003846|disseminated neuroblastoma|disseminated neuroblastoma
5393221|NCT00003846|stage 4S neuroblastoma|stage 4s neuroblastoma
5393222|NCT00003846|untreated childhood supratentorial primitive neuroectodermal tumor|untreated childhood supratentorial primitive neuroectodermal tumor
5393223|NCT00003846|untreated childhood medulloblastoma|untreated childhood medulloblastoma
5393224|NCT00003846|newly diagnosed childhood ependymoma|newly diagnosed childhood ependymoma
5393225|NCT00003752|stage IV breast cancer|stage iv breast cancer
5393226|NCT00003752|recurrent breast cancer|recurrent breast cancer
5393227|NCT00003669|stage IV endometrial carcinoma|stage iv endometrial carcinoma
5393228|NCT00003669|recurrent endometrial carcinoma|recurrent endometrial carcinoma
5393229|NCT00003580|oral complications|oral complications
5404067|NCT00073853|paralysis|paralysis
5393230|NCT00003580|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
5393231|NCT00003580|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5393232|NCT00003580|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
5393233|NCT00003580|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5393234|NCT00003580|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
5393235|NCT00003580|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
5393236|NCT00003580|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
5393237|NCT00003580|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5393238|NCT00003580|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
5393239|NCT00003580|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5393240|NCT00003580|drug/agent toxicity by tissue/organ|drug/agent toxicity by tissue/organ
5393241|NCT00003580|radiation toxicity|radiation toxicity
5393242|NCT00083395|ARVC/ARVD|arvc/arvd
5393243|NCT00083395|Genetics|genetics
5393244|NCT00083395|Sudden Death|sudden death
5393246|NCT00083395|MRI|mri
5393247|NCT00083395|Cardiomyopathy|cardiomyopathy
5393248|NCT00083395|Arrhythmogenic Right Ventricular|arrhythmogenic right ventricular
5393249|NCT00083395|ARVC|arvc
5393250|NCT00083395|Healthy Volunteer|healthy volunteer
5393251|NCT00083395|HV|hv
5393252|NCT00083382|Myeloma|myeloma
5393253|NCT00083382|Thalidomide|thalidomide
5393254|NCT00083382|Pamidronate|pamidronate
5393255|NCT00083382|Aredia|aredia
5393256|NCT00083382|Bisphosphonate|bisphosphonate
5393257|NCT00083382|Anti-Angiogenesis|anti-angiogenesis
5393258|NCT00083382|Smoldering/Indolent Myeloma|smoldering/indolent myeloma
5393259|NCT00083382|Zometa|zometa
5393260|NCT00008229|stage I multiple myeloma|stage i multiple myeloma
5393261|NCT00008229|stage II multiple myeloma|stage ii multiple myeloma
5393262|NCT00008229|stage III multiple myeloma|stage iii multiple myeloma
5393263|NCT00008073|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5393264|NCT00006344|limited stage small cell lung cancer|limited stage small cell lung cancer
5393265|NCT00006344|extensive stage small cell lung cancer|extensive stage small cell lung cancer
5393266|NCT00006269|stage IV colon cancer|stage iv colon cancer
5393267|NCT00006269|stage IV rectal cancer|stage iv rectal cancer
5393268|NCT00006269|recurrent colon cancer|recurrent colon cancer
5393269|NCT00006269|recurrent rectal cancer|recurrent rectal cancer
5393270|NCT00006269|diarrhea|diarrhea
5393271|NCT00003614|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5393272|NCT00003614|stage IV prostate cancer|stage iv prostate cancer
5393273|NCT00003614|recurrent prostate cancer|recurrent prostate cancer
5393274|NCT00003523|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5393275|NCT00003523|primary peritoneal cavity cancer|primary peritoneal cavity cancer
5393276|NCT00003518|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
5393277|NCT00003518|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
5393278|NCT00003518|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
5393279|NCT00003518|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
5393280|NCT00003444|stage III melanoma|stage iii melanoma
5393281|NCT00003444|stage IV melanoma|stage iv melanoma
5393282|NCT00003444|recurrent melanoma|recurrent melanoma
5393283|NCT00003405|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
5393284|NCT00003405|untreated childhood acute myeloid leukemia and other myeloid malignancies|untreated childhood acute myeloid leukemia and other myeloid malignancies
5393285|NCT00003405|adult acute erythroid leukemia (M6)|adult acute erythroid leukemia (m6)
5393286|NCT00003405|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
5393287|NCT00003405|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
5393288|NCT00003405|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
5393289|NCT00003405|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
5393290|NCT00003405|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
5393291|NCT00003405|childhood acute myeloblastic leukemia without maturation (M1)|childhood acute myeloblastic leukemia without maturation (m1)
5393292|NCT00003405|childhood acute myeloblastic leukemia with maturation (M2)|childhood acute myeloblastic leukemia with maturation (m2)
5393293|NCT00003405|childhood acute myelomonocytic leukemia (M4)|childhood acute myelomonocytic leukemia (m4)
5393294|NCT00003405|childhood acute monoblastic leukemia (M5a)|childhood acute monoblastic leukemia (m5a)
5393295|NCT00003405|childhood acute monocytic leukemia (M5b)|childhood acute monocytic leukemia (m5b)
5393296|NCT00003405|childhood acute erythroleukemia (M6)|childhood acute erythroleukemia (m6)
5393297|NCT00003405|childhood acute megakaryocytic leukemia (M7)|childhood acute megakaryocytic leukemia (m7)
5393298|NCT00003405|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
5393299|NCT00003403|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5393300|NCT00003269|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
5393301|NCT00003269|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
5393302|NCT00003269|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5393303|NCT00003269|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5393304|NCT00003269|stage I breast cancer|stage i breast cancer
5393305|NCT00003269|stage II breast cancer|stage ii breast cancer
5393306|NCT00003269|stage IV breast cancer|stage iv breast cancer
5393307|NCT00003269|stage IIIA breast cancer|stage iiia breast cancer
5393308|NCT00003269|stage I non-small cell lung cancer|stage i non-small cell lung cancer
5393309|NCT00003269|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
5393310|NCT00003269|stage IIIB breast cancer|stage iiib breast cancer
5393311|NCT00003269|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
5393312|NCT00003269|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
5393313|NCT00003269|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
5393314|NCT00003269|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
5393315|NCT00003269|stage I ovarian epithelial cancer|stage i ovarian epithelial cancer
5393316|NCT00003269|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
5393317|NCT00003269|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5393318|NCT00003269|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5393319|NCT00003269|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
5393320|NCT00003269|limited stage small cell lung cancer|limited stage small cell lung cancer
5393321|NCT00003269|extensive stage small cell lung cancer|extensive stage small cell lung cancer
5393322|NCT00003269|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5393323|NCT00003269|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5393324|NCT00003269|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5393325|NCT00003269|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5393326|NCT00003269|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
5393327|NCT00003269|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
5393328|NCT00003269|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
5393329|NCT00003269|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
5393330|NCT00003269|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
5393331|NCT00003269|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
5393332|NCT00003269|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
5393333|NCT00003269|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
5393334|NCT00003269|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
5393335|NCT00003269|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5393336|NCT00003269|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5393337|NCT00003269|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5393338|NCT00003269|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5393339|NCT00003269|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5393340|NCT00003269|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5393341|NCT00003269|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5393342|NCT00003269|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5393343|NCT00003269|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5393344|NCT00003269|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5393345|NCT00003269|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5393346|NCT00003269|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5393347|NCT00003269|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5393348|NCT00003269|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5393349|NCT00003269|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5393350|NCT00003269|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5393351|NCT00003269|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5393352|NCT00003269|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5393353|NCT00003269|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
5393354|NCT00003269|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
5393355|NCT00003269|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
5393356|NCT00003269|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
5393357|NCT00003269|drug/agent toxicity by tissue/organ|drug/agent toxicity by tissue/organ
5393358|NCT00003269|stage I mantle cell lymphoma|stage i mantle cell lymphoma
5393359|NCT00003269|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
5393360|NCT00003269|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
5393361|NCT00003269|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
5393362|NCT00003269|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
5393363|NCT00003269|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
5393364|NCT00003269|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
5393365|NCT00003269|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
5393366|NCT00003269|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
5393367|NCT00003269|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
5393368|NCT00003269|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
5393369|NCT00003269|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5393370|NCT00003269|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5393371|NCT00003269|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5393372|NCT00003269|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
5393373|NCT00003269|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5393374|NCT00003269|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
5393375|NCT00003269|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
5393376|NCT00003269|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5393377|NCT00003269|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
5393378|NCT00003269|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
5393379|NCT00003269|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5393380|NCT00003269|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5393381|NCT00003269|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
5393382|NCT00003269|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
5393383|NCT00003269|stage I marginal zone lymphoma|stage i marginal zone lymphoma
5393384|NCT00003269|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
5393385|NCT00003269|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5393386|NCT00003269|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5393387|NCT00003269|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5393388|NCT00003269|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5393389|NCT00003269|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
5393390|NCT00003269|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
5393391|NCT00003269|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5393392|NCT00003269|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5393393|NCT00003269|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5393394|NCT00003195|refractory multiple myeloma|refractory multiple myeloma
5393395|NCT00003195|stage II multiple myeloma|stage ii multiple myeloma
5393396|NCT00003195|stage III multiple myeloma|stage iii multiple myeloma
5393397|NCT00003187|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5393398|NCT00003187|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
5393399|NCT00003187|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5393400|NCT00003187|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5393401|NCT00003187|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5393402|NCT00003187|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5393403|NCT00003187|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5393404|NCT00003187|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5393405|NCT00003187|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
5393406|NCT00003187|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
5393407|NCT00003187|untreated childhood acute myeloid leukemia and other myeloid malignancies|untreated childhood acute myeloid leukemia and other myeloid malignancies
5393408|NCT00003187|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
5393409|NCT00003187|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5393410|NCT00003187|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5393411|NCT00003187|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
5393412|NCT00003187|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
5393413|NCT00003187|refractory anemia|refractory anemia
5393414|NCT00003187|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
5393415|NCT00003187|refractory anemia with excess blasts|refractory anemia with excess blasts
5393416|NCT00003187|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
5393417|NCT00003187|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5393418|NCT00003187|acute undifferentiated leukemia|acute undifferentiated leukemia
5393419|NCT00003187|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5393420|NCT00003187|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5393421|NCT00003187|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5393422|NCT00003187|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5393423|NCT00003187|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
5393424|NCT00003098|breast cancer|breast cancer
5393425|NCT00003084|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5393426|NCT00003084|stage I prostate cancer|stage i prostate cancer
5393427|NCT00003084|stage II prostate cancer|stage ii prostate cancer
5393428|NCT00003084|stage III prostate cancer|stage iii prostate cancer
5393429|NCT00003084|stage IV prostate cancer|stage iv prostate cancer
5393430|NCT00003084|recurrent prostate cancer|recurrent prostate cancer
5393431|NCT00003084|Chemotherapy|chemotherapy
5393432|NCT00003084|Ketoconazole|ketoconazole
5393433|NCT00003084|Estramustine|estramustine
5393434|NCT00003084|Etoposide|etoposide
5393435|NCT00003084|Paclitaxel|paclitaxel
5393436|NCT00003084|Doxorubicin|doxorubicin
5393437|NCT00003084|Vinblastine|vinblastine
5393438|NCT00003056|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5393439|NCT00003056|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5393440|NCT00003056|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5393441|NCT00003056|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5393442|NCT00003056|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5393443|NCT00003056|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5393444|NCT00003056|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5393445|NCT00003056|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5393446|NCT00003056|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5393447|NCT00003056|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5393448|NCT00003056|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5393449|NCT00003056|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5393450|NCT00003056|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5393451|NCT00003056|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5393452|NCT00003056|graft versus host disease|graft versus host disease
5393453|NCT00003056|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5393454|NCT00003056|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5393455|NCT00003056|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5393456|NCT00003056|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5393457|NCT00003056|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5393458|NCT00003056|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5393459|NCT00003056|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5393460|NCT00003056|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5393461|NCT00003004|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5393462|NCT00002924|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5393463|NCT00002924|recurrent prostate cancer|recurrent prostate cancer
5393464|NCT00002902|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5393465|NCT00002875|untreated childhood medulloblastoma|untreated childhood medulloblastoma
5393466|NCT00002780|stage IV breast cancer|stage iv breast cancer
5393467|NCT00002780|recurrent breast cancer|recurrent breast cancer
5393468|NCT00002780|stage IIIB breast cancer|stage iiib breast cancer
5393469|NCT00002750|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5393470|NCT00002750|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5393471|NCT00002750|Waldenström macroglobulinemia|waldenström macroglobulinemia
5393472|NCT00002750|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
5393473|NCT00002750|childhood central nervous system germ cell tumor|childhood central nervous system germ cell tumor
5393474|NCT00002750|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5393475|NCT00002750|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5393476|NCT00002750|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5393477|NCT00002750|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
5393478|NCT00002750|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
5393479|NCT00002750|recurrent adult non-Hodgkin lymphoma|recurrent adult non-hodgkin lymphoma
5393480|NCT00002750|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5393481|NCT00002750|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5393482|NCT00002750|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5393483|NCT00002750|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5393484|NCT00002750|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5393485|NCT00002750|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5393486|NCT00002750|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5393487|NCT00002750|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5393488|NCT00002750|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5393489|NCT00002750|extragonadal germ cell tumor|extragonadal germ cell tumor
5393490|NCT00002750|leptomeningeal metastases|leptomeningeal metastases
5393491|NCT00002750|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
5393492|NCT00002750|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
5393493|NCT00002750|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5393494|NCT00002750|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5393495|NCT00002750|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5393496|NCT00002750|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5393497|NCT00002750|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5393498|NCT00002750|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5393499|NCT00002734|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5393500|NCT00002734|primary peritoneal cavity cancer|primary peritoneal cavity cancer
5393501|NCT00002671|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5393502|NCT00002671|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5393503|NCT00002671|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5393504|NCT00002664|recurrent colon cancer|recurrent colon cancer
5393505|NCT00002664|recurrent rectal cancer|recurrent rectal cancer
5393506|NCT00002576|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
5393507|NCT00002576|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
5393508|NCT00002576|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
5393509|NCT00002576|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
5393510|NCT00002576|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
5393511|NCT00002576|stage II adult diffuse mixed cell lymphoma|stage ii adult diffuse mixed cell lymphoma
5393512|NCT00002576|stage II adult diffuse large cell lymphoma|stage ii adult diffuse large cell lymphoma
5393513|NCT00002576|stage II adult immunoblastic large cell lymphoma|stage ii adult immunoblastic large cell lymphoma
5393514|NCT00002576|stage II adult lymphoblastic lymphoma|stage ii adult lymphoblastic lymphoma
5393515|NCT00002576|stage II adult Burkitt lymphoma|stage ii adult burkitt lymphoma
5393516|NCT00002576|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5393517|NCT00002576|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5393518|NCT00002576|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5393519|NCT00002576|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5393520|NCT00002576|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5393521|NCT00002576|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5393522|NCT00002576|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5393523|NCT00002576|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5393524|NCT00002576|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5393525|NCT00002576|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5393526|NCT00002576|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
5393527|NCT00002576|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
5393528|NCT00002576|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
5393529|NCT00002576|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
5393530|NCT00002576|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
5393531|NCT00002576|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
5393532|NCT00002576|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
5393533|NCT00002576|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5393534|NCT00002576|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
5393535|NCT00002576|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
5393536|NCT00002571|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
5393537|NCT00002571|AIDS-related diffuse large cell lymphoma|aids-related diffuse large cell lymphoma
5393538|NCT00002571|AIDS-related immunoblastic large cell lymphoma|aids-related immunoblastic large cell lymphoma
5393539|NCT00002571|AIDS-related small noncleaved cell lymphoma|aids-related small noncleaved cell lymphoma
5393540|NCT00002571|AIDS-related diffuse mixed cell lymphoma|aids-related diffuse mixed cell lymphoma
5393541|NCT00002571|AIDS-related diffuse small cleaved cell lymphoma|aids-related diffuse small cleaved cell lymphoma
5393542|NCT00002567|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5393543|NCT00002567|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5393544|NCT00002567|adult acute erythroid leukemia (M6)|adult acute erythroid leukemia (m6)
5393545|NCT00002567|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
5393546|NCT00002567|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
5393547|NCT00002567|adult acute promyelocytic leukemia (M3)|adult acute promyelocytic leukemia (m3)
5393548|NCT00002567|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
5393549|NCT00002567|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
5393550|NCT00002567|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
5393551|NCT00002567|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
5393552|NCT00002567|bone marrow ablation|bone marrow ablation
5393553|NCT00002567|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
5393554|NCT00002552|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5393555|NCT00002552|refractory multiple myeloma|refractory multiple myeloma
5393556|NCT00002552|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5393557|NCT00002552|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5393558|NCT00002552|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5393559|NCT00002552|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5393560|NCT00002552|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5393561|NCT00002552|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5393562|NCT00002552|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5393563|NCT00002552|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5393564|NCT00002552|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5393565|NCT00002552|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5393566|NCT00002552|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5393567|NCT00002552|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5393568|NCT00002552|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5393569|NCT00002552|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5393570|NCT00002552|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5393571|NCT00002552|adult unfavorable prognosis Hodgkin lymphoma|adult unfavorable prognosis hodgkin lymphoma
5393572|NCT00002552|childhood unfavorable prognosis Hodgkin lymphoma|childhood unfavorable prognosis hodgkin lymphoma
5393573|NCT00002547|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5393574|NCT00002547|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5393575|NCT00002547|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
5393576|NCT00002547|untreated childhood acute myeloid leukemia and other myeloid malignancies|untreated childhood acute myeloid leukemia and other myeloid malignancies
5393577|NCT00002547|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5393578|NCT00002547|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
5393579|NCT00002547|adult acute erythroid leukemia (M6)|adult acute erythroid leukemia (m6)
5393580|NCT00002547|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
5393581|NCT00002547|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
5393582|NCT00002547|adult acute promyelocytic leukemia (M3)|adult acute promyelocytic leukemia (m3)
5393583|NCT00002547|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
5393584|NCT00002547|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
5393585|NCT00002547|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
5393586|NCT00002547|childhood acute myeloblastic leukemia without maturation (M1)|childhood acute myeloblastic leukemia without maturation (m1)
5393587|NCT00002547|childhood acute myeloblastic leukemia with maturation (M2)|childhood acute myeloblastic leukemia with maturation (m2)
5393588|NCT00002547|childhood acute promyelocytic leukemia (M3)|childhood acute promyelocytic leukemia (m3)
5393589|NCT00002547|childhood acute myelomonocytic leukemia (M4)|childhood acute myelomonocytic leukemia (m4)
5393590|NCT00002547|childhood acute monoblastic leukemia (M5a)|childhood acute monoblastic leukemia (m5a)
5393591|NCT00002547|childhood acute monocytic leukemia (M5b)|childhood acute monocytic leukemia (m5b)
5393592|NCT00002547|childhood acute erythroleukemia (M6)|childhood acute erythroleukemia (m6)
5393593|NCT00002547|childhood acute megakaryocytic leukemia (M7)|childhood acute megakaryocytic leukemia (m7)
5393594|NCT00002547|refractory anemia with excess blasts|refractory anemia with excess blasts
5393595|NCT00002547|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
5393596|NCT00002547|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5393597|NCT00002547|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5393598|NCT00002547|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
5393599|NCT00002547|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5393600|NCT00002547|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
5393601|NCT00083356|Pain|pain
5393602|NCT00083356|Kinins|kinins
5393603|NCT00083356|Inflammation|inflammation
5393604|NCT00083356|Gene Expression|gene expression
5393605|NCT00083356|Oral Surgey|oral surgey
5393606|NCT00083356|Bradykinin B1 Receptors|bradykinin b1 receptors
5393607|NCT00083356|Acute Peripheral Inflammation|acute peripheral inflammation
5393608|NCT00083356|Inflammatory Gene Expression|inflammatory gene expression
5393609|NCT00083356|Wisdom Teeth|wisdom teeth
5393610|NCT00083356|Third Molar Extraction|third molar extraction
5393611|NCT00005648|Stage II pancreatic cancer|stage ii pancreatic cancer
5393612|NCT00005648|Stage III pancreatic cancer|stage iii pancreatic cancer
5393613|NCT00005648|Recurrent pancreatic cancer|recurrent pancreatic cancer
5393614|NCT00005648|Adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
5393615|NCT00005648|Stage IV pancreatic cancer|stage iv pancreatic cancer
5393616|NCT00004198|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5393617|NCT00004198|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5393618|NCT00004198|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5393619|NCT00004198|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5393620|NCT00004126|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5393621|NCT00004126|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5393622|NCT00004126|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5393623|NCT00004122|stage I bladder cancer|stage i bladder cancer
5393624|NCT00004122|recurrent bladder cancer|recurrent bladder cancer
5394227|NCT00083213|recurrent vaginal cancer|recurrent vaginal cancer
5393625|NCT00004122|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
5393626|NCT00004113|recurrent adult brain tumor|recurrent adult brain tumor
5393627|NCT00004113|adult glioblastoma|adult glioblastoma
5393628|NCT00004113|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5393629|NCT00004113|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
5393630|NCT00004113|adult mixed glioma|adult mixed glioma
5393631|NCT00004113|adult giant cell glioblastoma|adult giant cell glioblastoma
5393632|NCT00004113|adult gliosarcoma|adult gliosarcoma
5393633|NCT00003976|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5393634|NCT00003908|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
5393635|NCT00003908|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
5393636|NCT00003908|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5393637|NCT00003908|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
5393638|NCT00003908|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5393639|NCT00003908|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
5393640|NCT00003908|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
5393641|NCT00003908|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
5393642|NCT00003908|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5393643|NCT00003908|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
5393644|NCT00003908|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5393645|NCT00003908|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
5393646|NCT00003908|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
5393647|NCT00003908|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
5393648|NCT00003822|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5393649|NCT00003747|stage IV melanoma|stage iv melanoma
5393650|NCT00003747|recurrent melanoma|recurrent melanoma
5393651|NCT00003724|lung metastases|lung metastases
5393652|NCT00003670|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5393653|NCT00003670|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5393654|NCT00003670|primary peritoneal cavity cancer|primary peritoneal cavity cancer
5393655|NCT00003606|extensive stage small cell lung cancer|extensive stage small cell lung cancer
5393656|NCT00003562|squamous cell lung cancer|squamous cell lung cancer
5393657|NCT00003562|large cell lung cancer|large cell lung cancer
5393658|NCT00003562|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5393659|NCT00003562|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5393660|NCT00003562|adenocarcinoma of the lung|adenocarcinoma of the lung
5393661|NCT00003490|refractory multiple myeloma|refractory multiple myeloma
5393662|NCT00003490|stage I multiple myeloma|stage i multiple myeloma
5393663|NCT00003490|stage II multiple myeloma|stage ii multiple myeloma
5393664|NCT00003490|stage III multiple myeloma|stage iii multiple myeloma
5393665|NCT00003447|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5393666|NCT00003447|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5393667|NCT00003365|colon cancer|colon cancer
5393668|NCT00003322|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5393669|NCT00003322|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5393670|NCT00003322|ovarian undifferentiated adenocarcinoma|ovarian undifferentiated adenocarcinoma
5393671|NCT00003322|ovarian mixed epithelial carcinoma|ovarian mixed epithelial carcinoma
5393672|NCT00003322|ovarian serous cystadenocarcinoma|ovarian serous cystadenocarcinoma
5393673|NCT00003322|ovarian mucinous cystadenocarcinoma|ovarian mucinous cystadenocarcinoma
5393674|NCT00003322|ovarian endometrioid adenocarcinoma|ovarian endometrioid adenocarcinoma
5393675|NCT00003322|ovarian clear cell cystadenocarcinoma|ovarian clear cell cystadenocarcinoma
5393676|NCT00003322|primary peritoneal cavity cancer|primary peritoneal cavity cancer
5393677|NCT00003322|Brenner tumor|brenner tumor
5393678|NCT00003289|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
5393679|NCT00003289|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5393680|NCT00003289|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5393681|NCT00003289|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5393682|NCT00003289|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5393683|NCT00003289|refractory hairy cell leukemia|refractory hairy cell leukemia
5393684|NCT00003289|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5393685|NCT00003289|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5393686|NCT00003289|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5393687|NCT00003289|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5393688|NCT00003289|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5393689|NCT00003289|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5393690|NCT00003289|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5393691|NCT00003289|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5393692|NCT00003289|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5393693|NCT00003289|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5393694|NCT00003289|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5393695|NCT00003289|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5393696|NCT00003289|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5393697|NCT00003289|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5393698|NCT00003289|prolymphocytic leukemia|prolymphocytic leukemia
5393699|NCT00003289|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5393700|NCT00003289|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5393701|NCT00003289|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5393702|NCT00003289|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5393703|NCT00003289|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5393704|NCT00003289|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5394183|NCT00083304|Brain|brain
5393705|NCT00003289|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5393706|NCT00003289|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5393707|NCT00003289|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5393708|NCT00003289|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5393709|NCT00003289|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5393710|NCT00003289|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5393711|NCT00003250|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5393712|NCT00003101|adult oligodendroglioma|adult oligodendroglioma
5393713|NCT00003101|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
5393714|NCT00002880|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
5393715|NCT00002880|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5393716|NCT00002880|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5393717|NCT00002880|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5393718|NCT00002880|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5393719|NCT00002880|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5393720|NCT00002880|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5393721|NCT00002880|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5393722|NCT00002880|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5393723|NCT00002876|recurrent adult brain tumor|recurrent adult brain tumor
5393724|NCT00002876|adult myxopapillary ependymoma|adult myxopapillary ependymoma
5393725|NCT00002876|adult anaplastic ependymoma|adult anaplastic ependymoma
5393726|NCT00002813|recurrent cervical cancer|recurrent cervical cancer
5393727|NCT00002813|stage IVB cervical cancer|stage ivb cervical cancer
5393728|NCT00002813|cervical squamous cell carcinoma|cervical squamous cell carcinoma
5393729|NCT00002707|stage I breast cancer|stage i breast cancer
5393730|NCT00002707|stage II breast cancer|stage ii breast cancer
5393731|NCT00002707|stage IIIA breast cancer|stage iiia breast cancer
5393732|NCT00002692|stage IV colon cancer|stage iv colon cancer
5393733|NCT00002692|stage IV rectal cancer|stage iv rectal cancer
5393734|NCT00002692|recurrent colon cancer|recurrent colon cancer
5393735|NCT00002692|recurrent rectal cancer|recurrent rectal cancer
5393736|NCT00002692|adenocarcinoma of the colon|adenocarcinoma of the colon
5393737|NCT00002692|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5393738|NCT00002692|liver metastases|liver metastases
5393739|NCT00002673|stage IV breast cancer|stage iv breast cancer
5393740|NCT00002673|stage IIIA breast cancer|stage iiia breast cancer
5393741|NCT00002673|stage IIIB breast cancer|stage iiib breast cancer
5393742|NCT00002673|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5393743|NCT00002673|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5393744|NCT00002673|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5393745|NCT00002673|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
5393746|NCT00002673|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
5393747|NCT00002673|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5393748|NCT00002673|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5393749|NCT00002673|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5393750|NCT00002673|disseminated neuroblastoma|disseminated neuroblastoma
5393751|NCT00002673|recurrent neuroblastoma|recurrent neuroblastoma
5393752|NCT00002673|recurrent Wilms tumor and other childhood kidney tumors|recurrent wilms tumor and other childhood kidney tumors
5393753|NCT00002673|stage I multiple myeloma|stage i multiple myeloma
5393754|NCT00002673|stage II multiple myeloma|stage ii multiple myeloma
5393755|NCT00002673|stage III multiple myeloma|stage iii multiple myeloma
5393756|NCT00002673|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
5393757|NCT00002673|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5393758|NCT00002673|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5393759|NCT00002673|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5409213|NCT00062881|Lymphoma|lymphoma
5393760|NCT00002673|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5393761|NCT00002673|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5393762|NCT00002673|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5393763|NCT00002673|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
5393764|NCT00002673|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
5393765|NCT00002673|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5393766|NCT00002673|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5393767|NCT00002673|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5393768|NCT00002673|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5393769|NCT00002673|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5393770|NCT00002673|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
5393771|NCT00002673|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
5393772|NCT00002673|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
5393773|NCT00002673|childhood acute promyelocytic leukemia (M3)|childhood acute promyelocytic leukemia (m3)
5393774|NCT00002673|testicular embryonal carcinoma|testicular embryonal carcinoma
5393775|NCT00002673|testicular choriocarcinoma|testicular choriocarcinoma
5393776|NCT00002673|testicular teratoma|testicular teratoma
5393777|NCT00002673|testicular yolk sac tumor|testicular yolk sac tumor
5393778|NCT00002673|testicular embryonal carcinoma and teratoma|testicular embryonal carcinoma and teratoma
5393779|NCT00002673|testicular embryonal carcinoma and teratoma with seminoma|testicular embryonal carcinoma and teratoma with seminoma
5393780|NCT00002673|testicular embryonal carcinoma and yolk sac tumor|testicular embryonal carcinoma and yolk sac tumor
5393781|NCT00002673|testicular embryonal carcinoma and yolk sac tumor with seminoma|testicular embryonal carcinoma and yolk sac tumor with seminoma
5393782|NCT00002673|testicular embryonal carcinoma and seminoma|testicular embryonal carcinoma and seminoma
5393783|NCT00002673|testicular yolk sac tumor and teratoma|testicular yolk sac tumor and teratoma
5393784|NCT00002673|testicular yolk sac tumor and teratoma with seminoma|testicular yolk sac tumor and teratoma with seminoma
5393785|NCT00002673|testicular choriocarcinoma and yolk sac tumor|testicular choriocarcinoma and yolk sac tumor
5393786|NCT00002673|testicular choriocarcinoma and embryonal carcinoma|testicular choriocarcinoma and embryonal carcinoma
5393787|NCT00002673|testicular choriocarcinoma and teratoma|testicular choriocarcinoma and teratoma
5393788|NCT00002673|testicular choriocarcinoma and seminoma|testicular choriocarcinoma and seminoma
5393789|NCT00002673|refractory hairy cell leukemia|refractory hairy cell leukemia
5393790|NCT00002673|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
5393791|NCT00002673|ovarian germ cell tumor|ovarian germ cell tumor
5393792|NCT00002673|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
5393793|NCT00002673|ovarian yolk sac tumor|ovarian yolk sac tumor
5393794|NCT00002673|ovarian embryonal carcinoma|ovarian embryonal carcinoma
5393795|NCT00002673|ovarian polyembryoma|ovarian polyembryoma
5393796|NCT00002673|ovarian choriocarcinoma|ovarian choriocarcinoma
5393797|NCT00002673|ovarian teratoma|ovarian teratoma
5393798|NCT00002673|ovarian immature teratoma|ovarian immature teratoma
5393799|NCT00002673|ovarian mature teratoma|ovarian mature teratoma
5393800|NCT00002673|ovarian monodermal and highly specialized teratoma|ovarian monodermal and highly specialized teratoma
5393801|NCT00002673|stage II adult lymphoblastic lymphoma|stage ii adult lymphoblastic lymphoma
5393802|NCT00002673|stage II adult Burkitt lymphoma|stage ii adult burkitt lymphoma
5393803|NCT00002673|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5393804|NCT00002673|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5393805|NCT00002673|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5393806|NCT00002673|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5393807|NCT00002673|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5393808|NCT00002673|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5393809|NCT00002673|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5393810|NCT00002673|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5393811|NCT00002673|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5393812|NCT00002673|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5393813|NCT00002673|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5393814|NCT00002673|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5393815|NCT00002673|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5393816|NCT00002673|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5393817|NCT00002673|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5393818|NCT00002673|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5393819|NCT00002673|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5393820|NCT00002673|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5393821|NCT00002673|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5393822|NCT00002673|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5393823|NCT00002673|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5393891|NCT00006220|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5393824|NCT00002673|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5393825|NCT00002673|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5393826|NCT00002673|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5393827|NCT00002673|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5393828|NCT00002673|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5393829|NCT00002673|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5393830|NCT00002673|poor prognosis metastatic gestational trophoblastic tumor|poor prognosis metastatic gestational trophoblastic tumor
5393831|NCT00002673|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5393832|NCT00002673|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5393833|NCT00002673|infection|infection
5393834|NCT00002673|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
5393835|NCT00002673|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
5393836|NCT00002673|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5393837|NCT00002673|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5393838|NCT00002673|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5393839|NCT00002673|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
5393840|NCT00002673|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5393841|NCT00002673|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
5393842|NCT00002673|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
5393843|NCT00002673|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5393844|NCT00002673|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
5393845|NCT00002673|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
5393846|NCT00002673|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5393847|NCT00002673|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5393848|NCT00002673|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
5393849|NCT00002673|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
5393850|NCT00002673|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
5393851|NCT00002673|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5393852|NCT00002673|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5393853|NCT00002673|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5393854|NCT00002673|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5393855|NCT00002673|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5393856|NCT00002673|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5393857|NCT00002673|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5393858|NCT00002673|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5393859|NCT00002673|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5393860|NCT00002673|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
5393861|NCT00002599|stage I multiple myeloma|stage i multiple myeloma
5393862|NCT00002599|stage II multiple myeloma|stage ii multiple myeloma
5393863|NCT00002599|stage III multiple myeloma|stage iii multiple myeloma
5393865|NCT00083330|T Cells|t cells
5393866|NCT00083330|Immunity|immunity
5393867|NCT00083330|Healthy Volunteer|healthy volunteer
5393868|NCT00083330|HV|hv
5393869|NCT00083278|Breast Cancer|breast cancer
5393870|NCT00083278|Stage IV adenocarcinoma of the breast|stage iv adenocarcinoma of the breast
5393871|NCT00012350|refractory multiple myeloma|refractory multiple myeloma
5393872|NCT00012350|stage II multiple myeloma|stage ii multiple myeloma
5393873|NCT00012350|stage III multiple myeloma|stage iii multiple myeloma
5393874|NCT00012350|plasma cell neoplasm|plasma cell neoplasm
5393875|NCT00010088|stage II pancreatic cancer|stage ii pancreatic cancer
5393876|NCT00010088|stage III pancreatic cancer|stage iii pancreatic cancer
5393877|NCT00010088|unresectable extrahepatic bile duct cancer|unresectable extrahepatic bile duct cancer
5393878|NCT00010088|adenocarcinoma of the extrahepatic bile duct|adenocarcinoma of the extrahepatic bile duct
5393879|NCT00010088|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
5393880|NCT00010088|stage IV pancreatic cancer|stage iv pancreatic cancer
5393881|NCT00006220|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5393882|NCT00006220|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5393883|NCT00006220|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5393884|NCT00006220|refractory multiple myeloma|refractory multiple myeloma
5393885|NCT00006220|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5393886|NCT00006220|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5393887|NCT00006220|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5393888|NCT00006220|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5393889|NCT00006220|refractory anemia with excess blasts|refractory anemia with excess blasts
5393890|NCT00006220|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
5409214|NCT00062881|Solid Tumor|solid tumor
5393892|NCT00006220|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5393893|NCT00006220|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5393894|NCT00006220|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5393895|NCT00006220|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5393896|NCT00006220|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5393897|NCT00006220|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5393898|NCT00006220|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5393899|NCT00006220|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5393900|NCT00006220|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5393901|NCT00006220|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5393902|NCT00006220|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5393903|NCT00006220|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5393904|NCT00006220|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5393905|NCT00006220|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5393906|NCT00006220|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5393907|NCT00006220|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5393908|NCT00006220|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5393909|NCT00006220|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5393910|NCT00006220|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5393911|NCT00006220|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5393912|NCT00006220|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5393913|NCT00006220|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5393914|NCT00006220|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5393915|NCT00006220|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5393916|NCT00006220|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
5393917|NCT00005814|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
5393918|NCT00005814|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5393919|NCT00005814|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
5393920|NCT00005814|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
5393921|NCT00005814|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5393922|NCT00005814|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
5393923|NCT00005814|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
5393924|NCT00005814|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5393925|NCT00005814|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
5393926|NCT00005814|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
5393927|NCT00005814|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5393928|NCT00005814|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
5393929|NCT00005814|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
5393930|NCT00005814|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
5393931|NCT00005814|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
5393932|NCT00005581|stage II breast cancer|stage ii breast cancer
5393933|NCT00005581|stage IIIA breast cancer|stage iiia breast cancer
5393934|NCT00005581|stage IIIB breast cancer|stage iiib breast cancer
5393935|NCT00004880|stage IV renal cell cancer|stage iv renal cell cancer
5393936|NCT00004880|recurrent renal cell cancer|recurrent renal cell cancer
5393937|NCT00004211|stage IV prostate cancer|stage iv prostate cancer
5393938|NCT00004211|recurrent prostate cancer|recurrent prostate cancer
5393939|NCT00004156|stage I breast cancer|stage i breast cancer
5393940|NCT00004156|stage II breast cancer|stage ii breast cancer
5393941|NCT00004156|stage IV breast cancer|stage iv breast cancer
5393942|NCT00004156|stage IIIA breast cancer|stage iiia breast cancer
5393943|NCT00004156|recurrent breast cancer|recurrent breast cancer
5393944|NCT00004156|stage IIIB breast cancer|stage iiib breast cancer
5393945|NCT00004132|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
5393946|NCT00004132|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
5393947|NCT00004132|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5393948|NCT00004132|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5393949|NCT00004132|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5393950|NCT00004132|childhood Burkitt lymphoma|childhood burkitt lymphoma
5393951|NCT00004132|refractory multiple myeloma|refractory multiple myeloma
5393952|NCT00004132|stage 0 chronic lymphocytic leukemia|stage 0 chronic lymphocytic leukemia
5393953|NCT00004132|stage I multiple myeloma|stage i multiple myeloma
5393954|NCT00004132|stage II multiple myeloma|stage ii multiple myeloma
5393955|NCT00004132|stage III multiple myeloma|stage iii multiple myeloma
5409215|NCT00062868|Lymphoma|lymphoma
5393956|NCT00004132|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
5393957|NCT00004132|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
5393958|NCT00004132|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
5393959|NCT00004132|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5393960|NCT00004132|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5393961|NCT00004132|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5393962|NCT00004132|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5393963|NCT00004132|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5393964|NCT00004132|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5393965|NCT00004132|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
5393966|NCT00004132|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
5393967|NCT00004132|untreated childhood acute myeloid leukemia and other myeloid malignancies|untreated childhood acute myeloid leukemia and other myeloid malignancies
5393968|NCT00004132|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
5393969|NCT00004132|oral complications|oral complications
5393970|NCT00004132|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
5393971|NCT00004132|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
5393972|NCT00004132|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
5393973|NCT00004132|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
5393974|NCT00004132|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
5393975|NCT00004132|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
5393976|NCT00004132|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
5393977|NCT00004132|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
5393978|NCT00004132|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
5393979|NCT00004132|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
5393980|NCT00004132|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5393981|NCT00004132|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5393982|NCT00004132|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5393983|NCT00004132|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5393984|NCT00004132|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5393985|NCT00004132|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5393986|NCT00004132|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5393987|NCT00004132|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5393988|NCT00004132|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5393989|NCT00004132|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5393990|NCT00004132|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5393991|NCT00004132|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5393992|NCT00004132|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5393993|NCT00004132|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5393994|NCT00004132|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5393995|NCT00004132|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5393996|NCT00004132|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5393997|NCT00004132|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5393998|NCT00004132|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5393999|NCT00004132|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5394000|NCT00004132|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5394001|NCT00004132|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5394002|NCT00004132|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5394003|NCT00004132|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5394004|NCT00004132|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5394005|NCT00004132|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5394006|NCT00004132|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5394007|NCT00004132|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
5394008|NCT00004132|drug/agent toxicity by tissue/organ|drug/agent toxicity by tissue/organ
5394009|NCT00004132|radiation toxicity|radiation toxicity
5394010|NCT00004132|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
5394011|NCT00004132|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
5394012|NCT00004132|stage I mantle cell lymphoma|stage i mantle cell lymphoma
5394013|NCT00004132|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
5394014|NCT00004132|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
5394015|NCT00004132|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
5394016|NCT00004132|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
5394017|NCT00004132|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
5394226|NCT00083213|ovarian stromal cancer|ovarian stromal cancer
5394018|NCT00004132|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
5394019|NCT00004132|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
5394020|NCT00004132|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
5394021|NCT00004132|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
5394022|NCT00004132|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
5394023|NCT00004132|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5394024|NCT00004132|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5394025|NCT00004132|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5394026|NCT00004132|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
5394027|NCT00004132|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5394028|NCT00004132|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
5394029|NCT00004132|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
5394030|NCT00004132|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5394031|NCT00004132|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
5394032|NCT00004132|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
5394033|NCT00004132|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5394034|NCT00004132|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5394035|NCT00004132|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5394036|NCT00004132|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5394037|NCT00004132|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
5394038|NCT00004132|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
5394039|NCT00004132|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5394040|NCT00004132|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5394041|NCT00004132|stage I marginal zone lymphoma|stage i marginal zone lymphoma
5394042|NCT00004132|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
5394043|NCT00004132|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5394044|NCT00004132|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5394045|NCT00004132|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5394046|NCT00004132|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5394047|NCT00004132|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
5394048|NCT00004132|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
5394049|NCT00004132|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5394050|NCT00004132|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5394051|NCT00004132|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5394052|NCT00004073|adult glioblastoma|adult glioblastoma
5394053|NCT00004073|adult giant cell glioblastoma|adult giant cell glioblastoma
5394054|NCT00004073|adult gliosarcoma|adult gliosarcoma
5394055|NCT00004056|untreated childhood acute myeloid leukemia and other myeloid malignancies|untreated childhood acute myeloid leukemia and other myeloid malignancies
5394056|NCT00004056|childhood acute monoblastic leukemia and acute monocytic leukemia (M5)|childhood acute monoblastic leukemia and acute monocytic leukemia (m5)
5394057|NCT00004056|childhood acute myeloblastic leukemia without maturation (M1)|childhood acute myeloblastic leukemia without maturation (m1)
5394058|NCT00004056|childhood acute myeloblastic leukemia with maturation (M2)|childhood acute myeloblastic leukemia with maturation (m2)
5394059|NCT00004056|childhood acute myelomonocytic leukemia (M4)|childhood acute myelomonocytic leukemia (m4)
5394060|NCT00004056|childhood acute erythroleukemia (M6)|childhood acute erythroleukemia (m6)
5394061|NCT00004056|childhood acute megakaryocytic leukemia (M7)|childhood acute megakaryocytic leukemia (m7)
5394062|NCT00004056|childhood acute minimally differentiated myeloid leukemia (M0)|childhood acute minimally differentiated myeloid leukemia (m0)
5394063|NCT00004051|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5394064|NCT00004038|stage I breast cancer|stage i breast cancer
5394065|NCT00004038|stage II breast cancer|stage ii breast cancer
5394066|NCT00004038|stage IV breast cancer|stage iv breast cancer
5394067|NCT00004038|stage IIIA breast cancer|stage iiia breast cancer
5394068|NCT00004038|recurrent breast cancer|recurrent breast cancer
5394069|NCT00004038|stage IIIB breast cancer|stage iiib breast cancer
5394070|NCT00003924|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5394071|NCT00003924|Waldenström macroglobulinemia|waldenström macroglobulinemia
5394072|NCT00003924|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5394073|NCT00003924|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5394074|NCT00003924|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5394075|NCT00003924|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5394076|NCT00003924|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5394077|NCT00003924|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5394078|NCT00003924|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5412034|NCT00058903|Cholestatic|cholestatic
5394079|NCT00003924|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5394184|NCT00083304|RSR13|rsr13
5394080|NCT00003924|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5394081|NCT00003924|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5394082|NCT00003924|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5394083|NCT00003924|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5394084|NCT00003924|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5394085|NCT00003924|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5394086|NCT00003924|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5394087|NCT00003876|recurrent adult brain tumor|recurrent adult brain tumor
5394088|NCT00003876|adult brain stem glioma|adult brain stem glioma
5394089|NCT00003876|adult glioblastoma|adult glioblastoma
5394090|NCT00003876|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5394091|NCT00003876|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
5394092|NCT00003876|adult mixed glioma|adult mixed glioma
5394093|NCT00003876|adult giant cell glioblastoma|adult giant cell glioblastoma
5394094|NCT00003876|adult gliosarcoma|adult gliosarcoma
5394095|NCT00003801|long-term effects secondary to cancer therapy in children|long-term effects secondary to cancer therapy in children
5394096|NCT00003801|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
5394097|NCT00003731|adult oligodendroglioma|adult oligodendroglioma
5394098|NCT00003731|adult mixed glioma|adult mixed glioma
5394099|NCT00003700|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
5394100|NCT00003700|L1 adult acute lymphoblastic leukemia|l1 adult acute lymphoblastic leukemia
5394101|NCT00003700|L2 adult acute lymphoblastic leukemia|l2 adult acute lymphoblastic leukemia
5394102|NCT00003698|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5394103|NCT00003697|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5394104|NCT00003685|stage III non-small cell lung cancer|stage iii non-small cell lung cancer
5394105|NCT00003685|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5394106|NCT00003685|squamous cell lung cancer|squamous cell lung cancer
5394107|NCT00003685|large cell lung cancer|large cell lung cancer
5394108|NCT00003685|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5394109|NCT00003685|adenocarcinoma of the lung|adenocarcinoma of the lung
5394110|NCT00003685|adenosquamous cell lung cancer|adenosquamous cell lung cancer
5394111|NCT00003685|fatigue|fatigue
5394112|NCT00003685|nausea and vomiting|nausea and vomiting
5394113|NCT00003685|pain|pain
5394114|NCT00003685|pulmonary complications|pulmonary complications
5394115|NCT00003685|quality of life|quality of life
5394116|NCT00003640|stage II bladder cancer|stage ii bladder cancer
5394117|NCT00003640|stage III bladder cancer|stage iii bladder cancer
5394118|NCT00003640|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
5394119|NCT00003575|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
5394120|NCT00003575|AIDS-related diffuse large cell lymphoma|aids-related diffuse large cell lymphoma
5394121|NCT00003575|AIDS-related immunoblastic large cell lymphoma|aids-related immunoblastic large cell lymphoma
5394122|NCT00003575|AIDS-related small noncleaved cell lymphoma|aids-related small noncleaved cell lymphoma
5394123|NCT00003439|stage IV colon cancer|stage iv colon cancer
5394124|NCT00003439|stage IV gastric cancer|stage iv gastric cancer
5394125|NCT00003439|recurrent gastric cancer|recurrent gastric cancer
5394126|NCT00003439|recurrent pancreatic cancer|recurrent pancreatic cancer
5394127|NCT00003439|stage IV rectal cancer|stage iv rectal cancer
5394128|NCT00003439|recurrent colon cancer|recurrent colon cancer
5394129|NCT00003439|recurrent rectal cancer|recurrent rectal cancer
5394130|NCT00003439|stage IV anal cancer|stage iv anal cancer
5394131|NCT00003439|recurrent anal cancer|recurrent anal cancer
5394132|NCT00003439|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5394133|NCT00003439|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5394134|NCT00003439|metastatic gastrointestinal carcinoid tumor|metastatic gastrointestinal carcinoid tumor
5394135|NCT00003439|recurrent gastrointestinal carcinoid tumor|recurrent gastrointestinal carcinoid tumor
5394136|NCT00003439|advanced adult primary liver cancer|advanced adult primary liver cancer
5394137|NCT00003439|recurrent adult primary liver cancer|recurrent adult primary liver cancer
5394138|NCT00003439|stage IV endometrial carcinoma|stage iv endometrial carcinoma
5394139|NCT00003439|recurrent endometrial carcinoma|recurrent endometrial carcinoma
5394140|NCT00003439|small intestine adenocarcinoma|small intestine adenocarcinoma
5394141|NCT00003439|unresectable gallbladder cancer|unresectable gallbladder cancer
5394142|NCT00003439|recurrent gallbladder cancer|recurrent gallbladder cancer
5394143|NCT00003439|unresectable extrahepatic bile duct cancer|unresectable extrahepatic bile duct cancer
5394144|NCT00003439|recurrent extrahepatic bile duct cancer|recurrent extrahepatic bile duct cancer
5394145|NCT00003439|recurrent small intestine cancer|recurrent small intestine cancer
5394146|NCT00003439|stage IV prostate cancer|stage iv prostate cancer
5394147|NCT00003439|recurrent prostate cancer|recurrent prostate cancer
5394148|NCT00003439|fallopian tube cancer|fallopian tube cancer
5394149|NCT00003439|primary peritoneal cavity cancer|primary peritoneal cavity cancer
5394150|NCT00003439|stage IV pancreatic cancer|stage iv pancreatic cancer
5394151|NCT00003423|stage I childhood lymphoblastic lymphoma|stage i childhood lymphoblastic lymphoma
5394152|NCT00003423|stage II childhood lymphoblastic lymphoma|stage ii childhood lymphoblastic lymphoma
5394153|NCT00003423|stage III childhood lymphoblastic lymphoma|stage iii childhood lymphoblastic lymphoma
5394154|NCT00003423|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
5394155|NCT00003423|stage I childhood large cell lymphoma|stage i childhood large cell lymphoma
5394156|NCT00003423|stage II childhood large cell lymphoma|stage ii childhood large cell lymphoma
5394157|NCT00003423|stage III childhood large cell lymphoma|stage iii childhood large cell lymphoma
5394158|NCT00003423|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
5394159|NCT00003330|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5394160|NCT00003326|stage IV esophageal cancer|stage iv esophageal cancer
5394161|NCT00003326|recurrent esophageal cancer|recurrent esophageal cancer
5394162|NCT00003326|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
5394163|NCT00003326|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
5394164|NCT00003255|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5394165|NCT00003255|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5394166|NCT00002578|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
5394167|NCT00002578|AIDS-related diffuse large cell lymphoma|aids-related diffuse large cell lymphoma
5394168|NCT00002578|AIDS-related immunoblastic large cell lymphoma|aids-related immunoblastic large cell lymphoma
5394169|NCT00002578|AIDS-related small noncleaved cell lymphoma|aids-related small noncleaved cell lymphoma
5394170|NCT00002578|AIDS-related diffuse mixed cell lymphoma|aids-related diffuse mixed cell lymphoma
5394171|NCT00002578|AIDS-related diffuse small cleaved cell lymphoma|aids-related diffuse small cleaved cell lymphoma
5394172|NCT00002578|AIDS-related lymphoblastic lymphoma|aids-related lymphoblastic lymphoma
5394173|NCT00002503|recurrent prostate cancer|recurrent prostate cancer
5394174|NCT00002503|bone metastases|bone metastases
5394175|NCT00083317|PFC|pfc
5394176|NCT00083317|Competition|competition
5394177|NCT00083317|Bargaining Games|bargaining games
5394178|NCT00083317|Hyper-Brain Scanning|hyper-brain scanning
5394179|NCT00083317|fMRI|fmri
5394180|NCT00083317|Healthy Volunteer|healthy volunteer
5394181|NCT00083317|HV|hv
5394182|NCT00083304|Breast|breast
5394185|NCT00083304|efaproxiral|efaproxiral
5394186|NCT00083304|Whole Brain Radiation Therapy|whole brain radiation therapy
5394187|NCT00083304|Brain metastases|brain metastases
5394188|NCT00083304|Metastatic breast cancer|metastatic breast cancer
5394189|NCT00083213|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5394190|NCT00083213|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5394191|NCT00083213|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5394192|NCT00083213|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5394193|NCT00083213|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5394194|NCT00083213|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5394195|NCT00083213|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5394196|NCT00083213|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5394197|NCT00083213|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5394198|NCT00083213|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5394199|NCT00083213|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5394200|NCT00083213|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5394201|NCT00083213|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5394202|NCT00083213|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5394203|NCT00083213|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5394204|NCT00083213|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5394205|NCT00083213|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5394206|NCT00083213|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5394207|NCT00083213|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5394208|NCT00083213|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5394209|NCT00083213|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5394210|NCT00083213|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
5394211|NCT00083213|recurrent adult primary liver cancer|recurrent adult primary liver cancer
5394212|NCT00083213|advanced adult primary liver cancer|advanced adult primary liver cancer
5394213|NCT00083213|recurrent cervical cancer|recurrent cervical cancer
5394214|NCT00083213|stage IVA cervical cancer|stage iva cervical cancer
5394215|NCT00083213|stage IVB cervical cancer|stage ivb cervical cancer
5394216|NCT00083213|fallopian tube cancer|fallopian tube cancer
5394217|NCT00083213|ovarian sarcoma|ovarian sarcoma
5394218|NCT00083213|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5394219|NCT00083213|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5394220|NCT00083213|recurrent endometrial carcinoma|recurrent endometrial carcinoma
5394221|NCT00083213|stage IV endometrial carcinoma|stage iv endometrial carcinoma
5394222|NCT00083213|recurrent uterine sarcoma|recurrent uterine sarcoma
5394223|NCT00083213|stage IV uterine sarcoma|stage iv uterine sarcoma
5394224|NCT00083213|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
5394225|NCT00083213|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
5394228|NCT00083213|stage IVA vaginal cancer|stage iva vaginal cancer
5394229|NCT00083213|stage IVB vaginal cancer|stage ivb vaginal cancer
5394230|NCT00083213|recurrent prostate cancer|recurrent prostate cancer
5394231|NCT00083213|stage IV prostate cancer|stage iv prostate cancer
5394232|NCT00083213|recurrent penile cancer|recurrent penile cancer
5394233|NCT00083213|stage IV penile cancer|stage iv penile cancer
5394234|NCT00083213|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
5394235|NCT00083213|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
5394236|NCT00083213|recurrent bladder cancer|recurrent bladder cancer
5394237|NCT00083213|stage IV bladder cancer|stage iv bladder cancer
5394238|NCT00083213|recurrent vulvar cancer|recurrent vulvar cancer
5394239|NCT00083213|stage IVB vulvar cancer|stage ivb vulvar cancer
5394240|NCT00083213|distal urethral cancer|distal urethral cancer
5394241|NCT00083213|proximal urethral cancer|proximal urethral cancer
5394242|NCT00083213|recurrent urethral cancer|recurrent urethral cancer
5394243|NCT00083213|urethral cancer associated with invasive bladder cancer|urethral cancer associated with invasive bladder cancer
5394244|NCT00083213|primary peritoneal cavity cancer|primary peritoneal cavity cancer
5394245|NCT00083213|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5394246|NCT00083213|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5394247|NCT00083213|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5394248|NCT00083213|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5394249|NCT00083213|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5394250|NCT00083213|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5394251|NCT00083213|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5394252|NCT00083213|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
5394253|NCT00082940|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
5394254|NCT00082940|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5394255|NCT00082927|stage IV prostate cancer|stage iv prostate cancer
5394256|NCT00082927|bone metastases|bone metastases
5394257|NCT00082927|pain|pain
5394258|NCT00082927|recurrent prostate cancer|recurrent prostate cancer
5394259|NCT00082914|recurrent renal cell cancer|recurrent renal cell cancer
5394260|NCT00082914|stage IV renal cell cancer|stage iv renal cell cancer
5394261|NCT00082914|recurrent melanoma|recurrent melanoma
5394262|NCT00082914|stage IV melanoma|stage iv melanoma
5394263|NCT00082862|stage II pancreatic cancer|stage ii pancreatic cancer
5394264|NCT00082862|stage III pancreatic cancer|stage iii pancreatic cancer
5394265|NCT00082862|recurrent pancreatic cancer|recurrent pancreatic cancer
5394266|NCT00082862|stage IV pancreatic cancer|stage iv pancreatic cancer
5394267|NCT00082836|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
5394268|NCT00082823|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5394269|NCT00082823|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5394270|NCT00082823|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5394271|NCT00082823|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5394272|NCT00082823|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5394273|NCT00082823|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5394274|NCT00082823|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5394275|NCT00082823|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5394276|NCT00082823|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5394277|NCT00082823|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5394278|NCT00082823|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5394279|NCT00082823|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5394280|NCT00082823|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5394281|NCT00082823|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5394282|NCT00082823|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5394283|NCT00082823|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5394284|NCT00082823|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5394285|NCT00082823|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5394286|NCT00082823|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5394287|NCT00082823|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5394288|NCT00082823|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5394289|NCT00082823|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
5394290|NCT00082823|advanced adult primary liver cancer|advanced adult primary liver cancer
5394291|NCT00082823|recurrent adult primary liver cancer|recurrent adult primary liver cancer
5394292|NCT00082823|recurrent cervical cancer|recurrent cervical cancer
5394293|NCT00082823|stage IVA cervical cancer|stage iva cervical cancer
5394294|NCT00082823|stage IVB cervical cancer|stage ivb cervical cancer
5394295|NCT00082823|fallopian tube cancer|fallopian tube cancer
5394296|NCT00082823|ovarian sarcoma|ovarian sarcoma
5394297|NCT00082823|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5394298|NCT00082823|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5394299|NCT00082823|recurrent endometrial carcinoma|recurrent endometrial carcinoma
5394300|NCT00082823|stage IV endometrial carcinoma|stage iv endometrial carcinoma
5394301|NCT00082823|recurrent uterine sarcoma|recurrent uterine sarcoma
5394302|NCT00082823|stage IV uterine sarcoma|stage iv uterine sarcoma
5394303|NCT00082823|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
5394304|NCT00082823|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
5394305|NCT00082823|ovarian stromal cancer|ovarian stromal cancer
5394306|NCT00082823|recurrent vaginal cancer|recurrent vaginal cancer
5394307|NCT00082823|stage IVA vaginal cancer|stage iva vaginal cancer
5394308|NCT00082823|stage IVB vaginal cancer|stage ivb vaginal cancer
5394309|NCT00082823|recurrent prostate cancer|recurrent prostate cancer
5394310|NCT00082823|stage IV prostate cancer|stage iv prostate cancer
5394311|NCT00082823|recurrent penile cancer|recurrent penile cancer
5394312|NCT00082823|stage IV penile cancer|stage iv penile cancer
5394313|NCT00082823|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
5394314|NCT00082823|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
5394315|NCT00082823|recurrent bladder cancer|recurrent bladder cancer
5394316|NCT00082823|stage IV bladder cancer|stage iv bladder cancer
5394317|NCT00082823|recurrent vulvar cancer|recurrent vulvar cancer
5394318|NCT00082823|stage IVB vulvar cancer|stage ivb vulvar cancer
5394319|NCT00082823|distal urethral cancer|distal urethral cancer
5394320|NCT00082823|proximal urethral cancer|proximal urethral cancer
5394321|NCT00082823|recurrent urethral cancer|recurrent urethral cancer
5394322|NCT00082823|urethral cancer associated with invasive bladder cancer|urethral cancer associated with invasive bladder cancer
5394323|NCT00082823|primary peritoneal cavity cancer|primary peritoneal cavity cancer
5394324|NCT00082823|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5394325|NCT00082823|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5394326|NCT00082823|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5394327|NCT00082823|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5394328|NCT00082823|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5394329|NCT00082823|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5394330|NCT00082823|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5394331|NCT00082823|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
5394332|NCT00082797|adult glioblastoma|adult glioblastoma
5394333|NCT00082797|adult giant cell glioblastoma|adult giant cell glioblastoma
5394334|NCT00082797|adult gliosarcoma|adult gliosarcoma
5394335|NCT00082758|recurrent neuroblastoma|recurrent neuroblastoma
5394336|NCT00082732|stage I prostate cancer|stage i prostate cancer
5394337|NCT00082732|stage II prostate cancer|stage ii prostate cancer
5394338|NCT00082732|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5394339|NCT00082719|stage II bladder cancer|stage ii bladder cancer
5394340|NCT00082719|stage III bladder cancer|stage iii bladder cancer
5394341|NCT00082719|stage IV bladder cancer|stage iv bladder cancer
5394342|NCT00082719|localized transitional cell cancer of the renal pelvis and ureter|localized transitional cell cancer of the renal pelvis and ureter
5394343|NCT00082719|regional transitional cell cancer of the renal pelvis and ureter|regional transitional cell cancer of the renal pelvis and ureter
5394344|NCT00082719|metastatic transitional cell cancer of the renal pelvis and ureter|metastatic transitional cell cancer of the renal pelvis and ureter
5394345|NCT00082719|anterior urethral cancer|anterior urethral cancer
5394346|NCT00082719|posterior urethral cancer|posterior urethral cancer
5394347|NCT00082719|urethral cancer associated with invasive bladder cancer|urethral cancer associated with invasive bladder cancer
5394348|NCT00082706|adenocarcinoma of the bladder|adenocarcinoma of the bladder
5394349|NCT00082706|recurrent bladder cancer|recurrent bladder cancer
5394350|NCT00082706|stage IV bladder cancer|stage iv bladder cancer
5394351|NCT00082706|recurrent urethral cancer|recurrent urethral cancer
5394352|NCT00082706|anterior urethral cancer|anterior urethral cancer
5394353|NCT00082706|posterior urethral cancer|posterior urethral cancer
5394354|NCT00082706|urethral cancer associated with invasive bladder cancer|urethral cancer associated with invasive bladder cancer
5394355|NCT00082706|stage III bladder cancer|stage iii bladder cancer
5394356|NCT00082667|breast cancer in situ|breast cancer in situ
5394357|NCT00082667|ductal breast carcinoma in situ|ductal breast carcinoma in situ
5394358|NCT00082654|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
5394359|NCT00082654|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5394360|NCT00082654|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5394361|NCT00082654|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5394362|NCT00082654|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
5394363|NCT00082654|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5394364|NCT00082654|chronic eosinophilic leukemia|chronic eosinophilic leukemia
5394365|NCT00082654|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
5394366|NCT00082654|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5394367|NCT00082654|chronic neutrophilic leukemia|chronic neutrophilic leukemia
5394368|NCT00082654|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5394369|NCT00082654|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5394370|NCT00082654|disseminated neuroblastoma|disseminated neuroblastoma
5394508|NCT00083265|Healthy Volunteer|healthy volunteer
5394371|NCT00082654|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
5394372|NCT00082654|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
5394373|NCT00082654|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5394374|NCT00082654|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
5394375|NCT00082654|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
5394376|NCT00082654|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
5394377|NCT00082654|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
5394378|NCT00082654|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5394379|NCT00082654|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5394380|NCT00082654|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5394381|NCT00082654|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5394478|NCT00003118|stage II esophageal cancer|stage ii esophageal cancer
5394382|NCT00082654|poor prognosis metastatic gestational trophoblastic tumor|poor prognosis metastatic gestational trophoblastic tumor
5394383|NCT00082654|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5394384|NCT00082654|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5394385|NCT00082654|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5394386|NCT00082654|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5394387|NCT00082654|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5394388|NCT00082654|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5394389|NCT00082654|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5394390|NCT00082654|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5394391|NCT00082654|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5394392|NCT00082654|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5394393|NCT00082654|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5394394|NCT00082654|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5394395|NCT00082654|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5394396|NCT00082654|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5394397|NCT00082654|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5394398|NCT00082654|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5394399|NCT00082654|recurrent neuroblastoma|recurrent neuroblastoma
5394400|NCT00082654|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5394401|NCT00082654|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
5394402|NCT00082654|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
5394403|NCT00082654|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5394404|NCT00082654|refractory hairy cell leukemia|refractory hairy cell leukemia
5394405|NCT00082654|refractory multiple myeloma|refractory multiple myeloma
5394406|NCT00082654|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5394407|NCT00082654|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5394408|NCT00082654|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5394409|NCT00082654|stage I multiple myeloma|stage i multiple myeloma
5394410|NCT00082654|stage II multiple myeloma|stage ii multiple myeloma
5394411|NCT00082654|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
5394412|NCT00082654|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5394413|NCT00082654|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5394414|NCT00082654|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5394415|NCT00082654|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5394416|NCT00082654|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5394417|NCT00082654|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5394418|NCT00082654|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5394419|NCT00082654|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5394420|NCT00082654|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5394421|NCT00082654|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5394422|NCT00082654|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5394423|NCT00082654|stage III multiple myeloma|stage iii multiple myeloma
5394424|NCT00082654|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5394425|NCT00082654|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
5394426|NCT00082654|stage IIIA breast cancer|stage iiia breast cancer
5394427|NCT00082654|stage IIIB breast cancer|stage iiib breast cancer
5394428|NCT00082654|stage IIIC breast cancer|stage iiic breast cancer
5394429|NCT00082654|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5394430|NCT00082654|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5394431|NCT00082654|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5394432|NCT00082654|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5394509|NCT00083265|HV|hv
5394433|NCT00082654|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5394434|NCT00082654|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5394435|NCT00082654|stage IV breast cancer|stage iv breast cancer
5394436|NCT00082654|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5394437|NCT00082654|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5394438|NCT00082654|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5394439|NCT00082654|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5394440|NCT00082654|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5394441|NCT00082654|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5394442|NCT00082654|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
5394443|NCT00082654|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
5394444|NCT00082654|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
5394445|NCT00082654|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
5394446|NCT00082654|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5394447|NCT00082654|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5394448|NCT00082654|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5394449|NCT00082654|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5394450|NCT00082654|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5394451|NCT00082654|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5394452|NCT00082654|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5394453|NCT00082654|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5394454|NCT00082654|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5394455|NCT00082654|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5394456|NCT00082654|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5394457|NCT00082654|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5394458|NCT00082654|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5394459|NCT00082654|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5394460|NCT00082641|stage IIIA breast cancer|stage iiia breast cancer
5394461|NCT00082641|stage IIIB breast cancer|stage iiib breast cancer
5394462|NCT00003186|stage I colon cancer|stage i colon cancer
5394463|NCT00003186|stage II colon cancer|stage ii colon cancer
5394464|NCT00003186|stage III colon cancer|stage iii colon cancer
5394465|NCT00003186|stage IV colon cancer|stage iv colon cancer
5394466|NCT00003186|stage I rectal cancer|stage i rectal cancer
5394467|NCT00003186|stage II rectal cancer|stage ii rectal cancer
5394468|NCT00003186|stage III rectal cancer|stage iii rectal cancer
5394469|NCT00003186|stage IV rectal cancer|stage iv rectal cancer
5394470|NCT00003186|adenocarcinoma of the colon|adenocarcinoma of the colon
5394471|NCT00003186|liver metastases|liver metastases
5394472|NCT00003183|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5394473|NCT00003183|stage IV prostate cancer|stage iv prostate cancer
5394474|NCT00003183|recurrent prostate cancer|recurrent prostate cancer
5394475|NCT00003154|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5394476|NCT00003154|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5394477|NCT00003118|stage I esophageal cancer|stage i esophageal cancer
5394700|NCT00082316|Herpes zoster|herpes zoster
5394479|NCT00003118|stage III esophageal cancer|stage iii esophageal cancer
5394480|NCT00003118|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
5394481|NCT00003118|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
5394482|NCT00003117|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5394483|NCT00003117|squamous cell lung cancer|squamous cell lung cancer
5394484|NCT00003117|large cell lung cancer|large cell lung cancer
5394485|NCT00003117|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5394486|NCT00003117|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5394487|NCT00003117|adenocarcinoma of the lung|adenocarcinoma of the lung
5394488|NCT00003117|adenosquamous cell lung cancer|adenosquamous cell lung cancer
5394489|NCT00003095|stage II breast cancer|stage ii breast cancer
5394490|NCT00003095|stage III breast cancer|stage iii breast cancer
5394491|NCT00003020|leptomeningeal metastases|leptomeningeal metastases
5394492|NCT00002988|recurrent adult brain tumor|recurrent adult brain tumor
5394493|NCT00002985|AIDS-related Kaposi sarcoma|aids-related kaposi sarcoma
5394494|NCT00002961|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5394495|NCT00002961|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
5394496|NCT00083291|Dry Eyes|dry eyes
5394497|NCT00083291|Conjunctiva|conjunctiva
5394498|NCT00083291|Infection|infection
5394499|NCT00083291|Antibodies|antibodies
5394500|NCT00083291|Inflammation|inflammation
5394501|NCT00083291|Ocular Surface Disease|ocular surface disease
5394502|NCT00083291|Helicobacter Pylori|helicobacter pylori
5394503|NCT00083265|Adenosine Receptor|adenosine receptor
5394504|NCT00083265|Panic Disorder|panic disorder
5394505|NCT00083265|Polymorphism|polymorphism
5394506|NCT00083265|Challenge Study|challenge study
5394507|NCT00083265|Caffeine|caffeine
5394511|NCT00083226|doxorubicin hydrochloride|doxorubicin hydrochloride
5394512|NCT00083226|bortezomib|bortezomib
5394513|NCT00083226|hepatocellular carcinoma|hepatocellular carcinoma
5394514|NCT00083187|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5394515|NCT00083187|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
5394516|NCT00083187|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
5394517|NCT00083187|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5394518|NCT00083187|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
5394519|NCT00083187|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5394520|NCT00083187|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5394521|NCT00083187|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5394522|NCT00083187|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5394523|NCT00083187|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5394524|NCT00083187|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5394525|NCT00083187|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5394526|NCT00083174|breast cancer|breast cancer
5394527|NCT00083161|extensive stage small cell lung cancer|extensive stage small cell lung cancer
5394528|NCT00083161|recurrent small cell lung cancer|recurrent small cell lung cancer
5394529|NCT00083148|recurrent breast cancer|recurrent breast cancer
5394530|NCT00083148|stage IV breast cancer|stage iv breast cancer
5394531|NCT00083135|recurrent neuroblastoma|recurrent neuroblastoma
5394532|NCT00083096|recurrent adult brain tumor|recurrent adult brain tumor
5394533|NCT00083096|adult mixed glioma|adult mixed glioma
5394534|NCT00083096|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5394535|NCT00083096|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
5394536|NCT00083096|adult glioblastoma|adult glioblastoma
5394537|NCT00083096|adult pilocytic astrocytoma|adult pilocytic astrocytoma
5394538|NCT00083096|adult anaplastic ependymoma|adult anaplastic ependymoma
5394539|NCT00083096|adult subependymoma|adult subependymoma
5394540|NCT00083096|adult myxopapillary ependymoma|adult myxopapillary ependymoma
5394541|NCT00083096|adult oligodendroglioma|adult oligodendroglioma
5394542|NCT00083096|adult giant cell glioblastoma|adult giant cell glioblastoma
5394543|NCT00083096|adult gliosarcoma|adult gliosarcoma
5394544|NCT00083096|adult diffuse astrocytoma|adult diffuse astrocytoma
5394545|NCT00083096|adult subependymal giant cell astrocytoma|adult subependymal giant cell astrocytoma
5394546|NCT00083096|adult pineal gland astrocytoma|adult pineal gland astrocytoma
5394547|NCT00083083|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
5394548|NCT00083083|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5394549|NCT00083083|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5394550|NCT00083070|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5394551|NCT00083070|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5394552|NCT00083070|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5394553|NCT00083070|childhood acute promyelocytic leukemia (M3)|childhood acute promyelocytic leukemia (m3)
5394554|NCT00083070|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5394555|NCT00083057|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
5394556|NCT00083057|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5394557|NCT00083057|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
5394558|NCT00083057|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
5394559|NCT00083057|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5394560|NCT00083057|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
5394561|NCT00083057|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
5394562|NCT00083057|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5394563|NCT00083057|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
5394564|NCT00083057|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
5394565|NCT00083057|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
5394566|NCT00083057|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
5394567|NCT00083057|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
5394568|NCT00083057|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
5394569|NCT00083057|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
5394570|NCT00083057|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5394571|NCT00083044|breast cancer|breast cancer
5394572|NCT00083044|breast cancer in situ|breast cancer in situ
5394573|NCT00083044|stage I breast cancer|stage i breast cancer
5394574|NCT00083044|lobular breast carcinoma in situ|lobular breast carcinoma in situ
5394575|NCT00083044|ductal breast carcinoma in situ|ductal breast carcinoma in situ
5394576|NCT00083031|recurrent breast cancer|recurrent breast cancer
5394577|NCT00083031|stage IV breast cancer|stage iv breast cancer
5394578|NCT00083018|stage II breast cancer|stage ii breast cancer
5394579|NCT00083018|stage IIIA breast cancer|stage iiia breast cancer
5394580|NCT00083018|stage IIIB breast cancer|stage iiib breast cancer
5394581|NCT00083018|stage IIIC breast cancer|stage iiic breast cancer
5394582|NCT00083018|stage IA breast cancer|stage ia breast cancer
5394583|NCT00083018|stage IB breast cancer|stage ib breast cancer
5394584|NCT00083005|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5394585|NCT00083005|recurrent prostate cancer|recurrent prostate cancer
5394586|NCT00083005|stage IV prostate cancer|stage iv prostate cancer
5394587|NCT00082979|breast cancer|breast cancer
5394588|NCT00082628|Growth hormone|growth hormone
5394589|NCT00082628|Serostim®|serostim®
5394590|NCT00082628|Human Adipose Redistribution Syndrome|human adipose redistribution syndrome
5394591|NCT00082628|Human Immunodeficiency Virus lipodystrophy|human immunodeficiency virus lipodystrophy
5394592|NCT00082602|galantamine|galantamine
5394593|NCT00082602|Alzheimer's disease|alzheimer's disease
5394594|NCT00082615|Movement Disorders|movement disorders
5394595|NCT00082615|Recovery Cycle|recovery cycle
5394596|NCT00082615|Blink Reflex|blink reflex
5394597|NCT00082615|Cervical Dystonia|cervical dystonia
5394598|NCT00082615|Blepharospasm|blepharospasm
5394599|NCT00082615|Dystonia|dystonia
5394600|NCT00082615|Craniofacial Dystonia|craniofacial dystonia
5394601|NCT00082615|Healthy Volunteer|healthy volunteer
5394602|NCT00082615|HV|hv
5394603|NCT00002936|AIDS-related Kaposi sarcoma|aids-related kaposi sarcoma
5394604|NCT00002936|recurrent Kaposi sarcoma|recurrent kaposi sarcoma
5394605|NCT00002936|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
5394606|NCT00002903|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
5394607|NCT00002903|testicular seminoma|testicular seminoma
5394608|NCT00002903|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
5394609|NCT00002903|extragonadal germ cell tumor|extragonadal germ cell tumor
5394610|NCT00002896|stage II rectal cancer|stage ii rectal cancer
5394611|NCT00002896|stage III rectal cancer|stage iii rectal cancer
5394612|NCT00002896|recurrent rectal cancer|recurrent rectal cancer
5394613|NCT00002896|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5394614|NCT00002896|mucinous adenocarcinoma of the rectum|mucinous adenocarcinoma of the rectum
5394615|NCT00002893|stage III colon cancer|stage iii colon cancer
5394616|NCT00002893|stage IV colon cancer|stage iv colon cancer
5394617|NCT00002893|stage III rectal cancer|stage iii rectal cancer
5394618|NCT00002893|stage IV rectal cancer|stage iv rectal cancer
5394619|NCT00002893|recurrent colon cancer|recurrent colon cancer
5394620|NCT00002893|recurrent rectal cancer|recurrent rectal cancer
5394621|NCT00002893|adenocarcinoma of the colon|adenocarcinoma of the colon
5394622|NCT00002893|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5394623|NCT00002892|stage II melanoma|stage ii melanoma
5394624|NCT00002892|stage III melanoma|stage iii melanoma
5394625|NCT00002892|recurrent melanoma|recurrent melanoma
5394626|NCT00082550|Genetics|genetics
5394627|NCT00082550|Serotonin Transporter|serotonin transporter
5394628|NCT00082550|Brain Imaging|brain imaging
5394629|NCT00082550|Neurotransmitter|neurotransmitter
5394630|NCT00082550|OCD|ocd
5394631|NCT00082550|Obsessive-Compulsive Disorder|obsessive-compulsive disorder
5394632|NCT00082550|PET|pet
5394633|NCT00082550|Obsessive Compulsive Disorder|obsessive compulsive disorder
5394634|NCT00082550|Healthy Volunteer|healthy volunteer
5394635|NCT00082550|HV|hv
5394636|NCT00082498|SCH-D|sch-d
5394637|NCT00082498|Schering D|schering d
5394638|NCT00082498|Treatment Experienced|treatment experienced
5394639|NCT00082498|Entry Inhibitors|entry inhibitors
5394640|NCT00082498|Fusion Inhibitors|fusion inhibitors
5394641|NCT00082498|Vicriviroc|vicriviroc
5394642|NCT00082485|Cocaine Dependence|cocaine dependence
5394643|NCT00082472|NSCLC|nsclc
5394644|NCT00082472|Metastatic|metastatic
5394645|NCT00082472|Unresectable|unresectable
5394646|NCT00082472|No Prior Chemotherapy|no prior chemotherapy
5394647|NCT00082459|Kidney Cancer|kidney cancer
5394648|NCT00082459|Renal|renal
5394649|NCT00082459|Tumor|tumor
5394650|NCT00082459|Immunotherapy|immunotherapy
5394651|NCT00082420|Vitamin A malnutrition|vitamin a malnutrition
5394652|NCT00082420|low vitamin A status|low vitamin a status
5394653|NCT00002870|stage IV breast cancer|stage iv breast cancer
5394654|NCT00002870|recurrent breast cancer|recurrent breast cancer
5394655|NCT00002826|stage IV breast cancer|stage iv breast cancer
5394656|NCT00002826|recurrent breast cancer|recurrent breast cancer
5394657|NCT00002803|localized resectable neuroblastoma|localized resectable neuroblastoma
5394658|NCT00002803|regional neuroblastoma|regional neuroblastoma
5394659|NCT00002803|stage 4S neuroblastoma|stage 4s neuroblastoma
5394660|NCT00002803|localized unresectable neuroblastoma|localized unresectable neuroblastoma
5394661|NCT00002802|localized resectable neuroblastoma|localized resectable neuroblastoma
5394662|NCT00002802|regional neuroblastoma|regional neuroblastoma
5394663|NCT00002802|disseminated neuroblastoma|disseminated neuroblastoma
5394664|NCT00002802|stage 4S neuroblastoma|stage 4s neuroblastoma
5394665|NCT00002802|localized unresectable neuroblastoma|localized unresectable neuroblastoma
5394666|NCT00082446|Smallpox, vaccine|smallpox, vaccine
5394667|NCT00082381|Diabetes|diabetes
5394668|NCT00082381|Insulin glargine|insulin glargine
5394669|NCT00082381|comparator|comparator
5394670|NCT00082381|Amylin|amylin
5394671|NCT00082381|Lilly|lilly
5394672|NCT00002788|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5394673|NCT00002788|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5394674|NCT00002788|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5394675|NCT00002788|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
5394676|NCT00002737|stage IV renal cell cancer|stage iv renal cell cancer
5394677|NCT00002737|recurrent renal cell cancer|recurrent renal cell cancer
5394678|NCT00002677|stage IV prostate cancer|stage iv prostate cancer
5394679|NCT00002677|recurrent prostate cancer|recurrent prostate cancer
5394680|NCT00002677|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5394681|NCT00002644|breast cancer|breast cancer
5394682|NCT00002587|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5394683|NCT00082407|diabetes|diabetes
5394684|NCT00082407|exendin|exendin
5394685|NCT00082407|Amylin|amylin
5394686|NCT00082407|Lilly|lilly
5394687|NCT00082407|insulin aspart|insulin aspart
5394688|NCT00082394|safety|safety
5394689|NCT00082394|drug efficacy|drug efficacy
5394690|NCT00082394|TRIZIVIR|trizivir
5394691|NCT00082394|tolerability|tolerability
5394692|NCT00082394|COMBIVIR|combivir
5394693|NCT00082394|HIV|hiv
5394694|NCT00082394|atazanavir|atazanavir
5394695|NCT00082316|Dermal assessment|dermal assessment
5394696|NCT00082316|Pain assessment|pain assessment
5394697|NCT00082316|Diary|diary
5394698|NCT00082316|Analgesics|analgesics
5394699|NCT00082316|Capsaicin|capsaicin
5394701|NCT00082316|Neuralgia|neuralgia
5394702|NCT00082316|HIV Infections|hiv infections
5394703|NCT00082316|Peripheral Nervous System Diseases|peripheral nervous system diseases
5394704|NCT00082316|Diabetic Neuropathies|diabetic neuropathies
5394705|NCT00082316|Diabetes Mellitus|diabetes mellitus
5394706|NCT00082316|Polyneuropathies|polyneuropathies
5394707|NCT00082316|Complementary Therapies|complementary therapies
5394708|NCT00082368|Tariquidar|tariquidar
5394709|NCT00082368|PET|pet
5394710|NCT00082368|Sestamibi|sestamibi
5394711|NCT00082368|Cancer|cancer
5394712|NCT00082355|r-tPA|r-tpa
5394713|NCT00082355|Thrombolysis|thrombolysis
5394714|NCT00082355|Clot|clot
5394715|NCT00082355|Anticoagulation|anticoagulation
5394716|NCT00082355|Fibrinolysis|fibrinolysis
5394717|NCT00082355|Deep Vein Thrombosis|deep vein thrombosis
5394718|NCT00082355|DVT|dvt
5394719|NCT00082342|Human Brain|human brain
5394720|NCT00082342|Electrical Stimulation|electrical stimulation
5394721|NCT00082342|Parkinson Disease|parkinson disease
5394722|NCT00082342|PD|pd
5394723|NCT00082329|Hematopoietic Stem Cells|hematopoietic stem cells
5394724|NCT00082329|PBSC's|pbsc's
5394725|NCT00082329|Mobilization|mobilization
5394726|NCT00082329|Alloreactivity|alloreactivity
5394727|NCT00082329|T Cell Polarization|t cell polarization
5394728|NCT00082329|Dendritic Cells|dendritic cells
5394729|NCT00082329|CXCR4|cxcr4
5394730|NCT00082329|Plerixafor|plerixafor
5394731|NCT00082329|Healthy Volunteer (HV)|healthy volunteer (hv)
5394732|NCT00082303|Music Therapy|music therapy
5394733|NCT00082303|Anxiety|anxiety
5394734|NCT00082303|Depression|depression
5394735|NCT00082290|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5394736|NCT00082290|pain|pain
5394737|NCT00082277|hormone-receptor positive, breast cancer|hormone-receptor positive, breast cancer
5394738|NCT00082277|Osteopenia|osteopenia
5394739|NCT00082277|Osteoporosis|osteoporosis
5394740|NCT00082277|risk of fracture|risk of fracture
5394741|NCT00082277|bone loss|bone loss
5394742|NCT00082251|Dyslipidemia|dyslipidemia
5394743|NCT00082251|High Blood Cholesterol|high blood cholesterol
5394744|NCT00082251|Coronary Heart Disease|coronary heart disease
5394745|NCT00082251|Hypertension|hypertension
5394746|NCT00082251|National Cholesterol Education Program|national cholesterol education program
5394747|NCT00082251|Adult Treatment Panel III|adult treatment panel iii
5394748|NCT00082251|Niacin|niacin
5394749|NCT00082251|Simvastatin|simvastatin
5394750|NCT00082251|Diabetes|diabetes
5394751|NCT00082251|Peripheral Vascular Disease|peripheral vascular disease
5394752|NCT00082251|Cerebrovascular disease|cerebrovascular disease
5394753|NCT00082251|Stroke|stroke
5394754|NCT00082251|High-Density Lipoprotein Cholesterol|high-density lipoprotein cholesterol
5394755|NCT00082251|Hydroxymethyl Glutaryl Coenzyme A|hydroxymethyl glutaryl coenzyme a
5394756|NCT00082251|High-Sensitivity C-Reactive Protein|high-sensitivity c-reactive protein
5394757|NCT00082251|Low-Density Lipoprotein Cholesterol|low-density lipoprotein cholesterol
5394758|NCT00082251|Lipoprotein (a)|lipoprotein (a)
5394759|NCT00082251|Lipoprotein A-I|lipoprotein a-i
5394760|NCT00082251|Total Cholesterol|total cholesterol
5394761|NCT00082251|Triglycerides|triglycerides
5394762|NCT00082225|Hodgkins|hodgkins
5394763|NCT00082225|Non-Hodgkins|non-hodgkins
5394764|NCT00082225|Lymphoma|lymphoma
5394765|NCT00082212|ovarian|ovarian
5394766|NCT00082212|primary peritoneal cancer|primary peritoneal cancer
5394767|NCT00082212|Persistent or Recurrent Ovarian Cancer|persistent or recurrent ovarian cancer
5394768|NCT00082212|Primary Peritoneal Carcinoma|primary peritoneal carcinoma
5394769|NCT00014651|perioperative/postoperative complications|perioperative/postoperative complications
5394770|NCT00014651|stage I pancreatic cancer|stage i pancreatic cancer
5394771|NCT00010322|stage IV breast cancer|stage iv breast cancer
5394772|NCT00010322|recurrent breast cancer|recurrent breast cancer
5394773|NCT00008255|non-small cell lung cancer|non-small cell lung cancer
5394774|NCT00008255|small cell lung cancer|small cell lung cancer
5394775|NCT00002568|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5394776|NCT00002568|ovarian undifferentiated adenocarcinoma|ovarian undifferentiated adenocarcinoma
5394777|NCT00002568|ovarian mixed epithelial carcinoma|ovarian mixed epithelial carcinoma
5394778|NCT00002568|ovarian serous cystadenocarcinoma|ovarian serous cystadenocarcinoma
5394779|NCT00002568|ovarian mucinous cystadenocarcinoma|ovarian mucinous cystadenocarcinoma
5394780|NCT00002568|ovarian endometrioid adenocarcinoma|ovarian endometrioid adenocarcinoma
5394781|NCT00002568|ovarian clear cell cystadenocarcinoma|ovarian clear cell cystadenocarcinoma
5394782|NCT00002568|Brenner tumor|brenner tumor
5394783|NCT00002516|localized Ewing sarcoma/peripheral primitive neuroectodermal tumor|localized ewing sarcoma/peripheral primitive neuroectodermal tumor
5394784|NCT00002516|metastatic Ewing sarcoma/peripheral primitive neuroectodermal tumor|metastatic ewing sarcoma/peripheral primitive neuroectodermal tumor
5394785|NCT00082160|Meditation|meditation
5394786|NCT00082160|Relaxation|relaxation
5394787|NCT00082134|Prostate cancer|prostate cancer
5394788|NCT00082134|Hormone-refractory prostate cancer|hormone-refractory prostate cancer
5394789|NCT00082134|HRPC|hrpc
5394790|NCT00082134|Prostate|prostate
5394791|NCT00082134|Docetaxel|docetaxel
5394792|NCT00082134|PSA progression|psa progression
5394793|NCT00082134|PSA progressed|psa progressed
5394794|NCT00082121|cardiac bypass|cardiac bypass
5394795|NCT00082121|CABG|cabg
5394796|NCT00082121|complement activation|complement activation
5394797|NCT00011934|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5394798|NCT00011934|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5394799|NCT00011934|Philadelphia chromosome positive chronic myelogenous leukemia|philadelphia chromosome positive chronic myelogenous leukemia
5394800|NCT00011934|Philadelphia chromosome negative chronic myelogenous leukemia|philadelphia chromosome negative chronic myelogenous leukemia
5394801|NCT00008242|stage II multiple myeloma|stage ii multiple myeloma
5394802|NCT00008242|stage III multiple myeloma|stage iii multiple myeloma
5394803|NCT00008125|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5394804|NCT00008099|stage I pancreatic cancer|stage i pancreatic cancer
5394805|NCT00008099|stage II pancreatic cancer|stage ii pancreatic cancer
5394806|NCT00008099|stage III pancreatic cancer|stage iii pancreatic cancer
5394807|NCT00008099|stage IV pancreatic cancer|stage iv pancreatic cancer
5394808|NCT00006682|stage IV breast cancer|stage iv breast cancer
5394809|NCT00006682|recurrent breast cancer|recurrent breast cancer
5394810|NCT00006669|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5394811|NCT00006669|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5394812|NCT00006669|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5394813|NCT00006669|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5394814|NCT00006342|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
5394815|NCT00006342|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
5394816|NCT00006342|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5394817|NCT00006342|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5394818|NCT00006342|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5394819|NCT00006342|childhood infratentorial ependymoma|childhood infratentorial ependymoma
5394820|NCT00006342|childhood low-grade cerebral astrocytoma|childhood low-grade cerebral astrocytoma
5394821|NCT00006342|childhood supratentorial ependymoma|childhood supratentorial ependymoma
5394822|NCT00006342|stage II childhood Hodgkin lymphoma|stage ii childhood hodgkin lymphoma
5394823|NCT00006342|stage I childhood Hodgkin lymphoma|stage i childhood hodgkin lymphoma
5394824|NCT00006342|stage III childhood Hodgkin lymphoma|stage iii childhood hodgkin lymphoma
5394825|NCT00006342|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
5394826|NCT00006342|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
5394827|NCT00006342|childhood high-grade cerebral astrocytoma|childhood high-grade cerebral astrocytoma
5394828|NCT00006342|untreated childhood brain stem glioma|untreated childhood brain stem glioma
5394829|NCT00006342|recurrent childhood brain stem glioma|recurrent childhood brain stem glioma
5394830|NCT00006342|untreated childhood supratentorial primitive neuroectodermal tumor|untreated childhood supratentorial primitive neuroectodermal tumor
5394831|NCT00006342|recurrent childhood supratentorial primitive neuroectodermal tumor|recurrent childhood supratentorial primitive neuroectodermal tumor
5394832|NCT00006342|untreated childhood cerebellar astrocytoma|untreated childhood cerebellar astrocytoma
5394833|NCT00006342|recurrent childhood cerebellar astrocytoma|recurrent childhood cerebellar astrocytoma
5394834|NCT00006342|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
5394835|NCT00006342|untreated childhood medulloblastoma|untreated childhood medulloblastoma
5394836|NCT00006342|recurrent childhood medulloblastoma|recurrent childhood medulloblastoma
5394837|NCT00006342|newly diagnosed childhood ependymoma|newly diagnosed childhood ependymoma
5394838|NCT00006342|recurrent childhood ependymoma|recurrent childhood ependymoma
5412035|NCT00058903|Pruritus|pruritus
5394839|NCT00006112|stage IV colon cancer|stage iv colon cancer
5394840|NCT00006112|stage IV rectal cancer|stage iv rectal cancer
5394841|NCT00006112|adenocarcinoma of the colon|adenocarcinoma of the colon
5394842|NCT00006112|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5394843|NCT00006112|carcinoma of the appendix|carcinoma of the appendix
5394844|NCT00006112|primary peritoneal cavity cancer|primary peritoneal cavity cancer
5394845|NCT00006097|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5394846|NCT00006097|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
5394847|NCT00006053|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5394848|NCT00006053|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5394849|NCT00006053|chronic myelogenous leukemia, BCR-ABL1 positive|chronic myelogenous leukemia, bcr-abl1 positive
5394850|NCT00006053|Philadelphia chromosome negative chronic myelogenous leukemia|philadelphia chromosome negative chronic myelogenous leukemia
5394851|NCT00006039|small intestine lymphoma|small intestine lymphoma
5394852|NCT00006039|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5394853|NCT00006039|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5394854|NCT00006039|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5394855|NCT00006039|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5394856|NCT00006039|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5394857|NCT00006039|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5394858|NCT00006039|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
5394859|NCT00006039|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
5394860|NCT00006039|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5394861|NCT00006039|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5394862|NCT00006039|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
5394863|NCT00006039|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
5394864|NCT00006039|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5394865|NCT00006039|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5394866|NCT00006039|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5394867|NCT00006039|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5394868|NCT00006039|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5394869|NCT00006039|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5394870|NCT00006039|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
5394871|NCT00006039|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
5394872|NCT00006039|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5394873|NCT00006039|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5394874|NCT00006039|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5394875|NCT00005988|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5394876|NCT00005988|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5394877|NCT00005988|refractory multiple myeloma|refractory multiple myeloma
5394878|NCT00005988|stage I multiple myeloma|stage i multiple myeloma
5394879|NCT00005988|stage II multiple myeloma|stage ii multiple myeloma
5394880|NCT00005988|stage III multiple myeloma|stage iii multiple myeloma
5394881|NCT00005988|stage I childhood lymphoblastic lymphoma|stage i childhood lymphoblastic lymphoma
5394882|NCT00005988|stage II childhood lymphoblastic lymphoma|stage ii childhood lymphoblastic lymphoma
5394883|NCT00005988|stage III childhood lymphoblastic lymphoma|stage iii childhood lymphoblastic lymphoma
5394884|NCT00005988|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
5394885|NCT00005988|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
5394886|NCT00005988|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5394887|NCT00005988|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5394888|NCT00005988|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5394889|NCT00005988|childhood diffuse large cell lymphoma|childhood diffuse large cell lymphoma
5394890|NCT00005988|childhood immunoblastic large cell lymphoma|childhood immunoblastic large cell lymphoma
5394891|NCT00005988|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5394892|NCT00005988|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5394893|NCT00005988|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
5394894|NCT00005988|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
5394895|NCT00005988|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
5394896|NCT00005988|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
5394897|NCT00005988|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
5394898|NCT00005988|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
5394899|NCT00005988|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
5394900|NCT00005988|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
5394901|NCT00005988|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
5394902|NCT00005988|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
5394903|NCT00005988|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5394904|NCT00005988|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5394905|NCT00005988|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5394906|NCT00005988|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5394907|NCT00005988|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5394908|NCT00005988|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5394909|NCT00005988|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5394910|NCT00005988|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5394911|NCT00005988|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5394912|NCT00005988|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5394913|NCT00005988|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5394914|NCT00005988|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5394915|NCT00005988|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5394916|NCT00005988|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5394917|NCT00005988|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5394918|NCT00005988|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5394919|NCT00005988|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5394920|NCT00005988|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5394921|NCT00005988|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5394922|NCT00005988|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5394923|NCT00005988|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5394924|NCT00005988|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5394925|NCT00005988|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5394926|NCT00005988|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5394927|NCT00005988|graft versus host disease|graft versus host disease
5394928|NCT00005988|stage I childhood small noncleaved cell lymphoma|stage i childhood small noncleaved cell lymphoma
5394929|NCT00005988|stage I childhood large cell lymphoma|stage i childhood large cell lymphoma
5394930|NCT00005988|stage II childhood small noncleaved cell lymphoma|stage ii childhood small noncleaved cell lymphoma
5394931|NCT00005988|stage II childhood large cell lymphoma|stage ii childhood large cell lymphoma
5394932|NCT00005988|stage III childhood small noncleaved cell lymphoma|stage iii childhood small noncleaved cell lymphoma
5394933|NCT00005988|stage III childhood large cell lymphoma|stage iii childhood large cell lymphoma
5394934|NCT00005988|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
5394935|NCT00005988|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
5394936|NCT00005988|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
5394937|NCT00005988|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
5394938|NCT00005988|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
5394939|NCT00005988|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
5394940|NCT00005988|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
5394941|NCT00005988|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
5394942|NCT00005988|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
5394943|NCT00005988|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
5394944|NCT00005988|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
5394945|NCT00005988|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5394946|NCT00005988|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
5394947|NCT00005988|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
5394948|NCT00005988|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
5394949|NCT00005988|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5394950|NCT00005988|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
5394951|NCT00005988|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
5394952|NCT00005988|refractory cytopenia with multilineage dysplasia|refractory cytopenia with multilineage dysplasia
5394953|NCT00005988|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
5394954|NCT00005974|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
5394955|NCT00005974|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
5394956|NCT00005871|recurrent pancreatic cancer|recurrent pancreatic cancer
5394957|NCT00005871|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
5394958|NCT00005612|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5394959|NCT00005612|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5394960|NCT00005612|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5394961|NCT00005594|stage III pancreatic cancer|stage iii pancreatic cancer
5394962|NCT00005594|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
5394963|NCT00005594|stage IV pancreatic cancer|stage iv pancreatic cancer
5412036|NCT00058903|Sertraline|sertraline
5394964|NCT00005081|recurrent adult brain tumor|recurrent adult brain tumor
5394965|NCT00005081|adult glioblastoma|adult glioblastoma
5394966|NCT00005081|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5394967|NCT00005081|adult mixed glioma|adult mixed glioma
5394968|NCT00005081|adult giant cell glioblastoma|adult giant cell glioblastoma
5394969|NCT00005081|adult gliosarcoma|adult gliosarcoma
5394970|NCT00005055|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5394971|NCT00005055|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5394972|NCT00005055|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5394973|NCT00005055|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5394974|NCT00005053|stage III pancreatic cancer|stage iii pancreatic cancer
5394975|NCT00005053|recurrent pancreatic cancer|recurrent pancreatic cancer
5394976|NCT00005053|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
5394977|NCT00005053|stage IV pancreatic cancer|stage iv pancreatic cancer
5394978|NCT00005021|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5394979|NCT00005021|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5394980|NCT00005021|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5394981|NCT00005021|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
5394982|NCT00005021|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
5394983|NCT00005021|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5394984|NCT00005021|small intestine lymphoma|small intestine lymphoma
5394985|NCT00005021|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5394986|NCT00005021|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5394987|NCT00005021|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5394988|NCT00005021|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5394989|NCT00005021|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5394990|NCT00005021|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5394991|NCT00005021|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5394992|NCT00005021|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5394993|NCT00005021|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5394994|NCT00005021|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5394995|NCT00005021|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5394996|NCT00005021|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5394997|NCT00005021|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5394998|NCT00005021|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5394999|NCT00005021|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5395000|NCT00005021|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5395001|NCT00005021|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5395002|NCT00005021|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5395003|NCT00005021|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5395004|NCT00005021|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5395005|NCT00005021|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5395006|NCT00005021|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5395007|NCT00005021|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5395008|NCT00005021|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5395009|NCT00005021|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5395010|NCT00005021|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5395011|NCT00005021|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5395012|NCT00005021|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5395013|NCT00005021|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
5395014|NCT00005021|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
5395015|NCT00005021|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
5395016|NCT00005021|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
5395017|NCT00005021|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
5395018|NCT00005021|AIDS-related primary CNS lymphoma|aids-related primary cns lymphoma
5395019|NCT00005021|intraocular lymphoma|intraocular lymphoma
5395020|NCT00005021|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5395021|NCT00005021|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5395022|NCT00005021|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5395023|NCT00005021|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
5395024|NCT00005021|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5395025|NCT00005021|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
5395026|NCT00005021|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
5395027|NCT00005021|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5395028|NCT00005021|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5395029|NCT00005021|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5395030|NCT00005021|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5395031|NCT00005021|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5395032|NCT00005021|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5395033|NCT00005021|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5395034|NCT00005021|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5395035|NCT00005021|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5395036|NCT00005021|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5395037|NCT00004893|stage IV breast cancer|stage iv breast cancer
5395038|NCT00004893|recurrent breast cancer|recurrent breast cancer
5395039|NCT00004892|recurrent adult brain tumor|recurrent adult brain tumor
5395040|NCT00004892|adult brain stem glioma|adult brain stem glioma
5395041|NCT00004892|adult ependymoma|adult ependymoma
5395042|NCT00004892|adult glioblastoma|adult glioblastoma
5395043|NCT00004892|adult oligodendroglioma|adult oligodendroglioma
5395044|NCT00004892|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5395045|NCT00004892|adult mixed glioma|adult mixed glioma
5395046|NCT00004892|adult giant cell glioblastoma|adult giant cell glioblastoma
5395047|NCT00004892|adult gliosarcoma|adult gliosarcoma
5395048|NCT00004884|stage III pancreatic cancer|stage iii pancreatic cancer
5395049|NCT00004884|recurrent pancreatic cancer|recurrent pancreatic cancer
5395050|NCT00004884|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
5395051|NCT00004884|stage IV pancreatic cancer|stage iv pancreatic cancer
5395052|NCT00004246|Radiation Therapy|radiation therapy
5395053|NCT00004246|RT|rt
5395054|NCT00004246|Radiotherapy|radiotherapy
5395055|NCT00004246|Fludarabine|fludarabine
5395056|NCT00004246|Fludara|fludara
5395057|NCT00004246|Fludarabine Phosphate|fludarabine phosphate
5395058|NCT00004246|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
5395059|NCT00004246|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5395060|NCT00004246|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
5395061|NCT00004246|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5395062|NCT00004246|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
5395063|NCT00004246|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
5395064|NCT00004246|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
5395065|NCT00004246|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5395066|NCT00004246|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
5395067|NCT00004246|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5395068|NCT00004230|pulmonary complications|pulmonary complications
5395069|NCT00004230|stage IV breast cancer|stage iv breast cancer
5395070|NCT00004230|stage IIIA breast cancer|stage iiia breast cancer
5395071|NCT00004230|stage IIIB breast cancer|stage iiib breast cancer
5395072|NCT00004230|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5395073|NCT00004230|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5395074|NCT00004230|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5395075|NCT00004230|refractory multiple myeloma|refractory multiple myeloma
5395076|NCT00004230|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
5395077|NCT00004230|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
5395078|NCT00004230|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5395079|NCT00004230|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5395080|NCT00004230|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5395081|NCT00004230|disseminated neuroblastoma|disseminated neuroblastoma
5395082|NCT00004230|recurrent neuroblastoma|recurrent neuroblastoma
5395083|NCT00004230|recurrent Wilms tumor and other childhood kidney tumors|recurrent wilms tumor and other childhood kidney tumors
5395084|NCT00004230|stage I multiple myeloma|stage i multiple myeloma
5395085|NCT00004230|stage II multiple myeloma|stage ii multiple myeloma
5395086|NCT00004230|stage III multiple myeloma|stage iii multiple myeloma
5395087|NCT00004230|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
5395088|NCT00004230|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5395089|NCT00004230|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5395090|NCT00004230|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5395091|NCT00004230|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5395092|NCT00004230|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5395093|NCT00004230|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5395094|NCT00004230|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5395095|NCT00004230|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
5395096|NCT00004230|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
5395097|NCT00004230|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5395098|NCT00004230|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5395099|NCT00004230|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5395100|NCT00004230|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
5395101|NCT00004230|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
5395102|NCT00004230|childhood acute promyelocytic leukemia (M3)|childhood acute promyelocytic leukemia (m3)
5395103|NCT00004230|testicular embryonal carcinoma|testicular embryonal carcinoma
5395104|NCT00004230|testicular choriocarcinoma|testicular choriocarcinoma
5395105|NCT00004230|testicular teratoma|testicular teratoma
5395106|NCT00004230|testicular yolk sac tumor|testicular yolk sac tumor
5395107|NCT00004230|testicular embryonal carcinoma and teratoma|testicular embryonal carcinoma and teratoma
5395108|NCT00004230|testicular embryonal carcinoma and teratoma with seminoma|testicular embryonal carcinoma and teratoma with seminoma
5395109|NCT00004230|testicular embryonal carcinoma and yolk sac tumor|testicular embryonal carcinoma and yolk sac tumor
5395110|NCT00004230|testicular embryonal carcinoma and yolk sac tumor with seminoma|testicular embryonal carcinoma and yolk sac tumor with seminoma
5395111|NCT00004230|testicular embryonal carcinoma and seminoma|testicular embryonal carcinoma and seminoma
5395112|NCT00004230|testicular yolk sac tumor and teratoma|testicular yolk sac tumor and teratoma
5395113|NCT00004230|testicular yolk sac tumor and teratoma with seminoma|testicular yolk sac tumor and teratoma with seminoma
5395114|NCT00004230|testicular choriocarcinoma and yolk sac tumor|testicular choriocarcinoma and yolk sac tumor
5395115|NCT00004230|testicular choriocarcinoma and embryonal carcinoma|testicular choriocarcinoma and embryonal carcinoma
5395116|NCT00004230|testicular choriocarcinoma and teratoma|testicular choriocarcinoma and teratoma
5395117|NCT00004230|testicular choriocarcinoma and seminoma|testicular choriocarcinoma and seminoma
5395118|NCT00004230|refractory hairy cell leukemia|refractory hairy cell leukemia
5395119|NCT00004230|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
5395120|NCT00004230|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
5395121|NCT00004230|ovarian yolk sac tumor|ovarian yolk sac tumor
5395122|NCT00004230|ovarian embryonal carcinoma|ovarian embryonal carcinoma
5395123|NCT00004230|ovarian polyembryoma|ovarian polyembryoma
5395124|NCT00004230|ovarian choriocarcinoma|ovarian choriocarcinoma
5395125|NCT00004230|ovarian immature teratoma|ovarian immature teratoma
5395126|NCT00004230|ovarian mature teratoma|ovarian mature teratoma
5395127|NCT00004230|ovarian monodermal and highly specialized teratoma|ovarian monodermal and highly specialized teratoma
5395128|NCT00004230|ovarian mixed germ cell tumor|ovarian mixed germ cell tumor
5395129|NCT00004230|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5395130|NCT00004230|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5395131|NCT00004230|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5395132|NCT00004230|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5395133|NCT00004230|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5395134|NCT00004230|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5395135|NCT00004230|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5395136|NCT00004230|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5395137|NCT00004230|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5395138|NCT00004230|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5395139|NCT00004230|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5395140|NCT00004230|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5395141|NCT00004230|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5395142|NCT00004230|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5395143|NCT00004230|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5395144|NCT00004230|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5395145|NCT00004230|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5395146|NCT00004230|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5395147|NCT00004230|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5395148|NCT00004230|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5395149|NCT00004230|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5395150|NCT00004230|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5395151|NCT00004230|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5395152|NCT00004230|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5395153|NCT00004230|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5395154|NCT00004230|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5395155|NCT00004230|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5395156|NCT00004230|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5395157|NCT00004230|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5395158|NCT00004230|poor prognosis metastatic gestational trophoblastic tumor|poor prognosis metastatic gestational trophoblastic tumor
5395159|NCT00004230|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5395160|NCT00004230|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5395161|NCT00004230|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
5395162|NCT00004230|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
5395163|NCT00004230|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5395164|NCT00004230|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5395165|NCT00004230|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5395166|NCT00004230|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
5395167|NCT00004230|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5395168|NCT00004230|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
5395169|NCT00004230|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
5395170|NCT00004230|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5395171|NCT00004230|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
5395172|NCT00004230|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
5395173|NCT00004230|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5395174|NCT00004230|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5395175|NCT00004230|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5395176|NCT00004230|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
5395177|NCT00004230|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5395178|NCT00004230|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
5395179|NCT00004230|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
5395180|NCT00004230|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5395181|NCT00004230|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5395182|NCT00004230|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5395183|NCT00004230|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5395184|NCT00004230|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5395185|NCT00004230|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5395186|NCT00004230|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5395187|NCT00004230|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5395188|NCT00004230|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5395189|NCT00004230|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
5395190|NCT00004213|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5395191|NCT00004101|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5395192|NCT00004101|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5395193|NCT00004101|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5395194|NCT00004101|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5395195|NCT00004101|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5395196|NCT00004101|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5395197|NCT00004101|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5395198|NCT00004101|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5395199|NCT00004101|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5395200|NCT00004101|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5395201|NCT00004101|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5395202|NCT00004101|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5395203|NCT00004101|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5395204|NCT00004101|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5395205|NCT00004101|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5395206|NCT00004049|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5395207|NCT00003972|stage II breast cancer|stage ii breast cancer
5395208|NCT00003972|stage IIIA breast cancer|stage iiia breast cancer
5395209|NCT00003968|stage IV renal cell cancer|stage iv renal cell cancer
5395210|NCT00003968|recurrent renal cell cancer|recurrent renal cell cancer
5395211|NCT00003943|extensive stage small cell lung cancer|extensive stage small cell lung cancer
5395212|NCT00003943|newly diagnosed carcinoma of unknown primary|newly diagnosed carcinoma of unknown primary
5395213|NCT00003900|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5395214|NCT00003900|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5395215|NCT00003849|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5395216|NCT00003849|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5395217|NCT00003849|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5395218|NCT00003825|radiation enteritis|radiation enteritis
5395219|NCT00003825|diarrhea|diarrhea
5395220|NCT00003768|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5395221|NCT00003726|extensive stage small cell lung cancer|extensive stage small cell lung cancer
5395222|NCT00003726|recurrent small cell lung cancer|recurrent small cell lung cancer
5395223|NCT00003713|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5395224|NCT00003680|stage III breast cancer|stage iii breast cancer
5395225|NCT00003680|inflammatory breast cancer|inflammatory breast cancer
5395226|NCT00003646|adult solid tumor|adult solid tumor
5395227|NCT00003646|body system/site cancer|body system/site cancer
5395229|NCT00003646|melanoma|melanoma
5395230|NCT00003646|recurrent melanoma|recurrent melanoma
5395231|NCT00003646|skin tumor|skin tumor
5395233|NCT00003646|stage III melanoma|stage iii melanoma
5395234|NCT00003646|stage IV melanoma|stage iv melanoma
5395235|NCT00003646|stage, melanoma|stage, melanoma
5395236|NCT00003638|stage IV breast cancer|stage iv breast cancer
5395237|NCT00003638|recurrent breast cancer|recurrent breast cancer
5395238|NCT00003622|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5395239|NCT00003622|stage IV prostate cancer|stage iv prostate cancer
5395240|NCT00003622|recurrent prostate cancer|recurrent prostate cancer
5395241|NCT00082147|MRI|mri
5395242|NCT00082147|Biopsy|biopsy
5395243|NCT00082147|Fiducial Marker|fiducial marker
5395244|NCT00082147|Prostate Cancer|prostate cancer
5395245|NCT00082108|Registry|registry
5395246|NCT00082108|FSHD|fshd
5395247|NCT00082108|DM|dm
5395248|NCT00082108|Muscular Dystrophy|muscular dystrophy
5395249|NCT00082108|Facioscapulohumeral Myotonic Dystrophy|facioscapulohumeral myotonic dystrophy
5395250|NCT00082108|Myotonic Dystrophy|myotonic dystrophy
5395251|NCT00082108|DM1|dm1
5395252|NCT00082108|DM2|dm2
5395253|NCT00082108|FSH|fsh
5395254|NCT00082108|MMD|mmd
5395255|NCT00082095|Metastatic breast cancer|metastatic breast cancer
5395256|NCT00082095|Breast Cancer|breast cancer
5395257|NCT00082095|Pegylated Liposomal Doxorubicin|pegylated liposomal doxorubicin
5395258|NCT00082095|Capecitabine|capecitabine
5395259|NCT00082095|DOXIL|doxil
5395260|NCT00082095|Xeloda|xeloda
5395261|NCT00082069|Shigella|shigella
5395262|NCT00082069|diarrhea|diarrhea
5395263|NCT00081978|HIV infection|hiv infection
5395264|NCT00081978|TMC125|tmc125
5395265|NCT00081978|Non-nucleoside reverse transcriptase inhibitor, TMC125-C223|non-nucleoside reverse transcriptase inhibitor, tmc125-c223
5395266|NCT00003583|limited stage small cell lung cancer|limited stage small cell lung cancer
5395267|NCT00003583|drug/agent toxicity by tissue/organ|drug/agent toxicity by tissue/organ
5395268|NCT00003583|radiation toxicity|radiation toxicity
5395269|NCT00003563|tumors metastatic to brain|tumors metastatic to brain
5395270|NCT00003554|stage I multiple myeloma|stage i multiple myeloma
5395271|NCT00003554|stage II multiple myeloma|stage ii multiple myeloma
5395272|NCT00003554|stage III multiple myeloma|stage iii multiple myeloma
5395273|NCT00003397|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
5395274|NCT00003397|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
5395275|NCT00003397|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
5395276|NCT00003397|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
5395277|NCT00003397|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
5395278|NCT00003397|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
5395279|NCT00003397|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
5395280|NCT00003397|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5395281|NCT00003397|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5395282|NCT00003397|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5395283|NCT00003397|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5395284|NCT00003397|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5395285|NCT00003397|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5395286|NCT00003397|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5395287|NCT00003397|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5395288|NCT00003397|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5395289|NCT00003397|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5395290|NCT00003397|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5395291|NCT00003397|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5395292|NCT00003397|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5395293|NCT00003397|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5395294|NCT00003397|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5395295|NCT00003397|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5395296|NCT00003397|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5395297|NCT00003397|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5395298|NCT00003397|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5395299|NCT00003397|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5395300|NCT00003397|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5395301|NCT00003397|stage I mantle cell lymphoma|stage i mantle cell lymphoma
5395302|NCT00003397|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
5395303|NCT00003397|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
5395304|NCT00003397|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
5395305|NCT00003397|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
5395306|NCT00003397|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
5395307|NCT00003397|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
5395308|NCT00003397|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
5395309|NCT00003397|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
5395310|NCT00003397|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5395311|NCT00003397|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
5395312|NCT00003397|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5395313|NCT00003397|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
5395314|NCT00003397|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
5395315|NCT00003397|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5395316|NCT00003397|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
5395317|NCT00003397|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
5395318|NCT00003397|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5395319|NCT00003397|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5395320|NCT00003397|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5395321|NCT00003394|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5395322|NCT00003394|stage I prostate cancer|stage i prostate cancer
5395323|NCT00003394|stage IIB prostate cancer|stage iib prostate cancer
5395324|NCT00003394|stage IIA prostate cancer|stage iia prostate cancer
5395325|NCT00003394|stage III prostate cancer|stage iii prostate cancer
5395326|NCT00003394|stage IV prostate cancer|stage iv prostate cancer
5395327|NCT00003394|recurrent prostate cancer|recurrent prostate cancer
5395328|NCT00003276|unresectable gallbladder cancer|unresectable gallbladder cancer
5395329|NCT00003276|recurrent gallbladder cancer|recurrent gallbladder cancer
5395330|NCT00003239|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5395331|NCT00003239|Philadelphia chromosome positive chronic myelogenous leukemia|philadelphia chromosome positive chronic myelogenous leukemia
5395332|NCT00003239|Homoharringtonine|homoharringtonine
5395334|NCT00003239|cephalotaxus alkaloid|cephalotaxus alkaloid
5395335|NCT00003239|cytarabine|cytarabine
5395336|NCT00003239|Interferon Alpha 2-A|interferon alpha 2-a
5395337|NCT00003239|Roferon-A|roferon-a
5395338|NCT00003239|Ara-C|ara-c
5395339|NCT00003239|DepotCyt|depotcyt
5395340|NCT00003239|Cytosine Arabinosine Hydrochloride|cytosine arabinosine hydrochloride
5395341|NCT00003181|stage IV renal cell cancer|stage iv renal cell cancer
5395342|NCT00003181|recurrent renal cell cancer|recurrent renal cell cancer
5395343|NCT00003175|recurrent bladder cancer|recurrent bladder cancer
5395344|NCT00003175|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
5395345|NCT00003175|recurrent urethral cancer|recurrent urethral cancer
5395346|NCT00003175|recurrent transitional cell cancer of the renal pelvis and ureter|recurrent transitional cell cancer of the renal pelvis and ureter
5395347|NCT00003165|stage IV breast cancer|stage iv breast cancer
5395348|NCT00003165|recurrent breast cancer|recurrent breast cancer
5395349|NCT00003133|stage III bladder cancer|stage iii bladder cancer
5395350|NCT00003133|stage IV bladder cancer|stage iv bladder cancer
5395351|NCT00003133|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
5395352|NCT00003133|metastatic transitional cell cancer of the renal pelvis and ureter|metastatic transitional cell cancer of the renal pelvis and ureter
5395353|NCT00003133|regional transitional cell cancer of the renal pelvis and ureter|regional transitional cell cancer of the renal pelvis and ureter
5395354|NCT00003038|stage IV colon cancer|stage iv colon cancer
5395355|NCT00003038|stage IV breast cancer|stage iv breast cancer
5395356|NCT00003038|recurrent breast cancer|recurrent breast cancer
5395357|NCT00003038|recurrent colon cancer|recurrent colon cancer
5395358|NCT00003038|stage IV adrenocortical carcinoma|stage iv adrenocortical carcinoma
5395359|NCT00003038|recurrent adrenocortical carcinoma|recurrent adrenocortical carcinoma
5395360|NCT00003038|stage IV prostate cancer|stage iv prostate cancer
5395361|NCT00003038|recurrent prostate cancer|recurrent prostate cancer
5395362|NCT00003038|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5395363|NCT00003019|desmoid tumor|desmoid tumor
5395364|NCT00081926|CML|cml
5395365|NCT00081926|Chronic Myelogenous Leukemia|chronic myelogenous leukemia
5395366|NCT00081926|RIGHT Trial|right trial
5395367|NCT00081926|US177|us177
5395368|NCT00081926|CSTI571|csti571
5395369|NCT00014365|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5395370|NCT00006483|stage IV renal cell cancer|stage iv renal cell cancer
5395371|NCT00006483|recurrent renal cell cancer|recurrent renal cell cancer
5395372|NCT00006483|lung metastases|lung metastases
5395373|NCT00006261|stage IV breast cancer|stage iv breast cancer
5395374|NCT00006261|recurrent breast cancer|recurrent breast cancer
5395375|NCT00006106|adult solid tumor|adult solid tumor
5395376|NCT00006106|body system/site cancer|body system/site cancer
5395377|NCT00006106|cancer|cancer
5395378|NCT00006106|cellular diagnosis, hypopharyngeal cancer|cellular diagnosis, hypopharyngeal cancer
5395379|NCT00006106|cellular diagnosis, laryngeal cancer|cellular diagnosis, laryngeal cancer
5395380|NCT00006106|cellular diagnosis, lip and oral cavity cancer|cellular diagnosis, lip and oral cavity cancer
5395381|NCT00006106|cellular diagnosis, nasopharyngeal cancer|cellular diagnosis, nasopharyngeal cancer
5395382|NCT00006106|cellular diagnosis, oropharyngeal cancer|cellular diagnosis, oropharyngeal cancer
5395521|NCT00082030|Healthy Volunteer|healthy volunteer
5395383|NCT00006106|cellular diagnosis, paranasal sinus and nasal cavity cancer|cellular diagnosis, paranasal sinus and nasal cavity cancer
5395384|NCT00006106|head and neck cancer|head and neck cancer
5395385|NCT00006106|hypopharyngeal cancer|hypopharyngeal cancer
5395386|NCT00006106|hypopharyngeal squamous cell carcinoma|hypopharyngeal squamous cell carcinoma
5395387|NCT00006106|laryngeal cancer|laryngeal cancer
5395388|NCT00006106|laryngeal squamous cell carcinoma|laryngeal squamous cell carcinoma
5395389|NCT00006106|lip and oral cavity cancer|lip and oral cavity cancer
5395390|NCT00006106|lip and oral cavity squamous cell carcinoma|lip and oral cavity squamous cell carcinoma
5395391|NCT00006106|metastatic squamous neck cancer with occult primary|metastatic squamous neck cancer with occult primary
5395392|NCT00006106|nasopharyngeal cancer|nasopharyngeal cancer
5395393|NCT00006106|nasopharyngeal squamous cell carcinoma|nasopharyngeal squamous cell carcinoma
5395394|NCT00006106|oropharyngeal cancer|oropharyngeal cancer
5395395|NCT00006106|oropharyngeal squamous cell carcinoma|oropharyngeal squamous cell carcinoma
5395396|NCT00006106|paranasal sinus and nasal cavity cancer|paranasal sinus and nasal cavity cancer
5395397|NCT00006106|paranasal sinus and nasal cavity squamous cell carcinoma|paranasal sinus and nasal cavity squamous cell carcinoma
5395398|NCT00006106|recurrent hypopharyngeal cancer|recurrent hypopharyngeal cancer
5395399|NCT00006106|recurrent laryngeal cancer|recurrent laryngeal cancer
5395400|NCT00006106|recurrent lip and oral cavity cancer|recurrent lip and oral cavity cancer
5395401|NCT00006106|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
5395402|NCT00006106|recurrent nasopharyngeal cancer|recurrent nasopharyngeal cancer
5395403|NCT00006106|recurrent oropharyngeal cancer|recurrent oropharyngeal cancer
5395404|NCT00006106|recurrent paranasal sinus and nasal cavity cancer|recurrent paranasal sinus and nasal cavity cancer
5395405|NCT00006106|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
5395406|NCT00006106|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
5395407|NCT00006106|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
5395408|NCT00006106|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
5395409|NCT00006106|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
5395410|NCT00006106|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
5395411|NCT00006106|solid tumor|solid tumor
5395412|NCT00006106|stage III hypopharyngeal cancer|stage iii hypopharyngeal cancer
5395413|NCT00006106|stage III laryngeal cancer|stage iii laryngeal cancer
5395414|NCT00006106|stage III lip and oral cavity cancer|stage iii lip and oral cavity cancer
5395415|NCT00006106|stage III nasopharyngeal cancer|stage iii nasopharyngeal cancer
5395416|NCT00006106|stage III oropharyngeal cancer|stage iii oropharyngeal cancer
5395417|NCT00006106|stage III paranasal sinus and nasal cavity cancer|stage iii paranasal sinus and nasal cavity cancer
5395418|NCT00006106|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
5395419|NCT00006106|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
5395420|NCT00006106|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
5395421|NCT00006106|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
5395422|NCT00006106|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
5395423|NCT00006106|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
5395424|NCT00006106|stage IV hypopharyngeal cancer|stage iv hypopharyngeal cancer
5395425|NCT00006106|stage IV laryngeal cancer|stage iv laryngeal cancer
5395426|NCT00006106|stage IV lip and oral cavity cancer|stage iv lip and oral cavity cancer
5395427|NCT00006106|stage IV nasopharyngeal cancer|stage iv nasopharyngeal cancer
5395428|NCT00006106|stage IV oropharyngeal cancer|stage iv oropharyngeal cancer
5395429|NCT00006106|stage IV paranasal sinus and nasal cavity cancer|stage iv paranasal sinus and nasal cavity cancer
5395430|NCT00006106|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5395431|NCT00006106|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5395432|NCT00006106|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5395433|NCT00006106|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
5395434|NCT00006106|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5395435|NCT00006106|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
5395436|NCT00006106|stage, hypopharyngeal cancer|stage, hypopharyngeal cancer
5395437|NCT00006106|stage, laryngeal cancer|stage, laryngeal cancer
5395438|NCT00006106|stage, lip and oral cavity cancer|stage, lip and oral cavity cancer
5395439|NCT00006106|stage, metastatic squamous neck cancer with occult primary|stage, metastatic squamous neck cancer with occult primary
5395440|NCT00006106|stage, nasopharyngeal cancer|stage, nasopharyngeal cancer
5395441|NCT00006106|stage, oropharyngeal cancer|stage, oropharyngeal cancer
5395442|NCT00006106|stage, paranasal sinus and nasal cavity cancer|stage, paranasal sinus and nasal cavity cancer
5395443|NCT00003001|stage IV colon cancer|stage iv colon cancer
5395444|NCT00003001|stage IV rectal cancer|stage iv rectal cancer
5395445|NCT00003001|recurrent colon cancer|recurrent colon cancer
5395446|NCT00003001|recurrent rectal cancer|recurrent rectal cancer
5395447|NCT00002977|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5395448|NCT00002977|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5395449|NCT00002977|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5395450|NCT00002977|ovarian undifferentiated adenocarcinoma|ovarian undifferentiated adenocarcinoma
5395451|NCT00002977|ovarian mixed epithelial carcinoma|ovarian mixed epithelial carcinoma
5395452|NCT00002977|ovarian serous cystadenocarcinoma|ovarian serous cystadenocarcinoma
5395453|NCT00002977|ovarian mucinous cystadenocarcinoma|ovarian mucinous cystadenocarcinoma
5395454|NCT00002977|ovarian endometrioid adenocarcinoma|ovarian endometrioid adenocarcinoma
5395455|NCT00002977|ovarian clear cell cystadenocarcinoma|ovarian clear cell cystadenocarcinoma
5395456|NCT00002977|Brenner tumor|brenner tumor
5395457|NCT00002939|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5395458|NCT00002912|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5395459|NCT00002912|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5395460|NCT00002912|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5395461|NCT00002884|stage I esophageal cancer|stage i esophageal cancer
5395462|NCT00002884|stage II esophageal cancer|stage ii esophageal cancer
5395463|NCT00002884|stage III esophageal cancer|stage iii esophageal cancer
5395464|NCT00002884|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
5395465|NCT00002884|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
5395466|NCT00002773|stage II pancreatic cancer|stage ii pancreatic cancer
5395467|NCT00002773|stage III pancreatic cancer|stage iii pancreatic cancer
5395468|NCT00002773|recurrent pancreatic cancer|recurrent pancreatic cancer
5395469|NCT00002773|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
5395470|NCT00002773|stage IV pancreatic cancer|stage iv pancreatic cancer
5395471|NCT00002719|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
5395472|NCT00002719|adult acute erythroid leukemia (M6)|adult acute erythroid leukemia (m6)
5395473|NCT00002719|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
5395474|NCT00002719|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
5395475|NCT00002719|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
5395476|NCT00002719|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
5395477|NCT00002719|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
5395478|NCT00002719|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5395479|NCT00002719|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
5395480|NCT00002719|neutropenia|neutropenia
5395481|NCT00002719|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
5395482|NCT00002680|stage IV breast cancer|stage iv breast cancer
5395483|NCT00002680|recurrent breast cancer|recurrent breast cancer
5395484|NCT00002590|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
5395485|NCT00002590|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
5395486|NCT00002564|recurrent breast cancer|recurrent breast cancer
5395487|NCT00002481|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5395488|NCT00002481|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5395489|NCT00002481|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5395490|NCT00002481|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5395491|NCT00002481|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5395492|NCT00002481|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5395493|NCT00002481|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5395494|NCT00002481|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5395495|NCT00002481|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5395496|NCT00002481|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5395497|NCT00002481|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5395498|NCT00002481|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5395499|NCT00002481|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5395500|NCT00002481|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5395501|NCT00002481|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5395502|NCT00082043|Neurosteroids|neurosteroids
5395503|NCT00082043|5 Alpha-Reductase Inhibitor|5 alpha-reductase inhibitor
5395504|NCT00082043|Depression|depression
5395505|NCT00082043|Menstrual Cycle|menstrual cycle
5395506|NCT00082043|Gonadal Steroids|gonadal steroids
5395507|NCT00082043|Menstrual Cycle Related Mood Disorder|menstrual cycle related mood disorder
5395508|NCT00082043|MRMD|mrmd
5395509|NCT00082043|Healthy Volunteer|healthy volunteer
5395510|NCT00082030|Depression|depression
5395511|NCT00082030|PET|pet
5395512|NCT00082030|fMRI|fmri
5395513|NCT00082030|Dopamine|dopamine
5395514|NCT00082030|Norepinephrine Depletion|norepinephrine depletion
5395515|NCT00082030|Emotional Stimuli|emotional stimuli
5395516|NCT00082030|Anhedonia|anhedonia
5395517|NCT00082030|Norepinephrine|norepinephrine
5395518|NCT00082030|Dopamine Depletion|dopamine depletion
5395519|NCT00082030|Major Depressive Disorder|major depressive disorder
5395520|NCT00082030|MDD|mdd
5395523|NCT00082017|Protein Kinase Inhibition|protein kinase inhibition
5395524|NCT00082017|Soluble Tac|soluble tac
5395525|NCT00082017|Gene Expression Profiling|gene expression profiling
5395526|NCT00082017|ALK Expression|alk expression
5395527|NCT00082017|Apoptosis|apoptosis
5395528|NCT00082017|Lymphoma|lymphoma
5395529|NCT00082017|Anaplastic Large Cell Lymphoma|anaplastic large cell lymphoma
5395530|NCT00082017|ALCL|alcl
5395531|NCT00082017|T-Cell Lymphoma|t-cell lymphoma
5395532|NCT00081991|Cataract|cataract
5395533|NCT00081991|Blindness|blindness
5395534|NCT00081991|Clinical|clinical
5395535|NCT00081991|Human Aging|human aging
5395536|NCT00081991|Dynamic Light Scattering (DLS)|dynamic light scattering (dls)
5395537|NCT00081991|Aging-Related Lens Changes|aging-related lens changes
5395538|NCT00081991|Early Cataract|early cataract
5395539|NCT00081991|Lens|lens
5395540|NCT00081991|AREDS Grading|areds grading
5395541|NCT00081991|In Vivo|in vivo
5395542|NCT00081991|Healthy Volunteer|healthy volunteer
5395543|NCT00081965|breast cancer in situ|breast cancer in situ
5395544|NCT00081965|stage I breast cancer|stage i breast cancer
5395545|NCT00081965|stage II breast cancer|stage ii breast cancer
5395546|NCT00081965|stage IIIA breast cancer|stage iiia breast cancer
5395547|NCT00081965|stage IIIB breast cancer|stage iiib breast cancer
5395548|NCT00081965|stage IV breast cancer|stage iv breast cancer
5395549|NCT00081965|recurrent breast cancer|recurrent breast cancer
5395550|NCT00081965|stage IIIC breast cancer|stage iiic breast cancer
5395551|NCT00081965|hot flashes|hot flashes
5395552|NCT00081952|Postmenopause|postmenopause
5395553|NCT00081913|Apheresis|apheresis
5395554|NCT00081913|Cell Transfer|cell transfer
5395555|NCT00081913|Chest Pain|chest pain
5395556|NCT00081913|Adult Stem Cell Therapy|adult stem cell therapy
5395557|NCT00081900|Carcinoma, Hepatocellular|carcinoma, hepatocellular
5395558|NCT00005969|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5395559|NCT00005969|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
5395560|NCT00005883|non-small cell lung cancer|non-small cell lung cancer
5395561|NCT00005883|small cell lung cancer|small cell lung cancer
5395562|NCT00005796|recurrent adult brain tumor|recurrent adult brain tumor
5395563|NCT00005796|adult brain stem glioma|adult brain stem glioma
5395564|NCT00005796|adult ependymoma|adult ependymoma
5395565|NCT00005796|adult medulloblastoma|adult medulloblastoma
5395566|NCT00005796|adult glioblastoma|adult glioblastoma
5395567|NCT00005796|childhood high-grade cerebral astrocytoma|childhood high-grade cerebral astrocytoma
5395568|NCT00005796|childhood oligodendroglioma|childhood oligodendroglioma
5395569|NCT00005796|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5395570|NCT00005796|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
5395571|NCT00005796|adult mixed glioma|adult mixed glioma
5395572|NCT00005796|drug/agent toxicity by tissue/organ|drug/agent toxicity by tissue/organ
5395573|NCT00005796|bone marrow suppression|bone marrow suppression
5395574|NCT00005796|untreated childhood brain stem glioma|untreated childhood brain stem glioma
5395575|NCT00005796|recurrent childhood brain stem glioma|recurrent childhood brain stem glioma
5395576|NCT00005796|untreated childhood cerebellar astrocytoma|untreated childhood cerebellar astrocytoma
5395577|NCT00005796|recurrent childhood cerebellar astrocytoma|recurrent childhood cerebellar astrocytoma
5395578|NCT00005796|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
5395579|NCT00005796|recurrent childhood medulloblastoma|recurrent childhood medulloblastoma
5395580|NCT00005796|newly diagnosed childhood ependymoma|newly diagnosed childhood ependymoma
5395581|NCT00005796|recurrent childhood ependymoma|recurrent childhood ependymoma
5395582|NCT00005796|adult giant cell glioblastoma|adult giant cell glioblastoma
5395583|NCT00005796|adult gliosarcoma|adult gliosarcoma
5395584|NCT00005649|stage IV breast cancer|stage iv breast cancer
5395585|NCT00005649|recurrent breast cancer|recurrent breast cancer
5395586|NCT00004933|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5395587|NCT00004933|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5395588|NCT00004933|Philadelphia chromosome positive chronic myelogenous leukemia|philadelphia chromosome positive chronic myelogenous leukemia
5395589|NCT00004923|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5395590|NCT00004903|refractory multiple myeloma|refractory multiple myeloma
5395591|NCT00004903|stage I multiple myeloma|stage i multiple myeloma
5395592|NCT00004903|stage II multiple myeloma|stage ii multiple myeloma
5395593|NCT00004903|stage III multiple myeloma|stage iii multiple myeloma
5395594|NCT00004878|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5395595|NCT00004878|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5395596|NCT00004878|Philadelphia chromosome positive chronic myelogenous leukemia|philadelphia chromosome positive chronic myelogenous leukemia
5395597|NCT00004878|graft versus host disease|graft versus host disease
5395598|NCT00004872|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5395599|NCT00004858|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5395600|NCT00004858|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
5395601|NCT00004858|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5395602|NCT00004858|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5412106|NCT00058734|AIDS|aids
5395603|NCT00004858|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5395604|NCT00004858|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5395605|NCT00004858|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5395606|NCT00004858|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5395607|NCT00004858|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5395608|NCT00004858|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5395609|NCT00004858|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5395610|NCT00004858|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5395611|NCT00004858|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
5395612|NCT00004858|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
5395613|NCT00004858|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5395614|NCT00004604|stage IV colon cancer|stage iv colon cancer
5395615|NCT00004604|stage IV breast cancer|stage iv breast cancer
5395616|NCT00004604|recurrent breast cancer|recurrent breast cancer
5395617|NCT00004604|stage IV gastric cancer|stage iv gastric cancer
5395618|NCT00004604|recurrent gastric cancer|recurrent gastric cancer
5395619|NCT00004604|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5395620|NCT00004604|recurrent pancreatic cancer|recurrent pancreatic cancer
5395621|NCT00004604|stage IV rectal cancer|stage iv rectal cancer
5395622|NCT00004604|recurrent colon cancer|recurrent colon cancer
5395623|NCT00004604|recurrent rectal cancer|recurrent rectal cancer
5395624|NCT00004604|inflammatory breast cancer|inflammatory breast cancer
5395625|NCT00004604|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5395626|NCT00004604|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5395627|NCT00004604|extensive stage small cell lung cancer|extensive stage small cell lung cancer
5395628|NCT00004604|recurrent small cell lung cancer|recurrent small cell lung cancer
5395629|NCT00004604|unresectable gallbladder cancer|unresectable gallbladder cancer
5395630|NCT00004604|recurrent gallbladder cancer|recurrent gallbladder cancer
5395631|NCT00004604|unresectable extrahepatic bile duct cancer|unresectable extrahepatic bile duct cancer
5395632|NCT00004604|recurrent extrahepatic bile duct cancer|recurrent extrahepatic bile duct cancer
5395633|NCT00004604|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
5395634|NCT00004604|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
5395635|NCT00004604|thyroid gland medullary carcinoma|thyroid gland medullary carcinoma
5395636|NCT00004604|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5395637|NCT00004604|stage IV salivary gland cancer|stage iv salivary gland cancer
5395638|NCT00004604|recurrent salivary gland cancer|recurrent salivary gland cancer
5395639|NCT00004604|Paget disease of the breast with invasive ductal carcinoma|paget disease of the breast with invasive ductal carcinoma
5395640|NCT00004604|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
5395641|NCT00004604|testicular yolk sac tumor|testicular yolk sac tumor
5395642|NCT00004604|lung metastases|lung metastases
5395643|NCT00004604|liver metastases|liver metastases
5395644|NCT00004604|cholangiocarcinoma of the gallbladder|cholangiocarcinoma of the gallbladder
5395645|NCT00004604|cholangiocarcinoma of the extrahepatic bile duct|cholangiocarcinoma of the extrahepatic bile duct
5395646|NCT00004604|male breast cancer|male breast cancer
5395647|NCT00004604|stage IV pancreatic cancer|stage iv pancreatic cancer
5395648|NCT00004249|limited stage small cell lung cancer|limited stage small cell lung cancer
5395649|NCT00004174|stage IV breast cancer|stage iv breast cancer
5395650|NCT00004174|stage IIIA breast cancer|stage iiia breast cancer
5395651|NCT00004174|recurrent breast cancer|recurrent breast cancer
5395652|NCT00004174|stage IIIB breast cancer|stage iiib breast cancer
5395653|NCT00003960|refractory multiple myeloma|refractory multiple myeloma
5395654|NCT00003960|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5395655|NCT00003960|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5395656|NCT00003960|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5395657|NCT00003960|refractory anemia with excess blasts|refractory anemia with excess blasts
5395658|NCT00003960|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
5395659|NCT00003960|acute undifferentiated leukemia|acute undifferentiated leukemia
5395660|NCT00003960|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5395661|NCT00003960|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5395662|NCT00003960|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5395663|NCT00003960|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5395664|NCT00003953|stage II breast cancer|stage ii breast cancer
5395665|NCT00003953|stage IIIA breast cancer|stage iiia breast cancer
5395666|NCT00003953|stage IIIB breast cancer|stage iiib breast cancer
5395667|NCT00081887|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
5395668|NCT00081887|CLL|cll
5395669|NCT00081887|Leukemia|leukemia
5395670|NCT00081887|Clofarabine|clofarabine
5395671|NCT00081887|Clofarex|clofarex
5395672|NCT00081887|Clolar|clolar
5395673|NCT00081874|Leukemia|leukemia
5395674|NCT00081874|Mantle cell lymphoma|mantle cell lymphoma
5395675|NCT00081874|Myelofibrosis|myelofibrosis
5395676|NCT00081874|Relapsed or Refractory Acute Myeloid Leukemia|relapsed or refractory acute myeloid leukemia
5395677|NCT00081874|Acute Lymphocytic Leukemia|acute lymphocytic leukemia
5395678|NCT00081874|Chronic Myeloid Leukemia in Blastic-Phase|chronic myeloid leukemia in blastic-phase
5395679|NCT00081874|Agnogenic Myeloid Metaplasia|agnogenic myeloid metaplasia
5395680|NCT00081874|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
5395681|NCT00081874|T-Cell Leukemia|t-cell leukemia
5395682|NCT00081874|RAD001|rad001
5395683|NCT00081874|Everolimus|everolimus
5395684|NCT00081874|Afinitor|afinitor
5395685|NCT00081861|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
5395686|NCT00081861|B-Cell Lymphoma|b-cell lymphoma
5395687|NCT00081861|Lymphoma|lymphoma
5395688|NCT00081861|Avastin|avastin
5395689|NCT00081861|Bevacizumab|bevacizumab
5395690|NCT00081861|Rituximab|rituximab
5395691|NCT00081861|Rituxan|rituxan
5395692|NCT00003950|stage IV colon cancer|stage iv colon cancer
5395693|NCT00003950|stage IV rectal cancer|stage iv rectal cancer
5395694|NCT00003950|recurrent colon cancer|recurrent colon cancer
5395695|NCT00003950|recurrent rectal cancer|recurrent rectal cancer
5395696|NCT00003950|adenocarcinoma of the colon|adenocarcinoma of the colon
5395697|NCT00003950|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5395698|NCT00003914|stage IV renal cell cancer|stage iv renal cell cancer
5395699|NCT00003914|recurrent renal cell cancer|recurrent renal cell cancer
5395700|NCT00003887|stage IV breast cancer|stage iv breast cancer
5395701|NCT00003887|stage IIIA breast cancer|stage iiia breast cancer
5395702|NCT00003887|stage IIIB breast cancer|stage iiib breast cancer
5395703|NCT00003887|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5395704|NCT00003887|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5395705|NCT00003887|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5395706|NCT00003887|refractory multiple myeloma|refractory multiple myeloma
5395707|NCT00003887|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
5395708|NCT00003887|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
5395709|NCT00003887|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5395710|NCT00003887|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5395711|NCT00003887|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5395712|NCT00003887|disseminated neuroblastoma|disseminated neuroblastoma
5395713|NCT00003887|recurrent neuroblastoma|recurrent neuroblastoma
5395714|NCT00003887|recurrent Wilms tumor and other childhood kidney tumors|recurrent wilms tumor and other childhood kidney tumors
5395715|NCT00003887|stage I multiple myeloma|stage i multiple myeloma
5395716|NCT00003887|stage II multiple myeloma|stage ii multiple myeloma
5395717|NCT00003887|stage III multiple myeloma|stage iii multiple myeloma
5395718|NCT00003887|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
5395719|NCT00003887|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5395720|NCT00003887|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5395721|NCT00003887|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5395722|NCT00003887|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5395723|NCT00003887|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5395724|NCT00003887|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5395725|NCT00003887|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5395726|NCT00003887|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
5395727|NCT00003887|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
5395728|NCT00003887|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5395729|NCT00003887|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5395730|NCT00003887|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5395731|NCT00003887|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
5395732|NCT00003887|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
5395733|NCT00003887|childhood acute promyelocytic leukemia (M3)|childhood acute promyelocytic leukemia (m3)
5395734|NCT00003887|testicular embryonal carcinoma|testicular embryonal carcinoma
5395735|NCT00003887|testicular choriocarcinoma|testicular choriocarcinoma
5395736|NCT00003887|testicular teratoma|testicular teratoma
5395737|NCT00003887|testicular yolk sac tumor|testicular yolk sac tumor
5395738|NCT00003887|testicular embryonal carcinoma and teratoma|testicular embryonal carcinoma and teratoma
5395739|NCT00003887|testicular embryonal carcinoma and teratoma with seminoma|testicular embryonal carcinoma and teratoma with seminoma
5395740|NCT00003887|testicular embryonal carcinoma and yolk sac tumor|testicular embryonal carcinoma and yolk sac tumor
5395741|NCT00003887|testicular embryonal carcinoma and yolk sac tumor with seminoma|testicular embryonal carcinoma and yolk sac tumor with seminoma
5395742|NCT00003887|testicular embryonal carcinoma and seminoma|testicular embryonal carcinoma and seminoma
5395743|NCT00003887|testicular yolk sac tumor and teratoma|testicular yolk sac tumor and teratoma
5395744|NCT00003887|testicular yolk sac tumor and teratoma with seminoma|testicular yolk sac tumor and teratoma with seminoma
5395745|NCT00003887|testicular choriocarcinoma and yolk sac tumor|testicular choriocarcinoma and yolk sac tumor
5395746|NCT00003887|testicular choriocarcinoma and embryonal carcinoma|testicular choriocarcinoma and embryonal carcinoma
5395747|NCT00003887|testicular choriocarcinoma and teratoma|testicular choriocarcinoma and teratoma
5395748|NCT00003887|testicular choriocarcinoma and seminoma|testicular choriocarcinoma and seminoma
5395749|NCT00003887|refractory hairy cell leukemia|refractory hairy cell leukemia
5395750|NCT00003887|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
5395751|NCT00003887|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
5395752|NCT00003887|ovarian yolk sac tumor|ovarian yolk sac tumor
5395753|NCT00003887|ovarian embryonal carcinoma|ovarian embryonal carcinoma
5395754|NCT00003887|ovarian polyembryoma|ovarian polyembryoma
5395755|NCT00003887|ovarian choriocarcinoma|ovarian choriocarcinoma
5395756|NCT00003887|ovarian immature teratoma|ovarian immature teratoma
5395757|NCT00003887|ovarian mature teratoma|ovarian mature teratoma
5395758|NCT00003887|ovarian monodermal and highly specialized teratoma|ovarian monodermal and highly specialized teratoma
5395759|NCT00003887|ovarian mixed germ cell tumor|ovarian mixed germ cell tumor
5395760|NCT00003887|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5395761|NCT00003887|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5395762|NCT00003887|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5395763|NCT00003887|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5395764|NCT00003887|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5395765|NCT00003887|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5395766|NCT00003887|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5395767|NCT00003887|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5395768|NCT00003887|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5395769|NCT00003887|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5395770|NCT00003887|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5395771|NCT00003887|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5395772|NCT00003887|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5395773|NCT00003887|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5395774|NCT00003887|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5395775|NCT00003887|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5395776|NCT00003887|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5395777|NCT00003887|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5395778|NCT00003887|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5395779|NCT00003887|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5395780|NCT00003887|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5395781|NCT00003887|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5395782|NCT00003887|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5395783|NCT00003887|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5395784|NCT00003887|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5395785|NCT00003887|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5395786|NCT00003887|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5395787|NCT00003887|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
5395788|NCT00003887|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5395789|NCT00003887|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5395790|NCT00003887|poor prognosis metastatic gestational trophoblastic tumor|poor prognosis metastatic gestational trophoblastic tumor
5395791|NCT00003887|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5395792|NCT00003887|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5395793|NCT00003887|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
5395794|NCT00003887|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
5395795|NCT00003887|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5395796|NCT00003887|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5395797|NCT00003887|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5395798|NCT00003887|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
5395799|NCT00003887|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5395800|NCT00003887|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
5395801|NCT00003887|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
5395802|NCT00003887|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5395803|NCT00003887|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
5395804|NCT00003887|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
5395805|NCT00003887|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5395806|NCT00003887|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5395807|NCT00003887|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5395808|NCT00003887|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
5395809|NCT00003887|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5395810|NCT00003887|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
5395811|NCT00003887|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
5396143|NCT00005842|stage III gastric cancer|stage iii gastric cancer
5395812|NCT00003887|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5395813|NCT00003887|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5395814|NCT00003887|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5395815|NCT00003887|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5395816|NCT00003887|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5395817|NCT00003887|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5395818|NCT00003887|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5395819|NCT00003887|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5395820|NCT00003887|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5395821|NCT00003887|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
5395822|NCT00003819|stage I prostate cancer|stage i prostate cancer
5395823|NCT00003819|stage IIB prostate cancer|stage iib prostate cancer
5395824|NCT00003819|stage IIA prostate cancer|stage iia prostate cancer
5395825|NCT00003819|stage III prostate cancer|stage iii prostate cancer
5395826|NCT00003819|recurrent prostate cancer|recurrent prostate cancer
5395827|NCT00003783|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
5395828|NCT00003783|L1 childhood acute lymphoblastic leukemia|l1 childhood acute lymphoblastic leukemia
5395829|NCT00003783|L2 childhood acute lymphoblastic leukemia|l2 childhood acute lymphoblastic leukemia
5395830|NCT00003783|B-cell childhood acute lymphoblastic leukemia|b-cell childhood acute lymphoblastic leukemia
5395831|NCT00003765|childhood craniopharyngioma|childhood craniopharyngioma
5395832|NCT00003765|childhood central nervous system germ cell tumor|childhood central nervous system germ cell tumor
5395833|NCT00003765|childhood oligodendroglioma|childhood oligodendroglioma
5395834|NCT00003765|childhood choroid plexus tumor|childhood choroid plexus tumor
5395835|NCT00003765|recurrent childhood brain stem glioma|recurrent childhood brain stem glioma
5395836|NCT00003765|recurrent childhood supratentorial primitive neuroectodermal tumor|recurrent childhood supratentorial primitive neuroectodermal tumor
5395837|NCT00003765|recurrent childhood visual pathway glioma|recurrent childhood visual pathway glioma
5395838|NCT00003765|recurrent childhood cerebellar astrocytoma|recurrent childhood cerebellar astrocytoma
5395839|NCT00003765|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
5395840|NCT00003765|recurrent childhood medulloblastoma|recurrent childhood medulloblastoma
5395841|NCT00003765|recurrent childhood ependymoma|recurrent childhood ependymoma
5395842|NCT00003619|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5395843|NCT00003619|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5395844|NCT00003619|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5395845|NCT00003619|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5395846|NCT00003619|polycythemia vera|polycythemia vera
5395847|NCT00003619|primary myelofibrosis|primary myelofibrosis
5395848|NCT00003619|refractory anemia|refractory anemia
5395849|NCT00003619|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
5395850|NCT00003619|refractory anemia with excess blasts|refractory anemia with excess blasts
5395851|NCT00003619|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5395852|NCT00003619|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5395853|NCT00003619|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5395854|NCT00003619|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5395855|NCT00003619|thrombocytopenia|thrombocytopenia
5395856|NCT00003544|stage IV colon cancer|stage iv colon cancer
5395857|NCT00003544|stage IV rectal cancer|stage iv rectal cancer
5395858|NCT00003544|recurrent colon cancer|recurrent colon cancer
5395859|NCT00003544|recurrent rectal cancer|recurrent rectal cancer
5395860|NCT00003434|stage I pancreatic cancer|stage i pancreatic cancer
5395861|NCT00003434|stage II pancreatic cancer|stage ii pancreatic cancer
5395862|NCT00003434|stage III pancreatic cancer|stage iii pancreatic cancer
5395863|NCT00003434|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
5395864|NCT00003427|stage IV colon cancer|stage iv colon cancer
5395865|NCT00003427|stage IV gastric cancer|stage iv gastric cancer
5395866|NCT00003427|recurrent gastric cancer|recurrent gastric cancer
5395867|NCT00003427|recurrent pancreatic cancer|recurrent pancreatic cancer
5395868|NCT00003427|stage IV rectal cancer|stage iv rectal cancer
5395869|NCT00003427|recurrent colon cancer|recurrent colon cancer
5395870|NCT00003427|recurrent rectal cancer|recurrent rectal cancer
5395871|NCT00003427|stage IV anal cancer|stage iv anal cancer
5395872|NCT00003427|recurrent anal cancer|recurrent anal cancer
5395873|NCT00003427|stage IV esophageal cancer|stage iv esophageal cancer
5395874|NCT00003427|recurrent esophageal cancer|recurrent esophageal cancer
5395875|NCT00003427|metastatic gastrointestinal carcinoid tumor|metastatic gastrointestinal carcinoid tumor
5395876|NCT00003427|recurrent gastrointestinal carcinoid tumor|recurrent gastrointestinal carcinoid tumor
5395877|NCT00003427|advanced adult primary liver cancer|advanced adult primary liver cancer
5395878|NCT00003427|recurrent adult primary liver cancer|recurrent adult primary liver cancer
5395879|NCT00003427|unresectable gallbladder cancer|unresectable gallbladder cancer
5395880|NCT00003427|recurrent gallbladder cancer|recurrent gallbladder cancer
5395881|NCT00003427|unresectable extrahepatic bile duct cancer|unresectable extrahepatic bile duct cancer
5395882|NCT00003427|recurrent extrahepatic bile duct cancer|recurrent extrahepatic bile duct cancer
5396144|NCT00005842|stage IV gastric cancer|stage iv gastric cancer
5395883|NCT00003427|recurrent small intestine cancer|recurrent small intestine cancer
5395884|NCT00003427|stage IV pancreatic cancer|stage iv pancreatic cancer
5395885|NCT00003407|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5395886|NCT00003407|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5395887|NCT00003407|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
5395888|NCT00003407|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
5395889|NCT00003407|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5395890|NCT00003407|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5395891|NCT00003407|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5395892|NCT00003407|drug/agent toxicity by tissue/organ|drug/agent toxicity by tissue/organ
5395893|NCT00003407|neutropenia|neutropenia
5395894|NCT00003398|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5395895|NCT00003398|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5395896|NCT00003398|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5395897|NCT00003398|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5395898|NCT00003398|Burkitt lymphoma|burkitt lymphoma
5395899|NCT00003398|refractory multiple myeloma|refractory multiple myeloma
5395900|NCT00003398|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
5395901|NCT00003398|stage I multiple myeloma|stage i multiple myeloma
5395902|NCT00003398|stage II multiple myeloma|stage ii multiple myeloma
5395903|NCT00003398|stage III multiple myeloma|stage iii multiple myeloma
5395904|NCT00003398|stage I childhood lymphoblastic lymphoma|stage i childhood lymphoblastic lymphoma
5395905|NCT00003398|stage II childhood lymphoblastic lymphoma|stage ii childhood lymphoblastic lymphoma
5395906|NCT00003398|stage III childhood lymphoblastic lymphoma|stage iii childhood lymphoblastic lymphoma
5395907|NCT00003398|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
5395908|NCT00003398|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
5395909|NCT00003398|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
5395910|NCT00003398|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
5395911|NCT00003398|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5395912|NCT00003398|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5395913|NCT00003398|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5395914|NCT00003398|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5395915|NCT00003398|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5395916|NCT00003398|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5395917|NCT00003398|childhood diffuse large cell lymphoma|childhood diffuse large cell lymphoma
5395918|NCT00003398|childhood immunoblastic large cell lymphoma|childhood immunoblastic large cell lymphoma
5395919|NCT00003398|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5395920|NCT00003398|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5395921|NCT00003398|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5395922|NCT00003398|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
5395923|NCT00003398|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5395924|NCT00003398|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5395925|NCT00003398|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
5395926|NCT00003398|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
5395927|NCT00003398|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
5395928|NCT00003398|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
5395929|NCT00003398|adult acute promyelocytic leukemia (M3)|adult acute promyelocytic leukemia (m3)
5395930|NCT00003398|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
5395931|NCT00003398|adult acute eosinophilic leukemia|adult acute eosinophilic leukemia
5395932|NCT00003398|adult acute basophilic leukemia|adult acute basophilic leukemia
5395933|NCT00003398|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
5395934|NCT00003398|childhood acute myeloblastic leukemia with maturation (M2)|childhood acute myeloblastic leukemia with maturation (m2)
5395935|NCT00003398|childhood acute promyelocytic leukemia (M3)|childhood acute promyelocytic leukemia (m3)
5395936|NCT00003398|childhood acute myelomonocytic leukemia (M4)|childhood acute myelomonocytic leukemia (m4)
5395937|NCT00003398|childhood acute eosinophilic leukemia|childhood acute eosinophilic leukemia
5395938|NCT00003398|childhood acute basophilic leukemia|childhood acute basophilic leukemia
5395939|NCT00003398|childhood acute megakaryocytic leukemia (M7)|childhood acute megakaryocytic leukemia (m7)
5395940|NCT00003398|stage III childhood Hodgkin lymphoma|stage iii childhood hodgkin lymphoma
5395941|NCT00003398|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
5395942|NCT00003398|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
5395943|NCT00003398|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
5395944|NCT00003398|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
5395945|NCT00003398|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
5395946|NCT00003398|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
5395947|NCT00003398|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
5395948|NCT00003398|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
5395949|NCT00003398|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
5395950|NCT00003398|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
5395951|NCT00003398|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
5395952|NCT00003398|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5395953|NCT00003398|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5395954|NCT00003398|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5395955|NCT00003398|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5395956|NCT00003398|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5395957|NCT00003398|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5395958|NCT00003398|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5395959|NCT00003398|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5395960|NCT00003398|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5395961|NCT00003398|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5395962|NCT00003398|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5395963|NCT00003398|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5395964|NCT00003398|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5395965|NCT00003398|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5395966|NCT00003398|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5395967|NCT00003398|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5395968|NCT00003398|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5395969|NCT00003398|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5395970|NCT00003398|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5395971|NCT00003398|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5395972|NCT00003398|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5395973|NCT00003398|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5395974|NCT00003398|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5395975|NCT00003398|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5395976|NCT00003398|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5395977|NCT00003398|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5395978|NCT00003398|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5395979|NCT00003398|anemia|anemia
5395980|NCT00003398|graft versus host disease|graft versus host disease
5395981|NCT00003398|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
5395982|NCT00003398|childhood acute minimally differentiated myeloid leukemia (M0)|childhood acute minimally differentiated myeloid leukemia (m0)
5395983|NCT00003398|stage I childhood small noncleaved cell lymphoma|stage i childhood small noncleaved cell lymphoma
5395984|NCT00003398|stage I childhood large cell lymphoma|stage i childhood large cell lymphoma
5395985|NCT00003398|stage II childhood small noncleaved cell lymphoma|stage ii childhood small noncleaved cell lymphoma
5395986|NCT00003398|stage II childhood large cell lymphoma|stage ii childhood large cell lymphoma
5395987|NCT00003398|stage III childhood small noncleaved cell lymphoma|stage iii childhood small noncleaved cell lymphoma
5395988|NCT00003398|stage III childhood large cell lymphoma|stage iii childhood large cell lymphoma
5395989|NCT00003398|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
5395990|NCT00003398|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
5395991|NCT00003398|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
5395992|NCT00003398|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
5395993|NCT00003398|stage I mantle cell lymphoma|stage i mantle cell lymphoma
5395994|NCT00003398|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
5395995|NCT00003398|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
5395996|NCT00003398|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
5395997|NCT00003398|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
5395998|NCT00003398|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
5395999|NCT00003398|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
5396000|NCT00003398|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
5396001|NCT00003398|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
5396002|NCT00003398|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
5396003|NCT00003398|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
5396004|NCT00003398|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5396005|NCT00003398|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5396006|NCT00003398|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5396007|NCT00003398|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
5425851|NCT00051285|CHF|chf
5396008|NCT00003398|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5396009|NCT00003398|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
5396010|NCT00003398|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
5396011|NCT00003398|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5396012|NCT00003398|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
5396013|NCT00003398|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
5396014|NCT00003398|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5396015|NCT00003398|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5396016|NCT00003398|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5396017|NCT00003398|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
5396018|NCT00003398|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
5396019|NCT00003398|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5396020|NCT00003398|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5396021|NCT00003398|stage I marginal zone lymphoma|stage i marginal zone lymphoma
5396022|NCT00003398|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
5396023|NCT00003398|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5396024|NCT00003398|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5396025|NCT00003398|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5396026|NCT00003398|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5396027|NCT00003398|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
5396028|NCT00003398|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
5396029|NCT00003398|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5396030|NCT00003398|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5396031|NCT00003398|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5396032|NCT00003398|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
5396033|NCT00003270|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5396034|NCT00003270|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5396035|NCT00003270|Burkitt lymphoma|burkitt lymphoma
5396036|NCT00003270|refractory multiple myeloma|refractory multiple myeloma
5396037|NCT00003270|stage I multiple myeloma|stage i multiple myeloma
5396038|NCT00003270|stage II multiple myeloma|stage ii multiple myeloma
5396039|NCT00003270|stage III multiple myeloma|stage iii multiple myeloma
5396040|NCT00003270|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
5396041|NCT00003270|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5396042|NCT00003270|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5396043|NCT00003270|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5396044|NCT00003270|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5396045|NCT00003270|childhood diffuse large cell lymphoma|childhood diffuse large cell lymphoma
5396046|NCT00003270|childhood immunoblastic large cell lymphoma|childhood immunoblastic large cell lymphoma
5396047|NCT00003270|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5396048|NCT00003270|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5396049|NCT00003270|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5396050|NCT00003270|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
5396051|NCT00003270|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5396052|NCT00003270|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5396053|NCT00003270|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
5396054|NCT00003270|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
5396055|NCT00003270|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
5396056|NCT00003270|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5396057|NCT00003270|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5396058|NCT00003270|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5396059|NCT00003270|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5396060|NCT00003270|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5396061|NCT00003270|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5396062|NCT00003270|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5396063|NCT00003270|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5396064|NCT00003270|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5396065|NCT00003270|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5396066|NCT00003270|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5396067|NCT00003270|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5396068|NCT00003270|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5396069|NCT00003270|graft versus host disease|graft versus host disease
5396070|NCT00003270|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
5396145|NCT00005842|recurrent gastric cancer|recurrent gastric cancer
5396071|NCT00003270|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
5396072|NCT00003270|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5396073|NCT00003270|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5396074|NCT00003270|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5396075|NCT00003270|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5396076|NCT00003270|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5396077|NCT00003270|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5396078|NCT00003270|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
5396079|NCT00003144|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5396377|NCT00002466|metastatic osteosarcoma|metastatic osteosarcoma
5396080|NCT00003144|drug/agent toxicity by tissue/organ|drug/agent toxicity by tissue/organ
5396081|NCT00003094|cervical cancer|cervical cancer
5396082|NCT00003081|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
5396083|NCT00003081|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
5396084|NCT00003081|adult rhabdomyosarcoma|adult rhabdomyosarcoma
5396085|NCT00003081|recurrent Ewing sarcoma/peripheral primitive neuroectodermal tumor|recurrent ewing sarcoma/peripheral primitive neuroectodermal tumor
5396086|NCT00002964|stage 0 oropharyngeal cancer|stage 0 oropharyngeal cancer
5396087|NCT00002964|stage 0 laryngeal cancer|stage 0 laryngeal cancer
5396088|NCT00002964|stage 0 hypopharyngeal cancer|stage 0 hypopharyngeal cancer
5396089|NCT00002964|stage 0 lip and oral cavity cancer|stage 0 lip and oral cavity cancer
5396090|NCT00002964|stage I lip and oral cavity cancer|stage i lip and oral cavity cancer
5396091|NCT00002964|stage I hypopharyngeal cancer|stage i hypopharyngeal cancer
5396092|NCT00002964|stage I laryngeal cancer|stage i laryngeal cancer
5396093|NCT00002964|stage I oropharyngeal cancer|stage i oropharyngeal cancer
5396094|NCT00002866|stage IV breast cancer|stage iv breast cancer
5396095|NCT00002866|recurrent breast cancer|recurrent breast cancer
5396096|NCT00002866|neutropenia|neutropenia
5396097|NCT00006475|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5396098|NCT00006475|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5396099|NCT00006475|chronic myelogenous leukemia, BCR-ABL1 positive|chronic myelogenous leukemia, bcr-abl1 positive
5396100|NCT00006475|Philadelphia chromosome negative chronic myelogenous leukemia|philadelphia chromosome negative chronic myelogenous leukemia
5396101|NCT00006463|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
5396102|NCT00006357|adult angiosarcoma|adult angiosarcoma
5396103|NCT00006357|adult fibrosarcoma|adult fibrosarcoma
5396104|NCT00006357|adult leiomyosarcoma|adult leiomyosarcoma
5396105|NCT00006357|adult liposarcoma|adult liposarcoma
5396106|NCT00006357|adult neurofibrosarcoma|adult neurofibrosarcoma
5396107|NCT00006357|adult synovial sarcoma|adult synovial sarcoma
5396108|NCT00006357|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
5396109|NCT00006357|small intestine leiomyosarcoma|small intestine leiomyosarcoma
5396110|NCT00006357|adult alveolar soft-part sarcoma|adult alveolar soft-part sarcoma
5396111|NCT00006357|adult epithelioid sarcoma|adult epithelioid sarcoma
5396112|NCT00006357|adult malignant fibrous histiocytoma|adult malignant fibrous histiocytoma
5396113|NCT00006357|adult malignant hemangiopericytoma|adult malignant hemangiopericytoma
5396114|NCT00006357|adult malignant mesenchymoma|adult malignant mesenchymoma
5396115|NCT00006357|adult rhabdomyosarcoma|adult rhabdomyosarcoma
5396116|NCT00006357|ovarian stromal cancer|ovarian stromal cancer
5396117|NCT00006357|recurrent uterine sarcoma|recurrent uterine sarcoma
5396118|NCT00006357|uterine carcinosarcoma|uterine carcinosarcoma
5396119|NCT00006357|uterine leiomyosarcoma|uterine leiomyosarcoma
5396120|NCT00006357|endometrial stromal sarcoma|endometrial stromal sarcoma
5396121|NCT00006357|ovarian sarcoma|ovarian sarcoma
5396122|NCT00006357|gastrointestinal stromal tumor|gastrointestinal stromal tumor
5396123|NCT00006216|stage IA malignant mesothelioma|stage ia malignant mesothelioma
5396124|NCT00006216|stage IB malignant mesothelioma|stage ib malignant mesothelioma
5396125|NCT00006216|stage II malignant mesothelioma|stage ii malignant mesothelioma
5396126|NCT00006216|stage III malignant mesothelioma|stage iii malignant mesothelioma
5396127|NCT00006049|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5396128|NCT00006049|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5396129|NCT00006049|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5396130|NCT00006048|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5396131|NCT00006048|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5396132|NCT00006048|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5396133|NCT00005870|recurrent pancreatic cancer|recurrent pancreatic cancer
5396134|NCT00005870|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
5396135|NCT00005849|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5396136|NCT00005849|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5396137|NCT00005849|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5396138|NCT00005842|stage III colon cancer|stage iii colon cancer
5396139|NCT00005842|stage IV colon cancer|stage iv colon cancer
5396140|NCT00005842|stage IV breast cancer|stage iv breast cancer
5396141|NCT00005842|stage IIIA breast cancer|stage iiia breast cancer
5396142|NCT00005842|recurrent breast cancer|recurrent breast cancer
5425858|NCT00051311|Lymphoma|lymphoma
5396146|NCT00005842|occult non-small cell lung cancer|occult non-small cell lung cancer
5396147|NCT00005842|stage IIIB breast cancer|stage iiib breast cancer
5396148|NCT00005842|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5396149|NCT00005842|stage III pancreatic cancer|stage iii pancreatic cancer
5396150|NCT00005842|recurrent pancreatic cancer|recurrent pancreatic cancer
5396151|NCT00005842|stage III rectal cancer|stage iii rectal cancer
5396152|NCT00005842|stage IV rectal cancer|stage iv rectal cancer
5396153|NCT00005842|recurrent colon cancer|recurrent colon cancer
5396154|NCT00005842|recurrent rectal cancer|recurrent rectal cancer
5396155|NCT00005842|stage IV anal cancer|stage iv anal cancer
5396156|NCT00005842|recurrent anal cancer|recurrent anal cancer
5396157|NCT00005842|stage III esophageal cancer|stage iii esophageal cancer
5396158|NCT00005842|stage IV esophageal cancer|stage iv esophageal cancer
5396159|NCT00005842|stage IIIA anal cancer|stage iiia anal cancer
5396160|NCT00005842|stage IIIB anal cancer|stage iiib anal cancer
5396161|NCT00005842|recurrent esophageal cancer|recurrent esophageal cancer
5396162|NCT00005842|stage III cervical cancer|stage iii cervical cancer
5396163|NCT00005842|recurrent cervical cancer|recurrent cervical cancer
5396164|NCT00005842|stage IVB cervical cancer|stage ivb cervical cancer
5396165|NCT00005842|stage IVA cervical cancer|stage iva cervical cancer
5396166|NCT00005842|inflammatory breast cancer|inflammatory breast cancer
5396167|NCT00005842|stage III renal cell cancer|stage iii renal cell cancer
5396168|NCT00005842|stage IV renal cell cancer|stage iv renal cell cancer
5396169|NCT00005842|recurrent renal cell cancer|recurrent renal cell cancer
5396170|NCT00005842|metastatic parathyroid cancer|metastatic parathyroid cancer
5396171|NCT00005842|recurrent parathyroid cancer|recurrent parathyroid cancer
5396172|NCT00005842|stage III vulvar cancer|stage iii vulvar cancer
5396173|NCT00005842|stage IVB vulvar cancer|stage ivb vulvar cancer
5396174|NCT00005842|recurrent vulvar cancer|recurrent vulvar cancer
5396175|NCT00005842|stage III vaginal cancer|stage iii vaginal cancer
5396176|NCT00005842|stage IVA vaginal cancer|stage iva vaginal cancer
5396177|NCT00005842|stage IVB vaginal cancer|stage ivb vaginal cancer
5396178|NCT00005842|recurrent vaginal cancer|recurrent vaginal cancer
5396179|NCT00005842|metastatic gastrointestinal carcinoid tumor|metastatic gastrointestinal carcinoid tumor
5396180|NCT00005842|recurrent gastrointestinal carcinoid tumor|recurrent gastrointestinal carcinoid tumor
5396181|NCT00005842|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
5396182|NCT00005842|advanced adult primary liver cancer|advanced adult primary liver cancer
5396183|NCT00005842|recurrent adult primary liver cancer|recurrent adult primary liver cancer
5396184|NCT00005842|gastrinoma|gastrinoma
5396185|NCT00005842|stage III endometrial carcinoma|stage iii endometrial carcinoma
5396186|NCT00005842|stage IV endometrial carcinoma|stage iv endometrial carcinoma
5396187|NCT00005842|recurrent endometrial carcinoma|recurrent endometrial carcinoma
5396188|NCT00005842|small intestine adenocarcinoma|small intestine adenocarcinoma
5396189|NCT00005842|unresectable gallbladder cancer|unresectable gallbladder cancer
5396190|NCT00005842|recurrent gallbladder cancer|recurrent gallbladder cancer
5396191|NCT00005842|unresectable extrahepatic bile duct cancer|unresectable extrahepatic bile duct cancer
5396192|NCT00005842|recurrent extrahepatic bile duct cancer|recurrent extrahepatic bile duct cancer
5396193|NCT00005842|recurrent small intestine cancer|recurrent small intestine cancer
5396194|NCT00005842|stage III adrenocortical carcinoma|stage iii adrenocortical carcinoma
5396195|NCT00005842|stage IV adrenocortical carcinoma|stage iv adrenocortical carcinoma
5396196|NCT00005842|recurrent adrenocortical carcinoma|recurrent adrenocortical carcinoma
5396197|NCT00005842|stage III bladder cancer|stage iii bladder cancer
5396198|NCT00005842|recurrent bladder cancer|recurrent bladder cancer
5396199|NCT00005842|stage IV bladder cancer|stage iv bladder cancer
5396200|NCT00005842|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
5396201|NCT00005842|stage III prostate cancer|stage iii prostate cancer
5396202|NCT00005842|stage IV prostate cancer|stage iv prostate cancer
5396203|NCT00005842|recurrent prostate cancer|recurrent prostate cancer
5396204|NCT00005842|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
5396205|NCT00005842|insulinoma|insulinoma
5396206|NCT00005842|recurrent islet cell carcinoma|recurrent islet cell carcinoma
5396207|NCT00005842|stage IV papillary thyroid cancer|stage iv papillary thyroid cancer
5396208|NCT00005842|stage IV follicular thyroid cancer|stage iv follicular thyroid cancer
5396209|NCT00005842|thyroid gland medullary carcinoma|thyroid gland medullary carcinoma
5396210|NCT00005842|anaplastic thyroid cancer|anaplastic thyroid cancer
5396211|NCT00005842|recurrent thyroid cancer|recurrent thyroid cancer
5396212|NCT00005842|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5396213|NCT00005842|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5396214|NCT00005842|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5396215|NCT00005842|stage III salivary gland cancer|stage iii salivary gland cancer
5396216|NCT00005842|stage IV salivary gland cancer|stage iv salivary gland cancer
5396217|NCT00005842|recurrent salivary gland cancer|recurrent salivary gland cancer
5396218|NCT00005842|WDHA syndrome|wdha syndrome
5396219|NCT00005842|somatostatinoma|somatostatinoma
5396220|NCT00005842|pancreatic polypeptide tumor|pancreatic polypeptide tumor
5396221|NCT00005842|glucagonoma|glucagonoma
5396222|NCT00005842|stage III follicular thyroid cancer|stage iii follicular thyroid cancer
5425859|NCT00051311|Leukemia|leukemia
5396223|NCT00005842|stage III papillary thyroid cancer|stage iii papillary thyroid cancer
5396224|NCT00005842|recurrent urethral cancer|recurrent urethral cancer
5396225|NCT00005842|distal urethral cancer|distal urethral cancer
5396226|NCT00005842|proximal urethral cancer|proximal urethral cancer
5396227|NCT00005842|urethral cancer associated with invasive bladder cancer|urethral cancer associated with invasive bladder cancer
5396228|NCT00005842|metastatic transitional cell cancer of the renal pelvis and ureter|metastatic transitional cell cancer of the renal pelvis and ureter
5396229|NCT00005842|pulmonary carcinoid tumor|pulmonary carcinoid tumor
5396230|NCT00005842|stage III mucoepidermoid carcinoma of the oral cavity|stage iii mucoepidermoid carcinoma of the oral cavity
5396231|NCT00005842|stage III adenoid cystic carcinoma of the oral cavity|stage iii adenoid cystic carcinoma of the oral cavity
5396232|NCT00005842|stage IV mucoepidermoid carcinoma of the oral cavity|stage iv mucoepidermoid carcinoma of the oral cavity
5396233|NCT00005842|stage IV adenoid cystic carcinoma of the oral cavity|stage iv adenoid cystic carcinoma of the oral cavity
5396234|NCT00005842|recurrent mucoepidermoid carcinoma of the oral cavity|recurrent mucoepidermoid carcinoma of the oral cavity
5396235|NCT00005842|recurrent adenoid cystic carcinoma of the oral cavity|recurrent adenoid cystic carcinoma of the oral cavity
5396236|NCT00005842|tumors metastatic to brain|tumors metastatic to brain
5396237|NCT00005842|lung metastases|lung metastases
5396238|NCT00005842|liver metastases|liver metastases
5396239|NCT00005842|bone metastases|bone metastases
5396240|NCT00005842|skin metastases|skin metastases
5396241|NCT00005842|leptomeningeal metastases|leptomeningeal metastases
5396242|NCT00005842|malignant pericardial effusion|malignant pericardial effusion
5396243|NCT00005842|malignant pleural effusion|malignant pleural effusion
5396244|NCT00005842|newly diagnosed carcinoma of unknown primary|newly diagnosed carcinoma of unknown primary
5396245|NCT00005842|recurrent transitional cell cancer of the renal pelvis and ureter|recurrent transitional cell cancer of the renal pelvis and ureter
5396246|NCT00005842|carcinoma of the appendix|carcinoma of the appendix
5396247|NCT00005842|primary peritoneal cavity cancer|primary peritoneal cavity cancer
5396248|NCT00005842|recurrent carcinoma of unknown primary|recurrent carcinoma of unknown primary
5396249|NCT00005842|male breast cancer|male breast cancer
5396250|NCT00005842|stage IV pancreatic cancer|stage iv pancreatic cancer
5396251|NCT00005832|stage II pancreatic cancer|stage ii pancreatic cancer
5396252|NCT00005832|stage III pancreatic cancer|stage iii pancreatic cancer
5396253|NCT00005832|duct cell adenocarcinoma of the pancreas|duct cell adenocarcinoma of the pancreas
5396254|NCT00005832|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
5396255|NCT00005832|stage IV pancreatic cancer|stage iv pancreatic cancer
5396256|NCT00002794|intraocular retinoblastoma|intraocular retinoblastoma
5396257|NCT00002553|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5396258|NCT00002553|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5396259|NCT00002553|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5396260|NCT00002553|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
5396261|NCT00002553|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
5396262|NCT00002553|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
5396263|NCT00002553|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5396264|NCT00002553|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5396265|NCT00002553|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5396266|NCT00002553|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5396267|NCT00002553|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5396268|NCT00002553|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5396269|NCT00002553|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5396270|NCT00002553|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
5396271|NCT00002553|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
5396272|NCT00002553|untreated childhood acute myeloid leukemia and other myeloid malignancies|untreated childhood acute myeloid leukemia and other myeloid malignancies
5396273|NCT00002553|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
5396274|NCT00002553|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5396275|NCT00002553|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5396276|NCT00002553|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
5396277|NCT00002553|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
5396278|NCT00002553|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
5396279|NCT00002553|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
5396280|NCT00002553|recurrent adult non-Hodgkin lymphoma|recurrent adult non-hodgkin lymphoma
5396281|NCT00002553|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5396282|NCT00002553|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5396283|NCT00002553|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5396284|NCT00002553|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5396285|NCT00002553|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5396286|NCT00002553|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5396287|NCT00002553|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5396288|NCT00002553|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5396289|NCT00002553|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5396290|NCT00002553|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
5396291|NCT00002553|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
5396292|NCT00002553|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
5396293|NCT00002553|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
5396294|NCT00002553|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5396295|NCT00002553|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5396296|NCT00002553|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5396297|NCT00002553|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5396298|NCT00002553|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5396299|NCT00002553|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5396300|NCT00002485|localized osteosarcoma|localized osteosarcoma
5396301|NCT00002485|metastatic osteosarcoma|metastatic osteosarcoma
5396302|NCT00002485|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5396303|NCT00002485|childhood infratentorial ependymoma|childhood infratentorial ependymoma
5396304|NCT00002485|childhood low-grade cerebral astrocytoma|childhood low-grade cerebral astrocytoma
5396305|NCT00002485|childhood supratentorial ependymoma|childhood supratentorial ependymoma
5396306|NCT00002485|childhood craniopharyngioma|childhood craniopharyngioma
5396307|NCT00002485|localized resectable neuroblastoma|localized resectable neuroblastoma
5396308|NCT00002485|regional neuroblastoma|regional neuroblastoma
5396309|NCT00002485|disseminated neuroblastoma|disseminated neuroblastoma
5396310|NCT00002485|stage 4S neuroblastoma|stage 4s neuroblastoma
5396311|NCT00002485|recurrent neuroblastoma|recurrent neuroblastoma
5396312|NCT00002485|stage I childhood liver cancer|stage i childhood liver cancer
5396313|NCT00002485|stage II childhood liver cancer|stage ii childhood liver cancer
5396314|NCT00002485|stage III childhood liver cancer|stage iii childhood liver cancer
5396315|NCT00002485|stage IV childhood liver cancer|stage iv childhood liver cancer
5396316|NCT00002485|recurrent childhood liver cancer|recurrent childhood liver cancer
5396317|NCT00002485|childhood hepatoblastoma|childhood hepatoblastoma
5396318|NCT00002485|stage I childhood lymphoblastic lymphoma|stage i childhood lymphoblastic lymphoma
5396319|NCT00002485|stage II childhood lymphoblastic lymphoma|stage ii childhood lymphoblastic lymphoma
5396320|NCT00002485|stage III childhood lymphoblastic lymphoma|stage iii childhood lymphoblastic lymphoma
5396321|NCT00002485|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
5396322|NCT00002485|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
5396323|NCT00002485|childhood central nervous system germ cell tumor|childhood central nervous system germ cell tumor
5396324|NCT00002485|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5396325|NCT00002485|recurrent osteosarcoma|recurrent osteosarcoma
5396326|NCT00002485|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
5396327|NCT00002485|childhood germ cell tumor|childhood germ cell tumor
5396328|NCT00002485|untreated childhood acute myeloid leukemia and other myeloid malignancies|untreated childhood acute myeloid leukemia and other myeloid malignancies
5396329|NCT00002485|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
5396330|NCT00002485|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
5396331|NCT00002485|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
5396332|NCT00002485|stage II childhood Hodgkin lymphoma|stage ii childhood hodgkin lymphoma
5396333|NCT00002485|stage I childhood Hodgkin lymphoma|stage i childhood hodgkin lymphoma
5396334|NCT00002485|stage III childhood Hodgkin lymphoma|stage iii childhood hodgkin lymphoma
5396335|NCT00002485|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
5396336|NCT00002485|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
5396337|NCT00002485|nonmetastatic childhood soft tissue sarcoma|nonmetastatic childhood soft tissue sarcoma
5396338|NCT00002485|metastatic childhood soft tissue sarcoma|metastatic childhood soft tissue sarcoma
5396339|NCT00002485|recurrent childhood soft tissue sarcoma|recurrent childhood soft tissue sarcoma
5396340|NCT00002485|extragonadal germ cell tumor|extragonadal germ cell tumor
5396341|NCT00002485|childhood high-grade cerebral astrocytoma|childhood high-grade cerebral astrocytoma
5396342|NCT00002485|childhood oligodendroglioma|childhood oligodendroglioma
5396343|NCT00002485|childhood choroid plexus tumor|childhood choroid plexus tumor
5396344|NCT00002485|childhood meningioma|childhood meningioma
5396345|NCT00002485|localized unresectable neuroblastoma|localized unresectable neuroblastoma
5396346|NCT00002485|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
5396347|NCT00002485|stage I childhood small noncleaved cell lymphoma|stage i childhood small noncleaved cell lymphoma
5396348|NCT00002485|stage I childhood large cell lymphoma|stage i childhood large cell lymphoma
5396349|NCT00002485|stage II childhood small noncleaved cell lymphoma|stage ii childhood small noncleaved cell lymphoma
5396350|NCT00002485|stage II childhood large cell lymphoma|stage ii childhood large cell lymphoma
5396351|NCT00002485|stage III childhood small noncleaved cell lymphoma|stage iii childhood small noncleaved cell lymphoma
5396352|NCT00002485|stage III childhood large cell lymphoma|stage iii childhood large cell lymphoma
5396615|NCT00003041|recurrent breast cancer|recurrent breast cancer
5396353|NCT00002485|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
5396354|NCT00002485|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
5396355|NCT00002485|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
5396356|NCT00002485|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
5396357|NCT00002485|untreated childhood brain stem glioma|untreated childhood brain stem glioma
5396358|NCT00002485|recurrent childhood brain stem glioma|recurrent childhood brain stem glioma
5396359|NCT00002485|untreated childhood supratentorial primitive neuroectodermal tumor|untreated childhood supratentorial primitive neuroectodermal tumor
5396360|NCT00002485|recurrent childhood supratentorial primitive neuroectodermal tumor|recurrent childhood supratentorial primitive neuroectodermal tumor
5396361|NCT00002485|untreated childhood cerebellar astrocytoma|untreated childhood cerebellar astrocytoma
5396362|NCT00002485|recurrent childhood cerebellar astrocytoma|recurrent childhood cerebellar astrocytoma
5396363|NCT00002485|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
5396364|NCT00002485|untreated childhood medulloblastoma|untreated childhood medulloblastoma
5396365|NCT00002485|recurrent childhood medulloblastoma|recurrent childhood medulloblastoma
5396366|NCT00002485|untreated childhood visual pathway and hypothalamic glioma|untreated childhood visual pathway and hypothalamic glioma
5396367|NCT00002485|recurrent childhood visual pathway and hypothalamic glioma|recurrent childhood visual pathway and hypothalamic glioma
5396368|NCT00002485|newly diagnosed childhood ependymoma|newly diagnosed childhood ependymoma
5396369|NCT00002485|recurrent childhood ependymoma|recurrent childhood ependymoma
5396370|NCT00002485|childhood teratoma|childhood teratoma
5396371|NCT00002485|childhood malignant testicular germ cell tumor|childhood malignant testicular germ cell tumor
5396372|NCT00002485|childhood malignant ovarian germ cell tumor|childhood malignant ovarian germ cell tumor
5396373|NCT00002485|childhood extragonadal germ cell tumor|childhood extragonadal germ cell tumor
5396374|NCT00002485|recurrent childhood malignant germ cell tumor|recurrent childhood malignant germ cell tumor
5396375|NCT00002485|childhood atypical teratoid/rhabdoid tumor|childhood atypical teratoid/rhabdoid tumor
5396376|NCT00002466|localized osteosarcoma|localized osteosarcoma
5396378|NCT00002466|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
5396379|NCT00002466|stage III Wilms tumor|stage iii wilms tumor
5396380|NCT00002466|stage IV Wilms tumor|stage iv wilms tumor
5396381|NCT00002466|nonmetastatic childhood soft tissue sarcoma|nonmetastatic childhood soft tissue sarcoma
5396382|NCT00002466|metastatic childhood soft tissue sarcoma|metastatic childhood soft tissue sarcoma
5396383|NCT00002466|childhood desmoplastic small round cell tumor|childhood desmoplastic small round cell tumor
5396384|NCT00002466|localized Ewing sarcoma/peripheral primitive neuroectodermal tumor|localized ewing sarcoma/peripheral primitive neuroectodermal tumor
5396385|NCT00002466|metastatic Ewing sarcoma/peripheral primitive neuroectodermal tumor|metastatic ewing sarcoma/peripheral primitive neuroectodermal tumor
5396386|NCT00002466|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
5396387|NCT00002466|Askin tumor|askin tumor
5396388|NCT00002466|peripheral primitive neuroectodermal tumor|peripheral primitive neuroectodermal tumor
5396389|NCT00002456|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5396390|NCT00002456|childhood non-Hodgkin lymphoma|childhood non-hodgkin lymphoma
5396391|NCT00002456|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
5396392|NCT00002456|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5396393|NCT00002456|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5396394|NCT00002456|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5396395|NCT00002456|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5396396|NCT00002456|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5396397|NCT00002456|recurrent adult non-Hodgkin lymphoma|recurrent adult non-hodgkin lymphoma
5396398|NCT00002456|graft versus host disease|graft versus host disease
5396399|NCT00081822|Foran|foran
5396400|NCT00081822|clofarabine|clofarabine
5396401|NCT00081822|cytosine arabinoside|cytosine arabinoside
5396402|NCT00081822|acute myeloid leukemia|acute myeloid leukemia
5396403|NCT00081809|non-Hodgkin's lymphoma|non-hodgkin's lymphoma
5396404|NCT00081809|Brill-Symmers Disease|brill-symmers disease
5396405|NCT00081809|Follicular Lymphoma|follicular lymphoma
5396406|NCT00081809|Lymphoma, Giant Follicular|lymphoma, giant follicular
5396407|NCT00081809|Lymphoma, Nodular|lymphoma, nodular
5396408|NCT00081809|Follicular Lymphoma, Giant|follicular lymphoma, giant
5396409|NCT00081809|Giant Follicular Lymphoma|giant follicular lymphoma
5396410|NCT00081809|Lymphocytic Lymphoma, Diffuse, Well-Differentiated|lymphocytic lymphoma, diffuse, well-differentiated
5396411|NCT00081809|Lymphocytic Lymphoma, Well-Differentiated|lymphocytic lymphoma, well-differentiated
5396412|NCT00081809|Lymphoma, Lymphocytic, Diffuse, Well-Differentiated|lymphoma, lymphocytic, diffuse, well-differentiated
5396413|NCT00081809|Lymphoma, Lymphocytic, Well-Differentiated|lymphoma, lymphocytic, well-differentiated
5396414|NCT00081809|Lymphoma, Lymphoplasmacytoid, CLL|lymphoma, lymphoplasmacytoid, cll
5396415|NCT00081809|Lymphoma, Small Lymphocytic, Plasmacytoid|lymphoma, small lymphocytic, plasmacytoid
5396416|NCT00081809|Lymphoplasmacytoid Lymphoma, CLL|lymphoplasmacytoid lymphoma, cll
5396417|NCT00081809|Diffuse Well-Differentiated Lymphocytic Lymphoma|diffuse well-differentiated lymphocytic lymphoma
5396418|NCT00081809|Lymphocytic Lymphoma, Diffuse, Well Differentiated|lymphocytic lymphoma, diffuse, well differentiated
5396419|NCT00081809|Lymphocytic Lymphoma, Well Differentiated|lymphocytic lymphoma, well differentiated
5396420|NCT00081809|Lymphoma, Lymphocytic, Diffuse, Well Differentiated|lymphoma, lymphocytic, diffuse, well differentiated
5396421|NCT00081809|Lymphoma, Lymphocytic, Well Differentiated|lymphoma, lymphocytic, well differentiated
5396422|NCT00081809|Lymphoma, Mucosa-Associated Lymphoid Tissue|lymphoma, mucosa-associated lymphoid tissue
5396423|NCT00081809|MALT Lymphoma|malt lymphoma
5396424|NCT00081809|Lymphoma of Mucosa-Associated Lymphoid Tissue|lymphoma of mucosa-associated lymphoid tissue
5396425|NCT00081809|Mucosa-Associated Lymphoid Tissue Lymphoma|mucosa-associated lymphoid tissue lymphoma
5396426|NCT00081809|Monocytoid B-cell lymphoma|monocytoid b-cell lymphoma
5396427|NCT00081809|Waldenstrom's macroglobulinemia|waldenstrom's macroglobulinemia
5396428|NCT00081809|Marginal zone lymphoma|marginal zone lymphoma
5396429|NCT00005092|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5396430|NCT00005092|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5396431|NCT00005092|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5396432|NCT00005092|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5396433|NCT00005092|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
5396434|NCT00005092|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
5396435|NCT00005092|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5396436|NCT00005092|refractory multiple myeloma|refractory multiple myeloma
5396437|NCT00005092|stage III multiple myeloma|stage iii multiple myeloma
5396438|NCT00005092|stage III childhood lymphoblastic lymphoma|stage iii childhood lymphoblastic lymphoma
5396439|NCT00005092|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
5396440|NCT00005092|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
5396441|NCT00005092|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5396442|NCT00005092|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5396443|NCT00005092|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5396444|NCT00005092|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5396445|NCT00005092|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5396446|NCT00005092|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5396447|NCT00005092|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5396448|NCT00005092|childhood diffuse large cell lymphoma|childhood diffuse large cell lymphoma
5396449|NCT00005092|childhood immunoblastic large cell lymphoma|childhood immunoblastic large cell lymphoma
5396450|NCT00005092|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5396451|NCT00005092|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5396452|NCT00005092|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5396453|NCT00005092|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
5396454|NCT00005092|adult acute monoblastic leukemia and acute monocytic leukemia (M5)|adult acute monoblastic leukemia and acute monocytic leukemia (m5)
5396455|NCT00005092|childhood acute monoblastic leukemia and acute monocytic leukemia (M5)|childhood acute monoblastic leukemia and acute monocytic leukemia (m5)
5396456|NCT00005092|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
5396457|NCT00005092|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
5396458|NCT00005092|Philadelphia chromosome positive chronic myelogenous leukemia|philadelphia chromosome positive chronic myelogenous leukemia
5396459|NCT00005092|Philadelphia chromosome negative chronic myelogenous leukemia|philadelphia chromosome negative chronic myelogenous leukemia
5396460|NCT00005092|L1 childhood acute lymphoblastic leukemia|l1 childhood acute lymphoblastic leukemia
5396461|NCT00005092|L2 childhood acute lymphoblastic leukemia|l2 childhood acute lymphoblastic leukemia
5396462|NCT00005092|L3 childhood acute lymphoblastic leukemia|l3 childhood acute lymphoblastic leukemia
5396463|NCT00005092|T-cell childhood acute lymphoblastic leukemia|t-cell childhood acute lymphoblastic leukemia
5396464|NCT00005092|B-cell childhood acute lymphoblastic leukemia|b-cell childhood acute lymphoblastic leukemia
5396465|NCT00005092|non-T, non-B childhood acute lymphoblastic leukemia|non-t, non-b childhood acute lymphoblastic leukemia
5396466|NCT00005092|non-T, non-B, cALLa positive childhood acute lymphoblastic leukemia|non-t, non-b, calla positive childhood acute lymphoblastic leukemia
5396467|NCT00005092|non-T, non-B, cALLa negative childhood acute lymphoblastic leukemia|non-t, non-b, calla negative childhood acute lymphoblastic leukemia
5396468|NCT00005092|non-T, non-B, cALLa positive, pre-B childhood acute lymphoblastic leukemia|non-t, non-b, calla positive, pre-b childhood acute lymphoblastic leukemia
5396469|NCT00005092|L1 adult acute lymphoblastic leukemia|l1 adult acute lymphoblastic leukemia
5396470|NCT00005092|L2 adult acute lymphoblastic leukemia|l2 adult acute lymphoblastic leukemia
5396471|NCT00005092|L3 adult acute lymphoblastic leukemia|l3 adult acute lymphoblastic leukemia
5396472|NCT00005092|T-cell adult acute lymphoblastic leukemia|t-cell adult acute lymphoblastic leukemia
5396473|NCT00005092|B-cell adult acute lymphoblastic leukemia|b-cell adult acute lymphoblastic leukemia
5396474|NCT00005092|non-T, non-B adult acute lymphoblastic leukemia|non-t, non-b adult acute lymphoblastic leukemia
5396475|NCT00005092|non-T, non-B, cALLa positive adult acute lymphoblastic leukemia|non-t, non-b, calla positive adult acute lymphoblastic leukemia
5396476|NCT00005092|non-T, non-B, cALLa positive, pre-B adult acute lymphoblastic leukemia|non-t, non-b, calla positive, pre-b adult acute lymphoblastic leukemia
5396477|NCT00005092|non-T, non-B, cALLa negative adult acute lymphoblastic leukemia|non-t, non-b, calla negative adult acute lymphoblastic leukemia
5396478|NCT00005092|TdT positive adult acute lymphoblastic leukemia|tdt positive adult acute lymphoblastic leukemia
5396479|NCT00005092|TdT negative adult acute lymphoblastic leukemia|tdt negative adult acute lymphoblastic leukemia
5396480|NCT00005092|TdT negative childhood acute lymphoblastic leukemia|tdt negative childhood acute lymphoblastic leukemia
5396481|NCT00005092|TdT positive childhood acute lymphoblastic leukemia|tdt positive childhood acute lymphoblastic leukemia
5396482|NCT00005092|adult acute erythroid leukemia (M6)|adult acute erythroid leukemia (m6)
5396483|NCT00005092|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
5396484|NCT00005092|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
5396485|NCT00005092|adult acute promyelocytic leukemia (M3)|adult acute promyelocytic leukemia (m3)
5396486|NCT00005092|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
5396487|NCT00005092|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
5396488|NCT00005092|adult acute eosinophilic leukemia|adult acute eosinophilic leukemia
5396489|NCT00005092|adult acute basophilic leukemia|adult acute basophilic leukemia
5396490|NCT00005092|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
5396491|NCT00005092|childhood acute myeloblastic leukemia without maturation (M1)|childhood acute myeloblastic leukemia without maturation (m1)
5396492|NCT00005092|childhood acute myeloblastic leukemia with maturation (M2)|childhood acute myeloblastic leukemia with maturation (m2)
5396493|NCT00005092|childhood acute promyelocytic leukemia (M3)|childhood acute promyelocytic leukemia (m3)
5396494|NCT00005092|childhood acute myelomonocytic leukemia (M4)|childhood acute myelomonocytic leukemia (m4)
5396495|NCT00005092|childhood acute monoblastic leukemia (M5a)|childhood acute monoblastic leukemia (m5a)
5396496|NCT00005092|childhood acute monocytic leukemia (M5b)|childhood acute monocytic leukemia (m5b)
5396497|NCT00005092|childhood acute erythroleukemia (M6)|childhood acute erythroleukemia (m6)
5396498|NCT00005092|childhood acute eosinophilic leukemia|childhood acute eosinophilic leukemia
5396499|NCT00005092|childhood acute basophilic leukemia|childhood acute basophilic leukemia
5396500|NCT00005092|childhood acute megakaryocytic leukemia (M7)|childhood acute megakaryocytic leukemia (m7)
5396501|NCT00005092|untreated hairy cell leukemia|untreated hairy cell leukemia
5396502|NCT00005092|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5396503|NCT00005092|acute undifferentiated leukemia|acute undifferentiated leukemia
5396504|NCT00005092|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5396505|NCT00005092|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5396506|NCT00005092|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5396507|NCT00005092|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5396508|NCT00005092|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5396509|NCT00005092|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5396510|NCT00005092|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5396511|NCT00005092|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5396512|NCT00005092|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5396513|NCT00005092|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5396514|NCT00005092|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5396515|NCT00005092|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5396516|NCT00005092|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5396517|NCT00005092|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5396518|NCT00005092|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5396519|NCT00005092|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5396520|NCT00005092|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5396521|NCT00005092|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5396522|NCT00005092|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5396523|NCT00005092|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5396524|NCT00005092|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5396525|NCT00005092|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5396526|NCT00005092|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
5396527|NCT00005092|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
5396528|NCT00005092|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
5396529|NCT00005092|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5396530|NCT00005092|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5396531|NCT00005092|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
5396532|NCT00005092|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5396533|NCT00005092|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5396534|NCT00005092|prolymphocytic leukemia|prolymphocytic leukemia
5396535|NCT00005092|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
5396536|NCT00005092|childhood acute minimally differentiated myeloid leukemia (M0)|childhood acute minimally differentiated myeloid leukemia (m0)
5396537|NCT00005092|intraocular lymphoma|intraocular lymphoma
5396538|NCT00005092|stage III childhood large cell lymphoma|stage iii childhood large cell lymphoma
5396539|NCT00005092|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
5396540|NCT00005092|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
5396541|NCT00005092|childhood large cell lymphoma|childhood large cell lymphoma
5425966|NCT00050882|GM-611|gm-611
5396542|NCT00005092|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5396543|NCT00005092|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5396544|NCT00005092|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5396545|NCT00005092|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
5396546|NCT00005092|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5396547|NCT00005092|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
5396548|NCT00005092|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
5396549|NCT00005092|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5396550|NCT00005092|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
5396551|NCT00005082|adult medulloblastoma|adult medulloblastoma
5396552|NCT00005082|adult glioblastoma|adult glioblastoma
5396553|NCT00005082|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5396554|NCT00005082|adult myxopapillary ependymoma|adult myxopapillary ependymoma
5396555|NCT00005082|adult anaplastic ependymoma|adult anaplastic ependymoma
5396556|NCT00005082|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
5396557|NCT00005082|adult mixed glioma|adult mixed glioma
5396558|NCT00005082|adult pilocytic astrocytoma|adult pilocytic astrocytoma
5396559|NCT00005082|adult subependymoma|adult subependymoma
5396560|NCT00005082|adult ependymoblastoma|adult ependymoblastoma
5396561|NCT00005082|adult oligodendroglioma|adult oligodendroglioma
5396562|NCT00005082|adult giant cell glioblastoma|adult giant cell glioblastoma
5396563|NCT00005082|adult gliosarcoma|adult gliosarcoma
5396564|NCT00005023|stage IV breast cancer|stage iv breast cancer
5396565|NCT00005023|stage IIIA breast cancer|stage iiia breast cancer
5396566|NCT00005023|stage III non-small cell lung cancer|stage iii non-small cell lung cancer
5396567|NCT00005023|stage IIIB breast cancer|stage iiib breast cancer
5396568|NCT00005023|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5396569|NCT00005023|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5396570|NCT00005023|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5396571|NCT00005023|adenocarcinoma of the lung|adenocarcinoma of the lung
5396572|NCT00004870|stage IV colon cancer|stage iv colon cancer
5396573|NCT00004870|stage IV rectal cancer|stage iv rectal cancer
5396574|NCT00004870|recurrent colon cancer|recurrent colon cancer
5396575|NCT00004870|recurrent rectal cancer|recurrent rectal cancer
5396576|NCT00004870|adenocarcinoma of the colon|adenocarcinoma of the colon
5396577|NCT00004870|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5396578|NCT00004254|localized malignant mesothelioma|localized malignant mesothelioma
5396579|NCT00004254|advanced malignant mesothelioma|advanced malignant mesothelioma
5396580|NCT00004254|recurrent malignant mesothelioma|recurrent malignant mesothelioma
5396581|NCT00004013|stage IV breast cancer|stage iv breast cancer
5396582|NCT00004013|recurrent breast cancer|recurrent breast cancer
5396583|NCT00003899|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5396584|NCT00003880|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5396585|NCT00003880|ovarian mixed epithelial carcinoma|ovarian mixed epithelial carcinoma
5396586|NCT00003880|ovarian serous cystadenocarcinoma|ovarian serous cystadenocarcinoma
5396587|NCT00003880|ovarian mucinous cystadenocarcinoma|ovarian mucinous cystadenocarcinoma
5396588|NCT00003880|ovarian endometrioid adenocarcinoma|ovarian endometrioid adenocarcinoma
5396589|NCT00003880|ovarian clear cell cystadenocarcinoma|ovarian clear cell cystadenocarcinoma
5396590|NCT00003880|primary peritoneal cavity cancer|primary peritoneal cavity cancer
5396591|NCT00003790|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5396592|NCT00003790|untreated childhood acute myeloid leukemia and other myeloid malignancies|untreated childhood acute myeloid leukemia and other myeloid malignancies
5396593|NCT00003790|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5396594|NCT00003790|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5396595|NCT00003790|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5396596|NCT00003735|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5396597|NCT00003735|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5396598|NCT00003735|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5396599|NCT00003715|stage III melanoma|stage iii melanoma
5396600|NCT00003701|stage III bladder cancer|stage iii bladder cancer
5396601|NCT00003701|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
5396602|NCT00003701|urethral cancer associated with invasive bladder cancer|urethral cancer associated with invasive bladder cancer
5396603|NCT00003621|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5396604|NCT00003445|stage III cervical cancer|stage iii cervical cancer
5396605|NCT00003445|stage IIB cervical cancer|stage iib cervical cancer
5396606|NCT00003445|stage IVA cervical cancer|stage iva cervical cancer
5396607|NCT00003445|cervical squamous cell carcinoma|cervical squamous cell carcinoma
5396608|NCT00003386|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5396609|NCT00003386|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5396610|NCT00003148|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5396611|NCT00003146|stage I multiple myeloma|stage i multiple myeloma
5396612|NCT00003146|stage II multiple myeloma|stage ii multiple myeloma
5396613|NCT00003146|stage III multiple myeloma|stage iii multiple myeloma
5396614|NCT00003076|esophageal cancer|esophageal cancer
5426283|NCT00001929|Levodopa|levodopa
5396616|NCT00081848|Colon Cancer|colon cancer
5396617|NCT00081848|Gastrointestinal Cancer|gastrointestinal cancer
5396618|NCT00081848|Cytokines|cytokines
5396619|NCT00081848|Immunotherapy|immunotherapy
5396620|NCT00081848|Cancer|cancer
5396621|NCT00081848|Solid Tumor|solid tumor
5396622|NCT00081848|Liver Metastasis|liver metastasis
5396623|NCT00081835|Smallpox|smallpox
5396624|NCT00081835|Cowpox|cowpox
5396625|NCT00081835|Corneal Ulcer|corneal ulcer
5396626|NCT00081835|Keratitis|keratitis
5396627|NCT00081835|Immune Response, Vaccine|immune response, vaccine
5396628|NCT00081835|Cornea|cornea
5396629|NCT00081835|Vaccinia|vaccinia
5396630|NCT00081835|Vaccinia Immune Globulin (VIG)|vaccinia immune globulin (vig)
5396631|NCT00081835|Conjunctivitis|conjunctivitis
5396632|NCT00081835|Vaccinia Vaccination|vaccinia vaccination
5396633|NCT00081835|Smallpox Vaccination|smallpox vaccination
5396634|NCT00081796|Metastatic Breast Cancer|metastatic breast cancer
5396635|NCT00081783|T Cells|t cells
5396636|NCT00081783|Immunotherapy|immunotherapy
5396637|NCT00081783|NHL|nhl
5396638|NCT00081783|Xcellerated T Cells|xcellerated t cells
5396639|NCT00081757|Advanced|advanced
5396640|NCT00081757|Refractory|refractory
5396641|NCT00081757|Plasmacytoma|plasmacytoma
5396642|NCT00081757|Myeloma Proteins|myeloma proteins
5396643|NCT00021346|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5396644|NCT00019357|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5396645|NCT00003018|stage II pancreatic cancer|stage ii pancreatic cancer
5396646|NCT00003018|stage III pancreatic cancer|stage iii pancreatic cancer
5396647|NCT00003018|duct cell adenocarcinoma of the pancreas|duct cell adenocarcinoma of the pancreas
5396648|NCT00003017|stage IV cervical cancer|stage iv cervical cancer
5396649|NCT00003017|recurrent cervical cancer|recurrent cervical cancer
5396650|NCT00003017|cervical squamous cell carcinoma|cervical squamous cell carcinoma
5396651|NCT00003017|cervical adenocarcinoma|cervical adenocarcinoma
5396652|NCT00003017|cervical adenosquamous cell carcinoma|cervical adenosquamous cell carcinoma
5396653|NCT00002952|stage IV melanoma|stage iv melanoma
5396654|NCT00002952|recurrent melanoma|recurrent melanoma
5396655|NCT00002889|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5396656|NCT00002889|stage I prostate cancer|stage i prostate cancer
5396657|NCT00002889|stage II prostate cancer|stage ii prostate cancer
5396658|NCT00002889|stage III prostate cancer|stage iii prostate cancer
5396659|NCT00002889|stage IV prostate cancer|stage iv prostate cancer
5396660|NCT00002818|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5396661|NCT00002818|refractory multiple myeloma|refractory multiple myeloma
5396662|NCT00002818|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5396663|NCT00002818|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5396664|NCT00002818|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5396665|NCT00002818|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5396666|NCT00002818|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5396667|NCT00002818|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5396668|NCT00002818|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5396669|NCT00002818|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5396670|NCT00002818|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5396671|NCT00002818|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5396672|NCT00002818|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5396673|NCT00002818|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5396674|NCT00002818|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5396675|NCT00002818|drug/agent toxicity by tissue/organ|drug/agent toxicity by tissue/organ
5396676|NCT00002818|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5396677|NCT00002818|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5396678|NCT00002818|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5396679|NCT00002818|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5396680|NCT00002818|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5396681|NCT00002818|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5396682|NCT00002800|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5396683|NCT00002800|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5396684|NCT00002800|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
5396685|NCT00002800|refractory anemia with excess blasts|refractory anemia with excess blasts
5396686|NCT00002800|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
5396687|NCT00002800|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5396688|NCT00002800|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5396689|NCT00002800|neutropenia|neutropenia
5396690|NCT00002772|stage II breast cancer|stage ii breast cancer
5396691|NCT00002772|stage IIIA breast cancer|stage iiia breast cancer
5396692|NCT00002768|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5396693|NCT00002768|adult acute erythroid leukemia (M6)|adult acute erythroid leukemia (m6)
5426284|NCT00001928|Diagnosis|diagnosis
5396694|NCT00002768|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
5396695|NCT00002768|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
5396696|NCT00002768|adult acute promyelocytic leukemia (M3)|adult acute promyelocytic leukemia (m3)
5396697|NCT00002768|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
5396698|NCT00002768|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
5396699|NCT00002768|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
5396700|NCT00002768|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
5396701|NCT00002768|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
5396702|NCT00002764|adult angiosarcoma|adult angiosarcoma
5396703|NCT00002764|adult fibrosarcoma|adult fibrosarcoma
5396704|NCT00002764|adult leiomyosarcoma|adult leiomyosarcoma
5396705|NCT00002764|adult liposarcoma|adult liposarcoma
5396706|NCT00002764|adult neurofibrosarcoma|adult neurofibrosarcoma
5396707|NCT00002764|adult synovial sarcoma|adult synovial sarcoma
5396708|NCT00002764|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
5396709|NCT00002764|adult malignant fibrous histiocytoma|adult malignant fibrous histiocytoma
5396710|NCT00002764|adult malignant hemangiopericytoma|adult malignant hemangiopericytoma
5396711|NCT00002764|adult malignant mesenchymoma|adult malignant mesenchymoma
5396712|NCT00002764|localized benign pheochromocytoma|localized benign pheochromocytoma
5396713|NCT00002764|regional pheochromocytoma|regional pheochromocytoma
5396714|NCT00002764|lung metastases|lung metastases
5396715|NCT00002764|stage IV uterine sarcoma|stage iv uterine sarcoma
5396716|NCT00002764|recurrent uterine sarcoma|recurrent uterine sarcoma
5396717|NCT00002764|uterine leiomyosarcoma|uterine leiomyosarcoma
5396718|NCT00002764|endometrial stromal sarcoma|endometrial stromal sarcoma
5396719|NCT00002764|ovarian sarcoma|ovarian sarcoma
5396720|NCT00002764|clear cell sarcoma of the kidney|clear cell sarcoma of the kidney
5396721|NCT00002764|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
5396722|NCT00002745|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
5396723|NCT00002745|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5396724|NCT00002745|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5396725|NCT00002745|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5396726|NCT00002722|stage III gastric cancer|stage iii gastric cancer
5396727|NCT00002722|stage IV gastric cancer|stage iv gastric cancer
5396728|NCT00002595|desmoid tumor|desmoid tumor
5396729|NCT00002583|stage I non-small cell lung cancer|stage i non-small cell lung cancer
5396730|NCT00002583|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
5396731|NCT00002534|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5396732|NCT00002534|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5396733|NCT00002534|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5396734|NCT00002534|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5396735|NCT00002534|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5396736|NCT00002534|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5396737|NCT00002534|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
5396738|NCT00002534|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
5396739|NCT00002534|acute undifferentiated leukemia|acute undifferentiated leukemia
5396740|NCT00002519|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5396741|NCT00002519|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5396742|NCT00002501|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5396743|NCT00002501|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5396744|NCT00002501|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5396745|NCT00002501|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5396746|NCT00002492|stage I adult soft tissue sarcoma|stage i adult soft tissue sarcoma
5396747|NCT00002492|stage II adult soft tissue sarcoma|stage ii adult soft tissue sarcoma
5396748|NCT00002492|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
5396749|NCT00002463|childhood infratentorial ependymoma|childhood infratentorial ependymoma
5396750|NCT00002463|childhood low-grade cerebral astrocytoma|childhood low-grade cerebral astrocytoma
5396751|NCT00002463|childhood low-grade cerebellar astrocytoma|childhood low-grade cerebellar astrocytoma
5396752|NCT00002463|childhood supratentorial ependymoma|childhood supratentorial ependymoma
5396753|NCT00002463|childhood high-grade cerebral astrocytoma|childhood high-grade cerebral astrocytoma
5396754|NCT00002463|untreated childhood supratentorial primitive neuroectodermal tumor|untreated childhood supratentorial primitive neuroectodermal tumor
5396755|NCT00002463|untreated childhood cerebellar astrocytoma|untreated childhood cerebellar astrocytoma
5396756|NCT00002463|untreated childhood medulloblastoma|untreated childhood medulloblastoma
5396757|NCT00002463|untreated childhood visual pathway and hypothalamic glioma|untreated childhood visual pathway and hypothalamic glioma
5396758|NCT00002463|newly diagnosed childhood ependymoma|newly diagnosed childhood ependymoma
5396759|NCT00081744|Bacterial Infections|bacterial infections
5396760|NCT00019344|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5396761|NCT00019344|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5396915|NCT00004178|stage IV esophageal cancer|stage iv esophageal cancer
5396762|NCT00019344|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
5396763|NCT00019344|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5396764|NCT00019344|small intestine lymphoma|small intestine lymphoma
5396765|NCT00019344|stage IV prostate cancer|stage iv prostate cancer
5396766|NCT00019344|recurrent prostate cancer|recurrent prostate cancer
5396767|NCT00019344|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5396768|NCT00019344|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5396769|NCT00019344|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5396770|NCT00019344|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5396771|NCT00019344|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5396772|NCT00019344|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5396773|NCT00019344|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5396774|NCT00019344|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5396775|NCT00019344|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5396776|NCT00019344|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5396777|NCT00019344|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5396778|NCT00019344|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5396779|NCT00019344|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5396780|NCT00019344|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5396781|NCT00019344|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5396782|NCT00019344|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5396783|NCT00019344|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5396784|NCT00019344|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5396785|NCT00019344|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5396786|NCT00019344|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
5396787|NCT00019344|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
5396788|NCT00019344|intraocular lymphoma|intraocular lymphoma
5396789|NCT00019344|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5396790|NCT00019344|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5396791|NCT00019344|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
5396792|NCT00019344|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5396793|NCT00019344|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
5396794|NCT00019344|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5396795|NCT00019344|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5396796|NCT00019344|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5396797|NCT00019344|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5396798|NCT00019344|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5396799|NCT00019344|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5396800|NCT00019344|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5396801|NCT00019344|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5396802|NCT00019240|classic Kaposi sarcoma|classic kaposi sarcoma
5396803|NCT00019240|AIDS-related Kaposi sarcoma|aids-related kaposi sarcoma
5396804|NCT00019240|recurrent Kaposi sarcoma|recurrent kaposi sarcoma
5396805|NCT00016900|stage III esophageal cancer|stage iii esophageal cancer
5396806|NCT00016900|stage IV esophageal cancer|stage iv esophageal cancer
5396807|NCT00016900|recurrent esophageal cancer|recurrent esophageal cancer
5396808|NCT00016900|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
5396809|NCT00016900|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
5396810|NCT00010010|stage IV breast cancer|stage iv breast cancer
5396811|NCT00010010|recurrent breast cancer|recurrent breast cancer
5396812|NCT00009828|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5396813|NCT00081614|Metastatic renal cell carcinoma|metastatic renal cell carcinoma
5396814|NCT00081549|Pancreatic Cancer|pancreatic cancer
5396815|NCT00081549|Neoplasms Pancreatic|neoplasms pancreatic
5396816|NCT00081549|Pancreas Cancer|pancreas cancer
5396817|NCT00081549|Pancreas Neoplasms|pancreas neoplasms
5396818|NCT00081549|Pancreatic Tumor|pancreatic tumor
5396819|NCT00081549|Pancreas Tumor|pancreas tumor
5396820|NCT00081549|Unresectable|unresectable
5396821|NCT00081549|Metastatic|metastatic
5396822|NCT00081549|Refractory|refractory
5396823|NCT00081536|Colorectal Neoplasms|colorectal neoplasms
5396824|NCT00081536|Colorectal Cancer|colorectal cancer
5396825|NCT00081536|Colorectal Carcinoma|colorectal carcinoma
5396826|NCT00081536|Colorectal Tumor|colorectal tumor
5396827|NCT00081536|Neoplasms, Colorectal|neoplasms, colorectal
5396828|NCT00081536|Unresectable|unresectable
5396829|NCT00081536|Metastatic|metastatic
5396830|NCT00081536|Refractory|refractory
5396831|NCT00012129|stage IV breast cancer|stage iv breast cancer
5396832|NCT00012129|stage IIIA breast cancer|stage iiia breast cancer
5396833|NCT00012129|recurrent breast cancer|recurrent breast cancer
5396834|NCT00012129|stage IIIB breast cancer|stage iiib breast cancer
5396835|NCT00012129|male breast cancer|male breast cancer
5396836|NCT00009815|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5396837|NCT00005989|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5396838|NCT00005989|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5396839|NCT00005958|stage III bladder cancer|stage iii bladder cancer
5396840|NCT00005958|recurrent bladder cancer|recurrent bladder cancer
5396841|NCT00005958|stage IV bladder cancer|stage iv bladder cancer
5396842|NCT00005958|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
5396843|NCT00005958|metastatic transitional cell cancer of the renal pelvis and ureter|metastatic transitional cell cancer of the renal pelvis and ureter
5396844|NCT00005958|regional transitional cell cancer of the renal pelvis and ureter|regional transitional cell cancer of the renal pelvis and ureter
5396845|NCT00005958|recurrent transitional cell cancer of the renal pelvis and ureter|recurrent transitional cell cancer of the renal pelvis and ureter
5396846|NCT00005938|localized gallbladder cancer|localized gallbladder cancer
5396847|NCT00005938|unresectable gallbladder cancer|unresectable gallbladder cancer
5396848|NCT00005938|recurrent gallbladder cancer|recurrent gallbladder cancer
5396849|NCT00005938|localized extrahepatic bile duct cancer|localized extrahepatic bile duct cancer
5396850|NCT00005938|unresectable extrahepatic bile duct cancer|unresectable extrahepatic bile duct cancer
5396851|NCT00005938|recurrent extrahepatic bile duct cancer|recurrent extrahepatic bile duct cancer
5396852|NCT00005938|liver and intrahepatic biliary tract cancer|liver and intrahepatic biliary tract cancer
5396853|NCT00005938|cholangiocarcinoma of the gallbladder|cholangiocarcinoma of the gallbladder
5396854|NCT00005938|cholangiocarcinoma of the extrahepatic bile duct|cholangiocarcinoma of the extrahepatic bile duct
5396855|NCT00005938|adult primary cholangiocellular carcinoma|adult primary cholangiocellular carcinoma
5396856|NCT00005828|stage IV prostate cancer|stage iv prostate cancer
5396857|NCT00005828|recurrent prostate cancer|recurrent prostate cancer
5396858|NCT00005827|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5396859|NCT00005827|stage II prostate cancer|stage ii prostate cancer
5396860|NCT00005827|stage III prostate cancer|stage iii prostate cancer
5396861|NCT00005827|stage IV prostate cancer|stage iv prostate cancer
5396862|NCT00005827|recurrent prostate cancer|recurrent prostate cancer
5396863|NCT00081640|HIV Seronegativity|hiv seronegativity
5396864|NCT00081640|Vaginal Microbicide|vaginal microbicide
5396865|NCT00081601|prostate cancer|prostate cancer
5396866|NCT00081601|prostate specific antigen|prostate specific antigen
5396867|NCT00081601|PSA|psa
5396868|NCT00081588|TMC114-C215|tmc114-c215
5396869|NCT00081588|Ritonavir|ritonavir
5396870|NCT00081588|HIV infections|hiv infections
5396871|NCT00081588|TMC114-C202|tmc114-c202
5396872|NCT00081588|TMC114-C213|tmc114-c213
5396873|NCT00081575|Bacterial Pneumonia|bacterial pneumonia
5396874|NCT00081380|Bipolar I Disorder|bipolar i disorder
5396875|NCT00081380|Manic Depressive Disorder|manic depressive disorder
5396876|NCT00081380|Manic Depression, Mixed|manic depression, mixed
5396877|NCT00005810|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5396878|NCT00005810|stage IV prostate cancer|stage iv prostate cancer
5396879|NCT00005810|recurrent prostate cancer|recurrent prostate cancer
5396880|NCT00005809|colon cancer|colon cancer
5396881|NCT00005809|rectal cancer|rectal cancer
5396882|NCT00005643|stage IV uterine sarcoma|stage iv uterine sarcoma
5396883|NCT00005643|recurrent uterine sarcoma|recurrent uterine sarcoma
5396884|NCT00005643|uterine carcinosarcoma|uterine carcinosarcoma
5396885|NCT00005643|uterine leiomyosarcoma|uterine leiomyosarcoma
5396886|NCT00005643|endometrial stromal sarcoma|endometrial stromal sarcoma
5396887|NCT00005625|metastatic osteosarcoma|metastatic osteosarcoma
5396888|NCT00005625|recurrent osteosarcoma|recurrent osteosarcoma
5396889|NCT00005608|stage IV breast cancer|stage iv breast cancer
5396890|NCT00005608|recurrent breast cancer|recurrent breast cancer
5396891|NCT00005071|stage I non-small cell lung cancer|stage i non-small cell lung cancer
5396892|NCT00005071|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
5396893|NCT00005071|limited stage small cell lung cancer|limited stage small cell lung cancer
5396894|NCT00004252|stage IV colon cancer|stage iv colon cancer
5396895|NCT00004252|stage IV rectal cancer|stage iv rectal cancer
5396896|NCT00004252|recurrent colon cancer|recurrent colon cancer
5396897|NCT00004252|recurrent rectal cancer|recurrent rectal cancer
5396898|NCT00004252|adenocarcinoma of the colon|adenocarcinoma of the colon
5396899|NCT00004229|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5396900|NCT00004178|stage III colon cancer|stage iii colon cancer
5396901|NCT00004178|stage IV colon cancer|stage iv colon cancer
5396902|NCT00004178|stage III gastric cancer|stage iii gastric cancer
5396903|NCT00004178|stage IV gastric cancer|stage iv gastric cancer
5396904|NCT00004178|recurrent gastric cancer|recurrent gastric cancer
5396905|NCT00004178|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5396906|NCT00004178|stage II pancreatic cancer|stage ii pancreatic cancer
5396907|NCT00004178|stage III pancreatic cancer|stage iii pancreatic cancer
5396908|NCT00004178|recurrent pancreatic cancer|recurrent pancreatic cancer
5396909|NCT00004178|stage III rectal cancer|stage iii rectal cancer
5396910|NCT00004178|stage IV rectal cancer|stage iv rectal cancer
5396911|NCT00004178|recurrent colon cancer|recurrent colon cancer
5396912|NCT00004178|recurrent rectal cancer|recurrent rectal cancer
5396913|NCT00004178|stage II esophageal cancer|stage ii esophageal cancer
5396914|NCT00004178|stage III esophageal cancer|stage iii esophageal cancer
5396916|NCT00004178|recurrent esophageal cancer|recurrent esophageal cancer
5396917|NCT00004178|stage III cervical cancer|stage iii cervical cancer
5396918|NCT00004178|recurrent cervical cancer|recurrent cervical cancer
5396919|NCT00004178|stage IVB cervical cancer|stage ivb cervical cancer
5396920|NCT00004178|stage IVA cervical cancer|stage iva cervical cancer
5396921|NCT00004178|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5396922|NCT00004178|stage III renal cell cancer|stage iii renal cell cancer
5396923|NCT00004178|stage IV renal cell cancer|stage iv renal cell cancer
5396924|NCT00004178|recurrent renal cell cancer|recurrent renal cell cancer
5396925|NCT00004178|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5396926|NCT00004178|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5396927|NCT00004178|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5396928|NCT00004178|adenocarcinoma of the stomach|adenocarcinoma of the stomach
5396929|NCT00004178|extensive stage small cell lung cancer|extensive stage small cell lung cancer
5396930|NCT00004178|recurrent small cell lung cancer|recurrent small cell lung cancer
5396931|NCT00004178|stage III vaginal cancer|stage iii vaginal cancer
5396932|NCT00004178|stage IVA vaginal cancer|stage iva vaginal cancer
5396933|NCT00004178|stage IVB vaginal cancer|stage ivb vaginal cancer
5396934|NCT00004178|recurrent vaginal cancer|recurrent vaginal cancer
5396935|NCT00004178|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
5396936|NCT00004178|advanced adult primary liver cancer|advanced adult primary liver cancer
5396937|NCT00004178|recurrent adult primary liver cancer|recurrent adult primary liver cancer
5396938|NCT00004178|stage III endometrial carcinoma|stage iii endometrial carcinoma
5396939|NCT00004178|stage IV endometrial carcinoma|stage iv endometrial carcinoma
5396940|NCT00004178|recurrent endometrial carcinoma|recurrent endometrial carcinoma
5396941|NCT00004178|small intestine adenocarcinoma|small intestine adenocarcinoma
5396942|NCT00004178|unresectable gallbladder cancer|unresectable gallbladder cancer
5396943|NCT00004178|recurrent gallbladder cancer|recurrent gallbladder cancer
5396944|NCT00004178|unresectable extrahepatic bile duct cancer|unresectable extrahepatic bile duct cancer
5396945|NCT00004178|recurrent extrahepatic bile duct cancer|recurrent extrahepatic bile duct cancer
5396946|NCT00004178|recurrent small intestine cancer|recurrent small intestine cancer
5396947|NCT00004178|stage III bladder cancer|stage iii bladder cancer
5396948|NCT00004178|recurrent bladder cancer|recurrent bladder cancer
5396949|NCT00004178|stage IV bladder cancer|stage iv bladder cancer
5396950|NCT00004178|stage III prostate cancer|stage iii prostate cancer
5396951|NCT00004178|stage IV prostate cancer|stage iv prostate cancer
5396952|NCT00004178|recurrent prostate cancer|recurrent prostate cancer
5396953|NCT00004178|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5396954|NCT00004178|stage III salivary gland cancer|stage iii salivary gland cancer
5396955|NCT00004178|stage IV salivary gland cancer|stage iv salivary gland cancer
5396956|NCT00004178|recurrent salivary gland cancer|recurrent salivary gland cancer
5396957|NCT00004178|duct cell adenocarcinoma of the pancreas|duct cell adenocarcinoma of the pancreas
5396958|NCT00004178|ovarian undifferentiated adenocarcinoma|ovarian undifferentiated adenocarcinoma
5396959|NCT00004178|adenocarcinoma of the lung|adenocarcinoma of the lung
5396960|NCT00004178|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
5396961|NCT00004178|intestinal adenocarcinoma of the stomach|intestinal adenocarcinoma of the stomach
5396962|NCT00004178|adenocarcinoma of the colon|adenocarcinoma of the colon
5396963|NCT00004178|diffuse adenocarcinoma of the stomach|diffuse adenocarcinoma of the stomach
5396964|NCT00004178|mixed adenocarcinoma of the stomach|mixed adenocarcinoma of the stomach
5396965|NCT00004178|mucinous adenocarcinoma of the colon|mucinous adenocarcinoma of the colon
5396966|NCT00004178|signet ring adenocarcinoma of the colon|signet ring adenocarcinoma of the colon
5396967|NCT00004178|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5396968|NCT00004178|adenocarcinoma of the gallbladder|adenocarcinoma of the gallbladder
5396969|NCT00004178|mucinous adenocarcinoma of the rectum|mucinous adenocarcinoma of the rectum
5396970|NCT00004178|signet ring adenocarcinoma of the rectum|signet ring adenocarcinoma of the rectum
5396971|NCT00004178|adenocarcinoma with squamous metaplasia of the gallbladder|adenocarcinoma with squamous metaplasia of the gallbladder
5396972|NCT00004178|adenocarcinoma of the extrahepatic bile duct|adenocarcinoma of the extrahepatic bile duct
5396973|NCT00004178|ovarian serous cystadenocarcinoma|ovarian serous cystadenocarcinoma
5396974|NCT00004178|ovarian mucinous cystadenocarcinoma|ovarian mucinous cystadenocarcinoma
5396975|NCT00004178|ovarian endometrioid adenocarcinoma|ovarian endometrioid adenocarcinoma
5397270|NCT00003032|recurrent breast cancer|recurrent breast cancer
5396976|NCT00004178|ovarian clear cell cystadenocarcinoma|ovarian clear cell cystadenocarcinoma
5396977|NCT00004178|vaginal adenocarcinoma|vaginal adenocarcinoma
5396978|NCT00004178|vaginal clear cell adenocarcinoma|vaginal clear cell adenocarcinoma
5396979|NCT00004178|endometrial adenocarcinoma|endometrial adenocarcinoma
5396980|NCT00004178|cervical adenocarcinoma|cervical adenocarcinoma
5396981|NCT00004178|adenocarcinoma of the bladder|adenocarcinoma of the bladder
5396982|NCT00004178|salivary gland adenocarcinoma|salivary gland adenocarcinoma
5396983|NCT00004178|adenocarcinoma of unknown primary|adenocarcinoma of unknown primary
5396984|NCT00004178|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
5396985|NCT00004178|stage IV pancreatic cancer|stage iv pancreatic cancer
5396986|NCT00081497|alpha-galactosidase A|alpha-galactosidase a
5396987|NCT00081497|a-GAL|a-gal
5396988|NCT00081497|r-haGAL|r-hagal
5396992|NCT00004177|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5396993|NCT00004108|localized resectable adult primary liver cancer|localized resectable adult primary liver cancer
5396994|NCT00004108|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
5396995|NCT00004108|advanced adult primary liver cancer|advanced adult primary liver cancer
5396996|NCT00004108|recurrent adult primary liver cancer|recurrent adult primary liver cancer
5396997|NCT00004108|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
5396998|NCT00004107|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
5396999|NCT00004107|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5397000|NCT00004107|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5397001|NCT00004107|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
5397002|NCT00004107|B-cell adult acute lymphoblastic leukemia|b-cell adult acute lymphoblastic leukemia
5397003|NCT00004107|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5397004|NCT00004107|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5397005|NCT00004107|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5397006|NCT00004107|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5397007|NCT00004107|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5397008|NCT00004107|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5397009|NCT00004107|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5397010|NCT00004107|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5397011|NCT00004107|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5397012|NCT00004107|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5397013|NCT00004107|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5397014|NCT00004107|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5397015|NCT00004107|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5397016|NCT00004107|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5397017|NCT00004107|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5397018|NCT00004100|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5397019|NCT00004100|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5397020|NCT00004087|stage IV colon cancer|stage iv colon cancer
5397021|NCT00004087|stage IV pancreatic cancer|stage iv pancreatic cancer
5397022|NCT00004087|recurrent pancreatic cancer|recurrent pancreatic cancer
5397023|NCT00004087|stage IV rectal cancer|stage iv rectal cancer
5397024|NCT00004087|recurrent colon cancer|recurrent colon cancer
5397025|NCT00004087|recurrent rectal cancer|recurrent rectal cancer
5397026|NCT00081523|Hemoglobin|hemoglobin
5397027|NCT00081523|Acute Chest Syndrome|acute chest syndrome
5397028|NCT00081523|Treatment Options|treatment options
5397029|NCT00081523|Nitric Oxide|nitric oxide
5397030|NCT00081523|Pulmonary Hypertension|pulmonary hypertension
5397031|NCT00081523|Sickle Cell Disease|sickle cell disease
5397032|NCT00081523|Sickle Cell Trait|sickle cell trait
5397033|NCT00081523|Red Blood Cell Disorder|red blood cell disorder
5397034|NCT00081523|Thalassemia|thalassemia
5397035|NCT00081523|Paroxysmal Nocturnal Hemoglobinuria|paroxysmal nocturnal hemoglobinuria
5397036|NCT00081523|Hemolytic Disorders|hemolytic disorders
5397037|NCT00004086|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
5397038|NCT00004086|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5397039|NCT00004086|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
5397040|NCT00004086|refractory hairy cell leukemia|refractory hairy cell leukemia
5397041|NCT00004086|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5397042|NCT00004086|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5397043|NCT00004086|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5397044|NCT00004086|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5397045|NCT00004086|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5397046|NCT00004086|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5397047|NCT00004086|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5397048|NCT00004086|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5397049|NCT00004086|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5397050|NCT00004086|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5397051|NCT00004086|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5397052|NCT00004086|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5397053|NCT00004086|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5397054|NCT00004086|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5397055|NCT00004086|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5397056|NCT00004085|stage IV breast cancer|stage iv breast cancer
5397057|NCT00004085|recurrent breast cancer|recurrent breast cancer
5397058|NCT00004084|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
5397059|NCT00004084|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
5397060|NCT00004084|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5397061|NCT00004084|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5397062|NCT00004084|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5397063|NCT00004084|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
5397064|NCT00004084|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
5397065|NCT00004084|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
5397066|NCT00004084|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
5397067|NCT00004084|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
5397068|NCT00004084|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
5397069|NCT00004084|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
5397070|NCT00004084|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
5397071|NCT00004084|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5397072|NCT00004084|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5397073|NCT00004084|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5397074|NCT00004084|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5397075|NCT00004084|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5397076|NCT00004084|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5397077|NCT00004084|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5397078|NCT00004084|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5397079|NCT00004084|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5397080|NCT00004084|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5397081|NCT00004084|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5397082|NCT00004084|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5397083|NCT00004084|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5397084|NCT00004084|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5397085|NCT00004084|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5397086|NCT00004084|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5397087|NCT00004084|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5397088|NCT00004084|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5397089|NCT00004084|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5397090|NCT00004084|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5397091|NCT00004084|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5397092|NCT00004084|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5397093|NCT00004084|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5397094|NCT00004084|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5397095|NCT00004084|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5397096|NCT00004084|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5397097|NCT00004084|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5397098|NCT00004084|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
5397099|NCT00004084|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
5397100|NCT00004084|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
5397101|NCT00004084|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
5397102|NCT00004084|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
5397103|NCT00004084|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
5397104|NCT00004084|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
5397105|NCT00004084|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
5397106|NCT00004084|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
5397107|NCT00004084|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
5397108|NCT00004084|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5397109|NCT00004084|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5397110|NCT00004084|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5397111|NCT00004084|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
5397112|NCT00004084|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5397113|NCT00004084|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
5397114|NCT00004084|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
5397115|NCT00004084|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5397116|NCT00004084|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
5397117|NCT00004084|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
5397118|NCT00004084|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5397119|NCT00004084|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5397120|NCT00004084|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5397121|NCT00004084|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
5426285|NCT00001928|Infusion|infusion
5397122|NCT00004084|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
5397123|NCT00004084|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
5397124|NCT00004084|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
5397125|NCT00004084|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5397126|NCT00004084|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5397127|NCT00004084|stage I marginal zone lymphoma|stage i marginal zone lymphoma
5397128|NCT00004084|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
5397129|NCT00004084|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5397130|NCT00004084|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5397131|NCT00004084|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5397132|NCT00004084|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5397133|NCT00004084|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5397134|NCT00004084|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5397135|NCT00004084|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5397136|NCT00004048|thyroid gland medullary carcinoma|thyroid gland medullary carcinoma
5397137|NCT00004046|stage IV breast cancer|stage iv breast cancer
5397138|NCT00004046|recurrent breast cancer|recurrent breast cancer
5397139|NCT00004045|stage IV prostate cancer|stage iv prostate cancer
5397140|NCT00004045|recurrent prostate cancer|recurrent prostate cancer
5397141|NCT00004033|localized malignant mesothelioma|localized malignant mesothelioma
5397142|NCT00004033|advanced malignant mesothelioma|advanced malignant mesothelioma
5397143|NCT00004033|recurrent malignant mesothelioma|recurrent malignant mesothelioma
5397144|NCT00004016|stage III melanoma|stage iii melanoma
5397145|NCT00004016|stage IV melanoma|stage iv melanoma
5397146|NCT00004016|recurrent melanoma|recurrent melanoma
5397147|NCT00004016|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5397148|NCT00004010|stage II childhood Hodgkin lymphoma|stage ii childhood hodgkin lymphoma
5397149|NCT00004010|stage III childhood Hodgkin lymphoma|stage iii childhood hodgkin lymphoma
5397150|NCT00004010|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
5397151|NCT00004010|childhood lymphocyte predominant Hodgkin lymphoma|childhood lymphocyte predominant hodgkin lymphoma
5397152|NCT00004010|childhood lymphocyte depletion Hodgkin lymphoma|childhood lymphocyte depletion hodgkin lymphoma
5397153|NCT00004010|childhood nodular sclerosis Hodgkin lymphoma|childhood nodular sclerosis hodgkin lymphoma
5397154|NCT00004010|childhood mixed cellularity Hodgkin lymphoma|childhood mixed cellularity hodgkin lymphoma
5397155|NCT00081458|Short Bowel Syndrome|short bowel syndrome
5397156|NCT00081458|Parenteral Nutrition|parenteral nutrition
5397157|NCT00081458|SBS|sbs
5397158|NCT00003917|limited stage small cell lung cancer|limited stage small cell lung cancer
5397159|NCT00003917|extensive stage small cell lung cancer|extensive stage small cell lung cancer
5397160|NCT00003917|recurrent small cell lung cancer|recurrent small cell lung cancer
5397161|NCT00003870|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5397162|NCT00003870|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5397163|NCT00003870|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5397164|NCT00003870|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
5397165|NCT00003834|stage IV colon cancer|stage iv colon cancer
5397166|NCT00003834|stage IV rectal cancer|stage iv rectal cancer
5397167|NCT00003834|recurrent colon cancer|recurrent colon cancer
5397168|NCT00003834|recurrent rectal cancer|recurrent rectal cancer
5397169|NCT00003834|adenocarcinoma of the colon|adenocarcinoma of the colon
5397170|NCT00003834|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5397171|NCT00003834|liver metastases|liver metastases
5397172|NCT00003824|stage 0 bladder cancer|stage 0 bladder cancer
5397173|NCT00003824|recurrent bladder cancer|recurrent bladder cancer
5397174|NCT00003824|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
5397175|NCT00003809|untreated metastatic squamous neck cancer with occult primary|untreated metastatic squamous neck cancer with occult primary
5397176|NCT00003809|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
5397177|NCT00003809|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
5397178|NCT00003809|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5397179|NCT00003809|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
5397180|NCT00003809|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
5397181|NCT00003809|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5397182|NCT00003809|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
5397183|NCT00003809|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
5397184|NCT00003809|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5397185|NCT00003809|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
5397186|NCT00003809|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
5397187|NCT00003809|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5397188|NCT00003809|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
5397189|NCT00003809|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
5397190|NCT00003809|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
5397191|NCT00003809|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
5397192|NCT00003719|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
5397193|NCT00003719|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
5397194|NCT00003718|adult angiosarcoma|adult angiosarcoma
5397195|NCT00003718|adult fibrosarcoma|adult fibrosarcoma
5397196|NCT00003718|adult leiomyosarcoma|adult leiomyosarcoma
5397197|NCT00003718|adult liposarcoma|adult liposarcoma
5397198|NCT00003718|adult neurofibrosarcoma|adult neurofibrosarcoma
5397199|NCT00003718|adult synovial sarcoma|adult synovial sarcoma
5397200|NCT00003718|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
5397201|NCT00003718|adult extraskeletal chondrosarcoma|adult extraskeletal chondrosarcoma
5397202|NCT00003718|adult alveolar soft-part sarcoma|adult alveolar soft-part sarcoma
5397203|NCT00003718|adult epithelioid sarcoma|adult epithelioid sarcoma
5397204|NCT00003718|adult malignant fibrous histiocytoma|adult malignant fibrous histiocytoma
5397205|NCT00003718|adult malignant hemangiopericytoma|adult malignant hemangiopericytoma
5397206|NCT00003718|adult malignant mesenchymoma|adult malignant mesenchymoma
5397207|NCT00003718|adult rhabdomyosarcoma|adult rhabdomyosarcoma
5397208|NCT00003718|stage IV uterine sarcoma|stage iv uterine sarcoma
5397209|NCT00003718|recurrent uterine sarcoma|recurrent uterine sarcoma
5397210|NCT00003718|uterine carcinosarcoma|uterine carcinosarcoma
5397211|NCT00003718|uterine leiomyosarcoma|uterine leiomyosarcoma
5397212|NCT00003718|endometrial stromal sarcoma|endometrial stromal sarcoma
5397213|NCT00003718|ovarian sarcoma|ovarian sarcoma
5397214|NCT00003718|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
5397215|NCT00003717|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5397216|NCT00003717|stage IV prostate cancer|stage iv prostate cancer
5397217|NCT00003717|recurrent prostate cancer|recurrent prostate cancer
5397218|NCT00003674|stage IV colon cancer|stage iv colon cancer
5397219|NCT00003674|stage IV breast cancer|stage iv breast cancer
5397220|NCT00003674|recurrent breast cancer|recurrent breast cancer
5397221|NCT00003674|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5397222|NCT00003674|stage IV rectal cancer|stage iv rectal cancer
5397223|NCT00003674|recurrent colon cancer|recurrent colon cancer
5397224|NCT00003674|recurrent rectal cancer|recurrent rectal cancer
5397225|NCT00003674|extensive stage small cell lung cancer|extensive stage small cell lung cancer
5397226|NCT00003674|recurrent small cell lung cancer|recurrent small cell lung cancer
5397227|NCT00003674|stage IV prostate cancer|stage iv prostate cancer
5397228|NCT00003674|recurrent prostate cancer|recurrent prostate cancer
5397229|NCT00003674|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5397230|NCT00003674|veno-occlusive disease|veno-occlusive disease
5397231|NCT00003493|refractory multiple myeloma|refractory multiple myeloma
5397232|NCT00003493|stage I multiple myeloma|stage i multiple myeloma
5397233|NCT00003493|stage II multiple myeloma|stage ii multiple myeloma
5397234|NCT00003493|stage III multiple myeloma|stage iii multiple myeloma
5397235|NCT00003307|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5397236|NCT00003307|stage I prostate cancer|stage i prostate cancer
5397237|NCT00003307|stage II prostate cancer|stage ii prostate cancer
5397238|NCT00003307|stage III prostate cancer|stage iii prostate cancer
5397239|NCT00003307|radiation toxicity|radiation toxicity
5397240|NCT00003283|invasive thymoma and thymic carcinoma|invasive thymoma and thymic carcinoma
5397241|NCT00003283|recurrent thymoma and thymic carcinoma|recurrent thymoma and thymic carcinoma
5397242|NCT00003235|squamous cell lung cancer|squamous cell lung cancer
5397243|NCT00003235|large cell lung cancer|large cell lung cancer
5397244|NCT00003235|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5397245|NCT00003235|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5397246|NCT00003235|adenocarcinoma of the lung|adenocarcinoma of the lung
5397247|NCT00003209|stage IB cervical cancer|stage ib cervical cancer
5397248|NCT00003209|stage IIA cervical cancer|stage iia cervical cancer
5397249|NCT00003209|cervical squamous cell carcinoma|cervical squamous cell carcinoma
5397250|NCT00003209|cervical adenocarcinoma|cervical adenocarcinoma
5397251|NCT00003209|cervical adenosquamous cell carcinoma|cervical adenosquamous cell carcinoma
5397252|NCT00003125|stage IV breast cancer|stage iv breast cancer
5397253|NCT00003125|stage IIIA breast cancer|stage iiia breast cancer
5397254|NCT00003125|stage III gastric cancer|stage iii gastric cancer
5397255|NCT00003125|stage IV gastric cancer|stage iv gastric cancer
5397256|NCT00003125|stage IIIB breast cancer|stage iiib breast cancer
5397257|NCT00003125|stage II pancreatic cancer|stage ii pancreatic cancer
5397258|NCT00003125|stage III pancreatic cancer|stage iii pancreatic cancer
5397259|NCT00003125|stage II esophageal cancer|stage ii esophageal cancer
5397260|NCT00003125|stage III esophageal cancer|stage iii esophageal cancer
5397261|NCT00003125|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5397262|NCT00003125|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5397263|NCT00003125|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5397264|NCT00003125|stage IV pancreatic cancer|stage iv pancreatic cancer
5397265|NCT00003080|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5397266|NCT00003080|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5397267|NCT00003080|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5397268|NCT00003061|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
5397269|NCT00003032|stage IV breast cancer|stage iv breast cancer
5397271|NCT00003010|recurrent breast cancer|recurrent breast cancer
5397272|NCT00021398|stage II rectal cancer|stage ii rectal cancer
5397273|NCT00021398|stage III rectal cancer|stage iii rectal cancer
5397274|NCT00021398|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5397275|NCT00021281|stage IV colon cancer|stage iv colon cancer
5397276|NCT00021281|stage IV rectal cancer|stage iv rectal cancer
5397277|NCT00021281|recurrent colon cancer|recurrent colon cancer
5397278|NCT00021281|recurrent rectal cancer|recurrent rectal cancer
5397279|NCT00021281|adenocarcinoma of the colon|adenocarcinoma of the colon
5397280|NCT00021281|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5397281|NCT00021151|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5397282|NCT00021151|prolymphocytic leukemia|prolymphocytic leukemia
5397283|NCT00021008|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5397284|NCT00021008|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5397285|NCT00021008|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5397286|NCT00020774|localized resectable adult primary liver cancer|localized resectable adult primary liver cancer
5397287|NCT00020774|recurrent adult primary liver cancer|recurrent adult primary liver cancer
5397288|NCT00020774|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
5397289|NCT00020774|adult primary cholangiocellular carcinoma|adult primary cholangiocellular carcinoma
5397290|NCT00019552|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5397291|NCT00019552|fallopian tube cancer|fallopian tube cancer
5397292|NCT00019552|primary peritoneal cavity cancer|primary peritoneal cavity cancer
5397293|NCT00019474|stage III gastric cancer|stage iii gastric cancer
5397294|NCT00019474|stage IV gastric cancer|stage iv gastric cancer
5397295|NCT00019474|recurrent gastric cancer|recurrent gastric cancer
5397296|NCT00019474|stage II pancreatic cancer|stage ii pancreatic cancer
5397297|NCT00019474|stage III pancreatic cancer|stage iii pancreatic cancer
5397298|NCT00019474|recurrent pancreatic cancer|recurrent pancreatic cancer
5397299|NCT00019474|regional gastrointestinal carcinoid tumor|regional gastrointestinal carcinoid tumor
5397300|NCT00019474|metastatic gastrointestinal carcinoid tumor|metastatic gastrointestinal carcinoid tumor
5397301|NCT00019474|recurrent gastrointestinal carcinoid tumor|recurrent gastrointestinal carcinoid tumor
5397302|NCT00019474|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
5397303|NCT00019474|advanced adult primary liver cancer|advanced adult primary liver cancer
5397304|NCT00019474|recurrent adult primary liver cancer|recurrent adult primary liver cancer
5397305|NCT00019474|small intestine adenocarcinoma|small intestine adenocarcinoma
5397306|NCT00019474|unresectable extrahepatic bile duct cancer|unresectable extrahepatic bile duct cancer
5397307|NCT00019474|recurrent extrahepatic bile duct cancer|recurrent extrahepatic bile duct cancer
5397308|NCT00019474|recurrent small intestine cancer|recurrent small intestine cancer
5397309|NCT00019474|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
5397310|NCT00019474|stage IV pancreatic cancer|stage iv pancreatic cancer
5397311|NCT00019318|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
5397312|NCT00019318|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
5397313|NCT00019318|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5397314|NCT00019318|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
5397315|NCT00019318|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
5397316|NCT00019318|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5397317|NCT00019123|AIDS-related Kaposi sarcoma|aids-related kaposi sarcoma
5397318|NCT00014391|stage IV breast cancer|stage iv breast cancer
5397319|NCT00014391|stage IIIA breast cancer|stage iiia breast cancer
5397320|NCT00014391|stage IIIB breast cancer|stage iiib breast cancer
5397321|NCT00014391|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5397322|NCT00014391|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5397323|NCT00014391|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5397324|NCT00014391|refractory multiple myeloma|refractory multiple myeloma
5397325|NCT00014391|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
5397326|NCT00014391|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
5397327|NCT00014391|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5397328|NCT00014391|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5397329|NCT00014391|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5397330|NCT00014391|disseminated neuroblastoma|disseminated neuroblastoma
5397331|NCT00014391|recurrent neuroblastoma|recurrent neuroblastoma
5397332|NCT00014391|recurrent Wilms tumor and other childhood kidney tumors|recurrent wilms tumor and other childhood kidney tumors
5397333|NCT00014391|stage I multiple myeloma|stage i multiple myeloma
5397334|NCT00014391|stage II multiple myeloma|stage ii multiple myeloma
5397335|NCT00014391|stage III multiple myeloma|stage iii multiple myeloma
5426920|NCT00001479|ACTH|acth
5397336|NCT00014391|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
5397337|NCT00014391|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5397338|NCT00014391|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5397339|NCT00014391|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5397340|NCT00014391|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5397341|NCT00014391|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5397342|NCT00014391|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5397343|NCT00014391|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5397344|NCT00014391|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
5397345|NCT00014391|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
5397346|NCT00014391|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5397347|NCT00014391|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5397348|NCT00014391|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5397349|NCT00014391|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
5397350|NCT00014391|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
5397351|NCT00014391|childhood acute promyelocytic leukemia (M3)|childhood acute promyelocytic leukemia (m3)
5397352|NCT00014391|testicular embryonal carcinoma|testicular embryonal carcinoma
5397353|NCT00014391|testicular choriocarcinoma|testicular choriocarcinoma
5397354|NCT00014391|testicular teratoma|testicular teratoma
5397355|NCT00014391|testicular yolk sac tumor|testicular yolk sac tumor
5397356|NCT00014391|testicular embryonal carcinoma and teratoma|testicular embryonal carcinoma and teratoma
5397357|NCT00014391|testicular embryonal carcinoma and teratoma with seminoma|testicular embryonal carcinoma and teratoma with seminoma
5397358|NCT00014391|testicular embryonal carcinoma and yolk sac tumor|testicular embryonal carcinoma and yolk sac tumor
5397359|NCT00014391|testicular embryonal carcinoma and yolk sac tumor with seminoma|testicular embryonal carcinoma and yolk sac tumor with seminoma
5397360|NCT00014391|testicular embryonal carcinoma and seminoma|testicular embryonal carcinoma and seminoma
5397361|NCT00014391|testicular yolk sac tumor and teratoma|testicular yolk sac tumor and teratoma
5397362|NCT00014391|testicular yolk sac tumor and teratoma with seminoma|testicular yolk sac tumor and teratoma with seminoma
5397363|NCT00014391|testicular choriocarcinoma and yolk sac tumor|testicular choriocarcinoma and yolk sac tumor
5397364|NCT00014391|testicular choriocarcinoma and embryonal carcinoma|testicular choriocarcinoma and embryonal carcinoma
5397365|NCT00014391|testicular choriocarcinoma and teratoma|testicular choriocarcinoma and teratoma
5397366|NCT00014391|testicular choriocarcinoma and seminoma|testicular choriocarcinoma and seminoma
5397367|NCT00014391|refractory hairy cell leukemia|refractory hairy cell leukemia
5397368|NCT00014391|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
5397369|NCT00014391|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
5397370|NCT00014391|ovarian yolk sac tumor|ovarian yolk sac tumor
5397371|NCT00014391|ovarian embryonal carcinoma|ovarian embryonal carcinoma
5397372|NCT00014391|ovarian polyembryoma|ovarian polyembryoma
5397373|NCT00014391|ovarian choriocarcinoma|ovarian choriocarcinoma
5397374|NCT00014391|ovarian immature teratoma|ovarian immature teratoma
5397375|NCT00014391|ovarian mature teratoma|ovarian mature teratoma
5397376|NCT00014391|ovarian monodermal and highly specialized teratoma|ovarian monodermal and highly specialized teratoma
5397377|NCT00014391|ovarian mixed germ cell tumor|ovarian mixed germ cell tumor
5397378|NCT00014391|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5397379|NCT00014391|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5397380|NCT00014391|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5397381|NCT00014391|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5397382|NCT00014391|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5397383|NCT00014391|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5397384|NCT00014391|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5397385|NCT00014391|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5397386|NCT00014391|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5397387|NCT00014391|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5397388|NCT00014391|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5397389|NCT00014391|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5397390|NCT00014391|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5397391|NCT00014391|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5397392|NCT00014391|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5397393|NCT00014391|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5397394|NCT00014391|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5397395|NCT00014391|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5397396|NCT00014391|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5397397|NCT00014391|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5397398|NCT00014391|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5397399|NCT00014391|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5427022|NCT00001435|Depression|depression
5397400|NCT00014391|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5397401|NCT00014391|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5397402|NCT00014391|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5397403|NCT00014391|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5397404|NCT00014391|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5397405|NCT00014391|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5397406|NCT00014391|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5397407|NCT00014391|poor prognosis metastatic gestational trophoblastic tumor|poor prognosis metastatic gestational trophoblastic tumor
5397408|NCT00014391|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5397409|NCT00014391|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5397410|NCT00014391|infection|infection
5397411|NCT00014391|pulmonary complications|pulmonary complications
5397412|NCT00014391|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
5397413|NCT00014391|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
5397414|NCT00014391|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5397415|NCT00014391|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5397416|NCT00014391|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5397417|NCT00014391|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
5397418|NCT00014391|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5397419|NCT00014391|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
5397420|NCT00014391|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
5397421|NCT00014391|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5397422|NCT00014391|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
5397423|NCT00014391|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
5397424|NCT00014391|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5397425|NCT00014391|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5397426|NCT00014391|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5397427|NCT00014391|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
5397428|NCT00014391|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
5397429|NCT00014391|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
5397430|NCT00014391|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5397431|NCT00014391|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5397432|NCT00014391|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5397433|NCT00014391|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5397434|NCT00014391|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5397435|NCT00014391|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5397436|NCT00014391|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5397437|NCT00014391|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5397438|NCT00014391|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5397439|NCT00014391|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
5397440|NCT00012311|stage IV breast cancer|stage iv breast cancer
5397441|NCT00012311|recurrent breast cancer|recurrent breast cancer
5397442|NCT00010283|stage III breast cancer|stage iii breast cancer
5397443|NCT00010283|stage IV breast cancer|stage iv breast cancer
5397444|NCT00010283|stage IIIA breast cancer|stage iiia breast cancer
5397445|NCT00010283|stage IIIB breast cancer|stage iiib breast cancer
5397446|NCT00010283|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5397447|NCT00010283|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5397448|NCT00010283|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
5397449|NCT00010283|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5397450|NCT00010283|Burkitt lymphoma|burkitt lymphoma
5397451|NCT00010283|extramedullary plasmacytoma|extramedullary plasmacytoma
5397452|NCT00010283|refractory multiple myeloma|refractory multiple myeloma
5397453|NCT00010283|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
5397454|NCT00010283|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5397455|NCT00010283|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5397456|NCT00010283|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5397457|NCT00010283|disseminated neuroblastoma|disseminated neuroblastoma
5397458|NCT00010283|recurrent neuroblastoma|recurrent neuroblastoma
5397459|NCT00010283|recurrent Wilms tumor and other childhood kidney tumors|recurrent wilms tumor and other childhood kidney tumors
5397460|NCT00010283|stage I multiple myeloma|stage i multiple myeloma
5397461|NCT00010283|stage II multiple myeloma|stage ii multiple myeloma
5397462|NCT00010283|stage III multiple myeloma|stage iii multiple myeloma
5397463|NCT00010283|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
5397464|NCT00010283|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5397465|NCT00010283|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5397466|NCT00010283|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5397467|NCT00010283|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5397468|NCT00010283|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5397469|NCT00010283|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5397470|NCT00010283|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5397471|NCT00010283|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
5397472|NCT00010283|childhood diffuse large cell lymphoma|childhood diffuse large cell lymphoma
5397473|NCT00010283|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
5397474|NCT00010283|childhood immunoblastic large cell lymphoma|childhood immunoblastic large cell lymphoma
5397475|NCT00010283|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5397476|NCT00010283|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5397477|NCT00010283|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5397478|NCT00010283|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
5397479|NCT00010283|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
5397480|NCT00010283|essential thrombocythemia|essential thrombocythemia
5397481|NCT00010283|testicular embryonal carcinoma|testicular embryonal carcinoma
5397482|NCT00010283|testicular choriocarcinoma|testicular choriocarcinoma
5397483|NCT00010283|testicular teratoma|testicular teratoma
5397484|NCT00010283|testicular yolk sac tumor|testicular yolk sac tumor
5397485|NCT00010283|testicular embryonal carcinoma and teratoma|testicular embryonal carcinoma and teratoma
5397486|NCT00010283|testicular embryonal carcinoma and teratoma with seminoma|testicular embryonal carcinoma and teratoma with seminoma
5397487|NCT00010283|testicular embryonal carcinoma and yolk sac tumor|testicular embryonal carcinoma and yolk sac tumor
5397488|NCT00010283|testicular embryonal carcinoma and yolk sac tumor with seminoma|testicular embryonal carcinoma and yolk sac tumor with seminoma
5397489|NCT00010283|testicular embryonal carcinoma and seminoma|testicular embryonal carcinoma and seminoma
5397490|NCT00010283|testicular yolk sac tumor and teratoma|testicular yolk sac tumor and teratoma
5397491|NCT00010283|testicular yolk sac tumor and teratoma with seminoma|testicular yolk sac tumor and teratoma with seminoma
5397492|NCT00010283|testicular choriocarcinoma and yolk sac tumor|testicular choriocarcinoma and yolk sac tumor
5397493|NCT00010283|testicular choriocarcinoma and embryonal carcinoma|testicular choriocarcinoma and embryonal carcinoma
5397494|NCT00010283|testicular choriocarcinoma and teratoma|testicular choriocarcinoma and teratoma
5397495|NCT00010283|testicular choriocarcinoma and seminoma|testicular choriocarcinoma and seminoma
5397496|NCT00010283|refractory hairy cell leukemia|refractory hairy cell leukemia
5397497|NCT00010283|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
5397498|NCT00010283|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
5397499|NCT00010283|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5397500|NCT00010283|ovarian yolk sac tumor|ovarian yolk sac tumor
5397501|NCT00010283|ovarian embryonal carcinoma|ovarian embryonal carcinoma
5397502|NCT00010283|ovarian polyembryoma|ovarian polyembryoma
5397503|NCT00010283|ovarian choriocarcinoma|ovarian choriocarcinoma
5397504|NCT00010283|ovarian immature teratoma|ovarian immature teratoma
5397505|NCT00010283|ovarian mature teratoma|ovarian mature teratoma
5397506|NCT00010283|ovarian monodermal and highly specialized teratoma|ovarian monodermal and highly specialized teratoma
5397507|NCT00010283|ovarian mixed germ cell tumor|ovarian mixed germ cell tumor
5397508|NCT00010283|acute undifferentiated leukemia|acute undifferentiated leukemia
5397509|NCT00010283|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5397510|NCT00010283|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5397511|NCT00010283|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5397512|NCT00010283|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5397513|NCT00010283|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5397514|NCT00010283|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5397515|NCT00010283|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5397516|NCT00010283|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5397517|NCT00010283|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5397518|NCT00010283|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5397519|NCT00010283|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5397520|NCT00010283|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5397521|NCT00010283|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5397522|NCT00010283|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5397523|NCT00010283|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5397524|NCT00010283|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5397525|NCT00010283|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5397526|NCT00010283|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5397527|NCT00010283|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5397528|NCT00010283|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5397529|NCT00010283|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5397530|NCT00010283|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5397531|NCT00010283|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5397532|NCT00010283|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5397533|NCT00010283|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5397534|NCT00010283|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5397535|NCT00010283|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5397536|NCT00010283|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
5397537|NCT00010283|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5397538|NCT00010283|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5397539|NCT00010283|poor prognosis metastatic gestational trophoblastic tumor|poor prognosis metastatic gestational trophoblastic tumor
5397540|NCT00010283|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5397541|NCT00010283|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5397542|NCT00010283|graft versus host disease|graft versus host disease
5397543|NCT00010283|prolymphocytic leukemia|prolymphocytic leukemia
5397544|NCT00010283|primary systemic amyloidosis|primary systemic amyloidosis
5397545|NCT00010283|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
5397546|NCT00010283|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
5397547|NCT00010283|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5397548|NCT00010283|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5397549|NCT00010283|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5397550|NCT00010283|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
5397551|NCT00010283|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5397552|NCT00010283|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
5397553|NCT00010283|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
5397554|NCT00010283|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5397555|NCT00010283|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
5397556|NCT00010283|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
5397557|NCT00010283|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5397558|NCT00010283|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5397559|NCT00010283|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5397560|NCT00010283|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5397561|NCT00010283|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
5397562|NCT00010283|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5397563|NCT00010283|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
5397564|NCT00010283|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
5397565|NCT00010283|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5397566|NCT00010283|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5397567|NCT00010283|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5397568|NCT00010283|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5397569|NCT00010283|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5397570|NCT00010283|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5397571|NCT00010283|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5397572|NCT00010283|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5397573|NCT00010283|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5397574|NCT00010283|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
5397575|NCT00007943|stage III colon cancer|stage iii colon cancer
5397576|NCT00007943|stage IV colon cancer|stage iv colon cancer
5397577|NCT00007943|stage III rectal cancer|stage iii rectal cancer
5397578|NCT00007943|stage IV rectal cancer|stage iv rectal cancer
5397579|NCT00007943|recurrent colon cancer|recurrent colon cancer
5397580|NCT00007943|recurrent rectal cancer|recurrent rectal cancer
5397581|NCT00006045|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5397582|NCT00006045|adult acute erythroid leukemia (M6)|adult acute erythroid leukemia (m6)
5397583|NCT00006045|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
5397584|NCT00006045|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
5397585|NCT00006045|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
5397586|NCT00006045|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
5397587|NCT00006045|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
5397588|NCT00006045|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5397589|NCT00006045|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
5397590|NCT00006045|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
5397591|NCT00005875|stage IV melanoma|stage iv melanoma
5397592|NCT00005875|recurrent melanoma|recurrent melanoma
5397593|NCT00005874|adult leiomyosarcoma|adult leiomyosarcoma
5397594|NCT00005874|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
5397672|NCT00004860|recurrent rectal cancer|recurrent rectal cancer
5397595|NCT00005874|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
5397596|NCT00005874|small intestine leiomyosarcoma|small intestine leiomyosarcoma
5397597|NCT00005874|metastatic childhood soft tissue sarcoma|metastatic childhood soft tissue sarcoma
5397598|NCT00005874|recurrent childhood soft tissue sarcoma|recurrent childhood soft tissue sarcoma
5397599|NCT00005874|childhood leiomyosarcoma|childhood leiomyosarcoma
5397600|NCT00005874|gastrointestinal stromal tumor|gastrointestinal stromal tumor
5397601|NCT00005874|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
5397602|NCT00005873|stage IV breast cancer|stage iv breast cancer
5397603|NCT00005873|recurrent breast cancer|recurrent breast cancer
5397604|NCT00002708|tumors metastatic to brain|tumors metastatic to brain
5397605|NCT00081432|Seizures|seizures
5397606|NCT00081432|Language|language
5397607|NCT00081432|Memory|memory
5397608|NCT00081432|Brain|brain
5397609|NCT00081432|Imaging|imaging
5397610|NCT00081432|Epilepsy|epilepsy
5397611|NCT00081432|Temporal Lobe Epilepsy|temporal lobe epilepsy
5397612|NCT00081419|Bereitschaftspotential|bereitschaftspotential
5397613|NCT00081419|Timing of Volition|timing of volition
5397614|NCT00081419|Urge|urge
5397615|NCT00081419|Conscious Will|conscious will
5397616|NCT00081419|Libet's Clock|libet's clock
5397617|NCT00081419|Tourette Syndrome|tourette syndrome
5397618|NCT00081419|Tic Disorder|tic disorder
5397619|NCT00081419|Healthy Volunteer|healthy volunteer
5397620|NCT00081419|HV|hv
5397621|NCT00081367|Minority Groups|minority groups
5397622|NCT00005872|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5397623|NCT00005833|stage IV colon cancer|stage iv colon cancer
5397624|NCT00005833|stage IV rectal cancer|stage iv rectal cancer
5397625|NCT00005833|recurrent colon cancer|recurrent colon cancer
5397626|NCT00005833|recurrent rectal cancer|recurrent rectal cancer
5397627|NCT00005833|adenocarcinoma of the colon|adenocarcinoma of the colon
5397628|NCT00005833|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5397629|NCT00005820|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5397630|NCT00005820|stage IV prostate cancer|stage iv prostate cancer
5397631|NCT00005820|recurrent prostate cancer|recurrent prostate cancer
5397632|NCT00005801|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5397633|NCT00005801|adult acute erythroid leukemia (M6)|adult acute erythroid leukemia (m6)
5397634|NCT00005801|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
5397635|NCT00005801|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
5397636|NCT00005801|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
5397637|NCT00005801|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
5397638|NCT00005801|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
5397639|NCT00005801|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
5397640|NCT00005077|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5397641|NCT00005066|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
5397642|NCT00005066|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
5397643|NCT00005061|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5397644|NCT00005058|stage I breast cancer|stage i breast cancer
5397645|NCT00005058|stage II breast cancer|stage ii breast cancer
5397646|NCT00005058|stage IIIA breast cancer|stage iiia breast cancer
5397647|NCT00005058|stage IIIB breast cancer|stage iiib breast cancer
5397648|NCT00005058|inflammatory breast cancer|inflammatory breast cancer
5397649|NCT00005040|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
5397650|NCT00005040|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5397651|NCT00005040|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5397652|NCT00005040|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5397653|NCT00005040|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5397654|NCT00005040|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5397655|NCT00005040|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5397656|NCT00005040|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5398174|NCT00003107|ovarian choriocarcinoma|ovarian choriocarcinoma
5397657|NCT00005040|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
5397658|NCT00005040|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5397659|NCT00005040|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
5397660|NCT00005040|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5397661|NCT00004885|stage IV colon cancer|stage iv colon cancer
5397662|NCT00004885|stage IV rectal cancer|stage iv rectal cancer
5397663|NCT00004885|recurrent colon cancer|recurrent colon cancer
5397664|NCT00004885|recurrent rectal cancer|recurrent rectal cancer
5397665|NCT00004885|adenocarcinoma of the colon|adenocarcinoma of the colon
5397666|NCT00004885|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5397667|NCT00004860|stage III colon cancer|stage iii colon cancer
5397668|NCT00004860|stage IV colon cancer|stage iv colon cancer
5397669|NCT00004860|stage III rectal cancer|stage iii rectal cancer
5397670|NCT00004860|stage IV rectal cancer|stage iv rectal cancer
5397671|NCT00004860|recurrent colon cancer|recurrent colon cancer
5427128|NCT00001375|Synovitis|synovitis
5397673|NCT00004860|adenocarcinoma of the colon|adenocarcinoma of the colon
5397674|NCT00004860|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5397675|NCT00004238|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5397676|NCT00004238|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5397677|NCT00004238|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5397678|NCT00004166|stage I ovarian epithelial cancer|stage i ovarian epithelial cancer
5397679|NCT00004166|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
5397680|NCT00004166|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5397681|NCT00004166|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5397682|NCT00004166|quality of life|quality of life
5397683|NCT00004137|extensive stage small cell lung cancer|extensive stage small cell lung cancer
5397684|NCT00004102|stage IV colon cancer|stage iv colon cancer
5397685|NCT00004102|stage IV rectal cancer|stage iv rectal cancer
5397686|NCT00004102|recurrent colon cancer|recurrent colon cancer
5397687|NCT00004102|recurrent rectal cancer|recurrent rectal cancer
5397688|NCT00004102|adenocarcinoma of the colon|adenocarcinoma of the colon
5397689|NCT00004102|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5397690|NCT00004082|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5397691|NCT00004082|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5397692|NCT00004082|stage III endometrial carcinoma|stage iii endometrial carcinoma
5397693|NCT00004082|stage IV endometrial carcinoma|stage iv endometrial carcinoma
5397694|NCT00004082|endometrial adenocarcinoma|endometrial adenocarcinoma
5397695|NCT00004082|fallopian tube cancer|fallopian tube cancer
5397696|NCT00004082|primary peritoneal cavity cancer|primary peritoneal cavity cancer
5397697|NCT00004002|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5397698|NCT00004002|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5397699|NCT00004002|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
5397700|NCT00004002|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5397701|NCT00004002|small intestine lymphoma|small intestine lymphoma
5397702|NCT00004002|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5397703|NCT00004002|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5397704|NCT00004002|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5397705|NCT00004002|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5397706|NCT00004002|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5397707|NCT00004002|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5397708|NCT00004002|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5397709|NCT00004002|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5397710|NCT00004002|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5397711|NCT00004002|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5397712|NCT00004002|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5397713|NCT00004002|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5397714|NCT00004002|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5397715|NCT00004002|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5397716|NCT00004002|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5397717|NCT00004002|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5397718|NCT00004002|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5397719|NCT00004002|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5397720|NCT00004002|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5397721|NCT00004002|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
5397722|NCT00004002|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
5397723|NCT00004002|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
5397724|NCT00004002|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
5397725|NCT00004002|AIDS-related primary CNS lymphoma|aids-related primary cns lymphoma
5397726|NCT00004002|intraocular lymphoma|intraocular lymphoma
5397727|NCT00004002|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5397728|NCT00004002|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5397729|NCT00004002|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
5397730|NCT00004002|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5397731|NCT00004002|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
5397732|NCT00004002|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5397733|NCT00004002|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5397734|NCT00004002|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5397735|NCT00004002|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5397736|NCT00004002|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5397737|NCT00004002|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5397738|NCT00004002|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5397739|NCT00004002|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5397740|NCT00003911|stage IV melanoma|stage iv melanoma
5397741|NCT00003911|recurrent melanoma|recurrent melanoma
5397742|NCT00003911|tumors metastatic to brain|tumors metastatic to brain
5397743|NCT00003840|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5397744|NCT00003840|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5397745|NCT00081354|Esophageal Adenocarcinoma|esophageal adenocarcinoma
5397746|NCT00081354|Dysplasia|dysplasia
5397747|NCT00081354|Surveillance|surveillance
5397748|NCT00081354|Proteomics|proteomics
5397749|NCT00081354|SNP's|snp's
5397750|NCT00081354|Barrett Esophagus|barrett esophagus
5397751|NCT00081354|Gastroesophageal Reflux Disease|gastroesophageal reflux disease
5397752|NCT00081354|GERD|gerd
5397753|NCT00081354|Dysphagia|dysphagia
5397754|NCT00081354|Swallowing Difficulty|swallowing difficulty
5397755|NCT00081315|- Non-Small cell lung cancer|- non-small cell lung cancer
5397756|NCT00005943|stage IV melanoma|stage iv melanoma
5397757|NCT00005943|recurrent melanoma|recurrent melanoma
5397758|NCT00003754|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
5399055|NCT00080236|Liver Transplantation|liver transplantation
5397759|NCT00003710|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5397760|NCT00003692|occult non-small cell lung cancer|occult non-small cell lung cancer
5397761|NCT00003692|stage I non-small cell lung cancer|stage i non-small cell lung cancer
5397762|NCT00003692|stage 0 non-small cell lung cancer|stage 0 non-small cell lung cancer
5397763|NCT00003642|stage II bladder cancer|stage ii bladder cancer
5397764|NCT00003642|stage III bladder cancer|stage iii bladder cancer
5397765|NCT00003642|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
5397766|NCT00003446|stage IV colon cancer|stage iv colon cancer
5397767|NCT00003446|stage IV rectal cancer|stage iv rectal cancer
5397768|NCT00003446|recurrent colon cancer|recurrent colon cancer
5397769|NCT00003446|recurrent rectal cancer|recurrent rectal cancer
5397770|NCT00003376|stage III bladder cancer|stage iii bladder cancer
5397771|NCT00003376|stage IV bladder cancer|stage iv bladder cancer
5397772|NCT00003376|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
5397773|NCT00003376|anterior urethral cancer|anterior urethral cancer
5397774|NCT00003376|posterior urethral cancer|posterior urethral cancer
5397775|NCT00003376|urethral cancer associated with invasive bladder cancer|urethral cancer associated with invasive bladder cancer
5397776|NCT00003376|metastatic transitional cell cancer of the renal pelvis and ureter|metastatic transitional cell cancer of the renal pelvis and ureter
5397777|NCT00003376|regional transitional cell cancer of the renal pelvis and ureter|regional transitional cell cancer of the renal pelvis and ureter
5397778|NCT00003316|recurrent uterine sarcoma|recurrent uterine sarcoma
5397779|NCT00003316|uterine leiomyosarcoma|uterine leiomyosarcoma
5397780|NCT00003301|recurrent adult brain tumor|recurrent adult brain tumor
5397781|NCT00003301|adult glioblastoma|adult glioblastoma
5397782|NCT00003301|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5397783|NCT00003301|adult giant cell glioblastoma|adult giant cell glioblastoma
5397784|NCT00003301|adult gliosarcoma|adult gliosarcoma
5397785|NCT00003232|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5397786|NCT00003232|recurrent prostate cancer|recurrent prostate cancer
5397787|NCT00003232|pain|pain
5397788|NCT00003232|quality of life|quality of life
5397789|NCT00081302|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5397790|NCT00081302|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5397791|NCT00081302|squamous cell lung cancer|squamous cell lung cancer
5397792|NCT00081302|large cell lung cancer|large cell lung cancer
5397793|NCT00081302|adenocarcinoma of the lung|adenocarcinoma of the lung
5397794|NCT00081302|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
5397795|NCT00081289|stage III rectal cancer|stage iii rectal cancer
5397796|NCT00081289|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5397797|NCT00081289|stage II rectal cancer|stage ii rectal cancer
5397798|NCT00081250|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5397799|NCT00081250|cachexia|cachexia
5397800|NCT00081250|anorexia|anorexia
5397801|NCT00081250|weight changes|weight changes
5397802|NCT00081237|recurrent colon cancer|recurrent colon cancer
5397803|NCT00081237|stage III colon cancer|stage iii colon cancer
5397804|NCT00081237|stage IV colon cancer|stage iv colon cancer
5397805|NCT00081237|recurrent rectal cancer|recurrent rectal cancer
5397806|NCT00081237|stage III rectal cancer|stage iii rectal cancer
5397807|NCT00081237|stage IV rectal cancer|stage iv rectal cancer
5397808|NCT00081224|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5397809|NCT00081224|stage II rectal cancer|stage ii rectal cancer
5397810|NCT00081224|stage III rectal cancer|stage iii rectal cancer
5397811|NCT00081172|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5397812|NCT00081172|recurrent prostate cancer|recurrent prostate cancer
5397813|NCT00081172|stage IV prostate cancer|stage iv prostate cancer
5397814|NCT00081159|recurrent prostate cancer|recurrent prostate cancer
5397815|NCT00081159|stage IV prostate cancer|stage iv prostate cancer
5397816|NCT00081159|bone metastases|bone metastases
5397817|NCT00081133|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5397818|NCT00081133|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5397819|NCT00081133|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5397887|NCT00080925|primary myelofibrosis|primary myelofibrosis
5397820|NCT00081133|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
5397821|NCT00081107|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5397822|NCT00081107|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5397823|NCT00081107|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5397824|NCT00081094|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
5397825|NCT00081094|recurrent adult primary liver cancer|recurrent adult primary liver cancer
5397826|NCT00081094|localized resectable adult primary liver cancer|localized resectable adult primary liver cancer
5397827|NCT00081068|Waldenström macroglobulinemia|waldenström macroglobulinemia
5397828|NCT00081055|graft versus host disease|graft versus host disease
5397829|NCT00081055|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5397830|NCT00081055|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5397831|NCT00081055|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5397832|NCT00081055|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5397833|NCT00081055|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5397834|NCT00081055|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5397835|NCT00081055|refractory anemia|refractory anemia
5397836|NCT00081055|refractory anemia with excess blasts|refractory anemia with excess blasts
5397837|NCT00081055|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
5397838|NCT00081055|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5397839|NCT00081055|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5397840|NCT00081055|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5397841|NCT00081055|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5397842|NCT00081055|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5397843|NCT00081055|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5397844|NCT00081055|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5397845|NCT00081055|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5397846|NCT00081042|recurrent melanoma|recurrent melanoma
5397847|NCT00081042|stage III melanoma|stage iii melanoma
5397848|NCT00081042|stage IV melanoma|stage iv melanoma
5397849|NCT00081029|xerostomia|xerostomia
5397850|NCT00081029|radiation toxicity|radiation toxicity
5397851|NCT00081029|stage I squamous cell carcinoma of the hypopharynx|stage i squamous cell carcinoma of the hypopharynx
5397852|NCT00081029|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
5397853|NCT00081029|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
5397854|NCT00081029|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
5397855|NCT00081029|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
5397856|NCT00081029|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
5397857|NCT00081029|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5397858|NCT00081029|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5397859|NCT00081003|breast cancer|breast cancer
5397860|NCT00080977|recurrent renal cell cancer|recurrent renal cell cancer
5397861|NCT00080977|stage IV renal cell cancer|stage iv renal cell cancer
5397862|NCT00080951|stage IV colon cancer|stage iv colon cancer
5397863|NCT00080951|stage IV rectal cancer|stage iv rectal cancer
5397864|NCT00080951|adenocarcinoma of the colon|adenocarcinoma of the colon
5397865|NCT00080951|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5397866|NCT00080938|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5397867|NCT00080938|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5397868|NCT00080938|squamous cell lung cancer|squamous cell lung cancer
5397869|NCT00080938|adenocarcinoma of the lung|adenocarcinoma of the lung
5397870|NCT00080938|large cell lung cancer|large cell lung cancer
5397871|NCT00080938|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
5397872|NCT00080938|adenosquamous cell lung cancer|adenosquamous cell lung cancer
5397873|NCT00080938|tumors metastatic to brain|tumors metastatic to brain
5397874|NCT00080925|prolymphocytic leukemia|prolymphocytic leukemia
5397875|NCT00080925|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5397876|NCT00080925|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5397877|NCT00080925|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5397878|NCT00080925|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5397879|NCT00080925|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5397880|NCT00080925|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
5397881|NCT00080925|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5397882|NCT00080925|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5397883|NCT00080925|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5397884|NCT00080925|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5397885|NCT00080925|refractory anemia with excess blasts|refractory anemia with excess blasts
5397886|NCT00080925|refractory multiple myeloma|refractory multiple myeloma
5427975|NCT00047463|epilepsy|epilepsy
5397888|NCT00080925|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5397889|NCT00080925|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5397890|NCT00080925|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5397891|NCT00080925|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5397892|NCT00080925|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5397893|NCT00080925|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5397894|NCT00080925|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5397895|NCT00080925|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5397896|NCT00080925|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5397897|NCT00080925|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5397898|NCT00080925|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5397899|NCT00080925|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5397900|NCT00080925|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5397901|NCT00080925|polycythemia vera|polycythemia vera
5397902|NCT00080925|essential thrombocythemia|essential thrombocythemia
5397903|NCT00080925|stage II multiple myeloma|stage ii multiple myeloma
5397904|NCT00080925|stage III multiple myeloma|stage iii multiple myeloma
5397905|NCT00080925|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5397906|NCT00080925|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5397907|NCT00080925|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5397908|NCT00080925|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5397909|NCT00080925|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5397910|NCT00080925|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5397911|NCT00080925|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5397912|NCT00080925|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5397913|NCT00080925|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5397914|NCT00080925|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5397915|NCT00080912|bone metastases|bone metastases
5397916|NCT00080912|pain|pain
5397917|NCT00080886|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5397918|NCT00080886|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5397919|NCT00080886|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5397920|NCT00080886|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5397921|NCT00080886|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5397922|NCT00080886|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5397923|NCT00080886|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5397924|NCT00080886|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5397925|NCT00080886|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5397926|NCT00080886|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5397927|NCT00080886|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5397928|NCT00080886|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5397929|NCT00080886|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5397930|NCT00080886|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5397931|NCT00080886|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5397932|NCT00080873|oral complications|oral complications
5397933|NCT00080873|disseminated neuroblastoma|disseminated neuroblastoma
5397934|NCT00080873|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
5397935|NCT00080873|recurrent Wilms tumor and other childhood kidney tumors|recurrent wilms tumor and other childhood kidney tumors
5397936|NCT00080873|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
5397937|NCT00080873|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5397938|NCT00080873|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5397939|NCT00080873|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
5397940|NCT00080873|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
5397941|NCT00080873|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
5397942|NCT00080873|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
5397943|NCT00080873|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
5397944|NCT00080873|untreated childhood acute myeloid leukemia and other myeloid malignancies|untreated childhood acute myeloid leukemia and other myeloid malignancies
5397945|NCT00080873|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
5397946|NCT00080873|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
5397947|NCT00080873|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
5397948|NCT00080873|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
5397949|NCT00080873|recurrent neuroblastoma|recurrent neuroblastoma
5397950|NCT00080860|stage II breast cancer|stage ii breast cancer
5397951|NCT00080860|stage IIIA breast cancer|stage iiia breast cancer
5397952|NCT00080860|stage IIIB breast cancer|stage iiib breast cancer
5397953|NCT00080860|stage IIIC breast cancer|stage iiic breast cancer
5397954|NCT00080860|stage IV breast cancer|stage iv breast cancer
5397955|NCT00080834|adenocarcinoma of the colon|adenocarcinoma of the colon
5397956|NCT00080834|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5397957|NCT00080834|recurrent colon cancer|recurrent colon cancer
5397958|NCT00080834|recurrent rectal cancer|recurrent rectal cancer
5397959|NCT00080834|stage III colon cancer|stage iii colon cancer
5397960|NCT00080834|stage IV colon cancer|stage iv colon cancer
5397961|NCT00080834|stage III rectal cancer|stage iii rectal cancer
5397962|NCT00080834|stage IV rectal cancer|stage iv rectal cancer
5397963|NCT00080808|perioperative/postoperative complications|perioperative/postoperative complications
5397964|NCT00080808|sexual dysfunction and infertility|sexual dysfunction and infertility
5397965|NCT00080808|sexuality and reproductive issues|sexuality and reproductive issues
5397966|NCT00080808|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5397967|NCT00080808|stage I prostate cancer|stage i prostate cancer
5397968|NCT00080808|stage II prostate cancer|stage ii prostate cancer
5397969|NCT00080808|prostaglandin E1|prostaglandin e1
5397970|NCT00080808|papaverine|papaverine
5397971|NCT00080808|phentolamine|phentolamine
5397972|NCT00080808|Nerve-sparing radical prostatectomy|nerve-sparing radical prostatectomy
5397973|NCT00080808|nerve grafting|nerve grafting
5397974|NCT00080795|stage III bladder cancer|stage iii bladder cancer
5397975|NCT00080795|regional transitional cell cancer of the renal pelvis and ureter|regional transitional cell cancer of the renal pelvis and ureter
5397976|NCT00080795|anterior urethral cancer|anterior urethral cancer
5397977|NCT00080795|posterior urethral cancer|posterior urethral cancer
5397978|NCT00080795|urethral cancer associated with invasive bladder cancer|urethral cancer associated with invasive bladder cancer
5397979|NCT00080782|recurrent prostate cancer|recurrent prostate cancer
5397980|NCT00080782|stage IV prostate cancer|stage iv prostate cancer
5397981|NCT00080782|bone metastases|bone metastases
5397982|NCT00080782|Progressive Androgen-Independent Prostate Cancer|progressive androgen-independent prostate cancer
5397983|NCT00080782|Metastron|metastron
5397984|NCT00080782|Sr-89|sr-89
5397985|NCT00080782|Strontium-89|strontium-89
5397986|NCT00080782|strontium chloride Sr 89|strontium chloride sr 89
5397987|NCT00080782|Celecoxib|celecoxib
5397988|NCT00080782|Celebrex|celebrex
5397989|NCT00080782|Doxorubicin|doxorubicin
5397990|NCT00080782|Rubex|rubex
5397991|NCT00080782|Adriamycin|adriamycin
5397992|NCT00080756|breast cancer|breast cancer
5397993|NCT00080756|BRCA1 mutation carrier|brca1 mutation carrier
5397994|NCT00080756|BRCA2 mutation carrier|brca2 mutation carrier
5397995|NCT00080743|recurrent breast cancer|recurrent breast cancer
5397996|NCT00080743|stage IV breast cancer|stage iv breast cancer
5397997|NCT00080678|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5397998|NCT00080678|recurrent prostate cancer|recurrent prostate cancer
5397999|NCT00080678|stage IV prostate cancer|stage iv prostate cancer
5398000|NCT00080678|bone metastases|bone metastases
5398001|NCT00080665|male breast cancer|male breast cancer
5398002|NCT00080665|stage IIIB breast cancer|stage iiib breast cancer
5398003|NCT00080665|stage IIIC breast cancer|stage iiic breast cancer
5398004|NCT00080665|stage IV breast cancer|stage iv breast cancer
5398005|NCT00080665|recurrent breast cancer|recurrent breast cancer
5398006|NCT00080639|ovarian epithelial cancer|ovarian epithelial cancer
5398007|NCT00080626|stage I breast cancer|stage i breast cancer
5398008|NCT00080626|stage II breast cancer|stage ii breast cancer
5398009|NCT00080626|stage IIIA breast cancer|stage iiia breast cancer
5398010|NCT00080626|stage IIIB breast cancer|stage iiib breast cancer
5398011|NCT00080626|stage IIIC breast cancer|stage iiic breast cancer
5398012|NCT00080626|stage IV breast cancer|stage iv breast cancer
5398013|NCT00080600|Post Polio Syndrome|post polio syndrome
5398014|NCT00080600|Magnetic Stimulation|magnetic stimulation
5398015|NCT00080600|Fatigue|fatigue
5398016|NCT00080600|Exercise|exercise
5398017|NCT00080600|Weakness|weakness
5398018|NCT00080600|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
5398019|NCT00080600|Post-Exercise Fatigue|post-exercise fatigue
5398020|NCT00080600|Motor Neuron Disease|motor neuron disease
5398021|NCT00080600|Cortical Reorganization|cortical reorganization
5398022|NCT00080600|Intracortical Facilitation|intracortical facilitation
5398023|NCT00080600|Polio|polio
5398024|NCT00080600|Healthy Volunteer|healthy volunteer
5398025|NCT00080600|HV|hv
5398026|NCT00080587|Intravascular Ultrasound|intravascular ultrasound
5398027|NCT00080587|Magnetic Resonance Imaging|magnetic resonance imaging
5398028|NCT00080587|Hyperlipidemia|hyperlipidemia
5398029|NCT00080587|Cholesterol|cholesterol
5398030|NCT00080587|Coronary Artery Disease|coronary artery disease
5398031|NCT00080574|Pharmacokinetics|pharmacokinetics
5398032|NCT00080574|Drug Metabolism|drug metabolism
5398033|NCT00080574|Levothyroxine|levothyroxine
5398034|NCT00080574|Hypothyroidism|hypothyroidism
5398035|NCT00080574|Hyperthyroidism|hyperthyroidism
5398036|NCT00080574|Drug Interactions|drug interactions
5398037|NCT00080574|Cytochrome P450|cytochrome p450
5398038|NCT00080574|P-Glycoprotein|p-glycoprotein
5398039|NCT00080574|Drug Transport Proteins|drug transport proteins
5398040|NCT00080574|Thyroid Hormone|thyroid hormone
5398041|NCT00080574|Thyroid Cancer|thyroid cancer
5398042|NCT00080548|Bereitschafts Potential|bereitschafts potential
5398043|NCT00080548|Timing of Volition|timing of volition
5398044|NCT00080548|Somatic Passivity Phenomenon|somatic passivity phenomenon
5398045|NCT00080548|Conscious Will|conscious will
5398046|NCT00080548|Libet's Clock|libet's clock
5398047|NCT00080548|Schizophrenia|schizophrenia
5398048|NCT00080548|Healthy Volunteer|healthy volunteer
5398049|NCT00080548|HV|hv
5398050|NCT00080535|LMB-2|lmb-2
5398051|NCT00080535|Cutaneous T Cell Lymphoma|cutaneous t cell lymphoma
5398052|NCT00080535|CTCL|ctcl
5398053|NCT00080535|Immunotoxin|immunotoxin
5398054|NCT00080535|Oncology|oncology
5398055|NCT00080522|Treatment Naive|treatment naive
5398056|NCT00080522|Resource Poor Setting|resource poor setting
5398057|NCT00080522|Drug Delivery|drug delivery
5398058|NCT00080522|Household|household
5398059|NCT00080522|South Africa|south africa
5398060|NCT00080496|Pneumonia|pneumonia
5398061|NCT00003176|recurrent adult brain tumor|recurrent adult brain tumor
5398062|NCT00003176|adult glioblastoma|adult glioblastoma
5398063|NCT00003176|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5398064|NCT00003176|adult mixed glioma|adult mixed glioma
5398065|NCT00003176|adult giant cell glioblastoma|adult giant cell glioblastoma
5398066|NCT00003176|adult gliosarcoma|adult gliosarcoma
5398067|NCT00003156|recurrent uterine sarcoma|recurrent uterine sarcoma
5398068|NCT00003156|uterine carcinosarcoma|uterine carcinosarcoma
5398069|NCT00003132|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5398070|NCT00003110|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
5398071|NCT00003110|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5398072|NCT00003110|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5398073|NCT00003110|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5398074|NCT00003110|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5398075|NCT00003110|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5398076|NCT00003110|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5398077|NCT00003110|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5398078|NCT00003110|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
5398079|NCT00003110|AIDS-related diffuse large cell lymphoma|aids-related diffuse large cell lymphoma
5398080|NCT00003110|AIDS-related immunoblastic large cell lymphoma|aids-related immunoblastic large cell lymphoma
5398081|NCT00003110|AIDS-related small noncleaved cell lymphoma|aids-related small noncleaved cell lymphoma
5398082|NCT00003110|AIDS-related diffuse mixed cell lymphoma|aids-related diffuse mixed cell lymphoma
5398083|NCT00003110|AIDS-related diffuse small cleaved cell lymphoma|aids-related diffuse small cleaved cell lymphoma
5398084|NCT00003110|AIDS-related lymphoblastic lymphoma|aids-related lymphoblastic lymphoma
5398085|NCT00003110|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
5398086|NCT00003110|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
5398087|NCT00003110|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5398088|NCT00002997|stage IV colon cancer|stage iv colon cancer
5398089|NCT00002997|stage IV rectal cancer|stage iv rectal cancer
5398090|NCT00002997|recurrent colon cancer|recurrent colon cancer
5398091|NCT00002997|recurrent rectal cancer|recurrent rectal cancer
5398092|NCT00002997|adenocarcinoma of the colon|adenocarcinoma of the colon
5398093|NCT00002997|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5398094|NCT00002997|liver metastases|liver metastases
5398095|NCT00024063|stage III colon cancer|stage iii colon cancer
5398096|NCT00024063|stage IV colon cancer|stage iv colon cancer
5398097|NCT00024063|stage IV breast cancer|stage iv breast cancer
5398098|NCT00024063|stage IIIA breast cancer|stage iiia breast cancer
5398099|NCT00024063|recurrent breast cancer|recurrent breast cancer
5398100|NCT00024063|stage III gastric cancer|stage iii gastric cancer
5398101|NCT00024063|stage IV gastric cancer|stage iv gastric cancer
5398102|NCT00024063|recurrent gastric cancer|recurrent gastric cancer
5398103|NCT00024063|stage IIIB breast cancer|stage iiib breast cancer
5398104|NCT00024063|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5398105|NCT00024063|stage II pancreatic cancer|stage ii pancreatic cancer
5398106|NCT00024063|stage III pancreatic cancer|stage iii pancreatic cancer
5398107|NCT00024063|recurrent pancreatic cancer|recurrent pancreatic cancer
5398108|NCT00024063|stage III rectal cancer|stage iii rectal cancer
5398109|NCT00024063|stage IV rectal cancer|stage iv rectal cancer
5398110|NCT00024063|recurrent colon cancer|recurrent colon cancer
5398111|NCT00024063|recurrent rectal cancer|recurrent rectal cancer
5398112|NCT00024063|refractory multiple myeloma|refractory multiple myeloma
5398113|NCT00024063|stage III renal cell cancer|stage iii renal cell cancer
5398114|NCT00024063|stage IV renal cell cancer|stage iv renal cell cancer
5398115|NCT00024063|recurrent renal cell cancer|recurrent renal cell cancer
5398116|NCT00024063|stage III multiple myeloma|stage iii multiple myeloma
5398117|NCT00024063|stage III prostate cancer|stage iii prostate cancer
5398118|NCT00024063|stage IV prostate cancer|stage iv prostate cancer
5398119|NCT00024063|recurrent prostate cancer|recurrent prostate cancer
5398120|NCT00024063|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5398121|NCT00024063|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5427976|NCT00047463|sleep apnea|sleep apnea
5398122|NCT00024063|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5398123|NCT00024063|male breast cancer|male breast cancer
5398124|NCT00024063|stage IV pancreatic cancer|stage iv pancreatic cancer
5398125|NCT00003107|stage IV breast cancer|stage iv breast cancer
5398126|NCT00003107|stage IIIA breast cancer|stage iiia breast cancer
5398127|NCT00003107|stage IIIB breast cancer|stage iiib breast cancer
5398128|NCT00003107|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5398129|NCT00003107|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5398130|NCT00003107|refractory multiple myeloma|refractory multiple myeloma
5398131|NCT00003107|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
5398132|NCT00003107|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5398133|NCT00003107|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5398134|NCT00003107|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5398135|NCT00003107|disseminated neuroblastoma|disseminated neuroblastoma
5398136|NCT00003107|recurrent neuroblastoma|recurrent neuroblastoma
5398137|NCT00003107|recurrent Wilms tumor and other childhood kidney tumors|recurrent wilms tumor and other childhood kidney tumors
5398138|NCT00003107|stage I multiple myeloma|stage i multiple myeloma
5398139|NCT00003107|stage II multiple myeloma|stage ii multiple myeloma
5398140|NCT00003107|stage III multiple myeloma|stage iii multiple myeloma
5398141|NCT00003107|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5398142|NCT00003107|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5398143|NCT00003107|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5398144|NCT00003107|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5398145|NCT00003107|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5398146|NCT00003107|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5398147|NCT00003107|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
5398148|NCT00003107|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
5398149|NCT00003107|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5398150|NCT00003107|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5398151|NCT00003107|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5398152|NCT00003107|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
5398153|NCT00003107|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
5398154|NCT00003107|testicular embryonal carcinoma|testicular embryonal carcinoma
5398155|NCT00003107|testicular choriocarcinoma|testicular choriocarcinoma
5398156|NCT00003107|testicular teratoma|testicular teratoma
5398157|NCT00003107|testicular yolk sac tumor|testicular yolk sac tumor
5398158|NCT00003107|testicular embryonal carcinoma and teratoma|testicular embryonal carcinoma and teratoma
5398159|NCT00003107|testicular embryonal carcinoma and teratoma with seminoma|testicular embryonal carcinoma and teratoma with seminoma
5398160|NCT00003107|testicular embryonal carcinoma and yolk sac tumor|testicular embryonal carcinoma and yolk sac tumor
5398161|NCT00003107|testicular embryonal carcinoma and yolk sac tumor with seminoma|testicular embryonal carcinoma and yolk sac tumor with seminoma
5398162|NCT00003107|testicular embryonal carcinoma and seminoma|testicular embryonal carcinoma and seminoma
5398163|NCT00003107|testicular yolk sac tumor and teratoma|testicular yolk sac tumor and teratoma
5398164|NCT00003107|testicular yolk sac tumor and teratoma with seminoma|testicular yolk sac tumor and teratoma with seminoma
5398165|NCT00003107|testicular choriocarcinoma and yolk sac tumor|testicular choriocarcinoma and yolk sac tumor
5398166|NCT00003107|testicular choriocarcinoma and embryonal carcinoma|testicular choriocarcinoma and embryonal carcinoma
5398167|NCT00003107|testicular choriocarcinoma and teratoma|testicular choriocarcinoma and teratoma
5398168|NCT00003107|testicular choriocarcinoma and seminoma|testicular choriocarcinoma and seminoma
5398169|NCT00003107|refractory hairy cell leukemia|refractory hairy cell leukemia
5398170|NCT00003107|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
5398171|NCT00003107|ovarian yolk sac tumor|ovarian yolk sac tumor
5398172|NCT00003107|ovarian embryonal carcinoma|ovarian embryonal carcinoma
5398173|NCT00003107|ovarian polyembryoma|ovarian polyembryoma
5398175|NCT00003107|ovarian immature teratoma|ovarian immature teratoma
5398176|NCT00003107|ovarian mature teratoma|ovarian mature teratoma
5398177|NCT00003107|ovarian monodermal and highly specialized teratoma|ovarian monodermal and highly specialized teratoma
5398178|NCT00003107|ovarian mixed germ cell tumor|ovarian mixed germ cell tumor
5398179|NCT00003107|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5398180|NCT00003107|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5398181|NCT00003107|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5398182|NCT00003107|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5398183|NCT00003107|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5398184|NCT00003107|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5398185|NCT00003107|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5398186|NCT00003107|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5398187|NCT00003107|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5398188|NCT00003107|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5398189|NCT00003107|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5428182|NCT00045968|brain tumor|brain tumor
5398190|NCT00003107|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5398191|NCT00003107|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5398192|NCT00003107|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5398193|NCT00003107|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5398194|NCT00003107|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5398195|NCT00003107|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5398196|NCT00003107|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5398197|NCT00003107|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5398198|NCT00003107|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5398199|NCT00003107|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5398200|NCT00003107|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5398201|NCT00003107|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5398202|NCT00003107|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5398203|NCT00003107|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5398204|NCT00003107|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5398205|NCT00003107|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5398206|NCT00003107|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5398207|NCT00003107|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5398208|NCT00003107|poor prognosis metastatic gestational trophoblastic tumor|poor prognosis metastatic gestational trophoblastic tumor
5398209|NCT00003107|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5398210|NCT00003107|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5398211|NCT00003107|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5398212|NCT00003107|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5398213|NCT00003107|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5398214|NCT00003107|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
5398215|NCT00003107|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5398216|NCT00003107|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
5398217|NCT00003107|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
5398218|NCT00003107|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5398219|NCT00003107|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
5398220|NCT00003107|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
5398221|NCT00003107|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5398222|NCT00003107|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5398223|NCT00003107|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5398224|NCT00003107|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5398225|NCT00003107|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
5398226|NCT00003107|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
5398227|NCT00003107|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5398228|NCT00003107|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5398229|NCT00003107|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5398230|NCT00003107|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5398231|NCT00003107|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5398232|NCT00003107|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5398233|NCT00003107|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5398234|NCT00003107|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5398235|NCT00003107|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5398236|NCT00003103|stage III colon cancer|stage iii colon cancer
5398237|NCT00003103|stage IV colon cancer|stage iv colon cancer
5398238|NCT00003103|stage IV breast cancer|stage iv breast cancer
5398239|NCT00003103|stage IIIA breast cancer|stage iiia breast cancer
5398240|NCT00003103|recurrent breast cancer|recurrent breast cancer
5398241|NCT00003103|stage IIIB breast cancer|stage iiib breast cancer
5398242|NCT00003103|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5398243|NCT00003103|stage III rectal cancer|stage iii rectal cancer
5398244|NCT00003103|stage IV rectal cancer|stage iv rectal cancer
5398245|NCT00003103|recurrent colon cancer|recurrent colon cancer
5398246|NCT00003103|recurrent rectal cancer|recurrent rectal cancer
5398247|NCT00003103|stage II esophageal cancer|stage ii esophageal cancer
5398248|NCT00003103|stage III esophageal cancer|stage iii esophageal cancer
5398249|NCT00003103|stage IV esophageal cancer|stage iv esophageal cancer
5398250|NCT00003103|recurrent esophageal cancer|recurrent esophageal cancer
5398251|NCT00003103|stage III renal cell cancer|stage iii renal cell cancer
5398252|NCT00003103|stage IV renal cell cancer|stage iv renal cell cancer
5398253|NCT00003103|recurrent renal cell cancer|recurrent renal cell cancer
5398254|NCT00003103|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5398255|NCT00003103|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5398256|NCT00003103|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5398257|NCT00003103|stage III Wilms tumor|stage iii wilms tumor
5398258|NCT00003103|stage IV Wilms tumor|stage iv wilms tumor
5398259|NCT00003103|stage V Wilms tumor|stage v wilms tumor
5398260|NCT00003103|recurrent Wilms tumor and other childhood kidney tumors|recurrent wilms tumor and other childhood kidney tumors
5398261|NCT00003103|stage III bladder cancer|stage iii bladder cancer
5398262|NCT00003103|recurrent bladder cancer|recurrent bladder cancer
5398263|NCT00003103|stage IV bladder cancer|stage iv bladder cancer
5398264|NCT00003103|stage III prostate cancer|stage iii prostate cancer
5398265|NCT00003103|stage IV prostate cancer|stage iv prostate cancer
5398266|NCT00003103|recurrent prostate cancer|recurrent prostate cancer
5398267|NCT00003103|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5398268|NCT00003103|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5398269|NCT00003103|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5398270|NCT00003103|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5398271|NCT00003103|untreated metastatic squamous neck cancer with occult primary|untreated metastatic squamous neck cancer with occult primary
5398272|NCT00003103|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
5398273|NCT00003103|ovarian stromal cancer|ovarian stromal cancer
5398274|NCT00003103|stage III ovarian germ cell tumor|stage iii ovarian germ cell tumor
5398275|NCT00003103|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
5398276|NCT00003103|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
5398277|NCT00003103|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
5398278|NCT00003103|stage III basal cell carcinoma of the lip|stage iii basal cell carcinoma of the lip
5398279|NCT00003103|stage III verrucous carcinoma of the oral cavity|stage iii verrucous carcinoma of the oral cavity
5398280|NCT00003103|stage III mucoepidermoid carcinoma of the oral cavity|stage iii mucoepidermoid carcinoma of the oral cavity
5398281|NCT00003103|stage III adenoid cystic carcinoma of the oral cavity|stage iii adenoid cystic carcinoma of the oral cavity
5398282|NCT00003103|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5398283|NCT00003103|stage IV basal cell carcinoma of the lip|stage iv basal cell carcinoma of the lip
5398284|NCT00003103|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
5398285|NCT00003103|stage IV mucoepidermoid carcinoma of the oral cavity|stage iv mucoepidermoid carcinoma of the oral cavity
5398286|NCT00003103|stage IV adenoid cystic carcinoma of the oral cavity|stage iv adenoid cystic carcinoma of the oral cavity
5398287|NCT00003103|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
5398288|NCT00003103|recurrent basal cell carcinoma of the lip|recurrent basal cell carcinoma of the lip
5398289|NCT00003103|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
5398290|NCT00003103|recurrent mucoepidermoid carcinoma of the oral cavity|recurrent mucoepidermoid carcinoma of the oral cavity
5398291|NCT00003103|recurrent adenoid cystic carcinoma of the oral cavity|recurrent adenoid cystic carcinoma of the oral cavity
5398292|NCT00003103|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
5398293|NCT00003103|stage III lymphoepithelioma of the oropharynx|stage iii lymphoepithelioma of the oropharynx
5398294|NCT00003103|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5398295|NCT00003103|stage IV lymphoepithelioma of the oropharynx|stage iv lymphoepithelioma of the oropharynx
5398296|NCT00003103|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
5398297|NCT00003103|recurrent lymphoepithelioma of the oropharynx|recurrent lymphoepithelioma of the oropharynx
5398298|NCT00003103|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
5398299|NCT00003103|stage III lymphoepithelioma of the nasopharynx|stage iii lymphoepithelioma of the nasopharynx
5398300|NCT00003103|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
5398301|NCT00003103|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
5398302|NCT00003103|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
5398303|NCT00003103|recurrent lymphoepithelioma of the nasopharynx|recurrent lymphoepithelioma of the nasopharynx
5398304|NCT00003103|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
5398305|NCT00003103|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5398306|NCT00003103|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
5398307|NCT00003103|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
5398308|NCT00003103|stage III verrucous carcinoma of the larynx|stage iii verrucous carcinoma of the larynx
5398309|NCT00003103|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5398310|NCT00003103|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
5398311|NCT00003103|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
5398312|NCT00003103|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
5398313|NCT00003103|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
5398314|NCT00003103|stage III inverted papilloma of the paranasal sinus and nasal cavity|stage iii inverted papilloma of the paranasal sinus and nasal cavity
5398315|NCT00003103|stage III midline lethal granuloma of the paranasal sinus and nasal cavity|stage iii midline lethal granuloma of the paranasal sinus and nasal cavity
5398316|NCT00003103|stage III esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iii esthesioneuroblastoma of the paranasal sinus and nasal cavity
5398317|NCT00003103|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
5398318|NCT00003103|stage IV inverted papilloma of the paranasal sinus and nasal cavity|stage iv inverted papilloma of the paranasal sinus and nasal cavity
5398319|NCT00003103|stage IV midline lethal granuloma of the paranasal sinus and nasal cavity|stage iv midline lethal granuloma of the paranasal sinus and nasal cavity
5398320|NCT00003103|stage IV esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iv esthesioneuroblastoma of the paranasal sinus and nasal cavity
5398321|NCT00003103|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
5398322|NCT00003103|recurrent inverted papilloma of the paranasal sinus and nasal cavity|recurrent inverted papilloma of the paranasal sinus and nasal cavity
5398323|NCT00003103|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity
5398324|NCT00003103|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity
5398325|NCT00003103|borderline ovarian surface epithelial-stromal tumor|borderline ovarian surface epithelial-stromal tumor
5398326|NCT00003103|ovarian sarcoma|ovarian sarcoma
5398327|NCT00003103|clear cell sarcoma of the kidney|clear cell sarcoma of the kidney
5398328|NCT00003103|rhabdoid tumor of the kidney|rhabdoid tumor of the kidney
5398329|NCT00003012|stage II breast cancer|stage ii breast cancer
5398330|NCT00003012|stage IIIA breast cancer|stage iiia breast cancer
5398331|NCT00002987|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
5398332|NCT00002987|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
5398333|NCT00002814|recurrent adult brain tumor|recurrent adult brain tumor
5398334|NCT00002814|adult glioblastoma|adult glioblastoma
5398335|NCT00002814|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5398336|NCT00002814|adult giant cell glioblastoma|adult giant cell glioblastoma
5398337|NCT00002814|adult gliosarcoma|adult gliosarcoma
5398338|NCT00002774|stage III|stage iii
5398339|NCT00002774|stage IV|stage iv
5398340|NCT00002774|recurrent|recurrent
5398341|NCT00002714|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
5398342|NCT00002714|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
5398343|NCT00002600|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5398344|NCT00002600|ovarian undifferentiated adenocarcinoma|ovarian undifferentiated adenocarcinoma
5398345|NCT00002600|ovarian mixed epithelial carcinoma|ovarian mixed epithelial carcinoma
5398346|NCT00002600|ovarian serous cystadenocarcinoma|ovarian serous cystadenocarcinoma
5398347|NCT00002600|ovarian mucinous cystadenocarcinoma|ovarian mucinous cystadenocarcinoma
5398348|NCT00002600|ovarian endometrioid adenocarcinoma|ovarian endometrioid adenocarcinoma
5398349|NCT00002600|ovarian clear cell cystadenocarcinoma|ovarian clear cell cystadenocarcinoma
5398350|NCT00002600|fallopian tube cancer|fallopian tube cancer
5398351|NCT00002600|primary peritoneal cavity cancer|primary peritoneal cavity cancer
5398352|NCT00002525|stage II colon cancer|stage ii colon cancer
5398353|NCT00002525|stage III colon cancer|stage iii colon cancer
5398354|NCT00002494|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
5398355|NCT00002494|L3 adult acute lymphoblastic leukemia|l3 adult acute lymphoblastic leukemia
5398356|NCT00002494|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
5398357|NCT00002494|stage II adult Burkitt lymphoma|stage ii adult burkitt lymphoma
5398358|NCT00002494|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5398359|NCT00002494|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5398360|NCT00002494|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
5398361|NCT00002494|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
5398362|NCT00080470|Incontinence|incontinence
5398363|NCT00080470|Refractory|refractory
5398364|NCT00080470|Urinary|urinary
5398365|NCT00080470|Urge|urge
5398366|NCT00080470|Stimulation|stimulation
5398367|NCT00080470|Nerve|nerve
5398368|NCT00080470|Microstimulator|microstimulator
5398369|NCT00080470|Neuromodulation|neuromodulation
5398370|NCT00080457|Primary or secondary pulmonary arterial hypertension|primary or secondary pulmonary arterial hypertension
5398371|NCT00080457|Scleroderma|scleroderma
5398372|NCT00080457|Connective tissue disease|connective tissue disease
5398373|NCT00080457|Congenital heart defects|congenital heart defects
5398374|NCT00080457|Lupus|lupus
5398375|NCT00080457|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
5398376|NCT00023816|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5398377|NCT00023816|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5398378|NCT00023816|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
5398379|NCT00023816|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5398380|NCT00023816|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5398381|NCT00023816|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5398382|NCT00023816|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5398383|NCT00023816|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5398457|NCT00014573|adult mixed glioma|adult mixed glioma
5398384|NCT00023816|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5398385|NCT00023816|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5398386|NCT00023816|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5398387|NCT00023816|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5398388|NCT00023816|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5398389|NCT00023816|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5398390|NCT00023816|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5398391|NCT00023816|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5398392|NCT00023816|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5398393|NCT00023816|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5398394|NCT00023816|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5398395|NCT00023816|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5398396|NCT00023816|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5398397|NCT00023816|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5398398|NCT00023816|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5398399|NCT00023816|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
5398400|NCT00023816|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
5398401|NCT00023816|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
5398402|NCT00023816|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
5398403|NCT00023816|AIDS-related primary CNS lymphoma|aids-related primary cns lymphoma
5398404|NCT00023816|intraocular lymphoma|intraocular lymphoma
5398405|NCT00023816|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5398406|NCT00023816|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5398407|NCT00023816|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5398408|NCT00023816|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
5398409|NCT00023816|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5398410|NCT00023816|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5398411|NCT00023816|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5398412|NCT00023816|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5398413|NCT00023816|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5398414|NCT00023816|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5398415|NCT00023816|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5398416|NCT00023816|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5398417|NCT00022386|stage I breast cancer|stage i breast cancer
5398418|NCT00022386|stage II breast cancer|stage ii breast cancer
5398419|NCT00022386|stage IIIA breast cancer|stage iiia breast cancer
5398420|NCT00022386|stage IIIB breast cancer|stage iiib breast cancer
5398421|NCT00022386|anemia|anemia
5398422|NCT00022386|fatigue|fatigue
5398423|NCT00022256|adult glioblastoma|adult glioblastoma
5398424|NCT00022256|adult giant cell glioblastoma|adult giant cell glioblastoma
5398425|NCT00022256|adult gliosarcoma|adult gliosarcoma
5398426|NCT00020605|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5398427|NCT00020605|constipation, impaction, and bowel obstruction|constipation, impaction, and bowel obstruction
5398428|NCT00020540|stage IV renal cell cancer|stage iv renal cell cancer
5398429|NCT00020540|recurrent renal cell cancer|recurrent renal cell cancer
5398430|NCT00020540|stage IV melanoma|stage iv melanoma
5398431|NCT00020540|recurrent melanoma|recurrent melanoma
5398432|NCT00019071|adult glioblastoma|adult glioblastoma
5398433|NCT00019071|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5398434|NCT00019071|adult giant cell glioblastoma|adult giant cell glioblastoma
5398435|NCT00019071|adult gliosarcoma|adult gliosarcoma
5398436|NCT00019058|adult glioblastoma|adult glioblastoma
5398437|NCT00019058|adult giant cell glioblastoma|adult giant cell glioblastoma
5398438|NCT00019058|adult gliosarcoma|adult gliosarcoma
5398439|NCT00016042|stage IV colon cancer|stage iv colon cancer
5398440|NCT00016042|stage IV rectal cancer|stage iv rectal cancer
5398441|NCT00016042|recurrent colon cancer|recurrent colon cancer
5398442|NCT00016042|recurrent rectal cancer|recurrent rectal cancer
5398443|NCT00016042|stage IV renal cell cancer|stage iv renal cell cancer
5398444|NCT00016042|recurrent renal cell cancer|recurrent renal cell cancer
5398445|NCT00014573|childhood infratentorial ependymoma|childhood infratentorial ependymoma
5398446|NCT00014573|childhood supratentorial ependymoma|childhood supratentorial ependymoma
5398447|NCT00014573|childhood central nervous system germ cell tumor|childhood central nervous system germ cell tumor
5398448|NCT00014573|recurrent adult brain tumor|recurrent adult brain tumor
5398449|NCT00014573|adult brain stem glioma|adult brain stem glioma
5398450|NCT00014573|adult medulloblastoma|adult medulloblastoma
5398451|NCT00014573|adult glioblastoma|adult glioblastoma
5398452|NCT00014573|childhood high-grade cerebral astrocytoma|childhood high-grade cerebral astrocytoma
5398453|NCT00014573|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5398454|NCT00014573|childhood choroid plexus tumor|childhood choroid plexus tumor
5398455|NCT00014573|childhood grade III meningioma|childhood grade iii meningioma
5398456|NCT00014573|adult anaplastic ependymoma|adult anaplastic ependymoma
5398458|NCT00014573|adult central nervous system germ cell tumor|adult central nervous system germ cell tumor
5398459|NCT00014573|adult ependymoblastoma|adult ependymoblastoma
5398460|NCT00014573|recurrent childhood brain stem glioma|recurrent childhood brain stem glioma
5398461|NCT00014573|recurrent childhood supratentorial primitive neuroectodermal tumor|recurrent childhood supratentorial primitive neuroectodermal tumor
5398462|NCT00014573|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
5398463|NCT00014573|recurrent childhood medulloblastoma|recurrent childhood medulloblastoma
5398464|NCT00014573|adult choroid plexus tumor|adult choroid plexus tumor
5398465|NCT00014573|recurrent childhood ependymoma|recurrent childhood ependymoma
5398466|NCT00014573|adult grade III meningioma|adult grade iii meningioma
5398467|NCT00014573|adult giant cell glioblastoma|adult giant cell glioblastoma
5398468|NCT00014573|adult gliosarcoma|adult gliosarcoma
5398469|NCT00080418|neoplasm|neoplasm
5398470|NCT00080418|cancer|cancer
5398471|NCT00080418|NeoPharm|neopharm
5398472|NCT00080418|liposomes|liposomes
5398473|NCT00080418|Taxol|taxol
5398474|NCT00080418|paclitaxel|paclitaxel
5398475|NCT00080418|anti-cancer|anti-cancer
5398476|NCT00080418|advanced neoplasm|advanced neoplasm
5398477|NCT00080418|advanced cancer|advanced cancer
5398478|NCT00080418|chemotherapy|chemotherapy
5398479|NCT00080418|refractory cancer|refractory cancer
5398480|NCT00080418|metastatic cancer|metastatic cancer
5398481|NCT00080405|Relapsed|relapsed
5398482|NCT00080405|Multiple Myeloma|multiple myeloma
5398483|NCT00080405|Pharmacokinetic|pharmacokinetic
5398484|NCT00080405|Pharmacodynamic|pharmacodynamic
5398485|NCT00009841|untreated metastatic squamous neck cancer with occult primary|untreated metastatic squamous neck cancer with occult primary
5398486|NCT00009841|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
5398487|NCT00009841|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
5398488|NCT00009841|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5398489|NCT00009841|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
5398490|NCT00009841|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5398491|NCT00009841|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
5398492|NCT00009841|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
5398493|NCT00009841|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
5398494|NCT00009841|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5398495|NCT00009841|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
5398496|NCT00009841|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5398497|NCT00009841|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
5398498|NCT00009841|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
5398499|NCT00009841|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
5398500|NCT00007813|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
5398501|NCT00007813|childhood craniopharyngioma|childhood craniopharyngioma
5398502|NCT00007813|recurrent childhood brain tumor|recurrent childhood brain tumor
5398503|NCT00007813|disseminated neuroblastoma|disseminated neuroblastoma
5398504|NCT00007813|stage 4S neuroblastoma|stage 4s neuroblastoma
5398505|NCT00007813|recurrent neuroblastoma|recurrent neuroblastoma
5398506|NCT00007813|stage IV childhood liver cancer|stage iv childhood liver cancer
5398507|NCT00007813|recurrent childhood liver cancer|recurrent childhood liver cancer
5398508|NCT00007813|childhood hepatoblastoma|childhood hepatoblastoma
5398509|NCT00007813|childhood central nervous system germ cell tumor|childhood central nervous system germ cell tumor
5398510|NCT00007813|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
5398511|NCT00007813|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
5398512|NCT00007813|childhood germ cell tumor|childhood germ cell tumor
5398513|NCT00007813|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
5398514|NCT00007813|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
5398515|NCT00007813|extragonadal germ cell tumor|extragonadal germ cell tumor
5398516|NCT00007813|childhood oligodendroglioma|childhood oligodendroglioma
5398517|NCT00007813|childhood choroid plexus tumor|childhood choroid plexus tumor
5398518|NCT00007813|childhood grade III meningioma|childhood grade iii meningioma
5398519|NCT00007813|recurrent childhood cerebellar astrocytoma|recurrent childhood cerebellar astrocytoma
5398520|NCT00007813|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
5398521|NCT00007813|recurrent childhood medulloblastoma|recurrent childhood medulloblastoma
5398522|NCT00007813|recurrent childhood visual pathway and hypothalamic glioma|recurrent childhood visual pathway and hypothalamic glioma
5398523|NCT00007813|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
5398524|NCT00007813|metastatic Ewing sarcoma/peripheral primitive neuroectodermal tumor|metastatic ewing sarcoma/peripheral primitive neuroectodermal tumor
5398525|NCT00007813|recurrent Ewing sarcoma/peripheral primitive neuroectodermal tumor|recurrent ewing sarcoma/peripheral primitive neuroectodermal tumor
5428285|NCT00044538|Taxane|taxane
5398526|NCT00007813|recurrent childhood ependymoma|recurrent childhood ependymoma
5398527|NCT00007813|childhood teratoma|childhood teratoma
5398528|NCT00007813|childhood malignant testicular germ cell tumor|childhood malignant testicular germ cell tumor
5398529|NCT00007813|childhood malignant ovarian germ cell tumor|childhood malignant ovarian germ cell tumor
5398530|NCT00007813|childhood extragonadal germ cell tumor|childhood extragonadal germ cell tumor
5398531|NCT00007813|recurrent childhood malignant germ cell tumor|recurrent childhood malignant germ cell tumor
5398532|NCT00007813|childhood atypical teratoid/rhabdoid tumor|childhood atypical teratoid/rhabdoid tumor
5398533|NCT00006487|limited stage small cell lung cancer|limited stage small cell lung cancer
5398534|NCT00006458|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5398535|NCT00006458|squamous cell lung cancer|squamous cell lung cancer
5398536|NCT00006458|large cell lung cancer|large cell lung cancer
5398537|NCT00006458|adenocarcinoma of the lung|adenocarcinoma of the lung
5398538|NCT00006458|adenosquamous cell lung cancer|adenosquamous cell lung cancer
5398539|NCT00006376|stage II bladder cancer|stage ii bladder cancer
5398540|NCT00006376|stage III bladder cancer|stage iii bladder cancer
5398541|NCT00006376|recurrent bladder cancer|recurrent bladder cancer
5398542|NCT00006376|stage IV bladder cancer|stage iv bladder cancer
5398543|NCT00006376|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
5398544|NCT00006376|metastatic transitional cell cancer of the renal pelvis and ureter|metastatic transitional cell cancer of the renal pelvis and ureter
5398545|NCT00006376|regional transitional cell cancer of the renal pelvis and ureter|regional transitional cell cancer of the renal pelvis and ureter
5398546|NCT00006376|recurrent transitional cell cancer of the renal pelvis and ureter|recurrent transitional cell cancer of the renal pelvis and ureter
5398547|NCT00006371|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5398548|NCT00006371|stage IV prostate cancer|stage iv prostate cancer
5398549|NCT00006371|recurrent prostate cancer|recurrent prostate cancer
5398550|NCT00006370|stage IV breast cancer|stage iv breast cancer
5398551|NCT00006370|recurrent breast cancer|recurrent breast cancer
5398552|NCT00006370|recurrent small cell lung cancer|recurrent small cell lung cancer
5398553|NCT00006370|male breast cancer|male breast cancer
5398554|NCT00006369|stage IV breast cancer|stage iv breast cancer
5398555|NCT00006369|recurrent breast cancer|recurrent breast cancer
5398556|NCT00006368|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5398557|NCT00006368|stage IV breast cancer|stage iv breast cancer
5398558|NCT00006368|recurrent breast cancer|recurrent breast cancer
5398559|NCT00006368|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5398560|NCT00006368|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5398561|NCT00006368|extensive stage small cell lung cancer|extensive stage small cell lung cancer
5398562|NCT00006368|recurrent small cell lung cancer|recurrent small cell lung cancer
5398563|NCT00006368|metastatic gastrointestinal carcinoid tumor|metastatic gastrointestinal carcinoid tumor
5398564|NCT00006368|recurrent gastrointestinal carcinoid tumor|recurrent gastrointestinal carcinoid tumor
5398565|NCT00006368|gastrinoma|gastrinoma
5398566|NCT00006368|recurrent adult brain tumor|recurrent adult brain tumor
5398567|NCT00006368|insulinoma|insulinoma
5398568|NCT00006368|recurrent islet cell carcinoma|recurrent islet cell carcinoma
5398569|NCT00006368|ACTH-producing pituitary tumor|acth-producing pituitary tumor
5398570|NCT00006368|prolactin-producing pituitary tumor|prolactin-producing pituitary tumor
5398571|NCT00006368|growth hormone-producing pituitary tumor|growth hormone-producing pituitary tumor
5398572|NCT00006368|recurrent pituitary tumor|recurrent pituitary tumor
5398573|NCT00006368|TSH producing pituitary tumor|tsh producing pituitary tumor
5398574|NCT00006368|nonfunctioning pituitary tumor|nonfunctioning pituitary tumor
5398575|NCT00006368|adult brain stem glioma|adult brain stem glioma
5398576|NCT00006368|adult craniopharyngioma|adult craniopharyngioma
5398577|NCT00006368|adult medulloblastoma|adult medulloblastoma
5398578|NCT00006368|adult meningioma|adult meningioma
5398579|NCT00006368|adult glioblastoma|adult glioblastoma
5398580|NCT00006368|stage IV melanoma|stage iv melanoma
5398581|NCT00006368|recurrent melanoma|recurrent melanoma
5398582|NCT00006368|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5398583|NCT00006368|WDHA syndrome|wdha syndrome
5398584|NCT00006368|somatostatinoma|somatostatinoma
5398585|NCT00006368|pancreatic polypeptide tumor|pancreatic polypeptide tumor
5398586|NCT00006368|glucagonoma|glucagonoma
5398587|NCT00006368|pulmonary carcinoid tumor|pulmonary carcinoid tumor
5398588|NCT00006368|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5398589|NCT00006368|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5398590|NCT00006368|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5398591|NCT00006368|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5398592|NCT00006368|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5398593|NCT00006368|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5398594|NCT00006368|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5398595|NCT00006368|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5398596|NCT00006368|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5398597|NCT00006368|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5398598|NCT00006368|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5398875|NCT00003657|metastatic osteosarcoma|metastatic osteosarcoma
5398599|NCT00006368|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5398600|NCT00006368|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5398601|NCT00006368|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5398602|NCT00006368|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5398603|NCT00006368|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5398604|NCT00006368|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5398605|NCT00006368|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5398606|NCT00006368|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5398607|NCT00006368|adult myxopapillary ependymoma|adult myxopapillary ependymoma
5398608|NCT00006368|adult anaplastic ependymoma|adult anaplastic ependymoma
5398609|NCT00006368|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
5398610|NCT00006368|adult central nervous system germ cell tumor|adult central nervous system germ cell tumor
5398611|NCT00006368|adult pilocytic astrocytoma|adult pilocytic astrocytoma
5398612|NCT00006368|adult subependymoma|adult subependymoma
5398613|NCT00006368|adult ependymoblastoma|adult ependymoblastoma
5398614|NCT00006368|adult pineocytoma|adult pineocytoma
5398615|NCT00006368|adult pineoblastoma|adult pineoblastoma
5398616|NCT00006368|adult meningeal hemangiopericytoma|adult meningeal hemangiopericytoma
5398617|NCT00006368|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5398618|NCT00006368|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5398619|NCT00006368|adult choroid plexus tumor|adult choroid plexus tumor
5398620|NCT00006368|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5398621|NCT00006368|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5398622|NCT00006368|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5398623|NCT00006368|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5398624|NCT00006368|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5398625|NCT00006368|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5398626|NCT00006368|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5398627|NCT00006368|adult grade III meningioma|adult grade iii meningioma
5398628|NCT00006368|adult giant cell glioblastoma|adult giant cell glioblastoma
5398629|NCT00006368|adult gliosarcoma|adult gliosarcoma
5398630|NCT00006052|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5398631|NCT00006052|chronic myelogenous leukemia, BCR-ABL1 positive|chronic myelogenous leukemia, bcr-abl1 positive
5398632|NCT00006052|Philadelphia chromosome negative chronic myelogenous leukemia|philadelphia chromosome negative chronic myelogenous leukemia
5398633|NCT00006043|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
5398634|NCT00006043|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
5398635|NCT00006043|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
5398636|NCT00006043|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
5398637|NCT00006032|stage IV breast cancer|stage iv breast cancer
5398638|NCT00006032|recurrent breast cancer|recurrent breast cancer
5398639|NCT00006031|biopsy|biopsy
5398640|NCT00006031|radioactive seed|radioactive seed
5398641|NCT00006031|nonpalpable lesions|nonpalpable lesions
5398642|NCT00005948|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5398643|NCT00005948|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5398644|NCT00005948|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5398645|NCT00005860|stage IV colon cancer|stage iv colon cancer
5398646|NCT00005860|stage IV gastric cancer|stage iv gastric cancer
5398647|NCT00005860|recurrent gastric cancer|recurrent gastric cancer
5398648|NCT00005860|recurrent pancreatic cancer|recurrent pancreatic cancer
5398649|NCT00005860|recurrent colon cancer|recurrent colon cancer
5398650|NCT00005860|regional neuroblastoma|regional neuroblastoma
5398651|NCT00005860|stage 4S neuroblastoma|stage 4s neuroblastoma
5398652|NCT00005860|recurrent neuroblastoma|recurrent neuroblastoma
5398653|NCT00005860|regional gastrointestinal carcinoid tumor|regional gastrointestinal carcinoid tumor
5398654|NCT00005860|metastatic gastrointestinal carcinoid tumor|metastatic gastrointestinal carcinoid tumor
5398655|NCT00005860|recurrent gastrointestinal carcinoid tumor|recurrent gastrointestinal carcinoid tumor
5398656|NCT00005860|advanced adult primary liver cancer|advanced adult primary liver cancer
5398657|NCT00005860|recurrent adult primary liver cancer|recurrent adult primary liver cancer
5398658|NCT00005860|gastrinoma|gastrinoma
5398659|NCT00005860|small intestine adenocarcinoma|small intestine adenocarcinoma
5398660|NCT00005860|small intestine lymphoma|small intestine lymphoma
5398661|NCT00005860|small intestine leiomyosarcoma|small intestine leiomyosarcoma
5398662|NCT00005860|unresectable gallbladder cancer|unresectable gallbladder cancer
5398663|NCT00005860|recurrent gallbladder cancer|recurrent gallbladder cancer
5399056|NCT00080223|pulmonary fibrosis|pulmonary fibrosis
5398664|NCT00005860|unresectable extrahepatic bile duct cancer|unresectable extrahepatic bile duct cancer
5398665|NCT00005860|recurrent extrahepatic bile duct cancer|recurrent extrahepatic bile duct cancer
5398666|NCT00005860|recurrent small intestine cancer|recurrent small intestine cancer
5398667|NCT00005860|insulinoma|insulinoma
5398668|NCT00005860|recurrent islet cell carcinoma|recurrent islet cell carcinoma
5398669|NCT00005860|WDHA syndrome|wdha syndrome
5398670|NCT00005860|somatostatinoma|somatostatinoma
5428812|NCT00042276|Muscle Pain|muscle pain
5398671|NCT00005860|pancreatic polypeptide tumor|pancreatic polypeptide tumor
5398672|NCT00005860|glucagonoma|glucagonoma
5398673|NCT00005860|regional pheochromocytoma|regional pheochromocytoma
5398674|NCT00005860|metastatic pheochromocytoma|metastatic pheochromocytoma
5398675|NCT00005860|recurrent pheochromocytoma|recurrent pheochromocytoma
5398676|NCT00005860|extragonadal germ cell tumor|extragonadal germ cell tumor
5398677|NCT00005860|liver metastases|liver metastases
5398678|NCT00005860|malignant ascites|malignant ascites
5398679|NCT00005860|newly diagnosed carcinoma of unknown primary|newly diagnosed carcinoma of unknown primary
5398680|NCT00005860|carcinoma of the appendix|carcinoma of the appendix
5398681|NCT00005860|pseudomyxoma peritonei|pseudomyxoma peritonei
5398682|NCT00005860|fallopian tube cancer|fallopian tube cancer
5398683|NCT00005860|primary peritoneal cavity cancer|primary peritoneal cavity cancer
5398684|NCT00005860|recurrent carcinoma of unknown primary|recurrent carcinoma of unknown primary
5398685|NCT00005860|gastrointestinal stromal tumor|gastrointestinal stromal tumor
5398686|NCT00005860|stage IV pancreatic cancer|stage iv pancreatic cancer
5398687|NCT00005798|stage II breast cancer|stage ii breast cancer
5398688|NCT00005798|stage IV breast cancer|stage iv breast cancer
5398689|NCT00005798|stage IIIA breast cancer|stage iiia breast cancer
5398690|NCT00005798|recurrent breast cancer|recurrent breast cancer
5398691|NCT00005798|stage IIIB breast cancer|stage iiib breast cancer
5398692|NCT00005798|inflammatory breast cancer|inflammatory breast cancer
5398693|NCT00005628|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
5398694|NCT00005628|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
5398695|NCT00005618|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5398696|NCT00005618|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5398697|NCT00005618|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5398698|NCT00005618|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5398699|NCT00005615|stage III melanoma|stage iii melanoma
5398700|NCT00005615|recurrent melanoma|recurrent melanoma
5398701|NCT00005577|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
5398702|NCT00005097|squamous cell carcinoma of the skin|squamous cell carcinoma of the skin
5398703|NCT00005068|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5398704|NCT00003864|stage III esophageal cancer|stage iii esophageal cancer
5398705|NCT00003864|stage IV esophageal cancer|stage iv esophageal cancer
5398706|NCT00003864|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
5398707|NCT00080431|Reservoir|reservoir
5398708|NCT00080431|Viral Load|viral load
5398709|NCT00080431|Immunosuppression|immunosuppression
5398710|NCT00080431|Activation|activation
5398711|NCT00080431|Latency|latency
5398712|NCT00080431|HIV|hiv
5398713|NCT00080431|HAART|haart
5398714|NCT00080431|Immunosuppressive Drug|immunosuppressive drug
5398715|NCT00080431|Viral Reservoirs|viral reservoirs
5398716|NCT00005031|recurrent endometrial carcinoma|recurrent endometrial carcinoma
5398717|NCT00004248|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
5398718|NCT00004248|recurrent adult primary liver cancer|recurrent adult primary liver cancer
5398719|NCT00004248|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
5398720|NCT00004097|stage III nasopharyngeal cancer|stage iii nasopharyngeal cancer
5398721|NCT00004097|stage IV nasopharyngeal cancer|stage iv nasopharyngeal cancer
5398722|NCT00004097|recurrent nasopharyngeal cancer|recurrent nasopharyngeal cancer
5398723|NCT00004097|untreated metastatic squamous neck cancer with occult primary|untreated metastatic squamous neck cancer with occult primary
5398724|NCT00004097|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
5398725|NCT00004097|stage III lip and oral cavity cancer|stage iii lip and oral cavity cancer
5398726|NCT00004097|stage IV lip and oral cavity cancer|stage iv lip and oral cavity cancer
5398727|NCT00004097|recurrent lip and oral cavity cancer|recurrent lip and oral cavity cancer
5398728|NCT00004097|stage III hypopharyngeal cancer|stage iii hypopharyngeal cancer
5398729|NCT00004097|stage IV hypopharyngeal cancer|stage iv hypopharyngeal cancer
5398730|NCT00004097|recurrent hypopharyngeal cancer|recurrent hypopharyngeal cancer
5398731|NCT00004097|stage III laryngeal cancer|stage iii laryngeal cancer
5398732|NCT00004097|stage IV laryngeal cancer|stage iv laryngeal cancer
5398733|NCT00004097|recurrent laryngeal cancer|recurrent laryngeal cancer
5398734|NCT00004097|stage III paranasal sinus and nasal cavity cancer|stage iii paranasal sinus and nasal cavity cancer
5398735|NCT00004097|stage IV paranasal sinus and nasal cavity cancer|stage iv paranasal sinus and nasal cavity cancer
5398736|NCT00004097|recurrent paranasal sinus and nasal cavity cancer|recurrent paranasal sinus and nasal cavity cancer
5398737|NCT00004097|stage III oropharyngeal cancer|stage iii oropharyngeal cancer
5398738|NCT00004097|stage IV oropharyngeal cancer|stage iv oropharyngeal cancer
5398739|NCT00004097|recurrent oropharyngeal cancer|recurrent oropharyngeal cancer
5398740|NCT00003967|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5398741|NCT00003967|ovarian undifferentiated adenocarcinoma|ovarian undifferentiated adenocarcinoma
5398742|NCT00003967|ovarian mixed epithelial carcinoma|ovarian mixed epithelial carcinoma
5398743|NCT00003967|ovarian serous cystadenocarcinoma|ovarian serous cystadenocarcinoma
5398744|NCT00003967|ovarian mucinous cystadenocarcinoma|ovarian mucinous cystadenocarcinoma
5398745|NCT00003967|ovarian endometrioid adenocarcinoma|ovarian endometrioid adenocarcinoma
5398746|NCT00003967|ovarian clear cell cystadenocarcinoma|ovarian clear cell cystadenocarcinoma
5398747|NCT00003967|fallopian tube cancer|fallopian tube cancer
5398748|NCT00003967|primary peritoneal cavity cancer|primary peritoneal cavity cancer
5398749|NCT00003967|Brenner tumor|brenner tumor
5398750|NCT00003883|stage IV breast cancer|stage iv breast cancer
5398751|NCT00003883|stage IIIA breast cancer|stage iiia breast cancer
5398752|NCT00003883|stage IIIB breast cancer|stage iiib breast cancer
5398753|NCT00003883|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5398754|NCT00003883|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5398755|NCT00003883|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5398756|NCT00003883|refractory multiple myeloma|refractory multiple myeloma
5398757|NCT00003883|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
5398758|NCT00003883|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
5398759|NCT00003883|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5398760|NCT00003883|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5398761|NCT00003883|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5398762|NCT00003883|disseminated neuroblastoma|disseminated neuroblastoma
5398763|NCT00003883|recurrent neuroblastoma|recurrent neuroblastoma
5398764|NCT00003883|recurrent Wilms tumor and other childhood kidney tumors|recurrent wilms tumor and other childhood kidney tumors
5398765|NCT00003883|stage I multiple myeloma|stage i multiple myeloma
5398766|NCT00003883|stage II multiple myeloma|stage ii multiple myeloma
5398767|NCT00003883|stage III multiple myeloma|stage iii multiple myeloma
5398768|NCT00003883|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
5398769|NCT00003883|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5398770|NCT00003883|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5398771|NCT00003883|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5398772|NCT00003883|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5398773|NCT00003883|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5398774|NCT00003883|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5398775|NCT00003883|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5398776|NCT00003883|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
5398777|NCT00003883|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
5398778|NCT00003883|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5398779|NCT00003883|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5398780|NCT00003883|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5398781|NCT00003883|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
5398782|NCT00003883|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
5398783|NCT00003883|childhood acute promyelocytic leukemia (M3)|childhood acute promyelocytic leukemia (m3)
5398784|NCT00003883|testicular embryonal carcinoma|testicular embryonal carcinoma
5398785|NCT00003883|testicular choriocarcinoma|testicular choriocarcinoma
5398786|NCT00003883|testicular teratoma|testicular teratoma
5398787|NCT00003883|testicular yolk sac tumor|testicular yolk sac tumor
5398788|NCT00003883|testicular embryonal carcinoma and teratoma|testicular embryonal carcinoma and teratoma
5398789|NCT00003883|testicular embryonal carcinoma and teratoma with seminoma|testicular embryonal carcinoma and teratoma with seminoma
5398790|NCT00003883|testicular embryonal carcinoma and yolk sac tumor|testicular embryonal carcinoma and yolk sac tumor
5398791|NCT00003883|testicular embryonal carcinoma and yolk sac tumor with seminoma|testicular embryonal carcinoma and yolk sac tumor with seminoma
5398792|NCT00003883|testicular embryonal carcinoma and seminoma|testicular embryonal carcinoma and seminoma
5398793|NCT00003883|testicular yolk sac tumor and teratoma|testicular yolk sac tumor and teratoma
5398794|NCT00003883|testicular yolk sac tumor and teratoma with seminoma|testicular yolk sac tumor and teratoma with seminoma
5398795|NCT00003883|testicular choriocarcinoma and yolk sac tumor|testicular choriocarcinoma and yolk sac tumor
5398796|NCT00003883|testicular choriocarcinoma and embryonal carcinoma|testicular choriocarcinoma and embryonal carcinoma
5398797|NCT00003883|testicular choriocarcinoma and teratoma|testicular choriocarcinoma and teratoma
5398798|NCT00003883|testicular choriocarcinoma and seminoma|testicular choriocarcinoma and seminoma
5398799|NCT00003883|refractory hairy cell leukemia|refractory hairy cell leukemia
5398800|NCT00003883|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
5398801|NCT00003883|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
5398802|NCT00003883|ovarian yolk sac tumor|ovarian yolk sac tumor
5398803|NCT00003883|ovarian embryonal carcinoma|ovarian embryonal carcinoma
5398804|NCT00003883|ovarian polyembryoma|ovarian polyembryoma
5398805|NCT00003883|ovarian choriocarcinoma|ovarian choriocarcinoma
5398806|NCT00003883|ovarian immature teratoma|ovarian immature teratoma
5398807|NCT00003883|ovarian mature teratoma|ovarian mature teratoma
5398808|NCT00003883|ovarian monodermal and highly specialized teratoma|ovarian monodermal and highly specialized teratoma
5398809|NCT00003883|ovarian mixed germ cell tumor|ovarian mixed germ cell tumor
5398810|NCT00003883|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5398811|NCT00003883|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5398812|NCT00003883|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5398876|NCT00003657|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5398813|NCT00003883|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5398814|NCT00003883|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5398815|NCT00003883|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5398816|NCT00003883|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5398817|NCT00003883|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5398818|NCT00003883|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5398819|NCT00003883|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5398820|NCT00003883|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5398821|NCT00003883|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5398822|NCT00003883|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5398823|NCT00003883|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5398824|NCT00003883|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5398825|NCT00003883|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5398826|NCT00003883|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5398827|NCT00003883|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5398828|NCT00003883|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5398829|NCT00003883|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5398830|NCT00003883|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5398831|NCT00003883|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5398832|NCT00003883|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5398833|NCT00003883|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5398834|NCT00003883|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5398835|NCT00003883|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5398836|NCT00003883|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5398837|NCT00003883|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5398838|NCT00003883|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5398839|NCT00003883|poor prognosis metastatic gestational trophoblastic tumor|poor prognosis metastatic gestational trophoblastic tumor
5398840|NCT00003883|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5398841|NCT00003883|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5398842|NCT00003883|infection|infection
5398843|NCT00003883|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
5398844|NCT00003883|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
5398845|NCT00003883|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5398846|NCT00003883|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5398847|NCT00003883|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5398848|NCT00003883|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
5398849|NCT00003883|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5398850|NCT00003883|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
5398851|NCT00003883|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
5398852|NCT00003883|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5398853|NCT00003883|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
5398854|NCT00003883|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
5398855|NCT00003883|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5398856|NCT00003883|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5398857|NCT00003883|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5398858|NCT00003883|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
5398859|NCT00003883|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5398860|NCT00003883|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
5398861|NCT00003883|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
5398862|NCT00003883|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5398863|NCT00003883|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5398864|NCT00003883|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5398865|NCT00003883|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5398866|NCT00003883|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5398867|NCT00003883|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5398868|NCT00003883|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5398869|NCT00003883|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5398870|NCT00003883|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5398871|NCT00003883|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
5398872|NCT00003769|stage II pancreatic cancer|stage ii pancreatic cancer
5398873|NCT00003769|stage III pancreatic cancer|stage iii pancreatic cancer
5398874|NCT00003769|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
5398877|NCT00003657|chondrosarcoma|chondrosarcoma
5398878|NCT00003657|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
5398879|NCT00003657|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
5398880|NCT00003657|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5398881|NCT00003657|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5398882|NCT00003657|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5398883|NCT00003657|extensive stage small cell lung cancer|extensive stage small cell lung cancer
5398884|NCT00003657|recurrent small cell lung cancer|recurrent small cell lung cancer
5398885|NCT00003657|recurrent osteosarcoma|recurrent osteosarcoma
5398886|NCT00003657|stage III bladder cancer|stage iii bladder cancer
5398887|NCT00003657|recurrent bladder cancer|recurrent bladder cancer
5398888|NCT00003657|stage IV bladder cancer|stage iv bladder cancer
5398889|NCT00003657|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
5398890|NCT00003657|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
5398891|NCT00003657|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5398892|NCT00003657|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5398893|NCT00003657|classic Kaposi sarcoma|classic kaposi sarcoma
5398894|NCT00003657|immunosuppressive treatment related Kaposi sarcoma|immunosuppressive treatment related kaposi sarcoma
5398895|NCT00003657|AIDS-related Kaposi sarcoma|aids-related kaposi sarcoma
5398896|NCT00003657|recurrent Kaposi sarcoma|recurrent kaposi sarcoma
5398897|NCT00003657|untreated metastatic squamous neck cancer with occult primary|untreated metastatic squamous neck cancer with occult primary
5398898|NCT00003657|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
5398899|NCT00003657|ovarian stromal cancer|ovarian stromal cancer
5398900|NCT00003657|stage III ovarian germ cell tumor|stage iii ovarian germ cell tumor
5398901|NCT00003657|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
5398902|NCT00003657|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
5398903|NCT00003657|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
5398904|NCT00003657|stage III basal cell carcinoma of the lip|stage iii basal cell carcinoma of the lip
5398905|NCT00003657|stage III verrucous carcinoma of the oral cavity|stage iii verrucous carcinoma of the oral cavity
5398906|NCT00003657|stage III mucoepidermoid carcinoma of the oral cavity|stage iii mucoepidermoid carcinoma of the oral cavity
5398907|NCT00003657|stage III adenoid cystic carcinoma of the oral cavity|stage iii adenoid cystic carcinoma of the oral cavity
5398908|NCT00003657|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5398909|NCT00003657|stage IV basal cell carcinoma of the lip|stage iv basal cell carcinoma of the lip
5398910|NCT00003657|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
5398911|NCT00003657|stage IV mucoepidermoid carcinoma of the oral cavity|stage iv mucoepidermoid carcinoma of the oral cavity
5398912|NCT00003657|stage IV adenoid cystic carcinoma of the oral cavity|stage iv adenoid cystic carcinoma of the oral cavity
5398913|NCT00003657|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
5398914|NCT00003657|recurrent basal cell carcinoma of the lip|recurrent basal cell carcinoma of the lip
5398915|NCT00003657|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
5398916|NCT00003657|recurrent mucoepidermoid carcinoma of the oral cavity|recurrent mucoepidermoid carcinoma of the oral cavity
5398917|NCT00003657|recurrent adenoid cystic carcinoma of the oral cavity|recurrent adenoid cystic carcinoma of the oral cavity
5398918|NCT00003657|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
5398919|NCT00003657|stage III lymphoepithelioma of the oropharynx|stage iii lymphoepithelioma of the oropharynx
5398920|NCT00003657|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5398921|NCT00003657|stage IV lymphoepithelioma of the oropharynx|stage iv lymphoepithelioma of the oropharynx
5398922|NCT00003657|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
5398923|NCT00003657|recurrent lymphoepithelioma of the oropharynx|recurrent lymphoepithelioma of the oropharynx
5398924|NCT00003657|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
5398925|NCT00003657|stage III lymphoepithelioma of the nasopharynx|stage iii lymphoepithelioma of the nasopharynx
5398926|NCT00003657|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
5398927|NCT00003657|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
5398928|NCT00003657|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
5398929|NCT00003657|recurrent lymphoepithelioma of the nasopharynx|recurrent lymphoepithelioma of the nasopharynx
5398930|NCT00003657|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
5398931|NCT00003657|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5398932|NCT00003657|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
5398933|NCT00003657|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
5398934|NCT00003657|stage III verrucous carcinoma of the larynx|stage iii verrucous carcinoma of the larynx
5398935|NCT00003657|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5398936|NCT00003657|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
5428813|NCT00042276|Neck Pain|neck pain
5398937|NCT00003657|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
5398938|NCT00003657|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
5398939|NCT00003657|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
5398940|NCT00003657|stage III inverted papilloma of the paranasal sinus and nasal cavity|stage iii inverted papilloma of the paranasal sinus and nasal cavity
5398941|NCT00003657|stage III midline lethal granuloma of the paranasal sinus and nasal cavity|stage iii midline lethal granuloma of the paranasal sinus and nasal cavity
5398942|NCT00003657|stage III esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iii esthesioneuroblastoma of the paranasal sinus and nasal cavity
5398943|NCT00003657|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
5398944|NCT00003657|stage IV inverted papilloma of the paranasal sinus and nasal cavity|stage iv inverted papilloma of the paranasal sinus and nasal cavity
5398945|NCT00003657|stage IV midline lethal granuloma of the paranasal sinus and nasal cavity|stage iv midline lethal granuloma of the paranasal sinus and nasal cavity
5398946|NCT00003657|stage IV esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iv esthesioneuroblastoma of the paranasal sinus and nasal cavity
5399057|NCT00080223|respiratory diseases|respiratory diseases
5398947|NCT00003657|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
5398948|NCT00003657|recurrent inverted papilloma of the paranasal sinus and nasal cavity|recurrent inverted papilloma of the paranasal sinus and nasal cavity
5398949|NCT00003657|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity
5398950|NCT00003657|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity
5398951|NCT00003657|extragonadal germ cell tumor|extragonadal germ cell tumor
5398952|NCT00003657|newly diagnosed carcinoma of unknown primary|newly diagnosed carcinoma of unknown primary
5398953|NCT00003657|stage III uterine sarcoma|stage iii uterine sarcoma
5398954|NCT00003657|stage IV uterine sarcoma|stage iv uterine sarcoma
5398955|NCT00003657|recurrent uterine sarcoma|recurrent uterine sarcoma
5398956|NCT00003657|borderline ovarian surface epithelial-stromal tumor|borderline ovarian surface epithelial-stromal tumor
5398957|NCT00003657|recurrent carcinoma of unknown primary|recurrent carcinoma of unknown primary
5398958|NCT00003657|ovarian sarcoma|ovarian sarcoma
5398959|NCT00003657|adult central nervous system germ cell tumor|adult central nervous system germ cell tumor
5398960|NCT00003657|metastatic Ewing sarcoma/peripheral primitive neuroectodermal tumor|metastatic ewing sarcoma/peripheral primitive neuroectodermal tumor
5398961|NCT00003657|recurrent Ewing sarcoma/peripheral primitive neuroectodermal tumor|recurrent ewing sarcoma/peripheral primitive neuroectodermal tumor
5398962|NCT00003657|clear cell sarcoma of the kidney|clear cell sarcoma of the kidney
5398963|NCT00003657|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
5398964|NCT00003635|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5398965|NCT00003635|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
5398966|NCT00003635|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
5398967|NCT00003412|stage IV breast cancer|stage iv breast cancer
5398968|NCT00003412|recurrent breast cancer|recurrent breast cancer
5398969|NCT00003402|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
5398970|NCT00003402|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5398971|NCT00003402|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5398972|NCT00003402|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5398973|NCT00003402|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5398974|NCT00003402|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5398975|NCT00003402|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5398976|NCT00003402|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5398977|NCT00003402|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5398978|NCT00003402|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5398979|NCT00003402|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5398980|NCT00003402|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5398981|NCT00003402|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5398982|NCT00080392|Gene Transfer|gene transfer
5398983|NCT00080392|Therapeutic Angiogenesis|therapeutic angiogenesis
5398984|NCT00080392|Peripheral Arterial Disease|peripheral arterial disease
5398985|NCT00080392|Perfusion|perfusion
5398986|NCT00080392|Magnetic Resonance Imaging|magnetic resonance imaging
5398987|NCT00080392|Peripheral Vascular Disease|peripheral vascular disease
5398988|NCT00080392|Claudication|claudication
5398989|NCT00080392|PAD|pad
5398990|NCT00080392|Leg Claudication|leg claudication
5398991|NCT00080392|Intermittent Claudication|intermittent claudication
5398992|NCT00080314|Bipolar 1 Disorder, depressed|bipolar 1 disorder, depressed
5398993|NCT00080301|Metastatic Breast Cancer|metastatic breast cancer
5398994|NCT00003345|stage I ovarian epithelial cancer|stage i ovarian epithelial cancer
5398995|NCT00003345|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
5398996|NCT00003345|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5398997|NCT00003345|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5398998|NCT00003345|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5398999|NCT00003345|fallopian tube cancer|fallopian tube cancer
5399000|NCT00003345|primary peritoneal cavity cancer|primary peritoneal cavity cancer
5399001|NCT00003192|stage III gastric cancer|stage iii gastric cancer
5399002|NCT00003192|stage IV gastric cancer|stage iv gastric cancer
5399003|NCT00003192|recurrent gastric cancer|recurrent gastric cancer
5399004|NCT00003192|stage III esophageal cancer|stage iii esophageal cancer
5399005|NCT00003192|stage IV esophageal cancer|stage iv esophageal cancer
5399006|NCT00003192|recurrent esophageal cancer|recurrent esophageal cancer
5399007|NCT00003192|adenocarcinoma of the stomach|adenocarcinoma of the stomach
5399008|NCT00003157|stage IV gastric cancer|stage iv gastric cancer
5399009|NCT00003157|recurrent gastric cancer|recurrent gastric cancer
5399010|NCT00003157|recurrent pancreatic cancer|recurrent pancreatic cancer
5399011|NCT00003157|stage IV pancreatic cancer|stage iv pancreatic cancer
5399012|NCT00003149|stage I multiple myeloma|stage i multiple myeloma
5399013|NCT00003149|stage II multiple myeloma|stage ii multiple myeloma
5399014|NCT00003149|stage III multiple myeloma|stage iii multiple myeloma
5399015|NCT00002974|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
5399016|NCT00002974|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
5399017|NCT00080366|Essential Tremor|essential tremor
5399018|NCT00080366|Cross over Design|cross over design
5399019|NCT00080366|Accelerometry|accelerometry
5399020|NCT00080366|Placebo|placebo
5399021|NCT00080366|Alcohol Responsive|alcohol responsive
5399022|NCT00080366|Double Blind|double blind
5399023|NCT00080366|1-Octanol|1-octanol
5399024|NCT00080353|Complete Tumor Regression|complete tumor regression
5399025|NCT00080353|Cell Survival|cell survival
5399026|NCT00080353|Chemotherapy Preparative Regimen|chemotherapy preparative regimen
5399027|NCT00080353|IL-2|il-2
5399028|NCT00080353|Toxicity|toxicity
5399029|NCT00080353|Metastatic Melanoma|metastatic melanoma
5399030|NCT00080288|Excessive Sleepiness|excessive sleepiness
5399031|NCT00080288|Chronic Shift Work Sleep Disorder|chronic shift work sleep disorder
5399032|NCT00080288|Chronic SWSD|chronic swsd
5399033|NCT00080288|Circadian Rhythm Disorder|circadian rhythm disorder
5399034|NCT00080288|Shift Worker|shift worker
5399035|NCT00080288|Cephalon|cephalon
5399036|NCT00080288|Cephalon, Inc|cephalon, inc
5399037|NCT00080288|Nuvigil|nuvigil
5399038|NCT00080275|Niacin|niacin
5399039|NCT00080275|Statin|statin
5399040|NCT00080275|Zocor|zocor
5399041|NCT00080275|Simvastatin|simvastatin
5399042|NCT00080275|Coronary Heart Disease|coronary heart disease
5399043|NCT00080275|Dyslipidemia|dyslipidemia
5399044|NCT00080275|Atherosclerosis|atherosclerosis
5399045|NCT00080275|Hypercholesterolemia|hypercholesterolemia
5399046|NCT00080275|Stroke|stroke
5399047|NCT00080275|High-Density Lipoprotein Cholesterol|high-density lipoprotein cholesterol
5399048|NCT00080275|Low-Density Lipoprotein Cholesterol|low-density lipoprotein cholesterol
5399049|NCT00080275|Lipoprotein|lipoprotein
5399050|NCT00080275|Lipid|lipid
5399051|NCT00080275|Niacin ER/simvastatin|niacin er/simvastatin
5399052|NCT00080275|Total Cholesterol|total cholesterol
5399053|NCT00080275|Triglycerides|triglycerides
5399054|NCT00080262|Metastatic Breast Cancer|metastatic breast cancer
5399058|NCT00080158|Dysthymic Disorder|dysthymic disorder
5399059|NCT00080158|Adolescent|adolescent
5399060|NCT00012142|stage IV prostate cancer|stage iv prostate cancer
5399061|NCT00002950|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5399062|NCT00002947|stage IV renal cell cancer|stage iv renal cell cancer
5399063|NCT00002947|recurrent renal cell cancer|recurrent renal cell cancer
5399064|NCT00002947|extensive stage small cell lung cancer|extensive stage small cell lung cancer
5399065|NCT00002947|recurrent small cell lung cancer|recurrent small cell lung cancer
5399066|NCT00002947|metastatic gastrointestinal carcinoid tumor|metastatic gastrointestinal carcinoid tumor
5399067|NCT00002947|recurrent gastrointestinal carcinoid tumor|recurrent gastrointestinal carcinoid tumor
5399068|NCT00002947|gastrinoma|gastrinoma
5399069|NCT00002947|insulinoma|insulinoma
5399070|NCT00002947|recurrent islet cell carcinoma|recurrent islet cell carcinoma
5399071|NCT00002947|thyroid gland medullary carcinoma|thyroid gland medullary carcinoma
5399072|NCT00002947|prolactin-producing pituitary tumor|prolactin-producing pituitary tumor
5399073|NCT00002947|iris melanoma|iris melanoma
5399074|NCT00002947|ciliary body and choroid melanoma, medium/large size|ciliary body and choroid melanoma, medium/large size
5399075|NCT00002947|extraocular extension melanoma|extraocular extension melanoma
5399076|NCT00002947|recurrent intraocular melanoma|recurrent intraocular melanoma
5399077|NCT00002947|stage IV melanoma|stage iv melanoma
5399078|NCT00002947|recurrent melanoma|recurrent melanoma
5399079|NCT00002947|WDHA syndrome|wdha syndrome
5399080|NCT00002947|somatostatinoma|somatostatinoma
5399081|NCT00002947|pancreatic polypeptide tumor|pancreatic polypeptide tumor
5399082|NCT00002947|glucagonoma|glucagonoma
5399083|NCT00002947|childhood Langerhans cell histiocytosis|childhood langerhans cell histiocytosis
5399084|NCT00002947|metastatic pheochromocytoma|metastatic pheochromocytoma
5399085|NCT00002947|recurrent pheochromocytoma|recurrent pheochromocytoma
5399086|NCT00002947|pulmonary carcinoid tumor|pulmonary carcinoid tumor
5399087|NCT00002947|stage IV esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iv esthesioneuroblastoma of the paranasal sinus and nasal cavity
5399088|NCT00002947|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity
5399089|NCT00002947|stage III neuroendocrine carcinoma of the skin|stage iii neuroendocrine carcinoma of the skin
5399090|NCT00002947|recurrent neuroendocrine carcinoma of the skin|recurrent neuroendocrine carcinoma of the skin
5399091|NCT00002887|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5399092|NCT00002759|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5399093|NCT00002759|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5399094|NCT00002759|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5399095|NCT00002759|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
5399096|NCT00002759|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
5399097|NCT00002759|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5399098|NCT00002759|small intestine lymphoma|small intestine lymphoma
5399099|NCT00002759|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5399100|NCT00002759|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5399101|NCT00002759|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5399102|NCT00002759|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5399103|NCT00002759|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5399104|NCT00002759|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5399105|NCT00002759|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5399106|NCT00002759|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5399107|NCT00002759|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5399108|NCT00002759|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5399109|NCT00002759|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5399110|NCT00002759|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5399111|NCT00002759|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5399112|NCT00002759|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5399113|NCT00002759|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5399114|NCT00002759|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5399115|NCT00002759|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5399116|NCT00002759|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5399117|NCT00002759|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5399118|NCT00002759|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5399119|NCT00002759|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5399120|NCT00002759|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5399121|NCT00002759|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5399122|NCT00002759|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5399123|NCT00002759|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5399124|NCT00002759|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5399125|NCT00002759|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5399126|NCT00002759|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5399127|NCT00002759|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
5399128|NCT00002759|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
5399129|NCT00002759|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
5399130|NCT00002759|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
5399131|NCT00002759|drug/agent toxicity by tissue/organ|drug/agent toxicity by tissue/organ
5399132|NCT00002759|neutropenia|neutropenia
5399133|NCT00002759|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
5399134|NCT00002759|AIDS-related primary CNS lymphoma|aids-related primary cns lymphoma
5399135|NCT00002759|intraocular lymphoma|intraocular lymphoma
5399136|NCT00002759|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5399137|NCT00002759|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5399138|NCT00002759|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5399139|NCT00002759|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
5399140|NCT00002759|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5399141|NCT00002759|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
5399142|NCT00002759|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
5399143|NCT00002759|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5399144|NCT00002759|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5399145|NCT00002759|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5399146|NCT00002759|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5399147|NCT00002759|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5399148|NCT00002759|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5399149|NCT00002759|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5399150|NCT00002759|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5399151|NCT00002759|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5399152|NCT00002759|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5399406|NCT00006023|recurrent prostate cancer|recurrent prostate cancer
5399153|NCT00002592|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5399154|NCT00002592|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5399155|NCT00002592|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5399156|NCT00002536|stage IB cervical cancer|stage ib cervical cancer
5399157|NCT00002461|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5399158|NCT00002461|adult lymphocyte predominant Hodgkin lymphoma|adult lymphocyte predominant hodgkin lymphoma
5399159|NCT00002461|adult lymphocyte depletion Hodgkin lymphoma|adult lymphocyte depletion hodgkin lymphoma
5399160|NCT00002461|adult nodular sclerosis Hodgkin lymphoma|adult nodular sclerosis hodgkin lymphoma
5399161|NCT00002461|adult mixed cellularity Hodgkin lymphoma|adult mixed cellularity hodgkin lymphoma
5399162|NCT00002461|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5399163|NCT00002461|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5399164|NCT00002461|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5399165|NCT00002461|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5399166|NCT00002461|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5399167|NCT00002461|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5399168|NCT00002461|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5399169|NCT00002461|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5399170|NCT00002461|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5399171|NCT00002461|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5399172|NCT00002461|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5399173|NCT00080210|elevated uric acid|elevated uric acid
5399174|NCT00080210|Elevated serum uric acid level|elevated serum uric acid level
5399175|NCT00080210|Symptomatic gout|symptomatic gout
5399176|NCT00080197|Breast Cancer|breast cancer
5399177|NCT00080197|Cancer of the Breast|cancer of the breast
5399178|NCT00080184|Fibromyalgia|fibromyalgia
5399179|NCT00080184|Electroencephalograph (EEG) biofeedback|electroencephalograph (eeg) biofeedback
5399180|NCT00080184|Electromagnetic stimulation|electromagnetic stimulation
5399181|NCT00080184|Neurofeedback|neurofeedback
5399182|NCT00080184|Neurotherapy|neurotherapy
5399183|NCT00080184|Complementary and Alternative Medicine|complementary and alternative medicine
5399184|NCT00080171|Osteoarthritis|osteoarthritis
5399185|NCT00080171|Knee Pain|knee pain
5399186|NCT00080171|Knee Health|knee health
5399187|NCT00080145|Autistic Disorder|autistic disorder
5399188|NCT00080145|Asperger Syndrome|asperger syndrome
5399189|NCT00080132|HTG|htg
5399190|NCT00080132|Hypertriglyceridemia, Fredrickson Type I|hypertriglyceridemia, fredrickson type i
5399191|NCT00080132|Hypertriglyceridemia, Fredrickson Type V|hypertriglyceridemia, fredrickson type v
5399192|NCT00080119|Treatment Naive|treatment naive
5399193|NCT00080119|INH Prophylaxis|inh prophylaxis
5399194|NCT00080119|HIV Seronegativity|hiv seronegativity
5399195|NCT00080106|HIV Therapeutic Vaccine|hiv therapeutic vaccine
5399196|NCT00080106|Treatment Experienced|treatment experienced
5399197|NCT00080106|Treatment Interruption|treatment interruption
5399198|NCT00080106|Adenovirus Vector|adenovirus vector
5399199|NCT00008320|stage IV breast cancer|stage iv breast cancer
5399200|NCT00008320|recurrent breast cancer|recurrent breast cancer
5399201|NCT00008151|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5399202|NCT00008151|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5399203|NCT00008151|refractory anemia with excess blasts|refractory anemia with excess blasts
5399204|NCT00008151|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
5399205|NCT00008151|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5399206|NCT00008151|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5399207|NCT00008151|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5399208|NCT00008151|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
5399209|NCT00006348|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5399210|NCT00006348|monoclonal gammopathy of undetermined significance|monoclonal gammopathy of undetermined significance
5399211|NCT00006348|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5399212|NCT00006348|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5399213|NCT00006348|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
5399214|NCT00006348|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5399215|NCT00006348|isolated plasmacytoma of bone|isolated plasmacytoma of bone
5399216|NCT00006348|extramedullary plasmacytoma|extramedullary plasmacytoma
5399217|NCT00006348|refractory multiple myeloma|refractory multiple myeloma
5399218|NCT00006348|Waldenström macroglobulinemia|waldenström macroglobulinemia
5399219|NCT00006348|stage III multiple myeloma|stage iii multiple myeloma
5399220|NCT00006348|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
5399221|NCT00006348|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
5399222|NCT00006348|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5399223|NCT00006348|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5399224|NCT00006348|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5399289|NCT00006348|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
5399225|NCT00006348|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5399226|NCT00006348|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5399227|NCT00006348|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5399228|NCT00006348|small intestine lymphoma|small intestine lymphoma
5399229|NCT00006348|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
5399230|NCT00006348|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5399231|NCT00006348|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5399232|NCT00006348|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5399233|NCT00006348|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5399234|NCT00006348|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
5399235|NCT00006348|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
5399236|NCT00006348|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
5399237|NCT00006348|untreated childhood acute myeloid leukemia and other myeloid malignancies|untreated childhood acute myeloid leukemia and other myeloid malignancies
5399238|NCT00006348|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
5399239|NCT00006348|polycythemia vera|polycythemia vera
5399240|NCT00006348|primary myelofibrosis|primary myelofibrosis
5399241|NCT00006348|essential thrombocythemia|essential thrombocythemia
5399242|NCT00006348|untreated hairy cell leukemia|untreated hairy cell leukemia
5399243|NCT00006348|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
5399244|NCT00006348|refractory hairy cell leukemia|refractory hairy cell leukemia
5399245|NCT00006348|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
5399246|NCT00006348|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
5399247|NCT00006348|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5399248|NCT00006348|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
5399249|NCT00006348|acute undifferentiated leukemia|acute undifferentiated leukemia
5399250|NCT00006348|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5399251|NCT00006348|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5399252|NCT00006348|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5399253|NCT00006348|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5399439|NCT00080028|SCCHN|scchn
5399254|NCT00006348|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5399255|NCT00006348|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5399256|NCT00006348|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5399257|NCT00006348|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5399258|NCT00006348|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5399259|NCT00006348|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5399260|NCT00006348|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5399261|NCT00006348|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5399262|NCT00006348|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5399263|NCT00006348|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5399264|NCT00006348|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5399265|NCT00006348|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5399266|NCT00006348|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5399267|NCT00006348|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5399268|NCT00006348|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
5399269|NCT00006348|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
5399270|NCT00006348|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5399271|NCT00006348|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5399272|NCT00006348|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5399273|NCT00006348|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5399274|NCT00006348|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
5399275|NCT00006348|nausea and vomiting|nausea and vomiting
5399276|NCT00006348|prolymphocytic leukemia|prolymphocytic leukemia
5399277|NCT00006348|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
5399278|NCT00006348|AIDS-related primary CNS lymphoma|aids-related primary cns lymphoma
5399279|NCT00006348|primary systemic amyloidosis|primary systemic amyloidosis
5399280|NCT00006348|intraocular lymphoma|intraocular lymphoma
5399281|NCT00006348|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
5399282|NCT00006348|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
5399283|NCT00006348|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
5399284|NCT00006348|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
5399285|NCT00006348|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5399286|NCT00006348|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5399287|NCT00006348|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
5399288|NCT00006348|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5399404|NCT00080093|Behavioral Intervention|behavioral intervention
5399290|NCT00006348|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5399291|NCT00006348|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5399292|NCT00006348|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5399293|NCT00006348|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5399294|NCT00006348|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5399295|NCT00006348|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5399296|NCT00006348|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5399297|NCT00006348|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5399298|NCT00006348|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
5399299|NCT00006345|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5399300|NCT00006345|drug/agent toxicity by tissue/organ|drug/agent toxicity by tissue/organ
5399301|NCT00006345|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5399302|NCT00006262|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5399303|NCT00006262|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5399304|NCT00006262|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5399305|NCT00006090|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5399306|NCT00006090|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
5399307|NCT00006084|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5399308|NCT00006084|adult acute erythroid leukemia (M6)|adult acute erythroid leukemia (m6)
5399309|NCT00006084|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
5399310|NCT00006084|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
5399311|NCT00006084|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
5399312|NCT00006084|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
5399313|NCT00006084|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
5399314|NCT00006084|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5399315|NCT00006084|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
5399316|NCT00006084|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
5399317|NCT00006051|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
5399318|NCT00006051|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
5399319|NCT00006051|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
5399320|NCT00006051|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5399321|NCT00006051|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
5399322|NCT00006051|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
5399323|NCT00006051|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
5399324|NCT00006051|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5399325|NCT00006051|stage I squamous cell carcinoma of the hypopharynx|stage i squamous cell carcinoma of the hypopharynx
5399326|NCT00006051|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
5399327|NCT00006051|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
5399328|NCT00006051|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5399329|NCT00006051|stage I squamous cell carcinoma of the larynx|stage i squamous cell carcinoma of the larynx
5399330|NCT00006051|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
5399331|NCT00006051|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
5399332|NCT00006051|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5399333|NCT00006036|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5399334|NCT00006036|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5399335|NCT00006036|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5399336|NCT00006036|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5399337|NCT00006036|extensive stage small cell lung cancer|extensive stage small cell lung cancer
5399338|NCT00006036|recurrent small cell lung cancer|recurrent small cell lung cancer
5399339|NCT00006036|stage IV nasopharyngeal cancer|stage iv nasopharyngeal cancer
5399340|NCT00006036|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5399341|NCT00006036|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5399342|NCT00006036|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5399343|NCT00006036|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5399344|NCT00006036|untreated metastatic squamous neck cancer with occult primary|untreated metastatic squamous neck cancer with occult primary
5399345|NCT00006036|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
5399346|NCT00006036|ovarian stromal cancer|ovarian stromal cancer
5399347|NCT00006036|stage III ovarian germ cell tumor|stage iii ovarian germ cell tumor
5399348|NCT00006036|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
5399349|NCT00006036|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
5399405|NCT00006023|stage IV prostate cancer|stage iv prostate cancer
5429225|NCT00039936|Obesity|obesity
5399350|NCT00006036|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
5399351|NCT00006036|stage III basal cell carcinoma of the lip|stage iii basal cell carcinoma of the lip
5399352|NCT00006036|stage III verrucous carcinoma of the oral cavity|stage iii verrucous carcinoma of the oral cavity
5399353|NCT00006036|stage III mucoepidermoid carcinoma of the oral cavity|stage iii mucoepidermoid carcinoma of the oral cavity
5399354|NCT00006036|stage III adenoid cystic carcinoma of the oral cavity|stage iii adenoid cystic carcinoma of the oral cavity
5399355|NCT00006036|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5399356|NCT00006036|stage IV basal cell carcinoma of the lip|stage iv basal cell carcinoma of the lip
5399357|NCT00006036|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
5399358|NCT00006036|stage IV mucoepidermoid carcinoma of the oral cavity|stage iv mucoepidermoid carcinoma of the oral cavity
5399359|NCT00006036|stage IV adenoid cystic carcinoma of the oral cavity|stage iv adenoid cystic carcinoma of the oral cavity
5399360|NCT00006036|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
5399361|NCT00006036|recurrent basal cell carcinoma of the lip|recurrent basal cell carcinoma of the lip
5399362|NCT00006036|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
5399363|NCT00006036|recurrent mucoepidermoid carcinoma of the oral cavity|recurrent mucoepidermoid carcinoma of the oral cavity
5399364|NCT00006036|recurrent adenoid cystic carcinoma of the oral cavity|recurrent adenoid cystic carcinoma of the oral cavity
5399365|NCT00006036|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
5399366|NCT00006036|stage III lymphoepithelioma of the oropharynx|stage iii lymphoepithelioma of the oropharynx
5399367|NCT00006036|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5399368|NCT00006036|stage IV lymphoepithelioma of the oropharynx|stage iv lymphoepithelioma of the oropharynx
5399369|NCT00006036|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
5399370|NCT00006036|recurrent lymphoepithelioma of the oropharynx|recurrent lymphoepithelioma of the oropharynx
5399371|NCT00006036|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
5399372|NCT00006036|stage III lymphoepithelioma of the nasopharynx|stage iii lymphoepithelioma of the nasopharynx
5399373|NCT00006036|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
5399374|NCT00006036|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
5399375|NCT00006036|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
5399376|NCT00006036|recurrent lymphoepithelioma of the nasopharynx|recurrent lymphoepithelioma of the nasopharynx
5399377|NCT00006036|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
5399378|NCT00006036|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5399379|NCT00006036|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
5399380|NCT00006036|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
5399381|NCT00006036|stage III verrucous carcinoma of the larynx|stage iii verrucous carcinoma of the larynx
5399382|NCT00006036|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5399383|NCT00006036|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
5399384|NCT00006036|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
5399385|NCT00006036|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
5399386|NCT00006036|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
5399387|NCT00006036|stage III inverted papilloma of the paranasal sinus and nasal cavity|stage iii inverted papilloma of the paranasal sinus and nasal cavity
5399388|NCT00006036|stage III midline lethal granuloma of the paranasal sinus and nasal cavity|stage iii midline lethal granuloma of the paranasal sinus and nasal cavity
5399389|NCT00006036|stage III esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iii esthesioneuroblastoma of the paranasal sinus and nasal cavity
5399390|NCT00006036|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
5399391|NCT00006036|stage IV inverted papilloma of the paranasal sinus and nasal cavity|stage iv inverted papilloma of the paranasal sinus and nasal cavity
5399392|NCT00006036|stage IV midline lethal granuloma of the paranasal sinus and nasal cavity|stage iv midline lethal granuloma of the paranasal sinus and nasal cavity
5399393|NCT00006036|stage IV esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iv esthesioneuroblastoma of the paranasal sinus and nasal cavity
5399394|NCT00006036|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
5399395|NCT00006036|recurrent inverted papilloma of the paranasal sinus and nasal cavity|recurrent inverted papilloma of the paranasal sinus and nasal cavity
5399396|NCT00006036|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity
5399397|NCT00006036|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity
5399398|NCT00006036|borderline ovarian surface epithelial-stromal tumor|borderline ovarian surface epithelial-stromal tumor
5399399|NCT00006036|ovarian sarcoma|ovarian sarcoma
5399400|NCT00006030|stage I breast cancer|stage i breast cancer
5399401|NCT00080093|Condom|condom
5399402|NCT00080093|HIV Seronegativity|hiv seronegativity
5399403|NCT00080093|HIV Prevention|hiv prevention
5399407|NCT00005992|stage IV prostate cancer|stage iv prostate cancer
5399408|NCT00005992|recurrent prostate cancer|recurrent prostate cancer
5399409|NCT00005972|recurrent small cell lung cancer|recurrent small cell lung cancer
5399410|NCT00005944|recurrent colon cancer|recurrent colon cancer
5399411|NCT00005944|recurrent rectal cancer|recurrent rectal cancer
5399412|NCT00005944|adenocarcinoma of the colon|adenocarcinoma of the colon
5399413|NCT00005944|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5399414|NCT00005944|liver metastases|liver metastases
5399415|NCT00005944|primary peritoneal cavity cancer|primary peritoneal cavity cancer
5399416|NCT00005865|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5399417|NCT00005865|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5399418|NCT00080067|Movement|movement
5399419|NCT00080067|Anticipation|anticipation
5399420|NCT00080067|Stimulation|stimulation
5399421|NCT00080067|Timing|timing
5399422|NCT00080067|Execution|execution
5399423|NCT00080067|Perception|perception
5399424|NCT00080067|Rhythm|rhythm
5399425|NCT00080067|Healthy Volunteer|healthy volunteer
5399426|NCT00080067|HV|hv
5399427|NCT00080054|Malignant Glioma|malignant glioma
5399428|NCT00080054|Glioblastoma multiforme|glioblastoma multiforme
5399429|NCT00080054|GBM|gbm
5399430|NCT00080054|Anaplastic astrocytoma|anaplastic astrocytoma
5399431|NCT00080054|AA|aa
5399432|NCT00080054|Anaplastic oligodendroglioma|anaplastic oligodendroglioma
5399433|NCT00080054|Anaplastic mixed glioma|anaplastic mixed glioma
5399434|NCT00080054|Brain tumor|brain tumor
5399435|NCT00080054|Brain neoplasm|brain neoplasm
5399436|NCT00080054|Glioma|glioma
5399437|NCT00080041|Antineoplastic Combined Chemotherapy Protocols|antineoplastic combined chemotherapy protocols
5399438|NCT00080028|Head and Neck Cancer|head and neck cancer
5399440|NCT00080028|Oropharynx Cancer|oropharynx cancer
5399441|NCT00080028|Hypopharynx Cancer|hypopharynx cancer
5399442|NCT00080028|Larynx Cancer|larynx cancer
5399443|NCT00080028|Soft palate Cancer|soft palate cancer
5399444|NCT00080028|Tonsil Cancer|tonsil cancer
5399445|NCT00080028|Base of tongue Cancer|base of tongue cancer
5399446|NCT00080028|Supraglottic Cancer|supraglottic cancer
5399447|NCT00080028|Glottic Cancer|glottic cancer
5399448|NCT00080028|Pyriform Sinus Cancer|pyriform sinus cancer
5399449|NCT00080028|Pharyngeal wall Cancer|pharyngeal wall cancer
5399450|NCT00080028|Throat cancer|throat cancer
5399451|NCT00080002|cancer|cancer
5399452|NCT00080002|gastric|gastric
5399453|NCT00080002|gastroesophageal junction|gastroesophageal junction
5399454|NCT00080002|neoplasms|neoplasms
5399455|NCT00080002|gastric cancer|gastric cancer
5399456|NCT00080002|gastric neoplasms|gastric neoplasms
5399457|NCT00079989|Bacterial Infections|bacterial infections
5399458|NCT00005816|stage III renal cell cancer|stage iii renal cell cancer
5399459|NCT00005816|stage IV renal cell cancer|stage iv renal cell cancer
5399460|NCT00004123|adult leiomyosarcoma|adult leiomyosarcoma
5399461|NCT00004123|adult liposarcoma|adult liposarcoma
5399462|NCT00004123|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
5399463|NCT00004123|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
5399464|NCT00004123|stage II adult soft tissue sarcoma|stage ii adult soft tissue sarcoma
5399465|NCT00003817|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5399466|NCT00003817|nausea and vomiting|nausea and vomiting
5399467|NCT00003693|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5399468|NCT00003693|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5399469|NCT00003693|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5399470|NCT00003693|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5399471|NCT00003693|refractory anemia with excess blasts|refractory anemia with excess blasts
5399472|NCT00003693|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
5399473|NCT00003693|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5399474|NCT00003693|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5399475|NCT00003693|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
5399476|NCT00003647|adult solid tumor|adult solid tumor
5399477|NCT00003647|body system/site cancer|body system/site cancer
5399478|NCT00003647|cancer|cancer
5399479|NCT00003647|melanoma|melanoma
5399480|NCT00003647|recurrent melanoma|recurrent melanoma
5399481|NCT00003647|skin tumor|skin tumor
5399482|NCT00003647|solid tumor|solid tumor
5399483|NCT00003647|stage III melanoma|stage iii melanoma
5399484|NCT00003647|stage IV melanoma|stage iv melanoma
5399485|NCT00003647|stage, melanoma|stage, melanoma
5399486|NCT00079976|Staphylococcus aureus|staphylococcus aureus
5399487|NCT00079976|Bacterial Infections|bacterial infections
5399488|NCT00079950|soft|soft
5399489|NCT00079950|sarcoma|sarcoma
5399490|NCT00079950|metastatic|metastatic
5399491|NCT00079937|allergic|allergic
5399492|NCT00079937|asthma|asthma
5399493|NCT00079937|atopic|atopic
5399494|NCT00079937|omalizumab|omalizumab
5399495|NCT00079937|immunoglobulin E|immunoglobulin e
5399496|NCT00079937|IgE|ige
5399497|NCT00079937|anti-IgE|anti-ige
5399498|NCT00003561|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5399912|NCT00003704|stage III vulvar cancer|stage iii vulvar cancer
5399499|NCT00003561|Philadelphia chromosome positive chronic myelogenous leukemia|philadelphia chromosome positive chronic myelogenous leukemia
5399500|NCT00003561|Philadelphia chromosome negative chronic myelogenous leukemia|philadelphia chromosome negative chronic myelogenous leukemia
5399501|NCT00003356|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
5399502|NCT00003356|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
5399503|NCT00003356|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5399504|NCT00003356|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5399505|NCT00003356|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5399506|NCT00003356|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5399507|NCT00003356|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5399508|NCT00003356|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5399509|NCT00003356|stage I mantle cell lymphoma|stage i mantle cell lymphoma
5399510|NCT00003356|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
5399511|NCT00003356|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
5399512|NCT00003356|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
5399513|NCT00003356|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5399514|NCT00003356|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5399515|NCT00003356|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5399516|NCT00003356|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5399517|NCT00003356|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5399518|NCT00003356|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5399519|NCT00003356|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
5399520|NCT00003356|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
5399521|NCT00003356|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5399522|NCT00003356|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5399523|NCT00003356|stage I marginal zone lymphoma|stage i marginal zone lymphoma
5399524|NCT00003356|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
5399525|NCT00003356|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5399526|NCT00003356|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5399527|NCT00003356|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5399528|NCT00003356|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5399529|NCT00003356|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
5399530|NCT00003356|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
5399531|NCT00003356|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5399532|NCT00003356|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5399533|NCT00003356|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5399534|NCT00003327|stage IV nasopharyngeal cancer|stage iv nasopharyngeal cancer
5399535|NCT00003327|recurrent nasopharyngeal cancer|recurrent nasopharyngeal cancer
5399536|NCT00003327|stage IV lip and oral cavity cancer|stage iv lip and oral cavity cancer
5399537|NCT00003327|recurrent lip and oral cavity cancer|recurrent lip and oral cavity cancer
5399538|NCT00003327|stage IV hypopharyngeal cancer|stage iv hypopharyngeal cancer
5399539|NCT00003327|recurrent hypopharyngeal cancer|recurrent hypopharyngeal cancer
5399540|NCT00003327|stage IV laryngeal cancer|stage iv laryngeal cancer
5399541|NCT00003327|recurrent laryngeal cancer|recurrent laryngeal cancer
5399542|NCT00003327|stage IV paranasal sinus and nasal cavity cancer|stage iv paranasal sinus and nasal cavity cancer
5399543|NCT00003327|recurrent paranasal sinus and nasal cavity cancer|recurrent paranasal sinus and nasal cavity cancer
5399544|NCT00003327|stage IV oropharyngeal cancer|stage iv oropharyngeal cancer
5399545|NCT00003327|recurrent oropharyngeal cancer|recurrent oropharyngeal cancer
5399546|NCT00003321|stage I esophageal cancer|stage i esophageal cancer
5399547|NCT00003321|stage II esophageal cancer|stage ii esophageal cancer
5399548|NCT00003321|stage III esophageal cancer|stage iii esophageal cancer
5399549|NCT00003321|stage IV esophageal cancer|stage iv esophageal cancer
5399550|NCT00003321|recurrent esophageal cancer|recurrent esophageal cancer
5399551|NCT00003274|stage II melanoma|stage ii melanoma
5399552|NCT00079911|Herpes|herpes
5399553|NCT00079911|Genital Herpes|genital herpes
5399554|NCT00079911|HIV|hiv
5399555|NCT00079911|HSV|hsv
5399556|NCT00079885|Bacterial Pneumonia|bacterial pneumonia
5399557|NCT00022360|recurrent adult brain tumor|recurrent adult brain tumor
5399558|NCT00022360|adult glioblastoma|adult glioblastoma
5399559|NCT00022360|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5399560|NCT00022360|adult giant cell glioblastoma|adult giant cell glioblastoma
5399561|NCT00022360|adult gliosarcoma|adult gliosarcoma
5399562|NCT00022165|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5399563|NCT00021138|non-small cell lung cancer|non-small cell lung cancer
5399564|NCT00021138|small cell lung cancer|small cell lung cancer
5399565|NCT00021138|esophageal cancer|esophageal cancer
5399566|NCT00021138|hypopharyngeal cancer|hypopharyngeal cancer
5399567|NCT00021138|laryngeal cancer|laryngeal cancer
5399568|NCT00021138|nasopharyngeal cancer|nasopharyngeal cancer
5399569|NCT00021138|oropharyngeal cancer|oropharyngeal cancer
5399570|NCT00021138|lip and oral cavity cancer|lip and oral cavity cancer
5399571|NCT00021138|paranasal sinus and nasal cavity cancer|paranasal sinus and nasal cavity cancer
5399572|NCT00021138|tongue cancer|tongue cancer
5399573|NCT00002789|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5399574|NCT00002789|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5399575|NCT00002789|Philadelphia chromosome positive chronic myelogenous leukemia|philadelphia chromosome positive chronic myelogenous leukemia
5399576|NCT00079859|Heterozygous Familial Hypercholesterolemia (HeFH)|heterozygous familial hypercholesterolemia (hefh)
5399577|NCT00079846|Homozygous Familial Hypercholesterolemia (HoFH)|homozygous familial hypercholesterolemia (hofh)
5399578|NCT00079833|gastric acid hypersecretory conditions|gastric acid hypersecretory conditions
5399579|NCT00079833|Idiopathic Hypersecretion|idiopathic hypersecretion
5399580|NCT00079833|Excessive Gastric Acid secretion|excessive gastric acid secretion
5399581|NCT00079820|Smallpox|smallpox
5399582|NCT00079820|Smallpox Vaccine|smallpox vaccine
5399583|NCT00079820|Variola virus|variola virus
5399584|NCT00079820|Smallpox Virus|smallpox virus
5399585|NCT00079820|MODIFIED VACCINIA ANKARA|modified vaccinia ankara
5399586|NCT00079820|MVA|mva
5399587|NCT00079820|Dryvax|dryvax
5399588|NCT00079820|Dryvax vaccine|dryvax vaccine
5399589|NCT00079820|Protection against smallpox|protection against smallpox
5399590|NCT00020930|stage IV colon cancer|stage iv colon cancer
5399591|NCT00020930|stage IV rectal cancer|stage iv rectal cancer
5399592|NCT00020930|recurrent colon cancer|recurrent colon cancer
5399593|NCT00020930|recurrent rectal cancer|recurrent rectal cancer
5399594|NCT00020865|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
5399595|NCT00020865|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
5399596|NCT00020865|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5399597|NCT00020865|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5399598|NCT00020865|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5399599|NCT00020865|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
5399600|NCT00020865|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
5399601|NCT00020865|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
5399602|NCT00020865|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
5399603|NCT00020865|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5399604|NCT00020865|stage 0 chronic lymphocytic leukemia|stage 0 chronic lymphocytic leukemia
5399605|NCT00020865|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
5399606|NCT00020865|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
5399607|NCT00020865|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5399608|NCT00020865|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5399609|NCT00020865|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5399610|NCT00020865|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5399611|NCT00020865|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5399612|NCT00020865|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5399613|NCT00020865|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5399614|NCT00020865|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5399615|NCT00020865|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5399616|NCT00020865|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5399617|NCT00020865|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
5399618|NCT00020865|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5399619|NCT00020865|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5399620|NCT00020865|fever, sweats, and hot flashes|fever, sweats, and hot flashes
5399621|NCT00020865|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
5399622|NCT00020865|refractory hairy cell leukemia|refractory hairy cell leukemia
5399623|NCT00020865|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
5399624|NCT00020865|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
5399625|NCT00020865|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
5399626|NCT00020865|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
5399627|NCT00020865|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
5399628|NCT00020865|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
5399629|NCT00020865|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
5399630|NCT00020865|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
5399631|NCT00020865|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
5399632|NCT00020865|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5399633|NCT00020865|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
5399634|NCT00020865|acute undifferentiated leukemia|acute undifferentiated leukemia
5399635|NCT00020865|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5399636|NCT00020865|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5399637|NCT00020865|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5399638|NCT00020865|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5399639|NCT00020865|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5399640|NCT00020865|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5399641|NCT00020865|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5399642|NCT00020865|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5399643|NCT00020865|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5399644|NCT00020865|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5399645|NCT00020865|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5399646|NCT00020865|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5399647|NCT00020865|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5399648|NCT00020865|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5399649|NCT00020865|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5399650|NCT00020865|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5399651|NCT00020865|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5399652|NCT00020865|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5399653|NCT00020865|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5399654|NCT00020865|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5399655|NCT00020865|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5399656|NCT00020865|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5399657|NCT00020865|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5399658|NCT00020865|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5399659|NCT00020865|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5399660|NCT00020865|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5399661|NCT00020865|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5399662|NCT00020865|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
5399663|NCT00020865|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
5399664|NCT00020865|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
5399665|NCT00020865|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
5399666|NCT00020865|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
5399667|NCT00020865|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5399668|NCT00020865|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
5399669|NCT00020865|neutropenia|neutropenia
5399670|NCT00020865|infection|infection
5399671|NCT00020865|prolymphocytic leukemia|prolymphocytic leukemia
5399672|NCT00020865|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
5399673|NCT00020865|AIDS-related primary CNS lymphoma|aids-related primary cns lymphoma
5399674|NCT00020865|intraocular lymphoma|intraocular lymphoma
5399675|NCT00020865|stage I mantle cell lymphoma|stage i mantle cell lymphoma
5399676|NCT00020865|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
5399677|NCT00020865|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
5399678|NCT00020865|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
5399679|NCT00020865|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
5399680|NCT00020865|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
5399681|NCT00020865|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
5399682|NCT00020865|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
5399683|NCT00020865|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
5399684|NCT00020865|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
5399685|NCT00020865|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
5399686|NCT00020865|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5399687|NCT00020865|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5399688|NCT00020865|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5399689|NCT00020865|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
5399690|NCT00020865|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5399691|NCT00020865|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
5399692|NCT00020865|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
5399693|NCT00020865|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5399694|NCT00020865|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
5399695|NCT00020865|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
5399696|NCT00020865|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5399697|NCT00020865|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5399698|NCT00020865|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5399699|NCT00020865|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
5399700|NCT00020865|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5399701|NCT00020865|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
5399702|NCT00020865|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
5399703|NCT00020865|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
5399704|NCT00020865|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
5399705|NCT00020865|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5399706|NCT00020865|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
5399707|NCT00020865|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
5399708|NCT00020865|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5399709|NCT00020865|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5399710|NCT00020865|stage I marginal zone lymphoma|stage i marginal zone lymphoma
5399711|NCT00020865|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
5399712|NCT00020865|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5399713|NCT00020865|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5399714|NCT00020865|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5399715|NCT00020865|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5399716|NCT00020865|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
5399717|NCT00020865|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
5399718|NCT00020865|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5399719|NCT00020865|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5399720|NCT00020865|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5399721|NCT00014300|recurrent adult brain tumor|recurrent adult brain tumor
5399722|NCT00014300|adult glioblastoma|adult glioblastoma
5399723|NCT00014300|adult giant cell glioblastoma|adult giant cell glioblastoma
5399724|NCT00014300|adult gliosarcoma|adult gliosarcoma
5399725|NCT00012337|stage IV renal cell cancer|stage iv renal cell cancer
5399726|NCT00012337|recurrent renal cell cancer|recurrent renal cell cancer
5399727|NCT00006812|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5399728|NCT00006812|primary peritoneal cavity cancer|primary peritoneal cavity cancer
5399729|NCT00006708|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5399730|NCT00006708|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5399731|NCT00006218|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5399732|NCT00006215|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5399733|NCT00006215|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5399734|NCT00006098|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5399735|NCT00006098|refractory multiple myeloma|refractory multiple myeloma
5399736|NCT00006098|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5399737|NCT00006098|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5399738|NCT00006098|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5399739|NCT00006098|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5399942|NCT00079768|Myositis|myositis
5399740|NCT00006098|refractory anemia with excess blasts|refractory anemia with excess blasts
5399741|NCT00006098|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
5399742|NCT00006098|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5399743|NCT00006098|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5399744|NCT00006098|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5399745|NCT00006098|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5399746|NCT00006098|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5399747|NCT00006098|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5399748|NCT00006098|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5399749|NCT00006098|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5399750|NCT00006098|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5399751|NCT00006098|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5399752|NCT00006098|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5399753|NCT00006098|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5399754|NCT00006098|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5399755|NCT00006098|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5399756|NCT00006098|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5399757|NCT00006098|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5399758|NCT00079807|HIV|hiv
5399759|NCT00079807|Peripheral neuropathy|peripheral neuropathy
5399760|NCT00079807|Alpha-Lipoic Acid|alpha-lipoic acid
5399761|NCT00079807|ALA|ala
5399762|NCT00079807|Complementary Therapies|complementary therapies
5399763|NCT00079794|lung cancer|lung cancer
5399764|NCT00079794|herbal medicine|herbal medicine
5399765|NCT00079794|non-small cell cancer|non-small cell cancer
5399766|NCT00079794|Iscar|iscar
5399767|NCT00079794|mistletoe|mistletoe
5399768|NCT00079781|Responsive Stimulation|responsive stimulation
5399769|NCT00079781|Brain Stimulator|brain stimulator
5399770|NCT00079781|Epilepsy|epilepsy
5399771|NCT00079781|Seizures|seizures
5429226|NCT00039936|Cognitive|cognitive
5399772|NCT00079755|Anaplastic Large-Cell Lymphoma|anaplastic large-cell lymphoma
5399773|NCT00079755|Lymphoma|lymphoma
5399774|NCT00079755|antigens, CD30|antigens, cd30
5399775|NCT00079755|Monoclonal Antibody|monoclonal antibody
5399776|NCT00079742|Growth restriction in children with cystic fibrosis|growth restriction in children with cystic fibrosis
5399777|NCT00079716|Antigens, CD40|antigens, cd40
5399778|NCT00079716|Antibody, Monoclonal|antibody, monoclonal
5399779|NCT00079716|Blood Coagulation Disorders|blood coagulation disorders
5399780|NCT00079716|Hematologic Diseases|hematologic diseases
5399781|NCT00079716|Hemorrhagic Disorders|hemorrhagic disorders
5399782|NCT00079716|Hemostatic Disorders|hemostatic disorders
5399783|NCT00079716|Immunoproliferative Disorders|immunoproliferative disorders
5399784|NCT00079716|Lymphoproliferative Disorders|lymphoproliferative disorders
5399785|NCT00079716|Paraproteinemias|paraproteinemias
5399786|NCT00079716|Vascular Diseases|vascular diseases
5399787|NCT00079716|Antibody-Dependent Cell Cytotoxicity|antibody-dependent cell cytotoxicity
5399788|NCT00006091|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5399789|NCT00006091|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5399790|NCT00006091|chronic myelogenous leukemia, BCR-ABL1 positive|chronic myelogenous leukemia, bcr-abl1 positive
5399791|NCT00006085|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5399792|NCT00006026|recurrent bladder cancer|recurrent bladder cancer
5399793|NCT00006026|stage IV bladder cancer|stage iv bladder cancer
5399794|NCT00006026|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
5399795|NCT00006026|squamous cell carcinoma of the bladder|squamous cell carcinoma of the bladder
5399796|NCT00006026|adenocarcinoma of the bladder|adenocarcinoma of the bladder
5399797|NCT00006026|recurrent urethral cancer|recurrent urethral cancer
5399798|NCT00006026|anterior urethral cancer|anterior urethral cancer
5399799|NCT00006026|posterior urethral cancer|posterior urethral cancer
5399800|NCT00006026|urethral cancer associated with invasive bladder cancer|urethral cancer associated with invasive bladder cancer
5399801|NCT00006026|metastatic transitional cell cancer of the renal pelvis and ureter|metastatic transitional cell cancer of the renal pelvis and ureter
5399802|NCT00006026|regional transitional cell cancer of the renal pelvis and ureter|regional transitional cell cancer of the renal pelvis and ureter
5399803|NCT00006026|recurrent transitional cell cancer of the renal pelvis and ureter|recurrent transitional cell cancer of the renal pelvis and ureter
5399804|NCT00005866|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
5399805|NCT00005866|refractory anemia with excess blasts|refractory anemia with excess blasts
5399806|NCT00005866|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
5399807|NCT00005866|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5399808|NCT00005866|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5399809|NCT00005866|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5399810|NCT00005866|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5399811|NCT00005866|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
5399812|NCT00005848|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5399813|NCT00005848|stage IV prostate cancer|stage iv prostate cancer
5399814|NCT00005848|recurrent prostate cancer|recurrent prostate cancer
5399815|NCT00005834|refractory multiple myeloma|refractory multiple myeloma
5399816|NCT00005834|stage I multiple myeloma|stage i multiple myeloma
5399817|NCT00005834|stage II multiple myeloma|stage ii multiple myeloma
5399818|NCT00005834|stage III multiple myeloma|stage iii multiple myeloma
5399819|NCT00005635|stage IV breast cancer|stage iv breast cancer
5399820|NCT00005635|recurrent breast cancer|recurrent breast cancer
5399821|NCT00005085|stage IV colon cancer|stage iv colon cancer
5399822|NCT00005085|stage IV rectal cancer|stage iv rectal cancer
5399823|NCT00005085|recurrent colon cancer|recurrent colon cancer
5399824|NCT00005085|recurrent rectal cancer|recurrent rectal cancer
5399825|NCT00005085|adenocarcinoma of the colon|adenocarcinoma of the colon
5399826|NCT00005085|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5399827|NCT00005037|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5399828|NCT00005037|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5399829|NCT00005037|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5399830|NCT00004926|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5399831|NCT00004913|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5399832|NCT00004909|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5399833|NCT00004909|peritoneal cavity cancer|peritoneal cavity cancer
5399834|NCT00004909|quality of life|quality of life
5399835|NCT00004865|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
5399836|NCT00004865|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
5399837|NCT00004865|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5399838|NCT00004865|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
5399839|NCT00004865|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5399840|NCT00004865|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
5399911|NCT00003704|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5399841|NCT00004865|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
5399842|NCT00004865|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
5399843|NCT00004865|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5399844|NCT00004865|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
5399845|NCT00004865|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5399846|NCT00004865|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
5399847|NCT00004865|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
5399848|NCT00004865|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
5399849|NCT00004864|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5399850|NCT00004863|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5399851|NCT00004163|stage III salivary gland cancer|stage iii salivary gland cancer
5399852|NCT00004163|stage IV salivary gland cancer|stage iv salivary gland cancer
5399853|NCT00004163|recurrent salivary gland cancer|recurrent salivary gland cancer
5399854|NCT00004163|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
5399855|NCT00004163|salivary gland acinic cell tumor|salivary gland acinic cell tumor
5399856|NCT00004163|low-grade salivary gland mucoepidermoid carcinoma|low-grade salivary gland mucoepidermoid carcinoma
5399857|NCT00004163|high-grade salivary gland mucoepidermoid carcinoma|high-grade salivary gland mucoepidermoid carcinoma
5399858|NCT00004163|salivary gland adenocarcinoma|salivary gland adenocarcinoma
5399859|NCT00004163|salivary gland poorly differentiated carcinoma|salivary gland poorly differentiated carcinoma
5399860|NCT00004163|salivary gland malignant mixed cell type tumor|salivary gland malignant mixed cell type tumor
5399861|NCT00004163|salivary gland adenoid cystic carcinoma|salivary gland adenoid cystic carcinoma
5399862|NCT00004151|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5399863|NCT00004151|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5399864|NCT00004151|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5399865|NCT00004151|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5399866|NCT00004142|stage IV colon cancer|stage iv colon cancer
5399867|NCT00004142|stage IV rectal cancer|stage iv rectal cancer
5399868|NCT00004142|recurrent colon cancer|recurrent colon cancer
5399869|NCT00004142|recurrent rectal cancer|recurrent rectal cancer
5399870|NCT00004142|liver metastases|liver metastases
5399871|NCT00004109|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
5399872|NCT00004109|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
5399873|NCT00004109|Doxorubicin|doxorubicin
5399874|NCT00004109|External-Beam RT|external-beam rt
5399875|NCT00004109|XRT|xrt
5399876|NCT00004109|cancer|cancer
5399877|NCT00004109|PREOPERATIVE CONCURRENT CHEMORADIATION|preoperative concurrent chemoradiation
5399878|NCT00004109|EXTREMITY SOFT TISSUE SARCOMAS|extremity soft tissue sarcomas
5399879|NCT00004109|TRUNK SOFT TISSUE SARCOMAS|trunk soft tissue sarcomas
5399880|NCT00004109|Concurrent Chemoradiation|concurrent chemoradiation
5399881|NCT00004109|Surgical Resection|surgical resection
5399882|NCT00004109|Localized Extremity Soft Tissue Sarcomas|localized extremity soft tissue sarcomas
5399883|NCT00004109|Body Wall Soft Tissue Sarcomas|body wall soft tissue sarcomas
5399884|NCT00003959|refractory anemia|refractory anemia
5399885|NCT00003959|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
5399886|NCT00003959|refractory anemia with excess blasts|refractory anemia with excess blasts
5399887|NCT00003959|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5399888|NCT00003959|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5399889|NCT00003959|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5399890|NCT00003959|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5399891|NCT00003779|stage 0 bladder cancer|stage 0 bladder cancer
5399892|NCT00003779|stage I bladder cancer|stage i bladder cancer
5399893|NCT00003772|stage I ovarian epithelial cancer|stage i ovarian epithelial cancer
5399894|NCT00003772|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
5399895|NCT00003772|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5399896|NCT00003772|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5399897|NCT00003772|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5399898|NCT00003742|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5399899|NCT00003706|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5399900|NCT00003705|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5399901|NCT00003704|stage III colon cancer|stage iii colon cancer
5399902|NCT00003704|stage III rectal cancer|stage iii rectal cancer
5399903|NCT00003704|recurrent colon cancer|recurrent colon cancer
5399904|NCT00003704|recurrent rectal cancer|recurrent rectal cancer
5399905|NCT00003704|recurrent anal cancer|recurrent anal cancer
5399906|NCT00003704|stage IIIA anal cancer|stage iiia anal cancer
5399907|NCT00003704|stage IIIB anal cancer|stage iiib anal cancer
5399908|NCT00003704|stage III cervical cancer|stage iii cervical cancer
5399909|NCT00003704|recurrent cervical cancer|recurrent cervical cancer
5399910|NCT00003704|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5399913|NCT00003704|recurrent vulvar cancer|recurrent vulvar cancer
5399914|NCT00003704|stage III vaginal cancer|stage iii vaginal cancer
5399915|NCT00003704|recurrent vaginal cancer|recurrent vaginal cancer
5399916|NCT00003704|stage III penile cancer|stage iii penile cancer
5399917|NCT00003704|recurrent penile cancer|recurrent penile cancer
5399918|NCT00003704|stage III endometrial carcinoma|stage iii endometrial carcinoma
5399919|NCT00003704|recurrent endometrial carcinoma|recurrent endometrial carcinoma
5399920|NCT00003704|stage III bladder cancer|stage iii bladder cancer
5399921|NCT00003704|recurrent bladder cancer|recurrent bladder cancer
5399922|NCT00003704|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
5399923|NCT00003704|stage III prostate cancer|stage iii prostate cancer
5399924|NCT00003704|recurrent prostate cancer|recurrent prostate cancer
5399925|NCT00003704|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
5399926|NCT00003704|ovarian stromal cancer|ovarian stromal cancer
5399927|NCT00003704|recurrent urethral cancer|recurrent urethral cancer
5399928|NCT00003704|distal urethral cancer|distal urethral cancer
5399929|NCT00003704|proximal urethral cancer|proximal urethral cancer
5399930|NCT00003704|stage III ovarian germ cell tumor|stage iii ovarian germ cell tumor
5399931|NCT00003704|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
5399932|NCT00003704|fallopian tube cancer|fallopian tube cancer
5399933|NCT00003704|primary peritoneal cavity cancer|primary peritoneal cavity cancer
5399934|NCT00003704|stage III uterine sarcoma|stage iii uterine sarcoma
5399935|NCT00003704|recurrent uterine sarcoma|recurrent uterine sarcoma
5399936|NCT00003704|borderline ovarian surface epithelial-stromal tumor|borderline ovarian surface epithelial-stromal tumor
5399937|NCT00003704|ovarian sarcoma|ovarian sarcoma
5399938|NCT00003703|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5399939|NCT00003695|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
5399940|NCT00003695|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5399941|NCT00079768|Inflammation|inflammation
5399943|NCT00079768|Humanized Monoclonal Antibody|humanized monoclonal antibody
5399944|NCT00079768|Cytotoxic T Cells|cytotoxic t cells
5399945|NCT00079768|Endomysial T Cells|endomysial t cells
5399946|NCT00079768|Alemtuzumab|alemtuzumab
5399947|NCT00079768|Monoclonal Antibodies|monoclonal antibodies
5399949|NCT00079768|Anti-CD 52|anti-cd 52
5399950|NCT00079768|Inclusion Body Myositis|inclusion body myositis
5399951|NCT00079729|Treatment Experienced|treatment experienced
5399952|NCT00079677|Excessive Sleepiness|excessive sleepiness
5399953|NCT00079677|Obstructive Sleep Apnea|obstructive sleep apnea
5399954|NCT00079677|Obstructive Sleep Hypopnea|obstructive sleep hypopnea
5399955|NCT00079677|nCPAP|ncpap
5399956|NCT00079677|Cephalon|cephalon
5399957|NCT00079677|Cephalon, Inc|cephalon, inc
5399958|NCT00079677|Nuvigil|nuvigil
5399959|NCT00079664|Tai Ji|tai ji
5399960|NCT00079651|Aged|aged
5399961|NCT00079651|Nursing Homes|nursing homes
5399962|NCT00079651|Assisted Living Facilities|assisted living facilities
5399963|NCT00079638|Niaspan|niaspan
5399964|NCT00079638|Niacin|niacin
5399965|NCT00079638|Statin|statin
5399966|NCT00079638|Cholesterol|cholesterol
5399967|NCT00079638|Triglycerides|triglycerides
5399968|NCT00079638|Lipid-Modifying Therapies|lipid-modifying therapies
5399969|NCT00079638|Dyslipidemia|dyslipidemia
5399970|NCT00079638|Coronary Heart Disease|coronary heart disease
5399971|NCT00079638|Atherosclerosis|atherosclerosis
5399972|NCT00079638|Stroke|stroke
5399973|NCT00079638|VA-HIT|va-hit
5399974|NCT00079638|Niacin Statin Combination Threrapy|niacin statin combination threrapy
5399975|NCT00079638|High Density Lipoprotein|high density lipoprotein
5399976|NCT00079638|Low Density Lipoprotein|low density lipoprotein
5399977|NCT00079638|Hypertension|hypertension
5399978|NCT00079638|Diabetes|diabetes
5399979|NCT00079638|Adult Treatment Panel III|adult treatment panel iii
5399980|NCT00078039|Schizophrenia, paliperidone|schizophrenia, paliperidone
5399981|NCT00003617|stage I gastric cancer|stage i gastric cancer
5399982|NCT00003465|recurrent adult brain tumor|recurrent adult brain tumor
5399983|NCT00003465|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
5399984|NCT00003421|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
5399985|NCT00003421|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
5399986|NCT00003421|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5399987|NCT00003421|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5399988|NCT00003368|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5399989|NCT00003368|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5399990|NCT00003368|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5399991|NCT00003368|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
5399992|NCT00003368|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
5399993|NCT00003368|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5399994|NCT00003368|small intestine lymphoma|small intestine lymphoma
5399995|NCT00003368|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5399996|NCT00003368|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5399997|NCT00003368|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5400384|NCT00079573|Premenopausal women|premenopausal women
5399998|NCT00003368|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5399999|NCT00003368|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5400000|NCT00003368|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5400001|NCT00003368|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5400002|NCT00003368|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5400003|NCT00003368|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5400004|NCT00003368|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5400005|NCT00003368|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5400006|NCT00003368|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5400007|NCT00003368|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5400008|NCT00003368|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5400009|NCT00003368|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5400010|NCT00003368|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5400011|NCT00003368|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5400012|NCT00003368|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5400013|NCT00003368|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5400014|NCT00003368|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5400015|NCT00003368|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5400016|NCT00003368|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5400017|NCT00003368|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5400018|NCT00003368|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5400019|NCT00003368|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5400020|NCT00003368|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5400021|NCT00003368|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5400022|NCT00003368|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5400023|NCT00003368|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
5400024|NCT00003368|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
5400025|NCT00003368|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
5400026|NCT00003368|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
5400027|NCT00003368|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
5400028|NCT00003368|AIDS-related primary CNS lymphoma|aids-related primary cns lymphoma
5400029|NCT00003368|intraocular lymphoma|intraocular lymphoma
5400030|NCT00003368|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5400031|NCT00003368|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5400032|NCT00003368|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5400033|NCT00003368|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
5400034|NCT00003368|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5400035|NCT00003368|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
5400036|NCT00003368|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
5400037|NCT00003368|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5400038|NCT00003368|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5400039|NCT00003368|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5400040|NCT00003368|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5400041|NCT00003368|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5400042|NCT00003368|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5400043|NCT00003368|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5400044|NCT00003368|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5400045|NCT00003368|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5400046|NCT00003368|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5400047|NCT00003361|refractory anemia|refractory anemia
5400048|NCT00003361|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
5400049|NCT00003361|refractory anemia with excess blasts|refractory anemia with excess blasts
5400050|NCT00003361|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
5400051|NCT00003361|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5400052|NCT00003361|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5400053|NCT00003361|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5400054|NCT00003361|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5400055|NCT00003361|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
5400056|NCT00003338|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
5400057|NCT00003338|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
5400058|NCT00003338|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
5400059|NCT00003338|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
5400060|NCT00003338|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
5400061|NCT00003338|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
5400385|NCT00079573|Diet|diet
5400062|NCT00003338|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
5400063|NCT00003338|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
5400064|NCT00003338|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
5400065|NCT00003338|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5400066|NCT00003338|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5400067|NCT00003338|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5400068|NCT00003338|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5400069|NCT00003338|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5400070|NCT00003338|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5400071|NCT00003338|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5400072|NCT00003338|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5400073|NCT00003338|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5400074|NCT00003338|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5400075|NCT00003338|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5400076|NCT00003338|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5400077|NCT00003338|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5400078|NCT00003338|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5400079|NCT00003338|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5400080|NCT00003338|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5400081|NCT00003338|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5400082|NCT00003338|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5400083|NCT00003338|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5400084|NCT00003338|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5400085|NCT00003338|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5400086|NCT00003338|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5400087|NCT00003338|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5400088|NCT00003338|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5400089|NCT00003338|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5400090|NCT00003338|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5400091|NCT00003338|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5400092|NCT00003338|stage I mantle cell lymphoma|stage i mantle cell lymphoma
5400093|NCT00003338|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
5400094|NCT00003338|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
5400095|NCT00003338|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
5400096|NCT00003338|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
5400097|NCT00003338|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
5400098|NCT00003338|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
5400099|NCT00003338|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
5400100|NCT00003338|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
5400101|NCT00003338|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
5400102|NCT00003338|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
5400103|NCT00003338|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5400104|NCT00003338|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5400105|NCT00003338|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5400106|NCT00003338|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
5400107|NCT00003338|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5400108|NCT00003338|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
5400109|NCT00003338|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
5400110|NCT00003338|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5400111|NCT00003338|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
5400112|NCT00003338|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
5400113|NCT00003338|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5400114|NCT00003338|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5400115|NCT00003338|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5400116|NCT00003338|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
5400117|NCT00003338|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
5400118|NCT00003338|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5400119|NCT00003338|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5400120|NCT00003338|stage I marginal zone lymphoma|stage i marginal zone lymphoma
5400121|NCT00003338|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
5400386|NCT00079560|HIV|hiv
5400122|NCT00003338|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5400123|NCT00003338|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5400124|NCT00003338|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5400125|NCT00003338|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5400126|NCT00003338|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
5400127|NCT00003338|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
5400128|NCT00003338|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5400129|NCT00003338|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5400130|NCT00003338|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5400131|NCT00003337|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
5400132|NCT00003337|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
5400133|NCT00003337|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
5400134|NCT00003337|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
5400135|NCT00003337|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
5400136|NCT00003337|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
5400137|NCT00003337|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
5400138|NCT00003337|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
5400139|NCT00003337|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
5400140|NCT00003337|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5400141|NCT00003337|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5400142|NCT00003337|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5400143|NCT00003337|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5400144|NCT00003337|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5400145|NCT00003337|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5400146|NCT00003337|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5400147|NCT00003337|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5400148|NCT00003337|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5400149|NCT00003337|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5400150|NCT00003337|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5400151|NCT00003337|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5400152|NCT00003337|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5400153|NCT00003337|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5400154|NCT00003337|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5400155|NCT00003337|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5400156|NCT00003337|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5400157|NCT00003337|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5400158|NCT00003337|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5400159|NCT00003337|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5400160|NCT00003337|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5400161|NCT00003337|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5400162|NCT00003337|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5400163|NCT00003337|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5400164|NCT00003337|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5400165|NCT00003337|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5400166|NCT00003337|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5400167|NCT00003337|stage I mantle cell lymphoma|stage i mantle cell lymphoma
5400168|NCT00003337|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
5400169|NCT00003337|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
5400170|NCT00003337|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
5400171|NCT00003337|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
5400172|NCT00003337|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
5400173|NCT00003337|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
5400174|NCT00003337|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
5400175|NCT00003337|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
5400176|NCT00003337|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
5400177|NCT00003337|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
5400178|NCT00003337|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5400179|NCT00003337|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5400180|NCT00003337|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5400181|NCT00003337|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
5400182|NCT00003337|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5400183|NCT00003337|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
5400184|NCT00003337|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
5400185|NCT00003337|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5400186|NCT00003337|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
5400187|NCT00003337|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
5400188|NCT00003337|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5400189|NCT00003337|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5400190|NCT00003337|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5400191|NCT00003337|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
5400192|NCT00003337|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
5400193|NCT00003337|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5400194|NCT00003337|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5400195|NCT00003337|stage I marginal zone lymphoma|stage i marginal zone lymphoma
5400196|NCT00003337|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
5400197|NCT00003337|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5400198|NCT00003337|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5400199|NCT00003337|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5400200|NCT00003337|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5400201|NCT00003337|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
5400202|NCT00003337|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
5400203|NCT00003337|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5400204|NCT00003337|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5400205|NCT00003337|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5400206|NCT00003212|adult angiosarcoma|adult angiosarcoma
5400207|NCT00003212|adult fibrosarcoma|adult fibrosarcoma
5400208|NCT00003212|adult leiomyosarcoma|adult leiomyosarcoma
5400209|NCT00003212|adult liposarcoma|adult liposarcoma
5400210|NCT00003212|adult neurofibrosarcoma|adult neurofibrosarcoma
5400211|NCT00003212|adult synovial sarcoma|adult synovial sarcoma
5400212|NCT00003212|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
5400213|NCT00003212|adult malignant fibrous histiocytoma|adult malignant fibrous histiocytoma
5400214|NCT00003212|adult malignant hemangiopericytoma|adult malignant hemangiopericytoma
5400215|NCT00003212|adult rhabdomyosarcoma|adult rhabdomyosarcoma
5400216|NCT00003212|stage IV uterine sarcoma|stage iv uterine sarcoma
5400217|NCT00003212|recurrent uterine sarcoma|recurrent uterine sarcoma
5400218|NCT00003212|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
5400219|NCT00003021|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5400220|NCT00003014|stage I malignant testicular germ cell tumor|stage i malignant testicular germ cell tumor
5400221|NCT00003014|testicular seminoma|testicular seminoma
5400222|NCT00002930|stage I non-small cell lung cancer|stage i non-small cell lung cancer
5400223|NCT00002930|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
5400224|NCT00002930|stage I esophageal cancer|stage i esophageal cancer
5400225|NCT00002930|stage II esophageal cancer|stage ii esophageal cancer
5400226|NCT00002930|stage III esophageal cancer|stage iii esophageal cancer
5400227|NCT00002930|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5400228|NCT00002930|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5400229|NCT00002928|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5400230|NCT00002919|stage II bladder cancer|stage ii bladder cancer
5400231|NCT00002919|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
5400232|NCT00002901|stage IV breast cancer|stage iv breast cancer
5400233|NCT00002901|stage IIIA breast cancer|stage iiia breast cancer
5400234|NCT00002901|recurrent breast cancer|recurrent breast cancer
5400235|NCT00002901|stage IIIB breast cancer|stage iiib breast cancer
5400236|NCT00002901|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5400237|NCT00002901|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5400238|NCT00002901|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5400239|NCT00002901|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5400240|NCT00002901|stage IV nasopharyngeal cancer|stage iv nasopharyngeal cancer
5400241|NCT00002901|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5400242|NCT00002901|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5400243|NCT00002901|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5400244|NCT00002901|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5400245|NCT00002901|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
5400246|NCT00002901|ovarian stromal cancer|ovarian stromal cancer
5400247|NCT00002901|stage III ovarian germ cell tumor|stage iii ovarian germ cell tumor
5400248|NCT00002901|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
5400249|NCT00002901|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
5400250|NCT00002901|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
5400387|NCT00079560|Marijuana|marijuana
5400251|NCT00002901|stage III basal cell carcinoma of the lip|stage iii basal cell carcinoma of the lip
5400252|NCT00002901|stage III verrucous carcinoma of the oral cavity|stage iii verrucous carcinoma of the oral cavity
5400253|NCT00002901|stage III mucoepidermoid carcinoma of the oral cavity|stage iii mucoepidermoid carcinoma of the oral cavity
5400254|NCT00002901|stage III adenoid cystic carcinoma of the oral cavity|stage iii adenoid cystic carcinoma of the oral cavity
5400255|NCT00002901|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5400256|NCT00002901|stage IV basal cell carcinoma of the lip|stage iv basal cell carcinoma of the lip
5400257|NCT00002901|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
5400258|NCT00002901|stage IV mucoepidermoid carcinoma of the oral cavity|stage iv mucoepidermoid carcinoma of the oral cavity
5400259|NCT00002901|stage IV adenoid cystic carcinoma of the oral cavity|stage iv adenoid cystic carcinoma of the oral cavity
5400260|NCT00002901|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
5400261|NCT00002901|recurrent basal cell carcinoma of the lip|recurrent basal cell carcinoma of the lip
5400262|NCT00002901|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
5400263|NCT00002901|recurrent mucoepidermoid carcinoma of the oral cavity|recurrent mucoepidermoid carcinoma of the oral cavity
5400264|NCT00002901|recurrent adenoid cystic carcinoma of the oral cavity|recurrent adenoid cystic carcinoma of the oral cavity
5400265|NCT00002901|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
5400266|NCT00002901|stage III lymphoepithelioma of the oropharynx|stage iii lymphoepithelioma of the oropharynx
5400267|NCT00002901|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5400268|NCT00002901|stage IV lymphoepithelioma of the oropharynx|stage iv lymphoepithelioma of the oropharynx
5400269|NCT00002901|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
5400270|NCT00002901|recurrent lymphoepithelioma of the oropharynx|recurrent lymphoepithelioma of the oropharynx
5400271|NCT00002901|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
5400272|NCT00002901|stage III lymphoepithelioma of the nasopharynx|stage iii lymphoepithelioma of the nasopharynx
5400273|NCT00002901|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
5400274|NCT00002901|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
5400275|NCT00002901|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
5400276|NCT00002901|recurrent lymphoepithelioma of the nasopharynx|recurrent lymphoepithelioma of the nasopharynx
5400277|NCT00002901|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
5400278|NCT00002901|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5400279|NCT00002901|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
5400280|NCT00002901|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
5400281|NCT00002901|stage III verrucous carcinoma of the larynx|stage iii verrucous carcinoma of the larynx
5400282|NCT00002901|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5400283|NCT00002901|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
5400284|NCT00002901|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
5400285|NCT00002901|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
5400286|NCT00002901|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
5400287|NCT00002901|stage III inverted papilloma of the paranasal sinus and nasal cavity|stage iii inverted papilloma of the paranasal sinus and nasal cavity
5400288|NCT00002901|stage III midline lethal granuloma of the paranasal sinus and nasal cavity|stage iii midline lethal granuloma of the paranasal sinus and nasal cavity
5400289|NCT00002901|stage III esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iii esthesioneuroblastoma of the paranasal sinus and nasal cavity
5400290|NCT00002901|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
5400291|NCT00002901|stage IV inverted papilloma of the paranasal sinus and nasal cavity|stage iv inverted papilloma of the paranasal sinus and nasal cavity
5400292|NCT00002901|stage IV midline lethal granuloma of the paranasal sinus and nasal cavity|stage iv midline lethal granuloma of the paranasal sinus and nasal cavity
5400293|NCT00002901|stage IV esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iv esthesioneuroblastoma of the paranasal sinus and nasal cavity
5400294|NCT00002901|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
5400295|NCT00002901|recurrent inverted papilloma of the paranasal sinus and nasal cavity|recurrent inverted papilloma of the paranasal sinus and nasal cavity
5400296|NCT00002901|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity
5400297|NCT00002901|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity
5400298|NCT00002901|borderline ovarian surface epithelial-stromal tumor|borderline ovarian surface epithelial-stromal tumor
5400299|NCT00002901|ovarian sarcoma|ovarian sarcoma
5400300|NCT00002858|limited stage small cell lung cancer|limited stage small cell lung cancer
5400301|NCT00079612|Renal Cell Cancer|renal cell cancer
5400302|NCT00079612|RCC|rcc
5400303|NCT00079612|Cancer|cancer
5400304|NCT00079508|Heparin-induced Thrombocytopenia|heparin-induced thrombocytopenia
5400388|NCT00079560|Marinol|marinol
5400305|NCT00079508|Heparin-induced Thrombocytopenia/Thrombosis Syndrome|heparin-induced thrombocytopenia/thrombosis syndrome
5400306|NCT00079508|HIT/HITTS|hit/hitts
5400307|NCT00079508|Heparin anti-body positive|heparin anti-body positive
5400308|NCT00021359|stage I multiple myeloma|stage i multiple myeloma
5400309|NCT00021359|stage II multiple myeloma|stage ii multiple myeloma
5400310|NCT00021359|stage III multiple myeloma|stage iii multiple myeloma
5400311|NCT00017030|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
5400312|NCT00017030|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
5400313|NCT00017030|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
5400314|NCT00016978|stage IV colon cancer|stage iv colon cancer
5400315|NCT00016978|stage IV rectal cancer|stage iv rectal cancer
5400316|NCT00016978|recurrent colon cancer|recurrent colon cancer
5400317|NCT00016978|recurrent rectal cancer|recurrent rectal cancer
5400318|NCT00016978|adenocarcinoma of the colon|adenocarcinoma of the colon
5400319|NCT00016978|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5400320|NCT00014547|extensive stage small cell lung cancer|extensive stage small cell lung cancer
5400321|NCT00014547|recurrent small cell lung cancer|recurrent small cell lung cancer
5400322|NCT00007969|stage III melanoma|stage iii melanoma
5400323|NCT00007969|stage IV melanoma|stage iv melanoma
5400324|NCT00007969|recurrent melanoma|recurrent melanoma
5400325|NCT00002823|stage I non-small cell lung cancer|stage i non-small cell lung cancer
5400326|NCT00002823|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
5400327|NCT00002823|stage III non-small cell lung cancer|stage iii non-small cell lung cancer
5400328|NCT00002823|squamous cell lung cancer|squamous cell lung cancer
5400329|NCT00002823|large cell lung cancer|large cell lung cancer
5400330|NCT00002823|adenocarcinoma of the lung|adenocarcinoma of the lung
5400331|NCT00002823|adenosquamous cell lung cancer|adenosquamous cell lung cancer
5400332|NCT00002650|colon cancer|colon cancer
5400333|NCT00002650|rectal cancer|rectal cancer
5400334|NCT00002601|metastatic osteosarcoma|metastatic osteosarcoma
5400335|NCT00002601|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
5400336|NCT00002601|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
5400337|NCT00002601|recurrent osteosarcoma|recurrent osteosarcoma
5400338|NCT00002601|adult rhabdomyosarcoma|adult rhabdomyosarcoma
5400339|NCT00002601|metastatic childhood soft tissue sarcoma|metastatic childhood soft tissue sarcoma
5400340|NCT00002601|recurrent childhood soft tissue sarcoma|recurrent childhood soft tissue sarcoma
5400341|NCT00002601|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
5400342|NCT00002601|metastatic Ewing sarcoma/peripheral primitive neuroectodermal tumor|metastatic ewing sarcoma/peripheral primitive neuroectodermal tumor
5400343|NCT00002601|recurrent Ewing sarcoma/peripheral primitive neuroectodermal tumor|recurrent ewing sarcoma/peripheral primitive neuroectodermal tumor
5400344|NCT00002601|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
5400345|NCT00002581|stage I breast cancer|stage i breast cancer
5400346|NCT00002581|stage II breast cancer|stage ii breast cancer
5400347|NCT00002581|stage IIIA breast cancer|stage iiia breast cancer
5400348|NCT00002580|stage I breast cancer|stage i breast cancer
5400349|NCT00002580|stage II breast cancer|stage ii breast cancer
5400350|NCT00002580|stage IIIA breast cancer|stage iiia breast cancer
5400351|NCT00002537|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5400352|NCT00002537|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5400353|NCT00002537|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5400354|NCT00002537|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5400355|NCT00002526|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
5400356|NCT00002526|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
5400357|NCT00002526|stage III uterine sarcoma|stage iii uterine sarcoma
5400358|NCT00002526|stage IV uterine sarcoma|stage iv uterine sarcoma
5400359|NCT00002526|recurrent uterine sarcoma|recurrent uterine sarcoma
5400360|NCT00002526|ovarian sarcoma|ovarian sarcoma
5400361|NCT00002526|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
5400362|NCT00002508|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
5400363|NCT00002508|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
5400364|NCT00002508|extragonadal germ cell tumor|extragonadal germ cell tumor
5400365|NCT00002480|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5400366|NCT00002480|stage IIB prostate cancer|stage iib prostate cancer
5400367|NCT00002480|stage IIA prostate cancer|stage iia prostate cancer
5400368|NCT00002480|stage III prostate cancer|stage iii prostate cancer
5400369|NCT00002459|stage I uterine sarcoma|stage i uterine sarcoma
5400370|NCT00002459|stage II uterine sarcoma|stage ii uterine sarcoma
5400371|NCT00002459|uterine carcinosarcoma|uterine carcinosarcoma
5400372|NCT00002459|uterine leiomyosarcoma|uterine leiomyosarcoma
5400373|NCT00002459|endometrial stromal sarcoma|endometrial stromal sarcoma
5400374|NCT00079625|Engraftment|engraftment
5400375|NCT00079625|Graft-Versus-Host Disease|graft-versus-host disease
5400376|NCT00079625|Metastatic Breast Cancer|metastatic breast cancer
5400377|NCT00079625|MBC|mbc
5400378|NCT00079599|Carnitine Deficiency|carnitine deficiency
5400379|NCT00079599|Fatigue|fatigue
5400380|NCT00079599|Complementary Therapies|complementary therapies
5400381|NCT00079573|Weight Loss|weight loss
5400382|NCT00079573|Obesity|obesity
5400383|NCT00079573|Overweight|overweight
5400391|NCT00079560|Complementary Therapies|complementary therapies
5400392|NCT00079547|Weight Loss|weight loss
5400393|NCT00079534|AIDS|aids
5400394|NCT00079534|HIV|hiv
5400395|NCT00079534|Prayer|prayer
5400396|NCT00079534|Healing|healing
5400397|NCT00079534|Complementary Therapies|complementary therapies
5400398|NCT00079521|Bone Metabolism|bone metabolism
5400399|NCT00079521|Therapeutic Touch|therapeutic touch
5400400|NCT00079495|MS|ms
5400401|NCT00079495|Autoimmune disease|autoimmune disease
5400402|NCT00079495|relapsing|relapsing
5400403|NCT00079495|progressive|progressive
5400404|NCT00079495|Myelin|myelin
5400405|NCT00079495|Myelin Basic Protein|myelin basic protein
5400406|NCT00079495|MBP|mbp
5400407|NCT00079495|acute fulminating|acute fulminating
5400408|NCT00079495|chronic progressive|chronic progressive
5400409|NCT00079495|Altered Peptide Ligand|altered peptide ligand
5400410|NCT00079495|APL|apl
5400411|NCT00079495|Neurocrine|neurocrine
5400412|NCT00079495|NBI-5788|nbi-5788
5400413|NCT00079495|Relapse|relapse
5400414|NCT00079482|AML|aml
5400415|NCT00079469|cancer survivor|cancer survivor
5400416|NCT00079469|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5400417|NCT00079391|Chronic Myelogenous Leukemia (CML)|chronic myelogenous leukemia (cml)
5400418|NCT00079391|Acute Lymphoblastic Leukemia (ALL)|acute lymphoblastic leukemia (all)
5400419|NCT00079391|Acute Myelogenous Leukemia (AML)|acute myelogenous leukemia (aml)
5400420|NCT00079391|Chronic Lymphocytic Leukemia (CLL)|chronic lymphocytic leukemia (cll)
5400421|NCT00079391|Myelodysplastic Syndromes (MDS)|myelodysplastic syndromes (mds)
5400422|NCT00079391|Peripheral Blood Stem Cells|peripheral blood stem cells
5400423|NCT00079391|Graft-Versus Leukemia/Myeloma|graft-versus leukemia/myeloma
5400424|NCT00079391|Graft-Versus-Host Disease (GVHD)|graft-versus-host disease (gvhd)
5400425|NCT00079391|Cyclosporine|cyclosporine
5400426|NCT00079391|Fludarabine|fludarabine
5400427|NCT00079391|Leukemia|leukemia
5400428|NCT00079391|Myelodysplastic Syndrome|myelodysplastic syndrome
5400429|NCT00079391|Myeloproliferative Syndrome|myeloproliferative syndrome
5400430|NCT00079391|Non-Hodgkin Lymphoma|non-hodgkin lymphoma
5400431|NCT00079365|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
5400432|NCT00079365|stage II pancreatic cancer|stage ii pancreatic cancer
5400627|NCT00079066|recurrent rectal cancer|recurrent rectal cancer
5400433|NCT00079365|stage III pancreatic cancer|stage iii pancreatic cancer
5400434|NCT00079365|stage IV pancreatic cancer|stage iv pancreatic cancer
5400435|NCT00079313|CMML|cmml
5400437|NCT00079313|Gleevec|gleevec
5400438|NCT00079313|Glivec|glivec
5400439|NCT00079313|STI-571|sti-571
5400440|NCT00079313|Tyrosine Kinase Inhibitor|tyrosine kinase inhibitor
5400441|NCT00079313|Chronic Myelogenous Leukemia|chronic myelogenous leukemia
5400442|NCT00079313|Atypical Chronic Myelogenous Leukemia|atypical chronic myelogenous leukemia
5400443|NCT00079313|Chronic Myelomoncytic Leukemia|chronic myelomoncytic leukemia
5400444|NCT00079313|Leukemia|leukemia
5400445|NCT00079300|basal cell carcinoma of the skin|basal cell carcinoma of the skin
5400446|NCT00079287|adenocarcinoma of the lung|adenocarcinoma of the lung
5400447|NCT00079287|large cell lung cancer|large cell lung cancer
5400448|NCT00079287|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5400449|NCT00079287|squamous cell lung cancer|squamous cell lung cancer
5400450|NCT00079287|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5400451|NCT00079287|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5400452|NCT00079261|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
5400453|NCT00079261|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5400454|NCT00079261|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5400455|NCT00079261|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5400456|NCT00079261|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
5400457|NCT00079261|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5400458|NCT00079261|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5400459|NCT00079261|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5400460|NCT00079261|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5400461|NCT00079261|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
5400462|NCT00079261|adult grade III lymphomatoid granulomatosis|adult grade iii lymphomatoid granulomatosis
5400463|NCT00079261|small intestine lymphoma|small intestine lymphoma
5400464|NCT00079248|osteoporosis|osteoporosis
5400465|NCT00079248|stage I breast cancer|stage i breast cancer
5400466|NCT00079248|stage II breast cancer|stage ii breast cancer
5400467|NCT00079248|menopausal symptoms|menopausal symptoms
5400468|NCT00079248|hot flashes|hot flashes
5400469|NCT00079222|infection|infection
5400470|NCT00079222|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5400471|NCT00079222|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5400472|NCT00079222|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
5400473|NCT00079222|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
5400474|NCT00079222|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5429227|NCT00039936|Behavior|behavior
5400475|NCT00079222|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5400476|NCT00079222|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5400477|NCT00079222|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5400478|NCT00079222|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
5400479|NCT00079222|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
5400480|NCT00079222|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
5400481|NCT00079222|untreated childhood acute myeloid leukemia and other myeloid malignancies|untreated childhood acute myeloid leukemia and other myeloid malignancies
5400482|NCT00079222|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5400483|NCT00079222|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5400484|NCT00079222|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5400485|NCT00079222|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5400486|NCT00079222|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
5400487|NCT00079222|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5400488|NCT00079222|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
5400489|NCT00079222|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5400490|NCT00079222|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5400491|NCT00079222|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5400492|NCT00079222|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5400493|NCT00079222|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5400494|NCT00079222|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5400495|NCT00079222|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
5400496|NCT00079222|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5400497|NCT00079222|chronic eosinophilic leukemia|chronic eosinophilic leukemia
5400498|NCT00079222|primary myelofibrosis|primary myelofibrosis
5400499|NCT00079222|chronic neutrophilic leukemia|chronic neutrophilic leukemia
5400500|NCT00079222|stage I multiple myeloma|stage i multiple myeloma
5400501|NCT00079222|stage II multiple myeloma|stage ii multiple myeloma
5400502|NCT00079222|stage III multiple myeloma|stage iii multiple myeloma
5400503|NCT00079222|refractory hairy cell leukemia|refractory hairy cell leukemia
5400504|NCT00079222|refractory multiple myeloma|refractory multiple myeloma
5400505|NCT00079222|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5400506|NCT00079222|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5400507|NCT00079222|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5400508|NCT00079222|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5400509|NCT00079222|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5400510|NCT00079222|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5400511|NCT00079222|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5400512|NCT00079222|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
5400513|NCT00079222|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
5400514|NCT00079222|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
5400515|NCT00079222|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5400516|NCT00079222|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5400517|NCT00079222|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5400518|NCT00079222|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5400519|NCT00079222|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5400520|NCT00079222|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
5400521|NCT00079222|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
5400522|NCT00079222|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5400523|NCT00079222|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
5400524|NCT00079222|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
5400525|NCT00079222|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
5400526|NCT00079222|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
5400527|NCT00079222|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5400528|NCT00079222|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5400529|NCT00079222|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5400530|NCT00079222|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5400531|NCT00079222|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5400532|NCT00079222|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5400533|NCT00079222|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5400534|NCT00079222|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5400535|NCT00079222|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5400536|NCT00079222|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5400537|NCT00079222|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5400538|NCT00079222|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5400539|NCT00079222|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5400540|NCT00079222|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5400541|NCT00079222|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5400542|NCT00079222|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5400543|NCT00079222|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5400544|NCT00079222|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5400545|NCT00079222|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5400546|NCT00079222|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5400547|NCT00079222|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5400548|NCT00079222|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5400549|NCT00079222|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5400550|NCT00079222|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5400551|NCT00079222|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5400552|NCT00079222|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
5400553|NCT00079222|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
5400554|NCT00079222|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5400555|NCT00079222|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
5400556|NCT00079222|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5400557|NCT00079222|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5400558|NCT00079222|poor prognosis metastatic gestational trophoblastic tumor|poor prognosis metastatic gestational trophoblastic tumor
5400559|NCT00079222|disseminated neuroblastoma|disseminated neuroblastoma
5400560|NCT00079222|recurrent neuroblastoma|recurrent neuroblastoma
5400561|NCT00079222|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
5400562|NCT00079222|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
5400563|NCT00079222|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
5400564|NCT00079222|recurrent Wilms tumor and other childhood kidney tumors|recurrent wilms tumor and other childhood kidney tumors
5400565|NCT00079222|stage IIIA breast cancer|stage iiia breast cancer
5400566|NCT00079222|stage IIIB breast cancer|stage iiib breast cancer
5400567|NCT00079222|stage IIIC breast cancer|stage iiic breast cancer
5400568|NCT00079222|stage IV breast cancer|stage iv breast cancer
5400569|NCT00079222|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
5400570|NCT00079222|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
5400571|NCT00079222|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
5400572|NCT00079222|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5400573|NCT00079222|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5400574|NCT00079222|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5400575|NCT00079222|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5400576|NCT00079222|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5400577|NCT00079222|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5400578|NCT00079222|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5400579|NCT00079222|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5400580|NCT00079222|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5400581|NCT00079222|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5400582|NCT00079222|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5400583|NCT00079222|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5400584|NCT00079222|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5400585|NCT00079222|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5400586|NCT00079222|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
5400587|NCT00079170|male breast cancer|male breast cancer
5400588|NCT00079170|recurrent breast cancer|recurrent breast cancer
5400589|NCT00079170|stage IIIA breast cancer|stage iiia breast cancer
5400590|NCT00079170|stage IIIB breast cancer|stage iiib breast cancer
5400591|NCT00079170|stage IIIC breast cancer|stage iiic breast cancer
5400592|NCT00079170|stage IV breast cancer|stage iv breast cancer
5400593|NCT00079157|recurrent breast cancer|recurrent breast cancer
5400594|NCT00079157|stage IV breast cancer|stage iv breast cancer
5400595|NCT00079144|recurrent melanoma|recurrent melanoma
5400596|NCT00079144|stage IV melanoma|stage iv melanoma
5400597|NCT00079118|stage IV breast cancer|stage iv breast cancer
5400598|NCT00079118|recurrent breast cancer|recurrent breast cancer
5400599|NCT00079118|male breast cancer|male breast cancer
5400600|NCT00079105|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
5400601|NCT00079105|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
5400602|NCT00079105|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5400603|NCT00079105|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5400604|NCT00079092|recurrent adult brain tumor|recurrent adult brain tumor
5400605|NCT00079092|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5400606|NCT00079092|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
5400607|NCT00079092|adult glioblastoma|adult glioblastoma
5400608|NCT00079092|adult mixed glioma|adult mixed glioma
5400609|NCT00079092|adult giant cell glioblastoma|adult giant cell glioblastoma
5400610|NCT00079092|adult gliosarcoma|adult gliosarcoma
5400611|NCT00079079|stage II salivary gland cancer|stage ii salivary gland cancer
5400612|NCT00079079|stage III salivary gland cancer|stage iii salivary gland cancer
5400613|NCT00079079|stage IV salivary gland cancer|stage iv salivary gland cancer
5400614|NCT00079079|recurrent salivary gland cancer|recurrent salivary gland cancer
5400615|NCT00079079|salivary gland acinic cell tumor|salivary gland acinic cell tumor
5400616|NCT00079079|salivary gland adenoid cystic carcinoma|salivary gland adenoid cystic carcinoma
5400617|NCT00079079|salivary gland poorly differentiated carcinoma|salivary gland poorly differentiated carcinoma
5400618|NCT00079079|high-grade salivary gland mucoepidermoid carcinoma|high-grade salivary gland mucoepidermoid carcinoma
5400619|NCT00079079|low-grade salivary gland mucoepidermoid carcinoma|low-grade salivary gland mucoepidermoid carcinoma
5400620|NCT00079079|salivary gland malignant mixed cell type tumor|salivary gland malignant mixed cell type tumor
5400621|NCT00079079|salivary gland adenocarcinoma|salivary gland adenocarcinoma
5400622|NCT00079079|salivary gland anaplastic carcinoma|salivary gland anaplastic carcinoma
5400623|NCT00079079|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
5400624|NCT00079066|quality of life|quality of life
5400625|NCT00079066|stage IV colon cancer|stage iv colon cancer
5400626|NCT00079066|recurrent colon cancer|recurrent colon cancer
5400628|NCT00079066|stage IV rectal cancer|stage iv rectal cancer
5400629|NCT00079053|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
5400630|NCT00079053|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
5400631|NCT00079053|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
5400632|NCT00079053|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
5400633|NCT00079053|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
5400634|NCT00079053|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
5400635|NCT00079053|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5400636|NCT00079053|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5400637|NCT00079053|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5400638|NCT00079053|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
5400639|NCT00079053|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5400640|NCT00079053|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
5400641|NCT00079053|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
5400642|NCT00079053|stage III salivary gland cancer|stage iii salivary gland cancer
5400643|NCT00079053|stage IV salivary gland cancer|stage iv salivary gland cancer
5400644|NCT00079027|advanced adult primary liver cancer|advanced adult primary liver cancer
5400645|NCT00079027|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
5400646|NCT00079001|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5400647|NCT00079001|recurrent prostate cancer|recurrent prostate cancer
5400648|NCT00079001|stage IV prostate cancer|stage iv prostate cancer
5400649|NCT00079001|bone metastases|bone metastases
5400650|NCT00078988|childhood high-grade cerebral astrocytoma|childhood high-grade cerebral astrocytoma
5400651|NCT00078988|recurrent childhood cerebellar astrocytoma|recurrent childhood cerebellar astrocytoma
5400652|NCT00078988|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
5400653|NCT00078975|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
5400654|NCT00078975|recurrent pancreatic cancer|recurrent pancreatic cancer
5400655|NCT00078975|stage II pancreatic cancer|stage ii pancreatic cancer
5400656|NCT00078975|stage III pancreatic cancer|stage iii pancreatic cancer
5400657|NCT00078975|stage IV pancreatic cancer|stage iv pancreatic cancer
5400658|NCT00078949|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5400659|NCT00078949|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5400660|NCT00078949|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5400661|NCT00078949|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
5400662|NCT00078923|stage I prostate cancer|stage i prostate cancer
5400663|NCT00078923|stage II prostate cancer|stage ii prostate cancer
5400664|NCT00078923|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5400665|NCT00078910|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5400666|NCT00078910|stage IIB prostate cancer|stage iib prostate cancer
5400667|NCT00078910|stage IIA prostate cancer|stage iia prostate cancer
5400668|NCT00078910|stage III prostate cancer|stage iii prostate cancer
5400669|NCT00078897|colon cancer|colon cancer
5400670|NCT00078897|rectal cancer|rectal cancer
5400671|NCT00078897|colorectal cancer|colorectal cancer
5400672|NCT00078897|adenomatous polyp|adenomatous polyp
5400673|NCT00078845|neurotoxicity|neurotoxicity
5400674|NCT00078845|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5400675|NCT00078845|recurrent prostate cancer|recurrent prostate cancer
5400676|NCT00078845|stage I prostate cancer|stage i prostate cancer
5400677|NCT00078845|stage IIB prostate cancer|stage iib prostate cancer
5400678|NCT00078845|stage IIA prostate cancer|stage iia prostate cancer
5400679|NCT00078845|stage III prostate cancer|stage iii prostate cancer
5400680|NCT00078845|stage IV prostate cancer|stage iv prostate cancer
5400681|NCT00078845|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5400682|NCT00078845|stage I non-small cell lung cancer|stage i non-small cell lung cancer
5400683|NCT00078845|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
5400684|NCT00078845|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5400685|NCT00078845|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5400686|NCT00078845|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5400687|NCT00078845|limited stage small cell lung cancer|limited stage small cell lung cancer
5400688|NCT00078845|extensive stage small cell lung cancer|extensive stage small cell lung cancer
5400689|NCT00078845|recurrent small cell lung cancer|recurrent small cell lung cancer
5400690|NCT00078845|recurrent breast cancer|recurrent breast cancer
5400691|NCT00078845|stage I breast cancer|stage i breast cancer
5400692|NCT00078845|stage II breast cancer|stage ii breast cancer
5400693|NCT00078845|stage IIIA breast cancer|stage iiia breast cancer
5400694|NCT00078845|stage IIIB breast cancer|stage iiib breast cancer
5400695|NCT00078845|stage IIIC breast cancer|stage iiic breast cancer
5400696|NCT00078845|stage IV breast cancer|stage iv breast cancer
5400697|NCT00078845|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5400698|NCT00078845|stage I ovarian epithelial cancer|stage i ovarian epithelial cancer
5400699|NCT00078845|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
5400700|NCT00078845|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5400701|NCT00078845|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5400702|NCT00078832|breast cancer, chemoprevention|breast cancer, chemoprevention
5400703|NCT00078819|Pediatric Psoriasis|pediatric psoriasis
5400704|NCT00078806|Systemic Onset Juvenile Rheumatoid Arthiritis|systemic onset juvenile rheumatoid arthiritis
5400705|NCT00078806|SOJRA|sojra
5400706|NCT00078806|Fever|fever
5400707|NCT00078806|Rash|rash
5400708|NCT00078806|Joint Pain|joint pain
5400709|NCT00078793|JRA|jra
5400710|NCT00078793|Registry|registry
5400711|NCT00078767|PTSD|ptsd
5400712|NCT00078767|Depression|depression
5400713|NCT00078767|Anxiety|anxiety
5400714|NCT00078741|Psychotic Disorders|psychotic disorders
5400715|NCT00078728|Anxiety|anxiety
5400716|NCT00078611|Crohn's disease|crohn's disease
5400717|NCT00078611|Inflammatory Bowel Disease|inflammatory bowel disease
5400718|NCT00078611|IBD|ibd
5400719|NCT00078611|Gastroenterology|gastroenterology
5400720|NCT00078611|Regional Enteritis|regional enteritis
5400721|NCT00078611|Colitis|colitis
5400722|NCT00007007|tumors metastatic to brain|tumors metastatic to brain
5400723|NCT00007007|radiation toxicity|radiation toxicity
5400724|NCT00007007|cognitive/functional effects|cognitive/functional effects
5400725|NCT00006890|refractory multiple myeloma|refractory multiple myeloma
5400726|NCT00006890|stage I multiple myeloma|stage i multiple myeloma
5400727|NCT00006890|stage II multiple myeloma|stage ii multiple myeloma
5400728|NCT00006890|stage III multiple myeloma|stage iii multiple myeloma
5400729|NCT00006467|stage III pancreatic cancer|stage iii pancreatic cancer
5400730|NCT00006467|recurrent pancreatic cancer|recurrent pancreatic cancer
5400731|NCT00006467|duct cell adenocarcinoma of the pancreas|duct cell adenocarcinoma of the pancreas
5400732|NCT00006467|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
5400733|NCT00006467|stage IV pancreatic cancer|stage iv pancreatic cancer
5400734|NCT00006452|adult glioblastoma|adult glioblastoma
5400735|NCT00006452|adult giant cell glioblastoma|adult giant cell glioblastoma
5400736|NCT00006452|adult gliosarcoma|adult gliosarcoma
5400737|NCT00006350|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5400738|NCT00006350|refractory multiple myeloma|refractory multiple myeloma
5400739|NCT00006350|stage I multiple myeloma|stage i multiple myeloma
5400740|NCT00006350|stage II multiple myeloma|stage ii multiple myeloma
5400741|NCT00006350|stage III multiple myeloma|stage iii multiple myeloma
5400742|NCT00006350|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5400743|NCT00006350|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5400744|NCT00006350|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5400745|NCT00006350|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5400746|NCT00006350|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5400747|NCT00006350|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5400748|NCT00006350|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5400749|NCT00006350|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5400750|NCT00006350|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5400751|NCT00006350|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
5400752|NCT00006350|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5400753|NCT00006350|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5400754|NCT00006350|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5400755|NCT00006350|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5400816|NCT00006253|symptom management|symptom management
5400756|NCT00006350|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5400757|NCT00006350|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5400758|NCT00006350|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5400759|NCT00006350|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5400760|NCT00006350|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5400761|NCT00006350|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5400762|NCT00006350|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5400763|NCT00006350|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5400764|NCT00006350|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5400765|NCT00006350|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5400766|NCT00006350|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5400767|NCT00006350|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5400768|NCT00006350|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5400769|NCT00006350|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5400770|NCT00006350|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5400771|NCT00006350|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5400772|NCT00006350|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5400773|NCT00006350|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5400774|NCT00006350|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5400775|NCT00006350|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5400776|NCT00006350|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5400777|NCT00006350|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5400778|NCT00006350|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5400779|NCT00006350|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5400780|NCT00006350|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5400781|NCT00006350|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5400782|NCT00006350|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5400783|NCT00006350|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
5400784|NCT00006350|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
5400785|NCT00006350|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
5400786|NCT00006350|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
5400787|NCT00006350|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
5400788|NCT00006350|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
5400789|NCT00006350|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
5400790|NCT00006350|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
5400791|NCT00006350|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
5400792|NCT00006350|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5400793|NCT00006350|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5400794|NCT00006350|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5400795|NCT00006350|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
5400796|NCT00006350|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
5400797|NCT00006350|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
5400798|NCT00006350|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5400799|NCT00006350|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
5400800|NCT00006350|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
5400801|NCT00006350|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5400802|NCT00006350|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
5400803|NCT00006350|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
5400804|NCT00006350|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5400805|NCT00006350|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5400806|NCT00006350|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5400807|NCT00006350|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5400808|NCT00006350|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5400809|NCT00006350|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5400810|NCT00006350|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
5400811|NCT00006350|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
5400812|NCT00006350|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5400813|NCT00006350|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5400814|NCT00006350|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5400815|NCT00006259|tumors metastatic to brain|tumors metastatic to brain
5400818|NCT00006253|chemotherapy treatment|chemotherapy treatment
5400819|NCT00006253|Behavioral Research|behavioral research
5400820|NCT00006253|Physiological Effects of Drugs|physiological effects of drugs
5400821|NCT00006253|Clinical Trial, Phase II|clinical trial, phase ii
5400822|NCT00006126|stage IV breast cancer|stage iv breast cancer
5400823|NCT00006126|recurrent breast cancer|recurrent breast cancer
5400824|NCT00006126|stage IV renal cell cancer|stage iv renal cell cancer
5400825|NCT00006126|recurrent renal cell cancer|recurrent renal cell cancer
5400826|NCT00006126|extensive stage small cell lung cancer|extensive stage small cell lung cancer
5400827|NCT00006126|recurrent small cell lung cancer|recurrent small cell lung cancer
5400828|NCT00006126|stage II malignant testicular germ cell tumor|stage ii malignant testicular germ cell tumor
5400829|NCT00006126|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
5400830|NCT00006126|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
5400831|NCT00006126|stage IV melanoma|stage iv melanoma
5400832|NCT00006126|recurrent melanoma|recurrent melanoma
5400833|NCT00006115|stage IV colon cancer|stage iv colon cancer
5400834|NCT00006115|stage IV rectal cancer|stage iv rectal cancer
5400835|NCT00006115|recurrent colon cancer|recurrent colon cancer
5400836|NCT00006115|recurrent rectal cancer|recurrent rectal cancer
5400837|NCT00006115|adenocarcinoma of the colon|adenocarcinoma of the colon
5400838|NCT00006115|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5400839|NCT00006018|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5400840|NCT00078715|Yohimbine|yohimbine
5400841|NCT00078715|Sleep Deprivation|sleep deprivation
5400842|NCT00078715|Depression|depression
5400843|NCT00078715|Mood Disorder|mood disorder
5400844|NCT00078715|Fast|fast
5400845|NCT00078715|Affective Disorder|affective disorder
5400846|NCT00078715|Rapid Onset|rapid onset
5400847|NCT00078715|Major Depression|major depression
5400848|NCT00078715|MDD|mdd
5400849|NCT00078689|Sirolimus|sirolimus
5400850|NCT00078689|Daclizumab|daclizumab
5400851|NCT00078689|Inflammation|inflammation
5400852|NCT00078689|Induce Tolerance|induce tolerance
5400853|NCT00078689|Uveitis|uveitis
5400854|NCT00078689|Immune Tolerance|immune tolerance
5400855|NCT00078689|T Cell|t cell
5400856|NCT00006000|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5400857|NCT00005965|stage III cervical cancer|stage iii cervical cancer
5400858|NCT00005965|recurrent cervical cancer|recurrent cervical cancer
5400859|NCT00005965|stage IVB cervical cancer|stage ivb cervical cancer
5400860|NCT00005965|stage IVA cervical cancer|stage iva cervical cancer
5400861|NCT00005965|cervical squamous cell carcinoma|cervical squamous cell carcinoma
5400862|NCT00005965|cervical adenocarcinoma|cervical adenocarcinoma
5400863|NCT00005965|cervical adenosquamous cell carcinoma|cervical adenosquamous cell carcinoma
5400864|NCT00005947|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5400865|NCT00005947|stage IV prostate cancer|stage iv prostate cancer
5400866|NCT00005947|recurrent prostate cancer|recurrent prostate cancer
5400867|NCT00005946|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5400868|NCT00005946|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5400869|NCT00005946|refractory multiple myeloma|refractory multiple myeloma
5400870|NCT00005946|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
5400871|NCT00005946|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5400872|NCT00005946|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5400873|NCT00005946|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5400874|NCT00005946|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5400875|NCT00005946|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5400876|NCT00005946|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5400877|NCT00005946|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5400878|NCT00005946|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5400879|NCT00005946|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
5400880|NCT00005946|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5400881|NCT00005946|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5400882|NCT00005946|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5400883|NCT00005946|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5400884|NCT00005946|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5400885|NCT00005946|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5400886|NCT00005946|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5400887|NCT00005946|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5400888|NCT00005946|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5400889|NCT00005946|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5400890|NCT00005946|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5400891|NCT00005946|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
5400892|NCT00005946|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
5400893|NCT00005946|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5400894|NCT00005946|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5400895|NCT00005946|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5400896|NCT00005946|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5400897|NCT00005946|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5400898|NCT00005946|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5400899|NCT00005946|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
5400900|NCT00005843|recurrent pancreatic cancer|recurrent pancreatic cancer
5400901|NCT00005843|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
5400902|NCT00005843|stage IV pancreatic cancer|stage iv pancreatic cancer
5400903|NCT00078663|Oral Care|oral care
5400904|NCT00078663|ICU|icu
5400905|NCT00078663|Pneumonia|pneumonia
5400906|NCT00078663|Pathogens|pathogens
5400907|NCT00078663|Intubation|intubation
5400908|NCT00078663|Intubated|intubated
5400909|NCT00078663|Oral Hygiene|oral hygiene
5400910|NCT00078663|Intensive Care|intensive care
5400911|NCT00078624|Osteoarthritis|osteoarthritis
5400912|NCT00078624|Knee Joint|knee joint
5400913|NCT00078624|Joint Stability|joint stability
5400914|NCT00078624|Motor Control|motor control
5400915|NCT00078624|Exercise Therapy|exercise therapy
5400916|NCT00005595|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5400917|NCT00005096|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5400918|NCT00005096|stage II prostate cancer|stage ii prostate cancer
5400919|NCT00005096|stage III prostate cancer|stage iii prostate cancer
5400920|NCT00005035|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
5400921|NCT00005035|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
5400922|NCT00005035|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5400923|NCT00005035|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
5400924|NCT00005035|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
5400925|NCT00005035|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5400926|NCT00005035|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
5400927|NCT00005035|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
5400928|NCT00005035|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
5400929|NCT00005035|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
5400930|NCT00005035|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
5400931|NCT00005035|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5400932|NCT00005035|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
5400933|NCT00005035|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
5400934|NCT00005035|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5400935|NCT00005035|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
5400936|NCT00005035|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
5400937|NCT00005035|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
5400938|NCT00005035|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
5400939|NCT00004914|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5400940|NCT00004914|anemia|anemia
5400941|NCT00004914|fatigue|fatigue
5400942|NCT00078598|Relapsed|relapsed
5400943|NCT00078598|Follicular|follicular
5400944|NCT00078572|XELODA|xeloda
5400945|NCT00078572|Metastatic|metastatic
5400946|NCT00078572|Breast Cancer|breast cancer
5400947|NCT00078572|Advanced|advanced
5400948|NCT00078572|HERCEPTIN|herceptin
5400949|NCT00078507|Outcome and Process Assessment (Health Care)|outcome and process assessment (health care)
5400950|NCT00078507|Behavior Control|behavior control
5400951|NCT00078507|Sensation|sensation
5400952|NCT00078507|Randomized Controlled Trials|randomized controlled trials
5400953|NCT00078507|Adolescent|adolescent
5400954|NCT00078507|Adult|adult
5400955|NCT00004912|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5400956|NCT00004912|fatigue|fatigue
5400957|NCT00004912|cachexia|cachexia
5400958|NCT00004908|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5400959|NCT00004908|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
5400960|NCT00004908|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5400961|NCT00004908|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5400962|NCT00004908|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5400963|NCT00004908|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5400964|NCT00004908|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5400965|NCT00004908|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5400966|NCT00004908|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5400967|NCT00004908|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
5400968|NCT00004908|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5400969|NCT00004908|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5400970|NCT00004908|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5400971|NCT00004908|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5400972|NCT00004908|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5400973|NCT00004904|monoclonal gammopathy of undetermined significance|monoclonal gammopathy of undetermined significance
5400974|NCT00004904|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
5400975|NCT00004904|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
5400976|NCT00004904|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5400977|NCT00004904|isolated plasmacytoma of bone|isolated plasmacytoma of bone
5400978|NCT00004904|extramedullary plasmacytoma|extramedullary plasmacytoma
5400979|NCT00004904|refractory multiple myeloma|refractory multiple myeloma
5400980|NCT00004904|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
5400981|NCT00004904|stage III multiple myeloma|stage iii multiple myeloma
5400982|NCT00004904|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
5400983|NCT00004904|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5400984|NCT00004904|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5400985|NCT00004904|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5400986|NCT00004904|small intestine lymphoma|small intestine lymphoma
5400987|NCT00004904|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5400988|NCT00004904|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5400989|NCT00004904|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5400990|NCT00004904|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5400991|NCT00004904|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5400992|NCT00004904|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
5400993|NCT00004904|polycythemia vera|polycythemia vera
5400994|NCT00004904|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
5400995|NCT00004904|essential thrombocythemia|essential thrombocythemia
5400996|NCT00004904|refractory hairy cell leukemia|refractory hairy cell leukemia
5400997|NCT00004904|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
5400998|NCT00004904|acute undifferentiated leukemia|acute undifferentiated leukemia
5400999|NCT00004904|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5401000|NCT00004904|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5401001|NCT00004904|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5401002|NCT00004904|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5401003|NCT00004904|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5401004|NCT00004904|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5401005|NCT00004904|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5401006|NCT00004904|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5401007|NCT00004904|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5401008|NCT00004904|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5401009|NCT00004904|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5401010|NCT00004904|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5401011|NCT00004904|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5401012|NCT00004904|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5401013|NCT00004904|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5401014|NCT00004904|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5401015|NCT00004904|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5401016|NCT00004904|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5401017|NCT00004904|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5401018|NCT00004904|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5401019|NCT00004904|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5401020|NCT00004904|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5401021|NCT00004904|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5401022|NCT00004904|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5401023|NCT00004904|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5401024|NCT00004904|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5401025|NCT00004904|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5401026|NCT00004904|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
5401027|NCT00004904|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
5401028|NCT00004904|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
5401029|NCT00004904|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5401030|NCT00004904|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5401031|NCT00004904|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5401032|NCT00004904|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5401033|NCT00004904|graft versus host disease|graft versus host disease
5401034|NCT00004904|primary systemic amyloidosis|primary systemic amyloidosis
5401035|NCT00004904|intraocular lymphoma|intraocular lymphoma
5401036|NCT00004904|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
5401037|NCT00004904|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
5401038|NCT00004904|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5401039|NCT00004904|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5401040|NCT00004904|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5401041|NCT00004904|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
5401042|NCT00004904|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
5401043|NCT00004904|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5401044|NCT00004904|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5401045|NCT00004904|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5401046|NCT00004904|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5401047|NCT00004904|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5401048|NCT00004904|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5401049|NCT00004904|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5401050|NCT00004904|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5401051|NCT00004904|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5401052|NCT00004904|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5401053|NCT00004904|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
5401054|NCT00004898|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5401055|NCT00004898|stage I childhood lymphoblastic lymphoma|stage i childhood lymphoblastic lymphoma
5401056|NCT00004898|stage II childhood lymphoblastic lymphoma|stage ii childhood lymphoblastic lymphoma
5401057|NCT00004898|stage III childhood lymphoblastic lymphoma|stage iii childhood lymphoblastic lymphoma
5401058|NCT00004898|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
5401059|NCT00004898|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
5401060|NCT00004898|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5401061|NCT00004898|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5401062|NCT00004898|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
5401063|NCT00004898|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
5401064|NCT00004898|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
5401065|NCT00004898|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
5401066|NCT00004898|stage II adult immunoblastic large cell lymphoma|stage ii adult immunoblastic large cell lymphoma
5401067|NCT00004898|stage II adult lymphoblastic lymphoma|stage ii adult lymphoblastic lymphoma
5401068|NCT00004898|stage II adult Burkitt lymphoma|stage ii adult burkitt lymphoma
5401069|NCT00004898|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5401070|NCT00004898|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5401071|NCT00004898|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5401072|NCT00004898|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5401073|NCT00004898|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5401074|NCT00004898|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5401075|NCT00004898|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5401076|NCT00004898|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5401077|NCT00004898|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5401078|NCT00004898|stage I childhood small noncleaved cell lymphoma|stage i childhood small noncleaved cell lymphoma
5401079|NCT00004898|stage I childhood large cell lymphoma|stage i childhood large cell lymphoma
5401080|NCT00004898|stage II childhood small noncleaved cell lymphoma|stage ii childhood small noncleaved cell lymphoma
5401081|NCT00004898|stage II childhood large cell lymphoma|stage ii childhood large cell lymphoma
5401082|NCT00004898|stage III childhood small noncleaved cell lymphoma|stage iii childhood small noncleaved cell lymphoma
5401083|NCT00004898|stage III childhood large cell lymphoma|stage iii childhood large cell lymphoma
5401084|NCT00004898|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
5401085|NCT00004898|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
5401086|NCT00004898|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
5401087|NCT00004898|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
5401088|NCT00004235|stage IV gastric cancer|stage iv gastric cancer
5401089|NCT00004235|recurrent gastric cancer|recurrent gastric cancer
5401090|NCT00004235|stage II esophageal cancer|stage ii esophageal cancer
5401091|NCT00004235|stage III esophageal cancer|stage iii esophageal cancer
5401092|NCT00004235|stage IV esophageal cancer|stage iv esophageal cancer
5401093|NCT00004235|recurrent esophageal cancer|recurrent esophageal cancer
5401094|NCT00004235|adenocarcinoma of the stomach|adenocarcinoma of the stomach
5401095|NCT00004235|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
5401096|NCT00004175|stage IIIA breast cancer|stage iiia breast cancer
5401097|NCT00004175|stage IIIB breast cancer|stage iiib breast cancer
5401098|NCT00078559|Immunosuppression|immunosuppression
5401099|NCT00078559|Renal Failure|renal failure
5401101|NCT00078546|NASOPHARYNGEAL|nasopharyngeal
5401102|NCT00078546|CARCINOMA|carcinoma
5401103|NCT00078546|EBV POSITIVE NASOPHARYNGEAL CARCINOMA|ebv positive nasopharyngeal carcinoma
5401104|NCT00078533|Allogeneic|allogeneic
5401105|NCT00078533|Transplant|transplant
5401106|NCT00078533|CMV|cmv
5401107|NCT00078533|Stem Cell|stem cell
5401108|NCT00078533|Donor|donor
5401109|NCT00078533|Allogeneic stem cell recipients at risk for CMV reactivation|allogeneic stem cell recipients at risk for cmv reactivation
5401110|NCT00078520|Leukemia|leukemia
5401111|NCT00078494|Immunization|immunization
5401112|NCT00078494|Vaccine|vaccine
5401113|NCT00078494|Nasopharyngeal Cancer|nasopharyngeal cancer
5401114|NCT00078494|Immunotherapy|immunotherapy
5401115|NCT00078494|Cancer|cancer
5401116|NCT00078494|NPC|npc
5401117|NCT00078481|Neurodegeneration|neurodegeneration
5401118|NCT00078481|Anti-Oxidant|anti-oxidant
5401119|NCT00078481|Neuropathy|neuropathy
5401120|NCT00078481|Hereditary|hereditary
5401121|NCT00078481|Spinocerebellar|spinocerebellar
5401122|NCT00078481|Friedreich Ataxia|friedreich ataxia
5401123|NCT00078481|FRDA|frda
5401124|NCT00078455|NSCLC|nsclc
5401125|NCT00078455|Non-small Cell Lung Cancer|non-small cell lung cancer
5401126|NCT00078455|Non-small Cell Lung Carcinoma|non-small cell lung carcinoma
5401127|NCT00078455|Locally Advanced NSCLC|locally advanced nsclc
5401128|NCT00078455|Metastatic NSCLC|metastatic nsclc
5401129|NCT00078221|Dry AMD|dry amd
5401130|NCT00078221|Age-related Macular Degeneration|age-related macular degeneration
5401131|NCT00078221|Rheopheresis|rheopheresis
5401132|NCT00004171|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5401133|NCT00004171|childhood immunoblastic large cell lymphoma|childhood immunoblastic large cell lymphoma
5401134|NCT00004171|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
5401135|NCT00004171|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5401136|NCT00004171|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5401137|NCT00004171|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5401138|NCT00004171|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5401139|NCT00004171|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5401140|NCT00004091|cervical cancer|cervical cancer
5401141|NCT00003351|stage IV breast cancer|stage iv breast cancer
5401142|NCT00003302|breast cancer|breast cancer
5401143|NCT00003264|stage IV salivary gland cancer|stage iv salivary gland cancer
5401144|NCT00003264|recurrent salivary gland cancer|recurrent salivary gland cancer
5401145|NCT00003264|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
5401146|NCT00003264|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
5401147|NCT00003264|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
5401148|NCT00003264|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5401149|NCT00003264|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
5401150|NCT00003264|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5401151|NCT00003264|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
5401152|NCT00003264|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
5401153|NCT00003264|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
5401154|NCT00003264|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5401155|NCT00003264|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
5401156|NCT00003264|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5401157|NCT00003264|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
5401158|NCT00003264|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
5401159|NCT00003264|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
5401160|NCT00003070|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
5401161|NCT00003070|cardiac toxicity|cardiac toxicity
5401162|NCT00003040|stage I squamous cell carcinoma of the larynx|stage i squamous cell carcinoma of the larynx
5401163|NCT00003040|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
5401164|NCT00003040|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
5401165|NCT00002825|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
5401166|NCT00002825|recurrent neuroblastoma|recurrent neuroblastoma
5401167|NCT00002825|recurrent osteosarcoma|recurrent osteosarcoma
5401168|NCT00002825|recurrent childhood soft tissue sarcoma|recurrent childhood soft tissue sarcoma
5401169|NCT00002825|recurrent childhood brain stem glioma|recurrent childhood brain stem glioma
5429439|NCT00038818|MM|mm
5401170|NCT00002825|recurrent childhood supratentorial primitive neuroectodermal tumor|recurrent childhood supratentorial primitive neuroectodermal tumor
5401171|NCT00002825|recurrent childhood cerebellar astrocytoma|recurrent childhood cerebellar astrocytoma
5401172|NCT00002825|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
5401173|NCT00002825|recurrent childhood medulloblastoma|recurrent childhood medulloblastoma
5401174|NCT00002825|recurrent Ewing sarcoma/peripheral primitive neuroectodermal tumor|recurrent ewing sarcoma/peripheral primitive neuroectodermal tumor
5401175|NCT00002825|recurrent childhood ependymoma|recurrent childhood ependymoma
5401176|NCT00002652|refractory multiple myeloma|refractory multiple myeloma
5401177|NCT00026429|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
5401178|NCT00026429|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
5401179|NCT00026429|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5401180|NCT00026429|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5401181|NCT00026429|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5401182|NCT00026429|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
5401183|NCT00026429|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
5401184|NCT00026429|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
5401185|NCT00026429|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
5401186|NCT00026429|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
5401187|NCT00026429|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
5401188|NCT00026429|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
5401189|NCT00026429|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5401190|NCT00026429|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5401191|NCT00026429|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5401192|NCT00026429|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5401193|NCT00026429|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5401194|NCT00026429|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5401195|NCT00026429|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5401196|NCT00026429|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5401197|NCT00026429|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5401198|NCT00026429|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5401199|NCT00026429|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5401200|NCT00026429|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5401201|NCT00026429|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5401202|NCT00026429|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5401203|NCT00026429|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5401204|NCT00026429|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5401205|NCT00026429|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5401206|NCT00026429|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5401207|NCT00026429|stage I mantle cell lymphoma|stage i mantle cell lymphoma
5401208|NCT00026429|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
5401209|NCT00026429|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
5401210|NCT00026429|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
5401211|NCT00026429|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
5401212|NCT00026429|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
5401213|NCT00026429|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
5401214|NCT00026429|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
5401215|NCT00026429|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5401216|NCT00026429|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5401217|NCT00026429|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5401218|NCT00026429|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
5401219|NCT00026429|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5401220|NCT00026429|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
5401221|NCT00026429|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5401222|NCT00026429|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5401223|NCT00026429|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5401224|NCT00026429|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5401225|NCT00026429|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
5401226|NCT00026429|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
5401227|NCT00026429|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5401228|NCT00026429|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5401229|NCT00026429|stage I marginal zone lymphoma|stage i marginal zone lymphoma
5401230|NCT00026429|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
5429440|NCT00038818|NHL|nhl
5401231|NCT00026429|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5401232|NCT00026429|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5401233|NCT00026429|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5401234|NCT00026429|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5401235|NCT00026429|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
5401236|NCT00026429|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
5401237|NCT00026429|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5401238|NCT00025012|basal cell carcinoma of the skin|basal cell carcinoma of the skin
5401239|NCT00025012|squamous cell carcinoma of the skin|squamous cell carcinoma of the skin
5401240|NCT00025012|melanoma|melanoma
5401241|NCT00024037|oral complications|oral complications
5401242|NCT00022308|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
5401243|NCT00022308|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5401244|NCT00022308|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5401245|NCT00022308|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5401246|NCT00022217|recurrent salivary gland cancer|recurrent salivary gland cancer
5401247|NCT00022217|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
5401248|NCT00022217|salivary gland anaplastic carcinoma|salivary gland anaplastic carcinoma
5401249|NCT00022217|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
5401250|NCT00022217|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
5401251|NCT00022217|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
5401252|NCT00022217|recurrent lymphoepithelioma of the oropharynx|recurrent lymphoepithelioma of the oropharynx
5401253|NCT00022217|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
5401254|NCT00022217|recurrent lymphoepithelioma of the nasopharynx|recurrent lymphoepithelioma of the nasopharynx
5401255|NCT00022217|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
5401256|NCT00022217|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
5401257|NCT00022217|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
5401258|NCT00022217|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
5401259|NCT00022178|adenocarcinoma of unknown primary|adenocarcinoma of unknown primary
5401260|NCT00022178|squamous cell carcinoma of unknown primary|squamous cell carcinoma of unknown primary
5401261|NCT00022178|undifferentiated carcinoma of unknown primary|undifferentiated carcinoma of unknown primary
5401262|NCT00022178|newly diagnosed carcinoma of unknown primary|newly diagnosed carcinoma of unknown primary
5401263|NCT00021996|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5401264|NCT00021996|pain|pain
5401265|NCT00021372|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5401266|NCT00021372|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5401267|NCT00021372|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5401268|NCT00021372|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5401269|NCT00021372|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5401270|NCT00021372|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5401271|NCT00021372|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5401272|NCT00021372|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5401273|NCT00021372|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5401274|NCT00021372|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5401275|NCT00021372|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5401276|NCT00021372|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5401277|NCT00021372|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5401278|NCT00021372|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5401279|NCT00021372|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5401280|NCT00020618|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5401281|NCT00020618|pain|pain
5401282|NCT00020098|breast cancer|breast cancer
5401283|NCT00019409|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
5401284|NCT00019409|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
5401285|NCT00019409|L1 childhood acute lymphoblastic leukemia|l1 childhood acute lymphoblastic leukemia
5401286|NCT00019409|L2 childhood acute lymphoblastic leukemia|l2 childhood acute lymphoblastic leukemia
5401287|NCT00017303|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5401288|NCT00017303|ovarian undifferentiated adenocarcinoma|ovarian undifferentiated adenocarcinoma
5401289|NCT00017303|ovarian mixed epithelial carcinoma|ovarian mixed epithelial carcinoma
5401290|NCT00017303|ovarian serous cystadenocarcinoma|ovarian serous cystadenocarcinoma
5401291|NCT00017303|ovarian mucinous cystadenocarcinoma|ovarian mucinous cystadenocarcinoma
5401292|NCT00017303|ovarian endometrioid adenocarcinoma|ovarian endometrioid adenocarcinoma
5401293|NCT00017303|ovarian clear cell cystadenocarcinoma|ovarian clear cell cystadenocarcinoma
5401294|NCT00017303|primary peritoneal cavity cancer|primary peritoneal cavity cancer
5401295|NCT00017303|Brenner tumor|brenner tumor
5401296|NCT00016367|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5401297|NCT00016367|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5401298|NCT00015964|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
5401299|NCT00015964|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
5401300|NCT00015964|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5401301|NCT00015964|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
5401302|NCT00015964|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5401303|NCT00015964|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
5401304|NCT00015964|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
5401305|NCT00015964|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
5401306|NCT00015964|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5401307|NCT00015964|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
5401308|NCT00015964|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5401309|NCT00015964|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
5401310|NCT00015964|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
5401311|NCT00015964|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
5401312|NCT00002597|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5401313|NCT00002597|stage I prostate cancer|stage i prostate cancer
5401314|NCT00002597|stage IIB prostate cancer|stage iib prostate cancer
5401315|NCT00002597|stage IIA prostate cancer|stage iia prostate cancer
5401316|NCT00002577|stage I non-small cell lung cancer|stage i non-small cell lung cancer
5401317|NCT00002577|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
5401318|NCT00002577|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5401319|NCT00002577|squamous cell lung cancer|squamous cell lung cancer
5401320|NCT00002577|large cell lung cancer|large cell lung cancer
5401321|NCT00002577|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5401322|NCT00002577|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5401323|NCT00002577|adenocarcinoma of the lung|adenocarcinoma of the lung
5401324|NCT00002454|lung papilloma|lung papilloma
5401325|NCT00078442|Treatment Experienced|treatment experienced
5401326|NCT00078442|Treatment Interruption|treatment interruption
5401327|NCT00078442|Treatment Naive|treatment naive
5401328|NCT00078390|Lung cancer|lung cancer
5401329|NCT00078390|Lung carcinoma|lung carcinoma
5401330|NCT00078390|Non small cell lung cancer|non small cell lung cancer
5401331|NCT00078390|Stage IIIA non small cell lung cancer|stage iiia non small cell lung cancer
5401332|NCT00078390|Stage IIIB non small cell lung cancer|stage iiib non small cell lung cancer
5401333|NCT00078390|NSCLC|nsclc
5401334|NCT00078390|Stage III|stage iii
5401335|NCT00078390|chemotherapy|chemotherapy
5401336|NCT00078390|radiation|radiation
5401337|NCT00078390|chemoradiation|chemoradiation
5401338|NCT00078390|matrix metalloproteinases|matrix metalloproteinases
5401339|NCT00078390|neovascularization|neovascularization
5401340|NCT00078390|antiangiogenesis|antiangiogenesis
5401341|NCT00078390|type IV collagenases|type iv collagenases
5401342|NCT00078390|Unresectable locally advanced non-small cell lung cancer|unresectable locally advanced non-small cell lung cancer
5401343|NCT00078377|Narcolepsy|narcolepsy
5401344|NCT00078377|Excessive Sleepiness|excessive sleepiness
5401345|NCT00078377|Cataplexy|cataplexy
5401346|NCT00078377|Sleep Attacks|sleep attacks
5401347|NCT00078377|Excessive Sleepiness associated with Narcolepsy|excessive sleepiness associated with narcolepsy
5401348|NCT00078377|Cephalon|cephalon
5401349|NCT00078377|Cephalon, Inc|cephalon, inc
5401350|NCT00078377|Nuvigil|nuvigil
5401351|NCT00014690|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5401352|NCT00014690|fallopian tube cancer|fallopian tube cancer
5401353|NCT00014690|primary peritoneal cavity cancer|primary peritoneal cavity cancer
5401354|NCT00014339|stage II multiple myeloma|stage ii multiple myeloma
5401355|NCT00014339|stage III multiple myeloma|stage iii multiple myeloma
5401356|NCT00012259|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5401357|NCT00012259|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5401358|NCT00012259|chronic myelogenous leukemia, BCR-ABL1 positive|chronic myelogenous leukemia, bcr-abl1 positive
5401359|NCT00010179|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5401360|NCT00010179|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5401361|NCT00010179|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5401362|NCT00010179|fallopian tube cancer|fallopian tube cancer
5401363|NCT00010179|peritoneal cavity cancer|peritoneal cavity cancer
5401364|NCT00006472|stage I esophageal cancer|stage i esophageal cancer
5401365|NCT00006472|stage II esophageal cancer|stage ii esophageal cancer
5401366|NCT00006472|stage III esophageal cancer|stage iii esophageal cancer
5401367|NCT00006472|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
5401368|NCT00006472|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
5401369|NCT00006365|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5401370|NCT00006365|stage I prostate cancer|stage i prostate cancer
5401371|NCT00006365|stage IIB prostate cancer|stage iib prostate cancer
5401372|NCT00006365|stage IIA prostate cancer|stage iia prostate cancer
5401373|NCT00006108|stage IV breast cancer|stage iv breast cancer
5401374|NCT00006108|recurrent breast cancer|recurrent breast cancer
5401375|NCT00006037|stage IV colon cancer|stage iv colon cancer
5401376|NCT00006037|stage IV rectal cancer|stage iv rectal cancer
5401377|NCT00006037|recurrent colon cancer|recurrent colon cancer
5401378|NCT00006037|recurrent rectal cancer|recurrent rectal cancer
5401379|NCT00006037|adenocarcinoma of the colon|adenocarcinoma of the colon
5401380|NCT00006037|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5401381|NCT00006014|advanced malignant mesothelioma|advanced malignant mesothelioma
5401382|NCT00006014|recurrent malignant mesothelioma|recurrent malignant mesothelioma
5401383|NCT00006014|epithelial mesothelioma|epithelial mesothelioma
5401384|NCT00006014|sarcomatous mesothelioma|sarcomatous mesothelioma
5401385|NCT00078403|Treatment Experienced|treatment experienced
5401386|NCT00078325|Excessive Sleepiness|excessive sleepiness
5401387|NCT00078325|Obstructive Sleep Apnea|obstructive sleep apnea
5401388|NCT00078325|Obstructive Sleep Hypopnea|obstructive sleep hypopnea
5401389|NCT00078325|nCPAP|ncpap
5401390|NCT00078325|Cephalon|cephalon
5401391|NCT00078325|Cephalon, Inc|cephalon, inc
5401392|NCT00078325|NUVIGIL|nuvigil
5401393|NCT00078312|Excessive Sleepiness|excessive sleepiness
5401394|NCT00078312|Narcolepsy|narcolepsy
5401395|NCT00078312|Cataplexy|cataplexy
5401396|NCT00078312|Sleep Attacks|sleep attacks
5401397|NCT00078312|Obstructive Sleep Apnea|obstructive sleep apnea
5401398|NCT00078312|Obstructive Sleep Hypopnea|obstructive sleep hypopnea
5401399|NCT00078312|nCPAP|ncpap
5401400|NCT00078312|Chronic Shift Work Sleep Disorder|chronic shift work sleep disorder
5401401|NCT00078312|Chronic SWSD|chronic swsd
5401402|NCT00078312|Circadian Rhythm Disorder|circadian rhythm disorder
5401403|NCT00078312|Shift Worker|shift worker
5401404|NCT00078312|Cepahlon|cepahlon
5401405|NCT00078312|Cephalon, Inc|cephalon, inc
5401406|NCT00078312|Nuvigil|nuvigil
5401407|NCT00005991|stage IV breast cancer|stage iv breast cancer
5401408|NCT00005991|recurrent breast cancer|recurrent breast cancer
5401409|NCT00005880|non-small cell lung cancer|non-small cell lung cancer
5401410|NCT00005880|small cell lung cancer|small cell lung cancer
5401411|NCT00005869|stage II pancreatic cancer|stage ii pancreatic cancer
5401412|NCT00005869|stage III pancreatic cancer|stage iii pancreatic cancer
5401413|NCT00005869|recurrent pancreatic cancer|recurrent pancreatic cancer
5401414|NCT00005869|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
5401415|NCT00005869|stage IV pancreatic cancer|stage iv pancreatic cancer
5401416|NCT00005864|stage IV colon cancer|stage iv colon cancer
5401417|NCT00005864|stage IV rectal cancer|stage iv rectal cancer
5401418|NCT00005864|recurrent colon cancer|recurrent colon cancer
5401419|NCT00005864|recurrent rectal cancer|recurrent rectal cancer
5401420|NCT00005593|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5401421|NCT00005593|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5401422|NCT00005593|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5401423|NCT00005593|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5401424|NCT00005593|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5401425|NCT00005593|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5401426|NCT00005593|L1 childhood acute lymphoblastic leukemia|l1 childhood acute lymphoblastic leukemia
5401427|NCT00005593|L2 childhood acute lymphoblastic leukemia|l2 childhood acute lymphoblastic leukemia
5401428|NCT00005593|L1 adult acute lymphoblastic leukemia|l1 adult acute lymphoblastic leukemia
5401429|NCT00005593|L2 adult acute lymphoblastic leukemia|l2 adult acute lymphoblastic leukemia
5401430|NCT00005593|adult acute erythroid leukemia (M6)|adult acute erythroid leukemia (m6)
5401431|NCT00005593|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
5401432|NCT00005593|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
5401433|NCT00005593|adult acute promyelocytic leukemia (M3)|adult acute promyelocytic leukemia (m3)
5401434|NCT00005593|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
5401435|NCT00005593|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
5401436|NCT00005593|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
5401437|NCT00005593|childhood acute myeloblastic leukemia without maturation (M1)|childhood acute myeloblastic leukemia without maturation (m1)
5401438|NCT00005593|childhood acute myeloblastic leukemia with maturation (M2)|childhood acute myeloblastic leukemia with maturation (m2)
5401439|NCT00005593|childhood acute promyelocytic leukemia (M3)|childhood acute promyelocytic leukemia (m3)
5401440|NCT00005593|childhood acute myelomonocytic leukemia (M4)|childhood acute myelomonocytic leukemia (m4)
5401441|NCT00005593|childhood acute monoblastic leukemia (M5a)|childhood acute monoblastic leukemia (m5a)
5401442|NCT00005593|childhood acute monocytic leukemia (M5b)|childhood acute monocytic leukemia (m5b)
5401443|NCT00005593|childhood acute erythroleukemia (M6)|childhood acute erythroleukemia (m6)
5401444|NCT00005593|childhood acute megakaryocytic leukemia (M7)|childhood acute megakaryocytic leukemia (m7)
5429441|NCT00038818|HD|hd
5401445|NCT00005593|refractory anemia with excess blasts|refractory anemia with excess blasts
5401446|NCT00005593|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
5401447|NCT00005593|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5401448|NCT00005593|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5401449|NCT00005593|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
5401450|NCT00005593|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5401451|NCT00005593|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5401452|NCT00005593|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
5401453|NCT00005593|childhood acute minimally differentiated myeloid leukemia (M0)|childhood acute minimally differentiated myeloid leukemia (m0)
5401454|NCT00005593|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
5401455|NCT00005075|stage I prostate cancer|stage i prostate cancer
5401456|NCT00005075|stage II prostate cancer|stage ii prostate cancer
5401457|NCT00005075|recurrent prostate cancer|recurrent prostate cancer
5401458|NCT00005026|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5401459|NCT00005026|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5401460|NCT00005026|ovarian undifferentiated adenocarcinoma|ovarian undifferentiated adenocarcinoma
5401461|NCT00005026|ovarian mixed epithelial carcinoma|ovarian mixed epithelial carcinoma
5401462|NCT00005026|ovarian serous cystadenocarcinoma|ovarian serous cystadenocarcinoma
5401463|NCT00005026|ovarian mucinous cystadenocarcinoma|ovarian mucinous cystadenocarcinoma
5401464|NCT00005026|ovarian endometrioid adenocarcinoma|ovarian endometrioid adenocarcinoma
5401465|NCT00005026|ovarian clear cell cystadenocarcinoma|ovarian clear cell cystadenocarcinoma
5401466|NCT00005026|primary peritoneal cavity cancer|primary peritoneal cavity cancer
5401467|NCT00005026|Brenner tumor|brenner tumor
5401468|NCT00004223|stage III bladder cancer|stage iii bladder cancer
5401469|NCT00004223|recurrent bladder cancer|recurrent bladder cancer
5401470|NCT00004223|stage IV bladder cancer|stage iv bladder cancer
5401471|NCT00004223|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
5401472|NCT00004223|posterior urethral cancer|posterior urethral cancer
5401473|NCT00004223|metastatic transitional cell cancer of the renal pelvis and ureter|metastatic transitional cell cancer of the renal pelvis and ureter
5401474|NCT00004223|regional transitional cell cancer of the renal pelvis and ureter|regional transitional cell cancer of the renal pelvis and ureter
5401475|NCT00004216|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5401476|NCT00004183|localized malignant mesothelioma|localized malignant mesothelioma
5401477|NCT00004183|advanced malignant mesothelioma|advanced malignant mesothelioma
5401478|NCT00004183|recurrent malignant mesothelioma|recurrent malignant mesothelioma
5401479|NCT00004183|epithelial mesothelioma|epithelial mesothelioma
5401480|NCT00004183|sarcomatous mesothelioma|sarcomatous mesothelioma
5401481|NCT00078364|MRI|mri
5401482|NCT00078364|NSAID Analgesia|nsaid analgesia
5401483|NCT00078364|Pain Mechanisms|pain mechanisms
5401484|NCT00078364|SNP's|snp's
5401485|NCT00078364|Acute Pain|acute pain
5401486|NCT00078364|Wisdom Teeth|wisdom teeth
5401487|NCT00078364|Third Molar Extraction|third molar extraction
5401488|NCT00078364|Third Molar Impaction|third molar impaction
5401489|NCT00078351|Chronic Pain|chronic pain
5401490|NCT00078351|Synvisc|synvisc
5401491|NCT00078351|Temporomandibular Joint|temporomandibular joint
5401492|NCT00078351|Osteoarthritis|osteoarthritis
5401493|NCT00078351|TMD|tmd
5401494|NCT00078351|Temporomandibular Joint Osteoarthritis|temporomandibular joint osteoarthritis
5401495|NCT00078351|TMJ OA|tmj oa
5401496|NCT00078351|Temporomandibular Joint Disease|temporomandibular joint disease
5401497|NCT00078351|TMJ|tmj
5401498|NCT00078286|Antidepressive Agents|antidepressive agents
5401499|NCT00078273|Gambling|gambling
5401500|NCT00078273|Pathological Gambling|pathological gambling
5401501|NCT00078273|Problem Gambling|problem gambling
5401502|NCT00078273|College Students|college students
5401503|NCT00078273|Prevention|prevention
5401504|NCT00078299|Cortical|cortical
5401505|NCT00078299|Nuclear Sclerosis|nuclear sclerosis
5401506|NCT00078299|Posterior Subcapsular|posterior subcapsular
5401507|NCT00078299|Photographic Methods|photographic methods
5401508|NCT00078299|Reproducibility (intra and interobserver)|reproducibility (intra and interobserver)
5401509|NCT00078299|Cataract|cataract
5401510|NCT00078299|Agreement|agreement
5401511|NCT00078299|Grading System|grading system
5401512|NCT00078247|Antiretroviral Therapy|antiretroviral therapy
5401513|NCT00078247|Africa|africa
5401514|NCT00078234|CLL|cll
5401515|NCT00078234|Leukemia|leukemia
5401516|NCT00078234|Chronic|chronic
5401517|NCT00078234|Cancer|cancer
5401518|NCT00078234|Adult|adult
5401519|NCT00078234|Lymphocytic|lymphocytic
5401520|NCT00078234|Genasense|genasense
5401521|NCT00078234|G3139|g3139
5401522|NCT00078234|Genta|genta
5401523|NCT00078234|Bcl-2|bcl-2
5401524|NCT00078234|Antisense|antisense
5401525|NCT00078234|Oligonucleotide|oligonucleotide
5401526|NCT00078234|oblimersen|oblimersen
5401527|NCT00078169|behavioral intervention|behavioral intervention
5401528|NCT00078156|behavioral intervention|behavioral intervention
5401529|NCT00078143|behavioral intervention|behavioral intervention
5401530|NCT00078208|Pediatric|pediatric
5401531|NCT00078208|Non-Invasive|non-invasive
5401532|NCT00078208|Anti-Inflammatory|anti-inflammatory
5401533|NCT00078208|pH|ph
5401534|NCT00078208|Mediators|mediators
5401535|NCT00078208|Asthma|asthma
5401536|NCT00078208|Childhood Asthma|childhood asthma
5401537|NCT00078208|Healthy Volunteer|healthy volunteer
5401538|NCT00078208|HV|hv
5401539|NCT00078195|Ragweed|ragweed
5401540|NCT00078195|Immunotherapy|immunotherapy
5401541|NCT00078195|Rush Immunotherapy|rush immunotherapy
5401542|NCT00078195|RIT|rit
5401543|NCT00078195|Hayfever|hayfever
5401544|NCT00078195|Seasonal Allergic Rhinitis|seasonal allergic rhinitis
5401545|NCT00078182|HIV Prevention|hiv prevention
5401546|NCT00078130|opioid dependence|opioid dependence
5401547|NCT00078130|behavioral intervention|behavioral intervention
5401548|NCT00078117|opiate dependence|opiate dependence
5401549|NCT00078065|multiple myeloma|multiple myeloma
5401550|NCT00078065|fludarabine|fludarabine
5401551|NCT00078065|Xcellerated T Cells|xcellerated t cells
5401552|NCT00004148|stage III melanoma|stage iii melanoma
5401553|NCT00004148|stage IV melanoma|stage iv melanoma
5401554|NCT00004148|recurrent melanoma|recurrent melanoma
5401555|NCT00003935|untreated childhood brain stem glioma|untreated childhood brain stem glioma
5401556|NCT00003814|stage 0 bladder cancer|stage 0 bladder cancer
5401557|NCT00003814|stage I bladder cancer|stage i bladder cancer
5401558|NCT00003814|recurrent bladder cancer|recurrent bladder cancer
5401559|NCT00003814|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
5401560|NCT00003766|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5401561|NCT00003623|recurrent bladder cancer|recurrent bladder cancer
5401562|NCT00003615|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
5401563|NCT00003615|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
5401564|NCT00003615|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
5401565|NCT00003615|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
5401566|NCT00003615|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
5401567|NCT00003615|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5401568|NCT00003615|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5401569|NCT00003615|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5401570|NCT00003615|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5401571|NCT00003615|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5401572|NCT00003615|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5401573|NCT00003615|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5401574|NCT00003615|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5401575|NCT00003615|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5401576|NCT00003615|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5401577|NCT00003615|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5401578|NCT00003615|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5401579|NCT00003615|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
5401580|NCT00003615|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
5401581|NCT00003615|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
5401582|NCT00003615|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
5401583|NCT00003615|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5401584|NCT00003615|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5401585|NCT00003615|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5401586|NCT00003615|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5401587|NCT00003615|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
5401588|NCT00003615|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
5401589|NCT00003615|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
5401590|NCT00003615|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
5401591|NCT00003615|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5401592|NCT00003615|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5401593|NCT00003615|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5401594|NCT00003615|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5401595|NCT00003615|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5401596|NCT00003615|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5401597|NCT00003615|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5401598|NCT00003615|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5401599|NCT00003615|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5401600|NCT00003573|untreated childhood medulloblastoma|untreated childhood medulloblastoma
5401601|NCT00003572|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
5401602|NCT00003572|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
5401603|NCT00003572|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5401604|NCT00003572|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5401605|NCT00003572|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5401606|NCT00003572|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
5401607|NCT00003572|stage I multiple myeloma|stage i multiple myeloma
5401608|NCT00003572|stage II multiple myeloma|stage ii multiple myeloma
5401609|NCT00003572|stage III multiple myeloma|stage iii multiple myeloma
5401610|NCT00003572|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5401611|NCT00003572|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5401612|NCT00003572|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5401613|NCT00003572|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5401614|NCT00003572|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5401615|NCT00003572|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
5401616|NCT00003572|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
5401617|NCT00003572|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
5401618|NCT00003572|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
5401619|NCT00003572|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
5401620|NCT00003572|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
5401621|NCT00003572|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
5401622|NCT00003572|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
5401623|NCT00003572|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
5401624|NCT00003572|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5401625|NCT00003572|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5401626|NCT00003572|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5401627|NCT00003572|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5401628|NCT00003572|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5401629|NCT00003572|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5401630|NCT00003572|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5401631|NCT00003572|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5401632|NCT00003572|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5401633|NCT00003572|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5401634|NCT00003572|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5401635|NCT00003572|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5401636|NCT00003572|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5401637|NCT00003572|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5401638|NCT00003572|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5401639|NCT00003572|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5401640|NCT00003572|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5401641|NCT00003572|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5401642|NCT00003572|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5401643|NCT00003572|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5401644|NCT00003572|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5401645|NCT00003572|stage I mantle cell lymphoma|stage i mantle cell lymphoma
5401646|NCT00003572|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
5401647|NCT00003572|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
5401648|NCT00003572|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
5401649|NCT00003572|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
5401650|NCT00003572|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
5401651|NCT00003572|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
5401652|NCT00003572|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
5401653|NCT00003572|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
5401654|NCT00003572|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
5401655|NCT00003572|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
5401656|NCT00003572|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5401657|NCT00003572|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5401658|NCT00003572|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5401659|NCT00003572|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
5401660|NCT00003572|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5401661|NCT00003572|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
5401662|NCT00003572|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
5401663|NCT00003572|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5401664|NCT00003572|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
5401665|NCT00003572|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
5401666|NCT00003572|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5401667|NCT00003572|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5401668|NCT00003572|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
5401669|NCT00003572|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
5401670|NCT00003572|stage I marginal zone lymphoma|stage i marginal zone lymphoma
5401671|NCT00003572|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
5401672|NCT00003572|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5401673|NCT00003572|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5401674|NCT00003572|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5401675|NCT00003572|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5401676|NCT00003572|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
5401677|NCT00003572|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
5401678|NCT00003572|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5401679|NCT00003572|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5401680|NCT00003572|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5401681|NCT00003548|stage IV colon cancer|stage iv colon cancer
5401682|NCT00003548|stage IV breast cancer|stage iv breast cancer
5401683|NCT00003548|recurrent breast cancer|recurrent breast cancer
5401684|NCT00003548|stage IV gastric cancer|stage iv gastric cancer
5401685|NCT00003548|recurrent gastric cancer|recurrent gastric cancer
5401686|NCT00003548|recurrent pancreatic cancer|recurrent pancreatic cancer
5401687|NCT00003548|stage IV rectal cancer|stage iv rectal cancer
5401688|NCT00003548|recurrent colon cancer|recurrent colon cancer
5401689|NCT00003548|recurrent rectal cancer|recurrent rectal cancer
5401690|NCT00003548|stage IV anal cancer|stage iv anal cancer
5401691|NCT00003548|recurrent anal cancer|recurrent anal cancer
5401692|NCT00003548|stage IV esophageal cancer|stage iv esophageal cancer
5401693|NCT00003548|recurrent esophageal cancer|recurrent esophageal cancer
5401694|NCT00003548|stage IV cervical cancer|stage iv cervical cancer
5401695|NCT00003548|recurrent cervical cancer|recurrent cervical cancer
5401696|NCT00003548|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5401697|NCT00003548|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5401698|NCT00003548|stage IV vulvar cancer|stage iv vulvar cancer
5401699|NCT00003548|recurrent vulvar cancer|recurrent vulvar cancer
5401700|NCT00003548|stage IVA vaginal cancer|stage iva vaginal cancer
5401701|NCT00003548|stage IVB vaginal cancer|stage ivb vaginal cancer
5401702|NCT00003548|recurrent vaginal cancer|recurrent vaginal cancer
5401703|NCT00003548|metastatic gastrointestinal carcinoid tumor|metastatic gastrointestinal carcinoid tumor
5401704|NCT00003548|recurrent gastrointestinal carcinoid tumor|recurrent gastrointestinal carcinoid tumor
5401705|NCT00003548|advanced adult primary liver cancer|advanced adult primary liver cancer
5401706|NCT00003548|recurrent adult primary liver cancer|recurrent adult primary liver cancer
5401707|NCT00003548|recurrent gestational trophoblastic tumor|recurrent gestational trophoblastic tumor
5401708|NCT00003548|stage IV endometrial carcinoma|stage iv endometrial carcinoma
5401709|NCT00003548|recurrent endometrial carcinoma|recurrent endometrial carcinoma
5401710|NCT00003548|unresectable gallbladder cancer|unresectable gallbladder cancer
5401711|NCT00003548|recurrent gallbladder cancer|recurrent gallbladder cancer
5401712|NCT00003548|unresectable extrahepatic bile duct cancer|unresectable extrahepatic bile duct cancer
5401713|NCT00003548|recurrent extrahepatic bile duct cancer|recurrent extrahepatic bile duct cancer
5401714|NCT00003548|recurrent small intestine cancer|recurrent small intestine cancer
5401715|NCT00003548|carcinoma of the appendix|carcinoma of the appendix
5401716|NCT00003548|fallopian tube cancer|fallopian tube cancer
5401717|NCT00003548|stage IV uterine sarcoma|stage iv uterine sarcoma
5401718|NCT00003548|recurrent uterine sarcoma|recurrent uterine sarcoma
5401719|NCT00003548|recurrent carcinoma of unknown primary|recurrent carcinoma of unknown primary
5401720|NCT00003548|stage IV pancreatic cancer|stage iv pancreatic cancer
5401721|NCT00003425|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5401722|NCT00003425|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5401723|NCT00003425|stage IV breast cancer|stage iv breast cancer
5401724|NCT00003425|stage IIIA breast cancer|stage iiia breast cancer
5401725|NCT00003425|recurrent breast cancer|recurrent breast cancer
5401726|NCT00003425|stage IIIB breast cancer|stage iiib breast cancer
5401727|NCT00003425|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5401728|NCT00003425|refractory multiple myeloma|refractory multiple myeloma
5401729|NCT00003425|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5401730|NCT00003425|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5401731|NCT00003425|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5401732|NCT00003425|regional neuroblastoma|regional neuroblastoma
5401733|NCT00003425|disseminated neuroblastoma|disseminated neuroblastoma
5401734|NCT00003425|stage 4S neuroblastoma|stage 4s neuroblastoma
5401735|NCT00003425|recurrent neuroblastoma|recurrent neuroblastoma
5401736|NCT00003425|stage III multiple myeloma|stage iii multiple myeloma
5401737|NCT00003425|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5401738|NCT00003425|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5401739|NCT00003425|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5401740|NCT00003425|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
5401741|NCT00003425|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
5401742|NCT00003425|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5401743|NCT00003425|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5401744|NCT00003425|ovarian stromal cancer|ovarian stromal cancer
5401745|NCT00003425|stage III ovarian germ cell tumor|stage iii ovarian germ cell tumor
5401746|NCT00003425|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
5401747|NCT00003425|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
5401748|NCT00003425|acute undifferentiated leukemia|acute undifferentiated leukemia
5401749|NCT00003425|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5401750|NCT00003425|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5401751|NCT00003425|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5401752|NCT00003425|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5401753|NCT00003425|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5401754|NCT00003425|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5401755|NCT00003425|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5401756|NCT00003425|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5401757|NCT00003425|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5401758|NCT00003425|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5401759|NCT00003425|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5401760|NCT00003425|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5401761|NCT00003425|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5401762|NCT00003425|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5401763|NCT00003425|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5401764|NCT00003425|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5401765|NCT00003425|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5401766|NCT00003425|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5401767|NCT00003425|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5401768|NCT00003425|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5401769|NCT00003425|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5401770|NCT00003425|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5401771|NCT00003425|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5401772|NCT00003425|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5401773|NCT00003425|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5401774|NCT00003425|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5401775|NCT00003425|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5401776|NCT00003425|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5401777|NCT00003425|borderline ovarian surface epithelial-stromal tumor|borderline ovarian surface epithelial-stromal tumor
5401778|NCT00003425|ovarian sarcoma|ovarian sarcoma
5401779|NCT00003425|localized unresectable neuroblastoma|localized unresectable neuroblastoma
5401780|NCT00003425|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5401781|NCT00003425|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5401782|NCT00003425|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5401783|NCT00003425|metastatic Ewing sarcoma/peripheral primitive neuroectodermal tumor|metastatic ewing sarcoma/peripheral primitive neuroectodermal tumor
5401784|NCT00003425|recurrent Ewing sarcoma/peripheral primitive neuroectodermal tumor|recurrent ewing sarcoma/peripheral primitive neuroectodermal tumor
5401785|NCT00003425|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5401786|NCT00003425|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5401787|NCT00003425|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5401788|NCT00003425|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5401789|NCT00003425|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5401790|NCT00003425|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5401791|NCT00003425|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5401792|NCT00003425|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5401793|NCT00003425|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5401794|NCT00003411|stage II pancreatic cancer|stage ii pancreatic cancer
5401795|NCT00003411|stage III pancreatic cancer|stage iii pancreatic cancer
5401796|NCT00003411|unresectable gallbladder cancer|unresectable gallbladder cancer
5401797|NCT00003411|unresectable extrahepatic bile duct cancer|unresectable extrahepatic bile duct cancer
5401798|NCT00003411|stage IV pancreatic cancer|stage iv pancreatic cancer
5401799|NCT00003299|extensive stage small cell lung cancer|extensive stage small cell lung cancer
5401800|NCT00003240|stage I non-small cell lung cancer|stage i non-small cell lung cancer
5401801|NCT00003240|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
5401802|NCT00003240|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5401803|NCT00003240|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5401804|NCT00003240|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5401805|NCT00003120|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5401806|NCT00003120|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5401807|NCT00003120|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5401808|NCT00003120|fallopian tube cancer|fallopian tube cancer
5401809|NCT00003120|peritoneal cavity cancer|peritoneal cavity cancer
5401810|NCT00078104|Prostanoid|prostanoid
5401811|NCT00078104|Cyclooxygenase (COX)|cyclooxygenase (cox)
5401812|NCT00078104|Selective Cox Inhibitor|selective cox inhibitor
5401813|NCT00078104|Acute Peripheral Inflammation|acute peripheral inflammation
5401814|NCT00078104|Neuronal Expression of COX|neuronal expression of cox
5401815|NCT00078104|Pain|pain
5401816|NCT00078104|Coxibs|coxibs
5401817|NCT00078104|Wisdom Teeth|wisdom teeth
5401818|NCT00078104|Third Molar Extraction|third molar extraction
5401819|NCT00078104|Third Molar Impaction|third molar impaction
5401820|NCT00078091|Obesity|obesity
5401821|NCT00078091|Retinopathy|retinopathy
5401822|NCT00078091|Dyslipidemia|dyslipidemia
5401823|NCT00078091|Insulin Resistance|insulin resistance
5401824|NCT00078091|Hypogonadism|hypogonadism
5401825|NCT00078091|Polydactyly|polydactyly
5401826|NCT00078091|Bardet-Biedl Syndrome|bardet-biedl syndrome
5401827|NCT00078091|BBS|bbs
5401828|NCT00078078|Organic Acidemias|organic acidemias
5401829|NCT00078078|Cobalamin|cobalamin
5401830|NCT00078078|Vitamin B12|vitamin b12
5401831|NCT00078078|Methylmalonic Acidemia|methylmalonic acidemia
5401832|NCT00078078|Hyperhomocysteinemia|hyperhomocysteinemia
5401833|NCT00078078|MMA|mma
5401834|NCT00078078|Metabolic Disease|metabolic disease
5401835|NCT00078026|Apomine|apomine
5401836|NCT00078026|Osteoporosis|osteoporosis
5401837|NCT00078026|Bone Mass|bone mass
5401838|NCT00078026|Postmenopausal|postmenopausal
5401839|NCT00030602|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5401840|NCT00030602|recurrent prostate cancer|recurrent prostate cancer
5401841|NCT00003089|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
5401842|NCT00003089|squamous cell lung cancer|squamous cell lung cancer
5401843|NCT00003089|large cell lung cancer|large cell lung cancer
5401844|NCT00003089|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5401845|NCT00003089|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5401846|NCT00003089|adenocarcinoma of the lung|adenocarcinoma of the lung
5401847|NCT00003089|drug/agent toxicity by tissue/organ|drug/agent toxicity by tissue/organ
5401848|NCT00003046|anal cancer|anal cancer
5401849|NCT00003046|carcinoma of the appendix|carcinoma of the appendix
5401850|NCT00003046|colorectal cancer|colorectal cancer
5401851|NCT00003046|extrahepatic bile duct cancer|extrahepatic bile duct cancer
5401852|NCT00003046|gallbladder cancer|gallbladder cancer
5401853|NCT00003046|gastric cancer|gastric cancer
5401854|NCT00003046|gastrointestinal carcinoid tumor|gastrointestinal carcinoid tumor
5401855|NCT00003046|malignant mesothelioma|malignant mesothelioma
5401856|NCT00003046|pancreatic cancer|pancreatic cancer
5401857|NCT00003046|small intestine cancer|small intestine cancer
5401858|NCT00003046|stage IV colon cancer|stage iv colon cancer
5401859|NCT00003046|stage IV gastric cancer|stage iv gastric cancer
5401860|NCT00003046|recurrent gastric cancer|recurrent gastric cancer
5401861|NCT00003046|recurrent pancreatic cancer|recurrent pancreatic cancer
5401862|NCT00003046|stage IV rectal cancer|stage iv rectal cancer
5401863|NCT00003046|recurrent colon cancer|recurrent colon cancer
5401864|NCT00003046|recurrent rectal cancer|recurrent rectal cancer
5401865|NCT00003046|stage IV anal cancer|stage iv anal cancer
5401866|NCT00003046|recurrent anal cancer|recurrent anal cancer
5401867|NCT00003046|metastatic gastrointestinal carcinoid tumor|metastatic gastrointestinal carcinoid tumor
5401868|NCT00003046|recurrent gastrointestinal carcinoid tumor|recurrent gastrointestinal carcinoid tumor
5401869|NCT00003046|advanced malignant mesothelioma|advanced malignant mesothelioma
5401870|NCT00003046|recurrent malignant mesothelioma|recurrent malignant mesothelioma
5401871|NCT00003046|small intestine adenocarcinoma|small intestine adenocarcinoma
5401872|NCT00003046|unresectable gallbladder cancer|unresectable gallbladder cancer
5401873|NCT00003046|recurrent gallbladder cancer|recurrent gallbladder cancer
5401874|NCT00003046|unresectable extrahepatic bile duct cancer|unresectable extrahepatic bile duct cancer
5401875|NCT00003046|recurrent extrahepatic bile duct cancer|recurrent extrahepatic bile duct cancer
5401876|NCT00003046|recurrent small intestine cancer|recurrent small intestine cancer
5401877|NCT00003046|stage IV pancreatic cancer|stage iv pancreatic cancer
5401878|NCT00003035|stage IIIA breast cancer|stage iiia breast cancer
5401879|NCT00003035|stage IIIB breast cancer|stage iiib breast cancer
5401880|NCT00078013|AMI|ami
5401881|NCT00078013|STEMI|stemi
5401882|NCT00078013|Infarct|infarct
5401883|NCT00078013|acute myocardial infarction with ST segment elevation|acute myocardial infarction with st segment elevation
5401884|NCT00077961|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
5401885|NCT00077961|NHL|nhl
5401886|NCT00077961|CAMPATH|campath
5401887|NCT00077961|alemtuzumab|alemtuzumab
5401888|NCT00077948|positive inotrope|positive inotrope
5401889|NCT00077948|enoximone|enoximone
5401890|NCT00077948|beta-blocker|beta-blocker
5401891|NCT00077948|intolerant|intolerant
5401892|NCT00077870|Moderate to severe rheumatoid arthritis|moderate to severe rheumatoid arthritis
5401893|NCT00077792|Receiving fibrinolytic therapy|receiving fibrinolytic therapy
5401894|NCT00077727|Schizophrenia|schizophrenia
5401895|NCT00077727|cognitive impairment|cognitive impairment
5401896|NCT00077727|galantamine|galantamine
5401897|NCT00077727|acetylcholinesterase inhibitors|acetylcholinesterase inhibitors
5401898|NCT00077727|antipsychotic drugs|antipsychotic drugs
5401899|NCT00077727|BACS|bacs
5401900|NCT00077714|Schizophrenia|schizophrenia
5401901|NCT00077714|Paliperidone|paliperidone
5401902|NCT00076973|RSV Bronchiolitis|rsv bronchiolitis
5401903|NCT00027924|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5401904|NCT00027924|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5401905|NCT00027924|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5401906|NCT00027924|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5401907|NCT00027924|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
5401908|NCT00027924|Philadelphia chromosome positive chronic myelogenous leukemia|philadelphia chromosome positive chronic myelogenous leukemia
5401909|NCT00027924|refractory anemia|refractory anemia
5401910|NCT00027924|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
5401911|NCT00027924|refractory anemia with excess blasts|refractory anemia with excess blasts
5401912|NCT00027924|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
5401913|NCT00027924|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5401914|NCT00027924|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5401915|NCT00027924|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5401916|NCT00027924|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5401917|NCT00027924|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5401918|NCT00027924|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
5401919|NCT00023647|stage IV melanoma|stage iv melanoma
5401920|NCT00023647|recurrent melanoma|recurrent melanoma
5401921|NCT00021294|basal cell carcinoma of the skin|basal cell carcinoma of the skin
5401922|NCT00021294|squamous cell carcinoma of the skin|squamous cell carcinoma of the skin
5401923|NCT00021294|actinic keratosis|actinic keratosis
5401924|NCT00021034|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
5401925|NCT00021034|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5401926|NCT00021034|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5401927|NCT00021034|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5401928|NCT00021034|fallopian tube cancer|fallopian tube cancer
5401929|NCT00021034|primary peritoneal cavity cancer|primary peritoneal cavity cancer
5401930|NCT00021021|stage IV renal cell cancer|stage iv renal cell cancer
5401931|NCT00021021|clear cell renal cell carcinoma|clear cell renal cell carcinoma
5401932|NCT00020917|stage IV colon cancer|stage iv colon cancer
5401933|NCT00020917|stage IV rectal cancer|stage iv rectal cancer
5401934|NCT00020553|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
5401935|NCT00017459|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5401936|NCT00017459|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5401937|NCT00017459|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5401938|NCT00017199|metastatic gastrointestinal carcinoid tumor|metastatic gastrointestinal carcinoid tumor
5401939|NCT00017199|gastrinoma|gastrinoma
5401940|NCT00017199|insulinoma|insulinoma
5401941|NCT00017199|somatostatinoma|somatostatinoma
5401942|NCT00017199|glucagonoma|glucagonoma
5401943|NCT00017056|stage IV gastric cancer|stage iv gastric cancer
5401944|NCT00017056|recurrent gastric cancer|recurrent gastric cancer
5401945|NCT00017056|stage IV esophageal cancer|stage iv esophageal cancer
5401946|NCT00017056|recurrent esophageal cancer|recurrent esophageal cancer
5401947|NCT00017056|adenocarcinoma of the stomach|adenocarcinoma of the stomach
5401948|NCT00017056|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
5401949|NCT00016172|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5401950|NCT00016172|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5401951|NCT00016172|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5401952|NCT00016172|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
5401953|NCT00016172|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
5401954|NCT00016172|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5401955|NCT00016172|small intestine lymphoma|small intestine lymphoma
5401956|NCT00016172|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5401957|NCT00016172|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5401958|NCT00016172|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5401959|NCT00016172|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5401960|NCT00016172|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5401961|NCT00016172|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5401962|NCT00016172|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5401963|NCT00016172|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5401964|NCT00016172|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5401965|NCT00016172|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5401966|NCT00016172|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5401967|NCT00016172|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5401968|NCT00016172|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5401969|NCT00016172|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5401970|NCT00016172|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5401971|NCT00016172|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5401972|NCT00016172|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5401973|NCT00016172|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5401974|NCT00016172|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5401975|NCT00016172|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5401976|NCT00016172|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5401977|NCT00016172|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5401978|NCT00016172|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5401979|NCT00016172|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5401980|NCT00016172|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5401981|NCT00016172|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5401982|NCT00016172|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5401983|NCT00016172|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5401984|NCT00016172|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
5401985|NCT00016172|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
5401986|NCT00016172|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
5401987|NCT00016172|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
5401988|NCT00016172|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
5401989|NCT00016172|AIDS-related primary CNS lymphoma|aids-related primary cns lymphoma
5401990|NCT00016172|intraocular lymphoma|intraocular lymphoma
5401991|NCT00016172|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5401992|NCT00016172|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5401993|NCT00016172|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5401994|NCT00016172|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
5401995|NCT00016172|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5401996|NCT00016172|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
5401997|NCT00016172|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
5401998|NCT00016172|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5401999|NCT00016172|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5402000|NCT00016172|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5402001|NCT00016172|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5402002|NCT00016172|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5402003|NCT00016172|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5402004|NCT00016172|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5402005|NCT00016172|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5402006|NCT00016172|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5402007|NCT00016172|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5402008|NCT00014625|stage IV melanoma|stage iv melanoma
5402009|NCT00014625|recurrent melanoma|recurrent melanoma
5402010|NCT00014430|stage IV breast cancer|stage iv breast cancer
5402011|NCT00014430|stage IIIA breast cancer|stage iiia breast cancer
5402012|NCT00014430|recurrent breast cancer|recurrent breast cancer
5402013|NCT00014430|stage IIIB breast cancer|stage iiib breast cancer
5402014|NCT00008281|stage IV colon cancer|stage iv colon cancer
5402015|NCT00008281|stage IV rectal cancer|stage iv rectal cancer
5402016|NCT00008281|recurrent colon cancer|recurrent colon cancer
5402017|NCT00008281|recurrent rectal cancer|recurrent rectal cancer
5402018|NCT00008281|adenocarcinoma of the colon|adenocarcinoma of the colon
5402019|NCT00008281|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5402020|NCT00006122|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
5402021|NCT00006122|adult acute erythroid leukemia (M6)|adult acute erythroid leukemia (m6)
5402022|NCT00006122|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
5402023|NCT00006122|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
5402024|NCT00006122|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
5402025|NCT00006122|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
5402026|NCT00006122|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
5402027|NCT00006122|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5402028|NCT00006122|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
5402029|NCT00006122|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
5402030|NCT00005795|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5402031|NCT00005795|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
5402032|NCT00005795|adult acute erythroid leukemia (M6)|adult acute erythroid leukemia (m6)
5402097|NCT00004145|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5402033|NCT00005795|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
5402034|NCT00005795|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
5402035|NCT00005795|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
5402036|NCT00005795|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
5402037|NCT00005795|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
5402038|NCT00005795|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5402039|NCT00005795|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
5402040|NCT00005795|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
5402041|NCT00005791|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5402042|NCT00005631|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5402043|NCT00005631|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5402044|NCT00005631|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5402045|NCT00005609|Waldenström macroglobulinemia|waldenström macroglobulinemia
5402046|NCT00005089|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
5402047|NCT00005089|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
5402048|NCT00005089|stage I mantle cell lymphoma|stage i mantle cell lymphoma
5402049|NCT00005089|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
5402050|NCT00005089|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
5402051|NCT00005089|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
5402052|NCT00005089|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5402053|NCT00005089|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5402054|NCT00005089|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
5402055|NCT00004152|stage III melanoma|stage iii melanoma
5402056|NCT00004152|stage IV melanoma|stage iv melanoma
5402057|NCT00004152|recurrent melanoma|recurrent melanoma
5402058|NCT00004145|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5402059|NCT00004145|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5402060|NCT00004145|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5402061|NCT00004145|refractory multiple myeloma|refractory multiple myeloma
5402062|NCT00004145|stage I multiple myeloma|stage i multiple myeloma
5402063|NCT00004145|stage II multiple myeloma|stage ii multiple myeloma
5402064|NCT00004145|stage III multiple myeloma|stage iii multiple myeloma
5402065|NCT00004145|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
5402066|NCT00004145|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5402067|NCT00004145|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5402068|NCT00004145|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5402069|NCT00004145|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5402070|NCT00004145|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5402071|NCT00004145|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5402072|NCT00004145|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5402073|NCT00004145|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5402074|NCT00004145|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5402075|NCT00004145|refractory anemia|refractory anemia
5402076|NCT00004145|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
5402077|NCT00004145|refractory anemia with excess blasts|refractory anemia with excess blasts
5402078|NCT00004145|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
5402079|NCT00004145|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5402080|NCT00004145|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5402081|NCT00004145|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5402082|NCT00004145|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5402083|NCT00004145|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5402084|NCT00004145|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5402085|NCT00004145|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5402086|NCT00004145|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5402087|NCT00004145|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5402088|NCT00004145|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5402089|NCT00004145|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5402090|NCT00004145|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5402091|NCT00004145|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5402092|NCT00004145|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5402093|NCT00004145|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5402094|NCT00004145|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5402095|NCT00004145|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5402096|NCT00004145|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5429442|NCT00038818|CLL|cll
5402098|NCT00004145|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5402099|NCT00004145|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5402100|NCT00004145|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5402101|NCT00004145|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5402102|NCT00004145|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5402103|NCT00004145|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5402104|NCT00004145|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5402105|NCT00004145|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5402106|NCT00004145|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5402107|NCT00004145|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5402108|NCT00004145|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5402109|NCT00004145|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5402110|NCT00004145|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5402111|NCT00004145|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5402112|NCT00004145|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5402113|NCT00004145|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5402114|NCT00004145|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5402115|NCT00004145|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5402116|NCT00004145|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5402117|NCT00004145|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5402118|NCT00004145|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5402119|NCT00004145|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5402120|NCT00004145|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5402121|NCT00004145|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5402122|NCT00004145|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5402123|NCT00004114|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5402124|NCT00004114|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5402125|NCT00004114|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5402519|NCT00077584|Digital Ulcers|digital ulcers
5402126|NCT00004114|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5402127|NCT00004114|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5402128|NCT00004114|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5402129|NCT00004114|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5402130|NCT00004114|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5402131|NCT00004114|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5402132|NCT00004114|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5402133|NCT00004114|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5402134|NCT00004114|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5402135|NCT00004114|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5402136|NCT00004114|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5402137|NCT00004114|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5402138|NCT00004114|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5402139|NCT00004114|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
5402140|NCT00004114|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5402141|NCT00004114|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
5402142|NCT00004114|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5402143|NCT00004114|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5402144|NCT00004114|refractory cytopenia with multilineage dysplasia|refractory cytopenia with multilineage dysplasia
5402145|NCT00004114|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5402146|NCT00004114|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5402147|NCT00004114|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5402148|NCT00004114|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5402149|NCT00004114|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5402150|NCT00004114|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5402151|NCT00003916|adult glioblastoma|adult glioblastoma
5402152|NCT00003916|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5402153|NCT00003916|adult giant cell glioblastoma|adult giant cell glioblastoma
5402154|NCT00003916|adult gliosarcoma|adult gliosarcoma
5402155|NCT00003867|stage III colon cancer|stage iii colon cancer
5402156|NCT00003867|stage IV colon cancer|stage iv colon cancer
5402157|NCT00003867|stage IV breast cancer|stage iv breast cancer
5402158|NCT00003867|stage IIIA breast cancer|stage iiia breast cancer
5402159|NCT00003867|recurrent breast cancer|recurrent breast cancer
5402160|NCT00003867|stage III gastric cancer|stage iii gastric cancer
5402161|NCT00003867|stage IV gastric cancer|stage iv gastric cancer
5402162|NCT00003867|recurrent gastric cancer|recurrent gastric cancer
5402163|NCT00003867|stage IIIB breast cancer|stage iiib breast cancer
5402164|NCT00003867|stage II pancreatic cancer|stage ii pancreatic cancer
5402165|NCT00003867|stage III pancreatic cancer|stage iii pancreatic cancer
5402166|NCT00003867|recurrent pancreatic cancer|recurrent pancreatic cancer
5402167|NCT00003867|stage III rectal cancer|stage iii rectal cancer
5402168|NCT00003867|stage IV rectal cancer|stage iv rectal cancer
5402169|NCT00003867|recurrent colon cancer|recurrent colon cancer
5402170|NCT00003867|recurrent rectal cancer|recurrent rectal cancer
5402171|NCT00003867|stage IV anal cancer|stage iv anal cancer
5402172|NCT00003867|recurrent anal cancer|recurrent anal cancer
5402173|NCT00003867|stage II esophageal cancer|stage ii esophageal cancer
5402174|NCT00003867|stage III esophageal cancer|stage iii esophageal cancer
5402175|NCT00003867|stage IV esophageal cancer|stage iv esophageal cancer
5402176|NCT00003867|stage IIIA anal cancer|stage iiia anal cancer
5402177|NCT00003867|stage IIIB anal cancer|stage iiib anal cancer
5402178|NCT00003867|recurrent esophageal cancer|recurrent esophageal cancer
5402179|NCT00003867|regional gastrointestinal carcinoid tumor|regional gastrointestinal carcinoid tumor
5402180|NCT00003867|metastatic gastrointestinal carcinoid tumor|metastatic gastrointestinal carcinoid tumor
5402181|NCT00003867|recurrent gastrointestinal carcinoid tumor|recurrent gastrointestinal carcinoid tumor
5402182|NCT00003867|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
5402183|NCT00003867|advanced adult primary liver cancer|advanced adult primary liver cancer
5402184|NCT00003867|recurrent adult primary liver cancer|recurrent adult primary liver cancer
5402185|NCT00003867|small intestine adenocarcinoma|small intestine adenocarcinoma
5402186|NCT00003867|small intestine lymphoma|small intestine lymphoma
5402187|NCT00003867|small intestine leiomyosarcoma|small intestine leiomyosarcoma
5402188|NCT00003867|unresectable gallbladder cancer|unresectable gallbladder cancer
5402189|NCT00003867|recurrent gallbladder cancer|recurrent gallbladder cancer
5402190|NCT00003867|unresectable extrahepatic bile duct cancer|unresectable extrahepatic bile duct cancer
5402191|NCT00003867|recurrent extrahepatic bile duct cancer|recurrent extrahepatic bile duct cancer
5402192|NCT00003867|recurrent small intestine cancer|recurrent small intestine cancer
5402193|NCT00003867|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5402194|NCT00003867|newly diagnosed carcinoma of unknown primary|newly diagnosed carcinoma of unknown primary
5402195|NCT00003867|carcinoma of the appendix|carcinoma of the appendix
5402196|NCT00003867|recurrent carcinoma of unknown primary|recurrent carcinoma of unknown primary
5402197|NCT00003867|stage IV pancreatic cancer|stage iv pancreatic cancer
5402198|NCT00003632|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
5402199|NCT00003582|squamous cell carcinoma of unknown primary|squamous cell carcinoma of unknown primary
5402200|NCT00003582|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
5402201|NCT00003582|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5402202|NCT00003582|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
5402203|NCT00003582|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5402204|NCT00003582|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
5402205|NCT00003582|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
5402206|NCT00003582|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
5402207|NCT00003582|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5402208|NCT00003582|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
5402209|NCT00003582|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5402210|NCT00003582|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
5402211|NCT00003582|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
5402212|NCT00003545|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5402213|NCT00003545|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
5402214|NCT00003545|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5402215|NCT00003545|T-cell childhood acute lymphoblastic leukemia|t-cell childhood acute lymphoblastic leukemia
5402216|NCT00003545|T-cell adult acute lymphoblastic leukemia|t-cell adult acute lymphoblastic leukemia
5402217|NCT00003545|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5402218|NCT00003545|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
5402219|NCT00003207|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5402220|NCT00003207|AIDS-related Kaposi sarcoma|aids-related kaposi sarcoma
5402221|NCT00003207|recurrent Kaposi sarcoma|recurrent kaposi sarcoma
5402222|NCT00003150|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
5402223|NCT00003150|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
5402224|NCT00003150|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
5402225|NCT00003150|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5402226|NCT00003150|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5402227|NCT00003150|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5402228|NCT00003150|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5429867|NCT00037115|brain|brain
5402229|NCT00003150|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5402230|NCT00003150|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5402231|NCT00003150|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
5402232|NCT00003150|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
5402233|NCT00003150|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
5402234|NCT00003150|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
5402235|NCT00003150|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
5402236|NCT00003150|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5402237|NCT00003066|stage IV breast cancer|stage iv breast cancer
5402238|NCT00003066|recurrent breast cancer|recurrent breast cancer
5402239|NCT00003062|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5402240|NCT00003062|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5402241|NCT00003011|recurrent small cell lung cancer|recurrent small cell lung cancer
5402242|NCT00002869|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5402243|NCT00002869|chronic myelogenous leukemia, BCR-ABL1 positive|chronic myelogenous leukemia, bcr-abl1 positive
5402244|NCT00002869|Philadelphia chromosome negative chronic myelogenous leukemia|philadelphia chromosome negative chronic myelogenous leukemia
5402245|NCT00002868|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5402246|NCT00002532|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5402247|NCT00002531|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
5402248|NCT00002531|T-cell adult acute lymphoblastic leukemia|t-cell adult acute lymphoblastic leukemia
5402249|NCT00002531|B-cell adult acute lymphoblastic leukemia|b-cell adult acute lymphoblastic leukemia
5402250|NCT00002531|non-T, non-B adult acute lymphoblastic leukemia|non-t, non-b adult acute lymphoblastic leukemia
5402251|NCT00077922|LMB-2|lmb-2
5402252|NCT00077922|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
5402253|NCT00077922|CLL|cll
5402254|NCT00077922|Immunotoxin|immunotoxin
5402255|NCT00077922|Oncology|oncology
5402256|NCT00077922|Lymphocytes|lymphocytes
5402257|NCT00077922|Hematological Disease|hematological disease
5402258|NCT00077922|Monoclonal Antibody|monoclonal antibody
5402259|NCT00077922|Neutralizing Antibodies|neutralizing antibodies
5402260|NCT00077909|Proteomics|proteomics
5402261|NCT00077909|Infection|infection
5402262|NCT00077909|Pneumonia|pneumonia
5402263|NCT00077909|Mass Spectrometry|mass spectrometry
5402264|NCT00077909|BAL|bal
5402265|NCT00077909|Lung|lung
5402266|NCT00077909|Pulmonary Disease|pulmonary disease
5402267|NCT00077909|Lung Infiltrates|lung infiltrates
5402268|NCT00077896|Treatment|treatment
5402269|NCT00077896|Transcranial Stimulation|transcranial stimulation
5402270|NCT00077896|Frontal Lobe|frontal lobe
5402271|NCT00077896|Pick's Disease|pick's disease
5402272|NCT00077896|Cognitive Impairment|cognitive impairment
5402273|NCT00077896|Dementia|dementia
5402274|NCT00077896|Frontotemporal Dementia|frontotemporal dementia
5402275|NCT00077896|FTD|ftd
5402276|NCT00077675|Abscess|abscess
5402277|NCT00077675|Burns|burns
5402278|NCT00077675|Cellulitis|cellulitis
5402279|NCT00077675|Ulcer|ulcer
5402280|NCT00077675|Wound infections|wound infections
5402281|NCT00077662|Pompe Disease|pompe disease
5402282|NCT00077662|Glycogen Storage Disease Type II|glycogen storage disease type ii
5402283|NCT00077662|GSD-II|gsd-ii
5402284|NCT00077662|Acid Maltase Deficiency Disease|acid maltase deficiency disease
5402285|NCT00077662|Glycogenosis 2|glycogenosis 2
5402286|NCT00077558|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5402287|NCT00077558|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5402288|NCT00077558|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5402289|NCT00077558|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5402290|NCT00077558|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5402291|NCT00077558|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5402292|NCT00077558|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5402293|NCT00077558|prolymphocytic leukemia|prolymphocytic leukemia
5402294|NCT00077558|refractory anemia with excess blasts|refractory anemia with excess blasts
5402295|NCT00077558|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5402296|NCT00077558|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5402297|NCT00077558|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5402298|NCT00077558|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
5402299|NCT00077558|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
5402300|NCT00077558|adult acute erythroid leukemia (M6)|adult acute erythroid leukemia (m6)
5402301|NCT00077558|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
5402302|NCT00077558|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
5402303|NCT00077558|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
5402375|NCT00006786|recurrent rectal cancer|recurrent rectal cancer
5402304|NCT00077558|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
5402305|NCT00077558|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
5402306|NCT00077558|adult acute promyelocytic leukemia (M3)|adult acute promyelocytic leukemia (m3)
5402307|NCT00077558|adult acute eosinophilic leukemia|adult acute eosinophilic leukemia
5402308|NCT00077558|adult acute basophilic leukemia|adult acute basophilic leukemia
5402309|NCT00077558|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
5402310|NCT00077558|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
5402311|NCT00077558|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5402312|NCT00077558|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5402313|NCT00077558|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5402314|NCT00077558|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5402315|NCT00077558|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5402316|NCT00077532|stage IV melanoma|stage iv melanoma
5402317|NCT00077532|recurrent melanoma|recurrent melanoma
5402318|NCT00077519|stage II pancreatic cancer|stage ii pancreatic cancer
5402319|NCT00077519|stage III pancreatic cancer|stage iii pancreatic cancer
5402320|NCT00077519|recurrent pancreatic cancer|recurrent pancreatic cancer
5402321|NCT00077493|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5402322|NCT00077493|Burkitt lymphoma|burkitt lymphoma
5402323|NCT00077493|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
5402324|NCT00077493|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
5402325|NCT00077493|childhood non-Hodgkin lymphoma|childhood non-hodgkin lymphoma
5402326|NCT00077415|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5402327|NCT00077415|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5402328|NCT00077415|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5402329|NCT00077415|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5402330|NCT00077415|adenocarcinoma of the lung|adenocarcinoma of the lung
5402331|NCT00077415|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
5402332|NCT00077415|large cell lung cancer|large cell lung cancer
5402333|NCT00077415|squamous cell lung cancer|squamous cell lung cancer
5402334|NCT00077402|recurrent prostate cancer|recurrent prostate cancer
5402335|NCT00077402|stage III prostate cancer|stage iii prostate cancer
5402336|NCT00077402|stage IV prostate cancer|stage iv prostate cancer
5402337|NCT00077402|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5402338|NCT00077389|childhood hepatoblastoma|childhood hepatoblastoma
5402339|NCT00077389|stage IV childhood liver cancer|stage iv childhood liver cancer
5402340|NCT00077337|recurrent colon cancer|recurrent colon cancer
5402341|NCT00077337|stage III colon cancer|stage iii colon cancer
5402342|NCT00077337|stage IV colon cancer|stage iv colon cancer
5402343|NCT00077337|recurrent rectal cancer|recurrent rectal cancer
5402344|NCT00077337|stage III rectal cancer|stage iii rectal cancer
5402345|NCT00077337|stage IV rectal cancer|stage iv rectal cancer
5402346|NCT00077324|stage I non-small cell lung cancer|stage i non-small cell lung cancer
5402347|NCT00077311|drug/agent toxicity by tissue/organ|drug/agent toxicity by tissue/organ
5402348|NCT00077311|anemia|anemia
5402349|NCT00077311|neutropenia|neutropenia
5402350|NCT00077311|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5402351|NCT00077311|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5402352|NCT00077311|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5402353|NCT00077311|squamous cell lung cancer|squamous cell lung cancer
5402354|NCT00077311|large cell lung cancer|large cell lung cancer
5402355|NCT00077311|adenocarcinoma of the lung|adenocarcinoma of the lung
5402356|NCT00077311|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
5402357|NCT00077311|adenosquamous cell lung cancer|adenosquamous cell lung cancer
5402358|NCT00007852|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5402359|NCT00007852|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5402360|NCT00007852|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5402361|NCT00007852|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5402362|NCT00007852|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5402363|NCT00007852|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5402364|NCT00007852|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5402365|NCT00007852|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5402366|NCT00007852|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5402367|NCT00007852|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5402368|NCT00007852|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5402369|NCT00007852|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5402370|NCT00007852|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5402371|NCT00007852|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5402372|NCT00006786|stage IV colon cancer|stage iv colon cancer
5402373|NCT00006786|stage IV rectal cancer|stage iv rectal cancer
5402374|NCT00006786|recurrent colon cancer|recurrent colon cancer
5402376|NCT00006786|adenocarcinoma of the colon|adenocarcinoma of the colon
5402377|NCT00006786|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5402378|NCT00006459|stage IV breast cancer|stage iv breast cancer
5402379|NCT00006459|stage IIIA breast cancer|stage iiia breast cancer
5402380|NCT00006459|recurrent breast cancer|recurrent breast cancer
5402381|NCT00006459|stage IIIB breast cancer|stage iiib breast cancer
5402382|NCT00006388|adult glioblastoma|adult glioblastoma
5402383|NCT00006388|adult giant cell glioblastoma|adult giant cell glioblastoma
5402384|NCT00006388|adult gliosarcoma|adult gliosarcoma
5402385|NCT00006375|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5402386|NCT00006123|stage IV breast cancer|stage iv breast cancer
5402387|NCT00006047|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5402388|NCT00006038|stage II gastric cancer|stage ii gastric cancer
5402389|NCT00006038|stage III gastric cancer|stage iii gastric cancer
5402390|NCT00006038|stage IV gastric cancer|stage iv gastric cancer
5402391|NCT00006038|stage II esophageal cancer|stage ii esophageal cancer
5402392|NCT00006038|stage III esophageal cancer|stage iii esophageal cancer
5402393|NCT00006038|adenocarcinoma of the stomach|adenocarcinoma of the stomach
5402394|NCT00006038|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
5402395|NCT00005995|stage IV renal cell cancer|stage iv renal cell cancer
5402396|NCT00005995|recurrent renal cell cancer|recurrent renal cell cancer
5402397|NCT00005986|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5402398|NCT00005986|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5402399|NCT00005986|Philadelphia chromosome positive chronic myelogenous leukemia|philadelphia chromosome positive chronic myelogenous leukemia
5402400|NCT00005877|stage III colon cancer|stage iii colon cancer
5402401|NCT00005877|stage IV colon cancer|stage iv colon cancer
5402402|NCT00005877|stage III rectal cancer|stage iii rectal cancer
5402403|NCT00005877|stage IV rectal cancer|stage iv rectal cancer
5402404|NCT00005877|recurrent colon cancer|recurrent colon cancer
5402405|NCT00005877|recurrent rectal cancer|recurrent rectal cancer
5402406|NCT00005862|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
5402407|NCT00005862|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
5402408|NCT00005862|gastrointestinal stromal tumor|gastrointestinal stromal tumor
5402409|NCT00005862|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
5402410|NCT00005610|stage IV melanoma|stage iv melanoma
5402411|NCT00005610|recurrent melanoma|recurrent melanoma
5402412|NCT00005610|lung metastases|lung metastases
5402413|NCT00004889|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
5402414|NCT00004203|recurrent bladder cancer|recurrent bladder cancer
5402415|NCT00004203|stage IV bladder cancer|stage iv bladder cancer
5402416|NCT00004203|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
5402417|NCT00004203|metastatic transitional cell cancer of the renal pelvis and ureter|metastatic transitional cell cancer of the renal pelvis and ureter
5402418|NCT00004203|recurrent transitional cell cancer of the renal pelvis and ureter|recurrent transitional cell cancer of the renal pelvis and ureter
5402419|NCT00004157|stage IV breast cancer|stage iv breast cancer
5402420|NCT00004157|stage IIIA breast cancer|stage iiia breast cancer
5402421|NCT00004157|stage IIIB breast cancer|stage iiib breast cancer
5402422|NCT00004157|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5402423|NCT00004157|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
5402424|NCT00004157|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
5402425|NCT00004157|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5402520|NCT00077584|Systemic Sclerosis|systemic sclerosis
5402426|NCT00004157|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5402427|NCT00004157|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5402428|NCT00004157|disseminated neuroblastoma|disseminated neuroblastoma
5402429|NCT00004157|recurrent neuroblastoma|recurrent neuroblastoma
5402430|NCT00004157|recurrent Wilms tumor and other childhood kidney tumors|recurrent wilms tumor and other childhood kidney tumors
5402431|NCT00004157|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
5402432|NCT00004157|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
5402433|NCT00004157|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
5402434|NCT00004157|testicular embryonal carcinoma|testicular embryonal carcinoma
5402435|NCT00004157|testicular choriocarcinoma|testicular choriocarcinoma
5402436|NCT00004157|testicular teratoma|testicular teratoma
5402437|NCT00004157|testicular yolk sac tumor|testicular yolk sac tumor
5402438|NCT00004157|testicular embryonal carcinoma and teratoma|testicular embryonal carcinoma and teratoma
5402439|NCT00004157|testicular embryonal carcinoma and teratoma with seminoma|testicular embryonal carcinoma and teratoma with seminoma
5402440|NCT00004157|testicular embryonal carcinoma and yolk sac tumor|testicular embryonal carcinoma and yolk sac tumor
5402441|NCT00004157|testicular embryonal carcinoma and yolk sac tumor with seminoma|testicular embryonal carcinoma and yolk sac tumor with seminoma
5402442|NCT00004157|testicular embryonal carcinoma and seminoma|testicular embryonal carcinoma and seminoma
5402443|NCT00004157|testicular yolk sac tumor and teratoma|testicular yolk sac tumor and teratoma
5402444|NCT00004157|testicular yolk sac tumor and teratoma with seminoma|testicular yolk sac tumor and teratoma with seminoma
5402445|NCT00004157|testicular choriocarcinoma and yolk sac tumor|testicular choriocarcinoma and yolk sac tumor
5402665|NCT00003367|stage III prostate cancer|stage iii prostate cancer
5402446|NCT00004157|testicular choriocarcinoma and embryonal carcinoma|testicular choriocarcinoma and embryonal carcinoma
5402447|NCT00004157|testicular choriocarcinoma and teratoma|testicular choriocarcinoma and teratoma
5402448|NCT00004157|testicular choriocarcinoma and seminoma|testicular choriocarcinoma and seminoma
5402449|NCT00004157|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
5402450|NCT00004157|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
5402451|NCT00004157|ovarian yolk sac tumor|ovarian yolk sac tumor
5402452|NCT00004157|ovarian embryonal carcinoma|ovarian embryonal carcinoma
5402453|NCT00004157|ovarian polyembryoma|ovarian polyembryoma
5402454|NCT00004157|ovarian choriocarcinoma|ovarian choriocarcinoma
5402455|NCT00004157|ovarian immature teratoma|ovarian immature teratoma
5402456|NCT00004157|ovarian mature teratoma|ovarian mature teratoma
5402457|NCT00004157|ovarian monodermal and highly specialized teratoma|ovarian monodermal and highly specialized teratoma
5402458|NCT00004157|ovarian mixed germ cell tumor|ovarian mixed germ cell tumor
5402459|NCT00004157|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5402460|NCT00004157|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5402461|NCT00004157|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5402462|NCT00004157|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5402463|NCT00004157|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5402464|NCT00004157|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5402465|NCT00004157|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5402466|NCT00004157|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5402467|NCT00004157|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5402468|NCT00004157|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5402469|NCT00004157|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5402470|NCT00004157|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5402471|NCT00004157|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5402472|NCT00004157|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5402473|NCT00004157|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5402474|NCT00004157|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5402475|NCT00004157|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5402476|NCT00004157|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5402477|NCT00004157|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5402478|NCT00004157|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5402479|NCT00004157|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5402480|NCT00004157|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5402481|NCT00004157|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5402482|NCT00004157|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5402483|NCT00004157|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5402484|NCT00004157|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5402485|NCT00004157|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5402486|NCT00004157|poor prognosis metastatic gestational trophoblastic tumor|poor prognosis metastatic gestational trophoblastic tumor
5402487|NCT00004157|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
5402488|NCT00004157|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
5402489|NCT00004157|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5402490|NCT00004157|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5402491|NCT00004157|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5402492|NCT00004157|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
5402493|NCT00004157|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5402494|NCT00004157|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
5402495|NCT00004157|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
5402496|NCT00004157|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5402497|NCT00004157|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
5402498|NCT00004157|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
5402499|NCT00004157|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5402500|NCT00004157|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5402501|NCT00004157|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5402502|NCT00004157|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
5402503|NCT00004157|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
5402504|NCT00004157|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
5402505|NCT00004157|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5402506|NCT00004157|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5402507|NCT00004157|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5402981|NCT00076570|Polyclonal|polyclonal
5402508|NCT00004157|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5402509|NCT00004157|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5402510|NCT00004157|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5402511|NCT00004157|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5402512|NCT00004157|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5402513|NCT00004157|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5402514|NCT00004003|stage III pancreatic cancer|stage iii pancreatic cancer
5402515|NCT00004003|recurrent pancreatic cancer|recurrent pancreatic cancer
5402516|NCT00004003|stage IV pancreatic cancer|stage iv pancreatic cancer
5402517|NCT00077584|Scleroderma|scleroderma
5402518|NCT00077584|Finger Ulcers|finger ulcers
5402521|NCT00077285|previously untreated childhood rhabdomyosarcoma|previously untreated childhood rhabdomyosarcoma
5402522|NCT00077285|embryonal childhood rhabdomyosarcoma|embryonal childhood rhabdomyosarcoma
5402523|NCT00077285|alveolar childhood rhabdomyosarcoma|alveolar childhood rhabdomyosarcoma
5402524|NCT00077285|adult rhabdomyosarcoma|adult rhabdomyosarcoma
5402525|NCT00077285|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
5402526|NCT00077285|metastatic childhood soft tissue sarcoma|metastatic childhood soft tissue sarcoma
5402527|NCT00077285|nonmetastatic childhood soft tissue sarcoma|nonmetastatic childhood soft tissue sarcoma
5402528|NCT00077285|childhood malignant mesenchymoma|childhood malignant mesenchymoma
5402529|NCT00077285|adult malignant mesenchymoma|adult malignant mesenchymoma
5402530|NCT00077285|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
5402531|NCT00077285|stage II adult soft tissue sarcoma|stage ii adult soft tissue sarcoma
5402532|NCT00077285|stage I adult soft tissue sarcoma|stage i adult soft tissue sarcoma
5402533|NCT00077259|recurrent colon cancer|recurrent colon cancer
5402534|NCT00077259|recurrent rectal cancer|recurrent rectal cancer
5402535|NCT00077259|stage III colon cancer|stage iii colon cancer
5402536|NCT00077259|stage III rectal cancer|stage iii rectal cancer
5402537|NCT00077259|stage IV colon cancer|stage iv colon cancer
5402538|NCT00077259|stage IV rectal cancer|stage iv rectal cancer
5402539|NCT00077259|adenocarcinoma of the colon|adenocarcinoma of the colon
5402540|NCT00077259|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5402541|NCT00077246|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5402542|NCT00077246|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5402543|NCT00077233|adenocarcinoma of the colon|adenocarcinoma of the colon
5402544|NCT00077233|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5402545|NCT00077233|recurrent colon cancer|recurrent colon cancer
5402546|NCT00077233|recurrent rectal cancer|recurrent rectal cancer
5402547|NCT00077233|stage IV colon cancer|stage iv colon cancer
5402548|NCT00077233|stage IV rectal cancer|stage iv rectal cancer
5402549|NCT00077220|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
5402550|NCT00077220|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5402551|NCT00077220|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5402552|NCT00077207|untreated childhood cerebellar astrocytoma|untreated childhood cerebellar astrocytoma
5402553|NCT00077207|untreated childhood visual pathway and hypothalamic glioma|untreated childhood visual pathway and hypothalamic glioma
5402554|NCT00077207|childhood spinal cord neoplasm|childhood spinal cord neoplasm
5402555|NCT00077207|childhood oligodendroglioma|childhood oligodendroglioma
5402556|NCT00077207|childhood low-grade cerebral astrocytoma|childhood low-grade cerebral astrocytoma
5402557|NCT00077194|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5402558|NCT00077194|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5402559|NCT00077194|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5402560|NCT00077168|ductal breast carcinoma in situ|ductal breast carcinoma in situ
5402561|NCT00077168|breast cancer in situ|breast cancer in situ
5402562|NCT00077142|advanced adult primary liver cancer|advanced adult primary liver cancer
5402563|NCT00077142|recurrent adult primary liver cancer|recurrent adult primary liver cancer
5402564|NCT00077142|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
5402565|NCT00077142|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
5402566|NCT00077142|Oral TAC-101|oral tac-101
5402567|NCT00077129|stage III renal cell cancer|stage iii renal cell cancer
5402568|NCT00077129|stage IV renal cell cancer|stage iv renal cell cancer
5402569|NCT00077129|recurrent renal cell cancer|recurrent renal cell cancer
5402570|NCT00077116|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
5402571|NCT00077116|refractory anemia with excess blasts|refractory anemia with excess blasts
5402572|NCT00077116|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
5402573|NCT00077116|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5402574|NCT00077116|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5402575|NCT00077116|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5402576|NCT00077116|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5402577|NCT00077116|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5402578|NCT00077116|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5402579|NCT00077116|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5402580|NCT00077116|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5402581|NCT00077116|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
5402582|NCT00077103|anaplastic thyroid cancer|anaplastic thyroid cancer
5402583|NCT00077090|lymphedema|lymphedema
5402584|NCT00077090|radiation fibrosis|radiation fibrosis
5402585|NCT00077090|perioperative/postoperative complications|perioperative/postoperative complications
5402586|NCT00077090|stage I breast cancer|stage i breast cancer
5402587|NCT00077090|stage II breast cancer|stage ii breast cancer
5402588|NCT00077090|stage IIIA breast cancer|stage iiia breast cancer
5402589|NCT00077077|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5402590|NCT00077064|radiation fibrosis|radiation fibrosis
5402591|NCT00077064|pulmonary complications|pulmonary complications
5402592|NCT00077064|limited stage small cell lung cancer|limited stage small cell lung cancer
5402593|NCT00077064|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
5402594|NCT00077064|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5402595|NCT00077064|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5402596|NCT00077064|stage I non-small cell lung cancer|stage i non-small cell lung cancer
5402597|NCT00077051|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
5402598|NCT00077051|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
5402599|NCT00077051|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5402600|NCT00077051|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5402601|NCT00077025|metastatic breast cancer|metastatic breast cancer
5402602|NCT00077012|BPH|bph
5402603|NCT00077038|Visual Feedback|visual feedback
5402604|NCT00077038|Cortical Connectivity|cortical connectivity
5402605|NCT00077038|Magnetoencephalography|magnetoencephalography
5402606|NCT00077038|Eye Tracking|eye tracking
5402607|NCT00077038|Healthy Volunteer|healthy volunteer
5402608|NCT00077038|HV|hv
5402609|NCT00076986|brain tumor|brain tumor
5402610|NCT00076986|recurrent malignant glioma|recurrent malignant glioma
5402611|NCT00076986|brain neoplasm|brain neoplasm
5402612|NCT00076986|central nervous system|central nervous system
5402613|NCT00076986|surgery|surgery
5402614|NCT00076986|resection|resection
5402615|NCT00076986|GLIADEL|gliadel
5402616|NCT00076986|infusion|infusion
5402617|NCT00076986|glioblastoma multiforme|glioblastoma multiforme
5402618|NCT00076986|convection-enhanced delivery|convection-enhanced delivery
5402619|NCT00076986|first recurrence|first recurrence
5402620|NCT00076986|recurrent GBM|recurrent gbm
5402621|NCT00076986|GBM|gbm
5402622|NCT00076986|supratentorial GBM|supratentorial gbm
5402623|NCT00076960|hyperbilirubinemia|hyperbilirubinemia
5402624|NCT00076960|jaundice|jaundice
5402625|NCT00076960|tin-mesoporphyrin|tin-mesoporphyrin
5402626|NCT00076960|stannsoporfin|stannsoporfin
5402627|NCT00076960|exchange transfusion|exchange transfusion
5402628|NCT00076960|neonatal hyperbilirubinemia|neonatal hyperbilirubinemia
5402629|NCT00076947|HIV Preventive Vaccine|hiv preventive vaccine
5402630|NCT00076947|HIV Seronegativity|hiv seronegativity
5402631|NCT00076947|Protein|protein
5402632|NCT00076934|Ataxia|ataxia
5402633|NCT00076934|MRI|mri
5402634|NCT00076934|MS|ms
5402635|NCT00076934|CTLA4-IgG4m|ctla4-igg4m
5402636|NCT00076934|Costimulatory Signals|costimulatory signals
5402637|NCT00076934|Autoimmune Disorders|autoimmune disorders
5402638|NCT00003937|localized osteosarcoma|localized osteosarcoma
5402639|NCT00003937|cardiac toxicity|cardiac toxicity
5402640|NCT00003923|stage I pancreatic cancer|stage i pancreatic cancer
5402641|NCT00003923|stage II pancreatic cancer|stage ii pancreatic cancer
5402642|NCT00003923|stage III pancreatic cancer|stage iii pancreatic cancer
5402643|NCT00003923|stage IV pancreatic cancer|stage iv pancreatic cancer
5402644|NCT00003923|recurrent pancreatic cancer|recurrent pancreatic cancer
5402645|NCT00003923|unresectable gallbladder cancer|unresectable gallbladder cancer
5402646|NCT00003923|recurrent gallbladder cancer|recurrent gallbladder cancer
5402647|NCT00003923|unresectable extrahepatic bile duct cancer|unresectable extrahepatic bile duct cancer
5402648|NCT00003923|recurrent extrahepatic bile duct cancer|recurrent extrahepatic bile duct cancer
5402649|NCT00003923|cholangiocarcinoma of the gallbladder|cholangiocarcinoma of the gallbladder
5402650|NCT00003923|cholangiocarcinoma of the extrahepatic bile duct|cholangiocarcinoma of the extrahepatic bile duct
5402651|NCT00003923|adult primary cholangiocellular carcinoma|adult primary cholangiocellular carcinoma
5402652|NCT00003721|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5402653|NCT00003665|stage IV melanoma|stage iv melanoma
5402654|NCT00003665|recurrent melanoma|recurrent melanoma
5402655|NCT00003616|recurrent adult brain tumor|recurrent adult brain tumor
5402656|NCT00003616|adult brain stem glioma|adult brain stem glioma
5402657|NCT00003616|adult oligodendroglioma|adult oligodendroglioma
5402658|NCT00003616|adult mixed glioma|adult mixed glioma
5402659|NCT00003616|adult diffuse astrocytoma|adult diffuse astrocytoma
5402660|NCT00003370|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
5402661|NCT00003367|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5402662|NCT00003367|stage I prostate cancer|stage i prostate cancer
5402663|NCT00003367|stage IIB prostate cancer|stage iib prostate cancer
5402664|NCT00003367|stage IIA prostate cancer|stage iia prostate cancer
5402666|NCT00003367|stage IV prostate cancer|stage iv prostate cancer
5402667|NCT00003367|recurrent prostate cancer|recurrent prostate cancer
5402668|NCT00003334|stage IV endometrial carcinoma|stage iv endometrial carcinoma
5402669|NCT00003334|recurrent endometrial carcinoma|recurrent endometrial carcinoma
5402670|NCT00003334|fallopian tube cancer|fallopian tube cancer
5402671|NCT00003334|stage IV uterine sarcoma|stage iv uterine sarcoma
5402672|NCT00003334|recurrent uterine sarcoma|recurrent uterine sarcoma
5402673|NCT00003334|uterine carcinosarcoma|uterine carcinosarcoma
5402674|NCT00003334|uterine leiomyosarcoma|uterine leiomyosarcoma
5402675|NCT00003334|endometrial stromal sarcoma|endometrial stromal sarcoma
5402676|NCT00003334|ovarian sarcoma|ovarian sarcoma
5402677|NCT00003334|ovarian carcinosarcoma|ovarian carcinosarcoma
5402678|NCT00003222|stage III melanoma|stage iii melanoma
5402679|NCT00003222|stage IV melanoma|stage iv melanoma
5402680|NCT00003222|recurrent melanoma|recurrent melanoma
5402681|NCT00003185|adult glioblastoma|adult glioblastoma
5402682|NCT00003185|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5402683|NCT00003185|adult giant cell glioblastoma|adult giant cell glioblastoma
5402684|NCT00003185|adult gliosarcoma|adult gliosarcoma
5402685|NCT00003108|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5402686|NCT00003086|stage IV breast cancer|stage iv breast cancer
5402687|NCT00076869|Definite or probable Invasive Aspergillosis either refractory or intolerant to prior antifungal treatment.|definite or probable invasive aspergillosis either refractory or intolerant to prior antifungal treatment.
5402688|NCT00076817|HIV Preventive Vaccine|hiv preventive vaccine
5402689|NCT00076817|ALVAC Vaccine|alvac vaccine
5402690|NCT00076817|Immunization Site|immunization site
5402691|NCT00076817|Deltoid|deltoid
5402692|NCT00076817|Groin|groin
5402693|NCT00076817|Targeted Inguinal Lymph Node|targeted inguinal lymph node
5402694|NCT00076817|TILN|tiln
5402695|NCT00076804|Directly Observed Therapy|directly observed therapy
5402696|NCT00076804|DOT|dot
5402697|NCT00076791|HIV Seronegativity|hiv seronegativity
5402698|NCT00033592|non-small cell lung cancer|non-small cell lung cancer
5402699|NCT00033592|small cell lung cancer|small cell lung cancer
5402700|NCT00026377|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5402701|NCT00026377|stage IIB prostate cancer|stage iib prostate cancer
5402702|NCT00026377|stage IIA prostate cancer|stage iia prostate cancer
5402703|NCT00026377|stage III prostate cancer|stage iii prostate cancer
5402704|NCT00026377|stage IV prostate cancer|stage iv prostate cancer
5402705|NCT00024362|stage III pancreatic cancer|stage iii pancreatic cancer
5402706|NCT00024362|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
5402707|NCT00024362|stage IV pancreatic cancer|stage iv pancreatic cancer
5402708|NCT00003320|tumors metastatic to brain|tumors metastatic to brain
5402709|NCT00003073|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5402710|NCT00003073|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
5402711|NCT00003073|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5402712|NCT00003073|childhood diffuse large cell lymphoma|childhood diffuse large cell lymphoma
5402713|NCT00003073|childhood immunoblastic large cell lymphoma|childhood immunoblastic large cell lymphoma
5402714|NCT00003073|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
5402715|NCT00003073|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
5402716|NCT00003073|leptomeningeal metastases|leptomeningeal metastases
5402717|NCT00003073|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
5402718|NCT00003073|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
5402719|NCT00002801|stage II colon cancer|stage ii colon cancer
5402720|NCT00002801|stage III colon cancer|stage iii colon cancer
5402721|NCT00002801|stage I rectal cancer|stage i rectal cancer
5402722|NCT00002801|stage II rectal cancer|stage ii rectal cancer
5402723|NCT00002801|stage III rectal cancer|stage iii rectal cancer
5402724|NCT00002679|stage II breast cancer|stage ii breast cancer
5402725|NCT00002679|stage IIIA breast cancer|stage iiia breast cancer
5402726|NCT00002679|male breast cancer|male breast cancer
5402727|NCT00076843|Interleukin-15|interleukin-15
5402728|NCT00076843|CD8+ T-cells|cd8+ t-cells
5402729|NCT00076843|HAM/TSP|ham/tsp
5402730|NCT00076843|HTLV-1|htlv-1
5402731|NCT00076843|HTLV-1 Associated Myelopathy|htlv-1 associated myelopathy
5402732|NCT00076843|Tropical Spastic Paraparesis|tropical spastic paraparesis
5402733|NCT00076830|Errors of Bone Matrix and Metabolism|errors of bone matrix and metabolism
5402734|NCT00076830|Connective Tissue Disorders|connective tissue disorders
5402735|NCT00076726|Giant Cell Arteritis|giant cell arteritis
5402736|NCT00076726|infliximab|infliximab
5402737|NCT00076544|Intrathecal|intrathecal
5402738|NCT00076518|Treatment Experienced|treatment experienced
5402739|NCT00022373|stage I nasopharyngeal cancer|stage i nasopharyngeal cancer
5402740|NCT00022373|stage II nasopharyngeal cancer|stage ii nasopharyngeal cancer
5402741|NCT00022373|stage III nasopharyngeal cancer|stage iii nasopharyngeal cancer
5402742|NCT00022373|stage IV nasopharyngeal cancer|stage iv nasopharyngeal cancer
5402743|NCT00022373|stage I salivary gland cancer|stage i salivary gland cancer
5402744|NCT00022373|stage II salivary gland cancer|stage ii salivary gland cancer
5402745|NCT00022373|stage III salivary gland cancer|stage iii salivary gland cancer
5402746|NCT00022373|stage IV salivary gland cancer|stage iv salivary gland cancer
5402747|NCT00022373|recurrent salivary gland cancer|recurrent salivary gland cancer
5402748|NCT00022373|untreated metastatic squamous neck cancer with occult primary|untreated metastatic squamous neck cancer with occult primary
5402749|NCT00022373|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
5402750|NCT00022373|stage I lip and oral cavity cancer|stage i lip and oral cavity cancer
5402751|NCT00022373|stage II lip and oral cavity cancer|stage ii lip and oral cavity cancer
5402752|NCT00022373|stage III lip and oral cavity cancer|stage iii lip and oral cavity cancer
5402753|NCT00022373|stage IV lip and oral cavity cancer|stage iv lip and oral cavity cancer
5402754|NCT00022373|stage I hypopharyngeal cancer|stage i hypopharyngeal cancer
5402755|NCT00022373|stage II hypopharyngeal cancer|stage ii hypopharyngeal cancer
5402756|NCT00022373|stage III hypopharyngeal cancer|stage iii hypopharyngeal cancer
5402757|NCT00022373|stage IV hypopharyngeal cancer|stage iv hypopharyngeal cancer
5402758|NCT00022373|stage I oropharyngeal cancer|stage i oropharyngeal cancer
5402759|NCT00022373|stage II oropharyngeal cancer|stage ii oropharyngeal cancer
5402760|NCT00022373|stage III oropharyngeal cancer|stage iii oropharyngeal cancer
5402761|NCT00022373|stage IV oropharyngeal cancer|stage iv oropharyngeal cancer
5402762|NCT00022373|radiation toxicity|radiation toxicity
5402763|NCT00022373|oral complications of radiation therapy|oral complications of radiation therapy
5402764|NCT00022243|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5402765|NCT00022243|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5402766|NCT00022243|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5402767|NCT00022243|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5402768|NCT00022204|stage I breast cancer|stage i breast cancer
5402769|NCT00022204|stage II breast cancer|stage ii breast cancer
5402770|NCT00022204|stage IIIA breast cancer|stage iiia breast cancer
5402771|NCT00022204|lymphedema|lymphedema
5402772|NCT00022204|male breast cancer|male breast cancer
5402773|NCT00021385|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5402774|NCT00021385|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5402775|NCT00021385|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5402776|NCT00021385|ovarian stromal cancer|ovarian stromal cancer
5402777|NCT00021385|stage III ovarian germ cell tumor|stage iii ovarian germ cell tumor
5402778|NCT00021385|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
5402779|NCT00021385|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
5402780|NCT00021385|borderline ovarian surface epithelial-stromal tumor|borderline ovarian surface epithelial-stromal tumor
5402781|NCT00021385|ovarian sarcoma|ovarian sarcoma
5402782|NCT00020696|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5402783|NCT00020696|primary peritoneal cavity cancer|primary peritoneal cavity cancer
5402784|NCT00017407|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5402785|NCT00017407|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5402786|NCT00017407|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5402787|NCT00014105|recurrent adult brain tumor|recurrent adult brain tumor
5402788|NCT00014105|adult glioblastoma|adult glioblastoma
5402789|NCT00014105|adult giant cell glioblastoma|adult giant cell glioblastoma
5402790|NCT00014105|adult gliosarcoma|adult gliosarcoma
5402791|NCT00014066|stage I non-small cell lung cancer|stage i non-small cell lung cancer
5402792|NCT00014066|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5402793|NCT00014066|limited stage small cell lung cancer|limited stage small cell lung cancer
5402794|NCT00014066|recurrent small cell lung cancer|recurrent small cell lung cancer
5402795|NCT00014066|stage 0 non-small cell lung cancer|stage 0 non-small cell lung cancer
5402796|NCT00010244|stage IIB prostate cancer|stage iib prostate cancer
5402797|NCT00010244|stage IIA prostate cancer|stage iia prostate cancer
5402798|NCT00010244|stage III prostate cancer|stage iii prostate cancer
5402799|NCT00076752|Refractory SLE|refractory sle
5402800|NCT00076752|Immunoablation|immunoablation
5402801|NCT00076752|Immunological Recovery|immunological recovery
5402802|NCT00076752|Efficacy|efficacy
5402803|NCT00076752|Mechanism of Disease|mechanism of disease
5402804|NCT00076752|Lupus|lupus
5402805|NCT00076752|Systemic Lupus Erythematosus|systemic lupus erythematosus
5402806|NCT00076752|SLE|sle
5402807|NCT00076739|Prefrontal Cortex|prefrontal cortex
5402808|NCT00076739|Semantic Memory|semantic memory
5402809|NCT00076739|Semantic Relations|semantic relations
5402810|NCT00076739|Priming Paradigm|priming paradigm
5402811|NCT00076739|fMRI|fmri
5402812|NCT00076739|Healthy Volunteer|healthy volunteer
5402813|NCT00076739|HV|hv
5402814|NCT00076713|Antiphospholipid|antiphospholipid
5402815|NCT00009997|stage II breast cancer|stage ii breast cancer
5402816|NCT00009997|stage IIIA breast cancer|stage iiia breast cancer
5402817|NCT00009997|stage IIIB breast cancer|stage iiib breast cancer
5402818|NCT00008333|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5402819|NCT00008333|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5402820|NCT00008034|stage II breast cancer|stage ii breast cancer
5402821|NCT00008034|stage IIIA breast cancer|stage iiia breast cancer
5402822|NCT00008034|stage IIIB breast cancer|stage iiib breast cancer
5402823|NCT00008034|inflammatory breast cancer|inflammatory breast cancer
5402824|NCT00006460|adult glioblastoma|adult glioblastoma
5402825|NCT00006460|adult giant cell glioblastoma|adult giant cell glioblastoma
5402826|NCT00006460|adult gliosarcoma|adult gliosarcoma
5402827|NCT00006454|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
5402828|NCT00006454|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5402829|NCT00006454|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5402830|NCT00006454|fallopian tube cancer|fallopian tube cancer
5402831|NCT00006111|stage II bladder cancer|stage ii bladder cancer
5402832|NCT00006111|stage III bladder cancer|stage iii bladder cancer
5402833|NCT00006111|stage IV bladder cancer|stage iv bladder cancer
5402834|NCT00006111|anterior urethral cancer|anterior urethral cancer
5402835|NCT00006111|posterior urethral cancer|posterior urethral cancer
5402836|NCT00006111|urethral cancer associated with invasive bladder cancer|urethral cancer associated with invasive bladder cancer
5402837|NCT00006111|metastatic transitional cell cancer of the renal pelvis and ureter|metastatic transitional cell cancer of the renal pelvis and ureter
5402838|NCT00006111|regional transitional cell cancer of the renal pelvis and ureter|regional transitional cell cancer of the renal pelvis and ureter
5402839|NCT00076700|Cross-Modal Plasticity|cross-modal plasticity
5402840|NCT00076700|Functional MRI|functional mri
5402841|NCT00076700|Behavior|behavior
5402842|NCT00076700|Memory|memory
5402843|NCT00076700|Blind|blind
5402844|NCT00076700|Blindness|blindness
5402845|NCT00076700|Healthy Volunteer|healthy volunteer
5402846|NCT00076700|HV|hv
5402847|NCT00006050|stage IV colon cancer|stage iv colon cancer
5402848|NCT00006050|stage IV rectal cancer|stage iv rectal cancer
5402849|NCT00006050|liver metastases|liver metastases
5402850|NCT00005881|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5402851|NCT00005881|childhood Burkitt lymphoma|childhood burkitt lymphoma
5402852|NCT00005881|stage I childhood lymphoblastic lymphoma|stage i childhood lymphoblastic lymphoma
5402853|NCT00005881|stage II childhood lymphoblastic lymphoma|stage ii childhood lymphoblastic lymphoma
5402854|NCT00005881|stage III childhood lymphoblastic lymphoma|stage iii childhood lymphoblastic lymphoma
5402855|NCT00005881|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
5402856|NCT00005881|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
5402857|NCT00005881|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5402858|NCT00005881|childhood diffuse large cell lymphoma|childhood diffuse large cell lymphoma
5402859|NCT00005881|childhood immunoblastic large cell lymphoma|childhood immunoblastic large cell lymphoma
5402860|NCT00005881|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
5402861|NCT00005881|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
5402862|NCT00005881|stage II childhood Hodgkin lymphoma|stage ii childhood hodgkin lymphoma
5402863|NCT00005881|stage I childhood Hodgkin lymphoma|stage i childhood hodgkin lymphoma
5402864|NCT00005881|stage III childhood Hodgkin lymphoma|stage iii childhood hodgkin lymphoma
5402865|NCT00005881|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
5402866|NCT00005881|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
5402867|NCT00005881|stage I childhood small noncleaved cell lymphoma|stage i childhood small noncleaved cell lymphoma
5402868|NCT00005881|stage I childhood large cell lymphoma|stage i childhood large cell lymphoma
5402869|NCT00005881|stage II childhood small noncleaved cell lymphoma|stage ii childhood small noncleaved cell lymphoma
5402870|NCT00005881|stage II childhood large cell lymphoma|stage ii childhood large cell lymphoma
5402871|NCT00005881|stage III childhood small noncleaved cell lymphoma|stage iii childhood small noncleaved cell lymphoma
5402872|NCT00005881|stage III childhood large cell lymphoma|stage iii childhood large cell lymphoma
5402873|NCT00005881|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
5402874|NCT00005881|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
5402875|NCT00005881|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
5402876|NCT00005881|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
5402877|NCT00005792|refractory multiple myeloma|refractory multiple myeloma
5402878|NCT00005792|stage I multiple myeloma|stage i multiple myeloma
5402879|NCT00005792|stage II multiple myeloma|stage ii multiple myeloma
5402880|NCT00005792|stage III multiple myeloma|stage iii multiple myeloma
5402881|NCT00076635|Idiopathic|idiopathic
5402882|NCT00076635|Pulmonary|pulmonary
5402883|NCT00076635|Fibrosis|fibrosis
5402884|NCT00076635|IPF|ipf
5402885|NCT00076635|Lung|lung
5402886|NCT00076635|Actimmune|actimmune
5402887|NCT00076635|Interferon|interferon
5402888|NCT00076635|Gamma|gamma
5402889|NCT00076635|InterMune|intermune
5402890|NCT00076674|Parkinson's Disease|parkinson's disease
5402891|NCT00076674|Keppra|keppra
5402892|NCT00076674|Motor Fluctuations|motor fluctuations
5402893|NCT00076674|Intravenous Levodopa|intravenous levodopa
5402894|NCT00076674|Antiparkinsonian Response|antiparkinsonian response
5402895|NCT00076674|Parkinson Disease|parkinson disease
5402896|NCT00076674|PD|pd
5402897|NCT00076622|Antidepressant drugs|antidepressant drugs
5402898|NCT00076622|Nursing Homes|nursing homes
5402899|NCT00005022|limited stage small cell lung cancer|limited stage small cell lung cancer
5402900|NCT00004862|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5402901|NCT00004862|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5402902|NCT00004239|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5402903|NCT00004239|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5402904|NCT00004239|refractory multiple myeloma|refractory multiple myeloma
5402905|NCT00004239|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
5402906|NCT00004239|stage III multiple myeloma|stage iii multiple myeloma
5402907|NCT00004239|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5402908|NCT00004239|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5402909|NCT00004239|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5402910|NCT00004239|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5402911|NCT00004239|polycythemia vera|polycythemia vera
5402912|NCT00004239|primary myelofibrosis|primary myelofibrosis
5402913|NCT00004239|essential thrombocythemia|essential thrombocythemia
5402914|NCT00004239|refractory hairy cell leukemia|refractory hairy cell leukemia
5402915|NCT00004239|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5402916|NCT00004239|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5402917|NCT00004239|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5402918|NCT00004239|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5402919|NCT00004239|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5402920|NCT00004239|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5402921|NCT00004239|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5402922|NCT00004239|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5402923|NCT00004239|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5402924|NCT00004239|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5402925|NCT00004239|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
5402926|NCT00004239|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5402927|NCT00004239|prolymphocytic leukemia|prolymphocytic leukemia
5402928|NCT00004239|primary systemic amyloidosis|primary systemic amyloidosis
5402929|NCT00004239|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5402930|NCT00004239|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5402931|NCT00004239|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5402932|NCT00004239|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5402933|NCT00004239|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5402934|NCT00004239|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5402935|NCT00004239|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5402936|NCT00004239|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5402937|NCT00003888|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
5402938|NCT00003888|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5402939|NCT00003888|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
5402940|NCT00003888|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5402941|NCT00003888|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
5402942|NCT00003888|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5402943|NCT00003888|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
5402944|NCT00003888|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5402945|NCT00076609|hepatocellular carcinoma|hepatocellular carcinoma
5402946|NCT00076609|advanced|advanced
5402947|NCT00076609|unresectable|unresectable
5402948|NCT00076609|liver cancer|liver cancer
5402949|NCT00076609|systemic chemotherapy|systemic chemotherapy
5402950|NCT00076609|botanical|botanical
5402951|NCT00076609|herbal|herbal
5402952|NCT00076609|alternative and complementary medicine|alternative and complementary medicine
5402953|NCT00076609|capecitabine|capecitabine
5402954|NCT00076609|PHY906|phy906
5402955|NCT00076609|oral|oral
5402956|NCT00076609|HCC|hcc
5402957|NCT00076609|traditional chinese medicine|traditional chinese medicine
5402958|NCT00076609|tcm|tcm
5402959|NCT00076609|QOL|qol
5402960|NCT00076609|quality of life|quality of life
5402961|NCT00076557|Hemophilia B|hemophilia b
5402962|NCT00076557|Factor IX|factor ix
5402963|NCT00076557|Gene Transfer|gene transfer
5402964|NCT00076557|Adeno-Associated Virus (AAV)|adeno-associated virus (aav)
5402965|NCT00076596|Corticospinal Tracts|corticospinal tracts
5402966|NCT00076596|Spastic Hemiplegia|spastic hemiplegia
5402967|NCT00076596|Spastic Diplegia|spastic diplegia
5402968|NCT00076596|Cortical Re-Organization|cortical re-organization
5402969|NCT00076596|Functional Outcome|functional outcome
5402970|NCT00076596|Cerebral Palsy|cerebral palsy
5402971|NCT00076583|Motor Learning|motor learning
5402972|NCT00076583|Co-contraction|co-contraction
5402973|NCT00076583|Reciprocal Inhibition|reciprocal inhibition
5402974|NCT00076583|Spinal Plasticity|spinal plasticity
5402975|NCT00076583|Rhythmic Movement|rhythmic movement
5402976|NCT00076583|Healthy Volunteer|healthy volunteer
5402977|NCT00076583|HV|hv
5402978|NCT00076570|Tolerance|tolerance
5402979|NCT00076570|Kidney|kidney
5402980|NCT00076570|Transplant|transplant
5402983|NCT00076570|Kidney Transplant|kidney transplant
5402984|NCT00076531|Prostate|prostate
5402985|NCT00076531|Cancer|cancer
5402986|NCT00076531|PSA|psa
5402987|NCT00076531|Leuprolide|leuprolide
5402988|NCT00076492|Parkinson's disease|parkinson's disease
5402989|NCT00076492|Parkinson disease|parkinson disease
5402990|NCT00076492|CoQ10|coq10
5402991|NCT00076492|GPI 1485|gpi 1485
5402992|NCT00003882|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5402993|NCT00003852|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
5402994|NCT00003852|childhood germ cell tumor|childhood germ cell tumor
5402995|NCT00003852|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
5402996|NCT00003852|extragonadal germ cell tumor|extragonadal germ cell tumor
5402997|NCT00003683|stage IV renal cell cancer|stage iv renal cell cancer
5402998|NCT00003682|stage IV prostate cancer|stage iv prostate cancer
5402999|NCT00003682|recurrent prostate cancer|recurrent prostate cancer
5403000|NCT00003578|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5403001|NCT00003578|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5403002|NCT00003578|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5403003|NCT00003578|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5403004|NCT00003578|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5403005|NCT00003578|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5403006|NCT00003578|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5403007|NCT00003578|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5403008|NCT00076505|Mitochondria|mitochondria
5403009|NCT00076505|Proteasome|proteasome
5403010|NCT00076505|Lipid|lipid
5403011|NCT00076505|Polymorphism|polymorphism
5403012|NCT00076505|Genetic|genetic
5403013|NCT00076505|Parkinson's Disease|parkinson's disease
5403014|NCT00076505|Parkinson Disease|parkinson disease
5403015|NCT00076505|PD|pd
5403016|NCT00076505|Heredity|heredity
5403017|NCT00076505|Parkinson Disease At Risk|parkinson disease at risk
5403018|NCT00076505|Healthy Volunteer|healthy volunteer
5403019|NCT00076505|HV|hv
5403020|NCT00076453|Knee Pain|knee pain
5403021|NCT00076453|Degenerative Arthritis|degenerative arthritis
5403022|NCT00076453|Cartilage Disease|cartilage disease
5403023|NCT00076453|Non-drug Therapy|non-drug therapy
5403024|NCT00076440|Alzheimer disease|alzheimer disease
5403025|NCT00076401|CLL|cll
5403026|NCT00076401|chronic lymphocytic leukemia|chronic lymphocytic leukemia
5403027|NCT00076401|relapsed chronic lymphocytic leukemia|relapsed chronic lymphocytic leukemia
5403028|NCT00076401|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5403029|NCT00076401|Leukemia|leukemia
5403030|NCT00076401|Motexafin gadolinium|motexafin gadolinium
5403031|NCT00076401|Chronic leukemia|chronic leukemia
5403032|NCT00076401|Lymphocytic leukemia, chronic|lymphocytic leukemia, chronic
5403033|NCT00076479|Aphasia|aphasia
5403034|NCT00076479|Rehabilitation|rehabilitation
5403035|NCT00076479|Neuroplasticity|neuroplasticity
5403036|NCT00076479|Picture Naming|picture naming
5403037|NCT00076479|Transcranial Magnetic|transcranial magnetic
5403038|NCT00076479|Stroke|stroke
5403039|NCT00076479|Healthy Volunteer|healthy volunteer
5403040|NCT00076479|HV|hv
5403041|NCT00076466|Brain Excitability|brain excitability
5403042|NCT00076466|Reaction Time|reaction time
5403043|NCT00076466|Plasticity|plasticity
5403044|NCT00076466|Motor Evoked Potential|motor evoked potential
5403045|NCT00076466|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
5403046|NCT00076466|Healthy Volunteer|healthy volunteer
5403047|NCT00076466|HV|hv
5403048|NCT00076388|Non-Small-Cell Lung Cancer|non-small-cell lung cancer
5403049|NCT00076375|Atopic Dermatitis|atopic dermatitis
5403050|NCT00076375|Eczema|eczema
5403051|NCT00003541|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5403052|NCT00003541|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5403053|NCT00003418|stage I breast cancer|stage i breast cancer
5403054|NCT00003418|stage II breast cancer|stage ii breast cancer
5403055|NCT00003418|stage III breast cancer|stage iii breast cancer
5403056|NCT00003364|limited stage small cell lung cancer|limited stage small cell lung cancer
5403057|NCT00003298|stage II gastric cancer|stage ii gastric cancer
5403058|NCT00003298|stage III gastric cancer|stage iii gastric cancer
5403059|NCT00003298|stage IV gastric cancer|stage iv gastric cancer
5403060|NCT00003298|adenocarcinoma of the stomach|adenocarcinoma of the stomach
5403061|NCT00003287|stage IV colon cancer|stage iv colon cancer
5403062|NCT00003287|stage IV rectal cancer|stage iv rectal cancer
5403063|NCT00003287|recurrent colon cancer|recurrent colon cancer
5403064|NCT00003287|recurrent rectal cancer|recurrent rectal cancer
5403065|NCT00003287|adenocarcinoma of the colon|adenocarcinoma of the colon
5403066|NCT00003287|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5403067|NCT00076427|Immunity|immunity
5403068|NCT00076427|Liver|liver
5403069|NCT00076427|Apheresis|apheresis
5403070|NCT00076427|Cytokine|cytokine
5403071|NCT00076427|Virology|virology
5403072|NCT00076427|Hepatitis C|hepatitis c
5403073|NCT00076427|HCV|hcv
5429868|NCT00037115|nerve|nerve
5403074|NCT00076427|Hepatitis C co-infection|hepatitis c co-infection
5403075|NCT00076414|Endothelial Function|endothelial function
5403076|NCT00076414|Lopinavir/Ritonavir|lopinavir/ritonavir
5403077|NCT00076414|HIV|hiv
5403078|NCT00076414|Blood Flow Studies|blood flow studies
5403079|NCT00076414|Flow-Mediated Vasodilatation|flow-mediated vasodilatation
5403080|NCT00076414|Healthy Volunteer|healthy volunteer
5403081|NCT00076414|HV|hv
5403082|NCT00076349|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
5403083|NCT00076349|NHL|nhl
5403084|NCT00076349|Rituxan|rituxan
5403085|NCT00076349|Mantle Cell|mantle cell
5403086|NCT00076349|mabs|mabs
5403087|NCT00003137|stage IV gastric cancer|stage iv gastric cancer
5403088|NCT00003137|stage IV esophageal cancer|stage iv esophageal cancer
5403089|NCT00003137|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
5403090|NCT00003137|intestinal adenocarcinoma of the stomach|intestinal adenocarcinoma of the stomach
5403091|NCT00003137|diffuse adenocarcinoma of the stomach|diffuse adenocarcinoma of the stomach
5403092|NCT00003137|mixed adenocarcinoma of the stomach|mixed adenocarcinoma of the stomach
5403093|NCT00003007|refractory multiple myeloma|refractory multiple myeloma
5403094|NCT00003007|stage III multiple myeloma|stage iii multiple myeloma
5403095|NCT00002840|recurrent adult brain tumor|recurrent adult brain tumor
5403096|NCT00002840|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
5403097|NCT00002840|adult mixed glioma|adult mixed glioma
5403098|NCT00002817|stage III melanoma|stage iii melanoma
5403099|NCT00002817|stage IV melanoma|stage iv melanoma
5403100|NCT00002817|recurrent melanoma|recurrent melanoma
5403101|NCT00002748|recurrent neuroblastoma|recurrent neuroblastoma
5403102|NCT00076323|G6PD|g6pd
5403103|NCT00076323|Favism|favism
5403104|NCT00076323|G6PD Deficiency|g6pd deficiency
5403105|NCT00076323|hemolysis|hemolysis
5403106|NCT00076323|drug reaction|drug reaction
5403107|NCT00076323|drug-induced hemolysis|drug-induced hemolysis
5403108|NCT00076310|Head and Neck Cancer|head and neck cancer
5403109|NCT00076310|Squamous Cell Cancer|squamous cell cancer
5403110|NCT00076310|OSI-774|osi-774
5403111|NCT00076310|Cisplatin|cisplatin
5403112|NCT00076310|Platinol®-AQ|platinol®-aq
5403113|NCT00076310|Platinol®|platinol®
5403114|NCT00076310|CDDP|cddp
5403115|NCT00076310|Docetaxel|docetaxel
5403116|NCT00076310|Taxotere|taxotere
5403117|NCT00076310|Tarceva|tarceva
5403118|NCT00076310|HNSCC|hnscc
5403119|NCT00076310|Erlotinib Hydrochloride|erlotinib hydrochloride
5403120|NCT00076284|CCR5 Antagonist|ccr5 antagonist
5403121|NCT00076284|Coreceptor Inhibitor|coreceptor inhibitor
5403122|NCT00076284|Fusion Inhibitor|fusion inhibitor
5403123|NCT00076284|Entry Inhibitor|entry inhibitor
5403124|NCT00076284|Antiretroviral|antiretroviral
5403125|NCT00076284|HIV|hiv
5403126|NCT00076271|Strabismus|strabismus
5403127|NCT00076271|Cataract, Pediatric|cataract, pediatric
5403128|NCT00076271|Optic Nerve Anomaly|optic nerve anomaly
5403129|NCT00076271|Coloboma|coloboma
5403130|NCT00076271|Evaluation and Treatment|evaluation and treatment
5403131|NCT00076271|Pediatric Ophthalmology|pediatric ophthalmology
5403132|NCT00076271|Genetic Eye Disease|genetic eye disease
5403133|NCT00076271|Nystagmus|nystagmus
5403134|NCT00076271|Pediatric Eye Disease|pediatric eye disease
5403135|NCT00076271|Developmental Eye Condition|developmental eye condition
5403136|NCT00076271|Cataract|cataract
5403137|NCT00076271|Juvenile Glaucoma|juvenile glaucoma
5403138|NCT00076271|Eye Movement Disorder|eye movement disorder
5403139|NCT00076258|Exercise therapy|exercise therapy
5403140|NCT00076258|Complementary Therapies|complementary therapies
5403141|NCT00076245|Phototherapy|phototherapy
5403142|NCT00076219|Acute Renal Failure|acute renal failure
5403143|NCT00076219|Renal Replacement Therapy|renal replacement therapy
5403144|NCT00076219|multi-site randomization trial|multi-site randomization trial
5403145|NCT00076219|Hemodialysis|hemodialysis
5403146|NCT00076219|Hemofiltration|hemofiltration
5403147|NCT00076219|Critical Illness|critical illness
5403148|NCT00076219|Hemodiafiltration|hemodiafiltration
5403149|NCT00076232|HIV Seronegativity|hiv seronegativity
5403150|NCT00076154|ALS|als
5403151|NCT00076141|relatively healthy male|relatively healthy male
5403152|NCT00076115|Bipolar|bipolar
5403153|NCT00076115|Mania|mania
5403154|NCT00076115|Manic|manic
5403155|NCT00076115|Depressive|depressive
5403156|NCT00076115|Manic Depressive|manic depressive
5403157|NCT00076115|Bipolar mania|bipolar mania
5403158|NCT00076115|risperidone|risperidone
5403159|NCT00076115|adolescents|adolescents
5403160|NCT00076115|children|children
5403161|NCT00076180|cytotoxic activity against T-LGL cells|cytotoxic activity against t-lgl cells
5403162|NCT00076180|chronic lymphoproliferative disorder|chronic lymphoproliferative disorder
5403163|NCT00076180|T-LGL Leukemia|t-lgl leukemia
5403164|NCT00076180|Natural Killer Cells|natural killer cells
5403165|NCT00076180|Leukemia|leukemia
5403166|NCT00076180|Lymphocytic Leukemia|lymphocytic leukemia
5403167|NCT00076180|T-LGL|t-lgl
5403168|NCT00076089|Roflumilast|roflumilast
5403169|NCT00076089|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
5403170|NCT00076089|COPD|copd
5403171|NCT00076076|Roflumilast|roflumilast
5403172|NCT00076076|Asthma|asthma
5403173|NCT00033735|recurrent pancreatic cancer|recurrent pancreatic cancer
5403174|NCT00033735|duct cell adenocarcinoma of the pancreas|duct cell adenocarcinoma of the pancreas
5403175|NCT00027508|advanced malignant mesothelioma|advanced malignant mesothelioma
5403176|NCT00027508|recurrent malignant mesothelioma|recurrent malignant mesothelioma
5403177|NCT00024401|stage IV colon cancer|stage iv colon cancer
5403178|NCT00024401|stage IV rectal cancer|stage iv rectal cancer
5403179|NCT00024401|recurrent colon cancer|recurrent colon cancer
5403180|NCT00024401|recurrent rectal cancer|recurrent rectal cancer
5403181|NCT00002566|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
5403182|NCT00002566|extragonadal germ cell tumor|extragonadal germ cell tumor
5403183|NCT00076102|Side Effect|side effect
5403184|NCT00076102|Oral Administration|oral administration
5403185|NCT00076102|Nerve Sheath Tumor|nerve sheath tumor
5403186|NCT00076102|Antifibrotic Agent|antifibrotic agent
5403187|NCT00076102|Volumetric Tumor Measurement|volumetric tumor measurement
5403188|NCT00076102|Plexiform Neurofibroma|plexiform neurofibroma
5403189|NCT00076102|Neurofibromatosis Type 1|neurofibromatosis type 1
5403190|NCT00076102|Volumetric MRI Analysis|volumetric mri analysis
5403191|NCT00076102|Time to Progression|time to progression
5403192|NCT00076102|NF1|nf1
5403193|NCT00076063|HIV Seronegativity|hiv seronegativity
5403194|NCT00076063|ALVAC-HIV vCP1452|alvac-hiv vcp1452
5403195|NCT00076063|ALVAC Vaccine|alvac vaccine
5403196|NCT00076063|HIV-1|hiv-1
5403197|NCT00076063|Normal Values|normal values
5403198|NCT00076063|HIV Preventive Vaccine|hiv preventive vaccine
5403199|NCT00076037|HIV Preventive Vaccine|hiv preventive vaccine
5403200|NCT00076037|Granulocyte-Macrophage Colony-Stimulating Factor|granulocyte-macrophage colony-stimulating factor
5403201|NCT00076037|AIDS Vaccines|aids vaccines
5403202|NCT00076037|HIV-1|hiv-1
5403203|NCT00076037|HIV Seronegativity|hiv seronegativity
5403204|NCT00076037|Injections, Intramuscular|injections, intramuscular
5403205|NCT00076037|RC529|rc529
5403206|NCT00076037|Epitopes|epitopes
5403207|NCT00076037|T-Lymphocytes, Cytotoxic|t-lymphocytes, cytotoxic
5403208|NCT00076024|metastatic breast cancer|metastatic breast cancer
5403209|NCT00075998|Idiopathic|idiopathic
5403210|NCT00075998|Pulmonary|pulmonary
5403211|NCT00075998|Fibrosis|fibrosis
5403212|NCT00075998|IPF|ipf
5403213|NCT00075998|Lung|lung
5403214|NCT00075998|Interferon|interferon
5403215|NCT00075998|Gamma|gamma
5403216|NCT00075998|Actimmune|actimmune
5403217|NCT00075998|INSPIRE|inspire
5403218|NCT00075998|InterMune|intermune
5403219|NCT00075959|Stroke|stroke
5403220|NCT00075959|cerebral vascular accident|cerebral vascular accident
5403221|NCT00075959|CVA|cva
5403222|NCT00075959|Hemorrhage|hemorrhage
5403223|NCT00075959|Intracerebral Hemorrhage (ICH)|intracerebral hemorrhage (ich)
5403224|NCT00075959|Brain Attack|brain attack
5403225|NCT00075959|Cataplexy|cataplexy
5403226|NCT00075946|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5403227|NCT00075946|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5403228|NCT00075946|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5403229|NCT00075946|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5403230|NCT00075946|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5403231|NCT00075946|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5403232|NCT00075946|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5403233|NCT00075946|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5403234|NCT00075946|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5403235|NCT00075946|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5403236|NCT00075946|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5403237|NCT00024388|stage III renal cell cancer|stage iii renal cell cancer
5403238|NCT00024388|stage IV renal cell cancer|stage iv renal cell cancer
5403239|NCT00024388|recurrent renal cell cancer|recurrent renal cell cancer
5403240|NCT00022347|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5403241|NCT00022347|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5403242|NCT00022347|ovarian undifferentiated adenocarcinoma|ovarian undifferentiated adenocarcinoma
5403243|NCT00022347|ovarian mixed epithelial carcinoma|ovarian mixed epithelial carcinoma
5403244|NCT00022347|ovarian serous cystadenocarcinoma|ovarian serous cystadenocarcinoma
5403245|NCT00022347|ovarian mucinous cystadenocarcinoma|ovarian mucinous cystadenocarcinoma
5403246|NCT00022347|ovarian endometrioid adenocarcinoma|ovarian endometrioid adenocarcinoma
5403247|NCT00022347|ovarian clear cell cystadenocarcinoma|ovarian clear cell cystadenocarcinoma
5403248|NCT00022347|fallopian tube cancer|fallopian tube cancer
5403249|NCT00022347|primary peritoneal cavity cancer|primary peritoneal cavity cancer
5403250|NCT00022321|refractory anemia|refractory anemia
5403251|NCT00022321|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
5403252|NCT00022321|refractory anemia with excess blasts|refractory anemia with excess blasts
5403253|NCT00022321|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
5403254|NCT00022321|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5403255|NCT00021333|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5403256|NCT00021333|recurrent small cell lung cancer|recurrent small cell lung cancer
5403257|NCT00021333|recurrent thyroid cancer|recurrent thyroid cancer
5403258|NCT00021333|recurrent salivary gland cancer|recurrent salivary gland cancer
5403259|NCT00021333|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
5403260|NCT00021333|recurrent basal cell carcinoma of the lip|recurrent basal cell carcinoma of the lip
5403261|NCT00021333|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
5403262|NCT00021333|recurrent mucoepidermoid carcinoma of the oral cavity|recurrent mucoepidermoid carcinoma of the oral cavity
5403263|NCT00021333|recurrent adenoid cystic carcinoma of the oral cavity|recurrent adenoid cystic carcinoma of the oral cavity
5403264|NCT00021333|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
5403265|NCT00021333|recurrent lymphoepithelioma of the oropharynx|recurrent lymphoepithelioma of the oropharynx
5403266|NCT00021333|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
5403267|NCT00021333|recurrent lymphoepithelioma of the nasopharynx|recurrent lymphoepithelioma of the nasopharynx
5403268|NCT00021333|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
5403269|NCT00021333|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
5403270|NCT00021333|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
5403271|NCT00021333|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
5403272|NCT00021333|recurrent inverted papilloma of the paranasal sinus and nasal cavity|recurrent inverted papilloma of the paranasal sinus and nasal cavity
5403273|NCT00021333|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity
5403274|NCT00021333|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity
5403275|NCT00021307|recurrent adult brain tumor|recurrent adult brain tumor
5403276|NCT00021307|adult glioblastoma|adult glioblastoma
5403277|NCT00021307|adult giant cell glioblastoma|adult giant cell glioblastoma
5403278|NCT00021307|adult gliosarcoma|adult gliosarcoma
5403279|NCT00075907|Acute Infection|acute infection
5403280|NCT00075907|Treatment Experienced|treatment experienced
5403281|NCT00075907|Treatment Naive|treatment naive
5403282|NCT00075894|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
5403283|NCT00075894|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5403284|NCT00075894|adult glioblastoma|adult glioblastoma
5403285|NCT00075894|recurrent adult brain tumor|recurrent adult brain tumor
5403286|NCT00075894|adult giant cell glioblastoma|adult giant cell glioblastoma
5403287|NCT00075894|adult gliosarcoma|adult gliosarcoma
5403288|NCT00075868|radiation enteritis|radiation enteritis
5403289|NCT00075868|drug/agent toxicity by tissue/organ|drug/agent toxicity by tissue/organ
5403290|NCT00075868|stage I rectal cancer|stage i rectal cancer
5403291|NCT00075868|stage II rectal cancer|stage ii rectal cancer
5403292|NCT00075868|stage III rectal cancer|stage iii rectal cancer
5403293|NCT00075868|stage IIIA anal cancer|stage iiia anal cancer
5403294|NCT00075868|stage IIIB anal cancer|stage iiib anal cancer
5403295|NCT00075868|recurrent anal cancer|recurrent anal cancer
5403296|NCT00075868|stage I anal cancer|stage i anal cancer
5403297|NCT00075868|stage II anal cancer|stage ii anal cancer
5403298|NCT00075868|recurrent rectal cancer|recurrent rectal cancer
5403299|NCT00075855|sexual dysfunction|sexual dysfunction
5403300|NCT00075855|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5403301|NCT00075855|sexuality and reproductive issues|sexuality and reproductive issues
5403302|NCT00075855|cancer survivor|cancer survivor
5403303|NCT00075842|sleep disorders|sleep disorders
5403304|NCT00075842|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5403305|NCT00075842|fatigue|fatigue
5403306|NCT00075829|Stage II Multiple Myeloma|stage ii multiple myeloma
5403307|NCT00075829|Stage III Multiple Myeloma|stage iii multiple myeloma
5403308|NCT00075829|Refractory Plasma Cell Neoplasm|refractory plasma cell neoplasm
5403309|NCT00075803|Myelodysplastic and Myeloproliferative Diseases|myelodysplastic and myeloproliferative diseases
5403310|NCT00075777|recurrent Kaposi sarcoma|recurrent kaposi sarcoma
5403311|NCT00075777|AIDS-related Kaposi sarcoma|aids-related kaposi sarcoma
5403312|NCT00075764|stage IV breast cancer|stage iv breast cancer
5403313|NCT00075764|recurrent breast cancer|recurrent breast cancer
5403314|NCT00075738|stage IV esophageal cancer|stage iv esophageal cancer
5403315|NCT00075738|recurrent esophageal cancer|recurrent esophageal cancer
5403316|NCT00075725|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
5403317|NCT00075725|B-cell childhood acute lymphoblastic leukemia|b-cell childhood acute lymphoblastic leukemia
5403318|NCT00075725|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
5403319|NCT00075725|B-cell adult acute lymphoblastic leukemia|b-cell adult acute lymphoblastic leukemia
5403320|NCT00075712|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5403321|NCT00075712|stage IIIA fallopian tube cancer|stage iiia fallopian tube cancer
5403322|NCT00075712|stage IIIB fallopian tube cancer|stage iiib fallopian tube cancer
5403323|NCT00075712|stage IIIC fallopian tube cancer|stage iiic fallopian tube cancer
5403324|NCT00075712|stage IV fallopian tube cancer|stage iv fallopian tube cancer
5403325|NCT00075712|stage IIIA primary peritoneal cavity cancer|stage iiia primary peritoneal cavity cancer
5403326|NCT00075712|stage IIIB primary peritoneal cavity cancer|stage iiib primary peritoneal cavity cancer
5403327|NCT00075712|stage IIIC primary peritoneal cavity cancer|stage iiic primary peritoneal cavity cancer
5403328|NCT00075712|stage IV primary peritoneal cavity cancer|stage iv primary peritoneal cavity cancer
5403329|NCT00075712|stage IIIA ovarian epithelial cancer|stage iiia ovarian epithelial cancer
5403330|NCT00075712|stage IIIB ovarian epithelial cancer|stage iiib ovarian epithelial cancer
5403331|NCT00075712|stage IIIC ovarian epithelial cancer|stage iiic ovarian epithelial cancer
5403332|NCT00075699|epithelial mesothelioma|epithelial mesothelioma
5403333|NCT00075699|localized malignant mesothelioma|localized malignant mesothelioma
5403334|NCT00075699|advanced malignant mesothelioma|advanced malignant mesothelioma
5403335|NCT00075686|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
5403336|NCT00075686|stage III pancreatic cancer|stage iii pancreatic cancer
5403337|NCT00075686|stage IV pancreatic cancer|stage iv pancreatic cancer
5403338|NCT00075920|Heart|heart
5403339|NCT00075920|Function|function
5403340|NCT00075920|Ultrasound|ultrasound
5403341|NCT00075920|MRI|mri
5403342|NCT00075920|Left Ventricle|left ventricle
5403343|NCT00075920|Healthy Volunteer|healthy volunteer
5403344|NCT00075920|HV|hv
5403345|NCT00075920|Heart Disease|heart disease
5403346|NCT00075673|recurrent breast cancer|recurrent breast cancer
5403347|NCT00075673|stage IV breast cancer|stage iv breast cancer
5403348|NCT00075660|recurrent renal cell cancer|recurrent renal cell cancer
5403349|NCT00075660|stage III renal cell cancer|stage iii renal cell cancer
5403350|NCT00075660|stage IV renal cell cancer|stage iv renal cell cancer
5403351|NCT00075621|primary systemic amyloidosis|primary systemic amyloidosis
5403352|NCT00075608|primary systemic amyloidosis|primary systemic amyloidosis
5403353|NCT00075595|stage IV colon cancer|stage iv colon cancer
5403354|NCT00075595|stage IV rectal cancer|stage iv rectal cancer
5403355|NCT00075595|recurrent colon cancer|recurrent colon cancer
5403356|NCT00075595|recurrent rectal cancer|recurrent rectal cancer
5403357|NCT00075595|adenocarcinoma of the colon|adenocarcinoma of the colon
5403358|NCT00075595|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5403359|NCT00075569|cervical cancer|cervical cancer
5403360|NCT00075569|cervical intraepithelial neoplasia grade 3|cervical intraepithelial neoplasia grade 3
5403361|NCT00075556|stage III colon cancer|stage iii colon cancer
5403362|NCT00075556|stage IV colon cancer|stage iv colon cancer
5403363|NCT00075556|stage III rectal cancer|stage iii rectal cancer
5403364|NCT00075556|stage IV rectal cancer|stage iv rectal cancer
5403365|NCT00075556|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5403366|NCT00075556|adenocarcinoma of the colon|adenocarcinoma of the colon
5403367|NCT00075543|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5403368|NCT00075543|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5403369|NCT00075543|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5403370|NCT00075517|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5403371|NCT00075517|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5403372|NCT00075517|adenocarcinoma of the lung|adenocarcinoma of the lung
5403373|NCT00075517|large cell lung cancer|large cell lung cancer
5403374|NCT00075517|squamous cell lung cancer|squamous cell lung cancer
5403375|NCT00075465|adenocarcinoma of the stomach|adenocarcinoma of the stomach
5403376|NCT00075465|stage III gastric cancer|stage iii gastric cancer
5403377|NCT00075465|stage IV gastric cancer|stage iv gastric cancer
5403378|NCT00075452|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
5403379|NCT00075452|stage II pancreatic cancer|stage ii pancreatic cancer
5403380|NCT00075452|stage III pancreatic cancer|stage iii pancreatic cancer
5403381|NCT00075452|stage IV pancreatic cancer|stage iv pancreatic cancer
5403382|NCT00075426|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5403383|NCT00075426|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5403384|NCT00075426|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5403385|NCT00075426|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5403386|NCT00075413|stage IIIB breast cancer|stage iiib breast cancer
5403387|NCT00075413|stage IIIC breast cancer|stage iiic breast cancer
5403388|NCT00075413|stage IV breast cancer|stage iv breast cancer
5403389|NCT00075413|recurrent breast cancer|recurrent breast cancer
5403390|NCT00075413|stage IIIA breast cancer|stage iiia breast cancer
5403391|NCT00075374|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5403392|NCT00075374|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5403393|NCT00075374|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5403394|NCT00075348|renal cell carcinoma|renal cell carcinoma
5403395|NCT00075348|von Hippel-Lindau syndrome|von hippel-lindau syndrome
5403396|NCT00075335|Hematopoietic Stem Cells|hematopoietic stem cells
5403397|NCT00075335|Mobilization|mobilization
5403398|NCT00075335|Alloreactivity|alloreactivity
5403399|NCT00075335|T Cell Polarization|t cell polarization
5403400|NCT00075335|Dendritic Cells|dendritic cells
5403401|NCT00075335|Plerixafor|plerixafor
5403402|NCT00075335|Mozobil|mozobil
5403403|NCT00075335|Healthy Volunteer (HV)|healthy volunteer (hv)
5403404|NCT00075296|Major Depressive Disorder|major depressive disorder
5403405|NCT00075296|Bipolar Disorder|bipolar disorder
5403406|NCT00075296|Negative Feedback|negative feedback
5403407|NCT00075296|Cognitive Performance|cognitive performance
5403408|NCT00075296|Negative Affect|negative affect
5403409|NCT00075296|Depression|depression
5403410|NCT00075296|Major Depression|major depression
5403411|NCT00075296|MDD|mdd
5403412|NCT00075296|Healthy Volunteer|healthy volunteer
5403413|NCT00075296|HV|hv
5403414|NCT00075283|Physical Therapy|physical therapy
5403415|NCT00075283|Locomotion therapy|locomotion therapy
5403416|NCT00075283|Gait training|gait training
5403417|NCT00075283|Stroke|stroke
5403418|NCT00075283|Robotics|robotics
5403419|NCT00075283|Rehabilitation|rehabilitation
5403420|NCT00075283|Treadmill|treadmill
5403421|NCT00075283|Hemiparetic stroke|hemiparetic stroke
5403422|NCT00075283|Unilateral brain lesion|unilateral brain lesion
5403423|NCT00075270|metastatic breast cancer|metastatic breast cancer
5403424|NCT00075270|ErbB1|erbb1
5403425|NCT00075270|kinase inhibitor|kinase inhibitor
5403426|NCT00075270|ErbB2|erbb2
5403427|NCT00075270|EGFR|egfr
5403428|NCT00075270|lapatinib|lapatinib
5403429|NCT00075270|Her2-neu|her2-neu
5403430|NCT00075231|Treatment Naive|treatment naive
5403431|NCT00075153|ADOLESCENCE|adolescence
5403432|NCT00075153|HIV INFECTION|hiv infection
5403433|NCT00075153|PEDIATRIC AIDS|pediatric aids
5403434|NCT00075153|QUALITY OF LIFE|quality of life
5403435|NCT00075153|HIV|hiv
5403436|NCT00020787|stage IV gastric cancer|stage iv gastric cancer
5403437|NCT00020787|recurrent gastric cancer|recurrent gastric cancer
5403438|NCT00020787|stage IV esophageal cancer|stage iv esophageal cancer
5403439|NCT00020787|recurrent esophageal cancer|recurrent esophageal cancer
5403440|NCT00020787|adenocarcinoma of the stomach|adenocarcinoma of the stomach
5403441|NCT00020787|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
5403442|NCT00017576|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5403443|NCT00017576|stage IV prostate cancer|stage iv prostate cancer
5403444|NCT00017576|recurrent prostate cancer|recurrent prostate cancer
5403445|NCT00017537|stage IV breast cancer|stage iv breast cancer
5403446|NCT00017537|recurrent breast cancer|recurrent breast cancer
5403447|NCT00017537|stage IV gastric cancer|stage iv gastric cancer
5403448|NCT00017537|recurrent gastric cancer|recurrent gastric cancer
5403449|NCT00017537|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5403450|NCT00017537|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5403451|NCT00017537|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5403452|NCT00017537|adenocarcinoma of the stomach|adenocarcinoma of the stomach
5403453|NCT00017537|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5403454|NCT00017537|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5403455|NCT00017433|refractory multiple myeloma|refractory multiple myeloma
5403456|NCT00017433|stage II multiple myeloma|stage ii multiple myeloma
5403457|NCT00017433|stage III multiple myeloma|stage iii multiple myeloma
5403458|NCT00075244|Lysosomes|lysosomes
5403459|NCT00075244|Storage|storage
5403460|NCT00075244|Glycolipid|glycolipid
5403461|NCT00075244|Fabry Disease|fabry disease
5403462|NCT00075244|Stroke|stroke
5403463|NCT00017082|stage IV colon cancer|stage iv colon cancer
5403464|NCT00017082|stage IV rectal cancer|stage iv rectal cancer
5403465|NCT00017082|recurrent colon cancer|recurrent colon cancer
5403466|NCT00017082|recurrent rectal cancer|recurrent rectal cancer
5403467|NCT00017082|adenocarcinoma of the colon|adenocarcinoma of the colon
5403468|NCT00017082|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5403469|NCT00016237|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5403470|NCT00016237|squamous cell lung cancer|squamous cell lung cancer
5403471|NCT00016237|stage IV renal cell cancer|stage iv renal cell cancer
5403472|NCT00016237|recurrent renal cell cancer|recurrent renal cell cancer
5403473|NCT00016237|extensive stage small cell lung cancer|extensive stage small cell lung cancer
5403474|NCT00016237|recurrent small cell lung cancer|recurrent small cell lung cancer
5403475|NCT00016237|recurrent bladder cancer|recurrent bladder cancer
5403476|NCT00016237|stage IV bladder cancer|stage iv bladder cancer
5403477|NCT00016237|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5403478|NCT00016237|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
5403479|NCT00016237|squamous cell carcinoma of the bladder|squamous cell carcinoma of the bladder
5403480|NCT00016198|stage IV colon cancer|stage iv colon cancer
5403481|NCT00016198|stage IV rectal cancer|stage iv rectal cancer
5403482|NCT00016198|recurrent colon cancer|recurrent colon cancer
5403483|NCT00016198|recurrent rectal cancer|recurrent rectal cancer
5403484|NCT00016198|adenocarcinoma of the colon|adenocarcinoma of the colon
5403485|NCT00016198|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5403486|NCT00014404|lip and oral cavity cancer|lip and oral cavity cancer
5403487|NCT00014287|stage 0 bladder cancer|stage 0 bladder cancer
5403488|NCT00014287|stage I bladder cancer|stage i bladder cancer
5403489|NCT00014287|recurrent bladder cancer|recurrent bladder cancer
5403490|NCT00075205|Alcohol Consumption|alcohol consumption
5403491|NCT00075205|Alcohol Treatment|alcohol treatment
5403492|NCT00075205|Medication Trial|medication trial
5403493|NCT00075205|Craving|craving
5403494|NCT00075205|Cannabinoids|cannabinoids
5403495|NCT00075205|CB 1 Receptor Antagonist|cb 1 receptor antagonist
5403496|NCT00075205|SR141716|sr141716
5403497|NCT00075205|Alcoholism|alcoholism
5403498|NCT00075179|Pulmonary hypertension|pulmonary hypertension
5403499|NCT00075179|cancer|cancer
5403500|NCT00075179|lung cancer|lung cancer
5403501|NCT00075179|lung disease|lung disease
5429869|NCT00037115|lesions|lesions
5403502|NCT00075179|cardiothoracic surgery|cardiothoracic surgery
5403503|NCT00075179|Nesiritide|nesiritide
5403504|NCT00075179|Natrecor|natrecor
5403505|NCT00075179|CV Surgery|cv surgery
5403506|NCT00075179|Lung Tumor|lung tumor
5403507|NCT00075166|Stereotactic|stereotactic
5403508|NCT00075166|Carcinoma|carcinoma
5403509|NCT00075166|Melanoma|melanoma
5403510|NCT00075166|Surgical Resection|surgical resection
5403511|NCT00075166|Metastases|metastases
5403512|NCT00075166|Metastatic Brain Tumor|metastatic brain tumor
5403513|NCT00075166|Surgery|surgery
5403514|NCT00075166|Radiosurgery|radiosurgery
5403515|NCT00075166|Treatment|treatment
5403516|NCT00075140|Patient Care Management|patient care management
5403517|NCT00075140|Family|family
5403518|NCT00075140|Huntington's Disease|huntington's disease
5403519|NCT00075114|Self Care|self care
5403520|NCT00075114|Behavior Modification|behavior modification
5403521|NCT00075101|Drug Adverse Effect|drug adverse effect
5403522|NCT00075101|Pediatric Cancer|pediatric cancer
5403523|NCT00075088|Telemedicine|telemedicine
5403524|NCT00075088|Emergency Care|emergency care
5403526|NCT00075075|Infliximab|infliximab
5403527|NCT00075075|Scleritis|scleritis
5403528|NCT00075075|Intraocular Inflammatory Disease|intraocular inflammatory disease
5403529|NCT00075075|Corticosteroids|corticosteroids
5403530|NCT00075075|Immunosuppressives|immunosuppressives
5403531|NCT00075049|malaria|malaria
5403532|NCT00014183|stage IV renal cell cancer|stage iv renal cell cancer
5403533|NCT00014183|recurrent renal cell cancer|recurrent renal cell cancer
5403534|NCT00012116|tumors metastatic to brain|tumors metastatic to brain
5403535|NCT00009893|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
5403536|NCT00009893|advanced adult primary liver cancer|advanced adult primary liver cancer
5403537|NCT00009893|recurrent adult primary liver cancer|recurrent adult primary liver cancer
5403538|NCT00009893|unresectable gallbladder cancer|unresectable gallbladder cancer
5403539|NCT00009893|recurrent gallbladder cancer|recurrent gallbladder cancer
5403540|NCT00009893|unresectable extrahepatic bile duct cancer|unresectable extrahepatic bile duct cancer
5403541|NCT00009893|recurrent extrahepatic bile duct cancer|recurrent extrahepatic bile duct cancer
5403542|NCT00075036|Health Disparities|health disparities
5403543|NCT00075036|Transplantation|transplantation
5403544|NCT00075036|Trust|trust
5403545|NCT00075036|Interview|interview
5403546|NCT00075036|Ethnic Bias|ethnic bias
5403547|NCT00075023|Stomatitis|stomatitis
5403548|NCT00075023|Oropharyngeal pain|oropharyngeal pain
5403549|NCT00075023|TNF-alpha|tnf-alpha
5403550|NCT00075023|Allogeneic hematopoietic stem cell transplant|allogeneic hematopoietic stem cell transplant
5403551|NCT00075023|Inflammation|inflammation
5403552|NCT00075023|Thalidomide|thalidomide
5403553|NCT00075023|Oral chronic graft-versus-host disease|oral chronic graft-versus-host disease
5403554|NCT00075010|Relapsed/Refractory Leukemia|relapsed/refractory leukemia
5403555|NCT00075010|Myelodysplastic Syndromes|myelodysplastic syndromes
5403556|NCT00074997|Gene Therapy|gene therapy
5403557|NCT00074997|Anti-HIV-1 Ribozyme|anti-hiv-1 ribozyme
5403558|NCT00074997|OZ1|oz1
5403559|NCT00074997|HIV-1 Infections|hiv-1 infections
5403560|NCT00009698|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5403561|NCT00009698|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
5403562|NCT00009698|childhood acute myeloblastic leukemia without maturation (M1)|childhood acute myeloblastic leukemia without maturation (m1)
5403563|NCT00009698|childhood acute myeloblastic leukemia with maturation (M2)|childhood acute myeloblastic leukemia with maturation (m2)
5403564|NCT00006481|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
5403565|NCT00006481|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5403566|NCT00006481|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
5403567|NCT00006481|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5403568|NCT00006481|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
5403569|NCT00006481|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5403570|NCT00006481|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
5403571|NCT00006481|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5403572|NCT00006481|skin reactions secondary to radiation therapy|skin reactions secondary to radiation therapy
5403573|NCT00006480|disseminated neuroblastoma|disseminated neuroblastoma
5403574|NCT00006480|recurrent neuroblastoma|recurrent neuroblastoma
5403575|NCT00074984|a-Galactosidase A|a-galactosidase a
5403576|NCT00074984|aGAL|agal
5403577|NCT00074984|r-haGAL|r-hagal
5403578|NCT00074984|Fabry|fabry
5403579|NCT00074984|GL-3|gl-3
5403580|NCT00074984|Fabrazyme|fabrazyme
5403581|NCT00074971|a-Galactosidase A|a-galactosidase a
5403582|NCT00074971|aGAL|agal
5403583|NCT00074971|r-haGAL|r-hagal
5403584|NCT00074971|Fabry|fabry
5403585|NCT00074971|GL-3|gl-3
5403586|NCT00074971|Fabrazyme|fabrazyme
5403587|NCT00074958|a-Galactosidase A|a-galactosidase a
5403588|NCT00074958|aGal|agal
5403589|NCT00074958|r-haGAL|r-hagal
5403590|NCT00074958|Fabry|fabry
5403591|NCT00074958|GL-3|gl-3
5403593|NCT00074932|Glycogen Storage Disease Type II|glycogen storage disease type ii
5403594|NCT00074932|GSD-II|gsd-ii
5403595|NCT00074932|Pompe Disease|pompe disease
5403596|NCT00074932|Acid Maltase Deficiency Disease|acid maltase deficiency disease
5403597|NCT00074919|Glycogen Storage Disease Type II|glycogen storage disease type ii
5403598|NCT00074919|GSD-II|gsd-ii
5403599|NCT00074919|Pompe Disease|pompe disease
5403600|NCT00074919|Acid Maltase Deficiency Disease|acid maltase deficiency disease
5403601|NCT00074906|Aspiration of gastric contents|aspiration of gastric contents
5403602|NCT00074945|Obesity|obesity
5403603|NCT00074945|Resting Energy Expenditure|resting energy expenditure
5403604|NCT00074945|Metabolic Rate|metabolic rate
5403605|NCT00074945|Visceral Fat|visceral fat
5403606|NCT00074945|Body Fat Distribution|body fat distribution
5403607|NCT00074893|Repetitive Strain Injuries|repetitive strain injuries
5403608|NCT00074893|Vibration Damping|vibration damping
5403609|NCT00074893|Protective Brace|protective brace
5403610|NCT00074893|Piezoelectric|piezoelectric
5403611|NCT00074893|SmartWear|smartwear
5403612|NCT00074841|MALARIA|malaria
5403613|NCT00074841|INDIA|india
5403614|NCT00074841|CHLOROQUINE|chloroquine
5403615|NCT00074841|PLASMODIUM FALCIPARUM|plasmodium falciparum
5403616|NCT00074841|SULFADOXINE-PYRIMETHAMINE|sulfadoxine-pyrimethamine
5403617|NCT00006384|stage IV renal cell cancer|stage iv renal cell cancer
5403618|NCT00006384|recurrent renal cell cancer|recurrent renal cell cancer
5403619|NCT00006353|adult glioblastoma|adult glioblastoma
5403620|NCT00006353|adult giant cell glioblastoma|adult giant cell glioblastoma
5403621|NCT00006353|adult gliosarcoma|adult gliosarcoma
5403622|NCT00006247|childhood craniopharyngioma|childhood craniopharyngioma
5403623|NCT00006247|childhood central nervous system germ cell tumor|childhood central nervous system germ cell tumor
5403624|NCT00006247|childhood oligodendroglioma|childhood oligodendroglioma
5403625|NCT00006247|childhood choroid plexus tumor|childhood choroid plexus tumor
5403626|NCT00006247|childhood grade I meningioma|childhood grade i meningioma
5403627|NCT00006247|childhood grade II meningioma|childhood grade ii meningioma
5403628|NCT00006247|childhood grade III meningioma|childhood grade iii meningioma
5403629|NCT00006247|recurrent childhood cerebellar astrocytoma|recurrent childhood cerebellar astrocytoma
5403630|NCT00006247|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
5403631|NCT00006247|recurrent childhood medulloblastoma|recurrent childhood medulloblastoma
5403632|NCT00006247|recurrent childhood visual pathway and hypothalamic glioma|recurrent childhood visual pathway and hypothalamic glioma
5403633|NCT00006247|recurrent childhood ependymoma|recurrent childhood ependymoma
5403634|NCT00006104|stage IV breast cancer|stage iv breast cancer
5403635|NCT00006104|recurrent breast cancer|recurrent breast cancer
5403636|NCT00074880|Cardiac Hypertrophy|cardiac hypertrophy
5403637|NCT00074880|Diastolic Dysfunction|diastolic dysfunction
5403638|NCT00074880|Cardiac Glycosides|cardiac glycosides
5403639|NCT00074880|Cardiac Fibrosis|cardiac fibrosis
5403640|NCT00074880|Atrial Systole|atrial systole
5403641|NCT00074828|elective|elective
5403642|NCT00074828|primary unilateral|primary unilateral
5403643|NCT00074763|Leukemia|leukemia
5403644|NCT00074763|Lymphoma|lymphoma
5403646|NCT00074763|CLL|cll
5403647|NCT00074763|AML|aml
5403648|NCT00074763|CML|cml
5403649|NCT00074763|MDS|mds
5403650|NCT00074763|Remission|remission
5403651|NCT00074763|Hematologic Disorder|hematologic disorder
5403652|NCT00074763|Transfusion|transfusion
5403653|NCT00074763|Thrombosol|thrombosol
5403654|NCT00074763|Autologous Platelet Transfusion|autologous platelet transfusion
5403655|NCT00074763|Platelet Transfusion|platelet transfusion
5403656|NCT00074763|Single donor platelet apheresis|single donor platelet apheresis
5403657|NCT00074763|Cryopreservation|cryopreservation
5403658|NCT00074763|Thrombocytopenia|thrombocytopenia
5403659|NCT00074750|AML|aml
5403660|NCT00074750|CMML|cmml
5403661|NCT00074737|Refractory or Relapsed Acute Myelogenous Leukemia (AML)|refractory or relapsed acute myelogenous leukemia (aml)
5403662|NCT00074737|Antisense|antisense
5403663|NCT00006099|ovarian epithelial cancer|ovarian epithelial cancer
5403664|NCT00006087|non-small cell lung cancer|non-small cell lung cancer
5403665|NCT00006087|small cell lung cancer|small cell lung cancer
5403666|NCT00006080|recurrent adult brain tumor|recurrent adult brain tumor
5403667|NCT00006080|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5403668|NCT00006080|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
5403669|NCT00006080|adult mixed glioma|adult mixed glioma
5403670|NCT00005978|localized resectable neuroblastoma|localized resectable neuroblastoma
5403671|NCT00005978|regional neuroblastoma|regional neuroblastoma
5403672|NCT00005978|disseminated neuroblastoma|disseminated neuroblastoma
5403673|NCT00005978|stage 4S neuroblastoma|stage 4s neuroblastoma
5403674|NCT00005978|recurrent neuroblastoma|recurrent neuroblastoma
5403675|NCT00005978|localized unresectable neuroblastoma|localized unresectable neuroblastoma
5403676|NCT00005963|stage IV breast cancer|stage iv breast cancer
5403677|NCT00005963|recurrent breast cancer|recurrent breast cancer
5403678|NCT00074815|Child|child
5403679|NCT00074815|Adolescent|adolescent
5403680|NCT00074802|Social Phobia|social phobia
5403681|NCT00074789|Early Head Start Program|early head start program
5403682|NCT00074776|Bipolar Depression|bipolar depression
5403683|NCT00074711|Bone Mineral Density|bone mineral density
5403685|NCT00074698|Idiopathic pulmonary fibrosis|idiopathic pulmonary fibrosis
5403686|NCT00074698|IPF|ipf
5403687|NCT00074698|Pulmonary fibrosis|pulmonary fibrosis
5403688|NCT00074698|Respiratory disease|respiratory disease
5403689|NCT00074685|Congenital|congenital
5403690|NCT00074685|Epidermal nevus|epidermal nevus
5403691|NCT00074685|Erythroderma|erythroderma
5403692|NCT00074685|Darier|darier
5403693|NCT00074685|Hailey-Hailey|hailey-hailey
5403694|NCT00074685|Harlequin|harlequin
5403695|NCT00074685|Ichthyosiform|ichthyosiform
5403696|NCT00074685|Ichthyosiform erythroderma|ichthyosiform erythroderma
5403697|NCT00074685|Keratoderma|keratoderma
5403698|NCT00074685|Keratosis|keratosis
5403699|NCT00074685|Pachyonychia|pachyonychia
5403700|NCT00074685|Sjogren-Larsson|sjogren-larsson
5403701|NCT00074646|CC-8490|cc-8490
5403702|NCT00074646|CC8490|cc8490
5403703|NCT00074646|Glio|glio
5403704|NCT00074646|Glioblastoma|glioblastoma
5403705|NCT00074646|Malignant Gliomas|malignant gliomas
5403706|NCT00074633|Type 2 Diabetes|type 2 diabetes
5403707|NCT00074633|Self-Esteem|self-esteem
5403708|NCT00074620|Haemodialysis|haemodialysis
5403709|NCT00074620|PEG-Hirudin|peg-hirudin
5403710|NCT00074620|Vascular graft occlusion|vascular graft occlusion
5403711|NCT00074620|Renal replacement therapy|renal replacement therapy
5403712|NCT00074620|Hemodialysis|hemodialysis
5403713|NCT00074672|Prepulse Inhibition|prepulse inhibition
5403714|NCT00074672|PPI|ppi
5403715|NCT00074672|Dopamine|dopamine
5403716|NCT00074672|Sensorimotor Integration|sensorimotor integration
5403717|NCT00074672|Dopaminergic|dopaminergic
5403718|NCT00074607|Neoplastic meningitis|neoplastic meningitis
5403719|NCT00074581|HIV Infections|hiv infections
5403720|NCT00074581|HIV Seronegativity|hiv seronegativity
5403721|NCT00074568|Genetic Study|genetic study
5403722|NCT00074568|Transmission Dysequilibrium Testing|transmission dysequilibrium testing
5403723|NCT00074568|Genome Wide Scan|genome wide scan
5403724|NCT00074568|Family Study|family study
5403725|NCT00074555|African American, Rheumatoid Arthritis|african american, rheumatoid arthritis
5403726|NCT00005959|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5403727|NCT00005959|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5403728|NCT00005959|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5403729|NCT00005959|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5403730|NCT00005959|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5403731|NCT00005959|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5403732|NCT00005959|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5403733|NCT00005959|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5403734|NCT00005959|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5403735|NCT00005959|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5403736|NCT00005959|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5403737|NCT00005959|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5403738|NCT00005959|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
5403739|NCT00005959|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
5403740|NCT00005959|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
5403741|NCT00005959|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
5403742|NCT00005959|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
5403743|NCT00005959|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
5403744|NCT00005959|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5403745|NCT00005959|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
5403746|NCT00005959|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
5403747|NCT00005959|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
5403748|NCT00005959|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5403749|NCT00005959|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
5403750|NCT00005876|stage III gastric cancer|stage iii gastric cancer
5403751|NCT00005876|stage IV gastric cancer|stage iv gastric cancer
5403752|NCT00005876|recurrent gastric cancer|recurrent gastric cancer
5403753|NCT00005876|stage III esophageal cancer|stage iii esophageal cancer
5403754|NCT00005876|stage IV esophageal cancer|stage iv esophageal cancer
5403755|NCT00005876|recurrent esophageal cancer|recurrent esophageal cancer
5403756|NCT00005876|adenocarcinoma of the stomach|adenocarcinoma of the stomach
5403757|NCT00005876|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
5403758|NCT00005646|extensive stage small cell lung cancer|extensive stage small cell lung cancer
5403759|NCT00005642|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5403760|NCT00005634|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5403761|NCT00005634|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5403762|NCT00005634|isolated plasmacytoma of bone|isolated plasmacytoma of bone
5403763|NCT00005634|extramedullary plasmacytoma|extramedullary plasmacytoma
5403764|NCT00005634|refractory multiple myeloma|refractory multiple myeloma
5403765|NCT00005634|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5403766|NCT00005634|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5403767|NCT00005634|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5403768|NCT00005634|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5403769|NCT00005634|small intestine lymphoma|small intestine lymphoma
5403770|NCT00005634|recurrent prostate cancer|recurrent prostate cancer
5403771|NCT00005634|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5403772|NCT00005634|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5403773|NCT00005634|refractory hairy cell leukemia|refractory hairy cell leukemia
5403774|NCT00005634|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5403775|NCT00005634|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5403776|NCT00005634|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5403777|NCT00005634|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5403778|NCT00005634|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5403779|NCT00005634|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5403780|NCT00005634|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5403781|NCT00005634|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5403782|NCT00005634|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5403783|NCT00005634|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5403784|NCT00005634|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
5403785|NCT00005634|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5403786|NCT00005634|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5403787|NCT00005634|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5403788|NCT00005634|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5403789|NCT00005634|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5403790|NCT00005634|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5403791|NCT00005634|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5403792|NCT00005634|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5403793|NCT00074542|Crohn's|crohn's
5403794|NCT00074542|colon|colon
5403795|NCT00074542|small bowel|small bowel
5403796|NCT00074542|inflammation|inflammation
5403797|NCT00074542|steroid therapy|steroid therapy
5403798|NCT00074542|free fatty acids|free fatty acids
5403799|NCT00005598|refractory anemia|refractory anemia
5403800|NCT00005598|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5403801|NCT00005598|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5403802|NCT00005598|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5403803|NCT00005592|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5403804|NCT00005592|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5403805|NCT00005592|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5403806|NCT00005592|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5403807|NCT00005592|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5403808|NCT00005592|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5403809|NCT00005592|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5403810|NCT00005592|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5403811|NCT00005592|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5403812|NCT00005083|adult glioblastoma|adult glioblastoma
5403813|NCT00005083|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5403814|NCT00005083|adult myxopapillary ependymoma|adult myxopapillary ependymoma
5403815|NCT00005083|adult anaplastic ependymoma|adult anaplastic ependymoma
5403816|NCT00005083|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
5403817|NCT00005083|adult mixed glioma|adult mixed glioma
5403818|NCT00005083|adult pilocytic astrocytoma|adult pilocytic astrocytoma
5403819|NCT00005083|adult subependymoma|adult subependymoma
5403820|NCT00005083|adult ependymoblastoma|adult ependymoblastoma
5403821|NCT00005083|adult oligodendroglioma|adult oligodendroglioma
5403822|NCT00005083|adult giant cell glioblastoma|adult giant cell glioblastoma
5403823|NCT00005083|adult gliosarcoma|adult gliosarcoma
5403824|NCT00004890|stage I renal cell cancer|stage i renal cell cancer
5403825|NCT00004890|stage II renal cell cancer|stage ii renal cell cancer
5403826|NCT00004890|stage III renal cell cancer|stage iii renal cell cancer
5403827|NCT00004890|stage IV renal cell cancer|stage iv renal cell cancer
5403828|NCT00004890|recurrent renal cell cancer|recurrent renal cell cancer
5403829|NCT00004890|drug extravasation|drug extravasation
5403830|NCT00004874|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5403831|NCT00004874|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5403832|NCT00004874|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5403833|NCT00074516|Immunosuppression|immunosuppression
5403834|NCT00074516|Kidney|kidney
5403835|NCT00074516|Cysteamine|cysteamine
5403836|NCT00074516|Steroid-Free|steroid-free
5403837|NCT00074516|Outcomes|outcomes
5403838|NCT00074503|Positron Emission Tomography|positron emission tomography
5403839|NCT00074503|Phospholipids|phospholipids
5403840|NCT00074503|Alcoholism|alcoholism
5403841|NCT00074503|[11C]Docosahexaenoate|[11c]docosahexaenoate
5403842|NCT00074503|[150]Water|[150]water
5403843|NCT00074503|Brain|brain
5403844|NCT00074503|Fatty Acids|fatty acids
5403845|NCT00074503|Blood Flow|blood flow
5403846|NCT00074503|Healthy|healthy
5403847|NCT00074490|Leukemia|leukemia
5403848|NCT00074490|Lymphoma|lymphoma
5403849|NCT00074490|Multiple Myeloma|multiple myeloma
5403850|NCT00074490|Bone Marrow Transplantation|bone marrow transplantation
5403851|NCT00074490|Immune Therapy|immune therapy
5403852|NCT00074477|Schizophrenia|schizophrenia
5403853|NCT00074477|Paliperidone palmitate|paliperidone palmitate
5403854|NCT00074477|R092670|r092670
5403855|NCT00074477|antipsychotic|antipsychotic
5403856|NCT00074438|Rituxan|rituxan
5403857|NCT00074438|RA|ra
5403858|NCT00074425|HIV Seronegativity|hiv seronegativity
5403859|NCT00074425|Anti-Infective Agents, Local|anti-infective agents, local
5403860|NCT00074425|BufferGel|buffergel
5403861|NCT00074425|PRO 2000|pro 2000
5403862|NCT00074425|Vagina|vagina
5403863|NCT00074425|Risk Factors|risk factors
5403864|NCT00074412|HIV Seronegativity|hiv seronegativity
5403865|NCT00074412|Treatment Experienced|treatment experienced
5403866|NCT00074412|Treatment Naive|treatment naive
5403867|NCT00074399|Maternal/Infant Transmisson|maternal/infant transmisson
5403868|NCT00074399|Vertical Transmission|vertical transmission
5403869|NCT00074399|Pregnancy|pregnancy
5403870|NCT00074399|HIV Seronegativity|hiv seronegativity
5403871|NCT00074386|HIV|hiv
5403872|NCT00074386|Transplant|transplant
5403873|NCT00074386|Liver|liver
5403874|NCT00074386|Kidney|kidney
5403875|NCT00074386|Organ|organ
5403876|NCT00074386|Treatment Experienced|treatment experienced
5403877|NCT00074386|Kidney Transplant|kidney transplant
5403878|NCT00074386|Liver Transplant|liver transplant
5403879|NCT00074373|Anti-SSA/Ro Antibodies|anti-ssa/ro antibodies
5403880|NCT00074373|Anti-SSB/La Antibodies|anti-ssb/la antibodies
5403881|NCT00021983|refractory hairy cell leukemia|refractory hairy cell leukemia
5403882|NCT00074360|Ethanol|ethanol
5403883|NCT00074360|fMRI|fmri
5403884|NCT00074360|Blood Flow|blood flow
5403885|NCT00074360|Conditioning|conditioning
5403886|NCT00074360|Reinforcement|reinforcement
5403887|NCT00074334|childhood high-grade cerebral astrocytoma|childhood high-grade cerebral astrocytoma
5403888|NCT00074334|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
5403889|NCT00074334|childhood oligodendroglioma|childhood oligodendroglioma
5403890|NCT00074334|childhood supratentorial ependymoma|childhood supratentorial ependymoma
5403891|NCT00074334|recurrent childhood ependymoma|recurrent childhood ependymoma
5403892|NCT00074334|recurrent childhood brain tumor|recurrent childhood brain tumor
5403893|NCT00074295|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
5403894|NCT00074295|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5403895|NCT00074295|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5403896|NCT00074295|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5403897|NCT00074282|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5403898|NCT00074282|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
5403899|NCT00074269|recurrent breast cancer|recurrent breast cancer
5403900|NCT00074269|stage IV breast cancer|stage iv breast cancer
5403901|NCT00074243|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5403902|NCT00074243|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
5403903|NCT00074243|adult glioblastoma|adult glioblastoma
5403904|NCT00074243|adult mixed glioma|adult mixed glioma
5403905|NCT00074243|adult brain stem glioma|adult brain stem glioma
5403906|NCT00074243|recurrent adult brain tumor|recurrent adult brain tumor
5403907|NCT00074243|adult giant cell glioblastoma|adult giant cell glioblastoma
5403908|NCT00074243|adult gliosarcoma|adult gliosarcoma
5403909|NCT00074230|stage IV melanoma|stage iv melanoma
5403910|NCT00074230|recurrent melanoma|recurrent melanoma
5403911|NCT00074204|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5403912|NCT00074204|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5403913|NCT00074204|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5403914|NCT00074191|intraocular lymphoma|intraocular lymphoma
5403915|NCT00074191|primary central nervous system lymphoma|primary central nervous system lymphoma
5403916|NCT00074178|primary central nervous system lymphoma|primary central nervous system lymphoma
5403917|NCT00074178|intraocular lymphoma|intraocular lymphoma
5403918|NCT00074165|drug/agent toxicity by tissue/organ|drug/agent toxicity by tissue/organ
5403919|NCT00074165|thrombocytopenia|thrombocytopenia
5403920|NCT00074165|intraocular lymphoma|intraocular lymphoma
5403921|NCT00074165|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
5403922|NCT00074165|primary central nervous system Hodgkin lymphoma|primary central nervous system hodgkin lymphoma
5403923|NCT00074152|recurrent breast cancer|recurrent breast cancer
5403924|NCT00074152|stage I breast cancer|stage i breast cancer
5403925|NCT00074152|stage II breast cancer|stage ii breast cancer
5429870|NCT00037115|enhancement|enhancement
5403926|NCT00074152|stage IIIA breast cancer|stage iiia breast cancer
5403927|NCT00074152|stage IIIB breast cancer|stage iiib breast cancer
5403928|NCT00074152|stage IIIC breast cancer|stage iiic breast cancer
5403929|NCT00074139|stage IIIA breast cancer|stage iiia breast cancer
5403930|NCT00074139|recurrent breast cancer|recurrent breast cancer
5403931|NCT00074139|stage IIIB breast cancer|stage iiib breast cancer
5403932|NCT00074139|stage IIIC breast cancer|stage iiic breast cancer
5403933|NCT00074139|stage IV breast cancer|stage iv breast cancer
5403934|NCT00074100|stage IV breast cancer|stage iv breast cancer
5403935|NCT00074100|recurrent breast cancer|recurrent breast cancer
5403936|NCT00074087|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
5403937|NCT00074087|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
5403938|NCT00074087|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5403939|NCT00074087|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
5403940|NCT00074087|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
5403941|NCT00074087|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5403942|NCT00074074|refractory anemia with excess blasts|refractory anemia with excess blasts
5403943|NCT00074074|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
5403944|NCT00074074|refractory anemia|refractory anemia
5403945|NCT00074074|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5403946|NCT00074074|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5403947|NCT00074074|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5403948|NCT00074048|refractory hairy cell leukemia|refractory hairy cell leukemia
5403949|NCT00074009|recurrent gastric cancer|recurrent gastric cancer
5403950|NCT00074009|stage III gastric cancer|stage iii gastric cancer
5403951|NCT00074009|stage IV gastric cancer|stage iv gastric cancer
5403952|NCT00074009|adenocarcinoma of the stomach|adenocarcinoma of the stomach
5403953|NCT00073983|recurrent Ewing sarcoma/peripheral primitive neuroectodermal tumor|recurrent ewing sarcoma/peripheral primitive neuroectodermal tumor
5403954|NCT00073983|chondrosarcoma|chondrosarcoma
5403955|NCT00073983|recurrent osteosarcoma|recurrent osteosarcoma
5403956|NCT00073970|recurrent prostate cancer|recurrent prostate cancer
5403957|NCT00073970|stage I prostate cancer|stage i prostate cancer
5403958|NCT00073970|stage II prostate cancer|stage ii prostate cancer
5403959|NCT00073970|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5403960|NCT00073957|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5403961|NCT00073957|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5403962|NCT00073957|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5403963|NCT00073944|acute undifferentiated leukemia|acute undifferentiated leukemia
5403964|NCT00073944|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5403965|NCT00073944|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
5403966|NCT00073944|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
5403967|NCT00073944|chronic eosinophilic leukemia|chronic eosinophilic leukemia
5403968|NCT00073944|primary myelofibrosis|primary myelofibrosis
5403969|NCT00073944|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5403970|NCT00073944|chronic neutrophilic leukemia|chronic neutrophilic leukemia
5403971|NCT00073944|essential thrombocythemia|essential thrombocythemia
5403972|NCT00073944|intraocular lymphoma|intraocular lymphoma
5403973|NCT00073944|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
5403974|NCT00073944|polycythemia vera|polycythemia vera
5403975|NCT00073944|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5403976|NCT00073944|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
5403977|NCT00073944|prolymphocytic leukemia|prolymphocytic leukemia
5403978|NCT00073944|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5403979|NCT00073944|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5403980|NCT00073944|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
5403981|NCT00073944|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5403982|NCT00073944|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5403983|NCT00073944|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5403984|NCT00073944|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5403985|NCT00073944|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5403986|NCT00073944|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5403987|NCT00073944|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5403988|NCT00073944|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5403989|NCT00073944|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5403990|NCT00073944|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5403991|NCT00073944|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5403992|NCT00073944|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5403993|NCT00073944|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5403994|NCT00073944|refractory hairy cell leukemia|refractory hairy cell leukemia
5403995|NCT00073944|refractory multiple myeloma|refractory multiple myeloma
5403996|NCT00073944|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5403997|NCT00073944|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5403998|NCT00073944|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5403999|NCT00073944|Waldenström macroglobulinemia|waldenström macroglobulinemia
5404000|NCT00073944|adenocarcinoma of the colon|adenocarcinoma of the colon
5404001|NCT00073944|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
5404002|NCT00073944|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
5404003|NCT00073944|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5404004|NCT00073944|recurrent adult brain tumor|recurrent adult brain tumor
5404005|NCT00073944|recurrent adult primary liver cancer|recurrent adult primary liver cancer
5404006|NCT00073944|recurrent colon cancer|recurrent colon cancer
5404007|NCT00073944|recurrent esophageal cancer|recurrent esophageal cancer
5404008|NCT00073944|recurrent gastric cancer|recurrent gastric cancer
5404009|NCT00073944|recurrent melanoma|recurrent melanoma
5404010|NCT00073944|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5404011|NCT00073944|recurrent pancreatic cancer|recurrent pancreatic cancer
5404012|NCT00073944|recurrent rectal cancer|recurrent rectal cancer
5404013|NCT00073944|adenocarcinoma of the stomach|adenocarcinoma of the stomach
5404014|NCT00073944|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5404015|NCT00073944|adult glioblastoma|adult glioblastoma
5404016|NCT00073944|adult pilocytic astrocytoma|adult pilocytic astrocytoma
5404017|NCT00073944|adult subependymoma|adult subependymoma
5404018|NCT00073944|adenocarcinoma of the extrahepatic bile duct|adenocarcinoma of the extrahepatic bile duct
5404019|NCT00073944|recurrent extrahepatic bile duct cancer|recurrent extrahepatic bile duct cancer
5404020|NCT00073944|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5404021|NCT00073944|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5404022|NCT00073944|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5404023|NCT00073944|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5404024|NCT00073944|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5404025|NCT00073944|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5404026|NCT00073944|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5404027|NCT00073944|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5404028|NCT00073944|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5404029|NCT00073944|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5404030|NCT00073944|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5404031|NCT00073944|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5404032|NCT00073944|adult diffuse astrocytoma|adult diffuse astrocytoma
5404033|NCT00073944|adult giant cell glioblastoma|adult giant cell glioblastoma
5404034|NCT00073944|adult gliosarcoma|adult gliosarcoma
5404035|NCT00073944|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
5404036|NCT00073931|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5404037|NCT00073931|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5404038|NCT00073931|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5404039|NCT00073931|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5404040|NCT00073931|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5404041|NCT00073931|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5404042|NCT00073931|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5404043|NCT00073931|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5404044|NCT00073931|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5404045|NCT00073931|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5404046|NCT00073905|unresectable gallbladder cancer|unresectable gallbladder cancer
5404047|NCT00073905|adenocarcinoma of the gallbladder|adenocarcinoma of the gallbladder
5404048|NCT00073905|adenocarcinoma of the extrahepatic bile duct|adenocarcinoma of the extrahepatic bile duct
5404049|NCT00073905|unresectable extrahepatic bile duct cancer|unresectable extrahepatic bile duct cancer
5404050|NCT00073905|pain|pain
5404051|NCT00073905|recurrent gallbladder cancer|recurrent gallbladder cancer
5404052|NCT00073905|recurrent extrahepatic bile duct cancer|recurrent extrahepatic bile duct cancer
5404053|NCT00073905|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
5404054|NCT00073905|advanced adult primary liver cancer|advanced adult primary liver cancer
5404055|NCT00073905|recurrent adult primary liver cancer|recurrent adult primary liver cancer
5404056|NCT00073892|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5404057|NCT00073892|stage IV melanoma|stage iv melanoma
5404058|NCT00073892|recurrent melanoma|recurrent melanoma
5404059|NCT00073879|stage IV renal cell cancer|stage iv renal cell cancer
5404060|NCT00073879|recurrent renal cell cancer|recurrent renal cell cancer
5404061|NCT00073866|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5404062|NCT00073866|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5404063|NCT00073866|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5404064|NCT00073853|paraplegia|paraplegia
5404065|NCT00073853|quadraplegia|quadraplegia
5404068|NCT00073853|nerve regeneration|nerve regeneration
5404069|NCT00073853|Acute, Complete SCI|acute, complete sci
5404070|NCT00073840|levalbuterol|levalbuterol
5404071|NCT00073840|asthma|asthma
5404072|NCT00073840|bronchoconstriction|bronchoconstriction
5404073|NCT00073840|adolescent|adolescent
5404074|NCT00073840|adult|adult
5404075|NCT00073827|adolescent|adolescent
5404076|NCT00073827|adult|adult
5404077|NCT00073827|asthma|asthma
5404078|NCT00073827|levalbuterol|levalbuterol
5404079|NCT00073827|bronchoconstriction|bronchoconstriction
5404080|NCT00004857|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
5404081|NCT00004857|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
5404082|NCT00004857|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5404083|NCT00004857|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5404084|NCT00004857|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
5404085|NCT00004261|stage I breast cancer|stage i breast cancer
5404086|NCT00004261|stage II breast cancer|stage ii breast cancer
5404087|NCT00004261|stage IV breast cancer|stage iv breast cancer
5404088|NCT00004261|stage IIIA breast cancer|stage iiia breast cancer
5404089|NCT00004261|breast cancer in situ|breast cancer in situ
5404090|NCT00004261|recurrent breast cancer|recurrent breast cancer
5404091|NCT00004261|stage IIIB breast cancer|stage iiib breast cancer
5404092|NCT00004261|stage 0 cervical cancer|stage 0 cervical cancer
5404093|NCT00004261|stage III cervical cancer|stage iii cervical cancer
5404094|NCT00004261|recurrent cervical cancer|recurrent cervical cancer
5404095|NCT00004261|stage IB cervical cancer|stage ib cervical cancer
5404096|NCT00004261|stage IIB cervical cancer|stage iib cervical cancer
5404097|NCT00004261|stage IVB cervical cancer|stage ivb cervical cancer
5404098|NCT00004261|stage IA cervical cancer|stage ia cervical cancer
5404099|NCT00004261|stage IIA cervical cancer|stage iia cervical cancer
5404100|NCT00004261|stage IVA cervical cancer|stage iva cervical cancer
5404101|NCT00004261|inflammatory breast cancer|inflammatory breast cancer
5404102|NCT00004261|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
5404103|NCT00004261|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
5404104|NCT00004261|stage I prostate cancer|stage i prostate cancer
5404105|NCT00004261|stage IIB prostate cancer|stage iib prostate cancer
5404106|NCT00004261|stage IIA prostate cancer|stage iia prostate cancer
5404107|NCT00004261|stage III prostate cancer|stage iii prostate cancer
5404108|NCT00004261|stage IV prostate cancer|stage iv prostate cancer
5404109|NCT00004261|recurrent prostate cancer|recurrent prostate cancer
5404110|NCT00004261|stage I nasopharyngeal cancer|stage i nasopharyngeal cancer
5404111|NCT00004261|stage II nasopharyngeal cancer|stage ii nasopharyngeal cancer
5404112|NCT00004261|stage III nasopharyngeal cancer|stage iii nasopharyngeal cancer
5404113|NCT00004261|stage IV nasopharyngeal cancer|stage iv nasopharyngeal cancer
5404114|NCT00004261|recurrent nasopharyngeal cancer|recurrent nasopharyngeal cancer
5404115|NCT00004261|stage 0 paranasal sinus and nasal cavity cancer|stage 0 paranasal sinus and nasal cavity cancer
5404116|NCT00004261|stage 0 nasopharyngeal cancer|stage 0 nasopharyngeal cancer
5404117|NCT00004261|stage 0 oropharyngeal cancer|stage 0 oropharyngeal cancer
5404118|NCT00004261|stage 0 laryngeal cancer|stage 0 laryngeal cancer
5404119|NCT00004261|stage 0 hypopharyngeal cancer|stage 0 hypopharyngeal cancer
5404120|NCT00004261|stage I salivary gland cancer|stage i salivary gland cancer
5404121|NCT00004261|stage II salivary gland cancer|stage ii salivary gland cancer
5404122|NCT00004261|stage III salivary gland cancer|stage iii salivary gland cancer
5404123|NCT00004261|stage IV salivary gland cancer|stage iv salivary gland cancer
5404124|NCT00004261|recurrent salivary gland cancer|recurrent salivary gland cancer
5404125|NCT00004261|untreated metastatic squamous neck cancer with occult primary|untreated metastatic squamous neck cancer with occult primary
5404126|NCT00004261|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
5404127|NCT00004261|stage 0 lip and oral cavity cancer|stage 0 lip and oral cavity cancer
5404128|NCT00004261|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
5404129|NCT00004261|stage I lip and oral cavity cancer|stage i lip and oral cavity cancer
5404130|NCT00004261|stage II lip and oral cavity cancer|stage ii lip and oral cavity cancer
5404131|NCT00004261|stage III lip and oral cavity cancer|stage iii lip and oral cavity cancer
5404132|NCT00004261|stage IV lip and oral cavity cancer|stage iv lip and oral cavity cancer
5404133|NCT00004261|recurrent lip and oral cavity cancer|recurrent lip and oral cavity cancer
5404134|NCT00004261|stage I hypopharyngeal cancer|stage i hypopharyngeal cancer
5404135|NCT00004261|stage II hypopharyngeal cancer|stage ii hypopharyngeal cancer
5404136|NCT00004261|stage III hypopharyngeal cancer|stage iii hypopharyngeal cancer
5404137|NCT00004261|stage IV hypopharyngeal cancer|stage iv hypopharyngeal cancer
5404138|NCT00004261|recurrent hypopharyngeal cancer|recurrent hypopharyngeal cancer
5404139|NCT00004261|stage I laryngeal cancer|stage i laryngeal cancer
5404140|NCT00004261|stage II laryngeal cancer|stage ii laryngeal cancer
5404141|NCT00004261|stage III laryngeal cancer|stage iii laryngeal cancer
5404142|NCT00004261|stage IV laryngeal cancer|stage iv laryngeal cancer
5404143|NCT00004261|recurrent laryngeal cancer|recurrent laryngeal cancer
5404144|NCT00004261|stage I paranasal sinus and nasal cavity cancer|stage i paranasal sinus and nasal cavity cancer
5404145|NCT00004261|stage II paranasal sinus and nasal cavity cancer|stage ii paranasal sinus and nasal cavity cancer
5429871|NCT00037115|enhancing|enhancing
5404146|NCT00004261|stage III paranasal sinus and nasal cavity cancer|stage iii paranasal sinus and nasal cavity cancer
5404147|NCT00004261|stage IV paranasal sinus and nasal cavity cancer|stage iv paranasal sinus and nasal cavity cancer
5404148|NCT00004261|recurrent paranasal sinus and nasal cavity cancer|recurrent paranasal sinus and nasal cavity cancer
5404149|NCT00004261|stage I oropharyngeal cancer|stage i oropharyngeal cancer
5404150|NCT00004261|stage II oropharyngeal cancer|stage ii oropharyngeal cancer
5404151|NCT00004261|stage III oropharyngeal cancer|stage iii oropharyngeal cancer
5404152|NCT00004261|stage IV oropharyngeal cancer|stage iv oropharyngeal cancer
5404153|NCT00004261|recurrent oropharyngeal cancer|recurrent oropharyngeal cancer
5404154|NCT00004261|stage II adult soft tissue sarcoma|stage ii adult soft tissue sarcoma
5404155|NCT00004261|stage I adult soft tissue sarcoma|stage i adult soft tissue sarcoma
5404156|NCT00004242|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5404157|NCT00003927|stage II breast cancer|stage ii breast cancer
5404158|NCT00003927|stage IV breast cancer|stage iv breast cancer
5404159|NCT00003927|stage IIIA breast cancer|stage iiia breast cancer
5404160|NCT00003927|stage IIIB breast cancer|stage iiib breast cancer
5404161|NCT00073814|levalbuterol|levalbuterol
5404162|NCT00073814|pediatric|pediatric
5404163|NCT00073814|asthma|asthma
5404164|NCT00003811|drug/agent toxicity by tissue/organ|drug/agent toxicity by tissue/organ
5404165|NCT00003811|childhood teratoma|childhood teratoma
5404166|NCT00003811|childhood malignant testicular germ cell tumor|childhood malignant testicular germ cell tumor
5404167|NCT00003811|childhood malignant ovarian germ cell tumor|childhood malignant ovarian germ cell tumor
5404168|NCT00003811|childhood extragonadal germ cell tumor|childhood extragonadal germ cell tumor
5404169|NCT00003811|recurrent childhood malignant germ cell tumor|recurrent childhood malignant germ cell tumor
5404170|NCT00003777|stage III lip and oral cavity cancer|stage iii lip and oral cavity cancer
5404604|NCT00072748|Colorectal Carcinoma|colorectal carcinoma
5404171|NCT00003777|stage IV lip and oral cavity cancer|stage iv lip and oral cavity cancer
5404172|NCT00003777|recurrent lip and oral cavity cancer|recurrent lip and oral cavity cancer
5404173|NCT00003777|stage III hypopharyngeal cancer|stage iii hypopharyngeal cancer
5404174|NCT00003777|stage IV hypopharyngeal cancer|stage iv hypopharyngeal cancer
5404175|NCT00003777|recurrent hypopharyngeal cancer|recurrent hypopharyngeal cancer
5404176|NCT00003777|stage III laryngeal cancer|stage iii laryngeal cancer
5404177|NCT00003777|stage IV laryngeal cancer|stage iv laryngeal cancer
5404178|NCT00003777|recurrent laryngeal cancer|recurrent laryngeal cancer
5404179|NCT00003777|stage III paranasal sinus and nasal cavity cancer|stage iii paranasal sinus and nasal cavity cancer
5404180|NCT00003777|stage IV paranasal sinus and nasal cavity cancer|stage iv paranasal sinus and nasal cavity cancer
5404181|NCT00003777|recurrent paranasal sinus and nasal cavity cancer|recurrent paranasal sinus and nasal cavity cancer
5404182|NCT00003777|stage III oropharyngeal cancer|stage iii oropharyngeal cancer
5404183|NCT00003777|stage IV oropharyngeal cancer|stage iv oropharyngeal cancer
5404184|NCT00003777|recurrent oropharyngeal cancer|recurrent oropharyngeal cancer
5404185|NCT00003761|stage IV breast cancer|stage iv breast cancer
5404186|NCT00003761|recurrent breast cancer|recurrent breast cancer
5404187|NCT00003729|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5404188|NCT00003729|L1 childhood acute lymphoblastic leukemia|l1 childhood acute lymphoblastic leukemia
5404189|NCT00003729|L2 childhood acute lymphoblastic leukemia|l2 childhood acute lymphoblastic leukemia
5404190|NCT00073801|Neuromusculoskeletal Pain|neuromusculoskeletal pain
5404191|NCT00073801|Laparoscopy|laparoscopy
5404192|NCT00073801|Cytokines|cytokines
5404193|NCT00073801|HPA Axis|hpa axis
5404194|NCT00073801|Neuroimmune|neuroimmune
5404195|NCT00073801|Endometriosis|endometriosis
5404196|NCT00073801|Surgical Excision|surgical excision
5404197|NCT00073801|Inflammatory Cytokines|inflammatory cytokines
5404198|NCT00003734|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5404199|NCT00003734|stage I prostate cancer|stage i prostate cancer
5404200|NCT00003734|stage IIB prostate cancer|stage iib prostate cancer
5404201|NCT00003734|stage IIA prostate cancer|stage iia prostate cancer
5404202|NCT00003734|stage III prostate cancer|stage iii prostate cancer
5404203|NCT00003734|stage IV prostate cancer|stage iv prostate cancer
5404204|NCT00073749|B-Cell|b-cell
5404205|NCT00073749|Non-Hodgkin's|non-hodgkin's
5404206|NCT00073749|Lymphoma|lymphoma
5404207|NCT00073736|Hepatocellular|hepatocellular
5404208|NCT00073736|Carcinoma|carcinoma
5404209|NCT00073736|Liver|liver
5404210|NCT00073736|Cancer|cancer
5404211|NCT00073723|Non-Small Cell Lung Cancer|non-small cell lung cancer
5404212|NCT00073723|Taxol|taxol
5404213|NCT00073723|Advanced Non-Small Cell Lung Cancer|advanced non-small cell lung cancer
5404214|NCT00003716|childhood Burkitt lymphoma|childhood burkitt lymphoma
5404215|NCT00003716|childhood immunoblastic large cell lymphoma|childhood immunoblastic large cell lymphoma
5404216|NCT00003716|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5404217|NCT00003716|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5404218|NCT00003716|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5404219|NCT00003716|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5404220|NCT00003716|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
5404221|NCT00003716|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
5404222|NCT00003716|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
5404223|NCT00003716|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
5404224|NCT00003679|stage IIIA breast cancer|stage iiia breast cancer
5404225|NCT00003679|stage IIIB breast cancer|stage iiib breast cancer
5404226|NCT00003679|inflammatory breast cancer|inflammatory breast cancer
5404227|NCT00003598|cervical cancer|cervical cancer
5404228|NCT00003598|cervical intraepithelial neoplasia grade 2|cervical intraepithelial neoplasia grade 2
5404229|NCT00003598|cervical intraepithelial neoplasia grade 3|cervical intraepithelial neoplasia grade 3
5404230|NCT00003450|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5404231|NCT00003450|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5404232|NCT00003450|peritoneal cavity cancer|peritoneal cavity cancer
5404233|NCT00073710|secondary hyperparathyroidism|secondary hyperparathyroidism
5404234|NCT00073697|Psychotherapy|psychotherapy
5404235|NCT00073697|Depressive disorder|depressive disorder
5404236|NCT00073697|Antidepressive agents|antidepressive agents
5404237|NCT00073697|Citalopram|citalopram
5404238|NCT00073684|Stress Disorders, Post-Traumatic|stress disorders, post-traumatic
5404239|NCT00073684|Depression|depression
5404240|NCT00073684|Anxiety|anxiety
5404241|NCT00073671|Adolescent|adolescent
5404242|NCT00073658|Alzheimer disease|alzheimer disease
5404243|NCT00073658|Aggression|aggression
5404244|NCT00073658|Delusions|delusions
5404245|NCT00073658|Paranoid behavior|paranoid behavior
5404246|NCT00073619|Violence|violence
5404247|NCT00073619|School based|school based
5404248|NCT00073619|Urban Youth|urban youth
5404249|NCT00073619|Prevention|prevention
5404250|NCT00073619|Community|community
5404251|NCT00073606|Spinal Reflexes|spinal reflexes
5404252|NCT00073606|Locomotion|locomotion
5404253|NCT00073606|Motor Practice|motor practice
5404254|NCT00073606|Healthy Volunteer|healthy volunteer
5404255|NCT00073606|HV|hv
5404256|NCT00003426|stage II pancreatic cancer|stage ii pancreatic cancer
5404257|NCT00003426|stage III pancreatic cancer|stage iii pancreatic cancer
5404258|NCT00003426|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
5404259|NCT00003414|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5404260|NCT00003414|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
5404261|NCT00003414|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
5404262|NCT00003414|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5404263|NCT00003414|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5404264|NCT00003414|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5404265|NCT00003414|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5404266|NCT00003414|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5404267|NCT00003414|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5404268|NCT00003414|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5404269|NCT00003414|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5404270|NCT00003414|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5404271|NCT00003414|graft versus host disease|graft versus host disease
5404272|NCT00003414|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
5404273|NCT00003414|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
5404274|NCT00003414|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5404275|NCT00003414|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5404276|NCT00003414|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5404277|NCT00003414|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5404278|NCT00003414|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5404279|NCT00003414|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5404280|NCT00003409|adult glioblastoma|adult glioblastoma
5404281|NCT00003409|adult giant cell glioblastoma|adult giant cell glioblastoma
5404282|NCT00003409|adult gliosarcoma|adult gliosarcoma
5404283|NCT00003388|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
5404284|NCT00003388|AIDS-related diffuse large cell lymphoma|aids-related diffuse large cell lymphoma
5404285|NCT00003388|AIDS-related immunoblastic large cell lymphoma|aids-related immunoblastic large cell lymphoma
5404286|NCT00003388|AIDS-related small noncleaved cell lymphoma|aids-related small noncleaved cell lymphoma
5404287|NCT00003388|AIDS-related diffuse mixed cell lymphoma|aids-related diffuse mixed cell lymphoma
5404288|NCT00003388|AIDS-related diffuse small cleaved cell lymphoma|aids-related diffuse small cleaved cell lymphoma
5404289|NCT00003388|AIDS-related lymphoblastic lymphoma|aids-related lymphoblastic lymphoma
5404290|NCT00003388|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5404291|NCT00073593|Off-Pump Coronary Artery Bypass Graft Surgery|off-pump coronary artery bypass graft surgery
5404292|NCT00073593|CABG|cabg
5404293|NCT00073593|OPCAB|opcab
5404294|NCT00073593|Heparin|heparin
5404295|NCT00073593|Patients requiring off-pump CABG|patients requiring off-pump cabg
5404296|NCT00073580|HIT|hit
5404297|NCT00073580|HITTS|hitts
5404298|NCT00073580|Heparin-antibodies|heparin-antibodies
5404299|NCT00073580|Coronary artery bypass surgery|coronary artery bypass surgery
5404300|NCT00073580|CABG|cabg
5404301|NCT00073580|Heparin-induced thrombocytopenia|heparin-induced thrombocytopenia
5404302|NCT00073580|Heparin-induced thrombocytopenia and thrombosis syndrome|heparin-induced thrombocytopenia and thrombosis syndrome
5404303|NCT00073541|EGFR; HER-1; monoclonal antibody; targeted therapy|egfr; her-1; monoclonal antibody; targeted therapy
5404304|NCT00073528|metastatic|metastatic
5404305|NCT00073528|advanced breast cancer|advanced breast cancer
5404306|NCT00073528|breast cancer|breast cancer
5404307|NCT00003387|stage III non-small cell lung cancer|stage iii non-small cell lung cancer
5404308|NCT00003387|squamous cell lung cancer|squamous cell lung cancer
5404309|NCT00003387|large cell lung cancer|large cell lung cancer
5404310|NCT00003387|adenocarcinoma of the lung|adenocarcinoma of the lung
5404311|NCT00003313|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
5404312|NCT00003313|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5404313|NCT00003313|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5404314|NCT00003313|oral complications|oral complications
5404315|NCT00003313|drug/agent toxicity by tissue/organ|drug/agent toxicity by tissue/organ
5404316|NCT00003313|radiation toxicity|radiation toxicity
5404317|NCT00003253|stage IV breast cancer|stage iv breast cancer
5404318|NCT00003253|recurrent breast cancer|recurrent breast cancer
5404319|NCT00003253|male breast cancer|male breast cancer
5404320|NCT00003202|squamous cell lung cancer|squamous cell lung cancer
5404321|NCT00003202|large cell lung cancer|large cell lung cancer
5404322|NCT00003202|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5404323|NCT00003202|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5404324|NCT00003202|adenocarcinoma of the lung|adenocarcinoma of the lung
5404325|NCT00003202|adenosquamous cell lung cancer|adenosquamous cell lung cancer
5404326|NCT00003191|recurrent neuroblastoma|recurrent neuroblastoma
5404327|NCT00003191|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
5404328|NCT00073515|central venous access device|central venous access device
5404329|NCT00073515|thrombosis|thrombosis
5404330|NCT00073515|central venous catheter|central venous catheter
5404331|NCT00073515|thrombolysis|thrombolysis
5404332|NCT00073515|fibrinolysis|fibrinolysis
5404333|NCT00073489|chronic leukemia|chronic leukemia
5404334|NCT00073489|leukemia|leukemia
5404335|NCT00073489|CLL|cll
5404336|NCT00073463|Gene Transfer|gene transfer
5404337|NCT00073463|Pulmonary function|pulmonary function
5404338|NCT00003130|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5404339|NCT00003060|recurrent melanoma|recurrent melanoma
5404340|NCT00003037|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5404341|NCT00003037|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5404342|NCT00002989|stage I multiple myeloma|stage i multiple myeloma
5404343|NCT00002989|stage II multiple myeloma|stage ii multiple myeloma
5404344|NCT00002989|stage III multiple myeloma|stage iii multiple myeloma
5404345|NCT00002989|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5404346|NCT00002989|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5404347|NCT00002989|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5404348|NCT00002989|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5404349|NCT00002989|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5404350|NCT00002989|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5404351|NCT00002989|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
5404352|NCT00002989|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
5404353|NCT00002989|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
5404354|NCT00002989|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
5404355|NCT00002989|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
5404356|NCT00002989|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
5404357|NCT00002989|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
5404358|NCT00002989|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
5404359|NCT00002989|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
5404360|NCT00002989|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5404361|NCT00002989|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5404362|NCT00002989|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5404363|NCT00002989|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5404364|NCT00002989|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5404365|NCT00002989|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5404366|NCT00002989|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5404367|NCT00002989|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5404368|NCT00002989|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5404369|NCT00002989|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5404370|NCT00002989|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5404371|NCT00002989|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5404372|NCT00002989|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5429978|NCT00036452|Stavudine|stavudine
5404373|NCT00002989|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5404374|NCT00002989|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5404375|NCT00002989|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5404376|NCT00002989|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5404377|NCT00002989|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5404378|NCT00002989|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5404379|NCT00002989|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5404605|NCT00072748|Colorectal Tumors|colorectal tumors
5404380|NCT00002989|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5404381|NCT00002989|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5404382|NCT00002989|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5404383|NCT00002989|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5404384|NCT00002989|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5404385|NCT00002989|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5404386|NCT00002989|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5404387|NCT00002989|stage I mantle cell lymphoma|stage i mantle cell lymphoma
5404388|NCT00002989|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
5404389|NCT00002989|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
5404390|NCT00002989|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
5404391|NCT00002989|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
5404392|NCT00002989|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
5404393|NCT00002989|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
5404394|NCT00002989|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
5404395|NCT00002989|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
5404396|NCT00002989|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
5404397|NCT00002989|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
5404398|NCT00002989|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5404399|NCT00002989|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5404400|NCT00002989|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5404401|NCT00002989|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
5404402|NCT00002989|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5404403|NCT00002989|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
5404404|NCT00002989|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
5404405|NCT00002989|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5404406|NCT00002989|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
5404407|NCT00002989|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
5404408|NCT00002989|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5404409|NCT00002989|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5404410|NCT00002989|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5404411|NCT00002989|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
5404412|NCT00002989|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
5404413|NCT00002989|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
5404414|NCT00002989|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
5404415|NCT00002989|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5404416|NCT00002989|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5404417|NCT00002989|stage I marginal zone lymphoma|stage i marginal zone lymphoma
5404418|NCT00002989|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
5404419|NCT00002989|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5404420|NCT00002989|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5404421|NCT00002989|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5404422|NCT00002989|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5404423|NCT00002989|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5404424|NCT00002989|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5404425|NCT00002989|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5404426|NCT00002989|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
5404427|NCT00073450|Squamous Cell Carcinoma of the Head & Neck|squamous cell carcinoma of the head & neck
5404428|NCT00073437|Sarcoidosis|sarcoidosis
5404429|NCT00073437|Infliximab|infliximab
5404430|NCT00073437|Pulmonary involvement|pulmonary involvement
5404431|NCT00073437|Remicade|remicade
5404432|NCT00002940|AIDS-related primary CNS lymphoma|aids-related primary cns lymphoma
5404433|NCT00002836|recurrent breast cancer|recurrent breast cancer
5404434|NCT00002828|stage III colon cancer|stage iii colon cancer
5404435|NCT00002828|stage IV colon cancer|stage iv colon cancer
5404436|NCT00002828|stage III rectal cancer|stage iii rectal cancer
5404437|NCT00002828|stage IV rectal cancer|stage iv rectal cancer
5404438|NCT00002828|recurrent colon cancer|recurrent colon cancer
5404439|NCT00002828|recurrent rectal cancer|recurrent rectal cancer
5404440|NCT00002812|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
5404441|NCT00002812|L1 childhood acute lymphoblastic leukemia|l1 childhood acute lymphoblastic leukemia
5404442|NCT00002812|L2 childhood acute lymphoblastic leukemia|l2 childhood acute lymphoblastic leukemia
5404443|NCT00002761|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5404444|NCT00002761|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5404445|NCT00002761|chronic myelogenous leukemia, BCR-ABL1 positive|chronic myelogenous leukemia, bcr-abl1 positive
5404446|NCT00073424|Treatment Experienced|treatment experienced
5404447|NCT00073385|Lung cancer, Docetaxel, Histone deacetylase inhibitor|lung cancer, docetaxel, histone deacetylase inhibitor
5404448|NCT00073372|Acute ischemic stroke|acute ischemic stroke
5404449|NCT00073372|abciximab|abciximab
5404450|NCT00073372|ReoPro|reopro
5404451|NCT00073372|drug safety|drug safety
5404452|NCT00073372|drug efficacy|drug efficacy
5404453|NCT00073372|intracranial hemorrhage|intracranial hemorrhage
5404454|NCT00073372|stroke|stroke
5404455|NCT00073359|Adolescent|adolescent
5404456|NCT00073346|Compulsive Hoarding|compulsive hoarding
5404457|NCT00073333|Phobic Disorders|phobic disorders
5404458|NCT00073320|Schizophrenia|schizophrenia
5404459|NCT00073320|Paliperidone palmitate|paliperidone palmitate
5404460|NCT00073320|R092670|r092670
5404461|NCT00073320|antipsychotic|antipsychotic
5404462|NCT00073307|Renal Cell Cancer (RCC)|renal cell cancer (rcc)
5404463|NCT00073307|Cancer|cancer
5404464|NCT00036920|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5404465|NCT00036920|squamous cell lung cancer|squamous cell lung cancer
5404466|NCT00036920|large cell lung cancer|large cell lung cancer
5404467|NCT00036920|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5404468|NCT00036920|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5404469|NCT00036920|adenocarcinoma of the lung|adenocarcinoma of the lung
5404470|NCT00036920|adenosquamous cell lung cancer|adenosquamous cell lung cancer
5404471|NCT00036920|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
5404472|NCT00027521|stage III pancreatic cancer|stage iii pancreatic cancer
5404473|NCT00027521|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
5404474|NCT00025532|stage III colon cancer|stage iii colon cancer
5404475|NCT00025532|stage IV colon cancer|stage iv colon cancer
5404476|NCT00025532|stage III gastric cancer|stage iii gastric cancer
5404477|NCT00025532|stage IV gastric cancer|stage iv gastric cancer
5404478|NCT00025532|recurrent gastric cancer|recurrent gastric cancer
5404479|NCT00025532|stage III pancreatic cancer|stage iii pancreatic cancer
5404480|NCT00025532|recurrent pancreatic cancer|recurrent pancreatic cancer
5404481|NCT00025532|stage III rectal cancer|stage iii rectal cancer
5404482|NCT00025532|stage IV rectal cancer|stage iv rectal cancer
5404483|NCT00025532|recurrent colon cancer|recurrent colon cancer
5404484|NCT00025532|recurrent rectal cancer|recurrent rectal cancer
5404485|NCT00025532|stage III esophageal cancer|stage iii esophageal cancer
5404486|NCT00025532|stage IV esophageal cancer|stage iv esophageal cancer
5404487|NCT00025532|recurrent esophageal cancer|recurrent esophageal cancer
5404488|NCT00025532|adenocarcinoma of the stomach|adenocarcinoma of the stomach
5404489|NCT00025532|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
5404490|NCT00025532|adenocarcinoma of the colon|adenocarcinoma of the colon
5404491|NCT00025532|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5404492|NCT00025532|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
5404493|NCT00025532|stage IV pancreatic cancer|stage iv pancreatic cancer
5404494|NCT00002561|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
5404495|NCT00002561|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
5404496|NCT00002561|adult lymphocyte predominant Hodgkin lymphoma|adult lymphocyte predominant hodgkin lymphoma
5404497|NCT00002561|adult lymphocyte depletion Hodgkin lymphoma|adult lymphocyte depletion hodgkin lymphoma
5404498|NCT00002561|adult nodular sclerosis Hodgkin lymphoma|adult nodular sclerosis hodgkin lymphoma
5404499|NCT00002561|adult mixed cellularity Hodgkin lymphoma|adult mixed cellularity hodgkin lymphoma
5404500|NCT00073398|Anti-tumor Vaccination|anti-tumor vaccination
5404501|NCT00073398|Alpha (1,3) Galactosyltransferase|alpha (1,3) galactosyltransferase
5404502|NCT00073398|Allogeneic Tumor Cells|allogeneic tumor cells
5404503|NCT00073398|Hyperacute Lung|hyperacute lung
5404504|NCT00073398|NSCLC|nsclc
5404505|NCT00073398|Lung Cancer|lung cancer
5404506|NCT00073398|Non-Small Cell Lung Cancer|non-small cell lung cancer
5404507|NCT00073294|diabetes|diabetes
5404508|NCT00073281|diabetes|diabetes
5404509|NCT00073281|autoimmunity|autoimmunity
5404510|NCT00073268|diabetes|diabetes
5404511|NCT00073268|adolescent|adolescent
5404512|NCT00073242|leptin|leptin
5404513|NCT00073242|obesity|obesity
5404514|NCT00073229|AIDS|aids
5404515|NCT00073229|Vertical Transmission|vertical transmission
5404516|NCT00073229|Acute Infection|acute infection
5404517|NCT00073216|HIV Seronegativity|hiv seronegativity
5404518|NCT00073216|HIV Preventive Vaccine|hiv preventive vaccine
5404519|NCT00073190|Patient Education|patient education
5430186|NCT00035204|Alzheimer's|alzheimer's
5404520|NCT00073190|Physician Education|physician education
5404521|NCT00073125|Advanced histologically documented renal cell carcinoma|advanced histologically documented renal cell carcinoma
5404522|NCT00073047|Ulcerative Colitis|ulcerative colitis
5404523|NCT00073047|Inflammatory Bowel Disease|inflammatory bowel disease
5404524|NCT00073047|Gastrointestinal|gastrointestinal
5404525|NCT00073047|Humanized Monoclonal antibody|humanized monoclonal antibody
5404526|NCT00073034|Neuropathic Pain|neuropathic pain
5404527|NCT00073034|Diabetic Neuropathy|diabetic neuropathy
5404528|NCT00073099|Dry Eye|dry eye
5404529|NCT00073099|Lissamine Green|lissamine green
5404530|NCT00073099|Fluorescein|fluorescein
5404531|NCT00073099|Conjunctiva|conjunctiva
5404532|NCT00073099|Cornea|cornea
5404533|NCT00073099|Digital Photography|digital photography
5404534|NCT00073099|Corneal and Conjunctival Staining|corneal and conjunctival staining
5404535|NCT00073086|Coronavirus|coronavirus
5404536|NCT00073086|Pneumonia|pneumonia
5404537|NCT00073086|Asia|asia
5404538|NCT00073086|China|china
5404539|NCT00073086|Severe Acut Respiratory Syndrome|severe acut respiratory syndrome
5404540|NCT00073086|SARS|sars
5404541|NCT00073086|Suspected SARS|suspected sars
5404542|NCT00073073|Chemoprevention|chemoprevention
5404543|NCT00073073|Mammographic Density|mammographic density
5404544|NCT00073073|Bone Mineral Density|bone mineral density
5404545|NCT00073073|Biomarkers|biomarkers
5404546|NCT00073073|Safety|safety
5404547|NCT00073073|Breast Cancer|breast cancer
5404548|NCT00073073|Postmenopausal|postmenopausal
5404549|NCT00073060|Plateletpheresis|plateletpheresis
5404550|NCT00073060|Lymphocytapheresis|lymphocytapheresis
5404551|NCT00073060|Apheresis|apheresis
5404552|NCT00073060|Citrate|citrate
5404553|NCT00073060|Bone Density|bone density
5404554|NCT00073060|Healthy Volunteer|healthy volunteer
5404555|NCT00073060|HV|hv
5404556|NCT00073008|EGFR|egfr
5404557|NCT00073008|ErbB1|erbb1
5404558|NCT00073008|ErbB2|erbb2
5404559|NCT00073008|metastatic|metastatic
5404560|NCT00073008|lapatinib|lapatinib
5404561|NCT00073008|Her-2/neu|her-2/neu
5404562|NCT00073008|protein kinase inhibitor|protein kinase inhibitor
5404563|NCT00073008|BAC|bac
5404564|NCT00073008|GW572016|gw572016
5404565|NCT00073008|Advanced|advanced
5404566|NCT00073008|NSCLC|nsclc
5404567|NCT00072982|Fish oil|fish oil
5404568|NCT00072982|Borage oil|borage oil
5404569|NCT00072943|Crohn's Disease|crohn's disease
5404570|NCT00072943|Colitis|colitis
5404571|NCT00072943|Monoclonal antibody therapy|monoclonal antibody therapy
5404572|NCT00072943|anti-interferon gamma|anti-interferon gamma
5404573|NCT00072917|obesity|obesity
5404574|NCT00072917|thinness|thinness
5404575|NCT00072917|weight gain|weight gain
5404576|NCT00072917|physical activity|physical activity
5404577|NCT00072917|diet|diet
5404578|NCT00072917|fat oxidation|fat oxidation
5404579|NCT00072917|hunger|hunger
5404580|NCT00072917|feeding behavior|feeding behavior
5404581|NCT00072917|overfeeding|overfeeding
5404582|NCT00072904|Cystic Fibrosis Related Diabetes|cystic fibrosis related diabetes
5404583|NCT00072904|Diabetes without Fasting Hyperglycemia|diabetes without fasting hyperglycemia
5404584|NCT00072891|Diabetes|diabetes
5404585|NCT00072969|Immunosuppression|immunosuppression
5404586|NCT00072969|Myelodysplastic Syndrome|myelodysplastic syndrome
5404587|NCT00072969|MDS|mds
5404588|NCT00072956|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
5404589|NCT00072956|Torticollis|torticollis
5404590|NCT00072956|Cervical Dystonia|cervical dystonia
5404591|NCT00072956|Surround Inhibition|surround inhibition
5404592|NCT00072956|Sensory Tricks|sensory tricks
5404593|NCT00072787|gastric cancer|gastric cancer
5404594|NCT00072787|phase 2 clinical trial|phase 2 clinical trial
5404595|NCT00072774|Depressive Disorder, Major|depressive disorder, major
5404596|NCT00072774|Melancholia, Involutional|melancholia, involutional
5404597|NCT00072774|Depression, Involutional|depression, involutional
5404598|NCT00072761|silent cerebral infarct|silent cerebral infarct
5404599|NCT00072761|silent stroke|silent stroke
5404600|NCT00072761|sickle cell anemia|sickle cell anemia
5404601|NCT00072761|stroke|stroke
5404602|NCT00072761|transfusion therapy|transfusion therapy
5404603|NCT00072748|Advanced Colorectal Cancer|advanced colorectal cancer
5404606|NCT00072748|Neoplasms, Colorectal|neoplasms, colorectal
5404607|NCT00072722|Prostate Cancer|prostate cancer
5404608|NCT00072722|Metastatic Hormone Refractory Prostate Cancer|metastatic hormone refractory prostate cancer
5404609|NCT00072722|CC4047|cc4047
5404610|NCT00072722|CC-4047|cc-4047
5404611|NCT00072722|Prostate Carcinoma|prostate carcinoma
5404612|NCT00072722|Celgene|celgene
5404613|NCT00017017|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5404614|NCT00017017|fallopian tube cancer|fallopian tube cancer
5404615|NCT00017017|primary peritoneal cavity cancer|primary peritoneal cavity cancer
5404616|NCT00014677|recurrent adult brain tumor|recurrent adult brain tumor
5404617|NCT00014677|adult glioblastoma|adult glioblastoma
5404618|NCT00014677|adult giant cell glioblastoma|adult giant cell glioblastoma
5404619|NCT00014677|adult gliosarcoma|adult gliosarcoma
5404620|NCT00014638|stage IV breast cancer|stage iv breast cancer
5404621|NCT00014638|recurrent breast cancer|recurrent breast cancer
5430187|NCT00035204|Dementia|dementia
5404622|NCT00014352|stage III prostate cancer|stage iii prostate cancer
5404623|NCT00014352|stage IV prostate cancer|stage iv prostate cancer
5404624|NCT00014352|recurrent prostate cancer|recurrent prostate cancer
5404625|NCT00014352|thromboembolism|thromboembolism
5404626|NCT00072826|3-hydroxy-3-methlglutaryl (HMG)|3-hydroxy-3-methlglutaryl (hmg)
5404627|NCT00072826|Inhibitors|inhibitors
5404628|NCT00072826|Endothelial Function|endothelial function
5404629|NCT00072826|Leukocyte Gene Expression|leukocyte gene expression
5404630|NCT00072826|Statins|statins
5404631|NCT00072826|Atorvastatin|atorvastatin
5404632|NCT00072826|Sickle Cell Disease|sickle cell disease
5404633|NCT00072813|Genetics|genetics
5404634|NCT00072813|Seizures|seizures
5404635|NCT00072813|Brain Imaging|brain imaging
5404636|NCT00072813|Diffusion|diffusion
5404637|NCT00072813|Temporal Lobe|temporal lobe
5404638|NCT00072800|Reliability|reliability
5404639|NCT00072800|Muscle Tone Abnormality|muscle tone abnormality
5404640|NCT00072800|Spasticity|spasticity
5404641|NCT00072800|Dystonia|dystonia
5404642|NCT00072800|Rigidity|rigidity
5404643|NCT00072800|Cerebral Palsy|cerebral palsy
5404644|NCT00072800|CP|cp
5404645|NCT00072800|Children|children
5404646|NCT00072709|ALS|als
5404647|NCT00072709|Lou Gehrig's disease|lou gehrig's disease
5404648|NCT00072683|Sodium|sodium
5404649|NCT00072683|SIADH|siadh
5404650|NCT00072683|Vasopressin|vasopressin
5404651|NCT00072683|CHF|chf
5404652|NCT00072683|Cirrhosis|cirrhosis
5404653|NCT00072683|salt|salt
5404654|NCT00072683|water|water
5404655|NCT00072683|electrolyte|electrolyte
5404656|NCT00072670|Prostate cancer|prostate cancer
5404657|NCT00072670|Advanced prostate cancer|advanced prostate cancer
5404658|NCT00072670|Metastatic prostate cancer|metastatic prostate cancer
5404659|NCT00072670|Trabectedin|trabectedin
5404660|NCT00072670|Yondelis|yondelis
5404661|NCT00072670|ET-743|et-743
5404662|NCT00012090|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5404663|NCT00012090|fallopian tube cancer|fallopian tube cancer
5404664|NCT00012090|primary peritoneal cavity cancer|primary peritoneal cavity cancer
5404665|NCT00010309|stage II melanoma|stage ii melanoma
5404666|NCT00010309|stage III melanoma|stage iii melanoma
5404667|NCT00010309|stage IV melanoma|stage iv melanoma
5404668|NCT00008372|extensive stage small cell lung cancer|extensive stage small cell lung cancer
5404669|NCT00008372|recurrent small cell lung cancer|recurrent small cell lung cancer
5404670|NCT00006367|polycythemia vera|polycythemia vera
5404671|NCT00006367|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
5404672|NCT00006367|essential thrombocythemia|essential thrombocythemia
5404673|NCT00006224|recurrent cervical cancer|recurrent cervical cancer
5404674|NCT00006224|cervical adenocarcinoma|cervical adenocarcinoma
5404675|NCT00006224|cervical adenosquamous cell carcinoma|cervical adenosquamous cell carcinoma
5404676|NCT00072735|Use Dependent Plasticity|use dependent plasticity
5404677|NCT00072735|Cortical Reorganization|cortical reorganization
5404678|NCT00072735|Rehabilitation|rehabilitation
5404679|NCT00072735|Somatosensory Nerve|somatosensory nerve
5404680|NCT00072735|Amphetamine|amphetamine
5404681|NCT00072735|Stroke|stroke
5404682|NCT00072735|Healthy Volunteer|healthy volunteer
5404683|NCT00072735|HV|hv
5404684|NCT00072657|Arthritis|arthritis
5404685|NCT00072657|Pain|pain
5404686|NCT00072657|Meditation|meditation
5404687|NCT00072657|Tai Chi|tai chi
5404688|NCT00072657|Chronic Illness|chronic illness
5404689|NCT00072657|Depression|depression
5404690|NCT00072644|HIV|hiv
5404691|NCT00072644|Osteonecrosis|osteonecrosis
5404692|NCT00072644|Drug Interaction|drug interaction
5404693|NCT00072644|P-Glycoprotein|p-glycoprotein
5404694|NCT00072644|Cytochrome P 450|cytochrome p 450
5404695|NCT00072644|Healthy Volunteer|healthy volunteer
5404696|NCT00072644|HV|hv
5404697|NCT00072631|Tarceva|tarceva
5404698|NCT00072631|erlotinib|erlotinib
5404699|NCT00072631|NSCLC|nsclc
5404700|NCT00072631|Non-Small Cell Lung Cancer|non-small cell lung cancer
5404701|NCT00072631|EGFR|egfr
5404702|NCT00072631|OSI-774|osi-774
5404703|NCT00072501|breast cancer|breast cancer
5404704|NCT00072488|disseminated neuroblastoma|disseminated neuroblastoma
5404705|NCT00072488|localized resectable neuroblastoma|localized resectable neuroblastoma
5404706|NCT00072488|localized unresectable neuroblastoma|localized unresectable neuroblastoma
5404707|NCT00072488|regional neuroblastoma|regional neuroblastoma
5404708|NCT00072488|stage 4S neuroblastoma|stage 4s neuroblastoma
5404709|NCT00072488|previously untreated childhood rhabdomyosarcoma|previously untreated childhood rhabdomyosarcoma
5404710|NCT00072488|stage I childhood Hodgkin lymphoma|stage i childhood hodgkin lymphoma
5404711|NCT00072488|stage I childhood large cell lymphoma|stage i childhood large cell lymphoma
5404712|NCT00072488|stage I childhood lymphoblastic lymphoma|stage i childhood lymphoblastic lymphoma
5404713|NCT00072488|stage I childhood small noncleaved cell lymphoma|stage i childhood small noncleaved cell lymphoma
5404714|NCT00072488|stage II childhood Hodgkin lymphoma|stage ii childhood hodgkin lymphoma
5404715|NCT00072488|stage II childhood large cell lymphoma|stage ii childhood large cell lymphoma
5404716|NCT00072488|stage II childhood lymphoblastic lymphoma|stage ii childhood lymphoblastic lymphoma
5404717|NCT00072488|stage II childhood small noncleaved cell lymphoma|stage ii childhood small noncleaved cell lymphoma
5404718|NCT00072488|stage III childhood Hodgkin lymphoma|stage iii childhood hodgkin lymphoma
5404719|NCT00072488|stage III childhood large cell lymphoma|stage iii childhood large cell lymphoma
5404720|NCT00072488|stage III childhood lymphoblastic lymphoma|stage iii childhood lymphoblastic lymphoma
5404721|NCT00072488|stage III childhood small noncleaved cell lymphoma|stage iii childhood small noncleaved cell lymphoma
5404722|NCT00072488|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
5404723|NCT00072488|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
5404724|NCT00072488|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
5404725|NCT00072488|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
5404726|NCT00072488|localized Ewing sarcoma/peripheral primitive neuroectodermal tumor|localized ewing sarcoma/peripheral primitive neuroectodermal tumor
5404727|NCT00072488|metastatic Ewing sarcoma/peripheral primitive neuroectodermal tumor|metastatic ewing sarcoma/peripheral primitive neuroectodermal tumor
5404728|NCT00072488|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
5404729|NCT00072475|refractory anemia with excess blasts|refractory anemia with excess blasts
5404730|NCT00072475|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
5404731|NCT00072475|refractory cytopenia with multilineage dysplasia|refractory cytopenia with multilineage dysplasia
5404732|NCT00072475|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5404733|NCT00072475|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5404734|NCT00072475|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5404735|NCT00072475|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
5404736|NCT00072475|refractory anemia|refractory anemia
5404737|NCT00072475|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5404738|NCT00072462|ductal breast carcinoma in situ|ductal breast carcinoma in situ
5404739|NCT00072462|breast cancer in situ|breast cancer in situ
5404740|NCT00072449|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
5404741|NCT00072410|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5404742|NCT00072410|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5404743|NCT00072358|disseminated neuroblastoma|disseminated neuroblastoma
5404744|NCT00072358|localized unresectable neuroblastoma|localized unresectable neuroblastoma
5404745|NCT00072358|recurrent neuroblastoma|recurrent neuroblastoma
5404746|NCT00072358|regional neuroblastoma|regional neuroblastoma
5404747|NCT00072358|stage 4S neuroblastoma|stage 4s neuroblastoma
5404748|NCT00072345|stage III melanoma|stage iii melanoma
5404749|NCT00072345|stage IV melanoma|stage iv melanoma
5404750|NCT00072345|recurrent melanoma|recurrent melanoma
5404751|NCT00072345|iris melanoma|iris melanoma
5404752|NCT00072345|ciliary body and choroid melanoma, medium/large size|ciliary body and choroid melanoma, medium/large size
5404753|NCT00072345|ciliary body and choroid melanoma, small size|ciliary body and choroid melanoma, small size
5404754|NCT00072345|extraocular extension melanoma|extraocular extension melanoma
5404755|NCT00072345|recurrent intraocular melanoma|recurrent intraocular melanoma
5404756|NCT00072332|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5404757|NCT00072332|stage IV esophageal cancer|stage iv esophageal cancer
5404758|NCT00072332|stage IV gastric cancer|stage iv gastric cancer
5404759|NCT00072319|stage I breast cancer|stage i breast cancer
5404760|NCT00072319|stage II breast cancer|stage ii breast cancer
5404761|NCT00072319|stage IIIA breast cancer|stage iiia breast cancer
5404762|NCT00072319|stage IIIB breast cancer|stage iiib breast cancer
5404763|NCT00072319|stage IIIC breast cancer|stage iiic breast cancer
5404764|NCT00072319|inflammatory breast cancer|inflammatory breast cancer
5404765|NCT00072293|stage IA breast cancer|stage ia breast cancer
5404766|NCT00072293|stage IB breast cancer|stage ib breast cancer
5404767|NCT00072293|stage II breast cancer|stage ii breast cancer
5404768|NCT00072293|estrogen receptor-negative breast cancer|estrogen receptor-negative breast cancer
5404769|NCT00072293|estrogen receptor-positive breast cancer|estrogen receptor-positive breast cancer
5404770|NCT00072293|progesterone receptor-negative breast cancer|progesterone receptor-negative breast cancer
5404771|NCT00072293|progesterone receptor-positive breast cancer|progesterone receptor-positive breast cancer
5404772|NCT00072280|childhood fibrosarcoma|childhood fibrosarcoma
5404773|NCT00072280|nonmetastatic childhood soft tissue sarcoma|nonmetastatic childhood soft tissue sarcoma
5404774|NCT00072267|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5404775|NCT00072267|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5404776|NCT00072267|primary peritoneal cavity cancer|primary peritoneal cavity cancer
5404777|NCT00072267|fallopian tube cancer|fallopian tube cancer
5404778|NCT00072267|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5404779|NCT00072215|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
5404780|NCT00072215|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
5404781|NCT00072215|testicular choriocarcinoma and embryonal carcinoma|testicular choriocarcinoma and embryonal carcinoma
5404782|NCT00072215|testicular choriocarcinoma and seminoma|testicular choriocarcinoma and seminoma
5404783|NCT00072215|testicular choriocarcinoma and teratoma|testicular choriocarcinoma and teratoma
5404784|NCT00072215|testicular choriocarcinoma and yolk sac tumor|testicular choriocarcinoma and yolk sac tumor
5404785|NCT00072215|testicular choriocarcinoma|testicular choriocarcinoma
5405209|NCT00016250|recurrent rectal cancer|recurrent rectal cancer
5404786|NCT00072215|testicular embryonal carcinoma and seminoma|testicular embryonal carcinoma and seminoma
5404787|NCT00072215|testicular embryonal carcinoma and teratoma with seminoma|testicular embryonal carcinoma and teratoma with seminoma
5404788|NCT00072215|testicular embryonal carcinoma and teratoma|testicular embryonal carcinoma and teratoma
5404789|NCT00072215|testicular embryonal carcinoma and yolk sac tumor with seminoma|testicular embryonal carcinoma and yolk sac tumor with seminoma
5404790|NCT00072215|testicular embryonal carcinoma and yolk sac tumor|testicular embryonal carcinoma and yolk sac tumor
5404791|NCT00072215|testicular embryonal carcinoma|testicular embryonal carcinoma
5404792|NCT00072215|testicular seminoma|testicular seminoma
5404793|NCT00072215|testicular yolk sac tumor and teratoma with seminoma|testicular yolk sac tumor and teratoma with seminoma
5404794|NCT00072215|testicular yolk sac tumor and teratoma|testicular yolk sac tumor and teratoma
5404795|NCT00072215|testicular yolk sac tumor|testicular yolk sac tumor
5404796|NCT00072215|recurrent extragonadal non-seminomatous germ cell tumor|recurrent extragonadal non-seminomatous germ cell tumor
5404797|NCT00072215|recurrent extragonadal seminoma|recurrent extragonadal seminoma
5404798|NCT00072215|stage IV extragonadal non-seminomatous germ cell tumor|stage iv extragonadal non-seminomatous germ cell tumor
5404799|NCT00072215|stage IV extragonadal seminoma|stage iv extragonadal seminoma
5404800|NCT00072215|testicular immature teratoma|testicular immature teratoma
5404801|NCT00072215|testicular mature teratoma|testicular mature teratoma
5404802|NCT00072215|recurrent extragonadal germ cell tumor|recurrent extragonadal germ cell tumor
5404803|NCT00072124|stage IV melanoma|stage iv melanoma
5404804|NCT00072124|recurrent melanoma|recurrent melanoma
5404805|NCT00072111|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5404806|NCT00072098|stage IV colon cancer|stage iv colon cancer
5404807|NCT00072098|stage IV rectal cancer|stage iv rectal cancer
5404808|NCT00072098|liver metastases|liver metastases
5404809|NCT00072098|recurrent rectal cancer|recurrent rectal cancer
5404810|NCT00072098|recurrent colon cancer|recurrent colon cancer
5404811|NCT00072085|stage IV melanoma|stage iv melanoma
5404812|NCT00072085|recurrent melanoma|recurrent melanoma
5404813|NCT00072072|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5404814|NCT00072072|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5404815|NCT00072072|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5404816|NCT00072059|anemia|anemia
5404817|NCT00072059|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5404818|NCT00072059|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5404819|NCT00072059|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5404820|NCT00072046|stage IV renal cell cancer|stage iv renal cell cancer
5404821|NCT00072046|clear cell renal cell carcinoma|clear cell renal cell carcinoma
5404822|NCT00072046|recurrent renal cell cancer|recurrent renal cell cancer
5404823|NCT00072033|stage II esophageal cancer|stage ii esophageal cancer
5405046|NCT00071513|Adolescent|adolescent
5404824|NCT00072033|stage III esophageal cancer|stage iii esophageal cancer
5404825|NCT00072033|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
5404826|NCT00072033|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
5404827|NCT00072020|bone metastases|bone metastases
5404828|NCT00072020|stage II breast cancer|stage ii breast cancer
5404829|NCT00072020|stage IIIA breast cancer|stage iiia breast cancer
5404830|NCT00072020|stage IIIB breast cancer|stage iiib breast cancer
5404831|NCT00072020|stage IIIC breast cancer|stage iiic breast cancer
5404832|NCT00072007|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
5404833|NCT00072007|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5404834|NCT00072007|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
5404835|NCT00072007|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5404836|NCT00072007|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
5404837|NCT00072007|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5404838|NCT00071981|stage IV melanoma|stage iv melanoma
5404839|NCT00071981|recurrent melanoma|recurrent melanoma
5404840|NCT00071968|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5404841|NCT00071968|stage IIB prostate cancer|stage iib prostate cancer
5404842|NCT00071968|stage IIA prostate cancer|stage iia prostate cancer
5404843|NCT00071968|stage I prostate cancer|stage i prostate cancer
5404844|NCT00071955|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5404845|NCT00071955|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5404846|NCT00071955|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5404847|NCT00071955|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5404848|NCT00071955|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5404849|NCT00071955|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5404850|NCT00071955|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5404851|NCT00071955|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5404852|NCT00071955|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5404853|NCT00071929|recurrent endometrial carcinoma|recurrent endometrial carcinoma
5404854|NCT00003141|childhood infratentorial ependymoma|childhood infratentorial ependymoma
5404855|NCT00003141|childhood supratentorial ependymoma|childhood supratentorial ependymoma
5404856|NCT00003141|disseminated neuroblastoma|disseminated neuroblastoma
5404857|NCT00003141|stage 4S neuroblastoma|stage 4s neuroblastoma
5404858|NCT00003141|embryonal childhood rhabdomyosarcoma|embryonal childhood rhabdomyosarcoma
5404859|NCT00003141|childhood high-grade cerebral astrocytoma|childhood high-grade cerebral astrocytoma
5404860|NCT00003141|childhood choroid plexus tumor|childhood choroid plexus tumor
5404861|NCT00003141|previously untreated childhood rhabdomyosarcoma|previously untreated childhood rhabdomyosarcoma
5404862|NCT00003141|untreated childhood brain stem glioma|untreated childhood brain stem glioma
5404863|NCT00003141|untreated childhood supratentorial primitive neuroectodermal tumor|untreated childhood supratentorial primitive neuroectodermal tumor
5404864|NCT00003141|untreated childhood cerebellar astrocytoma|untreated childhood cerebellar astrocytoma
5404865|NCT00003141|untreated childhood medulloblastoma|untreated childhood medulloblastoma
5404866|NCT00003141|newly diagnosed childhood ependymoma|newly diagnosed childhood ependymoma
5404867|NCT00003141|localized resectable neuroblastoma|localized resectable neuroblastoma
5404868|NCT00003141|localized unresectable neuroblastoma|localized unresectable neuroblastoma
5404869|NCT00003141|regional neuroblastoma|regional neuroblastoma
5404870|NCT00003141|childhood spinal cord neoplasm|childhood spinal cord neoplasm
5404871|NCT00003141|childhood atypical teratoid/rhabdoid tumor|childhood atypical teratoid/rhabdoid tumor
5404872|NCT00003141|childhood low-grade cerebral astrocytoma|childhood low-grade cerebral astrocytoma
5404873|NCT00003141|childhood central nervous system choriocarcinoma|childhood central nervous system choriocarcinoma
5404874|NCT00003141|childhood central nervous system embryonal tumor|childhood central nervous system embryonal tumor
5404875|NCT00003141|childhood central nervous system germinoma|childhood central nervous system germinoma
5404876|NCT00003141|childhood central nervous system mixed germ cell tumor|childhood central nervous system mixed germ cell tumor
5404877|NCT00003141|childhood central nervous system teratoma|childhood central nervous system teratoma
5404878|NCT00003141|childhood central nervous system yolk sac tumor|childhood central nervous system yolk sac tumor
5404879|NCT00072605|Healthy|healthy
5404880|NCT00072605|T Cells|t cells
5404881|NCT00072605|Immunity|immunity
5404882|NCT00072605|Hemorrhagic Fever|hemorrhagic fever
5404883|NCT00072605|Healthy Volunteer|healthy volunteer
5404884|NCT00072605|HV|hv
5404885|NCT00072592|ANCA|anca
5404886|NCT00072592|B Lymphocyte|b lymphocyte
5404887|NCT00072592|Vasculitis|vasculitis
5404888|NCT00072592|Treatment|treatment
5404889|NCT00072592|Remission|remission
5404890|NCT00072592|Wegener Granulomatosis|wegener granulomatosis
5404891|NCT00072592|WG|wg
5404892|NCT00072579|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5404893|NCT00072579|chronic myelogenous leukemia, BCR-ABL1 positive|chronic myelogenous leukemia, bcr-abl1 positive
5404894|NCT00072553|stage IV rectal cancer|stage iv rectal cancer
5404895|NCT00072553|stage IV colon cancer|stage iv colon cancer
5404896|NCT00072553|adenocarcinoma of the colon|adenocarcinoma of the colon
5404897|NCT00072553|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5404898|NCT00072553|recurrent rectal cancer|recurrent rectal cancer
5404899|NCT00072553|recurrent colon cancer|recurrent colon cancer
5404900|NCT00072527|limited stage small cell lung cancer|limited stage small cell lung cancer
5404901|NCT00071916|Hepatitis C, African Americans, ribavirin|hepatitis c, african americans, ribavirin
5404902|NCT00071851|HIV Seronegativity|hiv seronegativity
5404903|NCT00071851|HIV Preventive Vaccine|hiv preventive vaccine
5404904|NCT00071812|RA|ra
5404905|NCT00006008|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5404906|NCT00006008|L1 adult acute lymphoblastic leukemia|l1 adult acute lymphoblastic leukemia
5404907|NCT00006008|L2 adult acute lymphoblastic leukemia|l2 adult acute lymphoblastic leukemia
5404908|NCT00006008|L3 adult acute lymphoblastic leukemia|l3 adult acute lymphoblastic leukemia
5404909|NCT00005964|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5404910|NCT00005964|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5404911|NCT00005964|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5404912|NCT00005964|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5404913|NCT00005964|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5404914|NCT00005964|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5404915|NCT00005964|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
5404916|NCT00005964|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
5404917|NCT00005964|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
5404918|NCT00005964|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
5404919|NCT00005964|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5404920|NCT00005964|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
5404921|NCT00005962|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5404922|NCT00005962|adult acute erythroid leukemia (M6)|adult acute erythroid leukemia (m6)
5404923|NCT00005962|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
5405047|NCT00071513|Substance Abuse|substance abuse
5404924|NCT00005962|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
5404925|NCT00005962|adult acute promyelocytic leukemia (M3)|adult acute promyelocytic leukemia (m3)
5404926|NCT00005962|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
5404927|NCT00005962|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
5404928|NCT00005962|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
5404929|NCT00005962|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
5404930|NCT00005962|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
5404931|NCT00071903|Thrombophilia|thrombophilia
5404932|NCT00071903|Idiopathic Intracranial Hypertension|idiopathic intracranial hypertension
5404933|NCT00071903|Kidney Involvement|kidney involvement
5404934|NCT00071903|Lysosomal Storage Disorder|lysosomal storage disorder
5404935|NCT00071903|Cystine|cystine
5404936|NCT00071903|Pseudotumor Cerebri|pseudotumor cerebri
5404937|NCT00071903|Susceptibility to Thrombosis|susceptibility to thrombosis
5404938|NCT00071903|Nephropathic Cystinosis|nephropathic cystinosis
5404939|NCT00071903|PTC|ptc
5404940|NCT00071903|Intracranial Hypertension|intracranial hypertension
5404941|NCT00071890|Interleukin 2|interleukin 2
5404942|NCT00071890|Treatment Interruption|treatment interruption
5404943|NCT00071890|HIV|hiv
5404944|NCT00071877|Lysosomal Disease|lysosomal disease
5404945|NCT00071877|Hypohidrosis|hypohidrosis
5404946|NCT00071877|Pain|pain
5404947|NCT00071877|Neuropathy|neuropathy
5404948|NCT00071877|X-Linked|x-linked
5404949|NCT00071877|Fabry Disease|fabry disease
5404950|NCT00071877|Children|children
5404951|NCT00005072|stage I prostate cancer|stage i prostate cancer
5404952|NCT00005072|stage IIB prostate cancer|stage iib prostate cancer
5404953|NCT00005072|stage IIA prostate cancer|stage iia prostate cancer
5404954|NCT00005072|recurrent prostate cancer|recurrent prostate cancer
5404955|NCT00005046|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5404956|NCT00005046|primary peritoneal cavity cancer|primary peritoneal cavity cancer
5404957|NCT00004206|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5404958|NCT00004093|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5404959|NCT00004093|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5404960|NCT00071838|Neuroimmunology|neuroimmunology
5404961|NCT00071838|Therapy|therapy
5404962|NCT00071838|Demyelinating Disease|demyelinating disease
5404963|NCT00071838|Immunological Mechanism|immunological mechanism
5404964|NCT00071838|MRI|mri
5404965|NCT00071838|Multiple Sclerosis|multiple sclerosis
5404966|NCT00071838|MS|ms
5404967|NCT00071773|diabetic macular edema|diabetic macular edema
5404968|NCT00071773|laser photocoagulation|laser photocoagulation
5404969|NCT00071773|etdrs|etdrs
5404970|NCT00071773|macular grid photocoagulation|macular grid photocoagulation
5404971|NCT00071773|DME|dme
5404972|NCT00071786|Bipolar Mood Disorder|bipolar mood disorder
5404973|NCT00071786|Migraine|migraine
5404974|NCT00071786|Behavior Genetics|behavior genetics
5404975|NCT00071786|Genetic Epidemiology|genetic epidemiology
5404976|NCT00071786|Family Study|family study
5404977|NCT00071760|pediatrics|pediatrics
5404978|NCT00071760|ritonavir|ritonavir
5404979|NCT00071760|amprenavir|amprenavir
5404980|NCT00071760|AGENERASE|agenerase
5404981|NCT00071760|HIV|hiv
5404982|NCT00071760|Lexiva|lexiva
5404983|NCT00071760|protease inhibitors|protease inhibitors
5404984|NCT00071760|HIV Infection|hiv infection
5404985|NCT00071760|fosamprenavir|fosamprenavir
5404986|NCT00071747|schizophrenia|schizophrenia
5404987|NCT00071747|lamotrigine|lamotrigine
5404988|NCT00071721|Alzheimer disease|alzheimer disease
5404989|NCT00071721|Agitation|agitation
5404990|NCT00071721|Psychosis|psychosis
5404991|NCT00071682|herbal medicine|herbal medicine
5404992|NCT00071682|alternative medicines|alternative medicines
5404993|NCT00071682|anticoagulation|anticoagulation
5404994|NCT00071682|side effects|side effects
5404995|NCT00071682|bleeding|bleeding
5404996|NCT00071682|clotting|clotting
5404997|NCT00071669|Mood Disorder|mood disorder
5404998|NCT00071669|Acupuncture|acupuncture
5404999|NCT00071643|Stroke|stroke
5405000|NCT00071630|Adolescent|adolescent
5405001|NCT00071617|Suicide|suicide
5405002|NCT00071617|Adolescence|adolescence
5405003|NCT00071578|Psychotherapy|psychotherapy
5405004|NCT00071578|Treatment|treatment
5405005|NCT00071734|fMRI|fmri
5405006|NCT00071734|Auditory Feedback|auditory feedback
5405007|NCT00071734|Motor Control|motor control
5405008|NCT00071734|Adult|adult
5405009|NCT00071734|BOLD|bold
5405010|NCT00071734|Healthy Volunteer|healthy volunteer
5405011|NCT00071734|HV|hv
5405012|NCT00071565|familial intracranial aneurysm|familial intracranial aneurysm
5405013|NCT00071565|intracranial aneurysm|intracranial aneurysm
5405014|NCT00071565|brain aneurysm|brain aneurysm
5405015|NCT00071565|aneurysm|aneurysm
5405016|NCT00071565|subarachnoid hemorrhage|subarachnoid hemorrhage
5405017|NCT00071565|stroke|stroke
5405018|NCT00071552|Poorly Controlled Asthma|poorly controlled asthma
5405019|NCT00071539|gross total resection|gross total resection
5405020|NCT00004050|stage IIB prostate cancer|stage iib prostate cancer
5405021|NCT00004050|stage IIA prostate cancer|stage iia prostate cancer
5405022|NCT00004050|stage III prostate cancer|stage iii prostate cancer
5405023|NCT00004025|stage III melanoma|stage iii melanoma
5405024|NCT00004025|stage IV melanoma|stage iv melanoma
5405025|NCT00004025|recurrent melanoma|recurrent melanoma
5405026|NCT00003794|stage I ovarian germ cell tumor|stage i ovarian germ cell tumor
5405027|NCT00003794|stage II ovarian germ cell tumor|stage ii ovarian germ cell tumor
5405028|NCT00003794|stage III ovarian germ cell tumor|stage iii ovarian germ cell tumor
5405029|NCT00003794|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
5405030|NCT00003794|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
5405031|NCT00003648|stage I colon cancer|stage i colon cancer
5405032|NCT00003648|stage II colon cancer|stage ii colon cancer
5405033|NCT00003648|stage III colon cancer|stage iii colon cancer
5405034|NCT00003648|stage IV colon cancer|stage iv colon cancer
5405035|NCT00003648|stage I rectal cancer|stage i rectal cancer
5405036|NCT00003648|stage II rectal cancer|stage ii rectal cancer
5405037|NCT00003648|stage III rectal cancer|stage iii rectal cancer
5405038|NCT00003648|stage IV rectal cancer|stage iv rectal cancer
5405039|NCT00003648|recurrent colon cancer|recurrent colon cancer
5405040|NCT00003648|recurrent rectal cancer|recurrent rectal cancer
5405041|NCT00071526|Vitamin C|vitamin c
5405042|NCT00071526|Diabetes Mellitus|diabetes mellitus
5405043|NCT00071526|Proteinuria|proteinuria
5405044|NCT00071526|Renal Threshold|renal threshold
5405045|NCT00071526|Healthy Volunteer|healthy volunteer
5405048|NCT00071513|At-risk|at-risk
5405049|NCT00071500|Compliance|compliance
5405050|NCT00071500|Adherence|adherence
5405051|NCT00071500|Computerized|computerized
5405052|NCT00071500|Electronic Pillbox|electronic pillbox
5405053|NCT00071500|Treatment Experienced|treatment experienced
5405054|NCT00071487|SLE|sle
5405055|NCT00003595|childhood Burkitt lymphoma|childhood burkitt lymphoma
5405056|NCT00003595|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
5405057|NCT00003595|AIDS-related diffuse large cell lymphoma|aids-related diffuse large cell lymphoma
5405058|NCT00003595|AIDS-related immunoblastic large cell lymphoma|aids-related immunoblastic large cell lymphoma
5405059|NCT00003595|AIDS-related small noncleaved cell lymphoma|aids-related small noncleaved cell lymphoma
5405060|NCT00003266|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5405061|NCT00003266|fatigue|fatigue
5405062|NCT00003234|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
5405063|NCT00003234|recurrent neuroblastoma|recurrent neuroblastoma
5405064|NCT00003234|recurrent childhood soft tissue sarcoma|recurrent childhood soft tissue sarcoma
5405065|NCT00003234|recurrent childhood supratentorial primitive neuroectodermal tumor|recurrent childhood supratentorial primitive neuroectodermal tumor
5405066|NCT00003234|recurrent childhood cerebellar astrocytoma|recurrent childhood cerebellar astrocytoma
5405067|NCT00003234|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
5405068|NCT00003234|recurrent Ewing sarcoma/peripheral primitive neuroectodermal tumor|recurrent ewing sarcoma/peripheral primitive neuroectodermal tumor
5405069|NCT00003234|recurrent childhood ependymoma|recurrent childhood ependymoma
5405070|NCT00003126|renal cell cancer|renal cell cancer
5405071|NCT00003126|renal cell carcinoma|renal cell carcinoma
5405072|NCT00003126|interleukin-2|interleukin-2
5405073|NCT00071474|temporomandibular disroders|temporomandibular disroders
5405074|NCT00071474|shamanism|shamanism
5405075|NCT00071474|chronic pain|chronic pain
5405076|NCT00071461|Idiopathic pulmonary fibrosis|idiopathic pulmonary fibrosis
5405077|NCT00071461|Interstitial lung disease|interstitial lung disease
5405078|NCT00071461|Bosentan|bosentan
5405079|NCT00071461|BUILD|build
5405080|NCT00071435|EEG|eeg
5405081|NCT00071435|Voluntary Movement|voluntary movement
5405082|NCT00071435|Motor Cortex|motor cortex
5405083|NCT00071435|Reaction Time|reaction time
5405084|NCT00071435|Corticospinal|corticospinal
5405085|NCT00071435|Primary Lateral Sclerosis|primary lateral sclerosis
5405086|NCT00071435|PLS|pls
5405087|NCT00071435|Healthy Volunteer|healthy volunteer
5405088|NCT00071435|HV|hv
5405089|NCT00071422|Type 2 diabetes|type 2 diabetes
5405090|NCT00071409|Type 1 diabetes|type 1 diabetes
5405091|NCT00071396|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
5405092|NCT00071396|CD-52 and CD-20 Positive|cd-52 and cd-20 positive
5405093|NCT00071396|Refractory|refractory
5405094|NCT00071396|Relapsed|relapsed
5405095|NCT00033527|non-small cell lung cancer|non-small cell lung cancer
5405096|NCT00033527|small cell lung cancer|small cell lung cancer
5405097|NCT00025350|stage IV colon cancer|stage iv colon cancer
5405098|NCT00025350|stage IV rectal cancer|stage iv rectal cancer
5405099|NCT00025350|recurrent colon cancer|recurrent colon cancer
5405100|NCT00025350|recurrent rectal cancer|recurrent rectal cancer
5405101|NCT00025350|adenocarcinoma of the colon|adenocarcinoma of the colon
5405102|NCT00025350|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5405103|NCT00002935|stage 0 esophageal cancer|stage 0 esophageal cancer
5405104|NCT00002723|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5405105|NCT00002723|stage III prostate cancer|stage iii prostate cancer
5405106|NCT00002723|stage IV prostate cancer|stage iv prostate cancer
5405107|NCT00002723|recurrent prostate cancer|recurrent prostate cancer
5405108|NCT00071331|chronic heart failure|chronic heart failure
5405109|NCT00071331|heart failure|heart failure
5405110|NCT00071292|rheumatoid arthritis|rheumatoid arthritis
5405111|NCT00071292|stress reduction|stress reduction
5405112|NCT00071292|meditation|meditation
5405113|NCT00071292|mindfulness|mindfulness
5405114|NCT00071292|MBSR|mbsr
5431001|NCT00031161|Tyrosine|tyrosine
5405115|NCT00071292|mindfulness-based stress reduction|mindfulness-based stress reduction
5405116|NCT00071292|mind-body skills|mind-body skills
5405117|NCT00030420|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5405118|NCT00030420|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5405119|NCT00030420|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5405120|NCT00030420|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5405121|NCT00026260|recurrent cervical cancer|recurrent cervical cancer
5405122|NCT00026260|cervical squamous cell carcinoma|cervical squamous cell carcinoma
5405123|NCT00024128|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
5405124|NCT00024128|HIV-associated Hodgkin lymphoma|hiv-associated hodgkin lymphoma
5405125|NCT00023738|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
5405126|NCT00023738|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
5405127|NCT00023738|stage II adult soft tissue sarcoma|stage ii adult soft tissue sarcoma
5405128|NCT00071370|Magnetoencephalography|magnetoencephalography
5405129|NCT00071370|Electroencephalogram (EEG)|electroencephalogram (eeg)
5405130|NCT00071370|Interictal Epileptiform Discharges|interictal epileptiform discharges
5405131|NCT00071370|Epilepsy|epilepsy
5405132|NCT00071370|Sleep Deprivation|sleep deprivation
5405133|NCT00071370|Seizure|seizure
5405134|NCT00071305|Magnetoencephalography|magnetoencephalography
5405135|NCT00071305|Electroencephalography|electroencephalography
5405136|NCT00071305|Epilepsy|epilepsy
5405137|NCT00071305|Dipole Modeling|dipole modeling
5405138|NCT00071305|Surgery|surgery
5405139|NCT00071266|Intermittent Claudication|intermittent claudication
5405140|NCT00071266|Peripheral Arterial Disease|peripheral arterial disease
5405141|NCT00071266|Atherosclerosis|atherosclerosis
5405142|NCT00071266|Niacin|niacin
5405143|NCT00071266|Lovastatin|lovastatin
5405144|NCT00071266|PAD|pad
5405145|NCT00071266|IC|ic
5405146|NCT00071253|Bipolar Disorder - Mania|bipolar disorder - mania
5405147|NCT00071240|Growth Hormone|growth hormone
5405148|NCT00071240|HIV|hiv
5405149|NCT00071240|AIDS|aids
5405150|NCT00071240|Thymus|thymus
5405151|NCT00071240|CD4 Cell|cd4 cell
5405152|NCT00071240|Immune System|immune system
5405153|NCT00071240|Treatment Experienced|treatment experienced
5405154|NCT00071214|Staphylococcal infection|staphylococcal infection
5405155|NCT00071214|Gram positive bacteria|gram positive bacteria
5405156|NCT00071214|Staphylococcus|staphylococcus
5405157|NCT00071214|Staphylococcus aureus|staphylococcus aureus
5405158|NCT00071214|Staphylococcus aureus infection|staphylococcus aureus infection
5405159|NCT00064428|ST-segment elevation myocardial infarction|st-segment elevation myocardial infarction
5405160|NCT00064428|fondaparinux|fondaparinux
5405161|NCT00064428|Acute Myocardial Infarction|acute myocardial infarction
5405162|NCT00064428|acute coronary syndrome|acute coronary syndrome
5405163|NCT00071227|Age Related Macular Degeneration|age related macular degeneration
5405164|NCT00071227|Macular Edema|macular edema
5405165|NCT00071227|Inflammation|inflammation
5405166|NCT00071227|Choroidal Neovascularization|choroidal neovascularization
5405167|NCT00071227|CRVO|crvo
5405168|NCT00071227|Diabetic Retinopathy|diabetic retinopathy
5405169|NCT00071227|Age Related Macular Edema|age related macular edema
5405170|NCT00071227|AMD|amd
5405171|NCT00071188|Non-Small-Cell Lung Carcinoma|non-small-cell lung carcinoma
5405172|NCT00071175|Lupus|lupus
5405173|NCT00071175|Genetics|genetics
5405174|NCT00071162|Pain|pain
5405175|NCT00071162|Fatigue|fatigue
5405176|NCT00071162|Sleep|sleep
5405177|NCT00071162|Depression|depression
5405178|NCT00071162|Irritable Bowel Syndrome|irritable bowel syndrome
5405179|NCT00071162|Chronic Fatigue Syndrome|chronic fatigue syndrome
5405180|NCT00071149|Rheumatoid Arthritis|rheumatoid arthritis
5405181|NCT00071149|TCM|tcm
5405182|NCT00071149|Diagnosis|diagnosis
5405183|NCT00071149|Traditional Chinese Medicine|traditional chinese medicine
5405184|NCT00071149|Complementary Therapies|complementary therapies
5405185|NCT00071110|Acupuncture|acupuncture
5405186|NCT00071110|Electroacupuncture|electroacupuncture
5405187|NCT00071110|Alternative therapy|alternative therapy
5405188|NCT00071097|HIV|hiv
5405189|NCT00071097|TMC114|tmc114
5405190|NCT00071097|Ritonavir|ritonavir
5405191|NCT00071097|Tolerability|tolerability
5405192|NCT00071097|Safety and efficacy|safety and efficacy
5405193|NCT00071097|TMC114-C211|tmc114-c211
5405194|NCT00071084|Skin cancer|skin cancer
5405195|NCT00071084|Lymphoma|lymphoma
5405196|NCT00071084|Mycosis fungoides|mycosis fungoides
5405197|NCT00071084|Sezary syndrome|sezary syndrome
5405198|NCT00071071|Skin cancer|skin cancer
5405199|NCT00071071|Lymphoma|lymphoma
5405200|NCT00071071|Mycosis fungoides|mycosis fungoides
5405201|NCT00071071|Sezary syndrome|sezary syndrome
5405202|NCT00023725|stage I adult soft tissue sarcoma|stage i adult soft tissue sarcoma
5405203|NCT00023699|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5405204|NCT00023699|primary peritoneal cavity cancer|primary peritoneal cavity cancer
5405205|NCT00022282|refractory multiple myeloma|refractory multiple myeloma
5405206|NCT00016250|stage IV colon cancer|stage iv colon cancer
5405207|NCT00016250|stage IV rectal cancer|stage iv rectal cancer
5405208|NCT00016250|recurrent colon cancer|recurrent colon cancer
5431002|NCT00031161|Diet|diet
5405210|NCT00016250|adenocarcinoma of the colon|adenocarcinoma of the colon
5405211|NCT00016250|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5405212|NCT00015886|stage IV breast cancer|stage iv breast cancer
5405213|NCT00015886|recurrent breast cancer|recurrent breast cancer
5405214|NCT00015886|stage IIIB breast cancer|stage iiib breast cancer
5405215|NCT00014144|recurrent bladder cancer|recurrent bladder cancer
5405216|NCT00014144|stage IV bladder cancer|stage iv bladder cancer
5405217|NCT00014144|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
5405218|NCT00014144|recurrent urethral cancer|recurrent urethral cancer
5405219|NCT00014144|urethral cancer associated with invasive bladder cancer|urethral cancer associated with invasive bladder cancer
5405220|NCT00014144|metastatic transitional cell cancer of the renal pelvis and ureter|metastatic transitional cell cancer of the renal pelvis and ureter
5405221|NCT00014144|recurrent transitional cell cancer of the renal pelvis and ureter|recurrent transitional cell cancer of the renal pelvis and ureter
5405222|NCT00014144|anterior urethral cancer|anterior urethral cancer
5405223|NCT00014144|posterior urethral cancer|posterior urethral cancer
5405224|NCT00007917|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5405225|NCT00071383|Herceptin|herceptin
5405226|NCT00071383|Trastuzumab|trastuzumab
5405227|NCT00071383|Microdissection|microdissection
5405228|NCT00071383|Proteomics|proteomics
5405229|NCT00071383|Microarrays|microarrays
5405230|NCT00071383|Metastatic Brain Tumor|metastatic brain tumor
5405231|NCT00071383|Breast Cancer|breast cancer
5405232|NCT00071383|Brain|brain
5405233|NCT00071383|Carcinoma|carcinoma
5405234|NCT00071383|Genomics|genomics
5405235|NCT00071383|Metastatic Breast Cancer|metastatic breast cancer
5405236|NCT00071383|Metastatic Breast Tumor|metastatic breast tumor
5405237|NCT00071357|Microarray|microarray
5405238|NCT00071357|Herceptin|herceptin
5405239|NCT00071357|Trastuzumab|trastuzumab
5405240|NCT00071357|Carcinoma|carcinoma
5405241|NCT00071357|Proteomics|proteomics
5405242|NCT00071357|Breast Cancer|breast cancer
5405243|NCT00071357|Metastatic Breast Cancer|metastatic breast cancer
5405244|NCT00071357|Metastatic Breast Tumor|metastatic breast tumor
5405245|NCT00071344|Microarray|microarray
5405246|NCT00071344|Genomics|genomics
5405247|NCT00071344|Trastuzumab|trastuzumab
5405248|NCT00071344|Carcinoma|carcinoma
5405249|NCT00071344|Non-Small Cell Lung Cancer|non-small cell lung cancer
5405250|NCT00071344|Metastatic Brain Tumor|metastatic brain tumor
5405251|NCT00071344|Brain|brain
5405252|NCT00071344|Microarrays|microarrays
5405253|NCT00071344|Microdissection|microdissection
5405254|NCT00071344|Lung Cancer|lung cancer
5405255|NCT00071344|NSCLC|nsclc
5405256|NCT00071123|fMRI|fmri
5405257|NCT00071123|Habituation|habituation
5405258|NCT00071123|Extinction|extinction
5405259|NCT00071123|Amygdala|amygdala
5405260|NCT00071123|Emotion|emotion
5405261|NCT00071123|Major Depressive Disorder|major depressive disorder
5405262|NCT00071123|Medial Prefrontal Cortex|medial prefrontal cortex
5405263|NCT00071123|Backward Masking|backward masking
5405264|NCT00071123|Depression|depression
5405265|NCT00071123|MDD|mdd
5405266|NCT00071123|Healthy Volunteer|healthy volunteer
5405267|NCT00071123|HV|hv
5405268|NCT00071032|Blood Disease|blood disease
5405269|NCT00071032|blood transfusion|blood transfusion
5405270|NCT00070993|ALS|als
5405271|NCT00070993|Creatine|creatine
5405272|NCT00070980|Complementary Therapies|complementary therapies
5405273|NCT00070967|Acupuncture|acupuncture
5405274|NCT00070967|Quality of Life|quality of life
5405275|NCT00070967|Complementary Therapies|complementary therapies
5405276|NCT00070967|TCM|tcm
5405277|NCT00070967|Traditional Chinese Medicine|traditional chinese medicine
5405278|NCT00070954|ECT|ect
5405279|NCT00070954|Memory|memory
5405280|NCT00070954|Ginkgo biloba|ginkgo biloba
5405281|NCT00070941|Parkinsons Disease|parkinsons disease
5405282|NCT00070941|Depression|depression
5405283|NCT00070941|SAM-e|sam-e
5405284|NCT00070928|Sleep|sleep
5405285|NCT00070902|Spinal Manipulation|spinal manipulation
5405286|NCT00070902|Chiropractic|chiropractic
5405287|NCT00070902|Zygapophysial Joints|zygapophysial joints
5405288|NCT00070889|Complementary Therapies|complementary therapies
5405289|NCT00070850|Screening|screening
5405290|NCT00070850|Prenatal|prenatal
5405291|NCT00070850|Amniocentesis|amniocentesis
5405292|NCT00070824|Acupuncture|acupuncture
5405293|NCT00070824|SPECT|spect
5405294|NCT00070824|f-MRI|f-mri
5405295|NCT00070824|Functional brain imaging|functional brain imaging
5405296|NCT00070824|RCT|rct
5405297|NCT00070811|Facial form|facial form
5405298|NCT00070811|Facial animation|facial animation
5405299|NCT00070811|Lip muscle reconstruction|lip muscle reconstruction
5405300|NCT00070811|Lip form|lip form
5405301|NCT00070811|Lip function|lip function
5405302|NCT00070720|Behavior change|behavior change
5405303|NCT00070720|Change in practitioner behavior|change in practitioner behavior
5405304|NCT00070720|Episiotomy|episiotomy
5405305|NCT00070720|Active management of third stage of labor|active management of third stage of labor
5405306|NCT00070720|Global Network|global network
5405307|NCT00070720|Latin America|latin america
5405308|NCT00070720|Uruguay|uruguay
5405309|NCT00070720|Argentina|argentina
5405310|NCT00070720|Maternal and child health|maternal and child health
5405311|NCT00070720|International|international
5405312|NCT00070720|Women's health|women's health
5405313|NCT00071058|P-glycoprotein Inhibition|p-glycoprotein inhibition
5405314|NCT00071058|Drug Resistance Reversal|drug resistance reversal
5405315|NCT00071058|Pharmacodynamics|pharmacodynamics
5405316|NCT00071058|Molecular Target|molecular target
5405317|NCT00071058|Endocrine Cancer|endocrine cancer
5405318|NCT00071058|Adrenocortical Cancer|adrenocortical cancer
5405319|NCT00071058|ACC|acc
5405320|NCT00071058|Adrenocortical Tumor|adrenocortical tumor
5405321|NCT00071045|Tissue Procurement|tissue procurement
5405322|NCT00071045|Sample Collection|sample collection
5405323|NCT00071045|Laboratory Research|laboratory research
5405324|NCT00070746|Perinatal mortality [PNM]|perinatal mortality [pnm]
5405325|NCT00070746|Neonatal mortality|neonatal mortality
5405326|NCT00070746|Low birth weight [LBW]|low birth weight [lbw]
5405327|NCT00070746|Spontaneous preterm delivery [SPTD]|spontaneous preterm delivery [sptd]
5405328|NCT00070746|Premature rupture of membranes [PROM]|premature rupture of membranes [prom]
5405329|NCT00070746|Histological chorioamnionitis|histological chorioamnionitis
5405330|NCT00070746|Global Network|global network
5405331|NCT00070746|Pakistan|pakistan
5405332|NCT00070746|Maternal and child health|maternal and child health
5405333|NCT00070746|International|international
5405334|NCT00070746|Women's health|women's health
5405335|NCT00070733|Testosterone|testosterone
5405336|NCT00070733|5-alpha Reductase|5-alpha reductase
5405337|NCT00070733|Muscle Strength|muscle strength
5405338|NCT00070733|Libido|libido
5405339|NCT00070733|Sexual Function|sexual function
5405340|NCT00070733|Muscle Mass|muscle mass
5405341|NCT00070733|Testosterone 5-alpha-Reductase|testosterone 5-alpha-reductase
5405342|NCT00070707|Seasonal Allergic Rhinitis|seasonal allergic rhinitis
5405343|NCT00070707|Concomitant Asthma|concomitant asthma
5405344|NCT00070876|Child|child
5405345|NCT00070876|Adolescent|adolescent
5405346|NCT00069433|Psychotic Disorders|psychotic disorders
5405347|NCT00017368|regional neuroblastoma|regional neuroblastoma
5405348|NCT00017368|disseminated neuroblastoma|disseminated neuroblastoma
5405349|NCT00017368|localized unresectable neuroblastoma|localized unresectable neuroblastoma
5405350|NCT00017368|stage 4S neuroblastoma|stage 4s neuroblastoma
5405351|NCT00003907|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
5405352|NCT00003907|advanced adult primary liver cancer|advanced adult primary liver cancer
5405353|NCT00003907|recurrent adult primary liver cancer|recurrent adult primary liver cancer
5405354|NCT00003907|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
5405355|NCT00003907|liver metastases|liver metastases
5405356|NCT00070785|Nasopharyngeal Cancer|nasopharyngeal cancer
5405357|NCT00070785|EBV Virus|ebv virus
5405358|NCT00070785|Epitope Mapping|epitope mapping
5405359|NCT00070785|Epstein-Barr Virus|epstein-barr virus
5405360|NCT00070785|Latent Protein-2|latent protein-2
5405361|NCT00070785|Healthy Volunteer|healthy volunteer
5405362|NCT00070785|HV|hv
5405363|NCT00070759|Daclizumab|daclizumab
5405364|NCT00070759|Uveitis|uveitis
5405365|NCT00070759|Active|active
5405366|NCT00070759|Acute|acute
5405367|NCT00070642|Immunotherapy, skin cancer|immunotherapy, skin cancer
5405368|NCT00070629|Immunotherapy|immunotherapy
5405369|NCT00070629|lung cancer|lung cancer
5405370|NCT00070616|mucositis|mucositis
5405371|NCT00070616|chemotherapy|chemotherapy
5405372|NCT00070616|radiation therapy|radiation therapy
5405373|NCT00070590|Scleroderma|scleroderma
5405374|NCT00070590|Fibrosing alveolitis|fibrosing alveolitis
5405375|NCT00070590|Build|build
5405376|NCT00070590|bosentan|bosentan
5405377|NCT00007839|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
5405378|NCT00007839|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
5405379|NCT00007839|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
5405380|NCT00007839|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5405381|NCT00007839|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5405382|NCT00007839|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5405383|NCT00007839|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5405384|NCT00007839|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5405385|NCT00007839|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5405386|NCT00007839|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5405387|NCT00007839|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5405388|NCT00007839|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5405389|NCT00007839|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
5405390|NCT00007839|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
5405391|NCT00007839|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
5405392|NCT00007839|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5405393|NCT00007839|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5405460|NCT00005800|stage IIIA breast cancer|stage iiia breast cancer
5405394|NCT00007839|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
5405395|NCT00007839|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
5405396|NCT00007839|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
5405397|NCT00007839|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5405398|NCT00007839|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5405399|NCT00007839|stage I marginal zone lymphoma|stage i marginal zone lymphoma
5405400|NCT00007839|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
5405401|NCT00007839|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5405402|NCT00007839|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5405403|NCT00007839|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5405404|NCT00007839|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5405405|NCT00007839|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
5405406|NCT00007839|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
5405407|NCT00007839|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5405408|NCT00007839|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5405409|NCT00007839|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5405410|NCT00006482|recurrent cervical cancer|recurrent cervical cancer
5405411|NCT00006482|stage IVB cervical cancer|stage ivb cervical cancer
5405412|NCT00006482|stage IVA cervical cancer|stage iva cervical cancer
5405413|NCT00006482|cervical squamous cell carcinoma|cervical squamous cell carcinoma
5405414|NCT00006466|monoclonal gammopathy of undetermined significance|monoclonal gammopathy of undetermined significance
5405415|NCT00006466|isolated plasmacytoma of bone|isolated plasmacytoma of bone
5405416|NCT00006466|extramedullary plasmacytoma|extramedullary plasmacytoma
5405417|NCT00006466|refractory multiple myeloma|refractory multiple myeloma
5405418|NCT00006466|stage I multiple myeloma|stage i multiple myeloma
5405419|NCT00006466|stage II multiple myeloma|stage ii multiple myeloma
5405420|NCT00006466|stage III multiple myeloma|stage iii multiple myeloma
5405421|NCT00006257|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5405422|NCT00006121|stage III breast cancer|stage iii breast cancer
5405423|NCT00006121|stage IV breast cancer|stage iv breast cancer
5405424|NCT00006121|recurrent breast cancer|recurrent breast cancer
5405425|NCT00006012|drug/agent toxicity by tissue/organ|drug/agent toxicity by tissue/organ
5405426|NCT00006012|radiation toxicity|radiation toxicity
5405427|NCT00006012|limited stage small cell lung cancer|limited stage small cell lung cancer
5405428|NCT00006009|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
5405429|NCT00006009|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
5405430|NCT00006009|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
5405431|NCT00006009|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
5405432|NCT00006009|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5405433|NCT00006009|small intestine lymphoma|small intestine lymphoma
5405434|NCT00006009|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
5405435|NCT00006009|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
5405436|NCT00006009|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
5405437|NCT00006009|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
5405438|NCT00006009|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5405439|NCT00006009|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
5405440|NCT00006009|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
5405441|NCT00006009|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
5405442|NCT00006009|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
5405443|NCT00006009|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5405444|NCT00005998|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5405445|NCT00005998|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5405446|NCT00005998|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5405447|NCT00005998|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5405448|NCT00005998|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5405449|NCT00005998|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5405450|NCT00005998|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5405451|NCT00005998|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5405452|NCT00005998|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5405453|NCT00005998|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5405454|NCT00005998|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5405455|NCT00005998|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5405456|NCT00005998|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5405457|NCT00005998|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5405458|NCT00005998|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5405459|NCT00005998|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5405461|NCT00005800|stage IIIB breast cancer|stage iiib breast cancer
5405462|NCT00005800|inflammatory breast cancer|inflammatory breast cancer
5405463|NCT00005794|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5405464|NCT00070694|Affective Disorders|affective disorders
5405465|NCT00070694|Refractory|refractory
5405466|NCT00070694|Augmentation|augmentation
5405467|NCT00070694|Polysomogram|polysomogram
5405468|NCT00070694|Combination Therapy|combination therapy
5405469|NCT00070694|Affective Disorder|affective disorder
5405470|NCT00070694|Depression|depression
5405471|NCT00070694|Major Depression|major depression
5405472|NCT00070564|stage II breast cancer|stage ii breast cancer
5405473|NCT00070564|stage IA breast cancer|stage ia breast cancer
5405474|NCT00070564|stage IB breast cancer|stage ib breast cancer
5405475|NCT00070564|stage IIIC breast cancer|stage iiic breast cancer
5405476|NCT00070564|male breast cancer|male breast cancer
5405477|NCT00070564|HER2-positive breast cancer|her2-positive breast cancer
5405478|NCT00070564|estrogen receptor-negative breast cancer|estrogen receptor-negative breast cancer
5405479|NCT00070564|estrogen receptor-positive breast cancer|estrogen receptor-positive breast cancer
5405480|NCT00070564|progesterone receptor-negative breast cancer|progesterone receptor-negative breast cancer
5405481|NCT00070564|progesterone receptor-positive breast cancer|progesterone receptor-positive breast cancer
5405482|NCT00070538|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5405483|NCT00070538|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5405484|NCT00070538|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5405485|NCT00070538|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5405486|NCT00070538|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
5405487|NCT00070538|refractory anemia with excess blasts|refractory anemia with excess blasts
5405488|NCT00070538|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5405489|NCT00070538|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
5405490|NCT00070538|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
5405491|NCT00070538|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5405492|NCT00070538|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5405493|NCT00070538|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5405494|NCT00070538|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5405495|NCT00070538|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5405496|NCT00070538|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5405497|NCT00070538|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5405498|NCT00070538|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5405499|NCT00070486|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5405500|NCT00070486|adenocarcinoma of the lung|adenocarcinoma of the lung
5405501|NCT00070486|squamous cell lung cancer|squamous cell lung cancer
5405502|NCT00070486|large cell lung cancer|large cell lung cancer
5405503|NCT00070486|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5405504|NCT00070473|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
5405505|NCT00070447|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
5405506|NCT00070447|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5405507|NCT00070447|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5405508|NCT00070447|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5405509|NCT00070434|stage II rectal cancer|stage ii rectal cancer
5405510|NCT00070434|stage III rectal cancer|stage iii rectal cancer
5405511|NCT00070434|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5405512|NCT00070421|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
5405513|NCT00070421|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
5405514|NCT00070421|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
5405515|NCT00070421|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
5405516|NCT00070421|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5405517|NCT00070421|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5405518|NCT00070421|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
5405519|NCT00070421|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
5405520|NCT00070421|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
5405521|NCT00070421|stage I childhood Hodgkin lymphoma|stage i childhood hodgkin lymphoma
5405522|NCT00070421|stage I childhood large cell lymphoma|stage i childhood large cell lymphoma
5405523|NCT00070421|stage I childhood lymphoblastic lymphoma|stage i childhood lymphoblastic lymphoma
5405524|NCT00070421|stage I childhood small noncleaved cell lymphoma|stage i childhood small noncleaved cell lymphoma
5405525|NCT00070421|stage II childhood Hodgkin lymphoma|stage ii childhood hodgkin lymphoma
5405526|NCT00070421|stage II childhood large cell lymphoma|stage ii childhood large cell lymphoma
5405527|NCT00070421|stage II childhood lymphoblastic lymphoma|stage ii childhood lymphoblastic lymphoma
5405528|NCT00070421|stage II childhood small noncleaved cell lymphoma|stage ii childhood small noncleaved cell lymphoma
5405529|NCT00070421|stage III childhood Hodgkin lymphoma|stage iii childhood hodgkin lymphoma
5405530|NCT00070421|stage III childhood large cell lymphoma|stage iii childhood large cell lymphoma
5405531|NCT00070421|stage III childhood lymphoblastic lymphoma|stage iii childhood lymphoblastic lymphoma
5405532|NCT00070421|stage III childhood small noncleaved cell lymphoma|stage iii childhood small noncleaved cell lymphoma
5405533|NCT00070421|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
5405534|NCT00070421|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
5405535|NCT00070421|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
5405536|NCT00070421|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
5405537|NCT00070421|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
5405538|NCT00070382|anemia|anemia
5405539|NCT00070382|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5405540|NCT00070382|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
5405541|NCT00070382|monoclonal gammopathy of undetermined significance|monoclonal gammopathy of undetermined significance
5405542|NCT00070382|extramedullary plasmacytoma|extramedullary plasmacytoma
5405543|NCT00070382|isolated plasmacytoma of bone|isolated plasmacytoma of bone
5405544|NCT00070382|refractory multiple myeloma|refractory multiple myeloma
5405545|NCT00070382|primary systemic amyloidosis|primary systemic amyloidosis
5405546|NCT00070382|stage I multiple myeloma|stage i multiple myeloma
5405547|NCT00070382|stage II multiple myeloma|stage ii multiple myeloma
5405548|NCT00070382|stage III multiple myeloma|stage iii multiple myeloma
5405549|NCT00070382|post-transplant lymphoproliferative disorder|post-transplant lymphoproliferative disorder
5405550|NCT00070382|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
5405551|NCT00070382|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5405552|NCT00070382|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
5405553|NCT00070382|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
5405554|NCT00070382|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
5405555|NCT00070382|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
5405556|NCT00070382|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
5405557|NCT00070382|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
5405558|NCT00070382|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
5405559|NCT00070382|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
5405560|NCT00070382|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
5405561|NCT00070382|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5405562|NCT00070382|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5405563|NCT00070382|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
5405564|NCT00070382|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
5405565|NCT00070382|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
5405566|NCT00070382|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
5405567|NCT00070382|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5405568|NCT00070382|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
5405569|NCT00070382|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
5405570|NCT00070382|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5405571|NCT00070382|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5405572|NCT00070382|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
5405573|NCT00070382|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5405574|NCT00070382|stage 0 chronic lymphocytic leukemia|stage 0 chronic lymphocytic leukemia
5405575|NCT00070382|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
5405576|NCT00070382|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
5405577|NCT00070382|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5405578|NCT00070382|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5405579|NCT00070382|prolymphocytic leukemia|prolymphocytic leukemia
5405580|NCT00070382|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5405581|NCT00070382|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5405582|NCT00070382|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5405583|NCT00070382|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
5405584|NCT00070382|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
5405585|NCT00070382|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
5405586|NCT00070382|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5405587|NCT00070382|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5405588|NCT00070382|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5405589|NCT00070382|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5405590|NCT00070382|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5405591|NCT00070382|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5405592|NCT00070382|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
5405593|NCT00070382|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
5405783|NCT00069940|adult synovial sarcoma|adult synovial sarcoma
5405594|NCT00070382|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
5405595|NCT00070382|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5405596|NCT00070382|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
5405597|NCT00070382|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
5405598|NCT00070382|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5405599|NCT00070382|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5405600|NCT00070382|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5405601|NCT00070382|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
5405602|NCT00070382|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
5405603|NCT00070382|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
5405604|NCT00070382|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5405605|NCT00070382|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5405606|NCT00070382|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5405607|NCT00070382|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5405608|NCT00070382|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5405609|NCT00070382|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5405610|NCT00070382|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
5405611|NCT00070382|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
5405612|NCT00070382|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5405613|NCT00070382|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
5405614|NCT00070382|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5405615|NCT00070382|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5405616|NCT00070382|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
5405617|NCT00070382|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5405618|NCT00070382|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5405619|NCT00070382|stage I mantle cell lymphoma|stage i mantle cell lymphoma
5405620|NCT00070382|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5405621|NCT00070382|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5405622|NCT00070382|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
5405623|NCT00070382|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
5405624|NCT00070382|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
5405625|NCT00070382|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5405626|NCT00070382|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5405627|NCT00070382|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5405628|NCT00070343|stage IV melanoma|stage iv melanoma
5405629|NCT00070343|stage III melanoma|stage iii melanoma
5405630|NCT00070304|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
5405631|NCT00070304|childhood lymphocyte predominant Hodgkin lymphoma|childhood lymphocyte predominant hodgkin lymphoma
5405632|NCT00070304|childhood lymphocyte depletion Hodgkin lymphoma|childhood lymphocyte depletion hodgkin lymphoma
5405633|NCT00070304|childhood nodular sclerosis Hodgkin lymphoma|childhood nodular sclerosis hodgkin lymphoma
5405634|NCT00070304|childhood mixed cellularity Hodgkin lymphoma|childhood mixed cellularity hodgkin lymphoma
5405635|NCT00070291|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
5405636|NCT00070278|stage II breast cancer|stage ii breast cancer
5405637|NCT00070278|stage IIIA breast cancer|stage iiia breast cancer
5405638|NCT00070278|stage IIIB breast cancer|stage iiib breast cancer
5405639|NCT00070278|stage IIIC breast cancer|stage iiic breast cancer
5405640|NCT00070213|adenocarcinoma of the colon|adenocarcinoma of the colon
5405641|NCT00070213|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5405642|NCT00070213|stage IV rectal cancer|stage iv rectal cancer
5405643|NCT00070213|stage IV colon cancer|stage iv colon cancer
5405644|NCT00070213|recurrent rectal cancer|recurrent rectal cancer
5405645|NCT00070213|recurrent colon cancer|recurrent colon cancer
5405646|NCT00070200|recurrent neuroblastoma|recurrent neuroblastoma
5405647|NCT00070200|stage 4S neuroblastoma|stage 4s neuroblastoma
5405648|NCT00070200|localized unresectable neuroblastoma|localized unresectable neuroblastoma
5405649|NCT00070200|localized resectable neuroblastoma|localized resectable neuroblastoma
5405650|NCT00070200|regional neuroblastoma|regional neuroblastoma
5405651|NCT00070200|disseminated neuroblastoma|disseminated neuroblastoma
5405652|NCT00070187|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5405653|NCT00070187|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
5405654|NCT00070174|untreated childhood acute myeloid leukemia and other myeloid malignancies|untreated childhood acute myeloid leukemia and other myeloid malignancies
5405655|NCT00070174|childhood acute monocytic leukemia (M5b)|childhood acute monocytic leukemia (m5b)
5405656|NCT00070174|childhood acute megakaryocytic leukemia (M7)|childhood acute megakaryocytic leukemia (m7)
5405657|NCT00070174|childhood acute minimally differentiated myeloid leukemia (M0)|childhood acute minimally differentiated myeloid leukemia (m0)
5405658|NCT00070174|childhood acute myeloblastic leukemia with maturation (M2)|childhood acute myeloblastic leukemia with maturation (m2)
5405659|NCT00070174|childhood acute myeloblastic leukemia without maturation (M1)|childhood acute myeloblastic leukemia without maturation (m1)
5405660|NCT00070174|childhood acute myelomonocytic leukemia (M4)|childhood acute myelomonocytic leukemia (m4)
5405661|NCT00070174|childhood acute monoblastic leukemia (M5a)|childhood acute monoblastic leukemia (m5a)
5405662|NCT00070174|childhood acute erythroleukemia (M6)|childhood acute erythroleukemia (m6)
5405663|NCT00070161|radiation toxicity|radiation toxicity
5405664|NCT00070161|adult mixed glioma|adult mixed glioma
5405665|NCT00070161|adult central nervous system germ cell tumor|adult central nervous system germ cell tumor
5405666|NCT00070161|adult brain stem glioma|adult brain stem glioma
5405667|NCT00070161|adult craniopharyngioma|adult craniopharyngioma
5405668|NCT00070161|adult medulloblastoma|adult medulloblastoma
5405669|NCT00070161|adult meningioma|adult meningioma
5405670|NCT00070161|adult choroid plexus tumor|adult choroid plexus tumor
5405671|NCT00070161|adult tumors metastatic to brain|adult tumors metastatic to brain
5405672|NCT00070161|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
5405673|NCT00070161|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5405674|NCT00070161|adult pilocytic astrocytoma|adult pilocytic astrocytoma
5405675|NCT00070161|adult subependymoma|adult subependymoma
5405676|NCT00070161|adult meningeal hemangiopericytoma|adult meningeal hemangiopericytoma
5405677|NCT00070161|adult ependymoblastoma|adult ependymoblastoma
5405678|NCT00070161|adult anaplastic ependymoma|adult anaplastic ependymoma
5405679|NCT00070161|adult pineoblastoma|adult pineoblastoma
5405680|NCT00070161|adult pineocytoma|adult pineocytoma
5405681|NCT00070161|adult myxopapillary ependymoma|adult myxopapillary ependymoma
5405682|NCT00070161|adult glioblastoma|adult glioblastoma
5405683|NCT00070161|adult grade III meningioma|adult grade iii meningioma
5405684|NCT00070161|adult oligodendroglioma|adult oligodendroglioma
5405685|NCT00070161|adult giant cell glioblastoma|adult giant cell glioblastoma
5405686|NCT00070161|adult gliosarcoma|adult gliosarcoma
5405687|NCT00070161|adult ependymoma|adult ependymoma
5405688|NCT00070148|weight changes|weight changes
5405689|NCT00070148|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5405690|NCT00070135|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5405691|NCT00070135|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5405692|NCT00070135|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
5405693|NCT00070135|adult acute erythroid leukemia (M6)|adult acute erythroid leukemia (m6)
5405694|NCT00070135|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
5405695|NCT00070135|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
5405696|NCT00070135|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
5405697|NCT00070135|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
5405698|NCT00070135|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
5405699|NCT00070135|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
5405700|NCT00070135|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5405701|NCT00070135|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5405702|NCT00070135|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5405703|NCT00070135|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5405704|NCT00070096|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
5405705|NCT00070096|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
5405706|NCT00070096|adult central nervous system germ cell tumor|adult central nervous system germ cell tumor
5405707|NCT00070096|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
5405708|NCT00070096|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
5405709|NCT00070096|testicular seminoma|testicular seminoma
5405710|NCT00070096|testicular choriocarcinoma and embryonal carcinoma|testicular choriocarcinoma and embryonal carcinoma
5405711|NCT00070096|testicular choriocarcinoma and seminoma|testicular choriocarcinoma and seminoma
5405712|NCT00070096|testicular choriocarcinoma and teratoma|testicular choriocarcinoma and teratoma
5405713|NCT00070096|testicular choriocarcinoma and yolk sac tumor|testicular choriocarcinoma and yolk sac tumor
5405714|NCT00070096|testicular choriocarcinoma|testicular choriocarcinoma
5405715|NCT00070096|testicular embryonal carcinoma and seminoma|testicular embryonal carcinoma and seminoma
5405716|NCT00070096|testicular embryonal carcinoma and teratoma with seminoma|testicular embryonal carcinoma and teratoma with seminoma
5405717|NCT00070096|testicular embryonal carcinoma and teratoma|testicular embryonal carcinoma and teratoma
5405718|NCT00070096|testicular embryonal carcinoma and yolk sac tumor with seminoma|testicular embryonal carcinoma and yolk sac tumor with seminoma
5405719|NCT00070096|testicular embryonal carcinoma and yolk sac tumor|testicular embryonal carcinoma and yolk sac tumor
5405720|NCT00070096|testicular embryonal carcinoma|testicular embryonal carcinoma
5405721|NCT00070096|testicular yolk sac tumor and teratoma with seminoma|testicular yolk sac tumor and teratoma with seminoma
5405722|NCT00070096|testicular yolk sac tumor and teratoma|testicular yolk sac tumor and teratoma
5405723|NCT00070096|testicular yolk sac tumor|testicular yolk sac tumor
5405724|NCT00070096|recurrent extragonadal non-seminomatous germ cell tumor|recurrent extragonadal non-seminomatous germ cell tumor
5405725|NCT00070096|recurrent extragonadal seminoma|recurrent extragonadal seminoma
5405726|NCT00070096|stage IV extragonadal non-seminomatous germ cell tumor|stage iv extragonadal non-seminomatous germ cell tumor
5405727|NCT00070096|stage IV extragonadal seminoma|stage iv extragonadal seminoma
5405728|NCT00070096|recurrent extragonadal germ cell tumor|recurrent extragonadal germ cell tumor
5405729|NCT00070096|testicular immature teratoma|testicular immature teratoma
5405730|NCT00070096|testicular mature teratoma|testicular mature teratoma
5405731|NCT00070083|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
5405732|NCT00070083|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5405733|NCT00070083|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5405734|NCT00070083|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5405735|NCT00070070|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
5405736|NCT00070070|stage I bladder cancer|stage i bladder cancer
5405737|NCT00070031|recurrent breast cancer|recurrent breast cancer
5405738|NCT00070031|stage IIIA breast cancer|stage iiia breast cancer
5405739|NCT00070031|stage IIIB breast cancer|stage iiib breast cancer
5405740|NCT00070031|stage IIIC breast cancer|stage iiic breast cancer
5405741|NCT00070031|stage IV breast cancer|stage iv breast cancer
5405742|NCT00070018|stage I mantle cell lymphoma|stage i mantle cell lymphoma
5405743|NCT00070018|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
5405744|NCT00070018|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
5405745|NCT00070018|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5405746|NCT00070018|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
5405747|NCT00070018|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
5405748|NCT00070018|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
5405749|NCT00070018|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5405750|NCT00070018|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
5405751|NCT00070018|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5405752|NCT00070005|perioperative/postoperative complications|perioperative/postoperative complications
5405753|NCT00070005|stage I rectal cancer|stage i rectal cancer
5405754|NCT00070005|stage II rectal cancer|stage ii rectal cancer
5405755|NCT00070005|stage III rectal cancer|stage iii rectal cancer
5405756|NCT00070005|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5405757|NCT00069992|polycythemia vera|polycythemia vera
5405758|NCT00069992|essential thrombocythemia|essential thrombocythemia
5405759|NCT00069992|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5405760|NCT00069992|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5405761|NCT00069992|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5405762|NCT00069992|primary myelofibrosis|primary myelofibrosis
5405763|NCT00069992|chronic myelogenous leukemia|chronic myelogenous leukemia
5405764|NCT00069992|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5405765|NCT00069992|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5405766|NCT00069992|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5405767|NCT00069992|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5405768|NCT00069992|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5405769|NCT00069992|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
5405770|NCT00069966|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5405771|NCT00069966|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5405772|NCT00069966|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5405773|NCT00069966|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5405774|NCT00069966|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5405775|NCT00069966|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5405776|NCT00069953|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
5405777|NCT00069953|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
5405778|NCT00069953|stage II esophageal cancer|stage ii esophageal cancer
5405779|NCT00069953|stage III esophageal cancer|stage iii esophageal cancer
5405780|NCT00069940|adult glioblastoma|adult glioblastoma
5405781|NCT00069940|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
5405782|NCT00069940|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
5405784|NCT00069940|childhood synovial sarcoma|childhood synovial sarcoma
5405785|NCT00069940|childhood leiomyosarcoma|childhood leiomyosarcoma
5405786|NCT00069940|adult leiomyosarcoma|adult leiomyosarcoma
5405787|NCT00069940|adult liposarcoma|adult liposarcoma
5405788|NCT00069940|childhood liposarcoma|childhood liposarcoma
5405789|NCT00069940|gastrointestinal stromal tumor|gastrointestinal stromal tumor
5405790|NCT00069940|recurrent childhood brain tumor|recurrent childhood brain tumor
5405791|NCT00069940|recurrent adult brain tumor|recurrent adult brain tumor
5405792|NCT00069940|metastatic childhood soft tissue sarcoma|metastatic childhood soft tissue sarcoma
5405793|NCT00069940|recurrent childhood soft tissue sarcoma|recurrent childhood soft tissue sarcoma
5405794|NCT00069940|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
5405795|NCT00069940|adult giant cell glioblastoma|adult giant cell glioblastoma
5405796|NCT00069940|adult gliosarcoma|adult gliosarcoma
5405797|NCT00069940|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5405798|NCT00069940|adult oligodendroglioma|adult oligodendroglioma
5405799|NCT00069940|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
5405800|NCT00069940|adult diffuse astrocytoma|adult diffuse astrocytoma
5405801|NCT00069940|adult mixed glioma|adult mixed glioma
5405802|NCT00069940|adult myxopapillary ependymoma|adult myxopapillary ependymoma
5405803|NCT00069940|adult anaplastic ependymoma|adult anaplastic ependymoma
5405804|NCT00069940|childhood high-grade cerebral astrocytoma|childhood high-grade cerebral astrocytoma
5405805|NCT00069940|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
5405806|NCT00069940|untreated childhood cerebellar astrocytoma|untreated childhood cerebellar astrocytoma
5405807|NCT00069940|recurrent childhood cerebellar astrocytoma|recurrent childhood cerebellar astrocytoma
5405808|NCT00069940|childhood infratentorial ependymoma|childhood infratentorial ependymoma
5405809|NCT00069940|newly diagnosed childhood ependymoma|newly diagnosed childhood ependymoma
5405810|NCT00069940|recurrent childhood ependymoma|recurrent childhood ependymoma
5405811|NCT00069940|childhood oligodendroglioma|childhood oligodendroglioma
5405812|NCT00069927|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
5405813|NCT00069927|depression|depression
5405814|NCT00069927|neurotoxicity|neurotoxicity
5405815|NCT00006034|stage 0 bladder cancer|stage 0 bladder cancer
5405816|NCT00006034|recurrent bladder cancer|recurrent bladder cancer
5405817|NCT00003868|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5405818|NCT00003868|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5405819|NCT00003868|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5405820|NCT00003868|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5405821|NCT00003868|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5405822|NCT00003868|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5405823|NCT00003868|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5405824|NCT00003868|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5405825|NCT00070577|Alcohol Clamp|alcohol clamp
5405826|NCT00070577|Pharmacokinetics|pharmacokinetics
5405827|NCT00070577|Pharmacodynamics|pharmacodynamics
5405828|NCT00070577|Alcohol|alcohol
5405829|NCT00070577|Metabolism|metabolism
5405830|NCT00070577|Response|response
5405831|NCT00070577|Age|age
5405832|NCT00070577|Sex|sex
5405833|NCT00070577|Healthy Volunteer|healthy volunteer
5405834|NCT00070577|HV|hv
5405835|NCT00069901|ovarian cancer|ovarian cancer
5405836|NCT00069901|paclitaxel|paclitaxel
5405837|NCT00069901|carboplatin|carboplatin
5405838|NCT00069784|Impaired Fasting Glucose (IFG)|impaired fasting glucose (ifg)
5405839|NCT00069784|Impaired Glucose Tolerance (IGT)|impaired glucose tolerance (igt)
5405840|NCT00069745|Prostatic Neoplasms|prostatic neoplasms
5405841|NCT00069745|Cancer Treatment Protocols|cancer treatment protocols
5405842|NCT00069745|Antineoplastic protocols|antineoplastic protocols
5405843|NCT00069745|One Prior Cytotoxic Chemotherapy Regimen|one prior cytotoxic chemotherapy regimen
5405844|NCT00069719|open-angle|open-angle
5405845|NCT00069719|glaucoma|glaucoma
5405846|NCT00069719|ocular|ocular
5405847|NCT00069719|hypertension|hypertension
5405848|NCT00069719|POAG|poag
5405849|NCT00069706|open-angle|open-angle
5405850|NCT00069706|glaucoma|glaucoma
5405851|NCT00069706|ocular|ocular
5405852|NCT00069706|hypertension|hypertension
5405853|NCT00069706|POAG|poag
5405854|NCT00069914|Immunization|immunization
5405855|NCT00069914|Immune Activation|immune activation
5405856|NCT00069914|Flu|flu
5405857|NCT00069914|Antibodies|antibodies
5405858|NCT00069914|Titers|titers
5405859|NCT00069914|HIV|hiv
5405860|NCT00069914|Healthy Volunteer|healthy volunteer
5405861|NCT00069914|HV|hv
5405862|NCT00069862|Beta Thalassemia|beta thalassemia
5405863|NCT00069836|AVANDAMET insulin type 2 diabetes|avandamet insulin type 2 diabetes
5405864|NCT00069732|Overweight|overweight
5405865|NCT00069732|Weight loss maintenance|weight loss maintenance
5405866|NCT00069732|CAM therapy|cam therapy
5405867|NCT00069732|Qigong|qigong
5405868|NCT00069732|Acupressure|acupressure
5405869|NCT00069732|Traditional Chinese Medicine|traditional chinese medicine
5405870|NCT00069758|NHL, indolent NHL, non-Hodgkin's lymphoma, lymphoma|nhl, indolent nhl, non-hodgkin's lymphoma, lymphoma
5405871|NCT00069641|Mucopolysaccharidosis II|mucopolysaccharidosis ii
5405872|NCT00069641|MPS II|mps ii
5405873|NCT00069641|Hunter Syndrome|hunter syndrome
5405874|NCT00069641|iduronate-2-sulfatase|iduronate-2-sulfatase
5405875|NCT00069641|I2S|i2s
5405876|NCT00069641|Iduronate-2-sulfatase deficiency|iduronate-2-sulfatase deficiency
5405877|NCT00069524|Highly active antiretroviral therapy (HAART)|highly active antiretroviral therapy (haart)
5405878|NCT00069524|Ritonavir|ritonavir
5405879|NCT00069524|Oyster mushrooms|oyster mushrooms
5405880|NCT00069524|Non-HDL cholesterol|non-hdl cholesterol
5405881|NCT00069524|Complementary Therapies|complementary therapies
5405882|NCT00069524|Treatment Experienced|treatment experienced
5405883|NCT00005630|stage I non-small cell lung cancer|stage i non-small cell lung cancer
5405884|NCT00005630|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
5405885|NCT00005630|large cell lung cancer|large cell lung cancer
5405886|NCT00005630|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5405887|NCT00005630|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5405888|NCT00005630|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5405889|NCT00005630|adenocarcinoma of the lung|adenocarcinoma of the lung
5405890|NCT00005630|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
5405891|NCT00005629|localized resectable adult primary liver cancer|localized resectable adult primary liver cancer
5405892|NCT00005629|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
5405893|NCT00005629|advanced adult primary liver cancer|advanced adult primary liver cancer
5405894|NCT00005629|recurrent adult primary liver cancer|recurrent adult primary liver cancer
5405895|NCT00005629|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
5405896|NCT00004922|newly diagnosed carcinoma of unknown primary|newly diagnosed carcinoma of unknown primary
5405897|NCT00004922|recurrent carcinoma of unknown primary|recurrent carcinoma of unknown primary
5405898|NCT00004922|stage III neuroendocrine carcinoma of the skin|stage iii neuroendocrine carcinoma of the skin
5405899|NCT00004922|recurrent neuroendocrine carcinoma of the skin|recurrent neuroendocrine carcinoma of the skin
5405900|NCT00004922|neuroendocrine carcinoma|neuroendocrine carcinoma
5405901|NCT00004886|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5405902|NCT00069693|Dysautonomia|dysautonomia
5405903|NCT00069693|Sympathetic Nervous System|sympathetic nervous system
5405904|NCT00069693|Autonomic Nervous System|autonomic nervous system
5405905|NCT00069693|Syncope|syncope
5405906|NCT00069693|Post Tachycardia Syndrome|post tachycardia syndrome
5405907|NCT00069693|POTS|pots
5405908|NCT00069693|Neurocardiogenic Syncope|neurocardiogenic syncope
5405909|NCT00069693|Baroreflex|baroreflex
5405910|NCT00069693|Norepinephrine|norepinephrine
5405911|NCT00069693|Epinephrine|epinephrine
5405912|NCT00069693|Neurocardiology|neurocardiology
5405913|NCT00069693|Chronic Orthostatic Intolerance|chronic orthostatic intolerance
5405914|NCT00069693|COI|coi
5405915|NCT00069693|Healthy Volunteer|healthy volunteer
5405916|NCT00069693|HV|hv
5405917|NCT00069680|Gene Identification|gene identification
5405918|NCT00069680|Linkage Analysis|linkage analysis
5405919|NCT00069680|Homozygosity Mapping|homozygosity mapping
5405920|NCT00069680|Gray Platelet Syndrome|gray platelet syndrome
5405921|NCT00069680|GPS|gps
5405922|NCT00069680|Platelet Function Defect|platelet function defect
5405923|NCT00069680|Bleeding Disorder|bleeding disorder
5405924|NCT00069654|Endothelium|endothelium
5405925|NCT00069654|Atherosclerosis|atherosclerosis
5405926|NCT00069654|Vasodilation|vasodilation
5405927|NCT00069654|Ischemia|ischemia
5405928|NCT00069654|Exercise|exercise
5405929|NCT00069654|Coronary Artery Disease|coronary artery disease
5405930|NCT00069654|CAD|cad
5405931|NCT00069628|Diabetes Mellitus, Insulin-Dependent|diabetes mellitus, insulin-dependent
5405932|NCT00069628|Type 1 Diabetes|type 1 diabetes
5405933|NCT00069628|Diabetes in Children|diabetes in children
5405934|NCT00069628|Continuous Glucose Monitoring Devices|continuous glucose monitoring devices
5405935|NCT00069615|Diabetes Mellitus, Insulin-Dependent|diabetes mellitus, insulin-dependent
5405936|NCT00069615|Type 1 Diabetes|type 1 diabetes
5405937|NCT00069615|Continuous Glucose Monitoring Devices|continuous glucose monitoring devices
5405938|NCT00069615|Electronic Data Collection|electronic data collection
5405939|NCT00069602|Continuous Glucose Monitoring Devices|continuous glucose monitoring devices
5405940|NCT00069602|Blood glucose profiles in normal children|blood glucose profiles in normal children
5405941|NCT00069602|Blood glucose profiles in non-diabetic children|blood glucose profiles in non-diabetic children
5405942|NCT00069589|Baldness|baldness
5405943|NCT00069589|Autoimmunity|autoimmunity
5405944|NCT00069589|Hair|hair
5405945|NCT00069589|Alopecia Areata|alopecia areata
5405946|NCT00069589|Alopecia Partialis|alopecia partialis
5405947|NCT00069589|Alopecia Totalis|alopecia totalis
5405948|NCT00069589|Alopecia Universalis|alopecia universalis
5405949|NCT00069589|Autoimmune Hair Loss|autoimmune hair loss
5405950|NCT00069576|Mild gestational diabetes mellitus|mild gestational diabetes mellitus
5405951|NCT00069576|Maternal Fetal Medicine Units Network|maternal fetal medicine units network
5405952|NCT00069563|Internalizing psychopathology|internalizing psychopathology
5405953|NCT00069563|Externalizing psychopathology|externalizing psychopathology
5405954|NCT00069550|Glutamate/NMDA receptors|glutamate/nmda receptors
5405955|NCT00069550|Cholinergic upregulation|cholinergic upregulation
5405956|NCT00069550|Dextromethorphan|dextromethorphan
5405957|NCT00069550|Donepezil hydrochloride|donepezil hydrochloride
5405958|NCT00069550|Aricept|aricept
5405959|NCT00069537|Diabetes Mellitus, Insulin-Dependent|diabetes mellitus, insulin-dependent
5405960|NCT00069537|Type 1 Diabetes|type 1 diabetes
5405961|NCT00069537|Diabetes in Children|diabetes in children
5405962|NCT00069537|Continuous Glucose Monitoring Devices|continuous glucose monitoring devices
5405963|NCT00069511|Hepatitis C|hepatitis c
5405964|NCT00069498|Mucosa|mucosa
5405965|NCT00069498|Inflammation|inflammation
5406242|NCT00026286|hot flashes|hot flashes
5405966|NCT00069498|Tissue Viral Load|tissue viral load
5405967|NCT00069498|Anti-inflammatory|anti-inflammatory
5405968|NCT00069498|HIV-related diarrhea|hiv-related diarrhea
5405969|NCT00069498|Mucosal Inflammation|mucosal inflammation
5405970|NCT00069498|Treatment Experienced|treatment experienced
5405971|NCT00069485|HIV Seronegativity|hiv seronegativity
5405972|NCT00003930|stage II bladder cancer|stage ii bladder cancer
5405973|NCT00003930|stage III bladder cancer|stage iii bladder cancer
5405974|NCT00069472|Genetics|genetics
5405975|NCT00069459|Winter depression, winter blues, depression, seasonal depression, seasonal affective disorder|winter depression, winter blues, depression, seasonal depression, seasonal affective disorder
5405976|NCT00069446|Diabetes|diabetes
5405977|NCT00069446|Diabetic|diabetic
5405978|NCT00069446|Diabetic Foot Ulcer|diabetic foot ulcer
5405979|NCT00069368|Healthy|healthy
5405980|NCT00069407|Bipolar Disorder|bipolar disorder
5405981|NCT00003827|refractory anemia with excess blasts|refractory anemia with excess blasts
5405982|NCT00003827|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
5405983|NCT00003827|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5405984|NCT00003827|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5405985|NCT00003827|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
5405986|NCT00003594|stage III colon cancer|stage iii colon cancer
5405987|NCT00003594|stage IV colon cancer|stage iv colon cancer
5405988|NCT00003594|stage III rectal cancer|stage iii rectal cancer
5405989|NCT00003594|stage IV rectal cancer|stage iv rectal cancer
5405990|NCT00003594|recurrent colon cancer|recurrent colon cancer
5405991|NCT00003594|recurrent rectal cancer|recurrent rectal cancer
5405992|NCT00003594|adenocarcinoma of the colon|adenocarcinoma of the colon
5405993|NCT00003594|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5405994|NCT00003540|stage IV breast cancer|stage iv breast cancer
5405995|NCT00003540|recurrent breast cancer|recurrent breast cancer
5405996|NCT00003463|recurrent adult brain tumor|recurrent adult brain tumor
5405997|NCT00003463|adult brain stem glioma|adult brain stem glioma
5405998|NCT00003463|adult glioblastoma|adult glioblastoma
5405999|NCT00003463|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5406000|NCT00003463|adult mixed glioma|adult mixed glioma
5406001|NCT00003463|adult giant cell glioblastoma|adult giant cell glioblastoma
5406002|NCT00003463|adult gliosarcoma|adult gliosarcoma
5406003|NCT00069355|PTSD|ptsd
5406004|NCT00069355|Catecholamines|catecholamines
5406005|NCT00069355|Conditioning|conditioning
5406006|NCT00069355|Memory|memory
5406007|NCT00069355|Psychophysiology|psychophysiology
5406008|NCT00069355|Acute Stress Disorder|acute stress disorder
5406009|NCT00069355|Post-Traumatic Stress Disorder|post-traumatic stress disorder
5406010|NCT00069342|Chronic Pain|chronic pain
5406011|NCT00069342|Pain|pain
5406012|NCT00069342|Rheumatoid Arthritis|rheumatoid arthritis
5406013|NCT00069342|Depression|depression
5406014|NCT00069342|Function|function
5406015|NCT00069342|Rheumatic Disease|rheumatic disease
5406016|NCT00069277|Cancer, tumors|cancer, tumors
5406017|NCT00069264|Metastatic Tumors|metastatic tumors
5406018|NCT00069264|Advanced Solid Tumors|advanced solid tumors
5406019|NCT00069264|Stage IV Tumors|stage iv tumors
5406020|NCT00069264|Solid Tumors|solid tumors
5406021|NCT00069264|Recurrent Solid Tumors|recurrent solid tumors
5406022|NCT00069251|amphetamine dependence|amphetamine dependence
5406023|NCT00003449|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5406024|NCT00003281|recurrent small cell lung cancer|recurrent small cell lung cancer
5406025|NCT00003280|stage I mantle cell lymphoma|stage i mantle cell lymphoma
5406026|NCT00003280|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
5406027|NCT00003280|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5406028|NCT00003280|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5406029|NCT00003280|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5406030|NCT00003280|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5406031|NCT00003245|Waldenström macroglobulinemia|waldenström macroglobulinemia
5406032|NCT00003245|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5406033|NCT00003245|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5406034|NCT00003245|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5406035|NCT00003245|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5406036|NCT00003245|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5406037|NCT00003245|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5406038|NCT00003245|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5406039|NCT00003245|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5406040|NCT00003245|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5406041|NCT00003245|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5406042|NCT00003245|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5406043|NCT00003245|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5406044|NCT00003245|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5406045|NCT00003245|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5407004|NCT00067678|soy protein|soy protein
5406046|NCT00003113|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
5406047|NCT00003113|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
5406048|NCT00003113|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
5406049|NCT00003113|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
5406050|NCT00003113|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
5406051|NCT00003113|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
5406052|NCT00003113|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
5406053|NCT00003113|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5406054|NCT00003113|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5406055|NCT00003113|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5406056|NCT00003113|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5406057|NCT00003113|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5406058|NCT00003113|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5406059|NCT00003113|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5406060|NCT00003113|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5406061|NCT00003113|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5406062|NCT00003113|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5406063|NCT00003113|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5406064|NCT00003113|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5406065|NCT00003113|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5406066|NCT00003113|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5406067|NCT00003113|stage I mantle cell lymphoma|stage i mantle cell lymphoma
5406068|NCT00003113|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
5406069|NCT00003113|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
5406070|NCT00003113|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
5406071|NCT00003113|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
5406072|NCT00003113|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
5406073|NCT00003113|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
5406074|NCT00003113|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
5406075|NCT00003113|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
5406076|NCT00003113|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5406077|NCT00003113|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
5406078|NCT00003113|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5406079|NCT00003113|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
5406080|NCT00003113|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
5406081|NCT00003113|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5406082|NCT00003113|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
5406083|NCT00003113|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
5406084|NCT00003113|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5406085|NCT00003113|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5406086|NCT00003113|stage II mantle cell lymphoma|stage ii mantle cell lymphoma
5406087|NCT00069329|Central Nervous System|central nervous system
5406088|NCT00069329|Abnormalities|abnormalities
5406089|NCT00069329|Arthropathy|arthropathy
5406090|NCT00069329|Urticaria|urticaria
5406091|NCT00069329|Papilledema|papilledema
5406092|NCT00069329|Auto-Inflammation|auto-inflammation
5406093|NCT00069329|Inflammatory Disease|inflammatory disease
5406094|NCT00069329|Neonatal Onset Multisystem Inflammatory Disease|neonatal onset multisystem inflammatory disease
5406095|NCT00069329|NOMID|nomid
5406096|NCT00069329|CINCA Syndrome|cinca syndrome
5406097|NCT00069316|West Nile Virus|west nile virus
5406098|NCT00069316|Encephalitis|encephalitis
5406099|NCT00069316|Virus|virus
5406100|NCT00069316|Mosquito|mosquito
5406101|NCT00069316|Fever|fever
5406102|NCT00069316|WNV|wnv
5406103|NCT00069316|Myelitis|myelitis
5406104|NCT00069303|West Nile Virus|west nile virus
5406105|NCT00069303|Encephalitis|encephalitis
5406106|NCT00069303|Virus|virus
5406107|NCT00069303|Mosquito|mosquito
5406108|NCT00069303|Fever|fever
5406109|NCT00069303|WNV|wnv
5406110|NCT00069303|Myelitis|myelitis
5406111|NCT00069186|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
5406112|NCT00069186|ALS|als
5406113|NCT00069186|Creatine|creatine
5406114|NCT00069186|Creatine Monohydrate|creatine monohydrate
5406115|NCT00069186|Muscle Strength|muscle strength
5406116|NCT00069238|Lymphoma|lymphoma
5406117|NCT00069238|T-Cell Lymphoma|t-cell lymphoma
5406118|NCT00069238|NK -Cell Lymphoma|nk -cell lymphoma
5406119|NCT00069225|fMRI|fmri
5406120|NCT00069225|Prolonged Exposure|prolonged exposure
5406121|NCT00069225|Brain Activation|brain activation
5406122|NCT00069225|Conditioning|conditioning
5406123|NCT00069225|Paroxetine|paroxetine
5406124|NCT00069225|PTSD|ptsd
5406125|NCT00069225|Differential Fear Conditioning|differential fear conditioning
5406126|NCT00069225|Masked Faces|masked faces
5406127|NCT00069225|Amygdala|amygdala
5406128|NCT00069225|Hippocampus|hippocampus
5406129|NCT00069225|Post-Traumatic Stress Disorder|post-traumatic stress disorder
5406130|NCT00069212|Post-Traumatic Stress Disorder|post-traumatic stress disorder
5406131|NCT00069212|Neural Circuits|neural circuits
5406132|NCT00069212|Fear|fear
5406133|NCT00069212|Emotional Regulation|emotional regulation
5406134|NCT00069212|Reward|reward
5406135|NCT00069212|PTSD|ptsd
5406136|NCT00069199|Reproducibility|reproducibility
5406137|NCT00069199|Macular Edema|macular edema
5406138|NCT00069199|OCT2|oct2
5406139|NCT00069199|OCT3|oct3
5406140|NCT00069199|Retina|retina
5406141|NCT00002638|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5406142|NCT00002559|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
5406143|NCT00002559|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
5406144|NCT00002533|untreated metastatic squamous neck cancer with occult primary|untreated metastatic squamous neck cancer with occult primary
5406145|NCT00002533|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
5406146|NCT00002533|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
5406147|NCT00002533|oral complications|oral complications
5406148|NCT00002533|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
5406149|NCT00002533|stage I basal cell carcinoma of the lip|stage i basal cell carcinoma of the lip
5406150|NCT00002533|stage I verrucous carcinoma of the oral cavity|stage i verrucous carcinoma of the oral cavity
5406151|NCT00002533|stage I mucoepidermoid carcinoma of the oral cavity|stage i mucoepidermoid carcinoma of the oral cavity
5406152|NCT00002533|stage I adenoid cystic carcinoma of the oral cavity|stage i adenoid cystic carcinoma of the oral cavity
5406153|NCT00002533|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
5406154|NCT00002533|stage II basal cell carcinoma of the lip|stage ii basal cell carcinoma of the lip
5406155|NCT00002533|stage II verrucous carcinoma of the oral cavity|stage ii verrucous carcinoma of the oral cavity
5406156|NCT00002533|stage II mucoepidermoid carcinoma of the oral cavity|stage ii mucoepidermoid carcinoma of the oral cavity
5406157|NCT00002533|stage II adenoid cystic carcinoma of the oral cavity|stage ii adenoid cystic carcinoma of the oral cavity
5406158|NCT00002533|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
5406159|NCT00002533|stage III basal cell carcinoma of the lip|stage iii basal cell carcinoma of the lip
5406160|NCT00002533|stage III verrucous carcinoma of the oral cavity|stage iii verrucous carcinoma of the oral cavity
5406161|NCT00002533|stage III mucoepidermoid carcinoma of the oral cavity|stage iii mucoepidermoid carcinoma of the oral cavity
5406162|NCT00002533|stage III adenoid cystic carcinoma of the oral cavity|stage iii adenoid cystic carcinoma of the oral cavity
5406163|NCT00002533|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5406164|NCT00002533|stage IV basal cell carcinoma of the lip|stage iv basal cell carcinoma of the lip
5406165|NCT00002533|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
5406166|NCT00002533|stage IV mucoepidermoid carcinoma of the oral cavity|stage iv mucoepidermoid carcinoma of the oral cavity
5406167|NCT00002533|stage IV adenoid cystic carcinoma of the oral cavity|stage iv adenoid cystic carcinoma of the oral cavity
5406168|NCT00002533|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
5406169|NCT00002533|recurrent basal cell carcinoma of the lip|recurrent basal cell carcinoma of the lip
5406170|NCT00002533|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
5406171|NCT00002533|recurrent mucoepidermoid carcinoma of the oral cavity|recurrent mucoepidermoid carcinoma of the oral cavity
5406172|NCT00002533|recurrent adenoid cystic carcinoma of the oral cavity|recurrent adenoid cystic carcinoma of the oral cavity
5406173|NCT00002533|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
5406174|NCT00002533|stage I lymphoepithelioma of the oropharynx|stage i lymphoepithelioma of the oropharynx
5406175|NCT00002533|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
5406176|NCT00002533|stage II lymphoepithelioma of the oropharynx|stage ii lymphoepithelioma of the oropharynx
5406177|NCT00002533|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
5406178|NCT00002533|stage III lymphoepithelioma of the oropharynx|stage iii lymphoepithelioma of the oropharynx
5406179|NCT00002533|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5406180|NCT00002533|stage IV lymphoepithelioma of the oropharynx|stage iv lymphoepithelioma of the oropharynx
5406181|NCT00002533|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
5406182|NCT00002533|recurrent lymphoepithelioma of the oropharynx|recurrent lymphoepithelioma of the oropharynx
5406183|NCT00002533|stage I squamous cell carcinoma of the nasopharynx|stage i squamous cell carcinoma of the nasopharynx
5406184|NCT00002533|stage I lymphoepithelioma of the nasopharynx|stage i lymphoepithelioma of the nasopharynx
5406185|NCT00002533|stage II squamous cell carcinoma of the nasopharynx|stage ii squamous cell carcinoma of the nasopharynx
5406186|NCT00002533|stage II lymphoepithelioma of the nasopharynx|stage ii lymphoepithelioma of the nasopharynx
5406187|NCT00002533|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
5406188|NCT00002533|stage III lymphoepithelioma of the nasopharynx|stage iii lymphoepithelioma of the nasopharynx
5406189|NCT00002533|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
5406190|NCT00002533|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
5406191|NCT00002533|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
5406192|NCT00002533|recurrent lymphoepithelioma of the nasopharynx|recurrent lymphoepithelioma of the nasopharynx
5406193|NCT00002533|stage I squamous cell carcinoma of the hypopharynx|stage i squamous cell carcinoma of the hypopharynx
5406194|NCT00002533|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
5406195|NCT00002533|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
5406196|NCT00002533|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5406197|NCT00002533|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
5406198|NCT00002533|stage I squamous cell carcinoma of the larynx|stage i squamous cell carcinoma of the larynx
5406199|NCT00002533|stage I verrucous carcinoma of the larynx|stage i verrucous carcinoma of the larynx
5406200|NCT00002533|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
5406201|NCT00002533|stage II verrucous carcinoma of the larynx|stage ii verrucous carcinoma of the larynx
5406202|NCT00002533|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
5406203|NCT00002533|stage III verrucous carcinoma of the larynx|stage iii verrucous carcinoma of the larynx
5406204|NCT00002533|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5406205|NCT00002533|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
5406206|NCT00002533|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
5406207|NCT00002533|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
5406208|NCT00002533|stage I squamous cell carcinoma of the paranasal sinus and nasal cavity|stage i squamous cell carcinoma of the paranasal sinus and nasal cavity
5406209|NCT00002533|stage I inverted papilloma of the paranasal sinus and nasal cavity|stage i inverted papilloma of the paranasal sinus and nasal cavity
5406210|NCT00002533|stage I midline lethal granuloma of the paranasal sinus and nasal cavity|stage i midline lethal granuloma of the paranasal sinus and nasal cavity
5406211|NCT00002533|stage I esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage i esthesioneuroblastoma of the paranasal sinus and nasal cavity
5406212|NCT00002533|stage II squamous cell carcinoma of the paranasal sinus and nasal cavity|stage ii squamous cell carcinoma of the paranasal sinus and nasal cavity
5406213|NCT00002533|stage II inverted papilloma of the paranasal sinus and nasal cavity|stage ii inverted papilloma of the paranasal sinus and nasal cavity
5406214|NCT00002533|stage II midline lethal granuloma of the paranasal sinus and nasal cavity|stage ii midline lethal granuloma of the paranasal sinus and nasal cavity
5406215|NCT00002533|stage II esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage ii esthesioneuroblastoma of the paranasal sinus and nasal cavity
5406216|NCT00002533|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
5406217|NCT00002533|stage III inverted papilloma of the paranasal sinus and nasal cavity|stage iii inverted papilloma of the paranasal sinus and nasal cavity
5406218|NCT00002533|stage III midline lethal granuloma of the paranasal sinus and nasal cavity|stage iii midline lethal granuloma of the paranasal sinus and nasal cavity
5406219|NCT00002533|stage III esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iii esthesioneuroblastoma of the paranasal sinus and nasal cavity
5406220|NCT00002533|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
5406221|NCT00002533|stage IV inverted papilloma of the paranasal sinus and nasal cavity|stage iv inverted papilloma of the paranasal sinus and nasal cavity
5406222|NCT00002533|stage IV midline lethal granuloma of the paranasal sinus and nasal cavity|stage iv midline lethal granuloma of the paranasal sinus and nasal cavity
5406223|NCT00002533|stage IV esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iv esthesioneuroblastoma of the paranasal sinus and nasal cavity
5406224|NCT00002533|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
5406225|NCT00002533|recurrent inverted papilloma of the paranasal sinus and nasal cavity|recurrent inverted papilloma of the paranasal sinus and nasal cavity
5406226|NCT00002533|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity
5406227|NCT00002533|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity
5406228|NCT00002533|infection|infection
5406229|NCT00069173|Females|females
5406230|NCT00069173|Sedentary|sedentary
5406231|NCT00069173|School-based|school-based
5406232|NCT00069134|glutathione kinetics|glutathione kinetics
5406233|NCT00069134|oxidant damage|oxidant damage
5406234|NCT00069134|anti-oxidant capacity|anti-oxidant capacity
5406235|NCT00069134|oxidative stress|oxidative stress
5406236|NCT00069134|cysteine kinetics|cysteine kinetics
5406237|NCT00069134|severe childhood malnutrition|severe childhood malnutrition
5406238|NCT00026286|stage I breast cancer|stage i breast cancer
5406239|NCT00026286|stage II breast cancer|stage ii breast cancer
5406240|NCT00026286|breast cancer in situ|breast cancer in situ
5406241|NCT00026286|ductal breast carcinoma|ductal breast carcinoma
5406243|NCT00026286|menopausal symptoms|menopausal symptoms
5406244|NCT00025116|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5406245|NCT00025116|recurrent prostate cancer|recurrent prostate cancer
5406246|NCT00069160|Pharmacokinetics|pharmacokinetics
5406247|NCT00069160|Pharmacodynamics|pharmacodynamics
5406248|NCT00069160|Multidrug Resistance Reversal|multidrug resistance reversal
5406249|NCT00069160|Molecular Target|molecular target
5406250|NCT00069160|P-Glycoprotein Inhibition|p-glycoprotein inhibition
5406251|NCT00069160|Lung Cancer|lung cancer
5406252|NCT00069160|Ovarian Cancer|ovarian cancer
5406253|NCT00069160|Cervical Cancer|cervical cancer
5406254|NCT00069160|Renal Cancer|renal cancer
5406255|NCT00069082|Headache|headache
5406256|NCT00069082|Cluster|cluster
5406258|NCT00069082|Episodic Cluster|episodic cluster
5406259|NCT00069030|HIV Seronegativity|hiv seronegativity
5406260|NCT00069030|HIV Preventive Vaccine|hiv preventive vaccine
5406261|NCT00069030|HIV-1|hiv-1
5406262|NCT00069030|AIDS Vaccines|aids vaccines
5406263|NCT00069030|Vaccines, DNA|vaccines, dna
5406264|NCT00069030|Dose-Response Relationship, Immunologic|dose-response relationship, immunologic
5406265|NCT00069030|Cytokines|cytokines
5406266|NCT00069030|Plasmids|plasmids
5406267|NCT00069030|Adjuvants, Immunologic|adjuvants, immunologic
5406268|NCT00069030|Drug Administration Schedule|drug administration schedule
5406269|NCT00069030|Interleukin|interleukin
5406270|NCT00069030|IL2|il2
5406271|NCT00069030|Ig|ig
5406272|NCT00069030|IL@/Ig|il@/ig
5406273|NCT00069004|HIV-Associated Lipodystrophy Syndrome|hiv-associated lipodystrophy syndrome
5406274|NCT00069004|HIV Lipodystrophy Syndrome|hiv lipodystrophy syndrome
5406275|NCT00069004|Treatment Experienced|treatment experienced
5406276|NCT00069004|Lipodystrophy|lipodystrophy
5406277|NCT00069004|Dyslipidemia|dyslipidemia
5406278|NCT00069004|Osteoporosis|osteoporosis
5406279|NCT00069004|Osteopenia|osteopenia
5406280|NCT00068991|Behavioral Intervention Study|behavioral intervention study
5406281|NCT00068991|Randomized Prevention Trial|randomized prevention trial
5406282|NCT00068991|China|china
5406283|NCT00068991|Condom Use|condom use
5406284|NCT00068991|STDs|stds
5406285|NCT00068991|Sexual Partners|sexual partners
5406286|NCT00068991|HIV Seronegativity|hiv seronegativity
5406287|NCT00068978|HIV Seronegativity|hiv seronegativity
5406288|NCT00068978|HIV Preventive Vaccine|hiv preventive vaccine
5406289|NCT00068978|HIV Therapeutic Vaccine|hiv therapeutic vaccine
5406290|NCT00069069|Stroke|stroke
5406291|NCT00069069|TIA|tia
5406292|NCT00069056|Grid Laser|grid laser
5406293|NCT00069056|Focal Laser|focal laser
5406294|NCT00069056|Glycemic Control|glycemic control
5406295|NCT00069056|Diabetes|diabetes
5406296|NCT00069056|Diabetic Macular Edema|diabetic macular edema
5406297|NCT00069056|Macular Edema|macular edema
5406298|NCT00068887|type 2 diabetes|type 2 diabetes
5406299|NCT00068887|some studies - family history of type 2 diabetes|some studies - family history of type 2 diabetes
5406300|NCT00068926|Biodefense|biodefense
5406301|NCT00068926|Prevention|prevention
5406302|NCT00068926|Emergent|emergent
5406303|NCT00068926|Virus|virus
5406304|NCT00068926|Immune Response|immune response
5406305|NCT00068926|Healthy Volunteer|healthy volunteer
5406306|NCT00068926|HV|hv
5406307|NCT00068913|Lactic Acidosis|lactic acidosis
5406308|NCT00068913|Mitochondrial Disorder|mitochondrial disorder
5406309|NCT00068913|Stroke|stroke
5406310|NCT00068913|Seizure|seizure
5406311|NCT00068874|African American|african american
5406312|NCT00068874|Adolescent|adolescent
5406313|NCT00068874|Coping|coping
5406314|NCT00068874|Adjustment|adjustment
5406315|NCT00068874|Quality of Life|quality of life
5406316|NCT00068848|Oral Contraceptives|oral contraceptives
5406317|NCT00068848|Initiation|initiation
5406318|NCT00068848|Continuation|continuation
5406319|NCT00068835|Reading|reading
5406320|NCT00068835|Brain imaging|brain imaging
5406321|NCT00068822|Vertebroplasty|vertebroplasty
5406322|NCT00068822|Crushed Vertebrae|crushed vertebrae
5406323|NCT00068822|Back Pain|back pain
5406324|NCT00068822|Structurally Unstable Vertebrae|structurally unstable vertebrae
5406325|NCT00068822|polymethylmethacrylate|polymethylmethacrylate
5406326|NCT00068822|INVEST|invest
5406327|NCT00068822|PMMA|pmma
5406328|NCT00068822|RDQ|rdq
5406329|NCT00068809|Treatment experienced|treatment experienced
5406330|NCT00068809|Treatment interruption|treatment interruption
5406331|NCT00068770|adult glioblastoma|adult glioblastoma
5406332|NCT00068770|adult giant cell glioblastoma|adult giant cell glioblastoma
5406333|NCT00068770|adult gliosarcoma|adult gliosarcoma
5406334|NCT00068757|recurrent breast cancer|recurrent breast cancer
5406335|NCT00068757|stage IIIB breast cancer|stage iiib breast cancer
5406336|NCT00068757|stage IIIC breast cancer|stage iiic breast cancer
5406337|NCT00068757|stage IV breast cancer|stage iv breast cancer
5406338|NCT00068757|male breast cancer|male breast cancer
5406339|NCT00068757|HER2-positive breast cancer|her2-positive breast cancer
5406340|NCT00068744|squamous cell carcinoma of the anus|squamous cell carcinoma of the anus
5406341|NCT00068744|stage II anal cancer|stage ii anal cancer
5406342|NCT00068744|stage IIIA anal cancer|stage iiia anal cancer
5406343|NCT00068744|stage IIIB anal cancer|stage iiib anal cancer
5431211|NCT00029913|Viral Load|viral load
5406344|NCT00068731|stage IV prostate cancer|stage iv prostate cancer
5406345|NCT00068731|recurrent prostate cancer|recurrent prostate cancer
5406346|NCT00068666|stage IV melanoma|stage iv melanoma
5406347|NCT00068666|recurrent melanoma|recurrent melanoma
5406348|NCT00068666|tumors metastatic to brain|tumors metastatic to brain
5406349|NCT00068653|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5406350|NCT00068614|stage IV breast cancer|stage iv breast cancer
5406351|NCT00068614|stage II breast cancer|stage ii breast cancer
5406352|NCT00068614|stage IIIA breast cancer|stage iiia breast cancer
5406353|NCT00068614|stage IIIB breast cancer|stage iiib breast cancer
5406354|NCT00068614|stage IIIC breast cancer|stage iiic breast cancer
5406355|NCT00068601|infertility|infertility
5406356|NCT00068601|menopausal symptoms|menopausal symptoms
5406357|NCT00068601|stage II breast cancer|stage ii breast cancer
5406358|NCT00068601|stage IIIA breast cancer|stage iiia breast cancer
5406359|NCT00068601|stage IA breast cancer|stage ia breast cancer
5406360|NCT00068601|stage IB breast cancer|stage ib breast cancer
5406361|NCT00068601|estrogen receptor-negative breast cancer|estrogen receptor-negative breast cancer
5406362|NCT00068601|progesterone receptor-negative breast cancer|progesterone receptor-negative breast cancer
5406363|NCT00068575|stage I pancreatic cancer|stage i pancreatic cancer
5406364|NCT00068575|stage II pancreatic cancer|stage ii pancreatic cancer
5406365|NCT00068575|stage III pancreatic cancer|stage iii pancreatic cancer
5406366|NCT00068575|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
5406367|NCT00068523|refractory multiple myeloma|refractory multiple myeloma
5406368|NCT00068523|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5406369|NCT00068523|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5406370|NCT00068523|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5406371|NCT00068523|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5406372|NCT00068523|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5406373|NCT00068523|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5406374|NCT00068523|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5406375|NCT00068523|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5406376|NCT00068523|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5406377|NCT00068523|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5406378|NCT00068523|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5406379|NCT00068523|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5406380|NCT00068523|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5406381|NCT00068523|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5406382|NCT00068523|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5406383|NCT00068523|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5406384|NCT00068523|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5406385|NCT00068523|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5406386|NCT00068523|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5406387|NCT00068523|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5406388|NCT00068523|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
5406389|NCT00068523|refractory anemia with excess blasts|refractory anemia with excess blasts
5406390|NCT00068523|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5406391|NCT00068523|Philadelphia chromosome negative chronic myelogenous leukemia|philadelphia chromosome negative chronic myelogenous leukemia
5406392|NCT00068523|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
5406393|NCT00068523|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
5406394|NCT00068523|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
5406395|NCT00068523|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5406396|NCT00068523|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5406397|NCT00068523|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
5406398|NCT00068523|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5406399|NCT00068523|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5406400|NCT00068523|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5406401|NCT00068523|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5406402|NCT00068523|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5406403|NCT00068523|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
5406404|NCT00068523|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
5406405|NCT00068523|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5406406|NCT00068523|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5406407|NCT00068523|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5406408|NCT00068523|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5406409|NCT00068523|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5406410|NCT00068523|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5406411|NCT00068523|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5406412|NCT00068523|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5406413|NCT00068523|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5406414|NCT00068523|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5406415|NCT00068510|adult glioblastoma|adult glioblastoma
5406416|NCT00068510|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5406417|NCT00068510|adult brain tumor|adult brain tumor
5406418|NCT00068510|adult giant cell glioblastoma|adult giant cell glioblastoma
5406419|NCT00068510|adult gliosarcoma|adult gliosarcoma
5406420|NCT00068510|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
5406421|NCT00068471|infection|infection
5406422|NCT00068471|neutropenia|neutropenia
5406423|NCT00068471|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
5406424|NCT00068458|weight changes|weight changes
5406425|NCT00068458|depression|depression
5406426|NCT00068458|stage I breast cancer|stage i breast cancer
5406427|NCT00068458|stage II breast cancer|stage ii breast cancer
5406428|NCT00068458|stage IIIA breast cancer|stage iiia breast cancer
5406429|NCT00068445|neurotoxicity|neurotoxicity
5406430|NCT00068445|pain|pain
5406431|NCT00068445|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5406432|NCT00068432|recurrent pancreatic cancer|recurrent pancreatic cancer
5406433|NCT00068432|stage IV pancreatic cancer|stage iv pancreatic cancer
5406434|NCT00068393|Sarcomatoid|sarcomatoid
5406435|NCT00068393|Gemcitabine|gemcitabine
5406436|NCT00068393|Doxorubicin|doxorubicin
5406437|NCT00068393|Renal cell cancer|renal cell cancer
5406438|NCT00068393|Kidney cancer|kidney cancer
5406439|NCT00068367|adult neurofibrosarcoma|adult neurofibrosarcoma
5406440|NCT00068367|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
5406441|NCT00068367|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
5406442|NCT00068367|stage II adult soft tissue sarcoma|stage ii adult soft tissue sarcoma
5406443|NCT00068367|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
5406444|NCT00068341|stage IIIA breast cancer|stage iiia breast cancer
5406445|NCT00068341|stage IIIB breast cancer|stage iiib breast cancer
5406446|NCT00068341|stage IIIC breast cancer|stage iiic breast cancer
5406447|NCT00068341|stage II breast cancer|stage ii breast cancer
5406448|NCT00068328|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
5406449|NCT00068328|stage II breast cancer|stage ii breast cancer
5406450|NCT00068328|stage IIIA breast cancer|stage iiia breast cancer
5406451|NCT00068328|stage IIIB breast cancer|stage iiib breast cancer
5406452|NCT00068328|stage IIIC breast cancer|stage iiic breast cancer
5406453|NCT00068328|stage IA breast cancer|stage ia breast cancer
5406454|NCT00068328|stage IB breast cancer|stage ib breast cancer
5406455|NCT00068328|estrogen receptor-negative breast cancer|estrogen receptor-negative breast cancer
5406456|NCT00068328|estrogen receptor-positive breast cancer|estrogen receptor-positive breast cancer
5406457|NCT00068302|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
5406458|NCT00068302|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
5406459|NCT00068302|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
5406460|NCT00068302|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5406461|NCT00068302|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5406462|NCT00068289|extensive stage small cell lung cancer|extensive stage small cell lung cancer
5406463|NCT00068289|recurrent small cell lung cancer|recurrent small cell lung cancer
5406464|NCT00068276|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5406465|NCT00068276|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5406466|NCT00068276|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5406467|NCT00068276|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
5406468|NCT00068276|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
5406469|NCT00068276|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
5406470|NCT00068263|stage I breast cancer|stage i breast cancer
5406471|NCT00068263|stage II breast cancer|stage ii breast cancer
5406472|NCT00068250|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
5406473|NCT00068250|primary central nervous system Hodgkin lymphoma|primary central nervous system hodgkin lymphoma
5406474|NCT00068237|xerostomia|xerostomia
5406475|NCT00068237|radiation toxicity|radiation toxicity
5406476|NCT00068237|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
5406477|NCT00068237|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
5406478|NCT00068237|stage I squamous cell carcinoma of the hypopharynx|stage i squamous cell carcinoma of the hypopharynx
5406479|NCT00068237|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
5406480|NCT00068237|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
5406481|NCT00068237|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
5406482|NCT00068237|untreated metastatic squamous neck cancer with occult primary|untreated metastatic squamous neck cancer with occult primary
5406483|NCT00068237|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5406484|NCT00068237|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5406485|NCT00068237|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5406486|NCT00068211|Metastatic Melanoma|metastatic melanoma
5406487|NCT00068211|Melanoma|melanoma
5406488|NCT00068211|Inoperable Locally Advanced Melanoma|inoperable locally advanced melanoma
5406489|NCT00068224|Caroli's Syndrome|caroli's syndrome
5406490|NCT00068224|Congenital Hepatic Fibrosis|congenital hepatic fibrosis
5406491|NCT00068224|Ductal Plate Malformation|ductal plate malformation
5406492|NCT00068224|Ciliopathy|ciliopathy
5406493|NCT00068224|Polycystic Kidney|polycystic kidney
5406494|NCT00068224|Polycystic Liver|polycystic liver
5406495|NCT00068224|Nephronophthisis|nephronophthisis
5406496|NCT00068224|Molar Tooth Sign|molar tooth sign
5406497|NCT00068224|Dandy-Walker Malformation|dandy-walker malformation
5406498|NCT00068224|Retinopathy|retinopathy
5406499|NCT00068224|Situs Inversus|situs inversus
5406500|NCT00068224|Heterotaxia|heterotaxia
5406501|NCT00068224|Cerebellar Vermis Hypoplasia|cerebellar vermis hypoplasia
5406502|NCT00068224|Autosomal Recessive Polycystic Kidney Disease|autosomal recessive polycystic kidney disease
5406503|NCT00068224|ARPKD|arpkd
5406504|NCT00068224|Kidney|kidney
5406505|NCT00068224|Liver|liver
5406506|NCT00068185|Black cohosh|black cohosh
5406507|NCT00068185|Pharmacokinetics|pharmacokinetics
5406508|NCT00068185|Alternative therapies|alternative therapies
5406509|NCT00068185|Natural product|natural product
5406510|NCT00021268|stage IV colon cancer|stage iv colon cancer
5406511|NCT00021268|stage IV rectal cancer|stage iv rectal cancer
5406512|NCT00021268|recurrent colon cancer|recurrent colon cancer
5406513|NCT00021268|recurrent rectal cancer|recurrent rectal cancer
5406514|NCT00020904|stage IV breast cancer|stage iv breast cancer
5406515|NCT00020904|recurrent breast cancer|recurrent breast cancer
5406516|NCT00068159|Hereditary Disease|hereditary disease
5406517|NCT00068159|Diastolic Dysfunction|diastolic dysfunction
5406518|NCT00068159|Exercise Tolerance|exercise tolerance
5406519|NCT00068159|Exercise Stress Echocardiography|exercise stress echocardiography
5406520|NCT00068159|MRI|mri
5406521|NCT00068159|Hereditary Hemochromatosis|hereditary hemochromatosis
5406522|NCT00068159|HH|hh
5406523|NCT00068159|Iron Overload|iron overload
5406524|NCT00068146|Adenopathy|adenopathy
5406525|NCT00068146|Genetic Disorder|genetic disorder
5406526|NCT00068146|Apoptosis|apoptosis
5406527|NCT00068146|Diagnostic Imaging|diagnostic imaging
5406528|NCT00068146|Hodgkins|hodgkins
5406529|NCT00068146|Autoimmune Lymphoproliferative|autoimmune lymphoproliferative
5406530|NCT00068146|Syndrome|syndrome
5406531|NCT00068146|ALPS|alps
5406532|NCT00068146|ALPS-Associated Lymphoma|alps-associated lymphoma
5406533|NCT00068120|Urinary tract infection|urinary tract infection
5406534|NCT00068094|Probiotics|probiotics
5406535|NCT00068094|Bacteria|bacteria
5406536|NCT00068081|Dermal assessment|dermal assessment
5406537|NCT00068081|Pain measurement|pain measurement
5406538|NCT00068081|Diary|diary
5406539|NCT00068081|Analgesics/*therapeutic use|analgesics/*therapeutic use
5406540|NCT00068081|Capsaicin/*administration & dosage/adverse effects|capsaicin/*administration & dosage/adverse effects
5406541|NCT00068081|Herpes zoster/*complication/drug therapy|herpes zoster/*complication/drug therapy
5406542|NCT00068081|Neuralgia/*drug therapy/etiology|neuralgia/*drug therapy/etiology
5406543|NCT00068081|Pain|pain
5406544|NCT00068081|Peripheral nervous system diseases/*complications|peripheral nervous system diseases/*complications
5406545|NCT00017043|stage IV gastric cancer|stage iv gastric cancer
5406546|NCT00017043|recurrent gastric cancer|recurrent gastric cancer
5406547|NCT00017043|stage IV esophageal cancer|stage iv esophageal cancer
5406548|NCT00017043|recurrent esophageal cancer|recurrent esophageal cancer
5406549|NCT00017043|adenocarcinoma of the stomach|adenocarcinoma of the stomach
5406550|NCT00017043|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
5406551|NCT00016939|stage III renal cell cancer|stage iii renal cell cancer
5406552|NCT00016939|stage IV renal cell cancer|stage iv renal cell cancer
5406553|NCT00016939|recurrent renal cell cancer|recurrent renal cell cancer
5406554|NCT00016874|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5406555|NCT00016341|stage III endometrial carcinoma|stage iii endometrial carcinoma
5406556|NCT00016341|stage IV endometrial carcinoma|stage iv endometrial carcinoma
5406557|NCT00016341|recurrent endometrial carcinoma|recurrent endometrial carcinoma
5406558|NCT00068107|Lysosomal Storage|lysosomal storage
5406559|NCT00068107|Renal Insufficiency|renal insufficiency
5406560|NCT00068107|Stroke|stroke
5406561|NCT00068107|Hypohidrosis|hypohidrosis
5406562|NCT00068107|Peripheral Neuropathy|peripheral neuropathy
5406563|NCT00068107|Fabry Disease|fabry disease
5406564|NCT00068068|Photodynamic therapy|photodynamic therapy
5406565|NCT00068068|Liver metastases|liver metastases
5406566|NCT00068068|Colorectal cancer|colorectal cancer
5406567|NCT00068068|Litx™|litx™
5406568|NCT00068068|Light Infusion Technology™|light infusion technology™
5406569|NCT00068068|Talaporfin sodium|talaporfin sodium
5406570|NCT00068068|LS11|ls11
5406571|NCT00068068|Liver mets|liver mets
5406572|NCT00068068|Metastatic colorectal cancer|metastatic colorectal cancer
5406573|NCT00068068|Light emittting diodes (LED)|light emittting diodes (led)
5406574|NCT00068068|Tumor ablation|tumor ablation
5406575|NCT00068068|Combination therapy|combination therapy
5406576|NCT00068055|West Nile Virus, encephalitis, myelitis, immunoglobulin G|west nile virus, encephalitis, myelitis, immunoglobulin g
5406577|NCT00067899|cigarette smoking|cigarette smoking
5406578|NCT00067899|tocopherol|tocopherol
5406579|NCT00067899|bioavailability|bioavailability
5406580|NCT00067899|metabolism|metabolism
5406581|NCT00067899|oxidative stress|oxidative stress
5406582|NCT00067990|chronic allograft nephropathy|chronic allograft nephropathy
5406583|NCT00067990|post transplant proteinuria|post transplant proteinuria
5406584|NCT00067951|Hyperglycemia|hyperglycemia
5406585|NCT00067951|HbA1c|hba1c
5406586|NCT00067951|Hemoglobin A1c|hemoglobin a1c
5406587|NCT00067951|Type 2 diabetes mellitus|type 2 diabetes mellitus
5406588|NCT00067938|bipolar disorder|bipolar disorder
5406589|NCT00067938|lamotrigine|lamotrigine
5406590|NCT00068003|Adoptive Cell Therapy|adoptive cell therapy
5406591|NCT00068003|Screening|screening
5406592|NCT00068003|Cell Harvest|cell harvest
5406593|NCT00068003|Blood|blood
5406594|NCT00068003|Tumor Tissue|tumor tissue
5406595|NCT00067925|Weight-bearing physical activity|weight-bearing physical activity
5406596|NCT00067925|Calcium intake|calcium intake
5406597|NCT00067925|School-based health education|school-based health education
5406598|NCT00067925|Adolescent girls|adolescent girls
5406599|NCT00067925|Child nutrition|child nutrition
5406600|NCT00067925|Diet|diet
5406601|NCT00010036|adult glioblastoma|adult glioblastoma
5406602|NCT00010036|adult giant cell glioblastoma|adult giant cell glioblastoma
5406603|NCT00010036|adult gliosarcoma|adult gliosarcoma
5406604|NCT00008359|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
5406605|NCT00008359|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
5406606|NCT00008359|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5406607|NCT00008359|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5406608|NCT00008359|stage IV breast cancer|stage iv breast cancer
5406609|NCT00008359|stage IIIA breast cancer|stage iiia breast cancer
5406610|NCT00008359|monoclonal gammopathy of undetermined significance|monoclonal gammopathy of undetermined significance
5406611|NCT00008359|stage IIIB breast cancer|stage iiib breast cancer
5406612|NCT00008359|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5406613|NCT00008359|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
5406614|NCT00008359|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
5406615|NCT00008359|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
5406616|NCT00008359|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
5406617|NCT00008359|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5406618|NCT00008359|isolated plasmacytoma of bone|isolated plasmacytoma of bone
5406619|NCT00008359|extramedullary plasmacytoma|extramedullary plasmacytoma
5406620|NCT00008359|refractory multiple myeloma|refractory multiple myeloma
5406621|NCT00008359|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
5406622|NCT00008359|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5406623|NCT00008359|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5406624|NCT00008359|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5406625|NCT00008359|disseminated neuroblastoma|disseminated neuroblastoma
5406626|NCT00008359|recurrent neuroblastoma|recurrent neuroblastoma
5406627|NCT00008359|recurrent Wilms tumor and other childhood kidney tumors|recurrent wilms tumor and other childhood kidney tumors
5406628|NCT00008359|stage 0 chronic lymphocytic leukemia|stage 0 chronic lymphocytic leukemia
5406629|NCT00008359|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
5406630|NCT00008359|stage I multiple myeloma|stage i multiple myeloma
5406631|NCT00008359|stage II multiple myeloma|stage ii multiple myeloma
5406632|NCT00008359|stage III multiple myeloma|stage iii multiple myeloma
5406633|NCT00008359|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
5406634|NCT00008359|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
5406635|NCT00008359|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5406636|NCT00008359|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5406637|NCT00008359|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5406638|NCT00008359|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5406639|NCT00008359|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5406640|NCT00008359|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5406641|NCT00008359|small intestine lymphoma|small intestine lymphoma
5406642|NCT00008359|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
5406643|NCT00008359|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
5406644|NCT00008359|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5406645|NCT00008359|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5406646|NCT00008359|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5406647|NCT00008359|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5406648|NCT00008359|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
5406649|NCT00008359|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5431525|NCT00028366|VX-175|vx-175
5406650|NCT00008359|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5406651|NCT00008359|polycythemia vera|polycythemia vera
5406652|NCT00008359|primary myelofibrosis|primary myelofibrosis
5406653|NCT00008359|essential thrombocythemia|essential thrombocythemia
5406654|NCT00008359|fever, sweats, and hot flashes|fever, sweats, and hot flashes
5406655|NCT00008359|testicular embryonal carcinoma|testicular embryonal carcinoma
5406656|NCT00008359|testicular choriocarcinoma|testicular choriocarcinoma
5406657|NCT00008359|testicular teratoma|testicular teratoma
5406658|NCT00008359|testicular yolk sac tumor|testicular yolk sac tumor
5406659|NCT00008359|testicular embryonal carcinoma and teratoma|testicular embryonal carcinoma and teratoma
5406660|NCT00008359|testicular embryonal carcinoma and teratoma with seminoma|testicular embryonal carcinoma and teratoma with seminoma
5406661|NCT00008359|testicular embryonal carcinoma and yolk sac tumor|testicular embryonal carcinoma and yolk sac tumor
5406662|NCT00008359|testicular embryonal carcinoma and yolk sac tumor with seminoma|testicular embryonal carcinoma and yolk sac tumor with seminoma
5406663|NCT00008359|testicular embryonal carcinoma and seminoma|testicular embryonal carcinoma and seminoma
5406664|NCT00008359|testicular yolk sac tumor and teratoma|testicular yolk sac tumor and teratoma
5406665|NCT00008359|testicular yolk sac tumor and teratoma with seminoma|testicular yolk sac tumor and teratoma with seminoma
5406666|NCT00008359|testicular choriocarcinoma and yolk sac tumor|testicular choriocarcinoma and yolk sac tumor
5406667|NCT00008359|testicular choriocarcinoma and embryonal carcinoma|testicular choriocarcinoma and embryonal carcinoma
5406668|NCT00008359|testicular choriocarcinoma and teratoma|testicular choriocarcinoma and teratoma
5406669|NCT00008359|testicular choriocarcinoma and seminoma|testicular choriocarcinoma and seminoma
5406670|NCT00008359|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
5406671|NCT00008359|refractory hairy cell leukemia|refractory hairy cell leukemia
5406672|NCT00008359|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
5406673|NCT00008359|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
5406674|NCT00008359|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
5406675|NCT00008359|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
5406676|NCT00008359|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
5406677|NCT00008359|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
5406678|NCT00008359|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
5406679|NCT00008359|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
5406680|NCT00008359|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
5406681|NCT00008359|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
5406682|NCT00008359|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5406683|NCT00008359|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
5406684|NCT00008359|ovarian yolk sac tumor|ovarian yolk sac tumor
5406685|NCT00008359|ovarian embryonal carcinoma|ovarian embryonal carcinoma
5406686|NCT00008359|ovarian polyembryoma|ovarian polyembryoma
5406687|NCT00008359|ovarian choriocarcinoma|ovarian choriocarcinoma
5406688|NCT00008359|ovarian immature teratoma|ovarian immature teratoma
5406689|NCT00008359|ovarian mature teratoma|ovarian mature teratoma
5406690|NCT00008359|ovarian monodermal and highly specialized teratoma|ovarian monodermal and highly specialized teratoma
5406691|NCT00008359|ovarian mixed germ cell tumor|ovarian mixed germ cell tumor
5406692|NCT00008359|acute undifferentiated leukemia|acute undifferentiated leukemia
5406693|NCT00008359|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5406694|NCT00008359|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5406695|NCT00008359|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5406696|NCT00008359|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5406697|NCT00008359|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5406698|NCT00008359|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5406699|NCT00008359|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5406700|NCT00008359|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5406701|NCT00008359|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5406702|NCT00008359|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5406703|NCT00008359|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5406704|NCT00008359|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5406705|NCT00008359|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5406706|NCT00008359|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5406707|NCT00008359|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5406708|NCT00008359|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5406709|NCT00008359|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5406710|NCT00008359|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5406711|NCT00008359|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5406712|NCT00008359|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5406713|NCT00008359|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5406714|NCT00008359|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5406715|NCT00008359|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5406716|NCT00008359|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5406717|NCT00008359|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5406718|NCT00008359|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5406719|NCT00008359|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5406720|NCT00008359|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
5406721|NCT00008359|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
5406722|NCT00008359|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
5406723|NCT00008359|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
5406724|NCT00008359|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
5406725|NCT00008359|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5406726|NCT00008359|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5406727|NCT00008359|high risk metastatic gestational trophoblastic tumor|high risk metastatic gestational trophoblastic tumor
5406728|NCT00008359|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5406729|NCT00008359|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5406730|NCT00008359|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
5406731|NCT00008359|neutropenia|neutropenia
5406732|NCT00008359|infection|infection
5406733|NCT00008359|prolymphocytic leukemia|prolymphocytic leukemia
5406734|NCT00008359|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
5406735|NCT00008359|AIDS-related primary CNS lymphoma|aids-related primary cns lymphoma
5406736|NCT00008359|primary systemic amyloidosis|primary systemic amyloidosis
5406737|NCT00008359|intraocular lymphoma|intraocular lymphoma
5406738|NCT00008359|stage I mantle cell lymphoma|stage i mantle cell lymphoma
5406739|NCT00008359|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
5406740|NCT00008359|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
5406741|NCT00008359|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
5406742|NCT00008359|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
5406743|NCT00008359|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
5406744|NCT00008359|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
5406745|NCT00008359|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
5406746|NCT00008359|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
5406747|NCT00008359|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
5406748|NCT00008359|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
5406749|NCT00008359|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5406750|NCT00008359|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5406751|NCT00008359|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5406752|NCT00008359|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
5406753|NCT00008359|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5406754|NCT00008359|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
5406755|NCT00008359|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
5406756|NCT00008359|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5406757|NCT00008359|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
5406758|NCT00008359|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
5406759|NCT00008359|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5406760|NCT00008359|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5406761|NCT00008359|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5406762|NCT00008359|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
5406763|NCT00008359|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5406764|NCT00008359|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
5406765|NCT00008359|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
5406766|NCT00008359|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
5406767|NCT00008359|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
5406768|NCT00008359|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5406769|NCT00008359|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
5406770|NCT00008359|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
5406771|NCT00008359|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5406772|NCT00008359|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5406773|NCT00008359|stage I marginal zone lymphoma|stage i marginal zone lymphoma
5406774|NCT00008359|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
5406775|NCT00008359|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5406776|NCT00008359|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5406777|NCT00008359|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5431625|NCT00028184|HV|hv
5406778|NCT00008359|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5406779|NCT00008359|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
5406780|NCT00008359|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
5406781|NCT00008359|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5406782|NCT00008359|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5406783|NCT00008359|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5406784|NCT00008359|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
5406785|NCT00008086|recurrent adult brain tumor|recurrent adult brain tumor
5406786|NCT00008086|adult brain stem glioma|adult brain stem glioma
5406787|NCT00008086|adult craniopharyngioma|adult craniopharyngioma
5406788|NCT00008086|adult medulloblastoma|adult medulloblastoma
5406789|NCT00008086|adult meningioma|adult meningioma
5406790|NCT00008086|adult glioblastoma|adult glioblastoma
5406791|NCT00008086|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5406792|NCT00008086|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5406793|NCT00008086|adult myxopapillary ependymoma|adult myxopapillary ependymoma
5406794|NCT00008086|adult anaplastic ependymoma|adult anaplastic ependymoma
5406795|NCT00008086|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
5406796|NCT00008086|adult mixed glioma|adult mixed glioma
5406797|NCT00008086|adult central nervous system germ cell tumor|adult central nervous system germ cell tumor
5406798|NCT00008086|adult pilocytic astrocytoma|adult pilocytic astrocytoma
5406799|NCT00008086|adult subependymoma|adult subependymoma
5406800|NCT00008086|adult ependymoblastoma|adult ependymoblastoma
5406801|NCT00008086|adult pineocytoma|adult pineocytoma
5406802|NCT00008086|adult pineoblastoma|adult pineoblastoma
5406803|NCT00008086|adult meningeal hemangiopericytoma|adult meningeal hemangiopericytoma
5406804|NCT00008086|adult choroid plexus tumor|adult choroid plexus tumor
5406805|NCT00008086|adult grade III meningioma|adult grade iii meningioma
5406806|NCT00008086|adult oligodendroglioma|adult oligodendroglioma
5406807|NCT00008086|adult giant cell glioblastoma|adult giant cell glioblastoma
5406808|NCT00008086|adult gliosarcoma|adult gliosarcoma
5406809|NCT00006346|stage II breast cancer|stage ii breast cancer
5406810|NCT00006346|stage IV breast cancer|stage iv breast cancer
5406811|NCT00006346|stage IIIA breast cancer|stage iiia breast cancer
5406812|NCT00006346|stage IIIB breast cancer|stage iiib breast cancer
5406813|NCT00006346|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
5406814|NCT00006265|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5406815|NCT00006254|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5406816|NCT00006223|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5406817|NCT00006223|adult acute erythroid leukemia (M6)|adult acute erythroid leukemia (m6)
5406818|NCT00006223|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
5406819|NCT00006223|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
5406820|NCT00006223|adult acute promyelocytic leukemia (M3)|adult acute promyelocytic leukemia (m3)
5406821|NCT00006223|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
5406822|NCT00006223|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
5406823|NCT00006223|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
5406824|NCT00006223|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
5406825|NCT00006223|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
5406826|NCT00006103|stage III colon cancer|stage iii colon cancer
5406827|NCT00006103|stage IV colon cancer|stage iv colon cancer
5406828|NCT00006103|stage III rectal cancer|stage iii rectal cancer
5406829|NCT00006103|stage IV rectal cancer|stage iv rectal cancer
5406830|NCT00006103|recurrent colon cancer|recurrent colon cancer
5406831|NCT00006103|recurrent rectal cancer|recurrent rectal cancer
5406832|NCT00006103|adenocarcinoma of the colon|adenocarcinoma of the colon
5406833|NCT00006103|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5406834|NCT00006096|stage I vulvar cancer|stage i vulvar cancer
5406835|NCT00006096|stage II vulvar cancer|stage ii vulvar cancer
5406836|NCT00006096|stage III vulvar cancer|stage iii vulvar cancer
5406837|NCT00006096|stage IVB vulvar cancer|stage ivb vulvar cancer
5406838|NCT00006096|squamous cell carcinoma of the vulva|squamous cell carcinoma of the vulva
5406839|NCT00067847|obesity|obesity
5406840|NCT00067847|food policy|food policy
5406841|NCT00067847|physical fitness (Respiratory Burst)|physical fitness (respiratory burst)
5406842|NCT00067847|academic achievement|academic achievement
5406843|NCT00067834|Electromagnetic Fields|electromagnetic fields
5406844|NCT00067834|Bone|bone
5406845|NCT00067834|Forelimb|forelimb
5406846|NCT00067834|Radius|radius
5406847|NCT00006019|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5406848|NCT00006019|refractory multiple myeloma|refractory multiple myeloma
5406849|NCT00006019|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5406850|NCT00006019|recurrent prostate cancer|recurrent prostate cancer
5406851|NCT00006019|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
5406852|NCT00006019|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
5406853|NCT00006019|adult acute promyelocytic leukemia (M3)|adult acute promyelocytic leukemia (m3)
5406854|NCT00006019|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
5406855|NCT00006019|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
5406856|NCT00006019|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5406857|NCT00006019|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5406858|NCT00006019|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5406859|NCT00006019|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5406860|NCT00006019|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5406861|NCT00006019|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5406862|NCT00006019|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
5406863|NCT00006019|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5406864|NCT00006019|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5406865|NCT00006019|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5406866|NCT00006019|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5406867|NCT00006019|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5406868|NCT00006019|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5406869|NCT00006019|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5406870|NCT00006002|stage IV prostate cancer|stage iv prostate cancer
5406871|NCT00006002|recurrent prostate cancer|recurrent prostate cancer
5406872|NCT00005887|tumors metastatic to brain|tumors metastatic to brain
5406873|NCT00005886|stage I breast cancer|stage i breast cancer
5406874|NCT00005886|stage II breast cancer|stage ii breast cancer
5406875|NCT00005886|ductal breast carcinoma in situ|ductal breast carcinoma in situ
5406876|NCT00005886|breast cancer in situ|breast cancer in situ
5406877|NCT00005857|stage IV prostate cancer|stage iv prostate cancer
5406878|NCT00005857|recurrent prostate cancer|recurrent prostate cancer
5406879|NCT00067821|Brain Tumor|brain tumor
5406880|NCT00067821|Children|children
5406881|NCT00067821|Metabolic|metabolic
5406882|NCT00067821|Spectroscopy|spectroscopy
5406883|NCT00067821|PET|pet
5406884|NCT00067808|Myelodysplastic Syndrome|myelodysplastic syndrome
5406885|NCT00067808|Chronic Myelomonocytic Leukemia|chronic myelomonocytic leukemia
5406886|NCT00067808|MDS|mds
5406887|NCT00067808|Decitabine|decitabine
5406888|NCT00067808|Dacogen|dacogen
5406889|NCT00067808|Methylation|methylation
5406890|NCT00067795|Treatment Experienced|treatment experienced
5406891|NCT00067795|Antiretroviral Therapy, Highly Active|antiretroviral therapy, highly active
5406892|NCT00067795|HIV Antigens|hiv antigens
5406893|NCT00067795|Cohort Studies|cohort studies
5406894|NCT00067795|Immunity, Cellular|immunity, cellular
5406895|NCT00067795|T-Lymphocytes|t-lymphocytes
5406896|NCT00067782|HIV|hiv
5406897|NCT00067782|Treatment Experienced|treatment experienced
5406898|NCT00067769|Encopresis|encopresis
5406899|NCT00067769|Internet|internet
5406900|NCT00067769|Web|web
5406901|NCT00067769|Treatment|treatment
5406902|NCT00067769|Intervention|intervention
5406903|NCT00005804|monoclonal gammopathy of undetermined significance|monoclonal gammopathy of undetermined significance
5406904|NCT00005804|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5406905|NCT00005804|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5406906|NCT00005804|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5406907|NCT00005804|Burkitt lymphoma|burkitt lymphoma
5406908|NCT00005804|isolated plasmacytoma of bone|isolated plasmacytoma of bone
5406909|NCT00005804|extramedullary plasmacytoma|extramedullary plasmacytoma
5406910|NCT00005804|refractory multiple myeloma|refractory multiple myeloma
5406911|NCT00005804|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
5406912|NCT00005804|stage III multiple myeloma|stage iii multiple myeloma
5406913|NCT00005804|stage II childhood lymphoblastic lymphoma|stage ii childhood lymphoblastic lymphoma
5406914|NCT00005804|stage III childhood lymphoblastic lymphoma|stage iii childhood lymphoblastic lymphoma
5406915|NCT00005804|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
5406916|NCT00005804|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
5406917|NCT00005804|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5406918|NCT00005804|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5406919|NCT00005804|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5406920|NCT00005804|small intestine lymphoma|small intestine lymphoma
5406921|NCT00005804|childhood immunoblastic large cell lymphoma|childhood immunoblastic large cell lymphoma
5406922|NCT00005804|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5406923|NCT00005804|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5406924|NCT00005804|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5406925|NCT00005804|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
5406926|NCT00005804|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
5406927|NCT00005804|untreated childhood acute myeloid leukemia and other myeloid malignancies|untreated childhood acute myeloid leukemia and other myeloid malignancies
5407005|NCT00067665|hemodialysis|hemodialysis
5406928|NCT00005804|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
5406929|NCT00005804|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5406930|NCT00005804|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5406931|NCT00005804|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
5406932|NCT00005804|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
5406933|NCT00005804|polycythemia vera|polycythemia vera
5406934|NCT00005804|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
5406935|NCT00005804|essential thrombocythemia|essential thrombocythemia
5406936|NCT00005804|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
5406937|NCT00005804|refractory hairy cell leukemia|refractory hairy cell leukemia
5406938|NCT00005804|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
5406939|NCT00005804|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5406940|NCT00005804|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
5406941|NCT00005804|acute undifferentiated leukemia|acute undifferentiated leukemia
5406942|NCT00005804|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5406943|NCT00005804|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5406944|NCT00005804|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5406945|NCT00005804|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5406946|NCT00005804|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5406947|NCT00005804|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5406948|NCT00005804|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5406949|NCT00005804|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5406950|NCT00005804|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5406951|NCT00005804|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5406952|NCT00005804|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5406953|NCT00005804|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
5406954|NCT00005804|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5406955|NCT00005804|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5406956|NCT00005804|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5406957|NCT00005804|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5406958|NCT00005804|prolymphocytic leukemia|prolymphocytic leukemia
5406959|NCT00005804|primary systemic amyloidosis|primary systemic amyloidosis
5406960|NCT00005804|intraocular lymphoma|intraocular lymphoma
5406961|NCT00005804|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
5406962|NCT00005804|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
5406963|NCT00005804|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
5406964|NCT00005804|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
5406965|NCT00005804|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5406966|NCT00005804|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
5406967|NCT00005804|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5406968|NCT00005804|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5406969|NCT00005804|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5406970|NCT00005804|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5406971|NCT00005804|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5406972|NCT00005804|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5406973|NCT00005804|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5406974|NCT00005804|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
5406975|NCT00005090|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5406976|NCT00005090|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5406977|NCT00067756|Pulmonary Disease|pulmonary disease
5406978|NCT00067756|Liver Disease|liver disease
5406979|NCT00067743|Pain|pain
5406980|NCT00067743|Pain syndrome|pain syndrome
5406981|NCT00067743|Reflex sympathetic dystrophy|reflex sympathetic dystrophy
5406982|NCT00067743|CC-5013|cc-5013
5406983|NCT00067743|CC5013|cc5013
5406984|NCT00067743|Revlimid|revlimid
5406985|NCT00067743|Celgene|celgene
5406986|NCT00067743|CRPS|crps
5406987|NCT00067717|breast reconstruction surgery|breast reconstruction surgery
5406988|NCT00067717|prayer|prayer
5406989|NCT00067717|distance healing|distance healing
5406990|NCT00067717|wound healing|wound healing
5406991|NCT00067704|Complementary Therapies|complementary therapies
5406992|NCT00067691|Lung cancer|lung cancer
5406993|NCT00067691|Breast cancer|breast cancer
5406994|NCT00067691|Shortness of breath|shortness of breath
5406995|NCT00067691|Dyspnea|dyspnea
5406996|NCT00067691|Metastasis|metastasis
5406997|NCT00067691|Breathlessness|breathlessness
5406998|NCT00067691|Acupuncture|acupuncture
5406999|NCT00067678|diabetic nephropathy|diabetic nephropathy
5407000|NCT00067678|nephropathy|nephropathy
5407001|NCT00067678|diabetes|diabetes
5407002|NCT00067678|diabetes mellitus|diabetes mellitus
5407003|NCT00067678|type I diabetes|type i diabetes
5407006|NCT00067639|Multiple Myeloma|multiple myeloma
5407007|NCT00067639|PBSC mobilization|pbsc mobilization
5407008|NCT00067639|Pegfilgrastim|pegfilgrastim
5407009|NCT00067639|Neulasta|neulasta
5407010|NCT00067639|PEG-G-CSF|peg-g-csf
5407011|NCT00067626|glucose tolerance test|glucose tolerance test
5407012|NCT00067626|minerals|minerals
5407013|NCT00067626|chromium|chromium
5407014|NCT00067626|complementary and alternative medicine|complementary and alternative medicine
5407015|NCT00067613|NICHD Neonatal Research Network|nichd neonatal research network
5407016|NCT00067613|Extremely Low Birth Weight (ELBW)|extremely low birth weight (elbw)
5407017|NCT00067613|Very Low Birth Weight (VLBW)|very low birth weight (vlbw)
5407018|NCT00067613|Prematurity|prematurity
5407019|NCT00067613|Mechanical ventilation|mechanical ventilation
5407020|NCT00067613|Benchmarking|benchmarking
5407021|NCT00067613|Chronic Lung Disease (CLD)|chronic lung disease (cld)
5407022|NCT00067587|Treatment experienced|treatment experienced
5407023|NCT00067587|Treatment naive|treatment naive
5407024|NCT00067574|Structured treatment interruption|structured treatment interruption
5407025|NCT00067574|Treatment experienced|treatment experienced
5407026|NCT00067561|Dose-ranging|dose-ranging
5407027|NCT00067561|Diarrhea-Predominant Irritable Bowel Syndrome|diarrhea-predominant irritable bowel syndrome
5407028|NCT00067561|d-IBS|d-ibs
5407029|NCT00067561|IBS|ibs
5407030|NCT00067561|Irritable Bowel Syndrome|irritable bowel syndrome
5407031|NCT00067548|Advanced Non-Small Cell Lung Cancer|advanced non-small cell lung cancer
5407032|NCT00067535|cocaine dependence|cocaine dependence
5407033|NCT00067522|Family Planning|family planning
5407034|NCT00067522|Sexually Transmitted Diseases|sexually transmitted diseases
5407035|NCT00067522|HIV|hiv
5407036|NCT00067522|Africa|africa
5407037|NCT00067522|Zambia|zambia
5407038|NCT00067522|AIDS|aids
5407039|NCT00067522|Contraception|contraception
5407040|NCT00067522|HIV Prevention|hiv prevention
5407041|NCT00067509|Female|female
5407042|NCT00004256|stage I laryngeal cancer|stage i laryngeal cancer
5407043|NCT00004256|stage II laryngeal cancer|stage ii laryngeal cancer
5407044|NCT00004256|recurrent laryngeal cancer|recurrent laryngeal cancer
5407045|NCT00004256|oral complications|oral complications
5407046|NCT00004256|radiation toxicity|radiation toxicity
5407047|NCT00004233|stage III gastric cancer|stage iii gastric cancer
5407048|NCT00004233|stage IV gastric cancer|stage iv gastric cancer
5407049|NCT00004233|recurrent gastric cancer|recurrent gastric cancer
5407050|NCT00004233|stage III esophageal cancer|stage iii esophageal cancer
5407051|NCT00004233|stage IV esophageal cancer|stage iv esophageal cancer
5407052|NCT00004233|recurrent esophageal cancer|recurrent esophageal cancer
5407053|NCT00004233|adenocarcinoma of the stomach|adenocarcinoma of the stomach
5407054|NCT00004233|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
5407055|NCT00004125|stage II breast cancer|stage ii breast cancer
5407056|NCT00004125|stage IIIA breast cancer|stage iiia breast cancer
5407057|NCT00067496|Pain|pain
5407058|NCT00067496|Weakness|weakness
5407059|NCT00067496|Depression|depression
5407060|NCT00067496|Poliomyelitis|poliomyelitis
5407061|NCT00067496|Sleep Apnea|sleep apnea
5407062|NCT00067496|Post-Polio Syndrome|post-polio syndrome
5407063|NCT00067496|PPS|pps
5407064|NCT00067483|Cataract|cataract
5407065|NCT00067483|Pre-Senile|pre-senile
5407066|NCT00067483|Dynamic Light Scattering (DLS)|dynamic light scattering (dls)
5407067|NCT00067483|Light Scattering|light scattering
5407068|NCT00067483|Lens|lens
5407069|NCT00067483|Cataracts|cataracts
5407070|NCT00067457|PRN|prn
5407071|NCT00067457|Diarrhea-Predominant Irritable Bowel Syndrome|diarrhea-predominant irritable bowel syndrome
5407072|NCT00067457|Irritable Bowel Syndrome (IBS)|irritable bowel syndrome (ibs)
5407073|NCT00067444|Elderly|elderly
5407074|NCT00067444|Major Depressive Disorder|major depressive disorder
5407075|NCT00067444|MDD|mdd
5407076|NCT00067431|Partial Seizures|partial seizures
5407077|NCT00067405|Fibromyalgia|fibromyalgia
5407078|NCT00067405|Intravenous micronutrient therapy|intravenous micronutrient therapy
5407079|NCT00067405|IVMT|ivmt
5407080|NCT00067405|alternative medicine|alternative medicine
5407081|NCT00067405|complementary medicine|complementary medicine
5407082|NCT00067405|vitamins|vitamins
5407083|NCT00067405|vitamin supplements|vitamin supplements
5407084|NCT00067392|Partial edentulism|partial edentulism
5407085|NCT00067392|Bone atrophy|bone atrophy
5407086|NCT00067392|Bone healing|bone healing
5407087|NCT00004004|recurrent adult brain tumor|recurrent adult brain tumor
5407088|NCT00004004|adult glioblastoma|adult glioblastoma
5407089|NCT00004004|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5407090|NCT00004004|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
5407091|NCT00004004|adult giant cell glioblastoma|adult giant cell glioblastoma
5407092|NCT00004004|adult gliosarcoma|adult gliosarcoma
5407093|NCT00003931|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5407094|NCT00003931|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5407095|NCT00003890|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5407096|NCT00003736|breast cancer|breast cancer
5407097|NCT00003464|adult glioblastoma|adult glioblastoma
5407098|NCT00003464|adult giant cell glioblastoma|adult giant cell glioblastoma
5407099|NCT00003464|adult gliosarcoma|adult gliosarcoma
5407100|NCT00067418|Glioma|glioma
5407101|NCT00067418|Brain Tumor|brain tumor
5407102|NCT00067418|Spectroscopy|spectroscopy
5407103|NCT00067353|Early Childhood Caries|early childhood caries
5407104|NCT00067327|Relapsing remitting multiple sclerosis|relapsing remitting multiple sclerosis
5407105|NCT00067327|Multiple sclerosis|multiple sclerosis
5407106|NCT00067327|Peroxynitrite|peroxynitrite
5407107|NCT00067327|Uric acid|uric acid
5407108|NCT00067327|Inosine|inosine
5407109|NCT00067301|depression|depression
5407110|NCT00067301|citalopram|citalopram
5407111|NCT00067301|Celexa|celexa
5407112|NCT00067301|Polyunsaturated Fatty Acids|polyunsaturated fatty acids
5407113|NCT00067301|omega-3|omega-3
5407114|NCT00067301|EPA|epa
5407115|NCT00067301|antidepressants|antidepressants
5407116|NCT00067288|Stage 3 cancer;|stage 3 cancer;
5407117|NCT00067288|Stage 4 cancer;|stage 4 cancer;
5407118|NCT00067288|solid tumor cancer;|solid tumor cancer;
5407119|NCT00067288|Non-Hodgkin's Lymphoma;|non-hodgkin's lymphoma;
5407120|NCT00067288|solid tumors;|solid tumors;
5407121|NCT00067288|end-stage cancer;|end-stage cancer;
5407122|NCT00067288|group psychotherapy;|group psychotherapy;
5407123|NCT00067288|psychotherapy;|psychotherapy;
5407124|NCT00067288|emotional support;|emotional support;
5407125|NCT00067288|support groups|support groups
5407126|NCT00067262|Bipolar Disorder Type 1 (manic or mixed type)|bipolar disorder type 1 (manic or mixed type)
5407127|NCT00067249|Race|race
5407128|NCT00067249|Ethnicity|ethnicity
5407129|NCT00067249|Complementary and Alternative Medicine|complementary and alternative medicine
5407130|NCT00067249|Women's health|women's health
5407131|NCT00067249|Social determinants of Health|social determinants of health
5407132|NCT00067275|Stroke|stroke
5407133|NCT00067275|Motor Training|motor training
5407134|NCT00067275|Positron Emission Tomograhy|positron emission tomograhy
5407135|NCT00067275|Plasticity|plasticity
5407136|NCT00067275|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
5407137|NCT00067275|Healthy Volunteer|healthy volunteer
5407138|NCT00067275|HV|hv
5407139|NCT00067223|Transcranial Magnetic Stimulation (TMS)|transcranial magnetic stimulation (tms)
5407140|NCT00067223|Unilateral Finger Movement|unilateral finger movement
5407141|NCT00067223|Interhemispheric Inhibition|interhemispheric inhibition
5407142|NCT00067223|Motor Training|motor training
5407143|NCT00067223|Plasticity|plasticity
5407144|NCT00067223|Healthy Volunteer|healthy volunteer
5407145|NCT00067223|HV|hv
5407146|NCT00067210|Brain|brain
5407147|NCT00067210|Epilepsy|epilepsy
5407148|NCT00067210|Core|core
5407149|NCT00067210|Temperature|temperature
5407150|NCT00067197|Transcranial Direct Current Stimulation (tDCS)|transcranial direct current stimulation (tdcs)
5407151|NCT00067197|Cortical Reorganization|cortical reorganization
5407152|NCT00067197|Rehabilitation|rehabilitation
5407153|NCT00067197|Motor Learning|motor learning
5407154|NCT00067197|Activity of Daily Living (ADL)|activity of daily living (adl)
5407155|NCT00067197|Stroke|stroke
5407156|NCT00067197|Healthy Volunteer|healthy volunteer
5407157|NCT00067197|HV|hv
5407158|NCT00067184|methadone|methadone
5407159|NCT00067184|fetus|fetus
5407160|NCT00067171|behavioral intervention|behavioral intervention
5407161|NCT00067158|nicotine dependence|nicotine dependence
5407162|NCT00067119|Graft Failure|graft failure
5407163|NCT00067119|Access Blood Flow Monitoring|access blood flow monitoring
5407164|NCT00067119|Clinical Trial Vascular Access|clinical trial vascular access
5407165|NCT00067119|Fistula Failure|fistula failure
5407166|NCT00067119|Hemodialysis|hemodialysis
5407167|NCT00067119|Vascular Access|vascular access
5407168|NCT00067106|HIV|hiv
5407169|NCT00067106|Women|women
5407170|NCT00067106|Genital tract|genital tract
5407171|NCT00067106|Treatment experienced|treatment experienced
5407172|NCT00067106|Drug resistance|drug resistance
5407173|NCT00067080|Sickle cell disease|sickle cell disease
5407174|NCT00067080|iron overload|iron overload
5407175|NCT00067080|deferoxamine|deferoxamine
5407176|NCT00067080|hemosiderosis|hemosiderosis
5407177|NCT00067041|Critical Limb Ischemia|critical limb ischemia
5407178|NCT00067041|Autogenous Bypass Graft|autogenous bypass graft
5407179|NCT00067041|CLI|cli
5407180|NCT00067028|Chronic Myeloid Leukemia|chronic myeloid leukemia
5407181|NCT00067028|CML Myeloid Blast Phase|cml myeloid blast phase
5407182|NCT00067028|Acute Myeloid Leukemia|acute myeloid leukemia
5407183|NCT00067028|Myelodysplastic Syndrome|myelodysplastic syndrome
5407184|NCT00067028|Clofarabine|clofarabine
5407185|NCT00067028|Clofarex|clofarex
5407186|NCT00067028|Clolar|clolar
5407187|NCT00067028|Ara-C|ara-c
5407188|NCT00067028|Cytarabine|cytarabine
5407189|NCT00067028|Cytosar|cytosar
5407190|NCT00067028|DepoCyt|depocyt
5407191|NCT00067028|Cytosine arabinosine hydrochloride|cytosine arabinosine hydrochloride
5407192|NCT00067028|Idarubicin|idarubicin
5407193|NCT00067028|Idamycin|idamycin
5407194|NCT00003433|stage IV colon cancer|stage iv colon cancer
5407195|NCT00003433|liver metastases|liver metastases
5407196|NCT00003323|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5407197|NCT00003323|recurrent prostate cancer|recurrent prostate cancer
5407198|NCT00003323|sexual dysfunction and infertility|sexual dysfunction and infertility
5432154|NCT00025857|Emotion|emotion
5407199|NCT00003114|AIDS-related lymphoma|aids-related lymphoma
5407200|NCT00003114|HIV-associated Hodgkin lymphoma|hiv-associated hodgkin lymphoma
5407201|NCT00003006|stage I non-small cell lung cancer|stage i non-small cell lung cancer
5407202|NCT00067067|Glioma|glioma
5407203|NCT00067067|Brain Tumor|brain tumor
5407204|NCT00067067|Endothelial Progenitor Cells|endothelial progenitor cells
5407205|NCT00067054|Volunteer|volunteer
5407206|NCT00067054|Plasmapheresis|plasmapheresis
5407207|NCT00067054|Leukapheresis|leukapheresis
5407208|NCT00067054|Immunology|immunology
5407209|NCT00067054|Leukocyte|leukocyte
5407210|NCT00067054|Healthy Volunteer|healthy volunteer
5407211|NCT00067054|HV|hv
5407212|NCT00067015|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5407213|NCT00067015|stage III prostate cancer|stage iii prostate cancer
5407214|NCT00067002|ALL|all
5407215|NCT00067002|Leukemia, Lymphocytic, Acute|leukemia, lymphocytic, acute
5407216|NCT00067002|AML|aml
5407217|NCT00067002|Leukemia, Myelocytic, Acute|leukemia, myelocytic, acute
5407218|NCT00067002|CML|cml
5407219|NCT00067002|Leukemia, Myeloid, Chronic|leukemia, myeloid, chronic
5407220|NCT00067002|NHL|nhl
5407221|NCT00067002|Lymphoma, Non-Hodgkin|lymphoma, non-hodgkin
5407222|NCT00067002|double cord blood transplant|double cord blood transplant
5407223|NCT00067002|expanded cord blood transplant|expanded cord blood transplant
5407224|NCT00067002|Rituxan|rituxan
5407225|NCT00067002|Rituximab|rituximab
5407226|NCT00067002|Melphalan|melphalan
5407227|NCT00067002|Alkeran|alkeran
5407228|NCT00067002|Thiotepa|thiotepa
5407229|NCT00067002|Fludarabine|fludarabine
5407230|NCT00067002|Fludarabine phosphate|fludarabine phosphate
5407231|NCT00067002|Fludara|fludara
5407232|NCT00067002|Cyclophosphamide|cyclophosphamide
5407233|NCT00067002|Cytoxan|cytoxan
5407234|NCT00067002|Neosar|neosar
5407235|NCT00067002|Mesna|mesna
5407236|NCT00067002|Mesnex|mesnex
5407237|NCT00066989|Staphylococcal infection|staphylococcal infection
5407238|NCT00066989|Gram positive bacteria|gram positive bacteria
5407239|NCT00066989|Staphylococcus|staphylococcus
5407240|NCT00066989|Staphylococcus aureus|staphylococcus aureus
5407241|NCT00046878|adult glioblastoma|adult glioblastoma
5407242|NCT00046878|adult giant cell glioblastoma|adult giant cell glioblastoma
5407243|NCT00046878|adult gliosarcoma|adult gliosarcoma
5407244|NCT00002621|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5407245|NCT00002621|stage I childhood lymphoblastic lymphoma|stage i childhood lymphoblastic lymphoma
5407246|NCT00002621|stage II childhood lymphoblastic lymphoma|stage ii childhood lymphoblastic lymphoma
5407247|NCT00002621|stage III childhood lymphoblastic lymphoma|stage iii childhood lymphoblastic lymphoma
5407248|NCT00002621|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
5407249|NCT00002621|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
5407250|NCT00002621|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5407251|NCT00002621|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
5407252|NCT00002621|untreated childhood acute myeloid leukemia and other myeloid malignancies|untreated childhood acute myeloid leukemia and other myeloid malignancies
5407253|NCT00002621|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
5407254|NCT00002621|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
5407255|NCT00002621|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
5407256|NCT00002621|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
5407257|NCT00002621|AIDS-related primary CNS lymphoma|aids-related primary cns lymphoma
5407258|NCT00002621|stage I childhood small noncleaved cell lymphoma|stage i childhood small noncleaved cell lymphoma
5407259|NCT00002621|stage I childhood large cell lymphoma|stage i childhood large cell lymphoma
5407260|NCT00002621|stage II childhood small noncleaved cell lymphoma|stage ii childhood small noncleaved cell lymphoma
5407261|NCT00002621|stage II childhood large cell lymphoma|stage ii childhood large cell lymphoma
5407262|NCT00002621|stage III childhood small noncleaved cell lymphoma|stage iii childhood small noncleaved cell lymphoma
5407263|NCT00002621|stage III childhood large cell lymphoma|stage iii childhood large cell lymphoma
5407264|NCT00002621|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
5407265|NCT00002621|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
5407266|NCT00002621|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
5407267|NCT00002621|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
5407268|NCT00002548|stage I multiple myeloma|stage i multiple myeloma
5407269|NCT00002548|stage II multiple myeloma|stage ii multiple myeloma
5407270|NCT00002548|stage III multiple myeloma|stage iii multiple myeloma
5407271|NCT00002520|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
5407272|NCT00002520|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
5407273|NCT00002520|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
5407274|NCT00002520|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5407275|NCT00002520|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5407276|NCT00002520|stage I colon cancer|stage i colon cancer
5407277|NCT00002520|stage II colon cancer|stage ii colon cancer
5407278|NCT00002520|stage I breast cancer|stage i breast cancer
5407480|NCT00066794|adult erythroleukemia (M6a)|adult erythroleukemia (m6a)
5407279|NCT00002520|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
5407280|NCT00002520|AIDS-related primary CNS lymphoma|aids-related primary cns lymphoma
5407281|NCT00002520|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5407282|NCT00002520|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
5407283|NCT00002520|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
5407284|NCT00002520|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
5407285|NCT00002520|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
5407286|NCT00002520|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
5407287|NCT00002520|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
5407288|NCT00002520|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
5407289|NCT00002520|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
5407290|NCT00002520|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
5407291|NCT00002520|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
5407292|NCT00002520|intraocular lymphoma|intraocular lymphoma
5407293|NCT00002520|limited stage small cell lung cancer|limited stage small cell lung cancer
5407294|NCT00002520|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5407295|NCT00002520|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
5407296|NCT00002520|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
5407297|NCT00002520|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
5407298|NCT00002520|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
5407299|NCT00002520|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
5407300|NCT00002520|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5407301|NCT00002520|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5407302|NCT00002520|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5407303|NCT00002520|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5407304|NCT00002520|primary central nervous system lymphoma|primary central nervous system lymphoma
5407305|NCT00002520|tobacco use disorder|tobacco use disorder
5407306|NCT00002520|stage I adenoid cystic carcinoma of the oral cavity|stage i adenoid cystic carcinoma of the oral cavity
5407307|NCT00002520|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
5407308|NCT00002520|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
5407309|NCT00002520|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
5407310|NCT00002520|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
5407311|NCT00002520|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
5407312|NCT00002520|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
5407313|NCT00002520|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
5407314|NCT00002520|stage I basal cell carcinoma of the lip|stage i basal cell carcinoma of the lip
5407315|NCT00002520|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
5407316|NCT00002520|stage I esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage i esthesioneuroblastoma of the paranasal sinus and nasal cavity
5407317|NCT00002520|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
5407318|NCT00002520|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
5407319|NCT00002520|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
5407320|NCT00002520|stage I inverted papilloma of the paranasal sinus and nasal cavity|stage i inverted papilloma of the paranasal sinus and nasal cavity
5407321|NCT00002520|stage I lymphoepithelioma of the nasopharynx|stage i lymphoepithelioma of the nasopharynx
5407322|NCT00002520|stage I lymphoepithelioma of the oropharynx|stage i lymphoepithelioma of the oropharynx
5407323|NCT00002520|stage I mantle cell lymphoma|stage i mantle cell lymphoma
5407324|NCT00002520|stage I midline lethal granuloma of the paranasal sinus and nasal cavity|stage i midline lethal granuloma of the paranasal sinus and nasal cavity
5407325|NCT00002520|stage I mucoepidermoid carcinoma of the oral cavity|stage i mucoepidermoid carcinoma of the oral cavity
5407326|NCT00002520|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
5407327|NCT00002520|stage I non-small cell lung cancer|stage i non-small cell lung cancer
5407328|NCT00002520|stage I prostate cancer|stage i prostate cancer
5407329|NCT00002520|stage I rectal cancer|stage i rectal cancer
5407330|NCT00002520|stage I squamous cell carcinoma of the hypopharynx|stage i squamous cell carcinoma of the hypopharynx
5407331|NCT00002520|stage I squamous cell carcinoma of the larynx|stage i squamous cell carcinoma of the larynx
5407332|NCT00002520|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
5407333|NCT00002520|stage I squamous cell carcinoma of the nasopharynx|stage i squamous cell carcinoma of the nasopharynx
5407334|NCT00002520|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
5407335|NCT00002520|stage I squamous cell carcinoma of the paranasal sinus and nasal cavity|stage i squamous cell carcinoma of the paranasal sinus and nasal cavity
5407336|NCT00002520|stage I malignant testicular germ cell tumor|stage i malignant testicular germ cell tumor
5432662|NCT00014937|RNA, Viral|rna, viral
5407337|NCT00002520|stage I verrucous carcinoma of the larynx|stage i verrucous carcinoma of the larynx
5407338|NCT00002520|stage I verrucous carcinoma of the oral cavity|stage i verrucous carcinoma of the oral cavity
5407339|NCT00002520|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
5407340|NCT00002520|stage II adenoid cystic carcinoma of the oral cavity|stage ii adenoid cystic carcinoma of the oral cavity
5407341|NCT00002520|stage II basal cell carcinoma of the lip|stage ii basal cell carcinoma of the lip
5407342|NCT00002520|stage II bladder cancer|stage ii bladder cancer
5407343|NCT00002520|stage II breast cancer|stage ii breast cancer
5407344|NCT00002520|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
5407345|NCT00002520|stage II esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage ii esthesioneuroblastoma of the paranasal sinus and nasal cavity
5407346|NCT00002520|stage II inverted papilloma of the paranasal sinus and nasal cavity|stage ii inverted papilloma of the paranasal sinus and nasal cavity
5407347|NCT00002520|stage II lymphoepithelioma of the nasopharynx|stage ii lymphoepithelioma of the nasopharynx
5407348|NCT00002520|stage II lymphoepithelioma of the oropharynx|stage ii lymphoepithelioma of the oropharynx
5407349|NCT00002520|stage II midline lethal granuloma of the paranasal sinus and nasal cavity|stage ii midline lethal granuloma of the paranasal sinus and nasal cavity
5407350|NCT00002520|stage II mucoepidermoid carcinoma of the oral cavity|stage ii mucoepidermoid carcinoma of the oral cavity
5407351|NCT00002520|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
5407352|NCT00002520|stage I bladder cancer|stage i bladder cancer
5407353|NCT00002520|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
5407354|NCT00002520|stage II prostate cancer|stage ii prostate cancer
5407355|NCT00002520|stage II rectal cancer|stage ii rectal cancer
5407356|NCT00002520|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
5407357|NCT00002520|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
5407358|NCT00002520|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
5407359|NCT00002520|stage II squamous cell carcinoma of the nasopharynx|stage ii squamous cell carcinoma of the nasopharynx
5407360|NCT00002520|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
5407361|NCT00002520|stage II squamous cell carcinoma of the paranasal sinus and nasal cavity|stage ii squamous cell carcinoma of the paranasal sinus and nasal cavity
5407362|NCT00002520|stage II malignant testicular germ cell tumor|stage ii malignant testicular germ cell tumor
5407363|NCT00002520|stage II verrucous carcinoma of the larynx|stage ii verrucous carcinoma of the larynx
5407364|NCT00002520|stage II verrucous carcinoma of the oral cavity|stage ii verrucous carcinoma of the oral cavity
5407365|NCT00002520|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
5407366|NCT00002520|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5407367|NCT00002520|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5407662|NCT00066404|recurrent breast cancer|recurrent breast cancer
5407368|NCT00002520|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5407369|NCT00002520|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5407370|NCT00002520|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5407371|NCT00002520|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5407372|NCT00002520|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
5407373|NCT00002520|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5407374|NCT00002520|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5407375|NCT00002520|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5407376|NCT00002520|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5407377|NCT00002520|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
5407378|NCT00002520|stage III prostate cancer|stage iii prostate cancer
5407379|NCT00002520|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
5407380|NCT00002520|stage IIIA breast cancer|stage iiia breast cancer
5407381|NCT00002520|stage IIIB breast cancer|stage iiib breast cancer
5407382|NCT00002520|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
5407383|NCT00002520|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5407384|NCT00002520|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5407385|NCT00002520|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5407386|NCT00002520|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5407387|NCT00002520|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5407388|NCT00002520|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5407389|NCT00002520|stage IV breast cancer|stage iv breast cancer
5407390|NCT00002520|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
5407391|NCT00002520|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5407392|NCT00002520|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5407393|NCT00002520|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5407394|NCT00002520|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5407395|NCT00002520|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
5407396|NCT00002520|stage IV prostate cancer|stage iv prostate cancer
5407397|NCT00002520|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5407398|NCT00002520|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
5407399|NCT00002520|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
5407400|NCT00002520|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
5407401|NCT00002520|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
5407402|NCT00002520|stage I marginal zone lymphoma|stage i marginal zone lymphoma
5407403|NCT00002520|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
5407404|NCT00002520|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5407405|NCT00002520|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5407406|NCT00002520|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5407407|NCT00002520|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5407408|NCT00002520|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5407409|NCT00002520|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5407410|NCT00002520|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5407411|NCT00066976|Prenatal|prenatal
5407412|NCT00066976|Respiration|respiration
5407413|NCT00066976|Ultrasound|ultrasound
5407414|NCT00066976|Prematurity|prematurity
5407415|NCT00066976|Diagnoses|diagnoses
5407416|NCT00066976|Fetal Breathing-Movement|fetal breathing-movement
5407417|NCT00066976|Doppler Sonography|doppler sonography
5407418|NCT00066976|Amniotic Fluid|amniotic fluid
5407419|NCT00066976|Oligohydraminos|oligohydraminos
5407420|NCT00066976|Polyhydraminos|polyhydraminos
5407421|NCT00066976|Pregnancy|pregnancy
5407422|NCT00066963|Early Childhood Caries|early childhood caries
5407423|NCT00066950|Early childhood caries|early childhood caries
5407424|NCT00066924|spirituality|spirituality
5407425|NCT00066924|religiosity|religiosity
5407426|NCT00066924|immune functioning|immune functioning
5407427|NCT00066924|psychoneuroimmunology|psychoneuroimmunology
5407428|NCT00066924|cytokines|cytokines
5407430|NCT00066924|death|death
5407431|NCT00066924|depression|depression
5407432|NCT00066898|succinobucol|succinobucol
5407433|NCT00066898|AGI-1067|agi-1067
5407434|NCT00066898|coronary artery disease|coronary artery disease
5407435|NCT00066885|DN101|dn101
5407436|NCT00066885|Calcitriol|calcitriol
5407437|NCT00066885|Lung Cancer|lung cancer
5407438|NCT00066885|NSCLC|nsclc
5407439|NCT00066885|Taxotere|taxotere
5407440|NCT00011973|stage III renal cell cancer|stage iii renal cell cancer
5407441|NCT00011973|stage IV renal cell cancer|stage iv renal cell cancer
5407442|NCT00011973|recurrent renal cell cancer|recurrent renal cell cancer
5407443|NCT00005027|stage III renal cell cancer|stage iii renal cell cancer
5407444|NCT00005027|stage IV renal cell cancer|stage iv renal cell cancer
5407445|NCT00005027|recurrent renal cell cancer|recurrent renal cell cancer
5407446|NCT00066911|Functional Magnetic Resonance Imaging|functional magnetic resonance imaging
5407447|NCT00066911|Vocalization|vocalization
5407448|NCT00066911|Spasmodic Dysphonia|spasmodic dysphonia
5407449|NCT00066911|Muscular Tension Dysphonia|muscular tension dysphonia
5407450|NCT00066911|Topical Lidocaine|topical lidocaine
5407451|NCT00066911|Voice Disorders|voice disorders
5407452|NCT00066911|Vocal Tremor|vocal tremor
5407453|NCT00066911|Healthy Volunteer|healthy volunteer
5407454|NCT00066911|HV|hv
5407455|NCT00066872|basal cell carcinoma of the skin|basal cell carcinoma of the skin
5407456|NCT00066859|depression|depression
5407457|NCT00066859|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5407458|NCT00066846|adenocarcinoma of the colon|adenocarcinoma of the colon
5407459|NCT00066846|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5407460|NCT00066846|stage IV rectal cancer|stage iv rectal cancer
5407461|NCT00066846|recurrent rectal cancer|recurrent rectal cancer
5407462|NCT00066846|stage IV colon cancer|stage iv colon cancer
5407463|NCT00066846|recurrent colon cancer|recurrent colon cancer
5407464|NCT00066807|stage IIIA breast cancer|stage iiia breast cancer
5407465|NCT00066807|stage I breast cancer|stage i breast cancer
5407466|NCT00066807|stage II breast cancer|stage ii breast cancer
5407467|NCT00066794|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
5407468|NCT00066794|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
5407469|NCT00066794|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
5407470|NCT00066794|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
5407471|NCT00066794|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
5407472|NCT00066794|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
5407473|NCT00066794|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
5407474|NCT00066794|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
5407475|NCT00066794|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5407476|NCT00066794|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5407477|NCT00066794|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5407478|NCT00066794|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5407479|NCT00066794|adult pure erythroid leukemia (M6b)|adult pure erythroid leukemia (m6b)
5407481|NCT00066781|adenocarcinoma of unknown primary|adenocarcinoma of unknown primary
5407482|NCT00066781|newly diagnosed carcinoma of unknown primary|newly diagnosed carcinoma of unknown primary
5407483|NCT00066781|squamous cell carcinoma of unknown primary|squamous cell carcinoma of unknown primary
5407484|NCT00066781|undifferentiated carcinoma of unknown primary|undifferentiated carcinoma of unknown primary
5407485|NCT00066729|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
5407486|NCT00066729|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5407487|NCT00066729|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5407488|NCT00066729|primary peritoneal cavity cancer|primary peritoneal cavity cancer
5407489|NCT00066729|fallopian tube cancer|fallopian tube cancer
5407490|NCT00066716|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
5407491|NCT00066716|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
5407492|NCT00066716|stage I esophageal cancer|stage i esophageal cancer
5407493|NCT00066716|stage II esophageal cancer|stage ii esophageal cancer
5407494|NCT00066716|stage III esophageal cancer|stage iii esophageal cancer
5407495|NCT00066716|stage IV esophageal cancer (lymph node metastasis only)|stage iv esophageal cancer (lymph node metastasis only)
5407496|NCT00066703|stage II breast cancer|stage ii breast cancer
5407497|NCT00066703|stage IIIA breast cancer|stage iiia breast cancer
5407498|NCT00066703|estrogen receptor-positive breast cancer|estrogen receptor-positive breast cancer
5407499|NCT00066703|progesterone receptor-positive breast cancer|progesterone receptor-positive breast cancer
5407500|NCT00066703|stage IA breast cancer|stage ia breast cancer
5407501|NCT00066703|stage IB breast cancer|stage ib breast cancer
5407502|NCT00066690|tamoxifen|tamoxifen
5407503|NCT00066690|ovarian function suppression + tamoxifen|ovarian function suppression + tamoxifen
5407504|NCT00066690|ovarian function suppression + exemestane|ovarian function suppression + exemestane
5407505|NCT00066677|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
5407506|NCT00066677|recurrent pancreatic cancer|recurrent pancreatic cancer
5407507|NCT00066677|stage IV pancreatic cancer|stage iv pancreatic cancer
5407508|NCT00066664|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5407509|NCT00066664|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
5407510|NCT00066664|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
5407511|NCT00066664|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
5407512|NCT00066664|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
5407513|NCT00066664|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5407514|NCT00066664|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
5407515|NCT00066664|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
5407516|NCT00066664|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
5407517|NCT00066664|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
5407518|NCT00066651|ovarian carcinosarcoma|ovarian carcinosarcoma
5407519|NCT00066651|ovarian clear cell cystadenocarcinoma|ovarian clear cell cystadenocarcinoma
5407520|NCT00066651|ovarian endometrioid adenocarcinoma|ovarian endometrioid adenocarcinoma
5407521|NCT00066651|ovarian mixed epithelial carcinoma|ovarian mixed epithelial carcinoma
5407522|NCT00066651|ovarian serous cystadenocarcinoma|ovarian serous cystadenocarcinoma
5407523|NCT00066651|ovarian undifferentiated adenocarcinoma|ovarian undifferentiated adenocarcinoma
5407524|NCT00066651|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5407525|NCT00066651|Brenner tumor|brenner tumor
5407526|NCT00066651|primary peritoneal cavity cancer|primary peritoneal cavity cancer
5407527|NCT00066651|fallopian tube cancer|fallopian tube cancer
5407528|NCT00066651|epithelial mesothelioma|epithelial mesothelioma
5407529|NCT00066651|recurrent malignant mesothelioma|recurrent malignant mesothelioma
5407530|NCT00066651|recurrent pancreatic cancer|recurrent pancreatic cancer
5407531|NCT00066651|cervical squamous cell carcinoma|cervical squamous cell carcinoma
5407532|NCT00066651|recurrent cervical cancer|recurrent cervical cancer
5407533|NCT00066651|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5407534|NCT00066651|squamous cell lung cancer|squamous cell lung cancer
5407535|NCT00066651|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
5407536|NCT00066651|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
5407537|NCT00066651|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
5407538|NCT00066651|recurrent salivary gland cancer|recurrent salivary gland cancer
5407539|NCT00066651|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
5407540|NCT00066651|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
5407541|NCT00066651|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
5407542|NCT00066651|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
5407543|NCT00066651|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
5407544|NCT00066612|recurrent bladder cancer|recurrent bladder cancer
5407545|NCT00066612|stage IV bladder cancer|stage iv bladder cancer
5407546|NCT00066612|metastatic transitional cell cancer of the renal pelvis and ureter|metastatic transitional cell cancer of the renal pelvis and ureter
5407750|NCT00066248|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5407547|NCT00066612|recurrent transitional cell cancer of the renal pelvis and ureter|recurrent transitional cell cancer of the renal pelvis and ureter
5407548|NCT00066612|regional transitional cell cancer of the renal pelvis and ureter|regional transitional cell cancer of the renal pelvis and ureter
5407549|NCT00066612|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
5407550|NCT00066612|anterior urethral cancer|anterior urethral cancer
5407551|NCT00066612|posterior urethral cancer|posterior urethral cancer
5407552|NCT00066612|recurrent urethral cancer|recurrent urethral cancer
5407553|NCT00066612|urethral cancer associated with invasive bladder cancer|urethral cancer associated with invasive bladder cancer
5407554|NCT00066599|neutropenia|neutropenia
5407555|NCT00066599|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
5407556|NCT00066599|stage I childhood lymphoblastic lymphoma|stage i childhood lymphoblastic lymphoma
5407557|NCT00066599|stage II childhood lymphoblastic lymphoma|stage ii childhood lymphoblastic lymphoma
5407558|NCT00066599|stage III childhood lymphoblastic lymphoma|stage iii childhood lymphoblastic lymphoma
5407559|NCT00066599|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
5407560|NCT00066599|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
5407561|NCT00066599|stage I childhood small noncleaved cell lymphoma|stage i childhood small noncleaved cell lymphoma
5407562|NCT00066599|stage II childhood small noncleaved cell lymphoma|stage ii childhood small noncleaved cell lymphoma
5407563|NCT00066599|stage III childhood small noncleaved cell lymphoma|stage iii childhood small noncleaved cell lymphoma
5407564|NCT00066599|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
5407565|NCT00066599|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
5407566|NCT00066599|stage I childhood large cell lymphoma|stage i childhood large cell lymphoma
5407663|NCT00066404|recurrent penile cancer|recurrent penile cancer
5407567|NCT00066599|stage II childhood large cell lymphoma|stage ii childhood large cell lymphoma
5407568|NCT00066599|stage III childhood large cell lymphoma|stage iii childhood large cell lymphoma
5407569|NCT00066599|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
5407570|NCT00066599|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
5407571|NCT00066599|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5407572|NCT00066599|untreated childhood acute myeloid leukemia and other myeloid malignancies|untreated childhood acute myeloid leukemia and other myeloid malignancies
5407573|NCT00066599|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
5407574|NCT00066599|stage I childhood Hodgkin lymphoma|stage i childhood hodgkin lymphoma
5407575|NCT00066599|stage II childhood Hodgkin lymphoma|stage ii childhood hodgkin lymphoma
5407576|NCT00066599|stage III childhood Hodgkin lymphoma|stage iii childhood hodgkin lymphoma
5407577|NCT00066599|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
5407578|NCT00066599|childhood acute promyelocytic leukemia (M3)|childhood acute promyelocytic leukemia (m3)
5407579|NCT00066599|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
5407580|NCT00066599|recurrent Wilms tumor and other childhood kidney tumors|recurrent wilms tumor and other childhood kidney tumors
5407581|NCT00066599|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
5407582|NCT00066599|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
5407583|NCT00066599|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5407584|NCT00066599|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5407585|NCT00066599|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5407586|NCT00066599|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
5407587|NCT00066599|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5407588|NCT00066599|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5407589|NCT00066599|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
5407590|NCT00066599|intraocular lymphoma|intraocular lymphoma
5407591|NCT00066599|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
5407592|NCT00066599|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
5407593|NCT00066599|acute undifferentiated leukemia|acute undifferentiated leukemia
5407594|NCT00066599|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
5407595|NCT00066599|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5407596|NCT00066599|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5407597|NCT00066599|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
5407598|NCT00066599|disseminated neuroblastoma|disseminated neuroblastoma
5407599|NCT00066599|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5407600|NCT00066599|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5407601|NCT00066599|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5407602|NCT00066599|stage I multiple myeloma|stage i multiple myeloma
5407603|NCT00066599|stage II multiple myeloma|stage ii multiple myeloma
5407604|NCT00066599|stage III multiple myeloma|stage iii multiple myeloma
5407605|NCT00066599|refractory multiple myeloma|refractory multiple myeloma
5407606|NCT00066599|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
5407607|NCT00066599|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
5407608|NCT00066599|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
5432863|NCT00008489|Didanosine|didanosine
5407609|NCT00066599|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
5407610|NCT00066599|recurrent neuroblastoma|recurrent neuroblastoma
5407611|NCT00066599|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
5407612|NCT00066599|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
5407613|NCT00066586|breast cancer|breast cancer
5407614|NCT00066573|stage IIIA breast cancer|stage iiia breast cancer
5407615|NCT00066573|stage I breast cancer|stage i breast cancer
5407616|NCT00066573|stage II breast cancer|stage ii breast cancer
5407617|NCT00066547|recurrent breast cancer|recurrent breast cancer
5407618|NCT00066547|stage IIIA breast cancer|stage iiia breast cancer
5407619|NCT00066547|stage IIIB breast cancer|stage iiib breast cancer
5407620|NCT00066547|stage IIIC breast cancer|stage iiic breast cancer
5407621|NCT00066547|stage IV breast cancer|stage iv breast cancer
5407622|NCT00066508|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5407623|NCT00066482|childhood teratoma|childhood teratoma
5407624|NCT00066482|childhood extragonadal germ cell tumor|childhood extragonadal germ cell tumor
5407625|NCT00066469|post-transplant lymphoproliferative disorder|post-transplant lymphoproliferative disorder
5407626|NCT00066443|stage IIIA breast cancer|stage iiia breast cancer
5407627|NCT00066443|stage IIIB breast cancer|stage iiib breast cancer
5407628|NCT00066443|stage IIIC breast cancer|stage iiic breast cancer
5407629|NCT00066443|inflammatory breast cancer|inflammatory breast cancer
5407630|NCT00066430|anal cancer|anal cancer
5407631|NCT00066430|high-grade squamous intraepithelial lesion|high-grade squamous intraepithelial lesion
5407632|NCT00066417|essential thrombocythemia|essential thrombocythemia
5407633|NCT00066417|polycythemia vera|polycythemia vera
5407634|NCT00066417|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5407635|NCT00066417|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5407636|NCT00066417|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5407637|NCT00066417|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5407638|NCT00066417|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
5407639|NCT00066417|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5407640|NCT00066417|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5407641|NCT00066417|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5407642|NCT00066417|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
5407643|NCT00066417|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5407644|NCT00066417|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
5407645|NCT00066417|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5407646|NCT00066417|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5407647|NCT00066417|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5407648|NCT00066417|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
5407649|NCT00066417|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
5407650|NCT00066417|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
5407651|NCT00066417|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5407652|NCT00066417|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5407653|NCT00066417|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5407654|NCT00066417|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5407655|NCT00066417|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5407656|NCT00066404|advanced malignant mesothelioma|advanced malignant mesothelioma
5407657|NCT00066404|male breast cancer|male breast cancer
5407658|NCT00066404|localized malignant mesothelioma|localized malignant mesothelioma
5407659|NCT00066404|recurrent bladder cancer|recurrent bladder cancer
5407660|NCT00066404|recurrent renal cell cancer|recurrent renal cell cancer
5407661|NCT00066404|recurrent urethral cancer|recurrent urethral cancer
5407664|NCT00066404|recurrent prostate cancer|recurrent prostate cancer
5407665|NCT00066404|recurrent anal cancer|recurrent anal cancer
5407666|NCT00066404|recurrent colon cancer|recurrent colon cancer
5407667|NCT00066404|recurrent esophageal cancer|recurrent esophageal cancer
5407668|NCT00066404|recurrent gastric cancer|recurrent gastric cancer
5407669|NCT00066404|recurrent pancreatic cancer|recurrent pancreatic cancer
5407670|NCT00066404|recurrent rectal cancer|recurrent rectal cancer
5407671|NCT00066404|recurrent gastrointestinal carcinoid tumor|recurrent gastrointestinal carcinoid tumor
5407672|NCT00066404|recurrent small intestine cancer|recurrent small intestine cancer
5407673|NCT00066404|recurrent gallbladder cancer|recurrent gallbladder cancer
5407674|NCT00066404|recurrent extrahepatic bile duct cancer|recurrent extrahepatic bile duct cancer
5407675|NCT00066404|recurrent adult primary liver cancer|recurrent adult primary liver cancer
5407676|NCT00066404|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5407677|NCT00066404|recurrent small cell lung cancer|recurrent small cell lung cancer
5407678|NCT00066404|recurrent thymoma and thymic carcinoma|recurrent thymoma and thymic carcinoma
5407679|NCT00066404|recurrent melanoma|recurrent melanoma
5407680|NCT00066404|recurrent malignant mesothelioma|recurrent malignant mesothelioma
5432962|NCT00006591|VX 478|vx 478
5407681|NCT00066404|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
5407682|NCT00066404|recurrent cervical cancer|recurrent cervical cancer
5407683|NCT00066404|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5407684|NCT00066404|fallopian tube cancer|fallopian tube cancer
5407685|NCT00066404|recurrent vulvar cancer|recurrent vulvar cancer
5407686|NCT00066404|recurrent vaginal cancer|recurrent vaginal cancer
5407687|NCT00066404|recurrent gestational trophoblastic tumor|recurrent gestational trophoblastic tumor
5407688|NCT00066404|recurrent endometrial carcinoma|recurrent endometrial carcinoma
5407689|NCT00066404|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
5407690|NCT00066404|malignant pleural effusion|malignant pleural effusion
5407691|NCT00066391|penile squamous cell carcinoma|penile squamous cell carcinoma
5407692|NCT00066391|stage III penile cancer|stage iii penile cancer
5407693|NCT00066391|stage IV penile cancer|stage iv penile cancer
5407694|NCT00066378|recurrent breast cancer|recurrent breast cancer
5407695|NCT00066378|stage IIIA breast cancer|stage iiia breast cancer
5407696|NCT00066378|stage IIIB breast cancer|stage iiib breast cancer
5407697|NCT00066378|stage IIIC breast cancer|stage iiic breast cancer
5407698|NCT00066378|stage IV breast cancer|stage iv breast cancer
5407699|NCT00066365|metastatic osteosarcoma|metastatic osteosarcoma
5407700|NCT00066365|recurrent osteosarcoma|recurrent osteosarcoma
5407701|NCT00066365|lung metastases|lung metastases
5407702|NCT00066352|recurrent bladder cancer|recurrent bladder cancer
5407703|NCT00066352|stage IV bladder cancer|stage iv bladder cancer
5407704|NCT00066352|metastatic transitional cell cancer of the renal pelvis and ureter|metastatic transitional cell cancer of the renal pelvis and ureter
5407705|NCT00066352|recurrent transitional cell cancer of the renal pelvis and ureter|recurrent transitional cell cancer of the renal pelvis and ureter
5407706|NCT00066352|regional transitional cell cancer of the renal pelvis and ureter|regional transitional cell cancer of the renal pelvis and ureter
5407707|NCT00066352|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
5407708|NCT00066339|stage IV breast cancer|stage iv breast cancer
5407709|NCT00066339|recurrent breast cancer|recurrent breast cancer
5407710|NCT00066326|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5407711|NCT00066326|Philadelphia chromosome positive chronic myelogenous leukemia|philadelphia chromosome positive chronic myelogenous leukemia
5407712|NCT00066326|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5407713|NCT00066326|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5407714|NCT00066326|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5407715|NCT00066313|extensive stage small cell lung cancer|extensive stage small cell lung cancer
5407716|NCT00066313|limited stage small cell lung cancer|limited stage small cell lung cancer
5407717|NCT00066274|stage IV colon cancer|stage iv colon cancer
5407718|NCT00066274|stage IV rectal cancer|stage iv rectal cancer
5407719|NCT00066248|cachexia|cachexia
5407720|NCT00066248|unspecified childhood solid tumor|unspecified childhood solid tumor
5407721|NCT00066248|childhood spinal cord neoplasm|childhood spinal cord neoplasm
5407722|NCT00066248|recurrent childhood medulloblastoma|recurrent childhood medulloblastoma
5407723|NCT00066248|untreated childhood medulloblastoma|untreated childhood medulloblastoma
5407724|NCT00066248|childhood high-grade cerebral astrocytoma|childhood high-grade cerebral astrocytoma
5407725|NCT00066248|childhood low-grade cerebral astrocytoma|childhood low-grade cerebral astrocytoma
5407726|NCT00066248|recurrent childhood cerebellar astrocytoma|recurrent childhood cerebellar astrocytoma
5407727|NCT00066248|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
5407728|NCT00066248|untreated childhood cerebellar astrocytoma|untreated childhood cerebellar astrocytoma
5407729|NCT00066248|childhood oligodendroglioma|childhood oligodendroglioma
5407730|NCT00066248|recurrent childhood brain stem glioma|recurrent childhood brain stem glioma
5407731|NCT00066248|recurrent childhood visual pathway glioma|recurrent childhood visual pathway glioma
5407732|NCT00066248|hypothalamic glioma|hypothalamic glioma
5407733|NCT00066248|untreated childhood brain stem glioma|untreated childhood brain stem glioma
5407734|NCT00066248|untreated childhood visual pathway|untreated childhood visual pathway
5407735|NCT00066248|childhood supratentorial primitive neuroectodermal tumor|childhood supratentorial primitive neuroectodermal tumor
5407736|NCT00066248|childhood craniopharyngioma|childhood craniopharyngioma
5407737|NCT00066248|childhood infratentorial ependymoma|childhood infratentorial ependymoma
5407738|NCT00066248|childhood supratentorial ependymoma|childhood supratentorial ependymoma
5407739|NCT00066248|newly diagnosed childhood ependymoma|newly diagnosed childhood ependymoma
5407740|NCT00066248|recurrent childhood ependymoma|recurrent childhood ependymoma
5407741|NCT00066248|childhood choroid plexus tumor|childhood choroid plexus tumor
5407742|NCT00066248|childhood central nervous system germ cell tumor|childhood central nervous system germ cell tumor
5407743|NCT00066248|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
5407744|NCT00066248|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5407745|NCT00066248|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
5407746|NCT00066248|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
5407747|NCT00066248|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5407748|NCT00066248|untreated childhood acute myeloid leukemia|untreated childhood acute myeloid leukemia
5407749|NCT00066248|other myeloid malignancies|other myeloid malignancies
5407751|NCT00066248|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
5407752|NCT00066248|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
5407753|NCT00066248|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5407754|NCT00066248|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5407755|NCT00066248|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5407756|NCT00066248|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5407757|NCT00066248|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5407758|NCT00066248|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
5407759|NCT00066248|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5407760|NCT00066248|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
5407761|NCT00066248|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
5407762|NCT00066248|stage I childhood Hodgkin lymphoma|stage i childhood hodgkin lymphoma
5407763|NCT00066248|stage II childhood Hodgkin lymphoma|stage ii childhood hodgkin lymphoma
5407764|NCT00066248|stage III childhood Hodgkin lymphoma|stage iii childhood hodgkin lymphoma
5407765|NCT00066248|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
5407766|NCT00066248|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
5407767|NCT00066248|AIDS-related primary CNS lymphoma|aids-related primary cns lymphoma
5407768|NCT00066248|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
5407769|NCT00066248|refractory hairy cell leukemia|refractory hairy cell leukemia
5407770|NCT00066248|untreated hairy cell leukemia|untreated hairy cell leukemia
5407771|NCT00066248|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
5407772|NCT00066248|stage I childhood lymphoblastic lymphoma|stage i childhood lymphoblastic lymphoma
5407773|NCT00066248|stage II childhood lymphoblastic lymphoma|stage ii childhood lymphoblastic lymphoma
5407774|NCT00066248|stage III childhood lymphoblastic lymphoma|stage iii childhood lymphoblastic lymphoma
5407775|NCT00066248|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
5407776|NCT00066248|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
5407777|NCT00066248|stage I childhood small noncleaved cell lymphoma|stage i childhood small noncleaved cell lymphoma
5407778|NCT00066248|stage II childhood small noncleaved cell lymphoma|stage ii childhood small noncleaved cell lymphoma
5407779|NCT00066248|stage III childhood small noncleaved cell lymphoma|stage iii childhood small noncleaved cell lymphoma
5407780|NCT00066248|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
5407781|NCT00066248|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
5407782|NCT00066248|stage I childhood large cell lymphoma|stage i childhood large cell lymphoma
5407783|NCT00066248|stage II childhood large cell lymphoma|stage ii childhood large cell lymphoma
5407784|NCT00066248|stage III childhood large cell lymphoma|stage iii childhood large cell lymphoma
5407785|NCT00066248|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
5407786|NCT00066248|recurrent childhood brain tumor|recurrent childhood brain tumor
5407787|NCT00066248|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
5407788|NCT00066248|myelodysplastic/myeloproliferative disease|myelodysplastic/myeloproliferative disease
5407789|NCT00066248|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
5407790|NCT00066248|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5407791|NCT00066248|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5407792|NCT00066248|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5407793|NCT00066248|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5407794|NCT00066222|limited stage small cell lung cancer|limited stage small cell lung cancer
5407795|NCT00020462|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5407796|NCT00020462|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5407797|NCT00020462|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5407798|NCT00020462|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5407799|NCT00020462|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5407800|NCT00020462|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5407801|NCT00020462|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5407802|NCT00020462|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5407803|NCT00020462|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5407804|NCT00019721|stage IV melanoma|stage iv melanoma
5407805|NCT00019721|recurrent melanoma|recurrent melanoma
5407806|NCT00019383|recurrent melanoma|recurrent melanoma
5407807|NCT00066209|Inflammation|inflammation
5407808|NCT00066209|Coronavirus|coronavirus
5407809|NCT00066209|Immunity|immunity
5407810|NCT00066209|Interferon|interferon
5407811|NCT00066209|Cytokine|cytokine
5407812|NCT00066209|Severe Acute Respiratory Syndrome|severe acute respiratory syndrome
5407813|NCT00066209|SARS|sars
5407814|NCT00066209|Healthy Volunteer|healthy volunteer
5407815|NCT00066209|HV|hv
5407816|NCT00066170|Narcolepsy|narcolepsy
5407817|NCT00066170|Daytime Sleepiness|daytime sleepiness
5407818|NCT00066170|Daytime sleepiness in narcolepsy|daytime sleepiness in narcolepsy
5407819|NCT00033722|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5407820|NCT00033722|squamous cell lung cancer|squamous cell lung cancer
5407821|NCT00033722|large cell lung cancer|large cell lung cancer
5407822|NCT00033722|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5407823|NCT00033722|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5407824|NCT00033722|adenocarcinoma of the lung|adenocarcinoma of the lung
5407825|NCT00033722|adenosquamous cell lung cancer|adenosquamous cell lung cancer
5407826|NCT00033306|stage IV colon cancer|stage iv colon cancer
5407827|NCT00033306|stage IV rectal cancer|stage iv rectal cancer
5407828|NCT00033306|recurrent colon cancer|recurrent colon cancer
5407829|NCT00033306|recurrent rectal cancer|recurrent rectal cancer
5407830|NCT00033306|adenocarcinoma of the colon|adenocarcinoma of the colon
5407831|NCT00033306|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5407832|NCT00031811|stage I breast cancer|stage i breast cancer
5407833|NCT00031811|stage II breast cancer|stage ii breast cancer
5407834|NCT00031811|stage IIIA breast cancer|stage iiia breast cancer
5407835|NCT00031811|stage IIIB breast cancer|stage iiib breast cancer
5407836|NCT00031811|osteoporosis|osteoporosis
5407837|NCT00031811|menopausal symptoms|menopausal symptoms
5407838|NCT00031785|stage I non-small cell lung cancer|stage i non-small cell lung cancer
5407839|NCT00031785|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
5407840|NCT00031785|limited stage small cell lung cancer|limited stage small cell lung cancer
5407841|NCT00031785|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5407842|NCT00031785|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5407843|NCT00031785|anorexia|anorexia
5407844|NCT00031785|cachexia|cachexia
5407845|NCT00066183|Fibroblast Growth Factor 23|fibroblast growth factor 23
5407846|NCT00066183|FGF-23|fgf-23
5407847|NCT00066183|Hypophosphatemia|hypophosphatemia
5407848|NCT00066183|Phosphaturia|phosphaturia
5407849|NCT00066183|Phosphorus|phosphorus
5407850|NCT00066183|Phosphorus Metabolism|phosphorus metabolism
5407851|NCT00066157|Alzheimer disease|alzheimer disease
5407852|NCT00066157|Hormone replacement therapy|hormone replacement therapy
5407853|NCT00066157|Postmenopausal women|postmenopausal women
5407854|NCT00066144|menopause|menopause
5407855|NCT00066144|hot flashes|hot flashes
5407856|NCT00066144|red clover|red clover
5407857|NCT00066144|black cohosh|black cohosh
5407858|NCT00066144|sexual dysfunction|sexual dysfunction
5407859|NCT00066118|neurologic|neurologic
5407860|NCT00066118|nerve conduction|nerve conduction
5407861|NCT00066118|neurobehavioral|neurobehavioral
5407862|NCT00066118|renal disease|renal disease
5407863|NCT00066092|PBPC transplant|pbpc transplant
5407864|NCT00066092|Hodgkin's Disease|hodgkin's disease
5407865|NCT00066092|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
5407866|NCT00066092|NHL|nhl
5407867|NCT00066092|mobilization|mobilization
5407868|NCT00066079|Sickle Cell Pain|sickle cell pain
5407869|NCT00066079|Sickle Cell Disease|sickle cell disease
5407870|NCT00066079|Chronic Pain|chronic pain
5407871|NCT00066079|Alternative Medicine/Therapy|alternative medicine/therapy
5407872|NCT00066079|Complementary Medicine|complementary medicine
5407873|NCT00066079|Massage Therapy|massage therapy
5407874|NCT00066079|Relaxation Technique|relaxation technique
5407875|NCT00066079|Home-based Therapy|home-based therapy
5407876|NCT00066053|Heart attacks|heart attacks
5407878|NCT00066053|Angina|angina
5407879|NCT00066040|mutans streptococci infections|mutans streptococci infections
5407880|NCT00066027|periodontitis, metabolic bone diseases, doxycycline|periodontitis, metabolic bone diseases, doxycycline
5407881|NCT00066014|Dental Implantation-Osseointegrated|dental implantation-osseointegrated
5407882|NCT00066014|Dentures|dentures
5407883|NCT00066014|Dental Prostheses|dental prostheses
5407884|NCT00066014|Denture, Implant-Supported|denture, implant-supported
5407885|NCT00065975|chronic low back pain|chronic low back pain
5407886|NCT00065975|acupuncture|acupuncture
5407887|NCT00065975|chiropractic|chiropractic
5407888|NCT00065975|massage therapy|massage therapy
5407889|NCT00065975|CAM therapies|cam therapies
5407890|NCT00065962|Pervasive Developmental Disorders|pervasive developmental disorders
5407891|NCT00065962|Secretin, synthetic porcine|secretin, synthetic porcine
5407892|NCT00065962|Secretin, biological porcine|secretin, biological porcine
5407893|NCT00065962|Autism Diagnostic Observation Schedule - Generic (ADOS-G)|autism diagnostic observation schedule - generic (ados-g)
5407894|NCT00065962|Rimland Questionnaire|rimland questionnaire
5407895|NCT00065962|Expressive Vocabulary Test|expressive vocabulary test
5407896|NCT00065962|MacArthur Communication Inventory|macarthur communication inventory
5407897|NCT00065962|Aberrant Behavior Checklist|aberrant behavior checklist
5407898|NCT00065949|Low birthweight infants|low birthweight infants
5407899|NCT00065949|Magnesium supplementation|magnesium supplementation
5407900|NCT00065949|Intracranial hemorrhage|intracranial hemorrhage
5407901|NCT00065949|Cystic periventricular leukomalacia|cystic periventricular leukomalacia
5407902|NCT00065949|Mental retardation|mental retardation
5407903|NCT00065936|Intractable self-injurious behavior|intractable self-injurious behavior
5407904|NCT00065936|Naltrexone|naltrexone
5407905|NCT00065936|Transcutaneous electrical nerve stimulation|transcutaneous electrical nerve stimulation
5407906|NCT00065936|Substance P|substance p
5407907|NCT00065936|Met-enkephalin|met-enkephalin
5407908|NCT00065936|Cortisol|cortisol
5407909|NCT00065923|Prader-Willi Syndrome|prader-willi syndrome
5407910|NCT00065923|Self-Injurious Behavior|self-injurious behavior
5407911|NCT00065910|Joint attention|joint attention
5407912|NCT00065910|Developmental delay|developmental delay
5407913|NCT00065910|Caregiver interaction|caregiver interaction
5407914|NCT00065897|Amniocentesis|amniocentesis
5407915|NCT00065897|Transabdominal chorionic villus sampling|transabdominal chorionic villus sampling
5407916|NCT00065897|Fluorescence in situ hybridization|fluorescence in situ hybridization
5407917|NCT00065897|Alpha fetoprotein|alpha fetoprotein
5407918|NCT00065897|Acetylcholinesterase|acetylcholinesterase
5407919|NCT00065897|Prenatal testing|prenatal testing
5407920|NCT00065897|Prenatal diagnosis|prenatal diagnosis
5407921|NCT00065884|Adolescents|adolescents
5407922|NCT00065871|Pharmacist prescribers|pharmacist prescribers
5407923|NCT00065871|Increased access|increased access
5407924|NCT00065871|Hormonal contraception|hormonal contraception
5407925|NCT00065871|Birth control pills|birth control pills
5407926|NCT00065871|Birth control patch|birth control patch
5407927|NCT00065871|Vaginal contraceptive ring|vaginal contraceptive ring
5407928|NCT00065858|Contraception|contraception
5407929|NCT00065858|Nonoxynol 9|nonoxynol 9
5407930|NCT00065858|Microbicide|microbicide
5407931|NCT00065858|Spermicide|spermicide
5407932|NCT00065845|Urinary incontinence|urinary incontinence
5407933|NCT00065845|Pelvic organ prolapse|pelvic organ prolapse
5407934|NCT00065845|Stress incontinence|stress incontinence
5407935|NCT00065845|Sacrocolpopexy|sacrocolpopexy
5407936|NCT00065845|Burch urethropexy|burch urethropexy
5407937|NCT00065845|Surgical Trials|surgical trials
5407938|NCT00031707|anorexia|anorexia
5407939|NCT00031707|cachexia|cachexia
5407940|NCT00026273|stage III colon cancer|stage iii colon cancer
5407941|NCT00026273|stage III rectal cancer|stage iii rectal cancer
5407942|NCT00026273|adenocarcinoma of the colon|adenocarcinoma of the colon
5407943|NCT00026273|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5407944|NCT00025688|stage IV breast cancer|stage iv breast cancer
5407945|NCT00025688|recurrent breast cancer|recurrent breast cancer
5407946|NCT00024024|AIDS-related Kaposi sarcoma|aids-related kaposi sarcoma
5407947|NCT00024024|recurrent Kaposi sarcoma|recurrent kaposi sarcoma
5407948|NCT00022477|stage IV colon cancer|stage iv colon cancer
5407949|NCT00022477|stage IV rectal cancer|stage iv rectal cancer
5407950|NCT00022477|recurrent colon cancer|recurrent colon cancer
5407951|NCT00022477|recurrent rectal cancer|recurrent rectal cancer
5407952|NCT00022477|adenocarcinoma of the colon|adenocarcinoma of the colon
5407953|NCT00022477|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5407954|NCT00065832|Reading disabilities|reading disabilities
5407955|NCT00065832|Inner-city|inner-city
5407956|NCT00065832|Urban|urban
5407957|NCT00065819|HIV|hiv
5407958|NCT00065819|African American|african american
5407959|NCT00065819|Symptom Management|symptom management
5407960|NCT00065806|Pediatric lupus|pediatric lupus
5407961|NCT00065806|Atherosclerosis|atherosclerosis
5407962|NCT00065806|SLE|sle
5407963|NCT00065806|HMG CoA reductase inhibitor|hmg coa reductase inhibitor
5407964|NCT00065767|Alzheimer disease|alzheimer disease
5407965|NCT00065767|Postmenopausal women|postmenopausal women
5407966|NCT00065767|Hormone therapy|hormone therapy
5407967|NCT00065754|Placebo|placebo
5407968|NCT00065754|Analgesia|analgesia
5407969|NCT00065754|Pain|pain
5407970|NCT00065754|Brain mechanism|brain mechanism
5407971|NCT00065754|Expectation|expectation
5407972|NCT00065741|Milk thistle|milk thistle
5407973|NCT00065741|silymarin|silymarin
5407974|NCT00065741|piperine|piperine
5407975|NCT00065741|glucarate|glucarate
5407976|NCT00065741|zidovudine|zidovudine
5407977|NCT00065741|abacavir|abacavir
5407978|NCT00065741|mycophenolate mofetil|mycophenolate mofetil
5407979|NCT00065741|HIV|hiv
5407980|NCT00065741|pharmacokinetics|pharmacokinetics
5407981|NCT00065741|interaction|interaction
5407982|NCT00065741|glucuronidation|glucuronidation
5407983|NCT00065741|Healthy|healthy
5407984|NCT00065741|Complementary Therapies|complementary therapies
5407985|NCT00065728|AMD|amd
5407986|NCT00065728|age-related macular degeneration|age-related macular degeneration
5407987|NCT00065728|Anecortave|anecortave
5407988|NCT00065728|Acetate|acetate
5407989|NCT00065728|Wet form of age-related macular degeneration|wet form of age-related macular degeneration
5407990|NCT00065728|CNV|cnv
5407991|NCT00065728|Anecortave Acetate|anecortave acetate
5407992|NCT00065715|head cold|head cold
5407993|NCT00065715|common cold|common cold
5407994|NCT00065715|echinacea|echinacea
5407995|NCT00065715|placebo|placebo
5407996|NCT00065702|fibromyalgia|fibromyalgia
5407997|NCT00065702|homeopathy|homeopathy
5407998|NCT00065702|EEG|eeg
5407999|NCT00065702|EKG|ekg
5408000|NCT00065702|chronic pain|chronic pain
5408001|NCT00065689|Alzheimer's disease|alzheimer's disease
5408002|NCT00065689|light therapy|light therapy
5408003|NCT00065689|long-term care|long-term care
5408004|NCT00065689|depression|depression
5408005|NCT00065689|sleep|sleep
5408006|NCT00065689|agitation|agitation
5408007|NCT00065676|Hyperglycemia|hyperglycemia
5408008|NCT00065676|Hyperinsulinemia|hyperinsulinemia
5408009|NCT00065676|OGTT|ogtt
5408010|NCT00065676|GLUT2|glut2
5408011|NCT00065676|Post-Prandial|post-prandial
5408012|NCT00065676|Type 2 Diabetes|type 2 diabetes
5408013|NCT00065676|Obesity|obesity
5408014|NCT00065663|gene transfer|gene transfer
5408015|NCT00065663|adenovirus|adenovirus
5408016|NCT00065663|platelet-derived growth factor-B|platelet-derived growth factor-b
5408017|NCT00065663|collagen|collagen
5408018|NCT00065663|diabetic ulcer|diabetic ulcer
5408019|NCT00065663|foot|foot
5408020|NCT00065663|wounds|wounds
5408021|NCT00065663|diabetic|diabetic
5408022|NCT00065663|ulcers|ulcers
5408023|NCT00065650|Diabetes Mellitus Type 2|diabetes mellitus type 2
5408024|NCT00065650|Vedic medicine|vedic medicine
5408025|NCT00065650|Ayurveda|ayurveda
5408026|NCT00065650|Transcendental Meditation|transcendental meditation
5408027|NCT00065624|Lipoic acid|lipoic acid
5408028|NCT00065624|F2-isoprostanes|f2-isoprostanes
5408029|NCT00065624|endothelial dysfunction|endothelial dysfunction
5408030|NCT00065624|natural product|natural product
5408031|NCT00065585|low back pain|low back pain
5408032|NCT00065585|acupuncture|acupuncture
5408033|NCT00065572|Kidney Cancer|kidney cancer
5408034|NCT00065572|Metastatic|metastatic
5408035|NCT00065572|Newly diagnosed renal cell carcinoma|newly diagnosed renal cell carcinoma
5408036|NCT00014560|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5408037|NCT00014560|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5408038|NCT00014560|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5408039|NCT00014560|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5408040|NCT00014560|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5408041|NCT00014560|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5408042|NCT00014560|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5408043|NCT00014560|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5408044|NCT00014560|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5408045|NCT00014560|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5408046|NCT00014560|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5408047|NCT00014560|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5408048|NCT00014261|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5408049|NCT00014248|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5408050|NCT00014248|cachexia|cachexia
5408051|NCT00014209|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5408052|NCT00014209|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5408053|NCT00014209|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5408054|NCT00014209|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5408055|NCT00014209|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5408056|NCT00010127|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5408057|NCT00010127|stage IV prostate cancer|stage iv prostate cancer
5408058|NCT00065611|Steroids|steroids
5408059|NCT00065611|Osteoporosis|osteoporosis
5408060|NCT00065611|Proteinuria|proteinuria
5408061|NCT00065611|Minimal Change Disease|minimal change disease
5408062|NCT00065611|Focal Segmental Glomerulosclerosis|focal segmental glomerulosclerosis
5408063|NCT00065611|FSGS|fsgs
5408064|NCT00065611|MCD|mcd
5408065|NCT00065611|Kidney Disease|kidney disease
5408066|NCT00065507|hepatic decompensation|hepatic decompensation
5408067|NCT00006799|untreated metastatic squamous neck cancer with occult primary|untreated metastatic squamous neck cancer with occult primary
5408068|NCT00006799|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
5408069|NCT00006799|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
5408070|NCT00006799|stage I basal cell carcinoma of the lip|stage i basal cell carcinoma of the lip
5408071|NCT00006799|stage I verrucous carcinoma of the oral cavity|stage i verrucous carcinoma of the oral cavity
5408072|NCT00006799|stage I mucoepidermoid carcinoma of the oral cavity|stage i mucoepidermoid carcinoma of the oral cavity
5408073|NCT00006799|stage I adenoid cystic carcinoma of the oral cavity|stage i adenoid cystic carcinoma of the oral cavity
5408074|NCT00006799|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
5408075|NCT00006799|stage II basal cell carcinoma of the lip|stage ii basal cell carcinoma of the lip
5408076|NCT00006799|stage II verrucous carcinoma of the oral cavity|stage ii verrucous carcinoma of the oral cavity
5408077|NCT00006799|stage II mucoepidermoid carcinoma of the oral cavity|stage ii mucoepidermoid carcinoma of the oral cavity
5408078|NCT00006799|stage II adenoid cystic carcinoma of the oral cavity|stage ii adenoid cystic carcinoma of the oral cavity
5408079|NCT00006799|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
5408080|NCT00006799|stage III basal cell carcinoma of the lip|stage iii basal cell carcinoma of the lip
5408081|NCT00006799|stage III verrucous carcinoma of the oral cavity|stage iii verrucous carcinoma of the oral cavity
5408082|NCT00006799|stage III mucoepidermoid carcinoma of the oral cavity|stage iii mucoepidermoid carcinoma of the oral cavity
5408083|NCT00006799|stage III adenoid cystic carcinoma of the oral cavity|stage iii adenoid cystic carcinoma of the oral cavity
5408084|NCT00006799|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5408085|NCT00006799|stage IV basal cell carcinoma of the lip|stage iv basal cell carcinoma of the lip
5408140|NCT00065468|Kidney Cancer|kidney cancer
5408086|NCT00006799|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
5408087|NCT00006799|stage IV mucoepidermoid carcinoma of the oral cavity|stage iv mucoepidermoid carcinoma of the oral cavity
5408088|NCT00006799|stage IV adenoid cystic carcinoma of the oral cavity|stage iv adenoid cystic carcinoma of the oral cavity
5408089|NCT00006799|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
5408090|NCT00006799|stage I lymphoepithelioma of the oropharynx|stage i lymphoepithelioma of the oropharynx
5408091|NCT00006799|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
5408092|NCT00006799|stage II lymphoepithelioma of the oropharynx|stage ii lymphoepithelioma of the oropharynx
5408093|NCT00006799|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
5408094|NCT00006799|stage III lymphoepithelioma of the oropharynx|stage iii lymphoepithelioma of the oropharynx
5408095|NCT00006799|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5408096|NCT00006799|stage IV lymphoepithelioma of the oropharynx|stage iv lymphoepithelioma of the oropharynx
5408097|NCT00006799|stage I squamous cell carcinoma of the nasopharynx|stage i squamous cell carcinoma of the nasopharynx
5408098|NCT00006799|stage I lymphoepithelioma of the nasopharynx|stage i lymphoepithelioma of the nasopharynx
5408099|NCT00006799|stage II squamous cell carcinoma of the nasopharynx|stage ii squamous cell carcinoma of the nasopharynx
5408100|NCT00006799|stage II lymphoepithelioma of the nasopharynx|stage ii lymphoepithelioma of the nasopharynx
5408101|NCT00006799|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
5408102|NCT00006799|stage III lymphoepithelioma of the nasopharynx|stage iii lymphoepithelioma of the nasopharynx
5408103|NCT00006799|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
5408104|NCT00006799|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
5408105|NCT00006799|stage I squamous cell carcinoma of the hypopharynx|stage i squamous cell carcinoma of the hypopharynx
5408106|NCT00006799|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
5408107|NCT00006799|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
5408108|NCT00006799|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5408109|NCT00006799|stage I squamous cell carcinoma of the larynx|stage i squamous cell carcinoma of the larynx
5408110|NCT00006799|stage I verrucous carcinoma of the larynx|stage i verrucous carcinoma of the larynx
5408111|NCT00006799|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
5408112|NCT00006799|stage II verrucous carcinoma of the larynx|stage ii verrucous carcinoma of the larynx
5408113|NCT00006799|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
5408114|NCT00006799|stage III verrucous carcinoma of the larynx|stage iii verrucous carcinoma of the larynx
5408115|NCT00006799|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5408116|NCT00006799|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
5408117|NCT00006799|stage I squamous cell carcinoma of the paranasal sinus and nasal cavity|stage i squamous cell carcinoma of the paranasal sinus and nasal cavity
5408118|NCT00006799|stage I inverted papilloma of the paranasal sinus and nasal cavity|stage i inverted papilloma of the paranasal sinus and nasal cavity
5408119|NCT00006799|stage I midline lethal granuloma of the paranasal sinus and nasal cavity|stage i midline lethal granuloma of the paranasal sinus and nasal cavity
5408120|NCT00006799|stage I esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage i esthesioneuroblastoma of the paranasal sinus and nasal cavity
5408121|NCT00006799|stage II squamous cell carcinoma of the paranasal sinus and nasal cavity|stage ii squamous cell carcinoma of the paranasal sinus and nasal cavity
5408122|NCT00006799|stage II inverted papilloma of the paranasal sinus and nasal cavity|stage ii inverted papilloma of the paranasal sinus and nasal cavity
5408123|NCT00006799|stage II midline lethal granuloma of the paranasal sinus and nasal cavity|stage ii midline lethal granuloma of the paranasal sinus and nasal cavity
5408124|NCT00006799|stage II esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage ii esthesioneuroblastoma of the paranasal sinus and nasal cavity
5408125|NCT00006799|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
5408126|NCT00006799|stage III inverted papilloma of the paranasal sinus and nasal cavity|stage iii inverted papilloma of the paranasal sinus and nasal cavity
5408127|NCT00006799|stage III midline lethal granuloma of the paranasal sinus and nasal cavity|stage iii midline lethal granuloma of the paranasal sinus and nasal cavity
5408128|NCT00006799|stage III esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iii esthesioneuroblastoma of the paranasal sinus and nasal cavity
5408129|NCT00006799|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
5408130|NCT00006799|stage IV inverted papilloma of the paranasal sinus and nasal cavity|stage iv inverted papilloma of the paranasal sinus and nasal cavity
5408131|NCT00006799|stage IV midline lethal granuloma of the paranasal sinus and nasal cavity|stage iv midline lethal granuloma of the paranasal sinus and nasal cavity
5408132|NCT00006799|stage IV esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iv esthesioneuroblastoma of the paranasal sinus and nasal cavity
5408133|NCT00006799|anorexia|anorexia
5408134|NCT00006799|cachexia|cachexia
5408135|NCT00006799|quality of life|quality of life
5408136|NCT00006453|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5408137|NCT00006352|limited stage small cell lung cancer|limited stage small cell lung cancer
5408138|NCT00006240|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5408139|NCT00065468|Advanced Renal Cell Carcinoma|advanced renal cell carcinoma
5408141|NCT00006229|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5408142|NCT00006229|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5408143|NCT00006081|stage III gastric cancer|stage iii gastric cancer
5408144|NCT00006081|stage IV gastric cancer|stage iv gastric cancer
5408145|NCT00006081|stage III esophageal cancer|stage iii esophageal cancer
5408146|NCT00006081|stage IV esophageal cancer|stage iv esophageal cancer
5408147|NCT00006081|adenocarcinoma of the stomach|adenocarcinoma of the stomach
5408148|NCT00006081|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
5408149|NCT00065455|Retinitis Pigmentosa|retinitis pigmentosa
5408150|NCT00065455|Vitamin A|vitamin a
5408151|NCT00065455|ERG|erg
5408152|NCT00065455|RP|rp
5408153|NCT00065442|prostate cancer|prostate cancer
5408154|NCT00065442|prostate|prostate
5408155|NCT00065442|AIPC|aipc
5408156|NCT00065442|androgen-independent|androgen-independent
5408157|NCT00065442|androgen independent|androgen independent
5408158|NCT00065442|hormone insensitive|hormone insensitive
5408159|NCT00065442|hormone-insensitive|hormone-insensitive
5408160|NCT00065442|PSA|psa
5408161|NCT00065442|prostatic adenocarcinoma|prostatic adenocarcinoma
5408162|NCT00065442|hormone-refractory|hormone-refractory
5408163|NCT00065442|hormone refractory|hormone refractory
5408164|NCT00065442|HRPC|hrpc
5408165|NCT00065442|LHRH|lhrh
5408166|NCT00065442|immune therapy|immune therapy
5408167|NCT00065442|immunotherapy|immunotherapy
5408168|NCT00065442|vaccine|vaccine
5408169|NCT00065442|dendritic cells|dendritic cells
5408170|NCT00065442|antigen-presenting cells|antigen-presenting cells
5408171|NCT00065442|antigen presenting cells|antigen presenting cells
5408172|NCT00065442|cancer vaccine|cancer vaccine
5408173|NCT00065442|therapeutic vaccine|therapeutic vaccine
5408174|NCT00065442|therapeutic cancer vaccine|therapeutic cancer vaccine
5408175|NCT00065442|recombinant|recombinant
5408176|NCT00065442|biological|biological
5408177|NCT00065442|biopharmaceutical|biopharmaceutical
5408178|NCT00065442|biotechnology|biotechnology
5408179|NCT00065442|biotech|biotech
5408180|NCT00004887|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5408181|NCT00004887|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5408182|NCT00004887|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5408183|NCT00065416|neck pain|neck pain
5408184|NCT00065416|cervicalgia|cervicalgia
5408185|NCT00065416|massage|massage
5408186|NCT00065403|Irritable Bowel Syndrome|irritable bowel syndrome
5408187|NCT00065403|Acupuncture|acupuncture
5408188|NCT00065364|Preterm infant|preterm infant
5408189|NCT00065364|Premature infant|premature infant
5408190|NCT00065364|Developmental care|developmental care
5408191|NCT00065364|MRI|mri
5408192|NCT00065364|qEEG|qeeg
5408193|NCT00065364|Neurodevelopment|neurodevelopment
5408194|NCT00065364|Behavior|behavior
5408195|NCT00065364|Infants|infants
5408196|NCT00065364|NICU|nicu
5408197|NCT00065351|Multiple Myeloma|multiple myeloma
5408198|NCT00065351|CC-5013|cc-5013
5408199|NCT00065351|Revlimid|revlimid
5408200|NCT00065351|MM|mm
5408201|NCT00065351|CC5013|cc5013
5408202|NCT00065351|relapsed and refractory multiple myeloma|relapsed and refractory multiple myeloma
5408203|NCT00065338|Physical activity|physical activity
5408204|NCT00065325|Locally advanced breast cancer|locally advanced breast cancer
5408205|NCT00065325|metastatic breast cancer|metastatic breast cancer
5408206|NCT00065325|Breast Cancer|breast cancer
5408207|NCT00065325|Cancer of Breast|cancer of breast
5408208|NCT00065325|Cancer of the Breast|cancer of the breast
5408209|NCT00004253|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
5408210|NCT00004253|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5408211|NCT00004253|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5408212|NCT00065390|ALPS|alps
5408213|NCT00065390|Pyrimethamine|pyrimethamine
5408214|NCT00065390|Folinic Acid|folinic acid
5408215|NCT00065390|Lymphadenopathy|lymphadenopathy
5408216|NCT00065390|Splenomegaly|splenomegaly
5408217|NCT00065390|Autoimmune Lymphoproliferative Syndrome|autoimmune lymphoproliferative syndrome
5408218|NCT00065377|Diabetes|diabetes
5408219|NCT00065377|Insulin Resistance|insulin resistance
5408220|NCT00065377|Capillary Blood Flow|capillary blood flow
5408221|NCT00065377|Osteoarthritis|osteoarthritis
5408222|NCT00065377|Endothelial Dysfunction|endothelial dysfunction
5408223|NCT00065377|Obesity|obesity
5408224|NCT00065377|Healthy Volunteer|healthy volunteer
5408225|NCT00065377|HV|hv
5408226|NCT00065312|Type 2 diabetes|type 2 diabetes
5408227|NCT00065299|Hyperphenylalaninemia|hyperphenylalaninemia
5408228|NCT00065299|PKU|pku
5408229|NCT00065299|Maternal PKU|maternal pku
5408230|NCT00065299|Pregnancy outcome|pregnancy outcome
5408231|NCT00065299|Phenylalanine restricted diet|phenylalanine restricted diet
5408232|NCT00065299|Tyrosine supplementation|tyrosine supplementation
5408233|NCT00065299|Maternal hyperphenylalanemia during pregnancy|maternal hyperphenylalanemia during pregnancy
5408234|NCT00065286|Akathisia|akathisia
5408235|NCT00065286|Mental retardation|mental retardation
5408236|NCT00065286|Schizophrenia|schizophrenia
5408237|NCT00065286|Neuroleptic medication|neuroleptic medication
5408238|NCT00065286|Tardive dyskinesia|tardive dyskinesia
5408239|NCT00065286|Brief Psychiatric Rating Scale|brief psychiatric rating scale
5408240|NCT00065286|Barnes test|barnes test
5408241|NCT00065286|Stereotypy Checklist Test|stereotypy checklist test
5408242|NCT00065286|DISCUS Tardive Dyskinesia test|discus tardive dyskinesia test
5408243|NCT00065273|Severe aberrant behavior|severe aberrant behavior
5408244|NCT00065273|Risperidone|risperidone
5408245|NCT00065273|Clozapine|clozapine
5408246|NCT00065273|Haloperidol|haloperidol
5408247|NCT00065273|Laboratory operant tasks|laboratory operant tasks
5408248|NCT00065273|Simple acquisition procedures|simple acquisition procedures
5408249|NCT00065273|Matching to sample task|matching to sample task
5408250|NCT00065273|Lag sequential analysis|lag sequential analysis
5408251|NCT00065247|Bone|bone
5408252|NCT00065247|Children|children
5408253|NCT00065247|After-school program|after-school program
5408254|NCT00065247|Osteoporosis|osteoporosis
5408255|NCT00065247|Calcium|calcium
5408256|NCT00065247|Physical activity|physical activity
5408257|NCT00065234|Colostomy|colostomy
5408258|NCT00065234|Ileostomy|ileostomy
5408259|NCT00065221|Ginger|ginger
5408260|NCT00065221|Plant preparation|plant preparation
5408261|NCT00065221|Herbal medicine|herbal medicine
5408262|NCT00065221|Chemotherapy|chemotherapy
5408263|NCT00065221|Nausea|nausea
5408264|NCT00065208|Prostate cancer|prostate cancer
5408265|NCT00065208|Reiki|reiki
5408266|NCT00065208|Energy Healing|energy healing
5408267|NCT00065260|Alemtuzumab (Campath-1H)|alemtuzumab (campath-1h)
5408268|NCT00065260|Rabbit ATG|rabbit atg
5408269|NCT00065260|Severe Aplastic Anemia|severe aplastic anemia
5408270|NCT00065260|Cyclosporine|cyclosporine
5408271|NCT00065260|Thrombocytopenia|thrombocytopenia
5408272|NCT00065260|Leukopenia|leukopenia
5408273|NCT00065260|Neutropenia|neutropenia
5408274|NCT00065260|Autoimmunity|autoimmunity
5408275|NCT00065260|Relapse|relapse
5408276|NCT00065260|Anemia|anemia
5408277|NCT00065195|Massage|massage
5408278|NCT00065195|Palliative Care|palliative care
5408279|NCT00065195|Hospices|hospices
5408280|NCT00065195|Cancer|cancer
5408281|NCT00065182|Stage IIIB/IV|stage iiib/iv
5408282|NCT00065182|topotecan|topotecan
5408283|NCT00065182|docetaxel|docetaxel
5408284|NCT00065182|TAXOTERE|taxotere
5408285|NCT00065182|HYCAMTIN|hycamtin
5408286|NCT00065182|non-small cell lung cancer|non-small cell lung cancer
5408287|NCT00065182|Advanced|advanced
5408288|NCT00065182|NSCLC|nsclc
5408289|NCT00065156|MDS|mds
5408290|NCT00065156|CC-5013|cc-5013
5408291|NCT00065156|Revlimid|revlimid
5408292|NCT00065156|Celgene|celgene
5408293|NCT00065143|Newly diagnosed and previously untreated acute myeloid leukemia (AML)|newly diagnosed and previously untreated acute myeloid leukemia (aml)
5408294|NCT00065143|High-risk myelodysplastic syndrome (MDS) (>/= 10% bone marrow blasts)|high-risk myelodysplastic syndrome (mds) (>/= 10% bone marrow blasts)
5408295|NCT00065143|Acute Myeloid Leukemia (AML)|acute myeloid leukemia (aml)
5408296|NCT00065143|Myelodysplastic Syndrome (MDS)|myelodysplastic syndrome (mds)
5408297|NCT00065117|metastatic|metastatic
5408298|NCT00065117|colorectal|colorectal
5408299|NCT00065117|first-line|first-line
5408300|NCT00065117|adjuvant|adjuvant
5408301|NCT00065117|cancer|cancer
5408302|NCT00065117|Colorectal Cancer|colorectal cancer
5408303|NCT00065117|Colorectal Carcinoma|colorectal carcinoma
5408304|NCT00065117|Colorectal Tumors|colorectal tumors
5408305|NCT00065117|Neoplasms, Colorectal|neoplasms, colorectal
5408306|NCT00065104|HIV|hiv
5408307|NCT00065104|DHEA|dhea
5408308|NCT00065104|immune system|immune system
5408309|NCT00065104|hormones|hormones
5408310|NCT00065104|body composition|body composition
5408311|NCT00065104|quality of life|quality of life
5408312|NCT00065078|Home-visits|home-visits
5408313|NCT00065078|Community nurse|community nurse
5408314|NCT00065078|Unintended pregnancy|unintended pregnancy
5408315|NCT00065065|Rosiglitazone|rosiglitazone
5408316|NCT00065065|Ulcerative|ulcerative
5408317|NCT00065065|Colitis|colitis
5408318|NCT00065052|physical activity|physical activity
5408319|NCT00065052|television|television
5408320|NCT00065052|child obesity|child obesity
5408321|NCT00065052|Reduce TV|reduce tv
5408322|NCT00065052|Usual control|usual control
5408323|NCT00065013|obesity|obesity
5408324|NCT00065013|gastric bypass|gastric bypass
5408325|NCT00065013|obesity surgery|obesity surgery
5408326|NCT00065013|bariatric surgery|bariatric surgery
5408327|NCT00065013|exercise|exercise
5408328|NCT00004204|recurrent adult brain tumor|recurrent adult brain tumor
5408329|NCT00004204|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5408330|NCT00004204|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
5408331|NCT00004006|intraocular retinoblastoma|intraocular retinoblastoma
5408332|NCT00004006|extraocular retinoblastoma|extraocular retinoblastoma
5408333|NCT00004006|recurrent retinoblastoma|recurrent retinoblastoma
5408334|NCT00003795|stage I ovarian epithelial cancer|stage i ovarian epithelial cancer
5408335|NCT00003795|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
5408336|NCT00003795|stage I endometrial carcinoma|stage i endometrial carcinoma
5408337|NCT00003795|stage II endometrial carcinoma|stage ii endometrial carcinoma
5408338|NCT00003759|stage 0 bladder cancer|stage 0 bladder cancer
5433064|NCT00006412|Procetofen|procetofen
5408339|NCT00003759|stage I bladder cancer|stage i bladder cancer
5408340|NCT00003759|recurrent bladder cancer|recurrent bladder cancer
5408341|NCT00064987|Male reproduction hormones|male reproduction hormones
5408342|NCT00064987|Hypogonadotropic hypogonadism|hypogonadotropic hypogonadism
5408343|NCT00064987|FSH|fsh
5408344|NCT00064987|LH|lh
5408345|NCT00064987|GnRH|gnrh
5408346|NCT00064974|MDS|mds
5408347|NCT00064974|CC-5013|cc-5013
5408348|NCT00064974|Revlimid|revlimid
5408349|NCT00064974|Celgene|celgene
5408350|NCT00064961|Smoking Cessation|smoking cessation
5408351|NCT00064935|Endometrium|endometrium
5408352|NCT00064935|Luteal phase|luteal phase
5408353|NCT00064935|Endometrial biopsy|endometrial biopsy
5408354|NCT00064922|nicotine dependence|nicotine dependence
5408355|NCT00064870|Alzheimer disease|alzheimer disease
5408356|NCT00064870|Late Onset Alzheimer disease risk factor genes|late onset alzheimer disease risk factor genes
5408357|NCT00064870|Genetics|genetics
5408358|NCT00064870|Initiative|initiative
5408359|NCT00064870|Dementia|dementia
5408360|NCT00064857|lymphedema|lymphedema
5408361|NCT00064857|breast|breast
5408362|NCT00064857|cancer|cancer
5408363|NCT00064857|plant preparation|plant preparation
5408364|NCT00064857|herbal preparation|herbal preparation
5408365|NCT00064857|pine bark extract|pine bark extract
5408366|NCT00064909|Multiple Sclerosis|multiple sclerosis
5408367|NCT00064909|MRI|mri
5408368|NCT00064909|Perfusion|perfusion
5408369|NCT00064909|Imaging|imaging
5408370|NCT00064909|Cerebral Blood Flow|cerebral blood flow
5408371|NCT00064909|Cerebral Blood Volume|cerebral blood volume
5408372|NCT00064909|CO2 Inhalation|co2 inhalation
5408373|NCT00064909|Contrast Agent|contrast agent
5408374|NCT00064909|Healthy Volunteer|healthy volunteer
5408375|NCT00064909|HV|hv
5408376|NCT00064896|Blood Flow|blood flow
5408377|NCT00064896|Revascularization|revascularization
5408378|NCT00064896|Image Fusion|image fusion
5408379|NCT00064896|Fluoroscopy|fluoroscopy
5408380|NCT00064896|MRI|mri
5408381|NCT00064896|Chronic Total Occlusion of Arteries|chronic total occlusion of arteries
5408382|NCT00064896|Claudication|claudication
5408383|NCT00064896|Safety|safety
5408384|NCT00064896|Atherosclerosis|atherosclerosis
5408385|NCT00064896|Cardiovascular Disease|cardiovascular disease
5408386|NCT00064883|Radiation Therapy|radiation therapy
5408387|NCT00064883|Children|children
5408388|NCT00064883|Cancer|cancer
5408389|NCT00064883|Late Effects|late effects
5408390|NCT00064883|Natural History|natural history
5408391|NCT00064883|Radiation|radiation
5408392|NCT00064844|Smoking|smoking
5408393|NCT00064844|Alcoholism|alcoholism
5408394|NCT00064831|estrogen stimulation|estrogen stimulation
5408395|NCT00064831|relief of hot flashes|relief of hot flashes
5408396|NCT00064831|nipple aspirate fluid|nipple aspirate fluid
5408397|NCT00064831|body fluid levels of black cohosh|body fluid levels of black cohosh
5408398|NCT00064818|connective tissue|connective tissue
5408399|NCT00064818|ultrasound|ultrasound
5408400|NCT00064818|acupuncture|acupuncture
5408401|NCT00064805|Cognitive therapy|cognitive therapy
5408402|NCT00064805|Aphasia therapy|aphasia therapy
5408403|NCT00064805|Alexia|alexia
5408404|NCT00064805|Acquired dyslexia|acquired dyslexia
5408405|NCT00064805|Phonological deficits|phonological deficits
5408406|NCT00064805|Orthographic deficits|orthographic deficits
5408407|NCT00064805|Brain disorders|brain disorders
5408408|NCT00064805|Brain injury|brain injury
5408409|NCT00064805|Stroke|stroke
5408410|NCT00064779|CNS neoplasms|cns neoplasms
5408411|NCT00064779|Brain neoplasms|brain neoplasms
5408412|NCT00064779|neurosurgery|neurosurgery
5408413|NCT00064779|intralesional infusion|intralesional infusion
5408414|NCT00064779|recombinant proteins|recombinant proteins
5408415|NCT00064779|immunotoxins|immunotoxins
5408416|NCT00064766|Norplant|norplant
5408417|NCT00064766|Periodontal disease|periodontal disease
5408418|NCT00064766|Endometrial bleeding|endometrial bleeding
5408419|NCT00064766|Progestin-induced endometrial bleeding|progestin-induced endometrial bleeding
5408420|NCT00064753|homocysteine|homocysteine
5408421|NCT00064753|multi-vitamin|multi-vitamin
5408422|NCT00064753|cardiovascular disease|cardiovascular disease
5408423|NCT00064753|renal transplant recipients|renal transplant recipients
5408424|NCT00003712|recurrent adult brain tumor|recurrent adult brain tumor
5408425|NCT00003712|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5408426|NCT00003712|tumors metastatic to brain|tumors metastatic to brain
5408427|NCT00003707|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5408428|NCT00003645|stage I prostate cancer|stage i prostate cancer
5408429|NCT00003645|stage II prostate cancer|stage ii prostate cancer
5408430|NCT00003571|stage III colon cancer|stage iii colon cancer
5408431|NCT00003571|adenocarcinoma of the colon|adenocarcinoma of the colon
5408432|NCT00003382|stage I ovarian epithelial cancer|stage i ovarian epithelial cancer
5408433|NCT00003382|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
5408434|NCT00003382|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5408435|NCT00003382|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5408436|NCT00003382|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5433065|NCT00006412|Pravastatin|pravastatin
5408437|NCT00003382|fallopian tube cancer|fallopian tube cancer
5408438|NCT00003382|primary peritoneal cavity cancer|primary peritoneal cavity cancer
5408439|NCT00064792|Cholesterol|cholesterol
5408440|NCT00064792|SLOS|slos
5408441|NCT00064792|HMG-COA Reductase Inhibitor|hmg-coa reductase inhibitor
5408442|NCT00064792|Malformation Syndrome|malformation syndrome
5408443|NCT00064792|Mental Retardation|mental retardation
5408444|NCT00064792|Smith-Lemli-Opitz Syndrome|smith-lemli-opitz syndrome
5408445|NCT00064740|Human Immunodeficiency Viruses|human immunodeficiency viruses
5408446|NCT00064740|Relaxation|relaxation
5408447|NCT00064740|Acupuncture|acupuncture
5408448|NCT00064740|Complementary therapies|complementary therapies
5408449|NCT00064701|De Novo Kidney Transplant|de novo kidney transplant
5408450|NCT00064701|cyclosporine|cyclosporine
5408451|NCT00064701|Prograf®|prograf®
5408452|NCT00064701|mycophenolate mofetil|mycophenolate mofetil
5408453|NCT00064701|tacrolimus|tacrolimus
5408454|NCT00006073|Evaluation|evaluation
5408455|NCT00006073|Endocrinology|endocrinology
5408456|NCT00006073|Hormones|hormones
5408457|NCT00006073|Metabolism|metabolism
5408458|NCT00006073|Teaching|teaching
5408459|NCT00006073|Endocrine Disorder|endocrine disorder
5408460|NCT00064727|Ventricular Contractile Function|ventricular contractile function
5408461|NCT00064727|Diastolic Dysfunction|diastolic dysfunction
5408462|NCT00064727|PPAR gamma|ppar gamma
5408463|NCT00064727|Gene Expression Patterns|gene expression patterns
5408464|NCT00064727|Insulin Sensitization|insulin sensitization
5408465|NCT00064727|Glucose Intolerance|glucose intolerance
5408466|NCT00064727|Intolerance|intolerance
5408467|NCT00064714|Type 1 Diabetes Mellitus (T1DM)|type 1 diabetes mellitus (t1dm)
5408468|NCT00064714|Beta-Cell|beta-cell
5408469|NCT00064714|C-Peptide|c-peptide
5408470|NCT00064714|Immunosuppression|immunosuppression
5408471|NCT00064714|Insulin|insulin
5408472|NCT00064714|Islet|islet
5408473|NCT00064714|Function|function
5408474|NCT00064714|AC2993 (Synthetic Exendin-4)|ac2993 (synthetic exendin-4)
5408475|NCT00064714|Diabetes Mellitus|diabetes mellitus
5408476|NCT00064714|Type I Diabetes Mellitus|type i diabetes mellitus
5408477|NCT00064714|T1DM|t1dm
5408478|NCT00064662|Stress urinary incontinence|stress urinary incontinence
5408479|NCT00064662|Surgery|surgery
5408480|NCT00064649|prostate|prostate
5408481|NCT00064649|benign disease|benign disease
5408482|NCT00064649|TUNA|tuna
5408483|NCT00064649|TUMT|tumt
5408484|NCT00064649|medical therapy|medical therapy
5408485|NCT00064623|Dermal assessment|dermal assessment
5408486|NCT00064623|Pain measurement|pain measurement
5408487|NCT00064623|Diary|diary
5408488|NCT00064623|Analgesics/*therapeutic use|analgesics/*therapeutic use
5408489|NCT00064623|Capsaicin/*administration & dosage/adverse effects|capsaicin/*administration & dosage/adverse effects
5408490|NCT00064623|HIV Infections/*complications/*drug therapy|hiv infections/*complications/*drug therapy
5408491|NCT00064623|Peripheral Nervous System Diseases/*complications/diagnosis/*therapy|peripheral nervous system diseases/*complications/diagnosis/*therapy
5408492|NCT00064623|Peripheral Nervous System Diseases/drug therapy/*etiology/physiopathology|peripheral nervous system diseases/drug therapy/*etiology/physiopathology
5408493|NCT00064610|Advanced androgen-independent prostate cancer|advanced androgen-independent prostate cancer
5408494|NCT00064597|Fetal cells|fetal cells
5408495|NCT00064597|Prenatal diagnosis|prenatal diagnosis
5408496|NCT00064597|Cytogenetic disorders|cytogenetic disorders
5408497|NCT00064597|Chromosomal disorders|chromosomal disorders
5408498|NCT00064597|Single gene mutation detection|single gene mutation detection
5408499|NCT00064597|Abnormal serum marker profile|abnormal serum marker profile
5408500|NCT00064597|Fluorescence activated cell sorting (FACS)|fluorescence activated cell sorting (facs)
5408501|NCT00064597|Magnetic activated cell sorting (MACS)|magnetic activated cell sorting (macs)
5408502|NCT00064597|Fluorescence in situ hybridization (FISH)|fluorescence in situ hybridization (fish)
5408503|NCT00064597|Chromosomal disorders of the fetus|chromosomal disorders of the fetus
5408504|NCT00064597|Single gene defects of the fetus|single gene defects of the fetus
5408505|NCT00063726|Relapsed Multiple Myeloma|relapsed multiple myeloma
5408506|NCT00063726|Refractory Multiple Myeloma|refractory multiple myeloma
5408507|NCT00003184|stage IV breast cancer|stage iv breast cancer
5408508|NCT00003184|recurrent breast cancer|recurrent breast cancer
5408509|NCT00003045|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5408510|NCT00003045|stage II prostate cancer|stage ii prostate cancer
5408511|NCT00003045|stage III prostate cancer|stage iii prostate cancer
5408512|NCT00003008|AIDS-related Kaposi sarcoma|aids-related kaposi sarcoma
5408513|NCT00003008|recurrent Kaposi sarcoma|recurrent kaposi sarcoma
5408514|NCT00002965|recurrent adult brain tumor|recurrent adult brain tumor
5408515|NCT00064571|unilateral vocal fold paralysis|unilateral vocal fold paralysis
5408516|NCT00064467|lethargic|lethargic
5408517|NCT00064467|decreased interest|decreased interest
5408518|NCT00064467|decreased motivation|decreased motivation
5408519|NCT00064467|depression|depression
5408520|NCT00064454|Ulcerative Colitis|ulcerative colitis
5408521|NCT00064441|Ulcerative Colitis|ulcerative colitis
5408522|NCT00064376|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5408523|NCT00064376|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5408524|NCT00064376|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5408525|NCT00064376|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
5408526|NCT00064376|refractory anemia with excess blasts|refractory anemia with excess blasts
5408527|NCT00064376|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
5408528|NCT00064376|refractory anemia|refractory anemia
5408529|NCT00064376|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5408530|NCT00064363|recurrent adult brain tumor|recurrent adult brain tumor
5408531|NCT00064363|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5408532|NCT00064363|adult glioblastoma|adult glioblastoma
5408533|NCT00064363|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
5408534|NCT00064363|adult mixed glioma|adult mixed glioma
5408535|NCT00064363|adult giant cell glioblastoma|adult giant cell glioblastoma
5408536|NCT00064363|adult gliosarcoma|adult gliosarcoma
5408537|NCT00064363|adult brain stem glioma|adult brain stem glioma
5408538|NCT00064350|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5408539|NCT00064350|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5408540|NCT00064350|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5408541|NCT00064350|sorafenib|sorafenib
5408542|NCT00064337|primary systemic amyloidosis|primary systemic amyloidosis
5408543|NCT00064337|stage II multiple myeloma|stage ii multiple myeloma
5408544|NCT00064337|stage III multiple myeloma|stage iii multiple myeloma
5408545|NCT00064311|infection|infection
5408546|NCT00064311|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5408547|NCT00064311|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5408548|NCT00064311|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5408549|NCT00064311|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5408550|NCT00064311|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5408551|NCT00064311|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5408552|NCT00064311|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5408553|NCT00064311|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5408554|NCT00064311|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5408555|NCT00064311|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5408556|NCT00064311|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5408557|NCT00064311|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5408558|NCT00064311|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5408559|NCT00064311|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
5408560|NCT00064311|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
5408561|NCT00064311|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
5408562|NCT00064311|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
5408563|NCT00064311|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5408564|NCT00064311|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5408565|NCT00064311|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5408566|NCT00064311|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5408567|NCT00064311|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5408568|NCT00064311|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5408569|NCT00064311|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5408570|NCT00064311|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5408571|NCT00064311|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5408572|NCT00064311|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5408573|NCT00064311|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5408574|NCT00064311|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5408575|NCT00064311|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5408576|NCT00064311|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5408577|NCT00064311|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5408578|NCT00064311|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5408579|NCT00064311|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5408580|NCT00064311|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5408581|NCT00064311|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5408582|NCT00064311|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5408583|NCT00064311|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5408584|NCT00064311|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5408585|NCT00064311|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
5408586|NCT00064311|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5408587|NCT00064311|refractory hairy cell leukemia|refractory hairy cell leukemia
5408588|NCT00064311|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5408589|NCT00064311|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5408590|NCT00064311|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5408591|NCT00064311|stage I multiple myeloma|stage i multiple myeloma
5408592|NCT00064311|stage II multiple myeloma|stage ii multiple myeloma
5408593|NCT00064311|stage III multiple myeloma|stage iii multiple myeloma
5408594|NCT00064311|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
5408595|NCT00064311|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
5408596|NCT00064311|disseminated neuroblastoma|disseminated neuroblastoma
5408597|NCT00064311|recurrent neuroblastoma|recurrent neuroblastoma
5408598|NCT00064311|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
5408599|NCT00064311|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5408600|NCT00064311|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5408601|NCT00064311|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5408602|NCT00064311|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
5408603|NCT00064311|stage IIIA breast cancer|stage iiia breast cancer
5408604|NCT00064311|stage IIIB breast cancer|stage iiib breast cancer
5408605|NCT00064311|stage IV breast cancer|stage iv breast cancer
5408606|NCT00064311|high risk metastatic gestational trophoblastic tumor|high risk metastatic gestational trophoblastic tumor
5408607|NCT00064311|primary myelofibrosis|primary myelofibrosis
5408608|NCT00064311|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5408609|NCT00064311|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5408610|NCT00064311|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5408611|NCT00064311|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5408612|NCT00064311|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5408613|NCT00064311|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
5408614|NCT00064311|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
5408615|NCT00064311|stage IIIC breast cancer|stage iiic breast cancer
5408616|NCT00064311|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5408617|NCT00064311|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5408618|NCT00064311|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5408619|NCT00064311|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5408620|NCT00064311|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5408621|NCT00064311|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5408622|NCT00064311|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5408623|NCT00064311|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5408624|NCT00064311|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5408625|NCT00064311|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5408626|NCT00064298|stage I squamous cell carcinoma of the hypopharynx|stage i squamous cell carcinoma of the hypopharynx
5408627|NCT00064298|stage I squamous cell carcinoma of the larynx|stage i squamous cell carcinoma of the larynx
5408628|NCT00064298|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
5408629|NCT00064298|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
5408630|NCT00064298|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
5408631|NCT00064298|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
5408632|NCT00064298|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
5408633|NCT00064298|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
5408634|NCT00064298|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
5408635|NCT00064298|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
5408636|NCT00064298|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
5408637|NCT00064298|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
5408638|NCT00064298|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5408639|NCT00064298|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5408640|NCT00064298|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5408641|NCT00064298|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5408642|NCT00064285|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5408643|NCT00064285|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5408644|NCT00064285|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5408645|NCT00064285|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5408646|NCT00064285|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
5408647|NCT00064285|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5408648|NCT00064285|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5408649|NCT00064285|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5408650|NCT00064285|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
5408651|NCT00064285|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5408719|NCT00063960|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5408652|NCT00064285|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5408653|NCT00064285|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5408654|NCT00064285|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5408655|NCT00064285|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5408656|NCT00064285|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5408657|NCT00064272|nausea and vomiting|nausea and vomiting
5408658|NCT00064272|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5408659|NCT00064233|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5408660|NCT00064233|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5408661|NCT00064233|Philadelphia chromosome positive chronic myelogenous leukemia|philadelphia chromosome positive chronic myelogenous leukemia
5408662|NCT00064220|adult leiomyosarcoma|adult leiomyosarcoma
5408663|NCT00064220|adult malignant fibrous histiocytoma|adult malignant fibrous histiocytoma
5408664|NCT00064220|adult liposarcoma|adult liposarcoma
5408665|NCT00064220|adult rhabdomyosarcoma|adult rhabdomyosarcoma
5408666|NCT00064220|adult synovial sarcoma|adult synovial sarcoma
5408667|NCT00064220|adult fibrosarcoma|adult fibrosarcoma
5408668|NCT00064220|adult angiosarcoma|adult angiosarcoma
5408669|NCT00064220|adult malignant hemangiopericytoma|adult malignant hemangiopericytoma
5408670|NCT00064220|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
5408671|NCT00064220|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
5408672|NCT00064207|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
5408673|NCT00064207|stage I pancreatic cancer|stage i pancreatic cancer
5408674|NCT00064207|stage II pancreatic cancer|stage ii pancreatic cancer
5408675|NCT00064207|stage III pancreatic cancer|stage iii pancreatic cancer
5408676|NCT00064194|prostate cancer|prostate cancer
5408677|NCT00064194|high grade prostatic intraepithelial neoplasia|high grade prostatic intraepithelial neoplasia
5408678|NCT00064181|adenocarcinoma of the colon|adenocarcinoma of the colon
5408679|NCT00064181|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5408680|NCT00064181|stage IV colon cancer|stage iv colon cancer
5408681|NCT00064181|stage IV rectal cancer|stage iv rectal cancer
5408682|NCT00064116|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
5408683|NCT00064116|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
5408684|NCT00064116|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5408685|NCT00064116|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5408686|NCT00064116|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5408687|NCT00064090|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5408688|NCT00064090|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5408689|NCT00064090|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5408690|NCT00064090|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5408691|NCT00064090|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5408692|NCT00064090|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5408693|NCT00064090|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
5408694|NCT00064090|refractory anemia with excess blasts|refractory anemia with excess blasts
5408695|NCT00064090|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5408696|NCT00064090|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
5408697|NCT00064090|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
5408698|NCT00064090|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5408699|NCT00064090|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5408700|NCT00064090|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5408701|NCT00064090|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5408702|NCT00064090|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5408703|NCT00064064|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5408704|NCT00064064|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5408705|NCT00064051|stage II pancreatic cancer|stage ii pancreatic cancer
5408706|NCT00064051|stage III pancreatic cancer|stage iii pancreatic cancer
5408707|NCT00064051|recurrent pancreatic cancer|recurrent pancreatic cancer
5408708|NCT00064051|stage IV pancreatic cancer|stage iv pancreatic cancer
5408709|NCT00064038|stage I multiple myeloma|stage i multiple myeloma
5408710|NCT00064038|stage II multiple myeloma|stage ii multiple myeloma
5408711|NCT00064038|stage III multiple myeloma|stage iii multiple myeloma
5408712|NCT00064012|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5408713|NCT00064012|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5408714|NCT00064012|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5408715|NCT00063986|esophageal cancer|esophageal cancer
5408716|NCT00063986|minimally invasive esophagectomy (MIE)|minimally invasive esophagectomy (mie)
5408717|NCT00063960|stage IV colon cancer|stage iv colon cancer
5408718|NCT00063960|adenocarcinoma of the colon|adenocarcinoma of the colon
5408949|NCT00063323|Bupropion|bupropion
5408720|NCT00063960|stage IV rectal cancer|stage iv rectal cancer
5408721|NCT00063960|liver metastases|liver metastases
5408722|NCT00063882|stage IIB prostate cancer|stage iib prostate cancer
5408723|NCT00063882|stage IIA prostate cancer|stage iia prostate cancer
5408724|NCT00063882|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5408725|NCT00063869|Idiopathic Pulmonary Fibrosis|idiopathic pulmonary fibrosis
5408726|NCT00063869|Fibrosis, Pulmonary|fibrosis, pulmonary
5408727|NCT00063869|Pulmonary Fibroses|pulmonary fibroses
5408728|NCT00063869|Fibroses, Pulmonary|fibroses, pulmonary
5408729|NCT00023907|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5408730|NCT00023907|primary peritoneal cavity cancer|primary peritoneal cavity cancer
5408731|NCT00003211|untreated childhood supratentorial primitive neuroectodermal tumor|untreated childhood supratentorial primitive neuroectodermal tumor
5408732|NCT00003211|untreated childhood medulloblastoma|untreated childhood medulloblastoma
5408733|NCT00002878|refractory multiple myeloma|refractory multiple myeloma
5408734|NCT00063856|Smallpox, wetvax|smallpox, wetvax
5408735|NCT00063843|Bacillus anthracis (anthrax)|bacillus anthracis (anthrax)
5408736|NCT00063830|Ulcerative Colitis|ulcerative colitis
5408737|NCT00063817|End-stage renal disease|end-stage renal disease
5408738|NCT00063817|Renal Transplant|renal transplant
5408739|NCT00063817|Bone Marrow Transplant|bone marrow transplant
5408740|NCT00063817|nonmyeloablative conditioning regimen|nonmyeloablative conditioning regimen
5408741|NCT00063804|HIV Seronegativity|hiv seronegativity
5408742|NCT00063804|CXCR4|cxcr4
5408743|NCT00063804|AMD11070|amd11070
5408744|NCT00063791|Relapsed or Refractory|relapsed or refractory
5408745|NCT00063778|HIV Seronegativity|hiv seronegativity
5408746|NCT00063778|HIV Preventive Vaccine|hiv preventive vaccine
5408747|NCT00063778|AIDS Vaccines|aids vaccines
5408748|NCT00063778|Gene Products, gag|gene products, gag
5408749|NCT00063778|HIV-1|hiv-1
5408750|NCT00063778|Dose-Response Relationship, Immunologic|dose-response relationship, immunologic
5408751|NCT00063778|Injections, Subcutaneous|injections, subcutaneous
5408752|NCT00045357|recurrent melanoma|recurrent melanoma
5408753|NCT00045357|stage IV melanoma|stage iv melanoma
5408754|NCT00042900|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
5408755|NCT00042900|AIDS-related primary CNS lymphoma|aids-related primary cns lymphoma
5408756|NCT00042900|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
5408757|NCT00042900|Waldenström macroglobulinemia|waldenström macroglobulinemia
5408758|NCT00042900|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5408759|NCT00042900|acute undifferentiated leukemia|acute undifferentiated leukemia
5408760|NCT00042900|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5408761|NCT00042900|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5408762|NCT00042900|primary myelofibrosis|primary myelofibrosis
5408763|NCT00042900|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5408764|NCT00042900|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
5408765|NCT00042900|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5408766|NCT00042900|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5408767|NCT00042900|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5408768|NCT00042900|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5408769|NCT00042900|essential thrombocythemia|essential thrombocythemia
5408770|NCT00042900|extramedullary plasmacytoma|extramedullary plasmacytoma
5408771|NCT00042900|intraocular lymphoma|intraocular lymphoma
5408772|NCT00042900|isolated plasmacytoma of bone|isolated plasmacytoma of bone
5408773|NCT00042900|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
5408774|NCT00042900|monoclonal gammopathy of undetermined significance|monoclonal gammopathy of undetermined significance
5408775|NCT00042900|polycythemia vera|polycythemia vera
5408776|NCT00042900|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5408777|NCT00042900|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
5408778|NCT00042900|primary systemic amyloidosis|primary systemic amyloidosis
5408779|NCT00042900|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
5408780|NCT00042900|prolymphocytic leukemia|prolymphocytic leukemia
5408781|NCT00042900|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5408782|NCT00042900|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
5408783|NCT00042900|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5408784|NCT00042900|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5408785|NCT00042900|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5408786|NCT00042900|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5408787|NCT00042900|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5408788|NCT00042900|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5408789|NCT00042900|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5408790|NCT00042900|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5408791|NCT00042900|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5408792|NCT00042900|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5408793|NCT00042900|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5408794|NCT00042900|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5408795|NCT00042900|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5408796|NCT00042900|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5408797|NCT00042900|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5408798|NCT00042900|refractory hairy cell leukemia|refractory hairy cell leukemia
5408799|NCT00042900|refractory multiple myeloma|refractory multiple myeloma
5408800|NCT00042900|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5408801|NCT00042900|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5408802|NCT00042900|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5408803|NCT00042900|small intestine lymphoma|small intestine lymphoma
5408804|NCT00042900|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5408805|NCT00042900|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
5408806|NCT00042900|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5408807|NCT00042900|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5408808|NCT00042900|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5408809|NCT00042900|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5408810|NCT00042900|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5408811|NCT00042900|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5408812|NCT00042900|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5408813|NCT00042900|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
5408814|NCT00042900|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5408815|NCT00042900|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5408816|NCT00042900|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5408817|NCT00042900|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5408818|NCT00042900|stage III multiple myeloma|stage iii multiple myeloma
5408819|NCT00042900|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
5408820|NCT00042900|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5408821|NCT00042900|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5408822|NCT00042900|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5408823|NCT00042900|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5408824|NCT00042900|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5408825|NCT00042900|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5408826|NCT00042900|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5408827|NCT00042900|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
5408828|NCT00042900|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5408829|NCT00042900|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5408830|NCT00042900|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5408831|NCT00042900|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5408832|NCT00042900|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
5408833|NCT00042900|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
5408834|NCT00042900|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
5408835|NCT00042900|untreated hairy cell leukemia|untreated hairy cell leukemia
5408836|NCT00042900|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5408837|NCT00042900|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
5408838|NCT00042900|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5408839|NCT00042900|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5408840|NCT00042900|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5408841|NCT00042900|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5408842|NCT00042900|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5408843|NCT00042900|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5408844|NCT00042900|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5408845|NCT00042900|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5408846|NCT00042900|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5408847|NCT00042900|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5408848|NCT00040820|stage III colon cancer|stage iii colon cancer
5408849|NCT00040820|stage IV colon cancer|stage iv colon cancer
5408850|NCT00040820|stage III rectal cancer|stage iii rectal cancer
5408851|NCT00040820|stage IV rectal cancer|stage iv rectal cancer
5408852|NCT00040820|recurrent colon cancer|recurrent colon cancer
5408853|NCT00040820|recurrent rectal cancer|recurrent rectal cancer
5408854|NCT00040820|adenocarcinoma of the colon|adenocarcinoma of the colon
5408855|NCT00040820|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5408856|NCT00039169|stage III renal cell cancer|stage iii renal cell cancer
5408857|NCT00039169|stage IV renal cell cancer|stage iv renal cell cancer
5408858|NCT00039169|recurrent renal cell cancer|recurrent renal cell cancer
5408859|NCT00036660|recurrent adult brain tumor|recurrent adult brain tumor
5408860|NCT00036660|adult glioblastoma|adult glioblastoma
5408861|NCT00036660|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5409118|NCT00063180|Stroke|stroke
5408862|NCT00036660|adult giant cell glioblastoma|adult giant cell glioblastoma
5408863|NCT00036660|adult gliosarcoma|adult gliosarcoma
5408864|NCT00033384|stage III colon cancer|stage iii colon cancer
5408865|NCT00033384|stage IV colon cancer|stage iv colon cancer
5408866|NCT00033384|stage IV breast cancer|stage iv breast cancer
5408867|NCT00033384|stage IIIA breast cancer|stage iiia breast cancer
5408868|NCT00033384|recurrent breast cancer|recurrent breast cancer
5408869|NCT00033384|stage IIIB breast cancer|stage iiib breast cancer
5408870|NCT00033384|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5408871|NCT00033384|stage II pancreatic cancer|stage ii pancreatic cancer
5408872|NCT00033384|stage III pancreatic cancer|stage iii pancreatic cancer
5408873|NCT00033384|recurrent pancreatic cancer|recurrent pancreatic cancer
5408874|NCT00033384|recurrent colon cancer|recurrent colon cancer
5408875|NCT00033384|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5408876|NCT00033384|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5408877|NCT00033384|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5408878|NCT00033384|duct cell adenocarcinoma of the pancreas|duct cell adenocarcinoma of the pancreas
5408879|NCT00033384|stage IV pancreatic cancer|stage iv pancreatic cancer
5408880|NCT00002752|childhood supratentorial ependymoma|childhood supratentorial ependymoma
5408881|NCT00002752|recurrent childhood brain tumor|recurrent childhood brain tumor
5408882|NCT00002752|recurrent adult brain tumor|recurrent adult brain tumor
5408883|NCT00002752|adult medulloblastoma|adult medulloblastoma
5408884|NCT00002752|adult glioblastoma|adult glioblastoma
5408885|NCT00002752|tumors metastatic to brain|tumors metastatic to brain
5408886|NCT00002752|childhood high-grade cerebral astrocytoma|childhood high-grade cerebral astrocytoma
5408887|NCT00002752|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5408888|NCT00002752|adult myxopapillary ependymoma|adult myxopapillary ependymoma
5408889|NCT00002752|adult anaplastic ependymoma|adult anaplastic ependymoma
5408890|NCT00002752|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
5408891|NCT00002752|adult mixed glioma|adult mixed glioma
5408892|NCT00002752|adult pilocytic astrocytoma|adult pilocytic astrocytoma
5408893|NCT00002752|adult subependymoma|adult subependymoma
5408894|NCT00002752|adult ependymoblastoma|adult ependymoblastoma
5408895|NCT00002752|recurrent childhood supratentorial primitive neuroectodermal tumor|recurrent childhood supratentorial primitive neuroectodermal tumor
5408896|NCT00002752|recurrent childhood cerebellar astrocytoma|recurrent childhood cerebellar astrocytoma
5408897|NCT00002752|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
5408898|NCT00002752|recurrent childhood medulloblastoma|recurrent childhood medulloblastoma
5408899|NCT00002752|newly diagnosed childhood ependymoma|newly diagnosed childhood ependymoma
5408900|NCT00002752|recurrent childhood ependymoma|recurrent childhood ependymoma
5408901|NCT00002752|adult oligodendroglioma|adult oligodendroglioma
5408902|NCT00002752|adult giant cell glioblastoma|adult giant cell glioblastoma
5408903|NCT00002752|adult gliosarcoma|adult gliosarcoma
5408904|NCT00002582|stage I breast cancer|stage i breast cancer
5408905|NCT00002582|stage II breast cancer|stage ii breast cancer
5408906|NCT00002582|stage IIIA breast cancer|stage iiia breast cancer
5408907|NCT00063765|NT-501|nt-501
5408908|NCT00063765|CNTF|cntf
5408909|NCT00063765|Retinitis Pigmentosa|retinitis pigmentosa
5408910|NCT00063765|RP|rp
5408911|NCT00063700|obesity in school aged children|obesity in school aged children
5408912|NCT00063674|exercise|exercise
5408913|NCT00063674|eating|eating
5408914|NCT00063674|dance|dance
5408915|NCT00063674|health education|health education
5408916|NCT00063674|obesity prevention|obesity prevention
5408917|NCT00063674|diabetes prevention|diabetes prevention
5408918|NCT00063674|children|children
5408919|NCT00063648|PTLD|ptld
5408920|NCT00063648|CTL Therapy|ctl therapy
5408921|NCT00063648|Post-transplant lymphoproliferative disorder|post-transplant lymphoproliferative disorder
5408922|NCT00063635|Non alcoholic fatty liver disease|non alcoholic fatty liver disease
5408923|NCT00063622|Non alcoholic steatohepatitis|non alcoholic steatohepatitis
5408924|NCT00063622|Steatohepatitis|steatohepatitis
5408925|NCT00063609|Prostate Cancer|prostate cancer
5408926|NCT00063609|Bone Loss|bone loss
5408927|NCT00063609|Osteoporosis|osteoporosis
5408928|NCT00063609|Bone Mineral Density|bone mineral density
5408929|NCT00063609|Androgen Deprivation Therapy|androgen deprivation therapy
5408930|NCT00063661|fMRI|fmri
5408931|NCT00063661|Brain Activity|brain activity
5408932|NCT00063661|Overlearned|overlearned
5408933|NCT00063661|Dual-Task|dual-task
5408934|NCT00063661|Mechanism|mechanism
5408935|NCT00063661|Parkinson Disease|parkinson disease
5408936|NCT00063661|PD|pd
5408937|NCT00063596|Vitamin A|vitamin a
5408938|NCT00063596|Hepatitis B vaccine|hepatitis b vaccine
5408939|NCT00063596|Immune responses|immune responses
5408940|NCT00063596|T-cell subsets|t-cell subsets
5408941|NCT00063596|Chronic lung disease|chronic lung disease
5408942|NCT00063596|Cytokines, intracytoplasmic|cytokines, intracytoplasmic
5408943|NCT00063596|Antibodies, hepatitis B and tetanus toxoid|antibodies, hepatitis b and tetanus toxoid
5408944|NCT00063583|Kidney disease|kidney disease
5408945|NCT00063570|Cancer of Breast|cancer of breast
5408946|NCT00063570|Cancer of the Breast|cancer of the breast
5408947|NCT00063323|Maintenance treatment|maintenance treatment
5408948|NCT00063323|Smoking relapse|smoking relapse
5408950|NCT00063323|Nicotine replacement|nicotine replacement
5408951|NCT00033319|colon cancer|colon cancer
5408952|NCT00033319|rectal cancer|rectal cancer
5408953|NCT00031954|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
5408954|NCT00031954|stage I ovarian epithelial cancer|stage i ovarian epithelial cancer
5408955|NCT00031954|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5408956|NCT00031954|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5408957|NCT00031954|fallopian tube cancer|fallopian tube cancer
5408958|NCT00031954|primary peritoneal cavity cancer|primary peritoneal cavity cancer
5408959|NCT00031889|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5408960|NCT00031889|stage IV prostate cancer|stage iv prostate cancer
5408961|NCT00031889|recurrent prostate cancer|recurrent prostate cancer
5408962|NCT00031668|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
5408963|NCT00031668|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5408964|NCT00031668|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5408965|NCT00031668|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
5408966|NCT00031668|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5408967|NCT00028938|squamous cell lung cancer|squamous cell lung cancer
5408968|NCT00028938|large cell lung cancer|large cell lung cancer
5408969|NCT00028938|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5408970|NCT00028938|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5408971|NCT00028938|adenocarcinoma of the lung|adenocarcinoma of the lung
5408972|NCT00028938|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
5408973|NCT00063479|Osteogenesis Imperfecta|osteogenesis imperfecta
5408974|NCT00063479|OI|oi
5408975|NCT00063479|bone markers|bone markers
5408976|NCT00063479|fracture|fracture
5408977|NCT00063479|bone loss|bone loss
5408978|NCT00063479|pediatric|pediatric
5408979|NCT00063479|bisphosphonate|bisphosphonate
5408980|NCT00063479|brittle bone disease|brittle bone disease
5408981|NCT00063479|pamidronate|pamidronate
5408982|NCT00028925|extensive stage small cell lung cancer|extensive stage small cell lung cancer
5408983|NCT00028613|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5408984|NCT00063427|Colorectal Cancer|colorectal cancer
5408985|NCT00063427|Colorectal Carcinoma|colorectal carcinoma
5408986|NCT00063427|Colorectal Tumors|colorectal tumors
5408987|NCT00063427|Neoplasms, Colorectal|neoplasms, colorectal
5408988|NCT00063427|Colorectal Neoplasms|colorectal neoplasms
5408989|NCT00063401|ovarian|ovarian
5408990|NCT00063401|primary peritoneal cancer|primary peritoneal cancer
5408991|NCT00063401|fallopian tube cancer|fallopian tube cancer
5408992|NCT00063388|Non|non
5408993|NCT00063388|Small|small
5408994|NCT00063388|Cell|cell
5408995|NCT00063388|Lung|lung
5408996|NCT00063388|Cancer|cancer
5408997|NCT00063362|Depression|depression
5408998|NCT00030446|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5408999|NCT00030446|fallopian tube cancer|fallopian tube cancer
5409000|NCT00030446|peritoneal cavity cancer|peritoneal cavity cancer
5409001|NCT00028483|stage IV breast cancer|stage iv breast cancer
5409002|NCT00028483|recurrent breast cancer|recurrent breast cancer
5409003|NCT00006968|stage III renal cell cancer|stage iii renal cell cancer
5409004|NCT00006968|stage IV renal cell cancer|stage iv renal cell cancer
5409005|NCT00006968|recurrent renal cell cancer|recurrent renal cell cancer
5409006|NCT00003352|stage IV breast cancer|stage iv breast cancer
5409007|NCT00003352|recurrent breast cancer|recurrent breast cancer
5409008|NCT00003352|stage IIIB breast cancer|stage iiib breast cancer
5409009|NCT00063310|Alzheimer disease|alzheimer disease
5409010|NCT00063310|Aging Women|aging women
5409011|NCT00063310|Hormone therapy|hormone therapy
5409012|NCT00063297|schizophrenia with negative symptoms|schizophrenia with negative symptoms
5409013|NCT00040729|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5409014|NCT00063284|Electrical Stimulation|electrical stimulation
5409015|NCT00063284|Human Brain|human brain
5409016|NCT00063284|Parkinson Disease|parkinson disease
5409017|NCT00063284|PD|pd
5409018|NCT00063258|Non-Small Cell Lung Cancer|non-small cell lung cancer
5409019|NCT00063258|Lung Cancer|lung cancer
5409020|NCT00063258|OSI-774|osi-774
5409021|NCT00063258|Tarceva|tarceva
5409022|NCT00063258|Carboplatin|carboplatin
5409023|NCT00063258|Paclitaxel|paclitaxel
5409024|NCT00063258|NSCLC|nsclc
5409025|NCT00063219|Non-Small-Cell Lung Carcinoma|non-small-cell lung carcinoma
5409026|NCT00063219|Lung Cancer|lung cancer
5409027|NCT00063219|Cancer of Lung|cancer of lung
5409028|NCT00063206|Depressive Disorder, Major|depressive disorder, major
5409029|NCT00063206|Depression, Involutional|depression, involutional
5409030|NCT00063193|Parkinson's disease|parkinson's disease
5409031|NCT00063193|minocycline|minocycline
5409032|NCT00063193|creatine|creatine
5409033|NCT00063193|neuroprotection|neuroprotection
5409034|NCT00063154|Lung cancer|lung cancer
5409035|NCT00030797|stage III colon cancer|stage iii colon cancer
5409036|NCT00030797|stage IV colon cancer|stage iv colon cancer
5409037|NCT00030797|stage III rectal cancer|stage iii rectal cancer
5409038|NCT00030797|stage IV rectal cancer|stage iv rectal cancer
5409039|NCT00026520|stage IV melanoma|stage iv melanoma
5409040|NCT00026520|recurrent melanoma|recurrent melanoma
5409041|NCT00026364|stage IV colon cancer|stage iv colon cancer
5409042|NCT00026364|stage IV rectal cancer|stage iv rectal cancer
5409043|NCT00026364|recurrent colon cancer|recurrent colon cancer
5409044|NCT00026364|recurrent rectal cancer|recurrent rectal cancer
5409045|NCT00026364|adenocarcinoma of the colon|adenocarcinoma of the colon
5409046|NCT00026364|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5409047|NCT00026351|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
5409048|NCT00026351|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
5409049|NCT00026351|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5409050|NCT00026351|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5409051|NCT00026351|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5409052|NCT00026351|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
5409053|NCT00026351|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
5409054|NCT00026351|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
5409055|NCT00026351|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
5409056|NCT00026351|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5409057|NCT00026351|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5409058|NCT00026351|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5409059|NCT00026351|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5409060|NCT00026351|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5409061|NCT00026351|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5409062|NCT00026351|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5409063|NCT00026351|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5409064|NCT00026351|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5409065|NCT00026351|prolymphocytic leukemia|prolymphocytic leukemia
5409066|NCT00026351|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
5409067|NCT00026351|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
5409068|NCT00026351|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
5409069|NCT00026351|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5409070|NCT00026351|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5409071|NCT00026351|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5409072|NCT00026351|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
5409073|NCT00026351|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
5409074|NCT00026351|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5409075|NCT00026351|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5409076|NCT00026351|stage I marginal zone lymphoma|stage i marginal zone lymphoma
5409077|NCT00026351|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
5409078|NCT00026351|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5409079|NCT00026351|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5409080|NCT00026351|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5409081|NCT00026351|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5409082|NCT00026351|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
5409083|NCT00026351|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
5409084|NCT00026351|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5409085|NCT00025571|squamous cell lung cancer|squamous cell lung cancer
5409086|NCT00025571|large cell lung cancer|large cell lung cancer
5409087|NCT00025571|adenocarcinoma of the lung|adenocarcinoma of the lung
5409088|NCT00025571|stage I non-small cell lung cancer|stage i non-small cell lung cancer
5409089|NCT00025571|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
5409090|NCT00006013|refractory multiple myeloma|refractory multiple myeloma
5409091|NCT00004037|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5409092|NCT00004037|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5409093|NCT00004037|primary peritoneal cavity cancer|primary peritoneal cavity cancer
5409094|NCT00003054|recurrent uterine sarcoma|recurrent uterine sarcoma
5409095|NCT00003054|uterine leiomyosarcoma|uterine leiomyosarcoma
5409096|NCT00063245|Motor Cortex|motor cortex
5409097|NCT00063245|Mood|mood
5409098|NCT00063245|Reward|reward
5409099|NCT00063245|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
5409100|NCT00063245|Magnetic Coil|magnetic coil
5409101|NCT00063245|Healthy Volunteer|healthy volunteer
5409102|NCT00063245|HV|hv
5409103|NCT00063232|Insulin|insulin
5409104|NCT00063232|Obesity|obesity
5409105|NCT00063232|Fatty Liver|fatty liver
5409106|NCT00063232|Diabetes|diabetes
5409107|NCT00063232|Cirrhosis|cirrhosis
5409108|NCT00063232|Metformin|metformin
5409109|NCT00063232|Insulin Resistance|insulin resistance
5409110|NCT00063232|Nonalcoholic Steatohepatitis|nonalcoholic steatohepatitis
5409111|NCT00063232|Hepatitis|hepatitis
5409112|NCT00063232|NASH|nash
5409113|NCT00063180|Diaschisis|diaschisis
5409114|NCT00063180|Glucose|glucose
5409115|NCT00063180|GABA|gaba
5409116|NCT00063180|N-Acetylaspartate|n-acetylaspartate
5409117|NCT00063180|Glutamate|glutamate
5409119|NCT00063180|Healthy Volunteer|healthy volunteer
5409120|NCT00063180|HV|hv
5409121|NCT00063115|Praxis Movements|praxis movements
5409122|NCT00063115|Pantomime|pantomime
5409123|NCT00063115|Statistical Parametric Mapping|statistical parametric mapping
5409124|NCT00063115|Functional Connectivity|functional connectivity
5409125|NCT00063115|Path Analysis|path analysis
5409126|NCT00063115|Ideomotor Apraxia|ideomotor apraxia
5409127|NCT00063115|Healthy Volunteer|healthy volunteer
5409128|NCT00063115|HV|hv
5409129|NCT00063089|Staphylococcal infection|staphylococcal infection
5409130|NCT00063089|Gram positive bacteria|gram positive bacteria
5409131|NCT00063089|Staphylococcus|staphylococcus
5409132|NCT00063089|Staphylococcus aureus|staphylococcus aureus
5409133|NCT00063076|Alopecia Areata|alopecia areata
5409134|NCT00063076|Alopecia Totalis|alopecia totalis
5409135|NCT00063076|Alopecia Universalis|alopecia universalis
5409136|NCT00063076|Targretin Gel|targretin gel
5409137|NCT00063063|NICHD Neonatal Research Network|nichd neonatal research network
5409138|NCT00063063|Extremely Low Birth Weight (ELBW)|extremely low birth weight (elbw)
5409139|NCT00063063|Prematurity|prematurity
5409140|NCT00063050|Bone density|bone density
5409141|NCT00063050|Children|children
5409142|NCT00063050|Adolescents|adolescents
5409143|NCT00063050|Behavior|behavior
5409144|NCT00063050|Health education|health education
5409145|NCT00063050|Health promotion|health promotion
5409146|NCT00063050|Physical fitness|physical fitness
5409147|NCT00063050|Diet|diet
5409148|NCT00063050|Parent training|parent training
5409149|NCT00063050|Injury control|injury control
5409150|NCT00063037|Bone mass|bone mass
5409151|NCT00063037|Calcium intake|calcium intake
5409152|NCT00063037|Prevention of osteoporosis|prevention of osteoporosis
5409153|NCT00063037|Optimizing peak bone mass|optimizing peak bone mass
5409154|NCT00063037|Bone mineral density|bone mineral density
5409155|NCT00063024|Bone health|bone health
5409156|NCT00063024|Weight-bearing physical activity|weight-bearing physical activity
5409157|NCT00063024|Calcium|calcium
5409158|NCT00063011|Weight-bearing exercise|weight-bearing exercise
5409159|NCT00063011|Calcium-rich diet|calcium-rich diet
5409160|NCT00063011|Adolescents|adolescents
5409161|NCT00063011|Females|females
5409162|NCT00063011|Bone mass|bone mass
5409163|NCT00063011|Osteopenia|osteopenia
5409164|NCT00025545|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5409165|NCT00025545|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5409166|NCT00025545|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5409167|NCT00025545|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5409168|NCT00025545|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5409169|NCT00025545|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
5409170|NCT00025545|acute undifferentiated leukemia|acute undifferentiated leukemia
5409171|NCT00025545|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5409172|NCT00024323|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5409173|NCT00024310|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5409174|NCT00024310|drug/agent toxicity by tissue/organ|drug/agent toxicity by tissue/organ
5409175|NCT00024141|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5409176|NCT00062985|obesity treatment|obesity treatment
5409177|NCT00062985|weight management|weight management
5409178|NCT00062985|managed care|managed care
5409179|NCT00062972|Multiple Sclerosis|multiple sclerosis
5409180|NCT00062972|Cognitive Dysfunction|cognitive dysfunction
5409181|NCT00062972|Treatment Interventions|treatment interventions
5409182|NCT00062972|Verbal memory deficits|verbal memory deficits
5409183|NCT00062959|Adolescence|adolescence
5409184|NCT00062959|Parenting|parenting
5409185|NCT00062959|School|school
5409186|NCT00062959|Primary Prevention|primary prevention
5409187|NCT00062959|School-based intervention|school-based intervention
5409188|NCT00062894|Iodine I 131 Tositumomab|iodine i 131 tositumomab
5409189|NCT00062894|BEXXAR|bexxar
5409190|NCT00062894|non-Hodgkin's lymphoma|non-hodgkin's lymphoma
5409191|NCT00062946|Thalamus|thalamus
5409192|NCT00062946|Cerebral Cortices|cerebral cortices
5409193|NCT00062946|Quantification|quantification
5409194|NCT00062946|Reproducibility|reproducibility
5409195|NCT00062946|Dopamine Release|dopamine release
5409196|NCT00062946|(18F) Fallypride|(18f) fallypride
5409197|NCT00062946|D-Amphetamine|d-amphetamine
5409198|NCT00062946|Alpha-Methyl-Para-Tyrosine (AMPT)|alpha-methyl-para-tyrosine (ampt)
5409199|NCT00062946|PET|pet
5409200|NCT00062946|Dopamine D2 Receptor|dopamine d2 receptor
5409201|NCT00062946|Healthy Volunteer|healthy volunteer
5409202|NCT00062946|HV|hv
5409203|NCT00062933|Clinical Response|clinical response
5409204|NCT00062933|Duration of Response|duration of response
5409205|NCT00062933|Quality of Life|quality of life
5409206|NCT00062933|Hyperthermia|hyperthermia
5409207|NCT00062933|Survival|survival
5409208|NCT00062933|Melanoma|melanoma
5409209|NCT00062933|Ocular Melanoma|ocular melanoma
5409210|NCT00062933|Eye Cancer|eye cancer
5409211|NCT00062881|Cancer|cancer
5409212|NCT00062881|Leukemia|leukemia
5409216|NCT00062868|EBV-T/NK lymphoproliferative disease|ebv-t/nk lymphoproliferative disease
5409217|NCT00062868|Severe Chronic EBV|severe chronic ebv
5409218|NCT00062868|LMP1/2|lmp1/2
5409219|NCT00062868|CTL|ctl
5409220|NCT00062868|EBV|ebv
5409221|NCT00062868|Relapse|relapse
5409222|NCT00062855|GENE MODIFIED AUTOLOGOUS NEUROBLASTOMA CELLS|gene modified autologous neuroblastoma cells
5409223|NCT00062855|Gene Therapy|gene therapy
5409224|NCT00062829|Teen driving|teen driving
5409225|NCT00062829|Adolescent risk behavior|adolescent risk behavior
5409226|NCT00062829|Parenting|parenting
5409227|NCT00062829|Checkpoints Program|checkpoints program
5409228|NCT00062829|Health Education|health education
5409229|NCT00062816|Hepatitis|hepatitis
5409230|NCT00062816|Chronic|chronic
5409231|NCT00002643|neutropenia|neutropenia
5409232|NCT00002643|metastatic Ewing sarcoma/peripheral primitive neuroectodermal tumor|metastatic ewing sarcoma/peripheral primitive neuroectodermal tumor
5409233|NCT00062790|Testosterone|testosterone
5409234|NCT00062790|DHT|dht
5409235|NCT00062790|TURP|turp
5409236|NCT00027612|adult glioblastoma|adult glioblastoma
5409237|NCT00027612|adult giant cell glioblastoma|adult giant cell glioblastoma
5409238|NCT00027612|adult gliosarcoma|adult gliosarcoma
5409239|NCT00025376|stage IV renal cell cancer|stage iv renal cell cancer
5409240|NCT00025376|recurrent renal cell cancer|recurrent renal cell cancer
5409241|NCT00023868|stage IV colon cancer|stage iv colon cancer
5409242|NCT00023868|stage IV rectal cancer|stage iv rectal cancer
5409243|NCT00023868|recurrent colon cancer|recurrent colon cancer
5409244|NCT00023868|recurrent rectal cancer|recurrent rectal cancer
5409245|NCT00023868|adenocarcinoma of the colon|adenocarcinoma of the colon
5409246|NCT00023868|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5409247|NCT00023868|liver metastases|liver metastases
5409248|NCT00022594|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
5409249|NCT00022594|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
5409250|NCT00022594|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
5409251|NCT00022594|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5409252|NCT00022594|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
5409253|NCT00022594|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
5409254|NCT00022594|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5409255|NCT00022594|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
5409256|NCT00022594|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
5409257|NCT00022594|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5409258|NCT00022594|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
5409259|NCT00022594|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
5409260|NCT00022594|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5409261|NCT00022594|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
5409262|NCT00062777|Genetics|genetics
5409263|NCT00062777|Populations|populations
5409264|NCT00062777|CVD Risk|cvd risk
5409265|NCT00062777|Gene Mapping|gene mapping
5409266|NCT00062777|Epidemiology|epidemiology
5409267|NCT00062777|Framingham Study|framingham study
5409268|NCT00062777|Vascular Diseases|vascular diseases
5409269|NCT00062764|Insulin Resistance|insulin resistance
5409270|NCT00062764|Obesity|obesity
5409271|NCT00062764|Fatty Liver|fatty liver
5409272|NCT00062764|Cirrhosis|cirrhosis
5409273|NCT00062764|Diabetes|diabetes
5409274|NCT00062764|Pioglitazone|pioglitazone
5409275|NCT00062764|Thiazolidinediones|thiazolidinediones
5409276|NCT00062764|Peroxisome Proliferator-Advanced Receptor Gamma|peroxisome proliferator-advanced receptor gamma
5409277|NCT00062764|PPAR Gama|ppar gama
5409278|NCT00062764|Nonalcoholic Steatohepatitis|nonalcoholic steatohepatitis
5409279|NCT00062764|Hepatitis|hepatitis
5409280|NCT00062764|Non-Alcoholic Steatohepatitis|non-alcoholic steatohepatitis
5409281|NCT00062764|NASH|nash
5409282|NCT00062751|breast|breast
5409283|NCT00062751|neoplasms|neoplasms
5409284|NCT00062738|Parkinson's disease|parkinson's disease
5409285|NCT00062738|Parkinson disease|parkinson disease
5409286|NCT00062738|depression|depression
5409287|NCT00062738|antidepressants|antidepressants
5409288|NCT00062738|nortriptyline|nortriptyline
5409289|NCT00062738|paroxetine|paroxetine
5409290|NCT00062712|Immunosuppression|immunosuppression
5409291|NCT00062712|Transplant|transplant
5409292|NCT00062712|Kidney Transplant|kidney transplant
5409293|NCT00062686|Lapatinib|lapatinib
5409294|NCT00062686|Metastatic Breast Cancer|metastatic breast cancer
5409295|NCT00062686|HERCEPTIN refractory|herceptin refractory
5409296|NCT00062634|Female condom use|female condom use
5409297|NCT00062634|Male condom use|male condom use
5409298|NCT00062634|AIDS education|aids education
5409299|NCT00062634|AIDS prevention|aids prevention
5409300|NCT00062634|HIV Seronegativity|hiv seronegativity
5409301|NCT00062621|Immune tolerance|immune tolerance
5409302|NCT00062621|Graft vs host disease|graft vs host disease
5409303|NCT00062621|Kidney Failure|kidney failure
5409304|NCT00062621|Kidney diseases|kidney diseases
5409305|NCT00062621|End Stage Renal Disease|end stage renal disease
5409306|NCT00062621|Multiple Myeloma|multiple myeloma
5409307|NCT00062621|Bone Marrow Transplant|bone marrow transplant
5409308|NCT00062621|Kidney Transplant|kidney transplant
5409309|NCT00062621|Renal Transplant|renal transplant
5409310|NCT00062621|Tolerance|tolerance
5409311|NCT00062621|Chimerism|chimerism
5409312|NCT00062621|ESRD|esrd
5409313|NCT00062608|Abdominal|abdominal
5409314|NCT00062595|Menopause|menopause
5409315|NCT00062595|Vitamin K|vitamin k
5409316|NCT00062595|Bone turnover|bone turnover
5409317|NCT00062595|Bone Density|bone density
5409318|NCT00062569|Alzheimer disease|alzheimer disease
5409319|NCT00062569|Resistiveness to baths|resistiveness to baths
5409320|NCT00062569|Caregiver stress|caregiver stress
5409321|NCT00062569|Bathing support intervention|bathing support intervention
5409322|NCT00062569|Reminiscence|reminiscence
5409323|NCT00062569|Agitated behavior|agitated behavior
5409324|NCT00062569|Resistiveness to care|resistiveness to care
5409325|NCT00062556|Intermittent Claudication|intermittent claudication
5409326|NCT00062556|Peripheral Arterial Disease|peripheral arterial disease
5409327|NCT00062556|Atherosclerosis|atherosclerosis
5409328|NCT00062556|Niacin|niacin
5409329|NCT00062556|Lovastatin|lovastatin
5409330|NCT00062556|PAD|pad
5409331|NCT00062556|IC|ic
5409332|NCT00062543|Severe hepatic dysfunction post stem cell transplantation|severe hepatic dysfunction post stem cell transplantation
5409333|NCT00062543|Stem Cell Transplantation|stem cell transplantation
5409334|NCT00062543|Hepatic Artery Infusion|hepatic artery infusion
5409335|NCT00062543|Liver Diseases|liver diseases
5409336|NCT00062543|CD34+ Cells|cd34+ cells
5409337|NCT00062543|SCT|sct
5409338|NCT00062530|AIDS|aids
5409339|NCT00062530|HIV seronegativity|hiv seronegativity
5409340|NCT00062530|HIV preventive vaccine|hiv preventive vaccine
5409341|NCT00022009|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5409342|NCT00022009|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5409343|NCT00022009|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5409344|NCT00018954|stage I childhood lymphoblastic lymphoma|stage i childhood lymphoblastic lymphoma
5409345|NCT00018954|stage II childhood lymphoblastic lymphoma|stage ii childhood lymphoblastic lymphoma
5409346|NCT00018954|stage III childhood lymphoblastic lymphoma|stage iii childhood lymphoblastic lymphoma
5409347|NCT00018954|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
5409348|NCT00018954|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
5409349|NCT00018954|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
5409350|NCT00018954|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
5409351|NCT00018954|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
5409352|NCT00018954|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
5409353|NCT00018954|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
5409354|NCT00018954|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
5409355|NCT00018954|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
5409356|NCT00018954|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5409357|NCT00018954|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5409358|NCT00018954|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5409359|NCT00018954|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5409360|NCT00018954|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5409361|NCT00018954|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5409362|NCT00018954|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5409363|NCT00018954|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5409364|NCT00018954|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5409365|NCT00018954|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5409366|NCT00018954|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5409367|NCT00018954|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5409368|NCT00018954|stage I childhood small noncleaved cell lymphoma|stage i childhood small noncleaved cell lymphoma
5409369|NCT00018954|stage I childhood large cell lymphoma|stage i childhood large cell lymphoma
5409370|NCT00018954|stage II childhood small noncleaved cell lymphoma|stage ii childhood small noncleaved cell lymphoma
5409371|NCT00018954|stage II childhood large cell lymphoma|stage ii childhood large cell lymphoma
5409372|NCT00018954|stage III childhood small noncleaved cell lymphoma|stage iii childhood small noncleaved cell lymphoma
5409373|NCT00018954|stage III childhood large cell lymphoma|stage iii childhood large cell lymphoma
5409374|NCT00018954|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
5409375|NCT00018954|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
5409376|NCT00018954|stage I mantle cell lymphoma|stage i mantle cell lymphoma
5409377|NCT00018954|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
5433360|NCT00005758|RNA, Viral|rna, viral
5409378|NCT00018954|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
5409379|NCT00018954|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
5409380|NCT00018954|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
5409381|NCT00018954|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
5409382|NCT00018954|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
5409383|NCT00018954|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
5409384|NCT00018954|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
5409385|NCT00018954|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5409386|NCT00018954|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
5409387|NCT00018954|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
5409388|NCT00018954|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5409389|NCT00018954|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
5409390|NCT00018954|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
5409391|NCT00018954|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5409392|NCT00018954|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5409393|NCT00018954|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
5409394|NCT00018954|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
5409395|NCT00018954|stage I marginal zone lymphoma|stage i marginal zone lymphoma
5409396|NCT00018954|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
5409397|NCT00018954|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5409398|NCT00018954|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5409399|NCT00018954|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5409400|NCT00018954|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5409401|NCT00018954|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
5409402|NCT00018954|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
5409403|NCT00018954|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5409404|NCT00018954|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5409405|NCT00018954|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5409406|NCT00017446|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
5409407|NCT00017446|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
5409408|NCT00017446|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
5409409|NCT00017316|stage IV melanoma|stage iv melanoma
5409410|NCT00017316|recurrent melanoma|recurrent melanoma
5409411|NCT00062582|Roflumilast|roflumilast
5409412|NCT00062582|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5409413|NCT00062582|COPD|copd
5409414|NCT00014664|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5409415|NCT00014664|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5409416|NCT00014664|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5409417|NCT00014664|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5409418|NCT00014664|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5409419|NCT00014664|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5409420|NCT00014534|stage III bladder cancer|stage iii bladder cancer
5409421|NCT00014534|stage IV bladder cancer|stage iv bladder cancer
5409422|NCT00014534|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
5409423|NCT00062517|Amygdala|amygdala
5409424|NCT00062517|Generalized Anxiety Disorder|generalized anxiety disorder
5409425|NCT00062517|Anxiety Disorder|anxiety disorder
5409426|NCT00062517|GAD|gad
5409427|NCT00062517|Social Anxiety Disorder|social anxiety disorder
5409428|NCT00062517|SAD|sad
5409429|NCT00012155|stage IV colon cancer|stage iv colon cancer
5409430|NCT00012155|recurrent colon cancer|recurrent colon cancer
5409431|NCT00012155|adenocarcinoma of the colon|adenocarcinoma of the colon
5409432|NCT00012155|liver metastases|liver metastases
5409433|NCT00062465|DMARD|dmard
5409434|NCT00062465|Clinical Trial|clinical trial
5409435|NCT00062465|Thunder God Vine|thunder god vine
5409436|NCT00062465|Chinese Herb|chinese herb
5409437|NCT00062465|Rheumatoid Arthritis|rheumatoid arthritis
5409438|NCT00062465|RA|ra
5409439|NCT00062452|Esophageal|esophageal
5409440|NCT00062452|Airway|airway
5409441|NCT00062439|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
5409442|NCT00062439|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5409443|NCT00062439|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5409444|NCT00062426|adenocarcinoma of the colon|adenocarcinoma of the colon
5409445|NCT00062426|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5409446|NCT00062426|recurrent colon cancer|recurrent colon cancer
5409447|NCT00062426|stage IV colon cancer|stage iv colon cancer
5409448|NCT00062426|recurrent rectal cancer|recurrent rectal cancer
5409449|NCT00062426|stage IV rectal cancer|stage iv rectal cancer
5409450|NCT00062400|sexual dysfunction and infertility|sexual dysfunction and infertility
5409451|NCT00062400|sexuality and reproductive issues|sexuality and reproductive issues
5409452|NCT00062400|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
5409453|NCT00062400|stage II breast cancer|stage ii breast cancer
5409454|NCT00062400|stage IA breast cancer|stage ia breast cancer
5409455|NCT00062400|stage IB breast cancer|stage ib breast cancer
5409456|NCT00062387|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5409457|NCT00062387|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5409458|NCT00062387|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5409459|NCT00062387|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
5409460|NCT00062387|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5409461|NCT00062387|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
5409462|NCT00062387|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
5409463|NCT00062387|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
5409464|NCT00062387|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
5409465|NCT00062387|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
5409466|NCT00062387|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
5409467|NCT00062387|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
5409468|NCT00062387|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
5409469|NCT00062387|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
5409470|NCT00062387|recurrent salivary gland cancer|recurrent salivary gland cancer
5409471|NCT00062387|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
5409472|NCT00062387|stage IV salivary gland cancer|stage iv salivary gland cancer
5409473|NCT00062348|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
5409474|NCT00062348|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
5409475|NCT00062348|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
5409476|NCT00062348|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
5409477|NCT00062348|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
5409478|NCT00062348|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
5409479|NCT00062348|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5409480|NCT00062348|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5409481|NCT00062348|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5409482|NCT00062348|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
5409483|NCT00062348|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5409484|NCT00062348|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
5409485|NCT00062348|untreated metastatic squamous neck cancer with occult primary|untreated metastatic squamous neck cancer with occult primary
5409486|NCT00062348|recurrent thyroid cancer|recurrent thyroid cancer
5409487|NCT00062348|stage IV follicular thyroid cancer|stage iv follicular thyroid cancer
5409488|NCT00062348|stage IV papillary thyroid cancer|stage iv papillary thyroid cancer
5409489|NCT00062348|stage IVA colon cancer|stage iva colon cancer
5409490|NCT00062348|stage IVB colon cancer|stage ivb colon cancer
5409491|NCT00062348|recurrent colon cancer|recurrent colon cancer
5409492|NCT00062348|adenocarcinoma of the colon|adenocarcinoma of the colon
5409493|NCT00062348|recurrent rectal cancer|recurrent rectal cancer
5409494|NCT00062348|stage IVA rectal cancer|stage iva rectal cancer
5409495|NCT00062348|stage IVB rectal cancer|stage ivb rectal cancer
5409496|NCT00062348|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5409497|NCT00062348|anaplastic thyroid cancer|anaplastic thyroid cancer
5409498|NCT00062348|insular thyroid cancer|insular thyroid cancer
5409499|NCT00062348|thyroid gland medullary carcinoma|thyroid gland medullary carcinoma
5409500|NCT00062348|liver metastases|liver metastases
5409501|NCT00062348|stage I squamous cell carcinoma of the hypopharynx|stage i squamous cell carcinoma of the hypopharynx
5409502|NCT00062348|stage I squamous cell carcinoma of the larynx|stage i squamous cell carcinoma of the larynx
5409503|NCT00062348|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
5409504|NCT00062348|stage I squamous cell carcinoma of the nasopharynx|stage i squamous cell carcinoma of the nasopharynx
5409505|NCT00062348|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
5409506|NCT00062348|stage I squamous cell carcinoma of the paranasal sinus and nasal cavity|stage i squamous cell carcinoma of the paranasal sinus and nasal cavity
5409507|NCT00062348|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
5409508|NCT00062348|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
5409574|NCT00062257|recurrent gastric cancer|recurrent gastric cancer
5409509|NCT00062348|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
5409510|NCT00062348|stage II squamous cell carcinoma of the nasopharynx|stage ii squamous cell carcinoma of the nasopharynx
5409511|NCT00062348|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
5409512|NCT00062348|stage II squamous cell carcinoma of the paranasal sinus and nasal cavity|stage ii squamous cell carcinoma of the paranasal sinus and nasal cavity
5409513|NCT00062348|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
5409514|NCT00062348|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
5409515|NCT00062348|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
5409516|NCT00062348|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
5409517|NCT00062348|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
5409518|NCT00062348|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
5409519|NCT00062348|stage I papillary thyroid cancer|stage i papillary thyroid cancer
5409520|NCT00062348|stage II papillary thyroid cancer|stage ii papillary thyroid cancer
5409521|NCT00062348|stage III papillary thyroid cancer|stage iii papillary thyroid cancer
5409522|NCT00062348|stage I follicular thyroid cancer|stage i follicular thyroid cancer
5409523|NCT00062348|stage II follicular thyroid cancer|stage ii follicular thyroid cancer
5409524|NCT00062348|stage III follicular thyroid cancer|stage iii follicular thyroid cancer
5409525|NCT00062348|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
5409526|NCT00062348|recurrent salivary gland cancer|recurrent salivary gland cancer
5409527|NCT00062348|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
5409528|NCT00062348|stage I salivary gland cancer|stage i salivary gland cancer
5409529|NCT00062348|stage II salivary gland cancer|stage ii salivary gland cancer
5409530|NCT00062348|stage III salivary gland cancer|stage iii salivary gland cancer
5409531|NCT00062348|stage IV salivary gland cancer|stage iv salivary gland cancer
5409532|NCT00062348|tongue cancer|tongue cancer
5409533|NCT00062335|stage I non-small cell lung cancer|stage i non-small cell lung cancer
5409534|NCT00062335|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
5409535|NCT00062335|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5409536|NCT00062322|limited stage small cell lung cancer|limited stage small cell lung cancer
5409537|NCT00062309|stage II prostate cancer|stage ii prostate cancer
5409538|NCT00062309|stage III prostate cancer|stage iii prostate cancer
5409539|NCT00062309|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5409540|NCT00062296|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
5409541|NCT00062296|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5409542|NCT00062296|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5409543|NCT00062296|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5409544|NCT00062296|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5409545|NCT00062296|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5409546|NCT00062296|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5409547|NCT00062296|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5409548|NCT00062296|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5409549|NCT00062296|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5409550|NCT00062296|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5409551|NCT00062296|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5409552|NCT00062296|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5409553|NCT00062296|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5409554|NCT00062296|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5409555|NCT00062296|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5409556|NCT00062296|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5409557|NCT00062283|advanced malignant mesothelioma|advanced malignant mesothelioma
5409558|NCT00062283|recurrent malignant mesothelioma|recurrent malignant mesothelioma
5409559|NCT00062283|metastatic osteosarcoma|metastatic osteosarcoma
5409560|NCT00062283|recurrent osteosarcoma|recurrent osteosarcoma
5409561|NCT00062283|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
5409562|NCT00062283|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
5409563|NCT00062283|chondrosarcoma|chondrosarcoma
5409564|NCT00062283|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5409565|NCT00062283|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5409566|NCT00062283|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5409567|NCT00062283|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
5409568|NCT00062283|recurrent pancreatic cancer|recurrent pancreatic cancer
5409569|NCT00062283|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
5409570|NCT00062283|stage II adult soft tissue sarcoma|stage ii adult soft tissue sarcoma
5409571|NCT00062283|stage IV pancreatic cancer|stage iv pancreatic cancer
5409572|NCT00062270|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5409573|NCT00062270|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5433755|NCT00002433|Aerosols|aerosols
5409575|NCT00062257|stage IV gastric cancer|stage iv gastric cancer
5409576|NCT00062257|adenocarcinoma of the stomach|adenocarcinoma of the stomach
5409577|NCT00062231|infection|infection
5409578|NCT00062231|neutropenia|neutropenia
5409579|NCT00062231|fever, sweats, and hot flashes|fever, sweats, and hot flashes
5409580|NCT00062231|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5409581|NCT00062231|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
5409582|NCT00062231|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
5409583|NCT00062231|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5409584|NCT00062231|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5409585|NCT00062231|monoclonal gammopathy of undetermined significance|monoclonal gammopathy of undetermined significance
5409586|NCT00062231|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5409587|NCT00062231|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
5409588|NCT00062231|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
5409589|NCT00062231|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
5409590|NCT00062231|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
5409591|NCT00062231|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5409592|NCT00062231|isolated plasmacytoma of bone|isolated plasmacytoma of bone
5409593|NCT00062231|extramedullary plasmacytoma|extramedullary plasmacytoma
5410084|NCT00061386|Physical activity|physical activity
5409594|NCT00062231|refractory multiple myeloma|refractory multiple myeloma
5409595|NCT00062231|stage 0 chronic lymphocytic leukemia|stage 0 chronic lymphocytic leukemia
5409596|NCT00062231|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
5409597|NCT00062231|stage I multiple myeloma|stage i multiple myeloma
5409598|NCT00062231|stage II multiple myeloma|stage ii multiple myeloma
5409599|NCT00062231|stage III multiple myeloma|stage iii multiple myeloma
5409600|NCT00062231|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
5409601|NCT00062231|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
5409602|NCT00062231|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5409603|NCT00062231|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5409604|NCT00062231|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5409605|NCT00062231|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5409606|NCT00062231|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5409607|NCT00062231|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5409608|NCT00062231|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5409609|NCT00062231|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5409610|NCT00062231|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
5409611|NCT00062231|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5409612|NCT00062231|polycythemia vera|polycythemia vera
5409613|NCT00062231|primary myelofibrosis|primary myelofibrosis
5409614|NCT00062231|essential thrombocythemia|essential thrombocythemia
5409615|NCT00062231|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
5409616|NCT00062231|refractory hairy cell leukemia|refractory hairy cell leukemia
5409617|NCT00062231|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
5409618|NCT00062231|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
5409619|NCT00062231|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
5409620|NCT00062231|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5409621|NCT00062231|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5409622|NCT00062231|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5409623|NCT00062231|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5409624|NCT00062231|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5409625|NCT00062231|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5409626|NCT00062231|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
5409627|NCT00062231|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
5409628|NCT00062231|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
5409629|NCT00062231|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5409630|NCT00062231|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5409631|NCT00062231|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5409632|NCT00062231|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5409633|NCT00062231|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5409634|NCT00062231|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5409635|NCT00062231|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
5409636|NCT00062231|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
5409637|NCT00062231|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
5409638|NCT00062231|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
5409639|NCT00062231|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5409640|NCT00062231|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
5409641|NCT00062231|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
5409642|NCT00062231|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
5409643|NCT00062231|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5409644|NCT00062231|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5409645|NCT00062231|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5409646|NCT00062231|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5409647|NCT00062231|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
5409648|NCT00062231|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
5409649|NCT00062231|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
5409650|NCT00062231|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
5409651|NCT00062231|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5409652|NCT00062231|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5409653|NCT00062231|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5409654|NCT00062231|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5409655|NCT00062231|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5409656|NCT00062231|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5409657|NCT00062231|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5409658|NCT00062231|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5409659|NCT00062231|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
5409660|NCT00062231|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
5409661|NCT00062231|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5409662|NCT00062231|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
5409663|NCT00062231|acute undifferentiated leukemia|acute undifferentiated leukemia
5409664|NCT00062231|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5409665|NCT00062231|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5409666|NCT00062231|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5409667|NCT00062231|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5409668|NCT00062231|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5409669|NCT00062231|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5409670|NCT00062231|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
5409671|NCT00062231|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
5409672|NCT00062231|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
5409673|NCT00062231|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
5409674|NCT00062231|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
5409675|NCT00062231|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5409676|NCT00062231|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5409677|NCT00062231|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5409678|NCT00062231|prolymphocytic leukemia|prolymphocytic leukemia
5409679|NCT00062231|primary systemic amyloidosis|primary systemic amyloidosis
5409680|NCT00062231|intraocular lymphoma|intraocular lymphoma
5409681|NCT00062231|stage I mantle cell lymphoma|stage i mantle cell lymphoma
5409682|NCT00062231|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5409683|NCT00062231|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5409684|NCT00062231|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
5409685|NCT00062231|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5409686|NCT00062231|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5409687|NCT00062231|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5409688|NCT00062231|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
5409689|NCT00062231|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5409690|NCT00062231|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
5409691|NCT00062231|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
5409692|NCT00062231|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
5409693|NCT00062231|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
5409694|NCT00062231|chronic eosinophilic leukemia|chronic eosinophilic leukemia
5409695|NCT00062231|chronic neutrophilic leukemia|chronic neutrophilic leukemia
5409696|NCT00062231|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5409697|NCT00062231|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5409698|NCT00062231|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
5409699|NCT00062231|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
5409700|NCT00062231|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
5409701|NCT00062231|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
5409702|NCT00062231|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
5409703|NCT00062231|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
5409704|NCT00062231|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
5409705|NCT00062231|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
5409706|NCT00062231|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
5409707|NCT00062231|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
5409708|NCT00062231|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5409709|NCT00062231|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5409710|NCT00062231|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5409711|NCT00062231|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5409712|NCT00062231|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5409713|NCT00062231|stage I marginal zone lymphoma|stage i marginal zone lymphoma
5409714|NCT00062231|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
5409715|NCT00062231|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5409716|NCT00062231|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5409717|NCT00062231|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5409718|NCT00062231|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5409719|NCT00062231|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5409720|NCT00062231|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5409721|NCT00062231|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5409722|NCT00062231|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5409723|NCT00062231|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5409724|NCT00062205|recurrent Ewing sarcoma/peripheral primitive neuroectodermal tumor|recurrent ewing sarcoma/peripheral primitive neuroectodermal tumor
5409725|NCT00062179|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5409726|NCT00062166|Imaging Studies|imaging studies
5409727|NCT00062166|Rate of Tumor Growth|rate of tumor growth
5409728|NCT00062166|Familial Cancer Syndrome|familial cancer syndrome
5409729|NCT00062166|Surgical Resection|surgical resection
5409730|NCT00062140|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5409731|NCT00062140|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5409732|NCT00062140|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5409733|NCT00062140|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5409734|NCT00062140|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5409735|NCT00062140|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5409736|NCT00062140|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5409737|NCT00062140|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5409738|NCT00062140|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5409739|NCT00062140|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5409740|NCT00062140|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5409741|NCT00062140|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5409742|NCT00062140|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5409743|NCT00062140|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
5409744|NCT00062140|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
5409745|NCT00062140|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
5409746|NCT00062140|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
5409747|NCT00062140|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5409748|NCT00062140|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5409749|NCT00062140|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5409750|NCT00062140|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5409751|NCT00062140|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5409752|NCT00062140|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5409753|NCT00062140|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5409754|NCT00062140|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
5409755|NCT00062140|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5409756|NCT00062140|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5409757|NCT00062140|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5409758|NCT00062140|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
5409759|NCT00062140|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5409760|NCT00062140|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5409761|NCT00062140|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5409762|NCT00062140|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5409763|NCT00062140|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
5409764|NCT00062140|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5409765|NCT00062140|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5409766|NCT00062140|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5409767|NCT00062140|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5409768|NCT00062140|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5409769|NCT00062140|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5409770|NCT00062140|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5409771|NCT00062140|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5409772|NCT00062140|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5409773|NCT00062140|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5409774|NCT00062140|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5409775|NCT00062140|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5409776|NCT00062140|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5409777|NCT00062140|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5409778|NCT00062140|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5409779|NCT00062140|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5409780|NCT00062140|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5409781|NCT00062140|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5409782|NCT00062140|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5409783|NCT00062140|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5409784|NCT00062140|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5409785|NCT00062140|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
5409786|NCT00062140|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
5409787|NCT00062140|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
5409788|NCT00062140|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
5409789|NCT00062140|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
5409790|NCT00062140|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5409791|NCT00062140|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5409792|NCT00062140|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5409793|NCT00062140|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5409794|NCT00062140|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5409795|NCT00062140|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5409796|NCT00062140|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5409797|NCT00062140|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5409798|NCT00062140|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5409799|NCT00062140|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5409800|NCT00062140|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5409801|NCT00062140|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5409802|NCT00062140|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5409803|NCT00062140|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5409804|NCT00062114|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5409805|NCT00062114|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5409806|NCT00062114|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5409807|NCT00062062|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5409808|NCT00062062|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5409809|NCT00062049|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5409810|NCT00062036|stage IV melanoma|stage iv melanoma
5409811|NCT00062036|recurrent melanoma|recurrent melanoma
5409812|NCT00062023|colorectal cancer|colorectal cancer
5409813|NCT00062023|stage I colon cancer|stage i colon cancer
5409814|NCT00062023|stage II colon cancer|stage ii colon cancer
5409815|NCT00062023|stage III colon cancer|stage iii colon cancer
5409816|NCT00062023|stage IV colon cancer|stage iv colon cancer
5409817|NCT00062010|recurrent small cell lung cancer|recurrent small cell lung cancer
5409818|NCT00061997|non-small cell lung cancer|non-small cell lung cancer
5409819|NCT00061997|small cell lung cancer|small cell lung cancer
5409820|NCT00061997|precancerous condition|precancerous condition
5409821|NCT00061984|adult angiosarcoma|adult angiosarcoma
5409822|NCT00061984|adult epithelioid sarcoma|adult epithelioid sarcoma
5409823|NCT00061984|adult fibrosarcoma|adult fibrosarcoma
5409824|NCT00061984|adult leiomyosarcoma|adult leiomyosarcoma
5409825|NCT00061984|adult liposarcoma|adult liposarcoma
5409826|NCT00061984|adult rhabdomyosarcoma|adult rhabdomyosarcoma
5409827|NCT00061984|adult synovial sarcoma|adult synovial sarcoma
5409828|NCT00061984|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
5409829|NCT00061984|adult malignant fibrous histiocytoma|adult malignant fibrous histiocytoma
5409830|NCT00061984|adult neurofibrosarcoma|adult neurofibrosarcoma
5409831|NCT00061984|stage II adult soft tissue sarcoma|stage ii adult soft tissue sarcoma
5409832|NCT00061984|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
5409833|NCT00061919|extensive stage small cell lung cancer|extensive stage small cell lung cancer
5409834|NCT00061919|limited stage small cell lung cancer|limited stage small cell lung cancer
5409835|NCT00061906|insular thyroid cancer|insular thyroid cancer
5409836|NCT00061906|recurrent thyroid cancer|recurrent thyroid cancer
5409837|NCT00061906|stage II follicular thyroid cancer|stage ii follicular thyroid cancer
5409838|NCT00061906|stage II papillary thyroid cancer|stage ii papillary thyroid cancer
5409839|NCT00061906|stage IV follicular thyroid cancer|stage iv follicular thyroid cancer
5409840|NCT00061906|stage IV papillary thyroid cancer|stage iv papillary thyroid cancer
5409841|NCT00061893|metastatic Ewing sarcoma/peripheral primitive neuroectodermal tumor|metastatic ewing sarcoma/peripheral primitive neuroectodermal tumor
5409842|NCT00061880|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5409843|NCT00061880|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
5409844|NCT00061880|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
5409845|NCT00061880|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
5409846|NCT00061880|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
5409847|NCT00061880|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5409848|NCT00061880|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
5409849|NCT00061880|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
5409850|NCT00061880|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
5409851|NCT00061880|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
5409852|NCT00061867|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5409853|NCT00061867|stage III prostate cancer|stage iii prostate cancer
5409854|NCT00061867|stage IV prostate cancer|stage iv prostate cancer
5409855|NCT00061854|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5409856|NCT00061854|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5409857|NCT00061854|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5409858|NCT00061854|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5409859|NCT00010231|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5409860|NCT00010231|stage III prostate cancer|stage iii prostate cancer
5409861|NCT00010231|stage IV prostate cancer|stage iv prostate cancer
5409862|NCT00010231|recurrent prostate cancer|recurrent prostate cancer
5409863|NCT00010114|childhood central nervous system germ cell tumor|childhood central nervous system germ cell tumor
5409864|NCT00010114|childhood choroid plexus tumor|childhood choroid plexus tumor
5409865|NCT00010114|untreated childhood supratentorial primitive neuroectodermal tumor|untreated childhood supratentorial primitive neuroectodermal tumor
5409866|NCT00010114|untreated childhood medulloblastoma|untreated childhood medulloblastoma
5409867|NCT00010114|newly diagnosed childhood ependymoma|newly diagnosed childhood ependymoma
5409868|NCT00009932|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5409869|NCT00009802|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5409870|NCT00009789|stage I non-small cell lung cancer|stage i non-small cell lung cancer
5409871|NCT00009789|squamous cell lung cancer|squamous cell lung cancer
5409872|NCT00009789|large cell lung cancer|large cell lung cancer
5409873|NCT00009789|adenocarcinoma of the lung|adenocarcinoma of the lung
5409874|NCT00009789|adenosquamous cell lung cancer|adenosquamous cell lung cancer
5409875|NCT00009789|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
5409876|NCT00008424|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
5409877|NCT00008398|stage I nasopharyngeal cancer|stage i nasopharyngeal cancer
5409878|NCT00008398|stage II nasopharyngeal cancer|stage ii nasopharyngeal cancer
5409879|NCT00008398|stage III nasopharyngeal cancer|stage iii nasopharyngeal cancer
5409880|NCT00008398|stage IV nasopharyngeal cancer|stage iv nasopharyngeal cancer
5409881|NCT00008398|recurrent nasopharyngeal cancer|recurrent nasopharyngeal cancer
5409882|NCT00008398|stage 0 paranasal sinus and nasal cavity cancer|stage 0 paranasal sinus and nasal cavity cancer
5409883|NCT00008398|stage 0 nasopharyngeal cancer|stage 0 nasopharyngeal cancer
5409884|NCT00008398|stage 0 oropharyngeal cancer|stage 0 oropharyngeal cancer
5409885|NCT00008398|stage 0 laryngeal cancer|stage 0 laryngeal cancer
5409886|NCT00008398|stage 0 hypopharyngeal cancer|stage 0 hypopharyngeal cancer
5409887|NCT00008398|untreated metastatic squamous neck cancer with occult primary|untreated metastatic squamous neck cancer with occult primary
5409888|NCT00008398|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
5409889|NCT00008398|stage 0 lip and oral cavity cancer|stage 0 lip and oral cavity cancer
5409890|NCT00008398|stage I lip and oral cavity cancer|stage i lip and oral cavity cancer
5409891|NCT00008398|stage II lip and oral cavity cancer|stage ii lip and oral cavity cancer
5409892|NCT00008398|stage III lip and oral cavity cancer|stage iii lip and oral cavity cancer
5409893|NCT00008398|stage IV lip and oral cavity cancer|stage iv lip and oral cavity cancer
5409894|NCT00008398|recurrent lip and oral cavity cancer|recurrent lip and oral cavity cancer
5409895|NCT00008398|stage I hypopharyngeal cancer|stage i hypopharyngeal cancer
5409896|NCT00008398|stage II hypopharyngeal cancer|stage ii hypopharyngeal cancer
5409897|NCT00008398|stage III hypopharyngeal cancer|stage iii hypopharyngeal cancer
5409898|NCT00008398|stage IV hypopharyngeal cancer|stage iv hypopharyngeal cancer
5409899|NCT00008398|recurrent hypopharyngeal cancer|recurrent hypopharyngeal cancer
5409900|NCT00008398|stage I paranasal sinus and nasal cavity cancer|stage i paranasal sinus and nasal cavity cancer
5409901|NCT00008398|stage II paranasal sinus and nasal cavity cancer|stage ii paranasal sinus and nasal cavity cancer
5409902|NCT00008398|stage III paranasal sinus and nasal cavity cancer|stage iii paranasal sinus and nasal cavity cancer
5409903|NCT00008398|stage IV paranasal sinus and nasal cavity cancer|stage iv paranasal sinus and nasal cavity cancer
5409904|NCT00008398|recurrent paranasal sinus and nasal cavity cancer|recurrent paranasal sinus and nasal cavity cancer
5409905|NCT00008398|stage I oropharyngeal cancer|stage i oropharyngeal cancer
5409906|NCT00008398|stage II oropharyngeal cancer|stage ii oropharyngeal cancer
5409907|NCT00008398|stage III oropharyngeal cancer|stage iii oropharyngeal cancer
5409908|NCT00008398|stage IV oropharyngeal cancer|stage iv oropharyngeal cancer
5409909|NCT00008398|recurrent oropharyngeal cancer|recurrent oropharyngeal cancer
5409910|NCT00008398|oral complications|oral complications
5409911|NCT00008398|radiation toxicity|radiation toxicity
5409912|NCT00008203|stage II breast cancer|stage ii breast cancer
5409913|NCT00008203|stage IIIA breast cancer|stage iiia breast cancer
5409914|NCT00008203|stage IIIB breast cancer|stage iiib breast cancer
5409915|NCT00008112|stage III cervical cancer|stage iii cervical cancer
5409916|NCT00008112|stage IIB cervical cancer|stage iib cervical cancer
5409917|NCT00008112|stage IVA cervical cancer|stage iva cervical cancer
5409918|NCT00008112|cervical squamous cell carcinoma|cervical squamous cell carcinoma
5409919|NCT00008112|cervical adenocarcinoma|cervical adenocarcinoma
5409920|NCT00008112|cervical adenosquamous cell carcinoma|cervical adenosquamous cell carcinoma
5409921|NCT00061789|Schizophrenia|schizophrenia
5409922|NCT00061789|SPECT|spect
5409923|NCT00061789|Nicotinic Acetylcholine Receptors|nicotinic acetylcholine receptors
5409924|NCT00061789|Cigarette Smoking|cigarette smoking
5409925|NCT00061789|Cognitive Dysfunction|cognitive dysfunction
5409926|NCT00061789|Reproducibility|reproducibility
5409927|NCT00061789|Quantification|quantification
5409928|NCT00061789|Healthy Volunteer|healthy volunteer
5409929|NCT00061789|HV|hv
5409930|NCT00061776|Dermal assessment|dermal assessment
5409931|NCT00061776|Pain measurement|pain measurement
5409932|NCT00061776|Diary|diary
5409933|NCT00061776|Shingles|shingles
5409934|NCT00061776|Neuropathy|neuropathy
5409935|NCT00061776|Analgesics/*therapeutic use|analgesics/*therapeutic use
5409936|NCT00061776|Capsaicin/*administration & dosage/adverse effects|capsaicin/*administration & dosage/adverse effects
5409937|NCT00061776|Herpes Zoster/*complications/drug therapy|herpes zoster/*complications/drug therapy
5409938|NCT00061776|Neuralgia/*drug therapy/etiology|neuralgia/*drug therapy/etiology
5409939|NCT00061776|Pain|pain
5409940|NCT00061776|Peripheral Nervous System Diseases/*complications|peripheral nervous system diseases/*complications
5409941|NCT00061763|beta-thalassemia|beta-thalassemia
5409942|NCT00061763|iron overload|iron overload
5409943|NCT00061763|deferoxamine|deferoxamine
5409944|NCT00061763|Myelodysplastic Syndromes|myelodysplastic syndromes
5409945|NCT00061763|Fanconi Syndrome|fanconi syndrome
5409946|NCT00061763|Anemia, Diamond-Blackfan|anemia, diamond-blackfan
5409947|NCT00061763|Anemia, Aplastic|anemia, aplastic
5409948|NCT00061750|Thalassemia, iron overload, deferoxamine, hemosiderosis|thalassemia, iron overload, deferoxamine, hemosiderosis
5409949|NCT00061737|Pediatric IBD|pediatric ibd
5409950|NCT00061737|Inflammatory|inflammatory
5409951|NCT00061737|Bowel|bowel
5409952|NCT00061724|Esophageal|esophageal
5409953|NCT00061724|Reflux|reflux
5409954|NCT00061672|Non-Hodgkin's Lymphoma (NHL)|non-hodgkin's lymphoma (nhl)
5409955|NCT00061672|Hodgkin's Lymphoma (HL)|hodgkin's lymphoma (hl)
5409956|NCT00061659|high grade locally advanced/metastatic soft tissue sarcoma|high grade locally advanced/metastatic soft tissue sarcoma
5409957|NCT00061646|Stage IIIb with pleural effusion or IV NSCLC|stage iiib with pleural effusion or iv nsclc
5409958|NCT00051714|Social Behavior Disorders|social behavior disorders
5409959|NCT00061620|Investigational|investigational
5409960|NCT00061620|Chemotherapy|chemotherapy
5409961|NCT00061620|Hematologic Malignancies|hematologic malignancies
5409962|NCT00061620|Nucleoside analogue|nucleoside analogue
5409963|NCT00059462|Treatment experienced|treatment experienced
5409964|NCT00008021|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5409965|NCT00008021|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5409966|NCT00008021|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5409967|NCT00008021|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5409968|NCT00008021|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5409969|NCT00008021|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5409970|NCT00008021|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5409971|NCT00008021|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5409972|NCT00008021|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5409973|NCT00008021|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5409974|NCT00008021|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5409975|NCT00008021|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5409976|NCT00008021|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5409977|NCT00008021|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5409978|NCT00008021|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5409979|NCT00006864|stage IV renal cell cancer|stage iv renal cell cancer
5409980|NCT00006864|recurrent renal cell cancer|recurrent renal cell cancer
5409981|NCT00006864|clear cell renal cell carcinoma|clear cell renal cell carcinoma
5409982|NCT00006484|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5409983|NCT00006484|squamous cell lung cancer|squamous cell lung cancer
5409984|NCT00006484|large cell lung cancer|large cell lung cancer
5409985|NCT00006484|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5409986|NCT00006484|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5409987|NCT00006484|adenocarcinoma of the lung|adenocarcinoma of the lung
5409988|NCT00061607|Motor Neuron Disease|motor neuron disease
5409989|NCT00061607|Neuromuscular Disease|neuromuscular disease
5409990|NCT00061607|Histone Deacytelase Inhibitors|histone deacytelase inhibitors
5409991|NCT00061607|Spinal Muscular Atrophy|spinal muscular atrophy
5409993|NCT00061594|Neovascular age-related macular degeneration|neovascular age-related macular degeneration
5409994|NCT00061542|Glaucoma|glaucoma
5409995|NCT00061542|Ocular Hypertension|ocular hypertension
5409996|NCT00061529|Open-Angle Glaucoma|open-angle glaucoma
5409997|NCT00061529|Ocular Hypertension|ocular hypertension
5409998|NCT00061516|Glaucoma|glaucoma
5409999|NCT00061516|Ocular Hypertension|ocular hypertension
5410000|NCT00061503|Glaucoma|glaucoma
5410001|NCT00061503|Ocular Hypertension|ocular hypertension
5410002|NCT00006464|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5410003|NCT00006457|non-small cell lung cancer|non-small cell lung cancer
5410004|NCT00006457|small cell lung cancer|small cell lung cancer
5410005|NCT00006383|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5410006|NCT00006383|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5410007|NCT00006383|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
5410008|NCT00006383|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5410009|NCT00006377|stage III endometrial carcinoma|stage iii endometrial carcinoma
5410010|NCT00006377|stage IV endometrial carcinoma|stage iv endometrial carcinoma
5410011|NCT00006377|recurrent endometrial carcinoma|recurrent endometrial carcinoma
5410012|NCT00006361|squamous cell carcinoma of the skin|squamous cell carcinoma of the skin
5410013|NCT00006361|recurrent skin cancer|recurrent skin cancer
5410014|NCT00006361|stage IV nasopharyngeal cancer|stage iv nasopharyngeal cancer
5410015|NCT00006361|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
5410016|NCT00006361|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
5410017|NCT00006361|squamous cell carcinoma of unknown primary|squamous cell carcinoma of unknown primary
5410018|NCT00006361|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5410019|NCT00006361|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
5410020|NCT00006361|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5410021|NCT00006361|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
5410022|NCT00006361|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
5410023|NCT00006361|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
5410024|NCT00006361|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5410025|NCT00006361|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
5410026|NCT00006361|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5410027|NCT00006361|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
5410028|NCT00006361|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
5410029|NCT00006361|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
5410030|NCT00006361|recurrent carcinoma of unknown primary|recurrent carcinoma of unknown primary
5410031|NCT00061581|Chronic Myelogenous Leukemia|chronic myelogenous leukemia
5410032|NCT00061581|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
5410033|NCT00061581|Acute Myelogenous Leukemia (AML)|acute myelogenous leukemia (aml)
5410034|NCT00061581|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
5410035|NCT00061581|Myelodysplastic Syndrome|myelodysplastic syndrome
5410036|NCT00061581|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
5410037|NCT00061581|Graft-Versus Leukemia/Myeloma|graft-versus leukemia/myeloma
5410038|NCT00061581|Graft-Versus-Host Disease|graft-versus-host disease
5410039|NCT00061581|Cyclosporine|cyclosporine
5410040|NCT00061581|Fludarabine|fludarabine
5410041|NCT00061581|Myelodysplasia Syndrome|myelodysplasia syndrome
5410042|NCT00061568|Stem Cell Transplant|stem cell transplant
5410043|NCT00061568|Low Dose Radiation|low dose radiation
5410044|NCT00061568|Alemtuzumab (Campath)|alemtuzumab (campath)
5410045|NCT00061568|Sirolimus (Rapamune)|sirolimus (rapamune)
5410046|NCT00061568|Donor Apheresis|donor apheresis
5410047|NCT00061568|Graft-Versus-Host Disease|graft-versus-host disease
5410048|NCT00061568|Graft-Versus-Marrow|graft-versus-marrow
5410049|NCT00061568|Host-Donor Chimerism|host-donor chimerism
5410050|NCT00061568|Peripheral Blood Stem Cells|peripheral blood stem cells
5410051|NCT00061568|Low Dose Irradiation|low dose irradiation
5410052|NCT00061568|Sickle Cell Anemia|sickle cell anemia
5410053|NCT00061568|SCA|sca
5410054|NCT00061568|Thalassemia|thalassemia
5410055|NCT00061568|Diamond-Blackfan Anemia|diamond-blackfan anemia
5410056|NCT00061568|DBA|dba
5410057|NCT00061490|Osteoarthritis|osteoarthritis
5410058|NCT00061490|Arthritis|arthritis
5410059|NCT00061490|Weight Loss|weight loss
5410060|NCT00006349|depression|depression
5410061|NCT00006349|delirium|delirium
5410062|NCT00006349|cognitive/functional effects|cognitive/functional effects
5410063|NCT00006349|radiation toxicity|radiation toxicity
5410064|NCT00006349|limited stage small cell lung cancer|limited stage small cell lung cancer
5410065|NCT00006349|extensive stage small cell lung cancer|extensive stage small cell lung cancer
5410066|NCT00006349|recurrent small cell lung cancer|recurrent small cell lung cancer
5410067|NCT00006341|stage I lip and oral cavity cancer|stage i lip and oral cavity cancer
5410068|NCT00006341|stage II lip and oral cavity cancer|stage ii lip and oral cavity cancer
5410069|NCT00006341|stage III lip and oral cavity cancer|stage iii lip and oral cavity cancer
5410070|NCT00061438|non-infected necrotizing pancreatitis|non-infected necrotizing pancreatitis
5410071|NCT00061438|pancreatic infection|pancreatic infection
5410072|NCT00061438|peripancreatic infection|peripancreatic infection
5410073|NCT00061425|NHL|nhl
5410074|NCT00061425|recurrent B-cell lymphoma|recurrent b-cell lymphoma
5410075|NCT00061412|Low reading and writing achievement|low reading and writing achievement
5410076|NCT00061412|At-risk students|at-risk students
5410077|NCT00061412|Reading Disability|reading disability
5410078|NCT00061412|Writing Disability|writing disability
5410079|NCT00061399|TBI|tbi
5410080|NCT00061399|Prospective memory|prospective memory
5410081|NCT00061386|Postpartum|postpartum
5410082|NCT00061386|Low income|low income
5410083|NCT00061386|Diet|diet
5410085|NCT00061321|Nevirapine|nevirapine
5410086|NCT00061321|Pregnancy|pregnancy
5410087|NCT00061321|Maternal to Infant transmission|maternal to infant transmission
5410088|NCT00061321|Infant|infant
5410089|NCT00061321|Breastfeeding|breastfeeding
5410090|NCT00061321|HIV Seronegativity|hiv seronegativity
5410091|NCT00061308|Ovarian cancer|ovarian cancer
5410092|NCT00061308|peritoneal cancer|peritoneal cancer
5410093|NCT00061308|cancer|cancer
5410094|NCT00061308|Fallopian cancer|fallopian cancer
5410095|NCT00061295|Locomotion|locomotion
5410096|NCT00061295|Spinal Cord Injury|spinal cord injury
5410097|NCT00061295|Body Weight Supported Walking|body weight supported walking
5410098|NCT00045149|recurrent melanoma|recurrent melanoma
5410099|NCT00045149|stage IV melanoma|stage iv melanoma
5410100|NCT00019734|stage IV melanoma|stage iv melanoma
5410101|NCT00019734|recurrent melanoma|recurrent melanoma
5410102|NCT00061373|Alteplase|alteplase
5410103|NCT00061373|Recombinant tissue plasminogen activator|recombinant tissue plasminogen activator
5410104|NCT00061373|Reperfusion therapy|reperfusion therapy
5410105|NCT00061373|Magnetic Resonance Imaging|magnetic resonance imaging
5410106|NCT00061373|Clinical Trial|clinical trial
5410107|NCT00061373|Tinzaparin|tinzaparin
5410108|NCT00061373|Eptifibatide|eptifibatide
5410109|NCT00061373|Ischemic Stroke|ischemic stroke
5410110|NCT00061360|Bone Marrow Failure|bone marrow failure
5410111|NCT00061360|Cyclosporine|cyclosporine
5410112|NCT00061360|Anti Thymocyte Globulin|anti thymocyte globulin
5410113|NCT00061360|Severe Aplastic Anemia|severe aplastic anemia
5410114|NCT00061347|Fiducial Marker|fiducial marker
5410115|NCT00061347|MRI|mri
5410116|NCT00061347|Prostate Cancer|prostate cancer
5410117|NCT00061347|Radiation|radiation
5410118|NCT00061334|Attitudes|attitudes
5410119|NCT00061334|fMRI|fmri
5410120|NCT00061334|Development|development
5410121|NCT00061334|Stereotypes|stereotypes
5410122|NCT00061334|Memory|memory
5410123|NCT00061334|Healthy Volunteer|healthy volunteer
5410124|NCT00061334|HV|hv
5410125|NCT00061282|Pouchitis|pouchitis
5410126|NCT00061282|Colitis|colitis
5410127|NCT00061282|Ileitis|ileitis
5410128|NCT00041353|ductal breast carcinoma in situ|ductal breast carcinoma in situ
5410129|NCT00041353|lobular breast carcinoma in situ|lobular breast carcinoma in situ
5410130|NCT00019175|stage IV melanoma|stage iv melanoma
5410131|NCT00019175|recurrent melanoma|recurrent melanoma
5410132|NCT00002786|stage IV melanoma|stage iv melanoma
5410133|NCT00002786|recurrent melanoma|recurrent melanoma
5410134|NCT00061269|Infected pancreatic necrosis|infected pancreatic necrosis
5410135|NCT00061256|Bone Mineral Density|bone mineral density
5410136|NCT00061256|Lumbar Vertebrae|lumbar vertebrae
5410137|NCT00061256|Treatment Experienced|treatment experienced
5410138|NCT00061243|HIV|hiv
5410139|NCT00061243|Vaccine|vaccine
5410140|NCT00061243|DNA prime|dna prime
5410141|NCT00061243|Protein boost|protein boost
5410142|NCT00061243|HIV Seronegativity|hiv seronegativity
5410143|NCT00061243|HIV preventive vaccine|hiv preventive vaccine
5410144|NCT00061230|Relaxation training|relaxation training
5410145|NCT00061217|Transtibial amputees|transtibial amputees
5410146|NCT00061217|Rectified sockets|rectified sockets
5410147|NCT00061217|Unrectified sockets|unrectified sockets
5410148|NCT00061217|Gait|gait
5410149|NCT00061217|Energy expenditure|energy expenditure
5410150|NCT00061217|Prosthetic evaluation questionnaire|prosthetic evaluation questionnaire
5410151|NCT00061165|obesity|obesity
5410152|NCT00061165|overweight|overweight
5410153|NCT00061165|children|children
5410154|NCT00061165|adolescents|adolescents
5410155|NCT00061165|African American|african american
5410156|NCT00061165|diet|diet
5410157|NCT00061165|nutrition|nutrition
5410158|NCT00061165|physical activity|physical activity
5410159|NCT00061165|Chicago|chicago
5410160|NCT00019084|stage IV colon cancer|stage iv colon cancer
5410161|NCT00019084|stage IV breast cancer|stage iv breast cancer
5410162|NCT00019084|recurrent breast cancer|recurrent breast cancer
5410163|NCT00019084|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5410164|NCT00019084|stage II pancreatic cancer|stage ii pancreatic cancer
5410165|NCT00019084|stage III pancreatic cancer|stage iii pancreatic cancer
5410166|NCT00019084|recurrent pancreatic cancer|recurrent pancreatic cancer
5410167|NCT00019084|recurrent colon cancer|recurrent colon cancer
5410168|NCT00019084|recurrent cervical cancer|recurrent cervical cancer
5410169|NCT00019084|stage IVB cervical cancer|stage ivb cervical cancer
5410170|NCT00019084|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5410171|NCT00019084|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5410172|NCT00019084|extensive stage small cell lung cancer|extensive stage small cell lung cancer
5410173|NCT00019084|recurrent small cell lung cancer|recurrent small cell lung cancer
5410174|NCT00019084|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5410175|NCT00019084|stage IV pancreatic cancer|stage iv pancreatic cancer
5410176|NCT00004868|recurrent adult brain tumor|recurrent adult brain tumor
5410177|NCT00004868|adult meningioma|adult meningioma
5410178|NCT00004868|adult glioblastoma|adult glioblastoma
5410179|NCT00004868|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5410180|NCT00004868|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
5410181|NCT00004868|adult mixed glioma|adult mixed glioma
5410182|NCT00004868|adult grade III meningioma|adult grade iii meningioma
5410183|NCT00004868|adult giant cell glioblastoma|adult giant cell glioblastoma
5410184|NCT00004868|adult gliosarcoma|adult gliosarcoma
5410185|NCT00003408|stage IV breast cancer|stage iv breast cancer
5410186|NCT00003408|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5410187|NCT00003408|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5410188|NCT00003408|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5410189|NCT00003408|refractory multiple myeloma|refractory multiple myeloma
5410190|NCT00003408|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
5410191|NCT00003408|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
5410192|NCT00003408|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5410193|NCT00003408|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5410194|NCT00003408|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5410195|NCT00003408|disseminated neuroblastoma|disseminated neuroblastoma
5410196|NCT00003408|recurrent neuroblastoma|recurrent neuroblastoma
5410197|NCT00003408|recurrent Wilms tumor and other childhood kidney tumors|recurrent wilms tumor and other childhood kidney tumors
5410198|NCT00003408|stage I multiple myeloma|stage i multiple myeloma
5410199|NCT00003408|stage II multiple myeloma|stage ii multiple myeloma
5410200|NCT00003408|stage III multiple myeloma|stage iii multiple myeloma
5410201|NCT00003408|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
5410202|NCT00003408|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5410203|NCT00003408|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5410204|NCT00003408|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5410205|NCT00003408|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5410206|NCT00003408|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5410207|NCT00003408|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5410208|NCT00003408|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5410209|NCT00003408|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
5410210|NCT00003408|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
5410211|NCT00003408|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5410212|NCT00003408|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5410213|NCT00003408|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5410214|NCT00003408|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
5410215|NCT00003408|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
5410216|NCT00003408|childhood acute promyelocytic leukemia (M3)|childhood acute promyelocytic leukemia (m3)
5410217|NCT00003408|testicular embryonal carcinoma|testicular embryonal carcinoma
5410218|NCT00003408|testicular choriocarcinoma|testicular choriocarcinoma
5410219|NCT00003408|testicular teratoma|testicular teratoma
5410220|NCT00003408|testicular yolk sac tumor|testicular yolk sac tumor
5410221|NCT00003408|testicular embryonal carcinoma and teratoma|testicular embryonal carcinoma and teratoma
5410222|NCT00003408|testicular embryonal carcinoma and teratoma with seminoma|testicular embryonal carcinoma and teratoma with seminoma
5410223|NCT00003408|testicular embryonal carcinoma and yolk sac tumor|testicular embryonal carcinoma and yolk sac tumor
5410371|NCT00005977|childhood Burkitt lymphoma|childhood burkitt lymphoma
5410224|NCT00003408|testicular embryonal carcinoma and yolk sac tumor with seminoma|testicular embryonal carcinoma and yolk sac tumor with seminoma
5410225|NCT00003408|testicular embryonal carcinoma and seminoma|testicular embryonal carcinoma and seminoma
5410226|NCT00003408|testicular yolk sac tumor and teratoma|testicular yolk sac tumor and teratoma
5410227|NCT00003408|testicular yolk sac tumor and teratoma with seminoma|testicular yolk sac tumor and teratoma with seminoma
5410228|NCT00003408|testicular choriocarcinoma and yolk sac tumor|testicular choriocarcinoma and yolk sac tumor
5410229|NCT00003408|testicular choriocarcinoma and embryonal carcinoma|testicular choriocarcinoma and embryonal carcinoma
5410230|NCT00003408|testicular choriocarcinoma and teratoma|testicular choriocarcinoma and teratoma
5410231|NCT00003408|testicular choriocarcinoma and seminoma|testicular choriocarcinoma and seminoma
5410232|NCT00003408|refractory hairy cell leukemia|refractory hairy cell leukemia
5410233|NCT00003408|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
5410234|NCT00003408|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
5410235|NCT00003408|ovarian yolk sac tumor|ovarian yolk sac tumor
5410236|NCT00003408|ovarian embryonal carcinoma|ovarian embryonal carcinoma
5410237|NCT00003408|ovarian polyembryoma|ovarian polyembryoma
5410238|NCT00003408|ovarian choriocarcinoma|ovarian choriocarcinoma
5410239|NCT00003408|ovarian immature teratoma|ovarian immature teratoma
5410240|NCT00003408|ovarian mature teratoma|ovarian mature teratoma
5410241|NCT00003408|ovarian monodermal and highly specialized teratoma|ovarian monodermal and highly specialized teratoma
5410242|NCT00003408|ovarian mixed germ cell tumor|ovarian mixed germ cell tumor
5410243|NCT00003408|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5410244|NCT00003408|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5410245|NCT00003408|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5410246|NCT00003408|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5410247|NCT00003408|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5410248|NCT00003408|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5410249|NCT00003408|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5410250|NCT00003408|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5410251|NCT00003408|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5410252|NCT00003408|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5410253|NCT00003408|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5410254|NCT00003408|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5410255|NCT00003408|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5410256|NCT00003408|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5410257|NCT00003408|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5410258|NCT00003408|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5410259|NCT00003408|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5410260|NCT00003408|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5410261|NCT00003408|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5410262|NCT00003408|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5410263|NCT00003408|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5410264|NCT00003408|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5410265|NCT00003408|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5410266|NCT00003408|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5410267|NCT00003408|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5410268|NCT00003408|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5410269|NCT00003408|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5410270|NCT00003408|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5410271|NCT00003408|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5410272|NCT00003408|poor prognosis metastatic gestational trophoblastic tumor|poor prognosis metastatic gestational trophoblastic tumor
5410273|NCT00003408|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5410274|NCT00003408|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5410275|NCT00003408|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
5410276|NCT00003408|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
5410277|NCT00003408|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5410278|NCT00003408|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5410279|NCT00003408|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5410280|NCT00003408|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
5410281|NCT00003408|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5410282|NCT00003408|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
5410283|NCT00003408|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
5410284|NCT00003408|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5410285|NCT00003408|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
5410286|NCT00003408|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
5410287|NCT00003408|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5410288|NCT00003408|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5410289|NCT00003408|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5410290|NCT00003408|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
5410291|NCT00003408|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5410292|NCT00003408|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
5410293|NCT00003408|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
5410938|NCT00060528|Immune Assays|immune assays
5410294|NCT00003408|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5410295|NCT00003408|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5410296|NCT00003408|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5410297|NCT00003408|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5410298|NCT00003408|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5410299|NCT00003408|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5410300|NCT00003408|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5410301|NCT00003408|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5410302|NCT00003408|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5410303|NCT00003408|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
5410304|NCT00061204|fMRI|fmri
5410305|NCT00061204|Susceptibility Artifacts|susceptibility artifacts
5410306|NCT00061204|Prefrontal Cortex|prefrontal cortex
5410307|NCT00061204|Temporal Lobes|temporal lobes
5410308|NCT00061204|Methodology|methodology
5410309|NCT00061204|Healthy Volunteer|healthy volunteer
5410310|NCT00061204|HV|hv
5410311|NCT00061152|Pain Measurement|pain measurement
5410312|NCT00061152|Diary|diary
5410313|NCT00061152|Painful HIV Neuropathy|painful hiv neuropathy
5410314|NCT00061152|HIV Neuropathy|hiv neuropathy
5410315|NCT00061152|Capsaicin|capsaicin
5410316|NCT00061152|Analgesics/*therapeutic use|analgesics/*therapeutic use
5410317|NCT00061152|Capsaicin/*administration & dosage/adverse effects|capsaicin/*administration & dosage/adverse effects
5410318|NCT00061152|Peripheral Nervous System Diseases/*complications/diagnosis/*therapy|peripheral nervous system diseases/*complications/diagnosis/*therapy
5410319|NCT00061152|Peripheral Nervous System Diseases/drug therapy/*etiology/physiopathology|peripheral nervous system diseases/drug therapy/*etiology/physiopathology
5410320|NCT00061152|Pain|pain
5410321|NCT00061139|Cerebral palsy|cerebral palsy
5410322|NCT00061139|Hemiparesis|hemiparesis
5410323|NCT00061139|Pediatric CI therapy|pediatric ci therapy
5410324|NCT00061139|Upper extremity|upper extremity
5410325|NCT00061139|Training|training
5410326|NCT00061139|Limb restraint|limb restraint
5410327|NCT00061126|Prostate Cancer|prostate cancer
5410328|NCT00061126|PSA|psa
5410329|NCT00061126|Hormone refractory|hormone refractory
5410330|NCT00061126|Rising PSA|rising psa
5410331|NCT00061113|alcohol dependence|alcohol dependence
5410332|NCT00061113|marijuana dependence|marijuana dependence
5410333|NCT00061100|HIV|hiv
5410334|NCT00061100|methadone maintenance|methadone maintenance
5410335|NCT00061087|ADHD|adhd
5410336|NCT00061087|Cocaine|cocaine
5410337|NCT00061087|Treatment|treatment
5410338|NCT00061087|Methadone|methadone
5410339|NCT00061074|Smoking|smoking
5410340|NCT00061061|Tobacco Cessation|tobacco cessation
5410341|NCT00061061|Postmenopausal Women|postmenopausal women
5410342|NCT00061035|Prostate Cancer; Immunotherapy|prostate cancer; immunotherapy
5410343|NCT00006095|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
5410344|NCT00006086|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5410345|NCT00006082|extensive stage small cell lung cancer|extensive stage small cell lung cancer
5410346|NCT00006082|recurrent small cell lung cancer|recurrent small cell lung cancer
5410347|NCT00061048|Monoclonal Antibody|monoclonal antibody
5410348|NCT00061048|HTLV-1|htlv-1
5410349|NCT00061048|CD52|cd52
5410350|NCT00061048|Flow Cytometry|flow cytometry
5410351|NCT00061048|Antibody Saturation|antibody saturation
5410352|NCT00061048|Adult T-Cell Leukemia (ATL)|adult t-cell leukemia (atl)
5410353|NCT00061048|ATL|atl
5410354|NCT00061022|Stroke|stroke
5410355|NCT00061022|cerebral vascular accident|cerebral vascular accident
5410356|NCT00061022|CVA|cva
5410357|NCT00061022|Ischemia|ischemia
5410358|NCT00061022|Hemorrhage|hemorrhage
5410359|NCT00061022|TIA|tia
5410360|NCT00061022|Transient Ischemic Attack|transient ischemic attack
5410361|NCT00061022|Brain Attack|brain attack
5410362|NCT00061022|Cataplexy|cataplexy
5410363|NCT00006046|stage IV colon cancer|stage iv colon cancer
5410364|NCT00006046|stage IV rectal cancer|stage iv rectal cancer
5410365|NCT00006046|recurrent colon cancer|recurrent colon cancer
5410366|NCT00006046|recurrent rectal cancer|recurrent rectal cancer
5410367|NCT00005999|recurrent cervical cancer|recurrent cervical cancer
5410368|NCT00005999|stage IVB cervical cancer|stage ivb cervical cancer
5410369|NCT00005999|cervical squamous cell carcinoma|cervical squamous cell carcinoma
5410370|NCT00005999|cervical adenocarcinoma|cervical adenocarcinoma
5434425|NCT00002308|Stavudine|stavudine
5410372|NCT00005977|L3 childhood acute lymphoblastic leukemia|l3 childhood acute lymphoblastic leukemia
5410373|NCT00005977|B-cell childhood acute lymphoblastic leukemia|b-cell childhood acute lymphoblastic leukemia
5410374|NCT00005977|L3 adult acute lymphoblastic leukemia|l3 adult acute lymphoblastic leukemia
5410375|NCT00005977|B-cell adult acute lymphoblastic leukemia|b-cell adult acute lymphoblastic leukemia
5410376|NCT00005977|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5410377|NCT00005977|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5410378|NCT00005977|stage III childhood small noncleaved cell lymphoma|stage iii childhood small noncleaved cell lymphoma
5410379|NCT00005977|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
5410380|NCT00005971|stage IV melanoma|stage iv melanoma
5410381|NCT00005956|stage II breast cancer|stage ii breast cancer
5410382|NCT00005956|stage IV breast cancer|stage iv breast cancer
5410383|NCT00005956|stage IIIA breast cancer|stage iiia breast cancer
5410384|NCT00005956|stage II gastric cancer|stage ii gastric cancer
5410385|NCT00005956|stage III gastric cancer|stage iii gastric cancer
5410386|NCT00005956|stage IV gastric cancer|stage iv gastric cancer
5410387|NCT00005956|stage IIIB breast cancer|stage iiib breast cancer
5410388|NCT00005956|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5410389|NCT00005956|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5410390|NCT00005868|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5410391|NCT00061009|Chronic Orthostatic Intolerance|chronic orthostatic intolerance
5410392|NCT00061009|Dysautonomia|dysautonomia
5410393|NCT00061009|Postural Tachycardia Syndrome|postural tachycardia syndrome
5410394|NCT00061009|Neurocardiogenic|neurocardiogenic
5410395|NCT00061009|Syncope|syncope
5410396|NCT00061009|Neurocardiogenic Syncope|neurocardiogenic syncope
5410397|NCT00061009|COI|coi
5410398|NCT00061009|POTS|pots
5410399|NCT00061009|Neurocardogenic Syncope|neurocardogenic syncope
5410400|NCT00061009|NCS|ncs
5410401|NCT00061009|Healthy Volunteer|healthy volunteer
5410402|NCT00061009|HV|hv
5410403|NCT00060996|Critical Limb Ischemia|critical limb ischemia
5410404|NCT00060996|Peripheral Vascular Disease|peripheral vascular disease
5410405|NCT00060996|UT-15|ut-15
5410406|NCT00060996|Remodulin|remodulin
5410407|NCT00060996|treprostinil|treprostinil
5410408|NCT00005813|adult glioblastoma|adult glioblastoma
5410939|NCT00060528|Prostate Cancer|prostate cancer
5410409|NCT00005813|adult giant cell glioblastoma|adult giant cell glioblastoma
5410410|NCT00005813|adult gliosarcoma|adult gliosarcoma
5410411|NCT00060983|Locomotion|locomotion
5410412|NCT00060983|Spinal Cord Injury, ASIA C|spinal cord injury, asia c
5410413|NCT00060983|Body weight support (BWS)|body weight support (bws)
5410414|NCT00060983|Functional electrical stimulation (FES)|functional electrical stimulation (fes)
5410416|NCT00060983|Treadmill training|treadmill training
5410417|NCT00060983|Physical Therapy|physical therapy
5410418|NCT00060970|Disuse atrophy|disuse atrophy
5410419|NCT00060970|Ankle fracture|ankle fracture
5410420|NCT00060970|Exercise, therapy|exercise, therapy
5410421|NCT00060970|Cast immobilization|cast immobilization
5410422|NCT00060970|Deconditioning|deconditioning
5410423|NCT00060970|Sarcopenia|sarcopenia
5410424|NCT00060957|Cerebral Palsy|cerebral palsy
5410425|NCT00060957|Spasticity|spasticity
5410426|NCT00060957|Botulinum toxin|botulinum toxin
5410427|NCT00060957|BOTOX|botox
5410428|NCT00060944|Trabectedin|trabectedin
5410429|NCT00060944|Yondelis|yondelis
5410430|NCT00060944|ET-743|et-743
5410431|NCT00060944|Ecteinascidin|ecteinascidin
5410432|NCT00060944|Anthracycline|anthracycline
5410433|NCT00060944|Ifosfamide|ifosfamide
5410434|NCT00060944|Dexamethasone|dexamethasone
5410435|NCT00060944|Intravenous|intravenous
5410436|NCT00060944|Cancer|cancer
5410437|NCT00060944|Malignant|malignant
5410438|NCT00060944|Metastatic|metastatic
5410439|NCT00005861|stage III endometrial carcinoma|stage iii endometrial carcinoma
5410440|NCT00005861|stage IV endometrial carcinoma|stage iv endometrial carcinoma
5410441|NCT00005861|recurrent endometrial carcinoma|recurrent endometrial carcinoma
5410442|NCT00005588|stage I breast cancer|stage i breast cancer
5410443|NCT00005588|stage II breast cancer|stage ii breast cancer
5410444|NCT00005588|stage IIIA breast cancer|stage iiia breast cancer
5410445|NCT00005587|stage I breast cancer|stage i breast cancer
5410446|NCT00005587|stage II breast cancer|stage ii breast cancer
5410447|NCT00005587|stage IIIA breast cancer|stage iiia breast cancer
5410448|NCT00003203|untreated childhood supratentorial primitive neuroectodermal tumor|untreated childhood supratentorial primitive neuroectodermal tumor
5410449|NCT00003203|untreated childhood medulloblastoma|untreated childhood medulloblastoma
5410450|NCT00003203|localized unresectable neuroblastoma|localized unresectable neuroblastoma
5410451|NCT00003203|regional neuroblastoma|regional neuroblastoma
5410452|NCT00003203|stage 4S neuroblastoma|stage 4s neuroblastoma
5410453|NCT00060931|hypertension|hypertension
5410454|NCT00060931|beta-blockers|beta-blockers
5410455|NCT00060931|Type 2 diabetes|type 2 diabetes
5410456|NCT00060918|Type 2 diabetes|type 2 diabetes
5410457|NCT00060918|hypertension|hypertension
5410458|NCT00060918|beta-blockers|beta-blockers
5410459|NCT00060905|Bipolar Disorder (manic or mixed type)|bipolar disorder (manic or mixed type)
5410460|NCT00060892|Critical Limb Ischemia|critical limb ischemia
5410461|NCT00005086|stage IV bladder cancer|stage iv bladder cancer
5410462|NCT00005086|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
5410463|NCT00005078|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5410464|NCT00060866|Beta-Adrenoceptors|beta-adrenoceptors
5410465|NCT00060866|Beta-Adrenoceptor Blocker|beta-adrenoceptor blocker
5410466|NCT00060866|Neurocardiogenic Syncope|neurocardiogenic syncope
5410467|NCT00060866|Chronic Orthostatic Intolerance|chronic orthostatic intolerance
5410468|NCT00060866|Neurocardiogenic|neurocardiogenic
5410469|NCT00060866|Dysautonomia|dysautonomia
5410470|NCT00060866|Autonomic Nervous System|autonomic nervous system
5410471|NCT00060866|Nurocardiogenic Syncope|nurocardiogenic syncope
5410472|NCT00060866|NCS|ncs
5410473|NCT00060866|Sympathoadrenal Imbalance|sympathoadrenal imbalance
5410474|NCT00060866|SAI|sai
5410475|NCT00060866|Orthostatic Intolerance|orthostatic intolerance
5410476|NCT00060840|Left Ventricular Assist Device Implantation|left ventricular assist device implantation
5410477|NCT00060840|Progressive Left Ventricular Failure|progressive left ventricular failure
5410478|NCT00060827|Mild traumatic brain injury|mild traumatic brain injury
5410479|NCT00060853|Amygdala|amygdala
5410480|NCT00060853|Orbitofrontal Cortex|orbitofrontal cortex
5410481|NCT00060853|Emotion|emotion
5410482|NCT00060853|Cognition|cognition
5410483|NCT00060853|Theory of Mind|theory of mind
5410484|NCT00060853|Healthy Volunteer|healthy volunteer
5410485|NCT00060853|HV|hv
5410486|NCT00060801|Cystic Fibrosis|cystic fibrosis
5410487|NCT00060801|BIIL 284|biil 284
5410488|NCT00060801|Boehringer Ingelheim|boehringer ingelheim
5410489|NCT00060788|Antisocial behavior|antisocial behavior
5410490|NCT00060788|Mauritius Child Health Project|mauritius child health project
5410491|NCT00060788|Intergenerational transmission|intergenerational transmission
5410492|NCT00004928|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5410493|NCT00004928|stage I prostate cancer|stage i prostate cancer
5410494|NCT00004928|stage IIB prostate cancer|stage iib prostate cancer
5410495|NCT00004928|stage IIA prostate cancer|stage iia prostate cancer
5410496|NCT00004928|stage III prostate cancer|stage iii prostate cancer
5410497|NCT00004928|stage IV prostate cancer|stage iv prostate cancer
5410498|NCT00004928|recurrent prostate cancer|recurrent prostate cancer
5410499|NCT00004925|stage IV breast cancer|stage iv breast cancer
5410500|NCT00004925|recurrent breast cancer|recurrent breast cancer
5410501|NCT00004925|stage IIIB breast cancer|stage iiib breast cancer
5410502|NCT00004925|inflammatory breast cancer|inflammatory breast cancer
5410503|NCT00004916|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5410504|NCT00004916|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5410505|NCT00004916|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5410506|NCT00004916|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5410507|NCT00004916|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5410508|NCT00004911|stage I colon cancer|stage i colon cancer
5410509|NCT00004911|stage II colon cancer|stage ii colon cancer
5410510|NCT00004911|stage III colon cancer|stage iii colon cancer
5410511|NCT00004911|stage IV colon cancer|stage iv colon cancer
5410512|NCT00004911|stage I gastric cancer|stage i gastric cancer
5410513|NCT00004911|stage II gastric cancer|stage ii gastric cancer
5410514|NCT00004911|stage III gastric cancer|stage iii gastric cancer
5410515|NCT00004911|stage IV gastric cancer|stage iv gastric cancer
5410516|NCT00004911|recurrent gastric cancer|recurrent gastric cancer
5410517|NCT00004911|stage I rectal cancer|stage i rectal cancer
5410518|NCT00004911|stage II rectal cancer|stage ii rectal cancer
5410519|NCT00004911|stage III rectal cancer|stage iii rectal cancer
5410520|NCT00004911|stage IV rectal cancer|stage iv rectal cancer
5410521|NCT00004911|recurrent colon cancer|recurrent colon cancer
5410522|NCT00004911|recurrent rectal cancer|recurrent rectal cancer
5410523|NCT00004911|localized gastrointestinal carcinoid tumor|localized gastrointestinal carcinoid tumor
5410524|NCT00004911|regional gastrointestinal carcinoid tumor|regional gastrointestinal carcinoid tumor
5410525|NCT00004911|metastatic gastrointestinal carcinoid tumor|metastatic gastrointestinal carcinoid tumor
5410526|NCT00004911|recurrent gastrointestinal carcinoid tumor|recurrent gastrointestinal carcinoid tumor
5410527|NCT00004911|small intestine adenocarcinoma|small intestine adenocarcinoma
5410528|NCT00004911|small intestine lymphoma|small intestine lymphoma
5410529|NCT00004911|small intestine leiomyosarcoma|small intestine leiomyosarcoma
5410530|NCT00004911|recurrent small intestine cancer|recurrent small intestine cancer
5410531|NCT00004911|constipation, impaction, and bowel obstruction|constipation, impaction, and bowel obstruction
5410532|NCT00004911|quality of life|quality of life
5410533|NCT00004911|gastrointestinal stromal tumor|gastrointestinal stromal tumor
5410534|NCT00060775|Magnetic Resonance Imaging|magnetic resonance imaging
5410535|NCT00060775|fMRI|fmri
5410536|NCT00060775|Emotion|emotion
5410537|NCT00060775|Children|children
5410538|NCT00060775|Adolescence|adolescence
5410539|NCT00060775|Affective Neuroscience|affective neuroscience
5410540|NCT00060775|Neuroimaging|neuroimaging
5410541|NCT00060775|Behavioral Inhibition|behavioral inhibition
5410542|NCT00060775|Depression|depression
5410543|NCT00060775|Anxiety|anxiety
5410544|NCT00060775|Normal Volunteers|normal volunteers
5410545|NCT00060775|Healthy Volunteer|healthy volunteer
5410547|NCT00060762|Weight Loss|weight loss
5410548|NCT00060723|Polysomnography|polysomnography
5410549|NCT00060723|Sleep-disordered breathing|sleep-disordered breathing
5410550|NCT00060723|Sleep apnea, obstructive|sleep apnea, obstructive
5410551|NCT00060723|Hyperactivity|hyperactivity
5410552|NCT00060723|Sleep|sleep
5410553|NCT00060723|Child|child
5410554|NCT00060710|melanoma|melanoma
5410555|NCT00060749|Stargardt|stargardt
5410556|NCT00060749|Macular Dystrophy|macular dystrophy
5410557|NCT00060749|ELOVL4|elovl4
5410558|NCT00060749|DHA|dha
5410559|NCT00060749|Stargardt's Disease|stargardt's disease
5410560|NCT00060749|Autosomal Dominant Macular Dystrophy|autosomal dominant macular dystrophy
5410561|NCT00060749|Autosomal Recessive Macular Dystrophy|autosomal recessive macular dystrophy
5410562|NCT00060736|Hormone Replacement|hormone replacement
5410563|NCT00060736|Gonadal Steroids|gonadal steroids
5410564|NCT00060736|Estrogen|estrogen
5410565|NCT00060736|Major Depression|major depression
5410566|NCT00060736|Minor Depression|minor depression
5410567|NCT00060736|Perimenopause|perimenopause
5410568|NCT00060736|Estradiol|estradiol
5410569|NCT00060736|Depression|depression
5410570|NCT00060736|Perimenopausal Depression|perimenopausal depression
5410571|NCT00060697|Sexual risk taking|sexual risk taking
5410572|NCT00060697|Mother-child communication|mother-child communication
5410573|NCT00060697|Problem behaviors|problem behaviors
5410574|NCT00060684|Pixantrone|pixantrone
5410575|NCT00060684|BBR 2778|bbr 2778
5410576|NCT00060684|chemotherapy|chemotherapy
5410577|NCT00060684|DNA Intercalator|dna intercalator
5410578|NCT00060684|mitoxantrone|mitoxantrone
5410579|NCT00060684|fludarabine|fludarabine
5410580|NCT00060684|dexamethasone|dexamethasone
5410581|NCT00060684|Rituximab|rituximab
5410582|NCT00060684|Rituxan|rituxan
5410583|NCT00060684|Mabthera|mabthera
5410584|NCT00060684|monoclonal antibody|monoclonal antibody
5410585|NCT00060684|antibody|antibody
5410586|NCT00060684|NHL|nhl
5410587|NCT00060684|Non-Hodgkin's lymphoma|non-hodgkin's lymphoma
5410588|NCT00060684|indolent|indolent
5410589|NCT00060684|low grade|low grade
5410590|NCT00060684|Novuspharma|novuspharma
5410591|NCT00060671|Pixantrone|pixantrone
5410592|NCT00060671|BBR 2778|bbr 2778
5410593|NCT00060671|chemotherapy|chemotherapy
5410594|NCT00060671|DNA Intercalator|dna intercalator
5410595|NCT00060671|Anthracycline|anthracycline
5410596|NCT00060671|Rituximab|rituximab
5410597|NCT00060671|Rituxan|rituxan
5410598|NCT00060671|Mabthera|mabthera
5410599|NCT00060671|monoclonal antibody|monoclonal antibody
5410600|NCT00060671|antibody|antibody
5410601|NCT00060671|NHL|nhl
5410602|NCT00060671|Non-Hodgkin's lymphoma|non-hodgkin's lymphoma
5410603|NCT00060671|indolent|indolent
5410604|NCT00060671|low grade|low grade
5410605|NCT00060671|Novuspharma|novuspharma
5410606|NCT00060645|Advanced, refractory or recurrent solid tumors|advanced, refractory or recurrent solid tumors
5410607|NCT00060632|Advanced, refractory or recurrent solid tumors|advanced, refractory or recurrent solid tumors
5410608|NCT00060619|Migraine|migraine
5410609|NCT00060619|Functional abdominal pain|functional abdominal pain
5410610|NCT00060619|Biofeedback|biofeedback
5410611|NCT00060619|Psychological assessment|psychological assessment
5410612|NCT00060658|Prefrontal Cortex|prefrontal cortex
5410613|NCT00060658|Calculation|calculation
5410614|NCT00060658|Mathematician|mathematician
5410615|NCT00060658|Cognition|cognition
5410616|NCT00060658|Brain Mapping|brain mapping
5410617|NCT00060658|Healthy Volunteer|healthy volunteer
5410618|NCT00060658|HV|hv
5410619|NCT00060606|Maternal fetal surgery|maternal fetal surgery
5410620|NCT00060606|Fetal diagnosis|fetal diagnosis
5410621|NCT00060606|Myelomeningocele|myelomeningocele
5410622|NCT00060606|Meningomyelocele|meningomyelocele
5410623|NCT00060606|Open neural tube defect|open neural tube defect
5410624|NCT00060606|ONTD|ontd
5410625|NCT00060606|Spina bifida|spina bifida
5410626|NCT00060567|E7070|e7070
5410627|NCT00060567|Irinotecan|irinotecan
5410628|NCT00060567|hydrochloride|hydrochloride
5410629|NCT00060567|gastrointestinal|gastrointestinal
5410630|NCT00060567|cancer|cancer
5410631|NCT00004910|stage I colon cancer|stage i colon cancer
5410632|NCT00004910|stage II colon cancer|stage ii colon cancer
5410633|NCT00004910|stage III colon cancer|stage iii colon cancer
5410634|NCT00004910|stage IV colon cancer|stage iv colon cancer
5410635|NCT00004910|stage I gastric cancer|stage i gastric cancer
5410636|NCT00004910|stage II gastric cancer|stage ii gastric cancer
5410637|NCT00004910|stage III gastric cancer|stage iii gastric cancer
5410638|NCT00004910|stage IV gastric cancer|stage iv gastric cancer
5410639|NCT00004910|recurrent gastric cancer|recurrent gastric cancer
5410640|NCT00004910|stage I pancreatic cancer|stage i pancreatic cancer
5410641|NCT00004910|stage II pancreatic cancer|stage ii pancreatic cancer
5410642|NCT00004910|stage III pancreatic cancer|stage iii pancreatic cancer
5410643|NCT00004910|recurrent pancreatic cancer|recurrent pancreatic cancer
5410644|NCT00004910|recurrent colon cancer|recurrent colon cancer
5410645|NCT00004910|localized gastrointestinal carcinoid tumor|localized gastrointestinal carcinoid tumor
5410646|NCT00004910|regional gastrointestinal carcinoid tumor|regional gastrointestinal carcinoid tumor
5410647|NCT00004910|metastatic gastrointestinal carcinoid tumor|metastatic gastrointestinal carcinoid tumor
5410648|NCT00004910|recurrent gastrointestinal carcinoid tumor|recurrent gastrointestinal carcinoid tumor
5410649|NCT00004910|small intestine adenocarcinoma|small intestine adenocarcinoma
5410650|NCT00004910|small intestine lymphoma|small intestine lymphoma
5410651|NCT00004910|small intestine leiomyosarcoma|small intestine leiomyosarcoma
5410652|NCT00004910|localized extrahepatic bile duct cancer|localized extrahepatic bile duct cancer
5410653|NCT00004910|unresectable extrahepatic bile duct cancer|unresectable extrahepatic bile duct cancer
5410654|NCT00004910|recurrent extrahepatic bile duct cancer|recurrent extrahepatic bile duct cancer
5410655|NCT00004910|recurrent small intestine cancer|recurrent small intestine cancer
5410656|NCT00004910|constipation, impaction, and bowel obstruction|constipation, impaction, and bowel obstruction
5410657|NCT00004910|quality of life|quality of life
5410658|NCT00004910|gastrointestinal stromal tumor|gastrointestinal stromal tumor
5410659|NCT00004910|stage IV pancreatic cancer|stage iv pancreatic cancer
5410660|NCT00004895|stage I colon cancer|stage i colon cancer
5410661|NCT00004895|stage II colon cancer|stage ii colon cancer
5410662|NCT00004895|stage III colon cancer|stage iii colon cancer
5410663|NCT00004895|stage IV colon cancer|stage iv colon cancer
5410664|NCT00004895|stage I gastric cancer|stage i gastric cancer
5410665|NCT00004895|stage II gastric cancer|stage ii gastric cancer
5410666|NCT00004895|stage III gastric cancer|stage iii gastric cancer
5410667|NCT00004895|stage IV gastric cancer|stage iv gastric cancer
5410668|NCT00004895|recurrent gastric cancer|recurrent gastric cancer
5410669|NCT00004895|stage I pancreatic cancer|stage i pancreatic cancer
5410670|NCT00004895|stage II pancreatic cancer|stage ii pancreatic cancer
5410671|NCT00004895|stage III pancreatic cancer|stage iii pancreatic cancer
5410672|NCT00004895|stage IV pancreatic cancer|stage iv pancreatic cancer
5410673|NCT00004895|recurrent pancreatic cancer|recurrent pancreatic cancer
5410674|NCT00004895|stage I rectal cancer|stage i rectal cancer
5410675|NCT00004895|stage II rectal cancer|stage ii rectal cancer
5410676|NCT00004895|stage III rectal cancer|stage iii rectal cancer
5410677|NCT00004895|stage IV rectal cancer|stage iv rectal cancer
5410678|NCT00004895|recurrent colon cancer|recurrent colon cancer
5410679|NCT00004895|recurrent rectal cancer|recurrent rectal cancer
5410680|NCT00004895|stage I ovarian epithelial cancer|stage i ovarian epithelial cancer
5410681|NCT00004895|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
5410682|NCT00004895|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5410683|NCT00004895|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5410684|NCT00004895|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5410685|NCT00004895|small intestine adenocarcinoma|small intestine adenocarcinoma
5410686|NCT00004895|small intestine lymphoma|small intestine lymphoma
5410687|NCT00004895|small intestine leiomyosarcoma|small intestine leiomyosarcoma
5410688|NCT00004895|localized extrahepatic bile duct cancer|localized extrahepatic bile duct cancer
5410689|NCT00004895|unresectable extrahepatic bile duct cancer|unresectable extrahepatic bile duct cancer
5410690|NCT00004895|recurrent extrahepatic bile duct cancer|recurrent extrahepatic bile duct cancer
5410691|NCT00004895|recurrent small intestine cancer|recurrent small intestine cancer
5410692|NCT00004895|constipation, impaction, and bowel obstruction|constipation, impaction, and bowel obstruction
5410693|NCT00004895|peritoneal cavity cancer|peritoneal cavity cancer
5410694|NCT00004895|nausea and vomiting|nausea and vomiting
5410695|NCT00004895|gastrointestinal stromal tumor|gastrointestinal stromal tumor
5410696|NCT00004255|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5410697|NCT00004255|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5410698|NCT00004255|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5410699|NCT00004255|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5410700|NCT00004255|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5410701|NCT00004255|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5410702|NCT00004255|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5410703|NCT00004255|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5410704|NCT00004255|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
5410705|NCT00004255|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
5410706|NCT00004255|refractory anemia with excess blasts|refractory anemia with excess blasts
5410707|NCT00004255|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
5410708|NCT00004255|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5410709|NCT00004255|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5410710|NCT00004255|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5410711|NCT00004255|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5410712|NCT00004255|graft versus host disease|graft versus host disease
5410713|NCT00004255|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
5410714|NCT00004232|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
5410715|NCT00004232|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
5410716|NCT00004232|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5410717|NCT00004232|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5410718|NCT00004232|monoclonal gammopathy of undetermined significance|monoclonal gammopathy of undetermined significance
5410783|NCT00004232|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5410719|NCT00004232|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5410720|NCT00004232|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5410721|NCT00004232|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
5410722|NCT00004232|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
5410723|NCT00004232|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
5410724|NCT00004232|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
5410725|NCT00004232|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5410726|NCT00004232|Burkitt lymphoma|burkitt lymphoma
5410727|NCT00004232|isolated plasmacytoma of bone|isolated plasmacytoma of bone
5410728|NCT00004232|extramedullary plasmacytoma|extramedullary plasmacytoma
5410729|NCT00004232|refractory multiple myeloma|refractory multiple myeloma
5410730|NCT00004232|stage 0 chronic lymphocytic leukemia|stage 0 chronic lymphocytic leukemia
5410731|NCT00004232|stage I multiple myeloma|stage i multiple myeloma
5410732|NCT00004232|stage II multiple myeloma|stage ii multiple myeloma
5410733|NCT00004232|stage III multiple myeloma|stage iii multiple myeloma
5410734|NCT00004232|stage I childhood lymphoblastic lymphoma|stage i childhood lymphoblastic lymphoma
5410735|NCT00004232|stage II childhood lymphoblastic lymphoma|stage ii childhood lymphoblastic lymphoma
5410736|NCT00004232|stage III childhood lymphoblastic lymphoma|stage iii childhood lymphoblastic lymphoma
5410737|NCT00004232|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
5410738|NCT00004232|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
5410739|NCT00004232|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
5410740|NCT00004232|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
5410741|NCT00004232|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5410742|NCT00004232|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5410743|NCT00004232|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5410744|NCT00004232|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5410745|NCT00004232|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5410746|NCT00004232|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5410747|NCT00004232|childhood diffuse large cell lymphoma|childhood diffuse large cell lymphoma
5410748|NCT00004232|childhood immunoblastic large cell lymphoma|childhood immunoblastic large cell lymphoma
5410749|NCT00004232|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5410750|NCT00004232|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5410751|NCT00004232|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5410752|NCT00004232|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
5410753|NCT00004232|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
5410754|NCT00004232|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
5410755|NCT00004232|untreated childhood acute myeloid leukemia and other myeloid malignancies|untreated childhood acute myeloid leukemia and other myeloid malignancies
5410756|NCT00004232|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
5410757|NCT00004232|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5410758|NCT00004232|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5410759|NCT00004232|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
5410760|NCT00004232|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
5410761|NCT00004232|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
5410762|NCT00004232|essential thrombocythemia|essential thrombocythemia
5410763|NCT00004232|untreated hairy cell leukemia|untreated hairy cell leukemia
5410764|NCT00004232|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
5410765|NCT00004232|refractory hairy cell leukemia|refractory hairy cell leukemia
5410766|NCT00004232|stage II childhood Hodgkin lymphoma|stage ii childhood hodgkin lymphoma
5410767|NCT00004232|stage I childhood Hodgkin lymphoma|stage i childhood hodgkin lymphoma
5410768|NCT00004232|stage III childhood Hodgkin lymphoma|stage iii childhood hodgkin lymphoma
5410769|NCT00004232|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
5410770|NCT00004232|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
5410771|NCT00004232|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
5410772|NCT00004232|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
5410773|NCT00004232|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
5410774|NCT00004232|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
5410775|NCT00004232|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
5410776|NCT00004232|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
5410777|NCT00004232|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
5410778|NCT00004232|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
5410779|NCT00004232|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
5410780|NCT00004232|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5410781|NCT00004232|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
5410782|NCT00004232|acute undifferentiated leukemia|acute undifferentiated leukemia
5434426|NCT00002307|Zidovudine|zidovudine
5410784|NCT00004232|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5410785|NCT00004232|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5410786|NCT00004232|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5410787|NCT00004232|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5410788|NCT00004232|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5410789|NCT00004232|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5410790|NCT00004232|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5410791|NCT00004232|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5410792|NCT00004232|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5410793|NCT00004232|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5410794|NCT00004232|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5410795|NCT00004232|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5410796|NCT00004232|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5410797|NCT00004232|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5410798|NCT00004232|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5410799|NCT00004232|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5410800|NCT00004232|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5410801|NCT00004232|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5410802|NCT00004232|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5410803|NCT00004232|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5410804|NCT00004232|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5410805|NCT00004232|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5410806|NCT00004232|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5410807|NCT00004232|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5410808|NCT00004232|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5410809|NCT00004232|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5410810|NCT00004232|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
5410811|NCT00004232|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
5410812|NCT00004232|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
5410813|NCT00004232|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
5410814|NCT00004232|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
5410815|NCT00004232|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5410816|NCT00004232|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5410817|NCT00004232|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5410818|NCT00004232|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5410819|NCT00004232|graft versus host disease|graft versus host disease
5410820|NCT00004232|prolymphocytic leukemia|prolymphocytic leukemia
5410821|NCT00004232|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
5410822|NCT00004232|primary systemic amyloidosis|primary systemic amyloidosis
5410823|NCT00004232|stage I childhood small noncleaved cell lymphoma|stage i childhood small noncleaved cell lymphoma
5410824|NCT00004232|stage I childhood large cell lymphoma|stage i childhood large cell lymphoma
5410825|NCT00004232|stage II childhood small noncleaved cell lymphoma|stage ii childhood small noncleaved cell lymphoma
5410826|NCT00004232|stage II childhood large cell lymphoma|stage ii childhood large cell lymphoma
5410827|NCT00004232|stage III childhood small noncleaved cell lymphoma|stage iii childhood small noncleaved cell lymphoma
5410828|NCT00004232|stage III childhood large cell lymphoma|stage iii childhood large cell lymphoma
5410829|NCT00004232|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
5410830|NCT00004232|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
5410831|NCT00004232|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
5410832|NCT00004232|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
5410833|NCT00004232|stage I mantle cell lymphoma|stage i mantle cell lymphoma
5410834|NCT00004232|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
5410835|NCT00004232|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
5410836|NCT00004232|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
5410837|NCT00004232|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
5410838|NCT00004232|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
5410839|NCT00004232|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
5410840|NCT00004232|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
5410841|NCT00004232|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
5410842|NCT00004232|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
5410843|NCT00004232|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
5410844|NCT00004232|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5410914|NCT00004068|untreated childhood brain stem glioma|untreated childhood brain stem glioma
5410845|NCT00004232|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5410846|NCT00004232|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5410847|NCT00004232|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
5410848|NCT00004232|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5410849|NCT00004232|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
5410850|NCT00004232|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
5410851|NCT00004232|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5410852|NCT00004232|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
5410853|NCT00004232|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
5410854|NCT00004232|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5410855|NCT00004232|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5410856|NCT00004232|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5410857|NCT00004232|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
5410858|NCT00004232|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5410859|NCT00004232|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
5410860|NCT00004232|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
5410861|NCT00004232|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
5410862|NCT00004232|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
5410863|NCT00004232|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5410864|NCT00004232|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
5410865|NCT00004232|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
5410866|NCT00004232|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5410867|NCT00004232|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5410868|NCT00004232|stage I marginal zone lymphoma|stage i marginal zone lymphoma
5410869|NCT00004232|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
5410870|NCT00004232|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5410871|NCT00004232|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5410872|NCT00004232|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5410873|NCT00004232|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5410874|NCT00004232|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
5410875|NCT00004232|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
5410876|NCT00004232|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5410877|NCT00004232|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5410878|NCT00004232|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5410879|NCT00004232|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
5410880|NCT00004180|adult liposarcoma|adult liposarcoma
5410881|NCT00004180|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
5410882|NCT00060593|Balance|balance
5410883|NCT00060593|Functional Connectivity|functional connectivity
5410884|NCT00060593|Healthy Volunteer|healthy volunteer
5410885|NCT00060593|HV|hv
5410886|NCT00060580|Retinal Measurements|retinal measurements
5410887|NCT00060580|Lutein in Vivo|lutein in vivo
5410888|NCT00060580|Raman Spectroscopy|raman spectroscopy
5410889|NCT00060580|Retinal Measurements of Lutein in Vivo in the Human Eye|retinal measurements of lutein in vivo in the human eye
5410890|NCT00060580|Healthy Volunteer|healthy volunteer
5410891|NCT00060580|HV|hv
5410892|NCT00060554|Elective PCI|elective pci
5410893|NCT00060554|Heart catherization|heart catherization
5410894|NCT00060554|Acute coronary syndromes|acute coronary syndromes
5410895|NCT00060502|cachexia|cachexia
5410896|NCT00060502|pancreatic cancer|pancreatic cancer
5410897|NCT00060502|infliximab|infliximab
5410898|NCT00060502|anorexia|anorexia
5410899|NCT00060502|anemia|anemia
5410900|NCT00060502|Remicade.|remicade.
5410901|NCT00060489|Bipolar Depression|bipolar depression
5410902|NCT00004094|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
5410903|NCT00004094|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5410904|NCT00004094|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5410905|NCT00004094|stage IV lymphoepithelioma of the oropharynx|stage iv lymphoepithelioma of the oropharynx
5410906|NCT00004094|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
5410907|NCT00004094|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
5410908|NCT00004094|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
5410909|NCT00004094|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5410910|NCT00004094|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5410911|NCT00004068|childhood high-grade cerebral astrocytoma|childhood high-grade cerebral astrocytoma
5410912|NCT00004068|childhood high-grade cerebellar astrocytoma|childhood high-grade cerebellar astrocytoma
5410913|NCT00004068|childhood oligodendroglioma|childhood oligodendroglioma
5410915|NCT00004068|untreated childhood cerebellar astrocytoma|untreated childhood cerebellar astrocytoma
5410916|NCT00004059|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5410917|NCT00004052|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5410918|NCT00004052|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5410919|NCT00004008|stage I ovarian epithelial cancer|stage i ovarian epithelial cancer
5410920|NCT00004008|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
5410921|NCT00004008|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5410922|NCT00004008|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5410923|NCT00004008|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5410924|NCT00060541|Brain Tumor|brain tumor
5410925|NCT00060541|Epilepsy|epilepsy
5410926|NCT00060541|Pituitary Adenoma|pituitary adenoma
5410927|NCT00060541|Parkinson's Disease|parkinson's disease
5410928|NCT00060541|Vascular Malformation|vascular malformation
5410929|NCT00060541|Neurosurgery|neurosurgery
5410930|NCT00060541|Glioblastoma|glioblastoma
5410931|NCT00060541|Astrocytoma|astrocytoma
5410932|NCT00060541|Oligodendroglioma|oligodendroglioma
5410933|NCT00060541|Spinal Arteriovenous Malformation|spinal arteriovenous malformation
5410934|NCT00060541|Oncogenes|oncogenes
5410935|NCT00060541|Proteomics|proteomics
5410936|NCT00060528|Immunotherapy|immunotherapy
5410937|NCT00060528|Cytokines|cytokines
5410940|NCT00060463|Emergency contraceptive pills|emergency contraceptive pills
5410941|NCT00060463|Pregnancy|pregnancy
5410942|NCT00060463|Sexually transmitted infection|sexually transmitted infection
5410943|NCT00060463|Chlamydia|chlamydia
5410944|NCT00060463|Gonorrhea|gonorrhea
5410945|NCT00060463|Trichomonas|trichomonas
5410946|NCT00060463|Contraception|contraception
5410947|NCT00060450|Ischemia-reperfusion lung injury|ischemia-reperfusion lung injury
5410949|NCT00060437|stage IV prostate cancer|stage iv prostate cancer
5410950|NCT00060437|recurrent prostate cancer|recurrent prostate cancer
5410951|NCT00060437|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5410952|NCT00060398|recurrent prostate cancer|recurrent prostate cancer
5410953|NCT00060398|anemia|anemia
5410954|NCT00060398|fatigue|fatigue
5410955|NCT00060385|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
5410956|NCT00060385|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
5410957|NCT00060385|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
5410958|NCT00060385|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
5410959|NCT00060385|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
5410960|NCT00060385|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
5410961|NCT00060385|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
5410962|NCT00060385|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
5410963|NCT00060385|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
5410964|NCT00060385|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
5410965|NCT00060385|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
5410966|NCT00060385|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
5410967|NCT00060385|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
5410968|NCT00060385|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5410969|NCT00060385|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
5410970|NCT00060385|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5410971|NCT00060385|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5410972|NCT00060346|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
5410973|NCT00060346|Rituximab|rituximab
5410974|NCT00060346|CHOP|chop
5410975|NCT00060333|recurrent melanoma|recurrent melanoma
5410976|NCT00060333|stage I melanoma|stage i melanoma
5410977|NCT00060333|stage II melanoma|stage ii melanoma
5410978|NCT00060333|stage III melanoma|stage iii melanoma
5410979|NCT00060320|stage IV breast cancer|stage iv breast cancer
5410980|NCT00060320|stage I breast cancer|stage i breast cancer
5410981|NCT00060320|stage II breast cancer|stage ii breast cancer
5410982|NCT00060320|stage IIIA breast cancer|stage iiia breast cancer
5410983|NCT00060320|stage IIIB breast cancer|stage iiib breast cancer
5410984|NCT00060320|stage IIIC breast cancer|stage iiic breast cancer
5410985|NCT00060320|hot flashes|hot flashes
5410986|NCT00060294|Waldenström macroglobulinemia|waldenström macroglobulinemia
5410987|NCT00060268|recurrent esophageal cancer|recurrent esophageal cancer
5410988|NCT00060268|stage I esophageal cancer|stage i esophageal cancer
5410989|NCT00060268|stage II esophageal cancer|stage ii esophageal cancer
5410990|NCT00060268|stage III esophageal cancer|stage iii esophageal cancer
5410991|NCT00060268|stage IV esophageal cancer|stage iv esophageal cancer
5410992|NCT00060255|stage IV breast cancer|stage iv breast cancer
5410993|NCT00060255|male breast cancer|male breast cancer
5410994|NCT00060255|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
5410995|NCT00060255|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
5410996|NCT00060255|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
5410997|NCT00060255|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5410998|NCT00060255|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5410999|NCT00060255|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5411000|NCT00060255|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5411001|NCT00060255|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
5411002|NCT00060255|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5411003|NCT00060255|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5411004|NCT00060255|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5411005|NCT00060255|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5411006|NCT00060255|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5411007|NCT00060255|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5411008|NCT00060255|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5411009|NCT00060255|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5411010|NCT00060255|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5411011|NCT00060255|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5411012|NCT00060255|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
5411013|NCT00060255|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
5411014|NCT00060255|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
5411015|NCT00060255|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5411016|NCT00060255|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5411017|NCT00060255|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5411018|NCT00060255|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5411019|NCT00060255|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
5411020|NCT00060255|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5411021|NCT00060255|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
5411022|NCT00060255|stage IIIA breast cancer|stage iiia breast cancer
5411023|NCT00060255|stage IIIB breast cancer|stage iiib breast cancer
5411024|NCT00060255|stage IIIC breast cancer|stage iiic breast cancer
5411025|NCT00060255|recurrent breast cancer|recurrent breast cancer
5411026|NCT00060255|primary systemic amyloidosis|primary systemic amyloidosis
5411027|NCT00060255|refractory multiple myeloma|refractory multiple myeloma
5411028|NCT00060255|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
5411029|NCT00060255|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
5411030|NCT00060255|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5411031|NCT00060255|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5411032|NCT00060255|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5411033|NCT00060255|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5411034|NCT00060255|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5411035|NCT00060255|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5411036|NCT00060255|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5411037|NCT00060255|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5411038|NCT00060255|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5411039|NCT00060255|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5411040|NCT00060242|anaplastic thyroid cancer|anaplastic thyroid cancer
5411041|NCT00060242|recurrent thyroid cancer|recurrent thyroid cancer
5411042|NCT00060203|stage III multiple myeloma|stage iii multiple myeloma
5411043|NCT00060203|refractory multiple myeloma|refractory multiple myeloma
5411044|NCT00060151|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5411045|NCT00060138|hypercalcemia of malignancy|hypercalcemia of malignancy
5411046|NCT00060138|stage IV breast cancer|stage iv breast cancer
5411047|NCT00060138|recurrent breast cancer|recurrent breast cancer
5411048|NCT00060138|bone metastases|bone metastases
5411049|NCT00060138|pain|pain
5411050|NCT00060099|cervical intraepithelial neoplasia grade 2|cervical intraepithelial neoplasia grade 2
5411051|NCT00060099|cervical intraepithelial neoplasia grade 3|cervical intraepithelial neoplasia grade 3
5411052|NCT00060099|human papilloma virus infection|human papilloma virus infection
5411053|NCT00060086|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5411054|NCT00060086|recurrent prostate cancer|recurrent prostate cancer
5411055|NCT00060021|oral complications|oral complications
5411056|NCT00060021|pain|pain
5411057|NCT00060021|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5411058|NCT00060021|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5411059|NCT00060021|chronic eosinophilic leukemia|chronic eosinophilic leukemia
5411060|NCT00060021|primary myelofibrosis|primary myelofibrosis
5411061|NCT00060021|chronic neutrophilic leukemia|chronic neutrophilic leukemia
5411062|NCT00060021|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5411063|NCT00060021|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5412032|NCT00058955|abuse|abuse
5411064|NCT00060021|disseminated neuroblastoma|disseminated neuroblastoma
5411065|NCT00060021|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
5411066|NCT00060021|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5411067|NCT00060021|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
5411068|NCT00060021|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
5411069|NCT00060021|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
5411070|NCT00060021|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
5411071|NCT00060021|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
5411072|NCT00060021|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5411073|NCT00060021|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5411074|NCT00060021|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5411075|NCT00060021|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5411076|NCT00060021|ovarian choriocarcinoma|ovarian choriocarcinoma
5411077|NCT00060021|ovarian embryonal carcinoma|ovarian embryonal carcinoma
5411078|NCT00060021|ovarian yolk sac tumor|ovarian yolk sac tumor
5411079|NCT00060021|ovarian immature teratoma|ovarian immature teratoma
5411080|NCT00060021|ovarian mature teratoma|ovarian mature teratoma
5411081|NCT00060021|ovarian monodermal and highly specialized teratoma|ovarian monodermal and highly specialized teratoma
5411082|NCT00060021|ovarian polyembryoma|ovarian polyembryoma
5411083|NCT00060021|ovarian mixed germ cell tumor|ovarian mixed germ cell tumor
5411084|NCT00060021|high risk metastatic gestational trophoblastic tumor|high risk metastatic gestational trophoblastic tumor
5411085|NCT00060021|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5411086|NCT00060021|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5411087|NCT00060021|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5411088|NCT00060021|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5411089|NCT00060021|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5411090|NCT00060021|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5411091|NCT00060021|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5411092|NCT00060021|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5411093|NCT00060021|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5411094|NCT00060021|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5411095|NCT00060021|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5411096|NCT00060021|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5411097|NCT00060021|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5411098|NCT00060021|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5411099|NCT00060021|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5411100|NCT00060021|recurrent neuroblastoma|recurrent neuroblastoma
5411101|NCT00060021|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5411102|NCT00060021|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
5411103|NCT00060021|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
5411104|NCT00060021|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5411105|NCT00060021|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5411106|NCT00060021|refractory hairy cell leukemia|refractory hairy cell leukemia
5411107|NCT00060021|refractory multiple myeloma|refractory multiple myeloma
5411108|NCT00060021|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5411109|NCT00060021|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5411110|NCT00060021|stage I multiple myeloma|stage i multiple myeloma
5411111|NCT00060021|stage II multiple myeloma|stage ii multiple myeloma
5411112|NCT00060021|stage III multiple myeloma|stage iii multiple myeloma
5411113|NCT00060021|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
5411114|NCT00060021|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5411115|NCT00060021|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5411116|NCT00060021|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5411117|NCT00060021|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5411118|NCT00060021|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5411119|NCT00060021|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5411120|NCT00060021|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5411121|NCT00060021|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5411122|NCT00060021|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5411123|NCT00060021|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5411124|NCT00060021|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5411125|NCT00060021|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5411126|NCT00060021|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
5411127|NCT00060021|stage IIIA breast cancer|stage iiia breast cancer
5411128|NCT00060021|stage IIIB breast cancer|stage iiib breast cancer
5411129|NCT00060021|stage IIIC breast cancer|stage iiic breast cancer
5411130|NCT00060021|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5411131|NCT00060021|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5411132|NCT00060021|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5411133|NCT00060021|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5411134|NCT00060021|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5411135|NCT00060021|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5411136|NCT00060021|stage IV breast cancer|stage iv breast cancer
5411137|NCT00060021|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5411138|NCT00060021|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5411139|NCT00060021|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5411140|NCT00060021|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5411141|NCT00060021|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5411142|NCT00060021|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5411143|NCT00060021|testicular choriocarcinoma and embryonal carcinoma|testicular choriocarcinoma and embryonal carcinoma
5411144|NCT00060021|testicular choriocarcinoma and seminoma|testicular choriocarcinoma and seminoma
5411145|NCT00060021|testicular choriocarcinoma and teratoma|testicular choriocarcinoma and teratoma
5411146|NCT00060021|testicular choriocarcinoma and yolk sac tumor|testicular choriocarcinoma and yolk sac tumor
5411147|NCT00060021|testicular embryonal carcinoma and seminoma|testicular embryonal carcinoma and seminoma
5411148|NCT00060021|testicular embryonal carcinoma and teratoma with seminoma|testicular embryonal carcinoma and teratoma with seminoma
5411149|NCT00060021|testicular embryonal carcinoma and teratoma|testicular embryonal carcinoma and teratoma
5411150|NCT00060021|testicular embryonal carcinoma and yolk sac tumor with seminoma|testicular embryonal carcinoma and yolk sac tumor with seminoma
5411151|NCT00060021|testicular embryonal carcinoma and yolk sac tumor|testicular embryonal carcinoma and yolk sac tumor
5411152|NCT00060021|testicular embryonal carcinoma|testicular embryonal carcinoma
5411153|NCT00060021|testicular teratoma|testicular teratoma
5411154|NCT00060021|testicular yolk sac tumor and teratoma with seminoma|testicular yolk sac tumor and teratoma with seminoma
5411155|NCT00060021|testicular yolk sac tumor and teratoma|testicular yolk sac tumor and teratoma
5411156|NCT00060021|testicular yolk sac tumor|testicular yolk sac tumor
5411157|NCT00060021|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5411158|NCT00060021|testicular choriocarcinoma|testicular choriocarcinoma
5411159|NCT00060021|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
5411160|NCT00060021|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
5411161|NCT00060021|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
5411162|NCT00060021|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
5411163|NCT00060021|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5411164|NCT00060021|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5411165|NCT00060021|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5411166|NCT00060021|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5411167|NCT00060021|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5411168|NCT00060021|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5411169|NCT00060021|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5411170|NCT00060021|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5411171|NCT00060021|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5411172|NCT00060008|neurofibromatosis type 1|neurofibromatosis type 1
5411173|NCT00060008|plexiform neurofibroma|plexiform neurofibroma
5411174|NCT00059995|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5411175|NCT00059995|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
5411176|NCT00059995|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5411177|NCT00059995|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5411178|NCT00059995|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
5411179|NCT00059995|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5411180|NCT00059982|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
5411181|NCT00059982|stage II pancreatic cancer|stage ii pancreatic cancer
5411182|NCT00059982|stage III pancreatic cancer|stage iii pancreatic cancer
5411183|NCT00059982|stage IV pancreatic cancer|stage iv pancreatic cancer
5411184|NCT00059943|stage IV breast cancer|stage iv breast cancer
5411185|NCT00059943|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5411186|NCT00059943|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5411187|NCT00059943|recurrent breast cancer|recurrent breast cancer
5411188|NCT00059943|stage IV prostate cancer|stage iv prostate cancer
5411189|NCT00059943|recurrent prostate cancer|recurrent prostate cancer
5411190|NCT00059930|liver metastases|liver metastases
5411191|NCT00059930|stage IV colon cancer|stage iv colon cancer
5411192|NCT00059930|stage IV rectal cancer|stage iv rectal cancer
5411193|NCT00059930|adenocarcinoma of the colon|adenocarcinoma of the colon
5411194|NCT00059930|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5411195|NCT00059930|recurrent colon cancer|recurrent colon cancer
5411196|NCT00059930|recurrent rectal cancer|recurrent rectal cancer
5411197|NCT00059917|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5411198|NCT00059904|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5411199|NCT00059904|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5411200|NCT00059904|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5411201|NCT00059891|perioperative/postoperative complications|perioperative/postoperative complications
5411202|NCT00059891|stage II anal cancer|stage ii anal cancer
5411203|NCT00059891|stage I anal cancer|stage i anal cancer
5411204|NCT00059891|stage III anal cancer|stage iii anal cancer
5411205|NCT00059891|stage I rectal cancer|stage i rectal cancer
5411206|NCT00059891|stage II rectal cancer|stage ii rectal cancer
5411207|NCT00059891|stage III rectal cancer|stage iii rectal cancer
5411208|NCT00059878|infection|infection
5411209|NCT00059878|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5411210|NCT00059865|advanced adult primary liver cancer|advanced adult primary liver cancer
5411211|NCT00059865|unresectable gallbladder cancer|unresectable gallbladder cancer
5411212|NCT00059865|unresectable extrahepatic bile duct cancer|unresectable extrahepatic bile duct cancer
5411213|NCT00059865|adult primary cholangiocellular carcinoma|adult primary cholangiocellular carcinoma
5411214|NCT00059852|male breast cancer|male breast cancer
5411215|NCT00059852|recurrent breast cancer|recurrent breast cancer
5411216|NCT00059852|stage IV breast cancer|stage iv breast cancer
5411217|NCT00059839|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5411218|NCT00059826|stage I pancreatic cancer|stage i pancreatic cancer
5411219|NCT00059826|stage II pancreatic cancer|stage ii pancreatic cancer
5411220|NCT00059826|stage III pancreatic cancer|stage iii pancreatic cancer
5411221|NCT00059826|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
5411222|NCT00059800|recurrent melanoma|recurrent melanoma
5411223|NCT00059800|stage 0 melanoma|stage 0 melanoma
5411224|NCT00059800|stage I melanoma|stage i melanoma
5411225|NCT00059800|stage II melanoma|stage ii melanoma
5411226|NCT00059800|stage III melanoma|stage iii melanoma
5411227|NCT00059800|stage IV melanoma|stage iv melanoma
5411228|NCT00059761|limited stage small cell lung cancer|limited stage small cell lung cancer
5411229|NCT00059735|kidney cancer|kidney cancer
5411230|NCT00059735|kidney neoplasms|kidney neoplasms
5411231|NCT00059735|renal cell cancer|renal cell cancer
5411232|NCT00043108|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
5411233|NCT00043108|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5411234|NCT00043108|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5411235|NCT00030524|stage III colon cancer|stage iii colon cancer
5411236|NCT00030524|stage IV colon cancer|stage iv colon cancer
5411237|NCT00030524|stage III rectal cancer|stage iii rectal cancer
5411238|NCT00030524|stage IV rectal cancer|stage iv rectal cancer
5411239|NCT00030524|recurrent colon cancer|recurrent colon cancer
5411240|NCT00030524|recurrent rectal cancer|recurrent rectal cancer
5411241|NCT00030524|adenocarcinoma of the colon|adenocarcinoma of the colon
5411242|NCT00030524|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5411243|NCT00027599|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5411244|NCT00027599|stage I prostate cancer|stage i prostate cancer
5411245|NCT00027599|stage IIB prostate cancer|stage iib prostate cancer
5411246|NCT00027599|stage IIA prostate cancer|stage iia prostate cancer
5411247|NCT00027599|stage III prostate cancer|stage iii prostate cancer
5411248|NCT00027599|stage IV prostate cancer|stage iv prostate cancer
5411249|NCT00027599|recurrent prostate cancer|recurrent prostate cancer
5411250|NCT00017134|ovarian epithelial cancer|ovarian epithelial cancer
5411251|NCT00016315|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5411252|NCT00016315|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5411253|NCT00006225|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5411254|NCT00006225|stage IV breast cancer|stage iv breast cancer
5411255|NCT00006225|stage IIIA breast cancer|stage iiia breast cancer
5411256|NCT00006225|recurrent breast cancer|recurrent breast cancer
5411257|NCT00006225|stage IIIB breast cancer|stage iiib breast cancer
5411258|NCT00006225|stage IIIC breast cancer|stage iiic breast cancer
5411259|NCT00006225|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5411260|NCT00006225|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
5411261|NCT00006225|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
5411262|NCT00006225|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
5411263|NCT00006225|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5411264|NCT00006225|isolated plasmacytoma of bone|isolated plasmacytoma of bone
5411265|NCT00006225|extramedullary plasmacytoma|extramedullary plasmacytoma
5411266|NCT00006225|refractory multiple myeloma|refractory multiple myeloma
5411267|NCT00006225|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
5411268|NCT00006225|stage I multiple myeloma|stage i multiple myeloma
5411269|NCT00006225|stage II multiple myeloma|stage ii multiple myeloma
5411270|NCT00006225|stage III multiple myeloma|stage iii multiple myeloma
5411271|NCT00006225|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
5411272|NCT00006225|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5411273|NCT00006225|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5411274|NCT00006225|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5411275|NCT00006225|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5411276|NCT00006225|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
5411277|NCT00006225|acute undifferentiated leukemia|acute undifferentiated leukemia
5411278|NCT00006225|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5411279|NCT00006225|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5411280|NCT00006225|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5411281|NCT00006225|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5411282|NCT00006225|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5411283|NCT00006225|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5411284|NCT00006225|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5411285|NCT00006225|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5411286|NCT00006225|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5411287|NCT00006225|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5411288|NCT00006225|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5411289|NCT00006225|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5411290|NCT00006225|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5411291|NCT00006225|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5411292|NCT00006225|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5411293|NCT00006225|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5411294|NCT00006225|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5411295|NCT00006225|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5411296|NCT00006225|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5411297|NCT00006225|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5411298|NCT00006225|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5411299|NCT00006225|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5411300|NCT00006225|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5411301|NCT00006225|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5411302|NCT00006225|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5411303|NCT00006225|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5411304|NCT00006225|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5411305|NCT00006225|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
5411306|NCT00006225|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
5411307|NCT00006225|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
5411308|NCT00006225|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
5411309|NCT00006225|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
5411310|NCT00006225|primary central nervous system lymphoma|primary central nervous system lymphoma
5411311|NCT00006225|male breast cancer|male breast cancer
5411312|NCT00006225|intraocular lymphoma|intraocular lymphoma
5411313|NCT00006225|stage I mantle cell lymphoma|stage i mantle cell lymphoma
5411314|NCT00006225|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
5411315|NCT00006225|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
5411316|NCT00006225|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
5411317|NCT00006225|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
5411318|NCT00006225|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
5411319|NCT00006225|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
5411320|NCT00006225|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
5411321|NCT00006225|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
5411322|NCT00006225|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
5411323|NCT00006225|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
5411324|NCT00006225|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5411325|NCT00006225|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5411326|NCT00006225|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5411327|NCT00006225|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
5411328|NCT00006225|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5411329|NCT00006225|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
5411330|NCT00006225|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
5411331|NCT00006225|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5411332|NCT00006225|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
5411333|NCT00006225|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
5434427|NCT00002307|Stavudine|stavudine
5411334|NCT00006225|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5411335|NCT00006225|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5411336|NCT00006225|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5411337|NCT00006225|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
5411338|NCT00006225|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5411339|NCT00006225|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
5411340|NCT00006225|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
5411341|NCT00006225|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
5411342|NCT00006225|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
5411343|NCT00006225|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5411344|NCT00006225|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5411345|NCT00006225|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
5411346|NCT00006225|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
5411347|NCT00006225|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
5411348|NCT00006225|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
5411349|NCT00006225|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5411350|NCT00006225|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5411351|NCT00006225|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5411352|NCT00006225|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5411353|NCT00006225|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5411354|NCT00006225|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5411355|NCT00006225|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
5411356|NCT00006225|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
5411357|NCT00006225|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5411358|NCT00006225|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5411359|NCT00006225|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5411360|NCT00005793|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
5411361|NCT00005793|adult acute erythroid leukemia (M6)|adult acute erythroid leukemia (m6)
5411362|NCT00005793|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
5411363|NCT00005793|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
5411364|NCT00005793|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
5411365|NCT00005793|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
5411366|NCT00005793|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
5411367|NCT00005793|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
5411368|NCT00005793|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
5411369|NCT00005793|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5411370|NCT00005793|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5411371|NCT00005793|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5411372|NCT00005793|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5411373|NCT00004127|stage IV gastric cancer|stage iv gastric cancer
5411374|NCT00004127|recurrent gastric cancer|recurrent gastric cancer
5411375|NCT00004127|stage IV esophageal cancer|stage iv esophageal cancer
5411376|NCT00004127|recurrent esophageal cancer|recurrent esophageal cancer
5411377|NCT00004127|adenocarcinoma of the stomach|adenocarcinoma of the stomach
5411378|NCT00004127|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
5411379|NCT00004095|stage IV colon cancer|stage iv colon cancer
5411380|NCT00004095|stage IV breast cancer|stage iv breast cancer
5411381|NCT00004095|recurrent breast cancer|recurrent breast cancer
5411382|NCT00004095|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5411383|NCT00004095|recurrent pancreatic cancer|recurrent pancreatic cancer
5411384|NCT00004095|stage IV rectal cancer|stage iv rectal cancer
5411385|NCT00004095|recurrent colon cancer|recurrent colon cancer
5411386|NCT00004095|recurrent rectal cancer|recurrent rectal cancer
5411387|NCT00004095|stage IV renal cell cancer|stage iv renal cell cancer
5411388|NCT00004095|recurrent renal cell cancer|recurrent renal cell cancer
5411389|NCT00004095|extensive stage small cell lung cancer|extensive stage small cell lung cancer
5411390|NCT00004095|recurrent small cell lung cancer|recurrent small cell lung cancer
5411391|NCT00004095|recurrent bladder cancer|recurrent bladder cancer
5411392|NCT00004095|stage IV bladder cancer|stage iv bladder cancer
5411393|NCT00004095|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5411394|NCT00004095|stage IV pancreatic cancer|stage iv pancreatic cancer
5411395|NCT00059748|Central Nervous System Abnormalities|central nervous system abnormalities
5411396|NCT00059748|Arthropathy|arthropathy
5411397|NCT00059748|Urticaria|urticaria
5411398|NCT00059748|Papilledema|papilledema
5411399|NCT00059748|Autoinflammation|autoinflammation
5411400|NCT00059748|Neonatal Onset Multisystem Imflammatory|neonatal onset multisystem imflammatory
5411402|NCT00059748|NOMID|nomid
5411403|NCT00019435|stage IV colon cancer|stage iv colon cancer
5411404|NCT00019435|stage IV breast cancer|stage iv breast cancer
5411405|NCT00019435|recurrent breast cancer|recurrent breast cancer
5411406|NCT00019435|stage IV gastric cancer|stage iv gastric cancer
5411407|NCT00019435|recurrent gastric cancer|recurrent gastric cancer
5411408|NCT00019435|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5411409|NCT00019435|recurrent pancreatic cancer|recurrent pancreatic cancer
5411410|NCT00019435|recurrent colon cancer|recurrent colon cancer
5411411|NCT00019435|stage IV esophageal cancer|stage iv esophageal cancer
5411412|NCT00019435|recurrent esophageal cancer|recurrent esophageal cancer
5411413|NCT00019435|recurrent bladder cancer|recurrent bladder cancer
5411414|NCT00019435|stage IV bladder cancer|stage iv bladder cancer
5411415|NCT00019435|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5411416|NCT00019435|stage IV pancreatic cancer|stage iv pancreatic cancer
5411417|NCT00002765|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5411418|NCT00002765|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
5411419|NCT00002765|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5411420|NCT00002765|Waldenström macroglobulinemia|waldenström macroglobulinemia
5411421|NCT00002765|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5411422|NCT00002765|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5411423|NCT00002765|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5411424|NCT00002765|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5411425|NCT00002765|refractory hairy cell leukemia|refractory hairy cell leukemia
5411426|NCT00002765|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5411427|NCT00002765|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5411428|NCT00002765|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5411429|NCT00002765|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5411430|NCT00002765|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5411431|NCT00002765|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5411432|NCT00002765|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5411433|NCT00002765|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5411434|NCT00002765|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5411435|NCT00002765|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5411436|NCT00002765|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
5411437|NCT00002765|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
5411438|NCT00002765|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
5411439|NCT00002765|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
5411440|NCT00002765|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
5411441|NCT00002765|prolymphocytic leukemia|prolymphocytic leukemia
5411442|NCT00002765|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5411443|NCT00002765|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
5411444|NCT00002765|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5411445|NCT00002765|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5411446|NCT00002765|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5411447|NCT00002765|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5411448|NCT00002765|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5411449|NCT00059722|NSCLC|nsclc
5411450|NCT00059722|locally advanced or metastatic|locally advanced or metastatic
5411451|NCT00059722|second-line|second-line
5411452|NCT00059709|Conflict Resolution training|conflict resolution training
5411453|NCT00059709|Children|children
5411454|NCT00059696|Constraint-Induced Movement Therapy|constraint-induced movement therapy
5411455|NCT00059696|CI therapy|ci therapy
5411456|NCT00059696|Rehabilitation|rehabilitation
5411457|NCT00059696|Cerebrovascular accident|cerebrovascular accident
5411458|NCT00059696|Upper extremity|upper extremity
5411459|NCT00059696|Concentrated, extended practice|concentrated, extended practice
5411460|NCT00059696|Limb restraint|limb restraint
5411461|NCT00059696|Motor Deficits|motor deficits
5411462|NCT00059683|Preterm Birth|preterm birth
5411463|NCT00059683|Premature Birth|premature birth
5411464|NCT00059683|Cervical cerclage|cervical cerclage
5411465|NCT00059683|Vaginal ultrasound|vaginal ultrasound
5411466|NCT00059683|Cervical length|cervical length
5411467|NCT00018941|stage IV renal cell cancer|stage iv renal cell cancer
5411468|NCT00018941|recurrent renal cell cancer|recurrent renal cell cancer
5411469|NCT00005837|recurrent cervical cancer|recurrent cervical cancer
5411470|NCT00005837|cervical squamous cell carcinoma|cervical squamous cell carcinoma
5411471|NCT00005025|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5411472|NCT00005025|fallopian tube cancer|fallopian tube cancer
5411473|NCT00005025|primary peritoneal cavity cancer|primary peritoneal cavity cancer
5411474|NCT00002971|recurrent adult brain tumor|recurrent adult brain tumor
5411475|NCT00002971|adult glioblastoma|adult glioblastoma
5411476|NCT00002971|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5411477|NCT00002971|adult giant cell glioblastoma|adult giant cell glioblastoma
5411478|NCT00002971|adult gliosarcoma|adult gliosarcoma
5411479|NCT00059670|UES|ues
5411480|NCT00059670|Dysphagia|dysphagia
5411481|NCT00059657|Ecraprost in lipid emulsion|ecraprost in lipid emulsion
5411482|NCT00059657|CLI|cli
5411483|NCT00059657|peripheral, vascular|peripheral, vascular
5411484|NCT00059657|amputation|amputation
5411485|NCT00059657|Angioplasty|angioplasty
5411486|NCT00059657|by-pass|by-pass
5411487|NCT00059657|Critical Limb Ischemia due to peripheral arterial disease|critical limb ischemia due to peripheral arterial disease
5411488|NCT00059644|Ecraprost in lipid emulsion|ecraprost in lipid emulsion
5411489|NCT00059644|CLI|cli
5411490|NCT00059644|peripheral|peripheral
5411491|NCT00059644|vascular|vascular
5411492|NCT00059644|amputation|amputation
5411493|NCT00059644|Critical Limb Ischemia due to peripheral arterial disease|critical limb ischemia due to peripheral arterial disease
5411494|NCT00003933|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5411495|NCT00003926|soft tissue sarcoma|soft tissue sarcoma
5411496|NCT00003926|regional neuroblastoma|regional neuroblastoma
5411497|NCT00003926|disseminated neuroblastoma|disseminated neuroblastoma
5411498|NCT00003926|recurrent Wilms tumor|recurrent wilms tumor
5411499|NCT00003926|recurrent retinoblastoma|recurrent retinoblastoma
5411500|NCT00003926|recurrent adult brain tumor|recurrent adult brain tumor
5411501|NCT00003926|adult rhabdomyosarcoma|adult rhabdomyosarcoma
5411502|NCT00003926|ovarian germ cell tumor|ovarian germ cell tumor
5411503|NCT00003926|chordoma|chordoma
5411504|NCT00003926|ovarian sarcoma|ovarian sarcoma
5411505|NCT00003926|unresectable neuroblastoma|unresectable neuroblastoma
5411506|NCT00003926|desmoplastic small round cell tumor|desmoplastic small round cell tumor
5411507|NCT00003926|rhabdomyosarcoma|rhabdomyosarcoma
5411508|NCT00003926|Ewing sarcoma|ewing sarcoma
5411509|NCT00003926|neuroectodermal tumor|neuroectodermal tumor
5411510|NCT00003926|teratoma|teratoma
5411511|NCT00003926|malignant testicular germ cell tumor|malignant testicular germ cell tumor
5411512|NCT00003926|malignant ovarian germ cell tumor|malignant ovarian germ cell tumor
5411513|NCT00003926|extragonadal germ cell tumor|extragonadal germ cell tumor
5411514|NCT00003926|malignant germ cell tumor|malignant germ cell tumor
5411515|NCT00003926|hepatoblastoma|hepatoblastoma
5411516|NCT00003926|liver cancer|liver cancer
5411517|NCT00003926|medulloblastoma|medulloblastoma
5411518|NCT00003926|cerebellar astrocytoma|cerebellar astrocytoma
5411519|NCT00003926|brain stem glioma|brain stem glioma
5411520|NCT00003926|glioma|glioma
5411521|NCT00003926|cerebral astrocytoma|cerebral astrocytoma
5411522|NCT00003926|ependymoma|ependymoma
5411523|NCT00003925|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5411524|NCT00003802|iris melanoma|iris melanoma
5411525|NCT00003802|ciliary body and choroid melanoma, small size|ciliary body and choroid melanoma, small size
5411526|NCT00003802|ciliary body and choroid melanoma, medium/large size|ciliary body and choroid melanoma, medium/large size
5411527|NCT00003802|extraocular extension melanoma|extraocular extension melanoma
5411528|NCT00003802|recurrent intraocular melanoma|recurrent intraocular melanoma
5411529|NCT00003802|stage IV melanoma|stage iv melanoma
5411530|NCT00003802|recurrent melanoma|recurrent melanoma
5411531|NCT00003797|recurrent pancreatic cancer|recurrent pancreatic cancer
5411532|NCT00003797|stage IV pancreatic cancer|stage iv pancreatic cancer
5411533|NCT00059631|Prostate Cancer|prostate cancer
5411534|NCT00059631|Advanced Androgen-Independent Prostate Cancer|advanced androgen-independent prostate cancer
5411535|NCT00059631|AI-PCa|ai-pca
5411536|NCT00059631|Advanced Prostate Cancer|advanced prostate cancer
5411537|NCT00059631|Novantrone|novantrone
5411538|NCT00059631|Mitoxantrone|mitoxantrone
5411539|NCT00059631|PS-341|ps-341
5411540|NCT00059631|Bortezomib|bortezomib
5411541|NCT00059631|Velcade|velcade
5411542|NCT00059631|LDP-341|ldp-341
5411543|NCT00059631|MLN341|mln341
5411544|NCT00059631|20S proteasome|20s proteasome
5411545|NCT00059618|Platinum Resistant|platinum resistant
5411546|NCT00059618|Taxane Resistant|taxane resistant
5411547|NCT00059618|Ovarian Cancer|ovarian cancer
5411548|NCT00059618|Primary Peritoneal Cancer|primary peritoneal cancer
5411549|NCT00059618|Fallopian Tube Cancer|fallopian tube cancer
5411550|NCT00059618|Bortezomib|bortezomib
5411551|NCT00059618|PS-341|ps-341
5411552|NCT00059618|Velcade|velcade
5411553|NCT00059618|LDP-341|ldp-341
5411554|NCT00059618|MLN341|mln341
5411555|NCT00059618|Carboplatin|carboplatin
5411556|NCT00059618|Paraplatin|paraplatin
5411557|NCT00059605|Non-Small Cell Lung Cancer|non-small cell lung cancer
5411558|NCT00059605|Small Cell Lung Cancer|small cell lung cancer
5411559|NCT00059605|Lung Cancer|lung cancer
5411560|NCT00059605|NSCLC|nsclc
5411561|NCT00059605|SCLC|sclc
5411562|NCT00059605|DOTAP:Chol-fus1|dotap:chol-fus1
5411563|NCT00059605|gene|gene
5411564|NCT00059605|gene transfer|gene transfer
5411565|NCT00003757|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
5411566|NCT00003757|refractory hairy cell leukemia|refractory hairy cell leukemia
5411567|NCT00003649|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5411568|NCT00003649|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5411569|NCT00003649|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5411570|NCT00003649|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
5411571|NCT00003627|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
5411572|NCT00003627|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5411573|NCT00003627|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
5411574|NCT00003627|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5411575|NCT00003484|localized resectable neuroblastoma|localized resectable neuroblastoma
5411576|NCT00003484|recurrent adult brain tumor|recurrent adult brain tumor
5411577|NCT00003484|adult craniopharyngioma|adult craniopharyngioma
5411578|NCT00003484|adult medulloblastoma|adult medulloblastoma
5411579|NCT00003484|adult meningioma|adult meningioma
5411580|NCT00003484|adult glioblastoma|adult glioblastoma
5411581|NCT00003484|adult oligodendroglioma|adult oligodendroglioma
5411582|NCT00003484|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5411583|NCT00003484|adult mixed glioma|adult mixed glioma
5411584|NCT00003484|adult pineal parenchymal tumor|adult pineal parenchymal tumor
5411585|NCT00003484|adult central nervous system germ cell tumor|adult central nervous system germ cell tumor
5411586|NCT00003484|adult grade III meningioma|adult grade iii meningioma
5411587|NCT00003484|adult pilocytic astrocytoma|adult pilocytic astrocytoma
5411588|NCT00003484|adult giant cell glioblastoma|adult giant cell glioblastoma
5411589|NCT00003484|adult gliosarcoma|adult gliosarcoma
5411590|NCT00003436|untreated childhood acute myeloid leukemia and other myeloid malignancies|untreated childhood acute myeloid leukemia and other myeloid malignancies
5411591|NCT00003436|childhood acute promyelocytic leukemia (M3)|childhood acute promyelocytic leukemia (m3)
5411592|NCT00003436|refractory anemia with excess blasts|refractory anemia with excess blasts
5411593|NCT00003436|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
5411594|NCT00003436|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5411595|NCT00003436|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5411596|NCT00003436|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5411597|NCT00003436|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
5411598|NCT00059579|Reward|reward
5411599|NCT00059579|Cortex|cortex
5411600|NCT00059579|Dopamine|dopamine
5411601|NCT00059579|Neuroimaging|neuroimaging
5411602|NCT00059579|Strirtum|strirtum
5411603|NCT00059579|Major Depressive Disorder (MDD)|major depressive disorder (mdd)
5411604|NCT00059579|Melancholic Features|melancholic features
5411605|NCT00059579|Brain Imaging|brain imaging
5411606|NCT00059579|Functional Magnetic Resonance Imaging (fMRI)|functional magnetic resonance imaging (fmri)
5411607|NCT00059579|Dopaminergic Mechanisms|dopaminergic mechanisms
5411608|NCT00059579|Anhedonia|anhedonia
5411609|NCT00059579|Depression|depression
5411610|NCT00059579|Major Depressive Disorder|major depressive disorder
5411612|NCT00059579|Healthy Volunteer|healthy volunteer
5411613|NCT00059579|HV|hv
5411614|NCT00059553|spinal cord injury|spinal cord injury
5411615|NCT00059553|walking|walking
5411616|NCT00059553|training|training
5411617|NCT00059553|treadmill|treadmill
5411618|NCT00059553|incomplete spinal cord injury|incomplete spinal cord injury
5411619|NCT00059540|NICHD Neonatal Research Network|nichd neonatal research network
5411620|NCT00059540|Maternal Lifestyle Study|maternal lifestyle study
5411621|NCT00059540|Cocaine abuse|cocaine abuse
5411622|NCT00059540|Cocaine dependence|cocaine dependence
5411623|NCT00059540|Opiate abuse|opiate abuse
5411624|NCT00059540|Opiate dependence|opiate dependence
5411625|NCT00059540|Follow-up|follow-up
5411626|NCT00059540|Neurodevelopmental outcome|neurodevelopmental outcome
5411627|NCT00059540|Substance-related disorders|substance-related disorders
5411628|NCT00059527|Physical Activity|physical activity
5411629|NCT00059527|Nutrition|nutrition
5411630|NCT00059527|Self Efficacy|self efficacy
5411631|NCT00059527|Middle School|middle school
5411632|NCT00059527|Intervention|intervention
5411633|NCT00059514|Youth|youth
5411634|NCT00059514|Adolescents|adolescents
5411635|NCT00059514|Smoking cessation|smoking cessation
5411636|NCT00059514|Smoking prevention|smoking prevention
5411637|NCT00059514|Risk factors|risk factors
5411638|NCT00059514|Arab Americans|arab americans
5411639|NCT00059449|Enterocolitis|enterocolitis
5411640|NCT00005836|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5411641|NCT00005836|primary peritoneal cavity cancer|primary peritoneal cavity cancer
5411642|NCT00059501|Postural Stability|postural stability
5411643|NCT00059501|EEG|eeg
5411644|NCT00059501|Aging|aging
5411645|NCT00059501|Falls|falls
5411646|NCT00059501|Healthy Volunteer|healthy volunteer
5411647|NCT00059501|HV|hv
5411648|NCT00059475|Adjuvant Therapy|adjuvant therapy
5411649|NCT00059475|MART-1 Peptides|mart-1 peptides
5411650|NCT00059475|GP100 Peptide|gp100 peptide
5411651|NCT00059475|Immunologic Response|immunologic response
5411652|NCT00059475|Melanoma|melanoma
5411653|NCT00059436|Muscle strengthening|muscle strengthening
5411654|NCT00059436|Skeletal muscle Contractions|skeletal muscle contractions
5411655|NCT00059436|Rehabilitative exercise|rehabilitative exercise
5411656|NCT00059410|Alzheimer disease|alzheimer disease
5411657|NCT00059410|Caregivers|caregivers
5411658|NCT00059410|African Americans|african americans
5411659|NCT00059410|Perceptions|perceptions
5411660|NCT00059410|Cultural Competency|cultural competency
5411661|NCT00059423|Leukapheresis|leukapheresis
5411662|NCT00059423|G-CSF|g-csf
5411663|NCT00059423|Dexamethasone|dexamethasone
5411664|NCT00059423|mRNA|mrna
5411665|NCT00059423|Benign Ethnic Neutropenia|benign ethnic neutropenia
5411666|NCT00059423|BEN|ben
5411667|NCT00059423|Healthy Volunteer|healthy volunteer
5411668|NCT00059423|HV|hv
5411669|NCT00059397|Hepatitis C|hepatitis c
5411670|NCT00003432|stage IV breast cancer|stage iv breast cancer
5411671|NCT00003346|stage III melanoma|stage iii melanoma
5411672|NCT00003346|stage IV melanoma|stage iv melanoma
5411673|NCT00003346|recurrent melanoma|recurrent melanoma
5411674|NCT00003341|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
5411675|NCT00003341|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5411676|NCT00003341|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5411677|NCT00003341|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5411678|NCT00003341|refractory multiple myeloma|refractory multiple myeloma
5411679|NCT00003341|Waldenström macroglobulinemia|waldenström macroglobulinemia
5411680|NCT00003341|stage II multiple myeloma|stage ii multiple myeloma
5411681|NCT00003341|stage III multiple myeloma|stage iii multiple myeloma
5411682|NCT00003341|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
5411683|NCT00003341|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5411684|NCT00003341|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5411685|NCT00003341|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5411686|NCT00003341|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5411687|NCT00003341|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5411688|NCT00003341|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5411689|NCT00003341|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5411690|NCT00003341|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5411691|NCT00003341|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5411692|NCT00003341|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5411693|NCT00003341|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5411694|NCT00003341|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5411695|NCT00003341|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5411696|NCT00003341|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5411697|NCT00003341|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5411698|NCT00003341|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5411699|NCT00003341|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5411700|NCT00003341|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5411701|NCT00003341|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5411702|NCT00003341|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5411703|NCT00003341|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5411704|NCT00003341|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5411705|NCT00003341|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5411706|NCT00003341|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5411707|NCT00003341|anemia|anemia
5411708|NCT00003341|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
5411709|NCT00003341|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
5411710|NCT00003341|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
5411711|NCT00003341|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
5411712|NCT00003341|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
5411713|NCT00003341|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
5411714|NCT00003341|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
5411715|NCT00003341|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
5411716|NCT00003341|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5411717|NCT00003341|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5411718|NCT00003341|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5411719|NCT00003341|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
5411720|NCT00003341|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5411721|NCT00003341|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
5411722|NCT00003341|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
5411723|NCT00003341|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5411724|NCT00003341|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5411725|NCT00003341|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5411726|NCT00003341|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5411727|NCT00003341|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
5411728|NCT00003341|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
5411729|NCT00003341|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5411730|NCT00003341|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5411731|NCT00003341|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5411732|NCT00003341|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5411733|NCT00003341|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5411734|NCT00003341|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5411735|NCT00003341|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
5411736|NCT00003341|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
5411737|NCT00003341|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5411738|NCT00003341|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5411739|NCT00003341|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5411740|NCT00003324|tumors metastatic to brain|tumors metastatic to brain
5411741|NCT00003311|stage I mantle cell lymphoma|stage i mantle cell lymphoma
5411742|NCT00003311|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
5411743|NCT00003311|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5411744|NCT00003311|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5411745|NCT00003311|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5411746|NCT00059384|Treatment experienced|treatment experienced
5411747|NCT00059384|Therapeutic Drug Monitoring|therapeutic drug monitoring
5411748|NCT00059371|Male circumcision|male circumcision
5411749|NCT00059371|HIV acquisition|hiv acquisition
5411750|NCT00059371|Sexually transmitted infection|sexually transmitted infection
5411751|NCT00059371|HIV Seronegativity|hiv seronegativity
5411752|NCT00059358|HIV|hiv
5411753|NCT00059358|HCV|hcv
5411754|NCT00059358|Ribavirin|ribavirin
5411755|NCT00059358|Interferon|interferon
5411756|NCT00059358|Co-infection|co-infection
5411757|NCT00059358|Treatment experienced|treatment experienced
5411758|NCT00059345|Acupuncture|acupuncture
5411759|NCT00059345|Arthritis|arthritis
5411760|NCT00059332|stroke|stroke
5411761|NCT00059332|brain attack|brain attack
5411762|NCT00059332|magnesium sulfate|magnesium sulfate
5411763|NCT00059332|neuroprotection|neuroprotection
5411764|NCT00059332|prehospital care|prehospital care
5411765|NCT00059332|emergency medical services|emergency medical services
5411766|NCT00059319|coronary artery bypass graft surgery|coronary artery bypass graft surgery
5411767|NCT00059319|CABG surgery|cabg surgery
5411768|NCT00059319|neurobehavioral impairment|neurobehavioral impairment
5411769|NCT00059319|aorta clamping|aorta clamping
5411770|NCT00059319|aorta manipulation|aorta manipulation
5411771|NCT00059319|microemboli|microemboli
5411772|NCT00059306|stroke|stroke
5411773|NCT00059306|hypertension|hypertension
5411774|NCT00059306|high blood pressure|high blood pressure
5411775|NCT00059306|lacunar stroke|lacunar stroke
5411776|NCT00059306|subcortical stroke|subcortical stroke
5411777|NCT00059306|aspirin|aspirin
5411778|NCT00059306|clopidogrel|clopidogrel
5411779|NCT00058981|Diabetes|diabetes
5411780|NCT00058981|LADA|lada
5411781|NCT00058981|latent autoimmune diabetes in adults|latent autoimmune diabetes in adults
5411782|NCT00059280|Pompe disease|pompe disease
5411783|NCT00059280|Glycogen storage disease type II|glycogen storage disease type ii
5411784|NCT00059280|GSD-II|gsd-ii
5411785|NCT00059280|Acid maltase deficiency disease|acid maltase deficiency disease
5411786|NCT00059280|Glycogenosis 2|glycogenosis 2
5411787|NCT00059254|fatty acids|fatty acids
5411788|NCT00059254|oleic acid|oleic acid
5411789|NCT00059254|palmitic acid|palmitic acid
5411790|NCT00059254|fat oxidation|fat oxidation
5411791|NCT00059254|energy expenditure|energy expenditure
5411792|NCT00059254|body composition|body composition
5411793|NCT00059254|monounsaturated fat|monounsaturated fat
5411794|NCT00059254|human|human
5411795|NCT00059241|Early sexual initiation|early sexual initiation
5411796|NCT00059241|Prevention of early sexual activity|prevention of early sexual activity
5411797|NCT00059241|Middle childhood|middle childhood
5411798|NCT00003290|stage IIB prostate cancer|stage iib prostate cancer
5411799|NCT00003290|stage IIA prostate cancer|stage iia prostate cancer
5411800|NCT00003290|stage III prostate cancer|stage iii prostate cancer
5411801|NCT00003262|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
5411802|NCT00003262|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
5411803|NCT00003262|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5411804|NCT00003262|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5411805|NCT00003262|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
5411806|NCT00003262|HIV-associated Hodgkin lymphoma|hiv-associated hodgkin lymphoma
5411807|NCT00003205|stage IV breast cancer|stage iv breast cancer
5411808|NCT00003205|recurrent breast cancer|recurrent breast cancer
5411809|NCT00003193|oral complications|oral complications
5411810|NCT00003193|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
5411811|NCT00003193|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5411812|NCT00003193|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
5411813|NCT00003193|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5411814|NCT00003193|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
5411815|NCT00003193|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
5411816|NCT00003193|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
5411817|NCT00003193|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5411818|NCT00003193|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
5411819|NCT00003193|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5411820|NCT00003193|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
5411821|NCT00003193|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
5411822|NCT00003173|intraocular retinoblastoma|intraocular retinoblastoma
5411823|NCT00003173|recurrent retinoblastoma|recurrent retinoblastoma
5411824|NCT00003173|childhood central nervous system germ cell tumor|childhood central nervous system germ cell tumor
5411825|NCT00003173|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
5411826|NCT00003173|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
5411827|NCT00003173|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
5411828|NCT00003173|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5411829|NCT00003173|childhood germ cell tumor|childhood germ cell tumor
5411830|NCT00003173|stage III ovarian germ cell tumor|stage iii ovarian germ cell tumor
5411831|NCT00003173|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
5411832|NCT00003173|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
5411833|NCT00003173|extragonadal germ cell tumor|extragonadal germ cell tumor
5411834|NCT00003173|adult central nervous system germ cell tumor|adult central nervous system germ cell tumor
5411835|NCT00003173|childhood teratoma|childhood teratoma
5411836|NCT00003173|childhood malignant testicular germ cell tumor|childhood malignant testicular germ cell tumor
5411837|NCT00003173|childhood malignant ovarian germ cell tumor|childhood malignant ovarian germ cell tumor
5411838|NCT00003173|childhood extragonadal germ cell tumor|childhood extragonadal germ cell tumor
5411839|NCT00003173|recurrent childhood malignant germ cell tumor|recurrent childhood malignant germ cell tumor
5411840|NCT00059228|Pregnancy|pregnancy
5411841|NCT00059228|Gonadal Steroids|gonadal steroids
5411842|NCT00059228|Antidepressants|antidepressants
5411843|NCT00059228|Puerperium|puerperium
5411844|NCT00059228|Depression|depression
5411845|NCT00059228|Postpartum|postpartum
5411846|NCT00059228|Estradiol|estradiol
5411847|NCT00059228|Estrogen Response Element|estrogen response element
5411848|NCT00059228|Postpartum Depression|postpartum depression
5411849|NCT00059202|Urso|urso
5411850|NCT00059202|PSC|psc
5411851|NCT00059189|Occipital Cortex|occipital cortex
5411852|NCT00059189|Prefrontal Cortex|prefrontal cortex
5411853|NCT00059189|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
5411854|NCT00059189|Inhibition|inhibition
5411855|NCT00059189|Cortical Excitability|cortical excitability
5411856|NCT00059189|Blindness|blindness
5411857|NCT00059189|Healthy Volunteer|healthy volunteer
5411858|NCT00059189|HV|hv
5411859|NCT00005839|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5411860|NCT00004220|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5411861|NCT00059137|Gating|gating
5411862|NCT00059137|Respiratory Misregistration|respiratory misregistration
5411863|NCT00059137|Abdominal Belt|abdominal belt
5411864|NCT00059137|Percutaneous|percutaneous
5411865|NCT00059137|CT Guided Biopsy|ct guided biopsy
5411866|NCT00059137|Respiratory Cycle|respiratory cycle
5411867|NCT00059137|Needle Biopsy|needle biopsy
5411868|NCT00004257|stage I esophageal cancer|stage i esophageal cancer
5412609|NCT00056888|Dyskinesia|dyskinesia
5411869|NCT00004257|stage II esophageal cancer|stage ii esophageal cancer
5411870|NCT00004257|stage III esophageal cancer|stage iii esophageal cancer
5411871|NCT00004257|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
5411872|NCT00004257|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
5411873|NCT00004243|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5411874|NCT00003597|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
5411875|NCT00003597|recurrent renal cell cancer|recurrent renal cell cancer
5411876|NCT00003597|recurrent neuroblastoma|recurrent neuroblastoma
5411877|NCT00003597|recurrent childhood liver cancer|recurrent childhood liver cancer
5411878|NCT00003597|recurrent Wilms tumor and other childhood kidney tumors|recurrent wilms tumor and other childhood kidney tumors
5411879|NCT00003597|recurrent retinoblastoma|recurrent retinoblastoma
5411880|NCT00003597|childhood central nervous system germ cell tumor|childhood central nervous system germ cell tumor
5411881|NCT00003597|recurrent osteosarcoma|recurrent osteosarcoma
5411882|NCT00003597|recurrent gestational trophoblastic tumor|recurrent gestational trophoblastic tumor
5411883|NCT00003597|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
5411884|NCT00003597|recurrent intraocular melanoma|recurrent intraocular melanoma
5411885|NCT00003597|recurrent melanoma|recurrent melanoma
5411886|NCT00003597|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
5411887|NCT00003597|childhood germ cell tumor|childhood germ cell tumor
5411888|NCT00003597|recurrent childhood soft tissue sarcoma|recurrent childhood soft tissue sarcoma
5411889|NCT00003597|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
5411890|NCT00003597|extragonadal germ cell tumor|extragonadal germ cell tumor
5411891|NCT00003597|recurrent uterine sarcoma|recurrent uterine sarcoma
5411892|NCT00003597|neutropenia|neutropenia
5411893|NCT00003597|thrombocytopenia|thrombocytopenia
5411894|NCT00003597|recurrent childhood brain stem glioma|recurrent childhood brain stem glioma
5411895|NCT00003597|recurrent childhood supratentorial primitive neuroectodermal tumor|recurrent childhood supratentorial primitive neuroectodermal tumor
5411896|NCT00003597|recurrent childhood visual pathway glioma|recurrent childhood visual pathway glioma
5411897|NCT00003597|recurrent childhood cerebellar astrocytoma|recurrent childhood cerebellar astrocytoma
5411898|NCT00003597|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
5411899|NCT00003597|recurrent childhood medulloblastoma|recurrent childhood medulloblastoma
5411900|NCT00003597|recurrent Ewing sarcoma/peripheral primitive neuroectodermal tumor|recurrent ewing sarcoma/peripheral primitive neuroectodermal tumor
5411901|NCT00003163|refractory multiple myeloma|refractory multiple myeloma
5411902|NCT00003163|Waldenström macroglobulinemia|waldenström macroglobulinemia
5411903|NCT00003163|stage I multiple myeloma|stage i multiple myeloma
5411904|NCT00003163|stage II multiple myeloma|stage ii multiple myeloma
5411905|NCT00003163|stage III multiple myeloma|stage iii multiple myeloma
5411906|NCT00003163|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5411907|NCT00003163|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5411908|NCT00003163|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5411909|NCT00003163|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5411910|NCT00003163|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5411911|NCT00003163|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5411912|NCT00003163|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5411913|NCT00003163|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5411914|NCT00003163|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5411915|NCT00003163|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5411916|NCT00003163|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5411917|NCT00003163|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5411918|NCT00003163|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5411919|NCT00003163|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5411920|NCT00003163|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5411921|NCT00003163|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5411922|NCT00003163|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5411923|NCT00003163|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5411924|NCT00003163|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5411925|NCT00003163|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5411926|NCT00003163|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5411927|NCT00003163|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5411928|NCT00003163|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5411929|NCT00003163|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5411930|NCT00003163|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5411931|NCT00003163|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5411932|NCT00003163|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5411933|NCT00003163|primary systemic amyloidosis|primary systemic amyloidosis
5411934|NCT00003163|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
5411935|NCT00003163|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
5411936|NCT00003163|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
5411937|NCT00003163|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
5411938|NCT00003163|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
5411939|NCT00003163|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
5411940|NCT00003163|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
5411941|NCT00003163|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
5411942|NCT00003163|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
5411943|NCT00003163|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
5411944|NCT00003163|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5411945|NCT00003163|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5411946|NCT00003163|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5411947|NCT00003163|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
5411948|NCT00003163|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5412033|NCT00058942|Drinking Water|drinking water
5411949|NCT00003163|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
5411950|NCT00003163|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
5411951|NCT00003163|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5411952|NCT00003163|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
5411953|NCT00003163|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
5411954|NCT00003163|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5411955|NCT00003163|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5411956|NCT00003163|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5411957|NCT00003163|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
5411958|NCT00003163|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
5411959|NCT00003163|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5411960|NCT00003163|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5411961|NCT00003163|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5411962|NCT00003163|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5411963|NCT00003163|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5411964|NCT00003163|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5411965|NCT00003163|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
5411966|NCT00003163|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
5411967|NCT00003163|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5411968|NCT00003163|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5411969|NCT00003163|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5411970|NCT00003162|stage IV breast cancer|stage iv breast cancer
5411971|NCT00003162|recurrent breast cancer|recurrent breast cancer
5411972|NCT00003162|stage IV prostate cancer|stage iv prostate cancer
5411973|NCT00003162|recurrent prostate cancer|recurrent prostate cancer
5411974|NCT00003162|bone metastases|bone metastases
5411975|NCT00003162|pain|pain
5411976|NCT00003129|stage 0 bladder cancer|stage 0 bladder cancer
5411977|NCT00003129|stage I bladder cancer|stage i bladder cancer
5411978|NCT00003129|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
5411979|NCT00003124|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5411980|NCT00003124|stage I prostate cancer|stage i prostate cancer
5411981|NCT00003124|stage IIB prostate cancer|stage iib prostate cancer
5411982|NCT00003124|stage IIA prostate cancer|stage iia prostate cancer
5411983|NCT00003124|stage III prostate cancer|stage iii prostate cancer
5411984|NCT00003064|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5411985|NCT00003064|fallopian tube cancer|fallopian tube cancer
5411986|NCT00003064|primary peritoneal cavity cancer|primary peritoneal cavity cancer
5411987|NCT00002972|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5411988|NCT00002972|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5411989|NCT00002972|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5411990|NCT00002972|adenocarcinoma of the lung|adenocarcinoma of the lung
5411991|NCT00059046|Neuroreceptors|neuroreceptors
5411992|NCT00059046|PET Measurements|pet measurements
5411993|NCT00059046|Kinetic Analysis|kinetic analysis
5411994|NCT00059046|Test/Retest|test/retest
5411995|NCT00059046|Healthy Volunteer|healthy volunteer
5411996|NCT00059046|HV|hv
5411997|NCT00059033|6-[18F]Fluorodopamine|6-[18f]fluorodopamine
5411998|NCT00059033|Autonomic Failure|autonomic failure
5411999|NCT00059033|Parkinson's Disease|parkinson's disease
5412000|NCT00059033|Multiple System Atrophy|multiple system atrophy
5412001|NCT00059033|Pure Autonomic Failure|pure autonomic failure
5412002|NCT00059033|Primary Chronic Autonomic Failure|primary chronic autonomic failure
5412003|NCT00059033|CAF|caf
5412004|NCT00059020|Glioma|glioma
5412005|NCT00059020|Brain Tumor|brain tumor
5412006|NCT00059020|Epidermal Growth Factor|epidermal growth factor
5412007|NCT00059020|Polymorphisms|polymorphisms
5412008|NCT00058994|AMD|amd
5412009|NCT00058994|anecortave acetate|anecortave acetate
5412010|NCT00058994|wet AMD|wet amd
5412011|NCT00058994|age-related macular degeneration|age-related macular degeneration
5412012|NCT00058994|Macular Degeneration|macular degeneration
5412013|NCT00058994|Maculopathy, Age-Related|maculopathy, age-related
5412014|NCT00058994|Age-Related Maculopathies|age-related maculopathies
5412015|NCT00058994|Age-Related Maculopathy|age-related maculopathy
5412016|NCT00058994|Maculopathies, Age-Related|maculopathies, age-related
5412017|NCT00058968|neuropathy|neuropathy
5412018|NCT00058968|pain|pain
5412019|NCT00058968|diabetes|diabetes
5412020|NCT00058968|chronic pain|chronic pain
5412021|NCT00058968|persistent pain|persistent pain
5412022|NCT00058968|leg pain|leg pain
5412023|NCT00058968|peripheral neuropathy|peripheral neuropathy
5412024|NCT00058968|foot pain|foot pain
5412025|NCT00058968|painful neuropathy|painful neuropathy
5412026|NCT00058968|diabetic neuropathy|diabetic neuropathy
5412027|NCT00058955|ghb|ghb
5412028|NCT00058955|Xyrem|xyrem
5412029|NCT00058955|triazolam|triazolam
5412030|NCT00058955|pentobarbital|pentobarbital
5412031|NCT00058955|sedative|sedative
5412037|NCT00058903|primary biliary cirrhosis|primary biliary cirrhosis
5412038|NCT00058903|hepatitis C|hepatitis c
5412039|NCT00058890|itching|itching
5412040|NCT00058890|pruritus|pruritus
5412041|NCT00058890|cholestasis|cholestasis
5412042|NCT00058890|liver disease|liver disease
5412043|NCT00058890|hepatitis|hepatitis
5412044|NCT00058890|cirrhosis|cirrhosis
5412045|NCT00002945|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
5412046|NCT00002945|adult acute monoblastic leukemia and acute monocytic leukemia (M5)|adult acute monoblastic leukemia and acute monocytic leukemia (m5)
5412047|NCT00002945|adult acute erythroid leukemia (M6)|adult acute erythroid leukemia (m6)
5412048|NCT00002945|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
5412049|NCT00002945|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
5412050|NCT00002945|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
5412051|NCT00002945|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
5412052|NCT00002945|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5412053|NCT00002945|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
5412054|NCT00002934|breast cancer in situ|breast cancer in situ
5412055|NCT00002934|ductal breast carcinoma|ductal breast carcinoma
5412056|NCT00002835|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
5412057|NCT00002835|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
5412058|NCT00002835|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
5412059|NCT00002835|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
5412060|NCT00002835|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
5412061|NCT00002835|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5412062|NCT00002835|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5412063|NCT00002835|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5412064|NCT00002835|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5412065|NCT00002835|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5412066|NCT00002835|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5412067|NCT00002835|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5412068|NCT00002835|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5412069|NCT00002835|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5412070|NCT00002835|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5412071|NCT00002835|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
5412072|NCT00002835|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
5412073|NCT00002835|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
5412074|NCT00002835|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
5412075|NCT00002835|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
5412076|NCT00002835|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5412077|NCT00002835|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
5412078|NCT00002835|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
5412079|NCT00002835|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
5412080|NCT00002835|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5412081|NCT00002822|limited stage small cell lung cancer|limited stage small cell lung cancer
5412082|NCT00002822|extensive stage small cell lung cancer|extensive stage small cell lung cancer
5412083|NCT00058851|Manual lymph drainage|manual lymph drainage
5412084|NCT00058851|Combined physiotherapy|combined physiotherapy
5412085|NCT00058825|Campath|campath
5412086|NCT00058825|stem cell transplant|stem cell transplant
5412087|NCT00058812|Cytotoxic T Lymphocytes|cytotoxic t lymphocytes
5412088|NCT00058812|bone marrow transplant|bone marrow transplant
5412089|NCT00058812|EBV+ lymphoproliferative disease|ebv+ lymphoproliferative disease
5412090|NCT00058773|Hodgkin disease|hodgkin disease
5412091|NCT00058773|non-Hodgkins Lymphoma|non-hodgkins lymphoma
5412092|NCT00058773|bone marrow transplant|bone marrow transplant
5412093|NCT00058760|Prevention of early sexual behavior|prevention of early sexual behavior
5412094|NCT00058760|NIA intervention|nia intervention
5412095|NCT00058747|Granulocytic Leukemia, Chronic|granulocytic leukemia, chronic
5412096|NCT00058747|Leukemia, Granulocytic, Chronic|leukemia, granulocytic, chronic
5412097|NCT00058747|Leukemia, Myelocytic, Chronic|leukemia, myelocytic, chronic
5412098|NCT00058747|Leukemia, Myelogenous, Chronic|leukemia, myelogenous, chronic
5412099|NCT00058747|Myelocytic Leukemia, Chronic|myelocytic leukemia, chronic
5412100|NCT00058747|Myelogenous Leukemia, Chronic|myelogenous leukemia, chronic
5412101|NCT00058747|Myeloid Leukemia, Chronic|myeloid leukemia, chronic
5412102|NCT00058734|Dendritic Cell|dendritic cell
5412103|NCT00058734|Immunotherapy|immunotherapy
5412104|NCT00058734|Acute HIV|acute hiv
5412105|NCT00058734|Human Immunodeficiency Virus|human immunodeficiency virus
5412107|NCT00058734|HIV Therapeutic Vaccine|hiv therapeutic vaccine
5412108|NCT00058734|Treatment Experienced|treatment experienced
5412109|NCT00058734|Treatment Interruption|treatment interruption
5412110|NCT00058721|Dementia|dementia
5412111|NCT00058721|Feasibility|feasibility
5412112|NCT00058721|Dopamine|dopamine
5412113|NCT00058721|Lewy Body|lewy body
5412114|NCT00058721|Parkinson Disease|parkinson disease
5412115|NCT00058721|PD|pd
5412116|NCT00058721|Healthy Volunteer|healthy volunteer
5412117|NCT00058721|HV|hv
5412118|NCT00058695|Macualar Degeneration|macualar degeneration
5412119|NCT00058695|AMD|amd
5412120|NCT00058695|Healthy Volunteer|healthy volunteer
5412121|NCT00058695|HV|hv
5412122|NCT00058682|Fungal Infection|fungal infection
5412123|NCT00058682|Mycoses|mycoses
5412124|NCT00058682|Candida Species|candida species
5412125|NCT00058682|Candidiasis|candidiasis
5412126|NCT00002777|stage IV breast cancer|stage iv breast cancer
5412127|NCT00002777|recurrent breast cancer|recurrent breast cancer
5412128|NCT00002701|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
5412129|NCT00002701|adult acute promyelocytic leukemia (M3)|adult acute promyelocytic leukemia (m3)
5412130|NCT00002695|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
5412131|NCT00002695|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
5412132|NCT00002695|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
5412133|NCT00002695|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5412134|NCT00002695|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
5412135|NCT00002695|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
5412136|NCT00002695|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
5412137|NCT00002695|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
5412138|NCT00002695|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5412139|NCT00002695|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
5412140|NCT00002695|stage I squamous cell carcinoma of the hypopharynx|stage i squamous cell carcinoma of the hypopharynx
5412141|NCT00002695|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
5412142|NCT00002695|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
5412143|NCT00002695|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5412144|NCT00002695|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
5412145|NCT00002695|stage I squamous cell carcinoma of the larynx|stage i squamous cell carcinoma of the larynx
5412146|NCT00002695|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
5412147|NCT00002695|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
5412148|NCT00002695|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5412149|NCT00002695|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
5412150|NCT00002695|stage I squamous cell carcinoma of the paranasal sinus and nasal cavity|stage i squamous cell carcinoma of the paranasal sinus and nasal cavity
5412151|NCT00002695|stage II squamous cell carcinoma of the paranasal sinus and nasal cavity|stage ii squamous cell carcinoma of the paranasal sinus and nasal cavity
5412152|NCT00002695|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
5412153|NCT00002695|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
5412154|NCT00002695|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
5412155|NCT00002693|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5412156|NCT00002693|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5412157|NCT00002693|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5412158|NCT00002693|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5412159|NCT00002693|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5412160|NCT00002693|neutropenia|neutropenia
5412161|NCT00002669|stage IV melanoma|stage iv melanoma
5412162|NCT00002669|recurrent melanoma|recurrent melanoma
5412163|NCT00058656|Immunotherapy|immunotherapy
5412164|NCT00058656|T Cell Therapy|t cell therapy
5412165|NCT00058656|Adoptive immunotherapy|adoptive immunotherapy
5412166|NCT00058656|Xcellerate|xcellerate
5412167|NCT00058656|Xcellerated|xcellerated
5412168|NCT00002658|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
5412169|NCT00002658|adult acute erythroid leukemia (M6)|adult acute erythroid leukemia (m6)
5412610|NCT00056888|Kinesiogenic|kinesiogenic
5412170|NCT00002658|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
5412171|NCT00002658|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
5412172|NCT00002658|adult acute promyelocytic leukemia (M3)|adult acute promyelocytic leukemia (m3)
5412173|NCT00002658|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
5412174|NCT00002658|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
5412175|NCT00002658|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
5412176|NCT00002658|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5412177|NCT00002658|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
5412178|NCT00002658|neutropenia|neutropenia
5412179|NCT00002658|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
5412180|NCT00002653|stage I multiple myeloma|stage i multiple myeloma
5412181|NCT00002653|stage II multiple myeloma|stage ii multiple myeloma
5412182|NCT00002653|stage III multiple myeloma|stage iii multiple myeloma
5412183|NCT00002575|stage I colon cancer|stage i colon cancer
5412184|NCT00002575|stage II colon cancer|stage ii colon cancer
5412185|NCT00002575|stage III colon cancer|stage iii colon cancer
5412186|NCT00002575|adenocarcinoma of the colon|adenocarcinoma of the colon
5412187|NCT00002550|squamous cell lung cancer|squamous cell lung cancer
5412188|NCT00002550|large cell lung cancer|large cell lung cancer
5412189|NCT00002550|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5412190|NCT00002550|adenocarcinoma of the lung|adenocarcinoma of the lung
5412191|NCT00002550|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
5412192|NCT00002539|localized osteosarcoma|localized osteosarcoma
5412193|NCT00058617|EBV Positive Hodgkin's Lymphoma|ebv positive hodgkin's lymphoma
5412194|NCT00058617|EBV Positive Non-Hodgkin's Lymphoma|ebv positive non-hodgkin's lymphoma
5412195|NCT00058617|EBV Specific Cytotoxic T-Lymphocytes|ebv specific cytotoxic t-lymphocytes
5412196|NCT00058552|Advanced, refractory, or recurrent ovarian cancer|advanced, refractory, or recurrent ovarian cancer
5412197|NCT00058526|dHER2-AS15 ASCI|dher2-as15 asci
5412198|NCT00058526|Immunotherapeutic|immunotherapeutic
5412199|NCT00058526|Dose escalation|dose escalation
5412200|NCT00058526|Breast cancer|breast cancer
5412201|NCT00058487|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
5412202|NCT00058487|advanced adult primary liver cancer|advanced adult primary liver cancer
5412203|NCT00058487|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
5412204|NCT00058487|recurrent adult primary liver cancer|recurrent adult primary liver cancer
5412205|NCT00058474|stage II rectal cancer|stage ii rectal cancer
5412206|NCT00058474|stage III rectal cancer|stage iii rectal cancer
5412207|NCT00058474|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5412208|NCT00058448|stage II penile cancer|stage ii penile cancer
5412209|NCT00058448|stage III penile cancer|stage iii penile cancer
5412210|NCT00058448|stage IV penile cancer|stage iv penile cancer
5412211|NCT00058435|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
5412212|NCT00058435|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5412213|NCT00058435|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5412214|NCT00058435|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5412215|NCT00058435|fallopian tube cancer|fallopian tube cancer
5412216|NCT00058435|primary peritoneal cavity cancer|primary peritoneal cavity cancer
5412217|NCT00058422|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5412218|NCT00058422|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5412219|NCT00058422|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5412220|NCT00058396|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5412221|NCT00058396|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
5412222|NCT00058396|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
5412223|NCT00058396|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5412224|NCT00058396|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5412225|NCT00058396|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
5412226|NCT00058396|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5412227|NCT00058396|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
5412228|NCT00058396|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5412229|NCT00058396|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5412230|NCT00058396|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
5412231|NCT00058370|adult medulloblastoma|adult medulloblastoma
5412232|NCT00058370|untreated childhood medulloblastoma|untreated childhood medulloblastoma
5412233|NCT00058357|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5412234|NCT00058357|pain|pain
5412235|NCT00058318|stage IV renal cell cancer|stage iv renal cell cancer
5412236|NCT00058318|stage III renal cell cancer|stage iii renal cell cancer
5412237|NCT00058292|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5412238|NCT00058292|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5412239|NCT00058292|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5412240|NCT00058292|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5412241|NCT00058292|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5412242|NCT00058292|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5412243|NCT00058292|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5412244|NCT00058292|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5412245|NCT00058292|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5412317|NCT00057980|advanced adult primary liver cancer|advanced adult primary liver cancer
5412246|NCT00058292|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5412247|NCT00058292|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5412248|NCT00058292|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5412249|NCT00058292|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5412250|NCT00058292|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5412251|NCT00058292|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5412252|NCT00058279|stage IV melanoma|stage iv melanoma
5412253|NCT00058279|extraocular extension melanoma|extraocular extension melanoma
5412254|NCT00058279|recurrent melanoma|recurrent melanoma
5412255|NCT00058279|iris melanoma|iris melanoma
5412256|NCT00058279|ciliary body and choroid melanoma, medium/large size|ciliary body and choroid melanoma, medium/large size
5412257|NCT00058279|ciliary body and choroid melanoma, small size|ciliary body and choroid melanoma, small size
5412258|NCT00058279|recurrent intraocular melanoma|recurrent intraocular melanoma
5412259|NCT00058266|stage I prostate cancer|stage i prostate cancer
5412260|NCT00058266|stage II prostate cancer|stage ii prostate cancer
5412261|NCT00058201|acinar cell adenocarcinoma of the pancreas|acinar cell adenocarcinoma of the pancreas
5412262|NCT00058201|duct cell adenocarcinoma of the pancreas|duct cell adenocarcinoma of the pancreas
5412263|NCT00058201|stage I pancreatic cancer|stage i pancreatic cancer
5412264|NCT00058201|stage II pancreatic cancer|stage ii pancreatic cancer
5412265|NCT00058201|stage III pancreatic cancer|stage iii pancreatic cancer
5412266|NCT00058201|stage IV pancreatic cancer|stage iv pancreatic cancer
5412267|NCT00058188|osteoporosis|osteoporosis
5412268|NCT00058188|stage III prostate cancer|stage iii prostate cancer
5412269|NCT00058188|stage IV prostate cancer|stage iv prostate cancer
5412270|NCT00058149|stage II pancreatic cancer|stage ii pancreatic cancer
5412271|NCT00058149|stage III pancreatic cancer|stage iii pancreatic cancer
5412272|NCT00058149|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
5412273|NCT00058149|stage IV pancreatic cancer|stage iv pancreatic cancer
5412274|NCT00058123|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5412275|NCT00058123|adult mixed glioma|adult mixed glioma
5412276|NCT00058123|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
5412277|NCT00058123|recurrent adult brain tumor|recurrent adult brain tumor
5412278|NCT00058123|adult anaplastic ependymoma|adult anaplastic ependymoma
5412279|NCT00058071|peripheral neuropathy|peripheral neuropathy
5412280|NCT00058071|neurotoxicity|neurotoxicity
5412281|NCT00058071|hydatidiform mole|hydatidiform mole
5412282|NCT00058071|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5412283|NCT00058058|ductal breast carcinoma in situ|ductal breast carcinoma in situ
5412284|NCT00058058|invasive ductal breast carcinoma|invasive ductal breast carcinoma
5412285|NCT00058058|invasive lobular breast carcinoma|invasive lobular breast carcinoma
5412286|NCT00058058|breast cancer in situ|breast cancer in situ
5412287|NCT00058058|stage I breast cancer|stage i breast cancer
5412288|NCT00058058|stage II breast cancer|stage ii breast cancer
5412289|NCT00058058|stage IIIA breast cancer|stage iiia breast cancer
5412290|NCT00058058|stage IIIB breast cancer|stage iiib breast cancer
5412291|NCT00058058|stage IIIC breast cancer|stage iiic breast cancer
5412292|NCT00058058|stage IV breast cancer|stage iv breast cancer
5412293|NCT00058058|Magnetic resonance imaging|magnetic resonance imaging
5412294|NCT00058058|MRI|mri
5412295|NCT00058045|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
5412296|NCT00058032|ovarian epithelial cancer|ovarian epithelial cancer
5412297|NCT00058006|stage I non-small cell lung cancer|stage i non-small cell lung cancer
5412298|NCT00058006|stage I squamous cell carcinoma of the hypopharynx|stage i squamous cell carcinoma of the hypopharynx
5412299|NCT00058006|stage I squamous cell carcinoma of the larynx|stage i squamous cell carcinoma of the larynx
5412300|NCT00058006|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
5412301|NCT00058006|stage I squamous cell carcinoma of the nasopharynx|stage i squamous cell carcinoma of the nasopharynx
5412302|NCT00058006|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
5412303|NCT00058006|stage I squamous cell carcinoma of the paranasal sinus and nasal cavity|stage i squamous cell carcinoma of the paranasal sinus and nasal cavity
5412304|NCT00058006|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
5412305|NCT00058006|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
5412306|NCT00058006|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
5412307|NCT00058006|stage II squamous cell carcinoma of the nasopharynx|stage ii squamous cell carcinoma of the nasopharynx
5412308|NCT00058006|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
5412309|NCT00058006|stage II squamous cell carcinoma of the paranasal sinus and nasal cavity|stage ii squamous cell carcinoma of the paranasal sinus and nasal cavity
5412310|NCT00058006|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
5412311|NCT00058006|stage I salivary gland cancer|stage i salivary gland cancer
5412312|NCT00058006|stage II salivary gland cancer|stage ii salivary gland cancer
5412313|NCT00057993|stage IV breast cancer|stage iv breast cancer
5412314|NCT00057993|stage IIIA breast cancer|stage iiia breast cancer
5412315|NCT00057993|stage IIIB breast cancer|stage iiib breast cancer
5412316|NCT00057993|stage IIIC breast cancer|stage iiic breast cancer
5412318|NCT00057980|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
5412319|NCT00057980|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
5412320|NCT00057967|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5412321|NCT00057967|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
5412322|NCT00057967|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
5412323|NCT00057967|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
5412324|NCT00057967|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
5412325|NCT00057967|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5412326|NCT00057967|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
5412327|NCT00057967|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
5412328|NCT00057967|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
5412329|NCT00057967|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
5412330|NCT00057954|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5412331|NCT00057954|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5412332|NCT00057954|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5412333|NCT00057954|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5412334|NCT00057954|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5412335|NCT00057954|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5412336|NCT00057954|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5412337|NCT00057954|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5412338|NCT00057954|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5412339|NCT00057954|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5412340|NCT00057954|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5412341|NCT00057954|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5412342|NCT00057954|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
5412343|NCT00057954|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5412344|NCT00057954|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5412345|NCT00057954|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5412346|NCT00057954|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5412347|NCT00057954|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5412348|NCT00057954|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5412349|NCT00057928|recurrent cervical cancer|recurrent cervical cancer
5412350|NCT00057928|stage IVB cervical cancer|stage ivb cervical cancer
5412351|NCT00057915|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5412352|NCT00057889|clear cell renal cell carcinoma|clear cell renal cell carcinoma
5412353|NCT00057889|stage IV renal cell cancer|stage iv renal cell cancer
5412354|NCT00057889|recurrent renal cell cancer|recurrent renal cell cancer
5412355|NCT00057876|stage III pancreatic cancer|stage iii pancreatic cancer
5412356|NCT00057876|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
5412357|NCT00057850|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
5412358|NCT00057850|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
5412359|NCT00057850|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
5412360|NCT00057850|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
5412361|NCT00057850|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
5412362|NCT00057850|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5412363|NCT00057850|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5412611|NCT00056888|EEG|eeg
5412364|NCT00057850|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5412365|NCT00057850|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5412366|NCT00057850|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
5412367|NCT00057850|recurrent salivary gland cancer|recurrent salivary gland cancer
5412368|NCT00057850|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
5412369|NCT00057850|stage IV salivary gland cancer|stage iv salivary gland cancer
5412370|NCT00057837|extensive stage small cell lung cancer|extensive stage small cell lung cancer
5412371|NCT00057837|Topotecan|topotecan
5412372|NCT00057837|Etoposide|etoposide
5412373|NCT00057837|Cisplatin|cisplatin
5412374|NCT00057837|Irinotecan|irinotecan
5412375|NCT00057798|stage I non-small cell lung cancer|stage i non-small cell lung cancer
5412376|NCT00057798|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
5412377|NCT00057798|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5412378|NCT00057798|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5412379|NCT00057785|oral complications of radiation therapy|oral complications of radiation therapy
5412380|NCT00057785|radiation toxicity|radiation toxicity
5412381|NCT00057785|stage I squamous cell carcinoma of the nasopharynx|stage i squamous cell carcinoma of the nasopharynx
5412382|NCT00057785|stage II squamous cell carcinoma of the nasopharynx|stage ii squamous cell carcinoma of the nasopharynx
5412383|NCT00057785|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
5412384|NCT00057785|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
5412385|NCT00057759|sexual dysfunction|sexual dysfunction
5412386|NCT00057759|sexuality and reproductive issues|sexuality and reproductive issues
5412387|NCT00057759|radiation toxicity|radiation toxicity
5412388|NCT00057759|stage IIB prostate cancer|stage iib prostate cancer
5412389|NCT00057759|stage IIA prostate cancer|stage iia prostate cancer
5412390|NCT00057759|stage III prostate cancer|stage iii prostate cancer
5412391|NCT00057759|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
5412392|NCT00057746|limited stage small cell lung cancer|limited stage small cell lung cancer
5412393|NCT00057733|anxiety disorder|anxiety disorder
5412394|NCT00057733|depression|depression
5412395|NCT00057733|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5412396|NCT00023673|squamous cell lung cancer|squamous cell lung cancer
5412397|NCT00023673|large cell lung cancer|large cell lung cancer
5412398|NCT00023673|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5412399|NCT00023673|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5412400|NCT00023673|adenocarcinoma of the lung|adenocarcinoma of the lung
5412401|NCT00023673|adenosquamous cell lung cancer|adenosquamous cell lung cancer
5412402|NCT00057720|ovary|ovary
5412403|NCT00057707|Catecholamines|catecholamines
5412404|NCT00057707|Dopamine|dopamine
5412405|NCT00057707|fMRI|fmri
5412406|NCT00057707|Working Memory|working memory
5412407|NCT00057707|Clinical Trial|clinical trial
5412408|NCT00057707|Stabilization|stabilization
5412409|NCT00057707|Inpatients|inpatients
5412410|NCT00057707|Placebo|placebo
5412411|NCT00057707|Modafinil|modafinil
5412412|NCT00057707|Normal Volunteers|normal volunteers
5412413|NCT00057707|Schizophrenia|schizophrenia
5412414|NCT00057707|Schizoaffective Disorder|schizoaffective disorder
5412415|NCT00057707|Healthy Volunteer|healthy volunteer
5412416|NCT00057707|HV|hv
5412417|NCT00057694|Qualitative|qualitative
5412418|NCT00057694|Telephone Interviews|telephone interviews
5412419|NCT00057694|Genetic Counseling|genetic counseling
5412420|NCT00057694|Family History|family history
5412421|NCT00057694|Health Information|health information
5412422|NCT00057694|Adult Adoptees|adult adoptees
5412423|NCT00057694|Adult Adoptee|adult adoptee
5412424|NCT00057694|Interview|interview
5412425|NCT00057681|Mania|mania
5412426|NCT00057655|Social Welfare|social welfare
5412427|NCT00057655|Mentally Ill Persons|mentally ill persons
5412428|NCT00057655|Mental Health Services|mental health services
5412429|NCT00057642|Hispanic Americans|hispanic americans
5412430|NCT00057629|Rape|rape
5412431|NCT00057629|Sex Offenses|sex offenses
5412432|NCT00057616|Metastatic Melanoma|metastatic melanoma
5412433|NCT00057616|Melanoma|melanoma
5412434|NCT00057616|Revimid|revimid
5412435|NCT00057616|CC5013|cc5013
5412436|NCT00057564|Newly Diagnosed Multiple Myeloma|newly diagnosed multiple myeloma
5412437|NCT00057564|Multiple Myeloma|multiple myeloma
5412438|NCT00057538|HIV|hiv
5412439|NCT00057538|Randomized Trial|randomized trial
5412440|NCT00057538|Stress|stress
5412441|NCT00057538|Spirituality|spirituality
5412442|NCT00057538|Quality of Life|quality of life
5412443|NCT00057538|Complementary Therapies|complementary therapies
5412444|NCT00057525|Anthrax|anthrax
5412445|NCT00057499|Juvenile diabetes|juvenile diabetes
5412446|NCT00057499|Diabetes|diabetes
5412447|NCT00057499|Insulin|insulin
5412448|NCT00057499|Vaccine|vaccine
5412449|NCT00057499|Type 1 Diabetes|type 1 diabetes
5412450|NCT00057499|Diabetes Mellitus|diabetes mellitus
5412451|NCT00057486|Chronic Diarrhea|chronic diarrhea
5412452|NCT00057486|Interleukin 12|interleukin 12
5412453|NCT00057473|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
5412454|NCT00057447|lymphoma|lymphoma
5412455|NCT00057434|Vitamin A|vitamin a
5412456|NCT00057421|Tuberculosis|tuberculosis
5412457|NCT00057421|HIV infection|hiv infection
5412458|NCT00057421|Prednisolone|prednisolone
5412459|NCT00057421|Safety|safety
5412460|NCT00057421|Immune activation|immune activation
5412461|NCT00057460|Antiepileptic Drug|antiepileptic drug
5412462|NCT00057460|Neuroprotection|neuroprotection
5412463|NCT00057460|Seizure Disorder|seizure disorder
5412464|NCT00057460|TMS Stimulation|tms stimulation
5412465|NCT00057460|EEG|eeg
5412466|NCT00057460|AMPA Antagonist|ampa antagonist
5412467|NCT00057460|Dosing|dosing
5412468|NCT00057460|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
5412469|NCT00057460|Healthy Volunteer|healthy volunteer
5412470|NCT00057460|HV|hv
5412471|NCT00057408|Autism|autism
5412472|NCT00057408|Pervasive Developmental Disorder|pervasive developmental disorder
5412473|NCT00057408|Treatment|treatment
5412474|NCT00057408|Olanzapine|olanzapine
5412475|NCT00057408|Antipsychotic|antipsychotic
5412476|NCT00057395|Esophageal Neoplasms|esophageal neoplasms
5412477|NCT00057395|Esophagus Neoplasm|esophagus neoplasm
5412478|NCT00057395|Esophagus Cancer|esophagus cancer
5412479|NCT00057395|Esophageal Cancer|esophageal cancer
5412480|NCT00057395|Esophageal Tumors|esophageal tumors
5412481|NCT00057395|Esophagus Tumors|esophagus tumors
5412482|NCT00057395|Neoplasms, Esophageal|neoplasms, esophageal
5412483|NCT00057395|Hepatocellular Carcinoma|hepatocellular carcinoma
5412484|NCT00057395|Carcinoma, Hepatocellular|carcinoma, hepatocellular
5412485|NCT00057395|Hepatoma|hepatoma
5412486|NCT00057395|Colorectal Neoplasms|colorectal neoplasms
5412487|NCT00057395|Colorectal Cancer|colorectal cancer
5412488|NCT00057395|Colorectal Carcinoma|colorectal carcinoma
5412489|NCT00057395|Colorectal Tumor|colorectal tumor
5412490|NCT00057395|Neoplasms, Colorectal|neoplasms, colorectal
5412491|NCT00057395|Ovarian Neoplasms|ovarian neoplasms
5412492|NCT00057395|Ovary Neoplasms|ovary neoplasms
5412493|NCT00057395|Ovary Cancer|ovary cancer
5412494|NCT00057395|Ovary Carcinoma|ovary carcinoma
5412495|NCT00057395|Ovarian Cancer|ovarian cancer
5412496|NCT00057395|Ovarian Carcinoma|ovarian carcinoma
5412497|NCT00057395|Neoplasms, Ovarian|neoplasms, ovarian
5412498|NCT00057395|Pancreatic Neoplasms|pancreatic neoplasms
5412499|NCT00057395|Pancreatic Cancer|pancreatic cancer
5412500|NCT00057395|Pancreas Neoplasms|pancreas neoplasms
5412501|NCT00057395|Pancreas Cancer|pancreas cancer
5412502|NCT00057395|Neoplasms, Pancreatic|neoplasms, pancreatic
5412503|NCT00057395|Neoplasms, Pancreas|neoplasms, pancreas
5412504|NCT00057395|and other solid tumors|and other solid tumors
5412505|NCT00057382|liver cancer|liver cancer
5412506|NCT00057356|Chronic Heart Failure|chronic heart failure
5412507|NCT00057356|YM078|ym078
5412508|NCT00057291|Orphanage|orphanage
5412509|NCT00057291|Caregiving|caregiving
5412510|NCT00057291|Training|training
5412511|NCT00057291|Child development|child development
5412512|NCT00057031|myelodysplastic syndrome|myelodysplastic syndrome
5412513|NCT00057031|MDS|mds
5412514|NCT00057278|Gabapentin|gabapentin
5412515|NCT00057200|Home Care|home care
5412516|NCT00057252|Diagnostic Radiology|diagnostic radiology
5412517|NCT00057252|Imaging|imaging
5412518|NCT00057252|Algorithms|algorithms
5412519|NCT00057252|Healthy Volunteer|healthy volunteer
5412520|NCT00057252|HV|hv
5412521|NCT00057239|GW353162|gw353162
5412522|NCT00057239|Major Depressive Disorder|major depressive disorder
5412523|NCT00057239|MDD|mdd
5412524|NCT00057226|GW353162,|gw353162,
5412525|NCT00057226|Major depressive disorder,|major depressive disorder,
5412526|NCT00057226|flexible|flexible
5412527|NCT00057213|Major Depressive Disorder (MDD),|major depressive disorder (mdd),
5412528|NCT00057213|Flexible|flexible
5412529|NCT00057213|GW353162,|gw353162,
5412530|NCT00057174|Proton pump inhibitor|proton pump inhibitor
5412531|NCT00057148|massage therapy|massage therapy
5412532|NCT00057148|pain management|pain management
5412533|NCT00057148|post-surgical|post-surgical
5412534|NCT00057148|complementary therapy|complementary therapy
5412535|NCT00057135|Schizophrenia|schizophrenia
5412536|NCT00057135|Treatment Refusal|treatment refusal
5412537|NCT00057135|Drug Packaging|drug packaging
5412538|NCT00057135|Reminder Systems|reminder systems
5412539|NCT00057135|Antipsychotic Agents|antipsychotic agents
5412540|NCT00057122|Preventive therapy|preventive therapy
5412541|NCT00057083|Telemedicine|telemedicine
5412542|NCT00057083|Remote consultation|remote consultation
5412543|NCT00057083|Patient Satisfaction|patient satisfaction
5412544|NCT00057083|Physician patient relations|physician patient relations
5412545|NCT00057083|Provider satisfaction|provider satisfaction
5412546|NCT00057083|Doctor-patient relations|doctor-patient relations
5412547|NCT00057018|stroke|stroke
5412548|NCT00057018|cerebrovascular accident|cerebrovascular accident
5412549|NCT00057018|upper extremity|upper extremity
5412550|NCT00057018|physical therapy|physical therapy
5412551|NCT00057018|constraint-induced therapy|constraint-induced therapy
5412552|NCT00057005|LEUKEMIA|leukemia
5412553|NCT00056979|Metabolic diseases|metabolic diseases
5412554|NCT00056966|Acute myeloid leukemia|acute myeloid leukemia
5412555|NCT00056966|Acute lymphoblastic leukemia|acute lymphoblastic leukemia
5412556|NCT00056966|Chronic myeloid leukemia|chronic myeloid leukemia
5412557|NCT00056966|Non-Hodgkin's lymphoma|non-hodgkin's lymphoma
5412558|NCT00056966|Hodgkin's disease|hodgkin's disease
5412559|NCT00056966|Myelodysplastic syndrome|myelodysplastic syndrome
5412560|NCT00056966|Myeloproliferative disorders|myeloproliferative disorders
5412561|NCT00056966|Multiple myeloma|multiple myeloma
5412562|NCT00056966|Severe aplastic anemia|severe aplastic anemia
5412563|NCT00056953|health behavior|health behavior
5412564|NCT00056953|adolescent behavior|adolescent behavior
5412565|NCT00056953|peer mentoring|peer mentoring
5412566|NCT00056940|Prevention|prevention
5412567|NCT00056940|Parenting strategies|parenting strategies
5412568|NCT00056940|Media use|media use
5412569|NCT00056940|Discipline|discipline
5412570|NCT00056940|Firearm storage|firearm storage
5412571|NCT00056927|Smoking|smoking
5412572|NCT00056927|Primary Prevention|primary prevention
5412573|NCT00056927|Health Education|health education
5412574|NCT00056927|Child|child
5412575|NCT00056927|Parents|parents
5412576|NCT00056927|Parenting Education|parenting education
5412577|NCT00056927|Communication|communication
5413226|NCT00054938|SLE|sle
5412578|NCT00056875|graft versus host disease|graft versus host disease
5412579|NCT00056875|bone marrow transplant|bone marrow transplant
5412580|NCT00056875|alternative donor|alternative donor
5412581|NCT00056914|Magnetic Resonance Imaging|magnetic resonance imaging
5412582|NCT00056914|Functional Imaging|functional imaging
5412583|NCT00056914|Cerebral Blood Flow|cerebral blood flow
5412584|NCT00056914|Parallel Imaging|parallel imaging
5412585|NCT00056914|BOLD Effect|bold effect
5412586|NCT00056914|Spectroscopic Imaging|spectroscopic imaging
5412587|NCT00056914|Healthy Volunteer|healthy volunteer
5412588|NCT00056914|HV|hv
5412589|NCT00056901|Puerperium|puerperium
5412590|NCT00056901|Pregnancy|pregnancy
5412591|NCT00056901|Mood Disorders|mood disorders
5412592|NCT00056901|Estradiol|estradiol
5412593|NCT00056901|Progesterone|progesterone
5412594|NCT00056901|Mood|mood
5412595|NCT00056901|Behavior|behavior
5412596|NCT00056901|Cognition|cognition
5412597|NCT00056901|Perimenopause|perimenopause
5412598|NCT00056901|Menopause|menopause
5412599|NCT00056901|Post Partum Depression|post partum depression
5412600|NCT00056901|PPD|ppd
5412601|NCT00056901|Healthy Volunteer|healthy volunteer
5412602|NCT00056901|HV|hv
5412603|NCT00056888|Electroencephalogram|electroencephalogram
5412604|NCT00056888|Functional (BOLD) MRI|functional (bold) mri
5412605|NCT00056888|Startle Reflex|startle reflex
5412606|NCT00056888|Electromyogram|electromyogram
5412607|NCT00056888|Psychogenic|psychogenic
5412608|NCT00056888|Paroxysmal|paroxysmal
5412612|NCT00056888|Movement-Related Potential|movement-related potential
5412613|NCT00056888|Movement Disorder|movement disorder
5412614|NCT00056888|Paroxysmal Hyperkinetic Movement|paroxysmal hyperkinetic movement
5412615|NCT00056888|Disorder|disorder
5412616|NCT00056888|Paroxysmal Dyskinesia|paroxysmal dyskinesia
5412618|NCT00056836|Neovascular age-related macular degeneration|neovascular age-related macular degeneration
5412619|NCT00056823|AMD|amd
5412620|NCT00056862|Hepatitis C Virus|hepatitis c virus
5412621|NCT00056862|Antiviral Agents|antiviral agents
5412622|NCT00056862|Hemolysis|hemolysis
5412623|NCT00056862|Neutropenia|neutropenia
5412624|NCT00056862|Cirrhosis|cirrhosis
5412625|NCT00056862|Hemolytic Anemia|hemolytic anemia
5412626|NCT00056862|Viral Hepatitis|viral hepatitis
5412627|NCT00056862|Ribavirin|ribavirin
5412628|NCT00056862|Alfa Interferon|alfa interferon
5412629|NCT00056862|Pegylated Interferon|pegylated interferon
5412630|NCT00056862|Hepatitis C|hepatitis c
5412631|NCT00056862|HCV|hcv
5412632|NCT00056849|Arthritis|arthritis
5412633|NCT00056849|Spondyloarthropathy|spondyloarthropathy
5412634|NCT00056849|Spine|spine
5412635|NCT00056849|Hereditary|hereditary
5412636|NCT00056849|Disability|disability
5412637|NCT00056849|Ankylosing Spondylitis|ankylosing spondylitis
5412638|NCT00056849|AS|as
5412639|NCT00056849|Spondyloarthritis|spondyloarthritis
5412640|NCT00056810|Guillain Barre Syndrome|guillain barre syndrome
5412641|NCT00056810|4-aminopyridine|4-aminopyridine
5412642|NCT00056797|HIV Therapeutic vaccine|hiv therapeutic vaccine
5412643|NCT00056797|IL-2|il-2
5412644|NCT00056797|Structured Treatment Interruption|structured treatment interruption
5412645|NCT00056797|Treatment Experienced|treatment experienced
5412646|NCT00056784|TGF-Beta|tgf-beta
5412647|NCT00056784|Kidney|kidney
5412648|NCT00056784|Transplantation|transplantation
5412649|NCT00056784|Rejection|rejection
5412650|NCT00056784|Immunosuppression|immunosuppression
5412651|NCT00056784|Kidney Transplant|kidney transplant
5412652|NCT00056784|Chronic Allograft Nephropathy|chronic allograft nephropathy
5412653|NCT00056784|CAN|can
5412654|NCT00056771|Cataract|cataract
5412655|NCT00056771|Congenital Cataracts|congenital cataracts
5412656|NCT00056771|Hereditary Cataracts|hereditary cataracts
5412657|NCT00056758|HIV-1|hiv-1
5412658|NCT00056758|HAART|haart
5412659|NCT00056758|Therapeutic immunization|therapeutic immunization
5412660|NCT00056758|HIV Therapeutic Vaccine|hiv therapeutic vaccine
5412661|NCT00056758|Treatment Experienced|treatment experienced
5412662|NCT00056745|HIV seronegativity|hiv seronegativity
5412663|NCT00056745|HIV preventive vaccine|hiv preventive vaccine
5412664|NCT00056693|Neuroendocrine tumor, advanced disease, sunitinib, Phase 2|neuroendocrine tumor, advanced disease, sunitinib, phase 2
5412665|NCT00056680|Prematurity|prematurity
5412666|NCT00056680|low birthweight|low birthweight
5412667|NCT00056680|parenting|parenting
5412668|NCT00056680|intervention|intervention
5412669|NCT00056667|Treatment|treatment
5412670|NCT00056667|Pain|pain
5412671|NCT00056667|Relaxation Response|relaxation response
5412672|NCT00056667|Cognitive Behavioral Therapy|cognitive behavioral therapy
5412673|NCT00056654|Leuprolide|leuprolide
5412674|NCT00056654|Prostatic Neoplasms|prostatic neoplasms
5412675|NCT00056654|Testosterone|testosterone
5412676|NCT00056654|Prostate-specific Antigen|prostate-specific antigen
5412677|NCT00056654|Pharmacokinetics|pharmacokinetics
5412678|NCT00056654|luprolide acetate|luprolide acetate
5412679|NCT00056719|Arthritis|arthritis
5412680|NCT00056719|Spondylarthropathy|spondylarthropathy
5412681|NCT00056719|Spine|spine
5412682|NCT00056719|Hereditary|hereditary
5412683|NCT00056719|Disability|disability
5412684|NCT00056719|Ankylosing Spondylitis|ankylosing spondylitis
5412685|NCT00056719|Spondyloarthropathy|spondyloarthropathy
5412686|NCT00056719|Spondyloarthritis|spondyloarthritis
5412687|NCT00056719|AS|as
5412688|NCT00056706|Motor Deficit|motor deficit
5412689|NCT00056706|Somatosensory Deficit|somatosensory deficit
5412690|NCT00056706|Cortical Reorganization|cortical reorganization
5412691|NCT00056706|Disinhibition|disinhibition
5412692|NCT00056706|Rehabilitation|rehabilitation
5412693|NCT00056706|Plasticity|plasticity
5412694|NCT00056706|Stroke|stroke
5412695|NCT00056628|Alzheimer disease|alzheimer disease
5412696|NCT00056628|Dementia|dementia
5412697|NCT00056628|Ventriculoperitoneal shunt|ventriculoperitoneal shunt
5412698|NCT00056628|Tau|tau
5412699|NCT00056628|ABeta|abeta
5412700|NCT00056602|Utility|utility
5412701|NCT00056602|Health Status|health status
5412702|NCT00056602|Preferences|preferences
5412703|NCT00056602|Response Criteria|response criteria
5412704|NCT00056602|Treatment|treatment
5412705|NCT00056602|Rheumatoid Arthritis|rheumatoid arthritis
5412706|NCT00056602|RA|ra
5412707|NCT00056576|Monotherapy|monotherapy
5412708|NCT00056576|Complex Partial Seizures|complex partial seizures
5412709|NCT00056576|Epilepsy|epilepsy
5412710|NCT00056576|anti-epilepsy drug|anti-epilepsy drug
5412711|NCT00056576|AED|aed
5412712|NCT00056563|Parkinson's disease|parkinson's disease
5412713|NCT00056563|levo-dopa|levo-dopa
5412714|NCT00056563|tremor|tremor
5412715|NCT00056563|dyskinesia|dyskinesia
5412716|NCT00056563|subthalamic nucleus|subthalamic nucleus
5412717|NCT00056563|globus pallidus|globus pallidus
5412718|NCT00056550|Antithrombin Deficiency, Congenital|antithrombin deficiency, congenital
5412719|NCT00056550|Antithrombin III Deficiency|antithrombin iii deficiency
5412720|NCT00056524|ALS|als
5412721|NCT00056524|MS|ms
5412722|NCT00056524|CNS|cns
5412723|NCT00056524|AD|ad
5412724|NCT00056524|TBI|tbi
5412725|NCT00056524|Dextromethorphan|dextromethorphan
5412726|NCT00056524|IEED|ieed
5412727|NCT00056524|Emotional|emotional
5412728|NCT00056511|Garlic|garlic
5412729|NCT00056511|Supplements|supplements
5412730|NCT00056511|Adults|adults
5412731|NCT00056511|Hypercholesterolemics|hypercholesterolemics
5412732|NCT00056511|Randomized Clinical Trial|randomized clinical trial
5412733|NCT00056485|Nursing homes|nursing homes
5412734|NCT00056485|Aging|aging
5412735|NCT00056472|Major depressive disorder with psychotic features|major depressive disorder with psychotic features
5412736|NCT00056472|Delusional Depression|delusional depression
5412737|NCT00056472|Randomized Trial|randomized trial
5412738|NCT00056472|Combination Treatment|combination treatment
5412739|NCT00056472|SSRI|ssri
5412740|NCT00056472|Atypical Antipsychotic|atypical antipsychotic
5412741|NCT00012454|Transforming Growth Factor-Beta|transforming growth factor-beta
5412742|NCT00012454|Stroke|stroke
5412743|NCT00012454|Prevention|prevention
5412744|NCT00012454|Mucosal Tolerance|mucosal tolerance
5412745|NCT00012454|E-selectin|e-selectin
5412746|NCT00056459|Colorectal Cancer|colorectal cancer
5412747|NCT00056459|PTK787|ptk787
5412748|NCT00056459|Vatalanib|vatalanib
5412749|NCT00056459|VEGF inhibitor|vegf inhibitor
5412750|NCT00056459|Oxaliplatin|oxaliplatin
5412751|NCT00056459|Angiogenesis|angiogenesis
5412752|NCT00056459|Rectal Cancer|rectal cancer
5412753|NCT00056459|Colon Cancer|colon cancer
5412754|NCT00056459|Colorectal Carcinoma|colorectal carcinoma
5412755|NCT00056459|Colorectal Tumor|colorectal tumor
5412756|NCT00056446|Colorectal Cancer|colorectal cancer
5412757|NCT00056446|Oxaliplatin|oxaliplatin
5412758|NCT00056446|VEGF inhibitor|vegf inhibitor
5412759|NCT00056446|Vatalanib|vatalanib
5412760|NCT00056446|PTK787|ptk787
5412761|NCT00056446|Colon Cancer|colon cancer
5412762|NCT00056446|Colorectal Carcinoma|colorectal carcinoma
5412763|NCT00056446|Rectal Cancer|rectal cancer
5412764|NCT00056446|Colorectal Tumor|colorectal tumor
5412765|NCT00056433|Fetal Hemoglobin Induction|fetal hemoglobin induction
5412766|NCT00056433|L-Arginine|l-arginine
5412767|NCT00056433|Nitric Oxide Therapy|nitric oxide therapy
5412768|NCT00056433|Sickle Cell Disease|sickle cell disease
5412769|NCT00056433|Sildenafil (Viagra)|sildenafil (viagra)
5412770|NCT00056433|Sickle Cell Anemia|sickle cell anemia
5412771|NCT00056420|Tourette's Syndrome|tourette's syndrome
5412772|NCT00056420|Tic Disorder|tic disorder
5412773|NCT00056420|(EEG) Electroencephalography|(eeg) electroencephalography
5412774|NCT00056420|Event-Related Desynchronization/Synchronization|event-related desynchronization/synchronization
5412775|NCT00056420|Coherence|coherence
5412776|NCT00056420|Tourette's|tourette's
5412777|NCT00056420|Tourette Syndrome|tourette syndrome
5412778|NCT00056420|Healthy Volunteer|healthy volunteer
5412779|NCT00056420|HV|hv
5412780|NCT00056407|Prostate cancer prevention|prostate cancer prevention
5412781|NCT00056407|prostate|prostate
5412782|NCT00056407|BPH|bph
5412783|NCT00056407|enlarged prostate|enlarged prostate
5412784|NCT00056407|PSA|psa
5412785|NCT00056407|prostate cancer|prostate cancer
5412786|NCT00056394|Early Rheumatoid Arthritis|early rheumatoid arthritis
5412787|NCT00056394|Coping Skills Training|coping skills training
5412788|NCT00056394|Pain|pain
5412789|NCT00056394|Physical Disability|physical disability
5434518|NCT00002291|Pentamidine|pentamidine
5412790|NCT00056394|Psychological Disability|psychological disability
5412791|NCT00056394|Daily Diary Measures|daily diary measures
5412792|NCT00056381|neutropenia|neutropenia
5412793|NCT00056381|fever|fever
5412794|NCT00056381|febrile neutropenia|febrile neutropenia
5412795|NCT00056368|Candida blood stream infections|candida blood stream infections
5412796|NCT00056368|Candida infections|candida infections
5412797|NCT00056368|Candidemia|candidemia
5412798|NCT00056368|Invasive Candidiasis|invasive candidiasis
5412799|NCT00056329|Aging Persons|aging persons
5412800|NCT00056329|Down Syndrome|down syndrome
5412801|NCT00056329|Vitamin E|vitamin e
5412802|NCT00056329|Alzheimer disease|alzheimer disease
5412803|NCT00056355|Pheresis|pheresis
5412804|NCT00056355|Cytokine|cytokine
5412805|NCT00056355|Lymphocyte|lymphocyte
5412806|NCT00056355|Remission|remission
5412807|NCT00056355|Ultraviolet A Light|ultraviolet a light
5412808|NCT00056355|Crohn's Disease|crohn's disease
5412809|NCT00056355|Crohn Disease|crohn disease
5412810|NCT00056316|Caregiving|caregiving
5412811|NCT00056316|Dementia|dementia
5412812|NCT00056316|Alzheimer's|alzheimer's
5412813|NCT00056316|Depression|depression
5412814|NCT00056316|Technology|technology
5412815|NCT00056316|Treatment|treatment
5412816|NCT00056303|Attachment|attachment
5412817|NCT00056303|Intervention|intervention
5412818|NCT00056303|Prevention|prevention
5412819|NCT00056290|Diabetes Mellitus|diabetes mellitus
5412820|NCT00056290|Neuropathy|neuropathy
5412821|NCT00056290|Peripheral Artery Disease|peripheral artery disease
5412822|NCT00056264|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
5412823|NCT00056264|COPD|copd
5412824|NCT00056264|Infliximab|infliximab
5412825|NCT00056264|Remicade|remicade
5412826|NCT00056251|Interstitial Cystitis|interstitial cystitis
5412827|NCT00056251|Bladder|bladder
5412828|NCT00056238|Neurologic Diseases (General)|neurologic diseases (general)
5412829|NCT00056238|Hemorrhagic Stroke|hemorrhagic stroke
5412830|NCT00056238|Cerebral Amyloid Angiopathy|cerebral amyloid angiopathy
5412831|NCT00056238|Cerebrovascular Accident|cerebrovascular accident
5412832|NCT00056225|homocysteine|homocysteine
5412833|NCT00056173|Metastatic Renal Cell Carcinoma|metastatic renal cell carcinoma
5412834|NCT00056199|Vision Loss|vision loss
5412835|NCT00056199|Optic Nerve Tumors|optic nerve tumors
5412836|NCT00056199|Macular Edema|macular edema
5412837|NCT00056199|Von Hippel-Lindau Disease|von hippel-lindau disease
5412838|NCT00056199|VEGF|vegf
5412839|NCT00056199|EYE001|eye001
5412840|NCT00056199|VHL|vhl
5412841|NCT00056186|Adaptation|adaptation
5412842|NCT00056186|Neurodegenerative|neurodegenerative
5412843|NCT00056186|Health Care Provider|health care provider
5412844|NCT00056186|Psychosocial|psychosocial
5412845|NCT00056186|Chronic Illness/Disability|chronic illness/disability
5412846|NCT00056186|Friedreich's Ataxia|friedreich's ataxia
5412847|NCT00056186|Friedreich Ataxia|friedreich ataxia
5412848|NCT00056186|FA|fa
5412849|NCT00056160|Multiple Myeloma|multiple myeloma
5412850|NCT00056160|Refractory and Relapsed|refractory and relapsed
5412851|NCT00056160|Revlimid|revlimid
5412852|NCT00056160|CC5013|cc5013
5412853|NCT00056147|cystic fibrosis|cystic fibrosis
5412854|NCT00056134|recurrent melanoma|recurrent melanoma
5412855|NCT00056134|stage IV melanoma|stage iv melanoma
5412856|NCT00056134|stage IIIA melanoma|stage iiia melanoma
5412857|NCT00056134|stage IIIB melanoma|stage iiib melanoma
5412858|NCT00056134|stage IIIC melanoma|stage iiic melanoma
5412859|NCT00056095|recurrent renal cell cancer|recurrent renal cell cancer
5412860|NCT00056095|stage IV renal cell cancer|stage iv renal cell cancer
5412861|NCT00056082|breast cancer|breast cancer
5412862|NCT00056069|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
5412863|NCT00056069|childhood acute lymphoblastic leukemia|childhood acute lymphoblastic leukemia
5412864|NCT00056056|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
5413075|NCT00055380|Small Molecule|small molecule
5412865|NCT00056056|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
5412866|NCT00056056|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5412867|NCT00056030|liver metastases|liver metastases
5412868|NCT00056030|stage IV colon cancer|stage iv colon cancer
5412869|NCT00056030|stage IV rectal cancer|stage iv rectal cancer
5412870|NCT00056030|adenocarcinoma of the colon|adenocarcinoma of the colon
5412871|NCT00056030|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5412872|NCT00056004|non-small cell lung cancer|non-small cell lung cancer
5412873|NCT00056004|small cell lung cancer|small cell lung cancer
5412874|NCT00056004|stage I non-small cell lung cancer|stage i non-small cell lung cancer
5412875|NCT00056004|stage I squamous cell carcinoma of the hypopharynx|stage i squamous cell carcinoma of the hypopharynx
5412876|NCT00056004|stage I squamous cell carcinoma of the larynx|stage i squamous cell carcinoma of the larynx
5412877|NCT00056004|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
5412878|NCT00056004|stage I squamous cell carcinoma of the nasopharynx|stage i squamous cell carcinoma of the nasopharynx
5412879|NCT00056004|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
5412880|NCT00056004|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
5412881|NCT00056004|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
5412882|NCT00056004|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
5412883|NCT00056004|stage II squamous cell carcinoma of the nasopharynx|stage ii squamous cell carcinoma of the nasopharynx
5412884|NCT00056004|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
5412885|NCT00055991|breast cancer|breast cancer
5412886|NCT00055978|non-small cell lung cancer|non-small cell lung cancer
5412887|NCT00055978|stage I non-small cell lung cancer|stage i non-small cell lung cancer
5412888|NCT00055965|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5412889|NCT00055965|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5412890|NCT00055965|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5412891|NCT00055952|childhood desmoplastic small round cell tumor|childhood desmoplastic small round cell tumor
5412892|NCT00055952|metastatic childhood soft tissue sarcoma|metastatic childhood soft tissue sarcoma
5412893|NCT00055952|nonmetastatic childhood soft tissue sarcoma|nonmetastatic childhood soft tissue sarcoma
5412894|NCT00055952|recurrent childhood soft tissue sarcoma|recurrent childhood soft tissue sarcoma
5412895|NCT00055952|localized Ewing sarcoma/peripheral primitive neuroectodermal tumor|localized ewing sarcoma/peripheral primitive neuroectodermal tumor
5412896|NCT00055952|metastatic Ewing sarcoma/peripheral primitive neuroectodermal tumor|metastatic ewing sarcoma/peripheral primitive neuroectodermal tumor
5412897|NCT00055952|recurrent Ewing sarcoma/peripheral primitive neuroectodermal tumor|recurrent ewing sarcoma/peripheral primitive neuroectodermal tumor
5412898|NCT00055939|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
5412899|NCT00055939|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
5412900|NCT00055926|recurrent breast cancer|recurrent breast cancer
5412901|NCT00055926|stage IV breast cancer|stage iv breast cancer
5412902|NCT00055926|male breast cancer|male breast cancer
5412903|NCT00055887|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5412904|NCT00055887|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5412905|NCT00055887|adenocarcinoma of the lung|adenocarcinoma of the lung
5412906|NCT00055887|squamous cell lung cancer|squamous cell lung cancer
5412907|NCT00055887|large cell lung cancer|large cell lung cancer
5412908|NCT00055874|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5412909|NCT00055874|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
5412910|NCT00055874|chronic myelogenous leukemia, BCR-ABL1 positive|chronic myelogenous leukemia, bcr-abl1 positive
5412911|NCT00055848|adenocarcinoma of the colon|adenocarcinoma of the colon
5412912|NCT00055848|stage I colon cancer|stage i colon cancer
5412913|NCT00055848|stage II colon cancer|stage ii colon cancer
5412914|NCT00055848|stage III colon cancer|stage iii colon cancer
5412915|NCT00055848|stage IV colon cancer|stage iv colon cancer
5412916|NCT00055835|recurrent bladder cancer|recurrent bladder cancer
5412917|NCT00055835|stage III bladder cancer|stage iii bladder cancer
5412918|NCT00055835|squamous cell carcinoma of the bladder|squamous cell carcinoma of the bladder
5412919|NCT00055835|stage II bladder cancer|stage ii bladder cancer
5412920|NCT00055835|recurrent urethral cancer|recurrent urethral cancer
5412921|NCT00055835|urethral cancer associated with invasive bladder cancer|urethral cancer associated with invasive bladder cancer
5412922|NCT00055835|distal urethral cancer|distal urethral cancer
5412923|NCT00055835|proximal urethral cancer|proximal urethral cancer
5412924|NCT00055835|stage IV bladder cancer|stage iv bladder cancer
5412925|NCT00055835|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
5412926|NCT00055822|adenocarcinoma of the colon|adenocarcinoma of the colon
5412927|NCT00055822|recurrent colon cancer|recurrent colon cancer
5412928|NCT00055822|stage III colon cancer|stage iii colon cancer
5412929|NCT00055822|stage IV colon cancer|stage iv colon cancer
5412930|NCT00055822|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5412931|NCT00055822|recurrent rectal cancer|recurrent rectal cancer
5412932|NCT00055822|stage III rectal cancer|stage iii rectal cancer
5412933|NCT00055822|stage IV rectal cancer|stage iv rectal cancer
5412934|NCT00055783|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5412935|NCT00055731|stage III prostate cancer|stage iii prostate cancer
5412936|NCT00055731|stage IIB prostate cancer|stage iib prostate cancer
5412937|NCT00055731|stage IIA prostate cancer|stage iia prostate cancer
5412938|NCT00055718|drug/agent toxicity by tissue/organ|drug/agent toxicity by tissue/organ
5412939|NCT00055718|childhood acute lymphoblastic leukemia|childhood acute lymphoblastic leukemia
5412940|NCT00055705|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5412941|NCT00055705|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5412942|NCT00055705|fallopian tube cancer|fallopian tube cancer
5412943|NCT00055705|primary peritoneal cavity cancer|primary peritoneal cavity cancer
5412944|NCT00055705|recurrent colon cancer|recurrent colon cancer
5412945|NCT00055705|stage IV colon cancer|stage iv colon cancer
5412946|NCT00055705|ovarian sarcoma|ovarian sarcoma
5412947|NCT00055705|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
5412948|NCT00055705|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
5412949|NCT00055705|recurrent endometrial carcinoma|recurrent endometrial carcinoma
5412950|NCT00055705|stage IV endometrial carcinoma|stage iv endometrial carcinoma
5412951|NCT00055705|recurrent uterine sarcoma|recurrent uterine sarcoma
5412952|NCT00055705|stage IV uterine sarcoma|stage iv uterine sarcoma
5412953|NCT00055705|ovarian stromal cancer|ovarian stromal cancer
5412954|NCT00055705|recurrent rectal cancer|recurrent rectal cancer
5412955|NCT00055705|stage IV rectal cancer|stage iv rectal cancer
5412956|NCT00055705|metastatic gastrointestinal carcinoid tumor|metastatic gastrointestinal carcinoid tumor
5412957|NCT00055705|recurrent gastrointestinal carcinoid tumor|recurrent gastrointestinal carcinoid tumor
5412958|NCT00055705|gastrointestinal stromal tumor|gastrointestinal stromal tumor
5412959|NCT00055705|advanced malignant mesothelioma|advanced malignant mesothelioma
5412960|NCT00055705|recurrent malignant mesothelioma|recurrent malignant mesothelioma
5412961|NCT00055705|recurrent gastric cancer|recurrent gastric cancer
5412962|NCT00055705|stage IV gastric cancer|stage iv gastric cancer
5412963|NCT00055705|carcinoma of the appendix|carcinoma of the appendix
5412964|NCT00055705|small intestine adenocarcinoma|small intestine adenocarcinoma
5412965|NCT00055705|small intestine leiomyosarcoma|small intestine leiomyosarcoma
5412966|NCT00055705|small intestine lymphoma|small intestine lymphoma
5412967|NCT00055705|recurrent small intestine cancer|recurrent small intestine cancer
5412968|NCT00055705|recurrent gallbladder cancer|recurrent gallbladder cancer
5412969|NCT00055705|unresectable gallbladder cancer|unresectable gallbladder cancer
5412970|NCT00055705|advanced adult primary liver cancer|advanced adult primary liver cancer
5412971|NCT00055705|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
5412972|NCT00055705|recurrent adult primary liver cancer|recurrent adult primary liver cancer
5412973|NCT00055679|stage I breast cancer|stage i breast cancer
5412974|NCT00055666|graft versus host disease|graft versus host disease
5412975|NCT00055653|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
5412976|NCT00055653|refractory anemia with excess blasts|refractory anemia with excess blasts
5412977|NCT00055653|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
5412978|NCT00055653|refractory anemia|refractory anemia
5412979|NCT00055653|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5412980|NCT00055653|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
5412981|NCT00055653|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5412982|NCT00055653|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5412983|NCT00055653|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
5412984|NCT00055653|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5412985|NCT00055653|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5412986|NCT00055653|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5412987|NCT00055653|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5412988|NCT00055653|acute undifferentiated leukemia|acute undifferentiated leukemia
5412989|NCT00055653|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
5412990|NCT00055653|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
5412991|NCT00055653|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
5412992|NCT00055653|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
5412993|NCT00055653|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
5412994|NCT00055653|untreated childhood acute myeloid leukemia and other myeloid malignancies|untreated childhood acute myeloid leukemia and other myeloid malignancies
5412995|NCT00055653|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5412996|NCT00055653|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5412997|NCT00055653|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5412998|NCT00055653|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
5412999|NCT00055653|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
5413000|NCT00055640|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
5413001|NCT00055640|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
5413002|NCT00055640|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5413003|NCT00055640|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5413004|NCT00055640|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5413005|NCT00055614|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5413006|NCT00055614|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5413007|NCT00055614|fallopian tube cancer|fallopian tube cancer
5413008|NCT00055614|primary peritoneal cavity cancer|primary peritoneal cavity cancer
5413009|NCT00055601|stage II bladder cancer|stage ii bladder cancer
5413010|NCT00055601|stage III bladder cancer|stage iii bladder cancer
5413011|NCT00022139|stage III gastric cancer|stage iii gastric cancer
5413012|NCT00022139|stage II esophageal cancer|stage ii esophageal cancer
5413013|NCT00022139|stage III esophageal cancer|stage iii esophageal cancer
5413014|NCT00022139|adenocarcinoma of the stomach|adenocarcinoma of the stomach
5413015|NCT00022139|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
5413016|NCT00022139|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
5413017|NCT00005028|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5413018|NCT00005028|stage IV prostate cancer|stage iv prostate cancer
5413019|NCT00005028|recurrent prostate cancer|recurrent prostate cancer
5413020|NCT00055588|Spinal Reflexes|spinal reflexes
5413021|NCT00055588|Motor Practice|motor practice
5413022|NCT00055588|Spinal Cord Injury|spinal cord injury
5413023|NCT00055588|Locomotion|locomotion
5413024|NCT00055588|Healthy Volunteer|healthy volunteer
5413025|NCT00055588|HV|hv
5413026|NCT00055575|Scopolamine|scopolamine
5413027|NCT00055575|Depression|depression
5413028|NCT00055575|fMRI|fmri
5413029|NCT00055575|Cognition|cognition
5413030|NCT00055575|Emotion|emotion
5413031|NCT00055575|Brain|brain
5413032|NCT00055575|Bipolar Disorder|bipolar disorder
5413033|NCT00055575|Major Depressive Disorder|major depressive disorder
5413034|NCT00055575|MDD|mdd
5413035|NCT00055575|Healthy Volunteer|healthy volunteer
5413036|NCT00055575|HV|hv
5413037|NCT00055562|Metastatic Melanoma|metastatic melanoma
5413038|NCT00055562|Metastatic Malignant Melanoma|metastatic malignant melanoma
5413039|NCT00055562|Revimid|revimid
5413040|NCT00055562|CC5013|cc5013
5413041|NCT00055549|Dextromethorphan|dextromethorphan
5413042|NCT00055549|Sensorimotor Modulation|sensorimotor modulation
5413043|NCT00055549|Spasmodic Dysphonia|spasmodic dysphonia
5413044|NCT00055549|Muscular Tension Dysphonia|muscular tension dysphonia
5413045|NCT00055549|Voice Tremor|voice tremor
5413046|NCT00055549|Lorazepam|lorazepam
5413047|NCT00055549|Dysphonia|dysphonia
5413048|NCT00055549|Macular Tension Dysphonia|macular tension dysphonia
5413049|NCT00055510|BO-653|bo-653
5413050|NCT00055510|Coronary restenosis|coronary restenosis
5413051|NCT00055510|Stent restenosis|stent restenosis
5413052|NCT00055510|LDL oxidative inhibitor|ldl oxidative inhibitor
5413053|NCT00055510|Antioxidant|antioxidant
5413054|NCT00055484|Migraine Headache|migraine headache
5413055|NCT00055484|prophylaxis|prophylaxis
5413056|NCT00055484|AED|aed
5413057|NCT00055484|migraine prophylaxis|migraine prophylaxis
5413058|NCT00055471|prostate cancer|prostate cancer
5413059|NCT00055471|Metastatic prostate cancer|metastatic prostate cancer
5413060|NCT00055471|bone metastases|bone metastases
5413061|NCT00055445|Complementary Therapies|complementary therapies
5413062|NCT00055445|IdB 1016|idb 1016
5413063|NCT00055445|Silybin|silybin
5413064|NCT00055445|Antioxidant|antioxidant
5413065|NCT00055445|Hepatitis C Virus|hepatitis c virus
5413066|NCT00055445|Phosphatidylcholine|phosphatidylcholine
5413067|NCT00055432|recurrent ovarian cancer|recurrent ovarian cancer
5413068|NCT00055432|platinum-resistant|platinum-resistant
5413069|NCT00055432|platinum-sensitive|platinum-sensitive
5413070|NCT00055432|folate receptor antagonist|folate receptor antagonist
5413071|NCT00055419|Stage IV colorectal cancer|stage iv colorectal cancer
5413072|NCT00055380|Molecular Targets|molecular targets
5413073|NCT00055380|Keratinocytes|keratinocytes
5413074|NCT00055380|Cell Cycle|cell cycle
5413076|NCT00055380|Gene Expression|gene expression
5413077|NCT00055380|Pharmacodynamics|pharmacodynamics
5413078|NCT00055380|Surrogate Markers|surrogate markers
5413079|NCT00055380|Targeted Therapy|targeted therapy
5413080|NCT00055380|Buccal Mucosa|buccal mucosa
5413081|NCT00055380|Pharmacogenomics|pharmacogenomics
5413082|NCT00055380|Oral Mucosa|oral mucosa
5413083|NCT00055354|Acupuncture|acupuncture
5413084|NCT00055354|Medicine, Chinese Traditional|medicine, chinese traditional
5413085|NCT00055302|vaginal bleeding|vaginal bleeding
5413086|NCT00055302|advanced bone age|advanced bone age
5413087|NCT00055302|fibrous dysplasia|fibrous dysplasia
5413088|NCT00055302|MAS|mas
5413089|NCT00055302|McCune-Albright Syndrome|mccune-albright syndrome
5413090|NCT00055263|advanced solid tumor malignancies|advanced solid tumor malignancies
5413091|NCT00055289|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
5413092|NCT00055289|Counting|counting
5413093|NCT00055289|Sensorimotor Integration|sensorimotor integration
5413094|NCT00055289|Superior Temporal Cortex|superior temporal cortex
5413095|NCT00055289|Dorsal Premotor Cortex|dorsal premotor cortex
5413096|NCT00055289|Healthy Volunteer|healthy volunteer
5413097|NCT00055289|HV|hv
5413098|NCT00055237|Angiogenesis|angiogenesis
5413099|NCT00055237|Cancer|cancer
5413100|NCT00055237|HHV-8|hhv-8
5413101|NCT00055237|KSHV|kshv
5413102|NCT00055237|Skin|skin
5413103|NCT00055237|Kaposi Sarcoma|kaposi sarcoma
5413104|NCT00055237|KS|ks
5413105|NCT00055224|Anxiety Disorder|anxiety disorder
5413106|NCT00055224|Fear|fear
5413107|NCT00055224|Aversive Conditioning|aversive conditioning
5413108|NCT00055224|Psychophysiology|psychophysiology
5413109|NCT00055224|Predictability|predictability
5413110|NCT00055224|Startle|startle
5413111|NCT00055224|Context Conditioning|context conditioning
5413112|NCT00055224|Fear Conditioning|fear conditioning
5413113|NCT00055224|Agoraphobia|agoraphobia
5413114|NCT00055224|Panic Disorder|panic disorder
5413115|NCT00055224|Generalized Anxiety Disorder|generalized anxiety disorder
5413116|NCT00055224|GAD|gad
5413117|NCT00055224|Healthy Volunteer|healthy volunteer
5413118|NCT00055224|HV|hv
5413119|NCT00055198|Gram positive bacterial infections|gram positive bacterial infections
5413120|NCT00055198|expanded access program|expanded access program
5413121|NCT00055198|resistant infections|resistant infections
5413122|NCT00055198|bacteremia|bacteremia
5413123|NCT00055198|Bacterial and fungal infections|bacterial and fungal infections
5413124|NCT00055198|bacterial infections|bacterial infections
5413125|NCT00055185|Treatment Experienced|treatment experienced
5413126|NCT00055133|rheumatoid arthritis|rheumatoid arthritis
5413127|NCT00055133|Paxceed|paxceed
5413128|NCT00055133|Micellar Paclitaxel|micellar paclitaxel
5413129|NCT00055172|Cytokines|cytokines
5413130|NCT00055172|Mutation|mutation
5413131|NCT00055172|DNA|dna
5413132|NCT00055172|Phenotype|phenotype
5413133|NCT00055172|T Cell|t cell
5413134|NCT00055172|Immunodeficiency|immunodeficiency
5413135|NCT00055172|Inherited Immunodeficiency|inherited immunodeficiency
5413136|NCT00055159|RT PA|rt pa
5413137|NCT00055159|Blood Clots|blood clots
5413138|NCT00055159|Catheter Directed Thrombolytic Therapy|catheter directed thrombolytic therapy
5413139|NCT00055159|Alteplase|alteplase
5413140|NCT00055159|Deep Vein Thrombosis|deep vein thrombosis
5413141|NCT00055159|DVT|dvt
5413142|NCT00055120|Anti-HIV Agents|anti-hiv agents
5413143|NCT00055120|Disease Progression|disease progression
5413144|NCT00055120|Drug Administration Schedule|drug administration schedule
5413145|NCT00055120|Viral Load|viral load
5413146|NCT00055120|HIV-1|hiv-1
5413147|NCT00055120|Treatment Outcome|treatment outcome
5413148|NCT00055120|Survival Analysis|survival analysis
5413149|NCT00055120|Treatment Naive|treatment naive
5413150|NCT00055107|Nitazoxanide|nitazoxanide
5413151|NCT00055107|Antiprotozoal Agents|antiprotozoal agents
5413152|NCT00055107|Cryptosporidiosis|cryptosporidiosis
5413153|NCT00055107|Cryptosporidium parvum|cryptosporidium parvum
5413154|NCT00055107|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
5413155|NCT00055107|Pharmacokinetics|pharmacokinetics
5413156|NCT00055107|Drug Adminstration Schedule|drug adminstration schedule
5413157|NCT00055094|Immune system|immune system
5413158|NCT00055094|Helper T-Cells|helper t-cells
5413159|NCT00055094|Acute Infection|acute infection
5413160|NCT00055094|Treatment naive|treatment naive
5413161|NCT00055081|Homeless Persons|homeless persons
5413162|NCT00055055|Autoimmunity Pathogenesis|autoimmunity pathogenesis
5413163|NCT00055055|Microarray Analyses|microarray analyses
5413164|NCT00055055|Microchimerism|microchimerism
5413165|NCT00055055|Genetic and Environmental Risk Factors|genetic and environmental risk factors
5413166|NCT00055055|Adult and Pediatric Disease|adult and pediatric disease
5413167|NCT00055055|Rheumatoid Arthritis|rheumatoid arthritis
5413168|NCT00055055|Systemic Lupus Erythematosus|systemic lupus erythematosus
5413169|NCT00055055|Systemic Sclerosis|systemic sclerosis
5413170|NCT00055055|Idiopathic Inflammatory Myopathies|idiopathic inflammatory myopathies
5413171|NCT00055055|Juvenile Polymyositis|juvenile polymyositis
5413172|NCT00055055|Juvenile Idiopathic Arthritis|juvenile idiopathic arthritis
5413173|NCT00055055|Inflammatory Myopathies|inflammatory myopathies
5413174|NCT00055055|Dermatomyositis|dermatomyositis
5413175|NCT00055055|Scleroderma|scleroderma
5413176|NCT00055055|SLE|sle
5413177|NCT00055055|Lupus|lupus
5413178|NCT00055055|Rheumatic Disease|rheumatic disease
5413179|NCT00055055|RA|ra
5413180|NCT00055055|Healthy Volunteer|healthy volunteer
5413181|NCT00055055|HV|hv
5413182|NCT00055042|Types 1 and 2 Diabetes|types 1 and 2 diabetes
5413183|NCT00055042|Diode Laser Photocoagulation|diode laser photocoagulation
5413184|NCT00055042|Vitamin E|vitamin e
5413185|NCT00055042|Elevated Low-Density Lipoprotein (LDL-C) Cholesterol|elevated low-density lipoprotein (ldl-c) cholesterol
5413186|NCT00055042|Diabetes Type I|diabetes type i
5413187|NCT00055042|Diabetes Type II|diabetes type ii
5413188|NCT00055042|Diabetic Macular Edema|diabetic macular edema
5413189|NCT00055029|Retinoschisis|retinoschisis
5413190|NCT00055029|Genomic DNA|genomic dna
5413191|NCT00055029|Pedigree Analysis|pedigree analysis
5413192|NCT00055029|Genetic Analysis|genetic analysis
5413193|NCT00055029|Macular Degeneration|macular degeneration
5413194|NCT00055029|Juvenile Retinoschisis|juvenile retinoschisis
5413195|NCT00055029|X-Linked Juvenile Retinoschisis|x-linked juvenile retinoschisis
5413196|NCT00055029|XLRS|xlrs
5413197|NCT00055016|Lysosomal Disease|lysosomal disease
5413198|NCT00055016|Renal Function|renal function
5413199|NCT00055016|Stroke|stroke
5413200|NCT00055016|Cardiac Disease|cardiac disease
5413201|NCT00055016|Natural History|natural history
5413202|NCT00055016|Fabry Disease|fabry disease
5413203|NCT00055003|Amygdala|amygdala
5413204|NCT00055003|Medial Prefrontal Cortex|medial prefrontal cortex
5413205|NCT00055003|Orbitofrontal Cortex|orbitofrontal cortex
5413206|NCT00055003|Cortisol|cortisol
5413207|NCT00055003|Memory|memory
5413208|NCT00055003|Glucocorticoid|glucocorticoid
5413209|NCT00055003|Hydrocortisone|hydrocortisone
5413210|NCT00055003|Stress|stress
5413211|NCT00055003|Perception|perception
5413212|NCT00055003|Affect|affect
5413213|NCT00055003|Healthy Volunteer|healthy volunteer
5413214|NCT00055003|HV|hv
5413215|NCT00054990|Antiepileptic Drugs|antiepileptic drugs
5413216|NCT00054990|Cortical Excitability|cortical excitability
5413217|NCT00054990|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
5413218|NCT00054990|Epilepsy|epilepsy
5413219|NCT00054990|TMS|tms
5413220|NCT00054990|Healthy Volunteer|healthy volunteer
5413221|NCT00054990|HV|hv
5413222|NCT00054977|cancer|cancer
5413223|NCT00054977|tumor|tumor
5413224|NCT00054951|Hepatoma|hepatoma
5413225|NCT00054951|Liver Cancer|liver cancer
5413227|NCT00054938|Accelerated Atherosclerosis|accelerated atherosclerosis
5413228|NCT00054938|Cholesterol|cholesterol
5413229|NCT00054912|vaccine|vaccine
5413230|NCT00054912|colon|colon
5413231|NCT00054912|cancer|cancer
5413232|NCT00054912|colorectal|colorectal
5413233|NCT00054912|neoplasm|neoplasm
5413234|NCT00054912|Colonic Cancer|colonic cancer
5413235|NCT00054912|Colon Cancer|colon cancer
5413236|NCT00054912|Cancer of the Colon|cancer of the colon
5413237|NCT00054899|vaccine|vaccine
5413238|NCT00054899|lung|lung
5413239|NCT00054899|cancer|cancer
5413240|NCT00054899|Carcinoma, Large Cell|carcinoma, large cell
5413241|NCT00054899|Non-Small-Cell Lung Carcinoma|non-small-cell lung carcinoma
5413242|NCT00054873|Adenocarcinoma of the esophagus or stomach|adenocarcinoma of the esophagus or stomach
5413243|NCT00054860|HIV Preventive Vaccine|hiv preventive vaccine
5413244|NCT00054860|HIV Seronegativity|hiv seronegativity
5413245|NCT00054860|HIV-1|hiv-1
5413246|NCT00054860|AIDS Vaccines|aids vaccines
5413247|NCT00054860|Vaccines, DNA|vaccines, dna
5413248|NCT00054860|Dose-Response Relationship, Immunologic|dose-response relationship, immunologic
5413249|NCT00054860|CD4-Positive T-Lymphocytes|cd4-positive t-lymphocytes
5413250|NCT00054860|CD8-Positive T-Lymphocytes|cd8-positive t-lymphocytes
5413251|NCT00054860|Epitopes|epitopes
5413252|NCT00054847|CABG|cabg
5413253|NCT00054847|cardiovascular|cardiovascular
5413254|NCT00054847|chronic diseases|chronic diseases
5413255|NCT00054847|clinical trial|clinical trial
5413256|NCT00054847|heart|heart
5413257|NCT00054847|multi-site trial|multi-site trial
5413258|NCT00054847|prospective|prospective
5413259|NCT00054821|Osteoarthritis, Ankle|osteoarthritis, ankle
5413260|NCT00054821|Ankle Distraction|ankle distraction
5413261|NCT00054808|Gallium Nitrate|gallium nitrate
5413262|NCT00054808|Ganite|ganite
5413263|NCT00054808|NHL|nhl
5413264|NCT00054808|Relapsed|relapsed
5413265|NCT00054795|Brain Neoplasms/radiotherapy|brain neoplasms/radiotherapy
5413266|NCT00054795|Neoplasms/complications/prevention & control,|neoplasms/complications/prevention & control,
5413267|NCT00054795|Neuropsychological Tests,|neuropsychological tests,
5413268|NCT00054795|Metalloporphyrins/therapeutic use,|metalloporphyrins/therapeutic use,
5413269|NCT00054795|Combined Modality Therapy,|combined modality therapy,
5413270|NCT00054795|Drug therapy,|drug therapy,
5413271|NCT00054795|Quality of Life,|quality of life,
5413272|NCT00054795|Cranial Irradiation,|cranial irradiation,
5413273|NCT00054795|Radiotherapy/Targeted,|radiotherapy/targeted,
5413274|NCT00054795|Prospective Studies,|prospective studies,
5413275|NCT00054795|Neoplasm Recurrence/Local,|neoplasm recurrence/local,
5413276|NCT00054795|Treatment Outcome|treatment outcome
5413277|NCT00054795|Brain metastases|brain metastases
5413278|NCT00054795|Brain Neoplasms/secondary|brain neoplasms/secondary
5413279|NCT00054795|Non-small cell lung cancer|non-small cell lung cancer
5413280|NCT00054769|Pediatrics|pediatrics
5413281|NCT00054769|Polymerase Chain Reaction|polymerase chain reaction
5413282|NCT00054730|Fragile X Syndrome|fragile x syndrome
5413283|NCT00054730|Autism|autism
5413284|NCT00054756|Hypothalamic Releasing Factor|hypothalamic releasing factor
5413285|NCT00054756|Neuropeptide|neuropeptide
5413286|NCT00054756|Diagnostic Testing|diagnostic testing
5413287|NCT00054756|Pituitary Tumors|pituitary tumors
5413288|NCT00054756|Central Hypothyroidism|central hypothyroidism
5413289|NCT00054756|Pituitary Disorder|pituitary disorder
5413290|NCT00054756|Thyroid Disorder|thyroid disorder
5413291|NCT00054756|Healthy Volunteer|healthy volunteer
5413292|NCT00054743|Race|race
5413293|NCT00054743|Ethnicity|ethnicity
5413294|NCT00054743|Pharmacogenetics|pharmacogenetics
5413295|NCT00054743|Cytochrome P450|cytochrome p450
5413296|NCT00054743|Population Pharmacokinetics|population pharmacokinetics
5413297|NCT00054743|HIV|hiv
5413298|NCT00054704|Riluzole|riluzole
5413299|NCT00054704|Neuroprotective|neuroprotective
5413300|NCT00054704|Open-Label Study|open-label study
5413301|NCT00054704|Glutamate Dysfunction|glutamate dysfunction
5413302|NCT00054704|Bipolar Mood Disorder|bipolar mood disorder
5413303|NCT00054704|Bipolar Disorder|bipolar disorder
5413304|NCT00054704|Mood Disorder|mood disorder
5413305|NCT00054691|Skin Cancer|skin cancer
5413306|NCT00054691|Squamous Cell Carcinoma of the Skin|squamous cell carcinoma of the skin
5413307|NCT00054691|Gefitinib|gefitinib
5413308|NCT00054691|ZD1839|zd1839
5413309|NCT00054691|Iressa|iressa
5413310|NCT00054691|Epidermal Growth Factor Receptor|epidermal growth factor receptor
5413311|NCT00054691|EGFR|egfr
5413312|NCT00054678|Myocardial infarction|myocardial infarction
5413313|NCT00054678|Heart disease|heart disease
5413314|NCT00054678|Endoventricular|endoventricular
5413315|NCT00054678|Cardiovascular|cardiovascular
5413316|NCT00054678|Interventional|interventional
5413317|NCT00054678|ICD|icd
5413318|NCT00054678|Heart failure|heart failure
5413319|NCT00054678|Implantable Cardioverter Defibrillator|implantable cardioverter defibrillator
5413320|NCT00050531|Chronic Myelogenous Leukemia|chronic myelogenous leukemia
5413321|NCT00050531|CML|cml
5413322|NCT00050531|Early Chronic Phase Chronic Myelogenous Leukemia|early chronic phase chronic myelogenous leukemia
5413323|NCT00050531|Imatinib Mesylate|imatinib mesylate
5413324|NCT00050531|Gleevec|gleevec
5434994|NCT00002201|Nelfinavir|nelfinavir
5413325|NCT00050531|Peg-Alpha Interferon|peg-alpha interferon
5413326|NCT00050531|Peg-Intron|peg-intron
5413327|NCT00050531|Sargramostim|sargramostim
5413328|NCT00050531|GM-CSF|gm-csf
5413329|NCT00054665|BCL-2|bcl-2
5413330|NCT00054665|NFK-B|nfk-b
5413331|NCT00054665|Drug Resistance|drug resistance
5413332|NCT00054665|Translational|translational
5413333|NCT00054665|Lymphoma|lymphoma
5413334|NCT00054665|Large B-Cell Lymphoma|large b-cell lymphoma
5413335|NCT00054652|Geste Antagoniste|geste antagoniste
5413336|NCT00054652|TMS|tms
5413337|NCT00054652|Sensorimotor Integration|sensorimotor integration
5413338|NCT00054652|Writer's Cramp|writer's cramp
5413339|NCT00054652|Sensory Input|sensory input
5413340|NCT00054652|Focal Dystonia|focal dystonia
5413341|NCT00054626|stage II bladder cancer|stage ii bladder cancer
5413342|NCT00054626|stage III bladder cancer|stage iii bladder cancer
5413343|NCT00054626|stage IV bladder cancer|stage iv bladder cancer
5413344|NCT00054626|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
5413345|NCT00054613|Graft-versus-Host Disease|graft-versus-host disease
5413346|NCT00054613|Extracorporeal Photopheresis|extracorporeal photopheresis
5413347|NCT00054600|Extracorporeal Photopheresis|extracorporeal photopheresis
5413348|NCT00054600|Graft-versus-Host Disease|graft-versus-host disease
5413349|NCT00054587|stage II breast cancer|stage ii breast cancer
5413350|NCT00054587|stage IIIA breast cancer|stage iiia breast cancer
5413351|NCT00054574|recurrent prostate cancer|recurrent prostate cancer
5413352|NCT00054574|stage I prostate cancer|stage i prostate cancer
5413353|NCT00054574|stage II prostate cancer|stage ii prostate cancer
5413354|NCT00054574|stage III prostate cancer|stage iii prostate cancer
5413355|NCT00054561|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
5413356|NCT00054561|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5413357|NCT00054561|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
5413358|NCT00054561|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5413359|NCT00054561|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
5413360|NCT00054561|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5413361|NCT00054561|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
5413362|NCT00054561|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5413363|NCT00054535|stage IV melanoma|stage iv melanoma
5413364|NCT00054535|recurrent melanoma|recurrent melanoma
5413365|NCT00054522|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5413366|NCT00054522|recurrent prostate cancer|recurrent prostate cancer
5413367|NCT00054496|adult glioblastoma|adult glioblastoma
5413368|NCT00054496|recurrent adult brain tumor|recurrent adult brain tumor
5413369|NCT00054496|adult giant cell glioblastoma|adult giant cell glioblastoma
5413370|NCT00054496|adult gliosarcoma|adult gliosarcoma
5413371|NCT00054470|stage IV breast cancer|stage iv breast cancer
5413372|NCT00054470|recurrent breast cancer|recurrent breast cancer
5413373|NCT00054470|male breast cancer|male breast cancer
5413374|NCT00054457|adenocarcinoma of the stomach|adenocarcinoma of the stomach
5413375|NCT00054457|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
5413376|NCT00054457|stage IV gastric cancer|stage iv gastric cancer
5413377|NCT00054457|recurrent gastric cancer|recurrent gastric cancer
5413378|NCT00054457|stage IV esophageal cancer|stage iv esophageal cancer
5413379|NCT00054457|recurrent esophageal cancer|recurrent esophageal cancer
5413380|NCT00054418|osteoporosis|osteoporosis
5413381|NCT00054418|stage I breast cancer|stage i breast cancer
5413382|NCT00054418|stage II breast cancer|stage ii breast cancer
5413383|NCT00054418|stage IIIA breast cancer|stage iiia breast cancer
5413384|NCT00054418|stage IIIB breast cancer|stage iiib breast cancer
5413385|NCT00054392|adenosquamous cell lung cancer|adenosquamous cell lung cancer
5413386|NCT00054392|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
5413387|NCT00054392|large cell lung cancer|large cell lung cancer
5413388|NCT00054392|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5413389|NCT00054392|squamous cell lung cancer|squamous cell lung cancer
5413390|NCT00054392|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5413391|NCT00054392|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5413392|NCT00054392|adenocarcinoma of the lung|adenocarcinoma of the lung
5413393|NCT00054340|graft versus host disease|graft versus host disease
5413394|NCT00054340|polycythemia vera|polycythemia vera
5413395|NCT00054340|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
5413396|NCT00054340|essential thrombocythemia|essential thrombocythemia
5413397|NCT00054340|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
5413398|NCT00054340|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5413399|NCT00054340|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5413400|NCT00054340|untreated childhood acute myeloid leukemia and other myeloid malignancies|untreated childhood acute myeloid leukemia and other myeloid malignancies
5413401|NCT00054340|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5413402|NCT00054340|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5413403|NCT00054340|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5413404|NCT00054340|chronic eosinophilic leukemia|chronic eosinophilic leukemia
5413405|NCT00054340|chronic neutrophilic leukemia|chronic neutrophilic leukemia
5413406|NCT00054340|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
5413407|NCT00054340|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5413408|NCT00054340|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5413409|NCT00054340|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5413410|NCT00054340|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5413411|NCT00054340|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5413412|NCT00054340|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
5413413|NCT00054327|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5413414|NCT00054327|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
5413415|NCT00054327|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5413416|NCT00054327|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5413417|NCT00054327|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5413418|NCT00054327|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
5413419|NCT00054327|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
5413420|NCT00054327|refractory anemia with excess blasts|refractory anemia with excess blasts
5413421|NCT00054327|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5413422|NCT00054327|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5413423|NCT00054327|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5413424|NCT00054327|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5413425|NCT00054327|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5413426|NCT00054327|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5413427|NCT00054327|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5413428|NCT00054327|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5414687|NCT00049296|recurrent anal cancer|recurrent anal cancer
5413429|NCT00054327|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5413430|NCT00054327|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5413431|NCT00054327|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5413432|NCT00054327|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
5413433|NCT00054327|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
5413434|NCT00054327|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
5413435|NCT00054327|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5413436|NCT00054327|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
5413437|NCT00054327|refractory anemia|refractory anemia
5413438|NCT00054327|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5413439|NCT00054327|refractory cytopenia with multilineage dysplasia|refractory cytopenia with multilineage dysplasia
5413440|NCT00054327|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5413441|NCT00054327|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5413442|NCT00054327|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5413443|NCT00054327|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5413444|NCT00054327|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
5413445|NCT00054327|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
5413446|NCT00054327|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
5413447|NCT00054327|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
5413448|NCT00054327|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5413449|NCT00054327|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5413450|NCT00054327|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5413451|NCT00054327|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5413452|NCT00054327|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5413453|NCT00054327|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
5413454|NCT00054314|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5413455|NCT00054301|stage I breast cancer|stage i breast cancer
5413456|NCT00054301|stage II breast cancer|stage ii breast cancer
5413457|NCT00054301|stage IIIA breast cancer|stage iiia breast cancer
5413458|NCT00054301|ductal breast carcinoma in situ|ductal breast carcinoma in situ
5413459|NCT00054301|breast cancer in situ|breast cancer in situ
5413460|NCT00054288|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5413461|NCT00054275|recurrent breast cancer|recurrent breast cancer
5413462|NCT00054275|stage IV breast cancer|stage iv breast cancer
5413463|NCT00054275|male breast cancer|male breast cancer
5413464|NCT00054262|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
5413465|NCT00054262|advanced adult primary liver cancer|advanced adult primary liver cancer
5413466|NCT00054262|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
5413467|NCT00054249|recurrent gastric cancer|recurrent gastric cancer
5413468|NCT00054236|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
5413469|NCT00054236|refractory anemia with excess blasts|refractory anemia with excess blasts
5413470|NCT00054236|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5413471|NCT00054236|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
5413472|NCT00054236|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5413473|NCT00054236|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5413474|NCT00054236|adult erythroleukemia (M6a)|adult erythroleukemia (m6a)
5413475|NCT00054236|childhood acute erythroleukemia (M6)|childhood acute erythroleukemia (m6)
5413476|NCT00054236|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
5413477|NCT00054236|childhood acute minimally differentiated myeloid leukemia (M0)|childhood acute minimally differentiated myeloid leukemia (m0)
5413478|NCT00054236|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
5413479|NCT00054236|childhood acute megakaryocytic leukemia (M7)|childhood acute megakaryocytic leukemia (m7)
5413480|NCT00054236|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5413481|NCT00054236|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
5413482|NCT00054236|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5413483|NCT00054236|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5413484|NCT00054236|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5413485|NCT00054236|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5413486|NCT00054236|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5413487|NCT00054236|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5413488|NCT00054236|stage I multiple myeloma|stage i multiple myeloma
5413489|NCT00054236|stage II multiple myeloma|stage ii multiple myeloma
5413490|NCT00054236|stage III multiple myeloma|stage iii multiple myeloma
5413491|NCT00054236|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
5413492|NCT00054236|polycythemia vera|polycythemia vera
5413493|NCT00054236|primary myelofibrosis|primary myelofibrosis
5413494|NCT00054236|essential thrombocythemia|essential thrombocythemia
5413495|NCT00054236|refractory multiple myeloma|refractory multiple myeloma
5413496|NCT00054236|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5413497|NCT00054236|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5413498|NCT00054236|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5413499|NCT00054236|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5413500|NCT00054236|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5413501|NCT00054236|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5413502|NCT00054236|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5413503|NCT00054236|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5413504|NCT00054236|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5413505|NCT00054236|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5413506|NCT00054236|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
5413507|NCT00054236|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
5413508|NCT00054236|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
5413509|NCT00054236|childhood diffuse large cell lymphoma|childhood diffuse large cell lymphoma
5413510|NCT00054236|childhood immunoblastic large cell lymphoma|childhood immunoblastic large cell lymphoma
5413511|NCT00054236|Burkitt lymphoma|burkitt lymphoma
5413512|NCT00054236|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5413513|NCT00054236|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5413514|NCT00054236|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
5413515|NCT00054236|chronic eosinophilic leukemia|chronic eosinophilic leukemia
5413516|NCT00054236|chronic neutrophilic leukemia|chronic neutrophilic leukemia
5413517|NCT00054236|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
5413518|NCT00054236|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
5413519|NCT00054236|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5413520|NCT00054236|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5413521|NCT00054236|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5413522|NCT00054236|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5413523|NCT00054236|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5413524|NCT00054236|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5413525|NCT00054236|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5413526|NCT00054236|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5413527|NCT00054236|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5413528|NCT00054236|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5413529|NCT00054236|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
5434996|NCT00002200|HIV-1|hiv-1
5413530|NCT00054223|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
5413531|NCT00054223|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5413532|NCT00054210|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5413533|NCT00054210|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5413534|NCT00054210|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5413535|NCT00054197|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5413536|NCT00054197|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5413537|NCT00054197|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5413538|NCT00054184|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5413539|NCT00054184|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5413540|NCT00054184|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5413541|NCT00054171|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
5413542|NCT00054171|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
5413543|NCT00054171|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
5413544|NCT00054171|stage 0 chronic lymphocytic leukemia|stage 0 chronic lymphocytic leukemia
5413545|NCT00054171|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
5413546|NCT00054158|stage I multiple myeloma|stage i multiple myeloma
5413547|NCT00054158|stage II multiple myeloma|stage ii multiple myeloma
5413548|NCT00054158|stage III multiple myeloma|stage iii multiple myeloma
5413549|NCT00054145|male breast cancer|male breast cancer
5413550|NCT00054145|recurrent breast cancer|recurrent breast cancer
5413551|NCT00054145|stage IV breast cancer|stage iv breast cancer
5413552|NCT00054145|stage IIIA breast cancer|stage iiia breast cancer
5413553|NCT00054145|stage IIIB breast cancer|stage iiib breast cancer
5413554|NCT00054145|stage IIIC breast cancer|stage iiic breast cancer
5413555|NCT00054106|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5413556|NCT00054106|stage III prostate cancer|stage iii prostate cancer
5413557|NCT00054106|stage II prostate cancer|stage ii prostate cancer
5413558|NCT00054067|cervical adenocarcinoma|cervical adenocarcinoma
5413559|NCT00054067|cervical adenosquamous cell carcinoma|cervical adenosquamous cell carcinoma
5413560|NCT00054067|cervical squamous cell carcinoma|cervical squamous cell carcinoma
5413561|NCT00054067|stage IB cervical cancer|stage ib cervical cancer
5413562|NCT00054054|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
5413563|NCT00054054|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
5413564|NCT00054054|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
5413565|NCT00054054|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5413566|NCT00054054|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5413567|NCT00054054|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5413568|NCT00054015|recurrent prostate cancer|recurrent prostate cancer
5413569|NCT00054015|stage IV prostate cancer|stage iv prostate cancer
5413570|NCT00054002|localized malignant mesothelioma|localized malignant mesothelioma
5413571|NCT00054002|recurrent malignant mesothelioma|recurrent malignant mesothelioma
5413572|NCT00054002|epithelial mesothelioma|epithelial mesothelioma
5413573|NCT00054002|sarcomatous mesothelioma|sarcomatous mesothelioma
5413574|NCT00053989|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5413575|NCT00053989|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5413576|NCT00053989|primary myelofibrosis|primary myelofibrosis
5413577|NCT00053989|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5413578|NCT00053989|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5413579|NCT00053989|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5413580|NCT00053989|refractory anemia with excess blasts|refractory anemia with excess blasts
5413581|NCT00053989|stage I multiple myeloma|stage i multiple myeloma
5413582|NCT00053989|stage II multiple myeloma|stage ii multiple myeloma
5413583|NCT00053989|stage III multiple myeloma|stage iii multiple myeloma
5413584|NCT00053989|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
5413585|NCT00053989|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5413586|NCT00053989|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5413587|NCT00053989|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
5413588|NCT00053989|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5413589|NCT00053989|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5413590|NCT00053989|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5413591|NCT00053989|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5413592|NCT00053989|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5413593|NCT00053989|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5413594|NCT00053989|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5413595|NCT00053989|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
5413596|NCT00053989|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5413597|NCT00053989|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
5413598|NCT00053989|refractory multiple myeloma|refractory multiple myeloma
5413599|NCT00053989|refractory anemia|refractory anemia
5413600|NCT00053989|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5413601|NCT00053989|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5413602|NCT00053989|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5413603|NCT00053989|grade 1 follicular lymphoma|grade 1 follicular lymphoma
5413604|NCT00053989|grade 2 follicular lymphoma|grade 2 follicular lymphoma
5413605|NCT00053989|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
5413606|NCT00053989|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5413607|NCT00053989|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5413608|NCT00053989|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
5413609|NCT00053989|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
5413610|NCT00053989|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
5413611|NCT00053989|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
5413612|NCT00053989|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5413613|NCT00053989|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5413614|NCT00053989|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5413615|NCT00053989|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5413616|NCT00053989|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5413617|NCT00053989|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5416119|NCT00036894|adult mixed glioma|adult mixed glioma
5413618|NCT00053989|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5413619|NCT00053989|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5413620|NCT00053989|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5413621|NCT00053989|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5413622|NCT00053989|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
5413623|NCT00053976|graft versus host disease|graft versus host disease
5413624|NCT00053937|plexiform neurofibroma|plexiform neurofibroma
5413625|NCT00053937|neurofibromatosis type 1|neurofibromatosis type 1
5413626|NCT00053924|recurrent pancreatic cancer|recurrent pancreatic cancer
5413627|NCT00053924|stage II pancreatic cancer|stage ii pancreatic cancer
5413628|NCT00053924|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
5413629|NCT00053924|stage III pancreatic cancer|stage iii pancreatic cancer
5413630|NCT00053924|stage IV pancreatic cancer|stage iv pancreatic cancer
5413631|NCT00053911|recurrent breast cancer|recurrent breast cancer
5413632|NCT00053911|stage I breast cancer|stage i breast cancer
5413633|NCT00053911|stage II breast cancer|stage ii breast cancer
5413634|NCT00053911|stage IIIA breast cancer|stage iiia breast cancer
5413635|NCT00053898|breast cancer in situ|breast cancer in situ
5413636|NCT00053898|ductal breast carcinoma in situ|ductal breast carcinoma in situ
5413637|NCT00053885|advanced malignant mesothelioma|advanced malignant mesothelioma
5413638|NCT00053885|epithelial mesothelioma|epithelial mesothelioma
5413639|NCT00053885|recurrent malignant mesothelioma|recurrent malignant mesothelioma
5413640|NCT00053885|sarcomatous mesothelioma|sarcomatous mesothelioma
5413641|NCT00053872|untreated childhood medulloblastoma|untreated childhood medulloblastoma
5413643|NCT00053846|pulmonary complications|pulmonary complications
5413644|NCT00053846|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5413645|NCT00053833|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5413646|NCT00053833|fallopian tube cancer|fallopian tube cancer
5413647|NCT00053833|primary peritoneal cavity cancer|primary peritoneal cavity cancer
5413648|NCT00053833|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5413649|NCT00053833|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5413650|NCT00053820|stage IV renal cell cancer|stage iv renal cell cancer
5413651|NCT00053807|stage III renal cell cancer|stage iii renal cell cancer
5413652|NCT00053807|stage IV renal cell cancer|stage iv renal cell cancer
5413653|NCT00053794|adult alveolar soft-part sarcoma|adult alveolar soft-part sarcoma
5413654|NCT00053794|adult angiosarcoma|adult angiosarcoma
5413655|NCT00053794|adult fibrosarcoma|adult fibrosarcoma
5413656|NCT00053794|adult leiomyosarcoma|adult leiomyosarcoma
5413657|NCT00053794|adult liposarcoma|adult liposarcoma
5413658|NCT00053794|adult synovial sarcoma|adult synovial sarcoma
5413659|NCT00053794|endometrial stromal sarcoma|endometrial stromal sarcoma
5413660|NCT00053794|uterine leiomyosarcoma|uterine leiomyosarcoma
5413661|NCT00053794|adult malignant hemangiopericytoma|adult malignant hemangiopericytoma
5413662|NCT00053794|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
5413663|NCT00053794|stage III uterine sarcoma|stage iii uterine sarcoma
5413664|NCT00053794|stage IV uterine sarcoma|stage iv uterine sarcoma
5413665|NCT00053794|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
5413666|NCT00053794|recurrent uterine sarcoma|recurrent uterine sarcoma
5413667|NCT00053794|adult malignant fibrous histiocytoma|adult malignant fibrous histiocytoma
5413668|NCT00053794|adult neurofibrosarcoma|adult neurofibrosarcoma
5413669|NCT00053794|adult rhabdomyosarcoma|adult rhabdomyosarcoma
5413670|NCT00053794|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
5413671|NCT00053781|recurrent melanoma|recurrent melanoma
5413672|NCT00053781|stage IV melanoma|stage iv melanoma
5413673|NCT00053768|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
5413674|NCT00053768|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5413675|NCT00053768|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
5413676|NCT00053768|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5413677|NCT00053768|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5413678|NCT00053768|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
5413679|NCT00053768|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
5413680|NCT00053768|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
5413681|NCT00053768|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5413682|NCT00053768|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5413683|NCT00053768|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
5413684|NCT00053768|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
5413685|NCT00053768|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5413686|NCT00053768|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
5413687|NCT00053768|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
5413688|NCT00053768|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
5413689|NCT00053768|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5413690|NCT00053768|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5413691|NCT00053768|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5413692|NCT00053768|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5413693|NCT00053768|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
5413694|NCT00053768|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
5413695|NCT00053768|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
5413696|NCT00053768|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5413697|NCT00053768|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5413698|NCT00053768|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
5413699|NCT00053768|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
5413700|NCT00053768|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
5413701|NCT00053768|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5413702|NCT00053768|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5413703|NCT00053768|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
5413704|NCT00053768|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5413705|NCT00053768|stage I mantle cell lymphoma|stage i mantle cell lymphoma
5413706|NCT00053768|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5413707|NCT00053768|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5413708|NCT00053716|Angioplasty & PGE1 Treatment of Peripheral Vascular Disease|angioplasty & pge1 treatment of peripheral vascular disease
5413709|NCT00045123|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5413710|NCT00045123|recurrent prostate cancer|recurrent prostate cancer
5413711|NCT00028678|adult glioblastoma|adult glioblastoma
5413712|NCT00028678|adult giant cell glioblastoma|adult giant cell glioblastoma
5413713|NCT00028678|adult gliosarcoma|adult gliosarcoma
5413714|NCT00017342|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5413715|NCT00017342|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5413716|NCT00017342|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5413717|NCT00017342|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5413718|NCT00017342|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5413719|NCT00017342|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5413720|NCT00053742|Smallpox|smallpox
5413721|NCT00053742|Vaccine|vaccine
5413722|NCT00053742|Vaccination|vaccination
5413723|NCT00053742|Variola|variola
5413724|NCT00053742|Adults|adults
5413725|NCT00053742|Healthy Volunteer|healthy volunteer
5413726|NCT00053742|HV|hv
5413727|NCT00053742|Smallpox Vaccine|smallpox vaccine
5413728|NCT00053703|Psychotic Disorders|psychotic disorders
5413729|NCT00053703|Schizophreniform Disorder|schizophreniform disorder
5413730|NCT00053690|Comorbidity|comorbidity
5413731|NCT00053690|Schizophrenia|schizophrenia
5413732|NCT00053690|Bipolar Disorder|bipolar disorder
5413733|NCT00053690|Depression|depression
5413734|NCT00053677|Impulse Control Disorders|impulse control disorders
5413735|NCT00053638|HIV-1 Efavirenz Tenofovir|hiv-1 efavirenz tenofovir
5413736|NCT00053625|Parkinson's disease|parkinson's disease
5413737|NCT00053625|PD|pd
5413738|NCT00053625|deep brain stimulation|deep brain stimulation
5413739|NCT00053625|DBS|dbs
5413740|NCT00053612|HIV-1|hiv-1
5413741|NCT00053612|Women|women
5413742|NCT00053612|Vitamin A|vitamin a
5413743|NCT00053612|Shedding|shedding
5435092|NCT00002186|Acyclovir|acyclovir
5413744|NCT00053599|Cholesterol-lowering drug|cholesterol-lowering drug
5413745|NCT00053599|Mild to Moderate Alzheimer disease|mild to moderate alzheimer disease
5413746|NCT00053573|Glycogen Storage Disease Type II|glycogen storage disease type ii
5413747|NCT00053573|GSD-II|gsd-ii
5413748|NCT00053573|Pompe Disease|pompe disease
5413749|NCT00053560|lupus|lupus
5413750|NCT00053560|systemic lupus erythematosus|systemic lupus erythematosus
5413751|NCT00053560|SLE|sle
5413752|NCT00053560|bone loss|bone loss
5413753|NCT00053560|DHEA|dhea
5413754|NCT00053495|Smallpox|smallpox
5413755|NCT00053482|Smallpox vaccines|smallpox vaccines
5413756|NCT00053482|Dryvax®|dryvax®
5413757|NCT00053482|Orthopoxvirus|orthopoxvirus
5413758|NCT00053482|Vaccinia virus|vaccinia virus
5413759|NCT00053482|ACAM2000|acam2000
5413760|NCT00053469|Cognitive Development|cognitive development
5413761|NCT00053469|Motor Planning|motor planning
5413762|NCT00053469|Categorization|categorization
5413763|NCT00053469|Perception|perception
5413764|NCT00053469|Adaptation|adaptation
5413765|NCT00053456|Endothelium|endothelium
5413766|NCT00053456|Nitric Oxide|nitric oxide
5413767|NCT00053456|Myocardial Ischemia|myocardial ischemia
5413768|NCT00053456|Exercise|exercise
5413769|NCT00053456|Endothelial Progenitor Cells|endothelial progenitor cells
5413770|NCT00053443|Adherence|adherence
5413771|NCT00053443|Treatment Experienced|treatment experienced
5413772|NCT00053430|Immune Modulation|immune modulation
5413773|NCT00053430|Thalidomide|thalidomide
5413774|NCT00053430|Immune reconstitution|immune reconstitution
5413775|NCT00053430|Treatment Experienced|treatment experienced
5413776|NCT00053417|Walking Ability|walking ability
5413777|NCT00053417|Muscle strength|muscle strength
5413778|NCT00053417|Spasticity|spasticity
5413779|NCT00053404|Treatment Experienced|treatment experienced
5413780|NCT00053404|Drug Resistance|drug resistance
5413781|NCT00053391|stage III melanoma|stage iii melanoma
5413782|NCT00053391|stage IV melanoma|stage iv melanoma
5413783|NCT00053391|recurrent melanoma|recurrent melanoma
5413784|NCT00053378|hypocalcemia, ionized calcium, intensive care|hypocalcemia, ionized calcium, intensive care
5413785|NCT00053300|extensive stage small cell lung cancer|extensive stage small cell lung cancer
5413786|NCT00053287|adult acute promyelocytic leukemia (M3)|adult acute promyelocytic leukemia (m3)
5413787|NCT00053287|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
5413788|NCT00053287|refractory anemia with excess blasts|refractory anemia with excess blasts
5413789|NCT00053287|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5413790|NCT00053287|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5413791|NCT00053287|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5413792|NCT00053287|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
5413793|NCT00053287|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5413794|NCT00053287|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5413795|NCT00053287|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5413796|NCT00053287|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5413797|NCT00053287|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
5413798|NCT00053287|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
5413799|NCT00053287|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5413800|NCT00053287|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5413801|NCT00053287|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5413802|NCT00053287|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5413803|NCT00053287|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5413804|NCT00053261|sexuality and reproductive issues|sexuality and reproductive issues
5413805|NCT00053261|stage IB cervical cancer|stage ib cervical cancer
5413806|NCT00053248|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5413807|NCT00053248|Philadelphia chromosome positive chronic myelogenous leukemia|philadelphia chromosome positive chronic myelogenous leukemia
5413808|NCT00053222|recurrent pancreatic cancer|recurrent pancreatic cancer
5413809|NCT00053222|stage II pancreatic cancer|stage ii pancreatic cancer
5413810|NCT00053222|stage III pancreatic cancer|stage iii pancreatic cancer
5413811|NCT00053222|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
5413812|NCT00053222|stage IV pancreatic cancer|stage iv pancreatic cancer
5413813|NCT00053209|metastatic transitional cell cancer of the renal pelvis and ureter|metastatic transitional cell cancer of the renal pelvis and ureter
5413814|NCT00053209|recurrent transitional cell cancer of the renal pelvis and ureter|recurrent transitional cell cancer of the renal pelvis and ureter
5413815|NCT00053209|regional transitional cell cancer of the renal pelvis and ureter|regional transitional cell cancer of the renal pelvis and ureter
5413816|NCT00053209|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
5413817|NCT00053209|recurrent bladder cancer|recurrent bladder cancer
5413818|NCT00053209|stage III bladder cancer|stage iii bladder cancer
5413819|NCT00053209|stage IV bladder cancer|stage iv bladder cancer
5413820|NCT00053209|anterior urethral cancer|anterior urethral cancer
5413821|NCT00053209|posterior urethral cancer|posterior urethral cancer
5413822|NCT00053209|recurrent urethral cancer|recurrent urethral cancer
5413823|NCT00053209|urethral cancer associated with invasive bladder cancer|urethral cancer associated with invasive bladder cancer
5413824|NCT00053196|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5413825|NCT00053196|prolymphocytic leukemia|prolymphocytic leukemia
5413826|NCT00053196|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5413827|NCT00053196|stage I multiple myeloma|stage i multiple myeloma
5413828|NCT00053196|stage II multiple myeloma|stage ii multiple myeloma
5413829|NCT00053196|stage III multiple myeloma|stage iii multiple myeloma
5413830|NCT00053196|refractory multiple myeloma|refractory multiple myeloma
5413831|NCT00053196|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5413832|NCT00053196|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5413833|NCT00053196|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5413834|NCT00053196|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5413835|NCT00053196|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5413836|NCT00053196|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5413837|NCT00053196|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5413838|NCT00053196|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5413839|NCT00053196|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5413840|NCT00053196|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5413841|NCT00053196|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5413842|NCT00053196|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5413843|NCT00053196|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5413844|NCT00053196|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
5413845|NCT00053196|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
5413846|NCT00053196|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
5413847|NCT00053196|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
5413848|NCT00053196|atypical chronic myeloid leukemia, BCR-ABL negative|atypical chronic myeloid leukemia, bcr-abl negative
5413849|NCT00053196|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
5413850|NCT00053196|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5413851|NCT00053196|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5413852|NCT00053196|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5413853|NCT00053196|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5413854|NCT00053196|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5413855|NCT00053196|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5413856|NCT00053196|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5413857|NCT00053196|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5413858|NCT00053196|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5413859|NCT00053196|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5413860|NCT00053196|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
5413861|NCT00053183|adult glioblastoma|adult glioblastoma
5413862|NCT00053183|adult giant cell glioblastoma|adult giant cell glioblastoma
5413863|NCT00053183|adult gliosarcoma|adult gliosarcoma
5413864|NCT00053157|graft versus host disease|graft versus host disease
5413865|NCT00053157|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5413866|NCT00053157|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5413867|NCT00053157|primary myelofibrosis|primary myelofibrosis
5413868|NCT00053157|childhood acute myeloid leukemia/other myeloid malignancies|childhood acute myeloid leukemia/other myeloid malignancies
5413869|NCT00053157|childhood acute promyelocytic leukemia (M3)|childhood acute promyelocytic leukemia (m3)
5413870|NCT00053157|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5413871|NCT00053157|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5413872|NCT00053157|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
5413873|NCT00053157|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
5413874|NCT00053157|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
5413875|NCT00053157|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
5413876|NCT00053157|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5413877|NCT00053157|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5413878|NCT00053157|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5413879|NCT00053157|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
5413880|NCT00053157|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5413881|NCT00053157|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
5413882|NCT00053157|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
5413883|NCT00053157|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
5413884|NCT00053157|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
5413885|NCT00053157|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
5413886|NCT00053157|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5413887|NCT00053157|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5413888|NCT00053157|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5413889|NCT00053157|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5413890|NCT00053157|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5413891|NCT00053157|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5413892|NCT00053157|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5413893|NCT00053157|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5413894|NCT00053157|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5413895|NCT00053157|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5413896|NCT00053157|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5413897|NCT00053157|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5413898|NCT00053157|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5413899|NCT00053157|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5413900|NCT00053157|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5413901|NCT00053157|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5413902|NCT00053157|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5413903|NCT00053157|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5413904|NCT00053157|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5413905|NCT00053157|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5413906|NCT00053157|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5413907|NCT00053157|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5413908|NCT00053157|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5413909|NCT00053157|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5413910|NCT00053157|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5413911|NCT00053157|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5413912|NCT00053157|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5413913|NCT00053157|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5413914|NCT00053157|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5413915|NCT00053157|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5413916|NCT00053157|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5413917|NCT00053157|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5413918|NCT00053157|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5413919|NCT00053157|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5413920|NCT00053157|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5413921|NCT00053157|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5413922|NCT00053157|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5413923|NCT00053157|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5413924|NCT00053157|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5413925|NCT00053157|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5413926|NCT00053157|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5413927|NCT00053157|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5413928|NCT00053157|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5413929|NCT00053157|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
5413930|NCT00053157|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
5413931|NCT00053157|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
5413932|NCT00053157|untreated childhood acute myeloid leukemia and other myeloid malignancies|untreated childhood acute myeloid leukemia and other myeloid malignancies
5413933|NCT00053157|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
5413934|NCT00053157|chronic eosinophilic leukemia|chronic eosinophilic leukemia
5413935|NCT00053157|chronic neutrophilic leukemia|chronic neutrophilic leukemia
5413936|NCT00053157|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
5413937|NCT00053157|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
5413938|NCT00053157|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
5413939|NCT00053157|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
5413940|NCT00053157|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5413941|NCT00053157|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5413942|NCT00053157|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5413943|NCT00053157|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5413944|NCT00053157|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5413945|NCT00053157|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5413946|NCT00053157|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5413947|NCT00053157|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5413948|NCT00053157|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5413949|NCT00053157|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5413950|NCT00053157|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5413951|NCT00053157|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5413952|NCT00053157|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5413953|NCT00053157|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5413954|NCT00053157|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
5413955|NCT00053144|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5413956|NCT00053144|Philadelphia chromosome positive chronic myelogenous leukemia|philadelphia chromosome positive chronic myelogenous leukemia
5413957|NCT00053144|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5413958|NCT00053144|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5413959|NCT00053144|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5413960|NCT00053144|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
5413961|NCT00053144|adult acute erythroid leukemia (M6)|adult acute erythroid leukemia (m6)
5413962|NCT00053144|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
5413963|NCT00053144|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
5413964|NCT00053144|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
5413965|NCT00053144|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
5413966|NCT00053144|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
5413967|NCT00053144|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
5413968|NCT00053144|adult acute promyelocytic leukemia (M3)|adult acute promyelocytic leukemia (m3)
5413969|NCT00053131|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5413970|NCT00053131|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5413971|NCT00053131|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5413972|NCT00053131|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5413973|NCT00053118|childhood central nervous system germ cell tumor|childhood central nervous system germ cell tumor
5413974|NCT00053118|childhood choroid plexus tumor|childhood choroid plexus tumor
5413975|NCT00053118|childhood craniopharyngioma|childhood craniopharyngioma
5413976|NCT00053118|childhood grade I meningioma|childhood grade i meningioma
5413977|NCT00053118|childhood grade II meningioma|childhood grade ii meningioma
5413978|NCT00053118|childhood grade III meningioma|childhood grade iii meningioma
5413979|NCT00053118|recurrent childhood brain stem glioma|recurrent childhood brain stem glioma
5413980|NCT00053118|recurrent childhood cerebellar astrocytoma|recurrent childhood cerebellar astrocytoma
5413981|NCT00053118|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
5413982|NCT00053118|recurrent childhood ependymoma|recurrent childhood ependymoma
5413983|NCT00053118|recurrent childhood medulloblastoma|recurrent childhood medulloblastoma
5413984|NCT00053118|recurrent childhood supratentorial primitive neuroectodermal tumor|recurrent childhood supratentorial primitive neuroectodermal tumor
5413985|NCT00053118|recurrent neuroblastoma|recurrent neuroblastoma
5413986|NCT00053118|recurrent retinoblastoma|recurrent retinoblastoma
5413987|NCT00053118|childhood visual pathway and hypothalamic glioma|childhood visual pathway and hypothalamic glioma
5413988|NCT00053118|childhood atypical teratoid/rhabdoid tumor|childhood atypical teratoid/rhabdoid tumor
5413989|NCT00053118|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
5413990|NCT00053105|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5413991|NCT00053105|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5413992|NCT00053105|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5413993|NCT00053105|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5413994|NCT00053092|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
5413995|NCT00053092|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5413996|NCT00053092|stage I mantle cell lymphoma|stage i mantle cell lymphoma
5413997|NCT00053092|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5413998|NCT00053092|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5413999|NCT00053053|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5414000|NCT00053053|cachexia|cachexia
5414001|NCT00053053|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5414002|NCT00053053|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5414003|NCT00053053|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5414004|NCT00053053|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5414005|NCT00053053|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5414006|NCT00053053|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5414007|NCT00053053|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5414008|NCT00053053|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5414074|NCT00052962|Regional Therapy|regional therapy
5414009|NCT00053053|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5414010|NCT00053053|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5414011|NCT00053053|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5414012|NCT00053053|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5414013|NCT00053053|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5414014|NCT00053053|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5414015|NCT00053053|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5414016|NCT00053053|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5414017|NCT00053053|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5414018|NCT00053053|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5414019|NCT00053053|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
5414020|NCT00053053|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5414021|NCT00053053|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5414022|NCT00053053|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5414023|NCT00053053|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5414024|NCT00053053|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5414025|NCT00053053|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5414026|NCT00053053|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5414027|NCT00053053|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5414028|NCT00053053|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5414029|NCT00053053|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5414030|NCT00053053|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5414031|NCT00053053|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
5414032|NCT00053053|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5414033|NCT00053053|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5414034|NCT00053053|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5414035|NCT00053053|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5414036|NCT00053053|intraocular lymphoma|intraocular lymphoma
5414037|NCT00053053|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
5414038|NCT00053053|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5414039|NCT00053053|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5414040|NCT00053053|post-transplant lymphoproliferative disorder|post-transplant lymphoproliferative disorder
5414041|NCT00053053|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5414042|NCT00053053|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5414043|NCT00053053|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5414044|NCT00053053|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5414045|NCT00053053|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5414046|NCT00053053|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5414047|NCT00053053|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5414048|NCT00053053|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5414049|NCT00053053|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5414050|NCT00053040|recurrent childhood brain tumor|recurrent childhood brain tumor
5414051|NCT00053027|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
5414052|NCT00053027|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5414053|NCT00053027|stage I mantle cell lymphoma|stage i mantle cell lymphoma
5414054|NCT00053027|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5414055|NCT00053027|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5414056|NCT00053014|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5414057|NCT00053014|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5414058|NCT00053014|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5414059|NCT00053014|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5414060|NCT00053014|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5414061|NCT00053001|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5414062|NCT00053001|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5414063|NCT00053001|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5414064|NCT00053001|anemia|anemia
5414065|NCT00053001|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
5414066|NCT00053001|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
5414067|NCT00053001|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
5414068|NCT00041275|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
5414069|NCT00041275|advanced adult primary liver cancer|advanced adult primary liver cancer
5414070|NCT00041275|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
5414071|NCT00003830|stage I breast cancer|stage i breast cancer
5414072|NCT00003830|stage II breast cancer|stage ii breast cancer
5414073|NCT00052962|Appendiceal Cancer|appendiceal cancer
5435562|NCT00002096|Ganciclovir|ganciclovir
5414075|NCT00052962|Carcinomatosis|carcinomatosis
5414076|NCT00052962|Hyperthermia|hyperthermia
5414077|NCT00052936|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5414078|NCT00052936|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
5414079|NCT00052936|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5414080|NCT00052936|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5414081|NCT00052936|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5414082|NCT00052936|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
5414083|NCT00052936|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
5414084|NCT00052936|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
5414085|NCT00052936|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
5414086|NCT00052936|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
5414087|NCT00052936|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
5414088|NCT00052936|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
5414089|NCT00052936|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5414090|NCT00052936|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5414091|NCT00052936|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
5414092|NCT00052936|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5414093|NCT00052936|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
5414094|NCT00052936|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5414095|NCT00052936|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5414096|NCT00052936|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
5414097|NCT00052936|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5414098|NCT00052936|stage I mantle cell lymphoma|stage i mantle cell lymphoma
5414099|NCT00052936|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5414100|NCT00052936|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5414101|NCT00052936|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
5414102|NCT00052936|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
5414103|NCT00052936|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
5414104|NCT00052936|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5414105|NCT00052936|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5414106|NCT00052936|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
5414107|NCT00052936|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
5414108|NCT00052936|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5414109|NCT00052936|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5414110|NCT00052936|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5414111|NCT00052936|stage I marginal zone lymphoma|stage i marginal zone lymphoma
5414112|NCT00052936|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5414113|NCT00052936|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5414114|NCT00052923|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5414115|NCT00052910|stage I gastric cancer|stage i gastric cancer
5414116|NCT00052910|stage II gastric cancer|stage ii gastric cancer
5414117|NCT00052910|stage III gastric cancer|stage iii gastric cancer
5414118|NCT00052910|adenocarcinoma of the stomach|adenocarcinoma of the stomach
5414119|NCT00052910|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
5414120|NCT00052910|stage I esophageal cancer|stage i esophageal cancer
5414121|NCT00052910|stage II esophageal cancer|stage ii esophageal cancer
5414122|NCT00052910|stage III esophageal cancer|stage iii esophageal cancer
5414123|NCT00052897|anal cancer|anal cancer
5414124|NCT00052884|drug/agent toxicity by tissue/organ|drug/agent toxicity by tissue/organ
5414125|NCT00052884|primary systemic amyloidosis|primary systemic amyloidosis
5414126|NCT00052845|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5414127|NCT00052845|recurrent prostate cancer|recurrent prostate cancer
5414128|NCT00052845|stage IV prostate cancer|stage iv prostate cancer
5414129|NCT00052832|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5414130|NCT00052832|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5414131|NCT00052832|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5414132|NCT00052832|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5414133|NCT00052832|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
5414134|NCT00052832|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
5414135|NCT00052754|adult synovial sarcoma|adult synovial sarcoma
5414136|NCT00052754|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
5414137|NCT00052754|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
5414138|NCT00052754|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
5414139|NCT00052728|stage IV breast cancer|stage iv breast cancer
5414140|NCT00052728|recurrent breast cancer|recurrent breast cancer
5414141|NCT00052715|adult glioblastoma|adult glioblastoma
5414142|NCT00052715|adult giant cell glioblastoma|adult giant cell glioblastoma
5414143|NCT00052715|adult gliosarcoma|adult gliosarcoma
5414144|NCT00052676|stage I breast cancer|stage i breast cancer
5414145|NCT00052676|stage II breast cancer|stage ii breast cancer
5414146|NCT00052637|bladder cancer|bladder cancer
5414147|NCT00052637|recurrent bladder cancer|recurrent bladder cancer
5414148|NCT00052637|stage 0 bladder cancer|stage 0 bladder cancer
5414149|NCT00052624|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
5414150|NCT00052611|lip and oral cavity cancer|lip and oral cavity cancer
5414151|NCT00052611|paranasal sinus and nasal cavity cancer|paranasal sinus and nasal cavity cancer
5414152|NCT00052611|hypopharyngeal cancer|hypopharyngeal cancer
5414153|NCT00052611|laryngeal cancer|laryngeal cancer
5414154|NCT00052611|oropharyngeal cancer|oropharyngeal cancer
5414155|NCT00052611|nasopharyngeal cancer|nasopharyngeal cancer
5414156|NCT00052611|salivary gland cancer|salivary gland cancer
5414157|NCT00052572|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5414158|NCT00052572|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
5414159|NCT00052572|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5414160|NCT00052572|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5414161|NCT00052572|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5414162|NCT00052572|Waldenström macroglobulinemia|waldenström macroglobulinemia
5414163|NCT00052572|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5414164|NCT00052572|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5414165|NCT00052572|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5414166|NCT00052572|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5414167|NCT00052572|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5414168|NCT00052572|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5414169|NCT00052507|stage IV colon cancer|stage iv colon cancer
5414170|NCT00052507|stage IV rectal cancer|stage iv rectal cancer
5414171|NCT00052507|adenocarcinoma of the colon|adenocarcinoma of the colon
5414172|NCT00052507|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5414173|NCT00052507|recurrent colon cancer|recurrent colon cancer
5414174|NCT00052507|recurrent rectal cancer|recurrent rectal cancer
5414175|NCT00052494|extensive stage small cell lung cancer|extensive stage small cell lung cancer
5414176|NCT00052494|recurrent small cell lung cancer|recurrent small cell lung cancer
5414177|NCT00052481|stage IIB prostate cancer|stage iib prostate cancer
5414178|NCT00052481|stage IIA prostate cancer|stage iia prostate cancer
5414179|NCT00052481|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5414180|NCT00052468|stage I ovarian epithelial cancer|stage i ovarian epithelial cancer
5414181|NCT00052468|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
5414182|NCT00052468|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5414183|NCT00052468|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5414184|NCT00052468|fallopian tube cancer|fallopian tube cancer
5414185|NCT00052455|adult glioblastoma|adult glioblastoma
5414186|NCT00052455|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5414187|NCT00052455|recurrent adult brain tumor|recurrent adult brain tumor
5414188|NCT00052455|adult giant cell glioblastoma|adult giant cell glioblastoma
5414189|NCT00052455|adult gliosarcoma|adult gliosarcoma
5414190|NCT00052442|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5414191|NCT00052442|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5414192|NCT00052442|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5414193|NCT00052442|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5414194|NCT00052442|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5414195|NCT00052442|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5414196|NCT00052442|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5414197|NCT00052442|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5414198|NCT00052429|stage II lymphoepithelioma of the nasopharynx|stage ii lymphoepithelioma of the nasopharynx
5414199|NCT00052429|stage II squamous cell carcinoma of the nasopharynx|stage ii squamous cell carcinoma of the nasopharynx
5414200|NCT00052429|stage III lymphoepithelioma of the nasopharynx|stage iii lymphoepithelioma of the nasopharynx
5414201|NCT00052429|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
5414202|NCT00052429|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
5416120|NCT00036894|adult ependymoblastoma|adult ependymoblastoma
5414203|NCT00052429|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
5414204|NCT00052416|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
5414205|NCT00052416|stage 0 chronic lymphocytic leukemia|stage 0 chronic lymphocytic leukemia
5414206|NCT00052416|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
5414207|NCT00052416|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
5414208|NCT00052416|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5414209|NCT00052416|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5414210|NCT00052416|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
5414211|NCT00052416|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5414212|NCT00052416|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5414213|NCT00052416|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
5414287|NCT00049712|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5414214|NCT00052416|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5414215|NCT00052416|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
5414216|NCT00052416|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5414217|NCT00052416|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
5414218|NCT00052416|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5414219|NCT00052416|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5414220|NCT00052416|Waldenström macroglobulinemia|waldenström macroglobulinemia
5414221|NCT00052416|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
5414222|NCT00052416|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
5414223|NCT00052416|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
5414224|NCT00052416|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
5414225|NCT00052416|stage I marginal zone lymphoma|stage i marginal zone lymphoma
5414226|NCT00052416|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
5414227|NCT00052416|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5414228|NCT00052416|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5414229|NCT00052416|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5414230|NCT00052416|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5414231|NCT00052416|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5414232|NCT00052416|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5414233|NCT00052416|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5414234|NCT00052390|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
5414235|NCT00052390|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
5414236|NCT00052390|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
5414237|NCT00052351|stage II breast cancer|stage ii breast cancer
5414238|NCT00052351|stage IIIA breast cancer|stage iiia breast cancer
5414239|NCT00052351|stage IIIB breast cancer|stage iiib breast cancer
5414240|NCT00052325|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5414241|NCT00052325|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5414242|NCT00052312|recurrent endometrial carcinoma|recurrent endometrial carcinoma
5414243|NCT00052312|stage III endometrial carcinoma|stage iii endometrial carcinoma
5414244|NCT00052312|stage IV endometrial carcinoma|stage iv endometrial carcinoma
5414245|NCT00052312|endometrial papillary serous carcinoma|endometrial papillary serous carcinoma
5414246|NCT00052299|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
5414247|NCT00052299|adult acute erythroid leukemia (M6)|adult acute erythroid leukemia (m6)
5414248|NCT00052299|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
5414249|NCT00052299|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
5414250|NCT00052299|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
5414251|NCT00052299|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
5414252|NCT00052299|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
5414253|NCT00052299|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
5414254|NCT00052299|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
5414255|NCT00052299|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5414256|NCT00052299|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5414257|NCT00052299|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5414258|NCT00052299|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5414259|NCT00052299|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5414260|NCT00052286|adult brain tumor|adult brain tumor
5414261|NCT00052286|fatigue|fatigue
5414262|NCT00052286|cognitive/functional effects|cognitive/functional effects
5414263|NCT00052273|unspecified adult solid tumor|unspecified adult solid tumor
5414264|NCT00052273|protocol specific|protocol specific
5414265|NCT00052221|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5414266|NCT00052221|fatigue|fatigue
5414267|NCT00052195|Mycobacterium vaccae|mycobacterium vaccae
5414268|NCT00052195|BCG|bcg
5414269|NCT00052195|Disseminated tuberculosis|disseminated tuberculosis
5414270|NCT00052195|SRL-172|srl-172
5414271|NCT00052195|DAR-901|dar-901
5414272|NCT00052182|HIV Therapeutic Vaccine|hiv therapeutic vaccine
5414273|NCT00052182|CTL Epitope|ctl epitope
5414274|NCT00052182|Treatment Experienced|treatment experienced
5414275|NCT00052169|metastatic breast cancer|metastatic breast cancer
5414276|NCT00052169|docetaxel|docetaxel
5414277|NCT00052169|Taxotere|taxotere
5414278|NCT00052169|ZD 1839|zd 1839
5414279|NCT00052169|gefitinib|gefitinib
5414280|NCT00052169|NSABP|nsabp
5414281|NCT00052169|advanced breast cancer|advanced breast cancer
5414282|NCT00052169|AstraZeneca|astrazeneca
5414283|NCT00049712|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5414284|NCT00049712|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
5414285|NCT00049712|intraocular lymphoma|intraocular lymphoma
5414286|NCT00049712|primary central nervous system lymphoma|primary central nervous system lymphoma
5414288|NCT00049712|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5414289|NCT00049712|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5414290|NCT00049712|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5414291|NCT00049712|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5414292|NCT00049712|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5414293|NCT00049712|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5414294|NCT00049712|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
5414295|NCT00049712|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5414296|NCT00049712|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5414297|NCT00049712|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5414298|NCT00049712|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5414299|NCT00049712|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5414300|NCT00049712|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5414301|NCT00049712|small intestine lymphoma|small intestine lymphoma
5416218|NCT00036790|stage IV breast cancer|stage iv breast cancer
5414302|NCT00049712|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5414303|NCT00049712|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5414304|NCT00049712|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5414305|NCT00049712|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5414306|NCT00049712|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5414307|NCT00049712|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5414308|NCT00049712|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
5414309|NCT00049712|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
5414310|NCT00049712|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5414311|NCT00049712|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5414312|NCT00049712|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5414313|NCT00049712|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5414314|NCT00049712|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
5414315|NCT00049712|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5414316|NCT00049712|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5414317|NCT00049712|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5414318|NCT00049712|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5414319|NCT00049712|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5414320|NCT00049712|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5414321|NCT00049712|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5414322|NCT00049712|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5414323|NCT00049712|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5414324|NCT00049712|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
5414325|NCT00049712|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5414326|NCT00049712|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5414327|NCT00049712|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5414328|NCT00049712|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5414329|NCT00049712|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
5414330|NCT00049712|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
5414331|NCT00049712|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5414332|NCT00049712|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5414333|NCT00049712|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5414334|NCT00049712|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5414335|NCT00049712|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5414336|NCT00049712|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5414337|NCT00049712|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5414338|NCT00049712|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5414339|NCT00049712|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5414340|NCT00049699|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5414341|NCT00049699|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
5414342|NCT00049699|intraocular lymphoma|intraocular lymphoma
5414343|NCT00049699|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
5414344|NCT00049699|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5414345|NCT00049699|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5414346|NCT00049699|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5414347|NCT00049699|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5414348|NCT00049699|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5414349|NCT00049699|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5414350|NCT00049699|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5435745|NCT00002059|Neoplasms|neoplasms
5414351|NCT00049699|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
5414352|NCT00049699|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5414353|NCT00049699|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5414354|NCT00049699|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5414355|NCT00049699|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5414356|NCT00049699|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5414357|NCT00049699|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5414358|NCT00049699|small intestine lymphoma|small intestine lymphoma
5414359|NCT00049699|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5414360|NCT00049699|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5414361|NCT00049699|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5414362|NCT00049699|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5414363|NCT00049699|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5414364|NCT00049699|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5414365|NCT00049699|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5414366|NCT00049699|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
5414367|NCT00049699|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
5414368|NCT00049699|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5414369|NCT00049699|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5414370|NCT00049699|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5414371|NCT00049699|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5414372|NCT00049699|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
5414373|NCT00049699|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5414374|NCT00049699|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5414375|NCT00049699|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5414376|NCT00049699|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5414377|NCT00049699|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5414378|NCT00049699|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5414379|NCT00049699|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5414380|NCT00049699|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5414381|NCT00049686|acute undifferentiated leukemia|acute undifferentiated leukemia
5414382|NCT00049686|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5414383|NCT00049686|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5414384|NCT00049686|prolymphocytic leukemia|prolymphocytic leukemia
5414385|NCT00049686|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5414386|NCT00049686|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5414387|NCT00049686|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5414388|NCT00049686|refractory anemia with excess blasts|refractory anemia with excess blasts
5414389|NCT00049686|refractory cytopenia with multilineage dysplasia|refractory cytopenia with multilineage dysplasia
5414390|NCT00049686|refractory hairy cell leukemia|refractory hairy cell leukemia
5414391|NCT00049686|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5414392|NCT00049686|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5414393|NCT00049686|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5414394|NCT00049686|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
5416219|NCT00036790|recurrent colon cancer|recurrent colon cancer
5414395|NCT00049686|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
5414396|NCT00049673|stage I multiple myeloma|stage i multiple myeloma
5414397|NCT00049673|stage II multiple myeloma|stage ii multiple myeloma
5414398|NCT00049673|stage III multiple myeloma|stage iii multiple myeloma
5414399|NCT00049660|stage IV breast cancer|stage iv breast cancer
5414400|NCT00049634|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5414401|NCT00049634|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5414402|NCT00049634|essential thrombocythemia|essential thrombocythemia
5414403|NCT00049634|polycythemia vera|polycythemia vera
5414404|NCT00049634|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5414405|NCT00049634|refractory anemia with excess blasts|refractory anemia with excess blasts
5414406|NCT00049634|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
5414407|NCT00049634|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5414408|NCT00049634|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5414409|NCT00049634|chronic eosinophilic leukemia|chronic eosinophilic leukemia
5414410|NCT00049634|chronic neutrophilic leukemia|chronic neutrophilic leukemia
5414411|NCT00049634|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
5414412|NCT00049634|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
5414413|NCT00049608|male breast cancer|male breast cancer
5414414|NCT00049608|recurrent breast cancer|recurrent breast cancer
5414415|NCT00049608|recurrent colon cancer|recurrent colon cancer
5414416|NCT00049608|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5414417|NCT00049608|recurrent pancreatic cancer|recurrent pancreatic cancer
5414418|NCT00049608|recurrent rectal cancer|recurrent rectal cancer
5414419|NCT00049608|stage III colon cancer|stage iii colon cancer
5414420|NCT00049608|stage III pancreatic cancer|stage iii pancreatic cancer
5414421|NCT00049608|stage III rectal cancer|stage iii rectal cancer
5414422|NCT00049608|stage IIIA breast cancer|stage iiia breast cancer
5414423|NCT00049608|stage IIIB breast cancer|stage iiib breast cancer
5414424|NCT00049608|stage IIIC breast cancer|stage iiic breast cancer
5414425|NCT00049608|stage IV breast cancer|stage iv breast cancer
5414426|NCT00049608|stage IV colon cancer|stage iv colon cancer
5414427|NCT00049608|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5414428|NCT00049608|stage IV rectal cancer|stage iv rectal cancer
5414429|NCT00049608|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5414430|NCT00049608|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5414431|NCT00049608|stage IV pancreatic cancer|stage iv pancreatic cancer
5414432|NCT00049595|adult lymphocyte depletion Hodgkin lymphoma|adult lymphocyte depletion hodgkin lymphoma
5414433|NCT00049595|adult mixed cellularity Hodgkin lymphoma|adult mixed cellularity hodgkin lymphoma
5414434|NCT00049595|adult nodular sclerosis Hodgkin lymphoma|adult nodular sclerosis hodgkin lymphoma
5414435|NCT00049595|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5414436|NCT00049595|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5414437|NCT00049556|fallopian tube cancer|fallopian tube cancer
5414438|NCT00049556|borderline ovarian surface epithelial-stromal tumor|borderline ovarian surface epithelial-stromal tumor
5414439|NCT00049556|primary peritoneal cavity cancer|primary peritoneal cavity cancer
5414440|NCT00049556|recurrent cervical cancer|recurrent cervical cancer
5414441|NCT00049556|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5414442|NCT00049530|recurrent melanoma|recurrent melanoma
5414443|NCT00049530|stage IV melanoma|stage iv melanoma
5414444|NCT00049517|acute myeloid leukemia|acute myeloid leukemia
5414445|NCT00049517|autologous transplantation|autologous transplantation
5414446|NCT00049517|gemtuzumab ozogamicin|gemtuzumab ozogamicin
5414447|NCT00049465|depression|depression
5414448|NCT00049465|fatigue|fatigue
5414449|NCT00049465|menopausal symptoms|menopausal symptoms
5414450|NCT00049465|transitional care planning|transitional care planning
5414451|NCT00049465|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
5414452|NCT00049465|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5414453|NCT00049465|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
5414454|NCT00049465|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5414455|NCT00049465|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5414456|NCT00049465|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5414457|NCT00049465|disseminated neuroblastoma|disseminated neuroblastoma
5414458|NCT00049465|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
5414459|NCT00049465|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5414460|NCT00049465|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
5414461|NCT00049465|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
5414462|NCT00049465|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
5414463|NCT00049465|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
5414464|NCT00049465|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
5414465|NCT00049465|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5414466|NCT00049465|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5414467|NCT00049465|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5414468|NCT00049465|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5414469|NCT00049465|ovarian choriocarcinoma|ovarian choriocarcinoma
5414470|NCT00049465|ovarian embryonal carcinoma|ovarian embryonal carcinoma
5414471|NCT00049465|ovarian yolk sac tumor|ovarian yolk sac tumor
5414472|NCT00049465|ovarian immature teratoma|ovarian immature teratoma
5414473|NCT00049465|ovarian mature teratoma|ovarian mature teratoma
5414474|NCT00049465|ovarian monodermal and highly specialized teratoma|ovarian monodermal and highly specialized teratoma
5414475|NCT00049465|ovarian polyembryoma|ovarian polyembryoma
5414476|NCT00049465|ovarian mixed germ cell tumor|ovarian mixed germ cell tumor
5414477|NCT00049465|poor prognosis metastatic gestational trophoblastic tumor|poor prognosis metastatic gestational trophoblastic tumor
5414478|NCT00049465|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5414479|NCT00049465|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5414480|NCT00049465|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5414481|NCT00049465|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5414482|NCT00049465|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5414483|NCT00049465|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5414484|NCT00049465|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5414485|NCT00049465|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5414692|NCT00049296|recurrent esophageal cancer|recurrent esophageal cancer
5414486|NCT00049465|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5414487|NCT00049465|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5414488|NCT00049465|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5414489|NCT00049465|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5414490|NCT00049465|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5414491|NCT00049465|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5414492|NCT00049465|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5414493|NCT00049465|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5414494|NCT00049465|recurrent neuroblastoma|recurrent neuroblastoma
5414495|NCT00049465|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5414496|NCT00049465|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
5414497|NCT00049465|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
5414498|NCT00049465|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5414499|NCT00049465|refractory hairy cell leukemia|refractory hairy cell leukemia
5414500|NCT00049465|refractory multiple myeloma|refractory multiple myeloma
5414501|NCT00049465|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5414502|NCT00049465|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5414503|NCT00049465|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5414504|NCT00049465|stage I multiple myeloma|stage i multiple myeloma
5414505|NCT00049465|stage II multiple myeloma|stage ii multiple myeloma
5414506|NCT00049465|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
5414507|NCT00049465|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5414508|NCT00049465|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5414509|NCT00049465|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5414510|NCT00049465|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5414511|NCT00049465|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5414512|NCT00049465|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5414513|NCT00049465|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5414514|NCT00049465|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5414515|NCT00049465|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5414516|NCT00049465|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5414517|NCT00049465|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5414518|NCT00049465|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5414519|NCT00049465|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
5414520|NCT00049465|stage IIIA breast cancer|stage iiia breast cancer
5414521|NCT00049465|stage IIIB breast cancer|stage iiib breast cancer
5414522|NCT00049465|stage IIIC breast cancer|stage iiic breast cancer
5414523|NCT00049465|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5414524|NCT00049465|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5414525|NCT00049465|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5414526|NCT00049465|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5414527|NCT00049465|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5414528|NCT00049465|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5414529|NCT00049465|stage IV breast cancer|stage iv breast cancer
5414530|NCT00049465|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5414531|NCT00049465|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5414532|NCT00049465|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5414533|NCT00049465|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5414534|NCT00049465|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5414535|NCT00049465|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5414536|NCT00049465|testicular choriocarcinoma and embryonal carcinoma|testicular choriocarcinoma and embryonal carcinoma
5414537|NCT00049465|testicular choriocarcinoma and seminoma|testicular choriocarcinoma and seminoma
5414538|NCT00049465|testicular choriocarcinoma and teratoma|testicular choriocarcinoma and teratoma
5414539|NCT00049465|testicular choriocarcinoma and yolk sac tumor|testicular choriocarcinoma and yolk sac tumor
5414540|NCT00049465|testicular choriocarcinoma|testicular choriocarcinoma
5414541|NCT00049465|testicular embryonal carcinoma and seminoma|testicular embryonal carcinoma and seminoma
5414542|NCT00049465|testicular embryonal carcinoma and teratoma with seminoma|testicular embryonal carcinoma and teratoma with seminoma
5414543|NCT00049465|testicular embryonal carcinoma and teratoma|testicular embryonal carcinoma and teratoma
5414544|NCT00049465|testicular embryonal carcinoma and yolk sac tumor with seminoma|testicular embryonal carcinoma and yolk sac tumor with seminoma
5414545|NCT00049465|testicular embryonal carcinoma and yolk sac tumor|testicular embryonal carcinoma and yolk sac tumor
5414546|NCT00049465|testicular embryonal carcinoma|testicular embryonal carcinoma
5414547|NCT00049465|testicular teratoma|testicular teratoma
5414548|NCT00049465|testicular yolk sac tumor and teratoma with seminoma|testicular yolk sac tumor and teratoma with seminoma
5414549|NCT00049465|testicular yolk sac tumor and teratoma|testicular yolk sac tumor and teratoma
5414550|NCT00049465|testicular yolk sac tumor|testicular yolk sac tumor
5414551|NCT00049465|stage III multiple myeloma|stage iii multiple myeloma
5414552|NCT00049465|chronic eosinophilic leukemia|chronic eosinophilic leukemia
5414553|NCT00049465|chronic neutrophilic leukemia|chronic neutrophilic leukemia
5414554|NCT00049465|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
5414555|NCT00049465|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
5414556|NCT00049465|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
5414557|NCT00049465|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
5414558|NCT00049465|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5414559|NCT00049465|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5414560|NCT00049465|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5414561|NCT00049465|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5414562|NCT00049465|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5414563|NCT00049465|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5414564|NCT00049465|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5414565|NCT00049465|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5414566|NCT00049465|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5414567|NCT00049452|osteoporosis|osteoporosis
5414568|NCT00049452|stage I breast cancer|stage i breast cancer
5414569|NCT00049452|stage II breast cancer|stage ii breast cancer
5414570|NCT00049439|AIDS-related diffuse large cell lymphoma|aids-related diffuse large cell lymphoma
5414571|NCT00049439|AIDS-related diffuse mixed cell lymphoma|aids-related diffuse mixed cell lymphoma
5414572|NCT00049439|AIDS-related diffuse small cleaved cell lymphoma|aids-related diffuse small cleaved cell lymphoma
5414573|NCT00049439|AIDS-related immunoblastic large cell lymphoma|aids-related immunoblastic large cell lymphoma
5414574|NCT00049439|AIDS-related lymphoblastic lymphoma|aids-related lymphoblastic lymphoma
5414575|NCT00049439|AIDS-related small noncleaved cell lymphoma|aids-related small noncleaved cell lymphoma
5414576|NCT00049413|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
5414577|NCT00049413|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5414578|NCT00049413|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
5414579|NCT00049413|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
5414580|NCT00049413|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5414581|NCT00049413|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5414582|NCT00049413|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
5414583|NCT00049413|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
5414584|NCT00049413|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5414585|NCT00049413|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
5414586|NCT00049413|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5414587|NCT00049413|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5414588|NCT00049400|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5414589|NCT00049400|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5414590|NCT00049400|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
5414591|NCT00049400|intraocular lymphoma|intraocular lymphoma
5414592|NCT00049400|primary central nervous system lymphoma|primary central nervous system lymphoma
5414593|NCT00049400|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5414594|NCT00049400|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5414595|NCT00049400|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5414596|NCT00049400|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
5414597|NCT00049400|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5414598|NCT00049400|recurrent grade 1, 2, or 3 follicular lymphoma|recurrent grade 1, 2, or 3 follicular lymphoma
5414599|NCT00049400|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5414600|NCT00049400|small intestine lymphoma|small intestine lymphoma
5414601|NCT00049400|stage IV adult diffuse large cell or mixed cell lymphoma|stage iv adult diffuse large cell or mixed cell lymphoma
5414602|NCT00049400|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5414603|NCT00049400|stage IV adult Burkitt lymphoma or Hodgkin lymphoma|stage iv adult burkitt lymphoma or hodgkin lymphoma
5414604|NCT00049400|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5414605|NCT00049400|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5414606|NCT00049400|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
5414607|NCT00049400|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
5414608|NCT00049400|stage IV grade 1, 2, or 3 follicular lymphoma|stage iv grade 1, 2, or 3 follicular lymphoma
5414609|NCT00049400|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5414610|NCT00049400|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5414611|NCT00049400|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5414612|NCT00049400|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5414613|NCT00049400|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5414614|NCT00049400|extranodal marginal zone B-cell lymphoma of MALT|extranodal marginal zone b-cell lymphoma of malt
5414615|NCT00049400|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5414616|NCT00049400|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5414617|NCT00049400|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5414618|NCT00049400|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5414619|NCT00049400|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5414620|NCT00049400|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5414621|NCT00049374|refractory multiple myeloma|refractory multiple myeloma
5414622|NCT00049361|adult tumors metastatic to brain|adult tumors metastatic to brain
5414623|NCT00049361|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5414624|NCT00049348|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
5414625|NCT00049348|stage II pancreatic cancer|stage ii pancreatic cancer
5414626|NCT00049348|stage III pancreatic cancer|stage iii pancreatic cancer
5414627|NCT00049335|recurrent colon cancer|recurrent colon cancer
5414628|NCT00049335|stage IV colon cancer|stage iv colon cancer
5414629|NCT00049335|recurrent rectal cancer|recurrent rectal cancer
5414630|NCT00049335|stage IV rectal cancer|stage iv rectal cancer
5414631|NCT00049322|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
5414632|NCT00049322|recurrent adult primary liver cancer|recurrent adult primary liver cancer
5414633|NCT00049322|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
5414634|NCT00049309|stage I prostate cancer|stage i prostate cancer
5414635|NCT00049309|stage IIB prostate cancer|stage iib prostate cancer
5414636|NCT00049309|stage IIA prostate cancer|stage iia prostate cancer
5414637|NCT00049309|stage III prostate cancer|stage iii prostate cancer
5414638|NCT00049296|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5414639|NCT00049296|male breast cancer|male breast cancer
5414640|NCT00049296|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
5414641|NCT00049296|adult meningeal hemangiopericytoma|adult meningeal hemangiopericytoma
5414642|NCT00049296|adult brain stem glioma|adult brain stem glioma
5414643|NCT00049296|adult central nervous system germ cell tumor|adult central nervous system germ cell tumor
5414644|NCT00049296|adult choroid plexus tumor|adult choroid plexus tumor
5414645|NCT00049296|adult craniopharyngioma|adult craniopharyngioma
5414646|NCT00049296|adult ependymoblastoma|adult ependymoblastoma
5414647|NCT00049296|adult glioblastoma|adult glioblastoma
5414648|NCT00049296|adult pilocytic astrocytoma|adult pilocytic astrocytoma
5414649|NCT00049296|adult anaplastic ependymoma|adult anaplastic ependymoma
5414650|NCT00049296|adult medulloblastoma|adult medulloblastoma
5414651|NCT00049296|adult meningioma|adult meningioma
5414652|NCT00049296|adult pineoblastoma|adult pineoblastoma
5414653|NCT00049296|adult pineocytoma|adult pineocytoma
5414654|NCT00049296|adult subependymoma|adult subependymoma
5414655|NCT00049296|adult myxopapillary ependymoma|adult myxopapillary ependymoma
5414656|NCT00049296|advanced adult primary liver cancer|advanced adult primary liver cancer
5414657|NCT00049296|anterior urethral cancer|anterior urethral cancer
5414658|NCT00049296|carcinoma of the appendix|carcinoma of the appendix
5414659|NCT00049296|chondrosarcoma|chondrosarcoma
5414660|NCT00049296|classic Kaposi sarcoma|classic kaposi sarcoma
5414661|NCT00049296|AIDS-related Kaposi sarcoma|aids-related kaposi sarcoma
5414662|NCT00049296|immunosuppressive treatment related Kaposi sarcoma|immunosuppressive treatment related kaposi sarcoma
5414663|NCT00049296|recurrent Kaposi sarcoma|recurrent kaposi sarcoma
5414664|NCT00049296|clear cell sarcoma of the kidney|clear cell sarcoma of the kidney
5414665|NCT00049296|disseminated neuroblastoma|disseminated neuroblastoma
5414666|NCT00049296|extensive stage small cell lung cancer|extensive stage small cell lung cancer
5414667|NCT00049296|gastrointestinal stromal tumor|gastrointestinal stromal tumor
5414668|NCT00049296|metastatic gastrointestinal carcinoid tumor|metastatic gastrointestinal carcinoid tumor
5414669|NCT00049296|metastatic osteosarcoma|metastatic osteosarcoma
5414670|NCT00049296|metastatic transitional cell cancer of the renal pelvis and ureter|metastatic transitional cell cancer of the renal pelvis and ureter
5414671|NCT00049296|metastatic Ewing sarcoma/peripheral primitive neuroectodermal tumor|metastatic ewing sarcoma/peripheral primitive neuroectodermal tumor
5414672|NCT00049296|adult mixed glioma|adult mixed glioma
5414673|NCT00049296|ovarian sarcoma|ovarian sarcoma
5414674|NCT00049296|posterior urethral cancer|posterior urethral cancer
5414675|NCT00049296|primary central nervous system lymphoma|primary central nervous system lymphoma
5414676|NCT00049296|pulmonary carcinoid tumor|pulmonary carcinoid tumor
5414677|NCT00049296|recurrent adenoid cystic carcinoma of the oral cavity|recurrent adenoid cystic carcinoma of the oral cavity
5414678|NCT00049296|recurrent adult brain tumor|recurrent adult brain tumor
5414679|NCT00049296|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5414680|NCT00049296|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5414681|NCT00049296|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5414682|NCT00049296|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5414683|NCT00049296|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5414684|NCT00049296|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5414685|NCT00049296|recurrent adult primary liver cancer|recurrent adult primary liver cancer
5414686|NCT00049296|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
5414688|NCT00049296|recurrent basal cell carcinoma of the lip|recurrent basal cell carcinoma of the lip
5414689|NCT00049296|recurrent bladder cancer|recurrent bladder cancer
5414690|NCT00049296|recurrent breast cancer|recurrent breast cancer
5414691|NCT00049296|recurrent colon cancer|recurrent colon cancer
5414693|NCT00049296|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity
5414694|NCT00049296|recurrent extrahepatic bile duct cancer|recurrent extrahepatic bile duct cancer
5414695|NCT00049296|recurrent gallbladder cancer|recurrent gallbladder cancer
5414696|NCT00049296|recurrent gastric cancer|recurrent gastric cancer
5414697|NCT00049296|recurrent gastrointestinal carcinoid tumor|recurrent gastrointestinal carcinoid tumor
5414698|NCT00049296|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5414699|NCT00049296|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5414700|NCT00049296|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5414701|NCT00049296|recurrent inverted papilloma of the paranasal sinus and nasal cavity|recurrent inverted papilloma of the paranasal sinus and nasal cavity
5414702|NCT00049296|recurrent lymphoepithelioma of the nasopharynx|recurrent lymphoepithelioma of the nasopharynx
5414703|NCT00049296|recurrent lymphoepithelioma of the oropharynx|recurrent lymphoepithelioma of the oropharynx
5414704|NCT00049296|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5414705|NCT00049296|recurrent melanoma|recurrent melanoma
5414706|NCT00049296|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
5414707|NCT00049296|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity
5414708|NCT00049296|recurrent mucoepidermoid carcinoma of the oral cavity|recurrent mucoepidermoid carcinoma of the oral cavity
5414709|NCT00049296|recurrent neuroblastoma|recurrent neuroblastoma
5414710|NCT00049296|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5414711|NCT00049296|recurrent osteosarcoma|recurrent osteosarcoma
5414712|NCT00049296|recurrent pancreatic cancer|recurrent pancreatic cancer
5414713|NCT00049296|recurrent rectal cancer|recurrent rectal cancer
5414714|NCT00049296|recurrent renal cell cancer|recurrent renal cell cancer
5414715|NCT00049296|recurrent small cell lung cancer|recurrent small cell lung cancer
5414716|NCT00049296|recurrent small intestine cancer|recurrent small intestine cancer
5414717|NCT00049296|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
5414718|NCT00049296|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
5414719|NCT00049296|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
5414720|NCT00049296|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
5414721|NCT00049296|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
5414722|NCT00049296|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
5414723|NCT00049296|recurrent transitional cell cancer of the renal pelvis and ureter|recurrent transitional cell cancer of the renal pelvis and ureter
5414724|NCT00049296|recurrent Ewing sarcoma/peripheral primitive neuroectodermal tumor|recurrent ewing sarcoma/peripheral primitive neuroectodermal tumor
5414725|NCT00049296|recurrent urethral cancer|recurrent urethral cancer
5414726|NCT00049296|recurrent uterine sarcoma|recurrent uterine sarcoma
5414727|NCT00049296|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
5414728|NCT00049296|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
5414729|NCT00049296|refractory multiple myeloma|refractory multiple myeloma
5414730|NCT00049296|rhabdoid tumor of the kidney|rhabdoid tumor of the kidney
5414731|NCT00049296|small intestine adenocarcinoma|small intestine adenocarcinoma
5414732|NCT00049296|small intestine leiomyosarcoma|small intestine leiomyosarcoma
5414733|NCT00049296|small intestine lymphoma|small intestine lymphoma
5414734|NCT00049296|stage II esophageal cancer|stage ii esophageal cancer
5414735|NCT00049296|stage II pancreatic cancer|stage ii pancreatic cancer
5414736|NCT00049296|stage III esophageal cancer|stage iii esophageal cancer
5414737|NCT00049296|stage III multiple myeloma|stage iii multiple myeloma
5414738|NCT00049296|stage III pancreatic cancer|stage iii pancreatic cancer
5414739|NCT00049296|stage IV adenoid cystic carcinoma of the oral cavity|stage iv adenoid cystic carcinoma of the oral cavity
5414740|NCT00049296|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5414741|NCT00049296|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5414742|NCT00049296|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5414743|NCT00049296|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5414744|NCT00049296|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5414745|NCT00049296|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5414746|NCT00049296|stage IV anal cancer|stage iv anal cancer
5414747|NCT00049296|stage IV basal cell carcinoma of the lip|stage iv basal cell carcinoma of the lip
5414748|NCT00049296|stage IV bladder cancer|stage iv bladder cancer
5414749|NCT00049296|stage IV breast cancer|stage iv breast cancer
5414750|NCT00049296|stage IV colon cancer|stage iv colon cancer
5414751|NCT00049296|stage IV esophageal cancer|stage iv esophageal cancer
5414752|NCT00049296|stage IV esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iv esthesioneuroblastoma of the paranasal sinus and nasal cavity
5414753|NCT00049296|stage IV gastric cancer|stage iv gastric cancer
5414754|NCT00049296|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5414755|NCT00049296|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5414756|NCT00049296|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5436673|NCT00001040|Zidovudine|zidovudine
5414757|NCT00049296|stage IV inverted papilloma of the paranasal sinus and nasal cavity|stage iv inverted papilloma of the paranasal sinus and nasal cavity
5414758|NCT00049296|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
5414759|NCT00049296|stage IV lymphoepithelioma of the oropharynx|stage iv lymphoepithelioma of the oropharynx
5414760|NCT00049296|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5414761|NCT00049296|stage IV melanoma|stage iv melanoma
5414762|NCT00049296|stage IV midline lethal granuloma of the paranasal sinus and nasal cavity|stage iv midline lethal granuloma of the paranasal sinus and nasal cavity
5414763|NCT00049296|stage IV mucoepidermoid carcinoma of the oral cavity|stage iv mucoepidermoid carcinoma of the oral cavity
5414764|NCT00049296|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5414765|NCT00049296|stage IV rectal cancer|stage iv rectal cancer
5414766|NCT00049296|stage IV renal cell cancer|stage iv renal cell cancer
5414767|NCT00049296|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5414768|NCT00049296|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5414769|NCT00049296|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5414770|NCT00049296|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
5414771|NCT00049296|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5414772|NCT00049296|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
5414773|NCT00049296|stage IV uterine sarcoma|stage iv uterine sarcoma
5414774|NCT00049296|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
5414775|NCT00049296|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
5414776|NCT00049296|unresectable extrahepatic bile duct cancer|unresectable extrahepatic bile duct cancer
5414777|NCT00049296|unresectable gallbladder cancer|unresectable gallbladder cancer
5414778|NCT00049296|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5414779|NCT00049296|urethral cancer associated with invasive bladder cancer|urethral cancer associated with invasive bladder cancer
5414780|NCT00049296|recurrent salivary gland cancer|recurrent salivary gland cancer
5414781|NCT00049296|stage IV salivary gland cancer|stage iv salivary gland cancer
5414782|NCT00049296|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5414783|NCT00049296|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5414784|NCT00049296|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5414785|NCT00049296|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5414786|NCT00049296|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5414787|NCT00049296|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5414788|NCT00049296|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5414789|NCT00049296|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
5414790|NCT00049296|adult grade III meningioma|adult grade iii meningioma
5414791|NCT00049296|adult oligodendroglioma|adult oligodendroglioma
5414792|NCT00049296|adult giant cell glioblastoma|adult giant cell glioblastoma
5414793|NCT00049296|adult gliosarcoma|adult gliosarcoma
5414794|NCT00049296|stage IV pancreatic cancer|stage iv pancreatic cancer
5414795|NCT00049257|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5414796|NCT00049257|recurrent prostate cancer|recurrent prostate cancer
5414797|NCT00049257|stage IV prostate cancer|stage iv prostate cancer
5414798|NCT00049244|recurrent breast cancer|recurrent breast cancer
5414799|NCT00049244|stage IV breast cancer|stage iv breast cancer
5414800|NCT00049231|cervical adenocarcinoma|cervical adenocarcinoma
5414801|NCT00049231|cervical adenosquamous cell carcinoma|cervical adenosquamous cell carcinoma
5414802|NCT00049231|cervical squamous cell carcinoma|cervical squamous cell carcinoma
5414803|NCT00049231|stage IIB cervical cancer|stage iib cervical cancer
5414804|NCT00049231|stage III cervical cancer|stage iii cervical cancer
5414805|NCT00049231|stage IVA cervical cancer|stage iva cervical cancer
5414806|NCT00049218|extensive stage small cell lung cancer|extensive stage small cell lung cancer
5414807|NCT00049179|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
5414808|NCT00049179|adult acute erythroid leukemia (M6)|adult acute erythroid leukemia (m6)
5414809|NCT00049179|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
5414810|NCT00049179|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
5414811|NCT00049179|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
5414812|NCT00049179|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
5414813|NCT00049179|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
5414814|NCT00049179|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5414815|NCT00049179|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5414816|NCT00049179|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5414817|NCT00049179|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5414818|NCT00049179|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5414819|NCT00049179|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5414820|NCT00049140|stage I squamous cell carcinoma of the hypopharynx|stage i squamous cell carcinoma of the hypopharynx
5436674|NCT00001040|Saquinavir|saquinavir
5414821|NCT00049140|stage I squamous cell carcinoma of the larynx|stage i squamous cell carcinoma of the larynx
5414822|NCT00049140|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
5414823|NCT00049140|stage I squamous cell carcinoma of the nasopharynx|stage i squamous cell carcinoma of the nasopharynx
5414824|NCT00049140|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
5414825|NCT00049140|stage I squamous cell carcinoma of the paranasal sinus and nasal cavity|stage i squamous cell carcinoma of the paranasal sinus and nasal cavity
5414826|NCT00049140|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
5414827|NCT00049140|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
5414828|NCT00049140|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
5414829|NCT00049140|stage II squamous cell carcinoma of the nasopharynx|stage ii squamous cell carcinoma of the nasopharynx
5414830|NCT00049140|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
5414831|NCT00049140|stage II squamous cell carcinoma of the paranasal sinus and nasal cavity|stage ii squamous cell carcinoma of the paranasal sinus and nasal cavity
5414832|NCT00049140|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
5414833|NCT00049140|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
5414834|NCT00049140|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
5414835|NCT00049140|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
5414836|NCT00049140|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
5414837|NCT00049140|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
5414838|NCT00049140|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5414839|NCT00049140|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5414840|NCT00049140|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5414841|NCT00049140|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
5414842|NCT00049140|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5414843|NCT00049140|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
5414844|NCT00049140|stage I salivary gland cancer|stage i salivary gland cancer
5414845|NCT00049140|stage II salivary gland cancer|stage ii salivary gland cancer
5414846|NCT00049140|stage III salivary gland cancer|stage iii salivary gland cancer
5414847|NCT00049140|stage IV salivary gland cancer|stage iv salivary gland cancer
5414848|NCT00049140|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
5414849|NCT00049101|recurrent colon cancer|recurrent colon cancer
5414850|NCT00049101|stage IV colon cancer|stage iv colon cancer
5414851|NCT00049101|recurrent rectal cancer|recurrent rectal cancer
5414852|NCT00049101|stage IV rectal cancer|stage iv rectal cancer
5414853|NCT00049075|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
5414854|NCT00049075|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
5414855|NCT00049075|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
5414856|NCT00049075|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5414857|NCT00049075|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5414858|NCT00049062|recurrent breast cancer|recurrent breast cancer
5414859|NCT00049062|stage IIIB breast cancer|stage iiib breast cancer
5414860|NCT00049062|stage IIIC breast cancer|stage iiic breast cancer
5414861|NCT00049062|stage IV breast cancer|stage iv breast cancer
5414862|NCT00049023|childhood grade III meningioma|childhood grade iii meningioma
5414863|NCT00049023|disseminated neuroblastoma|disseminated neuroblastoma
5414864|NCT00049023|localized unresectable neuroblastoma|localized unresectable neuroblastoma
5414865|NCT00049023|metastatic pheochromocytoma|metastatic pheochromocytoma
5414866|NCT00049023|metastatic Ewing sarcoma/peripheral primitive neuroectodermal tumor|metastatic ewing sarcoma/peripheral primitive neuroectodermal tumor
5414867|NCT00049023|recurrent childhood brain tumor|recurrent childhood brain tumor
5414868|NCT00049023|recurrent childhood medulloblastoma|recurrent childhood medulloblastoma
5414869|NCT00049023|recurrent neuroblastoma|recurrent neuroblastoma
5414870|NCT00049023|recurrent pheochromocytoma|recurrent pheochromocytoma
5414871|NCT00049023|recurrent Ewing sarcoma/peripheral primitive neuroectodermal tumor|recurrent ewing sarcoma/peripheral primitive neuroectodermal tumor
5414872|NCT00049023|regional neuroblastoma|regional neuroblastoma
5414873|NCT00049023|regional pheochromocytoma|regional pheochromocytoma
5414874|NCT00049023|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
5414875|NCT00049023|recurrent childhood ependymoma|recurrent childhood ependymoma
5414876|NCT00049023|childhood infratentorial ependymoma|childhood infratentorial ependymoma
5414877|NCT00049023|childhood supratentorial ependymoma|childhood supratentorial ependymoma
5414878|NCT00049023|recurrent islet cell carcinoma|recurrent islet cell carcinoma
5414879|NCT00049023|gastrinoma|gastrinoma
5414880|NCT00049023|insulinoma|insulinoma
5414881|NCT00049023|metastatic gastrointestinal carcinoid tumor|metastatic gastrointestinal carcinoid tumor
5414882|NCT00049023|recurrent gastrointestinal carcinoid tumor|recurrent gastrointestinal carcinoid tumor
5414883|NCT00049023|regional gastrointestinal carcinoid tumor|regional gastrointestinal carcinoid tumor
5436768|NCT00001023|Rifabutin|rifabutin
5414884|NCT00049010|stage I melanoma|stage i melanoma
5414885|NCT00049010|stage II melanoma|stage ii melanoma
5414886|NCT00048997|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5414887|NCT00048997|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5414888|NCT00048971|adenocarcinoma of the colon|adenocarcinoma of the colon
5414889|NCT00048971|stage III colon cancer|stage iii colon cancer
5414890|NCT00048971|diarrhea|diarrhea
5414891|NCT00048971|neutropenia|neutropenia
5414892|NCT00047385|small cell lung cancer|small cell lung cancer
5414893|NCT00047385|non-small cell lung cancer|non-small cell lung cancer
5414894|NCT00047320|childhood central nervous system germ cell tumor|childhood central nervous system germ cell tumor
5414895|NCT00047320|childhood teratoma|childhood teratoma
5414896|NCT00047320|recurrent childhood malignant germ cell tumor|recurrent childhood malignant germ cell tumor
5414897|NCT00047320|childhood central nervous system choriocarcinoma|childhood central nervous system choriocarcinoma
5414898|NCT00047320|childhood central nervous system embryonal tumor|childhood central nervous system embryonal tumor
5414899|NCT00047320|childhood central nervous system germinoma|childhood central nervous system germinoma
5414900|NCT00047320|childhood central nervous system mixed germ cell tumor|childhood central nervous system mixed germ cell tumor
5414901|NCT00047320|childhood central nervous system teratoma|childhood central nervous system teratoma
5414902|NCT00047320|childhood central nervous system yolk sac tumor|childhood central nervous system yolk sac tumor
5414903|NCT00047320|recurrent childhood central nervous system embryonal tumor|recurrent childhood central nervous system embryonal tumor
5414904|NCT00047294|adult mixed glioma|adult mixed glioma
5414905|NCT00047294|adult glioblastoma|adult glioblastoma
5414906|NCT00047294|adult giant cell glioblastoma|adult giant cell glioblastoma
5414907|NCT00047294|adult gliosarcoma|adult gliosarcoma
5414908|NCT00047281|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5414909|NCT00047281|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
5414910|NCT00047281|adult glioblastoma|adult glioblastoma
5414911|NCT00047281|adult mixed glioma|adult mixed glioma
5414912|NCT00047281|recurrent adult brain tumor|recurrent adult brain tumor
5414913|NCT00047281|adult giant cell glioblastoma|adult giant cell glioblastoma
5414914|NCT00047281|adult gliosarcoma|adult gliosarcoma
5414915|NCT00047268|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
5414916|NCT00047268|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
5414917|NCT00047268|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
5414918|NCT00047268|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
5414919|NCT00047268|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5414920|NCT00047255|stage IIIB breast cancer|stage iiib breast cancer
5414921|NCT00047255|stage IIIC breast cancer|stage iiic breast cancer
5414922|NCT00047255|stage IV breast cancer|stage iv breast cancer
5414923|NCT00047255|recurrent breast cancer|recurrent breast cancer
5414924|NCT00047242|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5414925|NCT00047229|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
5414926|NCT00047229|advanced adult primary liver cancer|advanced adult primary liver cancer
5414927|NCT00047229|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
5414928|NCT00047229|recurrent adult primary liver cancer|recurrent adult primary liver cancer
5414929|NCT00047216|recurrent bladder cancer|recurrent bladder cancer
5414930|NCT00047216|stage 0 bladder cancer|stage 0 bladder cancer
5414931|NCT00047216|stage I bladder cancer|stage i bladder cancer
5414932|NCT00047216|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
5414933|NCT00047177|recurrent childhood medulloblastoma|recurrent childhood medulloblastoma
5414934|NCT00047177|recurrent childhood supratentorial primitive neuroectodermal tumor|recurrent childhood supratentorial primitive neuroectodermal tumor
5414935|NCT00047177|recurrent childhood ependymoma|recurrent childhood ependymoma
5414936|NCT00047177|childhood atypical teratoid/rhabdoid tumor|childhood atypical teratoid/rhabdoid tumor
5414937|NCT00047164|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5414938|NCT00047164|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5414939|NCT00047164|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
5414940|NCT00047164|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
5414941|NCT00047164|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5414942|NCT00047164|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
5414943|NCT00047164|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5414944|NCT00047164|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5414945|NCT00047164|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5414946|NCT00047164|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5414947|NCT00047164|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
5414948|NCT00047164|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5414949|NCT00047164|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5414950|NCT00047164|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
5414951|NCT00047164|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
5414952|NCT00047164|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
5414953|NCT00047164|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
5414954|NCT00047164|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
5414955|NCT00047164|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5414956|NCT00047164|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
5414957|NCT00047164|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5414958|NCT00047164|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5414959|NCT00047164|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
5414960|NCT00047164|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5414961|NCT00047164|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5414962|NCT00047164|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
5414963|NCT00047164|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5414964|NCT00047164|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5414965|NCT00047164|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
5414966|NCT00047164|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
5414967|NCT00047164|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5414968|NCT00047164|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
5414969|NCT00047164|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5414970|NCT00047164|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5414971|NCT00047164|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
5414972|NCT00047164|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
5414973|NCT00047164|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5414974|NCT00047164|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
5414975|NCT00047164|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5414976|NCT00047164|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5414977|NCT00047164|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
5414978|NCT00047164|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5414979|NCT00047164|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5414980|NCT00047164|stage I mantle cell lymphoma|stage i mantle cell lymphoma
5414981|NCT00047164|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5414982|NCT00047164|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5414983|NCT00047164|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5414984|NCT00047164|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
5414985|NCT00047164|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
5414986|NCT00047164|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5414987|NCT00047164|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5414988|NCT00047164|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5414989|NCT00047164|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
5414990|NCT00047164|stage II adult diffuse small cleaved cell lymphoma|stage ii adult diffuse small cleaved cell lymphoma
5414991|NCT00047164|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5414992|NCT00047164|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5414993|NCT00047164|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
5414994|NCT00047164|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5414995|NCT00047164|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5414996|NCT00047164|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
5414997|NCT00047164|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5414998|NCT00047164|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5414999|NCT00047164|stage I marginal zone lymphoma|stage i marginal zone lymphoma
5415000|NCT00047164|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5415001|NCT00047164|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5415002|NCT00047164|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
5415003|NCT00047164|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
5415004|NCT00047164|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5415005|NCT00047164|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
5415006|NCT00047164|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5415007|NCT00047164|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5415008|NCT00047164|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
5415009|NCT00047164|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5415010|NCT00047164|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
5415011|NCT00047164|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
5415012|NCT00047164|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
5415013|NCT00047164|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
5415936|NCT00039572|adult gliosarcoma|adult gliosarcoma
5415014|NCT00047164|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
5415015|NCT00047164|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
5415016|NCT00047164|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
5415017|NCT00047164|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
5415018|NCT00047138|blastema predominant Wilms tumor|blastema predominant wilms tumor
5415019|NCT00047138|epithelial predominant Wilms tumor|epithelial predominant wilms tumor
5415020|NCT00047138|mixed cell type Wilms tumor|mixed cell type wilms tumor
5415021|NCT00047138|stage I Wilms tumor|stage i wilms tumor
5415022|NCT00047138|stage II Wilms tumor|stage ii wilms tumor
5415023|NCT00047138|stage III Wilms tumor|stage iii wilms tumor
5415024|NCT00047138|stage IV Wilms tumor|stage iv wilms tumor
5415025|NCT00047138|stage V Wilms tumor|stage v wilms tumor
5415026|NCT00047138|stromal predominant Wilms tumor|stromal predominant wilms tumor
5415027|NCT00047125|newly diagnosed carcinoma of unknown primary|newly diagnosed carcinoma of unknown primary
5415028|NCT00047125|squamous cell carcinoma of unknown primary|squamous cell carcinoma of unknown primary
5415029|NCT00047112|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
5415030|NCT00047112|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
5415031|NCT00047112|stage I esophageal cancer|stage i esophageal cancer
5415032|NCT00047112|stage II esophageal cancer|stage ii esophageal cancer
5415033|NCT00047099|stage II breast cancer|stage ii breast cancer
5415034|NCT00047099|stage IIIA breast cancer|stage iiia breast cancer
5415035|NCT00047099|stage IIIB breast cancer|stage iiib breast cancer
5415036|NCT00047073|recurrent adult brain tumor|recurrent adult brain tumor
5415037|NCT00047073|adult glioblastoma|adult glioblastoma
5415038|NCT00047073|adult giant cell glioblastoma|adult giant cell glioblastoma
5415039|NCT00047073|adult gliosarcoma|adult gliosarcoma
5415040|NCT00047060|Cutaneous T Cell Lymphoma|cutaneous t cell lymphoma
5415041|NCT00047060|Allogeneic PBSCT|allogeneic pbsct
5415042|NCT00047060|Low Intensity Regimen|low intensity regimen
5415043|NCT00047060|Mycosis Fungoides|mycosis fungoides
5415044|NCT00047060|Sezary Syndrome|sezary syndrome
5415045|NCT00047060|CTCL|ctcl
5415046|NCT00047021|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5415047|NCT00047021|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5415048|NCT00047021|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5415049|NCT00047021|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5415050|NCT00047021|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5415051|NCT00047021|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5415052|NCT00047021|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5415053|NCT00047021|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5415054|NCT00047021|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5415055|NCT00047021|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5415056|NCT00047021|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5415057|NCT00047021|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5415058|NCT00047021|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5415059|NCT00047021|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
5415060|NCT00047021|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
5415061|NCT00047021|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
5415062|NCT00047021|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5415063|NCT00047021|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5415064|NCT00047021|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5415065|NCT00047021|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5415066|NCT00047021|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
5415067|NCT00047021|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5415068|NCT00047021|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5415069|NCT00047021|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
5415070|NCT00047021|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
5415071|NCT00047021|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5415072|NCT00047021|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5415073|NCT00047021|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5415074|NCT00047021|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5415075|NCT00047021|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5415076|NCT00047021|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5415077|NCT00047021|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5415078|NCT00047021|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5415079|NCT00047021|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5415080|NCT00047021|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5415081|NCT00047008|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
5415082|NCT00047008|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
5415083|NCT00047008|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
5415084|NCT00047008|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
5415085|NCT00047008|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5415086|NCT00047008|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5415087|NCT00047008|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5415088|NCT00047008|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5415089|NCT00046995|adenocarcinoma of the colon|adenocarcinoma of the colon
5415090|NCT00046995|stage IIB colon cancer|stage iib colon cancer
5415091|NCT00046995|stage IIIA colon cancer|stage iiia colon cancer
5415092|NCT00046995|stage IIIB colon cancer|stage iiib colon cancer
5415093|NCT00046995|stage IIIC colon cancer|stage iiic colon cancer
5415094|NCT00046969|anemia|anemia
5415095|NCT00046969|stage IIB cervical cancer|stage iib cervical cancer
5415096|NCT00046969|stage III cervical cancer|stage iii cervical cancer
5415097|NCT00046969|stage IVA cervical cancer|stage iva cervical cancer
5415098|NCT00046969|cervical adenosquamous cell carcinoma|cervical adenosquamous cell carcinoma
5415099|NCT00046969|cervical squamous cell carcinoma|cervical squamous cell carcinoma
5415100|NCT00046969|cervical adenocarcinoma|cervical adenocarcinoma
5415101|NCT00046943|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5415102|NCT00046943|recurrent prostate cancer|recurrent prostate cancer
5415103|NCT00046943|stage IIB prostate cancer|stage iib prostate cancer
5415104|NCT00046943|stage IIA prostate cancer|stage iia prostate cancer
5415105|NCT00046943|stage III prostate cancer|stage iii prostate cancer
5415106|NCT00046943|stage IV prostate cancer|stage iv prostate cancer
5415107|NCT00046930|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
5415108|NCT00046930|adult acute erythroid leukemia (M6)|adult acute erythroid leukemia (m6)
5415109|NCT00046930|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
5415110|NCT00046930|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
5415111|NCT00046930|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
5415112|NCT00046930|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
5415113|NCT00046930|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
5415114|NCT00046930|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
5415115|NCT00046930|refractory anemia with excess blasts|refractory anemia with excess blasts
5415116|NCT00046930|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5415117|NCT00046930|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
5415118|NCT00046930|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5415119|NCT00046930|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
5415120|NCT00046930|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5415121|NCT00046930|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5415122|NCT00046930|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5415123|NCT00046930|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5415124|NCT00046904|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5415125|NCT00046904|anorexia|anorexia
5415126|NCT00046904|cachexia|cachexia
5415127|NCT00046891|neurotoxicity|neurotoxicity
5415128|NCT00046891|stage I breast cancer|stage i breast cancer
5415129|NCT00046891|stage II breast cancer|stage ii breast cancer
5415130|NCT00046891|stage IIIA breast cancer|stage iiia breast cancer
5415131|NCT00046891|stage IIIB breast cancer|stage iiib breast cancer
5415132|NCT00046891|stage IIIC breast cancer|stage iiic breast cancer
5415133|NCT00046865|nausea and vomiting|nausea and vomiting
5415134|NCT00046865|stage I breast cancer|stage i breast cancer
5415135|NCT00046865|stage II breast cancer|stage ii breast cancer
5415136|NCT00046865|stage IIIA breast cancer|stage iiia breast cancer
5415137|NCT00046865|stage IIIB breast cancer|stage iiib breast cancer
5415138|NCT00046865|stage IIIC breast cancer|stage iiic breast cancer
5415139|NCT00046865|stage IV breast cancer|stage iv breast cancer
5415140|NCT00046852|infection|infection
5415141|NCT00046852|refractory multiple myeloma|refractory multiple myeloma
5415142|NCT00046852|stage I multiple myeloma|stage i multiple myeloma
5415143|NCT00046852|stage II multiple myeloma|stage ii multiple myeloma
5415144|NCT00046852|stage III multiple myeloma|stage iii multiple myeloma
5415145|NCT00046839|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
5415146|NCT00046839|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5415147|NCT00046839|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5415148|NCT00046826|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5415149|NCT00046826|stage IV prostate cancer|stage iv prostate cancer
5415150|NCT00046826|recurrent prostate cancer|recurrent prostate cancer
5415151|NCT00045747|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
5415152|NCT00045747|recurrent pancreatic cancer|recurrent pancreatic cancer
5415153|NCT00045747|stage IV pancreatic cancer|stage iv pancreatic cancer
5415154|NCT00045721|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
5415155|NCT00045695|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
5415156|NCT00045669|recurrent salivary gland cancer|recurrent salivary gland cancer
5415157|NCT00045669|salivary gland adenoid cystic carcinoma|salivary gland adenoid cystic carcinoma
5415158|NCT00045669|stage III salivary gland cancer|stage iii salivary gland cancer
5415159|NCT00045669|stage IV salivary gland cancer|stage iv salivary gland cancer
5415160|NCT00045630|anterior urethral cancer|anterior urethral cancer
5415161|NCT00045630|localized transitional cell cancer of the renal pelvis and ureter|localized transitional cell cancer of the renal pelvis and ureter
5415162|NCT00045630|posterior urethral cancer|posterior urethral cancer
5415163|NCT00045630|stage II bladder cancer|stage ii bladder cancer
5415164|NCT00045630|stage III bladder cancer|stage iii bladder cancer
5415165|NCT00045630|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
5415166|NCT00045630|urethral cancer associated with invasive bladder cancer|urethral cancer associated with invasive bladder cancer
5415167|NCT00045630|regional transitional cell cancer of the renal pelvis and ureter|regional transitional cell cancer of the renal pelvis and ureter
5415168|NCT00045617|limited stage small cell lung cancer|limited stage small cell lung cancer
5415169|NCT00045604|extensive stage small cell lung cancer|extensive stage small cell lung cancer
5415170|NCT00045591|recurrent breast cancer|recurrent breast cancer
5415171|NCT00045591|stage IV breast cancer|stage iv breast cancer
5415172|NCT00045539|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
5415173|NCT00045513|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5415174|NCT00045513|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5415175|NCT00045500|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5415176|NCT00045500|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
5415177|NCT00045500|intraocular lymphoma|intraocular lymphoma
5415178|NCT00045500|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
5415179|NCT00045500|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5415180|NCT00045500|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
5415181|NCT00045500|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5415182|NCT00045500|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5415183|NCT00045500|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5415184|NCT00045500|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5415185|NCT00045500|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5415186|NCT00045500|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5415187|NCT00045500|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5415188|NCT00045500|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5415189|NCT00045500|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5415190|NCT00045500|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5415191|NCT00045500|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5415192|NCT00045500|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5415193|NCT00045500|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5415194|NCT00045500|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5415195|NCT00045500|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5415196|NCT00045500|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5415197|NCT00045500|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5415198|NCT00045487|recurrent renal cell cancer|recurrent renal cell cancer
5415199|NCT00045487|stage III renal cell cancer|stage iii renal cell cancer
5415200|NCT00045487|stage IV renal cell cancer|stage iv renal cell cancer
5415201|NCT00045474|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5415202|NCT00045474|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
5415203|NCT00045474|adult glioblastoma|adult glioblastoma
5415204|NCT00045474|recurrent adult brain tumor|recurrent adult brain tumor
5415205|NCT00045474|adult giant cell glioblastoma|adult giant cell glioblastoma
5415206|NCT00045474|adult gliosarcoma|adult gliosarcoma
5415207|NCT00045461|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5415208|NCT00045461|recurrent fallopian tube cancer|recurrent fallopian tube cancer
5415209|NCT00045461|stage IIIA fallopian tube cancer|stage iiia fallopian tube cancer
5415210|NCT00045461|stage IIIB fallopian tube cancer|stage iiib fallopian tube cancer
5415211|NCT00045461|stage IIIC fallopian tube cancer|stage iiic fallopian tube cancer
5415212|NCT00045461|stage IV fallopian tube cancer|stage iv fallopian tube cancer
5415213|NCT00045461|recurrent primary peritoneal cavity cancer|recurrent primary peritoneal cavity cancer
5415214|NCT00045461|stage IIIA primary peritoneal cavity cancer|stage iiia primary peritoneal cavity cancer
5415215|NCT00045461|stage IIIB primary peritoneal cavity cancer|stage iiib primary peritoneal cavity cancer
5415216|NCT00045461|stage IIIC primary peritoneal cavity cancer|stage iiic primary peritoneal cavity cancer
5415217|NCT00045461|stage IV primary peritoneal cavity cancer|stage iv primary peritoneal cavity cancer
5415218|NCT00045461|stage IIIA ovarian epithelial cancer|stage iiia ovarian epithelial cancer
5415219|NCT00045461|stage IIIB ovarian epithelial cancer|stage iiib ovarian epithelial cancer
5415220|NCT00045461|stage IIIC ovarian epithelial cancer|stage iiic ovarian epithelial cancer
5415221|NCT00045461|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5415222|NCT00045448|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5415223|NCT00045422|chronic myelogenous leukemia, BCR-ABL1 positive|chronic myelogenous leukemia, bcr-abl1 positive
5415224|NCT00045422|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5415225|NCT00045422|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
5415226|NCT00045370|recurrent renal cell cancer|recurrent renal cell cancer
5415227|NCT00045370|stage III renal cell cancer|stage iii renal cell cancer
5415228|NCT00045370|stage IV renal cell cancer|stage iv renal cell cancer
5415229|NCT00045331|recurrent prostate cancer|recurrent prostate cancer
5415230|NCT00045331|stage I prostate cancer|stage i prostate cancer
5415231|NCT00045331|stage IIB prostate cancer|stage iib prostate cancer
5415232|NCT00045331|stage IIA prostate cancer|stage iia prostate cancer
5415233|NCT00045331|stage III prostate cancer|stage iii prostate cancer
5415234|NCT00045331|stage IV prostate cancer|stage iv prostate cancer
5415235|NCT00045318|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5415236|NCT00045305|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5415237|NCT00045305|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5415238|NCT00045305|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5415239|NCT00045305|refractory anemia|refractory anemia
5415240|NCT00045305|refractory anemia with excess blasts|refractory anemia with excess blasts
5415241|NCT00045305|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
5415242|NCT00045305|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5415243|NCT00045305|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
5415244|NCT00045305|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
5415245|NCT00045292|infection|infection
5415246|NCT00045292|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5415247|NCT00045292|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5415248|NCT00045292|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
5415249|NCT00045292|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5415250|NCT00045292|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5415251|NCT00045292|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5415252|NCT00045292|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
5415253|NCT00045292|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5415254|NCT00045292|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5415255|NCT00045292|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
5415256|NCT00045292|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
5415257|NCT00045292|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5415258|NCT00045292|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
5415259|NCT00045292|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5415260|NCT00045292|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5415261|NCT00045292|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5415262|NCT00045292|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
5415263|NCT00045292|untreated childhood acute myeloid leukemia and other myeloid malignancies|untreated childhood acute myeloid leukemia and other myeloid malignancies
5415264|NCT00045292|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
5415265|NCT00045292|chronic eosinophilic leukemia|chronic eosinophilic leukemia
5415266|NCT00045292|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
5415267|NCT00045292|chronic neutrophilic leukemia|chronic neutrophilic leukemia
5415268|NCT00045292|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5415269|NCT00045292|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
5415270|NCT00045292|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5415271|NCT00045292|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
5415272|NCT00045292|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5415273|NCT00045292|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5415274|NCT00045292|disseminated neuroblastoma|disseminated neuroblastoma
5415275|NCT00045292|recurrent neuroblastoma|recurrent neuroblastoma
5415276|NCT00045292|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5415277|NCT00045292|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5415278|NCT00045292|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5415279|NCT00045292|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5415280|NCT00045292|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
5415281|NCT00045292|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5415282|NCT00045292|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5415283|NCT00045292|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5415284|NCT00045292|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
5415285|NCT00045292|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5415286|NCT00045292|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5415287|NCT00045292|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5415288|NCT00045292|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
5415289|NCT00045292|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5415290|NCT00045292|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5415291|NCT00045292|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5415292|NCT00045292|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
5415293|NCT00045292|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5415294|NCT00045292|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5415295|NCT00045292|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5415296|NCT00045292|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
5415297|NCT00045292|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5415298|NCT00045292|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
5415299|NCT00045292|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5415300|NCT00045292|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5415301|NCT00045292|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5415302|NCT00045292|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5415303|NCT00045292|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5415304|NCT00045292|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5415305|NCT00045292|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5415306|NCT00045292|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5415307|NCT00045292|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5415308|NCT00045292|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5415309|NCT00045292|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5415310|NCT00045292|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5415311|NCT00045292|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5415312|NCT00045292|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5415313|NCT00045292|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5415314|NCT00045292|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5415315|NCT00045292|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5415316|NCT00045292|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5415317|NCT00045292|poor prognosis metastatic gestational trophoblastic tumor|poor prognosis metastatic gestational trophoblastic tumor
5415318|NCT00045292|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
5415319|NCT00045292|recurrent Wilms tumor and other childhood kidney tumors|recurrent wilms tumor and other childhood kidney tumors
5415320|NCT00045292|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5415321|NCT00045292|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
5415322|NCT00045292|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
5415323|NCT00045292|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
5415324|NCT00045292|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
5415325|NCT00045292|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5415326|NCT00045292|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5415327|NCT00045292|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5415328|NCT00045292|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
5415329|NCT00045292|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
5415330|NCT00045292|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5415331|NCT00045292|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5415332|NCT00045292|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
5415333|NCT00045292|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
5415334|NCT00045292|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5415335|NCT00045292|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5415336|NCT00045292|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5415337|NCT00045292|refractory hairy cell leukemia|refractory hairy cell leukemia
5415338|NCT00045292|refractory multiple myeloma|refractory multiple myeloma
5415339|NCT00045292|stage I multiple myeloma|stage i multiple myeloma
5415340|NCT00045292|stage II multiple myeloma|stage ii multiple myeloma
5415341|NCT00045292|stage III multiple myeloma|stage iii multiple myeloma
5415342|NCT00045292|stage IIIA breast cancer|stage iiia breast cancer
5415343|NCT00045292|stage IIIB breast cancer|stage iiib breast cancer
5415344|NCT00045292|stage IIIC breast cancer|stage iiic breast cancer
5415345|NCT00045292|stage IV breast cancer|stage iv breast cancer
5415346|NCT00045292|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
5415347|NCT00045292|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
5415348|NCT00045292|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5436948|NCT00000999|Zidovudine|zidovudine
5415349|NCT00045292|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5415350|NCT00045292|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5415351|NCT00045292|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5415352|NCT00045292|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5415353|NCT00045292|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5415354|NCT00045292|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5415355|NCT00045292|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5415356|NCT00045292|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5415357|NCT00045292|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
5415358|NCT00045279|stage IV renal cell cancer|stage iv renal cell cancer
5415359|NCT00045266|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5415360|NCT00045266|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5415361|NCT00045266|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5415362|NCT00045266|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5415363|NCT00045266|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5415364|NCT00045266|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5415365|NCT00045266|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5415366|NCT00045266|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5415367|NCT00045266|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5415368|NCT00045266|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5415369|NCT00045266|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5415370|NCT00045266|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5415371|NCT00045266|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5415372|NCT00045266|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5415373|NCT00045266|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5415374|NCT00045266|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5415375|NCT00045266|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5415376|NCT00045266|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5415377|NCT00045266|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5415378|NCT00045266|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5415379|NCT00045266|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5415380|NCT00045266|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5415381|NCT00045266|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5415382|NCT00045266|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5415383|NCT00045266|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5415384|NCT00045266|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5415385|NCT00045266|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5415386|NCT00045266|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5415387|NCT00045227|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5415388|NCT00045227|recurrent prostate cancer|recurrent prostate cancer
5415389|NCT00045227|stage IV prostate cancer|stage iv prostate cancer
5415390|NCT00045175|primary peritoneal cavity cancer|primary peritoneal cavity cancer
5415391|NCT00045175|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5415392|NCT00045175|fallopian tube cancer|fallopian tube cancer
5415393|NCT00045162|extensive stage small cell lung cancer|extensive stage small cell lung cancer
5415394|NCT00045136|refractory multiple myeloma|refractory multiple myeloma
5415395|NCT00045136|stage I multiple myeloma|stage i multiple myeloma
5415396|NCT00045136|stage II multiple myeloma|stage ii multiple myeloma
5415397|NCT00045136|stage III multiple myeloma|stage iii multiple myeloma
5415398|NCT00045097|male breast cancer|male breast cancer
5415399|NCT00045097|recurrent breast cancer|recurrent breast cancer
5415400|NCT00045097|stage IIIB breast cancer|stage iiib breast cancer
5415401|NCT00045097|stage IIIC breast cancer|stage iiic breast cancer
5415402|NCT00045097|stage IV breast cancer|stage iv breast cancer
5415403|NCT00045045|stage I malignant testicular germ cell tumor|stage i malignant testicular germ cell tumor
5415404|NCT00045045|testicular choriocarcinoma|testicular choriocarcinoma
5415405|NCT00045045|testicular choriocarcinoma and embryonal carcinoma|testicular choriocarcinoma and embryonal carcinoma
5415406|NCT00045045|testicular choriocarcinoma and seminoma|testicular choriocarcinoma and seminoma
5415407|NCT00045045|testicular choriocarcinoma and teratoma|testicular choriocarcinoma and teratoma
5415408|NCT00045045|testicular choriocarcinoma and yolk sac tumor|testicular choriocarcinoma and yolk sac tumor
5415409|NCT00045045|testicular embryonal carcinoma and seminoma|testicular embryonal carcinoma and seminoma
5415410|NCT00045045|testicular embryonal carcinoma and teratoma with seminoma|testicular embryonal carcinoma and teratoma with seminoma
5415411|NCT00045045|testicular embryonal carcinoma and teratoma|testicular embryonal carcinoma and teratoma
5415412|NCT00045045|testicular embryonal carcinoma and yolk sac tumor with seminoma|testicular embryonal carcinoma and yolk sac tumor with seminoma
5415413|NCT00045045|testicular embryonal carcinoma and yolk sac tumor|testicular embryonal carcinoma and yolk sac tumor
5415414|NCT00045045|testicular embryonal carcinoma|testicular embryonal carcinoma
5415415|NCT00045045|testicular teratoma|testicular teratoma
5415416|NCT00045045|testicular yolk sac tumor and teratoma with seminoma|testicular yolk sac tumor and teratoma with seminoma
5415417|NCT00045045|testicular yolk sac tumor and teratoma|testicular yolk sac tumor and teratoma
5415418|NCT00045045|testicular yolk sac tumor|testicular yolk sac tumor
5415419|NCT00045019|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5415420|NCT00045006|acute undifferentiated leukemia|acute undifferentiated leukemia
5415421|NCT00045006|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5415422|NCT00045006|borderline ovarian surface epithelial-stromal tumor|borderline ovarian surface epithelial-stromal tumor
5415423|NCT00045006|ovarian sarcoma|ovarian sarcoma
5415424|NCT00045006|ovarian stromal cancer|ovarian stromal cancer
5415425|NCT00045006|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5415426|NCT00045006|prolymphocytic leukemia|prolymphocytic leukemia
5415427|NCT00045006|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5415428|NCT00045006|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
5415429|NCT00045006|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5415430|NCT00045006|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5415431|NCT00045006|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5415432|NCT00045006|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5415433|NCT00045006|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5415434|NCT00045006|recurrent bladder cancer|recurrent bladder cancer
5415435|NCT00045006|recurrent breast cancer|recurrent breast cancer
5415436|NCT00045006|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5415437|NCT00045006|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5415438|NCT00045006|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5415439|NCT00045006|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5415440|NCT00045006|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
5415441|NCT00045006|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5415442|NCT00045006|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5415443|NCT00045006|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5415444|NCT00045006|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
5415445|NCT00045006|recurrent prostate cancer|recurrent prostate cancer
5415446|NCT00045006|recurrent renal cell cancer|recurrent renal cell cancer
5415447|NCT00045006|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5415448|NCT00045006|refractory hairy cell leukemia|refractory hairy cell leukemia
5415449|NCT00045006|refractory multiple myeloma|refractory multiple myeloma
5415450|NCT00045006|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5415451|NCT00045006|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5415452|NCT00045006|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5415453|NCT00045006|stage III multiple myeloma|stage iii multiple myeloma
5415454|NCT00045006|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
5415455|NCT00045006|stage III ovarian germ cell tumor|stage iii ovarian germ cell tumor
5415456|NCT00045006|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
5415457|NCT00045006|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
5415458|NCT00045006|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5415459|NCT00045006|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5415460|NCT00045006|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5415461|NCT00045006|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
5415462|NCT00045006|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
5415463|NCT00045006|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5415464|NCT00045006|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5415465|NCT00045006|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5415466|NCT00045006|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5415467|NCT00045006|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5415468|NCT00045006|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5415469|NCT00045006|stage III bladder cancer|stage iii bladder cancer
5415470|NCT00045006|stage IV bladder cancer|stage iv bladder cancer
5415471|NCT00045006|stage IIIA breast cancer|stage iiia breast cancer
5415472|NCT00045006|stage IIIB breast cancer|stage iiib breast cancer
5415473|NCT00045006|stage IIIC breast cancer|stage iiic breast cancer
5415474|NCT00045006|stage IV breast cancer|stage iv breast cancer
5415475|NCT00045006|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
5415476|NCT00045006|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
5415477|NCT00045006|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5415478|NCT00045006|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5415479|NCT00045006|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5415480|NCT00045006|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5415481|NCT00045006|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5415482|NCT00045006|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5415483|NCT00045006|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5415484|NCT00045006|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5415485|NCT00045006|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5415486|NCT00045006|stage III oropharyngeal cancer|stage iii oropharyngeal cancer
5415487|NCT00045006|stage IV oropharyngeal cancer|stage iv oropharyngeal cancer
5415488|NCT00045006|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5415489|NCT00045006|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5415490|NCT00045006|stage III prostate cancer|stage iii prostate cancer
5415491|NCT00045006|stage IV prostate cancer|stage iv prostate cancer
5415492|NCT00045006|stage III renal cell cancer|stage iii renal cell cancer
5415493|NCT00045006|stage IV renal cell cancer|stage iv renal cell cancer
5415494|NCT00045006|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5415495|NCT00045006|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5415496|NCT00045006|recurrent salivary gland cancer|recurrent salivary gland cancer
5415497|NCT00045006|stage IV salivary gland cancer|stage iv salivary gland cancer
5415498|NCT00045006|stage III salivary gland cancer|stage iii salivary gland cancer
5415499|NCT00045006|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
5415500|NCT00045006|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
5415501|NCT00045006|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5415502|NCT00045006|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
5415503|NCT00045006|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
5415504|NCT00045006|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
5415505|NCT00045006|stage III verrucous carcinoma of the larynx|stage iii verrucous carcinoma of the larynx
5415506|NCT00045006|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5415507|NCT00045006|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
5415508|NCT00045006|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
5415509|NCT00045006|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
5415510|NCT00045006|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5415511|NCT00045006|recurrent lymphoepithelioma of the nasopharynx|recurrent lymphoepithelioma of the nasopharynx
5415512|NCT00045006|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
5415513|NCT00045006|stage III lymphoepithelioma of the nasopharynx|stage iii lymphoepithelioma of the nasopharynx
5415514|NCT00045006|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
5415515|NCT00045006|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
5415516|NCT00045006|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
5415517|NCT00045006|recurrent lymphoepithelioma of the oropharynx|recurrent lymphoepithelioma of the oropharynx
5415518|NCT00045006|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
5415519|NCT00045006|stage III lymphoepithelioma of the oropharynx|stage iii lymphoepithelioma of the oropharynx
5415520|NCT00045006|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
5415521|NCT00045006|stage IV lymphoepithelioma of the oropharynx|stage iv lymphoepithelioma of the oropharynx
5415522|NCT00045006|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5415523|NCT00045006|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity
5415524|NCT00045006|recurrent inverted papilloma of the paranasal sinus and nasal cavity|recurrent inverted papilloma of the paranasal sinus and nasal cavity
5415525|NCT00045006|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity
5415526|NCT00045006|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
5415527|NCT00045006|stage III esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iii esthesioneuroblastoma of the paranasal sinus and nasal cavity
5415528|NCT00045006|stage III inverted papilloma of the paranasal sinus and nasal cavity|stage iii inverted papilloma of the paranasal sinus and nasal cavity
5415529|NCT00045006|stage III midline lethal granuloma of the paranasal sinus and nasal cavity|stage iii midline lethal granuloma of the paranasal sinus and nasal cavity
5415530|NCT00045006|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
5415531|NCT00045006|stage IV esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iv esthesioneuroblastoma of the paranasal sinus and nasal cavity
5415532|NCT00045006|stage IV inverted papilloma of the paranasal sinus and nasal cavity|stage iv inverted papilloma of the paranasal sinus and nasal cavity
5415533|NCT00045006|stage IV midline lethal granuloma of the paranasal sinus and nasal cavity|stage iv midline lethal granuloma of the paranasal sinus and nasal cavity
5415534|NCT00045006|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
5416220|NCT00036790|stage III colon cancer|stage iii colon cancer
5415535|NCT00045006|recurrent basal cell carcinoma of the lip|recurrent basal cell carcinoma of the lip
5415536|NCT00045006|stage III basal cell carcinoma of the lip|stage iii basal cell carcinoma of the lip
5415537|NCT00045006|stage IV basal cell carcinoma of the lip|stage iv basal cell carcinoma of the lip
5437907|NCT00000859|RNA, Viral|rna, viral
5415538|NCT00045006|recurrent mucoepidermoid carcinoma of the oral cavity|recurrent mucoepidermoid carcinoma of the oral cavity
5415539|NCT00045006|stage III mucoepidermoid carcinoma of the oral cavity|stage iii mucoepidermoid carcinoma of the oral cavity
5415540|NCT00045006|stage IV mucoepidermoid carcinoma of the oral cavity|stage iv mucoepidermoid carcinoma of the oral cavity
5415541|NCT00045006|recurrent adenoid cystic carcinoma of the oral cavity|recurrent adenoid cystic carcinoma of the oral cavity
5415542|NCT00045006|stage III adenoid cystic carcinoma of the oral cavity|stage iii adenoid cystic carcinoma of the oral cavity
5415543|NCT00045006|stage IV adenoid cystic carcinoma of the oral cavity|stage iv adenoid cystic carcinoma of the oral cavity
5415544|NCT00045006|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
5415545|NCT00045006|stage III verrucous carcinoma of the oral cavity|stage iii verrucous carcinoma of the oral cavity
5415546|NCT00045006|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
5415547|NCT00045006|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
5415548|NCT00045006|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
5415549|NCT00045006|male breast cancer|male breast cancer
5415550|NCT00044993|male breast cancer|male breast cancer
5415551|NCT00044993|stage IIIA breast cancer|stage iiia breast cancer
5415552|NCT00044993|stage IIIB breast cancer|stage iiib breast cancer
5415553|NCT00044993|stage IIIC breast cancer|stage iiic breast cancer
5415554|NCT00044993|stage IV breast cancer|stage iv breast cancer
5415555|NCT00044980|malnutrition|malnutrition
5415556|NCT00044980|stage I prostate cancer|stage i prostate cancer
5415557|NCT00044980|stage II B prostate cancer|stage ii b prostate cancer
5415558|NCT00044980|stage II A prostate cancer|stage ii a prostate cancer
5415559|NCT00044967|stage I colon cancer|stage i colon cancer
5415560|NCT00044967|stage II colon cancer|stage ii colon cancer
5415561|NCT00044967|stage III colon cancer|stage iii colon cancer
5415562|NCT00044967|stage I rectal cancer|stage i rectal cancer
5415563|NCT00044967|stage II rectal cancer|stage ii rectal cancer
5415564|NCT00044967|stage III rectal cancer|stage iii rectal cancer
5415565|NCT00044967|adenocarcinoma of the colon|adenocarcinoma of the colon
5415566|NCT00044967|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5415567|NCT00044954|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5415568|NCT00044954|stage I multiple myeloma|stage i multiple myeloma
5415569|NCT00044954|stage II multiple myeloma|stage ii multiple myeloma
5415570|NCT00044954|stage III multiple myeloma|stage iii multiple myeloma
5415571|NCT00044954|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5415572|NCT00044954|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5415573|NCT00044954|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5415574|NCT00044954|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5415575|NCT00044954|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5415576|NCT00044954|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5415577|NCT00044954|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5415578|NCT00044954|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5415579|NCT00044954|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5415580|NCT00044954|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5415581|NCT00044954|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5415582|NCT00044954|refractory multiple myeloma|refractory multiple myeloma
5415583|NCT00044954|stage I mantle cell lymphoma|stage i mantle cell lymphoma
5415584|NCT00044954|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
5415585|NCT00044954|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5415586|NCT00044954|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
5415587|NCT00044954|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
5415588|NCT00044954|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5415589|NCT00044954|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5415590|NCT00044954|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5415591|NCT00044954|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5415592|NCT00044954|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5415593|NCT00044954|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5415594|NCT00043147|graft versus host disease|graft versus host disease
5415595|NCT00043134|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5415596|NCT00043134|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5415597|NCT00043134|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5415598|NCT00043134|refractory anemia|refractory anemia
5415599|NCT00043134|refractory anemia with excess blasts|refractory anemia with excess blasts
5415600|NCT00043134|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
5415601|NCT00043134|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
5415602|NCT00043134|refractory cytopenia with multilineage dysplasia|refractory cytopenia with multilineage dysplasia
5415603|NCT00043134|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5415604|NCT00043134|atypical chronic myeloid leukemia, BCR-ABL negative|atypical chronic myeloid leukemia, bcr-abl negative
5415605|NCT00043134|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
5415606|NCT00043095|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5415607|NCT00043082|peritoneal cavity cancer|peritoneal cavity cancer
5415608|NCT00043082|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5415609|NCT00043082|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5415610|NCT00043082|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5415611|NCT00043069|osteoporosis|osteoporosis
5415612|NCT00043069|stage I prostate cancer|stage i prostate cancer
5415613|NCT00043069|stage IIB prostate cancer|stage iib prostate cancer
5415614|NCT00043069|stage IIA prostate cancer|stage iia prostate cancer
5415615|NCT00043069|stage III prostate cancer|stage iii prostate cancer
5415616|NCT00043043|colorectal cancer|colorectal cancer
5415617|NCT00043030|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
5415618|NCT00043030|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5415619|NCT00043017|stage IIIA breast cancer|stage iiia breast cancer
5415620|NCT00043017|stage IIIB breast cancer|stage iiib breast cancer
5415621|NCT00043017|stage IIIC breast cancer|stage iiic breast cancer
5415622|NCT00043004|liver metastases|liver metastases
5415623|NCT00043004|stage IV colon cancer|stage iv colon cancer
5415624|NCT00043004|stage IV rectal cancer|stage iv rectal cancer
5415625|NCT00042965|recurrent renal cell cancer|recurrent renal cell cancer
5415626|NCT00042965|stage IV renal cell cancer|stage iv renal cell cancer
5415627|NCT00042939|pancreatic cancer|pancreatic cancer
5415628|NCT00042939|metastatic pancreatic cancer|metastatic pancreatic cancer
5415629|NCT00042939|EGF-r|egf-r
5415630|NCT00042939|irinotecan|irinotecan
5415631|NCT00042939|docetaxel|docetaxel
5415632|NCT00042939|cetuximab|cetuximab
5416221|NCT00036790|stage IV colon cancer|stage iv colon cancer
5415633|NCT00042926|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
5415634|NCT00042926|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
5415635|NCT00042913|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5415636|NCT00042887|stage 0 bladder cancer|stage 0 bladder cancer
5415637|NCT00042887|stage I bladder cancer|stage i bladder cancer
5415638|NCT00042887|recurrent bladder cancer|recurrent bladder cancer
5415639|NCT00042887|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
5415640|NCT00042861|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5415641|NCT00042848|fatigue|fatigue
5415642|NCT00042848|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5415643|NCT00042822|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5415644|NCT00042822|refractory anemia with excess blasts|refractory anemia with excess blasts
5415645|NCT00042822|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
5415646|NCT00042822|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5415647|NCT00042822|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5415648|NCT00042822|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5415649|NCT00042822|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5415650|NCT00042822|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
5415651|NCT00042822|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5415652|NCT00042822|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5415653|NCT00042822|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5415654|NCT00042822|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5415655|NCT00042822|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5415656|NCT00042822|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
5415657|NCT00042822|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
5415658|NCT00042822|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5415659|NCT00042822|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5415660|NCT00042822|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5415661|NCT00042822|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5415662|NCT00042822|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5415663|NCT00042783|stage IV melanoma|stage iv melanoma
5415664|NCT00042783|recurrent melanoma|recurrent melanoma
5415665|NCT00042770|malignant pleural effusion|malignant pleural effusion
5415666|NCT00042770|pulmonary complications|pulmonary complications
5415667|NCT00042731|stage I prostate cancer|stage i prostate cancer
5415668|NCT00042731|stage IIB prostate cancer|stage iib prostate cancer
5415669|NCT00042731|stage IIA prostate cancer|stage iia prostate cancer
5415670|NCT00041379|Waldenström macroglobulinemia|waldenström macroglobulinemia
5415671|NCT00041327|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
5415672|NCT00041327|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
5415673|NCT00041327|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
5415937|NCT00039559|ovarian epithelial cancer|ovarian epithelial cancer
5415674|NCT00041327|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
5415675|NCT00041314|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5415676|NCT00041314|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5415677|NCT00041314|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5415678|NCT00041301|stage I prostate cancer|stage i prostate cancer
5415679|NCT00041301|stage IIB prostate cancer|stage iib prostate cancer
5415680|NCT00041301|stage IIA prostate cancer|stage iia prostate cancer
5415681|NCT00041301|stage III prostate cancer|stage iii prostate cancer
5415682|NCT00041301|stage IV prostate cancer|stage iv prostate cancer
5415683|NCT00041288|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
5415684|NCT00041288|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5415685|NCT00041288|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5415686|NCT00041288|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5415687|NCT00041288|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5415688|NCT00041288|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5415689|NCT00041262|stage IIB esophageal cancer|stage iib esophageal cancer
5415690|NCT00041262|stage IIIA esophageal cancer|stage iiia esophageal cancer
5415691|NCT00041262|stage IIIB esophageal cancer|stage iiib esophageal cancer
5415692|NCT00041262|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
5415693|NCT00041249|adult angiosarcoma|adult angiosarcoma
5415694|NCT00041249|adult fibrosarcoma|adult fibrosarcoma
5415695|NCT00041249|adult leiomyosarcoma|adult leiomyosarcoma
5415696|NCT00041249|adult liposarcoma|adult liposarcoma
5415697|NCT00041249|adult neurofibrosarcoma|adult neurofibrosarcoma
5415698|NCT00041249|adult synovial sarcoma|adult synovial sarcoma
5415699|NCT00041249|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
5415700|NCT00041249|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
5415701|NCT00041249|adult malignant fibrous histiocytoma|adult malignant fibrous histiocytoma
5415702|NCT00041249|adult malignant hemangiopericytoma|adult malignant hemangiopericytoma
5415703|NCT00041249|adult rhabdomyosarcoma|adult rhabdomyosarcoma
5415704|NCT00041249|gastrointestinal stromal tumor|gastrointestinal stromal tumor
5415705|NCT00041249|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
5415706|NCT00041236|adult angiosarcoma|adult angiosarcoma
5415707|NCT00041236|adult fibrosarcoma|adult fibrosarcoma
5415708|NCT00041236|adult leiomyosarcoma|adult leiomyosarcoma
5415709|NCT00041236|adult liposarcoma|adult liposarcoma
5415710|NCT00041236|adult neurofibrosarcoma|adult neurofibrosarcoma
5415711|NCT00041236|adult synovial sarcoma|adult synovial sarcoma
5415712|NCT00041236|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
5415713|NCT00041236|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
5415714|NCT00041236|adult malignant fibrous histiocytoma|adult malignant fibrous histiocytoma
5415715|NCT00041236|adult malignant hemangiopericytoma|adult malignant hemangiopericytoma
5415716|NCT00041236|adult rhabdomyosarcoma|adult rhabdomyosarcoma
5415717|NCT00041236|stage IV uterine sarcoma|stage iv uterine sarcoma
5415718|NCT00041236|recurrent uterine sarcoma|recurrent uterine sarcoma
5415719|NCT00041236|uterine leiomyosarcoma|uterine leiomyosarcoma
5415720|NCT00041223|radiation fibrosis|radiation fibrosis
5415721|NCT00041223|stage I breast cancer|stage i breast cancer
5415722|NCT00041223|stage II breast cancer|stage ii breast cancer
5415723|NCT00041223|stage IIIA breast cancer|stage iiia breast cancer
5415724|NCT00041210|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
5415725|NCT00041210|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
5415726|NCT00041210|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5415727|NCT00041210|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5415728|NCT00041210|adult lymphocyte predominant Hodgkin lymphoma|adult lymphocyte predominant hodgkin lymphoma
5415729|NCT00041210|adult lymphocyte depletion Hodgkin lymphoma|adult lymphocyte depletion hodgkin lymphoma
5415730|NCT00041210|adult nodular sclerosis Hodgkin lymphoma|adult nodular sclerosis hodgkin lymphoma
5415731|NCT00041210|adult mixed cellularity Hodgkin lymphoma|adult mixed cellularity hodgkin lymphoma
5415732|NCT00041171|stage IV breast cancer|stage iv breast cancer
5415733|NCT00041171|stage IIIA breast cancer|stage iiia breast cancer
5415734|NCT00041171|recurrent breast cancer|recurrent breast cancer
5415735|NCT00041171|stage IIIB breast cancer|stage iiib breast cancer
5415736|NCT00041171|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5415737|NCT00041171|extensive stage small cell lung cancer|extensive stage small cell lung cancer
5415738|NCT00041171|recurrent small cell lung cancer|recurrent small cell lung cancer
5415739|NCT00041171|stage III bladder cancer|stage iii bladder cancer
5415740|NCT00041171|recurrent bladder cancer|recurrent bladder cancer
5415741|NCT00041171|stage IV bladder cancer|stage iv bladder cancer
5415742|NCT00041171|stage III prostate cancer|stage iii prostate cancer
5415743|NCT00041171|stage IV prostate cancer|stage iv prostate cancer
5415744|NCT00041171|recurrent prostate cancer|recurrent prostate cancer
5415745|NCT00041171|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5415746|NCT00041171|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5415747|NCT00041171|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5415748|NCT00041171|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5415938|NCT00039546|stage I breast cancer|stage i breast cancer
5415749|NCT00041171|untreated metastatic squamous neck cancer with occult primary|untreated metastatic squamous neck cancer with occult primary
5415750|NCT00041171|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
5415751|NCT00041171|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
5415752|NCT00041171|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
5415753|NCT00041171|stage III basal cell carcinoma of the lip|stage iii basal cell carcinoma of the lip
5415754|NCT00041171|stage III verrucous carcinoma of the oral cavity|stage iii verrucous carcinoma of the oral cavity
5415755|NCT00041171|stage III mucoepidermoid carcinoma of the oral cavity|stage iii mucoepidermoid carcinoma of the oral cavity
5415756|NCT00041171|stage III adenoid cystic carcinoma of the oral cavity|stage iii adenoid cystic carcinoma of the oral cavity
5415757|NCT00041171|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5415758|NCT00041171|stage IV basal cell carcinoma of the lip|stage iv basal cell carcinoma of the lip
5415759|NCT00041171|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
5415760|NCT00041171|stage IV mucoepidermoid carcinoma of the oral cavity|stage iv mucoepidermoid carcinoma of the oral cavity
5415761|NCT00041171|stage IV adenoid cystic carcinoma of the oral cavity|stage iv adenoid cystic carcinoma of the oral cavity
5415762|NCT00041171|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
5415763|NCT00041171|recurrent basal cell carcinoma of the lip|recurrent basal cell carcinoma of the lip
5415764|NCT00041171|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
5415765|NCT00041171|recurrent mucoepidermoid carcinoma of the oral cavity|recurrent mucoepidermoid carcinoma of the oral cavity
5415766|NCT00041171|recurrent adenoid cystic carcinoma of the oral cavity|recurrent adenoid cystic carcinoma of the oral cavity
5415767|NCT00041171|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
5415768|NCT00041171|stage III lymphoepithelioma of the oropharynx|stage iii lymphoepithelioma of the oropharynx
5415769|NCT00041171|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5415770|NCT00041171|stage IV lymphoepithelioma of the oropharynx|stage iv lymphoepithelioma of the oropharynx
5415771|NCT00041171|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
5415772|NCT00041171|recurrent lymphoepithelioma of the oropharynx|recurrent lymphoepithelioma of the oropharynx
5415773|NCT00041171|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
5415774|NCT00041171|stage III lymphoepithelioma of the nasopharynx|stage iii lymphoepithelioma of the nasopharynx
5415775|NCT00041171|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
5415776|NCT00041171|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
5415777|NCT00041171|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
5415778|NCT00041171|recurrent lymphoepithelioma of the nasopharynx|recurrent lymphoepithelioma of the nasopharynx
5415779|NCT00041171|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
5415780|NCT00041171|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5415781|NCT00041171|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
5415782|NCT00041171|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
5415783|NCT00041171|stage III verrucous carcinoma of the larynx|stage iii verrucous carcinoma of the larynx
5415784|NCT00041171|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5415785|NCT00041171|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
5415786|NCT00041171|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
5415787|NCT00041171|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
5415788|NCT00041171|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
5415789|NCT00041171|stage III inverting papilloma of the paranasal sinus and nasal cavity|stage iii inverting papilloma of the paranasal sinus and nasal cavity
5415790|NCT00041171|stage III midline lethal granuloma of the paranasal sinus and nasal cavity|stage iii midline lethal granuloma of the paranasal sinus and nasal cavity
5415791|NCT00041171|stage III esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iii esthesioneuroblastoma of the paranasal sinus and nasal cavity
5415792|NCT00041171|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
5415793|NCT00041171|stage IV inverting papilloma of the paranasal sinus and nasal cavity|stage iv inverting papilloma of the paranasal sinus and nasal cavity
5415794|NCT00041171|stage IV midline lethal granuloma of the paranasal sinus and nasal cavity|stage iv midline lethal granuloma of the paranasal sinus and nasal cavity
5415795|NCT00041171|stage IV esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iv esthesioneuroblastoma of the paranasal sinus and nasal cavity
5415796|NCT00041171|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
5415797|NCT00041171|recurrent inverting papilloma of the paranasal sinus and nasal cavity|recurrent inverting papilloma of the paranasal sinus and nasal cavity
5415798|NCT00041171|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity
5415799|NCT00041171|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity
5415800|NCT00041171|recurrent salivary gland cancer|recurrent salivary gland cancer
5415801|NCT00041171|stage III salivary gland cancer|stage iii salivary gland cancer
5415802|NCT00041171|stage IV salivary gland cancer|stage iv salivary gland cancer
5415803|NCT00041132|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5415804|NCT00041132|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5415805|NCT00041132|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
5415806|NCT00041132|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5415807|NCT00041119|stage IB breast cancer|stage ib breast cancer
5415808|NCT00041119|stage II breast cancer|stage ii breast cancer
5415809|NCT00041067|stage IV breast cancer|stage iv breast cancer
5415810|NCT00041067|recurrent breast cancer|recurrent breast cancer
5415811|NCT00041054|extensive stage small cell lung cancer|extensive stage small cell lung cancer
5415812|NCT00041028|stage I non-small cell lung cancer|stage i non-small cell lung cancer
5415813|NCT00041028|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
5415814|NCT00041028|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5415815|NCT00041028|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5415816|NCT00041015|extensive stage small cell lung cancer|extensive stage small cell lung cancer
5415817|NCT00041015|recurrent small cell lung cancer|recurrent small cell lung cancer
5415818|NCT00040950|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5415819|NCT00040950|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5415820|NCT00040950|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5415821|NCT00040950|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5415822|NCT00040950|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5415823|NCT00040950|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5415824|NCT00040950|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5415825|NCT00040950|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5415826|NCT00040950|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5415827|NCT00040950|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5415828|NCT00040950|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5415829|NCT00040950|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5415830|NCT00040950|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5415831|NCT00040950|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5415832|NCT00040950|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5415833|NCT00040937|stage I multiple myeloma|stage i multiple myeloma
5415834|NCT00040937|stage II multiple myeloma|stage ii multiple myeloma
5415835|NCT00040937|stage III multiple myeloma|stage iii multiple myeloma
5415836|NCT00040911|nausea and vomiting|nausea and vomiting
5415837|NCT00040911|localized osteosarcoma|localized osteosarcoma
5415838|NCT00040911|metastatic osteosarcoma|metastatic osteosarcoma
5415839|NCT00040911|nonmetastatic childhood soft tissue sarcoma|nonmetastatic childhood soft tissue sarcoma
5415840|NCT00040911|metastatic childhood soft tissue sarcoma|metastatic childhood soft tissue sarcoma
5415841|NCT00040911|previously untreated childhood rhabdomyosarcoma|previously untreated childhood rhabdomyosarcoma
5415842|NCT00040911|localized Ewing sarcoma/peripheral primitive neuroectodermal tumor|localized ewing sarcoma/peripheral primitive neuroectodermal tumor
5415843|NCT00040911|metastatic Ewing sarcoma/peripheral primitive neuroectodermal tumor|metastatic ewing sarcoma/peripheral primitive neuroectodermal tumor
5415844|NCT00040911|childhood teratoma|childhood teratoma
5415845|NCT00040911|childhood extragonadal germ cell tumor|childhood extragonadal germ cell tumor
5415846|NCT00040911|childhood malignant testicular germ cell tumor|childhood malignant testicular germ cell tumor
5415847|NCT00040911|childhood malignant ovarian germ cell tumor|childhood malignant ovarian germ cell tumor
5415848|NCT00040911|childhood central nervous system germ cell tumor|childhood central nervous system germ cell tumor
5415849|NCT00040911|localized resectable neuroblastoma|localized resectable neuroblastoma
5415850|NCT00040911|localized unresectable neuroblastoma|localized unresectable neuroblastoma
5415851|NCT00040911|disseminated neuroblastoma|disseminated neuroblastoma
5415852|NCT00040911|regional neuroblastoma|regional neuroblastoma
5415853|NCT00040911|stage 4S neuroblastoma|stage 4s neuroblastoma
5415854|NCT00040911|stage I lymphoepithelioma of the nasopharynx|stage i lymphoepithelioma of the nasopharynx
5415855|NCT00040911|stage I squamous cell carcinoma of the nasopharynx|stage i squamous cell carcinoma of the nasopharynx
5415856|NCT00040911|stage II lymphoepithelioma of the nasopharynx|stage ii lymphoepithelioma of the nasopharynx
5415857|NCT00040911|stage II squamous cell carcinoma of the nasopharynx|stage ii squamous cell carcinoma of the nasopharynx
5415858|NCT00040911|stage III lymphoepithelioma of the nasopharynx|stage iii lymphoepithelioma of the nasopharynx
5415859|NCT00040911|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
5415860|NCT00040911|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
5415861|NCT00040911|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
5415862|NCT00040911|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
5415863|NCT00040911|stage I childhood Hodgkin lymphoma|stage i childhood hodgkin lymphoma
5415864|NCT00040911|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
5415865|NCT00040911|stage II childhood Hodgkin lymphoma|stage ii childhood hodgkin lymphoma
5415939|NCT00039546|stage II breast cancer|stage ii breast cancer
5415866|NCT00040911|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5415867|NCT00040911|stage III childhood Hodgkin lymphoma|stage iii childhood hodgkin lymphoma
5415868|NCT00040911|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5415869|NCT00040911|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
5415870|NCT00040898|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
5415871|NCT00040898|advanced adult primary liver cancer|advanced adult primary liver cancer
5415872|NCT00040898|recurrent adult primary liver cancer|recurrent adult primary liver cancer
5415873|NCT00040898|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
5415874|NCT00040885|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5415875|NCT00040885|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5415876|NCT00040885|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5415877|NCT00040885|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5415878|NCT00040885|fatigue|fatigue
5415879|NCT00040885|anorexia|anorexia
5415880|NCT00040885|cachexia|cachexia
5415881|NCT00040872|regional neuroblastoma|regional neuroblastoma
5415882|NCT00040872|disseminated neuroblastoma|disseminated neuroblastoma
5415883|NCT00040872|recurrent neuroblastoma|recurrent neuroblastoma
5415884|NCT00040872|localized unresectable neuroblastoma|localized unresectable neuroblastoma
5415885|NCT00040859|stage IV gastric cancer|stage iv gastric cancer
5415886|NCT00040859|recurrent gastric cancer|recurrent gastric cancer
5415887|NCT00040859|stage III esophageal cancer|stage iii esophageal cancer
5415888|NCT00040859|stage IV esophageal cancer|stage iv esophageal cancer
5415889|NCT00040859|recurrent esophageal cancer|recurrent esophageal cancer
5415890|NCT00040859|adenocarcinoma of the stomach|adenocarcinoma of the stomach
5415891|NCT00040859|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
5415892|NCT00040833|stage III pancreatic cancer|stage iii pancreatic cancer
5415893|NCT00040833|recurrent pancreatic cancer|recurrent pancreatic cancer
5415894|NCT00040833|pain|pain
5415895|NCT00040833|stage IV pancreatic cancer|stage iv pancreatic cancer
5415896|NCT00040807|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
5415897|NCT00040807|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
5415898|NCT00040807|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5415899|NCT00040807|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
5415900|NCT00040807|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5415901|NCT00040807|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
5415902|NCT00040807|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
5415903|NCT00040807|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
5415904|NCT00040807|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5415905|NCT00040807|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
5415906|NCT00040807|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5415907|NCT00040807|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
5415908|NCT00040807|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
5415909|NCT00040807|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
5415910|NCT00040807|recurrent salivary gland cancer|recurrent salivary gland cancer
5415911|NCT00040807|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
5415912|NCT00040807|stage IV salivary gland cancer|stage iv salivary gland cancer
5415913|NCT00040742|nausea|nausea
5415914|NCT00040742|vomiting|vomiting
5415915|NCT00040690|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
5415916|NCT00040690|L3 adult acute lymphoblastic leukemia|l3 adult acute lymphoblastic leukemia
5415917|NCT00040690|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
5415918|NCT00040690|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5415919|NCT00040690|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5415920|NCT00040690|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
5415921|NCT00040690|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
5415922|NCT00039611|stage III colon cancer|stage iii colon cancer
5415923|NCT00039611|stage IV colon cancer|stage iv colon cancer
5415924|NCT00039611|stage III rectal cancer|stage iii rectal cancer
5415925|NCT00039611|stage IV rectal cancer|stage iv rectal cancer
5415926|NCT00039611|recurrent colon cancer|recurrent colon cancer
5415927|NCT00039611|recurrent rectal cancer|recurrent rectal cancer
5415928|NCT00039585|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5415929|NCT00039585|fallopian tube cancer|fallopian tube cancer
5415930|NCT00039585|primary peritoneal cavity cancer|primary peritoneal cavity cancer
5415931|NCT00039585|borderline ovarian surface epithelial-stromal tumor|borderline ovarian surface epithelial-stromal tumor
5415932|NCT00039572|adult glioblastoma|adult glioblastoma
5415933|NCT00039572|stage IV melanoma|stage iv melanoma
5415934|NCT00039572|tumors metastatic to brain|tumors metastatic to brain
5415935|NCT00039572|adult giant cell glioblastoma|adult giant cell glioblastoma
5415940|NCT00039520|stage IV breast cancer|stage iv breast cancer
5415941|NCT00039520|recurrent breast cancer|recurrent breast cancer
5415942|NCT00039507|stage I non-small cell lung cancer|stage i non-small cell lung cancer
5415943|NCT00039507|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
5415944|NCT00039468|adult glioblastoma|adult glioblastoma
5415945|NCT00039468|recurrent adult brain tumor|recurrent adult brain tumor
5415946|NCT00039468|adult giant cell glioblastoma|adult giant cell glioblastoma
5415947|NCT00039468|adult gliosarcoma|adult gliosarcoma
5415948|NCT00039429|stage IV renal cell cancer|stage iv renal cell cancer
5415949|NCT00039429|recurrent renal cell cancer|recurrent renal cell cancer
5415950|NCT00039364|recurrent adult brain tumor|recurrent adult brain tumor
5415951|NCT00039364|adult glioblastoma|adult glioblastoma
5415952|NCT00039364|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5415953|NCT00039364|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
5415954|NCT00039364|adult mixed glioma|adult mixed glioma
5415955|NCT00039364|adult pilocytic astrocytoma|adult pilocytic astrocytoma
5415956|NCT00039364|adult subependymoma|adult subependymoma
5415957|NCT00039364|adult giant cell glioblastoma|adult giant cell glioblastoma
5415958|NCT00039364|adult gliosarcoma|adult gliosarcoma
5415959|NCT00039364|adult diffuse astrocytoma|adult diffuse astrocytoma
5415960|NCT00039351|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
5415961|NCT00039351|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5415962|NCT00039351|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5415963|NCT00039351|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
5415964|NCT00039351|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5415965|NCT00039351|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
5415966|NCT00039338|stage IB cervical cancer|stage ib cervical cancer
5415967|NCT00039338|stage IIB cervical cancer|stage iib cervical cancer
5415968|NCT00039338|stage IIA cervical cancer|stage iia cervical cancer
5415969|NCT00039338|cervical squamous cell carcinoma|cervical squamous cell carcinoma
5415970|NCT00039338|cervical adenocarcinoma|cervical adenocarcinoma
5415971|NCT00039338|cervical adenosquamous cell carcinoma|cervical adenosquamous cell carcinoma
5415972|NCT00039325|stage IV melanoma|stage iv melanoma
5415973|NCT00039325|recurrent melanoma|recurrent melanoma
5415974|NCT00039312|cervical cancer|cervical cancer
5415975|NCT00039299|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5415976|NCT00039299|recurrent prostate cancer|recurrent prostate cancer
5415977|NCT00039286|stage II breast cancer|stage ii breast cancer
5415978|NCT00039286|stage IIIA breast cancer|stage iiia breast cancer
5415979|NCT00039286|recurrent breast cancer|recurrent breast cancer
5415980|NCT00039273|stage IV colon cancer|stage iv colon cancer
5415981|NCT00039273|stage IV rectal cancer|stage iv rectal cancer
5415982|NCT00039273|recurrent colon cancer|recurrent colon cancer
5415983|NCT00039273|recurrent rectal cancer|recurrent rectal cancer
5415984|NCT00039234|stage IV melanoma|stage iv melanoma
5415985|NCT00039234|recurrent melanoma|recurrent melanoma
5415986|NCT00039234|liver metastases|liver metastases
5415987|NCT00039208|stage III colon cancer|stage iii colon cancer
5415988|NCT00039208|stage IV colon cancer|stage iv colon cancer
5415989|NCT00039208|stage III rectal cancer|stage iii rectal cancer
5415990|NCT00039208|stage IV rectal cancer|stage iv rectal cancer
5415991|NCT00039208|recurrent colon cancer|recurrent colon cancer
5415992|NCT00039208|recurrent rectal cancer|recurrent rectal cancer
5415993|NCT00039195|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
5415994|NCT00039195|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5415995|NCT00039195|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5415996|NCT00039195|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
5415997|NCT00039195|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5415998|NCT00039156|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5415999|NCT00039156|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5416000|NCT00039156|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5416001|NCT00039156|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5416002|NCT00039156|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5416003|NCT00039156|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5416004|NCT00039156|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5416005|NCT00039130|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
5416006|NCT00039130|L3 adult acute lymphoblastic leukemia|l3 adult acute lymphoblastic leukemia
5416007|NCT00039130|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
5416008|NCT00039130|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5416009|NCT00039130|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5416010|NCT00039130|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
5416011|NCT00039130|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
5416012|NCT00039078|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
5416013|NCT00039078|recurrent adult primary liver cancer|recurrent adult primary liver cancer
5437908|NCT00000859|Genotype|genotype
5416014|NCT00039078|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
5416015|NCT00039052|stage IV breast cancer|stage iv breast cancer
5416016|NCT00039052|recurrent breast cancer|recurrent breast cancer
5416017|NCT00039052|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5416018|NCT00039052|stage IV renal cell cancer|stage iv renal cell cancer
5416019|NCT00039052|recurrent renal cell cancer|recurrent renal cell cancer
5416020|NCT00039052|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5416021|NCT00039052|male breast cancer|male breast cancer
5416022|NCT00039039|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5416023|NCT00039039|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5416024|NCT00039039|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5416025|NCT00037037|stage III melanoma|stage iii melanoma
5416026|NCT00037037|stage IV melanoma|stage iv melanoma
5416027|NCT00037037|recurrent melanoma|recurrent melanoma
5416028|NCT00037024|stage I breast cancer|stage i breast cancer
5416029|NCT00037024|stage II breast cancer|stage ii breast cancer
5416030|NCT00037024|stage I prostate cancer|stage i prostate cancer
5416031|NCT00037024|stage II B prostate cancer|stage ii b prostate cancer
5416032|NCT00037024|stage II A prostate cancer|stage ii a prostate cancer
5416033|NCT00037024|male breast cancer|male breast cancer
5416034|NCT00037024|fatigue|fatigue
5416035|NCT00037024|malnutrition|malnutrition
5416036|NCT00037024|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
5416037|NCT00037024|depression|depression
5416038|NCT00037011|disseminated neuroblastoma|disseminated neuroblastoma
5416039|NCT00037011|recurrent neuroblastoma|recurrent neuroblastoma
5416040|NCT00036998|stage I breast cancer|stage i breast cancer
5416041|NCT00036998|stage II breast cancer|stage ii breast cancer
5416042|NCT00036985|stage IIIA breast cancer|stage iiia breast cancer
5416043|NCT00036972|recurrent adult brain tumor|recurrent adult brain tumor
5416044|NCT00036972|adult glioblastoma|adult glioblastoma
5416045|NCT00036972|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5416046|NCT00036972|adult mixed glioma|adult mixed glioma
5416047|NCT00036972|adult giant cell glioblastoma|adult giant cell glioblastoma
5416048|NCT00036972|adult gliosarcoma|adult gliosarcoma
5416049|NCT00036959|metastatic osteosarcoma|metastatic osteosarcoma
5416050|NCT00036959|childhood infratentorial ependymoma|childhood infratentorial ependymoma
5416051|NCT00036959|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
5416052|NCT00036959|childhood supratentorial ependymoma|childhood supratentorial ependymoma
5416053|NCT00036959|childhood craniopharyngioma|childhood craniopharyngioma
5416054|NCT00036959|disseminated neuroblastoma|disseminated neuroblastoma
5416055|NCT00036959|recurrent neuroblastoma|recurrent neuroblastoma
5416056|NCT00036959|recurrent childhood liver cancer|recurrent childhood liver cancer
5416057|NCT00036959|stage IV childhood liver cancer|stage iv childhood liver cancer
5416058|NCT00036959|recurrent Wilms tumor and other childhood kidney tumors|recurrent wilms tumor and other childhood kidney tumors
5416059|NCT00036959|stage IV Wilms tumor|stage iv wilms tumor
5416060|NCT00036959|childhood central nervous system germ cell tumor|childhood central nervous system germ cell tumor
5416061|NCT00036959|recurrent osteosarcoma|recurrent osteosarcoma
5416062|NCT00036959|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
5416063|NCT00036959|childhood germ cell tumor|childhood germ cell tumor
5416064|NCT00036959|metastatic childhood soft tissue sarcoma|metastatic childhood soft tissue sarcoma
5416065|NCT00036959|recurrent childhood soft tissue sarcoma|recurrent childhood soft tissue sarcoma
5416066|NCT00036959|childhood high-grade cerebral astrocytoma|childhood high-grade cerebral astrocytoma
5416067|NCT00036959|childhood oligodendroglioma|childhood oligodendroglioma
5416068|NCT00036959|childhood choroid plexus tumor|childhood choroid plexus tumor
5416069|NCT00036959|childhood grade I meningioma|childhood grade i meningioma
5416070|NCT00036959|childhood grade II meningioma|childhood grade ii meningioma
5416071|NCT00036959|childhood grade III meningioma|childhood grade iii meningioma
5416072|NCT00036959|recurrent childhood cerebellar astrocytoma|recurrent childhood cerebellar astrocytoma
5416073|NCT00036959|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
5416074|NCT00036959|recurrent childhood medulloblastoma|recurrent childhood medulloblastoma
5416075|NCT00036959|recurrent childhood visual pathway and hypothalamic glioma|recurrent childhood visual pathway and hypothalamic glioma
5416076|NCT00036959|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
5416077|NCT00036959|metastatic Ewing sarcoma/peripheral primitive neuroectodermal tumor|metastatic ewing sarcoma/peripheral primitive neuroectodermal tumor
5416078|NCT00036959|recurrent Ewing sarcoma/peripheral primitive neuroectodermal tumor|recurrent ewing sarcoma/peripheral primitive neuroectodermal tumor
5416079|NCT00036959|recurrent childhood ependymoma|recurrent childhood ependymoma
5416080|NCT00036959|childhood teratoma|childhood teratoma
5416081|NCT00036959|childhood malignant testicular germ cell tumor|childhood malignant testicular germ cell tumor
5416082|NCT00036959|childhood malignant ovarian germ cell tumor|childhood malignant ovarian germ cell tumor
5416083|NCT00036959|childhood extragonadal germ cell tumor|childhood extragonadal germ cell tumor
5416084|NCT00036959|recurrent childhood malignant germ cell tumor|recurrent childhood malignant germ cell tumor
5416085|NCT00036946|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5416086|NCT00036946|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5437909|NCT00000859|Nelfinavir|nelfinavir
5416087|NCT00036946|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5416088|NCT00036946|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5416089|NCT00036946|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5416090|NCT00036946|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5416091|NCT00036946|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5416092|NCT00036946|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5416093|NCT00036946|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5416094|NCT00036946|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5416095|NCT00036946|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5416096|NCT00036946|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5416097|NCT00036946|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5416098|NCT00036946|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5416099|NCT00036946|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5416100|NCT00036946|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5416101|NCT00036946|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5416102|NCT00036946|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5416103|NCT00036946|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5416104|NCT00036946|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5416105|NCT00036946|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5416106|NCT00036946|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5416107|NCT00036946|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5416108|NCT00036946|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5416109|NCT00036946|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5416110|NCT00036946|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5416111|NCT00036946|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5416112|NCT00036946|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5416113|NCT00036933|stage III prostate cancer|stage iii prostate cancer
5416114|NCT00036933|recurrent prostate cancer|recurrent prostate cancer
5416115|NCT00036894|recurrent adult brain tumor|recurrent adult brain tumor
5416116|NCT00036894|adult glioblastoma|adult glioblastoma
5416117|NCT00036894|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5416118|NCT00036894|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
5416121|NCT00036894|adult anaplastic ependymoma|adult anaplastic ependymoma
5416122|NCT00036894|adult myxopapillary ependymoma|adult myxopapillary ependymoma
5416123|NCT00036894|adult meningioma|adult meningioma
5416124|NCT00036894|adult meningeal hemangiopericytoma|adult meningeal hemangiopericytoma
5416125|NCT00036894|adult brain stem glioma|adult brain stem glioma
5416126|NCT00036894|adult grade III meningioma|adult grade iii meningioma
5416127|NCT00036894|adult giant cell glioblastoma|adult giant cell glioblastoma
5416128|NCT00036894|adult gliosarcoma|adult gliosarcoma
5416129|NCT00036868|stage IV breast cancer|stage iv breast cancer
5416130|NCT00036868|recurrent breast cancer|recurrent breast cancer
5416131|NCT00036842|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
5416132|NCT00036842|extragonadal germ cell tumor|extragonadal germ cell tumor
5416133|NCT00036829|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5416134|NCT00036829|pain|pain
5416135|NCT00036816|ciliary body and choroid melanoma, medium/large size|ciliary body and choroid melanoma, medium/large size
5416136|NCT00036790|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5416137|NCT00036790|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5416138|NCT00036790|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5416139|NCT00036790|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
5416140|NCT00036790|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
5416141|NCT00036790|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5416142|NCT00036790|isolated plasmacytoma of bone|isolated plasmacytoma of bone
5416143|NCT00036790|extramedullary plasmacytoma|extramedullary plasmacytoma
5416144|NCT00036790|refractory multiple myeloma|refractory multiple myeloma
5416145|NCT00036790|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
5416146|NCT00036790|stage III multiple myeloma|stage iii multiple myeloma
5416147|NCT00036790|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5416148|NCT00036790|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5416149|NCT00036790|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5416150|NCT00036790|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5416151|NCT00036790|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5416152|NCT00036790|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5416153|NCT00036790|small intestine lymphoma|small intestine lymphoma
5416154|NCT00036790|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5416155|NCT00036790|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5416156|NCT00036790|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5437911|NCT00000859|Viral Load|viral load
5416157|NCT00036790|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5416158|NCT00036790|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
5416159|NCT00036790|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
5416160|NCT00036790|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
5416161|NCT00036790|refractory hairy cell leukemia|refractory hairy cell leukemia
5416162|NCT00036790|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5416163|NCT00036790|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
5416164|NCT00036790|acute undifferentiated leukemia|acute undifferentiated leukemia
5416165|NCT00036790|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5416166|NCT00036790|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5416167|NCT00036790|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5416168|NCT00036790|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5416169|NCT00036790|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5416170|NCT00036790|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5416171|NCT00036790|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5416172|NCT00036790|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5416173|NCT00036790|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5416174|NCT00036790|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5416175|NCT00036790|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5416176|NCT00036790|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5416177|NCT00036790|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5416178|NCT00036790|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5416179|NCT00036790|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5416180|NCT00036790|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5416181|NCT00036790|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5416182|NCT00036790|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5416183|NCT00036790|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5416184|NCT00036790|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5416185|NCT00036790|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5416186|NCT00036790|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5416187|NCT00036790|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5416188|NCT00036790|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5416189|NCT00036790|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5416190|NCT00036790|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5416191|NCT00036790|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5416192|NCT00036790|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
5416193|NCT00036790|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
5416194|NCT00036790|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
5416195|NCT00036790|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5416196|NCT00036790|prolymphocytic leukemia|prolymphocytic leukemia
5416197|NCT00036790|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5416198|NCT00036790|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5416199|NCT00036790|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5416200|NCT00036790|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
5416201|NCT00036790|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5416202|NCT00036790|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
5416203|NCT00036790|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
5416204|NCT00036790|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5416205|NCT00036790|chronic eosinophilic leukemia|chronic eosinophilic leukemia
5416206|NCT00036790|chronic neutrophilic leukemia|chronic neutrophilic leukemia
5416207|NCT00036790|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5416208|NCT00036790|recurrent small cell lung cancer|recurrent small cell lung cancer
5416209|NCT00036790|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5416210|NCT00036790|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5416211|NCT00036790|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5416212|NCT00036790|extensive stage small cell lung cancer|extensive stage small cell lung cancer
5416213|NCT00036790|limited stage small cell lung cancer|limited stage small cell lung cancer
5416214|NCT00036790|recurrent breast cancer|recurrent breast cancer
5416215|NCT00036790|stage IIIA breast cancer|stage iiia breast cancer
5416216|NCT00036790|stage IIIB breast cancer|stage iiib breast cancer
5416217|NCT00036790|stage IIIC breast cancer|stage iiic breast cancer
5416222|NCT00036790|recurrent prostate cancer|recurrent prostate cancer
5416223|NCT00036790|stage III prostate cancer|stage iii prostate cancer
5416224|NCT00036790|stage IV prostate cancer|stage iv prostate cancer
5416225|NCT00036790|recurrent lip and oral cavity cancer|recurrent lip and oral cavity cancer
5416226|NCT00036790|stage III lip and oral cavity cancer|stage iii lip and oral cavity cancer
5416227|NCT00036790|stage IV lip and oral cavity cancer|stage iv lip and oral cavity cancer
5416228|NCT00036790|recurrent paranasal sinus and nasal cavity cancer|recurrent paranasal sinus and nasal cavity cancer
5416229|NCT00036790|stage III paranasal sinus and nasal cavity cancer|stage iii paranasal sinus and nasal cavity cancer
5416230|NCT00036790|stage IV paranasal sinus and nasal cavity cancer|stage iv paranasal sinus and nasal cavity cancer
5416231|NCT00036790|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
5416232|NCT00036790|recurrent hypopharyngeal cancer|recurrent hypopharyngeal cancer
5416233|NCT00036790|stage III hypopharyngeal cancer|stage iii hypopharyngeal cancer
5416234|NCT00036790|stage IV hypopharyngeal cancer|stage iv hypopharyngeal cancer
5416235|NCT00036790|recurrent laryngeal cancer|recurrent laryngeal cancer
5416236|NCT00036790|stage III laryngeal cancer|stage iii laryngeal cancer
5416237|NCT00036790|stage IV laryngeal cancer|stage iv laryngeal cancer
5416238|NCT00036790|recurrent oropharyngeal cancer|recurrent oropharyngeal cancer
5416239|NCT00036790|stage III oropharyngeal cancer|stage iii oropharyngeal cancer
5416240|NCT00036790|stage IV oropharyngeal cancer|stage iv oropharyngeal cancer
5416241|NCT00036790|recurrent nasopharyngeal cancer|recurrent nasopharyngeal cancer
5416242|NCT00036790|stage III nasopharyngeal cancer|stage iii nasopharyngeal cancer
5416243|NCT00036790|stage IV nasopharyngeal cancer|stage iv nasopharyngeal cancer
5416244|NCT00036790|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
5416245|NCT00036790|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
5416246|NCT00036790|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5416247|NCT00036790|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5416248|NCT00036790|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5416249|NCT00036790|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5416250|NCT00036790|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5416251|NCT00036790|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5416252|NCT00036790|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5416253|NCT00036790|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5416254|NCT00036790|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5416255|NCT00036790|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5416256|NCT00036790|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5416257|NCT00036790|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5416258|NCT00036790|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5416259|NCT00036790|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5416260|NCT00036712|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5416261|NCT00036712|refractory multiple myeloma|refractory multiple myeloma
5416262|NCT00036712|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
5416263|NCT00036712|disseminated neuroblastoma|disseminated neuroblastoma
5416264|NCT00036712|recurrent neuroblastoma|recurrent neuroblastoma
5416265|NCT00036712|recurrent Wilms tumor and other childhood kidney tumors|recurrent wilms tumor and other childhood kidney tumors
5416266|NCT00036712|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
5416267|NCT00036712|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5416268|NCT00036712|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5416269|NCT00036712|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5416270|NCT00036712|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5416271|NCT00036712|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5416272|NCT00036712|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5416273|NCT00036712|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5416274|NCT00036712|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5416275|NCT00036712|primary myelofibrosis|primary myelofibrosis
5416276|NCT00036712|childhood acute promyelocytic leukemia (M3)|childhood acute promyelocytic leukemia (m3)
5416277|NCT00036712|refractory hairy cell leukemia|refractory hairy cell leukemia
5416278|NCT00036712|oral complications|oral complications
5416279|NCT00036712|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
5416280|NCT00036712|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5416281|NCT00036712|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5416282|NCT00036712|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5416283|NCT00036712|pain|pain
5416284|NCT00036712|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
5416285|NCT00036712|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
5416286|NCT00036712|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
5416287|NCT00036712|childhood malignant ovarian germ cell tumor|childhood malignant ovarian germ cell tumor
5416288|NCT00036712|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
5416289|NCT00036712|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
5416290|NCT00036712|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
5416291|NCT00036712|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
5416292|NCT00036686|stage I breast cancer|stage i breast cancer
5416293|NCT00036686|stage II breast cancer|stage ii breast cancer
5416294|NCT00036686|stage IIIA breast cancer|stage iiia breast cancer
5416295|NCT00036686|stage IIIB breast cancer|stage iiib breast cancer
5416296|NCT00036686|stage IIIC breast cancer|stage iiic breast cancer
5416297|NCT00036686|recurrent breast cancer|recurrent breast cancer
5416298|NCT00036686|stage IV breast cancer|stage iv breast cancer
5416299|NCT00033748|stage IV colon cancer|stage iv colon cancer
5416300|NCT00033748|stage IV rectal cancer|stage iv rectal cancer
5416301|NCT00033748|recurrent colon cancer|recurrent colon cancer
5416302|NCT00033748|recurrent rectal cancer|recurrent rectal cancer
5416303|NCT00033748|liver metastases|liver metastases
5416304|NCT00033709|adult leiomyosarcoma|adult leiomyosarcoma
5416305|NCT00033709|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
5416306|NCT00033709|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
5416307|NCT00033709|stage III uterine sarcoma|stage iii uterine sarcoma
5416308|NCT00033709|stage IV uterine sarcoma|stage iv uterine sarcoma
5416309|NCT00033709|recurrent uterine sarcoma|recurrent uterine sarcoma
5416310|NCT00033709|uterine leiomyosarcoma|uterine leiomyosarcoma
5416311|NCT00033709|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
5416312|NCT00033696|limited stage small cell lung cancer|limited stage small cell lung cancer
5416313|NCT00033683|stage I breast cancer|stage i breast cancer
5416314|NCT00033683|stage II breast cancer|stage ii breast cancer
5416315|NCT00033657|stage I gastric cancer|stage i gastric cancer
5416316|NCT00033657|stage II gastric cancer|stage ii gastric cancer
5416317|NCT00033657|stage III gastric cancer|stage iii gastric cancer
5416318|NCT00033657|stage IV gastric cancer|stage iv gastric cancer
5416319|NCT00033657|stage I esophageal cancer|stage i esophageal cancer
5416320|NCT00033657|stage II esophageal cancer|stage ii esophageal cancer
5416321|NCT00033657|stage III esophageal cancer|stage iii esophageal cancer
5416322|NCT00033657|stage IV esophageal cancer|stage iv esophageal cancer
5416323|NCT00033657|adenocarcinoma of the stomach|adenocarcinoma of the stomach
5416324|NCT00033657|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
5416325|NCT00033644|stage IV uterine sarcoma|stage iv uterine sarcoma
5416326|NCT00033644|recurrent uterine sarcoma|recurrent uterine sarcoma
5416327|NCT00033644|uterine leiomyosarcoma|uterine leiomyosarcoma
5416328|NCT00033631|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5416329|NCT00033631|stage IIB prostate cancer|stage iib prostate cancer
5416330|NCT00033631|stage IIA prostate cancer|stage iia prostate cancer
5416331|NCT00033566|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5416332|NCT00033553|squamous cell lung cancer|squamous cell lung cancer
5416333|NCT00033553|large cell lung cancer|large cell lung cancer
5416334|NCT00033553|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5416335|NCT00033553|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5416336|NCT00033553|adenocarcinoma of the lung|adenocarcinoma of the lung
5416337|NCT00033553|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
5416338|NCT00033540|unresectable gallbladder cancer|unresectable gallbladder cancer
5416339|NCT00033540|recurrent gallbladder cancer|recurrent gallbladder cancer
5416340|NCT00033540|unresectable extrahepatic bile duct cancer|unresectable extrahepatic bile duct cancer
5416341|NCT00033540|recurrent extrahepatic bile duct cancer|recurrent extrahepatic bile duct cancer
5416342|NCT00033540|adenocarcinoma of the gallbladder|adenocarcinoma of the gallbladder
5416343|NCT00033540|adenocarcinoma with squamous metaplasia of the gallbladder|adenocarcinoma with squamous metaplasia of the gallbladder
5416344|NCT00033540|squamous cell carcinoma of the gallbladder|squamous cell carcinoma of the gallbladder
5416345|NCT00033540|adenocarcinoma of the extrahepatic bile duct|adenocarcinoma of the extrahepatic bile duct
5416346|NCT00033540|cholangiocarcinoma of the gallbladder|cholangiocarcinoma of the gallbladder
5416347|NCT00033540|cholangiocarcinoma of the extrahepatic bile duct|cholangiocarcinoma of the extrahepatic bile duct
5416348|NCT00033514|stage IV breast cancer|stage iv breast cancer
5416349|NCT00033514|recurrent breast cancer|recurrent breast cancer
5416350|NCT00033488|ovarian epithelial cancer|ovarian epithelial cancer
5416351|NCT00033475|post-transplant lymphoproliferative disorder|post-transplant lymphoproliferative disorder
5416352|NCT00033436|stage I bladder cancer|stage i bladder cancer
5416353|NCT00033436|stage II bladder cancer|stage ii bladder cancer
5416354|NCT00033436|stage III bladder cancer|stage iii bladder cancer
5416355|NCT00033436|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
5416356|NCT00033423|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5416357|NCT00033423|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5416358|NCT00033423|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5416359|NCT00033423|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5416360|NCT00033423|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5416361|NCT00033423|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5416362|NCT00033423|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5416363|NCT00033423|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5416364|NCT00033410|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
5416365|NCT00033410|squamous cell lung cancer|squamous cell lung cancer
5416366|NCT00033410|large cell lung cancer|large cell lung cancer
5416445|NCT00032045|recurrent melanoma|recurrent melanoma
5416367|NCT00033410|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5416368|NCT00033410|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5416369|NCT00033410|adenocarcinoma of the lung|adenocarcinoma of the lung
5416370|NCT00033397|stage II breast cancer|stage ii breast cancer
5416371|NCT00033397|stage IV breast cancer|stage iv breast cancer
5416372|NCT00033397|stage IIIA breast cancer|stage iiia breast cancer
5416373|NCT00033397|stage IIIB breast cancer|stage iiib breast cancer
5416374|NCT00033397|stage IIIC breast cancer|stage iiic breast cancer
5416375|NCT00033397|inflammatory breast cancer|inflammatory breast cancer
5416376|NCT00033345|breast cancer|breast cancer
5416377|NCT00033332|stage I multiple myeloma|stage i multiple myeloma
5416378|NCT00033332|stage II multiple myeloma|stage ii multiple myeloma
5416379|NCT00033332|stage III multiple myeloma|stage iii multiple myeloma
5416380|NCT00033280|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
5416381|NCT00033280|adult mixed glioma|adult mixed glioma
5416382|NCT00033241|stage II pancreatic cancer|stage ii pancreatic cancer
5416383|NCT00033241|stage III pancreatic cancer|stage iii pancreatic cancer
5416384|NCT00033241|recurrent pancreatic cancer|recurrent pancreatic cancer
5416385|NCT00033241|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5416386|NCT00033241|stage IV pancreatic cancer|stage iv pancreatic cancer
5416387|NCT00033228|stage IV melanoma|stage iv melanoma
5416388|NCT00033228|recurrent melanoma|recurrent melanoma
5416389|NCT00032175|stage III pancreatic cancer|stage iii pancreatic cancer
5416390|NCT00032175|duct cell adenocarcinoma of the pancreas|duct cell adenocarcinoma of the pancreas
5416391|NCT00032175|stage IV pancreatic cancer|stage iv pancreatic cancer
5416392|NCT00032162|stage III cervical cancer|stage iii cervical cancer
5416393|NCT00032162|recurrent cervical cancer|recurrent cervical cancer
5416394|NCT00032162|stage IB cervical cancer|stage ib cervical cancer
5416395|NCT00032162|stage IIB cervical cancer|stage iib cervical cancer
5416396|NCT00032162|stage IVB cervical cancer|stage ivb cervical cancer
5416397|NCT00032162|stage IA cervical cancer|stage ia cervical cancer
5416398|NCT00032162|stage IIA cervical cancer|stage iia cervical cancer
5416399|NCT00032162|stage IVA cervical cancer|stage iva cervical cancer
5416400|NCT00032162|stage I endometrial carcinoma|stage i endometrial carcinoma
5416401|NCT00032162|stage II endometrial carcinoma|stage ii endometrial carcinoma
5416402|NCT00032162|stage III endometrial carcinoma|stage iii endometrial carcinoma
5416403|NCT00032162|stage IV endometrial carcinoma|stage iv endometrial carcinoma
5416404|NCT00032162|recurrent endometrial carcinoma|recurrent endometrial carcinoma
5416405|NCT00032162|fallopian tube cancer|fallopian tube cancer
5416406|NCT00032162|stage I uterine sarcoma|stage i uterine sarcoma
5416407|NCT00032162|stage II uterine sarcoma|stage ii uterine sarcoma
5416408|NCT00032162|stage III uterine sarcoma|stage iii uterine sarcoma
5416409|NCT00032162|stage IV uterine sarcoma|stage iv uterine sarcoma
5416410|NCT00032162|recurrent uterine sarcoma|recurrent uterine sarcoma
5416411|NCT00032162|ovarian sarcoma|ovarian sarcoma
5416412|NCT00032162|ovarian carcinosarcoma|ovarian carcinosarcoma
5416413|NCT00032149|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
5416414|NCT00032149|AIDS-related primary CNS lymphoma|aids-related primary cns lymphoma
5416415|NCT00032149|AIDS-related diffuse large cell lymphoma|aids-related diffuse large cell lymphoma
5416416|NCT00032149|AIDS-related immunoblastic large cell lymphoma|aids-related immunoblastic large cell lymphoma
5416417|NCT00032149|AIDS-related small noncleaved cell lymphoma|aids-related small noncleaved cell lymphoma
5416418|NCT00032149|AIDS-related diffuse mixed cell lymphoma|aids-related diffuse mixed cell lymphoma
5416419|NCT00032149|AIDS-related diffuse small cleaved cell lymphoma|aids-related diffuse small cleaved cell lymphoma
5416420|NCT00032149|AIDS-related lymphoblastic lymphoma|aids-related lymphoblastic lymphoma
5416421|NCT00032136|stage I breast cancer|stage i breast cancer
5416422|NCT00032136|stage II breast cancer|stage ii breast cancer
5416423|NCT00032123|stage IV gastric cancer|stage iv gastric cancer
5416424|NCT00032123|stage IV esophageal cancer|stage iv esophageal cancer
5416425|NCT00032123|adenocarcinoma of the stomach|adenocarcinoma of the stomach
5416426|NCT00032123|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
5416427|NCT00032123|recurrent esophageal cancer|recurrent esophageal cancer
5416428|NCT00032123|recurrent gastric cancer|recurrent gastric cancer
5416429|NCT00032097|adult glioblastoma|adult glioblastoma
5416430|NCT00032097|adult giant cell glioblastoma|adult giant cell glioblastoma
5416431|NCT00032097|adult gliosarcoma|adult gliosarcoma
5416432|NCT00032084|non-small cell lung cancer|non-small cell lung cancer
5416433|NCT00032084|stage I non-small cell lung cancer|stage i non-small cell lung cancer
5416434|NCT00032084|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
5416435|NCT00032058|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5416436|NCT00032058|stage I prostate cancer|stage i prostate cancer
5416437|NCT00032058|stage IIB prostate cancer|stage iib prostate cancer
5416438|NCT00032058|stage IIA prostate cancer|stage iia prostate cancer
5416439|NCT00032045|iris melanoma|iris melanoma
5416440|NCT00032045|ciliary body and choroid melanoma, small size|ciliary body and choroid melanoma, small size
5416441|NCT00032045|ciliary body and choroid melanoma, medium/large size|ciliary body and choroid melanoma, medium/large size
5416442|NCT00032045|extraocular extension melanoma|extraocular extension melanoma
5416443|NCT00032045|recurrent intraocular melanoma|recurrent intraocular melanoma
5416444|NCT00032045|stage IV melanoma|stage iv melanoma
5416446|NCT00032032|stage I non-small cell lung cancer|stage i non-small cell lung cancer
5416447|NCT00032032|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
5416448|NCT00032032|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5416449|NCT00032032|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5416450|NCT00032019|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5416451|NCT00032019|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5416452|NCT00032019|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5416453|NCT00032019|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5416454|NCT00032019|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
5416455|NCT00032019|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
5416456|NCT00032019|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
5416457|NCT00032019|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5416458|NCT00032006|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5416459|NCT00032006|stage I prostate cancer|stage i prostate cancer
5416460|NCT00032006|stage IIB prostate cancer|stage iib prostate cancer
5416461|NCT00032006|stage IIA prostate cancer|stage iia prostate cancer
5416462|NCT00032006|recurrent prostate cancer|recurrent prostate cancer
5416463|NCT00031980|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
5416464|NCT00031980|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
5416465|NCT00031980|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5416466|NCT00031980|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5416467|NCT00031980|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
5416468|NCT00031980|anemia|anemia
5416469|NCT00031980|neutropenia|neutropenia
5416470|NCT00031980|thrombocytopenia|thrombocytopenia
5416471|NCT00031967|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5416472|NCT00031967|tumors metastatic to brain|tumors metastatic to brain
5416473|NCT00031967|radiation toxicity|radiation toxicity
5416474|NCT00031941|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5416475|NCT00031941|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5416476|NCT00031941|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
5416477|NCT00031941|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5416478|NCT00031941|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5416479|NCT00031941|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5416480|NCT00031941|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5416481|NCT00031941|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5416482|NCT00031941|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5416483|NCT00031941|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5416484|NCT00031941|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5416485|NCT00031941|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5416486|NCT00031941|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5416487|NCT00031941|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5416488|NCT00031941|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5416489|NCT00031941|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5416490|NCT00031941|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5416491|NCT00031941|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5416492|NCT00031941|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5416493|NCT00031941|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5416494|NCT00031941|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5416495|NCT00031941|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5416496|NCT00031941|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5416497|NCT00031941|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
5416498|NCT00031941|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
5416499|NCT00031941|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5416500|NCT00031941|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5416501|NCT00031941|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
5416502|NCT00031941|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5416503|NCT00031941|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5416504|NCT00031941|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
5416505|NCT00031941|small intestine lymphoma|small intestine lymphoma
5416506|NCT00031941|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5416507|NCT00031941|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5416508|NCT00031941|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5416509|NCT00031941|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5416510|NCT00031941|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5437912|NCT00000858|HIV-1|hiv-1
5416511|NCT00031941|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5416512|NCT00031941|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5416513|NCT00031928|leptomeningeal metastases|leptomeningeal metastases
5416514|NCT00031915|metastatic osteosarcoma|metastatic osteosarcoma
5416515|NCT00031915|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
5416516|NCT00031915|recurrent osteosarcoma|recurrent osteosarcoma
5416517|NCT00031915|embryonal childhood rhabdomyosarcoma|embryonal childhood rhabdomyosarcoma
5416518|NCT00031915|alveolar childhood rhabdomyosarcoma|alveolar childhood rhabdomyosarcoma
5416519|NCT00031915|pleomorphic childhood rhabdomyosarcoma|pleomorphic childhood rhabdomyosarcoma
5416520|NCT00031915|metastatic childhood soft tissue sarcoma|metastatic childhood soft tissue sarcoma
5416521|NCT00031915|recurrent childhood soft tissue sarcoma|recurrent childhood soft tissue sarcoma
5416522|NCT00031915|childhood fibrosarcoma|childhood fibrosarcoma
5416523|NCT00031915|childhood synovial sarcoma|childhood synovial sarcoma
5416524|NCT00031915|childhood liposarcoma|childhood liposarcoma
5416525|NCT00031915|childhood alveolar soft-part sarcoma|childhood alveolar soft-part sarcoma
5416526|NCT00031915|childhood neurofibrosarcoma|childhood neurofibrosarcoma
5416527|NCT00031915|childhood angiosarcoma|childhood angiosarcoma
5416528|NCT00031915|childhood malignant fibrous histiocytoma of bone|childhood malignant fibrous histiocytoma of bone
5416529|NCT00031915|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
5416530|NCT00031915|metastatic Ewing sarcoma/peripheral primitive neuroectodermal tumor|metastatic ewing sarcoma/peripheral primitive neuroectodermal tumor
5416531|NCT00031915|recurrent Ewing sarcoma/peripheral primitive neuroectodermal tumor|recurrent ewing sarcoma/peripheral primitive neuroectodermal tumor
5416532|NCT00031915|fibrosarcomatous osteosarcoma|fibrosarcomatous osteosarcoma
5416533|NCT00031902|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
5416534|NCT00031902|AIDS-related diffuse large cell lymphoma|aids-related diffuse large cell lymphoma
5416535|NCT00031902|AIDS-related immunoblastic large cell lymphoma|aids-related immunoblastic large cell lymphoma
5416536|NCT00031902|AIDS-related small noncleaved cell lymphoma|aids-related small noncleaved cell lymphoma
5416537|NCT00031902|AIDS-related diffuse mixed cell lymphoma|aids-related diffuse mixed cell lymphoma
5416538|NCT00031902|AIDS-related diffuse small cleaved cell lymphoma|aids-related diffuse small cleaved cell lymphoma
5416539|NCT00031902|AIDS-related lymphoblastic lymphoma|aids-related lymphoblastic lymphoma
5416540|NCT00031876|stage IV breast cancer|stage iv breast cancer
5416541|NCT00031876|recurrent breast cancer|recurrent breast cancer
5416542|NCT00031863|stage II colon cancer|stage ii colon cancer
5416543|NCT00031863|stage III colon cancer|stage iii colon cancer
5416544|NCT00031863|stage II rectal cancer|stage ii rectal cancer
5416545|NCT00031863|stage III rectal cancer|stage iii rectal cancer
5416546|NCT00031850|breast cancer|breast cancer
5416547|NCT00031837|thromboembolism|thromboembolism
5416548|NCT00031837|stage III pancreatic cancer|stage iii pancreatic cancer
5416549|NCT00031837|recurrent pancreatic cancer|recurrent pancreatic cancer
5416550|NCT00031837|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
5416551|NCT00031837|stage IV pancreatic cancer|stage iv pancreatic cancer
5416552|NCT00031824|graft versus host disease|graft versus host disease
5416553|NCT00031798|fatigue|fatigue
5416554|NCT00031798|depression|depression
5416555|NCT00031798|quality of life|quality of life
5416556|NCT00031798|cognitive/functional effects|cognitive/functional effects
5416557|NCT00031798|recurrent adult brain tumor|recurrent adult brain tumor
5416558|NCT00031798|adult brain stem glioma|adult brain stem glioma
5416559|NCT00031798|adult glioblastoma|adult glioblastoma
5416560|NCT00031798|adult tumors metastatic to brain|adult tumors metastatic to brain
5416561|NCT00031798|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5416562|NCT00031798|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
5416563|NCT00031798|adult mixed glioma|adult mixed glioma
5416564|NCT00031798|adult meningioma|adult meningioma
5416565|NCT00031798|adult anaplastic ependymoma|adult anaplastic ependymoma
5416566|NCT00031798|adult myxopapillary ependymoma|adult myxopapillary ependymoma
5416567|NCT00031798|adult ependymoblastoma|adult ependymoblastoma
5416568|NCT00031798|adult pilocytic astrocytoma|adult pilocytic astrocytoma
5416569|NCT00031798|adult subependymoma|adult subependymoma
5416570|NCT00031798|adult grade III meningioma|adult grade iii meningioma
5416571|NCT00031798|adult giant cell glioblastoma|adult giant cell glioblastoma
5416572|NCT00031798|adult gliosarcoma|adult gliosarcoma
5416573|NCT00031798|adult grade II meningioma|adult grade ii meningioma
5416574|NCT00031772|recurrent breast cancer|recurrent breast cancer
5416575|NCT00031772|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
5416576|NCT00031759|cervical cancer|cervical cancer
5416577|NCT00031759|cervical intraepithelial neoplasia grade 1|cervical intraepithelial neoplasia grade 1
5416578|NCT00031759|cervical intraepithelial neoplasia grade 2|cervical intraepithelial neoplasia grade 2
5416579|NCT00031759|cervical intraepithelial neoplasia grade 3|cervical intraepithelial neoplasia grade 3
5416580|NCT00031746|prostate cancer|prostate cancer
5416581|NCT00031733|iris melanoma|iris melanoma
5416582|NCT00031733|ciliary body and choroid melanoma, small size|ciliary body and choroid melanoma, small size
5416583|NCT00031733|ciliary body and choroid melanoma, medium/large size|ciliary body and choroid melanoma, medium/large size
5416584|NCT00031733|extraocular extension melanoma|extraocular extension melanoma
5416585|NCT00031733|recurrent intraocular melanoma|recurrent intraocular melanoma
5437913|NCT00000858|Vagina|vagina
5416586|NCT00031733|stage II melanoma|stage ii melanoma
5416587|NCT00031733|stage III melanoma|stage iii melanoma
5416588|NCT00031733|stage IV melanoma|stage iv melanoma
5416589|NCT00031733|recurrent melanoma|recurrent melanoma
5416590|NCT00031720|lobular breast carcinoma in situ|lobular breast carcinoma in situ
5416591|NCT00031720|stage I breast cancer|stage i breast cancer
5416592|NCT00031720|stage II breast cancer|stage ii breast cancer
5416593|NCT00031720|stage IIIA breast cancer|stage iiia breast cancer
5416594|NCT00031720|recurrent breast cancer|recurrent breast cancer
5416595|NCT00031720|ductal breast carcinoma in situ|ductal breast carcinoma in situ
5416596|NCT00031720|hot flashes|hot flashes
5416597|NCT00031642|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5416598|NCT00031642|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5416599|NCT00031642|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5416600|NCT00031642|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5416601|NCT00031642|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5416602|NCT00031642|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5416603|NCT00031642|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5416604|NCT00031642|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5416605|NCT00031642|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5416606|NCT00031642|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5416607|NCT00031642|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5416608|NCT00031642|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5416609|NCT00031642|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5416610|NCT00031642|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5416611|NCT00031616|stage IV colon cancer|stage iv colon cancer
5416612|NCT00031616|stage IV rectal cancer|stage iv rectal cancer
5416613|NCT00031616|recurrent colon cancer|recurrent colon cancer
5416614|NCT00031616|recurrent rectal cancer|recurrent rectal cancer
5416615|NCT00031616|adenocarcinoma of the colon|adenocarcinoma of the colon
5416616|NCT00031616|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5416617|NCT00031590|untreated childhood medulloblastoma|untreated childhood medulloblastoma
5416618|NCT00031590|PNET|pnet
5416619|NCT00031590|craniospinal radiotherapy|craniospinal radiotherapy
5416620|NCT00031577|untreated childhood brain stem glioma|untreated childhood brain stem glioma
5416621|NCT00031564|stage IV|stage iv
5416622|NCT00031564|renal cell carcinoma|renal cell carcinoma
5416623|NCT00030914|hot flashes|hot flashes
5416624|NCT00030901|prostate cancer|prostate cancer
5416625|NCT00030901|high grade prostatic intraepithelial neoplasia|high grade prostatic intraepithelial neoplasia
5416626|NCT00030888|stage III renal cell cancer|stage iii renal cell cancer
5416627|NCT00030888|stage IV renal cell cancer|stage iv renal cell cancer
5416628|NCT00030888|recurrent renal cell cancer|recurrent renal cell cancer
5416629|NCT00030875|stage I mantle cell lymphoma|stage i mantle cell lymphoma
5416630|NCT00030875|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
5416631|NCT00030875|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5416632|NCT00030875|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5416633|NCT00030875|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5416634|NCT00030875|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5416635|NCT00030862|stage II esophageal cancer|stage ii esophageal cancer
5416636|NCT00030862|stage III esophageal cancer|stage iii esophageal cancer
5416637|NCT00030862|stage IV esophageal cancer|stage iv esophageal cancer
5416638|NCT00030862|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
5416639|NCT00030862|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
5416640|NCT00030849|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
5416641|NCT00030849|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
5416642|NCT00030849|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
5416643|NCT00030849|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
5416644|NCT00030849|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5416645|NCT00030823|stage I breast cancer|stage i breast cancer
5416646|NCT00030823|stage II breast cancer|stage ii breast cancer
5416647|NCT00030823|stage IV breast cancer|stage iv breast cancer
5416648|NCT00030823|stage IIIA breast cancer|stage iiia breast cancer
5416649|NCT00030823|recurrent breast cancer|recurrent breast cancer
5416650|NCT00030823|stage IIIB breast cancer|stage iiib breast cancer
5416651|NCT00030823|stage IIIC breast cancer|stage iiic breast cancer
5416652|NCT00030823|male breast cancer|male breast cancer
5416653|NCT00030810|squamous cell lung cancer|squamous cell lung cancer
5416654|NCT00030810|large cell lung cancer|large cell lung cancer
5416655|NCT00030810|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5416656|NCT00030810|adenosquamous cell lung cancer|adenosquamous cell lung cancer
5416657|NCT00030784|adult angiosarcoma|adult angiosarcoma
5416658|NCT00030784|adult fibrosarcoma|adult fibrosarcoma
5416659|NCT00030784|adult leiomyosarcoma|adult leiomyosarcoma
5416660|NCT00030784|adult liposarcoma|adult liposarcoma
5416661|NCT00030784|adult neurofibrosarcoma|adult neurofibrosarcoma
5438646|NCT00000727|Sulfadoxine|sulfadoxine
5416662|NCT00030784|adult synovial sarcoma|adult synovial sarcoma
5416663|NCT00030784|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
5416664|NCT00030784|adult alveolar soft-part sarcoma|adult alveolar soft-part sarcoma
5416665|NCT00030784|adult epithelioid sarcoma|adult epithelioid sarcoma
5416666|NCT00030784|adult malignant fibrous histiocytoma|adult malignant fibrous histiocytoma
5416667|NCT00030784|adult malignant hemangiopericytoma|adult malignant hemangiopericytoma
5416668|NCT00030784|adult malignant mesenchymoma|adult malignant mesenchymoma
5416669|NCT00030784|adult rhabdomyosarcoma|adult rhabdomyosarcoma
5416670|NCT00030784|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
5416671|NCT00030771|squamous cell lung cancer|squamous cell lung cancer
5416672|NCT00030771|large cell lung cancer|large cell lung cancer
5416673|NCT00030771|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5416674|NCT00030771|adenosquamous cell lung cancer|adenosquamous cell lung cancer
5416675|NCT00030758|neutropenia|neutropenia
5416676|NCT00030758|stage I breast cancer|stage i breast cancer
5416677|NCT00030758|stage II breast cancer|stage ii breast cancer
5416678|NCT00030745|stage IA malignant mesothelioma|stage ia malignant mesothelioma
5416679|NCT00030745|stage IB malignant mesothelioma|stage ib malignant mesothelioma
5416680|NCT00030745|stage II malignant mesothelioma|stage ii malignant mesothelioma
5416681|NCT00030745|stage III malignant mesothelioma|stage iii malignant mesothelioma
5416682|NCT00030732|stage III pancreatic cancer|stage iii pancreatic cancer
5416683|NCT00030732|recurrent pancreatic cancer|recurrent pancreatic cancer
5416684|NCT00030732|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
5416685|NCT00030732|stage IV pancreatic cancer|stage iv pancreatic cancer
5416686|NCT00030719|regional neuroblastoma|regional neuroblastoma
5416687|NCT00030719|disseminated neuroblastoma|disseminated neuroblastoma
5416688|NCT00030719|stage 4S neuroblastoma|stage 4s neuroblastoma
5416689|NCT00030719|localized unresectable neuroblastoma|localized unresectable neuroblastoma
5416690|NCT00030706|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5416691|NCT00030706|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5416692|NCT00030706|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5416693|NCT00030706|peritoneal cavity cancer|peritoneal cavity cancer
5416694|NCT00030680|desmoid tumor|desmoid tumor
5416695|NCT00030654|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5416696|NCT00030654|stage IIB prostate cancer|stage iib prostate cancer
5416697|NCT00030654|stage IIA prostate cancer|stage iia prostate cancer
5416698|NCT00030654|stage III prostate cancer|stage iii prostate cancer
5416699|NCT00030654|stage IV prostate cancer|stage iv prostate cancer
5416700|NCT00030654|recurrent prostate cancer|recurrent prostate cancer
5416701|NCT00030641|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5416702|NCT00030641|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5416703|NCT00030641|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5416704|NCT00030628|tumors metastatic to brain|tumors metastatic to brain
5416705|NCT00030589|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
5416706|NCT00030589|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
5416707|NCT00030589|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5416708|NCT00030589|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
5416709|NCT00030589|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
5416710|NCT00030589|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5416711|NCT00030576|recurrent metastatic squamous neck cancer occult primary|recurrent metastatic squamous neck cancer occult primary
5416712|NCT00030576|neck cancer with occult primary squamous carcinoma|neck cancer with occult primary squamous carcinoma
5416713|NCT00030576|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5416714|NCT00030576|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
5416715|NCT00030576|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5416716|NCT00030576|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
5416717|NCT00030576|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
5416718|NCT00030576|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
5416719|NCT00030576|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5416720|NCT00030576|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
5416721|NCT00030576|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5416722|NCT00030576|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
5416723|NCT00030576|squamous cell carcinoma of paranasal sinus and nasal cavity|squamous cell carcinoma of paranasal sinus and nasal cavity
5416724|NCT00030576|recurrent squamous cell carcinoma of sinus and nasal cavity|recurrent squamous cell carcinoma of sinus and nasal cavity
5416725|NCT00030563|liver metastases|liver metastases
5416726|NCT00030563|stage IV colon cancer|stage iv colon cancer
5416727|NCT00030563|stage IV rectal cancer|stage iv rectal cancer
5416728|NCT00030563|adenocarcinoma of the colon|adenocarcinoma of the colon
5416729|NCT00030563|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5416730|NCT00030563|recurrent colon cancer|recurrent colon cancer
5416731|NCT00030563|recurrent rectal cancer|recurrent rectal cancer
5416732|NCT00030550|refractory anemia|refractory anemia
5416733|NCT00030550|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
5416734|NCT00030550|refractory anemia with excess blasts|refractory anemia with excess blasts
5416735|NCT00030550|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5416736|NCT00030550|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5416737|NCT00030550|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5416738|NCT00030550|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
5416739|NCT00030550|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
5416740|NCT00030537|stage IV breast cancer|stage iv breast cancer
5416741|NCT00030537|recurrent breast cancer|recurrent breast cancer
5416742|NCT00030537|stage IIIB breast cancer|stage iiib breast cancer
5416743|NCT00030537|male breast cancer|male breast cancer
5416744|NCT00030511|localized resectable adult primary liver cancer|localized resectable adult primary liver cancer
5416745|NCT00030511|recurrent adult primary liver cancer|recurrent adult primary liver cancer
5416746|NCT00030511|localized extrahepatic bile duct cancer|localized extrahepatic bile duct cancer
5416747|NCT00030511|recurrent extrahepatic bile duct cancer|recurrent extrahepatic bile duct cancer
5416748|NCT00030485|stage IV endometrial carcinoma|stage iv endometrial carcinoma
5416749|NCT00030485|recurrent endometrial carcinoma|recurrent endometrial carcinoma
5416750|NCT00030485|endometrial adenocarcinoma|endometrial adenocarcinoma
5416751|NCT00030485|endometrial adenosquamous cell carcinoma|endometrial adenosquamous cell carcinoma
5416752|NCT00030472|recurrent cervical cancer|recurrent cervical cancer
5416753|NCT00030472|stage IVB cervical cancer|stage ivb cervical cancer
5416754|NCT00030472|cervical squamous cell carcinoma|cervical squamous cell carcinoma
5416755|NCT00030459|localized malignant mesothelioma|localized malignant mesothelioma
5416756|NCT00030459|advanced malignant mesothelioma|advanced malignant mesothelioma
5416757|NCT00030459|recurrent malignant mesothelioma|recurrent malignant mesothelioma
5416758|NCT00030433|extensive stage small cell lung cancer|extensive stage small cell lung cancer
5416759|NCT00030407|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5416760|NCT00030407|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5416761|NCT00030355|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5416762|NCT00030355|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5416763|NCT00030355|adult acute promyelocytic leukemia (M3)|adult acute promyelocytic leukemia (m3)
5416764|NCT00030355|childhood acute promyelocytic leukemia (M3)|childhood acute promyelocytic leukemia (m3)
5416765|NCT00030355|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5416766|NCT00030342|stage IV colon cancer|stage iv colon cancer
5416767|NCT00030342|stage IV rectal cancer|stage iv rectal cancer
5416768|NCT00030342|recurrent colon cancer|recurrent colon cancer
5416769|NCT00030342|recurrent rectal cancer|recurrent rectal cancer
5416770|NCT00030342|stage IV renal cell cancer|stage iv renal cell cancer
5416771|NCT00030342|recurrent renal cell cancer|recurrent renal cell cancer
5416772|NCT00030303|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5416773|NCT00030303|chronic myelogenous leukemia, BCR-ABL1 positive|chronic myelogenous leukemia, bcr-abl1 positive
5416774|NCT00030290|stage I prostate cancer|stage i prostate cancer
5416775|NCT00030290|stage IIB prostate cancer|stage iib prostate cancer
5416776|NCT00030290|stage IIA prostate cancer|stage iia prostate cancer
5416777|NCT00030277|stage I prostate cancer|stage i prostate cancer
5416778|NCT00030277|stage IIB prostate cancer|stage iib prostate cancer
5416779|NCT00030277|stage IIA prostate cancer|stage iia prostate cancer
5416780|NCT00030277|recurrent prostate cancer|recurrent prostate cancer
5416781|NCT00030264|plexiform neurofibroma|plexiform neurofibroma
5416782|NCT00030264|neurofibromatosis type 1|neurofibromatosis type 1
5416783|NCT00030108|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
5416784|NCT00030108|childhood craniopharyngioma|childhood craniopharyngioma
5416785|NCT00030108|recurrent neuroblastoma|recurrent neuroblastoma
5416786|NCT00030108|recurrent childhood liver cancer|recurrent childhood liver cancer
5416787|NCT00030108|recurrent Wilms tumor and other childhood kidney tumors|recurrent wilms tumor and other childhood kidney tumors
5416788|NCT00030108|childhood central nervous system germ cell tumor|childhood central nervous system germ cell tumor
5416789|NCT00030108|recurrent osteosarcoma|recurrent osteosarcoma
5416790|NCT00030108|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
5416791|NCT00030108|childhood germ cell tumor|childhood germ cell tumor
5416792|NCT00030108|recurrent childhood soft tissue sarcoma|recurrent childhood soft tissue sarcoma
5416793|NCT00030108|childhood oligodendroglioma|childhood oligodendroglioma
5416794|NCT00030108|childhood choroid plexus tumor|childhood choroid plexus tumor
5416795|NCT00030108|childhood grade I meningioma|childhood grade i meningioma
5416796|NCT00030108|childhood grade II meningioma|childhood grade ii meningioma
5416797|NCT00030108|childhood grade III meningioma|childhood grade iii meningioma
5416798|NCT00030108|recurrent childhood cerebellar astrocytoma|recurrent childhood cerebellar astrocytoma
5416799|NCT00030108|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
5416800|NCT00030108|recurrent childhood medulloblastoma|recurrent childhood medulloblastoma
5416801|NCT00030108|recurrent childhood visual pathway and hypothalamic glioma|recurrent childhood visual pathway and hypothalamic glioma
5416870|NCT00028795|childhood spinal cord neoplasm|childhood spinal cord neoplasm
5416802|NCT00030108|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
5416803|NCT00030108|recurrent Ewing sarcoma/peripheral primitive neuroectodermal tumor|recurrent ewing sarcoma/peripheral primitive neuroectodermal tumor
5416804|NCT00030108|recurrent childhood ependymoma|recurrent childhood ependymoma
5416805|NCT00030108|childhood teratoma|childhood teratoma
5416806|NCT00030108|childhood malignant testicular germ cell tumor|childhood malignant testicular germ cell tumor
5416807|NCT00030108|childhood malignant ovarian germ cell tumor|childhood malignant ovarian germ cell tumor
5416808|NCT00030108|childhood extragonadal germ cell tumor|childhood extragonadal germ cell tumor
5416809|NCT00030108|recurrent childhood malignant germ cell tumor|recurrent childhood malignant germ cell tumor
5416810|NCT00030108|B-cell childhood acute lymphoblastic leukemia|b-cell childhood acute lymphoblastic leukemia
5416811|NCT00030108|childhood acute basophilic leukemia|childhood acute basophilic leukemia
5416812|NCT00030108|childhood acute eosinophilic leukemia|childhood acute eosinophilic leukemia
5416813|NCT00030108|childhood acute lymphoblastic leukemia|childhood acute lymphoblastic leukemia
5416814|NCT00030108|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
5416815|NCT00030108|childhood acute promyelocytic leukemia (M3)|childhood acute promyelocytic leukemia (m3)
5416816|NCT00030108|L1 childhood acute lymphoblastic leukemia|l1 childhood acute lymphoblastic leukemia
5416817|NCT00030108|L2 childhood acute lymphoblastic leukemia|l2 childhood acute lymphoblastic leukemia
5416818|NCT00030108|L3 childhood acute lymphoblastic leukemia|l3 childhood acute lymphoblastic leukemia
5416819|NCT00030108|non-T, non-B, cALLa negative childhood acute lymphoblastic leukemia|non-t, non-b, calla negative childhood acute lymphoblastic leukemia
5416820|NCT00030108|non-T, non-B, cALLa positive childhood acute lymphoblastic leukemia|non-t, non-b, calla positive childhood acute lymphoblastic leukemia
5416821|NCT00030108|non-T, non-B, cALLa positive, pre-B childhood acute lymphoblastic leukemia|non-t, non-b, calla positive, pre-b childhood acute lymphoblastic leukemia
5416822|NCT00030108|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5416823|NCT00030108|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5416824|NCT00030108|TdT negative childhood acute lymphoblastic leukemia|tdt negative childhood acute lymphoblastic leukemia
5416825|NCT00030108|TdT positive childhood acute lymphoblastic leukemia|tdt positive childhood acute lymphoblastic leukemia
5416826|NCT00030108|chronic myelogenous leukemia, BCR-ABL1 positive|chronic myelogenous leukemia, bcr-abl1 positive
5416827|NCT00030108|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
5416828|NCT00030095|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5416829|NCT00030082|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
5416830|NCT00030082|advanced adult primary liver cancer|advanced adult primary liver cancer
5416831|NCT00030082|recurrent adult primary liver cancer|recurrent adult primary liver cancer
5416832|NCT00030082|liver metastases|liver metastases
5416833|NCT00029029|bone metastases|bone metastases
5416834|NCT00029029|pain|pain
5416835|NCT00028990|stage IV breast cancer|stage iv breast cancer
5416836|NCT00028990|recurrent breast cancer|recurrent breast cancer
5416837|NCT00028990|male breast cancer|male breast cancer
5416838|NCT00028977|stage IV breast cancer|stage iv breast cancer
5416839|NCT00028977|recurrent breast cancer|recurrent breast cancer
5416840|NCT00028964|stage I breast cancer|stage i breast cancer
5416841|NCT00028964|stage II breast cancer|stage ii breast cancer
5416842|NCT00028964|stage IIIA breast cancer|stage iiia breast cancer
5416843|NCT00028964|recurrent breast cancer|recurrent breast cancer
5416844|NCT00028964|drug/agent toxicity by tissue/organ|drug/agent toxicity by tissue/organ
5416845|NCT00028951|lymphedema|lymphedema
5416846|NCT00028951|perioperative/postoperative complications|perioperative/postoperative complications
5416847|NCT00028951|stage I vulvar cancer|stage i vulvar cancer
5416848|NCT00028951|stage II vulvar cancer|stage ii vulvar cancer
5416849|NCT00028951|stage III vulvar cancer|stage iii vulvar cancer
5416850|NCT00028951|stage IVB vulvar cancer|stage ivb vulvar cancer
5416851|NCT00028912|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5416852|NCT00028912|primary peritoneal cavity cancer|primary peritoneal cavity cancer
5416853|NCT00028912|fallopian tube cancer|fallopian tube cancer
5416854|NCT00028899|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5416855|NCT00028899|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5416856|NCT00028899|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5416857|NCT00028886|stage II multiple myeloma|stage ii multiple myeloma
5416858|NCT00028886|stage III multiple myeloma|stage iii multiple myeloma
5416859|NCT00028873|stage IV breast cancer|stage iv breast cancer
5416860|NCT00028873|recurrent breast cancer|recurrent breast cancer
5416861|NCT00028860|stage III bladder cancer|stage iii bladder cancer
5416862|NCT00028860|stage IV bladder cancer|stage iv bladder cancer
5416863|NCT00028860|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
5416864|NCT00028860|localized transitional cell cancer of the renal pelvis and ureter|localized transitional cell cancer of the renal pelvis and ureter
5416865|NCT00028860|regional transitional cell cancer of the renal pelvis and ureter|regional transitional cell cancer of the renal pelvis and ureter
5416866|NCT00028847|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5416867|NCT00028847|chronic myelogenous leukemia, BCR-ABL1 positive|chronic myelogenous leukemia, bcr-abl1 positive
5416868|NCT00028795|childhood brain stem glioma|childhood brain stem glioma
5416869|NCT00028795|childhood high-grade cerebral astrocytoma|childhood high-grade cerebral astrocytoma
5416871|NCT00028795|untreated childhood brain stem glioma|untreated childhood brain stem glioma
5416872|NCT00028769|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5416873|NCT00028769|stage IV prostate cancer|stage iv prostate cancer
5416874|NCT00028769|recurrent prostate cancer|recurrent prostate cancer
5416875|NCT00028743|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
5416876|NCT00028743|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5416877|NCT00028743|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5416878|NCT00028743|fallopian tube cancer|fallopian tube cancer
5416879|NCT00028743|peritoneal cavity cancer|peritoneal cavity cancer
5416880|NCT00028730|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
5416881|NCT00028730|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5416882|NCT00028730|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
5416883|NCT00028730|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
5416884|NCT00028730|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5416885|NCT00028730|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5416886|NCT00028730|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5416887|NCT00028730|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5416888|NCT00028730|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
5416889|NCT00028730|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
5416890|NCT00028730|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
5416891|NCT00028717|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
5416892|NCT00028717|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
5416893|NCT00028717|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5416894|NCT00028717|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5416895|NCT00028717|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5416896|NCT00028717|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5416897|NCT00028717|stage I mantle cell lymphoma|stage i mantle cell lymphoma
5416898|NCT00028717|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
5416899|NCT00028717|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
5416900|NCT00028717|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
5416901|NCT00028717|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5416902|NCT00028717|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5416903|NCT00028717|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5416904|NCT00028717|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5416905|NCT00028717|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5416906|NCT00028704|stage II breast cancer|stage ii breast cancer
5416907|NCT00028704|stage IIIA breast cancer|stage iiia breast cancer
5416908|NCT00028704|stage IIIB breast cancer|stage iiib breast cancer
5416909|NCT00028704|inflammatory breast cancer|inflammatory breast cancer
5416910|NCT00028691|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5416911|NCT00028691|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5416912|NCT00028691|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5416913|NCT00028691|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5416914|NCT00028691|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5416915|NCT00028691|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5416916|NCT00028665|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5416917|NCT00028665|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5416918|NCT00028665|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5416919|NCT00028665|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5416920|NCT00028665|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5416921|NCT00028665|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5416922|NCT00028665|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5416923|NCT00028665|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5416924|NCT00028665|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5416925|NCT00028665|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5416926|NCT00028665|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5416927|NCT00028665|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5416928|NCT00028665|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5416929|NCT00028665|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5416930|NCT00028665|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5416931|NCT00028665|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5416932|NCT00028665|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5416933|NCT00028665|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5416934|NCT00028665|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5417008|NCT00027937|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5416935|NCT00028665|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5416936|NCT00028665|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5416937|NCT00028665|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5416938|NCT00028665|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5416939|NCT00028665|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5416940|NCT00028665|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5416941|NCT00028665|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5416942|NCT00028652|skin metastases|skin metastases
5416943|NCT00028639|stage IV breast cancer|stage iv breast cancer
5416944|NCT00028639|recurrent breast cancer|recurrent breast cancer
5416945|NCT00028626|liver metastases|liver metastases
5416946|NCT00028626|adenocarcinoma of the colon|adenocarcinoma of the colon
5416947|NCT00028626|recurrent colon cancer|recurrent colon cancer
5416948|NCT00028626|stage IV colon cancer|stage iv colon cancer
5416949|NCT00028626|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5416950|NCT00028626|recurrent rectal cancer|recurrent rectal cancer
5416951|NCT00028626|stage IV rectal cancer|stage iv rectal cancer
5416952|NCT00028600|refractory multiple myeloma|refractory multiple myeloma
5416953|NCT00028600|stage I multiple myeloma|stage i multiple myeloma
5416954|NCT00028600|stage II multiple myeloma|stage ii multiple myeloma
5416955|NCT00028600|stage III multiple myeloma|stage iii multiple myeloma
5416956|NCT00028574|stage I prostate cancer|stage i prostate cancer
5416957|NCT00028574|stage IIB prostate cancer|stage iib prostate cancer
5416958|NCT00028574|stage IIA prostate cancer|stage iia prostate cancer
5416959|NCT00028574|stage III prostate cancer|stage iii prostate cancer
5416960|NCT00028574|stage IV prostate cancer|stage iv prostate cancer
5416961|NCT00028574|recurrent prostate cancer|recurrent prostate cancer
5416962|NCT00028574|hot flashes|hot flashes
5416963|NCT00028548|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5416964|NCT00028509|neurotoxicity|neurotoxicity
5416965|NCT00028509|long-term effects secondary to cancer therapy in children|long-term effects secondary to cancer therapy in children
5416966|NCT00028015|stage IV colon cancer|stage iv colon cancer
5416967|NCT00028015|stage IV rectal cancer|stage iv rectal cancer
5416968|NCT00028015|recurrent colon cancer|recurrent colon cancer
5416969|NCT00028015|recurrent rectal cancer|recurrent rectal cancer
5416970|NCT00027989|stage IV breast cancer|stage iv breast cancer
5416971|NCT00027976|actinic keratosis|actinic keratosis
5416972|NCT00027963|neurotoxicity|neurotoxicity
5416974|NCT00027937|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
5416975|NCT00027937|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
5416976|NCT00027937|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5416977|NCT00027937|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5416978|NCT00027937|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5416979|NCT00027937|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
5416980|NCT00027937|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5416981|NCT00027937|stage II childhood Hodgkin lymphoma|stage ii childhood hodgkin lymphoma
5416982|NCT00027937|stage I childhood Hodgkin lymphoma|stage i childhood hodgkin lymphoma
5416983|NCT00027937|stage III childhood Hodgkin lymphoma|stage iii childhood hodgkin lymphoma
5416984|NCT00027937|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
5416985|NCT00027937|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
5416986|NCT00027937|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
5416987|NCT00027937|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
5416988|NCT00027937|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
5416989|NCT00027937|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
5416990|NCT00027937|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
5416991|NCT00027937|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
5416992|NCT00027937|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
5416993|NCT00027937|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
5416994|NCT00027937|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
5416995|NCT00027937|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5416996|NCT00027937|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5416997|NCT00027937|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5416998|NCT00027937|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5416999|NCT00027937|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5417000|NCT00027937|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5417001|NCT00027937|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5417002|NCT00027937|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5417003|NCT00027937|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5417004|NCT00027937|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5417005|NCT00027937|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5417006|NCT00027937|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5417007|NCT00027937|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5417009|NCT00027937|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5417010|NCT00027937|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5417011|NCT00027937|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5417012|NCT00027937|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5417013|NCT00027937|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5417014|NCT00027937|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5417015|NCT00027937|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5417016|NCT00027937|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5417017|NCT00027937|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5417018|NCT00027937|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5417019|NCT00027937|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5417020|NCT00027937|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5417021|NCT00027937|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5417022|NCT00027937|stage I childhood small noncleaved cell lymphoma|stage i childhood small noncleaved cell lymphoma
5417023|NCT00027937|stage I childhood large cell lymphoma|stage i childhood large cell lymphoma
5417024|NCT00027937|stage II childhood small noncleaved cell lymphoma|stage ii childhood small noncleaved cell lymphoma
5417025|NCT00027937|stage II childhood large cell lymphoma|stage ii childhood large cell lymphoma
5417026|NCT00027937|stage III childhood small noncleaved cell lymphoma|stage iii childhood small noncleaved cell lymphoma
5417027|NCT00027937|stage III childhood large cell lymphoma|stage iii childhood large cell lymphoma
5417028|NCT00027937|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
5417029|NCT00027937|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
5417030|NCT00027937|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
5417031|NCT00027937|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
5417032|NCT00027937|stage I mantle cell lymphoma|stage i mantle cell lymphoma
5417033|NCT00027937|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
5417034|NCT00027937|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
5417035|NCT00027937|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
5417036|NCT00027937|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
5417037|NCT00027937|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
5417038|NCT00027937|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
5417039|NCT00027937|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
5417040|NCT00027937|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
5417041|NCT00027937|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
5417042|NCT00027937|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
5417043|NCT00027937|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5417044|NCT00027937|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5417045|NCT00027937|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5417046|NCT00027937|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
5417047|NCT00027937|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5417048|NCT00027937|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
5417049|NCT00027937|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
5417050|NCT00027937|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5417051|NCT00027937|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
5417052|NCT00027937|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
5417053|NCT00027937|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5417054|NCT00027937|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5417055|NCT00027937|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5417056|NCT00027937|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
5417057|NCT00027937|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
5417058|NCT00027937|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5417059|NCT00027937|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5417060|NCT00027937|stage I marginal zone lymphoma|stage i marginal zone lymphoma
5417061|NCT00027937|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
5417062|NCT00027937|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5417063|NCT00027937|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5417064|NCT00027937|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5417065|NCT00027937|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5417066|NCT00027937|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
5417067|NCT00027937|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
5417147|NCT00027560|refractory multiple myeloma|refractory multiple myeloma
5438917|NCT00000689|Cytarabine|cytarabine
5417068|NCT00027937|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5417069|NCT00027937|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5417070|NCT00027937|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5417071|NCT00027911|adult synovial sarcoma|adult synovial sarcoma
5417072|NCT00027911|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
5417073|NCT00027911|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
5417074|NCT00027911|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
5417075|NCT00027911|stage II adult soft tissue sarcoma|stage ii adult soft tissue sarcoma
5417076|NCT00027885|stage IV breast cancer|stage iv breast cancer
5417077|NCT00027885|stage IIIA breast cancer|stage iiia breast cancer
5417078|NCT00027885|stage IIIB breast cancer|stage iiib breast cancer
5417079|NCT00027885|stage IIIC breast cancer|stage iiic breast cancer
5417080|NCT00027885|male breast cancer|male breast cancer
5417081|NCT00027859|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5417082|NCT00027859|stage III prostate cancer|stage iii prostate cancer
5417083|NCT00027846|childhood supratentorial ependymoma|childhood supratentorial ependymoma
5417084|NCT00027846|newly diagnosed childhood ependymoma|newly diagnosed childhood ependymoma
5417085|NCT00027846|childhood infratentorial ependymoma|childhood infratentorial ependymoma
5417086|NCT00027833|stage IV colon cancer|stage iv colon cancer
5417087|NCT00027833|stage IV rectal cancer|stage iv rectal cancer
5417088|NCT00027833|adenocarcinoma of the colon|adenocarcinoma of the colon
5417089|NCT00027833|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5417090|NCT00027807|stage IV breast cancer|stage iv breast cancer
5417091|NCT00027807|recurrent breast cancer|recurrent breast cancer
5417092|NCT00027807|ductal breast carcinoma|ductal breast carcinoma
5417093|NCT00027794|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5417094|NCT00027794|stage III prostate cancer|stage iii prostate cancer
5417095|NCT00027781|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5417096|NCT00027781|recurrent prostate cancer|recurrent prostate cancer
5417097|NCT00027768|localized resectable adult primary liver cancer|localized resectable adult primary liver cancer
5417098|NCT00027768|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
5417099|NCT00027742|iris melanoma|iris melanoma
5417100|NCT00027742|extraocular extension melanoma|extraocular extension melanoma
5417101|NCT00027742|recurrent intraocular melanoma|recurrent intraocular melanoma
5417102|NCT00027742|stage III melanoma|stage iii melanoma
5417103|NCT00027742|stage IV melanoma|stage iv melanoma
5417104|NCT00027742|recurrent melanoma|recurrent melanoma
5417105|NCT00027729|recurrent colon cancer|recurrent colon cancer
5417106|NCT00027729|recurrent rectal cancer|recurrent rectal cancer
5417107|NCT00027716|metastatic osteosarcoma|metastatic osteosarcoma
5417108|NCT00027716|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
5417109|NCT00027716|recurrent osteosarcoma|recurrent osteosarcoma
5417110|NCT00027716|adult rhabdomyosarcoma|adult rhabdomyosarcoma
5417111|NCT00027716|metastatic Ewing sarcoma/peripheral primitive neuroectodermal tumor|metastatic ewing sarcoma/peripheral primitive neuroectodermal tumor
5417112|NCT00027716|recurrent Ewing sarcoma/peripheral primitive neuroectodermal tumor|recurrent ewing sarcoma/peripheral primitive neuroectodermal tumor
5417113|NCT00027716|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
5417114|NCT00027677|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5417115|NCT00027664|stage IV renal cell cancer|stage iv renal cell cancer
5417116|NCT00027638|metastatic gastrointestinal carcinoid tumor|metastatic gastrointestinal carcinoid tumor
5417117|NCT00027638|recurrent gastrointestinal carcinoid tumor|recurrent gastrointestinal carcinoid tumor
5417118|NCT00027638|gastrinoma|gastrinoma
5417119|NCT00027638|insulinoma|insulinoma
5417120|NCT00027638|recurrent islet cell carcinoma|recurrent islet cell carcinoma
5417121|NCT00027638|WDHA syndrome|wdha syndrome
5417122|NCT00027638|somatostatinoma|somatostatinoma
5417123|NCT00027638|pancreatic polypeptide tumor|pancreatic polypeptide tumor
5417124|NCT00027638|glucagonoma|glucagonoma
5417125|NCT00027638|pulmonary carcinoid tumor|pulmonary carcinoid tumor
5417126|NCT00027625|recurrent adult brain tumor|recurrent adult brain tumor
5417127|NCT00027625|adult glioblastoma|adult glioblastoma
5417128|NCT00027625|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5417129|NCT00027625|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
5417130|NCT00027625|adult mixed glioma|adult mixed glioma
5417131|NCT00027625|adult giant cell glioblastoma|adult giant cell glioblastoma
5417132|NCT00027625|adult gliosarcoma|adult gliosarcoma
5417133|NCT00027586|stage IV melanoma|stage iv melanoma
5417134|NCT00027586|recurrent melanoma|recurrent melanoma
5417135|NCT00027586|Imatinib Mesylate|imatinib mesylate
5417136|NCT00027586|Gleevec|gleevec
5417137|NCT00027586|protein tyrosine kinases|protein tyrosine kinases
5417138|NCT00027586|PTK|ptk
5417139|NCT00027586|Gleevec targets|gleevec targets
5417140|NCT00027586|metastatic melanoma|metastatic melanoma
5417141|NCT00027573|stage IV renal cell cancer|stage iv renal cell cancer
5417142|NCT00027573|recurrent renal cell cancer|recurrent renal cell cancer
5417143|NCT00027573|clear cell renal cell carcinoma|clear cell renal cell carcinoma
5417144|NCT00027573|papillary renal cell carcinoma|papillary renal cell carcinoma
5417145|NCT00027560|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5417146|NCT00027560|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5417148|NCT00027560|stage II multiple myeloma|stage ii multiple myeloma
5417149|NCT00027560|stage III multiple myeloma|stage iii multiple myeloma
5417150|NCT00027560|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
5417151|NCT00027560|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5417152|NCT00027560|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5417153|NCT00027560|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5417154|NCT00027560|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5417155|NCT00027560|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5417156|NCT00027560|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
5417157|NCT00027560|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5417158|NCT00027560|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5417159|NCT00027560|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5417160|NCT00027560|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5417161|NCT00027560|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5417162|NCT00027560|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5417163|NCT00027560|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5417164|NCT00027560|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5417165|NCT00027560|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5417166|NCT00027560|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5417167|NCT00027560|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
5417168|NCT00027560|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
5417169|NCT00027560|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5417170|NCT00027560|Waldenström macroglobulinemia|waldenström macroglobulinemia
5417171|NCT00027560|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
5417172|NCT00027560|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
5417173|NCT00027560|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
5417174|NCT00027560|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5417175|NCT00027560|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5417176|NCT00027560|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5417177|NCT00027560|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5417178|NCT00027560|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5417179|NCT00027560|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5417180|NCT00027560|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
5417181|NCT00027547|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5417182|NCT00027547|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
5417183|NCT00027534|recurrent colon cancer|recurrent colon cancer
5417184|NCT00027534|stage III colon cancer|stage iii colon cancer
5417185|NCT00027534|stage IV colon cancer|stage iv colon cancer
5417186|NCT00027534|recurrent breast cancer|recurrent breast cancer
5417187|NCT00027534|stage IIIA breast cancer|stage iiia breast cancer
5417188|NCT00027534|stage IIIB breast cancer|stage iiib breast cancer
5417189|NCT00027534|stage IIIC breast cancer|stage iiic breast cancer
5417190|NCT00027534|stage IV breast cancer|stage iv breast cancer
5417191|NCT00027534|recurrent gastric cancer|recurrent gastric cancer
5417192|NCT00027534|stage III gastric cancer|stage iii gastric cancer
5417193|NCT00027534|stage IV gastric cancer|stage iv gastric cancer
5417194|NCT00027534|recurrent pancreatic cancer|recurrent pancreatic cancer
5417195|NCT00027534|stage II pancreatic cancer|stage ii pancreatic cancer
5417196|NCT00027534|stage III pancreatic cancer|stage iii pancreatic cancer
5417197|NCT00027534|recurrent rectal cancer|recurrent rectal cancer
5417198|NCT00027534|stage III rectal cancer|stage iii rectal cancer
5417199|NCT00027534|stage IV rectal cancer|stage iv rectal cancer
5417200|NCT00027534|advanced adult primary liver cancer|advanced adult primary liver cancer
5417201|NCT00027534|recurrent adult primary liver cancer|recurrent adult primary liver cancer
5417202|NCT00027534|recurrent gallbladder cancer|recurrent gallbladder cancer
5417203|NCT00027534|unresectable gallbladder cancer|unresectable gallbladder cancer
5417204|NCT00027534|thyroid gland medullary carcinoma|thyroid gland medullary carcinoma
5417205|NCT00027534|recurrent salivary gland cancer|recurrent salivary gland cancer
5417206|NCT00027534|stage III salivary gland cancer|stage iii salivary gland cancer
5417207|NCT00027534|stage IV salivary gland cancer|stage iv salivary gland cancer
5417208|NCT00027534|Paget disease of the breast with intraductal carcinoma|paget disease of the breast with intraductal carcinoma
5417209|NCT00027534|Paget disease of the breast with invasive ductal carcinoma|paget disease of the breast with invasive ductal carcinoma
5417210|NCT00027534|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
5417211|NCT00027534|diffuse adenocarcinoma of the stomach|diffuse adenocarcinoma of the stomach
5417212|NCT00027534|intestinal adenocarcinoma of the stomach|intestinal adenocarcinoma of the stomach
5417213|NCT00027534|mixed adenocarcinoma of the stomach|mixed adenocarcinoma of the stomach
5417214|NCT00027534|adenocarcinoma of the colon|adenocarcinoma of the colon
5417215|NCT00027534|adenocarcinoma of the gallbladder|adenocarcinoma of the gallbladder
5417216|NCT00027534|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5417217|NCT00027534|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
5417218|NCT00027534|stage II malignant testicular germ cell tumor|stage ii malignant testicular germ cell tumor
5417219|NCT00027534|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
5417220|NCT00027534|male breast cancer|male breast cancer
5417221|NCT00027534|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
5417222|NCT00027534|cholangiocarcinoma of the gallbladder|cholangiocarcinoma of the gallbladder
5417223|NCT00027534|salivary gland adenocarcinoma|salivary gland adenocarcinoma
5417224|NCT00027534|ovarian endometrioid adenocarcinoma|ovarian endometrioid adenocarcinoma
5417225|NCT00027534|stage IV pancreatic cancer|stage iv pancreatic cancer
5417226|NCT00027495|colon cancer|colon cancer
5417227|NCT00026533|stage IV papillary thyroid cancer|stage iv papillary thyroid cancer
5417228|NCT00026533|stage IV follicular thyroid cancer|stage iv follicular thyroid cancer
5417229|NCT00026533|thyroid gland medullary carcinoma|thyroid gland medullary carcinoma
5417230|NCT00026533|recurrent thyroid cancer|recurrent thyroid cancer
5417231|NCT00026533|insular thyroid cancer|insular thyroid cancer
5417232|NCT00026494|tumors metastatic to brain|tumors metastatic to brain
5417233|NCT00026468|colon cancer|colon cancer
5417234|NCT00026468|rectal cancer|rectal cancer
5417235|NCT00026468|small intestine cancer|small intestine cancer
5417236|NCT00026442|stage IV breast cancer|stage iv breast cancer
5417237|NCT00026442|stage IIIA breast cancer|stage iiia breast cancer
5417238|NCT00026442|stage IIIB breast cancer|stage iiib breast cancer
5417239|NCT00026442|stage IIIC breast cancer|stage iiic breast cancer
5417240|NCT00026416|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
5417241|NCT00026416|localized osteosarcoma|localized osteosarcoma
5417242|NCT00026416|metastatic osteosarcoma|metastatic osteosarcoma
5417243|NCT00026416|stage II adult soft tissue sarcoma|stage ii adult soft tissue sarcoma
5417244|NCT00026416|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
5417245|NCT00026403|stage III pancreatic cancer|stage iii pancreatic cancer
5417246|NCT00026403|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
5417247|NCT00026403|stage IV pancreatic cancer|stage iv pancreatic cancer
5417248|NCT00026338|stage III pancreatic cancer|stage iii pancreatic cancer
5417249|NCT00026338|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
5417250|NCT00026338|stage IV pancreatic cancer|stage iv pancreatic cancer
5417251|NCT00026299|stage IV colon cancer|stage iv colon cancer
5417252|NCT00026299|stage IV rectal cancer|stage iv rectal cancer
5417253|NCT00026299|recurrent colon cancer|recurrent colon cancer
5417254|NCT00026299|recurrent rectal cancer|recurrent rectal cancer
5417255|NCT00026299|adenocarcinoma of the colon|adenocarcinoma of the colon
5417256|NCT00026299|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5417257|NCT00026247|bone metastases|bone metastases
5417258|NCT00026247|pain|pain
5417259|NCT00026247|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5417260|NCT00026195|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5417261|NCT00026156|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5417262|NCT00026156|squamous cell lung cancer|squamous cell lung cancer
5417263|NCT00026156|large cell lung cancer|large cell lung cancer
5417264|NCT00026156|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5417265|NCT00026156|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5417266|NCT00026156|adenocarcinoma of the lung|adenocarcinoma of the lung
5417267|NCT00026130|stage II pancreatic cancer|stage ii pancreatic cancer
5417268|NCT00026130|stage III pancreatic cancer|stage iii pancreatic cancer
5417269|NCT00026130|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
5417270|NCT00026117|stage IV colon cancer|stage iv colon cancer
5417271|NCT00026117|stage IV breast cancer|stage iv breast cancer
5417272|NCT00026117|recurrent breast cancer|recurrent breast cancer
5417273|NCT00026117|stage IV rectal cancer|stage iv rectal cancer
5417274|NCT00026117|recurrent colon cancer|recurrent colon cancer
5417275|NCT00026117|recurrent rectal cancer|recurrent rectal cancer
5417276|NCT00026117|male breast cancer|male breast cancer
5417277|NCT00026078|stage IV breast cancer|stage iv breast cancer
5417278|NCT00026078|recurrent breast cancer|recurrent breast cancer
5417279|NCT00025675|recurrent adult brain tumor|recurrent adult brain tumor
5417280|NCT00025675|adult meningioma|adult meningioma
5417281|NCT00025675|adult glioblastoma|adult glioblastoma
5417282|NCT00025675|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5417283|NCT00025675|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
5417284|NCT00025675|adult pilocytic astrocytoma|adult pilocytic astrocytoma
5417285|NCT00025675|adult subependymoma|adult subependymoma
5417286|NCT00025675|adult mixed glioma|adult mixed glioma
5417287|NCT00025675|adult meningeal hemangiopericytoma|adult meningeal hemangiopericytoma
5417288|NCT00025675|adult grade III meningioma|adult grade iii meningioma
5417289|NCT00025675|adult giant cell glioblastoma|adult giant cell glioblastoma
5417290|NCT00025675|adult gliosarcoma|adult gliosarcoma
5417291|NCT00025675|adult grade I meningioma|adult grade i meningioma
5417292|NCT00025675|adult grade II meningioma|adult grade ii meningioma
5417293|NCT00025662|Peripheral Blood Stem Cell|peripheral blood stem cell
5417294|NCT00025662|Melphalan|melphalan
5417295|NCT00025662|Fludarabine|fludarabine
5417296|NCT00025662|Donor Apheresis|donor apheresis
5417297|NCT00025662|Non-Myeloablative|non-myeloablative
5417298|NCT00025662|MDS|mds
5417299|NCT00025662|Chronic Myeloid Leukemia|chronic myeloid leukemia
5417300|NCT00025662|CML|cml
5417301|NCT00025662|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
5417302|NCT00025662|CLL|cll
5417303|NCT00025662|Lymphoma|lymphoma
5417304|NCT00025662|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
5417305|NCT00025662|Hodgkin's Disease|hodgkin's disease
5417306|NCT00025662|Mantle Cell Lymphoma|mantle cell lymphoma
5417307|NCT00025662|Acute Myelogenous Leukemia (AML)|acute myelogenous leukemia (aml)
5417308|NCT00025662|Chronic Myeloid Leukemia (CML)|chronic myeloid leukemia (cml)
5417309|NCT00025662|Chronic Lymphocytic Leukemia (CLL)|chronic lymphocytic leukemia (cll)
5417310|NCT00025662|Myelodysplasia (MDS)|myelodysplasia (mds)
5417311|NCT00025662|Acute Lymphoblastic Leukemia (ALL)|acute lymphoblastic leukemia (all)
5417312|NCT00025662|Bone Marrow Transplant|bone marrow transplant
5417313|NCT00025649|localized resectable neuroblastoma|localized resectable neuroblastoma
5417314|NCT00025649|regional neuroblastoma|regional neuroblastoma
5417315|NCT00025649|disseminated neuroblastoma|disseminated neuroblastoma
5417316|NCT00025649|stage 4S neuroblastoma|stage 4s neuroblastoma
5417317|NCT00025649|localized unresectable neuroblastoma|localized unresectable neuroblastoma
5417318|NCT00025636|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5417319|NCT00025623|disseminated neuroblastoma|disseminated neuroblastoma
5417320|NCT00025610|disseminated neuroblastoma|disseminated neuroblastoma
5417321|NCT00025610|stage 4S neuroblastoma|stage 4s neuroblastoma
5417322|NCT00025597|localized unresectable neuroblastoma|localized unresectable neuroblastoma
5417323|NCT00025558|childhood central nervous system germ cell tumor|childhood central nervous system germ cell tumor
5417324|NCT00025558|recurrent adult brain tumor|recurrent adult brain tumor
5417325|NCT00025558|adult medulloblastoma|adult medulloblastoma
5417326|NCT00025558|adult glioblastoma|adult glioblastoma
5417327|NCT00025558|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5417328|NCT00025558|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
5417329|NCT00025558|adult mixed glioma|adult mixed glioma
5417330|NCT00025558|adult central nervous system germ cell tumor|adult central nervous system germ cell tumor
5417331|NCT00025558|adult pineoblastoma|adult pineoblastoma
5417332|NCT00025558|recurrent childhood supratentorial primitive neuroectodermal tumor|recurrent childhood supratentorial primitive neuroectodermal tumor
5417333|NCT00025558|recurrent childhood medulloblastoma|recurrent childhood medulloblastoma
5417334|NCT00025558|recurrent childhood ependymoma|recurrent childhood ependymoma
5417335|NCT00025558|adult giant cell glioblastoma|adult giant cell glioblastoma
5417336|NCT00025558|adult gliosarcoma|adult gliosarcoma
5417337|NCT00025558|adult anaplastic ependymoma|adult anaplastic ependymoma
5417338|NCT00025558|adult supratentorial primitive neuroectodermal tumor (PNET)|adult supratentorial primitive neuroectodermal tumor (pnet)
5417339|NCT00025519|stage IV renal cell cancer|stage iv renal cell cancer
5417340|NCT00025519|recurrent renal cell cancer|recurrent renal cell cancer
5417341|NCT00025519|clear cell renal cell carcinoma|clear cell renal cell carcinoma
5417342|NCT00025493|stage IV breast cancer|stage iv breast cancer
5417343|NCT00025493|recurrent breast cancer|recurrent breast cancer
5417344|NCT00025480|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5417345|NCT00025480|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5417346|NCT00025454|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5417347|NCT00025441|chondrosarcoma|chondrosarcoma
5417348|NCT00025441|small intestine leiomyosarcoma|small intestine leiomyosarcoma
5417349|NCT00025441|fibrosarcomatous osteosarcoma|fibrosarcomatous osteosarcoma
5417350|NCT00025441|embryonal childhood rhabdomyosarcoma|embryonal childhood rhabdomyosarcoma
5417351|NCT00025441|alveolar childhood rhabdomyosarcoma|alveolar childhood rhabdomyosarcoma
5417352|NCT00025441|pleomorphic childhood rhabdomyosarcoma|pleomorphic childhood rhabdomyosarcoma
5417353|NCT00025441|mixed childhood rhabdomyosarcoma|mixed childhood rhabdomyosarcoma
5417354|NCT00025441|embryonal-botryoid childhood rhabdomyosarcoma|embryonal-botryoid childhood rhabdomyosarcoma
5417355|NCT00025441|metastatic childhood soft tissue sarcoma|metastatic childhood soft tissue sarcoma
5417356|NCT00025441|extraosseous Ewing sarcoma/peripheral primitive neuroectodermal tumor|extraosseous ewing sarcoma/peripheral primitive neuroectodermal tumor
5417357|NCT00025441|childhood fibrosarcoma|childhood fibrosarcoma
5417358|NCT00025441|childhood synovial sarcoma|childhood synovial sarcoma
5417359|NCT00025441|childhood malignant hemangiopericytoma|childhood malignant hemangiopericytoma
5417360|NCT00025441|childhood liposarcoma|childhood liposarcoma
5417361|NCT00025441|childhood alveolar soft-part sarcoma|childhood alveolar soft-part sarcoma
5417362|NCT00025441|childhood leiomyosarcoma|childhood leiomyosarcoma
5417363|NCT00025441|childhood angiosarcoma|childhood angiosarcoma
5417364|NCT00025441|childhood epithelioid sarcoma|childhood epithelioid sarcoma
5417365|NCT00025441|childhood malignant mesenchymoma|childhood malignant mesenchymoma
5417366|NCT00025441|stage IV uterine sarcoma|stage iv uterine sarcoma
5417367|NCT00025441|uterine leiomyosarcoma|uterine leiomyosarcoma
5417368|NCT00025441|ovarian sarcoma|ovarian sarcoma
5417369|NCT00025441|previously untreated childhood rhabdomyosarcoma|previously untreated childhood rhabdomyosarcoma
5417370|NCT00025441|childhood desmoplastic small round cell tumor|childhood desmoplastic small round cell tumor
5417371|NCT00025428|localized unresectable neuroblastoma|localized unresectable neuroblastoma
5417372|NCT00025402|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5417373|NCT00025402|chronic myelogenous leukemia, BCR-ABL1 positive|chronic myelogenous leukemia, bcr-abl1 positive
5417374|NCT00025402|Philadelphia chromosome negative chronic myelogenous leukemia|philadelphia chromosome negative chronic myelogenous leukemia
5417375|NCT00025402|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
5417376|NCT00025402|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
5417377|NCT00025389|stage I non-small cell lung cancer|stage i non-small cell lung cancer
5417378|NCT00025389|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
5417379|NCT00025389|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5417380|NCT00025324|childhood central nervous system germ cell tumor|childhood central nervous system germ cell tumor
5417381|NCT00025324|adult central nervous system germ cell tumor|adult central nervous system germ cell tumor
5417382|NCT00025311|leptomeningeal metastases|leptomeningeal metastases
5417383|NCT00025298|stage II nasopharyngeal cancer|stage ii nasopharyngeal cancer
5417384|NCT00025298|stage III nasopharyngeal cancer|stage iii nasopharyngeal cancer
5417385|NCT00025298|stage IV nasopharyngeal cancer|stage iv nasopharyngeal cancer
5417386|NCT00025298|oral complications|oral complications
5417387|NCT00025298|drug/agent toxicity by tissue/organ|drug/agent toxicity by tissue/organ
5417388|NCT00025298|radiation toxicity|radiation toxicity
5417389|NCT00025285|squamous cell lung cancer|squamous cell lung cancer
5417390|NCT00025285|large cell lung cancer|large cell lung cancer
5417391|NCT00025285|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5417392|NCT00025285|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5417393|NCT00025285|adenocarcinoma of the lung|adenocarcinoma of the lung
5417394|NCT00025285|adenosquamous cell lung cancer|adenosquamous cell lung cancer
5417395|NCT00025285|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
5417396|NCT00025272|extensive stage small cell lung cancer|extensive stage small cell lung cancer
5417397|NCT00025194|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5417398|NCT00025194|stage IV prostate cancer|stage iv prostate cancer
5417399|NCT00025194|recurrent prostate cancer|recurrent prostate cancer
5417400|NCT00025181|iris melanoma|iris melanoma
5417401|NCT00025181|ciliary body and choroid melanoma, small size|ciliary body and choroid melanoma, small size
5417402|NCT00025181|ciliary body and choroid melanoma, medium/large size|ciliary body and choroid melanoma, medium/large size
5417403|NCT00025181|extraocular extension melanoma|extraocular extension melanoma
5417404|NCT00025181|recurrent intraocular melanoma|recurrent intraocular melanoma
5417405|NCT00025181|stage III melanoma|stage iii melanoma
5417406|NCT00025181|stage IV melanoma|stage iv melanoma
5417407|NCT00025181|recurrent melanoma|recurrent melanoma
5417408|NCT00025168|stage III pancreatic cancer|stage iii pancreatic cancer
5417409|NCT00025142|stage IV colon cancer|stage iv colon cancer
5417410|NCT00025142|stage IV rectal cancer|stage iv rectal cancer
5417411|NCT00025142|recurrent colon cancer|recurrent colon cancer
5417412|NCT00025142|recurrent rectal cancer|recurrent rectal cancer
5417413|NCT00025142|adenocarcinoma of the colon|adenocarcinoma of the colon
5417414|NCT00025142|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5417415|NCT00025129|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5417416|NCT00025129|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5417417|NCT00025129|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
5417418|NCT00025129|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5417419|NCT00025129|small intestine lymphoma|small intestine lymphoma
5417420|NCT00025129|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5417421|NCT00025129|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5417422|NCT00025129|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5417423|NCT00025129|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5417424|NCT00025129|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5417425|NCT00025129|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5417426|NCT00025129|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5424945|NCT00002854|recurrent anal cancer|recurrent anal cancer
5417427|NCT00025129|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5417428|NCT00025129|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5417429|NCT00025129|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5417430|NCT00025129|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5417431|NCT00025129|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5417432|NCT00025129|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5417433|NCT00025129|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5417434|NCT00025129|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5417435|NCT00025129|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5417436|NCT00025129|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5417437|NCT00025129|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5417438|NCT00025129|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5417439|NCT00025129|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
5417440|NCT00025129|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
5439195|NCT00000639|Meningitis|meningitis
5417441|NCT00025129|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
5417442|NCT00025129|intraocular lymphoma|intraocular lymphoma
5417443|NCT00025129|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5417444|NCT00025129|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5417445|NCT00025129|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
5417446|NCT00025129|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5417447|NCT00025129|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
5417448|NCT00025129|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5417449|NCT00025129|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5417450|NCT00025129|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5417451|NCT00025129|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5417452|NCT00025129|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5417453|NCT00025129|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5417454|NCT00025129|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5417455|NCT00025129|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5417456|NCT00025103|recurrent Wilms tumor and other childhood kidney tumors|recurrent wilms tumor and other childhood kidney tumors
5417457|NCT00025103|clear cell sarcoma of the kidney|clear cell sarcoma of the kidney
5417458|NCT00025090|stage I anal cancer|stage i anal cancer
5417459|NCT00025090|stage II anal cancer|stage ii anal cancer
5417460|NCT00025090|stage IIIA anal cancer|stage iiia anal cancer
5417461|NCT00025090|stage IIIB anal cancer|stage iiib anal cancer
5417462|NCT00025090|squamous cell carcinoma of the anus|squamous cell carcinoma of the anus
5417463|NCT00025090|cloacogenic carcinoma of the anus|cloacogenic carcinoma of the anus
5417464|NCT00025090|basaloid carcinoma of the anus|basaloid carcinoma of the anus
5417465|NCT00025077|recurrent childhood supratentorial primitive neuroectodermal tumor|recurrent childhood supratentorial primitive neuroectodermal tumor
5417466|NCT00025077|recurrent childhood medulloblastoma|recurrent childhood medulloblastoma
5417467|NCT00025064|stage II childhood Hodgkin lymphoma|stage ii childhood hodgkin lymphoma
5417468|NCT00025064|stage I childhood Hodgkin lymphoma|stage i childhood hodgkin lymphoma
5417469|NCT00025064|stage III childhood Hodgkin lymphoma|stage iii childhood hodgkin lymphoma
5417470|NCT00025064|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
5417471|NCT00025064|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
5417472|NCT00025051|basal cell carcinoma of the skin|basal cell carcinoma of the skin
5417473|NCT00025051|squamous cell carcinoma of the skin|squamous cell carcinoma of the skin
5417474|NCT00025025|colon cancer|colon cancer
5417475|NCT00025025|rectal cancer|rectal cancer
5417476|NCT00024466|stage I multiple myeloma|stage i multiple myeloma
5417477|NCT00024466|stage II multiple myeloma|stage ii multiple myeloma
5417478|NCT00024466|stage III multiple myeloma|stage iii multiple myeloma
5417479|NCT00024453|infection|infection
5417480|NCT00024440|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5417481|NCT00024440|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
5417482|NCT00024427|drug/agent toxicity by tissue/organ|drug/agent toxicity by tissue/organ
5417483|NCT00024427|stage II pancreatic cancer|stage ii pancreatic cancer
5417484|NCT00024427|stage III pancreatic cancer|stage iii pancreatic cancer
5417485|NCT00024427|recurrent pancreatic cancer|recurrent pancreatic cancer
5417486|NCT00024427|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
5417487|NCT00024427|stage IV pancreatic cancer|stage iv pancreatic cancer
5417488|NCT00024414|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5417489|NCT00024414|stage IV prostate cancer|stage iv prostate cancer
5417490|NCT00024414|recurrent prostate cancer|recurrent prostate cancer
5417491|NCT00024375|recurrent pancreatic cancer|recurrent pancreatic cancer
5417492|NCT00024375|stage IV pancreatic cancer|stage iv pancreatic cancer
5417493|NCT00024349|stage II bladder cancer|stage ii bladder cancer
5417494|NCT00024349|stage III bladder cancer|stage iii bladder cancer
5417495|NCT00024349|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
5417496|NCT00024349|squamous cell carcinoma of the bladder|squamous cell carcinoma of the bladder
5417497|NCT00024349|adenocarcinoma of the bladder|adenocarcinoma of the bladder
5417498|NCT00024336|untreated childhood brain stem glioma|untreated childhood brain stem glioma
5417499|NCT00024297|thromboembolism|thromboembolism
5417500|NCT00024284|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
5417501|NCT00024271|localized malignant mesothelioma|localized malignant mesothelioma
5417502|NCT00024271|advanced malignant mesothelioma|advanced malignant mesothelioma
5417503|NCT00024271|recurrent malignant mesothelioma|recurrent malignant mesothelioma
5417504|NCT00024258|metastatic osteosarcoma|metastatic osteosarcoma
5417505|NCT00024258|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
5417506|NCT00024258|regional neuroblastoma|regional neuroblastoma
5417507|NCT00024258|disseminated neuroblastoma|disseminated neuroblastoma
5417508|NCT00024258|stage 4S neuroblastoma|stage 4s neuroblastoma
5417509|NCT00024258|recurrent neuroblastoma|recurrent neuroblastoma
5417510|NCT00024258|stage III childhood liver cancer|stage iii childhood liver cancer
5417511|NCT00024258|stage IV childhood liver cancer|stage iv childhood liver cancer
5417512|NCT00024258|recurrent childhood liver cancer|recurrent childhood liver cancer
5417513|NCT00024258|childhood hepatoblastoma|childhood hepatoblastoma
5417514|NCT00024258|stage III Wilms tumor|stage iii wilms tumor
5417515|NCT00024258|stage IV Wilms tumor|stage iv wilms tumor
5417516|NCT00024258|stage V Wilms tumor|stage v wilms tumor
5417517|NCT00024258|recurrent Wilms tumor and other childhood kidney tumors|recurrent wilms tumor and other childhood kidney tumors
5417518|NCT00024258|intraocular retinoblastoma|intraocular retinoblastoma
5417519|NCT00024258|extraocular retinoblastoma|extraocular retinoblastoma
5417520|NCT00024258|recurrent retinoblastoma|recurrent retinoblastoma
5417521|NCT00024258|recurrent osteosarcoma|recurrent osteosarcoma
5417522|NCT00024258|childhood germ cell tumor|childhood germ cell tumor
5417523|NCT00024258|metastatic childhood soft tissue sarcoma|metastatic childhood soft tissue sarcoma
5417524|NCT00024258|recurrent childhood soft tissue sarcoma|recurrent childhood soft tissue sarcoma
5417525|NCT00024258|localized unresectable neuroblastoma|localized unresectable neuroblastoma
5417526|NCT00024258|previously untreated childhood rhabdomyosarcoma|previously untreated childhood rhabdomyosarcoma
5425523|NCT00002546|stage I uterine sarcoma|stage i uterine sarcoma
5417527|NCT00024258|childhood desmoplastic small round cell tumor|childhood desmoplastic small round cell tumor
5417528|NCT00024258|untreated childhood medulloblastoma|untreated childhood medulloblastoma
5417529|NCT00024258|recurrent childhood medulloblastoma|recurrent childhood medulloblastoma
5417530|NCT00024258|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
5417531|NCT00024258|metastatic Ewing sarcoma/peripheral primitive neuroectodermal tumor|metastatic ewing sarcoma/peripheral primitive neuroectodermal tumor
5417532|NCT00024258|recurrent Ewing sarcoma/peripheral primitive neuroectodermal tumor|recurrent ewing sarcoma/peripheral primitive neuroectodermal tumor
5417533|NCT00024258|childhood teratoma|childhood teratoma
5417534|NCT00024258|childhood malignant testicular germ cell tumor|childhood malignant testicular germ cell tumor
5417535|NCT00024258|childhood malignant ovarian germ cell tumor|childhood malignant ovarian germ cell tumor
5417536|NCT00024258|childhood extragonadal germ cell tumor|childhood extragonadal germ cell tumor
5417537|NCT00024258|recurrent childhood malignant germ cell tumor|recurrent childhood malignant germ cell tumor
5417538|NCT00024245|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5417539|NCT00024232|stage IV prostate cancer|stage iv prostate cancer
5417540|NCT00024232|recurrent prostate cancer|recurrent prostate cancer
5417541|NCT00024193|stage 4S neuroblastoma|stage 4s neuroblastoma
5417542|NCT00024180|Waldenström macroglobulinemia|waldenström macroglobulinemia
5417543|NCT00024180|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5417544|NCT00024180|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5417545|NCT00024180|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5417546|NCT00024180|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
5417547|NCT00024180|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
5417548|NCT00024180|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5417549|NCT00024167|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5417550|NCT00024167|stage IV prostate cancer|stage iv prostate cancer
5417551|NCT00024167|recurrent prostate cancer|recurrent prostate cancer
5417552|NCT00024167|Strontium-89|strontium-89
5417553|NCT00024167|Induction Chemotherapy|induction chemotherapy
5417554|NCT00024167|Androgen-Independent Prostate Cancer|androgen-independent prostate cancer
5417555|NCT00024115|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5417556|NCT00024115|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
5417557|NCT00024115|stage III grade I follicular small cleaved cell lymphoma|stage iii grade i follicular small cleaved cell lymphoma
5417558|NCT00024115|stage III grade II follicular mixed cell lymphoma|stage iii grade ii follicular mixed cell lymphoma
5417559|NCT00024115|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5417560|NCT00024115|stage IV grade I follicular small cleaved cell lymphoma|stage iv grade i follicular small cleaved cell lymphoma
5417561|NCT00024115|stage IV grade II follicular mixed cell lymphoma|stage iv grade ii follicular mixed cell lymphoma
5417562|NCT00024115|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5417563|NCT00024115|recurrent grade I follicular small cleaved cell lymphoma|recurrent grade i follicular small cleaved cell lymphoma
5417564|NCT00024115|recurrent grade II follicular mixed cell lymphoma|recurrent grade ii follicular mixed cell lymphoma
5417565|NCT00024115|recurrent grade III follicular large cell lymphoma|recurrent grade iii follicular large cell lymphoma
5417566|NCT00024115|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5417567|NCT00024115|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5417568|NCT00024115|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5417569|NCT00024115|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5417570|NCT00024115|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5417571|NCT00024115|recurrent adult diffuse small noncleaved cell/Burkitt's lymphoma|recurrent adult diffuse small noncleaved cell/burkitt's lymphoma
5417572|NCT00024115|prolymphocytic leukemia|prolymphocytic leukemia
5417573|NCT00024115|contiguous stage II grade I follicular small cleaved cell lymphoma|contiguous stage ii grade i follicular small cleaved cell lymphoma
5417574|NCT00024115|contiguous stage II grade II follicular mixed cell lymphoma|contiguous stage ii grade ii follicular mixed cell lymphoma
5417575|NCT00024115|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
5417695|NCT00023777|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
5417576|NCT00024115|noncontiguous stage II grade I follicular small cleaved cell lymphoma|noncontiguous stage ii grade i follicular small cleaved cell lymphoma
5417577|NCT00024115|noncontiguous stage II grade II follicular mixed cell lymphoma|noncontiguous stage ii grade ii follicular mixed cell lymphoma
5417578|NCT00024115|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
5417579|NCT00024115|stage III diffuse small lymphocytic/marginal zone lymphoma|stage iii diffuse small lymphocytic/marginal zone lymphoma
5417580|NCT00024115|contiguous stage II diffuse small lymphocytic/marginal zone lymphoma|contiguous stage ii diffuse small lymphocytic/marginal zone lymphoma
5417581|NCT00024115|noncontiguous stage II diffuse small lymphocytic/marginal zone lymphoma|noncontiguous stage ii diffuse small lymphocytic/marginal zone lymphoma
5417582|NCT00024115|stage IV diffuse small lymphocytic/marginal zone lymphoma|stage iv diffuse small lymphocytic/marginal zone lymphoma
5417583|NCT00024115|recurrent diffuse small lymphocytic/marginal zone lymphoma|recurrent diffuse small lymphocytic/marginal zone lymphoma
5417584|NCT00024115|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5417585|NCT00024102|stage I breast cancer|stage i breast cancer
5417586|NCT00024102|stage II breast cancer|stage ii breast cancer
5417587|NCT00024102|stage IIIA breast cancer|stage iiia breast cancer
5417588|NCT00024102|stage IIIB breast cancer|stage iiib breast cancer
5417589|NCT00024102|stage IIIC breast cancer|stage iiic breast cancer
5417590|NCT00024089|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
5417591|NCT00024089|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
5417592|NCT00024089|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5417593|NCT00024089|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
5417594|NCT00024089|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5417595|NCT00024089|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
5417596|NCT00024089|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
5417597|NCT00024089|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
5417598|NCT00024089|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5417599|NCT00024089|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
5417600|NCT00024089|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5417601|NCT00024089|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
5417602|NCT00024089|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
5417603|NCT00024089|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
5417604|NCT00024089|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
5417605|NCT00024076|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5417606|NCT00024076|recurrent small cell lung cancer|recurrent small cell lung cancer
5417607|NCT00024076|recurrent malignant mesothelioma|recurrent malignant mesothelioma
5417608|NCT00024076|recurrent thymoma and thymic carcinoma|recurrent thymoma and thymic carcinoma
5417609|NCT00024076|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5417610|NCT00024076|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5417611|NCT00024076|pulmonary carcinoid tumor|pulmonary carcinoid tumor
5417612|NCT00024076|lung metastases|lung metastases
5417613|NCT00024050|refractory anemia|refractory anemia
5417614|NCT00024050|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
5417615|NCT00024050|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5417616|NCT00024050|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5417617|NCT00024050|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5417618|NCT00024050|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
5417619|NCT00023985|stage I non-small cell lung cancer|stage i non-small cell lung cancer
5417620|NCT00023985|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
5417621|NCT00023985|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5417622|NCT00023972|stage III pancreatic cancer|stage iii pancreatic cancer
5417623|NCT00023972|stage IV pancreatic cancer|stage iv pancreatic cancer
5417624|NCT00023894|recurrent endometrial carcinoma|recurrent endometrial carcinoma
5417625|NCT00023881|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5417626|NCT00023881|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5417627|NCT00023881|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5417628|NCT00023881|chronic myelogenous leukemia, BCR-ABL1 positive|chronic myelogenous leukemia, bcr-abl1 positive
5417629|NCT00023855|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5417630|NCT00023842|stage 0 bladder cancer|stage 0 bladder cancer
5417631|NCT00023842|recurrent bladder cancer|recurrent bladder cancer
5417632|NCT00023842|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
5417633|NCT00023829|stage III prostate cancer|stage iii prostate cancer
5417634|NCT00023829|stage IIB prostate cancer|stage iib prostate cancer
5417635|NCT00023829|stage IIA prostate cancer|stage iia prostate cancer
5417636|NCT00023790|stage IV breast cancer|stage iv breast cancer
5417637|NCT00023790|recurrent breast cancer|recurrent breast cancer
5417638|NCT00023790|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
5417639|NCT00023790|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
5417640|NCT00023790|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
5417641|NCT00023790|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5417642|NCT00023790|basal cell carcinoma of the skin|basal cell carcinoma of the skin
5417643|NCT00023790|squamous cell carcinoma of the skin|squamous cell carcinoma of the skin
5417644|NCT00023790|recurrent skin cancer|recurrent skin cancer
5417645|NCT00023790|classic Kaposi sarcoma|classic kaposi sarcoma
5417646|NCT00023790|immunosuppressive treatment related Kaposi sarcoma|immunosuppressive treatment related kaposi sarcoma
5417647|NCT00023790|AIDS-related Kaposi sarcoma|aids-related kaposi sarcoma
5417648|NCT00023790|recurrent Kaposi sarcoma|recurrent kaposi sarcoma
5417649|NCT00023790|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5417650|NCT00023790|stage IV basal cell carcinoma of the lip|stage iv basal cell carcinoma of the lip
5417651|NCT00023790|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
5417652|NCT00023790|stage IV mucoepidermoid carcinoma of the oral cavity|stage iv mucoepidermoid carcinoma of the oral cavity
5417653|NCT00023790|stage IV adenoid cystic carcinoma of the oral cavity|stage iv adenoid cystic carcinoma of the oral cavity
5417654|NCT00023790|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
5417655|NCT00023790|recurrent basal cell carcinoma of the lip|recurrent basal cell carcinoma of the lip
5417656|NCT00023790|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
5417657|NCT00023790|recurrent mucoepidermoid carcinoma of the oral cavity|recurrent mucoepidermoid carcinoma of the oral cavity
5417658|NCT00023790|recurrent adenoid cystic carcinoma of the oral cavity|recurrent adenoid cystic carcinoma of the oral cavity
5417659|NCT00023790|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5417660|NCT00023790|stage IV lymphoepithelioma of the oropharynx|stage iv lymphoepithelioma of the oropharynx
5417661|NCT00023790|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
5417662|NCT00023790|recurrent lymphoepithelioma of the oropharynx|recurrent lymphoepithelioma of the oropharynx
5417663|NCT00023790|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
5417664|NCT00023790|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
5417665|NCT00023790|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
5417666|NCT00023790|recurrent lymphoepithelioma of the nasopharynx|recurrent lymphoepithelioma of the nasopharynx
5417667|NCT00023790|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5417668|NCT00023790|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
5417669|NCT00023790|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5417670|NCT00023790|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
5417671|NCT00023790|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
5417672|NCT00023790|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
5417673|NCT00023790|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
5417674|NCT00023790|stage IV inverted papilloma of the paranasal sinus and nasal cavity|stage iv inverted papilloma of the paranasal sinus and nasal cavity
5417675|NCT00023790|stage IV midline lethal granuloma of the paranasal sinus and nasal cavity|stage iv midline lethal granuloma of the paranasal sinus and nasal cavity
5417676|NCT00023790|stage IV esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iv esthesioneuroblastoma of the paranasal sinus and nasal cavity
5417677|NCT00023790|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
5417678|NCT00023790|recurrent inverted papilloma of the paranasal sinus and nasal cavity|recurrent inverted papilloma of the paranasal sinus and nasal cavity
5417679|NCT00023790|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity
5417680|NCT00023790|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity
5417681|NCT00023790|skin metastases|skin metastases
5417682|NCT00023790|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
5417683|NCT00023790|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
5417684|NCT00023790|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
5417685|NCT00023790|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5417686|NCT00023790|male breast cancer|male breast cancer
5417687|NCT00023777|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
5417688|NCT00023777|adult acute erythroid leukemia (M6)|adult acute erythroid leukemia (m6)
5417689|NCT00023777|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
5417690|NCT00023777|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
5417691|NCT00023777|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
5417692|NCT00023777|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
5417693|NCT00023777|adult acute eosinophilic leukemia|adult acute eosinophilic leukemia
5417694|NCT00023777|adult acute basophilic leukemia|adult acute basophilic leukemia
5439397|NCT00022997|Non-Tasters|non-tasters
5417696|NCT00023777|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
5417697|NCT00023777|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
5417698|NCT00023751|stage I rectal cancer|stage i rectal cancer
5417699|NCT00023751|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5417700|NCT00023686|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5417701|NCT00023686|stage IIB prostate cancer|stage iib prostate cancer
5417702|NCT00023686|stage IIA prostate cancer|stage iia prostate cancer
5417703|NCT00023660|stage III cervical cancer|stage iii cervical cancer
5417704|NCT00023660|stage IB cervical cancer|stage ib cervical cancer
5417705|NCT00023660|stage IIB cervical cancer|stage iib cervical cancer
5417706|NCT00023660|stage IIA cervical cancer|stage iia cervical cancer
5417707|NCT00023660|stage IVA cervical cancer|stage iva cervical cancer
5417708|NCT00023660|cervical squamous cell carcinoma|cervical squamous cell carcinoma
5417709|NCT00023660|cervical adenocarcinoma|cervical adenocarcinoma
5417710|NCT00023660|cervical adenosquamous cell carcinoma|cervical adenosquamous cell carcinoma
5417711|NCT00023634|stage II gastric cancer|stage ii gastric cancer
5417712|NCT00023634|stage III gastric cancer|stage iii gastric cancer
5417713|NCT00023634|stage IV gastric cancer|stage iv gastric cancer
5417714|NCT00023634|recurrent gastric cancer|recurrent gastric cancer
5417715|NCT00023634|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5417716|NCT00023634|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
5417717|NCT00023634|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5417718|NCT00023634|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5417719|NCT00023634|recurrent adult brain tumor|recurrent adult brain tumor
5417720|NCT00023634|stage IV prostate cancer|stage iv prostate cancer
5417721|NCT00023634|recurrent prostate cancer|recurrent prostate cancer
5417722|NCT00023634|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5417723|NCT00023621|basal cell carcinoma of the skin|basal cell carcinoma of the skin
5417724|NCT00022724|recurrent adult brain tumor|recurrent adult brain tumor
5417725|NCT00022724|adult glioblastoma|adult glioblastoma
5417726|NCT00022724|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5417727|NCT00022724|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
5417728|NCT00022724|adult mixed glioma|adult mixed glioma
5417729|NCT00022724|adult giant cell glioblastoma|adult giant cell glioblastoma
5417730|NCT00022724|adult gliosarcoma|adult gliosarcoma
5417731|NCT00022711|recurrent small cell lung cancer|recurrent small cell lung cancer
5417732|NCT00022711|intermediate type small cell lung cancer|intermediate type small cell lung cancer
5417733|NCT00022698|stage III colon cancer|stage iii colon cancer
5417734|NCT00022698|stage IV colon cancer|stage iv colon cancer
5417735|NCT00022698|stage III rectal cancer|stage iii rectal cancer
5417736|NCT00022698|stage IV rectal cancer|stage iv rectal cancer
5417737|NCT00022698|recurrent colon cancer|recurrent colon cancer
5417738|NCT00022698|recurrent rectal cancer|recurrent rectal cancer
5417739|NCT00022698|adenocarcinoma of the colon|adenocarcinoma of the colon
5417740|NCT00022698|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5417741|NCT00022685|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5417742|NCT00022685|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5417743|NCT00022646|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5417744|NCT00022646|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5417745|NCT00022633|recurrent bladder cancer|recurrent bladder cancer
5417746|NCT00022633|stage IV bladder cancer|stage iv bladder cancer
5417747|NCT00022633|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
5417748|NCT00022633|squamous cell carcinoma of the bladder|squamous cell carcinoma of the bladder
5417749|NCT00022633|adenocarcinoma of the bladder|adenocarcinoma of the bladder
5417750|NCT00022633|recurrent urethral cancer|recurrent urethral cancer
5417751|NCT00022633|anterior urethral cancer|anterior urethral cancer
5417752|NCT00022633|posterior urethral cancer|posterior urethral cancer
5417753|NCT00022633|urethral cancer associated with invasive bladder cancer|urethral cancer associated with invasive bladder cancer
5417754|NCT00022633|metastatic transitional cell cancer of the renal pelvis and ureter|metastatic transitional cell cancer of the renal pelvis and ureter
5417755|NCT00022633|regional transitional cell cancer of the renal pelvis and ureter|regional transitional cell cancer of the renal pelvis and ureter
5417756|NCT00022633|recurrent transitional cell cancer of the renal pelvis and ureter|recurrent transitional cell cancer of the renal pelvis and ureter
5417757|NCT00022620|recurrent endometrial carcinoma|recurrent endometrial carcinoma
5417758|NCT00022620|endometrial papillary serous carcinoma|endometrial papillary serous carcinoma
5417759|NCT00022607|refractory multiple myeloma|refractory multiple myeloma
5417760|NCT00022607|stage I multiple myeloma|stage i multiple myeloma
5417761|NCT00022607|stage II multiple myeloma|stage ii multiple myeloma
5417762|NCT00022607|stage III multiple myeloma|stage iii multiple myeloma
5417763|NCT00022568|stage IV melanoma|stage iv melanoma
5417764|NCT00022568|recurrent melanoma|recurrent melanoma
5417765|NCT00022516|stage IA breast cancer|stage ia breast cancer
5417766|NCT00022516|stage II breast cancer|stage ii breast cancer
5417767|NCT00022516|stage IIIA breast cancer|stage iiia breast cancer
5417768|NCT00022516|stage IIIB breast cancer|stage iiib breast cancer
5417769|NCT00022516|stage IB breast cancer|stage ib breast cancer
5417770|NCT00022516|estrogen receptor-negative breast cancer|estrogen receptor-negative breast cancer
5417771|NCT00022516|progesterone receptor-negative breast cancer|progesterone receptor-negative breast cancer
5417772|NCT00022516|triple-negative breast cancer|triple-negative breast cancer
5417773|NCT00022516|low-dose maintenance chemotherapy|low-dose maintenance chemotherapy
5417774|NCT00022516|stroma|stroma
5417775|NCT00022516|angiogenesis|angiogenesis
5417776|NCT00022490|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5417777|NCT00022490|Philadelphia chromosome positive chronic myelogenous leukemia|philadelphia chromosome positive chronic myelogenous leukemia
5417778|NCT00022464|stage IV melanoma|stage iv melanoma
5417779|NCT00022464|recurrent melanoma|recurrent melanoma
5417780|NCT00022451|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5417781|NCT00022451|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5417782|NCT00022451|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5417783|NCT00022451|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5417784|NCT00022451|chronic myelogenous leukemia, BCR-ABL1 positive|chronic myelogenous leukemia, bcr-abl1 positive
5417785|NCT00022451|childhood acute promyelocytic leukemia (M3)|childhood acute promyelocytic leukemia (m3)
5417786|NCT00022451|acute undifferentiated leukemia|acute undifferentiated leukemia
5417787|NCT00022451|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
5417788|NCT00022451|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
5417789|NCT00022438|stage IV melanoma|stage iv melanoma
5417790|NCT00022438|recurrent melanoma|recurrent melanoma
5417791|NCT00022425|recurrent breast cancer|recurrent breast cancer
5417792|NCT00022412|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5417793|NCT00022412|stage I prostate cancer|stage i prostate cancer
5417794|NCT00022412|stage II prostate cancer|stage ii prostate cancer
5417795|NCT00022399|stage I prostate cancer|stage i prostate cancer
5417796|NCT00022399|stage IIB prostate cancer|stage iib prostate cancer
5417797|NCT00022399|stage IIA prostate cancer|stage iia prostate cancer
5417798|NCT00022399|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5417799|NCT00022334|localized resectable adult primary liver cancer|localized resectable adult primary liver cancer
5417800|NCT00022334|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
5417801|NCT00022334|advanced adult primary liver cancer|advanced adult primary liver cancer
5417802|NCT00022334|recurrent adult primary liver cancer|recurrent adult primary liver cancer
5417803|NCT00022334|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
5417804|NCT00022295|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5417805|NCT00022230|stage II breast cancer|stage ii breast cancer
5417806|NCT00022230|stage IIIA breast cancer|stage iiia breast cancer
5417807|NCT00022230|stage IIIB breast cancer|stage iiib breast cancer
5417808|NCT00022230|stage IIIC breast cancer|stage iiic breast cancer
5417809|NCT00022191|stage IV bladder cancer|stage iv bladder cancer
5417810|NCT00022191|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
5417811|NCT00022191|urethral cancer associated with invasive bladder cancer|urethral cancer associated with invasive bladder cancer
5417812|NCT00022191|metastatic transitional cell cancer of the renal pelvis and ureter|metastatic transitional cell cancer of the renal pelvis and ureter
5417813|NCT00022191|regional transitional cell cancer of the renal pelvis and ureter|regional transitional cell cancer of the renal pelvis and ureter
5417814|NCT00022152|stage IV breast cancer|stage iv breast cancer
5417815|NCT00022152|recurrent breast cancer|recurrent breast cancer
5417816|NCT00022126|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
5417817|NCT00022126|L1 childhood acute lymphoblastic leukemia|l1 childhood acute lymphoblastic leukemia
5417818|NCT00022126|L2 childhood acute lymphoblastic leukemia|l2 childhood acute lymphoblastic leukemia
5417819|NCT00022126|acute undifferentiated leukemia|acute undifferentiated leukemia
5417820|NCT00022087|osteoporosis|osteoporosis
5417821|NCT00022087|stage I breast cancer|stage i breast cancer
5417822|NCT00022087|stage II breast cancer|stage ii breast cancer
5417823|NCT00022087|stage IV breast cancer|stage iv breast cancer
5417824|NCT00022087|stage IIIA breast cancer|stage iiia breast cancer
5417825|NCT00022087|stage IIIB breast cancer|stage iiib breast cancer
5417826|NCT00022087|stage IIIC breast cancer|stage iiic breast cancer
5417827|NCT00022074|stage I breast cancer|stage i breast cancer
5417828|NCT00022074|stage II breast cancer|stage ii breast cancer
5417829|NCT00022074|stage IV breast cancer|stage iv breast cancer
5417830|NCT00022074|stage IIIA breast cancer|stage iiia breast cancer
5417831|NCT00022074|recurrent breast cancer|recurrent breast cancer
5417832|NCT00022074|stage IIIB breast cancer|stage iiib breast cancer
5417833|NCT00022074|stage IIIC breast cancer|stage iiic breast cancer
5417834|NCT00022074|anxiety disorder|anxiety disorder
5417835|NCT00022074|depression|depression
5417836|NCT00022074|hot flashes|hot flashes
5417837|NCT00022048|refractory anemia|refractory anemia
5417838|NCT00022048|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
5417839|NCT00022048|refractory anemia with excess blasts|refractory anemia with excess blasts
5417840|NCT00022048|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
5417841|NCT00022048|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5417842|NCT00022048|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5417843|NCT00022048|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5417844|NCT00022048|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
5417845|NCT00022048|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
5417846|NCT00022035|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
5417847|NCT00022035|infection|infection
5417848|NCT00022022|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5417849|NCT00022022|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5417850|NCT00022022|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5417851|NCT00021450|stage IIB prostate cancer|stage iib prostate cancer
5417852|NCT00021450|stage IIA prostate cancer|stage iia prostate cancer
5417853|NCT00021424|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5417854|NCT00021424|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
5417855|NCT00021424|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5417856|NCT00021424|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
5417857|NCT00021424|skin metastases|skin metastases
5417858|NCT00021320|stage 0 esophageal cancer|stage 0 esophageal cancer
5417859|NCT00021320|stage I esophageal cancer|stage i esophageal cancer
5417860|NCT00021320|stage II esophageal cancer|stage ii esophageal cancer
5417861|NCT00021320|stage III esophageal cancer|stage iii esophageal cancer
5417862|NCT00021320|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
5417863|NCT00021320|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
5417864|NCT00021242|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5417865|NCT00021242|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5417866|NCT00021242|childhood acute promyelocytic leukemia (M3)|childhood acute promyelocytic leukemia (m3)
5417867|NCT00021229|childhood central nervous system germ cell tumor|childhood central nervous system germ cell tumor
5417868|NCT00021229|childhood high-grade cerebral astrocytoma|childhood high-grade cerebral astrocytoma
5417869|NCT00021229|untreated childhood brain stem glioma|untreated childhood brain stem glioma
5417870|NCT00021229|recurrent childhood brain stem glioma|recurrent childhood brain stem glioma
5417871|NCT00021229|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
5417872|NCT00021164|stage IV melanoma|stage iv melanoma
5417873|NCT00021164|recurrent melanoma|recurrent melanoma
5417874|NCT00021164|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5417875|NCT00021125|squamous cell carcinoma of the skin|squamous cell carcinoma of the skin
5417876|NCT00021125|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
5417877|NCT00021125|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
5417878|NCT00021125|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
5417879|NCT00021125|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5417880|NCT00021125|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
5417881|NCT00021125|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
5417882|NCT00021125|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
5417883|NCT00021125|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5417884|NCT00021125|stage I squamous cell carcinoma of the hypopharynx|stage i squamous cell carcinoma of the hypopharynx
5417885|NCT00021125|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
5417886|NCT00021125|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
5417887|NCT00021125|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5417888|NCT00021125|stage I squamous cell carcinoma of the larynx|stage i squamous cell carcinoma of the larynx
5417889|NCT00021125|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
5417890|NCT00021125|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
5417891|NCT00021125|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5417892|NCT00021125|stage I squamous cell carcinoma of the paranasal sinus and nasal cavity|stage i squamous cell carcinoma of the paranasal sinus and nasal cavity
5417893|NCT00021125|stage II squamous cell carcinoma of the paranasal sinus and nasal cavity|stage ii squamous cell carcinoma of the paranasal sinus and nasal cavity
5417894|NCT00021125|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
5417895|NCT00021125|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
5417896|NCT00021125|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
5417897|NCT00021125|stage I salivary gland cancer|stage i salivary gland cancer
5417898|NCT00021125|stage II salivary gland cancer|stage ii salivary gland cancer
5417899|NCT00021125|stage III salivary gland cancer|stage iii salivary gland cancer
5417900|NCT00021125|stage IV salivary gland cancer|stage iv salivary gland cancer
5425723|NCT00052026|Treatment Outcome|treatment outcome
5417901|NCT00021112|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5417902|NCT00021047|stage IV gastric cancer|stage iv gastric cancer
5417903|NCT00021047|recurrent gastric cancer|recurrent gastric cancer
5439398|NCT00022997|Taste|taste
5417904|NCT00021047|stage II esophageal cancer|stage ii esophageal cancer
5417905|NCT00021047|stage III esophageal cancer|stage iii esophageal cancer
5417906|NCT00021047|stage IV esophageal cancer|stage iv esophageal cancer
5417907|NCT00021047|recurrent esophageal cancer|recurrent esophageal cancer
5417908|NCT00021047|advanced adult primary liver cancer|advanced adult primary liver cancer
5417909|NCT00021047|recurrent adult primary liver cancer|recurrent adult primary liver cancer
5417910|NCT00021047|unresectable extrahepatic bile duct cancer|unresectable extrahepatic bile duct cancer
5417911|NCT00021047|recurrent extrahepatic bile duct cancer|recurrent extrahepatic bile duct cancer
5417912|NCT00021047|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5417913|NCT00021047|untreated metastatic squamous neck cancer with occult primary|untreated metastatic squamous neck cancer with occult primary
5417914|NCT00021047|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
5417915|NCT00021047|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5417916|NCT00021047|stage IV basal cell carcinoma of the lip|stage iv basal cell carcinoma of the lip
5417917|NCT00021047|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
5417918|NCT00021047|stage IV mucoepidermoid carcinoma of the oral cavity|stage iv mucoepidermoid carcinoma of the oral cavity
5417919|NCT00021047|stage IV adenoid cystic carcinoma of the oral cavity|stage iv adenoid cystic carcinoma of the oral cavity
5417920|NCT00021047|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
5417921|NCT00021047|recurrent basal cell carcinoma of the lip|recurrent basal cell carcinoma of the lip
5417922|NCT00021047|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
5417923|NCT00021047|recurrent mucoepidermoid carcinoma of the oral cavity|recurrent mucoepidermoid carcinoma of the oral cavity
5417924|NCT00021047|recurrent adenoid cystic carcinoma of the oral cavity|recurrent adenoid cystic carcinoma of the oral cavity
5417925|NCT00021047|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5417926|NCT00021047|stage IV lymphoepithelioma of the oropharynx|stage iv lymphoepithelioma of the oropharynx
5417927|NCT00021047|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
5417928|NCT00021047|recurrent lymphoepithelioma of the oropharynx|recurrent lymphoepithelioma of the oropharynx
5417929|NCT00021047|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
5417930|NCT00021047|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
5417931|NCT00021047|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
5417932|NCT00021047|recurrent lymphoepithelioma of the nasopharynx|recurrent lymphoepithelioma of the nasopharynx
5417933|NCT00021047|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5417934|NCT00021047|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
5417935|NCT00021047|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5417936|NCT00021047|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
5417937|NCT00021047|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
5417938|NCT00021047|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
5417939|NCT00021047|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
5417940|NCT00021047|stage IV inverted papilloma of the paranasal sinus and nasal cavity|stage iv inverted papilloma of the paranasal sinus and nasal cavity
5417941|NCT00021047|stage IV midline lethal granuloma of the paranasal sinus and nasal cavity|stage iv midline lethal granuloma of the paranasal sinus and nasal cavity
5417942|NCT00021047|stage IV esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iv esthesioneuroblastoma of the paranasal sinus and nasal cavity
5417943|NCT00021047|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
5417944|NCT00021047|recurrent inverted papilloma of the paranasal sinus and nasal cavity|recurrent inverted papilloma of the paranasal sinus and nasal cavity
5417945|NCT00021047|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity
5417946|NCT00021047|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity
5417947|NCT00021047|recurrent salivary gland cancer|recurrent salivary gland cancer
5417948|NCT00021047|stage IV salivary gland cancer|stage iv salivary gland cancer
5417949|NCT00020995|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5417950|NCT00020995|stage I prostate cancer|stage i prostate cancer
5417951|NCT00020995|stage IIB prostate cancer|stage iib prostate cancer
5417952|NCT00020995|stage IIA prostate cancer|stage iia prostate cancer
5417953|NCT00020995|stage III prostate cancer|stage iii prostate cancer
5417954|NCT00020995|stage IV prostate cancer|stage iv prostate cancer
5417955|NCT00020969|refractory anemia|refractory anemia
5417956|NCT00020969|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
5417957|NCT00020969|refractory anemia with excess blasts|refractory anemia with excess blasts
5417958|NCT00020969|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
5417959|NCT00020969|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5417960|NCT00020969|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5417961|NCT00020969|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5417962|NCT00020969|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5417963|NCT00020969|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
5417964|NCT00020969|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
5417965|NCT00020943|stage I mantle cell lymphoma|stage i mantle cell lymphoma
5417966|NCT00020943|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
5417967|NCT00020943|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5417968|NCT00020943|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5417969|NCT00020943|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5417970|NCT00020891|stage I prostate cancer|stage i prostate cancer
5417971|NCT00020891|stage IIB prostate cancer|stage iib prostate cancer
5417972|NCT00020891|stage IIA prostate cancer|stage iia prostate cancer
5417973|NCT00020891|stage III prostate cancer|stage iii prostate cancer
5417974|NCT00020891|stage IV prostate cancer|stage iv prostate cancer
5417975|NCT00020891|recurrent prostate cancer|recurrent prostate cancer
5417976|NCT00020878|non-small cell lung cancer|non-small cell lung cancer
5417977|NCT00020852|stage I breast cancer|stage i breast cancer
5417978|NCT00020852|stage II breast cancer|stage ii breast cancer
5417979|NCT00020839|stage IV melanoma|stage iv melanoma
5417980|NCT00020839|recurrent melanoma|recurrent melanoma
5417981|NCT00020839|tumors metastatic to brain|tumors metastatic to brain
5417982|NCT00020826|adenocarcinoma of the stomach|adenocarcinoma of the stomach
5417983|NCT00020800|Waldenström macroglobulinemia|waldenström macroglobulinemia
5417984|NCT00020761|stage IV gastric cancer|stage iv gastric cancer
5417985|NCT00020761|recurrent gastric cancer|recurrent gastric cancer
5417986|NCT00020761|stage IV esophageal cancer|stage iv esophageal cancer
5417987|NCT00020761|recurrent esophageal cancer|recurrent esophageal cancer
5417988|NCT00020761|adenocarcinoma of the stomach|adenocarcinoma of the stomach
5417989|NCT00020761|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
5417990|NCT00020748|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5417991|NCT00020735|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5417992|NCT00020735|stage I prostate cancer|stage i prostate cancer
5425852|NCT00051285|heart|heart
5417993|NCT00020735|stage II prostate cancer|stage ii prostate cancer
5417994|NCT00020722|stage IV breast cancer|stage iv breast cancer
5417995|NCT00020722|recurrent breast cancer|recurrent breast cancer
5417996|NCT00020670|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5417997|NCT00020670|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5417998|NCT00020670|B-cell childhood acute lymphoblastic leukemia|b-cell childhood acute lymphoblastic leukemia
5417999|NCT00020670|B-cell adult acute lymphoblastic leukemia|b-cell adult acute lymphoblastic leukemia
5418000|NCT00020657|nausea and vomiting|nausea and vomiting
5418001|NCT00020657|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5418002|NCT00020644|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5418003|NCT00020631|radiation fibrosis|radiation fibrosis
5418004|NCT00020579|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
5418005|NCT00020579|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5418006|NCT00020579|small intestine lymphoma|small intestine lymphoma
5418007|NCT00020579|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5418008|NCT00020579|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5418009|NCT00020579|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5418010|NCT00020579|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5418011|NCT00020579|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5418012|NCT00020579|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5418013|NCT00020579|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5418014|NCT00020579|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5418015|NCT00020579|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5418016|NCT00020579|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5418017|NCT00020579|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5418018|NCT00020579|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5418019|NCT00020579|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5418020|NCT00020579|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5418021|NCT00020579|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5418022|NCT00020579|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5418023|NCT00020579|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5418024|NCT00020579|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5418025|NCT00020579|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
5418026|NCT00020579|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
5418027|NCT00020579|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
5418028|NCT00020579|intraocular lymphoma|intraocular lymphoma
5418029|NCT00020579|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5418030|NCT00020579|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5418031|NCT00020579|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
5418032|NCT00020579|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5418033|NCT00020579|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
5418034|NCT00020579|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5418035|NCT00020579|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5418036|NCT00020579|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5418037|NCT00020579|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5418038|NCT00020579|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5418039|NCT00020579|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5418040|NCT00020579|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5418041|NCT00020579|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5418042|NCT00020579|male breast cancer|male breast cancer
5418043|NCT00020579|stage IIIA breast cancer|stage iiia breast cancer
5418044|NCT00020579|stage IIIB breast cancer|stage iiib breast cancer
5418045|NCT00020579|stage IIIC breast cancer|stage iiic breast cancer
5418046|NCT00020579|stage IV breast cancer|stage iv breast cancer
5418047|NCT00020579|recurrent pancreatic cancer|recurrent pancreatic cancer
5418048|NCT00020579|stage III pancreatic cancer|stage iii pancreatic cancer
5418049|NCT00020579|recurrent colon cancer|recurrent colon cancer
5418050|NCT00020579|stage III colon cancer|stage iii colon cancer
5418051|NCT00020579|stage IV colon cancer|stage iv colon cancer
5418052|NCT00020579|recurrent rectal cancer|recurrent rectal cancer
5418053|NCT00020579|stage III rectal cancer|stage iii rectal cancer
5418054|NCT00020579|stage IV rectal cancer|stage iv rectal cancer
5418055|NCT00020579|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5418056|NCT00020579|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
5418057|NCT00020579|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5418058|NCT00020579|stage III ovarian germ cell tumor|stage iii ovarian germ cell tumor
5418059|NCT00020579|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5418060|NCT00020579|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
5418061|NCT00020579|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
5418062|NCT00020579|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
5418063|NCT00020579|recurrent cervical cancer|recurrent cervical cancer
5418064|NCT00020579|stage III cervical cancer|stage iii cervical cancer
5418065|NCT00020579|stage IVA cervical cancer|stage iva cervical cancer
5418066|NCT00020579|stage IVB cervical cancer|stage ivb cervical cancer
5418067|NCT00020579|recurrent endometrial carcinoma|recurrent endometrial carcinoma
5418068|NCT00020579|stage III endometrial carcinoma|stage iii endometrial carcinoma
5418069|NCT00020579|stage IV endometrial carcinoma|stage iv endometrial carcinoma
5418070|NCT00020579|fallopian tube cancer|fallopian tube cancer
5418071|NCT00020579|primary peritoneal cavity cancer|primary peritoneal cavity cancer
5418072|NCT00020579|recurrent uterine sarcoma|recurrent uterine sarcoma
5418073|NCT00020579|stage III uterine sarcoma|stage iii uterine sarcoma
5418074|NCT00020579|stage IV uterine sarcoma|stage iv uterine sarcoma
5418075|NCT00020579|recurrent vaginal cancer|recurrent vaginal cancer
5418076|NCT00020579|stage III vaginal cancer|stage iii vaginal cancer
5418077|NCT00020579|stage IVA vaginal cancer|stage iva vaginal cancer
5418078|NCT00020579|stage IVB vaginal cancer|stage ivb vaginal cancer
5418079|NCT00020579|recurrent vulvar cancer|recurrent vulvar cancer
5418080|NCT00020579|stage III vulvar cancer|stage iii vulvar cancer
5418081|NCT00020579|stage IV vulvar cancer|stage iv vulvar cancer
5418082|NCT00020579|recurrent anal cancer|recurrent anal cancer
5418083|NCT00020579|stage IIIA anal cancer|stage iiia anal cancer
5418084|NCT00020579|stage IIIB anal cancer|stage iiib anal cancer
5418085|NCT00020579|stage IV anal cancer|stage iv anal cancer
5418086|NCT00020579|recurrent esophageal cancer|recurrent esophageal cancer
5418087|NCT00020579|stage III esophageal cancer|stage iii esophageal cancer
5418088|NCT00020579|stage IV esophageal cancer|stage iv esophageal cancer
5418089|NCT00020579|recurrent gastric cancer|recurrent gastric cancer
5418090|NCT00020579|stage III gastric cancer|stage iii gastric cancer
5418091|NCT00020579|stage IV gastric cancer|stage iv gastric cancer
5418092|NCT00020579|recurrent extrahepatic bile duct cancer|recurrent extrahepatic bile duct cancer
5418093|NCT00020579|unresectable extrahepatic bile duct cancer|unresectable extrahepatic bile duct cancer
5418094|NCT00020579|advanced adult primary liver cancer|advanced adult primary liver cancer
5418095|NCT00020579|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
5418096|NCT00020579|recurrent adult primary liver cancer|recurrent adult primary liver cancer
5418097|NCT00020579|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
5418098|NCT00020579|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
5418099|NCT00020579|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
5418100|NCT00020579|stage III verrucous carcinoma of the larynx|stage iii verrucous carcinoma of the larynx
5418101|NCT00020579|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5418102|NCT00020579|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
5418103|NCT00020579|recurrent basal cell carcinoma of the lip|recurrent basal cell carcinoma of the lip
5419014|NCT00016952|adenocarcinoma of the colon|adenocarcinoma of the colon
5418104|NCT00020579|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
5418105|NCT00020579|stage III basal cell carcinoma of the lip|stage iii basal cell carcinoma of the lip
5418106|NCT00020579|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
5418107|NCT00020579|stage IV basal cell carcinoma of the lip|stage iv basal cell carcinoma of the lip
5418108|NCT00020579|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5418109|NCT00020579|recurrent lymphoepithelioma of the oropharynx|recurrent lymphoepithelioma of the oropharynx
5418110|NCT00020579|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
5418111|NCT00020579|stage III lymphoepithelioma of the oropharynx|stage iii lymphoepithelioma of the oropharynx
5418112|NCT00020579|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
5418113|NCT00020579|stage IV lymphoepithelioma of the oropharynx|stage iv lymphoepithelioma of the oropharynx
5418114|NCT00020579|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5418115|NCT00020579|recurrent lymphoepithelioma of the nasopharynx|recurrent lymphoepithelioma of the nasopharynx
5418116|NCT00020579|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
5418117|NCT00020579|stage III lymphoepithelioma of the nasopharynx|stage iii lymphoepithelioma of the nasopharynx
5418118|NCT00020579|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
5418119|NCT00020579|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
5418120|NCT00020579|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
5418121|NCT00020579|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity
5418122|NCT00020579|recurrent inverted papilloma of the paranasal sinus and nasal cavity|recurrent inverted papilloma of the paranasal sinus and nasal cavity
5418123|NCT00020579|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity
5418124|NCT00020579|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
5418125|NCT00020579|stage III esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iii esthesioneuroblastoma of the paranasal sinus and nasal cavity
5418126|NCT00020579|stage III inverted papilloma of the paranasal sinus and nasal cavity|stage iii inverted papilloma of the paranasal sinus and nasal cavity
5418127|NCT00020579|stage III midline lethal granuloma of the paranasal sinus and nasal cavity|stage iii midline lethal granuloma of the paranasal sinus and nasal cavity
5418128|NCT00020579|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
5418129|NCT00020579|stage IV esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iv esthesioneuroblastoma of the paranasal sinus and nasal cavity
5418130|NCT00020579|stage IV inverted papilloma of the paranasal sinus and nasal cavity|stage iv inverted papilloma of the paranasal sinus and nasal cavity
5418131|NCT00020579|stage IV midline lethal granuloma of the paranasal sinus and nasal cavity|stage iv midline lethal granuloma of the paranasal sinus and nasal cavity
5418132|NCT00020579|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
5418133|NCT00020579|metastatic parathyroid cancer|metastatic parathyroid cancer
5418134|NCT00020579|recurrent parathyroid cancer|recurrent parathyroid cancer
5418135|NCT00020579|recurrent salivary gland cancer|recurrent salivary gland cancer
5418136|NCT00020579|stage III salivary gland cancer|stage iii salivary gland cancer
5418137|NCT00020579|stage IV salivary gland cancer|stage iv salivary gland cancer
5418138|NCT00020579|recurrent bladder cancer|recurrent bladder cancer
5418139|NCT00020579|recurrent gallbladder cancer|recurrent gallbladder cancer
5418140|NCT00020579|stage III bladder cancer|stage iii bladder cancer
5418141|NCT00020579|stage IV bladder cancer|stage iv bladder cancer
5418142|NCT00020579|unresectable gallbladder cancer|unresectable gallbladder cancer
5418143|NCT00020579|recurrent renal cell cancer|recurrent renal cell cancer
5418144|NCT00020579|stage III renal cell cancer|stage iii renal cell cancer
5418145|NCT00020579|stage IV renal cell cancer|stage iv renal cell cancer
5418146|NCT00020579|stage III Wilms tumor|stage iii wilms tumor
5418147|NCT00020579|stage IV Wilms tumor|stage iv wilms tumor
5418148|NCT00020579|stage V Wilms tumor|stage v wilms tumor
5418149|NCT00020579|metastatic transitional cell cancer of the renal pelvis and ureter|metastatic transitional cell cancer of the renal pelvis and ureter
5418150|NCT00020579|recurrent transitional cell cancer of the renal pelvis and ureter|recurrent transitional cell cancer of the renal pelvis and ureter
5418151|NCT00020579|regional transitional cell cancer of the renal pelvis and ureter|regional transitional cell cancer of the renal pelvis and ureter
5418152|NCT00020579|anterior urethral cancer|anterior urethral cancer
5418153|NCT00020579|posterior urethral cancer|posterior urethral cancer
5418154|NCT00020579|recurrent urethral cancer|recurrent urethral cancer
5418155|NCT00020579|recurrent penile cancer|recurrent penile cancer
5418156|NCT00020579|stage III penile cancer|stage iii penile cancer
5418157|NCT00020579|stage IV penile cancer|stage iv penile cancer
5418158|NCT00020579|recurrent prostate cancer|recurrent prostate cancer
5418159|NCT00020579|stage III prostate cancer|stage iii prostate cancer
5418160|NCT00020579|stage IV prostate cancer|stage iv prostate cancer
5418161|NCT00020579|metastatic Ewing sarcoma/peripheral primitive neuroectodermal tumor|metastatic ewing sarcoma/peripheral primitive neuroectodermal tumor
5418373|NCT00019838|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5418162|NCT00020579|recurrent Ewing sarcoma/peripheral primitive neuroectodermal tumor|recurrent ewing sarcoma/peripheral primitive neuroectodermal tumor
5418163|NCT00020579|metastatic osteosarcoma|metastatic osteosarcoma
5418164|NCT00020579|recurrent osteosarcoma|recurrent osteosarcoma
5418165|NCT00020579|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
5418166|NCT00020579|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
5418167|NCT00020579|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
5418168|NCT00020579|classic Kaposi sarcoma|classic kaposi sarcoma
5418169|NCT00020579|AIDS-related Kaposi sarcoma|aids-related kaposi sarcoma
5418170|NCT00020579|recurrent Kaposi sarcoma|recurrent kaposi sarcoma
5418171|NCT00020579|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
5418172|NCT00020579|ciliary body and choroid melanoma, medium/large size|ciliary body and choroid melanoma, medium/large size
5418173|NCT00020579|ciliary body and choroid melanoma, small size|ciliary body and choroid melanoma, small size
5418174|NCT00020579|extraocular extension melanoma|extraocular extension melanoma
5418175|NCT00020579|iris melanoma|iris melanoma
5418176|NCT00020579|recurrent intraocular melanoma|recurrent intraocular melanoma
5418177|NCT00020579|recurrent melanoma|recurrent melanoma
5418178|NCT00020579|stage III melanoma|stage iii melanoma
5418179|NCT00020579|stage IV melanoma|stage iv melanoma
5418180|NCT00020579|extensive stage small cell lung cancer|extensive stage small cell lung cancer
5418181|NCT00020579|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5418182|NCT00020579|recurrent small cell lung cancer|recurrent small cell lung cancer
5418183|NCT00020579|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5418184|NCT00020579|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5418185|NCT00020579|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5418186|NCT00020579|recurrent thymoma and thymic carcinoma|recurrent thymoma and thymic carcinoma
5418187|NCT00020579|advanced malignant mesothelioma|advanced malignant mesothelioma
5418188|NCT00020579|recurrent malignant mesothelioma|recurrent malignant mesothelioma
5418189|NCT00020579|recurrent adrenocortical carcinoma|recurrent adrenocortical carcinoma
5418190|NCT00020579|stage III adrenocortical carcinoma|stage iii adrenocortical carcinoma
5418191|NCT00020579|stage IV adrenocortical carcinoma|stage iv adrenocortical carcinoma
5418192|NCT00020579|metastatic gastrointestinal carcinoid tumor|metastatic gastrointestinal carcinoid tumor
5418193|NCT00020579|recurrent gastrointestinal carcinoid tumor|recurrent gastrointestinal carcinoid tumor
5418194|NCT00020579|regional gastrointestinal carcinoid tumor|regional gastrointestinal carcinoid tumor
5418195|NCT00020579|desmoid tumor|desmoid tumor
5418196|NCT00020579|newly diagnosed carcinoma of unknown primary|newly diagnosed carcinoma of unknown primary
5418197|NCT00020579|recurrent carcinoma of unknown primary|recurrent carcinoma of unknown primary
5418198|NCT00020579|undifferentiated carcinoma of unknown primary|undifferentiated carcinoma of unknown primary
5418199|NCT00020579|carcinoma of the appendix|carcinoma of the appendix
5418200|NCT00020579|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
5418201|NCT00020579|untreated metastatic squamous neck cancer with occult primary|untreated metastatic squamous neck cancer with occult primary
5418202|NCT00020579|recurrent pituitary tumor|recurrent pituitary tumor
5418203|NCT00020579|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5418204|NCT00020579|adult astrocytic tumors|adult astrocytic tumors
5418205|NCT00020579|adult diffuse astrocytoma|adult diffuse astrocytoma
5418206|NCT00020579|adult pilocytic astrocytoma|adult pilocytic astrocytoma
5418207|NCT00020579|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
5418208|NCT00020579|adult brain stem glioma|adult brain stem glioma
5418209|NCT00020579|adult oligodendroglioma|adult oligodendroglioma
5418210|NCT00020579|adult mixed glioma|adult mixed glioma
5418211|NCT00020579|adult central nervous system germ cell tumor|adult central nervous system germ cell tumor
5418212|NCT00020579|adult choroid plexus tumor|adult choroid plexus tumor
5418213|NCT00020579|adult craniopharyngioma|adult craniopharyngioma
5418214|NCT00020579|adult anaplastic ependymoma|adult anaplastic ependymoma
5418215|NCT00020579|adult subependymoma|adult subependymoma
5418216|NCT00020579|adult medulloblastoma|adult medulloblastoma
5418217|NCT00020579|adult supratentorial primitive neuroectodermal tumor (PNET)|adult supratentorial primitive neuroectodermal tumor (pnet)
5418218|NCT00020579|adult ependymoblastoma|adult ependymoblastoma
5418219|NCT00020579|adult ependymoma|adult ependymoma
5418220|NCT00020579|adult myxopapillary ependymoma|adult myxopapillary ependymoma
5418221|NCT00020579|adult anaplastic meningioma|adult anaplastic meningioma
5418222|NCT00020579|adult meningeal hemangiopericytoma|adult meningeal hemangiopericytoma
5418223|NCT00020579|adult meningioma|adult meningioma
5418224|NCT00020579|adult papillary meningioma|adult papillary meningioma
5418225|NCT00020579|adult grade I meningioma|adult grade i meningioma
5418226|NCT00020579|adult grade II meningioma|adult grade ii meningioma
5418227|NCT00020579|adult grade III meningioma|adult grade iii meningioma
5418228|NCT00020579|adult pineal parenchymal tumor|adult pineal parenchymal tumor
5418229|NCT00020579|recurrent adult brain tumor|recurrent adult brain tumor
5418230|NCT00020579|stage IV pancreatic cancer|stage iv pancreatic cancer
5418231|NCT00020579|stage III thymoma|stage iii thymoma
5418232|NCT00020579|stage IVA thymoma|stage iva thymoma
5418233|NCT00020579|stage IVB thymoma|stage ivb thymoma
5418234|NCT00020566|localized Ewing sarcoma/peripheral primitive neuroectodermal tumor|localized ewing sarcoma/peripheral primitive neuroectodermal tumor
5418235|NCT00020566|metastatic Ewing sarcoma/peripheral primitive neuroectodermal tumor|metastatic ewing sarcoma/peripheral primitive neuroectodermal tumor
5418236|NCT00020527|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5418237|NCT00020527|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
5418238|NCT00020527|disseminated neuroblastoma|disseminated neuroblastoma
5418239|NCT00020527|recurrent neuroblastoma|recurrent neuroblastoma
5418240|NCT00020527|recurrent Wilms tumor and other childhood kidney tumors|recurrent wilms tumor and other childhood kidney tumors
5418241|NCT00020527|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
5418242|NCT00020527|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5418243|NCT00020527|fever, sweats, and hot flashes|fever, sweats, and hot flashes
5418244|NCT00020527|childhood acute promyelocytic leukemia (M3)|childhood acute promyelocytic leukemia (m3)
5418245|NCT00020527|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
5418246|NCT00020527|neutropenia|neutropenia
5418247|NCT00020527|infection|infection
5418248|NCT00020527|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
5418249|NCT00020527|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
5418250|NCT00020527|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
5418251|NCT00020501|stage IV colon cancer|stage iv colon cancer
5418252|NCT00020501|stage IV rectal cancer|stage iv rectal cancer
5418253|NCT00020501|recurrent colon cancer|recurrent colon cancer
5418254|NCT00020501|recurrent rectal cancer|recurrent rectal cancer
5418255|NCT00020501|liver metastases|liver metastases
5418256|NCT00020488|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5418257|NCT00020449|AIDS-related Kaposi sarcoma|aids-related kaposi sarcoma
5418258|NCT00020449|recurrent Kaposi sarcoma|recurrent kaposi sarcoma
5418259|NCT00020410|stage IV breast cancer|stage iv breast cancer
5418260|NCT00020410|recurrent breast cancer|recurrent breast cancer
5418261|NCT00020410|male breast cancer|male breast cancer
5418262|NCT00020397|recurrent melanoma|recurrent melanoma
5418263|NCT00020397|stage IV melanoma|stage iv melanoma
5418264|NCT00020358|stage I melanoma|stage i melanoma
5418265|NCT00020358|stage II melanoma|stage ii melanoma
5418266|NCT00020358|stage III melanoma|stage iii melanoma
5418267|NCT00020358|stage IV melanoma|stage iv melanoma
5418268|NCT00020358|recurrent melanoma|recurrent melanoma
5418269|NCT00020332|stage IV breast cancer|stage iv breast cancer
5418270|NCT00020332|stage IIIA breast cancer|stage iiia breast cancer
5418271|NCT00020332|recurrent breast cancer|recurrent breast cancer
5418272|NCT00020332|stage IIIB breast cancer|stage iiib breast cancer
5418273|NCT00020332|male breast cancer|male breast cancer
5418274|NCT00020254|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5418275|NCT00020254|recurrent prostate cancer|recurrent prostate cancer
5418276|NCT00020189|thromboembolism|thromboembolism
5418277|NCT00020189|untreated metastatic squamous neck cancer with occult primary|untreated metastatic squamous neck cancer with occult primary
5418278|NCT00020189|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
5418279|NCT00020189|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
5418280|NCT00020189|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5418281|NCT00020189|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
5418282|NCT00020189|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5418283|NCT00020189|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
5418284|NCT00020189|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5418285|NCT00020189|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
5418286|NCT00020189|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5418287|NCT00020189|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
5418288|NCT00020189|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
5418289|NCT00020189|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
5418290|NCT00020189|recurrent salivary gland cancer|recurrent salivary gland cancer
5418291|NCT00020189|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
5418292|NCT00020189|stage IV salivary gland cancer|stage iv salivary gland cancer
5418293|NCT00020176|stage IV breast cancer|stage iv breast cancer
5418294|NCT00020176|recurrent breast cancer|recurrent breast cancer
5418295|NCT00020176|male breast cancer|male breast cancer
5418296|NCT00020150|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
5418297|NCT00020150|childhood craniopharyngioma|childhood craniopharyngioma
5418298|NCT00020150|recurrent childhood brain tumor|recurrent childhood brain tumor
5418299|NCT00020150|recurrent neuroblastoma|recurrent neuroblastoma
5418300|NCT00020150|recurrent childhood liver cancer|recurrent childhood liver cancer
5418301|NCT00020150|recurrent Wilms tumor and other childhood kidney tumors|recurrent wilms tumor and other childhood kidney tumors
5418302|NCT00020150|childhood central nervous system germ cell tumor|childhood central nervous system germ cell tumor
5418303|NCT00020150|recurrent osteosarcoma|recurrent osteosarcoma
5439503|NCT00022828|Spinal|spinal
5418304|NCT00020150|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
5418305|NCT00020150|childhood germ cell tumor|childhood germ cell tumor
5418306|NCT00020150|recurrent childhood soft tissue sarcoma|recurrent childhood soft tissue sarcoma
5418307|NCT00020150|childhood oligodendroglioma|childhood oligodendroglioma
5418308|NCT00020150|childhood choroid plexus tumor|childhood choroid plexus tumor
5418309|NCT00020150|childhood grade I meningioma|childhood grade i meningioma
5418310|NCT00020150|childhood grade II meningioma|childhood grade ii meningioma
5418311|NCT00020150|childhood grade III meningioma|childhood grade iii meningioma
5418312|NCT00020150|recurrent childhood cerebellar astrocytoma|recurrent childhood cerebellar astrocytoma
5418313|NCT00020150|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
5418314|NCT00020150|recurrent childhood medulloblastoma|recurrent childhood medulloblastoma
5418315|NCT00020150|recurrent childhood visual pathway and hypothalamic glioma|recurrent childhood visual pathway and hypothalamic glioma
5418316|NCT00020150|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
5418317|NCT00020150|recurrent Ewing sarcoma/peripheral primitive neuroectodermal tumor|recurrent ewing sarcoma/peripheral primitive neuroectodermal tumor
5418318|NCT00020150|recurrent childhood ependymoma|recurrent childhood ependymoma
5418319|NCT00020150|childhood teratoma|childhood teratoma
5418320|NCT00020150|childhood malignant testicular germ cell tumor|childhood malignant testicular germ cell tumor
5418321|NCT00020150|childhood extragonadal germ cell tumor|childhood extragonadal germ cell tumor
5418322|NCT00020150|childhood malignant ovarian germ cell tumor|childhood malignant ovarian germ cell tumor
5418323|NCT00020150|recurrent childhood malignant germ cell tumor|recurrent childhood malignant germ cell tumor
5418324|NCT00020124|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5418325|NCT00020124|extensive stage small cell lung cancer|extensive stage small cell lung cancer
5418326|NCT00020124|recurrent small cell lung cancer|recurrent small cell lung cancer
5418327|NCT00020124|advanced malignant mesothelioma|advanced malignant mesothelioma
5418328|NCT00020124|recurrent malignant mesothelioma|recurrent malignant mesothelioma
5418329|NCT00020124|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5418330|NCT00020124|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5418331|NCT00020124|pulmonary carcinoid tumor|pulmonary carcinoid tumor
5418332|NCT00020124|lung metastases|lung metastases
5418333|NCT00020111|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5418334|NCT00020111|childhood acute promyelocytic leukemia (M3)|childhood acute promyelocytic leukemia (m3)
5418335|NCT00020111|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5418336|NCT00020111|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
5418337|NCT00020111|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
5418338|NCT00020111|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
5418339|NCT00020111|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
5418340|NCT00020111|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
5418341|NCT00020111|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
5418342|NCT00020072|cutaneous T-cell non-Hodgkin lymphoma|cutaneous t-cell non-hodgkin lymphoma
5418343|NCT00020072|mycosis fungoides/Sezary syndrome|mycosis fungoides/sezary syndrome
5418344|NCT00020007|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5418345|NCT00020007|limited stage small cell lung cancer|limited stage small cell lung cancer
5418346|NCT00020007|extensive stage small cell lung cancer|extensive stage small cell lung cancer
5418347|NCT00020007|recurrent small cell lung cancer|recurrent small cell lung cancer
5418348|NCT00020007|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5418349|NCT00020007|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5418350|NCT00020007|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5418351|NCT00020007|lung metastases|lung metastases
5418352|NCT00020007|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
5418353|NCT00020007|pulmonary carcinoid tumor|pulmonary carcinoid tumor
5418354|NCT00019994|stage IV melanoma|stage iv melanoma
5418355|NCT00019994|recurrent melanoma|recurrent melanoma
5418356|NCT00019955|stage I renal cell cancer|stage i renal cell cancer
5418357|NCT00019955|stage II renal cell cancer|stage ii renal cell cancer
5418358|NCT00019929|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5418359|NCT00019929|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5418360|NCT00019916|stage IV breast cancer|stage iv breast cancer
5418361|NCT00019916|recurrent breast cancer|recurrent breast cancer
5418362|NCT00019916|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5418363|NCT00019916|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5418364|NCT00019864|cardiac toxicity|cardiac toxicity
5418365|NCT00019864|localized osteosarcoma|localized osteosarcoma
5418366|NCT00019864|metastatic osteosarcoma|metastatic osteosarcoma
5418367|NCT00019864|recurrent osteosarcoma|recurrent osteosarcoma
5418368|NCT00019838|Waldenström macroglobulinemia|waldenström macroglobulinemia
5418369|NCT00019838|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5418370|NCT00019838|refractory hairy cell leukemia|refractory hairy cell leukemia
5418371|NCT00019838|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5418372|NCT00019838|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5418374|NCT00019838|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5418375|NCT00019838|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5418376|NCT00019838|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5418377|NCT00019838|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5418378|NCT00019838|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5418379|NCT00019825|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5418380|NCT00019825|stage II esophageal cancer|stage ii esophageal cancer
5418381|NCT00019825|stage III esophageal cancer|stage iii esophageal cancer
5418382|NCT00019825|stage IV esophageal cancer|stage iv esophageal cancer
5418383|NCT00019825|recurrent esophageal cancer|recurrent esophageal cancer
5418384|NCT00019825|extensive stage small cell lung cancer|extensive stage small cell lung cancer
5418385|NCT00019825|recurrent small cell lung cancer|recurrent small cell lung cancer
5418386|NCT00019825|advanced malignant mesothelioma|advanced malignant mesothelioma
5418387|NCT00019825|recurrent malignant mesothelioma|recurrent malignant mesothelioma
5418388|NCT00019825|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5418389|NCT00019825|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5418390|NCT00019825|malignant pleural effusion|malignant pleural effusion
5418391|NCT00019812|stage IV breast cancer|stage iv breast cancer
5418392|NCT00019812|male breast cancer|male breast cancer
5418393|NCT00019786|stage IV colon cancer|stage iv colon cancer
5418394|NCT00019786|stage IV rectal cancer|stage iv rectal cancer
5418395|NCT00019786|recurrent colon cancer|recurrent colon cancer
5418396|NCT00019786|recurrent rectal cancer|recurrent rectal cancer
5418397|NCT00019786|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
5418398|NCT00019786|recurrent adult primary liver cancer|recurrent adult primary liver cancer
5418399|NCT00019786|recurrent islet cell carcinoma|recurrent islet cell carcinoma
5418400|NCT00019786|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
5418401|NCT00019786|adenocarcinoma of the colon|adenocarcinoma of the colon
5418402|NCT00019786|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5418403|NCT00019786|liver metastases|liver metastases
5418404|NCT00019786|adult primary cholangiocellular carcinoma|adult primary cholangiocellular carcinoma
5418405|NCT00019786|advanced adult primary liver cancer|advanced adult primary liver cancer
5418406|NCT00019786|recurrent childhood liver cancer|recurrent childhood liver cancer
5418407|NCT00019786|childhood hepatocellular carcinoma|childhood hepatocellular carcinoma
5418408|NCT00019786|stage III childhood liver cancer|stage iii childhood liver cancer
5418409|NCT00019786|stage IV childhood liver cancer|stage iv childhood liver cancer
5418410|NCT00019786|neuroendocrine carcinoma|neuroendocrine carcinoma
5418411|NCT00019773|stage I colon cancer|stage i colon cancer
5418412|NCT00019773|stage II colon cancer|stage ii colon cancer
5418413|NCT00019773|stage III colon cancer|stage iii colon cancer
5418414|NCT00019773|stage IV colon cancer|stage iv colon cancer
5418415|NCT00019773|stage 0 colon cancer|stage 0 colon cancer
5418416|NCT00019773|stage 0 rectal cancer|stage 0 rectal cancer
5418417|NCT00019773|stage I rectal cancer|stage i rectal cancer
5418418|NCT00019773|stage II rectal cancer|stage ii rectal cancer
5418419|NCT00019773|stage III rectal cancer|stage iii rectal cancer
5418420|NCT00019773|stage IV rectal cancer|stage iv rectal cancer
5418421|NCT00019773|recurrent colon cancer|recurrent colon cancer
5418422|NCT00019773|recurrent rectal cancer|recurrent rectal cancer
5418423|NCT00019773|small intestine adenocarcinoma|small intestine adenocarcinoma
5418424|NCT00019773|small intestine lymphoma|small intestine lymphoma
5418425|NCT00019773|small intestine leiomyosarcoma|small intestine leiomyosarcoma
5418426|NCT00019773|recurrent small intestine cancer|recurrent small intestine cancer
5418427|NCT00019773|carcinoma of the appendix|carcinoma of the appendix
5418428|NCT00019747|stage IV colon cancer|stage iv colon cancer
5418429|NCT00019747|stage IV rectal cancer|stage iv rectal cancer
5418430|NCT00019747|recurrent colon cancer|recurrent colon cancer
5418431|NCT00019747|recurrent rectal cancer|recurrent rectal cancer
5418432|NCT00019669|stage IV melanoma|stage iv melanoma
5418433|NCT00019669|recurrent melanoma|recurrent melanoma
5418434|NCT00019656|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5418435|NCT00019656|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5418436|NCT00019656|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5418437|NCT00019656|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5418438|NCT00019656|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5418439|NCT00019656|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5418440|NCT00019656|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5418441|NCT00019656|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5418442|NCT00019656|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5418443|NCT00019656|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5418444|NCT00019656|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5418445|NCT00019656|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5418446|NCT00019656|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5418447|NCT00019656|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5418448|NCT00019656|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5418449|NCT00019656|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5418450|NCT00019656|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5418451|NCT00019656|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5418452|NCT00019656|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5418453|NCT00019656|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5418454|NCT00019656|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5418455|NCT00019656|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5418456|NCT00019656|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5418457|NCT00019656|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5418458|NCT00019656|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5418459|NCT00019656|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5418460|NCT00019656|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5418461|NCT00019656|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5418462|NCT00019656|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5418463|NCT00019656|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
5418464|NCT00019656|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
5418465|NCT00019656|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5418466|NCT00019656|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5418467|NCT00019656|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5418468|NCT00019656|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5418469|NCT00019656|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5418470|NCT00019656|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5418471|NCT00019656|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5418472|NCT00019604|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
5418473|NCT00019604|recurrent adult primary liver cancer|recurrent adult primary liver cancer
5418474|NCT00019604|liver metastases|liver metastases
5418475|NCT00019604|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5418476|NCT00019591|stage III colon cancer|stage iii colon cancer
5418477|NCT00019591|stage IV colon cancer|stage iv colon cancer
5418478|NCT00019591|stage III rectal cancer|stage iii rectal cancer
5418479|NCT00019591|stage IV rectal cancer|stage iv rectal cancer
5418480|NCT00019591|recurrent colon cancer|recurrent colon cancer
5418481|NCT00019591|recurrent rectal cancer|recurrent rectal cancer
5418482|NCT00019565|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5418483|NCT00019513|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5418484|NCT00019513|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5425853|NCT00051285|failure|failure
5418485|NCT00019513|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
5418486|NCT00019513|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5418487|NCT00019513|small intestine lymphoma|small intestine lymphoma
5418488|NCT00019513|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5418489|NCT00019513|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5418490|NCT00019513|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5418491|NCT00019513|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5418492|NCT00019513|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5418493|NCT00019513|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5418494|NCT00019513|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5418495|NCT00019513|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5418496|NCT00019513|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5418497|NCT00019513|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5418498|NCT00019513|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5418499|NCT00019513|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5418500|NCT00019513|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5418501|NCT00019513|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5418502|NCT00019513|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5418503|NCT00019513|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5418504|NCT00019513|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5418505|NCT00019513|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5418506|NCT00019513|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5418507|NCT00019513|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
5418508|NCT00019513|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
5418509|NCT00019513|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5418510|NCT00019513|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5418511|NCT00019513|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5418512|NCT00019513|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
5418513|NCT00019513|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5418514|NCT00019513|recurrent adult primary liver cancer|recurrent adult primary liver cancer
5418515|NCT00019513|advanced adult primary liver cancer|advanced adult primary liver cancer
5418516|NCT00019513|adult primary cholangiocellular carcinoma|adult primary cholangiocellular carcinoma
5418517|NCT00019513|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5418518|NCT00019513|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5418519|NCT00019513|extensive stage small cell lung cancer|extensive stage small cell lung cancer
5418520|NCT00019513|recurrent small cell lung cancer|recurrent small cell lung cancer
5418521|NCT00019513|recurrent pancreatic cancer|recurrent pancreatic cancer
5418522|NCT00019513|stage IV esophageal cancer|stage iv esophageal cancer
5418523|NCT00019513|recurrent esophageal cancer|recurrent esophageal cancer
5418524|NCT00019513|recurrent colon cancer|recurrent colon cancer
5418525|NCT00019513|stage IV colon cancer|stage iv colon cancer
5418526|NCT00019513|recurrent gallbladder cancer|recurrent gallbladder cancer
5418527|NCT00019513|unresectable gallbladder cancer|unresectable gallbladder cancer
5418528|NCT00019513|cholangiocarcinoma of the gallbladder|cholangiocarcinoma of the gallbladder
5418529|NCT00019513|unresectable extrahepatic bile duct cancer|unresectable extrahepatic bile duct cancer
5418530|NCT00019513|recurrent extrahepatic bile duct cancer|recurrent extrahepatic bile duct cancer
5418531|NCT00019513|cholangiocarcinoma of the extrahepatic bile duct|cholangiocarcinoma of the extrahepatic bile duct
5418532|NCT00019513|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5418533|NCT00019513|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5418534|NCT00019513|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5418535|NCT00019513|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5418536|NCT00019513|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5418537|NCT00019513|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5418538|NCT00019513|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5418539|NCT00019513|stage IV pancreatic cancer|stage iv pancreatic cancer
5418540|NCT00019487|stage IV melanoma|stage iv melanoma
5418541|NCT00019487|recurrent melanoma|recurrent melanoma
5418542|NCT00019461|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5418543|NCT00019461|fallopian tube cancer|fallopian tube cancer
5418544|NCT00019461|primary peritoneal cavity cancer|primary peritoneal cavity cancer
5418545|NCT00019422|childhood low-grade cerebral astrocytoma|childhood low-grade cerebral astrocytoma
5418546|NCT00019422|recurrent childhood supratentorial primitive neuroectodermal tumor|recurrent childhood supratentorial primitive neuroectodermal tumor
5418547|NCT00019422|recurrent childhood cerebellar astrocytoma|recurrent childhood cerebellar astrocytoma
5418548|NCT00019422|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
5418549|NCT00019422|recurrent childhood medulloblastoma|recurrent childhood medulloblastoma
5418550|NCT00019422|untreated childhood visual pathway and hypothalamic glioma|untreated childhood visual pathway and hypothalamic glioma
5418551|NCT00019422|recurrent childhood visual pathway and hypothalamic glioma|recurrent childhood visual pathway and hypothalamic glioma
5418552|NCT00019422|recurrent childhood ependymoma|recurrent childhood ependymoma
5418553|NCT00019331|stage IV colon cancer|stage iv colon cancer
5418554|NCT00019331|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5418555|NCT00019331|stage II pancreatic cancer|stage ii pancreatic cancer
5418556|NCT00019331|stage III pancreatic cancer|stage iii pancreatic cancer
5418557|NCT00019331|recurrent pancreatic cancer|recurrent pancreatic cancer
5418558|NCT00019331|recurrent colon cancer|recurrent colon cancer
5418559|NCT00019331|extensive stage small cell lung cancer|extensive stage small cell lung cancer
5418560|NCT00019331|recurrent small cell lung cancer|recurrent small cell lung cancer
5418561|NCT00019331|advanced adult primary liver cancer|advanced adult primary liver cancer
5418562|NCT00019331|recurrent adult primary liver cancer|recurrent adult primary liver cancer
5418563|NCT00019331|stage IV endometrial carcinoma|stage iv endometrial carcinoma
5418564|NCT00019331|recurrent endometrial carcinoma|recurrent endometrial carcinoma
5418565|NCT00019331|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
5418566|NCT00019331|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
5418567|NCT00019331|stage IV papillary thyroid cancer|stage iv papillary thyroid cancer
5418568|NCT00019331|stage IV follicular thyroid cancer|stage iv follicular thyroid cancer
5418569|NCT00019331|thyroid gland medullary carcinoma|thyroid gland medullary carcinoma
5418570|NCT00019331|anaplastic thyroid cancer|anaplastic thyroid cancer
5418571|NCT00019331|recurrent thyroid cancer|recurrent thyroid cancer
5418572|NCT00019331|stage IV melanoma|stage iv melanoma
5418573|NCT00019331|recurrent melanoma|recurrent melanoma
5418574|NCT00019331|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5418575|NCT00019331|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5418576|NCT00019331|untreated metastatic squamous neck cancer with occult primary|untreated metastatic squamous neck cancer with occult primary
5418577|NCT00019331|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
5418578|NCT00019331|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
5418579|NCT00019331|pulmonary carcinoid tumor|pulmonary carcinoid tumor
5418671|NCT00019110|stage IV basal cell carcinoma of the lip|stage iv basal cell carcinoma of the lip
5439504|NCT00022828|Spine|spine
5418580|NCT00019331|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5418581|NCT00019331|stage IV basal cell carcinoma of the lip|stage iv basal cell carcinoma of the lip
5418582|NCT00019331|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
5418583|NCT00019331|stage IV mucoepidermoid carcinoma of the oral cavity|stage iv mucoepidermoid carcinoma of the oral cavity
5418584|NCT00019331|stage IV adenoid cystic carcinoma of the oral cavity|stage iv adenoid cystic carcinoma of the oral cavity
5418585|NCT00019331|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
5418586|NCT00019331|recurrent basal cell carcinoma of the lip|recurrent basal cell carcinoma of the lip
5418587|NCT00019331|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
5418588|NCT00019331|recurrent mucoepidermoid carcinoma of the oral cavity|recurrent mucoepidermoid carcinoma of the oral cavity
5418589|NCT00019331|recurrent adenoid cystic carcinoma of the oral cavity|recurrent adenoid cystic carcinoma of the oral cavity
5418590|NCT00019331|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5418591|NCT00019331|stage IV lymphoepithelioma of the oropharynx|stage iv lymphoepithelioma of the oropharynx
5418592|NCT00019331|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
5418593|NCT00019331|recurrent lymphoepithelioma of the oropharynx|recurrent lymphoepithelioma of the oropharynx
5418594|NCT00019331|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
5418595|NCT00019331|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
5418596|NCT00019331|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
5418597|NCT00019331|recurrent lymphoepithelioma of the nasopharynx|recurrent lymphoepithelioma of the nasopharynx
5418598|NCT00019331|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5418599|NCT00019331|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
5418600|NCT00019331|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5418601|NCT00019331|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
5418602|NCT00019331|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
5418603|NCT00019331|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
5418604|NCT00019331|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
5418605|NCT00019331|stage IV inverted papilloma of the paranasal sinus and nasal cavity|stage iv inverted papilloma of the paranasal sinus and nasal cavity
5418606|NCT00019331|stage IV midline lethal granuloma of the paranasal sinus and nasal cavity|stage iv midline lethal granuloma of the paranasal sinus and nasal cavity
5418607|NCT00019331|stage IV esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iv esthesioneuroblastoma of the paranasal sinus and nasal cavity
5418608|NCT00019331|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
5418609|NCT00019331|recurrent inverted papilloma of the paranasal sinus and nasal cavity|recurrent inverted papilloma of the paranasal sinus and nasal cavity
5418610|NCT00019331|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity
5418611|NCT00019331|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity
5418612|NCT00019331|insular thyroid cancer|insular thyroid cancer
5418613|NCT00019331|recurrent salivary gland cancer|recurrent salivary gland cancer
5418614|NCT00019331|stage IV salivary gland cancer|stage iv salivary gland cancer
5418615|NCT00019331|stage IV pancreatic cancer|stage iv pancreatic cancer
5418616|NCT00019227|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
5418617|NCT00019227|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
5418618|NCT00019227|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
5418619|NCT00019227|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
5418620|NCT00019227|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
5418621|NCT00019227|radiation toxicity|radiation toxicity
5418622|NCT00019214|recurrent melanoma|recurrent melanoma
5418623|NCT00019201|stage I non-small cell lung cancer|stage i non-small cell lung cancer
5418624|NCT00019201|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
5418625|NCT00019201|stage III non-small cell lung cancer|stage iii non-small cell lung cancer
5418626|NCT00019201|limited stage small cell lung cancer|limited stage small cell lung cancer
5418627|NCT00019201|stage I nasopharyngeal cancer|stage i nasopharyngeal cancer
5418628|NCT00019201|stage II nasopharyngeal cancer|stage ii nasopharyngeal cancer
5418629|NCT00019201|stage III nasopharyngeal cancer|stage iii nasopharyngeal cancer
5418630|NCT00019201|stage I lip and oral cavity cancer|stage i lip and oral cavity cancer
5418631|NCT00019201|stage II lip and oral cavity cancer|stage ii lip and oral cavity cancer
5418632|NCT00019201|stage III lip and oral cavity cancer|stage iii lip and oral cavity cancer
5418633|NCT00019201|stage I hypopharyngeal cancer|stage i hypopharyngeal cancer
5418634|NCT00019201|stage II hypopharyngeal cancer|stage ii hypopharyngeal cancer
5418635|NCT00019201|stage III hypopharyngeal cancer|stage iii hypopharyngeal cancer
5418636|NCT00019201|stage I laryngeal cancer|stage i laryngeal cancer
5418637|NCT00019201|stage II laryngeal cancer|stage ii laryngeal cancer
5418638|NCT00019201|stage III laryngeal cancer|stage iii laryngeal cancer
5419011|NCT00016952|stage IV rectal cancer|stage iv rectal cancer
5418639|NCT00019201|stage I paranasal sinus and nasal cavity cancer|stage i paranasal sinus and nasal cavity cancer
5418640|NCT00019201|stage II paranasal sinus and nasal cavity cancer|stage ii paranasal sinus and nasal cavity cancer
5418641|NCT00019201|stage III paranasal sinus and nasal cavity cancer|stage iii paranasal sinus and nasal cavity cancer
5418642|NCT00019201|stage I oropharyngeal cancer|stage i oropharyngeal cancer
5418643|NCT00019201|stage II oropharyngeal cancer|stage ii oropharyngeal cancer
5418644|NCT00019201|stage III oropharyngeal cancer|stage iii oropharyngeal cancer
5418645|NCT00019136|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5418646|NCT00019110|stage IV anal cancer|stage iv anal cancer
5418647|NCT00019110|recurrent anal cancer|recurrent anal cancer
5418648|NCT00019110|stage II esophageal cancer|stage ii esophageal cancer
5418649|NCT00019110|stage III esophageal cancer|stage iii esophageal cancer
5418650|NCT00019110|stage IV esophageal cancer|stage iv esophageal cancer
5418651|NCT00019110|stage IIIA anal cancer|stage iiia anal cancer
5418652|NCT00019110|stage IIIB anal cancer|stage iiib anal cancer
5418653|NCT00019110|recurrent esophageal cancer|recurrent esophageal cancer
5418654|NCT00019110|stage III cervical cancer|stage iii cervical cancer
5418655|NCT00019110|stage IV cervical cancer|stage iv cervical cancer
5418656|NCT00019110|recurrent cervical cancer|recurrent cervical cancer
5418657|NCT00019110|stage III vulvar cancer|stage iii vulvar cancer
5418658|NCT00019110|stage IVB vulvar cancer|stage ivb vulvar cancer
5418659|NCT00019110|recurrent vulvar cancer|recurrent vulvar cancer
5418660|NCT00019110|stage III penile cancer|stage iii penile cancer
5418661|NCT00019110|stage IV penile cancer|stage iv penile cancer
5418662|NCT00019110|recurrent penile cancer|recurrent penile cancer
5418663|NCT00019110|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
5418664|NCT00019110|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
5418665|NCT00019110|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
5418666|NCT00019110|stage III basal cell carcinoma of the lip|stage iii basal cell carcinoma of the lip
5418667|NCT00019110|stage III verrucous carcinoma of the oral cavity|stage iii verrucous carcinoma of the oral cavity
5418668|NCT00019110|stage III mucoepidermoid carcinoma of the oral cavity|stage iii mucoepidermoid carcinoma of the oral cavity
5418669|NCT00019110|stage III adenoid cystic carcinoma of the oral cavity|stage iii adenoid cystic carcinoma of the oral cavity
5418670|NCT00019110|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5425854|NCT00051285|congestive|congestive
5418672|NCT00019110|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
5418673|NCT00019110|stage IV mucoepidermoid carcinoma of the oral cavity|stage iv mucoepidermoid carcinoma of the oral cavity
5418674|NCT00019110|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
5418675|NCT00019110|recurrent basal cell carcinoma of the lip|recurrent basal cell carcinoma of the lip
5418676|NCT00019110|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
5418677|NCT00019110|recurrent mucoepidermoid carcinoma of the oral cavity|recurrent mucoepidermoid carcinoma of the oral cavity
5418678|NCT00019110|recurrent adenoid cystic carcinoma of the oral cavity|recurrent adenoid cystic carcinoma of the oral cavity
5418679|NCT00019110|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
5418680|NCT00019110|stage III lymphoepithelioma of the oropharynx|stage iii lymphoepithelioma of the oropharynx
5418681|NCT00019110|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5418682|NCT00019110|stage IV lymphoepithelioma of the oropharynx|stage iv lymphoepithelioma of the oropharynx
5418683|NCT00019110|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
5418684|NCT00019110|recurrent lymphoepithelioma of the oropharynx|recurrent lymphoepithelioma of the oropharynx
5418685|NCT00019110|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
5418686|NCT00019110|stage III lymphoepithelioma of the nasopharynx|stage iii lymphoepithelioma of the nasopharynx
5418687|NCT00019110|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
5418688|NCT00019110|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
5418689|NCT00019110|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
5418690|NCT00019110|recurrent lymphoepithelioma of the nasopharynx|recurrent lymphoepithelioma of the nasopharynx
5418691|NCT00019110|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
5418692|NCT00019110|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5418693|NCT00019110|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
5418694|NCT00019110|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
5418695|NCT00019110|stage III verrucous carcinoma of the larynx|stage iii verrucous carcinoma of the larynx
5418696|NCT00019110|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5418697|NCT00019110|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
5418698|NCT00019110|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
5418699|NCT00019110|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
5418700|NCT00019110|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
5418701|NCT00019110|stage III inverted papilloma of the paranasal sinus and nasal cavity|stage iii inverted papilloma of the paranasal sinus and nasal cavity
5418702|NCT00019110|stage III midline lethal granuloma of the paranasal sinus and nasal cavity|stage iii midline lethal granuloma of the paranasal sinus and nasal cavity
5418703|NCT00019110|stage III esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iii esthesioneuroblastoma of the paranasal sinus and nasal cavity
5418704|NCT00019110|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
5418705|NCT00019110|stage IV inverted papilloma of the paranasal sinus and nasal cavity|stage iv inverted papilloma of the paranasal sinus and nasal cavity
5418706|NCT00019110|stage IV midline lethal granuloma of the paranasal sinus and nasal cavity|stage iv midline lethal granuloma of the paranasal sinus and nasal cavity
5418707|NCT00019110|stage IV esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iv esthesioneuroblastoma of the paranasal sinus and nasal cavity
5418708|NCT00019110|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
5418709|NCT00019110|recurrent inverted papilloma of the paranasal sinus and nasal cavity|recurrent inverted papilloma of the paranasal sinus and nasal cavity
5418710|NCT00019110|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity
5418711|NCT00019110|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity
5418712|NCT00019110|recurrent salivary gland cancer|recurrent salivary gland cancer
5418713|NCT00019110|stage IV salivary gland cancer|stage iv salivary gland cancer
5418714|NCT00019110|stage III salivary gland cancer|stage iii salivary gland cancer
5418715|NCT00019032|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5418716|NCT00019032|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
5418717|NCT00019019|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5418718|NCT00019019|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5418719|NCT00019019|stage IV breast cancer|stage iv breast cancer
5418720|NCT00019019|stage IIIA breast cancer|stage iiia breast cancer
5418721|NCT00019019|recurrent breast cancer|recurrent breast cancer
5418722|NCT00019019|stage IIIB breast cancer|stage iiib breast cancer
5418723|NCT00019019|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5418724|NCT00019019|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5418725|NCT00019019|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
5418726|NCT00019019|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
5418727|NCT00019019|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5418728|NCT00019019|stage III renal cell cancer|stage iii renal cell cancer
5418729|NCT00019019|stage IV renal cell cancer|stage iv renal cell cancer
5418730|NCT00019019|recurrent renal cell cancer|recurrent renal cell cancer
5418731|NCT00019019|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5418732|NCT00019019|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5418733|NCT00019019|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5418734|NCT00019019|recurrent adult brain tumor|recurrent adult brain tumor
5418735|NCT00019019|small intestine lymphoma|small intestine lymphoma
5418736|NCT00019019|adult brain stem glioma|adult brain stem glioma
5418737|NCT00019019|adult craniopharyngioma|adult craniopharyngioma
5418738|NCT00019019|adult medulloblastoma|adult medulloblastoma
5418739|NCT00019019|adult meningioma|adult meningioma
5418740|NCT00019019|adult glioblastoma|adult glioblastoma
5418741|NCT00019019|stage III melanoma|stage iii melanoma
5418742|NCT00019019|stage IV melanoma|stage iv melanoma
5418743|NCT00019019|recurrent melanoma|recurrent melanoma
5418744|NCT00019019|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5418745|NCT00019019|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5418746|NCT00019019|stage IIIC breast cancer|stage iiic breast cancer
5418747|NCT00019019|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5418748|NCT00019019|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5418749|NCT00019019|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5418750|NCT00019019|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5418751|NCT00019019|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5418752|NCT00019019|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5418753|NCT00019019|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5418754|NCT00019019|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5418755|NCT00019019|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5418756|NCT00019019|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5418757|NCT00019019|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5418758|NCT00019019|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5418759|NCT00019019|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5418760|NCT00019019|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5425855|NCT00051285|enoximone|enoximone
5418761|NCT00019019|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5418762|NCT00019019|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5418763|NCT00019019|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5418764|NCT00019019|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5418765|NCT00019019|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5418766|NCT00019019|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5418767|NCT00019019|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5418768|NCT00019019|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5418769|NCT00019019|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5418770|NCT00019019|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5418771|NCT00019019|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5418772|NCT00019019|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5418773|NCT00019019|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5418774|NCT00019019|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5418775|NCT00019019|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5418776|NCT00019019|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
5418777|NCT00019019|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
5418778|NCT00019019|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
5418779|NCT00019019|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5418780|NCT00019019|adult myxopapillary ependymoma|adult myxopapillary ependymoma
5418781|NCT00019019|adult anaplastic ependymoma|adult anaplastic ependymoma
5418782|NCT00019019|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
5418783|NCT00019019|adult mixed glioma|adult mixed glioma
5418784|NCT00019019|adult central nervous system germ cell tumor|adult central nervous system germ cell tumor
5418785|NCT00019019|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
5418786|NCT00019019|adult pilocytic astrocytoma|adult pilocytic astrocytoma
5418787|NCT00019019|adult subependymoma|adult subependymoma
5418788|NCT00019019|adult ependymoblastoma|adult ependymoblastoma
5418789|NCT00019019|adult pineocytoma|adult pineocytoma
5418790|NCT00019019|adult pineoblastoma|adult pineoblastoma
5418791|NCT00019019|adult meningeal hemangiopericytoma|adult meningeal hemangiopericytoma
5418792|NCT00019019|intraocular lymphoma|intraocular lymphoma
5418793|NCT00019019|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5418794|NCT00019019|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5418795|NCT00019019|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5418796|NCT00019019|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
5418797|NCT00019019|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5418798|NCT00019019|adult choroid plexus tumor|adult choroid plexus tumor
5418799|NCT00019019|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
5418800|NCT00019019|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
5418801|NCT00019019|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5418802|NCT00019019|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5418803|NCT00019019|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5418804|NCT00019019|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5418805|NCT00019019|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5418806|NCT00019019|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5418807|NCT00019019|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5418808|NCT00019019|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5418809|NCT00019019|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5418810|NCT00019019|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5418811|NCT00019019|adult grade III meningioma|adult grade iii meningioma
5418812|NCT00019019|adult oligodendroglioma|adult oligodendroglioma
5418813|NCT00019019|adult giant cell glioblastoma|adult giant cell glioblastoma
5418814|NCT00019019|adult gliosarcoma|adult gliosarcoma
5418815|NCT00018967|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
5418816|NCT00018967|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5418817|NCT00018967|neurotoxicity|neurotoxicity
5418818|NCT00017602|refractory multiple myeloma|refractory multiple myeloma
5418819|NCT00017602|stage I multiple myeloma|stage i multiple myeloma
5418820|NCT00017602|stage II multiple myeloma|stage ii multiple myeloma
5418821|NCT00017602|stage III multiple myeloma|stage iii multiple myeloma
5418822|NCT00017589|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5418823|NCT00017563|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5418824|NCT00017563|stage II prostate cancer|stage ii prostate cancer
5418825|NCT00017563|stage III prostate cancer|stage iii prostate cancer
5418826|NCT00017550|refractory anemia|refractory anemia
5418827|NCT00017550|refractory anemia with excess blasts|refractory anemia with excess blasts
5418828|NCT00017550|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5418829|NCT00017550|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5418830|NCT00017524|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5418831|NCT00017511|stage I salivary gland cancer|stage i salivary gland cancer
5418832|NCT00017511|stage II salivary gland cancer|stage ii salivary gland cancer
5418833|NCT00017511|stage III salivary gland cancer|stage iii salivary gland cancer
5418834|NCT00017511|stage IV salivary gland cancer|stage iv salivary gland cancer
5418835|NCT00017511|recurrent salivary gland cancer|recurrent salivary gland cancer
5418836|NCT00017511|untreated metastatic squamous neck cancer with occult primary|untreated metastatic squamous neck cancer with occult primary
5418837|NCT00017511|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
5418838|NCT00017511|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
5418839|NCT00017511|oral complications|oral complications
5418840|NCT00017511|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
5418841|NCT00017511|stage I basal cell carcinoma of the lip|stage i basal cell carcinoma of the lip
5418842|NCT00017511|stage I verrucous carcinoma of the oral cavity|stage i verrucous carcinoma of the oral cavity
5418843|NCT00017511|stage I mucoepidermoid carcinoma of the oral cavity|stage i mucoepidermoid carcinoma of the oral cavity
5418844|NCT00017511|stage I adenoid cystic carcinoma of the oral cavity|stage i adenoid cystic carcinoma of the oral cavity
5418845|NCT00017511|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
5418846|NCT00017511|stage II basal cell carcinoma of the lip|stage ii basal cell carcinoma of the lip
5418847|NCT00017511|stage II verrucous carcinoma of the oral cavity|stage ii verrucous carcinoma of the oral cavity
5418848|NCT00017511|stage II mucoepidermoid carcinoma of the oral cavity|stage ii mucoepidermoid carcinoma of the oral cavity
5418849|NCT00017511|stage II adenoid cystic carcinoma of the oral cavity|stage ii adenoid cystic carcinoma of the oral cavity
5418850|NCT00017511|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
5418851|NCT00017511|stage III basal cell carcinoma of the lip|stage iii basal cell carcinoma of the lip
5418852|NCT00017511|stage III verrucous carcinoma of the oral cavity|stage iii verrucous carcinoma of the oral cavity
5418853|NCT00017511|stage III mucoepidermoid carcinoma of the oral cavity|stage iii mucoepidermoid carcinoma of the oral cavity
5418854|NCT00017511|stage III adenoid cystic carcinoma of the oral cavity|stage iii adenoid cystic carcinoma of the oral cavity
5419037|NCT00016406|stage IIIB breast cancer|stage iiib breast cancer
5418855|NCT00017511|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5418856|NCT00017511|stage IV basal cell carcinoma of the lip|stage iv basal cell carcinoma of the lip
5418857|NCT00017511|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
5418858|NCT00017511|stage IV mucoepidermoid carcinoma of the oral cavity|stage iv mucoepidermoid carcinoma of the oral cavity
5418859|NCT00017511|stage IV adenoid cystic carcinoma of the oral cavity|stage iv adenoid cystic carcinoma of the oral cavity
5418860|NCT00017511|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
5418861|NCT00017511|recurrent basal cell carcinoma of the lip|recurrent basal cell carcinoma of the lip
5418862|NCT00017511|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
5418863|NCT00017511|recurrent mucoepidermoid carcinoma of the oral cavity|recurrent mucoepidermoid carcinoma of the oral cavity
5418864|NCT00017511|recurrent adenoid cystic carcinoma of the oral cavity|recurrent adenoid cystic carcinoma of the oral cavity
5418865|NCT00017511|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
5418866|NCT00017511|stage I lymphoepithelioma of the oropharynx|stage i lymphoepithelioma of the oropharynx
5418867|NCT00017511|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
5418868|NCT00017511|stage II lymphoepithelioma of the oropharynx|stage ii lymphoepithelioma of the oropharynx
5418869|NCT00017511|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
5418870|NCT00017511|stage III lymphoepithelioma of the oropharynx|stage iii lymphoepithelioma of the oropharynx
5418871|NCT00017511|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5418872|NCT00017511|stage IV lymphoepithelioma of the oropharynx|stage iv lymphoepithelioma of the oropharynx
5418873|NCT00017511|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
5418874|NCT00017511|recurrent lymphoepithelioma of the oropharynx|recurrent lymphoepithelioma of the oropharynx
5418875|NCT00017511|stage I squamous cell carcinoma of the nasopharynx|stage i squamous cell carcinoma of the nasopharynx
5418876|NCT00017511|stage I lymphoepithelioma of the nasopharynx|stage i lymphoepithelioma of the nasopharynx
5418877|NCT00017511|stage II squamous cell carcinoma of the nasopharynx|stage ii squamous cell carcinoma of the nasopharynx
5418878|NCT00017511|stage II lymphoepithelioma of the nasopharynx|stage ii lymphoepithelioma of the nasopharynx
5418879|NCT00017511|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
5418880|NCT00017511|stage III lymphoepithelioma of the nasopharynx|stage iii lymphoepithelioma of the nasopharynx
5418881|NCT00017511|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
5418882|NCT00017511|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
5418883|NCT00017511|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
5418884|NCT00017511|recurrent lymphoepithelioma of the nasopharynx|recurrent lymphoepithelioma of the nasopharynx
5418885|NCT00017511|stage I squamous cell carcinoma of the hypopharynx|stage i squamous cell carcinoma of the hypopharynx
5418886|NCT00017511|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
5418887|NCT00017511|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
5419012|NCT00016952|recurrent colon cancer|recurrent colon cancer
5418888|NCT00017511|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5418889|NCT00017511|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
5418890|NCT00017511|stage I squamous cell carcinoma of the larynx|stage i squamous cell carcinoma of the larynx
5418891|NCT00017511|stage I verrucous carcinoma of the larynx|stage i verrucous carcinoma of the larynx
5418892|NCT00017511|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
5418893|NCT00017511|stage II verrucous carcinoma of the larynx|stage ii verrucous carcinoma of the larynx
5418894|NCT00017511|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
5418895|NCT00017511|stage III verrucous carcinoma of the larynx|stage iii verrucous carcinoma of the larynx
5418896|NCT00017511|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5418897|NCT00017511|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
5418898|NCT00017511|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
5418899|NCT00017511|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
5418900|NCT00017511|stage I squamous cell carcinoma of the paranasal sinus and nasal cavity|stage i squamous cell carcinoma of the paranasal sinus and nasal cavity
5418901|NCT00017511|stage I inverted papilloma of the paranasal sinus and nasal cavity|stage i inverted papilloma of the paranasal sinus and nasal cavity
5418902|NCT00017511|stage I midline lethal granuloma of the paranasal sinus and nasal cavity|stage i midline lethal granuloma of the paranasal sinus and nasal cavity
5418903|NCT00017511|stage I esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage i esthesioneuroblastoma of the paranasal sinus and nasal cavity
5418904|NCT00017511|stage II squamous cell carcinoma of the paranasal sinus and nasal cavity|stage ii squamous cell carcinoma of the paranasal sinus and nasal cavity
5418905|NCT00017511|stage II inverted papilloma of the paranasal sinus and nasal cavity|stage ii inverted papilloma of the paranasal sinus and nasal cavity
5418906|NCT00017511|stage II midline lethal granuloma of the paranasal sinus and nasal cavity|stage ii midline lethal granuloma of the paranasal sinus and nasal cavity
5418907|NCT00017511|stage II esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage ii esthesioneuroblastoma of the paranasal sinus and nasal cavity
5418908|NCT00017511|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
5418909|NCT00017511|stage III inverted papilloma of the paranasal sinus and nasal cavity|stage iii inverted papilloma of the paranasal sinus and nasal cavity
5418910|NCT00017511|stage III midline lethal granuloma of the paranasal sinus and nasal cavity|stage iii midline lethal granuloma of the paranasal sinus and nasal cavity
5418911|NCT00017511|stage III esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iii esthesioneuroblastoma of the paranasal sinus and nasal cavity
5418912|NCT00017511|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
5418913|NCT00017511|stage IV inverted papilloma of the paranasal sinus and nasal cavity|stage iv inverted papilloma of the paranasal sinus and nasal cavity
5418914|NCT00017511|stage IV midline lethal granuloma of the paranasal sinus and nasal cavity|stage iv midline lethal granuloma of the paranasal sinus and nasal cavity
5418915|NCT00017511|stage IV esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iv esthesioneuroblastoma of the paranasal sinus and nasal cavity
5418916|NCT00017511|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
5418917|NCT00017511|recurrent inverted papilloma of the paranasal sinus and nasal cavity|recurrent inverted papilloma of the paranasal sinus and nasal cavity
5418918|NCT00017511|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity
5418919|NCT00017511|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity
5418920|NCT00017511|radiation toxicity|radiation toxicity
5418921|NCT00017498|stage IV salivary gland cancer|stage iv salivary gland cancer
5418922|NCT00017498|recurrent salivary gland cancer|recurrent salivary gland cancer
5418923|NCT00017498|salivary gland adenoid cystic carcinoma|salivary gland adenoid cystic carcinoma
5418924|NCT00017498|stage IV adenoid cystic carcinoma of the oral cavity|stage iv adenoid cystic carcinoma of the oral cavity
5418925|NCT00017498|recurrent adenoid cystic carcinoma of the oral cavity|recurrent adenoid cystic carcinoma of the oral cavity
5418926|NCT00017485|basal cell carcinoma of the skin|basal cell carcinoma of the skin
5418927|NCT00017485|recurrent skin cancer|recurrent skin cancer
5418928|NCT00017355|stage IV melanoma|stage iv melanoma
5418929|NCT00017355|recurrent melanoma|recurrent melanoma
5418930|NCT00017329|stage IV renal cell cancer|stage iv renal cell cancer
5418931|NCT00017290|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5418932|NCT00017290|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5418933|NCT00017290|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5418934|NCT00017290|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5418935|NCT00017290|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5418936|NCT00017290|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5419897|NCT00008294|recurrent colon cancer|recurrent colon cancer
5418937|NCT00017277|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
5418938|NCT00017277|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
5418939|NCT00017277|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
5419013|NCT00016952|recurrent rectal cancer|recurrent rectal cancer
5418940|NCT00017277|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5418941|NCT00017277|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
5418942|NCT00017277|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
5418943|NCT00017277|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
5418944|NCT00017277|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5418945|NCT00017277|stage I squamous cell carcinoma of the hypopharynx|stage i squamous cell carcinoma of the hypopharynx
5418946|NCT00017277|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
5418947|NCT00017277|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
5418948|NCT00017277|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5418949|NCT00017277|stage I squamous cell carcinoma of the larynx|stage i squamous cell carcinoma of the larynx
5418950|NCT00017277|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
5418951|NCT00017277|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
5418952|NCT00017277|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5418953|NCT00017264|recurrent adult brain tumor|recurrent adult brain tumor
5418954|NCT00017264|adult glioblastoma|adult glioblastoma
5418955|NCT00017264|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5418956|NCT00017264|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
5418957|NCT00017264|adult giant cell glioblastoma|adult giant cell glioblastoma
5418958|NCT00017264|adult gliosarcoma|adult gliosarcoma
5418959|NCT00017225|localized resectable neuroblastoma|localized resectable neuroblastoma
5418960|NCT00017225|regional neuroblastoma|regional neuroblastoma
5418961|NCT00017225|disseminated neuroblastoma|disseminated neuroblastoma
5418962|NCT00017225|stage 4S neuroblastoma|stage 4s neuroblastoma
5418963|NCT00017225|recurrent neuroblastoma|recurrent neuroblastoma
5418964|NCT00017225|localized unresectable neuroblastoma|localized unresectable neuroblastoma
5418965|NCT00017212|stage III gastric cancer|stage iii gastric cancer
5418966|NCT00017212|stage IV gastric cancer|stage iv gastric cancer
5418967|NCT00017212|recurrent gastric cancer|recurrent gastric cancer
5418968|NCT00017212|stage III esophageal cancer|stage iii esophageal cancer
5418969|NCT00017212|stage IV esophageal cancer|stage iv esophageal cancer
5418970|NCT00017212|recurrent esophageal cancer|recurrent esophageal cancer
5418971|NCT00017212|adenocarcinoma of the stomach|adenocarcinoma of the stomach
5418972|NCT00017212|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
5418973|NCT00017186|localized malignant mesothelioma|localized malignant mesothelioma
5418974|NCT00017186|advanced malignant mesothelioma|advanced malignant mesothelioma
5418975|NCT00017186|recurrent malignant mesothelioma|recurrent malignant mesothelioma
5418976|NCT00017173|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
5418977|NCT00017173|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5418978|NCT00017173|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
5418979|NCT00017173|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5418980|NCT00017173|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
5418981|NCT00017173|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
5418982|NCT00017173|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5418983|NCT00017173|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
5418984|NCT00017147|adult glioblastoma|adult glioblastoma
5418985|NCT00017147|adult giant cell glioblastoma|adult giant cell glioblastoma
5418986|NCT00017147|adult gliosarcoma|adult gliosarcoma
5418987|NCT00017121|stage IV melanoma|stage iv melanoma
5418988|NCT00017121|recurrent melanoma|recurrent melanoma
5418989|NCT00017121|lung metastases|lung metastases
5418990|NCT00017108|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5418991|NCT00017108|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5418992|NCT00017108|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
5418993|NCT00017095|stage II breast cancer|stage ii breast cancer
5418994|NCT00017095|stage IIIA breast cancer|stage iiia breast cancer
5418995|NCT00017095|stage IIIB breast cancer|stage iiib breast cancer
5418996|NCT00017095|stage IIIC breast cancer|stage iiic breast cancer
5418997|NCT00017095|inflammatory breast cancer|inflammatory breast cancer
5418998|NCT00017069|refractory multiple myeloma|refractory multiple myeloma
5418999|NCT00017069|stage II multiple myeloma|stage ii multiple myeloma
5419000|NCT00017069|stage III multiple myeloma|stage iii multiple myeloma
5419001|NCT00016991|recurrent adult brain tumor|recurrent adult brain tumor
5419002|NCT00016991|adult glioblastoma|adult glioblastoma
5419003|NCT00016991|adult giant cell glioblastoma|adult giant cell glioblastoma
5419004|NCT00016991|adult gliosarcoma|adult gliosarcoma
5419005|NCT00016965|stage II pancreatic cancer|stage ii pancreatic cancer
5419006|NCT00016965|stage III pancreatic cancer|stage iii pancreatic cancer
5419007|NCT00016965|recurrent pancreatic cancer|recurrent pancreatic cancer
5419008|NCT00016965|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
5419009|NCT00016965|stage IV pancreatic cancer|stage iv pancreatic cancer
5419010|NCT00016952|stage IV colon cancer|stage iv colon cancer
5419015|NCT00016952|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5419016|NCT00016926|stage III cervical cancer|stage iii cervical cancer
5419017|NCT00016926|recurrent cervical cancer|recurrent cervical cancer
5419018|NCT00016926|stage IVB cervical cancer|stage ivb cervical cancer
5419019|NCT00016926|stage IVA cervical cancer|stage iva cervical cancer
5419020|NCT00016926|cervical squamous cell carcinoma|cervical squamous cell carcinoma
5419021|NCT00016913|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5419022|NCT00016913|stage III prostate cancer|stage iii prostate cancer
5419023|NCT00016887|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5419024|NCT00016887|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5419025|NCT00016861|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
5419026|NCT00016432|stage I breast cancer|stage i breast cancer
5419027|NCT00016432|stage II breast cancer|stage ii breast cancer
5419028|NCT00016432|stage IIIA breast cancer|stage iiia breast cancer
5419029|NCT00016419|refractory anemia|refractory anemia
5419030|NCT00016419|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
5419031|NCT00016419|refractory anemia with excess blasts|refractory anemia with excess blasts
5419032|NCT00016419|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5419033|NCT00016419|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5419034|NCT00016419|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
5419035|NCT00016406|stage II breast cancer|stage ii breast cancer
5419036|NCT00016406|stage IIIA breast cancer|stage iiia breast cancer
5419038|NCT00016406|stage IIIC breast cancer|stage iiic breast cancer
5419039|NCT00016406|inflammatory breast cancer|inflammatory breast cancer
5419040|NCT00016393|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5419041|NCT00016393|stage IV prostate cancer|stage iv prostate cancer
5419042|NCT00016393|recurrent prostate cancer|recurrent prostate cancer
5419043|NCT00016380|nausea and vomiting|nausea and vomiting
5419044|NCT00016380|stage I colon cancer|stage i colon cancer
5419045|NCT00016380|stage II colon cancer|stage ii colon cancer
5419046|NCT00016380|stage III colon cancer|stage iii colon cancer
5419047|NCT00016380|stage IV colon cancer|stage iv colon cancer
5419048|NCT00016380|stage I gastric cancer|stage i gastric cancer
5419049|NCT00016380|stage II gastric cancer|stage ii gastric cancer
5419050|NCT00016380|stage III gastric cancer|stage iii gastric cancer
5419051|NCT00016380|stage IV gastric cancer|stage iv gastric cancer
5419052|NCT00016380|recurrent gastric cancer|recurrent gastric cancer
5419053|NCT00016380|stage I pancreatic cancer|stage i pancreatic cancer
5419054|NCT00016380|stage II pancreatic cancer|stage ii pancreatic cancer
5419055|NCT00016380|stage III pancreatic cancer|stage iii pancreatic cancer
5419056|NCT00016380|recurrent pancreatic cancer|recurrent pancreatic cancer
5419057|NCT00016380|recurrent colon cancer|recurrent colon cancer
5419058|NCT00016380|recurrent cervical cancer|recurrent cervical cancer
5419059|NCT00016380|stage IB cervical cancer|stage ib cervical cancer
5419060|NCT00016380|stage IIB cervical cancer|stage iib cervical cancer
5419061|NCT00016380|stage IVB cervical cancer|stage ivb cervical cancer
5419062|NCT00016380|stage IA cervical cancer|stage ia cervical cancer
5419063|NCT00016380|stage IIA cervical cancer|stage iia cervical cancer
5419064|NCT00016380|stage IVA cervical cancer|stage iva cervical cancer
5419065|NCT00016380|stage I ovarian epithelial cancer|stage i ovarian epithelial cancer
5419066|NCT00016380|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
5419067|NCT00016380|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5419068|NCT00016380|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5419069|NCT00016380|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5419070|NCT00016380|localized gastrointestinal carcinoid tumor|localized gastrointestinal carcinoid tumor
5419071|NCT00016380|regional gastrointestinal carcinoid tumor|regional gastrointestinal carcinoid tumor
5419072|NCT00016380|metastatic gastrointestinal carcinoid tumor|metastatic gastrointestinal carcinoid tumor
5419073|NCT00016380|recurrent gastrointestinal carcinoid tumor|recurrent gastrointestinal carcinoid tumor
5419074|NCT00016380|localized resectable adult primary liver cancer|localized resectable adult primary liver cancer
5419075|NCT00016380|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
5419076|NCT00016380|advanced adult primary liver cancer|advanced adult primary liver cancer
5419077|NCT00016380|recurrent adult primary liver cancer|recurrent adult primary liver cancer
5419078|NCT00016380|small intestine adenocarcinoma|small intestine adenocarcinoma
5419079|NCT00016380|small intestine lymphoma|small intestine lymphoma
5419080|NCT00016380|small intestine leiomyosarcoma|small intestine leiomyosarcoma
5419081|NCT00016380|localized gallbladder cancer|localized gallbladder cancer
5419082|NCT00016380|unresectable gallbladder cancer|unresectable gallbladder cancer
5419083|NCT00016380|recurrent gallbladder cancer|recurrent gallbladder cancer
5419084|NCT00016380|localized extrahepatic bile duct cancer|localized extrahepatic bile duct cancer
5419085|NCT00016380|unresectable extrahepatic bile duct cancer|unresectable extrahepatic bile duct cancer
5419086|NCT00016380|recurrent extrahepatic bile duct cancer|recurrent extrahepatic bile duct cancer
5419087|NCT00016380|recurrent small intestine cancer|recurrent small intestine cancer
5419088|NCT00016380|testicular seminoma|testicular seminoma
5419089|NCT00016380|carcinoma of the appendix|carcinoma of the appendix
5419090|NCT00016380|quality of life|quality of life
5419091|NCT00016380|stage IV pancreatic cancer|stage iv pancreatic cancer
5419092|NCT00016354|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5419093|NCT00016263|stage III melanoma|stage iii melanoma
5419094|NCT00016263|stage IV melanoma|stage iv melanoma
5419095|NCT00016263|recurrent melanoma|recurrent melanoma
5419096|NCT00016224|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5419097|NCT00016211|extensive stage small cell lung cancer|extensive stage small cell lung cancer
5419098|NCT00016185|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5419099|NCT00016159|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5419100|NCT00016159|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
5419101|NCT00016159|adult acute promyelocytic leukemia (M3)|adult acute promyelocytic leukemia (m3)
5419102|NCT00016159|childhood acute promyelocytic leukemia (M3)|childhood acute promyelocytic leukemia (m3)
5419103|NCT00016159|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5419104|NCT00016146|recurrent prostate cancer|recurrent prostate cancer
5419105|NCT00016133|stage II colon cancer|stage ii colon cancer
5419106|NCT00016133|stage III colon cancer|stage iii colon cancer
5419107|NCT00016133|adenocarcinoma of the colon|adenocarcinoma of the colon
5419108|NCT00016081|infection|infection
5419109|NCT00016068|infection|infection
5419110|NCT00016055|stage IV melanoma|stage iv melanoma
5419111|NCT00016055|recurrent melanoma|recurrent melanoma
5419112|NCT00016029|colon cancer|colon cancer
5419113|NCT00016029|rectal cancer|rectal cancer
5419114|NCT00015977|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5419115|NCT00015977|stage IV prostate cancer|stage iv prostate cancer
5419116|NCT00015977|recurrent prostate cancer|recurrent prostate cancer
5419117|NCT00015951|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5419118|NCT00015951|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5419119|NCT00015951|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5419120|NCT00015951|refractory anemia with excess blasts|refractory anemia with excess blasts
5419121|NCT00015951|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
5419122|NCT00015951|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5419123|NCT00015951|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5419124|NCT00015951|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5419125|NCT00015951|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
5419126|NCT00015938|stage IV breast cancer|stage iv breast cancer
5419127|NCT00015938|recurrent breast cancer|recurrent breast cancer
5419128|NCT00015925|refractory multiple myeloma|refractory multiple myeloma
5419129|NCT00015925|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5419130|NCT00015925|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5419131|NCT00015925|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5419132|NCT00015925|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5419133|NCT00015925|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5419134|NCT00015925|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5419135|NCT00015925|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
5419136|NCT00015925|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
5419137|NCT00015925|adult acute promyelocytic leukemia (M3)|adult acute promyelocytic leukemia (m3)
5419138|NCT00015925|refractory anemia with excess blasts|refractory anemia with excess blasts
5419139|NCT00015925|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
5419140|NCT00015925|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5419141|NCT00015925|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5419142|NCT00015925|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5419143|NCT00015925|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5419144|NCT00015925|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
5419145|NCT00015925|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
5419146|NCT00015925|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5419147|NCT00015925|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5419148|NCT00015925|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5419149|NCT00015925|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5419150|NCT00015925|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5419151|NCT00015899|childhood craniopharyngioma|childhood craniopharyngioma
5419152|NCT00015899|childhood central nervous system germ cell tumor|childhood central nervous system germ cell tumor
5419153|NCT00015899|childhood oligodendroglioma|childhood oligodendroglioma
5419154|NCT00015899|childhood choroid plexus tumor|childhood choroid plexus tumor
5419155|NCT00015899|childhood grade I meningioma|childhood grade i meningioma
5419156|NCT00015899|childhood grade II meningioma|childhood grade ii meningioma
5419157|NCT00015899|childhood grade III meningioma|childhood grade iii meningioma
5419158|NCT00015899|recurrent childhood cerebellar astrocytoma|recurrent childhood cerebellar astrocytoma
5419159|NCT00015899|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
5419560|NCT00010270|recurrent esophageal cancer|recurrent esophageal cancer
5419160|NCT00015899|recurrent childhood medulloblastoma|recurrent childhood medulloblastoma
5419161|NCT00015899|recurrent childhood visual pathway and hypothalamic glioma|recurrent childhood visual pathway and hypothalamic glioma
5419162|NCT00015899|recurrent childhood ependymoma|recurrent childhood ependymoma
5419163|NCT00015899|childhood atypical teratoid/rhabdoid tumor|childhood atypical teratoid/rhabdoid tumor
5419164|NCT00015899|childhood spinal cord neoplasm|childhood spinal cord neoplasm
5419165|NCT00015873|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
5419166|NCT00015860|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5419167|NCT00015860|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5419168|NCT00015860|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5419169|NCT00015847|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5419170|NCT00015847|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5419171|NCT00015847|Philadelphia chromosome positive chronic myelogenous leukemia|philadelphia chromosome positive chronic myelogenous leukemia
5419172|NCT00014612|stage IA breast cancer|stage ia breast cancer
5419173|NCT00014612|stage IB breast cancer|stage ib breast cancer
5419174|NCT00014612|stage II breast cancer|stage ii breast cancer
5419175|NCT00014599|stage III vulvar cancer|stage iii vulvar cancer
5419176|NCT00014599|stage IV vulvar cancer|stage iv vulvar cancer
5419177|NCT00014599|recurrent vulvar cancer|recurrent vulvar cancer
5419178|NCT00014599|squamous cell carcinoma of the vulva|squamous cell carcinoma of the vulva
5419179|NCT00014586|stage I prostate cancer|stage i prostate cancer
5419180|NCT00014586|stage IIB prostate cancer|stage iib prostate cancer
5419181|NCT00014586|stage IIA prostate cancer|stage iia prostate cancer
5419182|NCT00014586|stage III prostate cancer|stage iii prostate cancer
5419183|NCT00014521|recurrent adult brain tumor|recurrent adult brain tumor
5419184|NCT00014521|adult glioblastoma|adult glioblastoma
5419185|NCT00014521|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5419186|NCT00014521|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
5419187|NCT00014521|adult giant cell glioblastoma|adult giant cell glioblastoma
5419188|NCT00014521|adult gliosarcoma|adult gliosarcoma
5419189|NCT00014508|refractory multiple myeloma|refractory multiple myeloma
5419190|NCT00014508|stage I multiple myeloma|stage i multiple myeloma
5419191|NCT00014508|stage II multiple myeloma|stage ii multiple myeloma
5419192|NCT00014508|stage III multiple myeloma|stage iii multiple myeloma
5419193|NCT00014495|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5419194|NCT00014495|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5419195|NCT00014495|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5419196|NCT00014495|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5419197|NCT00014495|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
5419198|NCT00014495|untreated childhood acute myeloid leukemia and other myeloid malignancies|untreated childhood acute myeloid leukemia and other myeloid malignancies
5419199|NCT00014495|refractory anemia with excess blasts|refractory anemia with excess blasts
5419200|NCT00014495|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
5419201|NCT00014495|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5419202|NCT00014495|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5419203|NCT00014495|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5419204|NCT00014495|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
5419205|NCT00014495|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
5419206|NCT00014495|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
5419207|NCT00014495|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5419208|NCT00014495|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5419209|NCT00014495|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5419210|NCT00014495|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5419211|NCT00014495|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5419212|NCT00014495|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
5419213|NCT00014482|anxiety disorder|anxiety disorder
5419214|NCT00014482|depression|depression
5419215|NCT00014482|pain|pain
5419216|NCT00014482|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5419217|NCT00014482|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5419218|NCT00014482|refractory multiple myeloma|refractory multiple myeloma
5419219|NCT00014482|stage I multiple myeloma|stage i multiple myeloma
5419220|NCT00014482|stage II multiple myeloma|stage ii multiple myeloma
5419221|NCT00014482|stage III multiple myeloma|stage iii multiple myeloma
5419222|NCT00014482|primary myelofibrosis|primary myelofibrosis
5419223|NCT00014482|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5419224|NCT00014482|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5419225|NCT00014482|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5419226|NCT00014482|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5419227|NCT00014482|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5439505|NCT00022828|Neck|neck
5419228|NCT00014482|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5419229|NCT00014482|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5419230|NCT00014482|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5419231|NCT00014482|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5419232|NCT00014482|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5419233|NCT00014482|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5419234|NCT00014482|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5419898|NCT00008294|recurrent rectal cancer|recurrent rectal cancer
5419235|NCT00014482|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5419236|NCT00014482|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5419237|NCT00014482|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5419238|NCT00014482|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5419239|NCT00014482|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5419240|NCT00014482|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5419241|NCT00014482|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5419242|NCT00014482|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5419243|NCT00014482|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5419244|NCT00014482|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5419245|NCT00014482|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5419246|NCT00014482|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5419247|NCT00014482|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5419248|NCT00014482|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5419249|NCT00014482|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5419250|NCT00014482|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5419251|NCT00014482|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5419252|NCT00014482|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5419253|NCT00014482|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5419254|NCT00014482|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5419255|NCT00014482|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5419256|NCT00014482|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
5419257|NCT00014482|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5419258|NCT00014482|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
5419259|NCT00014482|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
5419260|NCT00014482|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5419261|NCT00014482|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
5419262|NCT00014482|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
5419263|NCT00014482|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5419264|NCT00014482|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5419265|NCT00014482|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5419266|NCT00014482|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5419267|NCT00014482|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
5419268|NCT00014482|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
5419269|NCT00014482|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5419270|NCT00014482|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5419271|NCT00014482|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5419272|NCT00014482|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5419273|NCT00014482|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5419274|NCT00014482|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5419275|NCT00014482|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5419276|NCT00014482|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5419277|NCT00014482|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5419278|NCT00014469|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5419279|NCT00014469|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5419280|NCT00014469|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5419281|NCT00014469|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5419282|NCT00014469|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5419283|NCT00014469|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5419284|NCT00014469|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5419285|NCT00014469|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5419286|NCT00014469|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5419287|NCT00014469|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5419561|NCT00010270|stage II esophageal cancer|stage ii esophageal cancer
5419288|NCT00014469|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5419289|NCT00014469|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
5419290|NCT00014469|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
5419291|NCT00014469|refractory anemia with excess blasts|refractory anemia with excess blasts
5419292|NCT00014469|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
5419293|NCT00014469|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5419294|NCT00014469|acute undifferentiated leukemia|acute undifferentiated leukemia
5419295|NCT00014469|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5419296|NCT00014469|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5419297|NCT00014469|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5419298|NCT00014469|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5419299|NCT00014469|graft versus host disease|graft versus host disease
5419300|NCT00014469|refractory cytopenia with multilineage dysplasia|refractory cytopenia with multilineage dysplasia
5419301|NCT00014469|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
5419302|NCT00014469|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
5419303|NCT00014469|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
5419304|NCT00014469|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
5419305|NCT00014469|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5419306|NCT00014469|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5419307|NCT00014469|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5419308|NCT00014469|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5419309|NCT00014469|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5419310|NCT00014456|stage IV breast cancer|stage iv breast cancer
5419311|NCT00014456|recurrent breast cancer|recurrent breast cancer
5419312|NCT00014456|stage IV gastric cancer|stage iv gastric cancer
5419313|NCT00014456|recurrent gastric cancer|recurrent gastric cancer
5419314|NCT00014456|metastatic osteosarcoma|metastatic osteosarcoma
5419315|NCT00014456|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5419316|NCT00014456|stage II pancreatic cancer|stage ii pancreatic cancer
5419317|NCT00014456|stage III pancreatic cancer|stage iii pancreatic cancer
5419318|NCT00014456|recurrent pancreatic cancer|recurrent pancreatic cancer
5419319|NCT00014456|stage II esophageal cancer|stage ii esophageal cancer
5419320|NCT00014456|stage III esophageal cancer|stage iii esophageal cancer
5419321|NCT00014456|stage IV esophageal cancer|stage iv esophageal cancer
5419322|NCT00014456|recurrent esophageal cancer|recurrent esophageal cancer
5419323|NCT00014456|chondrosarcoma|chondrosarcoma
5419324|NCT00014456|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
5419325|NCT00014456|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5419326|NCT00014456|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5419327|NCT00014456|extensive stage small cell lung cancer|extensive stage small cell lung cancer
5419328|NCT00014456|recurrent small cell lung cancer|recurrent small cell lung cancer
5419329|NCT00014456|recurrent osteosarcoma|recurrent osteosarcoma
5419330|NCT00014456|recurrent bladder cancer|recurrent bladder cancer
5419331|NCT00014456|stage IV bladder cancer|stage iv bladder cancer
5419332|NCT00014456|stage IV prostate cancer|stage iv prostate cancer
5419333|NCT00014456|recurrent prostate cancer|recurrent prostate cancer
5419334|NCT00014456|stage IV melanoma|stage iv melanoma
5419335|NCT00014456|recurrent melanoma|recurrent melanoma
5419336|NCT00014456|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5419337|NCT00014456|stage IV salivary gland cancer|stage iv salivary gland cancer
5419338|NCT00014456|recurrent salivary gland cancer|recurrent salivary gland cancer
5419339|NCT00014456|classic Kaposi sarcoma|classic kaposi sarcoma
5419340|NCT00014456|AIDS-related Kaposi sarcoma|aids-related kaposi sarcoma
5419341|NCT00014456|recurrent Kaposi sarcoma|recurrent kaposi sarcoma
5419342|NCT00014456|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
5419343|NCT00014456|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
5419344|NCT00014456|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
5419345|NCT00014456|stage IV uterine sarcoma|stage iv uterine sarcoma
5419346|NCT00014456|recurrent uterine sarcoma|recurrent uterine sarcoma
5419347|NCT00014456|borderline ovarian surface epithelial-stromal tumor|borderline ovarian surface epithelial-stromal tumor
5419348|NCT00014456|recurrent carcinoma of unknown primary|recurrent carcinoma of unknown primary
5419349|NCT00014456|ovarian sarcoma|ovarian sarcoma
5419350|NCT00014456|metastatic Ewing sarcoma/peripheral primitive neuroectodermal tumor|metastatic ewing sarcoma/peripheral primitive neuroectodermal tumor
5419351|NCT00014456|recurrent Ewing sarcoma/peripheral primitive neuroectodermal tumor|recurrent ewing sarcoma/peripheral primitive neuroectodermal tumor
5419352|NCT00014456|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
5419353|NCT00014456|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5419354|NCT00014456|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
5419355|NCT00014456|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
5439506|NCT00022828|Illinois|illinois
5419356|NCT00014456|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5419357|NCT00014456|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
5419358|NCT00014456|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
5419359|NCT00014456|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5419360|NCT00014456|recurrent lymphoepithelioma of the nasopharynx|recurrent lymphoepithelioma of the nasopharynx
5419361|NCT00014456|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
5419362|NCT00014456|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
5419363|NCT00014456|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
5419364|NCT00014456|recurrent lymphoepithelioma of the oropharynx|recurrent lymphoepithelioma of the oropharynx
5419365|NCT00014456|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
5419366|NCT00014456|stage IV lymphoepithelioma of the oropharynx|stage iv lymphoepithelioma of the oropharynx
5419367|NCT00014456|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5419368|NCT00014456|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity
5419369|NCT00014456|recurrent inverted papilloma of the paranasal sinus and nasal cavity|recurrent inverted papilloma of the paranasal sinus and nasal cavity
5419370|NCT00014456|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity
5419371|NCT00014456|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
5419372|NCT00014456|stage IV esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iv esthesioneuroblastoma of the paranasal sinus and nasal cavity
5419373|NCT00014456|stage IV inverted papilloma of the paranasal sinus and nasal cavity|stage iv inverted papilloma of the paranasal sinus and nasal cavity
5419374|NCT00014456|stage IV midline lethal granuloma of the paranasal sinus and nasal cavity|stage iv midline lethal granuloma of the paranasal sinus and nasal cavity
5419375|NCT00014456|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
5419376|NCT00014456|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
5419377|NCT00014456|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
5419378|NCT00014456|recurrent basal cell carcinoma of the lip|recurrent basal cell carcinoma of the lip
5419379|NCT00014456|stage IV basal cell carcinoma of the lip|stage iv basal cell carcinoma of the lip
5419380|NCT00014456|recurrent mucoepidermoid carcinoma of the oral cavity|recurrent mucoepidermoid carcinoma of the oral cavity
5419381|NCT00014456|stage IV mucoepidermoid carcinoma of the oral cavity|stage iv mucoepidermoid carcinoma of the oral cavity
5419382|NCT00014456|recurrent adenoid cystic carcinoma of the oral cavity|recurrent adenoid cystic carcinoma of the oral cavity
5419383|NCT00014456|stage IV adenoid cystic carcinoma of the oral cavity|stage iv adenoid cystic carcinoma of the oral cavity
5419384|NCT00014456|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
5419385|NCT00014456|stage IV pancreatic cancer|stage iv pancreatic cancer
5419386|NCT00014443|recurrent adult brain tumor|recurrent adult brain tumor
5419387|NCT00014443|adult glioblastoma|adult glioblastoma
5419388|NCT00014443|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5419389|NCT00014443|adult giant cell glioblastoma|adult giant cell glioblastoma
5419390|NCT00014443|adult gliosarcoma|adult gliosarcoma
5419391|NCT00014378|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5419392|NCT00014326|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
5419393|NCT00014326|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
5419394|NCT00014326|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
5419395|NCT00014326|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
5419396|NCT00014326|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
5419397|NCT00014326|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
5419398|NCT00014326|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5419399|NCT00014326|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5419400|NCT00014326|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5419401|NCT00014326|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
5419402|NCT00014326|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
5419403|NCT00014326|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
5419404|NCT00014326|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
5419405|NCT00014326|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5419406|NCT00014326|stage I marginal zone lymphoma|stage i marginal zone lymphoma
5419407|NCT00014326|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
5419408|NCT00014313|metastatic Ewing sarcoma/peripheral primitive neuroectodermal tumor|metastatic ewing sarcoma/peripheral primitive neuroectodermal tumor
5419409|NCT00014274|stage III bladder cancer|stage iii bladder cancer
5419410|NCT00014274|stage IV bladder cancer|stage iv bladder cancer
5419411|NCT00014274|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
5419412|NCT00014274|anterior urethral cancer|anterior urethral cancer
5419413|NCT00014274|posterior urethral cancer|posterior urethral cancer
5419414|NCT00014274|urethral cancer associated with invasive bladder cancer|urethral cancer associated with invasive bladder cancer
5419415|NCT00014274|metastatic transitional cell cancer of the renal pelvis and ureter|metastatic transitional cell cancer of the renal pelvis and ureter
5419416|NCT00014274|regional transitional cell cancer of the renal pelvis and ureter|regional transitional cell cancer of the renal pelvis and ureter
5419417|NCT00014222|stage I breast cancer|stage i breast cancer
5419418|NCT00014222|stage II breast cancer|stage ii breast cancer
5419419|NCT00014222|stage IIIA breast cancer|stage iiia breast cancer
5419420|NCT00014222|stage IIIB breast cancer|stage iiib breast cancer
5419421|NCT00014196|squamous cell lung cancer|squamous cell lung cancer
5419422|NCT00014196|large cell lung cancer|large cell lung cancer
5419423|NCT00014196|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5419424|NCT00014196|adenocarcinoma of the lung|adenocarcinoma of the lung
5419425|NCT00014131|stage III renal cell cancer|stage iii renal cell cancer
5419426|NCT00014131|stage IV renal cell cancer|stage iv renal cell cancer
5419427|NCT00014131|recurrent renal cell cancer|recurrent renal cell cancer
5419428|NCT00014118|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
5419429|NCT00014118|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5419430|NCT00014118|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
5419431|NCT00014118|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5419432|NCT00014092|stage IV melanoma|stage iv melanoma
5419433|NCT00014092|recurrent melanoma|recurrent melanoma
5419434|NCT00014079|colon cancer|colon cancer
5419435|NCT00014079|rectal cancer|rectal cancer
5419436|NCT00012389|stage IV colon cancer|stage iv colon cancer
5419437|NCT00012389|stage IV rectal cancer|stage iv rectal cancer
5419438|NCT00012389|recurrent colon cancer|recurrent colon cancer
5419439|NCT00012389|recurrent rectal cancer|recurrent rectal cancer
5419440|NCT00012363|stage IV gastric cancer|stage iv gastric cancer
5419441|NCT00012363|recurrent gastric cancer|recurrent gastric cancer
5419442|NCT00012363|stage IV esophageal cancer|stage iv esophageal cancer
5419443|NCT00012363|recurrent esophageal cancer|recurrent esophageal cancer
5419444|NCT00012363|adenocarcinoma of the stomach|adenocarcinoma of the stomach
5419445|NCT00012363|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
5419446|NCT00012363|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
5419447|NCT00012324|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
5419448|NCT00012324|advanced adult primary liver cancer|advanced adult primary liver cancer
5419449|NCT00012324|recurrent adult primary liver cancer|recurrent adult primary liver cancer
5419450|NCT00012324|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
5419451|NCT00012246|stage II colon cancer|stage ii colon cancer
5419452|NCT00012246|stage III colon cancer|stage iii colon cancer
5419453|NCT00012246|stage IV colon cancer|stage iv colon cancer
5419454|NCT00012246|stage II gastric cancer|stage ii gastric cancer
5419455|NCT00012246|stage III gastric cancer|stage iii gastric cancer
5419456|NCT00012246|stage IV gastric cancer|stage iv gastric cancer
5419457|NCT00012246|recurrent gastric cancer|recurrent gastric cancer
5419458|NCT00012246|stage II pancreatic cancer|stage ii pancreatic cancer
5419459|NCT00012246|stage III pancreatic cancer|stage iii pancreatic cancer
5419460|NCT00012246|recurrent pancreatic cancer|recurrent pancreatic cancer
5419461|NCT00012246|stage II rectal cancer|stage ii rectal cancer
5419462|NCT00012246|stage III rectal cancer|stage iii rectal cancer
5419463|NCT00012246|stage IV rectal cancer|stage iv rectal cancer
5419464|NCT00012246|recurrent colon cancer|recurrent colon cancer
5419465|NCT00012246|recurrent rectal cancer|recurrent rectal cancer
5419466|NCT00012246|stage II esophageal cancer|stage ii esophageal cancer
5419467|NCT00012246|stage III esophageal cancer|stage iii esophageal cancer
5419468|NCT00012246|stage IV esophageal cancer|stage iv esophageal cancer
5419469|NCT00012246|recurrent esophageal cancer|recurrent esophageal cancer
5419470|NCT00012246|adenocarcinoma of the stomach|adenocarcinoma of the stomach
5419471|NCT00012246|small intestine adenocarcinoma|small intestine adenocarcinoma
5419472|NCT00012246|localized gallbladder cancer|localized gallbladder cancer
5419473|NCT00012246|unresectable gallbladder cancer|unresectable gallbladder cancer
5419474|NCT00012246|recurrent gallbladder cancer|recurrent gallbladder cancer
5419475|NCT00012246|localized extrahepatic bile duct cancer|localized extrahepatic bile duct cancer
5419476|NCT00012246|unresectable extrahepatic bile duct cancer|unresectable extrahepatic bile duct cancer
5419477|NCT00012246|recurrent extrahepatic bile duct cancer|recurrent extrahepatic bile duct cancer
5419478|NCT00012246|recurrent small intestine cancer|recurrent small intestine cancer
5419479|NCT00012246|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
5419480|NCT00012246|adenocarcinoma of the colon|adenocarcinoma of the colon
5419481|NCT00012246|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5419482|NCT00012246|adenocarcinoma of the gallbladder|adenocarcinoma of the gallbladder
5419483|NCT00012246|adenocarcinoma of the extrahepatic bile duct|adenocarcinoma of the extrahepatic bile duct
5419484|NCT00012246|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
5419485|NCT00012246|stage IV pancreatic cancer|stage iv pancreatic cancer
5419486|NCT00012220|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
5419487|NCT00012220|stage IV pancreatic cancer|stage iv pancreatic cancer
5419488|NCT00012207|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5439613|NCT00021658|asthma|asthma
5419489|NCT00012207|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5419490|NCT00012207|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5419491|NCT00012207|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5419492|NCT00012207|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5419493|NCT00012207|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5419494|NCT00012207|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5419495|NCT00012168|stage 0 oropharyngeal cancer|stage 0 oropharyngeal cancer
5419496|NCT00012168|stage 0 lip and oral cavity cancer|stage 0 lip and oral cavity cancer
5419497|NCT00012168|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
5419498|NCT00012168|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
5419499|NCT00012168|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
5419500|NCT00012168|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5419501|NCT00012168|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
5419502|NCT00012168|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
5419503|NCT00012168|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
5419504|NCT00012168|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5419505|NCT00012103|non-small cell lung cancer|non-small cell lung cancer
5419506|NCT00012103|small cell lung cancer|small cell lung cancer
5419507|NCT00012064|stage IV melanoma|stage iv melanoma
5419508|NCT00012064|recurrent melanoma|recurrent melanoma
5419509|NCT00012051|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5419510|NCT00012051|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5419511|NCT00012038|recurrent adult brain tumor|recurrent adult brain tumor
5419512|NCT00012038|adult glioblastoma|adult glioblastoma
5419513|NCT00012038|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5419514|NCT00012038|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
5419515|NCT00012038|adult giant cell glioblastoma|adult giant cell glioblastoma
5419516|NCT00012038|adult gliosarcoma|adult gliosarcoma
5419517|NCT00012025|stage IV breast cancer|stage iv breast cancer
5419518|NCT00012025|recurrent breast cancer|recurrent breast cancer
5419519|NCT00012025|stage IIIB breast cancer|stage iiib breast cancer
5419520|NCT00012025|stage IIIC breast cancer|stage iiic breast cancer
5419521|NCT00012012|radiation toxicity|radiation toxicity
5419522|NCT00012012|stage III cervical cancer|stage iii cervical cancer
5419523|NCT00012012|stage IVA cervical cancer|stage iva cervical cancer
5419524|NCT00012012|cervical squamous cell carcinoma|cervical squamous cell carcinoma
5419525|NCT00012012|cervical adenocarcinoma|cervical adenocarcinoma
5419526|NCT00012012|cervical adenosquamous cell carcinoma|cervical adenosquamous cell carcinoma
5419527|NCT00011999|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
5419528|NCT00011999|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5419529|NCT00011999|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
5419530|NCT00011999|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5419531|NCT00011999|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
5419532|NCT00011999|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5419533|NCT00011999|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
5419534|NCT00011999|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5419535|NCT00011960|stage I gastric cancer|stage i gastric cancer
5419536|NCT00011960|stage II gastric cancer|stage ii gastric cancer
5419537|NCT00011960|stage III gastric cancer|stage iii gastric cancer
5419538|NCT00011960|stage I esophageal cancer|stage i esophageal cancer
5419539|NCT00011960|stage II esophageal cancer|stage ii esophageal cancer
5419540|NCT00011960|stage III esophageal cancer|stage iii esophageal cancer
5419541|NCT00011960|adenocarcinoma of the stomach|adenocarcinoma of the stomach
5419542|NCT00011960|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
5419543|NCT00011921|limited stage small cell lung cancer|limited stage small cell lung cancer
5419544|NCT00011921|extensive stage small cell lung cancer|extensive stage small cell lung cancer
5419545|NCT00010270|stage IV colon cancer|stage iv colon cancer
5419546|NCT00010270|stage IV rectal cancer|stage iv rectal cancer
5419547|NCT00010270|recurrent colon cancer|recurrent colon cancer
5419548|NCT00010270|recurrent rectal cancer|recurrent rectal cancer
5419549|NCT00010270|adenocarcinoma of the colon|adenocarcinoma of the colon
5419550|NCT00010270|stage III pancreatic cancer|stage iii pancreatic cancer
5419551|NCT00010270|stage II pancreatic cancer|stage ii pancreatic cancer
5419552|NCT00010270|recurrent pancreatic cancer|recurrent pancreatic cancer
5419553|NCT00010270|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
5419554|NCT00010270|stage IV gastric cancer|stage iv gastric cancer
5419555|NCT00010270|adenocarcinoma of the stomach|adenocarcinoma of the stomach
5419556|NCT00010270|recurrent gastric cancer|recurrent gastric cancer
5419557|NCT00010270|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
5419558|NCT00010270|stage IV esophageal cancer|stage iv esophageal cancer
5419559|NCT00010270|stage III esophageal cancer|stage iii esophageal cancer
5419562|NCT00010270|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5419563|NCT00010270|stage III colon cancer|stage iii colon cancer
5419564|NCT00010270|stage III rectal cancer|stage iii rectal cancer
5419565|NCT00010270|stage III gastric cancer|stage iii gastric cancer
5419566|NCT00010270|stage IV pancreatic cancer|stage iv pancreatic cancer
5419567|NCT00010257|thymoma|thymoma
5419568|NCT00010257|thymic carcinoma|thymic carcinoma
5419569|NCT00010218|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5419570|NCT00010218|squamous cell lung cancer|squamous cell lung cancer
5419571|NCT00010218|large cell lung cancer|large cell lung cancer
5419572|NCT00010218|adenocarcinoma of the lung|adenocarcinoma of the lung
5419573|NCT00010218|adenosquamous cell lung cancer|adenosquamous cell lung cancer
5419574|NCT00010218|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
5419575|NCT00010166|stage I pancreatic cancer|stage i pancreatic cancer
5419576|NCT00010166|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
5419577|NCT00010153|stage I breast cancer|stage i breast cancer
5419578|NCT00010153|stage II breast cancer|stage ii breast cancer
5419579|NCT00010140|stage II breast cancer|stage ii breast cancer
5419580|NCT00010140|stage IIIA breast cancer|stage iiia breast cancer
5419581|NCT00010140|stage IIIB breast cancer|stage iiib breast cancer
5419582|NCT00010140|stage IIIC breast cancer|stage iiic breast cancer
5419583|NCT00010101|childhood choroid plexus tumor|childhood choroid plexus tumor
5419584|NCT00010101|untreated childhood supratentorial primitive neuroectodermal tumor|untreated childhood supratentorial primitive neuroectodermal tumor
5419585|NCT00010101|untreated childhood medulloblastoma|untreated childhood medulloblastoma
5419586|NCT00010101|childhood atypical teratoid/rhabdoid tumor|childhood atypical teratoid/rhabdoid tumor
5419587|NCT00010075|stage IV breast cancer|stage iv breast cancer
5419588|NCT00010075|recurrent breast cancer|recurrent breast cancer
5419589|NCT00010062|stage I pancreatic cancer|stage i pancreatic cancer
5419590|NCT00010062|stage II pancreatic cancer|stage ii pancreatic cancer
5419591|NCT00010062|stage III pancreatic cancer|stage iii pancreatic cancer
5419592|NCT00010062|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
5419593|NCT00010062|stage IV pancreatic cancer|stage iv pancreatic cancer
5419594|NCT00010049|recurrent adult brain tumor|recurrent adult brain tumor
5419595|NCT00010049|adult meningioma|adult meningioma
5419596|NCT00010049|adult glioblastoma|adult glioblastoma
5419597|NCT00010049|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5419598|NCT00010049|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
5419599|NCT00010049|adult mixed glioma|adult mixed glioma
5419600|NCT00010049|adult pilocytic astrocytoma|adult pilocytic astrocytoma
5419601|NCT00010049|adult subependymoma|adult subependymoma
5419602|NCT00010049|adult grade III meningioma|adult grade iii meningioma
5419603|NCT00010049|adult giant cell glioblastoma|adult giant cell glioblastoma
5419604|NCT00010049|adult gliosarcoma|adult gliosarcoma
5419605|NCT00010023|stage IV breast cancer|stage iv breast cancer
5419606|NCT00010023|stage IIIA breast cancer|stage iiia breast cancer
5419607|NCT00010023|recurrent breast cancer|recurrent breast cancer
5419608|NCT00010023|stage III gastric cancer|stage iii gastric cancer
5419609|NCT00010023|stage IV gastric cancer|stage iv gastric cancer
5419610|NCT00010023|recurrent gastric cancer|recurrent gastric cancer
5419611|NCT00010023|stage IIIB breast cancer|stage iiib breast cancer
5419612|NCT00010023|stage IIIC breast cancer|stage iiic breast cancer
5419613|NCT00010023|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5419614|NCT00010023|stage III pancreatic cancer|stage iii pancreatic cancer
5419615|NCT00010023|recurrent pancreatic cancer|recurrent pancreatic cancer
5419616|NCT00010023|stage III esophageal cancer|stage iii esophageal cancer
5419617|NCT00010023|stage IV esophageal cancer|stage iv esophageal cancer
5419618|NCT00010023|recurrent esophageal cancer|recurrent esophageal cancer
5419619|NCT00010023|extensive stage small cell lung cancer|extensive stage small cell lung cancer
5419620|NCT00010023|recurrent small cell lung cancer|recurrent small cell lung cancer
5419621|NCT00010023|metastatic gastrointestinal carcinoid tumor|metastatic gastrointestinal carcinoid tumor
5419622|NCT00010023|recurrent gastrointestinal carcinoid tumor|recurrent gastrointestinal carcinoid tumor
5419623|NCT00010023|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
5419624|NCT00010023|advanced adult primary liver cancer|advanced adult primary liver cancer
5419625|NCT00010023|recurrent adult primary liver cancer|recurrent adult primary liver cancer
5419626|NCT00010023|small intestine adenocarcinoma|small intestine adenocarcinoma
5419627|NCT00010023|unresectable gallbladder cancer|unresectable gallbladder cancer
5419628|NCT00010023|recurrent gallbladder cancer|recurrent gallbladder cancer
5419629|NCT00010023|unresectable extrahepatic bile duct cancer|unresectable extrahepatic bile duct cancer
5419630|NCT00010023|recurrent extrahepatic bile duct cancer|recurrent extrahepatic bile duct cancer
5419631|NCT00010023|recurrent small intestine cancer|recurrent small intestine cancer
5419632|NCT00010023|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5419633|NCT00010023|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5419634|NCT00010023|untreated metastatic squamous neck cancer with occult primary|untreated metastatic squamous neck cancer with occult primary
5419635|NCT00010023|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
5419636|NCT00010023|pulmonary carcinoid tumor|pulmonary carcinoid tumor
5419689|NCT00010023|recurrent salivary gland cancer|recurrent salivary gland cancer
5419637|NCT00010023|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
5419638|NCT00010023|stage III basal cell carcinoma of the lip|stage iii basal cell carcinoma of the lip
5419639|NCT00010023|stage III verrucous carcinoma of the oral cavity|stage iii verrucous carcinoma of the oral cavity
5419640|NCT00010023|stage III mucoepidermoid carcinoma of the oral cavity|stage iii mucoepidermoid carcinoma of the oral cavity
5419641|NCT00010023|stage III adenoid cystic carcinoma of the oral cavity|stage iii adenoid cystic carcinoma of the oral cavity
5419642|NCT00010023|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5419643|NCT00010023|stage IV basal cell carcinoma of the lip|stage iv basal cell carcinoma of the lip
5419644|NCT00010023|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
5419645|NCT00010023|stage IV mucoepidermoid carcinoma of the oral cavity|stage iv mucoepidermoid carcinoma of the oral cavity
5419646|NCT00010023|stage IV adenoid cystic carcinoma of the oral cavity|stage iv adenoid cystic carcinoma of the oral cavity
5419647|NCT00010023|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
5419648|NCT00010023|recurrent basal cell carcinoma of the lip|recurrent basal cell carcinoma of the lip
5419649|NCT00010023|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
5419650|NCT00010023|recurrent mucoepidermoid carcinoma of the oral cavity|recurrent mucoepidermoid carcinoma of the oral cavity
5419651|NCT00010023|recurrent adenoid cystic carcinoma of the oral cavity|recurrent adenoid cystic carcinoma of the oral cavity
5419652|NCT00010023|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
5419653|NCT00010023|stage III lymphoepithelioma of the oropharynx|stage iii lymphoepithelioma of the oropharynx
5419654|NCT00010023|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5419655|NCT00010023|stage IV lymphoepithelioma of the oropharynx|stage iv lymphoepithelioma of the oropharynx
5419656|NCT00010023|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
5419657|NCT00010023|recurrent lymphoepithelioma of the oropharynx|recurrent lymphoepithelioma of the oropharynx
5419658|NCT00010023|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
5419659|NCT00010023|stage III lymphoepithelioma of the nasopharynx|stage iii lymphoepithelioma of the nasopharynx
5419660|NCT00010023|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
5419661|NCT00010023|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
5419662|NCT00010023|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
5419663|NCT00010023|recurrent lymphoepithelioma of the nasopharynx|recurrent lymphoepithelioma of the nasopharynx
5419664|NCT00010023|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
5419665|NCT00010023|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5419666|NCT00010023|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
5419667|NCT00010023|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
5419668|NCT00010023|stage III verrucous carcinoma of the larynx|stage iii verrucous carcinoma of the larynx
5419669|NCT00010023|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5419670|NCT00010023|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
5419671|NCT00010023|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
5419672|NCT00010023|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
5419673|NCT00010023|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
5419674|NCT00010023|stage III inverted papilloma of the paranasal sinus and nasal cavity|stage iii inverted papilloma of the paranasal sinus and nasal cavity
5419675|NCT00010023|stage III midline lethal granuloma of the paranasal sinus and nasal cavity|stage iii midline lethal granuloma of the paranasal sinus and nasal cavity
5419676|NCT00010023|stage III esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iii esthesioneuroblastoma of the paranasal sinus and nasal cavity
5419677|NCT00010023|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
5419678|NCT00010023|stage IV inverted papilloma of the paranasal sinus and nasal cavity|stage iv inverted papilloma of the paranasal sinus and nasal cavity
5419679|NCT00010023|stage IV midline lethal granuloma of the paranasal sinus and nasal cavity|stage iv midline lethal granuloma of the paranasal sinus and nasal cavity
5419680|NCT00010023|stage IV esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iv esthesioneuroblastoma of the paranasal sinus and nasal cavity
5419681|NCT00010023|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
5419682|NCT00010023|recurrent inverted papilloma of the paranasal sinus and nasal cavity|recurrent inverted papilloma of the paranasal sinus and nasal cavity
5419683|NCT00010023|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity
5419684|NCT00010023|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity
5419685|NCT00010023|newly diagnosed carcinoma of unknown primary|newly diagnosed carcinoma of unknown primary
5419686|NCT00010023|carcinoma of the appendix|carcinoma of the appendix
5419687|NCT00010023|recurrent carcinoma of unknown primary|recurrent carcinoma of unknown primary
5419688|NCT00010023|gastrointestinal stromal tumor|gastrointestinal stromal tumor
5420329|NCT00006479|liver metastases|liver metastases
5419690|NCT00010023|stage III salivary gland cancer|stage iii salivary gland cancer
5419691|NCT00010023|stage IV salivary gland cancer|stage iv salivary gland cancer
5419692|NCT00010023|stage IV pancreatic cancer|stage iv pancreatic cancer
5419693|NCT00009971|limited stage small cell lung cancer|limited stage small cell lung cancer
5419694|NCT00009971|extensive stage small cell lung cancer|extensive stage small cell lung cancer
5419695|NCT00009971|recurrent small cell lung cancer|recurrent small cell lung cancer
5419696|NCT00009945|stage I breast cancer|stage i breast cancer
5419697|NCT00009945|stage II breast cancer|stage ii breast cancer
5419698|NCT00009880|stage I gastric cancer|stage i gastric cancer
5419699|NCT00009880|stage II gastric cancer|stage ii gastric cancer
5419700|NCT00009880|stage III gastric cancer|stage iii gastric cancer
5419701|NCT00009880|stage I esophageal cancer|stage i esophageal cancer
5419702|NCT00009880|stage II esophageal cancer|stage ii esophageal cancer
5419703|NCT00009880|stage III esophageal cancer|stage iii esophageal cancer
5419704|NCT00009880|adenocarcinoma of the stomach|adenocarcinoma of the stomach
5419705|NCT00009880|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
5419706|NCT00009880|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
5419707|NCT00009854|adult glioblastoma|adult glioblastoma
5419708|NCT00009854|tumors metastatic to brain|tumors metastatic to brain
5419709|NCT00009854|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5419710|NCT00009854|adult anaplastic ependymoma|adult anaplastic ependymoma
5419711|NCT00009854|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
5419712|NCT00009854|adult giant cell glioblastoma|adult giant cell glioblastoma
5419713|NCT00009854|adult gliosarcoma|adult gliosarcoma
5419714|NCT00009776|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5419715|NCT00009776|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5419716|NCT00009776|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5419717|NCT00009776|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5419718|NCT00009776|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5419719|NCT00009776|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5419720|NCT00009776|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5419721|NCT00009776|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5419722|NCT00009776|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5419723|NCT00009776|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5419724|NCT00009776|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5419725|NCT00009776|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5419726|NCT00009776|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5419727|NCT00009776|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5419728|NCT00009776|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5419729|NCT00009763|stage IV breast cancer|stage iv breast cancer
5419730|NCT00009763|recurrent breast cancer|recurrent breast cancer
5419731|NCT00009750|stage IV prostate cancer|stage iv prostate cancer
5419732|NCT00009750|recurrent prostate cancer|recurrent prostate cancer
5419733|NCT00009711|long-term effects secondary to cancer therapy in children|long-term effects secondary to cancer therapy in children
5419734|NCT00009711|pulmonary complications|pulmonary complications
5419735|NCT00008697|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5419736|NCT00008697|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5419737|NCT00008697|adult acute promyelocytic leukemia (M3)|adult acute promyelocytic leukemia (m3)
5419738|NCT00008697|childhood acute promyelocytic leukemia (M3)|childhood acute promyelocytic leukemia (m3)
5419739|NCT00008437|stage I breast cancer|stage i breast cancer
5419740|NCT00008437|stage II breast cancer|stage ii breast cancer
5419741|NCT00008437|stage IIIA breast cancer|stage iiia breast cancer
5419742|NCT00008411|stage IV breast cancer|stage iv breast cancer
5419743|NCT00008411|recurrent breast cancer|recurrent breast cancer
5419744|NCT00008385|stage I non-small cell lung cancer|stage i non-small cell lung cancer
5419745|NCT00008346|breast cancer|breast cancer
5419746|NCT00008307|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
5419747|NCT00008307|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
5419748|NCT00008307|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5419749|NCT00008307|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5419750|NCT00008307|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5419751|NCT00008307|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5419752|NCT00008307|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
5419753|NCT00008307|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
5419754|NCT00008307|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
5419755|NCT00008307|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
5419756|NCT00008307|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5419757|NCT00008307|refractory multiple myeloma|refractory multiple myeloma
5419758|NCT00008307|stage I multiple myeloma|stage i multiple myeloma
5419759|NCT00008307|stage II multiple myeloma|stage ii multiple myeloma
5419760|NCT00008307|stage III multiple myeloma|stage iii multiple myeloma
5420396|NCT00006381|recurrent breast cancer|recurrent breast cancer
5419761|NCT00008307|stage I childhood lymphoblastic lymphoma|stage i childhood lymphoblastic lymphoma
5419762|NCT00008307|stage II childhood lymphoblastic lymphoma|stage ii childhood lymphoblastic lymphoma
5419763|NCT00008307|stage III childhood lymphoblastic lymphoma|stage iii childhood lymphoblastic lymphoma
5419764|NCT00008307|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
5419765|NCT00008307|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
5419766|NCT00008307|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5419767|NCT00008307|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5419768|NCT00008307|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5419769|NCT00008307|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5419770|NCT00008307|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5419771|NCT00008307|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5419772|NCT00008307|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5419773|NCT00008307|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
5419774|NCT00008307|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
5419775|NCT00008307|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
5419776|NCT00008307|untreated childhood acute myeloid leukemia and other myeloid malignancies|untreated childhood acute myeloid leukemia and other myeloid malignancies
5419777|NCT00008307|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
5419778|NCT00008307|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5419779|NCT00008307|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5419780|NCT00008307|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
5419781|NCT00008307|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
5419782|NCT00008307|chronic myelogenous leukemia, BCR-ABL1 positive|chronic myelogenous leukemia, bcr-abl1 positive
5419783|NCT00008307|Philadelphia chromosome negative chronic myelogenous leukemia|philadelphia chromosome negative chronic myelogenous leukemia
5419784|NCT00008307|stage II childhood Hodgkin lymphoma|stage ii childhood hodgkin lymphoma
5419785|NCT00008307|stage I childhood Hodgkin lymphoma|stage i childhood hodgkin lymphoma
5419786|NCT00008307|stage III childhood Hodgkin lymphoma|stage iii childhood hodgkin lymphoma
5419787|NCT00008307|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
5419788|NCT00008307|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
5419789|NCT00008307|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
5419790|NCT00008307|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
5419791|NCT00008307|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
5419792|NCT00008307|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
5419793|NCT00008307|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
5419794|NCT00008307|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
5419795|NCT00008307|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
5419796|NCT00008307|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
5419797|NCT00008307|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
5419798|NCT00008307|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5419799|NCT00008307|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5419800|NCT00008307|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5419801|NCT00008307|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5419802|NCT00008307|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5419803|NCT00008307|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5419804|NCT00008307|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5419805|NCT00008307|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5419806|NCT00008307|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5419807|NCT00008307|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5419808|NCT00008307|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5419809|NCT00008307|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5419810|NCT00008307|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5419811|NCT00008307|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5419812|NCT00008307|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5419813|NCT00008307|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5419814|NCT00008307|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5419815|NCT00008307|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5419816|NCT00008307|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5419817|NCT00008307|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5419818|NCT00008307|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5419819|NCT00008307|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5419820|NCT00008307|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5419821|NCT00008307|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5420981|NCT00006093|adult gliosarcoma|adult gliosarcoma
5419822|NCT00008307|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5419823|NCT00008307|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5419824|NCT00008307|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5419825|NCT00008307|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
5419826|NCT00008307|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
5419827|NCT00008307|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
5419828|NCT00008307|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
5419829|NCT00008307|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
5419830|NCT00008307|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5419831|NCT00008307|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5419832|NCT00008307|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5419833|NCT00008307|intraocular lymphoma|intraocular lymphoma
5419834|NCT00008307|stage I childhood large cell lymphoma|stage i childhood large cell lymphoma
5419835|NCT00008307|stage II childhood large cell lymphoma|stage ii childhood large cell lymphoma
5419836|NCT00008307|stage III childhood large cell lymphoma|stage iii childhood large cell lymphoma
5419837|NCT00008307|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
5419838|NCT00008307|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
5419839|NCT00008307|stage I mantle cell lymphoma|stage i mantle cell lymphoma
5419840|NCT00008307|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
5419841|NCT00008307|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
5419842|NCT00008307|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
5419843|NCT00008307|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
5419844|NCT00008307|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
5419845|NCT00008307|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
5419846|NCT00008307|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
5419847|NCT00008307|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
5419848|NCT00008307|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
5419849|NCT00008307|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
5419850|NCT00008307|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5419851|NCT00008307|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5419852|NCT00008307|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5419853|NCT00008307|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
5419854|NCT00008307|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5419855|NCT00008307|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
5419856|NCT00008307|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
5419857|NCT00008307|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5419858|NCT00008307|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
5419859|NCT00008307|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
5419860|NCT00008307|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5419861|NCT00008307|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5419862|NCT00008307|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5419863|NCT00008307|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
5419864|NCT00008307|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5419865|NCT00008307|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
5419866|NCT00008307|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
5419867|NCT00008307|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
5419868|NCT00008307|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
5419869|NCT00008307|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5419870|NCT00008307|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
5419871|NCT00008307|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
5419872|NCT00008307|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
5419873|NCT00008307|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
5419874|NCT00008307|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
5419875|NCT00008307|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5419876|NCT00008307|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5419877|NCT00008307|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5419878|NCT00008307|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5419879|NCT00008307|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5419880|NCT00008307|stage I marginal zone lymphoma|stage i marginal zone lymphoma
5419881|NCT00008307|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
5419882|NCT00008307|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5419883|NCT00008307|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5419884|NCT00008307|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5419885|NCT00008307|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5419886|NCT00008307|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5419887|NCT00008307|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5419888|NCT00008307|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5419889|NCT00008307|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5419890|NCT00008307|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5419891|NCT00008307|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
5419892|NCT00008294|stage IV colon cancer|stage iv colon cancer
5419893|NCT00008294|stage IV rectal cancer|stage iv rectal cancer
5419894|NCT00008294|adenocarcinoma of the colon|adenocarcinoma of the colon
5419895|NCT00008294|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5419896|NCT00008294|liver metastases|liver metastases
5419899|NCT00008268|stage I multiple myeloma|stage i multiple myeloma
5419900|NCT00008268|stage II multiple myeloma|stage ii multiple myeloma
5419901|NCT00008268|stage III multiple myeloma|stage iii multiple myeloma
5419902|NCT00008216|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5419903|NCT00008216|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5419904|NCT00008216|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5419905|NCT00008216|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5419906|NCT00008216|refractory multiple myeloma|refractory multiple myeloma
5419907|NCT00008216|stage I multiple myeloma|stage i multiple myeloma
5419908|NCT00008216|stage II multiple myeloma|stage ii multiple myeloma
5419909|NCT00008216|stage III multiple myeloma|stage iii multiple myeloma
5419910|NCT00008216|stage II childhood lymphoblastic lymphoma|stage ii childhood lymphoblastic lymphoma
5419911|NCT00008216|stage III childhood lymphoblastic lymphoma|stage iii childhood lymphoblastic lymphoma
5419912|NCT00008216|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
5419913|NCT00008216|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
5419914|NCT00008216|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5419915|NCT00008216|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5419916|NCT00008216|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5419917|NCT00008216|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5419918|NCT00008216|childhood Langerhans cell histiocytosis|childhood langerhans cell histiocytosis
5419919|NCT00008216|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5419920|NCT00008216|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5419921|NCT00008216|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5419922|NCT00008216|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
5419923|NCT00008216|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
5419924|NCT00008216|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
5419925|NCT00008216|untreated childhood acute myeloid leukemia and other myeloid malignancies|untreated childhood acute myeloid leukemia and other myeloid malignancies
5419926|NCT00008216|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
5419927|NCT00008216|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5419928|NCT00008216|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5419929|NCT00008216|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
5419930|NCT00008216|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
5419931|NCT00008216|chronic myelogenous leukemia, BCR-ABL1 positive|chronic myelogenous leukemia, bcr-abl1 positive
5419932|NCT00008216|Philadelphia chromosome negative chronic myelogenous leukemia|philadelphia chromosome negative chronic myelogenous leukemia
5419933|NCT00008216|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
5419934|NCT00008216|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
5419935|NCT00008216|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5419936|NCT00008216|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5419937|NCT00008216|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5419938|NCT00008216|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5419939|NCT00008216|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5419940|NCT00008216|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5419941|NCT00008216|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5419942|NCT00008216|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5419943|NCT00008216|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5419944|NCT00008216|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5419945|NCT00008216|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5419946|NCT00008216|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5419947|NCT00008216|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5419948|NCT00008216|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5419949|NCT00008216|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5419950|NCT00008216|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5419951|NCT00008216|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5419952|NCT00008216|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5419953|NCT00008216|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5419954|NCT00008216|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5419955|NCT00008216|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5419956|NCT00008216|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5419957|NCT00008216|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5419958|NCT00008216|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5419959|NCT00008216|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5419960|NCT00008216|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5419961|NCT00008216|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5419962|NCT00008216|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
5419963|NCT00008216|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
5419964|NCT00008216|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
5419965|NCT00008216|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
5419966|NCT00008216|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5419967|NCT00008216|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5419968|NCT00008216|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5419969|NCT00008216|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5419970|NCT00008216|intraocular lymphoma|intraocular lymphoma
5419971|NCT00008216|stage II childhood small noncleaved cell lymphoma|stage ii childhood small noncleaved cell lymphoma
5419972|NCT00008216|stage II childhood large cell lymphoma|stage ii childhood large cell lymphoma
5419973|NCT00008216|stage III childhood small noncleaved cell lymphoma|stage iii childhood small noncleaved cell lymphoma
5419974|NCT00008216|stage III childhood large cell lymphoma|stage iii childhood large cell lymphoma
5419975|NCT00008216|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
5419976|NCT00008216|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
5419977|NCT00008216|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
5419978|NCT00008216|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
5419979|NCT00008216|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
5419980|NCT00008216|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
5419981|NCT00008216|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
5419982|NCT00008216|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
5419983|NCT00008216|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
5419984|NCT00008216|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
5419985|NCT00008216|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
5419986|NCT00008216|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
5419987|NCT00008216|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
5419988|NCT00008216|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
5421778|NCT00005622|refractory anemia|refractory anemia
5419989|NCT00008216|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5419990|NCT00008216|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5419991|NCT00008216|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5419992|NCT00008216|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
5419993|NCT00008216|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5419994|NCT00008216|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
5419995|NCT00008216|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
5419996|NCT00008216|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5419997|NCT00008216|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
5419998|NCT00008216|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
5419999|NCT00008216|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5420000|NCT00008216|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5420001|NCT00008216|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5420002|NCT00008216|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
5420003|NCT00008216|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5420004|NCT00008216|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5420005|NCT00008216|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
5420006|NCT00008216|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
5420007|NCT00008216|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
5422557|NCT00004141|recurrent melanoma|recurrent melanoma
5420008|NCT00008216|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
5420009|NCT00008216|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5420010|NCT00008216|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
5420011|NCT00008216|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
5420012|NCT00008216|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
5420013|NCT00008216|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
5420014|NCT00008216|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5420015|NCT00008216|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5420016|NCT00008216|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5420017|NCT00008216|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5420018|NCT00008216|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5420019|NCT00008216|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5420020|NCT00008216|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5420021|NCT00008216|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5420022|NCT00008216|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5420023|NCT00008216|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5420024|NCT00008216|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5420025|NCT00008216|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5420026|NCT00008216|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5420027|NCT00008216|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5420028|NCT00008216|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
5420029|NCT00008216|adult Langerhans cell histiocytosis|adult langerhans cell histiocytosis
5420030|NCT00008190|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5420031|NCT00008190|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5420032|NCT00008190|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5420033|NCT00008190|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5420034|NCT00008190|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5420035|NCT00008190|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5420036|NCT00008190|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
5420037|NCT00008190|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
5420038|NCT00008190|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5420039|NCT00008164|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5420040|NCT00008164|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5420041|NCT00008164|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5420042|NCT00008164|refractory multiple myeloma|refractory multiple myeloma
5420043|NCT00008164|stage I multiple myeloma|stage i multiple myeloma
5420044|NCT00008164|stage II multiple myeloma|stage ii multiple myeloma
5420045|NCT00008164|stage III multiple myeloma|stage iii multiple myeloma
5420046|NCT00008164|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
5420047|NCT00008164|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5420048|NCT00008164|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5420049|NCT00008164|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5420050|NCT00008164|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5420051|NCT00008164|childhood Langerhans cell histiocytosis|childhood langerhans cell histiocytosis
5420052|NCT00008164|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5420053|NCT00008164|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5420054|NCT00008164|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5420055|NCT00008164|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
5420056|NCT00008164|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
5420057|NCT00008164|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
5420058|NCT00008164|untreated childhood acute myeloid leukemia and other myeloid malignancies|untreated childhood acute myeloid leukemia and other myeloid malignancies
5420059|NCT00008164|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
5420060|NCT00008164|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
5420061|NCT00008164|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
5420062|NCT00008164|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5420063|NCT00008164|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5420064|NCT00008164|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5420065|NCT00008164|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5420066|NCT00008164|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5420067|NCT00008164|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5420068|NCT00008164|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5422699|NCT00004065|stage IV prostate cancer|stage iv prostate cancer
5420069|NCT00008164|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5420070|NCT00008164|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5420071|NCT00008164|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5420072|NCT00008164|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5420073|NCT00008164|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5420074|NCT00008164|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5420075|NCT00008164|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5420076|NCT00008164|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5420077|NCT00008164|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5422159|NCT00004934|fallopian tube cancer|fallopian tube cancer
5420078|NCT00008164|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5420079|NCT00008164|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5420080|NCT00008164|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5420081|NCT00008164|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5420082|NCT00008164|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5420083|NCT00008164|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5420084|NCT00008164|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5420085|NCT00008164|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5420086|NCT00008164|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5420087|NCT00008164|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5420088|NCT00008164|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5420089|NCT00008164|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5420090|NCT00008164|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5420091|NCT00008164|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5420092|NCT00008164|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
5420093|NCT00008164|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
5420094|NCT00008164|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
5420095|NCT00008164|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
5420096|NCT00008164|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5420097|NCT00008164|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5420098|NCT00008164|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5420099|NCT00008164|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
5420100|NCT00008164|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5420101|NCT00008164|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
5420102|NCT00008164|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
5420103|NCT00008164|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5420104|NCT00008164|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
5420105|NCT00008164|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
5420106|NCT00008164|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5420107|NCT00008164|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5420108|NCT00008164|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5420109|NCT00008164|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5420110|NCT00008164|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
5420111|NCT00008164|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
5420112|NCT00008164|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
5420113|NCT00008164|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
5420114|NCT00008164|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
5420115|NCT00008164|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5420116|NCT00008164|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5420117|NCT00008164|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5420118|NCT00008164|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5420119|NCT00008164|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5420120|NCT00008164|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5420121|NCT00008164|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5420122|NCT00008164|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5420123|NCT00008164|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5420124|NCT00008164|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5420125|NCT00008164|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5420126|NCT00008164|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5420127|NCT00008164|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5422700|NCT00004065|recurrent prostate cancer|recurrent prostate cancer
5420128|NCT00008164|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5420129|NCT00008164|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
5420130|NCT00008138|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5420131|NCT00008138|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5420132|NCT00008138|ovarian undifferentiated adenocarcinoma|ovarian undifferentiated adenocarcinoma
5420133|NCT00008138|ovarian serous cystadenocarcinoma|ovarian serous cystadenocarcinoma
5420134|NCT00008138|ovarian mucinous cystadenocarcinoma|ovarian mucinous cystadenocarcinoma
5420135|NCT00008138|ovarian endometrioid adenocarcinoma|ovarian endometrioid adenocarcinoma
5420136|NCT00008138|ovarian clear cell cystadenocarcinoma|ovarian clear cell cystadenocarcinoma
5420137|NCT00008138|fallopian tube cancer|fallopian tube cancer
5420138|NCT00008138|peritoneal cavity cancer|peritoneal cavity cancer
5420139|NCT00008060|stage IV colon cancer|stage iv colon cancer
5420140|NCT00008060|stage IV rectal cancer|stage iv rectal cancer
5420141|NCT00008060|recurrent colon cancer|recurrent colon cancer
5420142|NCT00008060|recurrent rectal cancer|recurrent rectal cancer
5420143|NCT00008060|adenocarcinoma of the colon|adenocarcinoma of the colon
5420144|NCT00008060|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5420145|NCT00008047|stage II esophageal cancer|stage ii esophageal cancer
5420146|NCT00008047|stage III esophageal cancer|stage iii esophageal cancer
5420147|NCT00008008|childhood infratentorial ependymoma|childhood infratentorial ependymoma
5420148|NCT00008008|childhood supratentorial ependymoma|childhood supratentorial ependymoma
5420149|NCT00008008|recurrent adult brain tumor|recurrent adult brain tumor
5420150|NCT00008008|adult medulloblastoma|adult medulloblastoma
5420151|NCT00008008|adult glioblastoma|adult glioblastoma
5420152|NCT00008008|adult oligodendroglioma|adult oligodendroglioma
5420153|NCT00008008|childhood high-grade cerebral astrocytoma|childhood high-grade cerebral astrocytoma
5420154|NCT00008008|childhood oligodendroglioma|childhood oligodendroglioma
5420155|NCT00008008|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5420156|NCT00008008|adult anaplastic ependymoma|adult anaplastic ependymoma
5420157|NCT00008008|adult mixed glioma|adult mixed glioma
5420158|NCT00008008|recurrent childhood supratentorial primitive neuroectodermal tumor|recurrent childhood supratentorial primitive neuroectodermal tumor
5420159|NCT00008008|recurrent childhood cerebellar astrocytoma|recurrent childhood cerebellar astrocytoma
5420160|NCT00008008|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
5420161|NCT00008008|recurrent childhood ependymoma|recurrent childhood ependymoma
5420162|NCT00008008|adult giant cell glioblastoma|adult giant cell glioblastoma
5420163|NCT00008008|adult gliosarcoma|adult gliosarcoma
5420164|NCT00008008|adult supratentorial primitive neuroectodermal tumor (PNET)|adult supratentorial primitive neuroectodermal tumor (pnet)
5420165|NCT00007995|refractory multiple myeloma|refractory multiple myeloma
5420166|NCT00007995|stage I multiple myeloma|stage i multiple myeloma
5420167|NCT00007995|stage II multiple myeloma|stage ii multiple myeloma
5420168|NCT00007995|stage III multiple myeloma|stage iii multiple myeloma
5420169|NCT00007995|primary systemic amyloidosis|primary systemic amyloidosis
5420170|NCT00007982|recurrent adult brain tumor|recurrent adult brain tumor
5420171|NCT00007982|adult medulloblastoma|adult medulloblastoma
5420172|NCT00007982|adult oligodendroglioma|adult oligodendroglioma
5420173|NCT00007982|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity
5420174|NCT00007982|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5420175|NCT00007982|adult central nervous system germ cell tumor|adult central nervous system germ cell tumor
5420176|NCT00007982|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
5420177|NCT00007982|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
5420178|NCT00007956|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5420179|NCT00007956|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5420180|NCT00007956|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5420181|NCT00007956|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5420182|NCT00007956|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5420183|NCT00007956|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5420184|NCT00007956|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5420185|NCT00007956|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5420186|NCT00007956|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5420187|NCT00007956|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5420188|NCT00007930|stage I rectal cancer|stage i rectal cancer
5420189|NCT00007930|stage II rectal cancer|stage ii rectal cancer
5420190|NCT00007930|stage III rectal cancer|stage iii rectal cancer
5420191|NCT00007904|stage II breast cancer|stage ii breast cancer
5420192|NCT00007904|stage IIIA breast cancer|stage iiia breast cancer
5420193|NCT00007904|male breast cancer|male breast cancer
5420194|NCT00007891|stage IV breast cancer|stage iv breast cancer
5420195|NCT00007891|recurrent breast cancer|recurrent breast cancer
5420196|NCT00007891|male breast cancer|male breast cancer
5420197|NCT00007865|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5420198|NCT00007865|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5420199|NCT00007865|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5422701|NCT00004065|stage III melanoma|stage iii melanoma
5420200|NCT00007865|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5420201|NCT00007865|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5420202|NCT00007865|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5420203|NCT00007865|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5420204|NCT00007865|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5420205|NCT00007865|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5420206|NCT00007865|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5420207|NCT00007865|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5420208|NCT00007865|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5420209|NCT00007865|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5420210|NCT00007865|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5420211|NCT00007826|stage II colon cancer|stage ii colon cancer
5420212|NCT00007826|stage III colon cancer|stage iii colon cancer
5420213|NCT00007826|stage IV colon cancer|stage iv colon cancer
5420214|NCT00007826|stage II rectal cancer|stage ii rectal cancer
5420215|NCT00007826|stage III rectal cancer|stage iii rectal cancer
5420216|NCT00007826|stage IV rectal cancer|stage iv rectal cancer
5420217|NCT00007826|adenocarcinoma of the colon|adenocarcinoma of the colon
5420218|NCT00007826|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5420219|NCT00006994|oral complications of radiation therapy|oral complications of radiation therapy
5420220|NCT00006994|pain|pain
5420221|NCT00006994|radiation toxicity|radiation toxicity
5420222|NCT00006994|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
5420223|NCT00006994|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
5420224|NCT00006994|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
5420225|NCT00006994|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5420226|NCT00006994|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
5420227|NCT00006994|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
5420228|NCT00006994|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
5420229|NCT00006994|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5420230|NCT00006981|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5420231|NCT00006981|stage III cervical cancer|stage iii cervical cancer
5420232|NCT00006981|recurrent cervical cancer|recurrent cervical cancer
5420233|NCT00006981|stage IVB cervical cancer|stage ivb cervical cancer
5420234|NCT00006981|stage IVA cervical cancer|stage iva cervical cancer
5420235|NCT00006981|squamous cell lung cancer|squamous cell lung cancer
5420236|NCT00006981|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5420237|NCT00006981|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5420238|NCT00006981|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5420239|NCT00006981|advanced malignant mesothelioma|advanced malignant mesothelioma
5420240|NCT00006981|recurrent malignant mesothelioma|recurrent malignant mesothelioma
5420241|NCT00006981|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5420242|NCT00006981|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5420243|NCT00006981|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5420244|NCT00006981|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
5420245|NCT00006981|ovarian undifferentiated adenocarcinoma|ovarian undifferentiated adenocarcinoma
5420246|NCT00006981|ovarian mixed epithelial carcinoma|ovarian mixed epithelial carcinoma
5420247|NCT00006981|ovarian serous cystadenocarcinoma|ovarian serous cystadenocarcinoma
5420248|NCT00006981|ovarian endometrioid adenocarcinoma|ovarian endometrioid adenocarcinoma
5420249|NCT00006981|ovarian clear cell cystadenocarcinoma|ovarian clear cell cystadenocarcinoma
5420250|NCT00006981|cervical squamous cell carcinoma|cervical squamous cell carcinoma
5420251|NCT00006981|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
5420252|NCT00006981|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
5420253|NCT00006981|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5420254|NCT00006981|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
5420255|NCT00006981|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
5420256|NCT00006981|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5420257|NCT00006981|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
5420258|NCT00006981|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
5420259|NCT00006981|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
5420260|NCT00006981|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
5420261|NCT00006981|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
5420262|NCT00006981|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5439614|NCT00021658|children|children
5420263|NCT00006981|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
5420264|NCT00006981|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
5420265|NCT00006981|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5422249|NCT00004896|refractory anemia|refractory anemia
5420266|NCT00006981|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
5420267|NCT00006981|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
5420268|NCT00006981|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
5420269|NCT00006981|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
5420270|NCT00006981|fallopian tube cancer|fallopian tube cancer
5420271|NCT00006981|primary peritoneal cavity cancer|primary peritoneal cavity cancer
5420272|NCT00006981|ovarian carcinosarcoma|ovarian carcinosarcoma
5420273|NCT00006981|Brenner tumor|brenner tumor
5420274|NCT00006981|untreated metastatic squamous neck cancer with occult primary|untreated metastatic squamous neck cancer with occult primary
5420275|NCT00006981|recurrent salivary gland cancer|recurrent salivary gland cancer
5420276|NCT00006981|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
5420277|NCT00006981|stage III salivary gland cancer|stage iii salivary gland cancer
5420278|NCT00006981|stage IV salivary gland cancer|stage iv salivary gland cancer
5420279|NCT00006981|recurrent pancreatic cancer|recurrent pancreatic cancer
5420280|NCT00006981|stage II pancreatic cancer|stage ii pancreatic cancer
5420281|NCT00006981|stage III pancreatic cancer|stage iii pancreatic cancer
5420282|NCT00006981|ovarian mucinous cystadenocarcinoma|ovarian mucinous cystadenocarcinoma
5420283|NCT00006981|borderline ovarian surface epithelial-stromal tumor|borderline ovarian surface epithelial-stromal tumor
5420284|NCT00006981|ovarian sarcoma|ovarian sarcoma
5420285|NCT00006981|ovarian stromal cancer|ovarian stromal cancer
5420286|NCT00006981|stage IV pancreatic cancer|stage iv pancreatic cancer
5420287|NCT00006916|adult glioblastoma|adult glioblastoma
5420288|NCT00006916|adult giant cell glioblastoma|adult giant cell glioblastoma
5420289|NCT00006916|adult gliosarcoma|adult gliosarcoma
5420290|NCT00006825|stage IV breast cancer|stage iv breast cancer
5420291|NCT00006825|recurrent breast cancer|recurrent breast cancer
5420292|NCT00006760|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
5420293|NCT00006760|childhood lymphocyte predominant Hodgkin lymphoma|childhood lymphocyte predominant hodgkin lymphoma
5420294|NCT00006760|childhood lymphocyte depletion Hodgkin lymphoma|childhood lymphocyte depletion hodgkin lymphoma
5420295|NCT00006760|childhood nodular sclerosis Hodgkin lymphoma|childhood nodular sclerosis hodgkin lymphoma
5420296|NCT00006760|childhood mixed cellularity Hodgkin lymphoma|childhood mixed cellularity hodgkin lymphoma
5420297|NCT00006747|graft versus host disease|graft versus host disease
5420298|NCT00006747|stage I mantle cell lymphoma|stage i mantle cell lymphoma
5420299|NCT00006747|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
5420300|NCT00006747|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5420301|NCT00006747|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5420302|NCT00006747|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5420303|NCT00006747|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5420304|NCT00006734|localized Ewing sarcoma/peripheral primitive neuroectodermal tumor|localized ewing sarcoma/peripheral primitive neuroectodermal tumor
5420305|NCT00006721|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5420306|NCT00006721|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5420307|NCT00006721|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5420308|NCT00006721|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5420309|NCT00006721|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5420310|NCT00006721|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5420311|NCT00006721|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
5420312|NCT00006721|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
5420313|NCT00006721|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
5420314|NCT00006721|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5420315|NCT00006721|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5420316|NCT00006721|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5420317|NCT00006695|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5420318|NCT00006695|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5420319|NCT00006695|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5420320|NCT00006656|recurrent adult brain tumor|recurrent adult brain tumor
5420321|NCT00006656|adult glioblastoma|adult glioblastoma
5420322|NCT00006656|adult giant cell glioblastoma|adult giant cell glioblastoma
5420323|NCT00006656|adult gliosarcoma|adult gliosarcoma
5420324|NCT00006485|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5420325|NCT00006479|stage IV colon cancer|stage iv colon cancer
5420326|NCT00006479|stage IV rectal cancer|stage iv rectal cancer
5420327|NCT00006479|recurrent colon cancer|recurrent colon cancer
5420328|NCT00006479|recurrent rectal cancer|recurrent rectal cancer
5420330|NCT00006478|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5420331|NCT00006478|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5420332|NCT00006478|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5420333|NCT00006477|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5420334|NCT00006476|stage 0 bladder cancer|stage 0 bladder cancer
5420335|NCT00006476|stage I bladder cancer|stage i bladder cancer
5420336|NCT00006476|recurrent bladder cancer|recurrent bladder cancer
5420337|NCT00006474|recurrent adult brain tumor|recurrent adult brain tumor
5420338|NCT00006474|adult glioblastoma|adult glioblastoma
5420339|NCT00006474|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5420340|NCT00006474|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
5420341|NCT00006474|adult mixed glioma|adult mixed glioma
5420342|NCT00006474|adult oligodendroglioma|adult oligodendroglioma
5420343|NCT00006474|adult giant cell glioblastoma|adult giant cell glioblastoma
5420344|NCT00006474|adult gliosarcoma|adult gliosarcoma
5420345|NCT00006471|untreated metastatic squamous neck cancer with occult primary|untreated metastatic squamous neck cancer with occult primary
5420346|NCT00006471|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
5420347|NCT00006471|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
5420348|NCT00006471|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5420349|NCT00006471|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
5420350|NCT00006471|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5420351|NCT00006471|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
5420352|NCT00006471|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
5420353|NCT00006471|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5420354|NCT00006471|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
5420355|NCT00006471|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5420356|NCT00006471|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
5420357|NCT00006471|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
5420358|NCT00006471|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
5420359|NCT00006471|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
5420360|NCT00006470|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
5420361|NCT00006470|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5420362|NCT00006469|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
5420363|NCT00006469|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5420364|NCT00006468|stage IV colon cancer|stage iv colon cancer
5420365|NCT00006468|stage IV rectal cancer|stage iv rectal cancer
5420366|NCT00006468|recurrent colon cancer|recurrent colon cancer
5420367|NCT00006468|recurrent rectal cancer|recurrent rectal cancer
5420368|NCT00006468|adenocarcinoma of the colon|adenocarcinoma of the colon
5420369|NCT00006468|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5420370|NCT00006465|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5420371|NCT00006462|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5420372|NCT00006462|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5420373|NCT00006456|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5420374|NCT00006456|lung metastases|lung metastases
5420375|NCT00006456|liver metastases|liver metastases
5420376|NCT00006455|stage I childhood anaplastic large cell lymphoma|stage i childhood anaplastic large cell lymphoma
5420377|NCT00006455|stage II childhood anaplastic large cell lymphoma|stage ii childhood anaplastic large cell lymphoma
5420378|NCT00006455|stage III childhood anaplastic large cell lymphoma|stage iii childhood anaplastic large cell lymphoma
5420379|NCT00006455|stage IV childhood anaplastic large cell lymphoma|stage iv childhood anaplastic large cell lymphoma
5420380|NCT00006455|recurrent childhood anaplastic large cell lymphoma|recurrent childhood anaplastic large cell lymphoma
5420381|NCT00006392|prostate cancer|prostate cancer
5420382|NCT00006391|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5420383|NCT00006391|fallopian tube cancer|fallopian tube cancer
5420384|NCT00006391|peritoneal cavity cancer|peritoneal cavity cancer
5420385|NCT00006390|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5420386|NCT00006390|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5420387|NCT00006390|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
5420388|NCT00006390|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
5420389|NCT00006390|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
5420390|NCT00006386|adult glioblastoma|adult glioblastoma
5420391|NCT00006386|adult giant cell glioblastoma|adult giant cell glioblastoma
5420392|NCT00006386|adult gliosarcoma|adult gliosarcoma
5420393|NCT00006385|stage IV melanoma|stage iv melanoma
5420394|NCT00006385|recurrent melanoma|recurrent melanoma
5420395|NCT00006381|stage IV breast cancer|stage iv breast cancer
5439615|NCT00021658|exposure|exposure
5420397|NCT00006379|monoclonal gammopathy of undetermined significance|monoclonal gammopathy of undetermined significance
5420398|NCT00006379|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5420399|NCT00006379|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5420400|NCT00006379|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5420401|NCT00006379|isolated plasmacytoma of bone|isolated plasmacytoma of bone
5420402|NCT00006379|extramedullary plasmacytoma|extramedullary plasmacytoma
5420403|NCT00006379|refractory multiple myeloma|refractory multiple myeloma
5420404|NCT00006379|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
5420405|NCT00006379|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
5420406|NCT00006379|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5420407|NCT00006379|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5420408|NCT00006379|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5420409|NCT00006379|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5420410|NCT00006379|small intestine lymphoma|small intestine lymphoma
5420411|NCT00006379|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5420412|NCT00006379|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5420413|NCT00006379|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5420414|NCT00006379|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5420415|NCT00006379|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5420416|NCT00006379|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
5420417|NCT00006379|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
5420418|NCT00006379|polycythemia vera|polycythemia vera
5420419|NCT00006379|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
5420420|NCT00006379|essential thrombocythemia|essential thrombocythemia
5420421|NCT00006379|adult acute erythroid leukemia (M6)|adult acute erythroid leukemia (m6)
5420422|NCT00006379|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
5420423|NCT00006379|childhood acute erythroleukemia (M6)|childhood acute erythroleukemia (m6)
5420424|NCT00006379|childhood acute megakaryocytic leukemia (M7)|childhood acute megakaryocytic leukemia (m7)
5420425|NCT00006379|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
5420426|NCT00006379|refractory anemia with excess blasts|refractory anemia with excess blasts
5420427|NCT00006379|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
5420428|NCT00006379|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5420429|NCT00006379|acute undifferentiated leukemia|acute undifferentiated leukemia
5420430|NCT00006379|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5420431|NCT00006379|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5420432|NCT00006379|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5420433|NCT00006379|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5420434|NCT00006379|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5420435|NCT00006379|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5420436|NCT00006379|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5420437|NCT00006379|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5420438|NCT00006379|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5420439|NCT00006379|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
5420440|NCT00006379|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5420441|NCT00006379|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5420442|NCT00006379|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5420443|NCT00006379|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5420444|NCT00006379|prolymphocytic leukemia|prolymphocytic leukemia
5420445|NCT00006379|primary systemic amyloidosis|primary systemic amyloidosis
5420446|NCT00006379|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
5420447|NCT00006379|childhood acute minimally differentiated myeloid leukemia (M0)|childhood acute minimally differentiated myeloid leukemia (m0)
5420448|NCT00006379|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
5420449|NCT00006379|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
5420450|NCT00006379|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5420451|NCT00006379|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
5420452|NCT00006379|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5420453|NCT00006379|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5420454|NCT00006379|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
5420455|NCT00006379|chronic eosinophilic leukemia|chronic eosinophilic leukemia
5420456|NCT00006379|chronic neutrophilic leukemia|chronic neutrophilic leukemia
5420457|NCT00006379|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
5420458|NCT00006379|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
5420459|NCT00006379|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
5420460|NCT00006379|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5422702|NCT00004065|stage IV melanoma|stage iv melanoma
5420461|NCT00006379|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5420462|NCT00006379|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5420463|NCT00006379|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5420464|NCT00006379|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5420465|NCT00006379|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5420466|NCT00006379|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5420467|NCT00006379|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5420468|NCT00006379|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5420469|NCT00006379|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5420470|NCT00006379|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
5420471|NCT00006373|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5420472|NCT00006373|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5420473|NCT00006373|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5420474|NCT00006373|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5420475|NCT00006373|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5420476|NCT00006373|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5420477|NCT00006373|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5420478|NCT00006373|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5420479|NCT00006373|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5420480|NCT00006373|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5420481|NCT00006373|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5420482|NCT00006373|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5420483|NCT00006373|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5420484|NCT00006373|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5420485|NCT00006373|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5420486|NCT00006373|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5420487|NCT00006373|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5420488|NCT00006372|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5420489|NCT00006366|stage II rectal cancer|stage ii rectal cancer
5420490|NCT00006366|stage III rectal cancer|stage iii rectal cancer
5420491|NCT00006366|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5420492|NCT00006362|monoclonal gammopathy of undetermined significance|monoclonal gammopathy of undetermined significance
5420493|NCT00006362|isolated plasmacytoma of bone|isolated plasmacytoma of bone
5420494|NCT00006362|extramedullary plasmacytoma|extramedullary plasmacytoma
5420495|NCT00006362|refractory multiple myeloma|refractory multiple myeloma
5420496|NCT00006362|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
5420497|NCT00006362|stage III multiple myeloma|stage iii multiple myeloma
5420498|NCT00006362|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5420499|NCT00006362|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5420500|NCT00006362|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5420501|NCT00006362|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
5420502|NCT00006362|untreated hairy cell leukemia|untreated hairy cell leukemia
5420503|NCT00006362|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
5420504|NCT00006362|refractory hairy cell leukemia|refractory hairy cell leukemia
5420505|NCT00006362|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5420506|NCT00006362|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5420507|NCT00006362|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5420508|NCT00006362|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5420509|NCT00006362|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5420510|NCT00006362|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5420511|NCT00006362|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5420512|NCT00006362|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5420513|NCT00006362|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5420514|NCT00006362|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5420515|NCT00006362|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5420516|NCT00006362|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5420517|NCT00006362|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5420518|NCT00006362|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5420519|NCT00006362|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5420520|NCT00006362|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5420521|NCT00006362|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5420522|NCT00006362|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5420523|NCT00006362|primary systemic amyloidosis|primary systemic amyloidosis
5420524|NCT00006362|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5420525|NCT00006362|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5420526|NCT00006362|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5420527|NCT00006362|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5420528|NCT00006362|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5420529|NCT00006362|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5420530|NCT00006362|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5420531|NCT00006362|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5420532|NCT00006362|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5420533|NCT00006360|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
5420534|NCT00006360|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
5420535|NCT00006360|radiation toxicity|radiation toxicity
5420536|NCT00006359|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5420537|NCT00006359|stage I prostate cancer|stage i prostate cancer
5420538|NCT00006359|stage II prostate cancer|stage ii prostate cancer
5420539|NCT00006359|stage III prostate cancer|stage iii prostate cancer
5420540|NCT00006356|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5420541|NCT00006355|adult glioblastoma|adult glioblastoma
5420542|NCT00006355|adult giant cell glioblastoma|adult giant cell glioblastoma
5420543|NCT00006355|adult gliosarcoma|adult gliosarcoma
5420544|NCT00006354|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5420545|NCT00006351|recurrent bladder cancer|recurrent bladder cancer
5420546|NCT00006351|stage IV bladder cancer|stage iv bladder cancer
5420547|NCT00006351|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
5420548|NCT00006351|recurrent urethral cancer|recurrent urethral cancer
5420549|NCT00006351|anterior urethral cancer|anterior urethral cancer
5420550|NCT00006351|posterior urethral cancer|posterior urethral cancer
5420551|NCT00006351|urethral cancer associated with invasive bladder cancer|urethral cancer associated with invasive bladder cancer
5420552|NCT00006351|metastatic transitional cell cancer of the renal pelvis and ureter|metastatic transitional cell cancer of the renal pelvis and ureter
5420553|NCT00006351|recurrent transitional cell cancer of the renal pelvis and ureter|recurrent transitional cell cancer of the renal pelvis and ureter
5420554|NCT00006347|recurrent small cell lung cancer|recurrent small cell lung cancer
5420555|NCT00006340|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
5420556|NCT00006340|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
5420557|NCT00006340|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5420558|NCT00006340|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5420559|NCT00006340|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5420560|NCT00006340|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
5420561|NCT00006340|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
5420562|NCT00006340|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
5420563|NCT00006340|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
5420564|NCT00006340|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5420565|NCT00006340|stage I childhood lymphoblastic lymphoma|stage i childhood lymphoblastic lymphoma
5420566|NCT00006340|stage II childhood lymphoblastic lymphoma|stage ii childhood lymphoblastic lymphoma
5420567|NCT00006340|stage III childhood lymphoblastic lymphoma|stage iii childhood lymphoblastic lymphoma
5420568|NCT00006340|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
5420569|NCT00006340|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
5420570|NCT00006340|small intestine lymphoma|small intestine lymphoma
5420571|NCT00006340|childhood immunoblastic large cell lymphoma|childhood immunoblastic large cell lymphoma
5420572|NCT00006340|grade I lymphomatoid granulomatosis|grade i lymphomatoid granulomatosis
5420573|NCT00006340|grade II lymphomatoid granulomatosis|grade ii lymphomatoid granulomatosis
5420574|NCT00006340|adult grade III lymphomatoid granulomatosis|adult grade iii lymphomatoid granulomatosis
5420575|NCT00006340|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
5420576|NCT00006340|childhood grade III lymphomatoid granulomatosis|childhood grade iii lymphomatoid granulomatosis
5420577|NCT00006340|recurrent childhood grade III lymphomatoid granulomatosis|recurrent childhood grade iii lymphomatoid granulomatosis
5420578|NCT00006340|recurrent grade I lymphomatoid granulomatosis|recurrent grade i lymphomatoid granulomatosis
5420579|NCT00006340|recurrent grade II lymphomatoid granulomatosis|recurrent grade ii lymphomatoid granulomatosis
5420580|NCT00006340|stage II childhood Hodgkin lymphoma|stage ii childhood hodgkin lymphoma
5420581|NCT00006340|stage I childhood Hodgkin lymphoma|stage i childhood hodgkin lymphoma
5420582|NCT00006340|stage III childhood Hodgkin lymphoma|stage iii childhood hodgkin lymphoma
5420583|NCT00006340|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
5420584|NCT00006340|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
5420585|NCT00006340|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
5420586|NCT00006340|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
5420587|NCT00006340|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
5420588|NCT00006340|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
5420589|NCT00006340|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
5439920|NCT00017680|amyloidosis|amyloidosis
5420590|NCT00006340|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
5420591|NCT00006340|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
5420592|NCT00006340|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
5420593|NCT00006340|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
5420594|NCT00006340|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
5420595|NCT00006340|stage II grade 1 follicular lymphoma|stage ii grade 1 follicular lymphoma
5420596|NCT00006340|stage II grade 2 follicular lymphoma|stage ii grade 2 follicular lymphoma
5420597|NCT00006340|stage II grade 3 follicular lymphoma|stage ii grade 3 follicular lymphoma
5420598|NCT00006340|stage II adult diffuse small cleaved cell lymphoma|stage ii adult diffuse small cleaved cell lymphoma
5420599|NCT00006340|stage II adult diffuse mixed cell lymphoma|stage ii adult diffuse mixed cell lymphoma
5420600|NCT00006340|stage II adult diffuse large cell lymphoma|stage ii adult diffuse large cell lymphoma
5420601|NCT00006340|stage II adult immunoblastic large cell lymphoma|stage ii adult immunoblastic large cell lymphoma
5420602|NCT00006340|stage II adult lymphoblastic lymphoma|stage ii adult lymphoblastic lymphoma
5420603|NCT00006340|stage II adult Burkitt lymphoma|stage ii adult burkitt lymphoma
5420604|NCT00006340|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5420605|NCT00006340|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5420606|NCT00006340|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5420607|NCT00006340|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5420608|NCT00006340|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5420609|NCT00006340|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5420610|NCT00006340|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5420611|NCT00006340|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5420612|NCT00006340|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5420613|NCT00006340|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5420614|NCT00006340|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5420615|NCT00006340|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5420616|NCT00006340|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5420617|NCT00006340|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5420618|NCT00006340|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5420619|NCT00006340|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5420620|NCT00006340|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5420621|NCT00006340|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5420622|NCT00006340|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5420623|NCT00006340|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5420624|NCT00006340|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5420625|NCT00006340|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5420626|NCT00006340|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5420627|NCT00006340|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5420628|NCT00006340|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5420629|NCT00006340|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5420630|NCT00006340|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5420631|NCT00006340|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
5420632|NCT00006340|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
5420633|NCT00006340|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
5420634|NCT00006340|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
5420635|NCT00006340|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
5420636|NCT00006340|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
5420637|NCT00006340|AIDS-related primary CNS lymphoma|aids-related primary cns lymphoma
5420638|NCT00006340|stage I childhood small noncleaved cell lymphoma|stage i childhood small noncleaved cell lymphoma
5420639|NCT00006340|stage I childhood large cell lymphoma|stage i childhood large cell lymphoma
5420640|NCT00006340|stage II childhood small noncleaved cell lymphoma|stage ii childhood small noncleaved cell lymphoma
5420641|NCT00006340|stage II childhood large cell lymphoma|stage ii childhood large cell lymphoma
5420642|NCT00006340|stage III childhood small noncleaved cell lymphoma|stage iii childhood small noncleaved cell lymphoma
5420643|NCT00006340|stage III childhood large cell lymphoma|stage iii childhood large cell lymphoma
5420644|NCT00006340|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
5420645|NCT00006340|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
5420646|NCT00006340|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
5420647|NCT00006340|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
5420648|NCT00006340|stage I mantle cell lymphoma|stage i mantle cell lymphoma
5420649|NCT00006340|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5420650|NCT00006340|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5420651|NCT00006340|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5420652|NCT00006340|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
5440325|NCT00013754|pesticide|pesticide
5420653|NCT00006340|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5420654|NCT00006340|stage II mantle cell lymphoma|stage ii mantle cell lymphoma
5420655|NCT00006340|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
5420656|NCT00006340|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
5420657|NCT00006340|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
5420658|NCT00006340|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
5420659|NCT00006340|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5420660|NCT00006340|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5420661|NCT00006340|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5420662|NCT00006340|stage I marginal zone lymphoma|stage i marginal zone lymphoma
5420663|NCT00006340|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
5420664|NCT00006340|stage II small lymphocytic lymphoma|stage ii small lymphocytic lymphoma
5420665|NCT00006340|stage II marginal zone lymphoma|stage ii marginal zone lymphoma
5420666|NCT00006340|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5420667|NCT00006340|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5420668|NCT00006340|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5420669|NCT00006340|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5420670|NCT00006340|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5420671|NCT00006340|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5420672|NCT00006340|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5420673|NCT00006268|recurrent adult brain tumor|recurrent adult brain tumor
5420674|NCT00006268|adult glioblastoma|adult glioblastoma
5420675|NCT00006268|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5420676|NCT00006268|adult mixed glioma|adult mixed glioma
5420677|NCT00006268|adult giant cell glioblastoma|adult giant cell glioblastoma
5420678|NCT00006268|adult gliosarcoma|adult gliosarcoma
5420679|NCT00006267|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5420680|NCT00006267|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5420681|NCT00006267|primary peritoneal cavity cancer|primary peritoneal cavity cancer
5420682|NCT00006264|AIDS-related primary CNS lymphoma|aids-related primary cns lymphoma
5420683|NCT00006263|adult brain stem glioma|adult brain stem glioma
5420684|NCT00006263|adult glioblastoma|adult glioblastoma
5420685|NCT00006263|childhood high-grade cerebral astrocytoma|childhood high-grade cerebral astrocytoma
5420686|NCT00006263|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5420687|NCT00006263|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
5420688|NCT00006263|adult giant cell glioblastoma|adult giant cell glioblastoma
5420689|NCT00006263|adult gliosarcoma|adult gliosarcoma
5420690|NCT00006260|stage IV breast cancer|stage iv breast cancer
5420691|NCT00006260|recurrent breast cancer|recurrent breast cancer
5420692|NCT00006258|childhood infratentorial ependymoma|childhood infratentorial ependymoma
5420693|NCT00006258|childhood supratentorial ependymoma|childhood supratentorial ependymoma
5420694|NCT00006258|adult medulloblastoma|adult medulloblastoma
5420695|NCT00006258|adult myxopapillary ependymoma|adult myxopapillary ependymoma
5420696|NCT00006258|adult anaplastic ependymoma|adult anaplastic ependymoma
5420697|NCT00006258|adult ependymoblastoma|adult ependymoblastoma
5420698|NCT00006258|untreated childhood supratentorial primitive neuroectodermal tumor|untreated childhood supratentorial primitive neuroectodermal tumor
5420699|NCT00006258|untreated childhood medulloblastoma|untreated childhood medulloblastoma
5420700|NCT00006258|newly diagnosed childhood ependymoma|newly diagnosed childhood ependymoma
5420701|NCT00006258|adult supratentorial primitive neuroectodermal tumor (PNET)|adult supratentorial primitive neuroectodermal tumor (pnet)
5420702|NCT00006256|stage II breast cancer|stage ii breast cancer
5420703|NCT00006256|stage IIIA breast cancer|stage iiia breast cancer
5420704|NCT00006256|stage IIIB breast cancer|stage iiib breast cancer
5420705|NCT00006256|stage IIIC breast cancer|stage iiic breast cancer
5420706|NCT00006255|stage III renal cell cancer|stage iii renal cell cancer
5420707|NCT00006255|stage IV renal cell cancer|stage iv renal cell cancer
5420708|NCT00006255|recurrent renal cell cancer|recurrent renal cell cancer
5420709|NCT00006255|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5420710|NCT00006255|liver metastases|liver metastases
5420711|NCT00006252|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5420712|NCT00006252|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
5420713|NCT00006252|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
5420714|NCT00006252|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
5420715|NCT00006252|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5420716|NCT00006252|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5420717|NCT00006252|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5420718|NCT00006252|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5420719|NCT00006252|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5420720|NCT00006252|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5420721|NCT00006252|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5420722|NCT00006252|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5440326|NCT00013754|insecticide|insecticide
5420723|NCT00006252|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5420724|NCT00006252|prolymphocytic leukemia|prolymphocytic leukemia
5420725|NCT00006252|stage I mantle cell lymphoma|stage i mantle cell lymphoma
5420726|NCT00006252|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
5420727|NCT00006252|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
5420728|NCT00006252|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
5420729|NCT00006252|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
5420730|NCT00006252|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5420731|NCT00006252|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5420732|NCT00006252|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
5420733|NCT00006252|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5420734|NCT00006252|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5420735|NCT00006252|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5420736|NCT00006252|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5420737|NCT00006252|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
5420738|NCT00006252|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
5420739|NCT00006252|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
5420740|NCT00006252|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
5420741|NCT00006252|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5420742|NCT00006252|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5420743|NCT00006252|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5420744|NCT00006252|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5420745|NCT00006252|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5420746|NCT00006252|stage I marginal zone lymphoma|stage i marginal zone lymphoma
5420747|NCT00006252|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
5420748|NCT00006252|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5420749|NCT00006252|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5420750|NCT00006252|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5420751|NCT00006252|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5420752|NCT00006250|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5420753|NCT00006250|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5420754|NCT00006250|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5420755|NCT00006250|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5420756|NCT00006250|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5420757|NCT00006250|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5420758|NCT00006249|stage III melanoma|stage iii melanoma
5420759|NCT00006248|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5420760|NCT00006248|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
5420761|NCT00006248|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5420762|NCT00006248|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
5420763|NCT00006248|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
5420764|NCT00006248|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
5420765|NCT00006248|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5420766|NCT00006248|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
5420767|NCT00006248|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5420768|NCT00006248|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
5420769|NCT00006248|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
5420770|NCT00006248|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
5420771|NCT00006246|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5420772|NCT00006246|childhood infratentorial ependymoma|childhood infratentorial ependymoma
5420773|NCT00006246|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
5420774|NCT00006246|recurrent childhood brain tumor|recurrent childhood brain tumor
5420775|NCT00006246|recurrent retinoblastoma|recurrent retinoblastoma
5420776|NCT00006246|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
5420777|NCT00006246|childhood central nervous system germ cell tumor|childhood central nervous system germ cell tumor
5420778|NCT00006246|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5420779|NCT00006246|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
5420780|NCT00006246|leptomeningeal metastases|leptomeningeal metastases
5420781|NCT00006246|childhood high-grade cerebral astrocytoma|childhood high-grade cerebral astrocytoma
5420782|NCT00006246|childhood oligodendroglioma|childhood oligodendroglioma
5420783|NCT00006246|childhood choroid plexus tumor|childhood choroid plexus tumor
5420784|NCT00006246|childhood grade I meningioma|childhood grade i meningioma
5420785|NCT00006246|childhood grade II meningioma|childhood grade ii meningioma
5420786|NCT00006246|childhood grade III meningioma|childhood grade iii meningioma
5420787|NCT00006246|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
5420788|NCT00006246|recurrent childhood brain stem glioma|recurrent childhood brain stem glioma
5420789|NCT00006246|recurrent childhood supratentorial primitive neuroectodermal tumor|recurrent childhood supratentorial primitive neuroectodermal tumor
5420790|NCT00006246|recurrent childhood cerebellar astrocytoma|recurrent childhood cerebellar astrocytoma
5420791|NCT00006246|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
5420792|NCT00006246|recurrent childhood medulloblastoma|recurrent childhood medulloblastoma
5420793|NCT00006246|recurrent childhood visual pathway and hypothalamic glioma|recurrent childhood visual pathway and hypothalamic glioma
5420794|NCT00006246|recurrent childhood ependymoma|recurrent childhood ependymoma
5420795|NCT00006246|recurrent childhood malignant germ cell tumor|recurrent childhood malignant germ cell tumor
5420796|NCT00006245|stage III esophageal cancer|stage iii esophageal cancer
5420797|NCT00006245|stage IV esophageal cancer|stage iv esophageal cancer
5420798|NCT00006245|recurrent esophageal cancer|recurrent esophageal cancer
5420799|NCT00006245|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
5420800|NCT00006245|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
5420801|NCT00006239|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5420802|NCT00006239|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
5420803|NCT00006239|refractory anemia|refractory anemia
5420804|NCT00006239|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
5420805|NCT00006239|refractory anemia with excess blasts|refractory anemia with excess blasts
5420806|NCT00006239|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
5420807|NCT00006239|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5420808|NCT00006239|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5420809|NCT00006239|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
5420810|NCT00006239|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
5420811|NCT00006239|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5420812|NCT00006239|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5420813|NCT00006239|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5420814|NCT00006239|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5420815|NCT00006239|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5420816|NCT00006237|stage III melanoma|stage iii melanoma
5420817|NCT00006237|recurrent melanoma|recurrent melanoma
5420818|NCT00006234|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
5420819|NCT00006234|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
5420820|NCT00006234|adult rhabdomyosarcoma|adult rhabdomyosarcoma
5420821|NCT00006234|bone metastases|bone metastases
5420822|NCT00006234|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
5420823|NCT00006234|metastatic Ewing sarcoma/peripheral primitive neuroectodermal tumor|metastatic ewing sarcoma/peripheral primitive neuroectodermal tumor
5420824|NCT00006234|recurrent Ewing sarcoma/peripheral primitive neuroectodermal tumor|recurrent ewing sarcoma/peripheral primitive neuroectodermal tumor
5420825|NCT00006234|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
5420826|NCT00006233|stage IV melanoma|stage iv melanoma
5420827|NCT00006233|recurrent melanoma|recurrent melanoma
5420828|NCT00006232|stage II multiple myeloma|stage ii multiple myeloma
5420829|NCT00006232|stage III multiple myeloma|stage iii multiple myeloma
5420830|NCT00006231|localized malignant mesothelioma|localized malignant mesothelioma
5420831|NCT00006231|advanced malignant mesothelioma|advanced malignant mesothelioma
5420832|NCT00006231|perioperative/postoperative complications|perioperative/postoperative complications
5420833|NCT00006230|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5420834|NCT00006230|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5420835|NCT00006230|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5420836|NCT00006221|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5420837|NCT00006221|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5420838|NCT00006221|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
5420839|NCT00006221|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5420840|NCT00006221|small intestine lymphoma|small intestine lymphoma
5420841|NCT00006221|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5420842|NCT00006221|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5420843|NCT00006221|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5420844|NCT00006221|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5420845|NCT00006221|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5420846|NCT00006221|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5420847|NCT00006221|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5420848|NCT00006221|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5422703|NCT00004065|recurrent melanoma|recurrent melanoma
5420849|NCT00006221|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5420850|NCT00006221|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5420851|NCT00006221|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5420852|NCT00006221|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5420853|NCT00006221|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5420854|NCT00006221|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5420855|NCT00006221|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5420856|NCT00006221|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5420857|NCT00006221|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5420858|NCT00006221|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5420859|NCT00006221|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5420860|NCT00006221|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
5420861|NCT00006221|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
5420862|NCT00006221|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
5420863|NCT00006221|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
5420864|NCT00006221|AIDS-related primary CNS lymphoma|aids-related primary cns lymphoma
5420865|NCT00006221|intraocular lymphoma|intraocular lymphoma
5420866|NCT00006221|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5420867|NCT00006221|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5420868|NCT00006221|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
5420869|NCT00006221|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5420870|NCT00006221|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
5420871|NCT00006221|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5420872|NCT00006221|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5420873|NCT00006221|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5420874|NCT00006221|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5420875|NCT00006221|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5420876|NCT00006221|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5420877|NCT00006221|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5420878|NCT00006221|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5420879|NCT00006219|multiple myeloma|multiple myeloma
5420880|NCT00006125|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5420881|NCT00006125|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5420882|NCT00006125|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5420883|NCT00006125|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5420884|NCT00006120|stage IV breast cancer|stage iv breast cancer
5420885|NCT00006120|stage IIIA breast cancer|stage iiia breast cancer
5420886|NCT00006120|recurrent breast cancer|recurrent breast cancer
5420887|NCT00006120|stage IIIB breast cancer|stage iiib breast cancer
5420888|NCT00006119|recurrent adult brain tumor|recurrent adult brain tumor
5420889|NCT00006119|adult grade III meningioma|adult grade iii meningioma
5420890|NCT00006119|adult grade I meningioma|adult grade i meningioma
5420891|NCT00006119|adult grade II meningioma|adult grade ii meningioma
5420892|NCT00006118|stage III bladder cancer|stage iii bladder cancer
5420893|NCT00006118|stage IV bladder cancer|stage iv bladder cancer
5420894|NCT00006118|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
5420895|NCT00006114|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5420896|NCT00006114|stage IV prostate cancer|stage iv prostate cancer
5420897|NCT00006114|recurrent prostate cancer|recurrent prostate cancer
5420898|NCT00006113|stage III melanoma|stage iii melanoma
5420899|NCT00006113|stage IV melanoma|stage iv melanoma
5420900|NCT00006113|recurrent melanoma|recurrent melanoma
5420901|NCT00006110|stage II breast cancer|stage ii breast cancer
5420902|NCT00006110|stage IV breast cancer|stage iv breast cancer
5420903|NCT00006110|stage IIIA breast cancer|stage iiia breast cancer
5420904|NCT00006110|stage IIIB breast cancer|stage iiib breast cancer
5420905|NCT00006110|stage IIIC breast cancer|stage iiic breast cancer
5420906|NCT00006110|inflammatory breast cancer|inflammatory breast cancer
5420907|NCT00006107|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
5420908|NCT00006107|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
5420909|NCT00006107|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
5420910|NCT00006107|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5420911|NCT00006107|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
5420912|NCT00006107|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
5420913|NCT00006107|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5420914|NCT00006107|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
5420915|NCT00006107|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
5420980|NCT00006093|adult giant cell glioblastoma|adult giant cell glioblastoma
5420916|NCT00006107|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
5420917|NCT00006107|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
5420918|NCT00006107|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
5420919|NCT00006107|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5420920|NCT00006107|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
5420921|NCT00006107|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
5420922|NCT00006107|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5420923|NCT00006107|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
5420924|NCT00006107|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
5420925|NCT00006107|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
5420926|NCT00006107|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
5420927|NCT00006107|recurrent salivary gland cancer|recurrent salivary gland cancer
5420928|NCT00006107|stage III salivary gland cancer|stage iii salivary gland cancer
5420929|NCT00006107|stage IV salivary gland cancer|stage iv salivary gland cancer
5420930|NCT00006107|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
5420931|NCT00006107|recurrent lymphoepithelioma of the nasopharynx|recurrent lymphoepithelioma of the nasopharynx
5420932|NCT00006107|recurrent lymphoepithelioma of the oropharynx|recurrent lymphoepithelioma of the oropharynx
5420933|NCT00006107|stage III lymphoepithelioma of the nasopharynx|stage iii lymphoepithelioma of the nasopharynx
5420934|NCT00006107|stage III lymphoepithelioma of the oropharynx|stage iii lymphoepithelioma of the oropharynx
5420935|NCT00006107|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
5420936|NCT00006107|stage IV lymphoepithelioma of the oropharynx|stage iv lymphoepithelioma of the oropharynx
5420937|NCT00006105|stage II bladder cancer|stage ii bladder cancer
5420938|NCT00006105|stage III bladder cancer|stage iii bladder cancer
5420939|NCT00006105|stage IV bladder cancer|stage iv bladder cancer
5420940|NCT00006105|drug/agent toxicity by tissue/organ|drug/agent toxicity by tissue/organ
5420941|NCT00006102|childhood infratentorial ependymoma|childhood infratentorial ependymoma
5420942|NCT00006102|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
5420943|NCT00006102|childhood supratentorial ependymoma|childhood supratentorial ependymoma
5420944|NCT00006102|childhood craniopharyngioma|childhood craniopharyngioma
5420945|NCT00006102|disseminated neuroblastoma|disseminated neuroblastoma
5420946|NCT00006102|recurrent neuroblastoma|recurrent neuroblastoma
5420947|NCT00006102|intraocular retinoblastoma|intraocular retinoblastoma
5420948|NCT00006102|extraocular retinoblastoma|extraocular retinoblastoma
5420949|NCT00006102|stage III childhood lymphoblastic lymphoma|stage iii childhood lymphoblastic lymphoma
5420950|NCT00006102|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
5420951|NCT00006102|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
5420952|NCT00006102|childhood central nervous system germ cell tumor|childhood central nervous system germ cell tumor
5420953|NCT00006102|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
5420954|NCT00006102|childhood high-grade cerebral astrocytoma|childhood high-grade cerebral astrocytoma
5420955|NCT00006102|childhood oligodendroglioma|childhood oligodendroglioma
5420956|NCT00006102|childhood choroid plexus tumor|childhood choroid plexus tumor
5420957|NCT00006102|childhood grade I meningioma|childhood grade i meningioma
5420958|NCT00006102|childhood grade II meningioma|childhood grade ii meningioma
5420959|NCT00006102|childhood grade III meningioma|childhood grade iii meningioma
5420960|NCT00006102|stage III childhood large cell lymphoma|stage iii childhood large cell lymphoma
5420961|NCT00006102|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
5420962|NCT00006102|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
5420963|NCT00006102|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
5420964|NCT00006102|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
5420965|NCT00006102|recurrent childhood brain stem glioma|recurrent childhood brain stem glioma
5420966|NCT00006102|recurrent childhood supratentorial primitive neuroectodermal tumor|recurrent childhood supratentorial primitive neuroectodermal tumor
5420967|NCT00006102|recurrent childhood cerebellar astrocytoma|recurrent childhood cerebellar astrocytoma
5420968|NCT00006102|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
5420969|NCT00006102|recurrent childhood medulloblastoma|recurrent childhood medulloblastoma
5420970|NCT00006102|recurrent childhood visual pathway and hypothalamic glioma|recurrent childhood visual pathway and hypothalamic glioma
5420971|NCT00006102|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
5420972|NCT00006102|recurrent childhood ependymoma|recurrent childhood ependymoma
5420973|NCT00006102|recurrent retinoblastoma|recurrent retinoblastoma
5420974|NCT00006101|stage I prostate cancer|stage i prostate cancer
5420975|NCT00006100|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5420976|NCT00006093|recurrent adult brain tumor|recurrent adult brain tumor
5420977|NCT00006093|adult glioblastoma|adult glioblastoma
5420978|NCT00006093|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5420979|NCT00006093|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
5420982|NCT00006092|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5420983|NCT00006092|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5420984|NCT00006092|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5420985|NCT00006092|chronic myelogenous leukemia, BCR-ABL1 positive|chronic myelogenous leukemia, bcr-abl1 positive
5420986|NCT00006092|lymphoid leukemia|lymphoid leukemia
5420987|NCT00006092|myeloid and monocytic leukemia|myeloid and monocytic leukemia
5420988|NCT00006078|prostate cancer|prostate cancer
5420989|NCT00006044|stage IV prostate cancer|stage iv prostate cancer
5420990|NCT00006044|recurrent prostate cancer|recurrent prostate cancer
5420991|NCT00006042|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5420992|NCT00006042|Burkitt lymphoma|burkitt lymphoma
5420993|NCT00006042|refractory multiple myeloma|refractory multiple myeloma
5420994|NCT00006042|stage II multiple myeloma|stage ii multiple myeloma
5420995|NCT00006042|stage III multiple myeloma|stage iii multiple myeloma
5420996|NCT00006042|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
5420997|NCT00006042|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5420998|NCT00006042|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5420999|NCT00006042|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5421000|NCT00006042|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5421001|NCT00006042|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5421002|NCT00006042|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5421003|NCT00006042|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5421004|NCT00006042|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
5421005|NCT00006042|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
5421006|NCT00006042|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
5421007|NCT00006042|stage II adult lymphoblastic lymphoma|stage ii adult lymphoblastic lymphoma
5421008|NCT00006042|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5421009|NCT00006042|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5421010|NCT00006042|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5421011|NCT00006042|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5421012|NCT00006042|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5421013|NCT00006042|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5421014|NCT00006042|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5421015|NCT00006042|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5421016|NCT00006042|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5421017|NCT00006042|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5421018|NCT00006042|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5421019|NCT00006042|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5423102|NCT00003938|ovarian polyembryoma|ovarian polyembryoma
5421020|NCT00006042|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5421021|NCT00006042|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5421022|NCT00006042|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5421023|NCT00006042|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5421024|NCT00006042|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5421025|NCT00006042|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5421026|NCT00006042|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5421027|NCT00006042|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5421028|NCT00006042|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5421029|NCT00006042|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5421030|NCT00006042|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5421031|NCT00006042|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5421032|NCT00006042|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5421033|NCT00006042|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5421034|NCT00006042|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
5421035|NCT00006042|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
5421036|NCT00006042|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5421037|NCT00006042|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5421038|NCT00006042|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
5421039|NCT00006042|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
5421040|NCT00006042|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5421041|NCT00006042|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
5421042|NCT00006042|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
5421043|NCT00006042|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5421044|NCT00006042|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5440526|NCT00011765|Rage|rage
5421045|NCT00006042|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5421046|NCT00006042|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
5421047|NCT00006042|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
5421048|NCT00006042|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
5421049|NCT00006042|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5421050|NCT00006042|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5421051|NCT00006042|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5421052|NCT00006042|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5421053|NCT00006042|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5421054|NCT00006042|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5421055|NCT00006042|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5421056|NCT00006042|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5421057|NCT00006042|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5421058|NCT00006042|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5421059|NCT00006042|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5421060|NCT00006042|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5421061|NCT00006042|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5421062|NCT00006042|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5421063|NCT00006042|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
5421064|NCT00006040|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5421065|NCT00006040|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5421066|NCT00006040|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5421067|NCT00006040|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5421068|NCT00006040|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5421069|NCT00006040|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5421070|NCT00006040|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
5421071|NCT00006040|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
5421072|NCT00006029|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5421073|NCT00006029|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
5421074|NCT00006028|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5421075|NCT00006028|primary peritoneal cavity cancer|primary peritoneal cavity cancer
5421076|NCT00006027|stage I endometrial carcinoma|stage i endometrial carcinoma
5421077|NCT00006027|stage II endometrial carcinoma|stage ii endometrial carcinoma
5421078|NCT00006027|endometrial adenocarcinoma|endometrial adenocarcinoma
5421079|NCT00006027|endometrial adenosquamous cell carcinoma|endometrial adenosquamous cell carcinoma
5421080|NCT00006027|endometrial adenoacanthoma|endometrial adenoacanthoma
5421081|NCT00006027|endometrial clear cell carcinoma|endometrial clear cell carcinoma
5421082|NCT00006027|endometrial papillary serous carcinoma|endometrial papillary serous carcinoma
5421083|NCT00006025|recurrent adult brain tumor|recurrent adult brain tumor
5421084|NCT00006025|adult glioblastoma|adult glioblastoma
5421085|NCT00006025|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5421086|NCT00006025|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
5421087|NCT00006025|adult mixed glioma|adult mixed glioma
5421088|NCT00006025|adult giant cell glioblastoma|adult giant cell glioblastoma
5421089|NCT00006025|adult gliosarcoma|adult gliosarcoma
5421090|NCT00006024|childhood high-grade cerebral astrocytoma|childhood high-grade cerebral astrocytoma
5421091|NCT00006022|stage III renal cell cancer|stage iii renal cell cancer
5421092|NCT00006022|stage IV renal cell cancer|stage iv renal cell cancer
5421093|NCT00006022|recurrent renal cell cancer|recurrent renal cell cancer
5421094|NCT00006022|stage III melanoma|stage iii melanoma
5421095|NCT00006022|stage IV melanoma|stage iv melanoma
5421096|NCT00006022|recurrent melanoma|recurrent melanoma
5421097|NCT00006021|refractory multiple myeloma|refractory multiple myeloma
5421098|NCT00006021|stage II multiple myeloma|stage ii multiple myeloma
5421099|NCT00006021|stage III multiple myeloma|stage iii multiple myeloma
5421100|NCT00006020|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5421101|NCT00006020|L1 adult acute lymphoblastic leukemia|l1 adult acute lymphoblastic leukemia
5421102|NCT00006020|L2 adult acute lymphoblastic leukemia|l2 adult acute lymphoblastic leukemia
5421103|NCT00006020|B-cell adult acute lymphoblastic leukemia|b-cell adult acute lymphoblastic leukemia
5421104|NCT00006020|non-T, non-B adult acute lymphoblastic leukemia|non-t, non-b adult acute lymphoblastic leukemia
5421105|NCT00006017|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5421106|NCT00006017|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5421107|NCT00006017|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5421108|NCT00006015|stage IV colon cancer|stage iv colon cancer
5421109|NCT00006015|stage IV rectal cancer|stage iv rectal cancer
5421110|NCT00006015|recurrent colon cancer|recurrent colon cancer
5421111|NCT00006015|recurrent rectal cancer|recurrent rectal cancer
5421112|NCT00006015|adenocarcinoma of the colon|adenocarcinoma of the colon
5440527|NCT00011765|Fear|fear
5421113|NCT00006015|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5421114|NCT00006010|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
5421115|NCT00006010|advanced adult primary liver cancer|advanced adult primary liver cancer
5421116|NCT00006010|recurrent adult primary liver cancer|recurrent adult primary liver cancer
5421117|NCT00006010|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
5421118|NCT00006007|stage IV breast cancer|stage iv breast cancer
5421119|NCT00006007|recurrent breast cancer|recurrent breast cancer
5421120|NCT00006006|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
5421121|NCT00006006|advanced adult primary liver cancer|advanced adult primary liver cancer
5421122|NCT00006006|recurrent adult primary liver cancer|recurrent adult primary liver cancer
5421123|NCT00006006|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
5421124|NCT00006005|stage I uterine sarcoma|stage i uterine sarcoma
5421125|NCT00006005|stage II uterine sarcoma|stage ii uterine sarcoma
5421126|NCT00006005|stage III uterine sarcoma|stage iii uterine sarcoma
5421127|NCT00006005|stage IV uterine sarcoma|stage iv uterine sarcoma
5421128|NCT00006005|recurrent uterine sarcoma|recurrent uterine sarcoma
5421129|NCT00006005|uterine carcinosarcoma|uterine carcinosarcoma
5421130|NCT00006005|uterine leiomyosarcoma|uterine leiomyosarcoma
5421131|NCT00006005|endometrial stromal sarcoma|endometrial stromal sarcoma
5421132|NCT00006004|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5421133|NCT00006004|squamous cell lung cancer|squamous cell lung cancer
5421134|NCT00006004|large cell lung cancer|large cell lung cancer
5421135|NCT00006004|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5421136|NCT00006004|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5421137|NCT00006004|adenocarcinoma of the lung|adenocarcinoma of the lung
5421138|NCT00006004|adenosquamous cell lung cancer|adenosquamous cell lung cancer
5421139|NCT00006004|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
5421140|NCT00005997|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
5421141|NCT00005997|advanced adult primary liver cancer|advanced adult primary liver cancer
5421142|NCT00005997|unresectable gallbladder cancer|unresectable gallbladder cancer
5421143|NCT00005997|unresectable extrahepatic bile duct cancer|unresectable extrahepatic bile duct cancer
5421144|NCT00005997|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
5421145|NCT00005997|cholangiocarcinoma of the gallbladder|cholangiocarcinoma of the gallbladder
5421146|NCT00005997|cholangiocarcinoma of the extrahepatic bile duct|cholangiocarcinoma of the extrahepatic bile duct
5421147|NCT00005997|adult primary cholangiocellular carcinoma|adult primary cholangiocellular carcinoma
5421148|NCT00005990|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5421149|NCT00005987|stage I multiple myeloma|stage i multiple myeloma
5421150|NCT00005987|stage II multiple myeloma|stage ii multiple myeloma
5421151|NCT00005987|stage III multiple myeloma|stage iii multiple myeloma
5421152|NCT00005985|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
5421153|NCT00005985|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
5421154|NCT00005985|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5421155|NCT00005985|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5421156|NCT00005985|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5421157|NCT00005985|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
5421158|NCT00005985|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
5421159|NCT00005985|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
5421160|NCT00005985|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
5421161|NCT00005985|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
5421162|NCT00005985|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
5421163|NCT00005985|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
5421164|NCT00005985|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
5421165|NCT00005985|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
5421166|NCT00005985|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5421167|NCT00005985|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5421168|NCT00005985|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5421169|NCT00005985|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5421170|NCT00005985|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5421171|NCT00005985|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5421172|NCT00005985|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5421173|NCT00005985|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5421174|NCT00005985|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5421175|NCT00005985|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5421176|NCT00005985|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5421177|NCT00005985|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5421178|NCT00005985|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5421179|NCT00005985|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5421180|NCT00005985|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5440528|NCT00011765|Violence|violence
5421181|NCT00005985|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5421182|NCT00005985|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5421183|NCT00005985|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5421184|NCT00005985|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5421185|NCT00005985|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5421186|NCT00005985|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5421187|NCT00005985|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5421188|NCT00005985|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5421189|NCT00005985|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5421190|NCT00005985|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5421191|NCT00005985|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5421192|NCT00005985|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5421193|NCT00005985|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
5421194|NCT00005985|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
5421195|NCT00005985|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
5421196|NCT00005985|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
5421197|NCT00005985|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
5421198|NCT00005985|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
5421199|NCT00005985|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
5421200|NCT00005985|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
5421201|NCT00005985|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
5421202|NCT00005985|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
5421203|NCT00005985|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
5421204|NCT00005985|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
5421205|NCT00005985|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
5421206|NCT00005985|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
5421207|NCT00005985|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5421208|NCT00005985|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5421209|NCT00005985|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5421210|NCT00005985|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
5421211|NCT00005985|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
5421212|NCT00005985|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
5421213|NCT00005985|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5421214|NCT00005985|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
5421215|NCT00005985|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
5421216|NCT00005985|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
5421217|NCT00005985|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
5421218|NCT00005985|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5421219|NCT00005985|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
5421220|NCT00005985|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5421221|NCT00005985|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5421222|NCT00005984|chronic phase myelogenous leukemia|chronic phase myelogenous leukemia
5421223|NCT00005984|accelerated phase myelogenous leukemia|accelerated phase myelogenous leukemia
5421224|NCT00005983|stage II breast cancer|stage ii breast cancer
5421225|NCT00005981|stage IV colon cancer|stage iv colon cancer
5421226|NCT00005981|stage IV rectal cancer|stage iv rectal cancer
5421227|NCT00005981|recurrent colon cancer|recurrent colon cancer
5421228|NCT00005981|recurrent rectal cancer|recurrent rectal cancer
5421229|NCT00005980|stage IV breast cancer|stage iv breast cancer
5421230|NCT00005980|recurrent breast cancer|recurrent breast cancer
5421231|NCT00005979|stage III colon cancer|stage iii colon cancer
5421232|NCT00005979|adenocarcinoma of the colon|adenocarcinoma of the colon
5421233|NCT00005976|recurrent adult brain tumor|recurrent adult brain tumor
5421234|NCT00005976|adult glioblastoma|adult glioblastoma
5421235|NCT00005976|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5421236|NCT00005976|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
5421237|NCT00005976|adult mixed glioma|adult mixed glioma
5421238|NCT00005976|adult oligodendroglioma|adult oligodendroglioma
5421239|NCT00005976|adult giant cell glioblastoma|adult giant cell glioblastoma
5421240|NCT00005976|adult gliosarcoma|adult gliosarcoma
5421241|NCT00005967|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5421242|NCT00005967|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5421243|NCT00005967|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5421244|NCT00005967|refractory multiple myeloma|refractory multiple myeloma
5421245|NCT00005967|stage III multiple myeloma|stage iii multiple myeloma
5421246|NCT00005967|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5421247|NCT00005967|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5421248|NCT00005967|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5421249|NCT00005967|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5421250|NCT00005967|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5421251|NCT00005967|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5421252|NCT00005967|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5421253|NCT00005967|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5421254|NCT00005967|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5421255|NCT00005967|refractory anemia with excess blasts|refractory anemia with excess blasts
5421256|NCT00005967|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
5421257|NCT00005967|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5421258|NCT00005967|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5421259|NCT00005967|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5421260|NCT00005967|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5421261|NCT00005967|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5421262|NCT00005967|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5421263|NCT00005967|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5421264|NCT00005967|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5421265|NCT00005967|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5421266|NCT00005967|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5421267|NCT00005967|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5421268|NCT00005967|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5421269|NCT00005967|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5421270|NCT00005967|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5421271|NCT00005967|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5421272|NCT00005967|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5421273|NCT00005967|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5421274|NCT00005967|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5421275|NCT00005967|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5421276|NCT00005967|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5421277|NCT00005967|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5421278|NCT00005967|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5421279|NCT00005967|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5421280|NCT00005967|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5421281|NCT00005967|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5421282|NCT00005967|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5421283|NCT00005967|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5421284|NCT00005967|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5421285|NCT00005967|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5421286|NCT00005967|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5421287|NCT00005967|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5421288|NCT00005967|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5421289|NCT00005967|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5421290|NCT00005967|polycythemia vera|polycythemia vera
5421291|NCT00005967|primary myelofibrosis|primary myelofibrosis
5421292|NCT00005967|essential thrombocythemia|essential thrombocythemia
5421293|NCT00005967|chronic eosinophilic leukemia|chronic eosinophilic leukemia
5421294|NCT00005967|chronic neutrophilic leukemia|chronic neutrophilic leukemia
5421295|NCT00005967|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5421296|NCT00005967|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5421297|NCT00005967|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5421298|NCT00005967|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5421299|NCT00005967|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5421300|NCT00005967|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5421301|NCT00005967|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5421302|NCT00005967|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5421303|NCT00005967|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5421304|NCT00005966|stage III renal cell cancer|stage iii renal cell cancer
5421305|NCT00005966|stage IV renal cell cancer|stage iv renal cell cancer
5421306|NCT00005961|stage III melanoma|stage iii melanoma
5421307|NCT00005961|stage IV melanoma|stage iv melanoma
5421308|NCT00005961|recurrent melanoma|recurrent melanoma
5421309|NCT00005957|stage I breast cancer|stage i breast cancer
5421310|NCT00005957|stage II breast cancer|stage ii breast cancer
5421311|NCT00005955|childhood infratentorial ependymoma|childhood infratentorial ependymoma
5421312|NCT00005955|childhood low-grade cerebral astrocytoma|childhood low-grade cerebral astrocytoma
5421313|NCT00005955|childhood supratentorial ependymoma|childhood supratentorial ependymoma
5421314|NCT00005955|childhood craniopharyngioma|childhood craniopharyngioma
5421315|NCT00005955|localized resectable neuroblastoma|localized resectable neuroblastoma
5421316|NCT00005955|regional neuroblastoma|regional neuroblastoma
5421317|NCT00005955|disseminated neuroblastoma|disseminated neuroblastoma
5421318|NCT00005955|stage 4S neuroblastoma|stage 4s neuroblastoma
5421319|NCT00005955|childhood high-grade cerebral astrocytoma|childhood high-grade cerebral astrocytoma
5421320|NCT00005955|childhood oligodendroglioma|childhood oligodendroglioma
5421321|NCT00005955|childhood choroid plexus tumor|childhood choroid plexus tumor
5421322|NCT00005955|childhood grade I meningioma|childhood grade i meningioma
5421323|NCT00005955|childhood grade II meningioma|childhood grade ii meningioma
5421324|NCT00005955|childhood grade III meningioma|childhood grade iii meningioma
5421325|NCT00005955|untreated childhood supratentorial primitive neuroectodermal tumor|untreated childhood supratentorial primitive neuroectodermal tumor
5421326|NCT00005955|untreated childhood cerebellar astrocytoma|untreated childhood cerebellar astrocytoma
5421327|NCT00005955|untreated childhood medulloblastoma|untreated childhood medulloblastoma
5421328|NCT00005955|untreated childhood visual pathway and hypothalamic glioma|untreated childhood visual pathway and hypothalamic glioma
5421329|NCT00005955|newly diagnosed childhood ependymoma|newly diagnosed childhood ependymoma
5421330|NCT00005955|childhood central nervous system choriocarcinoma|childhood central nervous system choriocarcinoma
5421331|NCT00005955|childhood central nervous system embryonal tumor|childhood central nervous system embryonal tumor
5421332|NCT00005955|childhood central nervous system mixed germ cell tumor|childhood central nervous system mixed germ cell tumor
5421333|NCT00005955|childhood central nervous system teratoma|childhood central nervous system teratoma
5421334|NCT00005955|childhood central nervous system yolk sac tumor|childhood central nervous system yolk sac tumor
5421335|NCT00005954|adult tumors metastatic to brain|adult tumors metastatic to brain
5421336|NCT00005952|childhood low-grade cerebral astrocytoma|childhood low-grade cerebral astrocytoma
5421337|NCT00005952|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
5421338|NCT00005952|childhood craniopharyngioma|childhood craniopharyngioma
5421339|NCT00005952|disseminated neuroblastoma|disseminated neuroblastoma
5421340|NCT00005952|stage 4S neuroblastoma|stage 4s neuroblastoma
5421341|NCT00005952|recurrent neuroblastoma|recurrent neuroblastoma
5421342|NCT00005952|stage IV Wilms tumor|stage iv wilms tumor
5421343|NCT00005952|stage V Wilms tumor|stage v wilms tumor
5421344|NCT00005952|recurrent Wilms tumor and other childhood kidney tumors|recurrent wilms tumor and other childhood kidney tumors
5421345|NCT00005952|childhood central nervous system germ cell tumor|childhood central nervous system germ cell tumor
5421346|NCT00005952|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
5421347|NCT00005952|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
5421348|NCT00005952|stage IV nasopharyngeal cancer|stage iv nasopharyngeal cancer
5421349|NCT00005952|recurrent nasopharyngeal cancer|recurrent nasopharyngeal cancer
5421350|NCT00005952|childhood germ cell tumor|childhood germ cell tumor
5421351|NCT00005952|metastatic childhood soft tissue sarcoma|metastatic childhood soft tissue sarcoma
5421352|NCT00005952|recurrent childhood soft tissue sarcoma|recurrent childhood soft tissue sarcoma
5421353|NCT00005952|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
5421354|NCT00005952|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
5421355|NCT00005952|childhood high-grade cerebral astrocytoma|childhood high-grade cerebral astrocytoma
5421356|NCT00005952|childhood oligodendroglioma|childhood oligodendroglioma
5421357|NCT00005952|childhood choroid plexus tumor|childhood choroid plexus tumor
5421358|NCT00005952|untreated childhood brain stem glioma|untreated childhood brain stem glioma
5421359|NCT00005952|recurrent childhood brain stem glioma|recurrent childhood brain stem glioma
5421360|NCT00005952|untreated childhood supratentorial primitive neuroectodermal tumor|untreated childhood supratentorial primitive neuroectodermal tumor
5421361|NCT00005952|recurrent childhood supratentorial primitive neuroectodermal tumor|recurrent childhood supratentorial primitive neuroectodermal tumor
5421362|NCT00005952|untreated childhood cerebellar astrocytoma|untreated childhood cerebellar astrocytoma
5421363|NCT00005952|recurrent childhood cerebellar astrocytoma|recurrent childhood cerebellar astrocytoma
5421364|NCT00005952|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
5421365|NCT00005952|untreated childhood medulloblastoma|untreated childhood medulloblastoma
5421366|NCT00005952|recurrent childhood medulloblastoma|recurrent childhood medulloblastoma
5421367|NCT00005952|untreated childhood visual pathway and hypothalamic glioma|untreated childhood visual pathway and hypothalamic glioma
5421368|NCT00005952|recurrent childhood visual pathway and hypothalamic glioma|recurrent childhood visual pathway and hypothalamic glioma
5421369|NCT00005952|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
5421370|NCT00005952|metastatic Ewing sarcoma/peripheral primitive neuroectodermal tumor|metastatic ewing sarcoma/peripheral primitive neuroectodermal tumor
5421371|NCT00005952|recurrent Ewing sarcoma/peripheral primitive neuroectodermal tumor|recurrent ewing sarcoma/peripheral primitive neuroectodermal tumor
5421372|NCT00005952|newly diagnosed childhood ependymoma|newly diagnosed childhood ependymoma
5421373|NCT00005952|recurrent childhood ependymoma|recurrent childhood ependymoma
5421374|NCT00005951|recurrent adult brain tumor|recurrent adult brain tumor
5421375|NCT00005951|adult glioblastoma|adult glioblastoma
5421376|NCT00005951|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5421377|NCT00005951|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
5421378|NCT00005951|adult mixed glioma|adult mixed glioma
5421379|NCT00005951|adult giant cell glioblastoma|adult giant cell glioblastoma
5421380|NCT00005951|adult gliosarcoma|adult gliosarcoma
5421381|NCT00005945|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
5421382|NCT00005945|L1 childhood acute lymphoblastic leukemia|l1 childhood acute lymphoblastic leukemia
5421383|NCT00005945|L2 childhood acute lymphoblastic leukemia|l2 childhood acute lymphoblastic leukemia
5421384|NCT00005945|L3 childhood acute lymphoblastic leukemia|l3 childhood acute lymphoblastic leukemia
5421385|NCT00005941|stage III cervical cancer|stage iii cervical cancer
5421386|NCT00005941|recurrent cervical cancer|recurrent cervical cancer
5421387|NCT00005941|stage IVB cervical cancer|stage ivb cervical cancer
5421388|NCT00005941|stage IVA cervical cancer|stage iva cervical cancer
5421389|NCT00005941|stage III vaginal cancer|stage iii vaginal cancer
5421390|NCT00005941|stage IVA vaginal cancer|stage iva vaginal cancer
5421391|NCT00005941|stage IVB vaginal cancer|stage ivb vaginal cancer
5421392|NCT00005941|recurrent vaginal cancer|recurrent vaginal cancer
5421393|NCT00005879|breast cancer|breast cancer
5421394|NCT00005878|esophageal cancer|esophageal cancer
5421395|NCT00005867|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
5421396|NCT00005867|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
5421397|NCT00005867|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
5421398|NCT00005867|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
5421399|NCT00005867|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5421400|NCT00005867|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5423103|NCT00003938|ovarian choriocarcinoma|ovarian choriocarcinoma
5421401|NCT00005867|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5421402|NCT00005867|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5421403|NCT00005867|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5421404|NCT00005867|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5421405|NCT00005867|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5421406|NCT00005867|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5421407|NCT00005867|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
5421408|NCT00005867|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
5421409|NCT00005867|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
5421410|NCT00005867|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
5421411|NCT00005867|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5421412|NCT00005867|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
5421413|NCT00005867|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
5421414|NCT00005867|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5421415|NCT00005863|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5421416|NCT00005863|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5421417|NCT00005863|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5421418|NCT00005863|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
5421419|NCT00005863|adult acute erythroid leukemia (M6)|adult acute erythroid leukemia (m6)
5421420|NCT00005863|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
5421421|NCT00005863|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
5421422|NCT00005863|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
5421423|NCT00005863|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
5421424|NCT00005863|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
5421425|NCT00005863|childhood acute myeloblastic leukemia without maturation (M1)|childhood acute myeloblastic leukemia without maturation (m1)
5421426|NCT00005863|childhood acute myeloblastic leukemia with maturation (M2)|childhood acute myeloblastic leukemia with maturation (m2)
5421427|NCT00005863|childhood acute myelomonocytic leukemia (M4)|childhood acute myelomonocytic leukemia (m4)
5421428|NCT00005863|childhood acute monoblastic leukemia (M5a)|childhood acute monoblastic leukemia (m5a)
5421429|NCT00005863|childhood acute monocytic leukemia (M5b)|childhood acute monocytic leukemia (m5b)
5421430|NCT00005863|childhood acute erythroleukemia (M6)|childhood acute erythroleukemia (m6)
5421431|NCT00005863|childhood acute megakaryocytic leukemia (M7)|childhood acute megakaryocytic leukemia (m7)
5421432|NCT00005863|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5421433|NCT00005863|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5421434|NCT00005863|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
5421435|NCT00005863|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5421436|NCT00005863|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5421437|NCT00005863|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
5421438|NCT00005863|childhood acute minimally differentiated myeloid leukemia (M0)|childhood acute minimally differentiated myeloid leukemia (m0)
5421439|NCT00005863|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
5421440|NCT00005863|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
5421441|NCT00005863|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5421442|NCT00005863|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5421443|NCT00005863|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5421444|NCT00005863|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5421445|NCT00005863|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
5421446|NCT00005859|recurrent adult brain tumor|recurrent adult brain tumor
5421447|NCT00005859|adult glioblastoma|adult glioblastoma
5421448|NCT00005859|adult giant cell glioblastoma|adult giant cell glioblastoma
5421449|NCT00005859|adult gliosarcoma|adult gliosarcoma
5421450|NCT00005858|stage III colon cancer|stage iii colon cancer
5421451|NCT00005858|stage IV colon cancer|stage iv colon cancer
5421452|NCT00005858|stage IV breast cancer|stage iv breast cancer
5421453|NCT00005858|stage IIIA breast cancer|stage iiia breast cancer
5421454|NCT00005858|recurrent breast cancer|recurrent breast cancer
5421455|NCT00005858|stage IIIB breast cancer|stage iiib breast cancer
5421456|NCT00005858|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5421457|NCT00005858|stage II pancreatic cancer|stage ii pancreatic cancer
5421458|NCT00005858|stage III pancreatic cancer|stage iii pancreatic cancer
5421459|NCT00005858|recurrent pancreatic cancer|recurrent pancreatic cancer
5421460|NCT00005858|recurrent colon cancer|recurrent colon cancer
5421461|NCT00005858|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5421462|NCT00005858|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5421463|NCT00005858|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5421464|NCT00005858|stage III bladder cancer|stage iii bladder cancer
5421465|NCT00005858|recurrent bladder cancer|recurrent bladder cancer
5421466|NCT00005858|stage IV bladder cancer|stage iv bladder cancer
5421467|NCT00005858|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5421468|NCT00005858|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5421469|NCT00005858|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5421470|NCT00005858|ovarian stromal cancer|ovarian stromal cancer
5421471|NCT00005858|stage III ovarian germ cell tumor|stage iii ovarian germ cell tumor
5421472|NCT00005858|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
5421473|NCT00005858|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
5421474|NCT00005858|borderline ovarian surface epithelial-stromal tumor|borderline ovarian surface epithelial-stromal tumor
5421475|NCT00005858|ovarian sarcoma|ovarian sarcoma
5421476|NCT00005858|male breast cancer|male breast cancer
5421477|NCT00005858|stage IV pancreatic cancer|stage iv pancreatic cancer
5421478|NCT00005855|adult glioblastoma|adult glioblastoma
5421479|NCT00005855|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5421480|NCT00005855|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
5421481|NCT00005855|recurrent adult brain tumor|recurrent adult brain tumor
5421482|NCT00005855|adult giant cell glioblastoma|adult giant cell glioblastoma
5421483|NCT00005855|adult gliosarcoma|adult gliosarcoma
5421484|NCT00005853|refractory anemia|refractory anemia
5421485|NCT00005853|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
5421486|NCT00005853|refractory anemia with excess blasts|refractory anemia with excess blasts
5421487|NCT00005853|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
5421488|NCT00005853|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5421489|NCT00005853|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5421490|NCT00005853|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5421491|NCT00005853|refractory cytopenia with multilineage dysplasia|refractory cytopenia with multilineage dysplasia
5421492|NCT00005853|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
5421493|NCT00005850|stage I non-small cell lung cancer|stage i non-small cell lung cancer
5421494|NCT00005850|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
5421495|NCT00005850|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5421496|NCT00005850|squamous cell lung cancer|squamous cell lung cancer
5421497|NCT00005850|large cell lung cancer|large cell lung cancer
5421498|NCT00005850|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5421499|NCT00005850|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5421500|NCT00005850|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5421501|NCT00005850|adenocarcinoma of the lung|adenocarcinoma of the lung
5421502|NCT00005850|adenosquamous cell lung cancer|adenosquamous cell lung cancer
5421503|NCT00005850|fatigue|fatigue
5421504|NCT00005850|anxiety disorder|anxiety disorder
5421505|NCT00005850|depression|depression
5421506|NCT00005847|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5421507|NCT00005847|stage IV prostate cancer|stage iv prostate cancer
5421508|NCT00005847|recurrent prostate cancer|recurrent prostate cancer
5421509|NCT00005844|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
5421510|NCT00005835|regional neuroblastoma|regional neuroblastoma
5421511|NCT00005835|disseminated neuroblastoma|disseminated neuroblastoma
5421512|NCT00005835|recurrent neuroblastoma|recurrent neuroblastoma
5421513|NCT00005835|localized unresectable neuroblastoma|localized unresectable neuroblastoma
5421514|NCT00005825|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5421515|NCT00005825|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5421516|NCT00005824|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
5421517|NCT00005824|AIDS-related diffuse large cell lymphoma|aids-related diffuse large cell lymphoma
5421518|NCT00005824|AIDS-related immunoblastic large cell lymphoma|aids-related immunoblastic large cell lymphoma
5421519|NCT00005824|AIDS-related small noncleaved cell lymphoma|aids-related small noncleaved cell lymphoma
5421520|NCT00005824|HIV-associated Hodgkin lymphoma|hiv-associated hodgkin lymphoma
5421521|NCT00005824|AIDS-related diffuse mixed cell lymphoma|aids-related diffuse mixed cell lymphoma
5421522|NCT00005824|AIDS-related diffuse small cleaved cell lymphoma|aids-related diffuse small cleaved cell lymphoma
5421523|NCT00005824|AIDS-related lymphoblastic lymphoma|aids-related lymphoblastic lymphoma
5421524|NCT00005823|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
5421525|NCT00005823|adult acute erythroid leukemia (M6)|adult acute erythroid leukemia (m6)
5421526|NCT00005823|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
5421527|NCT00005823|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
5421528|NCT00005823|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
5421529|NCT00005823|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
5421530|NCT00005823|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
5421531|NCT00005823|refractory anemia with excess blasts|refractory anemia with excess blasts
5421532|NCT00005823|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
5421533|NCT00005823|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5421534|NCT00005823|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5421535|NCT00005823|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5421536|NCT00005823|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
5421537|NCT00005823|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5421538|NCT00005823|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
5421539|NCT00005823|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
5421540|NCT00005823|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
5421541|NCT00005823|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5421542|NCT00005823|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5421543|NCT00005823|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5421544|NCT00005823|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5421545|NCT00005822|stage IV breast cancer|stage iv breast cancer
5421546|NCT00005822|recurrent breast cancer|recurrent breast cancer
5421547|NCT00005822|stage IIIB breast cancer|stage iiib breast cancer
5421548|NCT00005822|inflammatory breast cancer|inflammatory breast cancer
5421549|NCT00005822|male breast cancer|male breast cancer
5421550|NCT00005821|stage I breast cancer|stage i breast cancer
5421551|NCT00005821|stage II breast cancer|stage ii breast cancer
5421552|NCT00005819|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5421553|NCT00005815|iris melanoma|iris melanoma
5421554|NCT00005815|ciliary body and choroid melanoma, small size|ciliary body and choroid melanoma, small size
5421555|NCT00005815|ciliary body and choroid melanoma, medium/large size|ciliary body and choroid melanoma, medium/large size
5421556|NCT00005815|extraocular extension melanoma|extraocular extension melanoma
5421557|NCT00005815|recurrent intraocular melanoma|recurrent intraocular melanoma
5421558|NCT00005815|stage III melanoma|stage iii melanoma
5421559|NCT00005815|stage IV melanoma|stage iv melanoma
5421560|NCT00005815|recurrent melanoma|recurrent melanoma
5421561|NCT00005812|leptomeningeal metastases|leptomeningeal metastases
5421562|NCT00005812|temozolomide|temozolomide
5421563|NCT00005807|stage IV breast cancer|stage iv breast cancer
5421564|NCT00005807|stage IIIA breast cancer|stage iiia breast cancer
5421565|NCT00005807|recurrent breast cancer|recurrent breast cancer
5421566|NCT00005807|stage IIIB breast cancer|stage iiib breast cancer
5421567|NCT00005807|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5421568|NCT00005807|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5421569|NCT00005807|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5421570|NCT00005807|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5421571|NCT00005807|ovarian stromal cancer|ovarian stromal cancer
5421572|NCT00005807|stage III ovarian germ cell tumor|stage iii ovarian germ cell tumor
5421573|NCT00005807|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
5421574|NCT00005807|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
5421575|NCT00005807|borderline ovarian surface epithelial-stromal tumor|borderline ovarian surface epithelial-stromal tumor
5421576|NCT00005807|ovarian sarcoma|ovarian sarcoma
5421577|NCT00005807|male breast cancer|male breast cancer
5421578|NCT00005802|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5421579|NCT00005802|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5421580|NCT00005802|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5421581|NCT00005802|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5421582|NCT00005802|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5421583|NCT00005802|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5421584|NCT00005802|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5421585|NCT00005802|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5421586|NCT00005802|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5421587|NCT00005797|refractory multiple myeloma|refractory multiple myeloma
5421588|NCT00005797|stage II multiple myeloma|stage ii multiple myeloma
5421589|NCT00005797|stage III multiple myeloma|stage iii multiple myeloma
5421590|NCT00005797|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5421591|NCT00005797|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5421592|NCT00005797|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5421593|NCT00005797|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5421594|NCT00005797|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5421595|NCT00005797|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5421596|NCT00005797|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5421597|NCT00005797|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5421598|NCT00005797|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5421599|NCT00005797|polycythemia vera|polycythemia vera
5421600|NCT00005797|primary myelofibrosis|primary myelofibrosis
5421601|NCT00005797|essential thrombocythemia|essential thrombocythemia
5421602|NCT00005797|refractory anemia|refractory anemia
5421603|NCT00005797|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
5421604|NCT00005797|refractory anemia with excess blasts|refractory anemia with excess blasts
5421605|NCT00005797|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
5421606|NCT00005797|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5421607|NCT00005797|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5421608|NCT00005797|refractory cytopenia with multilineage dysplasia|refractory cytopenia with multilineage dysplasia
5421609|NCT00005797|chronic eosinophilic leukemia|chronic eosinophilic leukemia
5421610|NCT00005797|chronic neutrophilic leukemia|chronic neutrophilic leukemia
5421611|NCT00005797|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
5421612|NCT00005797|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
5421613|NCT00005797|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5421614|NCT00005797|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5421615|NCT00005797|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5421616|NCT00005797|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5421617|NCT00005797|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5421618|NCT00005797|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
5421619|NCT00005788|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
5421620|NCT00005788|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
5421621|NCT00005788|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
5421622|NCT00005788|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
5421623|NCT00005788|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5421624|NCT00005788|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
5421625|NCT00005788|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
5421626|NCT00005788|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
5421627|NCT00005788|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
5421628|NCT00005788|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5421629|NCT00005787|neutropenia|neutropenia
5421630|NCT00005787|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5421631|NCT00005787|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5421632|NCT00005787|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5421633|NCT00005787|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5421634|NCT00005787|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5421635|NCT00005787|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5421636|NCT00005787|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5421637|NCT00005787|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5421638|NCT00005787|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5421639|NCT00005787|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5421640|NCT00005787|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5421641|NCT00005787|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5421642|NCT00005787|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5421643|NCT00005787|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5441021|NCT00007293|Fiber optic|fiber optic
5421644|NCT00005787|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5421645|NCT00005647|thyroid gland medullary carcinoma|thyroid gland medullary carcinoma
5421646|NCT00005647|anaplastic thyroid cancer|anaplastic thyroid cancer
5421647|NCT00005647|recurrent thyroid cancer|recurrent thyroid cancer
5421648|NCT00005647|recurrent salivary gland cancer|recurrent salivary gland cancer
5421649|NCT00005647|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
5421650|NCT00005647|stage III follicular thyroid cancer|stage iii follicular thyroid cancer
5421651|NCT00005647|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
5421652|NCT00005647|recurrent hypopharyngeal cancer|recurrent hypopharyngeal cancer
5421653|NCT00005647|stage III adenoid cystic carcinoma of the oral cavity|stage iii adenoid cystic carcinoma of the oral cavity
5421654|NCT00005647|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
5421655|NCT00005647|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
5421656|NCT00005647|recurrent mucoepidermoid carcinoma of the oral cavity|recurrent mucoepidermoid carcinoma of the oral cavity
5421657|NCT00005647|recurrent adenoid cystic carcinoma of the oral cavity|recurrent adenoid cystic carcinoma of the oral cavity
5421658|NCT00005647|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
5421659|NCT00005647|recurrent lymphoepithelioma of the oropharynx|recurrent lymphoepithelioma of the oropharynx
5421660|NCT00005647|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
5421661|NCT00005647|recurrent lymphoepithelioma of the nasopharynx|recurrent lymphoepithelioma of the nasopharynx
5421662|NCT00005647|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
5421663|NCT00005647|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
5421664|NCT00005647|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
5421665|NCT00005647|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
5421666|NCT00005647|recurrent inverted papilloma of the paranasal sinus and nasal cavity|recurrent inverted papilloma of the paranasal sinus and nasal cavity
5421667|NCT00005647|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity
5421668|NCT00005644|stage III bladder cancer|stage iii bladder cancer
5421669|NCT00005644|recurrent bladder cancer|recurrent bladder cancer
5421670|NCT00005644|stage IV bladder cancer|stage iv bladder cancer
5421671|NCT00005644|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
5421672|NCT00005644|recurrent urethral cancer|recurrent urethral cancer
5421673|NCT00005644|distal urethral cancer|distal urethral cancer
5421674|NCT00005644|proximal urethral cancer|proximal urethral cancer
5421675|NCT00005644|urethral cancer associated with invasive bladder cancer|urethral cancer associated with invasive bladder cancer
5421676|NCT00005644|metastatic transitional cell cancer of the renal pelvis and ureter|metastatic transitional cell cancer of the renal pelvis and ureter
5421677|NCT00005644|regional transitional cell cancer of the renal pelvis and ureter|regional transitional cell cancer of the renal pelvis and ureter
5421678|NCT00005644|recurrent transitional cell cancer of the renal pelvis and ureter|recurrent transitional cell cancer of the renal pelvis and ureter
5421679|NCT00005639|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5421680|NCT00005639|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5421681|NCT00005639|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5423389|NCT00003816|prolymphocytic leukemia|prolymphocytic leukemia
5421682|NCT00005639|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
5421683|NCT00005639|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
5421684|NCT00005639|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5421685|NCT00005639|small intestine lymphoma|small intestine lymphoma
5421686|NCT00005639|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5421687|NCT00005639|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5421688|NCT00005639|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5421689|NCT00005639|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5421690|NCT00005639|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5421691|NCT00005639|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5421692|NCT00005639|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5421693|NCT00005639|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5421694|NCT00005639|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5421695|NCT00005639|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5421696|NCT00005639|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5421697|NCT00005639|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5421698|NCT00005639|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5421699|NCT00005639|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5421700|NCT00005639|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5421701|NCT00005639|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5421702|NCT00005639|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5421703|NCT00005639|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5421704|NCT00005639|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5421705|NCT00005639|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5421706|NCT00005639|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5421707|NCT00005639|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5421708|NCT00005639|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5421709|NCT00005639|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5421710|NCT00005639|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5421711|NCT00005639|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5421712|NCT00005639|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5421713|NCT00005639|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5421714|NCT00005639|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
5421715|NCT00005639|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
5421716|NCT00005639|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
5421717|NCT00005639|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
5421718|NCT00005639|intraocular lymphoma|intraocular lymphoma
5421719|NCT00005639|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5421720|NCT00005639|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5421721|NCT00005639|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5421722|NCT00005639|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
5421723|NCT00005639|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5421724|NCT00005639|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
5421725|NCT00005639|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
5421726|NCT00005639|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5421727|NCT00005639|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5421728|NCT00005639|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5421729|NCT00005639|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5421730|NCT00005639|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5421731|NCT00005639|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5421732|NCT00005639|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5421733|NCT00005639|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5421734|NCT00005639|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5421735|NCT00005639|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5421736|NCT00005638|stage II gastric cancer|stage ii gastric cancer
5421737|NCT00005638|stage III gastric cancer|stage iii gastric cancer
5421738|NCT00005638|stage II esophageal cancer|stage ii esophageal cancer
5421739|NCT00005638|stage III esophageal cancer|stage iii esophageal cancer
5421740|NCT00005638|adenocarcinoma of the stomach|adenocarcinoma of the stomach
5421741|NCT00005638|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
5421742|NCT00005638|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
5421743|NCT00005637|adult glioblastoma|adult glioblastoma
5421744|NCT00005637|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5421745|NCT00005637|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
5421746|NCT00005637|adult mixed glioma|adult mixed glioma
5421747|NCT00005637|adult giant cell glioblastoma|adult giant cell glioblastoma
5421748|NCT00005637|adult gliosarcoma|adult gliosarcoma
5421749|NCT00005637|adult anaplastic ependymoma|adult anaplastic ependymoma
5421750|NCT00005627|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5421751|NCT00005627|recurrent prostate cancer|recurrent prostate cancer
5421752|NCT00005623|stage IV prostate cancer|stage iv prostate cancer
5421753|NCT00005623|recurrent prostate cancer|recurrent prostate cancer
5421754|NCT00005623|hot flashes|hot flashes
5421755|NCT00005622|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5421756|NCT00005622|refractory multiple myeloma|refractory multiple myeloma
5421757|NCT00005622|stage I multiple myeloma|stage i multiple myeloma
5421758|NCT00005622|stage II multiple myeloma|stage ii multiple myeloma
5421759|NCT00005622|stage III multiple myeloma|stage iii multiple myeloma
5421760|NCT00005622|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
5421761|NCT00005622|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
5421762|NCT00005622|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5421763|NCT00005622|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5421764|NCT00005622|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5421765|NCT00005622|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5421766|NCT00005622|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5421767|NCT00005622|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5421768|NCT00005622|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5421769|NCT00005622|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5421770|NCT00005622|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5421771|NCT00005622|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5421772|NCT00005622|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5421773|NCT00005622|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
5421774|NCT00005622|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
5421775|NCT00005622|polycythemia vera|polycythemia vera
5421776|NCT00005622|primary myelofibrosis|primary myelofibrosis
5421777|NCT00005622|essential thrombocythemia|essential thrombocythemia
5421779|NCT00005622|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
5421780|NCT00005622|refractory anemia with excess blasts|refractory anemia with excess blasts
5421781|NCT00005622|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
5421782|NCT00005622|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5421783|NCT00005622|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5421784|NCT00005622|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5421785|NCT00005622|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5421786|NCT00005622|refractory cytopenia with multilineage dysplasia|refractory cytopenia with multilineage dysplasia
5421787|NCT00005622|chronic eosinophilic leukemia|chronic eosinophilic leukemia
5421788|NCT00005622|chronic neutrophilic leukemia|chronic neutrophilic leukemia
5421789|NCT00005622|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
5421790|NCT00005622|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
5421791|NCT00005622|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5421792|NCT00005622|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5421793|NCT00005622|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5421794|NCT00005622|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5421795|NCT00005622|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5421796|NCT00005622|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
5421797|NCT00005617|stage IV melanoma|stage iv melanoma
5421798|NCT00005617|recurrent melanoma|recurrent melanoma
5421799|NCT00005606|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
5421800|NCT00005606|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
5421801|NCT00005606|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5421802|NCT00005606|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5421803|NCT00005606|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5421804|NCT00005606|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5421805|NCT00005606|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
5421806|NCT00005606|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
5421807|NCT00005606|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
5421808|NCT00005606|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
5421809|NCT00005606|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5421810|NCT00005606|isolated plasmacytoma of bone|isolated plasmacytoma of bone
5421811|NCT00005606|extramedullary plasmacytoma|extramedullary plasmacytoma
5421812|NCT00005606|stage 0 chronic lymphocytic leukemia|stage 0 chronic lymphocytic leukemia
5421813|NCT00005606|stage I multiple myeloma|stage i multiple myeloma
5421814|NCT00005606|stage II multiple myeloma|stage ii multiple myeloma
5421815|NCT00005606|stage III multiple myeloma|stage iii multiple myeloma
5421816|NCT00005606|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
5421817|NCT00005606|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
5421818|NCT00005606|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5421819|NCT00005606|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5421820|NCT00005606|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5421821|NCT00005606|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5421822|NCT00005606|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
5421823|NCT00005606|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
5421824|NCT00005606|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5421825|NCT00005606|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
5421826|NCT00005606|untreated hairy cell leukemia|untreated hairy cell leukemia
5421827|NCT00005606|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
5421828|NCT00005606|refractory hairy cell leukemia|refractory hairy cell leukemia
5421829|NCT00005606|stage II childhood Hodgkin lymphoma|stage ii childhood hodgkin lymphoma
5421830|NCT00005606|stage I childhood Hodgkin lymphoma|stage i childhood hodgkin lymphoma
5421831|NCT00005606|stage III childhood Hodgkin lymphoma|stage iii childhood hodgkin lymphoma
5421832|NCT00005606|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
5421833|NCT00005606|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
5421834|NCT00005606|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5421835|NCT00005606|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
5421836|NCT00005606|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
5421837|NCT00005606|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
5421838|NCT00005606|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
5421839|NCT00005606|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
5421840|NCT00005606|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
5421841|NCT00005606|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
5421842|NCT00005606|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
5421843|NCT00005606|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
5421844|NCT00005606|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5421845|NCT00005606|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
5421846|NCT00005606|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
5421847|NCT00005606|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5421848|NCT00005606|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5421849|NCT00005606|stage I marginal zone lymphoma|stage i marginal zone lymphoma
5421850|NCT00005606|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
5421851|NCT00005606|stage II small lymphocytic lymphoma|stage ii small lymphocytic lymphoma
5421852|NCT00005606|stage II marginal zone lymphoma|stage ii marginal zone lymphoma
5421853|NCT00005606|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5421854|NCT00005606|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5421855|NCT00005606|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5421856|NCT00005606|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
5421857|NCT00005606|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
5421858|NCT00005606|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5421859|NCT00005606|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5421860|NCT00005606|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5421861|NCT00005605|osteoporosis|osteoporosis
5421862|NCT00005605|stage I breast cancer|stage i breast cancer
5421863|NCT00005605|stage II breast cancer|stage ii breast cancer
5421864|NCT00005603|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
5421865|NCT00005603|B-cell childhood acute lymphoblastic leukemia|b-cell childhood acute lymphoblastic leukemia
5421866|NCT00005602|untreated childhood brain stem glioma|untreated childhood brain stem glioma
5421867|NCT00005601|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5421868|NCT00005601|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5421869|NCT00005601|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5421870|NCT00005601|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5421871|NCT00005601|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5423390|NCT00003816|intraocular lymphoma|intraocular lymphoma
5421872|NCT00005601|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5421873|NCT00005601|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5421874|NCT00005601|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5421875|NCT00005601|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5421876|NCT00005601|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5421877|NCT00005601|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5421878|NCT00005601|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5421879|NCT00005601|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5421880|NCT00005601|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5421881|NCT00005601|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5421882|NCT00005600|stage I breast cancer|stage i breast cancer
5421883|NCT00005600|stage II breast cancer|stage ii breast cancer
5421884|NCT00005600|lymphedema|lymphedema
5421885|NCT00005600|perioperative/postoperative complications|perioperative/postoperative complications
5421886|NCT00005599|stage III gastric cancer|stage iii gastric cancer
5421887|NCT00005599|stage IV gastric cancer|stage iv gastric cancer
5421888|NCT00005599|recurrent gastric cancer|recurrent gastric cancer
5421889|NCT00005599|stage III esophageal cancer|stage iii esophageal cancer
5421890|NCT00005599|stage IV esophageal cancer|stage iv esophageal cancer
5421891|NCT00005599|recurrent esophageal cancer|recurrent esophageal cancer
5421892|NCT00005599|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
5421893|NCT00005599|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
5421894|NCT00005597|gastrointestinal stromal tumor|gastrointestinal stromal tumor
5421895|NCT00005596|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
5421896|NCT00005590|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
5421897|NCT00005590|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
5421898|NCT00005590|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5421899|NCT00005590|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5421900|NCT00005590|recurrent breast cancer|recurrent breast cancer
5421901|NCT00005590|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5421902|NCT00005590|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
5421903|NCT00005590|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
5423489|NCT00003753|recurrent colon cancer|recurrent colon cancer
5421904|NCT00005590|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
5421905|NCT00005590|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
5421906|NCT00005590|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5421907|NCT00005590|limited stage small cell lung cancer|limited stage small cell lung cancer
5421908|NCT00005590|extensive stage small cell lung cancer|extensive stage small cell lung cancer
5421909|NCT00005590|recurrent small cell lung cancer|recurrent small cell lung cancer
5421910|NCT00005590|small intestine lymphoma|small intestine lymphoma
5421911|NCT00005590|stage II malignant testicular germ cell tumor|stage ii malignant testicular germ cell tumor
5421912|NCT00005590|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
5421913|NCT00005590|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5421914|NCT00005590|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
5421915|NCT00005590|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
5421916|NCT00005590|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
5421917|NCT00005590|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
5421918|NCT00005590|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
5421919|NCT00005590|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
5421920|NCT00005590|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
5421921|NCT00005590|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
5421922|NCT00005590|stage II ovarian germ cell tumor|stage ii ovarian germ cell tumor
5421923|NCT00005590|stage III ovarian germ cell tumor|stage iii ovarian germ cell tumor
5421924|NCT00005590|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
5421925|NCT00005590|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5421926|NCT00005590|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5421927|NCT00005590|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5421928|NCT00005590|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5421929|NCT00005590|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5421930|NCT00005590|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5421931|NCT00005590|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5421932|NCT00005590|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5421933|NCT00005590|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5421934|NCT00005590|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5421935|NCT00005590|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5421936|NCT00005590|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5421937|NCT00005590|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5421938|NCT00005590|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5421939|NCT00005590|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5421940|NCT00005590|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5421941|NCT00005590|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5421942|NCT00005590|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5421943|NCT00005590|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5421944|NCT00005590|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5421945|NCT00005590|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5421946|NCT00005590|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5421947|NCT00005590|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5421948|NCT00005590|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5421949|NCT00005590|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5421950|NCT00005590|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5421951|NCT00005590|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5421952|NCT00005590|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
5421953|NCT00005590|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
5421954|NCT00005590|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
5421955|NCT00005590|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
5421956|NCT00005590|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
5421957|NCT00005590|extragonadal germ cell tumor|extragonadal germ cell tumor
5421958|NCT00005590|adult central nervous system germ cell tumor|adult central nervous system germ cell tumor
5421959|NCT00005590|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
5421960|NCT00005590|infection|infection
5421961|NCT00005590|intraocular lymphoma|intraocular lymphoma
5421962|NCT00005590|stage I mantle cell lymphoma|stage i mantle cell lymphoma
5421963|NCT00005590|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
5421964|NCT00005590|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
5421965|NCT00005590|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
5421966|NCT00005590|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
5441022|NCT00007293|Light comb|light comb
5421967|NCT00005590|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
5421968|NCT00005590|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
5421969|NCT00005590|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
5421970|NCT00005590|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
5421971|NCT00005590|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
5421972|NCT00005590|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
5421973|NCT00005590|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5421974|NCT00005590|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5421975|NCT00005590|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5421976|NCT00005590|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
5421977|NCT00005590|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5421978|NCT00005590|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
5421979|NCT00005590|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
5421980|NCT00005590|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5421981|NCT00005590|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
5421982|NCT00005590|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
5421983|NCT00005590|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5421984|NCT00005590|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5421985|NCT00005590|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5421986|NCT00005590|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
5421987|NCT00005590|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5421988|NCT00005590|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
5421989|NCT00005590|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
5421990|NCT00005590|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
5421991|NCT00005590|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
5421992|NCT00005590|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5421993|NCT00005590|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
5421994|NCT00005590|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
5421995|NCT00005590|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
5421996|NCT00005590|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
5421997|NCT00005590|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5421998|NCT00005590|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5421999|NCT00005590|stage I marginal zone lymphoma|stage i marginal zone lymphoma
5422000|NCT00005590|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
5422001|NCT00005590|stage II small lymphocytic lymphoma|stage ii small lymphocytic lymphoma
5422002|NCT00005590|stage II marginal zone lymphoma|stage ii marginal zone lymphoma
5422003|NCT00005590|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5422004|NCT00005590|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5422005|NCT00005590|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5422006|NCT00005590|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5422007|NCT00005590|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5422008|NCT00005590|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5422009|NCT00005590|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5422010|NCT00005589|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5422011|NCT00005589|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5422012|NCT00005589|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5422013|NCT00005586|stage II colon cancer|stage ii colon cancer
5422014|NCT00005586|stage III colon cancer|stage iii colon cancer
5422015|NCT00005586|stage II rectal cancer|stage ii rectal cancer
5422016|NCT00005586|stage III rectal cancer|stage iii rectal cancer
5422017|NCT00005585|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
5422018|NCT00005585|B-cell childhood acute lymphoblastic leukemia|b-cell childhood acute lymphoblastic leukemia
5422019|NCT00005584|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
5422020|NCT00005584|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
5422021|NCT00005584|adult lymphocyte predominant Hodgkin lymphoma|adult lymphocyte predominant hodgkin lymphoma
5422022|NCT00005583|stage I endometrial carcinoma|stage i endometrial carcinoma
5422023|NCT00005583|stage II endometrial carcinoma|stage ii endometrial carcinoma
5422024|NCT00005583|endometrial adenocarcinoma|endometrial adenocarcinoma
5422025|NCT00005583|endometrial papillary serous carcinoma|endometrial papillary serous carcinoma
5422026|NCT00005583|endometrial clear cell carcinoma|endometrial clear cell carcinoma
5422027|NCT00005580|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5422028|NCT00005580|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
5422029|NCT00005580|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
5441023|NCT00007293|UV source|uv source
5422030|NCT00005580|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
5422031|NCT00005580|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5422032|NCT00005580|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5422033|NCT00005580|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5422034|NCT00005580|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
5422035|NCT00005580|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
5422036|NCT00005580|refractory hairy cell leukemia|refractory hairy cell leukemia
5422037|NCT00005580|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5422038|NCT00005580|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5422039|NCT00005580|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5422040|NCT00005580|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
5422041|NCT00005580|prolymphocytic leukemia|prolymphocytic leukemia
5422042|NCT00005580|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5422043|NCT00005580|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5422044|NCT00005580|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5422045|NCT00005580|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5422046|NCT00005580|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5422047|NCT00005580|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5422048|NCT00005580|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5422049|NCT00005579|Waldenström macroglobulinemia|waldenström macroglobulinemia
5422050|NCT00005579|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
5422051|NCT00005579|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
5422052|NCT00005579|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5422053|NCT00005579|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5422054|NCT00005579|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5422055|NCT00005579|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5422056|NCT00005579|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5422057|NCT00005579|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5422058|NCT00005579|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5422059|NCT00005579|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5422060|NCT00005579|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5422061|NCT00005579|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5422062|NCT00005579|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5422063|NCT00005579|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5422064|NCT00005579|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5422065|NCT00005579|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5422066|NCT00005579|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5422067|NCT00005095|ovarian epithelial cancer|ovarian epithelial cancer
5422068|NCT00005095|hereditary breast/ovarian cancer (BRCA1, BRCA2)|hereditary breast/ovarian cancer (brca1, brca2)
5422069|NCT00005095|fallopian tube cancer|fallopian tube cancer
5422070|NCT00005095|ovarian germ cell tumor|ovarian germ cell tumor
5422071|NCT00005095|ovarian sarcoma|ovarian sarcoma
5422072|NCT00005095|ovarian stromal cancer|ovarian stromal cancer
5422073|NCT00005095|endometrial cancer|endometrial cancer
5422074|NCT00005095|uterine sarcoma|uterine sarcoma
5422075|NCT00005095|vaginal cancer|vaginal cancer
5422076|NCT00005095|cervical cancer|cervical cancer
5422077|NCT00005095|vulvar cancer|vulvar cancer
5422078|NCT00005095|uterine leiomyomata|uterine leiomyomata
5422079|NCT00005087|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
5422080|NCT00005087|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
5422081|NCT00005087|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
5422082|NCT00005087|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
5422083|NCT00005087|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
5422084|NCT00005087|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
5422085|NCT00005087|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
5422086|NCT00005087|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
5422087|NCT00005087|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
5422088|NCT00005087|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
5422089|NCT00005087|stage I squamous cell carcinoma of the hypopharynx|stage i squamous cell carcinoma of the hypopharynx
5422090|NCT00005087|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
5422091|NCT00005087|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
5422092|NCT00005087|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
5422093|NCT00005087|stage I squamous cell carcinoma of the larynx|stage i squamous cell carcinoma of the larynx
5422094|NCT00005087|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
5422095|NCT00005087|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
5422096|NCT00005087|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
5422097|NCT00005087|stage I squamous cell carcinoma of the paranasal sinus and nasal cavity|stage i squamous cell carcinoma of the paranasal sinus and nasal cavity
5422098|NCT00005087|stage II squamous cell carcinoma of the paranasal sinus and nasal cavity|stage ii squamous cell carcinoma of the paranasal sinus and nasal cavity
5422099|NCT00005087|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
5422100|NCT00005087|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
5422101|NCT00005079|stage I breast cancer|stage i breast cancer
5422102|NCT00005079|stage II breast cancer|stage ii breast cancer
5422103|NCT00005079|stage IIIA breast cancer|stage iiia breast cancer
5422104|NCT00005079|stage IIIB breast cancer|stage iiib breast cancer
5422105|NCT00005074|stage I mantle cell lymphoma|stage i mantle cell lymphoma
5422106|NCT00005074|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5422107|NCT00005074|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5422108|NCT00005074|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5422109|NCT00005074|stage II mantle cell lymphoma|stage ii mantle cell lymphoma
5422110|NCT00005062|limited stage small cell lung cancer|limited stage small cell lung cancer
5422111|NCT00005060|stage II gastric cancer|stage ii gastric cancer
5422112|NCT00005060|stage III gastric cancer|stage iii gastric cancer
5422113|NCT00005052|stage II melanoma|stage ii melanoma
5422114|NCT00005051|stage I ovarian epithelial cancer|stage i ovarian epithelial cancer
5422115|NCT00005051|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
5422116|NCT00005051|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5422117|NCT00005051|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5422118|NCT00005049|stage II colon cancer|stage ii colon cancer
5422119|NCT00005049|stage III colon cancer|stage iii colon cancer
5422120|NCT00005049|stage II gastric cancer|stage ii gastric cancer
5422121|NCT00005049|stage III gastric cancer|stage iii gastric cancer
5422122|NCT00005049|recurrent gastric cancer|recurrent gastric cancer
5422123|NCT00005049|stage II rectal cancer|stage ii rectal cancer
5422124|NCT00005049|stage III rectal cancer|stage iii rectal cancer
5422125|NCT00005049|recurrent colon cancer|recurrent colon cancer
5422126|NCT00005049|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5422127|NCT00005049|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5422128|NCT00005049|regional gastrointestinal carcinoid tumor|regional gastrointestinal carcinoid tumor
5422129|NCT00005049|small intestine adenocarcinoma|small intestine adenocarcinoma
5422130|NCT00005049|small intestine lymphoma|small intestine lymphoma
5422131|NCT00005049|small intestine leiomyosarcoma|small intestine leiomyosarcoma
5422132|NCT00005049|recurrent small intestine cancer|recurrent small intestine cancer
5422133|NCT00005049|peritoneal cavity cancer|peritoneal cavity cancer
5422134|NCT00005049|gastrointestinal stromal tumor|gastrointestinal stromal tumor
5422135|NCT00005047|stage I bladder cancer|stage i bladder cancer
5422136|NCT00005047|stage II bladder cancer|stage ii bladder cancer
5422137|NCT00005047|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
5422138|NCT00005044|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5422139|NCT00005044|stage IIB prostate cancer|stage iib prostate cancer
5422140|NCT00005044|stage IIA prostate cancer|stage iia prostate cancer
5422141|NCT00005044|stage III prostate cancer|stage iii prostate cancer
5422142|NCT00005038|stage IV renal cell cancer|stage iv renal cell cancer
5422143|NCT00005038|recurrent renal cell cancer|recurrent renal cell cancer
5422144|NCT00005033|recurrent osteosarcoma|recurrent osteosarcoma
5422145|NCT00004936|stage III cervical cancer|stage iii cervical cancer
5422146|NCT00004936|stage IB cervical cancer|stage ib cervical cancer
5422147|NCT00004936|stage IIB cervical cancer|stage iib cervical cancer
5422148|NCT00004936|stage IVB cervical cancer|stage ivb cervical cancer
5422149|NCT00004936|stage IIA cervical cancer|stage iia cervical cancer
5422150|NCT00004936|stage IVA cervical cancer|stage iva cervical cancer
5422151|NCT00004936|cervical squamous cell carcinoma|cervical squamous cell carcinoma
5422152|NCT00004936|cervical adenocarcinoma|cervical adenocarcinoma
5422153|NCT00004936|cervical adenosquamous cell carcinoma|cervical adenosquamous cell carcinoma
5422154|NCT00004935|stage IV breast cancer|stage iv breast cancer
5422155|NCT00004935|recurrent breast cancer|recurrent breast cancer
5422156|NCT00004934|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
5422157|NCT00004934|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5422158|NCT00004934|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5422160|NCT00004934|primary peritoneal cavity cancer|primary peritoneal cavity cancer
5422161|NCT00004932|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5422162|NCT00004932|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5422163|NCT00004932|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5422164|NCT00004932|chronic myelogenous leukemia, BCR-ABL1 positive|chronic myelogenous leukemia, bcr-abl1 positive
5422165|NCT00004932|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
5422166|NCT00004930|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5422167|NCT00004930|extensive stage small cell lung cancer|extensive stage small cell lung cancer
5422168|NCT00004930|recurrent small cell lung cancer|recurrent small cell lung cancer
5422169|NCT00004930|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5422170|NCT00004930|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5422171|NCT00004930|lung metastases|lung metastases
5422172|NCT00004930|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
5422173|NCT00004924|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5422174|NCT00004924|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5422175|NCT00004921|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5422176|NCT00004921|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5422177|NCT00004920|localized malignant mesothelioma|localized malignant mesothelioma
5422178|NCT00004920|advanced malignant mesothelioma|advanced malignant mesothelioma
5422179|NCT00004920|recurrent malignant mesothelioma|recurrent malignant mesothelioma
5422180|NCT00004917|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
5422181|NCT00004917|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
5422182|NCT00004917|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
5422183|NCT00004917|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5422184|NCT00004917|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
5422185|NCT00004917|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
5422186|NCT00004917|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
5422187|NCT00004917|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5422188|NCT00004917|stage I squamous cell carcinoma of the hypopharynx|stage i squamous cell carcinoma of the hypopharynx
5422189|NCT00004917|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
5422190|NCT00004917|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
5422191|NCT00004917|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5422192|NCT00004917|stage I squamous cell carcinoma of the larynx|stage i squamous cell carcinoma of the larynx
5422193|NCT00004917|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
5422194|NCT00004917|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
5422195|NCT00004917|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5422196|NCT00004917|anemia|anemia
5422197|NCT00004907|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5422198|NCT00004907|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5422199|NCT00004907|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5422200|NCT00004907|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5422201|NCT00004907|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5422202|NCT00004907|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5422203|NCT00004907|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5422204|NCT00004907|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5422205|NCT00004907|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5422206|NCT00004907|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5422207|NCT00004907|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5422208|NCT00004907|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5422209|NCT00004907|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5422210|NCT00004907|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5422211|NCT00004907|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5422212|NCT00004899|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5422213|NCT00004899|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5422214|NCT00004899|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5422215|NCT00004899|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
5422216|NCT00004899|adult acute erythroid leukemia (M6)|adult acute erythroid leukemia (m6)
5422217|NCT00004899|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
5422218|NCT00004899|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
5422219|NCT00004899|adult acute promyelocytic leukemia (M3)|adult acute promyelocytic leukemia (m3)
5422220|NCT00004899|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
5422221|NCT00004899|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
5422222|NCT00004899|childhood acute myeloblastic leukemia without maturation (M1)|childhood acute myeloblastic leukemia without maturation (m1)
5422223|NCT00004899|childhood acute myeloblastic leukemia with maturation (M2)|childhood acute myeloblastic leukemia with maturation (m2)
5422224|NCT00004899|childhood acute promyelocytic leukemia (M3)|childhood acute promyelocytic leukemia (m3)
5422225|NCT00004899|childhood acute myelomonocytic leukemia (M4)|childhood acute myelomonocytic leukemia (m4)
5422226|NCT00004899|childhood acute monoblastic leukemia (M5a)|childhood acute monoblastic leukemia (m5a)
5422227|NCT00004899|childhood acute monocytic leukemia (M5b)|childhood acute monocytic leukemia (m5b)
5422228|NCT00004899|childhood acute erythroleukemia (M6)|childhood acute erythroleukemia (m6)
5422229|NCT00004899|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5422230|NCT00004899|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
5422231|NCT00004899|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5422232|NCT00004899|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
5422233|NCT00004899|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
5422234|NCT00004899|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5422235|NCT00004899|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5422236|NCT00004899|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5422237|NCT00004899|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5422238|NCT00004899|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5422239|NCT00004899|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
5422240|NCT00004896|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5422241|NCT00004896|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5422242|NCT00004896|adult acute erythroid leukemia (M6)|adult acute erythroid leukemia (m6)
5422243|NCT00004896|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
5422244|NCT00004896|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
5422245|NCT00004896|adult acute promyelocytic leukemia (M3)|adult acute promyelocytic leukemia (m3)
5422246|NCT00004896|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
5422247|NCT00004896|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
5422248|NCT00004896|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
5422250|NCT00004896|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
5422251|NCT00004896|refractory anemia with excess blasts|refractory anemia with excess blasts
5422252|NCT00004896|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
5422253|NCT00004896|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5422254|NCT00004896|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
5422255|NCT00004896|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5422256|NCT00004896|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
5422257|NCT00004896|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
5422258|NCT00004896|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5422259|NCT00004896|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5422260|NCT00004896|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5422261|NCT00004896|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5422262|NCT00004896|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5422263|NCT00004896|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
5422264|NCT00004891|stage II rectal cancer|stage ii rectal cancer
5422265|NCT00004891|stage III rectal cancer|stage iii rectal cancer
5422266|NCT00004891|stage IV rectal cancer|stage iv rectal cancer
5422267|NCT00004879|recurrent renal cell cancer|recurrent renal cell cancer
5422268|NCT00004879|recurrent prostate cancer|recurrent prostate cancer
5422269|NCT00004879|recurrent colon cancer|recurrent colon cancer
5422270|NCT00004879|recurrent rectal cancer|recurrent rectal cancer
5422271|NCT00004879|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5422272|NCT00004879|recurrent pancreatic cancer|recurrent pancreatic cancer
5422273|NCT00004879|recurrent esophageal cancer|recurrent esophageal cancer
5422274|NCT00004876|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5422275|NCT00004876|stage IC ovarian epithelial cancer|stage ic ovarian epithelial cancer
5422276|NCT00004876|stage IIA ovarian epithelial cancer|stage iia ovarian epithelial cancer
5422277|NCT00004876|stage IIB ovarian epithelial cancer|stage iib ovarian epithelial cancer
5422278|NCT00004876|stage IIC ovarian epithelial cancer|stage iic ovarian epithelial cancer
5422279|NCT00004876|stage IIIA ovarian epithelial cancer|stage iiia ovarian epithelial cancer
5422280|NCT00004876|stage IIIB ovarian epithelial cancer|stage iiib ovarian epithelial cancer
5422281|NCT00004876|stage IIIC ovarian epithelial cancer|stage iiic ovarian epithelial cancer
5422282|NCT00004873|stage III gastric cancer|stage iii gastric cancer
5422283|NCT00004873|stage IV gastric cancer|stage iv gastric cancer
5422284|NCT00004873|recurrent gastric cancer|recurrent gastric cancer
5422285|NCT00004871|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5422286|NCT00004871|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
5422287|NCT00004871|refractory anemia|refractory anemia
5422288|NCT00004871|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
5422289|NCT00004871|refractory anemia with excess blasts|refractory anemia with excess blasts
5422290|NCT00004871|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
5422291|NCT00004871|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5422292|NCT00004871|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5422293|NCT00004871|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5422294|NCT00004871|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5422295|NCT00004871|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
5422296|NCT00004871|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
5422297|NCT00004867|stage I esophageal cancer|stage i esophageal cancer
5422298|NCT00004867|stage II esophageal cancer|stage ii esophageal cancer
5422299|NCT00004867|stage III esophageal cancer|stage iii esophageal cancer
5422300|NCT00004867|stage IV esophageal cancer|stage iv esophageal cancer
5422301|NCT00004867|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
5422302|NCT00004867|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
5422303|NCT00004866|stage III cervical cancer|stage iii cervical cancer
5422304|NCT00004866|stage IV cervical cancer|stage iv cervical cancer
5422305|NCT00004866|recurrent cervical cancer|recurrent cervical cancer
5422306|NCT00004866|cervical squamous cell carcinoma|cervical squamous cell carcinoma
5422307|NCT00004859|squamous cell lung cancer|squamous cell lung cancer
5422308|NCT00004859|large cell lung cancer|large cell lung cancer
5422309|NCT00004859|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5422310|NCT00004859|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5422311|NCT00004859|adenocarcinoma of the lung|adenocarcinoma of the lung
5422312|NCT00004859|adenosquamous cell lung cancer|adenosquamous cell lung cancer
5422313|NCT00004859|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
5422314|NCT00004259|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5422315|NCT00004259|adult mixed glioma|adult mixed glioma
5422316|NCT00004250|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
5422317|NCT00004250|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
5422318|NCT00004250|stage III melanoma|stage iii melanoma
5422319|NCT00004250|stage IV melanoma|stage iv melanoma
5422320|NCT00004250|recurrent melanoma|recurrent melanoma
5422321|NCT00004250|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
5422322|NCT00004245|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5422323|NCT00004245|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5422324|NCT00004245|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
5422325|NCT00004245|refractory anemia with excess blasts|refractory anemia with excess blasts
5422326|NCT00004245|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
5422327|NCT00004245|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5422328|NCT00004245|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5422329|NCT00004245|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
5422330|NCT00004245|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
5422331|NCT00004245|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5422332|NCT00004245|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5422333|NCT00004245|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5422334|NCT00004245|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5422335|NCT00004245|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5422336|NCT00004244|stage IV renal cell cancer|stage iv renal cell cancer
5422337|NCT00004244|recurrent renal cell cancer|recurrent renal cell cancer
5422338|NCT00004244|stage IV melanoma|stage iv melanoma
5422339|NCT00004244|recurrent melanoma|recurrent melanoma
5422340|NCT00004237|stage I breast cancer|stage i breast cancer
5422341|NCT00004237|stage II breast cancer|stage ii breast cancer
5422342|NCT00004234|oral complications|oral complications
5422343|NCT00004234|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
5422344|NCT00004234|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
5422345|NCT00004234|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
5422346|NCT00004234|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5422347|NCT00004234|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
5422348|NCT00004234|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
5422349|NCT00004234|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
5422350|NCT00004234|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
5422351|NCT00004234|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5422352|NCT00004234|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
5422353|NCT00004234|stage I squamous cell carcinoma of the nasopharynx|stage i squamous cell carcinoma of the nasopharynx
5422354|NCT00004234|stage II squamous cell carcinoma of the nasopharynx|stage ii squamous cell carcinoma of the nasopharynx
5422355|NCT00004234|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
5422356|NCT00004234|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
5422357|NCT00004234|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
5422358|NCT00004234|stage I squamous cell carcinoma of the hypopharynx|stage i squamous cell carcinoma of the hypopharynx
5441327|NCT00006335|Teenage|teenage
5422359|NCT00004234|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
5422360|NCT00004234|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
5422361|NCT00004234|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5422362|NCT00004234|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
5422363|NCT00004234|stage I squamous cell carcinoma of the larynx|stage i squamous cell carcinoma of the larynx
5422364|NCT00004234|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
5422365|NCT00004234|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
5422366|NCT00004234|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5422367|NCT00004234|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
5422368|NCT00004231|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5422369|NCT00004231|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5422370|NCT00004231|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5422371|NCT00004228|stage III childhood lymphoblastic lymphoma|stage iii childhood lymphoblastic lymphoma
5422372|NCT00004228|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
5422373|NCT00004227|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
5422374|NCT00004227|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5422375|NCT00004227|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
5422376|NCT00004227|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
5422377|NCT00004227|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5422378|NCT00004227|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
5422379|NCT00004227|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
5422380|NCT00004227|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5422381|NCT00004227|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
5422382|NCT00004226|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
5422383|NCT00004226|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
5422384|NCT00004226|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
5422385|NCT00004226|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
5422386|NCT00004226|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
5422387|NCT00004226|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
5422388|NCT00004225|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5422389|NCT00004224|childhood infratentorial ependymoma|childhood infratentorial ependymoma
5422390|NCT00004224|childhood supratentorial ependymoma|childhood supratentorial ependymoma
5422391|NCT00004224|newly diagnosed childhood ependymoma|newly diagnosed childhood ependymoma
5422392|NCT00004218|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
5422393|NCT00004218|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
5422394|NCT00004218|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5422395|NCT00004218|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
5422396|NCT00004218|stage 0 chronic lymphocytic leukemia|stage 0 chronic lymphocytic leukemia
5422397|NCT00004212|childhood infratentorial ependymoma|childhood infratentorial ependymoma
5422398|NCT00004212|childhood supratentorial ependymoma|childhood supratentorial ependymoma
5422399|NCT00004212|childhood craniopharyngioma|childhood craniopharyngioma
5422400|NCT00004212|stage III childhood lymphoblastic lymphoma|stage iii childhood lymphoblastic lymphoma
5422401|NCT00004212|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
5422402|NCT00004212|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
5422403|NCT00004212|childhood central nervous system germ cell tumor|childhood central nervous system germ cell tumor
5422404|NCT00004212|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
5422405|NCT00004212|stage III childhood Hodgkin lymphoma|stage iii childhood hodgkin lymphoma
5422406|NCT00004212|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
5422407|NCT00004212|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
5422408|NCT00004212|childhood high-grade cerebral astrocytoma|childhood high-grade cerebral astrocytoma
5422409|NCT00004212|childhood oligodendroglioma|childhood oligodendroglioma
5422410|NCT00004212|childhood choroid plexus tumor|childhood choroid plexus tumor
5422411|NCT00004212|stage III childhood small noncleaved cell lymphoma|stage iii childhood small noncleaved cell lymphoma
5422412|NCT00004212|stage III childhood large cell lymphoma|stage iii childhood large cell lymphoma
5422413|NCT00004212|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
5422414|NCT00004212|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
5422415|NCT00004212|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
5422416|NCT00004212|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
5422417|NCT00004212|untreated childhood brain stem glioma|untreated childhood brain stem glioma
5422418|NCT00004212|recurrent childhood brain stem glioma|recurrent childhood brain stem glioma
5422419|NCT00004212|untreated childhood supratentorial primitive neuroectodermal tumor|untreated childhood supratentorial primitive neuroectodermal tumor
5422420|NCT00004212|recurrent childhood supratentorial primitive neuroectodermal tumor|recurrent childhood supratentorial primitive neuroectodermal tumor
5422421|NCT00004212|untreated childhood cerebellar astrocytoma|untreated childhood cerebellar astrocytoma
5422422|NCT00004212|recurrent childhood cerebellar astrocytoma|recurrent childhood cerebellar astrocytoma
5422423|NCT00004212|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
5422424|NCT00004212|untreated childhood medulloblastoma|untreated childhood medulloblastoma
5422425|NCT00004212|recurrent childhood medulloblastoma|recurrent childhood medulloblastoma
5422426|NCT00004212|untreated childhood visual pathway and hypothalamic glioma|untreated childhood visual pathway and hypothalamic glioma
5422427|NCT00004212|recurrent childhood visual pathway and hypothalamic glioma|recurrent childhood visual pathway and hypothalamic glioma
5422428|NCT00004212|newly diagnosed childhood ependymoma|newly diagnosed childhood ependymoma
5422429|NCT00004212|recurrent childhood ependymoma|recurrent childhood ependymoma
5422430|NCT00004210|colon cancer|colon cancer
5422431|NCT00004210|rectal cancer|rectal cancer
5422432|NCT00004208|refractory anemia|refractory anemia
5422433|NCT00004208|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
5422434|NCT00004208|refractory anemia with excess blasts|refractory anemia with excess blasts
5422435|NCT00004208|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5422436|NCT00004208|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5422437|NCT00004208|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5422438|NCT00004205|stage I breast cancer|stage i breast cancer
5422439|NCT00004205|stage II breast cancer|stage ii breast cancer
5422440|NCT00004205|stage IIIA breast cancer|stage iiia breast cancer
5422441|NCT00004205|breast cancer in situ|breast cancer in situ
5422442|NCT00004205|recurrent breast cancer|recurrent breast cancer
5422443|NCT00004205|ductal breast carcinoma|ductal breast carcinoma
5422444|NCT00004205|lobular breast carcinoma in situ|lobular breast carcinoma in situ
5422445|NCT00004196|stage I melanoma|stage i melanoma
5422446|NCT00004196|stage II melanoma|stage ii melanoma
5422447|NCT00004196|stage III melanoma|stage iii melanoma
5422448|NCT00004189|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5422449|NCT00004189|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5422450|NCT00004189|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5422451|NCT00004189|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
5422452|NCT00004189|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
5422453|NCT00004189|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5422454|NCT00004189|small intestine lymphoma|small intestine lymphoma
5422455|NCT00004189|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5422456|NCT00004189|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5422457|NCT00004189|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5422458|NCT00004189|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5422459|NCT00004189|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5422460|NCT00004189|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5422461|NCT00004189|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5422462|NCT00004189|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5422463|NCT00004189|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5422464|NCT00004189|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5422465|NCT00004189|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5422466|NCT00004189|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5422467|NCT00004189|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5422468|NCT00004189|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5422469|NCT00004189|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5422470|NCT00004189|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5422471|NCT00004189|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5422472|NCT00004189|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5422473|NCT00004189|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5422474|NCT00004189|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5422475|NCT00004189|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5422476|NCT00004189|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5422477|NCT00004189|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5422478|NCT00004189|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5422479|NCT00004189|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5422480|NCT00004189|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5422481|NCT00004189|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5422482|NCT00004189|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5422483|NCT00004189|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
5422484|NCT00004189|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
5422485|NCT00004189|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
5422486|NCT00004189|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
5422487|NCT00004189|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
5422488|NCT00004189|AIDS-related primary CNS lymphoma|aids-related primary cns lymphoma
5422489|NCT00004189|intraocular lymphoma|intraocular lymphoma
5422490|NCT00004189|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5422491|NCT00004189|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5422492|NCT00004189|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5422493|NCT00004189|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
5422494|NCT00004189|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5422495|NCT00004189|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
5422496|NCT00004189|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
5422497|NCT00004189|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5422498|NCT00004189|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5422499|NCT00004189|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5422500|NCT00004189|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5422501|NCT00004189|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5422502|NCT00004189|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5422503|NCT00004189|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5422504|NCT00004189|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5422505|NCT00004189|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5422506|NCT00004189|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5422507|NCT00004188|localized resectable neuroblastoma|localized resectable neuroblastoma
5422508|NCT00004188|regional neuroblastoma|regional neuroblastoma
5422509|NCT00004188|disseminated neuroblastoma|disseminated neuroblastoma
5422510|NCT00004188|stage 4S neuroblastoma|stage 4s neuroblastoma
5422511|NCT00004188|localized unresectable neuroblastoma|localized unresectable neuroblastoma
5422512|NCT00004181|refractory multiple myeloma|refractory multiple myeloma
5422513|NCT00004181|stage I multiple myeloma|stage i multiple myeloma
5422514|NCT00004181|stage II multiple myeloma|stage ii multiple myeloma
5422515|NCT00004181|stage III multiple myeloma|stage iii multiple myeloma
5422516|NCT00004181|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5422517|NCT00004181|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
5422518|NCT00004181|Philadelphia chromosome positive chronic myelogenous leukemia|philadelphia chromosome positive chronic myelogenous leukemia
5422519|NCT00004179|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5422520|NCT00004179|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5422521|NCT00004179|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5422522|NCT00004179|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5422523|NCT00004179|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5422524|NCT00004179|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5422525|NCT00004179|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5422526|NCT00004179|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5422527|NCT00004179|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5422528|NCT00004173|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5422529|NCT00004165|refractory multiple myeloma|refractory multiple myeloma
5422530|NCT00004165|stage I multiple myeloma|stage i multiple myeloma
5423485|NCT00003753|stage IV rectal cancer|stage iv rectal cancer
5422531|NCT00004165|stage II multiple myeloma|stage ii multiple myeloma
5422532|NCT00004165|stage III multiple myeloma|stage iii multiple myeloma
5422533|NCT00004165|primary systemic amyloidosis|primary systemic amyloidosis
5422534|NCT00004154|stage 0 bladder cancer|stage 0 bladder cancer
5422535|NCT00004154|stage I bladder cancer|stage i bladder cancer
5422536|NCT00004154|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
5422537|NCT00004153|stage I melanoma|stage i melanoma
5422538|NCT00004153|stage II melanoma|stage ii melanoma
5422539|NCT00004153|stage III melanoma|stage iii melanoma
5422540|NCT00004153|stage IV melanoma|stage iv melanoma
5422541|NCT00004150|stage III colon cancer|stage iii colon cancer
5422542|NCT00004150|adenocarcinoma of the colon|adenocarcinoma of the colon
5422543|NCT00004150|mucinous adenocarcinoma of the colon|mucinous adenocarcinoma of the colon
5422544|NCT00004149|stage IV prostate cancer|stage iv prostate cancer
5422545|NCT00004149|recurrent prostate cancer|recurrent prostate cancer
5422546|NCT00004147|recurrent adult brain tumor|recurrent adult brain tumor
5422547|NCT00004147|adult glioblastoma|adult glioblastoma
5422548|NCT00004147|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5422549|NCT00004147|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
5422550|NCT00004147|adult giant cell glioblastoma|adult giant cell glioblastoma
5422551|NCT00004147|adult gliosarcoma|adult gliosarcoma
5422552|NCT00004144|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5422553|NCT00004143|sickle cell anemia|sickle cell anemia
5422554|NCT00004143|severe aplastic anemia|severe aplastic anemia
5422555|NCT00004141|stage III melanoma|stage iii melanoma
5422556|NCT00004141|stage IV melanoma|stage iv melanoma
5422558|NCT00004138|stage I non-small cell lung cancer|stage i non-small cell lung cancer
5422559|NCT00004138|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
5422560|NCT00004138|squamous cell lung cancer|squamous cell lung cancer
5422561|NCT00004138|large cell lung cancer|large cell lung cancer
5422562|NCT00004138|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5422563|NCT00004138|adenocarcinoma of the lung|adenocarcinoma of the lung
5422564|NCT00004138|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
5422565|NCT00004135|stage IV renal cell cancer|stage iv renal cell cancer
5422566|NCT00004135|recurrent renal cell cancer|recurrent renal cell cancer
5422567|NCT00004135|stage IV melanoma|stage iv melanoma
5422568|NCT00004135|recurrent melanoma|recurrent melanoma
5422569|NCT00004129|recurrent adult brain tumor|recurrent adult brain tumor
5422570|NCT00004129|adult glioblastoma|adult glioblastoma
5422571|NCT00004129|adult giant cell glioblastoma|adult giant cell glioblastoma
5422572|NCT00004129|adult gliosarcoma|adult gliosarcoma
5422573|NCT00004128|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
5422574|NCT00004128|adult acute erythroid leukemia (M6)|adult acute erythroid leukemia (m6)
5422575|NCT00004128|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
5422576|NCT00004128|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
5422577|NCT00004128|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
5422578|NCT00004128|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
5422579|NCT00004128|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
5422580|NCT00004128|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
5422581|NCT00004128|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
5422582|NCT00004128|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5422583|NCT00004128|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5422584|NCT00004128|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5422585|NCT00004128|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5422586|NCT00004124|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5422587|NCT00004124|stage I prostate cancer|stage i prostate cancer
5422588|NCT00004124|stage II prostate cancer|stage ii prostate cancer
5422589|NCT00004124|stage III prostate cancer|stage iii prostate cancer
5422590|NCT00004115|stage I ovarian epithelial cancer|stage i ovarian epithelial cancer
5422591|NCT00004115|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
5422592|NCT00004115|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5422593|NCT00004115|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5422594|NCT00004115|primary peritoneal cavity cancer|primary peritoneal cavity cancer
5422595|NCT00004110|regional neuroblastoma|regional neuroblastoma
5422596|NCT00004110|disseminated neuroblastoma|disseminated neuroblastoma
5422597|NCT00004110|recurrent neuroblastoma|recurrent neuroblastoma
5422598|NCT00004110|localized unresectable neuroblastoma|localized unresectable neuroblastoma
5422599|NCT00004106|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
5422600|NCT00004106|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
5422601|NCT00004106|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
5422602|NCT00004106|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
5422603|NCT00004106|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5422604|NCT00004106|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
5422605|NCT00004106|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
5422606|NCT00004106|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
5422607|NCT00004106|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
5422608|NCT00004106|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5422609|NCT00004103|stage I gastric cancer|stage i gastric cancer
5422610|NCT00004103|stage II gastric cancer|stage ii gastric cancer
5422611|NCT00004103|stage III gastric cancer|stage iii gastric cancer
5422612|NCT00004103|stage IV gastric cancer|stage iv gastric cancer
5422613|NCT00004099|stage II gastric cancer|stage ii gastric cancer
5422614|NCT00004099|stage III gastric cancer|stage iii gastric cancer
5422615|NCT00004099|stage IV gastric cancer|stage iv gastric cancer
5422616|NCT00004099|intestinal adenocarcinoma of the stomach|intestinal adenocarcinoma of the stomach
5422617|NCT00004099|diffuse adenocarcinoma of the stomach|diffuse adenocarcinoma of the stomach
5422618|NCT00004099|mixed adenocarcinoma of the stomach|mixed adenocarcinoma of the stomach
5422619|NCT00004092|stage II breast cancer|stage ii breast cancer
5422620|NCT00004092|stage IIIA breast cancer|stage iiia breast cancer
5422621|NCT00004092|stage IIIB breast cancer|stage iiib breast cancer
5422622|NCT00004088|stage I multiple myeloma|stage i multiple myeloma
5422623|NCT00004088|stage II multiple myeloma|stage ii multiple myeloma
5422624|NCT00004088|stage III multiple myeloma|stage iii multiple myeloma
5422625|NCT00004081|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5422626|NCT00004081|peritoneal cavity cancer|peritoneal cavity cancer
5422627|NCT00004077|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
5441328|NCT00006335|Girls|girls
5422628|NCT00004077|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
5422629|NCT00004077|testicular embryonal carcinoma|testicular embryonal carcinoma
5422630|NCT00004077|testicular choriocarcinoma|testicular choriocarcinoma
5422631|NCT00004077|testicular teratoma|testicular teratoma
5422632|NCT00004077|testicular yolk sac tumor|testicular yolk sac tumor
5422633|NCT00004077|testicular embryonal carcinoma and teratoma|testicular embryonal carcinoma and teratoma
5422634|NCT00004077|testicular embryonal carcinoma and yolk sac tumor|testicular embryonal carcinoma and yolk sac tumor
5422635|NCT00004077|testicular yolk sac tumor and teratoma|testicular yolk sac tumor and teratoma
5422636|NCT00004077|testicular choriocarcinoma and yolk sac tumor|testicular choriocarcinoma and yolk sac tumor
5422637|NCT00004077|testicular choriocarcinoma and embryonal carcinoma|testicular choriocarcinoma and embryonal carcinoma
5422638|NCT00004077|testicular choriocarcinoma and teratoma|testicular choriocarcinoma and teratoma
5422639|NCT00004075|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5422640|NCT00004075|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5422641|NCT00004075|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5422642|NCT00004075|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5422643|NCT00004075|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5422644|NCT00004075|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5422645|NCT00004075|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5422646|NCT00004075|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5422647|NCT00004075|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5422648|NCT00004075|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5422649|NCT00004075|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5422650|NCT00004075|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5422651|NCT00004075|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
5422652|NCT00004075|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5422653|NCT00004075|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5422654|NCT00004075|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
5422655|NCT00004075|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5422656|NCT00004075|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5422657|NCT00004075|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5422658|NCT00004075|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5422659|NCT00004075|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5422660|NCT00004072|refractory multiple myeloma|refractory multiple myeloma
5422661|NCT00004072|stage I multiple myeloma|stage i multiple myeloma
5422662|NCT00004072|stage II multiple myeloma|stage ii multiple myeloma
5422663|NCT00004072|stage III multiple myeloma|stage iii multiple myeloma
5422664|NCT00004067|stage II breast cancer|stage ii breast cancer
5422665|NCT00004067|stage IIIA breast cancer|stage iiia breast cancer
5422666|NCT00004066|adult leiomyosarcoma|adult leiomyosarcoma
5422667|NCT00004066|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
5422668|NCT00004066|small intestine leiomyosarcoma|small intestine leiomyosarcoma
5422669|NCT00004066|stage IV uterine sarcoma|stage iv uterine sarcoma
5422670|NCT00004066|recurrent uterine sarcoma|recurrent uterine sarcoma
5422671|NCT00004066|uterine leiomyosarcoma|uterine leiomyosarcoma
5422672|NCT00004066|ovarian sarcoma|ovarian sarcoma
5422673|NCT00004066|recurrent small intestine cancer|recurrent small intestine cancer
5422674|NCT00004066|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
5422675|NCT00004065|stage III colon cancer|stage iii colon cancer
5422676|NCT00004065|stage IV colon cancer|stage iv colon cancer
5422677|NCT00004065|stage IV breast cancer|stage iv breast cancer
5422678|NCT00004065|stage IIIA breast cancer|stage iiia breast cancer
5422679|NCT00004065|recurrent breast cancer|recurrent breast cancer
5422680|NCT00004065|stage III gastric cancer|stage iii gastric cancer
5422681|NCT00004065|stage IV gastric cancer|stage iv gastric cancer
5422682|NCT00004065|recurrent gastric cancer|recurrent gastric cancer
5422683|NCT00004065|stage IIIB breast cancer|stage iiib breast cancer
5422684|NCT00004065|stage IIIC breast cancer|stage iiic breast cancer
5422685|NCT00004065|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5422686|NCT00004065|recurrent colon cancer|recurrent colon cancer
5422687|NCT00004065|stage III renal cell cancer|stage iii renal cell cancer
5422688|NCT00004065|stage IV renal cell cancer|stage iv renal cell cancer
5422689|NCT00004065|recurrent renal cell cancer|recurrent renal cell cancer
5422690|NCT00004065|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5422691|NCT00004065|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5422692|NCT00004065|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5422693|NCT00004065|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5422694|NCT00004065|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5422695|NCT00004065|stage III bladder cancer|stage iii bladder cancer
5422696|NCT00004065|recurrent bladder cancer|recurrent bladder cancer
5422697|NCT00004065|stage IV bladder cancer|stage iv bladder cancer
5422698|NCT00004065|stage III prostate cancer|stage iii prostate cancer
5422704|NCT00004065|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5422705|NCT00004065|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5422706|NCT00004065|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5422707|NCT00004065|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5422708|NCT00004065|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5422709|NCT00004065|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5422710|NCT00004065|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5422711|NCT00004065|untreated metastatic squamous neck cancer with occult primary|untreated metastatic squamous neck cancer with occult primary
5422712|NCT00004065|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
5422713|NCT00004065|ovarian stromal cancer|ovarian stromal cancer
5422714|NCT00004065|stage III ovarian germ cell tumor|stage iii ovarian germ cell tumor
5422715|NCT00004065|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
5422716|NCT00004065|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
5422717|NCT00004065|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
5422718|NCT00004065|stage III basal cell carcinoma of the lip|stage iii basal cell carcinoma of the lip
5422719|NCT00004065|stage III mucoepidermoid carcinoma of the oral cavity|stage iii mucoepidermoid carcinoma of the oral cavity
5422720|NCT00004065|stage III adenoid cystic carcinoma of the oral cavity|stage iii adenoid cystic carcinoma of the oral cavity
5422721|NCT00004065|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5422722|NCT00004065|stage IV basal cell carcinoma of the lip|stage iv basal cell carcinoma of the lip
5422723|NCT00004065|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
5422724|NCT00004065|stage IV mucoepidermoid carcinoma of the oral cavity|stage iv mucoepidermoid carcinoma of the oral cavity
5422725|NCT00004065|stage IV adenoid cystic carcinoma of the oral cavity|stage iv adenoid cystic carcinoma of the oral cavity
5422726|NCT00004065|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
5422727|NCT00004065|recurrent basal cell carcinoma of the lip|recurrent basal cell carcinoma of the lip
5422728|NCT00004065|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
5422729|NCT00004065|recurrent mucoepidermoid carcinoma of the oral cavity|recurrent mucoepidermoid carcinoma of the oral cavity
5422730|NCT00004065|recurrent adenoid cystic carcinoma of the oral cavity|recurrent adenoid cystic carcinoma of the oral cavity
5422731|NCT00004065|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
5422732|NCT00004065|stage III lymphoepithelioma of the oropharynx|stage iii lymphoepithelioma of the oropharynx
5422733|NCT00004065|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5422734|NCT00004065|stage IV lymphoepithelioma of the oropharynx|stage iv lymphoepithelioma of the oropharynx
5422735|NCT00004065|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
5422736|NCT00004065|recurrent lymphoepithelioma of the oropharynx|recurrent lymphoepithelioma of the oropharynx
5422737|NCT00004065|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
5422738|NCT00004065|stage III lymphoepithelioma of the nasopharynx|stage iii lymphoepithelioma of the nasopharynx
5422739|NCT00004065|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
5422740|NCT00004065|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
5422741|NCT00004065|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
5422742|NCT00004065|recurrent lymphoepithelioma of the nasopharynx|recurrent lymphoepithelioma of the nasopharynx
5422743|NCT00004065|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
5422744|NCT00004065|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5422745|NCT00004065|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
5422746|NCT00004065|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
5422747|NCT00004065|stage III verrucous carcinoma of the larynx|stage iii verrucous carcinoma of the larynx
5422748|NCT00004065|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5422749|NCT00004065|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
5422750|NCT00004065|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
5422751|NCT00004065|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
5422752|NCT00004065|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
5422753|NCT00004065|stage III inverted papilloma of the paranasal sinus and nasal cavity|stage iii inverted papilloma of the paranasal sinus and nasal cavity
5422754|NCT00004065|stage III midline lethal granuloma of the paranasal sinus and nasal cavity|stage iii midline lethal granuloma of the paranasal sinus and nasal cavity
5422755|NCT00004065|stage III esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iii esthesioneuroblastoma of the paranasal sinus and nasal cavity
5422756|NCT00004065|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
5422757|NCT00004065|stage IV inverted papilloma of the paranasal sinus and nasal cavity|stage iv inverted papilloma of the paranasal sinus and nasal cavity
5422820|NCT00004058|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5422758|NCT00004065|stage IV midline lethal granuloma of the paranasal sinus and nasal cavity|stage iv midline lethal granuloma of the paranasal sinus and nasal cavity
5422759|NCT00004065|stage IV esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iv esthesioneuroblastoma of the paranasal sinus and nasal cavity
5422760|NCT00004065|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
5422761|NCT00004065|recurrent inverted papilloma of the paranasal sinus and nasal cavity|recurrent inverted papilloma of the paranasal sinus and nasal cavity
5422762|NCT00004065|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity
5422763|NCT00004065|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity
5422764|NCT00004065|borderline ovarian surface epithelial-stromal tumor|borderline ovarian surface epithelial-stromal tumor
5422765|NCT00004065|ovarian sarcoma|ovarian sarcoma
5422766|NCT00004065|stage III verrucous carcinoma of the oral cavity|stage iii verrucous carcinoma of the oral cavity
5422767|NCT00004065|recurrent salivary gland cancer|recurrent salivary gland cancer
5422768|NCT00004065|stage IV salivary gland cancer|stage iv salivary gland cancer
5422769|NCT00004065|stage III salivary gland cancer|stage iii salivary gland cancer
5422770|NCT00004063|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5422771|NCT00004058|monoclonal gammopathy of undetermined significance|monoclonal gammopathy of undetermined significance
5422772|NCT00004058|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5422773|NCT00004058|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5422774|NCT00004058|isolated plasmacytoma of bone|isolated plasmacytoma of bone
5422775|NCT00004058|extramedullary plasmacytoma|extramedullary plasmacytoma
5422776|NCT00004058|refractory multiple myeloma|refractory multiple myeloma
5422777|NCT00004058|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
5422778|NCT00004058|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5422779|NCT00004058|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5422780|NCT00004058|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5422781|NCT00004058|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5422782|NCT00004058|polycythemia vera|polycythemia vera
5422783|NCT00004058|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
5422784|NCT00004058|essential thrombocythemia|essential thrombocythemia
5422785|NCT00004058|refractory hairy cell leukemia|refractory hairy cell leukemia
5422786|NCT00004058|refractory anemia|refractory anemia
5422787|NCT00004058|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
5422788|NCT00004058|refractory anemia with excess blasts|refractory anemia with excess blasts
5422789|NCT00004058|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
5422790|NCT00004058|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5422791|NCT00004058|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
5422792|NCT00004058|acute undifferentiated leukemia|acute undifferentiated leukemia
5422793|NCT00004058|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5422794|NCT00004058|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5422795|NCT00004058|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5422796|NCT00004058|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5422797|NCT00004058|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5422798|NCT00004058|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5422799|NCT00004058|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5422800|NCT00004058|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5422801|NCT00004058|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5422802|NCT00004058|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
5422803|NCT00004058|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5422804|NCT00004058|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5422805|NCT00004058|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5422806|NCT00004058|primary central nervous system lymphoma|primary central nervous system lymphoma
5422807|NCT00004058|prolymphocytic leukemia|prolymphocytic leukemia
5422808|NCT00004058|primary systemic amyloidosis|primary systemic amyloidosis
5422809|NCT00004058|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5422810|NCT00004058|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
5422811|NCT00004058|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5422812|NCT00004058|refractory cytopenia with multilineage dysplasia|refractory cytopenia with multilineage dysplasia
5422813|NCT00004058|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5422814|NCT00004058|chronic eosinophilic leukemia|chronic eosinophilic leukemia
5422815|NCT00004058|chronic neutrophilic leukemia|chronic neutrophilic leukemia
5422816|NCT00004058|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
5423954|NCT00003560|fallopian tube cancer|fallopian tube cancer
5422817|NCT00004058|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
5422818|NCT00004058|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5422819|NCT00004058|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5441912|NCT00005916|Radiation|radiation
5422821|NCT00004058|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5422822|NCT00004058|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5422823|NCT00004054|stage IIB prostate cancer|stage iib prostate cancer
5422824|NCT00004054|stage IIA prostate cancer|stage iia prostate cancer
5422825|NCT00004054|stage III prostate cancer|stage iii prostate cancer
5422826|NCT00004054|stage IV prostate cancer|stage iv prostate cancer
5422827|NCT00004031|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5422828|NCT00004031|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5422829|NCT00004031|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5422830|NCT00004031|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5422831|NCT00004031|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5422832|NCT00004031|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5422833|NCT00004031|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5422834|NCT00004031|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5422835|NCT00004031|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5422836|NCT00004031|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5422837|NCT00004031|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5422838|NCT00004031|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5422839|NCT00004031|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
5422840|NCT00004031|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
5422841|NCT00004031|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
5422842|NCT00004031|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
5422843|NCT00004031|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
5422844|NCT00004031|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
5422845|NCT00004031|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5422846|NCT00004031|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
5422847|NCT00004031|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
5422848|NCT00004031|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
5422849|NCT00004031|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5422850|NCT00004031|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
5422851|NCT00004028|recurrent adult brain tumor|recurrent adult brain tumor
5422852|NCT00004028|adult glioblastoma|adult glioblastoma
5422853|NCT00004028|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5422854|NCT00004028|adult anaplastic ependymoma|adult anaplastic ependymoma
5422855|NCT00004028|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
5422856|NCT00004028|adult mixed glioma|adult mixed glioma
5422857|NCT00004028|adult ependymoblastoma|adult ependymoblastoma
5422858|NCT00004028|adult giant cell glioblastoma|adult giant cell glioblastoma
5422859|NCT00004028|adult gliosarcoma|adult gliosarcoma
5422860|NCT00004024|recurrent adult brain tumor|recurrent adult brain tumor
5422861|NCT00004024|adult glioblastoma|adult glioblastoma
5422862|NCT00004024|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5422863|NCT00004024|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
5422864|NCT00004024|adult subependymoma|adult subependymoma
5422865|NCT00004024|adult oligodendroglioma|adult oligodendroglioma
5422866|NCT00004024|adult giant cell glioblastoma|adult giant cell glioblastoma
5422867|NCT00004024|adult gliosarcoma|adult gliosarcoma
5422868|NCT00004024|adult diffuse astrocytoma|adult diffuse astrocytoma
5422869|NCT00004017|recurrent adult brain tumor|recurrent adult brain tumor
5422870|NCT00004017|adult glioblastoma|adult glioblastoma
5422871|NCT00004017|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5422872|NCT00004017|adult giant cell glioblastoma|adult giant cell glioblastoma
5422873|NCT00004017|adult gliosarcoma|adult gliosarcoma
5422874|NCT00004015|adult glioblastoma|adult glioblastoma
5422875|NCT00004015|adult giant cell glioblastoma|adult giant cell glioblastoma
5422876|NCT00004015|adult gliosarcoma|adult gliosarcoma
5422877|NCT00004011|stage I non-small cell lung cancer|stage i non-small cell lung cancer
5422878|NCT00004011|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
5422879|NCT00004011|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5422880|NCT00004005|stage III colon cancer|stage iii colon cancer
5422881|NCT00004005|stage IV colon cancer|stage iv colon cancer
5422882|NCT00004005|stage III rectal cancer|stage iii rectal cancer
5422883|NCT00004005|stage IV rectal cancer|stage iv rectal cancer
5422884|NCT00004005|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
5422885|NCT00004005|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5422886|NCT00004005|adenocarcinoma of unknown primary|adenocarcinoma of unknown primary
5422887|NCT00004005|newly diagnosed carcinoma of unknown primary|newly diagnosed carcinoma of unknown primary
5422888|NCT00004005|recurrent carcinoma of unknown primary|recurrent carcinoma of unknown primary
5422889|NCT00004001|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5422890|NCT00004001|stage IV prostate cancer|stage iv prostate cancer
5422891|NCT00004001|recurrent prostate cancer|recurrent prostate cancer
5422892|NCT00003993|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5422893|NCT00003993|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5422894|NCT00003993|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
5422895|NCT00003993|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5422896|NCT00003993|small intestine lymphoma|small intestine lymphoma
5422897|NCT00003993|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5422898|NCT00003993|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5422899|NCT00003993|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5422900|NCT00003993|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5422901|NCT00003993|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5422902|NCT00003993|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5422903|NCT00003993|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5422904|NCT00003993|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5422905|NCT00003993|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5422906|NCT00003993|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5422907|NCT00003993|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5422908|NCT00003993|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5422909|NCT00003993|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5422910|NCT00003993|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5422911|NCT00003993|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5422912|NCT00003993|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5422913|NCT00003993|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5422914|NCT00003993|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5422915|NCT00003993|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5422916|NCT00003993|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
5422917|NCT00003993|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
5422918|NCT00003993|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
5422919|NCT00003993|intraocular lymphoma|intraocular lymphoma
5422920|NCT00003993|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5422921|NCT00003993|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5422922|NCT00003993|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
5422923|NCT00003993|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5422924|NCT00003993|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
5422925|NCT00003993|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5422926|NCT00003993|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5422927|NCT00003993|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5422928|NCT00003993|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5422929|NCT00003993|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5422930|NCT00003993|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5422931|NCT00003993|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5422932|NCT00003993|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5422933|NCT00003981|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5422934|NCT00003979|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5422935|NCT00003977|stage III cervical cancer|stage iii cervical cancer
5422936|NCT00003977|recurrent cervical cancer|recurrent cervical cancer
5422937|NCT00003977|stage IB cervical cancer|stage ib cervical cancer
5422938|NCT00003977|stage IIB cervical cancer|stage iib cervical cancer
5422939|NCT00003977|stage IVB cervical cancer|stage ivb cervical cancer
5422940|NCT00003977|stage IA cervical cancer|stage ia cervical cancer
5422941|NCT00003977|stage IIA cervical cancer|stage iia cervical cancer
5422942|NCT00003977|stage IVA cervical cancer|stage iva cervical cancer
5422943|NCT00003969|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5422944|NCT00003966|veno-occlusive disease|veno-occlusive disease
5422945|NCT00003963|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
5422946|NCT00003963|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5422947|NCT00003963|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5422948|NCT00003963|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5422949|NCT00003963|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5422950|NCT00003963|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5422951|NCT00003963|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5422952|NCT00003963|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5422953|NCT00003963|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5422954|NCT00003963|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5422955|NCT00003963|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5422956|NCT00003963|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5422957|NCT00003963|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5422958|NCT00003963|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5422959|NCT00003963|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5422960|NCT00003963|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5422961|NCT00003961|refractory anemia with excess blasts|refractory anemia with excess blasts
5422962|NCT00003961|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
5422963|NCT00003961|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5422964|NCT00003961|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5422965|NCT00003961|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5422966|NCT00003961|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5422967|NCT00003961|refractory cytopenia with multilineage dysplasia|refractory cytopenia with multilineage dysplasia
5422968|NCT00003961|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
5422969|NCT00003961|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
5422970|NCT00003955|embryonal childhood rhabdomyosarcoma|embryonal childhood rhabdomyosarcoma
5422971|NCT00003955|alveolar childhood rhabdomyosarcoma|alveolar childhood rhabdomyosarcoma
5422972|NCT00003955|metastatic childhood soft tissue sarcoma|metastatic childhood soft tissue sarcoma
5422973|NCT00003955|childhood malignant mesenchymoma|childhood malignant mesenchymoma
5422974|NCT00003955|previously untreated childhood rhabdomyosarcoma|previously untreated childhood rhabdomyosarcoma
5422975|NCT00003955|adult rhabdomyosarcoma|adult rhabdomyosarcoma
5422976|NCT00003955|adult malignant mesenchymoma|adult malignant mesenchymoma
5422977|NCT00003955|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
5422978|NCT00003945|recurrent cervical cancer|recurrent cervical cancer
5422979|NCT00003945|stage IVB cervical cancer|stage ivb cervical cancer
5422980|NCT00003945|cervical squamous cell carcinoma|cervical squamous cell carcinoma
5422981|NCT00003945|cervical adenocarcinoma|cervical adenocarcinoma
5422982|NCT00003945|cervical adenosquamous cell carcinoma|cervical adenosquamous cell carcinoma
5422983|NCT00003941|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
5422984|NCT00003941|mediastinal cancer|mediastinal cancer
5422985|NCT00003941|testicular embryonal carcinoma|testicular embryonal carcinoma
5422986|NCT00003941|testicular choriocarcinoma|testicular choriocarcinoma
5422987|NCT00003941|testicular teratoma|testicular teratoma
5422988|NCT00003941|testicular yolk sac tumor|testicular yolk sac tumor
5422989|NCT00003941|testicular embryonal carcinoma and teratoma|testicular embryonal carcinoma and teratoma
5422990|NCT00003941|testicular embryonal carcinoma and teratoma with seminoma|testicular embryonal carcinoma and teratoma with seminoma
5422991|NCT00003941|testicular embryonal carcinoma and yolk sac tumor|testicular embryonal carcinoma and yolk sac tumor
5422992|NCT00003941|testicular embryonal carcinoma and yolk sac tumor with seminoma|testicular embryonal carcinoma and yolk sac tumor with seminoma
5422993|NCT00003941|testicular embryonal carcinoma and seminoma|testicular embryonal carcinoma and seminoma
5422994|NCT00003941|testicular yolk sac tumor and teratoma|testicular yolk sac tumor and teratoma
5422995|NCT00003941|testicular yolk sac tumor and teratoma with seminoma|testicular yolk sac tumor and teratoma with seminoma
5422996|NCT00003941|testicular choriocarcinoma and yolk sac tumor|testicular choriocarcinoma and yolk sac tumor
5422997|NCT00003941|testicular choriocarcinoma and embryonal carcinoma|testicular choriocarcinoma and embryonal carcinoma
5422998|NCT00003941|testicular choriocarcinoma and teratoma|testicular choriocarcinoma and teratoma
5422999|NCT00003941|testicular choriocarcinoma and seminoma|testicular choriocarcinoma and seminoma
5423000|NCT00003941|tumors metastatic to brain|tumors metastatic to brain
5423001|NCT00003941|liver metastases|liver metastases
5423002|NCT00003941|bone metastases|bone metastases
5423003|NCT00003938|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
5423004|NCT00003938|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
5423005|NCT00003938|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5423006|NCT00003938|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5423007|NCT00003938|stage IV breast cancer|stage iv breast cancer
5423008|NCT00003938|stage IIIA breast cancer|stage iiia breast cancer
5423009|NCT00003938|monoclonal gammopathy of undetermined significance|monoclonal gammopathy of undetermined significance
5423010|NCT00003938|stage IIIB breast cancer|stage iiib breast cancer
5423011|NCT00003938|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5423012|NCT00003938|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5423013|NCT00003938|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
5423014|NCT00003938|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
5423015|NCT00003938|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
5423016|NCT00003938|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
5423017|NCT00003938|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5423018|NCT00003938|isolated plasmacytoma of bone|isolated plasmacytoma of bone
5423019|NCT00003938|extramedullary plasmacytoma|extramedullary plasmacytoma
5423020|NCT00003938|refractory multiple myeloma|refractory multiple myeloma
5423021|NCT00003938|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
5423022|NCT00003938|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
5423023|NCT00003938|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5423024|NCT00003938|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5423025|NCT00003938|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5423026|NCT00003938|disseminated neuroblastoma|disseminated neuroblastoma
5423027|NCT00003938|recurrent neuroblastoma|recurrent neuroblastoma
5423028|NCT00003938|recurrent Wilms tumor and other childhood kidney tumors|recurrent wilms tumor and other childhood kidney tumors
5423029|NCT00003938|stage 0 chronic lymphocytic leukemia|stage 0 chronic lymphocytic leukemia
5423030|NCT00003938|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
5423031|NCT00003938|stage I multiple myeloma|stage i multiple myeloma
5423032|NCT00003938|stage II multiple myeloma|stage ii multiple myeloma
5423033|NCT00003938|stage III multiple myeloma|stage iii multiple myeloma
5423034|NCT00003938|stage I childhood lymphoblastic lymphoma|stage i childhood lymphoblastic lymphoma
5423035|NCT00003938|stage II childhood lymphoblastic lymphoma|stage ii childhood lymphoblastic lymphoma
5423036|NCT00003938|stage III childhood lymphoblastic lymphoma|stage iii childhood lymphoblastic lymphoma
5423037|NCT00003938|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
5423038|NCT00003938|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
5423039|NCT00003938|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
5423040|NCT00003938|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
5423041|NCT00003938|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5423042|NCT00003938|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5423043|NCT00003938|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5423044|NCT00003938|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5423045|NCT00003938|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5423046|NCT00003938|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5423047|NCT00003938|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5423048|NCT00003938|small intestine lymphoma|small intestine lymphoma
5423049|NCT00003938|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
5423050|NCT00003938|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
5423051|NCT00003938|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
5423052|NCT00003938|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5423053|NCT00003938|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5423054|NCT00003938|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5423055|NCT00003938|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5423056|NCT00003938|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
5423057|NCT00003938|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5423058|NCT00003938|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5423059|NCT00003938|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
5423060|NCT00003938|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
5423061|NCT00003938|polycythemia vera|polycythemia vera
5423062|NCT00003938|primary myelofibrosis|primary myelofibrosis
5423063|NCT00003938|essential thrombocythemia|essential thrombocythemia
5423064|NCT00003938|fever, sweats, and hot flashes|fever, sweats, and hot flashes
5423065|NCT00003938|childhood acute promyelocytic leukemia (M3)|childhood acute promyelocytic leukemia (m3)
5423066|NCT00003938|testicular embryonal carcinoma|testicular embryonal carcinoma
5423067|NCT00003938|testicular choriocarcinoma|testicular choriocarcinoma
5423068|NCT00003938|testicular teratoma|testicular teratoma
5423069|NCT00003938|testicular yolk sac tumor|testicular yolk sac tumor
5423070|NCT00003938|testicular embryonal carcinoma and teratoma|testicular embryonal carcinoma and teratoma
5423071|NCT00003938|testicular embryonal carcinoma and teratoma with seminoma|testicular embryonal carcinoma and teratoma with seminoma
5423072|NCT00003938|testicular embryonal carcinoma and yolk sac tumor|testicular embryonal carcinoma and yolk sac tumor
5423073|NCT00003938|testicular embryonal carcinoma and yolk sac tumor with seminoma|testicular embryonal carcinoma and yolk sac tumor with seminoma
5423074|NCT00003938|testicular embryonal carcinoma and seminoma|testicular embryonal carcinoma and seminoma
5423075|NCT00003938|testicular yolk sac tumor and teratoma|testicular yolk sac tumor and teratoma
5423076|NCT00003938|testicular yolk sac tumor and teratoma with seminoma|testicular yolk sac tumor and teratoma with seminoma
5423077|NCT00003938|testicular choriocarcinoma and yolk sac tumor|testicular choriocarcinoma and yolk sac tumor
5423078|NCT00003938|testicular choriocarcinoma and embryonal carcinoma|testicular choriocarcinoma and embryonal carcinoma
5423079|NCT00003938|testicular choriocarcinoma and teratoma|testicular choriocarcinoma and teratoma
5423080|NCT00003938|testicular choriocarcinoma and seminoma|testicular choriocarcinoma and seminoma
5423081|NCT00003938|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
5423082|NCT00003938|refractory hairy cell leukemia|refractory hairy cell leukemia
5423083|NCT00003938|stage II childhood Hodgkin lymphoma|stage ii childhood hodgkin lymphoma
5423084|NCT00003938|stage I childhood Hodgkin lymphoma|stage i childhood hodgkin lymphoma
5423085|NCT00003938|stage III childhood Hodgkin lymphoma|stage iii childhood hodgkin lymphoma
5423086|NCT00003938|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
5423087|NCT00003938|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
5423088|NCT00003938|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
5423089|NCT00003938|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
5423090|NCT00003938|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
5423091|NCT00003938|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
5423092|NCT00003938|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
5423093|NCT00003938|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
5423094|NCT00003938|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
5423095|NCT00003938|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
5423096|NCT00003938|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
5423097|NCT00003938|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
5423098|NCT00003938|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5423099|NCT00003938|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
5423100|NCT00003938|ovarian yolk sac tumor|ovarian yolk sac tumor
5423101|NCT00003938|ovarian embryonal carcinoma|ovarian embryonal carcinoma
5423104|NCT00003938|ovarian immature teratoma|ovarian immature teratoma
5423105|NCT00003938|ovarian mature teratoma|ovarian mature teratoma
5423106|NCT00003938|ovarian monodermal and highly specialized teratoma|ovarian monodermal and highly specialized teratoma
5423107|NCT00003938|ovarian mixed germ cell tumor|ovarian mixed germ cell tumor
5423108|NCT00003938|acute undifferentiated leukemia|acute undifferentiated leukemia
5423109|NCT00003938|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5423110|NCT00003938|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5423111|NCT00003938|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5423112|NCT00003938|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5423113|NCT00003938|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5423114|NCT00003938|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5423115|NCT00003938|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5423116|NCT00003938|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5423117|NCT00003938|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5423118|NCT00003938|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5423119|NCT00003938|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5423120|NCT00003938|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5423121|NCT00003938|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5423122|NCT00003938|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5423123|NCT00003938|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5423124|NCT00003938|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5423125|NCT00003938|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5423126|NCT00003938|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5423127|NCT00003938|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5423128|NCT00003938|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5423129|NCT00003938|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5423130|NCT00003938|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5423131|NCT00003938|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5423132|NCT00003938|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5423133|NCT00003938|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5423134|NCT00003938|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5423135|NCT00003938|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5423136|NCT00003938|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
5423137|NCT00003938|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
5423138|NCT00003938|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
5423139|NCT00003938|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
5423140|NCT00003938|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
5423141|NCT00003938|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5423142|NCT00003938|high risk metastatic gestational trophoblastic tumor|high risk metastatic gestational trophoblastic tumor
5423143|NCT00003938|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5423144|NCT00003938|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5423145|NCT00003938|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
5423146|NCT00003938|neutropenia|neutropenia
5423147|NCT00003938|infection|infection
5423148|NCT00003938|previously untreated childhood rhabdomyosarcoma|previously untreated childhood rhabdomyosarcoma
5423149|NCT00003938|prolymphocytic leukemia|prolymphocytic leukemia
5423150|NCT00003938|primary systemic amyloidosis|primary systemic amyloidosis
5423151|NCT00003938|intraocular lymphoma|intraocular lymphoma
5423152|NCT00003938|stage I childhood small noncleaved cell lymphoma|stage i childhood small noncleaved cell lymphoma
5423153|NCT00003938|stage I childhood large cell lymphoma|stage i childhood large cell lymphoma
5423354|NCT00003816|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
5423154|NCT00003938|stage II childhood small noncleaved cell lymphoma|stage ii childhood small noncleaved cell lymphoma
5423155|NCT00003938|stage II childhood large cell lymphoma|stage ii childhood large cell lymphoma
5423156|NCT00003938|stage III childhood small noncleaved cell lymphoma|stage iii childhood small noncleaved cell lymphoma
5423157|NCT00003938|stage III childhood large cell lymphoma|stage iii childhood large cell lymphoma
5423158|NCT00003938|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
5423159|NCT00003938|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
5423160|NCT00003938|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
5423161|NCT00003938|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
5423162|NCT00003938|stage I mantle cell lymphoma|stage i mantle cell lymphoma
5423163|NCT00003938|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
5423164|NCT00003938|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
5423165|NCT00003938|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
5423166|NCT00003938|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
5423167|NCT00003938|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
5423168|NCT00003938|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
5423169|NCT00003938|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
5423170|NCT00003938|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
5423171|NCT00003938|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
5423172|NCT00003938|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
5423173|NCT00003938|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5423174|NCT00003938|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5423175|NCT00003938|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5423176|NCT00003938|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
5423177|NCT00003938|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5423178|NCT00003938|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
5423179|NCT00003938|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
5423180|NCT00003938|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5423181|NCT00003938|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
5423182|NCT00003938|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
5423183|NCT00003938|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5423184|NCT00003938|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5423185|NCT00003938|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5423186|NCT00003938|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
5423187|NCT00003938|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5423188|NCT00003938|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
5423189|NCT00003938|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
5423190|NCT00003938|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
5423191|NCT00003938|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
5423192|NCT00003938|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
5423193|NCT00003938|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5423194|NCT00003938|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
5423195|NCT00003938|chronic eosinophilic leukemia|chronic eosinophilic leukemia
5423196|NCT00003938|chronic neutrophilic leukemia|chronic neutrophilic leukemia
5423197|NCT00003938|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
5423198|NCT00003938|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
5423199|NCT00003938|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
5423200|NCT00003938|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
5423201|NCT00003938|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5423202|NCT00003938|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5423203|NCT00003938|stage I marginal zone lymphoma|stage i marginal zone lymphoma
5423204|NCT00003938|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
5423205|NCT00003938|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5423206|NCT00003938|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5423207|NCT00003938|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5423208|NCT00003938|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5423209|NCT00003938|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5423210|NCT00003938|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5423211|NCT00003938|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5423212|NCT00003938|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
5423213|NCT00003928|stage IV renal cell cancer|stage iv renal cell cancer
5423214|NCT00003928|recurrent renal cell cancer|recurrent renal cell cancer
5423215|NCT00003913|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5423216|NCT00003913|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
5423217|NCT00003913|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5423218|NCT00003913|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5423219|NCT00003913|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5423220|NCT00003913|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5423221|NCT00003913|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
5423222|NCT00003913|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
5423223|NCT00003913|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
5423224|NCT00003913|refractory anemia|refractory anemia
5423225|NCT00003913|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
5423226|NCT00003913|refractory anemia with excess blasts|refractory anemia with excess blasts
5423227|NCT00003913|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
5423228|NCT00003913|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5423229|NCT00003913|acute undifferentiated leukemia|acute undifferentiated leukemia
5423230|NCT00003913|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5423231|NCT00003913|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5423232|NCT00003913|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5423233|NCT00003913|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5423234|NCT00003913|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
5423235|NCT00003913|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
5423236|NCT00003913|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
5423237|NCT00003913|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5423238|NCT00003913|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
5423239|NCT00003913|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
5423240|NCT00003913|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
5423241|NCT00003912|stage I childhood liver cancer|stage i childhood liver cancer
5423242|NCT00003912|stage II childhood liver cancer|stage ii childhood liver cancer
5423243|NCT00003912|stage III childhood liver cancer|stage iii childhood liver cancer
5423244|NCT00003912|stage IV childhood liver cancer|stage iv childhood liver cancer
5423245|NCT00003912|recurrent childhood liver cancer|recurrent childhood liver cancer
5423246|NCT00003912|childhood hepatoblastoma|childhood hepatoblastoma
5423247|NCT00003912|childhood hepatocellular carcinoma|childhood hepatocellular carcinoma
5423248|NCT00003910|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
5423249|NCT00003910|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
5423250|NCT00003910|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5423251|NCT00003910|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5423252|NCT00003910|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
5423253|NCT00003910|LGL clone|lgl clone
5423254|NCT00003906|breast cancer|breast cancer
5423255|NCT00003903|stage I prostate cancer|stage i prostate cancer
5423256|NCT00003903|stage IIB prostate cancer|stage iib prostate cancer
5423257|NCT00003903|stage IIA prostate cancer|stage iia prostate cancer
5423258|NCT00003903|stage III prostate cancer|stage iii prostate cancer
5423259|NCT00003903|stage IV prostate cancer|stage iv prostate cancer
5423260|NCT00003903|osteoporosis|osteoporosis
5423261|NCT00003902|stage IV breast cancer|stage iv breast cancer
5423262|NCT00003901|stage I non-small cell lung cancer|stage i non-small cell lung cancer
5423263|NCT00003901|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
5423264|NCT00003901|squamous cell lung cancer|squamous cell lung cancer
5423265|NCT00003901|large cell lung cancer|large cell lung cancer
5423266|NCT00003901|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5423267|NCT00003901|adenocarcinoma of the lung|adenocarcinoma of the lung
5423268|NCT00003896|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5423269|NCT00003896|peritoneal cavity cancer|peritoneal cavity cancer
5423270|NCT00003896|fallopian tube cancer|fallopian tube cancer
5423271|NCT00003893|stage I breast cancer|stage i breast cancer
5423272|NCT00003878|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5423273|NCT00003878|tumors metastatic to brain|tumors metastatic to brain
5423274|NCT00003865|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5423275|NCT00003865|ovarian serous cystadenocarcinoma|ovarian serous cystadenocarcinoma
5423276|NCT00003863|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
5423277|NCT00003863|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
5423278|NCT00003863|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
5423279|NCT00003863|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
5423280|NCT00003863|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
5423281|NCT00003863|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5423282|NCT00003863|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5423283|NCT00003863|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5423284|NCT00003863|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5423285|NCT00003863|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5423286|NCT00003863|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5423287|NCT00003863|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5423288|NCT00003863|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5423289|NCT00003863|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5423290|NCT00003863|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5423291|NCT00003863|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5423292|NCT00003863|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5423293|NCT00003863|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5423294|NCT00003863|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5423295|NCT00003863|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5423296|NCT00003863|stage I mantle cell lymphoma|stage i mantle cell lymphoma
5423297|NCT00003863|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
5423298|NCT00003863|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
5423299|NCT00003863|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
5423300|NCT00003863|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
5423301|NCT00003863|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
5423302|NCT00003863|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
5423303|NCT00003863|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
5423304|NCT00003863|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5423305|NCT00003863|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
5423306|NCT00003863|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
5423307|NCT00003863|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5423308|NCT00003863|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
5423309|NCT00003863|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5423310|NCT00003863|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5423311|NCT00003863|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5423312|NCT00003862|stage I gastric cancer|stage i gastric cancer
5423313|NCT00003862|stage II gastric cancer|stage ii gastric cancer
5423314|NCT00003862|stage III gastric cancer|stage iii gastric cancer
5423315|NCT00003862|stage IV gastric cancer|stage iv gastric cancer
5423316|NCT00003862|adenocarcinoma of the stomach|adenocarcinoma of the stomach
5423317|NCT00003857|breast cancer in situ|breast cancer in situ
5423318|NCT00003857|ductal breast carcinoma in situ|ductal breast carcinoma in situ
5423319|NCT00003855|stage IA breast cancer|stage ia breast cancer
5423320|NCT00003855|stage IB breast cancer|stage ib breast cancer
5423321|NCT00003855|stage II breast cancer|stage ii breast cancer
5423322|NCT00003854|stage IA breast cancer|stage ia breast cancer
5423323|NCT00003854|stage IB breast cancer|stage ib breast cancer
5423324|NCT00003854|stage II breast cancer|stage ii breast cancer
5423325|NCT00003851|malnutrition|malnutrition
5423326|NCT00003851|stage II pancreatic cancer|stage ii pancreatic cancer
5423327|NCT00003851|stage III pancreatic cancer|stage iii pancreatic cancer
5423328|NCT00003851|stage IV pancreatic cancer|stage iv pancreatic cancer
5423329|NCT00003851|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
5423330|NCT00003843|stage IV colon cancer|stage iv colon cancer
5423331|NCT00003843|stage IV rectal cancer|stage iv rectal cancer
5423332|NCT00003843|recurrent colon cancer|recurrent colon cancer
5423333|NCT00003843|recurrent rectal cancer|recurrent rectal cancer
5423334|NCT00003838|Graft vs. Host Disease|graft vs. host disease
5423335|NCT00003838|Peripheral Blood Stem Cells|peripheral blood stem cells
5423336|NCT00003838|Non-Myeloablative Bone Marrow Transplantation|non-myeloablative bone marrow transplantation
5423337|NCT00003838|Engraftment|engraftment
5423338|NCT00003838|Graft-Versus-Leukemia|graft-versus-leukemia
5423339|NCT00003837|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5423340|NCT00003837|T-cell adult acute lymphoblastic leukemia|t-cell adult acute lymphoblastic leukemia
5423341|NCT00003837|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5423342|NCT00003833|stage II colon cancer|stage ii colon cancer
5423343|NCT00003833|stage III colon cancer|stage iii colon cancer
5423344|NCT00003833|adenocarcinoma of the colon|adenocarcinoma of the colon
5423345|NCT00003831|stage I non-small cell lung cancer|stage i non-small cell lung cancer
5423346|NCT00003831|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
5423347|NCT00003831|squamous cell lung cancer|squamous cell lung cancer
5423348|NCT00003831|large cell lung cancer|large cell lung cancer
5423349|NCT00003831|adenocarcinoma of the lung|adenocarcinoma of the lung
5423350|NCT00003816|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5423351|NCT00003816|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5423352|NCT00003816|Burkitt lymphoma|burkitt lymphoma
5423353|NCT00003816|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
5423355|NCT00003816|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5423356|NCT00003816|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5423357|NCT00003816|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5423358|NCT00003816|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5423359|NCT00003816|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5423360|NCT00003816|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5423361|NCT00003816|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5423362|NCT00003816|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5423363|NCT00003816|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5423364|NCT00003816|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5423365|NCT00003816|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
5423366|NCT00003816|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
5423367|NCT00003816|polycythemia vera|polycythemia vera
5423368|NCT00003816|essential thrombocythemia|essential thrombocythemia
5423369|NCT00003816|refractory anemia|refractory anemia
5423370|NCT00003816|refractory anemia with excess blasts|refractory anemia with excess blasts
5423371|NCT00003816|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
5423372|NCT00003816|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5423373|NCT00003816|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
5423374|NCT00003816|acute undifferentiated leukemia|acute undifferentiated leukemia
5423375|NCT00003816|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5423376|NCT00003816|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5423377|NCT00003816|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5423378|NCT00003816|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5423379|NCT00003816|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5423380|NCT00003816|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5423381|NCT00003816|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5423382|NCT00003816|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5423383|NCT00003816|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5423384|NCT00003816|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
5423385|NCT00003816|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5423386|NCT00003816|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5423387|NCT00003816|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5423388|NCT00003816|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5423391|NCT00003816|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
5423392|NCT00003816|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
5423393|NCT00003816|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5423394|NCT00003816|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
5423395|NCT00003816|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5423396|NCT00003816|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5423397|NCT00003816|primary myelofibrosis|primary myelofibrosis
5423398|NCT00003816|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
5423399|NCT00003816|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
5423400|NCT00003816|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
5423401|NCT00003816|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5423402|NCT00003816|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5423403|NCT00003816|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5423404|NCT00003816|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5423405|NCT00003816|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5423406|NCT00003816|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5423407|NCT00003816|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5423408|NCT00003816|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5423409|NCT00003816|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5423410|NCT00003816|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5423411|NCT00003816|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
5423412|NCT00003816|aplastic anemia|aplastic anemia
5423413|NCT00003816|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5423414|NCT00003816|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
5423415|NCT00003815|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
5423416|NCT00003815|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
5423417|NCT00003815|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
5423418|NCT00003815|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
5423419|NCT00003815|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5423420|NCT00003815|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5423421|NCT00003815|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5423422|NCT00003815|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5423423|NCT00003815|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5423424|NCT00003815|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5423425|NCT00003815|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5423426|NCT00003815|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5423427|NCT00003815|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
5423428|NCT00003815|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
5423429|NCT00003815|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
5423430|NCT00003815|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
5423431|NCT00003815|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
5423432|NCT00003815|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
5423433|NCT00003815|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5423434|NCT00003815|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
5423435|NCT00003803|stage I non-small cell lung cancer|stage i non-small cell lung cancer
5423436|NCT00003803|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
5423437|NCT00003803|stage III non-small cell lung cancer|stage iii non-small cell lung cancer
5423438|NCT00003800|stage I malignant testicular germ cell tumor|stage i malignant testicular germ cell tumor
5423439|NCT00003800|stage II malignant testicular germ cell tumor|stage ii malignant testicular germ cell tumor
5423440|NCT00003800|testicular embryonal carcinoma|testicular embryonal carcinoma
5423441|NCT00003800|testicular choriocarcinoma|testicular choriocarcinoma
5423442|NCT00003800|testicular teratoma|testicular teratoma
5423443|NCT00003800|testicular yolk sac tumor|testicular yolk sac tumor
5423444|NCT00003800|testicular embryonal carcinoma and teratoma|testicular embryonal carcinoma and teratoma
5423445|NCT00003800|testicular embryonal carcinoma and yolk sac tumor|testicular embryonal carcinoma and yolk sac tumor
5423446|NCT00003800|testicular yolk sac tumor and teratoma|testicular yolk sac tumor and teratoma
5423447|NCT00003800|testicular choriocarcinoma and yolk sac tumor|testicular choriocarcinoma and yolk sac tumor
5423448|NCT00003800|testicular choriocarcinoma and embryonal carcinoma|testicular choriocarcinoma and embryonal carcinoma
5423449|NCT00003800|testicular choriocarcinoma and teratoma|testicular choriocarcinoma and teratoma
5423450|NCT00003796|stage IV breast cancer|stage iv breast cancer
5423451|NCT00003796|recurrent breast cancer|recurrent breast cancer
5423452|NCT00003796|male breast cancer|male breast cancer
5423453|NCT00003793|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5423454|NCT00003793|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5423455|NCT00003793|localized osteosarcoma|localized osteosarcoma
5423456|NCT00003793|metastatic osteosarcoma|metastatic osteosarcoma
5423457|NCT00003793|childhood soft tissue sarcoma|childhood soft tissue sarcoma
5423458|NCT00003793|nonmetastatic childhood soft tissue sarcoma|nonmetastatic childhood soft tissue sarcoma
5423459|NCT00003793|metastatic childhood soft tissue sarcoma|metastatic childhood soft tissue sarcoma
5423460|NCT00003793|childhood fibrosarcoma|childhood fibrosarcoma
5423461|NCT00003793|childhood synovial sarcoma|childhood synovial sarcoma
5423462|NCT00003793|childhood neurofibrosarcoma|childhood neurofibrosarcoma
5423463|NCT00003793|previously untreated childhood rhabdomyosarcoma|previously untreated childhood rhabdomyosarcoma
5423464|NCT00003793|localized Ewing sarcoma/peripheral primitive neuroectodermal tumor|localized ewing sarcoma/peripheral primitive neuroectodermal tumor
5423465|NCT00003793|metastatic Ewing sarcoma/peripheral primitive neuroectodermal tumor|metastatic ewing sarcoma/peripheral primitive neuroectodermal tumor
5423466|NCT00003788|recurrent adult brain tumor|recurrent adult brain tumor
5423467|NCT00003788|adult glioblastoma|adult glioblastoma
5423468|NCT00003788|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5423469|NCT00003788|adult giant cell glioblastoma|adult giant cell glioblastoma
5423470|NCT00003788|adult gliosarcoma|adult gliosarcoma
5423471|NCT00003782|stage I breast cancer|stage i breast cancer
5423472|NCT00003782|stage II breast cancer|stage ii breast cancer
5423473|NCT00003782|stage IIIA breast cancer|stage iiia breast cancer
5423474|NCT00003771|menopausal symptoms|menopausal symptoms
5423475|NCT00003771|stage I breast cancer|stage i breast cancer
5423476|NCT00003771|stage II breast cancer|stage ii breast cancer
5423477|NCT00003771|breast cancer in situ|breast cancer in situ
5423478|NCT00003764|stage 0 chronic lymphocytic leukemia|stage 0 chronic lymphocytic leukemia
5423479|NCT00003764|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
5423480|NCT00003764|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
5423481|NCT00003764|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5423482|NCT00003764|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5423483|NCT00003764|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
5423484|NCT00003753|stage IV colon cancer|stage iv colon cancer
5423486|NCT00003753|adenocarcinoma of the colon|adenocarcinoma of the colon
5423487|NCT00003753|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5423488|NCT00003753|liver metastases|liver metastases
5423490|NCT00003753|recurrent rectal cancer|recurrent rectal cancer
5423491|NCT00003750|metastatic osteosarcoma|metastatic osteosarcoma
5423492|NCT00003750|recurrent neuroblastoma|recurrent neuroblastoma
5423493|NCT00003750|recurrent osteosarcoma|recurrent osteosarcoma
5423494|NCT00003750|recurrent melanoma|recurrent melanoma
5423495|NCT00003750|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
5423496|NCT00003750|metastatic childhood soft tissue sarcoma|metastatic childhood soft tissue sarcoma
5423497|NCT00003750|recurrent childhood soft tissue sarcoma|recurrent childhood soft tissue sarcoma
5423498|NCT00003749|stage I endometrial carcinoma|stage i endometrial carcinoma
5423499|NCT00003749|stage II endometrial carcinoma|stage ii endometrial carcinoma
5423500|NCT00003749|endometrial clear cell carcinoma|endometrial clear cell carcinoma
5423501|NCT00003749|endometrial papillary serous carcinoma|endometrial papillary serous carcinoma
5423502|NCT00003746|untreated hairy cell leukemia|untreated hairy cell leukemia
5423503|NCT00003746|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
5423504|NCT00003746|prolymphocytic leukemia|prolymphocytic leukemia
5423505|NCT00003745|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
5423506|NCT00003745|recurrent osteosarcoma|recurrent osteosarcoma
5423507|NCT00003745|embryonal childhood rhabdomyosarcoma|embryonal childhood rhabdomyosarcoma
5423508|NCT00003745|alveolar childhood rhabdomyosarcoma|alveolar childhood rhabdomyosarcoma
5423509|NCT00003745|recurrent childhood soft tissue sarcoma|recurrent childhood soft tissue sarcoma
5423510|NCT00003745|extraosseous Ewing sarcoma/peripheral primitive neuroectodermal tumor|extraosseous ewing sarcoma/peripheral primitive neuroectodermal tumor
5423511|NCT00003745|recurrent Ewing sarcoma/peripheral primitive neuroectodermal tumor|recurrent ewing sarcoma/peripheral primitive neuroectodermal tumor
5423512|NCT00003744|stage III salivary gland cancer|stage iii salivary gland cancer
5423513|NCT00003744|stage IV salivary gland cancer|stage iv salivary gland cancer
5423514|NCT00003744|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
5423515|NCT00003744|salivary gland acinic cell tumor|salivary gland acinic cell tumor
5423516|NCT00003744|low-grade salivary gland mucoepidermoid carcinoma|low-grade salivary gland mucoepidermoid carcinoma
5423517|NCT00003744|high-grade salivary gland mucoepidermoid carcinoma|high-grade salivary gland mucoepidermoid carcinoma
5423518|NCT00003744|salivary gland adenocarcinoma|salivary gland adenocarcinoma
5423519|NCT00003744|salivary gland poorly differentiated carcinoma|salivary gland poorly differentiated carcinoma
5423520|NCT00003744|salivary gland anaplastic carcinoma|salivary gland anaplastic carcinoma
5423521|NCT00003744|salivary gland malignant mixed cell type tumor|salivary gland malignant mixed cell type tumor
5423522|NCT00003744|salivary gland adenoid cystic carcinoma|salivary gland adenoid cystic carcinoma
5423523|NCT00003741|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5423524|NCT00003741|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5423525|NCT00003739|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
5423526|NCT00003739|fever, sweats, and hot flashes|fever, sweats, and hot flashes
5423527|NCT00003739|neutropenia|neutropenia
5423528|NCT00003737|recurrent neuroblastoma|recurrent neuroblastoma
5423529|NCT00003732|stage IIB ovarian epithelial cancer|stage iib ovarian epithelial cancer
5423530|NCT00003732|stage IIC ovarian epithelial cancer|stage iic ovarian epithelial cancer
5423531|NCT00003732|stage IIIA ovarian epithelial cancer|stage iiia ovarian epithelial cancer
5423532|NCT00003732|stage IIIB ovarian epithelial cancer|stage iiib ovarian epithelial cancer
5423533|NCT00003732|stage IIIC ovarian epithelial cancer|stage iiic ovarian epithelial cancer
5423534|NCT00003732|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5423535|NCT00003730|stage IV breast cancer|stage iv breast cancer
5423536|NCT00003730|recurrent breast cancer|recurrent breast cancer
5423537|NCT00003728|stage I childhood lymphoblastic lymphoma|stage i childhood lymphoblastic lymphoma
5423538|NCT00003728|stage II childhood lymphoblastic lymphoma|stage ii childhood lymphoblastic lymphoma
5423539|NCT00003728|stage III childhood lymphoblastic lymphoma|stage iii childhood lymphoblastic lymphoma
5423540|NCT00003728|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
5423541|NCT00003728|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
5423542|NCT00003728|L1 childhood acute lymphoblastic leukemia|l1 childhood acute lymphoblastic leukemia
5423543|NCT00003728|L2 childhood acute lymphoblastic leukemia|l2 childhood acute lymphoblastic leukemia
5423544|NCT00003728|T-cell childhood acute lymphoblastic leukemia|t-cell childhood acute lymphoblastic leukemia
5423545|NCT00003728|B-cell childhood acute lymphoblastic leukemia|b-cell childhood acute lymphoblastic leukemia
5423546|NCT00003728|acute undifferentiated leukemia|acute undifferentiated leukemia
5423547|NCT00003727|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5423548|NCT00003727|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5423549|NCT00003727|Philadelphia chromosome positive chronic myelogenous leukemia|philadelphia chromosome positive chronic myelogenous leukemia
5423550|NCT00003727|Philadelphia chromosome negative chronic myelogenous leukemia|philadelphia chromosome negative chronic myelogenous leukemia
5423551|NCT00003727|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
5423552|NCT00003696|extensive stage small cell lung cancer|extensive stage small cell lung cancer
5423553|NCT00003690|stage IV breast cancer|stage iv breast cancer
5423554|NCT00003690|recurrent breast cancer|recurrent breast cancer
5423555|NCT00003690|stage IV prostate cancer|stage iv prostate cancer
5423556|NCT00003690|recurrent prostate cancer|recurrent prostate cancer
5423557|NCT00003690|stage IV melanoma|stage iv melanoma
5423558|NCT00003690|recurrent melanoma|recurrent melanoma
5423559|NCT00003690|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5423560|NCT00003688|recurrent gestational trophoblastic tumor|recurrent gestational trophoblastic tumor
5423561|NCT00003688|nonmetastatic gestational trophoblastic tumor|nonmetastatic gestational trophoblastic tumor
5423562|NCT00003688|low risk metastatic gestational trophoblastic tumor|low risk metastatic gestational trophoblastic tumor
5423563|NCT00003687|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5423564|NCT00003687|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5423565|NCT00003687|monoclonal gammopathy of undetermined significance|monoclonal gammopathy of undetermined significance
5423566|NCT00003687|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5423567|NCT00003687|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
5423568|NCT00003687|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
5423569|NCT00003687|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5423570|NCT00003687|isolated plasmacytoma of bone|isolated plasmacytoma of bone
5423571|NCT00003687|extramedullary plasmacytoma|extramedullary plasmacytoma
5423572|NCT00003687|refractory multiple myeloma|refractory multiple myeloma
5423573|NCT00003687|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
5423574|NCT00003687|stage III multiple myeloma|stage iii multiple myeloma
5423575|NCT00003687|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5423576|NCT00003687|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5423577|NCT00003687|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5423578|NCT00003687|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5423579|NCT00003687|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5423580|NCT00003687|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5423581|NCT00003687|small intestine lymphoma|small intestine lymphoma
5423582|NCT00003687|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5423583|NCT00003687|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5423584|NCT00003687|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5423585|NCT00003687|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5423586|NCT00003687|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
5423587|NCT00003687|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
5423588|NCT00003687|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
5423589|NCT00003687|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5423590|NCT00003687|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5423591|NCT00003687|polycythemia vera|polycythemia vera
5423592|NCT00003687|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
5423593|NCT00003687|essential thrombocythemia|essential thrombocythemia
5423594|NCT00003687|untreated hairy cell leukemia|untreated hairy cell leukemia
5423595|NCT00003687|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
5423596|NCT00003687|refractory hairy cell leukemia|refractory hairy cell leukemia
5423597|NCT00003687|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5423598|NCT00003687|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
5423599|NCT00003687|acute undifferentiated leukemia|acute undifferentiated leukemia
5423600|NCT00003687|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5423601|NCT00003687|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5423602|NCT00003687|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5423603|NCT00003687|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5423604|NCT00003687|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5423605|NCT00003687|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5423606|NCT00003687|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5423607|NCT00003687|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5423608|NCT00003687|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5423609|NCT00003687|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5423610|NCT00003687|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5423611|NCT00003687|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5423612|NCT00003687|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5423613|NCT00003687|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5423614|NCT00003687|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5423615|NCT00003687|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5423616|NCT00003687|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5423617|NCT00003687|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5423618|NCT00003687|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5423619|NCT00003687|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5423620|NCT00003687|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5423621|NCT00003687|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5441913|NCT00005916|Immunology|immunology
5423622|NCT00003687|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5423623|NCT00003687|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5423624|NCT00003687|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5423625|NCT00003687|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5423626|NCT00003687|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5423627|NCT00003687|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
5423628|NCT00003687|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
5423629|NCT00003687|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
5423630|NCT00003687|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5423631|NCT00003687|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5423632|NCT00003687|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5423633|NCT00003687|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5423634|NCT00003687|pain|pain
5423635|NCT00003687|prolymphocytic leukemia|prolymphocytic leukemia
5423636|NCT00003687|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
5423637|NCT00003687|AIDS-related primary CNS lymphoma|aids-related primary cns lymphoma
5423638|NCT00003687|primary systemic amyloidosis|primary systemic amyloidosis
5423639|NCT00003687|non-Hodgkin lymphoma during pregnancy|non-hodgkin lymphoma during pregnancy
5423640|NCT00003687|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5423641|NCT00003687|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5423642|NCT00003687|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5423643|NCT00003687|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
5423644|NCT00003687|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5423645|NCT00003687|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
5423646|NCT00003687|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
5423647|NCT00003687|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5423648|NCT00003687|chronic eosinophilic leukemia|chronic eosinophilic leukemia
5423649|NCT00003687|chronic neutrophilic leukemia|chronic neutrophilic leukemia
5423650|NCT00003687|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5423651|NCT00003687|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5423652|NCT00003687|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5423653|NCT00003687|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5423654|NCT00003687|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5423655|NCT00003687|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5423656|NCT00003687|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5423657|NCT00003687|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5423658|NCT00003687|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5423659|NCT00003687|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
5423660|NCT00003678|stage I breast cancer|stage i breast cancer
5423661|NCT00003678|stage II breast cancer|stage ii breast cancer
5423662|NCT00003659|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
5423663|NCT00003659|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5423664|NCT00003659|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5423665|NCT00003658|Waldenström macroglobulinemia|waldenström macroglobulinemia
5423666|NCT00003658|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
5423667|NCT00003658|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5423668|NCT00003658|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5423669|NCT00003658|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5423670|NCT00003658|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
5423671|NCT00003658|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
5423672|NCT00003658|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
5423673|NCT00003658|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5423674|NCT00003658|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5423675|NCT00003658|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5423676|NCT00003658|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5423677|NCT00003658|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5423678|NCT00003658|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5423679|NCT00003658|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
5423680|NCT00003658|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
5423681|NCT00003658|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5423682|NCT00003658|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5423683|NCT00003658|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
5423684|NCT00003658|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
5423685|NCT00003658|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5423686|NCT00003658|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
5423687|NCT00003658|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5423688|NCT00003658|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5423689|NCT00003656|stage IV renal cell cancer|stage iv renal cell cancer
5423690|NCT00003656|recurrent renal cell cancer|recurrent renal cell cancer
5423691|NCT00003653|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5423692|NCT00003653|recurrent prostate cancer|recurrent prostate cancer
5423693|NCT00003652|stage II anal cancer|stage ii anal cancer
5423694|NCT00003652|stage III anal cancer|stage iii anal cancer
5423695|NCT00003652|squamous cell carcinoma of the anus|squamous cell carcinoma of the anus
5423696|NCT00003652|cloacogenic carcinoma of the anus|cloacogenic carcinoma of the anus
5423697|NCT00003652|basaloid carcinoma of the anus|basaloid carcinoma of the anus
5423698|NCT00003650|stage I childhood lymphoblastic lymphoma|stage i childhood lymphoblastic lymphoma
5423699|NCT00003650|stage II childhood lymphoblastic lymphoma|stage ii childhood lymphoblastic lymphoma
5423700|NCT00003650|stage III childhood lymphoblastic lymphoma|stage iii childhood lymphoblastic lymphoma
5423701|NCT00003650|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
5423702|NCT00003644|stage I ovarian epithelial cancer|stage i ovarian epithelial cancer
5423703|NCT00003644|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
5423704|NCT00003644|ovarian undifferentiated adenocarcinoma|ovarian undifferentiated adenocarcinoma
5423705|NCT00003644|ovarian mixed epithelial carcinoma|ovarian mixed epithelial carcinoma
5423706|NCT00003644|ovarian serous cystadenocarcinoma|ovarian serous cystadenocarcinoma
5423707|NCT00003644|ovarian mucinous cystadenocarcinoma|ovarian mucinous cystadenocarcinoma
5423708|NCT00003644|ovarian endometrioid adenocarcinoma|ovarian endometrioid adenocarcinoma
5423709|NCT00003644|ovarian clear cell cystadenocarcinoma|ovarian clear cell cystadenocarcinoma
5423710|NCT00003644|Brenner tumor|brenner tumor
5423711|NCT00003643|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
5423712|NCT00003643|testicular seminoma|testicular seminoma
5423713|NCT00003643|testicular embryonal carcinoma|testicular embryonal carcinoma
5423714|NCT00003643|testicular choriocarcinoma|testicular choriocarcinoma
5423715|NCT00003643|testicular yolk sac tumor|testicular yolk sac tumor
5423716|NCT00003643|testicular embryonal carcinoma and teratoma|testicular embryonal carcinoma and teratoma
5423717|NCT00003643|testicular embryonal carcinoma and teratoma with seminoma|testicular embryonal carcinoma and teratoma with seminoma
5423718|NCT00003643|testicular embryonal carcinoma and yolk sac tumor|testicular embryonal carcinoma and yolk sac tumor
5423719|NCT00003643|testicular embryonal carcinoma and yolk sac tumor with seminoma|testicular embryonal carcinoma and yolk sac tumor with seminoma
5423720|NCT00003643|testicular embryonal carcinoma and seminoma|testicular embryonal carcinoma and seminoma
5423721|NCT00003643|testicular yolk sac tumor and teratoma|testicular yolk sac tumor and teratoma
5423722|NCT00003643|testicular yolk sac tumor and teratoma with seminoma|testicular yolk sac tumor and teratoma with seminoma
5423723|NCT00003643|testicular choriocarcinoma and yolk sac tumor|testicular choriocarcinoma and yolk sac tumor
5423724|NCT00003643|testicular choriocarcinoma and embryonal carcinoma|testicular choriocarcinoma and embryonal carcinoma
5423725|NCT00003643|testicular choriocarcinoma and teratoma|testicular choriocarcinoma and teratoma
5423726|NCT00003643|testicular choriocarcinoma and seminoma|testicular choriocarcinoma and seminoma
5423727|NCT00003643|stage IV extragonadal non-seminomatous germ cell tumor|stage iv extragonadal non-seminomatous germ cell tumor
5423728|NCT00003643|stage IV extragonadal seminoma|stage iv extragonadal seminoma
5423729|NCT00003643|testicular immature teratoma|testicular immature teratoma
5423730|NCT00003643|testicular mature teratoma|testicular mature teratoma
5423731|NCT00003643|adult teratoma|adult teratoma
5423732|NCT00003641|stage II melanoma|stage ii melanoma
5423733|NCT00003641|stage III melanoma|stage iii melanoma
5423734|NCT00003637|stage III lymphoepithelioma of the nasopharynx|stage iii lymphoepithelioma of the nasopharynx
5423735|NCT00003637|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
5423736|NCT00003637|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
5423737|NCT00003637|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
5423738|NCT00003636|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5423739|NCT00003636|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5423740|NCT00003636|fallopian tube cancer|fallopian tube cancer
5423741|NCT00003636|primary peritoneal cavity cancer|primary peritoneal cavity cancer
5423742|NCT00003633|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5423743|NCT00003633|stage IV prostate cancer|stage iv prostate cancer
5423744|NCT00003633|recurrent prostate cancer|recurrent prostate cancer
5423745|NCT00003631|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5423746|NCT00003631|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
5423747|NCT00003612|stage IV breast cancer|stage iv breast cancer
5423748|NCT00003612|recurrent breast cancer|recurrent breast cancer
5423749|NCT00003611|basal cell carcinoma of the skin|basal cell carcinoma of the skin
5423750|NCT00003611|squamous cell carcinoma of the skin|squamous cell carcinoma of the skin
5423751|NCT00003607|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5423752|NCT00003607|stage I prostate cancer|stage i prostate cancer
5423753|NCT00003607|stage IIB prostate cancer|stage iib prostate cancer
5423754|NCT00003607|stage IIA prostate cancer|stage iia prostate cancer
5423755|NCT00003607|stage III prostate cancer|stage iii prostate cancer
5423756|NCT00003603|refractory multiple myeloma|refractory multiple myeloma
5423757|NCT00003603|stage I multiple myeloma|stage i multiple myeloma
5423758|NCT00003603|stage II multiple myeloma|stage ii multiple myeloma
5441914|NCT00005916|Prostvac|prostvac
5423759|NCT00003603|stage III multiple myeloma|stage iii multiple myeloma
5423760|NCT00003602|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
5423761|NCT00003602|refractory anemia with excess blasts|refractory anemia with excess blasts
5423762|NCT00003602|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
5423763|NCT00003602|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5423764|NCT00003602|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5423765|NCT00003602|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5423766|NCT00003596|stage II anal cancer|stage ii anal cancer
5423767|NCT00003596|stage III anal cancer|stage iii anal cancer
5423768|NCT00003596|squamous cell carcinoma of the anus|squamous cell carcinoma of the anus
5423769|NCT00003596|cloacogenic carcinoma of the anus|cloacogenic carcinoma of the anus
5423770|NCT00003596|basaloid carcinoma of the anus|basaloid carcinoma of the anus
5423771|NCT00003593|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
5423772|NCT00003593|untreated childhood acute myeloid leukemia and other myeloid malignancies|untreated childhood acute myeloid leukemia and other myeloid malignancies
5423773|NCT00003593|childhood acute myeloblastic leukemia without maturation (M1)|childhood acute myeloblastic leukemia without maturation (m1)
5423774|NCT00003593|childhood acute myeloblastic leukemia with maturation (M2)|childhood acute myeloblastic leukemia with maturation (m2)
5423775|NCT00003593|childhood acute myelomonocytic leukemia (M4)|childhood acute myelomonocytic leukemia (m4)
5423776|NCT00003593|childhood acute erythroleukemia (M6)|childhood acute erythroleukemia (m6)
5423777|NCT00003593|childhood acute megakaryocytic leukemia (M7)|childhood acute megakaryocytic leukemia (m7)
5423778|NCT00003593|refractory anemia|refractory anemia
5423779|NCT00003593|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
5423780|NCT00003593|refractory anemia with excess blasts|refractory anemia with excess blasts
5423781|NCT00003593|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
5423782|NCT00003593|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5423783|NCT00003593|childhood acute minimally differentiated myeloid leukemia (M0)|childhood acute minimally differentiated myeloid leukemia (m0)
5423784|NCT00003593|childhood acute monocytic leukemia (M5b)|childhood acute monocytic leukemia (m5b)
5423785|NCT00003593|childhood acute monoblastic leukemia (M5a)|childhood acute monoblastic leukemia (m5a)
5423786|NCT00003593|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
5423787|NCT00003593|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
5423788|NCT00003593|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5423789|NCT00003593|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5423790|NCT00003590|recurrent adult brain tumor|recurrent adult brain tumor
5423791|NCT00003590|adult grade I meningioma|adult grade i meningioma
5423792|NCT00003577|stage I breast cancer|stage i breast cancer
5423793|NCT00003577|stage II breast cancer|stage ii breast cancer
5423794|NCT00003576|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
5423795|NCT00003576|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5423796|NCT00003576|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
5423797|NCT00003576|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5423798|NCT00003576|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
5423799|NCT00003576|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5423800|NCT00003576|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
5423801|NCT00003576|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5423802|NCT00003576|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
5423803|NCT00003576|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
5423804|NCT00003569|stage III non-small cell lung cancer|stage iii non-small cell lung cancer
5423805|NCT00003569|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5423806|NCT00003569|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5423807|NCT00003569|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5423808|NCT00003569|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5423809|NCT00003569|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5423810|NCT00003569|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
5423811|NCT00003569|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5423812|NCT00003569|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
5423813|NCT00003569|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
5423814|NCT00003569|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5423815|NCT00003569|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
5423816|NCT00003569|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
5423817|NCT00003569|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
5423818|NCT00003569|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
5442100|NCT00005777|Prematurity|prematurity
5423819|NCT00003569|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
5423820|NCT00003569|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5423821|NCT00003569|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
5423822|NCT00003569|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
5423823|NCT00003569|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5423824|NCT00003569|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
5423825|NCT00003569|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
5423826|NCT00003569|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
5423827|NCT00003569|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
5423828|NCT00003569|neurotoxicity|neurotoxicity
5423829|NCT00003569|recurrent salivary gland cancer|recurrent salivary gland cancer
5423830|NCT00003569|stage IV salivary gland cancer|stage iv salivary gland cancer
5423831|NCT00003569|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
5423832|NCT00003569|stage III salivary gland cancer|stage iii salivary gland cancer
5423833|NCT00003568|stage IV melanoma|stage iv melanoma
5423834|NCT00003568|recurrent melanoma|recurrent melanoma
5423835|NCT00003567|recurrent adult brain tumor|recurrent adult brain tumor
5423836|NCT00003567|adult brain stem glioma|adult brain stem glioma
5423837|NCT00003567|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5423838|NCT00003567|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5423839|NCT00003567|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5423840|NCT00003567|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5423841|NCT00003567|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5423842|NCT00003567|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5423843|NCT00003567|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5423844|NCT00003567|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5423845|NCT00003567|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5423846|NCT00003567|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5423847|NCT00003567|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5423848|NCT00003567|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5423849|NCT00003567|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5423850|NCT00003567|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5423851|NCT00003567|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5423852|NCT00003567|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5423853|NCT00003567|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5423854|NCT00003567|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5423855|NCT00003567|adult mixed glioma|adult mixed glioma
5423856|NCT00003567|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5423857|NCT00003567|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5423858|NCT00003567|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5423859|NCT00003567|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5423860|NCT00003567|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
5423861|NCT00003567|adult glioblastoma|adult glioblastoma
5423862|NCT00003567|adult pilocytic astrocytoma|adult pilocytic astrocytoma
5423863|NCT00003567|adult subependymoma|adult subependymoma
5423864|NCT00003567|adult anaplastic ependymoma|adult anaplastic ependymoma
5423865|NCT00003567|adult myxopapillary ependymoma|adult myxopapillary ependymoma
5423866|NCT00003567|adult ependymoblastoma|adult ependymoblastoma
5423867|NCT00003567|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5423868|NCT00003567|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5423869|NCT00003567|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5423870|NCT00003567|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5423871|NCT00003567|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5423872|NCT00003567|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5423873|NCT00003567|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5423874|NCT00003567|adult oligodendroglioma|adult oligodendroglioma
5423875|NCT00003567|adult giant cell glioblastoma|adult giant cell glioblastoma
5423876|NCT00003567|adult gliosarcoma|adult gliosarcoma
5423877|NCT00003567|adult diffuse astrocytoma|adult diffuse astrocytoma
5423878|NCT00003566|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5423879|NCT00003565|stage IV breast cancer|stage iv breast cancer
5423880|NCT00003565|stage IIIA breast cancer|stage iiia breast cancer
5423881|NCT00003565|recurrent breast cancer|recurrent breast cancer
5423882|NCT00003565|stage IIIB breast cancer|stage iiib breast cancer
5423883|NCT00003565|stage IIIC breast cancer|stage iiic breast cancer
5423884|NCT00003565|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5423885|NCT00003565|extensive stage small cell lung cancer|extensive stage small cell lung cancer
5424282|NCT00003458|Astrocytoma pilocytic|astrocytoma pilocytic
5423886|NCT00003565|recurrent small cell lung cancer|recurrent small cell lung cancer
5423887|NCT00003565|stage III bladder cancer|stage iii bladder cancer
5423888|NCT00003565|recurrent bladder cancer|recurrent bladder cancer
5423889|NCT00003565|stage IV bladder cancer|stage iv bladder cancer
5423890|NCT00003565|stage IV nasopharyngeal cancer|stage iv nasopharyngeal cancer
5423891|NCT00003565|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5423892|NCT00003565|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5423893|NCT00003565|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5423894|NCT00003565|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5423895|NCT00003565|untreated metastatic squamous neck cancer with occult primary|untreated metastatic squamous neck cancer with occult primary
5423896|NCT00003565|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
5423897|NCT00003565|pulmonary carcinoid tumor|pulmonary carcinoid tumor
5423898|NCT00003565|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
5423899|NCT00003565|stage III basal cell carcinoma of the lip|stage iii basal cell carcinoma of the lip
5423900|NCT00003565|stage III verrucous carcinoma of the oral cavity|stage iii verrucous carcinoma of the oral cavity
5423901|NCT00003565|stage III mucoepidermoid carcinoma of the oral cavity|stage iii mucoepidermoid carcinoma of the oral cavity
5423902|NCT00003565|stage III adenoid cystic carcinoma of the oral cavity|stage iii adenoid cystic carcinoma of the oral cavity
5423903|NCT00003565|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5423904|NCT00003565|stage IV basal cell carcinoma of the lip|stage iv basal cell carcinoma of the lip
5423905|NCT00003565|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
5423906|NCT00003565|stage IV mucoepidermoid carcinoma of the oral cavity|stage iv mucoepidermoid carcinoma of the oral cavity
5423907|NCT00003565|stage IV adenoid cystic carcinoma of the oral cavity|stage iv adenoid cystic carcinoma of the oral cavity
5423908|NCT00003565|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
5423909|NCT00003565|recurrent basal cell carcinoma of the lip|recurrent basal cell carcinoma of the lip
5423910|NCT00003565|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
5423911|NCT00003565|recurrent mucoepidermoid carcinoma of the oral cavity|recurrent mucoepidermoid carcinoma of the oral cavity
5423912|NCT00003565|recurrent adenoid cystic carcinoma of the oral cavity|recurrent adenoid cystic carcinoma of the oral cavity
5423913|NCT00003565|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
5423914|NCT00003565|stage III lymphoepithelioma of the oropharynx|stage iii lymphoepithelioma of the oropharynx
5423915|NCT00003565|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5423916|NCT00003565|stage IV lymphoepithelioma of the oropharynx|stage iv lymphoepithelioma of the oropharynx
5423917|NCT00003565|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
5423918|NCT00003565|recurrent lymphoepithelioma of the oropharynx|recurrent lymphoepithelioma of the oropharynx
5423919|NCT00003565|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
5423920|NCT00003565|stage III lymphoepithelioma of the nasopharynx|stage iii lymphoepithelioma of the nasopharynx
5423921|NCT00003565|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
5423922|NCT00003565|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
5423923|NCT00003565|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
5423924|NCT00003565|recurrent lymphoepithelioma of the nasopharynx|recurrent lymphoepithelioma of the nasopharynx
5423925|NCT00003565|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
5423926|NCT00003565|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5423927|NCT00003565|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
5423928|NCT00003565|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
5423929|NCT00003565|stage III verrucous carcinoma of the larynx|stage iii verrucous carcinoma of the larynx
5423930|NCT00003565|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5423931|NCT00003565|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
5423932|NCT00003565|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
5423933|NCT00003565|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
5423934|NCT00003565|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
5423935|NCT00003565|stage III inverted papilloma of the paranasal sinus and nasal cavity|stage iii inverted papilloma of the paranasal sinus and nasal cavity
5423936|NCT00003565|stage III midline lethal granuloma of the paranasal sinus and nasal cavity|stage iii midline lethal granuloma of the paranasal sinus and nasal cavity
5423937|NCT00003565|stage III esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iii esthesioneuroblastoma of the paranasal sinus and nasal cavity
5423938|NCT00003565|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
5423939|NCT00003565|stage IV inverted papilloma of the paranasal sinus and nasal cavity|stage iv inverted papilloma of the paranasal sinus and nasal cavity
5423940|NCT00003565|stage IV midline lethal granuloma of the paranasal sinus and nasal cavity|stage iv midline lethal granuloma of the paranasal sinus and nasal cavity
5423941|NCT00003565|stage IV esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iv esthesioneuroblastoma of the paranasal sinus and nasal cavity
5423942|NCT00003565|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
5423943|NCT00003565|recurrent inverted papilloma of the paranasal sinus and nasal cavity|recurrent inverted papilloma of the paranasal sinus and nasal cavity
5423944|NCT00003565|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity
5423945|NCT00003565|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity
5423946|NCT00003565|recurrent salivary gland cancer|recurrent salivary gland cancer
5423947|NCT00003565|stage III salivary gland cancer|stage iii salivary gland cancer
5423948|NCT00003565|stage IV salivary gland cancer|stage iv salivary gland cancer
5423949|NCT00003560|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5423950|NCT00003560|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5423951|NCT00003560|stage III endometrial carcinoma|stage iii endometrial carcinoma
5423952|NCT00003560|stage IV endometrial carcinoma|stage iv endometrial carcinoma
5423953|NCT00003560|endometrial papillary serous carcinoma|endometrial papillary serous carcinoma
5423955|NCT00003560|primary peritoneal cavity cancer|primary peritoneal cavity cancer
5423956|NCT00003558|adenocarcinoma of unknown primary|adenocarcinoma of unknown primary
5423957|NCT00003558|newly diagnosed carcinoma of unknown primary|newly diagnosed carcinoma of unknown primary
5423958|NCT00003553|stage IV renal cell cancer|stage iv renal cell cancer
5423959|NCT00003553|recurrent renal cell cancer|recurrent renal cell cancer
5423960|NCT00003538|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
5423961|NCT00003538|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
5423962|NCT00003538|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5423963|NCT00003538|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5423964|NCT00003538|stage IV breast cancer|stage iv breast cancer
5423965|NCT00003538|stage IIIA breast cancer|stage iiia breast cancer
5423966|NCT00003538|stage IIIB breast cancer|stage iiib breast cancer
5423967|NCT00003538|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5423968|NCT00003538|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5423969|NCT00003538|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
5423970|NCT00003538|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
5423971|NCT00003538|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5423972|NCT00003538|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5423973|NCT00003538|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5423974|NCT00003538|disseminated neuroblastoma|disseminated neuroblastoma
5423975|NCT00003538|recurrent neuroblastoma|recurrent neuroblastoma
5423976|NCT00003538|recurrent Wilms tumor and other childhood kidney tumors|recurrent wilms tumor and other childhood kidney tumors
5423977|NCT00003538|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
5423978|NCT00003538|stage I multiple myeloma|stage i multiple myeloma
5423979|NCT00003538|stage II multiple myeloma|stage ii multiple myeloma
5423980|NCT00003538|stage III multiple myeloma|stage iii multiple myeloma
5423981|NCT00003538|stage I childhood lymphoblastic lymphoma|stage i childhood lymphoblastic lymphoma
5423982|NCT00003538|stage III childhood lymphoblastic lymphoma|stage iii childhood lymphoblastic lymphoma
5423983|NCT00003538|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
5423984|NCT00003538|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
5423985|NCT00003538|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5423986|NCT00003538|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5423987|NCT00003538|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5423988|NCT00003538|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5423989|NCT00003538|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
5423990|NCT00003538|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
5423991|NCT00003538|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5423992|NCT00003538|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5423993|NCT00003538|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5423994|NCT00003538|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
5423995|NCT00003538|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
5423996|NCT00003538|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
5423997|NCT00003538|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5423998|NCT00003538|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5423999|NCT00003538|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
5424000|NCT00003538|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
5424001|NCT00003538|myelodysplastic syndromes|myelodysplastic syndromes
5424002|NCT00003538|Philadelphia chromosome positive chronic myelogenous leukemia|philadelphia chromosome positive chronic myelogenous leukemia
5424003|NCT00003538|Philadelphia chromosome negative chronic myelogenous leukemia|philadelphia chromosome negative chronic myelogenous leukemia
5424004|NCT00003538|untreated hairy cell leukemia|untreated hairy cell leukemia
5424005|NCT00003538|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
5424006|NCT00003538|refractory hairy cell leukemia|refractory hairy cell leukemia
5424007|NCT00003538|stage II childhood Hodgkin lymphoma|stage ii childhood hodgkin lymphoma
5424008|NCT00003538|stage I childhood Hodgkin lymphoma|stage i childhood hodgkin lymphoma
5424009|NCT00003538|stage III childhood Hodgkin lymphoma|stage iii childhood hodgkin lymphoma
5424010|NCT00003538|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
5424011|NCT00003538|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
5424012|NCT00003538|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
5424013|NCT00003538|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
5424014|NCT00003538|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
5424015|NCT00003538|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
5424016|NCT00003538|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
5424017|NCT00003538|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
5424018|NCT00003538|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
5424019|NCT00003538|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
5424020|NCT00003538|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
5424021|NCT00003538|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
5424022|NCT00003538|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5424023|NCT00003538|acute undifferentiated leukemia|acute undifferentiated leukemia
5424024|NCT00003538|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5424025|NCT00003538|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5424026|NCT00003538|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5424027|NCT00003538|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5424028|NCT00003538|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5424029|NCT00003538|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5424030|NCT00003538|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5424031|NCT00003538|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5424032|NCT00003538|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5424033|NCT00003538|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5424034|NCT00003538|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5424035|NCT00003538|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5424036|NCT00003538|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5424037|NCT00003538|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5424038|NCT00003538|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5424039|NCT00003538|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5424040|NCT00003538|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5424041|NCT00003538|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5424042|NCT00003538|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5424043|NCT00003538|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5424044|NCT00003538|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5424045|NCT00003538|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5424046|NCT00003538|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5424047|NCT00003538|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5424048|NCT00003538|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5424049|NCT00003538|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5424050|NCT00003538|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5424051|NCT00003538|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5424052|NCT00003538|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
5424053|NCT00003538|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
5424054|NCT00003538|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
5424055|NCT00003538|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5424056|NCT00003538|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5424057|NCT00003538|poor prognosis metastatic gestational trophoblastic tumor|poor prognosis metastatic gestational trophoblastic tumor
5424058|NCT00003538|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5424059|NCT00003538|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5424060|NCT00003538|anemia|anemia
5424061|NCT00003538|graft versus host disease|graft versus host disease
5424062|NCT00003538|prolymphocytic leukemia|prolymphocytic leukemia
5424063|NCT00003538|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
5424064|NCT00003538|AIDS-related primary CNS lymphoma|aids-related primary cns lymphoma
5424065|NCT00003538|stage I childhood large cell lymphoma|stage i childhood large cell lymphoma
5424066|NCT00003538|stage III childhood large cell lymphoma|stage iii childhood large cell lymphoma
5424067|NCT00003538|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
5424068|NCT00003538|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
5424069|NCT00003538|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
5424070|NCT00003538|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
5424071|NCT00003538|non-Hodgkin lymphoma during pregnancy|non-hodgkin lymphoma during pregnancy
5424072|NCT00003538|stage I mantle cell lymphoma|stage i mantle cell lymphoma
5424073|NCT00003538|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
5424074|NCT00003538|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
5424075|NCT00003538|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
5424076|NCT00003538|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
5424077|NCT00003538|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
5424078|NCT00003538|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
5424079|NCT00003538|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
5424080|NCT00003538|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
5424081|NCT00003538|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
5424082|NCT00003538|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
5424083|NCT00003538|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5424084|NCT00003538|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5424085|NCT00003538|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5424086|NCT00003538|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
5424087|NCT00003538|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5424088|NCT00003538|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
5424089|NCT00003538|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
5424090|NCT00003538|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5424091|NCT00003538|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
5424092|NCT00003538|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
5424093|NCT00003538|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5424094|NCT00003538|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5424095|NCT00003538|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5424096|NCT00003538|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
5424097|NCT00003538|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5424098|NCT00003538|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
5424099|NCT00003538|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
5424100|NCT00003538|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
5424101|NCT00003538|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5424102|NCT00003538|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5424103|NCT00003538|stage I marginal zone lymphoma|stage i marginal zone lymphoma
5424104|NCT00003538|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
5424105|NCT00003538|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5424106|NCT00003538|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5424107|NCT00003538|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5424108|NCT00003538|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
5424109|NCT00003538|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
5424110|NCT00003538|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5424111|NCT00003538|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5424112|NCT00003538|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5424113|NCT00003538|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
5424114|NCT00003537|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5424115|NCT00003535|childhood anaplastic astrocytoma|childhood anaplastic astrocytoma
5424116|NCT00003535|childhood glioblastoma multiforme|childhood glioblastoma multiforme
5424117|NCT00003534|Refractory stage IV prostate cancer|refractory stage iv prostate cancer
5424118|NCT00003533|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5424119|NCT00003532|Stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5424120|NCT00003532|Stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5424121|NCT00003532|Stage III ovarian germ cell tumor|stage iii ovarian germ cell tumor
5424122|NCT00003532|Stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
5424123|NCT00003531|Adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
5424124|NCT00003530|Childhood primary liver cancer|childhood primary liver cancer
5424125|NCT00003530|Adult primary liver cancer|adult primary liver cancer
5424126|NCT00003525|recurrent cervical cancer|recurrent cervical cancer
5424127|NCT00003525|recurrent vulvar cancer|recurrent vulvar cancer
5424128|NCT00003524|Stage III and IV Stomach (Gastric) Cancer|stage iii and iv stomach (gastric) cancer
5424129|NCT00003524|Recurrent Stomach (Gastric) Cancer|recurrent stomach (gastric) cancer
5424130|NCT00003522|recurrent small intestine cancer|recurrent small intestine cancer
5424131|NCT00003521|Stage III and IV Soft Tissue Sarcoma|stage iii and iv soft tissue sarcoma
5424132|NCT00003521|Recurrent Soft Tissue Sarcoma|recurrent soft tissue sarcoma
5424133|NCT00003520|stage IV renal cell cancer|stage iv renal cell cancer
5442191|NCT00005669|Body Fat|body fat
5424134|NCT00003516|Stage III or Stage IV Prostate Cancer Stage III|stage iii or stage iv prostate cancer stage iii
5424135|NCT00003516|Stage III or Stage IV Prostate Cancer Stage IV|stage iii or stage iv prostate cancer stage iv
5424136|NCT00003515|Metastatic Primitive Neuroectodermal Tumor|metastatic primitive neuroectodermal tumor
5424137|NCT00003515|Recurrent Primitive Neuroectodermal Tumor|recurrent primitive neuroectodermal tumor
5424138|NCT00003515|Refractory Primitive Neuroectodermal Tumor|refractory primitive neuroectodermal tumor
5424139|NCT00003514|ACTH-producing pituitary tumor|acth-producing pituitary tumor
5424140|NCT00003514|prolactin-producing pituitary tumor|prolactin-producing pituitary tumor
5424141|NCT00003514|growth hormone-producing pituitary tumor|growth hormone-producing pituitary tumor
5424142|NCT00003514|recurrent pituitary tumor|recurrent pituitary tumor
5424143|NCT00003514|TSH producing pituitary tumor|tsh producing pituitary tumor
5424144|NCT00003514|nonfunctioning pituitary tumor|nonfunctioning pituitary tumor
5424145|NCT00003514|somatostatinoma|somatostatinoma
5424146|NCT00003514|stage III Merkel cell carcinoma|stage iii merkel cell carcinoma
5424147|NCT00003514|recurrent Merkel cell carcinoma|recurrent merkel cell carcinoma
5424148|NCT00003514|neuroendocrine carcinoma|neuroendocrine carcinoma
5424149|NCT00003513|Metastatic Neuroblastoma|metastatic neuroblastoma
5424150|NCT00003513|Recurrent Neuroblastoma|recurrent neuroblastoma
5424151|NCT00003513|Refractory Neuroblastoma|refractory neuroblastoma
5424152|NCT00003512|Waldenstrom Macroglobulinemia Recurrent|waldenstrom macroglobulinemia recurrent
5424153|NCT00003512|Waldenstrom Macroglobulinemia Refractory|waldenstrom macroglobulinemia refractory
5424154|NCT00003511|Stage I multiple myeloma|stage i multiple myeloma
5424155|NCT00003511|Stage II multiple myeloma|stage ii multiple myeloma
5424156|NCT00003511|Stage III multiple myeloma|stage iii multiple myeloma
5424157|NCT00003509|Stage IV melanoma of the skin|stage iv melanoma of the skin
5424158|NCT00003508|advanced malignant mesothelioma|advanced malignant mesothelioma
5424159|NCT00003508|recurrent malignant mesothelioma|recurrent malignant mesothelioma
5424160|NCT00003501|Refractory Non-Hodgkin's Lymphoma|refractory non-hodgkin's lymphoma
5424161|NCT00003501|Recurrent Non-Hodgkin's Lymphoma|recurrent non-hodgkin's lymphoma
5424162|NCT00003501|High-Grade Stage II - IV Non-Hodgkin's Lymphoma|high-grade stage ii - iv non-hodgkin's lymphoma
5424163|NCT00003500|Refractory Non-Hodgkin's Lymphoma|refractory non-hodgkin's lymphoma
5424164|NCT00003500|Recurrent Non-Hodgkin's Lymphoma|recurrent non-hodgkin's lymphoma
5424165|NCT00003500|Intermediate-Grade Stage II - IV Non-Hodgkin's Lymphoma|intermediate-grade stage ii - iv non-hodgkin's lymphoma
5424166|NCT00003499|Low-grade non-Hodgkin's lymphoma|low-grade non-hodgkin's lymphoma
5424167|NCT00003498|Non Hodgkin Lymphoma Recurrent|non hodgkin lymphoma recurrent
5424168|NCT00003498|Non Hodgkin Lymphoma Refractory|non hodgkin lymphoma refractory
5424169|NCT00003497|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5424170|NCT00003496|recurrent small cell lung cancer|recurrent small cell lung cancer
5424171|NCT00003495|recurrent lung cancer|recurrent lung cancer
5424172|NCT00003494|Bronchial Alveolar Cancer Recurrent|bronchial alveolar cancer recurrent
5424173|NCT00003494|Bronchial Alveolar Cancer Stage IV|bronchial alveolar cancer stage iv
5424174|NCT00003492|Stage IV large cell lung cancer|stage iv large cell lung cancer
5424175|NCT00003492|Stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5424176|NCT00003491|non-small cell adenocarcinoma of the lung|non-small cell adenocarcinoma of the lung
5424177|NCT00003489|Advanced Head and Neck Cancer|advanced head and neck cancer
5424178|NCT00003489|Recurrent Head and Neck Cancer|recurrent head and neck cancer
5424179|NCT00003489|Oral Cavity Cancer|oral cavity cancer
5424180|NCT00003489|Nasopharyngeal Cancer|nasopharyngeal cancer
5424181|NCT00003489|Hypopharyngeal Cancer|hypopharyngeal cancer
5424182|NCT00003489|Laryngeal Cancer|laryngeal cancer
5424183|NCT00003489|Nasal Cavity Cancer|nasal cavity cancer
5424184|NCT00003489|Paranasal Sinus Cancer|paranasal sinus cancer
5424185|NCT00003489|Oropharyngeal Cancer|oropharyngeal cancer
5424186|NCT00003489|Salivary Gland Cancer|salivary gland cancer
5424187|NCT00003489|Stage IV Head and Neck Cancer|stage iv head and neck cancer
5424188|NCT00003487|stage IV esophageal cancer|stage iv esophageal cancer
5424189|NCT00003487|recurrent esophageal cancer|recurrent esophageal cancer
5424190|NCT00003487|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
5424191|NCT00003485|stage IV colon cancer|stage iv colon cancer
5424192|NCT00003485|unresectable colon cancer|unresectable colon cancer
5424193|NCT00003483|adult meningioma|adult meningioma
5424194|NCT00003483|recurrent adult meningioma|recurrent adult meningioma
5424195|NCT00003479|Ependymoma|ependymoma
5424196|NCT00003479|Anaplastic Ependymoma|anaplastic ependymoma
5424197|NCT00003478|recurrent adult brain tumor|recurrent adult brain tumor
5424198|NCT00003478|adult brain stem glioma|adult brain stem glioma
5424199|NCT00003478|adult medulloblastoma|adult medulloblastoma
5424200|NCT00003478|adult glioblastoma|adult glioblastoma
5424201|NCT00003478|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5424202|NCT00003478|adult anaplastic ependymoma|adult anaplastic ependymoma
5424203|NCT00003478|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
5424204|NCT00003478|adult mixed glioma|adult mixed glioma
5424205|NCT00003478|adult ependymoblastoma|adult ependymoblastoma
5424206|NCT00003478|adult giant cell glioblastoma|adult giant cell glioblastoma
5424207|NCT00003478|adult gliosarcoma|adult gliosarcoma
5424208|NCT00003477|visual pathway glioma not amenable to standard therapy|visual pathway glioma not amenable to standard therapy
5424283|NCT00003458|Brain stem glioma|brain stem glioma
5424209|NCT00003477|visual pathway glioma not responding to standard therapy|visual pathway glioma not responding to standard therapy
5424210|NCT00003476|childhood anaplastic astrocytoma|childhood anaplastic astrocytoma
5424211|NCT00003476|recurrent childhood anaplastic astrocytoma|recurrent childhood anaplastic astrocytoma
5424212|NCT00003476|childhood glioblastoma multiforme|childhood glioblastoma multiforme
5424213|NCT00003476|recurrent childhood glioblastoma multiforme|recurrent childhood glioblastoma multiforme
5424214|NCT00003476|childhood brainstem glioma|childhood brainstem glioma
5424215|NCT00003476|recurrent childhood brainstem glioma|recurrent childhood brainstem glioma
5424216|NCT00003476|childhood primitive neuroectodermal tumor|childhood primitive neuroectodermal tumor
5424217|NCT00003476|recurrent childhood primitive neuroectodermal tumor|recurrent childhood primitive neuroectodermal tumor
5424218|NCT00003475|adult glioblastoma multiforme|adult glioblastoma multiforme
5424219|NCT00003475|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5424220|NCT00003475|adult anaplastic astrocytoma/Mixed|adult anaplastic astrocytoma/mixed
5424221|NCT00003474|adult glioblastoma|adult glioblastoma
5424222|NCT00003474|recurrent glioblastoma|recurrent glioblastoma
5424223|NCT00003473|recurrent adult mixed glioma|recurrent adult mixed glioma
5424224|NCT00003473|refractoy adult mixed glioma|refractoy adult mixed glioma
5424225|NCT00003472|Recurrent/progressive adult oligodendroglioma|recurrent/progressive adult oligodendroglioma
5424226|NCT00003472|Recurrent/progressive adult anaplastic oligodendroglioma|recurrent/progressive adult anaplastic oligodendroglioma
5424227|NCT00003471|Recurrent/progressive adult low grade astrocytoma|recurrent/progressive adult low grade astrocytoma
5424228|NCT00003470|persistent anaplastic astrocytoma|persistent anaplastic astrocytoma
5424229|NCT00003470|recurrent anaplastic astrocytoma|recurrent anaplastic astrocytoma
5424230|NCT00003470|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5424231|NCT00003469|childhood rhabdoid tumor|childhood rhabdoid tumor
5424232|NCT00003468|childhood low-grade astrocytoma|childhood low-grade astrocytoma
5424233|NCT00003468|recurrent childhood astrocytoma|recurrent childhood astrocytoma
5424234|NCT00003468|persistent childhood astrocytoma|persistent childhood astrocytoma
5424235|NCT00003467|recurrent adult brain tumor|recurrent adult brain tumor
5424236|NCT00003467|adult brain stem glioma|adult brain stem glioma
5424237|NCT00003467|adult mixed glioma|adult mixed glioma
5424238|NCT00003467|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5424239|NCT00003467|adult pilocytic astrocytoma|adult pilocytic astrocytoma
5424240|NCT00003467|adult oligodendroglioma|adult oligodendroglioma
5424241|NCT00003466|recurrent adult brain tumor|recurrent adult brain tumor
5424242|NCT00003466|adult mixed glioma|adult mixed glioma
5424243|NCT00003466|childhood mixed glioma|childhood mixed glioma
5424244|NCT00003466|adult pilocytic astrocytoma|adult pilocytic astrocytoma
5424245|NCT00003466|adult subependymoma|adult subependymoma
5424543|NCT00003179|endometrial cancer|endometrial cancer
5424246|NCT00003466|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
5424247|NCT00003466|adult brain stem glioma|adult brain stem glioma
5424248|NCT00003466|recurrent childhood brain stem glioma|recurrent childhood brain stem glioma
5424249|NCT00003466|untreated childhood brain stem glioma|untreated childhood brain stem glioma
5424250|NCT00003466|recurrent childhood visual pathway and hypothalamic glioma|recurrent childhood visual pathway and hypothalamic glioma
5424251|NCT00003466|untreated childhood visual pathway and hypothalamic glioma|untreated childhood visual pathway and hypothalamic glioma
5424252|NCT00003466|adult oligodendroglioma|adult oligodendroglioma
5424253|NCT00003466|adult diffuse astrocytoma|adult diffuse astrocytoma
5424254|NCT00003462|leptomeningeal metastases|leptomeningeal metastases
5424255|NCT00003461|localized resectable neuroblastoma|localized resectable neuroblastoma
5424256|NCT00003461|recurrent neuroblastoma|recurrent neuroblastoma
5424257|NCT00003461|recurrent adult brain tumor|recurrent adult brain tumor
5424258|NCT00003461|adult craniopharyngioma|adult craniopharyngioma
5424259|NCT00003461|adult medulloblastoma|adult medulloblastoma
5424260|NCT00003461|adult meningioma|adult meningioma
5424261|NCT00003461|adult glioblastoma|adult glioblastoma
5424262|NCT00003461|adult oligodendroglioma|adult oligodendroglioma
5424263|NCT00003461|tumors metastatic to brain|tumors metastatic to brain
5424264|NCT00003461|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5424265|NCT00003461|adult mixed glioma|adult mixed glioma
5424266|NCT00003461|adult pineal parenchymal tumor|adult pineal parenchymal tumor
5424267|NCT00003461|adult central nervous system germ cell tumor|adult central nervous system germ cell tumor
5424268|NCT00003461|adult grade III meningioma|adult grade iii meningioma
5424269|NCT00003461|adult pilocytic astrocytoma|adult pilocytic astrocytoma
5424270|NCT00003461|adult giant cell glioblastoma|adult giant cell glioblastoma
5424271|NCT00003461|adult gliosarcoma|adult gliosarcoma
5424272|NCT00003461|adult pineal gland astrocytoma|adult pineal gland astrocytoma
5424273|NCT00003460|Recurrent primitive neuroectodermal tumor|recurrent primitive neuroectodermal tumor
5424274|NCT00003459|recurrent adult brain stem glioma|recurrent adult brain stem glioma
5424275|NCT00003459|untreated adult brain stem glioma|untreated adult brain stem glioma
5424276|NCT00003459|untreated childhood brain stem glioma|untreated childhood brain stem glioma
5424277|NCT00003459|recurrent childhood brain stem glioma|recurrent childhood brain stem glioma
5424278|NCT00003458|Anaplastic astrocytoma|anaplastic astrocytoma
5424279|NCT00003458|Anaplastic glioma|anaplastic glioma
5424280|NCT00003458|Anaplastic oligodendroglioma|anaplastic oligodendroglioma
5424281|NCT00003458|Astrocytoma|astrocytoma
5442192|NCT00005669|Food Intake|food intake
5424284|NCT00003458|Craniopharyngioma|craniopharyngioma
5424285|NCT00003458|Ganglioglioma|ganglioglioma
5424286|NCT00003458|Glioblastoma multiforme|glioblastoma multiforme
5424287|NCT00003458|Gliosarcoma|gliosarcoma
5424288|NCT00003458|Medulloepithelioma|medulloepithelioma
5424289|NCT00003458|Neurocytoma|neurocytoma
5424290|NCT00003458|Oligodendroglioma|oligodendroglioma
5424291|NCT00003458|Oligodendroglioma-brainstem|oligodendroglioma-brainstem
5424292|NCT00003458|Primitive neuroectodermal tumor|primitive neuroectodermal tumor
5424293|NCT00003457|Anaplastic astrocytoma|anaplastic astrocytoma
5424294|NCT00003457|Anaplastic astrocytoma/Mixed|anaplastic astrocytoma/mixed
5424295|NCT00003457|Astrocytoma|astrocytoma
5424296|NCT00003457|Astrocytoma/Pilocytic|astrocytoma/pilocytic
5424297|NCT00003457|Brainstem glioma|brainstem glioma
5424298|NCT00003457|Glioblastoma multiforme|glioblastoma multiforme
5424299|NCT00003457|Glioma|glioma
5424300|NCT00003457|Neurocytoma|neurocytoma
5424301|NCT00003457|Primitive neuroectodermal tumor|primitive neuroectodermal tumor
5424302|NCT00003457|Tectal glioma|tectal glioma
5424303|NCT00003456|adult glioblastoma|adult glioblastoma
5424304|NCT00003454|recurrent breast cancer|recurrent breast cancer
5424305|NCT00003453|recurrent adrenocortical carcinoma|recurrent adrenocortical carcinoma
5424306|NCT00003452|recurrent bladder cancer|recurrent bladder cancer
5424307|NCT00003437|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5424308|NCT00003437|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
5424309|NCT00003429|stage I cervical cancer|stage i cervical cancer
5424310|NCT00003429|stage II cervical cancer|stage ii cervical cancer
5424311|NCT00003429|recurrent cervical cancer|recurrent cervical cancer
5424312|NCT00003422|stage I rectal cancer|stage i rectal cancer
5424313|NCT00003422|stage II rectal cancer|stage ii rectal cancer
5424314|NCT00003422|stage III rectal cancer|stage iii rectal cancer
5424315|NCT00003422|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5424316|NCT00003420|stage I malignant testicular germ cell tumor|stage i malignant testicular germ cell tumor
5424317|NCT00003420|testicular teratoma|testicular teratoma
5424318|NCT00003419|AIDS-related Kaposi sarcoma|aids-related kaposi sarcoma
5424319|NCT00003417|adult glioblastoma|adult glioblastoma
5424320|NCT00003417|adult giant cell glioblastoma|adult giant cell glioblastoma
5424321|NCT00003417|adult gliosarcoma|adult gliosarcoma
5424322|NCT00003404|recurrent breast cancer|recurrent breast cancer
5424323|NCT00003404|phyllodes tumor|phyllodes tumor
5424324|NCT00003389|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
5424325|NCT00003389|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
5424326|NCT00003389|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5424327|NCT00003389|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5424328|NCT00003389|adult lymphocyte depletion Hodgkin lymphoma|adult lymphocyte depletion hodgkin lymphoma
5424329|NCT00003389|adult nodular sclerosis Hodgkin lymphoma|adult nodular sclerosis hodgkin lymphoma
5424330|NCT00003389|adult mixed cellularity Hodgkin lymphoma|adult mixed cellularity hodgkin lymphoma
5424331|NCT00003385|stage I ovarian epithelial cancer|stage i ovarian epithelial cancer
5424332|NCT00003385|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
5424333|NCT00003385|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5424334|NCT00003385|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5424335|NCT00003385|ovarian undifferentiated adenocarcinoma|ovarian undifferentiated adenocarcinoma
5424336|NCT00003385|ovarian mixed epithelial carcinoma|ovarian mixed epithelial carcinoma
5424337|NCT00003385|ovarian serous cystadenocarcinoma|ovarian serous cystadenocarcinoma
5424338|NCT00003385|ovarian mucinous cystadenocarcinoma|ovarian mucinous cystadenocarcinoma
5424339|NCT00003385|ovarian endometrioid adenocarcinoma|ovarian endometrioid adenocarcinoma
5424340|NCT00003385|ovarian clear cell cystadenocarcinoma|ovarian clear cell cystadenocarcinoma
5424341|NCT00003385|fallopian tube cancer|fallopian tube cancer
5424342|NCT00003385|primary peritoneal cavity cancer|primary peritoneal cavity cancer
5424343|NCT00003385|Brenner tumor|brenner tumor
5424344|NCT00003379|stage III cervical cancer|stage iii cervical cancer
5424345|NCT00003379|stage IB cervical cancer|stage ib cervical cancer
5424346|NCT00003379|stage IIB cervical cancer|stage iib cervical cancer
5424347|NCT00003379|stage IIA cervical cancer|stage iia cervical cancer
5424348|NCT00003379|stage IVA cervical cancer|stage iva cervical cancer
5424349|NCT00003379|cervical squamous cell carcinoma|cervical squamous cell carcinoma
5424350|NCT00003379|cervical adenocarcinoma|cervical adenocarcinoma
5424351|NCT00003379|cervical adenosquamous cell carcinoma|cervical adenosquamous cell carcinoma
5424352|NCT00003379|cervical small cell carcinoma|cervical small cell carcinoma
5424353|NCT00003377|stage III cervical cancer|stage iii cervical cancer
5424354|NCT00003377|stage IVA cervical cancer|stage iva cervical cancer
5424355|NCT00003377|cervical squamous cell carcinoma|cervical squamous cell carcinoma
5424356|NCT00003377|cervical adenocarcinoma|cervical adenocarcinoma
5424357|NCT00003377|cervical adenosquamous cell carcinoma|cervical adenosquamous cell carcinoma
5424358|NCT00003375|adult oligodendroglioma|adult oligodendroglioma
5424359|NCT00003375|adult diffuse astrocytoma|adult diffuse astrocytoma
5424360|NCT00003375|adult pilocytic astrocytoma|adult pilocytic astrocytoma
5424361|NCT00003354|stage I colon cancer|stage i colon cancer
5424362|NCT00003354|stage II colon cancer|stage ii colon cancer
5424363|NCT00003354|stage III colon cancer|stage iii colon cancer
5442492|NCT00004733|ELLDOPA|elldopa
5424364|NCT00003354|stage IV colon cancer|stage iv colon cancer
5424365|NCT00003354|stage 0 colon cancer|stage 0 colon cancer
5424366|NCT00003354|stage 0 rectal cancer|stage 0 rectal cancer
5424367|NCT00003354|stage I rectal cancer|stage i rectal cancer
5424368|NCT00003354|stage II rectal cancer|stage ii rectal cancer
5424369|NCT00003354|stage III rectal cancer|stage iii rectal cancer
5424370|NCT00003354|stage IV rectal cancer|stage iv rectal cancer
5424371|NCT00003342|stage III bladder cancer|stage iii bladder cancer
5424372|NCT00003342|stage IV bladder cancer|stage iv bladder cancer
5424373|NCT00003342|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
5424374|NCT00003342|metastatic transitional cell cancer of the renal pelvis and ureter|metastatic transitional cell cancer of the renal pelvis and ureter
5424375|NCT00003342|localized transitional cell cancer of the renal pelvis and ureter|localized transitional cell cancer of the renal pelvis and ureter
5424376|NCT00003342|regional transitional cell cancer of the renal pelvis and ureter|regional transitional cell cancer of the renal pelvis and ureter
5424377|NCT00003336|refractory anemia|refractory anemia
5424378|NCT00003336|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
5424379|NCT00003336|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5424380|NCT00003336|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5424381|NCT00003336|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5424382|NCT00003336|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
5424383|NCT00003336|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
5424384|NCT00003336|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
5424385|NCT00003335|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5424386|NCT00003335|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
5424387|NCT00003335|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5424388|NCT00003335|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5424389|NCT00003335|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5424390|NCT00003335|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5424391|NCT00003335|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
5424392|NCT00003335|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5424393|NCT00003335|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5424394|NCT00003335|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
5424395|NCT00003335|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
5424396|NCT00003335|adult acute erythroid leukemia (M6)|adult acute erythroid leukemia (m6)
5424397|NCT00003335|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
5424398|NCT00003335|childhood acute erythroleukemia (M6)|childhood acute erythroleukemia (m6)
5424399|NCT00003335|childhood acute megakaryocytic leukemia (M7)|childhood acute megakaryocytic leukemia (m7)
5424400|NCT00003335|refractory anemia with excess blasts|refractory anemia with excess blasts
5424401|NCT00003335|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
5424402|NCT00003335|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5424403|NCT00003335|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5424404|NCT00003335|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5424405|NCT00003335|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5424406|NCT00003335|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5424407|NCT00003335|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5424408|NCT00003335|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5424409|NCT00003335|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5424410|NCT00003335|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5424411|NCT00003335|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5424412|NCT00003335|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5424413|NCT00003335|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5424414|NCT00003335|graft versus host disease|graft versus host disease
5424415|NCT00003335|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
5424416|NCT00003335|childhood acute minimally differentiated myeloid leukemia (M0)|childhood acute minimally differentiated myeloid leukemia (m0)
5424417|NCT00003335|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
5424418|NCT00003335|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
5424419|NCT00003335|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5424420|NCT00003335|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
5424421|NCT00003335|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
5424422|NCT00003335|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
5424423|NCT00003335|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5424424|NCT00003335|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5424425|NCT00003335|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5424426|NCT00003335|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5424427|NCT00003335|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5424428|NCT00003335|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5424429|NCT00003335|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5424430|NCT00003335|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5424431|NCT00003335|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5424432|NCT00003335|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5424433|NCT00003335|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
5424434|NCT00003332|stage I pancreatic cancer|stage i pancreatic cancer
5424435|NCT00003332|stage II pancreatic cancer|stage ii pancreatic cancer
5424436|NCT00003332|stage III pancreatic cancer|stage iii pancreatic cancer
5424437|NCT00003332|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
5424438|NCT00003329|stage I colon cancer|stage i colon cancer
5424439|NCT00003329|stage II colon cancer|stage ii colon cancer
5424440|NCT00003329|stage III colon cancer|stage iii colon cancer
5424441|NCT00003329|stage IV colon cancer|stage iv colon cancer
5424442|NCT00003329|stage I breast cancer|stage i breast cancer
5424443|NCT00003329|stage II breast cancer|stage ii breast cancer
5424444|NCT00003329|stage IIIA breast cancer|stage iiia breast cancer
5424445|NCT00003329|stage IIIB breast cancer|stage iiib breast cancer
5424446|NCT00003329|stage IIIC breast cancer|stage iiic breast cancer
5424447|NCT00003329|stage IV breast cancer|stage iv breast cancer
5424448|NCT00003329|stage I non-small cell lung cancer|stage i non-small cell lung cancer
5424943|NCT00002854|recurrent rectal cancer|recurrent rectal cancer
5424449|NCT00003329|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
5424450|NCT00003329|stage III non-small cell lung cancer|stage iii non-small cell lung cancer
5424451|NCT00003329|limited stage small cell lung cancer|limited stage small cell lung cancer
5424452|NCT00003329|extensive stage small cell lung cancer|extensive stage small cell lung cancer
5424453|NCT00003329|stage I prostate cancer|stage i prostate cancer
5424454|NCT00003329|stage II prostate cancer|stage ii prostate cancer
5424455|NCT00003329|stage III prostate cancer|stage iii prostate cancer
5424456|NCT00003329|stage IV prostate cancer|stage iv prostate cancer
5424457|NCT00003329|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5424458|NCT00003325|stage I vulvar cancer|stage i vulvar cancer
5424459|NCT00003325|stage II vulvar cancer|stage ii vulvar cancer
5424460|NCT00003325|squamous cell carcinoma of the vulva|squamous cell carcinoma of the vulva
5424461|NCT00003309|adult medulloblastoma|adult medulloblastoma
5424462|NCT00003309|adult anaplastic ependymoma|adult anaplastic ependymoma
5424463|NCT00003309|adult ependymoma|adult ependymoma
5424464|NCT00003309|adult supratentorial primitive neuroectodermal tumor (PNET)|adult supratentorial primitive neuroectodermal tumor (pnet)
5424465|NCT00003308|metastatic osteosarcoma|metastatic osteosarcoma
5424466|NCT00003308|chondrosarcoma|chondrosarcoma
5424467|NCT00003308|stage IV renal cell cancer|stage iv renal cell cancer
5424468|NCT00003308|stage IV melanoma|stage iv melanoma
5424469|NCT00003308|tumors metastatic to brain|tumors metastatic to brain
5424470|NCT00003308|stage IV uterine sarcoma|stage iv uterine sarcoma
5424471|NCT00003308|ovarian sarcoma|ovarian sarcoma
5424472|NCT00003308|metastatic Ewing sarcoma/peripheral primitive neuroectodermal tumor|metastatic ewing sarcoma/peripheral primitive neuroectodermal tumor
5424473|NCT00003308|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
5424474|NCT00003291|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
5424475|NCT00003278|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
5424476|NCT00003278|intraocular lymphoma|intraocular lymphoma
5424477|NCT00003273|childhood infratentorial ependymoma|childhood infratentorial ependymoma
5424478|NCT00003273|childhood supratentorial ependymoma|childhood supratentorial ependymoma
5424479|NCT00003273|localized resectable neuroblastoma|localized resectable neuroblastoma
5424480|NCT00003273|regional neuroblastoma|regional neuroblastoma
5424481|NCT00003273|disseminated neuroblastoma|disseminated neuroblastoma
5424482|NCT00003273|stage 4S neuroblastoma|stage 4s neuroblastoma
5424483|NCT00003273|extraocular retinoblastoma|extraocular retinoblastoma
5424484|NCT00003273|childhood choroid plexus tumor|childhood choroid plexus tumor
5424485|NCT00003273|localized unresectable neuroblastoma|localized unresectable neuroblastoma
5424486|NCT00003273|previously untreated childhood rhabdomyosarcoma|previously untreated childhood rhabdomyosarcoma
5424487|NCT00003273|untreated childhood supratentorial primitive neuroectodermal tumor|untreated childhood supratentorial primitive neuroectodermal tumor
5424488|NCT00003273|untreated childhood medulloblastoma|untreated childhood medulloblastoma
5424489|NCT00003273|newly diagnosed childhood ependymoma|newly diagnosed childhood ependymoma
5424490|NCT00003268|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
5424491|NCT00003268|adult acute monoblastic leukemia and acute monocytic leukemia (M5)|adult acute monoblastic leukemia and acute monocytic leukemia (m5)
5424492|NCT00003268|adult acute erythroid leukemia (M6)|adult acute erythroid leukemia (m6)
5424493|NCT00003268|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
5424494|NCT00003268|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
5424495|NCT00003268|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
5424496|NCT00003268|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
5424497|NCT00003268|drug/agent toxicity by tissue/organ|drug/agent toxicity by tissue/organ
5424498|NCT00003268|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
5424499|NCT00003261|AIDS-related primary CNS lymphoma|aids-related primary cns lymphoma
5424500|NCT00003243|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5424501|NCT00003243|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
5424502|NCT00003243|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5424503|NCT00003243|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5424504|NCT00003243|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5424505|NCT00003243|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5424506|NCT00003243|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5424507|NCT00003243|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5424508|NCT00003243|acute undifferentiated leukemia|acute undifferentiated leukemia
5424509|NCT00003243|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5424510|NCT00003243|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5424511|NCT00003243|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5424512|NCT00003243|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5424513|NCT00003243|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5424514|NCT00003243|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5424515|NCT00003243|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
5424516|NCT00003243|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
5424517|NCT00003243|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
5424518|NCT00003243|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
5424519|NCT00003243|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
5424520|NCT00003243|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
5424521|NCT00003216|stage I pancreatic cancer|stage i pancreatic cancer
5424522|NCT00003216|stage II pancreatic cancer|stage ii pancreatic cancer
5424523|NCT00003216|stage III pancreatic cancer|stage iii pancreatic cancer
5424524|NCT00003216|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
5424525|NCT00003216|stage IV pancreatic cancer|stage iv pancreatic cancer
5424526|NCT00003215|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
5424527|NCT00003215|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
5424528|NCT00003215|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
5424529|NCT00003215|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5424530|NCT00003215|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5424531|NCT00003215|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5424532|NCT00003215|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5424533|NCT00003215|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5424534|NCT00003215|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5424535|NCT00003215|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
5424536|NCT00003215|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
5424537|NCT00003215|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
5424538|NCT00003215|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
5424539|NCT00003215|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
5424540|NCT00003215|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5424541|NCT00003215|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5424542|NCT00003194|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
5424544|NCT00003178|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5424545|NCT00003178|childhood acute myeloblastic leukemia without maturation (M1)|childhood acute myeloblastic leukemia without maturation (m1)
5424546|NCT00003178|childhood acute myeloblastic leukemia with maturation (M2)|childhood acute myeloblastic leukemia with maturation (m2)
5424547|NCT00003178|childhood acute promyelocytic leukemia (M3)|childhood acute promyelocytic leukemia (m3)
5424548|NCT00003178|childhood acute myelomonocytic leukemia (M4)|childhood acute myelomonocytic leukemia (m4)
5424549|NCT00003178|childhood acute monoblastic leukemia (M5a)|childhood acute monoblastic leukemia (m5a)
5424550|NCT00003178|childhood acute monocytic leukemia (M5b)|childhood acute monocytic leukemia (m5b)
5424551|NCT00003178|childhood acute erythroleukemia (M6)|childhood acute erythroleukemia (m6)
5424552|NCT00003178|childhood acute megakaryocytic leukemia (M7)|childhood acute megakaryocytic leukemia (m7)
5424553|NCT00003178|childhood acute minimally differentiated myeloid leukemia (M0)|childhood acute minimally differentiated myeloid leukemia (m0)
5424554|NCT00003174|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
5424555|NCT00003174|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
5424556|NCT00003174|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5424557|NCT00003174|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5424558|NCT00003174|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5424559|NCT00003159|stage I non-small cell lung cancer|stage i non-small cell lung cancer
5424560|NCT00003159|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
5424561|NCT00003159|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5424562|NCT00003159|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5424563|NCT00003159|stage 0 non-small cell lung cancer|stage 0 non-small cell lung cancer
5424564|NCT00003153|refractory multiple myeloma|refractory multiple myeloma
5424565|NCT00003140|stage I breast cancer|stage i breast cancer
5424566|NCT00003140|stage II breast cancer|stage ii breast cancer
5424567|NCT00003140|stage IIIA breast cancer|stage iiia breast cancer
5424568|NCT00003138|anemia|anemia
5424569|NCT00003138|refractory anemia|refractory anemia
5424570|NCT00003138|myelodysplastic syndromes|myelodysplastic syndromes
5424571|NCT00003138|erythropoietin|erythropoietin
5424572|NCT00003138|filgrastim|filgrastim
5424573|NCT00003135|stage IV breast cancer|stage iv breast cancer
5424574|NCT00003135|recurrent breast cancer|recurrent breast cancer
5424575|NCT00003135|recurrent cervical cancer|recurrent cervical cancer
5424576|NCT00003135|stage IVB cervical cancer|stage ivb cervical cancer
5424577|NCT00003135|stage IVA cervical cancer|stage iva cervical cancer
5424578|NCT00003135|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5424579|NCT00003135|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5424580|NCT00003135|stage IV endometrial carcinoma|stage iv endometrial carcinoma
5424581|NCT00003135|recurrent endometrial carcinoma|recurrent endometrial carcinoma
5424582|NCT00003135|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
5424583|NCT00003135|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
5424584|NCT00003135|male breast cancer|male breast cancer
5424585|NCT00003128|stage III uterine sarcoma|stage iii uterine sarcoma
5424586|NCT00003128|stage IV uterine sarcoma|stage iv uterine sarcoma
5424587|NCT00003128|recurrent uterine sarcoma|recurrent uterine sarcoma
5424588|NCT00003128|uterine carcinosarcoma|uterine carcinosarcoma
5424589|NCT00003122|localized resectable neuroblastoma|localized resectable neuroblastoma
5424590|NCT00003122|localized unresectable neuroblastoma|localized unresectable neuroblastoma
5424591|NCT00003119|localized resectable neuroblastoma|localized resectable neuroblastoma
5424592|NCT00003119|stage 4S neuroblastoma|stage 4s neuroblastoma
5424593|NCT00003116|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5424594|NCT00003116|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5424595|NCT00003116|refractory multiple myeloma|refractory multiple myeloma
5424596|NCT00003116|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
5424597|NCT00003116|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5424598|NCT00003116|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5424599|NCT00003116|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5424600|NCT00003116|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5424601|NCT00003116|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5424602|NCT00003116|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
5424603|NCT00003116|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
5424604|NCT00003116|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
5424605|NCT00003116|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5424606|NCT00003116|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5424607|NCT00003116|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5424608|NCT00003116|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5424609|NCT00003116|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5424610|NCT00003116|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5424611|NCT00003116|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5424612|NCT00003116|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5424613|NCT00003116|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5424614|NCT00003116|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5424615|NCT00003116|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5424616|NCT00003116|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5424617|NCT00003116|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
5424618|NCT00003116|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
5424619|NCT00003116|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5424620|NCT00003116|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
5424621|NCT00003116|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
5424622|NCT00003116|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5424623|NCT00003116|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5424624|NCT00003116|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5424625|NCT00003116|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5424626|NCT00003116|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5424627|NCT00003116|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5424701|NCT00003023|recurrent osteosarcoma|recurrent osteosarcoma
5424628|NCT00003116|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5424629|NCT00003116|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5424630|NCT00003116|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5424631|NCT00003116|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5424632|NCT00003116|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
5424633|NCT00003111|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5424634|NCT00003105|stage III bladder cancer|stage iii bladder cancer
5424635|NCT00003105|recurrent bladder cancer|recurrent bladder cancer
5424636|NCT00003105|stage IV bladder cancer|stage iv bladder cancer
5424637|NCT00003105|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
5424638|NCT00003105|metastatic transitional cell cancer of the renal pelvis and ureter|metastatic transitional cell cancer of the renal pelvis and ureter
5424944|NCT00002854|stage IV anal cancer|stage iv anal cancer
5424639|NCT00003105|regional transitional cell cancer of the renal pelvis and ureter|regional transitional cell cancer of the renal pelvis and ureter
5424640|NCT00003105|recurrent transitional cell cancer of the renal pelvis and ureter|recurrent transitional cell cancer of the renal pelvis and ureter
5424641|NCT00003104|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5424642|NCT00003104|stage IIB prostate cancer|stage iib prostate cancer
5424643|NCT00003104|stage IIA prostate cancer|stage iia prostate cancer
5424644|NCT00003096|untreated childhood supratentorial primitive neuroectodermal tumor|untreated childhood supratentorial primitive neuroectodermal tumor
5424645|NCT00003096|untreated childhood medulloblastoma|untreated childhood medulloblastoma
5424646|NCT00003093|regional neuroblastoma|regional neuroblastoma
5424647|NCT00003093|disseminated neuroblastoma|disseminated neuroblastoma
5424648|NCT00003093|stage 4S neuroblastoma|stage 4s neuroblastoma
5424649|NCT00003093|localized unresectable neuroblastoma|localized unresectable neuroblastoma
5424650|NCT00003092|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5424651|NCT00003067|recurrent adult brain tumor|recurrent adult brain tumor
5424652|NCT00003067|adult glioblastoma|adult glioblastoma
5424653|NCT00003067|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5424654|NCT00003067|adult mixed glioma|adult mixed glioma
5424655|NCT00003067|adult giant cell glioblastoma|adult giant cell glioblastoma
5424656|NCT00003067|adult gliosarcoma|adult gliosarcoma
5424657|NCT00003065|recurrent cervical cancer|recurrent cervical cancer
5424658|NCT00003065|stage IVB cervical cancer|stage ivb cervical cancer
5424659|NCT00003065|stage IVA cervical cancer|stage iva cervical cancer
5424660|NCT00003065|cervical squamous cell carcinoma|cervical squamous cell carcinoma
5424661|NCT00003065|cervical adenocarcinoma|cervical adenocarcinoma
5424662|NCT00003063|stage II colon cancer|stage ii colon cancer
5424663|NCT00003063|stage III colon cancer|stage iii colon cancer
5424664|NCT00003063|stage II rectal cancer|stage ii rectal cancer
5424665|NCT00003063|stage III rectal cancer|stage iii rectal cancer
5424666|NCT00003053|stage I non-small cell lung cancer|stage i non-small cell lung cancer
5424667|NCT00003053|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
5424668|NCT00003053|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5424669|NCT00003052|adult angiosarcoma|adult angiosarcoma
5424670|NCT00003052|adult fibrosarcoma|adult fibrosarcoma
5424671|NCT00003052|adult leiomyosarcoma|adult leiomyosarcoma
5424672|NCT00003052|adult liposarcoma|adult liposarcoma
5424673|NCT00003052|adult neurofibrosarcoma|adult neurofibrosarcoma
5424674|NCT00003052|adult synovial sarcoma|adult synovial sarcoma
5424675|NCT00003052|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
5424676|NCT00003052|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
5424677|NCT00003052|adult extraskeletal osteosarcoma|adult extraskeletal osteosarcoma
5424678|NCT00003052|adult malignant fibrous histiocytoma|adult malignant fibrous histiocytoma
5424679|NCT00003052|adult rhabdomyosarcoma|adult rhabdomyosarcoma
5424680|NCT00003052|stage I adult soft tissue sarcoma|stage i adult soft tissue sarcoma
5424681|NCT00003052|stage II adult soft tissue sarcoma|stage ii adult soft tissue sarcoma
5424682|NCT00003049|stage I pancreatic cancer|stage i pancreatic cancer
5424683|NCT00003049|stage II pancreatic cancer|stage ii pancreatic cancer
5424684|NCT00003049|stage III pancreatic cancer|stage iii pancreatic cancer
5424685|NCT00003049|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
5424686|NCT00003042|stage IIIB breast cancer|stage iiib breast cancer
5424687|NCT00003042|inflammatory breast cancer|inflammatory breast cancer
5424688|NCT00003034|localized malignant mesothelioma|localized malignant mesothelioma
5424689|NCT00003034|advanced malignant mesothelioma|advanced malignant mesothelioma
5424690|NCT00003034|recurrent malignant mesothelioma|recurrent malignant mesothelioma
5424691|NCT00003029|stage III pancreatic cancer|stage iii pancreatic cancer
5424692|NCT00003029|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
5424693|NCT00003029|stage IV pancreatic cancer|stage iv pancreatic cancer
5424694|NCT00003027|stage IV melanoma|stage iv melanoma
5424695|NCT00003026|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5424696|NCT00003023|metastatic osteosarcoma|metastatic osteosarcoma
5424697|NCT00003023|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
5424698|NCT00003023|disseminated neuroblastoma|disseminated neuroblastoma
5424699|NCT00003023|stage 4S neuroblastoma|stage 4s neuroblastoma
5424700|NCT00003023|recurrent neuroblastoma|recurrent neuroblastoma
5424702|NCT00003023|metastatic childhood soft tissue sarcoma|metastatic childhood soft tissue sarcoma
5424703|NCT00003023|recurrent childhood soft tissue sarcoma|recurrent childhood soft tissue sarcoma
5424704|NCT00003023|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
5424705|NCT00003022|metastatic osteosarcoma|metastatic osteosarcoma
5424706|NCT00003022|childhood infratentorial ependymoma|childhood infratentorial ependymoma
5424707|NCT00003022|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
5424708|NCT00003022|childhood supratentorial ependymoma|childhood supratentorial ependymoma
5424709|NCT00003022|regional neuroblastoma|regional neuroblastoma
5424710|NCT00003022|disseminated neuroblastoma|disseminated neuroblastoma
5424711|NCT00003022|stage 4S neuroblastoma|stage 4s neuroblastoma
5424712|NCT00003022|recurrent neuroblastoma|recurrent neuroblastoma
5424713|NCT00003022|retinoblastoma|retinoblastoma
5424714|NCT00003022|intraocular retinoblastoma|intraocular retinoblastoma
5424715|NCT00003022|extraocular retinoblastoma|extraocular retinoblastoma
5424716|NCT00003022|recurrent retinoblastoma|recurrent retinoblastoma
5424717|NCT00003022|extensive stage small cell lung cancer|extensive stage small cell lung cancer
5424718|NCT00003022|recurrent small cell lung cancer|recurrent small cell lung cancer
5424719|NCT00003022|recurrent osteosarcoma|recurrent osteosarcoma
5424720|NCT00003022|recurrent adult brain tumor|recurrent adult brain tumor
5424721|NCT00003022|iris melanoma|iris melanoma
5424722|NCT00003022|ciliary body and choroid melanoma, small size|ciliary body and choroid melanoma, small size
5424723|NCT00003022|ciliary body and choroid melanoma, medium/large size|ciliary body and choroid melanoma, medium/large size
5424724|NCT00003022|extraocular extension melanoma|extraocular extension melanoma
5424725|NCT00003022|recurrent intraocular melanoma|recurrent intraocular melanoma
5424726|NCT00003022|adult brain stem glioma|adult brain stem glioma
5424727|NCT00003022|adult medulloblastoma|adult medulloblastoma
5424728|NCT00003022|stage IV melanoma|stage iv melanoma
5424729|NCT00003022|recurrent melanoma|recurrent melanoma
5424730|NCT00003022|metastatic childhood soft tissue sarcoma|metastatic childhood soft tissue sarcoma
5424731|NCT00003022|recurrent childhood soft tissue sarcoma|recurrent childhood soft tissue sarcoma
5424732|NCT00003022|adult myxopapillary ependymoma|adult myxopapillary ependymoma
5424733|NCT00003022|adult anaplastic ependymoma|adult anaplastic ependymoma
5424734|NCT00003022|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
5424735|NCT00003022|adult mixed glioma|adult mixed glioma
5424736|NCT00003022|localized unresectable neuroblastoma|localized unresectable neuroblastoma
5424737|NCT00003022|adult ependymoblastoma|adult ependymoblastoma
5424738|NCT00003022|recurrent childhood brain stem glioma|recurrent childhood brain stem glioma
5424739|NCT00003022|recurrent childhood supratentorial primitive neuroectodermal tumor|recurrent childhood supratentorial primitive neuroectodermal tumor
5424740|NCT00003022|recurrent childhood visual pathway glioma|recurrent childhood visual pathway glioma
5424741|NCT00003022|recurrent childhood medulloblastoma|recurrent childhood medulloblastoma
5424742|NCT00003022|recurrent childhood visual pathway and hypothalamic glioma|recurrent childhood visual pathway and hypothalamic glioma
5424743|NCT00003022|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
5424744|NCT00003022|localized Ewing sarcoma/peripheral primitive neuroectodermal tumor|localized ewing sarcoma/peripheral primitive neuroectodermal tumor
5424745|NCT00003022|metastatic Ewing sarcoma/peripheral primitive neuroectodermal tumor|metastatic ewing sarcoma/peripheral primitive neuroectodermal tumor
5424746|NCT00003022|recurrent Ewing sarcoma/peripheral primitive neuroectodermal tumor|recurrent ewing sarcoma/peripheral primitive neuroectodermal tumor
5424747|NCT00003022|recurrent childhood ependymoma|recurrent childhood ependymoma
5424748|NCT00003022|adult oligodendroglioma|adult oligodendroglioma
5424749|NCT00003022|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5424750|NCT00003022|adult supratentorial primitive neuroectodermal tumor (PNET)|adult supratentorial primitive neuroectodermal tumor (pnet)
5424751|NCT00003022|adult diffuse astrocytoma|adult diffuse astrocytoma
5424752|NCT00003022|adult pilocytic astrocytoma|adult pilocytic astrocytoma
5424753|NCT00003022|adult giant cell glioblastoma|adult giant cell glioblastoma
5424754|NCT00003022|adult glioblastoma|adult glioblastoma
5424755|NCT00003022|adult gliosarcoma|adult gliosarcoma
5424756|NCT00003016|stage I breast cancer|stage i breast cancer
5424757|NCT00003016|stage II breast cancer|stage ii breast cancer
5424758|NCT00003016|stage IIIA breast cancer|stage iiia breast cancer
5424759|NCT00003016|stage IIIB breast cancer|stage iiib breast cancer
5424760|NCT00003016|stage IIIC breast cancer|stage iiic breast cancer
5424761|NCT00003013|stage II breast cancer|stage ii breast cancer
5424762|NCT00003013|stage IIIA breast cancer|stage iiia breast cancer
5424763|NCT00002996|pain|pain
5424764|NCT00002995|embryonal childhood rhabdomyosarcoma|embryonal childhood rhabdomyosarcoma
5424765|NCT00002995|embryonal-botryoid childhood rhabdomyosarcoma|embryonal-botryoid childhood rhabdomyosarcoma
5424766|NCT00002995|previously untreated childhood rhabdomyosarcoma|previously untreated childhood rhabdomyosarcoma
5424767|NCT00002995|adult rhabdomyosarcoma|adult rhabdomyosarcoma
5424768|NCT00002995|adult malignant mesenchymoma|adult malignant mesenchymoma
5424769|NCT00002995|childhood malignant mesenchymoma|childhood malignant mesenchymoma
5424770|NCT00002995|nonmetastatic childhood soft tissue sarcoma|nonmetastatic childhood soft tissue sarcoma
5424771|NCT00002995|stage II adult soft tissue sarcoma|stage ii adult soft tissue sarcoma
5424772|NCT00002995|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
5424773|NCT00002995|stage I adult soft tissue sarcoma|stage i adult soft tissue sarcoma
5424774|NCT00002990|stage 0 bladder cancer|stage 0 bladder cancer
5424775|NCT00002990|stage I bladder cancer|stage i bladder cancer
5424776|NCT00002990|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
5424777|NCT00002986|recurrent adult brain tumor|recurrent adult brain tumor
5424778|NCT00002982|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5424779|NCT00002982|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5424780|NCT00002982|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5424781|NCT00002982|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5424782|NCT00002982|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5424783|NCT00002982|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5424784|NCT00002981|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5424785|NCT00002981|stage IV prostate cancer|stage iv prostate cancer
5424786|NCT00002981|recurrent prostate cancer|recurrent prostate cancer
5424787|NCT00002976|stage I endometrial carcinoma|stage i endometrial carcinoma
5424788|NCT00002976|stage II endometrial carcinoma|stage ii endometrial carcinoma
5424789|NCT00002976|endometrial adenocarcinoma|endometrial adenocarcinoma
5424790|NCT00002975|basal cell carcinoma of the skin|basal cell carcinoma of the skin
5424791|NCT00002975|squamous cell carcinoma of the skin|squamous cell carcinoma of the skin
5424792|NCT00002975|actinic keratosis|actinic keratosis
5424793|NCT00002963|basal cell carcinoma of the skin|basal cell carcinoma of the skin
5424794|NCT00002963|squamous cell carcinoma of the skin|squamous cell carcinoma of the skin
5424795|NCT00002951|stage II esophageal cancer|stage ii esophageal cancer
5424796|NCT00002951|stage III esophageal cancer|stage iii esophageal cancer
5424797|NCT00002951|stage II nasopharyngeal cancer|stage ii nasopharyngeal cancer
5424798|NCT00002951|stage III nasopharyngeal cancer|stage iii nasopharyngeal cancer
5424799|NCT00002951|stage II lip and oral cavity cancer|stage ii lip and oral cavity cancer
5424800|NCT00002951|stage III lip and oral cavity cancer|stage iii lip and oral cavity cancer
5424801|NCT00002951|stage II hypopharyngeal cancer|stage ii hypopharyngeal cancer
5424802|NCT00002951|stage III hypopharyngeal cancer|stage iii hypopharyngeal cancer
5424803|NCT00002951|stage II laryngeal cancer|stage ii laryngeal cancer
5424804|NCT00002951|stage III laryngeal cancer|stage iii laryngeal cancer
5424805|NCT00002951|stage II paranasal sinus and nasal cavity cancer|stage ii paranasal sinus and nasal cavity cancer
5424806|NCT00002951|stage III paranasal sinus and nasal cavity cancer|stage iii paranasal sinus and nasal cavity cancer
5424807|NCT00002951|stage II oropharyngeal cancer|stage ii oropharyngeal cancer
5424808|NCT00002951|stage III oropharyngeal cancer|stage iii oropharyngeal cancer
5424809|NCT00002948|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5424810|NCT00002944|recurrent childhood brain stem glioma|recurrent childhood brain stem glioma
5424811|NCT00002944|recurrent childhood visual pathway glioma|recurrent childhood visual pathway glioma
5424812|NCT00002944|recurrent childhood cerebellar astrocytoma|recurrent childhood cerebellar astrocytoma
5424813|NCT00002944|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
5424814|NCT00002944|childhood low-grade cerebellar astrocytoma|childhood low-grade cerebellar astrocytoma
5424815|NCT00002944|childhood low-grade cerebral astrocytoma|childhood low-grade cerebral astrocytoma
5424816|NCT00002943|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
5424817|NCT00002943|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
5424818|NCT00002943|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5424819|NCT00002943|stage III ovarian germ cell tumor|stage iii ovarian germ cell tumor
5424820|NCT00002943|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
5424821|NCT00002943|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
5424822|NCT00002943|extragonadal germ cell tumor|extragonadal germ cell tumor
5424823|NCT00002941|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
5424824|NCT00002941|childhood diffuse large cell lymphoma|childhood diffuse large cell lymphoma
5424825|NCT00002941|childhood immunoblastic large cell lymphoma|childhood immunoblastic large cell lymphoma
5424826|NCT00002941|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
5424827|NCT00002941|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
5424828|NCT00002941|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
5424829|NCT00002938|recurrent prostate cancer|recurrent prostate cancer
5424830|NCT00002931|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
5424831|NCT00002931|testicular seminoma|testicular seminoma
5424832|NCT00002931|testicular embryonal carcinoma|testicular embryonal carcinoma
5424833|NCT00002931|testicular choriocarcinoma|testicular choriocarcinoma
5424834|NCT00002931|testicular yolk sac tumor|testicular yolk sac tumor
5424835|NCT00002931|testicular embryonal carcinoma and teratoma|testicular embryonal carcinoma and teratoma
5424836|NCT00002931|testicular embryonal carcinoma and teratoma with seminoma|testicular embryonal carcinoma and teratoma with seminoma
5424837|NCT00002931|testicular embryonal carcinoma and yolk sac tumor|testicular embryonal carcinoma and yolk sac tumor
5424838|NCT00002931|testicular embryonal carcinoma and yolk sac tumor with seminoma|testicular embryonal carcinoma and yolk sac tumor with seminoma
5424839|NCT00002931|testicular embryonal carcinoma and seminoma|testicular embryonal carcinoma and seminoma
5424840|NCT00002931|testicular yolk sac tumor and teratoma|testicular yolk sac tumor and teratoma
5442493|NCT00004733|L-dopa|l-dopa
5424841|NCT00002931|testicular yolk sac tumor and teratoma with seminoma|testicular yolk sac tumor and teratoma with seminoma
5424842|NCT00002931|testicular choriocarcinoma and yolk sac tumor|testicular choriocarcinoma and yolk sac tumor
5424843|NCT00002931|testicular choriocarcinoma and embryonal carcinoma|testicular choriocarcinoma and embryonal carcinoma
5424844|NCT00002931|testicular choriocarcinoma and teratoma|testicular choriocarcinoma and teratoma
5424845|NCT00002931|testicular choriocarcinoma and seminoma|testicular choriocarcinoma and seminoma
5424846|NCT00002931|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
5424847|NCT00002931|recurrent extragonadal non-seminomatous germ cell tumor|recurrent extragonadal non-seminomatous germ cell tumor
5424848|NCT00002931|recurrent extragonadal seminoma|recurrent extragonadal seminoma
5424849|NCT00002931|recurrent extragonadal germ cell tumor|recurrent extragonadal germ cell tumor
5424850|NCT00002931|adult teratoma|adult teratoma
5424851|NCT00002931|testicular immature teratoma|testicular immature teratoma
5424852|NCT00002931|testicular mature teratoma|testicular mature teratoma
5424853|NCT00002931|ovarian immature teratoma|ovarian immature teratoma
5424854|NCT00002931|ovarian mature teratoma|ovarian mature teratoma
5424855|NCT00002931|ovarian monodermal and highly specialized teratoma|ovarian monodermal and highly specialized teratoma
5424856|NCT00002931|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
5424857|NCT00002931|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
5424858|NCT00002931|stage IV extragonadal non-seminomatous germ cell tumor|stage iv extragonadal non-seminomatous germ cell tumor
5424859|NCT00002931|stage IV extragonadal seminoma|stage iv extragonadal seminoma
5424860|NCT00002931|adult central nervous system germ cell tumor|adult central nervous system germ cell tumor
5424861|NCT00002926|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5424862|NCT00002926|refractory anemia|refractory anemia
5424863|NCT00002926|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
5424864|NCT00002926|refractory anemia with excess blasts|refractory anemia with excess blasts
5424865|NCT00002926|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
5424866|NCT00002926|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5424867|NCT00002926|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5424868|NCT00002926|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5424869|NCT00002926|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5424870|NCT00002926|refractory cytopenia with multilineage dysplasia|refractory cytopenia with multilineage dysplasia
5424871|NCT00002926|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
5424872|NCT00002920|endometrial cancer|endometrial cancer
5424873|NCT00002920|stage I breast cancer|stage i breast cancer
5424874|NCT00002920|stage II breast cancer|stage ii breast cancer
5424875|NCT00002920|ductal breast carcinoma in situ|ductal breast carcinoma in situ
5424876|NCT00002920|lobular breast carcinoma in situ|lobular breast carcinoma in situ
5424877|NCT00002920|Paget disease of the breast|paget disease of the breast
5424878|NCT00002916|stage IB cervical cancer|stage ib cervical cancer
5424879|NCT00002916|stage IIA cervical cancer|stage iia cervical cancer
5424880|NCT00002916|cervical squamous cell carcinoma|cervical squamous cell carcinoma
5424881|NCT00002916|cervical adenocarcinoma|cervical adenocarcinoma
5424882|NCT00002916|cervical adenosquamous cell carcinoma|cervical adenosquamous cell carcinoma
5424883|NCT00002900|stage I breast cancer|stage i breast cancer
5424884|NCT00002900|stage II breast cancer|stage ii breast cancer
5424885|NCT00002900|ductal breast carcinoma|ductal breast carcinoma
5424886|NCT00002900|cardiac toxicity|cardiac toxicity
5424887|NCT00002899|tumors metastatic to brain|tumors metastatic to brain
5424888|NCT00002898|embryonal childhood rhabdomyosarcoma|embryonal childhood rhabdomyosarcoma
5424889|NCT00002898|alveolar childhood rhabdomyosarcoma|alveolar childhood rhabdomyosarcoma
5424890|NCT00002898|pleomorphic childhood rhabdomyosarcoma|pleomorphic childhood rhabdomyosarcoma
5424891|NCT00002898|mixed childhood rhabdomyosarcoma|mixed childhood rhabdomyosarcoma
5424892|NCT00002898|embryonal-botryoid childhood rhabdomyosarcoma|embryonal-botryoid childhood rhabdomyosarcoma
5424893|NCT00002898|nonmetastatic childhood soft tissue sarcoma|nonmetastatic childhood soft tissue sarcoma
5424894|NCT00002898|childhood fibrosarcoma|childhood fibrosarcoma
5424895|NCT00002898|childhood synovial sarcoma|childhood synovial sarcoma
5424896|NCT00002898|childhood malignant hemangiopericytoma|childhood malignant hemangiopericytoma
5424897|NCT00002898|childhood liposarcoma|childhood liposarcoma
5424898|NCT00002898|childhood alveolar soft-part sarcoma|childhood alveolar soft-part sarcoma
5424899|NCT00002898|childhood leiomyosarcoma|childhood leiomyosarcoma
5424900|NCT00002898|childhood neurofibrosarcoma|childhood neurofibrosarcoma
5424901|NCT00002898|childhood angiosarcoma|childhood angiosarcoma
5424902|NCT00002898|childhood epithelioid sarcoma|childhood epithelioid sarcoma
5424903|NCT00002898|childhood malignant fibrous histiocytoma of bone|childhood malignant fibrous histiocytoma of bone
5424904|NCT00002898|childhood malignant mesenchymoma|childhood malignant mesenchymoma
5424905|NCT00002898|previously untreated childhood rhabdomyosarcoma|previously untreated childhood rhabdomyosarcoma
5424906|NCT00002898|childhood desmoplastic small round cell tumor|childhood desmoplastic small round cell tumor
5424907|NCT00002898|localized Ewing sarcoma/peripheral primitive neuroectodermal tumor|localized ewing sarcoma/peripheral primitive neuroectodermal tumor
5424908|NCT00002895|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5424909|NCT00002895|primary peritoneal cavity cancer|primary peritoneal cavity cancer
5424910|NCT00002895|fallopian tube cancer|fallopian tube cancer
5424911|NCT00002894|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5424912|NCT00002894|primary peritoneal cavity cancer|primary peritoneal cavity cancer
5424913|NCT00002883|stage I gastric cancer|stage i gastric cancer
5424914|NCT00002883|stage II gastric cancer|stage ii gastric cancer
5424915|NCT00002883|stage I esophageal cancer|stage i esophageal cancer
5424916|NCT00002883|stage II esophageal cancer|stage ii esophageal cancer
5424917|NCT00002883|adenocarcinoma of the stomach|adenocarcinoma of the stomach
5424918|NCT00002883|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
5424919|NCT00002882|stage III melanoma|stage iii melanoma
5424920|NCT00002874|stage IIB prostate cancer|stage iib prostate cancer
5424921|NCT00002874|stage IIA prostate cancer|stage iia prostate cancer
5424922|NCT00002874|stage III prostate cancer|stage iii prostate cancer
5424923|NCT00002874|recurrent prostate cancer|recurrent prostate cancer
5424924|NCT00002860|stage IV melanoma|stage iv melanoma
5424925|NCT00002860|recurrent melanoma|recurrent melanoma
5424926|NCT00002855|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5424927|NCT00002855|stage III prostate cancer|stage iii prostate cancer
5424928|NCT00002855|stage IV prostate cancer|stage iv prostate cancer
5424929|NCT00002855|recurrent prostate cancer|recurrent prostate cancer
5424930|NCT00002854|stage IV colon cancer|stage iv colon cancer
5424931|NCT00002854|stage II breast cancer|stage ii breast cancer
5424932|NCT00002854|stage IV breast cancer|stage iv breast cancer
5424933|NCT00002854|stage IIIA breast cancer|stage iiia breast cancer
5424934|NCT00002854|recurrent breast cancer|recurrent breast cancer
5424935|NCT00002854|stage IV gastric cancer|stage iv gastric cancer
5424936|NCT00002854|recurrent gastric cancer|recurrent gastric cancer
5424937|NCT00002854|localized osteosarcoma|localized osteosarcoma
5424938|NCT00002854|metastatic osteosarcoma|metastatic osteosarcoma
5424939|NCT00002854|stage IIIB breast cancer|stage iiib breast cancer
5424940|NCT00002854|recurrent pancreatic cancer|recurrent pancreatic cancer
5424941|NCT00002854|stage IV rectal cancer|stage iv rectal cancer
5424942|NCT00002854|recurrent colon cancer|recurrent colon cancer
5424946|NCT00002854|stage IV esophageal cancer|stage iv esophageal cancer
5424947|NCT00002854|recurrent esophageal cancer|recurrent esophageal cancer
5424948|NCT00002854|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
5424949|NCT00002854|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
5424950|NCT00002854|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5424951|NCT00002854|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5424952|NCT00002854|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5424953|NCT00002854|recurrent Wilms tumor and other childhood kidney tumors|recurrent wilms tumor and other childhood kidney tumors
5424954|NCT00002854|advanced adult primary liver cancer|advanced adult primary liver cancer
5424955|NCT00002854|recurrent adult primary liver cancer|recurrent adult primary liver cancer
5424956|NCT00002854|recurrent osteosarcoma|recurrent osteosarcoma
5424957|NCT00002854|recurrent gallbladder cancer|recurrent gallbladder cancer
5424958|NCT00002854|recurrent extrahepatic bile duct cancer|recurrent extrahepatic bile duct cancer
5424959|NCT00002854|recurrent small intestine cancer|recurrent small intestine cancer
5424960|NCT00002854|stage II melanoma|stage ii melanoma
5424961|NCT00002854|stage III melanoma|stage iii melanoma
5424962|NCT00002854|stage IV melanoma|stage iv melanoma
5424963|NCT00002854|recurrent melanoma|recurrent melanoma
5424964|NCT00002854|metastatic Ewing sarcoma/peripheral primitive neuroectodermal tumor|metastatic ewing sarcoma/peripheral primitive neuroectodermal tumor
5424965|NCT00002854|recurrent Ewing sarcoma/peripheral primitive neuroectodermal tumor|recurrent ewing sarcoma/peripheral primitive neuroectodermal tumor
5424966|NCT00002854|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
5424967|NCT00002854|stage IV pancreatic cancer|stage iv pancreatic cancer
5424968|NCT00002851|stage I breast cancer|stage i breast cancer
5424969|NCT00002851|stage II breast cancer|stage ii breast cancer
5424970|NCT00002851|stage IIIA breast cancer|stage iiia breast cancer
5424971|NCT00002850|stage I multiple myeloma|stage i multiple myeloma
5424972|NCT00002850|stage II multiple myeloma|stage ii multiple myeloma
5424973|NCT00002850|stage III multiple myeloma|stage iii multiple myeloma
5424974|NCT00002850|infection|infection
5424975|NCT00002849|primary systemic amyloidosis|primary systemic amyloidosis
5424976|NCT00002848|stage I prostate cancer|stage i prostate cancer
5424977|NCT00002848|stage IIB prostate cancer|stage iib prostate cancer
5424978|NCT00002848|stage IIA prostate cancer|stage iia prostate cancer
5424979|NCT00002848|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
5424980|NCT00002847|stage IV renal cell cancer|stage iv renal cell cancer
5424981|NCT00002847|recurrent renal cell cancer|recurrent renal cell cancer
5424982|NCT00002846|stage IV renal cell cancer|stage iv renal cell cancer
5424983|NCT00002846|recurrent renal cell cancer|recurrent renal cell cancer
5424984|NCT00002842|stage IV colon cancer|stage iv colon cancer
5424985|NCT00002842|stage IV rectal cancer|stage iv rectal cancer
5424986|NCT00002842|recurrent colon cancer|recurrent colon cancer
5424987|NCT00002842|recurrent rectal cancer|recurrent rectal cancer
5424988|NCT00002842|liver metastases|liver metastases
5424989|NCT00002839|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
5424990|NCT00002839|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
5424991|NCT00002839|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5424992|NCT00002839|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
5424993|NCT00002839|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5424994|NCT00002810|refractory multiple myeloma|refractory multiple myeloma
5424995|NCT00002810|stage I multiple myeloma|stage i multiple myeloma
5424996|NCT00002810|stage II multiple myeloma|stage ii multiple myeloma
5424997|NCT00002810|stage III multiple myeloma|stage iii multiple myeloma
5424998|NCT00002810|primary systemic amyloidosis|primary systemic amyloidosis
5424999|NCT00002809|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5425000|NCT00002809|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5425001|NCT00002809|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5425002|NCT00002809|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5425003|NCT00002809|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5425004|NCT00002809|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5425005|NCT00002809|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5425006|NCT00002809|refractory anemia|refractory anemia
5425007|NCT00002809|refractory anemia with excess blasts|refractory anemia with excess blasts
5425008|NCT00002809|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
5425009|NCT00002809|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5425010|NCT00002809|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5425011|NCT00002809|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
5425012|NCT00002809|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
5425013|NCT00002809|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5425014|NCT00002809|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5425015|NCT00002809|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5425016|NCT00002809|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5425017|NCT00002809|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5425018|NCT00002807|stage I endometrial carcinoma|stage i endometrial carcinoma
5425019|NCT00002807|stage II endometrial carcinoma|stage ii endometrial carcinoma
5425020|NCT00002807|endometrial adenocarcinoma|endometrial adenocarcinoma
5425021|NCT00002807|endometrial adenosquamous cell carcinoma|endometrial adenosquamous cell carcinoma
5425022|NCT00002807|endometrial papillary carcinoma|endometrial papillary carcinoma
5425023|NCT00002807|endometrial clear cell carcinoma|endometrial clear cell carcinoma
5425024|NCT00002792|polycythemia vera|polycythemia vera
5425025|NCT00002792|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
5425026|NCT00002792|essential thrombocythemia|essential thrombocythemia
5425027|NCT00002792|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
5425028|NCT00002792|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
5425029|NCT00002778|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5425030|NCT00002778|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5425031|NCT00002778|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5425032|NCT00002778|Philadelphia chromosome positive chronic myelogenous leukemia|philadelphia chromosome positive chronic myelogenous leukemia
5425033|NCT00002778|Philadelphia chromosome negative chronic myelogenous leukemia|philadelphia chromosome negative chronic myelogenous leukemia
5425034|NCT00002778|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
5425035|NCT00002771|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5425036|NCT00002771|chronic myelogenous leukemia, BCR-ABL1 positive|chronic myelogenous leukemia, bcr-abl1 positive
5425037|NCT00002771|Philadelphia chromosome negative chronic myelogenous leukemia|philadelphia chromosome negative chronic myelogenous leukemia
5425038|NCT00002771|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
5425039|NCT00002766|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5425040|NCT00002766|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
5425041|NCT00002766|chronic myelogenous leukemia, BCR-ABL1 positive|chronic myelogenous leukemia, bcr-abl1 positive
5425856|NCT00051285|phosphodiesterase|phosphodiesterase
5425042|NCT00002766|T-cell adult acute lymphoblastic leukemia|t-cell adult acute lymphoblastic leukemia
5425043|NCT00002766|B-cell adult acute lymphoblastic leukemia|b-cell adult acute lymphoblastic leukemia
5425044|NCT00002766|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
5425045|NCT00002766|stage II adult lymphoblastic lymphoma|stage ii adult lymphoblastic lymphoma
5425046|NCT00002766|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5425047|NCT00002766|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5425048|NCT00002766|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
5425049|NCT00002766|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
5425050|NCT00002762|stage I breast cancer|stage i breast cancer
5425051|NCT00002762|stage II breast cancer|stage ii breast cancer
5425052|NCT00002762|perioperative/postoperative complications|perioperative/postoperative complications
5425053|NCT00002757|childhood Burkitt lymphoma|childhood burkitt lymphoma
5425054|NCT00002757|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
5425055|NCT00002757|L3 childhood acute lymphoblastic leukemia|l3 childhood acute lymphoblastic leukemia
5425056|NCT00002757|stage I childhood small noncleaved cell lymphoma|stage i childhood small noncleaved cell lymphoma
5425057|NCT00002757|stage I childhood large cell lymphoma|stage i childhood large cell lymphoma
5425058|NCT00002757|stage II childhood small noncleaved cell lymphoma|stage ii childhood small noncleaved cell lymphoma
5425059|NCT00002757|stage II childhood large cell lymphoma|stage ii childhood large cell lymphoma
5425060|NCT00002757|stage III childhood small noncleaved cell lymphoma|stage iii childhood small noncleaved cell lymphoma
5425061|NCT00002757|stage III childhood large cell lymphoma|stage iii childhood large cell lymphoma
5425062|NCT00002757|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
5425063|NCT00002757|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
5425064|NCT00002756|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
5425065|NCT00002756|acute undifferentiated leukemia|acute undifferentiated leukemia
5425066|NCT00002746|refractory anemia|refractory anemia
5425067|NCT00002746|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
5425068|NCT00002746|refractory anemia with excess blasts|refractory anemia with excess blasts
5425069|NCT00002746|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5425070|NCT00002746|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5425071|NCT00002746|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5425072|NCT00002746|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5425073|NCT00002746|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
5425074|NCT00002746|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
5425075|NCT00002746|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
5425076|NCT00002738|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5425077|NCT00002738|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
5425078|NCT00002738|recurrent osteosarcoma|recurrent osteosarcoma
5425079|NCT00002738|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
5425080|NCT00002738|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
5425081|NCT00002727|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
5425082|NCT00002720|stage I breast cancer|stage i breast cancer
5425083|NCT00002718|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5425084|NCT00002718|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
5425085|NCT00002718|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
5425086|NCT00002718|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5425087|NCT00002718|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5425088|NCT00002718|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5425089|NCT00002718|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5425090|NCT00002718|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5425091|NCT00002718|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5425092|NCT00002718|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5425093|NCT00002718|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5425094|NCT00002718|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
5425095|NCT00002718|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
5425096|NCT00002718|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5425097|NCT00002718|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5425098|NCT00002718|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5425099|NCT00002718|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5425100|NCT00002718|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5425101|NCT00002718|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5425102|NCT00002718|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
5425103|NCT00002718|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
5425104|NCT00002718|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
5425105|NCT00002718|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
5425106|NCT00002718|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5425107|NCT00002718|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
5425108|NCT00002716|stage IV colon cancer|stage iv colon cancer
5425109|NCT00002716|stage IV rectal cancer|stage iv rectal cancer
5425110|NCT00002716|recurrent colon cancer|recurrent colon cancer
5425111|NCT00002716|recurrent rectal cancer|recurrent rectal cancer
5425112|NCT00002716|adenocarcinoma of the colon|adenocarcinoma of the colon
5425113|NCT00002716|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5425114|NCT00002716|liver metastases|liver metastases
5425115|NCT00002715|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
5425116|NCT00002715|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
5425117|NCT00002715|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5425118|NCT00002715|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5425119|NCT00002715|adult lymphocyte predominant Hodgkin lymphoma|adult lymphocyte predominant hodgkin lymphoma
5425120|NCT00002715|adult lymphocyte depletion Hodgkin lymphoma|adult lymphocyte depletion hodgkin lymphoma
5425121|NCT00002715|adult nodular sclerosis Hodgkin lymphoma|adult nodular sclerosis hodgkin lymphoma
5425122|NCT00002715|adult mixed cellularity Hodgkin lymphoma|adult mixed cellularity hodgkin lymphoma
5425123|NCT00002702|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
5425124|NCT00002702|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
5425125|NCT00002702|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5425126|NCT00002702|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
5425127|NCT00002702|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
5425128|NCT00002702|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5425129|NCT00002702|tongue cancer|tongue cancer
5425130|NCT00002700|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
5425131|NCT00002700|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
5425132|NCT00002700|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5425133|NCT00002700|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5425134|NCT00002700|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
5425135|NCT00002700|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
5425136|NCT00002697|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5425137|NCT00002697|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5425138|NCT00002697|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5425139|NCT00002697|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5425140|NCT00002697|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5425141|NCT00002697|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5425142|NCT00002697|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5425143|NCT00002697|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5425144|NCT00002697|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5425145|NCT00002697|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5425146|NCT00002697|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5425147|NCT00002697|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5425148|NCT00002696|stage IIIA breast cancer|stage iiia breast cancer
5425149|NCT00002696|stage IIIB breast cancer|stage iiib breast cancer
5425150|NCT00002696|stage IIIC breast cancer|stage iiic breast cancer
5425151|NCT00002689|stage I pancreatic cancer|stage i pancreatic cancer
5425152|NCT00002689|stage II pancreatic cancer|stage ii pancreatic cancer
5425153|NCT00002689|stage III pancreatic cancer|stage iii pancreatic cancer
5425154|NCT00002689|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
5425155|NCT00002687|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
5425156|NCT00002687|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
5425157|NCT00002687|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
5425158|NCT00002687|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5425159|NCT00002687|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
5425160|NCT00002687|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
5425161|NCT00002687|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
5425162|NCT00002687|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5425163|NCT00002684|stage III bladder cancer|stage iii bladder cancer
5425164|NCT00002684|recurrent bladder cancer|recurrent bladder cancer
5425165|NCT00002684|stage IV bladder cancer|stage iv bladder cancer
5425166|NCT00002684|squamous cell carcinoma of the bladder|squamous cell carcinoma of the bladder
5425167|NCT00002684|adenocarcinoma of the bladder|adenocarcinoma of the bladder
5425168|NCT00002684|recurrent urethral cancer|recurrent urethral cancer
5425169|NCT00002684|distal urethral cancer|distal urethral cancer
5425170|NCT00002684|proximal urethral cancer|proximal urethral cancer
5425171|NCT00002684|urethral cancer associated with invasive bladder cancer|urethral cancer associated with invasive bladder cancer
5425172|NCT00002681|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5425173|NCT00002681|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5425174|NCT00002681|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5425175|NCT00002681|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5425176|NCT00002681|atypical chronic myeloid leukemia, BCR-ABL negative|atypical chronic myeloid leukemia, bcr-abl negative
5425177|NCT00002678|stage I multiple myeloma|stage i multiple myeloma
5425178|NCT00002678|stage II multiple myeloma|stage ii multiple myeloma
5425179|NCT00002678|stage III multiple myeloma|stage iii multiple myeloma
5425180|NCT00002668|stage IV breast cancer|stage iv breast cancer
5425181|NCT00002668|recurrent breast cancer|recurrent breast cancer
5425182|NCT00002668|stage IV prostate cancer|stage iv prostate cancer
5425183|NCT00002668|recurrent prostate cancer|recurrent prostate cancer
5425184|NCT00002668|pain|pain
5425185|NCT00002663|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
5442494|NCT00004733|levodopa|levodopa
5425186|NCT00002663|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
5425187|NCT00002663|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5425188|NCT00002663|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5425189|NCT00002663|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5425190|NCT00002663|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
5425191|NCT00002663|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
5425192|NCT00002663|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
5425193|NCT00002663|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
5425194|NCT00002663|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5425195|NCT00002663|childhood Burkitt lymphoma|childhood burkitt lymphoma
5425196|NCT00002663|stage I childhood lymphoblastic lymphoma|stage i childhood lymphoblastic lymphoma
5425197|NCT00002663|stage II childhood lymphoblastic lymphoma|stage ii childhood lymphoblastic lymphoma
5425198|NCT00002663|stage III childhood lymphoblastic lymphoma|stage iii childhood lymphoblastic lymphoma
5425199|NCT00002663|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
5425200|NCT00002663|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
5425201|NCT00002663|childhood diffuse large cell lymphoma|childhood diffuse large cell lymphoma
5425202|NCT00002663|childhood immunoblastic large cell lymphoma|childhood immunoblastic large cell lymphoma
5425203|NCT00002663|stage II childhood Hodgkin lymphoma|stage ii childhood hodgkin lymphoma
5425204|NCT00002663|stage I childhood Hodgkin lymphoma|stage i childhood hodgkin lymphoma
5425205|NCT00002663|stage III childhood Hodgkin lymphoma|stage iii childhood hodgkin lymphoma
5425206|NCT00002663|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
5425207|NCT00002663|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
5425208|NCT00002663|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
5425209|NCT00002663|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
5425210|NCT00002663|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
5425211|NCT00002663|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
5425212|NCT00002663|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
5425213|NCT00002663|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
5425214|NCT00002663|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
5425215|NCT00002663|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
5425216|NCT00002663|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
5425217|NCT00002663|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
5425218|NCT00002663|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5425219|NCT00002663|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5425220|NCT00002663|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5425221|NCT00002663|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5425222|NCT00002663|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5425223|NCT00002663|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5425224|NCT00002663|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5425225|NCT00002663|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5425226|NCT00002663|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5425227|NCT00002663|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5425228|NCT00002663|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5425229|NCT00002663|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5425857|NCT00051285|inhibitor|inhibitor
5425230|NCT00002663|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5425231|NCT00002663|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5425232|NCT00002663|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5425233|NCT00002663|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5425234|NCT00002663|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5425235|NCT00002663|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5425236|NCT00002663|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5425237|NCT00002663|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5425238|NCT00002663|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5425239|NCT00002663|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5425240|NCT00002663|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5425241|NCT00002663|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5425242|NCT00002663|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5425243|NCT00002663|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5425244|NCT00002663|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5425245|NCT00002663|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
5425246|NCT00002663|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
5425247|NCT00002663|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
5425248|NCT00002663|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
5425249|NCT00002663|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
5425250|NCT00002663|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
5425251|NCT00002663|HIV-associated Hodgkin lymphoma|hiv-associated hodgkin lymphoma
5425252|NCT00002663|stage I childhood small noncleaved cell lymphoma|stage i childhood small noncleaved cell lymphoma
5425253|NCT00002663|stage I childhood large cell lymphoma|stage i childhood large cell lymphoma
5425254|NCT00002663|stage II childhood small noncleaved cell lymphoma|stage ii childhood small noncleaved cell lymphoma
5425255|NCT00002663|stage II childhood large cell lymphoma|stage ii childhood large cell lymphoma
5425256|NCT00002663|stage III childhood small noncleaved cell lymphoma|stage iii childhood small noncleaved cell lymphoma
5425257|NCT00002663|stage III childhood large cell lymphoma|stage iii childhood large cell lymphoma
5425258|NCT00002663|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
5425259|NCT00002663|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
5425260|NCT00002663|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
5425261|NCT00002663|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
5425262|NCT00002663|stage I mantle cell lymphoma|stage i mantle cell lymphoma
5425263|NCT00002663|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
5425264|NCT00002663|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
5425265|NCT00002663|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
5425266|NCT00002663|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
5425267|NCT00002663|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
5425268|NCT00002663|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
5425269|NCT00002663|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
5425270|NCT00002663|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
5425271|NCT00002663|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
5425272|NCT00002663|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
5425273|NCT00002663|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5425274|NCT00002663|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5425275|NCT00002663|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5425276|NCT00002663|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
5425277|NCT00002663|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5425278|NCT00002663|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
5425279|NCT00002663|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
5425280|NCT00002663|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5425281|NCT00002663|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
5425282|NCT00002663|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
5425283|NCT00002663|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5425284|NCT00002663|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5425285|NCT00002663|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5425286|NCT00002663|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
5425287|NCT00002663|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
5425288|NCT00002663|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
5425289|NCT00002663|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
5425290|NCT00002663|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5425291|NCT00002663|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
5425292|NCT00002663|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
5425293|NCT00002663|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
5425294|NCT00002663|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
5425295|NCT00002663|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5425296|NCT00002663|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5425297|NCT00002663|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5425298|NCT00002663|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5425299|NCT00002663|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5425300|NCT00002663|stage I marginal zone lymphoma|stage i marginal zone lymphoma
5425301|NCT00002663|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
5425302|NCT00002663|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5425303|NCT00002663|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5425304|NCT00002663|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5425305|NCT00002663|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5425306|NCT00002663|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5425307|NCT00002663|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
5425308|NCT00002662|stage IV breast cancer|stage iv breast cancer
5425309|NCT00002662|stage IIIA breast cancer|stage iiia breast cancer
5425310|NCT00002662|recurrent breast cancer|recurrent breast cancer
5425311|NCT00002662|stage IIIB breast cancer|stage iiib breast cancer
5425312|NCT00002662|stage IIIC breast cancer|stage iiic breast cancer
5425313|NCT00002651|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5425314|NCT00002651|stage IV prostate cancer|stage iv prostate cancer
5425315|NCT00002651|recurrent prostate cancer|recurrent prostate cancer
5425316|NCT00002647|recurrent adult brain tumor|recurrent adult brain tumor
5425317|NCT00002647|tumors metastatic to brain|tumors metastatic to brain
5425318|NCT00002647|recurrent childhood brain stem glioma|recurrent childhood brain stem glioma
5425319|NCT00002647|recurrent childhood anaplastic astrocytoma|recurrent childhood anaplastic astrocytoma
5425320|NCT00002647|recurrent childhood anaplastic oligoastrocytoma|recurrent childhood anaplastic oligoastrocytoma
5425321|NCT00002647|recurrent childhood anaplastic oligodendroglioma|recurrent childhood anaplastic oligodendroglioma
5425322|NCT00002647|recurrent childhood cerebellar astrocytoma|recurrent childhood cerebellar astrocytoma
5425323|NCT00002647|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
5425324|NCT00002647|recurrent childhood diffuse astrocytoma|recurrent childhood diffuse astrocytoma
5425325|NCT00002647|recurrent childhood fibrillary astrocytoma|recurrent childhood fibrillary astrocytoma
5425326|NCT00002647|recurrent childhood gemistocytic astrocytoma|recurrent childhood gemistocytic astrocytoma
5425327|NCT00002647|recurrent childhood giant cell glioblastoma|recurrent childhood giant cell glioblastoma
5425328|NCT00002647|recurrent childhood glioblastoma|recurrent childhood glioblastoma
5425329|NCT00002647|recurrent childhood gliomatosis cerebri|recurrent childhood gliomatosis cerebri
5425330|NCT00002647|recurrent childhood gliosarcoma|recurrent childhood gliosarcoma
5425331|NCT00002647|recurrent childhood oligodendroglioma|recurrent childhood oligodendroglioma
5425332|NCT00002647|recurrent childhood pilocytic astrocytoma|recurrent childhood pilocytic astrocytoma
5425333|NCT00002647|recurrent childhood pilomyxoid astrocytoma|recurrent childhood pilomyxoid astrocytoma
5425334|NCT00002647|recurrent childhood pleomorphic xanthoastrocytoma|recurrent childhood pleomorphic xanthoastrocytoma
5425335|NCT00002647|recurrent childhood protoplasmic astrocytoma|recurrent childhood protoplasmic astrocytoma
5425336|NCT00002647|recurrent childhood subependymal giant cell astrocytoma|recurrent childhood subependymal giant cell astrocytoma
5425337|NCT00002647|recurrent childhood visual pathway and hypothalamic glioma|recurrent childhood visual pathway and hypothalamic glioma
5425338|NCT00002647|recurrent childhood visual pathway glioma|recurrent childhood visual pathway glioma
5425339|NCT00002647|recurrent childhood pineoblastoma|recurrent childhood pineoblastoma
5425340|NCT00002647|recurrent childhood supratentorial primitive neuroectodermal tumor|recurrent childhood supratentorial primitive neuroectodermal tumor
5425341|NCT00002647|recurrent childhood medulloblastoma|recurrent childhood medulloblastoma
5425342|NCT00002647|recurrent childhood ependymoma|recurrent childhood ependymoma
5425343|NCT00002647|recurrent childhood brain tumor|recurrent childhood brain tumor
5425344|NCT00002647|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5425345|NCT00002647|adult anaplastic ependymoma|adult anaplastic ependymoma
5425346|NCT00002647|adult anaplastic meningioma|adult anaplastic meningioma
5425347|NCT00002647|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
5425348|NCT00002647|adult brain stem glioma|adult brain stem glioma
5425349|NCT00002647|adult central nervous system germ cell tumor|adult central nervous system germ cell tumor
5425350|NCT00002647|adult choroid plexus tumor|adult choroid plexus tumor
5425351|NCT00002647|adult craniopharyngioma|adult craniopharyngioma
5425352|NCT00002647|adult diffuse astrocytoma|adult diffuse astrocytoma
5425353|NCT00002647|adult ependymoblastoma|adult ependymoblastoma
5425354|NCT00002647|adult ependymoma|adult ependymoma
5425355|NCT00002647|adult giant cell glioblastoma|adult giant cell glioblastoma
5425356|NCT00002647|adult glioblastoma|adult glioblastoma
5425357|NCT00002647|adult gliosarcoma|adult gliosarcoma
5425358|NCT00002647|adult medulloblastoma|adult medulloblastoma
5425359|NCT00002647|meningeal melanocytoma|meningeal melanocytoma
5425360|NCT00002647|adult meningeal hemangiopericytoma|adult meningeal hemangiopericytoma
5425361|NCT00002647|adult oligodendroglioma|adult oligodendroglioma
5425362|NCT00002647|adult papillary meningioma|adult papillary meningioma
5425363|NCT00002647|adult pilocytic astrocytoma|adult pilocytic astrocytoma
5425364|NCT00002647|adult pineal gland astrocytoma|adult pineal gland astrocytoma
5425365|NCT00002647|adult pineoblastoma|adult pineoblastoma
5425366|NCT00002647|adult pineocytoma|adult pineocytoma
5425367|NCT00002647|adult subependymal giant cell astrocytoma|adult subependymal giant cell astrocytoma
5425368|NCT00002647|adult subependymoma|adult subependymoma
5425369|NCT00002647|adult supratentorial primitive neuroectodermal tumor (PNET)|adult supratentorial primitive neuroectodermal tumor (pnet)
5425370|NCT00002647|childhood grade I meningioma|childhood grade i meningioma
5425371|NCT00002647|childhood grade II meningioma|childhood grade ii meningioma
5425372|NCT00002647|childhood grade III meningioma|childhood grade iii meningioma
5425373|NCT00002647|adult grade III meningioma|adult grade iii meningioma
5425374|NCT00002647|childhood central nervous system germ cell tumor|childhood central nervous system germ cell tumor
5425375|NCT00002647|childhood choroid plexus tumor|childhood choroid plexus tumor
5425376|NCT00002647|childhood craniopharyngioma|childhood craniopharyngioma
5425377|NCT00002647|childhood infratentorial ependymoma|childhood infratentorial ependymoma
5425378|NCT00002647|childhood supratentorial ependymoma|childhood supratentorial ependymoma
5425379|NCT00002647|childhood low-grade cerebral astrocytoma|childhood low-grade cerebral astrocytoma
5425380|NCT00002647|childhood high-grade cerebral astrocytoma|childhood high-grade cerebral astrocytoma
5425381|NCT00002641|adult angiosarcoma|adult angiosarcoma
5425382|NCT00002641|adult fibrosarcoma|adult fibrosarcoma
5425383|NCT00002641|adult leiomyosarcoma|adult leiomyosarcoma
5425384|NCT00002641|adult liposarcoma|adult liposarcoma
5425385|NCT00002641|adult neurofibrosarcoma|adult neurofibrosarcoma
5425386|NCT00002641|adult synovial sarcoma|adult synovial sarcoma
5425387|NCT00002641|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
5425388|NCT00002641|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
5425389|NCT00002641|adult alveolar soft-part sarcoma|adult alveolar soft-part sarcoma
5425390|NCT00002641|adult epithelioid sarcoma|adult epithelioid sarcoma
5425391|NCT00002641|adult malignant fibrous histiocytoma|adult malignant fibrous histiocytoma
5425392|NCT00002641|adult malignant hemangiopericytoma|adult malignant hemangiopericytoma
5425393|NCT00002641|adult malignant mesenchymoma|adult malignant mesenchymoma
5425394|NCT00002641|adult rhabdomyosarcoma|adult rhabdomyosarcoma
5425395|NCT00002641|localized benign pheochromocytoma|localized benign pheochromocytoma
5425396|NCT00002641|regional pheochromocytoma|regional pheochromocytoma
5425397|NCT00002641|recurrent pheochromocytoma|recurrent pheochromocytoma
5425398|NCT00002641|stage II uterine sarcoma|stage ii uterine sarcoma
5425399|NCT00002641|stage III uterine sarcoma|stage iii uterine sarcoma
5425400|NCT00002641|recurrent uterine sarcoma|recurrent uterine sarcoma
5425401|NCT00002641|uterine carcinosarcoma|uterine carcinosarcoma
5425402|NCT00002641|uterine leiomyosarcoma|uterine leiomyosarcoma
5425403|NCT00002641|endometrial stromal sarcoma|endometrial stromal sarcoma
5425404|NCT00002641|ovarian sarcoma|ovarian sarcoma
5425405|NCT00002641|clear cell sarcoma of the kidney|clear cell sarcoma of the kidney
5425406|NCT00002641|stage II adult soft tissue sarcoma|stage ii adult soft tissue sarcoma
5425407|NCT00002633|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5425408|NCT00002633|stage II prostate cancer|stage ii prostate cancer
5425409|NCT00002633|stage III prostate cancer|stage iii prostate cancer
5425410|NCT00002633|stage IV prostate cancer|stage iv prostate cancer
5425411|NCT00002624|stage I non-small cell lung cancer|stage i non-small cell lung cancer
5425412|NCT00002624|squamous cell lung cancer|squamous cell lung cancer
5425413|NCT00002624|large cell lung cancer|large cell lung cancer
5425414|NCT00002624|adenocarcinoma of the lung|adenocarcinoma of the lung
5425415|NCT00002624|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
5425416|NCT00002623|squamous cell lung cancer|squamous cell lung cancer
5425417|NCT00002623|large cell lung cancer|large cell lung cancer
5425418|NCT00002623|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5425419|NCT00002623|adenocarcinoma of the lung|adenocarcinoma of the lung
5425420|NCT00002623|adenosquamous cell lung cancer|adenosquamous cell lung cancer
5425421|NCT00002623|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
5425422|NCT00002615|stage II gastric cancer|stage ii gastric cancer
5425423|NCT00002615|stage III gastric cancer|stage iii gastric cancer
5425424|NCT00002615|adenocarcinoma of the stomach|adenocarcinoma of the stomach
5425425|NCT00002611|stage I Wilms tumor|stage i wilms tumor
5425426|NCT00002611|stage II Wilms tumor|stage ii wilms tumor
5425427|NCT00002611|stage III Wilms tumor|stage iii wilms tumor
5425428|NCT00002611|stage IV Wilms tumor|stage iv wilms tumor
5425429|NCT00002611|stage V Wilms tumor|stage v wilms tumor
5425430|NCT00002611|clear cell sarcoma of the kidney|clear cell sarcoma of the kidney
5425431|NCT00002610|recurrent Wilms tumor and other childhood kidney tumors|recurrent wilms tumor and other childhood kidney tumors
5425432|NCT00002610|clear cell sarcoma of the kidney|clear cell sarcoma of the kidney
5425433|NCT00002610|rhabdoid tumor of the kidney|rhabdoid tumor of the kidney
5425434|NCT00002608|childhood brain tumor|childhood brain tumor
5425435|NCT00002608|childhood infratentorial ependymoma|childhood infratentorial ependymoma
5425436|NCT00002608|childhood supratentorial ependymoma|childhood supratentorial ependymoma
5425437|NCT00002608|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
5425438|NCT00002608|recurrent childhood brain tumor|recurrent childhood brain tumor
5425439|NCT00002608|childhood liver cancer|childhood liver cancer
5425440|NCT00002608|stage IV childhood liver cancer|stage iv childhood liver cancer
5425441|NCT00002608|recurrent childhood liver cancer|recurrent childhood liver cancer
5425442|NCT00002608|advanced malignant mesothelioma|advanced malignant mesothelioma
5425443|NCT00002608|recurrent malignant mesothelioma|recurrent malignant mesothelioma
5425444|NCT00002608|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
5425445|NCT00002608|advanced adult primary liver cancer|advanced adult primary liver cancer
5425446|NCT00002608|recurrent adult primary liver cancer|recurrent adult primary liver cancer
5425447|NCT00002608|recurrent adult brain tumor|recurrent adult brain tumor
5425448|NCT00002608|stage IV adrenocortical carcinoma|stage iv adrenocortical carcinoma
5425449|NCT00002608|recurrent adrenocortical carcinoma|recurrent adrenocortical carcinoma
5425450|NCT00002608|stage IV papillary thyroid cancer|stage iv papillary thyroid cancer
5425451|NCT00002608|stage IV follicular thyroid cancer|stage iv follicular thyroid cancer
5425452|NCT00002608|thyroid gland medullary carcinoma|thyroid gland medullary carcinoma
5425453|NCT00002608|anaplastic thyroid cancer|anaplastic thyroid cancer
5425454|NCT00002608|recurrent thyroid cancer|recurrent thyroid cancer
5425455|NCT00002608|adult brain stem glioma|adult brain stem glioma
5425456|NCT00002608|adult medulloblastoma|adult medulloblastoma
5425457|NCT00002608|adult glioblastoma|adult glioblastoma
5425458|NCT00002608|metastatic pheochromocytoma|metastatic pheochromocytoma
5425459|NCT00002608|recurrent pheochromocytoma|recurrent pheochromocytoma
5425460|NCT00002608|childhood soft tissue sarcoma|childhood soft tissue sarcoma
5425461|NCT00002608|metastatic childhood soft tissue sarcoma|metastatic childhood soft tissue sarcoma
5425462|NCT00002608|recurrent childhood soft tissue sarcoma|recurrent childhood soft tissue sarcoma
5425463|NCT00002608|childhood high-grade cerebral astrocytoma|childhood high-grade cerebral astrocytoma
5425464|NCT00002608|childhood oligodendroglioma|childhood oligodendroglioma
5425465|NCT00002608|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5425466|NCT00002608|adult myxopapillary ependymoma|adult myxopapillary ependymoma
5425467|NCT00002608|adult anaplastic ependymoma|adult anaplastic ependymoma
5425468|NCT00002608|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
5425469|NCT00002608|adult mixed glioma|adult mixed glioma
5425470|NCT00002608|adult pilocytic astrocytoma|adult pilocytic astrocytoma
5425471|NCT00002608|adult subependymoma|adult subependymoma
5425472|NCT00002608|recurrent childhood brain stem glioma|recurrent childhood brain stem glioma
5425473|NCT00002608|recurrent childhood cerebellar astrocytoma|recurrent childhood cerebellar astrocytoma
5425474|NCT00002608|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
5425475|NCT00002608|recurrent childhood medulloblastoma|recurrent childhood medulloblastoma
5425476|NCT00002608|recurrent childhood visual pathway and hypothalamic glioma|recurrent childhood visual pathway and hypothalamic glioma
5425477|NCT00002608|recurrent childhood ependymoma|recurrent childhood ependymoma
5425478|NCT00002608|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
5425479|NCT00002608|adult oligodendroglioma|adult oligodendroglioma
5425480|NCT00002608|adult giant cell glioblastoma|adult giant cell glioblastoma
5425481|NCT00002608|adult gliosarcoma|adult gliosarcoma
5425482|NCT00002608|adult diffuse astrocytoma|adult diffuse astrocytoma
5425483|NCT00002598|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5425484|NCT00002598|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5425485|NCT00002598|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
5425486|NCT00002596|stage II malignant testicular germ cell tumor|stage ii malignant testicular germ cell tumor
5425487|NCT00002596|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
5425488|NCT00002596|testicular seminoma|testicular seminoma
5425489|NCT00002596|testicular embryonal carcinoma|testicular embryonal carcinoma
5425490|NCT00002596|testicular choriocarcinoma|testicular choriocarcinoma
5425491|NCT00002596|testicular teratoma|testicular teratoma
5425492|NCT00002596|testicular yolk sac tumor|testicular yolk sac tumor
5425493|NCT00002596|testicular embryonal carcinoma and teratoma|testicular embryonal carcinoma and teratoma
5425494|NCT00002596|testicular embryonal carcinoma and teratoma with seminoma|testicular embryonal carcinoma and teratoma with seminoma
5425495|NCT00002596|testicular embryonal carcinoma and yolk sac tumor|testicular embryonal carcinoma and yolk sac tumor
5425496|NCT00002596|testicular embryonal carcinoma and yolk sac tumor with seminoma|testicular embryonal carcinoma and yolk sac tumor with seminoma
5425497|NCT00002596|testicular embryonal carcinoma and seminoma|testicular embryonal carcinoma and seminoma
5425498|NCT00002596|testicular yolk sac tumor and teratoma|testicular yolk sac tumor and teratoma
5425499|NCT00002596|testicular yolk sac tumor and teratoma with seminoma|testicular yolk sac tumor and teratoma with seminoma
5425500|NCT00002596|testicular choriocarcinoma and yolk sac tumor|testicular choriocarcinoma and yolk sac tumor
5425501|NCT00002596|testicular choriocarcinoma and embryonal carcinoma|testicular choriocarcinoma and embryonal carcinoma
5425502|NCT00002596|testicular choriocarcinoma and teratoma|testicular choriocarcinoma and teratoma
5425503|NCT00002596|testicular choriocarcinoma and seminoma|testicular choriocarcinoma and seminoma
5425504|NCT00002596|extragonadal germ cell tumor|extragonadal germ cell tumor
5425505|NCT00002596|childhood teratoma|childhood teratoma
5425506|NCT00002596|childhood malignant testicular germ cell tumor|childhood malignant testicular germ cell tumor
5425507|NCT00002596|childhood extragonadal germ cell tumor|childhood extragonadal germ cell tumor
5425508|NCT00002594|recurrent childhood brain tumor|recurrent childhood brain tumor
5425509|NCT00002594|childhood central nervous system germ cell tumor|childhood central nervous system germ cell tumor
5425510|NCT00002594|recurrent childhood medulloblastoma|recurrent childhood medulloblastoma
5425511|NCT00002589|stage III renal cell cancer|stage iii renal cell cancer
5425512|NCT00002589|stage IV renal cell cancer|stage iv renal cell cancer
5425513|NCT00002589|recurrent renal cell cancer|recurrent renal cell cancer
5425514|NCT00002586|non-small cell lung cancer|non-small cell lung cancer
5425515|NCT00002586|small cell lung cancer|small cell lung cancer
5425516|NCT00002586|drug/agent toxicity by tissue/organ|drug/agent toxicity by tissue/organ
5425517|NCT00002569|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
5425518|NCT00002569|adult mixed glioma|adult mixed glioma
5425519|NCT00002560|recurrent neuroblastoma|recurrent neuroblastoma
5425520|NCT00002558|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
5425521|NCT00002558|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
5425522|NCT00002558|extragonadal germ cell tumor|extragonadal germ cell tumor
5425524|NCT00002546|stage II uterine sarcoma|stage ii uterine sarcoma
5425525|NCT00002546|stage III uterine sarcoma|stage iii uterine sarcoma
5425526|NCT00002546|stage IV uterine sarcoma|stage iv uterine sarcoma
5425527|NCT00002546|uterine carcinosarcoma|uterine carcinosarcoma
5425528|NCT00002544|stage IV breast cancer|stage iv breast cancer
5425529|NCT00002544|recurrent breast cancer|recurrent breast cancer
5425530|NCT00002528|stage I breast cancer|stage i breast cancer
5425531|NCT00002528|stage II breast cancer|stage ii breast cancer
5425532|NCT00002523|stage II rectal cancer|stage ii rectal cancer
5425533|NCT00002523|stage III rectal cancer|stage iii rectal cancer
5425534|NCT00002523|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5425535|NCT00002522|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
5425536|NCT00002522|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
5425537|NCT00002522|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5425538|NCT00002522|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5425539|NCT00002522|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5425540|NCT00002521|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
5425541|NCT00002521|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
5425542|NCT00002521|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
5425543|NCT00002521|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
5425544|NCT00002521|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
5425545|NCT00002521|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
5425546|NCT00002521|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5425547|NCT00002521|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5425548|NCT00002521|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5425549|NCT00002521|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5425550|NCT00002521|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5425551|NCT00002521|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5425552|NCT00002521|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5425553|NCT00002521|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5425554|NCT00002521|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5425555|NCT00002521|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5425556|NCT00002521|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5425557|NCT00002521|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5425558|NCT00002521|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5425559|NCT00002521|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5425560|NCT00002521|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5425561|NCT00002521|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5425562|NCT00002521|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5425563|NCT00002521|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5425564|NCT00002521|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
5425565|NCT00002521|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
5425566|NCT00002521|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
5425567|NCT00002521|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
5425568|NCT00002521|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
5425569|NCT00002521|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
5425570|NCT00002521|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
5425571|NCT00002521|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
5425572|NCT00002521|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
5425573|NCT00002521|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5425574|NCT00002521|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
5425575|NCT00002521|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
5425576|NCT00002517|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
5425577|NCT00002517|untreated childhood acute myeloid leukemia and other myeloid malignancies|untreated childhood acute myeloid leukemia and other myeloid malignancies
5425578|NCT00002517|childhood acute myeloblastic leukemia without maturation (M1)|childhood acute myeloblastic leukemia without maturation (m1)
5425579|NCT00002517|childhood acute myeloblastic leukemia with maturation (M2)|childhood acute myeloblastic leukemia with maturation (m2)
5425580|NCT00002517|childhood acute myelomonocytic leukemia (M4)|childhood acute myelomonocytic leukemia (m4)
5425581|NCT00002517|childhood acute monoblastic leukemia (M5a)|childhood acute monoblastic leukemia (m5a)
5425582|NCT00002517|childhood acute monocytic leukemia (M5b)|childhood acute monocytic leukemia (m5b)
5425583|NCT00002517|childhood acute erythroleukemia (M6)|childhood acute erythroleukemia (m6)
5425584|NCT00002517|childhood acute megakaryocytic leukemia (M7)|childhood acute megakaryocytic leukemia (m7)
5425585|NCT00002517|refractory anemia with excess blasts|refractory anemia with excess blasts
5425586|NCT00002517|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
5425587|NCT00002517|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5425588|NCT00002517|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5425743|NCT00051961|Motor Control|motor control
5425744|NCT00051961|Dopaminergic|dopaminergic
5425589|NCT00002517|childhood acute minimally differentiated myeloid leukemia (M0)|childhood acute minimally differentiated myeloid leukemia (m0)
5425590|NCT00002515|chondrosarcoma|chondrosarcoma
5425591|NCT00002515|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
5425592|NCT00002515|stage IV childhood liver cancer|stage iv childhood liver cancer
5425593|NCT00002515|recurrent neuroblastoma|recurrent neuroblastoma
5425594|NCT00002515|recurrent childhood liver cancer|recurrent childhood liver cancer
5425595|NCT00002515|recurrent Wilms tumor and other childhood kidney tumors|recurrent wilms tumor and other childhood kidney tumors
5425596|NCT00002515|stage IV Wilms tumor|stage iv wilms tumor
5425597|NCT00002515|recurrent retinoblastoma|recurrent retinoblastoma
5425598|NCT00002515|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
5425599|NCT00002515|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
5425600|NCT00002515|recurrent osteosarcoma|recurrent osteosarcoma
5425601|NCT00002515|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
5425602|NCT00002515|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
5425603|NCT00002515|childhood germ cell tumor|childhood germ cell tumor
5425604|NCT00002515|alveolar childhood rhabdomyosarcoma|alveolar childhood rhabdomyosarcoma
5425605|NCT00002515|recurrent childhood soft tissue sarcoma|recurrent childhood soft tissue sarcoma
5425606|NCT00002515|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
5425607|NCT00002515|childhood fibrosarcoma|childhood fibrosarcoma
5425608|NCT00002515|extragonadal germ cell tumor|extragonadal germ cell tumor
5425609|NCT00002515|childhood desmoplastic small round cell tumor|childhood desmoplastic small round cell tumor
5425610|NCT00002515|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
5425611|NCT00002515|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
5425612|NCT00002515|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
5425613|NCT00002515|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
5425614|NCT00002515|recurrent Ewing sarcoma/peripheral primitive neuroectodermal tumor|recurrent ewing sarcoma/peripheral primitive neuroectodermal tumor
5425615|NCT00002515|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
5425616|NCT00002515|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
5425617|NCT00002515|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
5425618|NCT00002515|recurrent lymphoepithelioma of the nasopharynx|recurrent lymphoepithelioma of the nasopharynx
5425619|NCT00002514|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5425620|NCT00002511|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5425621|NCT00002511|stage I prostate cancer|stage i prostate cancer
5425622|NCT00002511|stage IIB prostate cancer|stage iib prostate cancer
5425623|NCT00002511|stage IIA prostate cancer|stage iia prostate cancer
5425624|NCT00002511|stage III prostate cancer|stage iii prostate cancer
5425625|NCT00002490|stage I bladder cancer|stage i bladder cancer
5425626|NCT00002490|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
5425627|NCT00002484|stage I non-small cell lung cancer|stage i non-small cell lung cancer
5425628|NCT00002484|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
5425629|NCT00002484|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5425630|NCT00002484|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5425631|NCT00002475|stage III colon cancer|stage iii colon cancer
5425632|NCT00002475|stage IV colon cancer|stage iv colon cancer
5425633|NCT00002475|stage IV breast cancer|stage iv breast cancer
5425634|NCT00002475|stage IIIA breast cancer|stage iiia breast cancer
5425635|NCT00002475|recurrent breast cancer|recurrent breast cancer
5425636|NCT00002475|stage IIIB breast cancer|stage iiib breast cancer
5425637|NCT00002475|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5425638|NCT00002475|stage II pancreatic cancer|stage ii pancreatic cancer
5425639|NCT00002475|stage III pancreatic cancer|stage iii pancreatic cancer
5425640|NCT00002475|recurrent pancreatic cancer|recurrent pancreatic cancer
5425641|NCT00002475|recurrent colon cancer|recurrent colon cancer
5425642|NCT00002475|stage III renal cell cancer|stage iii renal cell cancer
5425643|NCT00002475|stage IV renal cell cancer|stage iv renal cell cancer
5425644|NCT00002475|recurrent renal cell cancer|recurrent renal cell cancer
5425645|NCT00002475|extensive stage small cell lung cancer|extensive stage small cell lung cancer
5425646|NCT00002475|recurrent small cell lung cancer|recurrent small cell lung cancer
5425647|NCT00002475|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5425648|NCT00002475|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5425649|NCT00002475|stage IIIC breast cancer|stage iiic breast cancer
5425650|NCT00002475|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5425651|NCT00002475|pulmonary carcinoid tumor|pulmonary carcinoid tumor
5425652|NCT00002475|recurrent malignant mesothelioma|recurrent malignant mesothelioma
5425653|NCT00002475|stage IV pancreatic cancer|stage iv pancreatic cancer
5425654|NCT00002474|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5425655|NCT00002473|stage I renal cell cancer|stage i renal cell cancer
5425656|NCT00002473|stage II renal cell cancer|stage ii renal cell cancer
5425657|NCT00002472|childhood central nervous system germ cell tumor|childhood central nervous system germ cell tumor
5425658|NCT00002472|extragonadal germ cell tumor|extragonadal germ cell tumor
5425850|NCT00051324|HD|hd
5425659|NCT00002472|adult central nervous system germ cell tumor|adult central nervous system germ cell tumor
5425660|NCT00002472|childhood teratoma|childhood teratoma
5425661|NCT00002472|childhood central nervous system choriocarcinoma|childhood central nervous system choriocarcinoma
5425662|NCT00002472|childhood central nervous system embryonal tumor|childhood central nervous system embryonal tumor
5425663|NCT00002472|childhood central nervous system germinoma|childhood central nervous system germinoma
5425664|NCT00002472|childhood central nervous system mixed germ cell tumor|childhood central nervous system mixed germ cell tumor
5425665|NCT00002472|childhood central nervous system teratoma|childhood central nervous system teratoma
5425666|NCT00002472|childhood central nervous system yolk sac tumor|childhood central nervous system yolk sac tumor
5425667|NCT00002470|metastatic gastrointestinal carcinoid tumor|metastatic gastrointestinal carcinoid tumor
5425668|NCT00002470|recurrent gastrointestinal carcinoid tumor|recurrent gastrointestinal carcinoid tumor
5425669|NCT00002470|pulmonary carcinoid tumor|pulmonary carcinoid tumor
5425670|NCT00002455|stage I colon cancer|stage i colon cancer
5425671|NCT00002455|stage II colon cancer|stage ii colon cancer
5425672|NCT00002455|stage III colon cancer|stage iii colon cancer
5425673|NCT00002455|stage I breast cancer|stage i breast cancer
5425674|NCT00002455|stage II breast cancer|stage ii breast cancer
5425675|NCT00002455|stage IIIA breast cancer|stage iiia breast cancer
5425676|NCT00002455|recurrent breast cancer|recurrent breast cancer
5425677|NCT00002455|recurrent colon cancer|recurrent colon cancer
5425678|NCT00002455|stage I melanoma|stage i melanoma
5425679|NCT00002455|stage II melanoma|stage ii melanoma
5425680|NCT00002455|stage III melanoma|stage iii melanoma
5425681|NCT00002455|recurrent melanoma|recurrent melanoma
5425682|NCT00052143|Huntington's disease|huntington's disease
5425683|NCT00052143|HD|hd
5425684|NCT00052143|Huntington disease|huntington disease
5425685|NCT00051818|chronic HIV infection|chronic hiv infection
5425686|NCT00051818|treatment interruption|treatment interruption
5425687|NCT00051818|HIV-specific immune response|hiv-specific immune response
5425688|NCT00051818|immune response|immune response
5425689|NCT00051818|virological response|virological response
5425690|NCT00051818|treatment experienced|treatment experienced
5425691|NCT00052091|Geriatrics|geriatrics
5425692|NCT00052078|Phobic Disorders|phobic disorders
5425693|NCT00052078|Anxiety, Separation|anxiety, separation
5425694|NCT00052052|idiopathic pulmonary fibrosis|idiopathic pulmonary fibrosis
5425695|NCT00052052|IPF|ipf
5425696|NCT00052026|Adolescent|adolescent
5425697|NCT00052026|Adrenergic alpha-Antagonists/therapeutic use|adrenergic alpha-antagonists/therapeutic use
5425698|NCT00052026|Adrenergic alpha-Antagonists/pharmacokinetics|adrenergic alpha-antagonists/pharmacokinetics
5425699|NCT00052026|Adrenergic alpha-Antagonists/administration & dosage|adrenergic alpha-antagonists/administration & dosage
5425700|NCT00052026|Adrenergic beta-Antagonists/therapeutic use|adrenergic beta-antagonists/therapeutic use
5425701|NCT00052026|Adrenergic beta-Antagonists/pharmacokinetics|adrenergic beta-antagonists/pharmacokinetics
5425702|NCT00052026|Adrenergic beta-Antagonists/administration & dosage|adrenergic beta-antagonists/administration & dosage
5425703|NCT00052026|Age Factors|age factors
5425704|NCT00052026|Carbazoles/therapeutic use|carbazoles/therapeutic use
5425705|NCT00052026|Carbazoles/administration & dosage|carbazoles/administration & dosage
5425706|NCT00052026|Child|child
5425707|NCT00052026|Child, Preschool|child, preschool
5425708|NCT00052026|Drug Administration Schedule|drug administration schedule
5425709|NCT00052026|Female|female
5425710|NCT00052026|Heart Failure, Congestive/etiology|heart failure, congestive/etiology
5425711|NCT00052026|Heart Failure, Congestive/drug therapy|heart failure, congestive/drug therapy
5425712|NCT00052026|Heart Failure, Congestive/blood|heart failure, congestive/blood
5425713|NCT00052026|Human|human
5425714|NCT00052026|Infant|infant
5425715|NCT00052026|Infant, Newborn|infant, newborn
5425716|NCT00052026|Male|male
5425717|NCT00052026|Natriuretic Peptide, Brain/blood|natriuretic peptide, brain/blood
5425718|NCT00052026|Placebos|placebos
5425719|NCT00052026|Propanolamines/therapeutic use|propanolamines/therapeutic use
5425720|NCT00052026|Propanolamines/administration & dosage|propanolamines/administration & dosage
5425721|NCT00052026|Prospective Studies|prospective studies
5425722|NCT00052026|Support, Non-U.S. Gov't|support, non-u.s. gov't
5425724|NCT00052026|Ventricular Dysfunction/drug therapy|ventricular dysfunction/drug therapy
5425725|NCT00052026|Ventricular Dysfunction/complications|ventricular dysfunction/complications
5425726|NCT00052026|Ventricular Dysfunction/blood|ventricular dysfunction/blood
5425727|NCT00052026|Ventricular Function/drug effects|ventricular function/drug effects
5425728|NCT00052026|Ventricular Remodeling/drug effects|ventricular remodeling/drug effects
5425729|NCT00052039|idiopathic pulmonary fibrosis|idiopathic pulmonary fibrosis
5425730|NCT00052013|von Hippel-Lindau disease,|von hippel-lindau disease,
5425731|NCT00052013|CNS,|cns,
5425732|NCT00052013|hemangioblastoma,|hemangioblastoma,
5425733|NCT00052013|retinal|retinal
5425734|NCT00051935|Glycogen Storage Disease Type II|glycogen storage disease type ii
5425735|NCT00051935|GSD-II|gsd-ii
5425736|NCT00051935|Pompe Disease|pompe disease
5425737|NCT00051922|HIV Preventive Vaccine|hiv preventive vaccine
5425738|NCT00051922|HIV Seronegativity|hiv seronegativity
5425739|NCT00051961|Dopamine|dopamine
5425740|NCT00051961|Spinal Physiology|spinal physiology
5425741|NCT00051961|Flexor Reflex|flexor reflex
5425742|NCT00051961|Ropinirole|ropinirole
5425745|NCT00051961|Restless Legs|restless legs
5425746|NCT00051909|Alzheimer's Disease|alzheimer's disease
5425747|NCT00051844|HIV|hiv
5425748|NCT00051844|NNRTI Failure|nnrti failure
5425749|NCT00051844|HIV Infections|hiv infections
5425750|NCT00051831|Treatment Naive|treatment naive
5425751|NCT00051831|HIV-1|hiv-1
5425752|NCT00051831|Virus Replication|virus replication
5425753|NCT00051831|CD4-Positive T-Lymphocytes|cd4-positive t-lymphocytes
5425754|NCT00051831|Immunologic Memory|immunologic memory
5425755|NCT00051831|Pentafuside|pentafuside
5425756|NCT00051831|Anti-HIV Agents|anti-hiv agents
5425757|NCT00051831|Drug Therapy, Combination|drug therapy, combination
5425758|NCT00051831|Saquinavir|saquinavir
5425759|NCT00051831|Ritonavir|ritonavir
5425760|NCT00051831|Tenofovir Disoproxil Fumarate|tenofovir disoproxil fumarate
5425761|NCT00051831|RNA, Viral|rna, viral
5425762|NCT00051831|Viral Load|viral load
5425763|NCT00051831|Fusion Inhibitors|fusion inhibitors
5425764|NCT00051831|Entry Inhibitors|entry inhibitors
5425765|NCT00051870|Verbal Memory|verbal memory
5425766|NCT00051870|Inhibition|inhibition
5425767|NCT00051870|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
5425768|NCT00051870|Cortical Excitability|cortical excitability
5425769|NCT00051870|Nonverbal Memory|nonverbal memory
5425770|NCT00051857|Magnetic Resonance Imaging|magnetic resonance imaging
5425771|NCT00051857|Muscle|muscle
5425772|NCT00051857|Bone|bone
5425773|NCT00051857|Dynamics|dynamics
5425774|NCT00051857|Visualization|visualization
5425775|NCT00051805|Patient Compliance|patient compliance
5425776|NCT00051805|Adherence|adherence
5425777|NCT00051805|Treatment Experienced|treatment experienced
5425778|NCT00051779|CAL|cal
5425779|NCT00051779|Parathyroid hormone-related protein (PTHrP)|parathyroid hormone-related protein (pthrp)
5425780|NCT00051779|Breast Cancer|breast cancer
5425781|NCT00051779|Bone Metastasis|bone metastasis
5425782|NCT00051779|Hypercalcemia|hypercalcemia
5425783|NCT00051766|compliance|compliance
5425784|NCT00051766|medication|medication
5425785|NCT00051766|antiretroviral|antiretroviral
5425786|NCT00051766|adherence|adherence
5425787|NCT00051766|intervention|intervention
5425788|NCT00051766|treatment experienced|treatment experienced
5425789|NCT00051753|Otitis Media|otitis media
5425790|NCT00051753|Acute Otitis Media|acute otitis media
5425791|NCT00051753|ear infection|ear infection
5425792|NCT00051753|levofloxacin|levofloxacin
5425793|NCT00051753|amoxicillin|amoxicillin
5425794|NCT00051753|clavulanate|clavulanate
5425795|NCT00051701|Non-Hodgkins lymphoma|non-hodgkins lymphoma
5425796|NCT00051701|NHL|nhl
5425797|NCT00051701|Campath|campath
5425798|NCT00051701|alemtuzumab|alemtuzumab
5425799|NCT00051675|adenocarcinoma|adenocarcinoma
5425800|NCT00051675|monoclonal antibody|monoclonal antibody
5425801|NCT00051636|Bisphosphonate|bisphosphonate
5425802|NCT00051636|SAP|sap
5425803|NCT00051636|SAP excess|sap excess
5425804|NCT00051636|non-inferiority|non-inferiority
5425805|NCT00051636|therapeutic response|therapeutic response
5425806|NCT00051636|extended observation period|extended observation period
5425807|NCT00051623|Psoriatic arthritis|psoriatic arthritis
5425808|NCT00051623|Infliximab|infliximab
5425809|NCT00051623|Remicade|remicade
5425810|NCT00051571|Carcinoma, Non-Small-Cell Lung|carcinoma, non-small-cell lung
5425811|NCT00051428|Fibromyalgia, Reiki, Energy Medicine|fibromyalgia, reiki, energy medicine
5425812|NCT00051415|Flaxseed|flaxseed
5425813|NCT00051415|Cholesterol|cholesterol
5425814|NCT00051402|Postmenopausal|postmenopausal
5425815|NCT00051402|Memory Loss|memory loss
5425816|NCT00051402|Cognition|cognition
5425817|NCT00051402|Phytoestrogens|phytoestrogens
5425818|NCT00051545|liver|liver
5425819|NCT00051545|cancer|cancer
5425820|NCT00051545|hepatocellular|hepatocellular
5425821|NCT00051545|carcinoma|carcinoma
5425822|NCT00051532|hepatocellular|hepatocellular
5425823|NCT00051532|carcinoma|carcinoma
5425824|NCT00051532|liver|liver
5425825|NCT00051532|cancer|cancer
5425826|NCT00051493|Non-Small Cell Lung Cancer|non-small cell lung cancer
5425827|NCT00051493|Lung Cancer|lung cancer
5425828|NCT00051493|NSCLC|nsclc
5425829|NCT00051493|Advanced Non-Small Cell Lung Cancer|advanced non-small cell lung cancer
5425830|NCT00051519|HIV|hiv
5425831|NCT00051519|AIDS|aids
5425832|NCT00051519|Vaccine|vaccine
5425833|NCT00051519|HIV-positive|hiv-positive
5425834|NCT00051519|Therapy|therapy
5425835|NCT00051454|HIV Seronegativity|hiv seronegativity
5425836|NCT00051454|HIV Preventive Vaccine|hiv preventive vaccine
5425837|NCT00051441|stomatitis|stomatitis
5425838|NCT00051441|radiation effects|radiation effects
5425839|NCT00051363|Obstructive Sleep Apnea|obstructive sleep apnea
5425840|NCT00051337|Kinesiogenic|kinesiogenic
5425841|NCT00051337|Psychogenic|psychogenic
5425842|NCT00051337|Channelopathy|channelopathy
5425843|NCT00051337|Ictal|ictal
5425844|NCT00051337|Paroxysmal Dyskinesia|paroxysmal dyskinesia
5425845|NCT00051337|Psychogenic Movement Disorders|psychogenic movement disorders
5425846|NCT00051337|Single Photon Emission|single photon emission
5425847|NCT00051337|Computed Tomography (SPECT)|computed tomography (spect)
5425848|NCT00051324|Huntington's disease|huntington's disease
5425849|NCT00051324|Huntington disease|huntington disease
5425860|NCT00051311|Hodgkin's Disease|hodgkin's disease
5425861|NCT00051311|Multiple Myeloma|multiple myeloma
5425862|NCT00051311|Immunotherapy|immunotherapy
5425863|NCT00051272|depression, sexual dysfunction, orgasm disorder, MDD|depression, sexual dysfunction, orgasm disorder, mdd
5425864|NCT00051259|depression|depression
5425865|NCT00051259|MDD|mdd
5425866|NCT00051259|sexual dysfunction|sexual dysfunction
5425867|NCT00051259|orgasm disorder|orgasm disorder
5425868|NCT00051207|Mood Disorders|mood disorders
5425869|NCT00051207|Psychotherapy|psychotherapy
5425870|NCT00051207|Comorbidity|comorbidity
5425871|NCT00051194|Glaucoma|glaucoma
5425872|NCT00051194|POAG|poag
5425873|NCT00051194|OAG|oag
5425874|NCT00051194|OHT|oht
5425875|NCT00051181|Glaucoma|glaucoma
5425876|NCT00051181|POAG|poag
5425877|NCT00051181|OAG|oag
5425878|NCT00051181|OHT|oht
5425879|NCT00051168|Glaucoma|glaucoma
5425880|NCT00051168|POAG|poag
5425881|NCT00051168|OAG|oag
5425882|NCT00051168|OHT|oht
5425883|NCT00051155|Glaucoma|glaucoma
5425884|NCT00051155|POAG|poag
5425885|NCT00051155|OAG|oag
5425886|NCT00051155|OHT|oht
5425887|NCT00051142|Glaucoma|glaucoma
5425888|NCT00051142|POAG|poag
5425889|NCT00051142|OAG|oag
5425890|NCT00051142|OHT|oht
5425891|NCT00051129|AMD|amd
5425892|NCT00051129|anecortave acetate|anecortave acetate
5425893|NCT00051129|wet AMD|wet amd
5425894|NCT00051129|age-related macular degeneration|age-related macular degeneration
5425895|NCT00051129|Macular Degeneration|macular degeneration
5425896|NCT00051129|Maculopathy, Age-Related|maculopathy, age-related
5425897|NCT00051129|Age-Related Maculopathies|age-related maculopathies
5425898|NCT00051129|Age-Related Maculopathy|age-related maculopathy
5425899|NCT00051129|Maculopathies, Age-Related|maculopathies, age-related
5425900|NCT00051116|Multiple Myeloma|multiple myeloma
5425901|NCT00051116|Revimid|revimid
5425902|NCT00051116|CC5013|cc5013
5425903|NCT00051116|CC-5013|cc-5013
5425904|NCT00051103|Refractory|refractory
5425905|NCT00051090|Hepatitis B|hepatitis b
5425906|NCT00051090|Antiretroviral Therapy, Highly-Active|antiretroviral therapy, highly-active
5425907|NCT00051090|HIV Infections|hiv infections
5425908|NCT00051090|Lamivudine|lamivudine
5425909|NCT00051090|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5425910|NCT00051090|Antiviral Agents|antiviral agents
5425911|NCT00051090|Drug Therapy, Combination|drug therapy, combination
5425912|NCT00051090|Treatment Naive|treatment naive
5425913|NCT00051077|HIV Infections|hiv infections
5425914|NCT00051077|Hepatitis B|hepatitis b
5425915|NCT00051077|Hepatitis C|hepatitis c
5425916|NCT00051077|Interferon Alfa-2a|interferon alfa-2a
5425917|NCT00051077|Adefovir dipivoxil|adefovir dipivoxil
5425918|NCT00051077|Ribavirin|ribavirin
5425919|NCT00051077|Antiviral Agents|antiviral agents
5425920|NCT00051077|Drug Resistance, Viral|drug resistance, viral
5425921|NCT00051077|Treatment Experienced|treatment experienced
5425922|NCT00050986|Brain Neoplasms|brain neoplasms
5425923|NCT00050986|CNS Diseases|cns diseases
5425924|NCT00050986|Glioblastoma Multiforme|glioblastoma multiforme
5425925|NCT00050986|Temozolomide|temozolomide
5425926|NCT00050986|Temodar|temodar
5425927|NCT00050986|R115777|r115777
5425928|NCT00050986|Zarnestra|zarnestra
5425929|NCT00050973|NSCLC|nsclc
5425930|NCT00050973|Targretin|targretin
5425931|NCT00050973|Retinoid|retinoid
5425932|NCT00050973|Bexarotene|bexarotene
5425933|NCT00050960|NSCLC|nsclc
5425934|NCT00050960|Targretin|targretin
5425935|NCT00050960|Retinoid|retinoid
5425936|NCT00050960|Bexarotene|bexarotene
5425937|NCT00050947|partial seizures|partial seizures
5425938|NCT00050934|partial seizures|partial seizures
5425939|NCT00050921|HIV Infections|hiv infections
5425940|NCT00050921|CD4 Lymphocyte Count|cd4 lymphocyte count
5425941|NCT00050921|Antiretroviral Therapy, Highly Active|antiretroviral therapy, highly active
5425942|NCT00050921|Growth Hormone|growth hormone
5425943|NCT00050921|Cell Division|cell division
5425944|NCT00050921|CD4-Positive T-Lymphocytes|cd4-positive t-lymphocytes
5425945|NCT00050921|Treatment Experienced|treatment experienced
5425946|NCT00050908|Brachial Artery|brachial artery
5425947|NCT00050908|Endothelium, Vascular|endothelium, vascular
5425948|NCT00050908|Vasodilation|vasodilation
5425949|NCT00050908|Nitroglycerin|nitroglycerin
5425950|NCT00050908|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5425951|NCT00050908|HIV Protease Inhibitors|hiv protease inhibitors
5425952|NCT00050908|Drug Therapy, Combination|drug therapy, combination
5425953|NCT00050908|Ritonavir|ritonavir
5425954|NCT00050908|efavirenz|efavirenz
5425955|NCT00050908|lopinavir|lopinavir
5425956|NCT00050908|stavudine|stavudine
5425957|NCT00050908|lamivudine|lamivudine
5425958|NCT00050908|zidovudine|zidovudine
5425959|NCT00050908|Treatment Naive|treatment naive
5425960|NCT00050895|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5425961|NCT00050895|HIV Protease Inhibitors|hiv protease inhibitors
5425962|NCT00050895|Drug Therapy, Combination|drug therapy, combination
5425963|NCT00050895|Delayed Action Preparations|delayed action preparations
5425964|NCT00050895|Treatment Naive|treatment naive
5425965|NCT00050895|HIV-1|hiv-1
5425967|NCT00050882|Diabetic gastroparesis|diabetic gastroparesis
5425968|NCT00050882|Bloating|bloating
5425969|NCT00050882|Delayed gastric emptying|delayed gastric emptying
5425970|NCT00050882|Mitemcinal|mitemcinal
5425971|NCT00050869|Mirror Neurons|mirror neurons
5425972|NCT00050869|Performance|performance
5425973|NCT00050869|Use-Dependent Plasticity|use-dependent plasticity
5425974|NCT00050869|Attention|attention
5425975|NCT00050869|Premotor Cortex|premotor cortex
5425976|NCT00050856|Antiretrovial Therapy|antiretrovial therapy
5425977|NCT00050856|Salvage|salvage
5425978|NCT00050856|CD4+Lymphocyte Count|cd4+lymphocyte count
5425979|NCT00050856|HIV-1 RNA Level|hiv-1 rna level
5425980|NCT00050856|Subcutaneous Injection|subcutaneous injection
5425981|NCT00050817|Embolism|embolism
5425982|NCT00050791|Obesity|obesity
5425983|NCT00050791|Weightloss|weightloss
5425984|NCT00050791|Leptin|leptin
5425985|NCT00050791|Diet|diet
5425986|NCT00050791|Reducing|reducing
5425987|NCT00050791|Overweight|overweight
5425988|NCT00050791|Fat|fat
5425989|NCT00050778|Multiple Sclerosis|multiple sclerosis
5425990|NCT00050778|Active Relapsing-Remitting Multiple Sclerosis|active relapsing-remitting multiple sclerosis
5425991|NCT00050804|Acute Stress Disorder|acute stress disorder
5425992|NCT00050804|PTSD|ptsd
5425993|NCT00050804|Treatment|treatment
5425994|NCT00050804|SSRI|ssri
5425995|NCT00050804|Startle|startle
5425996|NCT00050804|Psychophysiology|psychophysiology
5425997|NCT00050804|Trauma|trauma
5425998|NCT00050804|Anxiety|anxiety
5425999|NCT00050804|Emotion|emotion
5426000|NCT00050765|Myocardial Infarction|myocardial infarction
5426001|NCT00050765|Heart disease|heart disease
5426002|NCT00050765|Coronary bypass graft (CABG) surgery|coronary bypass graft (cabg) surgery
5426003|NCT00050765|Implantable Cardioverter Defibrillator (ICD)|implantable cardioverter defibrillator (icd)
5426004|NCT00050765|CABG|cabg
5426005|NCT00050765|ICD|icd
5426006|NCT00050765|Heart failure|heart failure
5426007|NCT00050752|Renal Cancer|renal cancer
5426008|NCT00050752|Hereditary Leiomyomatosis|hereditary leiomyomatosis
5426009|NCT00050752|Uterine Fibroid|uterine fibroid
5426010|NCT00050752|Cutaneous Leiomyoma|cutaneous leiomyoma
5426011|NCT00050726|Interleukin-2|interleukin-2
5426012|NCT00050726|Immunotherapy|immunotherapy
5426013|NCT00050726|HIV|hiv
5426014|NCT00050726|IL-2|il-2
5426015|NCT00050713|Kidney Disease|kidney disease
5426016|NCT00050713|Glomerulonephritis|glomerulonephritis
5426017|NCT00050713|Lupus Nephritis|lupus nephritis
5426018|NCT00050713|Nephrotic Syndrome|nephrotic syndrome
5426019|NCT00050713|Hyperlipidemia|hyperlipidemia
5426020|NCT00050700|PET|pet
5426021|NCT00050700|[18F]FP-TZTP|[18f]fp-tztp
5426022|NCT00050700|Bipolar Disorder|bipolar disorder
5426023|NCT00050700|Major Depressive Disorder|major depressive disorder
5426024|NCT00050700|Muscarinic 2 Receptors|muscarinic 2 receptors
5426025|NCT00050674|lung cancer, oncology, neutropenia, chemotherapy, filgrastim|lung cancer, oncology, neutropenia, chemotherapy, filgrastim
5426026|NCT00050661|psoriasis|psoriasis
5426027|NCT00050661|Cyclosporine|cyclosporine
5426028|NCT00050661|Daclizamub|daclizamub
5426029|NCT00050661|anti-TAC|anti-tac
5426030|NCT00050661|dermatology|dermatology
5426031|NCT00050661|skin|skin
5426032|NCT00050661|lesions|lesions
5426033|NCT00050648|psoriasis|psoriasis
5426034|NCT00050648|Daclizumab|daclizumab
5426035|NCT00050648|Cyclosporin|cyclosporin
5426036|NCT00050648|anti-TAC|anti-tac
5426037|NCT00050648|dermatology|dermatology
5426038|NCT00050648|skin|skin
5426039|NCT00050635|chemotherapy induced diarrhea|chemotherapy induced diarrhea
5426040|NCT00050635|diarrhea|diarrhea
5426041|NCT00050635|CTID|ctid
5426042|NCT00050635|colorectal cancer|colorectal cancer
5426043|NCT00050635|Sandostatin LAR Depot|sandostatin lar depot
5426044|NCT00050635|Sandostatin|sandostatin
5426045|NCT00050635|adverse events|adverse events
5426046|NCT00050635|side effects|side effects
5426047|NCT00050427|Trabectedin|trabectedin
5426048|NCT00050427|Yondelis|yondelis
5426049|NCT00050427|ET743|et743
5426050|NCT00050427|Advanced breast cancer|advanced breast cancer
5426051|NCT00050427|Breast|breast
5426052|NCT00050427|Cancer|cancer
5426053|NCT00050427|Antineoplastic Agents, Alkylating Agents|antineoplastic agents, alkylating agents
5426054|NCT00050427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
5426055|NCT00050518|Smallpox|smallpox
5426056|NCT00050518|Aventis Pasteur|aventis pasteur
5426057|NCT00050518|Vaccine|vaccine
5426058|NCT00050505|smallpox, Dryvax, vaccine, dilution|smallpox, dryvax, vaccine, dilution
5426059|NCT00050492|Ocular|ocular
5426060|NCT00050492|Cytokine|cytokine
5426061|NCT00050492|Chemokine|chemokine
5426062|NCT00050492|Viruses|viruses
5426063|NCT00050492|Autoantibody|autoantibody
5426064|NCT00050492|Retina|retina
5426065|NCT00050492|Vasculitis|vasculitis
5426066|NCT00050492|Adhesion Molecules|adhesion molecules
5426067|NCT00050479|Types 1 and 2 diabetes|types 1 and 2 diabetes
5426068|NCT00050479|Diode Laser Photocoagulation|diode laser photocoagulation
5426069|NCT00050479|Elevated Low-Density Lipoprotein (LDL-C) Cholesterol|elevated low-density lipoprotein (ldl-c) cholesterol
5426070|NCT00050466|Normal Volunteers|normal volunteers
5426071|NCT00050466|Dynamic Light Scattering (DLS)|dynamic light scattering (dls)
5426072|NCT00050466|Corneal Opacities|corneal opacities
5426073|NCT00050466|Cornea|cornea
5426074|NCT00050466|Transparency|transparency
5426075|NCT00050466|Vision|vision
5426076|NCT00050440|Endometrial|endometrial
5426077|NCT00050440|Cancer|cancer
5426078|NCT00050440|Carcinoma|carcinoma
5426079|NCT00050440|Trabectedin|trabectedin
5426080|NCT00050440|Ecteinascidin 743|ecteinascidin 743
5426081|NCT00050440|ET743|et743
5426082|NCT00050440|Antineoplastic Agents|antineoplastic agents
5426083|NCT00050440|Alkylating Agents|alkylating agents
5426084|NCT00050440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
5426085|NCT00050414|Ovarian cancer|ovarian cancer
5426086|NCT00050414|Ovary|ovary
5426087|NCT00050414|Cancer|cancer
5426088|NCT00050414|Trabectedin|trabectedin
5426089|NCT00050414|Yondelis|yondelis
5426090|NCT00050414|ET743|et743
5426091|NCT00050414|Ecteinascidin 743|ecteinascidin 743
5426092|NCT00050414|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating
5426093|NCT00050414|Alkylating Agents|alkylating agents
5426094|NCT00050401|ventilator-associated|ventilator-associated
5426095|NCT00050401|nosocomial|nosocomial
5426096|NCT00011635|Caffeine|caffeine
5426097|NCT00011635|Cytochrome P 450|cytochrome p 450
5426098|NCT00011635|Dextromethorphan|dextromethorphan
5426099|NCT00011635|Drug Interaction|drug interaction
5426100|NCT00011635|Metabolism|metabolism
5426101|NCT00011635|Drug Metabolism|drug metabolism
5426102|NCT00011635|Healthy Volunteer|healthy volunteer
5426103|NCT00011635|Milk Thistle|milk thistle
5426104|NCT00011063|Anti-Epileptic|anti-epileptic
5426105|NCT00011063|CYP2C9|cyp2c9
5426106|NCT00011063|Herbal|herbal
5426107|NCT00011063|Interaction|interaction
5426108|NCT00011063|Metabolism|metabolism
5426109|NCT00011063|Drug Interaction|drug interaction
5426110|NCT00011063|Drug Metabolism|drug metabolism
5426111|NCT00011063|Ginko Biloba|ginko biloba
5426112|NCT00011063|Healthy Volunteer|healthy volunteer
5426113|NCT00009542|Caffeine|caffeine
5426114|NCT00009542|Cytochrome P 450|cytochrome p 450
5426115|NCT00009542|Dextromethorphan|dextromethorphan
5426116|NCT00009542|Herbal|herbal
5426117|NCT00009542|Interactions|interactions
5426118|NCT00009542|Alternative Therapy|alternative therapy
5426119|NCT00009542|Healthy Volunteer|healthy volunteer
5426120|NCT00009542|Kava|kava
5426121|NCT00006395|Antiepileptic|antiepileptic
5426122|NCT00006395|CYP3A4|cyp3a4
5426123|NCT00006395|Herbal|herbal
5426124|NCT00006395|Induction|induction
5426125|NCT00006395|Interaction|interaction
5426126|NCT00006191|Antiepileptic Drugs|antiepileptic drugs
5426127|NCT00006191|Motor Cortex|motor cortex
5426128|NCT00006191|Myoclonus|myoclonus
5426129|NCT00006191|Healthy Volunteer|healthy volunteer
5426130|NCT00006155|DNA Damage|dna damage
5426131|NCT00006155|DNA Repair|dna repair
5426132|NCT00006155|FLK-1|flk-1
5426133|NCT00006155|Pharmacokinetics|pharmacokinetics
5426134|NCT00006155|VEGF|vegf
5426135|NCT00006155|Fallopian Tube Cancer|fallopian tube cancer
5426136|NCT00006155|Ovarian Cancer|ovarian cancer
5426137|NCT00006155|Platinum-Refractory Disease|platinum-refractory disease
5426138|NCT00006071|Brachial Reactivity|brachial reactivity
5426139|NCT00006071|Endothelial Function|endothelial function
5426140|NCT00006071|Endothelial Markers|endothelial markers
5426141|NCT00006071|Forearm Flow|forearm flow
5426142|NCT00006071|Insulin Resistance|insulin resistance
5426143|NCT00006071|Elevated Cholesterol|elevated cholesterol
5426144|NCT00006071|Hypertension|hypertension
5426145|NCT00006062|Liver Impairment|liver impairment
5426146|NCT00006062|Pharmacokinetics|pharmacokinetics
5426147|NCT00006062|Platinum Analogues|platinum analogues
5426148|NCT00005926|Cancer|cancer
5426149|NCT00005926|Gemzar|gemzar
5426150|NCT00005926|Her-2/Neu|her-2/neu
5426151|NCT00005926|Pancreatic|pancreatic
5426152|NCT00005926|Radiotherapy|radiotherapy
5426153|NCT00005926|Pancreatic Cancer|pancreatic cancer
5426154|NCT00005912|Aspergillosis|aspergillosis
5426155|NCT00005912|Candidiasis|candidiasis
5426156|NCT00005912|Fungal Infections|fungal infections
5426157|NCT00005912|Fungemia|fungemia
5426158|NCT00005912|Prophylactic Antifungal Therapy|prophylactic antifungal therapy
5426159|NCT00005912|Pediatric Fungal Infection|pediatric fungal infection
5426160|NCT00005783|Fetal Hemoglobin|fetal hemoglobin
5426161|NCT00005783|Hematopoietic Growth Factor|hematopoietic growth factor
5426162|NCT00005783|Peripheral Blood CD34 Cells|peripheral blood cd34 cells
5426163|NCT00005783|Vasoocclusive Crisis|vasoocclusive crisis
5426164|NCT00005783|Sickle Cell Anemia|sickle cell anemia
5426165|NCT00005783|Sickle Cell Disease|sickle cell disease
5426166|NCT00005783|Sickle Cell Disorder|sickle cell disorder
5426167|NCT00005781|Epidemiology|epidemiology
5426168|NCT00005781|NHANES|nhanes
5426169|NCT00005781|Photography|photography
5426170|NCT00005781|Prevalence|prevalence
5426171|NCT00005781|Skin Disease|skin disease
5426172|NCT00005781|Healthy Volunteer|healthy volunteer
5426173|NCT00005574|Becker Muscular Dystrophy|becker muscular dystrophy
5426174|NCT00005574|Duchenne Muscular Dystrophy|duchenne muscular dystrophy
5426175|NCT00005574|Muscle Disease|muscle disease
5426176|NCT00005574|Myopathy|myopathy
5426177|NCT00005570|Bleeding|bleeding
5426178|NCT00005570|Cytokines|cytokines
5426179|NCT00005570|Immune Response|immune response
5426180|NCT00005570|Pharmacogenomic|pharmacogenomic
5426181|NCT00005570|Serum Antibodies|serum antibodies
5426182|NCT00005570|ITP|itp
5426183|NCT00005570|Immune Thrombocytopenia Purpura|immune thrombocytopenia purpura
5426184|NCT00005111|Blood Flow|blood flow
5426185|NCT00005111|Glucose|glucose
5426186|NCT00005111|Lysosomal Disease|lysosomal disease
5426187|NCT00005111|Metabolic|metabolic
5426188|NCT00005111|Uptake|uptake
5426189|NCT00005111|Fabry Disease|fabry disease
5426190|NCT00005016|Fetal Anomaly|fetal anomaly
5426191|NCT00005016|Genetic Counseling|genetic counseling
5426192|NCT00005016|Prenatal Diagnosis|prenatal diagnosis
5426193|NCT00005016|Psychosocial Issues|psychosocial issues
5426194|NCT00005016|Qualitative|qualitative
5426195|NCT00005016|HPE|hpe
5426196|NCT00005016|Holoprosencephaly|holoprosencephaly
5426197|NCT00004851|HCV Antibody Library|hcv antibody library
5426198|NCT00004848|AIDS|aids
5426199|NCT00004848|Autologous Blood|autologous blood
5426200|NCT00004848|Cardiac Surgery|cardiac surgery
5426201|NCT00004848|HIV|hiv
5426202|NCT00004848|Hepatocellular Inflammation|hepatocellular inflammation
5426203|NCT00004848|Liver Biopsy|liver biopsy
5426204|NCT00004848|Long Term Sera Storage|long term sera storage
5426205|NCT00004848|Non-A Hepatitis|non-a hepatitis
5426206|NCT00004848|Non-B Hepatitis|non-b hepatitis
5426207|NCT00004576|Dyskinesias|dyskinesias
5426208|NCT00004576|Glutamate|glutamate
5426209|NCT00004576|Levodopa|levodopa
5426210|NCT00004576|Parkinson's Disease|parkinson's disease
5426211|NCT00004574|Abetalipoproteinemia|abetalipoproteinemia
5426212|NCT00004574|Ataxia|ataxia
5426213|NCT00004574|Retinitis Pigmentosa|retinitis pigmentosa
5426214|NCT00004574|Vitamin A|vitamin a
5426215|NCT00004574|Vitamin E|vitamin e
5426216|NCT00004557|Attention|attention
5426217|NCT00004557|Cognition|cognition
5426218|NCT00004557|Dementia|dementia
5426219|NCT00004557|Memory|memory
5426220|NCT00004557|Object Recognition|object recognition
5426221|NCT00004557|Spatial Processes|spatial processes
5426222|NCT00001986|Alcohol|alcohol
5426223|NCT00001986|Octanol|octanol
5426224|NCT00001986|Treatment|treatment
5426225|NCT00001986|Tremor|tremor
5426226|NCT00001982|Aminotransferases|aminotransferases
5426227|NCT00001982|Anti-HCV|anti-hcv
5426228|NCT00001982|Blood Donors|blood donors
5426229|NCT00001982|HCV RNA|hcv rna
5426230|NCT00001982|Hepatitis C|hepatitis c
5426231|NCT00001982|Liver Biopsy|liver biopsy
5426232|NCT00001982|Serum Aminotransferases|serum aminotransferases
5426233|NCT00001982|Transfusion|transfusion
5426234|NCT00001977|Alzheimer's Disease|alzheimer's disease
5426235|NCT00001977|Attention|attention
5426236|NCT00001977|Brain|brain
5426237|NCT00001977|Functional Magnetic Resonance Imaging|functional magnetic resonance imaging
5426238|NCT00001977|Physostigmine|physostigmine
5426239|NCT00001977|Positron Emission Tomography|positron emission tomography
5426240|NCT00001977|Working Memory|working memory
5426241|NCT00001968|AIDS|aids
5426242|NCT00001968|Anti-Retroviral Therapy|anti-retroviral therapy
5426243|NCT00001968|Drug Interactions|drug interactions
5426244|NCT00001968|HIV|hiv
5426245|NCT00001968|Protease Inhibitor|protease inhibitor
5426246|NCT00001966|Adjustment|adjustment
5426247|NCT00001966|Alternative|alternative
5426248|NCT00001966|Anxiety|anxiety
5426249|NCT00001966|Guided-Imagery|guided-imagery
5426250|NCT00001966|Meditation|meditation
5426251|NCT00001966|Ehlers-Danlos Syndrome|ehlers-danlos syndrome
5426252|NCT00001965|Calcineurin|calcineurin
5426253|NCT00001965|Cardiac Hypertrophy|cardiac hypertrophy
5426254|NCT00001965|Hypertrophic Cardiomyopathy|hypertrophic cardiomyopathy
5426255|NCT00001963|Blood Flow|blood flow
5426256|NCT00001963|Exercise|exercise
5426257|NCT00001963|Microcirculation|microcirculation
5426258|NCT00001963|S-nitrosohemoglobin|s-nitrosohemoglobin
5426259|NCT00001963|Vasodilation|vasodilation
5426260|NCT00001963|Healthy Volunteer|healthy volunteer
5426261|NCT00001944|Drug Resistance|drug resistance
5426262|NCT00001944|MDR-1|mdr-1
5426263|NCT00001944|P-Glycoprotein Blocker|p-glycoprotein blocker
5426264|NCT00001944|Pgp|pgp
5426265|NCT00001944|Resistance Reversal|resistance reversal
5426266|NCT00001940|Antifungal Agent|antifungal agent
5426267|NCT00001940|Aspergillosis|aspergillosis
5426268|NCT00001940|Candidemia|candidemia
5426269|NCT00001940|Fungemia|fungemia
5426270|NCT00001937|Aspergillosis|aspergillosis
5426271|NCT00001937|Candidiasis|candidiasis
5426272|NCT00001937|Fungal Infections|fungal infections
5426273|NCT00001937|Fungemia|fungemia
5426274|NCT00001937|Prophylactic Antifungal Therapy|prophylactic antifungal therapy
5426275|NCT00001931|Continuous Stimulation|continuous stimulation
5426276|NCT00001931|Dose Finding|dose finding
5426277|NCT00001931|Skin Patch|skin patch
5426278|NCT00001930|Amantadine|amantadine
5426279|NCT00001930|Chorea|chorea
5426280|NCT00001930|Glutamate Antagonist|glutamate antagonist
5426281|NCT00001929|Dyskinesias|dyskinesias
5426282|NCT00001929|Glutamate Antagonist|glutamate antagonist
5426286|NCT00001928|Parkinsonism|parkinsonism
5426287|NCT00001918|Cognitive Function|cognitive function
5426288|NCT00001918|Depression|depression
5426289|NCT00001918|EMG|emg
5426290|NCT00001918|Eosinophilia Myalgia Syndrome|eosinophilia myalgia syndrome
5426291|NCT00001918|Impurities|impurities
5426292|NCT00001918|L-5-HTP|l-5-htp
5426293|NCT00001918|Memory Impairment|memory impairment
5426294|NCT00001918|Nerve-Muscle Biopsy|nerve-muscle biopsy
5426295|NCT00001918|Sleep Disorders|sleep disorders
5426296|NCT00001916|Bone Remodeling|bone remodeling
5426297|NCT00001916|Corticosteroids|corticosteroids
5426298|NCT00001916|Cytokine|cytokine
5426299|NCT00001916|Depression|depression
5426300|NCT00001916|Glucocorticoids|glucocorticoids
5426301|NCT00001916|Osteopenia|osteopenia
5426302|NCT00001916|Osteoporosis|osteoporosis
5426303|NCT00001916|Primary Affective Disorder|primary affective disorder
5426304|NCT00001909|Allergy|allergy
5426305|NCT00001909|Immunomodulator|immunomodulator
5426306|NCT00001909|Inflammation|inflammation
5426307|NCT00001909|Interleukin|interleukin
5426308|NCT00001909|Th2|th2
5426309|NCT00001909|Asthma|asthma
5426310|NCT00001906|Alum|alum
5426311|NCT00001906|Antigen|antigen
5426312|NCT00001906|Cytokine|cytokine
5426313|NCT00001906|Parasitic Infection|parasitic infection
5426314|NCT00001906|Phase I|phase i
5426315|NCT00001906|Cutaneous Leishmaniasis|cutaneous leishmaniasis
5426316|NCT00001904|Atherosclerosis|atherosclerosis
5426317|NCT00001904|Cardiovascular Disease|cardiovascular disease
5426318|NCT00001904|Computerized Edge Reader|computerized edge reader
5426319|NCT00001904|Myocardial Infarction|myocardial infarction
5426320|NCT00001904|Risk Factor|risk factor
5426321|NCT00001903|Immunization|immunization
5426322|NCT00001903|Immunocompromised|immunocompromised
5426323|NCT00001903|Immunoglobulin|immunoglobulin
5426324|NCT00001903|Prophylaxis|prophylaxis
5426325|NCT00001903|Respiratory Virus|respiratory virus
5426326|NCT00001903|Bone Marrow Transplantation|bone marrow transplantation
5426327|NCT00001903|Mini-Transplantation|mini-transplantation
5426328|NCT00001903|Peripheral Stem Cell Transplantation|peripheral stem cell transplantation
5426329|NCT00001891|CABG|cabg
5426330|NCT00001891|Hibernation|hibernation
5426331|NCT00001891|LV Function|lv function
5426332|NCT00001891|Microbubbles|microbubbles
5426333|NCT00001891|Revascularization|revascularization
5426334|NCT00001891|Coronary Artery Disease|coronary artery disease
5426335|NCT00001890|Cellular Immunity|cellular immunity
5426336|NCT00001890|Cytokines|cytokines
5426337|NCT00001890|Estrogen|estrogen
5426338|NCT00001890|Humoral Immunity|humoral immunity
5426339|NCT00001890|Progesterone|progesterone
5426340|NCT00001890|Chlamydia Pneumoniae|chlamydia pneumoniae
5426341|NCT00001890|Human Cytomegalovirus|human cytomegalovirus
5426342|NCT00001890|Postmenopause|postmenopause
5426343|NCT00001889|Microbubbles|microbubbles
5426344|NCT00001889|Myocardial Blood Flow|myocardial blood flow
5426345|NCT00001889|Myocardial Ischemia|myocardial ischemia
5426346|NCT00001889|Second Harmonics|second harmonics
5426347|NCT00001889|Ultrasound|ultrasound
5426348|NCT00001889|Coronary Artery Disease|coronary artery disease
5426349|NCT00001887|Airway Inflammation|airway inflammation
5426350|NCT00001887|Allergen Challenge|allergen challenge
5426351|NCT00001887|Bronchoscopy|bronchoscopy
5426352|NCT00001887|Cytokines|cytokines
5426353|NCT00001887|Receptors|receptors
5426354|NCT00001887|Asthma|asthma
5426355|NCT00001887|Normal Volunteer|normal volunteer
5426356|NCT00001886|Coronary Artery Disease|coronary artery disease
5426357|NCT00001886|Ischemia|ischemia
5426358|NCT00001886|Ultrasound|ultrasound
5426359|NCT00001886|Ventricular Function|ventricular function
5426360|NCT00001886|Wall Motion|wall motion
5426361|NCT00001881|Cardiac Hypertrophy|cardiac hypertrophy
5426362|NCT00001881|Genetics|genetics
5426363|NCT00001881|Phenotypes|phenotypes
5426364|NCT00001881|Hypertrophic Cardiomyopathy|hypertrophic cardiomyopathy
5426365|NCT00001879|Liver Disease|liver disease
5426366|NCT00001879|Novel Agents|novel agents
5426367|NCT00001879|Serum|serum
5426368|NCT00001879|Viruses|viruses
5426369|NCT00001879|non-A,G Hepatitis|non-a,g hepatitis
5426370|NCT00001879|Seronegative Acute Hepatitis|seronegative acute hepatitis
5426371|NCT00001871|Genetic Mutations|genetic mutations
5426372|NCT00001871|Hypertrophic Cardiomyopathy|hypertrophic cardiomyopathy
5426373|NCT00001871|Oculopharyngeal Muscular Dystrophy|oculopharyngeal muscular dystrophy
5426374|NCT00001867|Cytokine|cytokine
5426375|NCT00001867|Gestation|gestation
5426376|NCT00001867|Postpartum|postpartum
5426377|NCT00001867|Pregnancy|pregnancy
5426378|NCT00001867|Th 1 Lymphocyte|th 1 lymphocyte
5426379|NCT00001867|Th 2 Lymphocyte|th 2 lymphocyte
5426380|NCT00001867|Uveitis|uveitis
5426381|NCT00001857|Costimulation|costimulation
5426382|NCT00001857|Immunosuppression|immunosuppression
5426383|NCT00001857|Tolerance|tolerance
5426384|NCT00001840|Infarct|infarct
5426385|NCT00001840|Ischemia|ischemia
5426387|NCT00001840|Natural History|natural history
5426388|NCT00001840|Stroke|stroke
5426389|NCT00001840|Treatment|treatment
5426390|NCT00001840|Brain Stroke|brain stroke
5426391|NCT00001839|Anemia|anemia
5426392|NCT00001839|Immunosuppressive|immunosuppressive
5426393|NCT00001839|Phase II Trial|phase ii trial
5426394|NCT00001839|Pre-Leukemia|pre-leukemia
5426395|NCT00001839|Therapy|therapy
5426396|NCT00001839|Myelodysplastic Syndrome|myelodysplastic syndrome
5426397|NCT00001816|Anger|anger
5426398|NCT00001816|Loneliness|loneliness
5426399|NCT00001816|Mood|mood
5426400|NCT00001816|Psychosocial|psychosocial
5426401|NCT00001816|Virtual Network|virtual network
5426402|NCT00001814|Hereditary|hereditary
5426403|NCT00001814|Kidney|kidney
5426404|NCT00001814|MET|met
5426405|NCT00001814|Oncocytoma|oncocytoma
5426406|NCT00001814|VHL|vhl
5426407|NCT00001812|Mucositis|mucositis
5426408|NCT00001812|Oral Candidiasis|oral candidiasis
5426409|NCT00001812|Prophylaxis|prophylaxis
5426410|NCT00001812|Stomatitis|stomatitis
5426411|NCT00001812|Swish and Swallow|swish and swallow
5426412|NCT00001810|Antifungal Agent|antifungal agent
5426413|NCT00001810|Aspergillosis|aspergillosis
5426414|NCT00001810|Candidiasis|candidiasis
5426415|NCT00001810|Fungemia|fungemia
5426416|NCT00001805|Breast Cancer|breast cancer
5426417|NCT00001805|Colon Cancer|colon cancer
5426418|NCT00001805|Gastric Cancer|gastric cancer
5426419|NCT00001805|Lung Cancer|lung cancer
5426420|NCT00001805|Pancreatic Cancer|pancreatic cancer
5426421|NCT00001797|Cytokines|cytokines
5426422|NCT00001797|Immunomodulation|immunomodulation
5426423|NCT00001797|Inflammation|inflammation
5426424|NCT00001797|Skin|skin
5426425|NCT00001797|Therapy|therapy
5426426|NCT00001790|Aspergillosis|aspergillosis
5426427|NCT00001790|Candidiasis|candidiasis
5426428|NCT00001790|Empiric Therapy|empiric therapy
5426429|NCT00001790|Fungal Infection|fungal infection
5426430|NCT00001790|Fungemia|fungemia
5426431|NCT00001789|Autoantibody|autoantibody
5426432|NCT00001789|Autoimmunity|autoimmunity
5426433|NCT00001789|Inflammation|inflammation
5426434|NCT00001789|Kidney|kidney
5426435|NCT00001789|Lymphocyte|lymphocyte
5426436|NCT00001789|Proliferative Lupus Glomerulonephritis|proliferative lupus glomerulonephritis
5426437|NCT00001789|SLE-GN|sle-gn
5426438|NCT00001782|Deafness|deafness
5426439|NCT00001782|Hemisphere Dominance|hemisphere dominance
5426440|NCT00001782|Language|language
5426441|NCT00001782|Plasticity|plasticity
5426442|NCT00001782|Speech|speech
5426443|NCT00001782|rTMS|rtms
5426444|NCT00001777|Frontal Lobe Dementia|frontal lobe dementia
5426445|NCT00001777|Serotonergic Transmission|serotonergic transmission
5426446|NCT00001774|Acetylcholine|acetylcholine
5426447|NCT00001774|Blood Flow|blood flow
5426448|NCT00001774|Blood vessel|blood vessel
5426449|NCT00001774|Resistance|resistance
5426450|NCT00001774|Sodium Nitroprusside|sodium nitroprusside
5426451|NCT00001774|Fabry Disease|fabry disease
5426452|NCT00001774|Normal Volunteer|normal volunteer
5426453|NCT00001772|Bipolar Disorder|bipolar disorder
5426454|NCT00001772|Rapid Cycling|rapid cycling
5426455|NCT00001772|Screening|screening
5426456|NCT00001768|Autoimmunity|autoimmunity
5426457|NCT00001768|Childhood Onset Schizophrenia|childhood onset schizophrenia
5426458|NCT00001768|Intravenous Gammaglobulin|intravenous gammaglobulin
5426459|NCT00001763|AIDS|aids
5426460|NCT00001763|Cell Mediated Immunity|cell mediated immunity
5426461|NCT00001763|Cytokine|cytokine
5426462|NCT00001763|MAC|mac
5426463|NCT00001763|Thl Response|thl response
5426464|NCT00001761|Autoimmunity|autoimmunity
5426465|NCT00001761|Cytokine|cytokine
5426466|NCT00001761|Inflammation|inflammation
5426467|NCT00001761|Interleukin|interleukin
5426468|NCT00001761|Vasculitis|vasculitis
5426469|NCT00001761|Wegener's Granulomatosis|wegener's granulomatosis
5426470|NCT00001759|Allergy|allergy
5426471|NCT00001759|Fluorodeoxyglucose|fluorodeoxyglucose
5426472|NCT00001759|Imaging|imaging
5426473|NCT00001759|PET|pet
5426474|NCT00001759|Wegener's Granulomatosis|wegener's granulomatosis
5426475|NCT00001759|Asthma|asthma
5426476|NCT00001757|Azole|azole
5426477|NCT00001757|Immunocompromised|immunocompromised
5426478|NCT00001757|Mycosis|mycosis
5426479|NCT00001757|Invasive Fungal Infection|invasive fungal infection
5426480|NCT00001757|Systemic Fungal Infection|systemic fungal infection
5426481|NCT00001754|Dwarfism|dwarfism
5426482|NCT00001754|Gene Mapping|gene mapping
5426483|NCT00001754|Linkage|linkage
5426484|NCT00001754|Mutation Analysis|mutation analysis
5426485|NCT00001754|Skeletal Biology|skeletal biology
5426486|NCT00001754|Brachydactyly Types C & E|brachydactyly types c & e
5426487|NCT00001754|Cartilage-Hair Hypoplasia|cartilage-hair hypoplasia
5426488|NCT00001754|Ellis Van Crevald|ellis van crevald
5426489|NCT00001754|FgFR-3|fgfr-3
5426490|NCT00001754|Proximal Symphalangism|proximal symphalangism
5426491|NCT00001754|Pyknodysotosis|pyknodysotosis
5426492|NCT00001754|Schmid Metaphyseal|schmid metaphyseal
5426493|NCT00001754|Short Stature|short stature
5426494|NCT00001754|Skeletal Dysplasia|skeletal dysplasia
5426495|NCT00001754|Type II Collagen Disorder|type ii collagen disorder
5426496|NCT00001753|Exercise|exercise
5426497|NCT00001753|MRI|mri
5426498|NCT00001753|MRS|mrs
5426499|NCT00001753|Normal Volunteer|normal volunteer
5426500|NCT00001753|Tibialix Anterior|tibialix anterior
5426501|NCT00001752|Adhesion Molecules|adhesion molecules
5426502|NCT00001752|Endothelial Function|endothelial function
5426503|NCT00001752|Inflammation|inflammation
5426504|NCT00001752|Lipoproteins|lipoproteins
5426505|NCT00001752|Nitric Oxide|nitric oxide
5426506|NCT00001752|Hormone Therapy|hormone therapy
5426507|NCT00001752|Postmenopausal Women|postmenopausal women
5426508|NCT00001748|Cyclophosphamide|cyclophosphamide
5426509|NCT00001748|Donor Apheresis|donor apheresis
5426510|NCT00001748|Graft vs. Host Disease|graft vs. host disease
5426511|NCT00001748|Graft-Versus-Leukemia|graft-versus-leukemia
5426512|NCT00001748|Leukemic Relapse|leukemic relapse
5426513|NCT00001748|Myeloma|myeloma
5426514|NCT00001748|Peripheral Blood Stem Cells|peripheral blood stem cells
5426515|NCT00001748|Whole Body Irradiation|whole body irradiation
5426516|NCT00001748|Acute Lymphoblastic Leukemia (ALL)|acute lymphoblastic leukemia (all)
5426517|NCT00001748|Chronic Lymphocytic Leukemia (CLL)|chronic lymphocytic leukemia (cll)
5426518|NCT00001748|Chronic Myelogenous Leukemia (CML)|chronic myelogenous leukemia (cml)
5426519|NCT00001748|Hematological Malignancies|hematological malignancies
5426520|NCT00001748|Myelodysplastic Syndrome|myelodysplastic syndrome
5426521|NCT00001748|Myeloproliferative Disorders|myeloproliferative disorders
5426522|NCT00001747|Brachial Artery|brachial artery
5426523|NCT00001747|Doppler|doppler
5426524|NCT00001747|Endothelium|endothelium
5426525|NCT00001747|Nitric Oxide|nitric oxide
5426526|NCT00001747|Nitroglycerin|nitroglycerin
5426527|NCT00001747|Normal Volunteer|normal volunteer
5426528|NCT00001742|Acetylcholine|acetylcholine
5426529|NCT00001742|Aspirin|aspirin
5426530|NCT00001742|Nitric Oxide|nitric oxide
5426531|NCT00001742|Sodium Nitroprusside|sodium nitroprusside
5426532|NCT00001742|Hypercholesterolemia|hypercholesterolemia
5426533|NCT00001742|Hypertension|hypertension
5426534|NCT00001740|Cardiac|cardiac
5426535|NCT00001740|Function|function
5426536|NCT00001740|MRI|mri
5426537|NCT00001740|Reconstruction|reconstruction
5426538|NCT00001740|Ultrasound|ultrasound
5426539|NCT00001740|Heart Disease (Cardiovascular Disease)|heart disease (cardiovascular disease)
5426540|NCT00001738|Intermediate Uveitis|intermediate uveitis
5426541|NCT00001738|Pars Planitis|pars planitis
5426542|NCT00001738|Retinal Vasculature|retinal vasculature
5426543|NCT00001738|Uveitis|uveitis
5426544|NCT00001738|Vascular Permeability|vascular permeability
5426545|NCT00001738|Vitreous|vitreous
5426546|NCT00001736|Corneal Crystals|corneal crystals
5426547|NCT00001736|Cysteamine|cysteamine
5426548|NCT00001736|Cystinosis|cystinosis
5426549|NCT00001736|Eye|eye
5426550|NCT00001735|Gene Therapy|gene therapy
5426551|NCT00001735|Graft|graft
5426552|NCT00001735|Ornithine|ornithine
5426553|NCT00001735|Retina|retina
5426554|NCT00001735|Retinovirus|retinovirus
5426555|NCT00001735|Retrovirus|retrovirus
5426556|NCT00001735|Skin|skin
5426557|NCT00001735|Gyrate Atrophy|gyrate atrophy
5426558|NCT00001731|Conjunctiva|conjunctiva
5426559|NCT00001731|Dry Eyes|dry eyes
5426560|NCT00001731|Inflammation|inflammation
5426561|NCT00001731|Lacrimal Gland|lacrimal gland
5426562|NCT00001731|T Lymphocyte|t lymphocyte
5426563|NCT00001731|Keratoconjunctivitis Sicca|keratoconjunctivitis sicca
5426564|NCT00001730|Ablation|ablation
5426565|NCT00001730|Activity-Time Curves|activity-time curves
5426566|NCT00001730|Iodine Biokinetics|iodine biokinetics
5426567|NCT00001730|Thyroid Carcinoma|thyroid carcinoma
5426568|NCT00001730|Thyroid Remnant|thyroid remnant
5426569|NCT00001718|Biofeedback|biofeedback
5426570|NCT00001718|Swallowing|swallowing
5426571|NCT00001718|Swallowing Therapy|swallowing therapy
5426572|NCT00001718|Tongue/Palate|tongue/palate
5426573|NCT00001718|Ultrasound|ultrasound
5426574|NCT00001718|Dysphagia|dysphagia
5426575|NCT00001717|Compensation|compensation
5426576|NCT00001717|Motivations|motivations
5426577|NCT00001717|Volunteers|volunteers
5426578|NCT00001717|HIV|hiv
5426579|NCT00001714|MRI|mri
5426580|NCT00001714|Macromolecules|macromolecules
5426581|NCT00001714|Magnetization Transfer|magnetization transfer
5426582|NCT00001714|Metabolites|metabolites
5426583|NCT00001714|Tissue Characterization|tissue characterization
5426584|NCT00001714|Normal Volunteer|normal volunteer
5426585|NCT00001705|Antigen|antigen
5426586|NCT00001705|Cancer|cancer
5426587|NCT00001705|Immunotherapy|immunotherapy
5426588|NCT00001699|AIDS|aids
5426589|NCT00001699|Compliance|compliance
5426590|NCT00001699|HIV|hiv
5426591|NCT00001699|Medication|medication
5426592|NCT00001699|Perceived Threat|perceived threat
5426593|NCT00001699|Teenagers|teenagers
5426594|NCT00001696|Anti-metastatic|anti-metastatic
5426595|NCT00001696|Chemoprevention|chemoprevention
5426596|NCT00001696|Isoflavinoid|isoflavinoid
5426597|NCT00001696|Prostate Cancer|prostate cancer
5426598|NCT00001696|Signal Transduction|signal transduction
5426599|NCT00001685|Cancer|cancer
5426600|NCT00001685|IL-12|il-12
5426601|NCT00001685|IL-2|il-2
5426602|NCT00001685|Immunotherapy|immunotherapy
5426603|NCT00001685|Vaccine|vaccine
5426604|NCT00001681|Cytokines|cytokines
5426605|NCT00001681|Gene Regulation|gene regulation
5426606|NCT00001681|Immunization|immunization
5426607|NCT00001681|Influenza|influenza
5426608|NCT00001681|Pathogenesis|pathogenesis
5426609|NCT00001680|Double-masked|double-masked
5426610|NCT00001680|Neuropathy|neuropathy
5426611|NCT00001680|Occlusive Dressing|occlusive dressing
5426612|NCT00001680|Pilot|pilot
5426613|NCT00001680|Placebo|placebo
5426614|NCT00001679|Immunogenetics|immunogenetics
5426615|NCT00001679|Joint Damage|joint damage
5426616|NCT00001679|Reactive Arthritis|reactive arthritis
5426617|NCT00001679|Rheumatoid Arthritis|rheumatoid arthritis
5426618|NCT00001679|Synovium|synovium
5426619|NCT00001679|Synovitis|synovitis
5426620|NCT00001677|Immunosuppression|immunosuppression
5426621|NCT00001677|Lymphocytes|lymphocytes
5426622|NCT00001677|Magnetic Resonance|magnetic resonance
5426623|NCT00001677|Synovial Biopsy|synovial biopsy
5426624|NCT00001677|Synovitis|synovitis
5426625|NCT00001677|Rheumatoid Arthritis|rheumatoid arthritis
5426626|NCT00001672|Brain Mapping|brain mapping
5426627|NCT00001672|Cognition|cognition
5426628|NCT00001672|Noninvasive|noninvasive
5426629|NCT00001672|Temporal Lobe|temporal lobe
5426630|NCT00001672|Visual Naming|visual naming
5426631|NCT00001669|EAE|eae
5426632|NCT00001669|EDSS|edss
5426633|NCT00001669|MRI|mri
5426634|NCT00001669|SNRS|snrs
5426635|NCT00001669|Multiple Sclerosis|multiple sclerosis
5426636|NCT00001668|Deafness|deafness
5426637|NCT00001668|Hemangioblastoma|hemangioblastoma
5426638|NCT00001668|Papillary Carcinoma|papillary carcinoma
5426639|NCT00001668|VHL Gene|vhl gene
5426640|NCT00001668|Vestibular Function|vestibular function
5426641|NCT00001668|von Hippel-Lindau Disease|von hippel-lindau disease
5426642|NCT00001667|Family Studies|family studies
5426643|NCT00001667|Genetic|genetic
5426644|NCT00001667|Myoclonus|myoclonus
5426645|NCT00001667|Tics|tics
5426646|NCT00001667|Tremor|tremor
5426647|NCT00001667|Movement Disorders|movement disorders
5426648|NCT00001667|Neurological Disease|neurological disease
5426649|NCT00001665|Magnetic Stimulation|magnetic stimulation
5426650|NCT00001665|Motor Skills|motor skills
5426651|NCT00001665|Parkinson's Disease|parkinson's disease
5426652|NCT00001665|rTMS|rtms
5426653|NCT00001658|Amoxicillin|amoxicillin
5426654|NCT00001658|Antibiotics|antibiotics
5426655|NCT00001658|Cytokines|cytokines
5426656|NCT00001658|Group A beta-Hemolytic Strep Infections|group a beta-hemolytic strep infections
5426657|NCT00001658|Obsessive Compulsive Disorder|obsessive compulsive disorder
5426658|NCT00001658|Streptococcal Infection|streptococcal infection
5426659|NCT00001658|Tic Disorders|tic disorders
5426660|NCT00001657|15 O PET Scanning|15 o pet scanning
5426661|NCT00001657|Anxiety|anxiety
5426662|NCT00001657|Cerebral Blood Flow|cerebral blood flow
5426663|NCT00001657|Depression|depression
5426664|NCT00001657|Domestic Abuse|domestic abuse
5426665|NCT00001657|Neuroendocrine|neuroendocrine
5426666|NCT00001657|PET Scanning|pet scanning
5426667|NCT00001657|Police Officers|police officers
5426668|NCT00001657|Post Traumatic Stress Disorder|post traumatic stress disorder
5426669|NCT00001657|Repetitive Transcranial Magnetic Stimulation|repetitive transcranial magnetic stimulation
5426670|NCT00001646|Aspergillus|aspergillus
5426671|NCT00001646|Azole|azole
5426672|NCT00001646|Immunocompromise|immunocompromise
5426673|NCT00001642|Chromosomal Deletion|chromosomal deletion
5426674|NCT00001642|Mutations|mutations
5426675|NCT00001642|Paucity of Bile Ducts|paucity of bile ducts
5426676|NCT00001642|Physical Map|physical map
5426677|NCT00001642|Transcript Identification|transcript identification
5426678|NCT00001642|Alagille Syndrome|alagille syndrome
5426679|NCT00001642|Syndromic Bile Duct Paucity|syndromic bile duct paucity
5426680|NCT00001639|Gene Dosage|gene dosage
5426681|NCT00001639|Haploinsufficiency|haploinsufficiency
5426682|NCT00001639|Karyotype|karyotype
5426683|NCT00001639|Malformations|malformations
5426684|NCT00001639|Mental Retardation|mental retardation
5426685|NCT00001633|Contrast Media|contrast media
5426686|NCT00001633|Coronary Artery Disease|coronary artery disease
5426687|NCT00001633|Coronary Vessels|coronary vessels
5426688|NCT00001633|Magnetic Resonance Angiography|magnetic resonance angiography
5426689|NCT00001633|Magnetic Resonance Imaging|magnetic resonance imaging
5426690|NCT00001629|Angiotensin AT-1 Receptor|angiotensin at-1 receptor
5426691|NCT00001629|Angiotensin Receptor Antagonist|angiotensin receptor antagonist
5426692|NCT00001629|Atherosclerosis|atherosclerosis
5426693|NCT00001629|Blood Flow|blood flow
5426694|NCT00001629|Cold Pressor Test|cold pressor test
5426695|NCT00001629|Endothelium|endothelium
5426696|NCT00001629|Exercise|exercise
5426697|NCT00001629|Coronary Artery Disease|coronary artery disease
5426698|NCT00001629|Heart Failure|heart failure
5426699|NCT00001628|Angiotensin Receptor Antagonist|angiotensin receptor antagonist
5426700|NCT00001628|Atherosclerosis|atherosclerosis
5426701|NCT00001628|Blood Flow|blood flow
5426702|NCT00001628|Endothelium|endothelium
5426703|NCT00001628|Endothelial Dysfunction|endothelial dysfunction
5426704|NCT00001624|BQ-123|bq-123
5426705|NCT00001624|Endothelin|endothelin
5426706|NCT00001624|Insulin|insulin
5426707|NCT00001624|Plethysmography|plethysmography
5426708|NCT00001624|Vasoconstriction|vasoconstriction
5426709|NCT00001624|Healthy Volunteer|healthy volunteer
5426710|NCT00001622|Endothelium|endothelium
5442495|NCT00004733|Sinemet|sinemet
5426711|NCT00001622|Hypercholesterolemia|hypercholesterolemia
5426712|NCT00001622|Hypertension|hypertension
5426713|NCT00001622|Microvessels|microvessels
5426714|NCT00001622|Vasodilation|vasodilation
5426715|NCT00001622|Normal Volunteer|normal volunteer
5426716|NCT00001617|Aging|aging
5426717|NCT00001617|Cataract|cataract
5426718|NCT00001617|Eye|eye
5426719|NCT00001617|Human Lens|human lens
5426720|NCT00001617|Normal Volunteer|normal volunteer
5426721|NCT00001615|Age-Related Macular Degeneration|age-related macular degeneration
5426722|NCT00001615|Choroidal Neovascularization|choroidal neovascularization
5426723|NCT00001615|Disciform|disciform
5426724|NCT00001615|Drusen|drusen
5426725|NCT00001615|Natural History|natural history
5426726|NCT00001615|Periocular|periocular
5426727|NCT00001615|Quality of Life|quality of life
5426728|NCT00001615|Steroids|steroids
5426729|NCT00001615|Corticosteroid|corticosteroid
5426730|NCT00001614|Eye|eye
5426731|NCT00001614|Immunosuppression|immunosuppression
5426732|NCT00001614|Inflammation|inflammation
5426733|NCT00001614|Iritis|iritis
5426734|NCT00001614|Joint|joint
5426735|NCT00001614|Oral Tolerance|oral tolerance
5426736|NCT00001614|Juvenile Rheumatoid Arthritis|juvenile rheumatoid arthritis
5426737|NCT00001614|Uveitis|uveitis
5426738|NCT00001612|Diabetic Retinopathy|diabetic retinopathy
5426739|NCT00001612|Long-Term Visual Outcome|long-term visual outcome
5426740|NCT00001612|Photocoagulation|photocoagulation
5426741|NCT00001612|J. H. Wilmer Eye Institute|j. h. wilmer eye institute
5426742|NCT00001605|Conjugate Vaccine|conjugate vaccine
5426743|NCT00001605|Detoxified Lipooligosaccharide|detoxified lipooligosaccharide
5426744|NCT00001605|Tetanus Toxoid|tetanus toxoid
5426745|NCT00001605|Normal Volunteers|normal volunteers
5426746|NCT00001587|Hyperthermia|hyperthermia
5426747|NCT00001587|Metastases|metastases
5426748|NCT00001587|Organ Perfusion|organ perfusion
5426749|NCT00001587|Regional Therapy|regional therapy
5426750|NCT00001584|Pathogenesis|pathogenesis
5426751|NCT00001584|Resistance|resistance
5426752|NCT00001584|Sanctuary Sites|sanctuary sites
5426753|NCT00001584|Semen|semen
5426754|NCT00001584|Sexual Transmission|sexual transmission
5426755|NCT00001579|Biochemical Modulation|biochemical modulation
5426756|NCT00001579|Dihydropyrimidine Dehydrogenase|dihydropyrimidine dehydrogenase
5426757|NCT00001579|Oral Administration|oral administration
5426758|NCT00001579|Pharmacokinetics|pharmacokinetics
5426759|NCT00001577|Chemotherapy|chemotherapy
5426760|NCT00001577|Hyperthermia|hyperthermia
5426761|NCT00001577|Isolation perfusion|isolation perfusion
5426762|NCT00001577|Regional Therapy|regional therapy
5426763|NCT00001573|Glioma|glioma
5426764|NCT00001573|PDGF|pdgf
5426765|NCT00001573|Pharmacokinetics|pharmacokinetics
5426766|NCT00001573|Sarcoma|sarcoma
5426767|NCT00001573|Toxicity|toxicity
5426768|NCT00001571|Cancer|cancer
5426769|NCT00001571|DDT, PCB|ddt, pcb
5426770|NCT00001571|Epidemiology|epidemiology
5426771|NCT00001571|Pesticides|pesticides
5426772|NCT00001571|Serum|serum
5426773|NCT00001570|Cytochrome P 450|cytochrome p 450
5426774|NCT00001570|Multi-Drug Resistance|multi-drug resistance
5426775|NCT00001570|P-Glycoprotein|p-glycoprotein
5426776|NCT00001570|Pharmacokinetics|pharmacokinetics
5426777|NCT00001565|Brain Tumors|brain tumors
5426778|NCT00001565|Differentiation|differentiation
5426779|NCT00001565|Maximally Tolerated Dose|maximally tolerated dose
5426780|NCT00001565|Neuroblastoma|neuroblastoma
5426781|NCT00001565|Phenylacetate|phenylacetate
5426782|NCT00001554|Cortical Localization|cortical localization
5426783|NCT00001554|Optical Imaging|optical imaging
5426784|NCT00001554|Thermal Imaging|thermal imaging
5426785|NCT00001553|Plasticity|plasticity
5426786|NCT00001553|Recovery|recovery
5426787|NCT00001553|Stroke|stroke
5426788|NCT00001553|Use|use
5426789|NCT00001553|Cortico-subcortical Stroke|cortico-subcortical stroke
5426790|NCT00001546|Biochemical Screening|biochemical screening
5426791|NCT00001546|Body Temperature|body temperature
5426792|NCT00001546|Consent Form|consent form
5426793|NCT00001546|EEG|eeg
5426794|NCT00001546|EKG|ekg
5426795|NCT00001546|Melatonin|melatonin
5426796|NCT00001546|Mood|mood
5426797|NCT00001546|Physical Examination|physical examination
5426798|NCT00001546|Psychiatric Examination|psychiatric examination
5426799|NCT00001546|Sleep Duration|sleep duration
5426800|NCT00001546|Sleep Disorders|sleep disorders
5426801|NCT00001540|Diagnostic|diagnostic
5426802|NCT00001540|Immune Function|immune function
5426803|NCT00001540|Immunization|immunization
5426804|NCT00001540|Immunodeficiency|immunodeficiency
5426805|NCT00001540|Quantitative|quantitative
5426806|NCT00001538|AIDS|aids
5426807|NCT00001538|DNA Vaccine|dna vaccine
5426808|NCT00001538|Naked DNA|naked dna
5426809|NCT00001538|Plasmid|plasmid
5426810|NCT00001538|gp 160|gp 160
5426811|NCT00001536|Disability|disability
5426812|NCT00001536|Dwarfism|dwarfism
5426813|NCT00001536|Ethics in Genetic Counseling|ethics in genetic counseling
5426814|NCT00001536|Quality of Life|quality of life
5426815|NCT00001536|Reproductive Issues|reproductive issues
5426816|NCT00001536|Support Groups|support groups
5426817|NCT00001536|Achondroplasia|achondroplasia
5426818|NCT00001533|Anemia|anemia
5426819|NCT00001533|Chronic T Cell Lymphocytosis with Neutropenia|chronic t cell lymphocytosis with neutropenia
5426820|NCT00001533|Immunosuppression|immunosuppression
5426821|NCT00001533|Neutropenia|neutropenia
5426822|NCT00001533|T-LGL Leukemia|t-lgl leukemia
5426823|NCT00001531|Atherogenesis|atherogenesis
5426824|NCT00001531|Cell Mediated Immunity|cell mediated immunity
5426825|NCT00001531|Coronary Artery Disease|coronary artery disease
5426826|NCT00001530|Cardiac Hypertrophy|cardiac hypertrophy
5426827|NCT00001530|Drug-Refractory|drug-refractory
5426828|NCT00001530|Hemodynamic Benefits|hemodynamic benefits
5426829|NCT00001530|Obstruction|obstruction
5426830|NCT00001530|Pacemaker Therapy|pacemaker therapy
5426831|NCT00001530|Hypertrophic Cardiomyopathy|hypertrophic cardiomyopathy
5426832|NCT00001528|Coronary Artery Disease|coronary artery disease
5426833|NCT00001528|Gated Blood Pool Tomography|gated blood pool tomography
5426834|NCT00001528|Myocardial Blood Flow|myocardial blood flow
5426835|NCT00001528|Myocardial Stunning|myocardial stunning
5426836|NCT00001528|Positron Emission Tomography|positron emission tomography
5426837|NCT00001527|BQ-123|bq-123
5426838|NCT00001527|BQ-788|bq-788
5426839|NCT00001527|Endothelin|endothelin
5426840|NCT00001527|Endothelium|endothelium
5426841|NCT00001527|Plethysmography|plethysmography
5426842|NCT00001527|Essential Hypertension|essential hypertension
5426843|NCT00001523|Cytology|cytology
5426844|NCT00001523|Diagnostic Imaging|diagnostic imaging
5426845|NCT00001523|Radiation Damage|radiation damage
5426846|NCT00001523|Saliva|saliva
5426847|NCT00001523|Serostomia|serostomia
5426848|NCT00001523|Xerostomia|xerostomia
5426849|NCT00001523|Head Cancer|head cancer
5426850|NCT00001523|Neck Cancer|neck cancer
5426851|NCT00001520|Endotracheal Intubation|endotracheal intubation
5426852|NCT00001520|Neuromuscular Blockade|neuromuscular blockade
5426853|NCT00001520|Neuromuscular Blocking Agents|neuromuscular blocking agents
5426854|NCT00001520|Paralysis|paralysis
5426855|NCT00001520|Reversal Agents|reversal agents
5426856|NCT00001519|Exercise|exercise
5426857|NCT00001519|Exercise Intensity|exercise intensity
5426858|NCT00001519|Non-Linear Regression|non-linear regression
5426859|NCT00001519|Oxygen Uptake|oxygen uptake
5426860|NCT00001519|Recovery|recovery
5426861|NCT00001519|Subject Comparison|subject comparison
5426862|NCT00001519|Time Constant|time constant
5426863|NCT00001519|VO2|vo2
5426864|NCT00001518|Groshong Catheter|groshong catheter
5426865|NCT00001518|Heparinized Flush Solution|heparinized flush solution
5426866|NCT00001518|Intraluminal Clot|intraluminal clot
5426867|NCT00001518|Urokinase|urokinase
5426868|NCT00001518|Venous Access Device|venous access device
5426869|NCT00001518|Withdrawal Occlusion|withdrawal occlusion
5426870|NCT00001509|Differentiation|differentiation
5426871|NCT00001509|N-myc Expression|n-myc expression
5426872|NCT00001509|Retinoid|retinoid
5426873|NCT00001509|Solid Tumor|solid tumor
5426874|NCT00001509|Trk Expression|trk expression
5426875|NCT00001502|Blood-Brain Barrier|blood-brain barrier
5426876|NCT00001502|Bradykinin|bradykinin
5426877|NCT00001502|Children|children
5426878|NCT00001502|Glioma|glioma
5426879|NCT00001502|Medulloblastoma|medulloblastoma
5426880|NCT00001499|Carcinoma|carcinoma
5426881|NCT00001499|Combination Chemotherapy|combination chemotherapy
5426882|NCT00001499|Combined Modality Therapy|combined modality therapy
5426883|NCT00001499|Infusion|infusion
5426884|NCT00001499|Intravenous|intravenous
5426885|NCT00001499|Lung Neoplasm|lung neoplasm
5426886|NCT00001499|Non-Small Cell Lung Cancer|non-small cell lung cancer
5426887|NCT00001498|5-Fluorouracil|5-fluorouracil
5426888|NCT00001498|Cyclophosphamide|cyclophosphamide
5426889|NCT00001498|Methotrexate|methotrexate
5426890|NCT00001498|Thiotepa|thiotepa
5426891|NCT00001497|Brain Imaging|brain imaging
5426892|NCT00001497|Encephalopathy|encephalopathy
5426893|NCT00001497|Hyperactivity|hyperactivity
5426894|NCT00001497|Neuroimmunology|neuroimmunology
5426895|NCT00001497|Reaction Time Tasks|reaction time tasks
5426896|NCT00001495|Camptothecin|camptothecin
5426897|NCT00001495|Cancer|cancer
5426898|NCT00001495|Chemotherapy|chemotherapy
5426899|NCT00001495|Natural Products|natural products
5426900|NCT00001495|Neoplasms|neoplasms
5426901|NCT00001493|Dose Intensity|dose intensity
5426902|NCT00001493|Gene Therapy|gene therapy
5426903|NCT00001493|Multidrug Resistance|multidrug resistance
5426904|NCT00001489|Cerebral Metabolism|cerebral metabolism
5426905|NCT00001489|Complex Partial Seizures|complex partial seizures
5426906|NCT00001489|Epilepsy|epilepsy
5426907|NCT00001485|Chemical Mediators|chemical mediators
5426908|NCT00001485|Circadian Rhythms|circadian rhythms
5426909|NCT00001485|Gender Differences|gender differences
5426910|NCT00001485|Melatonin|melatonin
5426911|NCT00001485|Photoperiodism|photoperiodism
5426912|NCT00001485|Seasonal Changes|seasonal changes
5426913|NCT00001482|Anticonvulsants|anticonvulsants
5426914|NCT00001482|Bipolar Disorder|bipolar disorder
5426915|NCT00001482|Depression|depression
5426916|NCT00001482|Gabapentin|gabapentin
5426917|NCT00001482|Lamotrigine|lamotrigine
5426918|NCT00001482|Mania|mania
5426919|NCT00001482|Mood Disorders|mood disorders
5426921|NCT00001479|Adrenocorticotropic Hormone|adrenocorticotropic hormone
5426922|NCT00001479|Antidepressant Treatment|antidepressant treatment
5426923|NCT00001479|Chaos Theory|chaos theory
5426924|NCT00001479|Chronic Fatigue Syndrome|chronic fatigue syndrome
5426925|NCT00001479|Major Depression|major depression
5426926|NCT00001479|Normal Volunteer|normal volunteer
5426927|NCT00001479|Primary Affective Disorder|primary affective disorder
5426928|NCT00001478|Bupropion|bupropion
5426929|NCT00001478|Carbamazepine|carbamazepine
5426930|NCT00001478|Cerebral Blood Flow|cerebral blood flow
5426931|NCT00001478|Gabapentin|gabapentin
5426932|NCT00001478|Lamotrigine|lamotrigine
5426933|NCT00001478|Mood Disorders|mood disorders
5426934|NCT00001478|Nimodipine|nimodipine
5426935|NCT00001478|Oxygen-15|oxygen-15
5426936|NCT00001478|Positron Emission Tomography|positron emission tomography
5426937|NCT00001478|Venlafaxine|venlafaxine
5426938|NCT00001477|Communicable Infection|communicable infection
5426939|NCT00001477|Monitoring|monitoring
5426940|NCT00001477|Non-Invasive Tests|non-invasive tests
5426941|NCT00001477|Opportunistic Infection|opportunistic infection
5426942|NCT00001468|Behavioral and Attitudinal Changes|behavioral and attitudinal changes
5426943|NCT00001468|Breast Cancer|breast cancer
5426944|NCT00001468|High Risk Families|high risk families
5426945|NCT00001468|Inherited Susceptibility|inherited susceptibility
5426946|NCT00001468|Psychological Responses to Risk|psychological responses to risk
5426947|NCT00001466|Clinical Genetics|clinical genetics
5426948|NCT00001466|Etiology|etiology
5426949|NCT00001466|Medical Screening|medical screening
5426950|NCT00001466|Prognosis|prognosis
5426951|NCT00001466|Genetic Disorders|genetic disorders
5426952|NCT00001462|Alpha 1-Antitrypsin Deficiency|alpha 1-antitrypsin deficiency
5426953|NCT00001462|Emphysema|emphysema
5426954|NCT00001462|Genetic Diseases|genetic diseases
5426955|NCT00001462|Inflammation|inflammation
5426956|NCT00001462|Nitric Oxide|nitric oxide
5426957|NCT00001462|Protease|protease
5426958|NCT00001461|Angiotensin Converting Enzyme|angiotensin converting enzyme
5426959|NCT00001461|Angiotensin Converting Enzyme Inhibitors|angiotensin converting enzyme inhibitors
5426960|NCT00001461|Bradykinin|bradykinin
5426961|NCT00001461|Endothelial Function|endothelial function
5426962|NCT00001461|Nitric Oxide|nitric oxide
5426963|NCT00001461|Coronary Artery Disease|coronary artery disease
5426964|NCT00001459|Gated Blood Pool|gated blood pool
5426965|NCT00001459|SPECT Scan|spect scan
5426966|NCT00001459|Coronary Artery Disease|coronary artery disease
5426967|NCT00001459|Hypertrophic Cardiomyopathy|hypertrophic cardiomyopathy
5426968|NCT00001459|Microvascular Angina|microvascular angina
5426969|NCT00001455|Genetics|genetics
5426970|NCT00001455|Hemochromatosis|hemochromatosis
5426971|NCT00001455|Iron Metabolism|iron metabolism
5426972|NCT00001455|Iron Storage Disorder|iron storage disorder
5426973|NCT00001455|Pedigree|pedigree
5426974|NCT00001455|Iron Overload|iron overload
5426975|NCT00001450|Chemotherapy|chemotherapy
5426976|NCT00001450|In Vitro Testing|in vitro testing
5426977|NCT00001450|Infusional|infusional
5426978|NCT00001450|Lung Neoplasm|lung neoplasm
5426979|NCT00001450|Pharmacokinetics|pharmacokinetics
5426980|NCT00001449|Anti-Cancer Agents|anti-cancer agents
5426981|NCT00001449|Antimetabolite|antimetabolite
5426982|NCT00001449|Palliation|palliation
5426983|NCT00001449|Pharmacodynamics|pharmacodynamics
5426984|NCT00001449|Pharmacokinetics|pharmacokinetics
5426985|NCT00001448|Antifungal Therapy|antifungal therapy
5426986|NCT00001448|Articulation|articulation
5426987|NCT00001448|Behavior|behavior
5426988|NCT00001448|Expressive Language|expressive language
5426989|NCT00001448|Thrush|thrush
5426990|NCT00001446|Angiogenesis|angiogenesis
5426991|NCT00001446|Malignancy|malignancy
5426992|NCT00001446|Neuropathy|neuropathy
5426993|NCT00001446|Pharmacokinetics|pharmacokinetics
5426994|NCT00001446|Sedation|sedation
5426995|NCT00001445|Adjuvant-Controlled Study|adjuvant-controlled study
5426996|NCT00001445|Double Blind Randomization|double blind randomization
5426997|NCT00001445|Env-Deleted Inactivated HIV-1|env-deleted inactivated hiv-1
5426998|NCT00001445|Therapeutic HIV Vaccine|therapeutic hiv vaccine
5426999|NCT00001443|AIDS|aids
5427000|NCT00001443|Bioavailability|bioavailability
5427001|NCT00001443|Immunologic Evaluations|immunologic evaluations
5427002|NCT00001443|Pharmacokinetics|pharmacokinetics
5427003|NCT00001443|Toxicity|toxicity
5427004|NCT00001439|Cancer|cancer
5427005|NCT00001439|Immunotherapy|immunotherapy
5427006|NCT00001438|HIV Infection|hiv infection
5427007|NCT00001438|Immune Response|immune response
5427008|NCT00001438|Pediatric|pediatric
5427009|NCT00001438|Pharmacokinetics|pharmacokinetics
5427010|NCT00001438|Toxicity|toxicity
5427011|NCT00001437|Cytokines|cytokines
5427012|NCT00001437|Fibrosis Intensity|fibrosis intensity
5427013|NCT00001437|Post-Radiation Fibrosis|post-radiation fibrosis
5427014|NCT00001437|Radiation Injury|radiation injury
5427015|NCT00001437|Trental|trental
5427016|NCT00001436|Hormone Interactions|hormone interactions
5427017|NCT00001436|IGF-I|igf-i
5427018|NCT00001436|Metastatic|metastatic
5427019|NCT00001436|Pediatric|pediatric
5427020|NCT00001436|Recurrent|recurrent
5427021|NCT00001435|Anxiety|anxiety
5427023|NCT00001435|Family Functioning|family functioning
5427024|NCT00001435|Psychosocial Adjustment|psychosocial adjustment
5427025|NCT00001435|Social Support|social support
5427026|NCT00001431|Combined Modality|combined modality
5427027|NCT00001431|GI Cancer|gi cancer
5427028|NCT00001431|Pancreatic Cancer|pancreatic cancer
5427029|NCT00001431|Radiotherapy|radiotherapy
5427030|NCT00001428|Chemotherapy|chemotherapy
5427031|NCT00001428|Cytokine|cytokine
5427032|NCT00001428|Efficacy|efficacy
5427033|NCT00001428|Palliation|palliation
5427034|NCT00001428|Solid Tumor|solid tumor
5427035|NCT00001427|Pharmacodynamic Studies|pharmacodynamic studies
5427036|NCT00001427|Pharmacokinetics|pharmacokinetics
5427037|NCT00001424|AIDS|aids
5427038|NCT00001424|Children|children
5427039|NCT00001424|Human Immunodeficiency Virus|human immunodeficiency virus
5427040|NCT00001422|Adenine Analogue|adenine analogue
5427041|NCT00001422|Apoptosis|apoptosis
5427042|NCT00001422|Cytokines|cytokines
5427043|NCT00001422|Psoriasis|psoriasis
5427044|NCT00001422|Synovium|synovium
5427045|NCT00001422|Psoriatic Arthritis|psoriatic arthritis
5427046|NCT00001421|Cytotoxicity|cytotoxicity
5427047|NCT00001421|HLA Class I|hla class i
5427048|NCT00001421|Lymphocytes|lymphocytes
5427049|NCT00001421|Muscle|muscle
5427050|NCT00001421|Myositis|myositis
5427051|NCT00001421|Thionamides|thionamides
5427052|NCT00001421|Dermatomyositis|dermatomyositis
5427053|NCT00001421|Polymyositis|polymyositis
5427054|NCT00001416|Bone Disease|bone disease
5427055|NCT00001416|Calcitriol|calcitriol
5427056|NCT00001416|Enzyme Replacement Therapy|enzyme replacement therapy
5427057|NCT00001416|Gaucher's Disease|gaucher's disease
5427058|NCT00001416|Vitamin D|vitamin d
5427059|NCT00001415|IL-1|il-1
5427060|NCT00001415|IL-6|il-6
5427061|NCT00001415|Immune Response|immune response
5427062|NCT00001415|Inflammation|inflammation
5427063|NCT00001415|Steroids|steroids
5427064|NCT00001415|Chronic Fatigue Syndrome|chronic fatigue syndrome
5427065|NCT00001415|Depression|depression
5427066|NCT00001415|Fibromyalgia|fibromyalgia
5427067|NCT00001415|Normal Volunteer|normal volunteer
5427068|NCT00001402|Dilated Cardiomyopathy|dilated cardiomyopathy
5427069|NCT00001402|Hibernating Myocardium|hibernating myocardium
5427070|NCT00001402|Ischemic Cardiomyopathy|ischemic cardiomyopathy
5427071|NCT00001402|Metoprolol|metoprolol
5427072|NCT00001402|Stress Thallium Scintigraphy|stress thallium scintigraphy
5427073|NCT00001402|Congestive Cardiomyopathy|congestive cardiomyopathy
5427074|NCT00001402|Congestive Heart Failure|congestive heart failure
5427075|NCT00001402|Heart Failure|heart failure
5427076|NCT00001395|Cataracts|cataracts
5427077|NCT00001395|Complications|complications
5427078|NCT00001395|Rates of Progression|rates of progression
5427079|NCT00001395|Diabetic Retinopathy|diabetic retinopathy
5427080|NCT00001387|Paclitaxel|paclitaxel
5427081|NCT00001387|Pediatric|pediatric
5427082|NCT00001387|Pharmacokinetics|pharmacokinetics
5427083|NCT00001387|Phase I|phase i
5427084|NCT00001387|Toxicity|toxicity
5427085|NCT00001385|Cancer Diagnosis|cancer diagnosis
5427086|NCT00001385|Cancer Metabolism|cancer metabolism
5427088|NCT00001385|FDG Breast Imaging|fdg breast imaging
5427089|NCT00001385|PET|pet
5427090|NCT00001385|Positron Emission Mammography|positron emission mammography
5427091|NCT00001385|Radiopharmaceutical|radiopharmaceutical
5427092|NCT00001385|Scintimammography|scintimammography
5427093|NCT00001384|14-Day Cycle|14-day cycle
5427094|NCT00001384|Dose Intensity|dose intensity
5427095|NCT00001384|Filgrastim|filgrastim
5427096|NCT00001384|Lymph Node Positive|lymph node positive
5427097|NCT00001384|Non-Cross Resistant|non-cross resistant
5427098|NCT00001383|Cyclosporine Analogue|cyclosporine analogue
5427099|NCT00001383|Multidrug Resistance|multidrug resistance
5427100|NCT00001383|Pgp Blocker|pgp blocker
5427101|NCT00001383|Pump Blocker|pump blocker
5427102|NCT00001383|Taxol Over 90 Hours|taxol over 90 hours
5427103|NCT00001382|Immunotherapy|immunotherapy
5427104|NCT00001382|Vaccine|vaccine
5427105|NCT00001381|Adult|adult
5427106|NCT00001381|Intravesical Chemotherapy|intravesical chemotherapy
5427107|NCT00001378|4-Quadrant Fine Needle Aspiration|4-quadrant fine needle aspiration
5427108|NCT00001378|Biomarkers|biomarkers
5427109|NCT00001378|Chemoprevention|chemoprevention
5427110|NCT00001378|Nipple Suction Aspirates|nipple suction aspirates
5427111|NCT00001378|TGF Beta|tgf beta
5427112|NCT00001377|Familial|familial
5427113|NCT00001377|Inherited Prostate Cancer|inherited prostate cancer
5427114|NCT00001377|Linkage|linkage
5427115|NCT00001377|Prostate Cancer|prostate cancer
5427116|NCT00001376|Androgens|androgens
5427117|NCT00001376|Female|female
5427118|NCT00001376|Immunology|immunology
5427119|NCT00001376|Neuroendocrine Axis|neuroendocrine axis
5427120|NCT00001376|Rheumatoid Arthritis|rheumatoid arthritis
5427121|NCT00001376|Postpartum|postpartum
5427122|NCT00001376|Pregnancy|pregnancy
5427123|NCT00001375|Infection|infection
5427124|NCT00001375|Reactive Arthritis|reactive arthritis
5427125|NCT00001375|Rheumatoid Arthritis|rheumatoid arthritis
5427126|NCT00001375|Synovial Biopsy|synovial biopsy
5427127|NCT00001375|Synovial Fluid|synovial fluid
5427129|NCT00001371|Inflammation|inflammation
5427130|NCT00001371|Lipocortin|lipocortin
5427131|NCT00001371|Phospholipase A-2|phospholipase a-2
5427132|NCT00001371|Skin|skin
5427133|NCT00001371|Uteroglobin|uteroglobin
5427134|NCT00001371|Psoriasis|psoriasis
5427135|NCT00001365|Dextromethorphan|dextromethorphan
5427136|NCT00001365|Dextrorphan|dextrorphan
5427137|NCT00001365|Glutamate Antagonist|glutamate antagonist
5427138|NCT00001365|Parkinson's Disease|parkinson's disease
5427139|NCT00001363|Blood Flow|blood flow
5427140|NCT00001363|Chess Play|chess play
5427141|NCT00001363|Frontal Lobe|frontal lobe
5427142|NCT00001363|Neurobehavioral Deficits|neurobehavioral deficits
5427143|NCT00001363|Neuropsychology|neuropsychology
5427144|NCT00001363|Positron Emission Tomography|positron emission tomography
5427145|NCT00001363|Prefrontal Cortex|prefrontal cortex
5427146|NCT00001346|Diabetic Macular Edema|diabetic macular edema
5427147|NCT00001346|Diabetic Retinopathy|diabetic retinopathy
5427148|NCT00001346|Macular Edema|macular edema
5427149|NCT00001346|Photocoagulation|photocoagulation
5427150|NCT00001346|Psychophysical Testing|psychophysical testing
5427151|NCT00001346|Stiles-Crawford Effect|stiles-crawford effect
5427152|NCT00001344|Diabetes Mellitus|diabetes mellitus
5427153|NCT00001344|Diabetic Neuropathy|diabetic neuropathy
5427154|NCT00001344|Memantine|memantine
5427155|NCT00001344|NMDA Receptor Antagonists|nmda receptor antagonists
5427156|NCT00001344|Neuropathic Pain|neuropathic pain
5427157|NCT00001344|Neuropathy|neuropathy
5427158|NCT00001344|Post-Herpetic Neuralgia|post-herpetic neuralgia
5427159|NCT00001344|Shingles|shingles
5427160|NCT00001342|Electrooculography|electrooculography
5427161|NCT00001342|Electroretinogram|electroretinogram
5427162|NCT00001342|Fluorescein Angiogram|fluorescein angiogram
5427163|NCT00001342|Glycogen Storage Disease|glycogen storage disease
5427164|NCT00001341|Antifolate|antifolate
5427165|NCT00001341|Inhibitor|inhibitor
5427166|NCT00001341|Pharmacokinetics|pharmacokinetics
5427167|NCT00001341|Thymidylate Synthetase|thymidylate synthetase
5427168|NCT00001341|Toxicity|toxicity
5427169|NCT00001338|Fusion Protein|fusion protein
5427170|NCT00001333|Intraventricular|intraventricular
5427171|NCT00001333|Meningeal Malignancy|meningeal malignancy
5427172|NCT00001333|NSC 609699|nsc 609699
5427173|NCT00001333|SKF 104864|skf 104864
5427174|NCT00001333|Topoisomerase 1|topoisomerase 1
5427175|NCT00001332|Cancer Treatment|cancer treatment
5427176|NCT00001332|Chemotherapy|chemotherapy
5427177|NCT00001332|Regional Therapy|regional therapy
5427178|NCT00001332|Surgery|surgery
5427179|NCT00001330|Autoimmune Diseases|autoimmune diseases
5427180|NCT00001330|Connective Tissue Disease|connective tissue disease
5427181|NCT00001330|Scleroderma|scleroderma
5427182|NCT00001330|Silicone Device Implants|silicone device implants
5427183|NCT00001330|Silicone Injection|silicone injection
5427184|NCT00001330|Idiopathic Scleroderma|idiopathic scleroderma
5427185|NCT00001330|Myositis|myositis
5427186|NCT00001330|Systemic Sclerosis|systemic sclerosis
5427187|NCT00001324|Ataxia|ataxia
5427188|NCT00001324|Brain|brain
5427189|NCT00001324|Motor Learning|motor learning
5427190|NCT00001324|Parkinson's Disease|parkinson's disease
5427191|NCT00001324|Physiology|physiology
5427192|NCT00001324|Positron Emission Tomography|positron emission tomography
5427193|NCT00001324|Stroke|stroke
5427194|NCT00001324|Tremor|tremor
5427195|NCT00001324|Voluntary and Involuntary Movement Physiology|voluntary and involuntary movement physiology
5427196|NCT00001324|Movement Disorders|movement disorders
5427197|NCT00001324|Normal Volunteer|normal volunteer
5427198|NCT00001318|Immune Adjuvant|immune adjuvant
5427199|NCT00001318|Phagocytes|phagocytes
5427200|NCT00001318|Non-tuberculous Mycobacterial Infection|non-tuberculous mycobacterial infection
5427201|NCT00001317|Children|children
5427202|NCT00001317|Gamma Interferon|gamma interferon
5427203|NCT00001317|Hospitalizations|hospitalizations
5427204|NCT00001317|Infection|infection
5427205|NCT00001317|Chronic Granulomatous Disease|chronic granulomatous disease
5427206|NCT00001314|Aortic Regurgitation|aortic regurgitation
5427207|NCT00001314|Dobutamine Stress|dobutamine stress
5427208|NCT00001314|Left Ventricular Function|left ventricular function
5427209|NCT00001314|Mitral Regurgitation|mitral regurgitation
5427210|NCT00001314|Myocardial Contractile Reserve|myocardial contractile reserve
5427211|NCT00001314|Transesophageal Echocardiography|transesophageal echocardiography
5427212|NCT00001311|Cell/Flare Meter|cell/flare meter
5427213|NCT00001311|Heparin Coating|heparin coating
5427214|NCT00001311|Inflammation|inflammation
5427215|NCT00001311|Laser Cell Flare Photometry|laser cell flare photometry
5427216|NCT00001311|Multicentric|multicentric
5427217|NCT00001311|Polymethylmetacrylate|polymethylmetacrylate
5427218|NCT00001311|Specular Micrography|specular micrography
5427219|NCT00001311|Specular Microscopy|specular microscopy
5427220|NCT00001301|Adverse Effects|adverse effects
5427221|NCT00001301|Burkitt's Lymphoma|burkitt's lymphoma
5427222|NCT00001301|Diffuse Large Cell Lymphoma|diffuse large cell lymphoma
5427223|NCT00001301|Extended Remission|extended remission
5427224|NCT00001301|Health Status|health status
5427225|NCT00001301|Lymphoblastic Lymphoma|lymphoblastic lymphoma
5427226|NCT00001301|Molecular Studies|molecular studies
5427227|NCT00001300|Adjuvant Chemotherapy|adjuvant chemotherapy
5427228|NCT00001300|Ifosfamide|ifosfamide
5427229|NCT00001300|Randomized Study|randomized study
5427230|NCT00001300|Soft Tissue Sarcoma|soft tissue sarcoma
5427231|NCT00001298|Antibody|antibody
5427232|NCT00001298|DAMPA|dampa
5427233|NCT00001298|Enzyme|enzyme
5427234|NCT00001298|Kidney|kidney
5427235|NCT00001298|Pharmacokinetics|pharmacokinetics
5427236|NCT00001298|Thymidine|thymidine
5427237|NCT00001298|Toxicity|toxicity
5427238|NCT00001296|Interferon-Gamma|interferon-gamma
5427239|NCT00001296|Isolated Limb Perfusion|isolated limb perfusion
5427240|NCT00001296|Melanoma|melanoma
5427241|NCT00001296|Melphalan|melphalan
5427243|NCT00001292|DNA Markers|dna markers
5427244|NCT00001292|Family Studies|family studies
5427245|NCT00001292|Gene Mapping|gene mapping
5427246|NCT00001292|Ichthyosis|ichthyosis
5427247|NCT00001292|Keratin|keratin
5427248|NCT00001292|Linkage Analysis|linkage analysis
5427249|NCT00001292|Scaling Disorders|scaling disorders
5427250|NCT00001292|Skin|skin
5427251|NCT00001291|Osteoarthritis|osteoarthritis
5427252|NCT00001291|Psoriatic Arthritis|psoriatic arthritis
5427253|NCT00001291|Rheumatoid Arthritis|rheumatoid arthritis
5427254|NCT00001291|Synovial Biopsy|synovial biopsy
5427255|NCT00001291|Synovitis|synovitis
5427256|NCT00001291|Synovium|synovium
5427257|NCT00001287|Intravenous High-Dose Immunoglobulin|intravenous high-dose immunoglobulin
5427258|NCT00001287|Monoclonal Gammopathies|monoclonal gammopathies
5427259|NCT00001287|Peripheral Nerve Demyelination|peripheral nerve demyelination
5427260|NCT00001287|CIDP|cidp
5427261|NCT00001287|Chronic Inflammatory Demyelinating Polyneuropathy|chronic inflammatory demyelinating polyneuropathy
5427262|NCT00001285|Circadian Rhythms|circadian rhythms
5427263|NCT00001285|Environmental Light|environmental light
5427264|NCT00001285|Estrogen|estrogen
5427265|NCT00001285|Melatonin|melatonin
5427266|NCT00001285|Progesterone|progesterone
5427267|NCT00001285|Rapid Cycling Bipolar Disorder|rapid cycling bipolar disorder
5427268|NCT00001285|Sleep|sleep
5427269|NCT00001285|Testosterone|testosterone
5427270|NCT00001285|Depression|depression
5427271|NCT00001285|Hypomania|hypomania
5427272|NCT00001285|Mania|mania
5427273|NCT00001280|Aspergillosis|aspergillosis
5427274|NCT00001280|Phagocyte Defect|phagocyte defect
5427275|NCT00001280|Torulopsis|torulopsis
5427276|NCT00001280|Chronic Granulomatous Disease|chronic granulomatous disease
5427277|NCT00001278|Conjunctival Biopsy|conjunctival biopsy
5427278|NCT00001278|Lacrimal Gland Biopsy|lacrimal gland biopsy
5427279|NCT00001278|Sarcoid Uveitis|sarcoid uveitis
5427280|NCT00001278|Sarcoidosis|sarcoidosis
5427281|NCT00001278|Conjunctiva|conjunctiva
5427282|NCT00001278|Inflammatory Eye Disease|inflammatory eye disease
5427283|NCT00001272|Adult|adult
5427284|NCT00001272|Cytotoxic Chemotherapy|cytotoxic chemotherapy
5427285|NCT00001272|Hematopoietic Growth Factor|hematopoietic growth factor
5427286|NCT00001271|Antigen Modulation|antigen modulation
5427287|NCT00001271|Pharmacokinetics|pharmacokinetics
5427288|NCT00001271|Ricin A Chain|ricin a chain
5427289|NCT00001270|Chemotherapy|chemotherapy
5427290|NCT00001270|High Dose|high dose
5427291|NCT00001270|Protection|protection
5427292|NCT00001269|Dose-Intensive Chemotherapy|dose-intensive chemotherapy
5427293|NCT00001269|Hematopoietic Growth Factor|hematopoietic growth factor
5427294|NCT00001269|Peripheral Blood Progenitor Cell|peripheral blood progenitor cell
5427295|NCT00001267|Anti-Viral|anti-viral
5427296|NCT00001267|Dideoxynucleosides|dideoxynucleosides
5427297|NCT00001267|HIV|hiv
5427298|NCT00001267|Retrovirus|retrovirus
5427299|NCT00001249|Interleukin-2 Receptor|interleukin-2 receptor
5427300|NCT00001239|5-Fluorouracil|5-fluorouracil
5427301|NCT00001239|Adriamycin|adriamycin
5427302|NCT00001239|Breast Carcinoma|breast carcinoma
5427303|NCT00001239|Leucovorin|leucovorin
5427304|NCT00001239|Phase II|phase ii
5427305|NCT00001237|Burkitt's Lymphoma|burkitt's lymphoma
5427306|NCT00001237|GM-CSF|gm-csf
5427307|NCT00001237|High-Grade|high-grade
5427308|NCT00001233|Adolescence|adolescence
5427309|NCT00001233|Aggressivity|aggressivity
5427310|NCT00001233|Anger|anger
5427311|NCT00001233|Developmental Psychopathology|developmental psychopathology
5427312|NCT00001233|Disruptive Behavior Disorders|disruptive behavior disorders
5427313|NCT00001233|Early Onset Aggression|early onset aggression
5427314|NCT00001233|Emotion Regulation|emotion regulation
5427315|NCT00001233|Family Violence|family violence
5427316|NCT00001233|Preschool Conduct Problems|preschool conduct problems
5427317|NCT00001232|Depression|depression
5427318|NCT00001232|FSH|fsh
5427319|NCT00001232|GnRH|gnrh
5427320|NCT00001232|LH|lh
5427321|NCT00001232|Menopause|menopause
5427322|NCT00001232|Menstrual Cycle|menstrual cycle
5427323|NCT00001229|Calcium-Pentagastrin|calcium-pentagastrin
5427324|NCT00001229|Clonidine|clonidine
5427325|NCT00001229|Glucagon|glucagon
5427326|NCT00001229|Pheochromocytoma|pheochromocytoma
5427327|NCT00001218|Baseline Data|baseline data
5427328|NCT00001218|Curve Averaging|curve averaging
5427329|NCT00001218|Curve Fitting|curve fitting
5427330|NCT00001218|Movement Patterns|movement patterns
5427331|NCT00001218|Normative Data|normative data
5427332|NCT00001218|Polar Distribution|polar distribution
5427333|NCT00001218|Tongue|tongue
5427334|NCT00001218|Tongue Shape|tongue shape
5427335|NCT00001218|Ultrasound|ultrasound
5427336|NCT00001217|Non-Metastatic Osteosarcoma|non-metastatic osteosarcoma
5427337|NCT00001217|Presurgical Chemotherapy|presurgical chemotherapy
5427338|NCT00001216|Amputations|amputations
5427339|NCT00001216|Brainstem Stimulation|brainstem stimulation
5427340|NCT00001216|Cerebellar Stimulation|cerebellar stimulation
5427341|NCT00001216|Cortical Motor Physiology|cortical motor physiology
5427342|NCT00001216|Electrical Stimulation|electrical stimulation
5427343|NCT00001216|Motor Cortex|motor cortex
5427344|NCT00001216|Plasticity|plasticity
5427345|NCT00001216|Spinal Cord Injury|spinal cord injury
5427346|NCT00001216|Stroke|stroke
5427347|NCT00001211|Ectodermal Dysplasia|ectodermal dysplasia
5427348|NCT00001211|Edentulous|edentulous
5427349|NCT00001211|Endosseous|endosseous
5427350|NCT00001211|Implants|implants
5427351|NCT00001211|Mandibular Atrophy|mandibular atrophy
5427352|NCT00001211|Oral|oral
5427353|NCT00001211|Titanium|titanium
5427354|NCT00001210|Blood Donors|blood donors
5427355|NCT00001210|Epitopes|epitopes
5427356|NCT00001210|HIV|hiv
5427357|NCT00001209|Combined Chemotherapy|combined chemotherapy
5427358|NCT00001209|Irradiation|irradiation
5427359|NCT00001209|Unresectable|unresectable
5427360|NCT00001194|Helium Cryogen|helium cryogen
5427361|NCT00001194|Magnetic Field|magnetic field
5427362|NCT00001194|Multi-Institute|multi-institute
5427363|NCT00001194|Nitrogen Cryogen|nitrogen cryogen
5427364|NCT00001194|Radiofrequency|radiofrequency
5427365|NCT00001193|Autologous|autologous
5427366|NCT00001193|Melphalan|melphalan
5427367|NCT00001193|Stage III|stage iii
5427368|NCT00001193|Transplantation|transplantation
5427369|NCT00001189|Adjuvant Radiotherapy|adjuvant radiotherapy
5427370|NCT00001189|Low-Grade Sarcoma|low-grade sarcoma
5427371|NCT00001189|Radiotherapy|radiotherapy
5427372|NCT00001189|Randomized Study|randomized study
5427373|NCT00001189|Sarcoma|sarcoma
5427374|NCT00001189|Surgery|surgery
5427375|NCT00001188|Chemotherapy|chemotherapy
5427376|NCT00001188|Radiation Therapy|radiation therapy
5427377|NCT00001188|Sarcoma|sarcoma
5427378|NCT00001188|Surgery|surgery
5427379|NCT00001173|B Cells|b cells
5427380|NCT00001173|Humoral Immunity|humoral immunity
5427381|NCT00001173|Lymphocytes|lymphocytes
5427382|NCT00001173|Tetanus Toxoid|tetanus toxoid
5427383|NCT00001169|Chemotherapy|chemotherapy
5427384|NCT00001169|Cytokines|cytokines
5427385|NCT00001169|Immunology|immunology
5427386|NCT00001169|Kala-Azar|kala-azar
5427387|NCT00001169|Leishmaniasis|leishmaniasis
5427388|NCT00001164|Genetic Evaluation|genetic evaluation
5427389|NCT00001164|Immunologic Evaluations|immunologic evaluations
5427390|NCT00001164|Inflammatory Skin Disease|inflammatory skin disease
5427391|NCT00001164|Muscular Dystrophies|muscular dystrophies
5427392|NCT00001164|Neoplastic Skin Diseases|neoplastic skin diseases
5427393|NCT00001164|Neuronal Degenerations|neuronal degenerations
5427394|NCT00001164|Retinal Degenerations|retinal degenerations
5427395|NCT00001164|Viral Diseases|viral diseases
5427396|NCT00001158|Cellular Immunity|cellular immunity
5427397|NCT00001158|Humoral Immunity|humoral immunity
5427398|NCT00001158|Immunodeficiency Disease|immunodeficiency disease
5427399|NCT00001153|Albinism|albinism
5427400|NCT00001153|Ocular Albinism|ocular albinism
5427401|NCT00001153|Oculocutaneous Albinism|oculocutaneous albinism
5427402|NCT00001153|Tyrosinase Negative|tyrosinase negative
5427403|NCT00001153|Tyrosinase Positive|tyrosinase positive
5427404|NCT00001152|Aqueous Humor Dynamics|aqueous humor dynamics
5427405|NCT00001152|Glaucoma|glaucoma
5427406|NCT00001152|Ocular Hypertension|ocular hypertension
5427407|NCT00001152|Pigment Dispersion Syndrome|pigment dispersion syndrome
5427408|NCT00001152|Primary Open Angle Glaucoma|primary open angle glaucoma
5427409|NCT00001152|Pseudo-Exfoliation of the Lens Capsule|pseudo-exfoliation of the lens capsule
5427410|NCT00001142|Body Fat|body fat
5427411|NCT00001142|DXA|dxa
5427412|NCT00001142|HAART|haart
5427413|NCT00001142|Hyperlipidemia|hyperlipidemia
5427414|NCT00001142|Insulin Resistance|insulin resistance
5427415|NCT00001142|Lipodystrophy|lipodystrophy
5427416|NCT00001142|MRI|mri
5427417|NCT00001142|Protease Inhibitor|protease inhibitor
5427418|NCT00001142|Side-Effects|side-effects
5427419|NCT00001142|Visceral Fat|visceral fat
5427420|NCT00001142|Chronic Infection|chronic infection
5427421|NCT00001142|HIV|hiv
5427422|NCT00001142|Healthy Volunteer|healthy volunteer
5427423|NCT00050388|Cancer|cancer
5427424|NCT00050388|Carcinoma|carcinoma
5427425|NCT00050388|Neoplasm|neoplasm
5427426|NCT00050388|Head cancer|head cancer
5427427|NCT00050388|Neck cancer|neck cancer
5427428|NCT00050388|Tongue cancer|tongue cancer
5427429|NCT00050388|Lip cancer|lip cancer
5427430|NCT00050388|Oral Cavity|oral cavity
5427431|NCT00050388|Oropharynx|oropharynx
5427432|NCT00050388|Pharynx|pharynx
5427433|NCT00050388|Larynx|larynx
5427434|NCT00050388|Squamous Cell|squamous cell
5427435|NCT00050388|Salivary Glands|salivary glands
5427436|NCT00050388|Tumor|tumor
5427437|NCT00050388|Lesion|lesion
5427438|NCT00050388|Cancer treatment|cancer treatment
5427439|NCT00050388|Clinical trial|clinical trial
5427440|NCT00050388|Allovectin-7®|allovectin-7®
5427441|NCT00050388|Otorhinolaryngologic Neoplasm|otorhinolaryngologic neoplasm
5427442|NCT00050388|Otolaryngologic Cancer|otolaryngologic cancer
5427443|NCT00050388|Gene therapy|gene therapy
5427444|NCT00050388|Immunotherapy|immunotherapy
5427445|NCT00050388|Cancer research|cancer research
5427446|NCT00050388|Cancer vaccine|cancer vaccine
5427447|NCT00050388|Cancer cells|cancer cells
5427448|NCT00050375|OvaRex|ovarex
5427449|NCT00050375|ovarian|ovarian
5427450|NCT00050375|CA125|ca125
5427451|NCT00050375|murine|murine
5427452|NCT00050375|antibody|antibody
5427453|NCT00050375|immunotherapy|immunotherapy
5427454|NCT00050362|Pain|pain
5427455|NCT00050362|NSAID|nsaid
5427456|NCT00050362|Oral Surgery|oral surgery
5427457|NCT00050362|Hyperalgesia|hyperalgesia
5427458|NCT00050362|Preemptive Analgesia|preemptive analgesia
5427459|NCT00050349|cancer|cancer
5427460|NCT00050349|tumor|tumor
5427461|NCT00050349|tumour|tumour
5427462|NCT00050349|neoplasm|neoplasm
5427463|NCT00050349|carcinoma|carcinoma
5427464|NCT00050349|carcinoid|carcinoid
5427465|NCT00050349|neuroendocrine|neuroendocrine
5427466|NCT00050349|Islet cell|islet cell
5427467|NCT00050349|Gastrinoma|gastrinoma
5427468|NCT00050349|VIPoma|vipoma
5427469|NCT00050349|metastatic|metastatic
5427470|NCT00050349|intravenous|intravenous
5427471|NCT00050349|epothilone|epothilone
5427472|NCT00050336|Stage 3b or 4 (metastatic) non-small cell lung cancer|stage 3b or 4 (metastatic) non-small cell lung cancer
5427473|NCT00050323|Stage IV Renal Cell Carcinoma|stage iv renal cell carcinoma
5427474|NCT00050323|Kidney Cancer|kidney cancer
5427475|NCT00050323|Cancer (General)|cancer (general)
5427476|NCT00050310|Confirmed|confirmed
5427477|NCT00050310|Suspected|suspected
5427478|NCT00050310|Pathogenesis|pathogenesis
5427479|NCT00050310|Bronchoscopy|bronchoscopy
5427480|NCT00050310|Cultures|cultures
5427481|NCT00050310|Anthrax|anthrax
5427482|NCT00050310|Natural History|natural history
5427483|NCT00050310|Vaccinated Healthy Volunteer|vaccinated healthy volunteer
5427484|NCT00050284|Treatment Experienced|treatment experienced
5427485|NCT00050284|Disease Progression|disease progression
5427486|NCT00050284|Anti-HIV Agents|anti-hiv agents
5427487|NCT00050284|Treatment Interruption|treatment interruption
5427488|NCT00050271|Acetylcarnitine|acetylcarnitine
5427489|NCT00050271|Dideoxynucleosides|dideoxynucleosides
5427490|NCT00050271|Epidermis|epidermis
5427491|NCT00050271|Biopsy|biopsy
5427492|NCT00050271|Immunohistochemistry|immunohistochemistry
5427493|NCT00050271|Nerve Fibers|nerve fibers
5427494|NCT00050271|Treatment Experienced|treatment experienced
5427495|NCT00050245|Neuropathy|neuropathy
5427496|NCT00050245|B Cells|b cells
5427497|NCT00050245|Anti-MAG|anti-mag
5427498|NCT00050245|Demyelination|demyelination
5427499|NCT00050245|MAG|mag
5427500|NCT00050245|RITUXAN|rituxan
5427501|NCT00050245|Monoclonal Antibodies|monoclonal antibodies
5427502|NCT00050245|Retuximab|retuximab
5427503|NCT00050245|Demyelinating Neuropathy|demyelinating neuropathy
5427504|NCT00050232|Pseudobulbar Affect|pseudobulbar affect
5427505|NCT00050232|Uncontrolled|uncontrolled
5427506|NCT00050232|Laughing|laughing
5427507|NCT00050232|Crying|crying
5427508|NCT00050219|Raclopride|raclopride
5427509|NCT00050219|D2 Receptors|d2 receptors
5427510|NCT00050219|Striatum|striatum
5427511|NCT00050219|Low-Response|low-response
5427512|NCT00050219|Alcoholism|alcoholism
5427513|NCT00050219|Alcohol|alcohol
5427514|NCT00050219|Dopamine|dopamine
5427515|NCT00050219|Response|response
5427516|NCT00050141|Breast cancer|breast cancer
5427517|NCT00050141|ZARNESTRA|zarnestra
5427518|NCT00050141|tipifarnib|tipifarnib
5427519|NCT00050141|R115777|r115777
5427520|NCT00050141|Estrogen receptor positive|estrogen receptor positive
5427521|NCT00050141|Progesterone receptor positive|progesterone receptor positive
5427522|NCT00050141|Anti-estrogen therapy|anti-estrogen therapy
5427523|NCT00050167|Breast Cancer|breast cancer
5427524|NCT00050167|Capecitabine|capecitabine
5427525|NCT00050167|Docetaxel|docetaxel
5427526|NCT00050167|Paclitaxel|paclitaxel
5427527|NCT00050167|Taxotere|taxotere
5427528|NCT00050167|Taxol|taxol
5427529|NCT00050167|Xeloda|xeloda
5427530|NCT00050167|Taxanes|taxanes
5427531|NCT00050167|Operable Breast Cancer|operable breast cancer
5427532|NCT00050193|Children|children
5427533|NCT00050193|Mast Cells|mast cells
5427534|NCT00050193|Urticaria Pigmentosa|urticaria pigmentosa
5427535|NCT00050193|Bone Marrow|bone marrow
5427536|NCT00050193|Severe|severe
5427537|NCT00050193|Mastocytosis|mastocytosis
5427538|NCT00050193|Pediatric Mastocytosis|pediatric mastocytosis
5427539|NCT00050180|P-Glycoprotein|p-glycoprotein
5427540|NCT00050180|Protease Inhibitor|protease inhibitor
5427541|NCT00050180|Antiretrovirals|antiretrovirals
5427542|NCT00050180|Cytochrome P450|cytochrome p450
5427543|NCT00050180|Drug Transporters|drug transporters
5427544|NCT00050180|Healthy Volunteer|healthy volunteer
5427546|NCT00050154|R115777|r115777
5442496|NCT00004733|tremor|tremor
5427547|NCT00050154|Myelodysplastic syndromes|myelodysplastic syndromes
5427548|NCT00050154|Tipifarnib|tipifarnib
5427549|NCT00050154|Zarnestra|zarnestra
5427550|NCT00050128|Rehabilitation|rehabilitation
5427551|NCT00050128|Plasticity|plasticity
5427552|NCT00050128|Frequency|frequency
5427553|NCT00050128|Inhibition|inhibition
5427554|NCT00050128|Pinch|pinch
5427555|NCT00050128|Stroke|stroke
5427556|NCT00050089|AIDS|aids
5427557|NCT00050089|antiretrovirals|antiretrovirals
5427558|NCT00050089|ART|art
5427559|NCT00050089|drug-free period|drug-free period
5427560|NCT00050089|HAART|haart
5427561|NCT00050089|HIV|hiv
5427562|NCT00050089|human immunodeficiency virus|human immunodeficiency virus
5427563|NCT00050089|randomized|randomized
5427564|NCT00050089|structured treatment interruptions|structured treatment interruptions
5427565|NCT00050076|Congestive Heart Failure|congestive heart failure
5427566|NCT00050076|Cardiac Failure|cardiac failure
5427567|NCT00050076|Heart Decompensation|heart decompensation
5427568|NCT00050076|Drug Therapy|drug therapy
5427569|NCT00050063|HIV Therapeutic Vaccine|hiv therapeutic vaccine
5427570|NCT00050063|Treatment Experienced|treatment experienced
5427571|NCT00050063|AIDS Vaccines|aids vaccines
5427572|NCT00050063|Treatment Interruption|treatment interruption
5427573|NCT00050063|Viral Load|viral load
5427574|NCT00050063|T-Lymphocytes, Cytotoxic|t-lymphocytes, cytotoxic
5427575|NCT00050063|T-Lymphocytes, Helper-Inducer|t-lymphocytes, helper-inducer
5427576|NCT00050050|Adult|adult
5427577|NCT00050050|ADHD|adhd
5427578|NCT00050050|ADD|add
5427579|NCT00050115|Bone Marrow Failure|bone marrow failure
5427580|NCT00050115|Seronegative Hepatitis|seronegative hepatitis
5427581|NCT00050115|Fulminate Hepatitis|fulminate hepatitis
5427582|NCT00050115|Hepatitis|hepatitis
5427583|NCT00050115|Aplastic Anemia|aplastic anemia
5427584|NCT00050115|Hepatitis Associated Aplastic Anemia|hepatitis associated aplastic anemia
5427585|NCT00050024|TMS|tms
5427586|NCT00050024|Afferent Stimulation|afferent stimulation
5427587|NCT00050024|Motor Cortex|motor cortex
5427588|NCT00050024|Writer's Cramp|writer's cramp
5427589|NCT00050024|Surround Inhibition|surround inhibition
5427590|NCT00050024|Heterotopic Inhibition|heterotopic inhibition
5427591|NCT00050024|Focal Dystonia|focal dystonia
5427592|NCT00050024|Writer Cramp|writer cramp
5427593|NCT00050011|cancer-treatment related bone loss|cancer-treatment related bone loss
5427594|NCT00050011|postmenopausal women|postmenopausal women
5427595|NCT00050011|breast cancer|breast cancer
5427596|NCT00050011|hormone receptor positive breast cancer|hormone receptor positive breast cancer
5427597|NCT00050011|adjuvant therapy|adjuvant therapy
5427598|NCT00050011|hormonal therapy|hormonal therapy
5427599|NCT00050011|bone loss|bone loss
5427600|NCT00050011|bisphosphonates|bisphosphonates
5427601|NCT00050011|ZFAST|zfast
5427602|NCT00050011|Letrozole|letrozole
5427603|NCT00050011|Zoledronic Acid|zoledronic acid
5427604|NCT00050011|US32|us32
5427605|NCT00049998|Nonsmall Cell Lung cancer|nonsmall cell lung cancer
5427606|NCT00049998|advanced|advanced
5427607|NCT00049998|Second-line|second-line
5427608|NCT00049998|topotecan|topotecan
5427609|NCT00049998|Hycamtin|hycamtin
5427610|NCT00049998|oral|oral
5427611|NCT00049998|docetaxel|docetaxel
5427612|NCT00049972|Major Depressive Disorder Open-label discontinued|major depressive disorder open-label discontinued
5427613|NCT00049959|Verteporfin PDT|verteporfin pdt
5427614|NCT00049959|multiple basal cell carcinoma|multiple basal cell carcinoma
5427615|NCT00049959|nevoid basal cell carcinoma syndrome|nevoid basal cell carcinoma syndrome
5427616|NCT00049946|Talnetant|talnetant
5427617|NCT00049946|schizophrenia|schizophrenia
5427618|NCT00049946|NK3 receptor antagonist|nk3 receptor antagonist
5427619|NCT00049946|psychosis|psychosis
5427620|NCT00049829|Bisphosphonate,BMD,Height loss, Hip protectors,HRT,|bisphosphonate,bmd,height loss, hip protectors,hrt,
5427621|NCT00049829|Osteoporosis|osteoporosis
5427622|NCT00049816|knee|knee
5427623|NCT00049816|aerobic exercise|aerobic exercise
5427624|NCT00049816|walking|walking
5427625|NCT00049816|cycling|cycling
5427626|NCT00049816|gait|gait
5427627|NCT00049816|MRI|mri
5427628|NCT00049803|Narcolepsy|narcolepsy
5427629|NCT00049803|Sodium Oxybate|sodium oxybate
5427630|NCT00049803|Cataplexy|cataplexy
5427631|NCT00049803|Excessive Daytime Sleepiness|excessive daytime sleepiness
5427632|NCT00049803|GHB|ghb
5427633|NCT00049803|Gamma Hydroxybutyric Acid|gamma hydroxybutyric acid
5427634|NCT00049803|Orphan Medical|orphan medical
5427635|NCT00049803|Orphan Drug|orphan drug
5427636|NCT00049790|Advanced non-small cell lung cancer|advanced non-small cell lung cancer
5427637|NCT00049738|Psychosis|psychosis
5427638|NCT00049738|Childhood Onset Schizophrenia|childhood onset schizophrenia
5427639|NCT00049738|Schizophrenia|schizophrenia
5427640|NCT00049738|Schizoaffective|schizoaffective
5427641|NCT00049738|Psychotic Disorder|psychotic disorder
5427642|NCT00049738|Multidimensionally Impaired Syndrome|multidimensionally impaired syndrome
5427643|NCT00049725|Autoimmune Disease|autoimmune disease
5427644|NCT00049725|Monoclonal Antibody Therapy|monoclonal antibody therapy
5427645|NCT00049725|Anti-IL2 Receptor|anti-il2 receptor
5427646|NCT00049725|Platelets|platelets
5427647|NCT00049725|Monoclonal Antibody|monoclonal antibody
5427648|NCT00049725|Immune Thrombocytopenia|immune thrombocytopenia
5427649|NCT00049725|ITP|itp
5427650|NCT00048841|Male|male
5427651|NCT00048841|Osteoporosis|osteoporosis
5427652|NCT00048841|Prostate cancer|prostate cancer
5427653|NCT00048841|Hypogonadism|hypogonadism
5427654|NCT00048841|Bisphosphonates|bisphosphonates
5427655|NCT00048841|Bone mineral density|bone mineral density
5427656|NCT00048815|Minor Depression|minor depression
5427657|NCT00048815|St. John's Wart|st. john's wart
5427658|NCT00048802|Adolescence|adolescence
5427659|NCT00048906|Pharmacokinetics|pharmacokinetics
5427660|NCT00048906|Enzyme|enzyme
5427661|NCT00048906|Lysosomal|lysosomal
5427662|NCT00048906|Kidney|kidney
5427663|NCT00048906|Stroke|stroke
5427664|NCT00048906|Fabry Disease|fabry disease
5427665|NCT00048906|Fabrys|fabrys
5427666|NCT00048906|Fabry's|fabry's
5427667|NCT00048893|CEA vaccine|cea vaccine
5427668|NCT00048893|Metastatic Breast Cancer|metastatic breast cancer
5427669|NCT00048893|T- Cell Repertoire|t- cell repertoire
5427670|NCT00048893|High-dose Chemotherapy|high-dose chemotherapy
5427671|NCT00048893|Breast Cancer|breast cancer
5427672|NCT00048880|Anaplastic Large Cell Lymphoma|anaplastic large cell lymphoma
5427673|NCT00048880|Monoclonal Antibody|monoclonal antibody
5427674|NCT00048880|CD30|cd30
5427675|NCT00048880|Antibody Saturation|antibody saturation
5427676|NCT00048880|Apoptosis|apoptosis
5427677|NCT00048880|Flow Cytometry|flow cytometry
5427678|NCT00048880|Cancer|cancer
5427679|NCT00048776|Secondary Raynaud's|secondary raynaud's
5427680|NCT00048776|circulatory|circulatory
5427681|NCT00048776|vascular|vascular
5427682|NCT00048776|scleroderma|scleroderma
5427683|NCT00048776|lupus|lupus
5427684|NCT00048776|mixed connective tissue disease|mixed connective tissue disease
5427685|NCT00048763|circulatory|circulatory
5427686|NCT00048763|vascular|vascular
5427687|NCT00048763|idiopathic|idiopathic
5427688|NCT00048789|Psoralen|psoralen
5427689|NCT00048789|Refractory|refractory
5427690|NCT00048789|Transplantation|transplantation
5427691|NCT00048789|Stem Cell|stem cell
5427692|NCT00048789|UVA|uva
5427693|NCT00048789|Graft-versus-host Disease|graft-versus-host disease
5427694|NCT00048789|GVHD|gvhd
5427695|NCT00048750|Anti-Fungal Therapy|anti-fungal therapy
5427696|NCT00048750|Preemptive Anti-Fungal Therapy|preemptive anti-fungal therapy
5427697|NCT00048750|Invasive Fungal Infection|invasive fungal infection
5427698|NCT00048750|Micafungin|micafungin
5427699|NCT00048750|ICU|icu
5427700|NCT00048737|Leukemia|leukemia
5427701|NCT00048737|Lymphoma|lymphoma
5427702|NCT00048737|Lymphoid Malignancy|lymphoid malignancy
5427703|NCT00048737|Cyclophosphamide|cyclophosphamide
5427704|NCT00048737|Cytoxan|cytoxan
5427705|NCT00048737|Neosar|neosar
5427706|NCT00048737|Fludarabine|fludarabine
5427707|NCT00048737|Fludarabine Phosphate|fludarabine phosphate
5427708|NCT00048737|Fludara|fludara
5427709|NCT00048737|Rituximab|rituximab
5427710|NCT00048737|Rituxan|rituxan
5427711|NCT00048737|Zevalin|zevalin
5427712|NCT00048737|Indium Zevalin|indium zevalin
5427713|NCT00048737|90Y Zevalin|90y zevalin
5427714|NCT00048737|CD-20-positive|cd-20-positive
5427715|NCT00048737|B-cell Lymphoma|b-cell lymphoma
5427716|NCT00048737|CD-20-positive B-cell Lymphoma|cd-20-positive b-cell lymphoma
5427717|NCT00048737|NHL|nhl
5427718|NCT00048737|CLL|cll
5427719|NCT00048737|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
5427720|NCT00048737|Allogeneic Stem Cell Transplantation|allogeneic stem cell transplantation
5427721|NCT00048737|ASCT|asct
5427722|NCT00048724|Hepatitis C; Cirrhosis|hepatitis c; cirrhosis
5427723|NCT00048698|Frontal Lobe|frontal lobe
5427724|NCT00048698|Motor Cortex|motor cortex
5427725|NCT00048698|Dementia|dementia
5427726|NCT00048698|Cognition|cognition
5427727|NCT00048698|Healthy Volunteer|healthy volunteer
5427728|NCT00048698|HV|hv
5427729|NCT00048685|Caries|caries
5427730|NCT00048685|Bacteria|bacteria
5427731|NCT00048685|Saliva|saliva
5427732|NCT00048685|Teeth|teeth
5427733|NCT00048685|Autoimmune|autoimmune
5427734|NCT00048685|Dry Mouth|dry mouth
5427735|NCT00048685|Salivary Gland Dysfunction|salivary gland dysfunction
5427736|NCT00048685|Sjogren's Syndrome|sjogren's syndrome
5427737|NCT00048672|Early Chronic Phase Chronic Myelogenous Leukemia|early chronic phase chronic myelogenous leukemia
5427738|NCT00048672|Leukemia|leukemia
5427739|NCT00048672|Gleevec|gleevec
5427740|NCT00048672|STI571|sti571
5427741|NCT00048672|Imatinib mesylate|imatinib mesylate
5427742|NCT00048659|Androgen-independent prostate cancer|androgen-independent prostate cancer
5427743|NCT00048646|TBI|tbi
5427744|NCT00048646|ProTECT|protect
5427745|NCT00048633|Chemotherapy resistance advanced breast cancer|chemotherapy resistance advanced breast cancer
5427746|NCT00048542|Polyarticular Juvenile Idiopathic Arthritis|polyarticular juvenile idiopathic arthritis
5427747|NCT00048529|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
5427748|NCT00048503|Zarnestra|zarnestra
5427749|NCT00048503|Acute myeloid leukemia|acute myeloid leukemia
5427750|NCT00048503|Tipifarnib|tipifarnib
5427751|NCT00048464|Immunotherapy|immunotherapy
5427752|NCT00048464|T Cell Therapy|t cell therapy
5427753|NCT00048464|Peripheral Blood Stem Cell Transplant|peripheral blood stem cell transplant
5427754|NCT00048464|Bone marrow transplant|bone marrow transplant
5427755|NCT00048464|Adoptive immunotherapy|adoptive immunotherapy
5427756|NCT00048464|Xcellerate|xcellerate
5427757|NCT00048425|Decompensated chronic heart failure|decompensated chronic heart failure
5427758|NCT00048490|Seizures|seizures
5427759|NCT00048490|Magnetism|magnetism
5427760|NCT00048490|Brain|brain
5427761|NCT00048490|Stimulation|stimulation
5427762|NCT00048490|Therapy|therapy
5427763|NCT00048490|Epilepsy|epilepsy
5427764|NCT00048477|Endothelium|endothelium
5427765|NCT00048477|Vasodilation|vasodilation
5427766|NCT00048477|Exercise|exercise
5427767|NCT00048477|Hemoglobin|hemoglobin
5427768|NCT00048477|Blood Flow|blood flow
5427769|NCT00048477|Healthy Volunteer|healthy volunteer
5427770|NCT00048477|HV|hv
5427771|NCT00048373|LANGERHANS|langerhans
5427772|NCT00048373|HISTIOCYTOSIS|histiocytosis
5427773|NCT00048360|ADD|add
5427774|NCT00048360|ADHD|adhd
5427775|NCT00048360|attention deficit|attention deficit
5427776|NCT00048360|hyperactivity|hyperactivity
5427777|NCT00048308|CABG|cabg
5427778|NCT00048347|Lymphocyte|lymphocyte
5427779|NCT00048347|Monocyte|monocyte
5427780|NCT00048347|Inflammation|inflammation
5427781|NCT00048347|Th2|th2
5427782|NCT00048347|Colonoscopy|colonoscopy
5427783|NCT00048347|Ulcerative Colitis|ulcerative colitis
5427784|NCT00048334|Histone Acetylation|histone acetylation
5427785|NCT00048334|Cancer|cancer
5427786|NCT00048282|Incidence|incidence
5427787|NCT00048282|HIV Seroprevalence|hiv seroprevalence
5427788|NCT00048282|Vagina|vagina
5427789|NCT00048282|Anti-Infective Agents|anti-infective agents
5427790|NCT00048282|Administration, Topical|administration, topical
5427791|NCT00048282|Gels|gels
5427792|NCT00048282|HIV Seronegativity|hiv seronegativity
5427793|NCT00048230|Relapsed Multiple Myeloma|relapsed multiple myeloma
5427794|NCT00048230|Refractory Multiple Myeloma|refractory multiple myeloma
5427795|NCT00048217|Treatment Experienced|treatment experienced
5427796|NCT00048204|Depression|depression
5427797|NCT00048204|Psychiatry|psychiatry
5427798|NCT00048204|Major Depressive Disorder|major depressive disorder
5427799|NCT00048256|Cancer|cancer
5427800|NCT00048256|Personality Assessment|personality assessment
5427801|NCT00048256|Coping Styles|coping styles
5427802|NCT00048256|Psychological Distress|psychological distress
5427803|NCT00048256|Bone Marrow Transplants|bone marrow transplants
5427804|NCT00048256|Bone Marrow Transplant|bone marrow transplant
5427805|NCT00048113|Crohn's|crohn's
5427806|NCT00048100|Dendritic cells|dendritic cells
5427807|NCT00048100|Lymphocytes|lymphocytes
5427808|NCT00048100|AML|aml
5427809|NCT00048087|Non-small cell lung cancer|non-small cell lung cancer
5427810|NCT00047983|Kidney Transplantation|kidney transplantation
5427811|NCT00047983|Fatty Acids, Omega-3|fatty acids, omega-3
5427812|NCT00047983|Erythrocyte Membrane|erythrocyte membrane
5427813|NCT00047983|Graft Survival|graft survival
5427814|NCT00047970|Breast Cancer|breast cancer
5427815|NCT00047970|Sisters|sisters
5427816|NCT00047827|Aspergillus|aspergillus
5427817|NCT00047827|Aspergillosis|aspergillosis
5427818|NCT00047827|Anti-Fungal|anti-fungal
5427819|NCT00047827|AmBisome|ambisome
5427820|NCT00047827|Micafungin|micafungin
5427821|NCT00047814|HCV|hcv
5427822|NCT00047957|Transcranial|transcranial
5427823|NCT00047957|Magnetic|magnetic
5427824|NCT00047957|Stimulation|stimulation
5427825|NCT00047957|Motor|motor
5427826|NCT00047957|Cortex|cortex
5427827|NCT00047957|Motor Cortex|motor cortex
5427828|NCT00047957|Afferent Stimulation|afferent stimulation
5427829|NCT00047957|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
5427830|NCT00047957|Healthy Volunteer|healthy volunteer
5427831|NCT00047957|HV|hv
5427832|NCT00047944|Attention|attention
5427833|NCT00047944|Emotion|emotion
5427834|NCT00047944|Amygdala|amygdala
5427835|NCT00047944|Prefrontal Cortex|prefrontal cortex
5427836|NCT00047944|Facial Expression|facial expression
5427837|NCT00047944|Magnetic Resonance Imaging|magnetic resonance imaging
5427838|NCT00047944|fMRI|fmri
5427839|NCT00047944|Depression|depression
5427840|NCT00047944|Anxiety|anxiety
5427841|NCT00047944|Adolescence|adolescence
5427842|NCT00047944|Children|children
5427843|NCT00047931|Healthy|healthy
5427844|NCT00047931|HIV-Negative|hiv-negative
5427845|NCT00047931|Placebo-Controlled|placebo-controlled
5427846|NCT00047931|Volunteer|volunteer
5427847|NCT00047931|Dose-Escalation|dose-escalation
5427848|NCT00047931|HIV Seronegativity|hiv seronegativity
5427849|NCT00047931|Healthy Volunteer|healthy volunteer
5427850|NCT00047931|HV|hv
5427851|NCT00047918|Mast Cells|mast cells
5427852|NCT00047918|Bone Marrow|bone marrow
5427853|NCT00047918|Flushing|flushing
5427854|NCT00047918|Mutations|mutations
5427855|NCT00047918|Mastocytosis|mastocytosis
5427856|NCT00047918|Anaphylaxis|anaphylaxis
5427857|NCT00047905|Qualitative|qualitative
5427858|NCT00047905|Communication Analysis|communication analysis
5427859|NCT00047905|RIAS|rias
5427860|NCT00047905|Counseling Models|counseling models
5427861|NCT00047905|Videotaping|videotaping
5427862|NCT00047905|Prenatal Genetic Counselors|prenatal genetic counselors
5427863|NCT00047905|Counseling Process|counseling process
5427864|NCT00047905|Video Tape Study|video tape study
5427865|NCT00047905|Simulated Clients|simulated clients
5427866|NCT00047905|Prenatal Genetic Counseling|prenatal genetic counseling
5427867|NCT00047879|Brain Tumors|brain tumors
5427868|NCT00047879|Experimental|experimental
5427869|NCT00047879|Toxicities|toxicities
5427870|NCT00047879|Efficacy|efficacy
5427871|NCT00047879|Progression-Free|progression-free
5427872|NCT00047879|Brain Tumor|brain tumor
5427873|NCT00047879|Glioma|glioma
5427874|NCT00047866|Limbic System|limbic system
5427875|NCT00047866|Amphetamine|amphetamine
5427876|NCT00047866|Dopamine|dopamine
5427877|NCT00047866|Brain Imaging|brain imaging
5427878|NCT00047866|Cerebral Blood Flow|cerebral blood flow
5427879|NCT00047866|Cerebral Blood Volume|cerebral blood volume
5427880|NCT00047866|Alcoholism|alcoholism
5427881|NCT00047866|Tyrosine Depletion|tyrosine depletion
5427882|NCT00047866|Amino Acids|amino acids
5427883|NCT00047866|Affect|affect
5427884|NCT00047866|Healthy Volunteer|healthy volunteer
5427885|NCT00047866|HV|hv
5427886|NCT00047853|Anxiety|anxiety
5427887|NCT00047853|Neuroimaging|neuroimaging
5427888|NCT00047853|Affective Neuroscience|affective neuroscience
5427889|NCT00047853|Healthy Volunteer|healthy volunteer
5427890|NCT00047853|HV|hv
5427891|NCT00047788|Relapsed Multiple Myeloma|relapsed multiple myeloma
5427892|NCT00047554|open-angle|open-angle
5427893|NCT00047554|glaucoma|glaucoma
5427894|NCT00047554|ocular|ocular
5427895|NCT00047554|hypertension|hypertension
5427896|NCT00047554|primary open-angle glaucoma|primary open-angle glaucoma
5427897|NCT00047554|iris|iris
5427898|NCT00047554|pigmentation|pigmentation
5427899|NCT00047541|open-angle|open-angle
5427900|NCT00047541|glaucoma|glaucoma
5427901|NCT00047541|ocular|ocular
5427902|NCT00047541|hypertension|hypertension
5427903|NCT00047541|POAG|poag
5427904|NCT00047528|open-angle|open-angle
5427905|NCT00047528|glaucoma|glaucoma
5427906|NCT00047528|ocular|ocular
5427907|NCT00047528|hypertension|hypertension
5427908|NCT00047528|POAG|poag
5427909|NCT00047515|open-angle|open-angle
5427910|NCT00047515|glaucoma|glaucoma
5427911|NCT00047515|ocular|ocular
5427912|NCT00047515|hypertension|hypertension
5427913|NCT00047515|POAG|poag
5427914|NCT00047749|pain|pain
5427915|NCT00047749|ziconotide|ziconotide
5427916|NCT00047749|Prialt|prialt
5427917|NCT00047749|intrathecal|intrathecal
5427918|NCT00047749|Synchromed|synchromed
5427919|NCT00047736|Non-small cell lung cancer|non-small cell lung cancer
5427920|NCT00047723|ALS|als
5427921|NCT00047723|amyotrophic lateral sclerosis|amyotrophic lateral sclerosis
5427922|NCT00047723|minocycline|minocycline
5427923|NCT00047710|pancreatic cancer|pancreatic cancer
5427924|NCT00047710|pancreas cancer|pancreas cancer
5427925|NCT00047710|pancreas|pancreas
5427926|NCT00047684|Child Abuse, Sexual|child abuse, sexual
5427927|NCT00047671|Depressive Disorder|depressive disorder
5427928|NCT00047645|lung|lung
5427929|NCT00047645|IPF|ipf
5427930|NCT00047632|ovarian|ovarian
5427931|NCT00047632|carcinoma|carcinoma
5427932|NCT00047632|peritoneal|peritoneal
5427933|NCT00047632|cancer|cancer
5427934|NCT00047632|ovary|ovary
5427935|NCT00047632|interferon gamma|interferon gamma
5427936|NCT00047606|open-angle|open-angle
5427937|NCT00047606|glaucoma|glaucoma
5427938|NCT00047606|ocular|ocular
5427939|NCT00047606|hypertension|hypertension
5427940|NCT00047606|POAG|poag
5427941|NCT00047606|Iris|iris
5427942|NCT00047606|Pigmentation|pigmentation
5427943|NCT00047606|Japanese|japanese
5427944|NCT00047593|open-angle|open-angle
5427945|NCT00047593|glaucoma|glaucoma
5427946|NCT00047593|ocular|ocular
5427947|NCT00047593|hypertension|hypertension
5427948|NCT00047593|POAG|poag
5427949|NCT00047593|Iris|iris
5427950|NCT00047593|Pigmentation|pigmentation
5427951|NCT00047593|Japanese|japanese
5427952|NCT00047619|Decubitus Ulcers|decubitus ulcers
5427953|NCT00047619|Pulsatile Lavage|pulsatile lavage
5427954|NCT00047619|SCI|sci
5427955|NCT00047619|Spinal Cord Injury|spinal cord injury
5427956|NCT00047619|Wound healing|wound healing
5427957|NCT00047619|pressure ulcer|pressure ulcer
5427958|NCT00047580|Spasticity|spasticity
5427959|NCT00047580|spasticity secondary to Multiple Sclerosis|spasticity secondary to multiple sclerosis
5427960|NCT00047580|Spinal Cord Injury|spinal cord injury
5427961|NCT00047580|Stroke|stroke
5427962|NCT00047567|ZONISAMIDE|zonisamide
5427963|NCT00047567|BIPOLAR|bipolar
5427964|NCT00046371|Cancer Vaccines|cancer vaccines
5427965|NCT00046371|Aromatase|aromatase
5427966|NCT00046371|Receptors, Estrogen|receptors, estrogen
5427967|NCT00046371|Receptors, Progesterone|receptors, progesterone
5427968|NCT00047476|neurobehavioral function|neurobehavioral function
5427969|NCT00047476|chemobrain|chemobrain
5427970|NCT00047476|chemo brain|chemo brain
5427971|NCT00047476|fatigue|fatigue
5427972|NCT00047476|memory loss|memory loss
5427973|NCT00047476|exhausted|exhausted
5427974|NCT00047476|trouble concentrating|trouble concentrating
5427977|NCT00047463|obstructive sleep apnea|obstructive sleep apnea
5427978|NCT00047463|continuous positive airway pressure|continuous positive airway pressure
5427979|NCT00047463|CPAP|cpap
5427980|NCT00047450|Psychotic Disorders|psychotic disorders
5427981|NCT00047411|CPR, AED|cpr, aed
5427982|NCT00046800|Ovarian Cancer|ovarian cancer
5427983|NCT00046787|Small Cell Lung Cancer|small cell lung cancer
5427984|NCT00046761|Acute Ischemic Stroke|acute ischemic stroke
5427985|NCT00046774|Safety|safety
5427986|NCT00046774|Nephritis|nephritis
5427987|NCT00046774|Biologic Therapy|biologic therapy
5427988|NCT00046774|Lymphocytes|lymphocytes
5427989|NCT00046774|Response|response
5427990|NCT00046774|Lupus|lupus
5427991|NCT00046774|Systemic Lupus Erythematosus|systemic lupus erythematosus
5427992|NCT00046774|SLE|sle
5427993|NCT00046735|solid tumors|solid tumors
5427994|NCT00046735|Revimid|revimid
5427995|NCT00046735|CC5013|cc5013
5427996|NCT00046735|CC-5013|cc-5013
5427997|NCT00046722|treatment experienced|treatment experienced
5427998|NCT00046722|complementary therapies|complementary therapies
5427999|NCT00046722|Neuropathy|neuropathy
5428000|NCT00046722|Peripheral Neuropathy|peripheral neuropathy
5428001|NCT00046722|HIV-Related Peripheral Neuropathy|hiv-related peripheral neuropathy
5428002|NCT00046722|HIV|hiv
5428003|NCT00046527|Metastatic breast cancer|metastatic breast cancer
5428004|NCT00046527|Taxol|taxol
5428005|NCT00046527|Taxane|taxane
5428006|NCT00046514|Metastatic Breast Cancer|metastatic breast cancer
5428007|NCT00046514|Taxol|taxol
5428008|NCT00046423|Cancer|cancer
5428009|NCT00046423|solid tumor|solid tumor
5428010|NCT00046423|Advanced malignancy|advanced malignancy
5428011|NCT00046423|Taxane therapy|taxane therapy
5428012|NCT00046423|Biopsy-proven diagnosis of advanced malignancy|biopsy-proven diagnosis of advanced malignancy
5428013|NCT00046423|Various solid tumors which are refractory|various solid tumors which are refractory
5428014|NCT00046709|Cancer pain|cancer pain
5428015|NCT00046709|All types of cancer except lung cancer|all types of cancer except lung cancer
5428016|NCT00046696|Cancer|cancer
5428017|NCT00046696|Cancer Alternative Therapies|cancer alternative therapies
5428018|NCT00046696|Living with Cancer|living with cancer
5428019|NCT00046683|Adult acute leukemia|adult acute leukemia
5428020|NCT00046683|Adult chronic leukemia|adult chronic leukemia
5428021|NCT00046683|Childhood leukemia|childhood leukemia
5428022|NCT00046683|Campath|campath
5428023|NCT00046683|Alemtuzumab|alemtuzumab
5428024|NCT00046540|Liposome-Encapsulated SN38|liposome-encapsulated sn38
5428025|NCT00046540|Irinotecan|irinotecan
5428026|NCT00046540|CPT-11|cpt-11
5428027|NCT00046540|Malignant Tumors|malignant tumors
5428028|NCT00046488|Chronic Lymphoblastic Leukemia|chronic lymphoblastic leukemia
5428029|NCT00046488|Leukemia, Lymphoblastic, Chronic|leukemia, lymphoblastic, chronic
5428030|NCT00046488|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
5428031|NCT00046488|CLL|cll
5428032|NCT00046631|built environment|built environment
5428033|NCT00046631|parks|parks
5428034|NCT00046631|retail outlets|retail outlets
5428035|NCT00046631|adolescent girls|adolescent girls
5428036|NCT00046631|physical activity|physical activity
5428037|NCT00046553|Cortisol|cortisol
5428038|NCT00046553|CRH|crh
5428039|NCT00046553|HPA Axis|hpa axis
5428040|NCT00046553|Hypothalamus|hypothalamus
5428041|NCT00046553|Hippocampus|hippocampus
5428042|NCT00046553|Post-Traumatic Stress Disorder|post-traumatic stress disorder
5428043|NCT00046553|PTSD|ptsd
5428044|NCT00046553|Healthy Volunteer|healthy volunteer
5428045|NCT00046436|AIDS Serodiagnosis|aids serodiagnosis
5428046|NCT00046436|Pregnancy Complications, Infectious|pregnancy complications, infectious
5428047|NCT00046436|Anti-HIV Agents|anti-hiv agents
5428048|NCT00046436|Disease Transmission, Vertical|disease transmission, vertical
5428049|NCT00046410|MRI|mri
5428050|NCT00046410|Diffusion|diffusion
5428051|NCT00046410|Cognitive|cognitive
5428052|NCT00046410|Stroke|stroke
5428053|NCT00046410|Heart|heart
5428054|NCT00046410|Coronary Artery Disease|coronary artery disease
5428055|NCT00046410|Heart Disease|heart disease
5428056|NCT00046397|Smallpox|smallpox
5428057|NCT00046397|Vaccine|vaccine
5428058|NCT00046397|Vaccination|vaccination
5428059|NCT00046397|Variola|variola
5428060|NCT00046397|Adults|adults
5428061|NCT00046397|Smallpox Vaccine|smallpox vaccine
5428062|NCT00046397|Healthy Volunteer|healthy volunteer
5428063|NCT00046397|Small Pox|small pox
5428064|NCT00046345|treatment experienced|treatment experienced
5428065|NCT00046332|Integrase inhibitors|integrase inhibitors
5428066|NCT00046332|Monotherapy|monotherapy
5428067|NCT00046332|HIV-1 infection|hiv-1 infection
5428068|NCT00046319|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
5428069|NCT00046319|Primary Pulmonary Hypertension|primary pulmonary hypertension
5428070|NCT00046306|Oxidative Stress|oxidative stress
5428071|NCT00046306|Cardiovascular Disease|cardiovascular disease
5428072|NCT00046306|Cancer|cancer
5428073|NCT00046358|Cerebrospinal Fluid|cerebrospinal fluid
5428074|NCT00046358|Cholesterol|cholesterol
5428075|NCT00046358|Statin|statin
5428076|NCT00046358|NSAID|nsaid
5428077|NCT00046358|Antiinflammatory|antiinflammatory
5428078|NCT00046358|Dementia|dementia
5428079|NCT00046358|Alzheimer's Disease|alzheimer's disease
5428080|NCT00046358|Nonsteroidal Antiinflammatory|nonsteroidal antiinflammatory
5428081|NCT00046358|Healthy Volunteer|healthy volunteer
5428082|NCT00046293|Stroke|stroke
5428083|NCT00046293|Abciximab|abciximab
5428084|NCT00046293|Retavase|retavase
5428085|NCT00046293|MRI|mri
5428086|NCT00046293|Cerebral Blood Flow|cerebral blood flow
5428087|NCT00046267|Delayed-Action Preparations|delayed-action preparations
5428088|NCT00046267|Blood Glucose|blood glucose
5428089|NCT00046267|Insulin|insulin
5428090|NCT00046267|Alanine Transaminase|alanine transaminase
5428091|NCT00046267|Aspartate Aminotransferases|aspartate aminotransferases
5428092|NCT00046267|Fructosamine|fructosamine
5428093|NCT00046267|Glucose Tolerance Test|glucose tolerance test
5428094|NCT00046267|Treatment Experienced|treatment experienced
5428095|NCT00046254|hip fracture|hip fracture
5428096|NCT00046254|recurrent fracture|recurrent fracture
5428097|NCT00046254|fracture|fracture
5428098|NCT00046254|bone loss|bone loss
5428099|NCT00046254|bisphosphonate|bisphosphonate
5428100|NCT00046254|bone mineral density|bone mineral density
5428101|NCT00046254|osteoporosis|osteoporosis
5428102|NCT00046254|zoledronic acid|zoledronic acid
5428103|NCT00046254|geriatrics|geriatrics
5428104|NCT00046254|rehabilitation|rehabilitation
5428105|NCT00046254|elderly|elderly
5428106|NCT00046254|nursing home|nursing home
5428107|NCT00046254|orthopedic|orthopedic
5428108|NCT00046241|seasonal depression winter blues winter depression|seasonal depression winter blues winter depression
5428109|NCT00046228|Myocardial infarction|myocardial infarction
5428110|NCT00046228|percutaneous coronary intervention|percutaneous coronary intervention
5428111|NCT00046228|abciximab|abciximab
5428112|NCT00046228|reteplase|reteplase
5428113|NCT00046228|safety and efficacy|safety and efficacy
5428114|NCT00046215|Virtual Lesion Study|virtual lesion study
5428115|NCT00046215|Motor Imagery|motor imagery
5428116|NCT00046215|Primary Motor Cortex|primary motor cortex
5428117|NCT00046215|Motor Inhibition|motor inhibition
5428118|NCT00046215|Motor Execution|motor execution
5428119|NCT00046215|Healthy Volunteer|healthy volunteer
5428120|NCT00046202|Smith-Lemli-Opitz Syndrome|smith-lemli-opitz syndrome
5428121|NCT00046202|Sterol|sterol
5428122|NCT00046202|Mutations|mutations
5428123|NCT00046202|Dysmorphology|dysmorphology
5428124|NCT00046202|Mental Retardation|mental retardation
5428125|NCT00046202|Inborn Errors of Cholesterol Synthesis|inborn errors of cholesterol synthesis
5428126|NCT00046202|Smith-Lemli-Optiz Syndrome|smith-lemli-optiz syndrome
5428127|NCT00046202|Lathosterolosis|lathosterolosis
5428128|NCT00046202|Desmosterols|desmosterols
5428129|NCT00046202|CHILD Syndrome|child syndrome
5428130|NCT00046202|Greenberg Dysplasia|greenberg dysplasia
5428131|NCT00046202|X Linked Dominant Chrondrodysplasia|x linked dominant chrondrodysplasia
5428132|NCT00046189|Sun Exposure|sun exposure
5428133|NCT00046189|Xeroderma Pigmentosum|xeroderma pigmentosum
5428134|NCT00046189|Skin Cancer|skin cancer
5428135|NCT00046189|Family History|family history
5428136|NCT00046189|HETEROZYGOTE|heterozygote
5428137|NCT00046189|XP|xp
5428138|NCT00046176|HIV-1 Abacavir Lamivudine Antiretroviral-experienced|hiv-1 abacavir lamivudine antiretroviral-experienced
5428139|NCT00046163|Neurology|neurology
5428140|NCT00046163|Cardiology|cardiology
5428141|NCT00046111|oral|oral
5428142|NCT00046111|Bioequivalence|bioequivalence
5428143|NCT00046111|Hycamtin|hycamtin
5428144|NCT00046111|Topotecan|topotecan
5428145|NCT00046085|Schizophrenia|schizophrenia
5428146|NCT00046085|Family|family
5428147|NCT00046085|Psychoeducation|psychoeducation
5428148|NCT00046085|Internet|internet
5428149|NCT00046072|Sepsis|sepsis
5428150|NCT00046072|Shock|shock
5428151|NCT00046072|Septic|septic
5428152|NCT00046072|Sepsis Syndrome|sepsis syndrome
5428153|NCT00046072|Septicemia|septicemia
5428154|NCT00046072|Endotoxins|endotoxins
5428155|NCT00046072|Endotoxemia|endotoxemia
5428156|NCT00046072|Infection|infection
5428157|NCT00046059|Linkage|linkage
5428158|NCT00046059|Gene Identification|gene identification
5428159|NCT00046059|ADHD|adhd
5428160|NCT00046059|Hyperactivity|hyperactivity
5428161|NCT00046059|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
5428162|NCT00046033|Dose-Relationship, Drug|dose-relationship, drug
5428163|NCT00046033|HIV Protease Inhibitors|hiv protease inhibitors
5428164|NCT00046033|Salvage Therapy|salvage therapy
5428165|NCT00046033|Viral Load|viral load
5428166|NCT00046033|RNA, Viral|rna, viral
5428167|NCT00046033|Drug Therapy, Combination|drug therapy, combination
5428168|NCT00046020|Depression|depression
5428169|NCT00045994|cardiovascular|cardiovascular
5428170|NCT00045994|aged|aged
5428171|NCT00045994|antihypertensive agents/therapeutic use|antihypertensive agents/therapeutic use
5428172|NCT00045994|hypertension/*drug therapy|hypertension/*drug therapy
5428173|NCT00045994|blood pressure|blood pressure
5428174|NCT00045981|cardiovascular|cardiovascular
5428175|NCT00045981|aged|aged
5428176|NCT00045981|antihypertensive agents/therapeutic use|antihypertensive agents/therapeutic use
5428177|NCT00045981|hypertension/*drug therapy|hypertension/*drug therapy
5428178|NCT00045981|blood pressure|blood pressure
5428179|NCT00045968|oncology|oncology
5428180|NCT00045968|neurology|neurology
5428181|NCT00045968|glioma|glioma
5428183|NCT00045968|brain cancer|brain cancer
5428184|NCT00045968|glioblastoma multiforme|glioblastoma multiforme
5428185|NCT00045968|glioblastoma|glioblastoma
5428186|NCT00045968|newly diagnosed glioblastoma|newly diagnosed glioblastoma
5428187|NCT00045968|immunotherapy|immunotherapy
5428188|NCT00045968|dendritic cells|dendritic cells
5428189|NCT00045968|immune therapy|immune therapy
5428190|NCT00045968|GBM|gbm
5428191|NCT00045968|Brain cancer, primary|brain cancer, primary
5428192|NCT00045968|tumor vaccine|tumor vaccine
5428193|NCT00045968|grade IV astrocytoma|grade iv astrocytoma
5428194|NCT00045968|DCVax|dcvax
5428195|NCT00045968|Grade IV brain cancer|grade iv brain cancer
5428196|NCT00045942|AML|aml
5428197|NCT00045942|MDS|mds
5428198|NCT00045942|high risk myelodysplastic syndrome|high risk myelodysplastic syndrome
5428199|NCT00045916|Electroconvulsive therapy|electroconvulsive therapy
5428200|NCT00045916|Antidepressive Agents|antidepressive agents
5428201|NCT00045903|Cognitive Behavioral Therapy|cognitive behavioral therapy
5428202|NCT00045877|Low-Grade or Follicular Non-Hodgkin's Lymphoma|low-grade or follicular non-hodgkin's lymphoma
5428203|NCT00045864|Intermediate and High-Grade Non-Hodgkin's Lymphoma|intermediate and high-grade non-hodgkin's lymphoma
5428204|NCT00045838|Healthy|healthy
5428205|NCT00045838|HIV-Negative|hiv-negative
5428206|NCT00045838|Placebo Controlled|placebo controlled
5428207|NCT00045838|Volunteer|volunteer
5428208|NCT00045838|Dose-Escalation|dose-escalation
5428209|NCT00045838|Healthy Volunteers|healthy volunteers
5428210|NCT00045838|HV|hv
5428211|NCT00045838|HIV Seronegativity|hiv seronegativity
5428212|NCT00045838|HIV Preventive Vaccine|hiv preventive vaccine
5428213|NCT00045812|Cholesterol|cholesterol
5428214|NCT00045812|Sitosterol|sitosterol
5428215|NCT00045812|Atherosclerosis|atherosclerosis
5428216|NCT00045812|Intestine|intestine
5428217|NCT00045812|Absorption|absorption
5428218|NCT00045812|Homozygous Sitosterolemia|homozygous sitosterolemia
5428219|NCT00045812|Sterol Metabolism|sterol metabolism
5428220|NCT00045786|myelodysplastic syndrome|myelodysplastic syndrome
5428221|NCT00044928|Abdominal Infections|abdominal infections
5428222|NCT00044915|Acute Ischemic Stroke Without Hemorrhage|acute ischemic stroke without hemorrhage
5428223|NCT00044889|CLO221|clo221
5428224|NCT00044889|clolar|clolar
5428225|NCT00044863|EGFr|egfr
5428226|NCT00044863|Metastatic Colorectal Carcinoma|metastatic colorectal carcinoma
5428227|NCT00044837|Lopinavir|lopinavir
5428228|NCT00044837|HIV-1|hiv-1
5428229|NCT00044837|HIV Protease Inhibitors|hiv protease inhibitors
5428230|NCT00044837|Ritonavir|ritonavir
5428231|NCT00044837|Postmenopause|postmenopause
5428232|NCT00044837|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5428233|NCT00044837|Pharmacokinetics|pharmacokinetics
5428234|NCT00044837|Area Under Curve|area under curve
5428235|NCT00044837|Hormone Replacement Therapy|hormone replacement therapy
5428236|NCT00044837|efavirenz|efavirenz
5428237|NCT00044837|estradiol|estradiol
5428238|NCT00044876|Endometrium|endometrium
5428239|NCT00044876|Progesterone|progesterone
5428240|NCT00044876|Estrogen|estrogen
5428241|NCT00044876|Leiomyoma|leiomyoma
5428242|NCT00044876|Uterine Leiomyoma|uterine leiomyoma
5428243|NCT00044876|Uterine Fibroids|uterine fibroids
5428244|NCT00044876|Fibroids|fibroids
5428245|NCT00044798|Aged|aged
5428246|NCT00044785|colorectal cancer|colorectal cancer
5428247|NCT00044785|gastric cancer|gastric cancer
5428248|NCT00044785|breast cancer|breast cancer
5428249|NCT00044772|Panic|panic
5428250|NCT00044772|Disorder|disorder
5428251|NCT00044759|Hematologic|hematologic
5428252|NCT00044759|Neoplasms|neoplasms
5428253|NCT00044746|Diabetes|diabetes
5428254|NCT00044733|Leukemia|leukemia
5428255|NCT00044733|Stem Cell Transplant|stem cell transplant
5428256|NCT00044720|Kidney Transplant|kidney transplant
5428257|NCT00044707|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
5428258|NCT00044694|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
5428259|NCT00044681|Risperidone|risperidone
5428260|NCT00044681|depression|depression
5428261|NCT00044681|melancholia|melancholia
5428262|NCT00044681|depressive disorder|depressive disorder
5428263|NCT00044681|antipsychotic agents|antipsychotic agents
5428264|NCT00044668|exenatide|exenatide
5428265|NCT00044668|exendin-4|exendin-4
5428266|NCT00044668|diabetes|diabetes
5428267|NCT00044668|Amylin|amylin
5428268|NCT00044668|Lilly|lilly
5428269|NCT00044642|Anxiety|anxiety
5428270|NCT00044629|Sleep Deprivation|sleep deprivation
5428271|NCT00044629|Insomnia|insomnia
5428272|NCT00044629|Sleep Disorders|sleep disorders
5428273|NCT00044603|Pregnancy|pregnancy
5428274|NCT00044590|Parkinson's disease|parkinson's disease
5428275|NCT00044590|Pesticides|pesticides
5428276|NCT00044590|Genetic susceptibility|genetic susceptibility
5428277|NCT00044590|Polymorphisms|polymorphisms
5428278|NCT00044577|HIV-1 Abacavir Lamivudine Tenofovir|hiv-1 abacavir lamivudine tenofovir
5428279|NCT00044564|Taxane|taxane
5428280|NCT00044564|Renal Cell Carcinoma|renal cell carcinoma
5428281|NCT00044564|Advanced Renal Cell Carcinoma|advanced renal cell carcinoma
5428282|NCT00044551|Taxane|taxane
5428283|NCT00044551|Lymphoma|lymphoma
5428284|NCT00044551|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
5428286|NCT00044538|Lung cancer, non-small cell|lung cancer, non-small cell
5428287|NCT00044538|NSCLC|nsclc
5428288|NCT00044525|Taxane|taxane
5428289|NCT00044525|Breast Cancer|breast cancer
5428290|NCT00044525|Metastasis|metastasis
5428291|NCT00044512|Cancer|cancer
5428292|NCT00044512|Liver Cancer|liver cancer
5428293|NCT00044512|Hepatocellular carcinoma (HCC)|hepatocellular carcinoma (hcc)
5428294|NCT00044486|Prophylaxis|prophylaxis
5428295|NCT00044486|neutropenia|neutropenia
5428296|NCT00044486|AML|aml
5428297|NCT00044486|MDS|mds
5428298|NCT00044486|fungal infections|fungal infections
5428299|NCT00044486|Acute Myelogenous Leukemia|acute myelogenous leukemia
5428300|NCT00044486|Anticipated prolonged profound neutropenia|anticipated prolonged profound neutropenia
5428301|NCT00044473|Otitis Media|otitis media
5428302|NCT00044473|Ear Diaeases|ear diaeases
5428303|NCT00044473|Levofloxacin|levofloxacin
5428304|NCT00044473|Quinolones|quinolones
5428305|NCT00044460|Type 2 diabetes drug-naive|type 2 diabetes drug-naive
5428306|NCT00044382|Revimid|revimid
5428307|NCT00044382|CC5013|cc5013
5428308|NCT00044382|CC-5013|cc-5013
5428309|NCT00044369|Varicocele|varicocele
5428310|NCT00044369|environmental toxins|environmental toxins
5428311|NCT00044369|male infertility|male infertility
5428312|NCT00044369|cadmium|cadmium
5428313|NCT00044356|Melanoma|melanoma
5428314|NCT00044356|Metastatic Melanoma|metastatic melanoma
5428315|NCT00044356|Malignant Melanoma|malignant melanoma
5428316|NCT00044356|Skin Cancer|skin cancer
5428317|NCT00044356|Tumor|tumor
5428318|NCT00044356|Experimental Treatment|experimental treatment
5428319|NCT00044356|Clinical Trial|clinical trial
5428320|NCT00044356|Gene Therapy|gene therapy
5428321|NCT00044356|Gene Delivery|gene delivery
5428322|NCT00044356|Gene Transfer|gene transfer
5428323|NCT00044356|Immunotherapy|immunotherapy
5428324|NCT00044356|Cancer|cancer
5428325|NCT00044356|Neoplasm|neoplasm
5428326|NCT00044356|Lesion|lesion
5428327|NCT00044356|Metastasis|metastasis
5428328|NCT00044356|Cancerous mole|cancerous mole
5428329|NCT00044356|Melanoma vaccine|melanoma vaccine
5428330|NCT00044356|Cancer research|cancer research
5428331|NCT00044356|Cancer cells|cancer cells
5428332|NCT00044356|Allovectin-7®|allovectin-7®
5428333|NCT00044343|colorectal cancer|colorectal cancer
5428334|NCT00044343|EGFR inhibitor|egfr inhibitor
5428335|NCT00044343|lapatinib|lapatinib
5428336|NCT00044343|metastatic|metastatic
5428337|NCT00044317|FEV|fev
5428338|NCT00044317|Smoking|smoking
5428339|NCT00044317|antioxidents|antioxidents
5428340|NCT00044317|lung growth|lung growth
5428341|NCT00044291|Atamestane|atamestane
5428342|NCT00044291|Toremifene|toremifene
5428343|NCT00044291|Letrozole|letrozole
5428344|NCT00044291|Aromatase inhibitor|aromatase inhibitor
5428345|NCT00044291|Receptor-positive|receptor-positive
5428346|NCT00044291|First line therapy|first line therapy
5428347|NCT00044291|Estrogen blocker|estrogen blocker
5428348|NCT00044291|Metastatic breast cancer|metastatic breast cancer
5428349|NCT00044291|Locally advanced breast cancer|locally advanced breast cancer
5428350|NCT00044291|Locally recurrent breast cancer|locally recurrent breast cancer
5428351|NCT00044291|stage IV breast cancer|stage iv breast cancer
5428352|NCT00044291|ductal breast carcinoma|ductal breast carcinoma
5428353|NCT00044291|lobular breast carcinoma|lobular breast carcinoma
5428354|NCT00044291|stage IIIA breast cancer|stage iiia breast cancer
5428355|NCT00044291|stage IIIB breast cancer|stage iiib breast cancer
5428356|NCT00044291|recurrent breast cancer|recurrent breast cancer
5428357|NCT00044304|Treatment|treatment
5428358|NCT00044304|Eosinophil|eosinophil
5428359|NCT00044304|Tyrosine Kinase Inhibitor|tyrosine kinase inhibitor
5428360|NCT00044304|Hypereosinophilia|hypereosinophilia
5428361|NCT00044304|Biologicals|biologicals
5428362|NCT00044304|Chemotherapy|chemotherapy
5428363|NCT00044304|Gleevec|gleevec
5428364|NCT00044304|Eosinophils|eosinophils
5428365|NCT00044304|Hypereosinophilic Syndrome|hypereosinophilic syndrome
5428366|NCT00044304|HES|hes
5428367|NCT00044278|epilepsy|epilepsy
5428368|NCT00044278|pediatric|pediatric
5428369|NCT00044278|partial seizures|partial seizures
5428370|NCT00044265|ACE inhibitor|ace inhibitor
5428371|NCT00044265|high blood pressure|high blood pressure
5428372|NCT00044265|pediatric|pediatric
5428373|NCT00044252|Neurosteroids|neurosteroids
5428374|NCT00044252|Complex Partial Seizure|complex partial seizure
5428375|NCT00044252|Menstrual Cycle|menstrual cycle
5428376|NCT00044252|Allopregnanolone|allopregnanolone
5428377|NCT00044252|Catamenial Epilepsy|catamenial epilepsy
5428378|NCT00044252|Seizures|seizures
5428379|NCT00044252|Epilepsy|epilepsy
5428380|NCT00044252|Healthy Volunteer|healthy volunteer
5428381|NCT00044252|HV|hv
5428382|NCT00044252|Normal Control|normal control
5428383|NCT00044239|Tic Disorders|tic disorders
5428384|NCT00044239|Neurophyschological|neurophyschological
5428385|NCT00044239|Immunology|immunology
5428386|NCT00044239|Magnetic Resonance Imaging|magnetic resonance imaging
5428387|NCT00044239|Basal Ganglia|basal ganglia
5428388|NCT00044239|Obsessive-Compulsive Disorder|obsessive-compulsive disorder
5428389|NCT00044239|Children|children
5428390|NCT00044239|Adolescents|adolescents
5428391|NCT00044239|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
5428392|NCT00044239|PANDAS (Pediatric Autoimmune Neuropsychiatric Disorders Associated d|pandas (pediatric autoimmune neuropsychiatric disorders associated d
5428393|NCT00044239|Obsessive Compulsive Disorder|obsessive compulsive disorder
5428394|NCT00044239|OCD|ocd
5428395|NCT00044239|Healthy Volunteers|healthy volunteers
5428396|NCT00044239|HV|hv
5428397|NCT00044226|BPH|bph
5428398|NCT00044226|Benign Prostatic Hyperplasia|benign prostatic hyperplasia
5428399|NCT00044226|Benign Prostatic Hypertrophy|benign prostatic hypertrophy
5428400|NCT00044226|Enlarged Prostate|enlarged prostate
5428401|NCT00044187|schizoaffective disorder|schizoaffective disorder
5428402|NCT00044187|schizophreniform disorder|schizophreniform disorder
5428403|NCT00044187|bipolar I disorder|bipolar i disorder
5428404|NCT00044200|Phospholipase A2|phospholipase a2
5428405|NCT00044200|Arachidonic Acid|arachidonic acid
5428406|NCT00044200|Blood Flow|blood flow
5428407|NCT00044200|Coupling|coupling
5428408|NCT00044200|Neurotransmission|neurotransmission
5428409|NCT00044200|PET|pet
5428410|NCT00044200|Signal Transduction|signal transduction
5428411|NCT00044200|Activation|activation
5428412|NCT00044200|Brain|brain
5428413|NCT00044200|[15O]H20|[15o]h20
5428414|NCT00044174|Depression|depression
5428415|NCT00044174|Mother-Infant Interaction|mother-infant interaction
5428416|NCT00044174|Still-face|still-face
5428417|NCT00044174|Socioemotional Development|socioemotional development
5428418|NCT00044174|Cognitive Development|cognitive development
5428419|NCT00044174|Healthy|healthy
5428420|NCT00044174|Mothers|mothers
5428421|NCT00044174|Postpartum|postpartum
5428422|NCT00044174|Postpartum Depression|postpartum depression
5428423|NCT00044148|Persistent Albuminuria|persistent albuminuria
5428424|NCT00044135|clevudine|clevudine
5428425|NCT00044135|hepatitis B|hepatitis b
5428426|NCT00044070|ARTIST|artist
5428427|NCT00044070|Acute ischemic stroke|acute ischemic stroke
5428428|NCT00044057|ARTIST|artist
5428429|NCT00044044|Schizophrenia|schizophrenia
5428430|NCT00044044|Latuda|latuda
5428431|NCT00044044|Lurasidone|lurasidone
5428432|NCT00044031|pancreatic cancer|pancreatic cancer
5428433|NCT00044031|G17DT|g17dt
5428434|NCT00044031|gemcitabine|gemcitabine
5428435|NCT00044018|Revimid|revimid
5428436|NCT00044018|CC5013|cc5013
5428437|NCT00044005|Schizophrenia|schizophrenia
5428438|NCT00044005|Latuda|latuda
5428439|NCT00044005|Lurasidone|lurasidone
5428440|NCT00043329|Registry|registry
5428441|NCT00043329|Actimmune|actimmune
5428442|NCT00043329|osteopetrosis|osteopetrosis
5428443|NCT00044122|Mastocytosis|mastocytosis
5428444|NCT00044122|Urticaria Pigmentosa|urticaria pigmentosa
5428445|NCT00044122|Classification|classification
5428446|NCT00044122|Tryptase|tryptase
5428447|NCT00044122|Mutations|mutations
5428448|NCT00044109|Pain|pain
5428449|NCT00044109|Low Back|low back
5428450|NCT00044109|Radiculopathy|radiculopathy
5428451|NCT00044109|Electromagnetic Treatment|electromagnetic treatment
5428452|NCT00044109|Back Device|back device
5428453|NCT00044109|Sciatica|sciatica
5428454|NCT00044109|Low Back Pain|low back pain
5428455|NCT00044096|SSRI|ssri
5428456|NCT00044096|Anxiety|anxiety
5428457|NCT00044096|Stress|stress
5428458|NCT00044096|Citalopram|citalopram
5428459|NCT00044096|Benadryl|benadryl
5428460|NCT00044096|Diphenhydramine|diphenhydramine
5428461|NCT00044096|Startle|startle
5428462|NCT00044096|Fear-Potentiated Startle|fear-potentiated startle
5428463|NCT00044096|Fear|fear
5428464|NCT00044096|Normal Volunteers|normal volunteers
5428465|NCT00044096|Healthy Volunteers|healthy volunteers
5428466|NCT00044096|HV|hv
5428467|NCT00044083|Catecholamines|catecholamines
5428468|NCT00044083|Dopamine|dopamine
5428469|NCT00044083|Clinical Trial|clinical trial
5428470|NCT00044083|fMRI|fmri
5428471|NCT00044083|PFC|pfc
5428472|NCT00044083|Vitamin B2|vitamin b2
5428473|NCT00044083|Riboflavin|riboflavin
5428474|NCT00044083|Tolcapone|tolcapone
5428475|NCT00044083|Placebo|placebo
5428476|NCT00044083|Normal Volunteers|normal volunteers
5428477|NCT00044083|Schizophrenia|schizophrenia
5428478|NCT00044083|Healthy Volunteers|healthy volunteers
5428479|NCT00044083|HV|hv
5428480|NCT00043992|Asthma|asthma
5428481|NCT00043992|Allergens|allergens
5428482|NCT00043966|treatment naive|treatment naive
5428483|NCT00043953|treatment naive|treatment naive
5428484|NCT00043888|fosamprenavir|fosamprenavir
5428485|NCT00043888|ritonavir|ritonavir
5428486|NCT00043888|COMBIVIR|combivir
5428487|NCT00043888|TRIZIVIR|trizivir
5428488|NCT00043888|abacavir|abacavir
5428489|NCT00043888|lamivudine|lamivudine
5428490|NCT00043888|zidovudine|zidovudine
5428491|NCT00043888|HIV|hiv
5428492|NCT00043888|protease inhibitors|protease inhibitors
5428493|NCT00043979|Ewing's Sarcoma|ewing's sarcoma
5428494|NCT00043979|Rhabdomyosarcoma|rhabdomyosarcoma
5428495|NCT00043979|Desmoplastic Small Round Cell Tumor|desmoplastic small round cell tumor
5428496|NCT00043979|Sarcoma|sarcoma
5428497|NCT00043979|Ewing Sarcoma|ewing sarcoma
5428498|NCT00043940|thrombosis|thrombosis
5428499|NCT00043940|bivalirudin|bivalirudin
5428500|NCT00043940|direct thrombin inhibitor|direct thrombin inhibitor
5428501|NCT00043940|HIT|hit
5428502|NCT00043940|HITTS|hitts
5428503|NCT00043940|HIT/HITTS|hit/hitts
5428504|NCT00043927|Chemotherapy-naive|chemotherapy-naive
5428505|NCT00043927|Small Cell Lung Cancer|small cell lung cancer
5428506|NCT00043927|SCLC|sclc
5428507|NCT00043927|Extensive disease|extensive disease
5428508|NCT00043927|ED|ed
5428509|NCT00043927|topotecan|topotecan
5428510|NCT00043927|Hycamtin|hycamtin
5428511|NCT00043927|oral|oral
5428512|NCT00043914|epilepsy|epilepsy
5428513|NCT00043914|monotherapy conversion|monotherapy conversion
5428514|NCT00043901|PGTC|pgtc
5428515|NCT00043901|Lamotrigine|lamotrigine
5428516|NCT00043901|epilepsy|epilepsy
5428517|NCT00043901|seizures|seizures
5428518|NCT00043901|primary generalized tonic-clonic|primary generalized tonic-clonic
5428519|NCT00043875|partial seizures|partial seizures
5428520|NCT00043875|pediatric|pediatric
5428521|NCT00043875|epilepsy|epilepsy
5428522|NCT00043862|Hycamtin|hycamtin
5428523|NCT00043862|oral|oral
5428524|NCT00043862|Radiation Sensitization|radiation sensitization
5428525|NCT00043862|Small Cell Lung Cancer|small cell lung cancer
5428526|NCT00043862|newly diagnosed|newly diagnosed
5428527|NCT00043862|limited stage|limited stage
5428528|NCT00043862|topotecan|topotecan
5428529|NCT00043849|Psychosis|psychosis
5428530|NCT00043849|Agitation, Psychomotor|agitation, psychomotor
5428531|NCT00043836|ejection fraction|ejection fraction
5428532|NCT00043836|exercise tolerance|exercise tolerance
5428533|NCT00043836|heart failure, congestive|heart failure, congestive
5428534|NCT00043836|quality of life|quality of life
5428535|NCT00043823|Non-Small Cell Lung Cancer|non-small cell lung cancer
5428536|NCT00043823|NSCLC|nsclc
5428537|NCT00043823|Lung Cancer|lung cancer
5428538|NCT00043823|Avastin|avastin
5428539|NCT00043823|Bevacizumab|bevacizumab
5428540|NCT00043823|rhuMAb VEGF|rhumab vegf
5428541|NCT00043823|Anti-VEGF monoclonal antibody|anti-vegf monoclonal antibody
5428542|NCT00043823|Tarceva|tarceva
5428543|NCT00043823|OSI-774|osi-774
5428544|NCT00043823|Erlotinib Hydrocholoride|erlotinib hydrocholoride
5428545|NCT00043810|AML|aml
5428546|NCT00043810|MDS|mds
5428547|NCT00043810|Gelonin|gelonin
5428548|NCT00043810|Purging|purging
5428549|NCT00043810|Transplant|transplant
5428550|NCT00043810|Peripheral Stem Cell|peripheral stem cell
5428551|NCT00043797|ARI|ari
5428552|NCT00043797|Diabetic polyneuropathy|diabetic polyneuropathy
5428553|NCT00043797|Diabetic complications|diabetic complications
5428554|NCT00043784|Acute coronary syndromes|acute coronary syndromes
5428555|NCT00043784|non-ST-segment elevation|non-st-segment elevation
5428556|NCT00043693|Psychotic Disorders|psychotic disorders
5428557|NCT00043693|Schizoaffective Disorder|schizoaffective disorder
5428558|NCT00043693|Substance Abuse|substance abuse
5428559|NCT00043771|CHF|chf
5428560|NCT00043758|CHF|chf
5428561|NCT00043745|soy|soy
5428562|NCT00043745|isoflavones|isoflavones
5428563|NCT00043745|alternative hormone therapy|alternative hormone therapy
5428564|NCT00043745|bone loss|bone loss
5428565|NCT00043732|Rheumatoid arthritis|rheumatoid arthritis
5428566|NCT00043732|Scio-469|scio-469
5428567|NCT00043719|Human Female|human female
5428568|NCT00043719|Osteoporosis|osteoporosis
5428569|NCT00043719|Postmenopausal|postmenopausal
5428570|NCT00043719|Nitric Oxide|nitric oxide
5428571|NCT00043719|Nitroglycerin|nitroglycerin
5428572|NCT00043719|Calcium|calcium
5428573|NCT00043719|Vitamin D|vitamin d
5428574|NCT00043589|Memory|memory
5428575|NCT00043576|Prostate Cancer|prostate cancer
5428576|NCT00043576|Androgen Independent Prostate Cancer|androgen independent prostate cancer
5428577|NCT00043680|Classic|classic
5428578|NCT00043680|Occult|occult
5428579|NCT00043680|Neovascular|neovascular
5428580|NCT00043680|Celecoxib|celecoxib
5428707|NCT00042692|Parkinson's disease|parkinson's disease
5428581|NCT00043680|Age-Related Macular Degeneration|age-related macular degeneration
5428582|NCT00043680|Photodynamic Therapy|photodynamic therapy
5428583|NCT00043680|Choroidal Neovascularization|choroidal neovascularization
5428584|NCT00043680|Cyclooxygenase 2|cyclooxygenase 2
5428585|NCT00043680|Macular Degeneration|macular degeneration
5428586|NCT00043680|AMD|amd
5428587|NCT00043680|Age Related Macular Degeneration|age related macular degeneration
5428588|NCT00043667|Interleukin 2|interleukin 2
5428589|NCT00043667|IL-2 Receptor|il-2 receptor
5428590|NCT00043667|Anti-CD25|anti-cd25
5428591|NCT00043667|Anti-Tac|anti-tac
5428592|NCT00043667|Anti-IL-2R|anti-il-2r
5428593|NCT00043667|Uveitis|uveitis
5428594|NCT00043667|Daclizumab|daclizumab
5428595|NCT00043667|Inflammatory Eye DIsease|inflammatory eye disease
5428596|NCT00043654|Antidepressant|antidepressant
5428597|NCT00043654|Manic-Depressive Disorder|manic-depressive disorder
5428598|NCT00043654|Cortisol|cortisol
5428599|NCT00043654|Neuroendocrine|neuroendocrine
5428600|NCT00043654|Cognition|cognition
5428601|NCT00043654|Bipolar|bipolar
5428602|NCT00043654|Bipolar Disorder|bipolar disorder
5428603|NCT00043654|BPD|bpd
5428604|NCT00043654|HV|hv
5428605|NCT00043641|RT PCR|rt pcr
5428606|NCT00043641|Antiretrovial Therapy|antiretrovial therapy
5428607|NCT00043641|Drug Intensification|drug intensification
5428608|NCT00043641|Ultra-low|ultra-low
5428609|NCT00043641|Sequence|sequence
5428610|NCT00043641|HIV|hiv
5428611|NCT00043641|Treatment Experienced|treatment experienced
5428612|NCT00043628|Progenitor Cells|progenitor cells
5428613|NCT00043628|MRI|mri
5428614|NCT00043628|Coronary Blood Flow|coronary blood flow
5428615|NCT00043628|Hematopoiesis|hematopoiesis
5428616|NCT00043628|Myocardial Contractility|myocardial contractility
5428617|NCT00043628|Coronary Artery Disease|coronary artery disease
5428618|NCT00043628|CAD|cad
5428619|NCT00043628|Heart Disease|heart disease
5428620|NCT00043615|Angiogenesis|angiogenesis
5428621|NCT00043615|Drug Resistance|drug resistance
5428622|NCT00043615|Signal Transduction|signal transduction
5428623|NCT00043615|EGFR|egfr
5428624|NCT00043615|Survival Factors|survival factors
5428625|NCT00043615|Malignancy|malignancy
5428626|NCT00043615|Pre-Cancer Condition|pre-cancer condition
5428627|NCT00043615|Cancer Risk|cancer risk
5428628|NCT00043563|Cognitive-behavior Therapy|cognitive-behavior therapy
5428629|NCT00043563|Minimal Attention Control|minimal attention control
5428630|NCT00043550|Major Depressive Disorder|major depressive disorder
5428631|NCT00043537|Phobic Disorders|phobic disorders
5428632|NCT00043537|Mutism|mutism
5428633|NCT00043511|Injections, Intramuscular|injections, intramuscular
5428634|NCT00043511|HIV Seronegativity|hiv seronegativity
5428635|NCT00043511|Plasmids|plasmids
5428636|NCT00043511|Vaccines, DNA|vaccines, dna
5428637|NCT00043511|HIV Preventive Vaccine|hiv preventive vaccine
5428638|NCT00043498|Pollutants|pollutants
5428639|NCT00043459|NHL|nhl
5428640|NCT00043433|HCC|hcc
5428641|NCT00043420|immunotherapy, lymphoma|immunotherapy, lymphoma
5428642|NCT00043407|Renal Cell Carcinoma, Phase I, Phase II, Immunotherapy|renal cell carcinoma, phase i, phase ii, immunotherapy
5428643|NCT00043394|CpG 7909 subcutaneous injection combination with Herceptin® metastatic breast cancer.|cpg 7909 subcutaneous injection combination with herceptin® metastatic breast cancer.
5428644|NCT00043381|myelodysplastic syndrome|myelodysplastic syndrome
5428645|NCT00043381|MDS|mds
5428646|NCT00043381|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5428647|NCT00043381|CMML|cmml
5428648|NCT00043381|decitabine|decitabine
5428649|NCT00043381|5-aza-2'deoxycytidine|5-aza-2'deoxycytidine
5428650|NCT00043368|CPG 7909 continuation study|cpg 7909 continuation study
5428651|NCT00043355|pulmonary|pulmonary
5428652|NCT00043355|mycobacterium avium complex infection|mycobacterium avium complex infection
5428653|NCT00043355|MAC|mac
5428654|NCT00043355|nontuberculous|nontuberculous
5428655|NCT00043355|mycobacteria|mycobacteria
5428656|NCT00043355|lung|lung
5428657|NCT00043342|cystic fibrosis|cystic fibrosis
5428658|NCT00043342|pulmonary impairment|pulmonary impairment
5428659|NCT00043472|Screening|screening
5428660|NCT00043472|Oophorectomy|oophorectomy
5428661|NCT00043472|Hereditary|hereditary
5428662|NCT00043472|Genetics|genetics
5428663|NCT00043472|Cancer|cancer
5428664|NCT00043472|Ovarian Cancer|ovarian cancer
5428665|NCT00043472|Ovarian Cancer Risk|ovarian cancer risk
5428666|NCT00043316|cystic fibrosis|cystic fibrosis
5428667|NCT00043316|pulmonary impairment|pulmonary impairment
5428668|NCT00043303|hepatitis C|hepatitis c
5428669|NCT00043303|liver fibrosis|liver fibrosis
5428670|NCT00043303|liver cirrhosis|liver cirrhosis
5428671|NCT00043277|neonates|neonates
5428672|NCT00043277|thrombosis|thrombosis
5428673|NCT00043277|bivalirudin|bivalirudin
5428674|NCT00043277|direct thrombin inhibitor|direct thrombin inhibitor
5428675|NCT00043238|PCBs|pcbs
5428676|NCT00043238|Thyroid|thyroid
5428677|NCT00043238|Hyperactivity|hyperactivity
5428678|NCT00043238|School Performance|school performance
5428679|NCT00043238|Mohawk Tribe|mohawk tribe
5428680|NCT00043212|prostate cancer|prostate cancer
5428681|NCT00043212|oncology|oncology
5428682|NCT00043212|urology|urology
5428683|NCT00043212|hormone refractory prostate cancer|hormone refractory prostate cancer
5428684|NCT00043199|Colorectal Neoplasms|colorectal neoplasms
5428685|NCT00043199|Colorectal Cancer|colorectal cancer
5428686|NCT00043199|Colorectal Carcinoma|colorectal carcinoma
5428687|NCT00043199|Colorectal Tumor|colorectal tumor
5428688|NCT00043199|Neoplasms, Colorectal|neoplasms, colorectal
5428689|NCT00043199|Unresectable|unresectable
5428690|NCT00043199|Metastatic|metastatic
5428691|NCT00043199|Refractory|refractory
5428692|NCT00043225|Type III Secretion Pathways|type iii secretion pathways
5428693|NCT00043225|Exotoxin A Polymorphisms|exotoxin a polymorphisms
5428694|NCT00043225|Cystic Fibrosis and Pseudomonas Aeruginosa|cystic fibrosis and pseudomonas aeruginosa
5428695|NCT00043225|Adenosine Deaminase Deficiency|adenosine deaminase deficiency
5428696|NCT00043225|Severe Combined Immune Deficiency|severe combined immune deficiency
5428697|NCT00043225|SCID|scid
5428698|NCT00043225|ADA-SCID|ada-scid
5428699|NCT00043225|Immune Deficiency|immune deficiency
5428700|NCT00043186|bone loss|bone loss
5428701|NCT00043186|osteoporosis|osteoporosis
5428702|NCT00042718|Chronic Bronchitis|chronic bronchitis
5428703|NCT00042718|Acute Bacterial Exacerbation of Chronic Bronchitis|acute bacterial exacerbation of chronic bronchitis
5428704|NCT00042705|asthma|asthma
5428705|NCT00042705|indoor allergens|indoor allergens
5428706|NCT00042692|catechol thioethers|catechol thioethers
5428708|NCT00042692|neurodegenerative disease|neurodegenerative disease
5428709|NCT00042679|Non-Small-Cell Lung Cancer|non-small-cell lung cancer
5428710|NCT00042679|Adenocarcinoma|adenocarcinoma
5428711|NCT00042679|Carcinoma Squamous|carcinoma squamous
5428712|NCT00042679|Adult Lung Cancer|adult lung cancer
5428713|NCT00042588|Safety and Efficacy|safety and efficacy
5428714|NCT00042588|Community-Acquired Pneumonia, Sepsis|community-acquired pneumonia, sepsis
5428715|NCT00042575|Sad, blue, lack of energy, depressed, hopelessness, guilt|sad, blue, lack of energy, depressed, hopelessness, guilt
5428716|NCT00042562|Depressed|depressed
5428717|NCT00042562|blues|blues
5428718|NCT00042562|sadness|sadness
5428719|NCT00042562|feelings of guilt|feelings of guilt
5428720|NCT00042562|hopelessness|hopelessness
5428721|NCT00042562|lack of energy|lack of energy
5428722|NCT00042549|Gallstones|gallstones
5428723|NCT00042549|Gallstone|gallstone
5428724|NCT00042549|Biliary stones|biliary stones
5428725|NCT00042549|Gallbladder stones|gallbladder stones
5428726|NCT00042549|Gallbladder|gallbladder
5428727|NCT00042549|Lithotripsy|lithotripsy
5428728|NCT00042549|Cholelithiasis|cholelithiasis
5428729|NCT00042549|ESWL|eswl
5428730|NCT00042549|Shock wave|shock wave
5428731|NCT00042549|Shock waves|shock waves
5428732|NCT00042549|shockwaves|shockwaves
5428733|NCT00042549|shockwave|shockwave
5428734|NCT00042627|Cataracts|cataracts
5428735|NCT00042627|Granulocytapheresis|granulocytapheresis
5428736|NCT00042627|Granulocyte Donors|granulocyte donors
5428737|NCT00042614|Genes|genes
5428738|NCT00042614|Heart|heart
5428739|NCT00042614|Lymphocytes|lymphocytes
5428740|NCT00042614|Proteomics|proteomics
5428741|NCT00042614|Transplant|transplant
5428742|NCT00042614|Heart Transplant|heart transplant
5428743|NCT00042614|Healthy Volunteer|healthy volunteer
5428744|NCT00042614|HV|hv
5428745|NCT00042614|Normal Control|normal control
5428746|NCT00042536|Yohimbine|yohimbine
5428747|NCT00042536|Naltrexone|naltrexone
5428748|NCT00042536|Sexual Function|sexual function
5428749|NCT00042536|Erectile Dysfunction|erectile dysfunction
5428750|NCT00042536|Alpha-2 Adrenoreceptor|alpha-2 adrenoreceptor
5428751|NCT00042536|Opiate Receptor|opiate receptor
5428752|NCT00042536|Male Impotence|male impotence
5428753|NCT00042536|ED|ed
5428754|NCT00042536|Healthy Volunteer|healthy volunteer
5428755|NCT00042536|HV|hv
5428756|NCT00042536|Normal Control|normal control
5428757|NCT00042523|Autoantibody|autoantibody
5428758|NCT00042523|Anti-DNA Antibody|anti-dna antibody
5428759|NCT00042523|Cross-Reactivity|cross-reactivity
5428760|NCT00042523|Neuron Loss|neuron loss
5428761|NCT00042523|Imaging|imaging
5428762|NCT00042523|Lupus|lupus
5428763|NCT00042523|SLE|sle
5428764|NCT00042523|Systemic Lupus Erythematosus|systemic lupus erythematosus
5428765|NCT00042510|Gastroesophageal cancer|gastroesophageal cancer
5428766|NCT00042510|Gastric cancer|gastric cancer
5428767|NCT00042484|Asthma|asthma
5428768|NCT00042484|Children's Health|children's health
5428769|NCT00042484|Community Based Research|community based research
5428770|NCT00042445|Neoplasm|neoplasm
5428771|NCT00042445|Petrochemical|petrochemical
5428772|NCT00042445|Leukemia|leukemia
5428773|NCT00042445|Taiwan|taiwan
5428774|NCT00042419|Industrial Injuries|industrial injuries
5428775|NCT00042419|Tendonitis|tendonitis
5428776|NCT00042419|Assembly Line|assembly line
5428777|NCT00042393|Hepatitis B, Chronic|hepatitis b, chronic
5428778|NCT00042354|CLO222|clo222
5428779|NCT00042354|clolar|clolar
5428780|NCT00042354|Pediatric Acute Myelogenous Leukemia|pediatric acute myelogenous leukemia
5428781|NCT00042341|CLO212|clo212
5428782|NCT00042341|clolar|clolar
5428783|NCT00042341|pediatric ALL|pediatric all
5428784|NCT00042341|Leukemia, Lymphoblastic, Acute - pediatric|leukemia, lymphoblastic, acute - pediatric
5428785|NCT00042328|Cancer|cancer
5428786|NCT00042289|Pregnancy|pregnancy
5428787|NCT00042289|Pharmacokinetics|pharmacokinetics
5428788|NCT00042289|Treatment Experienced|treatment experienced
5428789|NCT00041483|AMD|amd
5428790|NCT00041483|age-related macular degeneration|age-related macular degeneration
5428791|NCT00041483|Anecortave|anecortave
5428792|NCT00041483|Acetate|acetate
5428793|NCT00041483|Wet form of age-related macular degeneration|wet form of age-related macular degeneration
5428794|NCT00042380|Antidepressant|antidepressant
5428795|NCT00042380|Anxiety|anxiety
5428796|NCT00042380|Dopamine|dopamine
5428797|NCT00042380|Tyrosine Kinase Inhibitor|tyrosine kinase inhibitor
5428798|NCT00042380|Affective Disorder|affective disorder
5428799|NCT00042380|Phytoestrogen|phytoestrogen
5428800|NCT00042380|Genistein|genistein
5428801|NCT00042380|Major Depression|major depression
5428802|NCT00042380|Depression|depression
5428803|NCT00042276|Pressure Pain Threshold|pressure pain threshold
5428804|NCT00042276|MTrP|mtrp
5428805|NCT00042276|Musculoskeletal Pain|musculoskeletal pain
5428806|NCT00042276|Soft Tissue Pain|soft tissue pain
5428807|NCT00042276|Pathophysiology|pathophysiology
5428808|NCT00042276|Myofascial Pain|myofascial pain
5428809|NCT00042276|Microdialysis|microdialysis
5428810|NCT00042276|Myofascial Trigger Points|myofascial trigger points
5428811|NCT00042276|Rehabilitation|rehabilitation
5428814|NCT00042276|Healthy Volunteer|healthy volunteer
5428815|NCT00042276|HV|hv
5428816|NCT00042276|Normal Control|normal control
5428817|NCT00042263|health disparities|health disparities
5428818|NCT00042263|social environment|social environment
5428819|NCT00042263|physical environment|physical environment
5428820|NCT00042263|racial health disparities|racial health disparities
5428821|NCT00042250|Cell Cycle Interphase|cell cycle interphase
5428822|NCT00042250|G0|g0
5428823|NCT00042250|G1|g1
5428824|NCT00042250|G2|g2
5428825|NCT00042250|S Phase|s phase
5428826|NCT00042237|Child Abuse, Sexual|child abuse, sexual
5428827|NCT00042224|Electroconvulsive Therapy|electroconvulsive therapy
5428828|NCT00042211|Depressive Disorder|depressive disorder
5428829|NCT00042211|Blindness|blindness
5428830|NCT00042211|Aged|aged
5428831|NCT00042198|Cognitive therapy|cognitive therapy
5428832|NCT00042198|Relaxation techniques|relaxation techniques
5428833|NCT00042185|Adolescence|adolescence
5428834|NCT00042185|Prevention and Control|prevention and control
5428835|NCT00042185|Bulimia|bulimia
5428836|NCT00042172|Cognition|cognition
5428837|NCT00042172|Memory|memory
5428838|NCT00042159|Auditory hallucinations (voices)|auditory hallucinations (voices)
5428839|NCT00042146|Insomnia|insomnia
5428840|NCT00042146|Sleep Disorders|sleep disorders
5428841|NCT00042146|Sleep Deprivation|sleep deprivation
5428842|NCT00042133|aging|aging
5428843|NCT00042133|disability|disability
5428844|NCT00042133|longitudinal studies|longitudinal studies
5428845|NCT00042133|neighborhood factors|neighborhood factors
5428846|NCT00042133|socio-economic status|socio-economic status
5428847|NCT00042133|race|race
5428848|NCT00042120|Parkinson's disease|parkinson's disease
5428849|NCT00042120|Movement Disorders|movement disorders
5428850|NCT00042120|Epidemiological Study|epidemiological study
5428851|NCT00042107|Parkinson Disease|parkinson disease
5428852|NCT00042107|Neurodegenerative|neurodegenerative
5428853|NCT00042094|Smallpox|smallpox
5428854|NCT00042094|Smallpox Vaccine|smallpox vaccine
5428855|NCT00042094|Vaccinia|vaccinia
5428856|NCT00042081|CABG|cabg
5428857|NCT00042081|coronary artery bypass surgery|coronary artery bypass surgery
5428858|NCT00042081|coronary artery disease|coronary artery disease
5428859|NCT00042081|coronary arteriosclerosis|coronary arteriosclerosis
5428860|NCT00042081|coronary stenosis|coronary stenosis
5428861|NCT00042081|coronary occlusion|coronary occlusion
5428862|NCT00042055|Crohn's Disease|crohn's disease
5428863|NCT00042055|Inflammatory Bowel Disease|inflammatory bowel disease
5428864|NCT00042016|Chronic myelogenous leukemia|chronic myelogenous leukemia
5428865|NCT00042016|CML|cml
5428866|NCT00042016|CML-CP|cml-cp
5428867|NCT00042016|Chronic phase|chronic phase
5428868|NCT00042016|Decitabine|decitabine
5428869|NCT00042016|5-aza-2'deoxycytidine|5-aza-2'deoxycytidine
5428870|NCT00042016|Methylation|methylation
5428871|NCT00042016|STI 571|sti 571
5428872|NCT00042016|Imatinib mesylate|imatinib mesylate
5428873|NCT00042016|Gleevec|gleevec
5428874|NCT00042016|BCR/ABL|bcr/abl
5428875|NCT00042003|Chronic myelogenous leukemia|chronic myelogenous leukemia
5428876|NCT00042003|CML|cml
5428877|NCT00042003|CML-BP|cml-bp
5428878|NCT00042003|Blast phase|blast phase
5428879|NCT00042003|Decitabine|decitabine
5428880|NCT00042003|5-aza-2'deoxycytidine|5-aza-2'deoxycytidine
5428881|NCT00042003|Methylation|methylation
5428882|NCT00042003|STI 571|sti 571
5428883|NCT00042003|Imatinib mesylate|imatinib mesylate
5428884|NCT00042003|Gleevec|gleevec
5428885|NCT00042003|BCR/ABL|bcr/abl
5428886|NCT00041990|Chronic myelogenous leukemia|chronic myelogenous leukemia
5428887|NCT00041990|CML|cml
5428888|NCT00041990|CML-AP|cml-ap
5428889|NCT00041990|Accelerated phase|accelerated phase
5428890|NCT00041990|Decitabine|decitabine
5428891|NCT00041990|5-aza-2'deoxycytidine|5-aza-2'deoxycytidine
5428892|NCT00041990|Methylation|methylation
5428893|NCT00041990|STI 571|sti 571
5428894|NCT00041990|Imatinib mesylate|imatinib mesylate
5428895|NCT00041990|Gleevec|gleevec
5428896|NCT00041990|BCR/ABL|bcr/abl
5428897|NCT00041977|Rosacea|rosacea
5428898|NCT00041964|Lopinavir|lopinavir
5428899|NCT00041964|Pregnancy Trimester, Third|pregnancy trimester, third
5428900|NCT00041964|Pregnancy Complications, Infectious|pregnancy complications, infectious
5428901|NCT00041964|HIV Protease Inhibitors|hiv protease inhibitors
5428902|NCT00041964|Ritonavir|ritonavir
5428903|NCT00041964|Nelfinavir|nelfinavir
5428904|NCT00041964|Viral Load|viral load
5428905|NCT00041964|puerperium|puerperium
5428906|NCT00041951|Childhood Absence Epilepsy|childhood absence epilepsy
5428907|NCT00041951|CAE|cae
5428908|NCT00041951|Petit Mal|petit mal
5428909|NCT00041951|Epilepsy|epilepsy
5428910|NCT00041951|Seizures|seizures
5428911|NCT00041951|Genes|genes
5428912|NCT00041951|Inheritance|inheritance
5428913|NCT00041951|Genetics|genetics
5428914|NCT00041951|Genetic Linkage|genetic linkage
5428915|NCT00041938|heart disease|heart disease
5428916|NCT00041938|stroke|stroke
5428917|NCT00041938|ischemic heart disease|ischemic heart disease
5428918|NCT00041938|myocardial infarction|myocardial infarction
5428919|NCT00041938|atrial fibrillation|atrial fibrillation
5428920|NCT00041938|low ejection fraction|low ejection fraction
5428921|NCT00041938|cardiac failure|cardiac failure
5428922|NCT00041938|aspirin|aspirin
5428923|NCT00041938|Warfarin|warfarin
5428924|NCT00041938|anticoagulant|anticoagulant
5428925|NCT00041925|atherosclerotic vascular disease|atherosclerotic vascular disease
5428926|NCT00041925|chronic critical limb ischemia|chronic critical limb ischemia
5428927|NCT00041925|neointimal hyperplasia|neointimal hyperplasia
5428928|NCT00041925|peripheral vein bypass|peripheral vein bypass
5428929|NCT00041925|infra-inguinal bypass grafting surgery|infra-inguinal bypass grafting surgery
5428930|NCT00041925|graft stenosis|graft stenosis
5428931|NCT00041925|occluded grafts|occluded grafts
5428932|NCT00041860|Benzene|benzene
5428933|NCT00041860|Air pollution|air pollution
5428934|NCT00041847|gene|gene
5428935|NCT00041847|environment|environment
5428936|NCT00041847|occupation|occupation
5428937|NCT00041847|diet|diet
5428938|NCT00041847|interaction|interaction
5428939|NCT00041834|childhood asthma|childhood asthma
5428940|NCT00041834|traffic|traffic
5428941|NCT00041821|rhinitis|rhinitis
5428942|NCT00041821|irritation|irritation
5428943|NCT00041821|trigeminal|trigeminal
5428944|NCT00041899|Progesterone|progesterone
5428945|NCT00041899|Cortisol|cortisol
5428946|NCT00041899|Menstrual Cycle|menstrual cycle
5428947|NCT00041899|Formulation|formulation
5428948|NCT00041899|Endometrium|endometrium
5428949|NCT00041899|Estrogen|estrogen
5428950|NCT00041886|Minimally Invasive Surgery|minimally invasive surgery
5428951|NCT00041886|Percutaneous|percutaneous
5428952|NCT00041886|Radiofrequency Ablation|radiofrequency ablation
5428953|NCT00041886|Soft Tissue Metastases|soft tissue metastases
5428954|NCT00041886|Thermal Ablation|thermal ablation
5428955|NCT00041886|Soft Tissue Neoplasm|soft tissue neoplasm
5428956|NCT00041886|Tumor|tumor
5428957|NCT00041808|Metastatic liver cancer|metastatic liver cancer
5428958|NCT00041808|Cholangiocarcinoma|cholangiocarcinoma
5428959|NCT00041808|colorectal cancer|colorectal cancer
5428960|NCT00041808|esophageal cancer|esophageal cancer
5428961|NCT00041808|gastric cancer|gastric cancer
5428962|NCT00041808|pancreatic cancer|pancreatic cancer
5428963|NCT00041808|breast cancer|breast cancer
5428964|NCT00041808|malignant melanoma|malignant melanoma
5428965|NCT00041808|sarcoma|sarcoma
5428966|NCT00041808|GIST|gist
5428967|NCT00041808|gastrointestinal stromal tumor|gastrointestinal stromal tumor
5428968|NCT00041808|lung cancer|lung cancer
5428969|NCT00041808|liver cancer|liver cancer
5428970|NCT00041782|Deep Vein Thrombosis|deep vein thrombosis
5428971|NCT00041769|Drug Therapy, Combination|drug therapy, combination
5428972|NCT00041769|HIV Protease Inhibitors|hiv protease inhibitors
5428973|NCT00041769|Salvage Therapy|salvage therapy
5428974|NCT00041769|Viral Load|viral load
5428975|NCT00041769|Treatment Experienced|treatment experienced
5428976|NCT00041756|Primary Disease: Knee Primary Osteoarthritis|primary disease: knee primary osteoarthritis
5428977|NCT00041730|lymphoma|lymphoma
5428978|NCT00041730|vaccine|vaccine
5428979|NCT00041730|idiotype|idiotype
5428980|NCT00041730|KLH|klh
5428981|NCT00041730|GM-CSF|gm-csf
5428982|NCT00041730|FavId|favid
5428983|NCT00041717|spinal cord injury|spinal cord injury
5428984|NCT00041717|muscle spasticity|muscle spasticity
5428985|NCT00041704|Azole-Refractory Mucosal Candidiasis|azole-refractory mucosal candidiasis
5428986|NCT00041704|Mucosal Candidiasis|mucosal candidiasis
5428987|NCT00041691|Colorectal Cancer|colorectal cancer
5428988|NCT00041691|Colon Cancer|colon cancer
5428989|NCT00041691|Rectal Cancer|rectal cancer
5428990|NCT00041691|Colorectal Neoplasms|colorectal neoplasms
5428991|NCT00041691|Colorectal Carcinoma|colorectal carcinoma
5428992|NCT00041691|Colorectal Tumor|colorectal tumor
5428993|NCT00041678|Psychosis Associated with Dementia of the Alzheimer's Type|psychosis associated with dementia of the alzheimer's type
5428994|NCT00041652|Colorectal Cancer|colorectal cancer
5428995|NCT00041652|Colon Cancer|colon cancer
5428996|NCT00041652|Rectal Cancer|rectal cancer
5428997|NCT00041652|Colorectal Neoplasms|colorectal neoplasms
5428998|NCT00041652|Colorectal Carcinoma|colorectal carcinoma
5428999|NCT00041652|Breast Cancer|breast cancer
5429000|NCT00041652|Breast Neoplasms|breast neoplasms
5429001|NCT00041639|Pancreatic Cancer|pancreatic cancer
5429002|NCT00041639|Pancreatic Carcinoma|pancreatic carcinoma
5429003|NCT00041639|Pancreatic Neoplasms|pancreatic neoplasms
5429004|NCT00041639|Pancreas Cancer|pancreas cancer
5429005|NCT00041639|Pancreatic Tumor|pancreatic tumor
5429006|NCT00041626|Recurrent Squamous Cell Carcinoma of the Head and Neck|recurrent squamous cell carcinoma of the head and neck
5429007|NCT00041613|Refractory Squamous Cell Carcinoma of the Head and Neck|refractory squamous cell carcinoma of the head and neck
5429008|NCT00041600|epilepsy|epilepsy
5429009|NCT00041600|seizures|seizures
5429010|NCT00041600|disorders of human cognition|disorders of human cognition
5429011|NCT00041600|neuronal migration|neuronal migration
5429012|NCT00041600|neuronal migration disorders|neuronal migration disorders
5429013|NCT00041600|lissencephaly|lissencephaly
5429014|NCT00041600|schizencephaly|schizencephaly
5429015|NCT00041600|polymicrogyria|polymicrogyria
5429016|NCT00041600|agenesis of the corpus callosum|agenesis of the corpus callosum
5429017|NCT00041600|heterotopia|heterotopia
5429018|NCT00041587|Cancer|cancer
5429019|NCT00041587|Recurrent resectable supratentorial malignant glioma|recurrent resectable supratentorial malignant glioma
5429020|NCT00041509|venous thromboembolism|venous thromboembolism
5429021|NCT00041509|thromboembolism|thromboembolism
5429022|NCT00041509|pulmonary embolism|pulmonary embolism
5429023|NCT00041509|deep vein thrombosis|deep vein thrombosis
5429024|NCT00041496|symptomatic atrial fibrillation|symptomatic atrial fibrillation
5429025|NCT00041496|persistent atrial fibrillation|persistent atrial fibrillation
5429026|NCT00041561|Acute hypoxemic respiratory failure|acute hypoxemic respiratory failure
5429027|NCT00041535|Eye Movements|eye movements
5429028|NCT00041535|Saccades|saccades
5429029|NCT00041535|Metabolic|metabolic
5429030|NCT00041535|Lysosomal|lysosomal
5429031|NCT00041535|Myoclonus|myoclonus
5429032|NCT00041535|Gaucher Disease|gaucher disease
5429033|NCT00041535|Neuronopathic Gaucher Disease|neuronopathic gaucher disease
5429034|NCT00040677|sickle cell anemia|sickle cell anemia
5429035|NCT00040677|sickle cell disease|sickle cell disease
5429036|NCT00040677|anemia|anemia
5429037|NCT00040677|ICA-17043|ica-17043
5429038|NCT00040677|senicapoc|senicapoc
5429039|NCT00040664|pediatrics|pediatrics
5429040|NCT00040664|HIV|hiv
5429041|NCT00040664|protease inhibitors|protease inhibitors
5429042|NCT00040664|ritonavir|ritonavir
5429043|NCT00040664|fosamprenavir|fosamprenavir
5429044|NCT00040664|LEXIVA|lexiva
5429045|NCT00040664|AGENERASE|agenerase
5429046|NCT00040664|amprenavir|amprenavir
5429047|NCT00040651|Systemic Sclerosis|systemic sclerosis
5429048|NCT00040651|Chemotherapy|chemotherapy
5429049|NCT00040651|Cyclophosphamide|cyclophosphamide
5429050|NCT00040651|Fludarabine|fludarabine
5429051|NCT00040651|Leukapheresis|leukapheresis
5429052|NCT00040651|Mesna|mesna
5429053|NCT00040651|Stem Cell|stem cell
5429054|NCT00040651|T-Cell|t-cell
5429055|NCT00040651|Thymoglobulin|thymoglobulin
5429056|NCT00040651|Scleroderma|scleroderma
5429057|NCT00040027|hepatitis C|hepatitis c
5429058|NCT00040027|hepatitis C, chronic|hepatitis c, chronic
5429059|NCT00040599|Colon Cancer|colon cancer
5429060|NCT00040599|Rectal Cancer|rectal cancer
5429061|NCT00040599|Colorectal Neoplasms|colorectal neoplasms
5429062|NCT00040599|Colorectal Carcinoma|colorectal carcinoma
5429063|NCT00040599|Colorectal Tumor|colorectal tumor
5429064|NCT00040586|hormone-refractory|hormone-refractory
5429065|NCT00040573|Brain neoplasm|brain neoplasm
5429066|NCT00040573|Clinical trial, phase I/II|clinical trial, phase i/ii
5429067|NCT00040560|Lung Cancer|lung cancer
5429068|NCT00040560|Metastatic Brain Cancer|metastatic brain cancer
5429069|NCT00040547|Cancer-Advanced Solid Tumors|cancer-advanced solid tumors
5429070|NCT00040534|Advanced Cancer|advanced cancer
5429071|NCT00040521|Crohn's Disease|crohn's disease
5429072|NCT00040521|Active Crohns Disease|active crohns disease
5429073|NCT00040495|Peptic|peptic
5429074|NCT00040495|Ulcer|ulcer
5429075|NCT00040495|Hemorrhage|hemorrhage
5429076|NCT00040456|Hemoglobin SC disease|hemoglobin sc disease
5429077|NCT00040456|sickle cell-hemoglobin|sickle cell-hemoglobin
5429078|NCT00040443|Mild Cognitive Impairment|mild cognitive impairment
5429079|NCT00040443|Memory Loss|memory loss
5429080|NCT00040443|Alzheimer's Disease|alzheimer's disease
5429081|NCT00040443|Brain Aging|brain aging
5429082|NCT00040443|Ampalex®|ampalex®
5429083|NCT00040443|CX516|cx516
5429084|NCT00040508|Proteinuria|proteinuria
5429085|NCT00040508|Renal Failure|renal failure
5429086|NCT00040508|Fibrosis|fibrosis
5429087|NCT00040508|Rapamycin|rapamycin
5429088|NCT00040508|Immunosuppression|immunosuppression
5429089|NCT00040508|Focal Segmental Glomerulosclerosis|focal segmental glomerulosclerosis
5429090|NCT00040508|FSGS|fsgs
5429091|NCT00040404|Parkinson's disease|parkinson's disease
5429092|NCT00040404|Idiopathic Parkinson's disease|idiopathic parkinson's disease
5429093|NCT00040404|Idiopathic Parkinson disease|idiopathic parkinson disease
5429094|NCT00040404|Parkinson's disease, idiopathic|parkinson's disease, idiopathic
5429095|NCT00040391|Pharmacia|pharmacia
5429096|NCT00040378|Alzheimer Disease|alzheimer disease
5429097|NCT00040378|Vitamin E|vitamin e
5429098|NCT00040378|Selenium|selenium
5429099|NCT00040365|Prostate Cancer|prostate cancer
5429100|NCT00040365|Radiation Therapy|radiation therapy
5429101|NCT00040365|Rectal Toxicity|rectal toxicity
5429102|NCT00040365|Amifostine|amifostine
5429103|NCT00040365|Radioprotector|radioprotector
5429104|NCT00040352|Genetics|genetics
5429105|NCT00040352|Risk Factors|risk factors
5429106|NCT00040352|Natural History|natural history
5429107|NCT00040352|Melanoma Precursors|melanoma precursors
5429108|NCT00040352|Skin Cancer|skin cancer
5429109|NCT00040352|Melanoma|melanoma
5429110|NCT00040339|brain injury|brain injury
5429111|NCT00040339|hypothermia|hypothermia
5429112|NCT00040339|body cooling|body cooling
5429113|NCT00040339|body temperature|body temperature
5429114|NCT00040326|epilepsy|epilepsy
5429115|NCT00040326|mesial temporal lobe epilepsy|mesial temporal lobe epilepsy
5429116|NCT00040326|temporal lobe epilepsy|temporal lobe epilepsy
5429117|NCT00040326|MTLE|mtle
5429118|NCT00040326|seizures|seizures
5429119|NCT00040326|anteromesial temporal resection|anteromesial temporal resection
5429120|NCT00040326|surgery|surgery
5442497|NCT00004732|angioplasty|angioplasty
5429121|NCT00040326|antiepileptic drugs|antiepileptic drugs
5429122|NCT00040326|hippocampal sclerosis|hippocampal sclerosis
5429123|NCT00040300|treatment experienced|treatment experienced
5429124|NCT00040300|HIV|hiv
5429125|NCT00040300|Phase I|phase i
5429126|NCT00040300|Combination Therapy|combination therapy
5429127|NCT00040287|smoking|smoking
5429128|NCT00040287|obesity|obesity
5429129|NCT00040287|weight loss|weight loss
5429130|NCT00040287|smoking cessation|smoking cessation
5429131|NCT00040287|weight control|weight control
5429132|NCT00040274|HIV|hiv
5429133|NCT00040274|Phase I|phase i
5429134|NCT00040183|Tarceva, EGFR, erlotinib, OSI-774|tarceva, egfr, erlotinib, osi-774
5429135|NCT00040170|Adenocarcinoma of the prostate|adenocarcinoma of the prostate
5429136|NCT00040157|treatment experienced,|treatment experienced,
5429137|NCT00040157|Stable triple anti-retroviral combination therapy in HIV-infected,|stable triple anti-retroviral combination therapy in hiv-infected,
5429138|NCT00040157|Achillion|achillion
5429139|NCT00040144|E-Antigen positive,|e-antigen positive,
5429140|NCT00040144|Lamivudine-Resistant Chronic Hepatitis B,|lamivudine-resistant chronic hepatitis b,
5429141|NCT00040144|Achillion|achillion
5429142|NCT00040261|Antiglutamatergic|antiglutamatergic
5429143|NCT00040261|Neuroprotective|neuroprotective
5429144|NCT00040261|Unipolar Depression|unipolar depression
5429145|NCT00040261|Treatment|treatment
5429146|NCT00040261|Antidepressant|antidepressant
5429147|NCT00040261|Depression|depression
5429148|NCT00040261|Glutamate|glutamate
5429149|NCT00040261|Memantine|memantine
5429150|NCT00040261|Pathophysiology|pathophysiology
5429151|NCT00040261|Positron Emission Tomography|positron emission tomography
5429152|NCT00040261|Major Depression|major depression
5429153|NCT00040248|Relapse|relapse
5429154|NCT00040248|Monoclonal Antibody|monoclonal antibody
5429155|NCT00040248|Biologic Agent|biologic agent
5429156|NCT00040248|Anti-CD25|anti-cd25
5429157|NCT00040248|Activated Lymphocyte|activated lymphocyte
5429158|NCT00040248|Wegener Granulomatosis|wegener granulomatosis
5429159|NCT00040248|Wegener's Granulomatosis|wegener's granulomatosis
5429160|NCT00040248|WG|wg
5429161|NCT00040235|Leukapheresis|leukapheresis
5429162|NCT00040235|Hypomagnesemia|hypomagnesemia
5429163|NCT00040235|Plateletpheresis|plateletpheresis
5429164|NCT00040235|Hypocalcemia|hypocalcemia
5429165|NCT00040235|Citrate|citrate
5429166|NCT00040235|Healthy Volunteer|healthy volunteer
5429167|NCT00040235|HV|hv
5429168|NCT00040235|Normal Control|normal control
5429169|NCT00040222|Counseling/behavioral/psychosocial|counseling/behavioral/psychosocial
5429170|NCT00040222|Gene discovery|gene discovery
5429171|NCT00040222|Cancer prevention|cancer prevention
5429172|NCT00040222|Risk-reduction|risk-reduction
5429173|NCT00040222|Hereditary|hereditary
5429174|NCT00040222|Breast Cancer|breast cancer
5429175|NCT00040222|Ovarian Cancer|ovarian cancer
5429176|NCT00040222|Cowden Syndrome|cowden syndrome
5429177|NCT00040222|Peutz-Jegher Syndrome|peutz-jegher syndrome
5429178|NCT00040222|Li-Fraumeni Syndrome|li-fraumeni syndrome
5429179|NCT00040209|JP 1730|jp 1730
5429180|NCT00040209|Dyskinesias|dyskinesias
5429181|NCT00040209|Levodopa Infusion|levodopa infusion
5429182|NCT00040209|Apomorphine Infusion|apomorphine infusion
5429183|NCT00040209|Clinical Trial|clinical trial
5429184|NCT00040209|Parkinson Disease|parkinson disease
5429185|NCT00040209|PD|pd
5429186|NCT00040196|Parkinson's Disease|parkinson's disease
5429187|NCT00040196|Levodopa|levodopa
5429188|NCT00040196|Perfusion fMRI|perfusion fmri
5429189|NCT00040196|Aging|aging
5429190|NCT00040196|Motor Control|motor control
5429191|NCT00040196|PD|pd
5429192|NCT00040196|Healthy Volunteer|healthy volunteer
5429193|NCT00040196|HV|hv
5429194|NCT00040196|Normal Control|normal control
5429195|NCT00040105|Chronic Myelogenous Leukemia, Chronic Phase|chronic myelogenous leukemia, chronic phase
5429196|NCT00040105|R115777|r115777
5429197|NCT00040105|Zarnestra|zarnestra
5429198|NCT00040105|Tipifarnib|tipifarnib
5429199|NCT00040105|Imatinib Mesylate|imatinib mesylate
5429200|NCT00040105|Gleevec|gleevec
5429201|NCT00040105|Imatinib|imatinib
5429202|NCT00040105|STI571|sti571
5429203|NCT00040105|NSC-716051|nsc-716051
5429204|NCT00040092|Virulizin|virulizin
5429205|NCT00040092|Immunotherapy|immunotherapy
5429206|NCT00040092|Pancreas|pancreas
5429207|NCT00040092|Pancreatic Cancer|pancreatic cancer
5429208|NCT00040092|clinical trial|clinical trial
5429209|NCT00039988|Treatment Outcome|treatment outcome
5429210|NCT00039988|Multiple Sclerosis|multiple sclerosis
5429211|NCT00039988|Albuterol|albuterol
5429212|NCT00039988|Copolymer 1|copolymer 1
5429213|NCT00039975|Drug Interactions|drug interactions
5429214|NCT00039975|HIV Protease Inhibitors|hiv protease inhibitors
5429215|NCT00039975|Ritonavir|ritonavir
5429216|NCT00039975|Indinavir|indinavir
5429217|NCT00039975|Calcium Channel Blockers|calcium channel blockers
5429218|NCT00039975|Pharmacokinetics|pharmacokinetics
5429219|NCT00039975|Diltiazem|diltiazem
5429220|NCT00039975|Amlodipine|amlodipine
5429221|NCT00039962|hepatitis C|hepatitis c
5429222|NCT00039962|hepatitis C, chronic|hepatitis c, chronic
5429223|NCT00039962|cirrhosis, liver|cirrhosis, liver
5429224|NCT00039936|Binge Eating|binge eating
5429228|NCT00040053|amphetamine dependence|amphetamine dependence
5429229|NCT00039923|Hemolysis|hemolysis
5429230|NCT00039923|CD55|cd55
5429231|NCT00039923|CD59|cd59
5429232|NCT00039923|Transfusion|transfusion
5429233|NCT00039923|Paroxysmal Nocturnal Hemoglobinuria|paroxysmal nocturnal hemoglobinuria
5429234|NCT00039923|PNH|pnh
5429235|NCT00039884|Cervical cancer|cervical cancer
5429236|NCT00039858|heparin-induced thrombocytopenia|heparin-induced thrombocytopenia
5429237|NCT00039858|heparin-induced thrombocytopenia and thrombosis|heparin-induced thrombocytopenia and thrombosis
5429238|NCT00039858|HIT|hit
5429239|NCT00039858|HITTS|hitts
5429240|NCT00039858|anticoagulation|anticoagulation
5429241|NCT00039845|Brain|brain
5429242|NCT00039845|Imaging|imaging
5429243|NCT00039845|Pediatrics|pediatrics
5429244|NCT00039845|Mapping|mapping
5429245|NCT00039845|Development|development
5429246|NCT00039845|fMRI|fmri
5429247|NCT00039845|Children|children
5429248|NCT00039845|Language|language
5429249|NCT00039845|Healthy Volunteer|healthy volunteer
5429250|NCT00039845|HV|hv
5429251|NCT00039845|Normal Control|normal control
5429252|NCT00039832|Stroke|stroke
5429253|NCT00039832|Abciximab|abciximab
5429254|NCT00039832|Reteplase|reteplase
5429255|NCT00039832|MRI|mri
5429256|NCT00039832|Cerebral Blood Flow|cerebral blood flow
5429257|NCT00039793|Cancer-related fatigue|cancer-related fatigue
5429258|NCT00039793|alternative medicine|alternative medicine
5429259|NCT00039793|cancer rehabilitation /care|cancer rehabilitation /care
5429260|NCT00039793|fatigue|fatigue
5429261|NCT00039793|human therapy evaluation|human therapy evaluation
5429262|NCT00039793|physical therapy|physical therapy
5429263|NCT00039793|neoplasm /cancer chemotherapy|neoplasm /cancer chemotherapy
5429264|NCT00039793|neoplasm /cancer palliative treatment|neoplasm /cancer palliative treatment
5429265|NCT00039780|Breast|breast
5429266|NCT00039780|Cancer|cancer
5429267|NCT00039780|Metastatic|metastatic
5429268|NCT00039780|Paclitaxel|paclitaxel
5429269|NCT00039780|Peripheral|peripheral
5429270|NCT00039780|Taxol|taxol
5429271|NCT00039780|Neuropathy|neuropathy
5429272|NCT00039780|Neurotoxicity|neurotoxicity
5429273|NCT00039780|Paresthesias|paresthesias
5429274|NCT00039780|Weekly|weekly
5429275|NCT00039780|BNP7787|bnp7787
5429276|NCT00039780|7787|7787
5429277|NCT00039780|Tavocept|tavocept
5429278|NCT00039780|Prevention|prevention
5429279|NCT00039819|Spinal Cord|spinal cord
5429280|NCT00039819|Sensory Stimulation|sensory stimulation
5429281|NCT00039819|Locomotion|locomotion
5429282|NCT00039819|Magnetic Stimulation|magnetic stimulation
5429283|NCT00039819|Reflexes|reflexes
5429284|NCT00039819|Healthy Volunteer|healthy volunteer
5429285|NCT00039819|HV|hv
5429286|NCT00039819|Normal Control|normal control
5429287|NCT00039754|Multiple myeloma|multiple myeloma
5429288|NCT00039754|Transplant|transplant
5429289|NCT00039754|Skeletal Targeted Radiotherapy|skeletal targeted radiotherapy
5429290|NCT00039754|Holmium|holmium
5429291|NCT00039741|Drug Therapy, Combination|drug therapy, combination
5429292|NCT00039741|HIV Protease Inhibitors|hiv protease inhibitors
5429293|NCT00039741|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5429294|NCT00039741|Viral Load|viral load
5429295|NCT00039741|Treatment Naive|treatment naive
5429296|NCT00039767|Fibrin Sleeves|fibrin sleeves
5429297|NCT00039767|Anticoagulants|anticoagulants
5429298|NCT00039767|Catheters|catheters
5429299|NCT00039767|Thrombosis|thrombosis
5429300|NCT00039767|Hirudin|hirudin
5429301|NCT00039767|Lepirudin|lepirudin
5429302|NCT00039026|Type 2 Diabetes Mellitis|type 2 diabetes mellitis
5429303|NCT00039000|Immunotherapy, Cancer, Melanoma, Skin Cancer, tumor|immunotherapy, cancer, melanoma, skin cancer, tumor
5429304|NCT00038987|Smallpox|smallpox
5429305|NCT00038987|APSV|apsv
5429306|NCT00038987|Aventis Pasteur Smallpox Vaccine|aventis pasteur smallpox vaccine
5429307|NCT00038987|vaccinia-naive|vaccinia-naive
5429308|NCT00038974|Hepatitis C|hepatitis c
5429309|NCT00038974|Interferon|interferon
5429310|NCT00038974|Ribavirin|ribavirin
5429311|NCT00038974|Efficacy|efficacy
5429312|NCT00038974|Viral load|viral load
5429313|NCT00038974|Genetics|genetics
5429314|NCT00038974|Cytokines|cytokines
5429315|NCT00038974|Immunology|immunology
5429316|NCT00038961|fondaparinux sodium|fondaparinux sodium
5429317|NCT00038961|DVT Prevention|dvt prevention
5429318|NCT00038961|abdominal surgery|abdominal surgery
5429319|NCT00038961|VTE prevention|vte prevention
5429320|NCT00038961|venous thromboembolism|venous thromboembolism
5429321|NCT00038961|pulmonary embolism|pulmonary embolism
5429322|NCT00039715|Glucocorticoid Receptor|glucocorticoid receptor
5429323|NCT00039715|Traumatic Reminders|traumatic reminders
5429324|NCT00039715|Stress|stress
5429325|NCT00039715|Hippocampus|hippocampus
5429326|NCT00039715|Flashbacks|flashbacks
5429327|NCT00039715|PTSD|ptsd
5429328|NCT00039715|Type II GR Receptor|type ii gr receptor
5429329|NCT00039715|Hydrocortisone|hydrocortisone
5429330|NCT00039715|Memory|memory
5429331|NCT00039715|Major Depression|major depression
5429332|NCT00039715|Post-Traumatic Stress Disorder|post-traumatic stress disorder
5429333|NCT00039715|Healthy Volunteer|healthy volunteer
5429334|NCT00039715|HV|hv
5429335|NCT00039715|Normal Control|normal control
5429336|NCT00039702|Nicotinic Acetylcholine Receptors|nicotinic acetylcholine receptors
5429337|NCT00039702|Alzheimer's Disease|alzheimer's disease
5429338|NCT00039702|SPECT|spect
5429339|NCT00039702|AD|ad
5429340|NCT00039702|Healthy Volunteer|healthy volunteer
5429341|NCT00039702|HV|hv
5429342|NCT00039702|Normal Control|normal control
5429343|NCT00039689|Primary HIV Infection|primary hiv infection
5429344|NCT00039689|Chronic HIV Infection|chronic hiv infection
5429345|NCT00039689|Antiretroviral Therapy|antiretroviral therapy
5429346|NCT00039689|Innate Immunity|innate immunity
5429347|NCT00039689|B Cell|b cell
5429348|NCT00039689|HIV Infection|hiv infection
5429349|NCT00039689|Acute Infection|acute infection
5429350|NCT00039689|Treatment Naive|treatment naive
5429351|NCT00039676|Genetics|genetics
5429352|NCT00039676|Risk Factors|risk factors
5429353|NCT00039676|Natural History|natural history
5429354|NCT00039676|Lymphoma|lymphoma
5429355|NCT00039676|Leukemia|leukemia
5429356|NCT00039676|Lymph Node Cancer|lymph node cancer
5429357|NCT00039663|Hyperlipidemia|hyperlipidemia
5429358|NCT00039663|Insulin Resistance|insulin resistance
5429359|NCT00039663|Coronary Artery Disease|coronary artery disease
5429360|NCT00039663|Lipodystrophy|lipodystrophy
5429361|NCT00039663|Antiretroviral Therapy|antiretroviral therapy
5429362|NCT00039663|HIV Infection|hiv infection
5429363|NCT00039663|Treatment Experienced|treatment experienced
5429364|NCT00039650|Granulocyte Colony-Stimulating Factor|granulocyte colony-stimulating factor
5429365|NCT00039650|T Cells|t cells
5429366|NCT00039650|Peripheral Blood Stem Cells|peripheral blood stem cells
5429367|NCT00039650|Apheresis|apheresis
5429368|NCT00039650|Hematopoietic Progenitor Cell Transplantation|hematopoietic progenitor cell transplantation
5429369|NCT00039650|Healthy Volunteer|healthy volunteer
5429370|NCT00039650|HV|hv
5429371|NCT00039650|Normal Control|normal control
5429372|NCT00039624|Radiation Therapy|radiation therapy
5429373|NCT00039624|Prostate|prostate
5429374|NCT00039624|MRI|mri
5429375|NCT00039624|Brachytherapy|brachytherapy
5429376|NCT00039624|Phase II|phase ii
5429377|NCT00039624|Prostate Cancer|prostate cancer
5429378|NCT00038948|Renal|renal
5429379|NCT00038948|Allograft|allograft
5429380|NCT00038948|Recipients|recipients
5429381|NCT00038935|Hemophilia|hemophilia
5429382|NCT00038922|Left-Sided|left-sided
5429383|NCT00038922|Ulcerative|ulcerative
5429384|NCT00038922|Colitis|colitis
5429385|NCT00038896|Panic|panic
5429386|NCT00038896|Disorder|disorder
5429387|NCT00038883|Lymphoid Malignancies|lymphoid malignancies
5429388|NCT00038883|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
5429389|NCT00038883|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
5429390|NCT00038883|Low grade Lymphoma|low grade lymphoma
5429391|NCT00038883|B and T cell Lymphoma of the intermediate and high grade|b and t cell lymphoma of the intermediate and high grade
5429392|NCT00038870|AML|aml
5429393|NCT00038870|CML|cml
5429394|NCT00038870|Dendritic Cells|dendritic cells
5429395|NCT00038857|Acute Myelogenous Leukemia|acute myelogenous leukemia
5429396|NCT00038857|Acute Lymphocytic Leukemia|acute lymphocytic leukemia
5429397|NCT00038857|Myelodysplastic Syndrome|myelodysplastic syndrome
5429398|NCT00038857|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
5429399|NCT00038857|Leukemia|leukemia
5429400|NCT00038857|Lymphoma|lymphoma
5429401|NCT00038857|Non Hodgkin's Lymphoma|non hodgkin's lymphoma
5429402|NCT00038857|T cell depletion|t cell depletion
5429403|NCT00038857|CD34 selected progenitors cell|cd34 selected progenitors cell
5429404|NCT00038857|GVHD|gvhd
5429405|NCT00038844|Lymphoma|lymphoma
5429406|NCT00038844|Leukemia|leukemia
5429407|NCT00038844|Campath-1 H|campath-1 h
5429408|NCT00038844|Campath|campath
5429409|NCT00038844|Alemtuzumab|alemtuzumab
5429410|NCT00038844|Fludarabine|fludarabine
5429411|NCT00038844|Fludarabine Phosphate|fludarabine phosphate
5429412|NCT00038844|Fludara|fludara
5429413|NCT00038844|Cyclophosphamide|cyclophosphamide
5429414|NCT00038844|Cytoxan|cytoxan
5429415|NCT00038844|Neosar|neosar
5429416|NCT00038844|Rituxan|rituxan
5429417|NCT00038844|Rituximab|rituximab
5429418|NCT00038831|Acute Myelogenous leukemia|acute myelogenous leukemia
5429419|NCT00038831|AML|aml
5429420|NCT00038831|Myelodysplastic Syndrome|myelodysplastic syndrome
5429421|NCT00038831|MDS|mds
5429422|NCT00038831|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
5429423|NCT00038831|CML|cml
5429424|NCT00038831|Mylotarg|mylotarg
5429425|NCT00038831|Gemtuzumab|gemtuzumab
5429426|NCT00038831|Gemtuzumab ozogamicin|gemtuzumab ozogamicin
5429427|NCT00038831|Melphalan|melphalan
5429428|NCT00038831|Alkeran|alkeran
5429429|NCT00038831|Fludarabine Phosphate|fludarabine phosphate
5429430|NCT00038831|Fludarabine|fludarabine
5429431|NCT00038831|Fludara|fludara
5429432|NCT00038831|Anti-thymocyte globulin|anti-thymocyte globulin
5429433|NCT00038831|ATG|atg
5429434|NCT00038831|Allogeneic Bone Marrow|allogeneic bone marrow
5429435|NCT00038831|Peripheral Blood Stem Cell Transplantation|peripheral blood stem cell transplantation
5429436|NCT00038831|Allo PBSCT|allo pbsct
5429437|NCT00038831|Allogeneic transplantation|allogeneic transplantation
5429438|NCT00038818|CML|cml
5429443|NCT00038818|CD8 Depleted|cd8 depleted
5429444|NCT00038818|Donor Lymphocyte|donor lymphocyte
5429445|NCT00038805|High Risk Acute Myeloid Leukemia|high risk acute myeloid leukemia
5429446|NCT00038805|Acute Lymphocytic Leukemia|acute lymphocytic leukemia
5429447|NCT00038805|Chronic Myeloid Leukemia|chronic myeloid leukemia
5429448|NCT00038805|Myelodysplastic Syndrome|myelodysplastic syndrome
5429449|NCT00038805|ALL|all
5429450|NCT00038805|AML|aml
5429451|NCT00038805|MDS|mds
5429452|NCT00038805|CML|cml
5429453|NCT00038805|CMML|cmml
5429454|NCT00038805|Nonmyeloablative Preparative Regimen|nonmyeloablative preparative regimen
5429455|NCT00038805|Mylotarg|mylotarg
5429456|NCT00038805|CMA-676|cma-676
5429457|NCT00038792|Acute Graft Versus Host Disease|acute graft versus host disease
5429458|NCT00038792|Refractory|refractory
5429459|NCT00038779|Lymphoma|lymphoma
5429460|NCT00038779|CML|cml
5429461|NCT00038779|CLL|cll
5429462|NCT00038779|AML|aml
5429463|NCT00038779|ALL|all
5429464|NCT00038779|MDS|mds
5429465|NCT00038779|AA|aa
5429466|NCT00038766|Inflammatory Bowel Disease|inflammatory bowel disease
5429467|NCT00038753|vision screening|vision screening
5429468|NCT00038727|DPP|dpp
5429469|NCT00038727|IGT|igt
5429470|NCT00038727|Prediabetes|prediabetes
5429471|NCT00038727|Type 2 diabetes|type 2 diabetes
5429472|NCT00038727|Macrovascular disease|macrovascular disease
5429473|NCT00038727|Microvascular disease|microvascular disease
5429474|NCT00038727|Lifestyle|lifestyle
5429475|NCT00038727|Metformin|metformin
5429476|NCT00038727|Obesity|obesity
5429477|NCT00038714|HPV|hpv
5429478|NCT00038714|Papilloma|papilloma
5429479|NCT00038701|Metastatic Pancreas Cancer|metastatic pancreas cancer
5429480|NCT00038688|Health Education|health education
5429481|NCT00038688|Substance Abuse, Intravenous|substance abuse, intravenous
5429482|NCT00038688|Program Evaluation|program evaluation
5429483|NCT00038688|Peer Group|peer group
5429484|NCT00038688|Risk-Taking|risk-taking
5429485|NCT00038688|HIV Seronegativity|hiv seronegativity
5429486|NCT00038688|Substance-related Disorders|substance-related disorders
5429487|NCT00038675|Leukemia|leukemia
5429488|NCT00038675|Chronic Myelomonocytic Leukemia|chronic myelomonocytic leukemia
5429489|NCT00038675|Chronic Myeloid Leukemia|chronic myeloid leukemia
5429490|NCT00038675|Polycythemia Vera|polycythemia vera
5429491|NCT00038675|Hypereosinophilic Syndrome|hypereosinophilic syndrome
5429492|NCT00038675|Mastocytosis|mastocytosis
5429493|NCT00038675|Imatinib Mesylate|imatinib mesylate
5429494|NCT00038675|Gleevec|gleevec
5429495|NCT00038649|Philadelphia chromosome positive|philadelphia chromosome positive
5429496|NCT00038649|early chronic phase (diagnosis < 12 months)|early chronic phase (diagnosis < 12 months)
5429497|NCT00038649|Chronic Myelogenous Leukemia, Chronic Phase|chronic myelogenous leukemia, chronic phase
5429498|NCT00038649|Chronic Myelogenous Leukemia|chronic myelogenous leukemia
5429499|NCT00038649|CML|cml
5429500|NCT00038649|Gleevec|gleevec
5429501|NCT00038649|STI571|sti571
5429502|NCT00038636|HIV|hiv
5429503|NCT00038623|Relapsed/Refractory Mantle Cell Lymphoma|relapsed/refractory mantle cell lymphoma
5429504|NCT00038623|Yttrium-Ibritumomab|yttrium-ibritumomab
5429505|NCT00038623|Zevalin|zevalin
5429506|NCT00038610|Leukemia|leukemia
5429507|NCT00038610|Lymphoblastic|lymphoblastic
5429508|NCT00038610|Acute|acute
5429509|NCT00038610|Philadelphia-Positive|philadelphia-positive
5429510|NCT00038610|Imatinib Mesylate|imatinib mesylate
5429511|NCT00038610|Gleevec|gleevec
5429512|NCT00038610|Glivec|glivec
5429513|NCT00038610|Imatinib|imatinib
5429514|NCT00038610|STI571|sti571
5429515|NCT00038610|STI-571|sti-571
5429516|NCT00038610|CGP-57148B|cgp-57148b
5429517|NCT00038610|NSC-716051|nsc-716051
5429518|NCT00038610|Cyclophosphamide|cyclophosphamide
5429519|NCT00038610|Cytoxan®,|cytoxan®,
5429520|NCT00038610|Neosar®|neosar®
5429521|NCT00038610|Doxorubicin|doxorubicin
5429522|NCT00038610|Adriamycin ®|adriamycin ®
5429523|NCT00038610|Rubex ®|rubex ®
5429524|NCT00038610|Adriamycin PFS|adriamycin pfs
5429525|NCT00038610|Adriamycin RDF|adriamycin rdf
5429526|NCT00038610|Vincristine|vincristine
5429527|NCT00038610|Dexamethasone|dexamethasone
5429528|NCT00038610|Decadron|decadron
5429529|NCT00038610|Methotrexate|methotrexate
5429530|NCT00038610|Cytarabine|cytarabine
5429531|NCT00038610|Ara-C|ara-c
5429532|NCT00038610|Cytosar|cytosar
5429533|NCT00038610|DepoCyt|depocyt
5429534|NCT00038610|Cytosine Arabinosine Hydrochloride|cytosine arabinosine hydrochloride
5429535|NCT00038610|Mesna|mesna
5429536|NCT00038610|Mesnex|mesnex
5429537|NCT00038610|G-CSF|g-csf
5429538|NCT00038610|Filgrastim|filgrastim
5429539|NCT00038610|Neupogen|neupogen
5429540|NCT00038597|Philadelphia chromosome positive CML|philadelphia chromosome positive cml
5429541|NCT00038597|Myelogenous Leukemia, Chronic, Chronic Phase|myelogenous leukemia, chronic, chronic phase
5429542|NCT00038597|Myelogenous Leukemia, Chronic, Accelerated Phase|myelogenous leukemia, chronic, accelerated phase
5429543|NCT00038571|Cancer|cancer
5429544|NCT00038571|Relapsed|relapsed
5429545|NCT00038571|Refractory|refractory
5429546|NCT00038571|B cell lymphoma|b cell lymphoma
5429547|NCT00038571|Proteasome Inhibitor|proteasome inhibitor
5429548|NCT00038571|PS-341|ps-341
5429549|NCT00038558|Hodgkin's lymphoma|hodgkin's lymphoma
5429550|NCT00038558|Dacarbazine|dacarbazine
5429551|NCT00038558|DTIC|dtic
5429552|NCT00038558|DTIC-Dome|dtic-dome
5429553|NCT00038558|Vinblastine|vinblastine
5429554|NCT00038558|Velban|velban
5429555|NCT00038558|Bleomycin sulfate|bleomycin sulfate
5429556|NCT00038558|Blenoxane|blenoxane
5429557|NCT00038558|BLM|blm
5429558|NCT00038558|Doxorubicin Hydrochloride|doxorubicin hydrochloride
5429559|NCT00038558|Adriamycin|adriamycin
5429560|NCT00038558|Filgrastim|filgrastim
5429561|NCT00038558|G-CSF|g-csf
5429562|NCT00038558|Neupogen|neupogen
5429563|NCT00038558|Pegfilgrastim|pegfilgrastim
5429564|NCT00038558|granulocyte colony-stimulating factor|granulocyte colony-stimulating factor
5429565|NCT00038545|LYMPHOMA|lymphoma
5429566|NCT00038545|NON-HODGKINS|non-hodgkins
5429567|NCT00038545|AGGRESSIVE|aggressive
5429568|NCT00038545|RELAPSED AND REFRACTORY|relapsed and refractory
5429569|NCT00038532|treatment experienced|treatment experienced
5429570|NCT00038532|HIV|hiv
5429571|NCT00038519|treatment experienced|treatment experienced
5429572|NCT00038519|HIV|hiv
5429573|NCT00038506|HIV-1 TRIZIVIR Tenofovir|hiv-1 trizivir tenofovir
5429574|NCT00038493|GBM|gbm
5429575|NCT00038493|Glioma|glioma
5429576|NCT00038493|Brain Tumor|brain tumor
5429577|NCT00038480|Lopinavir|lopinavir
5429578|NCT00038480|HIV-1|hiv-1
5429579|NCT00038480|Drug Therapy, Combination|drug therapy, combination
5429580|NCT00038480|HIV Protease Inhibitors|hiv protease inhibitors
5429581|NCT00038480|Ritonavir|ritonavir
5429582|NCT00038480|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5429583|NCT00038454|Oxygen Therapeutics|oxygen therapeutics
5429584|NCT00038454|CABG|cabg
5429585|NCT00038454|Transfusion|transfusion
5429586|NCT00038441|Malignant Glioma|malignant glioma
5429587|NCT00038415|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
5429588|NCT00038415|CLL|cll
5429589|NCT00038415|Binet Stage A|binet stage a
5429590|NCT00038415|Vaccination|vaccination
5429591|NCT00038415|Idiotypic|idiotypic
5429592|NCT00038415|Genetic|genetic
5429593|NCT00038415|Deoxyribonucleic acid|deoxyribonucleic acid
5429594|NCT00038415|DNA|dna
5429595|NCT00038402|Breast Cancer|breast cancer
5429596|NCT00038402|Non-Inflammatory Breast Cancer|non-inflammatory breast cancer
5429597|NCT00038402|Operable Breast Cancer|operable breast cancer
5429598|NCT00038402|Herceptin|herceptin
5429599|NCT00038402|Taxol|taxol
5429600|NCT00038402|FEC|fec
5429601|NCT00038402|Fluorouracil|fluorouracil
5429602|NCT00038402|Cyclophosphamide|cyclophosphamide
5429603|NCT00038402|Epirubicin|epirubicin
5429604|NCT00038402|Trastuzumab|trastuzumab
5429605|NCT00038402|Paclitaxel|paclitaxel
5429606|NCT00038402|Neosar|neosar
5429607|NCT00038389|Brain Stem Tumor|brain stem tumor
5429608|NCT00038376|T-cell lymphoma|t-cell lymphoma
5429609|NCT00038376|accutane|accutane
5429610|NCT00038376|isotretinoin|isotretinoin
5429611|NCT00038376|mycosis fungoides|mycosis fungoides
5429612|NCT00038376|T-cell malignancies|t-cell malignancies
5429613|NCT00038363|Frail|frail
5429614|NCT00038363|Disable|disable
5429615|NCT00038363|Disabled Persons|disabled persons
5429616|NCT00038363|Physically disabled|physically disabled
5429617|NCT00038363|Elderly|elderly
5429618|NCT00038363|Rehabilitation|rehabilitation
5429619|NCT00038363|Subacute care|subacute care
5429620|NCT00038350|Age|age
5429621|NCT00038350|Dysphagia|dysphagia
5429622|NCT00038350|Swallowing|swallowing
5429623|NCT00038337|Health Literacy|health literacy
5429624|NCT00038337|Visual|visual
5429625|NCT00038337|Cognitive|cognitive
5429626|NCT00038285|Amputation|amputation
5429627|NCT00038285|Cardiovascular Disease|cardiovascular disease
5429628|NCT00038285|PVD|pvd
5429629|NCT00038272|Placebos|placebos
5429630|NCT00038272|Drug Therapy, Combination|drug therapy, combination
5429631|NCT00038272|Anti-HIV Agents|anti-hiv agents
5429632|NCT00038272|Mycophenolate Mofetil|mycophenolate mofetil
5429633|NCT00038272|2,6-diaminopurine dioxolane|2,6-diaminopurine dioxolane
5429634|NCT00038272|Treatment Experienced|treatment experienced
5429635|NCT00038272|DAPD|dapd
5429636|NCT00038272|MMF|mmf
5429637|NCT00038259|Interleukin-2|interleukin-2
5429638|NCT00038259|Drug Administration Schedule|drug administration schedule
5429639|NCT00038259|CD4 Lymphocyte Count|cd4 lymphocyte count
5429640|NCT00038259|Anti-HIV Agents|anti-hiv agents
5429641|NCT00038259|Viral Load|viral load
5429642|NCT00038259|Treatment Interruption|treatment interruption
5429643|NCT00038259|Treatment Experienced|treatment experienced
5429644|NCT00038259|STI|sti
5429645|NCT00038246|Prostate Cancer|prostate cancer
5429646|NCT00038233|myeloma|myeloma
5429647|NCT00038220|HIV|hiv
5429648|NCT00038207|soft tissue sarcoma|soft tissue sarcoma
5429649|NCT00038207|Bone sarcomas|bone sarcomas
5429650|NCT00038194|Prostate Cancer|prostate cancer
5429651|NCT00038194|bone metastasis|bone metastasis
5429652|NCT00038181|Prostate Cancer|prostate cancer
5429653|NCT00038168|Prostate Cancer|prostate cancer
5429654|NCT00038155|Ambulation|ambulation
5429655|NCT00038155|Difficulties in ambulation|difficulties in ambulation
5429656|NCT00038155|Geriatric|geriatric
5429657|NCT00038155|Rehabilitation|rehabilitation
5429658|NCT00038142|Ewing's Sarcoma|ewing's sarcoma
5429659|NCT00038142|Vincristine|vincristine
5429660|NCT00038142|Doxorubicin|doxorubicin
5429661|NCT00038142|Adriamycin|adriamycin
5429662|NCT00038142|Rubex|rubex
5429663|NCT00038142|Cyclophosphamide|cyclophosphamide
5429664|NCT00038142|Dexrazoxane|dexrazoxane
5429665|NCT00038142|Zinecard|zinecard
5429666|NCT00038142|VACdxr|vacdxr
5429667|NCT00038142|ImmTher|immther
5429668|NCT00038116|Parkinson's disease|parkinson's disease
5429669|NCT00038116|PD|pd
5429670|NCT00038116|dopamine|dopamine
5429671|NCT00038116|embryonic dopamine cell implant surgery|embryonic dopamine cell implant surgery
5429672|NCT00038116|tissue implants|tissue implants
5429673|NCT00038090|Myeloma|myeloma
5429674|NCT00038090|Thalidomide|thalidomide
5429675|NCT00038090|Thalomid|thalomid
5429676|NCT00038090|Dexamethasone|dexamethasone
5429677|NCT00038090|Decadron|decadron
5429678|NCT00038064|anemia of cancer/chemotherapy|anemia of cancer/chemotherapy
5429679|NCT00038064|non-myeloid malignancies|non-myeloid malignancies
5429680|NCT00038064|Drug Therapy|drug therapy
5429681|NCT00038051|Acute Myeloid Leukemia|acute myeloid leukemia
5429682|NCT00038051|AML|aml
5429683|NCT00038051|Chronic Myelomonocytic Leukemia|chronic myelomonocytic leukemia
5429684|NCT00038051|CMML|cmml
5429685|NCT00038051|Myeloproliferative Disorders|myeloproliferative disorders
5429686|NCT00038051|Refractory Anemia with Excess of Blasts|refractory anemia with excess of blasts
5429687|NCT00038051|RAEB-t|raeb-t
5429688|NCT00038051|RAEB|raeb
5429689|NCT00038051|Hum-195/rGel|hum-195/rgel
5429690|NCT00038038|Squamous cell carcinoma of head and neck|squamous cell carcinoma of head and neck
5429691|NCT00038025|Mycosis Fungoides|mycosis fungoides
5429692|NCT00038025|Lymphoma|lymphoma
5429693|NCT00038025|Chronic lymphocytic leukemia|chronic lymphocytic leukemia
5429694|NCT00038025|Deoxycoformycin|deoxycoformycin
5429695|NCT00038025|Pentostatin|pentostatin
5429696|NCT00038025|All other lymphomas|all other lymphomas
5429697|NCT00038025|Nucleoside analogue|nucleoside analogue
5429698|NCT00038025|Adenosine deaminase inhibitor|adenosine deaminase inhibitor
5429699|NCT00038025|T-cells|t-cells
5429700|NCT00038012|Dose-intensified carboplatin|dose-intensified carboplatin
5429701|NCT00038012|autologous cryopreserved platelets|autologous cryopreserved platelets
5429702|NCT00038012|thrombopoietin|thrombopoietin
5429703|NCT00038012|Gynecologic malignancy|gynecologic malignancy
5429704|NCT00037999|Muscle strength|muscle strength
5429705|NCT00037999|Testosterone|testosterone
5429706|NCT00037999|Rehabilitation|rehabilitation
5429707|NCT00037999|Impaired muscle strength|impaired muscle strength
5429708|NCT00037986|Audiology|audiology
5429709|NCT00037986|Hearing|hearing
5429710|NCT00037986|Hearing Aids|hearing aids
5429711|NCT00037986|Quality of Life|quality of life
5429712|NCT00037973|COPD|copd
5429713|NCT00037973|Ventilation|ventilation
5429714|NCT00037960|Constrained Induced|constrained induced
5429715|NCT00037960|CI therapy|ci therapy
5429716|NCT00037960|CVA|cva
5429717|NCT00037960|Strokes|strokes
5429718|NCT00037947|Multiple Sclerosis|multiple sclerosis
5429719|NCT00037947|MS|ms
5429720|NCT00037947|Hearing|hearing
5429721|NCT00037934|Robot|robot
5429722|NCT00037934|Stroke|stroke
5429723|NCT00037934|Upper Extremity|upper extremity
5429724|NCT00037921|SCI|sci
5429725|NCT00037921|UTI|uti
5429726|NCT00037908|Stroke|stroke
5429727|NCT00037908|Hemiparesis|hemiparesis
5429728|NCT00037908|Upper limb function|upper limb function
5429729|NCT00037908|Strength training|strength training
5429730|NCT00037895|Stroke|stroke
5429731|NCT00037895|Ambulation Training|ambulation training
5429732|NCT00037895|Rehabilitation|rehabilitation
5429733|NCT00037895|Treadmill|treadmill
5429734|NCT00037882|Chronic Myelogenous Leukemia|chronic myelogenous leukemia
5429735|NCT00037882|Interferon alpha|interferon alpha
5429736|NCT00037882|Roferon|roferon
5429737|NCT00037882|Intron|intron
5429738|NCT00037882|Chronic Myelogenous Leukemia-Philadelphia positive|chronic myelogenous leukemia-philadelphia positive
5429739|NCT00037869|Metastatic neuroendocrine tumors|metastatic neuroendocrine tumors
5429740|NCT00037843|adrenal diseases|adrenal diseases
5429741|NCT00037830|Parkinson's disease|parkinson's disease
5429742|NCT00037830|PD|pd
5429743|NCT00037830|GM1 Ganglioside|gm1 ganglioside
5429744|NCT00037830|Sygen|sygen
5429745|NCT00037817|Toxicity Evaluation|toxicity evaluation
5429746|NCT00037817|Pharmacokinetics|pharmacokinetics
5429747|NCT00037817|Apoptosis|apoptosis
5429748|NCT00037817|Gene Induction|gene induction
5429749|NCT00037817|Gene Expression|gene expression
5429750|NCT00037817|Lung Cancer|lung cancer
5429751|NCT00037817|Small Cell Lung Cancer|small cell lung cancer
5429752|NCT00037817|Non-Small Cell Lung Cancer|non-small cell lung cancer
5429753|NCT00037817|Pleural Mesothelioma|pleural mesothelioma
5429754|NCT00037804|Pharmacia|pharmacia
5429755|NCT00004575|Endothelium|endothelium
5429756|NCT00004575|Vasodilation|vasodilation
5429757|NCT00004575|Vascular Biology|vascular biology
5429758|NCT00004575|Venous Occlusion Plethysmography|venous occlusion plethysmography
5429759|NCT00001908|Allergy|allergy
5429760|NCT00001908|Interleukin|interleukin
5429761|NCT00001908|Immunomodulator|immunomodulator
5429762|NCT00001908|Th2|th2
5429763|NCT00001908|Inflammation|inflammation
5429764|NCT00001908|Asthma|asthma
5429765|NCT00001866|Eye Movements|eye movements
5429766|NCT00001866|Eye Oscillations|eye oscillations
5429767|NCT00001866|Extraocular Muscles|extraocular muscles
5429768|NCT00001866|Eye Development|eye development
5429769|NCT00001866|Pediatric Ophthalmology|pediatric ophthalmology
5429770|NCT00001866|Congenital Nystagmus|congenital nystagmus
5429771|NCT00001864|Lazy Eye|lazy eye
5429772|NCT00001864|Atropine Penalization|atropine penalization
5429773|NCT00001864|Patching|patching
5429774|NCT00001864|Vision Loss|vision loss
5429775|NCT00001864|Amblyopia|amblyopia
5429776|NCT00001818|Antiretrovirals|antiretrovirals
5429777|NCT00001818|Resistant Virus|resistant virus
5429778|NCT00001818|T-cell activation|t-cell activation
5429779|NCT00001818|Immune Suppression|immune suppression
5429780|NCT00001818|Cytotoxic Agent|cytotoxic agent
5429781|NCT00001688|CD4 Cells|cd4 cells
5429782|NCT00001688|Cytokines|cytokines
5429783|NCT00001688|Anti-Retroviral Activity|anti-retroviral activity
5429784|NCT00001688|V Beta Repertoire|v beta repertoire
5429785|NCT00001688|CD-4-Naive T Cells|cd-4-naive t cells
5429786|NCT00001688|CD-4-Memory T Cells|cd-4-memory t cells
5429787|NCT00001542|Candidiasis|candidiasis
5429788|NCT00001542|Azole|azole
5429789|NCT00001542|Resistance|resistance
5429790|NCT00001542|Candida Albicans|candida albicans
5429791|NCT00001542|Oropharynx|oropharynx
5429792|NCT00001190|Growth|growth
5429793|NCT00001190|Adolescence|adolescence
5429794|NCT00001190|Children|children
5429795|NCT00037713|LD Small Cell Lung Cancer|ld small cell lung cancer
5429796|NCT00037713|BEC2, vaccine|bec2, vaccine
5429797|NCT00037713|adjuvant, monoclonal antibody|adjuvant, monoclonal antibody
5429798|NCT00037713|LD Small Cell Lung Cancer (VA Classification, Zelen, 1973)|ld small cell lung cancer (va classification, zelen, 1973)
5429799|NCT00037687|Severe sepsis|severe sepsis
5429800|NCT00037687|Platelet-activating factor acetylhydrolase|platelet-activating factor acetylhydrolase
5429801|NCT00037674|Bipolar Disorder|bipolar disorder
5429802|NCT00037674|Bipolar|bipolar
5429803|NCT00037674|Mania|mania
5429804|NCT00037674|Topiramate|topiramate
5429805|NCT00037674|Lithium|lithium
5429806|NCT00037661|dry eye|dry eye
5429807|NCT00037622|E-antigen positive, treatment naïve chronic HBV infected, lamivudine resistant chronic Hepatitis B, Achillion|e-antigen positive, treatment naïve chronic hbv infected, lamivudine resistant chronic hepatitis b, achillion
5429808|NCT00037609|Metastatic breast cancer|metastatic breast cancer
5429809|NCT00037583|Acute|acute
5429810|NCT00037583|Myeloid|myeloid
5429811|NCT00037583|Leukemia|leukemia
5429812|NCT00037570|Peptic|peptic
5429813|NCT00037570|Ulcer|ulcer
5429814|NCT00037570|Hemorrhage|hemorrhage
5429815|NCT00037557|Hemophilia B|hemophilia b
5429816|NCT00037544|Severe|severe
5429817|NCT00037544|Hemophilia|hemophilia
5429818|NCT00037544|A|a
5429819|NCT00037531|Transplant|transplant
5429820|NCT00037531|Kidney|kidney
5429821|NCT00037518|Severe primary hyperparathyroidism|severe primary hyperparathyroidism
5429822|NCT00037518|Parathyroid carcinoma|parathyroid carcinoma
5429823|NCT00037492|stroke|stroke
5429824|NCT00037492|recovery|recovery
5429825|NCT00037479|neurologic Lyme disease|neurologic lyme disease
5429826|NCT00037479|Lyme disease|lyme disease
5429827|NCT00037479|ceftriaxone|ceftriaxone
5429828|NCT00037479|Rocephin|rocephin
5429829|NCT00037479|PET scans|pet scans
5429830|NCT00037479|Lyme encephalopathy|lyme encephalopathy
5429831|NCT00037479|neuroborreliosis|neuroborreliosis
5429832|NCT00037479|borreliosis|borreliosis
5429833|NCT00037219|Anidulafungin|anidulafungin
5429834|NCT00037219|Candidemia|candidemia
5429835|NCT00037219|Invasive Candidiasis|invasive candidiasis
5429836|NCT00037206|Invasive Aspergillosis|invasive aspergillosis
5429837|NCT00037167|Fall-Prevention|fall-prevention
5429838|NCT00037167|Balance|balance
5429839|NCT00037167|Musculoskeletal Systems|musculoskeletal systems
5429840|NCT00037167|Protective Devices|protective devices
5429841|NCT00037167|Gait|gait
5429842|NCT00037167|Equilibrium|equilibrium
5429843|NCT00037167|Accidental Falls|accidental falls
5429844|NCT00037167|Frail Elderly|frail elderly
5429845|NCT00037154|Benign Prostatic Hyperplasia|benign prostatic hyperplasia
5429846|NCT00037154|Herbal Therapies|herbal therapies
5429847|NCT00037154|Complementary and Alternative Medicine|complementary and alternative medicine
5429848|NCT00037154|Men's Health|men's health
5429849|NCT00037141|Prostate|prostate
5429850|NCT00037141|BPH|bph
5429851|NCT00037141|Prostatitis|prostatitis
5429852|NCT00037128|Lupus|lupus
5429853|NCT00037128|SLE|sle
5429854|NCT00037128|DHEA|dhea
5429855|NCT00037128|GL701|gl701
5429856|NCT00037115|Demyelinating|demyelinating
5429857|NCT00037115|Multiple Sclerosis|multiple sclerosis
5429858|NCT00037115|Myelitis|myelitis
5429859|NCT00037115|Neuritis|neuritis
5429860|NCT00037115|Optic Neuritis|optic neuritis
5429861|NCT00037115|AVONEX|avonex
5429862|NCT00037115|methotrexate|methotrexate
5429863|NCT00037115|methylprednisolone|methylprednisolone
5429864|NCT00037115|interferon beta 1a|interferon beta 1a
5429865|NCT00037115|demyelination|demyelination
5429866|NCT00037115|central nervous system|central nervous system
5429872|NCT00037102|Multiple Sclerosis|multiple sclerosis
5429873|NCT00037102|Relapsing|relapsing
5429874|NCT00037102|Methotrexate|methotrexate
5429875|NCT00037102|AVONEX|avonex
5429876|NCT00037102|interferon beta 1a|interferon beta 1a
5429877|NCT00037102|demyelinating|demyelinating
5429878|NCT00037102|autoimmune|autoimmune
5429879|NCT00037076|HIV Seropositivity|hiv seropositivity
5429880|NCT00037076|Hepatitis C|hepatitis c
5429881|NCT00037076|Polymerase Chain Reaction|polymerase chain reaction
5429882|NCT00037076|RNA, Viral|rna, viral
5429883|NCT00037076|Prevalence|prevalence
5429884|NCT00037076|Disease Transmission, Vertical|disease transmission, vertical
5429885|NCT00037076|Hepacivirus|hepacivirus
5429886|NCT00037076|Enzyme Immunoassay|enzyme immunoassay
5429887|NCT00037076|GB virus C|gb virus c
5429888|NCT00037063|Pilot Projects|pilot projects
5429889|NCT00037063|Recurrence|recurrence
5429890|NCT00037063|Antioxidants|antioxidants
5429891|NCT00037063|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5429892|NCT00037063|Anti-HIV Agents|anti-hiv agents
5429893|NCT00037063|Ascorbic Acid|ascorbic acid
5429894|NCT00037063|Alpha-Tocopherol|alpha-tocopherol
5429895|NCT00037063|Riboflavin|riboflavin
5429896|NCT00037063|Thiamine|thiamine
5429897|NCT00037063|Lactic Acid|lactic acid
5429898|NCT00036647|Non-Small Cell Lung Cancer|non-small cell lung cancer
5429899|NCT00036647|Tarceva|tarceva
5429900|NCT00036647|EGFR|egfr
5429901|NCT00036647|erlotinib|erlotinib
5429902|NCT00036634|treatment naive|treatment naive
5429903|NCT00036595|Subdural|subdural
5429904|NCT00036595|Epilepsy|epilepsy
5429905|NCT00036595|Motor Function|motor function
5429906|NCT00036595|Desynchronization|desynchronization
5429907|NCT00036595|Coherence|coherence
5429908|NCT00036595|Motor Control|motor control
5429909|NCT00036582|Psychophysiology|psychophysiology
5429910|NCT00036582|Structural MRI|structural mri
5429911|NCT00036582|Genetics|genetics
5429912|NCT00036582|Bipolar Disorder|bipolar disorder
5429913|NCT00036582|Children and Adolescents|children and adolescents
5429914|NCT00036582|Clozapine|clozapine
5429915|NCT00036582|Placebo|placebo
5429916|NCT00036582|Treatment-Refractory|treatment-refractory
5429917|NCT00036582|Bipolar|bipolar
5429918|NCT00036582|Healthy Volunteer|healthy volunteer
5429919|NCT00036582|HV|hv
5429920|NCT00036582|BPD|bpd
5429921|NCT00036582|Normal Control|normal control
5429922|NCT00036569|Brainstem Glioma|brainstem glioma
5429923|NCT00036569|Pediatric|pediatric
5429924|NCT00036569|Interferon|interferon
5429925|NCT00036569|MR Imaging|mr imaging
5429926|NCT00036569|Angiogenesis|angiogenesis
5429927|NCT00036569|Brain Tumor|brain tumor
5429928|NCT00036569|Glioma|glioma
5429929|NCT00036569|Pediatric Brain Tumor|pediatric brain tumor
5429930|NCT00036556|Hormone-Refractory Prostate Cancer|hormone-refractory prostate cancer
5429931|NCT00036543|Hormone-Refractory, Prostate Cancer|hormone-refractory, prostate cancer
5429932|NCT00036517|Stage III and Stage IV colorectal cancer|stage iii and stage iv colorectal cancer
5429933|NCT00036517|diarrhea|diarrhea
5429934|NCT00036517|reduce|reduce
5429935|NCT00036517|alleviate|alleviate
5429936|NCT00036517|modulate|modulate
5429937|NCT00036517|Saltz regimen|saltz regimen
5429938|NCT00036517|CPT-11|cpt-11
5429939|NCT00036517|irinotecan|irinotecan
5429940|NCT00036517|camptosar|camptosar
5429941|NCT00036517|5-fluorouracil|5-fluorouracil
5429942|NCT00036517|leucovorin|leucovorin
5429943|NCT00036517|5-FU|5-fu
5429944|NCT00036517|LV|lv
5429945|NCT00036517|chemotherapy|chemotherapy
5429946|NCT00036517|side effect|side effect
5429947|NCT00036517|toxicity|toxicity
5429948|NCT00036517|botanical drug|botanical drug
5429949|NCT00036517|herbal medicine|herbal medicine
5429950|NCT00036517|chinese herbal medicine|chinese herbal medicine
5429951|NCT00036517|traditional chinese medicine|traditional chinese medicine
5429952|NCT00036517|TCM|tcm
5429953|NCT00036517|oral dose|oral dose
5429954|NCT00036517|oral administration|oral administration
5429955|NCT00036517|concomitant use|concomitant use
5429956|NCT00036504|Diabetes mellitus, insulin deficiency, hyperglycemia|diabetes mellitus, insulin deficiency, hyperglycemia
5429957|NCT00036491|Systemic Lupus Erythematosus|systemic lupus erythematosus
5429958|NCT00036491|SLE|sle
5429959|NCT00036491|B-Lymphocytes|b-lymphocytes
5429960|NCT00036491|anti-CD20|anti-cd20
5429961|NCT00036491|rituximab|rituximab
5429962|NCT00036478|Pilot Projects|pilot projects
5429963|NCT00036478|Exercise|exercise
5429964|NCT00036478|Phosphorus Isotopes|phosphorus isotopes
5429965|NCT00036478|Mitochondria|mitochondria
5429966|NCT00036478|Lactates|lactates
5429967|NCT00036478|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
5429968|NCT00036465|Pilot Projects|pilot projects
5429969|NCT00036465|HIV-1|hiv-1
5429970|NCT00036465|RNA, Viral|rna, viral
5429971|NCT00036465|Genotype|genotype
5429972|NCT00036465|Viral Load|viral load
5429973|NCT00036465|Antiretroviral Therapy, Highly Active|antiretroviral therapy, highly active
5429974|NCT00036465|Treatment Experienced|treatment experienced
5429975|NCT00036452|Lopinavir|lopinavir
5429976|NCT00036452|HIV-1|hiv-1
5429977|NCT00036452|Drug Administration Schedule|drug administration schedule
5429979|NCT00036452|HIV Protease Inhibitors|hiv protease inhibitors
5429980|NCT00036452|Ritonavir|ritonavir
5429981|NCT00036452|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5429982|NCT00036452|Self Care|self care
5429983|NCT00036452|Viral Load|viral load
5429984|NCT00036452|Emtricitabine|emtricitabine
5429985|NCT00036452|Directly Observed Therapy|directly observed therapy
5429986|NCT00036452|Tenofovir Disoproxil Fumarate|tenofovir disoproxil fumarate
5429987|NCT00036452|Treatment Naive|treatment naive
5429988|NCT00036439|ulcerative colitis|ulcerative colitis
5429989|NCT00036439|infliximab|infliximab
5429990|NCT00036439|Remicade|remicade
5429991|NCT00036439|infusion|infusion
5429992|NCT00036426|lymphoma|lymphoma
5429993|NCT00036426|vaccine|vaccine
5429994|NCT00036426|idiotype|idiotype
5429995|NCT00036426|KLH|klh
5429996|NCT00036426|GM-CSF|gm-csf
5429997|NCT00036413|(ALS)|(als)
5429998|NCT00036400|Anemia|anemia
5429999|NCT00036400|Gastric Cancer|gastric cancer
5430000|NCT00036400|Rectal Cancer|rectal cancer
5430001|NCT00036400|Epoetin Alfa|epoetin alfa
5430002|NCT00036387|Rheumatoid arthritis|rheumatoid arthritis
5430003|NCT00036387|infliximab|infliximab
5430004|NCT00036387|anti-TNF|anti-tnf
5430005|NCT00036387|methotrexate|methotrexate
5430006|NCT00036387|safety and efficacy|safety and efficacy
5430007|NCT00036387|Remicade|remicade
5430008|NCT00036374|Juvenile rheumatoid arthritis|juvenile rheumatoid arthritis
5430009|NCT00036374|Infliximab|infliximab
5430010|NCT00036374|Methotrexate|methotrexate
5430011|NCT00036374|remicade|remicade
5430012|NCT00036348|Bipolar I disorder|bipolar i disorder
5430013|NCT00036335|depression|depression
5430014|NCT00036335|pain|pain
5430015|NCT00036335|blues|blues
5430016|NCT00036335|sadness|sadness
5430017|NCT00036335|aches|aches
5430018|NCT00036309|Major Depressive Disorder|major depressive disorder
5430019|NCT00036309|Diagnostic and Statistical Manual of Mental Disorders Fourth Edition-defined major depressive disorder without psychotic features|diagnostic and statistical manual of mental disorders fourth edition-defined major depressive disorder without psychotic features
5430020|NCT00036296|Involuntary Movements|involuntary movements
5430021|NCT00036296|Abnormal Movements|abnormal movements
5430022|NCT00036296|Advanced Parkinson's disease|advanced parkinson's disease
5430023|NCT00036296|Levodopa induced dyskinesia|levodopa induced dyskinesia
5430024|NCT00036257|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
5430025|NCT00036257|Leukemia|leukemia
5430026|NCT00036257|CLL|cll
5430027|NCT00036179|Candidemia|candidemia
5430028|NCT00036179|Anti-Fungal|anti-fungal
5430029|NCT00036166|Aspergillus|aspergillus
5430030|NCT00036166|Anti-Fungal|anti-fungal
5430031|NCT00036153|Tacrolimus, Prograf®, FK506|tacrolimus, prograf®, fk506
5430032|NCT00036140|Pharmacia|pharmacia
5430033|NCT00036127|agitated schizophrenic patients|agitated schizophrenic patients
5430034|NCT00036114|Psychosis associated with dementia of the Alzheimer's type|psychosis associated with dementia of the alzheimer's type
5430035|NCT00036101|Bipolar I Disorder|bipolar i disorder
5430036|NCT00036075|prostate cancer|prostate cancer
5430037|NCT00036075|prostate|prostate
5430038|NCT00036062|Sivelestat|sivelestat
5430039|NCT00036062|acute lung injury|acute lung injury
5430040|NCT00036036|renal|renal
5430041|NCT00036036|renal cell cancer|renal cell cancer
5430042|NCT00036036|renal cell carcinoma|renal cell carcinoma
5430043|NCT00036036|kidney cancer|kidney cancer
5430044|NCT00035997|Hormone-sensitive Prostate Cancer|hormone-sensitive prostate cancer
5430045|NCT00035997|Prostate Cancer|prostate cancer
5430046|NCT00035997|Bone Metastasis|bone metastasis
5430047|NCT00035984|Type 2 Diabetes Mellitis|type 2 diabetes mellitis
5430048|NCT00035958|Juvenile Dermatomyositis|juvenile dermatomyositis
5430049|NCT00035958|Pediatric|pediatric
5430050|NCT00035958|Randomized Clinical Trial|randomized clinical trial
5430051|NCT00035958|Pediatric Rheumatology|pediatric rheumatology
5430052|NCT00035919|Colon cancer|colon cancer
5430053|NCT00035919|Targeted Injectable Vector|targeted injectable vector
5430054|NCT00035919|Gene Transfer|gene transfer
5430055|NCT00035919|Gene Therapy|gene therapy
5430056|NCT00035919|Retroviral vector|retroviral vector
5430057|NCT00035906|Diabetes|diabetes
5430058|NCT00035906|Macular Edema|macular edema
5430059|NCT00035906|Diabetic Macular Edema|diabetic macular edema
5430060|NCT00035906|Diabetic Retinopathy|diabetic retinopathy
5430061|NCT00035906|Cystoid Macular Edema|cystoid macular edema
5430062|NCT00035906|Uveitis|uveitis
5430063|NCT00035906|Vision|vision
5430064|NCT00035906|Eye|eye
5430065|NCT00035906|Retina|retina
5430066|NCT00035906|Retinal Vein Occlusion|retinal vein occlusion
5430067|NCT00035906|Irvine-Gass Syndrome|irvine-gass syndrome
5430068|NCT00035893|treatment interruption|treatment interruption
5430069|NCT00035893|HIV Infections|hiv infections
5430070|NCT00035880|Acute graft versus host disease|acute graft versus host disease
5430071|NCT00035880|Stem Cell Transplantation|stem cell transplantation
5430072|NCT00035854|Pharmacia|pharmacia
5430073|NCT00035854|Drug Resistance, Microbial|drug resistance, microbial
5430074|NCT00035828|COPD|copd
5430075|NCT00035828|Chronic bronchitis|chronic bronchitis
5430076|NCT00035828|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
5430077|NCT00035828|Shortness of breath|shortness of breath
5430078|NCT00035828|Dyspnea|dyspnea
5430079|NCT00035828|Bronchitis|bronchitis
5430080|NCT00035815|amyotrophic lateral sclerosis|amyotrophic lateral sclerosis
5430081|NCT00035815|ALS|als
5430082|NCT00035815|progressive weakness|progressive weakness
5430083|NCT00035815|insulin-like growth factor-1|insulin-like growth factor-1
5430084|NCT00035815|IGF-I|igf-i
5430085|NCT00035815|Myotrophin|myotrophin
5430086|NCT00035802|Bipolar|bipolar
5430087|NCT00035802|Mania|mania
5430088|NCT00035802|Pediatric|pediatric
5430089|NCT00035802|Children|children
5430090|NCT00035802|Adolescent|adolescent
5430091|NCT00035802|Topiramate|topiramate
5430092|NCT00035802|Anticonvulsants|anticonvulsants
5430093|NCT00035802|Central Nervous System Agents|central nervous system agents
5430094|NCT00035802|Protective Agents|protective agents
5430095|NCT00035802|Neuroprotectiive Agents|neuroprotectiive agents
5430096|NCT00035620|Bone cancer|bone cancer
5430097|NCT00035620|Sarcoma|sarcoma
5430098|NCT00035620|Neutropenia|neutropenia
5430099|NCT00035620|Chemotherapy|chemotherapy
5430100|NCT00035594|Breast cancer|breast cancer
5430101|NCT00035594|Neutropenia|neutropenia
5430102|NCT00035594|Chemotherapy|chemotherapy
5430103|NCT00035581|treatment experienced|treatment experienced
5430104|NCT00035581|HIV Infections|hiv infections
5430105|NCT00035581|HIV|hiv
5430106|NCT00035581|HAART|haart
5430107|NCT00035581|early virologic failure|early virologic failure
5430108|NCT00035568|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
5430109|NCT00035555|kidney|kidney
5430110|NCT00035555|transplant|transplant
5430111|NCT00035555|rejection|rejection
5430112|NCT00035542|Diabetes Mellitus, Type II|diabetes mellitus, type ii
5430113|NCT00035529|MS|ms
5430114|NCT00035438|obsessive compulsive disorder|obsessive compulsive disorder
5430115|NCT00035438|ocd|ocd
5430116|NCT00035438|Anxiety|anxiety
5430117|NCT00035438|St. John’s Wort|st. john’s wort
5430118|NCT00035438|Wisconsin|wisconsin
5430119|NCT00035438|Psychiatric|psychiatric
5430120|NCT00035438|Mental health|mental health
5430121|NCT00035412|Social phobia|social phobia
5430122|NCT00035412|Social anxiety|social anxiety
5430123|NCT00035412|Anxiety|anxiety
5430124|NCT00035412|St. John’ Wort|st. john’ wort
5430125|NCT00035412|Wisconsin|wisconsin
5430126|NCT00035412|Psychiatric|psychiatric
5430127|NCT00035412|Mental health|mental health
5430128|NCT00035399|acupressure /acupuncture|acupressure /acupuncture
5430129|NCT00035399|alternative medicine|alternative medicine
5430130|NCT00035399|arthritis therapy|arthritis therapy
5430131|NCT00035399|combination therapy|combination therapy
5430132|NCT00035399|human therapy evaluation|human therapy evaluation
5430133|NCT00035399|knee|knee
5430134|NCT00035399|osteoarthritis|osteoarthritis
5430135|NCT00035399|physical therapy|physical therapy
5430136|NCT00035399|chronic pain|chronic pain
5430137|NCT00035399|clinical trial|clinical trial
5430138|NCT00035399|functional ability|functional ability
5430139|NCT00035360|PEG-Intron|peg-intron
5430140|NCT00035360|treatment experienced|treatment experienced
5430141|NCT00035386|Outflow Obstruction|outflow obstruction
5430142|NCT00035386|ICE|ice
5430143|NCT00035386|HCM|hcm
5430144|NCT00035386|Hypertrophic Cardiomyopathy|hypertrophic cardiomyopathy
5430145|NCT00035386|OHC|ohc
5430146|NCT00035386|Obstructive HCM|obstructive hcm
5430147|NCT00035386|Cardiomyopathy|cardiomyopathy
5430148|NCT00035373|Tumor|tumor
5430149|NCT00035373|Brain|brain
5430150|NCT00035373|Chemotherapy|chemotherapy
5430151|NCT00035373|Anti-Angiogenesis|anti-angiogenesis
5430152|NCT00035373|Radiation Therapy|radiation therapy
5430153|NCT00035373|CNS Tumor|cns tumor
5430154|NCT00035334|Familial Mediterranean Fever|familial mediterranean fever
5430155|NCT00035334|Amyloidosis|amyloidosis
5430156|NCT00035334|Secondary (AA) Amyloidosis|secondary (aa) amyloidosis
5430157|NCT00035334|Nephrotic Syndrome|nephrotic syndrome
5430158|NCT00035308|Immunologic Diseases|immunologic diseases
5430159|NCT00035308|Autoimmune Diseases|autoimmune diseases
5430160|NCT00035308|Systemic Lupus Erythematosus|systemic lupus erythematosus
5430161|NCT00035308|SLE|sle
5430162|NCT00035308|Lupus Nephritis|lupus nephritis
5430163|NCT00035308|Lupus Glomerulonephritis|lupus glomerulonephritis
5430164|NCT00035269|Pharmacia|pharmacia
5430165|NCT00035243|kidney cancer|kidney cancer
5430166|NCT00035243|renal cancer|renal cancer
5430167|NCT00035243|cancer|cancer
5430168|NCT00035243|tumor|tumor
5430169|NCT00035243|tumour|tumour
5430170|NCT00035243|neoplasm|neoplasm
5430171|NCT00035243|carcinoma|carcinoma
5430172|NCT00035243|clear cell|clear cell
5430173|NCT00035243|sarcomatoid|sarcomatoid
5430174|NCT00035243|papillary|papillary
5430175|NCT00035243|medullary|medullary
5430176|NCT00035243|collecting duct|collecting duct
5430177|NCT00035243|chromophobe|chromophobe
5430178|NCT00035243|intravenous|intravenous
5430179|NCT00035243|epothilone|epothilone
5430180|NCT00035230|Bipolar disorders|bipolar disorders
5430181|NCT00035230|Bipolar|bipolar
5430182|NCT00035230|mania|mania
5430183|NCT00035230|Topiramate|topiramate
5430184|NCT00035230|Lithium|lithium
5430185|NCT00035204|Donepezil|donepezil
5430188|NCT00035204|Cognitive impairment|cognitive impairment
5430189|NCT00035204|Aricept|aricept
5430190|NCT00035204|Alzheimer's disease|alzheimer's disease
5430191|NCT00035204|Razadyne|razadyne
5430192|NCT00035204|Galantamine|galantamine
5430193|NCT00035191|Dementia|dementia
5430194|NCT00035191|vascular dementia|vascular dementia
5430195|NCT00035191|cerebral vascular disease|cerebral vascular disease
5430196|NCT00035178|ESRD|esrd
5430197|NCT00035178|End-stage renal disease|end-stage renal disease
5430198|NCT00035178|Hemodialysis|hemodialysis
5430199|NCT00035165|melanoma|melanoma
5430200|NCT00035165|cancer|cancer
5430201|NCT00035165|tumor|tumor
5430202|NCT00035165|tumour|tumour
5430203|NCT00035165|malignant|malignant
5430204|NCT00035165|metastatic|metastatic
5430205|NCT00035165|intravenous|intravenous
5430206|NCT00035165|epothilone|epothilone
5430207|NCT00035139|pediatric traumatic brain injury|pediatric traumatic brain injury
5430208|NCT00035126|breast|breast
5430209|NCT00035126|cancer|cancer
5430210|NCT00035126|tumor|tumor
5430211|NCT00035126|tumour|tumour
5430212|NCT00035126|intravenous|intravenous
5430213|NCT00035126|epothilone|epothilone
5430214|NCT00035126|taxane|taxane
5430215|NCT00035126|anthracycline|anthracycline
5430216|NCT00035113|prostate cancer|prostate cancer
5430217|NCT00035113|prostate|prostate
5430218|NCT00035113|androgen independent|androgen independent
5430219|NCT00035113|cancer|cancer
5430220|NCT00035113|tumor|tumor
5430221|NCT00035113|tumour|tumour
5430222|NCT00035113|neoplasm|neoplasm
5430223|NCT00035113|carcinoma|carcinoma
5430224|NCT00035113|intravenous|intravenous
5430225|NCT00035113|epothilone|epothilone
5430226|NCT00035100|ovarian|ovarian
5430227|NCT00035100|ovary|ovary
5430228|NCT00035100|peritoneal cancer|peritoneal cancer
5430229|NCT00035100|fallopian cancer|fallopian cancer
5430230|NCT00035100|cancer|cancer
5430231|NCT00035100|tumor|tumor
5430232|NCT00035100|tumour|tumour
5430233|NCT00035100|neoplasm|neoplasm
5430234|NCT00035100|carcinoma|carcinoma
5430235|NCT00035100|intravenous|intravenous
5430236|NCT00035100|epothilone|epothilone
5430237|NCT00035087|colon|colon
5430238|NCT00035087|rectum|rectum
5430239|NCT00035087|colorectal|colorectal
5430240|NCT00035087|rectal|rectal
5430241|NCT00035087|cancer|cancer
5430242|NCT00035087|tumor|tumor
5430243|NCT00035087|tumour|tumour
5430244|NCT00035087|neoplasm|neoplasm
5430245|NCT00035087|carcinoma|carcinoma
5430246|NCT00035087|intravenous|intravenous
5430247|NCT00035087|epothilone|epothilone
5430248|NCT00035061|Bladder Cancer|bladder cancer
5430249|NCT00035061|Metastatic|metastatic
5430250|NCT00035061|Recurrent|recurrent
5430251|NCT00035061|Transitional cell carcinoma of the urothelium|transitional cell carcinoma of the urothelium
5430252|NCT00035035|Pancreas|pancreas
5430253|NCT00035035|Cancer|cancer
5430254|NCT00035035|Unresectable or Metastatic Cancer of the Pancreas|unresectable or metastatic cancer of the pancreas
5430255|NCT00035035|Alimta|alimta
5430256|NCT00035022|Leukemia, Lymphoma, T-Cell|leukemia, lymphoma, t-cell
5430257|NCT00034970|alternative medicine|alternative medicine
5430258|NCT00034970|art|art
5430259|NCT00034970|cancer|cancer
5430260|NCT00034970|combination cancer therapy|combination cancer therapy
5430261|NCT00034970|creative-expression|creative-expression
5430262|NCT00034970|group therapy|group therapy
5430263|NCT00034970|holistic|holistic
5430264|NCT00034970|human therapy evaluation|human therapy evaluation
5430265|NCT00034970|meditation|meditation
5430266|NCT00034970|neoplasm /cancer chemotherapy|neoplasm /cancer chemotherapy
5430267|NCT00034970|coping|coping
5430268|NCT00034970|gender difference|gender difference
5430269|NCT00034970|outcomes research|outcomes research
5430270|NCT00034970|psychological aspect of cancer|psychological aspect of cancer
5430271|NCT00034970|psychological stressor|psychological stressor
5430272|NCT00034970|quality of life|quality of life
5430273|NCT00034970|racial /ethnic difference|racial /ethnic difference
5430274|NCT00034970|stress management|stress management
5430275|NCT00034970|support|support
5430276|NCT00034970|behavioral /social science research|behavioral /social science research
5430277|NCT00034970|patient oriented research|patient oriented research
5430278|NCT00034957|Pharmacia|pharmacia
5430279|NCT00034918|Metastatic breast cancer|metastatic breast cancer
5430280|NCT00034879|Locally advanced and/or metastatic non-operable|locally advanced and/or metastatic non-operable
5430281|NCT00034879|non-small cell lung cancer (stage III or IV)|non-small cell lung cancer (stage iii or iv)
5430282|NCT00034879|patients who have failed standard therapy.|patients who have failed standard therapy.
5430283|NCT00034866|HIV|hiv
5430284|NCT00034866|treatment experienced|treatment experienced
5430285|NCT00034866|Boehringer|boehringer
5430286|NCT00034866|tipranavir|tipranavir
5430287|NCT00034866|ritonavir|ritonavir
5430288|NCT00034840|hypertension|hypertension
5430289|NCT00034840|telmisartan|telmisartan
5430290|NCT00034840|valsartan|valsartan
5430291|NCT00034840|boehringer|boehringer
5430292|NCT00034801|Depression|depression
5430293|NCT00034801|Comorbid Depression|comorbid depression
5430294|NCT00034801|Schizophrenia|schizophrenia
5430295|NCT00034801|Schizoaffective Disorder|schizoaffective disorder
5430296|NCT00034788|Regranex|regranex
5430297|NCT00034788|Foot ulcers|foot ulcers
5430298|NCT00034788|Diabetes|diabetes
5430299|NCT00034788|Diabetes mellitus|diabetes mellitus
5430300|NCT00034788|Diabetic foot|diabetic foot
5430301|NCT00034775|Schizophrenia|schizophrenia
5430302|NCT00034775|intramuscular injection|intramuscular injection
5430303|NCT00034775|antipsychotic agents|antipsychotic agents
5430304|NCT00034775|risperidone|risperidone
5430305|NCT00034762|Alzheimer's disease|alzheimer's disease
5430306|NCT00034762|psychosis|psychosis
5430307|NCT00034762|elderly|elderly
5430308|NCT00034762|dementia|dementia
5430309|NCT00034762|risperidone|risperidone
5430310|NCT00034762|antipsychotic agents|antipsychotic agents
5430311|NCT00034749|Adolescents|adolescents
5430312|NCT00034749|Schizophrenia|schizophrenia
5430313|NCT00034749|risperidone|risperidone
5430314|NCT00034736|Pneumonia|pneumonia
5430315|NCT00034736|Bacterial pneumonia|bacterial pneumonia
5430316|NCT00034736|Community acquired pneumonia|community acquired pneumonia
5430317|NCT00034736|Lung Inflammation|lung inflammation
5430318|NCT00034736|Quinolones|quinolones
5430319|NCT00034736|Levofloxacin|levofloxacin
5430320|NCT00034736|Ceftriaxone|ceftriaxone
5430321|NCT00034736|Erythromycin|erythromycin
5430322|NCT00034736|Clarithromycin|clarithromycin
5430323|NCT00034723|DTI|dti
5430324|NCT00034723|MRSI|mrsi
5430325|NCT00034723|MTR|mtr
5430326|NCT00034723|NAWN|nawn
5430327|NCT00034723|Fiber-Tract|fiber-tract
5430328|NCT00034723|Normal Control|normal control
5430329|NCT00034723|Healthy Volunteer|healthy volunteer
5430330|NCT00034723|HV|hv
5430331|NCT00034723|HTLV-1 Associated Myelopathy|htlv-1 associated myelopathy
5430332|NCT00034723|Tropical Spastic Paraparesis|tropical spastic paraparesis
5430333|NCT00034723|HAM/TSP|ham/tsp
5430334|NCT00034710|Analgesics/*therapeutic use|analgesics/*therapeutic use
5430335|NCT00034710|Capsaicin/*administration & dosage/adverse effects|capsaicin/*administration & dosage/adverse effects
5430336|NCT00034710|Herpes Zoster/*complications/drug therapy|herpes zoster/*complications/drug therapy
5430337|NCT00034710|Neuralgia/*drug therapy/etiology|neuralgia/*drug therapy/etiology
5430338|NCT00034710|Pain|pain
5430339|NCT00034710|Capsicum|capsicum
5430340|NCT00034710|Pepper|pepper
5430341|NCT00034710|Dermal assessment|dermal assessment
5430342|NCT00034710|Pain measurement|pain measurement
5430343|NCT00034710|Diary|diary
5430344|NCT00034710|PHN|phn
5430345|NCT00034710|Postherpetic Neuralgia|postherpetic neuralgia
5430346|NCT00034710|allodynia|allodynia
5430347|NCT00034710|hyperalgesia|hyperalgesia
5430348|NCT00034710|shingles|shingles
5430349|NCT00034710|varicella|varicella
5430350|NCT00034697|Brain mets|brain mets
5430351|NCT00034697|non-small cell lung cancer|non-small cell lung cancer
5430352|NCT00034684|Leukemia|leukemia
5430353|NCT00034684|Myelodysplastic Syndromes|myelodysplastic syndromes
5430354|NCT00034684|Leukemia, Myeloid|leukemia, myeloid
5430355|NCT00034684|Leukemia, Lymphocytic|leukemia, lymphocytic
5430356|NCT00034671|Aspergillosis, Candidiasis, Mucormycosis, Cryptococcosis|aspergillosis, candidiasis, mucormycosis, cryptococcosis
5430357|NCT00034671|Invasive Fungal Infections|invasive fungal infections
5430358|NCT00034658|Aspergillosis, Candidiasis, Cryptococcosis,|aspergillosis, candidiasis, cryptococcosis,
5430359|NCT00034645|Allogenic Stem cell transplantation|allogenic stem cell transplantation
5430360|NCT00034645|Fungal infections|fungal infections
5430361|NCT00034632|Aspergillosis, Candidiasis, Cryptococcosis, Phaeohyphomycosis|aspergillosis, candidiasis, cryptococcosis, phaeohyphomycosis
5430362|NCT00034632|Invasive Fungal Infections|invasive fungal infections
5430363|NCT00034606|Lung cancer|lung cancer
5430364|NCT00034606|cancer|cancer
5430365|NCT00034606|neoplasm|neoplasm
5430366|NCT00034606|non-small|non-small
5430367|NCT00034606|chemotherapy|chemotherapy
5430368|NCT00034593|Bladder cancer|bladder cancer
5430369|NCT00034593|metastatic|metastatic
5430370|NCT00034593|transitional cell carcinoma of the urothelium|transitional cell carcinoma of the urothelium
5430371|NCT00034580|Bipolar I Disorder|bipolar i disorder
5430372|NCT00034567|Prevention|prevention
5430373|NCT00034554|AJCC stage III or stage IV malignant melanoma|ajcc stage iii or stage iv malignant melanoma
5430374|NCT00034554|melanoma|melanoma
5430375|NCT00034554|gp75|gp75
5430376|NCT00034554|DNA vaccine|dna vaccine
5430377|NCT00034541|cetuximab|cetuximab
5430378|NCT00034541|epidermal growth factor receptor|epidermal growth factor receptor
5430379|NCT00034541|antibody|antibody
5430380|NCT00034541|non-small cell lung cancer|non-small cell lung cancer
5430381|NCT00034541|carboplatin|carboplatin
5430382|NCT00034541|paclitaxel|paclitaxel
5430383|NCT00034489|metastatic breast cancer|metastatic breast cancer
5430384|NCT00034489|combination therapy|combination therapy
5430385|NCT00034489|Alimta|alimta
5430386|NCT00034476|Sepsis, sPLA2 Inhibitor|sepsis, spla2 inhibitor
5430387|NCT00034463|metastatic cancer|metastatic cancer
5430388|NCT00034463|chemotherapy|chemotherapy
5430389|NCT00034450|Terminal Cancer|terminal cancer
5430390|NCT00034437|Normal Volunteer|normal volunteer
5430391|NCT00034437|Phlebotomy|phlebotomy
5430392|NCT00034437|Cytomegalovirus|cytomegalovirus
5430393|NCT00034437|CMV|cmv
5442943|NCT00004659|brain tumor|brain tumor
5430394|NCT00034437|CMV Seropositve|cmv seropositve
5430395|NCT00034424|Genetics|genetics
5430396|NCT00034424|Hereditary|hereditary
5430397|NCT00034424|Screening|screening
5430398|NCT00034424|Behavioral|behavioral
5430399|NCT00034424|Familial Testicular Germ Cell Tumor|familial testicular germ cell tumor
5430400|NCT00034424|Testicular Cancer|testicular cancer
5430401|NCT00034398|Basal Ganglia|basal ganglia
5430402|NCT00034398|Neuroimaging|neuroimaging
5430403|NCT00034398|Inhibitory Neurons|inhibitory neurons
5430404|NCT00034398|Disinhibition|disinhibition
5430405|NCT00034398|Tics|tics
5430406|NCT00034398|Tourette's Syndrome|tourette's syndrome
5430407|NCT00034398|Tourette Syndrome|tourette syndrome
5430408|NCT00034398|Healthy Volunteer|healthy volunteer
5430409|NCT00034398|HV|hv
5430410|NCT00034398|Normal Control|normal control
5430411|NCT00034385|Cytomegalovirus|cytomegalovirus
5430412|NCT00034385|Prophylaxis|prophylaxis
5430413|NCT00034385|Renal Transplant|renal transplant
5430414|NCT00034385|Valcyte|valcyte
5430415|NCT00034385|Kidney Transplant|kidney transplant
5430416|NCT00034372|immunotherapy|immunotherapy
5430417|NCT00034372|monoclonal|monoclonal
5430418|NCT00034372|antibody|antibody
5430419|NCT00034372|Stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5430420|NCT00034372|Stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5430421|NCT00034359|E-antigen positive|e-antigen positive
5430422|NCT00034359|Treatment Naive Chronic Hepatitis B, Achillion|treatment naive chronic hepatitis b, achillion
5430423|NCT00017862|Eosinophils|eosinophils
5430424|NCT00017862|Monoclonal Antibody|monoclonal antibody
5430425|NCT00017862|Hypereosinophilia|hypereosinophilia
5430426|NCT00017862|Biologicals|biologicals
5430427|NCT00017862|Hypereosinophilic Syndrome|hypereosinophilic syndrome
5430428|NCT00034346|Advanced|advanced
5430429|NCT00034346|Non-Small-Cell|non-small-cell
5430430|NCT00034346|Lung|lung
5430431|NCT00034346|Cancer|cancer
5430432|NCT00034346|NSCLC|nsclc
5430433|NCT00034346|Carcinoma|carcinoma
5430434|NCT00034346|Advanced Non-Small-Cell Lung Cancer (NSCLC)|advanced non-small-cell lung cancer (nsclc)
5430435|NCT00034333|Hepatoma|hepatoma
5430436|NCT00034333|Unresectable adult primary liver cancer|unresectable adult primary liver cancer
5430437|NCT00034333|liver cancer|liver cancer
5430438|NCT00034333|HCC|hcc
5430439|NCT00034333|Hepatocellular Carcinoma|hepatocellular carcinoma
5430440|NCT00034294|C. difficile-associated diarrhea|c. difficile-associated diarrhea
5430441|NCT00034294|CDAD|cdad
5430442|NCT00034294|Clostridium difficile-Associated Diarrhea|clostridium difficile-associated diarrhea
5430443|NCT00034294|Clostridium enterocolitis|clostridium enterocolitis
5430444|NCT00034294|antibiotic-associated diarrhea|antibiotic-associated diarrhea
5430445|NCT00034294|clostridium difficile colitis|clostridium difficile colitis
5430446|NCT00034294|infectious diarrhea|infectious diarrhea
5430447|NCT00034294|chronic diarrhea|chronic diarrhea
5430448|NCT00034294|antibiotic-associated colitis|antibiotic-associated colitis
5430449|NCT00034281|Gene, HER2|gene, her2
5430450|NCT00034281|Clinical Trial, Phase I|clinical trial, phase i
5430451|NCT00034281|Breast neoplasm|breast neoplasm
5430452|NCT00034281|Pancreatic neoplasm|pancreatic neoplasm
5430453|NCT00034281|Ovarian neoplasm|ovarian neoplasm
5430454|NCT00034281|Colorectal neoplasm|colorectal neoplasm
5430455|NCT00034281|Renal neoplasm|renal neoplasm
5430456|NCT00034281|Prostate neoplasm|prostate neoplasm
5430457|NCT00034281|Cancer|cancer
5430458|NCT00034268|non-small cell lung cancer|non-small cell lung cancer
5430459|NCT00034268|Stage IIIB or IV non-small cell lung cancer (NSCLC)|stage iiib or iv non-small cell lung cancer (nsclc)
5430460|NCT00034177|Locally Advanced, Metastatic, or Recurrent Transitional Cell Carcinoma of the Urothelium|locally advanced, metastatic, or recurrent transitional cell carcinoma of the urothelium
5430461|NCT00034242|Ataxia|ataxia
5430462|NCT00034242|Treatment|treatment
5430463|NCT00034242|IVIG|ivig
5430464|NCT00034242|SCA|sca
5430465|NCT00034242|Cerebellar Degeneration|cerebellar degeneration
5430466|NCT00034242|Cerebellar Ataxia|cerebellar ataxia
5430467|NCT00034242|Cerebellum|cerebellum
5430468|NCT00034229|Antidepressant|antidepressant
5430469|NCT00034229|Anti-Glutamatergic|anti-glutamatergic
5430470|NCT00034229|Bipolar Disorder|bipolar disorder
5430471|NCT00034229|Depression|depression
5430472|NCT00034229|Treatment Refractory|treatment refractory
5430473|NCT00034229|Felbamate|felbamate
5430474|NCT00034229|Glutamate|glutamate
5430475|NCT00034229|Treatment-Resistant|treatment-resistant
5430476|NCT00034229|Bipolar|bipolar
5430477|NCT00034229|BPD|bpd
5430478|NCT00034229|Bipolar Depression|bipolar depression
5430479|NCT00034216|Suppressor Cells|suppressor cells
5430480|NCT00034216|T-cells|t-cells
5430481|NCT00034216|CD4+/CD25+ Cells|cd4+/cd25+ cells
5430482|NCT00034216|Cancer|cancer
5430483|NCT00034216|Malignancy|malignancy
5430484|NCT00034216|Blood Sample|blood sample
5430485|NCT00034138|immunotherapy|immunotherapy
5430486|NCT00034138|monoclonal|monoclonal
5430487|NCT00034138|antibody|antibody
5430488|NCT00034138|Stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5430489|NCT00034138|Stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5430490|NCT00034125|cancer|cancer
5430491|NCT00034125|metastatic breast cancer|metastatic breast cancer
5430492|NCT00034125|hormonal therapy|hormonal therapy
5430493|NCT00034112|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
5430494|NCT00034112|combination therapy,|combination therapy,
5430495|NCT00034112|emphysema|emphysema
5430496|NCT00034112|exercise|exercise
5430497|NCT00034112|human therapy evaluation|human therapy evaluation
5430498|NCT00034112|rehabilitation|rehabilitation
5430499|NCT00034112|respiratory disease /disorder therapy|respiratory disease /disorder therapy
5430500|NCT00034112|respiratory function|respiratory function
5430501|NCT00034112|biomechanics|biomechanics
5430502|NCT00034112|body movement|body movement
5430503|NCT00034112|diaphragm|diaphragm
5430504|NCT00034112|dyspnea|dyspnea
5430505|NCT00034112|muscle tension|muscle tension
5430506|NCT00034112|musculoskeletal system|musculoskeletal system
5430507|NCT00034112|outcomes research|outcomes research
5430508|NCT00034112|quality of life|quality of life
5430509|NCT00034112|somatic reflex|somatic reflex
5430510|NCT00034086|Lopinavir|lopinavir
5430511|NCT00034086|OspA Protein|ospa protein
5430512|NCT00034086|HIV-1|hiv-1
5430513|NCT00034086|HIV Protease Inhibitors|hiv protease inhibitors
5430514|NCT00034086|CD4 Lymphocyte Count|cd4 lymphocyte count
5430515|NCT00034086|Ritonavir|ritonavir
5430516|NCT00034086|Haemophilus Vaccines|haemophilus vaccines
5430517|NCT00034086|HAART|haart
5430518|NCT00034086|Pneumococcal Vaccines|pneumococcal vaccines
5430519|NCT00034086|tenofovir disoproxil|tenofovir disoproxil
5430520|NCT00034073|Imaging|imaging
5430521|NCT00034073|Pediatrics|pediatrics
5430522|NCT00034073|Brain|brain
5430523|NCT00034073|Mapping|mapping
5430524|NCT00034073|Development|development
5430525|NCT00034073|Healthy Volunteer|healthy volunteer
5430526|NCT00034073|HV|hv
5430527|NCT00034073|Normal Control|normal control
5430528|NCT00034060|Cytokines|cytokines
5430529|NCT00034060|Exanercept|exanercept
5430530|NCT00034060|Cachexia|cachexia
5430531|NCT00034060|Body Composition|body composition
5430532|NCT00034060|Vascular Endothelial System|vascular endothelial system
5430533|NCT00034060|Rheumatoid Arthritis|rheumatoid arthritis
5430534|NCT00034060|RA|ra
5430535|NCT00034060|Women|women
5430536|NCT00034060|Healthy Volunteer|healthy volunteer
5430537|NCT00034060|HV|hv
5430538|NCT00034060|Normal Control|normal control
5430539|NCT00034047|Endometriosis|endometriosis
5430540|NCT00034047|Pelvic pain|pelvic pain
5430541|NCT00034047|Acupuncture|acupuncture
5430542|NCT00034047|Chinese herbs|chinese herbs
5430543|NCT00034047|Hormone therapy|hormone therapy
5430544|NCT00034047|Nafarelin|nafarelin
5430545|NCT00034034|Advanced colorectal cancer|advanced colorectal cancer
5430546|NCT00034034|acupressure /acupuncture|acupressure /acupuncture
5430547|NCT00034034|anxiety|anxiety
5430548|NCT00034034|colorectal neoplasm|colorectal neoplasm
5430549|NCT00034034|human therapy evaluation|human therapy evaluation
5430550|NCT00034034|neoplasm /cancer palliative treatment|neoplasm /cancer palliative treatment
5430551|NCT00034034|quality of life|quality of life
5430552|NCT00034034|terminal patient care|terminal patient care
5430553|NCT00034034|hypothalamic pituitary adrenal axis|hypothalamic pituitary adrenal axis
5430554|NCT00034034|pain|pain
5430555|NCT00034034|psychological aspect of cancer|psychological aspect of cancer
5430556|NCT00034034|stress management|stress management
5430557|NCT00034034|alternative medicine|alternative medicine
5430558|NCT00034034|behavioral /social science research tag|behavioral /social science research tag
5430559|NCT00034034|human subject|human subject
5430560|NCT00034034|patient oriented research|patient oriented research
5430561|NCT00034021|Female Sexual Arousal Disorder|female sexual arousal disorder
5430562|NCT00034021|Female Orgasmic Disorder|female orgasmic disorder
5430563|NCT00034021|ginkgo biloba|ginkgo biloba
5430564|NCT00034021|human therapy evaluation|human therapy evaluation
5430565|NCT00034021|sex behavior|sex behavior
5430566|NCT00034021|antidepressant|antidepressant
5430567|NCT00034021|blood flow|blood flow
5430568|NCT00034021|clinical trial|clinical trial
5430569|NCT00034021|drug adverse effect|drug adverse effect
5430570|NCT00034021|mental disorder chemotherapy|mental disorder chemotherapy
5430571|NCT00034021|relaxation|relaxation
5430572|NCT00034021|smooth muscle|smooth muscle
5430573|NCT00034021|alternative medicine|alternative medicine
5430574|NCT00034021|blood flow measurement|blood flow measurement
5430575|NCT00034021|female|female
5430576|NCT00034021|placebo|placebo
5430577|NCT00034021|women's health|women's health
5430578|NCT00034021|Secondary to either to fluoxetine, sertraline, or paroxetine use.|secondary to either to fluoxetine, sertraline, or paroxetine use.
5430579|NCT00034008|Energy Medicine|energy medicine
5430580|NCT00034008|Healing Touch|healing touch
5430581|NCT00034008|CAM Research|cam research
5430582|NCT00034008|Neonates|neonates
5430583|NCT00034008|Stress|stress
5430584|NCT00034008|Conditions resulting from stress|conditions resulting from stress
5430585|NCT00034008|Neonatal intensive care|neonatal intensive care
5430586|NCT00034008|Healing of stress and prevention of negative|healing of stress and prevention of negative
5430587|NCT00034008|Developmental outcomes – physical and behavioral|developmental outcomes – physical and behavioral
5430588|NCT00034008|Therapeutic Touch|therapeutic touch
5430589|NCT00034008|Touch therapies|touch therapies
5430590|NCT00034008|Energy therapies|energy therapies
5430591|NCT00034008|Infant touch|infant touch
5430592|NCT00034008|Infant stimulation|infant stimulation
5430593|NCT00033995|Tics|tics
5430594|NCT00033995|Basal Ganglia|basal ganglia
5430595|NCT00033995|Neuroimaging|neuroimaging
5430596|NCT00033995|Sleep|sleep
5430597|NCT00033995|Suppression of Tics|suppression of tics
5430598|NCT00033995|Tourette Syndrome|tourette syndrome
5430599|NCT00033995|Tourette's Syndrome|tourette's syndrome
5430600|NCT00033995|Tic Disorder|tic disorder
5430601|NCT00033995|Healthy Volunteer|healthy volunteer
5430602|NCT00033995|HV|hv
5430603|NCT00033995|Normal Control|normal control
5430604|NCT00033982|Triazole|triazole
5430605|NCT00033982|Refractory|refractory
5430606|NCT00033982|Antifungal|antifungal
5430607|NCT00033982|Fungal Infection|fungal infection
5430608|NCT00033969|CRPS|crps
5430609|NCT00033969|RSD|rsd
5430610|NCT00033969|Causalgia|causalgia
5430611|NCT00033969|Chronic Pain|chronic pain
5430612|NCT00033969|Neuropathic Pain|neuropathic pain
5430613|NCT00033969|Normal Control|normal control
5430614|NCT00033969|Complex Regional Pain Syndrome|complex regional pain syndrome
5430615|NCT00033969|Healthy Volunteer|healthy volunteer
5430616|NCT00033969|HV|hv
5430617|NCT00033956|Metastatic Melanoma|metastatic melanoma
5430618|NCT00033956|Renal Cell Carcinoma|renal cell carcinoma
5430619|NCT00033956|IL-2|il-2
5430620|NCT00033956|Interleukin-2|interleukin-2
5430621|NCT00033956|Hypotension|hypotension
5430622|NCT00033917|intraventricular hemorrhage (IVH)|intraventricular hemorrhage (ivh)
5430623|NCT00033917|bleeding in the brain|bleeding in the brain
5430624|NCT00033917|indomethacin|indomethacin
5430625|NCT00033917|prematurity|prematurity
5430626|NCT00033917|very low birth weight infants|very low birth weight infants
5430627|NCT00033904|Kidney Cancer, renal, immunotherapy, tumor,|kidney cancer, renal, immunotherapy, tumor,
5430628|NCT00033891|Muscle Weakness|muscle weakness
5430629|NCT00033891|Muscle Biopsy|muscle biopsy
5430630|NCT00033891|Gene Expression Profiling|gene expression profiling
5430631|NCT00033891|MRI|mri
5430632|NCT00033891|Inflammation|inflammation
5430633|NCT00033891|Polymyositis|polymyositis
5430634|NCT00033891|Dermatomyositis|dermatomyositis
5430635|NCT00033878|Advanced Cancer|advanced cancer
5430636|NCT00033865|Insomnia|insomnia
5430637|NCT00033865|Yoga|yoga
5430638|NCT00033865|Meditation|meditation
5430639|NCT00033865|Behavioral treatment|behavioral treatment
5430640|NCT00033852|complementary therapies|complementary therapies
5430641|NCT00033852|Depression|depression
5430642|NCT00033852|HIV|hiv
5430643|NCT00033852|Massage Therapy|massage therapy
5430644|NCT00033852|Alternative Treatments|alternative treatments
5430645|NCT00033839|Headache|headache
5430646|NCT00033839|Cluster|cluster
5430647|NCT00033839|EC|ec
5430648|NCT00033839|Episodic Cluster|episodic cluster
5430649|NCT00033826|Vitamin D|vitamin d
5430650|NCT00033826|Adipose tissue|adipose tissue
5430651|NCT00033826|Metabolism|metabolism
5430652|NCT00033813|Duchenne|duchenne
5430653|NCT00033813|muscular|muscular
5430654|NCT00033813|dystrophy|dystrophy
5430655|NCT00033813|controlled clinical trial|controlled clinical trial
5430656|NCT00033813|CINRG|cinrg
5430657|NCT00033787|Depression|depression
5430658|NCT00033787|Tryptophan Depletion|tryptophan depletion
5430659|NCT00033787|PET|pet
5430660|NCT00033787|Serotonin|serotonin
5430661|NCT00033787|Pathophysiology|pathophysiology
5430662|NCT00033787|Emotional Stimuli|emotional stimuli
5430663|NCT00033787|GABA MRS|gaba mrs
5430664|NCT00033787|MDD|mdd
5430665|NCT00033787|Healthy Volunteer|healthy volunteer
5430666|NCT00033787|HV|hv
5430667|NCT00033787|Normal Control|normal control
5430668|NCT00033774|Leukapheresis|leukapheresis
5430669|NCT00033774|G-CSF|g-csf
5430670|NCT00033774|Mobilization|mobilization
5430671|NCT00033774|Stem Cells|stem cells
5430672|NCT00033774|Adult|adult
5430673|NCT00033774|Healthy Volunteer|healthy volunteer
5430674|NCT00033774|HV|hv
5430675|NCT00033774|Normal Control|normal control
5430676|NCT00033215|neovascularization|neovascularization
5430677|NCT00033215|matrix metalloproteinases|matrix metalloproteinases
5430678|NCT00033215|antiangiogenesis|antiangiogenesis
5430679|NCT00033215|type IV collagenases|type iv collagenases
5430680|NCT00033202|Solid Tumor|solid tumor
5430681|NCT00033202|Camptothecin|camptothecin
5430682|NCT00033202|Pharmacokinetics|pharmacokinetics
5430683|NCT00033189|duchenne|duchenne
5430684|NCT00033189|dystrophy|dystrophy
5430685|NCT00033189|DMD|dmd
5430686|NCT00033189|clinical trial|clinical trial
5430687|NCT00033189|CINRG|cinrg
5430688|NCT00033176|complementary therapies|complementary therapies
5430689|NCT00033176|Immune restoration|immune restoration
5430690|NCT00033176|HIV infection|hiv infection
5430691|NCT00033176|AIDS|aids
5430692|NCT00033176|HAART non-responsiveness|haart non-responsiveness
5430693|NCT00033176|glutathione restoration|glutathione restoration
5430694|NCT00033176|lipoic acid|lipoic acid
5430695|NCT00033176|dithiol|dithiol
5430696|NCT00033163|Antiviral Agents|antiviral agents
5430697|NCT00033163|Hepatitis B|hepatitis b
5430698|NCT00033163|Drug Resistance, Microbial|drug resistance, microbial
5430699|NCT00033163|Lamivudine|lamivudine
5430700|NCT00033163|DNA, Viral|dna, viral
5430701|NCT00033163|Hepatitis B Virus|hepatitis b virus
5430702|NCT00033163|Adefovir dipivoxil|adefovir dipivoxil
5430703|NCT00033163|Tenofovir disoproxil fumarate|tenofovir disoproxil fumarate
5430704|NCT00033163|Treatment Experienced|treatment experienced
5430705|NCT00033150|Specific Language Impairment|specific language impairment
5430706|NCT00033150|Fast ForWord|fast forword
5430707|NCT00033150|Language therapy|language therapy
5430708|NCT00033150|Auditory processing|auditory processing
5430709|NCT00033137|Pneumothorax|pneumothorax
5430710|NCT00033137|Kidney|kidney
5430711|NCT00033137|Fibrofolliculoma|fibrofolliculoma
5430712|NCT00033137|BHD|bhd
5430713|NCT00033137|Neoplasms|neoplasms
5430714|NCT00033137|Kidney Cancer|kidney cancer
5430715|NCT00033137|Birt Hogg Dube Syndrome|birt hogg dube syndrome
5430716|NCT00033137|Skin Papules|skin papules
5430717|NCT00033085|cocaine dependence|cocaine dependence
5430718|NCT00033033|cocaine dependence|cocaine dependence
5430719|NCT00033020|substance use disorders|substance use disorders
5430720|NCT00033007|substance use disorders|substance use disorders
5430721|NCT00032994|substance use disorders|substance use disorders
5430722|NCT00032981|substance use disorder|substance use disorder
5430723|NCT00032968|opiate dependence|opiate dependence
5430724|NCT00032955|opiate addiction|opiate addiction
5430725|NCT00032955|morphine addiction|morphine addiction
5430726|NCT00032942|opiate dependence|opiate dependence
5430727|NCT00032929|Cocaine Dependence|cocaine dependence
5430728|NCT00032903|Malignant Glioma, Camptothecin, Pharmacokinetics|malignant glioma, camptothecin, pharmacokinetics
5430729|NCT00032890|osteoarthritis|osteoarthritis
5430730|NCT00032890|knee pain|knee pain
5430731|NCT00032877|Linkage Study|linkage study
5430732|NCT00032877|Gene Identification Study|gene identification study
5430733|NCT00032877|Diaphragmatic Hernia|diaphragmatic hernia
5430734|NCT00032877|Fraser Syndrome|fraser syndrome
5430735|NCT00032877|Cryptophthalmos|cryptophthalmos
5430736|NCT00032877|Fryns Syndrome|fryns syndrome
5430737|NCT00032877|Hydrolethalus Syndrome|hydrolethalus syndrome
5430738|NCT00032877|Positional Cloning|positional cloning
5430739|NCT00032864|amputations, diabetes,|amputations, diabetes,
5430740|NCT00032838|Hydrocortisone|hydrocortisone
5430741|NCT00032838|Yohimbine|yohimbine
5430742|NCT00032838|Cognition|cognition
5430743|NCT00032838|Norepinephrine|norepinephrine
5430744|NCT00032838|Cortisol|cortisol
5430745|NCT00032838|Emotion|emotion
5430746|NCT00032838|Healthy Volunteer|healthy volunteer
5430747|NCT00032838|HV|hv
5430748|NCT00032838|Normal Control|normal control
5430749|NCT00032825|Combination|combination
5430750|NCT00032825|Microtubule|microtubule
5430751|NCT00032825|Hormonal|hormonal
5430752|NCT00032825|Chemotherapy|chemotherapy
5430753|NCT00032825|Pharmacokinetics|pharmacokinetics
5430754|NCT00032825|Prostate Cancer|prostate cancer
5430755|NCT00032825|Prostate|prostate
5430756|NCT00032773|acute graft versus host disease|acute graft versus host disease
5430757|NCT00032773|aGVHD|agvhd
5430758|NCT00032773|allogeneic hematopoietic stem cell transplantation|allogeneic hematopoietic stem cell transplantation
5430759|NCT00032773|peripheral blood stem cell transplantation|peripheral blood stem cell transplantation
5430760|NCT00032773|cord blood transplant|cord blood transplant
5430761|NCT00032773|pentostatin|pentostatin
5430762|NCT00032773|Nipent|nipent
5430763|NCT00032773|deoxycoformycin|deoxycoformycin
5430764|NCT00032812|Motor Learning|motor learning
5430765|NCT00032812|Sequencing|sequencing
5430766|NCT00032812|Functional Imaging|functional imaging
5430767|NCT00032812|Raclopride|raclopride
5430768|NCT00032812|Connectivity|connectivity
5430769|NCT00032812|Parkinson Disease|parkinson disease
5430770|NCT00032812|Parkinson's Disease|parkinson's disease
5430771|NCT00032812|PD|pd
5430772|NCT00032812|Healthy Volunteer|healthy volunteer
5430773|NCT00032812|HV|hv
5430774|NCT00032812|Normal Control|normal control
5430775|NCT00032760|binge eating disorder|binge eating disorder
5430776|NCT00032760|human therapy evaluation|human therapy evaluation
5430777|NCT00032760|meditation|meditation
5430778|NCT00032760|obesity|obesity
5430779|NCT00032760|nutrition education|nutrition education
5430780|NCT00032760|psychotherapy|psychotherapy
5430781|NCT00032760|racial /ethnic difference|racial /ethnic difference
5430782|NCT00032760|adult human|adult human
5430783|NCT00032760|alternative medicine|alternative medicine
5430784|NCT00032760|patient oriented research|patient oriented research
5430785|NCT00032747|Chronic Heart Failure|chronic heart failure
5430786|NCT00032747|Heart Disease|heart disease
5430787|NCT00032734|Low Blood Sodium (Hyponatremia)|low blood sodium (hyponatremia)
5430788|NCT00032734|SIADH|siadh
5430789|NCT00032734|Inappropriate ADH Syndrome|inappropriate adh syndrome
5430790|NCT00032721|complementary therapies|complementary therapies
5430791|NCT00032721|Alternative medicine|alternative medicine
5430792|NCT00032721|Complementary and alternative medicine|complementary and alternative medicine
5430793|NCT00032721|Subtle energy therapy|subtle energy therapy
5430794|NCT00032721|Reiki|reiki
5430795|NCT00032721|HIV/AIDS|hiv/aids
5430796|NCT00032695|myelopathy|myelopathy
5430797|NCT00032695|AIDS-myelopathy|aids-myelopathy
5430798|NCT00032695|AIDS vacuolar myelopathy|aids vacuolar myelopathy
5430799|NCT00032695|methionine|methionine
5430800|NCT00032682|Bowel Movement|bowel movement
5430801|NCT00032682|Children|children
5430802|NCT00032682|Stool|stool
5430803|NCT00032682|Symptom Management|symptom management
5430804|NCT00032682|Cancer|cancer
5430805|NCT00032682|Constipation|constipation
5430806|NCT00032669|Antiretrovirals|antiretrovirals
5430807|NCT00032669|Adherence|adherence
5430808|NCT00032669|Dose Adjustments|dose adjustments
5430809|NCT00032669|Genotypic Resistance|genotypic resistance
5430810|NCT00032669|Phenotypic Resistance|phenotypic resistance
5430811|NCT00032656|Adolescents|adolescents
5430812|NCT00032656|Alternative and complimentary medication use|alternative and complimentary medication use
5430813|NCT00032656|Health services utilization|health services utilization
5430814|NCT00032656|Communication|communication
5430815|NCT00032656|Quality of care|quality of care
5430816|NCT00032617|PTSD|ptsd
5430817|NCT00032617|Stress Disorder|stress disorder
5430818|NCT00032617|Trauma|trauma
5430819|NCT00032591|AF|af
5430820|NCT00032591|Mechanical heart valve (MHV)|mechanical heart valve (mhv)
5430821|NCT00032539|Informed Consent|informed consent
5430822|NCT00032513|Herpesvirus|herpesvirus
5430823|NCT00032513|Hemophagocytosis|hemophagocytosis
5430824|NCT00032513|Lymphoproliferative|lymphoproliferative
5430825|NCT00032513|Epstein-Barr|epstein-barr
5430826|NCT00032513|Mononucleosis|mononucleosis
5430827|NCT00032513|EBV|ebv
5430828|NCT00032513|CAEBV|caebv
5430829|NCT00032513|Chronic Active Epstein-Barr Virus|chronic active epstein-barr virus
5430830|NCT00032513|Virus|virus
5430831|NCT00032500|common cold|common cold
5430832|NCT00032500|Echinacea|echinacea
5430833|NCT00032487|DM|dm
5430834|NCT00032487|glycemic control|glycemic control
5430835|NCT00032487|insulin|insulin
5430836|NCT00032487|type 2 diabetes mellitus|type 2 diabetes mellitus
5430837|NCT00032474|Ginkgo biloba|ginkgo biloba
5430838|NCT00032474|type 2 diabetes|type 2 diabetes
5430839|NCT00032474|platelet function|platelet function
5430840|NCT00032474|antioxidant|antioxidant
5430841|NCT00032461|chronic fatigue syndrome|chronic fatigue syndrome
5430842|NCT00032461|fibromyalgia|fibromyalgia
5430843|NCT00032461|post-traumatic stress disorder|post-traumatic stress disorder
5430844|NCT00032461|neurologic abnormalities|neurologic abnormalities
5430845|NCT00032448|Hernia|hernia
5430846|NCT00032448|laparoscopic herniorrhaphy|laparoscopic herniorrhaphy
5430847|NCT00032448|tension-free herniorrhaphy|tension-free herniorrhaphy
5430848|NCT00032435|folate|folate
5430849|NCT00032435|pyridoxine|pyridoxine
5430850|NCT00032435|vitamin B6|vitamin b6
5430851|NCT00032435|cyanocobalamin|cyanocobalamin
5430852|NCT00032435|homoc|homoc
5430853|NCT00032422|Acupuncture|acupuncture
5430854|NCT00032422|Heart Failure|heart failure
5430855|NCT00032422|Autonomic nervous system|autonomic nervous system
5430856|NCT00032409|Music Therapy|music therapy
5430857|NCT00032409|Relaxation Therapy|relaxation therapy
5430858|NCT00032409|Stress Reduction|stress reduction
5430859|NCT00032409|Bone Marrow Transplantation|bone marrow transplantation
5430860|NCT00032409|Stem Cell Transplantation|stem cell transplantation
5430861|NCT00032396|AMD|amd
5430862|NCT00032396|ARMD|armd
5430863|NCT00032396|Age-Related Macular Degeneration|age-related macular degeneration
5430864|NCT00032396|Subfoveal Choroidal Neovascularization|subfoveal choroidal neovascularization
5430865|NCT00032396|CNV|cnv
5430866|NCT00032383|Rehabilitation|rehabilitation
5430867|NCT00032383|Tai Chi|tai chi
5430868|NCT00032370|myocardial infarction|myocardial infarction
5430869|NCT00032370|Prophylactic coronary artery revascularization|prophylactic coronary artery revascularization
5430870|NCT00032357|Ferritin reduction|ferritin reduction
5430871|NCT00032357|Peripheral Vascular Disease (PVD)|peripheral vascular disease (pvd)
5430872|NCT00032357|phlebotomy|phlebotomy
5430873|NCT00032357|Reduction of Total Body Iron Storage(TBIS)|reduction of total body iron storage(tbis)
5430874|NCT00032357|Total Body Iron Storage(TBIS)|total body iron storage(tbis)
5430875|NCT00032344|large (>1 cm) adenomas|large (>1 cm) adenomas
5430876|NCT00032331|PET imaging, benign and malignant solitary pulmonary nodules|pet imaging, benign and malignant solitary pulmonary nodules
5430877|NCT00032305|Colitis|colitis
5430878|NCT00032305|Gastrointestinal Disease|gastrointestinal disease
5430879|NCT00032305|Digestive System Disease|digestive system disease
5430880|NCT00032305|Intestinal Disease|intestinal disease
5430881|NCT00032305|Colonic Disease|colonic disease
5430882|NCT00032240|Biomechanics|biomechanics
5430883|NCT00032227|Carpal Tunnel Release|carpal tunnel release
5430884|NCT00032227|MR Nerve Imaging|mr nerve imaging
5430885|NCT00032227|Wrist MRI|wrist mri
5430886|NCT00032201|Surgery|surgery
5430887|NCT00032201|Tissue Sample|tissue sample
5430888|NCT00032201|Gene Expression Profiling|gene expression profiling
5430889|NCT00032201|Tissue Array Gene Expression|tissue array gene expression
5430890|NCT00032201|Comparative Genomic Hybridization|comparative genomic hybridization
5430891|NCT00032201|Breast Cancer|breast cancer
5430892|NCT00032201|Breast Cancer Risk|breast cancer risk
5430893|NCT00032201|Breast|breast
5430894|NCT00031551|Stomatitis|stomatitis
5443958|NCT00001750|G-CSF|g-csf
5430895|NCT00031551|Oropharyngeal pain|oropharyngeal pain
5430897|NCT00031551|Etanercept|etanercept
5430898|NCT00031551|Bone marrow transplantation|bone marrow transplantation
5430899|NCT00031551|Chemotherapy|chemotherapy
5430900|NCT00031551|Cancer|cancer
5430901|NCT00031551|Oral cavity|oral cavity
5430902|NCT00031551|Oral mucous membranes|oral mucous membranes
5430903|NCT00031551|Randomized controlled clinical trial|randomized controlled clinical trial
5430904|NCT00031551|Inflammation|inflammation
5430905|NCT00031538|Brain Tumor|brain tumor
5430906|NCT00031538|Surgery|surgery
5430907|NCT00031538|Molecular|molecular
5430908|NCT00031538|Glioma|glioma
5430909|NCT00031538|Intraoperative|intraoperative
5430910|NCT00031538|Gliomas|gliomas
5430911|NCT00031512|enterovirus, enteroviral sepsis, Pleconaril, infants|enterovirus, enteroviral sepsis, pleconaril, infants
5430912|NCT00031499|Azithromycin, Syphilis, Penicillin|azithromycin, syphilis, penicillin
5430913|NCT00031486|encephalitis, herpes simplex, valacyclovir|encephalitis, herpes simplex, valacyclovir
5430914|NCT00031473|Ribavirin|ribavirin
5430915|NCT00031473|RSV|rsv
5430916|NCT00031460|acyclovir, central nervous system, Herpes Simplex Virus|acyclovir, central nervous system, herpes simplex virus
5430917|NCT00031447|Herpes Simplex, Acyclovir, Infants|herpes simplex, acyclovir, infants
5430918|NCT00031434|Valganciclovir, congenital cytomegalovirus, ganciclovir|valganciclovir, congenital cytomegalovirus, ganciclovir
5430919|NCT00031421|CMV, cytomegalovirus, children, ganciclovir|cmv, cytomegalovirus, children, ganciclovir
5430920|NCT00031408|Specimen Handling|specimen handling
5430921|NCT00031408|Blood|blood
5430922|NCT00031408|Informed Consent|informed consent
5430923|NCT00031408|Genetic Screening|genetic screening
5430924|NCT00031395|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
5430925|NCT00031395|ADHD|adhd
5430926|NCT00031395|clonidine|clonidine
5430927|NCT00031395|methylphenidate|methylphenidate
5430928|NCT00031395|MPH|mph
5430929|NCT00031382|Functional MRI|functional mri
5430930|NCT00031382|Dual Task|dual task
5430931|NCT00031382|Neural Activation|neural activation
5430932|NCT00031382|Basal Ganglia|basal ganglia
5430933|NCT00031382|Cerebellum|cerebellum
5430934|NCT00031382|Healthy Volunteer|healthy volunteer
5430935|NCT00031382|HV|hv
5430936|NCT00031382|Normal Control|normal control
5430937|NCT00031369|MRI|mri
5430938|NCT00031369|Writer's Cramp|writer's cramp
5430939|NCT00031369|Movement Disorder|movement disorder
5430940|NCT00031369|Gray Matter|gray matter
5430941|NCT00031369|Brain Morphology|brain morphology
5430942|NCT00031369|Dystonia|dystonia
5430943|NCT00031369|Focal Hand Dystonia|focal hand dystonia
5430944|NCT00031369|Healthy Volunteer|healthy volunteer
5430945|NCT00031369|HV|hv
5430946|NCT00031369|Normal Control|normal control
5430947|NCT00031343|Liver Disease|liver disease
5430948|NCT00031343|Virologic Response|virologic response
5430949|NCT00031343|Immune Mechanisms|immune mechanisms
5430950|NCT00031343|Eradication|eradication
5430951|NCT00031343|Antiviral Therapy|antiviral therapy
5430952|NCT00031343|HIV|hiv
5430953|NCT00031343|Hepatitis C|hepatitis c
5430954|NCT00031343|HCV|hcv
5430955|NCT00031343|Coinfection|coinfection
5430956|NCT00031317|Depression|depression
5430957|NCT00031317|Treatment|treatment
5430958|NCT00031317|Antidepressant|antidepressant
5430959|NCT00031317|Benzodiazepine (clonazepam)|benzodiazepine (clonazepam)
5430960|NCT00031317|SSRI (paroxetine)|ssri (paroxetine)
5430961|NCT00031317|Combined Treatment|combined treatment
5430962|NCT00031317|Panic Disorder (PD)|panic disorder (pd)
5430963|NCT00031317|Panic Disorder|panic disorder
5430964|NCT00031317|PD|pd
5430965|NCT00031304|HIV|hiv
5430966|NCT00031304|AIDS|aids
5430967|NCT00031304|Vaccine|vaccine
5430968|NCT00031304|Screening|screening
5430969|NCT00031304|Prevention|prevention
5430970|NCT00031304|HV|hv
5430971|NCT00031304|Healthy Volunteer|healthy volunteer
5430972|NCT00031304|Volunteer|volunteer
5430973|NCT00031304|HIV Seronegativity|hiv seronegativity
5430974|NCT00031304|HIV Preventive Vaccine|hiv preventive vaccine
5430975|NCT00031291|Anthrax|anthrax
5430976|NCT00031291|Immune Globulin|immune globulin
5430977|NCT00031291|Plasmapheresis|plasmapheresis
5430978|NCT00031291|Vaccine|vaccine
5430979|NCT00031278|Metastatic|metastatic
5430980|NCT00031278|Breast|breast
5430981|NCT00031278|Cancer|cancer
5430982|NCT00031278|immunotherapy|immunotherapy
5430983|NCT00031278|CPG 7909|cpg 7909
5430984|NCT00031265|stroke|stroke
5430985|NCT00031265|telephone|telephone
5430986|NCT00031265|intervention|intervention
5430987|NCT00031187|Prostate|prostate
5430988|NCT00031187|Lewis Blood-Group System|lewis blood-group system
5430989|NCT00031187|Antibodies, Monoclonal|antibodies, monoclonal
5430990|NCT00031187|Antigens, Neoplasm|antigens, neoplasm
5430991|NCT00031187|Antineoplastic Agents|antineoplastic agents
5430992|NCT00031174|Apheresis|apheresis
5430993|NCT00031174|Healthy Volunteer|healthy volunteer
5430994|NCT00031174|Rheumatoid Disease|rheumatoid disease
5430995|NCT00031174|Rheumatic Disease|rheumatic disease
5430996|NCT00031174|Lupus|lupus
5430997|NCT00031174|Rheumatoid Arthritis|rheumatoid arthritis
5430998|NCT00031174|Myositis|myositis
5430999|NCT00031174|HV|hv
5431000|NCT00031174|Normal Control|normal control
5431003|NCT00031161|2-(2-nitro-4-trifluoromethylbenzoyl)-1,3-cyclohexanedione|2-(2-nitro-4-trifluoromethylbenzoyl)-1,3-cyclohexanedione
5431004|NCT00031161|4-Hydroxyphenylpyruvate Dioxygenase|4-hydroxyphenylpyruvate dioxygenase
5431005|NCT00031161|Enzyme Inhibitors|enzyme inhibitors
5431006|NCT00031148|Keratinocyte growth factor|keratinocyte growth factor
5431007|NCT00031148|Bone Marrow Transplantation|bone marrow transplantation
5431008|NCT00031148|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
5431009|NCT00031148|HLA Antigens|hla antigens
5431010|NCT00031148|Transplantation, Homologous|transplantation, homologous
5431011|NCT00031148|Recombinant Proteins|recombinant proteins
5431012|NCT00031135|Parenteral Nutrition, Total|parenteral nutrition, total
5431013|NCT00031135|Lipotropic Agents|lipotropic agents
5431014|NCT00031135|Choline|choline
5431015|NCT00031122|Genetic Predisposition to Disease|genetic predisposition to disease
5431016|NCT00031122|Environmental Exposure|environmental exposure
5431017|NCT00031122|Chromosome Mapping|chromosome mapping
5431018|NCT00031122|Data Collection|data collection
5431019|NCT00031109|HIV Antibodies|hiv antibodies
5431020|NCT00031109|HIV-1|hiv-1
5431021|NCT00031109|HIV Envelope Protein gp160|hiv envelope protein gp160
5431022|NCT00031109|Adjuvants, Immunologic|adjuvants, immunologic
5431023|NCT00031109|AIDS Vaccines|aids vaccines
5431024|NCT00031109|CD4 Lymphocyte Count|cd4 lymphocyte count
5431025|NCT00031109|Disease Models, Animal|disease models, animal
5431026|NCT00031109|Antibody Formation|antibody formation
5431027|NCT00031109|Macaca|macaca
5431028|NCT00031109|Neutralization Tests|neutralization tests
5431029|NCT00031109|Viral Load|viral load
5431030|NCT00031109|aluminum hydroxide|aluminum hydroxide
5431031|NCT00031109|HIV Preventive Vaccine|hiv preventive vaccine
5431032|NCT00031096|Acne Vulgaris|acne vulgaris
5431033|NCT00031096|Propionibacterium acnes|propionibacterium acnes
5431034|NCT00031083|Glioma|glioma
5431035|NCT00031083|Brain Tumor|brain tumor
5431036|NCT00031083|Adenovirus|adenovirus
5431037|NCT00031083|Gene Therapy|gene therapy
5431038|NCT00031083|Biogen|biogen
5431039|NCT00031070|Zidovudine|zidovudine
5431040|NCT00031070|CD4 Lymphocyte Count|cd4 lymphocyte count
5431041|NCT00031070|Lamivudine|lamivudine
5431042|NCT00031070|Cyclosporine|cyclosporine
5431043|NCT00031070|Hepatitis A Vaccine|hepatitis a vaccine
5431044|NCT00031070|Rabies Vaccine|rabies vaccine
5431045|NCT00031070|abacavir|abacavir
5431046|NCT00031070|Antiretroviral Therapy, Highly Active|antiretroviral therapy, highly active
5431047|NCT00031070|efavirenz|efavirenz
5431048|NCT00031070|Treatment Naive|treatment naive
5431049|NCT00031057|Administration, Oral|administration, oral
5431050|NCT00031057|Blood|blood
5431051|NCT00031057|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5431052|NCT00031057|Riboflavin|riboflavin
5431053|NCT00031057|Thiamine|thiamine
5431054|NCT00031057|Vitamin B Complex|vitamin b complex
5431055|NCT00031057|Lactic Acid|lactic acid
5431056|NCT00031044|HIV-1|hiv-1
5431057|NCT00031044|Drug Therapy, Combination|drug therapy, combination
5431058|NCT00031044|RNA, Viral|rna, viral
5431059|NCT00031044|Salvage Therapy|salvage therapy
5431060|NCT00031044|Anti-HIV Agents|anti-hiv agents
5431061|NCT00031044|Viral Load|viral load
5431062|NCT00031044|Purines|purines
5431063|NCT00031044|T-20 Peptide|t-20 peptide
5431064|NCT00031044|ABT 378|abt 378
5431065|NCT00031044|Treatment Experienced|treatment experienced
5431066|NCT00031031|MTD|mtd
5431067|NCT00031031|Safety|safety
5431068|NCT00031031|Pharmacokinetics|pharmacokinetics
5431069|NCT00031031|Efficacy|efficacy
5431070|NCT00031018|Inflammation|inflammation
5431071|NCT00031018|immunosenescence|immunosenescence
5431072|NCT00031018|autoimmunity|autoimmunity
5431073|NCT00031018|atherosclerosis|atherosclerosis
5431074|NCT00031018|pro-inflammatory cytokines|pro-inflammatory cytokines
5431075|NCT00031018|Hayflick phenomenon|hayflick phenomenon
5431076|NCT00031005|Non-Myeloablative|non-myeloablative
5431077|NCT00031005|Campath 1-H|campath 1-h
5431078|NCT00031005|Fludarabine|fludarabine
5431079|NCT00031005|Immunodeficiency|immunodeficiency
5431080|NCT00031005|Infection|infection
5431081|NCT00031005|Leukocyte Adhesion Deficiency|leukocyte adhesion deficiency
5431082|NCT00031005|LAD|lad
5431083|NCT00030992|Epothilone B|epothilone b
5431084|NCT00030992|Ixabepilone|ixabepilone
5431085|NCT00030992|Renal Cell Carcinoma|renal cell carcinoma
5431086|NCT00030992|Kidney Cancer|kidney cancer
5431087|NCT00030979|Mild Dementia|mild dementia
5431088|NCT00030979|Acetylcholine|acetylcholine
5431089|NCT00030979|Memory|memory
5431090|NCT00030979|Hallucinations|hallucinations
5431091|NCT00030979|Washout|washout
5431092|NCT00030979|Parkinson Disease|parkinson disease
5431093|NCT00030979|Parkinson's Disease|parkinson's disease
5431094|NCT00030979|PD|pd
5431095|NCT00030979|Dementia|dementia
5431096|NCT00030966|Multiple Sclerosis|multiple sclerosis
5431097|NCT00030966|MS|ms
5431098|NCT00030953|Tourette's Syndrome|tourette's syndrome
5431099|NCT00030953|GABA|gaba
5431100|NCT00030953|NAA|naa
5431101|NCT00030953|Choline|choline
5431102|NCT00030953|Creatine|creatine
5431103|NCT00030953|Tourette Syndrome|tourette syndrome
5431104|NCT00030953|Healthy Volunteer|healthy volunteer
5431105|NCT00030953|HV|hv
5431106|NCT00030953|Normal Control|normal control
5431107|NCT00030940|Antigenic Epitopes|antigenic epitopes
5431108|NCT00030940|Glutamic Acid Decarboxylase (GAD)|glutamic acid decarboxylase (gad)
5431109|NCT00030940|Auto-antibodies|auto-antibodies
5431110|NCT00030940|Stiffness Index|stiffness index
5431111|NCT00030940|SPS|sps
5431112|NCT00030940|Anti-GAD|anti-gad
5431113|NCT00030940|MR Spectroscopy|mr spectroscopy
5431114|NCT00030940|GAD|gad
5431115|NCT00030940|Stiff Person Syndrome|stiff person syndrome
5431116|NCT00030238|Body Fat|body fat
5431117|NCT00030238|Weight Gain|weight gain
5431118|NCT00030238|Adult|adult
5431119|NCT00030238|Hypertension|hypertension
5431120|NCT00030238|Dietary Supplements|dietary supplements
5431121|NCT00030238|Healthy Volunteer|healthy volunteer
5431122|NCT00030238|HIV|hiv
5431123|NCT00030238|Body Weight|body weight
5431124|NCT00030225|Fulminant Hepatic Failure|fulminant hepatic failure
5431125|NCT00030212|T Cell|t cell
5431126|NCT00030212|IBM|ibm
5431127|NCT00030212|Inflammatory Myopathies|inflammatory myopathies
5431128|NCT00030212|Antigenic Epitopes|antigenic epitopes
5431129|NCT00030212|Endomysial T Lymphocytes|endomysial t lymphocytes
5431130|NCT00030212|Myositis|myositis
5431131|NCT00030212|Inclusion Body Myositis|inclusion body myositis
5431132|NCT00030212|Inflammatory Myopathy|inflammatory myopathy
5431133|NCT00030199|Transcranial Magnetic Stimuli|transcranial magnetic stimuli
5431134|NCT00030199|Eletromyography|eletromyography
5431135|NCT00030199|Needle Electrode|needle electrode
5431136|NCT00030199|Facial Muscles|facial muscles
5431137|NCT00030199|Blink Reflex|blink reflex
5431138|NCT00030199|Motor Cortex|motor cortex
5431139|NCT00030199|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
5431140|NCT00030199|Healthy Volunteer|healthy volunteer
5431141|NCT00030199|HV|hv
5431142|NCT00030199|Normal Control|normal control
5431143|NCT00030186|AML|aml
5431144|NCT00030186|FLT-3 mutation|flt-3 mutation
5431145|NCT00030173|Epothilone D|epothilone d
5431146|NCT00030173|tubulin polymerization|tubulin polymerization
5431147|NCT00030160|Obesity|obesity
5431148|NCT00030160|Prevention|prevention
5431149|NCT00030160|Exercise|exercise
5431150|NCT00030147|Gonadal Steroids|gonadal steroids
5431151|NCT00030147|Estrogen Receptor|estrogen receptor
5431152|NCT00030147|Mood Disorders|mood disorders
5431153|NCT00030147|Perimenopause|perimenopause
5431154|NCT00030147|Estradiol|estradiol
5431155|NCT00030147|Depression|depression
5431156|NCT00030147|Estrogen Response Element|estrogen response element
5431157|NCT00030147|Perimenopausal|perimenopausal
5431158|NCT00030147|Perimenopausal Depression|perimenopausal depression
5431159|NCT00030134|Natural History|natural history
5431160|NCT00030134|Female Carrier|female carrier
5431161|NCT00030134|Alpha-Galactosidase|alpha-galactosidase
5431162|NCT00030134|Lysosomal Disease|lysosomal disease
5431163|NCT00030134|X-Linked|x-linked
5431164|NCT00030134|Fabry|fabry
5431165|NCT00030134|Fabry Disease|fabry disease
5431166|NCT00030121|Acute Respiratory Distress|acute respiratory distress
5431167|NCT00030121|Acute Lung Injury|acute lung injury
5431168|NCT00030069|Hematopoiesis|hematopoiesis
5431169|NCT00030069|Apoptosis|apoptosis
5431170|NCT00030069|Cell Differentiation|cell differentiation
5431171|NCT00030069|Bone Marrow Cells|bone marrow cells
5431172|NCT00030056|Sargramostim|sargramostim
5431173|NCT00030056|Injections, Subcutaneous|injections, subcutaneous
5431174|NCT00030043|Electric Stimulation|electric stimulation
5431175|NCT00030043|Implants, Artificial|implants, artificial
5431176|NCT00030043|Brainstem|brainstem
5431177|NCT00030043|Electrodes|electrodes
5431178|NCT00030043|Speech Perception|speech perception
5431179|NCT00029991|Leg pain|leg pain
5431180|NCT00029991|Peripheral angiopathies|peripheral angiopathies
5431181|NCT00029991|Vascular Diseases, peripheral|vascular diseases, peripheral
5431182|NCT00029965|Sialidosis|sialidosis
5431183|NCT00029965|Lysosomal Storage Disease|lysosomal storage disease
5431184|NCT00029965|GM1 Gangliosidosis|gm1 gangliosidosis
5431185|NCT00029965|GM2 Gangliosidosis|gm2 gangliosidosis
5431186|NCT00029965|Lysosomal Storage Disorder|lysosomal storage disorder
5431187|NCT00029965|Tay-Sachs|tay-sachs
5431188|NCT00029965|Sandhoff|sandhoff
5431189|NCT00029965|Gaucher|gaucher
5431190|NCT00029952|Cortisol|cortisol
5431191|NCT00029952|Bone Density|bone density
5431192|NCT00029952|Cushing Syndrome|cushing syndrome
5431193|NCT00029952|Postoperative|postoperative
5431194|NCT00029939|Preparation|preparation
5431195|NCT00029939|Subconscious|subconscious
5431196|NCT00029939|Healthy Volunteer|healthy volunteer
5431198|NCT00029939|Normal Control|normal control
5431199|NCT00029926|Imaging|imaging
5431200|NCT00029926|Immune System|immune system
5431201|NCT00029926|Autoimmune Disease|autoimmune disease
5431202|NCT00029926|Lymphonodes|lymphonodes
5431203|NCT00029926|Spleen|spleen
5431204|NCT00029926|Systemic Lupus Erythematosus|systemic lupus erythematosus
5431205|NCT00029926|Lupus|lupus
5431206|NCT00029926|SLE|sle
5431207|NCT00029913|Placebos|placebos
5431208|NCT00029913|AIDS Vaccines|aids vaccines
5431209|NCT00029913|CD4 Lymphocyte Count|cd4 lymphocyte count
5431210|NCT00029913|Disease Progression|disease progression
5431212|NCT00029913|HIV Preventive Vaccine|hiv preventive vaccine
5431213|NCT00029900|Dose-Response Relationship, Drug|dose-response relationship, drug
5431214|NCT00029900|Polyethylene Glycol|polyethylene glycol
5431215|NCT00029900|Arginine Deiminase|arginine deiminase
5431216|NCT00029874|Tetracyclines|tetracyclines
5431217|NCT00029874|Dose-Response Relationship, Drug|dose-response relationship, drug
5431218|NCT00029861|Weight Loss|weight loss
5431219|NCT00029861|Obesity|obesity
5431220|NCT00029861|Weight Reduction|weight reduction
5431221|NCT00029861|Overweight|overweight
5431222|NCT00029848|Diabetes|diabetes
5431223|NCT00029848|Obesity|obesity
5431224|NCT00029835|Obesity|obesity
5431225|NCT00029822|Acute Urinary Retention|acute urinary retention
5431226|NCT00029822|AUR|aur
5431227|NCT00029822|Benign Prostatic Hyperplasia|benign prostatic hyperplasia
5431228|NCT00029822|Benign Prostatic Hypertrophy|benign prostatic hypertrophy
5431229|NCT00029822|BPH|bph
5431230|NCT00029822|Enlarged Prostate|enlarged prostate
5431231|NCT00029809|Parkinsons Disease|parkinsons disease
5431232|NCT00029809|Chinese exercise|chinese exercise
5431233|NCT00029783|Glioblastoma|glioblastoma
5431234|NCT00029783|Brain tumor|brain tumor
5431235|NCT00029783|Distant healing|distant healing
5431236|NCT00029783|Distance healing|distance healing
5431237|NCT00029757|Surgical menopause|surgical menopause
5431238|NCT00029744|AIDS Vaccines|aids vaccines
5431239|NCT00029744|Clinical Protocols|clinical protocols
5431240|NCT00029744|HIV Seronegativity|hiv seronegativity
5431241|NCT00029744|Patient Selection|patient selection
5431242|NCT00029744|Patient Acceptance of Health Care|patient acceptance of health care
5431243|NCT00029744|Demography|demography
5431244|NCT00029744|HIV Preventive Vaccine|hiv preventive vaccine
5431245|NCT00029731|Nitric Oxide|nitric oxide
5431246|NCT00029731|Administration, Oral|administration, oral
5431247|NCT00029718|Chronic Stroke|chronic stroke
5431248|NCT00029718|Transcallosal Inhibition|transcallosal inhibition
5431249|NCT00029718|Motor Cortex|motor cortex
5431250|NCT00029718|Motor Control|motor control
5431251|NCT00029718|Motor Recovery|motor recovery
5431252|NCT00029718|Healthy Volunteer|healthy volunteer
5431253|NCT00029718|HV|hv
5431254|NCT00029718|Normal Control|normal control
5431255|NCT00029666|Motor Cortex|motor cortex
5431256|NCT00029666|Sham Stimulation|sham stimulation
5431257|NCT00029666|Prefrontal Cortex|prefrontal cortex
5431258|NCT00029666|Brain Stimulation|brain stimulation
5431259|NCT00029666|Gait|gait
5431260|NCT00029666|Parkinson|parkinson
5431261|NCT00029666|Parkinson's|parkinson's
5431262|NCT00029666|PD|pd
5431263|NCT00029653|Frontal Lobe|frontal lobe
5431264|NCT00029653|Reaction Time|reaction time
5431265|NCT00029653|Movement Preparation|movement preparation
5431266|NCT00029653|Motor Threshold|motor threshold
5431267|NCT00029653|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
5431268|NCT00029653|Motor Cortex|motor cortex
5431269|NCT00029653|Healthy Volunteer|healthy volunteer
5431270|NCT00029653|Normal Control|normal control
5431271|NCT00029653|HV|hv
5431272|NCT00029640|MRI|mri
5431273|NCT00029640|MRS|mrs
5431274|NCT00029640|SSRI|ssri
5431275|NCT00029640|Children|children
5431276|NCT00029640|Depression|depression
5431277|NCT00029640|Augmentation|augmentation
5431278|NCT00029640|Magnetic Resonance Imaging|magnetic resonance imaging
5431279|NCT00029640|Major Depression|major depression
5431281|NCT00029627|Alpha2-Adrenoreceptors|alpha2-adrenoreceptors
5431282|NCT00029627|Polymorphisms|polymorphisms
5431283|NCT00029627|Challenge Study|challenge study
5431284|NCT00029627|Yohimbine|yohimbine
5431285|NCT00029627|Clonidine|clonidine
5431286|NCT00029627|Subtypes|subtypes
5431287|NCT00029627|Normal Control|normal control
5431288|NCT00029627|HV|hv
5431289|NCT00029627|Healthy Volunteer|healthy volunteer
5431290|NCT00029614|ADHD|adhd
5431291|NCT00029614|Substance Use|substance use
5431292|NCT00029601|Magnetic Stimulation|magnetic stimulation
5431293|NCT00029601|Intracortical Inhibition|intracortical inhibition
5431294|NCT00029601|Intracortical Facilitation|intracortical facilitation
5431295|NCT00029601|Motor Evoked Potential|motor evoked potential
5431296|NCT00029601|Reaction Time|reaction time
5431297|NCT00029601|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
5431298|NCT00029601|Dystonia|dystonia
5431299|NCT00029601|Focal Dystonia|focal dystonia
5431300|NCT00029601|Healthy Volunteer|healthy volunteer
5431301|NCT00029601|HV|hv
5431302|NCT00029601|Normal Control|normal control
5431303|NCT00029588|fMRI|fmri
5431304|NCT00029588|Adolescents and Adults|adolescents and adults
5431305|NCT00029588|Depression|depression
5431306|NCT00029588|Anxiety|anxiety
5431307|NCT00029588|Anxiety Disorder|anxiety disorder
5431308|NCT00029588|GAD|gad
5431309|NCT00029588|Adolescents|adolescents
5431310|NCT00029588|Healthy Volunteer|healthy volunteer
5431311|NCT00029588|HV|hv
5431312|NCT00029588|Normal Control|normal control
5431313|NCT00029575|Atherosclerotic|atherosclerotic
5431314|NCT00029575|Plaque|plaque
5431315|NCT00029575|Resolution|resolution
5431316|NCT00029575|Adventitia|adventitia
5431317|NCT00029575|Ultrasound|ultrasound
5443959|NCT00001750|Cell-Cycle|cell-cycle
5431318|NCT00029575|Cardiac Catheterization|cardiac catheterization
5431319|NCT00029575|Arteriosclerosis|arteriosclerosis
5431320|NCT00029575|Coronary Artery Disease|coronary artery disease
5431321|NCT00029536|Epilepsy|epilepsy
5431322|NCT00029536|Seizure|seizure
5431323|NCT00029536|Hormone|hormone
5431324|NCT00029536|Progesterone|progesterone
5431325|NCT00029536|Catamenial|catamenial
5431326|NCT00029523|neoplastic|neoplastic
5431327|NCT00029523|meningitis|meningitis
5431328|NCT00029523|cerebrospinal fluid|cerebrospinal fluid
5431329|NCT00029523|CSF|csf
5431330|NCT00029523|meningeal|meningeal
5431331|NCT00029523|meninges|meninges
5431332|NCT00029523|CNS|cns
5431333|NCT00029523|Leptomeningeal Neoplasms|leptomeningeal neoplasms
5431334|NCT00029458|Placebo Controlled|placebo controlled
5431335|NCT00029458|Atypical Anti-Psychotic|atypical anti-psychotic
5431336|NCT00029458|Bipolar Mood Disorder|bipolar mood disorder
5431337|NCT00029458|Positron Emission Tomography|positron emission tomography
5431338|NCT00029458|Dopamine Receptor Blockade|dopamine receptor blockade
5431339|NCT00029458|Antimanic|antimanic
5431340|NCT00029458|Mania|mania
5431341|NCT00029458|Pathophysiology|pathophysiology
5431342|NCT00029458|Treatment-Resistant|treatment-resistant
5431343|NCT00029458|Mood Disorder|mood disorder
5431344|NCT00029458|BPD|bpd
5431345|NCT00029458|Bipolar|bipolar
5431346|NCT00029445|HLA B5701|hla b5701
5431347|NCT00029445|LTNP|ltnp
5431348|NCT00029445|Neutralizing Antibodies|neutralizing antibodies
5431349|NCT00029445|CTL|ctl
5431350|NCT00029445|Virus Restriction|virus restriction
5431351|NCT00029445|HIV|hiv
5431352|NCT00029445|HIV-Infected Long Term Nonprogressors|hiv-infected long term nonprogressors
5431353|NCT00029341|Drug Therapy, Combination|drug therapy, combination
5431354|NCT00029341|Drug Administration Schedule|drug administration schedule
5431355|NCT00029341|Drug Resistance, Microbial|drug resistance, microbial
5431356|NCT00029341|Genotype|genotype
5431357|NCT00029341|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5431358|NCT00029341|Anti-HIV Agents|anti-hiv agents
5431359|NCT00029341|Viral Load|viral load
5431360|NCT00029341|Pharmacokinetics|pharmacokinetics
5431361|NCT00029341|Efavirenz|efavirenz
5431362|NCT00029341|Treatment Interruption|treatment interruption
5431363|NCT00029328|TNFR-Fc fusion protein|tnfr-fc fusion protein
5431364|NCT00029328|Stem Cell Transplantation|stem cell transplantation
5431365|NCT00029328|Transplantation, Homologous|transplantation, homologous
5431366|NCT00029328|Respiratory Function Tests|respiratory function tests
5431367|NCT00029315|Intraventricular hemorrhage|intraventricular hemorrhage
5431368|NCT00029315|Subarachnoid hemorrhage|subarachnoid hemorrhage
5431369|NCT00029315|Intracerebral hemorrhage|intracerebral hemorrhage
5431370|NCT00029315|Pharmacokinetics|pharmacokinetics
5431371|NCT00029315|Recombinant Proteins|recombinant proteins
5431372|NCT00029315|Anticoagulants|anticoagulants
5431373|NCT00029315|Tissue Plasminogen Activator|tissue plasminogen activator
5431374|NCT00029315|Pharmacology|pharmacology
5431375|NCT00029315|Catheters, Indwelling|catheters, indwelling
5431376|NCT00029315|Cerebral Ventricles|cerebral ventricles
5431377|NCT00029302|fMRI|fmri
5431378|NCT00029302|Voluntary Movement|voluntary movement
5431379|NCT00029302|Healthy Volunteer|healthy volunteer
5431380|NCT00029302|HV|hv
5431381|NCT00029302|Normal Control|normal control
5431382|NCT00029276|Parkinson's|parkinson's
5431383|NCT00029276|Depression|depression
5431384|NCT00029276|Magnetic Stimulation|magnetic stimulation
5431385|NCT00029250|complementary therapies|complementary therapies
5431386|NCT00029250|garlic|garlic
5431387|NCT00029250|Allium sativum|allium sativum
5431388|NCT00029250|metabolic diseases|metabolic diseases
5431389|NCT00029250|HAART|haart
5431390|NCT00029250|Protease inhibitors|protease inhibitors
5431391|NCT00029237|Behavioral intervention|behavioral intervention
5431392|NCT00029237|Psychoneuroimmunology|psychoneuroimmunology
5431393|NCT00029237|Complementary therapy|complementary therapy
5431394|NCT00029237|Stress and coping|stress and coping
5431395|NCT00029237|complementary therapies|complementary therapies
5431396|NCT00029224|bone lesions|bone lesions
5431397|NCT00029224|breast cancer|breast cancer
5431398|NCT00029224|multiple myeloma|multiple myeloma
5431399|NCT00029224|prostate cancer|prostate cancer
5431400|NCT00029224|bone metastases|bone metastases
5431401|NCT00029224|pain|pain
5431402|NCT00029198|Massage Therapy|massage therapy
5431403|NCT00029198|Preterm Infants|preterm infants
5431404|NCT00029198|Weight Gain|weight gain
5431405|NCT00029198|Vagal Tone|vagal tone
5431406|NCT00029198|IGF-1|igf-1
5431407|NCT00029198|Oxytocin|oxytocin
5431408|NCT00029198|Brazelton|brazelton
5431409|NCT00029185|Corneal Erosion|corneal erosion
5431410|NCT00029185|Dextrans|dextrans
5431411|NCT00029185|Administration, Topical|administration, topical
5431412|NCT00029185|Ophthalmic Solutions|ophthalmic solutions
5431413|NCT00029185|Thimerosal|thimerosal
5431414|NCT00029172|stroke|stroke
5431415|NCT00029172|depression|depression
5431416|NCT00029159|Turner syndrome|turner syndrome
5431417|NCT00029159|estrogen|estrogen
5431418|NCT00029159|androgen|androgen
5431419|NCT00029159|growth hormone|growth hormone
5431420|NCT00029146|stroke|stroke
5431421|NCT00029146|transient ischemic attack (TIA)|transient ischemic attack (tia)
5431422|NCT00029146|carotid arteries|carotid arteries
5431423|NCT00029146|cerebral infarction|cerebral infarction
5431424|NCT00029133|aneurysm|aneurysm
5431425|NCT00029133|hypothermia|hypothermia
5431426|NCT00029133|subarachnoid intracranial hemorrhage|subarachnoid intracranial hemorrhage
5431427|NCT00028431|Stage III melanoma|stage iii melanoma
5431428|NCT00028431|Stage IV melanoma|stage iv melanoma
5431429|NCT00028431|Interleukin-12|interleukin-12
5431430|NCT00028431|Cancer Vaccines|cancer vaccines
5431431|NCT00028431|Antineoplastic Agents, Combined|antineoplastic agents, combined
5431432|NCT00028431|Incomplete Freund's adjuvant|incomplete freund's adjuvant
5431433|NCT00028431|Monophenol Monooxygenase|monophenol monooxygenase
5431434|NCT00028431|Mannitol|mannitol
5431435|NCT00028431|Adjuvants, Immunologic|adjuvants, immunologic
5431436|NCT00028431|Melan-A Protein|melan-a protein
5431437|NCT00028431|Antigens, Neoplasm|antigens, neoplasm
5431438|NCT00028431|Antibodies|antibodies
5431439|NCT00028431|Melanocyte lineage-specific antigen gp100|melanocyte lineage-specific antigen gp100
5431440|NCT00028431|CTLA-4|ctla-4
5431441|NCT00028418|Acute Leukemia|acute leukemia
5431442|NCT00028418|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
5431443|NCT00028418|Antineoplastic Agents|antineoplastic agents
5431444|NCT00028418|Nucleosides|nucleosides
5431445|NCT00028418|Dose-Response Relationship, Drug|dose-response relationship, drug
5431446|NCT00028418|Cladribine|cladribine
5431447|NCT00028418|Fludarabine|fludarabine
5431448|NCT00028405|Photodynamic Therapy|photodynamic therapy
5431449|NCT00028405|Bulky Tumor|bulky tumor
5431450|NCT00028405|Refractory Tumor|refractory tumor
5431451|NCT00028405|Head and Neck Cancer|head and neck cancer
5431452|NCT00028405|Breast Cancer|breast cancer
5431453|NCT00028405|Pelvic Tumors|pelvic tumors
5431454|NCT00028405|Liver Metastasis|liver metastasis
5431455|NCT00028405|Colorectal Cancer|colorectal cancer
5431456|NCT00028405|Sarcoma|sarcoma
5431457|NCT00028405|Anal Cancer|anal cancer
5431458|NCT00028405|Oral Cancer|oral cancer
5431459|NCT00028405|Recurrent|recurrent
5431460|NCT00028405|Lymphadenopathy|lymphadenopathy
5431461|NCT00028405|Ovarian Cancer|ovarian cancer
5431462|NCT00028405|Cervical Cancer|cervical cancer
5431463|NCT00029120|Alzheimer's Disease|alzheimer's disease
5431464|NCT00029120|Spectroscopy|spectroscopy
5431465|NCT00029120|Longitudinal|longitudinal
5431466|NCT00029120|Perfusion|perfusion
5431467|NCT00029120|Hippocampus|hippocampus
5431468|NCT00029120|N-acetylaspartic Acid|n-acetylaspartic acid
5431469|NCT00029120|Cerebral Blood Flow|cerebral blood flow
5431470|NCT00029120|Aging|aging
5431471|NCT00029120|Dementia|dementia
5431472|NCT00029120|Alzheimer's|alzheimer's
5431473|NCT00029120|Memory Disorder|memory disorder
5431474|NCT00029120|Memory|memory
5431475|NCT00029120|Healthy Volunteer|healthy volunteer
5431477|NCT00029120|Normal Control|normal control
5431478|NCT00029107|Hepatitis|hepatitis
5431479|NCT00029107|Vasculitis|vasculitis
5431480|NCT00029107|Rituximab|rituximab
5431481|NCT00029107|Cryoglobulinemia|cryoglobulinemia
5431482|NCT00029107|Hepatitis C|hepatitis c
5431483|NCT00029107|HcV-cV|hcv-cv
5431484|NCT00029107|Cryoglobulinemic Vasculitis|cryoglobulinemic vasculitis
5431485|NCT00029068|Neurophysiology|neurophysiology
5431486|NCT00029068|Tourette Syndrome|tourette syndrome
5431487|NCT00029068|Anorexia|anorexia
5431488|NCT00029068|SRIs|sris
5431489|NCT00029068|Personality|personality
5431490|NCT00029068|Obsessive-Compulsive Disorder (OCD)|obsessive-compulsive disorder (ocd)
5431491|NCT00029068|Cortical Excitability|cortical excitability
5431492|NCT00029068|Motor Cortex|motor cortex
5431493|NCT00029068|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
5431494|NCT00029068|OCD Spectrum Disorders|ocd spectrum disorders
5431495|NCT00029068|Obsessive Compulsive|obsessive compulsive
5431496|NCT00029068|OCD|ocd
5431497|NCT00029068|Healthy Volunteer|healthy volunteer
5431498|NCT00029068|Normal Control|normal control
5431499|NCT00029068|HV|hv
5431500|NCT00029042|MRI|mri
5431501|NCT00029042|Inflammation|inflammation
5431502|NCT00029042|Joint Disability|joint disability
5431503|NCT00029042|Imaging|imaging
5431504|NCT00029042|Biologic Therapy|biologic therapy
5431505|NCT00029042|Rheumatoid Arthritis|rheumatoid arthritis
5431506|NCT00029042|Juvenile Rheumatoid Arthritis|juvenile rheumatoid arthritis
5431507|NCT00029042|JRA|jra
5431508|NCT00029042|Children|children
5431509|NCT00029042|Joints|joints
5431510|NCT00029042|Joint Inflammation|joint inflammation
5431511|NCT00028379|Plasticity|plasticity
5431512|NCT00028379|Motor Cortex|motor cortex
5431513|NCT00028379|Stroke|stroke
5431514|NCT00028379|Somatosensory|somatosensory
5431515|NCT00028379|Hemiparesis|hemiparesis
5431516|NCT00028366|HIV-1|hiv-1
5431517|NCT00028366|Drug Therapy, Combination|drug therapy, combination
5431518|NCT00028366|HIV Protease Inhibitors|hiv protease inhibitors
5431519|NCT00028366|Ritonavir|ritonavir
5431520|NCT00028366|RNA, Viral|rna, viral
5431521|NCT00028366|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5431522|NCT00028366|Viral Load|viral load
5431523|NCT00028366|ABT 378|abt 378
5431524|NCT00028366|tenofovir disoproxil|tenofovir disoproxil
5431526|NCT00028366|Treatment Experienced|treatment experienced
5431527|NCT00028353|PIN|pin
5431528|NCT00028353|High Grade Prostate Intraepithelial Neoplasia (PIN)|high grade prostate intraepithelial neoplasia (pin)
5431529|NCT00028340|Breast Cancer|breast cancer
5431530|NCT00028327|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
5431531|NCT00028327|Zidovudine|zidovudine
5431532|NCT00028327|HIV Protease Inhibitors|hiv protease inhibitors
5431533|NCT00028327|CD4 Lymphocyte Count|cd4 lymphocyte count
5431534|NCT00028327|Lamivudine|lamivudine
5431535|NCT00028327|Pneumonia|pneumonia
5431536|NCT00028327|Nelfinavir|nelfinavir
5431537|NCT00028327|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5431538|NCT00028327|Antiretroviral Therapy, Highly Active|antiretroviral therapy, highly active
5431539|NCT00028327|Efavirenz|efavirenz
5431540|NCT00028327|Intensive Care Units|intensive care units
5431541|NCT00028327|Sepsis|sepsis
5431542|NCT00028314|HIV-1|hiv-1
5431543|NCT00028314|Abacavir|abacavir
5431544|NCT00028314|Nevirapine|nevirapine
5431545|NCT00028314|Ritonavir|ritonavir
5431546|NCT00028314|RNA, Viral|rna, viral
5431547|NCT00028314|HIV Protease Inhibitors|hiv protease inhibitors
5431548|NCT00028314|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5431549|NCT00028314|Anti-HIV Agents|anti-hiv agents
5431550|NCT00028314|Viral Load|viral load
5431551|NCT00028314|HIV Wasting Syndrome|hiv wasting syndrome
5431552|NCT00028314|ABT 378|abt 378
5431553|NCT00028314|Treatment Experienced|treatment experienced
5431554|NCT00028301|HIV Protease Inhibitors|hiv protease inhibitors
5431555|NCT00028301|RNA, Viral|rna, viral
5431556|NCT00028301|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5431557|NCT00028301|Anti-HIV Agents|anti-hiv agents
5431558|NCT00028301|Viral Load|viral load
5431559|NCT00028301|Lipids|lipids
5431560|NCT00028301|ABT 378|abt 378
5431561|NCT00028301|Antiretroviral Therapy, Highly Active|antiretroviral therapy, highly active
5431562|NCT00028301|Lipoproteins, LDL Cholesterol|lipoproteins, ldl cholesterol
5431563|NCT00028288|Asthma|asthma
5431564|NCT00028288|Daclizumab|daclizumab
5431565|NCT00028288|anti-Tac monoclonal antibody|anti-tac monoclonal antibody
5431566|NCT00028288|anti-IL-2|anti-il-2
5431567|NCT00028288|Zenapax|zenapax
5431568|NCT00028275|Hepatitis C Virus|hepatitis c virus
5431569|NCT00028275|Cirrhosis|cirrhosis
5431570|NCT00028275|Antiviral Agents|antiviral agents
5431571|NCT00028275|Viral Resistance|viral resistance
5431572|NCT00028275|Alpha Interferon|alpha interferon
5431573|NCT00028275|Hepatitis C|hepatitis c
5431574|NCT00028275|Hepatitis|hepatitis
5431575|NCT00028262|Palmitoyl-Protein Thioesterase|palmitoyl-protein thioesterase
5431576|NCT00028262|Lysosomes|lysosomes
5431577|NCT00028262|Batten Disease|batten disease
5431578|NCT00028262|Encephalopathy|encephalopathy
5431579|NCT00028262|Progressive Neurodegeneration|progressive neurodegeneration
5431580|NCT00028262|CLN 1|cln 1
5431581|NCT00028262|Infantile Neuronal Ceroid Lipofuscinosis|infantile neuronal ceroid lipofuscinosis
5431582|NCT00028262|Cystagon|cystagon
5431583|NCT00028249|Patient Satisfaction|patient satisfaction
5431584|NCT00028249|Self Efficacy|self efficacy
5431585|NCT00028249|Social Support|social support
5431586|NCT00028249|Symptom Management|symptom management
5431587|NCT00028249|Advanced Malignancies|advanced malignancies
5431588|NCT00028249|Pain Intervention|pain intervention
5431589|NCT00028236|Peripheral Blood Stem Cells|peripheral blood stem cells
5431590|NCT00028236|Common Gamma Chain (GC)|common gamma chain (gc)
5431591|NCT00028236|Immune Reconstitution|immune reconstitution
5431592|NCT00028236|T Lymphocytes|t lymphocytes
5431593|NCT00028236|B Lymphocytes|b lymphocytes
5431594|NCT00028236|X-Linked Severe Combined Immune Deficiency (XSCID)|x-linked severe combined immune deficiency (xscid)
5431595|NCT00028236|Gene Therapy|gene therapy
5431596|NCT00028236|NK Cell|nk cell
5431597|NCT00028236|Bone Marrow Transplantation|bone marrow transplantation
5431598|NCT00028236|Engraftment|engraftment
5431599|NCT00028236|XSCID|xscid
5431600|NCT00028236|Immune Deficiency|immune deficiency
5431601|NCT00028236|Immune System|immune system
5431602|NCT00028210|Amputee|amputee
5431603|NCT00028210|Plasticity|plasticity
5431604|NCT00028210|Somatosensory|somatosensory
5431605|NCT00028210|Upper Limb Amputation|upper limb amputation
5431606|NCT00028210|Tactile Performance|tactile performance
5431607|NCT00028210|Cortical Reorganization|cortical reorganization
5431608|NCT00028210|Healthy Volunteer|healthy volunteer
5431609|NCT00028210|HV|hv
5431610|NCT00028210|Normal Control|normal control
5431611|NCT00028197|Voluntary Movement|voluntary movement
5431612|NCT00028197|Functional MRI|functional mri
5431613|NCT00028197|Sensorimotor Integration|sensorimotor integration
5431614|NCT00028197|Superior Parietal Lobe|superior parietal lobe
5431615|NCT00028197|Supplementary Motor Area|supplementary motor area
5431616|NCT00028197|Normal Control|normal control
5431617|NCT00028197|HV|hv
5431618|NCT00028197|Healthy Volunteer|healthy volunteer
5431619|NCT00028184|Chronic Stroke|chronic stroke
5431620|NCT00028184|Ipsilateral Motor Cortex|ipsilateral motor cortex
5431621|NCT00028184|Motor Control|motor control
5431622|NCT00028184|Motor Recovery|motor recovery
5431623|NCT00028184|Stroke|stroke
5431624|NCT00028184|Healthy Volunteer|healthy volunteer
5431626|NCT00028184|Healthy Control|healthy control
5431627|NCT00028158|Antineoplastic agents|antineoplastic agents
5431628|NCT00028158|Herpes virus|herpes virus
5431629|NCT00028158|Brain tumor|brain tumor
5431630|NCT00028158|Oncolytic virs|oncolytic virs
5431631|NCT00028145|Women's Health|women's health
5431632|NCT00028145|Disease Transmission, Vertical|disease transmission, vertical
5431633|NCT00028145|Preventive Medicine|preventive medicine
5431634|NCT00028145|Treatment Experienced|treatment experienced
5431635|NCT00028132|Risk Factors|risk factors
5431636|NCT00028132|Mucous Membrane|mucous membrane
5431637|NCT00028132|Anti-Infective Agents|anti-infective agents
5431638|NCT00028132|Cervix Uteri|cervix uteri
5431639|NCT00028132|Vagina|vagina
5431640|NCT00028132|Anti-HIV Agents|anti-hiv agents
5431641|NCT00028132|Pharmacokinetics|pharmacokinetics
5431642|NCT00028132|Vulva|vulva
5431643|NCT00028132|9-(2-phosphonylmethoxypropyl)adenine|9-(2-phosphonylmethoxypropyl)adenine
5431644|NCT00028132|HIV Seronegativity|hiv seronegativity
5431645|NCT00028119|Clinical Trials|clinical trials
5431646|NCT00028119|Sexual Partners|sexual partners
5431647|NCT00028119|Risk Factors|risk factors
5431648|NCT00028119|Incidence|incidence
5431649|NCT00028119|HIV Seronegativity|hiv seronegativity
5431650|NCT00028119|India|india
5431651|NCT00028119|Patient Compliance|patient compliance
5431652|NCT00028119|Preventive Health Services|preventive health services
5431653|NCT00028106|Cancer|cancer
5431654|NCT00028106|Metastasis|metastasis
5431655|NCT00028106|Fluorodopamine|fluorodopamine
5431656|NCT00028106|PET|pet
5431657|NCT00028106|Methylprednisolone|methylprednisolone
5431658|NCT00028106|Catecholamines|catecholamines
5431659|NCT00028106|Metanephrines|metanephrines
5431660|NCT00028106|Alpha-Methyl-Para-Tyrosine|alpha-methyl-para-tyrosine
5431661|NCT00028106|Retinoic Acid|retinoic acid
5431662|NCT00028106|Carbidopa|carbidopa
5431663|NCT00028093|Chronic Hepatitis|chronic hepatitis
5431664|NCT00028093|Cirrhosis|cirrhosis
5431665|NCT00028093|Hepatitis C Virus|hepatitis c virus
5431666|NCT00028093|Hemolysis|hemolysis
5431667|NCT00028093|Ribavirin|ribavirin
5431668|NCT00028093|Alpha Interferon|alpha interferon
5431669|NCT00028093|Peginterferon|peginterferon
5431670|NCT00028093|Antiviral Agents|antiviral agents
5431671|NCT00028093|Viral Hepatitis|viral hepatitis
5431672|NCT00028093|Hemolytic Anemia|hemolytic anemia
5431673|NCT00028093|Renal Failure|renal failure
5431674|NCT00028093|Renal Dialysis|renal dialysis
5431675|NCT00028093|Hepatitis|hepatitis
5431676|NCT00028093|Hepatitis C|hepatitis c
5431677|NCT00028080|Borrelia Burgdorferi|borrelia burgdorferi
5431678|NCT00028080|Lyme Disease|lyme disease
5431679|NCT00028080|Infection|infection
5431680|NCT00028080|Therapy|therapy
5431681|NCT00028080|Lyme|lyme
5431682|NCT00028067|Drug Therapy, Combination|drug therapy, combination
5431683|NCT00028067|HIV Protease Inhibitors|hiv protease inhibitors
5431684|NCT00028067|RNA, Viral|rna, viral
5431685|NCT00028067|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5431686|NCT00028067|Viral Load|viral load
5431687|NCT00028067|BMS 232632|bms 232632
5431688|NCT00027482|T Cell|t cell
5431689|NCT00027482|B Cell|b cell
5431690|NCT00027482|Flow Cytometry|flow cytometry
5431691|NCT00027482|Cell-Mediated Immunity|cell-mediated immunity
5431692|NCT00027482|Thymus|thymus
5431693|NCT00027482|HIV|hiv
5431694|NCT00027482|Immunity|immunity
5431695|NCT00027482|Lymphocytes|lymphocytes
5431696|NCT00027482|Monocytes|monocytes
5431697|NCT00027482|Healthy Volunteer|healthy volunteer
5431698|NCT00027482|HV|hv
5431699|NCT00027482|Normal Control|normal control
5431700|NCT00027469|Atheroembolism|atheroembolism
5431701|NCT00027469|Atherosclerosis|atherosclerosis
5431702|NCT00027469|MRI|mri
5431703|NCT00027469|Renal Artery Stenosis|renal artery stenosis
5431704|NCT00027469|Renovascular Hypertension|renovascular hypertension
5431705|NCT00027469|ARAS|aras
5431706|NCT00027469|Renovascular Disease|renovascular disease
5431707|NCT00027469|Renal Artery Stenting|renal artery stenting
5431708|NCT00027469|PTRAS|ptras
5431709|NCT00027456|Insulin Resistance|insulin resistance
5431710|NCT00027456|Diabetes Mellitus|diabetes mellitus
5431711|NCT00027456|Adipocytes|adipocytes
5431712|NCT00027456|Rabson Mendenhall Syndrome|rabson mendenhall syndrome
5431713|NCT00027456|Leprechaunism|leprechaunism
5431714|NCT00027456|Leptin|leptin
5431715|NCT00027443|Giant Cell Myocarditis|giant cell myocarditis
5431716|NCT00027417|Congenital heart defects|congenital heart defects
5431717|NCT00027417|Hypoplastic left heart syndrome|hypoplastic left heart syndrome
5431718|NCT00027417|Complete atrioventricular canal defect|complete atrioventricular canal defect
5431719|NCT00027417|Triostat|triostat
5431720|NCT00027417|Cardiac surgery|cardiac surgery
5431721|NCT00027404|Adult, Autism|adult, autism
5431722|NCT00027391|Muscle Weakness, Muscular Dystrophy|muscle weakness, muscular dystrophy
5431723|NCT00027378|fluoxetine,|fluoxetine,
5431724|NCT00027378|adolescents,|adolescents,
5431725|NCT00027378|alcohol dependence,|alcohol dependence,
5431726|NCT00027378|major depression|major depression
5431727|NCT00027378|Alcoholism|alcoholism
5431728|NCT00027365|HIV Seronegativity|hiv seronegativity
5431729|NCT00027365|HIV Preventive Vaccine|hiv preventive vaccine
5431730|NCT00027365|Injections, Intramuscular|injections, intramuscular
5431731|NCT00027365|HIV Antibodies|hiv antibodies
5431732|NCT00027365|HIV-1|hiv-1
5431733|NCT00027365|HIV Envelope Protein gp120|hiv envelope protein gp120
5431734|NCT00027365|Gene Products, tat|gene products, tat
5431735|NCT00027365|AIDS Vaccines|aids vaccines
5431736|NCT00027365|Neutralization Tests|neutralization tests
5431737|NCT00027365|Vaccines, Combined|vaccines, combined
5431738|NCT00027365|AIDS Seronegativity|aids seronegativity
5431739|NCT00027365|Gene Products, nef|gene products, nef
5431740|NCT00027352|Physician's Practice Patterns|physician's practice patterns
5431741|NCT00027352|Anti-HIV Agents|anti-hiv agents
5431742|NCT00027339|HIV-1|hiv-1
5431743|NCT00027339|HIV Protease Inhibitors|hiv protease inhibitors
5431744|NCT00027339|RNA, Viral|rna, viral
5431745|NCT00027339|Phenotype|phenotype
5431746|NCT00027339|Viral Load|viral load
5431747|NCT00027339|Pharmacokinetics|pharmacokinetics
5431748|NCT00027339|Treatment Experienced|treatment experienced
5431749|NCT00027326|Blood|blood
5431750|NCT00027326|Samples|samples
5431751|NCT00027326|Radiation|radiation
5431752|NCT00027326|Urine|urine
5431753|NCT00027326|Cancer|cancer
5431754|NCT00027326|Radiation Therapy|radiation therapy
5431755|NCT00027300|Relapsing Remitting Multiple Sclerosis|relapsing remitting multiple sclerosis
5431756|NCT00027287|Type I Diabetes|type i diabetes
5431757|NCT00027287|Type 2 Diabetes|type 2 diabetes
5431758|NCT00027287|Diode Laser Photocoagulation|diode laser photocoagulation
5431759|NCT00027287|Vitamin E|vitamin e
5431760|NCT00027287|Elevated Low-Density Lipoprotein (LDL-C) Cholesterol|elevated low-density lipoprotein (ldl-c) cholesterol
5431761|NCT00027287|Diabetic Retinopathy|diabetic retinopathy
5431762|NCT00027287|Macular Edema|macular edema
5431763|NCT00027287|Type II Diabetes|type ii diabetes
5431764|NCT00027274|Fanconi's Anemia|fanconi's anemia
5431765|NCT00027274|Diamond Blackfan Anemia|diamond blackfan anemia
5431766|NCT00027274|Dyskeratosis Congenita|dyskeratosis congenita
5431767|NCT00027274|Shwachman-Diamond Syndrome|shwachman-diamond syndrome
5431768|NCT00027274|Hereditary|hereditary
5431769|NCT00027274|Bone Marrow|bone marrow
5431770|NCT00027274|Inherited Bone Marrow Failure Syndromes|inherited bone marrow failure syndromes
5431771|NCT00027274|IBMFS|ibmfs
5431772|NCT00027274|Familial Cancer|familial cancer
5431773|NCT00027261|Vaccines, Synthetic|vaccines, synthetic
5431774|NCT00027261|HIV-1|hiv-1
5431775|NCT00027261|AIDS Vaccines|aids vaccines
5431776|NCT00027261|CD8-Positive T-Lymphocytes|cd8-positive t-lymphocytes
5431777|NCT00027261|HIV Seronegativity|hiv seronegativity
5431778|NCT00027261|Avipoxvirus|avipoxvirus
5431779|NCT00027261|Dose-Response Relationship, Immunologic|dose-response relationship, immunologic
5431780|NCT00027261|HIV Preventive Vaccine|hiv preventive vaccine
5431781|NCT00027248|central venous catheter|central venous catheter
5431782|NCT00027248|bloodstream infection|bloodstream infection
5431783|NCT00027248|CVC|cvc
5431784|NCT00027248|catheter colonization|catheter colonization
5431785|NCT00027248|local catheter site infection|local catheter site infection
5431786|NCT00027209|seizures|seizures
5431787|NCT00027209|epilepsy|epilepsy
5431788|NCT00027209|menopause|menopause
5431789|NCT00027196|Genetics|genetics
5431790|NCT00027196|Cardiac Diseases|cardiac diseases
5431791|NCT00027196|Cardiac Hypertrophy|cardiac hypertrophy
5431792|NCT00027196|Sudden Death|sudden death
5431793|NCT00027196|Arrhythmias|arrhythmias
5431794|NCT00027183|Cystic Fibrosis|cystic fibrosis
5431795|NCT00027183|Effector Proteins|effector proteins
5431796|NCT00027183|Cytotoxin|cytotoxin
5431797|NCT00027183|Lung Injury|lung injury
5431798|NCT00027183|Genetic Screen|genetic screen
5431799|NCT00027170|Myocardial Infarction|myocardial infarction
5431800|NCT00027170|Myocardial Viability|myocardial viability
5431801|NCT00027170|Myocardial Perfusion|myocardial perfusion
5431802|NCT00027170|Myocardial Ischemia|myocardial ischemia
5431803|NCT00027170|Atherosclerosis|atherosclerosis
5431804|NCT00027170|Cardiovascular Disease|cardiovascular disease
5431805|NCT00027170|Coronary Artery Disease|coronary artery disease
5431806|NCT00027157|Coronary Spasm|coronary spasm
5431807|NCT00027157|Endothelial-Derived-Relaxation Factor|endothelial-derived-relaxation factor
5431808|NCT00027157|Nitric Oxide Synthase|nitric oxide synthase
5431809|NCT00027157|Susceptibility Genes|susceptibility genes
5431810|NCT00027157|Tetrahydrobiopterin|tetrahydrobiopterin
5431811|NCT00027144|Leukemia|leukemia
5431812|NCT00027144|Vaccine|vaccine
5431813|NCT00027131|vaccine|vaccine
5431814|NCT00027131|immunotherapy|immunotherapy
5431815|NCT00027118|Shoulder|shoulder
5431816|NCT00027118|Breast Cancer|breast cancer
5431817|NCT00027118|Physical Therapy|physical therapy
5431818|NCT00027118|Lymphedema|lymphedema
5431819|NCT00027118|Quality of Life|quality of life
5431820|NCT00027118|Breast Cancer Surgery|breast cancer surgery
5431821|NCT00027118|Healthy Volunteer|healthy volunteer
5431822|NCT00027118|HV|hv
5431823|NCT00027118|Normal Control|normal control
5431824|NCT00027105|Fatigue|fatigue
5431825|NCT00027105|Shoulder function|shoulder function
5431826|NCT00027105|Lymphedema|lymphedema
5431827|NCT00027105|Breast Cancer|breast cancer
5431828|NCT00027105|Breast Cancer Surgery|breast cancer surgery
5431829|NCT00027105|Quality of Life|quality of life
5431830|NCT00027092|Infusions, Intravenous|infusions, intravenous
5431831|NCT00027092|Testosterone|testosterone
5431832|NCT00027092|Insulin Resistance|insulin resistance
5431833|NCT00027092|Hormone Replacement Therapy|hormone replacement therapy
5431834|NCT00027092|Glucose Tolerance Test|glucose tolerance test
5431835|NCT00027066|stroke|stroke
5431836|NCT00027066|aspirin|aspirin
5431837|NCT00027066|warfarin|warfarin
5431838|NCT00027053|alcoholism|alcoholism
5431839|NCT00027053|alcohol dependence|alcohol dependence
5431840|NCT00027053|trazadone|trazadone
5431841|NCT00027053|sleep|sleep
5431842|NCT00027040|AIDS Dementia Complex|aids dementia complex
5431843|NCT00027040|Selegiline|selegiline
5431844|NCT00027040|Oxidative Stress|oxidative stress
5431845|NCT00027040|Cognition|cognition
5431846|NCT00027040|Neuroprotective Agents|neuroprotective agents
5431847|NCT00027040|Brain Injuries|brain injuries
5431848|NCT00027040|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
5431849|NCT00027040|Protons|protons
5431850|NCT00027014|opioid|opioid
5431851|NCT00027014|St. John's wort|st. john's wort
5431852|NCT00027014|analgesia|analgesia
5431853|NCT00027014|metabolism|metabolism
5431854|NCT00027014|transporter|transporter
5431855|NCT00027001|Qigong, exercise, circulatory assist devices|qigong, exercise, circulatory assist devices
5431856|NCT00026988|Huntington's disease|huntington's disease
5431857|NCT00026988|creatine|creatine
5431858|NCT00026988|energy depletion|energy depletion
5431859|NCT00026975|Laryngeal Cancer|laryngeal cancer
5431860|NCT00026975|Laryngectomy|laryngectomy
5431861|NCT00026975|Tissue Oxygenation|tissue oxygenation
5431862|NCT00026975|Irradiated Tissue|irradiated tissue
5431863|NCT00026975|Hyperbaric Oxygen|hyperbaric oxygen
5431864|NCT00026975|Angiogenesis|angiogenesis
5431865|NCT00026975|EF5|ef5
5431866|NCT00026962|Breast|breast
5431867|NCT00026962|Hormones|hormones
5431868|NCT00026962|Prevention|prevention
5431869|NCT00026962|Saliva|saliva
5431870|NCT00026962|Serum|serum
5431871|NCT00026949|Etoposide|etoposide
5431872|NCT00026949|Breast Cancer|breast cancer
5431873|NCT00026949|Pharmacokinetics|pharmacokinetics
5431874|NCT00026936|External Beam Radiotherapy|external beam radiotherapy
5431875|NCT00026936|TCP|tcp
5431876|NCT00026936|DVH|dvh
5431877|NCT00026936|NTCP|ntcp
5431878|NCT00026936|3-D Programming|3-d programming
5431879|NCT00026923|Laparoscopy|laparoscopy
5431880|NCT00026923|Telemedicine|telemedicine
5431881|NCT00026923|Surgery|surgery
5431882|NCT00026923|Endoscopy|endoscopy
5431883|NCT00026910|Cell-Cycle|cell-cycle
5431884|NCT00026910|Apoptosis|apoptosis
5431885|NCT00026910|Molecular Prognosis|molecular prognosis
5431886|NCT00026897|Adoptive Immunotherapy|adoptive immunotherapy
5431887|NCT00026897|Cellular Therapy|cellular therapy
5431888|NCT00026897|Lymphocyte Migration|lymphocyte migration
5431889|NCT00026897|Tumor Imaging|tumor imaging
5431890|NCT00026884|Serum|serum
5431891|NCT00026884|Collection of Tissue|collection of tissue
5431892|NCT00026884|Malignant Disease|malignant disease
5431893|NCT00026884|Molecular Basis|molecular basis
5431894|NCT00026884|Genome Sequencing|genome sequencing
5431895|NCT00026871|Non-Therapeutic|non-therapeutic
5431896|NCT00026871|Radiation Therapy|radiation therapy
5431897|NCT00026871|Dosimetry|dosimetry
5431898|NCT00026871|Dose-Rate|dose-rate
5431899|NCT00026871|Fiberoptic|fiberoptic
5431900|NCT00026858|Bone Marrow Transplantation|bone marrow transplantation
5431901|NCT00026858|Leukemia|leukemia
5431902|NCT00026858|Breast Cancer|breast cancer
5431903|NCT00026858|Multiple Myeloma|multiple myeloma
5431904|NCT00026858|Total Body Irradiation|total body irradiation
5431905|NCT00026832|PET|pet
5431906|NCT00026832|Major Depression|major depression
5431907|NCT00026832|MRI|mri
5431908|NCT00026832|Cerebral Blood Flow|cerebral blood flow
5431909|NCT00026832|Neuroendocrine|neuroendocrine
5431910|NCT00026832|Bipolar Disorder|bipolar disorder
5431911|NCT00026832|Serotonin1A|serotonin1a
5431912|NCT00026832|Mood Disorder|mood disorder
5431913|NCT00026832|Major Depressive Disorder|major depressive disorder
5431914|NCT00026832|MDD|mdd
5431915|NCT00026832|Depression|depression
5431916|NCT00026832|Healthy Volunteer|healthy volunteer
5431917|NCT00026832|HV|hv
5431918|NCT00026832|Normal Control|normal control
5431919|NCT00026819|NSAID|nsaid
5431920|NCT00026819|Acute Pain Model|acute pain model
5431921|NCT00026819|Hyperalgesia|hyperalgesia
5431922|NCT00026819|Central Sensitization|central sensitization
5431923|NCT00026819|Wisdom Teeth|wisdom teeth
5431924|NCT00026819|Wisdom Teeth Extraction|wisdom teeth extraction
5431925|NCT00026819|Third Molar|third molar
5431926|NCT00026806|HIV Infection|hiv infection
5431927|NCT00026806|Mental Health|mental health
5431928|NCT00026806|Risk Behaviors|risk behaviors
5431929|NCT00026806|Post-Traumatic Stress Disorder|post-traumatic stress disorder
5431930|NCT00026806|Youth|youth
5431931|NCT00026806|HIV|hiv
5431932|NCT00026806|Long Term Survivor|long term survivor
5431933|NCT00026793|Kaposi Sarcoma|kaposi sarcoma
5431934|NCT00026793|Doppler|doppler
5431935|NCT00026793|Infrared|infrared
5431936|NCT00026793|HIV|hiv
5431937|NCT00026793|Imaging|imaging
5431938|NCT00026793|Kaposi's Sarcoma|kaposi's sarcoma
5431939|NCT00026793|Laser Imaging|laser imaging
5431940|NCT00026793|Infrared Imaging|infrared imaging
5431941|NCT00026780|CT Scan|ct scan
5431942|NCT00026780|MRI Scan|mri scan
5431943|NCT00026780|Childhood Cancer|childhood cancer
5431944|NCT00026780|Eligibility Screening|eligibility screening
5431945|NCT00026780|Tissue Procurement|tissue procurement
5431946|NCT00026780|Pediatric|pediatric
5431947|NCT00026780|Children|children
5431948|NCT00026780|Screening|screening
5431949|NCT00026767|Risk Factors|risk factors
5431950|NCT00026767|Epidemiology|epidemiology
5431951|NCT00026767|BMT/SCT|bmt/sct
5431952|NCT00026767|Fungal Infection|fungal infection
5431953|NCT00026767|Bone Marrow Stem Cell Transplant|bone marrow stem cell transplant
5431954|NCT00026767|Organ Transplant|organ transplant
5431955|NCT00026754|Screening|screening
5431956|NCT00026754|Cancer|cancer
5431957|NCT00026754|HIV Infection|hiv infection
5431958|NCT00026754|Scans|scans
5431959|NCT00026754|Laboratory Tests|laboratory tests
5431960|NCT00026754|HIV|hiv
5431961|NCT00026754|Skin Disorders|skin disorders
5431962|NCT00026741|Cytokine|cytokine
5431963|NCT00026741|Inflammation|inflammation
5431964|NCT00026741|Lymphocyte|lymphocyte
5431965|NCT00026741|T Cell|t cell
5431966|NCT00026741|Migration|migration
5431967|NCT00026741|Healthy Volunteer|healthy volunteer
5431968|NCT00026741|Skin Biopsy|skin biopsy
5431969|NCT00026728|Human Herpesvirus B|human herpesvirus b
5431970|NCT00026728|NHANES|nhanes
5431971|NCT00026728|Epidemiology|epidemiology
5431972|NCT00026728|Population-Based Study|population-based study
5431973|NCT00026728|Kaposi's Sarcoma Herpes Virus|kaposi's sarcoma herpes virus
5431974|NCT00026715|Renal Function|renal function
5431975|NCT00026715|Iothalamate|iothalamate
5431976|NCT00026702|Acute Renal Failure|acute renal failure
5431977|NCT00026702|Biomarkers|biomarkers
5431978|NCT00026689|Evaluation|evaluation
5431979|NCT00026689|Screening|screening
5431980|NCT00026689|Cancer|cancer
5431981|NCT00026689|Radiation|radiation
5431982|NCT00026689|Eligibility|eligibility
5431983|NCT00026676|Surrogate Markers|surrogate markers
5431984|NCT00026676|Genotypic Resistance|genotypic resistance
5431985|NCT00026676|Phenotypic Resistance|phenotypic resistance
5431986|NCT00026676|Selenium|selenium
5431987|NCT00026663|Assays|assays
5431988|NCT00026663|Resistance|resistance
5431989|NCT00026663|Biopsy Samples|biopsy samples
5431990|NCT00026663|Specimen Acquisition|specimen acquisition
5431991|NCT00026663|Cancer Cells|cancer cells
5431992|NCT00026650|Late Effects|late effects
5431993|NCT00026650|Radiation Therapy|radiation therapy
5431994|NCT00026650|Cancer|cancer
5431995|NCT00026637|depression|depression
5431996|NCT00026637|epilepsy|epilepsy
5431997|NCT00026637|seizures|seizures
5431998|NCT00026624|Virus Replication|virus replication
5431999|NCT00026624|Injections, Subcutaneous|injections, subcutaneous
5432000|NCT00026624|HIV-1|hiv-1
5432001|NCT00026624|AIDS Vaccines|aids vaccines
5432002|NCT00026624|Dendritic Cells|dendritic cells
5432003|NCT00026624|Adoptive Transfer|adoptive transfer
5432004|NCT00026624|Keyhole-Limpet Hemocyanin|keyhole-limpet hemocyanin
5432005|NCT00026624|HIV Therapeutic Vaccine|hiv therapeutic vaccine
5432006|NCT00026611|Vaccine prophylaxis|vaccine prophylaxis
5432007|NCT00026598|Basal Ganglia|basal ganglia
5432008|NCT00026598|Cerebral Cortex|cerebral cortex
5432009|NCT00026598|Functional Neuroanatomy|functional neuroanatomy
5432010|NCT00026598|Bradykinesia|bradykinesia
5432011|NCT00026598|Bradyphrenia|bradyphrenia
5432012|NCT00026598|Parkinson's Disease|parkinson's disease
5432013|NCT00026598|Parkinson Disease|parkinson disease
5432014|NCT00026598|PD|pd
5432015|NCT00026598|Healthy Volunteer|healthy volunteer
5432016|NCT00026598|HV|hv
5432017|NCT00026598|Normal Control|normal control
5432018|NCT00026585|Bipolar Disorder|bipolar disorder
5432019|NCT00026585|Antimanic|antimanic
5432020|NCT00026585|Placebo Controlled|placebo controlled
5432021|NCT00026585|Randomized|randomized
5432022|NCT00026585|Cytochrome P450|cytochrome p450
5432023|NCT00026585|Mania|mania
5432024|NCT00026585|PKC Inhibitor|pkc inhibitor
5432025|NCT00026585|Tamoxifen|tamoxifen
5432026|NCT00026585|Bipolar|bipolar
5432027|NCT00026585|Manic|manic
5432028|NCT00026585|BPD|bpd
5432029|NCT00026559|Classical Conditioning|classical conditioning
5432030|NCT00026559|Fear Conditioning|fear conditioning
5432031|NCT00026559|Stress|stress
5432032|NCT00026559|Anxiety|anxiety
5432033|NCT00026559|Learning|learning
5432034|NCT00026559|Normal Volunteers|normal volunteers
5432035|NCT00026559|Adults|adults
5432036|NCT00026559|Healthy Volunteer|healthy volunteer
5432037|NCT00026559|Normal Control|normal control
5432038|NCT00026546|Stop Task|stop task
5432039|NCT00026546|Functional (BOLD) MRI|functional (bold) mri
5432040|NCT00026546|Developmental|developmental
5432041|NCT00026546|Inhibitory Control|inhibitory control
5432042|NCT00026546|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
5432043|NCT00026546|ADHD|adhd
5432044|NCT00026546|Impulsivity|impulsivity
5432045|NCT00026546|Healthy Volunteer|healthy volunteer
5432046|NCT00026546|Normal Volunteer|normal volunteer
5432047|NCT00026546|HV|hv
5432048|NCT00026065|Hypertension|hypertension
5432049|NCT00026065|BIofeedback|biofeedback
5432050|NCT00026065|Non-pharmacological treatment|non-pharmacological treatment
5432051|NCT00026065|Prediction|prediction
5432052|NCT00026052|Riluzole|riluzole
5432053|NCT00026052|Neuroprotective|neuroprotective
5432054|NCT00026052|Open-Label Study|open-label study
5432055|NCT00026052|Glutamate Dysfunction|glutamate dysfunction
5432056|NCT00026052|Unipolar Depression|unipolar depression
5432057|NCT00026052|Antidepressant|antidepressant
5432058|NCT00026052|Depression|depression
5432059|NCT00026052|Major Depression|major depression
5432060|NCT00026039|stroke|stroke
5432061|NCT00026039|estrogen|estrogen
5432062|NCT00026026|Human tooth agenesis|human tooth agenesis
5432063|NCT00026013|contraception|contraception
5432064|NCT00026013|hormonal contraception|hormonal contraception
5432065|NCT00026013|herbal remedies|herbal remedies
5432066|NCT00026013|hypericum perforatum|hypericum perforatum
5432067|NCT00026013|contraceptive effectiveness|contraceptive effectiveness
5432068|NCT00026000|Voluntary Movement|voluntary movement
5432069|NCT00026000|Basal Ganglia|basal ganglia
5432070|NCT00026000|Frontal Lobe|frontal lobe
5432071|NCT00026000|Motor Cortex|motor cortex
5432072|NCT00026000|Motor Tic Disorder|motor tic disorder
5432073|NCT00026000|Tourette's Syndrome|tourette's syndrome
5432074|NCT00026000|Vocal Tic Disorder|vocal tic disorder
5432075|NCT00026000|Tic|tic
5432076|NCT00026000|Healthy Volunteer|healthy volunteer
5432077|NCT00026000|HV|hv
5432078|NCT00026000|Normal Control|normal control
5432079|NCT00025987|Brain|brain
5432080|NCT00025987|Temperature|temperature
5432081|NCT00025987|Lower|lower
5432082|NCT00025987|Tympanic|tympanic
5432083|NCT00025987|Rectal|rectal
5432084|NCT00025987|Cooling of the Head and Neck|cooling of the head and neck
5432085|NCT00025987|Control|control
5432086|NCT00025987|Epilepsy|epilepsy
5432087|NCT00025987|Healthy Volunteer|healthy volunteer
5432088|NCT00025987|HV|hv
5432089|NCT00025974|PET|pet
5432090|NCT00025974|5-HT1A Receptors|5-ht1a receptors
5432091|NCT00025974|Benzodiazepine Receptors|benzodiazepine receptors
5432092|NCT00025974|Panic Disorder|panic disorder
5432093|NCT00025974|PTSD|ptsd
5432094|NCT00025974|Serotonin Type 1A Receptors|serotonin type 1a receptors
5432095|NCT00025974|Post-Traumatic Stress Disorder|post-traumatic stress disorder
5432096|NCT00025974|Major Depression|major depression
5432097|NCT00025974|Anxiety|anxiety
5432098|NCT00025974|Depression|depression
5432099|NCT00025974|Healthy Volunteer|healthy volunteer
5432100|NCT00025974|HV|hv
5432101|NCT00025974|Normal Control|normal control
5432102|NCT00025935|Mood Disorders|mood disorders
5432103|NCT00025935|Bipolar Disorder|bipolar disorder
5432104|NCT00025935|Neuroimaging|neuroimaging
5432105|NCT00025935|Psychophysiology|psychophysiology
5432106|NCT00025935|Frustration|frustration
5432107|NCT00025935|Emotional Dysregulation|emotional dysregulation
5432108|NCT00025935|Lithium|lithium
5432109|NCT00025935|Conduct Disorder|conduct disorder
5432110|NCT00025935|Children and Adolescents|children and adolescents
5432111|NCT00025935|Affective Neuroscience|affective neuroscience
5432112|NCT00025935|Behavioral Dysregulation|behavioral dysregulation
5432113|NCT00025935|Mood Disorder|mood disorder
5432114|NCT00025935|Behavior|behavior
5432115|NCT00025935|Children|children
5432116|NCT00025935|Adolescent|adolescent
5432117|NCT00025935|Healthy Volunteer|healthy volunteer
5432118|NCT00025935|HV|hv
5432119|NCT00025935|Normal Control|normal control
5432120|NCT00025922|Immunization|immunization
5432121|NCT00025922|Titers|titers
5432122|NCT00025922|Immune Activation|immune activation
5432123|NCT00025922|Antibody|antibody
5432124|NCT00025922|CD4 Cell Count|cd4 cell count
5432125|NCT00025922|HIV|hiv
5432126|NCT00025909|Therapy|therapy
5432127|NCT00025909|Antiretrovirals|antiretrovirals
5432128|NCT00025909|Interruption|interruption
5432129|NCT00025909|CD4+ T Cell|cd4+ t cell
5432130|NCT00025909|Plasma Viremia|plasma viremia
5432131|NCT00025909|HIV|hiv
5432132|NCT00025909|Treatment Experienced|treatment experienced
5432133|NCT00025909|Treatment Interuption|treatment interuption
5432134|NCT00025883|Lipoatrophic Diabetes|lipoatrophic diabetes
5432135|NCT00025883|Diabetes Mellitus|diabetes mellitus
5432136|NCT00025883|Hypertriglyceridemia|hypertriglyceridemia
5432137|NCT00025883|NASH|nash
5432138|NCT00025883|Lipodystrophy|lipodystrophy
5432139|NCT00025883|Leptin|leptin
5432140|NCT00025883|Diabetes|diabetes
5432141|NCT00025870|Genetics|genetics
5432142|NCT00025870|Metabolic|metabolic
5432143|NCT00025870|Dysmorphology|dysmorphology
5432144|NCT00025870|Training|training
5432145|NCT00025870|DNA|dna
5432146|NCT00025870|DNA Testing|dna testing
5432147|NCT00025870|Dysmorphic Syndromes|dysmorphic syndromes
5432148|NCT00025870|Developmental Delay|developmental delay
5432149|NCT00025870|Genetic Counseling|genetic counseling
5432150|NCT00025870|Molecular Genetics|molecular genetics
5432151|NCT00025857|fMRI|fmri
5432152|NCT00025857|Depression|depression
5432153|NCT00025857|PTSD|ptsd
5432155|NCT00025857|Magnetic Resonance Imaging|magnetic resonance imaging
5432156|NCT00025857|Anxiety|anxiety
5432157|NCT00025857|Normal Volunteers|normal volunteers
5432158|NCT00025857|Adolescence|adolescence
5432159|NCT00025857|Memory|memory
5432160|NCT00025857|Physical/Sexual Abuse History|physical/sexual abuse history
5432161|NCT00025857|Post-Traumatic Stress Disorder|post-traumatic stress disorder
5432162|NCT00025857|Adolescent|adolescent
5432163|NCT00025857|Healthy Volunteer|healthy volunteer
5432164|NCT00025857|HV|hv
5432165|NCT00025857|Normal Control|normal control
5432166|NCT00025844|Stress|stress
5432167|NCT00025844|Anxiety|anxiety
5432168|NCT00025844|Adults|adults
5432169|NCT00025844|Fear Conditioning|fear conditioning
5432170|NCT00025844|Normal Volunteers|normal volunteers
5432171|NCT00025844|Associative Learning|associative learning
5432172|NCT00025844|Virtual Reality|virtual reality
5432173|NCT00025844|Context Conditioning|context conditioning
5432174|NCT00025844|Healthy Volunteer|healthy volunteer
5432175|NCT00025844|HV|hv
5432176|NCT00025844|Normal Control|normal control
5432177|NCT00025831|Buccal|buccal
5432178|NCT00025831|DNA|dna
5432179|NCT00025831|Pooling|pooling
5432180|NCT00025831|Genotyping|genotyping
5432181|NCT00025831|Mouthwash|mouthwash
5432182|NCT00025831|Healthy Volunteer|healthy volunteer
5432183|NCT00025831|HV|hv
5432184|NCT00025831|Normal Control|normal control
5432185|NCT00025818|dry eyes|dry eyes
5432186|NCT00025818|rheumatoid arthritis|rheumatoid arthritis
5432187|NCT00025818|Lupus|lupus
5432188|NCT00025818|Sjogren's syndrome|sjogren's syndrome
5432189|NCT00025818|myositis|myositis
5432190|NCT00025818|scleroderma|scleroderma
5432191|NCT00025818|autoimmune disorder|autoimmune disorder
5432192|NCT00025805|Cytokines|cytokines
5432193|NCT00025805|Th1 Th2 Response|th1 th2 response
5432194|NCT00025805|Inflammatory Bowel Dx|inflammatory bowel dx
5432195|NCT00025805|Lymphocyte|lymphocyte
5432196|NCT00025805|Colonoscopy|colonoscopy
5432197|NCT00025805|Crohn's Disease|crohn's disease
5432198|NCT00025805|Crohn's|crohn's
5432199|NCT00025792|Pramipexole|pramipexole
5432200|NCT00025792|Neuroprotective|neuroprotective
5432201|NCT00025792|Placebo Controlled|placebo controlled
5432202|NCT00025792|Depression|depression
5432203|NCT00025792|Brain Imaging|brain imaging
5432204|NCT00025792|Antidepressant|antidepressant
5432205|NCT00025792|Bipolar Disorder|bipolar disorder
5432206|NCT00025792|Bipolar|bipolar
5432207|NCT00025792|BPD|bpd
5432208|NCT00025792|Bipolar Depression|bipolar depression
5432209|NCT00025779|Hyperactivity|hyperactivity
5432210|NCT00025779|Distractibility|distractibility
5432211|NCT00025779|Impulsiveness|impulsiveness
5432212|NCT00025779|Pervasive Development Disorders|pervasive development disorders
5432213|NCT00025740|SSRI (paroxetine)|ssri (paroxetine)
5432214|NCT00025740|Benzodiazepine (clonazepam)|benzodiazepine (clonazepam)
5432215|NCT00025740|Post-Traumatic Stress Disorder (PTSD)|post-traumatic stress disorder (ptsd)
5432216|NCT00025740|Combined Treatment|combined treatment
5432217|NCT00025740|Rapid Treatment|rapid treatment
5432218|NCT00025740|Post-Traumatic Stress Disorder|post-traumatic stress disorder
5432219|NCT00025740|PTSD|ptsd
5432220|NCT00025727|HIV-1|hiv-1
5432221|NCT00025727|HIV Protease Inhibitors|hiv protease inhibitors
5432222|NCT00025727|Ritonavir|ritonavir
5432223|NCT00025727|RNA, Viral|rna, viral
5432224|NCT00025727|Anti-HIV Agents|anti-hiv agents
5432225|NCT00025727|Viral Load|viral load
5432226|NCT00025727|ABT 378|abt 378
5432227|NCT00025727|VX-175|vx-175
5432228|NCT00025714|Serotonin Receptor|serotonin receptor
5432229|NCT00025714|Cell Culture|cell culture
5432230|NCT00025714|Temporal Lobe|temporal lobe
5432231|NCT00025714|Endothelial Cells|endothelial cells
5432232|NCT00025714|Superficial Temporal Artery|superficial temporal artery
5432233|NCT00025714|Magnetic Resonance Imaging (MRI)|magnetic resonance imaging (mri)
5432234|NCT00025714|Epilepsy|epilepsy
5432235|NCT00025714|Intractable Epilepsy|intractable epilepsy
5432236|NCT00025701|Cortex|cortex
5432237|NCT00025701|Inhibition|inhibition
5432238|NCT00025701|Motor Control|motor control
5432239|NCT00025701|Event-Related Synchronization|event-related synchronization
5432240|NCT00025701|Event-Related Desynchronization|event-related desynchronization
5432241|NCT00025701|Focal Hand Dystonia|focal hand dystonia
5432242|NCT00025701|Focal Dystonia|focal dystonia
5432243|NCT00025701|Dystonia|dystonia
5432244|NCT00025701|Hand|hand
5432245|NCT00025701|Healthy Volunteer|healthy volunteer
5432246|NCT00025701|HV|hv
5432247|NCT00024999|Movement|movement
5432248|NCT00024999|Coordination|coordination
5432249|NCT00024999|Correlation|correlation
5432250|NCT00024999|Coherence|coherence
5432251|NCT00024999|Parietofrontal Circuitry|parietofrontal circuitry
5432252|NCT00024999|Apraxia|apraxia
5432253|NCT00024999|Ideomotor Apraxia|ideomotor apraxia
5432254|NCT00024999|Healthy Volunteer|healthy volunteer
5432255|NCT00024999|HV|hv
5432256|NCT00024999|Normal Control|normal control
5432257|NCT00024986|HAART|haart
5432258|NCT00024986|Genotypic Resistance|genotypic resistance
5432259|NCT00024986|Phenotypic Resistance|phenotypic resistance
5432260|NCT00024986|Immune Reconstitution|immune reconstitution
5432261|NCT00024986|Bone Density|bone density
5432262|NCT00024986|HIV|hiv
5432263|NCT00024986|Children|children
5432264|NCT00024986|Pediatric HIV Infection|pediatric hiv infection
5432265|NCT00024960|Speech|speech
5432266|NCT00024960|Motor Control|motor control
5432267|NCT00024960|Phenotype|phenotype
5432268|NCT00024960|Dysfluency|dysfluency
5432269|NCT00024960|Fluency|fluency
5432270|NCT00024960|Stuttering|stuttering
5432271|NCT00024960|Healthy Volunteer|healthy volunteer
5432272|NCT00024960|HV|hv
5432273|NCT00024960|Normal Control|normal control
5432274|NCT00024934|Immunodeficiency|immunodeficiency
5432275|NCT00024934|Primary|primary
5432276|NCT00024934|Cancer|cancer
5432277|NCT00024934|Genetics|genetics
5432278|NCT00024934|IGA Deficiency|iga deficiency
5432279|NCT00024934|Immune Deficiency|immune deficiency
5432280|NCT00024908|Cognition|cognition
5432281|NCT00024908|Frontal Lobes|frontal lobes
5432282|NCT00024908|Frontotemporal Dementia|frontotemporal dementia
5432283|NCT00024908|Focal Lesions|focal lesions
5432284|NCT00024908|Executive Functions|executive functions
5432285|NCT00024908|Frontotemporal Lobe Dementia|frontotemporal lobe dementia
5432286|NCT00024908|Frontal Lobe|frontal lobe
5432287|NCT00024908|Frontal Lobe Dementia|frontal lobe dementia
5432288|NCT00024908|Healthy Volunteer|healthy volunteer
5432289|NCT00024908|HV|hv
5432290|NCT00024908|Normal Control|normal control
5432291|NCT00024804|SKELETAL DISEASE|skeletal disease
5432292|NCT00024804|Osteoporosis|osteoporosis
5432293|NCT00024804|Dysplasia|dysplasia
5432294|NCT00024804|Osteomalacia|osteomalacia
5432295|NCT00024804|Bone Diseases|bone diseases
5432296|NCT00024791|Cerebral Palsy|cerebral palsy
5432297|NCT00024791|Pediatric|pediatric
5432298|NCT00024791|Cognition|cognition
5432299|NCT00024791|Motor Learning|motor learning
5432300|NCT00024791|Visuomotor Integration|visuomotor integration
5432301|NCT00024791|Corticospinal Tracts|corticospinal tracts
5432302|NCT00024791|Cortical Re-Organization|cortical re-organization
5432303|NCT00024791|Spastic Hemiplegia|spastic hemiplegia
5432304|NCT00024791|Spastic Diplegia|spastic diplegia
5432305|NCT00024791|Functional Outcome|functional outcome
5432306|NCT00024791|Children|children
5432307|NCT00024791|Healthy Volunteer|healthy volunteer
5432308|NCT00024791|HV|hv
5432309|NCT00024791|Normal Control|normal control
5432310|NCT00024687|SS1(dsFv)-PE38 Anti-Mesothelin Immunotoxin|ss1(dsfv)-pe38 anti-mesothelin immunotoxin
5432311|NCT00024687|advanced malignancy|advanced malignancy
5432312|NCT00024674|SS1(dsFv)-PE38|ss1(dsfv)-pe38
5432313|NCT00024674|SS1P|ss1p
5432314|NCT00024674|anti-mesothelin immunotoxin|anti-mesothelin immunotoxin
5432315|NCT00024674|advanced malignancy|advanced malignancy
5432316|NCT00024661|recurrent solid tumors|recurrent solid tumors
5432317|NCT00024661|liposomes containing AON to c-raf protein (LErafAON)|liposomes containing aon to c-raf protein (lerafaon)
5432318|NCT00024648|advanced malignancy|advanced malignancy
5432319|NCT00024648|liposomes containing AON to c-raf messenger RNA|liposomes containing aon to c-raf messenger rna
5432320|NCT00024648|antisense oligodeoxynucleotide (AON)|antisense oligodeoxynucleotide (aon)
5432321|NCT00024648|LErafAON|lerafaon
5432322|NCT00024622|Familial|familial
5432323|NCT00024622|Genetic|genetic
5432324|NCT00024622|Symptomatic|symptomatic
5432325|NCT00024622|Equivocally Affected|equivocally affected
5432326|NCT00024622|18F-Fluoro-L-dopa|18f-fluoro-l-dopa
5432327|NCT00024622|O-15 Labelled Water|o-15 labelled water
5432328|NCT00024622|Carbidopa|carbidopa
5432329|NCT00024622|Adult|adult
5432330|NCT00024622|Schizophrenia|schizophrenia
5432331|NCT00024622|Parkinson's Disease|parkinson's disease
5432332|NCT00024622|PD|pd
5432333|NCT00024622|Parkinson|parkinson
5432334|NCT00024622|Healthy Control|healthy control
5432335|NCT00024622|HV|hv
5432336|NCT00024622|Normal Control|normal control
5432337|NCT00024570|neurosurgery, craniotomy|neurosurgery, craniotomy
5432338|NCT00024570|convection-enhanced delivery|convection-enhanced delivery
5432339|NCT00024570|CNS interstitial infusion|cns interstitial infusion
5432340|NCT00024570|recombinant toxins|recombinant toxins
5432341|NCT00024570|malignant glioma, recurrent|malignant glioma, recurrent
5432342|NCT00024570|catheter, stereotaxic|catheter, stereotaxic
5432343|NCT00024570|intratumoral therapy|intratumoral therapy
5432344|NCT00024570|positive pressure microinfusion|positive pressure microinfusion
5432345|NCT00024557|neurosurgery, craniotomy|neurosurgery, craniotomy
5432346|NCT00024557|convection-enhanced delivery|convection-enhanced delivery
5432347|NCT00024557|CNS interstitial infusion|cns interstitial infusion
5432348|NCT00024557|recombinant toxins|recombinant toxins
5432349|NCT00024557|malignant glioma, recurrent|malignant glioma, recurrent
5432350|NCT00024557|intratumoral therapy|intratumoral therapy
5432351|NCT00024557|positive pressure microinfusion|positive pressure microinfusion
5432352|NCT00024544|asthma|asthma
5432353|NCT00024544|anti-IL-4 monoclonal antibody|anti-il-4 monoclonal antibody
5432354|NCT00024544|pascolizumab|pascolizumab
5432355|NCT00024531|Alzheimer disease|alzheimer disease
5432356|NCT00024531|Cholesterol-lowering drugs|cholesterol-lowering drugs
5432357|NCT00024518|Diabetes|diabetes
5432358|NCT00024518|Immunotherapy|immunotherapy
5432359|NCT00024518|Study Drug|study drug
5443960|NCT00001750|Stem Cell|stem cell
5432360|NCT00024518|Insulin Dependent Diabetes|insulin dependent diabetes
5432361|NCT00024518|Diabetes Mellitus|diabetes mellitus
5432362|NCT00024518|TIBM|tibm
5432363|NCT00024492|Liposome Encapsulated Mitoxantrone (LEM)|liposome encapsulated mitoxantrone (lem)
5432364|NCT00024492|solid tumors|solid tumors
5432365|NCT00024479|Minorities|minorities
5432366|NCT00024479|Rheumatic Disease|rheumatic disease
5432367|NCT00024479|Community Based|community based
5432368|NCT00024479|Ethnicity|ethnicity
5432369|NCT00024479|Health Disparities|health disparities
5432370|NCT00023582|Syphilis|syphilis
5432371|NCT00023582|Herpes Genitalis|herpes genitalis
5432372|NCT00023582|Risk Factors|risk factors
5432373|NCT00023582|Incidence|incidence
5432374|NCT00023582|Prevalence|prevalence
5432375|NCT00023582|Homosexuality, Male|homosexuality, male
5432376|NCT00023582|Informed Consent|informed consent
5432377|NCT00023582|Peru|peru
5432378|NCT00023582|HIV Seronegativity|hiv seronegativity
5432379|NCT00023569|TMS|tms
5432380|NCT00023569|Conjoint Movement|conjoint movement
5432381|NCT00023569|Chronic Hemiplegia|chronic hemiplegia
5432382|NCT00023569|Brain Plasticity|brain plasticity
5432383|NCT00023569|Electrical Stimulation|electrical stimulation
5432384|NCT00023569|Stroke|stroke
5432385|NCT00023569|CVA|cva
5432386|NCT00023504|Immunization|immunization
5432387|NCT00023504|Antibody|antibody
5432388|NCT00023504|Immunodeficiency|immunodeficiency
5432389|NCT00023504|Pneumococcal Vaccines|pneumococcal vaccines
5432390|NCT00023504|Phi-X 174|phi-x 174
5432391|NCT00023504|Primary Immune Disorders|primary immune disorders
5432392|NCT00023452|Latent TB infection|latent tb infection
5432393|NCT00023439|tuberculosis|tuberculosis
5432394|NCT00023439|TB|tb
5432395|NCT00023426|tuberculosis|tuberculosis
5432396|NCT00023426|tb|tb
5432397|NCT00023426|rifapentine|rifapentine
5432398|NCT00023426|safety|safety
5432399|NCT00023426|dose|dose
5432400|NCT00023413|tuberculosis|tuberculosis
5432401|NCT00023413|TB|tb
5432402|NCT00023400|tuberculosis|tuberculosis
5432403|NCT00023400|TB|tb
5432404|NCT00023374|tuberculosis|tuberculosis
5432405|NCT00023374|TB|tb
5432406|NCT00023374|isoniazid resistance|isoniazid resistance
5432407|NCT00023374|isoniazid intolerance|isoniazid intolerance
5432408|NCT00023374|treatment|treatment
5432409|NCT00023374|efficacy|efficacy
5432410|NCT00023374|toxicity|toxicity
5432411|NCT00023361|tuberculosis|tuberculosis
5432412|NCT00023361|TB|tb
5432413|NCT00023348|Tuberculosis|tuberculosis
5432414|NCT00023348|TB|tb
5432415|NCT00023491|Sjogren's Syndrome|sjogren's syndrome
5432416|NCT00023491|Peripheral Blood Stem Cell|peripheral blood stem cell
5432417|NCT00023491|Tissue Regeneration|tissue regeneration
5432418|NCT00023491|Graft-versus-host Disease|graft-versus-host disease
5432419|NCT00023491|Head and Neck Cancer|head and neck cancer
5432420|NCT00023491|Salivary Gland|salivary gland
5432421|NCT00023491|Saliva Gland|saliva gland
5432422|NCT00023491|Salivary Gland Dysfunction|salivary gland dysfunction
5432423|NCT00023322|Cirrhosis|cirrhosis
5432424|NCT00023322|Chronic Hepatitis|chronic hepatitis
5432425|NCT00023322|Alpha Interferon|alpha interferon
5432426|NCT00023322|Hepatitis D Virus|hepatitis d virus
5432427|NCT00023322|Delta Hepatitis|delta hepatitis
5432428|NCT00023322|Viral Hepatitis|viral hepatitis
5432429|NCT00023322|Antiviral Agents|antiviral agents
5432430|NCT00023322|Hepatitis D|hepatitis d
5432431|NCT00023322|HDV|hdv
5432432|NCT00023322|Liver|liver
5432433|NCT00023322|Hepatitis|hepatitis
5432434|NCT00023309|Adefovir Dipivoxil|adefovir dipivoxil
5432435|NCT00023309|Lamivudine|lamivudine
5432436|NCT00023309|Nucleoside/Nucleotide Analogue|nucleoside/nucleotide analogue
5432437|NCT00023309|Chronic Hepatitis B|chronic hepatitis b
5432438|NCT00023309|Hepatitis B Mutants|hepatitis b mutants
5432439|NCT00023309|Liver Biopsy|liver biopsy
5432440|NCT00023309|Hepatitis B|hepatitis b
5432441|NCT00023309|Hepatitis|hepatitis
5432442|NCT00023309|HBV|hbv
5432443|NCT00023309|Liver|liver
5432444|NCT00023296|Acute Chest Syndrome|acute chest syndrome
5432445|NCT00023296|Blood Flow|blood flow
5432446|NCT00023296|Nitric Oxide|nitric oxide
5432447|NCT00023296|NO Therapy|no therapy
5432448|NCT00023296|Vaso-Occlusive Crisis|vaso-occlusive crisis
5432449|NCT00023296|Sickle Cell Anemia|sickle cell anemia
5432450|NCT00023296|Sickle Cell|sickle cell
5432451|NCT00023296|ACS|acs
5432452|NCT00023296|Pulmonary Hypertension|pulmonary hypertension
5432453|NCT00023218|Liver|liver
5432454|NCT00023218|HIV-1|hiv-1
5432455|NCT00023218|HIV Protease Inhibitors|hiv protease inhibitors
5432456|NCT00023218|Ritonavir|ritonavir
5432457|NCT00023218|Biopsy|biopsy
5432458|NCT00023218|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5432459|NCT00023218|Anti-HIV Agents|anti-hiv agents
5432460|NCT00023218|ABT 378|abt 378
5432461|NCT00023218|Acidosis, Lactic|acidosis, lactic
5432462|NCT00023218|efavirenz|efavirenz
5432463|NCT00023218|Alanine Transaminase|alanine transaminase
5432464|NCT00023205|Arthritis|arthritis
5432465|NCT00023205|Health literacy|health literacy
5432466|NCT00023205|Patient education|patient education
5432467|NCT00023205|Self-efficacy|self-efficacy
5432468|NCT00022763|Anti-HIV Agents|anti-hiv agents
5432469|NCT00022763|pentafuside|pentafuside
5432470|NCT00021775|Risk Factors|risk factors
5432471|NCT00021775|Incidence|incidence
5432472|NCT00021775|Patient Selection|patient selection
5432473|NCT00021775|HIV Seronegativity|hiv seronegativity
5432474|NCT00021762|Virus Replication|virus replication
5432475|NCT00021762|HIV-1|hiv-1
5432476|NCT00021762|Drug Administration Schedule|drug administration schedule
5432477|NCT00021762|AIDS Vaccines|aids vaccines
5432478|NCT00021762|RNA, Viral|rna, viral
5432479|NCT00021762|Viral Load|viral load
5432480|NCT00021762|HIV-1 immunogen, incomplete Freund's adjuvant|hiv-1 immunogen, incomplete freund's adjuvant
5432481|NCT00021762|Treatment Interruption|treatment interruption
5432482|NCT00021762|HIV Therapeutic Vaccine|hiv therapeutic vaccine
5432483|NCT00021671|Drug Therapy, Combination|drug therapy, combination
5432484|NCT00021671|Ampicillin|ampicillin
5432485|NCT00021671|Nevirapine|nevirapine
5432486|NCT00021671|Disease Transmission, Vertical|disease transmission, vertical
5432487|NCT00021671|Anti-Infective Agents|anti-infective agents
5432488|NCT00021671|Erythromycin|erythromycin
5432489|NCT00021671|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5432490|NCT00021671|Metronidazole|metronidazole
5432491|NCT00021671|Anti-HIV Agents|anti-hiv agents
5432492|NCT00021671|Chorioamnionitis|chorioamnionitis
5432493|NCT00021671|HIV Seronegativity|hiv seronegativity
5432494|NCT00021632|Ribavirin|ribavirin
5432495|NCT00021632|Drug Interactions|drug interactions
5432496|NCT00021632|Drug Therapy, Combination|drug therapy, combination
5432497|NCT00021632|Zidovudine|zidovudine
5432498|NCT00021632|Stavudine|stavudine
5432499|NCT00021632|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5432500|NCT00021632|Anti-HIV Agents|anti-hiv agents
5432501|NCT00021632|Pharmacokinetics|pharmacokinetics
5432502|NCT00021632|Area Under Curve|area under curve
5432503|NCT00021554|HIV-1|hiv-1
5432504|NCT00021554|Drug Therapy, Combination|drug therapy, combination
5432505|NCT00021554|HIV Protease Inhibitors|hiv protease inhibitors
5432506|NCT00021554|RNA, Viral|rna, viral
5432507|NCT00021554|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5432508|NCT00021554|Anti-HIV Agents|anti-hiv agents
5432509|NCT00021554|Viral Load|viral load
5432510|NCT00021554|pentafuside|pentafuside
5432511|NCT00021489|Placebos|placebos
5432512|NCT00021489|Drug Therapy, Combination|drug therapy, combination
5432513|NCT00021489|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5432514|NCT00021489|Anti-HIV Agents|anti-hiv agents
5432515|NCT00021489|abacavir|abacavir
5432516|NCT00021489|mycophenolate mofetil|mycophenolate mofetil
5432517|NCT00021463|Nevirapine|nevirapine
5432518|NCT00021463|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5432519|NCT00021463|Anti-HIV Agents|anti-hiv agents
5432520|NCT00021463|Triglycerides|triglycerides
5432521|NCT00021463|abacavir|abacavir
5432522|NCT00021463|efavirenz|efavirenz
5432523|NCT00021463|Lipoproteins, LDL Cholesterol|lipoproteins, ldl cholesterol
5432524|NCT00017992|HIV-1|hiv-1
5432525|NCT00017992|Drug Administration Schedule|drug administration schedule
5432526|NCT00017992|Stavudine|stavudine
5432527|NCT00017992|HIV Protease Inhibitors|hiv protease inhibitors
5432528|NCT00017992|Ritonavir|ritonavir
5432529|NCT00017992|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5432530|NCT00017992|Anti-HIV Agents|anti-hiv agents
5432531|NCT00017992|Pharmacokinetics|pharmacokinetics
5432532|NCT00017992|ABT 378|abt 378
5432533|NCT00017992|emtricitabine|emtricitabine
5432534|NCT00017797|Pregnancy Complications, Infectious|pregnancy complications, infectious
5432535|NCT00017797|HIV-1|hiv-1
5432536|NCT00017797|HIV Protease Inhibitors|hiv protease inhibitors
5432537|NCT00017797|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5432538|NCT00017797|Anti-HIV Agents|anti-hiv agents
5432539|NCT00017797|Glucose Intolerance|glucose intolerance
5432540|NCT00017784|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
5432541|NCT00017784|Infusions, Intravenous|infusions, intravenous
5432542|NCT00017784|Antiviral Agents|antiviral agents
5432543|NCT00017784|Cytomegalovirus Retinitis|cytomegalovirus retinitis
5432544|NCT00017784|valganciclovir|valganciclovir
5432545|NCT00017771|HIV-1|hiv-1
5432546|NCT00017771|CD4 Lymphocyte Count|cd4 lymphocyte count
5432547|NCT00017771|Risk Factors|risk factors
5432548|NCT00017771|Hydroxyurea|hydroxyurea
5432549|NCT00017771|Disease Progression|disease progression
5432550|NCT00017771|Alcohol Drinking|alcohol drinking
5432551|NCT00017771|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5432552|NCT00017771|Anti-HIV Agents|anti-hiv agents
5432553|NCT00017771|Viral Load|viral load
5432554|NCT00017771|Polyneuropathies|polyneuropathies
5432555|NCT00017771|Treatment Experienced|treatment experienced
5432556|NCT00017758|Drug Interactions|drug interactions
5432557|NCT00017758|Nelfinavir|nelfinavir
5432558|NCT00017758|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5432559|NCT00017758|Anti-HIV Agents|anti-hiv agents
5432560|NCT00017758|Pharmacokinetics|pharmacokinetics
5432561|NCT00017758|Pravastatin|pravastatin
5432562|NCT00017758|efavirenz|efavirenz
5432563|NCT00017758|Simvastatin|simvastatin
5432564|NCT00017758|atorvastatin|atorvastatin
5432565|NCT00017758|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors
5432566|NCT00017719|Pregnancy Complications, Infectious|pregnancy complications, infectious
5432567|NCT00017719|HIV Protease Inhibitors|hiv protease inhibitors
5432568|NCT00017719|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5432569|NCT00017719|Anti-HIV Agents|anti-hiv agents
5432570|NCT00017719|Viral Load|viral load
5432571|NCT00017719|Combivir|combivir
5432572|NCT00017719|Treatment Naive|treatment naive
5432573|NCT00017693|Recombinant Proteins|recombinant proteins
5432574|NCT00017693|Aerosols|aerosols
5432575|NCT00017693|Asthma|asthma
5432576|NCT00017693|Receptors, Interleukin-4|receptors, interleukin-4
5432577|NCT00017693|Forced Expiratory Volume|forced expiratory volume
5432578|NCT00016783|Drug Therapy, Combination|drug therapy, combination
5432579|NCT00016783|Drug Administration Schedule|drug administration schedule
5432580|NCT00016783|HIV Protease Inhibitors|hiv protease inhibitors
5432581|NCT00016783|CD4 Lymphocyte Count|cd4 lymphocyte count
5432582|NCT00016783|CD8-Positive T-Lymphocytes|cd8-positive t-lymphocytes
5432583|NCT00016783|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5432584|NCT00016783|Anti-HIV Agents|anti-hiv agents
5432585|NCT00016783|Viral Load|viral load
5432586|NCT00016783|Antiretroviral Therapy, Highly Active|antiretroviral therapy, highly active
5432587|NCT00016783|Treatment Experienced|treatment experienced
5432588|NCT00016783|Treatment Interruption|treatment interruption
5432589|NCT00016718|Didanosine|didanosine
5432590|NCT00016718|Drug Therapy, Combination|drug therapy, combination
5432591|NCT00016718|Drug Administration Schedule|drug administration schedule
5432592|NCT00016718|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5432593|NCT00016718|Anti-HIV Agents|anti-hiv agents
5432594|NCT00016718|Pharmacokinetics|pharmacokinetics
5432595|NCT00016718|Deoxycytidine|deoxycytidine
5432596|NCT00016718|Efavirenz|efavirenz
5432597|NCT00016718|Treatment Naive|treatment naive
5432598|NCT00016692|Drug tolerance|drug tolerance
5432599|NCT00016692|Acute Infection|acute infection
5432600|NCT00016601|Delayed-Action Preparations|delayed-action preparations
5432601|NCT00016601|Drug Interactions|drug interactions
5432602|NCT00016601|Drug Therapy, Combination|drug therapy, combination
5432603|NCT00016601|Nevirapine|nevirapine
5432604|NCT00016601|HIV Protease Inhibitors|hiv protease inhibitors
5432605|NCT00016601|Ritonavir|ritonavir
5432606|NCT00016601|Indinavir|indinavir
5432607|NCT00016601|Nelfinavir|nelfinavir
5432608|NCT00016601|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5432609|NCT00016601|Anti-HIV Agents|anti-hiv agents
5432610|NCT00016601|Pharmacokinetics|pharmacokinetics
5432611|NCT00016601|Medroxyprogesterone 17-Acetate|medroxyprogesterone 17-acetate
5432612|NCT00016601|efavirenz|efavirenz
5432613|NCT00016588|HIV-1|hiv-1
5432614|NCT00016588|Adenine|adenine
5432615|NCT00016588|Anti-HIV Agents|anti-hiv agents
5432616|NCT00016588|Viral Load|viral load
5432617|NCT00016588|Organophosphorus Compounds|organophosphorus compounds
5432618|NCT00016536|Antiviral Agents|antiviral agents
5432619|NCT00016536|Mucous Membrane|mucous membrane
5432620|NCT00016536|Spermatocidal Agents|spermatocidal agents
5432621|NCT00016536|Penis|penis
5432622|NCT00016536|Epithelium|epithelium
5432623|NCT00016536|PRO 2000|pro 2000
5432624|NCT00016536|Urethra|urethra
5432625|NCT00016536|HIV Seronegativity|hiv seronegativity
5432626|NCT00015704|Treatment Experienced|treatment experienced
5432627|NCT00015704|Treatment Interruption|treatment interruption
5432628|NCT00015704|Drug Administration Schedule|drug administration schedule
5432629|NCT00015704|CD4 Lymphocyte Count|cd4 lymphocyte count
5432630|NCT00015704|Anti-HIV Agents|anti-hiv agents
5432631|NCT00015704|Tetanus Toxoid|tetanus toxoid
5432632|NCT00015704|Aldesleukin|aldesleukin
5432633|NCT00015704|Diphtheria Toxoid|diphtheria toxoid
5432634|NCT00015691|Drug Therapy, Combination|drug therapy, combination
5432635|NCT00015691|Adipose Tissue|adipose tissue
5432636|NCT00015691|Area Under Curve|area under curve
5432637|NCT00015691|Hypoglycemic Agents|hypoglycemic agents
5432638|NCT00015691|Anthropometry|anthropometry
5432639|NCT00015691|Hyperinsulinemia|hyperinsulinemia
5432640|NCT00015691|Metformin|metformin
5432641|NCT00015691|BRL 49653|brl 49653
5432642|NCT00015691|Insulin|insulin
5432643|NCT00015691|Glucose Tolerance Test|glucose tolerance test
5432644|NCT00015652|Ribavirin|ribavirin
5432645|NCT00015652|Polyethylene Glycols|polyethylene glycols
5432646|NCT00015652|Interferon Alfa-2b|interferon alfa-2b
5432647|NCT00015652|Dose-Response Relationship, Drug|dose-response relationship, drug
5432648|NCT00015652|Drug Therapy, Combination|drug therapy, combination
5432649|NCT00015652|Antiviral Agents|antiviral agents
5432650|NCT00015652|Hepatitis C|hepatitis c
5432651|NCT00015652|Aldesleukin|aldesleukin
5432652|NCT00015652|Peginterferon|peginterferon
5432653|NCT00014937|HIV-1|hiv-1
5432654|NCT00014937|Didanosine|didanosine
5432655|NCT00014937|Drug Therapy, Combination|drug therapy, combination
5432656|NCT00014937|Zidovudine|zidovudine
5432657|NCT00014937|Nevirapine|nevirapine
5432658|NCT00014937|Stavudine|stavudine
5432659|NCT00014937|HIV Protease Inhibitors|hiv protease inhibitors
5432660|NCT00014937|Ritonavir|ritonavir
5432661|NCT00014937|Lamivudine|lamivudine
5432663|NCT00014937|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5432664|NCT00014937|Anti-HIV Agents|anti-hiv agents
5432665|NCT00014937|Viral Load|viral load
5432666|NCT00014937|ABT 378|abt 378
5432667|NCT00014937|Combivir|combivir
5432668|NCT00014937|Efavirenz|efavirenz
5432669|NCT00014937|Treatment Experienced|treatment experienced
5432670|NCT00014053|Reference Values|reference values
5432671|NCT00014053|HIV Seropositivity|hiv seropositivity
5432672|NCT00014053|Immune System|immune system
5432673|NCT00014053|CD4-Positive T-Lymphocytes|cd4-positive t-lymphocytes
5432674|NCT00014053|HIV Seronegativity|hiv seronegativity
5432675|NCT00014053|Antigens, CD|antigens, cd
5432676|NCT00014014|Zidovudine|zidovudine
5432677|NCT00014014|Phosphorylation|phosphorylation
5432678|NCT00014014|Drug Administration Schedule|drug administration schedule
5432679|NCT00014014|Lamivudine|lamivudine
5432680|NCT00014014|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5432681|NCT00014014|Anti-HIV Agents|anti-hiv agents
5432682|NCT00014014|Pharmacokinetics|pharmacokinetics
5432683|NCT00014014|Combivir|combivir
5432684|NCT00013897|Placebos|placebos
5432685|NCT00013897|Drug Therapy, Combination|drug therapy, combination
5432686|NCT00013897|Zidovudine|zidovudine
5432687|NCT00013897|HIV Protease Inhibitors|hiv protease inhibitors
5432688|NCT00013897|Lamivudine|lamivudine
5432689|NCT00013897|RNA, Viral|rna, viral
5432690|NCT00013897|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5432691|NCT00013897|Anti-HIV Agents|anti-hiv agents
5432692|NCT00013897|Viral Load|viral load
5432693|NCT00013897|BMS 232632|bms 232632
5432694|NCT00013897|efavirenz|efavirenz
5432695|NCT00013871|Measles-Mumps-Rubella Vaccine|measles-mumps-rubella vaccine
5432696|NCT00013871|Antibodies, Viral|antibodies, viral
5432697|NCT00013871|Hepatitis B Vaccines|hepatitis b vaccines
5432698|NCT00013871|Immunization, Secondary|immunization, secondary
5432699|NCT00013871|Pneumococcal Vaccines|pneumococcal vaccines
5432700|NCT00013871|Antiretroviral Therapy, Highly Active|antiretroviral therapy, highly active
5432701|NCT00013871|Diphtheria-Tetanus-acellular Pertussis Vaccines|diphtheria-tetanus-acellular pertussis vaccines
5432702|NCT00013663|Virus Replication|virus replication
5432703|NCT00013663|HIV-1|hiv-1
5432704|NCT00013663|AIDS Vaccines|aids vaccines
5432705|NCT00013663|RNA, Viral|rna, viral
5432706|NCT00013663|Avipoxvirus|avipoxvirus
5432707|NCT00013663|Genetic Vectors|genetic vectors
5432708|NCT00013663|Viral Load|viral load
5432709|NCT00013663|aldesleukin|aldesleukin
5432710|NCT00013663|Antiretroviral Therapy, Highly Active|antiretroviral therapy, highly active
5432711|NCT00013663|HIV Therapeutic Vaccine|hiv therapeutic vaccine
5432712|NCT00013663|Treatment Interruption|treatment interruption
5432713|NCT00013585|Cognitive Disorders|cognitive disorders
5432714|NCT00013585|AIDS Dementia Complex|aids dementia complex
5432715|NCT00013585|Selegiline|selegiline
5432716|NCT00013585|Administration, Cutaneous|administration, cutaneous
5432717|NCT00013585|Neuroprotective Agents|neuroprotective agents
5432718|NCT00013572|Injections, Intramuscular|injections, intramuscular
5432719|NCT00013572|Injections, Intradermal|injections, intradermal
5432720|NCT00013572|Injections, Subcutaneous|injections, subcutaneous
5432721|NCT00013572|HIV-1|hiv-1
5432722|NCT00013572|AIDS Vaccines|aids vaccines
5432723|NCT00013572|Dendritic Cells|dendritic cells
5432724|NCT00013572|HIV Seronegativity|hiv seronegativity
5432725|NCT00013572|Genes, env|genes, env
5432726|NCT00013572|Genes, pol|genes, pol
5432727|NCT00013572|Genes, gag|genes, gag
5432728|NCT00013572|Transfection|transfection
5432729|NCT00013572|HIV Preventive Vaccine|hiv preventive vaccine
5432730|NCT00013520|HIV-1|hiv-1
5432731|NCT00013520|Didanosine|didanosine
5432732|NCT00013520|Drug Therapy, Combination|drug therapy, combination
5432733|NCT00013520|Zidovudine|zidovudine
5432734|NCT00013520|Nevirapine|nevirapine
5432735|NCT00013520|Stavudine|stavudine
5432736|NCT00013520|Lamivudine|lamivudine
5432737|NCT00013520|RNA, Viral|rna, viral
5432738|NCT00013520|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5432739|NCT00013520|Anti-HIV Agents|anti-hiv agents
5432740|NCT00013520|Viral Load|viral load
5432741|NCT00013520|Combivir|combivir
5432742|NCT00013520|BMS 232632|bms 232632
5432743|NCT00013520|Efavirenz|efavirenz
5432744|NCT00013520|Treatment Naive|treatment naive
5432745|NCT00012519|Dose-Response Relationship, Drug|dose-response relationship, drug
5432746|NCT00012519|Drug Therapy, Combination|drug therapy, combination
5432747|NCT00012519|HIV Protease Inhibitors|hiv protease inhibitors
5432748|NCT00012519|Ritonavir|ritonavir
5432749|NCT00012519|Indinavir|indinavir
5432750|NCT00012519|Anti-HIV Agents|anti-hiv agents
5432751|NCT00012519|Viral Load|viral load
5432752|NCT00012519|Pharmacokinetics|pharmacokinetics
5432753|NCT00012519|Treatment Experienced|treatment experienced
5432754|NCT00012467|Interferon-gamma, Recombinant|interferon-gamma, recombinant
5432755|NCT00012467|Injections, Subcutaneous|injections, subcutaneous
5432756|NCT00012467|Itraconazole|itraconazole
5432757|NCT00012467|Dose-Response Relationship, Drug|dose-response relationship, drug
5432758|NCT00012467|Fluconazole|fluconazole
5432759|NCT00012467|Flucytosine|flucytosine
5432760|NCT00012467|Antifungal Agents|antifungal agents
5432761|NCT00012467|Amphotericin B|amphotericin b
5432762|NCT00012467|Meningitis, Cryptococcal|meningitis, cryptococcal
5432763|NCT00011895|HIV-1|hiv-1
5432764|NCT00011895|Drug Therapy, Combination|drug therapy, combination
5432765|NCT00011895|Zidovudine|zidovudine
5432766|NCT00011895|Lamivudine|lamivudine
5432767|NCT00011895|Drug Combinations|drug combinations
5432768|NCT00011895|RNA, Viral|rna, viral
5432769|NCT00011895|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5432770|NCT00011895|Anti-HIV Agents|anti-hiv agents
5432771|NCT00011895|Viral Load|viral load
5432772|NCT00011895|abacavir|abacavir
5432773|NCT00011895|efavirenz|efavirenz
5432774|NCT00011479|Administration, Oral|administration, oral
5432775|NCT00011479|Drug Administration Schedule|drug administration schedule
5432776|NCT00011479|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5432777|NCT00011479|Anti-HIV Agents|anti-hiv agents
5432778|NCT00011479|Pharmacokinetics|pharmacokinetics
5432779|NCT00011479|abacavir|abacavir
5432780|NCT00011128|HIV-1|hiv-1
5432781|NCT00011128|Drug Resistance, Microbial|drug resistance, microbial
5432782|NCT00011128|Microbial Sensitivity Tests|microbial sensitivity tests
5432783|NCT00011128|Salvage Therapy|salvage therapy
5432784|NCT00011128|Anti-HIV Agents|anti-hiv agents
5432785|NCT00011128|Viral Load|viral load
5432786|NCT00011128|Treatment Experienced|treatment experienced
5432787|NCT00011089|HIV-1|hiv-1
5432788|NCT00011089|Disease Progression|disease progression
5432789|NCT00011089|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5432790|NCT00011089|Anti-HIV Agents|anti-hiv agents
5432791|NCT00011089|9-(2-phosphonylmethoxypropyl)adenine|9-(2-phosphonylmethoxypropyl)adenine
5432792|NCT00011050|Specimen Handling|specimen handling
5432793|NCT00011050|Blood|blood
5432794|NCT00011050|Cryopreservation|cryopreservation
5432795|NCT00011050|Lactic Acid|lactic acid
5432796|NCT00011050|Sodium Fluoride|sodium fluoride
5432797|NCT00011050|Oxalates|oxalates
5432798|NCT00011037|HIV Antibodies|hiv antibodies
5432799|NCT00011037|HIV Antigens|hiv antigens
5432800|NCT00011037|HIV Envelope Protein gp120|hiv envelope protein gp120
5432801|NCT00011037|AIDS Vaccines|aids vaccines
5432802|NCT00011037|CD4-Positive T-Lymphocytes|cd4-positive t-lymphocytes
5432803|NCT00011037|CD8-Positive T-Lymphocytes|cd8-positive t-lymphocytes
5432804|NCT00011037|Neutralization Tests|neutralization tests
5432805|NCT00011037|Haiti|haiti
5432806|NCT00011037|Brazil|brazil
5432807|NCT00011037|Cytotoxicity, Immunologic|cytotoxicity, immunologic
5432808|NCT00011037|Epitopes|epitopes
5432809|NCT00011037|Viral Proteins|viral proteins
5432810|NCT00011037|Trinidad and Tobago|trinidad and tobago
5432811|NCT00011037|Peru|peru
5432812|NCT00011037|HIV Preventive Vaccine|hiv preventive vaccine
5432813|NCT00011037|HIV Seronegativity|hiv seronegativity
5432814|NCT00011011|HIV-1|hiv-1
5432815|NCT00011011|Drug Administration Schedule|drug administration schedule
5432816|NCT00011011|AIDS Vaccines|aids vaccines
5432817|NCT00011011|CD4 Lymphocyte Count|cd4 lymphocyte count
5432818|NCT00011011|RNA, Viral|rna, viral
5432819|NCT00011011|Anti-HIV Agents|anti-hiv agents
5432820|NCT00011011|Viral Load|viral load
5432821|NCT00011011|HIV Therapeutic Vaccine|hiv therapeutic vaccine
5432822|NCT00011011|Treatment Interruption|treatment interruption
5432823|NCT00009555|Testosterone|testosterone
5432824|NCT00009555|Anthropometry|anthropometry
5432825|NCT00009555|Obesity|obesity
5432826|NCT00009555|Abdomen|abdomen
5432827|NCT00009061|HIV-1|hiv-1
5432828|NCT00009061|Drug Therapy, Combination|drug therapy, combination
5432829|NCT00009061|HIV Protease Inhibitors|hiv protease inhibitors
5432830|NCT00009061|Ritonavir|ritonavir
5432831|NCT00009061|Lamivudine|lamivudine
5432832|NCT00009061|Nelfinavir|nelfinavir
5432833|NCT00009061|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5432834|NCT00009061|Anti-HIV Agents|anti-hiv agents
5432835|NCT00009061|abacavir|abacavir
5432836|NCT00008866|HIV-1|hiv-1
5432837|NCT00008866|Didanosine|didanosine
5432838|NCT00008866|Drug Therapy, Combination|drug therapy, combination
5432839|NCT00008866|Drug Administration Schedule|drug administration schedule
5432840|NCT00008866|CD4-Positive T-Lymphocytes|cd4-positive t-lymphocytes
5432841|NCT00008866|Hydroxyurea|hydroxyurea
5432842|NCT00008866|RNA, Viral|rna, viral
5432843|NCT00008866|Genotype|genotype
5432844|NCT00008866|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5432845|NCT00008866|Anti-HIV Agents|anti-hiv agents
5432846|NCT00008866|Viral Load|viral load
5432847|NCT00008853|Clinical Evaluation|clinical evaluation
5432848|NCT00008554|HIV-1|hiv-1
5432849|NCT00008554|Drug Therapy, Combination|drug therapy, combination
5432850|NCT00008554|HIV Protease Inhibitors|hiv protease inhibitors
5432851|NCT00008554|Lamivudine|lamivudine
5432852|NCT00008554|Nelfinavir|nelfinavir
5432853|NCT00008554|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5432854|NCT00008554|Anti-HIV Agents|anti-hiv agents
5432855|NCT00008554|abacavir|abacavir
5432856|NCT00008528|HIV-1|hiv-1
5432857|NCT00008528|Drug Therapy, Combination|drug therapy, combination
5432858|NCT00008528|Drug Resistance, Microbial|drug resistance, microbial
5432859|NCT00008528|RNA, Viral|rna, viral
5432860|NCT00008528|Membrane Fusion|membrane fusion
5432861|NCT00008528|Anti-HIV Agents|anti-hiv agents
5432862|NCT00008528|Viral Load|viral load
5432864|NCT00008489|Gastrointestinal System|gastrointestinal system
5432865|NCT00008489|Tablets|tablets
5432866|NCT00008489|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5432867|NCT00008489|Anti-HIV Agents|anti-hiv agents
5432868|NCT00008489|Capsules|capsules
5432869|NCT00008463|Ribavirin|ribavirin
5432870|NCT00008463|Polyethylene Glycols|polyethylene glycols
5432871|NCT00008463|Interferon Alfa-2a|interferon alfa-2a
5432872|NCT00008463|HIV-1|hiv-1
5432873|NCT00008463|Antiviral Agents|antiviral agents
5432874|NCT00008463|Hepatitis C, Chronic|hepatitis c, chronic
5432875|NCT00007488|HIV-1|hiv-1
5432876|NCT00007488|Lymphoid Tissue|lymphoid tissue
5432877|NCT00007488|Viremia|viremia
5432878|NCT00007488|RNA, Viral|rna, viral
5432879|NCT00007488|Saliva|saliva
5432880|NCT00007488|Anti-HIV Agents|anti-hiv agents
5432881|NCT00007488|Viral Load|viral load
5432882|NCT00007488|Genitalia, Female|genitalia, female
5432883|NCT00007488|Genitalia, Male|genitalia, male
5432884|NCT00007449|HIV-1|hiv-1
5432885|NCT00007449|Drug Therapy, Combination|drug therapy, combination
5432886|NCT00007449|RNA, Viral|rna, viral
5432887|NCT00007449|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5432888|NCT00007449|Anti-HIV Agents|anti-hiv agents
5432889|NCT00007449|Viral Load|viral load
5432890|NCT00007436|HIV-1|hiv-1
5432891|NCT00007436|Drug Therapy, Combination|drug therapy, combination
5432892|NCT00007436|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5432893|NCT00007436|Anti-HIV Agents|anti-hiv agents
5432894|NCT00007436|9-(2-phosphonylmethoxypropyl)adenine|9-(2-phosphonylmethoxypropyl)adenine
5432895|NCT00007423|HIV Antibodies|hiv antibodies
5432896|NCT00007423|HIV-1|hiv-1
5432897|NCT00007423|AIDS Vaccines|aids vaccines
5432898|NCT00007423|HIV Seronegativity|hiv seronegativity
5432899|NCT00007423|Uganda|uganda
5432900|NCT00007423|Cross Reactions|cross reactions
5432901|NCT00007423|HIV Preventive Vaccine|hiv preventive vaccine
5432902|NCT00007332|Drug Therapy, Combination|drug therapy, combination
5432903|NCT00007332|HIV Envelope Protein gp120|hiv envelope protein gp120
5432904|NCT00007332|AIDS Vaccines|aids vaccines
5432905|NCT00007332|CD8-Positive T-Lymphocytes|cd8-positive t-lymphocytes
5432906|NCT00007332|HIV Seronegativity|hiv seronegativity
5432907|NCT00007332|AIDSVAX|aidsvax
5432908|NCT00007332|HIV Preventive Vaccine|hiv preventive vaccine
5432909|NCT00007319|HIV Protease Inhibitors|hiv protease inhibitors
5432910|NCT00007319|Risk Factors|risk factors
5432911|NCT00007319|HIV Seronegativity|hiv seronegativity
5432912|NCT00007319|Anti-HIV Agents|anti-hiv agents
5432913|NCT00007319|Carotid Artery|carotid artery
5432914|NCT00007319|Tunica Intima|tunica intima
5432915|NCT00007319|Atherosclerosis|atherosclerosis
5432916|NCT00007202|Virus Replication|virus replication
5432917|NCT00007202|HIV-1|hiv-1
5432918|NCT00007202|Didanosine|didanosine
5432919|NCT00007202|Drug Therapy, Combination|drug therapy, combination
5432920|NCT00007202|Stavudine|stavudine
5432921|NCT00007202|HIV Protease Inhibitors|hiv protease inhibitors
5432922|NCT00007202|Sensitivity and Specificity|sensitivity and specificity
5432923|NCT00007202|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5432924|NCT00007202|Anti-HIV Agents|anti-hiv agents
5432925|NCT00007202|Viral Load|viral load
5432926|NCT00007202|Reverse Transcriptase Polymerase Chain Reaction|reverse transcriptase polymerase chain reaction
5432927|NCT00007202|Acute Infection|acute infection
5432928|NCT00006643|Liver|liver
5432929|NCT00006643|Hepatitis C|hepatitis c
5432930|NCT00006643|Biopsy|biopsy
5432931|NCT00006643|Tomography, Emission-Computed, Single-Photon|tomography, emission-computed, single-photon
5432932|NCT00006630|Smallpox Vaccine|smallpox vaccine
5432933|NCT00006630|Injections, Intramuscular|injections, intramuscular
5432934|NCT00006630|Immunoglobulins|immunoglobulins
5432935|NCT00006630|Orthopoxvirus|orthopoxvirus
5432936|NCT00006617|HIV-1|hiv-1
5432937|NCT00006617|Drug Therapy, Combination|drug therapy, combination
5432938|NCT00006617|Zidovudine|zidovudine
5432939|NCT00006617|Lymphoid Tissue|lymphoid tissue
5432940|NCT00006617|Gastrointestinal System|gastrointestinal system
5432941|NCT00006617|HIV Protease Inhibitors|hiv protease inhibitors
5432942|NCT00006617|Lamivudine|lamivudine
5432943|NCT00006617|Lymphocyte Subsets|lymphocyte subsets
5432944|NCT00006617|VX 478|vx 478
5432945|NCT00006617|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5432946|NCT00006617|Anti-HIV Agents|anti-hiv agents
5432947|NCT00006617|Viral Load|viral load
5432948|NCT00006617|Cerebrospinal Fluid|cerebrospinal fluid
5432949|NCT00006617|abacavir|abacavir
5432950|NCT00006604|Dose-Response Relationship, Drug|dose-response relationship, drug
5432951|NCT00006604|Drug Therapy, Combination|drug therapy, combination
5432952|NCT00006604|Drug Administration Schedule|drug administration schedule
5432953|NCT00006604|HIV Protease Inhibitors|hiv protease inhibitors
5432954|NCT00006604|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5432955|NCT00006604|Anti-HIV Agents|anti-hiv agents
5432956|NCT00006604|Pharmacokinetics|pharmacokinetics
5432957|NCT00006604|Treatment Experienced|treatment experienced
5432958|NCT00006604|Treatment Naive|treatment naive
5432959|NCT00006591|Drug Therapy, Combination|drug therapy, combination
5432960|NCT00006591|HIV Protease Inhibitors|hiv protease inhibitors
5432961|NCT00006591|Ritonavir|ritonavir
5432963|NCT00006591|Salvage Therapy|salvage therapy
5432964|NCT00006591|Anti-HIV Agents|anti-hiv agents
5432965|NCT00006591|Drug Monitoring|drug monitoring
5432966|NCT00006591|Nelfinavir|nelfinavir
5432967|NCT00006591|Treatment Experienced|treatment experienced
5432968|NCT00006578|Drug Therapy, Combination|drug therapy, combination
5432969|NCT00006578|Granulocyte Colony-Stimulating Factor|granulocyte colony-stimulating factor
5432970|NCT00006578|HIV Protease Inhibitors|hiv protease inhibitors
5432971|NCT00006578|Ritonavir|ritonavir
5432972|NCT00006578|Lamivudine|lamivudine
5432973|NCT00006578|Stem Cells|stem cells
5432974|NCT00006578|VX 478|vx 478
5432975|NCT00006578|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5432976|NCT00006578|Anti-HIV Agents|anti-hiv agents
5432977|NCT00006578|Antigens, CD34|antigens, cd34
5432978|NCT00006578|abacavir|abacavir
5432979|NCT00006578|Treatment Naive|treatment naive
5432980|NCT00006509|Recombinant Proteins|recombinant proteins
5432981|NCT00006509|HIV Envelope Protein gp160|hiv envelope protein gp160
5432982|NCT00006509|AIDS Vaccines|aids vaccines
5432983|NCT00006509|Anti-HIV Agents|anti-hiv agents
5432984|NCT00006509|Treatment Experienced|treatment experienced
5432985|NCT00006509|HIV Therapeutic Vaccine|hiv therapeutic vaccine
5432986|NCT00006495|Placebos|placebos
5432987|NCT00006495|T-Lymphocytes, Helper-Inducer|t-lymphocytes, helper-inducer
5432988|NCT00006495|AIDS Vaccines|aids vaccines
5432989|NCT00006495|RNA, Viral|rna, viral
5432990|NCT00006495|HIV Core Protein p24|hiv core protein p24
5432991|NCT00006495|T-Lymphocytes, Cytotoxic|t-lymphocytes, cytotoxic
5432992|NCT00006495|Anti-HIV Agents|anti-hiv agents
5432993|NCT00006495|HIV Therapeutic Vaccine|hiv therapeutic vaccine
5432994|NCT00006490|HIV-1|hiv-1
5432995|NCT00006490|Drug Resistance, Microbial|drug resistance, microbial
5432996|NCT00006490|Sequence Analysis, DNA|sequence analysis, dna
5432997|NCT00006490|Microbial Sensitivity Tests|microbial sensitivity tests
5432998|NCT00006490|Genotype|genotype
5432999|NCT00006490|Phenotype|phenotype
5433000|NCT00006490|Anti-HIV Agents|anti-hiv agents
5433001|NCT00006444|Drug Therapy, Combination|drug therapy, combination
5433002|NCT00006444|Papillomavirus, Human|papillomavirus, human
5433003|NCT00006444|DNA, Viral|dna, viral
5433004|NCT00006444|Anti-HIV Agent|anti-hiv agent
5433005|NCT00006444|Treatment Naive|treatment naive
5433006|NCT00006443|T-Lymphocytes|t-lymphocytes
5433007|NCT00006443|HIV-1|hiv-1
5433008|NCT00006443|Lymphoid Tissue|lymphoid tissue
5433009|NCT00006443|Stavudine|stavudine
5433010|NCT00006443|HIV Protease Inhibitors|hiv protease inhibitors
5433011|NCT00006443|Polymerase Chain Reaction|polymerase chain reaction
5433012|NCT00006443|Biological Markers|biological markers
5433013|NCT00006443|Lamivudine|lamivudine
5433014|NCT00006443|Indinavir|indinavir
5433015|NCT00006443|RNA, Viral|rna, viral
5433016|NCT00006443|Genotype|genotype
5433017|NCT00006443|Phenotype|phenotype
5433018|NCT00006443|Cytokines|cytokines
5433019|NCT00006443|Nelfinavir|nelfinavir
5433020|NCT00006443|Macrophages|macrophages
5433021|NCT00006443|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5433022|NCT00006443|In Situ Hybridization|in situ hybridization
5433023|NCT00006443|Anti-HIV Agents|anti-hiv agents
5433024|NCT00006443|Viral Load|viral load
5433025|NCT00006443|Cell Membrane|cell membrane
5433026|NCT00006443|Acute Infection|acute infection
5433027|NCT00006443|Treatment Naive|treatment naive
5433028|NCT00006442|Lymphocytes|lymphocytes
5433029|NCT00006442|HIV-1|hiv-1
5433030|NCT00006442|Lymphoid Tissue|lymphoid tissue
5433031|NCT00006442|Blood|blood
5433032|NCT00006442|Anti-HIV Agents|anti-hiv agents
5433033|NCT00006442|Viral Load|viral load
5433034|NCT00006441|Virus Replication|virus replication
5433035|NCT00006441|HIV-1|hiv-1
5433036|NCT00006441|Interleukin-2|interleukin-2
5433037|NCT00006441|Drug Therapy, Combination|drug therapy, combination
5433038|NCT00006441|Zidovudine|zidovudine
5433039|NCT00006441|HIV Protease Inhibitors|hiv protease inhibitors
5433040|NCT00006441|CD4-Positive T-Lymphocytes|cd4-positive t-lymphocytes
5433041|NCT00006441|CD8-Positive T-Lymphocytes|cd8-positive t-lymphocytes
5433042|NCT00006441|Biological Markers|biological markers
5433043|NCT00006441|Lamivudine|lamivudine
5433044|NCT00006441|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5433045|NCT00006441|Anti-HIV Agents|anti-hiv agents
5433046|NCT00006441|Nelfinavir|nelfinavir
5433047|NCT00006441|Cytotoxicity, Immunologic|cytotoxicity, immunologic
5433048|NCT00006441|Acute Infection|acute infection
5433049|NCT00006440|Risk Factors|risk factors
5433050|NCT00006440|Behavior Therapy|behavior therapy
5433051|NCT00006440|Substance-Related Disorders|substance-related disorders
5433052|NCT00006440|Feasibility Studies|feasibility studies
5433053|NCT00006415|Virus Replication|virus replication
5433054|NCT00006415|HIV-1|hiv-1
5433055|NCT00006415|Polymerase Chain Reaction|polymerase chain reaction
5433056|NCT00006415|DNA, Viral|dna, viral
5433057|NCT00006415|RNA, Viral|rna, viral
5433058|NCT00006415|Sensitivity and Specificity|sensitivity and specificity
5433059|NCT00006415|Anti-HIV Agents|anti-hiv agents
5433060|NCT00006415|Viral Load|viral load
5433061|NCT00006415|Proviruses|proviruses
5433062|NCT00006415|Acute Infection|acute infection
5433063|NCT00006412|Hyperlipidemia|hyperlipidemia
5433066|NCT00006412|Antilipemic Agents|antilipemic agents
5433067|NCT00006397|Didanosine|didanosine
5433068|NCT00006397|Drug Therapy, Combination|drug therapy, combination
5433069|NCT00006397|Stavudine|stavudine
5433070|NCT00006397|HIV Protease Inhibitors|hiv protease inhibitors
5433071|NCT00006397|Sex Factors|sex factors
5433072|NCT00006397|Ritonavir|ritonavir
5433073|NCT00006397|Indinavir|indinavir
5433074|NCT00006397|Dosage Forms|dosage forms
5433075|NCT00006397|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5433076|NCT00006397|Anti-HIV Agents|anti-hiv agents
5433077|NCT00006396|Pregnancy Complications, Infectious|pregnancy complications, infectious
5433078|NCT00006396|HIV-1|hiv-1
5433079|NCT00006396|Administration, Oral|administration, oral
5433080|NCT00006396|Zidovudine|zidovudine
5433081|NCT00006396|Nevirapine|nevirapine
5433082|NCT00006396|RNA, Viral|rna, viral
5433083|NCT00006396|Disease Transmission, Vertical|disease transmission, vertical
5433084|NCT00006396|Enzyme-Linked Immunosorbent Assay|enzyme-linked immunosorbent assay
5433085|NCT00006396|Blotting, Western|blotting, western
5433086|NCT00006396|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5433087|NCT00006396|Anti-HIV Agents|anti-hiv agents
5433088|NCT00006396|Viral Load|viral load
5433089|NCT00006396|HIV Seronegativity|hiv seronegativity
5433090|NCT00006339|Prospective Studies|prospective studies
5433091|NCT00006339|HIV-1|hiv-1
5433092|NCT00006339|Didanosine|didanosine
5433093|NCT00006339|Drug Therapy, Combination|drug therapy, combination
5433094|NCT00006339|Stavudine|stavudine
5433095|NCT00006339|HIV Protease Inhibitors|hiv protease inhibitors
5433096|NCT00006339|Hydroxyurea|hydroxyurea
5433097|NCT00006339|Ritonavir|ritonavir
5433098|NCT00006339|Indinavir|indinavir
5433099|NCT00006339|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5433100|NCT00006339|Anti-HIV Agents|anti-hiv agents
5433101|NCT00006339|Viral Load|viral load
5433102|NCT00006339|Reverse Transcriptase Polymerase Chain Reaction|reverse transcriptase polymerase chain reaction
5433103|NCT00006327|Recombinant Proteins|recombinant proteins
5433104|NCT00006327|HIV-1|hiv-1
5433105|NCT00006327|AIDS Serodiagnosis|aids serodiagnosis
5433106|NCT00006327|Substance Abuse, Intravenous|substance abuse, intravenous
5433107|NCT00006327|Enzyme-Linked Immunosorbent Assay|enzyme-linked immunosorbent assay
5433108|NCT00006327|Blotting, Western|blotting, western
5433109|NCT00006327|HIV Envelope Protein gp120|hiv envelope protein gp120
5433110|NCT00006327|AIDSVAX|aidsvax
5433111|NCT00006326|Drug Therapy, Combination|drug therapy, combination
5433112|NCT00006326|HIV Protease Inhibitors|hiv protease inhibitors
5433113|NCT00006326|Ritonavir|ritonavir
5433114|NCT00006326|Indinavir|indinavir
5433115|NCT00006326|Delavirdine|delavirdine
5433116|NCT00006326|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5433117|NCT00006326|Salvage Therapy|salvage therapy
5433118|NCT00006326|Anti-HIV Agents|anti-hiv agents
5433119|NCT00006326|Viral Load|viral load
5433120|NCT00006326|Nelfinavir|nelfinavir
5433121|NCT00006325|Polyethylene Glycols|polyethylene glycols
5433122|NCT00006325|Interferon Alfa-2b|interferon alfa-2b
5433123|NCT00006325|HIV-1|hiv-1
5433124|NCT00006325|Dose-Response Relationship, Drug|dose-response relationship, drug
5433125|NCT00006325|Drug Therapy, Combination|drug therapy, combination
5433126|NCT00006325|Virus Inhibitors|virus inhibitors
5433127|NCT00006325|Anti-HIV Agents|anti-hiv agents
5433128|NCT00006325|Pharmacokinetics|pharmacokinetics
5433129|NCT00006324|HIV Seronegativity|hiv seronegativity
5433130|NCT00006324|Delayed-Action Preparations|delayed-action preparations
5433131|NCT00006324|Risk Factors|risk factors
5433132|NCT00006324|Prevalence|prevalence
5433133|NCT00006324|Contraceptive Agents, Female|contraceptive agents, female
5433134|NCT00006324|Contraceptives, Oral, Combined|contraceptives, oral, combined
5433135|NCT00006324|Medroxyprogesterone 17-Acetate|medroxyprogesterone 17-acetate
5433136|NCT00006316|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
5433137|NCT00006316|Histoplasmosis|histoplasmosis
5433138|NCT00006316|Antifungal Agents|antifungal agents
5433139|NCT00006316|Recurrence|recurrence
5433140|NCT00006316|Anti-HIV Agents|anti-hiv agents
5433141|NCT00006304|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5433142|NCT00006304|AIDS-Related Complex|aids-related complex
5433143|NCT00006298|HIV Antibodies|hiv antibodies
5433144|NCT00006298|HIV-1|hiv-1
5433145|NCT00006298|CD4 Lymphocyte Count|cd4 lymphocyte count
5433146|NCT00006298|T-Lymphocytes, Cytotoxic|t-lymphocytes, cytotoxic
5433147|NCT00006298|Genotype|genotype
5433148|NCT00006298|Species Specificity|species specificity
5433149|NCT00006298|Neutralization Tests|neutralization tests
5433150|NCT00006298|Viral Load|viral load
5433151|NCT00006298|Alleles|alleles
5433152|NCT00006298|HLA Antigens|hla antigens
5433153|NCT00006298|Cross Reactions|cross reactions
5433154|NCT00006298|Immunodominant Epitopes|immunodominant epitopes
5433155|NCT00006298|Haplotypes|haplotypes
5433156|NCT00006291|Virus Replication|virus replication
5433157|NCT00006291|T-Lymphocytes|t-lymphocytes
5433158|NCT00006291|Lymphocyte Transformation|lymphocyte transformation
5433159|NCT00006291|AIDS Vaccines|aids vaccines
5433160|NCT00006291|Anti-HIV Agents|anti-hiv agents
5433161|NCT00006291|Viral Load|viral load
5433162|NCT00006291|Aldesleukin|aldesleukin
5433163|NCT00006291|HIV Therapeutic Vaccine|hiv therapeutic vaccine
5433164|NCT00006290|Drug Therapy, Combination|drug therapy, combination
5433165|NCT00006290|Questionnaires|questionnaires
5433166|NCT00006290|Quality of Life|quality of life
5433167|NCT00006290|Patient Compliance|patient compliance
5433168|NCT00006290|Body Composition|body composition
5433169|NCT00006290|Anti-HIV Agents|anti-hiv agents
5433170|NCT00006290|Adipose Tissue|adipose tissue
5433171|NCT00006290|Body Image|body image
5433172|NCT00006279|Pregnancy Complications, Infectious|pregnancy complications, infectious
5433173|NCT00006279|Dose-Response Relationship, Drug|dose-response relationship, drug
5433174|NCT00006279|Drug Administration Schedule|drug administration schedule
5433175|NCT00006279|Nevirapine|nevirapine
5433176|NCT00006279|Disease Transmission, Vertical|disease transmission, vertical
5433177|NCT00006279|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5433178|NCT00006279|Anti-HIV Agents|anti-hiv agents
5433179|NCT00006279|Breast Feeding|breast feeding
5433180|NCT00006211|Drug Therapy, Combination|drug therapy, combination
5433181|NCT00006211|HIV Protease Inhibitors|hiv protease inhibitors
5433182|NCT00006211|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5433183|NCT00006211|Anti-HIV Agents|anti-hiv agents
5433184|NCT00006211|Viral Load|viral load
5433185|NCT00006211|Nelfinavir|nelfinavir
5433186|NCT00006209|HIV-1|hiv-1
5433187|NCT00006209|Immunity, Cellular|immunity, cellular
5433188|NCT00006209|Drug Therapy, Combination|drug therapy, combination
5433189|NCT00006209|CD4-Positive T-Lymphocytes|cd4-positive t-lymphocytes
5433190|NCT00006209|Antigens|antigens
5433191|NCT00006209|Anti-HIV Agents|anti-hiv agents
5433192|NCT00006209|Viral Load|viral load
5433193|NCT00006209|tucaresol|tucaresol
5433194|NCT00006208|HIV-1|hiv-1
5433195|NCT00006208|Didanosine|didanosine
5433196|NCT00006208|Drug Therapy, Combination|drug therapy, combination
5433197|NCT00006208|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5433198|NCT00006208|Anti-HIV Agents|anti-hiv agents
5433199|NCT00006208|Deoxycytidine|deoxycytidine
5433200|NCT00006208|efavirenz|efavirenz
5433201|NCT00006207|HIV Seropositivity|hiv seropositivity
5433202|NCT00006207|Dose-Response Relationship, Drug|dose-response relationship, drug
5433203|NCT00006207|HIV Seronegativity|hiv seronegativity
5433204|NCT00006207|Mucous Membrane|mucous membrane
5433205|NCT00006207|Ulcer|ulcer
5433206|NCT00006207|Vagina|vagina
5433207|NCT00006207|Anti-HIV Agents|anti-hiv agents
5433208|NCT00006207|Sexual Abstinence|sexual abstinence
5433209|NCT00006207|Irritants|irritants
5433210|NCT00006207|PRO 2000|pro 2000
5433211|NCT00006154|Interleukin-2|interleukin-2
5433212|NCT00006154|Didanosine|didanosine
5433213|NCT00006154|Drug Therapy, Combination|drug therapy, combination
5433214|NCT00006154|Stavudine|stavudine
5433215|NCT00006154|HIV Protease Inhibitors|hiv protease inhibitors
5433216|NCT00006154|Ritonavir|ritonavir
5433217|NCT00006154|Indinavir|indinavir
5433218|NCT00006154|Virus Latency|virus latency
5433219|NCT00006154|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5433220|NCT00006154|Anti-HIV Agents|anti-hiv agents
5433221|NCT00006154|abacavir|abacavir
5433222|NCT00006154|efavirenz|efavirenz
5433223|NCT00006154|Acute Infection|acute infection
5433224|NCT00006153|HIV Antibodies|hiv antibodies
5433225|NCT00006153|Immunity, Cellular|immunity, cellular
5433226|NCT00006153|Drug Therapy, Combination|drug therapy, combination
5433227|NCT00006153|Anti-HIV Agents|anti-hiv agents
5433228|NCT00006153|remune|remune
5433229|NCT00006153|HIV Therapeutic Vaccine|hiv therapeutic vaccine
5433230|NCT00006152|Drug Therapy, Combination|drug therapy, combination
5433231|NCT00006152|HIV Protease Inhibitors|hiv protease inhibitors
5433232|NCT00006152|Ritonavir|ritonavir
5433233|NCT00006152|VX 478|vx 478
5433234|NCT00006152|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5433235|NCT00006152|Anti-HIV Agents|anti-hiv agents
5433236|NCT00006152|Viral Load|viral load
5433237|NCT00006152|abacavir|abacavir
5433238|NCT00006145|Ganciclovir|ganciclovir
5433239|NCT00006145|Cytomegalovirus|cytomegalovirus
5433240|NCT00006145|Cytomegalovirus Infections|cytomegalovirus infections
5433241|NCT00006145|Administration, Oral|administration, oral
5433242|NCT00006145|Antiviral Agents|antiviral agents
5433243|NCT00006145|Polymerase Chain Reaction|polymerase chain reaction
5433244|NCT00006145|Viremia|viremia
5433245|NCT00006145|DNA, Viral|dna, viral
5433246|NCT00006144|Drug Therapy, Combination|drug therapy, combination
5433247|NCT00006144|Stavudine|stavudine
5433248|NCT00006144|HIV Protease Inhibitors|hiv protease inhibitors
5433249|NCT00006144|Cohort Studies|cohort studies
5433250|NCT00006144|Ritonavir|ritonavir
5433251|NCT00006144|Disease Progression|disease progression
5433252|NCT00006144|Antigens, CD|antigens, cd
5433253|NCT00006144|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5433254|NCT00006144|Anti-HIV Agents|anti-hiv agents
5433255|NCT00006144|Immunophenotyping|immunophenotyping
5433256|NCT00006144|Deoxycytidine|deoxycytidine
5433257|NCT00006143|Treatment Outcome|treatment outcome
5433258|NCT00006143|serostim|serostim
5433259|NCT00006143|Developmental Disabilities|developmental disabilities
5433260|NCT00006075|Pregnancy Complications, Infectious|pregnancy complications, infectious
5443961|NCT00001750|Apheresis|apheresis
5433261|NCT00006075|Dose-Response Relationship, Drug|dose-response relationship, drug
5433262|NCT00006075|Polymerase Chain Reaction|polymerase chain reaction
5433263|NCT00006075|Disease Transmission, Vertical|disease transmission, vertical
5433264|NCT00006075|Labor|labor
5433265|NCT00006075|Disinfectants|disinfectants
5433266|NCT00006075|Vagina|vagina
5433267|NCT00006075|Chlorhexidine|chlorhexidine
5433268|NCT00006075|Irrigation|irrigation
5433269|NCT00006066|Injections, Subcutaneous|injections, subcutaneous
5433270|NCT00006066|Interleukin-2|interleukin-2
5433271|NCT00006066|Dose-Response Relationship, Drug|dose-response relationship, drug
5433272|NCT00006066|Drug Therapy, Combination|drug therapy, combination
5433273|NCT00006066|Immunocompromised Host|immunocompromised host
5433274|NCT00006066|CD4 Lymphocyte Count|cd4 lymphocyte count
5433275|NCT00006066|Anti-HIV Agents|anti-hiv agents
5433276|NCT00006064|Tumor Necrosis Factor|tumor necrosis factor
5433277|NCT00006064|CD4 Lymphocyte Count|cd4 lymphocyte count
5433278|NCT00006064|Polymerase Chain Reaction|polymerase chain reaction
5433279|NCT00006064|Enzyme-Linked Immunosorbent Assay|enzyme-linked immunosorbent assay
5433280|NCT00006064|RNA, Messenger|rna, messenger
5433281|NCT00006064|Interleukin-1|interleukin-1
5433282|NCT00006064|Body Composition|body composition
5433283|NCT00006064|Anti-HIV Agents|anti-hiv agents
5433284|NCT00006064|Viral Load|viral load
5433285|NCT00006064|Age Factors|age factors
5433286|NCT00006064|Anthropometry|anthropometry
5433287|NCT00005931|Skin Neoplasms|skin neoplasms
5433288|NCT00005931|Sarcoma, Kaposi|sarcoma, kaposi
5433289|NCT00005931|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5433290|NCT00005931|Antineoplastic Agents|antineoplastic agents
5433291|NCT00005931|Enzyme Inhibitors|enzyme inhibitors
5433292|NCT00005931|SU 5416|su 5416
5433293|NCT00005931|Protein-Tyrosine Kinase|protein-tyrosine kinase
5433294|NCT00005921|Dose-Response Relationship, Drug|dose-response relationship, drug
5433295|NCT00005921|Antifungal Agents|antifungal agents
5433296|NCT00005921|Candidiasis|candidiasis
5433297|NCT00005921|Esophageal Diseases|esophageal diseases
5433298|NCT00005921|MK 0991|mk 0991
5433299|NCT00005920|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
5433300|NCT00005920|Dose-Response Relationship, Drug|dose-response relationship, drug
5433301|NCT00005920|Fluconazole|fluconazole
5433302|NCT00005920|Antifungal Agents|antifungal agents
5433303|NCT00005920|Candidiasis, Oral|candidiasis, oral
5433304|NCT00005920|Pharyngeal Diseases|pharyngeal diseases
5433305|NCT00005920|MK 0991|mk 0991
5433306|NCT00005918|Drug Therapy, Combination|drug therapy, combination
5433307|NCT00005918|Stavudine|stavudine
5433308|NCT00005918|Lamivudine|lamivudine
5433309|NCT00005918|RNA, Viral|rna, viral
5433310|NCT00005918|Dosage Forms|dosage forms
5433311|NCT00005918|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5433312|NCT00005918|Anti-HIV Agents|anti-hiv agents
5433313|NCT00005918|Viral Load|viral load
5433314|NCT00005918|efavirenz|efavirenz
5433315|NCT00005915|HIV-1|hiv-1
5433316|NCT00005915|Drug Administration Schedule|drug administration schedule
5433317|NCT00005915|Drug Resistance, Microbial|drug resistance, microbial
5433318|NCT00005915|Disease Progression|disease progression
5433319|NCT00005915|Genotype|genotype
5433320|NCT00005915|Phenotype|phenotype
5433321|NCT00005915|Drug Resistance, Multiple|drug resistance, multiple
5433322|NCT00005915|Anti-HIV Agents|anti-hiv agents
5433323|NCT00005915|Treatment Experienced|treatment experienced
5433324|NCT00005779|Virus Replication|virus replication
5433325|NCT00005779|HIV-1|hiv-1
5433326|NCT00005779|AIDS Vaccines|aids vaccines
5433327|NCT00005779|CD4 Lymphocyte Count|cd4 lymphocyte count
5433328|NCT00005779|Cohort Studies|cohort studies
5433329|NCT00005779|Interleukin-12|interleukin-12
5433330|NCT00005779|HIV Therapeutic Vaccine|hiv therapeutic vaccine
5433331|NCT00005764|HIV-1|hiv-1
5433332|NCT00005764|Zalcitabine|zalcitabine
5433333|NCT00005764|Didanosine|didanosine
5433334|NCT00005764|Drug Therapy, Combination|drug therapy, combination
5433335|NCT00005764|Zidovudine|zidovudine
5433336|NCT00005764|Stavudine|stavudine
5433337|NCT00005764|Lamivudine|lamivudine
5433338|NCT00005764|Blood|blood
5433339|NCT00005764|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5433340|NCT00005764|Anti-HIV Agents|anti-hiv agents
5433341|NCT00005764|Lipodystrophy|lipodystrophy
5433342|NCT00005764|Combivir|combivir
5433343|NCT00005764|Lactic Acid|lactic acid
5433344|NCT00005764|abacavir|abacavir
5433345|NCT00005762|Drug Interactions|drug interactions
5433346|NCT00005762|Drug Therapy, Combination|drug therapy, combination
5433347|NCT00005762|HIV Protease Inhibitors|hiv protease inhibitors
5433348|NCT00005762|Ritonavir|ritonavir
5433349|NCT00005762|Dosage Forms|dosage forms
5433350|NCT00005762|Saquinavir|saquinavir
5433351|NCT00005762|VX 478|vx 478
5433352|NCT00005762|Anti-HIV Agents|anti-hiv agents
5433353|NCT00005762|Nelfinavir|nelfinavir
5433354|NCT00005762|Pharmacokinetics|pharmacokinetics
5433355|NCT00005762|efavirenz|efavirenz
5433356|NCT00005758|T-Lymphocytes, Helper-Inducer|t-lymphocytes, helper-inducer
5433357|NCT00005758|Combined Modality Therapy|combined modality therapy
5433358|NCT00005758|HIV Envelope Protein gp120|hiv envelope protein gp120
5433359|NCT00005758|AIDS Vaccines|aids vaccines
5433361|NCT00005758|HIV Core Protein p24|hiv core protein p24
5433362|NCT00005758|T-Lymphocytes, Cytotoxic|t-lymphocytes, cytotoxic
5433363|NCT00005758|Anti-HIV Agents|anti-hiv agents
5433364|NCT00005758|Viral Load|viral load
5433365|NCT00005758|HIV Therapeutic Vaccine|hiv therapeutic vaccine
5433366|NCT00005663|Herpes Simplex|herpes simplex
5433367|NCT00005663|Antiviral Agents|antiviral agents
5433368|NCT00005663|Anus Diseases|anus diseases
5433369|NCT00005663|Herpes Genitalis|herpes genitalis
5433370|NCT00005663|Recurrence|recurrence
5433371|NCT00005663|valacyclovir|valacyclovir
5433372|NCT00005572|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
5433373|NCT00005572|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
5433374|NCT00005572|Lymphocytes|lymphocytes
5433375|NCT00005572|Histoplasmosis|histoplasmosis
5433376|NCT00005572|Recurrence|recurrence
5433377|NCT00005572|Cytomegalovirus Retinitis|cytomegalovirus retinitis
5433378|NCT00005572|Cell Division|cell division
5433379|NCT00005572|Immunocompetence|immunocompetence
5433380|NCT00005572|Anti-HIV Agents|anti-hiv agents
5433381|NCT00005120|CD4 Lymphocyte Count|cd4 lymphocyte count
5433382|NCT00005120|Biological Markers|biological markers
5433383|NCT00005120|Anti-HIV Agents|anti-hiv agents
5433384|NCT00005120|Viral Load|viral load
5433385|NCT00005120|Pharmacokinetics|pharmacokinetics
5433386|NCT00005120|calanolide A|calanolide a
5433387|NCT00005118|HIV-1|hiv-1
5433388|NCT00005118|Drug Therapy, Combination|drug therapy, combination
5433389|NCT00005118|HIV Protease Inhibitors|hiv protease inhibitors
5433390|NCT00005118|Ritonavir|ritonavir
5433391|NCT00005118|Indinavir|indinavir
5433392|NCT00005118|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5433393|NCT00005118|Anti-HIV Agents|anti-hiv agents
5433394|NCT00005118|Viral Load|viral load
5433395|NCT00005118|Nelfinavir|nelfinavir
5433396|NCT00005106|Drug Therapy, Combination|drug therapy, combination
5433397|NCT00005106|Zidovudine|zidovudine
5433398|NCT00005106|Stavudine|stavudine
5433399|NCT00005106|HIV Protease Inhibitors|hiv protease inhibitors
5433400|NCT00005106|Lamivudine|lamivudine
5433401|NCT00005106|Nelfinavir|nelfinavir
5433402|NCT00005106|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5433403|NCT00005106|Anti-HIV Agents|anti-hiv agents
5433404|NCT00005106|Adipose Tissue|adipose tissue
5433405|NCT00005106|Lipodystrophy|lipodystrophy
5433406|NCT00005106|abacavir|abacavir
5433407|NCT00005020|CD4 Lymphocyte Count|cd4 lymphocyte count
5433408|NCT00005020|CD4-Positive T-Lymphocytes|cd4-positive t-lymphocytes
5433409|NCT00005020|Phenotype|phenotype
5433410|NCT00005020|Viral Load|viral load
5433411|NCT00005020|Acute Infection|acute infection
5433412|NCT00005018|HIV-1|hiv-1
5433413|NCT00005018|Didanosine|didanosine
5433414|NCT00005018|Drug Therapy, Combination|drug therapy, combination
5433415|NCT00005018|Zidovudine|zidovudine
5433416|NCT00005018|Stavudine|stavudine
5433417|NCT00005018|HIV Protease Inhibitors|hiv protease inhibitors
5433418|NCT00005018|Hydroxyurea|hydroxyurea
5433419|NCT00005018|RNA, Viral|rna, viral
5433420|NCT00005018|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5433421|NCT00005018|Anti-HIV Agents|anti-hiv agents
5433422|NCT00005018|Viral Load|viral load
5433423|NCT00005018|abacavir|abacavir
5433424|NCT00005018|efavirenz|efavirenz
5433425|NCT00005017|HIV-1|hiv-1
5433426|NCT00005017|Drug Therapy, Combination|drug therapy, combination
5433427|NCT00005017|Stavudine|stavudine
5433428|NCT00005017|HIV Protease Inhibitors|hiv protease inhibitors
5433429|NCT00005017|Ritonavir|ritonavir
5433430|NCT00005017|Lamivudine|lamivudine
5433431|NCT00005017|VX 478|vx 478
5433432|NCT00005017|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5433433|NCT00005017|Anti-HIV Agents|anti-hiv agents
5433434|NCT00005017|abacavir|abacavir
5433435|NCT00005017|efavirenz|efavirenz
5433436|NCT00005012|Interferon Alfa-2b|interferon alfa-2b
5433437|NCT00005012|Lymphocyte Transformation|lymphocyte transformation
5433438|NCT00005012|CD4 Lymphocyte Count|cd4 lymphocyte count
5433439|NCT00005012|RNA, Viral|rna, viral
5433440|NCT00005012|Virus Inhibitors|virus inhibitors
5433441|NCT00005012|Anti-HIV Agents|anti-hiv agents
5433442|NCT00005012|Viral Load|viral load
5433443|NCT00005009|pediatric renal transplant recipients|pediatric renal transplant recipients
5433444|NCT00005009|varicella zoster virus (VZV) vaccine|varicella zoster virus (vzv) vaccine
5433445|NCT00005009|herpes zoster vaccine|herpes zoster vaccine
5433446|NCT00005009|VZV susceptible|vzv susceptible
5433447|NCT00005009|safety|safety
5433448|NCT00005009|immunogenicity|immunogenicity
5433449|NCT00005002|HIV-1|hiv-1
5433450|NCT00005002|Drug Therapy, Combination|drug therapy, combination
5433451|NCT00005002|HIV Protease Inhibitors|hiv protease inhibitors
5433452|NCT00005002|CD4 Lymphocyte Count|cd4 lymphocyte count
5433453|NCT00005002|Nelfinavir|nelfinavir
5433454|NCT00005002|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5433455|NCT00005002|Anti-HIV Agents|anti-hiv agents
5433456|NCT00005002|Viral Load|viral load
5433457|NCT00005002|remune|remune
5433458|NCT00005002|Combivir|combivir
5433459|NCT00005001|HIV-1|hiv-1
5433460|NCT00005001|Drug Therapy, Combination|drug therapy, combination
5433461|NCT00005001|RNA, Viral|rna, viral
5433462|NCT00005001|Anti-HIV Agents|anti-hiv agents
5433463|NCT00005001|Viral Load|viral load
5433464|NCT00005001|remune|remune
5433465|NCT00005000|HIV-1|hiv-1
5433466|NCT00005000|Drug Therapy, Combination|drug therapy, combination
5433467|NCT00005000|Lymphoid Tissue|lymphoid tissue
5433468|NCT00005000|HIV Protease Inhibitors|hiv protease inhibitors
5433469|NCT00005000|Genotype|genotype
5433470|NCT00005000|Phenotype|phenotype
5433471|NCT00005000|Nelfinavir|nelfinavir
5433472|NCT00005000|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5433473|NCT00005000|Anti-HIV Agents|anti-hiv agents
5433474|NCT00005000|Viral Load|viral load
5433475|NCT00005000|Adipose Tissue|adipose tissue
5433476|NCT00005000|Glucose|glucose
5433477|NCT00005000|Lipids|lipids
5433478|NCT00005000|Immunophenotyping|immunophenotyping
5433479|NCT00005000|efavirenz|efavirenz
5433480|NCT00004999|Drug Therapy, Combination|drug therapy, combination
5433481|NCT00004999|Zidovudine|zidovudine
5433482|NCT00004999|HIV Protease Inhibitors|hiv protease inhibitors
5433483|NCT00004999|Lamivudine|lamivudine
5433484|NCT00004999|Disease Progression|disease progression
5433485|NCT00004999|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5433486|NCT00004999|Anti-HIV Agents|anti-hiv agents
5433487|NCT00004999|Viral Load|viral load
5433488|NCT00004999|Nelfinavir|nelfinavir
5433489|NCT00004999|Combivir|combivir
5433490|NCT00004998|Drug Therapy, Combination|drug therapy, combination
5433491|NCT00004998|Zidovudine|zidovudine
5433492|NCT00004998|HIV Protease Inhibitors|hiv protease inhibitors
5433493|NCT00004998|Lamivudine|lamivudine
5433494|NCT00004998|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5433495|NCT00004998|Anti-HIV Agents|anti-hiv agents
5433496|NCT00004998|Nelfinavir|nelfinavir
5433497|NCT00004998|Combivir|combivir
5433498|NCT00004987|Anti-HIV Agents|anti-hiv agents
5433499|NCT00004987|Viral Load|viral load
5433500|NCT00004987|dextrin 2-sulfate|dextrin 2-sulfate
5433501|NCT00004987|Infusions, Parenteral|infusions, parenteral
5433502|NCT00004986|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
5433503|NCT00004986|Cryptosporidiosis|cryptosporidiosis
5433504|NCT00004986|Drug Evaluation|drug evaluation
5433505|NCT00004986|Antiprotozoal Agents|antiprotozoal agents
5433506|NCT00004986|Treatment Failure|treatment failure
5433507|NCT00004986|nitazoxanide|nitazoxanide
5433508|NCT00004985|HIV-1|hiv-1
5433509|NCT00004985|Drug Therapy, Combination|drug therapy, combination
5433510|NCT00004985|HIV Protease Inhibitors|hiv protease inhibitors
5433511|NCT00004985|RNA, Viral|rna, viral
5433512|NCT00004985|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5433513|NCT00004985|Anti-HIV Agents|anti-hiv agents
5433514|NCT00004985|Viral Load|viral load
5433515|NCT00004985|Nelfinavir|nelfinavir
5433516|NCT00004981|Drug Therapy, Combination|drug therapy, combination
5433517|NCT00004981|Zidovudine|zidovudine
5433518|NCT00004981|Drug Administration Schedule|drug administration schedule
5433519|NCT00004981|Lamivudine|lamivudine
5433520|NCT00004981|RNA, Viral|rna, viral
5433521|NCT00004981|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5433522|NCT00004981|Anti-HIV Agents|anti-hiv agents
5433523|NCT00004981|Viral Load|viral load
5433524|NCT00004981|Combivir|combivir
5433525|NCT00004981|abacavir|abacavir
5433526|NCT00004978|Recombinant Proteins|recombinant proteins
5433527|NCT00004978|Injections, Subcutaneous|injections, subcutaneous
5433528|NCT00004978|HIV-1|hiv-1
5433529|NCT00004978|Interleukin-2|interleukin-2
5433530|NCT00004978|Drug Therapy, Combination|drug therapy, combination
5433531|NCT00004978|CD4 Lymphocyte Count|cd4 lymphocyte count
5433532|NCT00004978|Disease Progression|disease progression
5433533|NCT00004978|Follow-Up Studies|follow-up studies
5433534|NCT00004978|Anti-HIV Agents|anti-hiv agents
5433535|NCT00004855|Drug Therapy, Combination|drug therapy, combination
5433536|NCT00004855|Nevirapine|nevirapine
5433537|NCT00004855|Stavudine|stavudine
5433538|NCT00004855|HIV Protease Inhibitors|hiv protease inhibitors
5433539|NCT00004855|Ritonavir|ritonavir
5433540|NCT00004855|Lamivudine|lamivudine
5433541|NCT00004855|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5433542|NCT00004855|Anti-HIV Agents|anti-hiv agents
5433543|NCT00004855|ABT 378|abt 378
5433544|NCT00004855|abacavir|abacavir
5433545|NCT00004852|HIV-1|hiv-1
5433546|NCT00004852|Drug Therapy, Combination|drug therapy, combination
5433547|NCT00004852|Zidovudine|zidovudine
5433548|NCT00004852|Drug Administration Schedule|drug administration schedule
5433549|NCT00004852|Lamivudine|lamivudine
5433550|NCT00004852|Genotype|genotype
5433551|NCT00004852|Phenotype|phenotype
5433552|NCT00004852|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5433553|NCT00004852|Anti-HIV Agents|anti-hiv agents
5433554|NCT00004852|Viral Load|viral load
5433555|NCT00004852|efavirenz|efavirenz
5433556|NCT00004736|Tuberculosis|tuberculosis
5433557|NCT00004736|Rifabutin|rifabutin
5433558|NCT00004736|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
5433559|NCT00004736|Drug Therapy, Combination|drug therapy, combination
5433560|NCT00004736|Antitubercular Agents|antitubercular agents
5433561|NCT00004736|Anti-HIV Agents|anti-hiv agents
5433562|NCT00004735|Viral Vaccines|viral vaccines
5433563|NCT00004735|Drug Therapy, Combination|drug therapy, combination
5433564|NCT00004735|CD4-Positive T-Lymphocytes|cd4-positive t-lymphocytes
5433565|NCT00004735|Immunologic Memory|immunologic memory
5433566|NCT00004735|Antibody Formation|antibody formation
5433567|NCT00004735|Anti-HIV Agents|anti-hiv agents
5433568|NCT00004735|Tetanus Toxoid|tetanus toxoid
5433569|NCT00004735|Hepatitis A Virus, Human|hepatitis a virus, human
5433570|NCT00004735|Enfuvirtide|enfuvirtide
5433571|NCT00004735|T-20|t-20
5433572|NCT00004735|Treatment Naive|treatment naive
5433573|NCT00004735|Treatment Experienced|treatment experienced
5433574|NCT00004585|Drug Therapy, Combination|drug therapy, combination
5433575|NCT00004585|Zidovudine|zidovudine
5433576|NCT00004585|Lamivudine|lamivudine
5433577|NCT00004585|RNA, Viral|rna, viral
5433578|NCT00004585|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5433579|NCT00004585|Anti-HIV Agents|anti-hiv agents
5433580|NCT00004585|Viral Load|viral load
5433581|NCT00004585|abacavir|abacavir
5433582|NCT00004585|efavirenz|efavirenz
5433583|NCT00004584|Dose-Response Relationship, Drug|dose-response relationship, drug
5433584|NCT00004584|Drug Therapy, Combination|drug therapy, combination
5433585|NCT00004584|HIV Protease Inhibitors|hiv protease inhibitors
5433586|NCT00004584|Ritonavir|ritonavir
5433587|NCT00004584|Saquinavir|saquinavir
5433588|NCT00004584|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5433589|NCT00004584|Anti-HIV Agents|anti-hiv agents
5433590|NCT00004583|Drug Therapy, Combination|drug therapy, combination
5433591|NCT00004583|Administration, Oral|administration, oral
5433592|NCT00004583|Stavudine|stavudine
5433593|NCT00004583|HIV Protease Inhibitors|hiv protease inhibitors
5433594|NCT00004583|Lamivudine|lamivudine
5433595|NCT00004583|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5433596|NCT00004583|Anti-HIV Agents|anti-hiv agents
5433597|NCT00004583|Nelfinavir|nelfinavir
5433598|NCT00004583|ABT 378|abt 378
5433599|NCT00004582|HIV Protease Inhibitors|hiv protease inhibitors
5433600|NCT00004582|Ritonavir|ritonavir
5433601|NCT00004582|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5433602|NCT00004582|Anti-HIV Agents|anti-hiv agents
5433603|NCT00004582|Viral Load|viral load
5433604|NCT00004582|ABT 378|abt 378
5433605|NCT00004582|efavirenz|efavirenz
5433606|NCT00004581|Drug Therapy, Combination|drug therapy, combination
5433607|NCT00004581|Nevirapine|nevirapine
5433608|NCT00004581|HIV Protease Inhibitors|hiv protease inhibitors
5433609|NCT00004581|Ritonavir|ritonavir
5433610|NCT00004581|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5433611|NCT00004581|Anti-HIV Agents|anti-hiv agents
5433612|NCT00004581|ABT 378|abt 378
5433613|NCT00004580|Drug Therapy, Combination|drug therapy, combination
5433614|NCT00004580|Nevirapine|nevirapine
5433615|NCT00004580|HIV Protease Inhibitors|hiv protease inhibitors
5433616|NCT00004580|Ritonavir|ritonavir
5433617|NCT00004580|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5433618|NCT00004579|Vaccines, Synthetic|vaccines, synthetic
5433619|NCT00004579|Viral Vaccines|viral vaccines
5433620|NCT00004579|HIV-1|hiv-1
5433621|NCT00004579|Dose-Response Relationship, Drug|dose-response relationship, drug
5433622|NCT00004579|HIV Envelope Protein gp160|hiv envelope protein gp160
5433623|NCT00004579|AIDS Vaccines|aids vaccines
5433624|NCT00004579|HIV Seronegativity|hiv seronegativity
5433625|NCT00004579|Avipoxvirus|avipoxvirus
5433626|NCT00004579|Immunization|immunization
5433627|NCT00004579|HIV Envelope Protein gp120|hiv envelope protein gp120
5433628|NCT00004579|Recombination, Genetic|recombination, genetic
5433629|NCT00004578|Stavudine|stavudine
5433630|NCT00004578|HIV Protease Inhibitors|hiv protease inhibitors
5433631|NCT00004578|Ritonavir|ritonavir
5433632|NCT00004578|Lamivudine|lamivudine
5433633|NCT00004578|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5433634|NCT00002453|HIV-1|hiv-1
5433635|NCT00002453|Drug Therapy, Combination|drug therapy, combination
5433636|NCT00002453|Disease Progression|disease progression
5433637|NCT00002453|Anti-HIV Agents|anti-hiv agents
5433638|NCT00002452|Drug Therapy, Combination|drug therapy, combination
5433639|NCT00002452|HIV Protease Inhibitors|hiv protease inhibitors
5433640|NCT00002452|Indinavir|indinavir
5433641|NCT00002452|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5433642|NCT00002452|Anti-HIV Agents|anti-hiv agents
5433643|NCT00002452|Viral Load|viral load
5433644|NCT00002451|Drug Therapy, Combination|drug therapy, combination
5433645|NCT00002451|Stavudine|stavudine
5433646|NCT00002451|HIV Protease Inhibitors|hiv protease inhibitors
5433647|NCT00002451|CD4 Lymphocyte Count|cd4 lymphocyte count
5433648|NCT00002451|Ritonavir|ritonavir
5433649|NCT00002451|Lamivudine|lamivudine
5433650|NCT00002451|Indinavir|indinavir
5433651|NCT00002451|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5433652|NCT00002451|Anti-HIV Agents|anti-hiv agents
5433653|NCT00002451|Viral Load|viral load
5433654|NCT00002450|HIV-1|hiv-1
5433655|NCT00002450|Drug Therapy, Combination|drug therapy, combination
5433656|NCT00002450|Drug Administration Schedule|drug administration schedule
5433657|NCT00002450|RNA, Viral|rna, viral
5433658|NCT00002450|Anti-HIV Agents|anti-hiv agents
5433659|NCT00002450|Viral Load|viral load
5433660|NCT00002449|Recombinant Proteins|recombinant proteins
5433661|NCT00002449|Injections, Subcutaneous|injections, subcutaneous
5433662|NCT00002449|Interleukin-2|interleukin-2
5433663|NCT00002449|Dose-Response Relationship, Drug|dose-response relationship, drug
5433664|NCT00002449|CD4 Lymphocyte Count|cd4 lymphocyte count
5433665|NCT00002449|Anti-HIV Agents|anti-hiv agents
5433666|NCT00002449|Viral Load|viral load
5433667|NCT00002449|Pharmacokinetics|pharmacokinetics
5433668|NCT00002448|Drug Therapy, Combination|drug therapy, combination
5433669|NCT00002448|HIV Protease Inhibitors|hiv protease inhibitors
5433670|NCT00002448|Ritonavir|ritonavir
5433671|NCT00002448|Dosage Forms|dosage forms
5433672|NCT00002448|Saquinavir|saquinavir
5433673|NCT00002448|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5433674|NCT00002448|Anti-HIV Agents|anti-hiv agents
5433675|NCT00002448|efavirenz|efavirenz
5433676|NCT00002447|Drug Therapy, Combination|drug therapy, combination
5433677|NCT00002447|Saquinavir|saquinavir
5433678|NCT00002447|HIV Protease Inhibitors|hiv protease inhibitors
5433679|NCT00002447|Ritonavir|ritonavir
5433680|NCT00002447|Dosage Forms|dosage forms
5433681|NCT00002447|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5433682|NCT00002447|Anti-HIV Agents|anti-hiv agents
5433683|NCT00002447|efavirenz|efavirenz
5433684|NCT00002446|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
5433685|NCT00002446|Fluconazole|fluconazole
5433686|NCT00002446|Administration, Oral|administration, oral
5433687|NCT00002446|Antifungal Agents|antifungal agents
5433688|NCT00002446|Candidiasis, Oral|candidiasis, oral
5433689|NCT00002446|Pharyngeal Diseases|pharyngeal diseases
5433690|NCT00002446|posaconazole|posaconazole
5433691|NCT00002445|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
5433692|NCT00002445|Placebos|placebos
5433693|NCT00002445|Sarcoma, Kaposi|sarcoma, kaposi
5433694|NCT00002445|Antineoplastic Agents|antineoplastic agents
5433695|NCT00002445|Treatment Outcome|treatment outcome
5433696|NCT00002445|Quality of Life|quality of life
5433697|NCT00002442|Drug Therapy, Combination|drug therapy, combination
5433698|NCT00002442|Zidovudine|zidovudine
5433699|NCT00002442|Drug Administration Schedule|drug administration schedule
5433700|NCT00002442|Stavudine|stavudine
5433701|NCT00002442|HIV Protease Inhibitors|hiv protease inhibitors
5433702|NCT00002442|Lamivudine|lamivudine
5433703|NCT00002442|Indinavir|indinavir
5433704|NCT00002442|Dosage Forms|dosage forms
5433705|NCT00002442|Nelfinavir|nelfinavir
5433706|NCT00002442|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5433707|NCT00002442|Anti-HIV Agents|anti-hiv agents
5433708|NCT00002441|HIV-1|hiv-1
5433709|NCT00002441|Dose-Response Relationship, Drug|dose-response relationship, drug
5433710|NCT00002441|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5433711|NCT00002441|AIDS Vaccines|aids vaccines
5433712|NCT00002441|Sexually Transmitted Diseases|sexually transmitted diseases
5433713|NCT00002441|Risk Factors|risk factors
5433714|NCT00002441|HIV Seronegativity|hiv seronegativity
5433715|NCT00002441|Antigens, Viral|antigens, viral
5433716|NCT00002441|Alum Compounds|alum compounds
5433717|NCT00002440|HIV-1|hiv-1
5433718|NCT00002440|Drug Therapy, Combination|drug therapy, combination
5433719|NCT00002440|HIV Protease Inhibitors|hiv protease inhibitors
5433720|NCT00002440|Mutation|mutation
5433721|NCT00002440|HIV-1 Reverse Transcriptase|hiv-1 reverse transcriptase
5433722|NCT00002440|HIV Protease|hiv protease
5433723|NCT00002440|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5433724|NCT00002440|Anti-HIV Agents|anti-hiv agents
5433725|NCT00002440|abacavir|abacavir
5433726|NCT00002438|Itraconazole|itraconazole
5433727|NCT00002438|Histoplasmosis|histoplasmosis
5433728|NCT00002438|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5433729|NCT00002437|Retinitis|retinitis
5433730|NCT00002437|Probenecid|probenecid
5433731|NCT00002437|Drug Therapy, Combination|drug therapy, combination
5433732|NCT00002437|Cytomegalovirus Infections|cytomegalovirus infections
5433733|NCT00002437|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5433734|NCT00002437|Antiviral Agents|antiviral agents
5433735|NCT00002437|cidofovir|cidofovir
5433736|NCT00002436|Zalcitabine|zalcitabine
5433737|NCT00002436|Drug Therapy, Combination|drug therapy, combination
5433738|NCT00002436|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5433739|NCT00002436|AIDS-Related Complex|aids-related complex
5433740|NCT00002436|Antiviral Agents|antiviral agents
5433741|NCT00002436|Zidovudine|zidovudine
5433742|NCT00002435|Drug Therapy, Combination|drug therapy, combination
5433743|NCT00002435|Antiviral Agents|antiviral agents
5433744|NCT00002435|Zidovudine|zidovudine
5433745|NCT00002435|thymic humoral factor gamma 2|thymic humoral factor gamma 2
5433746|NCT00002434|Trimetrexate|trimetrexate
5433747|NCT00002434|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
5433748|NCT00002434|Leucovorin|leucovorin
5433749|NCT00002434|Drug Therapy, Combination|drug therapy, combination
5433750|NCT00002434|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5433751|NCT00002433|Pulmonary Alveoli|pulmonary alveoli
5433752|NCT00002433|Macrophage Activation|macrophage activation
5433753|NCT00002433|Interferon-gamma, Recombinant|interferon-gamma, recombinant
5433754|NCT00002433|Injections, Subcutaneous|injections, subcutaneous
5433756|NCT00002433|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5433757|NCT00002432|Retinitis|retinitis
5433758|NCT00002432|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
5433759|NCT00002432|Foscarnet|foscarnet
5433760|NCT00002432|Cytomegalovirus Infections|cytomegalovirus infections
5433761|NCT00002432|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5433762|NCT00002431|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
5433763|NCT00002431|chlorhexidine gluconate|chlorhexidine gluconate
5433764|NCT00002431|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5433765|NCT00002431|Anti-Infective Agents, Local|anti-infective agents, local
5433766|NCT00002431|AIDS-Related Complex|aids-related complex
5433767|NCT00002431|Candidiasis, Oral|candidiasis, oral
5433768|NCT00002430|Drug Therapy, Combination|drug therapy, combination
5433769|NCT00002430|HIV Protease Inhibitors|hiv protease inhibitors
5433770|NCT00002430|Lamivudine|lamivudine
5433771|NCT00002430|Indinavir|indinavir
5433772|NCT00002430|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5433773|NCT00002430|Anti-HIV Agents|anti-hiv agents
5433774|NCT00002430|Nelfinavir|nelfinavir
5433775|NCT00002429|Didanosine|didanosine
5433776|NCT00002429|Drug Therapy, Combination|drug therapy, combination
5433777|NCT00002429|Stavudine|stavudine
5433778|NCT00002429|RNA, Viral|rna, viral
5433779|NCT00002429|Nelfinavir|nelfinavir
5433780|NCT00002429|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5433781|NCT00002429|Anti-HIV Agents|anti-hiv agents
5433782|NCT00002428|Vaccines, Synthetic|vaccines, synthetic
5433783|NCT00002428|HIV-1|hiv-1
5433784|NCT00002428|HIV Envelope Protein gp120|hiv envelope protein gp120
5433785|NCT00002428|AIDS Vaccines|aids vaccines
5433786|NCT00002428|HIV Seronegativity|hiv seronegativity
5433787|NCT00002427|Didanosine|didanosine
5433788|NCT00002427|Dose-Response Relationship, Drug|dose-response relationship, drug
5433789|NCT00002427|Drug Therapy, Combination|drug therapy, combination
5433790|NCT00002427|Stavudine|stavudine
5433791|NCT00002427|Hydroxyurea|hydroxyurea
5433792|NCT00002427|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5433793|NCT00002427|Anti-HIV Agents|anti-hiv agents
5433794|NCT00002426|HIV-1|hiv-1
5433795|NCT00002426|RNA, Viral|rna, viral
5433796|NCT00002426|VX 478|vx 478
5433797|NCT00002426|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5433798|NCT00002426|Anti-HIV Agents|anti-hiv agents
5433799|NCT00002426|Viral Load|viral load
5433800|NCT00002425|Drug Therapy, Combination|drug therapy, combination
5433801|NCT00002425|Saquinavir|saquinavir
5433802|NCT00002425|HIV Protease Inhibitors|hiv protease inhibitors
5433803|NCT00002425|Dosage Forms|dosage forms
5433804|NCT00002425|Anti-HIV Agents|anti-hiv agents
5433805|NCT00002424|Drug Therapy, Combination|drug therapy, combination
5433806|NCT00002424|Drug Administration Schedule|drug administration schedule
5433807|NCT00002424|Stavudine|stavudine
5433808|NCT00002424|HIV Protease Inhibitors|hiv protease inhibitors
5433809|NCT00002424|Lamivudine|lamivudine
5433810|NCT00002424|Indinavir|indinavir
5433811|NCT00002424|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5433812|NCT00002424|Anti-HIV Agents|anti-hiv agents
5433813|NCT00002423|Drug Therapy, Combination|drug therapy, combination
5433814|NCT00002423|HIV Protease Inhibitors|hiv protease inhibitors
5433815|NCT00002423|Lamivudine|lamivudine
5433816|NCT00002423|Indinavir|indinavir
5433817|NCT00002423|Nelfinavir|nelfinavir
5433818|NCT00002423|VX 478|vx 478
5433819|NCT00002423|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5433820|NCT00002423|Anti-HIV Agents|anti-hiv agents
5433821|NCT00002423|Viral Load|viral load
5433822|NCT00002423|abacavir|abacavir
5433823|NCT00002422|Injections, Intramuscular|injections, intramuscular
5433824|NCT00002422|Drug Interactions|drug interactions
5433825|NCT00002422|Salvage Therapy|salvage therapy
5433826|NCT00002422|Anti-HIV Agents|anti-hiv agents
5433827|NCT00002420|Drug Therapy, Combination|drug therapy, combination
5433828|NCT00002420|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5433829|NCT00002420|Anti-HIV Agents|anti-hiv agents
5433830|NCT00002419|Drug Therapy, Combination|drug therapy, combination
5433831|NCT00002419|HIV Protease Inhibitors|hiv protease inhibitors
5433832|NCT00002419|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5433833|NCT00002419|Anti-HIV Agents|anti-hiv agents
5433834|NCT00002418|Drug Therapy, Combination|drug therapy, combination
5433835|NCT00002418|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5433836|NCT00002418|Anti-HIV Agents|anti-hiv agents
5433837|NCT00002418|Viral Load|viral load
5433838|NCT00002417|Drug Therapy, Combination|drug therapy, combination
5433839|NCT00002417|HIV Protease Inhibitors|hiv protease inhibitors
5433840|NCT00002417|VX 478|vx 478
5433841|NCT00002417|Lipodystrophy|lipodystrophy
5433842|NCT00002417|Hyperlipidemia|hyperlipidemia
5433843|NCT00002416|HIV-1|hiv-1
5433844|NCT00002416|Zalcitabine|zalcitabine
5433845|NCT00002416|Zidovudine|zidovudine
5433846|NCT00002416|Stavudine|stavudine
5433847|NCT00002416|HIV Protease Inhibitors|hiv protease inhibitors
5433848|NCT00002416|Lamivudine|lamivudine
5433849|NCT00002416|RNA, Viral|rna, viral
5433850|NCT00002416|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5443962|NCT00001750|Melphalan|melphalan
5433851|NCT00002416|Anti-HIV Agents|anti-hiv agents
5433852|NCT00002415|Drug Therapy, Combination|drug therapy, combination
5433853|NCT00002415|Prodrugs|prodrugs
5433854|NCT00002415|Anti-HIV Agents|anti-hiv agents
5433855|NCT00002414|AIDS Dementia Complex|aids dementia complex
5433856|NCT00002414|Anti-HIV Agents|anti-hiv agents
5433857|NCT00002413|Anti-HIV Agents|anti-hiv agents
5433858|NCT00002413|Viral Load|viral load
5433859|NCT00002413|MKC 442|mkc 442
5433860|NCT00002412|Didanosine|didanosine
5433861|NCT00002412|Drug Therapy, Combination|drug therapy, combination
5433862|NCT00002412|Stavudine|stavudine
5433863|NCT00002412|Hydroxyurea|hydroxyurea
5433864|NCT00002412|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5433865|NCT00002412|Anti-HIV Agents|anti-hiv agents
5433866|NCT00002412|Viral Load|viral load
5433867|NCT00002412|MKC 442|mkc 442
5433868|NCT00002411|HIV-1|hiv-1
5433869|NCT00002411|Didanosine|didanosine
5433870|NCT00002411|Drug Therapy, Combination|drug therapy, combination
5433871|NCT00002411|Zidovudine|zidovudine
5433872|NCT00002411|Stavudine|stavudine
5433873|NCT00002411|Lamivudine|lamivudine
5433874|NCT00002411|RNA, Viral|rna, viral
5433875|NCT00002411|Nelfinavir|nelfinavir
5433876|NCT00002411|Anti-HIV Agents|anti-hiv agents
5433877|NCT00002411|Viral Load|viral load
5433878|NCT00002410|HIV-1|hiv-1
5433879|NCT00002410|Drug Therapy, Combination|drug therapy, combination
5433880|NCT00002410|Zidovudine|zidovudine
5433881|NCT00002410|Drug Resistance, Microbial|drug resistance, microbial
5433882|NCT00002410|HIV Protease Inhibitors|hiv protease inhibitors
5433883|NCT00002410|Lamivudine|lamivudine
5433884|NCT00002410|Indinavir|indinavir
5433885|NCT00002410|Genotype|genotype
5433886|NCT00002410|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5433887|NCT00002410|efavirenz|efavirenz
5433888|NCT00002409|Drug Therapy, Combination|drug therapy, combination
5433889|NCT00002409|Zidovudine|zidovudine
5433890|NCT00002409|HIV Protease Inhibitors|hiv protease inhibitors
5433891|NCT00002409|Lamivudine|lamivudine
5433892|NCT00002409|Patient Education|patient education
5433893|NCT00002409|Patient Compliance|patient compliance
5433894|NCT00002409|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5433895|NCT00002409|Anti-HIV Agents|anti-hiv agents
5433896|NCT00002409|Viral Load|viral load
5433897|NCT00002409|abacavir|abacavir
5433898|NCT00002408|Diarrhea|diarrhea
5433899|NCT00002408|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5433900|NCT00002406|HIV-1|hiv-1
5433901|NCT00002406|Dose-Response Relationship, Drug|dose-response relationship, drug
5433902|NCT00002406|HIV Protease Inhibitors|hiv protease inhibitors
5433903|NCT00002406|Indinavir|indinavir
5433904|NCT00002406|RNA, Viral|rna, viral
5433905|NCT00002406|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5433906|NCT00002405|Drug Therapy, Combination|drug therapy, combination
5433907|NCT00002405|HIV Protease Inhibitors|hiv protease inhibitors
5433908|NCT00002405|VX 478|vx 478
5433909|NCT00002405|Anti-HIV Agents|anti-hiv agents
5433910|NCT00002404|HIV-1|hiv-1
5433911|NCT00002404|Antiviral Agents|antiviral agents
5433912|NCT00002404|Herpes Genitalis|herpes genitalis
5433913|NCT00002404|Recurrence|recurrence
5433914|NCT00002404|DNA, Viral|dna, viral
5433915|NCT00002404|RNA, Viral|rna, viral
5433916|NCT00002404|valacyclovir|valacyclovir
5433917|NCT00002404|Herpesvirus 2, Human|herpesvirus 2, human
5433918|NCT00002403|HIV-1|hiv-1
5433919|NCT00002403|Dose-Response Relationship, Drug|dose-response relationship, drug
5433920|NCT00002403|HIV Integrase Inhibitors|hiv integrase inhibitors
5433921|NCT00002403|HIV Integrase|hiv integrase
5433922|NCT00002402|HIV-1|hiv-1
5433923|NCT00002402|Dose-Response Relationship, Drug|dose-response relationship, drug
5433924|NCT00002402|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5433925|NCT00002402|AIDS Vaccines|aids vaccines
5433926|NCT00002402|HIV Seronegativity|hiv seronegativity
5433927|NCT00002402|Antigens, Viral|antigens, viral
5433928|NCT00002402|Alum Compounds|alum compounds
5433929|NCT00002401|HIV-1|hiv-1
5433930|NCT00002401|Zidovudine|zidovudine
5433931|NCT00002401|HIV Protease Inhibitors|hiv protease inhibitors
5433932|NCT00002401|Lamivudine|lamivudine
5433933|NCT00002401|Indinavir|indinavir
5433934|NCT00002401|RNA, Viral|rna, viral
5433935|NCT00002401|Delavirdine|delavirdine
5433936|NCT00002401|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5433937|NCT00002401|Viral Load|viral load
5433938|NCT00002400|HIV-1|hiv-1
5433939|NCT00002400|Drug Therapy, Combination|drug therapy, combination
5433940|NCT00002400|Zidovudine|zidovudine
5433941|NCT00002400|HIV Protease Inhibitors|hiv protease inhibitors
5433942|NCT00002400|Lamivudine|lamivudine
5433943|NCT00002400|Indinavir|indinavir
5433944|NCT00002400|RNA, Viral|rna, viral
5433945|NCT00002400|Delavirdine|delavirdine
5433946|NCT00002400|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5433947|NCT00002399|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
5433948|NCT00002399|Fluconazole|fluconazole
5433949|NCT00002399|Antifungal Agents|antifungal agents
5433950|NCT00002399|Candidiasis|candidiasis
5433951|NCT00002399|Triazoles|triazoles
5433952|NCT00002398|HIV-1|hiv-1
5433953|NCT00002398|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5433954|NCT00002398|Adenine|adenine
5433955|NCT00002398|Anti-HIV Agents|anti-hiv agents
5433956|NCT00002397|Kidney Failure, Chronic|kidney failure, chronic
5433957|NCT00002397|HIV-1|hiv-1
5433958|NCT00002397|Drug Therapy, Combination|drug therapy, combination
5433959|NCT00002397|Stavudine|stavudine
5433960|NCT00002397|HIV Protease Inhibitors|hiv protease inhibitors
5433961|NCT00002397|Lamivudine|lamivudine
5433962|NCT00002397|Saquinavir|saquinavir
5433963|NCT00002397|AIDS-Associated Nephropathy|aids-associated nephropathy
5433964|NCT00002397|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5433965|NCT00002397|Viral Load|viral load
5433966|NCT00002397|Nelfinavir|nelfinavir
5433967|NCT00002396|Dose-Response Relationship, Drug|dose-response relationship, drug
5433968|NCT00002396|Adenine|adenine
5433969|NCT00002396|Anti-HIV Agents|anti-hiv agents
5433970|NCT00002395|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
5433971|NCT00002395|Leukoencephalopathy, Progressive Multifocal|leukoencephalopathy, progressive multifocal
5433972|NCT00002395|Infusions, Intravenous|infusions, intravenous
5433973|NCT00002395|Drug Administration Schedule|drug administration schedule
5433974|NCT00002395|Topotecan|topotecan
5433975|NCT00002394|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
5433976|NCT00002394|Dose-Response Relationship, Drug|dose-response relationship, drug
5433977|NCT00002394|Fluconazole|fluconazole
5433978|NCT00002394|Antifungal Agents|antifungal agents
5433979|NCT00002394|Candidiasis, Oral|candidiasis, oral
5433980|NCT00002394|Drug Administration Schedule|drug administration schedule
5433981|NCT00002394|terbinafine|terbinafine
5433982|NCT00002393|Placebos|placebos
5433983|NCT00002393|Drug Therapy, Combination|drug therapy, combination
5433984|NCT00002393|HIV Protease Inhibitors|hiv protease inhibitors
5433985|NCT00002393|Indinavir|indinavir
5433986|NCT00002393|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5433987|NCT00002393|efavirenz|efavirenz
5433988|NCT00002392|Lymphocyte Transformation|lymphocyte transformation
5433989|NCT00002392|Immunity, Cellular|immunity, cellular
5433990|NCT00002392|Drug Therapy, Combination|drug therapy, combination
5433991|NCT00002392|Adjuvants, Immunologic|adjuvants, immunologic
5433992|NCT00002392|Thalidomide|thalidomide
5433993|NCT00002392|Immunologic Memory|immunologic memory
5433994|NCT00002392|Streptococcus pneumoniae|streptococcus pneumoniae
5433995|NCT00002392|Tetanus Toxoid|tetanus toxoid
5433996|NCT00002392|Pneumococcal Vaccines|pneumococcal vaccines
5433997|NCT00002391|HIV-1|hiv-1
5433998|NCT00002391|Drug Therapy, Combination|drug therapy, combination
5433999|NCT00002391|Zidovudine|zidovudine
5434000|NCT00002391|Lamivudine|lamivudine
5434001|NCT00002391|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5434002|NCT00002391|Anti-HIV Agents|anti-hiv agents
5434003|NCT00002391|Viral Load|viral load
5434004|NCT00002391|Child Development|child development
5434005|NCT00002391|abacavir|abacavir
5434006|NCT00002389|HIV-1|hiv-1
5434007|NCT00002389|Drug Therapy, Combination|drug therapy, combination
5434008|NCT00002389|Antiviral Agents|antiviral agents
5434009|NCT00002389|Zidovudine|zidovudine
5434010|NCT00002389|CD4 Lymphocyte Count|cd4 lymphocyte count
5434011|NCT00002389|Lamivudine|lamivudine
5434012|NCT00002389|RNA, Viral|rna, viral
5434013|NCT00002389|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5434014|NCT00002389|Anti-HIV Agents|anti-hiv agents
5434015|NCT00002389|Viral Load|viral load
5434016|NCT00002389|abacavir|abacavir
5434017|NCT00002388|HIV-1|hiv-1
5434018|NCT00002388|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5434019|NCT00002388|Anti-HIV Agents|anti-hiv agents
5434020|NCT00002387|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5434021|NCT00002387|Drug Administration Schedule|drug administration schedule
5434022|NCT00002387|HIV Protease Inhibitors|hiv protease inhibitors
5434023|NCT00002387|Indinavir|indinavir
5434024|NCT00002387|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5434025|NCT00002387|Anti-HIV Agents|anti-hiv agents
5434026|NCT00002387|efavirenz|efavirenz
5434027|NCT00002386|Drug Therapy, Combination|drug therapy, combination
5434028|NCT00002386|HIV Protease Inhibitors|hiv protease inhibitors
5434029|NCT00002386|Indinavir|indinavir
5434030|NCT00002386|Factor VIII|factor viii
5434031|NCT00002386|Factor IX|factor ix
5434032|NCT00002386|Half-Life|half-life
5434033|NCT00002386|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5434034|NCT00002386|Anti-HIV Agents|anti-hiv agents
5434035|NCT00002386|Platelet Aggregation|platelet aggregation
5434036|NCT00002386|Hemophilia A|hemophilia a
5434037|NCT00002386|Hemophilia B|hemophilia b
5434038|NCT00002385|Dose-Response Relationship, Drug|dose-response relationship, drug
5434039|NCT00002385|Cohort Studies|cohort studies
5434040|NCT00002385|Anti-HIV Agents|anti-hiv agents
5434041|NCT00002383|Drug Administration Schedule|drug administration schedule
5434042|NCT00002383|HIV Protease Inhibitors|hiv protease inhibitors
5434043|NCT00002383|Dosage Forms|dosage forms
5434044|NCT00002383|Saquinavir|saquinavir
5434045|NCT00002383|Anti-HIV Agents|anti-hiv agents
5434046|NCT00002382|Zalcitabine|zalcitabine
5434047|NCT00002382|Didanosine|didanosine
5444066|NCT00001721|Cholesterol|cholesterol
5434048|NCT00002382|Drug Therapy, Combination|drug therapy, combination
5434049|NCT00002382|Zidovudine|zidovudine
5434050|NCT00002382|HIV Protease Inhibitors|hiv protease inhibitors
5434051|NCT00002382|Saquinavir|saquinavir
5434052|NCT00002382|Patient Selection|patient selection
5434053|NCT00002382|Anti-HIV Agents|anti-hiv agents
5434054|NCT00002381|HIV-1|hiv-1
5434055|NCT00002381|Drug Therapy, Combination|drug therapy, combination
5434056|NCT00002381|Nevirapine|nevirapine
5434057|NCT00002381|Stavudine|stavudine
5434058|NCT00002381|RNA, Viral|rna, viral
5434059|NCT00002381|Nelfinavir|nelfinavir
5434060|NCT00002381|Anti-HIV Agents|anti-hiv agents
5434061|NCT00002381|Viral Load|viral load
5434062|NCT00002380|Drug Therapy, Combination|drug therapy, combination
5434063|NCT00002380|HIV Protease Inhibitors|hiv protease inhibitors
5434064|NCT00002380|Dosage Forms|dosage forms
5434065|NCT00002380|Saquinavir|saquinavir
5434066|NCT00002380|Nelfinavir|nelfinavir
5434067|NCT00002380|Anti-HIV Agents|anti-hiv agents
5434068|NCT00002379|HIV-1|hiv-1
5434069|NCT00002379|Drug Therapy, Combination|drug therapy, combination
5434070|NCT00002379|Administration, Oral|administration, oral
5434071|NCT00002379|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5434072|NCT00002379|Zidovudine|zidovudine
5434073|NCT00002379|Stavudine|stavudine
5434074|NCT00002379|HIV Protease Inhibitors|hiv protease inhibitors
5434075|NCT00002379|CD4 Lymphocyte Count|cd4 lymphocyte count
5434076|NCT00002379|Lamivudine|lamivudine
5434077|NCT00002379|Indinavir|indinavir
5434078|NCT00002379|RNA, Viral|rna, viral
5434079|NCT00002379|Adenine|adenine
5434080|NCT00002379|Anti-HIV Agents|anti-hiv agents
5434081|NCT00002379|Viral Load|viral load
5434082|NCT00002378|HIV-1|hiv-1
5434083|NCT00002378|Drug Therapy, Combination|drug therapy, combination
5434084|NCT00002378|Zidovudine|zidovudine
5434085|NCT00002378|Stavudine|stavudine
5434086|NCT00002378|HIV Protease Inhibitors|hiv protease inhibitors
5434087|NCT00002378|Lamivudine|lamivudine
5434088|NCT00002378|RNA, Viral|rna, viral
5434089|NCT00002378|Dosage Forms|dosage forms
5434090|NCT00002378|Saquinavir|saquinavir
5434091|NCT00002378|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5434092|NCT00002378|Anti-HIV Agents|anti-hiv agents
5434093|NCT00002378|Viral Load|viral load
5434094|NCT00002378|Nelfinavir|nelfinavir
5434095|NCT00002376|HIV-1|hiv-1
5434096|NCT00002376|CD4 Lymphocyte Count|cd4 lymphocyte count
5434097|NCT00002376|RNA, Viral|rna, viral
5434098|NCT00002376|Anti-HIV Agents|anti-hiv agents
5434099|NCT00002376|Viral Load|viral load
5434100|NCT00002375|Drug Therapy, Combination|drug therapy, combination
5434101|NCT00002375|HIV Protease Inhibitors|hiv protease inhibitors
5434102|NCT00002375|Indinavir|indinavir
5434103|NCT00002375|Nelfinavir|nelfinavir
5434104|NCT00002375|Anti-HIV Agents|anti-hiv agents
5434105|NCT00002374|HIV-1|hiv-1
5434106|NCT00002374|Drug Therapy, Combination|drug therapy, combination
5434107|NCT00002374|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5434108|NCT00002374|HIV Protease Inhibitors|hiv protease inhibitors
5434109|NCT00002374|RNA, Viral|rna, viral
5434110|NCT00002374|Saquinavir|saquinavir
5434111|NCT00002374|Anti-HIV Agents|anti-hiv agents
5434112|NCT00002374|Viral Load|viral load
5434113|NCT00002373|Cytomegalovirus|cytomegalovirus
5434114|NCT00002373|Cytomegalovirus Infections|cytomegalovirus infections
5434115|NCT00002373|Administration, Oral|administration, oral
5434116|NCT00002373|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5434117|NCT00002373|Antiviral Agents|antiviral agents
5434118|NCT00002373|Virus Shedding|virus shedding
5434119|NCT00002373|Viral Load|viral load
5434120|NCT00002372|Drug Therapy, Combination|drug therapy, combination
5434121|NCT00002372|Administration, Oral|administration, oral
5434122|NCT00002372|HIV Protease Inhibitors|hiv protease inhibitors
5434123|NCT00002372|Indinavir|indinavir
5434124|NCT00002372|Saquinavir|saquinavir
5434125|NCT00002372|Nelfinavir|nelfinavir
5434126|NCT00002372|VX 478|vx 478
5434127|NCT00002371|HIV-1|hiv-1
5434128|NCT00002371|Drug Therapy, Combination|drug therapy, combination
5434129|NCT00002371|Stavudine|stavudine
5434130|NCT00002371|Lamivudine|lamivudine
5434131|NCT00002371|RNA, Viral|rna, viral
5434132|NCT00002371|Anti-HIV Agents|anti-hiv agents
5434133|NCT00002371|Viral Load|viral load
5434134|NCT00002370|Itraconazole|itraconazole
5434135|NCT00002370|Administration, Oral|administration, oral
5434136|NCT00002370|Antifungal Agents|antifungal agents
5434137|NCT00002370|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5434138|NCT00002370|Drug Administration Schedule|drug administration schedule
5434139|NCT00002369|Drug Therapy, Combination|drug therapy, combination
5434140|NCT00002369|Zidovudine|zidovudine
5434141|NCT00002369|Stavudine|stavudine
5434142|NCT00002369|HIV Protease Inhibitors|hiv protease inhibitors
5434143|NCT00002369|CD4 Lymphocyte Count|cd4 lymphocyte count
5434144|NCT00002369|Lamivudine|lamivudine
5434145|NCT00002369|Indinavir|indinavir
5434146|NCT00002369|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5434147|NCT00002369|Anti-HIV Agents|anti-hiv agents
5434148|NCT00002369|Viral Load|viral load
5434149|NCT00002368|Drug Therapy, Combination|drug therapy, combination
5434150|NCT00002368|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5434151|NCT00002368|Nevirapine|nevirapine
5434152|NCT00002368|Lamivudine|lamivudine
5434153|NCT00002368|Disease Progression|disease progression
5434154|NCT00002368|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5434155|NCT00002368|Anti-HIV Agents|anti-hiv agents
5434156|NCT00002367|Drug Therapy, Combination|drug therapy, combination
5434157|NCT00002367|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5434158|NCT00002367|Zidovudine|zidovudine
5434159|NCT00002367|HIV Protease Inhibitors|hiv protease inhibitors
5434160|NCT00002367|Lamivudine|lamivudine
5434161|NCT00002367|Saquinavir|saquinavir
5434162|NCT00002367|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5434163|NCT00002367|Anti-HIV Agents|anti-hiv agents
5434164|NCT00002366|Skin Neoplasms|skin neoplasms
5434165|NCT00002366|Sarcoma, Kaposi|sarcoma, kaposi
5434166|NCT00002366|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5434167|NCT00002366|HIV Protease Inhibitors|hiv protease inhibitors
5434168|NCT00002366|Ritonavir|ritonavir
5434169|NCT00002365|Dose-Response Relationship, Drug|dose-response relationship, drug
5434170|NCT00002365|Administration, Oral|administration, oral
5434171|NCT00002365|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5434172|NCT00002365|Anti-HIV Agents|anti-hiv agents
5434173|NCT00002364|Drug Therapy, Combination|drug therapy, combination
5434174|NCT00002364|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5434175|NCT00002364|AIDS-Related Complex|aids-related complex
5434176|NCT00002364|Antiviral Agents|antiviral agents
5434177|NCT00002363|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5434178|NCT00002363|AIDS-Related Complex|aids-related complex
5434179|NCT00002363|Antiviral Agents|antiviral agents
5434180|NCT00002362|Dideoxynucleosides|dideoxynucleosides
5434181|NCT00002362|Drug Therapy, Combination|drug therapy, combination
5434182|NCT00002362|Stavudine|stavudine
5434183|NCT00002362|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5434184|NCT00002362|abacavir|abacavir
5434185|NCT00002362|efavirenz|efavirenz
5434186|NCT00002361|Drug Therapy, Combination|drug therapy, combination
5434187|NCT00002361|HIV Protease Inhibitors|hiv protease inhibitors
5434188|NCT00002361|Ritonavir|ritonavir
5434189|NCT00002361|Indinavir|indinavir
5434190|NCT00002361|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5434191|NCT00002361|Anti-HIV Agents|anti-hiv agents
5434192|NCT00002361|Viral Load|viral load
5434193|NCT00002360|Didanosine|didanosine
5434194|NCT00002360|Tablets|tablets
5434195|NCT00002360|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5434196|NCT00002360|Anti-HIV Agents|anti-hiv agents
5434197|NCT00002360|Therapeutic Equivalency|therapeutic equivalency
5434198|NCT00002359|Vaccines, Synthetic|vaccines, synthetic
5434199|NCT00002359|Viral Vaccines|viral vaccines
5434200|NCT00002359|HIV-1|hiv-1
5434201|NCT00002359|AIDS-Related Complex|aids-related complex
5434202|NCT00002359|AIDS Vaccines|aids vaccines
5434203|NCT00002359|Salk HIV Immunogen|salk hiv immunogen
5434204|NCT00002358|Herpes Zoster|herpes zoster
5434205|NCT00002358|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5434206|NCT00002358|AIDS-Related Complex|aids-related complex
5434207|NCT00002358|Antiviral Agents|antiviral agents
5434208|NCT00002358|sorivudine|sorivudine
5434209|NCT00002358|Chickenpox|chickenpox
5434210|NCT00002357|Drug Therapy, Combination|drug therapy, combination
5434211|NCT00002357|AIDS-Related Complex|aids-related complex
5434212|NCT00002357|Antiviral Agents|antiviral agents
5434213|NCT00002357|Zidovudine|zidovudine
5434214|NCT00002356|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5434215|NCT00002356|Antiviral Agents|antiviral agents
5434216|NCT00002356|Cytomegalovirus Retinitis|cytomegalovirus retinitis
5434217|NCT00002355|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
5434218|NCT00002355|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5434219|NCT00002355|Antiviral Agents|antiviral agents
5434220|NCT00002355|Cytomegalovirus Retinitis|cytomegalovirus retinitis
5434221|NCT00002354|Drug Therapy, Combination|drug therapy, combination
5434222|NCT00002354|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5434223|NCT00002354|AIDS-Related Complex|aids-related complex
5434224|NCT00002354|Stavudine|stavudine
5434225|NCT00002354|HIV Protease Inhibitors|hiv protease inhibitors
5434226|NCT00002354|Indinavir|indinavir
5434227|NCT00002353|Vaccines, Synthetic|vaccines, synthetic
5434228|NCT00002353|AIDS Vaccines|aids vaccines
5434229|NCT00002352|Cytomegalovirus Infections|cytomegalovirus infections
5434230|NCT00002352|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5434231|NCT00002352|Antiviral Agents|antiviral agents
5434232|NCT00002351|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5434233|NCT00002351|AIDS-Related Complex|aids-related complex
5434234|NCT00002351|HIV Protease Inhibitors|hiv protease inhibitors
5434235|NCT00002351|Indinavir|indinavir
5434236|NCT00002350|Vaccines, Synthetic|vaccines, synthetic
5434237|NCT00002350|AIDS Vaccines|aids vaccines
5434238|NCT00002350|DNA, Viral|dna, viral
5434239|NCT00002349|AIDS-Related Complex|aids-related complex
5434240|NCT00002349|Stavudine|stavudine
5434241|NCT00002348|Lymphoma, Non-Hodgkin|lymphoma, non-hodgkin
5434242|NCT00002348|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5434243|NCT00002348|Lymphoma, AIDS-Related|lymphoma, aids-related
5434244|NCT00002348|Mitoguazone|mitoguazone
5434245|NCT00002347|Zalcitabine|zalcitabine
5434246|NCT00002347|Drug Therapy, Combination|drug therapy, combination
5434247|NCT00002347|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5434248|NCT00002347|AIDS-Related Complex|aids-related complex
5434249|NCT00002347|Zidovudine|zidovudine
5434250|NCT00002347|Nevirapine|nevirapine
5434251|NCT00002347|Saquinavir|saquinavir
5434252|NCT00002346|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5434253|NCT00002346|AIDS-Related Complex|aids-related complex
5434254|NCT00002346|Antiviral Agents|antiviral agents
5434255|NCT00002346|Adenine|adenine
5434256|NCT00002345|Megestrol|megestrol
5434257|NCT00002345|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5434258|NCT00002345|Anorexia|anorexia
5434259|NCT00002345|Cachexia|cachexia
5434260|NCT00002345|Suspensions|suspensions
5434261|NCT00002344|Azithromycin|azithromycin
5434262|NCT00002344|Bacterial Infections|bacterial infections
5434263|NCT00002343|Rifabutin|rifabutin
5434264|NCT00002343|Mycobacterium avium-intracellulare Infection|mycobacterium avium-intracellulare infection
5434265|NCT00002343|Drug Therapy, Combination|drug therapy, combination
5434266|NCT00002343|Ethambutol|ethambutol
5434267|NCT00002343|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5434268|NCT00002342|Neoplasms|neoplasms
5434269|NCT00002342|Sarcoma, Kaposi|sarcoma, kaposi
5434270|NCT00002342|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5434271|NCT00002342|Antineoplastic Agents|antineoplastic agents
5434272|NCT00002342|tecogalan|tecogalan
5434273|NCT00002341|Itraconazole|itraconazole
5434274|NCT00002341|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5434275|NCT00002341|AIDS-Related Complex|aids-related complex
5434276|NCT00002341|Candidiasis, Oral|candidiasis, oral
5434277|NCT00002340|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
5434278|NCT00002340|Pentamidine|pentamidine
5434279|NCT00002340|Antifungal Agents|antifungal agents
5434280|NCT00002340|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5434281|NCT00002340|AIDS-Related Complex|aids-related complex
5434282|NCT00002340|atovaquone|atovaquone
5434283|NCT00002339|Esophagitis|esophagitis
5434284|NCT00002339|Fluconazole|fluconazole
5434285|NCT00002339|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5434286|NCT00002339|Candidiasis|candidiasis
5434287|NCT00002339|Immunocompromised Host|immunocompromised host
5434288|NCT00002338|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5434289|NCT00002338|AIDS-Related Complex|aids-related complex
5434290|NCT00002338|Antiviral Agents|antiviral agents
5434291|NCT00002337|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5434292|NCT00002337|Antiviral Agents|antiviral agents
5434293|NCT00002337|vesnarinone|vesnarinone
5434412|NCT00002311|Wobenzym|wobenzym
5434294|NCT00002336|Mycobacterium avium-intracellular Infection|mycobacterium avium-intracellular infection
5434295|NCT00002336|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5434296|NCT00002336|Clarithromycin|clarithromycin
5434297|NCT00002335|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5434298|NCT00002335|AIDS-Related Complex|aids-related complex
5434299|NCT00002335|Antiviral Agents|antiviral agents
5434300|NCT00002334|Drug Therapy, Combination|drug therapy, combination
5434301|NCT00002334|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5434302|NCT00002334|AIDS-Related Complex|aids-related complex
5434303|NCT00002334|Zidovudine|zidovudine
5434304|NCT00002334|Saquinavir|saquinavir
5434305|NCT00002334|HIV Protease Inhibitors|hiv protease inhibitors
5434306|NCT00002333|Zalcitabine|zalcitabine
5434307|NCT00002333|Drug Therapy, Combination|drug therapy, combination
5434308|NCT00002333|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5434309|NCT00002333|AIDS-Related Complex|aids-related complex
5434310|NCT00002333|Saquinavir|saquinavir
5434311|NCT00002333|HIV Protease Inhibitors|hiv protease inhibitors
5434312|NCT00002332|Thymopentin|thymopentin
5434313|NCT00002332|AIDS-Related Complex|aids-related complex
5434314|NCT00002331|Mycobacterium avium-intracellular Infection|mycobacterium avium-intracellular infection
5434315|NCT00002331|Drug Therapy, Combination|drug therapy, combination
5434316|NCT00002331|Ethambutol|ethambutol
5434317|NCT00002331|Clofazimine|clofazimine
5434318|NCT00002331|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5434319|NCT00002331|Clarithromycin|clarithromycin
5434320|NCT00002330|Retinitis|retinitis
5434321|NCT00002330|Ganciclovir|ganciclovir
5434322|NCT00002330|Cytomegalovirus Infections|cytomegalovirus infections
5434323|NCT00002330|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5434324|NCT00002329|MDL 28574|mdl 28574
5434325|NCT00002328|Antidiarrheals|antidiarrheals
5434326|NCT00002328|Cryptosporidiosis|cryptosporidiosis
5434327|NCT00002328|Diarrhea|diarrhea
5434328|NCT00002328|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5434329|NCT00002328|Azithromycin|azithromycin
5434330|NCT00002327|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
5434331|NCT00002327|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5434332|NCT00002327|AIDS-Related Complex|aids-related complex
5434333|NCT00002327|Antiviral Agents|antiviral agents
5434334|NCT00002327|Condylomata Acuminata|condylomata acuminata
5434335|NCT00002327|cidofovir|cidofovir
5434336|NCT00002326|Drug Therapy, Combination|drug therapy, combination
5434337|NCT00002326|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5434338|NCT00002326|AIDS-Related Complex|aids-related complex
5434339|NCT00002326|Antiviral Agents|antiviral agents
5434340|NCT00002326|Zidovudine|zidovudine
5434341|NCT00002326|Adenine|adenine
5434342|NCT00002325|Mycoses|mycoses
5434343|NCT00002325|Fluconazole|fluconazole
5434344|NCT00002325|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5434345|NCT00002325|AIDS-Related Complex|aids-related complex
5434346|NCT00002325|Coccidioidomycosis|coccidioidomycosis
5434347|NCT00002324|Drug Therapy, Combination|drug therapy, combination
5434348|NCT00002324|AIDS-Related Complex|aids-related complex
5434349|NCT00002324|Zidovudine|zidovudine
5434350|NCT00002324|Nevirapine|nevirapine
5434351|NCT00002323|Drug Therapy, Combination|drug therapy, combination
5434352|NCT00002323|Zidovudine|zidovudine
5434353|NCT00002323|Nevirapine|nevirapine
5434354|NCT00002322|Drug Therapy, Combination|drug therapy, combination
5434355|NCT00002322|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5434356|NCT00002322|AIDS-Related Complex|aids-related complex
5434357|NCT00002322|Antiviral Agents|antiviral agents
5434358|NCT00002321|Retinitis|retinitis
5434359|NCT00002321|Interleukin-2|interleukin-2
5434360|NCT00002321|Ganciclovir|ganciclovir
5434361|NCT00002321|Drug Therapy, Combination|drug therapy, combination
5434362|NCT00002321|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5434363|NCT00002321|Antiviral Agents|antiviral agents
5434364|NCT00002320|Drug Therapy, Combination|drug therapy, combination
5434365|NCT00002320|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5434366|NCT00002320|AIDS-Related Complex|aids-related complex
5434367|NCT00002320|Antiviral Agents|antiviral agents
5434368|NCT00002320|Zidovudine|zidovudine
5434369|NCT00002319|Sarcoma, Kaposi|sarcoma, kaposi
5434370|NCT00002319|Liposomes|liposomes
5434371|NCT00002319|Doxorubicin|doxorubicin
5434372|NCT00002319|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5434373|NCT00002319|Drug Carriers|drug carriers
5434374|NCT00002318|Vincristine|vincristine
5434375|NCT00002318|Sarcoma, Kaposi|sarcoma, kaposi
5434376|NCT00002318|Liposomes|liposomes
5434377|NCT00002318|Doxorubicin|doxorubicin
5434378|NCT00002318|Drug Therapy, Combination|drug therapy, combination
5434379|NCT00002318|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5434380|NCT00002318|Bleomycin|bleomycin
5434381|NCT00002318|Drug Carriers|drug carriers
5434382|NCT00002317|Trimetrexate|trimetrexate
5434383|NCT00002317|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
5434384|NCT00002317|Leucovorin|leucovorin
5434385|NCT00002317|Drug Therapy, Combination|drug therapy, combination
5434386|NCT00002317|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5434387|NCT00002316|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
5434388|NCT00002316|Meningitis|meningitis
5434389|NCT00002316|Drug Therapy, Combination|drug therapy, combination
5434390|NCT00002316|Antifungal Agents|antifungal agents
5434391|NCT00002316|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5434392|NCT00002316|Amphotericin B|amphotericin b
5434393|NCT00002315|Herpes Zoster|herpes zoster
5434394|NCT00002315|Acyclovir|acyclovir
5434395|NCT00002315|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5434396|NCT00002315|AIDS-Related Complex|aids-related complex
5434397|NCT00002315|Antiviral Agents|antiviral agents
5434398|NCT00002314|Sarcoma, Kaposi|sarcoma, kaposi
5434399|NCT00002314|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5434400|NCT00002314|Antineoplastic Agents|antineoplastic agents
5434401|NCT00002314|Gene Products, tat|gene products, tat
5434402|NCT00002313|Nystatin|nystatin
5434403|NCT00002313|Didanosine|didanosine
5434404|NCT00002313|Drug Therapy, Combination|drug therapy, combination
5434405|NCT00002313|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5434406|NCT00002313|AIDS-Related Complex|aids-related complex
5434407|NCT00002312|Drug Interactions|drug interactions
5434408|NCT00002312|Antiviral Agents|antiviral agents
5434409|NCT00002312|Zidovudine|zidovudine
5434410|NCT00002311|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5434411|NCT00002311|AIDS-Related Complex|aids-related complex
5434413|NCT00002311|Hydrolases|hydrolases
5434414|NCT00002310|Herpes Simplex|herpes simplex
5434415|NCT00002310|HIV-1|hiv-1
5434416|NCT00002310|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5434417|NCT00002310|Antiviral Agents|antiviral agents
5434418|NCT00002310|Administration, Topical|administration, topical
5434419|NCT00002309|Mycobacterium avium-intracellulare Infection|mycobacterium avium-intracellulare infection
5434420|NCT00002309|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5434421|NCT00002309|AIDS-Related Complex|aids-related complex
5434422|NCT00002309|Azithromycin|azithromycin
5434423|NCT00002308|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5434424|NCT00002308|AIDS-Related Complex|aids-related complex
5434428|NCT00002306|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
5434429|NCT00002306|Meningitis|meningitis
5434430|NCT00002306|Cryptococcosis|cryptococcosis
5434431|NCT00002306|Fluconazole|fluconazole
5434432|NCT00002306|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5434433|NCT00002306|Amphotericin B|amphotericin b
5434434|NCT00002305|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
5434435|NCT00002305|Meningitis|meningitis
5434436|NCT00002305|Cryptococcosis|cryptococcosis
5434437|NCT00002305|Drug Therapy, Combination|drug therapy, combination
5434438|NCT00002305|Fluconazole|fluconazole
5434439|NCT00002305|Flucytosine|flucytosine
5434440|NCT00002305|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5434441|NCT00002305|Amphotericin B|amphotericin b
5434442|NCT00002304|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
5434443|NCT00002304|Immune Tolerance|immune tolerance
5434444|NCT00002304|Ketoconazole|ketoconazole
5434445|NCT00002304|Esophagitis|esophagitis
5434446|NCT00002304|Fluconazole|fluconazole
5434447|NCT00002304|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5434448|NCT00002304|Candidiasis, Oral|candidiasis, oral
5434449|NCT00002303|Recombinant Proteins|recombinant proteins
5434450|NCT00002303|Erythropoietin|erythropoietin
5434451|NCT00002303|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5434452|NCT00002303|Anemia|anemia
5434453|NCT00002303|AIDS-Related Complex|aids-related complex
5434454|NCT00002303|Zidovudine|zidovudine
5434455|NCT00002302|Recombinant Proteins|recombinant proteins
5434456|NCT00002302|Injections, Subcutaneous|injections, subcutaneous
5434457|NCT00002302|Erythropoietin|erythropoietin
5434458|NCT00002302|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5434459|NCT00002302|Anemia|anemia
5434460|NCT00002302|Zidovudine|zidovudine
5434461|NCT00002301|Retinitis|retinitis
5434462|NCT00002301|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
5434463|NCT00002301|Ganciclovir|ganciclovir
5434464|NCT00002301|Foscarnet|foscarnet
5434465|NCT00002301|Cytomegalovirus Infections|cytomegalovirus infections
5434466|NCT00002301|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5434467|NCT00002301|Antiviral Agents|antiviral agents
5434468|NCT00002300|T-Lymphocytes|t-lymphocytes
5434469|NCT00002300|Megestrol|megestrol
5434470|NCT00002300|Dose-Response Relationship, Drug|dose-response relationship, drug
5434471|NCT00002300|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5434472|NCT00002300|Anorexia|anorexia
5434473|NCT00002300|Cachexia|cachexia
5434474|NCT00002299|Retinitis|retinitis
5434475|NCT00002299|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
5434476|NCT00002299|Ganciclovir|ganciclovir
5434477|NCT00002299|Drug Therapy, Combination|drug therapy, combination
5434478|NCT00002299|Cytomegalovirus Infections|cytomegalovirus infections
5434479|NCT00002299|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5434480|NCT00002299|Interferon Type I|interferon type i
5434481|NCT00002298|Ribavirin|ribavirin
5434482|NCT00002298|AIDS-Related Complex|aids-related complex
5434483|NCT00002297|Inosine Pranobex|inosine pranobex
5434484|NCT00002297|AIDS-Related Complex|aids-related complex
5434485|NCT00002296|T-Lymphocytes|t-lymphocytes
5434486|NCT00002296|Immune Tolerance|immune tolerance
5434487|NCT00002296|Inosine Pranobex|inosine pranobex
5434488|NCT00002296|Killer Cells|killer cells
5434489|NCT00002296|T-Lymphocytes, Helper-Inducer|t-lymphocytes, helper-inducer
5434490|NCT00002296|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5434491|NCT00002296|AIDS-Related Complex|aids-related complex
5434492|NCT00002295|Infusions, Intravenous|infusions, intravenous
5434493|NCT00002295|Drug Evaluation|drug evaluation
5434494|NCT00002295|Administration, Oral|administration, oral
5434495|NCT00002295|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5434496|NCT00002295|AIDS-Related Complex|aids-related complex
5434497|NCT00002295|Zidovudine|zidovudine
5434498|NCT00002295|Biological Availability|biological availability
5434499|NCT00002294|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
5434500|NCT00002294|Meningitis|meningitis
5434501|NCT00002294|Cryptococcosis|cryptococcosis
5434502|NCT00002294|Fluconazole|fluconazole
5434503|NCT00002294|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5434504|NCT00002293|Nystatin|nystatin
5434505|NCT00002293|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
5434506|NCT00002293|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5434507|NCT00002293|AIDS-Related Complex|aids-related complex
5434508|NCT00002293|Candidiasis, Oral|candidiasis, oral
5434509|NCT00002292|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
5434510|NCT00002292|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
5434511|NCT00002292|Pentamidine|pentamidine
5434512|NCT00002292|Injections, Intravenous|injections, intravenous
5434513|NCT00002292|Administration, Inhalation|administration, inhalation
5434514|NCT00002292|Aerosols|aerosols
5434515|NCT00002292|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5434516|NCT00002291|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
5434517|NCT00002291|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
5434519|NCT00002291|Dose-Response Relationship, Drug|dose-response relationship, drug
5434520|NCT00002291|Aerosols|aerosols
5434521|NCT00002291|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5434522|NCT00002290|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
5434523|NCT00002290|Drug Therapy, Combination|drug therapy, combination
5434524|NCT00002290|Acyclovir|acyclovir
5434525|NCT00002290|AIDS-Related Complex|aids-related complex
5434526|NCT00002290|Zidovudine|zidovudine
5434527|NCT00002289|Semen|semen
5434528|NCT00002289|Thymopentin|thymopentin
5434529|NCT00002289|Leukocytes, Mononuclear|leukocytes, mononuclear
5434530|NCT00002289|HIV Seropositivity|hiv seropositivity
5434531|NCT00002289|AIDS-Related Complex|aids-related complex
5434532|NCT00002288|Neuropsychological Tests|neuropsychological tests
5434533|NCT00002288|AIDS-Related Complex|aids-related complex
5434534|NCT00002288|Zidovudine|zidovudine
5434535|NCT00002287|Health Manpower|health manpower
5434536|NCT00002287|Accidents, Occupational|accidents, occupational
5434537|NCT00002287|Zidovudine|zidovudine
5434538|NCT00002286|Pilot Projects|pilot projects
5434539|NCT00002286|Psoriasis|psoriasis
5434540|NCT00002286|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5434541|NCT00002286|Zidovudine|zidovudine
5434542|NCT00002285|Virus Replication|virus replication
5434543|NCT00002285|Pilot Projects|pilot projects
5434544|NCT00002285|Immune Tolerance|immune tolerance
5434545|NCT00002285|Lymphocytes|lymphocytes
5434546|NCT00002285|Drug Evaluation|drug evaluation
5434547|NCT00002285|Combined Modality Therapy|combined modality therapy
5434548|NCT00002285|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5434549|NCT00002285|Transplantation, Homologous|transplantation, homologous
5434550|NCT00002285|Zidovudine|zidovudine
5434551|NCT00002284|Lymphoma, Large-Cell|lymphoma, large-cell
5434552|NCT00002284|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5434553|NCT00002284|AIDS-Related Complex|aids-related complex
5434554|NCT00002284|Zidovudine|zidovudine
5434555|NCT00002284|Bone Marrow Transplantation|bone marrow transplantation
5434556|NCT00002283|Trimethoprim-Sulfamethoxazole Combination|trimethoprim-sulfamethoxazole combination
5434557|NCT00002283|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
5434558|NCT00002283|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
5434559|NCT00002283|Dapsone|dapsone
5434560|NCT00002283|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5434561|NCT00002282|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
5434562|NCT00002282|Fluconazole|fluconazole
5434563|NCT00002282|Clotrimazole|clotrimazole
5434564|NCT00002282|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5434565|NCT00002282|Candidiasis, Oral|candidiasis, oral
5434566|NCT00002281|Injections, Subcutaneous|injections, subcutaneous
5434567|NCT00002281|Erythropoietin|erythropoietin
5434568|NCT00002281|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5434569|NCT00002281|AIDS-Related Complex|aids-related complex
5434570|NCT00002281|Zidovudine|zidovudine
5434571|NCT00002280|Didanosine|didanosine
5434572|NCT00002280|Drugs, Investigational|drugs, investigational
5434573|NCT00002280|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5434574|NCT00002280|Zidovudine|zidovudine
5434575|NCT00002279|Zalcitabine|zalcitabine
5434576|NCT00002279|Didanosine|didanosine
5434577|NCT00002279|Drugs, Investigational|drugs, investigational
5434578|NCT00002279|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5434579|NCT00002279|AIDS-Related Complex|aids-related complex
5434580|NCT00002279|Zidovudine|zidovudine
5434581|NCT00002278|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
5434582|NCT00002278|Cryptosporidiosis|cryptosporidiosis
5434583|NCT00002278|Diarrhea|diarrhea
5434584|NCT00002278|diclazuril|diclazuril
5434585|NCT00002278|Coccidiostats|coccidiostats
5434586|NCT00002278|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5434587|NCT00002277|Mycoses|mycoses
5434588|NCT00002277|Neoplasms|neoplasms
5434589|NCT00002277|Neutropenia|neutropenia
5434590|NCT00002277|Fluconazole|fluconazole
5434591|NCT00002277|Amphotericin B|amphotericin b
5434592|NCT00002276|Blood Platelets|blood platelets
5434593|NCT00002276|Ibuprofen|ibuprofen
5434594|NCT00002276|Drug Interactions|drug interactions
5434595|NCT00002276|Zidovudine|zidovudine
5434596|NCT00002276|Hemophilia A|hemophilia a
5434597|NCT00002275|Weight Loss|weight loss
5434598|NCT00002275|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
5434599|NCT00002275|Parenteral Nutrition|parenteral nutrition
5434600|NCT00002275|Liposyn|liposyn
5434601|NCT00002275|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5434602|NCT00002274|Didanosine|didanosine
5434603|NCT00002274|Drugs, Investigational|drugs, investigational
5434604|NCT00002274|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5434605|NCT00002274|Zidovudine|zidovudine
5434606|NCT00002273|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
5434607|NCT00002273|Ganciclovir|ganciclovir
5434608|NCT00002273|Cytomegalovirus Infections|cytomegalovirus infections
5434609|NCT00002273|Colitis|colitis
5434610|NCT00002273|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5434611|NCT00002272|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
5434612|NCT00002272|Immune Tolerance|immune tolerance
5434613|NCT00002272|Injections, Intravenous|injections, intravenous
5434614|NCT00002272|Herpes Simplex|herpes simplex
5434615|NCT00002272|Immunity, Cellular|immunity, cellular
5434616|NCT00002272|Drug Resistance|drug resistance
5434617|NCT00002272|Foscarnet|foscarnet
5434618|NCT00002272|Acyclovir|acyclovir
5434619|NCT00002272|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5434620|NCT00002272|Antiviral Agents|antiviral agents
5434621|NCT00002271|Thymidine|thymidine
5434622|NCT00002271|Nucleosides|nucleosides
5434623|NCT00002271|Antiviral Agents|antiviral agents
5434624|NCT00002270|Leukoencephalopathy, Progressive Multifocal|leukoencephalopathy, progressive multifocal
5434625|NCT00002270|Interferon Alfa-2b|interferon alfa-2b
5434626|NCT00002270|Drug Evaluation|drug evaluation
5434627|NCT00002270|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5434628|NCT00002270|Zidovudine|zidovudine
5434629|NCT00002269|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5434630|NCT00002269|ampligen|ampligen
5434631|NCT00002269|AIDS-Related Complex|aids-related complex
5434632|NCT00002269|Zidovudine|zidovudine
5434633|NCT00002268|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
5434634|NCT00002268|Immunotherapy|immunotherapy
5434635|NCT00002268|Drug Evaluation|drug evaluation
5434636|NCT00002268|Cytomegalovirus Infections|cytomegalovirus infections
5434637|NCT00002268|Antibodies, Monoclonal|antibodies, monoclonal
5434638|NCT00002267|Rifabutin|rifabutin
5434639|NCT00002267|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
5434640|NCT00002267|Mycobacterium avium-intracellulare Infection|mycobacterium avium-intracellulare infection
5434641|NCT00002267|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5434642|NCT00002267|Antitubercular Agents|antitubercular agents
5434643|NCT00002266|Drug Therapy, Combination|drug therapy, combination
5434644|NCT00002266|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5434645|NCT00002266|AIDS-Related Complex|aids-related complex
5434646|NCT00002266|ammonium trichloro(dioxoethylene-O,O'-)tellurute|ammonium trichloro(dioxoethylene-o,o'-)tellurute
5434647|NCT00002265|Zalcitabine|zalcitabine
5434648|NCT00002265|Drug Evaluation|drug evaluation
5434649|NCT00002265|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5434650|NCT00002265|AIDS-Related Complex|aids-related complex
5434651|NCT00002265|Zidovudine|zidovudine
5434652|NCT00002263|Pilot Projects|pilot projects
5434653|NCT00002263|Neutropenia|neutropenia
5434654|NCT00002263|Granulocyte-Macrophage Colony-Stimulating Factor|granulocyte-macrophage colony-stimulating factor
5434655|NCT00002263|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5434656|NCT00002263|Zidovudine|zidovudine
5434657|NCT00002262|Skin Neoplasms|skin neoplasms
5434658|NCT00002262|Tumor Necrosis Factor|tumor necrosis factor
5434659|NCT00002262|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5434660|NCT00002261|Vaccines, Synthetic|vaccines, synthetic
5434661|NCT00002261|Vaccinia Virus|vaccinia virus
5434662|NCT00002261|Viral Vaccines|viral vaccines
5434663|NCT00002261|Smallpox Vaccine|smallpox vaccine
5434664|NCT00002261|HIV-1|hiv-1
5434665|NCT00002261|AIDS Vaccines|aids vaccines
5434666|NCT00002261|HIV Seronegativity|hiv seronegativity
5434667|NCT00002260|Biological Availability|biological availability
5434668|NCT00002260|alovudine|alovudine
5434669|NCT00002260|Food|food
5434670|NCT00002259|Mitoxantrone|mitoxantrone
5434671|NCT00002259|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5434672|NCT00002258|Interleukin-3|interleukin-3
5434673|NCT00002258|Recombinant Proteins|recombinant proteins
5434674|NCT00002258|Leukopenia|leukopenia
5434675|NCT00002258|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5434676|NCT00002258|AIDS-Related Complex|aids-related complex
5434677|NCT00002258|Thrombocytopenia|thrombocytopenia
5434678|NCT00002257|Retinitis|retinitis
5434679|NCT00002257|Ganciclovir|ganciclovir
5434680|NCT00002257|Cytomegalovirus Infections|cytomegalovirus infections
5434681|NCT00002257|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5434682|NCT00002256|Zalcitabine|zalcitabine
5434683|NCT00002256|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5434684|NCT00002256|AIDS-Related Complex|aids-related complex
5434685|NCT00002256|Zidovudine|zidovudine
5434686|NCT00002255|Erythropoietin|erythropoietin
5434687|NCT00002255|Granulocyte Colony-Stimulating Factor|granulocyte colony-stimulating factor
5434688|NCT00002255|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5434689|NCT00002255|AIDS-Related Complex|aids-related complex
5434690|NCT00002255|Zidovudine|zidovudine
5434691|NCT00002254|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5434692|NCT00002253|Octreotide|octreotide
5434693|NCT00002253|Diarrhea|diarrhea
5434694|NCT00002253|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5434695|NCT00002253|AIDS-Related Complex|aids-related complex
5434696|NCT00002252|Octreotide|octreotide
5434697|NCT00002252|Diarrhea|diarrhea
5434698|NCT00002252|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5434699|NCT00002252|AIDS-Related Complex|aids-related complex
5434700|NCT00002251|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
5434701|NCT00002251|Ganciclovir|ganciclovir
5444067|NCT00001721|Endocrine|endocrine
5434702|NCT00002251|Cytomegalovirus Infections|cytomegalovirus infections
5434703|NCT00002251|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5434704|NCT00002251|Biological Availability|biological availability
5434705|NCT00002250|Recombinant Proteins|recombinant proteins
5434706|NCT00002250|IgG|igg
5434707|NCT00002250|Drug Evaluation|drug evaluation
5434708|NCT00002250|Antigens, CD4|antigens, cd4
5434709|NCT00002249|Anti-Infective Agents, Quinolone|anti-infective agents, quinolone
5434710|NCT00002249|Ofloxacin|ofloxacin
5434711|NCT00002249|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5434712|NCT00002248|Antidiarrheals|antidiarrheals
5434713|NCT00002248|Cryptosporidiosis|cryptosporidiosis
5434714|NCT00002248|Diarrhea|diarrhea
5434715|NCT00002248|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5434716|NCT00002248|Cryptosporidium|cryptosporidium
5434717|NCT00002248|Immunization, Passive|immunization, passive
5434718|NCT00002247|Retinitis|retinitis
5434719|NCT00002247|Ganciclovir|ganciclovir
5434720|NCT00002247|Cytomegalovirus Infections|cytomegalovirus infections
5434721|NCT00002247|Administration, Oral|administration, oral
5434722|NCT00002247|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5434723|NCT00002246|AIDS Dementia Complex|aids dementia complex
5434724|NCT00002246|Zidovudine|zidovudine
5434725|NCT00002246|Stavudine|stavudine
5434726|NCT00002246|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5434727|NCT00002245|Drug Therapy, Combination|drug therapy, combination
5434728|NCT00002245|HIV Protease Inhibitors|hiv protease inhibitors
5434729|NCT00002245|Lamivudine|lamivudine
5434730|NCT00002245|Carbohydrates|carbohydrates
5434731|NCT00002245|VX 478|vx 478
5434732|NCT00002245|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5434733|NCT00002245|Anti-HIV Agents|anti-hiv agents
5434734|NCT00002245|Lipids|lipids
5434735|NCT00002245|Insulin Resistance|insulin resistance
5434736|NCT00002245|abacavir|abacavir
5434737|NCT00002244|Placebos|placebos
5434738|NCT00002244|Infusions, Intravenous|infusions, intravenous
5434739|NCT00002244|Quality of Life|quality of life
5434740|NCT00002244|Anti-HIV Agents|anti-hiv agents
5434741|NCT00002244|tetrachlorodecaoxide|tetrachlorodecaoxide
5434742|NCT00002243|Anti-HIV Agents|anti-hiv agents
5434743|NCT00002241|Drug Therapy, Combination|drug therapy, combination
5434744|NCT00002241|Stavudine|stavudine
5434745|NCT00002241|HIV Protease Inhibitors|hiv protease inhibitors
5434746|NCT00002241|Ritonavir|ritonavir
5434747|NCT00002241|Lamivudine|lamivudine
5434748|NCT00002241|Indinavir|indinavir
5434749|NCT00002241|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5434750|NCT00002241|Anti-HIV Agents|anti-hiv agents
5434751|NCT00002241|Viral Load|viral load
5434752|NCT00002240|Didanosine|didanosine
5434753|NCT00002240|Dose-Response Relationship, Drug|dose-response relationship, drug
5434754|NCT00002240|Drug Therapy, Combination|drug therapy, combination
5434755|NCT00002240|Stavudine|stavudine
5434756|NCT00002240|HIV Protease Inhibitors|hiv protease inhibitors
5434757|NCT00002240|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5434758|NCT00002240|Anti-HIV Agents|anti-hiv agents
5434759|NCT00002240|Nelfinavir|nelfinavir
5434760|NCT00002239|HIV-1|hiv-1
5434761|NCT00002239|Dose-Response Relationship, Drug|dose-response relationship, drug
5434762|NCT00002239|Drug Therapy, Combination|drug therapy, combination
5434763|NCT00002239|VX 478|vx 478
5434764|NCT00002239|Anti-HIV Agents|anti-hiv agents
5434765|NCT00002239|pentafuside|pentafuside
5434766|NCT00002239|abacavir|abacavir
5434767|NCT00002239|efavirenz|efavirenz
5434768|NCT00002238|Drug Therapy, Combination|drug therapy, combination
5434891|NCT00002219|Viral Load|viral load
5434769|NCT00002238|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5434770|NCT00002238|AIDS-Related Complex|aids-related complex
5434771|NCT00002238|Zidovudine|zidovudine
5434772|NCT00002238|Interferon Type I|interferon type i
5434773|NCT00002237|Placebos|placebos
5434774|NCT00002237|Administration, Oral|administration, oral
5434775|NCT00002237|Anti-HIV Agents|anti-hiv agents
5434776|NCT00002237|Viral Load|viral load
5434777|NCT00002237|peldesine|peldesine
5434778|NCT00002236|Drug Therapy, Combination|drug therapy, combination
5434779|NCT00002236|Zidovudine|zidovudine
5434780|NCT00002236|Drug Administration Schedule|drug administration schedule
5434781|NCT00002236|HIV Protease Inhibitors|hiv protease inhibitors
5434782|NCT00002236|CD4 Lymphocyte Count|cd4 lymphocyte count
5434783|NCT00002236|Indinavir|indinavir
5434784|NCT00002236|Delavirdine|delavirdine
5434785|NCT00002236|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5434786|NCT00002236|Anti-HIV Agents|anti-hiv agents
5434787|NCT00002236|Viral Load|viral load
5434788|NCT00002235|Drug Therapy, Combination|drug therapy, combination
5434789|NCT00002235|HIV Protease Inhibitors|hiv protease inhibitors
5434790|NCT00002235|Indinavir|indinavir
5434791|NCT00002235|Nelfinavir|nelfinavir
5434792|NCT00002235|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5434793|NCT00002235|Anti-HIV Agents|anti-hiv agents
5434794|NCT00002235|efavirenz|efavirenz
5434795|NCT00002234|Drug Therapy, Combination|drug therapy, combination
5434796|NCT00002234|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5434797|NCT00002234|Anti-HIV Agents|anti-hiv agents
5434798|NCT00002233|Drug Therapy, Combination|drug therapy, combination
5434799|NCT00002233|HIV Protease Inhibitors|hiv protease inhibitors
5434800|NCT00002233|CD4 Lymphocyte Count|cd4 lymphocyte count
5434801|NCT00002233|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5434802|NCT00002233|Anti-HIV Agents|anti-hiv agents
5434803|NCT00002233|Viral Load|viral load
5434804|NCT00002232|Injections, Intradermal|injections, intradermal
5434805|NCT00002232|Injections, Intramuscular|injections, intramuscular
5434806|NCT00002232|HIV Antibodies|hiv antibodies
5434807|NCT00002232|Immunity, Cellular|immunity, cellular
5434808|NCT00002232|AIDS Vaccines|aids vaccines
5434809|NCT00002232|HIV Seronegativity|hiv seronegativity
5434810|NCT00002232|Dose-Response Relationship, Immunologic|dose-response relationship, immunologic
5434811|NCT00002232|Vaccines, DNA|vaccines, dna
5434812|NCT00002232|Immunity, Mucosal|immunity, mucosal
5434813|NCT00002231|Injections, Intramuscular|injections, intramuscular
5434814|NCT00002231|HIV Antibodies|hiv antibodies
5434815|NCT00002231|Immunity, Cellular|immunity, cellular
5434816|NCT00002231|AIDS Vaccines|aids vaccines
5434817|NCT00002231|HIV Seronegativity|hiv seronegativity
5434818|NCT00002231|Dose-Response Relationship, Immunologic|dose-response relationship, immunologic
5434819|NCT00002231|Vaccines, DNA|vaccines, dna
5434820|NCT00002230|Didanosine|didanosine
5434821|NCT00002230|Drug Therapy, Combination|drug therapy, combination
5434822|NCT00002230|Stavudine|stavudine
5434823|NCT00002230|Hydroxyurea|hydroxyurea
5434824|NCT00002230|Anti-HIV Agents|anti-hiv agents
5434825|NCT00002229|Drug Therapy, Combination|drug therapy, combination
5434826|NCT00002229|HIV Protease Inhibitors|hiv protease inhibitors
5434827|NCT00002229|Dosage Forms|dosage forms
5434828|NCT00002229|Saquinavir|saquinavir
5434829|NCT00002229|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5434830|NCT00002229|Anti-HIV Agents|anti-hiv agents
5434831|NCT00002228|Injections, Subcutaneous|injections, subcutaneous
5434832|NCT00002228|HIV-1|hiv-1
5434833|NCT00002228|Anti-HIV Agents|anti-hiv agents
5434834|NCT00002228|peptide T20|peptide t20
5434835|NCT00002227|Drug Therapy, Combination|drug therapy, combination
5434836|NCT00002227|Stavudine|stavudine
5434837|NCT00002227|Lamivudine|lamivudine
5434838|NCT00002227|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5434839|NCT00002227|efavirenz|efavirenz
5434840|NCT00002226|Skin Neoplasms|skin neoplasms
5434841|NCT00002226|Sarcoma, Kaposi|sarcoma, kaposi
5434842|NCT00002226|Antineoplastic Agents|antineoplastic agents
5434843|NCT00002225|Didanosine|didanosine
5434844|NCT00002225|Drug Therapy, Combination|drug therapy, combination
5434845|NCT00002225|Stavudine|stavudine
5434846|NCT00002225|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5434847|NCT00002225|efavirenz|efavirenz
5434848|NCT00002224|Didanosine|didanosine
5434849|NCT00002224|Drug Therapy, Combination|drug therapy, combination
5434850|NCT00002224|Drug Administration Schedule|drug administration schedule
5434851|NCT00002224|Stavudine|stavudine
5434852|NCT00002224|HIV Protease Inhibitors|hiv protease inhibitors
5434853|NCT00002224|Nelfinavir|nelfinavir
5434854|NCT00002224|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5434855|NCT00002224|Anti-HIV Agents|anti-hiv agents
5434856|NCT00002224|Viral Load|viral load
5434857|NCT00002223|Drug Therapy, Combination|drug therapy, combination
5434858|NCT00002223|Adolescent Behavior|adolescent behavior
5434859|NCT00002223|HIV Protease Inhibitors|hiv protease inhibitors
5434860|NCT00002223|Ritonavir|ritonavir
5434861|NCT00002223|Indinavir|indinavir
5434862|NCT00002222|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
5434863|NCT00002222|Ganciclovir|ganciclovir
5434864|NCT00002222|Antiviral Agents|antiviral agents
5434865|NCT00002222|Drug Administration Schedule|drug administration schedule
5434866|NCT00002222|Cytomegalovirus Retinitis|cytomegalovirus retinitis
5434867|NCT00002222|Prodrugs|prodrugs
5434868|NCT00002221|Lymphoma, Non-Hodgkin|lymphoma, non-hodgkin
5434869|NCT00002221|Bone Marrow|bone marrow
5434870|NCT00002221|Lymphocyte Transformation|lymphocyte transformation
5434871|NCT00002221|HIV-1|hiv-1
5434872|NCT00002221|Retroviridae|retroviridae
5434873|NCT00002221|Lymphoma, AIDS-Related|lymphoma, aids-related
5434874|NCT00002221|Genetic Vectors|genetic vectors
5434875|NCT00002221|Transduction, Genetic|transduction, genetic
5434876|NCT00002221|Gene Transfer Techniques|gene transfer techniques
5434877|NCT00002220|Drug Resistance|drug resistance
5434878|NCT00002220|Drug Therapy, Combination|drug therapy, combination
5434879|NCT00002220|Antiviral Agents|antiviral agents
5434880|NCT00002220|HIV Protease Inhibitors|hiv protease inhibitors
5434881|NCT00002220|Indinavir|indinavir
5434882|NCT00002220|RNA, Viral|rna, viral
5434883|NCT00002220|Adenine|adenine
5434884|NCT00002220|efavirenz|efavirenz
5434885|NCT00002219|Dose-Response Relationship, Drug|dose-response relationship, drug
5434886|NCT00002219|Antiviral Agents|antiviral agents
5434887|NCT00002219|HIV Protease Inhibitors|hiv protease inhibitors
5434888|NCT00002219|Disease Progression|disease progression
5434889|NCT00002219|RNA, Viral|rna, viral
5434890|NCT00002219|Adenine|adenine
5434892|NCT00002219|Age Factors|age factors
5434893|NCT00002219|Nelfinavir|nelfinavir
5434894|NCT00002218|HIV-1|hiv-1
5434995|NCT00002201|Anti-HIV Agents|anti-hiv agents
5434895|NCT00002218|Dose-Response Relationship, Drug|dose-response relationship, drug
5434896|NCT00002218|Anti-HIV Agents|anti-hiv agents
5434897|NCT00002217|Drug Therapy, Combination|drug therapy, combination
5434898|NCT00002217|Patient Compliance|patient compliance
5434899|NCT00002217|Anti-HIV Agents|anti-hiv agents
5434900|NCT00002217|abacavir|abacavir
5434901|NCT00002216|Drug Therapy, Combination|drug therapy, combination
5434902|NCT00002216|HIV Protease Inhibitors|hiv protease inhibitors
5434903|NCT00002216|VX 478|vx 478
5434904|NCT00002216|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5434905|NCT00002216|Anti-HIV Agents|anti-hiv agents
5434906|NCT00002216|abacavir|abacavir
5434907|NCT00002215|Drug Therapy, Combination|drug therapy, combination
5434908|NCT00002215|HIV Protease Inhibitors|hiv protease inhibitors
5434909|NCT00002215|RNA, Viral|rna, viral
5434910|NCT00002215|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5434911|NCT00002215|Viral Load|viral load
5434912|NCT00002215|Nelfinavir|nelfinavir
5434913|NCT00002215|Uracil|uracil
5434914|NCT00002214|Dose-Response Relationship, Drug|dose-response relationship, drug
5434915|NCT00002214|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5434916|NCT00002213|HIV-1|hiv-1
5434917|NCT00002213|Drug Therapy, Combination|drug therapy, combination
5434918|NCT00002213|Antiviral Agents|antiviral agents
5434919|NCT00002213|HIV Protease Inhibitors|hiv protease inhibitors
5434920|NCT00002213|RNA, Viral|rna, viral
5434921|NCT00002213|VX 478|vx 478
5434922|NCT00002213|Anti-HIV Agents|anti-hiv agents
5434923|NCT00002213|abacavir|abacavir
5434924|NCT00002213|efavirenz|efavirenz
5434925|NCT00002212|Sarcoma, Kaposi|sarcoma, kaposi
5434926|NCT00002212|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5434927|NCT00002212|Anticarcinogenic Agents|anticarcinogenic agents
5434928|NCT00002211|HIV-1|hiv-1
5434929|NCT00002211|Didanosine|didanosine
5434930|NCT00002211|Stavudine|stavudine
5434931|NCT00002211|HIV Protease Inhibitors|hiv protease inhibitors
5434932|NCT00002211|RNA, Viral|rna, viral
5434933|NCT00002211|Delavirdine|delavirdine
5434934|NCT00002211|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5434935|NCT00002211|Viral Load|viral load
5434936|NCT00002211|Nelfinavir|nelfinavir
5434937|NCT00002210|HIV-1|hiv-1
5434938|NCT00002210|Drug Therapy, Combination|drug therapy, combination
5434939|NCT00002210|Delavirdine|delavirdine
5434940|NCT00002210|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5434941|NCT00002209|Dose-Response Relationship, Drug|dose-response relationship, drug
5434942|NCT00002209|Drug Therapy, Combination|drug therapy, combination
5434943|NCT00002209|AIDS Dementia Complex|aids dementia complex
5434944|NCT00002209|Zidovudine|zidovudine
5434945|NCT00002209|Lamivudine|lamivudine
5434946|NCT00002209|Indinavir|indinavir
5434947|NCT00002209|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5434948|NCT00002208|HIV-1|hiv-1
5434949|NCT00002208|Drug Therapy, Combination|drug therapy, combination
5434950|NCT00002208|Zidovudine|zidovudine
5434951|NCT00002208|HIV Protease Inhibitors|hiv protease inhibitors
5434952|NCT00002208|Lamivudine|lamivudine
5434953|NCT00002208|Indinavir|indinavir
5434954|NCT00002208|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5434955|NCT00002207|Didanosine|didanosine
5434956|NCT00002207|Drug Therapy, Combination|drug therapy, combination
5434957|NCT00002207|Stavudine|stavudine
5434958|NCT00002207|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5434959|NCT00002206|HIV-1|hiv-1
5434960|NCT00002206|Adenine|adenine
5434961|NCT00002206|Anti-HIV Agents|anti-hiv agents
5434962|NCT00002205|HIV Protease Inhibitors|hiv protease inhibitors
5434963|NCT00002205|VX 478|vx 478
5434964|NCT00002205|Anti-HIV Agents|anti-hiv agents
5434965|NCT00002205|abacavir|abacavir
5434966|NCT00002204|Reference Values|reference values
5434967|NCT00002204|Placebos|placebos
5434968|NCT00002204|AIDS Vaccines|aids vaccines
5434969|NCT00002204|HIV Core Protein p24|hiv core protein p24
5434970|NCT00002204|HIV Seronegativity|hiv seronegativity
5434971|NCT00002204|MF59 oil emulsion|mf59 oil emulsion
5434972|NCT00002203|Drug Therapy, Combination|drug therapy, combination
5434973|NCT00002203|Zidovudine|zidovudine
5434974|NCT00002203|HIV Protease Inhibitors|hiv protease inhibitors
5434975|NCT00002203|CD4 Lymphocyte Count|cd4 lymphocyte count
5434976|NCT00002203|CD4-CD8 Ratio|cd4-cd8 ratio
5434977|NCT00002203|Lamivudine|lamivudine
5434978|NCT00002203|Patient Compliance|patient compliance
5434979|NCT00002203|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5434980|NCT00002203|Anti-HIV Agents|anti-hiv agents
5434981|NCT00002203|Viral Load|viral load
5434982|NCT00002202|HIV-1|hiv-1
5434983|NCT00002202|Drug Therapy, Combination|drug therapy, combination
5434984|NCT00002202|HIV Protease Inhibitors|hiv protease inhibitors
5434985|NCT00002202|Indinavir|indinavir
5434986|NCT00002202|RNA, Viral|rna, viral
5434987|NCT00002202|VX 478|vx 478
5434988|NCT00002202|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5434989|NCT00002202|Anti-HIV Agents|anti-hiv agents
5434990|NCT00002202|Viral Load|viral load
5434991|NCT00002201|Drug Therapy, Combination|drug therapy, combination
5434992|NCT00002201|HIV Protease Inhibitors|hiv protease inhibitors
5434993|NCT00002201|Ritonavir|ritonavir
5434997|NCT00002200|Administration, Oral|administration, oral
5434998|NCT00002200|CD4 Lymphocyte Count|cd4 lymphocyte count
5434999|NCT00002200|RNA, Viral|rna, viral
5435000|NCT00002200|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5435001|NCT00002200|Anti-HIV Agents|anti-hiv agents
5435002|NCT00002200|Viral Load|viral load
5435003|NCT00002200|abacavir|abacavir
5435004|NCT00002199|HIV-1|hiv-1
5435005|NCT00002199|Drug Therapy, Combination|drug therapy, combination
5435006|NCT00002199|Zidovudine|zidovudine
5435007|NCT00002199|Drug Resistance, Microbial|drug resistance, microbial
5435008|NCT00002199|HIV Protease Inhibitors|hiv protease inhibitors
5435009|NCT00002199|Lamivudine|lamivudine
5435010|NCT00002199|Indinavir|indinavir
5435011|NCT00002199|Genotype|genotype
5435012|NCT00002199|Phenotype|phenotype
5435013|NCT00002199|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5435014|NCT00002199|Anti-HIV Agents|anti-hiv agents
5435015|NCT00002199|abacavir|abacavir
5435016|NCT00002198|Drug Interactions|drug interactions
5435017|NCT00002198|Antiviral Agents|antiviral agents
5435018|NCT00002198|Ethanol|ethanol
5435019|NCT00002198|abacavir|abacavir
5435020|NCT00002197|HIV-1|hiv-1
5435021|NCT00002197|CD4 Lymphocyte Count|cd4 lymphocyte count
5435022|NCT00002197|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5435023|NCT00002197|Anti-HIV Agents|anti-hiv agents
5435024|NCT00002197|Viral Load|viral load
5435025|NCT00002197|abacavir|abacavir
5435026|NCT00002196|Dose-Response Relationship, Drug|dose-response relationship, drug
5435027|NCT00002196|Administration, Oral|administration, oral
5435028|NCT00002196|Drug Administration Schedule|drug administration schedule
5435029|NCT00002196|CD4 Lymphocyte Count|cd4 lymphocyte count
5435030|NCT00002196|Anti-HIV Agents|anti-hiv agents
5435031|NCT00002195|Drug Therapy, Combination|drug therapy, combination
5435032|NCT00002195|Zidovudine|zidovudine
5435033|NCT00002195|HIV Protease Inhibitors|hiv protease inhibitors
5435034|NCT00002195|Lamivudine|lamivudine
5435035|NCT00002195|VX 478|vx 478
5435036|NCT00002195|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5435037|NCT00002195|Anti-HIV Agents|anti-hiv agents
5435038|NCT00002195|Viral Load|viral load
5435039|NCT00002194|Antibiotics, Macrolide|antibiotics, macrolide
5435040|NCT00002194|Clarithromycin|clarithromycin
5435041|NCT00002194|Nevirapine|nevirapine
5435042|NCT00002194|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5435043|NCT00002194|Cytochrome P-450|cytochrome p-450
5435044|NCT00002194|Anti-HIV Agents|anti-hiv agents
5435045|NCT00002193|HIV-1|hiv-1
5435046|NCT00002193|Drug Therapy, Combination|drug therapy, combination
5435047|NCT00002193|HIV Protease Inhibitors|hiv protease inhibitors
5435048|NCT00002193|RNA, Viral|rna, viral
5435049|NCT00002193|VX 478|vx 478
5435050|NCT00002193|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5435051|NCT00002193|Anti-HIV Agents|anti-hiv agents
5435052|NCT00002193|Viral Load|viral load
5435053|NCT00002192|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
5435054|NCT00002192|Mycobacterium avium-intracellulare Infection|mycobacterium avium-intracellulare infection
5435055|NCT00002192|Drug Therapy, Combination|drug therapy, combination
5435056|NCT00002192|Antitubercular Agents|antitubercular agents
5435057|NCT00002192|Azithromycin|azithromycin
5435058|NCT00002192|Clarithromycin|clarithromycin
5435059|NCT00002192|Bacteremia|bacteremia
5435060|NCT00002192|rifapentine|rifapentine
5435061|NCT00002191|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
5435062|NCT00002191|Placebos|placebos
5435063|NCT00002191|Protozoan Infections|protozoan infections
5435064|NCT00002191|Intestinal Diseases|intestinal diseases
5435065|NCT00002191|Albendazole|albendazole
5435066|NCT00002191|Microsporida|microsporida
5435067|NCT00002191|Anthelmintics|anthelmintics
5435068|NCT00002190|Drug Therapy, Combination|drug therapy, combination
5435069|NCT00002190|Zidovudine|zidovudine
5435070|NCT00002190|HIV Protease Inhibitors|hiv protease inhibitors
5435071|NCT00002190|Lamivudine|lamivudine
5435072|NCT00002190|Saquinavir|saquinavir
5435073|NCT00002190|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5435074|NCT00002190|Anti-HIV Agents|anti-hiv agents
5435075|NCT00002189|Sarcoma, Kaposi|sarcoma, kaposi
5435076|NCT00002189|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5435077|NCT00002189|Paclitaxel|paclitaxel
5435078|NCT00002189|Treatment Outcome|treatment outcome
5435079|NCT00002189|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic
5435080|NCT00002188|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
5435081|NCT00002188|Sarcoma, Kaposi|sarcoma, kaposi
5435082|NCT00002188|Antineoplastic Agents|antineoplastic agents
5435083|NCT00002187|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
5435084|NCT00002187|Antiviral Agents|antiviral agents
5435085|NCT00002187|Drug Administration Schedule|drug administration schedule
5435086|NCT00002187|Cytomegalovirus Retinitis|cytomegalovirus retinitis
5435087|NCT00002187|fomivirsen|fomivirsen
5435088|NCT00002187|Vitreous Body|vitreous body
5435089|NCT00002186|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
5435090|NCT00002186|Herpes Simplex|herpes simplex
5435091|NCT00002186|Drug Therapy, Combination|drug therapy, combination
5435093|NCT00002186|Antiviral Agents|antiviral agents
5435094|NCT00002186|Gels|gels
5435095|NCT00002186|SP 303|sp 303
5435096|NCT00002185|Skin Neoplasms|skin neoplasms
5435097|NCT00002185|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
5435098|NCT00002185|Sarcoma, Kaposi|sarcoma, kaposi
5435099|NCT00002185|Drug Therapy, Combination|drug therapy, combination
5435100|NCT00002185|HIV Protease Inhibitors|hiv protease inhibitors
5435101|NCT00002185|Mucous Membrane|mucous membrane
5435102|NCT00002185|Nelfinavir|nelfinavir
5435103|NCT00002185|Anti-HIV Agents|anti-hiv agents
5435104|NCT00002184|HIV-1|hiv-1
5435105|NCT00002184|Dose-Response Relationship, Drug|dose-response relationship, drug
5435106|NCT00002184|Drug Therapy, Combination|drug therapy, combination
5435107|NCT00002184|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5435108|NCT00002184|Zidovudine|zidovudine
5435109|NCT00002184|Stavudine|stavudine
5435110|NCT00002184|HIV Protease Inhibitors|hiv protease inhibitors
5435111|NCT00002184|CD4 Lymphocyte Count|cd4 lymphocyte count
5435112|NCT00002184|Lamivudine|lamivudine
5435113|NCT00002184|RNA, Viral|rna, viral
5435114|NCT00002184|Saquinavir|saquinavir
5435115|NCT00002184|Nelfinavir|nelfinavir
5435116|NCT00002184|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5435117|NCT00002184|Adenine|adenine
5435118|NCT00002184|Anti-HIV Agents|anti-hiv agents
5435119|NCT00002184|Viral Load|viral load
5435120|NCT00002183|Drug Therapy, Combination|drug therapy, combination
5435121|NCT00002183|Drug Administration Schedule|drug administration schedule
5435122|NCT00002183|HIV Protease Inhibitors|hiv protease inhibitors
5435123|NCT00002183|VX 478|vx 478
5435124|NCT00002183|Anti-HIV Agents|anti-hiv agents
5435125|NCT00002182|Placebos|placebos
5435126|NCT00002182|Appetite Stimulants|appetite stimulants
5435127|NCT00002182|Megestrol Acetate|megestrol acetate
5435128|NCT00002182|Failure to Thrive|failure to thrive
5435129|NCT00002181|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
5435130|NCT00002181|Herpes Simplex|herpes simplex
5435131|NCT00002181|Acyclovir|acyclovir
5435132|NCT00002181|Antiviral Agents|antiviral agents
5435133|NCT00002181|Gels|gels
5435134|NCT00002181|cidofovir|cidofovir
5435135|NCT00002180|Placebos|placebos
5435136|NCT00002180|Anti-HIV Agents|anti-hiv agents
5435137|NCT00002180|Adenine|adenine
5435138|NCT00002179|Semen|semen
5435139|NCT00002179|Monocytes|monocytes
5435140|NCT00002179|HIV-1|hiv-1
5435141|NCT00002179|Drug Therapy, Combination|drug therapy, combination
5435142|NCT00002179|Zidovudine|zidovudine
5435143|NCT00002179|Lymph Nodes|lymph nodes
5435144|NCT00002179|HIV Protease Inhibitors|hiv protease inhibitors
5435145|NCT00002179|Lamivudine|lamivudine
5435146|NCT00002179|Indinavir|indinavir
5435147|NCT00002179|RNA, Viral|rna, viral
5435148|NCT00002179|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5435149|NCT00002179|Anti-HIV Agents|anti-hiv agents
5435150|NCT00002179|Viral Load|viral load
5435151|NCT00002178|HIV-1|hiv-1
5435152|NCT00002178|Drug Therapy, Combination|drug therapy, combination
5435153|NCT00002178|HIV Protease Inhibitors|hiv protease inhibitors
5435154|NCT00002178|RNA, Viral|rna, viral
5435155|NCT00002178|Dosage Forms|dosage forms
5435156|NCT00002178|Saquinavir|saquinavir
5435157|NCT00002178|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5435158|NCT00002178|Anti-HIV Agents|anti-hiv agents
5435159|NCT00002178|Viral Load|viral load
5435160|NCT00002177|Pilot Projects|pilot projects
5435161|NCT00002177|HIV-1|hiv-1
5435162|NCT00002177|Didanosine|didanosine
5435163|NCT00002177|Drug Therapy, Combination|drug therapy, combination
5435164|NCT00002177|Stavudine|stavudine
5435165|NCT00002177|Hydroxyurea|hydroxyurea
5435166|NCT00002177|RNA, Viral|rna, viral
5435167|NCT00002177|Nelfinavir|nelfinavir
5435168|NCT00002177|Anti-HIV Agents|anti-hiv agents
5435169|NCT00002177|Viral Load|viral load
5435170|NCT00002176|Pilot Projects|pilot projects
5435171|NCT00002176|Didanosine|didanosine
5435172|NCT00002176|Drug Therapy, Combination|drug therapy, combination
5435173|NCT00002176|Stavudine|stavudine
5435174|NCT00002176|Hydroxyurea|hydroxyurea
5435175|NCT00002176|Nelfinavir|nelfinavir
5435176|NCT00002176|Anti-HIV Agents|anti-hiv agents
5435177|NCT00002176|Viral Load|viral load
5435178|NCT00002175|Cohort Studies|cohort studies
5435179|NCT00002175|RNA, Viral|rna, viral
5435180|NCT00002175|Administration, Cutaneous|administration, cutaneous
5435181|NCT00002175|Anti-HIV Agents|anti-hiv agents
5435182|NCT00002175|Dinitrobenzenes|dinitrobenzenes
5435183|NCT00002174|Adjuvants, Immunologic|adjuvants, immunologic
5435184|NCT00002174|Thalidomide|thalidomide
5435185|NCT00002174|Cytokines|cytokines
5435186|NCT00002174|Viral Load|viral load
5435187|NCT00002173|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5435188|NCT00002173|AIDS Vaccines|aids vaccines
5435189|NCT00002173|CD4 Lymphocyte Count|cd4 lymphocyte count
5435190|NCT00002173|Salk HIV Immunogen|salk hiv immunogen
5435191|NCT00002172|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5435192|NCT00002172|AIDS Vaccines|aids vaccines
5435193|NCT00002172|CD4 Lymphocyte Count|cd4 lymphocyte count
5435194|NCT00002172|Salk HIV Immunogen|salk hiv immunogen
5435195|NCT00002171|Placebos|placebos
5435196|NCT00002171|Drug Therapy, Combination|drug therapy, combination
5435197|NCT00002171|Stavudine|stavudine
5435198|NCT00002171|HIV Protease Inhibitors|hiv protease inhibitors
5435199|NCT00002171|Lamivudine|lamivudine
5435200|NCT00002171|Nelfinavir|nelfinavir
5435201|NCT00002171|Anti-HIV Agents|anti-hiv agents
5435202|NCT00002170|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
5435203|NCT00002170|Placebos|placebos
5435204|NCT00002170|Mycobacterium avium-intracellulare Infection|mycobacterium avium-intracellulare infection
5435205|NCT00002170|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5435206|NCT00002170|HIV Protease Inhibitors|hiv protease inhibitors
5435207|NCT00002170|Nelfinavir|nelfinavir
5435208|NCT00002170|Anti-Infective Agents|anti-infective agents
5435209|NCT00002170|Anti-HIV Agents|anti-hiv agents
5435210|NCT00002169|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
5435211|NCT00002169|Placebos|placebos
5435212|NCT00002169|Antiviral Agents|antiviral agents
5435213|NCT00002169|Cytomegalovirus Retinitis|cytomegalovirus retinitis
5435214|NCT00002169|Treatment Outcome|treatment outcome
5435215|NCT00002169|Nelfinavir|nelfinavir
5435216|NCT00002168|Didanosine|didanosine
5435217|NCT00002168|Drug Therapy, Combination|drug therapy, combination
5435218|NCT00002168|Zidovudine|zidovudine
5435219|NCT00002168|Stavudine|stavudine
5435220|NCT00002168|HIV Protease Inhibitors|hiv protease inhibitors
5435221|NCT00002168|CD4 Lymphocyte Count|cd4 lymphocyte count
5435222|NCT00002168|Lamivudine|lamivudine
5435223|NCT00002168|Indinavir|indinavir
5435224|NCT00002168|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5435225|NCT00002168|Anti-HIV Agents|anti-hiv agents
5435226|NCT00002168|Viral Load|viral load
5435227|NCT00002167|Skin Neoplasms|skin neoplasms
5435228|NCT00002167|Sarcoma, Kaposi|sarcoma, kaposi
5435229|NCT00002167|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5435230|NCT00002167|Photochemotherapy|photochemotherapy
5435231|NCT00002167|tin etiopurpurin|tin etiopurpurin
5435232|NCT00002167|Radiation-Sensitizing Agents|radiation-sensitizing agents
5435233|NCT00002166|Nevirapine|nevirapine
5435234|NCT00002166|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5435235|NCT00002166|Anti-HIV Agents|anti-hiv agents
5435236|NCT00002165|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5435237|NCT00002165|HIV Protease Inhibitors|hiv protease inhibitors
5435238|NCT00002165|CD4 Lymphocyte Count|cd4 lymphocyte count
5435239|NCT00002165|Nelfinavir|nelfinavir
5435240|NCT00002165|Anti-HIV Agents|anti-hiv agents
5435241|NCT00002164|Biological Availability|biological availability
5435242|NCT00002164|HIV Protease Inhibitors|hiv protease inhibitors
5435243|NCT00002164|Dosage Forms|dosage forms
5435244|NCT00002164|Nelfinavir|nelfinavir
5435245|NCT00002163|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5435246|NCT00002163|AIDS Dementia Complex|aids dementia complex
5435247|NCT00002163|Antiviral Agents|antiviral agents
5435248|NCT00002163|abacavir|abacavir
5435249|NCT00002162|Drug Therapy, Combination|drug therapy, combination
5435250|NCT00002162|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5435251|NCT00002162|AIDS-Related Complex|aids-related complex
5435252|NCT00002162|Antiviral Agents|antiviral agents
5435253|NCT00002162|Saquinavir|saquinavir
5435254|NCT00002161|Drug Therapy, Combination|drug therapy, combination
5435255|NCT00002161|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5435256|NCT00002161|AIDS-Related Complex|aids-related complex
5435257|NCT00002161|Antiviral Agents|antiviral agents
5435258|NCT00002161|Adenine|adenine
5435259|NCT00002160|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5435260|NCT00002160|AIDS-Related Complex|aids-related complex
5435261|NCT00002160|Pain|pain
5435262|NCT00002160|Palliative Care|palliative care
5435263|NCT00002160|omega-conopeptide MVIIA|omega-conopeptide mviia
5435264|NCT00002160|Calcium Channel Blockers|calcium channel blockers
5435265|NCT00002159|Itraconazole|itraconazole
5435266|NCT00002159|Histoplasmosis|histoplasmosis
5435267|NCT00002159|Antifungal Agents|antifungal agents
5435268|NCT00002159|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5435269|NCT00002159|Amphotericin B|amphotericin b
5435270|NCT00002159|AIDS-Related Complex|aids-related complex
5435271|NCT00002159|Blastomycosis|blastomycosis
5435272|NCT00002159|Antibiotics, Antifungal|antibiotics, antifungal
5435273|NCT00002158|Cryptosporidiosis|cryptosporidiosis
5435274|NCT00002158|Diarrhea|diarrhea
5435275|NCT00002158|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5435276|NCT00002158|nitazoxanide|nitazoxanide
5435277|NCT00002158|Antiparasitic Agents|antiparasitic agents
5435278|NCT00002157|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5435279|NCT00002157|Cachexia|cachexia
5435280|NCT00002157|Thalidomide|thalidomide
5435281|NCT00002156|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
5435282|NCT00002156|Ganciclovir|ganciclovir
5435283|NCT00002156|Drug Therapy, Combination|drug therapy, combination
5435284|NCT00002156|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5435285|NCT00002156|Antiviral Agents|antiviral agents
5435286|NCT00002156|Cytomegalovirus Retinitis|cytomegalovirus retinitis
5435287|NCT00002156|Injections|injections
5444068|NCT00001721|MRI|mri
5435288|NCT00002155|Drug Therapy, Combination|drug therapy, combination
5435289|NCT00002155|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5435290|NCT00002155|Antiviral Agents|antiviral agents
5435291|NCT00002155|Zidovudine|zidovudine
5435292|NCT00002155|HIV Protease Inhibitors|hiv protease inhibitors
5435293|NCT00002155|Lamivudine|lamivudine
5435294|NCT00002155|Indinavir|indinavir
5435295|NCT00002154|Drug Therapy, Combination|drug therapy, combination
5435296|NCT00002154|Cognition Disorders|cognition disorders
5435297|NCT00002154|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5435298|NCT00002154|AIDS-Related Complex|aids-related complex
5435299|NCT00002154|Thioctic Acid|thioctic acid
5435300|NCT00002154|Selegiline|selegiline
5435301|NCT00002153|Skin Neoplasms|skin neoplasms
5435302|NCT00002153|Sarcoma, Kaposi|sarcoma, kaposi
5435303|NCT00002153|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5435304|NCT00002153|Antineoplastic Agents|antineoplastic agents
5435305|NCT00002152|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5435306|NCT00002152|Antiviral Agents|antiviral agents
5435307|NCT00002151|Drug Therapy, Combination|drug therapy, combination
5435308|NCT00002151|AIDS-Related Complex|aids-related complex
5435309|NCT00002151|Zidovudine|zidovudine
5435310|NCT00002151|MDL 28574|mdl 28574
5435311|NCT00002150|Drug Therapy, Combination|drug therapy, combination
5435312|NCT00002150|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5435313|NCT00002150|AIDS-Related Complex|aids-related complex
5435314|NCT00002150|Zidovudine|zidovudine
5435315|NCT00002150|MDL 28574|mdl 28574
5435316|NCT00002149|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
5435317|NCT00002149|Drug Therapy, Combination|drug therapy, combination
5435318|NCT00002149|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5435319|NCT00002149|AIDS-Related Complex|aids-related complex
5435320|NCT00002149|Sinusitis|sinusitis
5435321|NCT00002149|Ephedrine|ephedrine
5435322|NCT00002149|Acupuncture Therapy|acupuncture therapy
5435323|NCT00002149|Drugs, Chinese Herbal|drugs, chinese herbal
5435324|NCT00002149|Medicine, Chinese Traditional|medicine, chinese traditional
5435325|NCT00002149|Drug Combinations|drug combinations
5435326|NCT00002149|Antibiotics, Combined|antibiotics, combined
5435327|NCT00002149|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination
5435328|NCT00002148|Cognition Disorders|cognition disorders
5435329|NCT00002148|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5435330|NCT00002148|AIDS-Related Complex|aids-related complex
5435331|NCT00002148|Free Radical Scavengers|free radical scavengers
5435332|NCT00002148|Antioxidants|antioxidants
5435333|NCT00002148|OPC 14117|opc 14117
5435334|NCT00002147|Sarcoma, Kaposi|sarcoma, kaposi
5435335|NCT00002147|Liposomes|liposomes
5435336|NCT00002147|Doxorubicin|doxorubicin
5435337|NCT00002147|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5435338|NCT00002147|Drug Carriers|drug carriers
5435339|NCT00002146|Infusions, Intravenous|infusions, intravenous
5435340|NCT00002146|Foscarnet|foscarnet
5435341|NCT00002146|Cytomegalovirus Infections|cytomegalovirus infections
5435342|NCT00002146|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5435343|NCT00002146|Magnesium Sulfate|magnesium sulfate
5435344|NCT00002146|Magnesium Deficiency|magnesium deficiency
5435345|NCT00002146|Hypocalcemia|hypocalcemia
5435346|NCT00002145|Foscarnet|foscarnet
5435347|NCT00002145|Cytomegalovirus Infections|cytomegalovirus infections
5435348|NCT00002145|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5435349|NCT00002144|Herpes Simplex|herpes simplex
5435350|NCT00002144|Foscarnet|foscarnet
5435351|NCT00002144|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5435352|NCT00002143|Psoriasis|psoriasis
5435353|NCT00002143|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5435354|NCT00002143|AIDS-Related Complex|aids-related complex
5435355|NCT00002143|Acitretin|acitretin
5435356|NCT00002142|Retinitis|retinitis
5435357|NCT00002142|Probenecid|probenecid
5435358|NCT00002142|Drug Therapy, Combination|drug therapy, combination
5435359|NCT00002142|Cytomegalovirus Infections|cytomegalovirus infections
5435360|NCT00002142|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5435361|NCT00002142|Antiviral Agents|antiviral agents
5435362|NCT00002142|cidofovir|cidofovir
5435363|NCT00002141|Biological Availability|biological availability
5435364|NCT00002141|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5435365|NCT00002141|Food-Drug Interactions|food-drug interactions
5435366|NCT00002141|abacavir|abacavir
5435367|NCT00002140|Mycobacterium avium-intracellulare Infection|mycobacterium avium-intracellulare infection
5435368|NCT00002140|Drug Therapy, Combination|drug therapy, combination
5435369|NCT00002140|Ethambutol|ethambutol
5435370|NCT00002140|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5435371|NCT00002140|Azithromycin|azithromycin
5435372|NCT00002140|Clarithromycin|clarithromycin
5435373|NCT00002139|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5435374|NCT00002139|Azithromycin|azithromycin
5435375|NCT00002139|Bacterial Infections|bacterial infections
5435376|NCT00002138|Neoplasms|neoplasms
5435377|NCT00002138|Sarcoma, Kaposi|sarcoma, kaposi
5435469|NCT00002117|Drug Therapy, Combination|drug therapy, combination
5435378|NCT00002138|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5435379|NCT00002138|Antineoplastic Agents|antineoplastic agents
5435380|NCT00002138|tecogalan|tecogalan
5435381|NCT00002137|Neoplasms|neoplasms
5435382|NCT00002137|Sarcoma, Kaposi|sarcoma, kaposi
5435383|NCT00002137|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5435384|NCT00002137|Antineoplastic Agents|antineoplastic agents
5435385|NCT00002137|tecogalan|tecogalan
5435386|NCT00002136|Neoplasms|neoplasms
5435387|NCT00002136|Sarcoma, Kaposi|sarcoma, kaposi
5435388|NCT00002136|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5435389|NCT00002136|Antineoplastic Agents|antineoplastic agents
5435390|NCT00002136|tecogalan|tecogalan
5435391|NCT00002135|Retinitis|retinitis
5435392|NCT00002135|Ganciclovir|ganciclovir
5435393|NCT00002135|Administration, Oral|administration, oral
5435394|NCT00002135|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5435395|NCT00002134|Retinitis|retinitis
5435396|NCT00002134|Ganciclovir|ganciclovir
5435397|NCT00002134|Administration, Oral|administration, oral
5435398|NCT00002134|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5435399|NCT00002133|Itraconazole|itraconazole
5435400|NCT00002133|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5435401|NCT00002133|AIDS-Related Complex|aids-related complex
5435402|NCT00002133|Candidiasis, Oral|candidiasis, oral
5435403|NCT00002132|Itraconazole|itraconazole
5435404|NCT00002132|Fluconazole|fluconazole
5435405|NCT00002132|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5435406|NCT00002132|Candidiasis|candidiasis
5435407|NCT00002132|Immunocompromised Host|immunocompromised host
5435408|NCT00002131|Sarcoma, Kaposi|sarcoma, kaposi
5435409|NCT00002131|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5435410|NCT00002131|Antiviral Agents|antiviral agents
5435411|NCT00002131|vesnarinone|vesnarinone
5435412|NCT00002130|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5435413|NCT00002130|Antiviral Agents|antiviral agents
5435414|NCT00002130|vesnarinone|vesnarinone
5435415|NCT00002129|vesnarinone|vesnarinone
5435416|NCT00002128|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5435417|NCT00002128|AIDS-Related Complex|aids-related complex
5435418|NCT00002128|Antiviral Agents|antiviral agents
5435419|NCT00002128|Adenine|adenine
5435420|NCT00002127|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5435421|NCT00002127|Cachexia|cachexia
5435422|NCT00002127|Thalidomide|thalidomide
5435423|NCT00002126|Neutropenia|neutropenia
5435424|NCT00002126|Granulocyte Colony-Stimulating Factor|granulocyte colony-stimulating factor
5435425|NCT00002126|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5435426|NCT00002125|Retinitis|retinitis
5435427|NCT00002125|Infusions, Intravenous|infusions, intravenous
5435428|NCT00002125|Foscarnet|foscarnet
5435429|NCT00002125|Cytomegalovirus Infections|cytomegalovirus infections
5435430|NCT00002125|Administration, Oral|administration, oral
5435431|NCT00002125|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5435432|NCT00002125|Fluid Therapy|fluid therapy
5435433|NCT00002124|Drug Therapy, Combination|drug therapy, combination
5435434|NCT00002124|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5435435|NCT00002124|AIDS-Related Complex|aids-related complex
5435436|NCT00002124|Antiviral Agents|antiviral agents
5435437|NCT00002124|Zidovudine|zidovudine
5435438|NCT00002123|Didanosine|didanosine
5435439|NCT00002123|Drug Therapy, Combination|drug therapy, combination
5435440|NCT00002123|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5435441|NCT00002123|AIDS-Related Complex|aids-related complex
5435442|NCT00002123|Antiviral Agents|antiviral agents
5435443|NCT00002122|Rifabutin|rifabutin
5435444|NCT00002122|Mycobacterium avium-intracellulare Infection|mycobacterium avium-intracellulare infection
5435445|NCT00002122|Mycoses|mycoses
5435446|NCT00002122|Drug Therapy, Combination|drug therapy, combination
5435447|NCT00002122|Fluconazole|fluconazole
5435448|NCT00002122|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5435449|NCT00002122|Azithromycin|azithromycin
5435450|NCT00002121|Antidiarrheals|antidiarrheals
5435451|NCT00002121|Diarrhea|diarrhea
5435452|NCT00002121|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5435453|NCT00002121|AIDS-Related Complex|aids-related complex
5435454|NCT00002121|N(1),N(14)-bis(ethyl)homospermine|n(1),n(14)-bis(ethyl)homospermine
5435455|NCT00002120|Trimethoprim-Sulfamethoxazole Combination|trimethoprim-sulfamethoxazole combination
5435456|NCT00002120|Trimetrexate|trimetrexate
5435457|NCT00002120|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
5435458|NCT00002120|Leucovorin|leucovorin
5435459|NCT00002120|Dapsone|dapsone
5435460|NCT00002120|Drug Therapy, Combination|drug therapy, combination
5435461|NCT00002120|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5435462|NCT00002119|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5435463|NCT00002119|AIDS-Related Complex|aids-related complex
5435464|NCT00002119|Antiviral Agents|antiviral agents
5435465|NCT00002118|Zalcitabine|zalcitabine
5435466|NCT00002118|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5435467|NCT00002118|AIDS-Related Complex|aids-related complex
5435468|NCT00002117|Zalcitabine|zalcitabine
5435470|NCT00002117|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5435471|NCT00002117|AIDS-Related Complex|aids-related complex
5435472|NCT00002117|Zidovudine|zidovudine
5435473|NCT00002116|Herpes Simplex|herpes simplex
5435474|NCT00002116|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5435475|NCT00002116|Antiviral Agents|antiviral agents
5435476|NCT00002116|cidofovir|cidofovir
5435477|NCT00002115|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5435478|NCT00002115|Antiviral Agents|antiviral agents
5435479|NCT00002115|Adenine|adenine
5435480|NCT00002113|Meningitis|meningitis
5435481|NCT00002113|Cryptococcosis|cryptococcosis
5435482|NCT00002113|Drug Therapy, Combination|drug therapy, combination
5435483|NCT00002113|Fluconazole|fluconazole
5435484|NCT00002113|Flucytosine|flucytosine
5435485|NCT00002113|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5435486|NCT00002112|Nystatin|nystatin
5435487|NCT00002112|Fluconazole|fluconazole
5435488|NCT00002112|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5435489|NCT00002112|AIDS-Related Complex|aids-related complex
5435490|NCT00002112|Candidiasis, Oral|candidiasis, oral
5435491|NCT00002111|AIDS-Related Complex|aids-related complex
5435492|NCT00002111|Saquinavir|saquinavir
5435493|NCT00002111|HIV Protease Inhibitors|hiv protease inhibitors
5435494|NCT00002110|Drug Therapy, Combination|drug therapy, combination
5435495|NCT00002110|AIDS-Related Complex|aids-related complex
5435496|NCT00002110|Zidovudine|zidovudine
5435497|NCT00002110|Cysteamine|cysteamine
5435498|NCT00002109|Thymopentin|thymopentin
5435499|NCT00002109|Zalcitabine|zalcitabine
5435500|NCT00002109|Didanosine|didanosine
5435501|NCT00002109|Drug Therapy, Combination|drug therapy, combination
5435502|NCT00002109|Zidovudine|zidovudine
5435503|NCT00002109|Stavudine|stavudine
5435504|NCT00002108|Drug Therapy, Combination|drug therapy, combination
5435505|NCT00002108|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5435506|NCT00002108|AIDS-Related Complex|aids-related complex
5435507|NCT00002108|Antiviral Agents|antiviral agents
5435508|NCT00002108|Zidovudine|zidovudine
5435509|NCT00002107|Interleukin-2|interleukin-2
5435510|NCT00002107|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5435511|NCT00002107|AIDS-Related Complex|aids-related complex
5435512|NCT00002106|Ranitidine|ranitidine
5435513|NCT00002105|Vincristine|vincristine
5435514|NCT00002105|Sarcoma, Kaposi|sarcoma, kaposi
5435515|NCT00002105|Liposomes|liposomes
5435516|NCT00002105|Doxorubicin|doxorubicin
5435517|NCT00002105|Drug Therapy, Combination|drug therapy, combination
5435518|NCT00002105|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5435519|NCT00002105|Bleomycin|bleomycin
5435520|NCT00002105|Drug Carriers|drug carriers
5435521|NCT00002104|Mycobacterium tuberculosis|mycobacterium tuberculosis
5435522|NCT00002104|Mycobacterium Infections|mycobacterium infections
5435523|NCT00002104|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
5435524|NCT00002104|Mycobacterium avium-intracellulare Infection|mycobacterium avium-intracellulare infection
5435525|NCT00002104|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5435526|NCT00002104|AIDS-Related Complex|aids-related complex
5435527|NCT00002104|Mycobacterium Infections, Atypical|mycobacterium infections, atypical
5435528|NCT00002104|Thalidomide|thalidomide
5435529|NCT00002103|Trimetrexate|trimetrexate
5435530|NCT00002103|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
5435531|NCT00002103|Leucovorin|leucovorin
5435532|NCT00002103|Drug Therapy, Combination|drug therapy, combination
5435533|NCT00002103|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5435534|NCT00002102|Trimetrexate|trimetrexate
5435535|NCT00002102|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
5435536|NCT00002102|Leucovorin|leucovorin
5435537|NCT00002102|Drug Therapy, Combination|drug therapy, combination
5435538|NCT00002102|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5435539|NCT00002101|Rifabutin|rifabutin
5435540|NCT00002101|Mycobacterium avium-intracellulare Infection|mycobacterium avium-intracellulare infection
5435541|NCT00002101|Drug Therapy, Combination|drug therapy, combination
5435542|NCT00002101|Ethambutol|ethambutol
5435543|NCT00002101|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5435544|NCT00002101|Clarithromycin|clarithromycin
5435545|NCT00002100|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5435546|NCT00002100|AIDS-Related Complex|aids-related complex
5435547|NCT00002100|curdlan sulfate|curdlan sulfate
5435548|NCT00002099|Didanosine|didanosine
5435549|NCT00002099|Drug Therapy, Combination|drug therapy, combination
5435550|NCT00002099|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5435551|NCT00002099|AIDS-Related Complex|aids-related complex
5435552|NCT00002099|Lentinan|lentinan
5435553|NCT00002098|Didanosine|didanosine
5435554|NCT00002098|Drug Therapy, Combination|drug therapy, combination
5435555|NCT00002098|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5435556|NCT00002098|AIDS-Related Complex|aids-related complex
5435557|NCT00002098|Lentinan|lentinan
5435558|NCT00002097|Nystatin|nystatin
5435559|NCT00002097|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5435560|NCT00002097|AIDS-Related Complex|aids-related complex
5435561|NCT00002096|Didanosine|didanosine
5435563|NCT00002096|Drug Interactions|drug interactions
5435564|NCT00002096|Cytomegalovirus Infections|cytomegalovirus infections
5435565|NCT00002096|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5435566|NCT00002096|Zidovudine|zidovudine
5435567|NCT00002095|Ganciclovir|ganciclovir
5435568|NCT00002095|Cytomegalovirus Infections|cytomegalovirus infections
5435569|NCT00002095|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5435570|NCT00002094|Virus Replication|virus replication
5435571|NCT00002094|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5435572|NCT00002094|Antiviral Agents|antiviral agents
5435573|NCT00002093|Vincristine|vincristine
5435574|NCT00002093|Sarcoma, Kaposi|sarcoma, kaposi
5435575|NCT00002093|Liposomes|liposomes
5435576|NCT00002093|Doxorubicin|doxorubicin
5435577|NCT00002093|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5435578|NCT00002093|Bleomycin|bleomycin
5435579|NCT00002093|Daunorubicin|daunorubicin
5435580|NCT00002093|Drug Carriers|drug carriers
5435581|NCT00002092|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5435582|NCT00002092|AIDS-Related Complex|aids-related complex
5435583|NCT00002092|Cimetidine|cimetidine
5435584|NCT00002091|Pentoxifylline|pentoxifylline
5435585|NCT00002091|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5435586|NCT00002091|AIDS-Related Complex|aids-related complex
5435587|NCT00002090|Mycobacterium avium-intracellulare Infection|mycobacterium avium-intracellulare infection
5435588|NCT00002090|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5435589|NCT00002090|Azithromycin|azithromycin
5435590|NCT00002089|Mycobacterium avium-intracellulare Infection|mycobacterium avium-intracellulare infection
5435591|NCT00002089|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5435592|NCT00002089|Azithromycin|azithromycin
5435593|NCT00002088|Diarrhea|diarrhea
5435594|NCT00002088|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5435595|NCT00002088|AIDS-Related Complex|aids-related complex
5435596|NCT00002088|Saccharomyces|saccharomyces
5435597|NCT00002087|Recombinant Proteins|recombinant proteins
5435598|NCT00002087|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5435599|NCT00002087|Antigens, CD4|antigens, cd4
5435600|NCT00002087|AIDS-Related Complex|aids-related complex
5435601|NCT00002086|Zalcitabine|zalcitabine
5435602|NCT00002086|Drug Therapy, Combination|drug therapy, combination
5435603|NCT00002086|AIDS-Related Complex|aids-related complex
5435604|NCT00002086|Zidovudine|zidovudine
5435605|NCT00002086|Interferon-alpha|interferon-alpha
5435606|NCT00002085|Mycobacterium avium-intracellulare Infection|mycobacterium avium-intracellulare infection
5435607|NCT00002085|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5435608|NCT00002085|Azithromycin|azithromycin
5435609|NCT00002085|Mycobacterium Infections, Atypical|mycobacterium infections, atypical
5435610|NCT00002084|Acyclovir|acyclovir
5435611|NCT00002084|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5435612|NCT00002084|AIDS-Related Complex|aids-related complex
5435613|NCT00002084|Antiviral Agents|antiviral agents
5435614|NCT00002084|Anus Diseases|anus diseases
5435615|NCT00002084|Herpes Genitalis|herpes genitalis
5435616|NCT00002083|Peptide T|peptide t
5435617|NCT00002083|HIV-1|hiv-1
5435618|NCT00002083|Administration, Intranasal|administration, intranasal
5435619|NCT00002083|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5435620|NCT00002083|Peripheral Nervous System Diseases|peripheral nervous system diseases
5435621|NCT00002082|Cryptosporidiosis|cryptosporidiosis
5435622|NCT00002082|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5435623|NCT00002082|Azithromycin|azithromycin
5435624|NCT00002081|Zalcitabine|zalcitabine
5435625|NCT00002081|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5435626|NCT00002081|AIDS-Related Complex|aids-related complex
5435627|NCT00002081|Zidovudine|zidovudine
5435628|NCT00002080|Rifabutin|rifabutin
5435629|NCT00002080|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5435630|NCT00002080|AIDS-Related Complex|aids-related complex
5435631|NCT00002080|Mycobacterium avium Complex|mycobacterium avium complex
5435632|NCT00002080|Bacteremia|bacteremia
5435633|NCT00002079|Zidovudine|zidovudine
5435634|NCT00002079|1-Deoxynojirimycin|1-deoxynojirimycin
5435635|NCT00002078|Drug Evaluation|drug evaluation
5435636|NCT00002078|Interferon-alpha|interferon-alpha
5435637|NCT00002077|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
5435638|NCT00002077|Meningitis|meningitis
5435639|NCT00002077|Injections, Intravenous|injections, intravenous
5435640|NCT00002077|Cryptococcosis|cryptococcosis
5435641|NCT00002077|Fluconazole|fluconazole
5435642|NCT00002077|Administration, Oral|administration, oral
5435643|NCT00002077|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5435644|NCT00002076|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
5435645|NCT00002076|Meningitis|meningitis
5435646|NCT00002076|Cryptococcosis|cryptococcosis
5435647|NCT00002076|Fluconazole|fluconazole
5435648|NCT00002076|Administration, Oral|administration, oral
5435649|NCT00002076|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5435650|NCT00002075|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
5435651|NCT00002075|Meningitis|meningitis
5435652|NCT00002075|Cryptococcosis|cryptococcosis
5435653|NCT00002075|Drug Therapy, Combination|drug therapy, combination
5435654|NCT00002075|Fluconazole|fluconazole
5435655|NCT00002075|Flucytosine|flucytosine
5435656|NCT00002075|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5435657|NCT00002075|Amphotericin B|amphotericin b
5435658|NCT00002074|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
5435659|NCT00002074|Meningitis|meningitis
5435660|NCT00002074|Cryptococcosis|cryptococcosis
5435661|NCT00002074|Fluconazole|fluconazole
5435662|NCT00002074|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5435663|NCT00002074|Amphotericin B|amphotericin b
5435664|NCT00002073|Recombinant Proteins|recombinant proteins
5435665|NCT00002073|Injections, Subcutaneous|injections, subcutaneous
5435666|NCT00002073|Erythropoietin|erythropoietin
5435667|NCT00002073|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5435668|NCT00002073|Anemia|anemia
5435669|NCT00002073|Zidovudine|zidovudine
5435670|NCT00002072|Recombinant Proteins|recombinant proteins
5435671|NCT00002072|Erythropoietin|erythropoietin
5435672|NCT00002072|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5435673|NCT00002072|Anemia|anemia
5435674|NCT00002072|Zidovudine|zidovudine
5435675|NCT00002071|Recombinant Proteins|recombinant proteins
5435676|NCT00002071|Erythropoietin|erythropoietin
5435677|NCT00002071|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5435678|NCT00002071|Anemia|anemia
5435679|NCT00002071|Zidovudine|zidovudine
5435680|NCT00002070|Recombinant Proteins|recombinant proteins
5435681|NCT00002070|Retinitis|retinitis
5435682|NCT00002070|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
5435683|NCT00002070|Neutropenia|neutropenia
5435684|NCT00002070|Ganciclovir|ganciclovir
5435685|NCT00002070|Drug Therapy, Combination|drug therapy, combination
5435686|NCT00002070|Granulocyte-Macrophage Colony-Stimulating Factor|granulocyte-macrophage colony-stimulating factor
5435687|NCT00002070|Cytomegalovirus Infections|cytomegalovirus infections
5435688|NCT00002070|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5435689|NCT00002069|Ditiocarb|ditiocarb
5435690|NCT00002069|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5435691|NCT00002069|AIDS-Related Complex|aids-related complex
5435692|NCT00002068|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
5435693|NCT00002068|Meningitis|meningitis
5435694|NCT00002068|Cryptococcosis|cryptococcosis
5435695|NCT00002068|Drug Therapy, Combination|drug therapy, combination
5435696|NCT00002068|Fluconazole|fluconazole
5435697|NCT00002068|Flucytosine|flucytosine
5435698|NCT00002068|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5435699|NCT00002068|Amphotericin B|amphotericin b
5435700|NCT00002067|Body Weight|body weight
5435701|NCT00002067|T-Lymphocytes|t-lymphocytes
5435702|NCT00002067|Nutritional Status|nutritional status
5435703|NCT00002067|Megestrol|megestrol
5435704|NCT00002067|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5435705|NCT00002067|Anorexia|anorexia
5435706|NCT00002067|Cachexia|cachexia
5435707|NCT00002067|Energy Intake|energy intake
5435708|NCT00002066|Thymopentin|thymopentin
5435709|NCT00002066|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5435710|NCT00002065|Delayed-Action Preparations|delayed-action preparations
5435711|NCT00002065|Disulfiram|disulfiram
5435712|NCT00002065|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5435713|NCT00002065|AIDS-Related Complex|aids-related complex
5435714|NCT00002064|Sulfonamides|sulfonamides
5435715|NCT00002064|Toxoplasmosis|toxoplasmosis
5435716|NCT00002064|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
5435717|NCT00002064|Pyrimethamine|pyrimethamine
5435718|NCT00002064|Drug Therapy, Combination|drug therapy, combination
5435719|NCT00002064|Encephalitis|encephalitis
5435720|NCT00002064|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5435721|NCT00002064|Clindamycin|clindamycin
5435722|NCT00002063|Immune Tolerance|immune tolerance
5435723|NCT00002063|AIDS-Related Complex|aids-related complex
5435724|NCT00002063|Zidovudine|zidovudine
5435725|NCT00002062|Spiramycin|spiramycin
5435726|NCT00002062|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
5435727|NCT00002062|Immune Tolerance|immune tolerance
5435728|NCT00002062|Cryptosporidiosis|cryptosporidiosis
5435729|NCT00002062|Diarrhea|diarrhea
5435730|NCT00002062|Drugs, Investigational|drugs, investigational
5435731|NCT00002062|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5435732|NCT00002061|T-Lymphocytes|t-lymphocytes
5435733|NCT00002061|Immune Tolerance|immune tolerance
5435734|NCT00002061|Inosine Pranobex|inosine pranobex
5435735|NCT00002061|Killer Cells|killer cells
5435736|NCT00002061|T-Lymphocytes, Helper-Inducer|t-lymphocytes, helper-inducer
5435737|NCT00002061|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5435738|NCT00002061|AIDS-Related Complex|aids-related complex
5435739|NCT00002060|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
5435740|NCT00002060|Inosine Pranobex|inosine pranobex
5435741|NCT00002060|Homosexuality|homosexuality
5435742|NCT00002060|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5435743|NCT00002060|AIDS-Related Complex|aids-related complex
5435744|NCT00002059|T-Lymphocytes, Suppressor-Effector|t-lymphocytes, suppressor-effector
5435746|NCT00002059|Inosine Pranobex|inosine pranobex
5435747|NCT00002059|Killer Cells|killer cells
5435748|NCT00002059|T-Lymphocytes, Helper-Inducer|t-lymphocytes, helper-inducer
5435749|NCT00002059|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5435750|NCT00002059|AIDS-Related Complex|aids-related complex
5435751|NCT00002058|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
5435752|NCT00002058|Mycobacterium avium-intracellulare Infection|mycobacterium avium-intracellulare infection
5435753|NCT00002058|Clofazimine|clofazimine
5435754|NCT00002058|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5435755|NCT00002057|Nystatin|nystatin
5435756|NCT00002057|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
5435757|NCT00002057|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5435758|NCT00002057|AIDS-Related Complex|aids-related complex
5435759|NCT00002057|Candidiasis, Oral|candidiasis, oral
5435760|NCT00002056|Trimethoprim-Sulfamethoxazole Combination|trimethoprim-sulfamethoxazole combination
5435761|NCT00002056|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
5435762|NCT00002056|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
5435763|NCT00002056|Pentamidine|pentamidine
5435764|NCT00002056|Injections, Intravenous|injections, intravenous
5435765|NCT00002056|Administration, Oral|administration, oral
5435766|NCT00002056|Aerosols|aerosols
5435767|NCT00002056|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5435768|NCT00002055|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
5435769|NCT00002055|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
5435770|NCT00002055|Pentamidine|pentamidine
5435771|NCT00002055|Dose-Response Relationship, Drug|dose-response relationship, drug
5435772|NCT00002055|Aerosols|aerosols
5435773|NCT00002055|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5435774|NCT00002054|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
5435775|NCT00002054|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
5435776|NCT00002054|Pentamidine|pentamidine
5435777|NCT00002054|Dose-Response Relationship, Drug|dose-response relationship, drug
5435778|NCT00002054|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5435779|NCT00002053|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
5435780|NCT00002053|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
5435781|NCT00002053|Pentamidine|pentamidine
5435782|NCT00002053|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5435783|NCT00002052|Salmonella Infections|salmonella infections
5435784|NCT00002052|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
5435785|NCT00002052|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5435786|NCT00002052|Amoxicillin|amoxicillin
5435787|NCT00002052|Ceftriaxone|ceftriaxone
5435788|NCT00002051|Thymopentin|thymopentin
5435789|NCT00002051|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5435790|NCT00002050|Semen|semen
5435791|NCT00002050|Thymopentin|thymopentin
5435792|NCT00002050|Leukocytes, Mononuclear|leukocytes, mononuclear
5435793|NCT00002050|AIDS-Related Complex|aids-related complex
5435794|NCT00002049|Semen|semen
5435795|NCT00002049|Thymopentin|thymopentin
5435796|NCT00002049|Leukocytes, Mononuclear|leukocytes, mononuclear
5435797|NCT00002049|HIV Seropositivity|hiv seropositivity
5435798|NCT00002049|AIDS-Related Complex|aids-related complex
5435799|NCT00002048|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5435800|NCT00002048|Zidovudine|zidovudine
5435801|NCT00002047|Kidney Failure, Chronic|kidney failure, chronic
5435802|NCT00002047|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5435803|NCT00002047|AIDS-Related Complex|aids-related complex
5435804|NCT00002047|Zidovudine|zidovudine
5435805|NCT00002047|Renal Dialysis|renal dialysis
5435806|NCT00002046|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5435807|NCT00002046|AIDS-Related Complex|aids-related complex
5435808|NCT00002046|Zidovudine|zidovudine
5435809|NCT00002045|Prospective Studies|prospective studies
5435810|NCT00002045|Zidovudine|zidovudine
5435811|NCT00002044|Pilot Projects|pilot projects
5435812|NCT00002044|Neuromuscular Diseases|neuromuscular diseases
5435813|NCT00002044|Drug Evaluation|drug evaluation
5435814|NCT00002044|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5435815|NCT00002044|AIDS Dementia Complex|aids dementia complex
5435816|NCT00002044|AIDS-Related Complex|aids-related complex
5435817|NCT00002044|Zidovudine|zidovudine
5435818|NCT00002043|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
5435819|NCT00002043|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
5435820|NCT00002043|Leukoplakia, Oral|leukoplakia, oral
5435821|NCT00002043|Dapsone|dapsone
5435822|NCT00002043|AIDS-Related Complex|aids-related complex
5435823|NCT00002043|Candidiasis, Oral|candidiasis, oral
5435824|NCT00002042|Recombinant Proteins|recombinant proteins
5435825|NCT00002042|Erythropoietin|erythropoietin
5435826|NCT00002042|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5435827|NCT00002042|Anemia|anemia
5435828|NCT00002042|AIDS-Related Complex|aids-related complex
5435829|NCT00002042|Zidovudine|zidovudine
5435830|NCT00002041|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
5435831|NCT00002041|Esophagitis|esophagitis
5435832|NCT00002041|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5435833|NCT00002041|Amphotericin B|amphotericin b
5435834|NCT00002041|Candidiasis, Oral|candidiasis, oral
5435835|NCT00002040|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
5435836|NCT00002040|Meningitis|meningitis
5435837|NCT00002040|Injections, Intravenous|injections, intravenous
5435838|NCT00002040|Cryptococcosis|cryptococcosis
5435839|NCT00002040|Fluconazole|fluconazole
5435840|NCT00002040|Administration, Oral|administration, oral
5435841|NCT00002040|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5435842|NCT00002039|Retinitis|retinitis
5435843|NCT00002039|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
5435844|NCT00002039|Drug Therapy, Combination|drug therapy, combination
5435845|NCT00002039|Foscarnet|foscarnet
5435846|NCT00002039|Cytomegalovirus Infections|cytomegalovirus infections
5435847|NCT00002039|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5435848|NCT00002039|Antiviral Agents|antiviral agents
5435849|NCT00002039|Zidovudine|zidovudine
5435850|NCT00002038|Mycoses|mycoses
5435851|NCT00002038|Drugs, Investigational|drugs, investigational
5435852|NCT00002038|Fluconazole|fluconazole
5435853|NCT00002037|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
5435854|NCT00002037|Mycobacterium avium-intracellulare Infection|mycobacterium avium-intracellulare infection
5435855|NCT00002037|Interferon-gamma, Recombinant|interferon-gamma, recombinant
5435856|NCT00002037|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5435857|NCT00002036|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5435858|NCT00002036|AIDS-Related Complex|aids-related complex
5435859|NCT00002036|Immunization, Passive|immunization, passive
5435860|NCT00002035|Didanosine|didanosine
5435861|NCT00002035|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5435862|NCT00002035|AIDS-Related Complex|aids-related complex
5435863|NCT00002035|Zidovudine|zidovudine
5435864|NCT00002034|Retinitis|retinitis
5435865|NCT00002034|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
5435866|NCT00002034|Ganciclovir|ganciclovir
5435867|NCT00002034|Drug Interactions|drug interactions
5435868|NCT00002034|Cytomegalovirus Infections|cytomegalovirus infections
5435869|NCT00002034|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5435870|NCT00002034|Zidovudine|zidovudine
5435871|NCT00002033|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5435872|NCT00002033|AIDS-Related Complex|aids-related complex
5435873|NCT00002033|ammonium trichloro(dioxoethylene-O,O'-)tellurute|ammonium trichloro(dioxoethylene-o,o'-)tellurute
5435874|NCT00002033|Zidovudine|zidovudine
5435875|NCT00002032|Rifabutin|rifabutin
5435876|NCT00002032|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
5435877|NCT00002032|Mycobacterium avium-intracellulare Infection|mycobacterium avium-intracellulare infection
5435878|NCT00002032|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5435879|NCT00002032|Antitubercular Agents|antitubercular agents
5435880|NCT00002031|Langerhans Cells|langerhans cells
5435881|NCT00002031|Dinitrochlorobenzene|dinitrochlorobenzene
5435882|NCT00002031|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5435883|NCT00002031|AIDS-Related Complex|aids-related complex
5435884|NCT00002030|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
5435885|NCT00002030|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
5435886|NCT00002030|Pentamidine|pentamidine
5435887|NCT00002030|Aerosols|aerosols
5435888|NCT00002030|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5435889|NCT00002029|Weight Loss|weight loss
5435890|NCT00002029|Parenteral Nutrition, Total|parenteral nutrition, total
5435891|NCT00002029|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
5435892|NCT00002029|Liposyn|liposyn
5435893|NCT00002029|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5435894|NCT00002028|Didanosine|didanosine
5435895|NCT00002028|Drugs, Investigational|drugs, investigational
5435896|NCT00002028|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5435897|NCT00002028|AIDS-Related Complex|aids-related complex
5435898|NCT00002028|Zidovudine|zidovudine
5435899|NCT00002027|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
5435900|NCT00002027|Cryptosporidiosis|cryptosporidiosis
5435901|NCT00002027|Diarrhea|diarrhea
5435902|NCT00002027|diclazuril|diclazuril
5435903|NCT00002027|Coccidiostats|coccidiostats
5435904|NCT00002027|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5435905|NCT00002026|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
5435906|NCT00002026|Leukoplakia, Oral|leukoplakia, oral
5435907|NCT00002026|Herpesvirus 4, Human|herpesvirus 4, human
5435908|NCT00002026|Acyclovir|acyclovir
5435909|NCT00002026|AIDS-Related Complex|aids-related complex
5435910|NCT00002025|Retinitis|retinitis
5435911|NCT00002025|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
5435912|NCT00002025|Immune Tolerance|immune tolerance
5435913|NCT00002025|Injections, Intravenous|injections, intravenous
5435914|NCT00002025|Ganciclovir|ganciclovir
5435915|NCT00002025|Cytomegalovirus Infections|cytomegalovirus infections
5435916|NCT00002025|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5435917|NCT00002024|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
5435918|NCT00002024|Immune Tolerance|immune tolerance
5435919|NCT00002024|Ganciclovir|ganciclovir
5435920|NCT00002024|Drugs, Investigational|drugs, investigational
5435921|NCT00002024|Cytomegalovirus Infections|cytomegalovirus infections
5435922|NCT00002024|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5435923|NCT00002023|Dose-Response Relationship, Drug|dose-response relationship, drug
5435924|NCT00002023|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5435925|NCT00002023|AIDS-Related Complex|aids-related complex
5435926|NCT00002023|Zidovudine|zidovudine
5435927|NCT00002022|Recombinant Proteins|recombinant proteins
5435928|NCT00002022|Drugs, Investigational|drugs, investigational
5435929|NCT00002022|Erythropoietin|erythropoietin
5435930|NCT00002022|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5435931|NCT00002022|Anemia|anemia
5435932|NCT00002022|Zidovudine|zidovudine
5435933|NCT00002021|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
5435934|NCT00002021|Immune Tolerance|immune tolerance
5435935|NCT00002021|Injections, Intravenous|injections, intravenous
5435936|NCT00002021|Herpes Simplex|herpes simplex
5435937|NCT00002021|Immunity, Cellular|immunity, cellular
5435938|NCT00002021|Foscarnet|foscarnet
5435939|NCT00002021|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5435940|NCT00002021|Antiviral Agents|antiviral agents
5435941|NCT00002020|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5435942|NCT00002020|AIDS-Related Complex|aids-related complex
5435943|NCT00002020|Zidovudine|zidovudine
5435944|NCT00002019|Meningitis|meningitis
5435945|NCT00002019|Liposomes|liposomes
5435946|NCT00002019|Cryptococcosis|cryptococcosis
5435947|NCT00002019|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5435948|NCT00002019|Amphotericin B|amphotericin b
5435949|NCT00002019|Chemistry, Pharmaceutical|chemistry, pharmaceutical
5435950|NCT00002018|Interferon Type I|interferon type i
5435951|NCT00002017|Polyethylene Glycols|polyethylene glycols
5435952|NCT00002017|Interleukin-2|interleukin-2
5435953|NCT00002016|Retinitis|retinitis
5435954|NCT00002016|Ganciclovir|ganciclovir
5435955|NCT00002016|Cytomegalovirus|cytomegalovirus
5435956|NCT00002016|Cytomegalovirus Infections|cytomegalovirus infections
5435957|NCT00002016|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5435958|NCT00002016|Antibodies, Monoclonal|antibodies, monoclonal
5435959|NCT00002015|Retinitis|retinitis
5435960|NCT00002015|Ganciclovir|ganciclovir
5435961|NCT00002015|Cytomegalovirus Infections|cytomegalovirus infections
5435962|NCT00002015|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5435963|NCT00002015|Immunocompromised Host|immunocompromised host
5435964|NCT00002014|Didanosine|didanosine
5435965|NCT00002014|Drug Evaluation|drug evaluation
5435966|NCT00002014|Zidovudine|zidovudine
5435967|NCT00002013|Drug Therapy, Combination|drug therapy, combination
5435968|NCT00002013|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5435969|NCT00002013|AIDS-Related Complex|aids-related complex
5435970|NCT00002013|ammonium trichloro(dioxoethylene-O,O'-)tellurute|ammonium trichloro(dioxoethylene-o,o'-)tellurute
5435971|NCT00002013|Zidovudine|zidovudine
5435972|NCT00002012|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5435973|NCT00002012|AIDS-Related Complex|aids-related complex
5435974|NCT00002012|Interferon Type I, Recombinant|interferon type i, recombinant
5435975|NCT00002011|PUVA Therapy|puva therapy
5435976|NCT00002011|Methoxsalen|methoxsalen
5435977|NCT00002011|AIDS-Related Complex|aids-related complex
5435978|NCT00002010|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
5435979|NCT00002010|Meningitis|meningitis
5435980|NCT00002010|Fluconazole|fluconazole
5435981|NCT00002010|Coccidioidin|coccidioidin
5435982|NCT00002010|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5435983|NCT00002010|Coccidioidomycosis|coccidioidomycosis
5435984|NCT00002009|Leukopenia|leukopenia
5435985|NCT00002009|Drug Evaluation|drug evaluation
5435986|NCT00002009|Granulocyte-Macrophage Colony-Stimulating Factor|granulocyte-macrophage colony-stimulating factor
5435987|NCT00002008|Leukopenia|leukopenia
5435988|NCT00002008|Drug Evaluation|drug evaluation
5435989|NCT00002008|Granulocyte-Macrophage Colony-Stimulating Factor|granulocyte-macrophage colony-stimulating factor
5435990|NCT00002007|Leukopenia|leukopenia
5435991|NCT00002007|Granulocyte-Macrophage Colony-Stimulating Factor|granulocyte-macrophage colony-stimulating factor
5435992|NCT00002007|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5435993|NCT00002007|Zidovudine|zidovudine
5435994|NCT00002006|Neutropenia|neutropenia
5435995|NCT00002006|Drug Interactions|drug interactions
5435996|NCT00002006|Granulocyte-Macrophage Colony-Stimulating Factor|granulocyte-macrophage colony-stimulating factor
5435997|NCT00002006|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5435998|NCT00002006|Zidovudine|zidovudine
5435999|NCT00002005|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5436000|NCT00002005|Antigens, CD4|antigens, cd4
5436001|NCT00002005|AIDS-Related Complex|aids-related complex
5436002|NCT00002004|Recombinant Proteins|recombinant proteins
5436003|NCT00002004|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5436004|NCT00002004|Antigens, CD4|antigens, cd4
5436005|NCT00002004|AIDS-Related Complex|aids-related complex
5436006|NCT00002003|Mitoxantrone|mitoxantrone
5436007|NCT00002003|Lymphoma, Large-Cell|lymphoma, large-cell
5436008|NCT00002003|Etoposide|etoposide
5436009|NCT00002003|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5436010|NCT00002002|Trimethoprim-Sulfamethoxazole Combination|trimethoprim-sulfamethoxazole combination
5436011|NCT00002002|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
5436012|NCT00002002|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
5436013|NCT00002002|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5436014|NCT00002001|Zalcitabine|zalcitabine
5436015|NCT00002001|Didanosine|didanosine
5436016|NCT00002001|Drug Therapy, Combination|drug therapy, combination
5436017|NCT00002001|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5436018|NCT00002001|Zidovudine|zidovudine
5436019|NCT00002000|Acyclovir|acyclovir
5436020|NCT00002000|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5436021|NCT00002000|AIDS-Related Complex|aids-related complex
5436022|NCT00002000|Antiviral Agents|antiviral agents
5436023|NCT00002000|Anus Diseases|anus diseases
5436024|NCT00002000|Herpes Genitalis|herpes genitalis
5436025|NCT00001999|Retinitis|retinitis
5436026|NCT00001999|Gamma-Globulins|gamma-globulins
5436027|NCT00001999|Ganciclovir|ganciclovir
5436028|NCT00001999|Drug Therapy, Combination|drug therapy, combination
5436029|NCT00001999|Cytomegalovirus Infections|cytomegalovirus infections
5436030|NCT00001999|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5436031|NCT00001999|Immunization, Passive|immunization, passive
5436032|NCT00001998|Nystatin|nystatin
5436033|NCT00001998|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5436034|NCT00001998|AIDS-Related Complex|aids-related complex
5436035|NCT00001997|Recombinant Proteins|recombinant proteins
5436036|NCT00001997|Polyethylene Glycols|polyethylene glycols
5436037|NCT00001997|Interleukin-2|interleukin-2
5436038|NCT00001997|Didanosine|didanosine
5436039|NCT00001997|Zidovudine|zidovudine
5436040|NCT00001996|Trimethoprim-Sulfamethoxazole Combination|trimethoprim-sulfamethoxazole combination
5436041|NCT00001996|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
5436042|NCT00001996|Pentamidine|pentamidine
5436043|NCT00001996|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5436044|NCT00001996|atovaquone|atovaquone
5436045|NCT00001995|Rifabutin|rifabutin
5436046|NCT00001995|Mycobacterium avium-intracellulare Infection|mycobacterium avium-intracellulare infection
5436047|NCT00001995|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5436048|NCT00001994|Toxoplasmosis|toxoplasmosis
5436049|NCT00001994|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
5436050|NCT00001994|Naphthoquinones|naphthoquinones
5436051|NCT00001994|Encephalitis|encephalitis
5436052|NCT00001994|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5436053|NCT00001993|Drug Therapy, Combination|drug therapy, combination
5436054|NCT00001993|Zidovudine|zidovudine
5436055|NCT00001992|Vaccines, Synthetic|vaccines, synthetic
5436056|NCT00001992|Drug Evaluation|drug evaluation
5436057|NCT00001992|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5436058|NCT00001992|AIDS Vaccines|aids vaccines
5436059|NCT00001991|Trimethoprim-Sulfamethoxazole Combination|trimethoprim-sulfamethoxazole combination
5436060|NCT00001991|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
5436061|NCT00001991|Antifungal Agents|antifungal agents
5436062|NCT00001991|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5436063|NCT00001991|atovaquone|atovaquone
5436064|NCT00001990|Trimethoprim-Sulfamethoxazole Combination|trimethoprim-sulfamethoxazole combination
5436065|NCT00001990|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
5436066|NCT00001990|Pentamidine|pentamidine
5436067|NCT00001990|Antifungal Agents|antifungal agents
5436068|NCT00001990|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5436069|NCT00001990|atovaquone|atovaquone
5436070|NCT00001989|Trichosanthin|trichosanthin
5436071|NCT00001989|Drug Evaluation|drug evaluation
5436072|NCT00001989|Drug Therapy, Combination|drug therapy, combination
5436073|NCT00001989|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5436074|NCT00001989|AIDS-Related Complex|aids-related complex
5436075|NCT00001989|Antiviral Agents|antiviral agents
5436076|NCT00001989|Zidovudine|zidovudine
5436077|NCT00001137|Treatment Experienced|treatment experienced
5436078|NCT00001137|Treatment Naive|treatment naive
5436079|NCT00001137|Virus Replication|virus replication
5436080|NCT00001137|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
5436082|NCT00001137|Risk Factors|risk factors
5436083|NCT00001137|Incidence|incidence
5436084|NCT00001137|RNA, Viral|rna, viral
5436085|NCT00001137|Anti-HIV Agents|anti-hiv agents
5436086|NCT00001137|Viral Load|viral load
5436087|NCT00001137|Lipodystrophy|lipodystrophy
5436088|NCT00001137|Nervous System|nervous system
5436089|NCT00001137|Cardiovascular System|cardiovascular system
5436090|NCT00001137|Neurologic Symptoms|neurologic symptoms
5436091|NCT00001136|Injections, Intramuscular|injections, intramuscular
5436092|NCT00001136|HIV-1|hiv-1
5436093|NCT00001136|AIDS Vaccines|aids vaccines
5436094|NCT00001136|CD4-Positive T-Lymphocytes|cd4-positive t-lymphocytes
5436095|NCT00001136|CD8-Positive T-Lymphocytes|cd8-positive t-lymphocytes
5436096|NCT00001136|T-Lymphocytes, Cytotoxic|t-lymphocytes, cytotoxic
5436097|NCT00001136|Gene Products, gag|gene products, gag
5436098|NCT00001136|HIV Seronegativity|hiv seronegativity
5444280|NCT00001643|Lewy Body|lewy body
5436099|NCT00001136|Immunologic Memory|immunologic memory
5436100|NCT00001136|Antibodies, Viral|antibodies, viral
5436101|NCT00001136|Genetic Vectors|genetic vectors
5436102|NCT00001136|Gene Products, env|gene products, env
5436103|NCT00001136|Poxviridae|poxviridae
5436104|NCT00001136|HIV Preventive Vaccine|hiv preventive vaccine
5436105|NCT00001135|Placebos|placebos
5436106|NCT00001135|Pregnancy|pregnancy
5436107|NCT00001135|Pregnancy Complications, Infectious|pregnancy complications, infectious
5436108|NCT00001135|Nevirapine|nevirapine
5436109|NCT00001135|Disease Transmission, Vertical|disease transmission, vertical
5436110|NCT00001135|Labor|labor
5436111|NCT00001135|Anti-HIV Agents|anti-hiv agents
5436112|NCT00001133|Dose-Response Relationship, Drug|dose-response relationship, drug
5436113|NCT00001133|Drug Therapy, Combination|drug therapy, combination
5436114|NCT00001133|HIV Protease Inhibitors|hiv protease inhibitors
5436115|NCT00001133|Ritonavir|ritonavir
5436116|NCT00001133|Indinavir|indinavir
5436117|NCT00001133|Anti-HIV Agents|anti-hiv agents
5436118|NCT00001133|Pharmacokinetics|pharmacokinetics
5436119|NCT00001133|Treatment Experienced|treatment experienced
5436120|NCT00001132|Placebos|placebos
5436121|NCT00001132|HIV-1|hiv-1
5436122|NCT00001132|Drug Therapy, Combination|drug therapy, combination
5436123|NCT00001132|RNA, Viral|rna, viral
5436124|NCT00001132|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5436125|NCT00001132|Anti-HIV Agents|anti-hiv agents
5436126|NCT00001132|Viral Load|viral load
5436127|NCT00001132|abacavir|abacavir
5436128|NCT00001131|Interleukin-2|interleukin-2
5436129|NCT00001131|Drug Therapy, Combination|drug therapy, combination
5436130|NCT00001131|Drug Administration Schedule|drug administration schedule
5436131|NCT00001131|Viremia|viremia
5436132|NCT00001131|T-Lymphocytes, Cytotoxic|t-lymphocytes, cytotoxic
5436133|NCT00001131|Anti-HIV Agents|anti-hiv agents
5436134|NCT00001131|Treatment Experienced|treatment experienced
5436135|NCT00001130|Questionnaires|questionnaires
5436136|NCT00001130|Antibodies, Viral|antibodies, viral
5436137|NCT00001130|Emergency Service, Hospital|emergency service, hospital
5436138|NCT00001129|Drug Therapy, Combination|drug therapy, combination
5436139|NCT00001129|RNA, Viral|rna, viral
5436140|NCT00001129|Patient Compliance|patient compliance
5436141|NCT00001129|Anti-HIV Agents|anti-hiv agents
5436142|NCT00001129|Viral Load|viral load
5436143|NCT00001129|Reminder Systems|reminder systems
5436144|NCT00001129|Treatment Experienced|treatment experienced
5436145|NCT00001129|Treatment Naive|treatment naive
5436146|NCT00001128|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
5436147|NCT00001128|Cryptosporidiosis|cryptosporidiosis
5436148|NCT00001128|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5436149|NCT00001128|Azithromycin|azithromycin
5436150|NCT00001128|Paromomycin|paromomycin
5436151|NCT00001128|Interleukin-12|interleukin-12
5436152|NCT00001125|Antibodies, Viral|antibodies, viral
5436153|NCT00001125|Chickenpox|chickenpox
5436154|NCT00001125|Chickenpox Vaccine|chickenpox vaccine
5436155|NCT00001122|Didanosine|didanosine
5436156|NCT00001122|Drug Therapy, Combination|drug therapy, combination
5436157|NCT00001122|Stavudine|stavudine
5436158|NCT00001122|HIV Protease Inhibitors|hiv protease inhibitors
5436159|NCT00001122|CD4 Lymphocyte Count|cd4 lymphocyte count
5436160|NCT00001122|Nelfinavir|nelfinavir
5436161|NCT00001122|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5436162|NCT00001122|Self Care|self care
5436163|NCT00001122|Anti-HIV Agents|anti-hiv agents
5436164|NCT00001122|Viral Load|viral load
5436165|NCT00001122|efavirenz|efavirenz
5436166|NCT00001122|Treatment Naive|treatment naive
5436167|NCT00001121|Placebos|placebos
5436168|NCT00001121|AIDS Vaccines|aids vaccines
5436169|NCT00001121|Follow-Up Studies|follow-up studies
5436170|NCT00001121|HIV Therapeutic Vaccine|hiv therapeutic vaccine
5436171|NCT00001120|Prospective Studies|prospective studies
5436172|NCT00001120|Sarcoma, Kaposi|sarcoma, kaposi
5436173|NCT00001120|Herpesvirus 4, Human|herpesvirus 4, human
5436174|NCT00001120|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5436175|NCT00001120|Cohort Studies|cohort studies
5436176|NCT00001120|Risk Factors|risk factors
5436177|NCT00001120|Lymphoma, AIDS-Related|lymphoma, aids-related
5436178|NCT00001120|Antibodies, Viral|antibodies, viral
5436179|NCT00001120|Lymphoproliferative Disorders|lymphoproliferative disorders
5436180|NCT00001120|Viral Load|viral load
5436181|NCT00001120|Herpesvirus, Kaposi Sarcoma-Associated|herpesvirus, kaposi sarcoma-associated
5436182|NCT00001120|Translocation (Genetics)|translocation (genetics)
5436183|NCT00001119|Immunity, Cellular|immunity, cellular
5436184|NCT00001119|Drug Therapy, Combination|drug therapy, combination
5436185|NCT00001119|HIV Protease Inhibitors|hiv protease inhibitors
5436186|NCT00001119|Antibody Formation|antibody formation
5436187|NCT00001119|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5436188|NCT00001119|Anti-HIV Agents|anti-hiv agents
5436189|NCT00001119|Viral Load|viral load
5436190|NCT00001119|Tetanus Toxoid|tetanus toxoid
5436191|NCT00001119|Case-Control Studies|case-control studies
5436192|NCT00001119|Hepatitis B Surface Antigens|hepatitis b surface antigens
5436193|NCT00001119|Acute Infection|acute infection
5436194|NCT00001118|Injections, Intravenous|injections, intravenous
5436195|NCT00001118|Injections, Subcutaneous|injections, subcutaneous
5436196|NCT00001118|Drug Therapy, Combination|drug therapy, combination
5436197|NCT00001118|HIV Protease Inhibitors|hiv protease inhibitors
5436198|NCT00001118|Membrane Fusion|membrane fusion
5436199|NCT00001118|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5436200|NCT00001118|Anti-HIV Agents|anti-hiv agents
5436201|NCT00001118|Viral Load|viral load
5436202|NCT00001118|peptide T20|peptide t20
5436203|NCT00001117|HIV-1|hiv-1
5436204|NCT00001117|Drug Therapy, Combination|drug therapy, combination
5436205|NCT00001117|Hepatitis C|hepatitis c
5436206|NCT00001117|RNA, Viral|rna, viral
5436207|NCT00001117|Anti-HIV Agents|anti-hiv agents
5436208|NCT00001116|Tumor Necrosis Factor|tumor necrosis factor
5436209|NCT00001116|Interleukin-2|interleukin-2
5436210|NCT00001116|Immunity, Cellular|immunity, cellular
5436211|NCT00001116|Antiviral Agents|antiviral agents
5436212|NCT00001116|Interleukin-6|interleukin-6
5436213|NCT00001116|Receptors, Tumor Necrosis Factor|receptors, tumor necrosis factor
5436214|NCT00001115|Herpes Simplex|herpes simplex
5436215|NCT00001115|Acyclovir|acyclovir
5436216|NCT00001115|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5436217|NCT00001114|Sarcoma, Kaposi|sarcoma, kaposi
5436218|NCT00001114|Didanosine|didanosine
5436219|NCT00001114|Drug Interactions|drug interactions
5436220|NCT00001114|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5436221|NCT00001114|Interferon-alpha|interferon-alpha
5436222|NCT00001113|Interferon Alfa-2a|interferon alfa-2a
5436223|NCT00001113|Sarcoma, Kaposi|sarcoma, kaposi
5436224|NCT00001113|Dose-Response Relationship, Drug|dose-response relationship, drug
5436225|NCT00001113|Drug Evaluation|drug evaluation
5436226|NCT00001113|Drug Therapy, Combination|drug therapy, combination
5436227|NCT00001113|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5436228|NCT00001113|Zidovudine|zidovudine
5436229|NCT00001113|Interferon Type I|interferon type i
5436230|NCT00001112|Monocytes|monocytes
5436231|NCT00001112|Interferon-gamma, Recombinant|interferon-gamma, recombinant
5436232|NCT00001112|Injections, Subcutaneous|injections, subcutaneous
5436233|NCT00001112|Immune System|immune system
5436234|NCT00001112|Drug Evaluation|drug evaluation
5436235|NCT00001112|Drug Therapy, Combination|drug therapy, combination
5436236|NCT00001112|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5436237|NCT00001112|Zidovudine|zidovudine
5436238|NCT00001112|Blood Bactericidal Activity|blood bactericidal activity
5436239|NCT00001111|Drug Therapy, Combination|drug therapy, combination
5436240|NCT00001111|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5436241|NCT00001111|AIDS-Related Complex|aids-related complex
5436242|NCT00001111|Antiviral Agents|antiviral agents
5436243|NCT00001111|Zidovudine|zidovudine
5436244|NCT00001111|Nevirapine|nevirapine
5436245|NCT00001110|Lung|lung
5436246|NCT00001110|HIV-1|hiv-1
5436247|NCT00001110|Viremia|viremia
5436248|NCT00001110|Anti-HIV Agents|anti-hiv agents
5436249|NCT00001110|Viral Load|viral load
5436250|NCT00001110|Bronchoalveolar Lavage Fluid|bronchoalveolar lavage fluid
5436251|NCT00001109|Monocytes|monocytes
5436252|NCT00001109|Flow Cytometry|flow cytometry
5436253|NCT00001109|HIV Seronegativity|hiv seronegativity
5436254|NCT00001109|Phenotype|phenotype
5436255|NCT00001109|Lymphocyte Subsets|lymphocyte subsets
5436256|NCT00001108|Dose-Response Relationship, Drug|dose-response relationship, drug
5436257|NCT00001108|Drug Therapy, Combination|drug therapy, combination
5436258|NCT00001108|HIV Protease Inhibitors|hiv protease inhibitors
5436259|NCT00001108|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5436260|NCT00001108|Salvage Therapy|salvage therapy
5436261|NCT00001108|Anti-HIV Agents|anti-hiv agents
5436262|NCT00001106|Pregnancy|pregnancy
5436263|NCT00001106|Pregnancy Complications, Infectious|pregnancy complications, infectious
5436264|NCT00001106|Prenatal Exposure Delayed Effects|prenatal exposure delayed effects
5436265|NCT00001106|Drug Evaluation|drug evaluation
5436266|NCT00001106|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5436267|NCT00001106|Zidovudine|zidovudine
5436268|NCT00001105|Antibodies, Monoclonal|antibodies, monoclonal
5436269|NCT00001105|AIDS-Related Complex|aids-related complex
5436270|NCT00001105|Immunization, Passive|immunization, passive
5436271|NCT00001104|Sex Behavior|sex behavior
5436272|NCT00001104|T-Lymphocytes|t-lymphocytes
5436273|NCT00001104|HIV Antibodies|hiv antibodies
5436274|NCT00001104|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5436275|NCT00001104|AIDS-Related Complex|aids-related complex
5436276|NCT00001104|Zidovudine|zidovudine
5436277|NCT00001104|Hemophilia A|hemophilia a
5436278|NCT00001103|Neuropsychological Tests|neuropsychological tests
5436279|NCT00001103|HIV-1|hiv-1
5436280|NCT00001103|RNA, Viral|rna, viral
5436281|NCT00001103|Anti-HIV Agents|anti-hiv agents
5436282|NCT00001103|Viral Load|viral load
5436283|NCT00001102|Drug Therapy, Combination|drug therapy, combination
5436284|NCT00001102|HIV Protease Inhibitors|hiv protease inhibitors
5436285|NCT00001102|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5436286|NCT00001102|Body Composition|body composition
5436287|NCT00001102|Anti-HIV Agents|anti-hiv agents
5436288|NCT00001102|Cholesterol|cholesterol
5436289|NCT00001102|Triglycerides|triglycerides
5436290|NCT00001097|Drug Therapy, Combination|drug therapy, combination
5436291|NCT00001097|HIV Protease Inhibitors|hiv protease inhibitors
5436292|NCT00001097|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5436293|NCT00001097|Anti-HIV Agents|anti-hiv agents
5436294|NCT00001096|Vaccines, Synthetic|vaccines, synthetic
5436295|NCT00001096|HIV Antibodies|hiv antibodies
5436296|NCT00001096|HIV Antigens|hiv antigens
5436297|NCT00001096|HIV-1|hiv-1
5436298|NCT00001096|Adjuvants, Immunologic|adjuvants, immunologic
5436299|NCT00001096|AIDS Vaccines|aids vaccines
5436300|NCT00001096|T-Lymphocytes, Cytotoxic|t-lymphocytes, cytotoxic
5436301|NCT00001096|HIV Seronegativity|hiv seronegativity
5436302|NCT00001096|HIV Envelope Protein gp120|hiv envelope protein gp120
5436303|NCT00001096|Alum Compounds|alum compounds
5436304|NCT00001096|HIV Preventive Vaccine|hiv preventive vaccine
5436305|NCT00001095|Drug Therapy, Combination|drug therapy, combination
5436306|NCT00001095|Zidovudine|zidovudine
5436307|NCT00001095|Nevirapine|nevirapine
5436308|NCT00001095|Stavudine|stavudine
5436309|NCT00001095|HIV Protease Inhibitors|hiv protease inhibitors
5436310|NCT00001095|Lamivudine|lamivudine
5436311|NCT00001095|VX 478|vx 478
5436312|NCT00001095|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5436313|NCT00001095|Anti-HIV Agents|anti-hiv agents
5436314|NCT00001095|Viral Load|viral load
5436315|NCT00001094|HIV-1|hiv-1
5436316|NCT00001094|Drug Therapy, Combination|drug therapy, combination
5436317|NCT00001094|Zidovudine|zidovudine
5436318|NCT00001094|Lamivudine|lamivudine
5436319|NCT00001094|RNA, Viral|rna, viral
5436320|NCT00001094|Saquinavir|saquinavir
5436321|NCT00001094|Delavirdine|delavirdine
5436322|NCT00001094|Anti-HIV Agents|anti-hiv agents
5436323|NCT00001094|Nelfinavir|nelfinavir
5436324|NCT00001093|Immunity, Cellular|immunity, cellular
5436325|NCT00001093|Sexual Partners|sexual partners
5436326|NCT00001093|Treatment Outcome|treatment outcome
5436327|NCT00001093|Anti-HIV Agents|anti-hiv agents
5436328|NCT00001093|Viral Load|viral load
5436329|NCT00001093|Acute Infection|acute infection
5436330|NCT00001092|Semen|semen
5436331|NCT00001092|HIV-1|hiv-1
5436332|NCT00001092|Sexual Partners|sexual partners
5436333|NCT00001092|Drug Resistance, Microbial|drug resistance, microbial
5436334|NCT00001092|CD8-Positive T-Lymphocytes|cd8-positive t-lymphocytes
5436335|NCT00001092|Saliva|saliva
5436336|NCT00001092|Blood|blood
5436337|NCT00001092|Cervix Uteri|cervix uteri
5436338|NCT00001092|Vagina|vagina
5436339|NCT00001092|Acute Infection|acute infection
5436340|NCT00001091|Drug Therapy, Combination|drug therapy, combination
5436341|NCT00001091|Nevirapine|nevirapine
5436342|NCT00001091|Stavudine|stavudine
5436343|NCT00001091|HIV Protease Inhibitors|hiv protease inhibitors
5436344|NCT00001091|Ritonavir|ritonavir
5436345|NCT00001091|Lamivudine|lamivudine
5436346|NCT00001091|Nelfinavir|nelfinavir
5436347|NCT00001091|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5436348|NCT00001090|Reference Values|reference values
5436349|NCT00001090|Granulocyte-Macrophage Colony-Stimulating Factor|granulocyte-macrophage colony-stimulating factor
5436350|NCT00001090|AIDS Vaccines|aids vaccines
5436351|NCT00001090|HIV Seronegativity|hiv seronegativity
5436352|NCT00001090|Dose-Response Relationship, Immunologic|dose-response relationship, immunologic
5436353|NCT00001090|HIV Preventive Vaccine|hiv preventive vaccine
5436354|NCT00001089|Prospective Studies|prospective studies
5436355|NCT00001089|HIV-1|hiv-1
5436356|NCT00001089|Cytomegalovirus|cytomegalovirus
5436357|NCT00001089|Cytomegalovirus Infections|cytomegalovirus infections
5436358|NCT00001089|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5436359|NCT00001089|Anti-HIV Agents|anti-hiv agents
5436360|NCT00001089|Viral Load|viral load
5436361|NCT00001089|Multiple Organ Failure|multiple organ failure
5436362|NCT00001088|Injections, Intramuscular|injections, intramuscular
5436363|NCT00001088|AIDS Vaccines|aids vaccines
5436364|NCT00001088|HIV Seronegativity|hiv seronegativity
5436365|NCT00001088|Dose-Response Relationship, Immunologic|dose-response relationship, immunologic
5436366|NCT00001088|Fusion Proteins, gag-pol|fusion proteins, gag-pol
5436367|NCT00001088|Vaccines, DNA|vaccines, dna
5436368|NCT00001088|HIV Preventive Vaccine|hiv preventive vaccine
5436369|NCT00001087|Drug Therapy, Combination|drug therapy, combination
5436370|NCT00001087|Antiviral Agents|antiviral agents
5436371|NCT00001087|HIV Protease Inhibitors|hiv protease inhibitors
5436372|NCT00001087|Ritonavir|ritonavir
5436373|NCT00001087|Saquinavir|saquinavir
5436374|NCT00001087|Nelfinavir|nelfinavir
5436375|NCT00001087|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5436376|NCT00001087|Adenine|adenine
5436377|NCT00001087|Anti-HIV Agents|anti-hiv agents
5436378|NCT00001087|efavirenz|efavirenz
5436379|NCT00001086|Placebos|placebos
5436380|NCT00001086|HIV-1|hiv-1
5436381|NCT00001086|Drug Therapy, Combination|drug therapy, combination
5436382|NCT00001086|HIV Protease Inhibitors|hiv protease inhibitors
5436383|NCT00001086|Indinavir|indinavir
5436384|NCT00001086|RNA, Viral|rna, viral
5436385|NCT00001086|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5436386|NCT00001086|Anti-HIV Agents|anti-hiv agents
5436387|NCT00001086|Viral Load|viral load
5436388|NCT00001086|efavirenz|efavirenz
5436389|NCT00001085|HIV-1|hiv-1
5436390|NCT00001085|Drug Therapy, Combination|drug therapy, combination
5436391|NCT00001085|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5436392|NCT00001085|Zidovudine|zidovudine
5436393|NCT00001085|HIV Protease Inhibitors|hiv protease inhibitors
5436394|NCT00001085|Lamivudine|lamivudine
5436395|NCT00001085|RNA, Viral|rna, viral
5436396|NCT00001085|VX 478|vx 478
5436397|NCT00001085|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5436398|NCT00001085|Anti-HIV Agents|anti-hiv agents
5436399|NCT00001085|Viral Load|viral load
5436400|NCT00001084|Prospective Studies|prospective studies
5436401|NCT00001084|Drug Therapy, Combination|drug therapy, combination
5436402|NCT00001084|Zidovudine|zidovudine
5436403|NCT00001084|HIV Protease Inhibitors|hiv protease inhibitors
5436404|NCT00001084|Lamivudine|lamivudine
5436405|NCT00001084|Indinavir|indinavir
5436406|NCT00001084|RNA, Viral|rna, viral
5436407|NCT00001084|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5436408|NCT00001084|Anti-HIV Agents|anti-hiv agents
5436409|NCT00001084|Viral Load|viral load
5436410|NCT00001083|HIV-1|hiv-1
5436411|NCT00001083|Drug Therapy, Combination|drug therapy, combination
5436412|NCT00001083|Zidovudine|zidovudine
5436413|NCT00001083|Nevirapine|nevirapine
5436414|NCT00001083|Stavudine|stavudine
5436415|NCT00001083|HIV Protease Inhibitors|hiv protease inhibitors
5436416|NCT00001083|Ritonavir|ritonavir
5436417|NCT00001083|Lamivudine|lamivudine
5436418|NCT00001083|Indinavir|indinavir
5436419|NCT00001083|RNA, Viral|rna, viral
5436420|NCT00001083|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5436421|NCT00001083|Anti-HIV Agents|anti-hiv agents
5436422|NCT00001082|Cytomegalovirus Infections|cytomegalovirus infections
5436423|NCT00001082|Antiviral Agents|antiviral agents
5436424|NCT00001082|CD4 Lymphocyte Count|cd4 lymphocyte count
5436425|NCT00001082|Prodrugs|prodrugs
5436426|NCT00001082|Survival|survival
5436427|NCT00001082|Adenine|adenine
5436428|NCT00001081|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
5436429|NCT00001081|Cryptosporidiosis|cryptosporidiosis
5436430|NCT00001081|Antiprotozoal Agents|antiprotozoal agents
5436431|NCT00001081|nitazoxanide|nitazoxanide
5436432|NCT00001080|Lymphocyte Transformation|lymphocyte transformation
5436433|NCT00001080|HIV-1|hiv-1
5436434|NCT00001080|Drug Resistance, Microbial|drug resistance, microbial
5436435|NCT00001080|CD4-Positive T-Lymphocytes|cd4-positive t-lymphocytes
5436436|NCT00001080|Lamivudine|lamivudine
5436437|NCT00001080|Influenza Vaccine|influenza vaccine
5436438|NCT00001080|RNA, Viral|rna, viral
5436439|NCT00001080|Bacterial Vaccines|bacterial vaccines
5436440|NCT00001080|Anti-HIV Agents|anti-hiv agents
5436441|NCT00001080|Pneumonia, Pneumococcal|pneumonia, pneumococcal
5436442|NCT00001080|Viral Load|viral load
5436443|NCT00001079|Placebos|placebos
5436444|NCT00001079|Drug Therapy, Combination|drug therapy, combination
5436564|NCT00001058|Clarithromycin|clarithromycin
5436445|NCT00001079|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5436446|NCT00001079|AIDS-Related Complex|aids-related complex
5436447|NCT00001079|HIV Wasting Syndrome|hiv wasting syndrome
5436448|NCT00001079|Megestrol Acetate|megestrol acetate
5436449|NCT00001079|dihydrotestosterone heptanoate|dihydrotestosterone heptanoate
5436450|NCT00001078|Viral Vaccines|viral vaccines
5436451|NCT00001078|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
5436452|NCT00001078|Anti-HIV Agents|anti-hiv agents
5436453|NCT00001078|Hepatitis A Virus, Human|hepatitis a virus, human
5436454|NCT00001077|Weight Loss|weight loss
5436455|NCT00001077|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5436456|NCT00001077|Nutritional Support|nutritional support
5436457|NCT00001076|Vaccines, Synthetic|vaccines, synthetic
5436458|NCT00001076|HIV Envelope Protein gp120|hiv envelope protein gp120
5436459|NCT00001076|AIDS Vaccines|aids vaccines
5436460|NCT00001076|HIV Seronegativity|hiv seronegativity
5436461|NCT00001076|Avipoxvirus|avipoxvirus
5436462|NCT00001076|HIV Preventive Vaccine|hiv preventive vaccine
5436463|NCT00001075|Drug Therapy, Combination|drug therapy, combination
5436464|NCT00001075|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5436465|NCT00001075|AIDS-Related Complex|aids-related complex
5436466|NCT00001075|Antiviral Agents|antiviral agents
5436467|NCT00001075|Zidovudine|zidovudine
5436468|NCT00001075|HIV Protease Inhibitors|hiv protease inhibitors
5436469|NCT00001075|Ritonavir|ritonavir
5436470|NCT00001075|Lamivudine|lamivudine
5436471|NCT00001074|Didanosine|didanosine
5436472|NCT00001074|Drug Therapy, Combination|drug therapy, combination
5436473|NCT00001074|Antiviral Agents|antiviral agents
5436474|NCT00001074|Hydroxyurea|hydroxyurea
5436475|NCT00001073|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5436476|NCT00001073|AIDS-Related Complex|aids-related complex
5436477|NCT00001073|Cervix Dysplasia|cervix dysplasia
5436478|NCT00001073|Cervix Diseases|cervix diseases
5436479|NCT00001073|Isotretinoin|isotretinoin
5436480|NCT00001073|Cervical Intraepithelial Neoplasia|cervical intraepithelial neoplasia
5436481|NCT00001073|Cervix Neoplasms|cervix neoplasms
5436482|NCT00001073|Keratolytic Agents|keratolytic agents
5436483|NCT00001072|Vaccines, Synthetic|vaccines, synthetic
5436484|NCT00001072|HIV Envelope Protein gp120|hiv envelope protein gp120
5436485|NCT00001072|AIDS Vaccines|aids vaccines
5436486|NCT00001072|HIV Seronegativity|hiv seronegativity
5436487|NCT00001072|Avipoxvirus|avipoxvirus
5436488|NCT00001072|HIV Preventive Vaccine|hiv preventive vaccine
5436489|NCT00001071|Granulocyte Colony-Stimulating Factor|granulocyte colony-stimulating factor
5436490|NCT00001071|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5436491|NCT00001071|AIDS-Related Complex|aids-related complex
5436492|NCT00001071|Stem Cells|stem cells
5436493|NCT00001069|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5436494|NCT00001069|AIDS-Related Complex|aids-related complex
5436495|NCT00001069|Antiviral Agents|antiviral agents
5436496|NCT00001069|Decision Making|decision making
5436497|NCT00001069|Physician's Practice Patterns|physician's practice patterns
5436498|NCT00001068|Zalcitabine|zalcitabine
5436499|NCT00001068|Didanosine|didanosine
5436500|NCT00001068|Drug Therapy, Combination|drug therapy, combination
5436501|NCT00001068|AIDS-Related Complex|aids-related complex
5436502|NCT00001068|Antiviral Agents|antiviral agents
5436503|NCT00001068|Zidovudine|zidovudine
5436504|NCT00001068|Lamivudine|lamivudine
5436505|NCT00001067|Drug Therapy, Combination|drug therapy, combination
5436506|NCT00001067|AIDS-Related Complex|aids-related complex
5436507|NCT00001067|Zidovudine|zidovudine
5436508|NCT00001067|Stavudine|stavudine
5436509|NCT00001067|Lamivudine|lamivudine
5436510|NCT00001066|Didanosine|didanosine
5436511|NCT00001066|Drug Therapy, Combination|drug therapy, combination
5436512|NCT00001066|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5436513|NCT00001066|AIDS-Related Complex|aids-related complex
5436514|NCT00001066|Zidovudine|zidovudine
5436515|NCT00001066|Lamivudine|lamivudine
5436516|NCT00001065|Administration, Oral|administration, oral
5436517|NCT00001065|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5436518|NCT00001065|Amphotericin B|amphotericin b
5436519|NCT00001065|AIDS-Related Complex|aids-related complex
5436520|NCT00001065|Candidiasis, Oral|candidiasis, oral
5436521|NCT00001065|Suspensions|suspensions
5436522|NCT00001064|HIV Antigens|hiv antigens
5436523|NCT00001064|Immunotherapy, Adoptive|immunotherapy, adoptive
5436524|NCT00001064|Dendritic Cells|dendritic cells
5436525|NCT00001063|Didanosine|didanosine
5436526|NCT00001063|Drug Therapy, Combination|drug therapy, combination
5436527|NCT00001063|AIDS-Related Complex|aids-related complex
5436528|NCT00001063|Zidovudine|zidovudine
5436529|NCT00001063|Stavudine|stavudine
5436530|NCT00001062|Infusions, Intravenous|infusions, intravenous
5436531|NCT00001062|Ganciclovir|ganciclovir
5436532|NCT00001062|Administration, Oral|administration, oral
5436533|NCT00001062|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5436534|NCT00001062|Antiviral Agents|antiviral agents
5436535|NCT00001062|Cytomegalovirus Retinitis|cytomegalovirus retinitis
5436536|NCT00001061|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
5436537|NCT00001061|Ganciclovir|ganciclovir
5436538|NCT00001061|Foscarnet|foscarnet
5436539|NCT00001061|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5436540|NCT00001061|Antibodies, Monoclonal|antibodies, monoclonal
5436541|NCT00001061|Cytomegalovirus Retinitis|cytomegalovirus retinitis
5436542|NCT00001060|Vaccines, Synthetic|vaccines, synthetic
5436543|NCT00001060|HIV-1|hiv-1
5436544|NCT00001060|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5436545|NCT00001060|AIDS-Related Complex|aids-related complex
5436546|NCT00001060|AIDS Vaccines|aids vaccines
5436547|NCT00001060|HIV Therapeutic Vaccine|hiv therapeutic vaccine
5436548|NCT00001059|Vincristine|vincristine
5436549|NCT00001059|Sarcoma, Kaposi|sarcoma, kaposi
5436550|NCT00001059|Liposomes|liposomes
5436551|NCT00001059|Doxorubicin|doxorubicin
5436552|NCT00001059|Drug Therapy, Combination|drug therapy, combination
5436553|NCT00001059|Granulocyte Colony-Stimulating Factor|granulocyte colony-stimulating factor
5436554|NCT00001059|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5436555|NCT00001059|Bleomycin|bleomycin
5436556|NCT00001059|Drug Carriers|drug carriers
5436557|NCT00001058|Rifabutin|rifabutin
5436558|NCT00001058|Mycobacterium avium-intracellulare Infection|mycobacterium avium-intracellulare infection
5436559|NCT00001058|Drug Therapy, Combination|drug therapy, combination
5436560|NCT00001058|Ethambutol|ethambutol
5436561|NCT00001058|Clofazimine|clofazimine
5436562|NCT00001058|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5436563|NCT00001058|Ciprofloxacin|ciprofloxacin
5436565|NCT00001057|Didanosine|didanosine
5436566|NCT00001057|Drug Therapy, Combination|drug therapy, combination
5436567|NCT00001057|Zidovudine|zidovudine
5436568|NCT00001056|Vaccines, Synthetic|vaccines, synthetic
5436569|NCT00001056|Vaccinia Virus|vaccinia virus
5436570|NCT00001056|Viral Vaccines|viral vaccines
5436571|NCT00001056|HIV-1|hiv-1
5436572|NCT00001056|HIV Envelope Protein gp160|hiv envelope protein gp160
5436573|NCT00001056|AIDS Vaccines|aids vaccines
5436574|NCT00001056|HIV Seronegativity|hiv seronegativity
5436575|NCT00001056|HIV Preventive Vaccine|hiv preventive vaccine
5436576|NCT00001055|Vaccines, Synthetic|vaccines, synthetic
5436577|NCT00001055|HIV Envelope Protein gp120|hiv envelope protein gp120
5436578|NCT00001055|AIDS Vaccines|aids vaccines
5436579|NCT00001055|HIV Seronegativity|hiv seronegativity
5436580|NCT00001055|Avipoxvirus|avipoxvirus
5436581|NCT00001055|HIV Preventive Vaccine|hiv preventive vaccine
5436582|NCT00001054|Herpes Zoster|herpes zoster
5436583|NCT00001054|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
5436584|NCT00001054|Herpes Simplex|herpes simplex
5436585|NCT00001054|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5436586|NCT00001054|AIDS-Related Complex|aids-related complex
5436587|NCT00001054|valacyclovir|valacyclovir
5436588|NCT00001054|Chickenpox|chickenpox
5436589|NCT00001053|Vaccines, Synthetic|vaccines, synthetic
5436590|NCT00001053|Recombinant Proteins|recombinant proteins
5436591|NCT00001053|HIV-1|hiv-1
5436592|NCT00001053|AIDS Vaccines|aids vaccines
5436593|NCT00001053|HIV Core Protein p24|hiv core protein p24
5436594|NCT00001053|p24-VLP vaccine|p24-vlp vaccine
5436595|NCT00001053|Gene Products, gag|gene products, gag
5436596|NCT00001053|HIV Seronegativity|hiv seronegativity
5436597|NCT00001053|HIV Preventive Vaccine|hiv preventive vaccine
5436598|NCT00001052|Vaccines, Synthetic|vaccines, synthetic
5436599|NCT00001052|Drug Therapy, Combination|drug therapy, combination
5436600|NCT00001052|Adjuvants, Immunologic|adjuvants, immunologic
5436601|NCT00001052|HIV Envelope Protein gp120|hiv envelope protein gp120
5436602|NCT00001052|AIDS Vaccines|aids vaccines
5436603|NCT00001052|HIV Seronegativity|hiv seronegativity
5436604|NCT00001052|HIV Preventive Vaccine|hiv preventive vaccine
5436605|NCT00001049|Didanosine|didanosine
5436606|NCT00001049|Drug Therapy, Combination|drug therapy, combination
5436607|NCT00001049|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5436608|NCT00001049|AIDS-Related Complex|aids-related complex
5436609|NCT00001049|Zidovudine|zidovudine
5436610|NCT00001048|Leukoencephalopathy, Progressive Multifocal|leukoencephalopathy, progressive multifocal
5436611|NCT00001048|Infusions, Intravenous|infusions, intravenous
5436612|NCT00001048|Cytarabine|cytarabine
5436613|NCT00001048|Zalcitabine|zalcitabine
5436614|NCT00001048|Didanosine|didanosine
5436615|NCT00001048|Drug Therapy, Combination|drug therapy, combination
5436616|NCT00001048|Granulocyte Colony-Stimulating Factor|granulocyte colony-stimulating factor
5436617|NCT00001048|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5436618|NCT00001048|Zidovudine|zidovudine
5436619|NCT00001048|Injections, Spinal|injections, spinal
5436620|NCT00001047|Rifabutin|rifabutin
5436621|NCT00001047|Mycobacterium avium-intracellulare Infection|mycobacterium avium-intracellulare infection
5436622|NCT00001047|Drug Therapy, Combination|drug therapy, combination
5436623|NCT00001047|Ethambutol|ethambutol
5436624|NCT00001047|Clofazimine|clofazimine
5436625|NCT00001047|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5436626|NCT00001047|Clarithromycin|clarithromycin
5436627|NCT00001046|Vaccines, Synthetic|vaccines, synthetic
5436628|NCT00001046|Pregnancy|pregnancy
5436629|NCT00001046|Pregnancy Complications, Infectious|pregnancy complications, infectious
5436630|NCT00001046|AIDS-Related Complex|aids-related complex
5436631|NCT00001046|HIV Envelope Protein gp120|hiv envelope protein gp120
5436632|NCT00001046|HIV Preventive Vaccine|hiv preventive vaccine
5436633|NCT00001046|HIV Therapeutic Vaccine|hiv therapeutic vaccine
5436634|NCT00001045|Didanosine|didanosine
5436635|NCT00001045|Drug Therapy, Combination|drug therapy, combination
5436636|NCT00001045|Zidovudine|zidovudine
5436637|NCT00001045|Nevirapine|nevirapine
5436638|NCT00001044|Vaccines, Synthetic|vaccines, synthetic
5436639|NCT00001044|Drug Therapy, Combination|drug therapy, combination
5436640|NCT00001044|Adjuvants, Immunologic|adjuvants, immunologic
5436641|NCT00001044|HIV Envelope Protein gp120|hiv envelope protein gp120
5436642|NCT00001044|AIDS Vaccines|aids vaccines
5436643|NCT00001044|HIV Seronegativity|hiv seronegativity
5436644|NCT00001044|HIV Preventive Vaccine|hiv preventive vaccine
5436645|NCT00001043|Vaccines, Synthetic|vaccines, synthetic
5436646|NCT00001043|Vaccinia Virus|vaccinia virus
5436647|NCT00001043|Viral Vaccines|viral vaccines
5436648|NCT00001043|Smallpox Vaccine|smallpox vaccine
5436649|NCT00001043|HIV-1|hiv-1
5436650|NCT00001043|HIV Envelope Protein gp160|hiv envelope protein gp160
5436651|NCT00001043|AIDS Vaccines|aids vaccines
5436652|NCT00001043|HIV Seronegativity|hiv seronegativity
5436653|NCT00001043|HIV Preventive Vaccine|hiv preventive vaccine
5436654|NCT00001042|Vaccines, Synthetic|vaccines, synthetic
5436655|NCT00001042|Drug Therapy, Combination|drug therapy, combination
5436656|NCT00001042|Adjuvants, Immunologic|adjuvants, immunologic
5436657|NCT00001042|HIV Envelope Protein gp120|hiv envelope protein gp120
5436658|NCT00001042|Acetylmuramyl-Alanyl-Isoglutamine|acetylmuramyl-alanyl-isoglutamine
5436659|NCT00001042|monophosphoryl lipid A|monophosphoryl lipid a
5436660|NCT00001042|AIDS Vaccines|aids vaccines
5436661|NCT00001042|HIV Seronegativity|hiv seronegativity
5436662|NCT00001042|HIV Preventive Vaccine|hiv preventive vaccine
5436663|NCT00001041|Vaccines, Synthetic|vaccines, synthetic
5436664|NCT00001041|Pregnancy|pregnancy
5436665|NCT00001041|Pregnancy Complications, Infectious|pregnancy complications, infectious
5436666|NCT00001041|HIV Envelope Protein gp120|hiv envelope protein gp120
5436667|NCT00001041|AIDS Vaccines|aids vaccines
5436668|NCT00001041|HIV Therapeutic Vaccine|hiv therapeutic vaccine
5436669|NCT00001040|Zalcitabine|zalcitabine
5436670|NCT00001040|Drug Therapy, Combination|drug therapy, combination
5436671|NCT00001040|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5436672|NCT00001040|AIDS-Related Complex|aids-related complex
5436675|NCT00001040|HIV Protease Inhibitors|hiv protease inhibitors
5436676|NCT00001039|Mycobacterium avium-intracellulare Infection|mycobacterium avium-intracellulare infection
5436677|NCT00001039|Drug Therapy, Combination|drug therapy, combination
5436678|NCT00001039|Ethambutol|ethambutol
5436679|NCT00001039|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5436680|NCT00001039|Clarithromycin|clarithromycin
5436681|NCT00001038|Cytomegalovirus Infections|cytomegalovirus infections
5436682|NCT00001038|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5436683|NCT00001038|Antiviral Agents|antiviral agents
5436684|NCT00001037|Vaccines, Synthetic|vaccines, synthetic
5436685|NCT00001037|HIV-1|hiv-1
5436686|NCT00001037|HIV Envelope Protein gp160|hiv envelope protein gp160
5436687|NCT00001037|AIDS Vaccines|aids vaccines
5436688|NCT00001037|HIV Seronegativity|hiv seronegativity
5436689|NCT00001037|HIV Preventive Vaccine|hiv preventive vaccine
5436690|NCT00001036|T-Lymphocytes|t-lymphocytes
5436691|NCT00001036|Polyethylene Glycols|polyethylene glycols
5436692|NCT00001036|Interleukin-2|interleukin-2
5436693|NCT00001036|Drug Therapy, Combination|drug therapy, combination
5436694|NCT00001036|Adjuvants, Immunologic|adjuvants, immunologic
5436695|NCT00001036|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5436696|NCT00001036|Zidovudine|zidovudine
5436697|NCT00001036|thymosin alpha(1)|thymosin alpha(1)
5436698|NCT00001035|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
5436699|NCT00001035|Interferon Alfa-2b|interferon alfa-2b
5436700|NCT00001035|Zalcitabine|zalcitabine
5436701|NCT00001035|Didanosine|didanosine
5436702|NCT00001035|Drug Therapy, Combination|drug therapy, combination
5436703|NCT00001035|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5436704|NCT00001035|Zidovudine|zidovudine
5436705|NCT00001035|Hepatitis C|hepatitis c
5436706|NCT00001034|Retinitis|retinitis
5436707|NCT00001034|Ganciclovir|ganciclovir
5436708|NCT00001034|Cytomegalovirus Infections|cytomegalovirus infections
5436709|NCT00001034|Administration, Oral|administration, oral
5436710|NCT00001034|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5436711|NCT00001034|Gastrointestinal System|gastrointestinal system
5436712|NCT00001033|Isoniazid|isoniazid
5436713|NCT00001033|Tuberculosis, Pulmonary|tuberculosis, pulmonary
5436714|NCT00001033|Pyrazinamide|pyrazinamide
5436715|NCT00001033|Pyridoxine|pyridoxine
5436716|NCT00001033|Ofloxacin|ofloxacin
5436717|NCT00001033|Rifampin|rifampin
5436718|NCT00001033|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
5436719|NCT00001033|Ethambutol|ethambutol
5436720|NCT00001033|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5436721|NCT00001032|Zalcitabine|zalcitabine
5436722|NCT00001032|Drug Therapy, Combination|drug therapy, combination
5436723|NCT00001032|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5436724|NCT00001032|AIDS-Related Complex|aids-related complex
5436725|NCT00001032|Zidovudine|zidovudine
5436726|NCT00001031|Vaccines, Synthetic|vaccines, synthetic
5436727|NCT00001031|HIV-1|hiv-1
5436728|NCT00001031|HIV Envelope Protein gp120|hiv envelope protein gp120
5436729|NCT00001031|AIDS Vaccines|aids vaccines
5436730|NCT00001031|HIV Seronegativity|hiv seronegativity
5436731|NCT00001031|HIV Preventive Vaccine|hiv preventive vaccine
5436732|NCT00001030|Rifabutin|rifabutin
5436733|NCT00001030|Mycobacterium avium-intracellulare Infection|mycobacterium avium-intracellulare infection
5436734|NCT00001030|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5436735|NCT00001030|Clarithromycin|clarithromycin
5436736|NCT00001029|Zalcitabine|zalcitabine
5436737|NCT00001029|Didanosine|didanosine
5436738|NCT00001029|Drug Therapy, Combination|drug therapy, combination
5436739|NCT00001029|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5436740|NCT00001029|Zidovudine|zidovudine
5436741|NCT00001028|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
5436742|NCT00001028|Pentamidine|pentamidine
5436743|NCT00001028|Dapsone|dapsone
5436744|NCT00001028|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5436745|NCT00001028|AIDS-Related Complex|aids-related complex
5436746|NCT00001027|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
5436747|NCT00001027|Pentamidine|pentamidine
5436748|NCT00001027|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5436749|NCT00001027|AIDS-Related Complex|aids-related complex
5436750|NCT00001026|Vaccines, Synthetic|vaccines, synthetic
5436751|NCT00001026|Vaccinia Virus|vaccinia virus
5436752|NCT00001026|Viral Vaccines|viral vaccines
5436753|NCT00001026|HIV Envelope Protein gp160|hiv envelope protein gp160
5436754|NCT00001026|HIV Envelope Protein gp120|hiv envelope protein gp120
5436755|NCT00001026|AIDS Vaccines|aids vaccines
5436756|NCT00001026|HIV Seronegativity|hiv seronegativity
5436757|NCT00001026|HIV Preventive Vaccine|hiv preventive vaccine
5436758|NCT00001025|Virus Replication|virus replication
5436759|NCT00001025|Didanosine|didanosine
5436760|NCT00001025|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5436761|NCT00001025|AIDS-Related Complex|aids-related complex
5436762|NCT00001025|Zidovudine|zidovudine
5436763|NCT00001024|Didanosine|didanosine
5436764|NCT00001024|AIDS-Related Complex|aids-related complex
5436765|NCT00001024|Zidovudine|zidovudine
5436766|NCT00001024|Lymph Nodes|lymph nodes
5436767|NCT00001024|Lymphoid Tissue|lymphoid tissue
5436769|NCT00001023|Mycobacterium avium-intracellulare Infection|mycobacterium avium-intracellulare infection
5436770|NCT00001023|Drug Interactions|drug interactions
5436771|NCT00001023|Azithromycin|azithromycin
5436772|NCT00001023|Clarithromycin|clarithromycin
5436773|NCT00001022|Zalcitabine|zalcitabine
5436774|NCT00001022|Didanosine|didanosine
5436775|NCT00001022|Drug Therapy, Combination|drug therapy, combination
5436776|NCT00001022|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5436777|NCT00001022|AIDS-Related Complex|aids-related complex
5436778|NCT00001022|Zidovudine|zidovudine
5436779|NCT00001021|Vaccines, Synthetic|vaccines, synthetic
5436780|NCT00001021|HIV-1|hiv-1
5436781|NCT00001021|HIV Envelope Protein gp120|hiv envelope protein gp120
5436782|NCT00001021|AIDS Vaccines|aids vaccines
5436783|NCT00001021|HIV Seronegativity|hiv seronegativity
5436784|NCT00001021|HIV Preventive Vaccine|hiv preventive vaccine
5436785|NCT00001020|Vaccines, Synthetic|vaccines, synthetic
5436786|NCT00001020|Viral Vaccines|viral vaccines
5436787|NCT00001020|HIV-1|hiv-1
5436788|NCT00001020|HIV Envelope Protein gp120|hiv envelope protein gp120
5436789|NCT00001020|AIDS Vaccines|aids vaccines
5436790|NCT00001020|HIV Seronegativity|hiv seronegativity
5436791|NCT00001020|HIV Preventive Vaccine|hiv preventive vaccine
5436792|NCT00001019|Vaccines, Synthetic|vaccines, synthetic
5436793|NCT00001019|Adjuvants, Immunologic|adjuvants, immunologic
5436794|NCT00001019|HIV Envelope Protein gp120|hiv envelope protein gp120
5436795|NCT00001019|AIDS Vaccines|aids vaccines
5436796|NCT00001019|HIV Seronegativity|hiv seronegativity
5436797|NCT00001019|HIV Preventive Vaccine|hiv preventive vaccine
5436798|NCT00001018|Cryptosporidiosis|cryptosporidiosis
5436799|NCT00001018|Diarrhea|diarrhea
5436800|NCT00001018|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5436801|NCT00001018|Antiprotozoal Agents|antiprotozoal agents
5436802|NCT00001018|Triazines|triazines
5436803|NCT00001017|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
5436804|NCT00001017|Meningitis|meningitis
5436805|NCT00001017|Injections, Intravenous|injections, intravenous
5436806|NCT00001017|Cryptococcosis|cryptococcosis
5436807|NCT00001017|Fluconazole|fluconazole
5436808|NCT00001017|Administration, Oral|administration, oral
5436809|NCT00001017|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5436810|NCT00001017|Amphotericin B|amphotericin b
5436811|NCT00001016|Trimetrexate|trimetrexate
5436812|NCT00001016|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
5436813|NCT00001016|Quinazolines|quinazolines
5436814|NCT00001016|Infusions, Intravenous|infusions, intravenous
5436815|NCT00001016|Injections, Intravenous|injections, intravenous
5436816|NCT00001016|Leucovorin|leucovorin
5436817|NCT00001016|Drug Evaluation|drug evaluation
5436818|NCT00001016|Drug Therapy, Combination|drug therapy, combination
5436819|NCT00001016|Administration, Oral|administration, oral
5436820|NCT00001016|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5436821|NCT00001016|Antiprotozoal Agents|antiprotozoal agents
5436822|NCT00001016|AIDS-Related Complex|aids-related complex
5436823|NCT00001015|Ribavirin|ribavirin
5436824|NCT00001015|T-Lymphocytes|t-lymphocytes
5436825|NCT00001015|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5436826|NCT00001015|AIDS-Related Complex|aids-related complex
5436827|NCT00001014|Trimethoprim-Sulfamethoxazole Combination|trimethoprim-sulfamethoxazole combination
5436828|NCT00001014|Trimetrexate|trimetrexate
5436829|NCT00001014|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
5436830|NCT00001014|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
5436831|NCT00001014|Infusions, Intravenous|infusions, intravenous
5436832|NCT00001014|Leucovorin|leucovorin
5436833|NCT00001014|Drug Therapy, Combination|drug therapy, combination
5436834|NCT00001014|Administration, Oral|administration, oral
5436835|NCT00001014|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5436836|NCT00001014|Antiprotozoal Agents|antiprotozoal agents
5436837|NCT00001014|AIDS-Related Complex|aids-related complex
5436838|NCT00001014|Sulfamethoxazole-Trimethoprim|sulfamethoxazole-trimethoprim
5436839|NCT00001013|Trimethoprim-Sulfamethoxazole Combination|trimethoprim-sulfamethoxazole combination
5436840|NCT00001013|Trimetrexate|trimetrexate
5436841|NCT00001013|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
5436842|NCT00001013|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
5436843|NCT00001013|Pentamidine|pentamidine
5436844|NCT00001013|Infusions, Intravenous|infusions, intravenous
5436845|NCT00001013|Leucovorin|leucovorin
5436846|NCT00001013|Drug Therapy, Combination|drug therapy, combination
5436847|NCT00001013|Folic Acid Antagonists|folic acid antagonists
5436848|NCT00001013|Aerosols|aerosols
5436849|NCT00001013|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5436850|NCT00001013|Antiprotozoal Agents|antiprotozoal agents
5436851|NCT00001013|AIDS-Related Complex|aids-related complex
5436852|NCT00001013|Sulfamethoxazole-Trimethoprim|sulfamethoxazole-trimethoprim
5436853|NCT00001012|Virus Replication|virus replication
5436854|NCT00001012|T-Lymphocytes|t-lymphocytes
5436855|NCT00001012|Dose-Response Relationship, Drug|dose-response relationship, drug
5436856|NCT00001012|Drug Evaluation|drug evaluation
5436857|NCT00001012|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5436858|NCT00001012|AL 721|al 721
5436859|NCT00001012|AIDS-Related Complex|aids-related complex
5436860|NCT00001012|Antiviral Agents|antiviral agents
5436861|NCT00001011|Virus Replication|virus replication
5436862|NCT00001011|AIDS-Related Complex|aids-related complex
5436863|NCT00001011|Zidovudine|zidovudine
5436864|NCT00001010|Immune Tolerance|immune tolerance
5436865|NCT00001010|Dose-Response Relationship, Drug|dose-response relationship, drug
5436866|NCT00001010|Drug Evaluation|drug evaluation
5436867|NCT00001010|Drug Therapy, Combination|drug therapy, combination
5436868|NCT00001010|Acyclovir|acyclovir
5436869|NCT00001010|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5436870|NCT00001010|AIDS-Related Complex|aids-related complex
5436871|NCT00001010|Zidovudine|zidovudine
5436872|NCT00001009|T-Lymphocytes|t-lymphocytes
5436873|NCT00001009|HIV Antigens|hiv antigens
5436874|NCT00001009|Dextran Sulfate|dextran sulfate
5436875|NCT00001009|Dose-Response Relationship, Drug|dose-response relationship, drug
5436876|NCT00001009|Drug Evaluation|drug evaluation
5436877|NCT00001009|Drug Therapy, Combination|drug therapy, combination
5436878|NCT00001009|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5436879|NCT00001009|AIDS-Related Complex|aids-related complex
5436880|NCT00001008|Substance Withdrawal Syndrome|substance withdrawal syndrome
5436881|NCT00001008|Methadone|methadone
5436882|NCT00001008|Opioid-Related Disorders|opioid-related disorders
5436883|NCT00001008|Drug Evaluation|drug evaluation
5436884|NCT00001008|Drug Interactions|drug interactions
5436885|NCT00001008|Drug Therapy, Combination|drug therapy, combination
5436886|NCT00001008|Administration, Oral|administration, oral
5436887|NCT00001008|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5436888|NCT00001008|AIDS-Related Complex|aids-related complex
5436889|NCT00001008|Zidovudine|zidovudine
5436890|NCT00001007|Pregnancy|pregnancy
5436891|NCT00001007|Pregnancy Complications, Infectious|pregnancy complications, infectious
5436892|NCT00001007|Infant, Newborn, Diseases|infant, newborn, diseases
5436893|NCT00001007|Infusions, Intravenous|infusions, intravenous
5436894|NCT00001007|Drug Evaluation|drug evaluation
5436895|NCT00001007|Administration, Oral|administration, oral
5436896|NCT00001007|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5436897|NCT00001007|Zidovudine|zidovudine
5436898|NCT00001006|Infusions, Intravenous|infusions, intravenous
5436899|NCT00001006|Immunologic Surveillance|immunologic surveillance
5436900|NCT00001006|Drug Evaluation|drug evaluation
5436901|NCT00001006|Adjuvants, Immunologic|adjuvants, immunologic
5436902|NCT00001006|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5436903|NCT00001006|AIDS-Related Complex|aids-related complex
5436904|NCT00001006|ammonium trichloro(dioxoethylene-O,O'-)tellurute|ammonium trichloro(dioxoethylene-o,o'-)tellurute
5436905|NCT00001005|Recombinant Proteins|recombinant proteins
5436906|NCT00001005|HIV Seropositivity|hiv seropositivity
5436907|NCT00001005|Interleukin-2|interleukin-2
5436908|NCT00001005|Drug Evaluation|drug evaluation
5436909|NCT00001005|Drug Therapy, Combination|drug therapy, combination
5436910|NCT00001005|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5436911|NCT00001005|AIDS-Related Complex|aids-related complex
5436912|NCT00001005|Zidovudine|zidovudine
5436913|NCT00001004|Tumor Necrosis Factor|tumor necrosis factor
5436914|NCT00001004|Interferon-gamma, Recombinant|interferon-gamma, recombinant
5436915|NCT00001004|HIV Antigens|hiv antigens
5436916|NCT00001004|Immunologic Surveillance|immunologic surveillance
5436917|NCT00001004|Drug Therapy, Combination|drug therapy, combination
5436918|NCT00001004|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5436919|NCT00001004|AIDS-Related Complex|aids-related complex
5436920|NCT00001003|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
5436921|NCT00001003|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
5436922|NCT00001003|Pentamidine|pentamidine
5436923|NCT00001003|Nebulizers and Vaporizers|nebulizers and vaporizers
5436924|NCT00001003|Lung|lung
5436925|NCT00001003|Administration, Inhalation|administration, inhalation
5436926|NCT00001003|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5436927|NCT00001003|Zidovudine|zidovudine
5436928|NCT00001002|Drug Therapy, Combination|drug therapy, combination
5436929|NCT00001002|Foscarnet|foscarnet
5436930|NCT00001002|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5436931|NCT00001002|AIDS-Related Complex|aids-related complex
5436932|NCT00001002|Antiviral Agents|antiviral agents
5436933|NCT00001002|Zidovudine|zidovudine
5436934|NCT00001001|Liver|liver
5436935|NCT00001001|Liver Diseases|liver diseases
5436936|NCT00001001|Liver Function Tests|liver function tests
5436937|NCT00001001|HIV Seropositivity|hiv seropositivity
5436938|NCT00001001|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5436939|NCT00001001|Zidovudine|zidovudine
5436940|NCT00001001|Biological Availability|biological availability
5436941|NCT00001000|Macrophage Activation|macrophage activation
5436942|NCT00001000|Lymphocyte Transformation|lymphocyte transformation
5436943|NCT00001000|Immunologic Surveillance|immunologic surveillance
5436944|NCT00001000|ampligen|ampligen
5436945|NCT00001000|Antiviral Agents|antiviral agents
5436946|NCT00000999|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5436947|NCT00000999|AIDS-Related Complex|aids-related complex
5436949|NCT00000998|Trimetrexate|trimetrexate
5436950|NCT00000998|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
5436951|NCT00000998|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
5436952|NCT00000998|Injections, Intravenous|injections, intravenous
5436953|NCT00000998|Leucovorin|leucovorin
5436954|NCT00000998|Dose-Response Relationship, Drug|dose-response relationship, drug
5436955|NCT00000998|Drug Therapy, Combination|drug therapy, combination
5436956|NCT00000998|Folic Acid Antagonists|folic acid antagonists
5436957|NCT00000998|Administration, Oral|administration, oral
5436958|NCT00000998|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5436959|NCT00000998|Antineoplastic Agents|antineoplastic agents
5436960|NCT00000997|Zalcitabine|zalcitabine
5436961|NCT00000997|Drug Evaluation|drug evaluation
5436962|NCT00000997|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5436963|NCT00000997|AIDS-Related Complex|aids-related complex
5436964|NCT00000997|Biological Availability|biological availability
5436965|NCT00000996|Doxorubicin|doxorubicin
5436966|NCT00000996|Drug Evaluation|drug evaluation
5436967|NCT00000996|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5436968|NCT00000995|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
5436969|NCT00000995|Ganciclovir|ganciclovir
5436970|NCT00000995|Drug Evaluation|drug evaluation
5436971|NCT00000995|Drug Therapy, Combination|drug therapy, combination
5436972|NCT00000995|Cytomegalovirus Infections|cytomegalovirus infections
5436973|NCT00000995|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5436974|NCT00000995|Zidovudine|zidovudine
5436975|NCT00000994|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
5436976|NCT00000994|Sarcoma, Kaposi|sarcoma, kaposi
5436977|NCT00000994|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5436978|NCT00000994|Zidovudine|zidovudine
5436979|NCT00000993|HIV-1|hiv-1
5436980|NCT00000993|Drug Evaluation|drug evaluation
5436981|NCT00000993|Accidents|accidents
5436982|NCT00000993|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5436983|NCT00000993|AIDS Serodiagnosis|aids serodiagnosis
5436984|NCT00000993|Zidovudine|zidovudine
5436985|NCT00000992|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
5436986|NCT00000992|Ketoconazole|ketoconazole
5436987|NCT00000992|Histoplasmosis|histoplasmosis
5436988|NCT00000992|Drug Evaluation|drug evaluation
5436989|NCT00000992|Antifungal Agents|antifungal agents
5436990|NCT00000992|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5436991|NCT00000991|Trimethoprim-Sulfamethoxazole Combination|trimethoprim-sulfamethoxazole combination
5436992|NCT00000991|Toxoplasmosis|toxoplasmosis
5436993|NCT00000991|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
5436994|NCT00000991|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
5436995|NCT00000991|Pentamidine|pentamidine
5436996|NCT00000991|Dapsone|dapsone
5436997|NCT00000991|Drug Evaluation|drug evaluation
5436998|NCT00000991|Drug Therapy, Combination|drug therapy, combination
5436999|NCT00000991|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5437000|NCT00000991|Zidovudine|zidovudine
5437001|NCT00000991|Sulfamethoxazole-Trimethoprim|sulfamethoxazole-trimethoprim
5437002|NCT00000990|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
5437003|NCT00000990|Pulmonary Fibrosis|pulmonary fibrosis
5437004|NCT00000990|Zidovudine|zidovudine
5437005|NCT00000989|Retinitis|retinitis
5437006|NCT00000989|Ganciclovir|ganciclovir
5437007|NCT00000989|Drug Evaluation|drug evaluation
5437008|NCT00000989|Drug Therapy, Combination|drug therapy, combination
5437009|NCT00000989|Cytomegalovirus Infections|cytomegalovirus infections
5437010|NCT00000989|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5437011|NCT00000989|Zidovudine|zidovudine
5437012|NCT00000988|Injections, Intravenous|injections, intravenous
5437013|NCT00000988|Drug Evaluation|drug evaluation
5437014|NCT00000988|Administration, Oral|administration, oral
5437015|NCT00000988|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5437016|NCT00000988|AIDS-Related Complex|aids-related complex
5437017|NCT00000988|Antiviral Agents|antiviral agents
5437018|NCT00000987|Vincristine|vincristine
5437019|NCT00000987|Doxorubicin|doxorubicin
5437020|NCT00000987|Drug Therapy, Combination|drug therapy, combination
5437021|NCT00000987|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5437022|NCT00000987|Zidovudine|zidovudine
5437023|NCT00000987|Bleomycin|bleomycin
5437024|NCT00000986|Recombinant Proteins|recombinant proteins
5437025|NCT00000986|Interleukin-2|interleukin-2
5437026|NCT00000986|Drug Interactions|drug interactions
5437027|NCT00000986|Drug Therapy, Combination|drug therapy, combination
5437028|NCT00000986|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5437029|NCT00000986|AIDS-Related Complex|aids-related complex
5437030|NCT00000986|Zidovudine|zidovudine
5437031|NCT00000985|Vidarabine|vidarabine
5437032|NCT00000985|Phosphonoacetic Acid|phosphonoacetic acid
5437033|NCT00000985|Herpes Simplex|herpes simplex
5437034|NCT00000985|Foscarnet|foscarnet
5437035|NCT00000985|Acyclovir|acyclovir
5437036|NCT00000985|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5437037|NCT00000984|Recombinant Proteins|recombinant proteins
5437038|NCT00000984|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5437039|NCT00000984|Antigens, CD4|antigens, cd4
5437040|NCT00000984|Antiviral Agents|antiviral agents
5437041|NCT00000983|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5437042|NCT00000983|Zidovudine|zidovudine
5437043|NCT00000982|Central Nervous System Diseases|central nervous system diseases
5437044|NCT00000982|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5437045|NCT00000982|Zidovudine|zidovudine
5437046|NCT00000981|Retinitis|retinitis
5437047|NCT00000981|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
5437048|NCT00000981|Pyrimidine Nucleosides|pyrimidine nucleosides
5437049|NCT00000981|Drug Evaluation|drug evaluation
5437050|NCT00000981|fiacitabine|fiacitabine
5437051|NCT00000981|Cytomegalovirus Infections|cytomegalovirus infections
5437052|NCT00000981|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5437053|NCT00000981|Antiviral Agents|antiviral agents
5437054|NCT00000980|Single-Blind Method|single-blind method
5437055|NCT00000980|Spiramycin|spiramycin
5437056|NCT00000980|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
5437057|NCT00000980|Injections, Intravenous|injections, intravenous
5437058|NCT00000980|Cryptosporidiosis|cryptosporidiosis
5437059|NCT00000980|Diarrhea|diarrhea
5437060|NCT00000980|Drug Evaluation|drug evaluation
5437061|NCT00000980|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5437062|NCT00000979|Didanosine|didanosine
5437063|NCT00000979|Zidovudine|zidovudine
5437064|NCT00000978|Zalcitabine|zalcitabine
5437065|NCT00000978|Drug Therapy, Combination|drug therapy, combination
5437066|NCT00000978|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5437067|NCT00000978|AIDS-Related Complex|aids-related complex
5437068|NCT00000978|Zidovudine|zidovudine
5437069|NCT00000977|Vaccines, Synthetic|vaccines, synthetic
5437070|NCT00000977|HIV Seropositivity|hiv seropositivity
5437071|NCT00000977|HIV-1|hiv-1
5437072|NCT00000977|Drug Evaluation|drug evaluation
5437073|NCT00000977|AIDS Vaccines|aids vaccines
5437074|NCT00000977|HIV Therapeutic Vaccine|hiv therapeutic vaccine
5437075|NCT00000976|Recombinant Proteins|recombinant proteins
5437076|NCT00000976|Injections, Intravenous|injections, intravenous
5437077|NCT00000976|IgG|igg
5437078|NCT00000976|Drug Evaluation|drug evaluation
5437079|NCT00000976|Administration, Oral|administration, oral
5437080|NCT00000976|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5437081|NCT00000976|Antigens, CD4|antigens, cd4
5437082|NCT00000976|Zidovudine|zidovudine
5437083|NCT00000976|Carrier Proteins|carrier proteins
5437084|NCT00000975|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
5437085|NCT00000975|Histoplasmosis|histoplasmosis
5437086|NCT00000975|Drug Evaluation|drug evaluation
5437087|NCT00000975|Antifungal Agents|antifungal agents
5437088|NCT00000975|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5437089|NCT00000974|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
5437090|NCT00000974|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
5437091|NCT00000974|Pentamidine|pentamidine
5437092|NCT00000974|Injections, Intravenous|injections, intravenous
5437093|NCT00000974|Drug Evaluation|drug evaluation
5437094|NCT00000974|Aerosols|aerosols
5437095|NCT00000974|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5437096|NCT00000973|Toxoplasmosis|toxoplasmosis
5437097|NCT00000973|Toxoplasma|toxoplasma
5437098|NCT00000973|Pyrimethamine|pyrimethamine
5437099|NCT00000973|Leucovorin|leucovorin
5437100|NCT00000973|Drug Evaluation|drug evaluation
5437101|NCT00000973|Encephalitis|encephalitis
5437102|NCT00000973|Zidovudine|zidovudine
5437103|NCT00000972|Vaccines, Synthetic|vaccines, synthetic
5437104|NCT00000972|Drug Evaluation|drug evaluation
5437105|NCT00000972|Adjuvants, Immunologic|adjuvants, immunologic
5437106|NCT00000972|AIDS Vaccines|aids vaccines
5437107|NCT00000972|HIV Preventive Vaccine|hiv preventive vaccine
5437108|NCT00000971|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
5437109|NCT00000971|Mycobacterium avium-intracellulare Infection|mycobacterium avium-intracellulare infection
5437110|NCT00000971|Didanosine|didanosine
5437111|NCT00000971|Drug Evaluation|drug evaluation
5437112|NCT00000971|Drug Interactions|drug interactions
5437113|NCT00000971|Drug Therapy, Combination|drug therapy, combination
5437114|NCT00000971|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5437115|NCT00000971|Zidovudine|zidovudine
5437116|NCT00000970|Retinitis|retinitis
5437117|NCT00000970|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
5437118|NCT00000970|Ganciclovir|ganciclovir
5437119|NCT00000970|Drug Evaluation|drug evaluation
5437120|NCT00000970|Drug Therapy, Combination|drug therapy, combination
5437121|NCT00000970|Foscarnet|foscarnet
5437122|NCT00000970|Cytomegalovirus Infections|cytomegalovirus infections
5437123|NCT00000970|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5437124|NCT00000969|Zalcitabine|zalcitabine
5437125|NCT00000969|Didanosine|didanosine
5437126|NCT00000969|Drug Evaluation|drug evaluation
5437127|NCT00000969|Zidovudine|zidovudine
5437128|NCT00000968|Vaccines, Synthetic|vaccines, synthetic
5437129|NCT00000968|Drug Evaluation|drug evaluation
5437130|NCT00000968|HIV Envelope Protein gp160|hiv envelope protein gp160
5437131|NCT00000968|AIDS Vaccines|aids vaccines
5437132|NCT00000968|HIV Seronegativity|hiv seronegativity
5437133|NCT00000968|HIV Preventive Vaccine|hiv preventive vaccine
5437134|NCT00000967|Drug Therapy, Combination|drug therapy, combination
5437135|NCT00000967|AIDS-Related Complex|aids-related complex
5437136|NCT00000967|Zidovudine|zidovudine
5437137|NCT00000967|Interferon Type I|interferon type i
5437138|NCT00000966|Toxoplasmosis|toxoplasmosis
5437139|NCT00000966|Toxoplasma|toxoplasma
5437140|NCT00000966|Pyrimethamine|pyrimethamine
5437141|NCT00000966|Leucovorin|leucovorin
5437142|NCT00000966|Drug Evaluation|drug evaluation
5437143|NCT00000966|Drug Therapy, Combination|drug therapy, combination
5437144|NCT00000966|Encephalitis|encephalitis
5437145|NCT00000966|Administration, Oral|administration, oral
5437146|NCT00000966|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5437147|NCT00000966|Azithromycin|azithromycin
5437148|NCT00000965|Leukocytes, Mononuclear|leukocytes, mononuclear
5437149|NCT00000965|Drug Evaluation|drug evaluation
5437150|NCT00000965|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5437151|NCT00000965|AIDS-Related Complex|aids-related complex
5437152|NCT00000965|Zidovudine|zidovudine
5437153|NCT00000965|Phosphorylation|phosphorylation
5437154|NCT00000964|Ranitidine|ranitidine
5437155|NCT00000964|Phosphorus Acids|phosphorus acids
5437156|NCT00000964|Drug Evaluation|drug evaluation
5437157|NCT00000964|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5437158|NCT00000963|Didanosine|didanosine
5437159|NCT00000963|Drug Evaluation|drug evaluation
5437160|NCT00000963|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5437161|NCT00000963|AIDS-Related Complex|aids-related complex
5437162|NCT00000963|Zidovudine|zidovudine
5437163|NCT00000962|Drug Evaluation|drug evaluation
5437164|NCT00000962|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5437165|NCT00000962|AIDS-Related Complex|aids-related complex
5437166|NCT00000962|Nevirapine|nevirapine
5437167|NCT00000961|Drug Therapy, Combination|drug therapy, combination
5437168|NCT00000961|Zidovudine|zidovudine
5437169|NCT00000960|Pregnancy|pregnancy
5437170|NCT00000960|Pregnancy Complications, Infectious|pregnancy complications, infectious
5437171|NCT00000960|Prenatal Exposure Delayed Effects|prenatal exposure delayed effects
5437172|NCT00000960|Administration, Oral|administration, oral
5437173|NCT00000960|AIDS-Related Complex|aids-related complex
5437174|NCT00000960|Zidovudine|zidovudine
5437175|NCT00000959|Tuberculosis|tuberculosis
5437176|NCT00000959|Isoniazid|isoniazid
5437177|NCT00000959|Pyridoxine|pyridoxine
5437178|NCT00000959|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
5437179|NCT00000959|Drug Evaluation|drug evaluation
5437180|NCT00000959|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5437181|NCT00000959|Antitubercular Agents|antitubercular agents
5437182|NCT00000958|Vaccines, Synthetic|vaccines, synthetic
5437183|NCT00000958|Recombinant Proteins|recombinant proteins
5437184|NCT00000958|Adjuvants, Immunologic|adjuvants, immunologic
5437185|NCT00000958|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5437186|NCT00000958|HIV Envelope Protein gp120|hiv envelope protein gp120
5437187|NCT00000958|AIDS Vaccines|aids vaccines
5437188|NCT00000958|HIV Therapeutic Vaccine|hiv therapeutic vaccine
5437189|NCT00000957|Vaccines, Synthetic|vaccines, synthetic
5437190|NCT00000957|Vaccinia Virus|vaccinia virus
5437191|NCT00000957|Viral Vaccines|viral vaccines
5437192|NCT00000957|HIV-1|hiv-1
5437193|NCT00000957|Drug Evaluation|drug evaluation
5437194|NCT00000957|HIV Envelope Protein gp160|hiv envelope protein gp160
5437195|NCT00000957|Drug Administration Schedule|drug administration schedule
5437196|NCT00000957|AIDS Vaccines|aids vaccines
5437197|NCT00000957|HIV Seronegativity|hiv seronegativity
5437198|NCT00000957|HIV Preventive Vaccine|hiv preventive vaccine
5437199|NCT00000956|Vaccines, Synthetic|vaccines, synthetic
5437200|NCT00000956|Vaccinia Virus|vaccinia virus
5437201|NCT00000956|HIV-1|hiv-1
5437202|NCT00000956|HIV Envelope Protein gp160|hiv envelope protein gp160
5437203|NCT00000956|AIDS Vaccines|aids vaccines
5437204|NCT00000956|HIV Seronegativity|hiv seronegativity
5437205|NCT00000956|HIV Preventive Vaccine|hiv preventive vaccine
5437206|NCT00000955|Tuberculosis|tuberculosis
5437207|NCT00000955|Immunologic Tests|immunologic tests
5437208|NCT00000955|Tuberculin|tuberculin
5437209|NCT00000955|Tuberculin Test|tuberculin test
5437210|NCT00000955|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
5437211|NCT00000955|Injections, Intradermal|injections, intradermal
5437212|NCT00000955|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5437213|NCT00000955|AIDS-Related Complex|aids-related complex
5437214|NCT00000955|Hypersensitivity, Delayed|hypersensitivity, delayed
5437215|NCT00000954|Vincristine|vincristine
5437216|NCT00000954|Sarcoma, Kaposi|sarcoma, kaposi
5437217|NCT00000954|Zalcitabine|zalcitabine
5437218|NCT00000954|Didanosine|didanosine
5437219|NCT00000954|Doxorubicin|doxorubicin
5437220|NCT00000954|Drug Evaluation|drug evaluation
5437221|NCT00000954|Drug Interactions|drug interactions
5437222|NCT00000954|Drug Therapy, Combination|drug therapy, combination
5437223|NCT00000954|Combined Modality Therapy|combined modality therapy
5437224|NCT00000954|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5437225|NCT00000954|Antineoplastic Agents|antineoplastic agents
5437226|NCT00000954|Antineoplastic Agents, Combined|antineoplastic agents, combined
5437227|NCT00000954|Antiviral Agents|antiviral agents
5437228|NCT00000954|Bleomycin|bleomycin
5437229|NCT00000953|Herpes Zoster|herpes zoster
5437230|NCT00000953|Acyclovir|acyclovir
5437231|NCT00000953|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5437232|NCT00000953|AIDS-Related Complex|aids-related complex
5437233|NCT00000953|Antiviral Agents|antiviral agents
5437234|NCT00000953|sorivudine|sorivudine
5437235|NCT00000952|Dose-Response Relationship, Drug|dose-response relationship, drug
5437236|NCT00000952|Drug Therapy, Combination|drug therapy, combination
5437237|NCT00000952|Zidovudine|zidovudine
5437238|NCT00000952|HIV Protease Inhibitors|hiv protease inhibitors
5437239|NCT00000952|Ritonavir|ritonavir
5437240|NCT00000952|Lamivudine|lamivudine
5437241|NCT00000952|Anti-HIV Agents|anti-hiv agents
5437242|NCT00000951|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
5437243|NCT00000951|Fluconazole|fluconazole
5437244|NCT00000951|Antifungal Agents|antifungal agents
5437245|NCT00000951|Candidiasis, Oral|candidiasis, oral
5437246|NCT00000951|Drug Administration Schedule|drug administration schedule
5437247|NCT00000951|Pharyngeal Diseases|pharyngeal diseases
5437248|NCT00000950|Tuberculosis|tuberculosis
5437249|NCT00000950|Isoniazid|isoniazid
5437250|NCT00000950|Pyrazinamide|pyrazinamide
5437251|NCT00000950|Pyridoxine|pyridoxine
5437252|NCT00000950|Rifampin|rifampin
5437253|NCT00000950|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
5437254|NCT00000950|Drug Therapy, Combination|drug therapy, combination
5437255|NCT00000950|Ethambutol|ethambutol
5437256|NCT00000950|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5437257|NCT00000950|Antitubercular Agents|antitubercular agents
5437258|NCT00000949|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
5437259|NCT00000949|Interleukin-2|interleukin-2
5437260|NCT00000949|Dose-Response Relationship, Drug|dose-response relationship, drug
5437261|NCT00000949|Adolescent Behavior|adolescent behavior
5437262|NCT00000949|CD4 Lymphocyte Count|cd4 lymphocyte count
5437263|NCT00000949|RNA, Viral|rna, viral
5437264|NCT00000949|Quality of Life|quality of life
5437265|NCT00000949|Anti-HIV Agents|anti-hiv agents
5437266|NCT00000949|Viral Load|viral load
5437267|NCT00000948|Injections, Subcutaneous|injections, subcutaneous
5437268|NCT00000948|Interleukin-2|interleukin-2
5437269|NCT00000948|Dose-Response Relationship, Drug|dose-response relationship, drug
5437270|NCT00000948|Drug Therapy, Combination|drug therapy, combination
5437271|NCT00000948|CD4 Lymphocyte Count|cd4 lymphocyte count
5437272|NCT00000948|Anti-HIV Agents|anti-hiv agents
5437273|NCT00000947|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
5437274|NCT00000947|Placebos|placebos
5437275|NCT00000947|Mycobacterium avium-intracellulare Infection|mycobacterium avium-intracellulare infection
5437276|NCT00000947|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5437277|NCT00000947|Antitubercular Agents|antitubercular agents
5437278|NCT00000947|Azithromycin|azithromycin
5437279|NCT00000947|Drug Resistance, Microbial|drug resistance, microbial
5437280|NCT00000947|CD4 Lymphocyte Count|cd4 lymphocyte count
5437281|NCT00000947|Antibiotics|antibiotics
5437282|NCT00000947|Time Factors|time factors
5437283|NCT00000947|Anti-HIV Agents|anti-hiv agents
5437284|NCT00000947|Pneumonia, Bacterial|pneumonia, bacterial
5437285|NCT00000947|Streptococcus pneumoniae|streptococcus pneumoniae
5437286|NCT00000946|Drug Evaluation|drug evaluation
5437287|NCT00000946|Drug Therapy, Combination|drug therapy, combination
5437288|NCT00000946|AIDS Vaccines|aids vaccines
5437289|NCT00000946|HIV Seronegativity|hiv seronegativity
5437290|NCT00000946|HIV Preventive Vaccine|hiv preventive vaccine
5437291|NCT00000945|Leukoencephalopathy, Progressive Multifocal|leukoencephalopathy, progressive multifocal
5437292|NCT00000945|Probenecid|probenecid
5437293|NCT00000945|HIV-1|hiv-1
5437294|NCT00000945|Central Nervous System Diseases|central nervous system diseases
5437295|NCT00000945|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5437296|NCT00000945|DNA, Viral|dna, viral
5437297|NCT00000945|cidofovir|cidofovir
5437298|NCT00000945|Anti-HIV Agents|anti-hiv agents
5437299|NCT00000945|Neurologic Examination|neurologic examination
5437300|NCT00000945|Renal Agents|renal agents
5437301|NCT00000944|Pregnancy|pregnancy
5437302|NCT00000944|Pregnancy Complications, Infectious|pregnancy complications, infectious
5437303|NCT00000944|Drug Therapy, Combination|drug therapy, combination
5437304|NCT00000944|Zidovudine|zidovudine
5437305|NCT00000944|HIV Protease Inhibitors|hiv protease inhibitors
5437306|NCT00000944|Lamivudine|lamivudine
5437307|NCT00000944|Indinavir|indinavir
5437308|NCT00000944|Disease Transmission, Vertical|disease transmission, vertical
5437309|NCT00000944|Anti-HIV Agents|anti-hiv agents
5437310|NCT00000943|Lymphocytes|lymphocytes
5437311|NCT00000943|Interleukin-2|interleukin-2
5437312|NCT00000943|Drug Therapy, Combination|drug therapy, combination
5437313|NCT00000943|AIDS Vaccines|aids vaccines
5437314|NCT00000943|CD4 Lymphocyte Count|cd4 lymphocyte count
5437315|NCT00000943|Cell Division|cell division
5437316|NCT00000943|HIV Core Protein p24|hiv core protein p24
5437317|NCT00000943|Anti-HIV Agents|anti-hiv agents
5437318|NCT00000943|HIV Therapeutic Vaccine|hiv therapeutic vaccine
5437319|NCT00000942|Placebos|placebos
5437320|NCT00000942|Pregnancy|pregnancy
5437321|NCT00000942|Pregnancy Complications, Infectious|pregnancy complications, infectious
5437322|NCT00000942|Nevirapine|nevirapine
5437323|NCT00000942|Disease Transmission, Vertical|disease transmission, vertical
5437324|NCT00000942|Labor|labor
5437325|NCT00000942|Anti-HIV Agents|anti-hiv agents
5437326|NCT00000941|Drug Interactions|drug interactions
5437327|NCT00000941|HIV Protease Inhibitors|hiv protease inhibitors
5437328|NCT00000941|Ritonavir|ritonavir
5437329|NCT00000941|HIV Seronegativity|hiv seronegativity
5437330|NCT00000941|Saquinavir|saquinavir
5437331|NCT00000941|Nelfinavir|nelfinavir
5437332|NCT00000941|Anticholesteremic Agents|anticholesteremic agents
5437333|NCT00000940|Drug Therapy, Combination|drug therapy, combination
5437334|NCT00000940|Stavudine|stavudine
5437335|NCT00000940|Amprenavir/Ritonavir|amprenavir/ritonavir
5437336|NCT00000940|Protease Inhibitors|protease inhibitors
5437337|NCT00000940|Lamivudine|lamivudine
5437338|NCT00000940|VX 478|vx 478
5437339|NCT00000940|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5437340|NCT00000940|Anti-HIV Agents|anti-hiv agents
5437341|NCT00000940|Viral Load|viral load
5437342|NCT00000940|Abacavir Sulfate|abacavir sulfate
5437343|NCT00000940|Acute Infection|acute infection
5437344|NCT00000940|Treatment Interruption|treatment interruption
5437345|NCT00000939|Didanosine|didanosine
5437346|NCT00000939|Drug Therapy, Combination|drug therapy, combination
5437347|NCT00000939|Stavudine|stavudine
5437348|NCT00000939|HIV Protease Inhibitors|hiv protease inhibitors
5437349|NCT00000939|Hydroxyurea|hydroxyurea
5437350|NCT00000939|RNA, Viral|rna, viral
5437351|NCT00000939|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5437352|NCT00000939|Anti-HIV Agents|anti-hiv agents
5437353|NCT00000939|Viral Load|viral load
5437354|NCT00000939|efavirenz|efavirenz
5437355|NCT00000933|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
5437356|NCT00000933|Mycobacterium avium-intracellulare Infection|mycobacterium avium-intracellulare infection
5437357|NCT00000933|Antibiotics, Macrolide|antibiotics, macrolide
5437358|NCT00000933|Azithromycin|azithromycin
5437359|NCT00000933|Drug Administration Schedule|drug administration schedule
5437360|NCT00000933|Drug Resistance, Microbial|drug resistance, microbial
5437361|NCT00000933|Carrier State|carrier state
5437362|NCT00000933|Streptococcus pneumoniae|streptococcus pneumoniae
5437363|NCT00000932|Prospective Studies|prospective studies
5437364|NCT00000932|HIV-1|hiv-1
5437365|NCT00000932|Drug Therapy, Combination|drug therapy, combination
5437366|NCT00000932|Drug Resistance, Microbial|drug resistance, microbial
5437367|NCT00000932|CD4 Lymphocyte Count|cd4 lymphocyte count
5437368|NCT00000932|Disease Progression|disease progression
5437369|NCT00000932|Treatment Outcome|treatment outcome
5437370|NCT00000932|Genotype|genotype
5437371|NCT00000932|Anti-HIV Agents|anti-hiv agents
5437372|NCT00000932|Viral Load|viral load
5437373|NCT00000931|Homosexuality, Male|homosexuality, male
5437374|NCT00000931|Risk-Taking|risk-taking
5437375|NCT00000931|Behavior Therapy|behavior therapy
5437376|NCT00000931|HIV Seronegativity|hiv seronegativity
5437377|NCT00000930|Sexual Partners|sexual partners
5437378|NCT00000930|Drug Resistance, Microbial|drug resistance, microbial
5437379|NCT00000930|Cohort Studies|cohort studies
5437380|NCT00000930|Risk Factors|risk factors
5437381|NCT00000930|Substance Abuse, Intravenous|substance abuse, intravenous
5437382|NCT00000930|Disease Progression|disease progression
5437383|NCT00000930|Homosexuality, Male|homosexuality, male
5437384|NCT00000930|Genotype|genotype
5437385|NCT00000930|Phenotype|phenotype
5437386|NCT00000929|Sexual Partners|sexual partners
5437387|NCT00000929|Homosexuality, Male|homosexuality, male
5437388|NCT00000929|Anti-Infective Agents|anti-infective agents
5437389|NCT00000929|Patient Compliance|patient compliance
5437390|NCT00000929|Nonoxynol|nonoxynol
5437391|NCT00000929|Rectum|rectum
5437392|NCT00000928|Sexual Partners|sexual partners
5437393|NCT00000928|Condoms|condoms
5437394|NCT00000928|Counseling|counseling
5437395|NCT00000927|Administration, Topical|administration, topical
5437396|NCT00000927|Mucous Membrane|mucous membrane
5437397|NCT00000927|Anti-Infective Agents|anti-infective agents
5437398|NCT00000927|Cervix Uteri|cervix uteri
5437399|NCT00000927|Vagina|vagina
5437400|NCT00000927|Vulva|vulva
5437401|NCT00000927|Buffers|buffers
5437402|NCT00000926|Nonoxynol|nonoxynol
5437403|NCT00000925|Dietary Proteins|dietary proteins
5437404|NCT00000925|HIV Wasting Syndrome|hiv wasting syndrome
5437405|NCT00000924|Drug Therapy, Combination|drug therapy, combination
5437406|NCT00000924|HIV Protease Inhibitors|hiv protease inhibitors
5437407|NCT00000924|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5437408|NCT00000924|Anti-HIV Agents|anti-hiv agents
5437409|NCT00000923|Interleukin-2|interleukin-2
5437410|NCT00000923|Drug Therapy, Combination|drug therapy, combination
5437411|NCT00000923|CD4 Lymphocyte Count|cd4 lymphocyte count
5437412|NCT00000923|Anti-HIV Agents|anti-hiv agents
5437413|NCT00000923|Viral Load|viral load
5437414|NCT00000922|Drug Therapy, Combination|drug therapy, combination
5437415|NCT00000922|HIV Protease Inhibitors|hiv protease inhibitors
5437416|NCT00000922|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5437417|NCT00000922|Anti-HIV Agents|anti-hiv agents
5437418|NCT00000922|Treatment Naive|treatment naive
5437419|NCT00000921|Drug Therapy, Combination|drug therapy, combination
5437420|NCT00000921|Prednisone|prednisone
5437421|NCT00000921|Anti-HIV Agents|anti-hiv agents
5437422|NCT00000920|Pregnancy|pregnancy
5437423|NCT00000920|Drug Therapy, Combination|drug therapy, combination
5437424|NCT00000920|Zidovudine|zidovudine
5437425|NCT00000920|Pregnancy Complications|pregnancy complications
5437426|NCT00000920|Ritonavir|ritonavir
5437427|NCT00000920|Lamivudine|lamivudine
5437428|NCT00000920|Saquinavir|saquinavir
5437429|NCT00000920|Anti-HIV Agents|anti-hiv agents
5437430|NCT00000919|HIV Protease Inhibitors|hiv protease inhibitors
5437431|NCT00000919|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5437432|NCT00000919|Anti-HIV Agents|anti-hiv agents
5437433|NCT00000919|Viral Load|viral load
5437434|NCT00000918|Drug Therapy, Combination|drug therapy, combination
5437435|NCT00000918|HIV Protease Inhibitors|hiv protease inhibitors
5437436|NCT00000918|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5437437|NCT00000918|Salvage Therapy|salvage therapy
5437438|NCT00000918|Anti-HIV Agents|anti-hiv agents
5437439|NCT00000918|Viral Load|viral load
5437440|NCT00000917|Gene Therapy|gene therapy
5437441|NCT00000917|Specimen Handling|specimen handling
5437442|NCT00000917|Blood Banks|blood banks
5437443|NCT00000917|Fetal Blood|fetal blood
5437444|NCT00000916|Drug Therapy, Combination|drug therapy, combination
5437445|NCT00000916|HIV Protease Inhibitors|hiv protease inhibitors
5437446|NCT00000916|Hydroxyurea|hydroxyurea
5437447|NCT00000916|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5437448|NCT00000916|Anti-HIV Agents|anti-hiv agents
5437449|NCT00000916|Viral Load|viral load
5437450|NCT00000915|AIDS Vaccines|aids vaccines
5437451|NCT00000915|Incidence|incidence
5437452|NCT00000915|Knowledge, Attitudes, Practice|knowledge, attitudes, practice
5437453|NCT00000915|Risk-Taking|risk-taking
5437454|NCT00000914|Drug Therapy, Combination|drug therapy, combination
5437455|NCT00000914|HIV Protease Inhibitors|hiv protease inhibitors
5437456|NCT00000914|Ritonavir|ritonavir
5437457|NCT00000914|Indinavir|indinavir
5437458|NCT00000914|Saquinavir|saquinavir
5437459|NCT00000914|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5437460|NCT00000914|Viral Load|viral load
5437461|NCT00000914|Nelfinavir|nelfinavir
5437462|NCT00000913|Saquinavir|saquinavir
5437463|NCT00000913|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5437464|NCT00000913|Anti-HIV Agents|anti-hiv agents
5437465|NCT00000913|Viral Load|viral load
5437466|NCT00000912|Placebos|placebos
5437467|NCT00000912|Drug Therapy, Combination|drug therapy, combination
5437468|NCT00000912|HIV Protease Inhibitors|hiv protease inhibitors
5437469|NCT00000912|VX 478|vx 478
5437470|NCT00000912|Anti-HIV Agents|anti-hiv agents
5437471|NCT00000912|Viral Load|viral load
5437472|NCT00000912|efavirenz|efavirenz
5437473|NCT00000911|Semen|semen
5437474|NCT00000911|HIV-1|hiv-1
5437475|NCT00000911|Immunity, Cellular|immunity, cellular
5437476|NCT00000911|Lymph Nodes|lymph nodes
5437477|NCT00000911|Viremia|viremia
5437478|NCT00000911|Antibodies, Viral|antibodies, viral
5437479|NCT00000911|Vagina|vagina
5437480|NCT00000911|Viral Load|viral load
5437481|NCT00000911|Acute Infection|acute infection
5437482|NCT00000910|Pregnancy|pregnancy
5437483|NCT00000910|Anti-HIV Agents|anti-hiv agents
5437484|NCT00000909|Interleukin-2|interleukin-2
5437485|NCT00000909|Dose-Response Relationship, Drug|dose-response relationship, drug
5437486|NCT00000909|CD4 Lymphocyte Count|cd4 lymphocyte count
5437487|NCT00000909|RNA, Viral|rna, viral
5437488|NCT00000908|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
5437489|NCT00000908|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
5437490|NCT00000908|Antiviral Agents|antiviral agents
5437491|NCT00000908|CD4 Lymphocyte Count|cd4 lymphocyte count
5437492|NCT00000908|RNA, Viral|rna, viral
5437493|NCT00000907|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
5437494|NCT00000907|Mycobacterium avium-intracellulare Infection|mycobacterium avium-intracellulare infection
5437495|NCT00000907|Immunity, Cellular|immunity, cellular
5437496|NCT00000907|Antibiotics, Macrolide|antibiotics, macrolide
5437497|NCT00000907|Mycobacterium avium Complex|mycobacterium avium complex
5437498|NCT00000907|CD4 Lymphocyte Count|cd4 lymphocyte count
5437499|NCT00000907|Disease Progression|disease progression
5437500|NCT00000907|Anti-HIV Agents|anti-hiv agents
5437501|NCT00000906|Methadone|methadone
5437502|NCT00000906|HIV-1|hiv-1
5437503|NCT00000906|Dose-Response Relationship, Drug|dose-response relationship, drug
5437504|NCT00000906|Drug Interactions|drug interactions
5437505|NCT00000906|Drug Therapy, Combination|drug therapy, combination
5437506|NCT00000906|Saquinavir|saquinavir
5437507|NCT00000906|Adolescent Behavior|adolescent behavior
5437508|NCT00000906|HIV Protease Inhibitors|hiv protease inhibitors
5437509|NCT00000906|Ritonavir|ritonavir
5437510|NCT00000906|Narcotics|narcotics
5437511|NCT00000906|Substance-Related Disorders|substance-related disorders
5437512|NCT00000905|Immunity, Cellular|immunity, cellular
5437513|NCT00000905|Disease Progression|disease progression
5437514|NCT00000905|Cytomegalovirus Retinitis|cytomegalovirus retinitis
5437515|NCT00000905|DNA, Viral|dna, viral
5437516|NCT00000905|Prognosis|prognosis
5437517|NCT00000904|Vaccines, Synthetic|vaccines, synthetic
5437518|NCT00000904|Viral Vaccines|viral vaccines
5437519|NCT00000904|HIV Antibodies|hiv antibodies
5437520|NCT00000904|HIV Envelope Protein gp160|hiv envelope protein gp160
5437521|NCT00000904|AIDS Vaccines|aids vaccines
5437522|NCT00000904|T-Lymphocytes, Cytotoxic|t-lymphocytes, cytotoxic
5437523|NCT00000904|HIV Seronegativity|hiv seronegativity
5437524|NCT00000904|Antibody Formation|antibody formation
5437525|NCT00000904|Risk-Taking|risk-taking
5437526|NCT00000904|Avipoxvirus|avipoxvirus
5437527|NCT00000904|Genetic Vectors|genetic vectors
5437528|NCT00000904|Immunization|immunization
5437529|NCT00000904|HIV Preventive Vaccine|hiv preventive vaccine
5437530|NCT00000903|Drug Therapy, Combination|drug therapy, combination
5437531|NCT00000903|Zidovudine|zidovudine
5437532|NCT00000903|HIV Protease Inhibitors|hiv protease inhibitors
5437533|NCT00000903|Lamivudine|lamivudine
5437534|NCT00000903|Indinavir|indinavir
5437535|NCT00000903|RNA, Viral|rna, viral
5437536|NCT00000903|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5437537|NCT00000903|Nelfinavir|nelfinavir
5437538|NCT00000903|efavirenz|efavirenz
5437539|NCT00000902|Zalcitabine|zalcitabine
5437540|NCT00000902|Didanosine|didanosine
5437541|NCT00000902|Drug Therapy, Combination|drug therapy, combination
5437542|NCT00000902|Zidovudine|zidovudine
5437543|NCT00000902|Nevirapine|nevirapine
5437544|NCT00000902|Stavudine|stavudine
5437545|NCT00000902|Ritonavir|ritonavir
5437546|NCT00000902|Lamivudine|lamivudine
5437547|NCT00000902|RNA, Viral|rna, viral
5437548|NCT00000902|Anti-HIV Agents|anti-hiv agents
5437549|NCT00000902|Nelfinavir|nelfinavir
5437550|NCT00000901|Dose-Response Relationship, Drug|dose-response relationship, drug
5437551|NCT00000901|Drug Therapy, Combination|drug therapy, combination
5437552|NCT00000901|Stavudine|stavudine
5437553|NCT00000901|HIV Protease Inhibitors|hiv protease inhibitors
5437554|NCT00000901|Lamivudine|lamivudine
5437555|NCT00000901|Indinavir|indinavir
5437556|NCT00000901|RNA, Viral|rna, viral
5437557|NCT00000901|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5437558|NCT00000901|Viral Load|viral load
5437559|NCT00000900|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
5437560|NCT00000900|HIV-1|hiv-1
5437561|NCT00000900|Antiviral Agents|antiviral agents
5437562|NCT00000900|CD4 Lymphocyte Count|cd4 lymphocyte count
5437563|NCT00000900|Polymerase Chain Reaction|polymerase chain reaction
5437564|NCT00000900|RNA, Viral|rna, viral
5437565|NCT00000900|Fever|fever
5437566|NCT00000900|Viral Load|viral load
5437567|NCT00000899|Cyclophosphamide|cyclophosphamide
5437568|NCT00000899|Dose-Response Relationship, Drug|dose-response relationship, drug
5437569|NCT00000899|Drug Therapy, Combination|drug therapy, combination
5437570|NCT00000899|Granulocyte Colony-Stimulating Factor|granulocyte colony-stimulating factor
5437571|NCT00000899|Combined Modality Therapy|combined modality therapy
5437572|NCT00000899|Antineoplastic Agents|antineoplastic agents
5437573|NCT00000899|Lymph Nodes|lymph nodes
5437574|NCT00000899|Stavudine|stavudine
5437575|NCT00000899|HIV Protease Inhibitors|hiv protease inhibitors
5437576|NCT00000899|Lamivudine|lamivudine
5437577|NCT00000899|DNA, Viral|dna, viral
5437578|NCT00000899|RNA, Viral|rna, viral
5437579|NCT00000899|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5437580|NCT00000899|Anti-HIV Agents|anti-hiv agents
5437581|NCT00000899|Nelfinavir|nelfinavir
5437582|NCT00000899|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating
5437583|NCT00000898|Drug Interactions|drug interactions
5437584|NCT00000898|Drug Therapy, Combination|drug therapy, combination
5437585|NCT00000898|Saquinavir|saquinavir
5437586|NCT00000898|HIV Protease Inhibitors|hiv protease inhibitors
5437587|NCT00000898|Ritonavir|ritonavir
5437588|NCT00000898|Nelfinavir|nelfinavir
5437589|NCT00000897|Drug Interactions|drug interactions
5437590|NCT00000897|Zidovudine|zidovudine
5437591|NCT00000897|Sex Factors|sex factors
5437592|NCT00000897|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5437593|NCT00000897|Contraceptives, Oral|contraceptives, oral
5437594|NCT00000897|Progestational Hormones, Synthetic|progestational hormones, synthetic
5437595|NCT00000897|Anti-HIV Agents|anti-hiv agents
5437596|NCT00000897|Viral Load|viral load
5437597|NCT00000897|Estrogens|estrogens
5437598|NCT00000896|HIV-1|hiv-1
5437599|NCT00000896|Drug Therapy, Combination|drug therapy, combination
5437600|NCT00000896|Granulocyte Colony-Stimulating Factor|granulocyte colony-stimulating factor
5437601|NCT00000896|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5437602|NCT00000896|Zidovudine|zidovudine
5437603|NCT00000896|Nevirapine|nevirapine
5437604|NCT00000896|Stavudine|stavudine
5437605|NCT00000896|HIV Protease Inhibitors|hiv protease inhibitors
5437606|NCT00000896|Lamivudine|lamivudine
5437607|NCT00000896|Indinavir|indinavir
5437608|NCT00000896|Interleukin-12|interleukin-12
5437609|NCT00000896|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5437610|NCT00000895|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
5437611|NCT00000895|Mycobacterium avium-intracellulare Infection|mycobacterium avium-intracellulare infection
5437612|NCT00000895|HIV-1|hiv-1
5437613|NCT00000895|Drug Therapy, Combination|drug therapy, combination
5437614|NCT00000895|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5437615|NCT00000895|Mycobacterium avium Complex|mycobacterium avium complex
5437616|NCT00000895|Bacteremia|bacteremia
5437617|NCT00000895|Nevirapine|nevirapine
5437618|NCT00000895|HIV Protease Inhibitors|hiv protease inhibitors
5437619|NCT00000895|Risk Factors|risk factors
5437620|NCT00000895|RNA, Viral|rna, viral
5437621|NCT00000895|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5437622|NCT00000895|Nelfinavir|nelfinavir
5437623|NCT00000894|Infusions, Intravenous|infusions, intravenous
5437624|NCT00000894|Ganciclovir|ganciclovir
5437625|NCT00000894|Drug Therapy, Combination|drug therapy, combination
5437626|NCT00000894|Administration, Oral|administration, oral
5437627|NCT00000894|Antiviral Agents|antiviral agents
5437628|NCT00000894|Drug Implants|drug implants
5437629|NCT00000894|Cytomegalovirus Retinitis|cytomegalovirus retinitis
5437630|NCT00000894|Eye|eye
5437631|NCT00000894|cidofovir|cidofovir
5437632|NCT00000893|Dose-Response Relationship, Drug|dose-response relationship, drug
5437633|NCT00000893|Drug Therapy, Combination|drug therapy, combination
5437634|NCT00000893|HIV Protease Inhibitors|hiv protease inhibitors
5437635|NCT00000893|Nelfinavir|nelfinavir
5437636|NCT00000893|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5437637|NCT00000893|Area Under Curve|area under curve
5437638|NCT00000893|efavirenz|efavirenz
5437639|NCT00000892|HIV-1|hiv-1
5437640|NCT00000892|Drug Therapy, Combination|drug therapy, combination
5437641|NCT00000892|HIV Protease Inhibitors|hiv protease inhibitors
5437642|NCT00000892|Ritonavir|ritonavir
5437643|NCT00000892|Indinavir|indinavir
5437644|NCT00000892|RNA, Viral|rna, viral
5437645|NCT00000892|Saquinavir|saquinavir
5437646|NCT00000892|Delavirdine|delavirdine
5437647|NCT00000892|Nelfinavir|nelfinavir
5437648|NCT00000892|Adenine|adenine
5437649|NCT00000892|Anti-HIV Agents|anti-hiv agents
5437650|NCT00000892|Viral Load|viral load
5437651|NCT00000891|Drug Therapy, Combination|drug therapy, combination
5437652|NCT00000891|Hypersensitivity, Delayed|hypersensitivity, delayed
5437653|NCT00000891|Follow-Up Studies|follow-up studies
5437654|NCT00000891|Anti-HIV Agents|anti-hiv agents
5437655|NCT00000891|Viral Load|viral load
5437656|NCT00000890|HIV-1|hiv-1
5437657|NCT00000890|Muscles|muscles
5437658|NCT00000890|RNA, Viral|rna, viral
5437659|NCT00000890|Body Composition|body composition
5437660|NCT00000890|Anti-HIV Agents|anti-hiv agents
5437661|NCT00000890|Viral Load|viral load
5437662|NCT00000889|Interleukin-2|interleukin-2
5437663|NCT00000889|CD4 Lymphocyte Count|cd4 lymphocyte count
5437664|NCT00000889|Anti-HIV Agents|anti-hiv agents
5437665|NCT00000888|Pregnancy|pregnancy
5437666|NCT00000888|Pregnancy Complications, Infectious|pregnancy complications, infectious
5437667|NCT00000888|Drug Therapy, Combination|drug therapy, combination
5437668|NCT00000888|Administration, Oral|administration, oral
5437669|NCT00000888|Zidovudine|zidovudine
5437670|NCT00000888|HIV Protease Inhibitors|hiv protease inhibitors
5437671|NCT00000888|Ritonavir|ritonavir
5437672|NCT00000888|Disease Transmission, Vertical|disease transmission, vertical
5437673|NCT00000888|Anti-HIV Agents|anti-hiv agents
5437674|NCT00000888|Fetal Blood|fetal blood
5437675|NCT00000887|Pregnancy|pregnancy
5437676|NCT00000887|Pregnancy Complications, Infectious|pregnancy complications, infectious
5437677|NCT00000887|Drug Therapy, Combination|drug therapy, combination
5437678|NCT00000887|Zidovudine|zidovudine
5437679|NCT00000887|HIV Protease Inhibitors|hiv protease inhibitors
5437680|NCT00000887|Lamivudine|lamivudine
5437681|NCT00000887|Disease Transmission, Vertical|disease transmission, vertical
5437682|NCT00000887|Nelfinavir|nelfinavir
5437683|NCT00000887|Anti-HIV Agents|anti-hiv agents
5437684|NCT00000886|HIV Antibodies|hiv antibodies
5437685|NCT00000886|HIV Envelope Protein gp120|hiv envelope protein gp120
5437686|NCT00000886|Drug Carriers|drug carriers
5437687|NCT00000886|Hypersensitivity, Delayed|hypersensitivity, delayed
5437688|NCT00000886|AIDS Vaccines|aids vaccines
5437689|NCT00000886|CD4-Positive T-Lymphocytes|cd4-positive t-lymphocytes
5437690|NCT00000886|CD8-Positive T-Lymphocytes|cd8-positive t-lymphocytes
5437691|NCT00000886|HIV Seronegativity|hiv seronegativity
5437692|NCT00000886|Neutralization Tests|neutralization tests
5437693|NCT00000886|Mineral Oil|mineral oil
5437694|NCT00000886|Oleic Acids|oleic acids
5437695|NCT00000886|Mannose|mannose
5437696|NCT00000886|HLA-B7 Antigen|hla-b7 antigen
5437697|NCT00000886|HLA-A2 Antigen|hla-a2 antigen
5437698|NCT00000886|HIV Preventive Vaccine|hiv preventive vaccine
5437699|NCT00000885|HIV-1|hiv-1
5437700|NCT00000885|Drug Therapy, Combination|drug therapy, combination
5437701|NCT00000885|Zidovudine|zidovudine
5437702|NCT00000885|HIV Protease Inhibitors|hiv protease inhibitors
5437703|NCT00000885|Lamivudine|lamivudine
5437704|NCT00000885|Indinavir|indinavir
5437705|NCT00000885|RNA, Viral|rna, viral
5437706|NCT00000885|Treatment Failure|treatment failure
5437707|NCT00000885|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5437708|NCT00000885|Anti-HIV Agents|anti-hiv agents
5437709|NCT00000885|Viral Load|viral load
5437710|NCT00000884|Vaccines, Synthetic|vaccines, synthetic
5437711|NCT00000884|Injections, Intramuscular|injections, intramuscular
5437712|NCT00000884|HIV-1|hiv-1
5437713|NCT00000884|Immunity, Cellular|immunity, cellular
5437714|NCT00000884|AIDS Vaccines|aids vaccines
5437715|NCT00000884|HIV Seronegativity|hiv seronegativity
5437716|NCT00000884|Mucous Membrane|mucous membrane
5437717|NCT00000884|Antibodies, Viral|antibodies, viral
5437718|NCT00000884|Avipoxvirus|avipoxvirus
5437719|NCT00000884|Genetic Vectors|genetic vectors
5437720|NCT00000884|HIV Envelope Protein gp120|hiv envelope protein gp120
5437721|NCT00000884|Immunity, Mucosal|immunity, mucosal
5437722|NCT00000884|Rabies Vaccines|rabies vaccines
5437723|NCT00000884|HIV Preventive Vaccine|hiv preventive vaccine
5437724|NCT00000883|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
5437725|NCT00000883|Mycobacterium avium-intracellulare Infection|mycobacterium avium-intracellulare infection
5437726|NCT00000883|Antibiotics, Macrolide|antibiotics, macrolide
5437727|NCT00000883|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5437728|NCT00000883|Azithromycin|azithromycin
5437729|NCT00000883|CD4 Lymphocyte Count|cd4 lymphocyte count
5437730|NCT00000883|Anti-HIV Agents|anti-hiv agents
5437731|NCT00000882|HIV-1|hiv-1
5437732|NCT00000882|Drug Therapy, Combination|drug therapy, combination
5437733|NCT00000882|Stavudine|stavudine
5437734|NCT00000882|HIV Protease Inhibitors|hiv protease inhibitors
5437735|NCT00000882|Lamivudine|lamivudine
5437736|NCT00000882|Indinavir|indinavir
5437737|NCT00000882|RNA, Viral|rna, viral
5437738|NCT00000882|Delavirdine|delavirdine
5437739|NCT00000882|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5437740|NCT00000882|Anti-HIV Agents|anti-hiv agents
5437741|NCT00000882|Viral Load|viral load
5437742|NCT00000881|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
5437743|NCT00000881|Cytomegalovirus Infections|cytomegalovirus infections
5437744|NCT00000881|Antiviral Agents|antiviral agents
5437745|NCT00000881|cidofovir|cidofovir
5437746|NCT00000880|T-Lymphocytes|t-lymphocytes
5437747|NCT00000880|Lymphocyte Transformation|lymphocyte transformation
5437748|NCT00000880|HIV-1|hiv-1
5437749|NCT00000880|Drug Therapy, Combination|drug therapy, combination
5437750|NCT00000880|Immunosuppressive Agents|immunosuppressive agents
5437751|NCT00000880|Apoptosis|apoptosis
5437752|NCT00000880|Cyclosporine|cyclosporine
5437753|NCT00000880|Anti-HIV Agents|anti-hiv agents
5437754|NCT00000879|Pregnancy|pregnancy
5437755|NCT00000879|Pregnancy Complications, Infectious|pregnancy complications, infectious
5437756|NCT00000879|AIDS Vaccines|aids vaccines
5437757|NCT00000879|Disease Transmission, Vertical|disease transmission, vertical
5437758|NCT00000879|Avipoxvirus|avipoxvirus
5437759|NCT00000879|HIV Preventive Vaccine|hiv preventive vaccine
5437760|NCT00000879|HIV Therapeutic Vaccine|hiv therapeutic vaccine
5437761|NCT00000878|Pregnancy|pregnancy
5437762|NCT00000878|Pregnancy Complications, Infectious|pregnancy complications, infectious
5437763|NCT00000878|Drug Therapy, Combination|drug therapy, combination
5437764|NCT00000878|Stavudine|stavudine
5437765|NCT00000878|Lamivudine|lamivudine
5437766|NCT00000878|Disease Transmission, Vertical|disease transmission, vertical
5437767|NCT00000878|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5437768|NCT00000878|Anti-HIV Agents|anti-hiv agents
5437769|NCT00000878|Viral Load|viral load
5437770|NCT00000877|Rifabutin|rifabutin
5437771|NCT00000877|Drug Therapy, Combination|drug therapy, combination
5437772|NCT00000877|HIV Protease Inhibitors|hiv protease inhibitors
5437773|NCT00000877|Indinavir|indinavir
5437774|NCT00000877|HIV Seronegativity|hiv seronegativity
5437775|NCT00000877|Anti-HIV Agents|anti-hiv agents
5437776|NCT00000876|Antiviral Agents|antiviral agents
5437777|NCT00000876|CD4-IgG(2)|cd4-igg(2)
5437778|NCT00000876|PRO 542|pro 542
5437779|NCT00000875|Drug Therapy, Combination|drug therapy, combination
5437780|NCT00000875|Immunotherapy, Adoptive|immunotherapy, adoptive
5437781|NCT00000875|T-Lymphocytes, Cytotoxic|t-lymphocytes, cytotoxic
5437782|NCT00000875|Anti-HIV Agents|anti-hiv agents
5437783|NCT00000875|Viral Load|viral load
5437784|NCT00000874|HIV-1|hiv-1
5437785|NCT00000874|Drug Therapy, Combination|drug therapy, combination
5437786|NCT00000874|Zidovudine|zidovudine
5437787|NCT00000874|Stavudine|stavudine
5437788|NCT00000874|Drug Resistance, Microbial|drug resistance, microbial
5437789|NCT00000874|HIV Protease Inhibitors|hiv protease inhibitors
5437790|NCT00000874|CD4 Lymphocyte Count|cd4 lymphocyte count
5437791|NCT00000874|Ritonavir|ritonavir
5437792|NCT00000874|Lamivudine|lamivudine
5437793|NCT00000874|Indinavir|indinavir
5437794|NCT00000874|RNA, Viral|rna, viral
5437795|NCT00000874|Genotype|genotype
5437796|NCT00000874|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5437797|NCT00000874|Anti-HIV Agents|anti-hiv agents
5437798|NCT00000874|Viral Load|viral load
5437799|NCT00000873|Nutritional Status|nutritional status
5437800|NCT00000873|HIV Seronegativity|hiv seronegativity
5437801|NCT00000873|Infant Food|infant food
5437802|NCT00000872|Virus Replication|virus replication
5437803|NCT00000872|HIV-1|hiv-1
5437804|NCT00000872|Drug Therapy, Combination|drug therapy, combination
5437805|NCT00000872|Zidovudine|zidovudine
5437806|NCT00000872|Nevirapine|nevirapine
5437807|NCT00000872|Stavudine|stavudine
5437808|NCT00000872|HIV Protease Inhibitors|hiv protease inhibitors
5437809|NCT00000872|CD4 Lymphocyte Count|cd4 lymphocyte count
5437810|NCT00000872|Lamivudine|lamivudine
5437811|NCT00000872|RNA, Viral|rna, viral
5437910|NCT00000859|Anti-HIV Agents|anti-hiv agents
5437812|NCT00000872|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5437813|NCT00000872|Anti-HIV Agents|anti-hiv agents
5437814|NCT00000872|Viral Load|viral load
5437815|NCT00000872|Nelfinavir|nelfinavir
5437816|NCT00000871|Vaccines, Synthetic|vaccines, synthetic
5437817|NCT00000871|AIDS Vaccines|aids vaccines
5437818|NCT00000871|HIV Seronegativity|hiv seronegativity
5437819|NCT00000871|Avipoxvirus|avipoxvirus
5437820|NCT00000871|HIV Preventive Vaccine|hiv preventive vaccine
5437821|NCT00000870|Recombinant Proteins|recombinant proteins
5437822|NCT00000870|Infusions, Intravenous|infusions, intravenous
5437823|NCT00000870|Injections, Intravenous|injections, intravenous
5437824|NCT00000870|Injections, Subcutaneous|injections, subcutaneous
5437825|NCT00000870|Interleukin-2|interleukin-2
5437826|NCT00000870|Drug Administration Schedule|drug administration schedule
5437827|NCT00000870|CD4 Lymphocyte Count|cd4 lymphocyte count
5437828|NCT00000870|Quality of Life|quality of life
5437829|NCT00000870|Anti-HIV Agents|anti-hiv agents
5437830|NCT00000869|Pregnancy Trimester, Third|pregnancy trimester, third
5437831|NCT00000869|Placebos|placebos
5437832|NCT00000869|Pregnancy|pregnancy
5437833|NCT00000869|Pregnancy Complications, Infectious|pregnancy complications, infectious
5437834|NCT00000869|Administration, Oral|administration, oral
5437835|NCT00000869|Nevirapine|nevirapine
5437836|NCT00000869|Disease Transmission, Vertical|disease transmission, vertical
5437837|NCT00000869|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5437838|NCT00000869|Anti-HIV Agents|anti-hiv agents
5437839|NCT00000868|Vaccines, Synthetic|vaccines, synthetic
5437840|NCT00000868|HIV-1|hiv-1
5437841|NCT00000868|Administration, Oral|administration, oral
5437842|NCT00000868|AIDS Vaccines|aids vaccines
5437843|NCT00000868|HIV Seronegativity|hiv seronegativity
5437844|NCT00000868|HIV Envelope Protein gp120|hiv envelope protein gp120
5437845|NCT00000868|Recombination, Genetic|recombination, genetic
5437846|NCT00000868|Salmonella typhi|salmonella typhi
5437847|NCT00000868|HIV Preventive Vaccine|hiv preventive vaccine
5437848|NCT00000867|Drug Therapy, Combination|drug therapy, combination
5437849|NCT00000867|Administration, Oral|administration, oral
5437850|NCT00000867|AIDS Dementia Complex|aids dementia complex
5437851|NCT00000867|Zidovudine|zidovudine
5437852|NCT00000867|Anti-HIV Agents|anti-hiv agents
5437853|NCT00000867|Memantine|memantine
5437854|NCT00000866|Vaccines, Synthetic|vaccines, synthetic
5437855|NCT00000866|Vaccinia Virus|vaccinia virus
5437856|NCT00000866|Placebos|placebos
5437857|NCT00000866|HIV-1|hiv-1
5437858|NCT00000866|AIDS Vaccines|aids vaccines
5437859|NCT00000866|HIV Seronegativity|hiv seronegativity
5437860|NCT00000866|Genes, env|genes, env
5437861|NCT00000866|Genes, pol|genes, pol
5437862|NCT00000866|Genes, gag|genes, gag
5437863|NCT00000866|HIV Preventive Vaccine|hiv preventive vaccine
5437864|NCT00000865|Drug Therapy, Combination|drug therapy, combination
5437865|NCT00000865|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5437866|NCT00000865|Anti-HIV Agents|anti-hiv agents
5437867|NCT00000864|Pregnancy|pregnancy
5437868|NCT00000864|Pregnancy Complications, Infectious|pregnancy complications, infectious
5437869|NCT00000864|HIV-1|hiv-1
5437870|NCT00000864|Drug Therapy, Combination|drug therapy, combination
5437871|NCT00000864|Zidovudine|zidovudine
5437872|NCT00000864|Drug Administration Schedule|drug administration schedule
5437873|NCT00000864|Disease Transmission, Vertical|disease transmission, vertical
5437874|NCT00000864|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5437875|NCT00000864|Anti-HIV Agents|anti-hiv agents
5437876|NCT00000863|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
5437877|NCT00000863|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
5437878|NCT00000863|Administration, Oral|administration, oral
5437879|NCT00000863|WR 6026|wr 6026
5437880|NCT00000862|Pregnancy|pregnancy
5437881|NCT00000862|Pregnancy Complications, Infectious|pregnancy complications, infectious
5437882|NCT00000862|Administration, Oral|administration, oral
5437883|NCT00000862|Zidovudine|zidovudine
5437884|NCT00000862|Delivery|delivery
5437885|NCT00000862|Labor|labor
5437886|NCT00000862|Anti-HIV Agents|anti-hiv agents
5437887|NCT00000861|Drug Administration Schedule|drug administration schedule
5437888|NCT00000861|HIV Protease Inhibitors|hiv protease inhibitors
5437889|NCT00000861|CD4 Lymphocyte Count|cd4 lymphocyte count
5437890|NCT00000861|Indinavir|indinavir
5437891|NCT00000861|RNA, Viral|rna, viral
5437892|NCT00000861|Anti-HIV Agents|anti-hiv agents
5437893|NCT00000861|Viral Load|viral load
5437894|NCT00000860|Tumor Necrosis Factor|tumor necrosis factor
5437895|NCT00000860|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
5437896|NCT00000860|Mycobacterium avium-intracellulare Infection|mycobacterium avium-intracellulare infection
5437897|NCT00000860|Drug Therapy, Combination|drug therapy, combination
5437898|NCT00000860|Anti-HIV Agents|anti-hiv agents
5437899|NCT00000859|HIV-1|hiv-1
5437900|NCT00000859|Drug Resistance|drug resistance
5437901|NCT00000859|Drug Therapy, Combination|drug therapy, combination
5437902|NCT00000859|HIV Protease Inhibitors|hiv protease inhibitors
5437903|NCT00000859|CD4 Lymphocyte Count|cd4 lymphocyte count
5437904|NCT00000859|Ritonavir|ritonavir
5437905|NCT00000859|Indinavir|indinavir
5437906|NCT00000859|Disease Progression|disease progression
5437914|NCT00000857|Recombinant Proteins|recombinant proteins
5437915|NCT00000857|T-Lymphocytes|t-lymphocytes
5437916|NCT00000857|Dose-Response Relationship, Drug|dose-response relationship, drug
5437917|NCT00000857|Mycobacterium avium Complex|mycobacterium avium complex
5437918|NCT00000857|CD4 Lymphocyte Count|cd4 lymphocyte count
5437919|NCT00000857|Interleukin-12|interleukin-12
5437920|NCT00000857|Killer Cells, Natural|killer cells, natural
5437921|NCT00000857|Th1 Cells|th1 cells
5437922|NCT00000857|Interferon Type II|interferon type ii
5437923|NCT00000856|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
5437924|NCT00000856|Ganciclovir|ganciclovir
5437925|NCT00000856|Drug Therapy, Combination|drug therapy, combination
5437926|NCT00000856|Encephalitis|encephalitis
5437927|NCT00000856|Foscarnet|foscarnet
5437928|NCT00000856|Cytomegalovirus Infections|cytomegalovirus infections
5437929|NCT00000856|Antiviral Agents|antiviral agents
5437930|NCT00000856|Radiculopathy|radiculopathy
5437931|NCT00000855|Zidovudine|zidovudine
5437932|NCT00000855|Anti-HIV Agents|anti-hiv agents
5437933|NCT00000854|Placebos|placebos
5437934|NCT00000854|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5437935|NCT00000854|AIDS-Related Complex|aids-related complex
5437936|NCT00000854|Anabolic Steroids|anabolic steroids
5437937|NCT00000854|HIV Wasting Syndrome|hiv wasting syndrome
5437938|NCT00000854|nandrolone decanoate|nandrolone decanoate
5437939|NCT00000853|Vaccines, Synthetic|vaccines, synthetic
5437940|NCT00000853|HIV-1|hiv-1
5437941|NCT00000853|HIV Envelope Protein gp120|hiv envelope protein gp120
5437942|NCT00000853|AIDS Vaccines|aids vaccines
5437943|NCT00000853|HIV Seronegativity|hiv seronegativity
5437944|NCT00000853|HIV Preventive Vaccine|hiv preventive vaccine
5437945|NCT00000852|T-Lymphocytes|t-lymphocytes
5437946|NCT00000852|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5437947|NCT00000852|Transplantation, Homologous|transplantation, homologous
5437948|NCT00000852|Immunotherapy, Adoptive|immunotherapy, adoptive
5437949|NCT00000851|Didanosine|didanosine
5437950|NCT00000851|Drug Therapy, Combination|drug therapy, combination
5437951|NCT00000851|Antiviral Agents|antiviral agents
5437952|NCT00000851|Stavudine|stavudine
5437953|NCT00000850|HIV-1|hiv-1
5437954|NCT00000850|Granulocyte-Macrophage Colony-Stimulating Factor|granulocyte-macrophage colony-stimulating factor
5437955|NCT00000850|RNA, Viral|rna, viral
5437956|NCT00000850|Anti-HIV Agents|anti-hiv agents
5437957|NCT00000850|Viral Load|viral load
5437958|NCT00000850|Receptors, Chemokine|receptors, chemokine
5437959|NCT00000849|Interleukin-2|interleukin-2
5437960|NCT00000849|Immunity, Cellular|immunity, cellular
5437961|NCT00000849|Dose-Response Relationship, Drug|dose-response relationship, drug
5437962|NCT00000849|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5437963|NCT00000849|AIDS-Related Complex|aids-related complex
5437964|NCT00000849|Viral Load|viral load
5437965|NCT00000848|Administration, Oral|administration, oral
5437966|NCT00000848|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5437967|NCT00000848|AIDS-Related Complex|aids-related complex
5437968|NCT00000848|Antiviral Agents|antiviral agents
5437969|NCT00000848|HIV Protease Inhibitors|hiv protease inhibitors
5437970|NCT00000848|Biological Markers|biological markers
5437971|NCT00000848|Indinavir|indinavir
5437972|NCT00000848|Viremia|viremia
5437973|NCT00000848|RNA, Viral|rna, viral
5437974|NCT00000848|Saquinavir|saquinavir
5437975|NCT00000847|Vaccines, Synthetic|vaccines, synthetic
5437976|NCT00000847|HIV Envelope Protein gp120|hiv envelope protein gp120
5437977|NCT00000847|AIDS Vaccines|aids vaccines
5437978|NCT00000847|HIV Seronegativity|hiv seronegativity
5437979|NCT00000847|Avipoxvirus|avipoxvirus
5437980|NCT00000847|HIV Preventive Vaccine|hiv preventive vaccine
5437981|NCT00000846|Vaccines, Synthetic|vaccines, synthetic
5437982|NCT00000846|HIV-1|hiv-1
5437983|NCT00000846|AIDS Vaccines|aids vaccines
5437984|NCT00000846|HIV Seronegativity|hiv seronegativity
5437985|NCT00000846|HIV Preventive Vaccine|hiv preventive vaccine
5437986|NCT00000845|Vaccines, Synthetic|vaccines, synthetic
5437987|NCT00000845|AIDS Vaccines|aids vaccines
5437988|NCT00000845|HIV Seronegativity|hiv seronegativity
5437989|NCT00000845|HIV Preventive Vaccine|hiv preventive vaccine
5437990|NCT00000844|Drug Therapy, Combination|drug therapy, combination
5437991|NCT00000844|Adjuvants, Immunologic|adjuvants, immunologic
5437992|NCT00000844|Administration, Oral|administration, oral
5437993|NCT00000844|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5437994|NCT00000844|AIDS-Related Complex|aids-related complex
5437995|NCT00000844|Interferon-alpha|interferon-alpha
5437996|NCT00000843|Antiviral Agents|antiviral agents
5437997|NCT00000843|Adenine|adenine
5437998|NCT00000842|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5437999|NCT00000842|AIDS-Related Complex|aids-related complex
5438000|NCT00000842|Peripheral Nervous System Diseases|peripheral nervous system diseases
5438001|NCT00000842|Nerve Growth Factors|nerve growth factors
5438002|NCT00000842|Growth Substances|growth substances
5438003|NCT00000841|Drug Therapy, Combination|drug therapy, combination
5438004|NCT00000841|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5438005|NCT00000841|Antiviral Agents|antiviral agents
5438006|NCT00000841|Zidovudine|zidovudine
5438007|NCT00000841|Stavudine|stavudine
5438008|NCT00000841|HIV Protease Inhibitors|hiv protease inhibitors
5438009|NCT00000841|Lamivudine|lamivudine
5438010|NCT00000841|Indinavir|indinavir
5438011|NCT00000840|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5438012|NCT00000840|AIDS-Related Complex|aids-related complex
5438013|NCT00000840|Antiviral Agents|antiviral agents
5438014|NCT00000840|Zidovudine|zidovudine
5438015|NCT00000840|Biological Markers|biological markers
5438016|NCT00000840|Viremia|viremia
5438017|NCT00000840|RNA, Viral|rna, viral
5438018|NCT00000839|Pregnancy Trimester, Third|pregnancy trimester, third
5438019|NCT00000839|Pregnancy|pregnancy
5438020|NCT00000839|Pregnancy Complications, Infectious|pregnancy complications, infectious
5438021|NCT00000839|Didanosine|didanosine
5438022|NCT00000839|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5438023|NCT00000839|AIDS-Related Complex|aids-related complex
5438024|NCT00000838|Didanosine|didanosine
5438025|NCT00000838|Drug Therapy, Combination|drug therapy, combination
5438026|NCT00000838|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5438027|NCT00000838|AIDS-Related Complex|aids-related complex
5438028|NCT00000838|Antiviral Agents|antiviral agents
5438029|NCT00000838|Zidovudine|zidovudine
5438030|NCT00000838|Stavudine|stavudine
5438031|NCT00000838|Lamivudine|lamivudine
5438032|NCT00000837|Herpesvirus 3, Human|herpesvirus 3, human
5438033|NCT00000837|Viral Vaccines|viral vaccines
5438034|NCT00000837|AIDS-Related Complex|aids-related complex
5438035|NCT00000837|Vaccines, Attenuated|vaccines, attenuated
5438036|NCT00000837|Chickenpox|chickenpox
5438037|NCT00000837|Chickenpox Vaccine|chickenpox vaccine
5438038|NCT00000836|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
5438039|NCT00000836|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5438040|NCT00000836|Antibodies, Monoclonal|antibodies, monoclonal
5438041|NCT00000836|Cytomegalovirus Retinitis|cytomegalovirus retinitis
5438042|NCT00000834|Methotrexate|methotrexate
5438043|NCT00000834|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5438044|NCT00000834|AIDS-Related Complex|aids-related complex
5438045|NCT00000834|Zidovudine|zidovudine
5438046|NCT00000834|Lamivudine|lamivudine
5438047|NCT00000834|Disease Progression|disease progression
5438048|NCT00000834|Anti-Inflammatory Agents|anti-inflammatory agents
5438049|NCT00000834|Anti-HIV Agents|anti-hiv agents
5438050|NCT00000833|Ribavirin|ribavirin
5438051|NCT00000833|Didanosine|didanosine
5438052|NCT00000833|Drug Therapy, Combination|drug therapy, combination
5438053|NCT00000833|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5438054|NCT00000833|AIDS-Related Complex|aids-related complex
5438055|NCT00000833|Antiviral Agents|antiviral agents
5438056|NCT00000832|Vaccines, Synthetic|vaccines, synthetic
5438057|NCT00000832|HIV-1|hiv-1
5438058|NCT00000832|Adjuvants, Immunologic|adjuvants, immunologic
5438059|NCT00000832|HIV Envelope Protein gp120|hiv envelope protein gp120
5438060|NCT00000832|AIDS Vaccines|aids vaccines
5438061|NCT00000832|HIV Seronegativity|hiv seronegativity
5438062|NCT00000832|HIV Preventive Vaccine|hiv preventive vaccine
5438063|NCT00000831|Didanosine|didanosine
5438064|NCT00000831|Drug Therapy, Combination|drug therapy, combination
5438065|NCT00000831|AIDS-Related Complex|aids-related complex
5438066|NCT00000831|Antiviral Agents|antiviral agents
5438067|NCT00000831|Zidovudine|zidovudine
5438068|NCT00000831|Stavudine|stavudine
5438069|NCT00000831|Lamivudine|lamivudine
5438070|NCT00000831|Drug Combinations|drug combinations
5438071|NCT00000829|Vaccines, Synthetic|vaccines, synthetic
5438072|NCT00000829|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5438073|NCT00000829|AIDS-Related Complex|aids-related complex
5438074|NCT00000829|Pneumococcal Infections|pneumococcal infections
5438075|NCT00000829|Bacterial Vaccines|bacterial vaccines
5438076|NCT00000828|Pregnancy|pregnancy
5438077|NCT00000828|Pregnancy Complications, Infectious|pregnancy complications, infectious
5438078|NCT00000828|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5438079|NCT00000828|AIDS-Related Complex|aids-related complex
5438080|NCT00000828|Zidovudine|zidovudine
5438081|NCT00000828|Drug Resistance, Microbial|drug resistance, microbial
5438082|NCT00000828|Disease Transmission, Vertical|disease transmission, vertical
5438083|NCT00000827|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5438084|NCT00000827|AIDS-Related Complex|aids-related complex
5438085|NCT00000827|Immunoglobulins, Intravenous|immunoglobulins, intravenous
5438086|NCT00000827|Immunization, Passive|immunization, passive
5438087|NCT00000826|Rifabutin|rifabutin
5438088|NCT00000826|Trimethoprim-Sulfamethoxazole Combination|trimethoprim-sulfamethoxazole combination
5438089|NCT00000826|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
5438090|NCT00000826|Dapsone|dapsone
5438091|NCT00000826|Drug Interactions|drug interactions
5438092|NCT00000826|Fluconazole|fluconazole
5438093|NCT00000826|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5438094|NCT00000826|AIDS-Related Complex|aids-related complex
5438095|NCT00000826|Clarithromycin|clarithromycin
5438096|NCT00000826|Sulfamethoxazole-Trimethoprim|sulfamethoxazole-trimethoprim
5438097|NCT00000825|HIV-1|hiv-1
5438098|NCT00000825|Interleukin-2|interleukin-2
5438099|NCT00000825|Dose-Response Relationship, Drug|dose-response relationship, drug
5438100|NCT00000825|Antiviral Agents|antiviral agents
5438101|NCT00000825|CD4 Lymphocyte Count|cd4 lymphocyte count
5438102|NCT00000825|DNA, Viral|dna, viral
5438103|NCT00000824|Immunotherapy, Adoptive|immunotherapy, adoptive
5438104|NCT00000824|T-Lymphocyte Subsets|t-lymphocyte subsets
5438105|NCT00000824|T-Lymphocytes, Cytotoxic|t-lymphocytes, cytotoxic
5438106|NCT00000824|Dendritic Cells|dendritic cells
5438107|NCT00000823|Didanosine|didanosine
5438108|NCT00000823|Drug Therapy, Combination|drug therapy, combination
5438109|NCT00000823|Zidovudine|zidovudine
5438110|NCT00000823|Drug Administration Schedule|drug administration schedule
5438111|NCT00000822|Vaccines, Synthetic|vaccines, synthetic
5438112|NCT00000822|Didanosine|didanosine
5438113|NCT00000822|Drug Therapy, Combination|drug therapy, combination
5438114|NCT00000822|HIV Envelope Protein gp160|hiv envelope protein gp160
5438115|NCT00000822|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5438116|NCT00000822|AIDS-Related Complex|aids-related complex
5438117|NCT00000822|Stavudine|stavudine
5438118|NCT00000822|HIV Protease Inhibitors|hiv protease inhibitors
5438119|NCT00000822|AIDS Vaccines|aids vaccines
5438120|NCT00000822|Ritonavir|ritonavir
5438121|NCT00000822|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5438122|NCT00000822|HIV Therapeutic Vaccine|hiv therapeutic vaccine
5438123|NCT00000821|Interleukin-2|interleukin-2
5438124|NCT00000821|AIDS-Related Complex|aids-related complex
5438125|NCT00000820|Interleukin-2|interleukin-2
5438126|NCT00000820|Drug Therapy, Combination|drug therapy, combination
5438127|NCT00000820|AIDS-Related Complex|aids-related complex
5438128|NCT00000820|Antiviral Agents|antiviral agents
5438129|NCT00000819|AIDS-Related Complex|aids-related complex
5438130|NCT00000819|Prednisone|prednisone
5438131|NCT00000819|AIDS-Associated Nephropathy|aids-associated nephropathy
5438132|NCT00000818|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5438133|NCT00000818|AIDS-Related Complex|aids-related complex
5438134|NCT00000818|Zidovudine|zidovudine
5438135|NCT00000818|Lymph Nodes|lymph nodes
5438136|NCT00000818|Lymphoid Tissue|lymphoid tissue
5438137|NCT00000817|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5438138|NCT00000817|AIDS-Related Complex|aids-related complex
5438139|NCT00000817|Peripheral Nervous System Diseases|peripheral nervous system diseases
5438140|NCT00000817|Amitriptyline|amitriptyline
5438141|NCT00000817|Pain|pain
5438142|NCT00000817|Acupuncture Therapy|acupuncture therapy
5438143|NCT00000816|Trimethoprim-Sulfamethoxazole Combination|trimethoprim-sulfamethoxazole combination
5438144|NCT00000816|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
5438145|NCT00000816|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5438146|NCT00000816|AIDS-Related Complex|aids-related complex
5438147|NCT00000816|Sulfamethoxazole-Trimethoprim|sulfamethoxazole-trimethoprim
5438148|NCT00000815|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5438149|NCT00000815|AIDS-Related Complex|aids-related complex
5438150|NCT00000815|Measles-Mumps-Rubella Vaccine|measles-mumps-rubella vaccine
5438151|NCT00000815|Vaccines, Attenuated|vaccines, attenuated
5438152|NCT00000815|Measles Vaccine|measles vaccine
5438153|NCT00000815|Immunization Schedule|immunization schedule
5438154|NCT00000815|Measles Virus|measles virus
5438155|NCT00000815|Measles|measles
5438156|NCT00000814|Didanosine|didanosine
5438157|NCT00000814|Drug Therapy, Combination|drug therapy, combination
5438158|NCT00000814|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5438159|NCT00000814|AIDS-Related Complex|aids-related complex
5438160|NCT00000814|Zidovudine|zidovudine
5438161|NCT00000814|Nevirapine|nevirapine
5438162|NCT00000813|Vaccines, Synthetic|vaccines, synthetic
5438163|NCT00000813|HIV Envelope Protein gp160|hiv envelope protein gp160
5438164|NCT00000813|HIV Envelope Protein gp120|hiv envelope protein gp120
5438165|NCT00000813|AIDS Vaccines|aids vaccines
5438166|NCT00000813|HIV Seronegativity|hiv seronegativity
5438167|NCT00000813|Avipoxvirus|avipoxvirus
5438168|NCT00000813|HIV Preventive Vaccine|hiv preventive vaccine
5438169|NCT00000812|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5438170|NCT00000812|AIDS-Related Complex|aids-related complex
5438171|NCT00000812|Thalidomide|thalidomide
5438172|NCT00000811|Trimethoprim-Sulfamethoxazole Combination|trimethoprim-sulfamethoxazole combination
5438173|NCT00000811|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
5438174|NCT00000811|Drug Therapy, Combination|drug therapy, combination
5438175|NCT00000811|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5438176|NCT00000811|Antiprotozoal Agents|antiprotozoal agents
5438177|NCT00000811|AIDS-Related Complex|aids-related complex
5438178|NCT00000811|Azithromycin|azithromycin
5438179|NCT00000811|Bacterial Infections|bacterial infections
5438180|NCT00000811|atovaquone|atovaquone
5438181|NCT00000810|Didanosine|didanosine
5438182|NCT00000810|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5438183|NCT00000810|AIDS-Related Complex|aids-related complex
5438184|NCT00000810|Antiviral Agents|antiviral agents
5438185|NCT00000810|Zidovudine|zidovudine
5438186|NCT00000809|HIV Preventive Vaccine|hiv preventive vaccine
5438187|NCT00000809|HIV Therapeutic Vaccine|hiv therapeutic vaccine
5438188|NCT00000808|Pregnancy|pregnancy
5438189|NCT00000808|Pregnancy Complications, Infectious|pregnancy complications, infectious
5444281|NCT00001643|Mutation|mutation
5438190|NCT00000808|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5438191|NCT00000808|AIDS-Related Complex|aids-related complex
5438192|NCT00000808|Nevirapine|nevirapine
5438193|NCT00000807|Sarcoma, Kaposi|sarcoma, kaposi
5438194|NCT00000807|Etoposide|etoposide
5438195|NCT00000807|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5438196|NCT00000806|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5438197|NCT00000806|AIDS-Related Complex|aids-related complex
5438198|NCT00000806|HIV Protease Inhibitors|hiv protease inhibitors
5438199|NCT00000805|Ganciclovir|ganciclovir
5438200|NCT00000805|Cytomegalovirus Infections|cytomegalovirus infections
5438201|NCT00000805|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5438202|NCT00000803|Didanosine|didanosine
5438203|NCT00000803|Drug Therapy, Combination|drug therapy, combination
5438204|NCT00000803|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5438205|NCT00000803|AIDS-Related Complex|aids-related complex
5438206|NCT00000803|Antiviral Agents|antiviral agents
5438207|NCT00000803|Zidovudine|zidovudine
5438208|NCT00000802|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
5438209|NCT00000802|Dapsone|dapsone
5438210|NCT00000802|Antifungal Agents|antifungal agents
5438211|NCT00000802|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5438212|NCT00000802|atovaquone|atovaquone
5438213|NCT00000801|Vincristine|vincristine
5438214|NCT00000801|Cyclophosphamide|cyclophosphamide
5438215|NCT00000801|Cytarabine|cytarabine
5438216|NCT00000801|Dexamethasone|dexamethasone
5438217|NCT00000801|Doxorubicin|doxorubicin
5438218|NCT00000801|Granulocyte Colony-Stimulating Factor|granulocyte colony-stimulating factor
5438219|NCT00000801|Combined Modality Therapy|combined modality therapy
5438220|NCT00000801|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5438221|NCT00000801|Antineoplastic Agents, Combined|antineoplastic agents, combined
5438222|NCT00000801|Brain Neoplasms|brain neoplasms
5438223|NCT00000801|Lymphoma, High-Grade|lymphoma, high-grade
5438224|NCT00000801|Lymphoma, Intermediate-Grade|lymphoma, intermediate-grade
5438225|NCT00000800|Methadone|methadone
5438226|NCT00000800|Drug Interactions|drug interactions
5438227|NCT00000800|Drug Therapy, Combination|drug therapy, combination
5438228|NCT00000800|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5438229|NCT00000800|AIDS-Related Complex|aids-related complex
5438230|NCT00000800|Zidovudine|zidovudine
5438231|NCT00000799|Retinitis|retinitis
5438232|NCT00000799|Cytomegalovirus Infections|cytomegalovirus infections
5438233|NCT00000799|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5438234|NCT00000799|Antiviral Agents|antiviral agents
5438235|NCT00000799|cidofovir|cidofovir
5438236|NCT00000798|Vaccines, Synthetic|vaccines, synthetic
5438237|NCT00000798|HIV-1|hiv-1
5438238|NCT00000798|Administration, Oral|administration, oral
5438239|NCT00000798|AIDS Vaccines|aids vaccines
5438240|NCT00000798|HIV Seronegativity|hiv seronegativity
5438241|NCT00000798|HIV Preventive Vaccine|hiv preventive vaccine
5438242|NCT00000796|Isoniazid|isoniazid
5438243|NCT00000796|Tuberculosis, Pulmonary|tuberculosis, pulmonary
5438244|NCT00000796|Pyrazinamide|pyrazinamide
5438245|NCT00000796|Pyridoxine|pyridoxine
5438246|NCT00000796|Ofloxacin|ofloxacin
5438247|NCT00000796|Rifampin|rifampin
5438248|NCT00000796|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
5438249|NCT00000796|Drug Therapy, Combination|drug therapy, combination
5438250|NCT00000796|Ethambutol|ethambutol
5438251|NCT00000796|Clofazimine|clofazimine
5438252|NCT00000796|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5438253|NCT00000796|Amikacin|amikacin
5438254|NCT00000796|Drug Resistance, Microbial|drug resistance, microbial
5438255|NCT00000796|Cycloserine|cycloserine
5438256|NCT00000796|Capreomycin Sulfate|capreomycin sulfate
5438257|NCT00000796|Ethionamide|ethionamide
5438258|NCT00000796|Aminosalicylic Acids|aminosalicylic acids
5438259|NCT00000796|Streptomycin|streptomycin
5438260|NCT00000796|p-Aminosalicylic Acid|p-aminosalicylic acid
5438261|NCT00000795|Vaccines, Synthetic|vaccines, synthetic
5438262|NCT00000795|HIV-1|hiv-1
5438263|NCT00000795|AIDS Vaccines|aids vaccines
5438264|NCT00000795|HIV Seronegativity|hiv seronegativity
5438265|NCT00000795|HIV Preventive Vaccine|hiv preventive vaccine
5438266|NCT00000794|Pyrimethamine|pyrimethamine
5438267|NCT00000794|Leucovorin|leucovorin
5438268|NCT00000794|Drug Therapy, Combination|drug therapy, combination
5438269|NCT00000794|Encephalitis|encephalitis
5438270|NCT00000794|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5438271|NCT00000794|Antiprotozoal Agents|antiprotozoal agents
5438272|NCT00000794|Clarithromycin|clarithromycin
5438273|NCT00000794|atovaquone|atovaquone
5438274|NCT00000794|Toxoplasmosis, Cerebral|toxoplasmosis, cerebral
5438275|NCT00000794|Sulfadiazine|sulfadiazine
5438276|NCT00000793|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5438277|NCT00000793|AIDS-Related Complex|aids-related complex
5438278|NCT00000793|Peripheral Nervous System Diseases|peripheral nervous system diseases
5438279|NCT00000793|Amitriptyline|amitriptyline
5438280|NCT00000793|Pain|pain
5438281|NCT00000793|Mexiletine|mexiletine
5438282|NCT00000793|benzatropine methanesulfonate|benzatropine methanesulfonate
5438283|NCT00000793|Parasympatholytics|parasympatholytics
5438284|NCT00000792|Administration, Oral|administration, oral
5438285|NCT00000792|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5438286|NCT00000792|AIDS-Related Complex|aids-related complex
5438287|NCT00000792|Antiviral Agents|antiviral agents
5438288|NCT00000791|Drug Therapy, Combination|drug therapy, combination
5438289|NCT00000791|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5438290|NCT00000791|AIDS-Related Complex|aids-related complex
5438291|NCT00000791|Antiviral Agents|antiviral agents
5438292|NCT00000791|Zidovudine|zidovudine
5438293|NCT00000790|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5438294|NCT00000790|AIDS-Related Complex|aids-related complex
5438295|NCT00000790|Thalidomide|thalidomide
5438296|NCT00000790|Stomatitis, Aphthous|stomatitis, aphthous
5438297|NCT00000789|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5438298|NCT00000789|AIDS-Related Complex|aids-related complex
5438299|NCT00000789|Zidovudine|zidovudine
5438300|NCT00000789|Stavudine|stavudine
5438301|NCT00000788|Methadone|methadone
5438302|NCT00000788|Drug Interactions|drug interactions
5438303|NCT00000788|Drug Therapy, Combination|drug therapy, combination
5438304|NCT00000788|Fluconazole|fluconazole
5438305|NCT00000788|Antifungal Agents|antifungal agents
5438306|NCT00000788|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5438307|NCT00000788|AIDS-Related Complex|aids-related complex
5438308|NCT00000787|Sex Behavior|sex behavior
5438309|NCT00000785|Tuberculosis|tuberculosis
5438310|NCT00000785|Mycobacterium tuberculosis|mycobacterium tuberculosis
5438311|NCT00000785|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
5438312|NCT00000785|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5438313|NCT00000785|Drug Resistance, Microbial|drug resistance, microbial
5438314|NCT00000784|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5438315|NCT00000784|AIDS-Related Complex|aids-related complex
5438316|NCT00000783|Sex Behavior|sex behavior
5438317|NCT00000783|Sexual Partners|sexual partners
5438318|NCT00000782|Vaccines, Synthetic|vaccines, synthetic
5438319|NCT00000782|Injections, Intradermal|injections, intradermal
5438320|NCT00000782|HIV Antigens|hiv antigens
5438321|NCT00000782|HIV-1|hiv-1
5438322|NCT00000782|HIV Envelope Protein gp160|hiv envelope protein gp160
5438323|NCT00000782|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5438324|NCT00000782|AIDS-Related Complex|aids-related complex
5438325|NCT00000782|Hypersensitivity, Delayed|hypersensitivity, delayed
5438326|NCT00000782|AIDS Vaccines|aids vaccines
5438327|NCT00000782|HIV Therapeutic Vaccine|hiv therapeutic vaccine
5438328|NCT00000781|Zalcitabine|zalcitabine
5438329|NCT00000781|Didanosine|didanosine
5438330|NCT00000781|Drug Therapy, Combination|drug therapy, combination
5438331|NCT00000781|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5438332|NCT00000781|Zidovudine|zidovudine
5438333|NCT00000781|Nevirapine|nevirapine
5438334|NCT00000780|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5438335|NCT00000780|AIDS-Related Complex|aids-related complex
5438336|NCT00000780|Adolescent Behavior|adolescent behavior
5438337|NCT00000779|Vaccines, Synthetic|vaccines, synthetic
5438338|NCT00000779|HIV-1|hiv-1
5438339|NCT00000779|Adjuvants, Immunologic|adjuvants, immunologic
5438340|NCT00000779|AIDS-Related Complex|aids-related complex
5438341|NCT00000779|HIV Envelope Protein gp120|hiv envelope protein gp120
5438342|NCT00000779|AIDS Vaccines|aids vaccines
5438343|NCT00000779|HIV Therapeutic Vaccine|hiv therapeutic vaccine
5438344|NCT00000778|Isoniazid|isoniazid
5438345|NCT00000778|Tuberculosis, Pulmonary|tuberculosis, pulmonary
5438346|NCT00000778|Pyridoxine|pyridoxine
5438347|NCT00000778|Ofloxacin|ofloxacin
5438348|NCT00000778|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
5438349|NCT00000778|Drug Evaluation|drug evaluation
5438350|NCT00000778|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5438351|NCT00000778|Sputum|sputum
5438352|NCT00000778|Colony Count, Microbial|colony count, microbial
5438353|NCT00000777|Vaccines, Synthetic|vaccines, synthetic
5438354|NCT00000777|Pregnancy|pregnancy
5438355|NCT00000777|Pregnancy Complications, Infectious|pregnancy complications, infectious
5438356|NCT00000777|HIV Envelope Protein gp160|hiv envelope protein gp160
5438357|NCT00000777|AIDS Vaccines|aids vaccines
5438358|NCT00000777|HIV Preventive Vaccine|hiv preventive vaccine
5438359|NCT00000777|HIV Therapeutic Vaccine|hiv therapeutic vaccine
5438360|NCT00000776|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
5438361|NCT00000776|Meningitis|meningitis
5438362|NCT00000776|Cryptococcosis|cryptococcosis
5438363|NCT00000776|Dexamethasone|dexamethasone
5438364|NCT00000776|Drug Therapy, Combination|drug therapy, combination
5438365|NCT00000776|Fluconazole|fluconazole
5438366|NCT00000776|Flucytosine|flucytosine
5438367|NCT00000776|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5438368|NCT00000776|Amphotericin B|amphotericin b
5438369|NCT00000776|Brain Diseases|brain diseases
5438370|NCT00000775|Vaccines, Synthetic|vaccines, synthetic
5438371|NCT00000775|HIV-1|hiv-1
5438372|NCT00000775|HIV Envelope Protein gp120|hiv envelope protein gp120
5438373|NCT00000775|AIDS Vaccines|aids vaccines
5438374|NCT00000775|HIV Seronegativity|hiv seronegativity
5438375|NCT00000775|HIV Preventive Vaccine|hiv preventive vaccine
5438376|NCT00000774|Vaccines, Synthetic|vaccines, synthetic
5438377|NCT00000774|Virus Replication|virus replication
5438378|NCT00000774|HIV Envelope Protein gp120|hiv envelope protein gp120
5438379|NCT00000774|AIDS Vaccines|aids vaccines
5438380|NCT00000774|HIV Preventive Vaccine|hiv preventive vaccine
5438381|NCT00000774|HIV Therapeutic Vaccine|hiv therapeutic vaccine
5438382|NCT00000773|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
5438383|NCT00000773|Antifungal Agents|antifungal agents
5438384|NCT00000773|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5438385|NCT00000773|AIDS-Related Complex|aids-related complex
5438386|NCT00000773|Biological Availability|biological availability
5438387|NCT00000773|atovaquone|atovaquone
5438388|NCT00000772|Ribavirin|ribavirin
5438389|NCT00000772|Didanosine|didanosine
5438390|NCT00000772|Drug Therapy, Combination|drug therapy, combination
5438391|NCT00000772|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5438392|NCT00000772|AIDS-Related Complex|aids-related complex
5438393|NCT00000771|Cryptosporidiosis|cryptosporidiosis
5438394|NCT00000771|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5438395|NCT00000771|Paromomycin|paromomycin
5438396|NCT00000770|Didanosine|didanosine
5438397|NCT00000770|Drug Therapy, Combination|drug therapy, combination
5438398|NCT00000770|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5438399|NCT00000770|AIDS-Related Complex|aids-related complex
5438400|NCT00000770|Zidovudine|zidovudine
5438401|NCT00000770|Nevirapine|nevirapine
5438402|NCT00000769|Sarcoma, Kaposi|sarcoma, kaposi
5438403|NCT00000769|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5438404|NCT00000769|Interleukin-4|interleukin-4
5438405|NCT00000768|Intestinal Absorption|intestinal absorption
5438406|NCT00000768|Ganciclovir|ganciclovir
5438407|NCT00000768|Drug Therapy, Combination|drug therapy, combination
5438408|NCT00000768|Cytomegalovirus Infections|cytomegalovirus infections
5438409|NCT00000768|Colitis|colitis
5438410|NCT00000768|Administration, Oral|administration, oral
5438411|NCT00000768|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5438412|NCT00000768|Biological Availability|biological availability
5438413|NCT00000768|Glutamic Acid|glutamic acid
5438414|NCT00000767|Vaccines, Synthetic|vaccines, synthetic
5438415|NCT00000767|Vaccinia Virus|vaccinia virus
5438416|NCT00000767|Viral Vaccines|viral vaccines
5438417|NCT00000767|Smallpox Vaccine|smallpox vaccine
5438418|NCT00000767|HIV-1|hiv-1
5438419|NCT00000767|AIDS Vaccines|aids vaccines
5438420|NCT00000767|HIV Seronegativity|hiv seronegativity
5438421|NCT00000767|HIV Preventive Vaccine|hiv preventive vaccine
5438422|NCT00000766|Retinitis|retinitis
5438423|NCT00000766|Ganciclovir|ganciclovir
5438424|NCT00000766|Foscarnet|foscarnet
5438425|NCT00000766|Cytomegalovirus Infections|cytomegalovirus infections
5438426|NCT00000766|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5438427|NCT00000765|Zidovudine|zidovudine
5438428|NCT00000764|Interferon Alfa-2a|interferon alfa-2a
5438429|NCT00000764|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5438430|NCT00000764|AIDS-Related Complex|aids-related complex
5438431|NCT00000764|Anus Neoplasms|anus neoplasms
5438432|NCT00000764|Papillomavirus, Human|papillomavirus, human
5438433|NCT00000764|Papovaviridae Infections|papovaviridae infections
5438434|NCT00000764|Tumor Virus Infections|tumor virus infections
5438435|NCT00000764|Isotretinoin|isotretinoin
5438436|NCT00000763|Sarcoma, Kaposi|sarcoma, kaposi
5438437|NCT00000763|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5438438|NCT00000763|Antineoplastic Agents|antineoplastic agents
5438439|NCT00000762|Vaccines, Synthetic|vaccines, synthetic
5438440|NCT00000762|HIV Envelope Protein gp160|hiv envelope protein gp160
5438441|NCT00000762|HIV Envelope Protein gp120|hiv envelope protein gp120
5438442|NCT00000762|AIDS Vaccines|aids vaccines
5438443|NCT00000762|HIV Therapeutic Vaccine|hiv therapeutic vaccine
5438444|NCT00000761|Interferon-gamma, Recombinant|interferon-gamma, recombinant
5438445|NCT00000761|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5438446|NCT00000761|AIDS-Related Complex|aids-related complex
5438447|NCT00000760|Didanosine|didanosine
5438448|NCT00000760|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5438449|NCT00000760|AIDS-Related Complex|aids-related complex
5438450|NCT00000760|Antiviral Agents|antiviral agents
5438451|NCT00000760|Zidovudine|zidovudine
5438452|NCT00000760|Gene Products, tat|gene products, tat
5438453|NCT00000759|Central Nervous System Diseases|central nervous system diseases
5438454|NCT00000759|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5438455|NCT00000759|AIDS-Related Complex|aids-related complex
5438456|NCT00000759|Peripheral Nervous System Diseases|peripheral nervous system diseases
5438457|NCT00000758|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5438458|NCT00000758|AIDS-Related Complex|aids-related complex
5438459|NCT00000758|Fluorouracil|fluorouracil
5438460|NCT00000758|Cervix Dysplasia|cervix dysplasia
5438461|NCT00000758|Cervix Diseases|cervix diseases
5438462|NCT00000757|Vaccines, Synthetic|vaccines, synthetic
5438463|NCT00000757|Vaccinia Virus|vaccinia virus
5438464|NCT00000757|HIV-1|hiv-1
5438465|NCT00000757|HIV Envelope Protein gp160|hiv envelope protein gp160
5438466|NCT00000757|AIDS Vaccines|aids vaccines
5438467|NCT00000757|HIV Seronegativity|hiv seronegativity
5438468|NCT00000757|HIV Preventive Vaccine|hiv preventive vaccine
5438469|NCT00000756|T-Lymphocytes|t-lymphocytes
5438470|NCT00000756|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5438471|NCT00000756|AIDS-Related Complex|aids-related complex
5438472|NCT00000756|Immunotherapy, Adoptive|immunotherapy, adoptive
5438473|NCT00000756|Transplantation, Autologous|transplantation, autologous
5438474|NCT00000755|Vaccines, Synthetic|vaccines, synthetic
5438475|NCT00000755|HIV-1|hiv-1
5438476|NCT00000755|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5438477|NCT00000755|AIDS-Related Complex|aids-related complex
5438478|NCT00000755|Zidovudine|zidovudine
5438479|NCT00000755|HIV Envelope Protein gp120|hiv envelope protein gp120
5438480|NCT00000755|AIDS Vaccines|aids vaccines
5438481|NCT00000755|HIV Therapeutic Vaccine|hiv therapeutic vaccine
5438482|NCT00000754|Zalcitabine|zalcitabine
5438483|NCT00000754|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5438484|NCT00000754|AIDS-Related Complex|aids-related complex
5438485|NCT00000754|Zidovudine|zidovudine
5438486|NCT00000754|Interferon-alpha|interferon-alpha
5438487|NCT00000753|Zalcitabine|zalcitabine
5438488|NCT00000753|Didanosine|didanosine
5438489|NCT00000753|Drug Therapy, Combination|drug therapy, combination
5438490|NCT00000753|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5438491|NCT00000753|AIDS-Related Complex|aids-related complex
5438492|NCT00000753|Antiviral Agents|antiviral agents
5438493|NCT00000753|Zidovudine|zidovudine
5438494|NCT00000752|Drug Therapy, Combination|drug therapy, combination
5438495|NCT00000752|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5438496|NCT00000752|AIDS-Related Complex|aids-related complex
5438497|NCT00000752|cefuroxime axetil|cefuroxime axetil
5438498|NCT00000752|Beclomethasone|beclomethasone
5438499|NCT00000752|Guaiacol Glyceryl Ether|guaiacol glyceryl ether
5438500|NCT00000752|Sinusitis|sinusitis
5438501|NCT00000752|Ephedrine|ephedrine
5438502|NCT00000751|Pregnancy|pregnancy
5438503|NCT00000751|Pregnancy Complications, Infectious|pregnancy complications, infectious
5438504|NCT00000751|Drug Therapy, Combination|drug therapy, combination
5438505|NCT00000751|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5438506|NCT00000751|AIDS-Related Complex|aids-related complex
5438507|NCT00000751|Zidovudine|zidovudine
5438508|NCT00000751|Immunoglobulins, Intravenous|immunoglobulins, intravenous
5438509|NCT00000751|Immunization, Passive|immunization, passive
5438510|NCT00000750|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5438511|NCT00000750|AIDS-Related Complex|aids-related complex
5438512|NCT00000750|Zidovudine|zidovudine
5438513|NCT00000749|Vaccines, Synthetic|vaccines, synthetic
5438514|NCT00000749|HIV Envelope Protein gp120|hiv envelope protein gp120
5438515|NCT00000749|AIDS Vaccines|aids vaccines
5438516|NCT00000749|HIV Seronegativity|hiv seronegativity
5438517|NCT00000749|HIV Preventive Vaccine|hiv preventive vaccine
5438518|NCT00000748|Trimethoprim-Sulfamethoxazole Combination|trimethoprim-sulfamethoxazole combination
5438519|NCT00000748|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
5438520|NCT00000748|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5438521|NCT00000748|AIDS-Related Complex|aids-related complex
5438522|NCT00000748|Sulfamethoxazole-Trimethoprim|sulfamethoxazole-trimethoprim
5438523|NCT00000747|Drug Resistance|drug resistance
5438524|NCT00000747|AIDS-Related Complex|aids-related complex
5438525|NCT00000747|Antiviral Agents|antiviral agents
5438526|NCT00000747|Nevirapine|nevirapine
5438527|NCT00000746|Vaccines, Synthetic|vaccines, synthetic
5438528|NCT00000746|Vaccinia Virus|vaccinia virus
5438529|NCT00000746|Viral Vaccines|viral vaccines
5438530|NCT00000746|HIV-1|hiv-1
5438531|NCT00000746|HIV Envelope Protein gp160|hiv envelope protein gp160
5438532|NCT00000746|HIV Envelope Protein gp120|hiv envelope protein gp120
5438533|NCT00000746|AIDS Vaccines|aids vaccines
5438534|NCT00000746|HIV Seronegativity|hiv seronegativity
5438535|NCT00000746|HIV Preventive Vaccine|hiv preventive vaccine
5438536|NCT00000745|Vaccines, Synthetic|vaccines, synthetic
5438537|NCT00000745|Vaccinia Virus|vaccinia virus
5438538|NCT00000745|Viral Vaccines|viral vaccines
5438539|NCT00000745|HIV-1|hiv-1
5438540|NCT00000745|HIV Envelope Protein gp160|hiv envelope protein gp160
5438541|NCT00000745|AIDS Vaccines|aids vaccines
5438542|NCT00000745|HIV Seronegativity|hiv seronegativity
5438543|NCT00000745|HIV Preventive Vaccine|hiv preventive vaccine
5438544|NCT00000744|Fluconazole|fluconazole
5438545|NCT00000744|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5438546|NCT00000744|AIDS-Related Complex|aids-related complex
5438547|NCT00000744|Candidiasis|candidiasis
5438548|NCT00000743|Recombinant Proteins|recombinant proteins
5438549|NCT00000743|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5438550|NCT00000743|Antigens, CD4|antigens, cd4
5438551|NCT00000743|AIDS-Related Complex|aids-related complex
5438552|NCT00000743|Zidovudine|zidovudine
5438553|NCT00000742|Didanosine|didanosine
5438554|NCT00000742|Drug Therapy, Combination|drug therapy, combination
5438555|NCT00000742|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5438556|NCT00000742|AIDS-Related Complex|aids-related complex
5438557|NCT00000742|Antiviral Agents|antiviral agents
5438558|NCT00000742|Zidovudine|zidovudine
5438559|NCT00000741|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
5438560|NCT00000741|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5438561|NCT00000741|Methylprednisolone|methylprednisolone
5438562|NCT00000740|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
5438563|NCT00000740|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5438564|NCT00000740|AIDS-Related Complex|aids-related complex
5438565|NCT00000740|WR 6026|wr 6026
5438566|NCT00000739|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
5438567|NCT00000739|Dapsone|dapsone
5438568|NCT00000739|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5438569|NCT00000739|AIDS-Related Complex|aids-related complex
5438570|NCT00000739|Drug Administration Schedule|drug administration schedule
5438571|NCT00000738|Central Nervous System Diseases|central nervous system diseases
5438572|NCT00000738|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5438573|NCT00000738|AIDS Dementia Complex|aids dementia complex
5438574|NCT00000738|AIDS-Related Complex|aids-related complex
5438575|NCT00000738|Zidovudine|zidovudine
5438576|NCT00000738|Nimodipine|nimodipine
5438577|NCT00000737|Weight Loss|weight loss
5438578|NCT00000737|Megestrol|megestrol
5438579|NCT00000737|Cachexia|cachexia
5438580|NCT00000737|Eating Disorders|eating disorders
5438581|NCT00000737|Tetrahydrocannabinol|tetrahydrocannabinol
5438582|NCT00000737|Appetite|appetite
5438583|NCT00000736|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5438584|NCT00000736|AIDS-Related Complex|aids-related complex
5438585|NCT00000736|Zidovudine|zidovudine
5438586|NCT00000735|Virus Replication|virus replication
5438587|NCT00000735|T-Lymphocytes|t-lymphocytes
5438588|NCT00000735|Infusions, Intravenous|infusions, intravenous
5438589|NCT00000735|Immunologic Surveillance|immunologic surveillance
5438590|NCT00000735|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5438591|NCT00000735|ampligen|ampligen
5438592|NCT00000735|AIDS-Related Complex|aids-related complex
5438593|NCT00000735|Antiviral Agents|antiviral agents
5438594|NCT00000734|Trimethoprim-Sulfamethoxazole Combination|trimethoprim-sulfamethoxazole combination
5438595|NCT00000734|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
5438596|NCT00000734|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
5438597|NCT00000734|Drug Interactions|drug interactions
5438598|NCT00000734|Drug Therapy, Combination|drug therapy, combination
5438599|NCT00000734|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5438600|NCT00000734|AIDS-Related Complex|aids-related complex
5438601|NCT00000734|Zidovudine|zidovudine
5438602|NCT00000734|Sulfamethoxazole-Trimethoprim|sulfamethoxazole-trimethoprim
5438603|NCT00000733|Ribavirin|ribavirin
5438604|NCT00000733|T-Lymphocytes|t-lymphocytes
5438605|NCT00000733|Infusions, Intravenous|infusions, intravenous
5438606|NCT00000733|Immunologic Surveillance|immunologic surveillance
5438607|NCT00000733|Administration, Oral|administration, oral
5438608|NCT00000733|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5438724|NCT00000718|AIDS-Related Complex|aids-related complex
5438609|NCT00000732|Trimethoprim-Sulfamethoxazole Combination|trimethoprim-sulfamethoxazole combination
5438610|NCT00000732|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
5438611|NCT00000732|Drug Interactions|drug interactions
5438612|NCT00000732|Drug Therapy, Combination|drug therapy, combination
5438613|NCT00000732|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5438614|NCT00000732|AIDS-Related Complex|aids-related complex
5438615|NCT00000732|Zidovudine|zidovudine
5438616|NCT00000732|Sulfamethoxazole-Trimethoprim|sulfamethoxazole-trimethoprim
5438617|NCT00000731|Acetaminophen|acetaminophen
5438618|NCT00000731|Drug Interactions|drug interactions
5438619|NCT00000731|Drug Therapy, Combination|drug therapy, combination
5438620|NCT00000731|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5438621|NCT00000731|AIDS-Related Complex|aids-related complex
5438622|NCT00000731|Zidovudine|zidovudine
5438623|NCT00000730|Trimethoprim-Sulfamethoxazole Combination|trimethoprim-sulfamethoxazole combination
5438624|NCT00000730|Trimetrexate|trimetrexate
5438625|NCT00000730|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
5438626|NCT00000730|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
5438627|NCT00000730|Leucovorin|leucovorin
5438628|NCT00000730|Folic Acid Antagonists|folic acid antagonists
5438629|NCT00000730|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5438630|NCT00000730|Antiprotozoal Agents|antiprotozoal agents
5438631|NCT00000730|Sulfamethoxazole-Trimethoprim|sulfamethoxazole-trimethoprim
5438632|NCT00000729|Virus Replication|virus replication
5438633|NCT00000729|Infusions, Intravenous|infusions, intravenous
5438634|NCT00000729|Dose-Response Relationship, Drug|dose-response relationship, drug
5438635|NCT00000729|Foscarnet|foscarnet
5438636|NCT00000729|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5438637|NCT00000729|AIDS-Related Complex|aids-related complex
5438638|NCT00000729|Antiviral Agents|antiviral agents
5438639|NCT00000729|CD4-Positive T-Lymphocytes|cd4-positive t-lymphocytes
5438640|NCT00000728|Immune Tolerance|immune tolerance
5438641|NCT00000728|Interleukin-2|interleukin-2
5438642|NCT00000728|Drug Therapy, Combination|drug therapy, combination
5438643|NCT00000728|AIDS-Related Complex|aids-related complex
5438644|NCT00000728|Zidovudine|zidovudine
5438645|NCT00000728|CD4-Positive T-Lymphocytes|cd4-positive t-lymphocytes
5438647|NCT00000727|Trimethoprim-Sulfamethoxazole Combination|trimethoprim-sulfamethoxazole combination
5438648|NCT00000727|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
5438649|NCT00000727|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
5438650|NCT00000727|Pentamidine|pentamidine
5438651|NCT00000727|Pyrimethamine|pyrimethamine
5438652|NCT00000727|Drug Evaluation|drug evaluation
5438653|NCT00000727|Administration, Inhalation|administration, inhalation
5438654|NCT00000727|Administration, Oral|administration, oral
5438655|NCT00000727|Aerosols|aerosols
5438656|NCT00000727|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5438657|NCT00000727|Zidovudine|zidovudine
5438658|NCT00000726|Retinitis|retinitis
5438659|NCT00000726|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
5438660|NCT00000726|Foscarnet|foscarnet
5438661|NCT00000726|Cytomegalovirus Infections|cytomegalovirus infections
5438662|NCT00000726|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5438663|NCT00000726|Antiviral Agents|antiviral agents
5438664|NCT00000725|Interferon Alfa-2a|interferon alfa-2a
5438665|NCT00000725|Sarcoma, Kaposi|sarcoma, kaposi
5438666|NCT00000725|Dose-Response Relationship, Drug|dose-response relationship, drug
5438667|NCT00000725|Drug Therapy, Combination|drug therapy, combination
5438668|NCT00000725|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5438669|NCT00000725|Zidovudine|zidovudine
5438670|NCT00000725|Interferon Type I|interferon type i
5438671|NCT00000724|Trimetrexate|trimetrexate
5438672|NCT00000724|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
5438673|NCT00000724|Injections, Intravenous|injections, intravenous
5438674|NCT00000724|Leucovorin|leucovorin
5438675|NCT00000724|Drug Evaluation|drug evaluation
5438676|NCT00000724|Drug Therapy, Combination|drug therapy, combination
5438677|NCT00000724|Folic Acid Antagonists|folic acid antagonists
5438678|NCT00000724|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5438679|NCT00000724|Antiprotozoal Agents|antiprotozoal agents
5438680|NCT00000723|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
5438681|NCT00000723|Lymphoma|lymphoma
5438682|NCT00000723|Methotrexate|methotrexate
5438683|NCT00000723|Leucovorin|leucovorin
5438684|NCT00000723|Dexamethasone|dexamethasone
5438685|NCT00000723|Drug Evaluation|drug evaluation
5438686|NCT00000723|Drug Therapy, Combination|drug therapy, combination
5438687|NCT00000723|Combined Modality Therapy|combined modality therapy
5438688|NCT00000723|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5438689|NCT00000723|Zidovudine|zidovudine
5438690|NCT00000723|Brain Neoplasms|brain neoplasms
5438691|NCT00000722|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
5438692|NCT00000722|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
5438693|NCT00000722|Pentamidine|pentamidine
5438694|NCT00000722|Injections, Intravenous|injections, intravenous
5438695|NCT00000722|Lung|lung
5438696|NCT00000722|Administration, Inhalation|administration, inhalation
5438697|NCT00000722|Aerosols|aerosols
5438698|NCT00000722|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5438699|NCT00000721|Recombinant Proteins|recombinant proteins
5438700|NCT00000721|Infusions, Intravenous|infusions, intravenous
5438701|NCT00000721|Injections, Intramuscular|injections, intramuscular
5438702|NCT00000721|Injections, Intravenous|injections, intravenous
5438703|NCT00000721|Injections, Subcutaneous|injections, subcutaneous
5438704|NCT00000721|Dose-Response Relationship, Drug|dose-response relationship, drug
5438705|NCT00000721|Drug Evaluation|drug evaluation
5438706|NCT00000721|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5438707|NCT00000721|Antigens, CD4|antigens, cd4
5438708|NCT00000721|AIDS-Related Complex|aids-related complex
5438709|NCT00000720|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
5438710|NCT00000720|Placebos|placebos
5438711|NCT00000720|Infusions, Intravenous|infusions, intravenous
5438712|NCT00000720|Gamma-Globulins|gamma-globulins
5438713|NCT00000720|Combined Modality Therapy|combined modality therapy
5438714|NCT00000720|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5438715|NCT00000720|Zidovudine|zidovudine
5438716|NCT00000720|Bacterial Infections|bacterial infections
5438717|NCT00000720|Immunization, Passive|immunization, passive
5438718|NCT00000719|Zalcitabine|zalcitabine
5438719|NCT00000719|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5438720|NCT00000719|Zidovudine|zidovudine
5438721|NCT00000718|Zalcitabine|zalcitabine
5438722|NCT00000718|Dose-Response Relationship, Drug|dose-response relationship, drug
5438723|NCT00000718|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5438725|NCT00000718|Zidovudine|zidovudine
5438726|NCT00000717|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
5438727|NCT00000717|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
5438728|NCT00000717|Primaquine|primaquine
5438729|NCT00000717|Infusions, Intravenous|infusions, intravenous
5438730|NCT00000717|Drug Evaluation|drug evaluation
5438731|NCT00000717|Drug Therapy, Combination|drug therapy, combination
5438732|NCT00000717|Administration, Oral|administration, oral
5438733|NCT00000717|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5438734|NCT00000717|Clindamycin|clindamycin
5438735|NCT00000716|Drug Evaluation|drug evaluation
5438736|NCT00000716|Administration, Oral|administration, oral
5438737|NCT00000716|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5438738|NCT00000716|Zidovudine|zidovudine
5438739|NCT00000715|Trimethoprim-Sulfamethoxazole Combination|trimethoprim-sulfamethoxazole combination
5438740|NCT00000715|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
5438741|NCT00000715|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
5438742|NCT00000715|Pentamidine|pentamidine
5438743|NCT00000715|Infusions, Intravenous|infusions, intravenous
5438744|NCT00000715|Administration, Inhalation|administration, inhalation
5438745|NCT00000715|Aerosols|aerosols
5438746|NCT00000715|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5438747|NCT00000715|Sulfamethoxazole-Trimethoprim|sulfamethoxazole-trimethoprim
5438748|NCT00000714|Trimetrexate|trimetrexate
5438749|NCT00000714|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
5438750|NCT00000714|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
5438751|NCT00000714|Leucovorin|leucovorin
5438752|NCT00000714|Drug Evaluation|drug evaluation
5438753|NCT00000714|Drug Therapy, Combination|drug therapy, combination
5438754|NCT00000714|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5438755|NCT00000714|Antiprotozoal Agents|antiprotozoal agents
5438756|NCT00000713|Polyribonucleotides|polyribonucleotides
5438757|NCT00000713|HIV Seropositivity|hiv seropositivity
5438758|NCT00000713|Dose-Response Relationship, Drug|dose-response relationship, drug
5438759|NCT00000713|Drug Evaluation|drug evaluation
5438760|NCT00000713|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5438761|NCT00000713|ampligen|ampligen
5438762|NCT00000713|AIDS-Related Complex|aids-related complex
5438763|NCT00000713|Antiviral Agents|antiviral agents
5438764|NCT00000712|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
5438765|NCT00000712|Herpesviridae Infections|herpesviridae infections
5438766|NCT00000712|Drug Evaluation|drug evaluation
5438767|NCT00000712|Drug Therapy, Combination|drug therapy, combination
5438768|NCT00000712|Herpesvirus 4, Human|herpesvirus 4, human
5438769|NCT00000712|Cytomegalovirus Infections|cytomegalovirus infections
5438770|NCT00000712|Acyclovir|acyclovir
5438771|NCT00000712|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5438772|NCT00000712|Antiviral Agents|antiviral agents
5438773|NCT00000712|Zidovudine|zidovudine
5438774|NCT00000711|Neutropenia|neutropenia
5438775|NCT00000711|Drug Evaluation|drug evaluation
5438776|NCT00000711|Drug Therapy, Combination|drug therapy, combination
5438777|NCT00000711|Granulocyte-Macrophage Colony-Stimulating Factor|granulocyte-macrophage colony-stimulating factor
5438778|NCT00000711|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5438779|NCT00000711|AIDS-Related Complex|aids-related complex
5438780|NCT00000711|Zidovudine|zidovudine
5438781|NCT00000710|Injections, Intravenous|injections, intravenous
5438782|NCT00000710|Didanosine|didanosine
5438783|NCT00000710|Dose-Response Relationship, Drug|dose-response relationship, drug
5438784|NCT00000710|Drug Evaluation|drug evaluation
5438785|NCT00000710|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5438786|NCT00000710|AIDS-Related Complex|aids-related complex
5438787|NCT00000709|Neuropsychological Tests|neuropsychological tests
5438788|NCT00000709|AIDS Dementia Complex|aids dementia complex
5438789|NCT00000709|Zidovudine|zidovudine
5438790|NCT00000709|CD4-Positive T-Lymphocytes|cd4-positive t-lymphocytes
5438791|NCT00000708|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
5438792|NCT00000708|Meningitis|meningitis
5438793|NCT00000708|Injections, Intravenous|injections, intravenous
5438794|NCT00000708|Cryptococcus neoformans|cryptococcus neoformans
5438795|NCT00000708|Cryptococcosis|cryptococcosis
5438796|NCT00000708|Drug Therapy, Combination|drug therapy, combination
5438797|NCT00000708|Fluconazole|fluconazole
5438798|NCT00000708|Administration, Oral|administration, oral
5438799|NCT00000708|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5438800|NCT00000708|Amphotericin B|amphotericin b
5438801|NCT00000707|Respiratory Function Tests|respiratory function tests
5438802|NCT00000707|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
5438803|NCT00000707|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
5438804|NCT00000707|Pentamidine|pentamidine
5438805|NCT00000707|Lung|lung
5438806|NCT00000707|HIV Seropositivity|hiv seropositivity
5438807|NCT00000707|Drug Evaluation|drug evaluation
5438808|NCT00000707|Administration, Inhalation|administration, inhalation
5438809|NCT00000707|Aerosols|aerosols
5438810|NCT00000707|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5438811|NCT00000706|Quinine|quinine
5438812|NCT00000706|Probenecid|probenecid
5438813|NCT00000706|Drug Therapy, Combination|drug therapy, combination
5438814|NCT00000706|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5438815|NCT00000706|AIDS-Related Complex|aids-related complex
5438816|NCT00000706|Zidovudine|zidovudine
5438817|NCT00000705|Drug Evaluation|drug evaluation
5438818|NCT00000705|Zidovudine|zidovudine
5438819|NCT00000705|Hemophilia A|hemophilia a
5438820|NCT00000704|HIV Antigens|hiv antigens
5438821|NCT00000704|Immunologic Surveillance|immunologic surveillance
5438822|NCT00000704|Zalcitabine|zalcitabine
5438823|NCT00000704|Dose-Response Relationship, Drug|dose-response relationship, drug
5438824|NCT00000704|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5438825|NCT00000704|AIDS-Related Complex|aids-related complex
5438826|NCT00000704|CD4-Positive T-Lymphocytes|cd4-positive t-lymphocytes
5438827|NCT00000703|Vincristine|vincristine
5438828|NCT00000703|Lymphoma|lymphoma
5438829|NCT00000703|Methotrexate|methotrexate
5438830|NCT00000703|Cyclophosphamide|cyclophosphamide
5438831|NCT00000703|Cytarabine|cytarabine
5438832|NCT00000703|Dexamethasone|dexamethasone
5438833|NCT00000703|Doxorubicin|doxorubicin
5438834|NCT00000703|Drug Therapy, Combination|drug therapy, combination
5438835|NCT00000703|Combined Modality Therapy|combined modality therapy
5438836|NCT00000703|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5438837|NCT00000703|Antineoplastic Agents, Combined|antineoplastic agents, combined
5438838|NCT00000703|Zidovudine|zidovudine
5438839|NCT00000703|Bleomycin|bleomycin
5438840|NCT00000702|AIDS Dementia Complex|aids dementia complex
5438841|NCT00000702|Zidovudine|zidovudine
5438842|NCT00000701|Drug Evaluation|drug evaluation
5438843|NCT00000701|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5438844|NCT00000701|AIDS-Related Complex|aids-related complex
5438845|NCT00000701|Zidovudine|zidovudine
5438846|NCT00000700|United States|united states
5438847|NCT00000700|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
5438848|NCT00000700|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
5438849|NCT00000700|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5438850|NCT00000700|Zidovudine|zidovudine
5438851|NCT00000699|Ribavirin|ribavirin
5438852|NCT00000699|Inosine Pranobex|inosine pranobex
5438853|NCT00000699|Dose-Response Relationship, Drug|dose-response relationship, drug
5438854|NCT00000699|Drug Evaluation|drug evaluation
5438855|NCT00000699|Drug Therapy, Combination|drug therapy, combination
5438856|NCT00000699|AIDS-Related Complex|aids-related complex
5438857|NCT00000698|Retinitis|retinitis
5438858|NCT00000698|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
5438859|NCT00000698|Ganciclovir|ganciclovir
5438860|NCT00000698|Cytomegalovirus Infections|cytomegalovirus infections
5438861|NCT00000698|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5438862|NCT00000697|Retinitis|retinitis
5438863|NCT00000697|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
5438864|NCT00000697|Bone Marrow|bone marrow
5438865|NCT00000697|Ganciclovir|ganciclovir
5438866|NCT00000697|Foscarnet|foscarnet
5438867|NCT00000697|Cytomegalovirus Infections|cytomegalovirus infections
5438868|NCT00000697|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5438869|NCT00000697|Antiviral Agents|antiviral agents
5438870|NCT00000696|Interferon Alfa-2a|interferon alfa-2a
5438871|NCT00000696|Drug Therapy, Combination|drug therapy, combination
5438872|NCT00000696|AIDS-Related Complex|aids-related complex
5438873|NCT00000696|Zidovudine|zidovudine
5438874|NCT00000695|Drug Evaluation|drug evaluation
5438875|NCT00000695|Drug Therapy, Combination|drug therapy, combination
5438876|NCT00000695|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5438877|NCT00000695|Zidovudine|zidovudine
5438878|NCT00000695|Interferon Type I|interferon type i
5438879|NCT00000694|Interferon Alfa-2b|interferon alfa-2b
5438880|NCT00000694|Immune System|immune system
5438881|NCT00000694|Drug Evaluation|drug evaluation
5438882|NCT00000694|Drug Therapy, Combination|drug therapy, combination
5438883|NCT00000694|Granulocyte-Macrophage Colony-Stimulating Factor|granulocyte-macrophage colony-stimulating factor
5438884|NCT00000694|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5438885|NCT00000694|Zidovudine|zidovudine
5438886|NCT00000693|Retinitis|retinitis
5438887|NCT00000693|Drug Evaluation|drug evaluation
5438888|NCT00000693|Drug Therapy, Combination|drug therapy, combination
5438889|NCT00000693|Cytomegalovirus Infections|cytomegalovirus infections
5438890|NCT00000693|Acyclovir|acyclovir
5438891|NCT00000693|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5438892|NCT00000693|Zidovudine|zidovudine
5438893|NCT00000692|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5438894|NCT00000692|AIDS-Related Complex|aids-related complex
5438895|NCT00000692|Antiviral Agents|antiviral agents
5438896|NCT00000692|Biological Availability|biological availability
5438897|NCT00000692|1-Deoxynojirimycin|1-deoxynojirimycin
5438898|NCT00000691|Retinitis|retinitis
5438899|NCT00000691|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
5438900|NCT00000691|Ganciclovir|ganciclovir
5438901|NCT00000691|Drug Evaluation|drug evaluation
5438902|NCT00000691|Foscarnet|foscarnet
5438903|NCT00000691|Cytomegalovirus Infections|cytomegalovirus infections
5438904|NCT00000691|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5438905|NCT00000691|Antiviral Agents|antiviral agents
5438906|NCT00000690|Reference Values|reference values
5438907|NCT00000690|Infusions, Intravenous|infusions, intravenous
5438908|NCT00000690|Intestinal Absorption|intestinal absorption
5438909|NCT00000690|Dextran Sulfate|dextran sulfate
5438910|NCT00000690|Administration, Oral|administration, oral
5438911|NCT00000690|Blood Coagulation|blood coagulation
5438912|NCT00000689|M-BACOD protocol|m-bacod protocol
5438913|NCT00000689|Nervous System Neoplasms|nervous system neoplasms
5438914|NCT00000689|Infusions, Intravenous|infusions, intravenous
5438915|NCT00000689|Injections, Intravenous|injections, intravenous
5438916|NCT00000689|Leucovorin|leucovorin
5438918|NCT00000689|Drug Evaluation|drug evaluation
5438919|NCT00000689|Drug Therapy, Combination|drug therapy, combination
5438920|NCT00000689|Granulocyte-Macrophage Colony-Stimulating Factor|granulocyte-macrophage colony-stimulating factor
5438921|NCT00000689|Administration, Oral|administration, oral
5438922|NCT00000689|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5438923|NCT00000689|Antineoplastic Agents, Combined|antineoplastic agents, combined
5438924|NCT00000688|Retinitis|retinitis
5438925|NCT00000688|Injections, Intravenous|injections, intravenous
5438926|NCT00000688|Ganciclovir|ganciclovir
5438927|NCT00000688|Cytomegalovirus Infections|cytomegalovirus infections
5438928|NCT00000688|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5438929|NCT00000687|Interferon Alfa-2a|interferon alfa-2a
5438930|NCT00000687|Drug Evaluation|drug evaluation
5438931|NCT00000687|Drug Therapy, Combination|drug therapy, combination
5438932|NCT00000687|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5438933|NCT00000687|Zidovudine|zidovudine
5438934|NCT00000686|Drug Evaluation|drug evaluation
5438935|NCT00000686|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5438936|NCT00000686|AIDS-Related Complex|aids-related complex
5438937|NCT00000686|Antiviral Agents|antiviral agents
5438938|NCT00000686|Zidovudine|zidovudine
5438939|NCT00000685|Kidney Diseases|kidney diseases
5438940|NCT00000685|Drug Evaluation|drug evaluation
5438941|NCT00000685|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5438942|NCT00000685|Zidovudine|zidovudine
5438943|NCT00000685|Renal Dialysis|renal dialysis
5438944|NCT00000684|Infusions, Intravenous|infusions, intravenous
5438945|NCT00000684|Dextran Sulfate|dextran sulfate
5438946|NCT00000684|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5438947|NCT00000683|Vaccines, Synthetic|vaccines, synthetic
5438948|NCT00000683|Vaccinia Virus|vaccinia virus
5438949|NCT00000683|Viral Envelope Proteins|viral envelope proteins
5438950|NCT00000683|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5438951|NCT00000683|AIDS Vaccines|aids vaccines
5438952|NCT00000683|HIV Seronegativity|hiv seronegativity
5438953|NCT00000683|HIV Preventive Vaccine|hiv preventive vaccine
5438954|NCT00000682|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
5438955|NCT00000682|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
5438956|NCT00000682|Zalcitabine|zalcitabine
5438957|NCT00000682|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5438958|NCT00000682|Zidovudine|zidovudine
5438959|NCT00000681|Vincristine|vincristine
5438960|NCT00000681|Doxorubicin|doxorubicin
5438961|NCT00000681|Drug Evaluation|drug evaluation
5438962|NCT00000681|Drug Therapy, Combination|drug therapy, combination
5438963|NCT00000681|Granulocyte-Macrophage Colony-Stimulating Factor|granulocyte-macrophage colony-stimulating factor
5438964|NCT00000681|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5438965|NCT00000681|Zidovudine|zidovudine
5438966|NCT00000681|Bleomycin|bleomycin
5438967|NCT00000680|T-Lymphocytes, Suppressor-Effector|t-lymphocytes, suppressor-effector
5438968|NCT00000680|Indium Radioisotopes|indium radioisotopes
5438969|NCT00000680|Leukapheresis|leukapheresis
5438970|NCT00000680|Interleukin-2|interleukin-2
5438971|NCT00000680|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5438972|NCT00000680|AIDS-Related Complex|aids-related complex
5438973|NCT00000680|Zidovudine|zidovudine
5438974|NCT00000680|Immunization, Passive|immunization, passive
5438975|NCT00000679|Zalcitabine|zalcitabine
5438976|NCT00000679|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5438977|NCT00000679|AIDS-Related Complex|aids-related complex
5438978|NCT00000679|Zidovudine|zidovudine
5438979|NCT00000678|Zalcitabine|zalcitabine
5438980|NCT00000678|Drug Evaluation|drug evaluation
5438981|NCT00000678|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5438982|NCT00000678|AIDS-Related Complex|aids-related complex
5438983|NCT00000678|Zidovudine|zidovudine
5438984|NCT00000677|Sch 39304|sch 39304
5438985|NCT00000677|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
5438986|NCT00000677|Meningitis|meningitis
5438987|NCT00000677|Cryptococcosis|cryptococcosis
5438988|NCT00000677|Drug Evaluation|drug evaluation
5438989|NCT00000677|Antifungal Agents|antifungal agents
5438990|NCT00000677|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5438991|NCT00000676|Mycoses|mycoses
5438992|NCT00000676|Fluconazole|fluconazole
5438993|NCT00000676|Clotrimazole|clotrimazole
5438994|NCT00000676|Antifungal Agents|antifungal agents
5438995|NCT00000676|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5438996|NCT00000676|AIDS-Related Complex|aids-related complex
5438997|NCT00000675|Recombinant Proteins|recombinant proteins
5438999|NCT00000675|Drug Evaluation|drug evaluation
5439000|NCT00000675|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5439001|NCT00000675|Antigens, CD4|antigens, cd4
5439002|NCT00000675|AIDS-Related Complex|aids-related complex
5439003|NCT00000675|Carrier Proteins|carrier proteins
5439004|NCT00000674|Toxoplasmosis|toxoplasmosis
5439005|NCT00000674|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
5439006|NCT00000674|Pyrimethamine|pyrimethamine
5439007|NCT00000674|Leucovorin|leucovorin
5439008|NCT00000674|Drug Evaluation|drug evaluation
5439009|NCT00000674|Drug Therapy, Combination|drug therapy, combination
5439010|NCT00000674|Encephalitis|encephalitis
5439011|NCT00000674|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5439012|NCT00000674|Clindamycin|clindamycin
5439013|NCT00000673|Retinitis|retinitis
5439014|NCT00000673|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
5439015|NCT00000673|Ganciclovir|ganciclovir
5439016|NCT00000673|Cytomegalovirus Infections|cytomegalovirus infections
5439017|NCT00000673|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5439018|NCT00000672|Didanosine|didanosine
5439019|NCT00000672|Zidovudine|zidovudine
5439020|NCT00000671|Didanosine|didanosine
5439021|NCT00000671|Zidovudine|zidovudine
5439022|NCT00000670|Probenecid|probenecid
5439023|NCT00000670|Drug Evaluation|drug evaluation
5439024|NCT00000670|Drug Interactions|drug interactions
5439025|NCT00000670|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5439026|NCT00000670|Zidovudine|zidovudine
5439027|NCT00000669|Didanosine|didanosine
5439028|NCT00000669|Drug Evaluation|drug evaluation
5439029|NCT00000669|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5439030|NCT00000669|AIDS-Related Complex|aids-related complex
5439031|NCT00000668|Retinitis|retinitis
5439032|NCT00000668|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
5439033|NCT00000668|Ganciclovir|ganciclovir
5439034|NCT00000668|Cytomegalovirus Infections|cytomegalovirus infections
5439035|NCT00000668|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5439036|NCT00000667|Vaccines, Synthetic|vaccines, synthetic
5439037|NCT00000667|Injections, Intradermal|injections, intradermal
5439038|NCT00000667|HIV Antigens|hiv antigens
5439039|NCT00000667|HIV Seropositivity|hiv seropositivity
5439040|NCT00000667|HIV-1|hiv-1
5439041|NCT00000667|Drug Evaluation|drug evaluation
5439042|NCT00000667|Hypersensitivity, Delayed|hypersensitivity, delayed
5439043|NCT00000667|AIDS Vaccines|aids vaccines
5439044|NCT00000667|HIV Therapeutic Vaccine|hiv therapeutic vaccine
5439045|NCT00000666|Toxoplasmosis|toxoplasmosis
5439046|NCT00000666|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
5439047|NCT00000666|Pyrimethamine|pyrimethamine
5439048|NCT00000666|Drug Evaluation|drug evaluation
5439049|NCT00000666|Encephalitis|encephalitis
5439050|NCT00000666|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5439051|NCT00000665|Retinitis|retinitis
5439052|NCT00000665|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
5439053|NCT00000665|Ganciclovir|ganciclovir
5439054|NCT00000665|Foscarnet|foscarnet
5439055|NCT00000665|Cytomegalovirus Infections|cytomegalovirus infections
5439056|NCT00000665|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5439057|NCT00000665|Antiviral Agents|antiviral agents
5439058|NCT00000664|Polyethylene Glycols|polyethylene glycols
5439059|NCT00000664|Interleukin-2|interleukin-2
5439060|NCT00000664|Drug Evaluation|drug evaluation
5439061|NCT00000664|Zidovudine|zidovudine
5439062|NCT00000663|Recombinant Proteins|recombinant proteins
5439063|NCT00000663|Injections, Intravenous|injections, intravenous
5439064|NCT00000663|IgG|igg
5439065|NCT00000663|Drug Evaluation|drug evaluation
5439066|NCT00000663|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5439067|NCT00000663|Antigens, CD4|antigens, cd4
5439068|NCT00000663|Carrier Proteins|carrier proteins
5439069|NCT00000662|Drugs, Investigational|drugs, investigational
5439070|NCT00000662|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5439071|NCT00000662|AIDS-Related Complex|aids-related complex
5439072|NCT00000662|Zidovudine|zidovudine
5439073|NCT00000661|Oxazepam|oxazepam
5439074|NCT00000661|Drug Evaluation|drug evaluation
5439075|NCT00000661|Drug Interactions|drug interactions
5439076|NCT00000661|Zidovudine|zidovudine
5439077|NCT00000660|Sarcoma, Kaposi|sarcoma, kaposi
5439078|NCT00000660|Drug Evaluation|drug evaluation
5439079|NCT00000660|Etoposide|etoposide
5439080|NCT00000660|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5439081|NCT00000659|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5439082|NCT00000659|Antigens, CD4|antigens, cd4
5439083|NCT00000659|AIDS-Related Complex|aids-related complex
5439084|NCT00000659|Zidovudine|zidovudine
5439085|NCT00000658|M-BACOD protocol|m-bacod protocol
5439086|NCT00000658|Granulocyte-Macrophage Colony-Stimulating Factor|granulocyte-macrophage colony-stimulating factor
5439087|NCT00000658|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5439088|NCT00000658|Allopurinol|allopurinol
5439089|NCT00000658|Antineoplastic Agents, Combined|antineoplastic agents, combined
5439090|NCT00000657|Didanosine|didanosine
5439091|NCT00000657|Drug Evaluation|drug evaluation
5439092|NCT00000657|Drugs, Investigational|drugs, investigational
5439093|NCT00000657|AIDS Dementia Complex|aids dementia complex
5439094|NCT00000657|Zidovudine|zidovudine
5439095|NCT00000656|Didanosine|didanosine
5439096|NCT00000656|Drug Therapy, Combination|drug therapy, combination
5439097|NCT00000656|Zidovudine|zidovudine
5439098|NCT00000655|Trimethoprim-Sulfamethoxazole Combination|trimethoprim-sulfamethoxazole combination
5439099|NCT00000655|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
5439100|NCT00000655|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
5439101|NCT00000655|Naphthoquinones|naphthoquinones
5439102|NCT00000655|Antifungal Agents|antifungal agents
5444282|NCT00001643|Hereditary|hereditary
5439103|NCT00000655|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5439104|NCT00000655|Sulfamethoxazole-Trimethoprim|sulfamethoxazole-trimethoprim
5439105|NCT00000654|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
5439106|NCT00000654|Pyrimidine Nucleosides|pyrimidine nucleosides
5439107|NCT00000654|Herpesviridae Infections|herpesviridae infections
5439108|NCT00000654|Drug Evaluation|drug evaluation
5439109|NCT00000654|Antiviral Agents|antiviral agents
5439110|NCT00000654|Hepatitis B|hepatitis b
5439111|NCT00000653|Zalcitabine|zalcitabine
5439112|NCT00000653|Drug Evaluation|drug evaluation
5439113|NCT00000653|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5439114|NCT00000653|AIDS-Related Complex|aids-related complex
5439115|NCT00000652|Didanosine|didanosine
5439116|NCT00000652|Drug Evaluation|drug evaluation
5439117|NCT00000652|Drug Therapy, Combination|drug therapy, combination
5439118|NCT00000652|Zidovudine|zidovudine
5439119|NCT00000651|Zalcitabine|zalcitabine
5439120|NCT00000651|Antiviral Agents|antiviral agents
5439121|NCT00000651|Zidovudine|zidovudine
5439122|NCT00000650|Drug Evaluation|drug evaluation
5439123|NCT00000650|Ditiocarb|ditiocarb
5439124|NCT00000650|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5439125|NCT00000649|Drug Therapy, Combination|drug therapy, combination
5439126|NCT00000649|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5439127|NCT00000649|AIDS-Related Complex|aids-related complex
5439128|NCT00000649|Zidovudine|zidovudine
5439129|NCT00000649|Nevirapine|nevirapine
5439130|NCT00000648|Penicillin G|penicillin g
5439131|NCT00000648|Neurosyphilis|neurosyphilis
5439132|NCT00000648|Drug Evaluation|drug evaluation
5439133|NCT00000648|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5439134|NCT00000648|AIDS-Related Complex|aids-related complex
5439135|NCT00000648|Ceftriaxone|ceftriaxone
5439136|NCT00000647|Recombinant Proteins|recombinant proteins
5439137|NCT00000647|IgG|igg
5439138|NCT00000647|Drug Evaluation|drug evaluation
5439139|NCT00000647|Drug Therapy, Combination|drug therapy, combination
5439140|NCT00000647|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5439141|NCT00000647|Antigens, CD4|antigens, cd4
5439142|NCT00000647|Zidovudine|zidovudine
5439143|NCT00000647|Carrier Proteins|carrier proteins
5439144|NCT00000647|Interferon Type I|interferon type i
5439145|NCT00000646|Pentoxifylline|pentoxifylline
5439146|NCT00000646|Virus Replication|virus replication
5439147|NCT00000646|Tumor Necrosis Factor|tumor necrosis factor
5439148|NCT00000646|Drug Evaluation|drug evaluation
5439149|NCT00000646|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5439150|NCT00000646|Cachexia|cachexia
5439151|NCT00000646|Drug Synergism|drug synergism
5439152|NCT00000645|Drug Evaluation|drug evaluation
5439153|NCT00000645|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5439154|NCT00000645|AIDS-Related Complex|aids-related complex
5439155|NCT00000645|Antiviral Agents|antiviral agents
5439156|NCT00000644|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
5439157|NCT00000644|Mycobacterium avium-intracellulare Infection|mycobacterium avium-intracellulare infection
5439158|NCT00000644|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5439159|NCT00000644|Clarithromycin|clarithromycin
5439160|NCT00000643|Toxoplasmosis|toxoplasmosis
5439161|NCT00000643|Pyrimethamine|pyrimethamine
5439162|NCT00000643|Leucovorin|leucovorin
5439163|NCT00000643|Drug Evaluation|drug evaluation
5439164|NCT00000643|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5439165|NCT00000643|AIDS-Related Complex|aids-related complex
5439166|NCT00000643|Brain Diseases|brain diseases
5439167|NCT00000642|Recombinant Proteins|recombinant proteins
5439168|NCT00000642|Pregnancy Trimester, Third|pregnancy trimester, third
5439169|NCT00000642|Pregnancy|pregnancy
5439170|NCT00000642|Pregnancy Complications, Infectious|pregnancy complications, infectious
5439171|NCT00000642|IgG|igg
5439172|NCT00000642|Drug Evaluation|drug evaluation
5439173|NCT00000642|Antigens, CD4|antigens, cd4
5439174|NCT00000642|AIDS-Related Complex|aids-related complex
5439175|NCT00000642|Immunization, Passive|immunization, passive
5439176|NCT00000641|Rifampin|rifampin
5439177|NCT00000641|Mycobacterium avium-intracellulare Infection|mycobacterium avium-intracellulare infection
5439178|NCT00000641|Drug Evaluation|drug evaluation
5439179|NCT00000641|Drug Therapy, Combination|drug therapy, combination
5439180|NCT00000641|Ethambutol|ethambutol
5439181|NCT00000641|Clofazimine|clofazimine
5439182|NCT00000641|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5439183|NCT00000641|Amikacin|amikacin
5439184|NCT00000641|Azithromycin|azithromycin
5439185|NCT00000641|Ciprofloxacin|ciprofloxacin
5439186|NCT00000640|Trimethoprim-Sulfamethoxazole Combination|trimethoprim-sulfamethoxazole combination
5439187|NCT00000640|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
5439188|NCT00000640|Primaquine|primaquine
5439189|NCT00000640|Dapsone|dapsone
5439190|NCT00000640|Drug Therapy, Combination|drug therapy, combination
5439191|NCT00000640|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5439192|NCT00000640|Clindamycin|clindamycin
5439193|NCT00000640|Sulfamethoxazole-Trimethoprim|sulfamethoxazole-trimethoprim
5439194|NCT00000639|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
5439196|NCT00000639|Cryptococcosis|cryptococcosis
5439197|NCT00000639|Drug Evaluation|drug evaluation
5439198|NCT00000639|Drug Therapy, Combination|drug therapy, combination
5439199|NCT00000639|Fluconazole|fluconazole
5439200|NCT00000639|Flucytosine|flucytosine
5439201|NCT00000639|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5439202|NCT00000639|Amphotericin B|amphotericin b
5439203|NCT00000639|Brain Diseases|brain diseases
5439204|NCT00000638|Tuberculosis|tuberculosis
5439205|NCT00000638|Isoniazid|isoniazid
5439206|NCT00000638|Mycobacterium tuberculosis|mycobacterium tuberculosis
5439207|NCT00000638|Pyrazinamide|pyrazinamide
5439208|NCT00000638|Pyridoxine|pyridoxine
5439209|NCT00000638|Rifampin|rifampin
5439210|NCT00000638|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
5439211|NCT00000638|Drug Therapy, Combination|drug therapy, combination
5439212|NCT00000638|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5439213|NCT00000638|Antitubercular Agents|antitubercular agents
5439214|NCT00000638|AIDS-Related Complex|aids-related complex
5439215|NCT00000637|Didanosine|didanosine
5439216|NCT00000637|Drug Evaluation|drug evaluation
5439217|NCT00000637|Drug Therapy, Combination|drug therapy, combination
5439218|NCT00000637|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5439219|NCT00000637|AIDS-Related Complex|aids-related complex
5439220|NCT00000637|Zidovudine|zidovudine
5439221|NCT00000636|Tuberculosis|tuberculosis
5439222|NCT00000636|Isoniazid|isoniazid
5439223|NCT00000636|Pyrazinamide|pyrazinamide
5439224|NCT00000636|Pyridoxine|pyridoxine
5439225|NCT00000636|Rifampin|rifampin
5439226|NCT00000636|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
5439227|NCT00000636|Drug Therapy, Combination|drug therapy, combination
5439228|NCT00000636|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5439229|NCT00000636|Antitubercular Agents|antitubercular agents
5439230|NCT00000636|AIDS-Related Complex|aids-related complex
5439231|NCT00000635|Bacitracin|bacitracin
5439232|NCT00000635|Polymyxin B|polymyxin b
5439233|NCT00000635|Trifluridine|trifluridine
5439234|NCT00000635|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
5439235|NCT00000635|Herpesviridae Infections|herpesviridae infections
5439236|NCT00000635|Drug Evaluation|drug evaluation
5439237|NCT00000635|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5439238|NCT00000635|Anti-Infective Agents, Local|anti-infective agents, local
5439239|NCT00000635|Antiviral Agents|antiviral agents
5439240|NCT00000634|Benzodiazepines|benzodiazepines
5439241|NCT00000634|Drug Evaluation|drug evaluation
5439242|NCT00000634|Drugs, Investigational|drugs, investigational
5439243|NCT00000634|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5439244|NCT00000634|Antiviral Agents|antiviral agents
5439245|NCT00000633|Vaccines, Synthetic|vaccines, synthetic
5439246|NCT00000633|Vaccinia Virus|vaccinia virus
5439247|NCT00000633|Viral Vaccines|viral vaccines
5439248|NCT00000633|HIV-1|hiv-1
5439249|NCT00000633|HIV Envelope Protein gp160|hiv envelope protein gp160
5439250|NCT00000633|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5439251|NCT00000633|AIDS-Related Complex|aids-related complex
5439252|NCT00000633|AIDS Vaccines|aids vaccines
5439253|NCT00000633|HIV Therapeutic Vaccine|hiv therapeutic vaccine
5439254|NCT00000632|Vaccines, Synthetic|vaccines, synthetic
5439255|NCT00000632|Drug Evaluation|drug evaluation
5439256|NCT00000632|Adjuvants, Immunologic|adjuvants, immunologic
5439257|NCT00000632|AIDS Vaccines|aids vaccines
5439258|NCT00000632|HIV Preventive Vaccine|hiv preventive vaccine
5439259|NCT00000631|Vaccines, Synthetic|vaccines, synthetic
5439260|NCT00000631|Vaccinia Virus|vaccinia virus
5439261|NCT00000631|Viral Envelope Proteins|viral envelope proteins
5439262|NCT00000631|Viral Vaccines|viral vaccines
5439263|NCT00000631|AIDS Vaccines|aids vaccines
5439264|NCT00000631|HIV Seronegativity|hiv seronegativity
5439265|NCT00000631|HIV Preventive Vaccine|hiv preventive vaccine
5439266|NCT00000630|Vaccines, Synthetic|vaccines, synthetic
5439267|NCT00000630|Vaccinia Virus|vaccinia virus
5439268|NCT00000630|Viral Envelope Proteins|viral envelope proteins
5439269|NCT00000630|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5439270|NCT00000630|AIDS Vaccines|aids vaccines
5439271|NCT00000630|HIV Seronegativity|hiv seronegativity
5439272|NCT00000630|HIV Preventive Vaccine|hiv preventive vaccine
5439273|NCT00000629|Valproic Acid|valproic acid
5439274|NCT00000629|Zidovudine|zidovudine
5439275|NCT00000628|Drug Evaluation|drug evaluation
5439276|NCT00000628|Drugs, Investigational|drugs, investigational
5439277|NCT00000628|Drug Therapy, Combination|drug therapy, combination
5439278|NCT00000628|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5439279|NCT00000628|AIDS-Related Complex|aids-related complex
5439280|NCT00000628|Antiviral Agents|antiviral agents
5439281|NCT00000627|Pilot Projects|pilot projects
5439282|NCT00000627|Histoplasmosis|histoplasmosis
5439283|NCT00000627|Drug Evaluation|drug evaluation
5439284|NCT00000627|Fluconazole|fluconazole
5439285|NCT00000627|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5439286|NCT00000627|Recurrence|recurrence
5439287|NCT00000626|Granulocyte Colony-Stimulating Factor|granulocyte colony-stimulating factor
5439288|NCT00000626|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5439289|NCT00000626|Antineoplastic Agents, Combined|antineoplastic agents, combined
5439290|NCT00000626|AIDS-Related Complex|aids-related complex
5439291|NCT00000626|Hodgkin Disease|hodgkin disease
5439292|NCT00000626|ABVD protocol|abvd protocol
5439293|NCT00000625|Zalcitabine|zalcitabine
5439294|NCT00000625|Didanosine|didanosine
5439295|NCT00000625|Drug Therapy, Combination|drug therapy, combination
5439296|NCT00000625|AIDS-Related Complex|aids-related complex
5439297|NCT00000625|Antiviral Agents|antiviral agents
5439298|NCT00000625|Zidovudine|zidovudine
5439299|NCT00023192|Campath 1-H|campath 1-h
5439300|NCT00023192|T-Cell Depletion|t-cell depletion
5439301|NCT00023192|Therapy|therapy
5439302|NCT00023192|Stem Cell Transplantation|stem cell transplantation
5439303|NCT00023192|Chronic Granulomatous Disease|chronic granulomatous disease
5439304|NCT00023192|CGD|cgd
5439305|NCT00023166|Phase I|phase i
5439306|NCT00023166|Open label|open label
5439307|NCT00023166|Safety/efficacy|safety/efficacy
5439308|NCT00023166|Lymphomas|lymphomas
5439309|NCT00023166|Advanced primary and/or metastatic solid tumors|advanced primary and/or metastatic solid tumors
5439310|NCT00023166|Neoplasms|neoplasms
5439311|NCT00023166|Neoplasm metastasis|neoplasm metastasis
5439312|NCT00023153|Drug Resistance|drug resistance
5439313|NCT00023153|Viral Load|viral load
5439314|NCT00023153|Liver|liver
5439315|NCT00023153|Immunology|immunology
5439316|NCT00023153|Liver Histology|liver histology
5439317|NCT00023153|Hepatitis B|hepatitis b
5439318|NCT00023153|HBV|hbv
5439319|NCT00023153|HIV|hiv
5439320|NCT00023140|biomarkers|biomarkers
5439321|NCT00023140|exposure|exposure
5439322|NCT00023140|adducts|adducts
5439323|NCT00023140|metabolites|metabolites
5439324|NCT00023140|butadiene|butadiene
5439325|NCT00023127|Asthma|asthma
5439326|NCT00023127|Allergen|allergen
5439327|NCT00023127|Cockroach|cockroach
5439328|NCT00023114|lung function|lung function
5439329|NCT00023114|smoking|smoking
5439330|NCT00023114|metabolism|metabolism
5439331|NCT00023101|lead|lead
5439332|NCT00023101|endocrine dysfunction|endocrine dysfunction
5439333|NCT00023088|Rehabilitation|rehabilitation
5439334|NCT00023088|Functional Level|functional level
5439335|NCT00023088|Activity of Daily Living|activity of daily living
5439336|NCT00023088|Mobility|mobility
5439337|NCT00023088|Normal Volunteer|normal volunteer
5439338|NCT00023075|MRI|mri
5439339|NCT00023075|Neuromuscular Disease|neuromuscular disease
5439340|NCT00023075|N-Acetyl Aspartate|n-acetyl aspartate
5439341|NCT00023075|Choline|choline
5439342|NCT00023075|Creatine|creatine
5439343|NCT00023075|Spasms|spasms
5439344|NCT00023075|Spasticity|spasticity
5439345|NCT00023075|Primary Lateral Sclerosis|primary lateral sclerosis
5439346|NCT00023075|Hereditary Spastic Paraplegia|hereditary spastic paraplegia
5439347|NCT00023075|Spastic Paraparesis|spastic paraparesis
5439348|NCT00023075|Healthy Volunteer|healthy volunteer
5439349|NCT00023075|HV|hv
5439350|NCT00023075|Normal Control|normal control
5439351|NCT00023062|Natural History|natural history
5439352|NCT00023062|Motor Cortex|motor cortex
5439353|NCT00023062|Behavior|behavior
5439354|NCT00023062|Healthy Volunteers|healthy volunteers
5439355|NCT00023062|Motor Control|motor control
5439356|NCT00023062|Parkinson Disease|parkinson disease
5439357|NCT00023062|Parkinson's|parkinson's
5439358|NCT00023062|Healthy Volunteer|healthy volunteer
5439359|NCT00023062|HV|hv
5439360|NCT00023062|Normal Control|normal control
5439361|NCT00023049|Deafness|deafness
5439362|NCT00023049|Genes|genes
5439363|NCT00023049|Impairment|impairment
5439364|NCT00023049|Auditory|auditory
5439365|NCT00023049|Vestibular|vestibular
5439366|NCT00023049|Hereditary Hearing Disorder|hereditary hearing disorder
5439367|NCT00023049|Hearing Impairment|hearing impairment
5439368|NCT00023049|Sensorineural Hearing Loss|sensorineural hearing loss
5439369|NCT00023049|Vestibular Dysfunction|vestibular dysfunction
5439370|NCT00023049|SNHL|snhl
5439371|NCT00023036|Genetics|genetics
5439372|NCT00023036|Deafness|deafness
5439373|NCT00023036|EVA|eva
5439374|NCT00023036|Pendred|pendred
5439375|NCT00023036|Hearing|hearing
5439376|NCT00023036|Hearing Impairment|hearing impairment
5439377|NCT00023036|Nonsyndromic Hereditary Hearing Impairment|nonsyndromic hereditary hearing impairment
5439378|NCT00023036|SNHL|snhl
5439379|NCT00023036|Inner Ear|inner ear
5439380|NCT00023036|Enlarged Vestibular Aqueducts|enlarged vestibular aqueducts
5439381|NCT00023023|Hepatitis|hepatitis
5439382|NCT00023023|Blood Bank|blood bank
5439383|NCT00023023|Viruses|viruses
5439384|NCT00023023|Blood Donors|blood donors
5439385|NCT00023023|Blood Recipients|blood recipients
5439386|NCT00023010|CD18|cd18
5439387|NCT00023010|Retrovirus|retrovirus
5439388|NCT00023010|RCR|rcr
5439389|NCT00023010|Stem Cell|stem cell
5439390|NCT00023010|Gene Transfer|gene transfer
5439391|NCT00023010|Leukocyte Adhesion Deficiency|leukocyte adhesion deficiency
5439392|NCT00023010|LAD|lad
5439393|NCT00022997|Phenylthiocarbamide|phenylthiocarbamide
5439394|NCT00022997|Phlebotomy|phlebotomy
5439395|NCT00022997|Chemoreceptors|chemoreceptors
5439396|NCT00022997|Population Associations|population associations
5439399|NCT00022997|Healthy Volunteer|healthy volunteer
5439400|NCT00022997|HV|hv
5439401|NCT00022997|Normal Control|normal control
5439402|NCT00022984|Attitudes Towards Technology|attitudes towards technology
5439403|NCT00022984|Cardiovascular Disease|cardiovascular disease
5439404|NCT00022984|Illness Representation|illness representation
5439405|NCT00022984|Implantable Cardioverter Defibrillator|implantable cardioverter defibrillator
5439406|NCT00022984|Symptom Distress|symptom distress
5439407|NCT00022984|Heart Disease|heart disease
5439408|NCT00022984|ICD|icd
5439409|NCT00022971|Monoclonal Antibody|monoclonal antibody
5439410|NCT00022971|Lymphoma|lymphoma
5439411|NCT00022971|Rituximab|rituximab
5439412|NCT00022971|Hu1D10|hu1d10
5439413|NCT00022971|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
5439414|NCT00022971|NHL|nhl
5439415|NCT00022971|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
5439416|NCT00022971|CLL|cll
5439417|NCT00022971|Leukemia|leukemia
5439418|NCT00022958|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
5439419|NCT00022958|Radioimmunotherapy|radioimmunotherapy
5439420|NCT00022958|Monoclonal Antibody|monoclonal antibody
5439421|NCT00022958|Corixa|corixa
5439422|NCT00022958|Bexxar|bexxar
5439423|NCT00022958|Anti-B1 Antibody|anti-b1 antibody
5439424|NCT00022958|Tositumomab|tositumomab
5439425|NCT00022958|Iodine -131 Anti-B1 Antibody|iodine -131 anti-b1 antibody
5439426|NCT00022958|Iodine I 131 Tositumomab|iodine i 131 tositumomab
5439427|NCT00022945|Mantle Cell Lymphoma|mantle cell lymphoma
5439428|NCT00022945|Radioimmunotherapy|radioimmunotherapy
5439429|NCT00022945|Monoclonal Antibody|monoclonal antibody
5439430|NCT00022945|Corixa|corixa
5439431|NCT00022945|Bexxar|bexxar
5439432|NCT00022945|Anti-B1 Antibody|anti-b1 antibody
5439433|NCT00022945|Tositumomab|tositumomab
5439434|NCT00022945|Iodine -131 Anti-B1 Antibody|iodine -131 anti-b1 antibody
5439435|NCT00022945|Iodine I 131 Tositumomab|iodine i 131 tositumomab
5439436|NCT00022932|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
5439437|NCT00022932|Radioimmunotherapy|radioimmunotherapy
5439438|NCT00022932|Monoclonal Antibody|monoclonal antibody
5439439|NCT00022932|Corixa|corixa
5439440|NCT00022932|Bexxar|bexxar
5439441|NCT00022932|Anti-B1 Antibody|anti-b1 antibody
5439442|NCT00022932|Tositumomab|tositumomab
5439443|NCT00022932|Iodine -131 Anti-B1 Antibody|iodine -131 anti-b1 antibody
5439444|NCT00022932|Iodine I 131 Tositumomab|iodine i 131 tositumomab
5439445|NCT00022919|Microdissection|microdissection
5439446|NCT00022919|Chromosome|chromosome
5439447|NCT00022919|Karyotype|karyotype
5439448|NCT00022919|Tumor|tumor
5439449|NCT00022919|Malignancy|malignancy
5439450|NCT00022919|Prostate Adenocarcinoma|prostate adenocarcinoma
5439451|NCT00022919|Prostate Intraepithelial Neoplasia|prostate intraepithelial neoplasia
5439452|NCT00022919|Prostate Cancer|prostate cancer
5439453|NCT00022919|Prostate|prostate
5439454|NCT00022906|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
5439455|NCT00022906|Radioimmunotherapy|radioimmunotherapy
5439456|NCT00022906|Monoclonal Antibody|monoclonal antibody
5439457|NCT00022906|Corixa|corixa
5439458|NCT00022906|Bexxar|bexxar
5439459|NCT00022906|Anti-B1 Antibody|anti-b1 antibody
5439460|NCT00022906|Tositumomab|tositumomab
5439461|NCT00022906|Iodine -131 Anti-B1 Antibody|iodine -131 anti-b1 antibody
5439462|NCT00022906|Iodine I 131 Tositumomab|iodine i 131 tositumomab
5439463|NCT00022893|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
5439464|NCT00022893|Radioimmunotherapy|radioimmunotherapy
5439465|NCT00022893|Monoclonal Antibody|monoclonal antibody
5439466|NCT00022893|Corixa|corixa
5439467|NCT00022893|Bexxar|bexxar
5439468|NCT00022893|Anti-B1 Antibody|anti-b1 antibody
5439469|NCT00022893|Tositumomab|tositumomab
5439470|NCT00022893|Iodine -131 Anti-B1 Antibody|iodine -131 anti-b1 antibody
5439471|NCT00022893|Iodine I 131 Tositumomab|iodine i 131 tositumomab
5439472|NCT00022880|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
5439473|NCT00022880|Dose-Escalation|dose-escalation
5439474|NCT00022880|Radioimmunotherapy|radioimmunotherapy
5439475|NCT00022880|Monoclonal Antibody|monoclonal antibody
5439476|NCT00022880|Corixa|corixa
5439477|NCT00022880|Bexxar|bexxar
5439478|NCT00022880|Anti-B1 Antibody|anti-b1 antibody
5439479|NCT00022880|Tositumomab|tositumomab
5439480|NCT00022880|Iodine -131 Anti-B1 Antibody|iodine -131 anti-b1 antibody
5439481|NCT00022880|Iodine I 131 Tositumomab|iodine i 131 tositumomab
5439482|NCT00022867|Bone growth|bone growth
5439483|NCT00022867|Calcium|calcium
5439484|NCT00022867|Children|children
5439485|NCT00022867|Diet|diet
5439486|NCT00022867|Puberty|puberty
5439487|NCT00022854|ACL|acl
5439488|NCT00022854|Nerve block|nerve block
5439489|NCT00022854|Knee|knee
5439490|NCT00022854|Outcome survey|outcome survey
5439491|NCT00022854|Anesthesia|anesthesia
5439492|NCT00022854|Analgesia|analgesia
5439493|NCT00022854|Pain|pain
5439494|NCT00022841|Bone mineral density (BMD)|bone mineral density (bmd)
5439495|NCT00022841|Children|children
5439496|NCT00022841|Glucocorticoids|glucocorticoids
5439497|NCT00022841|Osteoporosis|osteoporosis
5439498|NCT00022841|Pediatric|pediatric
5439499|NCT00022841|Pamidronate|pamidronate
5439500|NCT00022841|Steroids|steroids
5439501|NCT00022828|Laser|laser
5439502|NCT00022828|Cervical|cervical
5439507|NCT00022815|Compartment syndrome|compartment syndrome
5439508|NCT00022815|Tissue ultrafiltration|tissue ultrafiltration
5439509|NCT00022815|Reperfusion injury|reperfusion injury
5439510|NCT00022815|Ischemia|ischemia
5439511|NCT00022802|Biomedical equipment development|biomedical equipment development
5439512|NCT00022802|Computer assisted patient care|computer assisted patient care
5439513|NCT00022802|Digital imaging|digital imaging
5439514|NCT00022802|Hip surgery|hip surgery
5439515|NCT00022802|Orthopedics|orthopedics
5439516|NCT00022802|Trauma|trauma
5439517|NCT00022802|Radiography|radiography
5439518|NCT00022802|Biomedical imaging|biomedical imaging
5439519|NCT00022776|Human therapy evaluation|human therapy evaluation
5439520|NCT00022776|Orthopedics|orthopedics
5439521|NCT00022776|Physical therapy|physical therapy
5439522|NCT00022776|Nonsurgical treatment|nonsurgical treatment
5439523|NCT00022776|Surgical decompression|surgical decompression
5439524|NCT00022776|Surgery|surgery
5439525|NCT00022776|Lumbar|lumbar
5439526|NCT00022776|Spine disorder|spine disorder
5439527|NCT00022776|Spinal stenosis|spinal stenosis
5439528|NCT00022776|Gender difference|gender difference
5439529|NCT00022776|Medical rehabilitation|medical rehabilitation
5439530|NCT00022789|Sleep-Disordered Breathing|sleep-disordered breathing
5439531|NCT00022750|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
5439532|NCT00022750|Nurse Case Manager|nurse case manager
5439533|NCT00022750|Community Health Worker|community health worker
5439534|NCT00022750|Behavioral Interventions|behavioral interventions
5439535|NCT00022750|Cost-effectiveness|cost-effectiveness
5439536|NCT00022750|Randomized trial|randomized trial
5439537|NCT00021866|epilepsy|epilepsy
5439538|NCT00021866|seizure|seizure
5439539|NCT00021866|pregnancy|pregnancy
5439540|NCT00021866|antiepileptic|antiepileptic
5439541|NCT00021866|AED|aed
5439542|NCT00021866|carbamazepine|carbamazepine
5439543|NCT00021866|phenytoin|phenytoin
5439544|NCT00021866|valproate|valproate
5439545|NCT00021866|lamotrigine|lamotrigine
5439546|NCT00021866|child|child
5439547|NCT00021866|behavior|behavior
5439548|NCT00021853|Individualized|individualized
5439549|NCT00021853|Finger|finger
5439550|NCT00021853|Training|training
5439551|NCT00021853|Splinting|splinting
5439552|NCT00021853|TMS|tms
5439553|NCT00021853|Dystonia|dystonia
5439554|NCT00021853|Focal Dystonia|focal dystonia
5439555|NCT00021853|Movement Disorder|movement disorder
5439556|NCT00021853|Focal Hand Dystonia|focal hand dystonia
5439557|NCT00021853|Writer's Cramp|writer's cramp
5439558|NCT00021827|parathyroid hormone-related protein|parathyroid hormone-related protein
5439559|NCT00021827|parathyroid hormone|parathyroid hormone
5439560|NCT00021827|anabolic skeletal therapy|anabolic skeletal therapy
5439561|NCT00021827|postmenopausal women|postmenopausal women
5439562|NCT00021814|BPH progression|bph progression
5439563|NCT00021814|Medical Therapy|medical therapy
5439564|NCT00021814|Finasteride|finasteride
5439565|NCT00021814|Doxazosin|doxazosin
5439566|NCT00021814|Randomized|randomized
5439567|NCT00021814|Multi-center|multi-center
5439568|NCT00021814|Clinical Trial|clinical trial
5439569|NCT00021814|Proscar|proscar
5439570|NCT00021814|Cardura|cardura
5439571|NCT00021801|Type I Diabetes Mellitus|type i diabetes mellitus
5439572|NCT00021801|Immunosuppression|immunosuppression
5439573|NCT00021801|Islet Cell Transplant|islet cell transplant
5439574|NCT00021801|Percutaneous Transhepatic Portal|percutaneous transhepatic portal
5439575|NCT00021788|Type I Diabetes Mellitus|type i diabetes mellitus
5439576|NCT00021788|Immunosuppression|immunosuppression
5439577|NCT00021788|Islet Cell Transplantation|islet cell transplantation
5439578|NCT00021788|PercutaneousTranshepaticPortalVein Catheterization|percutaneoustranshepaticportalvein catheterization
5439579|NCT00021749|CLL|cll
5439580|NCT00021749|Leukemia|leukemia
5439581|NCT00021749|Chronic|chronic
5439582|NCT00021749|Cancer|cancer
5439583|NCT00021749|Adult|adult
5439584|NCT00021749|Lymphocytic|lymphocytic
5439585|NCT00021749|Genasense|genasense
5439586|NCT00021749|G3139|g3139
5439587|NCT00021749|Genta|genta
5439588|NCT00021749|Bcl-2|bcl-2
5439589|NCT00021749|Antisense|antisense
5439590|NCT00021749|Oligonucleotide|oligonucleotide
5439591|NCT00021749|oblimerson|oblimerson
5439592|NCT00021736|choroidal neovascularization (CNV)|choroidal neovascularization (cnv)
5439593|NCT00021736|subretinal neovascularization|subretinal neovascularization
5439594|NCT00021723|Alzheimer's|alzheimer's
5439595|NCT00021723|AN-1792|an-1792
5439596|NCT00021723|AIP-001|aip-001
5439597|NCT00021710|Stroke|stroke
5439598|NCT00021710|Learning|learning
5439599|NCT00021710|Plasticity|plasticity
5439600|NCT00021710|Motor|motor
5439601|NCT00021710|Rehabilitation|rehabilitation
5439602|NCT00021710|Premotor|premotor
5439603|NCT00021710|Normal Control|normal control
5439604|NCT00021710|Healthy Volunteer|healthy volunteer
5439605|NCT00021710|HV|hv
5439606|NCT00021710|Motor Learning|motor learning
5439607|NCT00021697|AVP-923|avp-923
5439608|NCT00021697|Dextromethorphan|dextromethorphan
5439609|NCT00021697|Quinidine|quinidine
5439610|NCT00021697|Pseudobulbar Affect|pseudobulbar affect
5439611|NCT00021658|Epidemiology|epidemiology
5439612|NCT00021658|pesticide|pesticide
5439616|NCT00021645|Corticosteroids|corticosteroids
5439617|NCT00021645|Immunosuppressives|immunosuppressives
5439618|NCT00021645|Intraocular Inflammatory Disease|intraocular inflammatory disease
5439619|NCT00021645|Uveitis|uveitis
5439620|NCT00021645|Macular Edema|macular edema
5439621|NCT00021567|Pneumonia|pneumonia
5439622|NCT00021567|Cytokine|cytokine
5439623|NCT00021567|Aerosol|aerosol
5439624|NCT00021567|Therapy|therapy
5439625|NCT00021567|Mycobacteria|mycobacteria
5439626|NCT00021567|Mycobacterium Avium Complex|mycobacterium avium complex
5439627|NCT00021567|MAC|mac
5439628|NCT00021567|Pulmonary Infection|pulmonary infection
5439629|NCT00021567|Lung Infection|lung infection
5439630|NCT00021541|Surrogate Markers|surrogate markers
5439631|NCT00021541|3-Dimensional Magnetic Resonance Imaging (MRI)|3-dimensional magnetic resonance imaging (mri)
5439632|NCT00021541|Natural History of Neurofibromatosis Type 1 (NF1)|natural history of neurofibromatosis type 1 (nf1)
5439633|NCT00021541|Tumor Tissue Bank|tumor tissue bank
5439634|NCT00021541|Neurofibromatosis|neurofibromatosis
5439635|NCT00021541|NF1|nf1
5439636|NCT00021541|Neurofibromatosis Type 1|neurofibromatosis type 1
5439637|NCT00021541|Plexiform Neurofibroma|plexiform neurofibroma
5439638|NCT00021541|Neurofibroma|neurofibroma
5439639|NCT00021528|Sequential Treatment|sequential treatment
5439640|NCT00021528|Major Depression|major depression
5439641|NCT00021528|Treatment Resistant Depression|treatment resistant depression
5439642|NCT00021502|Pyridoxalated hemoglobin polyoxyethylene conjugate (PHP)|pyridoxalated hemoglobin polyoxyethylene conjugate (php)
5439643|NCT00021502|Systemic Inflammatory Response Syndrome (SIRS)|systemic inflammatory response syndrome (sirs)
5439644|NCT00021502|Nitric oxide (NO)|nitric oxide (no)
5439645|NCT00021502|Shock|shock
5439646|NCT00021476|Whiplash|whiplash
5439647|NCT00021476|Chronic pain|chronic pain
5439648|NCT00021476|Motor vehicle accidents|motor vehicle accidents
5439649|NCT00021437|Bloom syndrome protein|bloom syndrome protein
5439650|NCT00018902|Depressive Disorder|depressive disorder
5439651|NCT00018902|Adolescents|adolescents
5439652|NCT00018902|Teenagers|teenagers
5439653|NCT00018902|Teens|teens
5439654|NCT00018902|Cognitive Behavior Therapy|cognitive behavior therapy
5439655|NCT00018889|Clinical Evaluation|clinical evaluation
5439656|NCT00018889|Genetic Study|genetic study
5439657|NCT00018889|Essential Tremor|essential tremor
5439658|NCT00018889|Familial Myoclonus|familial myoclonus
5439659|NCT00018889|Hereditary Ataxia|hereditary ataxia
5439660|NCT00018889|Movement Disorder|movement disorder
5439661|NCT00018889|Inherited Movement Disorder|inherited movement disorder
5439662|NCT00018876|Epidural fibrosis|epidural fibrosis
5439663|NCT00018876|Failed back surgery syndrome|failed back surgery syndrome
5439664|NCT00018876|Postlaminectomy syndrome|postlaminectomy syndrome
5439665|NCT00018876|Lumbar laminectomy|lumbar laminectomy
5439666|NCT00018876|Radiotherapy|radiotherapy
5439667|NCT00018876|Radiation|radiation
5439668|NCT00018876|Perineural scar formation|perineural scar formation
5439669|NCT00018876|Peridural fibrosis|peridural fibrosis
5439670|NCT00018876|Back surgery|back surgery
5439671|NCT00018863|ADHD|adhd
5439672|NCT00018850|schizophrenia|schizophrenia
5439673|NCT00018850|ondansetron|ondansetron
5439674|NCT00018850|nicotine|nicotine
5439675|NCT00018850|haloperidol|haloperidol
5439676|NCT00018811|Relaxation Techniques|relaxation techniques
5439677|NCT00018811|Behavior Therapy Feedback|behavior therapy feedback
5439678|NCT00018811|Psychophysiology|psychophysiology
5439679|NCT00018798|Combat-Related PTSD, Vietnam Veterans|combat-related ptsd, vietnam veterans
5439680|NCT00018785|kidney transplantation|kidney transplantation
5439681|NCT00018785|immunosuppression|immunosuppression
5439682|NCT00018785|bone marrow|bone marrow
5439683|NCT00018772|coagulation|coagulation
5439684|NCT00018772|thrombosis genetic markers|thrombosis genetic markers
5439685|NCT00018759|Serotonin, Hypertension, Depression|serotonin, hypertension, depression
5439686|NCT00018733|Depression|depression
5439687|NCT00018720|triglyceride|triglyceride
5439688|NCT00018720|bile acids|bile acids
5439689|NCT00018720|cholelithias|cholelithias
5439690|NCT00018694|bile acid synthesis|bile acid synthesis
5439691|NCT00018694|chenodeoxycholic acid|chenodeoxycholic acid
5439692|NCT00018694|sterol 27-hydroxylase|sterol 27-hydroxylase
5439693|NCT00018668|Antipsychotics|antipsychotics
5439694|NCT00018668|schizophrenia|schizophrenia
5439695|NCT00018668|motor retardation|motor retardation
5439696|NCT00018668|bradykinesia|bradykinesia
5439697|NCT00018655|Mood Disorders|mood disorders
5439698|NCT00018655|Substance-Related Disorders|substance-related disorders
5439699|NCT00018642|quetiapine|quetiapine
5439700|NCT00018642|haloperidol decanoate|haloperidol decanoate
5439701|NCT00018629|Aging|aging
5439702|NCT00018629|Neuropsychology|neuropsychology
5439703|NCT00018629|Psychotherapy|psychotherapy
5439704|NCT00018629|Rehabilitation|rehabilitation
5439705|NCT00018629|Schizophrenia|schizophrenia
5439706|NCT00018616|compliance|compliance
5439707|NCT00018616|MEMS|mems
5439708|NCT00018616|metformin|metformin
5439709|NCT00018603|PTSD|ptsd
5439710|NCT00018590|Vascular Diseases|vascular diseases
5439711|NCT00018538|vitamin D|vitamin d
5439712|NCT00018538|prostatic neoplasms|prostatic neoplasms
5439713|NCT00018538|neoplasm recurrence|neoplasm recurrence
5439714|NCT00018512|dental implant|dental implant
5439715|NCT00018499|Traumatic Brain Injury|traumatic brain injury
5439716|NCT00018473|Risk Factors|risk factors
5439717|NCT00018473|Genes|genes
5439718|NCT00018473|Epidemiology|epidemiology
5439719|NCT00018473|Apolipoproteins E|apolipoproteins e
5439720|NCT00018473|Alzheimer's Disease|alzheimer's disease
5439721|NCT00018460|geriatrics|geriatrics
5439722|NCT00018460|vitamin B complex|vitamin b complex
5439723|NCT00018460|thrombomodulin|thrombomodulin
5439724|NCT00018460|anticoagulants|anticoagulants
5439725|NCT00018447|osteoporosis|osteoporosis
5439726|NCT00018434|Infection|infection
5439727|NCT00018421|Cerebrovascular Disorders|cerebrovascular disorders
5439728|NCT00018421|Exercise|exercise
5439729|NCT00018421|Rehabilitation|rehabilitation
5439730|NCT00018408|COPD|copd
5439731|NCT00018408|Smoking|smoking
5439732|NCT00018395|Calcium Metabolism|calcium metabolism
5439733|NCT00018369|Aging|aging
5439734|NCT00018369|Hydrocortisone Corticotropin Feedback|hydrocortisone corticotropin feedback
5439735|NCT00018356|Aging|aging
5439736|NCT00018356|nutrition|nutrition
5439737|NCT00018356|rehabilitation|rehabilitation
5439738|NCT00018330|Behavioral|behavioral
5439739|NCT00018330|Weight Loss|weight loss
5439740|NCT00018330|Genetics|genetics
5439741|NCT00018330|Lipoprotein lipase|lipoprotein lipase
5439742|NCT00018330|Visceral fat|visceral fat
5439743|NCT00018330|Lipoprotein|lipoprotein
5439744|NCT00018317|Diet|diet
5439745|NCT00018317|exercise|exercise
5439746|NCT00018304|blood pressure|blood pressure
5439747|NCT00018304|insulin sensitivity|insulin sensitivity
5439748|NCT00018304|blood flow|blood flow
5439749|NCT00018291|Dementia|dementia
5439750|NCT00018291|Agitated Behavior|agitated behavior
5439751|NCT00018291|Behavioral disturbance|behavioral disturbance
5439752|NCT00018265|Rehabilitation|rehabilitation
5439753|NCT00018265|exercise test|exercise test
5439754|NCT00018265|aging|aging
5439755|NCT00018213|Naltrexone|naltrexone
5439756|NCT00018213|Nicotine patch|nicotine patch
5439757|NCT00018213|Tobacco dependence|tobacco dependence
5439758|NCT00018200|analgesia|analgesia
5439759|NCT00018200|Back pain|back pain
5439760|NCT00018200|sciatica|sciatica
5439761|NCT00018187|smoking cessation|smoking cessation
5439762|NCT00018187|bupropion|bupropion
5439763|NCT00018187|mecamylamine|mecamylamine
5439764|NCT00018187|nicotine|nicotine
5439765|NCT00018174|Depression|depression
5439766|NCT00018174|Fluoxetine|fluoxetine
5439767|NCT00018174|Nicotine dependence|nicotine dependence
5439768|NCT00018161|Nicotine|nicotine
5439769|NCT00018161|addiction|addiction
5439770|NCT00018161|cigarette smoking|cigarette smoking
5439771|NCT00018148|smoking cessation|smoking cessation
5439772|NCT00018135|high iPTH levels|high ipth levels
5439773|NCT00018122|Islet cell transplant|islet cell transplant
5439774|NCT00018096|Genetics|genetics
5439775|NCT00018096|Lipopolysaccharide|lipopolysaccharide
5439776|NCT00018070|Age-Related Macular Degeneration|age-related macular degeneration
5439777|NCT00018070|Choroid|choroid
5439778|NCT00018070|Blood Vessels|blood vessels
5439779|NCT00018070|Choroidal Neovascularization|choroidal neovascularization
5439780|NCT00018070|Laser|laser
5439781|NCT00018070|Macular Degeneration|macular degeneration
5439782|NCT00018070|AMD|amd
5439783|NCT00018057|fMRI|fmri
5439784|NCT00018057|SSRI|ssri
5439785|NCT00018057|Neuropsychological|neuropsychological
5439786|NCT00018057|Evaluative Learning|evaluative learning
5439787|NCT00018057|Adolescent|adolescent
5439788|NCT00018057|Normal Volunteers|normal volunteers
5439789|NCT00018057|Magnetic Resonance Imaging|magnetic resonance imaging
5439790|NCT00018057|CBT|cbt
5439791|NCT00018057|IPT|ipt
5439792|NCT00018057|Anxiety|anxiety
5439793|NCT00018057|Anxiety Disorder|anxiety disorder
5439794|NCT00018057|Mood Disorder|mood disorder
5439795|NCT00018057|Depression|depression
5439796|NCT00018057|Healthy Volunteer|healthy volunteer
5439797|NCT00018057|Normal Control|normal control
5439798|NCT00018044|Morphotype|morphotype
5439799|NCT00018044|Pulmonary|pulmonary
5439800|NCT00018044|Infection|infection
5439801|NCT00018044|Mycobacterium|mycobacterium
5439802|NCT00018044|Nontuberculous|nontuberculous
5439803|NCT00018044|Mycobacterial Infection|mycobacterial infection
5439804|NCT00018044|Nontuberculous Mycobacterial Infection|nontuberculous mycobacterial infection
5439805|NCT00018044|NTM|ntm
5439806|NCT00018044|Job's Syndrome|job's syndrome
5439807|NCT00018044|Job Syndrome|job syndrome
5439808|NCT00018044|Cystic Fibrosis|cystic fibrosis
5439809|NCT00018044|CF|cf
5439810|NCT00018031|Liver Disease|liver disease
5439811|NCT00018031|Virologic Response|virologic response
5439812|NCT00018031|Immune Mechanisms|immune mechanisms
5439813|NCT00018031|Cirrhosis|cirrhosis
5439814|NCT00018031|Eradication|eradication
5439815|NCT00018031|HIV|hiv
5439816|NCT00018031|Hepatitis C|hepatitis c
5439817|NCT00018018|Gene Therapy|gene therapy
5439818|NCT00018018|ADA-SCID|ada-scid
5439819|NCT00018018|Stem Cells|stem cells
5439820|NCT00018018|Retroviruses|retroviruses
5439821|NCT00018018|Immune Deficiency Disease|immune deficiency disease
5439822|NCT00018018|Adenosine Deaminase Deficiency|adenosine deaminase deficiency
5439823|NCT00018018|ADA-Deficiency|ada-deficiency
5439824|NCT00018018|Retroviral Vectors|retroviral vectors
5439825|NCT00018018|Hematopoietic Progenitors|hematopoietic progenitors
5439826|NCT00018018|Severe Combined Immunodeficiency|severe combined immunodeficiency
5439827|NCT00018018|SCID|scid
5439828|NCT00018018|Immune Deficiency|immune deficiency
5439829|NCT00018005|Heart Failure|heart failure
5439830|NCT00018005|Self-Management|self-management
5439831|NCT00018005|Behavioral Clinical Trial|behavioral clinical trial
5439832|NCT00017979|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
5439833|NCT00017979|Motor Cortex|motor cortex
5439834|NCT00017979|Motor Imagery|motor imagery
5439835|NCT00017979|Reaction Time|reaction time
5439836|NCT00017979|Cerebral Inhibition|cerebral inhibition
5439837|NCT00017979|Healthy Volunteer|healthy volunteer
5439838|NCT00017979|Normal Control|normal control
5439839|NCT00017966|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
5439840|NCT00017966|Motor Cortex|motor cortex
5439841|NCT00017966|Cerebral Inhibition|cerebral inhibition
5439842|NCT00017966|Corpus Callosum|corpus callosum
5439843|NCT00017966|Evoked Potential|evoked potential
5439844|NCT00017966|Healthy Volunteer|healthy volunteer
5439845|NCT00017966|Normal Control|normal control
5439846|NCT00017940|Gene Therapy|gene therapy
5439847|NCT00017953|Diabetes|diabetes
5439848|NCT00017953|Weight loss|weight loss
5439849|NCT00017953|Heart Attack|heart attack
5439850|NCT00017953|Heart disease|heart disease
5439851|NCT00017953|Lifestyle Intervention|lifestyle intervention
5439852|NCT00017953|Physical Fitness/Physical Activity|physical fitness/physical activity
5439853|NCT00017953|Psychosocial outcomes (e.g., depression, eating disorders)|psychosocial outcomes (e.g., depression, eating disorders)
5439854|NCT00017953|Bone Density|bone density
5439855|NCT00017927|Acromegaly|acromegaly
5439856|NCT00017927|McCune-Albright Syndrome|mccune-albright syndrome
5439857|NCT00017927|IGF-1|igf-1
5439858|NCT00017927|Adenoma|adenoma
5439859|NCT00017927|Hyperplasia|hyperplasia
5439860|NCT00017927|MAS|mas
5439861|NCT00017927|Polyostotic Fibrous Dysplasia|polyostotic fibrous dysplasia
5439862|NCT00017927|PFD|pfd
5439863|NCT00017914|Adult and Pediatric Disease|adult and pediatric disease
5439864|NCT00017914|Idiopathic Inflammatory Myopathies|idiopathic inflammatory myopathies
5439865|NCT00017914|Autoimmunity Pathogenesis|autoimmunity pathogenesis
5439866|NCT00017914|Disease Assessment|disease assessment
5439867|NCT00017914|Genetic and Environmental Risk Factors|genetic and environmental risk factors
5439868|NCT00017914|Juvenile Polymyositis|juvenile polymyositis
5439869|NCT00017914|Juvenile Dermatomyositis|juvenile dermatomyositis
5439870|NCT00017914|Calcinosis|calcinosis
5439871|NCT00017914|Idiopathic Inflammatory Myopathy|idiopathic inflammatory myopathy
5439872|NCT00017875|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
5439873|NCT00017875|Intracortical Inhibition|intracortical inhibition
5439874|NCT00017875|Dystonia|dystonia
5439875|NCT00017875|Focal Dystonia|focal dystonia
5439876|NCT00017875|Dystonic Disorder|dystonic disorder
5439877|NCT00017875|DYTI Dystonia|dyti dystonia
5439878|NCT00017875|Movement Disorder|movement disorder
5439879|NCT00017875|Generalized Dystonia|generalized dystonia
5439880|NCT00017875|Healthy Control|healthy control
5439881|NCT00017875|Normal Volunteer|normal volunteer
5439882|NCT00017823|complementary therapies|complementary therapies
5439883|NCT00017823|Acupressure|acupressure
5439884|NCT00017823|HIV Infections|hiv infections
5439885|NCT00017823|Nausea|nausea
5439886|NCT00017823|Vomiting|vomiting
5439887|NCT00017810|complementary therapies|complementary therapies
5439888|NCT00017810|Behavior Therapy|behavior therapy
5439889|NCT00017810|Diarrhea|diarrhea
5439890|NCT00017810|Diet Therapy|diet therapy
5439891|NCT00017810|Food|food
5439892|NCT00017810|HIV Seropositivity|hiv seropositivity
5439893|NCT00017745|DNA|dna
5439894|NCT00017745|Hereditary Myopathies|hereditary myopathies
5439895|NCT00017745|Intermediate Filaments|intermediate filaments
5439896|NCT00017745|Cardiomyopathies|cardiomyopathies
5439897|NCT00017745|Genetic Testing|genetic testing
5439898|NCT00017745|Myopathy|myopathy
5439899|NCT00017745|Inherited Neuromuscular Disorder|inherited neuromuscular disorder
5439900|NCT00017732|Malformations|malformations
5439901|NCT00017732|Ethnicity|ethnicity
5439902|NCT00017732|Mutations|mutations
5439903|NCT00017732|Cholesterol|cholesterol
5439904|NCT00017732|Metabolism|metabolism
5439905|NCT00017732|Smith-Lemli-Opitz Syndrome|smith-lemli-opitz syndrome
5439906|NCT00017732|SLOS|slos
5439907|NCT00017732|Cholesterol Metabolism|cholesterol metabolism
5439908|NCT00017706|physician education|physician education
5439909|NCT00017706|behavioral weight control|behavioral weight control
5439910|NCT00017706|physician intervention|physician intervention
5439911|NCT00017706|obesity counseling|obesity counseling
5439912|NCT00016848|Obesity|obesity
5439913|NCT00016848|Endocrine|endocrine
5439914|NCT00016848|Diet|diet
5439915|NCT00016848|Metabolism|metabolism
5439916|NCT00016848|Macronutrients|macronutrients
5439917|NCT00016835|Type 2 diabetes mellitus|type 2 diabetes mellitus
5439918|NCT00016835|Glycemic control|glycemic control
5439919|NCT00016835|Periodontal therapy|periodontal therapy
5439921|NCT00017680|arthritis & connective tissue diseases|arthritis & connective tissue diseases
5439922|NCT00017680|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
5439923|NCT00017680|hematopoietic/lymphoid cancer|hematopoietic/lymphoid cancer
5439924|NCT00017680|oncologic disorders|oncologic disorders
5439925|NCT00017680|plasma cell neoplasm|plasma cell neoplasm
5439926|NCT00017680|primary systemic amyloidosis|primary systemic amyloidosis
5439927|NCT00017680|rare disease|rare disease
5439928|NCT00017654|aplastic anemia|aplastic anemia
5439929|NCT00017654|disease-related problem/condition|disease-related problem/condition
5439930|NCT00017654|graft versus host disease|graft versus host disease
5439931|NCT00017654|hematologic disorders|hematologic disorders
5439932|NCT00017654|rare disease|rare disease
5439933|NCT00017641|arthritis & connective tissue diseases|arthritis & connective tissue diseases
5439934|NCT00017641|immunologic disorders and infectious disorders|immunologic disorders and infectious disorders
5439935|NCT00017641|rare disease|rare disease
5439936|NCT00017641|systemic lupus erythematosus|systemic lupus erythematosus
5439937|NCT00017628|multiple sclerosis|multiple sclerosis
5439938|NCT00017628|neurologic and psychiatric disorders|neurologic and psychiatric disorders
5439939|NCT00017628|rare disease|rare disease
5439940|NCT00016796|Reading|reading
5439941|NCT00016796|Naming|naming
5439942|NCT00016731|Depression|depression
5439943|NCT00016731|Anxiety|anxiety
5439944|NCT00016731|CAH|cah
5439945|NCT00016731|Adults|adults
5439946|NCT00016731|FMPP|fmpp
5439947|NCT00016731|Emotion|emotion
5439948|NCT00016731|Cushing's Syndrome|cushing's syndrome
5439949|NCT00016731|Adolescence|adolescence
5439950|NCT00016731|Magnetic Resonance Imaging|magnetic resonance imaging
5439951|NCT00016731|fMRI|fmri
5439952|NCT00016731|Healthy Volunteer|healthy volunteer
5439953|NCT00016731|HV|hv
5439954|NCT00016731|MRI|mri
5439955|NCT00016679|Pharmacokinetics|pharmacokinetics
5439956|NCT00016679|Metabolism|metabolism
5439957|NCT00016679|Toxicity|toxicity
5439958|NCT00016679|Side Effects|side effects
5439959|NCT00016679|Essential Tremor|essential tremor
5439960|NCT00016679|Tremor|tremor
5439961|NCT00016679|Movement Disorder|movement disorder
5439962|NCT00016666|Season|season
5439963|NCT00016666|Light|light
5439964|NCT00016666|Propranolol|propranolol
5439965|NCT00016666|Photoperiod|photoperiod
5439966|NCT00016666|Pharmacokinetics|pharmacokinetics
5439967|NCT00016666|Circadian Rhythm|circadian rhythm
5439968|NCT00016666|Seasonal Rhythm|seasonal rhythm
5439969|NCT00016666|Seasonal Affective Disorder|seasonal affective disorder
5439970|NCT00016666|Pineal Gland|pineal gland
5439971|NCT00016666|Suprachiasmatic Nucleus|suprachiasmatic nucleus
5439972|NCT00016666|Healthy Volunteer|healthy volunteer
5439973|NCT00016666|HV|hv
5439974|NCT00016666|Winter Depression|winter depression
5439975|NCT00016666|SAD|sad
5439976|NCT00016653|Duchenne|duchenne
5439977|NCT00016653|muscular|muscular
5439978|NCT00016653|dystrophy|dystrophy
5439979|NCT00016653|treatment|treatment
5439980|NCT00016562|Genetic|genetic
5439981|NCT00016562|Degenerative|degenerative
5439982|NCT00016562|Lysosomal|lysosomal
5439983|NCT00016562|Brain|brain
5439984|NCT00016562|Mental Retardation|mental retardation
5439985|NCT00016562|Neurodegenerative Disorder|neurodegenerative disorder
5439986|NCT00016562|Neurometabolic|neurometabolic
5439987|NCT00016562|Metabolic Neurological Disorder|metabolic neurological disorder
5439988|NCT00016562|Abnormal Metabolism|abnormal metabolism
5439989|NCT00016549|Endothelial Proliferation|endothelial proliferation
5439990|NCT00016549|Endothelial Apoptosis|endothelial apoptosis
5439991|NCT00016549|VEGF|vegf
5439992|NCT00016549|Magnetic Resonance Imaging|magnetic resonance imaging
5439993|NCT00016549|Molecular Targets|molecular targets
5439994|NCT00016549|Breast Cancer|breast cancer
5439995|NCT00016549|Inflammatory Breast Cancer|inflammatory breast cancer
5439996|NCT00016549|IBC|ibc
5439997|NCT00016523|NICHD Neonatal Research Network|nichd neonatal research network
5439998|NCT00016523|Extremely Low Birth Weight (ELBW)|extremely low birth weight (elbw)
5439999|NCT00016523|Very Low Birth Weight (VLBW)|very low birth weight (vlbw)
5440000|NCT00016523|Prematurity|prematurity
5440001|NCT00016523|Inhaled nitric oxide|inhaled nitric oxide
5440002|NCT00016523|Aspiration syndrome|aspiration syndrome
5440003|NCT00016523|Idiopathic pulmonary hypertension|idiopathic pulmonary hypertension
5440004|NCT00016523|Pulmonary hypoplasia|pulmonary hypoplasia
5440005|NCT00016510|Bilingualism|bilingualism
5440006|NCT00016510|Fluency|fluency
5440007|NCT00016510|Age at Acquisition|age at acquisition
5440008|NCT00016510|Words and Sentences|words and sentences
5440009|NCT00016510|Cortical Area|cortical area
5440010|NCT00016510|Healthy Volunteer|healthy volunteer
5440011|NCT00016510|HV|hv
5440012|NCT00016510|Bilingual|bilingual
5440013|NCT00016510|Second Language|second language
5440014|NCT00016497|otitis media with effusion|otitis media with effusion
5440015|NCT00016497|children|children
5440016|NCT00016497|tympanostomy tubes|tympanostomy tubes
5440017|NCT00016497|adenoidectomy|adenoidectomy
5440018|NCT00016458|arthritis & connective tissue diseases|arthritis & connective tissue diseases
5440019|NCT00016458|rare disease|rare disease
5440020|NCT00016458|systemic sclerosis|systemic sclerosis
5440021|NCT00016445|cardiovascular and respiratory diseases|cardiovascular and respiratory diseases
5440022|NCT00016445|cystic fibrosis|cystic fibrosis
5440023|NCT00016445|disease-related problem/condition|disease-related problem/condition
5440024|NCT00016445|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
5440025|NCT00016445|quality of life|quality of life
5440026|NCT00016445|rare disease|rare disease
5440027|NCT00015808|Neurodegeneration|neurodegeneration
5440028|NCT00015808|Anti-Oxidant|anti-oxidant
5440029|NCT00015808|Neuropathy|neuropathy
5440030|NCT00015808|Hereditary|hereditary
5440031|NCT00015808|Spinocerebellar|spinocerebellar
5440032|NCT00015808|Friedreich's Ataxia|friedreich's ataxia
5440033|NCT00015808|Friedreich Ataxia|friedreich ataxia
5440034|NCT00015808|FRDA|frda
5440035|NCT00015795|Pressure|pressure
5440036|NCT00015795|Botulinum Toxin|botulinum toxin
5440037|NCT00015795|Voice|voice
5440038|NCT00015795|Dystonia|dystonia
5440039|NCT00015795|Pathophysiology|pathophysiology
5440040|NCT00015795|Healthy Volunteer|healthy volunteer
5440041|NCT00015795|HV|hv
5440042|NCT00015795|ABSD|absd
5440043|NCT00015795|Spasmodic Dysphonia|spasmodic dysphonia
5440044|NCT00015795|Abductor Spasmodic Dysphonia|abductor spasmodic dysphonia
5440045|NCT00015782|Metabolic|metabolic
5440046|NCT00015782|Genetic|genetic
5440047|NCT00015782|Storage|storage
5440048|NCT00015782|Retinal Disease|retinal disease
5440049|NCT00015782|Degenerative|degenerative
5440050|NCT00015782|Mucolipidosis Type IV|mucolipidosis type iv
5440051|NCT00015782|ML-IV|ml-iv
5440052|NCT00015769|Mania|mania
5440053|NCT00015769|Depression|depression
5440054|NCT00015769|Anticonvulsants|anticonvulsants
5440055|NCT00015769|Mood Stabilizers|mood stabilizers
5440056|NCT00015769|Bipolar|bipolar
5440057|NCT00015769|Mood Stabilizer|mood stabilizer
5440058|NCT00015756|Apheresis|apheresis
5440059|NCT00015756|Transplantation|transplantation
5440060|NCT00015756|Type III Secretion Pathway|type iii secretion pathway
5440061|NCT00015756|Exotoxins|exotoxins
5440062|NCT00015756|Pseudomonas Aeruginosa|pseudomonas aeruginosa
5440063|NCT00015756|Cystic Fibrosis|cystic fibrosis
5440064|NCT00015756|CF|cf
5440065|NCT00015717|Imaging|imaging
5440066|NCT00015717|Complications|complications
5440067|NCT00015717|Stenosis|stenosis
5440068|NCT00015717|Treatment|treatment
5440069|NCT00015717|Strokes|strokes
5440070|NCT00015717|Cerebral Ischemia|cerebral ischemia
5440071|NCT00015717|Cranial Cervical Angioplasty|cranial cervical angioplasty
5440072|NCT00015678|Motor Cortex|motor cortex
5440073|NCT00015678|Drug|drug
5440074|NCT00015678|GABA|gaba
5440075|NCT00015678|Cortical Modulation|cortical modulation
5440076|NCT00015678|Magnetic Stimulation|magnetic stimulation
5440077|NCT00015678|Healthy Volunteer|healthy volunteer
5440078|NCT00015665|Fungal|fungal
5440079|NCT00015665|Immunodeficiency|immunodeficiency
5440080|NCT00015665|Infection|infection
5440081|NCT00015665|Refractory|refractory
5440082|NCT00015665|Severe|severe
5440083|NCT00015665|Fungal Infections|fungal infections
5440084|NCT00015639|Blood Donors|blood donors
5440085|NCT00015639|Employees|employees
5440086|NCT00015639|Heparin|heparin
5440087|NCT00015639|Histidine-Rich Glycoprotein|histidine-rich glycoprotein
5440088|NCT00015639|Membrane|membrane
5440089|NCT00015639|Healthy Volunteer|healthy volunteer
5440090|NCT00015613|Hispanics|hispanics
5440091|NCT00015613|Acculturation|acculturation
5440092|NCT00015613|Maternal Exposure|maternal exposure
5440093|NCT00015613|Infant, Low Birth Weight|infant, low birth weight
5440094|NCT00015613|Infant, Premature|infant, premature
5440095|NCT00015613|Organophosphates|organophosphates
5440096|NCT00015613|Pesticides|pesticides
5440097|NCT00015613|Stress|stress
5440098|NCT00015613|Nutrition|nutrition
5440099|NCT00015600|Pesticide|pesticide
5440100|NCT00015600|Farmworker|farmworker
5440101|NCT00015600|Occupational health|occupational health
5440102|NCT00015587|Molecular Epidemiology|molecular epidemiology
5440103|NCT00015587|Case Control|case control
5440104|NCT00015574|arrhythmia|arrhythmia
5440105|NCT00015574|cardiac|cardiac
5440106|NCT00015574|air pollution|air pollution
5440107|NCT00015574|time series|time series
5440108|NCT00015561|population studies|population studies
5440109|NCT00015561|laboratory evaluation|laboratory evaluation
5440110|NCT00015561|hormone analysis|hormone analysis
5440111|NCT00015561|semen analysis|semen analysis
5440112|NCT00015561|chromosome studies|chromosome studies
5440113|NCT00015548|antipsychotic treatment|antipsychotic treatment
5440114|NCT00015548|Alzheimer's disease|alzheimer's disease
5440115|NCT00015548|agitation|agitation
5440116|NCT00015548|dementia|dementia
5440117|NCT00015548|psychosis|psychosis
5440118|NCT00015548|behavioral symptoms|behavioral symptoms
5440119|NCT00015548|hallucinations|hallucinations
5440120|NCT00015548|delusions|delusions
5440121|NCT00015483|Hematotoxicity|hematotoxicity
5440122|NCT00015483|Benzene|benzene
5440123|NCT00015483|Bone Marrow|bone marrow
5440124|NCT00015470|Myopathy|myopathy
5440125|NCT00015470|Dystrophy|dystrophy
5440126|NCT00015470|Neuropathy|neuropathy
5440127|NCT00015470|Muscle Weakness|muscle weakness
5440128|NCT00015470|Muscle Cramps and Pains|muscle cramps and pains
5440129|NCT00015470|Neuromuscular Disorders|neuromuscular disorders
5440130|NCT00015457|Writer's Cramp|writer's cramp
5440131|NCT00015457|Calcium Channel Antagonists|calcium channel antagonists
5440132|NCT00015457|Torticollis|torticollis
5440133|NCT00015457|Chemodenervation|chemodenervation
5440134|NCT00015444|Apparently Sporadic Spastic Paraplegia|apparently sporadic spastic paraplegia
5440135|NCT00015444|Spasticity|spasticity
5440136|NCT00015444|Motor Neuron Disease|motor neuron disease
5440137|NCT00015444|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
5440138|NCT00015444|Primary Lateral Sclerosis|primary lateral sclerosis
5440139|NCT00015444|Muscle Stiffness|muscle stiffness
5440140|NCT00015444|Involuntary Muscle Contraction|involuntary muscle contraction
5440141|NCT00015444|Isaacs Syndrome|isaacs syndrome
5440142|NCT00015431|Malabsorption|malabsorption
5440143|NCT00015431|Endoscopy|endoscopy
5440144|NCT00015431|Cytokine|cytokine
5440145|NCT00015431|Immunophenotype|immunophenotype
5440146|NCT00015431|Lymphocyte|lymphocyte
5440147|NCT00015431|Common Variable Immunodeficiency|common variable immunodeficiency
5440148|NCT00015431|Gastrointestinal|gastrointestinal
5440149|NCT00015015|Dichloroacetate|dichloroacetate
5440150|NCT00015015|Chlorinated hydrocarbons|chlorinated hydrocarbons
5440151|NCT00015015|Genetic disease|genetic disease
5440152|NCT00015015|Toxicology|toxicology
5440153|NCT00015015|Biotransformation|biotransformation
5440154|NCT00015340|Opioid Dependence|opioid dependence
5440155|NCT00015249|cocaine dependence|cocaine dependence
5440156|NCT00015210|Cocaine Use Disorders Dependence Depression|cocaine use disorders dependence depression
5440157|NCT00015171|opioid dependence|opioid dependence
5440158|NCT00015132|cocaine dependence|cocaine dependence
5440159|NCT00015106|cocaine dependence|cocaine dependence
5440160|NCT00015080|cocaine dependence|cocaine dependence
5440161|NCT00015054|cocaine dependence|cocaine dependence
5440162|NCT00015041|opiate dependence|opiate dependence
5440163|NCT00015028|opioid dependence|opioid dependence
5440164|NCT00015002|Antenatal corticosteroids|antenatal corticosteroids
5440165|NCT00015002|Preterm delivery|preterm delivery
5440166|NCT00014989|Preterm delivery|preterm delivery
5440167|NCT00014989|Cerebral palsy|cerebral palsy
5440168|NCT00014989|Magnesium sulfate|magnesium sulfate
5440169|NCT00014976|Pyramidal Tract|pyramidal tract
5440170|NCT00014976|Primary Lateral Sclerosis|primary lateral sclerosis
5440171|NCT00014976|Spastic Paraparesis|spastic paraparesis
5440172|NCT00014976|EMG|emg
5440173|NCT00014976|Magnetic Stimulation|magnetic stimulation
5440174|NCT00014976|Muscle Spasticity|muscle spasticity
5440175|NCT00014976|Healthy Volunteer|healthy volunteer
5440176|NCT00014963|benzene|benzene
5440177|NCT00014963|biomarkers|biomarkers
5440178|NCT00014963|air pollution|air pollution
5440179|NCT00014963|muconic acid|muconic acid
5440180|NCT00014963|phenylmercapturic acid|phenylmercapturic acid
5440181|NCT00014950|Cystic Fibrosis|cystic fibrosis
5440182|NCT00014950|Immunoreactive trypsinogen|immunoreactive trypsinogen
5440183|NCT00014950|deltaF508- CFTR gene|deltaf508- cftr gene
5440184|NCT00014950|newborn screening|newborn screening
5440185|NCT00014950|Pseudomonas aeruginosa infection|pseudomonas aeruginosa infection
5440186|NCT00014950|nutrition|nutrition
5440187|NCT00014950|pulmonary status|pulmonary status
5440188|NCT00014950|meconium ileus|meconium ileus
5440189|NCT00014950|growth|growth
5440190|NCT00014950|Genetic counseling|genetic counseling
5440191|NCT00014950|risk communication|risk communication
5440192|NCT00014898|Lead exposure|lead exposure
5440193|NCT00014898|Bone lead|bone lead
5440194|NCT00014898|Attention deficit|attention deficit
5440195|NCT00014885|Lead exposure|lead exposure
5440196|NCT00014885|Bone lead|bone lead
5440197|NCT00014885|Cognitive function|cognitive function
5440198|NCT00014885|Academic achievement|academic achievement
5440199|NCT00014885|Neurobehavior|neurobehavior
5440200|NCT00014859|Pulmonary surfactant|pulmonary surfactant
5440201|NCT00014859|Surfactant protein B|surfactant protein b
5440202|NCT00014859|Surfactant protein C|surfactant protein c
5440203|NCT00014859|ABCA3|abca3
5440204|NCT00014859|NKX2-1|nkx2-1
5440205|NCT00014807|Pesticide exposure|pesticide exposure
5440206|NCT00014807|Organophosphate|organophosphate
5440207|NCT00014807|Biomarkers of exposure|biomarkers of exposure
5440208|NCT00014807|Poisoning|poisoning
5440209|NCT00014807|Occupational Health|occupational health
5440210|NCT00014794|Arthritis|arthritis
5440211|NCT00014794|Vascularity|vascularity
5440212|NCT00014794|Angiogenesis|angiogenesis
5440213|NCT00014794|Imaging|imaging
5440214|NCT00014794|MRI|mri
5440215|NCT00014794|Rheumatoid Arthritis|rheumatoid arthritis
5440216|NCT00014794|PET Scan|pet scan
5440217|NCT00014794|Synovitis|synovitis
5440218|NCT00014781|cardiovascular and respiratory diseases|cardiovascular and respiratory diseases
5440219|NCT00014781|cystic fibrosis|cystic fibrosis
5440220|NCT00014781|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
5440221|NCT00014781|rare disease|rare disease
5440222|NCT00014768|cardiovascular and respiratory diseases|cardiovascular and respiratory diseases
5440223|NCT00014768|cystic fibrosis|cystic fibrosis
5440224|NCT00014768|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
5440225|NCT00014768|rare disease|rare disease
5440226|NCT00014755|multiple sclerosis|multiple sclerosis
5440227|NCT00014755|neurologic and psychiatric disorders|neurologic and psychiatric disorders
5440228|NCT00014755|rare disease|rare disease
5440229|NCT00014742|Dupuytren's disease|dupuytren's disease
5440230|NCT00014742|arthritis & connective tissue diseases|arthritis & connective tissue diseases
5440231|NCT00014742|rare disease|rare disease
5440232|NCT00014729|dermatologic disorders|dermatologic disorders
5440233|NCT00014729|epidermolysis bullosa|epidermolysis bullosa
5440234|NCT00014729|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
5440235|NCT00014729|rare disease|rare disease
5440236|NCT00014040|Angina Pectoris|angina pectoris
5440237|NCT00014040|Endothelium|endothelium
5440238|NCT00014040|Platelets|platelets
5440239|NCT00014040|Inflammation|inflammation
5440240|NCT00014040|Atherosclerosis|atherosclerosis
5440241|NCT00014040|Coronary Artery Disease|coronary artery disease
5440242|NCT00014040|Chest Pain|chest pain
5440243|NCT00014040|Nitrous Oxide Inhalation|nitrous oxide inhalation
5440244|NCT00014040|Treadmill Exercise|treadmill exercise
5440245|NCT00014027|Omega-3 Fatty Acids|omega-3 fatty acids
5440246|NCT00014027|Cerebrospinal Fluid|cerebrospinal fluid
5440247|NCT00014027|Neurotransmitters|neurotransmitters
5440248|NCT00014027|Cardiovascular|cardiovascular
5440249|NCT00014027|Reactivity|reactivity
5440250|NCT00014027|Healthy Volunteer|healthy volunteer
5440251|NCT00014027|Lumbar Puncture|lumbar puncture
5440252|NCT00014027|MRI|mri
5440253|NCT00014001|Antipsychotic Treatment|antipsychotic treatment
5440254|NCT00014001|Effectiveness|effectiveness
5440255|NCT00013975|Framingham Risk Scoring|framingham risk scoring
5440256|NCT00013975|Brachial Artery Reactivity|brachial artery reactivity
5440257|NCT00013975|EPC Colony Assay|epc colony assay
5440258|NCT00013975|Healthy Volunteer|healthy volunteer
5440259|NCT00013975|Atherosclerosis Risk Factors|atherosclerosis risk factors
5440260|NCT00013975|Cholesterol|cholesterol
5440261|NCT00013975|Hypertension|hypertension
5440262|NCT00013975|Smoking|smoking
5440263|NCT00013975|Diabetes|diabetes
5440264|NCT00013975|Postmenopausal|postmenopausal
5440265|NCT00013975|Heart Disease Risk Factors|heart disease risk factors
5440266|NCT00013975|Risk Factors|risk factors
5440267|NCT00013949|Holter monitoring|holter monitoring
5440268|NCT00013949|ECG|ecg
5440269|NCT00013949|Cardiac|cardiac
5440270|NCT00013949|particulate exposure|particulate exposure
5440271|NCT00013936|Instrument Development|instrument development
5440272|NCT00013936|Psychophysical Methods|psychophysical methods
5440273|NCT00013936|ETDRS|etdrs
5440274|NCT00013936|Computer-Based Methods|computer-based methods
5440275|NCT00013936|Validation Study|validation study
5440276|NCT00013936|Visual Acuity|visual acuity
5440277|NCT00013936|Vision Tests/Instrumentation|vision tests/instrumentation
5440278|NCT00013936|Psychophysics|psychophysics
5440279|NCT00013936|Modified Binary Search|modified binary search
5440280|NCT00013936|Visual Acuity Test|visual acuity test
5440281|NCT00013923|Nutritional Supplement|nutritional supplement
5440282|NCT00013910|glucagon-like peptide 1|glucagon-like peptide 1
5440283|NCT00013858|methylmercury|methylmercury
5440284|NCT00013858|PCBs|pcbs
5440285|NCT00013858|lead|lead
5440286|NCT00013858|fish consumption|fish consumption
5440287|NCT00013858|breast-feeding|breast-feeding
5440288|NCT00013884|HIV|hiv
5440289|NCT00013884|T20|t20
5440290|NCT00013884|HAART|haart
5440291|NCT00013884|Interruption|interruption
5440292|NCT00013884|Therapy|therapy
5440293|NCT00013884|Fusion Inhibitor T20|fusion inhibitor t20
5440294|NCT00013884|Treatment Interuption|treatment interuption
5440295|NCT00013845|Seizures|seizures
5440296|NCT00013845|Anti-Epileptic Drugs|anti-epileptic drugs
5440297|NCT00013845|Pharmacotherapy|pharmacotherapy
5440298|NCT00013845|Neuropsychology|neuropsychology
5440299|NCT00013845|Temporal Lobe Epilepsy|temporal lobe epilepsy
5440300|NCT00013845|Frontal Lobe Epilepsy|frontal lobe epilepsy
5440301|NCT00013845|Complex Partial Seizures|complex partial seizures
5440302|NCT00013845|Grand Mal Seizures|grand mal seizures
5440303|NCT00013845|Generalized Seizures|generalized seizures
5440304|NCT00013845|Epilepsy|epilepsy
5440305|NCT00013832|Pressure|pressure
5440306|NCT00013832|Swallowing|swallowing
5440307|NCT00013832|Tongue|tongue
5440308|NCT00013832|Healthy Volunteer|healthy volunteer
5440309|NCT00013832|Dysphagia|dysphagia
5440310|NCT00013819|lead poisoning|lead poisoning
5440311|NCT00013819|central nervous system|central nervous system
5440312|NCT00013819|peripheral nervous system|peripheral nervous system
5440313|NCT00013819|occupational health|occupational health
5440314|NCT00013819|genetic susceptibility|genetic susceptibility
5440315|NCT00013806|Relapsed and refractory neuroblastoma|relapsed and refractory neuroblastoma
5440316|NCT00013780|ozone uptake|ozone uptake
5440317|NCT00013780|inhalation toxicology|inhalation toxicology
5440318|NCT00013780|nasal cavities|nasal cavities
5440319|NCT00013780|antioxidants|antioxidants
5440320|NCT00013767|Pesticide|pesticide
5440321|NCT00013767|Insecticide|insecticide
5440322|NCT00013767|Organophosphate|organophosphate
5440323|NCT00013767|Child Health|child health
5440324|NCT00013767|Exposure Prevention|exposure prevention
5440327|NCT00013754|organophosphate|organophosphate
5440328|NCT00013754|exposure|exposure
5440329|NCT00013754|child health|child health
5440330|NCT00013741|Acute Myocardial Infarction|acute myocardial infarction
5440331|NCT00013741|Diabetes Mellitus|diabetes mellitus
5440332|NCT00013741|Renal Dialysis|renal dialysis
5440333|NCT00013741|Heart Attack|heart attack
5440334|NCT00013741|Coronary Heart Disease|coronary heart disease
5440335|NCT00013728|asthma|asthma
5440336|NCT00013728|particulate matter|particulate matter
5440337|NCT00013715|Asthma|asthma
5440338|NCT00013715|Rhinovirus|rhinovirus
5440339|NCT00013715|Ozone|ozone
5440340|NCT00013702|Immunology|immunology
5440341|NCT00013702|Cirrhosis|cirrhosis
5440342|NCT00013702|Ascites|ascites
5440343|NCT00013702|Open-Label|open-label
5440345|NCT00013702|HIV|hiv
5440346|NCT00013702|Hepatitis B|hepatitis b
5440347|NCT00013689|Lymphadenopathy|lymphadenopathy
5440348|NCT00013689|Splenomegaly|splenomegaly
5440349|NCT00013689|Children|children
5440350|NCT00013689|Tomography|tomography
5440351|NCT00013689|Autoimmune Lymphoproliferative Syndrome (ALPS)|autoimmune lymphoproliferative syndrome (alps)
5440352|NCT00013650|Alzheimer's Disease|alzheimer's disease
5440353|NCT00013650|Immunomodulatory|immunomodulatory
5440354|NCT00013650|Antiinflammatory|antiinflammatory
5440355|NCT00013650|Cyclophosphamide|cyclophosphamide
5440356|NCT00013650|Non-steroidal|non-steroidal
5440357|NCT00013650|Complement|complement
5440358|NCT00013650|Immune Function|immune function
5440359|NCT00013650|Immunotherapy|immunotherapy
5440360|NCT00013637|Osteoporosis|osteoporosis
5440361|NCT00013637|Lead|lead
5440362|NCT00013624|Riluzole|riluzole
5440363|NCT00013624|Dyskinesias|dyskinesias
5440364|NCT00013624|L-Dopa Infusion|l-dopa infusion
5440365|NCT00013624|Parkinson's Disease|parkinson's disease
5440366|NCT00013611|HIV|hiv
5440367|NCT00013611|Proleukin|proleukin
5440368|NCT00013611|IL-2|il-2
5440369|NCT00013611|Adult|adult
5440370|NCT00013611|HAART|haart
5440371|NCT00013611|Treatment Experienced|treatment experienced
5440372|NCT00013598|Insulin Resistance|insulin resistance
5440373|NCT00013598|Obesity|obesity
5440374|NCT00013598|Diabetes|diabetes
5440375|NCT00013598|Fatty Liver|fatty liver
5440376|NCT00013598|Cirrhosis|cirrhosis
5440377|NCT00013598|Thiazolidinediones|thiazolidinediones
5440378|NCT00013598|Peroxisome Proliferator-Activated Receptor Gamma|peroxisome proliferator-activated receptor gamma
5440379|NCT00013598|PPARgamma|ppargamma
5440380|NCT00013598|Nonalcoholic Steatohepatitis|nonalcoholic steatohepatitis
5440381|NCT00013598|Pioglitazone|pioglitazone
5440382|NCT00013598|Non-Alcoholic Steatohepatitis|non-alcoholic steatohepatitis
5440383|NCT00013598|Liver Biopsy|liver biopsy
5440384|NCT00013598|Pharmacotherapy|pharmacotherapy
5440385|NCT00013559|Sleep Disturbance|sleep disturbance
5440386|NCT00013559|Developmental Delay/ MR|developmental delay/ mr
5440387|NCT00013559|Deletion 17p11.2|deletion 17p11.2
5440388|NCT00013559|Chromosomal Abnormalities|chromosomal abnormalities
5440389|NCT00013559|Behavioral Phenotype|behavioral phenotype
5440390|NCT00013559|Smith-Magenis Syndrome|smith-magenis syndrome
5440391|NCT00013559|Genetics|genetics
5440392|NCT00013546|Osteoporosis|osteoporosis
5440393|NCT00013546|Body Composition|body composition
5440394|NCT00013546|Estrogen|estrogen
5440395|NCT00013546|Androgen|androgen
5440396|NCT00013546|Ovarian Failure|ovarian failure
5440397|NCT00013546|Turner's Syndrome|turner's syndrome
5440398|NCT00013546|Hormone Replacement|hormone replacement
5440399|NCT00013546|Turners|turners
5440400|NCT00013546|Turner's|turner's
5440401|NCT00013546|TS|ts
5440402|NCT00013533|Leukemia|leukemia
5440403|NCT00013533|Myelodysplastic Syndrome|myelodysplastic syndrome
5440404|NCT00013533|Bone Marrow Transplant|bone marrow transplant
5440405|NCT00013533|Pediatric Oncology|pediatric oncology
5440406|NCT00013533|Lymphoma|lymphoma
5440407|NCT00013533|Efficacy|efficacy
5440408|NCT00013533|Safety|safety
5440409|NCT00013533|Childhood Cancer|childhood cancer
5440410|NCT00013507|Frail|frail
5440411|NCT00013507|FIT|fit
5440412|NCT00013507|transfer|transfer
5440413|NCT00013507|continence|continence
5440414|NCT00013507|ambulation|ambulation
5440415|NCT00013507|balance|balance
5440416|NCT00013507|fall risk|fall risk
5440417|NCT00013507|strength,endurance|strength,endurance
5440418|NCT00013494|Hemiplegia|hemiplegia
5440419|NCT00013494|elderly|elderly
5440420|NCT00013494|Video|video
5440421|NCT00013494|F-PAT,Functional Performance|f-pat,functional performance
5440422|NCT00013494|digitized videoclips|digitized videoclips
5440423|NCT00013481|stroke, hemiparesis, CNS, motor coordination|stroke, hemiparesis, cns, motor coordination
5440424|NCT00013468|Hearing loss, ear, steroids, auditory|hearing loss, ear, steroids, auditory
5440425|NCT00013455|Hearing aid, hearing impaired|hearing aid, hearing impaired
5440426|NCT00013442|Aphasia, auditory evoked, aging|aphasia, auditory evoked, aging
5440427|NCT00013429|Vision, Opthalmology, blindness, aging|vision, opthalmology, blindness, aging
5440428|NCT00013416|Hearing loss, hearing aid, amplification|hearing loss, hearing aid, amplification
5440429|NCT00013403|Vision, quality of life|vision, quality of life
5440430|NCT00013390|Auditory, tinnitus|auditory, tinnitus
5440431|NCT00013377|Low vision, Driving rehabilitation|low vision, driving rehabilitation
5440432|NCT00013364|Hearing loss, speech recognition|hearing loss, speech recognition
5440433|NCT00013351|Aging adult, attention, falls, vision|aging adult, attention, falls, vision
5440434|NCT00013338|Spinal cord injury, ambulation, treadmill|spinal cord injury, ambulation, treadmill
5440435|NCT00013325|Spinal cord injury, heart disease, electrocardiography|spinal cord injury, heart disease, electrocardiography
5440436|NCT00013312|Spinal cord injury, gastrointestinal motility, gastrointestinal transit|spinal cord injury, gastrointestinal motility, gastrointestinal transit
5440437|NCT00013299|Foot ulcers, amputation prevention, diabetes, footwear, insoles|foot ulcers, amputation prevention, diabetes, footwear, insoles
5440438|NCT00013286|Diabetes mellitus, foot ulcer, endothelium|diabetes mellitus, foot ulcer, endothelium
5440439|NCT00013273|Venous insufficiency, plethysmography, hypertension|venous insufficiency, plethysmography, hypertension
5440440|NCT00013260|Case management|case management
5440441|NCT00013260|Nurse intervention|nurse intervention
5440442|NCT00013195|Telephone|telephone
5440443|NCT00013026|Congestive Heart Failure|congestive heart failure
5440444|NCT00012844|Musculoskeletal Disorders|musculoskeletal disorders
5440445|NCT00012844|Patient Lifting|patient lifting
5440446|NCT00012844|Occupational Accidents|occupational accidents
5440447|NCT00012779|Health Care Education|health care education
5440448|NCT00012779|Health Care Cost|health care cost
5440449|NCT00012558|Psychotic Disorders|psychotic disorders
5440450|NCT00012558|Mood Disorders|mood disorders
5440451|NCT00012558|Manic-Depressive Illness|manic-depressive illness
5440452|NCT00012558|Hypomania|hypomania
5440453|NCT00012558|Mania|mania
5440454|NCT00012558|Mood Stabilizer|mood stabilizer
5440455|NCT00012545|Stem Cells|stem cells
5440456|NCT00012545|Sickle Cell Disease|sickle cell disease
5440457|NCT00012545|Umbilical Cord Blood|umbilical cord blood
5440458|NCT00012493|Cardiac event|cardiac event
5440459|NCT00012493|Heart disease|heart disease
5440460|NCT00012493|Particulate Matter|particulate matter
5440461|NCT00012480|Lead|lead
5440462|NCT00012480|Male infertility|male infertility
5440463|NCT00012480|Gene expression|gene expression
5440464|NCT00012480|Economics, Medical|economics, medical
5440465|NCT00012441|Renal Dialysis|renal dialysis
5440466|NCT00012428|Cognitive development|cognitive development
5440467|NCT00012428|Prenatal exposure|prenatal exposure
5440468|NCT00012428|PCBs|pcbs
5440469|NCT00011908|Safety|safety
5440470|NCT00011908|B-Lymphocyte Depletion|b-lymphocyte depletion
5440471|NCT00011908|Anti-CD22|anti-cd22
5440472|NCT00011908|Response|response
5440473|NCT00011908|Efficacy|efficacy
5440474|NCT00011908|Lupus|lupus
5440475|NCT00011908|Immunotherapy|immunotherapy
5440476|NCT00011856|Intracranial Aneurysms|intracranial aneurysms
5440477|NCT00011856|Cerebral|cerebral
5440478|NCT00011856|Loci|loci
5440479|NCT00011856|Susceptibility Genes|susceptibility genes
5440480|NCT00011856|Cerebral Aneurysm|cerebral aneurysm
5440481|NCT00011856|Familial Cerebral Aneurysm|familial cerebral aneurysm
5440482|NCT00011856|Genetics|genetics
5440483|NCT00011843|X-Linked|x-linked
5440484|NCT00011843|Heterogeneous|heterogeneous
5440485|NCT00011843|Embryologic Development|embryologic development
5440486|NCT00011843|Mental Retardation|mental retardation
5440487|NCT00011843|Brain Development|brain development
5440488|NCT00011843|Microphthalmia|microphthalmia
5440489|NCT00011843|Anophthalmia|anophthalmia
5440490|NCT00011843|Malformations|malformations
5440491|NCT00011843|Lenz Dysplasia|lenz dysplasia
5440492|NCT00011843|Microphthalmia/Anophthalmia|microphthalmia/anophthalmia
5440493|NCT00011843|Mutation Screening|mutation screening
5440494|NCT00011843|Gene Characterization|gene characterization
5440495|NCT00011830|Stem Cell Cryopreservation|stem cell cryopreservation
5440496|NCT00011830|Leukapheresis|leukapheresis
5440497|NCT00011817|Evaluation and Treatment|evaluation and treatment
5440498|NCT00011817|Ophthalmic Genetic Diseases|ophthalmic genetic diseases
5440499|NCT00011817|Genetic Testing|genetic testing
5440500|NCT00011817|Genetic Eye Diseases|genetic eye diseases
5440501|NCT00011817|Evaluation|evaluation
5440502|NCT00011804|Low Back Pain|low back pain
5440503|NCT00011804|Lumbar Radiculopathy|lumbar radiculopathy
5440504|NCT00011804|Anticonvulsants|anticonvulsants
5440505|NCT00011804|Neuropathic Pain|neuropathic pain
5440506|NCT00011804|Analgesia|analgesia
5440507|NCT00011804|Sciatica|sciatica
5440508|NCT00011791|CAH|cah
5440509|NCT00011791|Catecholamines|catecholamines
5440510|NCT00011791|Adrenal Medulla|adrenal medulla
5440511|NCT00011791|Endocrine|endocrine
5440512|NCT00011791|Congenital Adrenal Hyperplasia|congenital adrenal hyperplasia
5440513|NCT00011791|Exercise|exercise
5440514|NCT00011791|Healthy Volunteer|healthy volunteer
5440515|NCT00011778|Cell Cycle|cell cycle
5440516|NCT00011778|NFKB|nfkb
5440517|NCT00011778|Combined Modality|combined modality
5440518|NCT00011778|Radiosensitizer|radiosensitizer
5440519|NCT00011778|Ubiquitin|ubiquitin
5440520|NCT00011778|Head and Neck Cancer|head and neck cancer
5440521|NCT00011778|Squamous Cell Carcinoma|squamous cell carcinoma
5440522|NCT00011778|Radiation Therapy|radiation therapy
5440523|NCT00011778|Protease Inhibitor|protease inhibitor
5440524|NCT00011765|Aggression|aggression
5440525|NCT00011765|Serotonin Reuptake Inhibitors (SSRI)|serotonin reuptake inhibitors (ssri)
5440529|NCT00011765|Domestic Violence|domestic violence
5440530|NCT00011765|Physical Aggression|physical aggression
5440531|NCT00011765|Serotonin Reuptake Inhibitor|serotonin reuptake inhibitor
5440532|NCT00011752|Serotonin Reuptake|serotonin reuptake
5440533|NCT00011752|Large Neutral Amino Acids|large neutral amino acids
5440534|NCT00011752|5-Hydroxyindoleacetic Acid|5-hydroxyindoleacetic acid
5440535|NCT00011752|Alcoholism|alcoholism
5440536|NCT00011752|PET|pet
5440537|NCT00011752|TRP|trp
5440538|NCT00011752|Tryptophan Depletion|tryptophan depletion
5440539|NCT00011752|Healthy Volunteer|healthy volunteer
5440540|NCT00011739|Low back pain, Magnetic resonance imaging (MRI),|low back pain, magnetic resonance imaging (mri),
5440541|NCT00011726|Pregnancy|pregnancy
5440542|NCT00011726|Lead Exposure|lead exposure
5440543|NCT00011726|Lactation|lactation
5440544|NCT00011726|Bone Mineralization|bone mineralization
5440545|NCT00011726|Maternal-Fetal Exchange|maternal-fetal exchange
5440546|NCT00011713|Semen|semen
5440547|NCT00011713|Infertility|infertility
5440548|NCT00011713|ART - Assisted Reproduction Technology|art - assisted reproduction technology
5440549|NCT00011713|Phthalates|phthalates
5440550|NCT00011713|Bisphenol A|bisphenol a
5440551|NCT00011700|idiopathic pulmonary hemorrhage in infants,|idiopathic pulmonary hemorrhage in infants,
5440552|NCT00011700|toxigenic mold exposure|toxigenic mold exposure
5440553|NCT00011687|Fertility|fertility
5440554|NCT00011687|Hormones|hormones
5440555|NCT00011687|Semen|semen
5440556|NCT00011687|Reproductive Health|reproductive health
5440557|NCT00011674|Lead|lead
5440558|NCT00011674|Prenatal|prenatal
5440559|NCT00011674|Development|development
5440560|NCT00011674|Children|children
5440561|NCT00011674|Psychology|psychology
5440562|NCT00011674|Toxicology|toxicology
5440563|NCT00011674|Teratology|teratology
5440564|NCT00011661|Lead poisoning|lead poisoning
5440565|NCT00011661|Native Americans|native americans
5440566|NCT00011648|Echocardiogram|echocardiogram
5440567|NCT00011648|Morbidity|morbidity
5440568|NCT00011648|Mortality|mortality
5440569|NCT00011648|Sickle Cell Anemia|sickle cell anemia
5440570|NCT00011648|Secondary Pulmonary Hypertension|secondary pulmonary hypertension
5440571|NCT00011609|Robotics; Activities of Daily Living; Spinal Cord Injuries|robotics; activities of daily living; spinal cord injuries
5440572|NCT00011596|Hemiplegia, gait, electric stimulation|hemiplegia, gait, electric stimulation
5440573|NCT00011583|Cerebrovascular|cerebrovascular
5440574|NCT00011583|Hemiplegia|hemiplegia
5440575|NCT00011583|Robotics|robotics
5440576|NCT00011570|defecation|defecation
5440577|NCT00011570|electrical stimulation|electrical stimulation
5440578|NCT00011570|penile erection|penile erection
5440579|NCT00011570|Spinal cord injury|spinal cord injury
5440580|NCT00011570|urology|urology
5440581|NCT00011557|Bladder, electromagnetic fields, Spinal cord injury|bladder, electromagnetic fields, spinal cord injury
5440582|NCT00011544|wheelchair, biomechanics, aging, functional outcome, disability|wheelchair, biomechanics, aging, functional outcome, disability
5440583|NCT00011531|Decubitus Ulcers|decubitus ulcers
5440584|NCT00011531|dehiscence|dehiscence
5440585|NCT00011531|SCI|sci
5440586|NCT00011531|wound healing|wound healing
5440587|NCT00011518|Arsenic|arsenic
5440588|NCT00011518|Bladder Cancer|bladder cancer
5440589|NCT00011518|Drinking Water|drinking water
5440590|NCT00011505|G-CSF|g-csf
5440591|NCT00011505|Leukapheresis|leukapheresis
5440592|NCT00011505|Stem Cell Cryopreservation|stem cell cryopreservation
5440593|NCT00011505|Central Line Placement|central line placement
5440594|NCT00011505|G-CSF Administration|g-csf administration
5440595|NCT00011505|Stem Cell Preservation|stem cell preservation
5440596|NCT00011505|Diamond Blackfan Anemia|diamond blackfan anemia
5440597|NCT00011505|Healthy Volunteer|healthy volunteer
5440598|NCT00011492|Oral Cancer|oral cancer
5440599|NCT00011492|Squamous Cell Cancer|squamous cell cancer
5440600|NCT00011492|Head and Neck Cancer|head and neck cancer
5440601|NCT00011492|Laryngeal Cancer|laryngeal cancer
5440602|NCT00011492|Pharnygeal Cancer|pharnygeal cancer
5440603|NCT00011492|Squamous Cell Carcinoma|squamous cell carcinoma
5440605|NCT00011466|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
5440606|NCT00011466|Carbohydrate Craving|carbohydrate craving
5440607|NCT00011453|NQO1|nqo1
5440608|NCT00011453|DT-diaphorase|dt-diaphorase
5440609|NCT00011453|Benzene|benzene
5440610|NCT00011453|Leukemia|leukemia
5440611|NCT00011453|Aplastic anemia|aplastic anemia
5440612|NCT00011440|Allergy|allergy
5440613|NCT00011440|Air pollution|air pollution
5440614|NCT00011440|Lung function|lung function
5440615|NCT00011440|Inflammation|inflammation
5440616|NCT00011414|Drug Resistance|drug resistance
5440617|NCT00011414|PEDIATRIC SOLID TUMORS|pediatric solid tumors
5440618|NCT00011414|Chemotherapy|chemotherapy
5440619|NCT00011414|p-glycoprotien|p-glycoprotien
5440620|NCT00011414|Brain Tumors|brain tumors
5440621|NCT00011414|Childhood Cancer|childhood cancer
5440622|NCT00011414|Brain Tumor|brain tumor
5440623|NCT00011388|Organochlorine compounds|organochlorine compounds
5440624|NCT00011388|Endocrine disruptors|endocrine disruptors
5440625|NCT00011388|Sex Hormones|sex hormones
5440626|NCT00011388|Reproductive function|reproductive function
5440627|NCT00011388|Menstrual Disturbances|menstrual disturbances
5440628|NCT00011375|Phosphodiesterase Inhibitor|phosphodiesterase inhibitor
5440629|NCT00011375|Immunology|immunology
5440630|NCT00011375|Immunomodulation|immunomodulation
5440631|NCT00011375|Antidepressant|antidepressant
5440632|NCT00011375|Therapy|therapy
5440633|NCT00011375|Multiple Sclerosis|multiple sclerosis
5440634|NCT00011375|Immunotherapy|immunotherapy
5440635|NCT00011362|NICHD Neonatal Research Network|nichd neonatal research network
5440636|NCT00011362|Extremely Low Birth Weight (ELBW)|extremely low birth weight (elbw)
5440637|NCT00011362|Prematurity|prematurity
5440638|NCT00011362|Dexamethasone|dexamethasone
5440639|NCT00011362|Glucocorticoids|glucocorticoids
5440640|NCT00011362|Respiratory Distress Syndrome|respiratory distress syndrome
5440641|NCT00011362|Respiratory insufficiency|respiratory insufficiency
5440642|NCT00011362|Steroids|steroids
5440643|NCT00011349|Prostate Cancer|prostate cancer
5440644|NCT00011336|SCI|sci
5440645|NCT00011336|chronic respiratory symptoms|chronic respiratory symptoms
5440646|NCT00011336|measures of pulmonary function|measures of pulmonary function
5440647|NCT00011336|respiratory illness|respiratory illness
5440648|NCT00011323|osteoporosis,smoking, alcohol, caffeine|osteoporosis,smoking, alcohol, caffeine
5440649|NCT00011310|Particulates|particulates
5440650|NCT00011310|Air Pollution|air pollution
5440651|NCT00011310|Cardiopulmonary Disease|cardiopulmonary disease
5440652|NCT00011310|Lung|lung
5440653|NCT00011310|Inflammation|inflammation
5440654|NCT00011284|Liver|liver
5440655|NCT00011284|Inflammation|inflammation
5440656|NCT00011284|Endotoxin|endotoxin
5440657|NCT00011284|Neutrophils|neutrophils
5440658|NCT00011284|Hepatocytes|hepatocytes
5440659|NCT00011258|Atherosclerosis of the carotid arteries|atherosclerosis of the carotid arteries
5440660|NCT00011258|stroke|stroke
5440661|NCT00011258|lipoprotein metabolism|lipoprotein metabolism
5440662|NCT00011258|paraoxonase|paraoxonase
5440663|NCT00011245|Arachnoiditis|arachnoiditis
5440664|NCT00011245|Myelography|myelography
5440665|NCT00011245|Intraoperative Ultrasonography|intraoperative ultrasonography
5440666|NCT00011245|Magnetic Resonance|magnetic resonance
5440667|NCT00011245|CSF Pressure|csf pressure
5440668|NCT00011245|Trauma|trauma
5440669|NCT00011245|Meningitis|meningitis
5440670|NCT00011245|Paralysis|paralysis
5440671|NCT00011245|Spondylosis|spondylosis
5440672|NCT00011245|Spinal Syringomyelia|spinal syringomyelia
5440673|NCT00011245|Presyringomyelia|presyringomyelia
5440674|NCT00011245|Spinal Cord Edema|spinal cord edema
5440675|NCT00011245|Magnetic Resonance Imaging (MRI)|magnetic resonance imaging (mri)
5440676|NCT00011245|Intraoperative Radiation|intraoperative radiation
5440677|NCT00011245|Ultrasonography|ultrasonography
5440678|NCT00011141|Immune-mediated diabetes mellitus|immune-mediated diabetes mellitus
5440679|NCT00011193|Cardiovascular Diseases|cardiovascular diseases
5440680|NCT00011193|Hypertension|hypertension
5440681|NCT00011193|Postmenopausal|postmenopausal
5440682|NCT00011193|Overweight or Obese|overweight or obese
5440683|NCT00011193|Women|women
5440684|NCT00011193|Sedentary|sedentary
5440685|NCT00011180|Venous thromboembolism (VTE)|venous thromboembolism (vte)
5440686|NCT00011180|Deep vein thrombosis (DVT)|deep vein thrombosis (dvt)
5440687|NCT00011180|Pulmonary embolism (PE)|pulmonary embolism (pe)
5440688|NCT00011076|Deskar|deskar
5440689|NCT00011076|Fibrosis|fibrosis
5440690|NCT00011076|Myocardium|myocardium
5440691|NCT00011076|Scarring|scarring
5440692|NCT00011076|Arrhythmia|arrhythmia
5440693|NCT00011076|Hypertrophic Cardiomyopathy|hypertrophic cardiomyopathy
5440694|NCT00011076|Left Ventricular Diastolic Dysfunction|left ventricular diastolic dysfunction
5440695|NCT00011076|Myocardial Fibrosis|myocardial fibrosis
5440696|NCT00011115|overweight|overweight
5440697|NCT00011102|weight gain|weight gain
5440698|NCT00010998|Multiple Sclerosis|multiple sclerosis
5440699|NCT00010998|Yoga|yoga
5440700|NCT00010985|Backpain|backpain
5440701|NCT00010985|Pain|pain
5440702|NCT00010985|Alternative Medicine|alternative medicine
5440703|NCT00010985|Acupuncture|acupuncture
5440704|NCT00010985|Chiropractic|chiropractic
5440705|NCT00010985|Massage Therapy|massage therapy
5440706|NCT00010959|menopause|menopause
5440707|NCT00010959|hot flashes|hot flashes
5440708|NCT00010959|botanicals|botanicals
5440709|NCT00010946|acupuncture|acupuncture
5440710|NCT00010946|osteoarthritis|osteoarthritis
5440711|NCT00010946|elderly|elderly
5440712|NCT00010868|bipolar disorder|bipolar disorder
5440713|NCT00010868|omega-3 fatty acids|omega-3 fatty acids
5440714|NCT00010868|eicosapentaenoic acid|eicosapentaenoic acid
5440715|NCT00010868|docosahexaenoic acid|docosahexaenoic acid
5440716|NCT00010855|hypnosis|hypnosis
5440717|NCT00010855|relaxation|relaxation
5440718|NCT00010855|invasive medical procedures|invasive medical procedures
5440719|NCT00010855|interventional radiology|interventional radiology
5440720|NCT00010855|conscious sedation|conscious sedation
5440721|NCT00010855|anesthesia|anesthesia
5440722|NCT00010855|complications|complications
5440723|NCT00010855|cost analysis|cost analysis
5440724|NCT00010855|Interventional procedures, complications|interventional procedures, complications
5440725|NCT00010855|Angiography|angiography
5440726|NCT00010855|Nephrostomy|nephrostomy
5440727|NCT00010855|Hepatic chemoembolization|hepatic chemoembolization
5440728|NCT00010855|Fibroid Embolization|fibroid embolization
5440729|NCT00010829|Cardiovascular Diseases|cardiovascular diseases
5440730|NCT00010829|Osteoporosis|osteoporosis
5440731|NCT00010829|Breast Cancer|breast cancer
5440732|NCT00010829|Endometrial Cancer|endometrial cancer
5440733|NCT00010725|CVD|cvd
5440734|NCT00010712|Menopause|menopause
5440735|NCT00010712|Hot Flashes|hot flashes
5440736|NCT00010712|Osteoporosis|osteoporosis
5440737|NCT00010712|Postmenopausal|postmenopausal
5440738|NCT00010699|cvd|cvd
5440739|NCT00010608|CVD|cvd
5440740|NCT00010530|CVD|cvd
5440741|NCT00010504|acupuncture|acupuncture
5440742|NCT00010504|fibromyalgia|fibromyalgia
5440743|NCT00010504|pain|pain
5440744|NCT00010504|analgesia|analgesia
5440745|NCT00010491|Diarrhea|diarrhea
5440746|NCT00010491|complementary therapies|complementary therapies
5440747|NCT00009685|Vaccine|vaccine
5440748|NCT00009685|HIV|hiv
5440749|NCT00009685|Codon-Optimized|codon-optimized
5440750|NCT00009685|HIV Vaccine|hiv vaccine
5440751|NCT00009685|Healthy Volunteer|healthy volunteer
5440752|NCT00009685|HIV-1 DNA Vaccine|hiv-1 dna vaccine
5440753|NCT00009685|HIV Seronegativity|hiv seronegativity
5440754|NCT00009685|HIV Preventive Vaccine|hiv preventive vaccine
5440755|NCT00009672|Low Back Pain|low back pain
5440756|NCT00009672|Opioid|opioid
5440757|NCT00009672|Antidepressant|antidepressant
5440758|NCT00009672|Randomized Controlled Trial|randomized controlled trial
5440759|NCT00009672|Analgesic|analgesic
5440760|NCT00009672|Sciatica|sciatica
5440761|NCT00009659|Endometrium|endometrium
5440762|NCT00009659|Estrogen|estrogen
5440763|NCT00009659|Antihormone|antihormone
5440764|NCT00009659|Menopause|menopause
5440765|NCT00009659|Progesterone|progesterone
5440766|NCT00009659|Postmenopausal Women|postmenopausal women
5440767|NCT00009659|Hormone Replacement|hormone replacement
5440768|NCT00009646|Chronic lung disease|chronic lung disease
5440769|NCT00009646|Indocin|indocin
5440770|NCT00009646|Indomethacin|indomethacin
5440771|NCT00009646|Infants, very low birth weight|infants, very low birth weight
5440772|NCT00009646|Intraventricular hemorrhage|intraventricular hemorrhage
5440773|NCT00009646|Necrotizing enterocolitis|necrotizing enterocolitis
5440774|NCT00009646|Patent ductus arteriosus|patent ductus arteriosus
5440775|NCT00009646|Pulmonary hemorrhage|pulmonary hemorrhage
5440776|NCT00009633|NICHD Neonatal Research Network|nichd neonatal research network
5440777|NCT00009633|Extremely Low Birth Weight (ELBW)|extremely low birth weight (elbw)
5440778|NCT00009633|Prematurity|prematurity
5440779|NCT00009633|Neurodevelopmental Outcome|neurodevelopmental outcome
5440780|NCT00009633|Follow up studies|follow up studies
5440781|NCT00009620|NICHD Neonatal Research Network|nichd neonatal research network
5440782|NCT00009620|Extremely Low Birth Weight (ELBW)|extremely low birth weight (elbw)
5440783|NCT00009620|Prematurity|prematurity
5440784|NCT00009620|Cerebral hemorrhage|cerebral hemorrhage
5440785|NCT00009620|Phenobarbital|phenobarbital
5440786|NCT00009620|Pregnancy|pregnancy
5440787|NCT00009620|Prenatal care|prenatal care
5440788|NCT00009620|Intraventricular hemorrhage|intraventricular hemorrhage
5440789|NCT00009620|Periventricular leukomalacia|periventricular leukomalacia
5440790|NCT00009620|Brain injury|brain injury
5440791|NCT00009620|Brain hemorrhage|brain hemorrhage
5440792|NCT00010452|cystic hygroma|cystic hygroma
5440793|NCT00010452|lymphangiomas|lymphangiomas
5440794|NCT00010452|lymphatic malformations|lymphatic malformations
5440795|NCT00010439|arthritis & connective tissue diseases|arthritis & connective tissue diseases
5440796|NCT00010439|idiopathic juvenile osteoporosis|idiopathic juvenile osteoporosis
5440797|NCT00010439|rare disease|rare disease
5440798|NCT00010426|cystinosis|cystinosis
5440799|NCT00010426|rare disease|rare disease
5440800|NCT00010426|renal and genitourinary disorders|renal and genitourinary disorders
5440801|NCT00010413|immunologic disorders and infectious disorders|immunologic disorders and infectious disorders
5440802|NCT00010413|pemphigus|pemphigus
5440803|NCT00010413|rare disease|rare disease
5440804|NCT00010400|antiphospholipid antibody syndrome|antiphospholipid antibody syndrome
5440805|NCT00010400|arthritis & connective tissue diseases|arthritis & connective tissue diseases
5440806|NCT00010400|immunologic disorders and infectious disorders|immunologic disorders and infectious disorders
5440807|NCT00010400|rare disease|rare disease
5440808|NCT00010400|systemic lupus erythematosus|systemic lupus erythematosus
5440809|NCT00010387|Felty syndrome|felty syndrome
5440810|NCT00010387|autoimmune hemolytic anemia|autoimmune hemolytic anemia
5440811|NCT00010387|autoimmune neutropenia|autoimmune neutropenia
5440812|NCT00010387|hematologic disorders|hematologic disorders
5440813|NCT00010387|immune thrombocytopenic purpura|immune thrombocytopenic purpura
5440814|NCT00010387|rare disease|rare disease
5440815|NCT00010374|Diaphragm for Ventilatory Assist|diaphragm for ventilatory assist
5440816|NCT00010374|environmental/toxic disorders|environmental/toxic disorders
5440817|NCT00010374|neurologic and psychiatric disorders|neurologic and psychiatric disorders
5440818|NCT00010374|rare disease|rare disease
5440819|NCT00010374|spinal cord injury|spinal cord injury
5440820|NCT00010335|arthritis & connective tissue diseases|arthritis & connective tissue diseases
5440821|NCT00010335|dermatomyositis|dermatomyositis
5440822|NCT00010335|immunologic disorders and infectious disorders|immunologic disorders and infectious disorders
5440823|NCT00010335|juvenile rheumatoid arthritis|juvenile rheumatoid arthritis
5440824|NCT00010335|rare disease|rare disease
5440825|NCT00010335|systemic lupus erythematosus|systemic lupus erythematosus
5440826|NCT00010335|systemic sclerosis|systemic sclerosis
5440827|NCT00009581|Endothelial Function|endothelial function
5440828|NCT00009581|Hydroxyurea|hydroxyurea
5440829|NCT00009581|Leukocyte Gene Expression|leukocyte gene expression
5440830|NCT00009581|Nitrosylated Hemoglobin|nitrosylated hemoglobin
5440831|NCT00009581|Sickle Cell Anemia|sickle cell anemia
5440832|NCT00009581|Nitric Oxide|nitric oxide
5440833|NCT00009568|Antidepressants|antidepressants
5440834|NCT00009568|Platelet Function|platelet function
5440835|NCT00009568|SSRI|ssri
5440836|NCT00009568|Depression|depression
5440837|NCT00009568|Bleeding Time|bleeding time
5440838|NCT00009256|Quasispecies Variation|quasispecies variation
5440839|NCT00009256|Genotyping|genotyping
5440840|NCT00009256|Phenotyping|phenotyping
5440841|NCT00009256|Antiretroviral Therapy|antiretroviral therapy
5440842|NCT00009256|Drug Naive Patients|drug naive patients
5440843|NCT00009256|HIV|hiv
5440844|NCT00009256|Treatment Naive|treatment naive
5440845|NCT00009243|Brain Scans|brain scans
5440846|NCT00009243|Brain Imaging|brain imaging
5440847|NCT00009243|Brain|brain
5440848|NCT00009243|Alteplase|alteplase
5440849|NCT00009243|Acute Stroke|acute stroke
5440850|NCT00009243|Stroke|stroke
5440851|NCT00009243|TIA|tia
5440852|NCT00009230|Age associated memory impairment|age associated memory impairment
5440853|NCT00009230|Mild cognitive impairment|mild cognitive impairment
5440854|NCT00009217|Alzheimer's disease|alzheimer's disease
5440855|NCT00009217|psychosis|psychosis
5440856|NCT00009217|agitation|agitation
5440857|NCT00009217|haloperidol|haloperidol
5440858|NCT00009204|Behavioral problems|behavioral problems
5440859|NCT00009204|Agitation|agitation
5440860|NCT00009048|Dyskinesias|dyskinesias
5440861|NCT00009048|L-Dopa Infusion|l-dopa infusion
5440862|NCT00009048|Clinical Trial|clinical trial
5440863|NCT00009048|Motor Function|motor function
5440864|NCT00009048|Psychosis|psychosis
5440865|NCT00009048|Parkinson's Disease|parkinson's disease
5440866|NCT00009035|Brain|brain
5440867|NCT00009035|Tumor|tumor
5440868|NCT00009035|Chemotherapy|chemotherapy
5440869|NCT00009035|Antiangiogenesis|antiangiogenesis
5440870|NCT00009035|Radiation|radiation
5440871|NCT00009035|CNS Tumor|cns tumor
5440872|NCT00009035|Glioma|glioma
5440873|NCT00009035|Medulloblastoma|medulloblastoma
5440874|NCT00009035|Astrocytoma|astrocytoma
5440875|NCT00009035|Glioblastoma|glioblastoma
5440876|NCT00009178|Primary Care|primary care
5440877|NCT00009178|Fluoxetine|fluoxetine
5440878|NCT00009009|Immune System|immune system
5440879|NCT00009009|Biopsy|biopsy
5440880|NCT00009009|AIDS|aids
5440881|NCT00009009|HIV|hiv
5440882|NCT00009009|End Stage Renal Disease|end stage renal disease
5440883|NCT00009009|Kidney Transplant|kidney transplant
5440884|NCT00008892|Magnetic Resonance Imaging|magnetic resonance imaging
5440885|NCT00008892|Diffusion Tensor Imaging|diffusion tensor imaging
5440886|NCT00008892|Twin Study|twin study
5440887|NCT00008892|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
5440888|NCT00008892|Normal Volunteers|normal volunteers
5440889|NCT00008814|Cognition|cognition
5440890|NCT00008814|Infant Development|infant development
5440891|NCT00008814|MRI, Functional|mri, functional
5440892|NCT00008736|Feeding intolerance|feeding intolerance
5440893|NCT00008736|Infant, premature|infant, premature
5440894|NCT00008827|Obesity|obesity
5440895|NCT00008827|Behavioral weight control|behavioral weight control
5440896|NCT00008827|Internet|internet
5440897|NCT00008541|Keratitis|keratitis
5440898|NCT00008541|Conjunctivitis|conjunctivitis
5440899|NCT00008541|Meibomitis|meibomitis
5440900|NCT00008541|Corneal Infiltrates|corneal infiltrates
5440901|NCT00008541|Dacryocystitis|dacryocystitis
5440902|NCT00008541|Blepharitis|blepharitis
5440903|NCT00008541|Dacryoadenitis|dacryoadenitis
5440904|NCT00008541|Corneal Eye Disease|corneal eye disease
5440905|NCT00008515|Steroids|steroids
5440906|NCT00008515|Age-Related Macular Degeneration|age-related macular degeneration
5440907|NCT00008515|Implant|implant
5440908|NCT00008515|Choroidal Neovascularization|choroidal neovascularization
5440909|NCT00008515|Sustained Release Implant|sustained release implant
5440910|NCT00008502|Genetics|genetics
5440911|NCT00008502|African Americans|african americans
5440912|NCT00008502|Skin|skin
5440913|NCT00008502|Keloids|keloids
5440914|NCT00008502|Familial Disposition|familial disposition
5440915|NCT00008476|Preemptive Analgesia|preemptive analgesia
5440916|NCT00008476|Vanilloid|vanilloid
5440917|NCT00008476|Vanilloid Receptor (VR)|vanilloid receptor (vr)
5440918|NCT00008476|Capsaicin|capsaicin
5440919|NCT00008476|Acute Pain|acute pain
5440920|NCT00008476|Orofacial|orofacial
5440921|NCT00008476|Visual Analog Scale (VAS)|visual analog scale (vas)
5440922|NCT00008476|Resiniferatoxin|resiniferatoxin
5440923|NCT00008476|Healthy Volunteer|healthy volunteer
5440924|NCT00008476|Wisdom Teeth|wisdom teeth
5440925|NCT00008476|Pain|pain
5440926|NCT00007800|obesity treatment|obesity treatment
5444283|NCT00001643|Dominant|dominant
5440927|NCT00007800|non insulin dependent diabetes|non insulin dependent diabetes
5440928|NCT00007800|type 2 diabetes|type 2 diabetes
5440929|NCT00007800|behavioral weight control|behavioral weight control
5440930|NCT00007800|motivational interviewing|motivational interviewing
5440931|NCT00007800|motivational enhancement|motivational enhancement
5440932|NCT00007696|Diabetes Mellitus,DM,glycemic control|diabetes mellitus,dm,glycemic control
5440933|NCT00007670|gabapentin|gabapentin
5440934|NCT00007670|lamotrigine|lamotrigine
5440935|NCT00007670|seizures in the elderly|seizures in the elderly
5440936|NCT00007670|Carbamazepine|carbamazepine
5440937|NCT00007657|PCI plus intensive medical therapy|pci plus intensive medical therapy
5440938|NCT00007774|Olanzapine, haloperidol, schizophrenia, schisoaffe|olanzapine, haloperidol, schizophrenia, schisoaffe
5440939|NCT00007761|Bipolar Disease Program intervention|bipolar disease program intervention
5440940|NCT00007748|aerobic exercise|aerobic exercise
5440941|NCT00007748|cognitive behavioral therapy|cognitive behavioral therapy
5440942|NCT00007748|CBT|cbt
5440943|NCT00007748|Gulf War Illnesses|gulf war illnesses
5440944|NCT00007748|GWI|gwi
5440945|NCT00007735|antibiotic treatment|antibiotic treatment
5440946|NCT00007735|mycoplasma species|mycoplasma species
5440947|NCT00007735|Gulf War Veterans' Illnesses (GWI)|gulf war veterans' illnesses (gwi)
5440948|NCT00007735|mycoplasma positive|mycoplasma positive
5440949|NCT00007735|Gulf War Syndrome|gulf war syndrome
5440950|NCT00007722|ALS|als
5440951|NCT00007722|amyotrophic lateral sclerosis|amyotrophic lateral sclerosis
5440952|NCT00007722|Gulf War Veterans|gulf war veterans
5440953|NCT00007709|Hepatitis C|hepatitis c
5440954|NCT00007709|HIV|hiv
5440955|NCT00007709|severe mental illness (SMI)|severe mental illness (smi)
5440956|NCT00007683|aspirin|aspirin
5440957|NCT00007683|clopidogrel|clopidogrel
5440958|NCT00007683|embolic events|embolic events
5440959|NCT00007683|Left ventricular ejection fraction less than or eq|left ventricular ejection fraction less than or eq
5440960|NCT00007683|NYHA Class II, III or IV CHF|nyha class ii, iii or iv chf
5440961|NCT00007683|symptomatic CHF|symptomatic chf
5440962|NCT00007683|warfarin|warfarin
5440963|NCT00007644|cancer of the prostate (CAP)|cancer of the prostate (cap)
5440964|NCT00007644|cancer treatment|cancer treatment
5440965|NCT00007644|chronic diseases|chronic diseases
5440966|NCT00007644|expectant management|expectant management
5440967|NCT00007644|genitourinary|genitourinary
5440968|NCT00007644|prostate|prostate
5440969|NCT00007644|prostate specific cancer mortality|prostate specific cancer mortality
5440970|NCT00007644|radical prostatectomy|radical prostatectomy
5440971|NCT00007631|NMSC|nmsc
5440972|NCT00007631|nonmelanoma skin cancer|nonmelanoma skin cancer
5440973|NCT00007631|topical tretinoin cream|topical tretinoin cream
5440974|NCT00007618|colorectal cancer|colorectal cancer
5440975|NCT00007605|amiodarone|amiodarone
5440976|NCT00007605|atrial fibrillation converted to sinus rhythm|atrial fibrillation converted to sinus rhythm
5440977|NCT00007605|cardiac mortality|cardiac mortality
5440978|NCT00007605|major and minor bleeds|major and minor bleeds
5440979|NCT00007605|sinus rhythm|sinus rhythm
5440980|NCT00007605|sotalol|sotalol
5440981|NCT00007592|Hypertension|hypertension
5440982|NCT00007592|national data base on the treatment of hypertension|national data base on the treatment of hypertension
5440983|NCT00007592|cost of different antihypertensive regimens|cost of different antihypertensive regimens
5440984|NCT00007579|prostate cancer|prostate cancer
5440985|NCT00007540|Prostate cancer|prostate cancer
5440986|NCT00007540|CAG repeat sequence|cag repeat sequence
5440987|NCT00007527|buprenorphine and naloxone|buprenorphine and naloxone
5440988|NCT00007527|opiate dependence|opiate dependence
5440989|NCT00007527|narcotic treatment|narcotic treatment
5440990|NCT00007514|olfactory functioning|olfactory functioning
5440991|NCT00007514|neurotoxic exposure|neurotoxic exposure
5440992|NCT00007514|Gulf War-era veterans|gulf war-era veterans
5440993|NCT00007501|varicella-zoster vaccine|varicella-zoster vaccine
5440994|NCT00007475|Plasma Exchange|plasma exchange
5440995|NCT00007475|Cyclophosphamide|cyclophosphamide
5440996|NCT00007475|Proteinuria|proteinuria
5440997|NCT00007475|Hemodialysis|hemodialysis
5440998|NCT00007475|Expression Profiling|expression profiling
5440999|NCT00007358|Dexamethasone|dexamethasone
5441000|NCT00007358|Anti-SSA/Ro antibodies|anti-ssa/ro antibodies
5441001|NCT00007358|Anti-SSB/La antibodies|anti-ssb/la antibodies
5441002|NCT00007358|Ultrasound|ultrasound
5441003|NCT00007358|Atrioventricular (AV) nodal dysfunction|atrioventricular (av) nodal dysfunction
5441004|NCT00007358|Echocardiograms|echocardiograms
5441005|NCT00007358|Mothers|mothers
5441006|NCT00007345|Histone Acetylase|histone acetylase
5441007|NCT00007345|Differentiation|differentiation
5441008|NCT00007345|Sezary Syndrome|sezary syndrome
5441009|NCT00007345|Mycosis Fungoides|mycosis fungoides
5441010|NCT00007345|CD 30 Lymphoma|cd 30 lymphoma
5441011|NCT00007306|Parathyroid hormone|parathyroid hormone
5441012|NCT00007306|Psoriasis|psoriasis
5441013|NCT00007306|Lesions|lesions
5441014|NCT00007306|Topical medications|topical medications
5441015|NCT00007306|Ointment|ointment
5441016|NCT00007306|Calcium metabolism|calcium metabolism
5441017|NCT00007306|Skin biopsy|skin biopsy
5441018|NCT00007293|Phototherapy|phototherapy
5441019|NCT00007293|Psoriasis|psoriasis
5441020|NCT00007293|Scalp psoriasis|scalp psoriasis
5441024|NCT00007280|Bioengineered skin|bioengineered skin
5441025|NCT00007280|Venous leg ulcer|venous leg ulcer
5441026|NCT00007267|Scleroderma|scleroderma
5441027|NCT00007267|Systemic sclerosis|systemic sclerosis
5441028|NCT00007267|Depression|depression
5441029|NCT00007267|Pain|pain
5441030|NCT00007267|Disfigurement|disfigurement
5441031|NCT00007267|Body image dissatisfaction|body image dissatisfaction
5441032|NCT00007267|Cognitive-behavioral therapy|cognitive-behavioral therapy
5441033|NCT00007267|Self-help|self-help
5441034|NCT00007267|Psychological intervention|psychological intervention
5441035|NCT00007254|Analgesia|analgesia
5441036|NCT00007254|Bedsore|bedsore
5441037|NCT00007254|Morphine gel|morphine gel
5441038|NCT00007254|Pressure ulcer|pressure ulcer
5441039|NCT00007254|Pain|pain
5441040|NCT00007254|Ulcer|ulcer
5441041|NCT00007241|Osteoarthritis|osteoarthritis
5441042|NCT00007241|Knee|knee
5441043|NCT00007241|OA|oa
5441044|NCT00007241|Isometric|isometric
5441045|NCT00007241|Exercise|exercise
5441046|NCT00007241|Strengthening|strengthening
5441047|NCT00007241|Joint-related pain|joint-related pain
5441048|NCT00007228|Chorea|chorea
5441049|NCT00007228|DCM|dcm
5441050|NCT00007228|Hypertrophic Cardiomyopathy|hypertrophic cardiomyopathy
5441051|NCT00007228|Sudden Death|sudden death
5441052|NCT00007228|Neuroacanthocytosis|neuroacanthocytosis
5441053|NCT00007215|Cataract|cataract
5441054|NCT00007215|Early Lens Changes|early lens changes
5441055|NCT00007215|Protein Aggregation|protein aggregation
5441056|NCT00007215|Blindness|blindness
5441057|NCT00007215|Vision|vision
5441058|NCT00007215|Dynamic Laser Scattering (DLS)|dynamic laser scattering (dls)
5441059|NCT00007215|Age-Related Changes|age-related changes
5441060|NCT00007215|Test Re-test Reproducibility|test re-test reproducibility
5441061|NCT00007215|Normal Volunteers|normal volunteers
5441062|NCT00007215|Lens|lens
5441063|NCT00007215|Healthy Volunteer|healthy volunteer
5441064|NCT00007189|Alzheimer disease|alzheimer disease
5441065|NCT00007189|Anti-inflammatory drugs|anti-inflammatory drugs
5441066|NCT00007163|Immunosuppression|immunosuppression
5441067|NCT00007163|Recombinant IgG1|recombinant igg1
5441068|NCT00007163|Apoptosis|apoptosis
5441069|NCT00007163|Interferon Gamma|interferon gamma
5441070|NCT00007163|Colonoscopy|colonoscopy
5441071|NCT00007163|Crohn's Disease|crohn's disease
5441072|NCT00007163|Immunotherapy|immunotherapy
5441073|NCT00007163|IL-12|il-12
5441074|NCT00007150|Phlebotomy Therapy|phlebotomy therapy
5441075|NCT00007150|Hemochromatosis|hemochromatosis
5441076|NCT00007150|Iron Overload|iron overload
5441077|NCT00007150|Hereditary Hemochromatosis|hereditary hemochromatosis
5441078|NCT00007150|Blood Donation|blood donation
5441079|NCT00007137|3D MRI|3d mri
5441080|NCT00007137|Diffusion Tensor|diffusion tensor
5441081|NCT00007137|Tongue|tongue
5441082|NCT00007137|Ultrasound|ultrasound
5441083|NCT00007137|Volume|volume
5441084|NCT00007137|Healthy Volunteer|healthy volunteer
5441085|NCT00007137|Swallowing|swallowing
5441086|NCT00007137|Tongue Weakness|tongue weakness
5441087|NCT00007137|Tongue Movement Coordination Problem|tongue movement coordination problem
5441088|NCT00007124|Myoclonus|myoclonus
5441089|NCT00007124|Epilepsy|epilepsy
5441090|NCT00007124|Dementia|dementia
5441091|NCT00007124|Polyglucosan|polyglucosan
5441092|NCT00007124|Insulin|insulin
5441093|NCT00007124|Lafora Disease|lafora disease
5441094|NCT00007124|Restrictive Carbohydrate Diet|restrictive carbohydrate diet
5441095|NCT00007059|disease-related problem/condition|disease-related problem/condition
5441096|NCT00007059|graft versus host disease|graft versus host disease
5441097|NCT00007059|rare disease|rare disease
5441098|NCT00007046|arthritis & connective tissue diseases|arthritis & connective tissue diseases
5441099|NCT00007046|bone cancer|bone cancer
5441100|NCT00007046|diaphyseal medullary stenosis|diaphyseal medullary stenosis
5441101|NCT00007046|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
5441102|NCT00007046|malignant fibrous histiocytoma of bone|malignant fibrous histiocytoma of bone
5441103|NCT00007046|musculoskeletal/mesodermal cancer|musculoskeletal/mesodermal cancer
5441104|NCT00007046|oncologic disorders|oncologic disorders
5441105|NCT00007046|rare disease|rare disease
5441106|NCT00007033|Alagille syndrome|alagille syndrome
5441107|NCT00007033|biliary atresia|biliary atresia
5441108|NCT00007033|cholestasis|cholestasis
5441109|NCT00007033|gastrointestinal disorders|gastrointestinal disorders
5441110|NCT00007033|rare disease|rare disease
5441111|NCT00006565|asthma|asthma
5441112|NCT00006565|HEPA|hepa
5441113|NCT00006565|ETS|ets
5441114|NCT00006519|Pharmacokinetic|pharmacokinetic
5441115|NCT00006519|Pediatric AIDS|pediatric aids
5441116|NCT00006519|Resistance Testing|resistance testing
5441117|NCT00006519|Combination Therapy|combination therapy
5441118|NCT00006519|Viral Drug Dynamics|viral drug dynamics
5441119|NCT00006519|Treatment Experienced|treatment experienced
5441120|NCT00006518|Tumor|tumor
5441121|NCT00006518|Viruses|viruses
5441122|NCT00006518|HIV|hiv
5441123|NCT00006518|KSHV|kshv
5441124|NCT00006518|AIDS|aids
5441125|NCT00006517|Seasonal Affective Disorder (SAD)|seasonal affective disorder (sad)
5441126|NCT00006517|Winter Depression|winter depression
5441127|NCT00006517|Mood disorders|mood disorders
5441128|NCT00006517|Bipolar I and II disorders|bipolar i and ii disorders
5441129|NCT00006517|Major Depressive Disorder, Recurrent|major depressive disorder, recurrent
5441130|NCT00006517|Light therapy|light therapy
5441131|NCT00006517|Phototherapy|phototherapy
5441132|NCT00006517|Dawn Simulation therapy|dawn simulation therapy
5441133|NCT00006517|Negative air ionization therapy|negative air ionization therapy
5441134|NCT00006517|Chronobiology|chronobiology
5441135|NCT00006517|Biological rhythms|biological rhythms
5441136|NCT00006516|Neonatal brain injury|neonatal brain injury
5441137|NCT00006516|Brain Hypoxia|brain hypoxia
5441138|NCT00006516|Cerebral Hypoxia|cerebral hypoxia
5441139|NCT00006516|Brain Hypoxia-Ischemia|brain hypoxia-ischemia
5441140|NCT00006516|Brain Ischemia-Hypoxia|brain ischemia-hypoxia
5441141|NCT00006516|Cerebral Hypoxia-Ischemia|cerebral hypoxia-ischemia
5441142|NCT00006516|Cerebral Ischemia-Hypoxia|cerebral ischemia-hypoxia
5441143|NCT00006516|Environmental enrichment|environmental enrichment
5441144|NCT00006516|Cognitive/sensorimotor stimulation|cognitive/sensorimotor stimulation
5441145|NCT00006516|Parent-infant interactions|parent-infant interactions
5441146|NCT00006516|Prenatal hypoxia|prenatal hypoxia
5441147|NCT00006515|Pediatric|pediatric
5441148|NCT00006515|Sarcoma|sarcoma
5441149|NCT00006515|Effects|effects
5441150|NCT00006515|Survivors|survivors
5441151|NCT00006515|Pilot|pilot
5441152|NCT00006505|Islet Isolation|islet isolation
5441153|NCT00006505|Diabetes|diabetes
5441154|NCT00006494|AIDS|aids
5441155|NCT00006494|Antiretroviral Therapy|antiretroviral therapy
5441156|NCT00006494|Drug Resistance|drug resistance
5441157|NCT00006494|Phenotype|phenotype
5441158|NCT00006494|HIV|hiv
5441159|NCT00006494|Genotype|genotype
5441160|NCT00006494|Treatment Experienced|treatment experienced
5441161|NCT00006493|HIV-associated hyperlipidemia|hiv-associated hyperlipidemia
5441162|NCT00006492|Celiac Disease|celiac disease
5441163|NCT00006492|Cerebellar Ataxia|cerebellar ataxia
5441164|NCT00006492|Gluten-Free Diet|gluten-free diet
5441165|NCT00006489|Alcoholism|alcoholism
5441166|NCT00006489|Alcohol Dependence|alcohol dependence
5441167|NCT00006489|Post-Traumatic Stress Disorder|post-traumatic stress disorder
5441168|NCT00006489|Naltrexone|naltrexone
5441169|NCT00006489|Cognitive Behavior Therapy|cognitive behavior therapy
5441170|NCT00006450|Children|children
5441171|NCT00006450|Brain|brain
5441172|NCT00006450|Maturation|maturation
5441173|NCT00006450|Phenylacetate|phenylacetate
5441174|NCT00006450|Differentiation|differentiation
5441175|NCT00006507|Sensory integration|sensory integration
5441176|NCT00006507|Occupational therapy|occupational therapy
5441177|NCT00006507|Sensory Modulation Dysfunction (SMD)|sensory modulation dysfunction (smd)
5441178|NCT00006448|Spinal cord injury|spinal cord injury
5441179|NCT00006448|Amputation|amputation
5441180|NCT00006448|Pain management|pain management
5441181|NCT00006447|Brain Injuries|brain injuries
5441182|NCT00006447|Trauma|trauma
5441183|NCT00006447|Caregivers|caregivers
5441184|NCT00006447|Burden and Dependency|burden and dependency
5441185|NCT00006447|Rehabilitation|rehabilitation
5441186|NCT00006447|Support, social|support, social
5441187|NCT00006447|Information System|information system
5441188|NCT00006447|Information Resources (PT)|information resources (pt)
5441189|NCT00006447|Disability, persons with|disability, persons with
5441190|NCT00006446|Behavioral disorders|behavioral disorders
5441191|NCT00006446|Parenting skills and communication|parenting skills and communication
5441192|NCT00006446|Parent-child interactions|parent-child interactions
5441193|NCT00006446|At-risk preschooler|at-risk preschooler
5441194|NCT00006446|Head Start|head start
5441195|NCT00006445|Pregnancy|pregnancy
5441196|NCT00006445|Ultrasound|ultrasound
5441197|NCT00006445|Serum screen|serum screen
5441198|NCT00006445|Pregnancy associated plasma protein-A (PAPP-A)|pregnancy associated plasma protein-a (papp-a)
5441199|NCT00006445|Free-beta human chorionic gonadotropin (FbhCG)|free-beta human chorionic gonadotropin (fbhcg)
5441200|NCT00006445|Alpha fetoprotein|alpha fetoprotein
5441201|NCT00006445|Unconjugated estriol|unconjugated estriol
5441202|NCT00006445|Inhibin-A|inhibin-a
5441203|NCT00006445|Down syndrome|down syndrome
5441204|NCT00006445|Aneuploidy|aneuploidy
5441205|NCT00006439|HIV|hiv
5441206|NCT00006438|Rocker sole|rocker sole
5441207|NCT00006438|Plantar pressure|plantar pressure
5441208|NCT00006438|Diabetic feet|diabetic feet
5441209|NCT00006438|Insensate feet|insensate feet
5441210|NCT00006438|gait analysis|gait analysis
5441211|NCT00006438|Pedorthics|pedorthics
5441212|NCT00006438|Gait abnormalities|gait abnormalities
5441213|NCT00006437|MMP|mmp
5441214|NCT00006437|Proteases|proteases
5441215|NCT00006437|Adhesion|adhesion
5441216|NCT00006437|Migration|migration
5441217|NCT00006437|Extracellular Matrix|extracellular matrix
5441218|NCT00006436|AIDS|aids
5441219|NCT00006436|Malignancy|malignancy
5441220|NCT00006436|Antiretroviral|antiretroviral
5441221|NCT00006436|Chemotherapy|chemotherapy
5441222|NCT00006436|Monoclonal|monoclonal
5441223|NCT00006435|Tissue Repository|tissue repository
5441224|NCT00006435|Growth Rate|growth rate
5441225|NCT00006435|Volumetric MRI|volumetric mri
5441226|NCT00006434|Dendritic cells|dendritic cells
5441227|NCT00006429|Spinal Cord Injury|spinal cord injury
5441228|NCT00006429|Body Weight Supported Ambulation Training|body weight supported ambulation training
5441229|NCT00006429|Treadmill Training|treadmill training
5441230|NCT00006429|Physical therapy|physical therapy
5441231|NCT00006429|Gait|gait
5441232|NCT00006429|Assisted Ambulation|assisted ambulation
5441233|NCT00006428|Spinal Cord injury (SCI)|spinal cord injury (sci)
5441234|NCT00006428|Chronic Pain|chronic pain
5441235|NCT00006428|Amitriptyline|amitriptyline
5441236|NCT00006427|Amputation|amputation
5441237|NCT00006427|Chronic Pain|chronic pain
5441238|NCT00006427|Amitriptyline|amitriptyline
5441239|NCT00006426|Foot ulcers|foot ulcers
5441240|NCT00006426|Diabetes|diabetes
5441241|NCT00006426|Peripheral neuropathy|peripheral neuropathy
5441242|NCT00006426|Casting|casting
5441243|NCT00006426|Achilles Lengthening|achilles lengthening
5441244|NCT00006426|Ambulatory surgery|ambulatory surgery
5441245|NCT00006426|Foot deformity|foot deformity
5441246|NCT00006425|Breast MRI|breast mri
5441247|NCT00006425|Ductal lavage|ductal lavage
5441248|NCT00006425|Nipple Aspirate Fluid|nipple aspirate fluid
5441249|NCT00006425|Transvaginal ultrasound|transvaginal ultrasound
5441250|NCT00006425|Healthy Volunteer|healthy volunteer
5441251|NCT00006424|Plasticity|plasticity
5441252|NCT00006424|Motor|motor
5441253|NCT00006424|Stroke|stroke
5441254|NCT00006424|Amphetamine|amphetamine
5441255|NCT00006424|fMRI|fmri
5441256|NCT00006424|Cortical Reorganization|cortical reorganization
5441257|NCT00006424|Spectroscopy|spectroscopy
5441258|NCT00006422|Lazy Eye|lazy eye
5441259|NCT00006422|Amblyopia|amblyopia
5441260|NCT00006422|Nystagmus|nystagmus
5441261|NCT00006422|Eye Movements|eye movements
5441262|NCT00006422|Child Vision|child vision
5441263|NCT00006421|Breast MRI|breast mri
5441264|NCT00006421|Nipple Aspirate Fluid|nipple aspirate fluid
5441265|NCT00006421|Transvaginal ultrasound|transvaginal ultrasound
5441266|NCT00006421|Ductal lavage|ductal lavage
5441267|NCT00006418|Schizophrenia|schizophrenia
5441268|NCT00006418|Genetics|genetics
5441269|NCT00006417|Fludarabine|fludarabine
5441270|NCT00006417|Non-Myeloablative BMT|non-myeloablative bmt
5441271|NCT00006417|Immunodeficiency|immunodeficiency
5441272|NCT00006417|Neutrophils|neutrophils
5441273|NCT00006417|Oxidase|oxidase
5441274|NCT00006417|Engraftment|engraftment
5441275|NCT00006417|Graft-versus-host Disease|graft-versus-host disease
5441276|NCT00006417|Cyclophosphamide|cyclophosphamide
5441277|NCT00006417|Donor Apheresis|donor apheresis
5441278|NCT00006417|Peripheral Blood Stem Cells|peripheral blood stem cells
5441279|NCT00006417|Therapy|therapy
5441280|NCT00006414|Anesthesia|anesthesia
5441281|NCT00006414|Magnetic Stimulation|magnetic stimulation
5441282|NCT00006414|Motor|motor
5441283|NCT00006414|Neuroplasticity|neuroplasticity
5441284|NCT00006414|Practice|practice
5441285|NCT00006414|Rehabilitation|rehabilitation
5441286|NCT00006414|Stroke|stroke
5441287|NCT00006413|Peripheral Blood Stem Cells|peripheral blood stem cells
5441288|NCT00006413|Non-Myeloablative Bone Marrow Transplantation|non-myeloablative bone marrow transplantation
5441289|NCT00006413|Engraftment|engraftment
5441290|NCT00006413|Graft-versus-host Disease|graft-versus-host disease
5441291|NCT00006413|Graft-Versus-Leukemia|graft-versus-leukemia
5441292|NCT00006413|Graft-Versus-Mast Cell|graft-versus-mast cell
5441293|NCT00006413|Cyclophosphamide|cyclophosphamide
5441294|NCT00006413|Fludarabine|fludarabine
5441295|NCT00006413|Donor Apheresis|donor apheresis
5441296|NCT00006413|Mast Cells|mast cells
5441297|NCT00006411|cornea transplant|cornea transplant
5441298|NCT00006411|corneal endothelial cell density|corneal endothelial cell density
5441299|NCT00006411|moderate risk corneal diseases requiring corneal transplantation|moderate risk corneal diseases requiring corneal transplantation
5441300|NCT00006411|corneal transplantation|corneal transplantation
5441301|NCT00006400|Blood Diseases|blood diseases
5441302|NCT00006400|Sickle Cell Anemia|sickle cell anemia
5441303|NCT00006398|cirrhosis|cirrhosis
5441304|NCT00006398|esophageal varices|esophageal varices
5441305|NCT00006398|variceal hemorrhage|variceal hemorrhage
5441306|NCT00006398|beta-adrenergic blocker|beta-adrenergic blocker
5441307|NCT00006394|disease-related problem/condition|disease-related problem/condition
5441308|NCT00006394|endocrine disorders|endocrine disorders
5441309|NCT00006394|growth hormone deficiency|growth hormone deficiency
5441310|NCT00006394|osteoporosis|osteoporosis
5441311|NCT00006394|quality of life|quality of life
5441312|NCT00006394|rare disease|rare disease
5441313|NCT00006393|arthritis & connective tissue diseases|arthritis & connective tissue diseases
5441314|NCT00006393|rare disease|rare disease
5441315|NCT00006393|systemic sclerosis|systemic sclerosis
5441316|NCT00006337|Clinical Trial|clinical trial
5441317|NCT00006337|Dyskinesias|dyskinesias
5441318|NCT00006337|Levodopa Infusion|levodopa infusion
5441319|NCT00006336|Gap Detection Test|gap detection test
5441320|NCT00006336|Fahn-Scale|fahn-scale
5441321|NCT00006336|Visual Analog and Verbal Scale|visual analog and verbal scale
5441322|NCT00006336|Writing Standard Paragraph|writing standard paragraph
5441323|NCT00006336|Braille Reading Grade I|braille reading grade i
5441324|NCT00006335|Genetic|genetic
5441325|NCT00006335|Analysis|analysis
5441326|NCT00006335|Immune|immune
5441329|NCT00006335|Severe Combined Immune Deficiency (SCID)|severe combined immune deficiency (scid)
5441330|NCT00006335|XSCID|xscid
5441331|NCT00006335|Carrier Testing|carrier testing
5441332|NCT00006335|X-Linked Disease|x-linked disease
5441333|NCT00006335|Adolescent|adolescent
5441334|NCT00006334|Genes|genes
5441335|NCT00006334|X-Chromosome|x-chromosome
5441336|NCT00006334|Osteoporosis|osteoporosis
5441337|NCT00006334|Ovarian Failure|ovarian failure
5441338|NCT00006334|Imprinting|imprinting
5441339|NCT00006334|Turner's|turner's
5441340|NCT00006334|Turner|turner
5441341|NCT00006334|TS|ts
5441342|NCT00006333|Rheumatoid Arthritis|rheumatoid arthritis
5441343|NCT00006333|Inflammation|inflammation
5441344|NCT00006333|Synovitis|synovitis
5441345|NCT00006333|Genetics|genetics
5441346|NCT00006333|Synovial Biopsy|synovial biopsy
5441347|NCT00006333|Arthritis|arthritis
5441348|NCT00006333|Juvenile Rheumatoid Arthritis|juvenile rheumatoid arthritis
5441349|NCT00006333|JRA|jra
5441350|NCT00006332|Molybdenum|molybdenum
5441351|NCT00006331|Kidney transplantation|kidney transplantation
5441352|NCT00006331|Immunology|immunology
5441353|NCT00006330|Digoxin|digoxin
5441354|NCT00006330|Effect modifiers (Epidemiology)|effect modifiers (epidemiology)
5441355|NCT00006330|Rosales|rosales
5441356|NCT00006330|Drug Interaction|drug interaction
5441357|NCT00006329|Radionuclide imaging|radionuclide imaging
5441358|NCT00006329|Surgery|surgery
5441359|NCT00006328|Chronic Allograft Nephropathy (CAN)|chronic allograft nephropathy (can)
5441360|NCT00006328|Transplantation immunology|transplantation immunology
5441361|NCT00006328|Genetics|genetics
5441362|NCT00006328|Graft Rejection|graft rejection
5441363|NCT00006320|Reverse Transcriptase Inhibitor|reverse transcriptase inhibitor
5441364|NCT00006320|Protease Inhibitor|protease inhibitor
5441365|NCT00006319|X-Linked Agammagloblinemia|x-linked agammagloblinemia
5441366|NCT00006319|Wiskott-Aldrich Syndrome|wiskott-aldrich syndrome
5441367|NCT00006319|Jak-3 SCID|jak-3 scid
5441368|NCT00006319|X-Linked SCID|x-linked scid
5441369|NCT00006319|X-Linked Hyper-IgM Syndrome|x-linked hyper-igm syndrome
5441370|NCT00006319|Primary Immunodeficiencies|primary immunodeficiencies
5441371|NCT00006319|ADA-SCID|ada-scid
5441372|NCT00006318|Cerebral Blood Flow|cerebral blood flow
5441373|NCT00006318|CO2 Inhalation|co2 inhalation
5441374|NCT00006318|Imaging|imaging
5441375|NCT00006318|MRI|mri
5441376|NCT00006318|Perfusion|perfusion
5441377|NCT00006318|Functional Activation|functional activation
5441378|NCT00006301|Hepatitis C|hepatitis c
5441379|NCT00006301|Viral Sequence|viral sequence
5441380|NCT00006301|PCR|pcr
5441381|NCT00006301|T Cell|t cell
5441382|NCT00006301|Seroconversion|seroconversion
5441383|NCT00006301|Cytokines|cytokines
5441384|NCT00006300|Immunosuppression|immunosuppression
5441385|NCT00006300|Treatment Recommendations|treatment recommendations
5441386|NCT00006300|Pancytopenia|pancytopenia
5441387|NCT00006300|Schizophrenia|schizophrenia
5441388|NCT00006300|Inpatient Population|inpatient population
5441389|NCT00006299|Celecoxib|celecoxib
5441390|NCT00006299|Thromboxane B2|thromboxane b2
5441391|NCT00006299|Prostaglandin E2|prostaglandin e2
5441392|NCT00006299|Microdialysis|microdialysis
5441393|NCT00006299|Ibuprofen|ibuprofen
5441394|NCT00006292|Biologic Therapy|biologic therapy
5441395|NCT00006292|Bone Erosion|bone erosion
5441396|NCT00006292|CT|ct
5441397|NCT00006292|MRI|mri
5441398|NCT00006292|Rheumatoid Arthritis|rheumatoid arthritis
5441399|NCT00006292|RA|ra
5441400|NCT00006289|Analgesia|analgesia
5441401|NCT00006289|Causalgia|causalgia
5441402|NCT00006289|CRPS|crps
5441403|NCT00006289|Neuropathic Pain|neuropathic pain
5441404|NCT00006289|Oral Surgery|oral surgery
5441405|NCT00006289|Reflex Sympathetic Dystrophy|reflex sympathetic dystrophy
5441406|NCT00006289|Sympathetic Nervous System|sympathetic nervous system
5441407|NCT00006289|Chronic Regional Pain Syndrome|chronic regional pain syndrome
5441408|NCT00006285|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
5441409|NCT00006285|Parietal Lobe|parietal lobe
5441410|NCT00006285|fMRI|fmri
5441411|NCT00006285|Cognition|cognition
5441412|NCT00006285|Perception|perception
5441413|NCT00006285|Cortical Stimulation|cortical stimulation
5441414|NCT00006285|Spatial Attention|spatial attention
5441415|NCT00006286|Depression|depression
5441416|NCT00006286|Major Depressive Disorder|major depressive disorder
5441417|NCT00006286|Fluoxetine|fluoxetine
5441418|NCT00006286|Prozac|prozac
5441419|NCT00006286|SSRI|ssri
5441420|NCT00006286|Psychotherapy|psychotherapy
5441421|NCT00006286|CBT|cbt
5441422|NCT00006286|Teenagers|teenagers
5441423|NCT00006286|Adolescents|adolescents
5441424|NCT00006286|Teens|teens
5441425|NCT00006278|Cushing's Syndrome|cushing's syndrome
5441426|NCT00006278|Adrenal Glands|adrenal glands
5441427|NCT00006278|Proteomics|proteomics
5441428|NCT00006278|Cortisol|cortisol
5441429|NCT00006276|Angiogenesis Inhibition|angiogenesis inhibition
5441430|NCT00006276|Skin Disease|skin disease
5441431|NCT00006276|Blood Vessels|blood vessels
5441432|NCT00006276|Cytokines|cytokines
5441433|NCT00006276|Autoimmune Disease|autoimmune disease
5441434|NCT00006280|Cystic Fibrosis|cystic fibrosis
5441435|NCT00006275|dermatologic disorders|dermatologic disorders
5441436|NCT00006275|psoriasis|psoriasis
5441437|NCT00006275|rare disease|rare disease
5441438|NCT00006274|cardiovascular and respiratory diseases|cardiovascular and respiratory diseases
5441439|NCT00006274|neonatal disorders|neonatal disorders
5441440|NCT00006274|rare disease|rare disease
5441441|NCT00006274|respiratory distress syndrome|respiratory distress syndrome
5441442|NCT00006273|cardiovascular and respiratory diseases|cardiovascular and respiratory diseases
5441443|NCT00006273|cystic fibrosis|cystic fibrosis
5441444|NCT00006273|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
5441445|NCT00006273|rare disease|rare disease
5441446|NCT00006272|cardiovascular and respiratory diseases|cardiovascular and respiratory diseases
5441447|NCT00006272|heart defects|heart defects
5441448|NCT00006272|rare disease|rare disease
5441449|NCT00006271|brain injury|brain injury
5441450|NCT00006271|neurologic and psychiatric disorders|neurologic and psychiatric disorders
5441451|NCT00006271|rare disease|rare disease
5441452|NCT00006270|brain injury|brain injury
5441453|NCT00006270|neurologic and psychiatric disorders|neurologic and psychiatric disorders
5441454|NCT00006270|rare disease|rare disease
5441455|NCT00006205|alcoholism|alcoholism
5441456|NCT00006205|alcohol addiction|alcohol addiction
5441457|NCT00006204|Alcoholism|alcoholism
5441458|NCT00006204|Alcohol Dependence|alcohol dependence
5441459|NCT00006204|Depression|depression
5441460|NCT00006204|Naltrexone|naltrexone
5441461|NCT00006204|Fluoxetine|fluoxetine
5441462|NCT00006202|Serum levels of Lutein|serum levels of lutein
5441463|NCT00006202|Age-Related Macular Degeneration|age-related macular degeneration
5441464|NCT00006202|Safety|safety
5441465|NCT00006202|Toxicity|toxicity
5441466|NCT00006199|solid tumor|solid tumor
5441467|NCT00006196|Vitamin D resistance|vitamin d resistance
5441468|NCT00006194|sarcopenia|sarcopenia
5441469|NCT00006190|Lipoproteins|lipoproteins
5441470|NCT00006190|Insulin resistance|insulin resistance
5441471|NCT00006190|Adipose tissue|adipose tissue
5441472|NCT00006188|Behcet's Disease|behcet's disease
5441473|NCT00006188|Sarcoidosis|sarcoidosis
5441474|NCT00006188|Iritis|iritis
5441475|NCT00006188|Choroiditis|choroiditis
5441476|NCT00006188|Iridocyclitis|iridocyclitis
5441477|NCT00006188|Retinal Disease|retinal disease
5441478|NCT00006188|Cystoid Macular Edema|cystoid macular edema
5441479|NCT00006188|Uveitis|uveitis
5441480|NCT00006188|Intraocular Inflammation|intraocular inflammation
5441481|NCT00006188|Inflammatory Eye DIsease|inflammatory eye disease
5441482|NCT00006187|Investigational Drug|investigational drug
5441483|NCT00006186|dilutional coagulopathy|dilutional coagulopathy
5441484|NCT00006184|Immunoablative|immunoablative
5441485|NCT00006184|Mobilization|mobilization
5441486|NCT00006184|Apheresis|apheresis
5441487|NCT00006184|Multiple Myeloma|multiple myeloma
5441488|NCT00006184|IgG Multiple Myeloma|igg multiple myeloma
5441489|NCT00006184|IgA Multiple Myeloma|iga multiple myeloma
5441490|NCT00006185|peripheral fat wasting|peripheral fat wasting
5441491|NCT00006185|truncal adiposity|truncal adiposity
5441492|NCT00006185|fat biopsy|fat biopsy
5441493|NCT00006185|muscle biopsy|muscle biopsy
5441494|NCT00006185|intravenous lines|intravenous lines
5441495|NCT00006185|blood draws|blood draws
5441496|NCT00006185|insulin administration|insulin administration
5441497|NCT00006185|sugar water|sugar water
5441498|NCT00006185|screening|screening
5441499|NCT00006399|Alzheimer disease|alzheimer disease
5441500|NCT00006399|Estrogen therapy|estrogen therapy
5441501|NCT00006399|Post-menopausal women|post-menopausal women
5441502|NCT00006181|Health behavior change|health behavior change
5441503|NCT00006181|Motivational interviewing|motivational interviewing
5441504|NCT00006181|Motivational enhancement|motivational enhancement
5441505|NCT00006181|Health counseling|health counseling
5441506|NCT00006181|Team intervention|team intervention
5441507|NCT00006181|One-on-one intervention|one-on-one intervention
5441508|NCT00006181|Physical activity|physical activity
5441509|NCT00006181|Exercise|exercise
5441510|NCT00006181|Nutrition|nutrition
5441511|NCT00006181|Health assessments|health assessments
5441512|NCT00006181|Strength|strength
5441513|NCT00006181|Flexibility|flexibility
5441514|NCT00006181|Percent body fat|percent body fat
5441515|NCT00006181|Social-learning theory|social-learning theory
5441516|NCT00006181|PHLAME|phlame
5441517|NCT00006181|Fire fighters|fire fighters
5441518|NCT00006181|Fire stations|fire stations
5441519|NCT00006181|Cancer|cancer
5441520|NCT00006181|Cardiovascular diseases|cardiovascular diseases
5441521|NCT00006180|Preventive Medicine|preventive medicine
5441522|NCT00006180|Women's Health|women's health
5441523|NCT00006180|Bone Formation|bone formation
5441524|NCT00006180|Mood Disorders|mood disorders
5441525|NCT00006180|Bone Resorption|bone resorption
5441526|NCT00006180|Major Depression|major depression
5441527|NCT00006180|Osteopenia|osteopenia
5441528|NCT00006180|Osteoporosis|osteoporosis
5441529|NCT00006180|Bone Fracture|bone fracture
5441530|NCT00006180|Bisphosphonate|bisphosphonate
5441531|NCT00006180|Depression|depression
5441532|NCT00006180|Bone Density|bone density
5441533|NCT00006180|Healthy Volunteer|healthy volunteer
5441534|NCT00006180|HV|hv
5441535|NCT00006180|Normal Control|normal control
5441536|NCT00006178|Renal Failure|renal failure
5441537|NCT00006178|Anti-rejection|anti-rejection
5441538|NCT00006178|Apoptosis|apoptosis
5441539|NCT00006178|Polyclonal Antibody|polyclonal antibody
5441540|NCT00006178|Kidney Transplant|kidney transplant
5441541|NCT00006177|Emotion|emotion
5441542|NCT00006177|Children and Adolescents|children and adolescents
5441543|NCT00006177|Affective Neuroscience|affective neuroscience
5441544|NCT00006177|Bipolar Disorder|bipolar disorder
5441545|NCT00006177|Child|child
5441546|NCT00006177|Child Bipolar|child bipolar
5441547|NCT00006177|BPD|bpd
5441548|NCT00006177|Adolescent Bipolar|adolescent bipolar
5441549|NCT00006176|FENIB|fenib
5441550|NCT00006176|Presenile Dementia|presenile dementia
5441551|NCT00006176|Progressive Myoclonic Epilepsy|progressive myoclonic epilepsy
5441552|NCT00006176|Dementia|dementia
5441553|NCT00006176|Early Onset Progressive Dementia|early onset progressive dementia
5441554|NCT00006176|Familial Presenile Dementia|familial presenile dementia
5441555|NCT00006176|FDNIB|fdnib
5441556|NCT00006176|familial encephalopathy with neuroserpin inclusion bodies|familial encephalopathy with neuroserpin inclusion bodies
5441557|NCT00006176|Heredodegenerative Disorders, Nervous System|heredodegenerative disorders, nervous system
5441558|NCT00006175|Cyclooxygenase|cyclooxygenase
5441559|NCT00006175|COX-1|cox-1
5441560|NCT00006175|COX-2|cox-2
5441561|NCT00006175|Prostanoids|prostanoids
5441562|NCT00006175|P.C.R.|p.c.r.
5441563|NCT00006175|Healthy Volunteer|healthy volunteer
5441564|NCT00006174|Precocious Puberty|precocious puberty
5441565|NCT00006174|Polyostotic|polyostotic
5441566|NCT00006174|Fibrous Dysplasia|fibrous dysplasia
5441567|NCT00006174|PFD|pfd
5441568|NCT00006174|McCune-Albright Syndrome (MAS)|mccune-albright syndrome (mas)
5441569|NCT00006173|Atherosclerosis|atherosclerosis
5441570|NCT00006173|Hypertension|hypertension
5441571|NCT00006173|Magnetic Resonance Angiography|magnetic resonance angiography
5441572|NCT00006172|Antidepressive Agents|antidepressive agents
5441573|NCT00006172|Chronobiology|chronobiology
5441574|NCT00006172|Chronotherapy|chronotherapy
5441575|NCT00006172|Circadian rhythms|circadian rhythms
5441576|NCT00006172|Depressive Disorder|depressive disorder
5441577|NCT00006172|Ions|ions
5441578|NCT00006172|Light|light
5441579|NCT00006172|Lighting|lighting
5441580|NCT00006172|Mood disorders|mood disorders
5441581|NCT00006172|Phototherapy.|phototherapy.
5441582|NCT00006171|HHV-8|hhv-8
5441583|NCT00006171|Pathophysiology|pathophysiology
5441584|NCT00006171|AIDS|aids
5441585|NCT00006171|Cancer|cancer
5441586|NCT00006171|Anti-Retroviral|anti-retroviral
5441587|NCT00006171|Kaposi's Sarcoma|kaposi's sarcoma
5441588|NCT00006171|HIV|hiv
5441589|NCT00006170|smoking cessation|smoking cessation
5441590|NCT00006170|Women|women
5441591|NCT00006170|bupropion|bupropion
5441592|NCT00006170|weight concerns|weight concerns
5441593|NCT00006170|weight|weight
5441594|NCT00006156|Ovarian Failure|ovarian failure
5441595|NCT00006156|Ovary|ovary
5441596|NCT00006156|Aging|aging
5441597|NCT00006156|Healthy Volunteer|healthy volunteer
5441598|NCT00006156|Primary Ovarian Insufficiency(POI)|primary ovarian insufficiency(poi)
5441599|NCT00006156|Premature Menopause|premature menopause
5441600|NCT00006156|Premature Ovarian Failure (POF)|premature ovarian failure (pof)
5441601|NCT00006169|Nutrition|nutrition
5441602|NCT00006169|Behavior Therapy|behavior therapy
5441603|NCT00006169|Cystic Fibrosis|cystic fibrosis
5441604|NCT00006168|primary biliary cirrhosis|primary biliary cirrhosis
5441605|NCT00006168|Ursodeoxycholic acid|ursodeoxycholic acid
5441606|NCT00006168|UDCA|udca
5441607|NCT00006168|MTX|mtx
5441608|NCT00006168|Hepatology|hepatology
5441609|NCT00006168|methotrexate|methotrexate
5441610|NCT00006168|liver|liver
5441611|NCT00006167|oxandrolone|oxandrolone
5441612|NCT00006167|AIDS wasting|aids wasting
5441613|NCT00006167|strength training|strength training
5441614|NCT00006167|progressive resistance training|progressive resistance training
5441615|NCT00006167|exercise|exercise
5441616|NCT00006167|dietary intervention|dietary intervention
5441617|NCT00006166|refractory ascites|refractory ascites
5441618|NCT00006166|paracenteses|paracenteses
5441619|NCT00006165|Native Hawaiian|native hawaiian
5441620|NCT00006165|Diabetes Mellitus|diabetes mellitus
5441621|NCT00006165|Lifestyle Intervention|lifestyle intervention
5441622|NCT00006165|Family Support|family support
5441623|NCT00006165|Diabetes Mellitus, at-risk|diabetes mellitus, at-risk
5441624|NCT00006164|liver disease|liver disease
5441625|NCT00006164|hepatitis c virus|hepatitis c virus
5441626|NCT00006164|antiviral agent|antiviral agent
5441627|NCT00006164|cirrhosis|cirrhosis
5441628|NCT00006163|diabetes|diabetes
5441629|NCT00006163|self-management|self-management
5441630|NCT00006163|randomized trial|randomized trial
5441631|NCT00006163|RE-AIM evaluation|re-aim evaluation
5441632|NCT00006163|participation|participation
5441633|NCT00006163|maintenance|maintenance
5441634|NCT00006163|community resources|community resources
5441635|NCT00006163|dietary change|dietary change
5441636|NCT00006162|low fat diet|low fat diet
5441637|NCT00006162|aerobic exercise|aerobic exercise
5444284|NCT00001643|Sporadic|sporadic
5441638|NCT00006162|impaired glucose tolerance|impaired glucose tolerance
5441639|NCT00006162|Japanese Americans|japanese americans
5441640|NCT00006162|metabolic risk factors|metabolic risk factors
5441641|NCT00006161|TIPS|tips
5441642|NCT00006161|DSRS|dsrs
5441643|NCT00006161|Varices|varices
5441644|NCT00006161|Variceal bleeding|variceal bleeding
5441645|NCT00006161|Splenorenal Shunt|splenorenal shunt
5441646|NCT00006161|Transjugular Intrahepatic Portosystemic Shunt|transjugular intrahepatic portosystemic shunt
5441647|NCT00006161|Cirrhosis|cirrhosis
5441648|NCT00006161|Portal hypertension|portal hypertension
5441649|NCT00006161|Liver disease|liver disease
5441650|NCT00006159|diabetes|diabetes
5441651|NCT00006159|lifestyle intervention|lifestyle intervention
5441652|NCT00006159|Native American|native american
5441653|NCT00006159|community intervention|community intervention
5441654|NCT00006159|diet|diet
5441655|NCT00006159|exercise|exercise
5441656|NCT00006158|AIDS|aids
5441657|NCT00006158|HIV|hiv
5441658|NCT00006158|weight loss|weight loss
5441659|NCT00006158|Wasting Syndrome|wasting syndrome
5441660|NCT00006158|testosterone|testosterone
5441661|NCT00006158|androgen levels|androgen levels
5441662|NCT00006158|hormones|hormones
5441663|NCT00006157|Functional bowel disorder|functional bowel disorder
5441664|NCT00006157|Irritable bowel syndrome|irritable bowel syndrome
5441665|NCT00006157|Painful constipation|painful constipation
5441666|NCT00006157|Unspecified functional bowel disorder|unspecified functional bowel disorder
5441667|NCT00006157|Chronic functional abdominal pain|chronic functional abdominal pain
5441668|NCT00006157|Cognitive-behavioral psychological treatment|cognitive-behavioral psychological treatment
5441669|NCT00006157|IBS|ibs
5441670|NCT00006157|CFAP|cfap
5441671|NCT00006151|nicotine fading|nicotine fading
5441672|NCT00006151|Accu Drop|accu drop
5441673|NCT00006151|cigarette tapering|cigarette tapering
5441674|NCT00006151|smoking cessation|smoking cessation
5441675|NCT00006151|motivational interviewing|motivational interviewing
5441676|NCT00006150|IgE|ige
5441677|NCT00006150|Fractures|fractures
5441678|NCT00006150|Pneumonia|pneumonia
5441679|NCT00006150|Scoliosis|scoliosis
5441680|NCT00006150|Eczema|eczema
5441681|NCT00006150|Job's Syndrome|job's syndrome
5441682|NCT00006150|Hyperimmunologobulin E Syndrome|hyperimmunologobulin e syndrome
5441683|NCT00006150|HIE Syndrome|hie syndrome
5441684|NCT00006148|Granulocyte Colony - Stimulation Factor|granulocyte colony - stimulation factor
5441685|NCT00006148|Peripheral Blood Stem Cells|peripheral blood stem cells
5441686|NCT00006148|Splenomegaly|splenomegaly
5441687|NCT00006077|Clinical Trial|clinical trial
5441688|NCT00006077|Dyskinesias|dyskinesias
5441689|NCT00006077|Levodopa Infusion|levodopa infusion
5441690|NCT00006077|Parkinson's Disease|parkinson's disease
5441691|NCT00006142|inborn errors of metabolism|inborn errors of metabolism
5441692|NCT00006142|phenylketonuria|phenylketonuria
5441693|NCT00006142|rare disease|rare disease
5441694|NCT00006138|disease-related problem/condition|disease-related problem/condition
5441695|NCT00006138|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
5441696|NCT00006138|hematologic disorders|hematologic disorders
5441697|NCT00006138|osteoporosis|osteoporosis
5441698|NCT00006138|rare disease|rare disease
5441699|NCT00006138|thalassemia major|thalassemia major
5441700|NCT00006137|IgA glomerulonephritis|iga glomerulonephritis
5441701|NCT00006137|rare disease|rare disease
5441702|NCT00006137|renal and genitourinary disorders|renal and genitourinary disorders
5441703|NCT00006136|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
5441704|NCT00006136|hematologic disorders|hematologic disorders
5441705|NCT00006136|rare disease|rare disease
5441706|NCT00006136|thalassemia intermedia|thalassemia intermedia
5441707|NCT00006135|herpes simplex virus infection|herpes simplex virus infection
5441708|NCT00006135|herpesvirus infection|herpesvirus infection
5441709|NCT00006135|immunologic disorders and infectious disorders|immunologic disorders and infectious disorders
5441710|NCT00006135|rare disease|rare disease
5441711|NCT00006135|viral infection|viral infection
5441712|NCT00006134|arthritis & connective tissue diseases|arthritis & connective tissue diseases
5441713|NCT00006134|immunologic disorders and infectious disorders|immunologic disorders and infectious disorders
5441714|NCT00006134|rare disease|rare disease
5441715|NCT00006134|systemic lupus erythematosus|systemic lupus erythematosus
5441716|NCT00006133|arthritis & connective tissue diseases|arthritis & connective tissue diseases
5441717|NCT00006133|immunologic disorders and infectious disorders|immunologic disorders and infectious disorders
5441718|NCT00006133|rare disease|rare disease
5441719|NCT00006133|systemic lupus erythematosus|systemic lupus erythematosus
5441720|NCT00006132|herpes simplex virus infection|herpes simplex virus infection
5441721|NCT00006132|herpes virus infection|herpes virus infection
5441722|NCT00006132|immunologic disorders and infectious disorders|immunologic disorders and infectious disorders
5441723|NCT00006132|rare disease|rare disease
5441724|NCT00006132|viral infection|viral infection
5441725|NCT00006130|arthritis & connective tissue diseases|arthritis & connective tissue diseases
5441726|NCT00006130|avascular necrosis|avascular necrosis
5441727|NCT00006130|disease-related problem/condition|disease-related problem/condition
5441728|NCT00006130|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
5441729|NCT00006130|hematologic disorders|hematologic disorders
5441730|NCT00006130|pain|pain
5441731|NCT00006130|rare disease|rare disease
5441732|NCT00006130|sickle cell anemia|sickle cell anemia
5441733|NCT00006129|burns|burns
5441734|NCT00006129|dermatologic disorders|dermatologic disorders
5441735|NCT00006129|rare disease|rare disease
5441736|NCT00006128|neurologic and psychiatric disorders|neurologic and psychiatric disorders
5441737|NCT00006128|rare disease|rare disease
5441738|NCT00006127|Fanconi's anemia|fanconi's anemia
5441739|NCT00006127|aplastic anemia|aplastic anemia
5441740|NCT00006127|hematologic disorders|hematologic disorders
5441741|NCT00006127|rare disease|rare disease
5441742|NCT00006076|Hearing|hearing
5441743|NCT00006076|Auditory Processing|auditory processing
5441744|NCT00006076|Pitch Recognition|pitch recognition
5441745|NCT00006076|Tone Deafness|tone deafness
5441746|NCT00006076|Tune Deafness|tune deafness
5441747|NCT00006076|HV|hv
5441748|NCT00006076|Deafness|deafness
5441749|NCT00006076|Congenital Amusia|congenital amusia
5441750|NCT00006076|Healthy Volunteer|healthy volunteer
5441751|NCT00006070|Oral Surgery|oral surgery
5441752|NCT00006070|Swelling|swelling
5441753|NCT00006070|Pain|pain
5441754|NCT00006070|TNF|tnf
5441755|NCT00006070|Etanercept|etanercept
5441756|NCT00005937|MDS|mds
5441757|NCT00005937|Immunosuppression|immunosuppression
5441758|NCT00005937|ATG|atg
5441759|NCT00005937|Cyclosporine|cyclosporine
5441760|NCT00005937|Myelodysplastic Syndrome|myelodysplastic syndrome
5441761|NCT00005936|Fulminant Hepatitis|fulminant hepatitis
5441762|NCT00005936|Parvovirus|parvovirus
5441763|NCT00005936|Hepatitis|hepatitis
5441764|NCT00005936|Biopsy|biopsy
5441765|NCT00005936|Control|control
5441766|NCT00005936|Liver Biopsy|liver biopsy
5441767|NCT00005935|Immunosuppression|immunosuppression
5441768|NCT00005935|T Cells|t cells
5441769|NCT00005935|Autoimmunity|autoimmunity
5441770|NCT00005935|Bone Marrow Failure|bone marrow failure
5441771|NCT00005935|Hematopoiesis|hematopoiesis
5441772|NCT00005935|Relapsing Aplastic Anemia|relapsing aplastic anemia
5441773|NCT00005934|Fetal Hemoglobin|fetal hemoglobin
5441774|NCT00005934|5-Azacytidine|5-azacytidine
5441775|NCT00005934|Phenylbutyrate|phenylbutyrate
5441776|NCT00005934|Thalassemia|thalassemia
5441777|NCT00005934|Hemoglobin|hemoglobin
5441778|NCT00005934|Anemia|anemia
5441779|NCT00005934|Blood|blood
5441780|NCT00005934|Thalassemia Major|thalassemia major
5441781|NCT00005934|Beta Thalassemia|beta thalassemia
5441782|NCT00006063|cardiovascular and respiratory diseases|cardiovascular and respiratory diseases
5441783|NCT00006063|cystic fibrosis|cystic fibrosis
5441784|NCT00006063|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
5441785|NCT00006063|rare disease|rare disease
5441786|NCT00006061|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
5441787|NCT00006061|inborn errors of metabolism|inborn errors of metabolism
5441788|NCT00006061|methionine adenosyltransferase deficiency|methionine adenosyltransferase deficiency
5441789|NCT00006061|rare disease|rare disease
5441790|NCT00006060|multiple sclerosis|multiple sclerosis
5441791|NCT00006060|neurologic and psychiatric disorders|neurologic and psychiatric disorders
5441792|NCT00006060|rare disease|rare disease
5441793|NCT00006059|epilepsy|epilepsy
5441794|NCT00006059|neurologic and psychiatric disorders|neurologic and psychiatric disorders
5441795|NCT00006059|rare disease|rare disease
5441796|NCT00006059|seizures|seizures
5441797|NCT00006058|bronchopulmonary dysplasia|bronchopulmonary dysplasia
5441798|NCT00006058|cardiovascular and respiratory diseases|cardiovascular and respiratory diseases
5441799|NCT00006058|neonatal disorders|neonatal disorders
5441800|NCT00006058|rare disease|rare disease
5441801|NCT00006058|respiratory distress syndrome|respiratory distress syndrome
5441802|NCT00006056|Chediak-Higashi syndrome|chediak-higashi syndrome
5441803|NCT00006056|X-linked lymphoproliferative syndrome|x-linked lymphoproliferative syndrome
5441804|NCT00006056|disease-related problem/condition|disease-related problem/condition
5441805|NCT00006056|familial erythrophagocytic lymphohistiocytosis|familial erythrophagocytic lymphohistiocytosis
5441806|NCT00006056|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
5441807|NCT00006056|graft versus host disease|graft versus host disease
5441808|NCT00006056|hematologic disorders|hematologic disorders
5441809|NCT00006056|hemophagocytic lymphohistiocytosis|hemophagocytic lymphohistiocytosis
5441810|NCT00006056|histiocytosis|histiocytosis
5441811|NCT00006056|immunologic disorders and infectious disorders|immunologic disorders and infectious disorders
5441812|NCT00006056|primary immunodeficiency disease|primary immunodeficiency disease
5441813|NCT00006056|rare disease|rare disease
5441814|NCT00006056|virus-associated hemophagocytic syndrome|virus-associated hemophagocytic syndrome
5441815|NCT00006055|Churg-Strauss syndrome|churg-strauss syndrome
5441816|NCT00006055|Schonlein-Henoch purpura|schonlein-henoch purpura
5441817|NCT00006055|Takayasu arteritis|takayasu arteritis
5441818|NCT00006055|Wegener's granulomatosis|wegener's granulomatosis
5441819|NCT00006055|arthritis & connective tissue diseases|arthritis & connective tissue diseases
5441820|NCT00006055|autoimmune hemolytic anemia|autoimmune hemolytic anemia
5441821|NCT00006055|cardiovascular and respiratory diseases|cardiovascular and respiratory diseases
5441822|NCT00006055|disease-related problem/condition|disease-related problem/condition
5441823|NCT00006055|giant cell arteritis|giant cell arteritis
5441824|NCT00006055|graft versus host disease|graft versus host disease
5441825|NCT00006055|hematologic disorders|hematologic disorders
5441826|NCT00006055|hypersensitivity vasculitis|hypersensitivity vasculitis
5441827|NCT00006055|immune thrombocytopenic purpura|immune thrombocytopenic purpura
5441828|NCT00006055|immunologic disorders and infectious disorders|immunologic disorders and infectious disorders
5441829|NCT00006055|juvenile rheumatoid arthritis|juvenile rheumatoid arthritis
5441830|NCT00006055|polyarteritis nodosa|polyarteritis nodosa
5441831|NCT00006055|pure red cell aplasia|pure red cell aplasia
5441832|NCT00006055|rare disease|rare disease
5441833|NCT00006055|rheumatoid arthritis|rheumatoid arthritis
5441834|NCT00006055|systemic lupus erythematosus|systemic lupus erythematosus
5441835|NCT00006055|vasculitis|vasculitis
5441836|NCT00006054|Chediak-Higashi syndrome|chediak-higashi syndrome
5441837|NCT00006054|Langerhans cell histiocytosis|langerhans cell histiocytosis
5441838|NCT00006054|Wiskott-Aldrich syndrome|wiskott-aldrich syndrome
5441839|NCT00006054|X-linked agammaglobulinemia|x-linked agammaglobulinemia
5441840|NCT00006054|X-linked hyper IgM syndrome|x-linked hyper igm syndrome
5441841|NCT00006054|X-linked lymphoproliferative syndrome|x-linked lymphoproliferative syndrome
5441842|NCT00006054|chronic granulomatous disease|chronic granulomatous disease
5441843|NCT00006054|common variable immunodeficiency|common variable immunodeficiency
5441844|NCT00006054|complement deficiency|complement deficiency
5441845|NCT00006054|disease-related problem/condition|disease-related problem/condition
5441846|NCT00006054|familial erythrophagocytic lymphohistiocytosis|familial erythrophagocytic lymphohistiocytosis
5441847|NCT00006054|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
5441848|NCT00006054|graft versus host disease|graft versus host disease
5441849|NCT00006054|hematologic disorders|hematologic disorders
5441850|NCT00006054|hemophagocytic lymphohistiocytosis|hemophagocytic lymphohistiocytosis
5441851|NCT00006054|histiocytosis|histiocytosis
5441852|NCT00006054|immunologic disorders and infectious disorders|immunologic disorders and infectious disorders
5441853|NCT00006054|leukocyte adhesion deficiency syndrome|leukocyte adhesion deficiency syndrome
5441854|NCT00006054|primary immunodeficiency disease|primary immunodeficiency disease
5441855|NCT00006054|rare disease|rare disease
5441856|NCT00006054|severe combined immunodeficiency|severe combined immunodeficiency
5441857|NCT00006054|virus-associated hemophagocytic syndrome|virus-associated hemophagocytic syndrome
5441858|NCT00005933|Chronic Disease|chronic disease
5441859|NCT00005933|Pediatric|pediatric
5441860|NCT00005933|Pulmonary|pulmonary
5441861|NCT00005933|Intelligence|intelligence
5441862|NCT00005933|Coping|coping
5441863|NCT00005933|Chronic Illness|chronic illness
5441864|NCT00005933|Learning|learning
5441865|NCT00005928|ACE Inhibitor|ace inhibitor
5441866|NCT00005928|Vascular Inflammation|vascular inflammation
5441867|NCT00005928|Vascular Compliance|vascular compliance
5441868|NCT00005928|Cell Adhesion Molecules|cell adhesion molecules
5441869|NCT00005928|Coronary Artery Disease|coronary artery disease
5441870|NCT00005927|Adrenal Adenoma|adrenal adenoma
5441871|NCT00005927|Adrenal Cancer|adrenal cancer
5441872|NCT00005927|Macronodular Adrenals|macronodular adrenals
5441873|NCT00005927|Ectopic Receptors|ectopic receptors
5441874|NCT00005927|Gene Profiling|gene profiling
5441875|NCT00005927|Adrenocortical Carcinoma|adrenocortical carcinoma
5441876|NCT00005927|Cushing Syndrome|cushing syndrome
5441877|NCT00005927|Virilizing Adrenal Tumor|virilizing adrenal tumor
5441878|NCT00005927|Feminizing Adrenal Tumor|feminizing adrenal tumor
5441879|NCT00005927|Massive Macronodular Adrenocortical Disease|massive macronodular adrenocortical disease
5441880|NCT00005927|Adrenal Gland Tumor|adrenal gland tumor
5441881|NCT00005925|Video-EEG|video-eeg
5441882|NCT00005925|Muscimol|muscimol
5441883|NCT00005925|Depth Electrode|depth electrode
5441884|NCT00005925|Brain Catheter|brain catheter
5441885|NCT00005925|Pharmacology|pharmacology
5441886|NCT00005925|Epilepsy|epilepsy
5441887|NCT00005925|Infusion|infusion
5441888|NCT00005925|Magnetic Resonance Imaging|magnetic resonance imaging
5441889|NCT00005924|B Cell|b cell
5441890|NCT00005924|Epstein-Barr Virus|epstein-barr virus
5441891|NCT00005923|Joint Instability|joint instability
5441892|NCT00005922|Conditioning|conditioning
5441893|NCT00005922|Corticosteroid|corticosteroid
5441894|NCT00005922|Lesions|lesions
5441895|NCT00005922|Pharmacotherapy|pharmacotherapy
5441896|NCT00005922|Placebo effect|placebo effect
5441897|NCT00005922|Psoriasis|psoriasis
5441898|NCT00005922|Psychoneuroimmunology|psychoneuroimmunology
5441899|NCT00005919|Pigment Dispersion|pigment dispersion
5441900|NCT00005919|Ocular Hypertension|ocular hypertension
5441901|NCT00005919|Glaucoma|glaucoma
5441902|NCT00005919|Pupil Reaction|pupil reaction
5441903|NCT00005919|Natural History|natural history
5441904|NCT00005919|Pigment Dispersion Syndrome|pigment dispersion syndrome
5441905|NCT00005919|Gene Mutation|gene mutation
5441906|NCT00005917|Albinism|albinism
5441907|NCT00005917|Giant Granules|giant granules
5441908|NCT00005917|Infection|infection
5441909|NCT00005917|Melanosomes|melanosomes
5441910|NCT00005917|Platelet Storage Pool Defect|platelet storage pool defect
5441911|NCT00005916|Immunotherapy|immunotherapy
5441915|NCT00005916|Prostate Cancer|prostate cancer
5441916|NCT00005914|Depression|depression
5441917|NCT00005914|Depressive Disorder|depressive disorder
5441918|NCT00005914|Family|family
5441919|NCT00005914|Genes|genes
5441920|NCT00005914|Genetic Techniques|genetic techniques
5441921|NCT00005914|Genetics|genetics
5441922|NCT00005914|Linkage (Genetics)|linkage (genetics)
5441923|NCT00005914|Nuclear Family|nuclear family
5441924|NCT00005914|Recurrence|recurrence
5441925|NCT00005914|Severity of Illness Index|severity of illness index
5441926|NCT00005911|Magnetic Resonance Imaging|magnetic resonance imaging
5441927|NCT00005911|Human Eye|human eye
5441928|NCT00005911|Lens|lens
5441929|NCT00005911|Normal Volunteers|normal volunteers
5441930|NCT00005911|Cataract|cataract
5441931|NCT00005911|Human Lens|human lens
5441932|NCT00005911|Healthy Volunteer|healthy volunteer
5441933|NCT00005910|Islet Cell Tumors|islet cell tumors
5441934|NCT00005910|Surgery|surgery
5441935|NCT00005910|Ultrasound|ultrasound
5441936|NCT00005910|Insulin|insulin
5441937|NCT00005910|Rapid Assay|rapid assay
5441938|NCT00005910|Arteriogram|arteriogram
5441939|NCT00005910|Pancreas|pancreas
5441940|NCT00005910|Laparoscopy|laparoscopy
5441941|NCT00005910|Insulinoma|insulinoma
5441942|NCT00005910|Localization|localization
5441943|NCT00005910|Hypoglycemia|hypoglycemia
5441944|NCT00005909|Homogentisic Acid|homogentisic acid
5441945|NCT00005909|Ochronosis|ochronosis
5441946|NCT00005909|Inborn Error of Metabolism|inborn error of metabolism
5441947|NCT00005909|Arthritis|arthritis
5441948|NCT00005909|Enzyme Defect|enzyme defect
5441949|NCT00005909|Alkaptonuria|alkaptonuria
5441950|NCT00005909|Homogentisic Acid Oxidase|homogentisic acid oxidase
5441951|NCT00005908|cDNA Microarray|cdna microarray
5441952|NCT00005908|Stage II and Stage III Breast Cancer|stage ii and stage iii breast cancer
5441953|NCT00005908|Biological Response|biological response
5441954|NCT00005908|Molecular Profiling|molecular profiling
5441955|NCT00005908|Fine Needle Aspirate|fine needle aspirate
5441956|NCT00005908|Breast Cancer|breast cancer
5441957|NCT00005907|B Cell|b cell
5441958|NCT00005907|Reconstitution|reconstitution
5441959|NCT00005907|T Cell|t cell
5441960|NCT00005907|Transplant|transplant
5441961|NCT00005907|Vaccine|vaccine
5441962|NCT00005906|Chylous Ascites|chylous ascites
5441963|NCT00005906|Chylous Pleural Effusion|chylous pleural effusion
5441964|NCT00005906|Inhibitory Effects|inhibitory effects
5441965|NCT00005906|Lymphangioleiomyoma|lymphangioleiomyoma
5441966|NCT00005906|Somatostatin|somatostatin
5441967|NCT00005906|Lymphangioleiomyomatosis (LAM)|lymphangioleiomyomatosis (lam)
5441968|NCT00005905|Adipocyte - Development|adipocyte - development
5441969|NCT00005905|Insulin Resistance|insulin resistance
5441970|NCT00005905|Dyslipidemia|dyslipidemia
5441971|NCT00005905|Diabetes Mellitus|diabetes mellitus
5441972|NCT00005905|Non-Alcoholic Steatohepatitis|non-alcoholic steatohepatitis
5441973|NCT00005905|Leptin Replacement|leptin replacement
5441974|NCT00005903|Parkinsonism|parkinsonism
5441975|NCT00005903|Trophic Factor|trophic factor
5441976|NCT00005903|Neurodegenerative Disorder|neurodegenerative disorder
5441977|NCT00005903|Progressive Supranuclear Palsy|progressive supranuclear palsy
5441978|NCT00005902|Brain|brain
5441979|NCT00005902|Brainstem|brainstem
5441980|NCT00005902|Cyst|cyst
5441981|NCT00005902|Magnetic Resonance Imaging|magnetic resonance imaging
5441982|NCT00005902|Spinal Cord|spinal cord
5441983|NCT00005902|von Hippel-Lindau|von hippel-lindau
5441984|NCT00005901|Bisphosphonates|bisphosphonates
5441985|NCT00005901|Growth Hormone|growth hormone
5441986|NCT00005901|Bone Density|bone density
5441987|NCT00005901|Osteogenesis Imperfecta|osteogenesis imperfecta
5441988|NCT00005900|Gaucher's disease|gaucher's disease
5441989|NCT00005900|I cell disease|i cell disease
5441990|NCT00005900|Niemann-Pick disease|niemann-pick disease
5441991|NCT00005900|Wolman disease|wolman disease
5441992|NCT00005900|adrenoleukodystrophy|adrenoleukodystrophy
5441993|NCT00005900|disease-related problem/condition|disease-related problem/condition
5441994|NCT00005900|fucosidosis|fucosidosis
5441995|NCT00005900|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
5441996|NCT00005900|globoid cell leukodystrophy|globoid cell leukodystrophy
5441997|NCT00005900|inborn errors of metabolism|inborn errors of metabolism
5441998|NCT00005900|mannosidosis|mannosidosis
5441999|NCT00005900|metachromatic leukodystrophy|metachromatic leukodystrophy
5442000|NCT00005900|mucopolysaccharidosis|mucopolysaccharidosis
5442001|NCT00005900|mucopolysaccharidosis I|mucopolysaccharidosis i
5442002|NCT00005900|mucopolysaccharidosis VI|mucopolysaccharidosis vi
5442003|NCT00005900|oncologic disorders|oncologic disorders
5442004|NCT00005900|pulmonary complications|pulmonary complications
5442005|NCT00005900|rare disease|rare disease
5442006|NCT00005900|sphingolipidoses|sphingolipidoses
5442007|NCT00005896|Fanconi's anemia|fanconi's anemia
5442008|NCT00005896|aplastic anemia|aplastic anemia
5442009|NCT00005896|hematologic disorders|hematologic disorders
5442010|NCT00005896|rare disease|rare disease
5442011|NCT00005893|chronic congenital neutropenia|chronic congenital neutropenia
5442012|NCT00005893|chronic neutropenia|chronic neutropenia
5442013|NCT00005893|congenital pure red cell aplasia|congenital pure red cell aplasia
5442014|NCT00005893|disease-related problem/condition|disease-related problem/condition
5442015|NCT00005893|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
5442016|NCT00005893|hematologic disorders|hematologic disorders
5442017|NCT00005893|neutropenia|neutropenia
5442018|NCT00005893|pure red cell aplasia|pure red cell aplasia
5442019|NCT00005893|rare disease|rare disease
5442020|NCT00005893|sickle cell anemia|sickle cell anemia
5442021|NCT00005893|thalassemia major|thalassemia major
5442022|NCT00005892|Fanconi's anemia|fanconi's anemia
5442023|NCT00005892|acute leukemia|acute leukemia
5442024|NCT00005892|acute lymphocytic leukemia|acute lymphocytic leukemia
5442025|NCT00005892|acute myeloid leukemia|acute myeloid leukemia
5442026|NCT00005892|acute undifferentiated leukemia|acute undifferentiated leukemia
5442027|NCT00005892|adult acute lymphoblastic leukemia|adult acute lymphoblastic leukemia
5442028|NCT00005892|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5442029|NCT00005892|adult acute myeloid leukemia|adult acute myeloid leukemia
5442030|NCT00005892|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5442031|NCT00005892|aplastic anemia|aplastic anemia
5442032|NCT00005892|childhood acute lymphoblastic leukemia|childhood acute lymphoblastic leukemia
5442033|NCT00005892|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
5442034|NCT00005892|childhood acute myeloid leukemia|childhood acute myeloid leukemia
5442035|NCT00005892|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
5442036|NCT00005892|de novo myelodysplastic syndrome|de novo myelodysplastic syndrome
5442037|NCT00005892|hematologic disorders|hematologic disorders
5442038|NCT00005892|hematopoietic/lymphoid cancer|hematopoietic/lymphoid cancer
5442039|NCT00005892|leukemia|leukemia
5442040|NCT00005892|myelodysplastic syndrome|myelodysplastic syndrome
5442041|NCT00005892|oncologic disorders|oncologic disorders
5442042|NCT00005892|previously treated myelodysplastic syndrome|previously treated myelodysplastic syndrome
5442043|NCT00005892|rare disease|rare disease
5442044|NCT00005892|secondary myelodysplastic syndrome|secondary myelodysplastic syndrome
5442045|NCT00005891|Fanconi's Anemia|fanconi's anemia
5442046|NCT00005891|aplastic anemia|aplastic anemia
5442047|NCT00005891|hematologic disorders|hematologic disorders
5442048|NCT00005891|rare disease|rare disease
5442049|NCT00005890|immunologic disorders and infectious disorders|immunologic disorders and infectious disorders
5442050|NCT00005890|rare disease|rare disease
5442051|NCT00005890|sepsis|sepsis
5442052|NCT00005890|septic shock|septic shock
5442053|NCT00005889|endocrine disorders|endocrine disorders
5442054|NCT00005889|hyperglycemia|hyperglycemia
5442055|NCT00005889|low birth weight|low birth weight
5442056|NCT00005889|neonatal disorders|neonatal disorders
5442057|NCT00005889|rare disease|rare disease
5442058|NCT00005888|gastrointestinal disorders|gastrointestinal disorders
5442059|NCT00005888|immunologic disorders and infectious disorders|immunologic disorders and infectious disorders
5442060|NCT00005888|low birth weight|low birth weight
5442061|NCT00005888|necrotizing enterocolitis|necrotizing enterocolitis
5442062|NCT00005888|neonatal disorders|neonatal disorders
5442063|NCT00005888|rare disease|rare disease
5442064|NCT00005888|sepsis|sepsis
5442065|NCT00005785|Peripheral Blood Stem Cells|peripheral blood stem cells
5442066|NCT00005785|Engraftment|engraftment
5442067|NCT00005785|Graft vs. Host Disease|graft vs. host disease
5442068|NCT00005785|Graft-Versus-Leukemia|graft-versus-leukemia
5442069|NCT00005785|Donor Apheresis|donor apheresis
5442070|NCT00005785|Cyclophosphamide|cyclophosphamide
5442071|NCT00005785|Fludarabine|fludarabine
5442072|NCT00005785|HIV|hiv
5442073|NCT00005785|AIDS|aids
5442074|NCT00005785|Gene Therapy|gene therapy
5442075|NCT00005785|Chronic Myelogenous Leukemia|chronic myelogenous leukemia
5442076|NCT00005785|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
5442077|NCT00005785|Acute Myelogenous Leukemia|acute myelogenous leukemia
5442078|NCT00005785|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
5442079|NCT00005784|Macular Degeneration|macular degeneration
5442080|NCT00005784|Diabetic Retinopathy|diabetic retinopathy
5442081|NCT00005784|Vascular Occlusive Disease|vascular occlusive disease
5442082|NCT00005784|Central Serous Retinopathy|central serous retinopathy
5442083|NCT00005784|Rare/Unknown Retinal Disease|rare/unknown retinal disease
5442084|NCT00005784|Retinal Disease|retinal disease
5442085|NCT00005784|Age-Related Macular Degeneration|age-related macular degeneration
5442086|NCT00005782|Donor Apheresis|donor apheresis
5442087|NCT00005782|Sickle Cell Trait|sickle cell trait
5442088|NCT00005782|Red Cell Alloimmunization|red cell alloimmunization
5442089|NCT00005780|Lymphoma Vaccines|lymphoma vaccines
5442090|NCT00005780|Immune Response Against Lymphoma|immune response against lymphoma
5442091|NCT00005780|Molecular Complete Remissions|molecular complete remissions
5442092|NCT00005780|Novel Treatment Approach|novel treatment approach
5442093|NCT00005780|Mantle Cell Lymphoma|mantle cell lymphoma
5442094|NCT00005778|Systemic Lupus Erythematosus (SLE)|systemic lupus erythematosus (sle)
5442095|NCT00005778|Cytoxan|cytoxan
5442096|NCT00005778|Cyclophosphamide|cyclophosphamide
5442097|NCT00005778|High-dose immunoablative therapy|high-dose immunoablative therapy
5442098|NCT00005777|NICHD Neonatal Research Network|nichd neonatal research network
5442099|NCT00005777|Extremely Low Birth Weight (ELBW)|extremely low birth weight (elbw)
5442101|NCT00005777|Chronic Lung Disease (CLD)|chronic lung disease (cld)
5442102|NCT00005777|Dexamethasone|dexamethasone
5442103|NCT00005777|Glucocorticoids|glucocorticoids
5442104|NCT00005777|Respiration, Artificial|respiration, artificial
5442105|NCT00005777|Mechanical ventilation|mechanical ventilation
5442106|NCT00005777|Respiratory Insufficiency|respiratory insufficiency
5442107|NCT00005776|NICHD Neonatal Research Network|nichd neonatal research network
5442108|NCT00005776|Hypertension, pulmonary|hypertension, pulmonary
5442109|NCT00005776|Hypoxic respiratory failure|hypoxic respiratory failure
5442110|NCT00005776|Meconium aspiration|meconium aspiration
5442111|NCT00005776|Methemoglobinemia|methemoglobinemia
5442112|NCT00005776|Nitric oxide|nitric oxide
5442113|NCT00005776|Oxygen inhalation therapy|oxygen inhalation therapy
5442114|NCT00005776|Persistent Fetal Circulation Syndrome|persistent fetal circulation syndrome
5442115|NCT00005776|Pneumonia, aspiration|pneumonia, aspiration
5442116|NCT00005776|Respiratory distress syndrome|respiratory distress syndrome
5442117|NCT00005776|Respiratory insufficiency|respiratory insufficiency
5442118|NCT00005776|Severe respiratory failure|severe respiratory failure
5442119|NCT00005775|NICHD Neonatal Research Network|nichd neonatal research network
5442120|NCT00005775|Extremely Low Birth Weight (ELBW) infants|extremely low birth weight (elbw) infants
5442121|NCT00005775|Prematurity|prematurity
5442122|NCT00005775|Glutamine|glutamine
5442123|NCT00005775|Total parenteral nutrition|total parenteral nutrition
5442124|NCT00005775|Nutrition|nutrition
5442125|NCT00005775|Very low birth weight (VLBW) infants|very low birth weight (vlbw) infants
5442126|NCT00005774|NICHD Neonatal Research Network|nichd neonatal research network
5442127|NCT00005774|Pulmonary ventilation|pulmonary ventilation
5442128|NCT00005774|Respiratory distress syndrome|respiratory distress syndrome
5442129|NCT00005774|Respiratory insufficiency|respiratory insufficiency
5442130|NCT00005774|Surfactant, pulmonary|surfactant, pulmonary
5442131|NCT00005774|Mechanical Ventilation|mechanical ventilation
5442132|NCT00005774|Survanta|survanta
5442133|NCT00005773|NICHD Neonatal Research Network|nichd neonatal research network
5442134|NCT00005773|Hypertension, pulmonary|hypertension, pulmonary
5442135|NCT00005773|Hypoxic respiratory failure|hypoxic respiratory failure
5442136|NCT00005773|Meconium aspiration|meconium aspiration
5442137|NCT00005773|Methemoglobinemia|methemoglobinemia
5442138|NCT00005773|Nitric oxide|nitric oxide
5442139|NCT00005773|Oxygen inhalation therapy|oxygen inhalation therapy
5442140|NCT00005773|Persistent Fetal Circulation Syndrome|persistent fetal circulation syndrome
5442141|NCT00005773|Pneumonia, aspiration|pneumonia, aspiration
5442142|NCT00005773|Respiratory distress syndrome|respiratory distress syndrome
5442143|NCT00005773|Respiratory insufficiency|respiratory insufficiency
5442144|NCT00005773|Severe respiratory failure|severe respiratory failure
5442145|NCT00005772|NICHD Neonatal Research Network|nichd neonatal research network
5442146|NCT00005772|Hypoxic-ischemic encephalopathy (HIE)|hypoxic-ischemic encephalopathy (hie)
5442147|NCT00005772|Hypothermia|hypothermia
5442148|NCT00005772|Neonatal depression|neonatal depression
5442149|NCT00005772|Perinatal asphyxia|perinatal asphyxia
5442150|NCT00005771|Abdominal Hollowing Exercises|abdominal hollowing exercises
5442151|NCT00005770|elastic property of skin|elastic property of skin
5442152|NCT00005767|Amino Acid Metabolism|amino acid metabolism
5442153|NCT00005766|ALS|als
5442154|NCT00005761|Types 1 & 2 Diabetes|types 1 & 2 diabetes
5442155|NCT00005761|Cell Adhesion Molecules|cell adhesion molecules
5442156|NCT00005761|Chemokines|chemokines
5442157|NCT00005761|Vascular Endothelial Growth Factor|vascular endothelial growth factor
5442158|NCT00005761|Cross-Sectional|cross-sectional
5442159|NCT00005761|Serum Levels|serum levels
5442160|NCT00005761|Diabetic Retinopathy|diabetic retinopathy
5442161|NCT00005760|Dyslipidemia|dyslipidemia
5442162|NCT00005760|Hypertension|hypertension
5442163|NCT00005760|Metabolic Syndrome X|metabolic syndrome x
5442164|NCT00005760|Obesity|obesity
5442165|NCT00005760|Subcutaneous Adipose Tissue|subcutaneous adipose tissue
5442166|NCT00005760|Visceral Abdominal Adipose Tissue|visceral abdominal adipose tissue
5442167|NCT00005675|Systemic Scleroderma (SSc)|systemic scleroderma (ssc)
5442168|NCT00005675|Bovine Type I Collagen (CI)|bovine type i collagen (ci)
5442169|NCT00005675|Multicenter|multicenter
5442170|NCT00005727|Nutrition|nutrition
5442171|NCT00005727|Education|education
5442172|NCT00005520|Hypertension|hypertension
5442173|NCT00005520|Pharmacogenetics|pharmacogenetics
5442174|NCT00005520|Hydrochlorothiazide|hydrochlorothiazide
5442175|NCT00005520|Candesartan|candesartan
5442176|NCT00005487|Coronary Arteriosclerosis|coronary arteriosclerosis
5442177|NCT00005487|Cerebrovascular Accident|cerebrovascular accident
5442178|NCT00005487|Heart Failure, Congestive|heart failure, congestive
5442179|NCT00005487|Diabetes Mellitus, Non-Insulin Dependent|diabetes mellitus, non-insulin dependent
5442180|NCT00005673|HIV|hiv
5442181|NCT00005673|Antiretroviral|antiretroviral
5442182|NCT00005673|NNRTI|nnrti
5442183|NCT00005671|Angina|angina
5442184|NCT00005671|Condition Specific|condition specific
5442185|NCT00005671|Heart Failure|heart failure
5442186|NCT00005671|Symptom Distress|symptom distress
5442187|NCT00005671|Revascularization|revascularization
5442188|NCT00005671|Coronary Artery Disease|coronary artery disease
5442189|NCT00005671|Ischemic Heart Disease|ischemic heart disease
5442190|NCT00005669|Child|child
5442193|NCT00005669|Diabetes Mellitus|diabetes mellitus
5442194|NCT00005669|Dyslipidemia|dyslipidemia
5442195|NCT00005669|Vitamin B12|vitamin b12
5442196|NCT00005669|Childhood Obesity|childhood obesity
5442197|NCT00005667|liver transplantation|liver transplantation
5442198|NCT00005667|vancomycin resistance|vancomycin resistance
5442199|NCT00005666|Diagnostic imaging|diagnostic imaging
5442200|NCT00005664|Healthy Volunteers|healthy volunteers
5442327|NCT00005007|Tumor necrosis factor|tumor necrosis factor
5442201|NCT00005664|Endocrine Related Conditions|endocrine related conditions
5442202|NCT00005664|Endocrine Dysfunction|endocrine dysfunction
5442203|NCT00005664|Early Pubertal Development|early pubertal development
5442204|NCT00005660|Hypertriglyceridemia|hypertriglyceridemia
5442205|NCT00005660|Teratogenicity|teratogenicity
5442206|NCT00005660|Ichthyosis|ichthyosis
5442207|NCT00005660|Darier's Disease|darier's disease
5442208|NCT00005660|Retinoids|retinoids
5442209|NCT00005660|Skin|skin
5442210|NCT00005660|Psoriasis|psoriasis
5442211|NCT00005660|Basal cell carcinoma|basal cell carcinoma
5442212|NCT00005660|Skin Cancer|skin cancer
5442213|NCT00005658|Biochemical|biochemical
5442214|NCT00005658|Schizophrenia|schizophrenia
5442215|NCT00005658|NMDA|nmda
5442216|NCT00005658|Adolescence|adolescence
5442217|NCT00005658|Psychosis|psychosis
5442218|NCT00005658|Child Psychosis|child psychosis
5442219|NCT00005658|Biochemical Correlates|biochemical correlates
5442220|NCT00005658|Brain Imaging|brain imaging
5442221|NCT00005658|Glycine|glycine
5442222|NCT00005658|Adjunctive Glycine Therapy|adjunctive glycine therapy
5442223|NCT00005657|Cytokines|cytokines
5442224|NCT00005657|Treatment|treatment
5442225|NCT00005657|Genetic Polymorphism|genetic polymorphism
5442226|NCT00005657|Chronic Hepatitis C|chronic hepatitis c
5442227|NCT00005657|Mononuclear Cells|mononuclear cells
5442228|NCT00005655|Gene Expression|gene expression
5442229|NCT00005655|Neovascularization|neovascularization
5442230|NCT00005655|antiangiogenic therapy|antiangiogenic therapy
5442231|NCT00005655|immunomodulatory therapy|immunomodulatory therapy
5442232|NCT00005655|Immunotherapy|immunotherapy
5442233|NCT00005655|Tumor|tumor
5442234|NCT00005654|endocrine disorders|endocrine disorders
5442235|NCT00005654|hyperinsulinism|hyperinsulinism
5442236|NCT00005654|polycystic ovarian syndrome|polycystic ovarian syndrome
5442237|NCT00005654|rare disease|rare disease
5442238|NCT00005652|hematologic disorders|hematologic disorders
5442239|NCT00005652|immune thrombocytopenic purpura|immune thrombocytopenic purpura
5442240|NCT00005652|rare disease|rare disease
5442241|NCT00005650|cardiovascular and respiratory diseases|cardiovascular and respiratory diseases
5442242|NCT00005650|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
5442243|NCT00005650|primary ciliary dyskinesia|primary ciliary dyskinesia
5442244|NCT00005650|rare disease|rare disease
5442245|NCT00005575|Imipramine|imipramine
5442246|NCT00005575|Cognitive-Behavioral Therapy|cognitive-behavioral therapy
5442247|NCT00005571|Skin|skin
5442248|NCT00005571|Humoral Immunity|humoral immunity
5442249|NCT00005571|Myositis|myositis
5442250|NCT00005571|Complement|complement
5442251|NCT00005571|Antibody|antibody
5442252|NCT00005571|Dermatomyositis|dermatomyositis
5442253|NCT00005569|Elastase|elastase
5442254|NCT00005569|Inflammation|inflammation
5442255|NCT00005569|Age|age
5442256|NCT00005569|Gender|gender
5442257|NCT00005569|Cytokine|cytokine
5442258|NCT00005569|Healthy Volunteer|healthy volunteer
5442259|NCT00005566|Suicide|suicide
5442260|NCT00005119|Premenstrual Dysphoric Disorder|premenstrual dysphoric disorder
5442261|NCT00005119|Severe Premenstrual Syndrome|severe premenstrual syndrome
5442262|NCT00005119|Calcium metabolism|calcium metabolism
5442263|NCT00005119|Vitamin D|vitamin d
5442264|NCT00005119|Bone Markers|bone markers
5442265|NCT00005119|Premenopausal|premenopausal
5442266|NCT00005119|Menstrual Cycle|menstrual cycle
5442267|NCT00005117|endothelial dysfunction|endothelial dysfunction
5442268|NCT00005116|depression|depression
5442269|NCT00005108|Menopause|menopause
5442270|NCT00005108|Atherosclerosis|atherosclerosis
5442271|NCT00005108|Estrogen|estrogen
5442272|NCT00005108|MRI|mri
5442273|NCT00005108|Ultrasound|ultrasound
5442274|NCT00005105|endocrine disorders|endocrine disorders
5442275|NCT00005105|intrauterine growth retardation|intrauterine growth retardation
5442276|NCT00005105|rare disease|rare disease
5442277|NCT00005104|endocrine disorders|endocrine disorders
5442278|NCT00005104|hyperinsulinism|hyperinsulinism
5442279|NCT00005104|polycystic ovarian syndrome|polycystic ovarian syndrome
5442280|NCT00005104|rare disease|rare disease
5442281|NCT00005103|inborn errors of metabolism|inborn errors of metabolism
5442282|NCT00005103|porphyria|porphyria
5442283|NCT00005103|porphyria cutanea tarda|porphyria cutanea tarda
5442284|NCT00005103|rare disease|rare disease
5442285|NCT00005102|DiGeorge syndrome|digeorge syndrome
5442286|NCT00005102|Shprintzen syndrome|shprintzen syndrome
5442287|NCT00005102|cardiovascular and respiratory diseases|cardiovascular and respiratory diseases
5442288|NCT00005102|conotruncal cardiac defects|conotruncal cardiac defects
5442289|NCT00005102|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
5442290|NCT00005102|rare disease|rare disease
5444382|NCT00001620|Cytopenia|cytopenia
5442291|NCT00005101|disease-related problem/condition|disease-related problem/condition
5442292|NCT00005101|osteoporosis|osteoporosis
5442293|NCT00005101|rare disease|rare disease
5442294|NCT00005100|acromegaly|acromegaly
5442295|NCT00005100|endocrine disorders|endocrine disorders
5442296|NCT00005100|rare disease|rare disease
5442297|NCT00005098|alpha 1-antitrypsin deficiency|alpha 1-antitrypsin deficiency
5442298|NCT00005098|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
5442299|NCT00005098|rare disease|rare disease
5442300|NCT00005015|Bipolar Disorder|bipolar disorder
5442301|NCT00005015|Depression|depression
5442302|NCT00005015|Fluoxetine|fluoxetine
5442303|NCT00005014|Autistic Disorder|autistic disorder
5442304|NCT00005014|Risperidone|risperidone
5442305|NCT00005013|Antidepressive Agents|antidepressive agents
5442306|NCT00005013|Depression|depression
5442307|NCT00005013|Depressive Disorder|depressive disorder
5442308|NCT00005013|Herbs|herbs
5442309|NCT00005013|Hypericum|hypericum
5442310|NCT00005013|Medicine, Herbal|medicine, herbal
5442311|NCT00005013|Plant Extracts|plant extracts
5442312|NCT00005013|Alternative Medicine|alternative medicine
5442313|NCT00005011|Depression|depression
5442314|NCT00005011|Menstrual Cycle|menstrual cycle
5442315|NCT00005011|Gonadal Steroids|gonadal steroids
5442316|NCT00005011|GnRH Agonist|gnrh agonist
5442317|NCT00005011|PMS|pms
5442318|NCT00005011|Estradiol|estradiol
5442319|NCT00005011|Progesterone|progesterone
5442320|NCT00005011|Mood|mood
5442321|NCT00005011|MRMD|mrmd
5442322|NCT00005011|PMDD|pmdd
5442323|NCT00005011|Menstrually Related Mood Disorders|menstrually related mood disorders
5442324|NCT00005007|Wegener's granulomatosis|wegener's granulomatosis
5442325|NCT00005007|Vasculitis|vasculitis
5442326|NCT00005007|Etanercept|etanercept
5442328|NCT00005006|Anabolic agent|anabolic agent
5442329|NCT00005006|hPTH|hpth
5442330|NCT00005006|PTH|pth
5442331|NCT00005006|Parathyroid hormone|parathyroid hormone
5442332|NCT00005006|Bone mass|bone mass
5442333|NCT00005006|Bone turnover|bone turnover
5442334|NCT00005006|Bone formation|bone formation
5442335|NCT00005006|Alendronate|alendronate
5442336|NCT00005006|Osteoporosis|osteoporosis
5442337|NCT00005006|Cyclical therapy|cyclical therapy
5442338|NCT00005005|PTH|pth
5442339|NCT00005005|Alendronate|alendronate
5442340|NCT00005005|Parathyroid hormone|parathyroid hormone
5442341|NCT00005005|Osteoporosis|osteoporosis
5442342|NCT00005005|Postmenopausal|postmenopausal
5442343|NCT00005004|Cognitive Processes|cognitive processes
5442344|NCT00005004|Inferential Ambiguities|inferential ambiguities
5442345|NCT00005004|Language Processes|language processes
5442346|NCT00005004|Lexical Ambiguities|lexical ambiguities
5442347|NCT00005004|Suppression Mechanism|suppression mechanism
5442348|NCT00005004|Discourse Processes|discourse processes
5442349|NCT00005004|Discourse Production Analysis|discourse production analysis
5442350|NCT00005004|Magnetic Resonance Imaging|magnetic resonance imaging
5442351|NCT00005004|Prefrontal Cortex Function|prefrontal cortex function
5442352|NCT00005004|Aging Effects|aging effects
5442353|NCT00005004|Garden Path Phenomena|garden path phenomena
5442354|NCT00005004|Text Integration|text integration
5442355|NCT00005003|Handedness|handedness
5442356|NCT00005003|Laterality|laterality
5442357|NCT00005003|Linkage|linkage
5442358|NCT00005003|VNTR/Dinucleotide|vntr/dinucleotide
5442359|NCT00005003|Dinucleotide|dinucleotide
5442360|NCT00005003|High-Frequency-Trait Analysis|high-frequency-trait analysis
5442361|NCT00004997|Hematopoietic|hematopoietic
5442362|NCT00004997|DHFR Enzyme|dhfr enzyme
5442363|NCT00004997|Anemia|anemia
5442364|NCT00004997|Folic Acid|folic acid
5442365|NCT00004997|MDS|mds
5442366|NCT00004997|Myelodysplasia|myelodysplasia
5442367|NCT00004997|Myelodysplastic|myelodysplastic
5442368|NCT00004996|Antigen Presentation|antigen presentation
5442369|NCT00004996|Cytokines|cytokines
5442370|NCT00004996|Helminth|helminth
5442371|NCT00004996|Healthy Volunteer|healthy volunteer
5442372|NCT00004996|Cross-Over Study|cross-over study
5442373|NCT00004996|Helminth Infection|helminth infection
5442374|NCT00004994|Allogeneic Transplant|allogeneic transplant
5442375|NCT00004994|Function|function
5442376|NCT00004994|Mini-Transplant|mini-transplant
5442377|NCT00004994|Physical Symptoms|physical symptoms
5442378|NCT00004994|Symptom Distress|symptom distress
5442379|NCT00004993|Parathyroid hormone (1-34)|parathyroid hormone (1-34)
5442380|NCT00004993|Glucocorticoid-induced osteoporosis|glucocorticoid-induced osteoporosis
5442381|NCT00004993|Postmenopausal women|postmenopausal women
5442382|NCT00004993|osteoporotic fractures|osteoporotic fractures
5442383|NCT00004992|clinical trial|clinical trial
5442384|NCT00004992|multi-center|multi-center
5442385|NCT00004992|NIDDM|niddm
5442386|NCT00004992|NIDDK|niddk
5442387|NCT00004992|Diabetes Prevention Program (DPP)|diabetes prevention program (dpp)
5442388|NCT00004992|diabetes risk factors|diabetes risk factors
5442389|NCT00004992|diabetes|diabetes
5442390|NCT00004992|glycemia|glycemia
5442391|NCT00004992|cardiovascular risk factors|cardiovascular risk factors
5442392|NCT00004992|quality of life|quality of life
5442393|NCT00004992|physical activity and nutrition|physical activity and nutrition
5442394|NCT00004992|occurrence of adverse events|occurrence of adverse events
5442395|NCT00004992|insulin secretion and sensitivity|insulin secretion and sensitivity
5442396|NCT00004992|prevention|prevention
5442397|NCT00004992|abnormal glucose metabolism|abnormal glucose metabolism
5442398|NCT00004992|lifestyle intervention|lifestyle intervention
5442399|NCT00004992|drug intervention|drug intervention
5442400|NCT00004991|Functional Magnetic Resonance Imaging|functional magnetic resonance imaging
5442401|NCT00004991|Stuttering|stuttering
5442402|NCT00004991|Speech Perception|speech perception
5442403|NCT00004991|Speech Production|speech production
5442404|NCT00004991|Phonology|phonology
5442405|NCT00004991|Development|development
5442406|NCT00004991|Motor Control|motor control
5442407|NCT00004991|Neural Networks|neural networks
5442408|NCT00004991|Phonological Disorders|phonological disorders
5442409|NCT00004990|Nephrotic Syndrome|nephrotic syndrome
5442410|NCT00004990|Steroids|steroids
5442411|NCT00004990|Osteoporosis|osteoporosis
5442412|NCT00004990|Adrenal Suppression|adrenal suppression
5442413|NCT00004990|Proteinuria|proteinuria
5442414|NCT00004990|Focal Segmental Glomerulosclerosis|focal segmental glomerulosclerosis
5442415|NCT00004988|Anti-Tumor Effects|anti-tumor effects
5442416|NCT00004988|Maximum Tolerated Dose (MTD)|maximum tolerated dose (mtd)
5442417|NCT00004988|Metastatic Cancer|metastatic cancer
5442418|NCT00004988|Pharmacokinetics|pharmacokinetics
5442419|NCT00004988|Solid Tumors|solid tumors
5442420|NCT00004988|Tumor|tumor
5442421|NCT00004984|diabetes|diabetes
5442422|NCT00004984|insulin|insulin
5442423|NCT00004984|prediction|prediction
5442424|NCT00004984|prevention|prevention
5442425|NCT00004984|C-peptide levels|c-peptide levels
5442426|NCT00004984|insulin autoantibodies|insulin autoantibodies
5442427|NCT00004984|pancreatic beta cell autoantibodies|pancreatic beta cell autoantibodies
5442428|NCT00004984|cellular immune responses|cellular immune responses
5442429|NCT00004984|prediction of type 1 diabetes|prediction of type 1 diabetes
5442430|NCT00004983|diabetes mellitus, type 2|diabetes mellitus, type 2
5442431|NCT00004983|diabetes self-management education|diabetes self-management education
5442432|NCT00004983|diabetes self-care|diabetes self-care
5442433|NCT00004983|blood glucose self-monitoring|blood glucose self-monitoring
5442434|NCT00004983|health education|health education
5442435|NCT00004983|patient education|patient education
5442436|NCT00004982|chelation therapy|chelation therapy
5442437|NCT00004982|combination chemotherapy|combination chemotherapy
5442438|NCT00004982|iron poisoning|iron poisoning
5442439|NCT00004982|thalassemia|thalassemia
5442440|NCT00004982|chelating agent|chelating agent
5442441|NCT00004982|deferoxamine|deferoxamine
5442442|NCT00004982|drug screening /evaluation|drug screening /evaluation
5442443|NCT00004982|therapy evaluation|therapy evaluation
5442444|NCT00004980|neurologic and psychiatric disorders|neurologic and psychiatric disorders
5442445|NCT00004980|rare disease|rare disease
5442446|NCT00004980|schizophrenia|schizophrenia
5442447|NCT00004854|moderate heart failure|moderate heart failure
5442448|NCT00004853|AMGEN|amgen
5442449|NCT00004853|Granulocyte Colony-Stimulating Factor|granulocyte colony-stimulating factor
5442450|NCT00004853|MPNST|mpnst
5442451|NCT00004853|Randomized|randomized
5442452|NCT00004853|Sarcoma|sarcoma
5442453|NCT00004853|Tumor|tumor
5442454|NCT00004850|Hepatitis C Virus|hepatitis c virus
5442455|NCT00004850|Blood Donors|blood donors
5442456|NCT00004850|Liver Biopsy|liver biopsy
5442457|NCT00004850|ALT|alt
5442458|NCT00004850|Natural History|natural history
5442459|NCT00004847|Neurofibromatosis|neurofibromatosis
5442460|NCT00004847|Multiple Endocrine Neoplasia (MEN)|multiple endocrine neoplasia (men)
5442461|NCT00004847|Von Hippel-Lindau Disease|von hippel-lindau disease
5442462|NCT00004847|Norepinephrine|norepinephrine
5442463|NCT00004847|Epinephrine|epinephrine
5442464|NCT00004847|Metanephrines|metanephrines
5442465|NCT00004847|PET|pet
5442466|NCT00004847|Paraganglioma|paraganglioma
5442467|NCT00004847|Pheochromocytoma|pheochromocytoma
5442468|NCT00004846|Viral Gene Amplification|viral gene amplification
5442469|NCT00004846|Blood Transmitted Infections|blood transmitted infections
5442470|NCT00004846|Transfusion Risks|transfusion risks
5442471|NCT00004846|Transcription Mediated Analysis|transcription mediated analysis
5442472|NCT00004846|Viral Detection Assays|viral detection assays
5442473|NCT00004846|HIV Seronegativity|hiv seronegativity
5442474|NCT00004739|Pediatric HIV infection|pediatric hiv infection
5442475|NCT00004845|Anti-inflammatory|anti-inflammatory
5442476|NCT00004738|Arnold Chiari Malformation|arnold chiari malformation
5442477|NCT00004738|Skeletal Dysplasia|skeletal dysplasia
5442478|NCT00004738|Syringomyelia|syringomyelia
5442479|NCT00004738|Genetics|genetics
5442480|NCT00004738|Chiari I Malformation|chiari i malformation
5442481|NCT00004734|stroke|stroke
5442482|NCT00004734|cerebral infarction|cerebral infarction
5442483|NCT00004734|homocysteine|homocysteine
5442484|NCT00004734|vitamin|vitamin
5442485|NCT00004734|folic acid|folic acid
5442486|NCT00004734|pyridoxine|pyridoxine
5442487|NCT00004734|vitamin B6|vitamin b6
5442488|NCT00004734|cyanocobalamin|cyanocobalamin
5442489|NCT00004734|vitamin B12|vitamin b12
5442490|NCT00004734|multivitamin|multivitamin
5442491|NCT00004733|Parkinson's|parkinson's
5442498|NCT00004732|asymptomatic|asymptomatic
5442499|NCT00004732|atherosclerosis|atherosclerosis
5442500|NCT00004732|carotid endarterectomy|carotid endarterectomy
5442501|NCT00004732|carotid stenting|carotid stenting
5442502|NCT00004732|CREST|crest
5442503|NCT00004732|Cerebral Infarction|cerebral infarction
5442504|NCT00004732|device|device
5442505|NCT00004732|intervention|intervention
5442506|NCT00004732|restenosis|restenosis
5442507|NCT00004732|revascularization|revascularization
5442508|NCT00004732|stenosis|stenosis
5442509|NCT00004732|stent|stent
5442510|NCT00004732|stroke|stroke
5442511|NCT00004732|symptomatic|symptomatic
5442512|NCT00004732|surgery|surgery
5442513|NCT00004732|transient ischemic attack|transient ischemic attack
5442514|NCT00004731|Parkinson's disease|parkinson's disease
5442515|NCT00004731|coenzyme Q10|coenzyme q10
5442516|NCT00004730|head injury|head injury
5442517|NCT00004730|traumatic brain injury|traumatic brain injury
5442518|NCT00004730|concussion|concussion
5442519|NCT00004730|magnesium sulfate|magnesium sulfate
5442520|NCT00004730|neuroprotection|neuroprotection
5442521|NCT00004729|child|child
5442522|NCT00004729|children|children
5442523|NCT00004729|epilepsy|epilepsy
5442524|NCT00004729|seizure|seizure
5442525|NCT00004729|ketogenic|ketogenic
5442526|NCT00004729|diet|diet
5442527|NCT00004729|Lennox-Gastaut Syndrome|lennox-gastaut syndrome
5442528|NCT00004729|LGS|lgs
5442529|NCT00004728|stroke|stroke
5442530|NCT00004728|cerebral infarction|cerebral infarction
5442531|NCT00004728|warfarin|warfarin
5442532|NCT00004728|coumadin|coumadin
5442533|NCT00004728|aspirin|aspirin
5442534|NCT00004728|ASA|asa
5442535|NCT00004728|acetysalicylic acid|acetysalicylic acid
5442536|NCT00004728|atherosclerosis|atherosclerosis
5442537|NCT00004728|stenosis|stenosis
5442538|NCT00004728|intracranial|intracranial
5442539|NCT00004728|artery|artery
5442540|NCT00004728|arteries|arteries
5442541|NCT00004728|transient ischemic attack|transient ischemic attack
5442542|NCT00004728|TIA|tia
5442543|NCT00004728|minorities|minorities
5442544|NCT00004727|African American|african american
5442545|NCT00004727|antiplatelet|antiplatelet
5442546|NCT00004727|aspirin|aspirin
5442547|NCT00004727|ASA|asa
5442548|NCT00004727|acetylsalicylic acid|acetylsalicylic acid
5442549|NCT00004727|ticlopidine|ticlopidine
5442550|NCT00004727|prevention|prevention
5442551|NCT00004727|stroke|stroke
5442552|NCT00004727|cerebral infarction|cerebral infarction
5442553|NCT00004727|Chicago|chicago
5442554|NCT00004727|non-cardioembolic ischemic stroke|non-cardioembolic ischemic stroke
5442555|NCT00004941|Crohn's disease|crohn's disease
5442556|NCT00004941|gastrointestinal disorders|gastrointestinal disorders
5442557|NCT00004941|rare disease|rare disease
5442558|NCT00004940|erythropoietic protoporphyria|erythropoietic protoporphyria
5442559|NCT00004940|inborn errors of metabolism|inborn errors of metabolism
5442560|NCT00004940|porphyria|porphyria
5442561|NCT00004940|rare disease|rare disease
5442562|NCT00004939|demyelinating neuropathy|demyelinating neuropathy
5442563|NCT00004939|neurologic and psychiatric disorders|neurologic and psychiatric disorders
5442564|NCT00004939|rare disease|rare disease
5442565|NCT00004938|fungal infection|fungal infection
5442566|NCT00004938|rare disease|rare disease
5442567|NCT00004938|sporotrichosis|sporotrichosis
5442568|NCT00004844|Parkinson Disease|parkinson disease
5442569|NCT00004844|neurologic and psychiatric disorders|neurologic and psychiatric disorders
5442570|NCT00004844|rare disease|rare disease
5442571|NCT00004843|disease-related problem/condition|disease-related problem/condition
5442572|NCT00004843|endocrine disorders|endocrine disorders
5442573|NCT00004843|hyperparathyroidism|hyperparathyroidism
5442574|NCT00004843|quality of life|quality of life
5442575|NCT00004843|rare disease|rare disease
5442576|NCT00004842|cirrhosis|cirrhosis
5442577|NCT00004842|gastrointestinal disorders|gastrointestinal disorders
5442578|NCT00004842|primary biliary cirrhosis|primary biliary cirrhosis
5442579|NCT00004842|primary sclerosing cholangitis|primary sclerosing cholangitis
5442580|NCT00004842|rare disease|rare disease
5442581|NCT00004840|cardiovascular and respiratory diseases|cardiovascular and respiratory diseases
5442582|NCT00004840|neonatal disorders|neonatal disorders
5442583|NCT00004840|rare disease|rare disease
5442584|NCT00004840|respiratory distress syndrome|respiratory distress syndrome
5442585|NCT00004838|environmental/toxic disorders|environmental/toxic disorders
5442586|NCT00004838|lead poisoning|lead poisoning
5442587|NCT00004838|rare disease|rare disease
5442588|NCT00004834|anxiety disorder|anxiety disorder
5442589|NCT00004834|disease-related problem/condition|disease-related problem/condition
5442590|NCT00004834|neurologic and psychiatric disorders|neurologic and psychiatric disorders
5442591|NCT00004834|panic disorder|panic disorder
5442592|NCT00004834|rare disease|rare disease
5442593|NCT00004833|Guillain-Barre syndrome|guillain-barre syndrome
5442594|NCT00004833|demyelinating neuropathy|demyelinating neuropathy
5442595|NCT00004833|neurologic and psychiatric disorders|neurologic and psychiatric disorders
5442596|NCT00004833|rare disease|rare disease
5442597|NCT00004832|Lambert-Eaton myasthenic syndrome|lambert-eaton myasthenic syndrome
5442685|NCT00004799|bacterial infection|bacterial infection
5442598|NCT00004832|neurologic and psychiatric disorders|neurologic and psychiatric disorders
5442599|NCT00004832|rare disease|rare disease
5442600|NCT00004831|erythropoietic protoporphyria|erythropoietic protoporphyria
5442601|NCT00004831|inborn errors of metabolism|inborn errors of metabolism
5442602|NCT00004831|porphyria|porphyria
5442603|NCT00004831|rare disease|rare disease
5442604|NCT00004829|bacterial infection|bacterial infection
5442605|NCT00004829|cardiovascular and respiratory diseases|cardiovascular and respiratory diseases
5442606|NCT00004829|cystic fibrosis|cystic fibrosis
5442607|NCT00004829|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
5442608|NCT00004829|immunologic disorders and infectious disorders|immunologic disorders and infectious disorders
5442609|NCT00004829|rare disease|rare disease
5442610|NCT00004828|cardiovascular and respiratory diseases|cardiovascular and respiratory diseases
5442611|NCT00004828|heart defects|heart defects
5442612|NCT00004828|rare disease|rare disease
5442613|NCT00004827|ophthalmologic disorders|ophthalmologic disorders
5442614|NCT00004827|rare disease|rare disease
5442615|NCT00004827|retinitis pigmentosa|retinitis pigmentosa
5442616|NCT00004826|Parkinson disease|parkinson disease
5442617|NCT00004826|neurologic and psychiatric disorders|neurologic and psychiatric disorders
5442618|NCT00004826|rare disease|rare disease
5442619|NCT00004825|endocrine disorders|endocrine disorders
5442620|NCT00004825|hyperinsulinism|hyperinsulinism
5442621|NCT00004825|rare disease|rare disease
5442622|NCT00004817|neurologic and psychiatric disorders|neurologic and psychiatric disorders
5442623|NCT00004817|rare disease|rare disease
5442624|NCT00004817|seizures|seizures
5442625|NCT00004816|multiple sclerosis|multiple sclerosis
5442626|NCT00004816|neurologic and psychiatric disorders|neurologic and psychiatric disorders
5442627|NCT00004816|rare disease|rare disease
5442628|NCT00004815|Werner's syndrome|werner's syndrome
5442629|NCT00004815|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
5442630|NCT00004815|rare disease|rare disease
5442631|NCT00004814|multiple sclerosis|multiple sclerosis
5442632|NCT00004814|neurologic and psychiatric disorders|neurologic and psychiatric disorders
5442633|NCT00004814|rare disease|rare disease
5442634|NCT00004812|environmental/toxic disorders|environmental/toxic disorders
5442635|NCT00004812|neurologic and psychiatric disorders|neurologic and psychiatric disorders
5442636|NCT00004812|rare disease|rare disease
5442637|NCT00004812|spinal cord injury|spinal cord injury
5442638|NCT00004811|blastomycosis|blastomycosis
5442639|NCT00004811|fungal infection|fungal infection
5442640|NCT00004811|histoplasmosis|histoplasmosis
5442641|NCT00004811|immunologic disorders and infectious disorders|immunologic disorders and infectious disorders
5442642|NCT00004811|rare disease|rare disease
5442643|NCT00004811|sporotrichosis|sporotrichosis
5442644|NCT00004810|gastrointestinal disorders|gastrointestinal disorders
5442645|NCT00004810|rare disease|rare disease
5442646|NCT00004810|ulcerative colitis|ulcerative colitis
5442647|NCT00004809|familial hypercholesterolemia|familial hypercholesterolemia
5442648|NCT00004809|inborn errors of metabolism|inborn errors of metabolism
5442649|NCT00004809|rare disease|rare disease
5442650|NCT00004808|blastomycosis|blastomycosis
5442651|NCT00004808|fungal infection|fungal infection
5442652|NCT00004808|histoplasmosis|histoplasmosis
5442653|NCT00004808|immunologic disorders and infectious disorders|immunologic disorders and infectious disorders
5442654|NCT00004808|rare disease|rare disease
5442655|NCT00004808|sporotrichosis|sporotrichosis
5442656|NCT00004807|Rett syndrome|rett syndrome
5442657|NCT00004807|neurologic and psychiatric disorders|neurologic and psychiatric disorders
5442658|NCT00004807|rare disease|rare disease
5442659|NCT00004806|cardiovascular and respiratory diseases|cardiovascular and respiratory diseases
5442660|NCT00004806|cystic fibrosis|cystic fibrosis
5442661|NCT00004806|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
5442662|NCT00004806|rare disease|rare disease
5442663|NCT00004805|bronchopulmonary dysplasia|bronchopulmonary dysplasia
5442664|NCT00004805|cardiovascular and respiratory diseases|cardiovascular and respiratory diseases
5442665|NCT00004805|disease-related problem/condition|disease-related problem/condition
5442666|NCT00004805|educational needs|educational needs
5442667|NCT00004805|hypertensive disorder|hypertensive disorder
5442668|NCT00004805|neonatal disorders|neonatal disorders
5442669|NCT00004805|primary pulmonary hypertension|primary pulmonary hypertension
5442670|NCT00004805|rare disease|rare disease
5442671|NCT00004805|respiratory distress syndrome|respiratory distress syndrome
5442672|NCT00004804|hepatitis C|hepatitis c
5442673|NCT00004804|immunologic disorders and infectious disorders|immunologic disorders and infectious disorders
5442674|NCT00004804|rare disease|rare disease
5442675|NCT00004804|viral infection|viral infection
5442676|NCT00004802|neurologic and psychiatric disorders|neurologic and psychiatric disorders
5442677|NCT00004802|periodic paralysis|periodic paralysis
5442678|NCT00004802|rare disease|rare disease
5442679|NCT00004801|hematologic disorders|hematologic disorders
5442680|NCT00004801|rare disease|rare disease
5442681|NCT00004800|bacterial infection|bacterial infection
5442682|NCT00004800|immunologic disorders and infectious disorders|immunologic disorders and infectious disorders
5442683|NCT00004800|pertussis|pertussis
5442684|NCT00004800|rare disease|rare disease
5442686|NCT00004799|immunologic disorders and infectious disorders|immunologic disorders and infectious disorders
5442687|NCT00004799|pertussis|pertussis
5442688|NCT00004799|rare disease|rare disease
5442689|NCT00004797|disease-related problem/condition|disease-related problem/condition
5442690|NCT00004797|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
5442691|NCT00004797|hematologic disorders|hematologic disorders
5442692|NCT00004797|pain|pain
5442693|NCT00004797|rare disease|rare disease
5442694|NCT00004797|sickle cell anemia|sickle cell anemia
5442695|NCT00004796|cardiovascular and respiratory diseases|cardiovascular and respiratory diseases
5442696|NCT00004796|cirrhosis|cirrhosis
5442697|NCT00004796|gastrointestinal disorders|gastrointestinal disorders
5442698|NCT00004796|hypertensive disorder|hypertensive disorder
5442699|NCT00004796|portal hypertension|portal hypertension
5442700|NCT00004796|rare disease|rare disease
5442701|NCT00004795|arthritis & connective tissue diseases|arthritis & connective tissue diseases
5442702|NCT00004795|immunologic disorders and infectious disorders|immunologic disorders and infectious disorders
5442703|NCT00004795|rare disease|rare disease
5442704|NCT00004795|systemic lupus erythematosus|systemic lupus erythematosus
5442705|NCT00004794|cytomegalovirus retinitis|cytomegalovirus retinitis
5442706|NCT00004794|ophthalmologic disorders|ophthalmologic disorders
5442707|NCT00004794|rare disease|rare disease
5442708|NCT00004793|constitutional growth delay|constitutional growth delay
5442709|NCT00004793|endocrine disorders|endocrine disorders
5442710|NCT00004793|rare disease|rare disease
5442711|NCT00004791|dermatologic disorders|dermatologic disorders
5442712|NCT00004791|epidermolysis bullosa|epidermolysis bullosa
5442713|NCT00004791|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
5442714|NCT00004791|rare disease|rare disease
5442715|NCT00004789|inborn errors of metabolism|inborn errors of metabolism
5442716|NCT00004789|acute porphyria|acute porphyria
5442717|NCT00004789|rare disease|rare disease
5442718|NCT00004788|inborn errors of metabolism|inborn errors of metabolism
5442719|NCT00004788|porphyria|porphyria
5442720|NCT00004788|rare disease|rare disease
5442721|NCT00004787|Fanconi's anemia|fanconi's anemia
5442722|NCT00004787|Shwachman syndrome|shwachman syndrome
5442723|NCT00004787|aplastic anemia|aplastic anemia
5442724|NCT00004787|dermatologic disorders|dermatologic disorders
5442725|NCT00004787|dyskeratosis congenita|dyskeratosis congenita
5442726|NCT00004787|hematologic disorders|hematologic disorders
5442727|NCT00004787|rare disease|rare disease
5442728|NCT00004787|thrombocytopenia|thrombocytopenia
5442729|NCT00004786|Raynaud's syndrome|raynaud's syndrome
5442730|NCT00004786|arthritis & connective tissue diseases|arthritis & connective tissue diseases
5442731|NCT00004786|cardiovascular and respiratory diseases|cardiovascular and respiratory diseases
5442732|NCT00004786|rare disease|rare disease
5442733|NCT00004786|systemic sclerosis|systemic sclerosis
5442734|NCT00004785|bronchopulmonary dysplasia|bronchopulmonary dysplasia
5442735|NCT00004785|cardiovascular and respiratory diseases|cardiovascular and respiratory diseases
5442736|NCT00004785|neonatal disorders|neonatal disorders
5442737|NCT00004785|rare disease|rare disease
5442738|NCT00004784|cirrhosis|cirrhosis
5442739|NCT00004784|gastrointestinal disorders|gastrointestinal disorders
5442740|NCT00004784|primary biliary cirrhosis|primary biliary cirrhosis
5442741|NCT00004784|rare disease|rare disease
5442742|NCT00004781|HIV-associated candidiasis|hiv-associated candidiasis
5442743|NCT00004781|candidiasis|candidiasis
5442744|NCT00004781|disease-related problem/condition|disease-related problem/condition
5442745|NCT00004781|fungal infection|fungal infection
5442746|NCT00004781|immunologic disorders and infectious disorders|immunologic disorders and infectious disorders
5442747|NCT00004781|infection|infection
5442748|NCT00004781|rare disease|rare disease
5442749|NCT00004779|cardiovascular and respiratory diseases|cardiovascular and respiratory diseases
5442750|NCT00004779|cystic fibrosis|cystic fibrosis
5442751|NCT00004779|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
5442752|NCT00004779|rare disease|rare disease
5442753|NCT00004778|cardiovascular and respiratory diseases|cardiovascular and respiratory diseases
5442754|NCT00004778|neonatal disorders|neonatal disorders
5442755|NCT00004778|rare disease|rare disease
5442756|NCT00004778|respiratory distress syndrome|respiratory distress syndrome
5442757|NCT00004776|Lennox-Gastaut syndrome|lennox-gastaut syndrome
5442758|NCT00004776|epilepsy|epilepsy
5442759|NCT00004776|neurologic and psychiatric disorders|neurologic and psychiatric disorders
5442760|NCT00004776|rare disease|rare disease
5442761|NCT00004776|seizures|seizures
5442762|NCT00004773|Rett syndrome|rett syndrome
5442763|NCT00004773|neurologic and psychiatric disorders|neurologic and psychiatric disorders
5442764|NCT00004773|rare disease|rare disease
5442765|NCT00004772|demyelinating neuropathy|demyelinating neuropathy
5442766|NCT00004772|neurologic and psychiatric disorders|neurologic and psychiatric disorders
5442767|NCT00004772|rare disease|rare disease
5442768|NCT00004771|amyotrophic lateral sclerosis|amyotrophic lateral sclerosis
5442769|NCT00004771|motor neuron disease|motor neuron disease
5442770|NCT00004771|neurologic and psychiatric disorders|neurologic and psychiatric disorders
5442771|NCT00004771|rare disease|rare disease
5442772|NCT00004771|spinal and bulbar muscular atrophy|spinal and bulbar muscular atrophy
5442773|NCT00004771|spinal muscular atrophy|spinal muscular atrophy
5442774|NCT00004771|Kennedy's Syndrome|kennedy's syndrome
5442775|NCT00004770|inborn errors of metabolism|inborn errors of metabolism
5442776|NCT00004770|mitochondrial myopathy|mitochondrial myopathy
5442777|NCT00004770|rare disease|rare disease
5442778|NCT00004769|Genetic diseases|genetic diseases
5442779|NCT00004769|Myotonic muscular dystrophy|myotonic muscular dystrophy
5442780|NCT00004769|Facioscapulohumeral muscular dystrophy|facioscapulohumeral muscular dystrophy
5442781|NCT00004769|CMT|cmt
5442782|NCT00004769|Rare disease|rare disease
5442783|NCT00004767|inborn errors of metabolism|inborn errors of metabolism
5442784|NCT00004767|rare disease|rare disease
5442785|NCT00004767|urea cycle disorder|urea cycle disorder
5442786|NCT00004763|endocrine disorders|endocrine disorders
5442787|NCT00004763|hyperandrogenism|hyperandrogenism
5442788|NCT00004763|rare disease|rare disease
5442789|NCT00004762|gastrointestinal disorders|gastrointestinal disorders
5442790|NCT00004762|primary sclerosing cholangitis|primary sclerosing cholangitis
5442791|NCT00004762|rare disease|rare disease
5442792|NCT00004761|dermatologic disorders|dermatologic disorders
5442793|NCT00004761|epidermolysis bullosa|epidermolysis bullosa
5442794|NCT00004761|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
5442795|NCT00004761|rare disease|rare disease
5442796|NCT00004760|Parkinson disease|parkinson disease
5442797|NCT00004760|Neurologic and psychiatric disorders|neurologic and psychiatric disorders
5442798|NCT00004760|Rare disease|rare disease
5442799|NCT00004759|environmental/toxic disorders|environmental/toxic disorders
5442800|NCT00004759|neurologic and psychiatric disorders|neurologic and psychiatric disorders
5442801|NCT00004759|rare disease|rare disease
5442802|NCT00004759|spinal cord injury|spinal cord injury
5442803|NCT00004758|infantile spasms|infantile spasms
5442804|NCT00004758|epilepsy|epilepsy
5442805|NCT00004758|neurologic and psychiatric disorders|neurologic and psychiatric disorders
5442806|NCT00004758|rare disease|rare disease
5442807|NCT00004758|seizures|seizures
5442808|NCT00004757|herpes simplex virus infection|herpes simplex virus infection
5442809|NCT00004757|herpesvirus infection|herpesvirus infection
5442810|NCT00004757|immunologic disorders and infectious disorders|immunologic disorders and infectious disorders
5442811|NCT00004757|rare disease|rare disease
5442812|NCT00004757|viral infection|viral infection
5442813|NCT00004756|arthritis & connective tissue diseases|arthritis & connective tissue diseases
5442814|NCT00004756|disease-related problem/condition|disease-related problem/condition
5442815|NCT00004756|educational needs|educational needs
5442816|NCT00004756|immunologic disorders and infectious disorders|immunologic disorders and infectious disorders
5442817|NCT00004756|rare disease|rare disease
5442818|NCT00004756|systemic lupus erythematosus|systemic lupus erythematosus
5442819|NCT00004755|dermatologic disorders|dermatologic disorders
5442820|NCT00004755|environmental/toxic disorders|environmental/toxic disorders
5442821|NCT00004755|immunologic disorders and infectious disorders|immunologic disorders and infectious disorders
5442822|NCT00004755|leishmaniasis|leishmaniasis
5442823|NCT00004755|rare disease|rare disease
5442824|NCT00004754|cardiovascular and respiratory diseases|cardiovascular and respiratory diseases
5442825|NCT00004754|hypertensive disorder|hypertensive disorder
5442826|NCT00004754|primary pulmonary hypertension|primary pulmonary hypertension
5442827|NCT00004754|rare disease|rare disease
5442828|NCT00004753|Huntington's disease|huntington's disease
5442829|NCT00004753|neurologic and psychiatric disorders|neurologic and psychiatric disorders
5442830|NCT00004753|rare disease|rare disease
5442831|NCT00004751|cerebral palsy|cerebral palsy
5442832|NCT00004751|neurologic and psychiatric disorders|neurologic and psychiatric disorders
5442833|NCT00004751|rare disease|rare disease
5442834|NCT00004751|spastic diplegia|spastic diplegia
5442835|NCT00004748|cirrhosis|cirrhosis
5442836|NCT00004748|gastrointestinal disorders|gastrointestinal disorders
5442837|NCT00004748|primary biliary cirrhosis|primary biliary cirrhosis
5442838|NCT00004748|rare disease|rare disease
5442839|NCT00004747|bacterial infections|bacterial infections
5442840|NCT00004747|cardiovascular and respiratory diseases|cardiovascular and respiratory diseases
5442841|NCT00004747|cystic fibrosis|cystic fibrosis
5442842|NCT00004747|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
5442843|NCT00004747|immunologic disorders and infectious disorders|immunologic disorders and infectious disorders
5442844|NCT00004747|rare disease|rare disease
5442845|NCT00004744|multiple sclerosis|multiple sclerosis
5442846|NCT00004744|neurologic and psychiatric disorders|neurologic and psychiatric disorders
5442847|NCT00004744|rare disease|rare disease
5442848|NCT00004740|cardiovascular and respiratory diseases|cardiovascular and respiratory diseases
5442849|NCT00004740|rare disease|rare disease
5442850|NCT00004740|tuberculosis|tuberculosis
5442851|NCT00004705|cardiovascular and respiratory diseases|cardiovascular and respiratory diseases
5442852|NCT00004705|cystic fibrosis|cystic fibrosis
5442853|NCT00004705|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
5442854|NCT00004705|rare disease|rare disease
5442855|NCT00004700|endocrine disorders|endocrine disorders
5442856|NCT00004700|hyperinsulinism|hyperinsulinism
5442857|NCT00004700|rare disease|rare disease
5442858|NCT00004699|endocrine disorders|endocrine disorders
5442859|NCT00004699|hyperinsulinism|hyperinsulinism
5442860|NCT00004699|rare disease|rare disease
5442861|NCT00004697|gastrointestinal disorders|gastrointestinal disorders
5442862|NCT00004697|hepatic steatosis|hepatic steatosis
5442863|NCT00004697|rare disease|rare disease
5442864|NCT00004696|disease-related problem/condition|disease-related problem/condition
5442865|NCT00004696|pain|pain
5442866|NCT00004696|intraoperative/postoperative complications|intraoperative/postoperative complications
5442867|NCT00004696|rare disease|rare disease
5442868|NCT00004695|common variable immunodeficiency|common variable immunodeficiency
5442869|NCT00004695|immunologic disorders and infectious disorders|immunologic disorders and infectious disorders
5442870|NCT00004695|primary immunodeficiency disease|primary immunodeficiency disease
5442871|NCT00004695|rare disease|rare disease
5442872|NCT00004694|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
5442873|NCT00004694|hereditary angioedema|hereditary angioedema
5442874|NCT00004694|rare disease|rare disease
5442875|NCT00004690|dermatologic disorders|dermatologic disorders
5442876|NCT00004690|ichthyosis|ichthyosis
5442877|NCT00004690|rare disease|rare disease
5442878|NCT00004689|bacterial infection|bacterial infection
5442879|NCT00004689|immunologic disorders and infectious disorders|immunologic disorders and infectious disorders
5442880|NCT00004689|mycobacterium avium infection|mycobacterium avium infection
5442881|NCT00004689|mycobacterium infection|mycobacterium infection
5442882|NCT00004689|rare disease|rare disease
5442883|NCT00004688|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5442884|NCT00004688|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
5442885|NCT00004688|adult brain stem glioma|adult brain stem glioma
5442886|NCT00004688|adult brain tumor|adult brain tumor
5442887|NCT00004688|adult glioblastoma multiforme|adult glioblastoma multiforme
5442888|NCT00004688|adult infiltrating astrocytoma|adult infiltrating astrocytoma
5442889|NCT00004688|brain tumor|brain tumor
5442890|NCT00004688|genetic condition|genetic condition
5442891|NCT00004688|miscellaneous sites/terms|miscellaneous sites/terms
5442892|NCT00004688|mixed gliomas|mixed gliomas
5442893|NCT00004688|nervous tissue tumors|nervous tissue tumors
5442894|NCT00004688|oncologic disorders|oncologic disorders
5442895|NCT00004688|rare disease|rare disease
5442896|NCT00004688|recurrent adult brain tumor|recurrent adult brain tumor
5442897|NCT00004686|cardiovascular and respiratory diseases|cardiovascular and respiratory diseases
5442898|NCT00004686|giant cell arteritis|giant cell arteritis
5442899|NCT00004686|rare disease|rare disease
5442900|NCT00004685|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
5442901|NCT00004685|muscular dystrophy|muscular dystrophy
5442902|NCT00004685|neurologic and psychiatric disorders|neurologic and psychiatric disorders
5442903|NCT00004685|rare disease|rare disease
5442904|NCT00004682|myasthenia gravis|myasthenia gravis
5442905|NCT00004682|neurologic and psychiatric disorders|neurologic and psychiatric disorders
5442906|NCT00004682|rare disease|rare disease
5442907|NCT00004670|Parkinson disease|parkinson disease
5442908|NCT00004670|neurologic and psychiatric disorders|neurologic and psychiatric disorders
5442909|NCT00004670|rare disease|rare disease
5442910|NCT00004669|bronchopulmonary dysplasia|bronchopulmonary dysplasia
5442911|NCT00004669|cardiovascular and respiratory diseases|cardiovascular and respiratory diseases
5442912|NCT00004669|neonatal disorders|neonatal disorders
5442913|NCT00004669|rare disease|rare disease
5442914|NCT00004667|hematologic disorders|hematologic disorders
5442915|NCT00004667|rare disease|rare disease
5442916|NCT00004667|von Willebrand's disease|von willebrand's disease
5442917|NCT00004665|arthritis & connective tissue diseases|arthritis & connective tissue diseases
5442918|NCT00004665|immunologic disorders and infectious disorders|immunologic disorders and infectious disorders
5442919|NCT00004665|rare disease|rare disease
5442920|NCT00004665|systemic lupus erythematosus|systemic lupus erythematosus
5442921|NCT00004664|disease-related problem/condition|disease-related problem/condition
5442922|NCT00004664|human immunodeficiency virus infection|human immunodeficiency virus infection
5442923|NCT00004664|immunologic disorders and infectious disorders|immunologic disorders and infectious disorders
5442924|NCT00004664|nutrition|nutrition
5442925|NCT00004664|rare disease|rare disease
5442926|NCT00004664|viral infection|viral infection
5442927|NCT00004663|arthritis & connective tissue diseases|arthritis & connective tissue diseases
5442928|NCT00004663|immunologic disorders and infectious disorders|immunologic disorders and infectious disorders
5442929|NCT00004663|rare disease|rare disease
5442930|NCT00004663|systemic lupus erythematosus|systemic lupus erythematosus
5442931|NCT00004662|arthritis & connective tissue diseases|arthritis & connective tissue diseases
5442932|NCT00004662|immunologic disorders and infectious disorders|immunologic disorders and infectious disorders
5442933|NCT00004662|rare disease|rare disease
5442934|NCT00004662|systemic lupus erythematosus|systemic lupus erythematosus
5442935|NCT00004661|endocrine disorders|endocrine disorders
5442936|NCT00004661|pseudohypoparathyroidism|pseudohypoparathyroidism
5442937|NCT00004661|rare disease|rare disease
5442938|NCT00004660|Graves' disease|graves' disease
5442939|NCT00004660|thyroid disease|thyroid disease
5442940|NCT00004660|endocrine disorders|endocrine disorders
5442941|NCT00004660|rare disease|rare disease
5442942|NCT00004659|adult brain tumor|adult brain tumor
5442944|NCT00004659|childhood brain tumor|childhood brain tumor
5442945|NCT00004659|genetic condition|genetic condition
5442946|NCT00004659|nervous tissue tumors|nervous tissue tumors
5442947|NCT00004659|oncologic disorders|oncologic disorders
5442948|NCT00004659|rare disease|rare disease
5442949|NCT00004658|5'-nucleotidase syndrome|5'-nucleotidase syndrome
5442950|NCT00004658|inborn errors of metabolism|inborn errors of metabolism
5442951|NCT00004658|rare disease|rare disease
5442952|NCT00004656|Rett syndrome|rett syndrome
5442953|NCT00004656|neurologic and psychiatric disorders|neurologic and psychiatric disorders
5442954|NCT00004656|rare disease|rare disease
5442955|NCT00004654|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
5442956|NCT00004654|hematologic disorders|hematologic disorders
5442957|NCT00004654|hereditary hemorrhagic telangiectasia|hereditary hemorrhagic telangiectasia
5442958|NCT00004654|rare disease|rare disease
5442959|NCT00004652|Tourette syndrome|tourette syndrome
5442960|NCT00004652|neurologic and psychiatric disorders|neurologic and psychiatric disorders
5442961|NCT00004652|rare disease|rare disease
5442962|NCT00004650|disease-related problem/condition|disease-related problem/condition
5442963|NCT00004650|osteoporosis|osteoporosis
5442964|NCT00004650|rare disease|rare disease
5442965|NCT00004649|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
5442966|NCT00004649|hematologic disorders|hematologic disorders
5442967|NCT00004649|hereditary hemorrhagic telangiectasia|hereditary hemorrhagic telangiectasia
5442968|NCT00004649|rare disease|rare disease
5442969|NCT00004648|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
5442970|NCT00004648|hematologic disorders|hematologic disorders
5442971|NCT00004648|hereditary hemorrhagic telangiectasia|hereditary hemorrhagic telangiectasia
5442972|NCT00004648|rare disease|rare disease
5442973|NCT00004648|Osler-Rendu-Weber disease|osler-rendu-weber disease
5442974|NCT00004647|diabetic neuropathy|diabetic neuropathy
5442975|NCT00004647|disease-related problem/condition|disease-related problem/condition
5442976|NCT00004647|neurologic and psychiatric disorders|neurologic and psychiatric disorders
5442977|NCT00004647|pain|pain
5442978|NCT00004647|rare disease|rare disease
5442979|NCT00004646|Duchenne muscular dystrophy|duchenne muscular dystrophy
5442980|NCT00004646|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
5442981|NCT00004646|muscular dystrophy|muscular dystrophy
5442982|NCT00004646|neurologic and psychiatric disorders|neurologic and psychiatric disorders
5442983|NCT00004646|rare disease|rare disease
5442984|NCT00004645|Balo's concentric sclerosis|balo's concentric sclerosis
5442985|NCT00004645|Devic's syndrome|devic's syndrome
5442986|NCT00004645|Marburg's variant of multiple sclerosis|marburg's variant of multiple sclerosis
5442987|NCT00004645|acute disseminated encephalomyelitis|acute disseminated encephalomyelitis
5442988|NCT00004645|acute transverse myelitis|acute transverse myelitis
5442989|NCT00004645|multiple sclerosis|multiple sclerosis
5442990|NCT00004645|neurologic and psychiatric disorders|neurologic and psychiatric disorders
5442991|NCT00004645|rare disease|rare disease
5442992|NCT00004644|herpes simplex virus infection|herpes simplex virus infection
5442993|NCT00004644|herpesvirus infection|herpesvirus infection
5442994|NCT00004644|immunologic disorders and infectious disorders|immunologic disorders and infectious disorders
5442995|NCT00004644|rare disease|rare disease
5442996|NCT00004644|viral infection|viral infection
5442997|NCT00004643|arthritis & connective tissue diseases|arthritis & connective tissue diseases
5442998|NCT00004643|immunologic disorders and infectious disorders|immunologic disorders and infectious disorders
5442999|NCT00004643|rare disease|rare disease
5443000|NCT00004643|systemic lupus erythematosus|systemic lupus erythematosus
5443001|NCT00004642|congenital cytomegalovirus infection|congenital cytomegalovirus infection
5443002|NCT00004642|cytomegalovirus infection|cytomegalovirus infection
5443003|NCT00004642|herpesvirus infection|herpesvirus infection
5443004|NCT00004642|immunologic disorders and infectious disorders|immunologic disorders and infectious disorders
5443005|NCT00004642|neonatal disorders|neonatal disorders
5443006|NCT00004642|rare disease|rare disease
5443007|NCT00004642|viral infection|viral infection
5443008|NCT00004638|chronic sinusitis|chronic sinusitis
5443009|NCT00004635|Angiogenesis|angiogenesis
5443010|NCT00004635|Cancer|cancer
5443011|NCT00004635|Hormonal Therapy|hormonal therapy
5443012|NCT00004635|Prostate|prostate
5443013|NCT00004635|Thalidomide|thalidomide
5443014|NCT00004635|Prostate Cancer|prostate cancer
5443015|NCT00004577|BOLD Effect|bold effect
5443016|NCT00004577|Cerebral Blood Flow|cerebral blood flow
5443017|NCT00004577|Cerebral Blood Volume|cerebral blood volume
5443018|NCT00004577|Functional Imaging|functional imaging
5443019|NCT00004577|Magnetic Resonance Imaging|magnetic resonance imaging
5443020|NCT00004577|Technical Developments|technical developments
5443021|NCT00004573|cytomegalovirus viremia|cytomegalovirus viremia
5443022|NCT00004572|Type 2 Diabetes|type 2 diabetes
5443023|NCT00004571|Magnetic Resonance Imaging|magnetic resonance imaging
5443024|NCT00004571|Brain Metabolism|brain metabolism
5443025|NCT00004571|Brain Physiology|brain physiology
5443026|NCT00004571|Neuropsychiatric Disorders|neuropsychiatric disorders
5443027|NCT00004571|Cognitition|cognitition
5443028|NCT00004570|Temporal Processing|temporal processing
5443029|NCT00004570|Language Impairment|language impairment
5443030|NCT00004570|Linkage Analysis|linkage analysis
5443031|NCT00004570|Inheritance|inheritance
5443032|NCT00004570|Language Delay|language delay
5443033|NCT00004570|Healthy|healthy
5443034|NCT00004570|Auditory Temporal Processing Disorder|auditory temporal processing disorder
5443035|NCT00004570|Speech Impediment|speech impediment
5443036|NCT00004568|Peripheral Neuropathies|peripheral neuropathies
5443037|NCT00004568|Myopathy|myopathy
5443038|NCT00004568|Muscular Dystrophy|muscular dystrophy
5443039|NCT00004568|Motor Neuron Disease|motor neuron disease
5443040|NCT00004568|Neurological Disorders|neurological disorders
5443041|NCT00004567|Relapse|relapse
5443042|NCT00004567|Immunosuppressive|immunosuppressive
5443043|NCT00004567|Toxicity|toxicity
5443044|NCT00004567|Purineantimetabolite|purineantimetabolite
5443045|NCT00004567|Alternative Agents|alternative agents
5443046|NCT00004567|Wegener's Granulomatosis|wegener's granulomatosis
5443047|NCT00004567|Wegener's Disease|wegener's disease
5443048|NCT00004567|Blood Vessel Disorder|blood vessel disorder
5443049|NCT00004567|Systemic Vasculitis|systemic vasculitis
5443050|NCT00004566|3D Imaging|3d imaging
5443051|NCT00004566|Swallowing|swallowing
5443052|NCT00004566|Fetal Development|fetal development
5443053|NCT00004566|High-Risk Pregnancy|high-risk pregnancy
5443054|NCT00004566|Ultrasound|ultrasound
5443055|NCT00004565|Breast Cancer|breast cancer
5443056|NCT00004565|Genetics|genetics
5443057|NCT00004565|High Risk|high risk
5443058|NCT00004565|Polymorphisms|polymorphisms
5443059|NCT00004565|Susceptibility|susceptibility
5443060|NCT00004565|Biomarkers|biomarkers
5443061|NCT00004565|Estrogen|estrogen
5443062|NCT00004565|Genes|genes
5443063|NCT00004564|Platelet Aggregation Inhibitors|platelet aggregation inhibitors
5443064|NCT00004564|Cerebrovascular accident|cerebrovascular accident
5443065|NCT00004563|Lung Diseases|lung diseases
5443066|NCT00004563|Pulmonary Fibrosis|pulmonary fibrosis
5443067|NCT00004563|Systemic Scleroderma|systemic scleroderma
5443068|NCT00004563|Scleroderma, systemic|scleroderma, systemic
5443069|NCT00004556|Stimulants|stimulants
5443070|NCT00004556|Affect|affect
5443071|NCT00004556|Cognition|cognition
5443072|NCT00004556|Brain Physiology|brain physiology
5443073|NCT00004556|Brain Metabolism|brain metabolism
5443074|NCT00004556|Catecholamines|catecholamines
5443075|NCT00004556|Brain Imaging|brain imaging
5443076|NCT00004556|Cognitive Efficiency|cognitive efficiency
5443077|NCT00004556|Dopamine Genes|dopamine genes
5443078|NCT00004553|Single Fiber EMG|single fiber emg
5443079|NCT00004553|Macro-EMG|macro-emg
5443080|NCT00004553|Myasthenia|myasthenia
5443081|NCT00004553|Post-Polio Syndrome|post-polio syndrome
5443082|NCT00004553|Neuromuscular Transmission|neuromuscular transmission
5443083|NCT00004553|Motor Dysfunction|motor dysfunction
5443084|NCT00004553|Neuromuscular Disorder|neuromuscular disorder
5443085|NCT00004550|Screening|screening
5443086|NCT00004550|Longitudinal|longitudinal
5443087|NCT00004550|Transition|transition
5443088|NCT00004550|Treatment|treatment
5443089|NCT00004550|Comorbidity|comorbidity
5443090|NCT00004550|Obsessive Compulsive Disorder|obsessive compulsive disorder
5443091|NCT00004550|Evaluation|evaluation
5443092|NCT00004550|Follow-Up|follow-up
5443093|NCT00004550|OC Spectrum Disorders|oc spectrum disorders
5443094|NCT00004550|OCD|ocd
5443095|NCT00004549|Atherosclerosis|atherosclerosis
5443096|NCT00004549|Endothelium|endothelium
5443097|NCT00004549|Peripheral Vascular Disease|peripheral vascular disease
5443098|NCT00004549|Markers of Inflammation|markers of inflammation
5443099|NCT00004549|Claudication|claudication
5443100|NCT00004547|Surgery|surgery
5443101|NCT00004547|Mesothelioma|mesothelioma
5443102|NCT00004547|Pseudomyxoma|pseudomyxoma
5443103|NCT00004547|Colon Cancer|colon cancer
5443104|NCT00004547|Chemotherapy|chemotherapy
5443105|NCT00004533|cardiovascular and respiratory diseases|cardiovascular and respiratory diseases
5443106|NCT00004533|cystic fibrosis|cystic fibrosis
5443107|NCT00004533|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
5443108|NCT00004533|rare disease|rare disease
5443109|NCT00001987|Diabetes Mellitus|diabetes mellitus
5443110|NCT00001987|Severe Insulin Resistance|severe insulin resistance
5443111|NCT00001987|Type B Insulin Resistance|type b insulin resistance
5443112|NCT00000436|Hip fracture|hip fracture
5443113|NCT00000436|Self-efficacy|self-efficacy
5443114|NCT00000436|Strength training|strength training
5443115|NCT00000436|Rehabilitation|rehabilitation
5443116|NCT00000436|Postoperative|postoperative
5443117|NCT00001985|Diabetes|diabetes
5443118|NCT00001985|Gene|gene
5443119|NCT00001984|Immunosuppression|immunosuppression
5443120|NCT00001984|Tolerance|tolerance
5443121|NCT00001984|DSG|dsg
5443122|NCT00001984|Alemtuzumab|alemtuzumab
5443123|NCT00001983|Questionnaires|questionnaires
5443124|NCT00001983|Eligibility|eligibility
5443125|NCT00001983|History|history
5443126|NCT00001983|Physical Examination|physical examination
5443127|NCT00001983|Tests|tests
5443128|NCT00001983|Fibromyalgia|fibromyalgia
5443129|NCT00001981|Somatostatin Analogue|somatostatin analogue
5443130|NCT00001981|Acromegaly|acromegaly
5443131|NCT00001981|TSH Producing Tumor|tsh producing tumor
5444791|NCT00001487|Andropause|andropause
5443132|NCT00001981|Islet Cell Tumor|islet cell tumor
5443133|NCT00001981|Ursodeoxycholate|ursodeoxycholate
5443134|NCT00001981|Pituitary|pituitary
5443135|NCT00001981|Irradiation|irradiation
5443136|NCT00001981|Treatment|treatment
5443137|NCT00000435|RA|ra
5443138|NCT00000435|Immune Modulation|immune modulation
5443139|NCT00000435|Oral Tolerance|oral tolerance
5443140|NCT00000435|Peptide|peptide
5443141|NCT00000435|dnaJ|dnaj
5443142|NCT00000434|Osteoarthritis|osteoarthritis
5443143|NCT00000434|Health education|health education
5443144|NCT00000434|Aerobic exercise|aerobic exercise
5443145|NCT00000434|Self-efficacy|self-efficacy
5443146|NCT00000434|Muscle strength|muscle strength
5443147|NCT00000434|Outcomes research|outcomes research
5443148|NCT00000434|Longitudinal study|longitudinal study
5443149|NCT00001979|Kidney Disease|kidney disease
5443150|NCT00001979|Autoimmune Diseases|autoimmune diseases
5443151|NCT00001979|Nephrotic Syndrome|nephrotic syndrome
5443152|NCT00001978|Kidney Disease|kidney disease
5443153|NCT00001978|Kidney Function Tests|kidney function tests
5443154|NCT00001978|Proteinuria|proteinuria
5443155|NCT00001976|CMV|cmv
5443156|NCT00001976|Infection|infection
5443157|NCT00001976|Comparison|comparison
5443158|NCT00001976|Observational|observational
5443159|NCT00001976|Cytomegalovirus|cytomegalovirus
5443160|NCT00001976|RT-PCR|rt-pcr
5443161|NCT00001975|Skin Biopsy|skin biopsy
5443162|NCT00001975|Familial Tumor Syndrome|familial tumor syndrome
5443163|NCT00001975|Cell Growth|cell growth
5443164|NCT00001975|Loss of Heterozygosity|loss of heterozygosity
5443165|NCT00001975|Cytokines|cytokines
5443166|NCT00001975|Tuberous Sclerosis|tuberous sclerosis
5443167|NCT00001973|G Protein Mutation|g protein mutation
5443168|NCT00001973|McCune-Albright Syndrome|mccune-albright syndrome
5443169|NCT00001973|Fibrous Dysplasia|fibrous dysplasia
5443170|NCT00001973|Mutation|mutation
5443171|NCT00001973|Pathology|pathology
5443172|NCT00001973|Immunohistochemistry|immunohistochemistry
5443173|NCT00001973|PCR|pcr
5443174|NCT00001973|In Situ Hybridization|in situ hybridization
5443175|NCT00001973|Juvenile Dermatomyositis|juvenile dermatomyositis
5443176|NCT00001973|Calcinosis|calcinosis
5443177|NCT00001972|Alzheimer's Disease|alzheimer's disease
5443178|NCT00001972|Positron Emission Tomography|positron emission tomography
5443179|NCT00001972|Brain Phospholipid|brain phospholipid
5443180|NCT00001972|Fatty Acids|fatty acids
5443181|NCT00001972|11C Arachidonate|11c arachidonate
5443182|NCT00001972|Signal Transduction|signal transduction
5443183|NCT00001972|Brain|brain
5443184|NCT00001971|Hepatitis B|hepatitis b
5443185|NCT00001971|Hepatitis C|hepatitis c
5443186|NCT00001971|Hepatitis D|hepatitis d
5443187|NCT00001971|Chronic Cholestatic Syndromes|chronic cholestatic syndromes
5443188|NCT00001971|Primary Biliary Cirrhosis|primary biliary cirrhosis
5443189|NCT00001971|Primary Sclerosing Cholangitis|primary sclerosing cholangitis
5443190|NCT00001971|Non-Alcoholic Steatohepatitis|non-alcoholic steatohepatitis
5443191|NCT00001971|Wilson's Disease|wilson's disease
5443192|NCT00001971|Hemochromatosis|hemochromatosis
5443193|NCT00001971|Liver Biopsy|liver biopsy
5443194|NCT00001971|Noncirrhotic Portal Hypertension|noncirrhotic portal hypertension
5443195|NCT00001971|Liver Disease|liver disease
5443196|NCT00001969|Cardiovascular Disease|cardiovascular disease
5443197|NCT00001969|Glucose Clamp|glucose clamp
5443198|NCT00001969|Hypercortisolism|hypercortisolism
5443199|NCT00001969|Insulin Sensitivity|insulin sensitivity
5443200|NCT00001969|Major Depression Disorder|major depression disorder
5443201|NCT00001969|Inflammation|inflammation
5443202|NCT00001969|Coagulation|coagulation
5443203|NCT00001969|Metabolic|metabolic
5443204|NCT00001969|Insulin|insulin
5443205|NCT00001969|Cytokine|cytokine
5443206|NCT00001969|Depression|depression
5443207|NCT00001969|Volunteer|volunteer
5443208|NCT00001969|Healthy Volunteer|healthy volunteer
5443209|NCT00001967|HIV|hiv
5443210|NCT00001967|HAART|haart
5443211|NCT00001967|Immunity|immunity
5443212|NCT00001967|Toxicity|toxicity
5443213|NCT00001967|Resistance|resistance
5443214|NCT00001967|Treatment Interruption|treatment interruption
5443215|NCT00001964|Hematopoiesis|hematopoiesis
5443216|NCT00001964|Bone Marrow Failure|bone marrow failure
5443217|NCT00001964|Aplastic Anemia|aplastic anemia
5443218|NCT00001962|Immunosuppression|immunosuppression
5443219|NCT00001962|T-cells|t-cells
5443220|NCT00001962|Hematopoiesis|hematopoiesis
5443221|NCT00001962|Monoclonal Antibody Therapy|monoclonal antibody therapy
5443222|NCT00001962|Immunosuppressive Therapy|immunosuppressive therapy
5443223|NCT00001962|Aplastic Anemia|aplastic anemia
5443224|NCT00001961|Myocardial Infarction|myocardial infarction
5443225|NCT00001961|Coronary Artery Disease|coronary artery disease
5443226|NCT00001961|Adenosine|adenosine
5443227|NCT00001961|Stress Testing|stress testing
5443228|NCT00001961|Perfusion|perfusion
5443229|NCT00001960|HCM|hcm
5443230|NCT00001960|Pediatric|pediatric
5443231|NCT00001960|Pacemaker|pacemaker
5443232|NCT00001960|Treatment|treatment
5443233|NCT00001960|Symptoms|symptoms
5443234|NCT00001959|Fibrosis|fibrosis
5443235|NCT00001959|Nephrotic Syndrome|nephrotic syndrome
5443236|NCT00001959|Proteinuria|proteinuria
5443237|NCT00001959|Renal Failure|renal failure
5443238|NCT00001959|TGF-Beta|tgf-beta
5443239|NCT00001959|Focal Segmental Glomerulosclerosis|focal segmental glomerulosclerosis
5443240|NCT00001959|FSGS|fsgs
5443241|NCT00001958|Gamma Gene|gamma gene
5443242|NCT00001958|Hemoglobin Switching|hemoglobin switching
5443243|NCT00001958|Erythropoiesis|erythropoiesis
5443244|NCT00001958|HbE Hemoglobin Chain Synthesis Imbalance|hbe hemoglobin chain synthesis imbalance
5443245|NCT00001958|Cooley's Anemia|cooley's anemia
5443246|NCT00001958|Beta-Thalassemia Intermedia|beta-thalassemia intermedia
5443247|NCT00001957|Ostoacoustic Emission|ostoacoustic emission
5443248|NCT00001957|Central Auditory Processing|central auditory processing
5443249|NCT00001957|CAPD|capd
5443250|NCT00001957|Medial Olivocochlear Bundle|medial olivocochlear bundle
5443251|NCT00001957|Speech Impediment|speech impediment
5443252|NCT00001956|Genetic Markers|genetic markers
5443253|NCT00001956|Thermal Pain|thermal pain
5443254|NCT00001956|Hyperalgesia|hyperalgesia
5443255|NCT00001956|Oral Surgery|oral surgery
5443256|NCT00001956|Cold Pain|cold pain
5443257|NCT00001956|Peripheral Nerve|peripheral nerve
5443258|NCT00001956|Allodynia|allodynia
5443259|NCT00001956|Spinal Cord|spinal cord
5443260|NCT00001956|Personality Traits|personality traits
5443261|NCT00001956|Pain Ratings|pain ratings
5443262|NCT00001955|Clinical Trial|clinical trial
5443263|NCT00001955|Temporomandibular Joints|temporomandibular joints
5443264|NCT00001955|Celecoxib|celecoxib
5443265|NCT00001955|Etanercept|etanercept
5443266|NCT00001955|Tumor Necrosis Factor|tumor necrosis factor
5443267|NCT00001955|TMJ|tmj
5443268|NCT00001955|TMD|tmd
5443269|NCT00001954|Clinical Trial|clinical trial
5443270|NCT00001954|Autoimmune|autoimmune
5443271|NCT00001954|Disease Activity|disease activity
5443272|NCT00001954|Cytokine|cytokine
5443273|NCT00001954|Saliva|saliva
5443274|NCT00001954|Xerostomia|xerostomia
5443275|NCT00001954|Salivary Glands|salivary glands
5443276|NCT00001954|Sjogren's Syndrome|sjogren's syndrome
5443277|NCT00001953|Endocrine System|endocrine system
5443278|NCT00001953|Autoimmunity|autoimmunity
5443279|NCT00001953|Salivary Glands|salivary glands
5443280|NCT00001953|Glucose Tolerance Test|glucose tolerance test
5443281|NCT00001953|Growth Hormone|growth hormone
5443282|NCT00001953|Somatostatin|somatostatin
5443283|NCT00001953|Sjogren's Syndrome|sjogren's syndrome
5443284|NCT00001952|Fentanyl|fentanyl
5443285|NCT00001952|Intraosseous-Anesthesia|intraosseous-anesthesia
5443286|NCT00001952|Endodontics|endodontics
5443287|NCT00001952|Denti Patch|denti patch
5443288|NCT00001952|Pain|pain
5443289|NCT00001952|Chronic Inflammation|chronic inflammation
5443290|NCT00001951|Bone|bone
5443291|NCT00001951|Cognition|cognition
5443292|NCT00001951|Estrogen|estrogen
5443293|NCT00001951|Mood|mood
5443294|NCT00001951|Testosterone|testosterone
5443295|NCT00001951|Osteoporosis|osteoporosis
5443296|NCT00001951|Ovarian Failure|ovarian failure
5443297|NCT00001951|Hormone Replacement Therapy|hormone replacement therapy
5443298|NCT00001951|POF|pof
5443299|NCT00001951|Premature Ovarian Failure|premature ovarian failure
5443300|NCT00001950|Cognition|cognition
5443301|NCT00001950|Infancy|infancy
5443302|NCT00001950|Perception|perception
5443303|NCT00001948|Human Immunodeficiency Virus|human immunodeficiency virus
5443304|NCT00001948|Symptom Distress|symptom distress
5443305|NCT00001948|Immune Function|immune function
5443306|NCT00001948|Medication Trial|medication trial
5443307|NCT00001948|Physical Symptoms|physical symptoms
5443308|NCT00001946|Magnetic Resonance Angiography|magnetic resonance angiography
5443309|NCT00001946|Gadolinium|gadolinium
5443310|NCT00001946|Suburban Hospital|suburban hospital
5443311|NCT00001946|Atherosclerosis|atherosclerosis
5443312|NCT00001941|Interleukin-2 Receptor alpha chain|interleukin-2 receptor alpha chain
5443313|NCT00001941|Interleukin-2|interleukin-2
5443314|NCT00001941|HTLV-I|htlv-i
5443315|NCT00001941|Adult T-Cell Leukemia (ATL)|adult t-cell leukemia (atl)
5443316|NCT00001941|Monoclonal Antibody (Daclizumab, Zenapax)|monoclonal antibody (daclizumab, zenapax)
5443317|NCT00001938|Ovarian Cancer|ovarian cancer
5443318|NCT00001938|Proteomics|proteomics
5443319|NCT00000433|Spondylitis|spondylitis
5443320|NCT00000433|Etanercept|etanercept
5443321|NCT00000433|ENBREL|enbrel
5443322|NCT00000433|Tumor necrosis factor-alpha|tumor necrosis factor-alpha
5443323|NCT00000432|Lyme disease|lyme disease
5443324|NCT00000432|Education evaluation|education evaluation
5443325|NCT00000432|Communicable disease control|communicable disease control
5443326|NCT00000432|Outcomes research|outcomes research
5443327|NCT00000432|Tick-transmitted diseases|tick-transmitted diseases
5443328|NCT00000431|Venous leg ulcer|venous leg ulcer
5443329|NCT00000431|Wound healing|wound healing
5443330|NCT00000431|Somatic gene therapy|somatic gene therapy
5443331|NCT00000431|PDGF-B|pdgf-b
5443332|NCT00000430|Osteoporosis|osteoporosis
5443333|NCT00000430|Osteopenia|osteopenia
5443334|NCT00000430|Postmenopausal women|postmenopausal women
5443335|NCT00000430|Hormone replacement therapy|hormone replacement therapy
5443336|NCT00000430|Alendronate|alendronate
5443337|NCT00000429|JRA|jra
5443338|NCT00000429|Osteopenia|osteopenia
5443339|NCT00000429|Dietary calcium|dietary calcium
5443340|NCT00000429|Diet therapy|diet therapy
5443341|NCT00000429|Bone density|bone density
5443342|NCT00000429|Ossification|ossification
5443343|NCT00000429|Biomarker|biomarker
5443344|NCT00000429|Dietary supplement|dietary supplement
5443345|NCT00000428|Fibromyalgia Syndrome (FMS)|fibromyalgia syndrome (fms)
5443346|NCT00000428|Amitriptyline|amitriptyline
5443347|NCT00000428|Fluoxetine|fluoxetine
5443348|NCT00000427|Parathyroid Hormone (PTH)|parathyroid hormone (pth)
5443349|NCT00000427|Alendronate|alendronate
5443350|NCT00000427|Bone metabolism|bone metabolism
5443351|NCT00000427|Bone mineral density (BMD)|bone mineral density (bmd)
5443352|NCT00000427|Bone loss|bone loss
5443353|NCT00000427|Postmenopausal osteoporosis|postmenopausal osteoporosis
5443354|NCT00000427|Osteoporosis in men|osteoporosis in men
5443355|NCT00000111|mouth mucosa|mouth mucosa
5443356|NCT00000111|transplants|transplants
5443357|NCT00000110|exercise|exercise
5443358|NCT00000110|exertion|exertion
5443359|NCT00000110|physical fitness|physical fitness
5443360|NCT00000110|lipids|lipids
5443361|NCT00000110|nutrition|nutrition
5443362|NCT00000108|exercise|exercise
5443363|NCT00000107|Cyanotic Congenital Heart Disease|cyanotic congenital heart disease
5443364|NCT00000106|Rheumatoid Diseases|rheumatoid diseases
5443365|NCT00000393|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5443366|NCT00000392|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5443367|NCT00000392|AIDS-Related Complex|aids-related complex
5443368|NCT00000391|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5443369|NCT00000391|AIDS-Related Complex|aids-related complex
5443370|NCT00000390|Adult|adult
5443371|NCT00000390|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5443372|NCT00000390|Depression|depression
5443373|NCT00000390|Female|female
5443374|NCT00000390|Human|human
5443375|NCT00000390|Imipramine|imipramine
5443376|NCT00000390|Male|male
5443377|NCT00000390|Middle Age|middle age
5443378|NCT00000390|Acquired Immunodeficiency Syndrome -- *complications|acquired immunodeficiency syndrome -- *complications
5443379|NCT00000390|Depression -- *drug therapy|depression -- *drug therapy
5443380|NCT00000390|Depression -- etiology|depression -- etiology
5443381|NCT00000390|Imipramine -- *therapeutic use|imipramine -- *therapeutic use
5443382|NCT00001936|Neuromuscular Stimulation|neuromuscular stimulation
5443383|NCT00001936|Laryngeal Elevation|laryngeal elevation
5443384|NCT00001936|Dysphagia|dysphagia
5443385|NCT00001936|Stroke|stroke
5443386|NCT00001936|Neuroprosthesis|neuroprosthesis
5443387|NCT00001936|Dysphonia|dysphonia
5443388|NCT00001936|Aspiration|aspiration
5443389|NCT00001936|Motor Control|motor control
5443390|NCT00001936|Videofluoroscopy|videofluoroscopy
5443391|NCT00001936|Upper Esophageal Sphincter|upper esophageal sphincter
5443392|NCT00001936|Healthy Volunteer|healthy volunteer
5443393|NCT00001936|Swallowing Disorders|swallowing disorders
5443394|NCT00001934|Multiple Sclerosis|multiple sclerosis
5443395|NCT00001934|Immunotherapy|immunotherapy
5443396|NCT00001934|MRI|mri
5443397|NCT00001933|Acetylcholine|acetylcholine
5443398|NCT00001933|Clinical Trial|clinical trial
5443399|NCT00001933|GABA|gaba
5443400|NCT00001933|Cognition|cognition
5443401|NCT00001933|Nicotine|nicotine
5443402|NCT00001932|Epilepsy|epilepsy
5443403|NCT00001932|Temporal Lobe|temporal lobe
5443404|NCT00001932|Blood Flow|blood flow
5443405|NCT00001932|Metabolism|metabolism
5443406|NCT00001932|Localization|localization
5443407|NCT00001927|Factor V Leiden|factor v leiden
5443408|NCT00001927|Prothrombin Mutation|prothrombin mutation
5443409|NCT00001927|Antiphospholipids|antiphospholipids
5443410|NCT00001927|Cerebral Infarction|cerebral infarction
5443411|NCT00001927|Thrombophilia|thrombophilia
5443412|NCT00001927|Porencephaly|porencephaly
5443413|NCT00001927|Perinatal Stroke|perinatal stroke
5443414|NCT00001927|Healthy Mothers|healthy mothers
5443415|NCT00001927|Healthy Children|healthy children
5443416|NCT00001926|Plasticity|plasticity
5443417|NCT00001926|Magnetic Stimulation|magnetic stimulation
5443418|NCT00001926|PET|pet
5443419|NCT00001926|Blind|blind
5443420|NCT00001926|Braille|braille
5443421|NCT00001926|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
5443422|NCT00001925|Inferior Olives|inferior olives
5443423|NCT00001925|Calcium Channels|calcium channels
5443424|NCT00001925|Accelerometry|accelerometry
5443425|NCT00001925|Electromyography|electromyography
5443426|NCT00001925|Palatal Tremor|palatal tremor
5443427|NCT00001923|Pain|pain
5443428|NCT00001923|Amputee|amputee
5443429|NCT00001923|Phantom Limb|phantom limb
5443430|NCT00001923|Amputation|amputation
5443431|NCT00001923|Magnetic Stimulation|magnetic stimulation
5443432|NCT00001923|Phantom|phantom
5443433|NCT00001922|Evoked Response|evoked response
5443434|NCT00001922|Spasmodic Dysphonia|spasmodic dysphonia
5443435|NCT00001922|Aerodynamic|aerodynamic
5443436|NCT00001922|Vibration|vibration
5443437|NCT00001922|Laryngeal|laryngeal
5443438|NCT00001922|Voice Disorders|voice disorders
5443439|NCT00001922|Laryngeal Brainstem Evoked Responses|laryngeal brainstem evoked responses
5443440|NCT00001922|Long-latency Responses|long-latency responses
5443441|NCT00001922|Muscular Tension Dysphonia|muscular tension dysphonia
5443442|NCT00001921|Functional Connectivity|functional connectivity
5443443|NCT00001921|Frontotemporal Interaction|frontotemporal interaction
5443444|NCT00001921|Electrophysiology|electrophysiology
5443445|NCT00001921|Functional Magnetic Resonance Imaging|functional magnetic resonance imaging
5443446|NCT00001921|Healthy Subjects|healthy subjects
5443447|NCT00001921|Schizophrenia|schizophrenia
5443448|NCT00001921|MEG|meg
5443449|NCT00001921|Neuroimaging|neuroimaging
5443450|NCT00001921|EEG|eeg
5443451|NCT00001921|MRI|mri
5443452|NCT00001920|Schizophrenia|schizophrenia
5443453|NCT00001920|Eyeblink|eyeblink
5443454|NCT00001920|Evoked Potentials|evoked potentials
5443455|NCT00001920|Learning|learning
5443456|NCT00001920|Normal Volunteer|normal volunteer
5443457|NCT00001920|Healthy Volunteer|healthy volunteer
5443458|NCT00001919|Mechanism of Action|mechanism of action
5443459|NCT00001919|BCIT-SPECT|bcit-spect
5443460|NCT00001919|St. John's Wort|st. john's wort
5443461|NCT00001919|Hypericum Perforatum|hypericum perforatum
5443462|NCT00001919|Depression|depression
5443463|NCT00001919|Serotonin|serotonin
5443464|NCT00001919|Dopamine Transporter|dopamine transporter
5443465|NCT00001919|SPECT|spect
5443466|NCT00001919|Brain Disorders|brain disorders
5443467|NCT00001917|Positron Emission Tomography|positron emission tomography
5443468|NCT00001917|Physostigmine|physostigmine
5443469|NCT00001917|Visual Stimulation|visual stimulation
5443470|NCT00001917|Cholinergic Stimulation|cholinergic stimulation
5443471|NCT00001917|[F-18] FP-TZIP|[f-18] fp-tzip
5443472|NCT00001917|Aging|aging
5443473|NCT00001917|Alzheimer's Disease|alzheimer's disease
5443474|NCT00001917|Visual Activation|visual activation
5443475|NCT00001915|Cortical Stimulation|cortical stimulation
5443476|NCT00001915|Motor Control|motor control
5443477|NCT00001915|Neuromotor Maturation|neuromotor maturation
5443478|NCT00001915|Magnetic Stimulation|magnetic stimulation
5443479|NCT00001915|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
5443480|NCT00001915|Hearing Loss|hearing loss
5443481|NCT00001915|Hearing Conservation|hearing conservation
5443482|NCT00001915|Hearing Protective Devices|hearing protective devices
5443483|NCT00001915|Safety Study|safety study
5443484|NCT00001915|Noise Induced Hearing Loss|noise induced hearing loss
5443485|NCT00001915|Normal Volunteer|normal volunteer
5443486|NCT00001913|Visual Processing|visual processing
5443487|NCT00001913|Functional Magnetic Resonance Imaging|functional magnetic resonance imaging
5443488|NCT00001913|Maternal Behavior|maternal behavior
5443489|NCT00001913|Attachment|attachment
5443490|NCT00001913|Bereavement|bereavement
5443491|NCT00001912|Cysticercosis|cysticercosis
5443492|NCT00001912|T. Solium|t. solium
5443493|NCT00001912|MRI|mri
5443494|NCT00001912|Seizures|seizures
5443495|NCT00001912|Calcified Cysts|calcified cysts
5443496|NCT00001912|Taenia|taenia
5443497|NCT00001911|Cytokine|cytokine
5443498|NCT00001911|Interferon Gamma|interferon gamma
5443499|NCT00001911|Pulmonary|pulmonary
5443500|NCT00001911|Disseminated|disseminated
5443501|NCT00001911|Refractory|refractory
5443502|NCT00001911|Mycobacterial Infection|mycobacterial infection
5443503|NCT00001911|Nontuberculosis Mycobacterial Infection|nontuberculosis mycobacterial infection
5443504|NCT00001911|Pulmonary Nontuberculous Mycobacterial Infection|pulmonary nontuberculous mycobacterial infection
5443505|NCT00001910|T Cells|t cells
5443506|NCT00001910|Allergy|allergy
5443507|NCT00001910|Asthma|asthma
5443508|NCT00001910|Cytokine|cytokine
5443509|NCT00001910|Vaccine|vaccine
5443510|NCT00001905|Neutrophil|neutrophil
5443511|NCT00001905|Immunodeficiency|immunodeficiency
5443512|NCT00001905|Cytokine|cytokine
5443513|NCT00001905|Treatment|treatment
5443514|NCT00001905|Trafficking|trafficking
5443515|NCT00001905|Leukocyte Adhesion Deficiency Type I|leukocyte adhesion deficiency type i
5443516|NCT00001905|LAD I|lad i
5443517|NCT00001901|Vasculitis|vasculitis
5443518|NCT00001901|Prednisone-sparing|prednisone-sparing
5443519|NCT00001901|Methotrexate|methotrexate
5443520|NCT00001901|Tumor Necrosis Factor|tumor necrosis factor
5443521|NCT00001901|Remission|remission
5443522|NCT00001901|Wegener's Granulomatosis|wegener's granulomatosis
5443523|NCT00001899|Viral Suppression|viral suppression
5443524|NCT00001899|Latency|latency
5443525|NCT00001899|AIDS Therapy|aids therapy
5443526|NCT00001899|Viral Relapse|viral relapse
5443527|NCT00001899|Immunodeficiency|immunodeficiency
5443528|NCT00001899|HIV|hiv
5443529|NCT00001899|Treatment Interruption|treatment interruption
5443530|NCT00001898|Melanoma|melanoma
5443531|NCT00001898|Breast Cancer|breast cancer
5443532|NCT00001898|Gene Expression|gene expression
5443533|NCT00001898|DNA Chip Technology|dna chip technology
5443534|NCT00001898|Expressed Sequence Tags|expressed sequence tags
5443535|NCT00001895|Electromechanical Mapping|electromechanical mapping
5443536|NCT00001895|Myocardial Viability|myocardial viability
5443537|NCT00001895|Myocardial Ischemia|myocardial ischemia
5443538|NCT00001895|Positron Emission Tomography|positron emission tomography
5443539|NCT00001895|Magnetic Resonance Imaging|magnetic resonance imaging
5443540|NCT00001894|HCM|hcm
5443541|NCT00001894|Alcohol|alcohol
5443542|NCT00001894|Septal Ablation|septal ablation
5443543|NCT00001894|Pacemaker|pacemaker
5443544|NCT00001893|Bronchoprovocation|bronchoprovocation
5443545|NCT00001893|Airway Inflammation|airway inflammation
5443546|NCT00001893|Tumor Necrosis Factor|tumor necrosis factor
5443547|NCT00001893|Bronchoalveolar Lavage|bronchoalveolar lavage
5443548|NCT00001893|Pulmonary Function Test|pulmonary function test
5443549|NCT00001893|Asthma|asthma
5443550|NCT00001888|Induced Sputum|induced sputum
5443551|NCT00001888|Exhaled Breath Condensate|exhaled breath condensate
5443552|NCT00001888|Fiberoptic Bronchoscopy|fiberoptic bronchoscopy
5443553|NCT00001888|Bronchoscopy|bronchoscopy
5443554|NCT00001888|mRNA|mrna
5443555|NCT00001888|Asthma|asthma
5443556|NCT00001888|Normal Volunteer|normal volunteer
5443557|NCT00001885|Interstitial Lung Disease|interstitial lung disease
5443558|NCT00001885|Inherited Disease|inherited disease
5443559|NCT00001885|Genetic Markers|genetic markers
5443560|NCT00001885|Alpha 1 Protease Inhibitor|alpha 1 protease inhibitor
5443561|NCT00001885|DNA Mutations|dna mutations
5443562|NCT00001885|Rheumatoid Arthritis|rheumatoid arthritis
5443563|NCT00001885|Pulmonary Fibrosis|pulmonary fibrosis
5443564|NCT00001885|Normal Volunteer|normal volunteer
5443565|NCT00001884|Bronchoscopy|bronchoscopy
5443566|NCT00001884|Idiopathic Pulmonary Fibrosis|idiopathic pulmonary fibrosis
5443567|NCT00001884|Proteases|proteases
5443568|NCT00001884|Fibroblast Proliferation|fibroblast proliferation
5443569|NCT00001884|Reactive Proteins|reactive proteins
5443570|NCT00001884|Rheumatoid Arthritis|rheumatoid arthritis
5443571|NCT00001884|Pulmonary Fibrosis|pulmonary fibrosis
5443572|NCT00001883|Treadmill|treadmill
5443573|NCT00001883|Bicycle|bicycle
5443574|NCT00001883|Lung Function|lung function
5443575|NCT00001883|Physiology|physiology
5443576|NCT00001883|Quality Control|quality control
5443577|NCT00001883|Normal Volunteers|normal volunteers
5443578|NCT00001880|Engraftment|engraftment
5443579|NCT00001880|Peripheral Blood Stem Cells|peripheral blood stem cells
5443580|NCT00001880|Non-Myeloablative Bone Marrow Transplantation|non-myeloablative bone marrow transplantation
5443581|NCT00001880|Metastatic Solid Tumors|metastatic solid tumors
5443582|NCT00001880|Graft-Versus-Host Disease|graft-versus-host disease
5443583|NCT00001880|Cancer|cancer
5443584|NCT00001880|Tumor|tumor
5443585|NCT00001878|Growth Hormone|growth hormone
5443586|NCT00001878|Cardiac Hypertrophy|cardiac hypertrophy
5443587|NCT00001878|Hypertrophic Cardiomyopathy|hypertrophic cardiomyopathy
5443588|NCT00001878|Sarcomeric Gene Mutations|sarcomeric gene mutations
5443589|NCT00001877|Tumor Necrosis Factor|tumor necrosis factor
5443590|NCT00001877|Corticosteroids|corticosteroids
5443591|NCT00001877|Macrophages|macrophages
5443592|NCT00001877|Phosphodiesterase|phosphodiesterase
5443593|NCT00001877|Autoimmune|autoimmune
5443594|NCT00001877|Pulmonary Sarcoidosis|pulmonary sarcoidosis
5443595|NCT00001876|Interstitial Lung Disease|interstitial lung disease
5443596|NCT00001876|Collagen Vascular Disease|collagen vascular disease
5443597|NCT00001876|Extracellular Matrix|extracellular matrix
5443598|NCT00001876|Pulmonary Function|pulmonary function
5443599|NCT00001876|DTPA Lung Clearance Scan|dtpa lung clearance scan
5443600|NCT00001876|Rheumatoid Arthritis|rheumatoid arthritis
5443601|NCT00001876|Pulmonary Fibrosis|pulmonary fibrosis
5443602|NCT00001876|Idiopathic Pulmonary Fibrosis|idiopathic pulmonary fibrosis
5443603|NCT00001874|Imaging|imaging
5443604|NCT00001874|Spectroscopy|spectroscopy
5443605|NCT00001874|MRI|mri
5443606|NCT00001874|Cardiovascular|cardiovascular
5443607|NCT00001874|Technical Development|technical development
5443608|NCT00001874|Safety|safety
5443609|NCT00001874|Gadolinium|gadolinium
5443610|NCT00001874|Heart|heart
5443611|NCT00001874|Toxicity|toxicity
5443612|NCT00001874|Adverse Events|adverse events
5443613|NCT00001874|Normal Volunteer|normal volunteer
5443614|NCT00001873|Peripheral Blood Stem Cells|peripheral blood stem cells
5443615|NCT00001873|Cyclosporine|cyclosporine
5443616|NCT00001873|Cyclosphosphamide|cyclosphosphamide
5443617|NCT00001873|Whole Body Irradiation|whole body irradiation
5443618|NCT00001873|Donor Apheresis|donor apheresis
5443619|NCT00001873|Leukemic Relapse|leukemic relapse
5443620|NCT00001873|Graft vs. Host Disease|graft vs. host disease
5443621|NCT00001873|Graft-Versus-Leukemia|graft-versus-leukemia
5443622|NCT00001873|Graft-Versus-Myeloma|graft-versus-myeloma
5443623|NCT00001873|Chronic Myelogenous Leukemia|chronic myelogenous leukemia
5443624|NCT00001873|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
5443625|NCT00001873|Acute Myelogenous Leukemia|acute myelogenous leukemia
5443626|NCT00001873|Myelodysplastic Syndromes|myelodysplastic syndromes
5443627|NCT00001873|Multiple Myeloma|multiple myeloma
5443628|NCT00001873|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
5443629|NCT00001873|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
5443630|NCT00001872|Volunteer|volunteer
5443631|NCT00001872|Leukocyte Donors|leukocyte donors
5443632|NCT00001872|Family Members|family members
5443633|NCT00001872|Leukocyte Collection|leukocyte collection
5443634|NCT00001872|No Reimbursement|no reimbursement
5443635|NCT00001870|Insulin Resistance|insulin resistance
5443636|NCT00001870|Oxidative Stress|oxidative stress
5443637|NCT00001870|Antioxidant|antioxidant
5443638|NCT00001870|Endothelial Function|endothelial function
5443639|NCT00001870|Glucose Clamp|glucose clamp
5443640|NCT00001870|Type 2 Diabetes|type 2 diabetes
5443641|NCT00001870|Vitamin C Deficiency|vitamin c deficiency
5443642|NCT00001869|Progesterone|progesterone
5443643|NCT00001869|Pulmonary Function Tests|pulmonary function tests
5443644|NCT00001869|Pneumothorax|pneumothorax
5443645|NCT00001869|Oopherectomy|oopherectomy
5443646|NCT00001869|High Resolution CT|high resolution ct
5443647|NCT00001869|Tuberous Sclerosis Complex|tuberous sclerosis complex
5443648|NCT00001869|Lymphangioleiomyomatosis (LAM)|lymphangioleiomyomatosis (lam)
5443649|NCT00001865|Behcet's|behcet's
5443650|NCT00001865|Monoclonal Antibody|monoclonal antibody
5443651|NCT00001865|Uveitis|uveitis
5443652|NCT00001865|Interleukin 2|interleukin 2
5443653|NCT00001865|Retinal Vasculitis|retinal vasculitis
5443654|NCT00001865|Hyopyon|hyopyon
5443655|NCT00001865|Interleukin 2 Receptor|interleukin 2 receptor
5443656|NCT00001865|Bechet's Disease|bechet's disease
5443657|NCT00001865|Ocular Disease|ocular disease
5443658|NCT00001863|Immunosuppression|immunosuppression
5443659|NCT00001863|Inflammation|inflammation
5443660|NCT00001863|Eye|eye
5443661|NCT00001863|Vision|vision
5443662|NCT00001863|Medication|medication
5443663|NCT00001863|Uveitis|uveitis
5443664|NCT00001863|Leflunomide|leflunomide
5443665|NCT00001863|Vitritis|vitritis
5443666|NCT00001862|Ocular Inflammation|ocular inflammation
5443667|NCT00001862|Children|children
5443668|NCT00001862|Immunotherapy|immunotherapy
5443669|NCT00001862|Cytokine|cytokine
5443670|NCT00001862|Clinical Trial|clinical trial
5443671|NCT00001862|Uveitis|uveitis
5443672|NCT00001862|Immunosuppression|immunosuppression
5443673|NCT00001862|Joint|joint
5443674|NCT00001862|Inflammation|inflammation
5443675|NCT00001861|Eye Movements|eye movements
5443676|NCT00001861|Amblyopia|amblyopia
5443677|NCT00001861|Orthoptics|orthoptics
5443678|NCT00001861|Lazy Eye|lazy eye
5443679|NCT00001861|Eye Development|eye development
5443680|NCT00001861|Nystagmus|nystagmus
5443681|NCT00001861|Strabismus|strabismus
5443682|NCT00001861|Screening Protocol|screening protocol
5443683|NCT00001861|Eye Movement Disorders|eye movement disorders
5443684|NCT00001860|Growth Hormone|growth hormone
5443685|NCT00001860|Somatostatin|somatostatin
5443686|NCT00001860|Insulin-like Growth Factor-One|insulin-like growth factor-one
5443687|NCT00001860|Acromegaly|acromegaly
5443688|NCT00001860|Macroadenoma|macroadenoma
5443689|NCT00001859|Evaluation|evaluation
5443690|NCT00001859|Diabetes|diabetes
5443691|NCT00001859|Renal Failure|renal failure
5443692|NCT00001858|Biopsy|biopsy
5443693|NCT00001858|Immune System|immune system
5443694|NCT00001858|Renal|renal
5443695|NCT00001856|Living Donor|living donor
5443696|NCT00001856|Transplantation|transplantation
5443697|NCT00001856|Nephrectomy|nephrectomy
5443698|NCT00001854|Ribavirin|ribavirin
5443699|NCT00001854|Liver Disease|liver disease
5443700|NCT00001854|Antiviral Agent|antiviral agent
5443701|NCT00001854|Cirrhosis|cirrhosis
5443702|NCT00001854|Chronic Hepatitis|chronic hepatitis
5443703|NCT00001854|Iron|iron
5443704|NCT00001854|Viral Hepatitis|viral hepatitis
5443705|NCT00001854|Hepatitis C Virus|hepatitis c virus
5443706|NCT00001854|Hemolytic Anemia|hemolytic anemia
5443707|NCT00001854|Hemolysis|hemolysis
5443708|NCT00001853|Healthy Volunteers|healthy volunteers
5443709|NCT00001853|Health Disparities|health disparities
5443710|NCT00001853|Diabetes|diabetes
5443711|NCT00001853|Cardiovascular Disease|cardiovascular disease
5443712|NCT00001852|Xerostomia|xerostomia
5443713|NCT00001852|Oral Dryness|oral dryness
5443714|NCT00001852|Salivary Function|salivary function
5443715|NCT00001851|Marrow|marrow
5443716|NCT00001851|Grafting|grafting
5443717|NCT00001851|Imaging|imaging
5443718|NCT00001851|Injection|injection
5443719|NCT00001851|Aspiration|aspiration
5443720|NCT00001851|Bone Marrow Stromal Cells|bone marrow stromal cells
5443721|NCT00001851|Bone Grafting|bone grafting
5443722|NCT00001851|Bone Graft Substitutes|bone graft substitutes
5443723|NCT00001851|Bio and Pharmacological Regulators of Bone Turnover|bio and pharmacological regulators of bone turnover
5443724|NCT00001850|Training|training
5443725|NCT00001850|Reproduction|reproduction
5443726|NCT00001850|Infertility|infertility
5443727|NCT00001850|Women's Health|women's health
5443728|NCT00001850|Hormone|hormone
5443729|NCT00001849|PET|pet
5443730|NCT00001849|(18F)-DOPA|(18f)-dopa
5443731|NCT00001849|Pentetreotide|pentetreotide
5443732|NCT00001849|ACTH|acth
5443733|NCT00001849|Octreotide|octreotide
5443734|NCT00001849|Cushing's Syndrome|cushing's syndrome
5443735|NCT00001849|Ectopic Cushing Syndrome|ectopic cushing syndrome
5443736|NCT00001848|Estrogen Receptor|estrogen receptor
5443737|NCT00001848|Laparoscopy|laparoscopy
5443738|NCT00001848|Surgical Excision|surgical excision
5443739|NCT00001848|Raloxifene|raloxifene
5443740|NCT00001848|Selective Estrogen Receptor Modulator|selective estrogen receptor modulator
5443741|NCT00001848|Estrogen|estrogen
5443742|NCT00001848|Endometriosis|endometriosis
5443743|NCT00001848|Pelvic Pain|pelvic pain
5443744|NCT00001846|Volunteer Donor|volunteer donor
5443745|NCT00001846|Research Samples|research samples
5443746|NCT00001846|Leukapheresis|leukapheresis
5443747|NCT00001846|Plateletpheresis|plateletpheresis
5443748|NCT00001846|Plasmapheresis|plasmapheresis
5443749|NCT00001846|Healthy Volunteer|healthy volunteer
5443750|NCT00001846|Normal Volunteer|normal volunteer
5443751|NCT00001845|MRI|mri
5443752|NCT00001845|Cerebral Blood Flow|cerebral blood flow
5443753|NCT00001845|CO2 Inhalation|co2 inhalation
5443754|NCT00001845|Acetazolamide|acetazolamide
5443755|NCT00001845|Perfusion|perfusion
5443756|NCT00001845|Healthy Volunteer|healthy volunteer
5443757|NCT00001844|MRI/MRS|mri/mrs
5443758|NCT00001844|Functional MRI|functional mri
5443759|NCT00001844|Metabolic Imaging|metabolic imaging
5443760|NCT00001844|Brain|brain
5443761|NCT00001844|Healthy Volunteer|healthy volunteer
5443762|NCT00001842|Granulocytes|granulocytes
5443763|NCT00001842|Granulocyte Colony Stimulating Factor|granulocyte colony stimulating factor
5443764|NCT00001842|Granulocyte Transfusion Factor|granulocyte transfusion factor
5443765|NCT00001842|Apheresis|apheresis
5443766|NCT00001842|Blood Donors|blood donors
5443767|NCT00001842|Healthy Volunteer|healthy volunteer
5443768|NCT00001841|Arteriosclerosis|arteriosclerosis
5443769|NCT00001841|Imaging|imaging
5443770|NCT00001841|MRA|mra
5443771|NCT00001841|Narrowing of Vessels|narrowing of vessels
5443772|NCT00001841|Hardening of Arteries|hardening of arteries
5443773|NCT00001837|Sonohysterography|sonohysterography
5443774|NCT00001837|Color Doppler Sonography|color doppler sonography
5443775|NCT00001837|Endometrium|endometrium
5443776|NCT00001837|Gynecologic|gynecologic
5443777|NCT00001837|Menstrual Cycle|menstrual cycle
5443778|NCT00001837|Premenopause|premenopause
5443779|NCT00001836|Coronary Artery Disease|coronary artery disease
5443780|NCT00001836|EBCT|ebct
5443781|NCT00001836|Volumetric Scan|volumetric scan
5443782|NCT00001836|Coronary Artery Calcium|coronary artery calcium
5443783|NCT00001836|Prospective Gating|prospective gating
5443784|NCT00001835|Renal Dysfunction|renal dysfunction
5443785|NCT00001835|Pharmacokinetics|pharmacokinetics
5443786|NCT00001835|Platinum Analogues|platinum analogues
5443787|NCT00001835|Renal Cancer|renal cancer
5443788|NCT00001835|Kidney Cancer|kidney cancer
5443789|NCT00001832|Immunotherapy|immunotherapy
5443790|NCT00001832|Adoptive Transfer|adoptive transfer
5443791|NCT00001832|IL-2|il-2
5443792|NCT00001832|Toxicity|toxicity
5443793|NCT00001832|Clinical Response|clinical response
5443794|NCT00001832|Breast Cancer|breast cancer
5443795|NCT00001830|Bone Marrow Transplantation|bone marrow transplantation
5443796|NCT00001830|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
5443797|NCT00001830|Immunotherapy|immunotherapy
5443798|NCT00001830|Lymphoma|lymphoma
5443799|NCT00001830|Multiple Myeloma|multiple myeloma
5443800|NCT00001830|Graft vs. Host Disease|graft vs. host disease
5443801|NCT00001830|Lymphoid Malignancy|lymphoid malignancy
5443802|NCT00001830|Leukemia|leukemia
5443803|NCT00001827|Immunotherapy|immunotherapy
5443804|NCT00001827|Cancer|cancer
5443805|NCT00001827|Oncogenes|oncogenes
5443806|NCT00001827|T-cells|t-cells
5443807|NCT00001827|Vaccine Therapy|vaccine therapy
5443808|NCT00001827|p53 Peptide|p53 peptide
5443809|NCT00001827|Ovarian Cancer|ovarian cancer
5443810|NCT00001826|CD-4-Naive T Cells|cd-4-naive t cells
5443811|NCT00001826|CD-4-Memory T Cells|cd-4-memory t cells
5443812|NCT00001826|Antiviral Activity|antiviral activity
5443813|NCT00001826|VB Repertoire|vb repertoire
5443814|NCT00001826|Immunizations|immunizations
5443815|NCT00001826|HIV|hiv
5443816|NCT00001826|Treatment Experienced|treatment experienced
5443817|NCT00001823|Cancer|cancer
5443818|NCT00001823|Gene Therapy|gene therapy
5443819|NCT00001823|Immunotherapy|immunotherapy
5443820|NCT00001823|Melanoma|melanoma
5443821|NCT00001823|Clinical Trial|clinical trial
5443822|NCT00001813|Xeroderma Pigmentosum|xeroderma pigmentosum
5443823|NCT00001813|Trichothiodystrophy|trichothiodystrophy
5443824|NCT00001813|Cockayne Syndrome|cockayne syndrome
5443825|NCT00001813|Skin Cancer|skin cancer
5443826|NCT00001813|DNA Repair|dna repair
5443827|NCT00001807|CNS directed therapy|cns directed therapy
5443828|NCT00001807|Neurotoxicity|neurotoxicity
5443829|NCT00001807|H-NMRS|h-nmrs
5443830|NCT00001807|MRI|mri
5443831|NCT00001806|Genetic Testing|genetic testing
5443832|NCT00001806|Genetic Counseling|genetic counseling
5443833|NCT00001806|BRCA1/BRCA2|brca1/brca2
5443834|NCT00001806|Genetic Education|genetic education
5443835|NCT00001806|Informed Consent|informed consent
5443836|NCT00001806|Breast Cancer|breast cancer
5443837|NCT00001806|Ovarian Cancer|ovarian cancer
5443838|NCT00001806|Known Family Mutation|known family mutation
5443839|NCT00001803|Gene-Environment Interaction|gene-environment interaction
5443840|NCT00001803|Kidney Cancer|kidney cancer
5443841|NCT00001803|VHL|vhl
5443842|NCT00001803|Genetic Epidemiology|genetic epidemiology
5443843|NCT00001788|Cytokine|cytokine
5443844|NCT00001788|Stat|stat
5443845|NCT00001788|Jak|jak
5443846|NCT00001788|IL-12|il-12
5443847|NCT00001788|Mutation|mutation
5443848|NCT00001788|Immunodeficiency|immunodeficiency
5443849|NCT00001785|HTLV-1-Associated Myelopathy|htlv-1-associated myelopathy
5443850|NCT00001785|Virus|virus
5443851|NCT00001785|Spontaneous Proliferation|spontaneous proliferation
5443852|NCT00001784|Blepharospasm|blepharospasm
5443853|NCT00001784|Writer's Cramp|writer's cramp
5443854|NCT00001784|Muscle Spindle Afferents|muscle spindle afferents
5443855|NCT00001784|Sodium Channels|sodium channels
5443856|NCT00001784|Sensorimotor Integration|sensorimotor integration
5443857|NCT00001784|Focal Dystonia|focal dystonia
5443858|NCT00001783|Rehabilitation|rehabilitation
5443859|NCT00001783|Plasticity|plasticity
5443860|NCT00001783|Stroke|stroke
5443861|NCT00001783|Amphetamine|amphetamine
5443862|NCT00001783|Motor|motor
5443863|NCT00001783|Hemiparetic|hemiparetic
5443864|NCT00001783|Thromboembolic Non-Hemorrhagic Infarction|thromboembolic non-hemorrhagic infarction
5443865|NCT00001781|Multiple Sclerosis|multiple sclerosis
5443866|NCT00001781|Immunology|immunology
5443867|NCT00001781|Treatment|treatment
5443868|NCT00001780|Myelopathy|myelopathy
5443869|NCT00001780|Demyelination|demyelination
5443870|NCT00001780|Leukodystrophy|leukodystrophy
5443871|NCT00001780|Motor Neuron Disease|motor neuron disease
5443872|NCT00001780|Movement Disorders|movement disorders
5443873|NCT00001780|Normal Volunteer|normal volunteer
5443874|NCT00001778|Immune Response|immune response
5443875|NCT00001778|Sero-Indeterminant|sero-indeterminant
5443876|NCT00001778|Transmission|transmission
5443877|NCT00001778|Tropical Spastic Paraparesis|tropical spastic paraparesis
5443878|NCT00001778|Viral Load|viral load
5443879|NCT00001778|HTLV-I|htlv-i
5443880|NCT00001778|HAM/TSP|ham/tsp
5443881|NCT00001776|Magnetic Stimulation|magnetic stimulation
5443882|NCT00001776|Plasticity|plasticity
5443883|NCT00001776|SRTT|srtt
5443884|NCT00001776|Sequence|sequence
5443885|NCT00001776|Implicit Memory|implicit memory
5443886|NCT00001776|Explicit Memory|explicit memory
5443887|NCT00001776|Memory|memory
5443888|NCT00001776|Parkinson's Disease|parkinson's disease
5443889|NCT00001776|Cerebellar Deficit|cerebellar deficit
5443890|NCT00001776|Frontal Lobe Lesions|frontal lobe lesions
5443891|NCT00001776|Frontal Lobe Dementia|frontal lobe dementia
5443892|NCT00001776|Normal Volunteer|normal volunteer
5443893|NCT00001771|Receptors|receptors
5443894|NCT00001771|Re-Uptake|re-uptake
5443895|NCT00001771|Neurotransmitters|neurotransmitters
5443896|NCT00001771|Neuroimaging|neuroimaging
5443897|NCT00001771|Drug Abuse|drug abuse
5443898|NCT00001771|Serotonin|serotonin
5443899|NCT00001771|Brain Scan|brain scan
5443900|NCT00001771|Tourette's Syndrome|tourette's syndrome
5443901|NCT00001771|Obsessive Compulsive Disorder|obsessive compulsive disorder
5443902|NCT00001771|Schizophrenia|schizophrenia
5443903|NCT00001771|Normal Volunteer|normal volunteer
5443904|NCT00001770|Depression|depression
5443905|NCT00001770|Estrogen|estrogen
5443906|NCT00001770|Hormone Replacement Therapy|hormone replacement therapy
5443907|NCT00001770|Mood|mood
5443908|NCT00001770|Progestin|progestin
5443909|NCT00001770|Progesterone|progesterone
5443910|NCT00001770|Anxiety|anxiety
5443911|NCT00001766|Abacavir|abacavir
5443912|NCT00001766|Salvage|salvage
5443913|NCT00001766|Drug Interaction|drug interaction
5443914|NCT00001766|Drug Levels|drug levels
5443915|NCT00001766|Anti-Viral|anti-viral
5443916|NCT00001766|HIV|hiv
5443917|NCT00001765|Engraftment|engraftment
5443918|NCT00001765|Minitransplant|minitransplant
5443919|NCT00001765|Fludarabine|fludarabine
5443920|NCT00001765|Neutrophil|neutrophil
5443921|NCT00001765|Allogenic|allogenic
5443922|NCT00001765|Donor Apheresis|donor apheresis
5443923|NCT00001765|Anti-Thymocyte Globin|anti-thymocyte globin
5443924|NCT00001765|Cyclophosphamide|cyclophosphamide
5443925|NCT00001765|Nonmyeloablative Bone Marrow Transplantation|nonmyeloablative bone marrow transplantation
5443926|NCT00001765|Graft-versus-host Disease|graft-versus-host disease
5443927|NCT00001765|Chronic Granulomatous Disease|chronic granulomatous disease
5443928|NCT00001764|Alternative agent|alternative agent
5443929|NCT00001764|Purine Antimetabolite|purine antimetabolite
5443930|NCT00001764|Immunosuppressive|immunosuppressive
5443931|NCT00001764|Previous relapse|previous relapse
5443932|NCT00001764|Drug Intolerance|drug intolerance
5443933|NCT00001764|Wegener's Granulomatosis|wegener's granulomatosis
5443934|NCT00001762|Protease Inhibitor|protease inhibitor
5443935|NCT00001762|HIV Infection|hiv infection
5443936|NCT00001762|Appearance|appearance
5443937|NCT00001762|Subcutaneous Fat|subcutaneous fat
5443938|NCT00001762|Facial Wasting|facial wasting
5443939|NCT00001760|Stem Cell Factor|stem cell factor
5443940|NCT00001760|Cytokine|cytokine
5443941|NCT00001760|Chemokines|chemokines
5443942|NCT00001760|Chemotaxis|chemotaxis
5443943|NCT00001760|Mast Cells|mast cells
5443944|NCT00001760|Normal Volunteer|normal volunteer
5443945|NCT00001760|Systemic Mastocytosis|systemic mastocytosis
5443946|NCT00001760|Atopic Dermatitis|atopic dermatitis
5443947|NCT00001758|Antiretroviral|antiretroviral
5443948|NCT00001758|HIV-1|hiv-1
5443949|NCT00001758|1592U89|1592u89
5443950|NCT00001758|141W94|141w94
5443951|NCT00001758|DMP 266|dmp 266
5443952|NCT00001756|Leukapheresis|leukapheresis
5443953|NCT00001756|Mastocytosis|mastocytosis
5443954|NCT00001756|G-CSF|g-csf
5443955|NCT00001756|Mast Cells|mast cells
5443956|NCT00001756|Normal Volunteer|normal volunteer
5443957|NCT00001756|Systemic Mastocytosis|systemic mastocytosis
5443963|NCT00001750|Gene Transfer|gene transfer
5443964|NCT00001750|Retroviral Receptor|retroviral receptor
5443965|NCT00001750|Stem Cell Expansion|stem cell expansion
5443966|NCT00001750|Multiple Myeloma|multiple myeloma
5443967|NCT00001749|Immune Suppression|immune suppression
5443968|NCT00001749|Erythroid Hypoplasia|erythroid hypoplasia
5443969|NCT00001749|Congenital Anemia|congenital anemia
5443970|NCT00001749|Reticulocytopenia|reticulocytopenia
5443971|NCT00001749|Diamond Blackfan Anemia|diamond blackfan anemia
5443972|NCT00001746|Hypertrophic Cardiomyopathy|hypertrophic cardiomyopathy
5443973|NCT00001746|HCM|hcm
5443974|NCT00001746|Evaluation for Research|evaluation for research
5443975|NCT00001746|Medical Advice|medical advice
5443976|NCT00001741|Angiotensin II Receptor|angiotensin ii receptor
5443977|NCT00001741|Polymorphism, Genetic|polymorphism, genetic
5443978|NCT00001741|Vascular Tone|vascular tone
5443979|NCT00001741|Angiotensin II|angiotensin ii
5443980|NCT00001741|Losartan|losartan
5443981|NCT00001737|Eye|eye
5443982|NCT00001737|Immunosuppression|immunosuppression
5443983|NCT00001737|Inflammation|inflammation
5443984|NCT00001737|Therapy|therapy
5443985|NCT00001737|Vitreous|vitreous
5443986|NCT00001737|Uveitis|uveitis
5443987|NCT00001734|Uveitis|uveitis
5443988|NCT00001734|Conjunctivitis|conjunctivitis
5443989|NCT00001734|Iritis|iritis
5443990|NCT00001734|Retinitis|retinitis
5443991|NCT00001734|Keratitis|keratitis
5443992|NCT00001734|Screening Protocol|screening protocol
5443993|NCT00001734|Ocular Immunology|ocular immunology
5443994|NCT00001734|Inflammation|inflammation
5443995|NCT00001734|Eye Inflammation|eye inflammation
5443996|NCT00001733|Diabetic Retinopathy|diabetic retinopathy
5443997|NCT00001733|Age-Related Macular Degeneration|age-related macular degeneration
5443998|NCT00001733|Neovascularization|neovascularization
5443999|NCT00001733|Macular Degeneration|macular degeneration
5444000|NCT00001733|Retinal Disease|retinal disease
5444001|NCT00001733|Diabetes|diabetes
5444002|NCT00001732|Genetics|genetics
5444003|NCT00001732|Diagnosis|diagnosis
5444004|NCT00001732|Screening Protocol|screening protocol
5444005|NCT00001732|Ophthalmic Genetic Diseases|ophthalmic genetic diseases
5444006|NCT00001732|Genetic Testing|genetic testing
5444007|NCT00001732|Family Studies|family studies
5444008|NCT00001729|Cirrhosis|cirrhosis
5444009|NCT00001729|Liver Disease|liver disease
5444010|NCT00001729|Hemolytic Anemia|hemolytic anemia
5444011|NCT00001729|Liver Biopsy|liver biopsy
5444012|NCT00001729|Ribavirin|ribavirin
5444013|NCT00001729|Alpha Interferon|alpha interferon
5444014|NCT00001729|Viral Hepatitis|viral hepatitis
5444015|NCT00001729|Hepatitis C Virus|hepatitis c virus
5444016|NCT00001729|Chronic Hepatitis|chronic hepatitis
5444017|NCT00001729|Antiviral Agents|antiviral agents
5444018|NCT00001728|Bone Marrow Stromal Cells|bone marrow stromal cells
5444019|NCT00001728|Bone Turnover|bone turnover
5444020|NCT00001728|Fibrous Dysplastic Lesion|fibrous dysplastic lesion
5444021|NCT00001728|Polyostotic Fibrous Dysplasia|polyostotic fibrous dysplasia
5444022|NCT00001728|McCune-Albright Syndrome|mccune-albright syndrome
5444023|NCT00001727|Fibrous Dysplasia (FD)|fibrous dysplasia (fd)
5444024|NCT00001727|McCune-Albright Syndrome|mccune-albright syndrome
5444025|NCT00001727|Polyostotic Fibrous Dysplasia|polyostotic fibrous dysplasia
5444026|NCT00001726|Bacterial Colonization|bacterial colonization
5444027|NCT00001726|Plaque|plaque
5444028|NCT00001726|Mouth|mouth
5444029|NCT00001726|Saliva|saliva
5444030|NCT00001726|Adhesion|adhesion
5444031|NCT00001726|Dental Plaque Formation|dental plaque formation
5444032|NCT00001726|Dental Caries|dental caries
5444033|NCT00001725|Trigeminal Neuralgia|trigeminal neuralgia
5444034|NCT00001725|Dextromethorphan|dextromethorphan
5444035|NCT00001725|Topiramate|topiramate
5444036|NCT00001725|Orofacial Pain|orofacial pain
5444037|NCT00001725|Neuropathic Pain|neuropathic pain
5444038|NCT00001725|Facial Neuralgia|facial neuralgia
5444039|NCT00001724|Pain|pain
5444040|NCT00001724|Microencapsulated Drug|microencapsulated drug
5444041|NCT00001724|NSAID|nsaid
5444042|NCT00001724|Acute Inflammation|acute inflammation
5444043|NCT00001724|Peripheral Administration|peripheral administration
5444044|NCT00001724|Dose-Response|dose-response
5444045|NCT00001724|Relative Potency Assay|relative potency assay
5444046|NCT00001724|Pharmacokinetics|pharmacokinetics
5444047|NCT00001723|Dyslipidemia|dyslipidemia
5444048|NCT00001723|Race|race
5444049|NCT00001723|Body Fat|body fat
5444050|NCT00001723|Visceral Fat|visceral fat
5444051|NCT00001723|Sleep Apnea|sleep apnea
5444052|NCT00001723|Fat-Soluble Vitamins|fat-soluble vitamins
5444053|NCT00001723|Type 2 Diabetes|type 2 diabetes
5444054|NCT00001723|Obesity|obesity
5444055|NCT00001723|Childhood Obesity|childhood obesity
5444056|NCT00001722|Obesity|obesity
5444057|NCT00001722|Sympathetic Nervous System|sympathetic nervous system
5444058|NCT00001722|Fat Tissue|fat tissue
5444059|NCT00001722|Metabolism|metabolism
5444060|NCT00001722|Adipose Tissue|adipose tissue
5444061|NCT00001722|Microdialysis|microdialysis
5444062|NCT00001722|Leptin|leptin
5444063|NCT00001722|Lipolysis|lipolysis
5444064|NCT00001722|Normal Volunteer|normal volunteer
5444065|NCT00001721|Dysmorphology|dysmorphology
5444069|NCT00001721|Demyelination|demyelination
5444070|NCT00001721|Smith-Lemli-Opitz Syndrome (SLO)|smith-lemli-opitz syndrome (slo)
5444071|NCT00001720|Glucocorticoids|glucocorticoids
5444072|NCT00001720|Bone Mineral Density|bone mineral density
5444073|NCT00001720|Bisphosphonates|bisphosphonates
5444074|NCT00001720|Vertebral Fracture|vertebral fracture
5444075|NCT00001720|Childhood Osteoporosis|childhood osteoporosis
5444076|NCT00001719|Blood Flow|blood flow
5444077|NCT00001719|Hepatic Disease|hepatic disease
5444078|NCT00001719|Liver|liver
5444079|NCT00001719|Modeling|modeling
5444080|NCT00001719|Rheology|rheology
5444081|NCT00001719|Normal Volunteer|normal volunteer
5444082|NCT00001716|Hemoglobin|hemoglobin
5444083|NCT00001716|P50|p50
5444084|NCT00001716|Microvascular|microvascular
5444085|NCT00001716|Perfusion|perfusion
5444086|NCT00001716|Magnetic Resonance Imaging|magnetic resonance imaging
5444087|NCT00001716|Sickle Cell Anemia|sickle cell anemia
5444088|NCT00001715|Consultation|consultation
5444089|NCT00001715|Training|training
5444090|NCT00001715|Referral|referral
5444091|NCT00001715|Fellowship Program|fellowship program
5444092|NCT00001715|Outpatient|outpatient
5444093|NCT00001715|Blood Disorder|blood disorder
5444094|NCT00001713|rtPA|rtpa
5444095|NCT00001713|Catheter Directed|catheter directed
5444096|NCT00001713|Thrombolysis|thrombolysis
5444097|NCT00001713|Anticoagulation|anticoagulation
5444098|NCT00001713|Emboli|emboli
5444099|NCT00001713|Acute Deep Venous Thrombosis|acute deep venous thrombosis
5444100|NCT00001713|TPA|tpa
5444101|NCT00001713|DVT|dvt
5444102|NCT00001712|Healthcare Worker|healthcare worker
5444103|NCT00001712|Bloodborne Diseases|bloodborne diseases
5444104|NCT00001712|Hepatitis B|hepatitis b
5444105|NCT00001712|Hepatitis C|hepatitis c
5444106|NCT00001712|Human Immunodeficiency Virus|human immunodeficiency virus
5444107|NCT00001712|Parenteral Exposure|parenteral exposure
5444108|NCT00001712|Non-Parenteral Exposure|non-parenteral exposure
5444109|NCT00001712|Blood and Body Substances|blood and body substances
5444110|NCT00001712|Universal Precautions|universal precautions
5444111|NCT00001712|HIV Seronegativity|hiv seronegativity
5444112|NCT00001711|Magnetic Resonance Imaging|magnetic resonance imaging
5444113|NCT00001711|Gadolinium|gadolinium
5444114|NCT00001711|Magnetic Resonance Angiography|magnetic resonance angiography
5444115|NCT00001711|Normal Volunteer|normal volunteer
5444116|NCT00001703|Immunotherapy|immunotherapy
5444117|NCT00001703|Kidney|kidney
5444118|NCT00001703|Genes|genes
5444119|NCT00001703|Vaccine Therapy|vaccine therapy
5444120|NCT00001703|Renal Cell Carcinoma|renal cell carcinoma
5444121|NCT00001702|Genetic|genetic
5444122|NCT00001702|Variant Alleles|variant alleles
5444123|NCT00001702|Risk Factor|risk factor
5444124|NCT00001702|Cancer|cancer
5444125|NCT00001702|Transplantation|transplantation
5444126|NCT00001701|Risk Factor|risk factor
5444127|NCT00001701|Genetic|genetic
5444128|NCT00001701|Variant Alleles|variant alleles
5444129|NCT00001701|Cancer|cancer
5444130|NCT00001701|Transplantation|transplantation
5444131|NCT00001698|Chemoprevention|chemoprevention
5444132|NCT00001698|Direct Epithelial Delivery|direct epithelial delivery
5444133|NCT00001698|Tobacco-induced Cancer|tobacco-induced cancer
5444134|NCT00001698|Field Cancerization|field cancerization
5444135|NCT00001695|Complementary Medicine|complementary medicine
5444136|NCT00001695|Unproven Treatments|unproven treatments
5444137|NCT00001695|Herbal|herbal
5444138|NCT00001693|Chemoprevention|chemoprevention
5444139|NCT00001693|Biomarkers|biomarkers
5444140|NCT00001693|Endoscopy|endoscopy
5444141|NCT00001693|Colorectal|colorectal
5444142|NCT00001693|Celecoxib|celecoxib
5444143|NCT00001689|Neurotoxicity|neurotoxicity
5444144|NCT00001689|A.L.L.|a.l.l.
5444145|NCT00001689|Limited Sampling|limited sampling
5444146|NCT00001689|Dose Individualization|dose individualization
5444147|NCT00001689|Vinca Alkaloids|vinca alkaloids
5444148|NCT00001686|Leukemia|leukemia
5444149|NCT00001686|Ewing's Sarcoma|ewing's sarcoma
5444150|NCT00001686|Neuroectodermal Tumors|neuroectodermal tumors
5444151|NCT00001686|Lymphoma, Osteosarcoma|lymphoma, osteosarcoma
5444152|NCT00001686|Brain Tumors, Rhabdomyosarcoma|brain tumors, rhabdomyosarcoma
5444153|NCT00001686|Lymphoma|lymphoma
5444154|NCT00001686|Neoplasm|neoplasm
5444155|NCT00001686|Sarcoma|sarcoma
5444156|NCT00001683|Collagen Breakdown|collagen breakdown
5444157|NCT00001683|Pharmacokinetics|pharmacokinetics
5444158|NCT00001683|Rapid Escalation Phase I|rapid escalation phase i
5444159|NCT00001683|Angiogenesis|angiogenesis
5444160|NCT00001683|Tissue Inhibitors of Metalloproteinase|tissue inhibitors of metalloproteinase
5444161|NCT00001678|Autoimmunity|autoimmunity
5444162|NCT00001678|Sibling Pairs|sibling pairs
5444163|NCT00001678|Genes|genes
5444164|NCT00001678|Rheumatoid Arthritis|rheumatoid arthritis
5444165|NCT00001678|Bone Erosion|bone erosion
5444166|NCT00001676|Remission|remission
5444167|NCT00001676|Renal Function|renal function
5444168|NCT00001676|Infection|infection
5444169|NCT00001676|Germinal Center|germinal center
5444170|NCT00001676|Immunoglobulin|immunoglobulin
5444171|NCT00001676|Glomerulonephritis|glomerulonephritis
5444172|NCT00001676|Systemic Lupus Erythematosus|systemic lupus erythematosus
5444173|NCT00001676|Lupus Nephritis|lupus nephritis
5444174|NCT00001671|White Matter|white matter
5444175|NCT00001671|Myelin|myelin
5444176|NCT00001671|Degenerative Diseases|degenerative diseases
5444177|NCT00001671|Genetic|genetic
5444178|NCT00001671|Oligodendrocytes|oligodendrocytes
5444179|NCT00001671|Leukodystrophy|leukodystrophy
5444180|NCT00001666|Seizures|seizures
5444181|NCT00001666|Partial Epilepsy|partial epilepsy
5444182|NCT00001666|Intractable|intractable
5444183|NCT00001666|TMS|tms
5444184|NCT00001664|Narcolepsy|narcolepsy
5444185|NCT00001664|Polysomnography|polysomnography
5444186|NCT00001664|Multiple Sleep Latency Test|multiple sleep latency test
5444187|NCT00001664|Sleep Disorders|sleep disorders
5444188|NCT00001664|Hypersomnia|hypersomnia
5444189|NCT00001664|Periodic Leg Movements|periodic leg movements
5444190|NCT00001663|Neurological Disorders|neurological disorders
5444191|NCT00001663|Movement Disorders|movement disorders
5444192|NCT00001663|Physiology|physiology
5444193|NCT00001663|Noninvasive|noninvasive
5444194|NCT00001663|Brain Stimulation|brain stimulation
5444195|NCT00001663|Cortical Myoclonus|cortical myoclonus
5444196|NCT00001662|Dementia|dementia
5444197|NCT00001662|Glutamate|glutamate
5444198|NCT00001662|Clinical Trial|clinical trial
5444199|NCT00001662|Neurotransmitter|neurotransmitter
5444200|NCT00001662|Alzheimer's Disease|alzheimer's disease
5444201|NCT00001661|Plasticity|plasticity
5444203|NCT00001661|Stroke|stroke
5444204|NCT00001661|Spinal Cord Injury|spinal cord injury
5444205|NCT00001661|Amputation|amputation
5444206|NCT00001661|Intracortical Inhibition|intracortical inhibition
5444207|NCT00001659|Bereavement|bereavement
5444208|NCT00001659|Depression|depression
5444209|NCT00001659|Suicide|suicide
5444210|NCT00001659|Activity of Daily Living|activity of daily living
5444211|NCT00001659|Immune Function|immune function
5444212|NCT00001659|Occupational Performance|occupational performance
5444213|NCT00001659|Sleep Disorders|sleep disorders
5444214|NCT00001659|Mood Changes|mood changes
5444215|NCT00001656|Clozapine|clozapine
5444216|NCT00001656|Olanzapine|olanzapine
5444217|NCT00001656|Drug Response|drug response
5444218|NCT00001656|Safety|safety
5444219|NCT00001656|Childhood Onset Schizophrenia|childhood onset schizophrenia
5444220|NCT00001656|Schizoaffective Disorder|schizoaffective disorder
5444221|NCT00001656|Multidimensionally Impaired Syndrome|multidimensionally impaired syndrome
5444222|NCT00001656|Phenomenology|phenomenology
5444223|NCT00001656|Biochemical Correlates|biochemical correlates
5444224|NCT00001656|Brain Imaging|brain imaging
5444225|NCT00001656|Schizophrenia|schizophrenia
5444226|NCT00001656|Childhood Schizophrenia|childhood schizophrenia
5444227|NCT00001656|Psychosis|psychosis
5444228|NCT00001654|Adolescence|adolescence
5444229|NCT00001654|Comorbid Disorders|comorbid disorders
5444230|NCT00001654|Physiology|physiology
5444231|NCT00001654|Socialization|socialization
5444232|NCT00001654|Gender|gender
5444233|NCT00001654|Conduct Problems|conduct problems
5444234|NCT00001654|Anxiety|anxiety
5444235|NCT00001654|Sadness|sadness
5444236|NCT00001654|Emotion|emotion
5444237|NCT00001654|Psychophysiology|psychophysiology
5444238|NCT00001652|Life-Charting|life-charting
5444239|NCT00001652|Cerebrospinal Fluid|cerebrospinal fluid
5444240|NCT00001652|Diagnostic Tests|diagnostic tests
5444241|NCT00001652|Cognitive Testing|cognitive testing
5444242|NCT00001652|Course of Illness|course of illness
5444243|NCT00001652|Bipolar Disorder|bipolar disorder
5444244|NCT00001651|Deuterium|deuterium
5444245|NCT00001651|HIV|hiv
5444246|NCT00001651|Labeling|labeling
5444247|NCT00001651|CD4 Cells|cd4 cells
5444248|NCT00001651|Immunodeficiency|immunodeficiency
5444249|NCT00001650|BrDU|brdu
5444250|NCT00001650|HIV|hiv
5444251|NCT00001650|Labeling|labeling
5444252|NCT00001650|CD4 Cells|cd4 cells
5444253|NCT00001650|Immunodeficiency|immunodeficiency
5444254|NCT00001649|Clinical Trial|clinical trial
5444255|NCT00001649|Sexual Transmitted Disease|sexual transmitted disease
5444256|NCT00001649|Phase III|phase iii
5444257|NCT00001649|HSV|hsv
5444258|NCT00001649|Valtrex|valtrex
5444259|NCT00001649|Valaciclovir|valaciclovir
5444260|NCT00001649|HS2A/B3009|hs2a/b3009
5444261|NCT00001649|Herpes Simplex Virus Transmission|herpes simplex virus transmission
5444262|NCT00001649|Heterosexual Couples|heterosexual couples
5444263|NCT00001648|HVEM Gene|hvem gene
5444264|NCT00001648|HSV|hsv
5444265|NCT00001648|Herpes Simplex Virus|herpes simplex virus
5444266|NCT00001647|AIDS|aids
5444267|NCT00001647|Immunotherapy|immunotherapy
5444268|NCT00001647|Adoptive Cell Transfers|adoptive cell transfers
5444269|NCT00001647|T Cell Repertoire|t cell repertoire
5444270|NCT00001647|Identical Twins|identical twins
5444271|NCT00001645|Chagas' Disease|chagas' disease
5444272|NCT00001645|Trypanosomiasis|trypanosomiasis
5444273|NCT00001645|Malaria|malaria
5444274|NCT00001645|Parasitic Infection|parasitic infection
5444275|NCT00001644|Immunodeficiency|immunodeficiency
5444276|NCT00001644|Latency|latency
5444277|NCT00001644|T Cell Turnover|t cell turnover
5444278|NCT00001644|Infected Cell Turnover|infected cell turnover
5444279|NCT00001644|Follicular Dendritic Cells|follicular dendritic cells
5444285|NCT00001643|Parkinson's Disease|parkinson's disease
5444286|NCT00001641|Fibrillin|fibrillin
5444287|NCT00001641|Collagen|collagen
5444288|NCT00001641|Marfan Syndrome|marfan syndrome
5444289|NCT00001641|Stickler Syndrome|stickler syndrome
5444290|NCT00001641|Aortic Dissection|aortic dissection
5444291|NCT00001641|Ehlers-Danlos|ehlers-danlos
5444292|NCT00001641|Connective Tissue Disorders|connective tissue disorders
5444293|NCT00001641|Ehlers-Danlos Syndrome|ehlers-danlos syndrome
5444294|NCT00001641|Nail-Patella Syndrome|nail-patella syndrome
5444295|NCT00001640|Parkinson's Disease|parkinson's disease
5444296|NCT00001638|Echocardiography|echocardiography
5444297|NCT00001638|Heart|heart
5444298|NCT00001638|Gadolinium|gadolinium
5444299|NCT00001638|Dobutamine|dobutamine
5444300|NCT00001638|Toxicity|toxicity
5444301|NCT00001638|Adverse Events|adverse events
5444302|NCT00001638|Myocardial Infarction|myocardial infarction
5444303|NCT00001638|Myocardial Viability|myocardial viability
5444304|NCT00001638|Myocardial Perfusion|myocardial perfusion
5444305|NCT00001638|Myocardial Function|myocardial function
5444306|NCT00001638|Cardiovascular Disease|cardiovascular disease
5444307|NCT00001637|Peripheral Blood Stem Cells|peripheral blood stem cells
5444308|NCT00001637|Engraftment|engraftment
5444309|NCT00001637|Fludarabine|fludarabine
5444310|NCT00001637|Nonmyeloablative|nonmyeloablative
5444311|NCT00001637|Graft-Versus-Leukemia|graft-versus-leukemia
5444312|NCT00001637|Graft vs. Host Disease|graft vs. host disease
5444313|NCT00001637|Cyclophosphamide|cyclophosphamide
5444314|NCT00001637|Donor Apheresis|donor apheresis
5444315|NCT00001637|Nonmyeloablative Bone Marrow Transplantation|nonmyeloablative bone marrow transplantation
5444316|NCT00001637|Chronic Myelogenous Leukemia (CML)|chronic myelogenous leukemia (cml)
5444317|NCT00001637|Acute Lymphoblastic Leukemia (ALL)|acute lymphoblastic leukemia (all)
5444318|NCT00001637|Acute Myelogenous Leukemia (AML)|acute myelogenous leukemia (aml)
5444319|NCT00001637|Myelodysplastic Syndromes|myelodysplastic syndromes
5444320|NCT00001637|Chronic Lymphocytic Leukemia (CLL)|chronic lymphocytic leukemia (cll)
5444321|NCT00001637|Prolymphocytic Leukemia|prolymphocytic leukemia
5444322|NCT00001632|Hypertrophy|hypertrophy
5444323|NCT00001632|Integrated|integrated
5444324|NCT00001632|Backscatter|backscatter
5444325|NCT00001632|Cyclic|cyclic
5444326|NCT00001632|Echocardiography|echocardiography
5444327|NCT00001632|Hypertrophic Cardiomyopathy|hypertrophic cardiomyopathy
5444328|NCT00001631|Gadolinium|gadolinium
5444329|NCT00001631|Ischemia|ischemia
5444330|NCT00001631|Coronary Artery Disease|coronary artery disease
5444331|NCT00001631|Hypertrophic Cardiomyopathy|hypertrophic cardiomyopathy
5444332|NCT00001631|Dipyridamole|dipyridamole
5444333|NCT00001630|Immunosuppression|immunosuppression
5444334|NCT00001630|Thrombocytopenia|thrombocytopenia
5444335|NCT00001630|Autoimmune Disease|autoimmune disease
5444336|NCT00001630|Evan's Syndrome|evan's syndrome
5444337|NCT00001630|Autoimmune Hemolytic Anemia|autoimmune hemolytic anemia
5444338|NCT00001630|Episodic Bleeding|episodic bleeding
5444339|NCT00001627|Bone Marrow|bone marrow
5444340|NCT00001627|Hematopoiesis|hematopoiesis
5444341|NCT00001627|DNA|dna
5444342|NCT00001627|RNA|rna
5444343|NCT00001627|Viruses|viruses
5444344|NCT00001627|Normal Volunteer|normal volunteer
5444345|NCT00001627|Aplastic Anemia|aplastic anemia
5444346|NCT00001627|Myelodysplasia|myelodysplasia
5444347|NCT00001627|Fanconi's Anemia|fanconi's anemia
5444348|NCT00001627|Single Lineage Cytopenia|single lineage cytopenia
5444349|NCT00001626|Cytopenia|cytopenia
5444350|NCT00001626|Randomized|randomized
5444351|NCT00001626|Immunosuppression|immunosuppression
5444352|NCT00001626|Severe Aplastic Anemia|severe aplastic anemia
5444353|NCT00001625|Insulin Resistance|insulin resistance
5444354|NCT00001625|Obesity|obesity
5444355|NCT00001625|Hypertension|hypertension
5444356|NCT00001625|Diabetes|diabetes
5444357|NCT00001625|Mathematical Modeling|mathematical modeling
5444358|NCT00001625|Normal Volunteer|normal volunteer
5444359|NCT00001623|Peripheral Blood Stem Cells|peripheral blood stem cells
5444360|NCT00001623|Graft-Versus-Leukemia|graft-versus-leukemia
5444361|NCT00001623|Graft vs. Host Disease|graft vs. host disease
5444362|NCT00001623|Whole Body Irradiation|whole body irradiation
5444363|NCT00001623|Donor Apheresis|donor apheresis
5444364|NCT00001623|Cyclophosphamide|cyclophosphamide
5444365|NCT00001623|Graft-Versus-Myeloma|graft-versus-myeloma
5444366|NCT00001623|Leukemic Relapse|leukemic relapse
5444367|NCT00001623|Multiple Myeloma|multiple myeloma
5444368|NCT00001623|Acute Myelogenous Leukemia (AML)|acute myelogenous leukemia (aml)
5444369|NCT00001623|Chronic Myelogenous Leukemia (CML)|chronic myelogenous leukemia (cml)
5444370|NCT00001623|Acute Lymphoblastic Leukemia (ALL)|acute lymphoblastic leukemia (all)
5444371|NCT00001623|Myelodysplastic Syndromes|myelodysplastic syndromes
5444372|NCT00001623|Chronic Lymphocytic Leukemia (CLL)|chronic lymphocytic leukemia (cll)
5444373|NCT00001621|Teaching|teaching
5444374|NCT00001621|Pulmonary Disease|pulmonary disease
5444375|NCT00001621|Routine Testing|routine testing
5444376|NCT00001621|Medically Indicated|medically indicated
5444377|NCT00001621|Pulmonary Function Test|pulmonary function test
5444378|NCT00001620|Thrombocytopenia|thrombocytopenia
5444379|NCT00001620|Anemia|anemia
5444380|NCT00001620|Neutropenia|neutropenia
5444381|NCT00001620|Dysplasia|dysplasia
5444383|NCT00001620|Hematologic Malignancy|hematologic malignancy
5444384|NCT00001619|Imaging|imaging
5444385|NCT00001619|Spectroscopy|spectroscopy
5444386|NCT00001619|MRI|mri
5444387|NCT00001619|Cardiovascular|cardiovascular
5444388|NCT00001619|Technical Development|technical development
5444389|NCT00001619|Heart|heart
5444390|NCT00001619|Safety|safety
5444391|NCT00001619|Toxicity|toxicity
5444392|NCT00001619|Gadolinium|gadolinium
5444393|NCT00001619|Adverse Events|adverse events
5444394|NCT00001619|Normal Volunteer|normal volunteer
5444395|NCT00001618|Cystic Fibrosis|cystic fibrosis
5444396|NCT00001618|Healthy Volunteers|healthy volunteers
5444397|NCT00001618|Asthma|asthma
5444398|NCT00001618|Normal Volunteer|normal volunteer
5444399|NCT00001618|Chronic Lung Disease|chronic lung disease
5444400|NCT00001613|Cataract Surgery|cataract surgery
5444401|NCT00001613|Human Lens|human lens
5444402|NCT00001613|Crystallins|crystallins
5444403|NCT00001613|Post-Translational|post-translational
5444404|NCT00001613|Protein Modification|protein modification
5444405|NCT00001613|Nuclear Cataract|nuclear cataract
5444406|NCT00001613|Cataract Extraction|cataract extraction
5444407|NCT00001611|AIDS|aids
5444408|NCT00001611|Eye|eye
5444409|NCT00001611|Treatment|treatment
5444410|NCT00001611|Opportunistic Infection|opportunistic infection
5444411|NCT00001611|Immunology|immunology
5444412|NCT00001611|Retinitis|retinitis
5444413|NCT00001610|Standing Potential|standing potential
5444414|NCT00001610|Fast Oscillation|fast oscillation
5444415|NCT00001610|Slow Oscillation|slow oscillation
5444416|NCT00001610|Retinal Pigment|retinal pigment
5444417|NCT00001610|Epithelium|epithelium
5444418|NCT00001610|Electro-oculogram|electro-oculogram
5444419|NCT00001610|Cellular Immune Response|cellular immune response
5444420|NCT00001610|Retinal Antigens|retinal antigens
5444421|NCT00001610|IRBP|irbp
5444422|NCT00001610|S-Antigen|s-antigen
5444423|NCT00001610|Normal Volunteer|normal volunteer
5444424|NCT00001609|Linkage|linkage
5444425|NCT00001609|Genetic Analysis|genetic analysis
5444426|NCT00001609|Lens|lens
5444427|NCT00001609|Opacity|opacity
5444428|NCT00001609|Inherited|inherited
5444429|NCT00001609|Linkage Analysis|linkage analysis
5444430|NCT00001609|Genomic DNA|genomic dna
5444431|NCT00001609|Risk Prediction|risk prediction
5444432|NCT00001609|Pedigree Analysis|pedigree analysis
5444433|NCT00001609|Congenital Cataracts|congenital cataracts
5444434|NCT00001609|Hereditary Cataracts|hereditary cataracts
5444435|NCT00001606|Linkage Analysis|linkage analysis
5444436|NCT00001606|Positional Cloning|positional cloning
5444437|NCT00001606|Mutation Screening|mutation screening
5444438|NCT00001606|Syndromic Hearing Impairment|syndromic hearing impairment
5444439|NCT00001606|Non-Syndromic Hearing Impairment|non-syndromic hearing impairment
5444440|NCT00001604|DNA Samples|dna samples
5444441|NCT00001604|Buccal Swab|buccal swab
5444442|NCT00001604|Genotyping|genotyping
5444443|NCT00001604|Statistical Analysis|statistical analysis
5444444|NCT00001604|Computers|computers
5444445|NCT00001604|Stuttering|stuttering
5444446|NCT00001603|Cytokines|cytokines
5444447|NCT00001603|Squamous Cell Carcinoma|squamous cell carcinoma
5444448|NCT00001603|Papilloma|papilloma
5444449|NCT00001603|Communication|communication
5444450|NCT00001603|Immunity|immunity
5444451|NCT00001603|Head|head
5444452|NCT00001603|Neck|neck
5444453|NCT00001603|Head and Neck Cancer|head and neck cancer
5444454|NCT00001602|Dysfluency|dysfluency
5444455|NCT00001602|Polymorphism|polymorphism
5444456|NCT00001602|Stuttering|stuttering
5444457|NCT00001602|Dopamine|dopamine
5444458|NCT00001602|Family Studies|family studies
5444459|NCT00001602|Receptors|receptors
5444460|NCT00001602|Serotonin|serotonin
5444461|NCT00001602|Enzymes|enzymes
5444462|NCT00001602|Genetics|genetics
5444463|NCT00001602|Linkage Analysis|linkage analysis
5444464|NCT00001601|Oral Medicine|oral medicine
5444465|NCT00001601|Clinical Experience|clinical experience
5444466|NCT00001601|Therapy|therapy
5444467|NCT00001601|Educational Training|educational training
5444468|NCT00001601|Pathogenesis|pathogenesis
5444469|NCT00001601|Oral Lesions|oral lesions
5444470|NCT00001601|Aphthous Ulcers|aphthous ulcers
5444471|NCT00001601|Lichen Planus|lichen planus
5444472|NCT00001601|Burning Mouth|burning mouth
5444473|NCT00001601|Temporomandibular Dysfunction (TMD)|temporomandibular dysfunction (tmd)
5444474|NCT00001601|Oral Disease|oral disease
5444475|NCT00001601|Oral Manifestations|oral manifestations
5444476|NCT00001600|Screening Protocol|screening protocol
5444477|NCT00001600|Temporomandibular Disorders|temporomandibular disorders
5444478|NCT00001600|Oral Surgery|oral surgery
5444479|NCT00001600|Chronic Orofacial Pain|chronic orofacial pain
5444480|NCT00001599|Xerostomia|xerostomia
5444481|NCT00001599|Autoimmunity|autoimmunity
5444482|NCT00001599|Salivary Glands|salivary glands
5444483|NCT00001599|Lacrimal Function|lacrimal function
5444484|NCT00001599|Immunomodulator|immunomodulator
5444485|NCT00001599|Sjogren's Syndrome|sjogren's syndrome
5444486|NCT00001599|Dry Mouth|dry mouth
5444487|NCT00001598|Xerostomia|xerostomia
5444488|NCT00001598|Autoimmunity|autoimmunity
5444489|NCT00001598|Salivary Glands|salivary glands
5444490|NCT00001598|Androgen Therapy|androgen therapy
5444491|NCT00001598|Lacrimal Function|lacrimal function
5444492|NCT00001598|DHEA|dhea
5444493|NCT00001598|Sjogren's Syndrome|sjogren's syndrome
5444494|NCT00001598|Dehydroepiandrosterone|dehydroepiandrosterone
5444495|NCT00001597|Psychophysics|psychophysics
5444496|NCT00001597|Validation|validation
5444497|NCT00001597|Fentanyl|fentanyl
5444498|NCT00001597|Normal Volunteer|normal volunteer
5444499|NCT00001597|Pain|pain
5444500|NCT00001596|Albinism|albinism
5444501|NCT00001596|Platelet Storage Pool Deficiency|platelet storage pool deficiency
5444502|NCT00001596|Pulmonary Fibrosis|pulmonary fibrosis
5444503|NCT00001596|Hermansky-Pudlak Syndrome|hermansky-pudlak syndrome
5444504|NCT00001595|Oncogenesis|oncogenesis
5444505|NCT00001595|Adenoma|adenoma
5444506|NCT00001595|Craniopharyngioma|craniopharyngioma
5444507|NCT00001595|Cushing Syndrome|cushing syndrome
5444508|NCT00001595|Homeobox-Containing Genes|homeobox-containing genes
5444509|NCT00001595|Developmental Defect|developmental defect
5444510|NCT00001595|Pituitary Gland|pituitary gland
5444511|NCT00001594|Osteogenesis Imperfecta|osteogenesis imperfecta
5444512|NCT00001594|Basilar Invagination|basilar invagination
5444513|NCT00001591|Central Nervous System|central nervous system
5444514|NCT00001591|Technical Development|technical development
5444515|NCT00001591|Activation Studies|activation studies
5444516|NCT00001591|Pulse Sequences|pulse sequences
5444517|NCT00001591|Metabolites|metabolites
5444518|NCT00001591|Normal Volunteer|normal volunteer
5444519|NCT00001589|Ferritin|ferritin
5444520|NCT00001589|Atherosclerosis|atherosclerosis
5444521|NCT00001589|Myocardial Infarction|myocardial infarction
5444522|NCT00001589|Blood Donors|blood donors
5444523|NCT00001589|Low Density Lipoprotein|low density lipoprotein
5444524|NCT00001589|Asymptomatic Carotid Atherosclerosis|asymptomatic carotid atherosclerosis
5444525|NCT00001586|Genetics|genetics
5444526|NCT00001586|Bone Marrow Transplantation|bone marrow transplantation
5444527|NCT00001586|Immunosuppression|immunosuppression
5444528|NCT00001586|T Lymphocytes|t lymphocytes
5444529|NCT00001586|Marrow Purging|marrow purging
5444530|NCT00001582|Autoimmune Disorder|autoimmune disorder
5444531|NCT00001582|Immune System Evaluation|immune system evaluation
5444532|NCT00001582|Human Response Investigation|human response investigation
5444533|NCT00001582|Tissue Acquisition|tissue acquisition
5444534|NCT00001580|Molecular Diagnostics|molecular diagnostics
5444535|NCT00001580|Ovary|ovary
5444536|NCT00001580|Tissue Acquisition|tissue acquisition
5444537|NCT00001580|cDNA Library|cdna library
5444538|NCT00001580|CGAP|cgap
5444539|NCT00001576|Regional Therapy|regional therapy
5444540|NCT00001576|Organ Perfusion|organ perfusion
5444541|NCT00001576|Metastases|metastases
5444542|NCT00001576|Hyperthermia|hyperthermia
5444543|NCT00001575|Yttrium 90|yttrium 90
5444544|NCT00001575|Radiolabeled|radiolabeled
5444545|NCT00001575|Anti -Tac|anti -tac
5444546|NCT00001575|Calcium DTPA|calcium dtpa
5444547|NCT00001574|Metabolites|metabolites
5444548|NCT00001574|Proton Nuclear Magnetic Resonance Spectroscopic Imaging|proton nuclear magnetic resonance spectroscopic imaging
5444549|NCT00001574|Scans|scans
5444550|NCT00001572|B-Cell Lymphoma|b-cell lymphoma
5444551|NCT00001572|BCL- 2 Positive Tumor|bcl- 2 positive tumor
5444552|NCT00001572|Immunization|immunization
5444553|NCT00001572|Induction Chemotherapy|induction chemotherapy
5444554|NCT00001572|Lymphoma Vaccine|lymphoma vaccine
5444555|NCT00001572|Follicular Lymphoma|follicular lymphoma
5444556|NCT00001572|Tumor-Derived Immunoglobulin Idiotype|tumor-derived immunoglobulin idiotype
5444557|NCT00001569|Gastrointestinal|gastrointestinal
5444558|NCT00001569|Adenocarcinoma|adenocarcinoma
5444559|NCT00001569|Taxol|taxol
5444560|NCT00001568|Tumors|tumors
5444561|NCT00001568|Detection|detection
5444562|NCT00001568|Follow-Up|follow-up
5444563|NCT00001568|Markers|markers
5444564|NCT00001568|Radiolabeled|radiolabeled
5444565|NCT00001567|Follow-Up Study|follow-up study
5444566|NCT00001567|Relapse-Free Survival|relapse-free survival
5444567|NCT00001567|Serum Soluble IL-2 Receptor|serum soluble il-2 receptor
5444568|NCT00001567|Hematologic Malignancy|hematologic malignancy
5444569|NCT00001567|Chronic Therapy|chronic therapy
5444570|NCT00001566|Rhabdomyosarcoma|rhabdomyosarcoma
5444571|NCT00001566|Ewing's Sarcoma|ewing's sarcoma
5444572|NCT00001566|Immunotherapy|immunotherapy
5444573|NCT00001566|Tumor Vaccine|tumor vaccine
5444574|NCT00001566|Interleukin-2|interleukin-2
5444575|NCT00001564|Rhabdomyosarcoma|rhabdomyosarcoma
5444576|NCT00001564|Ewing's Sarcoma|ewing's sarcoma
5444577|NCT00001564|Immunotherapy|immunotherapy
5444578|NCT00001564|Tumor Vaccine|tumor vaccine
5444579|NCT00001564|Fusion Protein|fusion protein
5444580|NCT00001563|Lymphomagenesis|lymphomagenesis
5444706|NCT00001526|Daclizumab|daclizumab
5444581|NCT00001563|Molecular markers of drug resistance|molecular markers of drug resistance
5444582|NCT00001563|Refractory, progressive, or relapsed HIV + NHL|refractory, progressive, or relapsed hiv + nhl
5444583|NCT00001563|AIDS-related NHL|aids-related nhl
5444584|NCT00001561|Multiple Myeloma|multiple myeloma
5444585|NCT00001561|Vaccine|vaccine
5444586|NCT00001561|Idiotype-Specific Immunity|idiotype-specific immunity
5444587|NCT00001561|Immune Transfer|immune transfer
5444588|NCT00001561|Myeloma Immunoglobulin|myeloma immunoglobulin
5444589|NCT00001560|AIDS|aids
5444590|NCT00001560|Multidisciplinary|multidisciplinary
5444591|NCT00001560|Leukemia|leukemia
5444592|NCT00001560|Lymphoma|lymphoma
5444593|NCT00001560|Kaposi's Sarcoma|kaposi's sarcoma
5444594|NCT00001552|Spasmodic Dysphonia|spasmodic dysphonia
5444595|NCT00001552|Pedigree|pedigree
5444596|NCT00001552|Vocal Fold Paralysis|vocal fold paralysis
5444597|NCT00001552|Voice Disorder|voice disorder
5444598|NCT00001551|Stuttering|stuttering
5444599|NCT00001551|Linkage|linkage
5444600|NCT00001551|Pedigree|pedigree
5444601|NCT00001551|Speech Articulation|speech articulation
5444602|NCT00001551|Phonological Processing Disorders|phonological processing disorders
5444603|NCT00001551|Speech Disorder|speech disorder
5444604|NCT00001550|Immunotherapy|immunotherapy
5444605|NCT00001550|Muscle Stiffness|muscle stiffness
5444606|NCT00001550|Rigidity|rigidity
5444607|NCT00001550|Anti-GAD Antibodies|anti-gad antibodies
5444608|NCT00001550|Episodic Spasms|episodic spasms
5444609|NCT00001550|Intravenous High-Dose Immunoglobulin|intravenous high-dose immunoglobulin
5444610|NCT00001550|Stiff-man Syndrome|stiff-man syndrome
5444611|NCT00001549|Movement Disorders|movement disorders
5444612|NCT00001549|Parkinson's|parkinson's
5444613|NCT00001549|Alzheimer's|alzheimer's
5444614|NCT00001549|Screening|screening
5444615|NCT00001549|Diagnostic Puzzles|diagnostic puzzles
5444616|NCT00001549|Alzheimer Disease|alzheimer disease
5444617|NCT00001549|Progressive Supranuclear Palsy|progressive supranuclear palsy
5444618|NCT00001549|PSP|psp
5444619|NCT00001549|Restless Leg Syndrome|restless leg syndrome
5444620|NCT00001549|RLS|rls
5444621|NCT00001549|Parkinsonism|parkinsonism
5444622|NCT00001549|PD|pd
5444623|NCT00001548|Genetic|genetic
5444624|NCT00001548|Psychiatric Disorder|psychiatric disorder
5444625|NCT00001548|Affected Sib Pairs|affected sib pairs
5444626|NCT00001548|Obsessions|obsessions
5444627|NCT00001548|Compulsions|compulsions
5444628|NCT00001548|Family Study|family study
5444629|NCT00001548|OCD Spectrum Disorders|ocd spectrum disorders
5444630|NCT00001548|Trichotillomania|trichotillomania
5444631|NCT00001548|Tourette's Syndrome|tourette's syndrome
5444632|NCT00001547|Drug|drug
5444633|NCT00001547|Imaging|imaging
5444634|NCT00001547|Brain|brain
5444635|NCT00001547|Metabolism|metabolism
5444636|NCT00001547|Organic Mental Syndrome|organic mental syndrome
5444637|NCT00001547|Magnetic Resonance Imaging|magnetic resonance imaging
5444638|NCT00001547|Spectroscopy|spectroscopy
5444639|NCT00001547|Neuropsychiatric Disorders|neuropsychiatric disorders
5444640|NCT00001547|Drug Effects|drug effects
5444641|NCT00001547|Interferon-alpha|interferon-alpha
5444642|NCT00001545|Affective Disorders|affective disorders
5444643|NCT00001545|Repetitive Transcranial Magnetic Stimulation|repetitive transcranial magnetic stimulation
5444644|NCT00001545|Mania|mania
5444645|NCT00001545|Bipolar Disorder|bipolar disorder
5444646|NCT00001545|Depression|depression
5444647|NCT00001545|Unipolar Disorder|unipolar disorder
5444648|NCT00001545|Unipolar Depression|unipolar depression
5444649|NCT00001544|DNA Probes|dna probes
5444650|NCT00001544|Trinucleotide Repeats|trinucleotide repeats
5444651|NCT00001544|Family Studies|family studies
5444652|NCT00001544|Lymphoblast Cell Lines|lymphoblast cell lines
5444653|NCT00001544|Genotyping|genotyping
5444654|NCT00001544|Bipolar Affective Disorders|bipolar affective disorders
5444655|NCT00001544|Schizophrenia|schizophrenia
5444656|NCT00001544|Mental Retardation|mental retardation
5444657|NCT00001544|Neuropsychiatric Disorders|neuropsychiatric disorders
5444658|NCT00001543|Major Depression|major depression
5444659|NCT00001543|Metabolic Clearance Rate|metabolic clearance rate
5444660|NCT00001543|Pulsatility|pulsatility
5444661|NCT00001543|Adrenocorticotropic Hormone|adrenocorticotropic hormone
5444662|NCT00001543|Cortisol|cortisol
5444663|NCT00001543|Corticotropin Releasing Hormone Binding Protein|corticotropin releasing hormone binding protein
5444664|NCT00001543|Pharmacokinetics|pharmacokinetics
5444665|NCT00001543|Half-Life|half-life
5444666|NCT00001543|Bioavailability|bioavailability
5444667|NCT00001543|Cushing's Syndrome|cushing's syndrome
5444668|NCT00001541|Vasculitis|vasculitis
5444669|NCT00001541|Inflammation|inflammation
5444670|NCT00001541|Bronchoscopy|bronchoscopy
5444671|NCT00001541|Cytokines|cytokines
5444672|NCT00001541|Inflammatory Mediators|inflammatory mediators
5444673|NCT00001541|Wegener's Granulomatosis|wegener's granulomatosis
5444674|NCT00001539|Central Nervous System|central nervous system
5444675|NCT00001539|Lyme Disease|lyme disease
5444676|NCT00001539|Borrelia Burgdorferi|borrelia burgdorferi
5444677|NCT00001539|Neuroborreliosis|neuroborreliosis
5444678|NCT00001539|Chronic Symptoms|chronic symptoms
5444679|NCT00001535|Intracellular Immunization|intracellular immunization
5444680|NCT00001535|Immune Based Therapy|immune based therapy
5444681|NCT00001535|Ex Vivo Cell Processing|ex vivo cell processing
5444682|NCT00001535|Identical Twins|identical twins
5444683|NCT00001535|HIV/AIDS|hiv/aids
5444684|NCT00001535|Kaposi's Sarcoma|kaposi's sarcoma
5444685|NCT00001534|Genetics|genetics
5444686|NCT00001534|Myocardial Ischemia|myocardial ischemia
5444792|NCT00001487|Depression|depression
5444687|NCT00001534|Diastolic Dysfunction|diastolic dysfunction
5444688|NCT00001534|Renin-Angiotensin System|renin-angiotensin system
5444689|NCT00001534|Hypertrophic Cardiomyopathy|hypertrophic cardiomyopathy
5444690|NCT00001534|Left Ventricular (LV) Hypertrophy|left ventricular (lv) hypertrophy
5444691|NCT00001532|Genetic Polymorphism|genetic polymorphism
5444692|NCT00001532|Nitric Oxide Synthase|nitric oxide synthase
5444693|NCT00001532|Alpha 1-Antitrypsin|alpha 1-antitrypsin
5444694|NCT00001532|Candidate Genes|candidate genes
5444695|NCT00001532|Lung Pathology|lung pathology
5444696|NCT00001532|Lung Disease|lung disease
5444697|NCT00001532|Cystic Fibrosis|cystic fibrosis
5444698|NCT00001532|Asthma|asthma
5444699|NCT00001529|G-CSF|g-csf
5444700|NCT00001529|Donor Apheresis|donor apheresis
5444701|NCT00001529|Graft vs. Host Disease|graft vs. host disease
5444702|NCT00001529|Graft-Versus-Leukemia|graft-versus-leukemia
5444703|NCT00001529|Normal Volunteer|normal volunteer
5444704|NCT00001526|Uveitis|uveitis
5444705|NCT00001526|Interleukin 2 Receptor|interleukin 2 receptor
5444707|NCT00001526|HAT|hat
5444708|NCT00001526|Zenapax|zenapax
5444709|NCT00001526|Interleukin 2|interleukin 2
5444710|NCT00001524|Thalidomide|thalidomide
5444711|NCT00001524|Clinical Trial|clinical trial
5444712|NCT00001524|Tumor Necrosis Factor|tumor necrosis factor
5444713|NCT00001524|Delayed Healing|delayed healing
5444714|NCT00001524|Painful Oral Lesions|painful oral lesions
5444715|NCT00001524|HIV/AIDS|hiv/aids
5444716|NCT00001524|Mouth Ulcers|mouth ulcers
5444717|NCT00001524|Aphthous Ulcers|aphthous ulcers
5444718|NCT00001524|Healing|healing
5444719|NCT00001524|Cytokines|cytokines
5444720|NCT00001522|Insulin Resistance|insulin resistance
5444721|NCT00001522|Race|race
5444722|NCT00001522|Body Fat|body fat
5444723|NCT00001522|Body Composition|body composition
5444724|NCT00001522|Obesity|obesity
5444725|NCT00001521|21-Hydroxylase Deficiency|21-hydroxylase deficiency
5444726|NCT00001521|11-Hydroxylase Deficiency|11-hydroxylase deficiency
5444727|NCT00001521|Antiandrogen|antiandrogen
5444728|NCT00001521|Aromatase Inhibitor|aromatase inhibitor
5444729|NCT00001521|Growth Disorder|growth disorder
5444730|NCT00001521|Congenital Adrenal Hyperplasia (CAH)|congenital adrenal hyperplasia (cah)
5444731|NCT00001516|Case Study Design|case study design
5444732|NCT00001516|Rehabilitation|rehabilitation
5444733|NCT00001516|Treatment Efficacy|treatment efficacy
5444734|NCT00001516|Occupational Therapy Process|occupational therapy process
5444735|NCT00001516|Reflection|reflection
5444736|NCT00001516|Occupational Therapy|occupational therapy
5444737|NCT00001515|Wegener's Granulomatosis|wegener's granulomatosis
5444738|NCT00001515|Computer Assisted Visualization|computer assisted visualization
5444739|NCT00001515|Lung Cavities|lung cavities
5444740|NCT00001515|Endobronchial Lesions|endobronchial lesions
5444741|NCT00001515|Computed Tomography (CT)|computed tomography (ct)
5444742|NCT00001515|Bronchogenic Carcinoma|bronchogenic carcinoma
5444743|NCT00001512|ProMace Chemotherapy|promace chemotherapy
5444744|NCT00001512|Indolent Lymphoma|indolent lymphoma
5444745|NCT00001512|Anti-Idiotype Antibody|anti-idiotype antibody
5444746|NCT00001512|GM-CSF|gm-csf
5444747|NCT00001512|B-Cell Lymphoma|b-cell lymphoma
5444748|NCT00001507|T-cells|t-cells
5444749|NCT00001507|CD34+ Selection|cd34+ selection
5444750|NCT00001507|T-Cell Depletion|t-cell depletion
5444751|NCT00001507|Apheresis|apheresis
5444752|NCT00001507|Mobilization|mobilization
5444753|NCT00001506|Training Protocol|training protocol
5444754|NCT00001506|Natural History|natural history
5444755|NCT00001506|Consultation|consultation
5444756|NCT00001506|Standard Therapy|standard therapy
5444757|NCT00001506|Standard Tests|standard tests
5444758|NCT00001506|Training|training
5444759|NCT00001505|Biopsy|biopsy
5444760|NCT00001505|Research|research
5444761|NCT00001505|Autoimmune|autoimmune
5444762|NCT00001505|Blistering|blistering
5444763|NCT00001505|Compensation|compensation
5444764|NCT00001504|Retinoids|retinoids
5444765|NCT00001504|Biomarkers|biomarkers
5444766|NCT00001503|Cancer|cancer
5444767|NCT00001503|Late Effects|late effects
5444768|NCT00001503|Survival|survival
5444769|NCT00001503|Follow-Up|follow-up
5444770|NCT00001500|Smoking|smoking
5444771|NCT00001500|Alcohol|alcohol
5444772|NCT00001500|HIV|hiv
5444773|NCT00001500|AIDS|aids
5444774|NCT00001500|DNA Markers|dna markers
5444775|NCT00001500|Personality|personality
5444776|NCT00001500|Healthy Volunteers|healthy volunteers
5444777|NCT00001500|Normal Volunteer|normal volunteer
5444778|NCT00001496|BRCA-1|brca-1
5444779|NCT00001496|Familial Breast Cancer|familial breast cancer
5444780|NCT00001496|Breast Cell Culture|breast cell culture
5444781|NCT00001496|High Risk|high risk
5444782|NCT00001491|Ceramidetrihexosidase Deficiency|ceramidetrihexosidase deficiency
5444783|NCT00001491|Sural Nerve Biopsy|sural nerve biopsy
5444784|NCT00001491|Nerve Conduction Studies|nerve conduction studies
5444785|NCT00001491|Quantitative Sensory Testing|quantitative sensory testing
5444786|NCT00001491|PGP 9.5 Levels (Skin, Serum and CSF)|pgp 9.5 levels (skin, serum and csf)
5444787|NCT00001491|Fabry Disease|fabry disease
5444788|NCT00001491|Fabrys|fabrys
5444789|NCT00001491|Fabry's|fabry's
5444790|NCT00001487|Menopause|menopause
5444793|NCT00001487|DHEA|dhea
5444794|NCT00001487|Steroids|steroids
5444795|NCT00001487|Mid-Life Depression|mid-life depression
5444796|NCT00001487|Mid Life|mid life
5444797|NCT00001487|Perimenopause|perimenopause
5444798|NCT00001487|Climecteric-Related Mood Disorder|climecteric-related mood disorder
5444799|NCT00001486|Paranoia|paranoia
5444800|NCT00001486|Schizophrenic Research|schizophrenic research
5444801|NCT00001486|Hallucinations|hallucinations
5444802|NCT00001486|Delusions|delusions
5444803|NCT00001486|Brain Scans|brain scans
5444804|NCT00001486|Negative Symptoms|negative symptoms
5444805|NCT00001486|Symptoms of Schizophrenia|symptoms of schizophrenia
5444806|NCT00001486|Causes of Schizophrenia|causes of schizophrenia
5444807|NCT00001486|Psychosis and Schizophrenia|psychosis and schizophrenia
5444808|NCT00001486|Compensation|compensation
5444809|NCT00001486|Schizophrenia|schizophrenia
5444810|NCT00001486|Schizoaffective Disorder|schizoaffective disorder
5444811|NCT00001486|Psychosis|psychosis
5444812|NCT00001486|Manic-Depression|manic-depression
5444813|NCT00001483|Manic-Depressive Disorder|manic-depressive disorder
5444814|NCT00001483|Antidepressants|antidepressants
5444815|NCT00001483|Re-Randomization|re-randomization
5444816|NCT00001483|Continuation|continuation
5444817|NCT00001483|Ratings|ratings
5444818|NCT00001483|Bipolar Illness|bipolar illness
5444819|NCT00001483|Depression|depression
5444820|NCT00001483|Bupropion|bupropion
5444821|NCT00001483|Sertraline|sertraline
5444822|NCT00001481|Postpartum Disorders|postpartum disorders
5444823|NCT00001481|Depression|depression
5444824|NCT00001481|Mood|mood
5444825|NCT00001481|Postpartum Depression|postpartum depression
5444826|NCT00001481|Hormones|hormones
5444827|NCT00001481|Pregnancy|pregnancy
5444828|NCT00001481|Estrogen|estrogen
5444829|NCT00001481|Progesterone|progesterone
5444830|NCT00001481|Gonadal Steroids|gonadal steroids
5444831|NCT00001481|GnRH Agonist|gnrh agonist
5444832|NCT00001481|Postpartum|postpartum
5444833|NCT00001481|Mood Disorder|mood disorder
5444834|NCT00001480|Dementia|dementia
5444835|NCT00001480|Alzheimer's Disease|alzheimer's disease
5444836|NCT00001480|Cerebrospinal Fluid|cerebrospinal fluid
5444837|NCT00001480|Diagnostic Test|diagnostic test
5444838|NCT00001480|Cognitive Testing|cognitive testing
5444839|NCT00001480|Memory Disorder|memory disorder
5444840|NCT00001480|Normal Volunteer|normal volunteer
5444841|NCT00001476|CD34+ Progenitor|cd34+ progenitor
5444842|NCT00001476|Retrovirus|retrovirus
5444843|NCT00001476|Leukapheresis|leukapheresis
5444844|NCT00001476|Transduction|transduction
5444845|NCT00001476|Granulocytes|granulocytes
5444846|NCT00001476|Chronic Granulomatous Disease|chronic granulomatous disease
5444847|NCT00001475|AIDS|aids
5444848|NCT00001475|Cytokines|cytokines
5444849|NCT00001475|Thalidomide|thalidomide
5444850|NCT00001475|Monoclonal Antibody|monoclonal antibody
5444851|NCT00001475|Immunomodulator|immunomodulator
5444852|NCT00001474|Cytokines|cytokines
5444853|NCT00001474|Immunoregulation|immunoregulation
5444854|NCT00001474|Infusion Duration|infusion duration
5444855|NCT00001474|CD4 Cells|cd4 cells
5444856|NCT00001473|Vasculitis|vasculitis
5444857|NCT00001473|Remission|remission
5444858|NCT00001473|Relapse|relapse
5444859|NCT00001473|Toxicity|toxicity
5444860|NCT00001473|ANCA|anca
5444861|NCT00001473|Wegener's Granulomatosis|wegener's granulomatosis
5444862|NCT00001471|AIDS|aids
5444863|NCT00001471|HIV|hiv
5444864|NCT00001471|Retrovirus|retrovirus
5444865|NCT00001471|Therapy|therapy
5444866|NCT00001471|Response|response
5444867|NCT00001469|Cancer Susceptibility Alleles|cancer susceptibility alleles
5444868|NCT00001469|Prostate Cancer|prostate cancer
5444869|NCT00001469|Cancer Genetics|cancer genetics
5444870|NCT00001469|Cancer|cancer
5444871|NCT00001469|Prostate Cancer (hereditary)|prostate cancer (hereditary)
5444872|NCT00001467|Primary Immunodeficiency Disorders|primary immunodeficiency disorders
5444873|NCT00001467|Immunologic Disorders|immunologic disorders
5444874|NCT00001465|Smooth Muscle Proliferation|smooth muscle proliferation
5444875|NCT00001465|Bronchoscopy|bronchoscopy
5444876|NCT00001465|Female|female
5444877|NCT00001465|Pneumothorax|pneumothorax
5444878|NCT00001465|Tuberous Sclerosis|tuberous sclerosis
5444879|NCT00001464|Oxygen|oxygen
5444880|NCT00001464|Bronchoalveolar Lavage|bronchoalveolar lavage
5444881|NCT00001464|DNA Repair|dna repair
5444882|NCT00001464|Carbonyl Groups|carbonyl groups
5444883|NCT00001464|Serum|serum
5444884|NCT00001464|ADP-ribosylation|adp-ribosylation
5444885|NCT00001464|Defensin|defensin
5444886|NCT00001464|Protein Oxidation|protein oxidation
5444887|NCT00001464|Human Volunteers|human volunteers
5444888|NCT00001460|Training Protocol|training protocol
5444889|NCT00001460|Cardiac Diagnosis|cardiac diagnosis
5444890|NCT00001460|Congenital Heart Disease|congenital heart disease
5444891|NCT00001460|Acquired Heart Disease|acquired heart disease
5444892|NCT00001460|Arrhythmias|arrhythmias
5444893|NCT00001458|Cardiovascular Treatment|cardiovascular treatment
5444894|NCT00001458|Cardiovascular Disease|cardiovascular disease
5444895|NCT00001458|Cardiovascular Testing|cardiovascular testing
5444896|NCT00001458|Heart Disease|heart disease
5444897|NCT00001458|Muscle Leg Pain|muscle leg pain
5444898|NCT00001458|Leg Pain|leg pain
5444899|NCT00001458|Circulation|circulation
5444900|NCT00001458|Peripheral Arterial Disease|peripheral arterial disease
5444901|NCT00001458|Intermittent Claudication|intermittent claudication
5444902|NCT00001458|Renal Vascular Disease|renal vascular disease
5444903|NCT00001458|Uncontrolled Hypertension|uncontrolled hypertension
5444904|NCT00001457|Nucleoside Analogues|nucleoside analogues
5444905|NCT00001457|Delta Hepatitis|delta hepatitis
5444906|NCT00001457|Glomerulonephritis|glomerulonephritis
5444907|NCT00001457|Polyarteritis Nodosa|polyarteritis nodosa
5444908|NCT00001457|Hepatitis Mutants|hepatitis mutants
5444909|NCT00001457|3TC|3tc
5444910|NCT00001457|Chronic Hepatitis B|chronic hepatitis b
5444911|NCT00001457|Chronic Hepatitis D|chronic hepatitis d
5444912|NCT00001457|Cirrhosis|cirrhosis
5444913|NCT00001457|Lamivudine|lamivudine
5444914|NCT00001456|Albinism|albinism
5444915|NCT00001456|Platelet Storage Pool Deficiency|platelet storage pool deficiency
5444916|NCT00001456|Metabolic Disease|metabolic disease
5444917|NCT00001456|Hermansky-Pudlak Syndrome|hermansky-pudlak syndrome
5444918|NCT00001454|Estrogen|estrogen
5444919|NCT00001454|Progesterone|progesterone
5444920|NCT00001454|Menses|menses
5444921|NCT00001454|Endometrium|endometrium
5444922|NCT00001454|Normal Volunteer|normal volunteer
5444923|NCT00001453|Petrosal Sinus Sampling|petrosal sinus sampling
5444924|NCT00001453|Corticotropin Releasing Hormone|corticotropin releasing hormone
5444925|NCT00001453|Cushing Syndrome|cushing syndrome
5444926|NCT00001453|Internal Jugular Vein Sampling|internal jugular vein sampling
5444927|NCT00001453|Corticotropin Releasing Hormone Stimulation|corticotropin releasing hormone stimulation
5444928|NCT00001452|Cushing Syndrome|cushing syndrome
5444929|NCT00001452|Gene Mapping|gene mapping
5444930|NCT00001452|Linkage|linkage
5444931|NCT00001452|Oncogene|oncogene
5444932|NCT00001452|Linkage Analysis|linkage analysis
5444933|NCT00001452|Gene Identification|gene identification
5444934|NCT00001452|Tumors|tumors
5444935|NCT00001452|Familial Neoplasia|familial neoplasia
5444936|NCT00001452|Adrenal Gland|adrenal gland
5444937|NCT00001452|Lentigines|lentigines
5444938|NCT00001452|Carney Complex|carney complex
5444939|NCT00001451|Bone Marrow Transplantation|bone marrow transplantation
5444940|NCT00001451|Bone Marrow Donor|bone marrow donor
5444941|NCT00001451|Marrow Transplant|marrow transplant
5444942|NCT00001451|National Marrow Donor Program (NMDP)|national marrow donor program (nmdp)
5444943|NCT00001451|Unrelated Marrow Donor|unrelated marrow donor
5444944|NCT00001451|Healthy Volunteer|healthy volunteer
5444945|NCT00001444|Pharmacokinetics|pharmacokinetics
5444946|NCT00001444|Natural Products|natural products
5444947|NCT00001444|Salvage Therapy|salvage therapy
5444948|NCT00001444|Protein Kinase Antagonist|protein kinase antagonist
5444949|NCT00001442|Taxol|taxol
5444950|NCT00001442|Squamous Cell Carcinoma|squamous cell carcinoma
5444951|NCT00001442|Radiosensitizer|radiosensitizer
5444952|NCT00001442|Radiotherapy|radiotherapy
5444953|NCT00001442|Tumor Potential Doubling Time (Tpot)|tumor potential doubling time (tpot)
5444954|NCT00001440|p53|p53
5444955|NCT00001440|Interleukin-2|interleukin-2
5444956|NCT00001440|T-Cell Repopulation|t-cell repopulation
5444957|NCT00001440|Apheresis|apheresis
5444958|NCT00001440|RAS|ras
5444959|NCT00001432|Purging|purging
5444960|NCT00001432|Apheresis|apheresis
5444961|NCT00001432|Long Term Culture|long term culture
5444962|NCT00001432|T Cells|t cells
5444963|NCT00001432|Stem Cell|stem cell
5444964|NCT00001430|IL-2|il-2
5444965|NCT00001430|Drug Resistance|drug resistance
5444966|NCT00001430|Continuous Infusion|continuous infusion
5444967|NCT00001430|Peripheral Stem Cells|peripheral stem cells
5444968|NCT00001430|MDR|mdr
5444969|NCT00001426|Ovarian Cancer|ovarian cancer
5444970|NCT00001426|Initial Therapy|initial therapy
5444971|NCT00001426|Paclitaxel|paclitaxel
5444972|NCT00001426|Cisplatin|cisplatin
5444973|NCT00001426|Cyclophosphamide|cyclophosphamide
5444974|NCT00001420|Lymphocytes|lymphocytes
5444975|NCT00001420|Cytokines|cytokines
5444976|NCT00001420|Apoptosis|apoptosis
5444977|NCT00001420|Psoriasis|psoriasis
5444978|NCT00001420|Genetics|genetics
5444979|NCT00001420|Psoriatic Arthritis|psoriatic arthritis
5444980|NCT00001418|Sympathetic Nervous System|sympathetic nervous system
5444981|NCT00001418|Dysautonomias|dysautonomias
5444982|NCT00001418|Postural Tachycardia Syndrome|postural tachycardia syndrome
5444983|NCT00001418|Neurocardiogenic Syncope|neurocardiogenic syncope
5444984|NCT00001418|Hypernoradrenergic Hypertension|hypernoradrenergic hypertension
5444985|NCT00001418|Sympathectomy|sympathectomy
5444986|NCT00001418|Fluorodopamine|fluorodopamine
5444987|NCT00001418|Positron Emission Tomography|positron emission tomography
5444988|NCT00001418|Norepinephrine|norepinephrine
5444989|NCT00001418|Dopamine|dopamine
5444990|NCT00001418|Neurocardiologic Disorder|neurocardiologic disorder
5444991|NCT00001417|Needle Biopsy|needle biopsy
5444992|NCT00001417|Computed Tomography|computed tomography
5444993|NCT00001417|Magnetic Resonance Imaging|magnetic resonance imaging
5444994|NCT00001417|Spinal Angiography|spinal angiography
5444995|NCT00001417|Intratumoral Pressure|intratumoral pressure
5444996|NCT00001417|Vertebral Hemangioma|vertebral hemangioma
5444997|NCT00001417|Spinal Metastasis|spinal metastasis
5444998|NCT00001417|Absolute Ethanol|absolute ethanol
5444999|NCT00001417|Spinal Tumor|spinal tumor
5445000|NCT00001417|Vertebral Tumor|vertebral tumor
5445001|NCT00001414|Behavior Genetics|behavior genetics
5445002|NCT00001414|Normal Personality|normal personality
5445003|NCT00001414|Intelligence|intelligence
5445004|NCT00001414|Siblings|siblings
5445005|NCT00001414|Sixteen Personality Factor Questionnaire|sixteen personality factor questionnaire
5445006|NCT00001414|NEO-Personality Inventory (Revised)|neo-personality inventory (revised)
5445007|NCT00001414|X-Chromosome|x-chromosome
5445008|NCT00001413|Corticosteroids|corticosteroids
5445009|NCT00001413|Osteoporosis|osteoporosis
5445010|NCT00001413|Depression|depression
5445011|NCT00001413|DEXA Scan|dexa scan
5445012|NCT00001413|Body Mass|body mass
5445013|NCT00001413|Dual X-Ray|dual x-ray
5445014|NCT00001413|Energy Absorptiometry|energy absorptiometry
5445015|NCT00001413|Normal Volunteer|normal volunteer
5445016|NCT00001412|Gonadal Steroids|gonadal steroids
5445017|NCT00001412|Central Nervous System Function|central nervous system function
5445018|NCT00001412|GnRH Agonist|gnrh agonist
5445019|NCT00001412|Testosterone|testosterone
5445020|NCT00001412|Leuprolide Acetate|leuprolide acetate
5445021|NCT00001412|Mood|mood
5445022|NCT00001412|Behavior|behavior
5445023|NCT00001412|Cognitive Function|cognitive function
5445024|NCT00001410|Recombinant Production|recombinant production
5445025|NCT00001410|Inherited Disease|inherited disease
5445026|NCT00001410|Lysosomal Disorder|lysosomal disorder
5445027|NCT00001410|Inborn Error of Metabolism|inborn error of metabolism
5445028|NCT00001410|Enzyme Replacement Therapy|enzyme replacement therapy
5445029|NCT00001410|Glucocerebrosidase|glucocerebrosidase
5445030|NCT00001410|Polyethylene Glycol|polyethylene glycol
5445031|NCT00001410|Gaucher Disease|gaucher disease
5445032|NCT00001410|Recombinant Enzyme|recombinant enzyme
5445033|NCT00001409|AIDS|aids
5445034|NCT00001409|Gene Therapy|gene therapy
5445035|NCT00001409|T Cell Universal Receptor|t cell universal receptor
5445036|NCT00001409|Ex Vivo Activation|ex vivo activation
5445037|NCT00001408|Lymphocytes|lymphocytes
5445038|NCT00001408|Asthma|asthma
5445039|NCT00001408|Cytokines|cytokines
5445040|NCT00001408|Interleukin-5|interleukin-5
5445041|NCT00001408|Late Phase Response|late phase response
5445042|NCT00001407|Cytokines|cytokines
5445043|NCT00001407|Mycobacteria|mycobacteria
5445044|NCT00001407|Pneumonia|pneumonia
5445045|NCT00001407|Multiple Drug Resistant Tuberculosis|multiple drug resistant tuberculosis
5445046|NCT00001406|Eosinophils|eosinophils
5445047|NCT00001406|Helminth Parasites|helminth parasites
5445048|NCT00001406|Hypereosinophilia|hypereosinophilia
5445049|NCT00001406|Allergy|allergy
5445050|NCT00001406|Asthma|asthma
5445051|NCT00001405|Chronic Granulomatous Disease|chronic granulomatous disease
5445052|NCT00001405|Apheresis|apheresis
5445053|NCT00001405|CD34 Cells|cd34 cells
5445054|NCT00001405|Infection|infection
5445055|NCT00001405|Nadph Oxidase|nadph oxidase
5445056|NCT00001405|Normal Volunteer|normal volunteer
5445057|NCT00001404|Abnormalities, Multiple|abnormalities, multiple
5445058|NCT00001404|Hypothalamic Hamartoma|hypothalamic hamartoma
5445059|NCT00001404|Polysyndactyly|polysyndactyly
5445060|NCT00001404|Autosomal Dominant|autosomal dominant
5445061|NCT00001404|Mutation|mutation
5445062|NCT00001404|Gelastic|gelastic
5445063|NCT00001404|Gelastic Seizure|gelastic seizure
5445064|NCT00001404|Hypothalamic|hypothalamic
5445065|NCT00001404|Malformations|malformations
5445066|NCT00001404|Polydactyly|polydactyly
5445067|NCT00001404|Pallister-Hall Syndrome|pallister-hall syndrome
5445068|NCT00001403|Sporadic|sporadic
5445069|NCT00001403|Mosaic|mosaic
5445070|NCT00001403|Growth Disorder|growth disorder
5445071|NCT00001403|Progressive|progressive
5445072|NCT00001403|Multiple Abnormalities|multiple abnormalities
5445073|NCT00001400|Heart Disease|heart disease
5445074|NCT00001400|Screening|screening
5445075|NCT00001400|Follow-Up|follow-up
5445076|NCT00001399|Gene Therapy|gene therapy
5445077|NCT00001399|Stem Cell Rescue|stem cell rescue
5445078|NCT00001399|Bone Marrow Failure|bone marrow failure
5445079|NCT00001399|Fanconi Anemia|fanconi anemia
5445080|NCT00001398|Hematopoiesis|hematopoiesis
5445081|NCT00001398|Stem Cell Cycling|stem cell cycling
5445082|NCT00001398|Bone Marrow Failure|bone marrow failure
5445083|NCT00001398|Acquired Aplastic Anemia|acquired aplastic anemia
5445084|NCT00001397|Hematologic Malignancies|hematologic malignancies
5445085|NCT00001396|Pacemaker|pacemaker
5445086|NCT00001396|Pediatric|pediatric
5445087|NCT00001396|Obstructive HCM|obstructive hcm
5445088|NCT00001394|Hyperparathyroidism|hyperparathyroidism
5445089|NCT00001394|Arterial Stimulation|arterial stimulation
5445090|NCT00001394|Venous Sampling|venous sampling
5445091|NCT00001394|Parathyroid Adenoma|parathyroid adenoma
5445092|NCT00001394|Parathyroid Hyperplasia|parathyroid hyperplasia
5445093|NCT00001393|Collapsing Glomerulopathy|collapsing glomerulopathy
5445094|NCT00001393|Renal Disease|renal disease
5445095|NCT00001393|HIV Associated Nephropathy|hiv associated nephropathy
5445096|NCT00001392|Retrovirus|retrovirus
5445097|NCT00001392|PCR|pcr
5445098|NCT00001392|Renal Failure|renal failure
5445099|NCT00001392|HIV|hiv
5445100|NCT00001392|Rituximab|rituximab
5445101|NCT00001391|Augmentation|augmentation
5445102|NCT00001391|Osteogenesis|osteogenesis
5445103|NCT00001391|Stem Cells|stem cells
5445104|NCT00001391|Bone Formation|bone formation
5445105|NCT00001391|Bone Induction|bone induction
5445106|NCT00001390|Saliva|saliva
5445107|NCT00001390|Parotid|parotid
5445108|NCT00001390|Lip Biopsy|lip biopsy
5445109|NCT00001390|Health|health
5445110|NCT00001390|Exocrine|exocrine
5445111|NCT00001390|Normal Volunteer|normal volunteer
5445112|NCT00001386|AIDS|aids
5445113|NCT00001386|Retrovirus|retrovirus
5445114|NCT00001386|Therapeutic Vaccine|therapeutic vaccine
5445115|NCT00001386|Vaccine|vaccine
5445116|NCT00001386|Helper T Cells|helper t cells
5445117|NCT00001379|Epstein-Barr Virus|epstein-barr virus
5445118|NCT00001379|Lymphoproliferative Disorder|lymphoproliferative disorder
5445119|NCT00001379|Viral|viral
5445120|NCT00001379|Immunosuppression|immunosuppression
5445121|NCT00001379|Lymphoma|lymphoma
5445122|NCT00001373|Auto-Inflammation|auto-inflammation
5445123|NCT00001373|Familial Mediterranean Fever|familial mediterranean fever
5445124|NCT00001373|Genetics|genetics
5445125|NCT00001373|Periodic Fever|periodic fever
5445126|NCT00001372|Systemic Lupus Erythematosus|systemic lupus erythematosus
5445127|NCT00001372|Natural History|natural history
5445128|NCT00001372|Lupus Nephritis|lupus nephritis
5445129|NCT00001372|Lupus|lupus
5445130|NCT00001372|Systemic Lupus|systemic lupus
5445131|NCT00001372|SLE|sle
5445132|NCT00001368|Cerebral Ischemia|cerebral ischemia
5445133|NCT00001368|Hypertension|hypertension
5445134|NCT00001368|Immune Response|immune response
5445135|NCT00001368|Carotid Stenosis|carotid stenosis
5445136|NCT00001368|Atherosclerosis|atherosclerosis
5445137|NCT00001367|Human|human
5445138|NCT00001367|Movement|movement
5445139|NCT00001367|Non-Investigational to Diagnostic Puzzle|non-investigational to diagnostic puzzle
5445140|NCT00001367|Parkinson's|parkinson's
5445141|NCT00001367|Dystonia|dystonia
5445142|NCT00001367|Cerebellar|cerebellar
5445143|NCT00001367|Puzzles|puzzles
5445144|NCT00001367|Neurological Disorders|neurological disorders
5445145|NCT00001367|Movement Disorders|movement disorders
5445146|NCT00001366|Neuroimaging|neuroimaging
5445147|NCT00001366|Seizures|seizures
5445148|NCT00001366|Cerebral Localization|cerebral localization
5445149|NCT00001366|Partial Epilepsy|partial epilepsy
5445150|NCT00001366|Epilepsy|epilepsy
5445151|NCT00001364|Spinal Arteriovenous Malformations|spinal arteriovenous malformations
5445152|NCT00001364|Spinal Dural Arteriovenous Fistulas|spinal dural arteriovenous fistulas
5445153|NCT00001364|Surgery|surgery
5445154|NCT00001364|Embolization|embolization
5445155|NCT00001364|Spinal Arteriography|spinal arteriography
5445156|NCT00001362|Magnetic Resonance Imaging|magnetic resonance imaging
5445157|NCT00001362|Contrast Enhancement|contrast enhancement
5445158|NCT00001362|Neuroanatomic Morphometry|neuroanatomic morphometry
5445159|NCT00001362|Neurobehavioral Deficits|neurobehavioral deficits
5445160|NCT00001362|Neurological Disorders|neurological disorders
5445161|NCT00001362|Blood Flow|blood flow
5445162|NCT00001362|Blood Volume|blood volume
5445163|NCT00001362|Normal Volunteer|normal volunteer
5445164|NCT00001361|Movement Disorders|movement disorders
5445165|NCT00001361|Sensory Processing|sensory processing
5445166|NCT00001361|Stroke|stroke
5445167|NCT00001361|Spinal Cord Injury|spinal cord injury
5445168|NCT00001361|Blood Flow|blood flow
5445169|NCT00001361|Blood Volume|blood volume
5445170|NCT00001361|Cognitive Function|cognitive function
5445171|NCT00001361|Neurobehavioral Deficits|neurobehavioral deficits
5445172|NCT00001361|Neurological Disorders|neurological disorders
5445173|NCT00001361|Magnetic Resonance Imaging|magnetic resonance imaging
5445174|NCT00001361|Plasticity|plasticity
5445175|NCT00001361|Normal Volunteer|normal volunteer
5445176|NCT00001360|Cognition|cognition
5445177|NCT00001360|Vision|vision
5445178|NCT00001360|Cortex|cortex
5445179|NCT00001360|Visual Processing|visual processing
5445180|NCT00001360|Magnetic Resonance Imaging|magnetic resonance imaging
5445181|NCT00001359|Obsessive Compulsive Disorder|obsessive compulsive disorder
5445182|NCT00001359|PANDAS Associated with Streptococcal Infections|pandas associated with streptococcal infections
5445183|NCT00001359|Adolescents|adolescents
5445184|NCT00001359|Autoimmune Illness|autoimmune illness
5445185|NCT00001359|Children|children
5445186|NCT00001359|Tic Disorders|tic disorders
5445187|NCT00001359|Streptococcal Infections|streptococcal infections
5445188|NCT00001359|Childhood Onset Neuropsychiatric Disorder|childhood onset neuropsychiatric disorder
5445189|NCT00001357|Cytokines|cytokines
5445190|NCT00001357|Immunoregulation|immunoregulation
5445191|NCT00001357|CD4 Cells|cd4 cells
5445192|NCT00001356|IL-3|il-3
5445193|NCT00001356|Stem Cell Factor|stem cell factor
5445194|NCT00001356|Cytokines|cytokines
5445195|NCT00001356|Cell Differentiation|cell differentiation
5445196|NCT00001356|Receptors|receptors
5445197|NCT00001356|Bone Marrow|bone marrow
5445198|NCT00001356|Mastocytosis|mastocytosis
5445199|NCT00001355|Immunodeficiency|immunodeficiency
5445200|NCT00001355|Infections|infections
5445201|NCT00001355|Phagocytes|phagocytes
5445202|NCT00001355|Cytokines|cytokines
5445203|NCT00001355|Genetics|genetics
5445204|NCT00001354|AIDS|aids
5445205|NCT00001354|Immunotherapy|immunotherapy
5445206|NCT00001354|CD4 Cells|cd4 cells
5445207|NCT00001354|Immunomodulator|immunomodulator
5445208|NCT00001354|Cytokines|cytokines
5445209|NCT00001353|AIDS|aids
5445210|NCT00001353|Immune Based Therapy|immune based therapy
5445211|NCT00001353|Adoptive Immunotherapy|adoptive immunotherapy
5445212|NCT00001353|Lymphapheresis|lymphapheresis
5445213|NCT00001353|Ex Vivo Activation|ex vivo activation
5445214|NCT00001353|HIV|hiv
5445215|NCT00001353|Gene Therapy|gene therapy
5445216|NCT00001353|Protease Inhibitor|protease inhibitor
5445217|NCT00001353|Interleukin-2|interleukin-2
5445218|NCT00001353|Indinavir|indinavir
5445219|NCT00001352|Cryptococcus Neoformans|cryptococcus neoformans
5445220|NCT00001352|Cryptococcosis|cryptococcosis
5445221|NCT00001352|CD4|cd4
5445222|NCT00001351|Chronic Infection|chronic infection
5445223|NCT00001351|Infectious Diseases|infectious diseases
5445224|NCT00001351|Host Response|host response
5445225|NCT00001351|Immunologic Disorders|immunologic disorders
5445226|NCT00001351|Acute Infection|acute infection
5445227|NCT00001350|Immunoregulation|immunoregulation
5445228|NCT00001350|T Cell Receptor Alpha/Beta|t cell receptor alpha/beta
5445229|NCT00001350|Lymphadenopathy|lymphadenopathy
5445230|NCT00001350|ALPS|alps
5445231|NCT00001350|Autoimmune Lymphoproliferative Syndrome|autoimmune lymphoproliferative syndrome
5445232|NCT00001349|Plasmapheresis|plasmapheresis
5445233|NCT00001349|Lymphocytes|lymphocytes
5445234|NCT00001349|Eosinophils|eosinophils
5445235|NCT00001349|Neutrophils|neutrophils
5445236|NCT00001347|Linkage Analysis|linkage analysis
5445237|NCT00001347|Genomic DNA|genomic dna
5445238|NCT00001347|Pedigree Analysis|pedigree analysis
5445239|NCT00001347|Usher Syndrome|usher syndrome
5445240|NCT00001347|Usher Syndrome Type 1|usher syndrome type 1
5445241|NCT00001347|Usher Syndrome Type 2|usher syndrome type 2
5445242|NCT00001345|Hypercalcemia|hypercalcemia
5445243|NCT00001345|Multiple Endocrine Neoplasia (MEN)|multiple endocrine neoplasia (men)
5445244|NCT00001345|Familial Hypocalciuric Hypercalcemia|familial hypocalciuric hypercalcemia
5445245|NCT00001345|Hyperparathyroidism|hyperparathyroidism
5445246|NCT00001345|Linkage Analysis|linkage analysis
5445247|NCT00001343|Turner's Syndrome|turner's syndrome
5445248|NCT00001343|Short Stature|short stature
5445249|NCT00001343|Cognitive Function|cognitive function
5445250|NCT00001343|Sex Steroids|sex steroids
5445251|NCT00001343|Turner Syndrome|turner syndrome
5445252|NCT00001343|TS|ts
5445253|NCT00001339|Multidrug Resistance|multidrug resistance
5445254|NCT00001339|Reversal of Drug Resistance|reversal of drug resistance
5445255|NCT00001339|P-Glycoprotein|p-glycoprotein
5445256|NCT00001339|MDR-1|mdr-1
5445257|NCT00001337|Primary Mediastinal B-Cell Lymphoma|primary mediastinal b-cell lymphoma
5445258|NCT00001337|CD20 +|cd20 +
5445259|NCT00001337|Diffuse Large B-Cell Lymphoma|diffuse large b-cell lymphoma
5445260|NCT00001337|Anaplastic Large Cell Lymphoma|anaplastic large cell lymphoma
5445261|NCT00001337|De Novo|de novo
5445262|NCT00001336|Transplantation|transplantation
5445263|NCT00001336|Cancer|cancer
5445264|NCT00001336|Cellular Immunity|cellular immunity
5445265|NCT00001336|Stem Cell Function|stem cell function
5445266|NCT00001336|Immunodeficiency|immunodeficiency
5445267|NCT00001335|Peripheral Stem Cell Transfusion|peripheral stem cell transfusion
5445268|NCT00001335|Up-Front Phase II Window|up-front phase ii window
5445269|NCT00001335|Dose-Intensive Vincristine|dose-intensive vincristine
5445270|NCT00001335|Dose-Intensive Doxorubicin|dose-intensive doxorubicin
5445271|NCT00001335|Dose-Intensive Cyclophosphamide|dose-intensive cyclophosphamide
5445272|NCT00001335|ADR-529 for Cardioprotection|adr-529 for cardioprotection
5445273|NCT00001335|BID Radiation Therapy for Local Control|bid radiation therapy for local control
5445274|NCT00001331|Myopathy|myopathy
5445275|NCT00001331|Phosphofructokinase|phosphofructokinase
5445276|NCT00001331|Acid Maltase|acid maltase
5445277|NCT00001331|Pompe|pompe
5445278|NCT00001331|Muscle Diseases|muscle diseases
5445279|NCT00001331|Genetic Muscle Diseases|genetic muscle diseases
5445280|NCT00001329|Yohimbine|yohimbine
5445281|NCT00001329|Catecholamines|catecholamines
5445282|NCT00001329|Sympathoadrenal Response|sympathoadrenal response
5445283|NCT00001329|Sympathetic Nervous System|sympathetic nervous system
5445284|NCT00001329|Stress|stress
5445285|NCT00001329|Hypertension|hypertension
5445286|NCT00001329|Autonomic Failure|autonomic failure
5445287|NCT00001328|Cancer|cancer
5445288|NCT00001328|Gene Transfer|gene transfer
5445289|NCT00001328|Recurrent Tumors|recurrent tumors
5445290|NCT00001328|Primary Tumors|primary tumors
5445291|NCT00001328|Metastases|metastases
5445292|NCT00001328|Anti-Viral Drugs|anti-viral drugs
5445293|NCT00001328|Chemosensitization|chemosensitization
5445294|NCT00001328|Brain Tumors|brain tumors
5445295|NCT00001328|Gene Therapy|gene therapy
5445296|NCT00001328|Ganciclovir|ganciclovir
5445297|NCT00001327|Syringomyelia|syringomyelia
5445298|NCT00001327|Chiari Malformation|chiari malformation
5445299|NCT00001327|Magnetic Resonance Imaging|magnetic resonance imaging
5445300|NCT00001327|Intraoperative Ultrasonography|intraoperative ultrasonography
5445301|NCT00001327|Hydrocephalus|hydrocephalus
5445302|NCT00001327|Spinal Cord|spinal cord
5445303|NCT00001327|Ventriculostomy|ventriculostomy
5445304|NCT00001327|Lumbar Puncture|lumbar puncture
5445305|NCT00001327|Pressure Measurement|pressure measurement
5445306|NCT00001325|Positron|positron
5445307|NCT00001325|Tomography|tomography
5445308|NCT00001325|Seizures|seizures
5445309|NCT00001325|Epileptic Focus|epileptic focus
5445310|NCT00001325|Electroencephalography|electroencephalography
5445311|NCT00001325|Metabolism|metabolism
5445312|NCT00001325|Glucose|glucose
5445313|NCT00001325|Cerebral|cerebral
5445314|NCT00001325|Positron Emission Tomography|positron emission tomography
5445315|NCT00001325|Lennox Gastaut Syndrome|lennox gastaut syndrome
5445316|NCT00001323|Cognition|cognition
5445317|NCT00001323|Neuropsychology|neuropsychology
5445318|NCT00001323|Neuropsychological Tests|neuropsychological tests
5445319|NCT00001323|Neurological Exam|neurological exam
5445320|NCT00001323|Psychiatric|psychiatric
5445321|NCT00001323|Attention|attention
5445322|NCT00001323|Schizophrenic|schizophrenic
5445323|NCT00001323|Schizoaffective|schizoaffective
5445324|NCT00001323|Working Memory|working memory
5445325|NCT00001323|Memory|memory
5445326|NCT00001322|Gonadal Steroids|gonadal steroids
5445327|NCT00001322|Mood|mood
5445328|NCT00001322|Menstrual Cycle|menstrual cycle
5445329|NCT00001322|Neuropsychological Testing|neuropsychological testing
5445330|NCT00001322|Estrogen|estrogen
5445331|NCT00001322|Dexamethasone|dexamethasone
5445332|NCT00001322|Progesterone|progesterone
5445333|NCT00001322|Central Nervous System Function|central nervous system function
5445334|NCT00001322|Estradiol|estradiol
5445335|NCT00001322|GnRH Agonist|gnrh agonist
5445336|NCT00001320|Parkinson's Disease|parkinson's disease
5445337|NCT00001320|Schizophrenia|schizophrenia
5445338|NCT00001320|Dopamine D2/D3 receptors|dopamine d2/d3 receptors
5445339|NCT00001320|Brain Imaging|brain imaging
5445340|NCT00001320|SPECT|spect
5445341|NCT00001320|Equilibrium|equilibrium
5445342|NCT00001320|Brain Scan|brain scan
5445343|NCT00001320|Brain Research|brain research
5445344|NCT00001320|Brain Disorders|brain disorders
5445345|NCT00001320|Schizoaffective Disorder|schizoaffective disorder
5445346|NCT00001320|Normal Volunteer|normal volunteer
5445347|NCT00001319|HIV Negative|hiv negative
5445348|NCT00001319|CD4 Deficiency|cd4 deficiency
5445349|NCT00001319|Retrovirus|retrovirus
5445350|NCT00001316|Lymph Node|lymph node
5445351|NCT00001316|Polymerase Chain Reaction (PCR)|polymerase chain reaction (pcr)
5445352|NCT00001316|In Situ Hybridization|in situ hybridization
5445353|NCT00001316|AIDS|aids
5445354|NCT00001316|Excisional Biopsy|excisional biopsy
5445355|NCT00001313|Cardiac Diagnosis|cardiac diagnosis
5445356|NCT00001313|Chest Pain|chest pain
5445357|NCT00001313|Hypertrophic Cardiomyopathy|hypertrophic cardiomyopathy
5445358|NCT00001313|Coronary Artery Disease|coronary artery disease
5445359|NCT00001313|Microvascular Angina|microvascular angina
5445360|NCT00001313|Cardiac Investigation|cardiac investigation
5445361|NCT00001313|Follow-up|follow-up
5445362|NCT00001313|Heart Disease|heart disease
5445363|NCT00001310|Retinal Disease|retinal disease
5445364|NCT00001310|Diabetic Retinopathy|diabetic retinopathy
5445365|NCT00001310|Uveitis|uveitis
5445366|NCT00001310|Age-Related Macular Degeneration|age-related macular degeneration
5445367|NCT00001310|Corneal Disease|corneal disease
5445368|NCT00001310|Ocular Disease|ocular disease
5445369|NCT00001309|Pharmacokinetics|pharmacokinetics
5445370|NCT00001309|Biodistribution|biodistribution
5445371|NCT00001309|Ascorbic Acid|ascorbic acid
5445372|NCT00001308|Stuttering|stuttering
5445373|NCT00001308|Tourette's Syndrome|tourette's syndrome
5445374|NCT00001308|Spasmodic Dysphonia|spasmodic dysphonia
5445375|NCT00001308|Dysarthria|dysarthria
5445376|NCT00001308|Parkinson's Disease|parkinson's disease
5445377|NCT00001308|Verbal Dyspraxia|verbal dyspraxia
5445378|NCT00001308|Aphasia|aphasia
5445379|NCT00001308|Speech|speech
5445380|NCT00001308|Motor Control|motor control
5445381|NCT00001307|Analgesia|analgesia
5445382|NCT00001307|PET|pet
5445383|NCT00001307|Positron Emission|positron emission
5445384|NCT00001307|Functional Brain Imaging|functional brain imaging
5445385|NCT00001307|Allodynia|allodynia
5445386|NCT00001307|Thalamus|thalamus
5445387|NCT00001307|Somatosensory Cortex|somatosensory cortex
5445388|NCT00001307|Reflex Sympathetic Dystrophy|reflex sympathetic dystrophy
5445389|NCT00001307|Normal Volunteer|normal volunteer
5445390|NCT00001307|Chronic Pain|chronic pain
5445391|NCT00001306|Infertility|infertility
5445392|NCT00001306|Ovulation|ovulation
5445393|NCT00001306|Autoimmune|autoimmune
5445394|NCT00001306|Follicle|follicle
5445395|NCT00001306|Menopause|menopause
5445396|NCT00001306|Biopsy|biopsy
5445397|NCT00001306|Glucocorticoids|glucocorticoids
5445398|NCT00001306|Premature Ovarian Failure|premature ovarian failure
5445399|NCT00001306|Amenorrhea|amenorrhea
5445400|NCT00001306|Ovarian Failure|ovarian failure
5445401|NCT00001306|POF|pof
5445402|NCT00001305|Osteogenesis Imperfecta|osteogenesis imperfecta
5445403|NCT00001304|Hypoparathyroidism|hypoparathyroidism
5445404|NCT00001304|Parathyroid Hormone|parathyroid hormone
5445405|NCT00001304|Vitamin D|vitamin d
5445406|NCT00001304|Calcium Metabolism|calcium metabolism
5445407|NCT00001304|PTH 1-34|pth 1-34
5445408|NCT00001304|Bone|bone
5445409|NCT00001303|Hemodynamics|hemodynamics
5445410|NCT00001303|Lung Permeability|lung permeability
5445411|NCT00001303|Endotoxin Tolerance|endotoxin tolerance
5445412|NCT00001303|Bronchoscopy|bronchoscopy
5445413|NCT00001303|Human Recombinant Interleukin-1 Receptor|human recombinant interleukin-1 receptor
5445414|NCT00001303|Normal Volunteer|normal volunteer
5445415|NCT00001302|Vinblastine|vinblastine
5445416|NCT00001302|Multidrug Resistance|multidrug resistance
5445417|NCT00001302|Resistance Reversal|resistance reversal
5445418|NCT00001302|Pgp Blocker|pgp blocker
5445419|NCT00001302|Pharmacokinetics|pharmacokinetics
5445420|NCT00001302|Cyclosporine|cyclosporine
5445421|NCT00001302|Drug Interactions|drug interactions
5445422|NCT00001295|Follow-Up|follow-up
5445423|NCT00001295|Treatment|treatment
5445424|NCT00001294|Genetic Linkage|genetic linkage
5445425|NCT00001294|Sex Behavior|sex behavior
5445426|NCT00001294|AIDS|aids
5445427|NCT00001294|Alcohol Dependence|alcohol dependence
5445428|NCT00001294|HLA System|hla system
5445429|NCT00001294|Cancer|cancer
5445430|NCT00001289|Enzyme Replacement|enzyme replacement
5445431|NCT00001289|Type 3 Gaucher's Disease|type 3 gaucher's disease
5445432|NCT00001289|Lysosomal Storage|lysosomal storage
5445433|NCT00001289|Supranuclear Gaze Palsy|supranuclear gaze palsy
5445434|NCT00001289|Seizures|seizures
5445435|NCT00001289|Mental Retardation|mental retardation
5445436|NCT00001289|Gaucher Disease|gaucher disease
5445437|NCT00001288|Positron Emission Tomography|positron emission tomography
5445438|NCT00001288|Epilepsy|epilepsy
5445439|NCT00001288|Stroke|stroke
5445440|NCT00001284|Cognition|cognition
5445441|NCT00001284|Schizophrenia|schizophrenia
5445442|NCT00001284|Magnetic Resonance Imaging|magnetic resonance imaging
5445443|NCT00001284|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
5445444|NCT00001284|Dopaminergic Mechanisms|dopaminergic mechanisms
5445445|NCT00001282|HIV|hiv
5445446|NCT00001282|Immunomodulator|immunomodulator
5445447|NCT00001282|Anti-Viral|anti-viral
5445448|NCT00001281|Lymphocytes|lymphocytes
5445449|NCT00001281|Venipuncture|venipuncture
5445450|NCT00001281|Mononuclear Cells|mononuclear cells
5445451|NCT00001277|Hypoglycemia|hypoglycemia
5445452|NCT00001277|Genetics|genetics
5445453|NCT00001277|Hyperparathyroidism|hyperparathyroidism
5445454|NCT00001276|Hypoglycemia|hypoglycemia
5445455|NCT00001276|Insulinoma|insulinoma
5445456|NCT00001275|Menopause|menopause
5445457|NCT00001275|Estrogen|estrogen
5445458|NCT00001275|Infertility|infertility
5445459|NCT00001275|Ovulation|ovulation
5445460|NCT00001275|Amenorrhea|amenorrhea
5445461|NCT00001275|Hypergonadotropic Hypogonadism|hypergonadotropic hypogonadism
5445462|NCT00001275|Young Women|young women
5445463|NCT00001275|Gonadal Steroid Deficiency|gonadal steroid deficiency
5445464|NCT00001275|Mineralocorticoid Deficiency|mineralocorticoid deficiency
5445465|NCT00001275|Premature Ovarian Failure|premature ovarian failure
5445466|NCT00001275|POF|pof
5445467|NCT00001266|Bayesian|bayesian
5445468|NCT00001266|Hydroxy-Flutamide|hydroxy-flutamide
5445469|NCT00001266|Combined Androgen Ablation|combined androgen ablation
5445598|NCT00001242|Parathyroid|parathyroid
5445470|NCT00001266|Prostate Specific Antigen|prostate specific antigen
5445471|NCT00001265|Autoimmune Diseases|autoimmune diseases
5445472|NCT00001265|Idiopathic Inflammatory Myopathies|idiopathic inflammatory myopathies
5445473|NCT00001265|Polymyositis|polymyositis
5445474|NCT00001265|Dermatomyositis|dermatomyositis
5445475|NCT00001265|Inclusion Body Myositis|inclusion body myositis
5445476|NCT00001265|Pathogenesis|pathogenesis
5445477|NCT00001265|Connective Tissue Diseases|connective tissue diseases
5445478|NCT00001262|Menkes|menkes
5445479|NCT00001262|Copper|copper
5445480|NCT00001262|X-Linked|x-linked
5445481|NCT00001262|Neurodegeneration|neurodegeneration
5445482|NCT00001262|ATP7A|atp7a
5445483|NCT00001261|Polymyositis/Dermatomyositis|polymyositis/dermatomyositis
5445484|NCT00001261|Muscle Immunopathology|muscle immunopathology
5445485|NCT00001261|Intravenous High-Dose Immunoglobulin|intravenous high-dose immunoglobulin
5445486|NCT00001261|Inclusion Body Myositis|inclusion body myositis
5445487|NCT00001260|Schizophrenia|schizophrenia
5445488|NCT00001260|Neuropathology|neuropathology
5445489|NCT00001260|Neurochemistry|neurochemistry
5445490|NCT00001260|Substance Abuse|substance abuse
5445491|NCT00001260|Bipolar Disorder|bipolar disorder
5445492|NCT00001260|Aging|aging
5445493|NCT00001260|Normal Development|normal development
5445494|NCT00001260|Depression|depression
5445495|NCT00001260|Anxiety Disorders|anxiety disorders
5445496|NCT00001260|Suicide|suicide
5445497|NCT00001260|Dementia|dementia
5445498|NCT00001260|Neuropsychiatric Disorders|neuropsychiatric disorders
5445499|NCT00001260|Tourette's Syndrome|tourette's syndrome
5445500|NCT00001260|Normal Controls|normal controls
5445501|NCT00001259|Depression|depression
5445502|NCT00001259|Menstrual Cycle|menstrual cycle
5445503|NCT00001259|Gonadal Steroids|gonadal steroids
5445504|NCT00001259|GnRH Agonist|gnrh agonist
5445505|NCT00001259|Mood Disorders|mood disorders
5445506|NCT00001258|Neuropsychology|neuropsychology
5445507|NCT00001258|Cerebral Blood Flow|cerebral blood flow
5445508|NCT00001258|Cognitive Disorders|cognitive disorders
5445509|NCT00001258|Prefrontal Cortex|prefrontal cortex
5445510|NCT00001258|Hormones|hormones
5445511|NCT00001258|Psychosis|psychosis
5445512|NCT00001258|Neuroimaging|neuroimaging
5445513|NCT00001258|Brain Scan|brain scan
5445514|NCT00001258|Healthy Volunteers|healthy volunteers
5445515|NCT00001258|Schizophrenia|schizophrenia
5445516|NCT00001257|Lymphokines|lymphokines
5445517|NCT00001257|LTB4|ltb4
5445518|NCT00001257|Inflammation|inflammation
5445519|NCT00001257|Normal Volunteer|normal volunteer
5445520|NCT00001257|Abnormal Phagocyte Function|abnormal phagocyte function
5445521|NCT00001256|Vasculitis|vasculitis
5445522|NCT00001256|Cytotoxic Therapy|cytotoxic therapy
5445523|NCT00001256|Inflammation|inflammation
5445524|NCT00001256|Glomerulonephritis|glomerulonephritis
5445525|NCT00001256|Inflammatory Sinusitis|inflammatory sinusitis
5445526|NCT00001255|Retroviral Vector|retroviral vector
5445527|NCT00001255|Gene Therapy|gene therapy
5445528|NCT00001255|PEG-ADA|peg-ada
5445529|NCT00001255|Severe Combined Immunodeficiency (SCID)|severe combined immunodeficiency (scid)
5445530|NCT00001255|Adenosine Deaminase Deficiency (ADA)|adenosine deaminase deficiency (ada)
5445531|NCT00001254|Islet Cell Tumors|islet cell tumors
5445532|NCT00001253|Turner's Syndrome|turner's syndrome
5445533|NCT00001253|Estrogen|estrogen
5445534|NCT00001253|Ethinyl estradiol|ethinyl estradiol
5445535|NCT00001253|Learning|learning
5445536|NCT00001253|Ovarian dysgenesis|ovarian dysgenesis
5445537|NCT00001252|Biomechanics|biomechanics
5445538|NCT00001252|Kinesiology|kinesiology
5445539|NCT00001252|Walking|walking
5445540|NCT00001252|ACL|acl
5445541|NCT00001252|Stroke|stroke
5445542|NCT00001252|Leg Weakness|leg weakness
5445543|NCT00001252|Paralysis|paralysis
5445544|NCT00001252|Anterior Cruciate Ligament|anterior cruciate ligament
5445545|NCT00001252|Gait Degicit|gait degicit
5445546|NCT00001251|Meningeal Malignancy|meningeal malignancy
5445547|NCT00001251|Pediatric|pediatric
5445548|NCT00001251|Alkylating Agents|alkylating agents
5445549|NCT00001250|Neoadjuvant Chemotherapy|neoadjuvant chemotherapy
5445550|NCT00001250|Dose Intense Chemotherapy|dose intense chemotherapy
5445551|NCT00001250|Stage II Breast Cancer|stage ii breast cancer
5445552|NCT00001250|Early Stage Breast Cancer|early stage breast cancer
5445553|NCT00001248|Multiple Sclerosis|multiple sclerosis
5445554|NCT00001248|MRI (Magnetic Resonance Imaging)|mri (magnetic resonance imaging)
5445555|NCT00001247|Schizophrenia|schizophrenia
5445556|NCT00001247|Psychosis|psychosis
5445557|NCT00001247|Neuroleptics|neuroleptics
5445558|NCT00001247|Schizoaffective Disorder|schizoaffective disorder
5445559|NCT00001246|Cognitive|cognitive
5445560|NCT00001246|Genetics|genetics
5445561|NCT00001246|Development|development
5445562|NCT00001246|Klinefelter Syndrome|klinefelter syndrome
5445563|NCT00001246|Jacob Syndrome|jacob syndrome
5445564|NCT00001246|Trisomy X|trisomy x
5445565|NCT00001246|Healthy Volunteer|healthy volunteer
5445566|NCT00001246|XXY|xxy
5445567|NCT00001246|XXXY|xxxy
5445568|NCT00001246|XXXXY|xxxxy
5445569|NCT00001246|XYY|xyy
5445570|NCT00001246|XXYY|xxyy
5445571|NCT00001246|XO|xo
5445572|NCT00001246|XXXX|xxxx
5445573|NCT00001246|XXX|xxx
5445574|NCT00001246|XXXXX|xxxxx
5445575|NCT00001246|Triple X|triple x
5445576|NCT00001246|Congenital Adrenal Hyperplasia|congenital adrenal hyperplasia
5445577|NCT00001246|Twin|twin
5445578|NCT00001245|Strongyloidiasis|strongyloidiasis
5445579|NCT00001245|Immediate Hypersensitivity Skin Test|immediate hypersensitivity skin test
5445580|NCT00001245|IgE|ige
5445581|NCT00001245|Nematode|nematode
5445582|NCT00001245|Immunosuppression|immunosuppression
5445583|NCT00001245|Skin Test|skin test
5445584|NCT00001245|Diagnosis|diagnosis
5445585|NCT00001245|Intestinal Helminth|intestinal helminth
5445586|NCT00001245|Immediate Hypersensitivity|immediate hypersensitivity
5445587|NCT00001244|Agammaglobulinemia|agammaglobulinemia
5445588|NCT00001244|Primary Immune Deficiency|primary immune deficiency
5445589|NCT00001244|Immune Response|immune response
5445590|NCT00001243|AIDS|aids
5445591|NCT00001243|Myeloid Progenitors|myeloid progenitors
5445592|NCT00001243|Monocytes|monocytes
5445593|NCT00001243|Plasmid Libraries|plasmid libraries
5445594|NCT00001243|Cytokines|cytokines
5445595|NCT00001242|Calcium|calcium
5445596|NCT00001242|Vitamin D|vitamin d
5445597|NCT00001242|Calcitriol|calcitriol
5445599|NCT00001242|Cyclic AMP|cyclic amp
5445600|NCT00001242|Rickets|rickets
5445601|NCT00001241|Gastric Acid Secretion|gastric acid secretion
5445602|NCT00001241|Histamine H2-Receptor Antagonists|histamine h2-receptor antagonists
5445603|NCT00001240|Stomach|stomach
5445604|NCT00001240|Hypersecretion|hypersecretion
5445605|NCT00001240|Hyposecretion|hyposecretion
5445606|NCT00001240|Gastrinoma|gastrinoma
5445607|NCT00001240|Zollinger-Ellison Syndrome|zollinger-ellison syndrome
5445608|NCT00001238|Urologic Malignant Disorders|urologic malignant disorders
5445609|NCT00001238|Birt Hogg Dube|birt hogg dube
5445610|NCT00001238|Von Hippel Lindau|von hippel lindau
5445907|NCT00001162|Giardia|giardia
5445611|NCT00001238|Hereditary Papillary Renal Cancer/Renal Cell Acarcinoma|hereditary papillary renal cancer/renal cell acarcinoma
5445612|NCT00001235|Primary Neuronal Degeneration|primary neuronal degeneration
5445613|NCT00001235|Genetics|genetics
5445614|NCT00001235|Neurotransmitters|neurotransmitters
5445615|NCT00001235|DNA|dna
5445616|NCT00001235|Lymphoblasts|lymphoblasts
5445617|NCT00001235|Skin Fibroblast|skin fibroblast
5445618|NCT00001235|Alzheimer's Disease|alzheimer's disease
5445619|NCT00001234|Bone Marrow|bone marrow
5445620|NCT00001234|Retroviral-Mediated Gene Transfer|retroviral-mediated gene transfer
5445621|NCT00001234|Hematopoietic Progenitor Cell|hematopoietic progenitor cell
5445622|NCT00001231|Mood|mood
5445623|NCT00001231|Behavior|behavior
5445624|NCT00001231|Cognition|cognition
5445625|NCT00001231|Climacteric|climacteric
5445626|NCT00001231|Menopause|menopause
5445627|NCT00001231|Perimenopause|perimenopause
5445628|NCT00001231|Midlife|midlife
5445629|NCT00001231|Depression|depression
5445630|NCT00001230|Wuchereria Bancrofti|wuchereria bancrofti
5445631|NCT00001230|Loa Loa|loa loa
5445632|NCT00001230|Brugia Malayi|brugia malayi
5445633|NCT00001230|Brugia Timori|brugia timori
5445634|NCT00001230|Onchocerca Volvulus|onchocerca volvulus
5445635|NCT00001230|Mansonella Perstans|mansonella perstans
5445636|NCT00001230|Mansonella Ozzardi|mansonella ozzardi
5445637|NCT00001230|Diethylcarbamazine (DEC)|diethylcarbamazine (dec)
5445638|NCT00001230|Suramin|suramin
5445639|NCT00001230|Ivermectin|ivermectin
5445640|NCT00001230|Filarial Infection|filarial infection
5445641|NCT00001228|Interferon|interferon
5445642|NCT00001228|Zollinger-Ellison Syndrome|zollinger-ellison syndrome
5445643|NCT00001226|Nonradioactive Isotopes|nonradioactive isotopes
5445644|NCT00001226|Lipoprotein Kinetics|lipoprotein kinetics
5445645|NCT00001226|Apolipoproteins|apolipoproteins
5445646|NCT00001226|Dyslipoproteinemia|dyslipoproteinemia
5445647|NCT00001226|Healthy Volunteers|healthy volunteers
5445648|NCT00001225|DNA Polymorphisms|dna polymorphisms
5445649|NCT00001225|Echocardiography|echocardiography
5445650|NCT00001225|Gene Mapping|gene mapping
5445651|NCT00001225|Linkage Analysis|linkage analysis
5445652|NCT00001225|Hypertrophic Cardiomyopathy|hypertrophic cardiomyopathy
5445653|NCT00001224|Ocular Inflammatory Disease|ocular inflammatory disease
5445654|NCT00001224|Cataracts|cataracts
5445655|NCT00001224|Vitrectomy|vitrectomy
5445656|NCT00001224|Extracapsular|extracapsular
5445657|NCT00001224|Cataract Surgery|cataract surgery
5445658|NCT00001224|Uveitis|uveitis
5445659|NCT00001224|Lenticular Opacity|lenticular opacity
5445660|NCT00001224|Vitreal Opacity|vitreal opacity
5445661|NCT00001223|Cystic Fibrosis|cystic fibrosis
5445662|NCT00001223|Pancreatic Insufficiency|pancreatic insufficiency
5445663|NCT00001223|Bronchiectasis|bronchiectasis
5445664|NCT00001221|Growth|growth
5445665|NCT00001221|Gonadal Dysgenesis|gonadal dysgenesis
5445666|NCT00001221|Estrogen|estrogen
5445667|NCT00001221|Somatotropin|somatotropin
5445668|NCT00001221|Turner's Syndrome|turner's syndrome
5445669|NCT00001221|Growth Hormone|growth hormone
5445670|NCT00001220|Swallowing Disorders|swallowing disorders
5445671|NCT00001220|Neuromotor Dysfunction|neuromotor dysfunction
5445672|NCT00001220|Aspiration|aspiration
5445673|NCT00001220|Imaging|imaging
5445674|NCT00001219|Magnetic Resonance Imaging|magnetic resonance imaging
5445675|NCT00001219|Pulse Sequences|pulse sequences
5445676|NCT00001215|Lysosomal Storage Disorders|lysosomal storage disorders
5445677|NCT00001215|Variants|variants
5445678|NCT00001215|Chemical Phenotype|chemical phenotype
5445679|NCT00001215|Proteins|proteins
5445680|NCT00001215|Genes|genes
5445681|NCT00001215|Phenotype|phenotype
5445682|NCT00001215|Mutations|mutations
5445683|NCT00001215|Parkinsonism|parkinsonism
5445684|NCT00001214|Bone Marrow Failure|bone marrow failure
5445685|NCT00001214|Lymphocytapheresis|lymphocytapheresis
5445686|NCT00001214|Pancytopenia|pancytopenia
5445687|NCT00001214|Aplastic Anemia|aplastic anemia
5445688|NCT00001214|Hematosuppressive Disease|hematosuppressive disease
5445689|NCT00001213|Cysteamine Eye Drops|cysteamine eye drops
5445690|NCT00001213|Nephropathic Cystinosis|nephropathic cystinosis
5445691|NCT00001213|Corneal Crystals|corneal crystals
5445692|NCT00001213|Benzalkonium|benzalkonium
5445693|NCT00001213|Toxicity|toxicity
5445694|NCT00001213|Efficacy|efficacy
5445695|NCT00001213|Cystinosis|cystinosis
5445696|NCT00001212|Systemic Lupus Erythematosus|systemic lupus erythematosus
5445697|NCT00001212|Nephrotic Syndrome|nephrotic syndrome
5445698|NCT00001212|Immunosuppressive Drugs|immunosuppressive drugs
5445699|NCT00001212|Prednisone|prednisone
5445700|NCT00001212|Methylprednisolone|methylprednisolone
5445701|NCT00001212|Cyclophosphamide|cyclophosphamide
5445702|NCT00001212|Cyclosporine|cyclosporine
5445703|NCT00001212|Cyclosporin A|cyclosporin a
5445704|NCT00001208|Spasmodic Torticollis|spasmodic torticollis
5445705|NCT00001208|Writer's Cramp|writer's cramp
5445706|NCT00001208|Spasmodic Dysphonia|spasmodic dysphonia
5445707|NCT00001208|Stuttering|stuttering
5445708|NCT00001208|Oromandibular Dystonia|oromandibular dystonia
5445709|NCT00001208|Palatal Myoclonus|palatal myoclonus
5445710|NCT00001208|Dystonia|dystonia
5445711|NCT00001208|Essential Tremor|essential tremor
5445712|NCT00001208|Movement Disorders|movement disorders
5445713|NCT00001206|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
5445714|NCT00001206|Disruptive Behavior Disorders|disruptive behavior disorders
5445715|NCT00001206|Cerebrospinal Fluid|cerebrospinal fluid
5445716|NCT00001206|Lumbar Puncture|lumbar puncture
5445717|NCT00001206|CSF|csf
5445718|NCT00001206|Longitudinal Prospective Follow-Up|longitudinal prospective follow-up
5445719|NCT00001206|Psychosocial Functioning|psychosocial functioning
5445720|NCT00001206|Risk Factors|risk factors
5445721|NCT00001206|Genetics|genetics
5445722|NCT00001205|Taenia Solium|taenia solium
5445723|NCT00001205|Cysticercosis|cysticercosis
5445724|NCT00001205|Praziquantel|praziquantel
5445725|NCT00001204|Dyslipoprotein|dyslipoprotein
5445726|NCT00001204|Hypercholesterolemia|hypercholesterolemia
5445727|NCT00001204|Atherosclerosis|atherosclerosis
5445728|NCT00001203|Desferal|desferal
5445729|NCT00001203|Thalassemia|thalassemia
5445730|NCT00001203|Liver Iron Concentration|liver iron concentration
5445731|NCT00001203|Endocrine Evaluation|endocrine evaluation
5445732|NCT00001203|Diabetes Mellitus|diabetes mellitus
5445733|NCT00001203|Cardiac Disease|cardiac disease
5445734|NCT00001203|Acquired Anemia|acquired anemia
5445735|NCT00001202|Luteinizing Hormone|luteinizing hormone
5445736|NCT00001202|High Serum Testosterone Levels|high serum testosterone levels
5445737|NCT00001202|Low Baseline Gonadotropin|low baseline gonadotropin
5445738|NCT00001202|LHRH|lhrh
5445739|NCT00001202|Precocious Puberty|precocious puberty
5445740|NCT00001202|Familial Isosexual Precocious Puberty|familial isosexual precocious puberty
5445741|NCT00001201|Nerve Conduction Studies|nerve conduction studies
5445742|NCT00001201|EMG|emg
5445743|NCT00001201|Normal Volunteer|normal volunteer
5445744|NCT00001201|Electrophysiology|electrophysiology
5445745|NCT00001201|Peripheral Neuropathies|peripheral neuropathies
5445746|NCT00001201|Myopathies|myopathies
5445747|NCT00001198|Schizophrenia|schizophrenia
5445748|NCT00001198|Observational|observational
5445749|NCT00001197|Gene Expression Therapy|gene expression therapy
5445750|NCT00001197|Gamma Globin Gene|gamma globin gene
5445751|NCT00001197|Hemoglobin Switching|hemoglobin switching
5445752|NCT00001197|Bone Marrow|bone marrow
5445753|NCT00001197|Sickle Cell Anemia|sickle cell anemia
5445754|NCT00001196|Salivary Function|salivary function
5445755|NCT00001196|Salivary Gland|salivary gland
5445756|NCT00001196|Sjogren's Syndrome|sjogren's syndrome
5445757|NCT00001196|Dry Mouth|dry mouth
5445758|NCT00001195|Development|development
5445759|NCT00001195|Hormones|hormones
5445760|NCT00001195|Growth|growth
5445761|NCT00001195|Metabolism|metabolism
5445762|NCT00001195|Eating Behavior|eating behavior
5445763|NCT00001195|Body Composition|body composition
5445764|NCT00001195|Normal Volunteer|normal volunteer
5445765|NCT00001192|Executive Functions|executive functions
5445766|NCT00001192|Language|language
5445767|NCT00001192|Attention|attention
5445768|NCT00001192|Visual-Spatial Ability|visual-spatial ability
5445769|NCT00001192|Memory|memory
5445770|NCT00001192|Motor Behavior|motor behavior
5445771|NCT00001192|Intelligence|intelligence
5445772|NCT00001192|Personality|personality
5445773|NCT00001192|Visual and Auditory Functioning|visual and auditory functioning
5445774|NCT00001192|Hand and Eye Dominance|hand and eye dominance
5445775|NCT00001192|Normal Volunteer|normal volunteer
5445776|NCT00001192|Neuropsychiatric Disorders|neuropsychiatric disorders
5445777|NCT00001191|Zollinger-Ellison Syndrome|zollinger-ellison syndrome
5445778|NCT00001191|Gastrinoma|gastrinoma
5445779|NCT00001191|Acid Hypersecretion|acid hypersecretion
5445780|NCT00001191|H+-K+ ATPase Inhibitor|h+-k+ atpase inhibitor
5445781|NCT00001186|Psychosocial|psychosocial
5445782|NCT00001186|Self Esteem|self esteem
5445783|NCT00001186|Oncology|oncology
5445784|NCT00001186|Well-Being|well-being
5445785|NCT00001186|Pediatrics|pediatrics
5445786|NCT00001185|Poliomyelitis|poliomyelitis
5445787|NCT00001185|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
5445788|NCT00001185|Motor Neurons|motor neurons
5445789|NCT00001185|Late Viral Infection|late viral infection
5445790|NCT00001185|Motor Neuron Firing|motor neuron firing
5445791|NCT00001185|Immune Defects|immune defects
5445792|NCT00001185|Post-polio Syndrome|post-polio syndrome
5445793|NCT00001185|Post-polio Motor Neuron Disease|post-polio motor neuron disease
5445794|NCT00001184|Inflammatory Bowel Disease|inflammatory bowel disease
5445795|NCT00001184|Regional Enteritis|regional enteritis
5445796|NCT00001184|Crohn's Disease|crohn's disease
5445797|NCT00001184|Ulcerative Colitis|ulcerative colitis
5445798|NCT00001184|IBD|ibd
5445799|NCT00001183|Computed Tomography|computed tomography
5445800|NCT00001183|Fiberoptic Bronchoscopy|fiberoptic bronchoscopy
5445801|NCT00001183|Pulmonary Function Testing|pulmonary function testing
5445802|NCT00001183|Cardiopulmonary Exercise Testing|cardiopulmonary exercise testing
5445803|NCT00001183|Allergen Skin Testing|allergen skin testing
5445804|NCT00001183|Chronic Lung Disease|chronic lung disease
5445805|NCT00001182|General Dental|general dental
5445806|NCT00001182|Diagnostic|diagnostic
5445807|NCT00001182|Therapeutic|therapeutic
5445808|NCT00001181|McCune-Albright Syndrome|mccune-albright syndrome
5445809|NCT00001181|Aromatase Inhibitor|aromatase inhibitor
5445810|NCT00001181|Teslac|teslac
5445811|NCT00001180|Corticotropin Releasing Hormone|corticotropin releasing hormone
5445812|NCT00001180|Cushing Syndrome|cushing syndrome
5445813|NCT00001180|Psychiatric Hypercortisolism|psychiatric hypercortisolism
5445814|NCT00001180|Adrenal Insufficiency|adrenal insufficiency
5445815|NCT00001180|Normal Volunteer|normal volunteer
5445816|NCT00001178|Alzheimer's Disease|alzheimer's disease
5445817|NCT00001178|Cerebral Metabolism|cerebral metabolism
5445818|NCT00001178|Cerebrospinal Fluid|cerebrospinal fluid
5445819|NCT00001178|Dementia of the Alzheimer Type|dementia of the alzheimer type
5445820|NCT00001178|18-F-Fluoro-2-Deoxy-D-Glucose (FDG)|18-f-fluoro-2-deoxy-d-glucose (fdg)
5445821|NCT00001178|Magnetic Resonance Imaging|magnetic resonance imaging
5445822|NCT00001178|Positron Emission Tomography|positron emission tomography
5445823|NCT00001178|X-Ray Computed Tomography (CT)|x-ray computed tomography (ct)
5445824|NCT00001178|Senile Dementia|senile dementia
5445825|NCT00001178|Down Syndrome|down syndrome
5445826|NCT00001178|Trisomy 21|trisomy 21
5445827|NCT00001177|Mood|mood
5445828|NCT00001177|Depression|depression
5445829|NCT00001177|Cognition|cognition
5445830|NCT00001177|Menstrual|menstrual
5445831|NCT00001177|Neuroendocrine|neuroendocrine
5445832|NCT00001177|Genetics|genetics
5445833|NCT00001177|PMDD|pmdd
5445834|NCT00001177|PMS Premenstrual Syndrome|pms premenstrual syndrome
5445835|NCT00001177|MRMD Menstrually Related Mood Disorder|mrmd menstrually related mood disorder
5445836|NCT00001176|Adrenergic Nervous System|adrenergic nervous system
5445837|NCT00001176|Dopaminergic Nervous System|dopaminergic nervous system
5445838|NCT00001176|Salt-Sensitive Hypertension|salt-sensitive hypertension
5445839|NCT00001176|Hypertension|hypertension
5445840|NCT00001176|Primary Aldosteronism|primary aldosteronism
5445841|NCT00001174|Bipolar Manic-Depressive Illness|bipolar manic-depressive illness
5445842|NCT00001174|Affective Disorder|affective disorder
5445843|NCT00001174|Depression|depression
5445844|NCT00001174|Genetic|genetic
5445845|NCT00001174|DNA|dna
5445846|NCT00001174|Mania|mania
5445847|NCT00001174|Affected Sibling Pairs|affected sibling pairs
5445848|NCT00001174|Family Study|family study
5445849|NCT00001174|Genome-Wide Scan|genome-wide scan
5445850|NCT00001174|Lymphoblastoid Cell Lines|lymphoblastoid cell lines
5445851|NCT00001174|Diagnostic Interview for Genetic Studies (DIGS)|diagnostic interview for genetic studies (digs)
5445852|NCT00001174|Panic Disorder|panic disorder
5445853|NCT00001174|Bipolar Disorder|bipolar disorder
5445854|NCT00001172|Vision|vision
5445855|NCT00001172|Eye Movement|eye movement
5445856|NCT00001172|Perception|perception
5445857|NCT00001172|Healthy Volunteer|healthy volunteer
5445858|NCT00001171|Brain Tumors|brain tumors
5445859|NCT00001171|Glioma|glioma
5445860|NCT00001171|Glioblastoma Multiforme|glioblastoma multiforme
5445861|NCT00001171|Pituitary Adenoma|pituitary adenoma
5445862|NCT00001170|Parental Psychopathology|parental psychopathology
5445863|NCT00001170|Child Rearing|child rearing
5445864|NCT00001170|Depression|depression
5445865|NCT00001170|Bipolar Affective Disorders|bipolar affective disorders
5445866|NCT00001170|Manic-Depression|manic-depression
5445867|NCT00001170|Social-Emotional Development|social-emotional development
5445868|NCT00001170|Cognitive Development|cognitive development
5445869|NCT00001170|Child Psychopathology|child psychopathology
5445870|NCT00001170|Affective Disorder|affective disorder
5445871|NCT00001170|Children at Risk|children at risk
5445872|NCT00001168|Dyslipoproteinemia|dyslipoproteinemia
5445873|NCT00001168|Hypercholesterolemia|hypercholesterolemia
5445874|NCT00001168|Hypertriglyceridemia|hypertriglyceridemia
5445875|NCT00001168|hypoalphalipoproteinemia|hypoalphalipoproteinemia
5445876|NCT00001168|Atherosclerosis|atherosclerosis
5445877|NCT00001168|Type III Hyperlipoproteinemia|type iii hyperlipoproteinemia
5445878|NCT00001168|Plasma Lipoproteins|plasma lipoproteins
5445879|NCT00001167|Dysphagia|dysphagia
5445880|NCT00001167|Dysarthria|dysarthria
5445881|NCT00001167|Tongue Motion|tongue motion
5445882|NCT00001167|Xerostomia|xerostomia
5445883|NCT00001167|Swallowing|swallowing
5445884|NCT00001167|Speech|speech
5445885|NCT00001167|Polymyositis|polymyositis
5445886|NCT00001167|Speech Disorders|speech disorders
5445887|NCT00001167|Oral-Facial Paralysis|oral-facial paralysis
5445888|NCT00001167|Ultrasound|ultrasound
5445889|NCT00001166|Hyperornithinemia|hyperornithinemia
5445890|NCT00001166|Ornithine-Aminotransferase (OAT)|ornithine-aminotransferase (oat)
5445891|NCT00001166|Tissue Culture|tissue culture
5445892|NCT00001166|Pyridoxine Hydrochloride|pyridoxine hydrochloride
5445893|NCT00001166|Pyridoxal Phosphate|pyridoxal phosphate
5445894|NCT00001166|Arginine|arginine
5445895|NCT00001166|Skin Fibroblast|skin fibroblast
5445896|NCT00001166|Gyrate Atrophy|gyrate atrophy
5445897|NCT00001166|Autosomal Recessive Retinitis Pigmentosa|autosomal recessive retinitis pigmentosa
5445898|NCT00001166|Bietti's Crystalline Retinopathy|bietti's crystalline retinopathy
5445899|NCT00001166|Chorioretinal Degeneration|chorioretinal degeneration
5445900|NCT00001165|Gastrinoma|gastrinoma
5445901|NCT00001165|Acid Secretion|acid secretion
5445902|NCT00001165|Toxicity|toxicity
5445903|NCT00001163|Cancer|cancer
5445904|NCT00001163|Genes/Genetics|genes/genetics
5445905|NCT00001163|Hereditary Neoplasms|hereditary neoplasms
5445906|NCT00001163|Environment|environment
5445908|NCT00001162|Helminth|helminth
5445909|NCT00001162|Cryptosporidium|cryptosporidium
5445910|NCT00001162|Hookworms|hookworms
5445911|NCT00001162|Trichuris|trichuris
5445912|NCT00001162|Strongyloides|strongyloides
5445913|NCT00001162|Protozoa|protozoa
5445914|NCT00001162|Small Bowel Biopsy|small bowel biopsy
5445915|NCT00001162|E. Histolytica|e. histolytica
5445916|NCT00001162|Duodenal Aspiration|duodenal aspiration
5445917|NCT00001162|Coccidiosis|coccidiosis
5445918|NCT00001162|Clonorchis|clonorchis
5445919|NCT00001162|Amebiasis|amebiasis
5445920|NCT00001162|Parasitic Disease|parasitic disease
5445921|NCT00001162|Tapeworm|tapeworm
5445922|NCT00001162|Trichinosis|trichinosis
5445923|NCT00001162|Gastrointestinal Trematodes|gastrointestinal trematodes
5445924|NCT00001162|Opisthorchis|opisthorchis
5445925|NCT00001162|Paragonimiasis|paragonimiasis
5445926|NCT00001162|Echinococcus|echinococcus
5445927|NCT00001161|Irido Corneal Angle|irido corneal angle
5445928|NCT00001161|Mesothelium|mesothelium
5445929|NCT00001161|Congenital Anomalies|congenital anomalies
5445930|NCT00001161|Neural Crest|neural crest
5445931|NCT00001161|Increased Intraocular Pressure|increased intraocular pressure
5445932|NCT00001161|Glaucoma|glaucoma
5445933|NCT00001161|Axenfeld's Syndrome|axenfeld's syndrome
5445934|NCT00001161|Rieger's Anomaly|rieger's anomaly
5445935|NCT00001161|Peter's Anomaly|peter's anomaly
5445936|NCT00001161|Iridocorneal Endothelial Syndrome|iridocorneal endothelial syndrome
5445937|NCT00001161|Aniridia|aniridia
5445938|NCT00001161|Pigment Dispersion Syndrome|pigment dispersion syndrome
5445939|NCT00001161|Megalocornea|megalocornea
5445940|NCT00001160|Thyroid Fine Needle Biopsy|thyroid fine needle biopsy
5445941|NCT00001160|Radioiodine|radioiodine
5445942|NCT00001160|Dosimetry|dosimetry
5445943|NCT00001159|Hyperthyroidism|hyperthyroidism
5445944|NCT00001159|Hypothyroidism|hypothyroidism
5445945|NCT00001159|Thyroid-Stimulating Hormone Secreting Pituitary Adenomas|thyroid-stimulating hormone secreting pituitary adenomas
5445946|NCT00001156|Immunogenetics|immunogenetics
5445947|NCT00001156|Tropical Spastic Paraplegia|tropical spastic paraplegia
5445948|NCT00001156|Twins|twins
5445949|NCT00001156|Epstein-Barr Virus|epstein-barr virus
5445950|NCT00001156|HTLV-I|htlv-i
5445951|NCT00001156|Vasculitis|vasculitis
5445952|NCT00001156|Cerebrospinal Fluid|cerebrospinal fluid
5445953|NCT00001156|Immunity to Viruses|immunity to viruses
5445954|NCT00001156|Multiple Sclerosis|multiple sclerosis
5445955|NCT00001156|Magnetic Resonance Imaging|magnetic resonance imaging
5445956|NCT00001155|Vasculitis|vasculitis
5445957|NCT00001155|Prednisone|prednisone
5445958|NCT00001155|Granuloma|granuloma
5445959|NCT00001155|Wegener's Granulomatosis|wegener's granulomatosis
5445960|NCT00001155|Cyclophosphamide|cyclophosphamide
5445961|NCT00001155|Renal Biopsy|renal biopsy
5445962|NCT00001154|Cholesterol|cholesterol
5445963|NCT00001154|Apolipoproteins|apolipoproteins
5445964|NCT00001154|Kinetics|kinetics
5445965|NCT00001151|Calciferol|calciferol
5445966|NCT00001151|Hypocalcemia|hypocalcemia
5445967|NCT00001151|Rickets|rickets
5445968|NCT00001150|Blister Formation|blister formation
5445969|NCT00001150|Inflammatory Mediator Assay|inflammatory mediator assay
5445970|NCT00001150|Ultraviolet Radiation|ultraviolet radiation
5445971|NCT00001149|Anticonvulsants|anticonvulsants
5445972|NCT00001149|Intensive Monitoring|intensive monitoring
5445973|NCT00001149|Epilepsy|epilepsy
5445974|NCT00001148|Metastasis|metastasis
5445975|NCT00001148|Glioma|glioma
5445976|NCT00001148|Venous|venous
5445977|NCT00001148|Sampling|sampling
5445978|NCT00001148|p53 Mutation|p53 mutation
5445979|NCT00001148|Glioblastoma Multiforme|glioblastoma multiforme
5445980|NCT00001148|Circulating Tumor Cells|circulating tumor cells
5445981|NCT00001148|Mutation|mutation
5445982|NCT00001148|Anaplastic Astrocytoma|anaplastic astrocytoma
5445983|NCT00001147|Dopamine|dopamine
5445984|NCT00001147|Metanephrine|metanephrine
5445985|NCT00001147|Norepinephrine|norepinephrine
5445986|NCT00001147|Epinephrine|epinephrine
5445987|NCT00001147|Catecholamines|catecholamines
5445988|NCT00001147|Tyrosine Hydroxylase|tyrosine hydroxylase
5445989|NCT00001147|Monoamine Oxidase|monoamine oxidase
5445990|NCT00001147|Phenosulfotransferase|phenosulfotransferase
5445991|NCT00001147|Sympathetic Nervous System|sympathetic nervous system
5445992|NCT00001147|Normetanephrine|normetanephrine
5445993|NCT00001146|Bipolar Disorder|bipolar disorder
5445994|NCT00001146|Clinical Trial|clinical trial
5445995|NCT00001146|Eicosapentaenoic Ethyl Ester|eicosapentaenoic ethyl ester
5445996|NCT00001146|Life Chart Methodology|life chart methodology
5445997|NCT00001146|Mood Disorders|mood disorders
5445998|NCT00001146|Omega-3 Fatty Acid|omega-3 fatty acid
5445999|NCT00001146|Rapid Cycling|rapid cycling
5446000|NCT00001146|Treatment|treatment
5446001|NCT00001145|Primary Immunodeficiency|primary immunodeficiency
5446002|NCT00001145|Gamma Globulin (IgG) Immunization|gamma globulin (igg) immunization
5446004|NCT00001145|Phi-X 174|phi-x 174
5446005|NCT00001145|X-linked HyperIgM Syndrome|x-linked hyperigm syndrome
5446006|NCT00001144|Peripheral Blood Stem Cells|peripheral blood stem cells
5446007|NCT00001144|Engraftment|engraftment
5446008|NCT00001144|Graft vs. Host Disease|graft vs. host disease
5446009|NCT00001144|Graft-Versus-Leukemia|graft-versus-leukemia
5446010|NCT00001144|Graft-Versus-Tumor/Melanoma|graft-versus-tumor/melanoma
5446011|NCT00001144|Chronic Myelogenous Leukemia|chronic myelogenous leukemia
5446012|NCT00001143|Eye Movements|eye movements
5446013|NCT00001143|Strabismus|strabismus
5446014|NCT00001143|Infants|infants
5446015|NCT00001143|Development|development
5446016|NCT00001143|Ocular Motor System|ocular motor system
5446017|NCT00000426|Calcium deficiency|calcium deficiency
5446018|NCT00000426|Dietary calcium|dietary calcium
5446019|NCT00000426|Dietary protein|dietary protein
5446020|NCT00000426|Osteoporosis|osteoporosis
5446021|NCT00000426|Calcium supplement|calcium supplement
5446022|NCT00000426|Bone density|bone density
5446023|NCT00000426|Bone mass|bone mass
5446024|NCT00000426|Bone mass accumulation|bone mass accumulation
5446025|NCT00000425|Osteoarthritis|osteoarthritis
5446026|NCT00000425|Skeletal disorder|skeletal disorder
5446027|NCT00000425|Chemotherapy|chemotherapy
5446028|NCT00000425|Nonsteroidal anti-inflammatory drugs (NSAIDs)|nonsteroidal anti-inflammatory drugs (nsaids)
5446029|NCT00000425|Arthroplasty|arthroplasty
5446030|NCT00000425|Cartilage metabolism|cartilage metabolism
5446031|NCT00000425|Hip|hip
5446032|NCT00000425|Knee|knee
5446033|NCT00000425|Outcomes research|outcomes research
5446034|NCT00000424|Osteoarthritis (OA)|osteoarthritis (oa)
5446035|NCT00000424|Knee|knee
5446036|NCT00000424|Sham lavage|sham lavage
5446037|NCT00000424|Tidal lavage|tidal lavage
5446038|NCT00000424|Lavage therapy|lavage therapy
5446039|NCT00000424|Nonsteroidal anti-inflammatory drug (NSAID)|nonsteroidal anti-inflammatory drug (nsaid)
5446040|NCT00000424|Placebo|placebo
5446041|NCT00000424|Radiography|radiography
5446042|NCT00000424|Human therapy evaluation|human therapy evaluation
5446043|NCT00000424|WOMAC|womac
5446044|NCT00000423|Fibromyalgia|fibromyalgia
5446045|NCT00000423|Health education|health education
5446046|NCT00000423|Program evaluation|program evaluation
5446047|NCT00000423|Social support|social support
5446048|NCT00000423|Managed care|managed care
5446049|NCT00000423|Quality of well-being|quality of well-being
5446050|NCT00000422|Fibromyalgia Syndrome (FMS)|fibromyalgia syndrome (fms)
5446051|NCT00000422|Physical therapy|physical therapy
5446052|NCT00000422|Psychotherapy|psychotherapy
5446053|NCT00000422|Group counseling|group counseling
5446054|NCT00000422|Human therapy relations|human therapy relations
5446055|NCT00000422|Interpersonal relations|interpersonal relations
5446056|NCT00000422|Chronic pain|chronic pain
5446057|NCT00000422|Cognition|cognition
5446058|NCT00000422|Emotion|emotion
5446059|NCT00000422|Memory|memory
5446060|NCT00000422|Musculoskeletal disorder|musculoskeletal disorder
5446061|NCT00000422|Psychological stressor|psychological stressor
5446062|NCT00000422|Psychological adaptation|psychological adaptation
5446063|NCT00000422|Outcomes research|outcomes research
5446064|NCT00000421|SLE|sle
5446065|NCT00000421|Lupus|lupus
5446066|NCT00000421|Anti-double-stranded DNA antibody|anti-double-stranded dna antibody
5446067|NCT00000421|Corticosteroid treatment|corticosteroid treatment
5446068|NCT00000421|Hormone therapy|hormone therapy
5446069|NCT00000421|Complement|complement
5446070|NCT00000421|Hypertension|hypertension
5446071|NCT00000421|Estrogen|estrogen
5446072|NCT00000421|SELENA|selena
5446073|NCT00000420|SLE|sle
5446074|NCT00000420|SELENA|selena
5446075|NCT00000420|Oral contraceptives|oral contraceptives
5446076|NCT00000420|The pill|the pill
5446077|NCT00000420|Birth control|birth control
5446078|NCT00000420|Condom|condom
5446079|NCT00000420|Diaphragm|diaphragm
5446080|NCT00000420|Estrogen|estrogen
5446081|NCT00000420|Lupus|lupus
5446082|NCT00000420|Placebo|placebo
5446083|NCT00000419|SLE|sle
5446084|NCT00000419|SELENA|selena
5446085|NCT00000419|Estrogen Replacement Therapy (ERT)|estrogen replacement therapy (ert)
5446086|NCT00000419|Postmenopause|postmenopause
5446087|NCT00000419|Osteoporosis|osteoporosis
5446088|NCT00000419|Estrogens|estrogens
5446089|NCT00000419|Steroids|steroids
5446090|NCT00000419|Progestin|progestin
5446091|NCT00000419|Placebo|placebo
5446092|NCT00000418|OA|oa
5446093|NCT00000418|Patient education|patient education
5446094|NCT00000418|Acute low back pain (ALBP)|acute low back pain (albp)
5446095|NCT00000418|Social support systems|social support systems
5446096|NCT00000417|SLE|sle
5446097|NCT00000417|Lupus|lupus
5446098|NCT00000417|Educational intervention|educational intervention
5446099|NCT00000417|Health education|health education
5446100|NCT00000417|Social support network|social support network
5446101|NCT00000417|Outcomes research|outcomes research
5446102|NCT00000417|Self-help|self-help
5446103|NCT00000416|Arthritis|arthritis
5446104|NCT00000416|Rheumatic disorders|rheumatic disorders
5446105|NCT00000416|Work-related disability|work-related disability
5446106|NCT00000416|Vocational rehabilitation (VR)|vocational rehabilitation (vr)
5446107|NCT00000416|Job retention services|job retention services
5446108|NCT00000416|Work limitations|work limitations
5446109|NCT00000416|Work instability|work instability
5446110|NCT00000415|Calcium|calcium
5446111|NCT00000415|Physical activity|physical activity
5446112|NCT00000415|Children|children
5446113|NCT00000415|Bone mass accretion|bone mass accretion
5446114|NCT00000415|Bone mineral density (BMD)|bone mineral density (bmd)
5446115|NCT00000415|Bone response to activity and calcium supplements|bone response to activity and calcium supplements
5446116|NCT00000415|Placebo|placebo
5446117|NCT00000415|Bone growth|bone growth
5446118|NCT00000414|Rheumatoid arthritis (RA)|rheumatoid arthritis (ra)
5446119|NCT00000414|Osteoarthritis (OA)|osteoarthritis (oa)
5446120|NCT00000414|Arthritis education|arthritis education
5446121|NCT00000414|Health care service evaluation|health care service evaluation
5446122|NCT00000414|Outcomes research|outcomes research
5446123|NCT00000414|Arthritis Self-Management Program (ASMP)|arthritis self-management program (asmp)
5446124|NCT00000414|Self-Managed Arthritis Relief Therapy (SMART) Program|self-managed arthritis relief therapy (smart) program
5446125|NCT00000413|Osteoporosis prevention|osteoporosis prevention
5446126|NCT00000413|Behavioral/educational intervention|behavioral/educational intervention
5446127|NCT00000413|Preadolescent|preadolescent
5446128|NCT00000413|Calcium|calcium
5446129|NCT00000413|Exercise|exercise
5446130|NCT00000413|Peak bone mass|peak bone mass
5446131|NCT00000413|Bone density|bone density
5446132|NCT00000412|Osteoporosis|osteoporosis
5446133|NCT00000412|Osteopenia|osteopenia
5446134|NCT00000412|Heart transplant|heart transplant
5446135|NCT00000412|Bone fracture|bone fracture
5446136|NCT00000412|Bone density|bone density
5446137|NCT00000412|Dual energy x-ray absorptiometry|dual energy x-ray absorptiometry
5446138|NCT00000411|Spinal stenosis (SpS)|spinal stenosis (sps)
5446139|NCT00000411|Intervertebral disc herniation (IDH)|intervertebral disc herniation (idh)
5446140|NCT00000411|Degenerative spondylolisthesis (DS)|degenerative spondylolisthesis (ds)
5446141|NCT00000411|Low back pain (LBP)|low back pain (lbp)
5446142|NCT00000411|Surgical therapy|surgical therapy
5446143|NCT00000411|Nonsurgical therapy|nonsurgical therapy
5446144|NCT00000411|Randomized study|randomized study
5446145|NCT00000411|Multicenter|multicenter
5446146|NCT00000411|MRI|mri
5446147|NCT00000410|Intervertebral disc herniation (IDH)|intervertebral disc herniation (idh)
5446148|NCT00000410|Stenosis with degenerative spondylolisthesis (DS)|stenosis with degenerative spondylolisthesis (ds)
5446149|NCT00000410|Spinal stenosis (SpS)|spinal stenosis (sps)
5446150|NCT00000410|Low back pain (LBP)|low back pain (lbp)
5446151|NCT00000410|Leg pain|leg pain
5446152|NCT00000410|Surgical therapy|surgical therapy
5446153|NCT00000410|Non-surgical therapy|non-surgical therapy
5446154|NCT00000410|Randomized study|randomized study
5446155|NCT00000410|Multicenter|multicenter
5446156|NCT00000410|MRI|mri
5446157|NCT00000409|Intervertebral disc herniation (IDH)|intervertebral disc herniation (idh)
5446158|NCT00000409|Degenerative spondylolisthesis (DS)|degenerative spondylolisthesis (ds)
5446159|NCT00000409|Spinal stenosis (SpS)|spinal stenosis (sps)
5446160|NCT00000409|Low back pain (LBP)|low back pain (lbp)
5446161|NCT00000409|Leg pain|leg pain
5446162|NCT00000409|Surgical therapy|surgical therapy
5446163|NCT00000409|Randomized study|randomized study
5446164|NCT00000409|Multicenter|multicenter
5446165|NCT00000409|MRI|mri
5446166|NCT00000409|Nonsurgical therapy|nonsurgical therapy
5446167|NCT00000408|Health education|health education
5446168|NCT00000408|Back injury|back injury
5446169|NCT00000408|Chronic pain|chronic pain
5446170|NCT00000408|Education/evaluation planning|education/evaluation planning
5446171|NCT00000408|Outcomes research|outcomes research
5446172|NCT00000407|Arthritis and related musculoskeletal disorders (ARMD)|arthritis and related musculoskeletal disorders (armd)
5446173|NCT00000407|Vocational rehabilitation (VR)|vocational rehabilitation (vr)
5446174|NCT00000407|Agency enhancement intervention|agency enhancement intervention
5446175|NCT00000407|Health care service evaluation|health care service evaluation
5446176|NCT00000407|Musculoskeletal disability|musculoskeletal disability
5446177|NCT00000407|Return to work|return to work
5446178|NCT00000407|Outcomes research|outcomes research
5446179|NCT00000407|Unemployment|unemployment
5446180|NCT00000407|Work disability|work disability
5446181|NCT00000406|Osteoarthritis (OA)|osteoarthritis (oa)
5446182|NCT00000406|Knee|knee
5446183|NCT00000406|Radiographic OA|radiographic oa
5446184|NCT00000406|Strength training|strength training
5446185|NCT00000406|Physical therapy|physical therapy
5446186|NCT00000406|Exercise|exercise
5446187|NCT00000406|Body composition|body composition
5446188|NCT00000406|Striated muscle|striated muscle
5446189|NCT00000406|Depression|depression
5446190|NCT00000406|Radiographic OA with knee pain|radiographic oa with knee pain
5446191|NCT00000406|Radiographic OA without knee pain|radiographic oa without knee pain
5446192|NCT00000406|Knee pain without radiographic OA|knee pain without radiographic oa
5446193|NCT00000406|Normal elderly (no radiographic OA, no knee pain)|normal elderly (no radiographic oa, no knee pain)
5446194|NCT00000405|Osteoporosis|osteoporosis
5446195|NCT00000405|Bone fractures|bone fractures
5446196|NCT00000405|Bone mass|bone mass
5446197|NCT00000405|Bone mineral density (BMD)|bone mineral density (bmd)
5446198|NCT00000405|Ossification|ossification
5446199|NCT00000405|Biomechanics|biomechanics
5446200|NCT00000405|Exercise|exercise
5446201|NCT00000405|Diet|diet
5446202|NCT00000405|Spine|spine
5446203|NCT00000405|Middle childhood (6-11)|middle childhood (6-11)
5446204|NCT00000404|Osteoarthritis (OA)|osteoarthritis (oa)
5446205|NCT00000404|Knee|knee
5446206|NCT00000404|HMO|hmo
5446207|NCT00000404|Comprehensive care|comprehensive care
5446208|NCT00000403|Osteoarthritis (OA)|osteoarthritis (oa)
5446209|NCT00000403|Knee|knee
5446210|NCT00000403|Doxycycline|doxycycline
5446211|NCT00000403|Skeletal disorder|skeletal disorder
5446212|NCT00000403|Placebo|placebo
5446213|NCT00000403|Urinalysis|urinalysis
5446214|NCT00000403|NSAIDs|nsaids
5446215|NCT00000403|Joint space narrowing (JSN)|joint space narrowing (jsn)
5446216|NCT00000403|WOMAC|womac
5446217|NCT00000402|Osteoporosis|osteoporosis
5446218|NCT00000402|Dietary calcium|dietary calcium
5446219|NCT00000402|Puberty|puberty
5446220|NCT00000402|Bone density|bone density
5446221|NCT00000402|Bone mass|bone mass
5446222|NCT00000402|Primary prevention of osteoporosis|primary prevention of osteoporosis
5446223|NCT00000401|NSAIDs|nsaids
5446224|NCT00000401|Oral Tolerance|oral tolerance
5446225|NCT00000401|Drug Interaction|drug interaction
5446226|NCT00000401|Oral Administration|oral administration
5446227|NCT00000401|Interleukin 10|interleukin 10
5446228|NCT00000401|Collagen|collagen
5446229|NCT00000401|Chemotherapy|chemotherapy
5446230|NCT00000401|Human Therapy Evaluation|human therapy evaluation
5446231|NCT00000401|DMARDs|dmards
5446232|NCT00000401|RA|ra
5446233|NCT00000401|IL-10|il-10
5446234|NCT00000400|Osteoporosis|osteoporosis
5446235|NCT00000400|Bone formation|bone formation
5446236|NCT00000400|Bone resorption|bone resorption
5446237|NCT00000400|Parathyroid hormone (PTH)|parathyroid hormone (pth)
5446238|NCT00000400|Postmenopause|postmenopause
5446239|NCT00000399|Estrogen|estrogen
5446240|NCT00000399|Hormone therapy|hormone therapy
5446241|NCT00000399|Strength training|strength training
5446242|NCT00000399|Exercise|exercise
5446243|NCT00000399|Postmenopause|postmenopause
5446244|NCT00000399|Disorder prevention|disorder prevention
5446245|NCT00000399|Osteoporosis|osteoporosis
5446246|NCT00000399|Bone mineral density|bone mineral density
5446247|NCT00000399|Bone mass|bone mass
5446248|NCT00000399|Cholesterol|cholesterol
5446249|NCT00000399|Body composition|body composition
5446250|NCT00000398|Fibromyalgia|fibromyalgia
5446251|NCT00000398|Pain|pain
5446252|NCT00000398|Coping skills training|coping skills training
5446253|NCT00000398|Physical exercise training|physical exercise training
5446254|NCT00000398|Combined coping skills training and exercise training|combined coping skills training and exercise training
5446255|NCT00000397|Fibromyalgia|fibromyalgia
5446256|NCT00000397|Insomnia|insomnia
5446257|NCT00000397|Cognitive-behavioral therapy (CBT)|cognitive-behavioral therapy (cbt)
5446258|NCT00000397|Behavioral insomnia therapy|behavioral insomnia therapy
5446259|NCT00000396|Arthritis|arthritis
5446260|NCT00000396|Arthritis education|arthritis education
5446261|NCT00000396|African Americans|african americans
5446262|NCT00000396|Self-help|self-help
5446263|NCT00000396|Self-management|self-management
5446264|NCT00000396|Cultural beliefs|cultural beliefs
5446265|NCT00000395|Rheumatoid arthritis|rheumatoid arthritis
5446266|NCT00000395|Lewis rat adjuvant arthritis|lewis rat adjuvant arthritis
5446267|NCT00000395|Antifolate efficacy|antifolate efficacy
5446268|NCT00000395|Autoimmunity|autoimmunity
5446269|NCT00000395|Adenosine metabolism|adenosine metabolism
5446270|NCT00000395|Methotrexate therapy|methotrexate therapy
5446271|NCT00000395|Skeletal disorder|skeletal disorder
5446272|NCT00000395|Dietary supplement|dietary supplement
5446273|NCT00000395|Antiarthritic agent|antiarthritic agent
5446274|NCT00000395|Folic acid|folic acid
5446275|NCT00000394|Carpal tunnel syndrome|carpal tunnel syndrome
5446276|NCT00000394|Acupuncture|acupuncture
5446277|NCT00000394|Median nerve|median nerve
5446278|NCT00000394|Single-blind mute methodology|single-blind mute methodology
5446279|NCT00000104|lead overburden|lead overburden
5446280|NCT00000456|Alcoholism|alcoholism
5446281|NCT00000456|Alcohol Dependence|alcohol dependence
5446282|NCT00000456|Naltrexone|naltrexone
5446283|NCT00000456|Cognitive Behavioral Therapy|cognitive behavioral therapy
5446284|NCT00000451|Alcoholism|alcoholism
5446285|NCT00000451|Alcohol Dependence|alcohol dependence
5446286|NCT00000389|Adolescence|adolescence
5446287|NCT00000389|Anxiety Disorders|anxiety disorders
5446288|NCT00000389|Child|child
5446289|NCT00000389|Female|female
5446290|NCT00000389|Fluvoxamine|fluvoxamine
5446291|NCT00000389|Human|human
5446292|NCT00000389|Male|male
5446293|NCT00000389|Serotonin Uptake Inhibitors|serotonin uptake inhibitors
5446294|NCT00000389|Anxiety Disorders -- *drug therapy|anxiety disorders -- *drug therapy
5446295|NCT00000389|Fluvoxamine -- *therapeutic use|fluvoxamine -- *therapeutic use
5446296|NCT00000389|Serotonin Uptake Inhibitors -- *therapeutic use|serotonin uptake inhibitors -- *therapeutic use
5446297|NCT00000388|Attention Deficit Disorder with Hyperactivity|attention deficit disorder with hyperactivity
5446298|NCT00000388|Adolescence|adolescence
5446299|NCT00000388|Child|child
5446300|NCT00000388|Cognition|cognition
5446301|NCT00000388|Combined Modality Therapy|combined modality therapy
5446302|NCT00000388|Female|female
5446303|NCT00000388|Human|human
5446304|NCT00000388|Male|male
5446305|NCT00000388|Peer Group|peer group
5446306|NCT00000388|Risk Factors|risk factors
5446307|NCT00000388|Treatment Outcome|treatment outcome
5446590|NCT00000363|Antibiotics|antibiotics
5446308|NCT00000388|Attention Deficit Disorder with Hyperactivity -- *therapy|attention deficit disorder with hyperactivity -- *therapy
5446309|NCT00000388|Attention Deficit Disorder with Hyperactivity -- drug therapy|attention deficit disorder with hyperactivity -- drug therapy
5446310|NCT00000388|Attention Deficit Disorder with Hyperactivity -- psychology|attention deficit disorder with hyperactivity -- psychology
5446311|NCT00000387|Adolescence|adolescence
5446312|NCT00000387|Family|family
5446313|NCT00000387|Female|female
5446314|NCT00000387|Human|human
5446315|NCT00000387|Male|male
5446316|NCT00000387|Schizophrenia|schizophrenia
5446317|NCT00000387|Self Care|self care
5446318|NCT00000387|Community Health Services|community health services
5446319|NCT00000386|Adolescence|adolescence
5446320|NCT00000386|Child|child
5446321|NCT00000386|Comparative Study|comparative study
5446322|NCT00000386|Family|family
5446323|NCT00000386|Female|female
5446324|NCT00000386|Human|human
5446325|NCT00000386|Male|male
5446326|NCT00000386|Obsessive-Compulsive Disorder|obsessive-compulsive disorder
5446327|NCT00000386|Relaxation Techniques|relaxation techniques
5446328|NCT00000386|Obsessive-Compulsive Disorder -- *therapy|obsessive-compulsive disorder -- *therapy
5446329|NCT00000385|Aggressive conduct disorder|aggressive conduct disorder
5446330|NCT00000385|Adolescence|adolescence
5446331|NCT00000385|Child|child
5446332|NCT00000385|Conduct Disorder|conduct disorder
5446333|NCT00000385|Female|female
5446334|NCT00000385|Lithium|lithium
5446335|NCT00000385|Male|male
5446336|NCT00000385|Placebos|placebos
5446337|NCT00000385|Conduct Disorder -- *drug therapy|conduct disorder -- *drug therapy
5446338|NCT00000385|Lithium -- *therapeutic use|lithium -- *therapeutic use
5446339|NCT00000384|Adolescence|adolescence
5446340|NCT00000384|Child|child
5446341|NCT00000384|Cognitive Therapy|cognitive therapy
5446342|NCT00000384|Combined Modality Therapy|combined modality therapy
5446343|NCT00000384|Obsessive-Compulsive Disorder|obsessive-compulsive disorder
5446344|NCT00000384|Placebos|placebos
5446345|NCT00000384|Sertraline|sertraline
5446346|NCT00000384|Patient Education|patient education
5446347|NCT00000384|Psychotherapy|psychotherapy
5446348|NCT00000383|Adolescence|adolescence
5446349|NCT00000383|Child|child
5446350|NCT00000383|Cognitive Therapy|cognitive therapy
5446351|NCT00000383|Comparative Study|comparative study
5446352|NCT00000383|Female|female
5446353|NCT00000383|Human|human
5446354|NCT00000383|Male|male
5446355|NCT00000383|Stress Disorders, Post-Traumatic|stress disorders, post-traumatic
5446356|NCT00000383|Child Abuse, Sexual|child abuse, sexual
5446357|NCT00000383|Stress Disorders, Post-Traumatic -- *therapy|stress disorders, post-traumatic -- *therapy
5446358|NCT00000383|Child Abuse, Sexual -- *psychology|child abuse, sexual -- *psychology
5446359|NCT00000382|Child Abuse|child abuse
5446360|NCT00000382|Female|female
5446361|NCT00000382|Human|human
5446362|NCT00000382|Infant|infant
5446363|NCT00000382|Male|male
5446364|NCT00000382|Caregivers|caregivers
5446365|NCT00000382|Patient Education|patient education
5446366|NCT00000382|Psychotherapy|psychotherapy
5446367|NCT00000382|Child Abuse -- *prevention & control|child abuse -- *prevention & control
5446368|NCT00000381|Adolescence|adolescence
5446369|NCT00000381|Anxiety Disorders|anxiety disorders
5446370|NCT00000381|Child|child
5446371|NCT00000381|Female|female
5446372|NCT00000381|Fluoxetine|fluoxetine
5446373|NCT00000381|Male|male
5446374|NCT00000381|Placebos|placebos
5446375|NCT00000381|Serotonin Uptake Inhibitors|serotonin uptake inhibitors
5446376|NCT00000381|Anxiety Disorders -- *drug therapy|anxiety disorders -- *drug therapy
5446377|NCT00000381|Fluoxetine -- *therapeutic use|fluoxetine -- *therapeutic use
5446378|NCT00000381|Serotonin Uptake Inhibitors -- *therapeutic use|serotonin uptake inhibitors -- *therapeutic use
5446379|NCT00000380|Adult|adult
5446380|NCT00000380|Estrogen Replacement Therapy|estrogen replacement therapy
5446381|NCT00000380|Female|female
5446382|NCT00000380|Hormone Replacement Therapy|hormone replacement therapy
5446383|NCT00000380|Human|human
5446384|NCT00000380|Insulin-Like Growth Factor I|insulin-like growth factor i
5446385|NCT00000380|Male|male
5446386|NCT00000380|Placebos|placebos
5446387|NCT00000380|Sleep Disorders|sleep disorders
5446388|NCT00000380|Somatotropin-Releasing Hormone|somatotropin-releasing hormone
5446389|NCT00000380|Somatotropin|somatotropin
5446390|NCT00000380|Insulin-Like Growth Factor I -- secretion|insulin-like growth factor i -- secretion
5446391|NCT00000380|Sleep Disorders -- *drug therapy|sleep disorders -- *drug therapy
5446392|NCT00000380|Somatotropin-Releasing Hormone -- *therapeutic use|somatotropin-releasing hormone -- *therapeutic use
5446393|NCT00000380|Somatotropin -- secretion|somatotropin -- secretion
5446394|NCT00000379|Adult|adult
5446395|NCT00000379|Comparative Study|comparative study
5446396|NCT00000379|Desensitization, Psychologic|desensitization, psychologic
5446397|NCT00000379|Eye Movements|eye movements
5446398|NCT00000379|Female|female
5446399|NCT00000379|Fluoxetine|fluoxetine
5446400|NCT00000379|Human|human
5446401|NCT00000379|Male|male
5446402|NCT00000379|Placebos|placebos
5446403|NCT00000379|Stress Disorders, Post-Traumatic|stress disorders, post-traumatic
5446404|NCT00000379|Treatment Outcome|treatment outcome
5446405|NCT00000379|Desensitization, Psychologic -- *methods|desensitization, psychologic -- *methods
5446406|NCT00000379|Fluoxetine -- *therapeutic use|fluoxetine -- *therapeutic use
5446407|NCT00000379|Stress Disorders, Post-Traumatic -- *therapy|stress disorders, post-traumatic -- *therapy
5446408|NCT00000379|Stress Disorders, Post-Traumatic -- drug therapy|stress disorders, post-traumatic -- drug therapy
5446409|NCT00000378|Aged|aged
5446410|NCT00000378|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic
5446411|NCT00000378|Depression|depression
5446412|NCT00000378|Female|female
5446413|NCT00000378|Human|human
5446414|NCT00000378|Male|male
5446415|NCT00000378|Middle Age|middle age
5446416|NCT00000378|Nortriptyline|nortriptyline
5446417|NCT00000378|Sertraline|sertraline
5446418|NCT00000378|Serotonin Uptake Inhibitors|serotonin uptake inhibitors
5446419|NCT00000378|Antidepressive Agents, Tricyclic -- *therapeutic use|antidepressive agents, tricyclic -- *therapeutic use
5446420|NCT00000378|Antidepressive Agents, Tricyclic -- adverse effects|antidepressive agents, tricyclic -- adverse effects
5446421|NCT00000378|Depression -- *drug therapy|depression -- *drug therapy
5446422|NCT00000378|Nortriptyline -- *therapeutic use|nortriptyline -- *therapeutic use
5446423|NCT00000378|Nortriptyline -- adverse effects|nortriptyline -- adverse effects
5446424|NCT00000378|Sertraline -- *therapeutic use|sertraline -- *therapeutic use
5446425|NCT00000378|Sertraline -- adverse effects|sertraline -- adverse effects
5446426|NCT00000378|Serotonin Uptake Inhibitors -- *therapeutic use|serotonin uptake inhibitors -- *therapeutic use
5446427|NCT00000378|Serotonin Uptake Inhibitors -- adverse effects|serotonin uptake inhibitors -- adverse effects
5446428|NCT00000377|Aged|aged
5446429|NCT00000377|Antidepressive Agents|antidepressive agents
5446430|NCT00000377|Depression|depression
5446431|NCT00000377|Dose-Response Relationship, Drug|dose-response relationship, drug
5446432|NCT00000377|Female|female
5446433|NCT00000377|Human|human
5446434|NCT00000377|Male|male
5446435|NCT00000377|Middle Age|middle age
5446436|NCT00000377|Nortriptyline|nortriptyline
5446437|NCT00000377|Placebos|placebos
5446438|NCT00000377|Recurrence|recurrence
5446439|NCT00000377|Aged, 80 and over|aged, 80 and over
5446440|NCT00000377|Antidepressive Agents -- *therapeutic use|antidepressive agents -- *therapeutic use
5446441|NCT00000377|Antidepressive Agents -- administration & dosage|antidepressive agents -- administration & dosage
5446442|NCT00000377|Depression -- *drug therapy|depression -- *drug therapy
5446443|NCT00000377|Nortriptyline -- *therapeutic use|nortriptyline -- *therapeutic use
5446444|NCT00000377|Nortriptyline -- administration & dosage|nortriptyline -- administration & dosage
5446445|NCT00000376|Adult|adult
5446446|NCT00000376|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic
5446447|NCT00000376|Anxiety Disorders|anxiety disorders
5446448|NCT00000376|Cognitive Therapy|cognitive therapy
5446449|NCT00000376|Combined Modality Therapy|combined modality therapy
5446450|NCT00000376|Depression|depression
5446451|NCT00000376|Desipramine|desipramine
5446452|NCT00000376|Female|female
5446453|NCT00000376|Human|human
5446454|NCT00000376|Male|male
5446455|NCT00000376|Personality Disorders|personality disorders
5446456|NCT00000376|Pilot Projects|pilot projects
5446457|NCT00000376|Patient Care Team|patient care team
5446458|NCT00000376|Antidepressive Agents, Tricyclic -- *therapeutic use|antidepressive agents, tricyclic -- *therapeutic use
5446459|NCT00000376|Depression -- *therapy|depression -- *therapy
5446460|NCT00000376|Depression -- drug therapy|depression -- drug therapy
5446461|NCT00000376|Desipramine -- *therapeutic use|desipramine -- *therapeutic use
5446462|NCT00000375|Adult|adult
5446463|NCT00000375|Antidepressive Agents|antidepressive agents
5446464|NCT00000375|Depressive Disorder|depressive disorder
5446465|NCT00000375|Electroconvulsive Therapy|electroconvulsive therapy
5446466|NCT00000375|Female|female
5446467|NCT00000375|Human|human
5446468|NCT00000375|Lithium|lithium
5446469|NCT00000375|Male|male
5446470|NCT00000375|Nortriptyline|nortriptyline
5446471|NCT00000375|Serotonin Uptake Inhibitors|serotonin uptake inhibitors
5446472|NCT00000375|Antidepressive Agents -- *therapeutic use|antidepressive agents -- *therapeutic use
5446473|NCT00000375|Antidepressive Agents -- adverse effects|antidepressive agents -- adverse effects
5446474|NCT00000375|Lithium -- *therapeutic use|lithium -- *therapeutic use
5446475|NCT00000375|Lithium -- adverse effects|lithium -- adverse effects
5446476|NCT00000375|Nortriptyline -- *therapeutic use|nortriptyline -- *therapeutic use
5446477|NCT00000375|Nortriptyline -- adverse effects|nortriptyline -- adverse effects
5446478|NCT00000374|Adolescence|adolescence
5446479|NCT00000374|Adult|adult
5446480|NCT00000374|Antipsychotic Agents|antipsychotic agents
5446481|NCT00000374|Female|female
5446482|NCT00000374|Human|human
5446483|NCT00000374|Male|male
5446484|NCT00000374|olanzapine|olanzapine
5446485|NCT00000374|Risperidone|risperidone
5446486|NCT00000374|Schizophrenia|schizophrenia
5446487|NCT00000374|Antipsychotic Agents -- *therapeutic use|antipsychotic agents -- *therapeutic use
5446488|NCT00000374|olanzapine -- *therapeutic use|olanzapine -- *therapeutic use
5446489|NCT00000374|Risperidone -- *therapeutic use|risperidone -- *therapeutic use
5446490|NCT00000374|Schizophrenia -- *drug therapy|schizophrenia -- *drug therapy
5446491|NCT00000373|Adolescence|adolescence
5446492|NCT00000373|Adult|adult
5446493|NCT00000373|Antipsychotic Agents|antipsychotic agents
5446494|NCT00000373|Dopamine Antagonists|dopamine antagonists
5446495|NCT00000373|Female|female
5446496|NCT00000373|Fluvoxamine|fluvoxamine
5446497|NCT00000373|Haloperidol|haloperidol
5446498|NCT00000373|Human|human
5446499|NCT00000373|Male|male
5446500|NCT00000373|Middle Age|middle age
5446501|NCT00000373|Obsessive-Compulsive Disorder|obsessive-compulsive disorder
5446502|NCT00000373|Placebos|placebos
5446503|NCT00000373|Serotonin Uptake Inhibitors|serotonin uptake inhibitors
5446504|NCT00000373|Tourette Syndrome|tourette syndrome
5446505|NCT00000373|Tryptophan|tryptophan
5446506|NCT00000373|Drug Combinations|drug combinations
5446507|NCT00000373|Antipsychotic Agents -- *therapeutic use|antipsychotic agents -- *therapeutic use
5446508|NCT00000373|Fluvoxamine -- *therapeutic use|fluvoxamine -- *therapeutic use
5446509|NCT00000373|Haloperidol -- *therapeutic use|haloperidol -- *therapeutic use
5446510|NCT00000373|Obsessive-Compulsive Disorder -- *drug therapy|obsessive-compulsive disorder -- *drug therapy
5446511|NCT00000373|Obsessive-Compulsive Disorder -- physiopathology|obsessive-compulsive disorder -- physiopathology
5446512|NCT00000373|Serotonin Uptake Inhibitors -- *therapeutic use|serotonin uptake inhibitors -- *therapeutic use
5446513|NCT00000372|Adult|adult
5446514|NCT00000372|Amino Acids|amino acids
5446515|NCT00000372|Cycloserine|cycloserine
5446516|NCT00000372|Female|female
5446517|NCT00000372|Glycine|glycine
5446518|NCT00000372|Human|human
5446519|NCT00000372|Male|male
5446520|NCT00000372|N-Methylaspartate|n-methylaspartate
5446521|NCT00000372|Placebos|placebos
5446522|NCT00000372|Schizophrenia|schizophrenia
5446523|NCT00000372|Amino Acids -- blood|amino acids -- blood
5446524|NCT00000372|Cycloserine -- *therapeutic use|cycloserine -- *therapeutic use
5446525|NCT00000372|Glycine -- *therapeutic use|glycine -- *therapeutic use
5446526|NCT00000372|Schizophrenia -- *drug therapy|schizophrenia -- *drug therapy
5446527|NCT00000372|Schizophrenia -- physiopathology|schizophrenia -- physiopathology
5446528|NCT00000371|Adult|adult
5446529|NCT00000371|Cognition|cognition
5446530|NCT00000371|Cycloserine|cycloserine
5446531|NCT00000371|Dopamine|dopamine
5446532|NCT00000371|Female|female
5446533|NCT00000371|Glutamic Acid|glutamic acid
5446534|NCT00000371|Human|human
5446535|NCT00000371|Male|male
5446536|NCT00000371|Receptors, N-Methyl-D-Aspartate|receptors, n-methyl-d-aspartate
5446537|NCT00000371|Schizophrenia|schizophrenia
5446538|NCT00000371|Serotonin|serotonin
5446539|NCT00000371|Quality of Life|quality of life
5446540|NCT00000371|Cycloserine -- *therapeutic use|cycloserine -- *therapeutic use
5446541|NCT00000371|Dopamine -- blood|dopamine -- blood
5446542|NCT00000371|Dopamine -- cerebrospinal fluid|dopamine -- cerebrospinal fluid
5446543|NCT00000371|Glutamic Acid -- blood|glutamic acid -- blood
5446544|NCT00000371|Glutamic Acid -- cerebrospinal fluid|glutamic acid -- cerebrospinal fluid
5446545|NCT00000371|Serotonin -- blood|serotonin -- blood
5446546|NCT00000371|Serotonin -- cerebrospinal fluid|serotonin -- cerebrospinal fluid
5446547|NCT00000370|Cognitive Therapy|cognitive therapy
5446548|NCT00000370|Cost of Illness|cost of illness
5446549|NCT00000370|Female|female
5446550|NCT00000370|Human|human
5446551|NCT00000370|Male|male
5446552|NCT00000370|Phobic Disorders|phobic disorders
5446553|NCT00000370|Phobic Disorders -- *therapy|phobic disorders -- *therapy
5446554|NCT00000370|Phobic Disorders -- pathology|phobic disorders -- pathology
5446555|NCT00000369|Adult|adult
5446556|NCT00000369|Antidepressive Agents|antidepressive agents
5446557|NCT00000369|Bipolar Disorder|bipolar disorder
5446558|NCT00000369|Combined Modality Therapy|combined modality therapy
5446559|NCT00000369|Female|female
5446560|NCT00000369|Human|human
5446561|NCT00000369|Lithium Carbonate|lithium carbonate
5446562|NCT00000369|Male|male
5446563|NCT00000369|Psychotherapy|psychotherapy
5446564|NCT00000369|Antidepressive Agents -- *therapeutic use|antidepressive agents -- *therapeutic use
5446565|NCT00000369|Bipolar Disorder -- *therapy|bipolar disorder -- *therapy
5446566|NCT00000369|Bipolar Disorder -- drug therapy|bipolar disorder -- drug therapy
5446567|NCT00000369|Lithium Carbonate -- *therapeutic use|lithium carbonate -- *therapeutic use
5446568|NCT00000368|Adult|adult
5446569|NCT00000368|Cognitive Behavioral Therapy|cognitive behavioral therapy
5446570|NCT00000368|Pharmacotherapy|pharmacotherapy
5446571|NCT00000368|Long term treatment|long term treatment
5446572|NCT00000368|Remission and relapse|remission and relapse
5446573|NCT00000368|Male|male
5446574|NCT00000368|Panic Disorder|panic disorder
5446575|NCT00000368|Paroxetine|paroxetine
5446576|NCT00000368|Serotonin Uptake Inhibitors|serotonin uptake inhibitors
5446577|NCT00000368|Panic Disorder -- *therapy|panic disorder -- *therapy
5446578|NCT00000368|Panic Disorder -- drug therapy|panic disorder -- drug therapy
5446579|NCT00000368|Paroxetine -- *therapeutic use|paroxetine -- *therapeutic use
5446580|NCT00000368|Serotonin Uptake Inhibitors -- *therapeutic use|serotonin uptake inhibitors -- *therapeutic use
5446581|NCT00000367|Depression|depression
5446582|NCT00000367|Family|family
5446583|NCT00000367|Female|female
5446584|NCT00000367|Human|human
5446585|NCT00000367|Male|male
5446586|NCT00000367|Practice Guidelines|practice guidelines
5446587|NCT00000367|Education, Medical, Continuing|education, medical, continuing
5446588|NCT00000367|Patient Education|patient education
5446589|NCT00000367|Suicide|suicide
5446591|NCT00000363|Adrenal Cortex Hormones|adrenal cortex hormones
5446592|NCT00000363|Histamine H1 Antagonists|histamine h1 antagonists
5446593|NCT00000363|Infant|infant
5446594|NCT00000363|Otitis Media|otitis media
5446595|NCT00000362|Deglutition Disorders|deglutition disorders
5446596|NCT00000362|Dementia|dementia
5446597|NCT00000362|Parkinson Disease|parkinson disease
5446598|NCT00000362|Pneumonia, Aspiration|pneumonia, aspiration
5446599|NCT00000361|Autoimmune Diseases|autoimmune diseases
5446600|NCT00000361|Cyclophosphamide|cyclophosphamide
5446601|NCT00000361|Hearing|hearing
5446602|NCT00000361|Labyrinth Diseases|labyrinth diseases
5446603|NCT00000361|Methotrexate|methotrexate
5446604|NCT00000361|Prednisone|prednisone
5446605|NCT00000359|Physical Therapy|physical therapy
5446606|NCT00000359|Vertigo|vertigo
5446607|NCT00000359|rehabilitation|rehabilitation
5446608|NCT00000359|occupational therapy|occupational therapy
5446609|NCT00000180|Memory|memory
5446610|NCT00000180|Mild cognitive impairment|mild cognitive impairment
5446611|NCT00000180|Nerve growth factors|nerve growth factors
5446612|NCT00000179|Alzheimer's disease|alzheimer's disease
5446613|NCT00000179|Psychomotor agitation|psychomotor agitation
5446614|NCT00000179|Behavioral symptoms|behavioral symptoms
5446615|NCT00000179|Haloperidol|haloperidol
5446616|NCT00000179|Trazodone|trazodone
5446617|NCT00000179|Anti-psychotic agents|anti-psychotic agents
5446618|NCT00000179|Anti-depressant agents|anti-depressant agents
5446619|NCT00000178|Alzheimer's disease|alzheimer's disease
5446620|NCT00000178|Prednisone|prednisone
5446621|NCT00000178|Anti-inflammatory agents|anti-inflammatory agents
5446622|NCT00000177|Alzheimer's disease|alzheimer's disease
5446623|NCT00000177|Estrogen|estrogen
5446624|NCT00000176|Alzheimer's disease|alzheimer's disease
5446625|NCT00000176|memory loss|memory loss
5446626|NCT00000176|Estrogen|estrogen
5446627|NCT00000175|Emotions|emotions
5446628|NCT00000175|Cognition|cognition
5446629|NCT00000175|Aging|aging
5446630|NCT00000175|Memory|memory
5446631|NCT00000174|Mild cognitive impairment|mild cognitive impairment
5446632|NCT00000174|Alzheimer's disease|alzheimer's disease
5446633|NCT00000174|Memory|memory
5446634|NCT00000174|Cholinergic agents|cholinergic agents
5446635|NCT00000174|Cholinesterase inhibitors|cholinesterase inhibitors
5446636|NCT00000173|Mild cognitive impairment|mild cognitive impairment
5446637|NCT00000173|Alzheimer's disease|alzheimer's disease
5446638|NCT00000173|Memory|memory
5446639|NCT00000173|Donepezil|donepezil
5446640|NCT00000173|Vitamin E|vitamin e
5446641|NCT00000173|Antioxidants|antioxidants
5446642|NCT00000173|Cholinergic agents|cholinergic agents
5446643|NCT00000173|Cholinesterase inhibitors|cholinesterase inhibitors
5446644|NCT00000172|Alzheimer's disease|alzheimer's disease
5446645|NCT00000172|Cholinergic agents|cholinergic agents
5446646|NCT00000172|Cholinergic agonists|cholinergic agonists
5446647|NCT00000172|Cholinesterase inhibitors|cholinesterase inhibitors
5446648|NCT00000171|Alzheimer's disease|alzheimer's disease
5446649|NCT00000171|Sleep disorders|sleep disorders
5446650|NCT00000171|Melatonin|melatonin
5446651|NCT00000623|chelator|chelator
5446652|NCT00000623|iron|iron
5446653|NCT00000623|transfusion|transfusion
5446654|NCT00000623|anemia|anemia
5446655|NCT00000623|thalassemia|thalassemia
5446656|NCT00000620|Diabetes Mellitus, Non-Insulin-Dependent|diabetes mellitus, non-insulin-dependent
5446657|NCT00004500|cardiovascular and respiratory diseases|cardiovascular and respiratory diseases
5446658|NCT00004500|meconium aspiration syndrome|meconium aspiration syndrome
5446659|NCT00004500|rare disease|rare disease
5446660|NCT00004498|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
5446661|NCT00004498|inborn errors of metabolism|inborn errors of metabolism
5446662|NCT00004498|ornithine transcarbamylase deficiency|ornithine transcarbamylase deficiency
5446663|NCT00004498|rare disease|rare disease
5446664|NCT00004498|urea cycle disorder|urea cycle disorder
5446665|NCT00004497|cardiovascular and respiratory diseases|cardiovascular and respiratory diseases
5446666|NCT00004497|hypertensive disorder|hypertensive disorder
5446667|NCT00004497|primary pulmonary hypertension|primary pulmonary hypertension
5446668|NCT00004497|rare disease|rare disease
5446669|NCT00004496|acute renal failure|acute renal failure
5446670|NCT00004496|rare disease|rare disease
5446671|NCT00004496|renal and genitourinary disorders|renal and genitourinary disorders
5446672|NCT00004495|cardiovascular and respiratory diseases|cardiovascular and respiratory diseases
5446673|NCT00004495|end stage renal disease|end stage renal disease
5446674|NCT00004495|hyperhomocysteinemia|hyperhomocysteinemia
5446675|NCT00004495|rare disease|rare disease
5446676|NCT00004495|renal and genitourinary disorders|renal and genitourinary disorders
5446677|NCT00004494|cardiovascular and respiratory diseases|cardiovascular and respiratory diseases
5446678|NCT00004494|immunologic disorders and infectious disorders|immunologic disorders and infectious disorders
5446679|NCT00004494|neonatal disorders|neonatal disorders
5446680|NCT00004494|rare disease|rare disease
5446681|NCT00004494|respiratory distress syndrome|respiratory distress syndrome
5446682|NCT00004494|sepsis|sepsis
5446683|NCT00004493|inborn errors of metabolism|inborn errors of metabolism
5446684|NCT00004493|lactic acidosis|lactic acidosis
5446685|NCT00004493|rare disease|rare disease
5446686|NCT00004492|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
5446687|NCT00004492|hematologic disorders|hematologic disorders
5446688|NCT00004492|rare disease|rare disease
5446689|NCT00004492|sickle cell anemia|sickle cell anemia
5446690|NCT00004490|disease-related problem/condition|disease-related problem/condition
5446691|NCT00004490|inborn errors of metabolism|inborn errors of metabolism
5446692|NCT00004490|lactic acidosis|lactic acidosis
5446693|NCT00004490|quality of life|quality of life
5446694|NCT00004490|rare disease|rare disease
5446695|NCT00004489|cardiovascular and respiratory diseases|cardiovascular and respiratory diseases
5446696|NCT00004489|cystic fibrosis|cystic fibrosis
5446697|NCT00004489|disease-related problem/condition|disease-related problem/condition
5446698|NCT00004489|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
5446699|NCT00004489|osteoporosis|osteoporosis
5446700|NCT00004489|rare disease|rare disease
5446701|NCT00004488|Gaucher's disease|gaucher's disease
5446702|NCT00004488|inborn errors of metabolism|inborn errors of metabolism
5446703|NCT00004488|rare disease|rare disease
5446704|NCT00004488|sphingolipidoses|sphingolipidoses
5446705|NCT00004487|rare disease|rare disease
5446706|NCT00004487|renal and genitourinary disorders|renal and genitourinary disorders
5446707|NCT00004487|vesicoureteral reflux|vesicoureteral reflux
5446708|NCT00004486|autism|autism
5446709|NCT00004486|neurologic and psychiatric disorders|neurologic and psychiatric disorders
5446710|NCT00004486|rare disease|rare disease
5446711|NCT00004485|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
5446712|NCT00004485|hematologic disorders|hematologic disorders
5446713|NCT00004485|rare disease|rare disease
5446714|NCT00004485|sickle cell anemia|sickle cell anemia
5446715|NCT00004482|cardiovascular and respiratory diseases|cardiovascular and respiratory diseases
5446716|NCT00004482|giant cell myocarditis|giant cell myocarditis
5446717|NCT00004482|rare disease|rare disease
5446718|NCT00004481|endocrine disorders|endocrine disorders
5446719|NCT00004481|inborn errors of metabolism|inborn errors of metabolism
5446720|NCT00004481|rare disease|rare disease
5446721|NCT00004481|sitosterolemia|sitosterolemia
5446722|NCT00004480|dermatologic disorders|dermatologic disorders
5446723|NCT00004480|hyperhidrosis|hyperhidrosis
5446724|NCT00004480|rare disease|rare disease
5446725|NCT00004479|neurologic and psychiatric disorders|neurologic and psychiatric disorders
5446726|NCT00004479|rare disease|rare disease
5446727|NCT00004479|syncope|syncope
5446728|NCT00004478|Shy-Drager Syndrome|shy-drager syndrome
5446729|NCT00004478|cardiovascular and respiratory diseases|cardiovascular and respiratory diseases
5446730|NCT00004478|neurologic and psychiatric disorders|neurologic and psychiatric disorders
5446731|NCT00004478|orthostatic hypotension|orthostatic hypotension
5446732|NCT00004478|rare disease|rare disease
5446733|NCT00004474|Hematologic Disorders|hematologic disorders
5446734|NCT00004474|Rare Disease|rare disease
5446735|NCT00004471|cardiovascular and respiratory diseases|cardiovascular and respiratory diseases
5446736|NCT00004471|cystic fibrosis|cystic fibrosis
5446737|NCT00004471|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
5446738|NCT00004471|rare disease|rare disease
5446739|NCT00004468|dermatologic disorders|dermatologic disorders
5446740|NCT00004468|psoriasis|psoriasis
5446741|NCT00004468|rare disease|rare disease
5446742|NCT00004467|acute liver failure|acute liver failure
5446743|NCT00004467|gastrointestinal disorders|gastrointestinal disorders
5446744|NCT00004467|rare disease|rare disease
5446745|NCT00004466|cardiovascular and respiratory diseases|cardiovascular and respiratory diseases
5446746|NCT00004466|hyperlipidemia|hyperlipidemia
5446747|NCT00004466|nephrotic syndrome|nephrotic syndrome
5446748|NCT00004466|rare disease|rare disease
5446749|NCT00004466|renal and genitourinary disorders|renal and genitourinary disorders
5446750|NCT00004465|E. coli infection|e. coli infection
5446751|NCT00004465|bacterial infection|bacterial infection
5446752|NCT00004465|hemolytic uremic syndrome|hemolytic uremic syndrome
5446753|NCT00004465|immunologic disorders and infectious disorders|immunologic disorders and infectious disorders
5446754|NCT00004465|rare disease|rare disease
5446755|NCT00004465|renal and genitourinary disorders|renal and genitourinary disorders
5446756|NCT00004464|aplastic anemia|aplastic anemia
5446757|NCT00004464|hematologic disorders|hematologic disorders
5446758|NCT00004464|paroxysmal nocturnal hemoglobinuria|paroxysmal nocturnal hemoglobinuria
5446759|NCT00004464|rare disease|rare disease
5446760|NCT00004458|autism|autism
5446761|NCT00004458|childhood disintegrative disorder|childhood disintegrative disorder
5446762|NCT00004458|neurologic and psychiatric disorders|neurologic and psychiatric disorders
5446763|NCT00004458|rare disease|rare disease
5446764|NCT00004457|amyotrophic lateral sclerosis|amyotrophic lateral sclerosis
5446765|NCT00004457|motor neuron disease|motor neuron disease
5446766|NCT00004457|neurologic and psychiatric disorders|neurologic and psychiatric disorders
5446767|NCT00004457|rare disease|rare disease
5446768|NCT00004454|inborn errors of metabolism|inborn errors of metabolism
5446769|NCT00004454|mucopolysaccharidosis|mucopolysaccharidosis
5446770|NCT00004454|mucopolysaccharidosis II|mucopolysaccharidosis ii
5446771|NCT00004454|rare disease|rare disease
5446772|NCT00004451|Parkinson disease|parkinson disease
5446859|NCT00004422|rare disease|rare disease
5446773|NCT00004451|neurologic and psychiatric disorders|neurologic and psychiatric disorders
5446774|NCT00004451|rare disease|rare disease
5446775|NCT00004450|adrenoleukodystrophy|adrenoleukodystrophy
5446776|NCT00004450|inborn errors of metabolism|inborn errors of metabolism
5446777|NCT00004450|rare disease|rare disease
5446778|NCT00004450|sphingolipidoses|sphingolipidoses
5446779|NCT00004449|autism|autism
5446780|NCT00004449|neurologic and psychiatric disorders|neurologic and psychiatric disorders
5446781|NCT00004449|rare disease|rare disease
5446782|NCT00004448|IgA glomerulonephritis|iga glomerulonephritis
5446783|NCT00004448|rare disease|rare disease
5446784|NCT00004448|renal and genitourinary disorders|renal and genitourinary disorders
5446785|NCT00004446|depersonalization disorder|depersonalization disorder
5446786|NCT00004446|neurologic and psychiatric disorders|neurologic and psychiatric disorders
5446787|NCT00004446|rare disease|rare disease
5446788|NCT00004445|environmental/toxic disorders|environmental/toxic disorders
5446789|NCT00004445|neurologic and psychiatric disorders|neurologic and psychiatric disorders
5446790|NCT00004445|rare disease|rare disease
5446791|NCT00004445|spinal cord injury|spinal cord injury
5446792|NCT00004444|bacterial infection|bacterial infection
5446793|NCT00004444|immunologic disorders and infectious disorders|immunologic disorders and infectious disorders
5446794|NCT00004444|mycobacterium infection|mycobacterium infection
5446795|NCT00004444|mycobacterium tuberculosis infection|mycobacterium tuberculosis infection
5446796|NCT00004444|rare disease|rare disease
5446797|NCT00004443|inborn errors of metabolism|inborn errors of metabolism
5446798|NCT00004443|rare disease|rare disease
5446799|NCT00004443|tyrosinemia I|tyrosinemia i
5446800|NCT00004442|Zellweger syndrome|zellweger syndrome
5446801|NCT00004442|adrenoleukodystrophy|adrenoleukodystrophy
5446802|NCT00004442|bifunctional enzyme deficiency|bifunctional enzyme deficiency
5446803|NCT00004442|inborn errors of metabolism|inborn errors of metabolism
5446804|NCT00004442|infantile Refsum's disease|infantile refsum's disease
5446805|NCT00004442|peroxisomal disorders|peroxisomal disorders
5446806|NCT00004442|pseudo-Zellweger syndrome|pseudo-zellweger syndrome
5446807|NCT00004442|rare disease|rare disease
5446808|NCT00004442|sphingolipidoses|sphingolipidoses
5446809|NCT00004441|cardiovascular and respiratory diseases|cardiovascular and respiratory diseases
5446810|NCT00004441|cystic fibrosis|cystic fibrosis
5446811|NCT00004441|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
5446812|NCT00004441|rare disease|rare disease
5446813|NCT00004440|cardiovascular and respiratory diseases|cardiovascular and respiratory diseases
5446814|NCT00004440|cystic fibrosis|cystic fibrosis
5446815|NCT00004440|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
5446816|NCT00004440|rare disease|rare disease
5446817|NCT00004438|endocrine disorders|endocrine disorders
5446818|NCT00004438|hypogonadism|hypogonadism
5446819|NCT00004438|rare disease|rare disease
5446820|NCT00004437|acoustic neuroma|acoustic neuroma
5446821|NCT00004437|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
5446822|NCT00004437|hearing loss|hearing loss
5446823|NCT00004437|neurofibromatosis|neurofibromatosis
5446824|NCT00004437|neurologic and psychiatric disorders|neurologic and psychiatric disorders
5446825|NCT00004437|rare disease|rare disease
5446826|NCT00004436|cardiovascular and respiratory diseases|cardiovascular and respiratory diseases
5446827|NCT00004436|hemangioma|hemangioma
5446828|NCT00004436|rare disease|rare disease
5446829|NCT00004433|Tourette syndrome|tourette syndrome
5446830|NCT00004433|neurologic and psychiatric disorders|neurologic and psychiatric disorders
5446831|NCT00004433|rare disease|rare disease
5446832|NCT00004431|neurologic and psychiatric disorders|neurologic and psychiatric disorders
5446833|NCT00004431|rare disease|rare disease
5446834|NCT00004431|trigeminal neuralgia|trigeminal neuralgia
5446835|NCT00004430|cardiovascular and respiratory diseases|cardiovascular and respiratory diseases
5446836|NCT00004430|corneal neovascularization|corneal neovascularization
5446837|NCT00004430|rare disease|rare disease
5446838|NCT00004429|end stage renal disease|end stage renal disease
5446839|NCT00004429|rare disease|rare disease
5446840|NCT00004429|renal and genitourinary disorders|renal and genitourinary disorders
5446841|NCT00004428|cardiovascular and respiratory diseases|cardiovascular and respiratory diseases
5446842|NCT00004428|cystic fibrosis|cystic fibrosis
5446843|NCT00004428|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
5446844|NCT00004428|rare disease|rare disease
5446845|NCT00004426|endocrine disorders|endocrine disorders
5446846|NCT00004426|hypogonadism|hypogonadism
5446847|NCT00004426|rare disease|rare disease
5446848|NCT00004424|disease-related problem/condition|disease-related problem/condition
5446849|NCT00004424|oncologic disorders|oncologic disorders
5446850|NCT00004424|pulmonary complications|pulmonary complications
5446851|NCT00004424|rare disease|rare disease
5446852|NCT00004424|Respiration, Artificial|respiration, artificial
5446853|NCT00004423|Crohn's disease|crohn's disease
5446854|NCT00004423|gastrointestinal disorders|gastrointestinal disorders
5446855|NCT00004423|rare disease|rare disease
5446856|NCT00004422|bacterial infection|bacterial infection
5446857|NCT00004422|immunologic disorders and infectious disorders|immunologic disorders and infectious disorders
5446858|NCT00004422|pertussis|pertussis
5446860|NCT00004421|dystonia|dystonia
5446861|NCT00004421|neurologic and psychiatric disorders|neurologic and psychiatric disorders
5446862|NCT00004421|rare disease|rare disease
5446863|NCT00004420|arthritis & connective tissue diseases|arthritis & connective tissue diseases
5446864|NCT00004420|juvenile rheumatoid arthritis|juvenile rheumatoid arthritis
5446865|NCT00004420|rare disease|rare disease
5446866|NCT00004419|endocrine disorders|endocrine disorders
5446867|NCT00004419|insulin resistance|insulin resistance
5446868|NCT00004419|rare disease|rare disease
5446869|NCT00004418|adrenoleukodystrophy|adrenoleukodystrophy
5446870|NCT00004418|inborn errors of metabolism|inborn errors of metabolism
5446871|NCT00004418|rare disease|rare disease
5446872|NCT00004418|sphingolipidoses|sphingolipidoses
5446873|NCT00004416|achalasia|achalasia
5446874|NCT00004416|gastrointestinal disorders|gastrointestinal disorders
5446875|NCT00004416|rare disease|rare disease
5446876|NCT00004415|environmental/toxic disorders|environmental/toxic disorders
5446877|NCT00004415|neurologic and psychiatric disorders|neurologic and psychiatric disorders
5446878|NCT00004415|rare disease|rare disease
5446879|NCT00004415|spinal cord injury|spinal cord injury
5446880|NCT00004414|cholestasis|cholestasis
5446881|NCT00004414|gastrointestinal disorders|gastrointestinal disorders
5446882|NCT00004414|rare disease|rare disease
5446883|NCT00004412|dermatologic disorders|dermatologic disorders
5446884|NCT00004412|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
5446885|NCT00004412|hematologic disorders|hematologic disorders
5446886|NCT00004412|rare disease|rare disease
5446887|NCT00004412|sickle cell anemia|sickle cell anemia
5446888|NCT00004412|skin ulcers|skin ulcers
5446889|NCT00004412|thalassemia major|thalassemia major
5446890|NCT00004410|cholestasis|cholestasis
5446891|NCT00004410|gastrointestinal disorders|gastrointestinal disorders
5446892|NCT00004410|rare disease|rare disease
5446893|NCT00004409|Dupuytren's disease|dupuytren's disease
5446894|NCT00004409|arthritis & connective tissue diseases|arthritis & connective tissue diseases
5446895|NCT00004409|rare disease|rare disease
5446896|NCT00004408|disease-related problem/condition|disease-related problem/condition
5446897|NCT00004408|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
5446898|NCT00004408|hematologic disorders|hematologic disorders
5446899|NCT00004408|pain|pain
5446900|NCT00004408|rare disease|rare disease
5446901|NCT00004408|sickle cell anemia|sickle cell anemia
5446902|NCT00004407|diabetic amyotrophy|diabetic amyotrophy
5446903|NCT00004407|diabetic lumbosacral radiculoplexus neuropathy|diabetic lumbosacral radiculoplexus neuropathy
5446904|NCT00004407|diabetic neuropathy|diabetic neuropathy
5446905|NCT00004407|diabetic proximal neuropathy|diabetic proximal neuropathy
5446906|NCT00004407|neurologic and psychiatric disorders|neurologic and psychiatric disorders
5446907|NCT00004407|rare disease|rare disease
5446908|NCT00004406|disease-related problem/condition|disease-related problem/condition
5446909|NCT00004406|osteoporosis|osteoporosis
5446910|NCT00004406|rare disease|rare disease
5446911|NCT00004404|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
5446912|NCT00004404|hematologic disorders|hematologic disorders
5446913|NCT00004404|rare disease|rare disease
5446914|NCT00004404|sickle cell anemia|sickle cell anemia
5446915|NCT00004403|cysticercosis|cysticercosis
5446916|NCT00004403|epilepsy|epilepsy
5446917|NCT00004403|immunologic disorders and infectious disorders|immunologic disorders and infectious disorders
5446918|NCT00004403|neurologic and psychiatric disorders|neurologic and psychiatric disorders
5446919|NCT00004403|parasitic infection|parasitic infection
5446920|NCT00004403|rare disease|rare disease
5446921|NCT00004403|seizures|seizures
5446922|NCT00004402|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
5446923|NCT00004402|osteopetrosis|osteopetrosis
5446924|NCT00004402|rare disease|rare disease
5446925|NCT00004401|bacterial infection|bacterial infection
5446926|NCT00004401|clostridium infection|clostridium infection
5446927|NCT00004401|immunologic disorders and infectious disorders|immunologic disorders and infectious disorders
5446928|NCT00004401|infant botulism|infant botulism
5446929|NCT00004401|rare disease|rare disease
5446930|NCT00004400|cachexia|cachexia
5446931|NCT00004400|disease-related problem/condition|disease-related problem/condition
5446932|NCT00004400|human immunodeficiency virus infection|human immunodeficiency virus infection
5446933|NCT00004400|immunologic disorders and infectious disorders|immunologic disorders and infectious disorders
5446934|NCT00004400|nutrition|nutrition
5446935|NCT00004400|quality of life|quality of life
5446936|NCT00004400|rare disease|rare disease
5446937|NCT00004400|viral infection|viral infection
5446938|NCT00004399|cardiovascular and respiratory diseases|cardiovascular and respiratory diseases
5446939|NCT00004399|hypertensive disorder|hypertensive disorder
5446940|NCT00004399|pre-eclampsia|pre-eclampsia
5446941|NCT00004399|rare disease|rare disease
5446942|NCT00004398|inborn errors of metabolism|inborn errors of metabolism
5446943|NCT00004398|porphyria|porphyria
5446944|NCT00004398|rare disease|rare disease
5446945|NCT00004397|inborn errors of metabolism|inborn errors of metabolism
5446946|NCT00004397|porphyria|porphyria
5446947|NCT00004397|rare disease|rare disease
5446948|NCT00004396|inborn errors of metabolism|inborn errors of metabolism
5446949|NCT00004396|porphyria|porphyria
5446950|NCT00004396|rare disease|rare disease
5446951|NCT00004393|Tourette syndrome|tourette syndrome
5446952|NCT00004393|neurologic and psychiatric disorders|neurologic and psychiatric disorders
5446953|NCT00004393|rare disease|rare disease
5446954|NCT00004392|apnea|apnea
5446955|NCT00004392|cardiovascular and respiratory diseases|cardiovascular and respiratory diseases
5446956|NCT00004392|neurologic and psychiatric disorders|neurologic and psychiatric disorders
5446957|NCT00004392|rare disease|rare disease
5446958|NCT00004392|sudden infant death syndrome|sudden infant death syndrome
5446959|NCT00004390|disease-related problem/condition|disease-related problem/condition
5446960|NCT00004390|herpes zoster infection|herpes zoster infection
5446961|NCT00004390|herpesvirus infection|herpesvirus infection
5446962|NCT00004390|immunologic disorders and infectious disorders|immunologic disorders and infectious disorders
5446963|NCT00004390|pain|pain
5446964|NCT00004390|rare disease|rare disease
5446965|NCT00004390|viral infection|viral infection
5446966|NCT00004387|Parkinson disease|parkinson disease
5446967|NCT00004387|neurologic and psychiatric disorders|neurologic and psychiatric disorders
5446968|NCT00004387|rare disease|rare disease
5446969|NCT00004386|inborn errors of metabolism|inborn errors of metabolism
5446970|NCT00004386|rare disease|rare disease
5446971|NCT00004386|urea cycle disorder|urea cycle disorder
5446972|NCT00004382|hematologic disorders|hematologic disorders
5446973|NCT00004382|hyperbilirubinemia|hyperbilirubinemia
5446974|NCT00004382|rare disease|rare disease
5446975|NCT00004381|glucose-6-phosphate dehydrogenase deficiency|glucose-6-phosphate dehydrogenase deficiency
5446976|NCT00004381|hematologic disorders|hematologic disorders
5446977|NCT00004381|hemolytic disease|hemolytic disease
5446978|NCT00004381|hyperbilirubinemia|hyperbilirubinemia
5446979|NCT00004381|neonatal disorders|neonatal disorders
5446980|NCT00004381|rare disease|rare disease
5446981|NCT00004380|arthritis & connective tissue diseases|arthritis & connective tissue diseases
5446982|NCT00004380|rare disease|rare disease
5446983|NCT00004380|systemic sclerosis|systemic sclerosis
5446984|NCT00004378|Fanconi's anemia|fanconi's anemia
5446985|NCT00004378|amegakaryocytic thrombocytopenia|amegakaryocytic thrombocytopenia
5446986|NCT00004378|aplastic anemia|aplastic anemia
5446987|NCT00004378|congenital pure red cell aplasia|congenital pure red cell aplasia
5446988|NCT00004378|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
5446989|NCT00004378|hematologic disorders|hematologic disorders
5446990|NCT00004378|inborn errors of metabolism|inborn errors of metabolism
5446991|NCT00004378|metachromatic leukodystrophy|metachromatic leukodystrophy
5446992|NCT00004378|pure red cell aplasia|pure red cell aplasia
5446993|NCT00004378|rare disease|rare disease
5446994|NCT00004378|sphingolipidoses|sphingolipidoses
5446995|NCT00004378|thalassemia major|thalassemia major
5446996|NCT00004376|Tourette syndrome|tourette syndrome
5446997|NCT00004376|neurologic and psychiatric disorders|neurologic and psychiatric disorders
5446998|NCT00004376|rare disease|rare disease
5446999|NCT00004375|arthritis & connective tissue diseases|arthritis & connective tissue diseases
5447000|NCT00004375|immunologic disorders and infectious disorders|immunologic disorders and infectious disorders
5447001|NCT00004375|rare disease|rare disease
5447002|NCT00004375|systemic lupus erythematosus|systemic lupus erythematosus
5447003|NCT00004374|amyloidosis|amyloidosis
5447004|NCT00004374|arthritis & connective tissue diseases|arthritis & connective tissue diseases
5447005|NCT00004374|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
5447006|NCT00004374|rare disease|rare disease
5447007|NCT00004373|anxiety disorder|anxiety disorder
5447008|NCT00004373|disease-related problem/condition|disease-related problem/condition
5447009|NCT00004373|neurologic and psychiatric disorders|neurologic and psychiatric disorders
5447010|NCT00004373|panic disorder|panic disorder
5447011|NCT00004373|rare disease|rare disease
5447012|NCT00004368|hepatic cirrhosis|hepatic cirrhosis
5447013|NCT00004368|gastrointestinal disorders|gastrointestinal disorders
5447014|NCT00004368|rare disease|rare disease
5447015|NCT00004367|anxiety disorder|anxiety disorder
5447016|NCT00004367|disease-related problem/condition|disease-related problem/condition
5447017|NCT00004367|neurologic and psychiatric disorders|neurologic and psychiatric disorders
5447018|NCT00004367|panic disorder|panic disorder
5447019|NCT00004367|rare disease|rare disease
5447020|NCT00004366|agoraphobia|agoraphobia
5447021|NCT00004366|anxiety disorder|anxiety disorder
5447022|NCT00004366|disease-related problem/condition|disease-related problem/condition
5447023|NCT00004366|neurologic and psychiatric disorders|neurologic and psychiatric disorders
5447024|NCT00004366|panic disorder|panic disorder
5447025|NCT00004366|rare disease|rare disease
5447026|NCT00004366|vestibular diseases|vestibular diseases
5447027|NCT00004365|endocrine disorders|endocrine disorders
5447028|NCT00004365|growth hormone deficiency|growth hormone deficiency
5447029|NCT00004365|rare disease|rare disease
5447030|NCT00004364|diabetes insipidus|diabetes insipidus
5447031|NCT00004364|endocrine disorders|endocrine disorders
5447032|NCT00004364|rare disease|rare disease
5447033|NCT00004363|diabetes insipidus|diabetes insipidus
5447034|NCT00004363|endocrine disorders|endocrine disorders
5447035|NCT00004363|rare disease|rare disease
5447036|NCT00004361|DiGeorge syndrome|digeorge syndrome
5447037|NCT00004361|cardiovascular and respiratory diseases|cardiovascular and respiratory diseases
5447038|NCT00004361|conotruncal cardiac defects|conotruncal cardiac defects
5447039|NCT00004361|endocrine disorders|endocrine disorders
5447040|NCT00004361|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
5447041|NCT00004361|hypoparathyroidism|hypoparathyroidism
5447042|NCT00004361|pulmonary valve stenosis|pulmonary valve stenosis
5447043|NCT00004361|rare disease|rare disease
5447044|NCT00004361|tetralogy of Fallot|tetralogy of fallot
5447045|NCT00004360|diabetes insipidus|diabetes insipidus
5447046|NCT00004360|endocrine disorders|endocrine disorders
5447047|NCT00004360|rare disease|rare disease
5447048|NCT00004359|dermatologic disorders|dermatologic disorders
5447049|NCT00004359|epidermolysis bullosa|epidermolysis bullosa
5447050|NCT00004359|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
5447051|NCT00004359|rare disease|rare disease
5447052|NCT00004358|arthritis & connective tissue diseases|arthritis & connective tissue diseases
5447053|NCT00004358|rare disease|rare disease
5447054|NCT00004358|tumoral calcinosis|tumoral calcinosis
5447055|NCT00004357|Cardiovascular Disease|cardiovascular disease
5447056|NCT00004357|Respiratory Disease|respiratory disease
5447057|NCT00004357|Rare Diseases|rare diseases
5447058|NCT00004357|Vasculitis|vasculitis
5447059|NCT00004356|homocystinuria|homocystinuria
5447060|NCT00004356|inborn errors of metabolism|inborn errors of metabolism
5447061|NCT00004356|rare disease|rare disease
5447062|NCT00004354|endocrine disorders|endocrine disorders
5447063|NCT00004354|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
5447064|NCT00004354|hyperaldosteronism|hyperaldosteronism
5447065|NCT00004354|rare disease|rare disease
5447066|NCT00004353|MELAS syndrome|melas syndrome
5447067|NCT00004353|inborn errors of metabolism|inborn errors of metabolism
5447068|NCT00004353|lactic acidosis|lactic acidosis
5447069|NCT00004353|mitochondrial myopathy|mitochondrial myopathy
5447070|NCT00004353|rare disease|rare disease
5447071|NCT00004351|Angelman syndrome|angelman syndrome
5447072|NCT00004351|DiGeorge syndrome|digeorge syndrome
5447073|NCT00004351|Prader-Willi syndrome|prader-willi syndrome
5447074|NCT00004351|Shprintzen syndrome|shprintzen syndrome
5447075|NCT00004351|Smith-Magenis syndrome|smith-magenis syndrome
5447076|NCT00004351|Williams syndrome|williams syndrome
5447077|NCT00004351|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
5447078|NCT00004351|neurologic and psychiatric disorders|neurologic and psychiatric disorders
5447079|NCT00004351|rare disease|rare disease
5447080|NCT00004350|Fanconi syndrome|fanconi syndrome
5447081|NCT00004350|cystinosis|cystinosis
5447082|NCT00004350|rare disease|rare disease
5447083|NCT00004350|renal and genitourinary disorders|renal and genitourinary disorders
5447084|NCT00004348|beta-oxidation disorder|beta-oxidation disorder
5447085|NCT00004348|inborn errors of metabolism|inborn errors of metabolism
5447086|NCT00004348|rare disease|rare disease
5447087|NCT00004347|Smith-Lemli-Opitz syndrome|smith-lemli-opitz syndrome
5447088|NCT00004347|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
5447089|NCT00004347|rare disease|rare disease
5447090|NCT00004346|cerebrotendinous xanthomatosis|cerebrotendinous xanthomatosis
5447091|NCT00004346|inborn errors of metabolism|inborn errors of metabolism
5447092|NCT00004346|rare disease|rare disease
5447093|NCT00004345|Usher syndrome|usher syndrome
5447094|NCT00004345|ophthalmologic disorders|ophthalmologic disorders
5447095|NCT00004345|rare disease|rare disease
5447096|NCT00004345|retinitis pigmentosa|retinitis pigmentosa
5447097|NCT00004344|endocrine disorders|endocrine disorders
5447098|NCT00004344|precocious puberty|precocious puberty
5447099|NCT00004344|rare disease|rare disease
5447100|NCT00004343|Cushing's syndrome|cushing's syndrome
5447101|NCT00004343|endocrine disorders|endocrine disorders
5447102|NCT00004343|rare disease|rare disease
5447103|NCT00004342|chronic neutropenia|chronic neutropenia
5447104|NCT00004342|disease-related problem/condition|disease-related problem/condition
5447105|NCT00004342|hematologic disorders|hematologic disorders
5447106|NCT00004342|neutropenia|neutropenia
5447107|NCT00004342|rare disease|rare disease
5447108|NCT00004342|severe chronic neutropenia|severe chronic neutropenia
5447109|NCT00004341|Wiskott-Aldrich syndrome|wiskott-aldrich syndrome
5447110|NCT00004341|X-linked agammaglobulinemia|x-linked agammaglobulinemia
5447111|NCT00004341|X-linked hyper IgM syndrome|x-linked hyper igm syndrome
5447112|NCT00004341|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
5447113|NCT00004341|immunologic disorders and infectious disorders|immunologic disorders and infectious disorders
5447114|NCT00004341|leukocyte adhesion deficiency syndrome|leukocyte adhesion deficiency syndrome
5447115|NCT00004341|primary immunodeficiency disease|primary immunodeficiency disease
5447116|NCT00004341|rare disease|rare disease
5447117|NCT00004340|end stage renal disease|end stage renal disease
5447118|NCT00004340|rare disease|rare disease
5447119|NCT00004340|renal and genitourinary disorders|renal and genitourinary disorders
5447120|NCT00004340|renal osteodystrophy|renal osteodystrophy
5447121|NCT00004339|Wilson disease|wilson disease
5447122|NCT00004339|inborn errors of metabolism|inborn errors of metabolism
5447123|NCT00004339|rare disease|rare disease
5447124|NCT00004338|Wilson disease|wilson disease
5447395|NCT00000280|cocaine|cocaine
5447125|NCT00004338|inborn errors of metabolism|inborn errors of metabolism
5447126|NCT00004338|rare disease|rare disease
5447127|NCT00004336|Mondini dysplasia|mondini dysplasia
5447128|NCT00004336|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
5447129|NCT00004336|rare disease|rare disease
5447130|NCT00004335|endocrine disorders|endocrine disorders
5447131|NCT00004335|growth hormone deficiency|growth hormone deficiency
5447132|NCT00004335|hypogonadism|hypogonadism
5447133|NCT00004335|precocious puberty|precocious puberty
5447134|NCT00004335|rare disease|rare disease
5447135|NCT00004334|Cushing's syndrome|cushing's syndrome
5447136|NCT00004334|endocrine disorders|endocrine disorders
5447137|NCT00004334|rare disease|rare disease
5447138|NCT00004333|inborn errors of metabolism|inborn errors of metabolism
5447139|NCT00004333|rare disease|rare disease
5447140|NCT00004333|tyrosinemia I|tyrosinemia i
5447141|NCT00004332|acromegaly|acromegaly
5447142|NCT00004332|endocrine disorders|endocrine disorders
5447143|NCT00004332|rare disease|rare disease
5447144|NCT00004331|inborn errors of metabolism|inborn errors of metabolism
5447145|NCT00004331|porphyria|porphyria
5447146|NCT00004331|rare disease|rare disease
5447147|NCT00004330|inborn errors of metabolism|inborn errors of metabolism
5447148|NCT00004330|porphyria|porphyria
5447149|NCT00004330|rare disease|rare disease
5447150|NCT00004329|endocrine disorders|endocrine disorders
5447151|NCT00004329|rare disease|rare disease
5447152|NCT00004328|endocrine disorders|endocrine disorders
5447153|NCT00004328|pseudohypoaldosteronism|pseudohypoaldosteronism
5447154|NCT00004328|rare disease|rare disease
5447155|NCT00004327|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
5447156|NCT00004327|hematologic disorders|hematologic disorders
5447157|NCT00004327|hereditary hemorrhagic telangiectasia|hereditary hemorrhagic telangiectasia
5447158|NCT00004327|rare disease|rare disease
5447159|NCT00004327|senile ectasia|senile ectasia
5447160|NCT00004326|Cushing's syndrome|cushing's syndrome
5447161|NCT00004326|endocrine disorders|endocrine disorders
5447162|NCT00004326|rare disease|rare disease
5447163|NCT00004325|Tourette syndrome|tourette syndrome
5447164|NCT00004325|anxiety disorder|anxiety disorder
5447165|NCT00004325|disease-related problem/condition|disease-related problem/condition
5447166|NCT00004325|neurologic and psychiatric disorders|neurologic and psychiatric disorders
5447167|NCT00004325|obsessive compulsive disorder|obsessive compulsive disorder
5447168|NCT00004325|oncologic disorders|oncologic disorders
5447169|NCT00004325|rare disease|rare disease
5447170|NCT00004324|Tourette syndrome|tourette syndrome
5447171|NCT00004324|anxiety disorder|anxiety disorder
5447172|NCT00004324|disease-related problem/condition|disease-related problem/condition
5447173|NCT00004324|neurologic and psychiatric disorders|neurologic and psychiatric disorders
5447174|NCT00004324|obsessive compulsive disorder|obsessive compulsive disorder
5447175|NCT00004324|oncologic disorders|oncologic disorders
5447176|NCT00004324|rare disease|rare disease
5447177|NCT00004323|aplastic anemia|aplastic anemia
5447178|NCT00004323|hematologic disorders|hematologic disorders
5447179|NCT00004323|rare disease|rare disease
5447180|NCT00004317|immunologic disorders and infectious disorders|immunologic disorders and infectious disorders
5447181|NCT00004317|rare disease|rare disease
5447182|NCT00004317|toxoplasmosis|toxoplasmosis
5447183|NCT00004316|interstitial cystitis|interstitial cystitis
5447184|NCT00004316|rare disease|rare disease
5447185|NCT00004316|renal and genitourinary disorders|renal and genitourinary disorders
5447186|NCT00004316|vulvar vestibulitis|vulvar vestibulitis
5447187|NCT00004315|cardiovascular and respiratory diseases|cardiovascular and respiratory diseases
5447188|NCT00004315|cholestasis|cholestasis
5447189|NCT00004315|cystic fibrosis|cystic fibrosis
5447190|NCT00004315|gastrointestinal disorders|gastrointestinal disorders
5447191|NCT00004315|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
5447192|NCT00004315|rare disease|rare disease
5447193|NCT00004314|Lesch-Nyhan syndrome|lesch-nyhan syndrome
5447194|NCT00004314|inborn errors of metabolism|inborn errors of metabolism
5447195|NCT00004314|neurologic and psychiatric disorders|neurologic and psychiatric disorders
5447196|NCT00004314|rare disease|rare disease
5447197|NCT00004313|Addison's disease|addison's disease
5447198|NCT00004313|endocrine disorders|endocrine disorders
5447199|NCT00004313|rare disease|rare disease
5447200|NCT00004313|primary adrenal insufficiency|primary adrenal insufficiency
5447201|NCT00004312|cystinosis|cystinosis
5447202|NCT00004312|rare disease|rare disease
5447203|NCT00004312|renal and genitourinary disorders|renal and genitourinary disorders
5447204|NCT00004311|acanthosis nigricans|acanthosis nigricans
5447205|NCT00004311|dermatologic disorders|dermatologic disorders
5447206|NCT00004311|endocrine disorders|endocrine disorders
5447207|NCT00004311|polycystic ovarian syndrome|polycystic ovarian syndrome
5447208|NCT00004311|rare disease|rare disease
5447209|NCT00004310|anxiety disorder|anxiety disorder
5447210|NCT00004310|disease-related problem/condition|disease-related problem/condition
5447211|NCT00004310|neurologic and psychiatric disorders|neurologic and psychiatric disorders
5447212|NCT00004310|obsessive compulsive disorder|obsessive compulsive disorder
5447213|NCT00004310|oncologic disorders|oncologic disorders
5447214|NCT00004310|rare disease|rare disease
5447215|NCT00004307|inborn errors of metabolism|inborn errors of metabolism
5447216|NCT00004307|rare disease|rare disease
5447217|NCT00004307|urea cycle disorder|urea cycle disorder
5447218|NCT00004306|hereditary ataxia|hereditary ataxia
5447219|NCT00004306|neurologic and psychiatric disorders|neurologic and psychiatric disorders
5447220|NCT00004306|rare disease|rare disease
5447221|NCT00004305|IgA glomerulonephritis|iga glomerulonephritis
5447222|NCT00004305|rare disease|rare disease
5447223|NCT00004305|renal and genitourinary disorders|renal and genitourinary disorders
5447224|NCT00004300|mental retardation|mental retardation
5447225|NCT00004300|neurologic and psychiatric disorders|neurologic and psychiatric disorders
5447226|NCT00004300|rare disease|rare disease
5447227|NCT00004300|stereotyped behavior|stereotyped behavior
5447228|NCT00004297|epilepsy|epilepsy
5447229|NCT00004297|neurologic and psychiatric disorders|neurologic and psychiatric disorders
5447230|NCT00004297|rare disease|rare disease
5447231|NCT00004297|seizures|seizures
5447232|NCT00004297|status epilepticus|status epilepticus
5447233|NCT00004296|atypical mycobacterium infection|atypical mycobacterium infection
5447234|NCT00004296|bacterial infection|bacterial infection
5447235|NCT00004296|cardiovascular and respiratory diseases|cardiovascular and respiratory diseases
5447236|NCT00004296|cystic fibrosis|cystic fibrosis
5447237|NCT00004296|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
5447238|NCT00004296|immunologic disorders and infectious disorders|immunologic disorders and infectious disorders
5447239|NCT00004296|mycobacterium infection|mycobacterium infection
5447240|NCT00004296|rare disease|rare disease
5447241|NCT00004294|Gaucher's disease|gaucher's disease
5447242|NCT00004294|inborn errors of metabolism|inborn errors of metabolism
5447243|NCT00004294|rare disease|rare disease
5447244|NCT00004294|sphingolipidoses|sphingolipidoses
5447245|NCT00004293|Gaucher's disease|gaucher's disease
5447246|NCT00004293|inborn errors of metabolism|inborn errors of metabolism
5447247|NCT00004293|rare disease|rare disease
5447248|NCT00004293|sphingolipidoses|sphingolipidoses
5447249|NCT00004288|ankylosing spondylitis|ankylosing spondylitis
5447250|NCT00004288|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
5447251|NCT00004288|rare disease|rare disease
5447252|NCT00004287|cardiovascular and respiratory diseases|cardiovascular and respiratory diseases
5447253|NCT00004287|cystic fibrosis|cystic fibrosis
5447254|NCT00004287|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
5447255|NCT00004287|rare disease|rare disease
5447256|NCT00004286|demyelinating neuropathy|demyelinating neuropathy
5447257|NCT00004286|neurologic and psychiatric disorders|neurologic and psychiatric disorders
5447258|NCT00004286|rare disease|rare disease
5447259|NCT00004285|end stage renal disease|end stage renal disease
5447260|NCT00004285|rare disease|rare disease
5447261|NCT00004285|renal and genitourinary disorders|renal and genitourinary disorders
5447262|NCT00004284|hypercalciuria|hypercalciuria
5447263|NCT00004284|nephrolithiasis|nephrolithiasis
5447264|NCT00004284|rare disease|rare disease
5447265|NCT00004284|renal and genitourinary disorders|renal and genitourinary disorders
5447266|NCT00004278|congenital cytomegalovirus infection|congenital cytomegalovirus infection
5447267|NCT00004278|cytomegalovirus infection|cytomegalovirus infection
5447268|NCT00004278|herpesvirus infection|herpesvirus infection
5447269|NCT00004278|immunologic disorders and infectious disorders|immunologic disorders and infectious disorders
5447270|NCT00004278|neonatal disorders|neonatal disorders
5447271|NCT00004278|rare disease|rare disease
5447272|NCT00004278|viral infection|viral infection
5447273|NCT00004276|bacterial infection|bacterial infection
5447274|NCT00004276|human immunodeficiency virus infection|human immunodeficiency virus infection
5447275|NCT00004276|immunologic disorders and infectious disorders|immunologic disorders and infectious disorders
5447276|NCT00004276|mycobacterium infection|mycobacterium infection
5447277|NCT00004276|mycobacterium tuberculosis infection|mycobacterium tuberculosis infection
5447278|NCT00004276|rare disease|rare disease
5447279|NCT00004276|viral infection|viral infection
5447280|NCT00004275|Turner's syndrome|turner's syndrome
5447281|NCT00004275|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
5447282|NCT00004275|rare disease|rare disease
5447283|NCT00004274|Turner's syndrome|turner's syndrome
5447284|NCT00004274|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
5447285|NCT00004274|rare disease|rare disease
5447286|NCT00004268|cardiovascular and respiratory diseases|cardiovascular and respiratory diseases
5447287|NCT00004268|disease-related problem/condition|disease-related problem/condition
5447288|NCT00004268|orthostatic hypotension|orthostatic hypotension
5447289|NCT00004268|quality of life|quality of life
5447290|NCT00004268|rare disease|rare disease
5447291|NCT00004266|diabetic nephropathy|diabetic nephropathy
5447292|NCT00004266|rare disease|rare disease
5447293|NCT00004266|renal and genitourinary disorders|renal and genitourinary disorders
5447294|NCT00000170|Amblyopia|amblyopia
5447295|NCT00000170|patching|patching
5447296|NCT00000170|atropine|atropine
5447297|NCT00000167|Age-Related Macular Degeneration|age-related macular degeneration
5447298|NCT00000163|Congenital Esotropia|congenital esotropia
5447299|NCT00000161|Age-Related Macular Degeneration|age-related macular degeneration
5447300|NCT00000160|Vision Loss|vision loss
5447301|NCT00000158|photocoagulation|photocoagulation
5447302|NCT00000158|argon blue-green laser|argon blue-green laser
5447303|NCT00000158|krypton red laser|krypton red laser
5447304|NCT00000153|Diabetic Disc Neovascularization|diabetic disc neovascularization
5447305|NCT00000153|Optic Disk|optic disk
5447306|NCT00000152|Age-Related Macular Degeneration|age-related macular degeneration
5447307|NCT00000150|Ocular Histoplasmosis Syndrome|ocular histoplasmosis syndrome
5447308|NCT00000150|Idiopathic Choroidal Neovascularization|idiopathic choroidal neovascularization
5447309|NCT00000145|Age-Related Macular Degeneration|age-related macular degeneration
5447310|NCT00000139|Herpes Simplex Stromal Keratitis|herpes simplex stromal keratitis
5447311|NCT00000138|Herpes Simplex Stromal Keratitis|herpes simplex stromal keratitis
5447312|NCT00000131|Central Vein Occlusion|central vein occlusion
5447313|NCT00000131|Ischemic Retina|ischemic retina
5447314|NCT00000130|Bacterial Endophthalmitis|bacterial endophthalmitis
5447315|NCT00000128|Near-point Esophoria|near-point esophoria
5447316|NCT00000127|Non-arteritic Ischemic Optic Neuropathy|non-arteritic ischemic optic neuropathy
5447317|NCT00000126|Non-arteritic Ischemic Optic Neuropathy|non-arteritic ischemic optic neuropathy
5447318|NCT00000124|Choroidal Melanoma|choroidal melanoma
5447319|NCT00000124|Ocular Melanoma|ocular melanoma
5447320|NCT00000121|strabismus|strabismus
5447321|NCT00000120|Neonatal Conjunctivitis|neonatal conjunctivitis
5447322|NCT00000114|retinitis pigmentosa|retinitis pigmentosa
5447323|NCT00000114|vitamin supplements|vitamin supplements
5447324|NCT00000113|myopia|myopia
5447325|NCT00000113|nearsightedness|nearsightedness
5447326|NCT00000357|opiate dependence|opiate dependence
5447327|NCT00000356|opiate dependence|opiate dependence
5447328|NCT00000355|opiate dependence|opiate dependence
5447329|NCT00000354|opiate dependence|opiate dependence
5447330|NCT00000353|opiate dependence|opiate dependence
5447331|NCT00000352|opiate dependence|opiate dependence
5447332|NCT00000350|amphetamine dependence|amphetamine dependence
5447333|NCT00000349|cocaine dependence|cocaine dependence
5447334|NCT00000348|cocaine dependence|cocaine dependence
5447335|NCT00000347|cocaine dependence|cocaine dependence
5447336|NCT00000346|amphetamine dependence|amphetamine dependence
5447337|NCT00000345|opioid dependence|opioid dependence
5447338|NCT00000344|opioid dependence|opioid dependence
5447339|NCT00000343|stimulant dependence|stimulant dependence
5447340|NCT00000342|cocaine dependence|cocaine dependence
5447341|NCT00000341|opioid dependence|opioid dependence
5447342|NCT00000340|cocaine dependence|cocaine dependence
5447343|NCT00000339|cocaine dependence|cocaine dependence
5447344|NCT00000338|cocaine dependence|cocaine dependence
5447345|NCT00000337|cocaine dependence|cocaine dependence
5447346|NCT00000336|cocaine dependence|cocaine dependence
5447347|NCT00000335|opioid dependence|opioid dependence
5447348|NCT00000331|Heroin Dependence|heroin dependence
5447349|NCT00000330|Heroin Dependence|heroin dependence
5447350|NCT00000329|drug dependence|drug dependence
5447351|NCT00000328|drug dependence|drug dependence
5447352|NCT00000327|drug dependence|drug dependence
5447353|NCT00000326|Heroin Dependence|heroin dependence
5447354|NCT00000325|cocaine dependence|cocaine dependence
5447355|NCT00000323|cocaine dependence|cocaine dependence
5447356|NCT00000322|amphetamine dependence|amphetamine dependence
5447357|NCT00000321|methamphetamine dependence|methamphetamine dependence
5447358|NCT00000320|opioid dependence|opioid dependence
5447359|NCT00000318|opioid dependence|opioid dependence
5447360|NCT00000317|Cocaine|cocaine
5447361|NCT00000317|METHADONE PATIENTS|methadone patients
5447362|NCT00000317|RISPERIDONE|risperidone
5447363|NCT00000316|cocaine dependence|cocaine dependence
5447364|NCT00000315|cocaine dependence|cocaine dependence
5447365|NCT00000314|cocaine dependence|cocaine dependence
5447366|NCT00000313|cocaine dependence|cocaine dependence
5447367|NCT00000311|Cocaine-Related Disorders|cocaine-related disorders
5447368|NCT00000311|Opioid-Related Disorders|opioid-related disorders
5447369|NCT00000311|Substance-Related Disorders|substance-related disorders
5447370|NCT00000310|cocaine dependence|cocaine dependence
5447371|NCT00000309|cocaine abuse, cocaine addiction|cocaine abuse, cocaine addiction
5447372|NCT00000308|cocaine dependence|cocaine dependence
5447373|NCT00000307|alcohol dependence|alcohol dependence
5447374|NCT00000306|cocaine dependence|cocaine dependence
5447375|NCT00000304|cocaine dependence|cocaine dependence
5447376|NCT00000303|Cocaine dependence|cocaine dependence
5447377|NCT00000301|Amantadine|amantadine
5447378|NCT00000301|Cocaine|cocaine
5447379|NCT00000301|Pharmacotherapy|pharmacotherapy
5447380|NCT00000301|Outpatient|outpatient
5447381|NCT00000300|opiate|opiate
5447382|NCT00000300|dependence|dependence
5447383|NCT00000299|Opioid-Related Disorders|opioid-related disorders
5447384|NCT00000296|nicotine dependence|nicotine dependence
5447385|NCT00000293|cocaine dependence|cocaine dependence
5447386|NCT00000291|cocaine dependence|cocaine dependence
5447387|NCT00000290|cocaine dependence|cocaine dependence
5447388|NCT00000288|nicotine dependence|nicotine dependence
5447389|NCT00000287|Cocaine-Related Disorders|cocaine-related disorders
5447390|NCT00000286|cocaine dependence|cocaine dependence
5447391|NCT00000285|cocaine dependence|cocaine dependence
5447392|NCT00000284|nicotine dependence|nicotine dependence
5447393|NCT00000282|pemoline|pemoline
5447394|NCT00000281|anti psychotic agents|anti psychotic agents
5447396|NCT00000275|cocaine dependence|cocaine dependence
5447397|NCT00000274|cocaine dependence|cocaine dependence
5447398|NCT00000273|heroin, opioid disorders, substance related disorders|heroin, opioid disorders, substance related disorders
5447399|NCT00000271|Desipramine, cocaine, depression|desipramine, cocaine, depression
5447400|NCT00000270|cocaine|cocaine
5447401|NCT00000269|cocaine dependence|cocaine dependence
5447402|NCT00000268|cocaine dependence|cocaine dependence
5447403|NCT00000267|cocaine dependence|cocaine dependence
5447404|NCT00000266|cocaine dependence|cocaine dependence
5447405|NCT00000265|nitrous oxide|nitrous oxide
5447406|NCT00000265|anxiety|anxiety
5447407|NCT00000265|subjective effects|subjective effects
5447408|NCT00000265|dental|dental
5447409|NCT00000265|patients|patients
5447410|NCT00000264|nitrous oxide|nitrous oxide
5447411|NCT00000264|inhalant|inhalant
5447412|NCT00000264|ethanol|ethanol
5447413|NCT00000264|subjective effects|subjective effects
5447414|NCT00000264|psychomotor effects|psychomotor effects
5447415|NCT00000264|healthy volunteer|healthy volunteer
5447416|NCT00000263|nitrous oxide|nitrous oxide
5447417|NCT00000263|ethanol|ethanol
5447418|NCT00000263|drug interaction|drug interaction
5447419|NCT00000263|subjective effects|subjective effects
5447420|NCT00000263|healthy volunteer|healthy volunteer
5447421|NCT00000262|nitrous oxide|nitrous oxide
5447422|NCT00000262|sevoflurane|sevoflurane
5447423|NCT00000262|drug interaction|drug interaction
5447424|NCT00000262|subjective effects|subjective effects
5447425|NCT00000262|analgesia|analgesia
5447426|NCT00000262|healthy volunteers|healthy volunteers
5447427|NCT00000261|nitrous oxide|nitrous oxide
5447428|NCT00000261|sevoflurane|sevoflurane
5447429|NCT00000261|ethanol|ethanol
5447430|NCT00000261|subjective effects|subjective effects
5447431|NCT00000261|healthy volunteer|healthy volunteer
5447432|NCT00000260|nitrous oxide|nitrous oxide
5447433|NCT00000260|subjective effects|subjective effects
5447434|NCT00000260|reinforcer|reinforcer
5447435|NCT00000260|inhalant|inhalant
5447436|NCT00000260|healthy volunteer|healthy volunteer
5447437|NCT00000259|sevoflurane|sevoflurane
5447438|NCT00000259|nitrous oxide|nitrous oxide
5447439|NCT00000259|subjective effects|subjective effects
5447440|NCT00000259|healthy volunteer|healthy volunteer
5447441|NCT00000258|nitrous oxide|nitrous oxide
5447442|NCT00000258|instruction|instruction
5447443|NCT00000258|subjective effects|subjective effects
5447444|NCT00000258|reinforcer|reinforcer
5447445|NCT00000258|healthy volunteer|healthy volunteer
5447446|NCT00000257|nitrous oxide|nitrous oxide
5447447|NCT00000257|subjective effects|subjective effects
5447448|NCT00000257|ethanol|ethanol
5447449|NCT00000257|healthy volunteer|healthy volunteer
5447450|NCT00000256|nitrous oxide|nitrous oxide
5447451|NCT00000256|reinforcer|reinforcer
5447452|NCT00000256|subjective effects|subjective effects
5447453|NCT00000256|healthy volunteer|healthy volunteer
5447454|NCT00000255|nitrous oxide|nitrous oxide
5447455|NCT00000255|acute tolerance|acute tolerance
5447456|NCT00000255|subjective effects|subjective effects
5447457|NCT00000255|analgesia|analgesia
5447458|NCT00000255|psychomotor|psychomotor
5447459|NCT00000255|healthy volunteer|healthy volunteer
5447460|NCT00000254|isoflurane|isoflurane
5447461|NCT00000254|general anesthetic|general anesthetic
5447462|NCT00000254|inhalant|inhalant
5447463|NCT00000254|subjective effects|subjective effects
5447464|NCT00000254|healthy volunteer|healthy volunteer
5447465|NCT00000253|nitrous oxide|nitrous oxide
5447466|NCT00000253|inhalant|inhalant
5447467|NCT00000253|subjective effects|subjective effects
5447468|NCT00000253|healthy volunteer|healthy volunteer
5447469|NCT00000252|nitrous oxide|nitrous oxide
5447470|NCT00000252|acute tolerance|acute tolerance
5447471|NCT00000252|subjective effects|subjective effects
5447472|NCT00000252|psychomotor|psychomotor
5447473|NCT00000252|analgesia|analgesia
5447474|NCT00000252|healthy volunteer|healthy volunteer
5447475|NCT00000251|nitrous oxide|nitrous oxide
5447476|NCT00000251|isoflurane|isoflurane
5447477|NCT00000251|subjective effects|subjective effects
5447478|NCT00000251|psychomotor|psychomotor
5447479|NCT00000251|healthy volunteer|healthy volunteer
5447480|NCT00000251|drug interaction|drug interaction
5447481|NCT00000250|nitrous oxide|nitrous oxide
5447482|NCT00000250|choice|choice
5447483|NCT00000250|subjective effects|subjective effects
5447484|NCT00000250|pain|pain
5447485|NCT00000250|analgesia|analgesia
5447486|NCT00000250|reinforcer|reinforcer
5447487|NCT00000250|healthy volunteer|healthy volunteer
5447488|NCT00000249|nitrous oxide|nitrous oxide
5447489|NCT00000249|subjective effects|subjective effects
5447490|NCT00000249|healthy volunteer|healthy volunteer
5447491|NCT00000246|Substance-Related Disorders|substance-related disorders
5447492|NCT00000245|cocaine dependence|cocaine dependence
5447493|NCT00000244|addiction|addiction
5447494|NCT00000244|opiate|opiate
5447495|NCT00000244|heroin|heroin
5447496|NCT00000244|dynorphin|dynorphin
5447497|NCT00000243|opioid dependence|opioid dependence
5447498|NCT00000242|Cocaine|cocaine
5447499|NCT00000242|Substance Abuse|substance abuse
5447500|NCT00000241|methamphetamine dependence|methamphetamine dependence
5447501|NCT00000218|cocaine dependence|cocaine dependence
5447502|NCT00000217|drug abuse|drug abuse
5447503|NCT00000215|cocaine dependence|cocaine dependence
5447504|NCT00000214|intravenous abuse|intravenous abuse
5447505|NCT00000213|intravenous abuse|intravenous abuse
5447506|NCT00000212|crack cocaine|crack cocaine
5447507|NCT00000210|opioid addiction|opioid addiction
5447508|NCT00000210|cocaine addiction|cocaine addiction
5447509|NCT00000207|Buprenorphine|buprenorphine
5447510|NCT00000207|Opioid|opioid
5447511|NCT00000206|Opioid|opioid
5447512|NCT00000201|cocaine dependence|cocaine dependence
5447513|NCT00000200|self-administration|self-administration
5447514|NCT00000199|cocaine|cocaine
5447515|NCT00000198|cocaine|cocaine
5447516|NCT00000197|cocaine|cocaine
5447517|NCT00000195|opioid disorders|opioid disorders
5447518|NCT00000194|opioid disorders|opioid disorders
5447519|NCT00000193|Opioid disorders|opioid disorders
5447520|NCT00000192|opioid disorders|opioid disorders
5447521|NCT00000191|Cocaine Dependence|cocaine dependence
5447522|NCT00000191|Carbamazepine|carbamazepine
5447523|NCT00000190|Cocaine Detection|cocaine detection
5447524|NCT00000190|Parotid Saliva|parotid saliva
5447525|NCT00000189|Cocaine Dependence|cocaine dependence
5447526|NCT00000189|Gepirone|gepirone
5447527|NCT00000188|Cocaine Dependence|cocaine dependence
5447528|NCT00000188|Selegiline|selegiline
5447529|NCT00000187|Cocaine Dependence|cocaine dependence
5447530|NCT00000187|ritanserin|ritanserin
5447531|NCT00004640|Aging|aging
5447532|NCT00004640|Elderly|elderly
5447533|NCT00004640|Periodontal Disease|periodontal disease
5447534|NCT00004640|Dental Caries|dental caries
5447535|NCT00004640|Fluoride|fluoride
5447536|NCT00004640|Antibacterial rinse|antibacterial rinse
5447537|NCT00004640|Chlorhexidine|chlorhexidine
5447538|NCT00004640|Tooth Mortality|tooth mortality
5447539|NCT00004639|cleft lip and palate|cleft lip and palate
5447540|NCT00004639|children|children
5447541|NCT00004639|speech|speech
5447542|NCT00004639|velopharyngeal function|velopharyngeal function
5447543|NCT00004639|congenital facial malformation|congenital facial malformation
5447544|NCT00004639|von Langenbeck procedure|von langenbeck procedure
5447545|NCT00004639|Furlow procedure|furlow procedure
5447546|NCT00004639|cleft lip and palate repair|cleft lip and palate repair
5447547|NCT00004639|Unilateral cleft lip and palate|unilateral cleft lip and palate
